id|nct_id|mesh_term|downcase_mesh_term|mesh_type
93112038|NCT04481048|Antidotes|antidotes|mesh-ancestor
93112641|NCT02759185|Dronabinol|dronabinol|mesh-list
93113174|NCT03898752|Vitamins|vitamins|mesh-ancestor
93113763|NCT03880968|Analgesics|analgesics|mesh-ancestor
93114357|NCT03874806|Ropivacaine|ropivacaine|mesh-list
93115035|NCT05321121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93115109|NCT04955938|Ivosidenib|ivosidenib|mesh-list
93115631|NCT02659293|Growth Substances|growth substances|mesh-ancestor
93116386|NCT01172964|Antifungal Agents|antifungal agents|mesh-ancestor
93116688|NCT02525172|Rituximab|rituximab|mesh-list
93116758|NCT05597800|Nivolumab|nivolumab|mesh-list
93116928|NCT05548426|Linezolid|linezolid|mesh-list
93117355|NCT01290276|Serotonin Agents|serotonin agents|mesh-ancestor
93117813|NCT01097746|Antibodies|antibodies|mesh-list
93118268|NCT05184816|Deferoxamine|deferoxamine|mesh-list
93118713|NCT01204476|Everolimus|everolimus|mesh-list
93118861|NCT01206972|Anticoagulants|anticoagulants|mesh-ancestor
93119164|NCT01560390|Anesthetics|anesthetics|mesh-ancestor
93119691|NCT03792984|Antacids|antacids|mesh-ancestor
93120136|NCT05688384|Anesthetics|anesthetics|mesh-ancestor
93120440|NCT03780270|Fluorides, Topical|fluorides, topical|mesh-list
93120441|NCT03780270|Cariostatic Agents|cariostatic agents|mesh-ancestor
93120442|NCT03780270|Protective Agents|protective agents|mesh-ancestor
93121050|NCT00112840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93121121|NCT05219656|Cyclosporine|cyclosporine|mesh-list
93121285|NCT04678492|Bismuth|bismuth|mesh-list
93121422|NCT05691556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121511|NCT03751202|Hormones|hormones|mesh-ancestor
93121575|NCT05359224|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93121959|NCT01562210|Olaparib|olaparib|mesh-list
93122426|NCT05180032|Denosumab|denosumab|mesh-list
93122632|NCT04136548|Analgesics|analgesics|mesh-ancestor
93122783|NCT04346628|Favipiravir|favipiravir|mesh-list
93122934|NCT05081206|Anesthetics|anesthetics|mesh-ancestor
93123682|NCT05501860|Carticaine|carticaine|mesh-list
93123755|NCT03050398|Hormone Antagonists|hormone antagonists|mesh-ancestor
93123907|NCT03629054|Metformin|metformin|mesh-list
93124430|NCT03619408|Antacids|antacids|mesh-list
93124579|NCT03608774|Antimalarials|antimalarials|mesh-ancestor
93120443|NCT03780270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125339|NCT00086385|Dopamine Agents|dopamine agents|mesh-ancestor
93120444|NCT03072160|Pembrolizumab|pembrolizumab|mesh-list
93126162|NCT03716804|Ciprofloxacin|ciprofloxacin|mesh-list
93126372|NCT00054717|Ritonavir|ritonavir|mesh-list
93126520|NCT04070157|Lofexidine|lofexidine|mesh-list
93126602|NCT01094769|Moxonidine|moxonidine|mesh-list
93127054|NCT03502070|Tobramycin|tobramycin|mesh-list
93127650|NCT03910738|Hormones|hormones|mesh-ancestor
93127801|NCT00064701|Cyclosporine|cyclosporine|mesh-list
93127953|NCT03669562|Vasodilator Agents|vasodilator agents|mesh-ancestor
93128031|NCT01979536|Antiviral Agents|antiviral agents|mesh-ancestor
93128182|NCT00031551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128566|NCT03541044|Nicotine|nicotine|mesh-list
93128851|NCT02998996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93129374|NCT03713216|Morphine|morphine|mesh-list
93129522|NCT00004635|Fertility Agents|fertility agents|mesh-ancestor
93129752|NCT01063036|Tenofovir|tenofovir|mesh-list
93130200|NCT03947229|Clopidogrel|clopidogrel|mesh-list
93130278|NCT01328301|Methamphetamine|methamphetamine|mesh-list
93120445|NCT03072160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130953|NCT01120119|Vitamins|vitamins|mesh-ancestor
93131113|NCT01219569|Propofol|propofol|mesh-list
93131188|NCT01123551|Morphine|morphine|mesh-list
93131401|NCT05284942|Glucocorticoids|glucocorticoids|mesh-ancestor
93131548|NCT01221831|Dienogest|dienogest|mesh-list
93131710|NCT03646318|Ketanserin|ketanserin|mesh-list
93131777|NCT01585623|Anesthetics|anesthetics|mesh-ancestor
93131924|NCT02969356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93132004|NCT03925779|Anesthetics|anesthetics|mesh-ancestor
93132382|NCT03919383|Lenvatinib|lenvatinib|mesh-list
93132823|NCT01138137|Acetylcysteine|acetylcysteine|mesh-list
93132976|NCT01234857|Sirolimus|sirolimus|mesh-list
93133122|NCT03618472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93133271|NCT02868892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120446|NCT03072160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133567|NCT01982955|Carboplatin|carboplatin|mesh-list
93133923|NCT03382262|FX006|fx006|mesh-list
93133944|NCT02259790|Amlodipine|amlodipine|mesh-list
93134095|NCT04125550|Anesthetics, General|anesthetics, general|mesh-ancestor
93134244|NCT03606928|Tubulin Modulators|tubulin modulators|mesh-ancestor
93134543|NCT03579082|Decitabine|decitabine|mesh-list
93135143|NCT03705728|Narcotics|narcotics|mesh-ancestor
93135220|NCT03708458|Protective Agents|protective agents|mesh-ancestor
93135521|NCT01358734|Growth Inhibitors|growth inhibitors|mesh-ancestor
93135745|NCT01256619|Desogestrel|desogestrel|mesh-list
93136271|NCT03338972|Cyclophosphamide|cyclophosphamide|mesh-list
93136423|NCT03894189|Theophylline|theophylline|mesh-list
93136654|NCT01158105|Bortezomib|bortezomib|mesh-list
93136777|NCT03879837|Xhance|xhance|mesh-list
93136881|NCT03883347|Narcotics|narcotics|mesh-ancestor
93137101|NCT01161459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137468|NCT01583283|Glucocorticoids|glucocorticoids|mesh-ancestor
93120447|NCT03072160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93137700|NCT01165905|ON 01910|on 01910|mesh-list
93138069|NCT01172691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93138296|NCT01284855|Antivenins|antivenins|mesh-list
93138590|NCT03865563|Antimetabolites|antimetabolites|mesh-ancestor
93138663|NCT01176747|Formoterol Fumarate|formoterol fumarate|mesh-list
93138826|NCT01287741|Hormones|hormones|mesh-ancestor
93139114|NCT01186029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93139337|NCT01291563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139559|NCT03847155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93139942|NCT01189773|Narcotics|narcotics|mesh-ancestor
93140239|NCT01198665|Glucocorticoids|glucocorticoids|mesh-ancestor
93140386|NCT03074240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140463|NCT03297398|Vitamins|vitamins|mesh-ancestor
93140553|NCT01204437|Paclitaxel|paclitaxel|mesh-list
93140689|NCT01204593|Insulin|insulin|mesh-list
93140771|NCT01205139|Simeprevir|simeprevir|mesh-list
93140836|NCT03723915|Pembrolizumab|pembrolizumab|mesh-list
93140912|NCT03818919|Antipyretics|antipyretics|mesh-ancestor
93141140|NCT02815540|Cannabidiol|cannabidiol|mesh-list
93141218|NCT03813303|GABA Agents|gaba agents|mesh-ancestor
93141286|NCT03804177|Micronutrients|micronutrients|mesh-ancestor
93141364|NCT04305470|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93141511|NCT02037802|Propofol|propofol|mesh-list
93141593|NCT03811509|Denosumab|denosumab|mesh-list
93141818|NCT02052934|Vaccines|vaccines|mesh-list
93141902|NCT03794505|Lidocaine|lidocaine|mesh-list
93142265|NCT01308177|Ecabet|ecabet|mesh-list
93142417|NCT03785067|Diuretics|diuretics|mesh-ancestor
93142794|NCT05654662|Sodium Fluoride|sodium fluoride|mesh-list
93142948|NCT02764268|Apatinib|apatinib|mesh-list
93143474|NCT03765645|Tazobactam|tazobactam|mesh-list
93143768|NCT03752229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93143845|NCT02066662|Rivaroxaban|rivaroxaban|mesh-list
93144223|NCT02078596|Valproic Acid|valproic acid|mesh-list
93144297|NCT02071342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144371|NCT04461015|Insulin|insulin|mesh-list
93144803|NCT04160091|FX006|fx006|mesh-list
93144977|NCT02088502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145201|NCT02089126|Glimepiride|glimepiride|mesh-list
93145505|NCT03555526|Antacids|antacids|mesh-ancestor
93145579|NCT02103166|Scopolamine|scopolamine|mesh-list
93146024|NCT02108548|Naproxen|naproxen|mesh-list
93146189|NCT02118844|Rocuronium|rocuronium|mesh-list
93146246|NCT04473716|Paclitaxel|paclitaxel|mesh-list
93146323|NCT04052139|Anticonvulsants|anticonvulsants|mesh-ancestor
93146415|NCT03238352|Listerine|listerine|mesh-list
93146620|NCT02113072|Beclomethasone|beclomethasone|mesh-list
93146769|NCT02117986|Colistin|colistin|mesh-list
93146846|NCT02126956|Ponesimod|ponesimod|mesh-list
93146921|NCT00574496|Vincristine|vincristine|mesh-list
93148375|NCT00126191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149567|NCT02761642|Epoetin Alfa|epoetin alfa|mesh-list
93149719|NCT02163070|Antioxidants|antioxidants|mesh-ancestor
93150020|NCT03726177|Aspirin|aspirin|mesh-list
93150319|NCT02762578|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93150395|NCT00100828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150848|NCT02174068|Nefopam|nefopam|mesh-list
93151074|NCT02183194|Paclitaxel|paclitaxel|mesh-list
93151338|NCT00108485|Niacin|niacin|mesh-list
93151374|NCT00107783|Nitisinone|nitisinone|mesh-list
93151661|NCT02256748|Anesthetics|anesthetics|mesh-ancestor
93152563|NCT02222428|Olodaterol|olodaterol|mesh-list
93152788|NCT01087229|Anesthetics|anesthetics|mesh-ancestor
93153616|NCT01090895|Vitamins|vitamins|mesh-ancestor
93153699|NCT01095185|Simvastatin|simvastatin|mesh-list
93153992|NCT00064025|Contraceptive Agents|contraceptive agents|mesh-ancestor
93154439|NCT01337752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93154592|NCT00154102|Leucovorin|leucovorin|mesh-list
93154683|NCT01193140|Veliparib|veliparib|mesh-list
93154816|NCT02269540|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93155189|NCT03209492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155566|NCT05064332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93155925|NCT00835354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156003|NCT04718740|Hemostatics|hemostatics|mesh-ancestor
93156073|NCT04621318|Denosumab|denosumab|mesh-list
93156380|NCT00039871|Immunologic Factors|immunologic factors|mesh-ancestor
93156754|NCT01342952|Ambrisentan|ambrisentan|mesh-list
93156834|NCT01332422|Glucocorticoids|glucocorticoids|mesh-ancestor
93156978|NCT01337804|Omeprazole|omeprazole|mesh-list
93157582|NCT03942601|Sirolimus|sirolimus|mesh-list
93158033|NCT02284204|Midazolam|midazolam|mesh-list
93158122|NCT02284282|Lidocaine|lidocaine|mesh-list
93158333|NCT01336166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158411|NCT00313768|Paclitaxel|paclitaxel|mesh-list
93158555|NCT02284984|Rituximab|rituximab|mesh-list
93158779|NCT03942289|Norepinephrine|norepinephrine|mesh-list
93158856|NCT02288338|Atorvastatin|atorvastatin|mesh-list
93159463|NCT01213849|Xhance|xhance|mesh-list
93159974|NCT01123057|Micronutrients|micronutrients|mesh-ancestor
93160270|NCT01121497|Miotics|miotics|mesh-ancestor
93160415|NCT03934333|Respiratory System Agents|respiratory system agents|mesh-ancestor
93160869|NCT05789186|Serotonin Agents|serotonin agents|mesh-ancestor
93161090|NCT05586529|Vitamin D|vitamin d|mesh-list
93161175|NCT05394727|Insulin|insulin|mesh-list
93161464|NCT04489888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161557|NCT04227522|Rucaparib|rucaparib|mesh-list
93163267|NCT02296996|Trametinib|trametinib|mesh-list
93163563|NCT03515200|Cytarabine|cytarabine|mesh-list
93163714|NCT01358396|Chrysarobin|chrysarobin|mesh-list
93163784|NCT01229761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163935|NCT03507556|Minocycline|minocycline|mesh-list
93164015|NCT01233505|Veliparib|veliparib|mesh-list
93164168|NCT01232647|Vitamins|vitamins|mesh-list
93164550|NCT05044429|Lidocaine|lidocaine|mesh-list
93164766|NCT01238029|Vinorelbine|vinorelbine|mesh-list
93165066|NCT01238185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93165139|NCT02324686|Hemostatics|hemostatics|mesh-ancestor
93165514|NCT01145677|Topiramate|topiramate|mesh-list
93165669|NCT04371640|Sirolimus|sirolimus|mesh-list
93165815|NCT01146145|Sensory System Agents|sensory system agents|mesh-ancestor
93166043|NCT03491098|Protective Agents|protective agents|mesh-ancestor
93166342|NCT02323282|Anesthetics, Local|anesthetics, local|mesh-ancestor
93166492|NCT01372280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166718|NCT03485482|Bisoprolol|bisoprolol|mesh-list
93166785|NCT01373528|Budesonide|budesonide|mesh-list
93167010|NCT01369082|Dermatologic Agents|dermatologic agents|mesh-ancestor
93167234|NCT05388448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93167536|NCT04754386|Immunologic Factors|immunologic factors|mesh-ancestor
93167908|NCT01883804|Methyldopa|methyldopa|mesh-list
93168022|NCT01248871|Dsuvia|dsuvia|mesh-list
93168354|NCT03574792|Oxycodone|oxycodone|mesh-list
93168661|NCT01149577|Serotonin Agents|serotonin agents|mesh-ancestor
93168877|NCT03899077|Fertility Agents|fertility agents|mesh-ancestor
93169338|NCT01153165|Citalopram|citalopram|mesh-list
93169554|NCT03448536|Naproxen|naproxen|mesh-list
93170011|NCT01100021|Doxazosin|doxazosin|mesh-list
93170155|NCT03877705|Listerine|listerine|mesh-list
93170455|NCT01347762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93170838|NCT01269151|Ranibizumab|ranibizumab|mesh-list
93171060|NCT01311570|Analgesics|analgesics|mesh-ancestor
93171294|NCT03863977|Hormones|hormones|mesh-ancestor
93171365|NCT00024167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93171894|NCT03480009|Oxycodone|oxycodone|mesh-list
93172130|NCT03393000|Vitamin A|vitamin a|mesh-list
93172263|NCT01180231|Moxonidine|moxonidine|mesh-list
93172719|NCT01291069|Tadalafil|tadalafil|mesh-list
93172790|NCT01185769|Vitamins|vitamins|mesh-ancestor
93172871|NCT01101659|Ketamine|ketamine|mesh-list
93173089|NCT03854383|Isosorbide|isosorbide|mesh-list
93173689|NCT01295047|Atenolol|atenolol|mesh-list
93173763|NCT01102595|Bevacizumab|bevacizumab|mesh-list
93173834|NCT03481725|Coal Tar|coal tar|mesh-list
93173909|NCT01190683|Antacids|antacids|mesh-ancestor
93174286|NCT01113671|Protective Agents|protective agents|mesh-ancestor
93174432|NCT03940391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93174660|NCT01115543|Vitamins|vitamins|mesh-ancestor
93174811|NCT03715725|Warfarin|warfarin|mesh-list
93175111|NCT01212887|Antimetabolites|antimetabolites|mesh-ancestor
93175254|NCT03408873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175930|NCT04249310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93176012|NCT04321174|Ritonavir|ritonavir|mesh-list
93176102|NCT01126073|Niacin|niacin|mesh-list
93176154|NCT05607550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176532|NCT03817411|Capecitabine|capecitabine|mesh-list
93176604|NCT01224977|Azithromycin|azithromycin|mesh-list
93176745|NCT00741988|Bevacizumab|bevacizumab|mesh-list
93176829|NCT03354429|Ticagrelor|ticagrelor|mesh-list
93176969|NCT03901144|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93177502|NCT03796507|Temozolomide|temozolomide|mesh-list
93177803|NCT01560481|Metformin|metformin|mesh-list
93178107|NCT01229813|Growth Inhibitors|growth inhibitors|mesh-ancestor
93178480|NCT03448744|Entecavir|entecavir|mesh-list
93178938|NCT03791515|Calcitonin|calcitonin|mesh-list
93179161|NCT03437590|JNJ-55308942|jnj-55308942|mesh-list
93179386|NCT04862650|Paclitaxel|paclitaxel|mesh-list
93179775|NCT05361486|Primaquine|primaquine|mesh-list
93179993|NCT01309789|Immunotoxins|immunotoxins|mesh-ancestor
93180290|NCT04751500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93180376|NCT04716634|Tislelizumab|tislelizumab|mesh-list
93182097|NCT05309070|Antidotes|antidotes|mesh-ancestor
93182320|NCT01321255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93182855|NCT01322191|Morphine|morphine|mesh-list
93184081|NCT03752749|Hormones|hormones|mesh-ancestor
93184205|NCT03755479|Insulin|insulin|mesh-list
93184277|NCT03391570|Analgesics|analgesics|mesh-ancestor
93184566|NCT03754543|Micronutrients|micronutrients|mesh-ancestor
93184646|NCT02566304|Tacrolimus|tacrolimus|mesh-list
93184806|NCT01383044|Carvedilol|carvedilol|mesh-list
93185172|NCT01858922|Antiemetics|antiemetics|mesh-ancestor
93185259|NCT03074162|Diclofenac|diclofenac|mesh-list
93185926|NCT03902249|Glucocorticoids|glucocorticoids|mesh-ancestor
93186224|NCT05208398|Warfarin|warfarin|mesh-list
93186741|NCT01259141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186817|NCT01257893|Analgesics|analgesics|mesh-ancestor
93187261|NCT03880877|Vitamins|vitamins|mesh-ancestor
93187490|NCT01159847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187939|NCT02472964|Mitosis Modulators|mitosis modulators|mesh-ancestor
93188088|NCT01269281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93188314|NCT01267643|Immunologic Factors|immunologic factors|mesh-ancestor
93188619|NCT01281527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93188772|NCT04058353|Ivacaftor|ivacaftor|mesh-list
93188998|NCT05181033|Lenvatinib|lenvatinib|mesh-list
93189149|NCT03377218|Micronutrients|micronutrients|mesh-ancestor
93189830|NCT01175291|Antidotes|antidotes|mesh-ancestor
93189979|NCT03982069|Vaccines|vaccines|mesh-list
93190356|NCT03368794|Sensory System Agents|sensory system agents|mesh-ancestor
93190666|NCT01285661|Vitamin K|vitamin k|mesh-list
93190738|NCT03860831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93190961|NCT03855527|Disinfectants|disinfectants|mesh-ancestor
93191180|NCT01188005|Vitamin E|vitamin e|mesh-list
93191636|NCT04521556|Anesthetics, Local|anesthetics, local|mesh-ancestor
93191936|NCT03856697|Abivertinib|abivertinib|mesh-list
93192846|NCT01295177|Insulin|insulin|mesh-list
93193205|NCT04539548|Glucocorticoids|glucocorticoids|mesh-ancestor
93193354|NCT02517424|Dronabinol|dronabinol|mesh-list
93193428|NCT03600805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193658|NCT01078454|Hormones|hormones|mesh-ancestor
93194183|NCT03843281|Acetaminophen|acetaminophen|mesh-list
93194268|NCT02510950|Poly ICLC|poly iclc|mesh-list
93194343|NCT02514538|Acetaminophen|acetaminophen|mesh-list
93194410|NCT02504476|Midazolam|midazolam|mesh-list
93194854|NCT03819101|Aspirin|aspirin|mesh-list
93195010|NCT02495662|Prednisolone|prednisolone|mesh-list
93195083|NCT03336346|Antiviral Agents|antiviral agents|mesh-ancestor
93195157|NCT01206881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195533|NCT02492308|Basiliximab|basiliximab|mesh-list
93195608|NCT05864053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93195913|NCT05756153|Cetuximab|cetuximab|mesh-list
93195997|NCT05562466|Budesonide|budesonide|mesh-list
93196594|NCT03578367|Vitamins|vitamins|mesh-ancestor
93196663|NCT03345823|Upadacitinib|upadacitinib|mesh-list
93196891|NCT03812003|Analgesics|analgesics|mesh-ancestor
93197084|NCT04851522|Eusol|eusol|mesh-list
93197492|NCT04576871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93198175|NCT02491528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198249|NCT05459402|Methadone|methadone|mesh-list
93198326|NCT03797729|Tirofiban|tirofiban|mesh-list
93198474|NCT01305707|Escitalopram|escitalopram|mesh-list
93198775|NCT03325348|Sympathomimetics|sympathomimetics|mesh-ancestor
93199299|NCT03720223|Anesthetics|anesthetics|mesh-ancestor
93199449|NCT03777605|Nitroglycerin|nitroglycerin|mesh-list
93199519|NCT03781895|Vitamins|vitamins|mesh-ancestor
93199592|NCT03488251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199739|NCT01444092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93199969|NCT03158220|Vaccines|vaccines|mesh-list
93200186|NCT01316952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93200337|NCT01560689|Glucocorticoids|glucocorticoids|mesh-ancestor
93200487|NCT05432531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200635|NCT01321775|Trastuzumab|trastuzumab|mesh-list
93200860|NCT03757559|Analgesics|analgesics|mesh-ancestor
93200934|NCT04507763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201765|NCT02468206|Polidocanol|polidocanol|mesh-list
93201913|NCT03305068|Celecoxib|celecoxib|mesh-list
93202074|NCT05245006|Antibodies|antibodies|mesh-list
93202213|NCT01318044|GABA Modulators|gaba modulators|mesh-ancestor
93202290|NCT03143166|Telmisartan|telmisartan|mesh-list
93202391|NCT03578172|Hormones|hormones|mesh-list
93202587|NCT02556606|GABA Modulators|gaba modulators|mesh-ancestor
93202820|NCT00005780|Prednisone|prednisone|mesh-list
93202896|NCT03228186|Docetaxel|docetaxel|mesh-list
93203193|NCT03296098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203270|NCT03295786|Dopamine|dopamine|mesh-list
93203421|NCT03108274|Fexofenadine|fexofenadine|mesh-list
93203795|NCT02461186|Artenimol|artenimol|mesh-list
93203939|NCT02459938|Hormones|hormones|mesh-ancestor
93204168|NCT02457286|Metformin|metformin|mesh-list
93204388|NCT05183997|Hemostatics|hemostatics|mesh-ancestor
93204684|NCT01367418|Sufentanil|sufentanil|mesh-list
93204719|NCT02458924|Niacin|niacin|mesh-list
93204763|NCT03126786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93204906|NCT01347957|Nitric Oxide|nitric oxide|mesh-list
93204990|NCT02456428|Incretins|incretins|mesh-list
93205144|NCT01361022|Brotizolam|brotizolam|mesh-list
93205523|NCT03421041|Hormones|hormones|mesh-ancestor
93205587|NCT01346865|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205736|NCT03247972|Evolocumab|evolocumab|mesh-list
93205959|NCT03256864|Everolimus|everolimus|mesh-list
93206184|NCT04425863|Analgesics|analgesics|mesh-ancestor
93206265|NCT03236584|Tenofovir|tenofovir|mesh-list
93206485|NCT03228238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93206706|NCT03208426|Amoxicillin|amoxicillin|mesh-list
93206863|NCT03209908|Tenofovir|tenofovir|mesh-list
93207089|NCT04292171|Gabapentin|gabapentin|mesh-list
93207162|NCT03195946|Midazolam|midazolam|mesh-list
93207385|NCT02449564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208065|NCT04779554|Mitomycins|mitomycins|mesh-list
93208141|NCT03701672|Analgesics, Opioid|analgesics, opioid|mesh-list
93208368|NCT03701984|Tramadol|tramadol|mesh-list
93208744|NCT02435368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209193|NCT00708526|Anesthetics|anesthetics|mesh-list
93209342|NCT03714685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93209723|NCT03987191|Insulin|insulin|mesh-list
93209816|NCT01375920|Metyrapone|metyrapone|mesh-list
93209879|NCT01376076|Dopamine Agents|dopamine agents|mesh-ancestor
93209957|NCT01361373|Levodopa|levodopa|mesh-list
93210024|NCT01442649|Leucovorin|leucovorin|mesh-list
93210479|NCT02427334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210774|NCT02930343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211168|NCT01365897|Modafinil|modafinil|mesh-list
93211373|NCT02873754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211596|NCT05029726|Mydriatics|mydriatics|mesh-ancestor
93211670|NCT03171610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93211827|NCT02408302|Anesthetics|anesthetics|mesh-ancestor
93211900|NCT03101358|Tubulin Modulators|tubulin modulators|mesh-ancestor
93212202|NCT02406508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93212278|NCT03631355|Hemostatics|hemostatics|mesh-ancestor
93212663|NCT05418660|Pembrolizumab|pembrolizumab|mesh-list
93212730|NCT03168100|Glucocorticoids|glucocorticoids|mesh-ancestor
93212808|NCT02399800|Triamcinolone|triamcinolone|mesh-list
93212956|NCT02394106|Ofatumumab|ofatumumab|mesh-list
93213340|NCT03359395|Alfentanil|alfentanil|mesh-list
93214003|NCT03705949|Viscosupplements|viscosupplements|mesh-ancestor
93214451|NCT03020966|Analgesics|analgesics|mesh-ancestor
93214529|NCT04923139|Rivaroxaban|rivaroxaban|mesh-list
93214905|NCT05010772|Venetoclax|venetoclax|mesh-list
93214978|NCT04702789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93215126|NCT05422716|GABA Agonists|gaba agonists|mesh-ancestor
93215512|NCT04055480|Insulin|insulin|mesh-list
93215821|NCT02199691|Vaccines|vaccines|mesh-list
93216020|NCT03655964|Olmesartan|olmesartan|mesh-list
93216098|NCT02381158|Beclomethasone|beclomethasone|mesh-list
93216698|NCT04381936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216989|NCT01371435|Antidepressive Agents|antidepressive agents|mesh-ancestor
93217300|NCT01382238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217673|NCT02532660|Dexetimide|dexetimide|mesh-list
93217744|NCT03147196|Androgen Antagonists|androgen antagonists|mesh-ancestor
93217819|NCT03968406|Talazoparib|talazoparib|mesh-list
93218263|NCT03562481|Mydriatics|mydriatics|mesh-ancestor
93218340|NCT04872426|Insulin|insulin|mesh-list
93218424|NCT02340988|Oritavancin|oritavancin|mesh-list
93218721|NCT02336854|Tacrolimus|tacrolimus|mesh-list
93218817|NCT02331862|Hormones|hormones|mesh-ancestor
93218862|NCT02331706|Interferons|interferons|mesh-list
93219015|NCT03488225|Antibodies|antibodies|mesh-list
93219096|NCT03720041|Ixazomib|ixazomib|mesh-list
93219165|NCT02334046|Sevoflurane|sevoflurane|mesh-list
93219254|NCT04278404|Glucocorticoids|glucocorticoids|mesh-ancestor
93219698|NCT03467945|Metformin|metformin|mesh-list
93219852|NCT04926454|Analgesics|analgesics|mesh-ancestor
93219998|NCT05003076|Methamphetamine|methamphetamine|mesh-list
93220906|NCT03417180|Narcotics|narcotics|mesh-ancestor
93221210|NCT05588453|Temozolomide|temozolomide|mesh-list
93221282|NCT03447821|Rifamycins|rifamycins|mesh-list
93221968|NCT02236806|Ramipril|ramipril|mesh-list
93222033|NCT05448677|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894682|NCT02702843|Xenon|xenon|mesh-list
93222651|NCT04051632|Insulin|insulin|mesh-list
93222782|NCT03814356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93222926|NCT05214807|Hylan|hylan|mesh-list
93223106|NCT01068704|Letrozole|letrozole|mesh-list
93223163|NCT05137496|Antiemetics|antiemetics|mesh-ancestor
93223254|NCT05178745|Irinotecan|irinotecan|mesh-list
93223306|NCT04105231|Dopamine Agents|dopamine agents|mesh-ancestor
93223532|NCT04507373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93223604|NCT01312415|Analgesics|analgesics|mesh-ancestor
93223685|NCT05438303|Analgesics|analgesics|mesh-ancestor
93223904|NCT02931695|Hormones|hormones|mesh-list
93224061|NCT04853147|Aprepitant|aprepitant|mesh-list
93224204|NCT01702571|Trastuzumab|trastuzumab|mesh-list
93224435|NCT03305081|Copper|copper|mesh-list
93224943|NCT05320926|Antipyretics|antipyretics|mesh-ancestor
93225025|NCT03257813|Timolol|timolol|mesh-list
93225395|NCT03697668|Artenimol|artenimol|mesh-list
93225466|NCT03699384|Antimetabolites|antimetabolites|mesh-ancestor
93225837|NCT03091491|Nivolumab|nivolumab|mesh-list
93226367|NCT03026166|Immunoconjugates|immunoconjugates|mesh-ancestor
93226820|NCT03668964|Cholecalciferol|cholecalciferol|mesh-list
93227051|NCT03003000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93227127|NCT05178953|Antioxidants|antioxidants|mesh-ancestor
93227349|NCT02996682|Ribavirin|ribavirin|mesh-list
93227425|NCT03214367|Insulin|insulin|mesh-list
93227496|NCT02032394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227726|NCT02033408|Amoxicillin|amoxicillin|mesh-list
93228407|NCT03636659|Amphotericin B|amphotericin b|mesh-list
93228645|NCT04221997|Sertraline|sertraline|mesh-list
93228860|NCT05353829|Antimetabolites|antimetabolites|mesh-ancestor
93229714|NCT04483115|Tadalafil|tadalafil|mesh-list
93229764|NCT04054206|Autonomic Agents|autonomic agents|mesh-ancestor
93229845|NCT01765218|Topiramate|topiramate|mesh-list
93230063|NCT03602690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93230292|NCT03586934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230971|NCT03574220|Pembrolizumab|pembrolizumab|mesh-list
93231038|NCT02239952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231343|NCT00092209|Losartan|losartan|mesh-list
93231416|NCT03619785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231569|NCT02847494|Antiemetics|antiemetics|mesh-ancestor
93231720|NCT03568916|Rivaroxaban|rivaroxaban|mesh-list
93231875|NCT01340521|Clomiphene|clomiphene|mesh-list
93232017|NCT00092651|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93232245|NCT03566030|Tenofovir|tenofovir|mesh-list
93232316|NCT03564704|Vincristine|vincristine|mesh-list
93232546|NCT03564158|Meropenem|meropenem|mesh-list
93232617|NCT00442897|Atorvastatin|atorvastatin|mesh-list
93232690|NCT01346917|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232764|NCT01317589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232845|NCT01338818|Dopamine Agents|dopamine agents|mesh-ancestor
93232914|NCT02035904|Morphine|morphine|mesh-list
93233004|NCT01352611|Baclofen|baclofen|mesh-list
93233211|NCT02048540|Oxaliplatin|oxaliplatin|mesh-list
93233516|NCT01065012|Udenafil|udenafil|mesh-list
93233589|NCT01337375|Antiviral Agents|antiviral agents|mesh-ancestor
93233893|NCT01350037|Alfentanil|alfentanil|mesh-list
93234188|NCT03618108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234568|NCT02062034|Antioxidants|antioxidants|mesh-list
93234642|NCT05208879|Protective Agents|protective agents|mesh-ancestor
93234864|NCT02032290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235086|NCT02465593|Fluorouracil|fluorouracil|mesh-list
93235164|NCT01356043|Antimetabolites|antimetabolites|mesh-ancestor
93235470|NCT02077478|Anesthetics|anesthetics|mesh-ancestor
93235765|NCT01350089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93235994|NCT02078648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93236149|NCT03060980|Incretins|incretins|mesh-ancestor
93236592|NCT02082236|Sufentanil|sufentanil|mesh-list
93236751|NCT02085902|Ropivacaine|ropivacaine|mesh-list
93236892|NCT02087462|Diclofenac|diclofenac|mesh-list
93237044|NCT01372579|Carboplatin|carboplatin|mesh-list
93237600|NCT03556592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92909780|NCT00804843|Niacin|niacin|mesh-list
93237827|NCT04033107|Ascorbic Acid|ascorbic acid|mesh-list
93237907|NCT02250794|Insulin|insulin|mesh-list
93237978|NCT03053427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93238204|NCT02104700|Tenofovir|tenofovir|mesh-list
93238293|NCT02251184|Aspirin|aspirin|mesh-list
93238797|NCT02116556|Rifaximin|rifaximin|mesh-list
93238869|NCT03553238|Antimetabolites|antimetabolites|mesh-ancestor
93239392|NCT03626727|Anesthetics|anesthetics|mesh-ancestor
93240010|NCT05420402|Propofol|propofol|mesh-list
93240068|NCT05383742|Rifampin|rifampin|mesh-list
93240215|NCT05100160|Gabapentin|gabapentin|mesh-list
93240432|NCT04823845|Dermatologic Agents|dermatologic agents|mesh-ancestor
93240665|NCT04314375|Glucocorticoids|glucocorticoids|mesh-ancestor
93241260|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
93241569|NCT00547196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93241647|NCT02983747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241793|NCT02136992|Pirfenidone|pirfenidone|mesh-list
93241868|NCT02137616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93242020|NCT02539693|Lidocaine|lidocaine|mesh-list
93242093|NCT02253212|Carboplatin|carboplatin|mesh-list
93242393|NCT01363817|Autonomic Agents|autonomic agents|mesh-ancestor
93242608|NCT03548948|Iron|iron|mesh-list
93242919|NCT01567735|Simeprevir|simeprevir|mesh-list
93243108|NCT01370915|Vitamins|vitamins|mesh-list
93243220|NCT03576378|Prednisone|prednisone|mesh-list
93243524|NCT03568994|Gemtuzumab|gemtuzumab|mesh-list
93244437|NCT01373333|Amifampridine|amifampridine|mesh-list
93244657|NCT01369667|Vitamin D|vitamin d|mesh-list
93244726|NCT05384821|Isotretinoin|isotretinoin|mesh-list
93244875|NCT02653963|Glucocorticoids|glucocorticoids|mesh-ancestor
93245472|NCT03097315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93245635|NCT03094416|Omeprazole|omeprazole|mesh-list
93245850|NCT03631615|Antibodies|antibodies|mesh-list
93246073|NCT05392361|Gabapentin|gabapentin|mesh-list
93246294|NCT03103763|Warfarin|warfarin|mesh-list
93246378|NCT05649605|Testosterone|testosterone|mesh-list
93246685|NCT02037672|Metformin|metformin|mesh-list
93246903|NCT04390399|Antidotes|antidotes|mesh-ancestor
93247257|NCT05959629|Eusol|eusol|mesh-list
93247351|NCT05958797|Primaquine|primaquine|mesh-list
93247875|NCT05554341|Paclitaxel|paclitaxel|mesh-list
93248404|NCT04974528|Insulin|insulin|mesh-list
93248628|NCT04686305|Pemetrexed|pemetrexed|mesh-list
93248704|NCT04645550|Anticoagulants|anticoagulants|mesh-ancestor
93249387|NCT03789240|Rituximab|rituximab|mesh-list
93249545|NCT03457142|Glycine Agents|glycine agents|mesh-ancestor
93249624|NCT03155620|Olaparib|olaparib|mesh-list
93249705|NCT02997228|Leucovorin|leucovorin|mesh-list
93249845|NCT02563002|Cetuximab|cetuximab|mesh-list
93250019|NCT01631617|Eusol|eusol|mesh-list
93250227|NCT00001230|Diethylcarbamazine|diethylcarbamazine|mesh-list
93250451|NCT02151812|Tubulin Modulators|tubulin modulators|mesh-ancestor
93250754|NCT02153606|Glycerol|glycerol|mesh-list
93250841|NCT01381835|Simeprevir|simeprevir|mesh-list
93250901|NCT02697383|Glucocorticoids|glucocorticoids|mesh-ancestor
93251867|NCT03561402|Teriflunomide|teriflunomide|mesh-list
93252017|NCT02167178|Polygeline|polygeline|mesh-list
93252615|NCT03688269|Anesthetics|anesthetics|mesh-ancestor
93252994|NCT03694119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253290|NCT03537326|Budesonide|budesonide|mesh-list
93253592|NCT02180516|Meloxicam|meloxicam|mesh-list
93253906|NCT03561870|Olaparib|olaparib|mesh-list
93253972|NCT02054676|Ibuprofen|ibuprofen|mesh-list
93254112|NCT02193698|Dexamethasone|dexamethasone|mesh-list
93254180|NCT04558190|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254412|NCT03676413|Xhance|xhance|mesh-list
93254619|NCT02060916|PAZ320|paz320|mesh-list
93254848|NCT03672435|Proxymetacaine|proxymetacaine|mesh-list
93255900|NCT02071368|Metformin|metformin|mesh-list
93256202|NCT02213744|Gemcitabine|gemcitabine|mesh-list
93256353|NCT04504045|Efavirenz|efavirenz|mesh-list
93257104|NCT02786329|Anesthetics, General|anesthetics, general|mesh-ancestor
93257177|NCT00744081|Analgesics|analgesics|mesh-ancestor
93257473|NCT03684278|Infliximab|infliximab|mesh-list
93257554|NCT05761171|Hormones|hormones|mesh-ancestor
93257920|NCT02490488|Gemcitabine|gemcitabine|mesh-list
93258076|NCT01418222|Vitamins|vitamins|mesh-ancestor
93258443|NCT01180634|Levofloxacin|levofloxacin|mesh-list
93258520|NCT01483742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93258590|NCT02269280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258671|NCT02269514|Nicotine|nicotine|mesh-list
93258814|NCT01442090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259494|NCT05617508|Niacin|niacin|mesh-list
93260758|NCT05200793|Incretins|incretins|mesh-ancestor
93260832|NCT02683018|Dronabinol|dronabinol|mesh-list
93260900|NCT04232423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93260976|NCT04094012|Isoniazid|isoniazid|mesh-list
93261048|NCT05111860|Growth Inhibitors|growth inhibitors|mesh-ancestor
93261276|NCT02283476|Antimetabolites|antimetabolites|mesh-ancestor
93261354|NCT03065933|Clonidine|clonidine|mesh-list
93261727|NCT00486512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262856|NCT01318135|Metformin|metformin|mesh-list
93263002|NCT00113438|Paclitaxel|paclitaxel|mesh-list
93263306|NCT05037994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263453|NCT04385667|Levonorgestrel|levonorgestrel|mesh-list
93263558|NCT02101476|Oxycodone|oxycodone|mesh-list
93264359|NCT02115204|Docetaxel|docetaxel|mesh-list
93264805|NCT01061775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93264884|NCT05045638|Sotorasib|sotorasib|mesh-list
93264951|NCT02788656|Valsartan|valsartan|mesh-list
93265025|NCT02288078|Glucocorticoids|glucocorticoids|mesh-ancestor
93266073|NCT03548246|Hormone Antagonists|hormone antagonists|mesh-ancestor
93266156|NCT05705635|Docetaxel|docetaxel|mesh-list
93266297|NCT03522428|Vitamins|vitamins|mesh-ancestor
93266448|NCT05162053|Purinergic Agents|purinergic agents|mesh-ancestor
93266600|NCT05303818|Anticoagulants|anticoagulants|mesh-ancestor
93266749|NCT05373446|Ritonavir|ritonavir|mesh-list
93266818|NCT03648333|Vitamin B Complex|vitamin b complex|mesh-ancestor
93266895|NCT04038099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93267192|NCT05577624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267558|NCT03990766|Autonomic Agents|autonomic agents|mesh-ancestor
93267859|NCT03843970|Bupivacaine|bupivacaine|mesh-list
93268025|NCT05884671|Sulpiride|sulpiride|mesh-list
93268755|NCT04060030|Antidotes|antidotes|mesh-ancestor
93268829|NCT03567720|Antimetabolites|antimetabolites|mesh-ancestor
93269431|NCT03643497|Meropenem|meropenem|mesh-list
93269562|NCT02956629|Ribavirin|ribavirin|mesh-list
93270091|NCT05810649|Viscosupplements|viscosupplements|mesh-ancestor
93270241|NCT05223231|Antibodies|antibodies|mesh-list
93270491|NCT04696029|Eflornithine|eflornithine|mesh-list
93270622|NCT04231877|Glucocorticoids|glucocorticoids|mesh-ancestor
93270772|NCT03404661|Secretin|secretin|mesh-list
93270919|NCT02807467|Anesthetics|anesthetics|mesh-ancestor
93271226|NCT02301650|Tenofovir|tenofovir|mesh-list
93271304|NCT02639650|Antimetabolites|antimetabolites|mesh-ancestor
93271449|NCT03506828|Phenol|phenol|mesh-list
93271670|NCT03506516|Ethanol|ethanol|mesh-list
93271753|NCT02312804|Paclitaxel|paclitaxel|mesh-list
93272206|NCT03210558|Hormones|hormones|mesh-ancestor
93272343|NCT03500432|Lidocaine|lidocaine|mesh-list
93272434|NCT02900352|Zonisamide|zonisamide|mesh-list
93272487|NCT02145546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93272790|NCT04462094|Analgesics|analgesics|mesh-ancestor
93272863|NCT03493568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93273317|NCT03455439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273468|NCT02869893|Secretin|secretin|mesh-list
93273838|NCT02152800|Valacyclovir|valacyclovir|mesh-list
93274292|NCT04737109|Hormones|hormones|mesh-ancestor
93274535|NCT02762370|FX006|fx006|mesh-list
93274598|NCT03091894|Anesthetics|anesthetics|mesh-ancestor
93274968|NCT02635984|Olanzapine|olanzapine|mesh-list
93275039|NCT04999930|Tiotropium Bromide|tiotropium bromide|mesh-list
93275187|NCT03607383|Red yeast rice|red yeast rice|mesh-list
93275930|NCT03604575|Insulin Lispro|insulin lispro|mesh-list
93276009|NCT02255370|Curcumin|curcumin|mesh-list
93276075|NCT02165046|Hormones|hormones|mesh-ancestor
93276453|NCT02170974|Dabigatran|dabigatran|mesh-list
93276597|NCT02237937|Adrenergic Agents|adrenergic agents|mesh-ancestor
93276912|NCT00101010|Hormones|hormones|mesh-ancestor
93277198|NCT03537612|Analgesics|analgesics|mesh-ancestor
93277574|NCT02256150|Mizoribine|mizoribine|mesh-list
93277720|NCT05717374|Hormones|hormones|mesh-ancestor
93277813|NCT02174328|Aspirin|aspirin|mesh-list
93277877|NCT04437654|Apixaban|apixaban|mesh-list
93278167|NCT03066544|Glucocorticoids|glucocorticoids|mesh-ancestor
93278244|NCT02239731|Doxycycline|doxycycline|mesh-list
93278767|NCT02187900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93279145|NCT03063658|Ibuprofen|ibuprofen|mesh-list
93279288|NCT02188368|Dexamethasone|dexamethasone|mesh-list
93279437|NCT03125902|Paclitaxel|paclitaxel|mesh-list
93279811|NCT03682939|Vaccines|vaccines|mesh-list
93280025|NCT02202720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280114|NCT03532854|Valsartan|valsartan|mesh-list
93280183|NCT03532698|Antipyretics|antipyretics|mesh-ancestor
93280631|NCT04425382|Lopinavir|lopinavir|mesh-list
93281007|NCT00303849|Sodium thiosulfate|sodium thiosulfate|mesh-list
93281320|NCT05914155|Rituximab|rituximab|mesh-list
93281381|NCT05853575|Adagrasib|adagrasib|mesh-list
93281529|NCT05742438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281609|NCT05634174|Mirabegron|mirabegron|mesh-list
93281681|NCT05608291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281764|NCT05539027|N-Methylaspartate|n-methylaspartate|mesh-list
93281910|NCT05303532|Durvalumab|durvalumab|mesh-list
93282081|NCT05214287|Nitrox|nitrox|mesh-list
93282581|NCT04528082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282966|NCT03538457|Acetaminophen|acetaminophen|mesh-list
93283184|NCT03143153|Nivolumab|nivolumab|mesh-list
93283491|NCT02257736|Hormones|hormones|mesh-ancestor
93283566|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
93284030|NCT02485574|Calcium|calcium|mesh-list
93284099|NCT02624050|Propofol|propofol|mesh-list
93284401|NCT01338987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284555|NCT03473210|Dexamethasone|dexamethasone|mesh-list
93284794|NCT04927936|Vaccines|vaccines|mesh-list
93284932|NCT04922008|Antimetabolites|antimetabolites|mesh-ancestor
93285163|NCT04977778|Fluorides|fluorides|mesh-list
93285606|NCT03054610|Cholinergic Agents|cholinergic agents|mesh-ancestor
93285749|NCT04891744|Autonomic Agents|autonomic agents|mesh-ancestor
93285900|NCT04101890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93286145|NCT02036697|Fentanyl|fentanyl|mesh-list
93286500|NCT02049411|Ketamine|ketamine|mesh-list
93286574|NCT02053935|Protective Agents|protective agents|mesh-ancestor
93286801|NCT02802735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286878|NCT01333059|Analgesics|analgesics|mesh-ancestor
93287039|NCT03045484|Oxycodone|oxycodone|mesh-list
93287105|NCT02798835|Hormones|hormones|mesh-ancestor
93287331|NCT01668784|Nivolumab|nivolumab|mesh-list
93287408|NCT02229786|Antipyretics|antipyretics|mesh-ancestor
93287703|NCT02233218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287924|NCT02235012|Anesthetics|anesthetics|mesh-ancestor
93287997|NCT05331690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288609|NCT02236182|Bromides|bromides|mesh-list
93288749|NCT02626338|Fludarabine phosphate|fludarabine phosphate|mesh-list
93288900|NCT02264184|Adrenergic Agents|adrenergic agents|mesh-ancestor
93288986|NCT02266524|Tamsulosin|tamsulosin|mesh-list
93289049|NCT02101034|Palbociclib|palbociclib|mesh-list
93289199|NCT05118776|Growth Substances|growth substances|mesh-ancestor
93289425|NCT03464864|Treprostinil|treprostinil|mesh-list
93289584|NCT03460964|Miotics|miotics|mesh-ancestor
93289724|NCT04768166|Miglustat|miglustat|mesh-list
93290161|NCT04697940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290543|NCT03036202|Mydriatics|mydriatics|mesh-ancestor
93290680|NCT04345146|Growth Inhibitors|growth inhibitors|mesh-ancestor
93291051|NCT00734292|Xhance|xhance|mesh-list
93291125|NCT02068287|Esmolol|esmolol|mesh-list
93291280|NCT02069145|Sorafenib|sorafenib|mesh-list
93291350|NCT03443960|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291498|NCT03432572|Riboflavin|riboflavin|mesh-list
93291575|NCT02605642|Infliximab|infliximab|mesh-list
93292245|NCT04449224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292333|NCT00430950|Olmesartan|olmesartan|mesh-list
93292389|NCT00650832|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292539|NCT01369641|Sodium thiosulfate|sodium thiosulfate|mesh-list
93292771|NCT00120042|Oxytocin|oxytocin|mesh-list
93292833|NCT04428268|Analgesics|analgesics|mesh-ancestor
93293058|NCT04802122|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93293207|NCT02087007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293486|NCT03417206|Analgesics|analgesics|mesh-ancestor
93293783|NCT05816694|Paclitaxel|paclitaxel|mesh-list
93293856|NCT05809453|Sensory System Agents|sensory system agents|mesh-ancestor
93294314|NCT04994977|Melphalan|melphalan|mesh-list
93294388|NCT04756687|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93294461|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
93294691|NCT04094142|Lenalidomide|lenalidomide|mesh-list
93294830|NCT03708315|Analgesics|analgesics|mesh-ancestor
93295580|NCT03415646|Morphine|morphine|mesh-list
93295729|NCT02095119|Gemcitabine|gemcitabine|mesh-list
93296476|NCT02102373|Laxatives|laxatives|mesh-ancestor
93296782|NCT02108847|Sensory System Agents|sensory system agents|mesh-ancestor
93297011|NCT02251509|Metoprolol|metoprolol|mesh-list
93297107|NCT02120703|Pregabalin|pregabalin|mesh-list
93297308|NCT00073866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298211|NCT03549897|Autonomic Agents|autonomic agents|mesh-ancestor
93298365|NCT04468542|Anesthetics|anesthetics|mesh-ancestor
93298512|NCT02261025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298671|NCT01666444|Doxorubicin|doxorubicin|mesh-list
93298887|NCT04076826|Anesthetics|anesthetics|mesh-ancestor
93299114|NCT02260947|Pregabalin|pregabalin|mesh-list
93299411|NCT01801072|Levetiracetam|levetiracetam|mesh-list
93299710|NCT04466904|Dulaglutide|dulaglutide|mesh-list
93299799|NCT02582632|Ritonavir|ritonavir|mesh-list
93300305|NCT02290002|Calcium|calcium|mesh-list
93300472|NCT05440942|Trametinib|trametinib|mesh-list
93300528|NCT02577016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93300904|NCT03390374|Ionophores|ionophores|mesh-ancestor
93300930|NCT02142777|Equol|equol|mesh-list
93301429|NCT05534230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93301525|NCT02467582|Aspirin|aspirin|mesh-list
93301580|NCT03520062|Liraglutide|liraglutide|mesh-list
93301727|NCT03367676|Docetaxel|docetaxel|mesh-list
93302025|NCT02293668|Hormone Antagonists|hormone antagonists|mesh-ancestor
93302101|NCT03366584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302475|NCT03506802|Melphalan|melphalan|mesh-list
93302551|NCT03504072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302774|NCT03503604|Leucovorin|leucovorin|mesh-list
93302854|NCT03359798|Narcotics|narcotics|mesh-list
93302926|NCT03506178|Protective Agents|protective agents|mesh-ancestor
93303003|NCT04443920|Hemostatics|hemostatics|mesh-ancestor
93303605|NCT05516446|Paclitaxel|paclitaxel|mesh-list
93303684|NCT03161028|Thioctic Acid|thioctic acid|mesh-list
93304208|NCT03495024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93304283|NCT02516774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93304515|NCT02515604|Oxytocics|oxytocics|mesh-ancestor
93305048|NCT02501564|Naproxen|naproxen|mesh-list
93305496|NCT02169609|Analgesics|analgesics|mesh-ancestor
93305945|NCT02496494|Immunologic Factors|immunologic factors|mesh-ancestor
93306026|NCT05464862|Lidocaine|lidocaine|mesh-list
93306246|NCT02560558|Abatacept|abatacept|mesh-list
93306319|NCT02182635|Parasympatholytics|parasympatholytics|mesh-ancestor
93306396|NCT02568046|Leucovorin|leucovorin|mesh-list
93306558|NCT05045170|Propofol|propofol|mesh-list
93306705|NCT03326960|Propofol|propofol|mesh-list
93306998|NCT02183181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307761|NCT02475824|Propofol|propofol|mesh-list
93307911|NCT02725268|Paclitaxel|paclitaxel|mesh-list
93308436|NCT02199951|Artenimol|artenimol|mesh-list
93308589|NCT02201667|Ticagrelor|ticagrelor|mesh-list
93308663|NCT02207361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309034|NCT02220153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309726|NCT05782751|Mitogens|mitogens|mesh-list
93309805|NCT05703074|Niacin|niacin|mesh-list
93309861|NCT05664464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93310017|NCT05351346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310922|NCT00657878|Paclitaxel|paclitaxel|mesh-list
93311144|NCT04356326|Analgesics|analgesics|mesh-ancestor
93311447|NCT02499900|Glatiramer Acetate|glatiramer acetate|mesh-list
93311746|NCT03311516|Insulin|insulin|mesh-list
93312115|NCT02234037|Decitabine|decitabine|mesh-list
93312427|NCT03306602|Z 350|z 350|mesh-list
93312568|NCT01232595|Vancomycin|vancomycin|mesh-list
93312642|NCT02468102|Rivaroxaban|rivaroxaban|mesh-list
93313026|NCT01116141|Folic Acid|folic acid|mesh-list
93313542|NCT03296930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93313764|NCT00840879|Sensory System Agents|sensory system agents|mesh-ancestor
93313931|NCT03050814|Vitamins|vitamins|mesh-ancestor
93314068|NCT02463110|Sertraline|sertraline|mesh-list
93314293|NCT00948753|Maraviroc|maraviroc|mesh-list
93314372|NCT01421264|Gabapentin|gabapentin|mesh-list
93314440|NCT00834639|Antimanic Agents|antimanic agents|mesh-ancestor
93314513|NCT00831051|Analgesics|analgesics|mesh-ancestor
93314585|NCT00828321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314661|NCT04285450|Vitamin K|vitamin k|mesh-list
93314811|NCT03298958|Sirolimus|sirolimus|mesh-list
93314890|NCT02460692|Hormones|hormones|mesh-ancestor
93315563|NCT02457026|Hormones|hormones|mesh-ancestor
93315633|NCT02456948|Minocycline|minocycline|mesh-list
93316010|NCT00687687|Paclitaxel|paclitaxel|mesh-list
93316093|NCT02455856|Itraconazole|itraconazole|mesh-list
93316235|NCT02945852|Apatinib|apatinib|mesh-list
93316387|NCT03249506|Glucagon|glucagon|mesh-list
93316748|NCT04094519|Digoxin|digoxin|mesh-list
93316927|NCT03709355|Hormones|hormones|mesh-ancestor
93317348|NCT03225950|Antibodies|antibodies|mesh-list
93317446|NCT04472481|Vitamin D|vitamin d|mesh-list
93317645|NCT00480831|Bevacizumab|bevacizumab|mesh-list
93318166|NCT03675841|Carbamide Peroxide|carbamide peroxide|mesh-list
93318314|NCT02283177|Cytarabine|cytarabine|mesh-list
93318394|NCT00436683|Sevelamer|sevelamer|mesh-list
93319754|NCT03527355|Vaccines|vaccines|mesh-list
93319819|NCT02450084|Analgesics|analgesics|mesh-ancestor
93321170|NCT03178994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321630|NCT02423096|Haloperidol|haloperidol|mesh-list
93321800|NCT02886065|Poly ICLC|poly iclc|mesh-list
93321854|NCT03389243|Analgesics|analgesics|mesh-ancestor
93322079|NCT03116516|Antimetabolites|antimetabolites|mesh-ancestor
93322157|NCT03176264|Growth Inhibitors|growth inhibitors|mesh-ancestor
93322232|NCT03171740|Midazolam|midazolam|mesh-list
93322456|NCT04482296|Zinc Sulfate|zinc sulfate|mesh-list
93322527|NCT04465695|Interferons|interferons|mesh-list
93322604|NCT02292069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322677|NCT02401880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323241|NCT02303769|Tamsulosin|tamsulosin|mesh-list
93323291|NCT02696798|Ixekizumab|ixekizumab|mesh-list
93323433|NCT04481282|Terbutaline|terbutaline|mesh-list
93323503|NCT02305173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93323665|NCT02312115|Furosemide|furosemide|mesh-list
93324099|NCT02441439|Iron|iron|mesh-list
93324633|NCT00431093|Anabolic Agents|anabolic agents|mesh-ancestor
93324705|NCT02314533|Fenofibrate|fenofibrate|mesh-list
93324815|NCT03673501|Sunitinib|sunitinib|mesh-list
93325155|NCT03498963|Dimercaprol|dimercaprol|mesh-list
93325680|NCT05439460|Hemostatics|hemostatics|mesh-ancestor
93325768|NCT05436652|Hormones|hormones|mesh-ancestor
93325990|NCT04703361|Niacin|niacin|mesh-list
93326058|NCT03703349|Analgesics|analgesics|mesh-ancestor
93326352|NCT05417386|Leucovorin|leucovorin|mesh-list
93326443|NCT01652092|Vidarabine|vidarabine|mesh-list
93326578|NCT04423276|Cholinergic Agents|cholinergic agents|mesh-ancestor
93326652|NCT03700229|Immunologic Factors|immunologic factors|mesh-ancestor
93327262|NCT03492255|Hormones|hormones|mesh-ancestor
93327337|NCT03132051|Hormones|hormones|mesh-ancestor
93327559|NCT04247074|Cholinergic Agents|cholinergic agents|mesh-ancestor
93328161|NCT05236036|Alkylating Agents|alkylating agents|mesh-ancestor
93328385|NCT03675191|Sympathomimetics|sympathomimetics|mesh-ancestor
93328990|NCT02665286|Analgesics|analgesics|mesh-ancestor
93329251|NCT03662035|Apatinib|apatinib|mesh-list
93329308|NCT05797870|Ethiodized Oil|ethiodized oil|mesh-list
93329374|NCT05797584|Dobutamine|dobutamine|mesh-list
93329746|NCT05247905|Antimetabolites|antimetabolites|mesh-ancestor
93329822|NCT05107856|Azacitidine|azacitidine|mesh-list
93329897|NCT04768010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93330049|NCT04354025|Analgesics|analgesics|mesh-ancestor
93331129|NCT03669263|Narcotics|narcotics|mesh-ancestor
93331204|NCT03113396|GABA Agonists|gaba agonists|mesh-ancestor
93331288|NCT05058976|Vitamin D|vitamin d|mesh-list
93331581|NCT02376296|Mitosis Modulators|mitosis modulators|mesh-ancestor
93332263|NCT03656965|Acyclovir|acyclovir|mesh-list
93332477|NCT04056845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332925|NCT02910167|Parasympatholytics|parasympatholytics|mesh-ancestor
93333150|NCT05009901|Vitamins|vitamins|mesh-ancestor
93333459|NCT03648697|Cyclophosphamide|cyclophosphamide|mesh-list
93333825|NCT03466983|Hematinics|hematinics|mesh-ancestor
93334249|NCT03655535|PAZ320|paz320|mesh-list
93334323|NCT02980133|Xhance|xhance|mesh-list
93334426|NCT05191875|Doxycycline|doxycycline|mesh-list
93334659|NCT05006638|Atropine|atropine|mesh-list
93334798|NCT03443037|Sensory System Agents|sensory system agents|mesh-ancestor
93335096|NCT02481934|Bortezomib|bortezomib|mesh-list
93335170|NCT02488330|Bevacizumab|bevacizumab|mesh-list
93335466|NCT02971007|Amebicides|amebicides|mesh-ancestor
93335848|NCT04448457|Analgesics|analgesics|mesh-ancestor
93336322|NCT02362256|Clonidine|clonidine|mesh-list
93336453|NCT01345253|Belimumab|belimumab|mesh-list
93336605|NCT02351102|Valacyclovir|valacyclovir|mesh-list
93337215|NCT03158168|Zinc Sulfate|zinc sulfate|mesh-list
93337434|NCT02033551|Paclitaxel|paclitaxel|mesh-list
93337581|NCT03390387|Bortezomib|bortezomib|mesh-list
93337958|NCT02332616|Prednisolone|prednisolone|mesh-list
93338032|NCT03612323|Analgesics|analgesics|mesh-ancestor
93338130|NCT03067844|Alirocumab|alirocumab|mesh-list
93338265|NCT03861039|Tirzepatide|tirzepatide|mesh-list
93338332|NCT03399435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338779|NCT02328716|Cisplatin|cisplatin|mesh-list
93338999|NCT04833764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339529|NCT04282239|Autonomic Agents|autonomic agents|mesh-ancestor
93340049|NCT02853331|Pembrolizumab|pembrolizumab|mesh-list
93340196|NCT03137498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340569|NCT05837013|Anesthetics|anesthetics|mesh-list
93340868|NCT05947500|Avelumab|avelumab|mesh-list
93340952|NCT05937854|Tadalafil|tadalafil|mesh-list
93341093|NCT05774951|Tamoxifen|tamoxifen|mesh-list
93341321|NCT05508009|Melphalan|melphalan|mesh-list
93341500|NCT05194397|Niacin|niacin|mesh-list
93342067|NCT04530565|Antiemetics|antiemetics|mesh-ancestor
93342141|NCT04397003|Durvalumab|durvalumab|mesh-list
93342217|NCT04222972|Antimetabolites|antimetabolites|mesh-ancestor
93342525|NCT03511118|Tranexamic Acid|tranexamic acid|mesh-list
93342823|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343583|NCT05570409|Methylprednisolone|methylprednisolone|mesh-list
93343808|NCT05312268|Rasburicase|rasburicase|mesh-list
93343883|NCT05211791|Anesthetics|anesthetics|mesh-list
93344184|NCT04609189|Micronutrients|micronutrients|mesh-ancestor
93344708|NCT03822091|Adrenergic Agents|adrenergic agents|mesh-ancestor
93344780|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93344855|NCT02914938|Rituximab|rituximab|mesh-list
93345550|NCT00151424|Olanzapine|olanzapine|mesh-list
93345619|NCT03136406|Leucovorin|leucovorin|mesh-list
93345770|NCT04444635|Narcotics|narcotics|mesh-ancestor
93345844|NCT03601091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93345924|NCT02848729|Analgesics|analgesics|mesh-ancestor
93346378|NCT03349359|Antiviral Agents|antiviral agents|mesh-ancestor
93346534|NCT04850144|Bromides|bromides|mesh-list
93346748|NCT03346629|Misoprostol|misoprostol|mesh-list
93346971|NCT05097950|Antipyretics|antipyretics|mesh-ancestor
93347042|NCT02511795|Olaparib|olaparib|mesh-list
93347426|NCT03574285|Serotonin Agents|serotonin agents|mesh-ancestor
93347727|NCT04725032|Propofol|propofol|mesh-list
93348626|NCT02497833|Tretinoin|tretinoin|mesh-list
93348858|NCT03337035|Oxytocin|oxytocin|mesh-list
93349158|NCT03327987|Vaccines|vaccines|mesh-list
93349311|NCT04494399|Interferons|interferons|mesh-list
93349381|NCT03326661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349608|NCT05229536|Immunologic Factors|immunologic factors|mesh-ancestor
93349775|NCT02489955|Tobramycin|tobramycin|mesh-list
93350207|NCT02483169|Aspirin|aspirin|mesh-list
93350436|NCT04049786|Anesthetics|anesthetics|mesh-ancestor
93350509|NCT03314493|Diuretics|diuretics|mesh-ancestor
93350585|NCT02479581|Floxacillin|floxacillin|mesh-list
93350893|NCT05870436|Miotics|miotics|mesh-ancestor
93350968|NCT05790577|Niacin|niacin|mesh-list
93351037|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
93351346|NCT05170334|Belinostat|belinostat|mesh-list
93351569|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
93351878|NCT04126200|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352725|NCT02176967|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352808|NCT02112916|Abortifacient Agents|abortifacient agents|mesh-ancestor
93353108|NCT02821819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353483|NCT01335997|Vitamins|vitamins|mesh-ancestor
93353634|NCT04821141|Hormone Antagonists|hormone antagonists|mesh-ancestor
93354056|NCT02477397|Xhance|xhance|mesh-list
93354075|NCT02477397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93354147|NCT02477007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354225|NCT02415400|Analgesics|analgesics|mesh-ancestor
93354675|NCT05302232|Protective Agents|protective agents|mesh-ancestor
93354752|NCT03312777|Analgesics|analgesics|mesh-ancestor
93354846|NCT03312153|Eusol|eusol|mesh-list
93355274|NCT03104270|Pomalidomide|pomalidomide|mesh-list
93355723|NCT02471404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355816|NCT02060851|Iron|iron|mesh-list
93356192|NCT05275491|Calcium|calcium|mesh-list
93356624|NCT02071069|Fluorouracil|fluorouracil|mesh-list
93356854|NCT02077777|Mesalamine|mesalamine|mesh-list
93356997|NCT04918069|Capsaicin|capsaicin|mesh-list
93357181|NCT02085655|Hormones|hormones|mesh-ancestor
93357228|NCT02085967|Dopamine Agents|dopamine agents|mesh-ancestor
93357296|NCT03557437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93357375|NCT02092597|Exenatide|exenatide|mesh-list
93357450|NCT02096419|Purinergic Agents|purinergic agents|mesh-ancestor
93357678|NCT04155008|Dronabinol|dronabinol|mesh-list
93357979|NCT02103049|Ezetimibe|ezetimibe|mesh-list
93358270|NCT02106793|Mitomycin|mitomycin|mesh-list
93358296|NCT02105077|Xenon|xenon|mesh-list
93358646|NCT03293511|Oxytocin|oxytocin|mesh-list
93358792|NCT02115763|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93359092|NCT03553537|Prednisone|prednisone|mesh-list
93359775|NCT02788279|Atezolizumab|atezolizumab|mesh-list
93359922|NCT03072992|Curcumin|curcumin|mesh-list
93360070|NCT02458755|Atorvastatin|atorvastatin|mesh-list
93360378|NCT02126293|Zinc|zinc|mesh-list
93360835|NCT03582605|Amoxicillin|amoxicillin|mesh-list
93361438|NCT03242499|Dihydromevinolin|dihydromevinolin|mesh-list
93361597|NCT02137681|Rituximab|rituximab|mesh-list
93361888|NCT03140423|Mupirocin|mupirocin|mesh-list
93362198|NCT05934409|Niacin|niacin|mesh-list
93362723|NCT05403385|Carboplatin|carboplatin|mesh-list
93363096|NCT04700124|Cisplatin|cisplatin|mesh-list
93363468|NCT03912428|Analgesics|analgesics|mesh-ancestor
93363617|NCT03556332|Glucocorticoids|glucocorticoids|mesh-ancestor
93363692|NCT03336216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363767|NCT02706873|Antimetabolites|antimetabolites|mesh-ancestor
93364220|NCT03565133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93364295|NCT03563963|Lidocaine|lidocaine|mesh-list
93364372|NCT04886414|Hand Sanitizers|hand sanitizers|mesh-list
93364443|NCT02396758|Plasminogen|plasminogen|mesh-list
93364592|NCT05357612|Serotonin Agents|serotonin agents|mesh-ancestor
93364820|NCT05395117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364890|NCT03546283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365055|NCT03897062|Suvorexant|suvorexant|mesh-list
93365271|NCT04981886|Bimatoprost|bimatoprost|mesh-list
93365716|NCT02048423|Anesthetics, General|anesthetics, general|mesh-ancestor
93366503|NCT02063945|Dopamine Agents|dopamine agents|mesh-ancestor
93366726|NCT02072213|Urological Agents|urological agents|mesh-ancestor
93367328|NCT03241875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93367401|NCT03241641|Tenofovir|tenofovir|mesh-list
93368172|NCT02081885|Chitosan|chitosan|mesh-list
93368227|NCT03222765|Metformin|metformin|mesh-list
93368297|NCT04917458|Vitamin D|vitamin d|mesh-list
93368982|NCT02149927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369362|NCT02447055|Tacrolimus|tacrolimus|mesh-list
93369512|NCT03197103|Antidotes|antidotes|mesh-ancestor
93369740|NCT02710071|Nebivolol|nebivolol|mesh-list
93120448|NCT03072160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120449|NCT05517486|Bupivacaine|bupivacaine|mesh-list
93120450|NCT05517486|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120451|NCT05517486|Anesthetics|anesthetics|mesh-ancestor
93120452|NCT05517486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120453|NCT05517486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120454|NCT05517486|Sensory System Agents|sensory system agents|mesh-ancestor
93120455|NCT05517486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120456|NCT01019356|Rosiglitazone|rosiglitazone|mesh-list
93120457|NCT01019356|Acarbose|acarbose|mesh-list
93120458|NCT01019356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93120459|NCT01019356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120460|NCT01019356|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93120461|NCT01019356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120462|NCT01019356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120463|NCT01314066|Bevacizumab|bevacizumab|mesh-list
93120464|NCT01314066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120465|NCT01314066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120466|NCT01314066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120467|NCT01314066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120468|NCT01314066|Growth Substances|growth substances|mesh-ancestor
93120469|NCT01314066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120470|NCT01314066|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120471|NCT01314300|Lidocaine|lidocaine|mesh-list
93120472|NCT01314300|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120473|NCT01314300|Anesthetics|anesthetics|mesh-ancestor
93120474|NCT01314300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120475|NCT01314300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120476|NCT01314300|Sensory System Agents|sensory system agents|mesh-ancestor
93120477|NCT01314300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120478|NCT01314300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93120479|NCT01314300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93120480|NCT01314300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93120481|NCT01314300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120482|NCT01314300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120483|NCT05762536|Docetaxel|docetaxel|mesh-list
93120484|NCT05762536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120485|NCT05762536|Tubulin Modulators|tubulin modulators|mesh-ancestor
93120486|NCT05762536|Antimitotic Agents|antimitotic agents|mesh-ancestor
93120487|NCT05762536|Mitosis Modulators|mitosis modulators|mesh-ancestor
93111961|NCT04657289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93111962|NCT04657289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93111963|NCT04657289|Growth Substances|growth substances|mesh-ancestor
93111964|NCT04657289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111965|NCT04657289|Growth Inhibitors|growth inhibitors|mesh-ancestor
93111966|NCT04657289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111967|NCT04631510|Gabapentin|gabapentin|mesh-list
93111968|NCT04631510|Analgesics|analgesics|mesh-ancestor
93111969|NCT04631510|Sensory System Agents|sensory system agents|mesh-ancestor
93111970|NCT04631510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111971|NCT04631510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111972|NCT04631510|Anticonvulsants|anticonvulsants|mesh-ancestor
93111973|NCT04631510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93111974|NCT04631510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93111975|NCT04631510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111976|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93111977|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93111978|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93111979|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111980|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111981|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
93111982|NCT04612257|Insulin|insulin|mesh-list
93111983|NCT04612257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111984|NCT04612257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111985|NCT04609904|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93111986|NCT04609904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93111987|NCT04609904|Respiratory System Agents|respiratory system agents|mesh-ancestor
93111988|NCT04609878|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93111989|NCT04609878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93111990|NCT04609878|Respiratory System Agents|respiratory system agents|mesh-ancestor
93111991|NCT04571619|Buprenorphine|buprenorphine|mesh-list
93111992|NCT04571619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93111993|NCT04571619|Narcotics|narcotics|mesh-ancestor
93111994|NCT04571619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111995|NCT04571619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111996|NCT04571619|Analgesics|analgesics|mesh-ancestor
93111997|NCT04571619|Sensory System Agents|sensory system agents|mesh-ancestor
93111998|NCT04571619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111999|NCT04571619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93112000|NCT04559581|Nintedanib|nintedanib|mesh-list
93112001|NCT04559581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112002|NCT04559581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112003|NCT04559581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112004|NCT04559581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112005|NCT04527380|Adalimumab|adalimumab|mesh-list
93112006|NCT04527380|Ixekizumab|ixekizumab|mesh-list
93112007|NCT04527380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93112008|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112009|NCT04527380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112010|NCT04527380|Dermatologic Agents|dermatologic agents|mesh-ancestor
93112011|NCT04522050|Gemcitabine|gemcitabine|mesh-list
93112012|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112013|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112014|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
93112015|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112016|NCT04509674|Empagliflozin|empagliflozin|mesh-list
93112017|NCT04509674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93112018|NCT04509674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112019|NCT04509674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93112020|NCT04509674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112021|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
93112022|NCT04485013|Cetuximab|cetuximab|mesh-list
93112023|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112024|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112025|NCT04485013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112026|NCT04485013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112027|NCT04481048|Acetylcysteine|acetylcysteine|mesh-list
93112028|NCT04481048|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93112029|NCT04481048|Antiviral Agents|antiviral agents|mesh-ancestor
93112030|NCT04481048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112031|NCT04481048|Expectorants|expectorants|mesh-ancestor
93112032|NCT04481048|Respiratory System Agents|respiratory system agents|mesh-ancestor
93112033|NCT04481048|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93112034|NCT04481048|Antioxidants|antioxidants|mesh-ancestor
93366256|NCT05636501|Prednisolone|prednisolone|mesh-list
93112035|NCT04481048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112036|NCT04481048|Protective Agents|protective agents|mesh-ancestor
93112037|NCT04481048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112039|NCT04472429|Paclitaxel|paclitaxel|mesh-list
93112040|NCT04472429|Carboplatin|carboplatin|mesh-list
93112041|NCT04472429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112042|NCT04472429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112043|NCT04472429|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112044|NCT04472429|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112045|NCT04472429|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112046|NCT04472429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112047|NCT04471597|Bupivacaine|bupivacaine|mesh-list
93112048|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
93112049|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
93112050|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93112051|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112052|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
93112053|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112054|NCT04464798|Rituximab|rituximab|mesh-list
93112055|NCT04464798|Obinutuzumab|obinutuzumab|mesh-list
93112056|NCT04464798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112057|NCT04464798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112058|NCT04464798|Immunologic Factors|immunologic factors|mesh-ancestor
93112059|NCT04464798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112060|NCT04464798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112061|NCT04442022|Dexamethasone|dexamethasone|mesh-list
93112062|NCT04442022|Rituximab|rituximab|mesh-list
93112063|NCT04442022|Gemcitabine|gemcitabine|mesh-list
93112064|NCT04442022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112065|NCT04442022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112066|NCT04442022|Immunologic Factors|immunologic factors|mesh-ancestor
93112067|NCT04442022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112068|NCT04442022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112069|NCT04442022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112070|NCT04442022|Antiemetics|antiemetics|mesh-ancestor
93112071|NCT04442022|Autonomic Agents|autonomic agents|mesh-ancestor
93112072|NCT04442022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112073|NCT04442022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93112074|NCT04442022|Glucocorticoids|glucocorticoids|mesh-ancestor
93112075|NCT04442022|Hormones|hormones|mesh-ancestor
93112076|NCT04442022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112077|NCT04442022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93112078|NCT04442022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112079|NCT04442022|Antimetabolites|antimetabolites|mesh-ancestor
93112080|NCT04442022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112081|NCT04375631|Cytarabine|cytarabine|mesh-list
93112082|NCT04375631|Cyclosporine|cyclosporine|mesh-list
93112083|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
93112084|NCT04375631|Cyclophosphamide|cyclophosphamide|mesh-list
93112085|NCT04375631|Fludarabine|fludarabine|mesh-list
93112086|NCT04375631|Fludarabine phosphate|fludarabine phosphate|mesh-list
93112087|NCT04375631|Mitoxantrone|mitoxantrone|mesh-list
93112088|NCT04375631|Idarubicin|idarubicin|mesh-list
93112089|NCT04375631|Cladribine|cladribine|mesh-list
93112090|NCT04375631|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93112091|NCT04375631|Cyclosporins|cyclosporins|mesh-list
93112092|NCT04375631|Lenograstim|lenograstim|mesh-list
93112093|NCT04375631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112094|NCT04375631|Immunologic Factors|immunologic factors|mesh-ancestor
93112095|NCT04375631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112096|NCT04375631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112097|NCT04375631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112098|NCT04375631|Alkylating Agents|alkylating agents|mesh-ancestor
93112099|NCT04375631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112100|NCT04375631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112101|NCT04375631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93112102|NCT04375631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112103|NCT04375631|Antimetabolites|antimetabolites|mesh-ancestor
93112104|NCT04375631|Antiviral Agents|antiviral agents|mesh-ancestor
93112105|NCT04375631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112106|NCT04375631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93112107|NCT04375631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112108|NCT04375631|Antifungal Agents|antifungal agents|mesh-ancestor
93112109|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
93112110|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93112111|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93112112|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93112113|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
93112114|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112115|NCT04375631|Analgesics|analgesics|mesh-ancestor
93112116|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
93112117|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112118|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93112119|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93112120|NCT04357587|Pembrolizumab|pembrolizumab|mesh-list
93112121|NCT04357587|Capecitabine|capecitabine|mesh-list
93112122|NCT04357587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112123|NCT04357587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112124|NCT04357587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112125|NCT04357587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112126|NCT04357587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112127|NCT04357587|Antimetabolites|antimetabolites|mesh-ancestor
93112128|NCT04353492|Ofatumumab|ofatumumab|mesh-list
93112129|NCT04353492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112130|NCT04325217|Nintedanib|nintedanib|mesh-list
93112131|NCT04325217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112132|NCT04325217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112133|NCT04325217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112134|NCT04325217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112135|NCT04269408|Nicardipine|nicardipine|mesh-list
93112136|NCT04269408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93112137|NCT04269408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93112138|NCT04269408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112139|NCT04269408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112140|NCT04269408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93112141|NCT04269408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112142|NCT04269408|Vasodilator Agents|vasodilator agents|mesh-ancestor
93112143|NCT04248829|Gefitinib|gefitinib|mesh-list
93112144|NCT04248829|Lazertinib|lazertinib|mesh-list
93112145|NCT04248829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112146|NCT04248829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112147|NCT04248829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112148|NCT04248829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112149|NCT04232761|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93112150|NCT04232761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112151|NCT04194944|Carboplatin|carboplatin|mesh-list
93112152|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
93112153|NCT04194944|Pemetrexed|pemetrexed|mesh-list
93112154|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112155|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112156|NCT04194944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112157|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112158|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112159|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93112160|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93112161|NCT04189757|Acalabrutinib|acalabrutinib|mesh-list
93112162|NCT04189757|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93112163|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112164|NCT04189757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112165|NCT04189757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112166|NCT04189757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112167|NCT04187833|Nivolumab|nivolumab|mesh-list
93112168|NCT04187833|Talazoparib|talazoparib|mesh-list
93112169|NCT04187833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112170|NCT04187833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112171|NCT04187833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112172|NCT04187833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112173|NCT04187833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93112174|NCT04187833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112175|NCT04184401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93112176|NCT04145349|Cyclophosphamide|cyclophosphamide|mesh-list
93112177|NCT04145349|Vinorelbine|vinorelbine|mesh-list
93112178|NCT04145349|Ramucirumab|ramucirumab|mesh-list
93112179|NCT04145349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112180|NCT04145349|Immunologic Factors|immunologic factors|mesh-ancestor
93112181|NCT04145349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112182|NCT04145349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112183|NCT04145349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112184|NCT04145349|Alkylating Agents|alkylating agents|mesh-ancestor
93366257|NCT05636501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117816|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112185|NCT04145349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112186|NCT04145349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112187|NCT04145349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93112188|NCT04145349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112189|NCT04145349|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112190|NCT04145349|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112191|NCT04145349|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112192|NCT04122170|Aspirin|aspirin|mesh-list
93112193|NCT04122170|Ticagrelor|ticagrelor|mesh-list
93112194|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93112195|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93112196|NCT04122170|Analgesics|analgesics|mesh-ancestor
93112197|NCT04122170|Sensory System Agents|sensory system agents|mesh-ancestor
93112198|NCT04122170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112199|NCT04122170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112200|NCT04122170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112201|NCT04122170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112202|NCT04122170|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93112203|NCT04122170|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93112204|NCT04122170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112205|NCT04122170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93112206|NCT04122170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93112207|NCT04122170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112208|NCT04122170|Antipyretics|antipyretics|mesh-ancestor
93112209|NCT04122170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93112210|NCT04122170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93112211|NCT04122170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93112212|NCT04122170|Purinergic Agents|purinergic agents|mesh-ancestor
93112213|NCT04122170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112214|NCT04086745|Adalimumab|adalimumab|mesh-list
93112215|NCT04086745|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93112216|NCT04086745|Etanercept|etanercept|mesh-list
93112217|NCT04086745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112218|NCT04086745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112219|NCT04086745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93112220|NCT04086745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93112221|NCT04086745|Analgesics|analgesics|mesh-ancestor
93112222|NCT04086745|Sensory System Agents|sensory system agents|mesh-ancestor
93112223|NCT04086745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112224|NCT04086745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112225|NCT04086745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93112226|NCT04086745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112227|NCT04086745|Immunologic Factors|immunologic factors|mesh-ancestor
93112228|NCT04075266|Ocrelizumab|ocrelizumab|mesh-list
93112229|NCT04075266|Immunologic Factors|immunologic factors|mesh-ancestor
93112230|NCT04075266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112231|NCT04073433|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112232|NCT04073433|Hallucinogens|hallucinogens|mesh-ancestor
93112233|NCT04073433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112234|NCT04073433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112235|NCT04073433|Serotonin Agents|serotonin agents|mesh-ancestor
93112236|NCT04073433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112237|NCT04073433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112238|NCT04073433|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112239|NCT04073433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112240|NCT04073433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112241|NCT04073433|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112242|NCT04038515|Menthol|menthol|mesh-list
93112243|NCT04038515|Nicotine|nicotine|mesh-list
93112244|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93112245|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
93112246|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112247|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112248|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93112249|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93112250|NCT04038515|Cholinergic Agents|cholinergic agents|mesh-ancestor
93112251|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112252|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112253|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
93112254|NCT04038515|Dermatologic Agents|dermatologic agents|mesh-ancestor
93112255|NCT03997266|Gentamicins|gentamicins|mesh-list
93112256|NCT03997266|Ampicillin|ampicillin|mesh-list
93112257|NCT03997266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112258|NCT03997266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112259|NCT03997266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93112260|NCT03997266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112261|NCT03997266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112262|NCT03970096|Cyclosporine|cyclosporine|mesh-list
93112263|NCT03970096|Sirolimus|sirolimus|mesh-list
93112264|NCT03970096|Cyclophosphamide|cyclophosphamide|mesh-list
93112265|NCT03970096|Busulfan|busulfan|mesh-list
93112266|NCT03970096|Thiotepa|thiotepa|mesh-list
93112267|NCT03970096|Methotrexate|methotrexate|mesh-list
93112268|NCT03970096|Fludarabine|fludarabine|mesh-list
93112269|NCT03970096|Tacrolimus|tacrolimus|mesh-list
93112270|NCT03970096|Cyclosporins|cyclosporins|mesh-list
93112271|NCT03970096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112272|NCT03970096|Immunologic Factors|immunologic factors|mesh-ancestor
93112273|NCT03970096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112274|NCT03970096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112275|NCT03970096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112276|NCT03970096|Alkylating Agents|alkylating agents|mesh-ancestor
93112277|NCT03970096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112278|NCT03970096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112279|NCT03970096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93112280|NCT03970096|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93112281|NCT03970096|Abortifacient Agents|abortifacient agents|mesh-ancestor
93112282|NCT03970096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93112283|NCT03970096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112284|NCT03970096|Antimetabolites|antimetabolites|mesh-ancestor
93112285|NCT03970096|Dermatologic Agents|dermatologic agents|mesh-ancestor
93112286|NCT03970096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112287|NCT03970096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93112288|NCT03970096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93112289|NCT03970096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93112290|NCT03970096|Antifungal Agents|antifungal agents|mesh-ancestor
93112291|NCT03970096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112292|NCT03970096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112293|NCT03970096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93112294|NCT03959293|Durvalumab|durvalumab|mesh-list
93112295|NCT03959293|Tremelimumab|tremelimumab|mesh-list
93112296|NCT03959293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112297|NCT03959293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112298|NCT03936153|Abexinostat|abexinostat|mesh-list
93112299|NCT03936153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93112300|NCT03936153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112301|NCT03936153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112302|NCT03818776|Durvalumab|durvalumab|mesh-list
93112303|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112304|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112305|NCT03792841|Etanercept|etanercept|mesh-list
93112306|NCT03792841|Pembrolizumab|pembrolizumab|mesh-list
93112307|NCT03792841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93112308|NCT03792841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112309|NCT03792841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112310|NCT03792841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112311|NCT03792841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93112312|NCT03792841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93112313|NCT03792841|Analgesics|analgesics|mesh-ancestor
93112314|NCT03792841|Sensory System Agents|sensory system agents|mesh-ancestor
93112315|NCT03792841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112316|NCT03792841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112317|NCT03792841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112318|NCT03792841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112319|NCT03792841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93112320|NCT03792841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112321|NCT03792841|Immunologic Factors|immunologic factors|mesh-ancestor
93112322|NCT03782987|Itraconazole|itraconazole|mesh-list
93112323|NCT03782987|Antifungal Agents|antifungal agents|mesh-ancestor
93112324|NCT03782987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112325|NCT03782987|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93112326|NCT03782987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93112327|NCT03782987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112328|NCT03782987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112329|NCT03782987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93112330|NCT03782987|Hormone Antagonists|hormone antagonists|mesh-ancestor
93112331|NCT03782987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112332|NCT03782987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042549|NCT00261495|Analgesics|analgesics|mesh-ancestor
93112333|NCT03782987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93112334|NCT03778229|Osimertinib|osimertinib|mesh-list
93112335|NCT03778229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112336|NCT03778229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112337|NCT03778229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112338|NCT03778229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112339|NCT03755791|Sorafenib|sorafenib|mesh-list
93112340|NCT03755791|Atezolizumab|atezolizumab|mesh-list
93112341|NCT03755791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112342|NCT03755791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112343|NCT03755791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112344|NCT03755791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112345|NCT03755791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112346|NCT03755791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112347|NCT03755102|Osimertinib|osimertinib|mesh-list
93112348|NCT03755102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112349|NCT03755102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112350|NCT03755102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112351|NCT03755102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112352|NCT03742986|Paclitaxel|paclitaxel|mesh-list
93112353|NCT03742986|Docetaxel|docetaxel|mesh-list
93112354|NCT03742986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93112355|NCT03742986|Cyclophosphamide|cyclophosphamide|mesh-list
93112356|NCT03742986|Doxorubicin|doxorubicin|mesh-list
93112357|NCT03742986|Nivolumab|nivolumab|mesh-list
93112358|NCT03742986|Trastuzumab|trastuzumab|mesh-list
93112359|NCT03742986|Pertuzumab|pertuzumab|mesh-list
93112360|NCT03742986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112361|NCT03742986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112362|NCT03742986|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112363|NCT03742986|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112364|NCT03742986|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112365|NCT03742986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112366|NCT03742986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112367|NCT03742986|Immunologic Factors|immunologic factors|mesh-ancestor
93112368|NCT03742986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112369|NCT03742986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112370|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112371|NCT03742986|Alkylating Agents|alkylating agents|mesh-ancestor
93112372|NCT03742986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93112373|NCT03742986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93112374|NCT03742986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93112375|NCT03742986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93112376|NCT03742986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112377|NCT03742986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112378|NCT03742986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112379|NCT03728673|Dexetimide|dexetimide|mesh-list
93112380|NCT03728673|Citalopram|citalopram|mesh-list
93112381|NCT03728673|Escitalopram|escitalopram|mesh-list
93112382|NCT03728673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93112383|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112384|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112385|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112386|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112387|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
93112388|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112389|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93112390|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93112391|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
93112392|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
93112393|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112394|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93112395|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93112396|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
93112397|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93112398|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
93112399|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112400|NCT03713580|Venetoclax|venetoclax|mesh-list
93112401|NCT03713580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112402|NCT03713437|Insulin|insulin|mesh-list
93112403|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93112404|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112405|NCT03706365|Prednisone|prednisone|mesh-list
93112406|NCT03706365|Abiraterone Acetate|abiraterone acetate|mesh-list
93112407|NCT03706365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112408|NCT03706365|Glucocorticoids|glucocorticoids|mesh-ancestor
93112409|NCT03706365|Hormones|hormones|mesh-ancestor
93112410|NCT03706365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112411|NCT03706365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112412|NCT03706365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93112413|NCT03706365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112414|NCT03706365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93112415|NCT03706365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112416|NCT03706365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112417|NCT03706365|Hormone Antagonists|hormone antagonists|mesh-ancestor
93112418|NCT03706365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93112419|NCT03594747|Paclitaxel|paclitaxel|mesh-list
93112420|NCT03594747|Carboplatin|carboplatin|mesh-list
93112421|NCT03594747|Tislelizumab|tislelizumab|mesh-list
93112422|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112423|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112424|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112425|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112426|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112427|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112428|NCT03594747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112429|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93112430|NCT03575403|Methylphenidate|methylphenidate|mesh-list
93112431|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93112432|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112433|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93112434|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112435|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112436|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112437|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
93112438|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112439|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93112440|NCT03575403|Analgesics|analgesics|mesh-ancestor
93112441|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
93112442|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112443|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
93112444|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112445|NCT03537014|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112446|NCT03537014|Hallucinogens|hallucinogens|mesh-ancestor
93112447|NCT03537014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112448|NCT03537014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112449|NCT03537014|Serotonin Agents|serotonin agents|mesh-ancestor
93112450|NCT03537014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112451|NCT03537014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112452|NCT03537014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112453|NCT03537014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112454|NCT03537014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112455|NCT03537014|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112456|NCT03485287|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112457|NCT03485287|Hallucinogens|hallucinogens|mesh-ancestor
93112458|NCT03485287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112459|NCT03485287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112460|NCT03485287|Serotonin Agents|serotonin agents|mesh-ancestor
93112461|NCT03485287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112462|NCT03485287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112463|NCT03485287|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112464|NCT03485287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112465|NCT03485287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112466|NCT03485287|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112467|NCT03474029|Rifampin|rifampin|mesh-list
93112468|NCT03474029|Rifapentine|rifapentine|mesh-list
93112469|NCT03474029|Isoniazid|isoniazid|mesh-list
93112470|NCT03474029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93112471|NCT03474029|Antitubercular Agents|antitubercular agents|mesh-ancestor
93112472|NCT03474029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112473|NCT03474029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112474|NCT03474029|Leprostatic Agents|leprostatic agents|mesh-ancestor
93112475|NCT03474029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93112476|NCT03474029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112477|NCT03474029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112478|NCT03474029|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93112479|NCT03474029|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93112480|NCT03474029|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93112481|NCT03474029|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93112482|NCT03474029|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93112483|NCT03474029|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93112484|NCT03474029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93112485|NCT03474029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93112486|NCT03474029|Antimetabolites|antimetabolites|mesh-ancestor
93112487|NCT03474029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93112488|NCT03443999|Sirolimus|sirolimus|mesh-list
93112489|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112490|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112491|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93112492|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112493|NCT03443999|Antifungal Agents|antifungal agents|mesh-ancestor
93112494|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112495|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
93112496|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112497|NCT03395080|Paclitaxel|paclitaxel|mesh-list
93112498|NCT03395080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112499|NCT03395080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112500|NCT03395080|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112501|NCT03395080|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112502|NCT03395080|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112503|NCT03395080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112504|NCT03356860|Paclitaxel|paclitaxel|mesh-list
93112505|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
93112506|NCT03356860|Durvalumab|durvalumab|mesh-list
93112507|NCT03356860|Epirubicin|epirubicin|mesh-list
93112508|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112509|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112510|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112511|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112512|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112513|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112514|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112515|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
93112516|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112517|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112518|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112519|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
93112520|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93112521|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112522|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93112523|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93112524|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93112525|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112526|NCT03313778|Pembrolizumab|pembrolizumab|mesh-list
93112527|NCT03313778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112528|NCT03313778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112529|NCT03313778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112530|NCT03313778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112531|NCT03282123|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112532|NCT03282123|Hallucinogens|hallucinogens|mesh-ancestor
93112533|NCT03282123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112534|NCT03282123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112535|NCT03282123|Serotonin Agents|serotonin agents|mesh-ancestor
93112536|NCT03282123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112537|NCT03282123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112538|NCT03282123|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112539|NCT03282123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112540|NCT03282123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112541|NCT03282123|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112542|NCT03245437|Oxytocin|oxytocin|mesh-list
93112543|NCT03245437|Oxytocics|oxytocics|mesh-ancestor
93112544|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93112545|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112546|NCT03229057|Metformin|metformin|mesh-list
93112547|NCT03229057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93112548|NCT03229057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112549|NCT03217643|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93112550|NCT03217643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112551|NCT03217643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112552|NCT03217643|Immunotoxins|immunotoxins|mesh-ancestor
93112553|NCT03217643|Immunoconjugates|immunoconjugates|mesh-ancestor
93112554|NCT03217643|Immunologic Factors|immunologic factors|mesh-ancestor
93112555|NCT03217643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366258|NCT05636501|Glucocorticoids|glucocorticoids|mesh-ancestor
93112556|NCT03207529|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
93112557|NCT03207529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112558|NCT03207529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112559|NCT03181763|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112560|NCT03181763|Hallucinogens|hallucinogens|mesh-ancestor
93112561|NCT03181763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112562|NCT03181763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112563|NCT03181763|Serotonin Agents|serotonin agents|mesh-ancestor
93112564|NCT03181763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112565|NCT03181763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112566|NCT03181763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112567|NCT03181763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112568|NCT03181763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112569|NCT03181763|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112570|NCT03175432|Bevacizumab|bevacizumab|mesh-list
93112571|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93112572|NCT03175432|Atezolizumab|atezolizumab|mesh-list
93112573|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
93112574|NCT03175432|Antibodies|antibodies|mesh-list
93112575|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
93112576|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93112577|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
93112578|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112579|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93112580|NCT03175432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93112581|NCT03175432|Growth Substances|growth substances|mesh-ancestor
93112582|NCT03175432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112583|NCT03175432|Growth Inhibitors|growth inhibitors|mesh-ancestor
93112584|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
93112585|NCT03175432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112586|NCT03175432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112587|NCT03099174|Letrozole|letrozole|mesh-list
93112588|NCT03099174|Fulvestrant|fulvestrant|mesh-list
93112589|NCT03099174|Anastrozole|anastrozole|mesh-list
93112590|NCT03099174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112591|NCT03099174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93112592|NCT03099174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93112593|NCT03099174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112594|NCT03099174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112595|NCT03099174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93112596|NCT03099174|Hormone Antagonists|hormone antagonists|mesh-ancestor
93112597|NCT03099174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112598|NCT03099174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112599|NCT03099174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93112600|NCT03099174|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93112601|NCT03092323|Pembrolizumab|pembrolizumab|mesh-list
93112602|NCT03092323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112603|NCT03092323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112604|NCT03092323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112605|NCT03092323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112606|NCT03006432|Leucovorin|leucovorin|mesh-list
93112607|NCT03006432|Folic Acid|folic acid|mesh-list
93112608|NCT03006432|Docetaxel|docetaxel|mesh-list
93112609|NCT03006432|Fluorouracil|fluorouracil|mesh-list
93112610|NCT03006432|Oxaliplatin|oxaliplatin|mesh-list
93112611|NCT03006432|Levoleucovorin|levoleucovorin|mesh-list
93112612|NCT03006432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112613|NCT03006432|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112614|NCT03006432|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112615|NCT03006432|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112616|NCT03006432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112617|NCT03006432|Antimetabolites|antimetabolites|mesh-ancestor
93112618|NCT03006432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112619|NCT03006432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112620|NCT03006432|Immunologic Factors|immunologic factors|mesh-ancestor
93112621|NCT03006432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112622|NCT03006432|Antidotes|antidotes|mesh-ancestor
93112623|NCT03006432|Protective Agents|protective agents|mesh-ancestor
93112624|NCT03006432|Vitamin B Complex|vitamin b complex|mesh-ancestor
93112625|NCT03006432|Vitamins|vitamins|mesh-ancestor
93112626|NCT03006432|Micronutrients|micronutrients|mesh-ancestor
93112627|NCT03006432|Hematinics|hematinics|mesh-ancestor
93112628|NCT02999022|Lithium Carbonate|lithium carbonate|mesh-list
93112629|NCT02999022|Antidepressive Agents|antidepressive agents|mesh-ancestor
93112630|NCT02999022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112631|NCT02999022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112632|NCT02999022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112633|NCT02999022|Antimanic Agents|antimanic agents|mesh-ancestor
93112634|NCT02999022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93112635|NCT02999022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93112636|NCT02999022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112637|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93112638|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112639|NCT02821013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112640|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112642|NCT02759185|Cannabidiol|cannabidiol|mesh-list
93112643|NCT02759185|Anticonvulsants|anticonvulsants|mesh-ancestor
93112644|NCT02759185|Hallucinogens|hallucinogens|mesh-ancestor
93112645|NCT02759185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112646|NCT02759185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112647|NCT02759185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93112648|NCT02759185|Analgesics|analgesics|mesh-ancestor
93112649|NCT02759185|Sensory System Agents|sensory system agents|mesh-ancestor
93112650|NCT02759185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112651|NCT02759185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93112652|NCT02759185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93112653|NCT02759185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112654|NCT02759185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112655|NCT02759185|Hormones|hormones|mesh-ancestor
93112656|NCT02759185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112657|NCT02619253|Pembrolizumab|pembrolizumab|mesh-list
93112658|NCT02619253|Vorinostat|vorinostat|mesh-list
93112659|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112660|NCT02619253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112661|NCT02619253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112662|NCT02619253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112663|NCT02619253|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93112664|NCT02619253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112665|NCT02584478|Paclitaxel|paclitaxel|mesh-list
93112666|NCT02584478|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93112667|NCT02584478|Carboplatin|carboplatin|mesh-list
93112668|NCT02584478|Doxorubicin|doxorubicin|mesh-list
93112669|NCT02584478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93112670|NCT02584478|Topotecan|topotecan|mesh-list
93112671|NCT02584478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112672|NCT02584478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112673|NCT02584478|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112674|NCT02584478|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112675|NCT02584478|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112676|NCT02584478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112677|NCT02584478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93112678|NCT02584478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93112679|NCT02584478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93112680|NCT02584478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112681|NCT02584478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93112682|NCT02502786|Antibodies|antibodies|mesh-list
93112683|NCT02502786|Immunologic Factors|immunologic factors|mesh-ancestor
93112684|NCT02502786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112685|NCT02436993|Paclitaxel|paclitaxel|mesh-list
93112686|NCT02436993|Bevacizumab|bevacizumab|mesh-list
93112687|NCT02436993|Carboplatin|carboplatin|mesh-list
93112688|NCT02436993|Trastuzumab|trastuzumab|mesh-list
93112689|NCT02436993|Pertuzumab|pertuzumab|mesh-list
93112690|NCT02436993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93112691|NCT02436993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112692|NCT02436993|Tubulin Modulators|tubulin modulators|mesh-ancestor
93112693|NCT02436993|Antimitotic Agents|antimitotic agents|mesh-ancestor
93112694|NCT02436993|Mitosis Modulators|mitosis modulators|mesh-ancestor
93112695|NCT02436993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112696|NCT02436993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112697|NCT02436993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93112698|NCT02436993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93112699|NCT02436993|Growth Substances|growth substances|mesh-ancestor
93112700|NCT02436993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112701|NCT02436993|Growth Inhibitors|growth inhibitors|mesh-ancestor
93112702|NCT02427568|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112703|NCT02427568|Hallucinogens|hallucinogens|mesh-ancestor
93112704|NCT02427568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112705|NCT02427568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112706|NCT02427568|Serotonin Agents|serotonin agents|mesh-ancestor
93112707|NCT02427568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112708|NCT02427568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112709|NCT02427568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112710|NCT02427568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112711|NCT02427568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112712|NCT02427568|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112713|NCT02343042|Clarithromycin|clarithromycin|mesh-list
93112714|NCT02343042|Dexamethasone|dexamethasone|mesh-list
93112715|NCT02343042|Lenalidomide|lenalidomide|mesh-list
93112716|NCT02343042|Bortezomib|bortezomib|mesh-list
93112717|NCT02343042|Daratumumab|daratumumab|mesh-list
93112718|NCT02343042|Pomalidomide|pomalidomide|mesh-list
93112719|NCT02343042|Ixazomib|ixazomib|mesh-list
93112720|NCT02343042|Elotuzumab|elotuzumab|mesh-list
93112721|NCT02343042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93112722|NCT02343042|Antiemetics|antiemetics|mesh-ancestor
93112723|NCT02343042|Autonomic Agents|autonomic agents|mesh-ancestor
93112724|NCT02343042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112725|NCT02343042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112726|NCT02343042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93112727|NCT02343042|Glucocorticoids|glucocorticoids|mesh-ancestor
93112728|NCT02343042|Hormones|hormones|mesh-ancestor
93112729|NCT02343042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112730|NCT02343042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93112731|NCT02343042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112732|NCT02343042|Immunologic Factors|immunologic factors|mesh-ancestor
93112733|NCT02343042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93112734|NCT02343042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93112735|NCT02343042|Growth Substances|growth substances|mesh-ancestor
93112736|NCT02343042|Growth Inhibitors|growth inhibitors|mesh-ancestor
93112737|NCT02343042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112738|NCT02343042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112739|NCT02343042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93112740|NCT02343042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112741|NCT02343042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112742|NCT02343042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93112743|NCT02343042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93112744|NCT02343042|Protease Inhibitors|protease inhibitors|mesh-ancestor
93112745|NCT02193841|Calcium|calcium|mesh-list
93112746|NCT02193841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93112747|NCT02193841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112748|NCT02102802|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112749|NCT02102802|Hallucinogens|hallucinogens|mesh-ancestor
93112750|NCT02102802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112751|NCT02102802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112752|NCT02102802|Serotonin Agents|serotonin agents|mesh-ancestor
93112753|NCT02102802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112754|NCT02102802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112755|NCT02102802|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112756|NCT02102802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112757|NCT02102802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112758|NCT02102802|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112759|NCT02011971|Vinpocetine|vinpocetine|mesh-list
93112760|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93112761|NCT02011971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112762|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112763|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
93112764|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93112765|NCT02011971|Protective Agents|protective agents|mesh-ancestor
93112766|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112767|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
93112768|NCT02008396|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112769|NCT02008396|Hallucinogens|hallucinogens|mesh-ancestor
93112770|NCT02008396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112771|NCT02008396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112772|NCT02008396|Serotonin Agents|serotonin agents|mesh-ancestor
93112773|NCT02008396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112774|NCT02008396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112775|NCT02008396|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112776|NCT02008396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112777|NCT02008396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112778|NCT02008396|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112779|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93112780|NCT01951339|Glimepiride|glimepiride|mesh-list
93112781|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93112782|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112783|NCT01951339|Incretins|incretins|mesh-ancestor
93112784|NCT01951339|Hormones|hormones|mesh-ancestor
93112785|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112786|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93112787|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
93112788|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112789|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112790|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93112791|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112792|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
93112793|NCT01950520|Topiramate|topiramate|mesh-list
93112794|NCT01950520|Phentermine|phentermine|mesh-list
93112795|NCT01950520|Magnesium Sulfate|magnesium sulfate|mesh-list
93112796|NCT01950520|Propranolol|propranolol|mesh-list
93112797|NCT01950520|Pindolol|pindolol|mesh-list
93112798|NCT01950520|Naltrexone|naltrexone|mesh-list
93112799|NCT01950520|Caffeine|caffeine|mesh-list
93112800|NCT01950520|Dantrolene|dantrolene|mesh-list
93112801|NCT01950520|Mirabegron|mirabegron|mesh-list
93112802|NCT01950520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93112803|NCT01950520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93112804|NCT01950520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112805|NCT01950520|Sensory System Agents|sensory system agents|mesh-ancestor
93112806|NCT01950520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112807|NCT01950520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93112808|NCT01950520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93112809|NCT01950520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112810|NCT01950520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112811|NCT01950520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93112812|NCT01950520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93112813|NCT01950520|Purinergic Agents|purinergic agents|mesh-ancestor
93112814|NCT01950520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112815|NCT01950520|Analgesics|analgesics|mesh-ancestor
93112816|NCT01950520|Anesthetics|anesthetics|mesh-ancestor
93112817|NCT01950520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93112818|NCT01950520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93112819|NCT01950520|Anticonvulsants|anticonvulsants|mesh-ancestor
93112820|NCT01950520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93112821|NCT01950520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112822|NCT01950520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93112823|NCT01950520|Tocolytic Agents|tocolytic agents|mesh-ancestor
93112824|NCT01950520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93112825|NCT01950520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93112826|NCT01950520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93112827|NCT01950520|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112828|NCT01950520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93112829|NCT01950520|Vasodilator Agents|vasodilator agents|mesh-ancestor
93112830|NCT01950520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93112831|NCT01950520|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93112832|NCT01950520|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93112833|NCT01950520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93112834|NCT01950520|Urological Agents|urological agents|mesh-ancestor
93112835|NCT01950520|Appetite Depressants|appetite depressants|mesh-ancestor
93112836|NCT01950520|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93112837|NCT01950520|Sympathomimetics|sympathomimetics|mesh-ancestor
93112838|NCT01950520|Autonomic Agents|autonomic agents|mesh-ancestor
93112839|NCT01950520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93112840|NCT01950520|Serotonin Agents|serotonin agents|mesh-ancestor
93112841|NCT01950520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93112842|NCT01950520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93112843|NCT01856478|Methotrexate|methotrexate|mesh-list
93112844|NCT01856478|Afatinib|afatinib|mesh-list
93112845|NCT01856478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93112846|NCT01856478|Abortifacient Agents|abortifacient agents|mesh-ancestor
93112847|NCT01856478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93112848|NCT01856478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112849|NCT01856478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112850|NCT01856478|Antimetabolites|antimetabolites|mesh-ancestor
93112851|NCT01856478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112852|NCT01856478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112853|NCT01856478|Dermatologic Agents|dermatologic agents|mesh-ancestor
93112854|NCT01856478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112855|NCT01856478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93112856|NCT01856478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112857|NCT01856478|Immunologic Factors|immunologic factors|mesh-ancestor
93112858|NCT01856478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112859|NCT01856478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93112860|NCT01856478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112861|NCT01853826|Afatinib|afatinib|mesh-list
93112862|NCT01853826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112863|NCT01853826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112864|NCT01853826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112865|NCT01853826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112866|NCT01844518|Abatacept|abatacept|mesh-list
93112867|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93112868|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112869|NCT01844518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93112870|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112871|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112872|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
93112873|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112874|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93112875|NCT01835041|Leucovorin|leucovorin|mesh-list
93112876|NCT01835041|Thioctic Acid|thioctic acid|mesh-list
93112877|NCT01835041|Fluorouracil|fluorouracil|mesh-list
93112878|NCT01835041|Oxaliplatin|oxaliplatin|mesh-list
93112879|NCT01835041|Irinotecan|irinotecan|mesh-list
93112880|NCT01835041|Calcium|calcium|mesh-list
93112881|NCT01835041|Levoleucovorin|levoleucovorin|mesh-list
93112882|NCT01835041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93112883|NCT01835041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112884|NCT01835041|Antimetabolites|antimetabolites|mesh-ancestor
93112885|NCT01835041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112886|NCT01835041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93112887|NCT01835041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112888|NCT01835041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112889|NCT01835041|Immunologic Factors|immunologic factors|mesh-ancestor
93112890|NCT01835041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93112891|NCT01835041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93112892|NCT01835041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112893|NCT01835041|Antidotes|antidotes|mesh-ancestor
93112894|NCT01835041|Protective Agents|protective agents|mesh-ancestor
93112895|NCT01835041|Vitamin B Complex|vitamin b complex|mesh-ancestor
93112896|NCT01835041|Vitamins|vitamins|mesh-ancestor
93112897|NCT01835041|Micronutrients|micronutrients|mesh-ancestor
93112898|NCT01835041|Antioxidants|antioxidants|mesh-ancestor
93112899|NCT01833572|Gefitinib|gefitinib|mesh-list
93112900|NCT01833572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112901|NCT01833572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112902|NCT01833572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112903|NCT01833572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112904|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93112905|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
93112906|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112907|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112908|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
93112909|NCT01793610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112910|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112911|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93112912|NCT01793610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93112913|NCT01793610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93112914|NCT01793610|Adrenergic Agents|adrenergic agents|mesh-ancestor
93112915|NCT01639690|Busulfan|busulfan|mesh-list
93112916|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
93112917|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112918|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93112919|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
93112920|NCT01639690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112921|NCT01639690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112922|NCT01639690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112923|NCT01639690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93112924|NCT01591577|Temozolomide|temozolomide|mesh-list
93112925|NCT01591577|Lapatinib|lapatinib|mesh-list
93112926|NCT01591577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93112927|NCT01591577|Alkylating Agents|alkylating agents|mesh-ancestor
93112928|NCT01591577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112929|NCT01591577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112930|NCT01591577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93112931|NCT01591577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112932|NCT01509586|Lobeline|lobeline|mesh-list
93112933|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93112934|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
93112935|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93112936|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112937|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93112938|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93112939|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
93112940|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112941|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112942|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
93112943|NCT01364584|Exenatide|exenatide|mesh-list
93112944|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93112945|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112946|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93112947|NCT01364584|Incretins|incretins|mesh-ancestor
93112948|NCT01364584|Hormones|hormones|mesh-ancestor
93112949|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93112950|NCT01163383|Iodine|iodine|mesh-list
93112951|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
93112952|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93112953|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93112954|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112955|NCT01163383|Trace Elements|trace elements|mesh-ancestor
93112956|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
93112957|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112958|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93112959|NCT01163383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112960|NCT01163383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112961|NCT01163383|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93112962|NCT01044264|Clindamycin|clindamycin|mesh-list
93112963|NCT01044264|Clindamycin palmitate|clindamycin palmitate|mesh-list
93112964|NCT01044264|Clindamycin phosphate|clindamycin phosphate|mesh-list
93112965|NCT01044264|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93112966|NCT01044264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93112967|NCT01044264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112968|NCT01044264|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93112969|NCT01044264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93112970|NCT01044264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112971|NCT01044264|Dermatologic Agents|dermatologic agents|mesh-ancestor
93112972|NCT01039584|Butoconazole|butoconazole|mesh-list
93112973|NCT01039584|Antifungal Agents|antifungal agents|mesh-ancestor
93112974|NCT01039584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93112975|NCT00979693|Psilocybin|psilocybin|mesh-list
93112976|NCT00979693|Hallucinogens|hallucinogens|mesh-ancestor
93112977|NCT00979693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112978|NCT00979693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112979|NCT00920387|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93112980|NCT00920387|Hallucinogens|hallucinogens|mesh-ancestor
93112981|NCT00920387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112982|NCT00920387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93112983|NCT00920387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93112984|NCT00920387|Serotonin Agents|serotonin agents|mesh-ancestor
93112985|NCT00920387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93112986|NCT00920387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112987|NCT00920387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93112988|NCT00786019|Vitamins|vitamins|mesh-list
93112989|NCT00786019|Ascorbic Acid|ascorbic acid|mesh-list
93112990|NCT00786019|Micronutrients|micronutrients|mesh-ancestor
93112991|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93112992|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
93112993|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93112994|NCT00786019|Protective Agents|protective agents|mesh-ancestor
93112995|NCT00692484|Chlorhexidine|chlorhexidine|mesh-list
93112996|NCT00692484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93112997|NCT00692484|Povidone-Iodine|povidone-iodine|mesh-list
93112998|NCT00692484|Povidone|povidone|mesh-list
93112999|NCT00692484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93113000|NCT00692484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113001|NCT00692484|Disinfectants|disinfectants|mesh-ancestor
93113002|NCT00692484|Dermatologic Agents|dermatologic agents|mesh-ancestor
93113003|NCT00692484|Plasma Substitutes|plasma substitutes|mesh-ancestor
93113004|NCT00692484|Blood Substitutes|blood substitutes|mesh-ancestor
93113005|NCT00679783|Olaparib|olaparib|mesh-list
93113006|NCT00679783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93113007|NCT00679783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113008|NCT00679783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113009|NCT00679783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113010|NCT00152698|Irbesartan|irbesartan|mesh-list
93113011|NCT00152698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93113012|NCT00152698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93113013|NCT00152698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93113014|NCT00152698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113015|NCT01257516|Pregabalin|pregabalin|mesh-list
93113016|NCT01257516|Analgesics|analgesics|mesh-ancestor
93113017|NCT01257516|Sensory System Agents|sensory system agents|mesh-ancestor
93113018|NCT01257516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113019|NCT01257516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113020|NCT01257516|Anticonvulsants|anticonvulsants|mesh-ancestor
93113021|NCT01257516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93113022|NCT01257516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113023|NCT01257516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113024|NCT01257516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113025|NCT01257516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93113026|NCT01257516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93113027|NCT01257516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113028|NCT01257516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93113029|NCT01149954|Ibuprofen|ibuprofen|mesh-list
93113030|NCT01149954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93113031|NCT01149954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113032|NCT01149954|Analgesics|analgesics|mesh-ancestor
93113033|NCT01149954|Sensory System Agents|sensory system agents|mesh-ancestor
93113034|NCT01149954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113035|NCT01149954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113036|NCT01149954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113037|NCT01149954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113038|NCT01149954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93113039|NCT01149954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113040|NCT01149954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113041|NCT03899610|Durvalumab|durvalumab|mesh-list
93113042|NCT03899610|Tremelimumab|tremelimumab|mesh-list
93113043|NCT03899610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93113044|NCT03899610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113045|NCT02527668|Vitamin D|vitamin d|mesh-list
93113046|NCT02527668|Cholecalciferol|cholecalciferol|mesh-list
93113047|NCT02527668|Calcifediol|calcifediol|mesh-list
93113048|NCT02527668|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93113049|NCT02527668|Vitamins|vitamins|mesh-ancestor
93113050|NCT02527668|Micronutrients|micronutrients|mesh-ancestor
93113051|NCT02527668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113052|NCT02527668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93113053|NCT02527668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113054|NCT03896646|Iminodiacetic acid|iminodiacetic acid|mesh-list
93113055|NCT03896646|Chelating Agents|chelating agents|mesh-ancestor
93113056|NCT03896646|Sequestering Agents|sequestering agents|mesh-ancestor
93113057|NCT03896646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113058|NCT03896256|Ketamine|ketamine|mesh-list
93113059|NCT03896256|Analgesics|analgesics|mesh-ancestor
93113060|NCT03896256|Sensory System Agents|sensory system agents|mesh-ancestor
93113061|NCT03896256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113062|NCT03896256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113063|NCT03896256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93113064|NCT03896256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93113065|NCT03896256|Anesthetics, General|anesthetics, general|mesh-ancestor
93113066|NCT03896256|Anesthetics|anesthetics|mesh-ancestor
93113067|NCT03896256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113068|NCT03896256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93113069|NCT03896256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93113070|NCT03896256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113071|NCT03896256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113072|NCT03893136|Leflunomide|leflunomide|mesh-list
93113073|NCT03893136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113074|NCT03893136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113075|NCT03893136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113076|NCT03893136|Immunologic Factors|immunologic factors|mesh-ancestor
93043298|NCT00353262|Capecitabine|capecitabine|mesh-list
93113077|NCT03893136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113078|NCT01258530|Oseltamivir|oseltamivir|mesh-list
93113079|NCT01258530|Antiviral Agents|antiviral agents|mesh-ancestor
93113080|NCT01258530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113081|NCT01258530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113082|NCT01258530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113083|NCT01255410|Vaccines|vaccines|mesh-list
93113084|NCT01255410|Immunologic Factors|immunologic factors|mesh-ancestor
93113085|NCT01255410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113086|NCT01150110|Salicylic Acid|salicylic acid|mesh-list
93113087|NCT01150110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113088|NCT01150110|Antifungal Agents|antifungal agents|mesh-ancestor
93113089|NCT01150110|Keratolytic Agents|keratolytic agents|mesh-ancestor
93113090|NCT01150110|Dermatologic Agents|dermatologic agents|mesh-ancestor
93113091|NCT01257672|Ondansetron|ondansetron|mesh-list
93113092|NCT01257672|Domperidone|domperidone|mesh-list
93113093|NCT01257672|Antiemetics|antiemetics|mesh-ancestor
93113094|NCT01257672|Autonomic Agents|autonomic agents|mesh-ancestor
93113095|NCT01257672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113096|NCT01257672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113097|NCT01257672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113098|NCT01257672|Antipruritics|antipruritics|mesh-ancestor
93113099|NCT01257672|Dermatologic Agents|dermatologic agents|mesh-ancestor
93113100|NCT01257672|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93113101|NCT01257672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93113102|NCT01257672|Serotonin Agents|serotonin agents|mesh-ancestor
93113103|NCT01257672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113104|NCT01257672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113105|NCT01257672|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93113106|NCT01257672|Dopamine Agents|dopamine agents|mesh-ancestor
93113107|NCT01258686|Silymarin|silymarin|mesh-list
93113108|NCT01258686|Antioxidants|antioxidants|mesh-ancestor
93113109|NCT01258686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113110|NCT01258686|Protective Agents|protective agents|mesh-ancestor
93113111|NCT01258686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113112|NCT01258764|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93113113|NCT01258764|Lisinopril|lisinopril|mesh-list
93113114|NCT01258764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93113115|NCT01258764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93113116|NCT01258764|Diuretics|diuretics|mesh-ancestor
93113117|NCT01258764|Natriuretic Agents|natriuretic agents|mesh-ancestor
93113118|NCT01258764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113119|NCT01258764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93113120|NCT01258764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113121|NCT01258764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113122|NCT01258764|Protease Inhibitors|protease inhibitors|mesh-ancestor
93113123|NCT01258764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113124|NCT01258764|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93113125|NCT01258764|Protective Agents|protective agents|mesh-ancestor
93113126|NCT03895788|Niraparib|niraparib|mesh-list
93113127|NCT03895788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93113128|NCT03895788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113129|NCT03895788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113130|NCT03895788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113131|NCT01257828|Riluzole|riluzole|mesh-list
93113132|NCT01257828|Anticonvulsants|anticonvulsants|mesh-ancestor
93113133|NCT01257828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93113134|NCT01257828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93113135|NCT01257828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113136|NCT01257828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113137|NCT01257828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113138|NCT01257828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93113139|NCT01257828|Protective Agents|protective agents|mesh-ancestor
93113140|NCT03899142|Immunoglobulins|immunoglobulins|mesh-list
93113141|NCT03899142|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93113142|NCT03899142|Antibodies|antibodies|mesh-list
93113143|NCT03899142|Immunologic Factors|immunologic factors|mesh-ancestor
93113144|NCT03899142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113145|NCT03892902|Zopiclone|zopiclone|mesh-list
93113146|NCT03892902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93113147|NCT03892902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113148|NCT03892902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113149|NCT03892668|Tranexamic Acid|tranexamic acid|mesh-list
93113150|NCT03892668|Oxytocin|oxytocin|mesh-list
93113151|NCT03892668|Oxytocics|oxytocics|mesh-ancestor
93113152|NCT03892668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113153|NCT03892668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113154|NCT03892668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93113155|NCT03892668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93113156|NCT03892668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113157|NCT03892668|Hemostatics|hemostatics|mesh-ancestor
93113158|NCT03892668|Coagulants|coagulants|mesh-ancestor
93113159|NCT01258920|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93113160|NCT01258920|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93113161|NCT01258920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93113162|NCT01258920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113163|NCT01258920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113164|NCT01258920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93113165|NCT01258920|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93113166|NCT01258920|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93113167|NCT01258920|Serotonin Agents|serotonin agents|mesh-ancestor
93113168|NCT01258920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113169|NCT01258920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113170|NCT01258920|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93113171|NCT01258920|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93113172|NCT01258920|Dopamine Agents|dopamine agents|mesh-ancestor
93113173|NCT03898752|Coenzyme Q10|coenzyme q10|mesh-list
93113175|NCT03898752|Micronutrients|micronutrients|mesh-ancestor
93113176|NCT03898752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113177|NCT01255644|Valganciclovir|valganciclovir|mesh-list
93113178|NCT01255644|Antiviral Agents|antiviral agents|mesh-ancestor
93113179|NCT01255644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113180|NCT01255800|Cetuximab|cetuximab|mesh-list
93113181|NCT01255800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93113182|NCT01255800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113183|NCT01257906|Tretinoin|tretinoin|mesh-list
93113184|NCT01257906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113185|NCT01257906|Keratolytic Agents|keratolytic agents|mesh-ancestor
93113186|NCT01257906|Dermatologic Agents|dermatologic agents|mesh-ancestor
93113187|NCT03892512|Dexmedetomidine|dexmedetomidine|mesh-list
93113188|NCT03892512|Esmolol|esmolol|mesh-list
93113189|NCT03892512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93113190|NCT03892512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113191|NCT03892512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113192|NCT03892512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113193|NCT03892512|Analgesics|analgesics|mesh-ancestor
93113194|NCT03892512|Sensory System Agents|sensory system agents|mesh-ancestor
93113195|NCT03892512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113196|NCT03892512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93113197|NCT03892512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93113198|NCT03892512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93113199|NCT03892512|Adrenergic Agents|adrenergic agents|mesh-ancestor
93113200|NCT03892512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113201|NCT03892512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113202|NCT03892512|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93113203|NCT03892512|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93113204|NCT03892512|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93113205|NCT01255878|Gabapentin|gabapentin|mesh-list
93113206|NCT01255878|Analgesics|analgesics|mesh-ancestor
93113207|NCT01255878|Sensory System Agents|sensory system agents|mesh-ancestor
93113208|NCT01255878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113209|NCT01255878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113210|NCT01255878|Anticonvulsants|anticonvulsants|mesh-ancestor
93113211|NCT01255878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93113212|NCT01255878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93113213|NCT01255878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113214|NCT01255878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93113215|NCT01255878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93113216|NCT01255878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93113217|NCT01255878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113218|NCT01255878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113219|NCT01255878|Antimanic Agents|antimanic agents|mesh-ancestor
93113220|NCT01255956|Sirolimus|sirolimus|mesh-list
93113221|NCT01255956|Paclitaxel|paclitaxel|mesh-list
93113222|NCT01255956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93113223|NCT01255956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113224|NCT01255956|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113225|NCT01255956|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113226|NCT01255956|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113227|NCT01255956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113228|NCT01255956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93113229|NCT01255956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113230|NCT01255956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93113231|NCT01255956|Antifungal Agents|antifungal agents|mesh-ancestor
93113232|NCT01255956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113233|NCT01255956|Immunologic Factors|immunologic factors|mesh-ancestor
93113234|NCT01255956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113235|NCT03892434|Dexamethasone|dexamethasone|mesh-list
93113236|NCT03892434|Dexamethasone acetate|dexamethasone acetate|mesh-list
93113237|NCT03892434|Bevacizumab|bevacizumab|mesh-list
93113238|NCT03892434|BB 1101|bb 1101|mesh-list
93113239|NCT03892434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93113240|NCT03892434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113241|NCT03892434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93113242|NCT03892434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93113243|NCT03892434|Growth Substances|growth substances|mesh-ancestor
93113244|NCT03892434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113245|NCT03892434|Growth Inhibitors|growth inhibitors|mesh-ancestor
93113246|NCT03892434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113247|NCT03892434|Antiemetics|antiemetics|mesh-ancestor
93113248|NCT03892434|Autonomic Agents|autonomic agents|mesh-ancestor
93113249|NCT03892434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113250|NCT03892434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113251|NCT03892434|Glucocorticoids|glucocorticoids|mesh-ancestor
93113252|NCT03892434|Hormones|hormones|mesh-ancestor
93113253|NCT03892434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113254|NCT03892434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113255|NCT03892434|Protease Inhibitors|protease inhibitors|mesh-ancestor
93113256|NCT03892434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113257|NCT03892434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113258|NCT03889626|Capecitabine|capecitabine|mesh-list
93113259|NCT03889626|Apatinib|apatinib|mesh-list
93113260|NCT03889626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93113261|NCT03889626|Antimetabolites|antimetabolites|mesh-ancestor
93113262|NCT03889626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113263|NCT03889626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113264|NCT03889626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93113265|NCT03889626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113266|NCT03892122|Dexmedetomidine|dexmedetomidine|mesh-list
93113267|NCT03892122|Propofol|propofol|mesh-list
93113268|NCT03892122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93113269|NCT03892122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113270|NCT03892122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113271|NCT03892122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113272|NCT03892122|Analgesics|analgesics|mesh-ancestor
93113273|NCT03892122|Sensory System Agents|sensory system agents|mesh-ancestor
93113274|NCT03892122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113275|NCT03892122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93113276|NCT03892122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93113277|NCT03892122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93113278|NCT03892122|Adrenergic Agents|adrenergic agents|mesh-ancestor
93113279|NCT03892122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113280|NCT03892122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113281|NCT03892122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93113282|NCT03892122|Anesthetics, General|anesthetics, general|mesh-ancestor
93113283|NCT03892122|Anesthetics|anesthetics|mesh-ancestor
93113284|NCT01589562|Megestrol|megestrol|mesh-list
93113285|NCT01589562|Megestrol Acetate|megestrol acetate|mesh-list
93113286|NCT01589562|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93113287|NCT01589562|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93113288|NCT01589562|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93113289|NCT01589562|Contraceptive Agents|contraceptive agents|mesh-ancestor
93113290|NCT01589562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113291|NCT01589562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113292|NCT01589562|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93113293|NCT01589562|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93113294|NCT01589562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113295|NCT01589562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113296|NCT01589562|Appetite Stimulants|appetite stimulants|mesh-ancestor
93113297|NCT01589562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93113298|NCT01152372|Insulin|insulin|mesh-list
93113299|NCT01152372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93113300|NCT01152372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113301|NCT01589640|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93113302|NCT01589640|Lubricant Eye Drops|lubricant eye drops|mesh-list
93113303|NCT01589640|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93113304|NCT01259934|Interferons|interferons|mesh-list
93113305|NCT01259934|Interferon-alpha|interferon-alpha|mesh-list
93113306|NCT01259934|Interferon alpha-2|interferon alpha-2|mesh-list
93113307|NCT01259934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113308|NCT01259934|Antiviral Agents|antiviral agents|mesh-ancestor
93113309|NCT01259934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113310|NCT01259934|Immunologic Factors|immunologic factors|mesh-ancestor
93113311|NCT01259934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113312|NCT01153386|Treprostinil|treprostinil|mesh-list
93113313|NCT01153386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93113314|NCT01260012|Praziquantel|praziquantel|mesh-list
93113315|NCT01260012|Antioxidants|antioxidants|mesh-list
93113316|NCT01260012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113317|NCT01260012|Protective Agents|protective agents|mesh-ancestor
93113318|NCT01260012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113319|NCT01260012|Anthelmintics|anthelmintics|mesh-ancestor
93113320|NCT01260012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93113321|NCT01260012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113322|NCT03888924|Vaccines|vaccines|mesh-list
93113323|NCT03888924|BCG Vaccine|bcg vaccine|mesh-list
93113324|NCT03888924|Immunologic Factors|immunologic factors|mesh-ancestor
93113325|NCT03888924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113326|NCT03888924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93113327|NCT01151592|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93113328|NCT01151592|Hematinics|hematinics|mesh-ancestor
93113329|NCT01151670|Pioglitazone|pioglitazone|mesh-list
93113330|NCT01151670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93113331|NCT01151670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113332|NCT03888846|Colchicine|colchicine|mesh-list
93113333|NCT03888846|Pentoxifylline|pentoxifylline|mesh-list
93113334|NCT03888846|Gout Suppressants|gout suppressants|mesh-ancestor
93113335|NCT03888846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113336|NCT03888846|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113337|NCT03888846|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113338|NCT03888846|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113339|NCT03888846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113340|NCT03888846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113341|NCT03888846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93113342|NCT03888846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113343|NCT03888846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93113344|NCT03888846|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93113345|NCT03888846|Protective Agents|protective agents|mesh-ancestor
93113346|NCT03888846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113347|NCT03888846|Vasodilator Agents|vasodilator agents|mesh-ancestor
93113348|NCT03888846|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93113349|NCT03888846|Antioxidants|antioxidants|mesh-ancestor
93113350|NCT03891420|Galidesivir|galidesivir|mesh-list
93113351|NCT03891420|Antiviral Agents|antiviral agents|mesh-ancestor
93113352|NCT03891420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113353|NCT01153542|Ivacaftor|ivacaftor|mesh-list
93113354|NCT01153542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93113355|NCT01153542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113356|NCT01153542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113357|NCT01152606|Trastuzumab|trastuzumab|mesh-list
93113358|NCT01152606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93113359|NCT01152606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113360|NCT01153854|Racecadotril|racecadotril|mesh-list
93113361|NCT01153854|Antidiarrheals|antidiarrheals|mesh-ancestor
93113362|NCT01153854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113363|NCT01153854|Protease Inhibitors|protease inhibitors|mesh-ancestor
93113364|NCT01153854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113365|NCT01153854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113366|NCT01260246|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93113367|NCT01260246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93113368|NCT01260246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113369|NCT01260246|Incretins|incretins|mesh-ancestor
93113370|NCT01260246|Hormones|hormones|mesh-ancestor
93113371|NCT01260246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113372|NCT01260246|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93113373|NCT01260246|Protease Inhibitors|protease inhibitors|mesh-ancestor
93113374|NCT01260246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113375|NCT01260246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113376|NCT03888534|Ixazomib|ixazomib|mesh-list
93113377|NCT03888534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113378|NCT03888534|Protease Inhibitors|protease inhibitors|mesh-ancestor
93113379|NCT03888534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113380|NCT03888534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113381|NCT03885804|Dexmedetomidine|dexmedetomidine|mesh-list
93113382|NCT03885804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93113383|NCT03885804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113384|NCT03885804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113385|NCT03885804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113386|NCT03885804|Analgesics|analgesics|mesh-ancestor
93113387|NCT03885804|Sensory System Agents|sensory system agents|mesh-ancestor
93113388|NCT03885804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113389|NCT03885804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93113390|NCT03885804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93113391|NCT03885804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93113392|NCT03885804|Adrenergic Agents|adrenergic agents|mesh-ancestor
93113393|NCT03885804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113394|NCT03885804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113395|NCT03885258|Melatonin|melatonin|mesh-list
93113396|NCT03885258|Antioxidants|antioxidants|mesh-ancestor
93113397|NCT03885258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113398|NCT03885258|Protective Agents|protective agents|mesh-ancestor
93113399|NCT03885258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113400|NCT03885258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113401|NCT01262196|Chrysarobin|chrysarobin|mesh-list
93113402|NCT01262196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93113403|NCT01262196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113404|NCT01262196|Analgesics|analgesics|mesh-ancestor
93113405|NCT01262196|Sensory System Agents|sensory system agents|mesh-ancestor
93113406|NCT01262196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113407|NCT01262196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113408|NCT01262196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113409|NCT01262196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113410|NCT03885180|Warfarin|warfarin|mesh-list
93113411|NCT03885180|Anticoagulants|anticoagulants|mesh-ancestor
93113412|NCT03888144|Ketorolac|ketorolac|mesh-list
93113413|NCT03888144|Oxycodone|oxycodone|mesh-list
93113414|NCT03888144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93113415|NCT03888144|Narcotics|narcotics|mesh-ancestor
93113416|NCT03888144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113417|NCT03888144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113418|NCT03888144|Analgesics|analgesics|mesh-ancestor
93113419|NCT03888144|Sensory System Agents|sensory system agents|mesh-ancestor
93113420|NCT03888144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113421|NCT03888144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93113422|NCT03888144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113423|NCT03888144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113424|NCT03888144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113425|NCT03888144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93113426|NCT03888144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113427|NCT03888144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113428|NCT03890406|Rocuronium|rocuronium|mesh-list
93113429|NCT03890406|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93113430|NCT03890406|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93113431|NCT03890406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93113432|NCT03890406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113433|NCT03890406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113434|NCT01154400|Caseins|caseins|mesh-list
93113435|NCT01154400|Chelating Agents|chelating agents|mesh-ancestor
93113436|NCT01154400|Sequestering Agents|sequestering agents|mesh-ancestor
93113437|NCT01154400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113438|NCT01152840|Everolimus|everolimus|mesh-list
93113439|NCT01152840|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93113440|NCT01152840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93113441|NCT01152840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113442|NCT01152840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113443|NCT01152840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113444|NCT01152840|Immunologic Factors|immunologic factors|mesh-ancestor
93113445|NCT01152840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113446|NCT01152840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113447|NCT01262274|Anastrozole|anastrozole|mesh-list
93113448|NCT01262274|Tegafur|tegafur|mesh-list
93113449|NCT01262274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113450|NCT01262274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113451|NCT01262274|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93113452|NCT01262274|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93113453|NCT01262274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113454|NCT01262274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113455|NCT01262274|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93113456|NCT01262274|Hormone Antagonists|hormone antagonists|mesh-ancestor
93113457|NCT01262274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113458|NCT01262274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113459|NCT01262274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93113460|NCT01262274|Antimetabolites|antimetabolites|mesh-ancestor
93113461|NCT01260558|Sirolimus|sirolimus|mesh-list
93113462|NCT01260558|Temsirolimus|temsirolimus|mesh-list
93113463|NCT01260558|MTOR Inhibitors|mtor inhibitors|mesh-list
93113464|NCT01260558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93113465|NCT01260558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113466|NCT01260558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93113467|NCT01260558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113468|NCT01260558|Antifungal Agents|antifungal agents|mesh-ancestor
93113469|NCT01260558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113470|NCT01260558|Immunologic Factors|immunologic factors|mesh-ancestor
93113471|NCT01260558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113472|NCT01260558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93113473|NCT01260558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113474|NCT01260558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113475|NCT01260714|Etoposide|etoposide|mesh-list
93113476|NCT01260714|Podophyllotoxin|podophyllotoxin|mesh-list
93113477|NCT01260714|Mitoxantrone|mitoxantrone|mesh-list
93113478|NCT01260714|Azacitidine|azacitidine|mesh-list
93113479|NCT01260714|Etoposide phosphate|etoposide phosphate|mesh-list
93113480|NCT01260714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93113481|NCT01260714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113482|NCT01260714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93113483|NCT01260714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93113484|NCT01260714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113485|NCT01260714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113486|NCT01260714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93113487|NCT01260714|Antimetabolites|antimetabolites|mesh-ancestor
93113488|NCT01260714|Analgesics|analgesics|mesh-ancestor
93113489|NCT01260714|Sensory System Agents|sensory system agents|mesh-ancestor
93113490|NCT01260714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113491|NCT01260714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113492|NCT01260714|Keratolytic Agents|keratolytic agents|mesh-ancestor
93113493|NCT01260714|Dermatologic Agents|dermatologic agents|mesh-ancestor
93113494|NCT01260714|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113495|NCT01260714|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113496|NCT01260714|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113497|NCT03890094|Sufentanil|sufentanil|mesh-list
93113498|NCT03890094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93113499|NCT03890094|Narcotics|narcotics|mesh-ancestor
93113500|NCT03890094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113501|NCT03890094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113502|NCT03890094|Analgesics|analgesics|mesh-ancestor
93113503|NCT03890094|Sensory System Agents|sensory system agents|mesh-ancestor
93113504|NCT03890094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113505|NCT03890094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93113506|NCT03890094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93113507|NCT03890094|Anesthetics, General|anesthetics, general|mesh-ancestor
93113508|NCT03890094|Anesthetics|anesthetics|mesh-ancestor
93113509|NCT03887754|Risperidone|risperidone|mesh-list
93113510|NCT03887754|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93113511|NCT03887754|Serotonin Agents|serotonin agents|mesh-ancestor
93113512|NCT03887754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113513|NCT03887754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113514|NCT03887754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113515|NCT03887754|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93113516|NCT03887754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93113517|NCT03887754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113518|NCT03887754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93113519|NCT03887754|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93113520|NCT03887754|Dopamine Agents|dopamine agents|mesh-ancestor
93113521|NCT03889470|Nitroglycerin|nitroglycerin|mesh-list
93113522|NCT03889470|Vasodilator Agents|vasodilator agents|mesh-ancestor
93113523|NCT01262586|Glimepiride|glimepiride|mesh-list
93113524|NCT01262586|Vildagliptin|vildagliptin|mesh-list
93113525|NCT01262586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93113526|NCT01262586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93113527|NCT01262586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113528|NCT01262586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113529|NCT01262586|Immunologic Factors|immunologic factors|mesh-ancestor
93113530|NCT01262586|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93113531|NCT01262586|Protease Inhibitors|protease inhibitors|mesh-ancestor
93113532|NCT01262586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113533|NCT01262586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113534|NCT01157052|Capecitabine|capecitabine|mesh-list
93113535|NCT01157052|Oxaliplatin|oxaliplatin|mesh-list
93113536|NCT01157052|Calcium|calcium|mesh-list
93366259|NCT05636501|Hormones|hormones|mesh-ancestor
93113537|NCT01157052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113538|NCT01157052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113539|NCT01157052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93113540|NCT01157052|Antimetabolites|antimetabolites|mesh-ancestor
93113541|NCT01157052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113542|NCT01157052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113543|NCT03887130|Paclitaxel|paclitaxel|mesh-list
93113544|NCT03887130|Vinorelbine|vinorelbine|mesh-list
93113545|NCT03887130|Docetaxel|docetaxel|mesh-list
93113546|NCT03887130|Gemcitabine|gemcitabine|mesh-list
93113547|NCT03887130|Capecitabine|capecitabine|mesh-list
93113548|NCT03887130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93113549|NCT03887130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113550|NCT03887130|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113551|NCT03887130|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113552|NCT03887130|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113553|NCT03887130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113554|NCT03887130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93113555|NCT03887130|Antimetabolites|antimetabolites|mesh-ancestor
93113556|NCT01155960|Anastrozole|anastrozole|mesh-list
93113557|NCT01155960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113558|NCT01155960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113559|NCT01155960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93113560|NCT01155960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93113561|NCT01155960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113562|NCT01155960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113563|NCT01155960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93113564|NCT01155960|Hormone Antagonists|hormone antagonists|mesh-ancestor
93113565|NCT01155960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113566|NCT01155960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113567|NCT03883776|Octreotide|octreotide|mesh-list
93113568|NCT03883776|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
93113569|NCT03883776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113570|NCT03883776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113571|NCT03883776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113572|NCT03883776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93113573|NCT03883776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113574|NCT03886896|Lidocaine|lidocaine|mesh-list
93113575|NCT03886896|Anesthetics, Local|anesthetics, local|mesh-ancestor
93113576|NCT03886896|Anesthetics|anesthetics|mesh-ancestor
93113577|NCT03886896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113578|NCT03886896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113579|NCT03886896|Sensory System Agents|sensory system agents|mesh-ancestor
93113580|NCT03886896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113581|NCT03886896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93113582|NCT03886896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93113583|NCT03886896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93113584|NCT03886896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113585|NCT03886896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113586|NCT03881904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93113587|NCT03881904|Gestodene|gestodene|mesh-list
93113588|NCT03881904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93113589|NCT03881904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93113590|NCT03881904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93113591|NCT03881904|Contraceptive Agents|contraceptive agents|mesh-ancestor
93113592|NCT03881904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113593|NCT03881904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113594|NCT03881904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93113595|NCT03881904|Estrogens|estrogens|mesh-ancestor
93113596|NCT03881904|Hormones|hormones|mesh-ancestor
93113597|NCT03881904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113598|NCT03881904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93113599|NCT03881904|Progestins|progestins|mesh-ancestor
93113600|NCT01262742|Carbetocin|carbetocin|mesh-list
93113601|NCT01262742|Oxytocin|oxytocin|mesh-list
93113602|NCT01262742|Oxytocics|oxytocics|mesh-ancestor
92117817|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113603|NCT01262742|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113604|NCT01262742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113605|NCT01261416|Levetiracetam|levetiracetam|mesh-list
93113606|NCT01261416|Anticonvulsants|anticonvulsants|mesh-ancestor
93113607|NCT01261416|Nootropic Agents|nootropic agents|mesh-ancestor
93113608|NCT03617172|Misoprostol|misoprostol|mesh-list
93113609|NCT03617172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92785857|NCT01192178|Xhance|xhance|mesh-list
93113610|NCT03617172|Abortifacient Agents|abortifacient agents|mesh-ancestor
93113611|NCT03617172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113612|NCT03617172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113613|NCT03617172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93113614|NCT03617172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113615|NCT03617172|Oxytocics|oxytocics|mesh-ancestor
93113616|NCT01154790|Naproxen|naproxen|mesh-list
93113617|NCT01154790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93113618|NCT01154790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113619|NCT01154790|Analgesics|analgesics|mesh-ancestor
93113620|NCT01154790|Sensory System Agents|sensory system agents|mesh-ancestor
93113621|NCT01154790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113622|NCT01154790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113623|NCT01154790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113624|NCT01154790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113625|NCT01154790|Gout Suppressants|gout suppressants|mesh-ancestor
93113626|NCT01154790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93113627|NCT01154790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113628|NCT01154790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113629|NCT03883698|Sofosbuvir|sofosbuvir|mesh-list
93113630|NCT03883698|Antiviral Agents|antiviral agents|mesh-ancestor
93113631|NCT03883698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113632|NCT01263210|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93113633|NCT01263210|Immunologic Factors|immunologic factors|mesh-ancestor
93113634|NCT01263210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113635|NCT01263288|Cholecalciferol|cholecalciferol|mesh-list
93113636|NCT01263288|Vitamin D|vitamin d|mesh-list
93113637|NCT01263288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113638|NCT01263288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113639|NCT01263288|Vitamins|vitamins|mesh-ancestor
93113640|NCT01263288|Micronutrients|micronutrients|mesh-ancestor
93113641|NCT01263288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93113642|NCT01263834|Bevacizumab|bevacizumab|mesh-list
93113643|NCT01263834|Mitomycins|mitomycins|mesh-list
93113644|NCT01263834|Mitomycin|mitomycin|mesh-list
93113645|NCT01263834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93113646|NCT01263834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113647|NCT01263834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93113648|NCT01263834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93113649|NCT01263834|Growth Substances|growth substances|mesh-ancestor
93113650|NCT01263834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113651|NCT01263834|Growth Inhibitors|growth inhibitors|mesh-ancestor
93113652|NCT01263834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93113653|NCT01263834|Alkylating Agents|alkylating agents|mesh-ancestor
93113654|NCT01263834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113655|NCT01263834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93113656|NCT01263834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113657|NCT01263366|Norepinephrine|norepinephrine|mesh-list
93113658|NCT01263366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93113659|NCT01263366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93113660|NCT01263366|Adrenergic Agents|adrenergic agents|mesh-ancestor
93113661|NCT01263366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113662|NCT01263366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113663|NCT01263366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113664|NCT01263366|Sympathomimetics|sympathomimetics|mesh-ancestor
93113665|NCT01263366|Autonomic Agents|autonomic agents|mesh-ancestor
93113666|NCT01263366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113667|NCT01263366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93113668|NCT01155102|Anastrozole|anastrozole|mesh-list
93113669|NCT01155102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113670|NCT01155102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113671|NCT01155102|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93113672|NCT01155102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93113673|NCT01155102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113674|NCT01155102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113675|NCT01155102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93113676|NCT01155102|Hormone Antagonists|hormone antagonists|mesh-ancestor
92117818|NCT03245970|Atenolol|atenolol|mesh-list
93113677|NCT01155102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113678|NCT01155102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113679|NCT01156350|Fludarabine|fludarabine|mesh-list
93113680|NCT01156350|Busulfan|busulfan|mesh-list
93113681|NCT01156350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113682|NCT01156350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113683|NCT01156350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113684|NCT01156350|Immunologic Factors|immunologic factors|mesh-ancestor
93113685|NCT01156350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113686|NCT01156350|Alkylating Agents|alkylating agents|mesh-ancestor
93113687|NCT01156350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93113688|NCT01156350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93113689|NCT03886662|LB100|lb100|mesh-list
93113690|NCT03886662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113691|NCT03886662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113692|NCT03886662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113693|NCT01155258|Sirolimus|sirolimus|mesh-list
93113694|NCT01155258|Vinorelbine|vinorelbine|mesh-list
93113695|NCT01155258|Temsirolimus|temsirolimus|mesh-list
93113696|NCT01155258|MTOR Inhibitors|mtor inhibitors|mesh-list
93113697|NCT01155258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93113698|NCT01155258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113699|NCT01155258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93113700|NCT01155258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113701|NCT01155258|Antifungal Agents|antifungal agents|mesh-ancestor
93113702|NCT01155258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113703|NCT01155258|Immunologic Factors|immunologic factors|mesh-ancestor
93113704|NCT01155258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113705|NCT01155258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93113706|NCT01155258|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113707|NCT01155258|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113708|NCT01155258|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113709|NCT01155258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113710|NCT01155258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93113711|NCT01155258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113712|NCT01156584|Flucytosine|flucytosine|mesh-list
93113713|NCT01156584|Antifungal Agents|antifungal agents|mesh-ancestor
93113714|NCT01156584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113715|NCT01156584|Antimetabolites|antimetabolites|mesh-ancestor
93113716|NCT01156584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113717|NCT03879174|Tamoxifen|tamoxifen|mesh-list
93113718|NCT03879174|Pembrolizumab|pembrolizumab|mesh-list
93113719|NCT03879174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93113720|NCT03879174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113721|NCT03879174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93113722|NCT03879174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113723|NCT03879174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93113724|NCT03879174|Hormone Antagonists|hormone antagonists|mesh-ancestor
93113725|NCT03879174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113726|NCT03879174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113727|NCT03879174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113728|NCT03879174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93113729|NCT03879174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93113730|NCT03879174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93113731|NCT01159548|Promethazine|promethazine|mesh-list
93113732|NCT01159548|Diphenhydramine|diphenhydramine|mesh-list
93113733|NCT01159548|Antipruritics|antipruritics|mesh-ancestor
93113734|NCT01159548|Dermatologic Agents|dermatologic agents|mesh-ancestor
93113735|NCT01159548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93113736|NCT01159548|Histamine Antagonists|histamine antagonists|mesh-ancestor
93113737|NCT01159548|Histamine Agents|histamine agents|mesh-ancestor
93113738|NCT01159548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113739|NCT01159548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113740|NCT01159548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113741|NCT01159548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93113742|NCT01159548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93113743|NCT01159548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93113744|NCT01159548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113745|NCT01159548|Anesthetics, Local|anesthetics, local|mesh-ancestor
93113746|NCT01159548|Anesthetics|anesthetics|mesh-ancestor
93113747|NCT01159548|Sensory System Agents|sensory system agents|mesh-ancestor
93113748|NCT01159548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113749|NCT01159548|Antiemetics|antiemetics|mesh-ancestor
93113750|NCT01159548|Autonomic Agents|autonomic agents|mesh-ancestor
93113751|NCT01159548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113752|NCT01156740|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93113753|NCT01156740|Amoxicillin|amoxicillin|mesh-list
93113754|NCT01156740|Penicillins|penicillins|mesh-list
93113755|NCT01156740|beta-Lactams|beta-lactams|mesh-list
93113756|NCT01156740|Penicillin G|penicillin g|mesh-list
93113757|NCT01156740|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93113758|NCT01156740|Penicillin G Procaine|penicillin g procaine|mesh-list
93113759|NCT01156740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113760|NCT03880968|Etanercept|etanercept|mesh-list
93113761|NCT03880968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93113762|NCT03880968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113764|NCT03880968|Sensory System Agents|sensory system agents|mesh-ancestor
93113765|NCT03880968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113766|NCT03880968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113767|NCT03880968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113768|NCT03880968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93113769|NCT03880968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113770|NCT03880968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93113771|NCT03880968|Immunologic Factors|immunologic factors|mesh-ancestor
93113772|NCT03880734|Cholecalciferol|cholecalciferol|mesh-list
93113773|NCT03880734|Vitamin D|vitamin d|mesh-list
93113774|NCT03880734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113775|NCT03880734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113776|NCT03880734|Vitamins|vitamins|mesh-ancestor
93113777|NCT03880734|Micronutrients|micronutrients|mesh-ancestor
93113778|NCT03880734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93113779|NCT01157754|Levonorgestrel|levonorgestrel|mesh-list
93113780|NCT01157754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93113781|NCT01157754|Contraceptive Agents|contraceptive agents|mesh-ancestor
93113782|NCT01157754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113783|NCT01157754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113784|NCT01157754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93113785|NCT01157754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93113786|NCT01157754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93113787|NCT01265940|Vinblastine|vinblastine|mesh-list
93113788|NCT01265940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93113789|NCT01265940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113790|NCT01265940|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113791|NCT01265940|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113792|NCT01265940|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113793|NCT01265940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113794|NCT01264302|Finasteride|finasteride|mesh-list
93113795|NCT01264302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93113796|NCT01264302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93113797|NCT01264302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113798|NCT01264302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113799|NCT01264302|Hormone Antagonists|hormone antagonists|mesh-ancestor
93113800|NCT01264302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113801|NCT01264302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113802|NCT01264302|Urological Agents|urological agents|mesh-ancestor
93113803|NCT03760146|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93113804|NCT03760146|Immunologic Factors|immunologic factors|mesh-ancestor
93113805|NCT03760146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113806|NCT01161654|Naratriptan|naratriptan|mesh-list
93113807|NCT01161654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93113808|NCT01161654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93113809|NCT01161654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93113810|NCT01161654|Serotonin Agents|serotonin agents|mesh-ancestor
93113811|NCT01161654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113812|NCT01161654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113813|NCT01161654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113814|NCT01266174|Eltoprazine|eltoprazine|mesh-list
93113815|NCT01266174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93113816|NCT01266174|Serotonin Agents|serotonin agents|mesh-ancestor
93113817|NCT01266174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113818|NCT01266174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113819|NCT01266174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113820|NCT01266252|Dexmedetomidine|dexmedetomidine|mesh-list
93113821|NCT01266252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93113822|NCT01266252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93113823|NCT01266252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113824|NCT01266252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93113825|NCT01266252|Analgesics|analgesics|mesh-ancestor
93113826|NCT01266252|Sensory System Agents|sensory system agents|mesh-ancestor
93113827|NCT01266252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113828|NCT01266252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93113829|NCT01266252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93113830|NCT01266252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93113831|NCT01266252|Adrenergic Agents|adrenergic agents|mesh-ancestor
93113832|NCT01266252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113833|NCT01266252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113834|NCT01266486|Metformin|metformin|mesh-list
93113835|NCT01266486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93113836|NCT01266486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113837|NCT01161888|Imiquimod|imiquimod|mesh-list
93113838|NCT01161888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93113839|NCT01161888|Immunologic Factors|immunologic factors|mesh-ancestor
93113840|NCT01161888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113841|NCT01161888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113842|NCT01161888|Interferon Inducers|interferon inducers|mesh-ancestor
93113843|NCT03760068|Insulin Aspart|insulin aspart|mesh-list
93113844|NCT03760068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93113845|NCT03760068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113846|NCT03759600|Niraparib|niraparib|mesh-list
93113847|NCT03759600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93113848|NCT03759600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113849|NCT03759600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113850|NCT03759600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113851|NCT01161966|Zonisamide|zonisamide|mesh-list
93113852|NCT01161966|Anticonvulsants|anticonvulsants|mesh-ancestor
93113853|NCT01161966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93113854|NCT01161966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113855|NCT01161966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113856|NCT01161966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113857|NCT01161966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113858|NCT01158144|Paclitaxel|paclitaxel|mesh-list
93113859|NCT01158144|Carboplatin|carboplatin|mesh-list
93113860|NCT01158144|Endostar protein|endostar protein|mesh-list
93113861|NCT01158144|Endostatins|endostatins|mesh-list
93113862|NCT01158144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93113863|NCT01158144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113864|NCT01158144|Tubulin Modulators|tubulin modulators|mesh-ancestor
93113865|NCT01158144|Antimitotic Agents|antimitotic agents|mesh-ancestor
93113866|NCT01158144|Mitosis Modulators|mitosis modulators|mesh-ancestor
93113867|NCT01158144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113868|NCT01158144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93113869|NCT01158144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93113870|NCT01158144|Growth Substances|growth substances|mesh-ancestor
93113871|NCT01158144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113872|NCT01158144|Growth Inhibitors|growth inhibitors|mesh-ancestor
93113873|NCT01264536|Lactoferrin|lactoferrin|mesh-list
93113874|NCT01264536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113875|NCT01160172|Vaccines|vaccines|mesh-list
93113876|NCT01160172|Immunologic Factors|immunologic factors|mesh-ancestor
93113877|NCT01160172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113878|NCT03878784|Sumatriptan|sumatriptan|mesh-list
93113879|NCT03878784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93113880|NCT03878784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93113881|NCT03878784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93113882|NCT03878784|Serotonin Agents|serotonin agents|mesh-ancestor
93113883|NCT03878784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113884|NCT03878784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113885|NCT03878784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113886|NCT01266720|Gemcitabine|gemcitabine|mesh-list
93113887|NCT01266720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93113888|NCT01266720|Antimetabolites|antimetabolites|mesh-ancestor
93113889|NCT01266720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113890|NCT01266720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113891|NCT01589952|Interferons|interferons|mesh-list
93113892|NCT01589952|Entecavir|entecavir|mesh-list
93113893|NCT01589952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113894|NCT01589952|Antiviral Agents|antiviral agents|mesh-ancestor
93113895|NCT01589952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93113896|NCT03876444|Methylprednisolone|methylprednisolone|mesh-list
93113897|NCT03876444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93113898|NCT03876444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93113899|NCT03876444|Prednisolone|prednisolone|mesh-list
93113900|NCT03876444|Prednisolone acetate|prednisolone acetate|mesh-list
93113901|NCT03876444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93113902|NCT03876444|Prednisolone phosphate|prednisolone phosphate|mesh-list
93113903|NCT03876444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113904|NCT03876444|Antiemetics|antiemetics|mesh-ancestor
93113905|NCT03876444|Autonomic Agents|autonomic agents|mesh-ancestor
93113906|NCT03876444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113907|NCT03876444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113908|NCT03876444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113909|NCT03876444|Glucocorticoids|glucocorticoids|mesh-ancestor
93113910|NCT03876444|Hormones|hormones|mesh-ancestor
93113911|NCT03876444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113912|NCT03876444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93113913|NCT03876444|Protective Agents|protective agents|mesh-ancestor
93113914|NCT03876444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113915|NCT03876444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113916|NCT01264692|Amlodipine|amlodipine|mesh-list
93113917|NCT01264692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93113918|NCT01264692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93113919|NCT01264692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113920|NCT01264692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113921|NCT01264692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113922|NCT01264692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113923|NCT01264692|Vasodilator Agents|vasodilator agents|mesh-ancestor
93113924|NCT01160328|Leuprolide|leuprolide|mesh-list
93113925|NCT01160328|Testosterone|testosterone|mesh-list
93113926|NCT01160328|Androgens|androgens|mesh-ancestor
93113927|NCT01160328|Hormones|hormones|mesh-ancestor
93113928|NCT01160328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113929|NCT01160328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113930|NCT01160328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113931|NCT01160328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113932|NCT01160328|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93113933|NCT01160328|Fertility Agents|fertility agents|mesh-ancestor
93113934|NCT01160328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93113935|NCT01162746|Dexamethasone|dexamethasone|mesh-list
93113936|NCT01162746|Ranibizumab|ranibizumab|mesh-list
93113937|NCT01162746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93113938|NCT01162746|Antiemetics|antiemetics|mesh-ancestor
93113939|NCT01162746|Autonomic Agents|autonomic agents|mesh-ancestor
93113940|NCT01162746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113941|NCT01162746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113942|NCT01162746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93113943|NCT01162746|Glucocorticoids|glucocorticoids|mesh-ancestor
93113944|NCT01162746|Hormones|hormones|mesh-ancestor
93113945|NCT01162746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93113946|NCT01162746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93113947|NCT01162746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93113948|NCT01162746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93113949|NCT01162746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93113950|NCT01162746|Growth Substances|growth substances|mesh-ancestor
93113951|NCT01162746|Growth Inhibitors|growth inhibitors|mesh-ancestor
93113952|NCT01268202|Pravastatin|pravastatin|mesh-list
93113953|NCT01268202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93113954|NCT01268202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93113955|NCT01268202|Antimetabolites|antimetabolites|mesh-ancestor
93113956|NCT01268202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113957|NCT01268202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93113958|NCT01268202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93113959|NCT01268202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93113960|NCT01162824|Adenosine|adenosine|mesh-list
93113961|NCT01162824|Acetylcholine|acetylcholine|mesh-list
93113962|NCT01162824|Analgesics|analgesics|mesh-ancestor
93113963|NCT01162824|Sensory System Agents|sensory system agents|mesh-ancestor
93113964|NCT01162824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113965|NCT01162824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113966|NCT01162824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93113967|NCT01162824|Vasodilator Agents|vasodilator agents|mesh-ancestor
93113968|NCT01162824|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93113969|NCT01162824|Purinergic Agonists|purinergic agonists|mesh-ancestor
93113970|NCT01162824|Purinergic Agents|purinergic agents|mesh-ancestor
93113971|NCT01162824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113972|NCT01162824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113973|NCT01162824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93113974|NCT01162824|Cholinergic Agents|cholinergic agents|mesh-ancestor
93113975|NCT01265004|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93113976|NCT01265004|Hemostatics|hemostatics|mesh-ancestor
93113977|NCT01265004|Coagulants|coagulants|mesh-ancestor
93113978|NCT01162902|Candesartan|candesartan|mesh-list
93113979|NCT01162902|Candesartan cilexetil|candesartan cilexetil|mesh-list
93113980|NCT01162902|Bisoprolol|bisoprolol|mesh-list
93113981|NCT01162902|Diltiazem|diltiazem|mesh-list
93113982|NCT01162902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93113983|NCT01162902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93113984|NCT01162902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93113985|NCT01162902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93113986|NCT01162902|Sympatholytics|sympatholytics|mesh-ancestor
93113987|NCT01162902|Autonomic Agents|autonomic agents|mesh-ancestor
93113988|NCT01162902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93113989|NCT01162902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93113990|NCT01162902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93113991|NCT01162902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93113992|NCT01162902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93113993|NCT01162902|Adrenergic Agents|adrenergic agents|mesh-ancestor
93113994|NCT01162902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93113995|NCT01162902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93113996|NCT01162902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93113997|NCT01162902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93113998|NCT01162902|Vasodilator Agents|vasodilator agents|mesh-ancestor
93113999|NCT03877536|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93114000|NCT03877536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93114001|NCT03877536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93114002|NCT03877536|Antiviral Agents|antiviral agents|mesh-ancestor
93114003|NCT03877536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114004|NCT02526888|Diltiazem|diltiazem|mesh-list
93114005|NCT02526888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93114006|NCT02526888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93114007|NCT02526888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93114008|NCT02526888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114009|NCT02526888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93114010|NCT02526888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114011|NCT02526888|Vasodilator Agents|vasodilator agents|mesh-ancestor
93114012|NCT01158612|Hormones|hormones|mesh-list
93114013|NCT01158612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114014|NCT01158612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114015|NCT03877692|Labetalol|labetalol|mesh-list
93114016|NCT03877692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93114017|NCT03877692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93114018|NCT03877692|Adrenergic Agents|adrenergic agents|mesh-ancestor
93114019|NCT03877692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114020|NCT03877692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114021|NCT03877692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114022|NCT03877692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93114023|NCT03877692|Sympathomimetics|sympathomimetics|mesh-ancestor
93114024|NCT03877692|Autonomic Agents|autonomic agents|mesh-ancestor
93114025|NCT03877692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114026|NCT03877692|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93114027|NCT03877692|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93114028|NCT01158846|Bivalirudin|bivalirudin|mesh-list
93114029|NCT01158846|Abciximab|abciximab|mesh-list
93114030|NCT01158846|Clopidogrel|clopidogrel|mesh-list
93114031|NCT01158846|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93114032|NCT01158846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93114033|NCT01158846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93114034|NCT01158846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93114035|NCT01158846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93114036|NCT01158846|Purinergic Agents|purinergic agents|mesh-ancestor
93114037|NCT01158846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114038|NCT01158846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114039|NCT01158846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114040|NCT01158846|Antithrombins|antithrombins|mesh-ancestor
93114041|NCT01158846|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93114042|NCT01158846|Protease Inhibitors|protease inhibitors|mesh-ancestor
93114043|NCT01158846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114044|NCT01158846|Anticoagulants|anticoagulants|mesh-ancestor
93114045|NCT01268670|Ibuprofen|ibuprofen|mesh-list
93114046|NCT01268670|Oxycodone|oxycodone|mesh-list
93114047|NCT01268670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93114048|NCT01268670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93114049|NCT01268670|Analgesics|analgesics|mesh-ancestor
93114050|NCT01268670|Sensory System Agents|sensory system agents|mesh-ancestor
93114051|NCT01268670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114052|NCT01268670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114053|NCT01268670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93114054|NCT01268670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114055|NCT01268670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93114056|NCT01268670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114057|NCT01268670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114058|NCT01268670|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93114059|NCT01268670|Narcotics|narcotics|mesh-ancestor
93114060|NCT01268670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114061|NCT01160718|Fulvestrant|fulvestrant|mesh-list
93114062|NCT01160718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93114063|NCT01160718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114064|NCT01160718|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93114065|NCT01160718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93114066|NCT01160718|Hormone Antagonists|hormone antagonists|mesh-ancestor
93114067|NCT01160718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114068|NCT01160718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114069|NCT01159080|Mycophenolic Acid|mycophenolic acid|mesh-list
93114070|NCT01159080|Tacrolimus|tacrolimus|mesh-list
93114071|NCT01159080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114072|NCT01159080|Immunologic Factors|immunologic factors|mesh-ancestor
93114073|NCT01159080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114074|NCT01159080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93114075|NCT01159080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114076|NCT01159080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114077|NCT01159080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93114078|NCT01159080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114079|NCT01159080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93114080|NCT01159080|Antitubercular Agents|antitubercular agents|mesh-ancestor
93114081|NCT01159080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114082|NCT01159080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114083|NCT01160952|Itraconazole|itraconazole|mesh-list
93114084|NCT01160952|Antifungal Agents|antifungal agents|mesh-ancestor
93114085|NCT01160952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114086|NCT01160952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93114087|NCT01160952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93114088|NCT01160952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114089|NCT01160952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114090|NCT01160952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93114091|NCT01160952|Hormone Antagonists|hormone antagonists|mesh-ancestor
93114092|NCT01160952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114093|NCT01160952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114094|NCT01160952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93114095|NCT01159158|Nateglinide|nateglinide|mesh-list
93114096|NCT01159158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114097|NCT01159158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114098|NCT01161108|Melatonin|melatonin|mesh-list
93114099|NCT01161108|Antioxidants|antioxidants|mesh-ancestor
93114100|NCT01161108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114101|NCT01161108|Protective Agents|protective agents|mesh-ancestor
93114102|NCT01161108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114103|NCT01161108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114104|NCT01161186|Paclitaxel|paclitaxel|mesh-list
93114105|NCT01161186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93114106|NCT01161186|Gemcitabine|gemcitabine|mesh-list
93114107|NCT01161186|Capecitabine|capecitabine|mesh-list
93114108|NCT01161186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114109|NCT01161186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114110|NCT01161186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114111|NCT01161186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114112|NCT01161186|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114113|NCT01161186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114114|NCT01161186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114115|NCT01161186|Antimetabolites|antimetabolites|mesh-ancestor
93114116|NCT01159236|Paclitaxel|paclitaxel|mesh-list
93114117|NCT01159236|Cyclophosphamide|cyclophosphamide|mesh-list
93114118|NCT01159236|Bevacizumab|bevacizumab|mesh-list
93114119|NCT01159236|Doxorubicin|doxorubicin|mesh-list
93114120|NCT01159236|Fluorouracil|fluorouracil|mesh-list
93114121|NCT01159236|Epirubicin|epirubicin|mesh-list
93114122|NCT01159236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114123|NCT01159236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114124|NCT01159236|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114125|NCT01159236|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114126|NCT01159236|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114127|NCT01159236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114128|NCT01159236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114129|NCT01159236|Immunologic Factors|immunologic factors|mesh-ancestor
92786368|NCT01074450|Antioxidants|antioxidants|mesh-ancestor
93114130|NCT01159236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114131|NCT01159236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114132|NCT01159236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93114133|NCT01159236|Alkylating Agents|alkylating agents|mesh-ancestor
93114134|NCT01159236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93114135|NCT01159236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114136|NCT01159236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93114137|NCT01159236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93114138|NCT01159236|Growth Substances|growth substances|mesh-ancestor
93114139|NCT01159236|Growth Inhibitors|growth inhibitors|mesh-ancestor
93114140|NCT01159236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93114141|NCT01159236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93114142|NCT01159236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114143|NCT01159236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114144|NCT01159236|Antimetabolites|antimetabolites|mesh-ancestor
93114145|NCT01159236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114146|NCT01267344|Gemcitabine|gemcitabine|mesh-list
93114147|NCT01267344|Oxaliplatin|oxaliplatin|mesh-list
93114148|NCT01267344|Cetuximab|cetuximab|mesh-list
93114149|NCT01267344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114150|NCT01267344|Antimetabolites|antimetabolites|mesh-ancestor
93114151|NCT01267344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114152|NCT01267344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114153|NCT01267344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114154|NCT03879564|Ketamine|ketamine|mesh-list
93114155|NCT03879564|Analgesics|analgesics|mesh-ancestor
93114156|NCT03879564|Sensory System Agents|sensory system agents|mesh-ancestor
93114157|NCT03879564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114158|NCT03879564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114159|NCT03879564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93114160|NCT03879564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93114161|NCT03879564|Anesthetics, General|anesthetics, general|mesh-ancestor
93114162|NCT03879564|Anesthetics|anesthetics|mesh-ancestor
93114163|NCT03879564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114164|NCT03879564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93114165|NCT03879564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93114166|NCT03879564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114167|NCT03879564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114168|NCT01581840|Panitumumab|panitumumab|mesh-list
93114169|NCT01581840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114170|NCT01581840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114171|NCT03879486|Povidone-Iodine|povidone-iodine|mesh-list
93114172|NCT03879486|Formaldehyde|formaldehyde|mesh-list
93114173|NCT03879486|Povidone|povidone|mesh-list
93114174|NCT03879486|Plasma Substitutes|plasma substitutes|mesh-ancestor
93114175|NCT03879486|Blood Substitutes|blood substitutes|mesh-ancestor
93114176|NCT03879486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93114177|NCT03879486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114178|NCT03879486|Disinfectants|disinfectants|mesh-ancestor
93114179|NCT01269294|Moxifloxacin|moxifloxacin|mesh-list
93114180|NCT01269294|Simeprevir|simeprevir|mesh-list
93114181|NCT01269294|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93114182|NCT01269294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114183|NCT01269294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114184|NCT01269294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93114185|NCT01269294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114186|NCT01269294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114187|NCT01269294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114188|NCT01269294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114189|NCT01269294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93114190|NCT01269294|Contraceptive Agents|contraceptive agents|mesh-ancestor
93114191|NCT01269294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114192|NCT01269294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044433|NCT00254163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114193|NCT01269294|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93114194|NCT01269294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93114195|NCT01269294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93114196|NCT01269294|Antiviral Agents|antiviral agents|mesh-ancestor
93114197|NCT01269294|Protease Inhibitors|protease inhibitors|mesh-ancestor
93114198|NCT01163994|Doxycycline|doxycycline|mesh-list
93114199|NCT01163994|Ceftriaxone|ceftriaxone|mesh-list
93114200|NCT01163994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114201|NCT01163994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114202|NCT01163994|Antimalarials|antimalarials|mesh-ancestor
93114203|NCT01163994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93114204|NCT01163994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93114205|NCT01267734|Everolimus|everolimus|mesh-list
93114206|NCT01267734|Clopidogrel|clopidogrel|mesh-list
93114207|NCT01267734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93114208|NCT01267734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93114209|NCT01267734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114210|NCT01267734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114211|NCT01267734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114212|NCT01267734|Immunologic Factors|immunologic factors|mesh-ancestor
93114213|NCT01267734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114214|NCT01267734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114215|NCT01267734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93114216|NCT01267734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93114217|NCT01267734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93114218|NCT01267734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93114219|NCT01267734|Purinergic Agents|purinergic agents|mesh-ancestor
93114220|NCT01267734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114221|NCT01164306|Nicotine|nicotine|mesh-list
93114222|NCT01164306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93114223|NCT01164306|Autonomic Agents|autonomic agents|mesh-ancestor
93114224|NCT01164306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114225|NCT01164306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114226|NCT01164306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93114227|NCT01164306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93114228|NCT01164306|Cholinergic Agents|cholinergic agents|mesh-ancestor
93114229|NCT01164306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114230|NCT01164306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114231|NCT01269450|Progesterone|progesterone|mesh-list
93114232|NCT01269450|Progestins|progestins|mesh-ancestor
93114233|NCT01269450|Hormones|hormones|mesh-ancestor
93114234|NCT01269450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114235|NCT01269450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114236|NCT01269528|Nitric Oxide|nitric oxide|mesh-list
93114237|NCT01269528|Methacholine Chloride|methacholine chloride|mesh-list
93114238|NCT01269528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93114239|NCT01269528|Autonomic Agents|autonomic agents|mesh-ancestor
93114240|NCT01269528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114241|NCT01269528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114242|NCT01269528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93114243|NCT01269528|Respiratory System Agents|respiratory system agents|mesh-ancestor
93114244|NCT01269528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93114245|NCT01269528|Antioxidants|antioxidants|mesh-ancestor
93114246|NCT01269528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114247|NCT01269528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114248|NCT01269528|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93114249|NCT01269528|Vasodilator Agents|vasodilator agents|mesh-ancestor
93114250|NCT01269528|Gasotransmitters|gasotransmitters|mesh-ancestor
93114251|NCT01269528|Protective Agents|protective agents|mesh-ancestor
93114252|NCT01269528|Miotics|miotics|mesh-ancestor
93114253|NCT01269528|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93114254|NCT01269528|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93114255|NCT01269528|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93114256|NCT01269528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93114257|NCT01269528|Cholinergic Agents|cholinergic agents|mesh-ancestor
93114258|NCT01268904|Valproic Acid|valproic acid|mesh-list
93114259|NCT01268904|Anticonvulsants|anticonvulsants|mesh-ancestor
93114260|NCT01268904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114261|NCT01268904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114262|NCT01268904|GABA Agents|gaba agents|mesh-ancestor
93114263|NCT01268904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114264|NCT01268904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114265|NCT01268904|Antimanic Agents|antimanic agents|mesh-ancestor
93114266|NCT01268904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93114267|NCT01268904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114268|NCT01268904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93114269|NCT01269606|Insulin|insulin|mesh-list
93114270|NCT01269606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93114271|NCT01269606|Insulin Aspart|insulin aspart|mesh-list
93114272|NCT01269606|Insulin, Long-Acting|insulin, long-acting|mesh-list
93114273|NCT01269606|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93114274|NCT01269606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114275|NCT01269606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114276|NCT03872232|Telmisartan|telmisartan|mesh-list
93114277|NCT03872232|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93114278|NCT03872232|Ezetimibe|ezetimibe|mesh-list
93114279|NCT03872232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93114280|NCT03872232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93114281|NCT03872232|Antimetabolites|antimetabolites|mesh-ancestor
93114282|NCT03872232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114283|NCT03872232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93114284|NCT03872232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93114285|NCT03872232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114286|NCT03872232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93114287|NCT03872232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93114288|NCT03872232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93114289|NCT01280214|Triamcinolone|triamcinolone|mesh-list
93114290|NCT01280214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93114291|NCT01280214|Glucocorticoids|glucocorticoids|mesh-ancestor
93114292|NCT01280214|Hormones|hormones|mesh-ancestor
93114293|NCT01280214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114294|NCT01280214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114295|NCT01165008|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93114296|NCT01165008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114297|NCT01164540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93114298|NCT01164540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93114299|NCT01164540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93114300|NCT01164540|Antimetabolites|antimetabolites|mesh-ancestor
93114301|NCT01164540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114302|NCT01164540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93114303|NCT01164540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93114304|NCT01164540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114305|NCT01269684|Everolimus|everolimus|mesh-list
93114306|NCT01269684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93114307|NCT01269684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93114308|NCT01269684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114309|NCT01269684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114310|NCT01269684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114311|NCT01269684|Immunologic Factors|immunologic factors|mesh-ancestor
93114312|NCT01269684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114313|NCT01269684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114314|NCT01165164|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93114315|NCT01165164|Lubricant Eye Drops|lubricant eye drops|mesh-list
93114316|NCT01165164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93114317|NCT01280526|Romidepsin|romidepsin|mesh-list
93114318|NCT01280526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93114319|NCT01280526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114320|NCT01280526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93114321|NCT01280526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114322|NCT01280526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114323|NCT01164774|Ramipril|ramipril|mesh-list
93114324|NCT01164774|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93114325|NCT01164774|Protease Inhibitors|protease inhibitors|mesh-ancestor
93114326|NCT01164774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114327|NCT01164774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114328|NCT01164774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93114329|NCT01269138|Thrombin|thrombin|mesh-list
93114330|NCT01269138|Hemostatics|hemostatics|mesh-ancestor
93114331|NCT01269138|Coagulants|coagulants|mesh-ancestor
93114332|NCT02526810|Insulin|insulin|mesh-list
93114333|NCT02526810|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93114334|NCT02526810|Insulin Glargine|insulin glargine|mesh-list
93114335|NCT02526810|Insulin Lispro|insulin lispro|mesh-list
93114336|NCT02526810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114337|NCT02526810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114338|NCT01280682|Rituximab|rituximab|mesh-list
93114339|NCT01280682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114340|NCT01280682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114341|NCT01280682|Immunologic Factors|immunologic factors|mesh-ancestor
93114342|NCT01280682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044582|NCT01074645|Tenofovir|tenofovir|mesh-list
93114343|NCT01280682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114344|NCT01269216|Leucovorin|leucovorin|mesh-list
93114345|NCT01269216|Irinotecan|irinotecan|mesh-list
93114346|NCT01269216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93114347|NCT01269216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114348|NCT01269216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114349|NCT01269216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114350|NCT01269216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114351|NCT01269216|Antidotes|antidotes|mesh-ancestor
93114352|NCT01269216|Protective Agents|protective agents|mesh-ancestor
93114353|NCT01269216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114354|NCT01269216|Vitamin B Complex|vitamin b complex|mesh-ancestor
93114355|NCT01269216|Vitamins|vitamins|mesh-ancestor
93114356|NCT01269216|Micronutrients|micronutrients|mesh-ancestor
93114358|NCT03874806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93114359|NCT03874806|Anesthetics, Local|anesthetics, local|mesh-ancestor
93114360|NCT03874806|Anesthetics|anesthetics|mesh-ancestor
93114361|NCT03874806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114362|NCT03874806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114363|NCT03874806|Sensory System Agents|sensory system agents|mesh-ancestor
93114364|NCT03874806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114365|NCT01165476|Treprostinil|treprostinil|mesh-list
93114366|NCT01165476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93114367|NCT01169922|Ethanol|ethanol|mesh-list
93114368|NCT01169922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93114369|NCT01169922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114370|NCT01169922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114371|NCT01169922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114372|NCT01283100|Dolutegravir|dolutegravir|mesh-list
93114373|NCT01283100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93114374|NCT01283100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93114375|NCT01283100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114376|NCT01283100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114377|NCT01283100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93114378|NCT01283100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93114379|NCT01283100|Antiviral Agents|antiviral agents|mesh-ancestor
93114380|NCT01283100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114381|NCT01269996|Metformin|metformin|mesh-list
93114382|NCT01269996|Gliclazide|gliclazide|mesh-list
93114383|NCT01269996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114384|NCT01269996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114385|NCT01283178|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93114386|NCT01283178|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93114387|NCT01283178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114388|NCT01281150|Paclitaxel|paclitaxel|mesh-list
93114389|NCT01281150|Carboplatin|carboplatin|mesh-list
93114390|NCT01281150|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93114391|NCT01281150|Veliparib|veliparib|mesh-list
93114392|NCT01281150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114393|NCT01281150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114394|NCT01281150|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114395|NCT01281150|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114396|NCT01281150|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114397|NCT01281150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114398|NCT01281150|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93114399|NCT01281150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114400|NCT03871218|Hyaluronic Acid|hyaluronic acid|mesh-list
93114401|NCT03871218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93114402|NCT03871218|Immunologic Factors|immunologic factors|mesh-ancestor
93114403|NCT03871218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114404|NCT03871218|Viscosupplements|viscosupplements|mesh-ancestor
93114405|NCT03871218|Protective Agents|protective agents|mesh-ancestor
93114406|NCT01281228|Exenatide|exenatide|mesh-list
93114407|NCT01281228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114408|NCT01281228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114409|NCT01281228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93114410|NCT01281228|Incretins|incretins|mesh-ancestor
93114411|NCT01281228|Hormones|hormones|mesh-ancestor
93114412|NCT01281228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114413|NCT01283256|Zonisamide|zonisamide|mesh-list
93114414|NCT01283256|Anticonvulsants|anticonvulsants|mesh-ancestor
93114415|NCT01283256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93114416|NCT01283256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93114417|NCT01283256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114418|NCT01283256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93114419|NCT01283256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114420|NCT01270776|Chlorhexidine|chlorhexidine|mesh-list
93114421|NCT01270776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93114422|NCT01270776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93114423|NCT01270776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114424|NCT01270776|Disinfectants|disinfectants|mesh-ancestor
93114425|NCT01270776|Dermatologic Agents|dermatologic agents|mesh-ancestor
93114426|NCT03874260|Fenofibrate|fenofibrate|mesh-list
93114427|NCT03874260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93114428|NCT03874260|Antimetabolites|antimetabolites|mesh-ancestor
93114429|NCT03874260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114430|NCT03874260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93114431|NCT01281540|Cisapride|cisapride|mesh-list
93114432|NCT01281540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93114433|NCT01281540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93114434|NCT01281540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93114435|NCT01281540|Serotonin Agents|serotonin agents|mesh-ancestor
93114436|NCT01281540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114437|NCT01281540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114438|NCT01281540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114439|NCT03874026|Cetuximab|cetuximab|mesh-list
93114440|NCT03874026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114441|NCT03874026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114442|NCT01283412|Dexmedetomidine|dexmedetomidine|mesh-list
93114443|NCT01283412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93114444|NCT01283412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114445|NCT01283412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114446|NCT01283412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93114447|NCT01283412|Analgesics|analgesics|mesh-ancestor
93114448|NCT01283412|Sensory System Agents|sensory system agents|mesh-ancestor
93114449|NCT01283412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114450|NCT01283412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93114451|NCT01283412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93114452|NCT01283412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93114453|NCT01283412|Adrenergic Agents|adrenergic agents|mesh-ancestor
93114454|NCT01283412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114455|NCT01283412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114456|NCT01271478|Telmisartan|telmisartan|mesh-list
93114457|NCT01271478|Captopril|captopril|mesh-list
93114458|NCT01271478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93114459|NCT01271478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93114460|NCT01271478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93114461|NCT01271478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114462|NCT01271478|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93114463|NCT01271478|Protease Inhibitors|protease inhibitors|mesh-ancestor
93114464|NCT01271478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114465|NCT03871062|Anesthetics|anesthetics|mesh-list
93114466|NCT03871062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114467|NCT03871062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114468|NCT01281696|Bevacizumab|bevacizumab|mesh-list
93114469|NCT01281696|Methotrexate|methotrexate|mesh-list
93114470|NCT01281696|Etoposide|etoposide|mesh-list
93114471|NCT01281696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114472|NCT01281696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114473|NCT01281696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93114474|NCT01281696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93114475|NCT01281696|Growth Substances|growth substances|mesh-ancestor
93114476|NCT01281696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114477|NCT01281696|Growth Inhibitors|growth inhibitors|mesh-ancestor
93114478|NCT01281696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93114479|NCT01281696|Abortifacient Agents|abortifacient agents|mesh-ancestor
93114480|NCT01281696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114481|NCT01281696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114482|NCT01281696|Antimetabolites|antimetabolites|mesh-ancestor
93114483|NCT01281696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114484|NCT01281696|Dermatologic Agents|dermatologic agents|mesh-ancestor
93114485|NCT01281696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114486|NCT01281696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93114487|NCT01281696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114488|NCT01281696|Immunologic Factors|immunologic factors|mesh-ancestor
93114489|NCT01281696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114490|NCT01281696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93114491|NCT01281696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114492|NCT01281696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044735|NCT01082848|Dopamine Agents|dopamine agents|mesh-ancestor
93114493|NCT01281696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114494|NCT05835713|Propofol|propofol|mesh-list
93114495|NCT05835713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93114496|NCT05835713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114497|NCT05835713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114498|NCT05835713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93114499|NCT05835713|Anesthetics, General|anesthetics, general|mesh-ancestor
93114500|NCT05835713|Anesthetics|anesthetics|mesh-ancestor
93114501|NCT05835479|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93114502|NCT05835479|Rezafungin|rezafungin|mesh-list
93114503|NCT05835479|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93114504|NCT05835479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786753|NCT00637325|Trastuzumab|trastuzumab|mesh-list
93114505|NCT05835479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114506|NCT05835479|Antimalarials|antimalarials|mesh-ancestor
93114507|NCT05835479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93114508|NCT05835479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93114509|NCT05835479|Antifungal Agents|antifungal agents|mesh-ancestor
93114510|NCT05835089|Estradiol|estradiol|mesh-list
93114511|NCT05835089|Testosterone|testosterone|mesh-list
93114512|NCT05835089|Estrogens|estrogens|mesh-ancestor
93114513|NCT05835089|Hormones|hormones|mesh-ancestor
93114514|NCT05835089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114515|NCT05835089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114516|NCT05835089|Androgens|androgens|mesh-ancestor
93114517|NCT05834868|Insulin Lispro|insulin lispro|mesh-list
93114518|NCT05834868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114519|NCT05834868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114520|NCT05834855|Rituximab|rituximab|mesh-list
93114521|NCT05834855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114522|NCT05834855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114523|NCT05834855|Immunologic Factors|immunologic factors|mesh-ancestor
93114524|NCT05834855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114525|NCT05834855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114526|NCT05834777|Icatibant|icatibant|mesh-list
93114527|NCT05834777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93114528|NCT05834777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93114529|NCT05834777|Analgesics|analgesics|mesh-ancestor
93114530|NCT05834777|Sensory System Agents|sensory system agents|mesh-ancestor
93114531|NCT05834777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114532|NCT05834777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114533|NCT05834777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93114534|NCT05834777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114535|NCT05834777|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
93114536|NCT05834777|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
93114537|NCT05834777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114538|NCT05834777|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93114539|NCT05834777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114540|NCT05834777|Immunologic Factors|immunologic factors|mesh-ancestor
93114541|NCT05834764|Maleic acid|maleic acid|mesh-list
93114542|NCT05834764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114543|NCT05834764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114544|NCT05834738|Atrasentan|atrasentan|mesh-list
93114545|NCT05834738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114546|NCT05834738|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93114547|NCT05834738|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93114548|NCT05834738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114549|NCT05834647|Lidocaine|lidocaine|mesh-list
93114550|NCT05834647|Prilocaine|prilocaine|mesh-list
93114551|NCT05834647|Anesthetics, Local|anesthetics, local|mesh-ancestor
93114552|NCT05834647|Anesthetics|anesthetics|mesh-ancestor
93114553|NCT05834647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114554|NCT05834647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114555|NCT05834647|Sensory System Agents|sensory system agents|mesh-ancestor
93114556|NCT05834647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114557|NCT05834647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93114558|NCT05834647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93114559|NCT05834647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93114560|NCT05834647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93114561|NCT05834647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114562|NCT05834582|Paclitaxel|paclitaxel|mesh-list
93114563|NCT05834582|Cyclophosphamide|cyclophosphamide|mesh-list
93114564|NCT05834582|Epirubicin|epirubicin|mesh-list
93114565|NCT05834582|Fluzoparib|fluzoparib|mesh-list
93114566|NCT05834582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114567|NCT05834582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114568|NCT05834582|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114569|NCT05834582|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114570|NCT05834582|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114571|NCT05834582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114572|NCT05834582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114573|NCT05834582|Immunologic Factors|immunologic factors|mesh-ancestor
93114574|NCT05834582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114575|NCT05834582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114576|NCT05834582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93114577|NCT05834582|Alkylating Agents|alkylating agents|mesh-ancestor
93114578|NCT05834582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93114579|NCT05834582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93114580|NCT05834582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93114581|NCT05834582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114582|NCT05834582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114583|NCT05834582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93114584|NCT05834543|Paclitaxel|paclitaxel|mesh-list
93114585|NCT05834543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93114586|NCT05834543|Cisplatin|cisplatin|mesh-list
93114587|NCT05834543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114588|NCT05834543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114589|NCT05834543|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114590|NCT05834543|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114591|NCT05834543|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114592|NCT05834543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114593|NCT05834517|Hyaluronic Acid|hyaluronic acid|mesh-list
93114594|NCT05834517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93114595|NCT05834517|Immunologic Factors|immunologic factors|mesh-ancestor
93114596|NCT05834517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114597|NCT05834517|Viscosupplements|viscosupplements|mesh-ancestor
93114598|NCT05834517|Protective Agents|protective agents|mesh-ancestor
93114599|NCT05834478|Fallypride|fallypride|mesh-list
93114600|NCT05834478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93114601|NCT05834478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93114602|NCT05834478|Dopamine Agents|dopamine agents|mesh-ancestor
93114603|NCT05834478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114604|NCT05834478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114605|NCT05834478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114606|NCT05834361|Carboprost|carboprost|mesh-list
93114607|NCT05834361|Carboprost tromethamine|carboprost tromethamine|mesh-list
93114608|NCT05834361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93114609|NCT05834361|Abortifacient Agents|abortifacient agents|mesh-ancestor
93114610|NCT05834361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114611|NCT05834361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114612|NCT05834361|Oxytocics|oxytocics|mesh-ancestor
93114613|NCT05834348|Docetaxel|docetaxel|mesh-list
93114614|NCT05834348|Bevacizumab|bevacizumab|mesh-list
93114615|NCT05834348|Carboplatin|carboplatin|mesh-list
93114616|NCT05834348|Pembrolizumab|pembrolizumab|mesh-list
93114617|NCT05834348|Nivolumab|nivolumab|mesh-list
93114618|NCT05834348|Atezolizumab|atezolizumab|mesh-list
93114619|NCT05834348|Gefitinib|gefitinib|mesh-list
93114620|NCT05834348|Osimertinib|osimertinib|mesh-list
93114621|NCT05834348|Afatinib|afatinib|mesh-list
93114622|NCT05834348|Crizotinib|crizotinib|mesh-list
93114623|NCT05834348|Ceritinib|ceritinib|mesh-list
93114624|NCT05834348|Entrectinib|entrectinib|mesh-list
93114625|NCT05834348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114626|NCT05834348|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114627|NCT05834348|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114628|NCT05834348|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114629|NCT05834348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114630|NCT05834348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114631|NCT05834348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93114632|NCT05834348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93114633|NCT05834348|Growth Substances|growth substances|mesh-ancestor
93114634|NCT05834348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114635|NCT05834348|Growth Inhibitors|growth inhibitors|mesh-ancestor
93114636|NCT05834348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93114637|NCT05834348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93114638|NCT05834348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114639|NCT05834270|Tamsulosin|tamsulosin|mesh-list
93114640|NCT05834270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93114641|NCT05834270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93114642|NCT05834270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93114643|NCT05834270|Adrenergic Agents|adrenergic agents|mesh-ancestor
93114644|NCT05834270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114645|NCT05834270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114646|NCT05834270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114647|NCT05834270|Urological Agents|urological agents|mesh-ancestor
93114648|NCT05834244|Azacitidine|azacitidine|mesh-list
93114649|NCT05834244|Venetoclax|venetoclax|mesh-list
93114650|NCT05834244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114651|NCT05834244|Antimetabolites|antimetabolites|mesh-ancestor
93114652|NCT05834244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114653|NCT05834244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114654|NCT05834244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114655|NCT05834231|Memantine|memantine|mesh-list
93114656|NCT05834231|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93114657|NCT05834231|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93114658|NCT05834231|Dopamine Agents|dopamine agents|mesh-ancestor
93114659|NCT05834231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114660|NCT05834231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114661|NCT05834231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114662|NCT05834231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93114663|NCT05834231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93114664|NCT05833958|Metformin|metformin|mesh-list
93114665|NCT05833958|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93114666|NCT05833958|Dapagliflozin|dapagliflozin|mesh-list
93114667|NCT05833958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114668|NCT05833958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114669|NCT05833958|Incretins|incretins|mesh-ancestor
93114670|NCT05833958|Hormones|hormones|mesh-ancestor
93114671|NCT05833958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114672|NCT05833958|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93114673|NCT05833958|Protease Inhibitors|protease inhibitors|mesh-ancestor
93114674|NCT05833958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114675|NCT05833958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114676|NCT05833958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93114677|NCT05830162|Amoxicillin|amoxicillin|mesh-list
93114678|NCT05830162|Clavulanic Acids|clavulanic acids|mesh-list
93114679|NCT05830162|Clavulanic Acid|clavulanic acid|mesh-list
93114680|NCT05830162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114681|NCT05830162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114682|NCT05830162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114683|NCT05830162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114684|NCT05830162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93114685|NCT05829707|Diclofenac|diclofenac|mesh-list
93114686|NCT05829707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93114687|NCT05829707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93114688|NCT05829707|Anesthetics|anesthetics|mesh-list
93114689|NCT05829707|Levobupivacaine|levobupivacaine|mesh-list
93114690|NCT05829707|Anesthetics, Local|anesthetics, local|mesh-list
93114691|NCT05829707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114692|NCT05829707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114693|NCT05829707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93114694|NCT05829707|Analgesics|analgesics|mesh-ancestor
93114695|NCT05829707|Sensory System Agents|sensory system agents|mesh-ancestor
93114696|NCT05829707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114697|NCT05829707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114698|NCT05829707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93114699|NCT05829707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114700|NCT05829707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114701|NCT05823948|Insulin|insulin|mesh-list
93114702|NCT05823948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114703|NCT05823948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114704|NCT05819918|Calcifediol|calcifediol|mesh-list
93114705|NCT05819918|Vitamins|vitamins|mesh-ancestor
93114706|NCT05819918|Micronutrients|micronutrients|mesh-ancestor
93114707|NCT05819918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114708|NCT05819918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93114709|NCT05810883|Insulin|insulin|mesh-list
93114710|NCT05810883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114711|NCT05810883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114712|NCT05807074|Tranexamic Acid|tranexamic acid|mesh-list
93114713|NCT05807074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93114714|NCT05807074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93114715|NCT05807074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114716|NCT05807074|Hemostatics|hemostatics|mesh-ancestor
93114717|NCT05807074|Coagulants|coagulants|mesh-ancestor
93114718|NCT05804162|Moxifloxacin|moxifloxacin|mesh-list
93114719|NCT05804162|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93114720|NCT05804162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114721|NCT05804162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114722|NCT05804162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93114723|NCT05804162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114724|NCT05804162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114725|NCT05804162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114726|NCT05804162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114727|NCT05804162|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93114728|NCT05804162|Contraceptive Agents|contraceptive agents|mesh-ancestor
93114729|NCT05804162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114730|NCT05804162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114731|NCT05804162|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93114732|NCT05804162|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93114733|NCT05804162|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93114734|NCT05789303|Dexamethasone|dexamethasone|mesh-list
93114735|NCT05789303|Pomalidomide|pomalidomide|mesh-list
93114736|NCT05789303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93114737|NCT05789303|Antiemetics|antiemetics|mesh-ancestor
93114738|NCT05789303|Autonomic Agents|autonomic agents|mesh-ancestor
93114739|NCT05789303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114740|NCT05789303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114741|NCT05789303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93114742|NCT05789303|Glucocorticoids|glucocorticoids|mesh-ancestor
93114743|NCT05789303|Hormones|hormones|mesh-ancestor
93114744|NCT05789303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114745|NCT05789303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93114746|NCT05789303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114747|NCT05789303|Immunologic Factors|immunologic factors|mesh-ancestor
93114748|NCT05789303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93114749|NCT05789303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93114750|NCT05789303|Growth Substances|growth substances|mesh-ancestor
93114751|NCT05789303|Growth Inhibitors|growth inhibitors|mesh-ancestor
93114752|NCT05772273|Azacitidine|azacitidine|mesh-list
93114753|NCT05772273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114754|NCT05772273|Antimetabolites|antimetabolites|mesh-ancestor
93114755|NCT05772273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114756|NCT05772273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114757|NCT05772273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114758|NCT05753098|Sildenafil Citrate|sildenafil citrate|mesh-list
93114759|NCT05753098|Clomiphene|clomiphene|mesh-list
93114760|NCT05753098|Enclomiphene|enclomiphene|mesh-list
93114761|NCT05753098|Zuclomiphene|zuclomiphene|mesh-list
93114762|NCT05753098|Estrogens|estrogens|mesh-list
93114763|NCT05753098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114764|NCT05753098|Vasodilator Agents|vasodilator agents|mesh-ancestor
93114765|NCT05753098|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93114766|NCT05753098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93114767|NCT05753098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114768|NCT05753098|Urological Agents|urological agents|mesh-ancestor
93114769|NCT05753098|Hormones|hormones|mesh-ancestor
93114770|NCT05753098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114771|NCT05753098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114772|NCT05753098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93114773|NCT05753098|Hormone Antagonists|hormone antagonists|mesh-ancestor
93114774|NCT05753098|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93114775|NCT05753098|Fertility Agents|fertility agents|mesh-ancestor
93114776|NCT05753098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114777|NCT05753098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93114778|NCT05753098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93114779|NCT05726292|Androgens|androgens|mesh-list
93114780|NCT05726292|Hormones|hormones|mesh-ancestor
93114781|NCT05726292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93114782|NCT05726292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114783|NCT05723562|Dostarlimab|dostarlimab|mesh-list
93114784|NCT05723562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114785|NCT05699811|Paclitaxel|paclitaxel|mesh-list
93114786|NCT05699811|Cyclophosphamide|cyclophosphamide|mesh-list
93114787|NCT05699811|Tislelizumab|tislelizumab|mesh-list
93114788|NCT05699811|Antibodies|antibodies|mesh-list
93114789|NCT05699811|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93114790|NCT05699811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114791|NCT05699811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114792|NCT05699811|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114793|NCT05699811|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114794|NCT05699811|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114795|NCT05699811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114796|NCT05699811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114797|NCT05699811|Immunologic Factors|immunologic factors|mesh-ancestor
93114798|NCT05699811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114799|NCT05699811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114800|NCT05699811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93114801|NCT05699811|Alkylating Agents|alkylating agents|mesh-ancestor
93114802|NCT05699811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93114803|NCT05699811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114804|NCT05692908|Immunoconjugates|immunoconjugates|mesh-list
93114805|NCT05692908|Immunologic Factors|immunologic factors|mesh-ancestor
93114806|NCT05692908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114807|NCT05692843|Cyclosporine|cyclosporine|mesh-list
93114808|NCT05692843|Cyclosporins|cyclosporins|mesh-list
93114809|NCT05692843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114810|NCT05692843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114811|NCT05692843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114812|NCT05692843|Immunologic Factors|immunologic factors|mesh-ancestor
93114813|NCT05692843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114814|NCT05692843|Antifungal Agents|antifungal agents|mesh-ancestor
93114815|NCT05692843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114816|NCT05692843|Dermatologic Agents|dermatologic agents|mesh-ancestor
93114817|NCT05692843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114818|NCT05692843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93114819|NCT05662865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93114820|NCT05662865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114821|NCT05662865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114822|NCT05662865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114823|NCT05660616|Gemcitabine|gemcitabine|mesh-list
93114824|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114825|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
93114826|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114827|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114828|NCT05659810|Gabapentin|gabapentin|mesh-list
93114829|NCT05659810|Analgesics|analgesics|mesh-ancestor
93114830|NCT05659810|Sensory System Agents|sensory system agents|mesh-ancestor
93114831|NCT05659810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114832|NCT05659810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114833|NCT05659810|Anticonvulsants|anticonvulsants|mesh-ancestor
93114834|NCT05659810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93114835|NCT05659810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93114836|NCT05659810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93114837|NCT05659810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93114838|NCT05659810|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93114839|NCT05659810|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93114840|NCT05659810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93114841|NCT05659810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114842|NCT05659810|Antimanic Agents|antimanic agents|mesh-ancestor
93114843|NCT05658497|Interferons|interferons|mesh-list
93114844|NCT05658497|Interferon-beta|interferon-beta|mesh-list
93114845|NCT05658497|Interferon beta-1a|interferon beta-1a|mesh-list
93114846|NCT05658497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93114847|NCT05658497|Natalizumab|natalizumab|mesh-list
93114848|NCT05658497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114849|NCT05658497|Antiviral Agents|antiviral agents|mesh-ancestor
93114850|NCT05658497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114851|NCT05658497|Immunologic Factors|immunologic factors|mesh-ancestor
93114852|NCT05658497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114853|NCT05658497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93114854|NCT05658497|Dermatologic Agents|dermatologic agents|mesh-ancestor
93114855|NCT05658497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114856|NCT05645757|Ertapenem|ertapenem|mesh-list
93114857|NCT05645757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93114858|NCT05645757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114859|NCT05625347|Aspirin|aspirin|mesh-list
93114860|NCT05625347|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93114861|NCT05625347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93114862|NCT05625347|Analgesics|analgesics|mesh-ancestor
93114863|NCT05625347|Sensory System Agents|sensory system agents|mesh-ancestor
93114864|NCT05625347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114865|NCT05625347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114866|NCT05625347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93114867|NCT05625347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114868|NCT05625347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93114869|NCT05625347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93114870|NCT05625347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114871|NCT05625347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93114872|NCT05625347|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93114873|NCT05625347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114874|NCT05625347|Antipyretics|antipyretics|mesh-ancestor
93114875|NCT05619913|Pembrolizumab|pembrolizumab|mesh-list
93114876|NCT05619913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114877|NCT05619913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114878|NCT05619913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93114879|NCT05619913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114880|NCT05602194|Asparaginase|asparaginase|mesh-list
93114881|NCT05602194|Pegaspargase|pegaspargase|mesh-list
93114882|NCT05602194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114883|NCT05594680|Methotrexate|methotrexate|mesh-list
93114884|NCT05594680|Cilostazol|cilostazol|mesh-list
93114885|NCT05594680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93114886|NCT05594680|Abortifacient Agents|abortifacient agents|mesh-ancestor
93114887|NCT05594680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114888|NCT05594680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114889|NCT05594680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114890|NCT05594680|Antimetabolites|antimetabolites|mesh-ancestor
93114891|NCT05594680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114892|NCT05594680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114893|NCT05594680|Dermatologic Agents|dermatologic agents|mesh-ancestor
93114894|NCT05594680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114895|NCT05594680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93114896|NCT05594680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114897|NCT05594680|Immunologic Factors|immunologic factors|mesh-ancestor
93114898|NCT05594680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114899|NCT05594680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93114900|NCT05594680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93114901|NCT05594680|Autonomic Agents|autonomic agents|mesh-ancestor
93114902|NCT05594680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93114903|NCT05594680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93114904|NCT05594680|Respiratory System Agents|respiratory system agents|mesh-ancestor
93114905|NCT05594680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93114906|NCT05594680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93114907|NCT05594680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93114908|NCT05594680|Vasodilator Agents|vasodilator agents|mesh-ancestor
93114909|NCT05594680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93114910|NCT05594680|Protective Agents|protective agents|mesh-ancestor
93114911|NCT05594680|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93114912|NCT05594680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93114913|NCT05594563|Eflornithine|eflornithine|mesh-list
93114914|NCT05594563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114915|NCT05594563|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93114916|NCT05594563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93114917|NCT05594563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93114918|NCT05594563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93114919|NCT05594563|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93114920|NCT05594563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114921|NCT05594563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114922|NCT05569044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93114923|NCT05567029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93114924|NCT05567029|Immunologic Factors|immunologic factors|mesh-ancestor
93114925|NCT05567029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114926|NCT05557643|Psilocybin|psilocybin|mesh-list
93114927|NCT05557643|Hallucinogens|hallucinogens|mesh-ancestor
93114928|NCT05557643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114929|NCT05557643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93114930|NCT05526443|Antineoplastic Agents|antineoplastic agents|mesh-list
93114931|NCT05488457|Oxytocin|oxytocin|mesh-list
93114932|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
93114933|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93114934|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114935|NCT05470283|Cyclophosphamide|cyclophosphamide|mesh-list
93114936|NCT05470283|Fludarabine|fludarabine|mesh-list
93114937|NCT05470283|Fludarabine phosphate|fludarabine phosphate|mesh-list
93114938|NCT05470283|Furosemide|furosemide|mesh-list
93114939|NCT05470283|Acetazolamide|acetazolamide|mesh-list
93114940|NCT05470283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93114941|NCT05470283|Immunologic Factors|immunologic factors|mesh-ancestor
93114942|NCT05470283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114943|NCT05470283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114944|NCT05470283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93114945|NCT05470283|Alkylating Agents|alkylating agents|mesh-ancestor
93114946|NCT05470283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114947|NCT05470283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114948|NCT05470283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93114949|NCT05470283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93114950|NCT05470283|Antimetabolites|antimetabolites|mesh-ancestor
93114951|NCT05470283|Diuretics|diuretics|mesh-ancestor
93114952|NCT05470283|Natriuretic Agents|natriuretic agents|mesh-ancestor
93114953|NCT05470283|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93114954|NCT05470283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93114955|NCT05470283|Anticonvulsants|anticonvulsants|mesh-ancestor
93114956|NCT05470283|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93114957|NCT05470283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114958|NCT05422534|Ubiquinone|ubiquinone|mesh-list
93114959|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
93114960|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114961|NCT05404945|Doxorubicin|doxorubicin|mesh-list
93114962|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
93114963|NCT05404945|Dacarbazine|dacarbazine|mesh-list
93114964|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93114965|NCT05404945|Vinblastine|vinblastine|mesh-list
93114966|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93114967|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93114968|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93114969|NCT05404945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93114970|NCT05404945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93114971|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114972|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93114973|NCT05404945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93114974|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93114975|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
93114976|NCT05404945|Immunotoxins|immunotoxins|mesh-ancestor
93114977|NCT05404945|Immunoconjugates|immunoconjugates|mesh-ancestor
93114978|NCT05404945|Immunologic Factors|immunologic factors|mesh-ancestor
93114979|NCT05404945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114980|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93114981|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
93114982|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
93114983|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
93114984|NCT05365451|Metformin|metformin|mesh-list
93114985|NCT05365451|Probenecid|probenecid|mesh-list
93114986|NCT05365451|Furosemide|furosemide|mesh-list
93114987|NCT05365451|Cimetidine|cimetidine|mesh-list
93114988|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93114989|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93114990|NCT05365451|Diuretics|diuretics|mesh-ancestor
93114991|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
93114992|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93114993|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93114994|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93114995|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
93114996|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
93114997|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93114998|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93114999|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115000|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93115001|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
93115002|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
93115003|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115004|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93115005|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93115006|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115007|NCT05325593|Dexamethasone|dexamethasone|mesh-list
93115008|NCT05325593|Dexamethasone acetate|dexamethasone acetate|mesh-list
93115009|NCT05325593|BB 1101|bb 1101|mesh-list
93115010|NCT05325593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115011|NCT05325593|Antiemetics|antiemetics|mesh-ancestor
93115012|NCT05325593|Autonomic Agents|autonomic agents|mesh-ancestor
93115013|NCT05325593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115014|NCT05325593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115015|NCT05325593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115016|NCT05325593|Glucocorticoids|glucocorticoids|mesh-ancestor
93115017|NCT05325593|Hormones|hormones|mesh-ancestor
93115018|NCT05325593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115019|NCT05325593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115020|NCT05325593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115021|NCT05325593|Protease Inhibitors|protease inhibitors|mesh-ancestor
93115022|NCT05325593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115023|NCT05325593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115024|NCT05322967|Antihypertensive Agents|antihypertensive agents|mesh-list
93115025|NCT05321121|Dexmedetomidine|dexmedetomidine|mesh-list
93115026|NCT05321121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93115027|NCT05321121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93115028|NCT05321121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115029|NCT05321121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93115030|NCT05321121|Analgesics|analgesics|mesh-ancestor
93115031|NCT05321121|Sensory System Agents|sensory system agents|mesh-ancestor
93115032|NCT05321121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115033|NCT05321121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93115034|NCT05321121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93115036|NCT05321121|Adrenergic Agents|adrenergic agents|mesh-ancestor
93115037|NCT05321121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115038|NCT05321121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115039|NCT05310734|Benzyl Alcohol|benzyl alcohol|mesh-list
93115040|NCT05310734|Anesthetics, Local|anesthetics, local|mesh-ancestor
93115041|NCT05310734|Anesthetics|anesthetics|mesh-ancestor
93115042|NCT05310734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93115043|NCT05310734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115044|NCT05310734|Sensory System Agents|sensory system agents|mesh-ancestor
93115045|NCT05310734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115046|NCT05284552|Tinzaparin|tinzaparin|mesh-list
93115047|NCT05284552|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93115048|NCT05284552|Dalteparin|dalteparin|mesh-list
93115049|NCT05284552|Anticoagulants|anticoagulants|mesh-ancestor
93115050|NCT05284552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93115051|NCT05284552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93115052|NCT05284552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115053|NCT05281614|Etanercept|etanercept|mesh-list
93115054|NCT05281614|Vedolizumab|vedolizumab|mesh-list
93115055|NCT05281614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93115056|NCT05281614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93115057|NCT05281614|Analgesics|analgesics|mesh-ancestor
93115058|NCT05281614|Sensory System Agents|sensory system agents|mesh-ancestor
93115059|NCT05281614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115060|NCT05281614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115061|NCT05281614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115062|NCT05281614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93115063|NCT05281614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115064|NCT05281614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115065|NCT05281614|Immunologic Factors|immunologic factors|mesh-ancestor
93115066|NCT05228288|Pyrithione zinc|pyrithione zinc|mesh-list
93115067|NCT05228288|Keratolytic Agents|keratolytic agents|mesh-ancestor
93115068|NCT05228288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93115069|NCT05215574|Pembrolizumab|pembrolizumab|mesh-list
93115070|NCT05215574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115071|NCT05215574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115072|NCT05215574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115073|NCT05215574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115074|NCT05215418|Topiramate|topiramate|mesh-list
93115075|NCT05215418|Phentermine|phentermine|mesh-list
93115076|NCT05215418|Anticonvulsants|anticonvulsants|mesh-ancestor
93115077|NCT05215418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93115078|NCT05215418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115079|NCT05215418|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93115080|NCT05215418|Appetite Depressants|appetite depressants|mesh-ancestor
93115081|NCT05215418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93115082|NCT05215418|Sympathomimetics|sympathomimetics|mesh-ancestor
93115083|NCT05215418|Autonomic Agents|autonomic agents|mesh-ancestor
93115084|NCT05215418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115085|NCT05215418|Adrenergic Agents|adrenergic agents|mesh-ancestor
93115086|NCT05215418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115087|NCT05215418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115088|NCT05053737|Atezolizumab|atezolizumab|mesh-list
93115089|NCT05053737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115090|NCT05053737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115091|NCT05053737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115092|NCT05053737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115093|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
93115094|NCT05041153|Lenvatinib|lenvatinib|mesh-list
93115095|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115096|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115097|NCT05041153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115098|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115099|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93115100|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115101|NCT05019703|Atezolizumab|atezolizumab|mesh-list
93115102|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93115103|NCT05019703|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115104|NCT05019703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115105|NCT05019703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115106|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787341|NCT02759926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93115107|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
93115108|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115110|NCT04955938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115111|NCT04955938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115112|NCT04955938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115113|NCT04907851|Denosumab|denosumab|mesh-list
93115114|NCT04907851|Pembrolizumab|pembrolizumab|mesh-list
93115115|NCT04907851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115116|NCT04907851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115117|NCT04907851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115118|NCT04907851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115119|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93115120|NCT04907851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115121|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
93115122|NCT04879589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115123|NCT04879589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93115124|NCT04879589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115125|NCT04879589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115126|NCT04879589|Hormone Antagonists|hormone antagonists|mesh-ancestor
93115127|NCT04879589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115128|NCT04879589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115129|NCT04879589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93115130|NCT04872608|Letrozole|letrozole|mesh-list
93115131|NCT04872608|Palbociclib|palbociclib|mesh-list
93115132|NCT04872608|Onapristone|onapristone|mesh-list
93115133|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115134|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93115135|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93115136|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115137|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115138|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93115139|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
93115140|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115141|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115142|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93115143|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93115144|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
93115145|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93115146|NCT04869501|Atezolizumab|atezolizumab|mesh-list
93115147|NCT04869501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115148|NCT04869501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115149|NCT04869501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115150|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115151|NCT04831398|Melatonin|melatonin|mesh-list
93115152|NCT04831398|Antioxidants|antioxidants|mesh-ancestor
93115153|NCT04831398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115154|NCT04831398|Protective Agents|protective agents|mesh-ancestor
93115155|NCT04831398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115156|NCT04831398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93115157|NCT04826484|Bupivacaine|bupivacaine|mesh-list
93115158|NCT04826484|Anesthetics, Local|anesthetics, local|mesh-ancestor
93115159|NCT04826484|Anesthetics|anesthetics|mesh-ancestor
93115160|NCT04826484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93115161|NCT04826484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115162|NCT04826484|Sensory System Agents|sensory system agents|mesh-ancestor
93115163|NCT04826484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115164|NCT04801849|Vitamin E|vitamin e|mesh-list
93115165|NCT04801849|Tocopherols|tocopherols|mesh-list
93115166|NCT04801849|alpha-Tocopherol|alpha-tocopherol|mesh-list
93115167|NCT04801849|Vitamins|vitamins|mesh-ancestor
93115168|NCT04801849|Micronutrients|micronutrients|mesh-ancestor
93115169|NCT04801849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115170|NCT04801849|Antioxidants|antioxidants|mesh-ancestor
93115171|NCT04801849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115172|NCT04801849|Protective Agents|protective agents|mesh-ancestor
93115173|NCT04714359|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93115174|NCT04714359|Hallucinogens|hallucinogens|mesh-ancestor
93115175|NCT04714359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115176|NCT04714359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93115177|NCT04714359|Serotonin Agents|serotonin agents|mesh-ancestor
93115178|NCT04714359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115179|NCT04714359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115180|NCT04714359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93115181|NCT04714359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93115182|NCT04714359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93115183|NCT04714359|Adrenergic Agents|adrenergic agents|mesh-ancestor
93115184|NCT04635839|Heparin|heparin|mesh-list
93115185|NCT04635839|Calcium heparin|calcium heparin|mesh-list
93115186|NCT04635839|Anticoagulants|anticoagulants|mesh-ancestor
93115187|NCT04635839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93115188|NCT04635839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93115189|NCT04635839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115190|NCT04610671|Nivolumab|nivolumab|mesh-list
93115191|NCT04610671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115192|NCT04610671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115193|NCT04610671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115194|NCT04610671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115195|NCT04591275|Denosumab|denosumab|mesh-list
93115196|NCT04591275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93115197|NCT04591275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115198|NCT04560179|Tobramycin|tobramycin|mesh-list
93115199|NCT04560179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93115200|NCT04560179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93115201|NCT04560179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115202|NCT04543591|Ravulizumab|ravulizumab|mesh-list
93115203|NCT04543591|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93115204|NCT04543591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115205|NCT04543591|Immunologic Factors|immunologic factors|mesh-ancestor
93115206|NCT04543591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115207|NCT04536337|Entecavir|entecavir|mesh-list
93115208|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
93115209|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115210|NCT04515836|Olaparib|olaparib|mesh-list
93115211|NCT04515836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93115212|NCT04515836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115213|NCT04515836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115214|NCT04515836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115215|NCT04454684|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93115216|NCT04454684|Hallucinogens|hallucinogens|mesh-ancestor
93115217|NCT04454684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115218|NCT04454684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93115219|NCT04454684|Serotonin Agents|serotonin agents|mesh-ancestor
93115220|NCT04454684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115221|NCT04454684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115222|NCT04454684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93115223|NCT04454684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93115224|NCT04454684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93115225|NCT04454684|Adrenergic Agents|adrenergic agents|mesh-ancestor
93115226|NCT04441034|Anticonvulsants|anticonvulsants|mesh-list
93115227|NCT04441034|Convulsants|convulsants|mesh-list
93115228|NCT04441034|Antidepressive Agents|antidepressive agents|mesh-list
93115229|NCT04441034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93115230|NCT04441034|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93115231|NCT04441034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115232|NCT04438824|Palbociclib|palbociclib|mesh-list
93115233|NCT04438824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115234|NCT04438824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93115235|NCT04438824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115236|NCT04438824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115237|NCT04361708|Leucovorin|leucovorin|mesh-list
93115238|NCT04361708|Docetaxel|docetaxel|mesh-list
93115239|NCT04361708|Fluorouracil|fluorouracil|mesh-list
93115240|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
93115241|NCT04361708|Irinotecan|irinotecan|mesh-list
93115242|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115243|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115244|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115245|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115246|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115247|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
93115248|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115249|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115250|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
93115251|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115252|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93115253|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92787490|NCT02755714|Cholinergic Agents|cholinergic agents|mesh-ancestor
93115254|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115255|NCT04361708|Antidotes|antidotes|mesh-ancestor
93115256|NCT04361708|Protective Agents|protective agents|mesh-ancestor
93115257|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
93115258|NCT04361708|Vitamins|vitamins|mesh-ancestor
93115259|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
93115260|NCT04348006|Dexamethasone|dexamethasone|mesh-list
93115261|NCT04348006|Cyclophosphamide|cyclophosphamide|mesh-list
93115262|NCT04348006|Lenalidomide|lenalidomide|mesh-list
93115263|NCT04348006|Bortezomib|bortezomib|mesh-list
93115264|NCT04348006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115265|NCT04348006|Immunologic Factors|immunologic factors|mesh-ancestor
93115266|NCT04348006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115267|NCT04348006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93115268|NCT04348006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115269|NCT04348006|Alkylating Agents|alkylating agents|mesh-ancestor
93115270|NCT04348006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115271|NCT04348006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115272|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115273|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115274|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
93115275|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
93115276|NCT04348006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115277|NCT04348006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115278|NCT04348006|Glucocorticoids|glucocorticoids|mesh-ancestor
93115279|NCT04348006|Hormones|hormones|mesh-ancestor
93115280|NCT04348006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115281|NCT04348006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115282|NCT04348006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115283|NCT04348006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115284|NCT04348006|Growth Substances|growth substances|mesh-ancestor
93115285|NCT04348006|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115286|NCT04313972|Naltrexone|naltrexone|mesh-list
93115287|NCT04313972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93115288|NCT04313972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93115289|NCT04313972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115290|NCT04313972|Sensory System Agents|sensory system agents|mesh-ancestor
93115291|NCT04313972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115292|NCT04304625|Tranexamic Acid|tranexamic acid|mesh-list
93115293|NCT04304625|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93115294|NCT04304625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93115295|NCT04304625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115296|NCT04304625|Hemostatics|hemostatics|mesh-ancestor
93115297|NCT04304625|Coagulants|coagulants|mesh-ancestor
93115298|NCT04295863|Pembrolizumab|pembrolizumab|mesh-list
93115299|NCT04295863|Nivolumab|nivolumab|mesh-list
93115300|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115301|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115302|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115303|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115304|NCT04231526|Pembrolizumab|pembrolizumab|mesh-list
93115305|NCT04231526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115306|NCT04231526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115307|NCT04231526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115308|NCT04231526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115309|NCT04201873|Poly I-C|poly i-c|mesh-list
93115310|NCT04201873|Pembrolizumab|pembrolizumab|mesh-list
93115311|NCT04201873|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93115312|NCT04201873|Vaccines|vaccines|mesh-list
93115313|NCT04201873|Poly ICLC|poly iclc|mesh-list
93115314|NCT04201873|Immunologic Factors|immunologic factors|mesh-ancestor
93115315|NCT04201873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115316|NCT04201873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115317|NCT04201873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115318|NCT04201873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115319|NCT04201873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115320|NCT04201873|Interferon Inducers|interferon inducers|mesh-ancestor
93115321|NCT04201873|Laxatives|laxatives|mesh-ancestor
93115322|NCT04201873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115323|NCT04201873|Antiviral Agents|antiviral agents|mesh-ancestor
93115324|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115325|NCT04107077|Mitomycins|mitomycins|mesh-list
93115326|NCT04107077|Mitomycin|mitomycin|mesh-list
93115327|NCT04107077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115328|NCT04107077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93115329|NCT04107077|Alkylating Agents|alkylating agents|mesh-ancestor
93115330|NCT04107077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115331|NCT04107077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115332|NCT04107077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115333|NCT03873883|Pembrolizumab|pembrolizumab|mesh-list
93115334|NCT03873883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115335|NCT03873883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115336|NCT03873883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115337|NCT03873883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115338|NCT03850574|Venetoclax|venetoclax|mesh-list
93115339|NCT03850574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115340|NCT03785678|Tenecteplase|tenecteplase|mesh-list
93115341|NCT03785678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93115342|NCT03785678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93115343|NCT03785678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115344|NCT03729804|Dexamethasone|dexamethasone|mesh-list
93115345|NCT03729804|Lenalidomide|lenalidomide|mesh-list
93115346|NCT03729804|Bortezomib|bortezomib|mesh-list
93115347|NCT03729804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115348|NCT03729804|Antiemetics|antiemetics|mesh-ancestor
93115349|NCT03729804|Autonomic Agents|autonomic agents|mesh-ancestor
93115350|NCT03729804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115351|NCT03729804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115352|NCT03729804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115353|NCT03729804|Glucocorticoids|glucocorticoids|mesh-ancestor
93115354|NCT03729804|Hormones|hormones|mesh-ancestor
93115355|NCT03729804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115356|NCT03729804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115357|NCT03729804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115358|NCT03729804|Immunologic Factors|immunologic factors|mesh-ancestor
93115359|NCT03729804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115360|NCT03729804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115361|NCT03729804|Growth Substances|growth substances|mesh-ancestor
93115362|NCT03729804|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115363|NCT03697564|Gemcitabine|gemcitabine|mesh-list
93115364|NCT03697564|Nivolumab|nivolumab|mesh-list
93115365|NCT03697564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115366|NCT03697564|Antimetabolites|antimetabolites|mesh-ancestor
93115367|NCT03697564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115368|NCT03697564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115369|NCT03697564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115370|NCT03697564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115371|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
93115372|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115373|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115374|NCT03595683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115375|NCT03595683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115376|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93115377|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93115378|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
93115379|NCT03571321|Cytarabine|cytarabine|mesh-list
93115380|NCT03571321|Dexamethasone|dexamethasone|mesh-list
93115381|NCT03571321|Cyclophosphamide|cyclophosphamide|mesh-list
93115382|NCT03571321|Rituximab|rituximab|mesh-list
93115383|NCT03571321|Doxorubicin|doxorubicin|mesh-list
93115384|NCT03571321|Methotrexate|methotrexate|mesh-list
93115385|NCT03571321|Vincristine|vincristine|mesh-list
93115386|NCT03571321|Mercaptopurine|mercaptopurine|mesh-list
93115387|NCT03571321|Pegaspargase|pegaspargase|mesh-list
93115388|NCT03571321|Thioguanine|thioguanine|mesh-list
93115389|NCT03571321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115390|NCT03571321|Immunologic Factors|immunologic factors|mesh-ancestor
93115391|NCT03571321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115392|NCT03571321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045626|NCT00162123|Ipilimumab|ipilimumab|mesh-list
93115393|NCT03571321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115394|NCT03571321|Alkylating Agents|alkylating agents|mesh-ancestor
93115395|NCT03571321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115396|NCT03571321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115397|NCT03571321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115398|NCT03571321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115399|NCT03571321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115400|NCT03571321|Antiemetics|antiemetics|mesh-ancestor
93115401|NCT03571321|Autonomic Agents|autonomic agents|mesh-ancestor
93115402|NCT03571321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115403|NCT03571321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115404|NCT03571321|Glucocorticoids|glucocorticoids|mesh-ancestor
93115405|NCT03571321|Hormones|hormones|mesh-ancestor
93115406|NCT03571321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115407|NCT03571321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115408|NCT03571321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93115409|NCT03571321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93115410|NCT03571321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93115411|NCT03571321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115412|NCT03571321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93115413|NCT03571321|Abortifacient Agents|abortifacient agents|mesh-ancestor
93115414|NCT03571321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93115415|NCT03571321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115416|NCT03571321|Antimetabolites|antimetabolites|mesh-ancestor
93115417|NCT03571321|Dermatologic Agents|dermatologic agents|mesh-ancestor
93115418|NCT03571321|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93115419|NCT03571321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115420|NCT03571321|Antiviral Agents|antiviral agents|mesh-ancestor
93115421|NCT03571321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115422|NCT03571321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93115423|NCT03571321|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115424|NCT03571321|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115425|NCT03571321|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115426|NCT03565445|Pembrolizumab|pembrolizumab|mesh-list
93115427|NCT03565445|Nivolumab|nivolumab|mesh-list
93115428|NCT03565445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115429|NCT03565445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115430|NCT03565445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115431|NCT03565445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115432|NCT03516812|Methyltestosterone|methyltestosterone|mesh-list
93115433|NCT03516812|Olaparib|olaparib|mesh-list
93115434|NCT03516812|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93115435|NCT03516812|Testosterone|testosterone|mesh-list
93115436|NCT03516812|Testosterone undecanoate|testosterone undecanoate|mesh-list
93115437|NCT03516812|Testosterone enanthate|testosterone enanthate|mesh-list
93115438|NCT03516812|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93115439|NCT03516812|Androgens|androgens|mesh-ancestor
93115440|NCT03516812|Hormones|hormones|mesh-ancestor
93115441|NCT03516812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115442|NCT03516812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115443|NCT03516812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115444|NCT03516812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115445|NCT03516812|Anabolic Agents|anabolic agents|mesh-ancestor
93115446|NCT03516812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115447|NCT03516812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115448|NCT03500445|Dexamethasone|dexamethasone|mesh-list
93115449|NCT03500445|Lenalidomide|lenalidomide|mesh-list
93115450|NCT03500445|Daratumumab|daratumumab|mesh-list
93115451|NCT03500445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115452|NCT03500445|Antiemetics|antiemetics|mesh-ancestor
93115453|NCT03500445|Autonomic Agents|autonomic agents|mesh-ancestor
93115454|NCT03500445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115455|NCT03500445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115456|NCT03500445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115457|NCT03500445|Glucocorticoids|glucocorticoids|mesh-ancestor
93115458|NCT03500445|Hormones|hormones|mesh-ancestor
93115459|NCT03500445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115460|NCT03500445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115461|NCT03500445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115462|NCT03500445|Immunologic Factors|immunologic factors|mesh-ancestor
93115463|NCT03500445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115464|NCT03500445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115465|NCT03500445|Growth Substances|growth substances|mesh-ancestor
93045722|NCT00504257|Docetaxel|docetaxel|mesh-list
93115466|NCT03500445|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115467|NCT03494530|Edoxaban|edoxaban|mesh-list
93115468|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93115469|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
93115470|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93115471|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
93115472|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115473|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115474|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
93115475|NCT03466736|Flutemetamol|flutemetamol|mesh-list
93115476|NCT03466736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93115477|NCT03466736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115478|NCT03423264|Gabapentin|gabapentin|mesh-list
93115479|NCT03423264|Analgesics|analgesics|mesh-ancestor
93115480|NCT03423264|Sensory System Agents|sensory system agents|mesh-ancestor
93115481|NCT03423264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787726|NCT01086384|Fluticasone|fluticasone|mesh-list
93115482|NCT03423264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115483|NCT03423264|Anticonvulsants|anticonvulsants|mesh-ancestor
93115484|NCT03423264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93115485|NCT03423264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93115486|NCT03423264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93115487|NCT03423264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93115488|NCT03423264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93115489|NCT03423264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93115490|NCT03423264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115491|NCT03423264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115492|NCT03423264|Antimanic Agents|antimanic agents|mesh-ancestor
93115493|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
93115494|NCT03225547|Mifepristone|mifepristone|mesh-list
93115495|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115496|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115497|NCT03225547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115498|NCT03225547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115499|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93115500|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
93115501|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93115502|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115503|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93115504|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93115505|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93115506|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
93115507|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93115508|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93115509|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
93115510|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115511|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
93115512|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93115513|NCT03225547|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93115514|NCT03107182|Diphenhydramine|diphenhydramine|mesh-list
93115515|NCT03107182|Promethazine|promethazine|mesh-list
93115516|NCT03107182|Dexamethasone|dexamethasone|mesh-list
93115517|NCT03107182|Paclitaxel|paclitaxel|mesh-list
93115518|NCT03107182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93115519|NCT03107182|Carboplatin|carboplatin|mesh-list
93115520|NCT03107182|Nivolumab|nivolumab|mesh-list
93115521|NCT03107182|Hydroxyurea|hydroxyurea|mesh-list
93115522|NCT03107182|Famotidine|famotidine|mesh-list
93115523|NCT03107182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93115524|NCT03107182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115525|NCT03107182|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115526|NCT03107182|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115527|NCT03107182|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115528|NCT03107182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115529|NCT03107182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115530|NCT03107182|Antiemetics|antiemetics|mesh-ancestor
93115531|NCT03107182|Autonomic Agents|autonomic agents|mesh-ancestor
93115532|NCT03107182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115533|NCT03107182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115534|NCT03107182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115535|NCT03107182|Glucocorticoids|glucocorticoids|mesh-ancestor
93115536|NCT03107182|Hormones|hormones|mesh-ancestor
93115537|NCT03107182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115538|NCT03107182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115539|NCT03107182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115540|NCT03107182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115541|NCT03107182|Antisickling Agents|antisickling agents|mesh-ancestor
93115542|NCT03107182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115543|NCT03107182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115544|NCT03107182|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93115545|NCT03107182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93115546|NCT03107182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93115547|NCT03107182|Anesthetics, Local|anesthetics, local|mesh-ancestor
93115548|NCT03107182|Anesthetics|anesthetics|mesh-ancestor
93115549|NCT03107182|Sensory System Agents|sensory system agents|mesh-ancestor
93115550|NCT03107182|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93115551|NCT03107182|Histamine Antagonists|histamine antagonists|mesh-ancestor
93115552|NCT03107182|Histamine Agents|histamine agents|mesh-ancestor
93115553|NCT03107182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115554|NCT03107182|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93115555|NCT03107182|Antipruritics|antipruritics|mesh-ancestor
93115556|NCT03107182|Dermatologic Agents|dermatologic agents|mesh-ancestor
93115557|NCT03107182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93115558|NCT03107182|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93115559|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
93115560|NCT02990533|Testosterone|testosterone|mesh-list
93115561|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
93115562|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
93115563|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93115564|NCT02990533|Androgens|androgens|mesh-ancestor
93115565|NCT02990533|Hormones|hormones|mesh-ancestor
93115566|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115567|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115568|NCT02990533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115569|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115570|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
93115571|NCT02969837|Dexamethasone|dexamethasone|mesh-list
93115572|NCT02969837|Lenalidomide|lenalidomide|mesh-list
93115573|NCT02969837|Elotuzumab|elotuzumab|mesh-list
93115574|NCT02969837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115575|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
93115576|NCT02969837|Autonomic Agents|autonomic agents|mesh-ancestor
93115577|NCT02969837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115578|NCT02969837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115579|NCT02969837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115580|NCT02969837|Glucocorticoids|glucocorticoids|mesh-ancestor
93115581|NCT02969837|Hormones|hormones|mesh-ancestor
93115582|NCT02969837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115583|NCT02969837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115584|NCT02969837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115585|NCT02969837|Immunologic Factors|immunologic factors|mesh-ancestor
93115586|NCT02969837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115587|NCT02969837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115588|NCT02969837|Growth Substances|growth substances|mesh-ancestor
93115589|NCT02969837|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115590|NCT02776917|Paclitaxel|paclitaxel|mesh-list
93115591|NCT02776917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93115592|NCT02776917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115593|NCT02776917|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115594|NCT02776917|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115595|NCT02776917|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115596|NCT02776917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115597|NCT02751255|Tretinoin|tretinoin|mesh-list
93115598|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115599|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
93115600|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
93115601|NCT02707666|Pembrolizumab|pembrolizumab|mesh-list
93115602|NCT02707666|Pemetrexed|pemetrexed|mesh-list
93115603|NCT02707666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115604|NCT02707666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115605|NCT02707666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115606|NCT02707666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115607|NCT02707666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115608|NCT02707666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93115609|NCT02707666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115610|NCT02668770|Ipilimumab|ipilimumab|mesh-list
93115611|NCT02668770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115612|NCT02668770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115613|NCT02668770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115614|NCT02668770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115615|NCT02659293|Dexamethasone|dexamethasone|mesh-list
93115616|NCT02659293|Lenalidomide|lenalidomide|mesh-list
93115617|NCT02659293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115618|NCT02659293|Antiemetics|antiemetics|mesh-ancestor
93115619|NCT02659293|Autonomic Agents|autonomic agents|mesh-ancestor
93115620|NCT02659293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115621|NCT02659293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115622|NCT02659293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115623|NCT02659293|Glucocorticoids|glucocorticoids|mesh-ancestor
93115624|NCT02659293|Hormones|hormones|mesh-ancestor
93115625|NCT02659293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115626|NCT02659293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115627|NCT02659293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115628|NCT02659293|Immunologic Factors|immunologic factors|mesh-ancestor
93115629|NCT02659293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115630|NCT02659293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92787862|NCT04218760|Diuretics|diuretics|mesh-ancestor
93115632|NCT02659293|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115633|NCT02656511|Tenofovir|tenofovir|mesh-list
93115634|NCT02656511|Emtricitabine|emtricitabine|mesh-list
93115635|NCT02656511|Dolutegravir|dolutegravir|mesh-list
93115636|NCT02656511|Antiviral Agents|antiviral agents|mesh-ancestor
93115637|NCT02656511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115638|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93115639|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115640|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115641|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115642|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93115643|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93115644|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93115645|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93115646|NCT02613169|Isoniazid|isoniazid|mesh-list
93115647|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
93115648|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93115649|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115650|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93115651|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93115652|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
93115653|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115654|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93115655|NCT02572323|Tesamorelin|tesamorelin|mesh-list
93115656|NCT02572323|Growth Substances|growth substances|mesh-ancestor
93115657|NCT02572323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115658|NCT02513186|Dexamethasone|dexamethasone|mesh-list
93115659|NCT02513186|Cyclophosphamide|cyclophosphamide|mesh-list
93115660|NCT02513186|Lenalidomide|lenalidomide|mesh-list
93115661|NCT02513186|Bortezomib|bortezomib|mesh-list
93115662|NCT02513186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115663|NCT02513186|Immunologic Factors|immunologic factors|mesh-ancestor
93115664|NCT02513186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115665|NCT02513186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93115666|NCT02513186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115667|NCT02513186|Alkylating Agents|alkylating agents|mesh-ancestor
93115668|NCT02513186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115669|NCT02513186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115670|NCT02513186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115671|NCT02513186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115672|NCT02513186|Antiemetics|antiemetics|mesh-ancestor
93115673|NCT02513186|Autonomic Agents|autonomic agents|mesh-ancestor
93115674|NCT02513186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115675|NCT02513186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115676|NCT02513186|Glucocorticoids|glucocorticoids|mesh-ancestor
93115677|NCT02513186|Hormones|hormones|mesh-ancestor
93115678|NCT02513186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115679|NCT02513186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115680|NCT02513186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115681|NCT02513186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115682|NCT02513186|Growth Substances|growth substances|mesh-ancestor
93115683|NCT02513186|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115684|NCT02441491|Cyclophosphamide|cyclophosphamide|mesh-list
93115685|NCT02441491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115686|NCT02441491|Immunologic Factors|immunologic factors|mesh-ancestor
93115687|NCT02441491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115688|NCT02441491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93115689|NCT02441491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115690|NCT02441491|Alkylating Agents|alkylating agents|mesh-ancestor
93115691|NCT02441491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115692|NCT02441491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115693|NCT02441491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115694|NCT02431988|Cyclophosphamide|cyclophosphamide|mesh-list
93115695|NCT02431988|Fludarabine|fludarabine|mesh-list
93115696|NCT02431988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115697|NCT02431988|Immunologic Factors|immunologic factors|mesh-ancestor
93115698|NCT02431988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115699|NCT02431988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93115700|NCT02431988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115701|NCT02431988|Alkylating Agents|alkylating agents|mesh-ancestor
93115702|NCT02431988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115703|NCT02431988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115704|NCT02431988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115705|NCT02399371|Pembrolizumab|pembrolizumab|mesh-list
93115706|NCT02399371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115707|NCT02399371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115708|NCT02399371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115709|NCT02399371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115710|NCT02389517|Dexamethasone|dexamethasone|mesh-list
93115711|NCT02389517|Lenalidomide|lenalidomide|mesh-list
93115712|NCT02389517|Ixazomib|ixazomib|mesh-list
93115713|NCT02389517|Glycine|glycine|mesh-list
93115714|NCT02389517|Proteasome Inhibitors|proteasome inhibitors|mesh-list
93115715|NCT02389517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115716|NCT02389517|Antiemetics|antiemetics|mesh-ancestor
93115717|NCT02389517|Autonomic Agents|autonomic agents|mesh-ancestor
93115718|NCT02389517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115719|NCT02389517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115720|NCT02389517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115721|NCT02389517|Glucocorticoids|glucocorticoids|mesh-ancestor
93115722|NCT02389517|Hormones|hormones|mesh-ancestor
93115723|NCT02389517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115724|NCT02389517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115725|NCT02389517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115726|NCT02389517|Immunologic Factors|immunologic factors|mesh-ancestor
93115727|NCT02389517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115728|NCT02389517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115729|NCT02389517|Growth Substances|growth substances|mesh-ancestor
93115730|NCT02389517|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115731|NCT02389517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115732|NCT02389517|Protease Inhibitors|protease inhibitors|mesh-ancestor
93115733|NCT02389517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115734|NCT02389517|Glycine Agents|glycine agents|mesh-ancestor
93115735|NCT02389517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115736|NCT02366819|Leucovorin|leucovorin|mesh-list
93115737|NCT02366819|Fluorouracil|fluorouracil|mesh-list
93115738|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
93115739|NCT02366819|Irinotecan|irinotecan|mesh-list
93115740|NCT02366819|Calcium|calcium|mesh-list
93115741|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
93115742|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93115743|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115744|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
93115745|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115746|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115747|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115748|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115749|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
93115750|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93115751|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93115752|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115753|NCT02366819|Antidotes|antidotes|mesh-ancestor
93115754|NCT02366819|Protective Agents|protective agents|mesh-ancestor
93115755|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
93115756|NCT02366819|Vitamins|vitamins|mesh-ancestor
93115757|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
93115758|NCT02352948|Gemcitabine|gemcitabine|mesh-list
93115759|NCT02352948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93115760|NCT02352948|Durvalumab|durvalumab|mesh-list
93115761|NCT02352948|Vinorelbine|vinorelbine|mesh-list
93115762|NCT02352948|Tremelimumab|tremelimumab|mesh-list
93115763|NCT02352948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93115764|NCT02352948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115765|NCT02352948|Antimetabolites|antimetabolites|mesh-ancestor
93115766|NCT02352948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115767|NCT02352948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115768|NCT02352948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93115769|NCT02352948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115770|NCT02352948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115771|NCT02352948|Immunologic Factors|immunologic factors|mesh-ancestor
93115772|NCT02352948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115773|NCT02352948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93115774|NCT02352948|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115775|NCT02352948|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115776|NCT02352948|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115777|NCT02333162|Mycophenolic Acid|mycophenolic acid|mesh-list
93115778|NCT02333162|Fludarabine|fludarabine|mesh-list
93115779|NCT02333162|Fludarabine phosphate|fludarabine phosphate|mesh-list
93115780|NCT02333162|Melphalan|melphalan|mesh-list
93115781|NCT02333162|Tacrolimus|tacrolimus|mesh-list
93115782|NCT02333162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115783|NCT02333162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115784|NCT02333162|Antimetabolites|antimetabolites|mesh-ancestor
93115785|NCT02333162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115786|NCT02333162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115787|NCT02333162|Immunologic Factors|immunologic factors|mesh-ancestor
93115788|NCT02333162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115789|NCT02333162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93115790|NCT02333162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115791|NCT02333162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93115792|NCT02333162|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93115793|NCT02333162|Antitubercular Agents|antitubercular agents|mesh-ancestor
93115794|NCT02333162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93115795|NCT02333162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115796|NCT02333162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115797|NCT02333162|Alkylating Agents|alkylating agents|mesh-ancestor
93115798|NCT02333162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115799|NCT02281838|Enalapril|enalapril|mesh-list
93115800|NCT02281838|Labetalol|labetalol|mesh-list
93115801|NCT02281838|Hydralazine|hydralazine|mesh-list
93115802|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93115803|NCT02281838|Protease Inhibitors|protease inhibitors|mesh-ancestor
93115804|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115805|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115806|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93115807|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93115808|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93115809|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
93115810|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93115811|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115812|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
93115813|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
93115814|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115815|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93115816|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93115817|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
93115818|NCT02213913|Prednisone|prednisone|mesh-list
93115819|NCT02213913|Cyclophosphamide|cyclophosphamide|mesh-list
93115820|NCT02213913|Rituximab|rituximab|mesh-list
93115821|NCT02213913|Doxorubicin|doxorubicin|mesh-list
93115822|NCT02213913|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93115823|NCT02213913|Etoposide|etoposide|mesh-list
93115824|NCT02213913|Vincristine|vincristine|mesh-list
93115825|NCT02213913|Lenalidomide|lenalidomide|mesh-list
93115826|NCT02213913|Etoposide phosphate|etoposide phosphate|mesh-list
93115827|NCT02213913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115828|NCT02213913|Immunologic Factors|immunologic factors|mesh-ancestor
93115829|NCT02213913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115830|NCT02213913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93115831|NCT02213913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115832|NCT02213913|Alkylating Agents|alkylating agents|mesh-ancestor
93115833|NCT02213913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115834|NCT02213913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115835|NCT02213913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115836|NCT02213913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115837|NCT02213913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93115838|NCT02213913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93115839|NCT02213913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93115840|NCT02213913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115841|NCT02213913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115842|NCT02213913|Glucocorticoids|glucocorticoids|mesh-ancestor
93115843|NCT02213913|Hormones|hormones|mesh-ancestor
93115844|NCT02213913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115845|NCT02213913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115846|NCT02213913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93115847|NCT02213913|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115848|NCT02213913|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115849|NCT02213913|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115850|NCT02213913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115851|NCT02213913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115852|NCT02213913|Growth Substances|growth substances|mesh-ancestor
93115853|NCT02213913|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115854|NCT02122172|Afatinib|afatinib|mesh-list
93115855|NCT02122172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115856|NCT02122172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93115857|NCT02122172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115858|NCT02122172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115859|NCT01847326|Paclitaxel|paclitaxel|mesh-list
93115860|NCT01847326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93115861|NCT01847326|Carboplatin|carboplatin|mesh-list
93115862|NCT01847326|Fluorouracil|fluorouracil|mesh-list
93115863|NCT01847326|Hydroxyurea|hydroxyurea|mesh-list
93115864|NCT01847326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93115865|NCT01847326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115866|NCT01847326|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115867|NCT01847326|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115868|NCT01847326|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115869|NCT01847326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115870|NCT01847326|Antimetabolites|antimetabolites|mesh-ancestor
93115871|NCT01847326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93115872|NCT01847326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115873|NCT01847326|Immunologic Factors|immunologic factors|mesh-ancestor
93115874|NCT01847326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115875|NCT01847326|Antisickling Agents|antisickling agents|mesh-ancestor
93115876|NCT01847326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115877|NCT01847326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115878|NCT01665794|Dexamethasone|dexamethasone|mesh-list
93115879|NCT01665794|Daratumumab|daratumumab|mesh-list
93115880|NCT01665794|Pomalidomide|pomalidomide|mesh-list
93115881|NCT01665794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115882|NCT01665794|Antiemetics|antiemetics|mesh-ancestor
93115883|NCT01665794|Autonomic Agents|autonomic agents|mesh-ancestor
93115884|NCT01665794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115885|NCT01665794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115886|NCT01665794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115887|NCT01665794|Glucocorticoids|glucocorticoids|mesh-ancestor
93115888|NCT01665794|Hormones|hormones|mesh-ancestor
93115889|NCT01665794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115890|NCT01665794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115891|NCT01665794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115892|NCT01665794|Immunologic Factors|immunologic factors|mesh-ancestor
93115893|NCT01665794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115894|NCT01665794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115895|NCT01665794|Growth Substances|growth substances|mesh-ancestor
93115896|NCT01665794|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115897|NCT01592370|Dexamethasone|dexamethasone|mesh-list
93115898|NCT01592370|Nivolumab|nivolumab|mesh-list
93115899|NCT01592370|Ipilimumab|ipilimumab|mesh-list
93115900|NCT01592370|Daratumumab|daratumumab|mesh-list
93115901|NCT01592370|Pomalidomide|pomalidomide|mesh-list
93115902|NCT01592370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93115903|NCT01592370|Antiemetics|antiemetics|mesh-ancestor
93115904|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
93115905|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93115906|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115907|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93115908|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
93115909|NCT01592370|Hormones|hormones|mesh-ancestor
93115910|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93115911|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93115912|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115913|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115914|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93115915|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115916|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
93115917|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93115918|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93115919|NCT01592370|Growth Substances|growth substances|mesh-ancestor
93115920|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115921|NCT01526096|Plerixafor|plerixafor|mesh-list
93115922|NCT01526096|Melphalan|melphalan|mesh-list
93115923|NCT01526096|Basiliximab|basiliximab|mesh-list
93115924|NCT01526096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93115925|NCT01526096|Alkylating Agents|alkylating agents|mesh-ancestor
93115926|NCT01526096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115927|NCT01526096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115928|NCT01526096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93115929|NCT01526096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93115930|NCT01526096|Immunologic Factors|immunologic factors|mesh-ancestor
93115931|NCT01526096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115932|NCT01526096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93115933|NCT01526096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93115934|NCT01526096|Antiviral Agents|antiviral agents|mesh-ancestor
93115935|NCT01526096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115936|NCT01369212|Tenofovir|tenofovir|mesh-list
93115937|NCT01369212|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93115938|NCT01369212|Antiviral Agents|antiviral agents|mesh-ancestor
93115939|NCT01369212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115940|NCT01369212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93115941|NCT01369212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93115942|NCT01369212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115943|NCT01369212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115944|NCT01369212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93115945|NCT01369212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93115946|NCT00800215|Lacosamide|lacosamide|mesh-list
93115947|NCT00800215|Anticonvulsants|anticonvulsants|mesh-ancestor
93115948|NCT00800215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93115949|NCT00800215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93115950|NCT00800215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93115951|NCT00800215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115952|NCT00669734|Metronidazole|metronidazole|mesh-list
93115953|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
93115954|NCT00669734|Vaccines|vaccines|mesh-list
93115955|NCT00669734|Sargramostim|sargramostim|mesh-list
93115956|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
93115957|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115958|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115959|NCT00669734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93115960|NCT00669734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93115961|NCT00669734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93115962|NCT00669734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93115963|NCT00669734|Antioxidants|antioxidants|mesh-ancestor
93115964|NCT00669734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115965|NCT00669734|Protective Agents|protective agents|mesh-ancestor
93115966|NCT00669734|Antiviral Agents|antiviral agents|mesh-ancestor
93115967|NCT00669734|Growth Inhibitors|growth inhibitors|mesh-ancestor
93115968|NCT00669734|Growth Substances|growth substances|mesh-ancestor
93115969|NCT00669734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93115970|NCT00669734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93115971|NCT00337649|Trastuzumab|trastuzumab|mesh-list
93115972|NCT00337649|Epothilones|epothilones|mesh-list
93115973|NCT00337649|Desoxyepothilone B|desoxyepothilone b|mesh-list
93115974|NCT00337649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115975|NCT00337649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115976|NCT00337649|Tubulin Modulators|tubulin modulators|mesh-ancestor
93115977|NCT00337649|Antimitotic Agents|antimitotic agents|mesh-ancestor
93115978|NCT00337649|Mitosis Modulators|mitosis modulators|mesh-ancestor
93115979|NCT00337649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93115980|NCT00071084|Zanolimumab|zanolimumab|mesh-list
93115981|NCT00071084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93115982|NCT00071084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115983|NCT00071084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115984|NCT00071084|Immunologic Factors|immunologic factors|mesh-ancestor
93115985|NCT00071084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115986|NCT00042406|Zanolimumab|zanolimumab|mesh-list
93115987|NCT00042406|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93115988|NCT00042406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93115989|NCT00042406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93115990|NCT00042406|Immunologic Factors|immunologic factors|mesh-ancestor
93115991|NCT00042406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115992|NCT01170078|Epoetin Alfa|epoetin alfa|mesh-list
93115993|NCT01170078|Hematinics|hematinics|mesh-ancestor
93115994|NCT01283646|Vitamins|vitamins|mesh-list
93115995|NCT01283646|Folic Acid|folic acid|mesh-list
93115996|NCT01283646|Vitamin B Complex|vitamin b complex|mesh-list
93115997|NCT01283646|Micronutrients|micronutrients|mesh-ancestor
93115998|NCT01283646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93115999|NCT01283646|Hematinics|hematinics|mesh-ancestor
93116000|NCT01283724|Dienogest|dienogest|mesh-list
93116001|NCT01283724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93116002|NCT01283724|Contraceptive Agents|contraceptive agents|mesh-ancestor
93116003|NCT01283724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93116004|NCT01283724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116005|NCT01283724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93116006|NCT01283724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93116007|NCT01283724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93116008|NCT01283724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93116009|NCT01283724|Hormone Antagonists|hormone antagonists|mesh-ancestor
93116010|NCT01283724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116011|NCT01283724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93116012|NCT01283724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116013|NCT01586442|Eplerenone|eplerenone|mesh-list
93116014|NCT01586442|Spironolactone|spironolactone|mesh-list
93116015|NCT01586442|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93116016|NCT01586442|Hormone Antagonists|hormone antagonists|mesh-ancestor
93116017|NCT01586442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116018|NCT01586442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116019|NCT01586442|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93116020|NCT01586442|Diuretics|diuretics|mesh-ancestor
93116021|NCT01586442|Natriuretic Agents|natriuretic agents|mesh-ancestor
93116022|NCT01586442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93116023|NCT01587066|Valproic Acid|valproic acid|mesh-list
93116024|NCT01587066|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93116025|NCT01587066|Antidepressive Agents|antidepressive agents|mesh-ancestor
93116026|NCT01587066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116027|NCT01587066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93116028|NCT01587066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116029|NCT01587066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116030|NCT01587066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116031|NCT01587066|Anticonvulsants|anticonvulsants|mesh-ancestor
93116032|NCT01587066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116033|NCT01587066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116034|NCT01587066|GABA Agents|gaba agents|mesh-ancestor
93116035|NCT01587066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116036|NCT01587066|Antimanic Agents|antimanic agents|mesh-ancestor
93116037|NCT01587144|Lucanthone|lucanthone|mesh-list
93116038|NCT01587144|Temozolomide|temozolomide|mesh-list
93116039|NCT01587144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93116040|NCT01587144|Alkylating Agents|alkylating agents|mesh-ancestor
93116041|NCT01587144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116042|NCT01587144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116043|NCT01587144|Schistosomicides|schistosomicides|mesh-ancestor
93116044|NCT01587144|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93116045|NCT01587144|Anthelmintics|anthelmintics|mesh-ancestor
93116046|NCT01587144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93116047|NCT01587144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116048|NCT01587222|Octreotide|octreotide|mesh-list
93116049|NCT01587222|Midodrine|midodrine|mesh-list
93116050|NCT01587222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116051|NCT01587222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93116052|NCT01587222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116053|NCT01587222|Sympathomimetics|sympathomimetics|mesh-ancestor
93116054|NCT01587222|Autonomic Agents|autonomic agents|mesh-ancestor
93116055|NCT01587222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116056|NCT01587222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116057|NCT01587222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93116058|NCT01587222|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93116059|NCT01587222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93116060|NCT01587222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93116061|NCT01587222|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116062|NCT01587222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116063|NCT01587222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116064|NCT01167738|Metformin|metformin|mesh-list
93116065|NCT01167738|Gemcitabine|gemcitabine|mesh-list
93116066|NCT01167738|Capecitabine|capecitabine|mesh-list
93116067|NCT01167738|Epirubicin|epirubicin|mesh-list
93116068|NCT01167738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116069|NCT01167738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116070|NCT01167738|Antimetabolites|antimetabolites|mesh-ancestor
93116071|NCT01167738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116072|NCT01167738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93116073|NCT01167738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116074|NCT01167738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93116075|NCT01167738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93116076|NCT01167738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93116077|NCT01167738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116078|NCT01167816|Azacitidine|azacitidine|mesh-list
93116079|NCT01167816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116080|NCT01167816|Antimetabolites|antimetabolites|mesh-ancestor
93116081|NCT01167816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116082|NCT01167816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116083|NCT01167816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116084|NCT01167894|Simvastatin|simvastatin|mesh-list
93116085|NCT01167894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93116086|NCT01167894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92788314|NCT02874768|Anesthetics|anesthetics|mesh-ancestor
93116087|NCT01167894|Antimetabolites|antimetabolites|mesh-ancestor
93116088|NCT01167894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116089|NCT01167894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93116090|NCT01167894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93116091|NCT01167894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116092|NCT03870828|Dimercaprol|dimercaprol|mesh-list
93116093|NCT03870828|Chelating Agents|chelating agents|mesh-ancestor
93116094|NCT03870828|Sequestering Agents|sequestering agents|mesh-ancestor
93116095|NCT03870828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116096|NCT03870594|Chrysarobin|chrysarobin|mesh-list
93116097|NCT03870594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93116098|NCT03870594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93116099|NCT03870594|Analgesics|analgesics|mesh-ancestor
93116100|NCT03870594|Sensory System Agents|sensory system agents|mesh-ancestor
93116101|NCT03870594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116102|NCT03870594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116103|NCT03870594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116104|NCT03870594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93116105|NCT01165866|Ondansetron|ondansetron|mesh-list
93116106|NCT01165866|Metoclopramide|metoclopramide|mesh-list
93116107|NCT01165866|Antiemetics|antiemetics|mesh-ancestor
93116108|NCT01165866|Autonomic Agents|autonomic agents|mesh-ancestor
93116109|NCT01165866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116110|NCT01165866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116111|NCT01165866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116112|NCT01165866|Antipruritics|antipruritics|mesh-ancestor
93116113|NCT01165866|Dermatologic Agents|dermatologic agents|mesh-ancestor
93116114|NCT01165866|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93116115|NCT01165866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93116116|NCT01165866|Serotonin Agents|serotonin agents|mesh-ancestor
93116117|NCT01165866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116118|NCT01165866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116119|NCT01165866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93116120|NCT01165866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93116121|NCT01165866|Dopamine Agents|dopamine agents|mesh-ancestor
93116122|NCT01170468|Vitamin D|vitamin d|mesh-list
93116123|NCT01170468|Cholecalciferol|cholecalciferol|mesh-list
93116124|NCT01170468|Vitamins|vitamins|mesh-ancestor
93116125|NCT01170468|Micronutrients|micronutrients|mesh-ancestor
93116126|NCT01170468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116127|NCT01170468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93116128|NCT01170468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93116129|NCT01273584|Metformin|metformin|mesh-list
93116130|NCT01273584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93116131|NCT01273584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116132|NCT01281852|Paclitaxel|paclitaxel|mesh-list
93116133|NCT01281852|Cisplatin|cisplatin|mesh-list
93116134|NCT01281852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93116135|NCT01281852|Veliparib|veliparib|mesh-list
93116136|NCT01281852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93116137|NCT01281852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116138|NCT01281852|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116139|NCT01281852|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116140|NCT01281852|Mitosis Modulators|mitosis modulators|mesh-ancestor
93116141|NCT01281852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116142|NCT01281852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93116143|NCT01281852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116144|NCT01168440|Sunitinib|sunitinib|mesh-list
93116145|NCT01168440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116146|NCT01168440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93116147|NCT01168440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93116148|NCT01168440|Growth Substances|growth substances|mesh-ancestor
93116149|NCT01168440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116150|NCT01168440|Growth Inhibitors|growth inhibitors|mesh-ancestor
93116151|NCT01168440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93116152|NCT01168440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116153|NCT01168440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116154|NCT01170780|Dexamethasone|dexamethasone|mesh-list
93116155|NCT01170780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116156|NCT01170780|Antiemetics|antiemetics|mesh-ancestor
93116157|NCT01170780|Autonomic Agents|autonomic agents|mesh-ancestor
93116158|NCT01170780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116159|NCT01170780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116160|NCT01170780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788393|NCT01070784|Budesonide|budesonide|mesh-list
93116161|NCT01170780|Glucocorticoids|glucocorticoids|mesh-ancestor
93116162|NCT01170780|Hormones|hormones|mesh-ancestor
93116163|NCT01170780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116164|NCT01170780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93116165|NCT01170780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116166|NCT01165944|Pramlintide|pramlintide|mesh-list
93116167|NCT01165944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93116168|NCT01165944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116169|NCT01170858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93116170|NCT01170858|Icodextrin|icodextrin|mesh-list
93116171|NCT01170858|Dialysis Solutions|dialysis solutions|mesh-ancestor
93116172|NCT01171092|Bortezomib|bortezomib|mesh-list
93116173|NCT01171092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116174|NCT03753204|Furosemide|furosemide|mesh-list
93116175|NCT03753204|Diuretics|diuretics|mesh-ancestor
93116176|NCT03753204|Natriuretic Agents|natriuretic agents|mesh-ancestor
93116177|NCT03753204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116178|NCT03753204|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93116179|NCT03753204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116180|NCT03753204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116181|NCT01171170|Paclitaxel|paclitaxel|mesh-list
93116182|NCT01171170|Bevacizumab|bevacizumab|mesh-list
93116183|NCT01171170|Carboplatin|carboplatin|mesh-list
93116184|NCT01171170|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93116185|NCT01171170|Nitroglycerin|nitroglycerin|mesh-list
93116186|NCT01171170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93116187|NCT01171170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116188|NCT01171170|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116189|NCT01171170|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116190|NCT01171170|Mitosis Modulators|mitosis modulators|mesh-ancestor
93116191|NCT01171170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116192|NCT01171170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93116193|NCT01171170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93116194|NCT01171170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93116195|NCT01171170|Growth Substances|growth substances|mesh-ancestor
93116196|NCT01171170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116197|NCT01171170|Growth Inhibitors|growth inhibitors|mesh-ancestor
93116198|NCT01171170|Vasodilator Agents|vasodilator agents|mesh-ancestor
93116199|NCT01166100|Fluoxetine|fluoxetine|mesh-list
93116200|NCT01166100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93116201|NCT01166100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93116202|NCT01166100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116203|NCT01166100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116204|NCT01166100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116205|NCT01166100|Serotonin Agents|serotonin agents|mesh-ancestor
93116206|NCT01166100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116207|NCT01166100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93116208|NCT01166100|Antidepressive Agents|antidepressive agents|mesh-ancestor
93116209|NCT01166100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116210|NCT01166100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93116211|NCT01166100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93116212|NCT01166100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116213|NCT01277016|Melphalan|melphalan|mesh-list
93116214|NCT01277016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93116215|NCT01277016|Alkylating Agents|alkylating agents|mesh-ancestor
93116216|NCT01277016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116217|NCT01277016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116218|NCT01277016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93116219|NCT01277016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93116220|NCT01277016|Immunologic Factors|immunologic factors|mesh-ancestor
93116221|NCT01277016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116222|NCT01171326|Minocycline|minocycline|mesh-list
93116223|NCT01171326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93116224|NCT01171326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116225|NCT01171482|Fluorouracil|fluorouracil|mesh-list
93116226|NCT01171482|Sorafenib|sorafenib|mesh-list
93116227|NCT01171482|Mitomycins|mitomycins|mesh-list
93116228|NCT01171482|Mitomycin|mitomycin|mesh-list
93116229|NCT01171482|Antimetabolites|antimetabolites|mesh-ancestor
93116230|NCT01171482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116231|NCT01171482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116232|NCT01171482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116233|NCT01171482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93116234|NCT01171482|Immunologic Factors|immunologic factors|mesh-ancestor
93116235|NCT01171482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116236|NCT01171482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93116237|NCT01171482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116238|NCT01171482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93116239|NCT01171482|Alkylating Agents|alkylating agents|mesh-ancestor
93116240|NCT01171482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116241|NCT01282398|Simvastatin|simvastatin|mesh-list
93116242|NCT01282398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93116243|NCT01282398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93116244|NCT01282398|Antimetabolites|antimetabolites|mesh-ancestor
93116245|NCT01282398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116246|NCT01282398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93116247|NCT01282398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93116248|NCT01282398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116249|NCT01169142|Vitamin D|vitamin d|mesh-list
93116250|NCT01169142|Ergocalciferols|ergocalciferols|mesh-list
93116251|NCT01169142|Cholecalciferol|cholecalciferol|mesh-list
93116252|NCT01169142|Vitamins|vitamins|mesh-list
93116253|NCT01169142|Micronutrients|micronutrients|mesh-ancestor
93116254|NCT01169142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116255|NCT01169142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93116256|NCT01169142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93116257|NCT01169298|Lenalidomide|lenalidomide|mesh-list
93116258|NCT01169298|Immunologic Factors|immunologic factors|mesh-ancestor
93116259|NCT01169298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116260|NCT01169298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93116261|NCT01169298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93116262|NCT01169298|Growth Substances|growth substances|mesh-ancestor
93116263|NCT01169298|Growth Inhibitors|growth inhibitors|mesh-ancestor
93116264|NCT01169298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116265|NCT01277484|Decitabine|decitabine|mesh-list
93116266|NCT01277484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116267|NCT01277484|Antimetabolites|antimetabolites|mesh-ancestor
93116268|NCT01277484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116269|NCT01277484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116270|NCT01277484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116271|NCT01282632|Olanzapine|olanzapine|mesh-list
93116272|NCT01282632|Risperidone|risperidone|mesh-list
93116273|NCT01282632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93116274|NCT01282632|Serotonin Agents|serotonin agents|mesh-ancestor
93116275|NCT01282632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116276|NCT01282632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116277|NCT01282632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116278|NCT01282632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93116279|NCT01282632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116280|NCT01282632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116281|NCT01282632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116282|NCT01282632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93116283|NCT01282632|Dopamine Agents|dopamine agents|mesh-ancestor
93116284|NCT01282632|Antiemetics|antiemetics|mesh-ancestor
93116285|NCT01282632|Autonomic Agents|autonomic agents|mesh-ancestor
93116286|NCT01282632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116287|NCT01282632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116288|NCT01282632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93116289|NCT01282632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93116290|NCT01282632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116291|NCT01172028|Docetaxel|docetaxel|mesh-list
93116292|NCT01172028|Pemetrexed|pemetrexed|mesh-list
93116293|NCT01172028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116294|NCT01172028|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116295|NCT01172028|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116296|NCT01172028|Mitosis Modulators|mitosis modulators|mesh-ancestor
93116297|NCT01172028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116298|NCT01172028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116299|NCT01172028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93116300|NCT01172028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116301|NCT01278186|Paclitaxel|paclitaxel|mesh-list
93116302|NCT01278186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93116303|NCT01278186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116304|NCT01278186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116305|NCT01278186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116306|NCT01278186|Mitosis Modulators|mitosis modulators|mesh-ancestor
92788549|NCT02738632|Amlodipine|amlodipine|mesh-list
93116307|NCT01278186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116308|NCT01169688|Phenylephrine|phenylephrine|mesh-list
93116309|NCT01169688|Oxymetazoline|oxymetazoline|mesh-list
93116310|NCT01169688|Cyclopentolate|cyclopentolate|mesh-list
93116311|NCT01169688|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93116312|NCT01169688|Mydriatics|mydriatics|mesh-ancestor
93116313|NCT01169688|Autonomic Agents|autonomic agents|mesh-ancestor
93116314|NCT01169688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116315|NCT01169688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116316|NCT01169688|Sympathomimetics|sympathomimetics|mesh-ancestor
93116317|NCT01169688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93116318|NCT01169688|Nasal Decongestants|nasal decongestants|mesh-ancestor
93116319|NCT01169688|Respiratory System Agents|respiratory system agents|mesh-ancestor
93116320|NCT01169688|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93116321|NCT01169688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93116322|NCT01169688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93116323|NCT01169688|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116324|NCT01169688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116325|NCT01169688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116326|NCT01169688|Protective Agents|protective agents|mesh-ancestor
93116327|NCT01169688|Parasympatholytics|parasympatholytics|mesh-ancestor
93116328|NCT01169688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93116329|NCT01169688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93116330|NCT01169688|Cholinergic Agents|cholinergic agents|mesh-ancestor
93116331|NCT01278264|Ropivacaine|ropivacaine|mesh-list
93116332|NCT01278264|Anesthetics, Local|anesthetics, local|mesh-ancestor
93116333|NCT01278264|Anesthetics|anesthetics|mesh-ancestor
93116334|NCT01278264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116335|NCT01278264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116336|NCT01278264|Sensory System Agents|sensory system agents|mesh-ancestor
93116337|NCT01278264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116338|NCT01172652|Ziprasidone|ziprasidone|mesh-list
93116339|NCT01172652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93116340|NCT01172652|Serotonin Agents|serotonin agents|mesh-ancestor
93116341|NCT01172652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116342|NCT01172652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116343|NCT01172652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116344|NCT01172652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93116345|NCT01172652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116346|NCT01172652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116347|NCT01172652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116348|NCT01172652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93116349|NCT01172652|Dopamine Agents|dopamine agents|mesh-ancestor
93116350|NCT02526030|Aripiprazole|aripiprazole|mesh-list
93116351|NCT02526030|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93116352|NCT02526030|Ziprasidone|ziprasidone|mesh-list
93116353|NCT02526030|Antidepressive Agents|antidepressive agents|mesh-ancestor
93116354|NCT02526030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116355|NCT02526030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93116356|NCT02526030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116357|NCT02526030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116358|NCT02526030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116359|NCT02526030|Dopamine Agonists|dopamine agonists|mesh-ancestor
93116360|NCT02526030|Dopamine Agents|dopamine agents|mesh-ancestor
93116361|NCT02526030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116362|NCT02526030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116363|NCT02526030|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93116364|NCT02526030|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93116365|NCT02526030|Serotonin Agents|serotonin agents|mesh-ancestor
93116366|NCT02526030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93116367|NCT02526030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93116368|NCT02526030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93046598|NCT01054508|Niacin|niacin|mesh-list
93116369|NCT02526030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93116370|NCT03867240|Gabapentin|gabapentin|mesh-list
93116371|NCT03867240|Analgesics|analgesics|mesh-ancestor
93116372|NCT03867240|Sensory System Agents|sensory system agents|mesh-ancestor
93116373|NCT03867240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116374|NCT03867240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116375|NCT03867240|Anticonvulsants|anticonvulsants|mesh-ancestor
93116376|NCT03867240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93116377|NCT03867240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116378|NCT03867240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116379|NCT03867240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116380|NCT03867240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93116381|NCT03867240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93116382|NCT03867240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116383|NCT03867240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116384|NCT03867240|Antimanic Agents|antimanic agents|mesh-ancestor
93116385|NCT01172964|Flucytosine|flucytosine|mesh-list
93116387|NCT01172964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116388|NCT01172964|Antimetabolites|antimetabolites|mesh-ancestor
93116389|NCT01172964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116390|NCT03866928|Stiripentol|stiripentol|mesh-list
93116391|NCT03866928|Anticonvulsants|anticonvulsants|mesh-ancestor
93116392|NCT01172496|Treprostinil|treprostinil|mesh-list
93116393|NCT01172496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93116394|NCT01178034|Warfarin|warfarin|mesh-list
93116395|NCT01178034|Anticoagulants|anticoagulants|mesh-ancestor
93116396|NCT01288170|Tobramycin|tobramycin|mesh-list
93116397|NCT01288170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93116398|NCT01288170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116399|NCT01178112|Carboplatin|carboplatin|mesh-list
93116400|NCT01178112|Trientine|trientine|mesh-list
93116401|NCT01178112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116402|NCT01178112|Chelating Agents|chelating agents|mesh-ancestor
93116403|NCT01178112|Sequestering Agents|sequestering agents|mesh-ancestor
93116404|NCT01178112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116405|NCT01175460|Nedaplatin|nedaplatin|mesh-list
93116406|NCT01175460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116407|NCT01175538|Lactulose|lactulose|mesh-list
93116408|NCT01175538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116409|NCT01288326|Liraglutide|liraglutide|mesh-list
93116410|NCT01288326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93116411|NCT01288326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116412|NCT01288326|Incretins|incretins|mesh-ancestor
93116413|NCT01288326|Hormones|hormones|mesh-ancestor
93116414|NCT01288326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116415|NCT01173510|Raltegravir Potassium|raltegravir potassium|mesh-list
93116416|NCT01173510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93116417|NCT01173510|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93116418|NCT01173510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93116419|NCT01173510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93116420|NCT01173510|Antiviral Agents|antiviral agents|mesh-ancestor
93116421|NCT01173510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116422|NCT01173510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93116423|NCT01173510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93116424|NCT01173510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116425|NCT01173510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116426|NCT01173510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93116427|NCT01173510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116428|NCT03435640|Nivolumab|nivolumab|mesh-list
93116429|NCT03435640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93116430|NCT03435640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116431|NCT03435640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93116432|NCT03435640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116433|NCT01175772|Celecoxib|celecoxib|mesh-list
93116434|NCT01175772|Methotrexate|methotrexate|mesh-list
93116435|NCT01175772|Cyclophosphamide|cyclophosphamide|mesh-list
93116436|NCT01175772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93116437|NCT01175772|Abortifacient Agents|abortifacient agents|mesh-ancestor
93116438|NCT01175772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93116439|NCT01175772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116440|NCT01175772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116441|NCT01175772|Antimetabolites|antimetabolites|mesh-ancestor
93116442|NCT01175772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116443|NCT01175772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116444|NCT01175772|Dermatologic Agents|dermatologic agents|mesh-ancestor
93116445|NCT01175772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116446|NCT01175772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93116447|NCT01175772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93116448|NCT01175772|Immunologic Factors|immunologic factors|mesh-ancestor
93116449|NCT01175772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93116450|NCT01175772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116451|NCT01175772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93116452|NCT01175772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93116453|NCT01175772|Analgesics|analgesics|mesh-ancestor
93116454|NCT01175772|Sensory System Agents|sensory system agents|mesh-ancestor
93116455|NCT01175772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116456|NCT01175772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116457|NCT01175772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92788686|NCT02737150|Anesthetics|anesthetics|mesh-list
93116458|NCT01175772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93116459|NCT01175772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93116460|NCT01175772|Alkylating Agents|alkylating agents|mesh-ancestor
93116461|NCT01175772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93116462|NCT03395392|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93116463|NCT03395392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93116464|NCT03395392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116465|NCT03395392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116466|NCT03395392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116467|NCT03395392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116468|NCT03395392|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93116469|NCT03395392|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93116470|NCT03395392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93116471|NCT03395392|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116472|NCT03395392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116473|NCT03395392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116474|NCT03395392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93116475|NCT03395392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93116476|NCT03395392|Serotonin Agents|serotonin agents|mesh-ancestor
93116477|NCT03395392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93116478|NCT03395392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93116479|NCT03395392|Dopamine Agents|dopamine agents|mesh-ancestor
93116480|NCT01536964|Morphine|morphine|mesh-list
93116481|NCT01536964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93116482|NCT01536964|Narcotics|narcotics|mesh-ancestor
93116483|NCT01536964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116484|NCT01536964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116485|NCT01536964|Analgesics|analgesics|mesh-ancestor
93116486|NCT01536964|Sensory System Agents|sensory system agents|mesh-ancestor
93116487|NCT01536964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116488|NCT01288404|Fluorometholone|fluorometholone|mesh-list
93116489|NCT01288404|Bevacizumab|bevacizumab|mesh-list
93116490|NCT01288404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93116491|NCT01288404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116492|NCT01288404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93116493|NCT01288404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93116494|NCT01288404|Growth Substances|growth substances|mesh-ancestor
93116495|NCT01288404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116496|NCT01288404|Growth Inhibitors|growth inhibitors|mesh-ancestor
93116497|NCT01288404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116498|NCT01288404|Glucocorticoids|glucocorticoids|mesh-ancestor
93116499|NCT01288404|Hormones|hormones|mesh-ancestor
93116500|NCT01288404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116501|NCT01288404|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93116502|NCT03860220|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
93116503|NCT03860220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93116504|NCT03860220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93116505|NCT03860220|Antimetabolites|antimetabolites|mesh-ancestor
93116506|NCT03860220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116507|NCT03860220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93116508|NCT03860220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93116509|NCT03860220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93116510|NCT03860220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116511|NCT03860220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93116512|NCT03860220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116513|NCT03860220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93116514|NCT03860220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116515|NCT01286688|Terbinafine|terbinafine|mesh-list
93116516|NCT01286688|Antifungal Agents|antifungal agents|mesh-ancestor
93116517|NCT01286688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116518|NCT01286688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116519|NCT01286688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116520|NCT01286766|Cisplatin|cisplatin|mesh-list
93116521|NCT01286766|Docetaxel|docetaxel|mesh-list
93116522|NCT01286766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116523|NCT01286766|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116524|NCT01286766|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116525|NCT01286766|Mitosis Modulators|mitosis modulators|mesh-ancestor
93116526|NCT01286766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116527|NCT02525484|Pirfenidone|pirfenidone|mesh-list
93116528|NCT02525484|Analgesics|analgesics|mesh-ancestor
93116529|NCT02525484|Sensory System Agents|sensory system agents|mesh-ancestor
93116530|NCT02525484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116531|NCT02525484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788772|NCT02731846|Xhance|xhance|mesh-list
93116532|NCT02525484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93116533|NCT02525484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93116534|NCT02525484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116535|NCT02525484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93116536|NCT02525484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116537|NCT01173978|Prednisolone|prednisolone|mesh-list
93116538|NCT01173978|Hormones|hormones|mesh-list
93116539|NCT01173978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116540|NCT01173978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116541|NCT01173978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116542|NCT01173978|Glucocorticoids|glucocorticoids|mesh-ancestor
93116543|NCT01173978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93116544|NCT01173978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116545|NCT01174056|Pioglitazone|pioglitazone|mesh-list
93116546|NCT01174056|Zileuton|zileuton|mesh-list
93116547|NCT01174056|Hydroxyurea|hydroxyurea|mesh-list
93116548|NCT01174056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93116549|NCT01174056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116550|NCT01174056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93116551|NCT01174056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93116552|NCT01174056|Analgesics|analgesics|mesh-ancestor
93116553|NCT01174056|Sensory System Agents|sensory system agents|mesh-ancestor
93116554|NCT01174056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116555|NCT01174056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116556|NCT01174056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93116557|NCT01174056|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93116558|NCT01174056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116559|NCT01174056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116560|NCT01174056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93116561|NCT01174056|Hormone Antagonists|hormone antagonists|mesh-ancestor
93116562|NCT01174056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116563|NCT01174056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116564|NCT01174056|Antisickling Agents|antisickling agents|mesh-ancestor
93116565|NCT01174056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116566|NCT01174212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93116567|NCT01174212|Vancomycin|vancomycin|mesh-list
93116568|NCT01174212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93116569|NCT01174212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116570|NCT01174212|Antitubercular Agents|antitubercular agents|mesh-ancestor
93116571|NCT01174290|Haloperidol|haloperidol|mesh-list
93116572|NCT01174290|Haloperidol decanoate|haloperidol decanoate|mesh-list
93116573|NCT01174290|Antiemetics|antiemetics|mesh-ancestor
93116574|NCT01174290|Autonomic Agents|autonomic agents|mesh-ancestor
93116575|NCT01174290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116576|NCT01174290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116577|NCT01174290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116578|NCT01174290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93116579|NCT01174290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116580|NCT01174290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116581|NCT01174290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116582|NCT01174290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93116583|NCT01174290|Dopamine Agents|dopamine agents|mesh-ancestor
93116584|NCT01174290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116585|NCT01174290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116586|NCT01174290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93116587|NCT03862404|Epinephrine|epinephrine|mesh-list
93116588|NCT03862404|Bupivacaine|bupivacaine|mesh-list
93116589|NCT03862404|Anesthetics, Local|anesthetics, local|mesh-ancestor
93116590|NCT03862404|Anesthetics|anesthetics|mesh-ancestor
93116591|NCT03862404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116592|NCT03862404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116593|NCT03862404|Sensory System Agents|sensory system agents|mesh-ancestor
93116594|NCT03862404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116595|NCT03862404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93116596|NCT03862404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93116597|NCT03862404|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116598|NCT03862404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116599|NCT03862404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116600|NCT03862404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93116601|NCT03862404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93116602|NCT03862404|Autonomic Agents|autonomic agents|mesh-ancestor
93116603|NCT03862404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93116604|NCT03862404|Respiratory System Agents|respiratory system agents|mesh-ancestor
93116605|NCT03862404|Mydriatics|mydriatics|mesh-ancestor
93116606|NCT03862404|Sympathomimetics|sympathomimetics|mesh-ancestor
93116607|NCT03862404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93116608|NCT03865680|Fluorides|fluorides|mesh-list
93116609|NCT03865680|Sodium Fluoride|sodium fluoride|mesh-list
93116610|NCT03865680|Fluorides, Topical|fluorides, topical|mesh-list
93116611|NCT03865680|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
93116612|NCT03865680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116613|NCT03865680|Cariostatic Agents|cariostatic agents|mesh-ancestor
93116614|NCT03865680|Protective Agents|protective agents|mesh-ancestor
93116615|NCT01288716|Baclofen|baclofen|mesh-list
93116616|NCT01288716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93116617|NCT01288716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116618|NCT01288716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93116619|NCT01288716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116620|NCT01288716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93116621|NCT01288716|GABA Agonists|gaba agonists|mesh-ancestor
93116622|NCT01288716|GABA Agents|gaba agents|mesh-ancestor
93116623|NCT01288716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116624|NCT01288716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116625|NCT01285596|Mirabegron|mirabegron|mesh-list
93116626|NCT01285596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93116627|NCT01285596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93116628|NCT01285596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93116629|NCT01285596|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116630|NCT01285596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116631|NCT01285596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116632|NCT01285596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116633|NCT01285596|Urological Agents|urological agents|mesh-ancestor
93116634|NCT00655876|Paclitaxel|paclitaxel|mesh-list
93116635|NCT00655876|Cetuximab|cetuximab|mesh-list
93116636|NCT00655876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93116637|NCT00655876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116638|NCT00655876|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116639|NCT00655876|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116640|NCT00655876|Mitosis Modulators|mitosis modulators|mesh-ancestor
93116641|NCT00655876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116642|NCT00655876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93116643|NCT01176318|Erdosteine|erdosteine|mesh-list
93116644|NCT01176318|Expectorants|expectorants|mesh-ancestor
93116645|NCT01176318|Respiratory System Agents|respiratory system agents|mesh-ancestor
93116646|NCT01178658|Cytarabine|cytarabine|mesh-list
93116647|NCT01178658|Etoposide|etoposide|mesh-list
93116648|NCT01178658|Melphalan|melphalan|mesh-list
93116649|NCT01178658|Busulfan|busulfan|mesh-list
93116650|NCT01178658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93116651|NCT01178658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116652|NCT01178658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93116653|NCT01178658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93116654|NCT01178658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116655|NCT01178658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116656|NCT01178658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116657|NCT01178658|Antimetabolites|antimetabolites|mesh-ancestor
93116658|NCT01178658|Antiviral Agents|antiviral agents|mesh-ancestor
93116659|NCT01178658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116660|NCT01178658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93116661|NCT01178658|Immunologic Factors|immunologic factors|mesh-ancestor
93116662|NCT01178658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116663|NCT01178658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93116664|NCT01178658|Alkylating Agents|alkylating agents|mesh-ancestor
93116665|NCT01178658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93116666|NCT03092752|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93116667|NCT03092752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116668|NCT01174524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93116669|NCT01174524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93116670|NCT01174524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93116671|NCT01174524|Gestodene|gestodene|mesh-list
93116672|NCT01174524|Femovan|femovan|mesh-list
93116673|NCT01174524|Contraceptive Agents|contraceptive agents|mesh-list
93116674|NCT01174524|Contraceptives, Oral|contraceptives, oral|mesh-list
93116675|NCT01174524|Estradiol|estradiol|mesh-list
93116676|NCT01174524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93116677|NCT01174524|Estrogens|estrogens|mesh-ancestor
93116678|NCT01174524|Hormones|hormones|mesh-ancestor
93116679|NCT01174524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93116680|NCT01174524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116681|NCT01174524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93116682|NCT01174524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92788907|NCT02733952|Tranexamic Acid|tranexamic acid|mesh-list
93116683|NCT01174524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93116684|NCT01174524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93116685|NCT01174524|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93116686|NCT01174524|Progestins|progestins|mesh-ancestor
93116687|NCT01174524|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93116689|NCT02525172|Methotrexate|methotrexate|mesh-list
93116690|NCT02525172|Bortezomib|bortezomib|mesh-list
93116691|NCT02525172|Immunoglobulins|immunoglobulins|mesh-list
93116692|NCT02525172|Antibodies|antibodies|mesh-list
93116693|NCT02525172|gamma-Globulins|gamma-globulins|mesh-list
93116694|NCT02525172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93116695|NCT02525172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93116696|NCT02525172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93116697|NCT02525172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116698|NCT02525172|Immunologic Factors|immunologic factors|mesh-ancestor
93116699|NCT02525172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116700|NCT02525172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93116701|NCT02525172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93116702|NCT02525172|Abortifacient Agents|abortifacient agents|mesh-ancestor
93116703|NCT02525172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93116704|NCT02525172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116705|NCT02525172|Antimetabolites|antimetabolites|mesh-ancestor
93116706|NCT02525172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116707|NCT02525172|Dermatologic Agents|dermatologic agents|mesh-ancestor
93116708|NCT02525172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116709|NCT02525172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93116710|NCT02525172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93116711|NCT02525172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116712|NCT01285674|Cisplatin|cisplatin|mesh-list
93116713|NCT01285674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116714|NCT03859362|Ertapenem|ertapenem|mesh-list
93116715|NCT03859362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93116716|NCT03859362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116717|NCT05598580|Lenalidomide|lenalidomide|mesh-list
93116718|NCT05598580|Immunologic Factors|immunologic factors|mesh-ancestor
93116719|NCT05598580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116720|NCT05598580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93116721|NCT05598580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93116722|NCT05598580|Growth Substances|growth substances|mesh-ancestor
93116723|NCT05598580|Growth Inhibitors|growth inhibitors|mesh-ancestor
93116724|NCT05598580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116725|NCT01287546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93116726|NCT01287546|Trametinib|trametinib|mesh-list
93116727|NCT01287546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116728|NCT01287546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93116729|NCT01287546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116730|NCT01287546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116731|NCT03182166|Golimumab|golimumab|mesh-list
93116732|NCT03182166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93116733|NCT03182166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93116734|NCT03182166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93116735|NCT03182166|Immunologic Factors|immunologic factors|mesh-ancestor
93116736|NCT03182166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116737|NCT03193216|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
93116738|NCT03193216|Antacids|antacids|mesh-ancestor
93116739|NCT03193216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116740|NCT03193216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116741|NCT03864978|Rifaximin|rifaximin|mesh-list
93116742|NCT03864978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93116743|NCT03864978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116744|NCT03864978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93116745|NCT01568788|Vaccines|vaccines|mesh-list
93116746|NCT01568788|Immunologic Factors|immunologic factors|mesh-ancestor
93116747|NCT01568788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116748|NCT01287624|Paclitaxel|paclitaxel|mesh-list
93116749|NCT01287624|Gemcitabine|gemcitabine|mesh-list
93116750|NCT01287624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93116751|NCT01287624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116752|NCT01287624|Tubulin Modulators|tubulin modulators|mesh-ancestor
93116753|NCT01287624|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116754|NCT01287624|Mitosis Modulators|mitosis modulators|mesh-ancestor
93116755|NCT01287624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116756|NCT01287624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788988|NCT02730364|Acetaminophen|acetaminophen|mesh-list
93116757|NCT01287624|Antimetabolites|antimetabolites|mesh-ancestor
93116759|NCT05597800|Ipilimumab|ipilimumab|mesh-list
93116760|NCT05597800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93116761|NCT05597800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116762|NCT05597800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93116763|NCT05597800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116764|NCT01176552|Interferon-alpha|interferon-alpha|mesh-list
93116765|NCT01176552|Interferon alpha-2|interferon alpha-2|mesh-list
93116766|NCT01176552|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93116767|NCT01176552|Antiviral Agents|antiviral agents|mesh-ancestor
93116768|NCT01176552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116769|NCT01176552|Immunologic Factors|immunologic factors|mesh-ancestor
93116770|NCT01176552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116771|NCT01176552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116772|NCT01179438|Dexmedetomidine|dexmedetomidine|mesh-list
93116773|NCT01179438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93116774|NCT01179438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116775|NCT01179438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116776|NCT01179438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93116777|NCT01179438|Analgesics|analgesics|mesh-ancestor
93116778|NCT01179438|Sensory System Agents|sensory system agents|mesh-ancestor
93116779|NCT01179438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116780|NCT01179438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93116781|NCT01179438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93116782|NCT01179438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93116783|NCT01179438|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116784|NCT01179438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116785|NCT01179438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116786|NCT03864666|Cilostazol|cilostazol|mesh-list
93116787|NCT03864666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93116788|NCT03864666|Autonomic Agents|autonomic agents|mesh-ancestor
93116789|NCT03864666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116790|NCT03864666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116791|NCT03864666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93116792|NCT03864666|Respiratory System Agents|respiratory system agents|mesh-ancestor
93116793|NCT03864666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93116794|NCT03864666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93116795|NCT03864666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116796|NCT03864666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93116797|NCT03864666|Vasodilator Agents|vasodilator agents|mesh-ancestor
93116798|NCT03864666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93116799|NCT03864666|Protective Agents|protective agents|mesh-ancestor
93116800|NCT03864666|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93116801|NCT03864666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93116802|NCT03864666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116803|NCT03858972|Capecitabine|capecitabine|mesh-list
93116804|NCT03858972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93116805|NCT03858972|Antimetabolites|antimetabolites|mesh-ancestor
93116806|NCT03858972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116807|NCT03858972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116808|NCT03091348|Methyltestosterone|methyltestosterone|mesh-list
93116809|NCT03091348|Testosterone|testosterone|mesh-list
93116810|NCT03091348|Testosterone undecanoate|testosterone undecanoate|mesh-list
93116811|NCT03091348|Testosterone enanthate|testosterone enanthate|mesh-list
93116812|NCT03091348|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93116813|NCT03091348|Androgens|androgens|mesh-ancestor
93116814|NCT03091348|Hormones|hormones|mesh-ancestor
93116815|NCT03091348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117819|NCT03245970|Labetalol|labetalol|mesh-list
93116816|NCT03091348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116817|NCT03091348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93116818|NCT03091348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93116819|NCT03091348|Anabolic Agents|anabolic agents|mesh-ancestor
93116820|NCT02525016|Lidocaine|lidocaine|mesh-list
93116821|NCT02525016|Anesthetics, Local|anesthetics, local|mesh-ancestor
93116822|NCT02525016|Anesthetics|anesthetics|mesh-ancestor
93116823|NCT02525016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116824|NCT02525016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116825|NCT02525016|Sensory System Agents|sensory system agents|mesh-ancestor
93116826|NCT02525016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116827|NCT02525016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93116828|NCT02525016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93116829|NCT02525016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92789058|NCT02733250|Antimitotic Agents|antimitotic agents|mesh-ancestor
93116830|NCT02525016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116831|NCT02525016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116832|NCT01179594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93116833|NCT01179594|Interferon-alpha|interferon-alpha|mesh-list
93116834|NCT01179594|Entecavir|entecavir|mesh-list
93116835|NCT01179594|Antiviral Agents|antiviral agents|mesh-ancestor
93116836|NCT01179594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116837|NCT01179594|Immunologic Factors|immunologic factors|mesh-ancestor
93116838|NCT01179594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116839|NCT03751098|Phenylephrine|phenylephrine|mesh-list
93116840|NCT03751098|Oxymetazoline|oxymetazoline|mesh-list
93116841|NCT03751098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93116842|NCT03751098|Tropicamide|tropicamide|mesh-list
93116843|NCT03751098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93116844|NCT03751098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93116845|NCT03751098|Mydriatics|mydriatics|mesh-ancestor
93116846|NCT03751098|Autonomic Agents|autonomic agents|mesh-ancestor
93116847|NCT03751098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116848|NCT03751098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116849|NCT03751098|Sympathomimetics|sympathomimetics|mesh-ancestor
93116850|NCT03751098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93116851|NCT03751098|Nasal Decongestants|nasal decongestants|mesh-ancestor
93116852|NCT03751098|Respiratory System Agents|respiratory system agents|mesh-ancestor
93116853|NCT03751098|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93116854|NCT03751098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93116855|NCT03751098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93116856|NCT03751098|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116857|NCT03751098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116858|NCT03751098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116859|NCT03751098|Protective Agents|protective agents|mesh-ancestor
93116860|NCT03751098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93116861|NCT03751098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93116862|NCT03751098|Cholinergic Agents|cholinergic agents|mesh-ancestor
93116863|NCT01176708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93116864|NCT01176708|Protease Inhibitors|protease inhibitors|mesh-ancestor
93116865|NCT01176708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116866|NCT01176708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116867|NCT01176708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93116868|NCT01176708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116869|NCT01288794|Furosemide|furosemide|mesh-list
93116870|NCT01288794|Diuretics|diuretics|mesh-list
93116871|NCT01288794|Natriuretic Agents|natriuretic agents|mesh-ancestor
93116872|NCT01288794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116873|NCT01288794|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93116874|NCT01288794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116875|NCT01288794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116876|NCT01288872|Praziquantel|praziquantel|mesh-list
93116877|NCT01288872|Anthelmintics|anthelmintics|mesh-ancestor
93116878|NCT01288872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93116879|NCT01288872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116880|NCT03864588|Ropivacaine|ropivacaine|mesh-list
93116881|NCT03864588|Anesthetics, Local|anesthetics, local|mesh-ancestor
93116882|NCT03864588|Anesthetics|anesthetics|mesh-ancestor
93116883|NCT03864588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116884|NCT03864588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116885|NCT03864588|Sensory System Agents|sensory system agents|mesh-ancestor
93116886|NCT03864588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116887|NCT01288950|Vitamin D|vitamin d|mesh-list
93116888|NCT01288950|Ergocalciferols|ergocalciferols|mesh-list
93116889|NCT01288950|Cholecalciferol|cholecalciferol|mesh-list
93116890|NCT01288950|Vitamins|vitamins|mesh-list
93116891|NCT01288950|Micronutrients|micronutrients|mesh-ancestor
93116892|NCT01288950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116893|NCT01288950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93116894|NCT01288950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93116895|NCT01174914|Tenofovir|tenofovir|mesh-list
93116896|NCT01174914|Lamivudine|lamivudine|mesh-list
93116897|NCT01174914|Emtricitabine|emtricitabine|mesh-list
93116898|NCT01174914|Efavirenz|efavirenz|mesh-list
93116899|NCT01174914|Lopinavir|lopinavir|mesh-list
93116900|NCT01174914|Nevirapine|nevirapine|mesh-list
93116901|NCT01174914|Stavudine|stavudine|mesh-list
93116902|NCT01174914|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
93116903|NCT01174914|Naltrexone|naltrexone|mesh-list
93116904|NCT01174914|Antiviral Agents|antiviral agents|mesh-ancestor
92789133|NCT01042236|Fesoterodine|fesoterodine|mesh-list
93116905|NCT01174914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116906|NCT01174914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93116907|NCT01174914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93116908|NCT01174914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116909|NCT01174914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116910|NCT01174914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93116911|NCT01174914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93116912|NCT01174914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93116913|NCT01174914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93116914|NCT01174914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116915|NCT01174914|Sensory System Agents|sensory system agents|mesh-ancestor
93116916|NCT01174914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116917|NCT01174914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93116918|NCT01174914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93116919|NCT01174914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93116920|NCT01174914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93116921|NCT01174914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93116922|NCT01174914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93116923|NCT01174914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93116924|NCT01174914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93116925|NCT01174914|Protease Inhibitors|protease inhibitors|mesh-ancestor
93116926|NCT01174914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93116927|NCT01174914|Antimetabolites|antimetabolites|mesh-ancestor
93116929|NCT05548426|Penicillins|penicillins|mesh-list
93116930|NCT05548426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93116931|NCT05548426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116932|NCT05548426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93116933|NCT05548426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116934|NCT05548426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116935|NCT03102892|Anti-Infective Agents|anti-infective agents|mesh-list
93116936|NCT03102892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93116937|NCT01177176|Bupropion|bupropion|mesh-list
93116938|NCT01177176|Nicotine|nicotine|mesh-list
93116939|NCT01177176|Varenicline|varenicline|mesh-list
93116940|NCT01177176|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93116941|NCT01177176|Autonomic Agents|autonomic agents|mesh-ancestor
93116942|NCT01177176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116943|NCT01177176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116944|NCT01177176|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93116945|NCT01177176|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93116946|NCT01177176|Cholinergic Agents|cholinergic agents|mesh-ancestor
93116947|NCT01177176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93116948|NCT01177176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116949|NCT01177176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93116950|NCT01177176|Antidepressive Agents|antidepressive agents|mesh-ancestor
93116951|NCT01177176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116952|NCT01177176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93116953|NCT01177176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93116954|NCT01177176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116955|NCT01177176|Dopamine Agents|dopamine agents|mesh-ancestor
93116956|NCT01177176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93116957|NCT01177176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93116958|NCT01177176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116959|NCT01287780|Gentamicins|gentamicins|mesh-list
93116960|NCT01287780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93116961|NCT01287780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93116962|NCT01287780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93116963|NCT01287780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93116964|NCT01287780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116965|NCT01179828|Oxycodone|oxycodone|mesh-list
93116966|NCT01179828|Clobazam|clobazam|mesh-list
93116967|NCT01179828|Imipramine|imipramine|mesh-list
93116968|NCT01179828|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93116969|NCT01179828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93116970|NCT01179828|Narcotics|narcotics|mesh-ancestor
93116971|NCT01179828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93116972|NCT01179828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93116973|NCT01179828|Analgesics|analgesics|mesh-ancestor
93116974|NCT01179828|Sensory System Agents|sensory system agents|mesh-ancestor
93116975|NCT01179828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93116976|NCT01179828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93116977|NCT01179828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93116978|NCT01179828|Cholinergic Agents|cholinergic agents|mesh-ancestor
93116979|NCT01179828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789211|NCT02719756|Metformin|metformin|mesh-list
93116980|NCT01179828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93116981|NCT01179828|Urological Agents|urological agents|mesh-ancestor
93116982|NCT01179828|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93116983|NCT01179828|Antidepressive Agents|antidepressive agents|mesh-ancestor
93116984|NCT01179828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93116985|NCT01179828|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93116986|NCT01179828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93116987|NCT01179828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93116988|NCT01179828|Adrenergic Agents|adrenergic agents|mesh-ancestor
93116989|NCT01179828|Anticonvulsants|anticonvulsants|mesh-ancestor
93116990|NCT01179828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93116991|NCT01179828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93116992|NCT01179828|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93116993|NCT01179828|GABA Agonists|gaba agonists|mesh-ancestor
93116994|NCT01179828|GABA Agents|gaba agents|mesh-ancestor
93116995|NCT01180062|Latanoprost|latanoprost|mesh-list
93116996|NCT01180062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93116997|NCT01180062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93116998|NCT03858582|Pembrolizumab|pembrolizumab|mesh-list
93116999|NCT03858582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117000|NCT03858582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117001|NCT03858582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93117002|NCT03858582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117003|NCT01177566|Pimecrolimus|pimecrolimus|mesh-list
93117004|NCT01177566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93117005|NCT01177566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93117006|NCT01177566|Analgesics|analgesics|mesh-ancestor
93117007|NCT01177566|Sensory System Agents|sensory system agents|mesh-ancestor
93117008|NCT01177566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117009|NCT01177566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117010|NCT01177566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117011|NCT01177566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117012|NCT01177566|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117013|NCT01177566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93117014|NCT01177566|Immunologic Factors|immunologic factors|mesh-ancestor
93117015|NCT01177566|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93117016|NCT01177566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117017|NCT01177566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117018|NCT01181154|Rituximab|rituximab|mesh-list
93117019|NCT01181154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117020|NCT01181154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117021|NCT01181154|Immunologic Factors|immunologic factors|mesh-ancestor
93117022|NCT01181154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117023|NCT01181154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117024|NCT03101566|Gemcitabine|gemcitabine|mesh-list
93117025|NCT03101566|Nivolumab|nivolumab|mesh-list
93117026|NCT03101566|Ipilimumab|ipilimumab|mesh-list
93117027|NCT03101566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117028|NCT03101566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93117029|NCT03101566|Antimetabolites|antimetabolites|mesh-ancestor
93117030|NCT03101566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117031|NCT03101566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117032|NCT03101566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93117033|NCT01289496|Interferons|interferons|mesh-list
93117034|NCT01289496|Ribavirin|ribavirin|mesh-list
93117035|NCT01289496|Interferon-alpha|interferon-alpha|mesh-list
93117036|NCT01289496|Interferon alpha-2|interferon alpha-2|mesh-list
93117037|NCT01289496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93117038|NCT01289496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117039|NCT01289496|Antiviral Agents|antiviral agents|mesh-ancestor
93117040|NCT01289496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117041|NCT01289496|Antimetabolites|antimetabolites|mesh-ancestor
93117042|NCT01289496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117043|NCT01289496|Immunologic Factors|immunologic factors|mesh-ancestor
93117044|NCT01289496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117045|NCT01181232|Zolpidem|zolpidem|mesh-list
93117046|NCT01181232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93117047|NCT01181232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93117048|NCT01181232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117049|NCT01181232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117050|NCT01181232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93117051|NCT01181232|GABA Agonists|gaba agonists|mesh-ancestor
93117052|NCT01181232|GABA Agents|gaba agents|mesh-ancestor
93117053|NCT01181232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117054|NCT01181232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117055|NCT01181310|Scopolamine|scopolamine|mesh-list
93117056|NCT01181310|Donepezil|donepezil|mesh-list
93117057|NCT01181310|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93117058|NCT01181310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93117059|NCT01181310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117060|NCT01181310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117061|NCT01181310|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117062|NCT01181310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117063|NCT01181310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117064|NCT01181310|Nootropic Agents|nootropic agents|mesh-ancestor
93117065|NCT01181310|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93117066|NCT01181310|Antiemetics|antiemetics|mesh-ancestor
93117067|NCT01181310|Autonomic Agents|autonomic agents|mesh-ancestor
93117068|NCT01181310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117069|NCT01181310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93117070|NCT01181310|Mydriatics|mydriatics|mesh-ancestor
93117071|NCT01181310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93117072|NCT01181310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93117073|NCT01181310|Parasympatholytics|parasympatholytics|mesh-ancestor
93117074|NCT02525250|Lenalidomide|lenalidomide|mesh-list
93117075|NCT02525250|Immunologic Factors|immunologic factors|mesh-ancestor
93117076|NCT02525250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117077|NCT02525250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93117078|NCT02525250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93117079|NCT02525250|Growth Substances|growth substances|mesh-ancestor
93117080|NCT02525250|Growth Inhibitors|growth inhibitors|mesh-ancestor
93117081|NCT02525250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117082|NCT01288092|Dactolisib|dactolisib|mesh-list
93117083|NCT01288092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117084|NCT01290744|Clofazimine|clofazimine|mesh-list
93117085|NCT01290744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117086|NCT01290744|Leprostatic Agents|leprostatic agents|mesh-ancestor
93117087|NCT01290744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93117088|NCT01290744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117089|NCT01181388|Tirofiban|tirofiban|mesh-list
93117090|NCT01181388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93117091|NCT01181388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93117092|NCT01181388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117093|NCT01181388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93117094|NCT01181544|Heparin|heparin|mesh-list
93117095|NCT01181544|Anticoagulants|anticoagulants|mesh-ancestor
93117096|NCT01181544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93117097|NCT01181544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93117098|NCT01181544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117099|NCT01184664|Nicotine|nicotine|mesh-list
93117100|NCT01184664|Varenicline|varenicline|mesh-list
93117101|NCT01184664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93117102|NCT01184664|Autonomic Agents|autonomic agents|mesh-ancestor
93117103|NCT01184664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117104|NCT01184664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117105|NCT01184664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93117106|NCT01184664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93117107|NCT01184664|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117108|NCT01184664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117109|NCT01184664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117110|NCT03858192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93117111|NCT03858192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117112|NCT01184820|Factor VIII|factor viii|mesh-list
93117113|NCT01184820|Coagulants|coagulants|mesh-ancestor
93117114|NCT03858270|Memantine|memantine|mesh-list
93117115|NCT03858270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93117116|NCT03858270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93117117|NCT03858270|Dopamine Agents|dopamine agents|mesh-ancestor
93117118|NCT03858270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117119|NCT03858270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117120|NCT03858270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117121|NCT03858270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93117122|NCT03858270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93117123|NCT01289730|Etanercept|etanercept|mesh-list
93117124|NCT01289730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93117125|NCT01289730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93117126|NCT01289730|Analgesics|analgesics|mesh-ancestor
93117127|NCT01289730|Sensory System Agents|sensory system agents|mesh-ancestor
93117128|NCT01289730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117129|NCT01289730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117130|NCT01289730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117131|NCT01289730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117132|NCT01289730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93117133|NCT01289730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93117134|NCT01289730|Immunologic Factors|immunologic factors|mesh-ancestor
93117135|NCT01290900|Moxifloxacin|moxifloxacin|mesh-list
93117136|NCT01290900|Ceftazidime|ceftazidime|mesh-list
93117137|NCT01290900|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93117138|NCT01290900|Avibactam|avibactam|mesh-list
93117139|NCT01290900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93117140|NCT01290900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117141|NCT01290900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93117142|NCT01290900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93117143|NCT01290900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117144|NCT01290900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117145|NCT01290900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117146|NCT01290900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93117147|NCT03855306|Glyburide|glyburide|mesh-list
93117148|NCT03855306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93117149|NCT03855306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117150|NCT03855384|Cisplatin|cisplatin|mesh-list
93117151|NCT03855384|Carboplatin|carboplatin|mesh-list
93117152|NCT03855384|Fluorouracil|fluorouracil|mesh-list
93117153|NCT03855384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117154|NCT03855384|Antimetabolites|antimetabolites|mesh-ancestor
93117155|NCT03855384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117156|NCT03855384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93117157|NCT03855384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93117158|NCT03855384|Immunologic Factors|immunologic factors|mesh-ancestor
93117159|NCT03855384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117160|NCT01181934|Nicotine|nicotine|mesh-list
93117161|NCT01181934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93117162|NCT01181934|Autonomic Agents|autonomic agents|mesh-ancestor
93117163|NCT01181934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117164|NCT01181934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117165|NCT01181934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93117166|NCT01181934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93117167|NCT01181934|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117168|NCT01181934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117169|NCT01181934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117170|NCT01187862|Efavirenz|efavirenz|mesh-list
93117171|NCT01187862|Losartan|losartan|mesh-list
93117172|NCT01187862|Metoprolol|metoprolol|mesh-list
93117173|NCT01187862|Midazolam|midazolam|mesh-list
93117174|NCT01187862|Caffeine|caffeine|mesh-list
93117175|NCT01187862|Chlorzoxazone|chlorzoxazone|mesh-list
93117176|NCT01187862|Omeprazole|omeprazole|mesh-list
93117177|NCT01187862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93117178|NCT01187862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93117179|NCT01187862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117180|NCT01187862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117181|NCT01187862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93117182|NCT01187862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93117183|NCT01187862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93117184|NCT01187862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93117185|NCT01187862|Anesthetics, General|anesthetics, general|mesh-ancestor
93117186|NCT01187862|Anesthetics|anesthetics|mesh-ancestor
93117187|NCT01187862|GABA Modulators|gaba modulators|mesh-ancestor
93117188|NCT01187862|GABA Agents|gaba agents|mesh-ancestor
93117189|NCT01187862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117190|NCT01187862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117191|NCT01187862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93117192|NCT01187862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93117193|NCT01187862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93117194|NCT01187862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93117195|NCT01187862|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93117196|NCT01187862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93117197|NCT01187862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117198|NCT01187862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93117199|NCT01187862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93117200|NCT01187862|Purinergic Agents|purinergic agents|mesh-ancestor
93117201|NCT01187862|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93117202|NCT01187862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93117203|NCT01187862|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93117204|NCT01187862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93117205|NCT01187862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93117206|NCT01187862|Antiviral Agents|antiviral agents|mesh-ancestor
93117207|NCT01187862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117208|NCT01187862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93117209|NCT01187862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93117210|NCT01187862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93117211|NCT01187862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93117212|NCT01187862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93117213|NCT01187862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93117214|NCT01187862|Sympatholytics|sympatholytics|mesh-ancestor
93117215|NCT01187862|Autonomic Agents|autonomic agents|mesh-ancestor
93117216|NCT01187862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117217|NCT01187862|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93117218|NCT01187862|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93117219|NCT01187862|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93117220|NCT01187862|Adrenergic Agents|adrenergic agents|mesh-ancestor
93117221|NCT01187862|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93117222|NCT01187862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93117223|NCT01290042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93117224|NCT01290042|Immunologic Factors|immunologic factors|mesh-ancestor
93117225|NCT01290042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117226|NCT01185444|Hyaluronic Acid|hyaluronic acid|mesh-list
93117227|NCT01185444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93117228|NCT01185444|Immunologic Factors|immunologic factors|mesh-ancestor
93117229|NCT01185444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117230|NCT01185444|Viscosupplements|viscosupplements|mesh-ancestor
93117231|NCT01185444|Protective Agents|protective agents|mesh-ancestor
93117232|NCT03857334|Cortivazol|cortivazol|mesh-list
93117233|NCT03857334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117234|NCT01185678|Contraceptive Agents|contraceptive agents|mesh-list
93117235|NCT01185678|Desogestrel|desogestrel|mesh-list
93117236|NCT01185678|Contraceptives, Oral|contraceptives, oral|mesh-list
93117237|NCT01185678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93117238|NCT01185678|Progestins|progestins|mesh-list
93117239|NCT01185678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93117240|NCT01185678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117241|NCT01185678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93117242|NCT01185678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93117243|NCT01185678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93117244|NCT01185678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93117245|NCT01185678|Hormones|hormones|mesh-ancestor
93117246|NCT01185678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117247|NCT01188174|Clofarabine|clofarabine|mesh-list
93117248|NCT01188174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93117249|NCT01188174|Antimetabolites|antimetabolites|mesh-ancestor
93117250|NCT01188174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117251|NCT01188174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117252|NCT01588002|Ritonavir|ritonavir|mesh-list
93117253|NCT01588002|Efavirenz|efavirenz|mesh-list
93117254|NCT01588002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93117255|NCT01588002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93117256|NCT01588002|Protease Inhibitors|protease inhibitors|mesh-ancestor
93117257|NCT01588002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117258|NCT01588002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117259|NCT01588002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93117260|NCT01588002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93117261|NCT01588002|Antiviral Agents|antiviral agents|mesh-ancestor
93117262|NCT01588002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117263|NCT01588002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93117264|NCT01588002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93117265|NCT01588002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93117266|NCT01588002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93117267|NCT01588002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93117268|NCT01588002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93117269|NCT01588002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93117270|NCT01588002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93117271|NCT01588002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93117272|NCT01291212|Methyltestosterone|methyltestosterone|mesh-list
93117273|NCT01291212|Testosterone|testosterone|mesh-list
93117274|NCT01291212|Testosterone undecanoate|testosterone undecanoate|mesh-list
93117275|NCT01291212|Testosterone enanthate|testosterone enanthate|mesh-list
93117276|NCT01291212|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93117277|NCT01291212|Androgens|androgens|mesh-ancestor
93117278|NCT01291212|Hormones|hormones|mesh-ancestor
93117279|NCT01291212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117280|NCT01291212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117281|NCT01291212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93117282|NCT01291212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117283|NCT01291212|Anabolic Agents|anabolic agents|mesh-ancestor
93117284|NCT01182168|Gemcitabine|gemcitabine|mesh-list
93117285|NCT01182168|Everolimus|everolimus|mesh-list
93117286|NCT01182168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117287|NCT01182168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93117288|NCT01182168|Antimetabolites|antimetabolites|mesh-ancestor
93117289|NCT01182168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117290|NCT01182168|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93117291|NCT01182168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93117292|NCT01182168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117293|NCT01182168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93117294|NCT01182168|Immunologic Factors|immunologic factors|mesh-ancestor
93117295|NCT01182168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117296|NCT01182246|Genistein|genistein|mesh-list
93117297|NCT01182246|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93117298|NCT01182246|Protective Agents|protective agents|mesh-ancestor
93117299|NCT01182246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117300|NCT01182246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117301|NCT01182246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93117302|NCT01182246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117303|NCT01182246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117304|NCT01182246|Phytoestrogens|phytoestrogens|mesh-ancestor
93117305|NCT01182246|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93117306|NCT01182246|Estrogens|estrogens|mesh-ancestor
93117307|NCT01182246|Hormones|hormones|mesh-ancestor
93117308|NCT01182246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117309|NCT01588626|Ticagrelor|ticagrelor|mesh-list
93117310|NCT01588626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93117311|NCT01588626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93117312|NCT01588626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93117313|NCT01588626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93117314|NCT01588626|Purinergic Agents|purinergic agents|mesh-ancestor
93117315|NCT01588626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117316|NCT01588626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117317|NCT01588626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117318|NCT01290120|Rituximab|rituximab|mesh-list
93117319|NCT01290120|Doxorubicin|doxorubicin|mesh-list
93117320|NCT01290120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117321|NCT01290120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117322|NCT01290120|Immunologic Factors|immunologic factors|mesh-ancestor
93117323|NCT01290120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117324|NCT01290120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117325|NCT01290120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93117326|NCT01290120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93117327|NCT01290120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93117328|NCT01290120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117329|NCT01290120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117330|NCT01290198|Fluconazole|fluconazole|mesh-list
93117331|NCT01290198|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
93117332|NCT01290198|Antifungal Agents|antifungal agents|mesh-ancestor
93117333|NCT01290198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117334|NCT01290198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93117335|NCT01290198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93117336|NCT01290198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117337|NCT01290198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117338|NCT01290198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93117339|NCT01290198|Hormone Antagonists|hormone antagonists|mesh-ancestor
93120488|NCT05762536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117340|NCT01290198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117341|NCT01290198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117342|NCT01290198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93117343|NCT01290198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93117344|NCT01290276|Ondansetron|ondansetron|mesh-list
93117345|NCT01290276|Methylphenidate|methylphenidate|mesh-list
93117346|NCT01290276|Antiemetics|antiemetics|mesh-ancestor
93117347|NCT01290276|Autonomic Agents|autonomic agents|mesh-ancestor
93117348|NCT01290276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117349|NCT01290276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117350|NCT01290276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93117351|NCT01290276|Antipruritics|antipruritics|mesh-ancestor
93117352|NCT01290276|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117353|NCT01290276|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93117354|NCT01290276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93117356|NCT01290276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117357|NCT01290276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117358|NCT01290276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93117359|NCT01290276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93117360|NCT01290276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93117361|NCT01290276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93117362|NCT01290276|Dopamine Agents|dopamine agents|mesh-ancestor
93117363|NCT03856866|Hydroxychloroquine|hydroxychloroquine|mesh-list
93117364|NCT03856866|Antimalarials|antimalarials|mesh-ancestor
93117365|NCT03856866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93117366|NCT03856866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93117367|NCT03856866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117368|NCT03856866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117369|NCT03856866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117370|NCT03856866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117371|NCT01587768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93117372|NCT01587768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117373|NCT01182636|Adapalene|adapalene|mesh-list
93117374|NCT01182636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93117375|NCT01182636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93117376|NCT01182636|Analgesics|analgesics|mesh-ancestor
93117377|NCT01182636|Sensory System Agents|sensory system agents|mesh-ancestor
93117378|NCT01182636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117379|NCT01182636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117380|NCT01182636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117381|NCT01182636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117382|NCT01182636|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117383|NCT01290354|Lapatinib|lapatinib|mesh-list
93117384|NCT01290354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117385|NCT01290354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93117386|NCT01290354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117387|NCT01290354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117388|NCT01188408|Docetaxel|docetaxel|mesh-list
93117389|NCT01188408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117390|NCT01188408|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117391|NCT01188408|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117392|NCT01188408|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117393|NCT01188408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117394|NCT01186146|Aspirin|aspirin|mesh-list
93117395|NCT01186146|Clopidogrel|clopidogrel|mesh-list
93117396|NCT01186146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93117397|NCT01186146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93117398|NCT01186146|Analgesics|analgesics|mesh-ancestor
93117399|NCT01186146|Sensory System Agents|sensory system agents|mesh-ancestor
93117400|NCT01186146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117401|NCT01186146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117402|NCT01186146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117403|NCT01186146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117404|NCT01186146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93117405|NCT01186146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93117406|NCT01186146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117407|NCT01186146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93117408|NCT01186146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93117409|NCT01186146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117410|NCT01186146|Antipyretics|antipyretics|mesh-ancestor
93117411|NCT01186146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93117412|NCT01186146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93117413|NCT01186146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93117414|NCT01186146|Purinergic Agents|purinergic agents|mesh-ancestor
93117415|NCT01186146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117416|NCT01186224|Plerixafor|plerixafor|mesh-list
93117417|NCT01186224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93117418|NCT01186224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93117419|NCT01186224|Antiviral Agents|antiviral agents|mesh-ancestor
93117420|NCT01186224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117421|NCT01183494|Irinotecan|irinotecan|mesh-list
93117422|NCT01183494|Bevacizumab|bevacizumab|mesh-list
93117423|NCT01183494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93117424|NCT01183494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93117425|NCT01183494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117426|NCT01183494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117427|NCT01183494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789653|NCT02710396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93117428|NCT01183494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117429|NCT01183494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93117430|NCT01183494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93117431|NCT01183494|Growth Substances|growth substances|mesh-ancestor
93117432|NCT01183494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117433|NCT01183494|Growth Inhibitors|growth inhibitors|mesh-ancestor
93117434|NCT01183572|Iron|iron|mesh-list
93117435|NCT01183572|Folic Acid|folic acid|mesh-list
93117436|NCT01183572|Vitamin B Complex|vitamin b complex|mesh-list
93117437|NCT01183572|Trace Elements|trace elements|mesh-ancestor
93117438|NCT01183572|Micronutrients|micronutrients|mesh-ancestor
93117439|NCT01183572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117440|NCT01183572|Hematinics|hematinics|mesh-ancestor
93117441|NCT01183572|Vitamins|vitamins|mesh-ancestor
93117442|NCT03856242|Tamsulosin|tamsulosin|mesh-list
93117443|NCT03856242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93117444|NCT03856242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93117445|NCT03856242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93117446|NCT03856242|Adrenergic Agents|adrenergic agents|mesh-ancestor
93117447|NCT03856242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117448|NCT03856242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117449|NCT03856242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117450|NCT03856242|Urological Agents|urological agents|mesh-ancestor
93117451|NCT01291524|Pregabalin|pregabalin|mesh-list
93117452|NCT01291524|Analgesics|analgesics|mesh-ancestor
93117453|NCT01291524|Sensory System Agents|sensory system agents|mesh-ancestor
93117454|NCT01291524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117455|NCT01291524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117456|NCT01291524|Anticonvulsants|anticonvulsants|mesh-ancestor
93117457|NCT01291524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93117458|NCT01291524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93117459|NCT01291524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117460|NCT01291524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93117461|NCT01291524|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93117462|NCT01291524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93117463|NCT01291524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117464|NCT01291524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93117465|NCT01183806|Rivastigmine|rivastigmine|mesh-list
93117466|NCT01183806|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93117467|NCT01183806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117468|NCT01183806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117469|NCT01183806|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117470|NCT01183806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117471|NCT01183806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117472|NCT01183806|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93117473|NCT01183806|Protective Agents|protective agents|mesh-ancestor
93117474|NCT01188954|Doxycycline|doxycycline|mesh-list
93117475|NCT01188954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93117476|NCT01188954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117477|NCT01188954|Antimalarials|antimalarials|mesh-ancestor
93117478|NCT01188954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93117479|NCT01188954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93117480|NCT01183962|Vitamin D|vitamin d|mesh-list
93117481|NCT01183962|Vitamins|vitamins|mesh-ancestor
93117482|NCT01183962|Micronutrients|micronutrients|mesh-ancestor
93117483|NCT01183962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117484|NCT01183962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93117485|NCT01187238|Cisplatin|cisplatin|mesh-list
93117486|NCT01187238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117487|NCT01588314|Gabapentin|gabapentin|mesh-list
93117488|NCT01588314|Analgesics|analgesics|mesh-ancestor
93117489|NCT01588314|Sensory System Agents|sensory system agents|mesh-ancestor
93117490|NCT01588314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117491|NCT01588314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117492|NCT01588314|Anticonvulsants|anticonvulsants|mesh-ancestor
93117493|NCT01588314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93117494|NCT01588314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93117495|NCT01588314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117496|NCT01588314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93117497|NCT01588314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93117498|NCT01588314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93117499|NCT01588314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117500|NCT01588314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117501|NCT01588314|Antimanic Agents|antimanic agents|mesh-ancestor
93117502|NCT01290432|Folic Acid|folic acid|mesh-list
93117503|NCT01290432|Melatonin|melatonin|mesh-list
93117504|NCT01290432|Antioxidants|antioxidants|mesh-ancestor
93117505|NCT01290432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117506|NCT01290432|Protective Agents|protective agents|mesh-ancestor
93117507|NCT01290432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117508|NCT01290432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117509|NCT01290432|Hematinics|hematinics|mesh-ancestor
93117510|NCT01290432|Vitamin B Complex|vitamin b complex|mesh-ancestor
93117511|NCT01290432|Vitamins|vitamins|mesh-ancestor
93117512|NCT01290432|Micronutrients|micronutrients|mesh-ancestor
93117513|NCT01290510|Hyaluronic Acid|hyaluronic acid|mesh-list
93117514|NCT01290510|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93117515|NCT01290510|Immunologic Factors|immunologic factors|mesh-ancestor
93117516|NCT01290510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117517|NCT01290510|Viscosupplements|viscosupplements|mesh-ancestor
93117518|NCT01290510|Protective Agents|protective agents|mesh-ancestor
93117519|NCT01184196|Povidone-Iodine|povidone-iodine|mesh-list
93117520|NCT01184196|Povidone|povidone|mesh-list
93117521|NCT01184196|Plasma Substitutes|plasma substitutes|mesh-ancestor
93117522|NCT01184196|Blood Substitutes|blood substitutes|mesh-ancestor
93117523|NCT01184196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93117524|NCT01184196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117525|NCT01292460|Timolol|timolol|mesh-list
93117526|NCT01292460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93117527|NCT01292460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93117528|NCT01292460|Adrenergic Agents|adrenergic agents|mesh-ancestor
93117529|NCT01292460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117530|NCT01292460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117531|NCT01292460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117532|NCT01292460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93117533|NCT01292460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93117534|NCT01292616|Antirheumatic Agents|antirheumatic agents|mesh-list
93117535|NCT01292694|Losartan|losartan|mesh-list
93117536|NCT01292694|Captopril|captopril|mesh-list
93117537|NCT01292694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93117538|NCT01292694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93117539|NCT01292694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93117540|NCT01292694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93117541|NCT01292694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117542|NCT01292694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93117543|NCT01292694|Protease Inhibitors|protease inhibitors|mesh-ancestor
93117544|NCT01292694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117545|NCT03851562|Alprostadil|alprostadil|mesh-list
93117546|NCT03851562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93117547|NCT03851562|Vasodilator Agents|vasodilator agents|mesh-ancestor
93117548|NCT03851562|Urological Agents|urological agents|mesh-ancestor
93117549|NCT01293630|Paclitaxel|paclitaxel|mesh-list
93117550|NCT01293630|Carboplatin|carboplatin|mesh-list
93117551|NCT01293630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93117552|NCT01293630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117553|NCT01293630|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117554|NCT01293630|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117555|NCT01293630|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117556|NCT01293630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117557|NCT01191060|Lenalidomide|lenalidomide|mesh-list
93117558|NCT01191060|Bortezomib|bortezomib|mesh-list
93117559|NCT01191060|Immunologic Factors|immunologic factors|mesh-ancestor
93117560|NCT01191060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117561|NCT01191060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93117562|NCT01191060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93047974|NCT01063140|Vaccines|vaccines|mesh-list
93117563|NCT01191060|Growth Substances|growth substances|mesh-ancestor
93117564|NCT01191060|Growth Inhibitors|growth inhibitors|mesh-ancestor
93117565|NCT01191060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117566|NCT01291602|Avibactam|avibactam|mesh-list
93117567|NCT01291602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93117568|NCT01291602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117569|NCT01291602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117570|NCT01291602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93117571|NCT01291602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117572|NCT03851172|Ketorolac|ketorolac|mesh-list
93117573|NCT03851172|Nepafenac|nepafenac|mesh-list
93117574|NCT03851172|Cyclopentolate|cyclopentolate|mesh-list
93117575|NCT03851172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93117576|NCT03851172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93117577|NCT03851172|Analgesics|analgesics|mesh-ancestor
93117578|NCT03851172|Sensory System Agents|sensory system agents|mesh-ancestor
93117579|NCT03851172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789812|NCT00607581|Hormones|hormones|mesh-ancestor
93117580|NCT03851172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117581|NCT03851172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117582|NCT03851172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117583|NCT03851172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93117584|NCT03851172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117585|NCT03851172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117586|NCT03851172|Mydriatics|mydriatics|mesh-ancestor
93117587|NCT03851172|Autonomic Agents|autonomic agents|mesh-ancestor
93117588|NCT03851172|Parasympatholytics|parasympatholytics|mesh-ancestor
93117589|NCT03851172|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93117590|NCT03851172|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93117591|NCT03851172|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117592|NCT03851172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117593|NCT03853512|Petrolatum|petrolatum|mesh-list
93117594|NCT03853512|Emollients|emollients|mesh-ancestor
93117595|NCT03853512|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117596|NCT03849612|Insulin Lispro|insulin lispro|mesh-list
93117597|NCT03849612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93117598|NCT03849612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117599|NCT03853200|Chlorhexidine|chlorhexidine|mesh-list
93117600|NCT03853200|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93117601|NCT03853200|Acetic Acid|acetic acid|mesh-list
93117602|NCT03853200|Root Canal Irrigants|root canal irrigants|mesh-list
93117603|NCT03853200|Edetic Acid|edetic acid|mesh-list
93117604|NCT03853200|Pentetic Acid|pentetic acid|mesh-list
93117605|NCT03853200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93117606|NCT03853200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117607|NCT03853200|Disinfectants|disinfectants|mesh-ancestor
93117608|NCT03853200|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117609|NCT03853200|Anticoagulants|anticoagulants|mesh-ancestor
93117610|NCT03853200|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93117611|NCT03853200|Chelating Agents|chelating agents|mesh-ancestor
93117612|NCT03853200|Sequestering Agents|sequestering agents|mesh-ancestor
93117613|NCT03853200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117614|NCT03853200|Antidotes|antidotes|mesh-ancestor
93117615|NCT03853200|Protective Agents|protective agents|mesh-ancestor
93117616|NCT03853200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117617|NCT03853200|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93117618|NCT03853200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93117619|NCT03853200|Dental Disinfectants|dental disinfectants|mesh-ancestor
93117620|NCT01293942|Bevacizumab|bevacizumab|mesh-list
93117621|NCT01293942|Capecitabine|capecitabine|mesh-list
93117622|NCT01293942|Oxaliplatin|oxaliplatin|mesh-list
93117623|NCT01293942|Irinotecan|irinotecan|mesh-list
93117624|NCT01293942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117625|NCT01293942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117626|NCT01293942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93117627|NCT01293942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93117628|NCT01293942|Growth Substances|growth substances|mesh-ancestor
93117629|NCT01293942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117630|NCT01293942|Growth Inhibitors|growth inhibitors|mesh-ancestor
93117631|NCT01293942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93117632|NCT01293942|Antimetabolites|antimetabolites|mesh-ancestor
93117633|NCT01293942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117634|NCT01293942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93117635|NCT01293942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93117636|NCT01293942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117637|NCT01189656|Vaccines|vaccines|mesh-list
93117638|NCT01189656|Immunologic Factors|immunologic factors|mesh-ancestor
93120489|NCT03776058|Cinacalcet|cinacalcet|mesh-list
93117639|NCT01189656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117640|NCT01581138|Ribavirin|ribavirin|mesh-list
93117641|NCT01581138|Antimetabolites|antimetabolites|mesh-ancestor
93117642|NCT01581138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117643|NCT01581138|Antiviral Agents|antiviral agents|mesh-ancestor
93117644|NCT01581138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117645|NCT01191216|Docetaxel|docetaxel|mesh-list
93117646|NCT01191216|Tryptophan|tryptophan|mesh-list
93117647|NCT01191216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117648|NCT01191216|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117649|NCT01191216|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117650|NCT01191216|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117651|NCT01191216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117652|NCT01191216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93117653|NCT01191216|Antidepressive Agents|antidepressive agents|mesh-ancestor
93117654|NCT01191216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93117655|NCT01294176|Thioctic Acid|thioctic acid|mesh-list
93117656|NCT01294176|Antioxidants|antioxidants|mesh-ancestor
93117657|NCT01294176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117658|NCT01294176|Protective Agents|protective agents|mesh-ancestor
93117659|NCT01294176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117660|NCT01294176|Vitamin B Complex|vitamin b complex|mesh-ancestor
93117661|NCT01294176|Vitamins|vitamins|mesh-ancestor
93117662|NCT01294176|Micronutrients|micronutrients|mesh-ancestor
93117663|NCT03847818|Carboplatin|carboplatin|mesh-list
93117664|NCT03847818|Docetaxel|docetaxel|mesh-list
93117665|NCT03847818|Trastuzumab|trastuzumab|mesh-list
93117666|NCT03847818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117667|NCT03847818|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117668|NCT03847818|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117669|NCT03847818|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117670|NCT03847818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117671|NCT03847818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117672|NCT01294410|Antibodies|antibodies|mesh-list
93117673|NCT01294410|Immunoglobulins|immunoglobulins|mesh-list
93117674|NCT01294410|Immunologic Factors|immunologic factors|mesh-ancestor
93117675|NCT01294410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117676|NCT01191450|Chlorthalidone|chlorthalidone|mesh-list
93117677|NCT01191450|Amiloride|amiloride|mesh-list
93117678|NCT01191450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93117679|NCT01191450|Diuretics|diuretics|mesh-ancestor
93117680|NCT01191450|Natriuretic Agents|natriuretic agents|mesh-ancestor
93117681|NCT01191450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117682|NCT01191450|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93117683|NCT01191450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93117684|NCT01191450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117685|NCT01191450|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93117686|NCT01191450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93117687|NCT01191450|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93117688|NCT01191450|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93117689|NCT01194336|Huperzine A|huperzine a|mesh-list
93117690|NCT01194336|Donepezil|donepezil|mesh-list
93117691|NCT01194336|Galantamine|galantamine|mesh-list
93117692|NCT01194336|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93117693|NCT01194336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117694|NCT01194336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117695|NCT01194336|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117696|NCT01194336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117697|NCT01194336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117698|NCT01194336|Nootropic Agents|nootropic agents|mesh-ancestor
93117699|NCT01194336|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93117700|NCT01194336|Autonomic Agents|autonomic agents|mesh-ancestor
93117701|NCT01194336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117702|NCT01194336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93117703|NCT01194336|Protective Agents|protective agents|mesh-ancestor
93117704|NCT02660710|Rituximab|rituximab|mesh-list
93117705|NCT02660710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117706|NCT02660710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117707|NCT02660710|Immunologic Factors|immunologic factors|mesh-ancestor
93117708|NCT02660710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117709|NCT02660710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93117710|NCT01294878|Omalizumab|omalizumab|mesh-list
93117711|NCT01294878|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93117712|NCT01294878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93117713|NCT01294878|Respiratory System Agents|respiratory system agents|mesh-ancestor
93117714|NCT01296438|Insulin|insulin|mesh-list
93117715|NCT01296438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93117716|NCT01296438|Insulin Aspart|insulin aspart|mesh-list
93117717|NCT01296438|Insulin, Long-Acting|insulin, long-acting|mesh-list
93117718|NCT01296438|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93117719|NCT01296438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93117720|NCT01296438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117721|NCT03847272|Prednisone|prednisone|mesh-list
93117722|NCT03847272|Ustekinumab|ustekinumab|mesh-list
93117723|NCT03847272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117724|NCT03847272|Glucocorticoids|glucocorticoids|mesh-ancestor
93117725|NCT03847272|Hormones|hormones|mesh-ancestor
93117726|NCT03847272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117727|NCT03847272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117728|NCT03847272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93117729|NCT03847272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117730|NCT03847272|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117731|NCT03850626|Immunomodulating Agents|immunomodulating agents|mesh-list
93117732|NCT03850626|Immunologic Factors|immunologic factors|mesh-ancestor
93117733|NCT03850626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117734|NCT01294956|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93117735|NCT01294956|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93117736|NCT01294956|Lubricant Eye Drops|lubricant eye drops|mesh-list
93117737|NCT01294956|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93117738|NCT01294956|Laxatives|laxatives|mesh-ancestor
93117739|NCT01294956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93117740|NCT01190358|Grape Seed Extract|grape seed extract|mesh-list
93117741|NCT01190358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93117742|NCT01190358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117743|NCT01190358|Antioxidants|antioxidants|mesh-ancestor
93117744|NCT01190358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117745|NCT01190358|Protective Agents|protective agents|mesh-ancestor
93117746|NCT01190358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117747|NCT01293162|Folic Acid|folic acid|mesh-list
93117748|NCT01293162|Policosanol|policosanol|mesh-list
93117749|NCT01293162|Hematinics|hematinics|mesh-ancestor
93117750|NCT01293162|Vitamin B Complex|vitamin b complex|mesh-ancestor
93117751|NCT01293162|Vitamins|vitamins|mesh-ancestor
93117752|NCT01293162|Micronutrients|micronutrients|mesh-ancestor
93117753|NCT01293162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117754|NCT01293162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93117755|NCT01293162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93117756|NCT01293162|Antimetabolites|antimetabolites|mesh-ancestor
93117757|NCT01293162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117758|NCT01293162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93117759|NCT01293162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93117760|NCT01190670|Tacrolimus|tacrolimus|mesh-list
93117761|NCT01190670|Peficitinib|peficitinib|mesh-list
93117762|NCT01190670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93117763|NCT01190670|Immunologic Factors|immunologic factors|mesh-ancestor
93117764|NCT01190670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117765|NCT01190670|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93117766|NCT01190670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117767|NCT01190670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117768|NCT01194882|Insulin|insulin|mesh-list
93117769|NCT01194882|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93117770|NCT01194882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93117771|NCT01194882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117772|NCT01191684|Vaccines|vaccines|mesh-list
93117773|NCT01191684|Immunologic Factors|immunologic factors|mesh-ancestor
93117774|NCT01191684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117775|NCT02659540|Nivolumab|nivolumab|mesh-list
93117776|NCT02659540|Ipilimumab|ipilimumab|mesh-list
93117777|NCT02659540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117778|NCT02659540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117779|NCT02659540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93117780|NCT02659540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117781|NCT01295268|Emu Oil|emu oil|mesh-list
93117782|NCT01295268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93117783|NCT01295268|Dermatologic Agents|dermatologic agents|mesh-ancestor
93117784|NCT01383694|Piperine|piperine|mesh-list
93117785|NCT01383694|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93117786|NCT01383694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117787|NCT01383694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117788|NCT01191918|Lithium Carbonate|lithium carbonate|mesh-list
93117789|NCT01191918|Donepezil|donepezil|mesh-list
93117790|NCT01191918|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93117791|NCT01191918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117820|NCT03245970|Nifedipine|nifedipine|mesh-list
93117792|NCT01191918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117793|NCT01191918|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117794|NCT01191918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117795|NCT01191918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117796|NCT01191918|Nootropic Agents|nootropic agents|mesh-ancestor
93117797|NCT01191918|Antidepressive Agents|antidepressive agents|mesh-ancestor
93117798|NCT01191918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93117799|NCT01191918|Antimanic Agents|antimanic agents|mesh-ancestor
93117800|NCT01191918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93117801|NCT01191918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117802|NCT03850314|Glycine|glycine|mesh-list
93117803|NCT03850314|Glycine Agents|glycine agents|mesh-ancestor
93117804|NCT03850314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117805|NCT03850314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117806|NCT03850314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117807|NCT01097746|Paclitaxel|paclitaxel|mesh-list
93117808|NCT01097746|Bevacizumab|bevacizumab|mesh-list
93117809|NCT01097746|Carboplatin|carboplatin|mesh-list
93117810|NCT01097746|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93117811|NCT01097746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93117812|NCT01097746|Endothelial Growth Factors|endothelial growth factors|mesh-list
93117814|NCT01097746|Immunoglobulins|immunoglobulins|mesh-list
93117815|NCT01097746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93117816|NCT01097746|Immunoglobulin G|immunoglobulin g|mesh-list
93117817|NCT01097746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93117818|NCT01097746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117819|NCT01097746|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117820|NCT01097746|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117821|NCT01097746|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117822|NCT01097746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117823|NCT01097746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93117824|NCT01097746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93117825|NCT01097746|Growth Substances|growth substances|mesh-ancestor
93117826|NCT01097746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117827|NCT01097746|Growth Inhibitors|growth inhibitors|mesh-ancestor
93117828|NCT01097746|Immunologic Factors|immunologic factors|mesh-ancestor
93117829|NCT01190748|Galantamine|galantamine|mesh-list
93117830|NCT01190748|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93117831|NCT01190748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117832|NCT01190748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117833|NCT01190748|Cholinergic Agents|cholinergic agents|mesh-ancestor
93117834|NCT01190748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117835|NCT01190748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117836|NCT01190748|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93117837|NCT01190748|Autonomic Agents|autonomic agents|mesh-ancestor
93117838|NCT01190748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117839|NCT01190748|Nootropic Agents|nootropic agents|mesh-ancestor
93117840|NCT01383538|Leucovorin|leucovorin|mesh-list
93117841|NCT01383538|Oxaliplatin|oxaliplatin|mesh-list
93117842|NCT01383538|Irinotecan|irinotecan|mesh-list
93117843|NCT01383538|Folfirinox|folfirinox|mesh-list
93117844|NCT01383538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117845|NCT01383538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93117846|NCT01383538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93117847|NCT01383538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117848|NCT01383538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117849|NCT01383538|Antidotes|antidotes|mesh-ancestor
93117850|NCT01383538|Protective Agents|protective agents|mesh-ancestor
93117851|NCT01383538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117852|NCT01383538|Vitamin B Complex|vitamin b complex|mesh-ancestor
93117853|NCT01383538|Vitamins|vitamins|mesh-ancestor
93117854|NCT01383538|Micronutrients|micronutrients|mesh-ancestor
93117855|NCT01383460|Epoetin Alfa|epoetin alfa|mesh-list
93117856|NCT01383460|Lenograstim|lenograstim|mesh-list
93117857|NCT01383460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93117858|NCT01383460|Immunologic Factors|immunologic factors|mesh-ancestor
93117859|NCT01383460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117860|NCT01383460|Hematinics|hematinics|mesh-ancestor
93117861|NCT01192230|Docetaxel|docetaxel|mesh-list
93117862|NCT01192230|Endostatins|endostatins|mesh-list
93117863|NCT01192230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117864|NCT01192230|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117865|NCT01192230|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117866|NCT01192230|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117867|NCT01192230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117868|NCT01192230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93117869|NCT01192230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93117870|NCT01192230|Growth Substances|growth substances|mesh-ancestor
93117871|NCT01192230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117872|NCT01192230|Growth Inhibitors|growth inhibitors|mesh-ancestor
93117873|NCT05416840|Amlodipine|amlodipine|mesh-list
93117874|NCT05416840|Clonidine|clonidine|mesh-list
93117875|NCT05416840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93117876|NCT05416840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93117877|NCT05416840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93117878|NCT05416840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117879|NCT05416840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93117880|NCT05416840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117881|NCT05416840|Vasodilator Agents|vasodilator agents|mesh-ancestor
93117882|NCT05416840|Analgesics|analgesics|mesh-ancestor
93117883|NCT05416840|Sensory System Agents|sensory system agents|mesh-ancestor
93117884|NCT05416840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117885|NCT05416840|Sympatholytics|sympatholytics|mesh-ancestor
93117886|NCT05416840|Autonomic Agents|autonomic agents|mesh-ancestor
92790104|NCT01124045|Antiemetics|antiemetics|mesh-ancestor
93117887|NCT05416840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93117888|NCT05416840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93117889|NCT05416840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93117890|NCT05416840|Adrenergic Agents|adrenergic agents|mesh-ancestor
93117891|NCT05416840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93117892|NCT01192308|Tamoxifen|tamoxifen|mesh-list
93117893|NCT01192308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93117894|NCT01192308|Hormone Antagonists|hormone antagonists|mesh-ancestor
93117895|NCT01192308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117896|NCT01192308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117897|NCT01192308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93117898|NCT01192308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117899|NCT01192308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93117900|NCT01192308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93117901|NCT01192308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93117902|NCT01190982|Paclitaxel|paclitaxel|mesh-list
93117903|NCT01190982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93117904|NCT01190982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117905|NCT01190982|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117906|NCT01190982|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117907|NCT01190982|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117908|NCT01190982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117909|NCT04170556|Nivolumab|nivolumab|mesh-list
93117910|NCT04170556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93117911|NCT04170556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117912|NCT04170556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93117913|NCT04170556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117914|NCT03846960|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93117915|NCT03846960|Respiratory System Agents|respiratory system agents|mesh-ancestor
93117916|NCT01196754|Sevoflurane|sevoflurane|mesh-list
93117917|NCT01196754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93117918|NCT01196754|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93117919|NCT01196754|Anesthetics, General|anesthetics, general|mesh-ancestor
93117920|NCT01196754|Anesthetics|anesthetics|mesh-ancestor
93117921|NCT01196754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117922|NCT01196754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117923|NCT01295502|Paclitaxel|paclitaxel|mesh-list
93117924|NCT01295502|Cisplatin|cisplatin|mesh-list
93117925|NCT01295502|Carboplatin|carboplatin|mesh-list
93117926|NCT01295502|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93117927|NCT01295502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93117928|NCT01295502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117929|NCT01295502|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117930|NCT01295502|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117931|NCT01295502|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117932|NCT01295502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117933|NCT05207644|Letrozole|letrozole|mesh-list
93117934|NCT05207644|Misoprostol|misoprostol|mesh-list
93117935|NCT05207644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117936|NCT05207644|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93117937|NCT05207644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93117938|NCT05207644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117939|NCT05207644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117940|NCT05207644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93117941|NCT05207644|Hormone Antagonists|hormone antagonists|mesh-ancestor
93117942|NCT05207644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93117943|NCT05207644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117944|NCT05207644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93117945|NCT05207644|Abortifacient Agents|abortifacient agents|mesh-ancestor
93117946|NCT05207644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93117947|NCT05207644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93117948|NCT05207644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93117949|NCT05207644|Oxytocics|oxytocics|mesh-ancestor
93117950|NCT03846102|Acetaminophen|acetaminophen|mesh-list
93117951|NCT03846102|Morphine|morphine|mesh-list
93117952|NCT03846102|Levobupivacaine|levobupivacaine|mesh-list
93117953|NCT03846102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93117954|NCT03846102|Narcotics|narcotics|mesh-ancestor
93117955|NCT03846102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93117956|NCT03846102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93117957|NCT03846102|Analgesics|analgesics|mesh-ancestor
93117958|NCT03846102|Sensory System Agents|sensory system agents|mesh-ancestor
93117959|NCT03846102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93117960|NCT03846102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92790185|NCT00607035|Olmesartan|olmesartan|mesh-list
93117961|NCT03846102|Antipyretics|antipyretics|mesh-ancestor
93117962|NCT03846102|Anesthetics, Local|anesthetics, local|mesh-ancestor
93117963|NCT03846102|Anesthetics|anesthetics|mesh-ancestor
93117964|NCT01383148|Paclitaxel|paclitaxel|mesh-list
93117965|NCT01383148|Cisplatin|cisplatin|mesh-list
93117966|NCT01383148|Carboplatin|carboplatin|mesh-list
93117967|NCT01383148|Gemcitabine|gemcitabine|mesh-list
93117968|NCT01383148|Pemetrexed|pemetrexed|mesh-list
93117969|NCT01383148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93117970|NCT01383148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93117971|NCT01383148|Tubulin Modulators|tubulin modulators|mesh-ancestor
93117972|NCT01383148|Antimitotic Agents|antimitotic agents|mesh-ancestor
93117973|NCT01383148|Mitosis Modulators|mitosis modulators|mesh-ancestor
93117974|NCT01383148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117975|NCT01383148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93117976|NCT01383148|Antimetabolites|antimetabolites|mesh-ancestor
93117977|NCT01383148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117978|NCT01383148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93117979|NCT01383148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93117980|NCT01192854|Adefovir|adefovir|mesh-list
93117981|NCT01192854|Clevudine|clevudine|mesh-list
93117982|NCT01192854|Antiviral Agents|antiviral agents|mesh-ancestor
93117983|NCT01192854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117984|NCT01192854|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93117985|NCT01192854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93117986|NCT01192854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93117987|NCT01192854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117988|NCT01382914|Chlorhexidine|chlorhexidine|mesh-list
93117989|NCT01382914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93117990|NCT01382914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93117991|NCT01382914|Disinfectants|disinfectants|mesh-ancestor
93117992|NCT01195428|Simvastatin|simvastatin|mesh-list
93117993|NCT01195428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93117994|NCT01195428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93117995|NCT01195428|Antimetabolites|antimetabolites|mesh-ancestor
93117996|NCT01195428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93117997|NCT01195428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93117998|NCT01195428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93117999|NCT01195428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118000|NCT03439462|Sirolimus|sirolimus|mesh-list
93118001|NCT03439462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118002|NCT03439462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118003|NCT03439462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118004|NCT03439462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118005|NCT03439462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93118006|NCT03439462|Antifungal Agents|antifungal agents|mesh-ancestor
93118007|NCT03439462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118008|NCT03439462|Immunologic Factors|immunologic factors|mesh-ancestor
93118009|NCT01193166|Olanzapine|olanzapine|mesh-list
93118010|NCT01193166|Risperidone|risperidone|mesh-list
93118011|NCT01193166|Aripiprazole|aripiprazole|mesh-list
93118012|NCT01193166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93118013|NCT01193166|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93118014|NCT01193166|Perphenazine|perphenazine|mesh-list
93118015|NCT01193166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93118016|NCT01193166|Serotonin Agents|serotonin agents|mesh-ancestor
93118017|NCT01193166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93118018|NCT01193166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048428|NCT00307736|Bevacizumab|bevacizumab|mesh-list
93118019|NCT01193166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118020|NCT01193166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93118021|NCT01193166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93118022|NCT01193166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118023|NCT01193166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93118024|NCT01193166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93118025|NCT01193166|Dopamine Agents|dopamine agents|mesh-ancestor
93118026|NCT01193166|Antiemetics|antiemetics|mesh-ancestor
93118027|NCT01193166|Autonomic Agents|autonomic agents|mesh-ancestor
93118028|NCT01193166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118029|NCT01193166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118030|NCT01193166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93118031|NCT01193166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93118032|NCT01193166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118033|NCT01193166|Antidepressive Agents|antidepressive agents|mesh-ancestor
93118034|NCT01193166|Dopamine Agonists|dopamine agonists|mesh-ancestor
93118035|NCT01193166|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93118036|NCT01193166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93118037|NCT01193166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93118038|NCT01193166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93118039|NCT01197144|Adalimumab|adalimumab|mesh-list
93118040|NCT01197144|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93118041|NCT01197144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118042|NCT01197144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118043|NCT01193400|Cytarabine|cytarabine|mesh-list
93118044|NCT01193400|Clofarabine|clofarabine|mesh-list
93118045|NCT01193400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118046|NCT01193400|Antimetabolites|antimetabolites|mesh-ancestor
93118047|NCT01193400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118048|NCT01193400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118049|NCT01193400|Antiviral Agents|antiviral agents|mesh-ancestor
93118050|NCT01193400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118051|NCT01193400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118052|NCT01193400|Immunologic Factors|immunologic factors|mesh-ancestor
93118053|NCT01193400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118054|NCT03904888|Anesthetics|anesthetics|mesh-list
93118055|NCT03904888|Anesthetics, Local|anesthetics, local|mesh-list
93118056|NCT03904888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118057|NCT03904888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118058|NCT03904888|Sensory System Agents|sensory system agents|mesh-ancestor
93118059|NCT03904888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118060|NCT03846258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93118061|NCT01193478|Ledipasvir|ledipasvir|mesh-list
93118062|NCT01193478|Antiviral Agents|antiviral agents|mesh-ancestor
93118063|NCT01193478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118064|NCT01295736|Sildenafil Citrate|sildenafil citrate|mesh-list
93118065|NCT01295736|Vasodilator Agents|vasodilator agents|mesh-ancestor
93118066|NCT01295736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93118067|NCT01295736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93118068|NCT01295736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118069|NCT01295736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118070|NCT01295736|Urological Agents|urological agents|mesh-ancestor
93118071|NCT03733470|Sildenafil Citrate|sildenafil citrate|mesh-list
93118072|NCT03733470|Vasodilator Agents|vasodilator agents|mesh-ancestor
93118073|NCT03733470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93118074|NCT03733470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93118075|NCT03733470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118076|NCT03733470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118077|NCT03733470|Urological Agents|urological agents|mesh-ancestor
93118078|NCT01195974|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93118079|NCT01195974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93118080|NCT01195974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118081|NCT04731376|Methyltestosterone|methyltestosterone|mesh-list
93118082|NCT04731376|Testosterone|testosterone|mesh-list
93118083|NCT04731376|Testosterone undecanoate|testosterone undecanoate|mesh-list
93118084|NCT04731376|Testosterone enanthate|testosterone enanthate|mesh-list
93118085|NCT04731376|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93118086|NCT04731376|Androgens|androgens|mesh-ancestor
93118087|NCT04731376|Hormones|hormones|mesh-ancestor
93118088|NCT04731376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118089|NCT04731376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118090|NCT04731376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93118091|NCT04731376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118092|NCT04731376|Anabolic Agents|anabolic agents|mesh-ancestor
93118093|NCT01196208|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93118094|NCT01196208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118095|NCT01196208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118096|NCT01196208|Immunotoxins|immunotoxins|mesh-ancestor
93118097|NCT01196208|Immunoconjugates|immunoconjugates|mesh-ancestor
93118098|NCT01196208|Immunologic Factors|immunologic factors|mesh-ancestor
93118099|NCT01196208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118100|NCT01295892|Estrogens|estrogens|mesh-list
93118101|NCT01295892|Hormones|hormones|mesh-ancestor
93118102|NCT01295892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118103|NCT01295892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118104|NCT03018418|Mitomycins|mitomycins|mesh-list
93118105|NCT03018418|Mitomycin|mitomycin|mesh-list
93118106|NCT03018418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93118107|NCT03018418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118108|NCT03018418|Alkylating Agents|alkylating agents|mesh-ancestor
93118109|NCT03018418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118110|NCT03018418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93118111|NCT03018418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118112|NCT01296204|Antibodies|antibodies|mesh-list
93118113|NCT01296204|Immunologic Factors|immunologic factors|mesh-ancestor
93118114|NCT01296204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118115|NCT01197846|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93118116|NCT01197846|Antidepressive Agents|antidepressive agents|mesh-ancestor
93118117|NCT01197846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93118118|NCT01197846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93118119|NCT01197846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93118120|NCT01197846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118121|NCT01197846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118122|NCT05670678|Lactoferrin|lactoferrin|mesh-list
93118123|NCT05670678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118124|NCT02914366|Ambroxol|ambroxol|mesh-list
93118125|NCT02914366|Expectorants|expectorants|mesh-ancestor
93118126|NCT02914366|Respiratory System Agents|respiratory system agents|mesh-ancestor
93118127|NCT03846180|Octreotide|octreotide|mesh-list
93118128|NCT03846180|Terlipressin|terlipressin|mesh-list
93118129|NCT03846180|Somatostatin|somatostatin|mesh-list
93118130|NCT03846180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118131|NCT03846180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93118132|NCT03846180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118133|NCT03846180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93118134|NCT03846180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93118135|NCT03846180|Hormones|hormones|mesh-ancestor
93118136|NCT03846180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118137|NCT03846180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118138|NCT01199406|Levobupivacaine|levobupivacaine|mesh-list
93118139|NCT01199406|Anesthetics, Local|anesthetics, local|mesh-ancestor
93118140|NCT01199406|Anesthetics|anesthetics|mesh-ancestor
93118141|NCT01199406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118142|NCT01199406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118143|NCT01199406|Sensory System Agents|sensory system agents|mesh-ancestor
93118144|NCT01199406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118145|NCT02729116|Ertapenem|ertapenem|mesh-list
93118146|NCT02729116|Sitafloxacin|sitafloxacin|mesh-list
93118147|NCT02729116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118148|NCT02729116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118149|NCT02729116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93118150|NCT02729116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93118151|NCT02729116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118152|NCT02729116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118153|NCT02729116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118154|NCT02627092|Copper|copper|mesh-list
93118155|NCT02627092|Trace Elements|trace elements|mesh-ancestor
93118156|NCT02627092|Micronutrients|micronutrients|mesh-ancestor
93118157|NCT02627092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118158|NCT05289648|Niraparib|niraparib|mesh-list
93118159|NCT05289648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93118160|NCT05289648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118161|NCT05289648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118162|NCT05289648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118163|NCT01199562|Valganciclovir|valganciclovir|mesh-list
93118164|NCT01199562|Ganciclovir|ganciclovir|mesh-list
93118165|NCT01199562|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93118166|NCT01199562|Antiviral Agents|antiviral agents|mesh-list
93118167|NCT01199562|Foscarnet|foscarnet|mesh-list
93118168|NCT01199562|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
93118169|NCT01199562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118170|NCT01199562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93118171|NCT01199562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118172|NCT01199562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118173|NCT01199562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93118174|NCT03845322|Curcumin|curcumin|mesh-list
93118175|NCT03845322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93118176|NCT03845322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118177|NCT03845322|Analgesics|analgesics|mesh-ancestor
93118178|NCT03845322|Sensory System Agents|sensory system agents|mesh-ancestor
93118179|NCT03845322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118180|NCT03845322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118181|NCT03845322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118182|NCT03845322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118183|NCT03845322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118184|NCT03845322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118185|NCT03845322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118186|NCT03844932|Cyclosporine|cyclosporine|mesh-list
93118187|NCT03844932|Cyclosporins|cyclosporins|mesh-list
93118188|NCT03844932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118189|NCT03844932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118190|NCT03844932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118191|NCT03844932|Immunologic Factors|immunologic factors|mesh-ancestor
93118192|NCT03844932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118193|NCT03844932|Antifungal Agents|antifungal agents|mesh-ancestor
93118194|NCT03844932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118195|NCT03844932|Dermatologic Agents|dermatologic agents|mesh-ancestor
93118196|NCT03844932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118197|NCT03844932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93118198|NCT03726996|Desipramine|desipramine|mesh-list
93118199|NCT03726996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93118200|NCT03726996|Antidepressive Agents|antidepressive agents|mesh-ancestor
93118201|NCT03726996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93118202|NCT03726996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118203|NCT03726996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118204|NCT03726996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93118205|NCT03726996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93118206|NCT03726996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118207|NCT03726996|Adrenergic Agents|adrenergic agents|mesh-ancestor
93118208|NCT03726996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93118209|NCT03726996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118210|NCT01202058|Sirolimus|sirolimus|mesh-list
93118211|NCT01202058|Everolimus|everolimus|mesh-list
93118212|NCT01202058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93118213|NCT01202058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93118214|NCT01202058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118215|NCT01202058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118216|NCT01202058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118217|NCT01202058|Immunologic Factors|immunologic factors|mesh-ancestor
93118218|NCT01202058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118219|NCT01202058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118220|NCT01202058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118221|NCT01202058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118222|NCT01202058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93118223|NCT01202058|Antifungal Agents|antifungal agents|mesh-ancestor
93118224|NCT03844854|Salicylic Acid|salicylic acid|mesh-list
93118225|NCT03844854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118226|NCT03844854|Antifungal Agents|antifungal agents|mesh-ancestor
93118227|NCT03844854|Keratolytic Agents|keratolytic agents|mesh-ancestor
93118228|NCT03844854|Dermatologic Agents|dermatologic agents|mesh-ancestor
93118229|NCT03842046|Phenylephrine|phenylephrine|mesh-list
93118230|NCT03842046|Oxymetazoline|oxymetazoline|mesh-list
93118231|NCT03842046|Norepinephrine|norepinephrine|mesh-list
93118232|NCT03842046|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93118233|NCT03842046|Mydriatics|mydriatics|mesh-ancestor
93118234|NCT03842046|Autonomic Agents|autonomic agents|mesh-ancestor
93118235|NCT03842046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118236|NCT03842046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118237|NCT03842046|Sympathomimetics|sympathomimetics|mesh-ancestor
93118238|NCT03842046|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93118239|NCT03842046|Nasal Decongestants|nasal decongestants|mesh-ancestor
93118240|NCT03842046|Respiratory System Agents|respiratory system agents|mesh-ancestor
93118241|NCT03842046|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93118242|NCT03842046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93118243|NCT03842046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93118244|NCT03842046|Adrenergic Agents|adrenergic agents|mesh-ancestor
93118245|NCT03842046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93118246|NCT03842046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118247|NCT03842046|Protective Agents|protective agents|mesh-ancestor
93118248|NCT01198236|Itraconazole|itraconazole|mesh-list
93118249|NCT01198236|Antifungal Agents|antifungal agents|mesh-ancestor
93118250|NCT01198236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118251|NCT01198236|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93118252|NCT01198236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93118253|NCT01198236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118254|NCT01198236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118255|NCT01198236|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93118256|NCT01198236|Hormone Antagonists|hormone antagonists|mesh-ancestor
93118257|NCT01198236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118258|NCT01198236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118259|NCT01198236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93118260|NCT01198314|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93118261|NCT01198314|Immunologic Factors|immunologic factors|mesh-ancestor
92790473|NCT01061736|Folic Acid|folic acid|mesh-list
93118262|NCT01198314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118263|NCT04091490|Nivolumab|nivolumab|mesh-list
93118264|NCT04091490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118265|NCT04091490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118266|NCT04091490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93118267|NCT04091490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118269|NCT05184816|Siderophores|siderophores|mesh-ancestor
93118270|NCT05184816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93118271|NCT05184816|Chelating Agents|chelating agents|mesh-ancestor
93118272|NCT05184816|Sequestering Agents|sequestering agents|mesh-ancestor
93118273|NCT05184816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118274|NCT03841890|Tolnaftate|tolnaftate|mesh-list
93118275|NCT03841890|Antifungal Agents|antifungal agents|mesh-ancestor
93118276|NCT03841890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118277|NCT01200108|Budesonide|budesonide|mesh-list
93118278|NCT01200108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118279|NCT01200108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93118280|NCT01200108|Autonomic Agents|autonomic agents|mesh-ancestor
93118281|NCT01200108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118282|NCT01200108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118283|NCT01200108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93118284|NCT01200108|Respiratory System Agents|respiratory system agents|mesh-ancestor
93118285|NCT01200108|Glucocorticoids|glucocorticoids|mesh-ancestor
93118286|NCT01200108|Hormones|hormones|mesh-ancestor
93118287|NCT01200108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118288|NCT01200186|Progestins|progestins|mesh-list
93118289|NCT01200186|Hormones|hormones|mesh-ancestor
93118290|NCT01200186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118291|NCT01200186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118292|NCT03841812|Propofol|propofol|mesh-list
93118293|NCT03841812|Sevoflurane|sevoflurane|mesh-list
93118294|NCT03841812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93118295|NCT03841812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118296|NCT03841812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118297|NCT03841812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93118298|NCT03841812|Anesthetics, General|anesthetics, general|mesh-ancestor
93118299|NCT03841812|Anesthetics|anesthetics|mesh-ancestor
93118300|NCT03841812|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93118301|NCT03841812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93118302|NCT03882970|Tirzepatide|tirzepatide|mesh-list
93118303|NCT03882970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93118304|NCT03882970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118305|NCT03882970|Incretins|incretins|mesh-ancestor
93118306|NCT03882970|Hormones|hormones|mesh-ancestor
93118307|NCT03882970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118308|NCT05111808|Methylene Blue|methylene blue|mesh-list
93118309|NCT05111808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118310|NCT05111808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118311|NCT01198392|Cisplatin|cisplatin|mesh-list
93118312|NCT01198392|Tegafur|tegafur|mesh-list
93118313|NCT01198392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118314|NCT01198392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118315|NCT01198392|Antimetabolites|antimetabolites|mesh-ancestor
93118316|NCT01198392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118317|NCT01200264|Apremilast|apremilast|mesh-list
93118318|NCT01200264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93118319|NCT01200264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118320|NCT01200264|Analgesics|analgesics|mesh-ancestor
93118321|NCT01200264|Sensory System Agents|sensory system agents|mesh-ancestor
93118322|NCT01200264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118323|NCT01200264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118324|NCT01200264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118325|NCT01200264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118326|NCT01200264|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93118327|NCT01200264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93118328|NCT01200264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118329|NCT01200264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118330|NCT04799236|Amphotericin B|amphotericin b|mesh-list
93118331|NCT04799236|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93118332|NCT04799236|Miltefosine|miltefosine|mesh-list
93118333|NCT04799236|Amebicides|amebicides|mesh-ancestor
93118334|NCT04799236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93118335|NCT04799236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93118336|NCT04799236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118337|NCT04799236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118338|NCT04799236|Antifungal Agents|antifungal agents|mesh-ancestor
93118339|NCT04799236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118340|NCT01202370|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
93118341|NCT01202370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93118342|NCT01202370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118343|NCT03630952|Aflibercept|aflibercept|mesh-list
93118344|NCT03630952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93118345|NCT03630952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93118346|NCT03630952|Growth Substances|growth substances|mesh-ancestor
93118347|NCT03630952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118348|NCT03630952|Growth Inhibitors|growth inhibitors|mesh-ancestor
93118349|NCT03630952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118350|NCT01198782|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93118351|NCT01198782|Lubricant Eye Drops|lubricant eye drops|mesh-list
93118352|NCT01198782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93118353|NCT01200654|Linezolid|linezolid|mesh-list
93118354|NCT01200654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118355|NCT01200654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118356|NCT01200654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93118357|NCT01200654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118358|NCT01200654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118359|NCT01200732|Tadalafil|tadalafil|mesh-list
93118360|NCT01200732|Vasodilator Agents|vasodilator agents|mesh-ancestor
93118361|NCT01200732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93118362|NCT01200732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93118363|NCT01200732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118364|NCT01200732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118365|NCT01200732|Urological Agents|urological agents|mesh-ancestor
93118366|NCT01198860|Ascorbic Acid|ascorbic acid|mesh-list
93118367|NCT01198860|Tenofovir|tenofovir|mesh-list
93118368|NCT01198860|Antiviral Agents|antiviral agents|mesh-ancestor
93118369|NCT01198860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118370|NCT01198860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93118371|NCT01198860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93118372|NCT01198860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118373|NCT01198860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118374|NCT01198860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93118375|NCT01198860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93118376|NCT01198860|Antioxidants|antioxidants|mesh-ancestor
93118377|NCT01198860|Protective Agents|protective agents|mesh-ancestor
93118378|NCT01198860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118379|NCT01198860|Vitamins|vitamins|mesh-ancestor
93118380|NCT01198860|Micronutrients|micronutrients|mesh-ancestor
93118381|NCT01198938|Melatonin|melatonin|mesh-list
93118382|NCT01198938|Antioxidants|antioxidants|mesh-ancestor
93118383|NCT01198938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118384|NCT01198938|Protective Agents|protective agents|mesh-ancestor
93118385|NCT01198938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118386|NCT01198938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118387|NCT01201044|Gemcitabine|gemcitabine|mesh-list
93118388|NCT01201044|Nedaplatin|nedaplatin|mesh-list
93118389|NCT01201044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118390|NCT01201044|Antimetabolites|antimetabolites|mesh-ancestor
93118391|NCT01201044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118392|NCT01201044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118393|NCT03843060|Itraconazole|itraconazole|mesh-list
93118394|NCT03843060|Antifungal Agents|antifungal agents|mesh-ancestor
93118395|NCT03843060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118396|NCT03843060|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93118397|NCT03843060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93118398|NCT03843060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118399|NCT03843060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118400|NCT03843060|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93118401|NCT03843060|Hormone Antagonists|hormone antagonists|mesh-ancestor
93118402|NCT03843060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118403|NCT03843060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118404|NCT03843060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93118405|NCT04427904|Lidocaine|lidocaine|mesh-list
93118406|NCT04427904|Epinephrine|epinephrine|mesh-list
93118407|NCT04427904|Racepinephrine|racepinephrine|mesh-list
93118408|NCT04427904|Bupivacaine|bupivacaine|mesh-list
93118409|NCT04427904|Epinephryl borate|epinephryl borate|mesh-list
93118410|NCT04427904|Anesthetics, Local|anesthetics, local|mesh-ancestor
93118411|NCT04427904|Anesthetics|anesthetics|mesh-ancestor
93118412|NCT04427904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118413|NCT04427904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118414|NCT04427904|Sensory System Agents|sensory system agents|mesh-ancestor
93118415|NCT04427904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118416|NCT04427904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93118417|NCT04427904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93118418|NCT04427904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93118419|NCT04427904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118420|NCT04427904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118421|NCT04427904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93118422|NCT04427904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93118423|NCT04427904|Adrenergic Agents|adrenergic agents|mesh-ancestor
93118424|NCT04427904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93118425|NCT04427904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93118426|NCT04427904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93118427|NCT04427904|Autonomic Agents|autonomic agents|mesh-ancestor
93118428|NCT04427904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93118429|NCT04427904|Respiratory System Agents|respiratory system agents|mesh-ancestor
93118430|NCT04427904|Mydriatics|mydriatics|mesh-ancestor
93118431|NCT04427904|Sympathomimetics|sympathomimetics|mesh-ancestor
93118432|NCT04427904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93118433|NCT03792516|Artesunate|artesunate|mesh-list
93118434|NCT03792516|Antimalarials|antimalarials|mesh-ancestor
93118435|NCT03792516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93118436|NCT03792516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93118437|NCT03792516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118438|NCT03792516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118439|NCT03792516|Antiviral Agents|antiviral agents|mesh-ancestor
93118440|NCT03792516|Schistosomicides|schistosomicides|mesh-ancestor
93118441|NCT03792516|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93118442|NCT03792516|Anthelmintics|anthelmintics|mesh-ancestor
93118443|NCT01201122|Mesalamine|mesalamine|mesh-list
93118444|NCT01201122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93118445|NCT01201122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118446|NCT01201122|Analgesics|analgesics|mesh-ancestor
93118447|NCT01201122|Sensory System Agents|sensory system agents|mesh-ancestor
93118448|NCT01201122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118449|NCT01201122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118450|NCT01201122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118451|NCT01201122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118452|NCT03674112|Trastuzumab|trastuzumab|mesh-list
93118453|NCT03674112|Pertuzumab|pertuzumab|mesh-list
93118454|NCT03674112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118455|NCT03674112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118456|NCT03668808|Insulin|insulin|mesh-list
93118457|NCT03668808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93118458|NCT03668808|Insulin Glargine|insulin glargine|mesh-list
93118459|NCT03668808|Insulin, Long-Acting|insulin, long-acting|mesh-list
93118460|NCT03668808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93118461|NCT03668808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118462|NCT05281926|Nivolumab|nivolumab|mesh-list
93118463|NCT05281926|Poly ICLC|poly iclc|mesh-list
93118464|NCT05281926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118465|NCT05281926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118466|NCT05281926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93118467|NCT05281926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118468|NCT05281926|Interferon Inducers|interferon inducers|mesh-ancestor
93118469|NCT05281926|Immunologic Factors|immunologic factors|mesh-ancestor
93118470|NCT05281926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118471|NCT03844776|Acetaminophen|acetaminophen|mesh-list
93118472|NCT03844776|Amoxicillin|amoxicillin|mesh-list
93118473|NCT03844776|Metronidazole|metronidazole|mesh-list
93118474|NCT03844776|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93118475|NCT03844776|Chlorhexidine|chlorhexidine|mesh-list
93118476|NCT03844776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118477|NCT03844776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118478|NCT03844776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93118479|NCT03844776|Disinfectants|disinfectants|mesh-ancestor
93118480|NCT03844776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118481|NCT03844776|Analgesics|analgesics|mesh-ancestor
93118482|NCT03844776|Sensory System Agents|sensory system agents|mesh-ancestor
93118483|NCT03844776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118484|NCT03844776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118485|NCT03844776|Antipyretics|antipyretics|mesh-ancestor
93118486|NCT03844776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93118487|NCT03844776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93118488|NCT03844776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93118489|NCT03844776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118490|NCT03844776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118491|NCT01566942|Oxaliplatin|oxaliplatin|mesh-list
93118492|NCT01566942|Irinotecan|irinotecan|mesh-list
93118493|NCT01566942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118494|NCT01566942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93118495|NCT01566942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93118496|NCT01566942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118497|NCT01566942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118498|NCT01201278|Insulin|insulin|mesh-list
93118499|NCT01201278|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93118500|NCT01201278|Insulin Lispro|insulin lispro|mesh-list
93118501|NCT01201278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93118502|NCT01201278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118503|NCT05667948|Immunomodulating Agents|immunomodulating agents|mesh-list
93118504|NCT05667948|Immunologic Factors|immunologic factors|mesh-ancestor
93118505|NCT05667948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118506|NCT01199328|Aspirin|aspirin|mesh-list
93118507|NCT01199328|Esomeprazole|esomeprazole|mesh-list
93118508|NCT01199328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93118509|NCT01199328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118510|NCT01199328|Analgesics|analgesics|mesh-ancestor
93118511|NCT01199328|Sensory System Agents|sensory system agents|mesh-ancestor
93118512|NCT01199328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118513|NCT01199328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118514|NCT01199328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118515|NCT01199328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118516|NCT01199328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93118517|NCT01199328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93118518|NCT01199328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118519|NCT01199328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93118520|NCT01199328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93118521|NCT01199328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118522|NCT01199328|Antipyretics|antipyretics|mesh-ancestor
93118523|NCT01199328|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93118524|NCT01199328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118525|NCT01199328|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93118526|NCT02982954|Nivolumab|nivolumab|mesh-list
93118527|NCT02982954|Ipilimumab|ipilimumab|mesh-list
93118528|NCT02982954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118529|NCT02982954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118530|NCT02982954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93118531|NCT02982954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118532|NCT01203228|Cyclophosphamide|cyclophosphamide|mesh-list
93118533|NCT01203228|Busulfan|busulfan|mesh-list
93118534|NCT01203228|Fludarabine phosphate|fludarabine phosphate|mesh-list
93118535|NCT01203228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118536|NCT01203228|Immunologic Factors|immunologic factors|mesh-ancestor
93118537|NCT01203228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118538|NCT01203228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118539|NCT01203228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93118540|NCT01203228|Alkylating Agents|alkylating agents|mesh-ancestor
93118541|NCT01203228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118542|NCT01203228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118543|NCT01203228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93118544|NCT01203228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118545|NCT01203228|Antimetabolites|antimetabolites|mesh-ancestor
93118546|NCT01203696|Amlodipine|amlodipine|mesh-list
93118547|NCT01203696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93118548|NCT01203696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93118549|NCT01203696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118550|NCT01203696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118551|NCT01203696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93118552|NCT01203696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118553|NCT01203696|Vasodilator Agents|vasodilator agents|mesh-ancestor
93118554|NCT01203306|Bevacizumab|bevacizumab|mesh-list
93118555|NCT01203306|Capecitabine|capecitabine|mesh-list
93118556|NCT01203306|Octreotide|octreotide|mesh-list
93118557|NCT01203306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118558|NCT01203306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118559|NCT01203306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93118560|NCT01203306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93118561|NCT01203306|Growth Substances|growth substances|mesh-ancestor
93118562|NCT01203306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118563|NCT01203306|Growth Inhibitors|growth inhibitors|mesh-ancestor
93118564|NCT01203306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790763|NCT03522064|Testosterone enanthate|testosterone enanthate|mesh-list
93118565|NCT01203306|Antimetabolites|antimetabolites|mesh-ancestor
93118566|NCT01203306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118567|NCT01203306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118568|NCT01203306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93118569|NCT01203384|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
93118570|NCT01203384|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93118571|NCT01203384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118572|NCT01203384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118573|NCT03724968|Nivolumab|nivolumab|mesh-list
93118574|NCT03724968|Ipilimumab|ipilimumab|mesh-list
93118575|NCT03724968|Relatlimab|relatlimab|mesh-list
93118576|NCT03724968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118577|NCT03724968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118578|NCT03724968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93118579|NCT03724968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118580|NCT01204086|Fluoxetine|fluoxetine|mesh-list
93118581|NCT01204086|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93118582|NCT01204086|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93118583|NCT01204086|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93118584|NCT01204086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118585|NCT01204086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118586|NCT01204086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93118587|NCT01204086|Serotonin Agents|serotonin agents|mesh-ancestor
93118588|NCT01204086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118589|NCT01204086|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93118590|NCT01204086|Antidepressive Agents|antidepressive agents|mesh-ancestor
93118591|NCT01204086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93118592|NCT01204086|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93118593|NCT01204086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93118594|NCT01204086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118595|NCT01204086|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93118596|NCT01201902|Vaccines|vaccines|mesh-list
93118597|NCT01201902|Immunologic Factors|immunologic factors|mesh-ancestor
93118598|NCT01201902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118599|NCT01204164|Dexamethasone|dexamethasone|mesh-list
93118600|NCT01204164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118601|NCT01204164|Antiemetics|antiemetics|mesh-ancestor
93118602|NCT01204164|Autonomic Agents|autonomic agents|mesh-ancestor
93118603|NCT01204164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118604|NCT01204164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118605|NCT01204164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118606|NCT01204164|Glucocorticoids|glucocorticoids|mesh-ancestor
93118607|NCT01204164|Hormones|hormones|mesh-ancestor
93118608|NCT01204164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118609|NCT01204164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93118610|NCT01204164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118611|NCT01206036|Sirolimus|sirolimus|mesh-list
93118612|NCT01206036|Docetaxel|docetaxel|mesh-list
93118613|NCT01206036|Temsirolimus|temsirolimus|mesh-list
93118614|NCT01206036|MTOR Inhibitors|mtor inhibitors|mesh-list
93118615|NCT01206036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118616|NCT01206036|Tubulin Modulators|tubulin modulators|mesh-ancestor
93118617|NCT01206036|Antimitotic Agents|antimitotic agents|mesh-ancestor
93118618|NCT01206036|Mitosis Modulators|mitosis modulators|mesh-ancestor
93118619|NCT01206036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118620|NCT01206036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93118621|NCT01206036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118622|NCT01206036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118623|NCT01206036|Immunologic Factors|immunologic factors|mesh-ancestor
93118624|NCT01206036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118625|NCT01206036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118626|NCT01206036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118627|NCT01206036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93118628|NCT01206036|Antifungal Agents|antifungal agents|mesh-ancestor
93118629|NCT01204320|Paclitaxel|paclitaxel|mesh-list
93118630|NCT01204320|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93118631|NCT01204320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93118632|NCT01204320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118633|NCT01204320|Tubulin Modulators|tubulin modulators|mesh-ancestor
93118634|NCT01204320|Antimitotic Agents|antimitotic agents|mesh-ancestor
93118635|NCT01204320|Mitosis Modulators|mitosis modulators|mesh-ancestor
93118636|NCT01204320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118637|NCT03722238|Ibuprofen|ibuprofen|mesh-list
93118638|NCT03722238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93118639|NCT03722238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118640|NCT03722238|Analgesics|analgesics|mesh-ancestor
93118641|NCT03722238|Sensory System Agents|sensory system agents|mesh-ancestor
93118642|NCT03722238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118643|NCT03722238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118644|NCT03722238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118645|NCT03722238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118646|NCT03722238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93118647|NCT03722238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118648|NCT03722238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118649|NCT01203540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93118650|NCT01203540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93118651|NCT01203618|Farletuzumab|farletuzumab|mesh-list
93118652|NCT01203618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118653|NCT01206270|Methyltestosterone|methyltestosterone|mesh-list
93118654|NCT01206270|Castor Oil|castor oil|mesh-list
93118655|NCT01206270|Testosterone|testosterone|mesh-list
93118656|NCT01206270|Testosterone undecanoate|testosterone undecanoate|mesh-list
93118657|NCT01206270|Testosterone enanthate|testosterone enanthate|mesh-list
93118658|NCT01206270|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93118659|NCT01206270|Androgens|androgens|mesh-ancestor
93118660|NCT01206270|Hormones|hormones|mesh-ancestor
93118661|NCT01206270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118662|NCT01206270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118663|NCT01206270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93118664|NCT01206270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118665|NCT01206270|Anabolic Agents|anabolic agents|mesh-ancestor
93118666|NCT01206270|Cathartics|cathartics|mesh-ancestor
93118667|NCT01206270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118668|NCT01298310|Lidocaine|lidocaine|mesh-list
93118669|NCT01298310|Anesthetics, Local|anesthetics, local|mesh-ancestor
93118670|NCT01298310|Anesthetics|anesthetics|mesh-ancestor
93118671|NCT01298310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118672|NCT01298310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118673|NCT01298310|Sensory System Agents|sensory system agents|mesh-ancestor
93118674|NCT01298310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118675|NCT01298310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93118676|NCT01298310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93118677|NCT01298310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93118678|NCT01298310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118679|NCT01298310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118680|NCT01298466|Pregabalin|pregabalin|mesh-list
93118681|NCT01298466|Analgesics|analgesics|mesh-ancestor
93118682|NCT01298466|Sensory System Agents|sensory system agents|mesh-ancestor
93118683|NCT01298466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118684|NCT01298466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118685|NCT01298466|Anticonvulsants|anticonvulsants|mesh-ancestor
93118686|NCT01298466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93118687|NCT01298466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118688|NCT01298466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118689|NCT01298466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93118690|NCT01298466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93118691|NCT01298466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93118692|NCT01298466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118693|NCT01298466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93118694|NCT01206348|Minocycline|minocycline|mesh-list
93118695|NCT01206348|Clindamycin|clindamycin|mesh-list
93118696|NCT01206348|Clindamycin palmitate|clindamycin palmitate|mesh-list
93118697|NCT01206348|Clindamycin phosphate|clindamycin phosphate|mesh-list
93118698|NCT01206348|Tretinoin|tretinoin|mesh-list
93118699|NCT01206348|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93118700|NCT01206348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118701|NCT01206348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118702|NCT01206348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93118703|NCT01206348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118704|NCT01206348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118705|NCT01206348|Dermatologic Agents|dermatologic agents|mesh-ancestor
93118706|NCT01206348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118707|NCT01206348|Keratolytic Agents|keratolytic agents|mesh-ancestor
93118708|NCT05669352|Pembrolizumab|pembrolizumab|mesh-list
93118709|NCT05669352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118710|NCT05669352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118711|NCT05669352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93118712|NCT05669352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118714|NCT01204476|Octreotide|octreotide|mesh-list
93118715|NCT01204476|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93118716|NCT01204476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93118717|NCT01204476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93118718|NCT01204476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118719|NCT01204476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118720|NCT01204476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118721|NCT01204476|Immunologic Factors|immunologic factors|mesh-ancestor
93118722|NCT01204476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118723|NCT01204476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118724|NCT01204476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93118725|NCT01204476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93118726|NCT03633292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93118727|NCT03633292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118728|NCT04630210|Atezolizumab|atezolizumab|mesh-list
93118729|NCT04630210|Letrozole|letrozole|mesh-list
93118730|NCT04630210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93118731|NCT04630210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118732|NCT04630210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118733|NCT04630210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118734|NCT04630210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93118735|NCT04630210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93118736|NCT04630210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118737|NCT04630210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93118738|NCT04630210|Hormone Antagonists|hormone antagonists|mesh-ancestor
93118739|NCT04630210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118740|NCT04630210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118741|NCT01382368|Sildenafil Citrate|sildenafil citrate|mesh-list
93118742|NCT01382368|Vasodilator Agents|vasodilator agents|mesh-ancestor
93118743|NCT01382368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93118744|NCT01382368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93118745|NCT01382368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118746|NCT01382368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118747|NCT01382368|Urological Agents|urological agents|mesh-ancestor
93118748|NCT04546828|Gemcitabine|gemcitabine|mesh-list
93118749|NCT04546828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118750|NCT04546828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118751|NCT04546828|Antimetabolites|antimetabolites|mesh-ancestor
93118752|NCT04546828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118753|NCT01382134|Aspirin|aspirin|mesh-list
93118754|NCT01382134|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93118755|NCT01382134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93118756|NCT01382134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93118757|NCT01382134|Analgesics|analgesics|mesh-ancestor
93118758|NCT01382134|Sensory System Agents|sensory system agents|mesh-ancestor
93118759|NCT01382134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118760|NCT01382134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118761|NCT01382134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118762|NCT01382134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118763|NCT01382134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93118764|NCT01382134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93118765|NCT01382134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118766|NCT01382134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93118767|NCT01382134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93118768|NCT01382134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118769|NCT01382134|Antipyretics|antipyretics|mesh-ancestor
93118770|NCT01382134|Hemostatics|hemostatics|mesh-ancestor
93118771|NCT01382134|Coagulants|coagulants|mesh-ancestor
93118772|NCT01382134|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93118773|NCT01382134|Natriuretic Agents|natriuretic agents|mesh-ancestor
93118774|NCT05077488|Lidocaine|lidocaine|mesh-list
93118775|NCT05077488|Anesthetics, Local|anesthetics, local|mesh-ancestor
93118776|NCT05077488|Anesthetics|anesthetics|mesh-ancestor
93118777|NCT05077488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118778|NCT05077488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118779|NCT05077488|Sensory System Agents|sensory system agents|mesh-ancestor
93118780|NCT05077488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118781|NCT05077488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93118782|NCT05077488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93118783|NCT05077488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93118784|NCT05077488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118785|NCT05077488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118786|NCT05668572|Vaccines|vaccines|mesh-list
93118787|NCT05668572|Immunologic Factors|immunologic factors|mesh-ancestor
93118788|NCT05668572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118789|NCT02410980|Tretinoin|tretinoin|mesh-list
93118790|NCT02410980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118791|NCT02410980|Keratolytic Agents|keratolytic agents|mesh-ancestor
93118792|NCT02410980|Dermatologic Agents|dermatologic agents|mesh-ancestor
93118793|NCT01298934|Panobinostat|panobinostat|mesh-list
93118794|NCT01298934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118795|NCT01298934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93118796|NCT01298934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118797|NCT01298934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118798|NCT01300962|Capecitabine|capecitabine|mesh-list
93118799|NCT01300962|Trastuzumab|trastuzumab|mesh-list
93118800|NCT01300962|Lapatinib|lapatinib|mesh-list
93118801|NCT01300962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118802|NCT01300962|Antimetabolites|antimetabolites|mesh-ancestor
93118803|NCT01300962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118804|NCT01300962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118805|NCT01300962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93118806|NCT01300962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93118807|NCT01300962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118808|NCT01299012|Liraglutide|liraglutide|mesh-list
93118809|NCT01299012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93118810|NCT01299012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118811|NCT01299012|Incretins|incretins|mesh-ancestor
93118812|NCT01299012|Hormones|hormones|mesh-ancestor
93118813|NCT01299012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118814|NCT02155920|Everolimus|everolimus|mesh-list
93118815|NCT02155920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93118816|NCT02155920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93118817|NCT02155920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118818|NCT02155920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118819|NCT02155920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118820|NCT02155920|Immunologic Factors|immunologic factors|mesh-ancestor
93118821|NCT02155920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118822|NCT02155920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118823|NCT01301040|Cyclophosphamide|cyclophosphamide|mesh-list
93118824|NCT01301040|Docetaxel|docetaxel|mesh-list
93118825|NCT01301040|Epirubicin|epirubicin|mesh-list
93118826|NCT01301040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118827|NCT01301040|Immunologic Factors|immunologic factors|mesh-ancestor
93118828|NCT01301040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118829|NCT01301040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118830|NCT01301040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93118831|NCT01301040|Alkylating Agents|alkylating agents|mesh-ancestor
93118832|NCT01301040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118833|NCT01301040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118834|NCT01301040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93118835|NCT01301040|Tubulin Modulators|tubulin modulators|mesh-ancestor
93118836|NCT01301040|Antimitotic Agents|antimitotic agents|mesh-ancestor
93118837|NCT01301040|Mitosis Modulators|mitosis modulators|mesh-ancestor
93118838|NCT01301040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049248|NCT00495755|Alemtuzumab|alemtuzumab|mesh-list
93118839|NCT01301040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93118840|NCT01301040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93118841|NCT01301040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118842|NCT03818334|Cyclophosphamide|cyclophosphamide|mesh-list
93118843|NCT03818334|Thymoglobulin|thymoglobulin|mesh-list
93118844|NCT03818334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118845|NCT03818334|Immunologic Factors|immunologic factors|mesh-ancestor
93118846|NCT03818334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118847|NCT03818334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118848|NCT03818334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93118849|NCT03818334|Alkylating Agents|alkylating agents|mesh-ancestor
93118850|NCT03818334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118851|NCT03818334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118852|NCT03818334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93118853|NCT01206972|Enoxaparin|enoxaparin|mesh-list
93118854|NCT01206972|Rivaroxaban|rivaroxaban|mesh-list
93118855|NCT01206972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93118856|NCT01206972|Antithrombins|antithrombins|mesh-ancestor
93118857|NCT01206972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93118858|NCT01206972|Protease Inhibitors|protease inhibitors|mesh-ancestor
93118859|NCT01206972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118860|NCT01206972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118862|NCT01206972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93118863|NCT01206972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93118864|NCT03817476|BI 425809|bi 425809|mesh-list
93118865|NCT03817476|Nootropic Agents|nootropic agents|mesh-ancestor
93118866|NCT02918292|Mycophenolic Acid|mycophenolic acid|mesh-list
93118867|NCT02918292|Cyclophosphamide|cyclophosphamide|mesh-list
93118868|NCT02918292|Fludarabine|fludarabine|mesh-list
93118869|NCT02918292|Tacrolimus|tacrolimus|mesh-list
93118870|NCT02918292|Thymoglobulin|thymoglobulin|mesh-list
93118871|NCT02918292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93118872|NCT02918292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118873|NCT02918292|Immunologic Factors|immunologic factors|mesh-ancestor
93118874|NCT02918292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118875|NCT02918292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118876|NCT02918292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93118877|NCT02918292|Alkylating Agents|alkylating agents|mesh-ancestor
93118878|NCT02918292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118879|NCT02918292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118880|NCT02918292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93118881|NCT02918292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93118882|NCT02918292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118883|NCT02918292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93118884|NCT02918292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93118885|NCT02918292|Antitubercular Agents|antitubercular agents|mesh-ancestor
93118886|NCT02918292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93118887|NCT02918292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118888|NCT01207128|Voriconazole|voriconazole|mesh-list
93118889|NCT01207128|Micafungin|micafungin|mesh-list
93118890|NCT01207128|Antifungal Agents|antifungal agents|mesh-ancestor
93118891|NCT01207128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118892|NCT01207128|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93118893|NCT01207128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93118894|NCT01207128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118895|NCT01207128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118896|NCT01207128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93118897|NCT01207128|Hormone Antagonists|hormone antagonists|mesh-ancestor
93118898|NCT01207128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93118899|NCT01207128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118900|NCT01207128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93118901|NCT01299558|Fluticasone|fluticasone|mesh-list
93118902|NCT01299558|Xhance|xhance|mesh-list
93118903|NCT01299558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93118904|NCT01299558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93118905|NCT01299558|Autonomic Agents|autonomic agents|mesh-ancestor
93118906|NCT01299558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118907|NCT01299558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118908|NCT01299558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93118909|NCT01299558|Respiratory System Agents|respiratory system agents|mesh-ancestor
93118910|NCT01299558|Dermatologic Agents|dermatologic agents|mesh-ancestor
93118911|NCT01299558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93118912|NCT01207206|Ketamine|ketamine|mesh-list
93118913|NCT01207206|Analgesics|analgesics|mesh-ancestor
93118914|NCT01207206|Sensory System Agents|sensory system agents|mesh-ancestor
93118915|NCT01207206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118916|NCT01207206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118917|NCT01207206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93118918|NCT01207206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93118919|NCT01207206|Anesthetics, General|anesthetics, general|mesh-ancestor
93118920|NCT01207206|Anesthetics|anesthetics|mesh-ancestor
93118921|NCT01207206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118922|NCT01207206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93118923|NCT01207206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93118924|NCT01207206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93118925|NCT01207206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118926|NCT03719586|Remdesivir|remdesivir|mesh-list
93118927|NCT03719586|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
93118928|NCT03719586|Antimetabolites|antimetabolites|mesh-ancestor
93118929|NCT03719586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118930|NCT03719586|Antiviral Agents|antiviral agents|mesh-ancestor
93118931|NCT03719586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118932|NCT01205022|Calcium, Dietary|calcium, dietary|mesh-list
93118933|NCT01205022|Leucovorin|leucovorin|mesh-list
93118934|NCT01205022|Bevacizumab|bevacizumab|mesh-list
92791136|NCT04263519|Tacrolimus|tacrolimus|mesh-list
93118935|NCT01205022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93118936|NCT01205022|Fluorouracil|fluorouracil|mesh-list
93118937|NCT01205022|Irinotecan|irinotecan|mesh-list
93118938|NCT01205022|Camptothecin|camptothecin|mesh-list
93118939|NCT01205022|Antibodies|antibodies|mesh-list
93118940|NCT01205022|Immunoglobulins|immunoglobulins|mesh-list
93118941|NCT01205022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93118942|NCT01205022|Calcium|calcium|mesh-list
93118943|NCT01205022|Levoleucovorin|levoleucovorin|mesh-list
93118944|NCT01205022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93118945|NCT01205022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93118946|NCT01205022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93118947|NCT01205022|Growth Substances|growth substances|mesh-ancestor
93118948|NCT01205022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118949|NCT01205022|Growth Inhibitors|growth inhibitors|mesh-ancestor
93118950|NCT01205022|Immunologic Factors|immunologic factors|mesh-ancestor
93118951|NCT01205022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93118952|NCT01205022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93118953|NCT01205022|Antimetabolites|antimetabolites|mesh-ancestor
93118954|NCT01205022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118955|NCT01205022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93118956|NCT01205022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93118957|NCT01205022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93118958|NCT01205022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93118959|NCT01205022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93118960|NCT01205022|Antidotes|antidotes|mesh-ancestor
93118961|NCT01205022|Protective Agents|protective agents|mesh-ancestor
93118962|NCT01205022|Vitamin B Complex|vitamin b complex|mesh-ancestor
93118963|NCT01205022|Vitamins|vitamins|mesh-ancestor
93118964|NCT01205022|Micronutrients|micronutrients|mesh-ancestor
93118965|NCT01205022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93118966|NCT01205178|Chloroquine|chloroquine|mesh-list
93118967|NCT01205178|Primaquine|primaquine|mesh-list
93118968|NCT01205178|Tafenoquine|tafenoquine|mesh-list
93118969|NCT01205178|Amebicides|amebicides|mesh-ancestor
93118970|NCT01205178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93118971|NCT01205178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93118972|NCT01205178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93118973|NCT01205178|Antimalarials|antimalarials|mesh-ancestor
93118974|NCT01205178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93118975|NCT01205256|Methadone|methadone|mesh-list
93118976|NCT01205256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93118977|NCT01205256|Narcotics|narcotics|mesh-ancestor
93118978|NCT01205256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118979|NCT01205256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118980|NCT01205256|Analgesics|analgesics|mesh-ancestor
93118981|NCT01205256|Sensory System Agents|sensory system agents|mesh-ancestor
93118982|NCT01205256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118983|NCT01205256|Antitussive Agents|antitussive agents|mesh-ancestor
93118984|NCT01205256|Respiratory System Agents|respiratory system agents|mesh-ancestor
93118985|NCT03823482|Lidocaine|lidocaine|mesh-list
93118986|NCT03823482|Anesthetics, Local|anesthetics, local|mesh-ancestor
93118987|NCT03823482|Anesthetics|anesthetics|mesh-ancestor
93118988|NCT03823482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93118989|NCT03823482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93118990|NCT03823482|Sensory System Agents|sensory system agents|mesh-ancestor
93118991|NCT03823482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93118992|NCT03823482|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93118993|NCT03823482|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93118994|NCT03823482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93118995|NCT03823482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93118996|NCT03823482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93118997|NCT03816306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93118998|NCT03816306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93118999|NCT03816306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119000|NCT03816072|Phenylephrine|phenylephrine|mesh-list
93119001|NCT03816072|Oxymetazoline|oxymetazoline|mesh-list
93119002|NCT03816072|Propofol|propofol|mesh-list
93119003|NCT03816072|Sevoflurane|sevoflurane|mesh-list
93119004|NCT03816072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93119005|NCT03816072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119006|NCT03816072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119007|NCT03816072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93119008|NCT03816072|Anesthetics, General|anesthetics, general|mesh-ancestor
92791210|NCT00610077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93119009|NCT03816072|Anesthetics|anesthetics|mesh-ancestor
93119010|NCT03816072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93119011|NCT03816072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93119012|NCT03816072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93119013|NCT03816072|Mydriatics|mydriatics|mesh-ancestor
93119014|NCT03816072|Autonomic Agents|autonomic agents|mesh-ancestor
93119015|NCT03816072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119016|NCT03816072|Sympathomimetics|sympathomimetics|mesh-ancestor
93119017|NCT03816072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93119018|NCT03816072|Nasal Decongestants|nasal decongestants|mesh-ancestor
93119019|NCT03816072|Respiratory System Agents|respiratory system agents|mesh-ancestor
93119020|NCT03816072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93119021|NCT03816072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93119022|NCT03816072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93119023|NCT03816072|Adrenergic Agents|adrenergic agents|mesh-ancestor
93119024|NCT03816072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119025|NCT03816072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119026|NCT03816072|Protective Agents|protective agents|mesh-ancestor
93119027|NCT01299948|Prednisolone|prednisolone|mesh-list
93119028|NCT01299948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119029|NCT01299948|Glucocorticoids|glucocorticoids|mesh-ancestor
93119030|NCT01299948|Hormones|hormones|mesh-ancestor
93119031|NCT01299948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119032|NCT01299948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119033|NCT01299948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119034|NCT01299948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119035|NCT01300026|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
93119036|NCT01300026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119037|NCT01300026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119038|NCT01297452|Paclitaxel|paclitaxel|mesh-list
93119039|NCT01297452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93119040|NCT01297452|Carboplatin|carboplatin|mesh-list
93119041|NCT01297452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93119042|NCT01297452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119043|NCT01297452|Tubulin Modulators|tubulin modulators|mesh-ancestor
93119044|NCT01297452|Antimitotic Agents|antimitotic agents|mesh-ancestor
93119045|NCT01297452|Mitosis Modulators|mitosis modulators|mesh-ancestor
93119046|NCT01297452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119047|NCT01301586|Doxycycline|doxycycline|mesh-list
93119048|NCT01301586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93119049|NCT01301586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119050|NCT01301586|Antimalarials|antimalarials|mesh-ancestor
93119051|NCT01301586|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93119052|NCT01301586|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93119053|NCT03815838|Fallypride|fallypride|mesh-list
93119054|NCT03815838|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93119055|NCT03815838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93119056|NCT03815838|Dopamine Agents|dopamine agents|mesh-ancestor
93119057|NCT03815838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119058|NCT03815838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119059|NCT03815838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119060|NCT01205724|Factor VIII|factor viii|mesh-list
93119061|NCT01205724|Coagulants|coagulants|mesh-ancestor
93119062|NCT01301820|Lenalidomide|lenalidomide|mesh-list
93119063|NCT01301820|Azacitidine|azacitidine|mesh-list
93119064|NCT01301820|Immunologic Factors|immunologic factors|mesh-ancestor
91927242|NCT04265534|Pembrolizumab|pembrolizumab|mesh-list
93119065|NCT01301820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119066|NCT01301820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93119067|NCT01301820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93119068|NCT01301820|Growth Substances|growth substances|mesh-ancestor
93119069|NCT01301820|Growth Inhibitors|growth inhibitors|mesh-ancestor
93119070|NCT01301820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119071|NCT01301820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119072|NCT01301820|Antimetabolites|antimetabolites|mesh-ancestor
93119073|NCT01301820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119074|NCT01301820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119075|NCT01297686|Dexamethasone|dexamethasone|mesh-list
93119076|NCT01297686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119077|NCT01297686|Antiemetics|antiemetics|mesh-ancestor
93119078|NCT01297686|Autonomic Agents|autonomic agents|mesh-ancestor
93119079|NCT01297686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119080|NCT01297686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119081|NCT01297686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119082|NCT01297686|Glucocorticoids|glucocorticoids|mesh-ancestor
93119083|NCT01297686|Hormones|hormones|mesh-ancestor
92791285|NCT01114529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119084|NCT01297686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119085|NCT01297686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119086|NCT01297686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119087|NCT01205880|Calcitriol|calcitriol|mesh-list
93119088|NCT01205880|Clobetasol|clobetasol|mesh-list
93119089|NCT01205880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93119090|NCT01205880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119091|NCT01205880|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93119092|NCT01205880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93119093|NCT01205880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119094|NCT01205880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93119095|NCT01205880|Vitamins|vitamins|mesh-ancestor
93119096|NCT01205880|Micronutrients|micronutrients|mesh-ancestor
93119097|NCT01205880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93119098|NCT01205880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119099|NCT01205880|Glucocorticoids|glucocorticoids|mesh-ancestor
93119100|NCT01205880|Hormones|hormones|mesh-ancestor
93119101|NCT01205880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119102|NCT01205958|Pyranoprofen|pyranoprofen|mesh-list
93119103|NCT01205958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93119104|NCT01205958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93119105|NCT01205958|Analgesics|analgesics|mesh-ancestor
93119106|NCT01205958|Sensory System Agents|sensory system agents|mesh-ancestor
93119107|NCT01205958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119108|NCT01205958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119109|NCT01205958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119110|NCT01205958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119111|NCT01205958|Gout Suppressants|gout suppressants|mesh-ancestor
93119112|NCT01297842|Meropenem|meropenem|mesh-list
93119113|NCT01297842|Imipenem|imipenem|mesh-list
93119114|NCT01297842|Ertapenem|ertapenem|mesh-list
93119115|NCT01297842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93119116|NCT01297842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119117|NCT01297998|Cisplatin|cisplatin|mesh-list
93119118|NCT01297998|Gemcitabine|gemcitabine|mesh-list
93119119|NCT01297998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119120|NCT01297998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119121|NCT01297998|Antimetabolites|antimetabolites|mesh-ancestor
93119122|NCT01297998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119123|NCT01298076|Dexamethasone|dexamethasone|mesh-list
93119124|NCT01298076|Bevacizumab|bevacizumab|mesh-list
93119125|NCT01298076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119126|NCT01298076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119127|NCT01298076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93119128|NCT01298076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93119129|NCT01298076|Growth Substances|growth substances|mesh-ancestor
93119130|NCT01298076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119131|NCT01298076|Growth Inhibitors|growth inhibitors|mesh-ancestor
93119132|NCT01298076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119133|NCT01298076|Antiemetics|antiemetics|mesh-ancestor
93119134|NCT01298076|Autonomic Agents|autonomic agents|mesh-ancestor
93119135|NCT01298076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119136|NCT01298076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119137|NCT01298076|Glucocorticoids|glucocorticoids|mesh-ancestor
93119138|NCT01298076|Hormones|hormones|mesh-ancestor
93049548|NCT00294554|Memantine|memantine|mesh-list
93119139|NCT01298076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119140|NCT01298076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119141|NCT03819348|Antifungal Agents|antifungal agents|mesh-list
93119142|NCT03819348|Clotrimazole|clotrimazole|mesh-list
93119143|NCT03819348|Miconazole|miconazole|mesh-list
93119144|NCT03819348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119145|NCT03819348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93119146|NCT03819348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93119147|NCT03819348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93119148|NCT03819348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119149|NCT03819348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119150|NCT03819348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93119151|NCT03819348|Hormone Antagonists|hormone antagonists|mesh-ancestor
93119152|NCT03819348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119153|NCT03819348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119154|NCT03819348|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93119155|NCT03819348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93119156|NCT01560390|Ketamine|ketamine|mesh-list
93119157|NCT01560390|Analgesics|analgesics|mesh-ancestor
93119158|NCT01560390|Sensory System Agents|sensory system agents|mesh-ancestor
92791360|NCT02601586|Oxycodone|oxycodone|mesh-list
93119159|NCT01560390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119160|NCT01560390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119161|NCT01560390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93119162|NCT01560390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93119163|NCT01560390|Anesthetics, General|anesthetics, general|mesh-ancestor
93119165|NCT01560390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119166|NCT01560390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93119167|NCT01560390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93119168|NCT01560390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119169|NCT01560390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119170|NCT03807882|Clozapine|clozapine|mesh-list
93119171|NCT03807882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93119172|NCT03807882|Serotonin Agents|serotonin agents|mesh-ancestor
93119173|NCT03807882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119174|NCT03807882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119175|NCT03807882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119176|NCT03807882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93119177|NCT03807882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93119178|NCT03807882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119179|NCT03807882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119180|NCT03807882|GABA Antagonists|gaba antagonists|mesh-ancestor
93119181|NCT03807882|GABA Agents|gaba agents|mesh-ancestor
93119182|NCT03796572|Ropivacaine|ropivacaine|mesh-list
93119183|NCT03796572|Anesthetics, Local|anesthetics, local|mesh-ancestor
93119184|NCT03796572|Anesthetics|anesthetics|mesh-ancestor
93119185|NCT03796572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119186|NCT03796572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119187|NCT03796572|Sensory System Agents|sensory system agents|mesh-ancestor
93119188|NCT03796572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119189|NCT01304472|Clopidogrel|clopidogrel|mesh-list
93119190|NCT01304472|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93119191|NCT01304472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93119192|NCT01304472|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93119193|NCT01304472|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93119194|NCT01304472|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93119195|NCT01304472|Purinergic Agents|purinergic agents|mesh-ancestor
93119196|NCT01304472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119197|NCT01304472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119198|NCT01304472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119199|NCT03795792|Curcumin|curcumin|mesh-list
93119200|NCT03795792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93119201|NCT03795792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93119202|NCT03795792|Analgesics|analgesics|mesh-ancestor
93119203|NCT03795792|Sensory System Agents|sensory system agents|mesh-ancestor
93119204|NCT03795792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119205|NCT03795792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119206|NCT03795792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119207|NCT03795792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119208|NCT03795792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119209|NCT03795792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119210|NCT03795792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119211|NCT01303536|Ondansetron|ondansetron|mesh-list
93119212|NCT01303536|Antiemetics|antiemetics|mesh-ancestor
93119213|NCT01303536|Autonomic Agents|autonomic agents|mesh-ancestor
93119214|NCT01303536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119215|NCT01303536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119216|NCT01303536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119217|NCT01303536|Antipruritics|antipruritics|mesh-ancestor
93119218|NCT01303536|Dermatologic Agents|dermatologic agents|mesh-ancestor
93119219|NCT01303536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93119220|NCT01303536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93119221|NCT01303536|Serotonin Agents|serotonin agents|mesh-ancestor
93119222|NCT01303536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119223|NCT01303536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119224|NCT01303614|Lidocaine|lidocaine|mesh-list
93119225|NCT01303614|Prilocaine|prilocaine|mesh-list
93119226|NCT01303614|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93119227|NCT01303614|Anesthetics, Local|anesthetics, local|mesh-ancestor
93119228|NCT01303614|Anesthetics|anesthetics|mesh-ancestor
93119229|NCT01303614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119230|NCT01303614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119231|NCT01303614|Sensory System Agents|sensory system agents|mesh-ancestor
93119232|NCT01303614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119233|NCT01303614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93119234|NCT01303614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93119235|NCT01303614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93119236|NCT01303614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93119237|NCT01303614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119238|NCT01303614|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93119239|NCT03347838|Nivolumab|nivolumab|mesh-list
93119240|NCT03347838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119241|NCT03347838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119242|NCT03347838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93119243|NCT03347838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119244|NCT03795090|Anti-Infective Agents|anti-infective agents|mesh-list
93119245|NCT03795090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93119246|NCT03802422|Vitamin B 12|vitamin b 12|mesh-list
93119247|NCT03802422|Hydroxocobalamin|hydroxocobalamin|mesh-list
93119248|NCT03802422|Vitamins|vitamins|mesh-ancestor
93119249|NCT03802422|Micronutrients|micronutrients|mesh-ancestor
93119250|NCT03802422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119251|NCT03802422|Vitamin B Complex|vitamin b complex|mesh-ancestor
93119252|NCT03802422|Hematinics|hematinics|mesh-ancestor
93119253|NCT03801564|Hyaluronic Acid|hyaluronic acid|mesh-list
93119254|NCT03801564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93119255|NCT03801564|Immunologic Factors|immunologic factors|mesh-ancestor
93119256|NCT03801564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119257|NCT03801564|Viscosupplements|viscosupplements|mesh-ancestor
93119258|NCT03801564|Protective Agents|protective agents|mesh-ancestor
93119259|NCT03813186|Decitabine|decitabine|mesh-list
93119260|NCT03813186|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93119261|NCT03813186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119262|NCT03813186|Antimetabolites|antimetabolites|mesh-ancestor
93119263|NCT03813186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119264|NCT03813186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119265|NCT03813186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119266|NCT03293784|Infliximab|infliximab|mesh-list
93119267|NCT03293784|Certolizumab Pegol|certolizumab pegol|mesh-list
93119268|NCT03293784|Nivolumab|nivolumab|mesh-list
93119269|NCT03293784|Ipilimumab|ipilimumab|mesh-list
93119270|NCT03293784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119271|NCT03293784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119272|NCT03293784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93119273|NCT03293784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119274|NCT03293784|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93119275|NCT03293784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119276|NCT03293784|Dermatologic Agents|dermatologic agents|mesh-ancestor
93119277|NCT03293784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119278|NCT03293784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119279|NCT03293784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93119280|NCT03293784|Immunologic Factors|immunologic factors|mesh-ancestor
93119281|NCT03293784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119282|NCT03353350|Efpeglenatide|efpeglenatide|mesh-list
93119283|NCT03353350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93119284|NCT03353350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119285|NCT01302132|Ipragliflozin|ipragliflozin|mesh-list
91927243|NCT04265534|Pemetrexed|pemetrexed|mesh-list
93119286|NCT01302132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93119287|NCT01302132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119288|NCT01302132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93119289|NCT01302132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119290|NCT03799536|Sotalol|sotalol|mesh-list
93119291|NCT03799536|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93119292|NCT03799536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93119293|NCT03799536|Adrenergic Agents|adrenergic agents|mesh-ancestor
93119294|NCT03799536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119295|NCT03799536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119296|NCT03799536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119297|NCT03799536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93119298|NCT03799536|Sympatholytics|sympatholytics|mesh-ancestor
93119299|NCT03799536|Autonomic Agents|autonomic agents|mesh-ancestor
93119300|NCT03799536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119301|NCT03229278|Pembrolizumab|pembrolizumab|mesh-list
93119302|NCT03229278|Nivolumab|nivolumab|mesh-list
93119303|NCT03229278|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93119304|NCT03229278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119305|NCT03229278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119306|NCT03229278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93119307|NCT03229278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119308|NCT03812796|Avelumab|avelumab|mesh-list
93119309|NCT03812796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119310|NCT03812796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119311|NCT05759104|Adalimumab|adalimumab|mesh-list
93119312|NCT05759104|Infliximab|infliximab|mesh-list
93119313|NCT05759104|Ustekinumab|ustekinumab|mesh-list
93119314|NCT05759104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93119315|NCT05759104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119316|NCT05759104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119317|NCT05759104|Dermatologic Agents|dermatologic agents|mesh-ancestor
93119318|NCT05759104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119319|NCT01384240|Proflavine|proflavine|mesh-list
93119320|NCT01384240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93119321|NCT01384240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119322|NCT01381510|Finasteride|finasteride|mesh-list
93119323|NCT01381510|Dutasteride|dutasteride|mesh-list
93119324|NCT01381510|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
93119325|NCT01381510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93119326|NCT01381510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119327|NCT01381510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119328|NCT01381510|Hormone Antagonists|hormone antagonists|mesh-ancestor
93119329|NCT01381510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119330|NCT01381510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119331|NCT01381510|Urological Agents|urological agents|mesh-ancestor
93119332|NCT04258072|Vactosertib|vactosertib|mesh-list
93119333|NCT04258072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119334|NCT04258072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119335|NCT04258072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119336|NCT02984800|Anesthetics|anesthetics|mesh-list
93119337|NCT02984800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119338|NCT02984800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119339|NCT04188730|Lofexidine|lofexidine|mesh-list
93119340|NCT04188730|Clonidine|clonidine|mesh-list
93119341|NCT04188730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93119342|NCT04188730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93119343|NCT04188730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119344|NCT04188730|Sensory System Agents|sensory system agents|mesh-ancestor
93119345|NCT04188730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119346|NCT04188730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93119347|NCT04188730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93119348|NCT04188730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93119349|NCT04188730|Adrenergic Agents|adrenergic agents|mesh-ancestor
93119350|NCT04188730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119351|NCT04188730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119352|NCT04188730|Analgesics|analgesics|mesh-ancestor
93119353|NCT04188730|Sympatholytics|sympatholytics|mesh-ancestor
93119354|NCT04188730|Autonomic Agents|autonomic agents|mesh-ancestor
93119355|NCT01381432|Azathioprine|azathioprine|mesh-list
93119356|NCT01381432|Antimetabolites|antimetabolites|mesh-ancestor
93119357|NCT01381432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119358|NCT01381432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119359|NCT01381432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119360|NCT01381432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93119361|NCT01381432|Immunologic Factors|immunologic factors|mesh-ancestor
93119362|NCT01381432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119363|NCT01381432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119364|NCT01381354|Thioctic Acid|thioctic acid|mesh-list
93119365|NCT01381354|Riboflavin|riboflavin|mesh-list
93119366|NCT01381354|Thiamine|thiamine|mesh-list
93119367|NCT01381354|Niacinamide|niacinamide|mesh-list
93119368|NCT01381354|Niacin|niacin|mesh-list
93119369|NCT01381354|Nicotinic Acids|nicotinic acids|mesh-list
93119370|NCT01381354|Acetylcarnitine|acetylcarnitine|mesh-list
93119371|NCT01381354|Ubiquinone|ubiquinone|mesh-list
93119372|NCT01381354|Acetylcysteine|acetylcysteine|mesh-list
93119373|NCT01381354|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
93119374|NCT01381354|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93119375|NCT01381354|Vitamins|vitamins|mesh-ancestor
93119376|NCT01381354|Micronutrients|micronutrients|mesh-ancestor
93119377|NCT01381354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119378|NCT01381354|Antiviral Agents|antiviral agents|mesh-ancestor
93119379|NCT01381354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119380|NCT01381354|Expectorants|expectorants|mesh-ancestor
93119381|NCT01381354|Respiratory System Agents|respiratory system agents|mesh-ancestor
93119382|NCT01381354|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93119383|NCT01381354|Antioxidants|antioxidants|mesh-ancestor
93119384|NCT01381354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119385|NCT01381354|Protective Agents|protective agents|mesh-ancestor
93119386|NCT01381354|Antidotes|antidotes|mesh-ancestor
93119387|NCT01381354|Vitamin B Complex|vitamin b complex|mesh-ancestor
93119388|NCT01381354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93119389|NCT01381354|Dermatologic Agents|dermatologic agents|mesh-ancestor
93119390|NCT01381354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93119391|NCT01381354|Antimetabolites|antimetabolites|mesh-ancestor
93119392|NCT01381354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93119393|NCT01381354|Vasodilator Agents|vasodilator agents|mesh-ancestor
93119394|NCT01381354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93119395|NCT01381354|Nootropic Agents|nootropic agents|mesh-ancestor
93119396|NCT01381276|Beta Carotene|beta carotene|mesh-list
93119397|NCT01381276|Vitamin A|vitamin a|mesh-list
93119398|NCT01381276|Retinol palmitate|retinol palmitate|mesh-list
93119399|NCT01381276|Carotenoids|carotenoids|mesh-list
93119400|NCT01381276|Antioxidants|antioxidants|mesh-ancestor
93119401|NCT01381276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119402|NCT01381276|Protective Agents|protective agents|mesh-ancestor
93119403|NCT01381276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119404|NCT01381276|Provitamins|provitamins|mesh-ancestor
93119405|NCT01381276|Vitamins|vitamins|mesh-ancestor
93119406|NCT01381276|Micronutrients|micronutrients|mesh-ancestor
93119407|NCT01381276|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93119408|NCT01381276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119409|NCT02661022|Dexamethasone|dexamethasone|mesh-list
93119410|NCT02661022|Pomalidomide|pomalidomide|mesh-list
93119411|NCT02661022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119412|NCT02661022|Antiemetics|antiemetics|mesh-ancestor
93119413|NCT02661022|Autonomic Agents|autonomic agents|mesh-ancestor
93119414|NCT02661022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119415|NCT02661022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119416|NCT02661022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119417|NCT02661022|Glucocorticoids|glucocorticoids|mesh-ancestor
93119418|NCT02661022|Hormones|hormones|mesh-ancestor
93119419|NCT02661022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119420|NCT02661022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119421|NCT02661022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119422|NCT02661022|Immunologic Factors|immunologic factors|mesh-ancestor
93119423|NCT02661022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93119424|NCT02661022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93119425|NCT02661022|Growth Substances|growth substances|mesh-ancestor
93119426|NCT02661022|Growth Inhibitors|growth inhibitors|mesh-ancestor
93119427|NCT01569256|Cabergoline|cabergoline|mesh-list
93119428|NCT01569256|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93119429|NCT01569256|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93119430|NCT01569256|Dopamine Agonists|dopamine agonists|mesh-ancestor
93119431|NCT01569256|Dopamine Agents|dopamine agents|mesh-ancestor
93119432|NCT01569256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119433|NCT01569256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119434|NCT01569256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119435|NCT03794544|Durvalumab|durvalumab|mesh-list
93119436|NCT03794544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119437|NCT03794544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119438|NCT01380808|Capecitabine|capecitabine|mesh-list
93049844|NCT03979664|Antiemetics|antiemetics|mesh-ancestor
93119439|NCT01380808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119440|NCT01380808|Antimetabolites|antimetabolites|mesh-ancestor
93119441|NCT01380808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119442|NCT01380808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119443|NCT03799224|Decitabine|decitabine|mesh-list
93119444|NCT03799224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119445|NCT03799224|Antimetabolites|antimetabolites|mesh-ancestor
93119446|NCT03799224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119447|NCT03799224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119448|NCT03799224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119449|NCT03798912|Octreotide|octreotide|mesh-list
93119450|NCT03798912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119451|NCT03798912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119452|NCT03798912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119453|NCT03798834|Anesthetics|anesthetics|mesh-list
93119454|NCT03798834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119455|NCT03798834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119456|NCT03812562|Nivolumab|nivolumab|mesh-list
93119457|NCT03812562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119458|NCT03812562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119459|NCT03812562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93119460|NCT03812562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791659|NCT00928707|Hydroxyurea|hydroxyurea|mesh-list
93119461|NCT01304784|Paclitaxel|paclitaxel|mesh-list
93119462|NCT01304784|Docetaxel|docetaxel|mesh-list
93119463|NCT01304784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93119464|NCT01304784|Capecitabine|capecitabine|mesh-list
93119465|NCT01304784|Trastuzumab|trastuzumab|mesh-list
93119466|NCT01304784|Lapatinib|lapatinib|mesh-list
93119467|NCT01304784|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93119468|NCT01304784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93119469|NCT01304784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119470|NCT01304784|Tubulin Modulators|tubulin modulators|mesh-ancestor
93119471|NCT01304784|Antimitotic Agents|antimitotic agents|mesh-ancestor
93119472|NCT01304784|Mitosis Modulators|mitosis modulators|mesh-ancestor
93119473|NCT01304784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119474|NCT01304784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119475|NCT01304784|Antimetabolites|antimetabolites|mesh-ancestor
93119476|NCT01304784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119477|NCT01304784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119478|NCT01304784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119479|NCT01304784|Immunologic Factors|immunologic factors|mesh-ancestor
93119480|NCT01304784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119481|NCT03798600|Caspofungin|caspofungin|mesh-list
93119482|NCT03798600|Antifungal Agents|antifungal agents|mesh-ancestor
93119483|NCT03798600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119484|NCT03798600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119485|NCT03798600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119486|NCT03798522|Nalbuphine|nalbuphine|mesh-list
93119487|NCT03798522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93119488|NCT03798522|Narcotics|narcotics|mesh-ancestor
93119489|NCT03798522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119490|NCT03798522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119491|NCT03798522|Analgesics|analgesics|mesh-ancestor
93119492|NCT03798522|Sensory System Agents|sensory system agents|mesh-ancestor
93119493|NCT03798522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119494|NCT01308034|Sunitinib|sunitinib|mesh-list
93119495|NCT01308034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119496|NCT01308034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93119497|NCT01308034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93119498|NCT01308034|Growth Substances|growth substances|mesh-ancestor
93119499|NCT01308034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119500|NCT01308034|Growth Inhibitors|growth inhibitors|mesh-ancestor
93119501|NCT01308034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119502|NCT01308034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119503|NCT01308034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119504|NCT01302210|Mupirocin|mupirocin|mesh-list
93119505|NCT01302210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93119506|NCT01302210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119507|NCT01302210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93119508|NCT01302210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119509|NCT01302210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119510|NCT00005044|Bicalutamide|bicalutamide|mesh-list
93119511|NCT00005044|Flutamide|flutamide|mesh-list
93119512|NCT00005044|Hormones|hormones|mesh-list
91927244|NCT04265534|Vitamins|vitamins|mesh-ancestor
93119513|NCT00005044|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93119514|NCT00005044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119515|NCT00005044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119516|NCT00005044|Androgen Antagonists|androgen antagonists|mesh-ancestor
93119517|NCT00005044|Hormone Antagonists|hormone antagonists|mesh-ancestor
93119518|NCT00005044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119519|NCT00005044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119520|NCT03794154|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93119521|NCT03794154|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93119522|NCT03794154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93119523|NCT03794154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93119524|NCT03794154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119525|NCT03794154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119526|NCT03794154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119527|NCT03794154|Analgesics|analgesics|mesh-ancestor
93119528|NCT03794154|Sensory System Agents|sensory system agents|mesh-ancestor
93119529|NCT03794154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119530|NCT03794154|Antidepressive Agents|antidepressive agents|mesh-ancestor
93119531|NCT03794154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119532|NCT03794154|Dopamine Agents|dopamine agents|mesh-ancestor
93119533|NCT03811860|Lithium Carbonate|lithium carbonate|mesh-list
93119534|NCT03811860|Antidepressive Agents|antidepressive agents|mesh-ancestor
93119535|NCT03811860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119536|NCT03811860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119537|NCT03811860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119538|NCT03811860|Antimanic Agents|antimanic agents|mesh-ancestor
93119539|NCT03811860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93119540|NCT03811860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119541|NCT03811860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119542|NCT02722668|Mycophenolic Acid|mycophenolic acid|mesh-list
93119543|NCT02722668|Sirolimus|sirolimus|mesh-list
93119544|NCT02722668|Cyclophosphamide|cyclophosphamide|mesh-list
93119545|NCT02722668|Fludarabine|fludarabine|mesh-list
93119546|NCT02722668|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93119547|NCT02722668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93119548|NCT02722668|Immunologic Factors|immunologic factors|mesh-ancestor
93119549|NCT02722668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119550|NCT02722668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119551|NCT02722668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93119552|NCT02722668|Alkylating Agents|alkylating agents|mesh-ancestor
93119553|NCT02722668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119554|NCT02722668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119555|NCT02722668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93119556|NCT02722668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93119557|NCT02722668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93119558|NCT02722668|Antitubercular Agents|antitubercular agents|mesh-ancestor
93119559|NCT02722668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93119560|NCT02722668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119561|NCT02722668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119562|NCT02722668|Antifungal Agents|antifungal agents|mesh-ancestor
93119563|NCT01303926|Paclitaxel|paclitaxel|mesh-list
93119564|NCT01303926|Bevacizumab|bevacizumab|mesh-list
93119565|NCT01303926|Carboplatin|carboplatin|mesh-list
93119566|NCT01303926|Pemetrexed|pemetrexed|mesh-list
93119567|NCT01303926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93119568|NCT01303926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119569|NCT01303926|Tubulin Modulators|tubulin modulators|mesh-ancestor
93119570|NCT01303926|Antimitotic Agents|antimitotic agents|mesh-ancestor
93119571|NCT01303926|Mitosis Modulators|mitosis modulators|mesh-ancestor
93119572|NCT01303926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119573|NCT01303926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119574|NCT01303926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93119575|NCT01303926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93119576|NCT01303926|Growth Substances|growth substances|mesh-ancestor
93119577|NCT01303926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119578|NCT01303926|Growth Inhibitors|growth inhibitors|mesh-ancestor
93119579|NCT01303926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119580|NCT01303926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93119581|NCT01303926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93119582|NCT03084796|Bromides|bromides|mesh-list
93119583|NCT03084796|Tiotropium Bromide|tiotropium bromide|mesh-list
93119584|NCT03084796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93119585|NCT03084796|Autonomic Agents|autonomic agents|mesh-ancestor
93119586|NCT03084796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119587|NCT03084796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119588|NCT03084796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93119589|NCT03084796|Respiratory System Agents|respiratory system agents|mesh-ancestor
93119590|NCT03084796|Parasympatholytics|parasympatholytics|mesh-ancestor
93119591|NCT03084796|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93119592|NCT03084796|Cholinergic Agents|cholinergic agents|mesh-ancestor
93119593|NCT03084796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119594|NCT03084796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119595|NCT03084796|Anticonvulsants|anticonvulsants|mesh-ancestor
93119596|NCT03717012|Nintedanib|nintedanib|mesh-list
93119597|NCT03717012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119598|NCT03717012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119599|NCT03717012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119600|NCT03717012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119601|NCT01302756|Folic Acid|folic acid|mesh-list
93119602|NCT01302756|Hematinics|hematinics|mesh-ancestor
93119603|NCT01302756|Vitamin B Complex|vitamin b complex|mesh-ancestor
93119604|NCT01302756|Vitamins|vitamins|mesh-ancestor
93119605|NCT01302756|Micronutrients|micronutrients|mesh-ancestor
93119606|NCT01302756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119607|NCT04893252|Durvalumab|durvalumab|mesh-list
93119608|NCT04893252|Vactosertib|vactosertib|mesh-list
93119609|NCT04893252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119610|NCT04893252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791809|NCT02700022|Immunologic Factors|immunologic factors|mesh-ancestor
93119611|NCT04893252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119612|NCT04893252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119613|NCT04893252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119614|NCT03797508|Progesterone|progesterone|mesh-list
93119615|NCT03797508|Progestins|progestins|mesh-ancestor
93119616|NCT03797508|Hormones|hormones|mesh-ancestor
93119617|NCT03797508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119618|NCT03797508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119619|NCT01380496|Doxycycline|doxycycline|mesh-list
93119620|NCT01380496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93119621|NCT01380496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119622|NCT01380496|Antimalarials|antimalarials|mesh-ancestor
93119623|NCT01380496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93119624|NCT01380496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93119625|NCT01304316|Phenylephrine|phenylephrine|mesh-list
93119626|NCT01304316|Oxymetazoline|oxymetazoline|mesh-list
93119627|NCT01304316|Tetracaine|tetracaine|mesh-list
93119628|NCT01304316|Anesthetics, Local|anesthetics, local|mesh-ancestor
93119629|NCT01304316|Anesthetics|anesthetics|mesh-ancestor
93119630|NCT01304316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119631|NCT01304316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119632|NCT01304316|Sensory System Agents|sensory system agents|mesh-ancestor
93119633|NCT01304316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119634|NCT01304316|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93119635|NCT01304316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93119636|NCT01304316|Adrenergic Agents|adrenergic agents|mesh-ancestor
93119637|NCT01304316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119638|NCT01304316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119639|NCT01304316|Sympathomimetics|sympathomimetics|mesh-ancestor
93119640|NCT01304316|Autonomic Agents|autonomic agents|mesh-ancestor
93119641|NCT01304316|Nasal Decongestants|nasal decongestants|mesh-ancestor
93119642|NCT01304316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93119643|NCT01304316|Respiratory System Agents|respiratory system agents|mesh-ancestor
93119644|NCT01304316|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93119645|NCT01304316|Mydriatics|mydriatics|mesh-ancestor
93119646|NCT01304316|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93119647|NCT01304316|Protective Agents|protective agents|mesh-ancestor
93119648|NCT03792828|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93119649|NCT03792828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93119650|NCT03792828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93119651|NCT03792828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93119652|NCT03792828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119653|NCT03792828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119654|NCT03792828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119655|NCT03792828|Analgesics|analgesics|mesh-ancestor
93119656|NCT03792828|Sensory System Agents|sensory system agents|mesh-ancestor
93119657|NCT03792828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119658|NCT03792828|Antidepressive Agents|antidepressive agents|mesh-ancestor
93119659|NCT03792828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119660|NCT03792828|Dopamine Agents|dopamine agents|mesh-ancestor
93119661|NCT01379326|Mebendazole|mebendazole|mesh-list
93119662|NCT01379326|Piperazine|piperazine|mesh-list
93119663|NCT01379326|Piperazine citrate|piperazine citrate|mesh-list
93119664|NCT01379326|DMP 777|dmp 777|mesh-list
93119665|NCT01379326|Antinematodal Agents|antinematodal agents|mesh-ancestor
93119666|NCT01379326|Anthelmintics|anthelmintics|mesh-ancestor
93119667|NCT01379326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93119668|NCT01379326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119669|NCT01379326|Tubulin Modulators|tubulin modulators|mesh-ancestor
93119670|NCT01379326|Antimitotic Agents|antimitotic agents|mesh-ancestor
93119671|NCT01379326|Mitosis Modulators|mitosis modulators|mesh-ancestor
93119672|NCT01379326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119673|NCT01379326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119674|NCT01379326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119675|NCT01560546|Testosterone|testosterone|mesh-list
93119676|NCT01560546|Androgens|androgens|mesh-ancestor
93119677|NCT01560546|Hormones|hormones|mesh-ancestor
93119678|NCT01560546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119679|NCT01560546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119680|NCT03792984|Vitamin D|vitamin d|mesh-list
93119681|NCT03792984|Cholecalciferol|cholecalciferol|mesh-list
93119682|NCT03792984|Metformin|metformin|mesh-list
93119683|NCT03792984|Calcium Carbonate|calcium carbonate|mesh-list
92791887|NCT01106651|Canagliflozin|canagliflozin|mesh-list
93119684|NCT03792984|Calcium|calcium|mesh-list
93119685|NCT03792984|Vitamins|vitamins|mesh-ancestor
93119686|NCT03792984|Micronutrients|micronutrients|mesh-ancestor
93119687|NCT03792984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119688|NCT03792984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93119689|NCT03792984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93119690|NCT03792984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93119692|NCT03792984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119693|NCT03792984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119694|NCT03792906|Norepinephrine|norepinephrine|mesh-list
93119695|NCT03792906|Bupivacaine|bupivacaine|mesh-list
93119696|NCT03792906|Anesthetics, Local|anesthetics, local|mesh-ancestor
93119697|NCT03792906|Anesthetics|anesthetics|mesh-ancestor
93119698|NCT03792906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119699|NCT03792906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119700|NCT03792906|Sensory System Agents|sensory system agents|mesh-ancestor
93119701|NCT03792906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119702|NCT03792906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93119703|NCT03792906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93119704|NCT03792906|Adrenergic Agents|adrenergic agents|mesh-ancestor
93119705|NCT03792906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119706|NCT03792906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119707|NCT03792906|Sympathomimetics|sympathomimetics|mesh-ancestor
93119708|NCT03792906|Autonomic Agents|autonomic agents|mesh-ancestor
93119709|NCT03792906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93119710|NCT03078556|Lamivudine|lamivudine|mesh-list
93119711|NCT03078556|Dolutegravir|dolutegravir|mesh-list
93119712|NCT03078556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93119713|NCT03078556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93119714|NCT03078556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119715|NCT03078556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119716|NCT03078556|Antiviral Agents|antiviral agents|mesh-ancestor
93119717|NCT03078556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119718|NCT03078556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93119719|NCT03078556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93119720|NCT03078556|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93119721|NCT03078556|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93119722|NCT03949894|Tolvaptan|tolvaptan|mesh-list
93119723|NCT03949894|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93119724|NCT03949894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119725|NCT03949894|Natriuretic Agents|natriuretic agents|mesh-ancestor
93119726|NCT03949894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119727|NCT03714672|Diclofenac|diclofenac|mesh-list
93119728|NCT03714672|Tramadol|tramadol|mesh-list
93119729|NCT03714672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93119730|NCT03714672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93119731|NCT03714672|Analgesics|analgesics|mesh-ancestor
93119732|NCT03714672|Sensory System Agents|sensory system agents|mesh-ancestor
93119733|NCT03714672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119734|NCT03714672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119735|NCT03714672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93119736|NCT03714672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93119737|NCT03714672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93119738|NCT03714672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119739|NCT03714672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119740|NCT03714672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93119741|NCT03714672|Narcotics|narcotics|mesh-ancestor
93119742|NCT03714672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119743|NCT03083470|Paclitaxel|paclitaxel|mesh-list
93119744|NCT03083470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93119745|NCT03083470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119746|NCT03083470|Tubulin Modulators|tubulin modulators|mesh-ancestor
93119747|NCT03083470|Antimitotic Agents|antimitotic agents|mesh-ancestor
93119748|NCT03083470|Mitosis Modulators|mitosis modulators|mesh-ancestor
93119749|NCT03083470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119750|NCT01377610|Naltrexone|naltrexone|mesh-list
93119751|NCT01377610|Buprenorphine|buprenorphine|mesh-list
93119752|NCT01377610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93119753|NCT01377610|Narcotics|narcotics|mesh-ancestor
93119754|NCT01377610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119755|NCT01377610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119756|NCT01377610|Analgesics|analgesics|mesh-ancestor
93119757|NCT01377610|Sensory System Agents|sensory system agents|mesh-ancestor
93119758|NCT01377610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119759|NCT01377610|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93119760|NCT01377610|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92791980|NCT00627744|Hormones|hormones|mesh-ancestor
93119761|NCT03811080|Fexuprazan|fexuprazan|mesh-list
93119762|NCT03811080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119763|NCT01377532|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93119764|NCT01377532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119765|NCT01377532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119766|NCT01377532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119767|NCT01377532|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93119768|NCT03810976|Gemcitabine|gemcitabine|mesh-list
93119769|NCT03810976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93119770|NCT03810976|Antimetabolites|antimetabolites|mesh-ancestor
93119771|NCT03810976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119772|NCT03810976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119773|NCT05405244|Bromocriptine|bromocriptine|mesh-list
93119774|NCT05405244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119775|NCT05405244|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93119776|NCT05405244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93119777|NCT05405244|Hormone Antagonists|hormone antagonists|mesh-ancestor
93119778|NCT05405244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119779|NCT05405244|Dopamine Agonists|dopamine agonists|mesh-ancestor
93119780|NCT05405244|Dopamine Agents|dopamine agents|mesh-ancestor
93119781|NCT05405244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119782|NCT05405244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119783|NCT03788694|Ketamine|ketamine|mesh-list
93119784|NCT03788694|Analgesics|analgesics|mesh-ancestor
93119785|NCT03788694|Sensory System Agents|sensory system agents|mesh-ancestor
93119786|NCT03788694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119787|NCT03788694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119788|NCT03788694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93119789|NCT03788694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93119790|NCT03788694|Anesthetics, General|anesthetics, general|mesh-ancestor
93119791|NCT03788694|Anesthetics|anesthetics|mesh-ancestor
93119792|NCT03788694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119793|NCT03788694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93119794|NCT03788694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93119795|NCT03788694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119796|NCT03788694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119797|NCT03789006|Interleukin-2|interleukin-2|mesh-list
93119798|NCT03789006|Immunoglobulins|immunoglobulins|mesh-list
93119799|NCT03789006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93119800|NCT03789006|Antibodies|antibodies|mesh-list
93119801|NCT03789006|Basiliximab|basiliximab|mesh-list
93119802|NCT03789006|Thymoglobulin|thymoglobulin|mesh-list
93119803|NCT03789006|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93119804|NCT03789006|Immunologic Factors|immunologic factors|mesh-ancestor
93119805|NCT03789006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119806|NCT03789006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119807|NCT03789006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93119808|NCT03789006|Analgesics|analgesics|mesh-ancestor
93119809|NCT03789006|Sensory System Agents|sensory system agents|mesh-ancestor
93119810|NCT03789006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119811|NCT03789006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93119812|NCT01306266|Rizatriptan|rizatriptan|mesh-list
93119813|NCT01306266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93119814|NCT01306266|Serotonin Agents|serotonin agents|mesh-ancestor
93119815|NCT01306266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119816|NCT01306266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119817|NCT01306266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119818|NCT03516214|Trametinib|trametinib|mesh-list
93119819|NCT03516214|Nazartinib|nazartinib|mesh-list
93119820|NCT03516214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119821|NCT03516214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119822|NCT03516214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119823|NCT03516214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119824|NCT03630796|Sevoflurane|sevoflurane|mesh-list
93119825|NCT03630796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93119826|NCT03630796|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93119827|NCT03630796|Anesthetics, General|anesthetics, general|mesh-ancestor
93119828|NCT03630796|Anesthetics|anesthetics|mesh-ancestor
93119829|NCT03630796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119830|NCT03630796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119831|NCT05202964|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93119832|NCT05202964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119833|NCT01096966|Bupivacaine|bupivacaine|mesh-list
93119834|NCT01096966|Anesthetics, Local|anesthetics, local|mesh-ancestor
93119835|NCT01096966|Anesthetics|anesthetics|mesh-ancestor
93119836|NCT01096966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119837|NCT01096966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119838|NCT01096966|Sensory System Agents|sensory system agents|mesh-ancestor
93119839|NCT01096966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119840|NCT01379560|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
93119841|NCT01379560|Dinoprost|dinoprost|mesh-list
93119842|NCT01379560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93119843|NCT01379560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93119844|NCT01379560|Abortifacient Agents|abortifacient agents|mesh-ancestor
93119845|NCT01379560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93119846|NCT01379560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119847|NCT01379560|Oxytocics|oxytocics|mesh-ancestor
93119848|NCT01379482|Paclitaxel|paclitaxel|mesh-list
93119849|NCT01379482|Docetaxel|docetaxel|mesh-list
93119850|NCT01379482|Cisplatin|cisplatin|mesh-list
93119851|NCT01379482|Doxorubicin|doxorubicin|mesh-list
93119852|NCT01379482|Oxaliplatin|oxaliplatin|mesh-list
93119853|NCT01379482|Irinotecan|irinotecan|mesh-list
93119854|NCT01379482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93119855|NCT01379482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119856|NCT01379482|Tubulin Modulators|tubulin modulators|mesh-ancestor
93119857|NCT01379482|Antimitotic Agents|antimitotic agents|mesh-ancestor
93119858|NCT01379482|Mitosis Modulators|mitosis modulators|mesh-ancestor
93119859|NCT01379482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119860|NCT01379482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93119861|NCT01379482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93119862|NCT01379482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93119863|NCT01379482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119864|NCT01379482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93119865|NCT05624424|Sufentanil|sufentanil|mesh-list
93119866|NCT05624424|Remifentanil|remifentanil|mesh-list
93119867|NCT05624424|Propofol|propofol|mesh-list
93119868|NCT05624424|Sevoflurane|sevoflurane|mesh-list
93119869|NCT05624424|Cisatracurium|cisatracurium|mesh-list
93119870|NCT05624424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93119871|NCT05624424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119872|NCT05624424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119873|NCT05624424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93119874|NCT05624424|Anesthetics, General|anesthetics, general|mesh-ancestor
93119875|NCT05624424|Anesthetics|anesthetics|mesh-ancestor
93119876|NCT05624424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93119877|NCT05624424|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93119878|NCT05624424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93119879|NCT05624424|Narcotics|narcotics|mesh-ancestor
93119880|NCT05624424|Analgesics|analgesics|mesh-ancestor
93119881|NCT05624424|Sensory System Agents|sensory system agents|mesh-ancestor
93119882|NCT05624424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119883|NCT05624424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93119884|NCT05624424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93119885|NCT05624424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93119886|NCT05461690|Niraparib|niraparib|mesh-list
93119887|NCT05461690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93119888|NCT05461690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119889|NCT05461690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119890|NCT05461690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119891|NCT05456230|Midazolam|midazolam|mesh-list
93119892|NCT05456230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93119893|NCT05456230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93119894|NCT05456230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119895|NCT05456230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119896|NCT05456230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93119897|NCT05456230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93119898|NCT05456230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119899|NCT05456230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93119900|NCT05456230|Anesthetics, General|anesthetics, general|mesh-ancestor
93119901|NCT05456230|Anesthetics|anesthetics|mesh-ancestor
93119902|NCT05456230|GABA Modulators|gaba modulators|mesh-ancestor
93119903|NCT05456230|GABA Agents|gaba agents|mesh-ancestor
93119904|NCT05456230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119905|NCT05456230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119906|NCT03791814|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93119907|NCT03791814|Antiviral Agents|antiviral agents|mesh-ancestor
93119908|NCT03791814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93119909|NCT05404048|Atezolizumab|atezolizumab|mesh-list
93119910|NCT05404048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92792103|NCT00918879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119911|NCT05404048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119912|NCT05404048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93119913|NCT05404048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119914|NCT01377376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93119915|NCT01377376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119916|NCT01377376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119917|NCT01377376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119918|NCT01377376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119919|NCT03788538|Dexmedetomidine|dexmedetomidine|mesh-list
93119920|NCT03788538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93119921|NCT03788538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119922|NCT03788538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119923|NCT03788538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93119924|NCT03788538|Analgesics|analgesics|mesh-ancestor
93119925|NCT03788538|Sensory System Agents|sensory system agents|mesh-ancestor
93119926|NCT03788538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119927|NCT03788538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93119928|NCT03788538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93119929|NCT03788538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93119930|NCT03788538|Adrenergic Agents|adrenergic agents|mesh-ancestor
93119931|NCT03788538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119932|NCT03788538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119933|NCT05320120|Esketamine|esketamine|mesh-list
93119934|NCT05320120|Antidepressive Agents|antidepressive agents|mesh-ancestor
93119935|NCT05320120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119936|NCT03077698|Megestrol|megestrol|mesh-list
93119937|NCT03077698|Megestrol Acetate|megestrol acetate|mesh-list
93119938|NCT03077698|Progestins|progestins|mesh-list
93119939|NCT03077698|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
93119940|NCT03077698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93119941|NCT03077698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93119942|NCT03077698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93119943|NCT03077698|Contraceptive Agents|contraceptive agents|mesh-ancestor
93119944|NCT03077698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93119945|NCT03077698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119946|NCT03077698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93119947|NCT03077698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93119948|NCT03077698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93119949|NCT03077698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119950|NCT03077698|Appetite Stimulants|appetite stimulants|mesh-ancestor
93119951|NCT03077698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93119952|NCT03077698|Hormones|hormones|mesh-ancestor
93119953|NCT03077698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93119954|NCT03077698|Interferon Inducers|interferon inducers|mesh-ancestor
93119955|NCT03077698|Immunologic Factors|immunologic factors|mesh-ancestor
93119956|NCT01377220|Choline|choline|mesh-list
93119957|NCT01377220|Lipotropic Agents|lipotropic agents|mesh-ancestor
93119958|NCT01377220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93119959|NCT01377220|Antimetabolites|antimetabolites|mesh-ancestor
93119960|NCT01377220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119961|NCT01377220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93119962|NCT01377220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93119963|NCT01377220|Nootropic Agents|nootropic agents|mesh-ancestor
93119964|NCT03079102|Nitric Oxide|nitric oxide|mesh-list
93119965|NCT03079102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93119966|NCT03079102|Autonomic Agents|autonomic agents|mesh-ancestor
93119967|NCT03079102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93119968|NCT03079102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119969|NCT03079102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93119970|NCT03079102|Respiratory System Agents|respiratory system agents|mesh-ancestor
93119971|NCT03079102|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93119972|NCT03079102|Antioxidants|antioxidants|mesh-ancestor
93119973|NCT03079102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119974|NCT03079102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119975|NCT03079102|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93119976|NCT03079102|Vasodilator Agents|vasodilator agents|mesh-ancestor
93119977|NCT03079102|Gasotransmitters|gasotransmitters|mesh-ancestor
93119978|NCT03079102|Protective Agents|protective agents|mesh-ancestor
93119979|NCT03791424|Midazolam|midazolam|mesh-list
93119980|NCT03791424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93119981|NCT03791424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93119982|NCT03791424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93119983|NCT03791424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93119984|NCT03791424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93119985|NCT03791424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92792180|NCT00833833|Analgesics|analgesics|mesh-ancestor
93119986|NCT03791424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93119987|NCT03791424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93119988|NCT03791424|Anesthetics, General|anesthetics, general|mesh-ancestor
93119989|NCT03791424|Anesthetics|anesthetics|mesh-ancestor
93119990|NCT03791424|GABA Modulators|gaba modulators|mesh-ancestor
93119991|NCT03791424|GABA Agents|gaba agents|mesh-ancestor
93119992|NCT03791424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93119993|NCT03791424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93119994|NCT03787992|Gefitinib|gefitinib|mesh-list
93119995|NCT03787992|Aflutinib|aflutinib|mesh-list
93119996|NCT03787992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93119997|NCT03787992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93119998|NCT03787992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93119999|NCT03787992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120000|NCT02434354|Pembrolizumab|pembrolizumab|mesh-list
93120001|NCT02434354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120002|NCT02434354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120003|NCT02434354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93120004|NCT02434354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120005|NCT05764018|Caffeine|caffeine|mesh-list
93120006|NCT05764018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93120007|NCT05764018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120008|NCT05764018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93120009|NCT05764018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120010|NCT05764018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120011|NCT05764018|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93120012|NCT05764018|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93120013|NCT05764018|Purinergic Agents|purinergic agents|mesh-ancestor
93120014|NCT05764018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120015|NCT01308528|Enoxaparin|enoxaparin|mesh-list
93120016|NCT01308528|Enoxaparin sodium|enoxaparin sodium|mesh-list
93120017|NCT01308528|Anticoagulants|anticoagulants|mesh-ancestor
93120018|NCT01308528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93120019|NCT01308528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93120020|NCT01308528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120021|NCT04839328|Hemay005|hemay005|mesh-list
93120022|NCT04839328|Dermatologic Agents|dermatologic agents|mesh-ancestor
93120023|NCT04839328|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93120024|NCT04839328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93120025|NCT04839328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120026|NCT04839328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120027|NCT03785496|Spartalizumab|spartalizumab|mesh-list
93120028|NCT03785496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93120029|NCT03785496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120030|NCT03785496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120031|NCT03785496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120032|NCT01307202|Gabapentin|gabapentin|mesh-list
93120033|NCT01307202|Analgesics|analgesics|mesh-ancestor
93120034|NCT01307202|Sensory System Agents|sensory system agents|mesh-ancestor
93120035|NCT01307202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120036|NCT01307202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120037|NCT01307202|Anticonvulsants|anticonvulsants|mesh-ancestor
93120038|NCT01307202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93120039|NCT01307202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93120040|NCT01307202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120041|NCT01307202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93120042|NCT01307202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93120043|NCT01307202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93120044|NCT01307202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120045|NCT01307202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120046|NCT01307202|Antimanic Agents|antimanic agents|mesh-ancestor
93120047|NCT04294576|Pembrolizumab|pembrolizumab|mesh-list
93120048|NCT04294576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120049|NCT04294576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120050|NCT04294576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93120051|NCT04294576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120052|NCT01308606|Simeprevir|simeprevir|mesh-list
93120053|NCT01308606|Antiviral Agents|antiviral agents|mesh-ancestor
93120054|NCT01308606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120055|NCT01308606|Protease Inhibitors|protease inhibitors|mesh-ancestor
93120056|NCT01308606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120057|NCT01308606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120058|NCT04637386|Anesthetics|anesthetics|mesh-list
93120059|NCT04637386|Anesthetics, Local|anesthetics, local|mesh-list
93120060|NCT04637386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120061|NCT04637386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120062|NCT04637386|Sensory System Agents|sensory system agents|mesh-ancestor
93120063|NCT04637386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120064|NCT01308684|Bevacizumab|bevacizumab|mesh-list
93120065|NCT01308684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120066|NCT01308684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120067|NCT01308684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120068|NCT01308684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120069|NCT01308684|Growth Substances|growth substances|mesh-ancestor
93120070|NCT01308684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120071|NCT01308684|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120072|NCT05613114|4-Aminopyridine|4-aminopyridine|mesh-list
93120073|NCT05613114|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93120074|NCT05613114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120075|NCT05613114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120076|NCT03790566|Bupivacaine|bupivacaine|mesh-list
93120077|NCT03790566|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120078|NCT03790566|Anesthetics|anesthetics|mesh-ancestor
93120079|NCT03790566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120080|NCT03790566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120081|NCT03790566|Sensory System Agents|sensory system agents|mesh-ancestor
93120082|NCT03790566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120083|NCT04436224|Fentanyl|fentanyl|mesh-list
93120084|NCT04436224|Hydromorphone|hydromorphone|mesh-list
93120085|NCT04436224|Butorphanol|butorphanol|mesh-list
93120086|NCT04436224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93120087|NCT04436224|Narcotics|narcotics|mesh-ancestor
93120088|NCT04436224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120089|NCT04436224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120090|NCT04436224|Analgesics|analgesics|mesh-ancestor
93120091|NCT04436224|Sensory System Agents|sensory system agents|mesh-ancestor
93120092|NCT04436224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120093|NCT04436224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93120094|NCT04436224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93120095|NCT04436224|Anesthetics, General|anesthetics, general|mesh-ancestor
93120096|NCT04436224|Anesthetics|anesthetics|mesh-ancestor
93120097|NCT04436224|Antitussive Agents|antitussive agents|mesh-ancestor
93120098|NCT04436224|Respiratory System Agents|respiratory system agents|mesh-ancestor
93120099|NCT04436224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93120100|NCT03785184|Dexamethasone|dexamethasone|mesh-list
93120101|NCT03785184|Lenalidomide|lenalidomide|mesh-list
93120102|NCT03785184|Venetoclax|venetoclax|mesh-list
93120103|NCT03785184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120104|NCT03785184|Antiemetics|antiemetics|mesh-ancestor
93120105|NCT03785184|Autonomic Agents|autonomic agents|mesh-ancestor
93120106|NCT03785184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120107|NCT03785184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120108|NCT03785184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120109|NCT03785184|Glucocorticoids|glucocorticoids|mesh-ancestor
93120110|NCT03785184|Hormones|hormones|mesh-ancestor
93120111|NCT03785184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120112|NCT03785184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93120113|NCT03785184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120114|NCT03785184|Immunologic Factors|immunologic factors|mesh-ancestor
93120115|NCT03785184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120116|NCT03785184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120117|NCT03785184|Growth Substances|growth substances|mesh-ancestor
93120118|NCT03785184|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120119|NCT03784794|Thrombin|thrombin|mesh-list
93120120|NCT03784794|Hemostatics|hemostatics|mesh-ancestor
93120121|NCT03784794|Coagulants|coagulants|mesh-ancestor
93120122|NCT01378546|Amifampridine|amifampridine|mesh-list
93120123|NCT01378546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93120124|NCT01378546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120125|NCT01378546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120126|NCT01378546|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93120127|NCT01378546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120128|NCT01378546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120129|NCT05688384|Alfentanil|alfentanil|mesh-list
93120130|NCT05688384|Propofol|propofol|mesh-list
93120131|NCT05688384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93120132|NCT05688384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120133|NCT05688384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120134|NCT05688384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93120135|NCT05688384|Anesthetics, General|anesthetics, general|mesh-ancestor
93120137|NCT05688384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93120138|NCT05688384|Narcotics|narcotics|mesh-ancestor
93120139|NCT05688384|Analgesics|analgesics|mesh-ancestor
93120140|NCT05688384|Sensory System Agents|sensory system agents|mesh-ancestor
93120141|NCT05688384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120142|NCT01307592|Rituximab|rituximab|mesh-list
93120143|NCT01307592|Gemcitabine|gemcitabine|mesh-list
93120144|NCT01307592|Oxaliplatin|oxaliplatin|mesh-list
93120145|NCT01307592|Lenalidomide|lenalidomide|mesh-list
93120146|NCT01307592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120147|NCT01307592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120148|NCT01307592|Immunologic Factors|immunologic factors|mesh-ancestor
93120149|NCT01307592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120150|NCT01307592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93120151|NCT01307592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93120152|NCT01307592|Antimetabolites|antimetabolites|mesh-ancestor
93120153|NCT01307592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120154|NCT01307592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120155|NCT01307592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120156|NCT01307592|Growth Substances|growth substances|mesh-ancestor
93120157|NCT01307592|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120158|NCT03790020|Bupivacaine|bupivacaine|mesh-list
93120159|NCT03790020|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120160|NCT03790020|Anesthetics|anesthetics|mesh-ancestor
93120161|NCT03790020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120162|NCT03790020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120163|NCT03790020|Sensory System Agents|sensory system agents|mesh-ancestor
93120164|NCT03790020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120165|NCT03075826|Guadecitabine|guadecitabine|mesh-list
93120166|NCT03075826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120167|NCT01378156|Vaccines|vaccines|mesh-list
93120168|NCT01378156|Immunologic Factors|immunologic factors|mesh-ancestor
93120169|NCT01378156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120170|NCT04108234|Ketamine|ketamine|mesh-list
93120171|NCT04108234|Analgesics|analgesics|mesh-ancestor
93120172|NCT04108234|Sensory System Agents|sensory system agents|mesh-ancestor
93120173|NCT04108234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120174|NCT04108234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120175|NCT04108234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93120176|NCT04108234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93120177|NCT04108234|Anesthetics, General|anesthetics, general|mesh-ancestor
93120178|NCT04108234|Anesthetics|anesthetics|mesh-ancestor
93120179|NCT04108234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120180|NCT04108234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93120181|NCT04108234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93120182|NCT04108234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120183|NCT04108234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120184|NCT03687814|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93120185|NCT03687814|Laxatives|laxatives|mesh-ancestor
93120186|NCT03687814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120187|NCT05763550|Pregabalin|pregabalin|mesh-list
93120188|NCT05763550|Analgesics|analgesics|mesh-ancestor
93120189|NCT05763550|Sensory System Agents|sensory system agents|mesh-ancestor
93120190|NCT05763550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120191|NCT05763550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120192|NCT05763550|Anticonvulsants|anticonvulsants|mesh-ancestor
93120193|NCT05763550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93120194|NCT05763550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120195|NCT05763550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120196|NCT05763550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93120197|NCT05763550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93120198|NCT05763550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93120199|NCT05763550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120200|NCT05763550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93120201|NCT03783936|Leucovorin|leucovorin|mesh-list
93120202|NCT03783936|Fluorouracil|fluorouracil|mesh-list
93120203|NCT03783936|Oxaliplatin|oxaliplatin|mesh-list
93120204|NCT03783936|Trastuzumab|trastuzumab|mesh-list
93120205|NCT03783936|Avelumab|avelumab|mesh-list
93120206|NCT03783936|Antimetabolites|antimetabolites|mesh-ancestor
93120207|NCT03783936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120208|NCT03783936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93120209|NCT03783936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120210|NCT03783936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120211|NCT03783936|Immunologic Factors|immunologic factors|mesh-ancestor
93120212|NCT03783936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120213|NCT03783936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120214|NCT03783936|Antidotes|antidotes|mesh-ancestor
93120215|NCT03783936|Protective Agents|protective agents|mesh-ancestor
93120216|NCT03783936|Vitamin B Complex|vitamin b complex|mesh-ancestor
93120217|NCT03783936|Vitamins|vitamins|mesh-ancestor
93120218|NCT03783936|Micronutrients|micronutrients|mesh-ancestor
93120219|NCT03781908|Silver Nitrate|silver nitrate|mesh-list
93120220|NCT03781908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93120221|NCT03781908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120222|NCT03781596|Fluticasone|fluticasone|mesh-list
93120223|NCT03781596|Omeprazole|omeprazole|mesh-list
93120224|NCT03781596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120225|NCT03781596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93120226|NCT03781596|Autonomic Agents|autonomic agents|mesh-ancestor
93120227|NCT03781596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120228|NCT03781596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120229|NCT03781596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93120230|NCT03781596|Respiratory System Agents|respiratory system agents|mesh-ancestor
93120231|NCT03781596|Dermatologic Agents|dermatologic agents|mesh-ancestor
93120232|NCT03781596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93120233|NCT03781596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93120234|NCT03781596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120235|NCT03781596|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93120236|NCT03781596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120237|NCT03781596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120238|NCT03781674|Progesterone|progesterone|mesh-list
93120239|NCT03781674|Progestins|progestins|mesh-ancestor
93120240|NCT03781674|Hormones|hormones|mesh-ancestor
93120241|NCT03781674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120242|NCT03781674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120243|NCT03786120|Zolpidem|zolpidem|mesh-list
93120244|NCT03786120|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93120245|NCT03786120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93120246|NCT03786120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120247|NCT03786120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120248|NCT03786120|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93120249|NCT03786120|GABA Agonists|gaba agonists|mesh-ancestor
93120250|NCT03786120|GABA Agents|gaba agents|mesh-ancestor
93120251|NCT03786120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120252|NCT03786120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120253|NCT01561014|Fluorouracil|fluorouracil|mesh-list
93120254|NCT01561014|Oxaliplatin|oxaliplatin|mesh-list
93120255|NCT01561014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93120256|NCT01561014|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93120257|NCT01561014|Antimetabolites|antimetabolites|mesh-ancestor
93120258|NCT01561014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120259|NCT01561014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93120260|NCT01561014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120261|NCT01561014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120262|NCT01561014|Immunologic Factors|immunologic factors|mesh-ancestor
93120263|NCT01561014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120264|NCT01561014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93120265|NCT01561014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120266|NCT01561014|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93120267|NCT01561092|Escitalopram|escitalopram|mesh-list
93120268|NCT01561092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93120269|NCT01561092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93120270|NCT01561092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120271|NCT01561092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120272|NCT01561092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120273|NCT01561092|Serotonin Agents|serotonin agents|mesh-ancestor
93120274|NCT01561092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120275|NCT05494866|Cobicistat|cobicistat|mesh-list
93120276|NCT05494866|Paclitaxel|paclitaxel|mesh-list
93120277|NCT05494866|Gemcitabine|gemcitabine|mesh-list
93120278|NCT05494866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93120279|NCT05494866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120280|NCT05494866|Tubulin Modulators|tubulin modulators|mesh-ancestor
93120281|NCT05494866|Antimitotic Agents|antimitotic agents|mesh-ancestor
93120282|NCT05494866|Mitosis Modulators|mitosis modulators|mesh-ancestor
93120283|NCT05494866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120284|NCT05494866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93120285|NCT05494866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93120286|NCT05494866|Antiviral Agents|antiviral agents|mesh-ancestor
93120287|NCT05494866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120288|NCT05494866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93120289|NCT05494866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93120290|NCT05494866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120291|NCT05494866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93120292|NCT05494866|Antimetabolites|antimetabolites|mesh-ancestor
93120293|NCT01316874|Valrubicin|valrubicin|mesh-list
93120294|NCT01316874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120295|NCT01316874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93120296|NCT01316874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93120297|NCT01316874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120298|NCT01316874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120299|NCT01309542|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93120300|NCT01309542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93120301|NCT01309542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93120302|NCT01309542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120303|NCT01309542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120304|NCT01309542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120305|NCT01309542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120306|NCT01309542|Antidepressive Agents|antidepressive agents|mesh-ancestor
93120307|NCT01309542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93120308|NCT01309620|Zinc|zinc|mesh-list
93120309|NCT01309620|Trace Elements|trace elements|mesh-ancestor
93120310|NCT01309620|Micronutrients|micronutrients|mesh-ancestor
93120311|NCT01309620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120312|NCT03783312|Acetaminophen|acetaminophen|mesh-list
93120313|NCT03783312|Ibuprofen|ibuprofen|mesh-list
93120314|NCT03783312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93120315|NCT03783312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93120316|NCT03783312|Analgesics|analgesics|mesh-ancestor
93120317|NCT03783312|Sensory System Agents|sensory system agents|mesh-ancestor
93120318|NCT03783312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120319|NCT03783312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120320|NCT03783312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120321|NCT03783312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93120322|NCT03783312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93120323|NCT03783312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120324|NCT03783312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120325|NCT03783312|Antipyretics|antipyretics|mesh-ancestor
93120326|NCT03776916|Simethicone|simethicone|mesh-list
93120327|NCT03776916|Antifoaming Agents|antifoaming agents|mesh-ancestor
93120328|NCT03776916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120329|NCT03776916|Emollients|emollients|mesh-ancestor
93120330|NCT03776916|Dermatologic Agents|dermatologic agents|mesh-ancestor
93120331|NCT01560702|Epinephrine|epinephrine|mesh-list
93120332|NCT01560702|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93120333|NCT01560702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93120334|NCT01560702|Adrenergic Agents|adrenergic agents|mesh-ancestor
93120335|NCT01560702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120336|NCT01560702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120337|NCT01560702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120338|NCT01560702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93120339|NCT01560702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93120340|NCT01560702|Autonomic Agents|autonomic agents|mesh-ancestor
93120341|NCT01560702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120342|NCT01560702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93120343|NCT01560702|Respiratory System Agents|respiratory system agents|mesh-ancestor
93120344|NCT01560702|Mydriatics|mydriatics|mesh-ancestor
93120345|NCT01560702|Sympathomimetics|sympathomimetics|mesh-ancestor
93120346|NCT01560702|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93120347|NCT03776838|Fentanyl|fentanyl|mesh-list
93120348|NCT03776838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93120349|NCT03776838|Narcotics|narcotics|mesh-ancestor
93120350|NCT03776838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120351|NCT03776838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120352|NCT03776838|Analgesics|analgesics|mesh-ancestor
93120353|NCT03776838|Sensory System Agents|sensory system agents|mesh-ancestor
93120354|NCT03776838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120355|NCT03776838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93120356|NCT03776838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93120357|NCT03776838|Anesthetics, General|anesthetics, general|mesh-ancestor
93120358|NCT03776838|Anesthetics|anesthetics|mesh-ancestor
93120359|NCT03781050|Sirolimus|sirolimus|mesh-list
93120360|NCT03781050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93120361|NCT03781050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792570|NCT04252443|Analgesics|analgesics|mesh-list
93120362|NCT03781050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93120363|NCT03781050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120364|NCT03781050|Antifungal Agents|antifungal agents|mesh-ancestor
93120365|NCT03781050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120366|NCT03781050|Immunologic Factors|immunologic factors|mesh-ancestor
93120367|NCT03781050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120368|NCT02865850|Darbepoetin alfa|darbepoetin alfa|mesh-list
93120369|NCT02865850|Hematinics|hematinics|mesh-ancestor
93120370|NCT01309698|Inositol|inositol|mesh-list
93120371|NCT01309698|Vildagliptin|vildagliptin|mesh-list
93120372|NCT01309698|Voglibose|voglibose|mesh-list
93120373|NCT01309698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93120374|NCT01309698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120375|NCT01309698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93120376|NCT01309698|Protease Inhibitors|protease inhibitors|mesh-ancestor
93120377|NCT01309698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120378|NCT01309698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120379|NCT01309698|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93120380|NCT01309698|Vitamin B Complex|vitamin b complex|mesh-ancestor
93120381|NCT01309698|Vitamins|vitamins|mesh-ancestor
93120382|NCT01309698|Micronutrients|micronutrients|mesh-ancestor
93120383|NCT01142284|Cilostazol|cilostazol|mesh-list
93120384|NCT01142284|Probucol|probucol|mesh-list
93120385|NCT01142284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93120386|NCT01142284|Autonomic Agents|autonomic agents|mesh-ancestor
93120387|NCT01142284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120388|NCT01142284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120389|NCT01142284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93120390|NCT01142284|Respiratory System Agents|respiratory system agents|mesh-ancestor
93120391|NCT01142284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93120392|NCT01142284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93120393|NCT01142284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120394|NCT01142284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93120395|NCT01142284|Vasodilator Agents|vasodilator agents|mesh-ancestor
93120396|NCT01142284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93120397|NCT01142284|Protective Agents|protective agents|mesh-ancestor
93120398|NCT01142284|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93120399|NCT01142284|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93120400|NCT01142284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120401|NCT01142284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93120402|NCT01142284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93120403|NCT01142284|Antimetabolites|antimetabolites|mesh-ancestor
93120404|NCT01142284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93120405|NCT01142284|Antioxidants|antioxidants|mesh-ancestor
93120406|NCT01309776|Tianeptine|tianeptine|mesh-list
93120407|NCT01309776|Escitalopram|escitalopram|mesh-list
93120408|NCT01309776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93120409|NCT01309776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93120410|NCT01309776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120411|NCT01309776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120412|NCT01309776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073787|NCT05933213|Glucocorticoids|glucocorticoids|mesh-list
93120413|NCT01309776|Serotonin Agents|serotonin agents|mesh-ancestor
93074393|NCT05894538|Ivermectin|ivermectin|mesh-list
93074686|NCT05701189|Immunoglobulins|immunoglobulins|mesh-list
93120414|NCT01309776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075587|NCT05117710|Protective Agents|protective agents|mesh-ancestor
93075765|NCT05023993|Niacin|niacin|mesh-list
93076102|NCT04707196|Fulvestrant|fulvestrant|mesh-list
93076633|NCT04176705|Glucocorticoids|glucocorticoids|mesh-ancestor
93076859|NCT03961334|Aspirin|aspirin|mesh-list
93077084|NCT03683251|Ranibizumab|ranibizumab|mesh-list
93077605|NCT02950051|Fludarabine|fludarabine|mesh-list
93077834|NCT02567435|Cyclophosphamide|cyclophosphamide|mesh-list
93077910|NCT02414269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078600|NCT00046930|Antimetabolites|antimetabolites|mesh-ancestor
93078674|NCT00003910|Abortifacient Agents|abortifacient agents|mesh-ancestor
93078827|NCT04069312|Azithromycin|azithromycin|mesh-list
93079047|NCT02332850|Glucocorticoids|glucocorticoids|mesh-ancestor
93079124|NCT01996267|Antimetabolites|antimetabolites|mesh-ancestor
93079278|NCT01583504|Anesthetics|anesthetics|mesh-list
93080399|NCT01085721|Sympathomimetics|sympathomimetics|mesh-ancestor
93120415|NCT01309776|Antidepressive Agents|antidepressive agents|mesh-ancestor
93120416|NCT01309776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080773|NCT00004412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081078|NCT00399035|Leucovorin|leucovorin|mesh-list
93081448|NCT05787600|Chlorhexidine|chlorhexidine|mesh-list
93081592|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
93081895|NCT04511013|Ipilimumab|ipilimumab|mesh-list
93081973|NCT04205968|Immunologic Factors|immunologic factors|mesh-ancestor
93082055|NCT03911466|Buprenorphine|buprenorphine|mesh-list
93082134|NCT03798626|Antimetabolites|antimetabolites|mesh-ancestor
93120417|NCT01309776|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93120418|NCT03783000|BI 425809|bi 425809|mesh-list
93120419|NCT03783000|Nootropic Agents|nootropic agents|mesh-ancestor
93083402|NCT01052129|Analgesics|analgesics|mesh-ancestor
93083851|NCT01112540|Analgesics|analgesics|mesh-ancestor
93084000|NCT01209806|TEMPO|tempo|mesh-list
93084154|NCT03942458|Clopidogrel|clopidogrel|mesh-list
93120420|NCT01309854|Pioglitazone|pioglitazone|mesh-list
93084820|NCT01219088|Bupivacaine|bupivacaine|mesh-list
93085058|NCT03710356|Danazol|danazol|mesh-list
93120421|NCT01309854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085560|NCT01220570|Sirolimus|sirolimus|mesh-list
93085782|NCT01124318|Lactulose|lactulose|mesh-list
93086175|NCT01129856|Hormones|hormones|mesh-ancestor
93086232|NCT01228994|Baclofen|baclofen|mesh-list
93086306|NCT01132586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087058|NCT05032508|Lidocaine|lidocaine|mesh-list
93087279|NCT01145456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087733|NCT00368927|Sulindac|sulindac|mesh-list
93120422|NCT01309854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088404|NCT00660218|Cetuximab|cetuximab|mesh-list
93088485|NCT03897452|Anesthetics|anesthetics|mesh-ancestor
92760960|NCT02826343|Xenon|xenon|mesh-list
93088705|NCT01149668|Abexinostat|abexinostat|mesh-list
93088927|NCT01152476|Narcotics|narcotics|mesh-ancestor
93120423|NCT03780192|Sirolimus|sirolimus|mesh-list
93089372|NCT01264874|Vitamins|vitamins|mesh-ancestor
93089599|NCT01265810|Calcium|calcium|mesh-list
93089972|NCT01280240|Hematinics|hematinics|mesh-ancestor
93090590|NCT03349268|Xenon|xenon|mesh-list
93090724|NCT01174472|Paclitaxel|paclitaxel|mesh-list
93091414|NCT05200312|Hormones|hormones|mesh-ancestor
93092153|NCT01183676|Valproic Acid|valproic acid|mesh-list
93092603|NCT03254134|Warfarin|warfarin|mesh-list
93092759|NCT01192802|Albendazole|albendazole|mesh-list
93092835|NCT03848780|Desflurane|desflurane|mesh-list
93093209|NCT03719326|Paclitaxel|paclitaxel|mesh-list
93093375|NCT01202084|Xhance|xhance|mesh-list
93093883|NCT01205516|Morphine|morphine|mesh-list
93094627|NCT00301067|Micronutrients|micronutrients|mesh-ancestor
93094787|NCT01060787|Hormones|hormones|mesh-ancestor
93095088|NCT00270413|Sunitinib|sunitinib|mesh-list
93120424|NCT03780192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93095224|NCT03206788|Losartan|losartan|mesh-list
93095591|NCT05186194|Vitamins|vitamins|mesh-ancestor
93095742|NCT01341262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095819|NCT00265343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096060|NCT01334632|Morphine|morphine|mesh-list
93096116|NCT01070225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096193|NCT00262847|Paclitaxel|paclitaxel|mesh-list
93096499|NCT01302158|Glimepiride|glimepiride|mesh-list
93096720|NCT00274937|Immunologic Factors|immunologic factors|mesh-ancestor
93096950|NCT03789890|Itraconazole|itraconazole|mesh-list
93097625|NCT03771638|Tenofovir|tenofovir|mesh-list
93097776|NCT02118610|Dopamine Agents|dopamine agents|mesh-ancestor
93097931|NCT03902314|Lidocaine|lidocaine|mesh-list
93098158|NCT04470778|Famotidine|famotidine|mesh-list
93098220|NCT01352728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120425|NCT03780192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098370|NCT04351256|Durvalumab|durvalumab|mesh-list
93098539|NCT00045630|Paclitaxel|paclitaxel|mesh-list
93099192|NCT01100346|Hormones|hormones|mesh-ancestor
93099646|NCT00233987|Alkylating Agents|alkylating agents|mesh-ancestor
93120426|NCT03780192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93100091|NCT03752294|Dabigatran|dabigatran|mesh-list
93100618|NCT01111968|Vaccines|vaccines|mesh-list
93120427|NCT03780192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100841|NCT04459598|Antiviral Agents|antiviral agents|mesh-ancestor
93120428|NCT03780192|Antifungal Agents|antifungal agents|mesh-ancestor
93101508|NCT01122342|Testosterone|testosterone|mesh-list
93101736|NCT01373554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102185|NCT01073501|Pregabalin|pregabalin|mesh-list
93102407|NCT05731804|Ritonavir|ritonavir|mesh-list
93102479|NCT03932526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102629|NCT05415826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120429|NCT03780192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93102848|NCT01229046|Clavulanic Acids|clavulanic acids|mesh-list
93102927|NCT03925662|Mebendazole|mebendazole|mesh-list
93120430|NCT03780192|Immunologic Factors|immunologic factors|mesh-ancestor
93120431|NCT03780192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120432|NCT05305560|Ivermectin|ivermectin|mesh-list
93103747|NCT01586052|Epoetin Alfa|epoetin alfa|mesh-list
93104049|NCT05845359|Methadone|methadone|mesh-list
93104230|NCT05843292|Taxane|taxane|mesh-list
93120433|NCT05305560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93104756|NCT05681780|Nivolumab|nivolumab|mesh-list
93104957|NCT05487040|Ritonavir|ritonavir|mesh-list
93105181|NCT05239624|Pembrolizumab|pembrolizumab|mesh-list
93105327|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
93105574|NCT05006599|Insulin|insulin|mesh-list
93106763|NCT03771651|Aspirin|aspirin|mesh-list
93106914|NCT03579771|Paclitaxel|paclitaxel|mesh-list
93107065|NCT03456843|Vitamins|vitamins|mesh-ancestor
93107288|NCT03059563|Varenicline|varenicline|mesh-list
93108134|NCT00301808|Docetaxel|docetaxel|mesh-list
93108356|NCT05426486|Docetaxel|docetaxel|mesh-list
93108496|NCT05138575|Empagliflozin|empagliflozin|mesh-list
93108577|NCT04796584|Antibodies|antibodies|mesh-list
93120434|NCT05305560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120435|NCT03776448|Charcoal|charcoal|mesh-list
93109113|NCT03724890|Avelumab|avelumab|mesh-list
93109183|NCT01141998|Vitamins|vitamins|mesh-ancestor
93120436|NCT03776448|Antidotes|antidotes|mesh-ancestor
93120437|NCT03776448|Protective Agents|protective agents|mesh-ancestor
93110010|NCT01147770|Progesterone|progesterone|mesh-list
93110241|NCT03913884|Mitogens|mitogens|mesh-list
93110614|NCT01258296|Fentanyl|fentanyl|mesh-list
93110681|NCT01149798|Cisplatin|cisplatin|mesh-list
93120438|NCT03776448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110984|NCT05922982|Norepinephrine|norepinephrine|mesh-list
93120439|NCT03780270|Fluorides|fluorides|mesh-list
93120490|NCT03776058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93120491|NCT03776058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120492|NCT03776058|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93120493|NCT03776058|Hormone Antagonists|hormone antagonists|mesh-ancestor
93120494|NCT03776058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120495|NCT05202496|Calcitriol|calcitriol|mesh-list
93120496|NCT05202496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93120497|NCT05202496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120498|NCT05202496|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93120499|NCT05202496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120500|NCT05202496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120501|NCT05202496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93120502|NCT05202496|Vitamins|vitamins|mesh-ancestor
93120503|NCT05202496|Micronutrients|micronutrients|mesh-ancestor
93120504|NCT05202496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93120505|NCT03779568|Bupivacaine|bupivacaine|mesh-list
93120506|NCT03779568|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120507|NCT03779568|Anesthetics|anesthetics|mesh-ancestor
93120508|NCT03779568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120509|NCT03779568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120510|NCT03779568|Sensory System Agents|sensory system agents|mesh-ancestor
93120511|NCT03779568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120512|NCT05201560|Fentanyl|fentanyl|mesh-list
93120513|NCT05201560|Butorphanol|butorphanol|mesh-list
93120514|NCT05201560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93120515|NCT05201560|Narcotics|narcotics|mesh-ancestor
93120516|NCT05201560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120517|NCT05201560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120518|NCT05201560|Analgesics|analgesics|mesh-ancestor
93120519|NCT05201560|Sensory System Agents|sensory system agents|mesh-ancestor
93120520|NCT05201560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120521|NCT05201560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93120522|NCT05201560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93120523|NCT05201560|Anesthetics, General|anesthetics, general|mesh-ancestor
93120524|NCT05201560|Anesthetics|anesthetics|mesh-ancestor
93120525|NCT05201560|Antitussive Agents|antitussive agents|mesh-ancestor
93120526|NCT05201560|Respiratory System Agents|respiratory system agents|mesh-ancestor
93120527|NCT05201560|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93120528|NCT05201326|Bevacizumab|bevacizumab|mesh-list
93120529|NCT05201326|Irinotecan|irinotecan|mesh-list
93120530|NCT05201326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120531|NCT05201326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120532|NCT05201326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120533|NCT05201326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120534|NCT05201326|Growth Substances|growth substances|mesh-ancestor
93120535|NCT05201326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120536|NCT05201326|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120537|NCT05201326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93120538|NCT05201326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93120539|NCT05201326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120540|NCT05201326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120541|NCT03775668|Enmetazobactam|enmetazobactam|mesh-list
93120542|NCT03775668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93120543|NCT03775668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120544|NCT03775668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120545|NCT03775668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93120546|NCT03775668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120547|NCT01561404|Everolimus|everolimus|mesh-list
93120548|NCT01561404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93120549|NCT01561404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93120550|NCT01561404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120551|NCT01561404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120552|NCT01561404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120553|NCT01561404|Immunologic Factors|immunologic factors|mesh-ancestor
93120554|NCT01561404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120555|NCT01561404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120556|NCT03775590|Acetic Acid|acetic acid|mesh-list
93120557|NCT03775590|Retinol acetate|retinol acetate|mesh-list
93120558|NCT03775590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93120559|NCT03775590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120560|NCT03775590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93120561|NCT03775590|Immunologic Factors|immunologic factors|mesh-ancestor
93120562|NCT03775590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120563|NCT03775590|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93120564|NCT03775590|Protective Agents|protective agents|mesh-ancestor
93120565|NCT03775590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120566|NCT03775746|Rivaroxaban|rivaroxaban|mesh-list
93120567|NCT03775746|Clopidogrel|clopidogrel|mesh-list
93120568|NCT03775746|Ticagrelor|ticagrelor|mesh-list
93120569|NCT03775746|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93120570|NCT03775746|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93120571|NCT03775746|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93120572|NCT03775746|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93120573|NCT03775746|Purinergic Agents|purinergic agents|mesh-ancestor
93120574|NCT03775746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120575|NCT03775746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120576|NCT03775746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120577|NCT03775746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93120578|NCT03775746|Antithrombins|antithrombins|mesh-ancestor
93120579|NCT03775746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93120580|NCT03775746|Protease Inhibitors|protease inhibitors|mesh-ancestor
93120581|NCT03775746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120582|NCT03775746|Anticoagulants|anticoagulants|mesh-ancestor
93120583|NCT03779178|Landiolol|landiolol|mesh-list
93120584|NCT03779178|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93120585|NCT03779178|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93120586|NCT03779178|Adrenergic Agents|adrenergic agents|mesh-ancestor
93120587|NCT03779178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120588|NCT03779178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120589|NCT03779178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120590|NCT03779178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93120591|NCT03779100|Lenvatinib|lenvatinib|mesh-list
93120592|NCT03779100|Antibodies|antibodies|mesh-list
93120593|NCT03779100|Immunoglobulins|immunoglobulins|mesh-list
93120594|NCT03779100|Immunologic Factors|immunologic factors|mesh-ancestor
93120595|NCT03779100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120596|NCT03779100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120597|NCT03779100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93120598|NCT03779100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120599|NCT03779100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120600|NCT05711212|Xanthohumol|xanthohumol|mesh-list
93120601|NCT05711212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120602|NCT05711212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120603|NCT05711212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120604|NCT05711212|Growth Substances|growth substances|mesh-ancestor
93120605|NCT05711212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120606|NCT05711212|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120607|NCT05212636|Antidepressive Agents|antidepressive agents|mesh-list
93120608|NCT05212636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93120609|NCT03773094|Chlorhexidine|chlorhexidine|mesh-list
93120610|NCT03773094|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93120611|NCT03773094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93120612|NCT03773094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120613|NCT03773094|Disinfectants|disinfectants|mesh-ancestor
93120614|NCT03773094|Dermatologic Agents|dermatologic agents|mesh-ancestor
93120615|NCT03775356|Anesthetics|anesthetics|mesh-list
93120616|NCT03775356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120617|NCT03775356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120618|NCT05211622|Thioctic Acid|thioctic acid|mesh-list
93120619|NCT05211622|Chlorhexidine|chlorhexidine|mesh-list
93120620|NCT05211622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93120621|NCT05211622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93120622|NCT05211622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93120623|NCT05211622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120624|NCT05211622|Disinfectants|disinfectants|mesh-ancestor
93120625|NCT05211622|Dermatologic Agents|dermatologic agents|mesh-ancestor
93120626|NCT05211622|Antioxidants|antioxidants|mesh-ancestor
93120627|NCT05211622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120628|NCT05211622|Protective Agents|protective agents|mesh-ancestor
93120629|NCT05211622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120630|NCT05211622|Vitamin B Complex|vitamin b complex|mesh-ancestor
93120631|NCT05211622|Vitamins|vitamins|mesh-ancestor
93120632|NCT05211622|Micronutrients|micronutrients|mesh-ancestor
93120633|NCT05705518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93120634|NCT05705518|Lubricant Eye Drops|lubricant eye drops|mesh-list
93120635|NCT05705518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93120636|NCT05191264|Analgesics|analgesics|mesh-list
93120637|NCT05191264|Sensory System Agents|sensory system agents|mesh-ancestor
93120638|NCT05191264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120639|NCT05191264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120640|NCT03778008|Vitamin B 12|vitamin b 12|mesh-list
93120641|NCT03778008|Gentamicins|gentamicins|mesh-list
93120642|NCT03778008|Dexamethasone|dexamethasone|mesh-list
93120643|NCT03778008|Lidocaine|lidocaine|mesh-list
93120644|NCT03778008|Mitogens|mitogens|mesh-list
93120645|NCT03778008|Vitamins|vitamins|mesh-ancestor
93120646|NCT03778008|Micronutrients|micronutrients|mesh-ancestor
93120647|NCT03778008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120648|NCT03778008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120649|NCT03778008|Antiemetics|antiemetics|mesh-ancestor
93120650|NCT03778008|Autonomic Agents|autonomic agents|mesh-ancestor
93120651|NCT03778008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120652|NCT03778008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120653|NCT03778008|Glucocorticoids|glucocorticoids|mesh-ancestor
93120654|NCT03778008|Hormones|hormones|mesh-ancestor
93120655|NCT03778008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120656|NCT03778008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93120657|NCT03778008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120658|NCT03778008|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120659|NCT03778008|Anesthetics|anesthetics|mesh-ancestor
93120660|NCT03778008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120661|NCT03778008|Sensory System Agents|sensory system agents|mesh-ancestor
93120662|NCT03778008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93120663|NCT03778008|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93120664|NCT03778008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93120665|NCT03778008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120666|NCT03778008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120667|NCT03778008|Mitosis Modulators|mitosis modulators|mesh-ancestor
93120668|NCT03778008|Vitamin B Complex|vitamin b complex|mesh-ancestor
93120669|NCT03778008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93120670|NCT03778008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120671|NCT03778008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93120672|NCT03778008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120673|NCT05697328|Pseudoephedrine|pseudoephedrine|mesh-list
93120674|NCT05697328|Ephedrine|ephedrine|mesh-list
93120675|NCT05697328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93120676|NCT05697328|Autonomic Agents|autonomic agents|mesh-ancestor
93120677|NCT05697328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120678|NCT05697328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120679|NCT05697328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93120680|NCT05697328|Respiratory System Agents|respiratory system agents|mesh-ancestor
93120681|NCT05697328|Nasal Decongestants|nasal decongestants|mesh-ancestor
93120682|NCT05697328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93120683|NCT05697328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93120684|NCT05697328|Sympathomimetics|sympathomimetics|mesh-ancestor
93120685|NCT05697328|Adrenergic Agents|adrenergic agents|mesh-ancestor
93120686|NCT05697328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120687|NCT05697328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120688|NCT03777930|Thalidomide|thalidomide|mesh-list
93120689|NCT03777930|Megestrol|megestrol|mesh-list
93120690|NCT03777930|Megestrol Acetate|megestrol acetate|mesh-list
93120691|NCT03777930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120692|NCT03777930|Immunologic Factors|immunologic factors|mesh-ancestor
93120693|NCT03777930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120694|NCT03777930|Leprostatic Agents|leprostatic agents|mesh-ancestor
93120695|NCT03777930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93120696|NCT03777930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120697|NCT03777930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120698|NCT03777930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120699|NCT03777930|Growth Substances|growth substances|mesh-ancestor
93120700|NCT03777930|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120701|NCT03777930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120702|NCT03777930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93120703|NCT03777930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93120704|NCT03777930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93120705|NCT03777930|Contraceptive Agents|contraceptive agents|mesh-ancestor
93120706|NCT03777930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93120707|NCT03777930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93120708|NCT03777930|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93120709|NCT03777930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93120710|NCT03777930|Appetite Stimulants|appetite stimulants|mesh-ancestor
93120711|NCT03777930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93120712|NCT03777696|Misoprostol|misoprostol|mesh-list
93120713|NCT03777696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93120714|NCT03777696|Abortifacient Agents|abortifacient agents|mesh-ancestor
93120715|NCT03777696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91930378|NCT02288923|Anesthetics|anesthetics|mesh-list
93120716|NCT03777696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120717|NCT03777696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93120718|NCT03777696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120719|NCT03777696|Oxytocics|oxytocics|mesh-ancestor
93120720|NCT04581148|Antibodies|antibodies|mesh-list
93120721|NCT04581148|Immunoglobulins|immunoglobulins|mesh-list
93120722|NCT04581148|Immunologic Factors|immunologic factors|mesh-ancestor
93120723|NCT04581148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120724|NCT03708744|Oxazolidinones|oxazolidinones|mesh-list
93120725|NCT03708744|Zolmitriptan|zolmitriptan|mesh-list
93120726|NCT03708744|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93120727|NCT03708744|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93120728|NCT03708744|Serotonin Agents|serotonin agents|mesh-ancestor
93120729|NCT03708744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120730|NCT03708744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120731|NCT03708744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120732|NCT03708744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120733|NCT03708744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93120734|NCT03708744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120735|NCT03774108|Metformin|metformin|mesh-list
93120736|NCT03774108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93120737|NCT03774108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120738|NCT03438526|Melatonin|melatonin|mesh-list
93120739|NCT03438526|Antioxidants|antioxidants|mesh-ancestor
93120740|NCT03438526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120741|NCT03438526|Protective Agents|protective agents|mesh-ancestor
93120742|NCT03438526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120743|NCT03438526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120744|NCT02575144|Clarithromycin|clarithromycin|mesh-list
93120745|NCT02575144|Dexamethasone|dexamethasone|mesh-list
93120746|NCT02575144|Lenalidomide|lenalidomide|mesh-list
93120747|NCT02575144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120748|NCT02575144|Antiemetics|antiemetics|mesh-ancestor
93120749|NCT02575144|Autonomic Agents|autonomic agents|mesh-ancestor
93120750|NCT02575144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120751|NCT02575144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120752|NCT02575144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120753|NCT02575144|Glucocorticoids|glucocorticoids|mesh-ancestor
93120754|NCT02575144|Hormones|hormones|mesh-ancestor
93120755|NCT02575144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120756|NCT02575144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93120757|NCT02575144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120758|NCT02575144|Immunologic Factors|immunologic factors|mesh-ancestor
93120759|NCT02575144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120760|NCT02575144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120761|NCT02575144|Growth Substances|growth substances|mesh-ancestor
93120762|NCT02575144|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120763|NCT02575144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93120764|NCT02575144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120765|NCT02575144|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93120766|NCT02575144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120767|NCT02575144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120768|NCT02575144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93120769|NCT02575144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93120770|NCT03768882|Acetaminophen|acetaminophen|mesh-list
93120771|NCT03768882|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93120772|NCT03768882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93120773|NCT03768882|Analgesics|analgesics|mesh-ancestor
93120774|NCT03768882|Sensory System Agents|sensory system agents|mesh-ancestor
93120775|NCT03768882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120776|NCT03768882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120777|NCT03768882|Antipyretics|antipyretics|mesh-ancestor
93120778|NCT03768882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93120779|NCT03768882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120780|NCT03768882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93120781|NCT02574286|Vitamin D|vitamin d|mesh-list
93120782|NCT02574286|Vitamins|vitamins|mesh-ancestor
93120783|NCT02574286|Micronutrients|micronutrients|mesh-ancestor
93120784|NCT02574286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120785|NCT02574286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93120786|NCT01321944|Nicotine|nicotine|mesh-list
93120787|NCT01321944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93120788|NCT01321944|Autonomic Agents|autonomic agents|mesh-ancestor
93120789|NCT01321944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120790|NCT01321944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120791|NCT01321944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93120792|NCT01321944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93120793|NCT01321944|Cholinergic Agents|cholinergic agents|mesh-ancestor
93120794|NCT01321944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120795|NCT01321944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120796|NCT03771846|Leucovorin|leucovorin|mesh-list
93120797|NCT03771846|Gemcitabine|gemcitabine|mesh-list
93120798|NCT03771846|Fluorouracil|fluorouracil|mesh-list
93120799|NCT03771846|Oxaliplatin|oxaliplatin|mesh-list
93120800|NCT03771846|Irinotecan|irinotecan|mesh-list
93120801|NCT03771846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93120802|NCT03771846|Antimetabolites|antimetabolites|mesh-ancestor
93120803|NCT03771846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120804|NCT03771846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120805|NCT03771846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120806|NCT03771846|Immunologic Factors|immunologic factors|mesh-ancestor
93120807|NCT03771846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120808|NCT03771846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93120809|NCT03771846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93120810|NCT03771846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120811|NCT03771846|Antidotes|antidotes|mesh-ancestor
93120812|NCT03771846|Protective Agents|protective agents|mesh-ancestor
93120813|NCT03771846|Vitamin B Complex|vitamin b complex|mesh-ancestor
93120814|NCT03771846|Vitamins|vitamins|mesh-ancestor
93120815|NCT03771846|Micronutrients|micronutrients|mesh-ancestor
93120816|NCT03763110|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93120817|NCT03763110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93120818|NCT03763110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93120819|NCT03763110|Antitubercular Agents|antitubercular agents|mesh-ancestor
93120820|NCT03771768|Triamcinolone|triamcinolone|mesh-list
93120821|NCT03771768|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93120822|NCT03771768|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93120823|NCT03771768|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93120824|NCT03771768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93120825|NCT03771768|Glucocorticoids|glucocorticoids|mesh-ancestor
93120826|NCT03771768|Hormones|hormones|mesh-ancestor
93120827|NCT03771768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120828|NCT03771768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120829|NCT03771768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120830|NCT03771768|Immunologic Factors|immunologic factors|mesh-ancestor
93120831|NCT03771768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120832|NCT03771768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120833|NCT04393350|Pembrolizumab|pembrolizumab|mesh-list
93120834|NCT04393350|Lenvatinib|lenvatinib|mesh-list
93120835|NCT04393350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120836|NCT04393350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120837|NCT04393350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93120838|NCT04393350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120839|NCT04393350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93120840|NCT04393350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120841|NCT03768258|Methyltestosterone|methyltestosterone|mesh-list
93120842|NCT03768258|Anastrozole|anastrozole|mesh-list
93120843|NCT03768258|Testosterone|testosterone|mesh-list
93120844|NCT03768258|Testosterone undecanoate|testosterone undecanoate|mesh-list
93120845|NCT03768258|Testosterone enanthate|testosterone enanthate|mesh-list
93120846|NCT03768258|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93120847|NCT03768258|Androgens|androgens|mesh-ancestor
93120848|NCT03768258|Hormones|hormones|mesh-ancestor
93120849|NCT03768258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120850|NCT03768258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120851|NCT03768258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93120852|NCT03768258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120853|NCT03768258|Anabolic Agents|anabolic agents|mesh-ancestor
93120854|NCT03768258|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93120855|NCT03768258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93120856|NCT03768258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120857|NCT03768258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120858|NCT03768258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93120859|NCT03768258|Hormone Antagonists|hormone antagonists|mesh-ancestor
93120860|NCT03771222|Decitabine|decitabine|mesh-list
93120861|NCT03771222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93120862|NCT03771222|Antimetabolites|antimetabolites|mesh-ancestor
93120863|NCT03771222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120864|NCT03771222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120865|NCT03771222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120866|NCT03771066|Bisphenol A|bisphenol a|mesh-list
93120867|NCT03771066|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93120868|NCT03771066|Estrogens|estrogens|mesh-ancestor
93120869|NCT03771066|Hormones|hormones|mesh-ancestor
93120870|NCT03771066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93120871|NCT03771066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120872|NCT03771066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93120873|NCT03771066|Antioxidants|antioxidants|mesh-ancestor
93120874|NCT03771066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120875|NCT03771066|Protective Agents|protective agents|mesh-ancestor
93120876|NCT04478838|Olanzapine|olanzapine|mesh-list
93120877|NCT04478838|Risperidone|risperidone|mesh-list
93120878|NCT04478838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93120879|NCT04478838|Serotonin Agents|serotonin agents|mesh-ancestor
93120880|NCT04478838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120881|NCT04478838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120882|NCT04478838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120883|NCT04478838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93120884|NCT04478838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93120885|NCT04478838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120886|NCT04478838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93120887|NCT04478838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93120888|NCT04478838|Dopamine Agents|dopamine agents|mesh-ancestor
93120889|NCT04478838|Antiemetics|antiemetics|mesh-ancestor
93120890|NCT04478838|Autonomic Agents|autonomic agents|mesh-ancestor
93120891|NCT04478838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120892|NCT04478838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93120893|NCT04478838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93120894|NCT04478838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93120895|NCT04478838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120896|NCT03768024|Hydromorphone|hydromorphone|mesh-list
93120897|NCT03768024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93120898|NCT03768024|Narcotics|narcotics|mesh-ancestor
93120899|NCT03768024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120900|NCT03768024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120901|NCT03768024|Analgesics|analgesics|mesh-ancestor
93120902|NCT03768024|Sensory System Agents|sensory system agents|mesh-ancestor
93120903|NCT03768024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120904|NCT03999684|Tretinoin|tretinoin|mesh-list
93120905|NCT03999684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120906|NCT03999684|Keratolytic Agents|keratolytic agents|mesh-ancestor
93120907|NCT03999684|Dermatologic Agents|dermatologic agents|mesh-ancestor
93120908|NCT02083354|Trametinib|trametinib|mesh-list
93120909|NCT02083354|Dabrafenib|dabrafenib|mesh-list
93120910|NCT02083354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120911|NCT02083354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93120912|NCT02083354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120913|NCT02083354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120914|NCT01399918|Bevacizumab|bevacizumab|mesh-list
93120915|NCT01399918|Everolimus|everolimus|mesh-list
93120916|NCT01399918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93120917|NCT01399918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120918|NCT01399918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93120919|NCT01399918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93120920|NCT01399918|Growth Substances|growth substances|mesh-ancestor
93120921|NCT01399918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120922|NCT01399918|Growth Inhibitors|growth inhibitors|mesh-ancestor
93120923|NCT01399918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93120924|NCT01399918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93120925|NCT01399918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120926|NCT01399918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120927|NCT01399918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93120928|NCT01399918|Immunologic Factors|immunologic factors|mesh-ancestor
93120929|NCT03761472|Hyaluronic Acid|hyaluronic acid|mesh-list
93120930|NCT03761472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93120931|NCT03761472|Immunologic Factors|immunologic factors|mesh-ancestor
93120932|NCT03761472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120933|NCT03761472|Viscosupplements|viscosupplements|mesh-ancestor
93120934|NCT03761472|Protective Agents|protective agents|mesh-ancestor
93120935|NCT03767322|Allopurinol|allopurinol|mesh-list
93120936|NCT03767322|Febuxostat|febuxostat|mesh-list
93120937|NCT03767322|Antimetabolites|antimetabolites|mesh-ancestor
93120938|NCT03767322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120939|NCT03767322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120940|NCT03767322|Gout Suppressants|gout suppressants|mesh-ancestor
93120941|NCT03767322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93120942|NCT03767322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93120943|NCT03767322|Antioxidants|antioxidants|mesh-ancestor
93120944|NCT03767322|Protective Agents|protective agents|mesh-ancestor
93120945|NCT03767322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120946|NCT03761004|Levodopa|levodopa|mesh-list
93120947|NCT03761004|Carbidopa|carbidopa|mesh-list
93120948|NCT03761004|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93120949|NCT03761004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93120950|NCT03761004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93120951|NCT03761004|Dopamine Agents|dopamine agents|mesh-ancestor
93120952|NCT03761004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120953|NCT03761004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120954|NCT03761004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120955|NCT03761004|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93120956|NCT03761004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93120957|NCT03761004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93120958|NCT03761004|Immunologic Factors|immunologic factors|mesh-ancestor
93120959|NCT03761004|Dopamine Agonists|dopamine agonists|mesh-ancestor
93120960|NCT03770208|Lidocaine|lidocaine|mesh-list
93120961|NCT03770208|Anesthetics, Local|anesthetics, local|mesh-ancestor
93120962|NCT03770208|Anesthetics|anesthetics|mesh-ancestor
93120963|NCT03770208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120964|NCT03770208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120965|NCT03770208|Sensory System Agents|sensory system agents|mesh-ancestor
93120966|NCT03770208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93120967|NCT03770208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93120968|NCT03770208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93120969|NCT03770208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93120970|NCT03770208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93120971|NCT03770208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120972|NCT03766854|Insulin|insulin|mesh-list
93120973|NCT03766854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93120974|NCT03766854|Insulin Glargine|insulin glargine|mesh-list
93120975|NCT03766854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93120976|NCT03766854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120977|NCT01322100|Bleomycin|bleomycin|mesh-list
93120978|NCT01322100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93120979|NCT01322100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93120980|NCT03760848|Midazolam|midazolam|mesh-list
93120981|NCT03760848|Atorvastatin|atorvastatin|mesh-list
93120982|NCT03760848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93120983|NCT03760848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93120984|NCT03760848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93120985|NCT03760848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93120986|NCT03760848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93120987|NCT03760848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93120988|NCT03760848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93120989|NCT03760848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93120990|NCT03760848|Anesthetics, General|anesthetics, general|mesh-ancestor
93120991|NCT03760848|Anesthetics|anesthetics|mesh-ancestor
93120992|NCT03760848|GABA Modulators|gaba modulators|mesh-ancestor
93120993|NCT03760848|GABA Agents|gaba agents|mesh-ancestor
93120994|NCT03760848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93120995|NCT03760848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93120996|NCT03760848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93120997|NCT03760848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93120998|NCT03760848|Antimetabolites|antimetabolites|mesh-ancestor
93120999|NCT03760848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93121000|NCT03760848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93121001|NCT03760848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121002|NCT01567488|Everolimus|everolimus|mesh-list
93121003|NCT01567488|Octreotide|octreotide|mesh-list
93121004|NCT01567488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93121005|NCT01567488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93121006|NCT01567488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121007|NCT01567488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121008|NCT01567488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121009|NCT01567488|Immunologic Factors|immunologic factors|mesh-ancestor
93121010|NCT01567488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121011|NCT01567488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121012|NCT01567488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121013|NCT01567488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93121014|NCT03760770|Riboflavin|riboflavin|mesh-list
93121015|NCT03760770|Vitamin B Complex|vitamin b complex|mesh-ancestor
93121016|NCT03760770|Vitamins|vitamins|mesh-ancestor
93121017|NCT03760770|Micronutrients|micronutrients|mesh-ancestor
93061183|NCT01284868|Sympatholytics|sympatholytics|mesh-ancestor
93121018|NCT03760770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121019|NCT03760770|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93121020|NCT03760770|Dermatologic Agents|dermatologic agents|mesh-ancestor
93121021|NCT01561794|Ciprofloxacin|ciprofloxacin|mesh-list
93121022|NCT01561794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121023|NCT01561794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121024|NCT01561794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93121025|NCT01561794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93121026|NCT01561794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121027|NCT01561794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121028|NCT01561794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121029|NCT01561794|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93121030|NCT01561794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121031|NCT01322178|Cetuximab|cetuximab|mesh-list
93121032|NCT01322178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121033|NCT01322178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121034|NCT03760614|Entinostat|entinostat|mesh-list
93121035|NCT03760614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121036|NCT03760614|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93121037|NCT03760614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121038|NCT03760614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121039|NCT00112840|Bevacizumab|bevacizumab|mesh-list
93121040|NCT00112840|Temsirolimus|temsirolimus|mesh-list
93121041|NCT00112840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121042|NCT00112840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121043|NCT00112840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93121044|NCT00112840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93121045|NCT00112840|Growth Substances|growth substances|mesh-ancestor
93121046|NCT00112840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121047|NCT00112840|Growth Inhibitors|growth inhibitors|mesh-ancestor
93121048|NCT00112840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121049|NCT00112840|Immunologic Factors|immunologic factors|mesh-ancestor
93121051|NCT00112840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93121052|NCT00112840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121053|NCT00112840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121054|NCT03769818|Dexamethasone|dexamethasone|mesh-list
93121055|NCT03769818|Dexamethasone acetate|dexamethasone acetate|mesh-list
93121056|NCT03769818|Bupivacaine|bupivacaine|mesh-list
93121057|NCT03769818|BB 1101|bb 1101|mesh-list
93121058|NCT03769818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121059|NCT03769818|Antiemetics|antiemetics|mesh-ancestor
93121060|NCT03769818|Autonomic Agents|autonomic agents|mesh-ancestor
93121061|NCT03769818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121062|NCT03769818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121063|NCT03769818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121064|NCT03769818|Glucocorticoids|glucocorticoids|mesh-ancestor
93121065|NCT03769818|Hormones|hormones|mesh-ancestor
93121066|NCT03769818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121067|NCT03769818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93121068|NCT03769818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121069|NCT03769818|Protease Inhibitors|protease inhibitors|mesh-ancestor
93121070|NCT03769818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121071|NCT03769818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121072|NCT03769818|Anesthetics, Local|anesthetics, local|mesh-ancestor
93121073|NCT03769818|Anesthetics|anesthetics|mesh-ancestor
93121074|NCT03769818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121075|NCT03769818|Sensory System Agents|sensory system agents|mesh-ancestor
93121076|NCT05223244|Triamcinolone|triamcinolone|mesh-list
93121077|NCT05223244|Heparin|heparin|mesh-list
93121078|NCT05223244|Bupivacaine|bupivacaine|mesh-list
93121079|NCT05223244|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93121080|NCT05223244|Anesthetics, Local|anesthetics, local|mesh-ancestor
93121081|NCT05223244|Anesthetics|anesthetics|mesh-ancestor
93121082|NCT05223244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121083|NCT05223244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121084|NCT05223244|Sensory System Agents|sensory system agents|mesh-ancestor
93121085|NCT05223244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121086|NCT05223244|Anticoagulants|anticoagulants|mesh-ancestor
93121087|NCT05223244|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93121088|NCT05223244|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93121089|NCT05223244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121090|NCT05223244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121091|NCT05223244|Glucocorticoids|glucocorticoids|mesh-ancestor
93121092|NCT05223244|Hormones|hormones|mesh-ancestor
93121093|NCT05223244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121094|NCT05223244|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93121095|NCT05223244|Protective Agents|protective agents|mesh-ancestor
93121096|NCT05223244|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93121097|NCT05223244|Antioxidants|antioxidants|mesh-ancestor
93121098|NCT05223010|Sevoflurane|sevoflurane|mesh-list
93121099|NCT05223010|Melatonin|melatonin|mesh-list
93121100|NCT05223010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93121101|NCT05223010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93121102|NCT05223010|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93121103|NCT05223010|Anesthetics, General|anesthetics, general|mesh-ancestor
93121104|NCT05223010|Anesthetics|anesthetics|mesh-ancestor
93121105|NCT05223010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121106|NCT05223010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121107|NCT05223010|Antioxidants|antioxidants|mesh-ancestor
93121108|NCT05223010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121109|NCT05223010|Protective Agents|protective agents|mesh-ancestor
93121110|NCT03760302|Analgesics|analgesics|mesh-list
93121111|NCT03760302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93121112|NCT03760302|Sensory System Agents|sensory system agents|mesh-ancestor
93121113|NCT03760302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121114|NCT03760302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121115|NCT03760302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121116|NCT03766074|Vitamin D|vitamin d|mesh-list
93121117|NCT03766074|Vitamins|vitamins|mesh-ancestor
93121118|NCT03766074|Micronutrients|micronutrients|mesh-ancestor
93121119|NCT03766074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121120|NCT03766074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93121122|NCT05219656|Cyclosporins|cyclosporins|mesh-list
93121123|NCT05219656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121124|NCT05219656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121125|NCT05219656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121126|NCT05219656|Immunologic Factors|immunologic factors|mesh-ancestor
93121127|NCT05219656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121128|NCT05219656|Antifungal Agents|antifungal agents|mesh-ancestor
93121129|NCT05219656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121130|NCT05219656|Dermatologic Agents|dermatologic agents|mesh-ancestor
93121131|NCT05219656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121132|NCT05219656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93121133|NCT05168644|Niclosamide|niclosamide|mesh-list
93121134|NCT05168644|Anticestodal Agents|anticestodal agents|mesh-ancestor
93121135|NCT05168644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93121136|NCT05168644|Anthelmintics|anthelmintics|mesh-ancestor
93121137|NCT05168644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121138|NCT05168644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121139|NCT05168644|Antinematodal Agents|antinematodal agents|mesh-ancestor
93121140|NCT05412888|Coenzyme Q10|coenzyme q10|mesh-list
93121141|NCT05412888|Ubiquinone|ubiquinone|mesh-list
93121142|NCT05412888|Vitamins|vitamins|mesh-ancestor
93121143|NCT05412888|Micronutrients|micronutrients|mesh-ancestor
93121144|NCT05412888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121145|NCT05558410|Acetaminophen|acetaminophen|mesh-list
93121146|NCT05558410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121147|NCT05558410|Analgesics|analgesics|mesh-ancestor
93121148|NCT05558410|Sensory System Agents|sensory system agents|mesh-ancestor
93121149|NCT05558410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121150|NCT05558410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121151|NCT05558410|Antipyretics|antipyretics|mesh-ancestor
93121152|NCT05087212|Plerixafor|plerixafor|mesh-list
93121153|NCT05087212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93121154|NCT05087212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93121155|NCT05087212|Antiviral Agents|antiviral agents|mesh-ancestor
93121156|NCT05087212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121157|NCT01532310|Belimumab|belimumab|mesh-list
93121158|NCT01532310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121159|NCT01532310|Immunologic Factors|immunologic factors|mesh-ancestor
93121160|NCT01532310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121161|NCT01321788|Tinzaparin|tinzaparin|mesh-list
93121162|NCT01321788|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93121163|NCT01321788|Dalteparin|dalteparin|mesh-list
93121164|NCT01321788|Anticoagulants|anticoagulants|mesh-ancestor
93121165|NCT01321788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93121166|NCT01321788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93121167|NCT01321788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121168|NCT05053828|Clopidogrel|clopidogrel|mesh-list
93121169|NCT05053828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93121170|NCT05053828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93121171|NCT05053828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93121172|NCT05053828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93121173|NCT05053828|Purinergic Agents|purinergic agents|mesh-ancestor
93121174|NCT05053828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121175|NCT05053828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121176|NCT05053828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121177|NCT03120780|Fentanyl|fentanyl|mesh-list
93121178|NCT03120780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93121179|NCT03120780|Narcotics|narcotics|mesh-ancestor
93121180|NCT03120780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121181|NCT03120780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121182|NCT03120780|Analgesics|analgesics|mesh-ancestor
93121183|NCT03120780|Sensory System Agents|sensory system agents|mesh-ancestor
93121184|NCT03120780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121185|NCT03120780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93121186|NCT03120780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93121187|NCT03120780|Anesthetics, General|anesthetics, general|mesh-ancestor
93121188|NCT03120780|Anesthetics|anesthetics|mesh-ancestor
93121189|NCT04920838|Acetaminophen|acetaminophen|mesh-list
93121190|NCT04920838|Ciclesonide|ciclesonide|mesh-list
93121191|NCT04920838|Nitazoxanide|nitazoxanide|mesh-list
93121192|NCT04920838|Budesonide|budesonide|mesh-list
93121193|NCT04920838|Telmisartan|telmisartan|mesh-list
93121194|NCT04920838|Fluoxetine|fluoxetine|mesh-list
93121195|NCT04920838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121196|NCT04920838|Analgesics|analgesics|mesh-ancestor
93121197|NCT04920838|Sensory System Agents|sensory system agents|mesh-ancestor
93121198|NCT04920838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121199|NCT04920838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121200|NCT04920838|Antipyretics|antipyretics|mesh-ancestor
93121201|NCT04920838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121202|NCT04920838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93121203|NCT04920838|Autonomic Agents|autonomic agents|mesh-ancestor
93121204|NCT04920838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93121205|NCT04920838|Respiratory System Agents|respiratory system agents|mesh-ancestor
93121206|NCT04920838|Glucocorticoids|glucocorticoids|mesh-ancestor
93121207|NCT04920838|Hormones|hormones|mesh-ancestor
93121208|NCT04920838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121209|NCT04920838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93121210|NCT04920838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93121211|NCT04920838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93121212|NCT04920838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121213|NCT04920838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93121214|NCT04920838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93121215|NCT04920838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121216|NCT04920838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121217|NCT04920838|Serotonin Agents|serotonin agents|mesh-ancestor
93121218|NCT04920838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93121219|NCT04920838|Antidepressive Agents|antidepressive agents|mesh-ancestor
93121220|NCT04920838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93121221|NCT04920838|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93121222|NCT04920838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121223|NCT04920838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121224|NCT04920838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121225|NCT04920838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121226|NCT04920838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93121227|NCT03764280|Insulin|insulin|mesh-list
93121228|NCT03764280|Insulin, Short-Acting|insulin, short-acting|mesh-list
93121229|NCT03764280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93121230|NCT03764280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121231|NCT05133804|Methylphenidate|methylphenidate|mesh-list
93121232|NCT05133804|Reboxetine|reboxetine|mesh-list
93121233|NCT05133804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93121234|NCT05133804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121235|NCT05133804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93121236|NCT05133804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93121237|NCT05133804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121238|NCT05133804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121239|NCT05133804|Dopamine Agents|dopamine agents|mesh-ancestor
93121240|NCT05133804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121241|NCT05133804|Antidepressive Agents|antidepressive agents|mesh-ancestor
93121242|NCT05133804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93121243|NCT05133804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93121244|NCT05133804|Adrenergic Agents|adrenergic agents|mesh-ancestor
93121245|NCT03764202|Sufentanil|sufentanil|mesh-list
93121246|NCT03764202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93121247|NCT03764202|Narcotics|narcotics|mesh-ancestor
93121248|NCT03764202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121249|NCT03764202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121250|NCT03764202|Analgesics|analgesics|mesh-ancestor
93121251|NCT03764202|Sensory System Agents|sensory system agents|mesh-ancestor
93121252|NCT03764202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121253|NCT03764202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93121254|NCT03764202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93121255|NCT03764202|Anesthetics, General|anesthetics, general|mesh-ancestor
93121256|NCT03764202|Anesthetics|anesthetics|mesh-ancestor
93121257|NCT05115630|Mycophenolic Acid|mycophenolic acid|mesh-list
93121258|NCT05115630|Cyclophosphamide|cyclophosphamide|mesh-list
93121259|NCT05115630|Melphalan|melphalan|mesh-list
93121260|NCT05115630|Fludarabine|fludarabine|mesh-list
93121261|NCT05115630|Fludarabine phosphate|fludarabine phosphate|mesh-list
93121262|NCT05115630|Tacrolimus|tacrolimus|mesh-list
93121263|NCT05115630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121264|NCT05115630|Immunologic Factors|immunologic factors|mesh-ancestor
93121265|NCT05115630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121266|NCT05115630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121267|NCT05115630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93121268|NCT05115630|Alkylating Agents|alkylating agents|mesh-ancestor
93121269|NCT05115630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121270|NCT05115630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121271|NCT05115630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93121272|NCT05115630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93121273|NCT05115630|Antimetabolites|antimetabolites|mesh-ancestor
93121274|NCT05115630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93121275|NCT05115630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121276|NCT05115630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93121277|NCT05115630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93121278|NCT05115630|Antitubercular Agents|antitubercular agents|mesh-ancestor
93121279|NCT05115630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121280|NCT05115630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121281|NCT04678492|Amoxicillin|amoxicillin|mesh-list
93121282|NCT04678492|Tetracycline|tetracycline|mesh-list
93121283|NCT04678492|Furazolidone|furazolidone|mesh-list
93121284|NCT04678492|Esomeprazole|esomeprazole|mesh-list
93121286|NCT04678492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121287|NCT04678492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121288|NCT04678492|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93121289|NCT04678492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121290|NCT04678492|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93121291|NCT04678492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121292|NCT04678492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121293|NCT04678492|Antacids|antacids|mesh-ancestor
93121294|NCT04678492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93121295|NCT04678492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93121296|NCT04678492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93121297|NCT04678492|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93121298|NCT04678492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121299|NCT04678492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121300|NCT04678492|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93121301|NCT03176784|Nicotine|nicotine|mesh-list
93121302|NCT03176784|Varenicline|varenicline|mesh-list
93121303|NCT03176784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93121304|NCT03176784|Autonomic Agents|autonomic agents|mesh-ancestor
93121305|NCT03176784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121306|NCT03176784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121307|NCT03176784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93121308|NCT03176784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93121309|NCT03176784|Cholinergic Agents|cholinergic agents|mesh-ancestor
93121310|NCT03176784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121311|NCT03176784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121312|NCT05091528|Capecitabine|capecitabine|mesh-list
93121313|NCT05091528|Trastuzumab|trastuzumab|mesh-list
93121314|NCT05091528|Tucatinib|tucatinib|mesh-list
93121315|NCT05091528|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93121316|NCT05091528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93121317|NCT05091528|Antimetabolites|antimetabolites|mesh-ancestor
93121318|NCT05091528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121319|NCT05091528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121320|NCT05091528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121321|NCT05091528|Immunoconjugates|immunoconjugates|mesh-ancestor
93121322|NCT05091528|Immunologic Factors|immunologic factors|mesh-ancestor
93121323|NCT05091528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121324|NCT05091528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93121325|NCT05091528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121326|NCT04236258|Enalapril|enalapril|mesh-list
93121327|NCT04236258|Nifedipine|nifedipine|mesh-list
93121328|NCT04236258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93121329|NCT04236258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121330|NCT04236258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121331|NCT04236258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93121332|NCT04236258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121333|NCT04236258|Vasodilator Agents|vasodilator agents|mesh-ancestor
93121334|NCT04236258|Tocolytic Agents|tocolytic agents|mesh-ancestor
93121335|NCT04236258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93121336|NCT04236258|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93121337|NCT04236258|Protease Inhibitors|protease inhibitors|mesh-ancestor
93121338|NCT04236258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121339|NCT04236258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93121340|NCT01317004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93121341|NCT01317004|Interferon beta-1b|interferon beta-1b|mesh-list
93121342|NCT01317004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93121343|NCT01317004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121344|NCT01317004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121345|NCT01317004|Immunologic Factors|immunologic factors|mesh-ancestor
93121346|NCT01317004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121347|NCT01317004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93121348|NCT03049618|Pembrolizumab|pembrolizumab|mesh-list
93121349|NCT03049618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121350|NCT03049618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121351|NCT03049618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93121352|NCT03049618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121353|NCT05536102|Doxorubicin|doxorubicin|mesh-list
93121354|NCT05536102|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93121355|NCT05536102|Capecitabine|capecitabine|mesh-list
93121356|NCT05536102|Oxaliplatin|oxaliplatin|mesh-list
93121357|NCT05536102|Tislelizumab|tislelizumab|mesh-list
93121358|NCT05536102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93121359|NCT05536102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121360|NCT05536102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93121361|NCT05536102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93121362|NCT05536102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121363|NCT05536102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121364|NCT05536102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93121365|NCT05536102|Antimetabolites|antimetabolites|mesh-ancestor
93121366|NCT05536102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121367|NCT04493164|Cytarabine|cytarabine|mesh-list
93121368|NCT04493164|Daunorubicin|daunorubicin|mesh-list
93121369|NCT04493164|Ivosidenib|ivosidenib|mesh-list
93121370|NCT04493164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93121371|NCT04493164|Antimetabolites|antimetabolites|mesh-ancestor
93121372|NCT04493164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121373|NCT04493164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121374|NCT04493164|Antiviral Agents|antiviral agents|mesh-ancestor
93121375|NCT04493164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121376|NCT04493164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121377|NCT04493164|Immunologic Factors|immunologic factors|mesh-ancestor
93121378|NCT04493164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121379|NCT04493164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93121380|NCT04493164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93121381|NCT04493164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93121382|NCT04493164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121383|NCT05524714|Xanthohumol|xanthohumol|mesh-list
93121384|NCT05524714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121385|NCT05524714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93121386|NCT05524714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93121387|NCT05524714|Growth Substances|growth substances|mesh-ancestor
93121388|NCT05524714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121389|NCT05524714|Growth Inhibitors|growth inhibitors|mesh-ancestor
93121390|NCT05692804|Protein S|protein s|mesh-list
93121391|NCT05692804|Anticoagulants|anticoagulants|mesh-ancestor
93121392|NCT01316380|Tiotropium Bromide|tiotropium bromide|mesh-list
93121393|NCT01316380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93121394|NCT01316380|Autonomic Agents|autonomic agents|mesh-ancestor
93121395|NCT01316380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121396|NCT01316380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121397|NCT01316380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93121398|NCT01316380|Respiratory System Agents|respiratory system agents|mesh-ancestor
93121399|NCT01316380|Parasympatholytics|parasympatholytics|mesh-ancestor
93121400|NCT01316380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93121401|NCT01316380|Cholinergic Agents|cholinergic agents|mesh-ancestor
93121402|NCT01316380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121403|NCT01316380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121404|NCT05692570|Ritonavir|ritonavir|mesh-list
93121405|NCT05692570|Cobicistat|cobicistat|mesh-list
93121406|NCT05692570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93121407|NCT05692570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93121408|NCT05692570|Protease Inhibitors|protease inhibitors|mesh-ancestor
93121409|NCT05692570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121410|NCT05692570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121411|NCT05692570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93121412|NCT05692570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93121413|NCT05692570|Antiviral Agents|antiviral agents|mesh-ancestor
93121414|NCT05692570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121415|NCT05692570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93121416|NCT05692570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121417|NCT05691556|Botulinum Toxins|botulinum toxins|mesh-list
93121418|NCT05691556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93121419|NCT05691556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121420|NCT05691556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121421|NCT05691556|Cholinergic Agents|cholinergic agents|mesh-ancestor
93121423|NCT05691556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121424|NCT05689450|Amikacin|amikacin|mesh-list
93121425|NCT05689450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121426|NCT05689450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121427|NCT05417308|Minoxidil|minoxidil|mesh-list
93121428|NCT05417308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93121429|NCT05417308|Vasodilator Agents|vasodilator agents|mesh-ancestor
93121430|NCT04650542|Paroxetine|paroxetine|mesh-list
93121431|NCT04650542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93121432|NCT04650542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93121433|NCT04650542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121434|NCT04650542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121435|NCT04650542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121436|NCT04650542|Serotonin Agents|serotonin agents|mesh-ancestor
93121437|NCT04650542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121438|NCT04650542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93121439|NCT04650542|Antidepressive Agents|antidepressive agents|mesh-ancestor
93121440|NCT04650542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93121441|NCT04650542|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93121442|NCT04650542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121443|NCT04650542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121444|NCT04621058|Vitamin D|vitamin d|mesh-list
93121445|NCT04621058|Vitamins|vitamins|mesh-list
93121446|NCT04621058|Micronutrients|micronutrients|mesh-ancestor
93121447|NCT04621058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121448|NCT04621058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93121449|NCT04308668|Hydroxychloroquine|hydroxychloroquine|mesh-list
93121450|NCT04308668|Antimalarials|antimalarials|mesh-ancestor
93121451|NCT04308668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121452|NCT04308668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121453|NCT04308668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121454|NCT04308668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121455|NCT04308668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121456|NCT04308668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121457|NCT04451330|Doxycycline|doxycycline|mesh-list
93121458|NCT04451330|Trifarotene|trifarotene|mesh-list
93121459|NCT04451330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121460|NCT04451330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121461|NCT04451330|Antimalarials|antimalarials|mesh-ancestor
93121462|NCT04451330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121463|NCT04451330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121464|NCT04451330|Dermatologic Agents|dermatologic agents|mesh-ancestor
93121465|NCT02493426|Oxytocin|oxytocin|mesh-list
93121466|NCT02493426|Oxytocics|oxytocics|mesh-ancestor
93121467|NCT02493426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93121468|NCT02493426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121469|NCT03763734|Dexamethasone|dexamethasone|mesh-list
93121470|NCT03763734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121471|NCT03763734|Antiemetics|antiemetics|mesh-ancestor
93121472|NCT03763734|Autonomic Agents|autonomic agents|mesh-ancestor
93121473|NCT03763734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121474|NCT03763734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121475|NCT03763734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121476|NCT03763734|Glucocorticoids|glucocorticoids|mesh-ancestor
93121477|NCT03763734|Hormones|hormones|mesh-ancestor
93121478|NCT03763734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121479|NCT03763734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93121480|NCT03763734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121481|NCT05063136|Capecitabine|capecitabine|mesh-list
93121482|NCT05063136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93121483|NCT05063136|Antimetabolites|antimetabolites|mesh-ancestor
93121484|NCT05063136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121485|NCT05063136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121486|NCT03756324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93121487|NCT03756324|Cefdinir|cefdinir|mesh-list
93121488|NCT03756324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93121489|NCT03756324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121490|NCT03756324|Antitubercular Agents|antitubercular agents|mesh-ancestor
93121491|NCT03751202|Fluticasone|fluticasone|mesh-list
93121492|NCT03751202|Xhance|xhance|mesh-list
93121493|NCT03751202|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93121494|NCT03751202|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93121495|NCT03751202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121496|NCT03751202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93121497|NCT03751202|Autonomic Agents|autonomic agents|mesh-ancestor
93121498|NCT03751202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121499|NCT03751202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121500|NCT03751202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93121501|NCT03751202|Respiratory System Agents|respiratory system agents|mesh-ancestor
93121502|NCT03751202|Dermatologic Agents|dermatologic agents|mesh-ancestor
93121503|NCT03751202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93121504|NCT03751202|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93121505|NCT03751202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93121506|NCT03751202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93121507|NCT03751202|Adrenergic Agents|adrenergic agents|mesh-ancestor
93121508|NCT03751202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121509|NCT03751202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121510|NCT03751202|Glucocorticoids|glucocorticoids|mesh-ancestor
93121512|NCT03751202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121513|NCT03751202|Sympathomimetics|sympathomimetics|mesh-ancestor
93121514|NCT03749408|Mannitol|mannitol|mesh-list
93121515|NCT03749408|Bupivacaine|bupivacaine|mesh-list
93121516|NCT03749408|Anesthetics, Local|anesthetics, local|mesh-ancestor
93121517|NCT03749408|Anesthetics|anesthetics|mesh-ancestor
93121518|NCT03749408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121519|NCT03749408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121520|NCT03749408|Sensory System Agents|sensory system agents|mesh-ancestor
93121521|NCT03749408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121522|NCT03749408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93121523|NCT03749408|Diuretics|diuretics|mesh-ancestor
93121524|NCT03749408|Natriuretic Agents|natriuretic agents|mesh-ancestor
93121525|NCT04387136|Sufentanil|sufentanil|mesh-list
93121526|NCT04387136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93121527|NCT04387136|Narcotics|narcotics|mesh-ancestor
93121528|NCT04387136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121529|NCT04387136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121530|NCT04387136|Analgesics|analgesics|mesh-ancestor
93121531|NCT04387136|Sensory System Agents|sensory system agents|mesh-ancestor
93121532|NCT04387136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121533|NCT04387136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93121534|NCT04387136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93121535|NCT04387136|Anesthetics, General|anesthetics, general|mesh-ancestor
93121536|NCT04387136|Anesthetics|anesthetics|mesh-ancestor
93121537|NCT04252586|Cannabidiol|cannabidiol|mesh-list
93121538|NCT04252586|Anticonvulsants|anticonvulsants|mesh-ancestor
93121539|NCT04507776|Etanercept|etanercept|mesh-list
93121540|NCT04507776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93121541|NCT04507776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121542|NCT04507776|Analgesics|analgesics|mesh-ancestor
93121543|NCT04507776|Sensory System Agents|sensory system agents|mesh-ancestor
93121544|NCT04507776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121545|NCT04507776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121546|NCT04507776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121547|NCT04507776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121548|NCT04507776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121549|NCT04507776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121550|NCT04507776|Immunologic Factors|immunologic factors|mesh-ancestor
93121551|NCT04504032|Rivaroxaban|rivaroxaban|mesh-list
93121552|NCT04504032|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93121553|NCT04504032|Antithrombins|antithrombins|mesh-ancestor
93121554|NCT04504032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93121555|NCT04504032|Protease Inhibitors|protease inhibitors|mesh-ancestor
93121556|NCT04504032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121557|NCT04504032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121558|NCT04504032|Anticoagulants|anticoagulants|mesh-ancestor
93121559|NCT03756246|Vaccines|vaccines|mesh-list
93121560|NCT03756246|Immunologic Factors|immunologic factors|mesh-ancestor
93121561|NCT03756246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121562|NCT05460858|Acetylcysteine|acetylcysteine|mesh-list
93121563|NCT05460858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93121564|NCT05460858|Antiviral Agents|antiviral agents|mesh-ancestor
93121565|NCT05460858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121566|NCT05460858|Expectorants|expectorants|mesh-ancestor
93121567|NCT05460858|Respiratory System Agents|respiratory system agents|mesh-ancestor
93121568|NCT05460858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93121569|NCT05460858|Antioxidants|antioxidants|mesh-ancestor
93121570|NCT05460858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121571|NCT05460858|Protective Agents|protective agents|mesh-ancestor
93121572|NCT05460858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121573|NCT05460858|Antidotes|antidotes|mesh-ancestor
93121574|NCT05359224|Clopidogrel|clopidogrel|mesh-list
93121576|NCT05359224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93121577|NCT05359224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93121578|NCT05359224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93121579|NCT05359224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93121580|NCT05359224|Purinergic Agents|purinergic agents|mesh-ancestor
93121581|NCT05359224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121582|NCT05359224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121583|NCT05359224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121584|NCT03758118|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93121585|NCT03758118|Nootropic Agents|nootropic agents|mesh-ancestor
93121586|NCT03756090|Paclitaxel|paclitaxel|mesh-list
93121587|NCT03756090|Cyclophosphamide|cyclophosphamide|mesh-list
93121588|NCT03756090|Epirubicin|epirubicin|mesh-list
93121589|NCT03756090|Palbociclib|palbociclib|mesh-list
93121590|NCT03756090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93121591|NCT03756090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121592|NCT03756090|Tubulin Modulators|tubulin modulators|mesh-ancestor
93121593|NCT03756090|Antimitotic Agents|antimitotic agents|mesh-ancestor
93121594|NCT03756090|Mitosis Modulators|mitosis modulators|mesh-ancestor
93121595|NCT03756090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121596|NCT03756090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121597|NCT03756090|Immunologic Factors|immunologic factors|mesh-ancestor
93121598|NCT03756090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121599|NCT03756090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121600|NCT03756090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93121601|NCT03756090|Alkylating Agents|alkylating agents|mesh-ancestor
93121602|NCT03756090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93121603|NCT03756090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93121604|NCT03756090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93121605|NCT03756090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93121606|NCT03756090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121607|NCT03756090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93121608|NCT04605588|Ribavirin|ribavirin|mesh-list
93121609|NCT04605588|Hydroxychloroquine|hydroxychloroquine|mesh-list
93121610|NCT04605588|Nitazoxanide|nitazoxanide|mesh-list
93121611|NCT04605588|Antimetabolites|antimetabolites|mesh-ancestor
93121612|NCT04605588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121613|NCT04605588|Antiviral Agents|antiviral agents|mesh-ancestor
93121614|NCT04605588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121615|NCT04605588|Antimalarials|antimalarials|mesh-ancestor
93121616|NCT04605588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121617|NCT04605588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121618|NCT04605588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121619|NCT04605588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121620|NCT03752736|Sunscreening Agents|sunscreening agents|mesh-list
93121621|NCT03752736|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93121622|NCT03752736|Protective Agents|protective agents|mesh-ancestor
93121623|NCT03752736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121624|NCT03752736|Dermatologic Agents|dermatologic agents|mesh-ancestor
93121625|NCT03752658|Tenofovir|tenofovir|mesh-list
93121626|NCT03752658|Antiviral Agents|antiviral agents|mesh-ancestor
93121627|NCT03752658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121628|NCT03752658|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93121629|NCT03752658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93121630|NCT03752658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121631|NCT03752658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121632|NCT03752658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93121633|NCT03752658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93121634|NCT03752424|Anti-Infective Agents|anti-infective agents|mesh-list
93121635|NCT03752424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93121636|NCT03755778|Itraconazole|itraconazole|mesh-list
93121637|NCT03755778|Rifampin|rifampin|mesh-list
93121638|NCT03755778|Quinidine|quinidine|mesh-list
93121639|NCT03755778|Antifungal Agents|antifungal agents|mesh-ancestor
93121640|NCT03755778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121641|NCT03755778|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93121642|NCT03755778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121643|NCT03755778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121644|NCT03755778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121645|NCT03755778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93121646|NCT03755778|Hormone Antagonists|hormone antagonists|mesh-ancestor
93121647|NCT03755778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121648|NCT03755778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121649|NCT03755778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93121650|NCT03755778|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93121651|NCT03755778|Antitubercular Agents|antitubercular agents|mesh-ancestor
93121652|NCT03755778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121653|NCT03755778|Leprostatic Agents|leprostatic agents|mesh-ancestor
93121654|NCT03755778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93121655|NCT03755778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93121656|NCT03755778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93121657|NCT03755778|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93121658|NCT03755778|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93121659|NCT03755778|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93121660|NCT03755778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93121661|NCT03755778|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93121662|NCT03755778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93121663|NCT03755778|Adrenergic Agents|adrenergic agents|mesh-ancestor
93121664|NCT03755778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121665|NCT03755778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93121666|NCT03755778|Antimalarials|antimalarials|mesh-ancestor
93121667|NCT03755778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121668|NCT03755778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121669|NCT03755778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93121670|NCT03755778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93121671|NCT03755778|Cholinergic Agents|cholinergic agents|mesh-ancestor
93121672|NCT03755778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93121673|NCT03755778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93121674|NCT03755778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121675|NCT03755778|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93121676|NCT03779074|Amoxicillin|amoxicillin|mesh-list
93121677|NCT03779074|Metronidazole|metronidazole|mesh-list
93121678|NCT03779074|Clarithromycin|clarithromycin|mesh-list
93121679|NCT03779074|Tetracycline|tetracycline|mesh-list
93121680|NCT03779074|Rabeprazole|rabeprazole|mesh-list
93121681|NCT03779074|Bismuth|bismuth|mesh-list
93121682|NCT03779074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121683|NCT03779074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121684|NCT03779074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121685|NCT03779074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121686|NCT03779074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93121687|NCT03779074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121688|NCT03779074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121689|NCT03779074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93121690|NCT03779074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121691|NCT03779074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93121692|NCT03779074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121693|NCT03779074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93121694|NCT03779074|Antacids|antacids|mesh-ancestor
93121695|NCT03755700|Vitamin E|vitamin e|mesh-list
93121696|NCT03755700|Acetylcysteine|acetylcysteine|mesh-list
93121697|NCT03755700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93121698|NCT03755700|Vitamins|vitamins|mesh-ancestor
93121699|NCT03755700|Micronutrients|micronutrients|mesh-ancestor
93121700|NCT03755700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121701|NCT03755700|Antioxidants|antioxidants|mesh-ancestor
91930379|NCT02288923|Emetics|emetics|mesh-list
93121702|NCT03755700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121703|NCT03755700|Protective Agents|protective agents|mesh-ancestor
93121704|NCT03755700|Antiviral Agents|antiviral agents|mesh-ancestor
93121705|NCT03755700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121706|NCT03755700|Expectorants|expectorants|mesh-ancestor
93121707|NCT03755700|Respiratory System Agents|respiratory system agents|mesh-ancestor
93121708|NCT03755700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93121709|NCT03755700|Antidotes|antidotes|mesh-ancestor
93121710|NCT03757650|Amoxicillin|amoxicillin|mesh-list
93121711|NCT03757650|Clarithromycin|clarithromycin|mesh-list
93121712|NCT03757650|Omeprazole|omeprazole|mesh-list
93121713|NCT03757650|Bismuth|bismuth|mesh-list
93121714|NCT03757650|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
93121715|NCT03757650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121716|NCT03757650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121717|NCT03757650|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93121718|NCT03757650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121719|NCT03757650|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93121720|NCT03757650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121721|NCT03757650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121722|NCT03757650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93121723|NCT03757650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93121724|NCT03757650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121725|NCT03757650|Antacids|antacids|mesh-ancestor
93121726|NCT03757650|Antidiarrheals|antidiarrheals|mesh-ancestor
93121727|NCT04432376|Miconazole|miconazole|mesh-list
93121728|NCT04432376|Antifungal Agents|antifungal agents|mesh-ancestor
93121729|NCT04432376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121730|NCT04432376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93121731|NCT04432376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93121732|NCT04432376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121733|NCT04432376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121734|NCT04432376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93121735|NCT04432376|Hormone Antagonists|hormone antagonists|mesh-ancestor
93121736|NCT04432376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121737|NCT04432376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121738|NCT04432376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93121739|NCT04432376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93121740|NCT05180968|Dronabinol|dronabinol|mesh-list
93121741|NCT05180968|Nabilone|nabilone|mesh-list
93121742|NCT05180968|Antiemetics|antiemetics|mesh-ancestor
93121743|NCT05180968|Autonomic Agents|autonomic agents|mesh-ancestor
93121744|NCT05180968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121745|NCT05180968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121746|NCT05180968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93121747|NCT05180968|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93121748|NCT05180968|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93121749|NCT05180968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121750|NCT05180968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93121751|NCT05180968|Hallucinogens|hallucinogens|mesh-ancestor
93121752|NCT05180968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121753|NCT05180968|Analgesics|analgesics|mesh-ancestor
93121754|NCT05180968|Sensory System Agents|sensory system agents|mesh-ancestor
93121755|NCT05180968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93121756|NCT05180968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93121757|NCT05180968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121758|NCT05180968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121759|NCT05180968|Hormones|hormones|mesh-ancestor
93121760|NCT05180968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121761|NCT03693404|Ketorolac|ketorolac|mesh-list
93121762|NCT03693404|Morphine|morphine|mesh-list
93121763|NCT03693404|Bupivacaine|bupivacaine|mesh-list
93121764|NCT03693404|Anesthetics|anesthetics|mesh-list
93121765|NCT03693404|Anesthetics, General|anesthetics, general|mesh-list
93121766|NCT03693404|Anesthetics, Local|anesthetics, local|mesh-ancestor
93121767|NCT03693404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121768|NCT03693404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121769|NCT03693404|Sensory System Agents|sensory system agents|mesh-ancestor
93121770|NCT03693404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121771|NCT03693404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93121772|NCT03693404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121773|NCT03693404|Analgesics|analgesics|mesh-ancestor
93121774|NCT03693404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121775|NCT03693404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121776|NCT03693404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93121777|NCT03693404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121778|NCT03693404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121779|NCT03693404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93121780|NCT03693404|Narcotics|narcotics|mesh-ancestor
93121781|NCT04219358|Imiquimod|imiquimod|mesh-list
93121782|NCT04219358|Sunscreening Agents|sunscreening agents|mesh-list
93121783|NCT04219358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93121784|NCT04219358|Immunologic Factors|immunologic factors|mesh-ancestor
93121785|NCT04219358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121786|NCT04219358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121787|NCT04219358|Interferon Inducers|interferon inducers|mesh-ancestor
93121788|NCT04219358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93121789|NCT04219358|Protective Agents|protective agents|mesh-ancestor
93121790|NCT04219358|Dermatologic Agents|dermatologic agents|mesh-ancestor
93121791|NCT04218110|Ethanol|ethanol|mesh-list
93121792|NCT04218110|Chlorhexidine|chlorhexidine|mesh-list
93121793|NCT04218110|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93121794|NCT04218110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93121795|NCT04218110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121796|NCT04218110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121797|NCT04218110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121798|NCT04218110|Disinfectants|disinfectants|mesh-ancestor
93121799|NCT04218110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92793991|NCT01955980|Hormones|hormones|mesh-ancestor
93121800|NCT05154994|Durvalumab|durvalumab|mesh-list
93121801|NCT05154994|Ipilimumab|ipilimumab|mesh-list
93121802|NCT05154994|Tremelimumab|tremelimumab|mesh-list
93121803|NCT05154994|Belinostat|belinostat|mesh-list
93121804|NCT05154994|Immunoglobulins|immunoglobulins|mesh-list
93121805|NCT05154994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93121806|NCT05154994|Immunoglobulin G|immunoglobulin g|mesh-list
93121807|NCT05154994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121808|NCT05154994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121809|NCT05154994|Immunologic Factors|immunologic factors|mesh-ancestor
93121810|NCT05154994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121811|NCT05154994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93121812|NCT05154994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121813|NCT05154994|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93121814|NCT05154994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121815|NCT03752190|Cosyntropin|cosyntropin|mesh-list
93121816|NCT03752190|Hormones|hormones|mesh-ancestor
93121817|NCT03752190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121818|NCT03752190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121819|NCT04210310|Oxytocin|oxytocin|mesh-list
93121820|NCT04210310|Oxytocics|oxytocics|mesh-ancestor
93121821|NCT04210310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93121822|NCT04210310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121823|NCT03755466|Tofacitinib|tofacitinib|mesh-list
93121824|NCT03755466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93121825|NCT03755466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93121826|NCT03755466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121827|NCT03755466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121828|NCT03755310|Suvorexant|suvorexant|mesh-list
93121829|NCT03755310|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93121830|NCT03755310|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93121831|NCT03755310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121832|NCT03755310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121833|NCT03755310|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93121834|NCT03755310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121835|NCT03755310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121836|NCT04381988|Hydroxychloroquine|hydroxychloroquine|mesh-list
93121837|NCT04381988|Antimalarials|antimalarials|mesh-ancestor
93121838|NCT04381988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93121839|NCT04381988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93121840|NCT04381988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121841|NCT04381988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121842|NCT04381988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121843|NCT04381988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121844|NCT03668392|Asparaginase|asparaginase|mesh-list
93121845|NCT03668392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121846|NCT04176016|Edetic Acid|edetic acid|mesh-list
93121847|NCT04176016|Pentetic Acid|pentetic acid|mesh-list
93121848|NCT04176016|Antidotes|antidotes|mesh-ancestor
93121849|NCT04176016|Protective Agents|protective agents|mesh-ancestor
93121850|NCT04176016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121851|NCT04176016|Chelating Agents|chelating agents|mesh-ancestor
93121852|NCT04176016|Sequestering Agents|sequestering agents|mesh-ancestor
93121853|NCT04176016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121854|NCT04176016|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93121855|NCT04176016|Anticoagulants|anticoagulants|mesh-ancestor
93121856|NCT04176016|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93121857|NCT03695094|Lamotrigine|lamotrigine|mesh-list
93121858|NCT03695094|Oxcarbazepine|oxcarbazepine|mesh-list
93121859|NCT03695094|Levetiracetam|levetiracetam|mesh-list
93121860|NCT03695094|Brivaracetam|brivaracetam|mesh-list
93121861|NCT03695094|Padsevonil|padsevonil|mesh-list
93121862|NCT03695094|Anticonvulsants|anticonvulsants|mesh-ancestor
93121863|NCT03695094|Nootropic Agents|nootropic agents|mesh-ancestor
93121864|NCT03695094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93121865|NCT03695094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121866|NCT03695094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121867|NCT03695094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93121868|NCT03695094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121869|NCT03695094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93121870|NCT03695094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93121871|NCT03695094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121872|NCT03695094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93121873|NCT03695094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93121874|NCT03695094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93121875|NCT03695094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93121876|NCT03695094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93121877|NCT04497948|Acalabrutinib|acalabrutinib|mesh-list
93121878|NCT04497948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121879|NCT04495374|Pregabalin|pregabalin|mesh-list
93121880|NCT04495374|Analgesics|analgesics|mesh-ancestor
93121881|NCT04495374|Sensory System Agents|sensory system agents|mesh-ancestor
93121882|NCT04495374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121883|NCT04495374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121884|NCT04495374|Anticonvulsants|anticonvulsants|mesh-ancestor
93121885|NCT04495374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93121886|NCT04495374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93121887|NCT04495374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121888|NCT04495374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93121889|NCT04495374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93121890|NCT04495374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93121891|NCT04495374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93121892|NCT04495374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93121893|NCT03752112|Penicillins|penicillins|mesh-list
93121894|NCT03752112|Cefixime|cefixime|mesh-list
93121895|NCT03752112|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93121896|NCT03752112|Penicillin G|penicillin g|mesh-list
93121897|NCT03752112|Penicillin G Procaine|penicillin g procaine|mesh-list
93121898|NCT03752112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121899|NCT03752112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121900|NCT04324606|Acetaminophen|acetaminophen|mesh-list
93121901|NCT04324606|Vaccines|vaccines|mesh-list
93121902|NCT04324606|Immunologic Factors|immunologic factors|mesh-ancestor
93121903|NCT04324606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121904|NCT04324606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121905|NCT04324606|Analgesics|analgesics|mesh-ancestor
93121906|NCT04324606|Sensory System Agents|sensory system agents|mesh-ancestor
93121907|NCT04324606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121908|NCT04324606|Antipyretics|antipyretics|mesh-ancestor
93121909|NCT03757338|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93121910|NCT03757338|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93121911|NCT03757338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121912|NCT03757338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121913|NCT03757338|Immunologic Factors|immunologic factors|mesh-ancestor
93121914|NCT03757338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121915|NCT03757260|Anti-Infective Agents|anti-infective agents|mesh-list
93121916|NCT03757260|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93121917|NCT04168190|Vaccines|vaccines|mesh-list
93121918|NCT04168190|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93121919|NCT04168190|Immunologic Factors|immunologic factors|mesh-ancestor
93121920|NCT04168190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121921|NCT03939520|Pirfenidone|pirfenidone|mesh-list
93121922|NCT03939520|Nintedanib|nintedanib|mesh-list
93121923|NCT03939520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121924|NCT03939520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93121925|NCT03939520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121926|NCT03939520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121927|NCT03939520|Analgesics|analgesics|mesh-ancestor
91930765|NCT02364531|Hormone Antagonists|hormone antagonists|mesh-ancestor
93121928|NCT03939520|Sensory System Agents|sensory system agents|mesh-ancestor
93121929|NCT03939520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93121930|NCT03939520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121931|NCT03939520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93121932|NCT03939520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93121933|NCT03939520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121934|NCT03939520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121935|NCT03529942|FX006|fx006|mesh-list
93121936|NCT03529942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93121937|NCT03529942|Glucocorticoids|glucocorticoids|mesh-ancestor
93121938|NCT03529942|Hormones|hormones|mesh-ancestor
93121939|NCT03529942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93121940|NCT03529942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121941|NCT03529942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93121942|NCT03529942|Immunologic Factors|immunologic factors|mesh-ancestor
93121943|NCT03501940|Fluorides|fluorides|mesh-list
93121944|NCT03501940|Cariostatic Agents|cariostatic agents|mesh-ancestor
93121945|NCT03501940|Protective Agents|protective agents|mesh-ancestor
93121946|NCT03501940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121947|NCT03754842|Niacinamide|niacinamide|mesh-list
93121948|NCT03754842|Niacin|niacin|mesh-list
93121949|NCT03754842|Nicotinic Acids|nicotinic acids|mesh-list
93121950|NCT03754842|Vitamin B Complex|vitamin b complex|mesh-ancestor
93121951|NCT03754842|Vitamins|vitamins|mesh-ancestor
93121952|NCT03754842|Micronutrients|micronutrients|mesh-ancestor
93121953|NCT03754842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121954|NCT03754842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93121955|NCT03754842|Antimetabolites|antimetabolites|mesh-ancestor
93121956|NCT03754842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121957|NCT03754842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93121958|NCT03754842|Vasodilator Agents|vasodilator agents|mesh-ancestor
93121960|NCT01562210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121961|NCT01562210|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93121962|NCT01562210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121963|NCT01562210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121964|NCT04189952|Rituximab|rituximab|mesh-list
93121965|NCT04189952|Carboplatin|carboplatin|mesh-list
93121966|NCT04189952|Etoposide|etoposide|mesh-list
93121967|NCT04189952|Ifosfamide|ifosfamide|mesh-list
93121968|NCT04189952|Acalabrutinib|acalabrutinib|mesh-list
93121969|NCT04189952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93121970|NCT04189952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93121971|NCT04189952|Immunologic Factors|immunologic factors|mesh-ancestor
93121972|NCT04189952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121973|NCT04189952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93121974|NCT04189952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93121975|NCT04189952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93121976|NCT04189952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93121977|NCT04189952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121978|NCT04189952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121979|NCT04189952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93121980|NCT04189952|Alkylating Agents|alkylating agents|mesh-ancestor
93121981|NCT04716426|Tetracycline|tetracycline|mesh-list
93121982|NCT04716426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93121983|NCT04716426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93121984|NCT04716426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93121985|NCT04716426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121986|NCT04716426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121987|NCT05761756|Caffeine|caffeine|mesh-list
93121988|NCT05761756|Methylphenidate|methylphenidate|mesh-list
93121989|NCT05761756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93121990|NCT05761756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93121991|NCT05761756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93121992|NCT05761756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93121993|NCT05761756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93121994|NCT05761756|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93121995|NCT05761756|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93121996|NCT05761756|Purinergic Agents|purinergic agents|mesh-ancestor
93121997|NCT05761756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93121998|NCT05761756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93121999|NCT05761756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93122000|NCT05761756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122001|NCT05761756|Dopamine Agents|dopamine agents|mesh-ancestor
93122002|NCT04164758|Pimavanserin|pimavanserin|mesh-list
93122003|NCT04164758|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93122004|NCT04164758|Antidepressive Agents|antidepressive agents|mesh-ancestor
93122005|NCT04164758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122006|NCT04164758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93122007|NCT04164758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93122008|NCT04164758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122009|NCT04164758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122010|NCT04164758|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93122011|NCT04164758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93122012|NCT04164758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93122013|NCT04164758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93122014|NCT04164758|Serotonin Agents|serotonin agents|mesh-ancestor
93122015|NCT04164758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122016|NCT04164758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122017|NCT03754686|Acetaminophen|acetaminophen|mesh-list
93122018|NCT03754686|Oseltamivir|oseltamivir|mesh-list
93122019|NCT03754686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122020|NCT03754686|Analgesics|analgesics|mesh-ancestor
93122021|NCT03754686|Sensory System Agents|sensory system agents|mesh-ancestor
93122022|NCT03754686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122023|NCT03754686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122024|NCT03754686|Antipyretics|antipyretics|mesh-ancestor
93122025|NCT03754686|Antiviral Agents|antiviral agents|mesh-ancestor
92794216|NCT01193842|Glucocorticoids|glucocorticoids|mesh-ancestor
93122026|NCT03754686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122027|NCT03754686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122028|NCT03754686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122029|NCT05200884|Lidocaine|lidocaine|mesh-list
93122030|NCT05200884|Carticaine|carticaine|mesh-list
93122031|NCT05200884|Anesthetics, Local|anesthetics, local|mesh-ancestor
93122032|NCT05200884|Anesthetics|anesthetics|mesh-ancestor
93122033|NCT05200884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122034|NCT05200884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122035|NCT05200884|Sensory System Agents|sensory system agents|mesh-ancestor
93122036|NCT05200884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122037|NCT05200884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93122038|NCT05200884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93122039|NCT05200884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93122040|NCT05200884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122041|NCT05200884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122042|NCT03746444|Anesthetics|anesthetics|mesh-list
93122043|NCT03746444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122044|NCT03746444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122045|NCT03749096|Immunoglobulins|immunoglobulins|mesh-list
93122046|NCT03749096|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93122047|NCT03749096|Antibodies|antibodies|mesh-list
93122048|NCT03749096|gamma-Globulins|gamma-globulins|mesh-list
93122049|NCT03749096|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93122050|NCT03749096|Immunologic Factors|immunologic factors|mesh-ancestor
93122051|NCT03749096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122052|NCT03748940|Mirikizumab|mirikizumab|mesh-list
93122053|NCT03748940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93122054|NCT03748940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122055|NCT03748940|Analgesics|analgesics|mesh-ancestor
93122056|NCT03748940|Sensory System Agents|sensory system agents|mesh-ancestor
93122057|NCT03748940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122058|NCT03748940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122059|NCT03748940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122060|NCT03748940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122061|NCT03748940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93122062|NCT03748940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93122063|NCT04177862|Fentanyl|fentanyl|mesh-list
93122064|NCT04177862|Sufentanil|sufentanil|mesh-list
93122065|NCT04177862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93122066|NCT04177862|Narcotics|narcotics|mesh-ancestor
93122067|NCT04177862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122068|NCT04177862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122069|NCT04177862|Analgesics|analgesics|mesh-ancestor
93122070|NCT04177862|Sensory System Agents|sensory system agents|mesh-ancestor
93122071|NCT04177862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122072|NCT04177862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93122073|NCT04177862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93122074|NCT04177862|Anesthetics, General|anesthetics, general|mesh-ancestor
93122075|NCT04177862|Anesthetics|anesthetics|mesh-ancestor
93122076|NCT03746366|Corticosterone|corticosterone|mesh-list
93122077|NCT03746366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122078|NCT04157738|Insulin|insulin|mesh-list
93122079|NCT04157738|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93122080|NCT04157738|Insulin, Short-Acting|insulin, short-acting|mesh-list
93122081|NCT04157738|Insulin, Long-Acting|insulin, long-acting|mesh-list
93122082|NCT04157738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93122083|NCT04157738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122084|NCT04156646|Balovaptan|balovaptan|mesh-list
93122085|NCT04156646|Esomeprazole|esomeprazole|mesh-list
93122086|NCT04156646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93122087|NCT04156646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93122088|NCT04156646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93122089|NCT04156646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122090|NCT04156646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122091|NCT04156646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93122092|NCT04156646|Natriuretic Agents|natriuretic agents|mesh-ancestor
93122093|NCT04156646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122094|NCT04676412|Pembrolizumab|pembrolizumab|mesh-list
93122095|NCT04676412|Lenvatinib|lenvatinib|mesh-list
93122096|NCT04676412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122097|NCT04676412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122098|NCT04676412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122099|NCT04676412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122100|NCT04676412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93122101|NCT04676412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122102|NCT03751488|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93122103|NCT03751488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93122104|NCT03751488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93122105|NCT03751488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122106|NCT03751488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122107|NCT03751488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122108|NCT03751488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93122109|NCT03751488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93122110|NCT03751488|Serotonin Agents|serotonin agents|mesh-ancestor
93122111|NCT03751488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122112|NCT03751488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122113|NCT03751488|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93122114|NCT03751488|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93122115|NCT03751488|Dopamine Agents|dopamine agents|mesh-ancestor
93122116|NCT04150250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93122117|NCT04150250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122118|NCT04537806|Pregnanolone|pregnanolone|mesh-list
93122119|NCT04537806|Brexanolone|brexanolone|mesh-list
93122120|NCT04537806|Anesthetics|anesthetics|mesh-ancestor
93122121|NCT04537806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122122|NCT04537806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122123|NCT04537806|Neurosteroids|neurosteroids|mesh-ancestor
93122124|NCT04537806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122125|NCT04537806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122126|NCT04537806|GABA Modulators|gaba modulators|mesh-ancestor
93122127|NCT04537806|GABA Agents|gaba agents|mesh-ancestor
93122128|NCT03744806|Bevacizumab|bevacizumab|mesh-list
93122129|NCT03744806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122130|NCT03744806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122131|NCT03744806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93122132|NCT03744806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93122133|NCT03744806|Growth Substances|growth substances|mesh-ancestor
93122134|NCT03744806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122135|NCT03744806|Growth Inhibitors|growth inhibitors|mesh-ancestor
93122136|NCT04531098|Vaccines|vaccines|mesh-list
93122137|NCT04531098|Immunologic Factors|immunologic factors|mesh-ancestor
93122138|NCT04531098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122139|NCT04529850|Avasopasem manganese|avasopasem manganese|mesh-list
93122140|NCT04529850|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93122141|NCT04529850|Antioxidants|antioxidants|mesh-ancestor
93122142|NCT04529850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122143|NCT04529850|Protective Agents|protective agents|mesh-ancestor
93122144|NCT04529850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122145|NCT04225676|Tisagenlecleucel|tisagenlecleucel|mesh-list
93122146|NCT04225676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122147|NCT04225676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122148|NCT01561950|Clopidogrel|clopidogrel|mesh-list
93122149|NCT01561950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93122150|NCT01561950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93122151|NCT01561950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93062305|NCT01184482|Cetuximab|cetuximab|mesh-list
93122152|NCT01561950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93122153|NCT01561950|Purinergic Agents|purinergic agents|mesh-ancestor
93122154|NCT01561950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122155|NCT01561950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122156|NCT01561950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122157|NCT04139018|Timolol|timolol|mesh-list
93122158|NCT04139018|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93122159|NCT04139018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93122160|NCT04139018|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122161|NCT04139018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122162|NCT04139018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122163|NCT04139018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122164|NCT04139018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93122165|NCT04139018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93122166|NCT05206318|Cysteamine|cysteamine|mesh-list
93122167|NCT05206318|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
93122168|NCT05206318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122169|NCT04136444|Padsevonil|padsevonil|mesh-list
93122170|NCT04136444|Anticonvulsants|anticonvulsants|mesh-ancestor
93122171|NCT05027048|Calcium|calcium|mesh-list
93122172|NCT05027048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93122173|NCT05027048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122174|NCT03751332|Tacrolimus|tacrolimus|mesh-list
93122175|NCT03751332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122176|NCT03751332|Immunologic Factors|immunologic factors|mesh-ancestor
93122177|NCT03751332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122178|NCT03751332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93122179|NCT03751332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122180|NCT03751332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122181|NCT04425252|Brequinar|brequinar|mesh-list
93122182|NCT04425252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122183|NCT04425252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122184|NCT04425252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122185|NCT04425252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122186|NCT04425252|Immunologic Factors|immunologic factors|mesh-ancestor
93122187|NCT04425252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122188|NCT04003610|Carboplatin|carboplatin|mesh-list
93122189|NCT04003610|Gemcitabine|gemcitabine|mesh-list
93122190|NCT04003610|Pembrolizumab|pembrolizumab|mesh-list
93122191|NCT04003610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122192|NCT04003610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93122193|NCT04003610|Antimetabolites|antimetabolites|mesh-ancestor
93122194|NCT04003610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122195|NCT04003610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122196|NCT04003610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122197|NCT03744104|Vaccines|vaccines|mesh-list
93122198|NCT03744104|Immunologic Factors|immunologic factors|mesh-ancestor
93122199|NCT03744104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122200|NCT03999554|Vaccines|vaccines|mesh-list
93122201|NCT03999554|Immunologic Factors|immunologic factors|mesh-ancestor
93122202|NCT03999554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122203|NCT05280626|Prednisolone|prednisolone|mesh-list
93122204|NCT05280626|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93122205|NCT05280626|Methylprednisolone|methylprednisolone|mesh-list
93122206|NCT05280626|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93122207|NCT05280626|Prednisolone acetate|prednisolone acetate|mesh-list
93122208|NCT05280626|Cyclophosphamide|cyclophosphamide|mesh-list
93122209|NCT05280626|Rituximab|rituximab|mesh-list
93122210|NCT05280626|Doxorubicin|doxorubicin|mesh-list
93122211|NCT05280626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93122212|NCT05280626|Vincristine|vincristine|mesh-list
93122213|NCT05280626|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93122214|NCT05280626|Prednisolone phosphate|prednisolone phosphate|mesh-list
93122215|NCT05280626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122216|NCT05280626|Immunologic Factors|immunologic factors|mesh-ancestor
93122217|NCT05280626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122218|NCT05280626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122219|NCT05280626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93122220|NCT05280626|Alkylating Agents|alkylating agents|mesh-ancestor
93122221|NCT05280626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122222|NCT05280626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122223|NCT05280626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93122224|NCT05280626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122225|NCT05280626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93122226|NCT05280626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93122227|NCT05280626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122228|NCT05280626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122229|NCT05280626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122230|NCT05280626|Glucocorticoids|glucocorticoids|mesh-ancestor
93122231|NCT05280626|Hormones|hormones|mesh-ancestor
93122232|NCT05280626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93122233|NCT05280626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93122234|NCT05280626|Antiemetics|antiemetics|mesh-ancestor
93122235|NCT05280626|Autonomic Agents|autonomic agents|mesh-ancestor
93122236|NCT05280626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122237|NCT05280626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93122238|NCT05280626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93122239|NCT05280626|Protective Agents|protective agents|mesh-ancestor
93122240|NCT05280626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93122241|NCT05280626|Tubulin Modulators|tubulin modulators|mesh-ancestor
93122242|NCT05280626|Antimitotic Agents|antimitotic agents|mesh-ancestor
93122243|NCT05280626|Mitosis Modulators|mitosis modulators|mesh-ancestor
93122244|NCT04526574|Vaccines|vaccines|mesh-list
93122245|NCT04526574|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93122246|NCT04526574|Immunologic Factors|immunologic factors|mesh-ancestor
93122247|NCT04526574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122248|NCT03993392|Buprenorphine|buprenorphine|mesh-list
93122249|NCT03993392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93122250|NCT03993392|Narcotics|narcotics|mesh-ancestor
93122251|NCT03993392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122252|NCT03993392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122253|NCT03993392|Analgesics|analgesics|mesh-ancestor
93122254|NCT03993392|Sensory System Agents|sensory system agents|mesh-ancestor
93122255|NCT03993392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122256|NCT03993392|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93122257|NCT04145258|Aspirin|aspirin|mesh-list
93122258|NCT04145258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93122259|NCT04145258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122260|NCT04145258|Analgesics|analgesics|mesh-ancestor
93122261|NCT04145258|Sensory System Agents|sensory system agents|mesh-ancestor
93122262|NCT04145258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122263|NCT04145258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122264|NCT04145258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122265|NCT04145258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122266|NCT04145258|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93122267|NCT04145258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93122268|NCT04145258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122269|NCT04145258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93122270|NCT04145258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93122271|NCT04145258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122272|NCT04145258|Antipyretics|antipyretics|mesh-ancestor
93122273|NCT03751176|Leucovorin|leucovorin|mesh-list
93122274|NCT03751176|Folic Acid|folic acid|mesh-list
93122275|NCT03751176|Fluorouracil|fluorouracil|mesh-list
93122276|NCT03751176|Irinotecan|irinotecan|mesh-list
93122277|NCT03751176|Panitumumab|panitumumab|mesh-list
93122278|NCT03751176|Levoleucovorin|levoleucovorin|mesh-list
93122279|NCT03751176|Antimetabolites|antimetabolites|mesh-ancestor
93122280|NCT03751176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122281|NCT03751176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93122282|NCT03751176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122283|NCT03751176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122284|NCT03751176|Immunologic Factors|immunologic factors|mesh-ancestor
93122285|NCT03751176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122286|NCT03751176|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93122287|NCT03751176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122288|NCT03751176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122289|NCT03751176|Antidotes|antidotes|mesh-ancestor
93122290|NCT03751176|Protective Agents|protective agents|mesh-ancestor
93122291|NCT03751176|Vitamin B Complex|vitamin b complex|mesh-ancestor
93122292|NCT03751176|Vitamins|vitamins|mesh-ancestor
93122293|NCT03751176|Micronutrients|micronutrients|mesh-ancestor
93122294|NCT03751176|Hematinics|hematinics|mesh-ancestor
93122295|NCT03751176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122296|NCT04377308|Fluoxetine|fluoxetine|mesh-list
93122297|NCT04377308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93122298|NCT04377308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93122299|NCT04377308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122300|NCT04377308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122301|NCT04377308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122302|NCT04377308|Serotonin Agents|serotonin agents|mesh-ancestor
93122303|NCT04377308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122304|NCT04377308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93122305|NCT04377308|Antidepressive Agents|antidepressive agents|mesh-ancestor
93122306|NCT04377308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122307|NCT04377308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93122308|NCT04377308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93122309|NCT04377308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122310|NCT03743870|Bupivacaine|bupivacaine|mesh-list
93122311|NCT03743870|Levobupivacaine|levobupivacaine|mesh-list
93122312|NCT03743870|Anesthetics, Local|anesthetics, local|mesh-ancestor
93122313|NCT03743870|Anesthetics|anesthetics|mesh-ancestor
93122314|NCT03743870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122315|NCT03743870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122316|NCT03743870|Sensory System Agents|sensory system agents|mesh-ancestor
93122317|NCT03743870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122318|NCT03988088|Lasmiditan|lasmiditan|mesh-list
93122319|NCT03988088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93122320|NCT03988088|Serotonin Agents|serotonin agents|mesh-ancestor
93122321|NCT03988088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122322|NCT03988088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122323|NCT03988088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122324|NCT03987620|Ibrexafungerp|ibrexafungerp|mesh-list
93122325|NCT03987620|Antifungal Agents|antifungal agents|mesh-ancestor
93122326|NCT03987620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122327|NCT05204524|Temozolomide|temozolomide|mesh-list
93122328|NCT05204524|Epirubicin|epirubicin|mesh-list
93122329|NCT05204524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93122330|NCT05204524|Alkylating Agents|alkylating agents|mesh-ancestor
93122331|NCT05204524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122332|NCT05204524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122333|NCT05204524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93122334|NCT05204524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93122335|NCT05204524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122336|NCT05204524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122337|NCT05204056|Epinephrine|epinephrine|mesh-list
93122338|NCT05204056|Morphine|morphine|mesh-list
93122339|NCT05204056|Ropivacaine|ropivacaine|mesh-list
93122340|NCT05204056|Tranexamic Acid|tranexamic acid|mesh-list
93122341|NCT05204056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93122342|NCT05204056|Narcotics|narcotics|mesh-ancestor
93122343|NCT05204056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122344|NCT05204056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122345|NCT05204056|Analgesics|analgesics|mesh-ancestor
93122346|NCT05204056|Sensory System Agents|sensory system agents|mesh-ancestor
93122347|NCT05204056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122348|NCT05204056|Anesthetics, Local|anesthetics, local|mesh-ancestor
93122349|NCT05204056|Anesthetics|anesthetics|mesh-ancestor
93122350|NCT05204056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93122351|NCT05204056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93122352|NCT05204056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122353|NCT05204056|Hemostatics|hemostatics|mesh-ancestor
93122354|NCT05204056|Coagulants|coagulants|mesh-ancestor
93122355|NCT05204056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93122356|NCT05204056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93122357|NCT05204056|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122358|NCT05204056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122359|NCT05204056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93122360|NCT05204056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93122361|NCT05204056|Autonomic Agents|autonomic agents|mesh-ancestor
93122362|NCT05204056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93122363|NCT05204056|Respiratory System Agents|respiratory system agents|mesh-ancestor
93122364|NCT05204056|Mydriatics|mydriatics|mesh-ancestor
93122365|NCT05204056|Sympathomimetics|sympathomimetics|mesh-ancestor
93122366|NCT05204056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93122367|NCT05203744|Tafenoquine|tafenoquine|mesh-list
93122368|NCT05203744|Antimalarials|antimalarials|mesh-ancestor
93122369|NCT05203744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93122370|NCT05203744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93122371|NCT05203744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122372|NCT03987074|Firsocostat|firsocostat|mesh-list
93122373|NCT03987074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122374|NCT03987074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122375|NCT05761366|PSMA-BCH|psma-bch|mesh-list
93122376|NCT05761366|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93122377|NCT05761366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122378|NCT05302466|Silicon|silicon|mesh-list
93122379|NCT05302466|Trace Elements|trace elements|mesh-ancestor
93122380|NCT05302466|Micronutrients|micronutrients|mesh-ancestor
93122381|NCT05302466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122382|NCT05203588|Vitamin D|vitamin d|mesh-list
93122383|NCT05203588|Denosumab|denosumab|mesh-list
93122384|NCT05203588|Calcium|calcium|mesh-list
93122385|NCT05203588|Vitamins|vitamins|mesh-ancestor
93122386|NCT05203588|Micronutrients|micronutrients|mesh-ancestor
93122387|NCT05203588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122388|NCT05203588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93122389|NCT05203588|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93122390|NCT05203354|Acitretin|acitretin|mesh-list
93122391|NCT05203354|Keratolytic Agents|keratolytic agents|mesh-ancestor
93122392|NCT05203354|Dermatologic Agents|dermatologic agents|mesh-ancestor
93122393|NCT04439214|Nivolumab|nivolumab|mesh-list
93122394|NCT04439214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122395|NCT04439214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122396|NCT04439214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122397|NCT04439214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122398|NCT03754062|Haloperidol|haloperidol|mesh-list
93122399|NCT03754062|Haloperidol decanoate|haloperidol decanoate|mesh-list
93122400|NCT03754062|Antiemetics|antiemetics|mesh-ancestor
92794598|NCT01004172|Bevacizumab|bevacizumab|mesh-list
93122401|NCT03754062|Autonomic Agents|autonomic agents|mesh-ancestor
93122402|NCT03754062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122403|NCT03754062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122404|NCT03754062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93122405|NCT03754062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93122406|NCT03754062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93122407|NCT03754062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122408|NCT03754062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122409|NCT03754062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93122410|NCT03754062|Dopamine Agents|dopamine agents|mesh-ancestor
93122411|NCT03754062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122412|NCT03754062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122413|NCT03754062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93122414|NCT03696342|Gatifloxacin|gatifloxacin|mesh-list
93122415|NCT03696342|Pazufloxacin|pazufloxacin|mesh-list
93122416|NCT03696342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93122417|NCT03696342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122418|NCT03696342|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93122419|NCT03696342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93122420|NCT03696342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93122421|NCT03696342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122422|NCT03696342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122423|NCT03696342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122424|NCT03696342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122425|NCT03696342|Antitubercular Agents|antitubercular agents|mesh-ancestor
93122427|NCT05180032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93122428|NCT05180032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122429|NCT05761132|Pembrolizumab|pembrolizumab|mesh-list
93122430|NCT05761132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122431|NCT05761132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122432|NCT05761132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122433|NCT05761132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122434|NCT04411680|Sargramostim|sargramostim|mesh-list
93122435|NCT04411680|Immunologic Factors|immunologic factors|mesh-ancestor
93122436|NCT04411680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122437|NCT05760976|Cisatracurium|cisatracurium|mesh-list
93122438|NCT05760976|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93122439|NCT05760976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93122440|NCT05760976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122441|NCT05760976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122442|NCT05324358|Ketorolac|ketorolac|mesh-list
93122443|NCT05324358|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93122444|NCT05324358|Morphine|morphine|mesh-list
93122445|NCT05324358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93122446|NCT05324358|Narcotics|narcotics|mesh-ancestor
93122447|NCT05324358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122448|NCT05324358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122449|NCT05324358|Analgesics|analgesics|mesh-ancestor
93122450|NCT05324358|Sensory System Agents|sensory system agents|mesh-ancestor
93122451|NCT05324358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122452|NCT05324358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93122453|NCT05324358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122454|NCT05324358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122455|NCT05324358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122456|NCT05324358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93122457|NCT05324358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122458|NCT05324358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122459|NCT03747978|Amlodipine|amlodipine|mesh-list
93122460|NCT03747978|Perindopril|perindopril|mesh-list
93122461|NCT03747978|Indapamide|indapamide|mesh-list
93122462|NCT03747978|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
93122463|NCT03747978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93122464|NCT03747978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93122465|NCT03747978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122466|NCT03747978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122467|NCT03747978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93122468|NCT03747978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122469|NCT03747978|Vasodilator Agents|vasodilator agents|mesh-ancestor
93122470|NCT03747978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93122471|NCT03747978|Protease Inhibitors|protease inhibitors|mesh-ancestor
93122472|NCT03747978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122473|NCT03747978|Diuretics|diuretics|mesh-ancestor
93122474|NCT03747978|Natriuretic Agents|natriuretic agents|mesh-ancestor
93122475|NCT03747978|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93122476|NCT04603846|Paclitaxel|paclitaxel|mesh-list
93122477|NCT04603846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93122478|NCT04603846|Antibodies|antibodies|mesh-list
93122479|NCT04603846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93122480|NCT04603846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122481|NCT04603846|Tubulin Modulators|tubulin modulators|mesh-ancestor
93122482|NCT04603846|Antimitotic Agents|antimitotic agents|mesh-ancestor
93122483|NCT04603846|Mitosis Modulators|mitosis modulators|mesh-ancestor
93122484|NCT04603846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122485|NCT04603846|Immunologic Factors|immunologic factors|mesh-ancestor
93122486|NCT04603846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122487|NCT03747900|Botulinum Toxins|botulinum toxins|mesh-list
93122488|NCT03747900|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93122489|NCT03747900|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93122490|NCT03747900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93122491|NCT03747900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122492|NCT03747900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122493|NCT03747900|Cholinergic Agents|cholinergic agents|mesh-ancestor
93122494|NCT03747900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122495|NCT03747900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122496|NCT03747900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93122497|NCT03747900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122498|NCT04578106|Trastuzumab|trastuzumab|mesh-list
93122499|NCT04578106|Pertuzumab|pertuzumab|mesh-list
93122500|NCT04578106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122501|NCT04578106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122502|NCT04472182|Calcium|calcium|mesh-list
93122503|NCT04472182|Fluorides|fluorides|mesh-list
93122504|NCT04472182|Fluorides, Topical|fluorides, topical|mesh-list
93122505|NCT04472182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93122506|NCT04472182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122507|NCT04472182|Cariostatic Agents|cariostatic agents|mesh-ancestor
93122508|NCT04472182|Protective Agents|protective agents|mesh-ancestor
93122509|NCT04423744|Moxifloxacin|moxifloxacin|mesh-list
93122510|NCT04423744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93122511|NCT04423744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122512|NCT04423744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93122513|NCT04423744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122514|NCT04423744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122515|NCT04423744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122516|NCT04423744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122517|NCT05759416|Melatonin|melatonin|mesh-list
93122518|NCT05759416|Antioxidants|antioxidants|mesh-ancestor
93122519|NCT05759416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122520|NCT05759416|Protective Agents|protective agents|mesh-ancestor
93122521|NCT05759416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122522|NCT05759416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122523|NCT03746340|Propofol|propofol|mesh-list
93122524|NCT03746340|Sevoflurane|sevoflurane|mesh-list
93122525|NCT03746340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93122526|NCT03746340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122527|NCT03746340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062683|NCT03853642|Nitric Oxide|nitric oxide|mesh-list
93122528|NCT03746340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93122529|NCT03746340|Anesthetics, General|anesthetics, general|mesh-ancestor
93122530|NCT03746340|Anesthetics|anesthetics|mesh-ancestor
93122531|NCT03746340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93122532|NCT03746340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93122533|NCT04222816|Lithium Carbonate|lithium carbonate|mesh-list
93122534|NCT04222816|Antidepressive Agents|antidepressive agents|mesh-ancestor
93122535|NCT04222816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122536|NCT04222816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122537|NCT04222816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122538|NCT04222816|Antimanic Agents|antimanic agents|mesh-ancestor
93122539|NCT04222816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93122540|NCT04222816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122541|NCT04222816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122542|NCT04161144|Sirolimus|sirolimus|mesh-list
93122543|NCT04161144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93122544|NCT04161144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122545|NCT04161144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93122546|NCT04161144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122547|NCT04161144|Antifungal Agents|antifungal agents|mesh-ancestor
93122548|NCT04161144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122549|NCT04161144|Immunologic Factors|immunologic factors|mesh-ancestor
93122550|NCT04161144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122551|NCT03747744|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93122552|NCT03747744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122553|NCT03747744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122554|NCT04823364|Neurotransmitter Agents|neurotransmitter agents|mesh-list
93122555|NCT04823364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122556|NCT04823364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122557|NCT04764630|Naloxone|naloxone|mesh-list
93122558|NCT04764630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93122559|NCT04764630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122560|NCT04764630|Sensory System Agents|sensory system agents|mesh-ancestor
93122561|NCT04764630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122562|NCT04153188|Phenylephrine|phenylephrine|mesh-list
93122563|NCT04153188|Oxymetazoline|oxymetazoline|mesh-list
93122564|NCT04153188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93122565|NCT04153188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93122566|NCT04153188|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122567|NCT04153188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122568|NCT04153188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122569|NCT04153188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122570|NCT04153188|Sympathomimetics|sympathomimetics|mesh-ancestor
93122571|NCT04153188|Autonomic Agents|autonomic agents|mesh-ancestor
93122572|NCT04153188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122573|NCT04153188|Nasal Decongestants|nasal decongestants|mesh-ancestor
93122574|NCT04153188|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93122575|NCT04153188|Respiratory System Agents|respiratory system agents|mesh-ancestor
93122576|NCT04153188|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93122577|NCT04153188|Mydriatics|mydriatics|mesh-ancestor
93122578|NCT04153188|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93122579|NCT04153188|Protective Agents|protective agents|mesh-ancestor
93122580|NCT03611010|Atorvastatin|atorvastatin|mesh-list
93122581|NCT03611010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93122582|NCT03611010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93122583|NCT03611010|Antimetabolites|antimetabolites|mesh-ancestor
93122584|NCT03611010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122585|NCT03611010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93122586|NCT03611010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93122587|NCT03611010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122588|NCT03749850|Cyclophosphamide|cyclophosphamide|mesh-list
93122589|NCT03749850|Doxorubicin|doxorubicin|mesh-list
93122590|NCT03749850|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93122591|NCT03749850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122592|NCT03749850|Immunologic Factors|immunologic factors|mesh-ancestor
93122593|NCT03749850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122594|NCT03749850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122595|NCT03749850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93122596|NCT03749850|Alkylating Agents|alkylating agents|mesh-ancestor
93122597|NCT03749850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122598|NCT03749850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122599|NCT03749850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93122600|NCT03749850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93122601|NCT03749850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93122602|NCT03749850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122603|NCT03749850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122604|NCT04357782|Ascorbic Acid|ascorbic acid|mesh-list
93122605|NCT04357782|Vitamins|vitamins|mesh-ancestor
93122606|NCT04357782|Micronutrients|micronutrients|mesh-ancestor
93122607|NCT04357782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122608|NCT04357782|Antioxidants|antioxidants|mesh-ancestor
93122609|NCT04357782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122610|NCT04357782|Protective Agents|protective agents|mesh-ancestor
93122611|NCT03980522|Rilonacept|rilonacept|mesh-list
93122612|NCT03980522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122613|NCT04400682|Favipiravir|favipiravir|mesh-list
93122614|NCT04400682|Antiviral Agents|antiviral agents|mesh-ancestor
93122615|NCT04400682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122616|NCT03066778|Carboplatin|carboplatin|mesh-list
93122617|NCT03066778|Pembrolizumab|pembrolizumab|mesh-list
93122618|NCT03066778|Etoposide|etoposide|mesh-list
93122619|NCT03066778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122620|NCT03066778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122621|NCT03066778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122622|NCT03066778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122623|NCT03066778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93122624|NCT03066778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93122625|NCT03066778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93122626|NCT03066778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122627|NCT04136548|Fentanyl|fentanyl|mesh-list
93122628|NCT04136548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92794818|NCT02683564|Infliximab|infliximab|mesh-list
93122629|NCT04136548|Narcotics|narcotics|mesh-ancestor
93122630|NCT04136548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122631|NCT04136548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122633|NCT04136548|Sensory System Agents|sensory system agents|mesh-ancestor
93122634|NCT04136548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122635|NCT04136548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93122636|NCT04136548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93122637|NCT04136548|Anesthetics, General|anesthetics, general|mesh-ancestor
93122638|NCT04136548|Anesthetics|anesthetics|mesh-ancestor
93122639|NCT04347954|Iodine|iodine|mesh-list
93122640|NCT04347954|Cadexomer iodine|cadexomer iodine|mesh-list
93122641|NCT04347954|Povidone-Iodine|povidone-iodine|mesh-list
93122642|NCT04347954|Povidone|povidone|mesh-list
93122643|NCT04347954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93122644|NCT04347954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122645|NCT04347954|Trace Elements|trace elements|mesh-ancestor
93122646|NCT04347954|Micronutrients|micronutrients|mesh-ancestor
93122647|NCT04347954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122648|NCT04347954|Plasma Substitutes|plasma substitutes|mesh-ancestor
93122649|NCT04347954|Blood Substitutes|blood substitutes|mesh-ancestor
93122650|NCT01565200|Trastuzumab|trastuzumab|mesh-list
93122651|NCT01565200|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93122652|NCT01565200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122653|NCT01565200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122654|NCT01565200|Immunotoxins|immunotoxins|mesh-ancestor
93122655|NCT01565200|Immunoconjugates|immunoconjugates|mesh-ancestor
93122656|NCT01565200|Immunologic Factors|immunologic factors|mesh-ancestor
93122657|NCT01565200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122658|NCT01565200|Tubulin Modulators|tubulin modulators|mesh-ancestor
93122659|NCT01565200|Antimitotic Agents|antimitotic agents|mesh-ancestor
93122660|NCT01565200|Mitosis Modulators|mitosis modulators|mesh-ancestor
93122661|NCT01565200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122662|NCT03065530|Dexmedetomidine|dexmedetomidine|mesh-list
93122663|NCT03065530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93122664|NCT03065530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122665|NCT03065530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122666|NCT03065530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122667|NCT03065530|Analgesics|analgesics|mesh-ancestor
93122668|NCT03065530|Sensory System Agents|sensory system agents|mesh-ancestor
93122669|NCT03065530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122670|NCT03065530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93122671|NCT03065530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93122672|NCT03065530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93122673|NCT03065530|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122674|NCT03065530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122675|NCT03065530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122676|NCT03979820|Phenelzine|phenelzine|mesh-list
93122677|NCT03979820|Tyramine|tyramine|mesh-list
93122678|NCT03979820|Antidepressive Agents|antidepressive agents|mesh-ancestor
93122679|NCT03979820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122680|NCT03979820|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93122681|NCT03979820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122682|NCT03979820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122683|NCT03979820|Sympathomimetics|sympathomimetics|mesh-ancestor
93122684|NCT03979820|Autonomic Agents|autonomic agents|mesh-ancestor
93122685|NCT03979820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122686|NCT03979820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122687|NCT03979820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93122688|NCT03979820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93122689|NCT03979820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122690|NCT03979820|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122691|NCT03979820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122692|NCT03647488|Docetaxel|docetaxel|mesh-list
93122693|NCT03647488|Spartalizumab|spartalizumab|mesh-list
93122694|NCT03647488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122695|NCT03647488|Tubulin Modulators|tubulin modulators|mesh-ancestor
93122696|NCT03647488|Antimitotic Agents|antimitotic agents|mesh-ancestor
93122697|NCT03647488|Mitosis Modulators|mitosis modulators|mesh-ancestor
93122698|NCT03647488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122699|NCT03647488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122700|NCT03647488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122701|NCT03693950|Darbepoetin alfa|darbepoetin alfa|mesh-list
93122702|NCT03693950|Hematinics|hematinics|mesh-ancestor
93122703|NCT03579160|Timolol|timolol|mesh-list
93122704|NCT03579160|Petrolatum|petrolatum|mesh-list
93122705|NCT03579160|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93122706|NCT03579160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93122707|NCT03579160|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122708|NCT03579160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122709|NCT03579160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122710|NCT03579160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122711|NCT03579160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93122712|NCT03579160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93122713|NCT03579160|Emollients|emollients|mesh-ancestor
93122714|NCT03579160|Dermatologic Agents|dermatologic agents|mesh-ancestor
93122715|NCT04109456|Atezolizumab|atezolizumab|mesh-list
93122716|NCT04109456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122717|NCT04109456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122718|NCT04109456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122719|NCT04109456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122720|NCT04109222|Vaccines|vaccines|mesh-list
93122721|NCT04109222|Immunologic Factors|immunologic factors|mesh-ancestor
93122722|NCT04109222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122723|NCT03745664|Methylprednisolone|methylprednisolone|mesh-list
93122724|NCT03745664|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93122725|NCT03745664|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93122726|NCT03745664|Prednisolone|prednisolone|mesh-list
93122727|NCT03745664|Prednisolone acetate|prednisolone acetate|mesh-list
93122728|NCT03745664|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93122729|NCT03745664|Prednisolone phosphate|prednisolone phosphate|mesh-list
93122730|NCT03745664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122731|NCT03745664|Antiemetics|antiemetics|mesh-ancestor
93122732|NCT03745664|Autonomic Agents|autonomic agents|mesh-ancestor
93122733|NCT03745664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122734|NCT03745664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122735|NCT03745664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93122736|NCT03745664|Glucocorticoids|glucocorticoids|mesh-ancestor
93122737|NCT03745664|Hormones|hormones|mesh-ancestor
93122738|NCT03745664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93122739|NCT03745664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93122740|NCT03745664|Protective Agents|protective agents|mesh-ancestor
93122741|NCT03745664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93122742|NCT03745664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122743|NCT03447262|Ivacaftor|ivacaftor|mesh-list
93122744|NCT03447262|VX-659|vx-659|mesh-list
93122745|NCT03447262|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93122746|NCT03447262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122747|NCT03447262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122748|NCT04094870|Sertraline|sertraline|mesh-list
93122749|NCT04094870|Antidepressive Agents|antidepressive agents|mesh-ancestor
93122750|NCT04094870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122751|NCT04094870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93122752|NCT04094870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93122753|NCT04094870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91930915|NCT02363361|Imatinib Mesylate|imatinib mesylate|mesh-list
93122754|NCT04094870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122755|NCT04094870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122756|NCT04094870|Serotonin Agents|serotonin agents|mesh-ancestor
93122757|NCT04094870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122758|NCT04399356|Niclosamide|niclosamide|mesh-list
93122759|NCT04399356|Anticestodal Agents|anticestodal agents|mesh-ancestor
93122760|NCT04399356|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93122761|NCT04399356|Anthelmintics|anthelmintics|mesh-ancestor
93122762|NCT04399356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93122763|NCT04399356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122764|NCT04399356|Antinematodal Agents|antinematodal agents|mesh-ancestor
93122765|NCT03692676|Tiotropium Bromide|tiotropium bromide|mesh-list
93122766|NCT03692676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93122767|NCT03692676|Autonomic Agents|autonomic agents|mesh-ancestor
93122768|NCT03692676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122769|NCT03692676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122770|NCT03692676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93122771|NCT03692676|Respiratory System Agents|respiratory system agents|mesh-ancestor
93122772|NCT03692676|Parasympatholytics|parasympatholytics|mesh-ancestor
93122773|NCT03692676|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93122774|NCT03692676|Cholinergic Agents|cholinergic agents|mesh-ancestor
93122775|NCT03692676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122776|NCT03692676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122777|NCT04118166|Nivolumab|nivolumab|mesh-list
93122778|NCT04118166|Ipilimumab|ipilimumab|mesh-list
93122779|NCT04118166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794974|NCT00641914|Hormones|hormones|mesh-ancestor
93122780|NCT04118166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122781|NCT04118166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122782|NCT04118166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122784|NCT04346628|Antiviral Agents|antiviral agents|mesh-ancestor
93122785|NCT04346628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122786|NCT03681470|Dapsone|dapsone|mesh-list
93122787|NCT03681470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122788|NCT03681470|Antimalarials|antimalarials|mesh-ancestor
93122789|NCT03681470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93122790|NCT03681470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93122791|NCT03681470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93122792|NCT03681470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122793|NCT03681470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122794|NCT03681470|Leprostatic Agents|leprostatic agents|mesh-ancestor
93122795|NCT03681470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93122796|NCT02414750|Vemurafenib|vemurafenib|mesh-list
93122797|NCT02414750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122798|NCT02414750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93122799|NCT02414750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122800|NCT02414750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122801|NCT04343976|Interferons|interferons|mesh-list
93122802|NCT04343976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122803|NCT04343976|Antiviral Agents|antiviral agents|mesh-ancestor
93122804|NCT04343976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122805|NCT03322540|Pembrolizumab|pembrolizumab|mesh-list
93122806|NCT03322540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122807|NCT03322540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122808|NCT03322540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122809|NCT03322540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122810|NCT02909452|Pembrolizumab|pembrolizumab|mesh-list
93122811|NCT02909452|Entinostat|entinostat|mesh-list
93122812|NCT02909452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122813|NCT02909452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122814|NCT02909452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93122815|NCT02909452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122816|NCT02909452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93122817|NCT02909452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122818|NCT02025556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93122819|NCT02025556|Immunologic Factors|immunologic factors|mesh-ancestor
93122820|NCT02025556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122821|NCT01935466|Pioglitazone|pioglitazone|mesh-list
93122822|NCT01935466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93122823|NCT01935466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122824|NCT04334148|Hydroxychloroquine|hydroxychloroquine|mesh-list
93122825|NCT04334148|Antimalarials|antimalarials|mesh-ancestor
93122826|NCT04334148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93122827|NCT04334148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93122828|NCT04334148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122829|NCT04334148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122830|NCT04334148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122831|NCT04334148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122832|NCT04399122|Acetaminophen|acetaminophen|mesh-list
93122833|NCT04399122|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93122834|NCT04399122|Oxycodone|oxycodone|mesh-list
93122835|NCT04399122|Codeine|codeine|mesh-list
93122836|NCT04399122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122837|NCT04399122|Analgesics|analgesics|mesh-ancestor
93122838|NCT04399122|Sensory System Agents|sensory system agents|mesh-ancestor
93122839|NCT04399122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122840|NCT04399122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122841|NCT04399122|Antipyretics|antipyretics|mesh-ancestor
93122842|NCT04399122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93122843|NCT04399122|Narcotics|narcotics|mesh-ancestor
93122844|NCT04399122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122845|NCT04399122|Antitussive Agents|antitussive agents|mesh-ancestor
93122846|NCT04399122|Respiratory System Agents|respiratory system agents|mesh-ancestor
93122847|NCT04399122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93122848|NCT04399122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122849|NCT04399122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122850|NCT00826462|Triamcinolone|triamcinolone|mesh-list
93122851|NCT00826462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93122852|NCT00826462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93122853|NCT00826462|Naproxen|naproxen|mesh-list
92795052|NCT00641446|Budesonide|budesonide|mesh-list
93122854|NCT00826462|Lidocaine|lidocaine|mesh-list
93122855|NCT00826462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93122856|NCT00826462|Anesthetics, Local|anesthetics, local|mesh-ancestor
93122857|NCT00826462|Anesthetics|anesthetics|mesh-ancestor
93122858|NCT00826462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122859|NCT00826462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122860|NCT00826462|Sensory System Agents|sensory system agents|mesh-ancestor
93122861|NCT00826462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122862|NCT00826462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93122863|NCT00826462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93122864|NCT00826462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93122865|NCT00826462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93122866|NCT00826462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122867|NCT00826462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122868|NCT00826462|Glucocorticoids|glucocorticoids|mesh-ancestor
93122869|NCT00826462|Hormones|hormones|mesh-ancestor
93122870|NCT00826462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93122871|NCT00826462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122872|NCT00826462|Immunologic Factors|immunologic factors|mesh-ancestor
93122873|NCT00826462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122874|NCT00826462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93122875|NCT00826462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122876|NCT00826462|Analgesics|analgesics|mesh-ancestor
93122877|NCT00826462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122878|NCT00826462|Gout Suppressants|gout suppressants|mesh-ancestor
93122879|NCT00826462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93122880|NCT04398732|Etanercept|etanercept|mesh-list
93122881|NCT04398732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93122882|NCT04398732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93122883|NCT04398732|Analgesics|analgesics|mesh-ancestor
93122884|NCT04398732|Sensory System Agents|sensory system agents|mesh-ancestor
93122885|NCT04398732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122886|NCT04398732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122887|NCT04398732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93122888|NCT04398732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122889|NCT04398732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93122890|NCT04398732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93122891|NCT04398732|Immunologic Factors|immunologic factors|mesh-ancestor
93122892|NCT04322682|Colchicine|colchicine|mesh-list
93122893|NCT04322682|Gout Suppressants|gout suppressants|mesh-ancestor
93122894|NCT04322682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122895|NCT04322682|Tubulin Modulators|tubulin modulators|mesh-ancestor
93122896|NCT04322682|Antimitotic Agents|antimitotic agents|mesh-ancestor
93122897|NCT04322682|Mitosis Modulators|mitosis modulators|mesh-ancestor
93122898|NCT04322682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122899|NCT04322682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122900|NCT04322526|Naltrexone|naltrexone|mesh-list
93122901|NCT04322526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93122902|NCT04322526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93063067|NCT05412082|Leucovorin|leucovorin|mesh-list
93122903|NCT04322526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122904|NCT04322526|Sensory System Agents|sensory system agents|mesh-ancestor
93122905|NCT04322526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122906|NCT05743036|Cetuximab|cetuximab|mesh-list
93122907|NCT05743036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122908|NCT05743036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122909|NCT04115358|Hyaluronic Acid|hyaluronic acid|mesh-list
93122910|NCT04115358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93122911|NCT04115358|Immunologic Factors|immunologic factors|mesh-ancestor
93122912|NCT04115358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122913|NCT04115358|Viscosupplements|viscosupplements|mesh-ancestor
93122914|NCT04115358|Protective Agents|protective agents|mesh-ancestor
93122915|NCT05668884|Gemcitabine|gemcitabine|mesh-list
93122916|NCT05668884|Oxaliplatin|oxaliplatin|mesh-list
93122917|NCT05668884|Tislelizumab|tislelizumab|mesh-list
93122918|NCT05668884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93122919|NCT05668884|Antimetabolites|antimetabolites|mesh-ancestor
93122920|NCT05668884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122921|NCT05668884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122922|NCT05668884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93122923|NCT05187208|Niraparib|niraparib|mesh-list
93122924|NCT05187208|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93122925|NCT05187208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93122926|NCT05187208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122927|NCT05187208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122928|NCT05081206|Propofol|propofol|mesh-list
92795119|NCT05511610|Sevoflurane|sevoflurane|mesh-list
93122929|NCT05081206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93122930|NCT05081206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122931|NCT05081206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122932|NCT05081206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93122933|NCT05081206|Anesthetics, General|anesthetics, general|mesh-ancestor
93122935|NCT04105998|Oxytocin|oxytocin|mesh-list
93122936|NCT04105998|Oxytocics|oxytocics|mesh-ancestor
93122937|NCT04105998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93122938|NCT04105998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122939|NCT04543968|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
93122940|NCT04543968|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
93122941|NCT04543968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122942|NCT04543968|Antioxidants|antioxidants|mesh-ancestor
93122943|NCT04543968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122944|NCT04543968|Protective Agents|protective agents|mesh-ancestor
93122945|NCT04543968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122946|NCT04543968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93122947|NCT04543968|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93122948|NCT04543968|Disinfectants|disinfectants|mesh-ancestor
93122949|NCT04368910|Artesunate|artesunate|mesh-list
93122950|NCT04368910|Chloroquine|chloroquine|mesh-list
93122951|NCT04368910|Pyronaridine|pyronaridine|mesh-list
93122952|NCT04368910|Antimalarials|antimalarials|mesh-ancestor
93122953|NCT04368910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93122954|NCT04368910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93122955|NCT04368910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93122956|NCT04368910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93122957|NCT04368910|Antiviral Agents|antiviral agents|mesh-ancestor
93122958|NCT04368910|Schistosomicides|schistosomicides|mesh-ancestor
93122959|NCT04368910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93122960|NCT04368910|Anthelmintics|anthelmintics|mesh-ancestor
93122961|NCT04368910|Amebicides|amebicides|mesh-ancestor
93122962|NCT04368910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93122963|NCT04249258|Dobutamine|dobutamine|mesh-list
93122964|NCT04249258|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93122965|NCT04249258|Sympathomimetics|sympathomimetics|mesh-ancestor
93122966|NCT04249258|Autonomic Agents|autonomic agents|mesh-ancestor
93122967|NCT04249258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122968|NCT04249258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122969|NCT04249258|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93122970|NCT04249258|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93122971|NCT04249258|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93122972|NCT04249258|Adrenergic Agents|adrenergic agents|mesh-ancestor
93122973|NCT04249258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122974|NCT04249258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122975|NCT04249258|Protective Agents|protective agents|mesh-ancestor
93122976|NCT03938584|Ascorbic Acid|ascorbic acid|mesh-list
93122977|NCT03938584|Vitamins|vitamins|mesh-ancestor
93122978|NCT03938584|Micronutrients|micronutrients|mesh-ancestor
93122979|NCT03938584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122980|NCT03938584|Antioxidants|antioxidants|mesh-ancestor
93122981|NCT03938584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122982|NCT03938584|Protective Agents|protective agents|mesh-ancestor
93122983|NCT03269344|Gabapentin|gabapentin|mesh-list
93122984|NCT03269344|Analgesics|analgesics|mesh-ancestor
93122985|NCT03269344|Sensory System Agents|sensory system agents|mesh-ancestor
93122986|NCT03269344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93122987|NCT03269344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93122988|NCT03269344|Anticonvulsants|anticonvulsants|mesh-ancestor
93122989|NCT03269344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93122990|NCT03269344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93122991|NCT03269344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93122992|NCT03269344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93122993|NCT03269344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93122994|NCT03269344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93122995|NCT03269344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93122996|NCT03269344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93122997|NCT03269344|Antimanic Agents|antimanic agents|mesh-ancestor
93122998|NCT04389840|Heparin|heparin|mesh-list
93122999|NCT04389840|Anticoagulants|anticoagulants|mesh-ancestor
93123000|NCT04389840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93123001|NCT04389840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93123002|NCT04389840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123003|NCT03747198|Dimethyl sulfone|dimethyl sulfone|mesh-list
93123004|NCT03747198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123005|NCT02933944|Pembrolizumab|pembrolizumab|mesh-list
93123006|NCT02933944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123007|NCT02933944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123008|NCT02933944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123009|NCT02933944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123010|NCT04307940|Acetaminophen|acetaminophen|mesh-list
93123011|NCT04307940|Naproxen|naproxen|mesh-list
93123012|NCT04307940|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93123013|NCT04307940|Hydrocodone|hydrocodone|mesh-list
93123014|NCT04307940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93123015|NCT04307940|Analgesics|analgesics|mesh-ancestor
93123016|NCT04307940|Sensory System Agents|sensory system agents|mesh-ancestor
93123017|NCT04307940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123018|NCT04307940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123019|NCT04307940|Antipyretics|antipyretics|mesh-ancestor
93123020|NCT04307940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93123021|NCT04307940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123022|NCT04307940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123023|NCT04307940|Gout Suppressants|gout suppressants|mesh-ancestor
93123024|NCT04307940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93123025|NCT04307940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123026|NCT04307940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123027|NCT04307940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93123028|NCT04307940|Narcotics|narcotics|mesh-ancestor
93123029|NCT04307940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123030|NCT04307940|Antitussive Agents|antitussive agents|mesh-ancestor
93123031|NCT04307940|Respiratory System Agents|respiratory system agents|mesh-ancestor
93123032|NCT02717416|Hemostatics|hemostatics|mesh-list
93123033|NCT02717416|Coagulants|coagulants|mesh-ancestor
93123034|NCT02054104|Celecoxib|celecoxib|mesh-list
93123035|NCT02054104|Cyclophosphamide|cyclophosphamide|mesh-list
93123036|NCT02054104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123037|NCT02054104|Immunologic Factors|immunologic factors|mesh-ancestor
93123038|NCT02054104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123039|NCT02054104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123040|NCT02054104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93123041|NCT02054104|Alkylating Agents|alkylating agents|mesh-ancestor
93123042|NCT02054104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123043|NCT02054104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123044|NCT02054104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93123045|NCT02054104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93123046|NCT02054104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93123047|NCT02054104|Analgesics|analgesics|mesh-ancestor
93123048|NCT02054104|Sensory System Agents|sensory system agents|mesh-ancestor
93123049|NCT02054104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123050|NCT02054104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123051|NCT02054104|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93123052|NCT02054104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93123053|NCT02054104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123054|NCT04331704|Tenofovir|tenofovir|mesh-list
93123055|NCT04331704|Emtricitabine|emtricitabine|mesh-list
93123056|NCT04331704|Antiviral Agents|antiviral agents|mesh-ancestor
93123057|NCT04331704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123058|NCT04331704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93123059|NCT04331704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93123060|NCT04331704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123061|NCT04331704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123062|NCT04331704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93123063|NCT04331704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93123064|NCT04229290|Dolutegravir|dolutegravir|mesh-list
93123065|NCT04229290|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93123066|NCT04229290|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93123067|NCT04229290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123068|NCT04229290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123069|NCT04229290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93123070|NCT04229290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93123071|NCT04229290|Antiviral Agents|antiviral agents|mesh-ancestor
93123072|NCT04229290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123073|NCT04181476|Sunscreening Agents|sunscreening agents|mesh-list
93123074|NCT04181476|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93123075|NCT04181476|Protective Agents|protective agents|mesh-ancestor
93123076|NCT04181476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123077|NCT04181476|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123078|NCT03855046|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93123079|NCT03855046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92795271|NCT02885168|Oxymetazoline|oxymetazoline|mesh-list
93123080|NCT03855046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123081|NCT03855046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123082|NCT03855046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93123083|NCT03855046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93123084|NCT03855046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123085|NCT03855046|Cholinergic Agents|cholinergic agents|mesh-ancestor
93123086|NCT03855046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123087|NCT03854110|Gemcitabine|gemcitabine|mesh-list
93123088|NCT03854110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93123089|NCT03854110|Antimetabolites|antimetabolites|mesh-ancestor
93123090|NCT03854110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123091|NCT03854110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123092|NCT04292730|Remdesivir|remdesivir|mesh-list
93123093|NCT04292730|Antimetabolites|antimetabolites|mesh-ancestor
93123094|NCT04292730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123095|NCT04292730|Antiviral Agents|antiviral agents|mesh-ancestor
93123096|NCT04292730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123097|NCT02861014|Ocrelizumab|ocrelizumab|mesh-list
93123098|NCT02861014|Immunologic Factors|immunologic factors|mesh-ancestor
93123099|NCT02861014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123100|NCT04382586|Zanubrutinib|zanubrutinib|mesh-list
93123101|NCT04382586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123102|NCT04382586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123103|NCT04382586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123104|NCT04382586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123105|NCT02737306|Leronlimab|leronlimab|mesh-list
93123106|NCT02737306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93123107|NCT02737306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93123108|NCT02737306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123109|NCT02737306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93123110|NCT02737306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93123111|NCT02737306|Antiviral Agents|antiviral agents|mesh-ancestor
93123112|NCT02737306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123113|NCT02728648|Oxycodone|oxycodone|mesh-list
93123114|NCT02728648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93123115|NCT02728648|Narcotics|narcotics|mesh-ancestor
93123116|NCT02728648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123117|NCT02728648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123118|NCT02728648|Analgesics|analgesics|mesh-ancestor
93123119|NCT02728648|Sensory System Agents|sensory system agents|mesh-ancestor
93123120|NCT02728648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123121|NCT04275336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93123122|NCT04275336|Anesthetics, Local|anesthetics, local|mesh-ancestor
93123123|NCT04275336|Anesthetics|anesthetics|mesh-ancestor
93123124|NCT04275336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123125|NCT04275336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123126|NCT04275336|Sensory System Agents|sensory system agents|mesh-ancestor
93123127|NCT04275336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123128|NCT04275336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93123129|NCT01971970|Adalimumab|adalimumab|mesh-list
93123130|NCT01971970|Infliximab|infliximab|mesh-list
93123131|NCT01971970|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93123132|NCT01971970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123133|NCT01971970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123134|NCT01971970|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123135|NCT01971970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123136|NCT01161394|Pioglitazone|pioglitazone|mesh-list
93123137|NCT01161394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93123138|NCT01161394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123139|NCT04079790|Gepotidacin|gepotidacin|mesh-list
93123140|NCT04079790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93123141|NCT04079790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123142|NCT04079790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123143|NCT04079790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123144|NCT03749226|Aztreonam|aztreonam|mesh-list
93123145|NCT03749226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123146|NCT03749226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123147|NCT04259346|Ixekizumab|ixekizumab|mesh-list
93123148|NCT04259346|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123149|NCT03748836|ALPN-101|alpn-101|mesh-list
93123150|NCT03748836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123151|NCT03748836|Immunologic Factors|immunologic factors|mesh-ancestor
93123152|NCT03748836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123153|NCT03745404|Lidocaine|lidocaine|mesh-list
93123154|NCT03745404|Anesthetics, Local|anesthetics, local|mesh-ancestor
93123155|NCT03745404|Anesthetics|anesthetics|mesh-ancestor
93123156|NCT03745404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123157|NCT03745404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123158|NCT03745404|Sensory System Agents|sensory system agents|mesh-ancestor
93123159|NCT03745404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123160|NCT03745404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93123161|NCT03745404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93123162|NCT03745404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93123163|NCT03745404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93123164|NCT03745404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123165|NCT01348100|Iloperidone|iloperidone|mesh-list
93123166|NCT01348100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93123167|NCT01348100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93123168|NCT01348100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123169|NCT01348100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123170|NCT01348100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93123171|NCT03673670|Tiotropium Bromide|tiotropium bromide|mesh-list
93123172|NCT03673670|Olodaterol|olodaterol|mesh-list
93123173|NCT03673670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93123174|NCT03673670|Autonomic Agents|autonomic agents|mesh-ancestor
93123175|NCT03673670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123176|NCT03673670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123177|NCT03673670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93123178|NCT03673670|Respiratory System Agents|respiratory system agents|mesh-ancestor
93123179|NCT03673670|Parasympatholytics|parasympatholytics|mesh-ancestor
93123180|NCT03673670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93123181|NCT03673670|Cholinergic Agents|cholinergic agents|mesh-ancestor
93123182|NCT03673670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123183|NCT03673670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123184|NCT04369742|Hydroxychloroquine|hydroxychloroquine|mesh-list
93123185|NCT04369742|Calcium|calcium|mesh-list
93123186|NCT04369742|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93123187|NCT04369742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123188|NCT04369742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123189|NCT04369742|Antimalarials|antimalarials|mesh-ancestor
93123190|NCT04369742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93123191|NCT04369742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93123192|NCT04369742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123193|NCT04369742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123194|NCT04369742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123195|NCT03745586|Glucocorticoids|glucocorticoids|mesh-list
93123196|NCT03745586|Hormones|hormones|mesh-ancestor
93123197|NCT03745586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123198|NCT03745586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123199|NCT03055936|Levodopa|levodopa|mesh-list
93123200|NCT03055936|Carbidopa|carbidopa|mesh-list
93123201|NCT03055936|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93123202|NCT03055936|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93123203|NCT03055936|Dopamine Agents|dopamine agents|mesh-ancestor
93123204|NCT03055936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123205|NCT03055936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123206|NCT03055936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123207|NCT03055936|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93123208|NCT03055936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123209|NCT05215366|Arginine Vasopressin|arginine vasopressin|mesh-list
93123210|NCT05215366|Hemostatics|hemostatics|mesh-ancestor
93123211|NCT05215366|Coagulants|coagulants|mesh-ancestor
93123212|NCT05215366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93123213|NCT05215366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93123214|NCT05215366|Natriuretic Agents|natriuretic agents|mesh-ancestor
93123215|NCT05215366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123216|NCT05201170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93123217|NCT03891524|Enoxaparin|enoxaparin|mesh-list
93123218|NCT03891524|Anticoagulants|anticoagulants|mesh-ancestor
93123219|NCT03891524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93123220|NCT03891524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93123221|NCT03891524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123222|NCT04695652|Somatomedin B|somatomedin b|mesh-list
93123223|NCT04695652|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93123224|NCT04695652|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93123225|NCT04695652|Protease Inhibitors|protease inhibitors|mesh-ancestor
93123226|NCT04695652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123227|NCT04695652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123228|NCT04489108|Tranexamic Acid|tranexamic acid|mesh-list
93123229|NCT04489108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93123230|NCT04489108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93123231|NCT04489108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123232|NCT04489108|Hemostatics|hemostatics|mesh-ancestor
93123233|NCT04489108|Coagulants|coagulants|mesh-ancestor
93123234|NCT03771586|Ketamine|ketamine|mesh-list
93123235|NCT03771586|Analgesics|analgesics|mesh-ancestor
93123236|NCT03771586|Sensory System Agents|sensory system agents|mesh-ancestor
93123237|NCT03771586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123238|NCT03771586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123239|NCT03771586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93123240|NCT03771586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93123241|NCT03771586|Anesthetics, General|anesthetics, general|mesh-ancestor
93123242|NCT03771586|Anesthetics|anesthetics|mesh-ancestor
93123243|NCT03771586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123244|NCT03771586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93123245|NCT03771586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93123246|NCT03771586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123247|NCT03771586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123248|NCT02335060|Acetylcysteine|acetylcysteine|mesh-list
93123249|NCT02335060|Dronabinol|dronabinol|mesh-list
93123250|NCT02335060|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93123251|NCT02335060|Antiviral Agents|antiviral agents|mesh-ancestor
93123252|NCT02335060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123253|NCT02335060|Expectorants|expectorants|mesh-ancestor
93123254|NCT02335060|Respiratory System Agents|respiratory system agents|mesh-ancestor
93123255|NCT02335060|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93123256|NCT02335060|Antioxidants|antioxidants|mesh-ancestor
93123257|NCT02335060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123258|NCT02335060|Protective Agents|protective agents|mesh-ancestor
93123259|NCT02335060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123260|NCT02335060|Antidotes|antidotes|mesh-ancestor
93123261|NCT02335060|Hallucinogens|hallucinogens|mesh-ancestor
93123262|NCT02335060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93123263|NCT02335060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93123264|NCT02335060|Analgesics|analgesics|mesh-ancestor
93123265|NCT02335060|Sensory System Agents|sensory system agents|mesh-ancestor
93123266|NCT02335060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123267|NCT02335060|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93123268|NCT02335060|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93123269|NCT02335060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123270|NCT02335060|Hormones|hormones|mesh-ancestor
93123271|NCT02335060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123272|NCT00284986|Remestemcel-l|remestemcel-l|mesh-list
93123273|NCT00284986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123274|NCT00284986|Antiviral Agents|antiviral agents|mesh-ancestor
93123275|NCT00284986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123276|NCT04075604|Nivolumab|nivolumab|mesh-list
93123277|NCT04075604|Palbociclib|palbociclib|mesh-list
93063431|NCT03841474|Sertraline|sertraline|mesh-list
93123278|NCT04075604|Anastrozole|anastrozole|mesh-list
93123279|NCT04075604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123280|NCT04075604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123281|NCT04075604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123282|NCT04075604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123283|NCT04075604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123284|NCT04075604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123285|NCT04075604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123286|NCT04075604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93123287|NCT04075604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93123288|NCT04075604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93123289|NCT04075604|Hormone Antagonists|hormone antagonists|mesh-ancestor
93123290|NCT04075604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123291|NCT04075604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123292|NCT01765400|Clopidogrel|clopidogrel|mesh-list
93123293|NCT01765400|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93123294|NCT01765400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93123295|NCT01765400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93123296|NCT01765400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93123297|NCT01765400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93123298|NCT01765400|Purinergic Agents|purinergic agents|mesh-ancestor
93123299|NCT01765400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123300|NCT01765400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123301|NCT01765400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123302|NCT05217238|Remifentanil|remifentanil|mesh-list
93123303|NCT05217238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93123304|NCT05217238|Narcotics|narcotics|mesh-ancestor
93123305|NCT05217238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123306|NCT05217238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123307|NCT05217238|Analgesics|analgesics|mesh-ancestor
93123308|NCT05217238|Sensory System Agents|sensory system agents|mesh-ancestor
93123309|NCT05217238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123310|NCT05217160|Morphine|morphine|mesh-list
93123311|NCT05217160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93123312|NCT05217160|Narcotics|narcotics|mesh-ancestor
93123313|NCT05217160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123314|NCT05217160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123315|NCT05217160|Analgesics|analgesics|mesh-ancestor
93123316|NCT05217160|Sensory System Agents|sensory system agents|mesh-ancestor
93123317|NCT05217160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123318|NCT01495676|Cisplatin|cisplatin|mesh-list
93123319|NCT01495676|Gemcitabine|gemcitabine|mesh-list
93123320|NCT01495676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123321|NCT01495676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93123322|NCT01495676|Antimetabolites|antimetabolites|mesh-ancestor
93123323|NCT01495676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123324|NCT05052970|Dexamethasone|dexamethasone|mesh-list
93123325|NCT05052970|Dexamethasone acetate|dexamethasone acetate|mesh-list
93123326|NCT05052970|Bortezomib|bortezomib|mesh-list
93123327|NCT05052970|Mitoxantrone|mitoxantrone|mesh-list
93123328|NCT05052970|BB 1101|bb 1101|mesh-list
93123329|NCT05052970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123330|NCT05052970|Antiemetics|antiemetics|mesh-ancestor
93123331|NCT05052970|Autonomic Agents|autonomic agents|mesh-ancestor
93123332|NCT05052970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123333|NCT05052970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123334|NCT05052970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123335|NCT05052970|Glucocorticoids|glucocorticoids|mesh-ancestor
93123336|NCT05052970|Hormones|hormones|mesh-ancestor
93123337|NCT05052970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123338|NCT05052970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123339|NCT05052970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123340|NCT05052970|Protease Inhibitors|protease inhibitors|mesh-ancestor
93123341|NCT05052970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123342|NCT05052970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123343|NCT05052970|Analgesics|analgesics|mesh-ancestor
93123344|NCT05052970|Sensory System Agents|sensory system agents|mesh-ancestor
93123345|NCT05052970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93123346|NCT05052970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93123347|NCT04903210|Niacinamide|niacinamide|mesh-list
93123348|NCT04903210|Niacin|niacin|mesh-list
93123349|NCT04903210|Nicotinic Acids|nicotinic acids|mesh-list
93123350|NCT04903210|Vitamin B Complex|vitamin b complex|mesh-ancestor
93123351|NCT04903210|Vitamins|vitamins|mesh-ancestor
93123352|NCT04903210|Micronutrients|micronutrients|mesh-ancestor
93123353|NCT04903210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123354|NCT04903210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93123355|NCT04903210|Antimetabolites|antimetabolites|mesh-ancestor
93123356|NCT04903210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123357|NCT04903210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93123358|NCT04903210|Vasodilator Agents|vasodilator agents|mesh-ancestor
93123359|NCT04719208|Chlorhexidine|chlorhexidine|mesh-list
93123360|NCT04719208|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93123361|NCT04719208|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93123362|NCT04719208|Povidone-Iodine|povidone-iodine|mesh-list
93123363|NCT04719208|Listerine|listerine|mesh-list
93123364|NCT04719208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93123365|NCT04719208|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93123366|NCT04719208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123367|NCT04719208|Disinfectants|disinfectants|mesh-ancestor
93123368|NCT04719208|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123369|NCT04701190|Norepinephrine|norepinephrine|mesh-list
93123370|NCT04701190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123371|NCT04701190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93123372|NCT04701190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93123373|NCT04701190|Adrenergic Agents|adrenergic agents|mesh-ancestor
93123374|NCT04701190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123375|NCT04701190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123376|NCT04701190|Sympathomimetics|sympathomimetics|mesh-ancestor
93123377|NCT04701190|Autonomic Agents|autonomic agents|mesh-ancestor
93123378|NCT04701190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795576|NCT00645502|Risperidone|risperidone|mesh-list
93123379|NCT04701190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93123380|NCT04496362|Heparin|heparin|mesh-list
93123381|NCT04496362|Anticoagulants|anticoagulants|mesh-ancestor
93123382|NCT04496362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93123383|NCT04496362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93123384|NCT04496362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123385|NCT04423588|Dexlansoprazole|dexlansoprazole|mesh-list
93123386|NCT04423588|Lansoprazole|lansoprazole|mesh-list
93123387|NCT04423588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93123388|NCT04423588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123389|NCT04423588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93123390|NCT04423588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123391|NCT04423588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123392|NCT04090684|Ciprofloxacin|ciprofloxacin|mesh-list
93123393|NCT04090684|Celecoxib|celecoxib|mesh-list
93123394|NCT04090684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93123395|NCT04090684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93123396|NCT04090684|Analgesics|analgesics|mesh-ancestor
93123397|NCT04090684|Sensory System Agents|sensory system agents|mesh-ancestor
93123398|NCT04090684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123399|NCT04090684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123400|NCT04090684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123401|NCT04090684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123402|NCT04090684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93123403|NCT04090684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93123404|NCT04090684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123405|NCT04090684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123406|NCT04090684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123407|NCT04090684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123408|NCT04090684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93123409|NCT04090684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93123410|NCT04090684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123411|NCT04090684|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93123412|NCT04090684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93123413|NCT04963816|Dexamethasone|dexamethasone|mesh-list
93123414|NCT04963816|Dexamethasone acetate|dexamethasone acetate|mesh-list
93123415|NCT04963816|Bupivacaine|bupivacaine|mesh-list
93123416|NCT04963816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93123417|NCT04963816|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93123418|NCT04963816|BB 1101|bb 1101|mesh-list
93123419|NCT04963816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123420|NCT04963816|Antiemetics|antiemetics|mesh-ancestor
93123421|NCT04963816|Autonomic Agents|autonomic agents|mesh-ancestor
93123422|NCT04963816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123423|NCT04963816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123424|NCT04963816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123425|NCT04963816|Glucocorticoids|glucocorticoids|mesh-ancestor
93123426|NCT04963816|Hormones|hormones|mesh-ancestor
93232081|NCT01332617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93123427|NCT04963816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123428|NCT04963816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123429|NCT04963816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123430|NCT04963816|Protease Inhibitors|protease inhibitors|mesh-ancestor
93123431|NCT04963816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123432|NCT04963816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123433|NCT04963816|Anesthetics, Local|anesthetics, local|mesh-ancestor
93123434|NCT04963816|Anesthetics|anesthetics|mesh-ancestor
93123435|NCT04963816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123436|NCT04963816|Sensory System Agents|sensory system agents|mesh-ancestor
93123437|NCT04933240|Tamoxifen|tamoxifen|mesh-list
93123438|NCT04933240|Estradiol|estradiol|mesh-list
93123439|NCT04933240|Estrogens|estrogens|mesh-ancestor
93123440|NCT04933240|Hormones|hormones|mesh-ancestor
93123441|NCT04933240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123442|NCT04933240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123443|NCT04933240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93123444|NCT04933240|Hormone Antagonists|hormone antagonists|mesh-ancestor
93123445|NCT04933240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123446|NCT04933240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123447|NCT04933240|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93123448|NCT04933240|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93123449|NCT04933240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93123450|NCT01317940|Calcium, Dietary|calcium, dietary|mesh-list
93123451|NCT01317940|Vitamin D|vitamin d|mesh-list
93123452|NCT01317940|Calcitriol|calcitriol|mesh-list
93123453|NCT01317940|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93123454|NCT01317940|Calcium Carbonate|calcium carbonate|mesh-list
93123455|NCT01317940|Calcium|calcium|mesh-list
93123456|NCT01317940|Vitamins|vitamins|mesh-ancestor
93123457|NCT01317940|Micronutrients|micronutrients|mesh-ancestor
93123458|NCT01317940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123459|NCT01317940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93123460|NCT01317940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93123461|NCT01317940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123462|NCT01317940|Antacids|antacids|mesh-ancestor
93123463|NCT01317940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123464|NCT01317940|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93123465|NCT01317940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93123466|NCT01317940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93123467|NCT05706688|Anesthetics|anesthetics|mesh-list
93123468|NCT05706688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123469|NCT05706688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123470|NCT05706454|Ramatroban|ramatroban|mesh-list
93123471|NCT05706454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93123472|NCT01317550|Minocycline|minocycline|mesh-list
93123473|NCT01317550|Modafinil|modafinil|mesh-list
93123474|NCT01317550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123475|NCT01317550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123476|NCT01317550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93123477|NCT01317550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123478|NCT01317550|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93123479|NCT01317550|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93123480|NCT01317550|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93123481|NCT01317550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123482|NCT01317472|Dexlansoprazole|dexlansoprazole|mesh-list
93123483|NCT01317472|Lansoprazole|lansoprazole|mesh-list
93123484|NCT01317472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93123485|NCT01317472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123486|NCT01317472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93123487|NCT01317472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123488|NCT01317472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123489|NCT01345630|Ritonavir|ritonavir|mesh-list
93123490|NCT01345630|Darunavir|darunavir|mesh-list
93123491|NCT01345630|Tenofovir|tenofovir|mesh-list
93123492|NCT01345630|Emtricitabine|emtricitabine|mesh-list
93123493|NCT01345630|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93123494|NCT01345630|Maraviroc|maraviroc|mesh-list
93123495|NCT01345630|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93123496|NCT01345630|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93123497|NCT01345630|Protease Inhibitors|protease inhibitors|mesh-ancestor
93123498|NCT01345630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123499|NCT01345630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123500|NCT01345630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93123501|NCT01345630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93123502|NCT01345630|Antiviral Agents|antiviral agents|mesh-ancestor
93123503|NCT01345630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123504|NCT01345630|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93123505|NCT01345630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93123506|NCT01345630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93123507|NCT01345630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93123508|NCT01345630|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93123509|NCT01345630|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93123510|NCT01345630|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93123511|NCT03693612|Paclitaxel|paclitaxel|mesh-list
93123512|NCT03693612|Docetaxel|docetaxel|mesh-list
93123513|NCT03693612|Cetuximab|cetuximab|mesh-list
93123514|NCT03693612|Tremelimumab|tremelimumab|mesh-list
93123515|NCT03693612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93123516|NCT03693612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123517|NCT03693612|Tubulin Modulators|tubulin modulators|mesh-ancestor
93123518|NCT03693612|Antimitotic Agents|antimitotic agents|mesh-ancestor
93123519|NCT03693612|Mitosis Modulators|mitosis modulators|mesh-ancestor
93123520|NCT03693612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123521|NCT03693612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123522|NCT03746652|Dexamethasone|dexamethasone|mesh-list
93123523|NCT03746652|Daratumumab|daratumumab|mesh-list
93123524|NCT03746652|Ixazomib|ixazomib|mesh-list
93123525|NCT03746652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123526|NCT03746652|Antiemetics|antiemetics|mesh-ancestor
93123527|NCT03746652|Autonomic Agents|autonomic agents|mesh-ancestor
93123528|NCT03746652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123529|NCT03746652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123530|NCT03746652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123531|NCT03746652|Glucocorticoids|glucocorticoids|mesh-ancestor
93123532|NCT03746652|Hormones|hormones|mesh-ancestor
93123533|NCT03746652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123534|NCT03746652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123535|NCT03746652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123536|NCT03746652|Protease Inhibitors|protease inhibitors|mesh-ancestor
93123537|NCT03746652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123538|NCT03746652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123539|NCT01562808|Aripiprazole|aripiprazole|mesh-list
93123540|NCT01562808|Antidepressive Agents|antidepressive agents|mesh-ancestor
93123541|NCT01562808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93123542|NCT01562808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93123543|NCT01562808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93123544|NCT01562808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123545|NCT01562808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123546|NCT01562808|Dopamine Agonists|dopamine agonists|mesh-ancestor
93123547|NCT01562808|Dopamine Agents|dopamine agents|mesh-ancestor
93123548|NCT01562808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123549|NCT01562808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123550|NCT01562808|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93123551|NCT01562808|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93123552|NCT01562808|Serotonin Agents|serotonin agents|mesh-ancestor
93123553|NCT01562808|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93123554|NCT01562808|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93123555|NCT01562808|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93123556|NCT01562808|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93123557|NCT04051944|Rozanolixizumab|rozanolixizumab|mesh-list
93123558|NCT04051944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123559|NCT04051944|Immunologic Factors|immunologic factors|mesh-ancestor
93123560|NCT04051944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123561|NCT04067492|Diclofenac|diclofenac|mesh-list
93123562|NCT04067492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93123563|NCT04067492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93123564|NCT04067492|Analgesics|analgesics|mesh-ancestor
93123565|NCT04067492|Sensory System Agents|sensory system agents|mesh-ancestor
93123566|NCT04067492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123567|NCT04067492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123568|NCT04067492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123569|NCT04067492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123570|NCT04067492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93123571|NCT04067492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123572|NCT04067492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123573|NCT04186806|Muramidase|muramidase|mesh-list
93123574|NCT04186806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123575|NCT03748446|Xenon|xenon|mesh-list
93123576|NCT03748446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93123577|NCT03748446|Anesthetics, General|anesthetics, general|mesh-ancestor
93123578|NCT03748446|Anesthetics|anesthetics|mesh-ancestor
93123579|NCT03748446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123580|NCT03748446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123581|NCT04036110|Vitamins|vitamins|mesh-list
93123582|NCT04036110|Ascorbic Acid|ascorbic acid|mesh-list
93123583|NCT04036110|Micronutrients|micronutrients|mesh-ancestor
93123584|NCT04036110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123585|NCT04036110|Antioxidants|antioxidants|mesh-ancestor
93123586|NCT04036110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123587|NCT04036110|Protective Agents|protective agents|mesh-ancestor
93123588|NCT03053050|Selonsertib|selonsertib|mesh-list
93123589|NCT03053050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123590|NCT03053050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123591|NCT03053050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123592|NCT04369950|Lidocaine|lidocaine|mesh-list
93123593|NCT04369950|Epinephrine|epinephrine|mesh-list
93123594|NCT04369950|Morphine|morphine|mesh-list
93123595|NCT04369950|Chloroprocaine|chloroprocaine|mesh-list
93123596|NCT04369950|Anesthetics, Local|anesthetics, local|mesh-ancestor
93123597|NCT04369950|Anesthetics|anesthetics|mesh-ancestor
93123598|NCT04369950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123599|NCT04369950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123600|NCT04369950|Sensory System Agents|sensory system agents|mesh-ancestor
93123601|NCT04369950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123602|NCT04369950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93123603|NCT04369950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93123604|NCT04369950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93123605|NCT04369950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93123606|NCT04369950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123607|NCT04369950|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93123608|NCT04369950|Narcotics|narcotics|mesh-ancestor
93123609|NCT04369950|Analgesics|analgesics|mesh-ancestor
93123610|NCT04369950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93123611|NCT04369950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93123612|NCT04369950|Adrenergic Agents|adrenergic agents|mesh-ancestor
93123613|NCT04369950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123614|NCT04369950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93123615|NCT04369950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93123616|NCT04369950|Autonomic Agents|autonomic agents|mesh-ancestor
93123617|NCT04369950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93123618|NCT04369950|Respiratory System Agents|respiratory system agents|mesh-ancestor
93123619|NCT04369950|Mydriatics|mydriatics|mesh-ancestor
93123620|NCT04369950|Sympathomimetics|sympathomimetics|mesh-ancestor
93123621|NCT04369950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93123622|NCT02955602|Seladelpar|seladelpar|mesh-list
93123623|NCT02955602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93123624|NCT02955602|Antimetabolites|antimetabolites|mesh-ancestor
93123625|NCT02955602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123626|NCT02955602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93123627|NCT03748290|Pregabalin|pregabalin|mesh-list
93123628|NCT03748290|Analgesics|analgesics|mesh-ancestor
93123629|NCT03748290|Sensory System Agents|sensory system agents|mesh-ancestor
93123630|NCT03748290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123631|NCT03748290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123632|NCT03748290|Anticonvulsants|anticonvulsants|mesh-ancestor
93123633|NCT03748290|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93123634|NCT03748290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93123635|NCT03748290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123636|NCT03748290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93123637|NCT03748290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93123638|NCT03748290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93123639|NCT03748290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123640|NCT03748290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93123641|NCT05651074|Omeprazole|omeprazole|mesh-list
93123642|NCT05651074|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93123643|NCT05651074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123644|NCT05651074|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93123645|NCT05651074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123646|NCT05651074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123647|NCT03738956|Tofacitinib|tofacitinib|mesh-list
93123648|NCT03738956|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93123649|NCT03738956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123650|NCT03738956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123651|NCT03738956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123652|NCT03738800|Trifarotene|trifarotene|mesh-list
93123653|NCT03738800|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123654|NCT05609656|Pembrolizumab|pembrolizumab|mesh-list
93123655|NCT05609656|Calcium|calcium|mesh-list
93123656|NCT05609656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123657|NCT05609656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123658|NCT05609656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123659|NCT05609656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123660|NCT05609656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93123661|NCT05609656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123662|NCT04175808|Moxifloxacin|moxifloxacin|mesh-list
93123663|NCT04175808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123664|NCT04175808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123665|NCT04175808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93123666|NCT04175808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93123667|NCT04175808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123668|NCT04175808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123669|NCT04175808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123670|NCT05598424|Methylprednisolone|methylprednisolone|mesh-list
93123671|NCT05598424|Glucocorticoids|glucocorticoids|mesh-list
93123672|NCT05598424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123673|NCT05598424|Antiemetics|antiemetics|mesh-ancestor
93123674|NCT05598424|Autonomic Agents|autonomic agents|mesh-ancestor
93123675|NCT05598424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123676|NCT05598424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123677|NCT05598424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123678|NCT05598424|Hormones|hormones|mesh-ancestor
93123679|NCT05598424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123680|NCT05598424|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93123681|NCT05598424|Protective Agents|protective agents|mesh-ancestor
93123683|NCT05501860|Anesthetics, Local|anesthetics, local|mesh-ancestor
93123684|NCT05501860|Anesthetics|anesthetics|mesh-ancestor
93123685|NCT05501860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123686|NCT05501860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123687|NCT05501860|Sensory System Agents|sensory system agents|mesh-ancestor
93123688|NCT05501860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123689|NCT03738176|Triamcinolone|triamcinolone|mesh-list
93123690|NCT03738176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123691|NCT03738176|Glucocorticoids|glucocorticoids|mesh-ancestor
93123692|NCT03738176|Hormones|hormones|mesh-ancestor
93123693|NCT03738176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123694|NCT03738176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123695|NCT03051100|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93123696|NCT03051100|Atorvastatin|atorvastatin|mesh-list
93123697|NCT03051100|Ezetimibe|ezetimibe|mesh-list
93123698|NCT03051100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93123699|NCT03051100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93123700|NCT03051100|Antimetabolites|antimetabolites|mesh-ancestor
93123701|NCT03051100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123702|NCT03051100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93123703|NCT03051100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93123704|NCT03051100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123705|NCT03051100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93123706|NCT03051100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123707|NCT05280028|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93123708|NCT05280028|Tibolone|tibolone|mesh-list
93123709|NCT05280028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93123710|NCT05280028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93123711|NCT05280028|Medroxyprogesterone|medroxyprogesterone|mesh-list
93123712|NCT05280028|Estradiol|estradiol|mesh-list
93123713|NCT05280028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93123714|NCT05280028|Estrogens|estrogens|mesh-ancestor
93123715|NCT05280028|Hormones|hormones|mesh-ancestor
93123716|NCT05280028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123717|NCT05280028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123718|NCT05280028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93123719|NCT05280028|Contraceptive Agents|contraceptive agents|mesh-ancestor
93123720|NCT05280028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93123721|NCT05280028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93123722|NCT05280028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93123723|NCT05280028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93123724|NCT05280028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93123725|NCT05280028|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93123726|NCT05280028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123727|NCT05280028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123728|NCT05280028|Androgen Antagonists|androgen antagonists|mesh-ancestor
93123729|NCT05280028|Hormone Antagonists|hormone antagonists|mesh-ancestor
93123730|NCT05280028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93123731|NCT05280028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93123732|NCT05280028|Anabolic Agents|anabolic agents|mesh-ancestor
93123733|NCT05569876|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93123734|NCT05569876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123735|NCT01343368|Leuprolide|leuprolide|mesh-list
93123736|NCT01343368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93123737|NCT01343368|Fertility Agents|fertility agents|mesh-ancestor
93123738|NCT01343368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93123739|NCT01343368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123740|NCT01343368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123741|NCT01343368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123742|NCT02955212|Upadacitinib|upadacitinib|mesh-list
93123743|NCT02955212|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93123744|NCT02955212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123745|NCT02955212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123746|NCT02955212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123747|NCT02955212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123748|NCT03050398|Letrozole|letrozole|mesh-list
93123749|NCT03050398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123750|NCT03050398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93123751|NCT03050398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93123752|NCT03050398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123753|NCT03050398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123754|NCT03050398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92795947|NCT02666014|Cholinergic Agents|cholinergic agents|mesh-ancestor
93123756|NCT03050398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123757|NCT03050398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123758|NCT03626506|Amlodipine|amlodipine|mesh-list
93123759|NCT03626506|Indapamide|indapamide|mesh-list
93123760|NCT03626506|Spironolactone|spironolactone|mesh-list
93123761|NCT03626506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93123762|NCT03626506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93123763|NCT03626506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93123764|NCT03626506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123765|NCT03626506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93123766|NCT03626506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123767|NCT03626506|Vasodilator Agents|vasodilator agents|mesh-ancestor
93123768|NCT03626506|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93123769|NCT03626506|Hormone Antagonists|hormone antagonists|mesh-ancestor
93123770|NCT03626506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123771|NCT03626506|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93123772|NCT03626506|Diuretics|diuretics|mesh-ancestor
93123773|NCT03626506|Natriuretic Agents|natriuretic agents|mesh-ancestor
93123774|NCT03626506|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93123775|NCT03737708|Adalimumab|adalimumab|mesh-list
93123776|NCT03737708|Methotrexate|methotrexate|mesh-list
93123777|NCT03737708|Abatacept|abatacept|mesh-list
93123778|NCT03737708|Tacrolimus|tacrolimus|mesh-list
93123779|NCT03737708|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93123780|NCT03737708|Abortifacient Agents|abortifacient agents|mesh-ancestor
93123781|NCT03737708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93123782|NCT03737708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123783|NCT03737708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93123784|NCT03737708|Antimetabolites|antimetabolites|mesh-ancestor
93123785|NCT03737708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123786|NCT03737708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123787|NCT03737708|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123788|NCT03737708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123789|NCT03737708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93123790|NCT03737708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123791|NCT03737708|Immunologic Factors|immunologic factors|mesh-ancestor
93123792|NCT03737708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93123793|NCT03737708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93123794|NCT03737708|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93123795|NCT03737708|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93123796|NCT03737708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123797|NCT03737708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123798|NCT03737708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123799|NCT05517928|Omeprazole|omeprazole|mesh-list
93123800|NCT05517928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93123801|NCT05517928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123802|NCT05517928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93123803|NCT05517928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123804|NCT05517928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123805|NCT04052204|Avelumab|avelumab|mesh-list
93123806|NCT04052204|Talazoparib|talazoparib|mesh-list
93123807|NCT04052204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123808|NCT04052204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123809|NCT04052204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93123810|NCT04052204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123811|NCT04052204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123812|NCT04050722|Listerine|listerine|mesh-list
93123813|NCT04050722|Sodium Fluoride|sodium fluoride|mesh-list
93123814|NCT04050722|Cariostatic Agents|cariostatic agents|mesh-ancestor
93123815|NCT04050722|Protective Agents|protective agents|mesh-ancestor
93123816|NCT04050722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123817|NCT04050722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93123818|NCT04050722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123819|NCT04049552|Sirolimus|sirolimus|mesh-list
93123820|NCT04049552|Temsirolimus|temsirolimus|mesh-list
93123821|NCT04049552|MTOR Inhibitors|mtor inhibitors|mesh-list
93123822|NCT04049552|Petrolatum|petrolatum|mesh-list
93123823|NCT04049552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123824|NCT04049552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123825|NCT04049552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93123826|NCT04049552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123827|NCT04049552|Antifungal Agents|antifungal agents|mesh-ancestor
92796022|NCT00646594|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123828|NCT04049552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123829|NCT04049552|Immunologic Factors|immunologic factors|mesh-ancestor
93123830|NCT04049552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123831|NCT04049552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123832|NCT04049552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123833|NCT04049552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123834|NCT04049552|Emollients|emollients|mesh-ancestor
93123835|NCT04049552|Dermatologic Agents|dermatologic agents|mesh-ancestor
93123836|NCT03737474|Brexpiprazole|brexpiprazole|mesh-list
93123837|NCT03737474|Serotonin Agents|serotonin agents|mesh-ancestor
93123838|NCT03737474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123839|NCT03737474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123840|NCT03737474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123841|NCT03737474|Dopamine Agonists|dopamine agonists|mesh-ancestor
93123842|NCT03737474|Dopamine Agents|dopamine agents|mesh-ancestor
93123843|NCT03048058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93123844|NCT03048058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93123845|NCT03048058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93123846|NCT03048058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93123847|NCT03048058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93123848|NCT03048058|Adrenergic Agents|adrenergic agents|mesh-ancestor
93123849|NCT03048058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93123850|NCT03048058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123851|NCT03048058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123852|NCT03047980|Sirolimus|sirolimus|mesh-list
93123853|NCT03047980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123854|NCT03047980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123855|NCT03047980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93123856|NCT03047980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123857|NCT03047980|Antifungal Agents|antifungal agents|mesh-ancestor
93123858|NCT03047980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123859|NCT03047980|Immunologic Factors|immunologic factors|mesh-ancestor
93123860|NCT03047980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123861|NCT04022980|Nivolumab|nivolumab|mesh-list
93123862|NCT04022980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123863|NCT04022980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123864|NCT04022980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123865|NCT04022980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123866|NCT03876028|Tisagenlecleucel|tisagenlecleucel|mesh-list
93123867|NCT03876028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123868|NCT03876028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123869|NCT03732482|Temozolomide|temozolomide|mesh-list
93123870|NCT03732482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93123871|NCT03732482|Alkylating Agents|alkylating agents|mesh-ancestor
93232082|NCT03569696|Nivolumab|nivolumab|mesh-list
93064031|NCT05345002|Tretinoin|tretinoin|mesh-list
93123872|NCT03732482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123873|NCT03732482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123874|NCT04047446|Dexamethasone|dexamethasone|mesh-list
93123875|NCT04047446|Bupivacaine|bupivacaine|mesh-list
93123876|NCT04047446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93123877|NCT04047446|Antiemetics|antiemetics|mesh-ancestor
93123878|NCT04047446|Autonomic Agents|autonomic agents|mesh-ancestor
93123879|NCT04047446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93123880|NCT04047446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123881|NCT04047446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93123882|NCT04047446|Glucocorticoids|glucocorticoids|mesh-ancestor
93123883|NCT04047446|Hormones|hormones|mesh-ancestor
93123884|NCT04047446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123885|NCT04047446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93123886|NCT04047446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123887|NCT04047446|Anesthetics, Local|anesthetics, local|mesh-ancestor
93123888|NCT04047446|Anesthetics|anesthetics|mesh-ancestor
93123889|NCT04047446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93123890|NCT04047446|Sensory System Agents|sensory system agents|mesh-ancestor
93123891|NCT02782546|Mycophenolic Acid|mycophenolic acid|mesh-list
93123892|NCT02782546|Tacrolimus|tacrolimus|mesh-list
93123893|NCT02782546|Lenograstim|lenograstim|mesh-list
93123894|NCT02782546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93123895|NCT02782546|Immunologic Factors|immunologic factors|mesh-ancestor
93123896|NCT02782546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123897|NCT02782546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93123898|NCT02782546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123899|NCT02782546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123900|NCT02782546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93123901|NCT02782546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123902|NCT02782546|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93123903|NCT02782546|Antitubercular Agents|antitubercular agents|mesh-ancestor
93123904|NCT02782546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123905|NCT02782546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123906|NCT02782546|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93123908|NCT03629054|Empagliflozin|empagliflozin|mesh-list
93123909|NCT03629054|Linagliptin|linagliptin|mesh-list
93123910|NCT03629054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93123911|NCT03629054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123912|NCT03629054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93123913|NCT03629054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123914|NCT03629054|Incretins|incretins|mesh-ancestor
93123915|NCT03629054|Hormones|hormones|mesh-ancestor
93123916|NCT03629054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93123917|NCT03629054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93123918|NCT03629054|Protease Inhibitors|protease inhibitors|mesh-ancestor
93123919|NCT03629054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123920|NCT02754856|Durvalumab|durvalumab|mesh-list
93123921|NCT02754856|Ipilimumab|ipilimumab|mesh-list
93123922|NCT02754856|Tremelimumab|tremelimumab|mesh-list
93123923|NCT02754856|Immunoglobulins|immunoglobulins|mesh-list
93123924|NCT02754856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93123925|NCT02754856|Immunoglobulin G|immunoglobulin g|mesh-list
93123926|NCT02754856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93123927|NCT02754856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123928|NCT02754856|Immunologic Factors|immunologic factors|mesh-ancestor
93123929|NCT02754856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123930|NCT02754856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123931|NCT02754856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123932|NCT02573896|Lenalidomide|lenalidomide|mesh-list
93123933|NCT02573896|Dinutuximab|dinutuximab|mesh-list
93123934|NCT02573896|Immunologic Factors|immunologic factors|mesh-ancestor
93123935|NCT02573896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123936|NCT02573896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93123937|NCT02573896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93123938|NCT02573896|Growth Substances|growth substances|mesh-ancestor
93123939|NCT02573896|Growth Inhibitors|growth inhibitors|mesh-ancestor
93123940|NCT02573896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123941|NCT03045328|Venetoclax|venetoclax|mesh-list
93123942|NCT03045328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123943|NCT02154490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93123944|NCT02154490|Nivolumab|nivolumab|mesh-list
93123945|NCT02154490|Ipilimumab|ipilimumab|mesh-list
93123946|NCT02154490|Durvalumab|durvalumab|mesh-list
93123947|NCT02154490|Rilotumumab|rilotumumab|mesh-list
93123948|NCT02154490|Docetaxel|docetaxel|mesh-list
93123949|NCT02154490|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93123950|NCT02154490|Palbociclib|palbociclib|mesh-list
93123951|NCT02154490|Tremelimumab|tremelimumab|mesh-list
93123952|NCT02154490|Talazoparib|talazoparib|mesh-list
93123953|NCT02154490|Antibodies|antibodies|mesh-list
93123954|NCT02154490|Immunoglobulins|immunoglobulins|mesh-list
93123955|NCT02154490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93123956|NCT02154490|Immunoglobulin G|immunoglobulin g|mesh-list
93123957|NCT02154490|Immunologic Factors|immunologic factors|mesh-ancestor
93123958|NCT02154490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123959|NCT02154490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123960|NCT02154490|Tubulin Modulators|tubulin modulators|mesh-ancestor
93123961|NCT02154490|Antimitotic Agents|antimitotic agents|mesh-ancestor
93123962|NCT02154490|Mitosis Modulators|mitosis modulators|mesh-ancestor
93123963|NCT02154490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123964|NCT02154490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93123965|NCT02154490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93123966|NCT02154490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93123967|NCT02154490|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93123968|NCT01512316|Cycloserine|cycloserine|mesh-list
93123969|NCT01512316|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93123970|NCT01512316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123971|NCT01512316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93123972|NCT01512316|Antitubercular Agents|antitubercular agents|mesh-ancestor
93123973|NCT01512316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93123974|NCT01512316|Antimetabolites|antimetabolites|mesh-ancestor
93123975|NCT01512316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123976|NCT01286272|Deoxyglucose|deoxyglucose|mesh-list
93123977|NCT01286272|Bortezomib|bortezomib|mesh-list
93123978|NCT01286272|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93123979|NCT01286272|Ofatumumab|ofatumumab|mesh-list
93123980|NCT01286272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93123981|NCT01286272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93123982|NCT01286272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93123983|NCT01286272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93123984|NCT01286272|Alkylating Agents|alkylating agents|mesh-ancestor
93123985|NCT01286272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93123986|NCT01286272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93123987|NCT01286272|Antimetabolites|antimetabolites|mesh-ancestor
93123988|NCT01286272|Antiviral Agents|antiviral agents|mesh-ancestor
93123989|NCT01286272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93123990|NCT01286272|Immunologic Factors|immunologic factors|mesh-ancestor
93123991|NCT01286272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123992|NCT03639740|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93123993|NCT03639740|Immunologic Factors|immunologic factors|mesh-ancestor
93123994|NCT03639740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93123995|NCT01048138|Biperiden|biperiden|mesh-list
93123996|NCT01048138|Biperiden lactate|biperiden lactate|mesh-list
93123997|NCT01048138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93123998|NCT01048138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93123999|NCT01048138|Parasympatholytics|parasympatholytics|mesh-ancestor
93124000|NCT01048138|Autonomic Agents|autonomic agents|mesh-ancestor
93124001|NCT01048138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124002|NCT01048138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124003|NCT01048138|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93124004|NCT01048138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93124005|NCT01048138|Cholinergic Agents|cholinergic agents|mesh-ancestor
93124006|NCT01048138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124007|NCT01048138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124008|NCT00972478|Prednisone|prednisone|mesh-list
93124009|NCT00972478|Cortisone|cortisone|mesh-list
93124010|NCT00972478|Cyclophosphamide|cyclophosphamide|mesh-list
93124011|NCT00972478|Rituximab|rituximab|mesh-list
93124012|NCT00972478|Doxorubicin|doxorubicin|mesh-list
93124013|NCT00972478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93124014|NCT00972478|Vincristine|vincristine|mesh-list
93124015|NCT00972478|Vorinostat|vorinostat|mesh-list
93124016|NCT00972478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93124017|NCT00972478|Antibodies|antibodies|mesh-list
93124018|NCT00972478|Immunoglobulins|immunoglobulins|mesh-list
93124019|NCT00972478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93124020|NCT00972478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93124021|NCT00972478|Immunologic Factors|immunologic factors|mesh-ancestor
93124022|NCT00972478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124023|NCT00972478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93124024|NCT00972478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93124025|NCT00972478|Alkylating Agents|alkylating agents|mesh-ancestor
93124026|NCT00972478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124027|NCT00972478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124028|NCT00972478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93124029|NCT00972478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93124030|NCT00972478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93124031|NCT00972478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93124032|NCT00972478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124033|NCT00972478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124034|NCT00972478|Glucocorticoids|glucocorticoids|mesh-ancestor
93124035|NCT00972478|Hormones|hormones|mesh-ancestor
93124036|NCT00972478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124037|NCT00972478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124038|NCT00972478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93124039|NCT00972478|Tubulin Modulators|tubulin modulators|mesh-ancestor
93124040|NCT00972478|Antimitotic Agents|antimitotic agents|mesh-ancestor
93124041|NCT00972478|Mitosis Modulators|mitosis modulators|mesh-ancestor
93124042|NCT00972478|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93124043|NCT00823342|Tenofovir|tenofovir|mesh-list
93124044|NCT00823342|Clevudine|clevudine|mesh-list
93124045|NCT00823342|Antiviral Agents|antiviral agents|mesh-ancestor
93124046|NCT00823342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124047|NCT00823342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93124048|NCT00823342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93124049|NCT00823342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124050|NCT00823342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124051|NCT00823342|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93124052|NCT00823342|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93124053|NCT01082445|Acetylcysteine|acetylcysteine|mesh-list
93124054|NCT01082445|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93124055|NCT01082445|Antiviral Agents|antiviral agents|mesh-ancestor
93124056|NCT01082445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124057|NCT01082445|Expectorants|expectorants|mesh-ancestor
93124058|NCT01082445|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124059|NCT01082445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93124060|NCT01082445|Antioxidants|antioxidants|mesh-ancestor
93124061|NCT01082445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124062|NCT01082445|Protective Agents|protective agents|mesh-ancestor
93124063|NCT01082445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124064|NCT01082445|Antidotes|antidotes|mesh-ancestor
93124065|NCT01085877|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93124066|NCT01085877|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93124067|NCT01085877|Estradiol|estradiol|mesh-list
93124068|NCT01085877|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93124069|NCT01085877|Estrogens|estrogens|mesh-ancestor
93124070|NCT01085877|Hormones|hormones|mesh-ancestor
93124071|NCT01085877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124072|NCT01085877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124073|NCT01085877|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93124074|NCT01085877|Contraceptive Agents|contraceptive agents|mesh-ancestor
93124075|NCT01085877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93124076|NCT01085877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93124077|NCT01089855|Carbamazepine|carbamazepine|mesh-list
93124078|NCT01089855|Anticonvulsants|anticonvulsants|mesh-ancestor
93124079|NCT01089855|Antimanic Agents|antimanic agents|mesh-ancestor
93124080|NCT01089855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124081|NCT01089855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124082|NCT01089855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124083|NCT01089855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124084|NCT01089855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93124085|NCT01089855|Analgesics|analgesics|mesh-ancestor
93124086|NCT01089855|Sensory System Agents|sensory system agents|mesh-ancestor
93124087|NCT01089855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124088|NCT01089855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93124089|NCT01089855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124090|NCT01089855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124091|NCT01089855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93124092|NCT01089855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93124093|NCT04132960|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93124094|NCT04132960|Immunoconjugates|immunoconjugates|mesh-ancestor
93124095|NCT04132960|Immunologic Factors|immunologic factors|mesh-ancestor
93124096|NCT04132960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124097|NCT03980314|Nivolumab|nivolumab|mesh-list
93124098|NCT03980314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93124099|NCT03980314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124100|NCT03980314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93124101|NCT03980314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124102|NCT03674320|Methyltestosterone|methyltestosterone|mesh-list
93124103|NCT03674320|Testosterone|testosterone|mesh-list
93124104|NCT03674320|Testosterone undecanoate|testosterone undecanoate|mesh-list
93124105|NCT03674320|Testosterone enanthate|testosterone enanthate|mesh-list
93124106|NCT03674320|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93124107|NCT03674320|Androgens|androgens|mesh-ancestor
93124108|NCT03674320|Hormones|hormones|mesh-ancestor
93124109|NCT03674320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124110|NCT03674320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124111|NCT03674320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124112|NCT03674320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124113|NCT03674320|Anabolic Agents|anabolic agents|mesh-ancestor
93124114|NCT05457946|Vaccines|vaccines|mesh-list
93124115|NCT05457946|Immunologic Factors|immunologic factors|mesh-ancestor
93124116|NCT05457946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124117|NCT03625960|Cantharidin|cantharidin|mesh-list
93124118|NCT03625960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124119|NCT03625960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124120|NCT03042910|Talazoparib|talazoparib|mesh-list
93124121|NCT03042910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93124122|NCT03042910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124123|NCT03042910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124124|NCT03042910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124125|NCT03243838|Apatinib|apatinib|mesh-list
93124126|NCT03243838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124127|NCT03243838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124128|NCT03243838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124129|NCT03243838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124130|NCT03059446|Cenicriviroc|cenicriviroc|mesh-list
93124131|NCT03059446|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93124132|NCT03059446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124133|NCT03059446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93124134|NCT03059446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93124135|NCT03059446|Antiviral Agents|antiviral agents|mesh-ancestor
93124136|NCT03059446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124137|NCT00090519|Ruboxistaurin|ruboxistaurin|mesh-list
93124138|NCT00090519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124139|NCT00090519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124140|NCT02980666|Teduglutide|teduglutide|mesh-list
93124141|NCT02980666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124142|NCT02980666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93124143|NCT02980666|Protective Agents|protective agents|mesh-ancestor
93124144|NCT02980666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124145|NCT02962102|Calcitriol|calcitriol|mesh-list
93124146|NCT02962102|Calcifediol|calcifediol|mesh-list
93124147|NCT02962102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93124148|NCT02962102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124149|NCT02962102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93124150|NCT02962102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124151|NCT02962102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124152|NCT02962102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93124153|NCT02962102|Vitamins|vitamins|mesh-ancestor
93124154|NCT02962102|Micronutrients|micronutrients|mesh-ancestor
93124155|NCT02962102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93124156|NCT02947750|Folic Acid|folic acid|mesh-list
93124157|NCT02947750|Hematinics|hematinics|mesh-ancestor
93124158|NCT02947750|Vitamin B Complex|vitamin b complex|mesh-ancestor
93124159|NCT02947750|Vitamins|vitamins|mesh-ancestor
93124160|NCT02947750|Micronutrients|micronutrients|mesh-ancestor
93124161|NCT02947750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124162|NCT02630368|Cyclophosphamide|cyclophosphamide|mesh-list
93124163|NCT02630368|Avelumab|avelumab|mesh-list
93124164|NCT02630368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93124165|NCT02630368|Immunologic Factors|immunologic factors|mesh-ancestor
93124166|NCT02630368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124167|NCT02630368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93124168|NCT02630368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93124169|NCT02630368|Alkylating Agents|alkylating agents|mesh-ancestor
93124170|NCT02630368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124171|NCT02630368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124172|NCT02630368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93124173|NCT02630368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93124174|NCT05692960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93124175|NCT05692960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124176|NCT05692960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124177|NCT05244460|Diphenhydramine|diphenhydramine|mesh-list
93124178|NCT05244460|Promethazine|promethazine|mesh-list
93124179|NCT05244460|Droperidol|droperidol|mesh-list
93124180|NCT05244460|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93124181|NCT05244460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93124182|NCT05244460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124183|NCT05244460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124184|NCT05244460|Anesthetics, Local|anesthetics, local|mesh-ancestor
93124185|NCT05244460|Anesthetics|anesthetics|mesh-ancestor
93124186|NCT05244460|Sensory System Agents|sensory system agents|mesh-ancestor
93124187|NCT05244460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124188|NCT05244460|Antiemetics|antiemetics|mesh-ancestor
93124189|NCT05244460|Autonomic Agents|autonomic agents|mesh-ancestor
93124190|NCT05244460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124191|NCT05244460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93124192|NCT05244460|Histamine Antagonists|histamine antagonists|mesh-ancestor
93124193|NCT05244460|Histamine Agents|histamine agents|mesh-ancestor
93124194|NCT05244460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124195|NCT05244460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124196|NCT05244460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93124197|NCT05244460|Antipruritics|antipruritics|mesh-ancestor
93124198|NCT05244460|Dermatologic Agents|dermatologic agents|mesh-ancestor
93124199|NCT05244460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93124200|NCT05244460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93124201|NCT05244460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124202|NCT05244460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124203|NCT05244460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93124204|NCT05244460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93124205|NCT05244460|Dopamine Agents|dopamine agents|mesh-ancestor
93124206|NCT00096993|Gemcitabine|gemcitabine|mesh-list
93124207|NCT00096993|Pertuzumab|pertuzumab|mesh-list
93124208|NCT00096993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93124209|NCT00096993|Antimetabolites|antimetabolites|mesh-ancestor
93124210|NCT00096993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124211|NCT00096993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124212|NCT00096993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93124213|NCT05172700|Pirtobrutinib|pirtobrutinib|mesh-list
93124214|NCT05172700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124215|NCT05172700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124216|NCT05172700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124217|NCT00072189|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
93124218|NCT00072189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124219|NCT00072189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124220|NCT00072189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124221|NCT00072189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124222|NCT03040024|Ketamine|ketamine|mesh-list
93124223|NCT03040024|Analgesics|analgesics|mesh-ancestor
93124224|NCT03040024|Sensory System Agents|sensory system agents|mesh-ancestor
93124225|NCT03040024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124226|NCT03040024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124227|NCT03040024|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93124228|NCT03040024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93124229|NCT03040024|Anesthetics, General|anesthetics, general|mesh-ancestor
93124230|NCT03040024|Anesthetics|anesthetics|mesh-ancestor
93124231|NCT03040024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124232|NCT03040024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93124233|NCT03040024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93124234|NCT03040024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124235|NCT03040024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124236|NCT05053126|Pregabalin|pregabalin|mesh-list
93124237|NCT05053126|Oxycodone|oxycodone|mesh-list
93124238|NCT05053126|Analgesics|analgesics|mesh-ancestor
93124239|NCT05053126|Sensory System Agents|sensory system agents|mesh-ancestor
93124240|NCT05053126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124241|NCT05053126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124242|NCT05053126|Anticonvulsants|anticonvulsants|mesh-ancestor
93124243|NCT05053126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93124244|NCT05053126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124245|NCT05053126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124246|NCT05053126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93124247|NCT05053126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93124248|NCT05053126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124249|NCT05053126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124250|NCT05053126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124251|NCT05053126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93124252|NCT05053126|Narcotics|narcotics|mesh-ancestor
93124253|NCT04716946|Durvalumab|durvalumab|mesh-list
93124254|NCT04716946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93124255|NCT04716946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124256|NCT03038620|Liraglutide|liraglutide|mesh-list
93124257|NCT03038620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93124258|NCT03038620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124259|NCT03038620|Incretins|incretins|mesh-ancestor
93124260|NCT03038620|Hormones|hormones|mesh-ancestor
93124261|NCT03038620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124262|NCT02032810|Ipilimumab|ipilimumab|mesh-list
93124263|NCT02032810|Panobinostat|panobinostat|mesh-list
93124264|NCT02032810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93124265|NCT02032810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124266|NCT02032810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93124267|NCT02032810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124268|NCT02032810|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93124269|NCT02032810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124270|NCT01415674|Afatinib|afatinib|mesh-list
93124271|NCT01415674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124272|NCT01415674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124273|NCT01415674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124274|NCT01415674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124275|NCT01350934|Vitamin D|vitamin d|mesh-list
93124276|NCT01350934|Cholecalciferol|cholecalciferol|mesh-list
93124277|NCT01350934|Alendronate|alendronate|mesh-list
93124278|NCT01350934|Calcitriol|calcitriol|mesh-list
93124279|NCT01350934|Calcium|calcium|mesh-list
93124280|NCT01350934|Vitamins|vitamins|mesh-ancestor
93124281|NCT01350934|Micronutrients|micronutrients|mesh-ancestor
93124282|NCT01350934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124283|NCT01350934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93124284|NCT01350934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93124285|NCT01350934|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93124286|NCT01350934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124287|NCT01350934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124288|NCT01350934|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93124289|NCT01146418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93124290|NCT01146418|Hormones|hormones|mesh-ancestor
93124291|NCT01146418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124292|NCT01146418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124293|NCT05654896|Ceftriaxone|ceftriaxone|mesh-list
93124294|NCT05654896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124295|NCT05654896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124296|NCT00745108|Tibolone|tibolone|mesh-list
93124297|NCT00745108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124298|NCT00745108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124299|NCT00745108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124300|NCT00745108|Hormones|hormones|mesh-ancestor
93124301|NCT00745108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124302|NCT00745108|Androgen Antagonists|androgen antagonists|mesh-ancestor
93124303|NCT00745108|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124304|NCT00745108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93124305|NCT00745108|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93124306|NCT00745108|Anabolic Agents|anabolic agents|mesh-ancestor
93124307|NCT00725374|Tibolone|tibolone|mesh-list
93124308|NCT00725374|Androgen Antagonists|androgen antagonists|mesh-ancestor
93124309|NCT00725374|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124310|NCT00725374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124311|NCT00725374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124312|NCT00725374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93124313|NCT00725374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124314|NCT00725374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124315|NCT00725374|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93124316|NCT00725374|Anabolic Agents|anabolic agents|mesh-ancestor
93124317|NCT00725374|Hormones|hormones|mesh-ancestor
93124318|NCT03622580|Aflibercept|aflibercept|mesh-list
93124319|NCT03622580|Faricimab|faricimab|mesh-list
93124320|NCT03622580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93124321|NCT03622580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93124322|NCT03622580|Growth Substances|growth substances|mesh-ancestor
93124323|NCT03622580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124324|NCT03622580|Growth Inhibitors|growth inhibitors|mesh-ancestor
93124325|NCT03622580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124326|NCT00461032|Montelukast|montelukast|mesh-list
93124327|NCT00461032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93124328|NCT00461032|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124329|NCT00461032|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93124330|NCT00461032|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124331|NCT00461032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124332|NCT00461032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124333|NCT00461032|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93124334|NCT00461032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93124335|NCT00461032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124336|NCT00446056|Ketotifen|ketotifen|mesh-list
93124337|NCT00446056|Montelukast|montelukast|mesh-list
93124338|NCT00446056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124339|NCT00446056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124340|NCT00446056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124341|NCT00446056|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124342|NCT00446056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93124343|NCT00446056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93124344|NCT00446056|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124345|NCT00446056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124346|NCT00446056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93124347|NCT00446056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93124348|NCT00446056|Antipruritics|antipruritics|mesh-ancestor
93124349|NCT00446056|Dermatologic Agents|dermatologic agents|mesh-ancestor
93124350|NCT00446056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93124351|NCT00446056|Histamine Antagonists|histamine antagonists|mesh-ancestor
93124352|NCT00446056|Histamine Agents|histamine agents|mesh-ancestor
92796546|NCT00648310|Cholinergic Agents|cholinergic agents|mesh-ancestor
93124353|NCT00446056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93124354|NCT00389740|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93124355|NCT00389740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124356|NCT00389740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93124357|NCT00389740|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124358|NCT00389740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124359|NCT00389740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93124360|NCT00389740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93124361|NCT00389740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93124362|NCT00092092|Budesonide|budesonide|mesh-list
93124363|NCT00092092|Montelukast|montelukast|mesh-list
93124364|NCT00092092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124365|NCT00092092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93124366|NCT00092092|Autonomic Agents|autonomic agents|mesh-ancestor
93124367|NCT00092092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124368|NCT00092092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124369|NCT00092092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93124370|NCT00092092|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124371|NCT00092092|Glucocorticoids|glucocorticoids|mesh-ancestor
93124372|NCT00092092|Hormones|hormones|mesh-ancestor
93124373|NCT00092092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124374|NCT00092092|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93124375|NCT00092092|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124376|NCT00092092|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93124377|NCT00092092|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93124378|NCT00092092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124379|NCT00092014|Vitamin D|vitamin d|mesh-list
93124380|NCT00092014|Alendronate|alendronate|mesh-list
93124381|NCT00092014|Risedronic Acid|risedronic acid|mesh-list
93124382|NCT00092014|Calcium|calcium|mesh-list
93124383|NCT00092014|Vitamins|vitamins|mesh-ancestor
93124384|NCT00092014|Micronutrients|micronutrients|mesh-ancestor
93124385|NCT00092014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124386|NCT00092014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93124387|NCT00092014|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93124388|NCT00092014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93124389|NCT00092014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124390|NCT00092014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124391|NCT00090142|Montelukast|montelukast|mesh-list
93124392|NCT00090142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93124393|NCT00090142|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124394|NCT00090142|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93124395|NCT00090142|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124396|NCT00090142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124397|NCT00090142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124398|NCT00090142|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93124399|NCT00090142|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93124400|NCT00090142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124401|NCT00043108|Paclitaxel|paclitaxel|mesh-list
93124402|NCT00043108|Carboplatin|carboplatin|mesh-list
93124403|NCT00043108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93124404|NCT00043108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124405|NCT00043108|Tubulin Modulators|tubulin modulators|mesh-ancestor
93124406|NCT00043108|Antimitotic Agents|antimitotic agents|mesh-ancestor
93124407|NCT00043108|Mitosis Modulators|mitosis modulators|mesh-ancestor
93124408|NCT00043108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124409|NCT04985266|Tamoxifen|tamoxifen|mesh-list
93124410|NCT04985266|Letrozole|letrozole|mesh-list
93124411|NCT04985266|Fulvestrant|fulvestrant|mesh-list
93124412|NCT04985266|Palbociclib|palbociclib|mesh-list
93124413|NCT04985266|Anastrozole|anastrozole|mesh-list
93124414|NCT04985266|Exemestane|exemestane|mesh-list
93124415|NCT04985266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124416|NCT04985266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93124417|NCT04985266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93124418|NCT04985266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124419|NCT04985266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124420|NCT04985266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93124421|NCT04985266|Hormone Antagonists|hormone antagonists|mesh-ancestor
93124422|NCT04985266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124423|NCT04985266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124424|NCT04985266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124425|NCT04985266|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93124426|NCT04985266|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93124427|NCT04985266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93124428|NCT04985266|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93124429|NCT04985266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124431|NCT03619408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124432|NCT03619408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124433|NCT04032158|Interferon beta-1a|interferon beta-1a|mesh-list
93124434|NCT04032158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93124435|NCT04032158|Immunologic Factors|immunologic factors|mesh-ancestor
93124436|NCT04032158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124437|NCT04032158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124438|NCT04032158|Antiviral Agents|antiviral agents|mesh-ancestor
93124439|NCT04032158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124440|NCT03620708|Nicotine|nicotine|mesh-list
93124441|NCT03620708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93124442|NCT03620708|Autonomic Agents|autonomic agents|mesh-ancestor
93124443|NCT03620708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124444|NCT03620708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124445|NCT03620708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93124446|NCT03620708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93124447|NCT03620708|Cholinergic Agents|cholinergic agents|mesh-ancestor
93124448|NCT03620708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124449|NCT03620708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124450|NCT03654326|Naproxen|naproxen|mesh-list
93124451|NCT03654326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93124452|NCT03654326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93124453|NCT03654326|Analgesics|analgesics|mesh-ancestor
93124454|NCT03654326|Sensory System Agents|sensory system agents|mesh-ancestor
93124455|NCT03654326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124456|NCT03654326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124457|NCT03654326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124458|NCT03654326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93124459|NCT03654326|Gout Suppressants|gout suppressants|mesh-ancestor
93124460|NCT03654326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93124461|NCT03654326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124462|NCT03654326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124463|NCT03735446|Cytarabine|cytarabine|mesh-list
93124464|NCT03735446|Etoposide|etoposide|mesh-list
93124465|NCT03735446|Mitoxantrone|mitoxantrone|mesh-list
93124466|NCT03735446|Prexasertib|prexasertib|mesh-list
93124467|NCT03735446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93124468|NCT03735446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124469|NCT03735446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93124470|NCT03735446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93124471|NCT03735446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124472|NCT03735446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124473|NCT03735446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93124474|NCT03735446|Antimetabolites|antimetabolites|mesh-ancestor
93124475|NCT03735446|Antiviral Agents|antiviral agents|mesh-ancestor
93124476|NCT03735446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124477|NCT03735446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93124478|NCT03735446|Immunologic Factors|immunologic factors|mesh-ancestor
93124479|NCT03735446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124480|NCT03735446|Analgesics|analgesics|mesh-ancestor
93124481|NCT03735446|Sensory System Agents|sensory system agents|mesh-ancestor
93124482|NCT03735446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124483|NCT03735446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124484|NCT03735368|Pregabalin|pregabalin|mesh-list
93124485|NCT03735368|Dexmedetomidine|dexmedetomidine|mesh-list
93124486|NCT03735368|Benoxinate|benoxinate|mesh-list
93124487|NCT03735368|Anesthetics|anesthetics|mesh-ancestor
93124488|NCT03735368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124489|NCT03735368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124490|NCT03735368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93124491|NCT03735368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93124492|NCT03735368|Analgesics|analgesics|mesh-ancestor
93124493|NCT03735368|Sensory System Agents|sensory system agents|mesh-ancestor
93124494|NCT03735368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124495|NCT03735368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93124496|NCT03735368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93124497|NCT03735368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93124498|NCT03735368|Adrenergic Agents|adrenergic agents|mesh-ancestor
93124499|NCT03735368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796698|NCT00852397|Apixaban|apixaban|mesh-list
93124500|NCT03735368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124501|NCT03735368|Anticonvulsants|anticonvulsants|mesh-ancestor
93124502|NCT03735368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93124503|NCT03735368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124504|NCT03735368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93124505|NCT03735368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93124506|NCT03735368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124507|NCT03735368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124508|NCT03735368|Anesthetics, Local|anesthetics, local|mesh-ancestor
93124509|NCT00071799|Cytarabine|cytarabine|mesh-list
93124510|NCT00071799|Azacitidine|azacitidine|mesh-list
93124511|NCT00071799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93124512|NCT00071799|Antimetabolites|antimetabolites|mesh-ancestor
93124513|NCT00071799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124514|NCT00071799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124515|NCT00071799|Antiviral Agents|antiviral agents|mesh-ancestor
93124516|NCT00071799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124517|NCT00071799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93124518|NCT00071799|Immunologic Factors|immunologic factors|mesh-ancestor
93124519|NCT00071799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124520|NCT00071799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124521|NCT03615482|Vaccines|vaccines|mesh-list
93124522|NCT03615482|Immunologic Factors|immunologic factors|mesh-ancestor
93124523|NCT03615482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124524|NCT03652610|Vaccines|vaccines|mesh-list
93124525|NCT03652610|Immunologic Factors|immunologic factors|mesh-ancestor
93124526|NCT03652610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124527|NCT03615404|Molgramostim|molgramostim|mesh-list
93124528|NCT03615404|Sargramostim|sargramostim|mesh-list
93124529|NCT03615404|Immunologic Factors|immunologic factors|mesh-ancestor
93124530|NCT03615404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124531|NCT03615404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124532|NCT03730064|Acetylcysteine|acetylcysteine|mesh-list
93124533|NCT03730064|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93124534|NCT03730064|Antiviral Agents|antiviral agents|mesh-ancestor
93124535|NCT03730064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124536|NCT03730064|Expectorants|expectorants|mesh-ancestor
93124537|NCT03730064|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124538|NCT03730064|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93124539|NCT03730064|Antioxidants|antioxidants|mesh-ancestor
93124540|NCT03730064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124541|NCT03730064|Protective Agents|protective agents|mesh-ancestor
93124542|NCT03730064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124543|NCT03730064|Antidotes|antidotes|mesh-ancestor
93124544|NCT03580382|Trametinib|trametinib|mesh-list
93124545|NCT03580382|Antibodies|antibodies|mesh-list
93124546|NCT03580382|Immunologic Factors|immunologic factors|mesh-ancestor
91931302|NCT05122182|Candesartan|candesartan|mesh-list
93124547|NCT03580382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124548|NCT03580382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124549|NCT03580382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124550|NCT03580382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124551|NCT03580382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124552|NCT03577730|Caffeine|caffeine|mesh-list
93124553|NCT03577730|Caffeine citrate|caffeine citrate|mesh-list
93124554|NCT03577730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124555|NCT03577730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93124556|NCT03577730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124557|NCT03577730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93124558|NCT03577730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124559|NCT03577730|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93124560|NCT03577730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93124561|NCT03577730|Purinergic Agents|purinergic agents|mesh-ancestor
93124562|NCT03577730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124563|NCT03731780|Chlorhexidine|chlorhexidine|mesh-list
93124564|NCT03731780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93124565|NCT03731780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124566|NCT03731780|Disinfectants|disinfectants|mesh-ancestor
93124567|NCT03735134|Colchicine|colchicine|mesh-list
93124568|NCT03735134|Gout Suppressants|gout suppressants|mesh-ancestor
93124569|NCT03735134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93124570|NCT03735134|Tubulin Modulators|tubulin modulators|mesh-ancestor
93124571|NCT03735134|Antimitotic Agents|antimitotic agents|mesh-ancestor
93124572|NCT03735134|Mitosis Modulators|mitosis modulators|mesh-ancestor
93124573|NCT03735134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124574|NCT03735134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124575|NCT03608774|Azithromycin|azithromycin|mesh-list
93124576|NCT03608774|Doxycycline|doxycycline|mesh-list
93124577|NCT03608774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124578|NCT03608774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124580|NCT03608774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93124581|NCT03608774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93124582|NCT04021524|Chlorhexidine|chlorhexidine|mesh-list
93124583|NCT04021524|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93124584|NCT04021524|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93124585|NCT04021524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93124586|NCT04021524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124587|NCT04021524|Disinfectants|disinfectants|mesh-ancestor
93124588|NCT04021524|Dermatologic Agents|dermatologic agents|mesh-ancestor
93124589|NCT03729674|Infliximab|infliximab|mesh-list
93124590|NCT03729674|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93124591|NCT03729674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124592|NCT03729674|Dermatologic Agents|dermatologic agents|mesh-ancestor
93124593|NCT03729674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124594|NCT03729674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93124595|NCT03731468|Dexamethasone|dexamethasone|mesh-list
93124596|NCT03731468|Anesthetics|anesthetics|mesh-list
93124597|NCT03731468|Anesthetics, Local|anesthetics, local|mesh-list
93124598|NCT03731468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124599|NCT03731468|Antiemetics|antiemetics|mesh-ancestor
93124600|NCT03731468|Autonomic Agents|autonomic agents|mesh-ancestor
93124601|NCT03731468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124602|NCT03731468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124603|NCT03731468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124604|NCT03731468|Glucocorticoids|glucocorticoids|mesh-ancestor
93124605|NCT03731468|Hormones|hormones|mesh-ancestor
93124606|NCT03731468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124607|NCT03731468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124608|NCT03731468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124609|NCT03731468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124610|NCT03731468|Sensory System Agents|sensory system agents|mesh-ancestor
93124611|NCT03600428|Vaccines|vaccines|mesh-list
93124612|NCT03600428|Immunologic Factors|immunologic factors|mesh-ancestor
93124613|NCT03600428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124614|NCT03575702|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93124615|NCT03575702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93124616|NCT03575702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93124617|NCT03575702|Cholinergic Agents|cholinergic agents|mesh-ancestor
93124618|NCT03575702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124619|NCT03575702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124620|NCT03575702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124621|NCT03575702|Urological Agents|urological agents|mesh-ancestor
93124622|NCT03639896|Dexmedetomidine|dexmedetomidine|mesh-list
93124623|NCT03639896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93124624|NCT03639896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124625|NCT03639896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124626|NCT03639896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93124627|NCT03639896|Analgesics|analgesics|mesh-ancestor
93124628|NCT03639896|Sensory System Agents|sensory system agents|mesh-ancestor
93124629|NCT03639896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124630|NCT03639896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93124631|NCT03639896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93124632|NCT03639896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93124633|NCT03639896|Adrenergic Agents|adrenergic agents|mesh-ancestor
93124634|NCT03639896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124635|NCT03639896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124636|NCT03573908|Linaclotide|linaclotide|mesh-list
93124637|NCT03573908|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93124638|NCT03573908|Enzyme Activators|enzyme activators|mesh-ancestor
93124639|NCT03573908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124640|NCT03573908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124641|NCT03729284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93124642|NCT03729284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93124643|NCT03729284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93124644|NCT03729284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124645|NCT03729284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124646|NCT03729284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124647|NCT03729284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124648|NCT03729284|Analgesics|analgesics|mesh-ancestor
92796849|NCT00707083|Hormones|hormones|mesh-ancestor
93124649|NCT03729284|Sensory System Agents|sensory system agents|mesh-ancestor
93124650|NCT03729284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124651|NCT03729284|Antidepressive Agents|antidepressive agents|mesh-ancestor
93124652|NCT03729284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124653|NCT03729284|Dopamine Agents|dopamine agents|mesh-ancestor
93124654|NCT03729128|Memantine|memantine|mesh-list
93124655|NCT03729128|Dextromethorphan|dextromethorphan|mesh-list
93124656|NCT03729128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93124657|NCT03729128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93124658|NCT03729128|Dopamine Agents|dopamine agents|mesh-ancestor
93124659|NCT03729128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124660|NCT03729128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124661|NCT03729128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124662|NCT03729128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93124663|NCT03729128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93124664|NCT03729128|Antitussive Agents|antitussive agents|mesh-ancestor
93124665|NCT03729128|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124666|NCT03734354|Brexpiprazole|brexpiprazole|mesh-list
93124667|NCT03734354|Serotonin Agents|serotonin agents|mesh-ancestor
93124668|NCT03734354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124669|NCT03734354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124670|NCT03734354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124671|NCT03734354|Dopamine Agonists|dopamine agonists|mesh-ancestor
93124672|NCT03734354|Dopamine Agents|dopamine agents|mesh-ancestor
93124673|NCT03728894|Midazolam|midazolam|mesh-list
93124674|NCT03728894|Hydroxyzine|hydroxyzine|mesh-list
93124675|NCT03728894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93124676|NCT03728894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93124677|NCT03728894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124678|NCT03728894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124679|NCT03728894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93124680|NCT03728894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124681|NCT03728894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124682|NCT03728894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93124683|NCT03728894|Anesthetics, General|anesthetics, general|mesh-ancestor
93124684|NCT03728894|Anesthetics|anesthetics|mesh-ancestor
93124685|NCT03728894|GABA Modulators|gaba modulators|mesh-ancestor
93124686|NCT03728894|GABA Agents|gaba agents|mesh-ancestor
93124687|NCT03728894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124688|NCT03728894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124689|NCT03728894|Antipruritics|antipruritics|mesh-ancestor
93124690|NCT03728894|Dermatologic Agents|dermatologic agents|mesh-ancestor
93124691|NCT03728894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93124692|NCT03728894|Histamine Antagonists|histamine antagonists|mesh-ancestor
93124693|NCT03728894|Histamine Agents|histamine agents|mesh-ancestor
93124694|NCT03730766|Amoxicillin|amoxicillin|mesh-list
93124695|NCT03730766|Metronidazole|metronidazole|mesh-list
93124696|NCT03730766|Potassium Citrate|potassium citrate|mesh-list
93124697|NCT03730766|Esomeprazole|esomeprazole|mesh-list
93124698|NCT03730766|Bismuth|bismuth|mesh-list
93124699|NCT03730766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124700|NCT03730766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124701|NCT03730766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124702|NCT03730766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93124703|NCT03730766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93124704|NCT03730766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93124705|NCT03730766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124706|NCT03730766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93124707|NCT03730766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124708|NCT03730766|Antacids|antacids|mesh-ancestor
93124709|NCT03730766|Diuretics|diuretics|mesh-ancestor
93124710|NCT03730766|Natriuretic Agents|natriuretic agents|mesh-ancestor
93124711|NCT03730766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124712|NCT03730766|Expectorants|expectorants|mesh-ancestor
93124713|NCT03730766|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124714|NCT00071487|Belimumab|belimumab|mesh-list
93124715|NCT00071487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93124716|NCT00071487|Immunologic Factors|immunologic factors|mesh-ancestor
93124717|NCT00071487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124718|NCT03962283|Rifaximin|rifaximin|mesh-list
93124719|NCT03962283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124720|NCT03962283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124721|NCT03962283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124722|NCT03591146|Ropivacaine|ropivacaine|mesh-list
93124723|NCT03591146|Anesthetics, Local|anesthetics, local|mesh-ancestor
93124724|NCT03591146|Anesthetics|anesthetics|mesh-ancestor
93124725|NCT03591146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124726|NCT03591146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124727|NCT03591146|Sensory System Agents|sensory system agents|mesh-ancestor
93124728|NCT03591146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124729|NCT00096447|Lapatinib|lapatinib|mesh-list
93124730|NCT00096447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124731|NCT00096447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93124732|NCT00096447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124733|NCT00096447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124734|NCT03588572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93124735|NCT03588572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93124736|NCT03588572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93124737|NCT03588572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124738|NCT03588572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124739|NCT03588572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124740|NCT03588572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124741|NCT03588572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93124742|NCT03588572|Antidepressive Agents|antidepressive agents|mesh-ancestor
93124743|NCT03588572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124744|NCT00070941|Escitalopram|escitalopram|mesh-list
93124745|NCT00070941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93124746|NCT00070941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93124747|NCT00070941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124748|NCT00070941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124749|NCT00070941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124750|NCT00070941|Serotonin Agents|serotonin agents|mesh-ancestor
93124751|NCT00070941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124752|NCT00070707|Mometasone Furoate|mometasone furoate|mesh-list
93124753|NCT00070707|Albuterol|albuterol|mesh-list
93124754|NCT00070707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93124755|NCT00070707|Autonomic Agents|autonomic agents|mesh-ancestor
93124756|NCT00070707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124757|NCT00070707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124758|NCT00070707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93124759|NCT00070707|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124760|NCT00070707|Tocolytic Agents|tocolytic agents|mesh-ancestor
93124761|NCT00070707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93124762|NCT00070707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93124763|NCT00070707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93124764|NCT00070707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93124765|NCT00070707|Adrenergic Agents|adrenergic agents|mesh-ancestor
93124766|NCT00070707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124767|NCT00070707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124768|NCT00070707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124769|NCT00070707|Dermatologic Agents|dermatologic agents|mesh-ancestor
93124770|NCT00070707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93124771|NCT03036124|Dapagliflozin|dapagliflozin|mesh-list
93124772|NCT03036124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93124773|NCT03036124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124774|NCT03036124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93124775|NCT03036124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124776|NCT00070317|Methylene Blue|methylene blue|mesh-list
93124777|NCT00070317|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
93124778|NCT00070317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124779|NCT00070317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124780|NCT00070317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93124781|NCT01086345|Bevacizumab|bevacizumab|mesh-list
93124782|NCT01086345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93124783|NCT01086345|Irinotecan|irinotecan|mesh-list
93124784|NCT01086345|Camptothecin|camptothecin|mesh-list
93124785|NCT01086345|Antibodies|antibodies|mesh-list
93124786|NCT01086345|Immunoglobulins|immunoglobulins|mesh-list
93124787|NCT01086345|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93124788|NCT01086345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124789|NCT01086345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93124790|NCT01086345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93124791|NCT01086345|Growth Substances|growth substances|mesh-ancestor
93124792|NCT01086345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124793|NCT01086345|Growth Inhibitors|growth inhibitors|mesh-ancestor
93124794|NCT01086345|Immunologic Factors|immunologic factors|mesh-ancestor
93124795|NCT01086345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93124796|NCT01086345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93124797|NCT01086345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124798|NCT01086345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124799|NCT01086345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93124800|NCT01089933|Anesthetics|anesthetics|mesh-list
93124801|NCT01089933|Anesthetics, Local|anesthetics, local|mesh-list
93124802|NCT01089933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124803|NCT01089933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124804|NCT01089933|Sensory System Agents|sensory system agents|mesh-ancestor
93124805|NCT01089933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124806|NCT03960411|Doxycycline|doxycycline|mesh-list
93124807|NCT03960411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124808|NCT03960411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124809|NCT03960411|Antimalarials|antimalarials|mesh-ancestor
93124810|NCT03960411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93124811|NCT03960411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93124812|NCT01090167|Clofarabine|clofarabine|mesh-list
93124813|NCT01090167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93124814|NCT01090167|Antimetabolites|antimetabolites|mesh-ancestor
93124815|NCT01090167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124816|NCT01090167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124817|NCT03587636|Bupivacaine|bupivacaine|mesh-list
93124818|NCT03587636|Anesthetics, Local|anesthetics, local|mesh-ancestor
93124819|NCT03587636|Anesthetics|anesthetics|mesh-ancestor
93124820|NCT03587636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124821|NCT03587636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124822|NCT03587636|Sensory System Agents|sensory system agents|mesh-ancestor
93124823|NCT03587636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124824|NCT03053362|Vortioxetine|vortioxetine|mesh-list
93124825|NCT03053362|Antidepressive Agents|antidepressive agents|mesh-ancestor
93124826|NCT03053362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124827|NCT03053362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93124828|NCT03053362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124829|NCT03053362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124830|NCT03053362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124831|NCT03053362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93124832|NCT03053362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93124833|NCT03053362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124834|NCT03053362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124835|NCT03053362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124836|NCT03053362|Serotonin Agents|serotonin agents|mesh-ancestor
93124837|NCT03053362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93124838|NCT03053362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93124839|NCT03053362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93124840|NCT03053362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93124841|NCT03733652|Interferons|interferons|mesh-list
93124842|NCT03733652|Interferon-alpha|interferon-alpha|mesh-list
93124843|NCT03733652|Interferon alpha-2|interferon alpha-2|mesh-list
93124844|NCT03733652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124845|NCT03733652|Antiviral Agents|antiviral agents|mesh-ancestor
93124846|NCT03733652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124847|NCT03733652|Immunologic Factors|immunologic factors|mesh-ancestor
93124848|NCT03733652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124849|NCT03586544|Albuterol|albuterol|mesh-list
93124850|NCT03586544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93124851|NCT03586544|Autonomic Agents|autonomic agents|mesh-ancestor
93124852|NCT03586544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124853|NCT03586544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124854|NCT03586544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93124855|NCT03586544|Respiratory System Agents|respiratory system agents|mesh-ancestor
93124856|NCT03586544|Tocolytic Agents|tocolytic agents|mesh-ancestor
93124857|NCT03586544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93124858|NCT03586544|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93124859|NCT03586544|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93124860|NCT03586544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93124861|NCT03586544|Adrenergic Agents|adrenergic agents|mesh-ancestor
93124862|NCT03586544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124863|NCT03586544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124864|NCT03737448|Trimetazidine|trimetazidine|mesh-list
93124865|NCT03737448|Vasodilator Agents|vasodilator agents|mesh-ancestor
93124866|NCT03733574|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93124867|NCT03733574|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93124868|NCT03733574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93124869|NCT03733574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124870|NCT03733574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124871|NCT03733574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124872|NCT03733574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124873|NCT03733574|Antidepressive Agents|antidepressive agents|mesh-ancestor
93124874|NCT03733574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124875|NCT03728192|Camptothecin|camptothecin|mesh-list
93124876|NCT03728192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93124877|NCT03728192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124878|NCT03728192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93124879|NCT03728192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93124880|NCT03728192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124881|NCT03728192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124882|NCT03589768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93124883|NCT03589768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93124884|NCT03589768|Immunologic Factors|immunologic factors|mesh-ancestor
93124885|NCT03589768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124886|NCT03589768|Antacids|antacids|mesh-ancestor
93124887|NCT03589768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124888|NCT03589768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124889|NCT03733340|Imipenem|imipenem|mesh-list
93124890|NCT03733340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124891|NCT03733340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124892|NCT05183308|Clodronic Acid|clodronic acid|mesh-list
93124893|NCT05183308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93124894|NCT05183308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124895|NCT05137600|Clarithromycin|clarithromycin|mesh-list
93124896|NCT05137600|Midazolam|midazolam|mesh-list
93124897|NCT05137600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93124898|NCT05137600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93124899|NCT05137600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124900|NCT05137600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124901|NCT05137600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93124902|NCT05137600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93124903|NCT05137600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93124904|NCT05137600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93124905|NCT05137600|Anesthetics, General|anesthetics, general|mesh-ancestor
93124906|NCT05137600|Anesthetics|anesthetics|mesh-ancestor
93124907|NCT05137600|GABA Modulators|gaba modulators|mesh-ancestor
93124908|NCT05137600|GABA Agents|gaba agents|mesh-ancestor
93124909|NCT05137600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93124910|NCT05137600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124911|NCT05137600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93124912|NCT05137600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124913|NCT05137600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93124914|NCT05137600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124915|NCT05137600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93124916|NCT05137600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93124917|NCT02906332|Dexamethasone|dexamethasone|mesh-list
93124918|NCT02906332|Pembrolizumab|pembrolizumab|mesh-list
93065075|NCT03714022|Abatacept|abatacept|mesh-list
93124919|NCT02906332|Lenalidomide|lenalidomide|mesh-list
93124920|NCT02906332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93124921|NCT02906332|Antiemetics|antiemetics|mesh-ancestor
93124922|NCT02906332|Autonomic Agents|autonomic agents|mesh-ancestor
93124923|NCT02906332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124924|NCT02906332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124925|NCT02906332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124926|NCT02906332|Glucocorticoids|glucocorticoids|mesh-ancestor
93124927|NCT02906332|Hormones|hormones|mesh-ancestor
93124928|NCT02906332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93124929|NCT02906332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93124930|NCT02906332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124931|NCT02906332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93124932|NCT02906332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93124933|NCT02906332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124934|NCT02906332|Immunologic Factors|immunologic factors|mesh-ancestor
93124935|NCT02906332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93124936|NCT02906332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93124937|NCT02906332|Growth Substances|growth substances|mesh-ancestor
93124938|NCT02906332|Growth Inhibitors|growth inhibitors|mesh-ancestor
93124939|NCT00089505|Ritonavir|ritonavir|mesh-list
93124940|NCT00089505|Lopinavir|lopinavir|mesh-list
93124941|NCT00089505|Tenofovir|tenofovir|mesh-list
93124942|NCT00089505|Emtricitabine|emtricitabine|mesh-list
93124943|NCT00089505|Nevirapine|nevirapine|mesh-list
93124944|NCT00089505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93124945|NCT00089505|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93124946|NCT00089505|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93124947|NCT00089505|Protease Inhibitors|protease inhibitors|mesh-ancestor
93124948|NCT00089505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124949|NCT00089505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124950|NCT00089505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93124951|NCT00089505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93124952|NCT00089505|Antiviral Agents|antiviral agents|mesh-ancestor
93124953|NCT00089505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124954|NCT00089505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93124955|NCT00089505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93124956|NCT00089505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93124957|NCT00089505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93124958|NCT00089505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93124959|NCT00089505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93124960|NCT04009824|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93124961|NCT04009824|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93124962|NCT04009824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93124963|NCT04009824|Immunologic Factors|immunologic factors|mesh-ancestor
93124964|NCT04009824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124965|NCT04009824|Antacids|antacids|mesh-ancestor
93124966|NCT04009824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124967|NCT04009824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93124968|NCT05041426|Valganciclovir|valganciclovir|mesh-list
93124969|NCT05041426|Letermovir|letermovir|mesh-list
93124970|NCT05041426|Antiviral Agents|antiviral agents|mesh-ancestor
93124971|NCT05041426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93124972|NCT05041426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93124973|NCT05041426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93124974|NCT05041426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124975|NCT05041426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93124976|NCT04987372|Lidocaine|lidocaine|mesh-list
93124977|NCT04987372|Magnesium Sulfate|magnesium sulfate|mesh-list
93124978|NCT04987372|Pregabalin|pregabalin|mesh-list
93124979|NCT04987372|Dexmedetomidine|dexmedetomidine|mesh-list
93124980|NCT04987372|Ketamine|ketamine|mesh-list
93124981|NCT04987372|Anesthetics, Local|anesthetics, local|mesh-ancestor
93124982|NCT04987372|Anesthetics|anesthetics|mesh-ancestor
93124983|NCT04987372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93124984|NCT04987372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93124985|NCT04987372|Sensory System Agents|sensory system agents|mesh-ancestor
93124986|NCT04987372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93124987|NCT04987372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93124988|NCT04987372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93124989|NCT04987372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93124990|NCT04987372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93124991|NCT04987372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93124992|NCT04987372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93124993|NCT04987372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93124994|NCT04987372|Analgesics|analgesics|mesh-ancestor
93124995|NCT04987372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93124996|NCT04987372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93124997|NCT04987372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93124998|NCT04987372|Adrenergic Agents|adrenergic agents|mesh-ancestor
93124999|NCT04987372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125000|NCT04987372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93125001|NCT04987372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125002|NCT04987372|Anesthetics, General|anesthetics, general|mesh-ancestor
93125003|NCT04987372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93125004|NCT04987372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93125005|NCT04987372|Anticonvulsants|anticonvulsants|mesh-ancestor
93125006|NCT04987372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93125007|NCT04987372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93125008|NCT04987372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93125009|NCT04987372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93125010|NCT04987372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125011|NCT04987372|Tocolytic Agents|tocolytic agents|mesh-ancestor
93125012|NCT04987372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125013|NCT03555890|Cetirizine|cetirizine|mesh-list
93125014|NCT03555890|Levocetirizine|levocetirizine|mesh-list
93125015|NCT03555890|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93125016|NCT03555890|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93125017|NCT03555890|Histamine Antagonists|histamine antagonists|mesh-ancestor
93125018|NCT03555890|Histamine Agents|histamine agents|mesh-ancestor
93125019|NCT03555890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125020|NCT03555890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125021|NCT03555890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797226|NCT00649714|Zonisamide|zonisamide|mesh-list
93125022|NCT03555890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93125023|NCT04905862|Antipyretics|antipyretics|mesh-list
93125024|NCT04905862|Analgesics|analgesics|mesh-list
93125025|NCT04905862|Sensory System Agents|sensory system agents|mesh-ancestor
93125026|NCT04905862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125027|NCT04905862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125028|NCT03630120|Sorafenib|sorafenib|mesh-list
93125029|NCT03630120|Lenvatinib|lenvatinib|mesh-list
93125030|NCT03630120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125031|NCT03630120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93125032|NCT03630120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125033|NCT03630120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125034|NCT03744702|Ascorbic Acid|ascorbic acid|mesh-list
93125035|NCT03744702|Antioxidants|antioxidants|mesh-ancestor
93125036|NCT03744702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125037|NCT03744702|Protective Agents|protective agents|mesh-ancestor
93125038|NCT03744702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125039|NCT03744702|Vitamins|vitamins|mesh-ancestor
93125040|NCT03744702|Micronutrients|micronutrients|mesh-ancestor
93125041|NCT04004442|Avelumab|avelumab|mesh-list
93125042|NCT04004442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93125043|NCT04004442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125044|NCT03736980|Psilocybin|psilocybin|mesh-list
93125045|NCT03736980|Hallucinogens|hallucinogens|mesh-ancestor
93125046|NCT03736980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125047|NCT03736980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125048|NCT03727646|Niacinamide|niacinamide|mesh-list
93125049|NCT03727646|Niacin|niacin|mesh-list
93125050|NCT03727646|Nicotinic Acids|nicotinic acids|mesh-list
93125051|NCT03727646|Vitamin B Complex|vitamin b complex|mesh-ancestor
93125052|NCT03727646|Vitamins|vitamins|mesh-ancestor
93125053|NCT03727646|Micronutrients|micronutrients|mesh-ancestor
93125054|NCT03727646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125055|NCT03727646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93125056|NCT03727646|Antimetabolites|antimetabolites|mesh-ancestor
93125057|NCT03727646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125058|NCT03727646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93125059|NCT03727646|Vasodilator Agents|vasodilator agents|mesh-ancestor
93125060|NCT05666336|Mycophenolic Acid|mycophenolic acid|mesh-list
93125061|NCT05666336|Hydroxychloroquine|hydroxychloroquine|mesh-list
93125062|NCT05666336|Prednisone|prednisone|mesh-list
93125063|NCT05666336|Methylprednisolone|methylprednisolone|mesh-list
93125064|NCT05666336|Cyclophosphamide|cyclophosphamide|mesh-list
93125065|NCT05666336|Tacrolimus|tacrolimus|mesh-list
93125066|NCT05666336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93125067|NCT05666336|Immunologic Factors|immunologic factors|mesh-ancestor
93125068|NCT05666336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125069|NCT05666336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931303|NCT05122182|Candesartan cilexetil|candesartan cilexetil|mesh-list
93125070|NCT05666336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93125071|NCT05666336|Alkylating Agents|alkylating agents|mesh-ancestor
93125072|NCT05666336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125073|NCT05666336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125074|NCT05666336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93125075|NCT05666336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125076|NCT05666336|Glucocorticoids|glucocorticoids|mesh-ancestor
93125077|NCT05666336|Hormones|hormones|mesh-ancestor
93125078|NCT05666336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125079|NCT05666336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125080|NCT05666336|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93125081|NCT05666336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125082|NCT05666336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93125083|NCT05666336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93125084|NCT05666336|Antitubercular Agents|antitubercular agents|mesh-ancestor
93125085|NCT05666336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93125086|NCT05666336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125087|NCT05666336|Antiemetics|antiemetics|mesh-ancestor
93125088|NCT05666336|Autonomic Agents|autonomic agents|mesh-ancestor
93125089|NCT05666336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125090|NCT05666336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125091|NCT05666336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93125092|NCT05666336|Protective Agents|protective agents|mesh-ancestor
93125093|NCT05666336|Antimalarials|antimalarials|mesh-ancestor
93125094|NCT05666336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93125095|NCT05666336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93125096|NCT03554486|Insulin|insulin|mesh-list
93125097|NCT03554486|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93125098|NCT03554486|Insulin Aspart|insulin aspart|mesh-list
93125099|NCT03554486|Insulin, Long-Acting|insulin, long-acting|mesh-list
93125100|NCT03554486|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93125101|NCT03554486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93125102|NCT03554486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125103|NCT03554018|Acetaminophen|acetaminophen|mesh-list
93125104|NCT03554018|Ibuprofen|ibuprofen|mesh-list
93125105|NCT03554018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125106|NCT03554018|Analgesics|analgesics|mesh-ancestor
93125107|NCT03554018|Sensory System Agents|sensory system agents|mesh-ancestor
93125108|NCT03554018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125109|NCT03554018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125110|NCT03554018|Antipyretics|antipyretics|mesh-ancestor
93125111|NCT03554018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125112|NCT03554018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125113|NCT03554018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125114|NCT03554018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93125115|NCT03554018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125116|NCT03554018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125117|NCT05462938|Dexmedetomidine|dexmedetomidine|mesh-list
93125118|NCT05462938|Propofol|propofol|mesh-list
93125119|NCT05462938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93125120|NCT05462938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125121|NCT05462938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125122|NCT05462938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125123|NCT05462938|Analgesics|analgesics|mesh-ancestor
93125124|NCT05462938|Sensory System Agents|sensory system agents|mesh-ancestor
93125125|NCT05462938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125126|NCT05462938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93125127|NCT05462938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93125128|NCT05462938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93125129|NCT05462938|Adrenergic Agents|adrenergic agents|mesh-ancestor
93125130|NCT05462938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125131|NCT05462938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125132|NCT05462938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125133|NCT05462938|Anesthetics, General|anesthetics, general|mesh-ancestor
93125134|NCT05462938|Anesthetics|anesthetics|mesh-ancestor
93125135|NCT04787692|Analgesics, Opioid|analgesics, opioid|mesh-list
93125136|NCT04787692|Narcotics|narcotics|mesh-ancestor
93125137|NCT04787692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125138|NCT04787692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125139|NCT04787692|Analgesics|analgesics|mesh-ancestor
93125140|NCT04787692|Sensory System Agents|sensory system agents|mesh-ancestor
93125141|NCT04787692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125142|NCT05462548|Luspatercept|luspatercept|mesh-list
93125143|NCT05462548|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93125144|NCT05462548|Hematinics|hematinics|mesh-ancestor
93125145|NCT05462548|Immunologic Factors|immunologic factors|mesh-ancestor
93125146|NCT05462548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125147|NCT03408340|Fentanyl|fentanyl|mesh-list
93125148|NCT03408340|Ketamine|ketamine|mesh-list
93125149|NCT03408340|Propofol|propofol|mesh-list
93125150|NCT03408340|Sevoflurane|sevoflurane|mesh-list
93125151|NCT03408340|Rocuronium|rocuronium|mesh-list
93125152|NCT03408340|Anesthetics|anesthetics|mesh-ancestor
93125153|NCT03408340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125154|NCT03408340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125155|NCT03408340|Sensory System Agents|sensory system agents|mesh-ancestor
93125156|NCT03408340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125157|NCT03408340|Analgesics|analgesics|mesh-ancestor
93125158|NCT03408340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93125159|NCT03408340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125160|NCT03408340|Anesthetics, General|anesthetics, general|mesh-ancestor
93125161|NCT03408340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93125162|NCT03408340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93125163|NCT03408340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125164|NCT03408340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125165|NCT03408340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93125166|NCT03408340|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93125167|NCT03408340|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93125168|NCT03408340|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93125169|NCT03408340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93125170|NCT03408340|Narcotics|narcotics|mesh-ancestor
93125171|NCT03408340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93125172|NCT03408340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93125173|NCT03408340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93125174|NCT03570554|Acetaminophen|acetaminophen|mesh-list
92797380|NCT02648854|Metformin|metformin|mesh-list
93125175|NCT03570554|Celecoxib|celecoxib|mesh-list
93125176|NCT03570554|Naproxen|naproxen|mesh-list
93125177|NCT03570554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125178|NCT03570554|Analgesics|analgesics|mesh-ancestor
93125179|NCT03570554|Sensory System Agents|sensory system agents|mesh-ancestor
93125180|NCT03570554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125181|NCT03570554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125182|NCT03570554|Antipyretics|antipyretics|mesh-ancestor
93125183|NCT03570554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125184|NCT03570554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125185|NCT03570554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125186|NCT03570554|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93125187|NCT03570554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93125188|NCT03570554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125189|NCT03570554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125190|NCT03570554|Gout Suppressants|gout suppressants|mesh-ancestor
93125191|NCT04004208|Aflibercept|aflibercept|mesh-list
93125192|NCT04004208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93125193|NCT04004208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93125194|NCT04004208|Growth Substances|growth substances|mesh-ancestor
93125195|NCT04004208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125196|NCT04004208|Growth Inhibitors|growth inhibitors|mesh-ancestor
93125197|NCT04004208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125198|NCT03727412|Naproxen|naproxen|mesh-list
93125199|NCT03727412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125200|NCT03727412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125201|NCT03727412|Analgesics|analgesics|mesh-ancestor
93125202|NCT03727412|Sensory System Agents|sensory system agents|mesh-ancestor
93125203|NCT03727412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125204|NCT03727412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125205|NCT03727412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125206|NCT03727412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125207|NCT03727412|Gout Suppressants|gout suppressants|mesh-ancestor
93125208|NCT03727412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93125209|NCT03727412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125210|NCT03727412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125211|NCT03643952|Daptomycin|daptomycin|mesh-list
93125212|NCT03643952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93125213|NCT03643952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125214|NCT03035032|Leuprolide|leuprolide|mesh-list
93125215|NCT03035032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93125216|NCT03035032|Fertility Agents|fertility agents|mesh-ancestor
93125217|NCT03035032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125218|NCT03035032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931385|NCT04868409|Rocuronium|rocuronium|mesh-list
93125219|NCT03035032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125220|NCT03035032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125221|NCT03629184|Oseltamivir|oseltamivir|mesh-list
93125222|NCT03629184|Baloxavir|baloxavir|mesh-list
93125223|NCT03629184|Antiviral Agents|antiviral agents|mesh-ancestor
93125224|NCT03629184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125225|NCT03629184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125226|NCT03629184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125227|NCT03725228|Lidocaine|lidocaine|mesh-list
93125228|NCT03725228|Magnesium Sulfate|magnesium sulfate|mesh-list
93125229|NCT03725228|Anesthetics, Local|anesthetics, local|mesh-ancestor
93125230|NCT03725228|Anesthetics|anesthetics|mesh-ancestor
93125231|NCT03725228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125232|NCT03725228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125233|NCT03725228|Sensory System Agents|sensory system agents|mesh-ancestor
93125234|NCT03725228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125235|NCT03725228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93125236|NCT03725228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93125237|NCT03725228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93125238|NCT03725228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125239|NCT03725228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125240|NCT03725228|Analgesics|analgesics|mesh-ancestor
93125241|NCT03725228|Anticonvulsants|anticonvulsants|mesh-ancestor
93125242|NCT03725228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93125243|NCT03725228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93125244|NCT03725228|Tocolytic Agents|tocolytic agents|mesh-ancestor
93125245|NCT03725228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125246|NCT03724838|Sildenafil Citrate|sildenafil citrate|mesh-list
93125247|NCT03724838|Esomeprazole|esomeprazole|mesh-list
93125248|NCT03724838|Citric Acid|citric acid|mesh-list
93125249|NCT03724838|Sodium Citrate|sodium citrate|mesh-list
93125250|NCT03724838|Anticoagulants|anticoagulants|mesh-ancestor
93125251|NCT03724838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93125252|NCT03724838|Chelating Agents|chelating agents|mesh-ancestor
93125253|NCT03724838|Sequestering Agents|sequestering agents|mesh-ancestor
93125254|NCT03724838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125255|NCT03724838|Vasodilator Agents|vasodilator agents|mesh-ancestor
93125256|NCT03724838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93125257|NCT03724838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93125258|NCT03724838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125259|NCT03724838|Urological Agents|urological agents|mesh-ancestor
93125260|NCT03724838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93125261|NCT03724838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125262|NCT03724838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93125263|NCT02892344|Mometasone Furoate|mometasone furoate|mesh-list
93125264|NCT02892344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125265|NCT02892344|Dermatologic Agents|dermatologic agents|mesh-ancestor
93125266|NCT02892344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93125267|NCT03727100|Clonidine|clonidine|mesh-list
93125268|NCT03727100|Analgesics|analgesics|mesh-ancestor
93125269|NCT03727100|Sensory System Agents|sensory system agents|mesh-ancestor
93125270|NCT03727100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125271|NCT03727100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125272|NCT03727100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93125273|NCT03727100|Sympatholytics|sympatholytics|mesh-ancestor
93125274|NCT03727100|Autonomic Agents|autonomic agents|mesh-ancestor
93125275|NCT03727100|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93125276|NCT03727100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93125277|NCT03727100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93125278|NCT03727100|Adrenergic Agents|adrenergic agents|mesh-ancestor
93125279|NCT03727100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125280|NCT03727100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125281|NCT03358030|Riboflavin|riboflavin|mesh-list
93125282|NCT03358030|Vitamin B Complex|vitamin b complex|mesh-ancestor
93125283|NCT03358030|Vitamins|vitamins|mesh-ancestor
93125284|NCT03358030|Micronutrients|micronutrients|mesh-ancestor
93125285|NCT03358030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125286|NCT03358030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93125287|NCT03358030|Dermatologic Agents|dermatologic agents|mesh-ancestor
93125288|NCT03566810|Metformin|metformin|mesh-list
93125289|NCT03566810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93125290|NCT03566810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125291|NCT03628716|Atezolizumab|atezolizumab|mesh-list
93125292|NCT03628716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93125293|NCT03628716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065447|NCT00419393|Anticonvulsants|anticonvulsants|mesh-ancestor
93125294|NCT03628716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93125295|NCT03628716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125296|NCT03840616|Fluconazole|fluconazole|mesh-list
93125297|NCT03840616|Antifungal Agents|antifungal agents|mesh-ancestor
93125298|NCT03840616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125299|NCT03840616|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93125300|NCT03840616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93125301|NCT03840616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125302|NCT03840616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125303|NCT03840616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93125304|NCT03840616|Hormone Antagonists|hormone antagonists|mesh-ancestor
93125305|NCT03840616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125306|NCT03840616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125307|NCT03840616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93125308|NCT03840616|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93125309|NCT00088413|Molgramostim|molgramostim|mesh-list
93125310|NCT00088413|Sargramostim|sargramostim|mesh-list
93125311|NCT00088413|Immunologic Factors|immunologic factors|mesh-ancestor
93125312|NCT00088413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125313|NCT00088413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125314|NCT03787654|Solifenacin Succinate|solifenacin succinate|mesh-list
93125315|NCT03787654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93125316|NCT03787654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93125317|NCT03787654|Cholinergic Agents|cholinergic agents|mesh-ancestor
93125318|NCT03787654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125319|NCT03787654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125320|NCT03787654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125321|NCT03787654|Urological Agents|urological agents|mesh-ancestor
93125322|NCT00086385|Bupropion|bupropion|mesh-list
93125323|NCT00086385|Nicotine|nicotine|mesh-list
93125324|NCT00086385|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93125325|NCT00086385|Autonomic Agents|autonomic agents|mesh-ancestor
93125326|NCT00086385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125327|NCT00086385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125328|NCT00086385|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93125329|NCT00086385|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93125330|NCT00086385|Cholinergic Agents|cholinergic agents|mesh-ancestor
93125331|NCT00086385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125332|NCT00086385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125333|NCT00086385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93125334|NCT00086385|Antidepressive Agents|antidepressive agents|mesh-ancestor
93125335|NCT00086385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125336|NCT00086385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93125337|NCT00086385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93125338|NCT00086385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125340|NCT00086385|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93125341|NCT00086385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93125342|NCT00086385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125343|NCT03993288|Iron|iron|mesh-list
93125344|NCT03993288|Trace Elements|trace elements|mesh-ancestor
93125345|NCT03993288|Micronutrients|micronutrients|mesh-ancestor
93125346|NCT03993288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125347|NCT05093608|Bevacizumab|bevacizumab|mesh-list
93125348|NCT05093608|Atezolizumab|atezolizumab|mesh-list
93125349|NCT05093608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93125350|NCT05093608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125351|NCT05093608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93125352|NCT05093608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93125353|NCT05093608|Growth Substances|growth substances|mesh-ancestor
93125354|NCT05093608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125355|NCT05093608|Growth Inhibitors|growth inhibitors|mesh-ancestor
93125356|NCT05093608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93125357|NCT05093608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125358|NCT03991494|Pamiparib|pamiparib|mesh-list
93125359|NCT03991494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93125360|NCT03991494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125361|NCT03991494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125362|NCT03991494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125363|NCT03736044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93125364|NCT03736044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125365|NCT03383770|Anesthetics|anesthetics|mesh-list
93065526|NCT00419159|Everolimus|everolimus|mesh-list
93125366|NCT03383770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125367|NCT03383770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125368|NCT00086307|Pramipexole|pramipexole|mesh-list
93125369|NCT00086307|Escitalopram|escitalopram|mesh-list
93125370|NCT00086307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93125371|NCT00086307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93125372|NCT00086307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125373|NCT00086307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125374|NCT00086307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125375|NCT00086307|Serotonin Agents|serotonin agents|mesh-ancestor
93125376|NCT00086307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125377|NCT00086307|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93125378|NCT00086307|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93125379|NCT00086307|Antioxidants|antioxidants|mesh-ancestor
93125380|NCT00086307|Protective Agents|protective agents|mesh-ancestor
93125381|NCT00086307|Dopamine Agonists|dopamine agonists|mesh-ancestor
93125382|NCT00086307|Dopamine Agents|dopamine agents|mesh-ancestor
93125383|NCT01086579|Paclitaxel|paclitaxel|mesh-list
93125384|NCT01086579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93125385|NCT01086579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93125386|NCT01086579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125387|NCT01086579|Tubulin Modulators|tubulin modulators|mesh-ancestor
93125388|NCT01086579|Antimitotic Agents|antimitotic agents|mesh-ancestor
93125389|NCT01086579|Mitosis Modulators|mitosis modulators|mesh-ancestor
93125390|NCT01086579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125391|NCT03743922|Ergocalciferols|ergocalciferols|mesh-list
93125392|NCT03743922|Cholecalciferol|cholecalciferol|mesh-list
93125393|NCT03743922|Vitamin D|vitamin d|mesh-list
93125394|NCT03743922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93125395|NCT03743922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125396|NCT03743922|Vitamins|vitamins|mesh-ancestor
92797597|NCT00818389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125397|NCT03743922|Micronutrients|micronutrients|mesh-ancestor
93125398|NCT03743922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93125399|NCT03988842|Heparin|heparin|mesh-list
93125400|NCT03988842|Calcium heparin|calcium heparin|mesh-list
93125401|NCT03988842|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93125402|NCT03988842|Plasminogen|plasminogen|mesh-list
93125403|NCT03988842|Apixaban|apixaban|mesh-list
93125404|NCT03988842|Anticoagulants|anticoagulants|mesh-ancestor
93125405|NCT03988842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93125406|NCT03988842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93125407|NCT03988842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125408|NCT03988842|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93125409|NCT03988842|Antithrombins|antithrombins|mesh-ancestor
93125410|NCT03988842|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93125411|NCT03988842|Protease Inhibitors|protease inhibitors|mesh-ancestor
93125412|NCT03988842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125413|NCT02668822|Ibuprofen|ibuprofen|mesh-list
93125414|NCT02668822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125415|NCT02668822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125416|NCT02668822|Analgesics|analgesics|mesh-ancestor
93125417|NCT02668822|Sensory System Agents|sensory system agents|mesh-ancestor
93125418|NCT02668822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125419|NCT02668822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125420|NCT02668822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125421|NCT02668822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125422|NCT02668822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93125423|NCT02668822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125424|NCT02668822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125425|NCT04112589|Cytarabine|cytarabine|mesh-list
93125426|NCT04112589|Fludarabine|fludarabine|mesh-list
93125427|NCT04112589|Idarubicin|idarubicin|mesh-list
93125428|NCT04112589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125429|NCT04112589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93125430|NCT04112589|Antimetabolites|antimetabolites|mesh-ancestor
93125431|NCT04112589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125432|NCT04112589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93125433|NCT04112589|Immunologic Factors|immunologic factors|mesh-ancestor
93125434|NCT04112589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125435|NCT04112589|Antiviral Agents|antiviral agents|mesh-ancestor
93125436|NCT04112589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125437|NCT04112589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93125438|NCT04112589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93125439|NCT04112589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93125440|NCT04112589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125441|NCT03547154|Interferons|interferons|mesh-list
93125442|NCT03547154|Interferon-alpha|interferon-alpha|mesh-list
93125443|NCT03547154|Interferon alpha-2|interferon alpha-2|mesh-list
93125444|NCT03547154|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93125445|NCT03547154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125446|NCT03547154|Antiviral Agents|antiviral agents|mesh-ancestor
93125447|NCT03547154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125448|NCT03547154|Immunologic Factors|immunologic factors|mesh-ancestor
93125449|NCT03547154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125450|NCT02275546|NuvaRing|nuvaring|mesh-list
93125451|NCT02275546|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93125452|NCT02275546|Desogestrel|desogestrel|mesh-list
93125453|NCT02275546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93125454|NCT02275546|Contraceptive Agents|contraceptive agents|mesh-ancestor
93125455|NCT02275546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125456|NCT02275546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125457|NCT02275546|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93125458|NCT02275546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93125459|NCT02275546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93125460|NCT02275546|Estrogens|estrogens|mesh-ancestor
93125461|NCT02275546|Hormones|hormones|mesh-ancestor
93125462|NCT02275546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125463|NCT02275546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93125464|NCT02275546|Progestins|progestins|mesh-ancestor
93125465|NCT01090713|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93125466|NCT01090713|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93125467|NCT01090713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125468|NCT01090713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93125469|NCT01090713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93125470|NCT01090713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125471|NCT01090713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125472|NCT01090713|Dopamine Agents|dopamine agents|mesh-ancestor
93125473|NCT01090713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125474|NCT01096797|Sevoflurane|sevoflurane|mesh-list
93125475|NCT01096797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93125476|NCT01096797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93125477|NCT01096797|Anesthetics, General|anesthetics, general|mesh-ancestor
93125478|NCT01096797|Anesthetics|anesthetics|mesh-ancestor
93125479|NCT01096797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125480|NCT01096797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125481|NCT00068601|Cyclophosphamide|cyclophosphamide|mesh-list
93125482|NCT00068601|Goserelin|goserelin|mesh-list
93125483|NCT00068601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93125484|NCT00068601|Immunologic Factors|immunologic factors|mesh-ancestor
93125485|NCT00068601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125486|NCT00068601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125487|NCT00068601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93125488|NCT00068601|Alkylating Agents|alkylating agents|mesh-ancestor
93125489|NCT00068601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125490|NCT00068601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125491|NCT00068601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93125492|NCT00068601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125493|NCT01670656|Ibuprofen|ibuprofen|mesh-list
93125494|NCT01670656|Contraceptive Agents|contraceptive agents|mesh-list
93125495|NCT01670656|Etonogestrel|etonogestrel|mesh-list
93125496|NCT01670656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125497|NCT01670656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125498|NCT01670656|Analgesics|analgesics|mesh-ancestor
93125499|NCT01670656|Sensory System Agents|sensory system agents|mesh-ancestor
93125500|NCT01670656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125501|NCT01670656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125502|NCT01670656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125503|NCT01670656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125504|NCT01670656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93125505|NCT01670656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125506|NCT01670656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125507|NCT01670656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125508|NCT01670656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93125509|NCT01670656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93125510|NCT03621696|Cisplatin|cisplatin|mesh-list
93125511|NCT03621696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125512|NCT00068445|Lamotrigine|lamotrigine|mesh-list
93125513|NCT00068445|Anticonvulsants|anticonvulsants|mesh-ancestor
93125514|NCT00068445|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93125515|NCT00068445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125516|NCT00068445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125517|NCT00068445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93125518|NCT00068445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125519|NCT00068445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93125520|NCT00068445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93125521|NCT00068445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125522|NCT00068445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125523|NCT00068445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93125524|NCT03033784|Oxytocin|oxytocin|mesh-list
93125525|NCT03033784|Oxytocics|oxytocics|mesh-ancestor
93125526|NCT03033784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125527|NCT03033784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125528|NCT00038649|Imatinib Mesylate|imatinib mesylate|mesh-list
93125529|NCT00038649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125530|NCT00038649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93125531|NCT00038649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125532|NCT00038649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125533|NCT02926690|OTS167|ots167|mesh-list
93125534|NCT02926690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93125535|NCT02926690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125536|NCT02926690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125537|NCT03652818|Acetaminophen|acetaminophen|mesh-list
93125538|NCT03652818|Pregabalin|pregabalin|mesh-list
93125539|NCT03652818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125540|NCT03652818|Analgesics|analgesics|mesh-ancestor
93125541|NCT03652818|Sensory System Agents|sensory system agents|mesh-ancestor
93125542|NCT03652818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125543|NCT03652818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125544|NCT03652818|Antipyretics|antipyretics|mesh-ancestor
93125545|NCT03652818|Anticonvulsants|anticonvulsants|mesh-ancestor
93125546|NCT03652818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93125547|NCT03652818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125548|NCT03652818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125549|NCT03652818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93125550|NCT03652818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93125551|NCT03652818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93125552|NCT03652818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125553|NCT03652818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125554|NCT03723824|Grazoprevir|grazoprevir|mesh-list
93125555|NCT03723824|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93125556|NCT03723824|Antiviral Agents|antiviral agents|mesh-ancestor
93125557|NCT03723824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125558|NCT00620464|Etonogestrel|etonogestrel|mesh-list
93125559|NCT00620464|Desogestrel|desogestrel|mesh-list
93125560|NCT00620464|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93125561|NCT00620464|Contraceptive Agents|contraceptive agents|mesh-ancestor
93125562|NCT00620464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125563|NCT00620464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125564|NCT00620464|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93125565|NCT00620464|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93125566|NCT00620464|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93125567|NCT00620464|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93125568|NCT00620464|Progestins|progestins|mesh-ancestor
93125569|NCT00620464|Hormones|hormones|mesh-ancestor
93125570|NCT00620464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125571|NCT00541684|Atenolol|atenolol|mesh-list
93125572|NCT00541684|Adrenergic Agents|adrenergic agents|mesh-ancestor
93125573|NCT00541684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125574|NCT00541684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125575|NCT00541684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125576|NCT00541684|Autonomic Agents|autonomic agents|mesh-ancestor
93125577|NCT00541684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125578|NCT00541684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93125579|NCT00541684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93125580|NCT00541684|Sympatholytics|sympatholytics|mesh-ancestor
93125581|NCT00541684|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93125582|NCT00541684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93125583|NCT00541684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93125584|NCT00413764|Tibolone|tibolone|mesh-list
93125585|NCT00413764|Norethindrone|norethindrone|mesh-list
93125586|NCT00413764|Norethindrone Acetate|norethindrone acetate|mesh-list
93125587|NCT00413764|Estradiol|estradiol|mesh-list
93125588|NCT00413764|Estrogens|estrogens|mesh-ancestor
93125589|NCT00413764|Hormones|hormones|mesh-ancestor
93125590|NCT00413764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125591|NCT00413764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125592|NCT00413764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93125593|NCT00413764|Contraceptive Agents|contraceptive agents|mesh-ancestor
93125594|NCT00413764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93125595|NCT00413764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93125596|NCT00413764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93125597|NCT00413764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93125598|NCT00413764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93125599|NCT00413764|Androgen Antagonists|androgen antagonists|mesh-ancestor
93125600|NCT00413764|Hormone Antagonists|hormone antagonists|mesh-ancestor
93125601|NCT00413764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93125602|NCT00413764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125603|NCT00413764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125604|NCT00413764|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93125605|NCT00413764|Anabolic Agents|anabolic agents|mesh-ancestor
93125606|NCT03726788|Triamcinolone|triamcinolone|mesh-list
93125607|NCT03726788|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93125608|NCT03726788|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93125609|NCT03726788|Botulinum Toxins|botulinum toxins|mesh-list
93125610|NCT03726788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93125611|NCT03726788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93125612|NCT03726788|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93125613|NCT03726788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93125614|NCT03726788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125615|NCT03726788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125616|NCT03726788|Cholinergic Agents|cholinergic agents|mesh-ancestor
93125617|NCT03726788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125618|NCT03726788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125619|NCT03726788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93125620|NCT03726788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797832|NCT02613091|Clemastine|clemastine|mesh-list
93125621|NCT03726788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125622|NCT03726788|Glucocorticoids|glucocorticoids|mesh-ancestor
93125623|NCT03726788|Hormones|hormones|mesh-ancestor
93125624|NCT03726788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125625|NCT03726788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93125626|NCT03726788|Immunologic Factors|immunologic factors|mesh-ancestor
93125627|NCT03726788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125628|NCT03735264|Docetaxel|docetaxel|mesh-list
93125629|NCT03735264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125630|NCT03735264|Tubulin Modulators|tubulin modulators|mesh-ancestor
93125631|NCT03735264|Antimitotic Agents|antimitotic agents|mesh-ancestor
93125632|NCT03735264|Mitosis Modulators|mitosis modulators|mesh-ancestor
93125633|NCT03735264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125634|NCT03560258|Vaccines|vaccines|mesh-list
93125635|NCT03560258|Immunologic Factors|immunologic factors|mesh-ancestor
93125636|NCT03560258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125637|NCT02759380|Phytoestrogens|phytoestrogens|mesh-list
93125638|NCT02759380|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93125639|NCT02759380|Estrogens|estrogens|mesh-ancestor
93125640|NCT02759380|Hormones|hormones|mesh-ancestor
93125641|NCT02759380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125642|NCT02759380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125643|NCT03539432|Gemfibrozil|gemfibrozil|mesh-list
93125644|NCT03539432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93125645|NCT03539432|Antimetabolites|antimetabolites|mesh-ancestor
93125646|NCT03539432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125647|NCT03539432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93125648|NCT03539432|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93125649|NCT03539432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93125650|NCT03539432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125651|NCT03615924|Ticagrelor|ticagrelor|mesh-list
93125652|NCT03615924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93125653|NCT03615924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93125654|NCT03615924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93125655|NCT03615924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93125656|NCT03615924|Purinergic Agents|purinergic agents|mesh-ancestor
93125657|NCT03615924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125658|NCT03615924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125659|NCT03615924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125660|NCT05576038|Tryptophan|tryptophan|mesh-list
93125661|NCT05576038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93125662|NCT05576038|Antidepressive Agents|antidepressive agents|mesh-ancestor
93125663|NCT05576038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125664|NCT04660240|Sirolimus|sirolimus|mesh-list
93125665|NCT04660240|Temsirolimus|temsirolimus|mesh-list
93125666|NCT04660240|MTOR Inhibitors|mtor inhibitors|mesh-list
93125667|NCT04660240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93125668|NCT04660240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125669|NCT04660240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93125670|NCT04660240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125671|NCT04660240|Antifungal Agents|antifungal agents|mesh-ancestor
93125672|NCT04660240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93125673|NCT04660240|Immunologic Factors|immunologic factors|mesh-ancestor
93125674|NCT04660240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125675|NCT04660240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93125676|NCT04660240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125677|NCT04660240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125678|NCT03033394|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93125679|NCT03033394|Penicillins|penicillins|mesh-list
93125680|NCT03033394|Lactams|lactams|mesh-list
93125681|NCT03033394|beta-Lactams|beta-lactams|mesh-list
93125682|NCT03033394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125683|NCT03639428|Midazolam|midazolam|mesh-list
93125684|NCT03639428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93125685|NCT03639428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93125686|NCT03639428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125687|NCT03639428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125688|NCT03639428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93125689|NCT03639428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93125690|NCT03639428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93125691|NCT03639428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125692|NCT03639428|Anesthetics, General|anesthetics, general|mesh-ancestor
93125693|NCT03639428|Anesthetics|anesthetics|mesh-ancestor
93125694|NCT03639428|GABA Modulators|gaba modulators|mesh-ancestor
93125695|NCT03639428|GABA Agents|gaba agents|mesh-ancestor
93125696|NCT03639428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125697|NCT03639428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125698|NCT04575688|Bupivacaine|bupivacaine|mesh-list
93125699|NCT04575688|Anesthetics, Local|anesthetics, local|mesh-ancestor
93125700|NCT04575688|Anesthetics|anesthetics|mesh-ancestor
93125701|NCT04575688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125702|NCT04575688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125703|NCT04575688|Sensory System Agents|sensory system agents|mesh-ancestor
93125704|NCT04575688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125705|NCT05528848|Fentanyl|fentanyl|mesh-list
93125706|NCT05528848|Carfentanil|carfentanil|mesh-list
93125707|NCT05528848|Naloxone|naloxone|mesh-list
93125708|NCT05528848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93125709|NCT05528848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125710|NCT05528848|Sensory System Agents|sensory system agents|mesh-ancestor
93125711|NCT05528848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125712|NCT05528848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93125713|NCT05528848|Narcotics|narcotics|mesh-ancestor
93125714|NCT05528848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125715|NCT05528848|Analgesics|analgesics|mesh-ancestor
93125716|NCT05528848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93125717|NCT05528848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125718|NCT05528848|Anesthetics, General|anesthetics, general|mesh-ancestor
93125719|NCT05528848|Anesthetics|anesthetics|mesh-ancestor
93125720|NCT04561648|Heparin|heparin|mesh-list
93125721|NCT04561648|Calcium heparin|calcium heparin|mesh-list
93125722|NCT04561648|Anticoagulants|anticoagulants|mesh-ancestor
93125723|NCT04561648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93125724|NCT04561648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93125725|NCT04561648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125726|NCT03981822|Cantharidin|cantharidin|mesh-list
93125727|NCT03981822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125728|NCT03981822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125729|NCT03704818|Dapagliflozin|dapagliflozin|mesh-list
93125730|NCT03704818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93125731|NCT03704818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125732|NCT03704818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93125733|NCT03704818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125734|NCT05506930|Morphine|morphine|mesh-list
93125735|NCT05506930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93125736|NCT05506930|Narcotics|narcotics|mesh-ancestor
93065899|NCT03783754|Diuretics|diuretics|mesh-ancestor
93125737|NCT05506930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125738|NCT05506930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125739|NCT05506930|Analgesics|analgesics|mesh-ancestor
93125740|NCT05506930|Sensory System Agents|sensory system agents|mesh-ancestor
93125741|NCT05506930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125742|NCT05464264|Ketamine|ketamine|mesh-list
93125743|NCT05464264|Analgesics|analgesics|mesh-ancestor
93125744|NCT05464264|Sensory System Agents|sensory system agents|mesh-ancestor
93125745|NCT05464264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125746|NCT05464264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125747|NCT05464264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93125748|NCT05464264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125749|NCT05464264|Anesthetics, General|anesthetics, general|mesh-ancestor
93125750|NCT05464264|Anesthetics|anesthetics|mesh-ancestor
93125751|NCT05464264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125752|NCT05464264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93125753|NCT05464264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93125754|NCT05464264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125755|NCT05464264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125756|NCT01310738|Amphotericin B|amphotericin b|mesh-list
93125757|NCT01310738|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93125758|NCT01310738|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
93125759|NCT01310738|Meglumine Antimoniate|meglumine antimoniate|mesh-list
93125760|NCT01310738|Deoxycholic Acid|deoxycholic acid|mesh-list
93125761|NCT01310738|Amebicides|amebicides|mesh-ancestor
93125762|NCT01310738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93125763|NCT01310738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93125764|NCT01310738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125765|NCT01310738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93125766|NCT01310738|Antifungal Agents|antifungal agents|mesh-ancestor
93125767|NCT01310738|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93125768|NCT01310738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125769|NCT03704506|Amoxicillin|amoxicillin|mesh-list
93125770|NCT03704506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93125771|NCT03704506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93125772|NCT03615144|Fludarabine|fludarabine|mesh-list
93125773|NCT03615144|Melphalan|melphalan|mesh-list
93125774|NCT03615144|Thiotepa|thiotepa|mesh-list
93125775|NCT03615144|Clofarabine|clofarabine|mesh-list
93125776|NCT03615144|Thymoglobulin|thymoglobulin|mesh-list
93125777|NCT03615144|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93125778|NCT03615144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125779|NCT03615144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93125780|NCT03615144|Antimetabolites|antimetabolites|mesh-ancestor
93125781|NCT03615144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125782|NCT03615144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93125783|NCT03615144|Immunologic Factors|immunologic factors|mesh-ancestor
93125784|NCT03615144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125785|NCT03615144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93125786|NCT03615144|Alkylating Agents|alkylating agents|mesh-ancestor
93125787|NCT03615144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93125788|NCT05340790|Anti-Infective Agents|anti-infective agents|mesh-list
93125789|NCT05340790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93125790|NCT03682302|Bupivacaine|bupivacaine|mesh-list
93125791|NCT03682302|Anesthetics, Local|anesthetics, local|mesh-ancestor
93125792|NCT03682302|Anesthetics|anesthetics|mesh-ancestor
93125793|NCT03682302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125794|NCT03682302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125795|NCT03682302|Sensory System Agents|sensory system agents|mesh-ancestor
93125796|NCT03682302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125797|NCT03522506|Modafinil|modafinil|mesh-list
93125798|NCT03522506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93125799|NCT03522506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125800|NCT03522506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93125801|NCT03522506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93125802|NCT03522506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93125803|NCT03522506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125804|NCT03320434|Prednisolone acetate|prednisolone acetate|mesh-list
93125805|NCT03320434|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93125806|NCT03320434|Methylprednisolone|methylprednisolone|mesh-list
93125807|NCT03320434|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93125808|NCT03320434|Prednisolone|prednisolone|mesh-list
93125809|NCT03320434|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93125810|NCT03320434|Prednisolone phosphate|prednisolone phosphate|mesh-list
93125811|NCT03320434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125812|NCT03320434|Antiemetics|antiemetics|mesh-ancestor
93125813|NCT03320434|Autonomic Agents|autonomic agents|mesh-ancestor
93125814|NCT03320434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125815|NCT03320434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125816|NCT03320434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125817|NCT03320434|Glucocorticoids|glucocorticoids|mesh-ancestor
93125818|NCT03320434|Hormones|hormones|mesh-ancestor
93125819|NCT03320434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125820|NCT03320434|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93125821|NCT03320434|Protective Agents|protective agents|mesh-ancestor
93125822|NCT03320434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125823|NCT03320434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125824|NCT02892734|Nivolumab|nivolumab|mesh-list
93125825|NCT02892734|Ipilimumab|ipilimumab|mesh-list
93125826|NCT02892734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93125827|NCT02892734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125828|NCT02892734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93125829|NCT02892734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125830|NCT05231590|Myeloma Proteins|myeloma proteins|mesh-list
93125831|NCT05231590|Paraproteins|paraproteins|mesh-list
93125832|NCT05231590|Immunologic Factors|immunologic factors|mesh-ancestor
93125833|NCT05231590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125834|NCT00055497|Adalimumab|adalimumab|mesh-list
93125835|NCT00055497|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93125836|NCT00055497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125837|NCT00055497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125838|NCT03726398|Macitentan|macitentan|mesh-list
93125839|NCT03726398|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93125840|NCT03726398|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93125841|NCT03726398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125842|NCT03726398|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93125843|NCT04050592|Estradiol|estradiol|mesh-list
93125844|NCT04050592|Estrogens|estrogens|mesh-ancestor
93125845|NCT04050592|Hormones|hormones|mesh-ancestor
92798044|NCT02641990|Incretins|incretins|mesh-ancestor
93125846|NCT04050592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125847|NCT04050592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125848|NCT03726242|Cromakalim|cromakalim|mesh-list
93125849|NCT03726242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93125850|NCT03726242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93125851|NCT03726242|Autonomic Agents|autonomic agents|mesh-ancestor
93125852|NCT03726242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125853|NCT03726242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125854|NCT03726242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93125855|NCT03726242|Respiratory System Agents|respiratory system agents|mesh-ancestor
93125856|NCT03726242|Parasympatholytics|parasympatholytics|mesh-ancestor
93125857|NCT03726242|Vasodilator Agents|vasodilator agents|mesh-ancestor
93125858|NCT03731988|Lidocaine|lidocaine|mesh-list
93125859|NCT03731988|Prilocaine|prilocaine|mesh-list
93125860|NCT03731988|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93125861|NCT03731988|Anesthetics, Local|anesthetics, local|mesh-ancestor
93125862|NCT03731988|Anesthetics|anesthetics|mesh-ancestor
93125863|NCT03731988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125864|NCT03731988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125865|NCT03731988|Sensory System Agents|sensory system agents|mesh-ancestor
93125866|NCT03731988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125867|NCT03731988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93125868|NCT03731988|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93125869|NCT03731988|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93125870|NCT03731988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125871|NCT03731988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125872|NCT03731988|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93125873|NCT01094457|Aspirin|aspirin|mesh-list
93125874|NCT01094457|Cilostazol|cilostazol|mesh-list
93125875|NCT01094457|Clopidogrel|clopidogrel|mesh-list
93125876|NCT01094457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125877|NCT01094457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125878|NCT01094457|Analgesics|analgesics|mesh-ancestor
93125879|NCT01094457|Sensory System Agents|sensory system agents|mesh-ancestor
93125880|NCT01094457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125881|NCT01094457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125882|NCT01094457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125883|NCT01094457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93125884|NCT01094457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93125885|NCT01094457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93125886|NCT01094457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125887|NCT01094457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93125888|NCT01094457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93125889|NCT01094457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125890|NCT01094457|Antipyretics|antipyretics|mesh-ancestor
93125891|NCT01094457|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93125892|NCT01094457|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93125893|NCT01094457|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93125894|NCT01094457|Purinergic Agents|purinergic agents|mesh-ancestor
93125895|NCT01094457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125896|NCT01094457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93125897|NCT01094457|Autonomic Agents|autonomic agents|mesh-ancestor
93125898|NCT01094457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93125899|NCT01094457|Respiratory System Agents|respiratory system agents|mesh-ancestor
93125900|NCT01094457|Vasodilator Agents|vasodilator agents|mesh-ancestor
93125901|NCT01094457|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93125902|NCT01094457|Protective Agents|protective agents|mesh-ancestor
93125903|NCT01094457|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93125904|NCT01094457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93125905|NCT03701698|Methylprednisolone|methylprednisolone|mesh-list
93125906|NCT03701698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93125907|NCT03701698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93125908|NCT03701698|Prednisolone|prednisolone|mesh-list
93125909|NCT03701698|Prednisolone acetate|prednisolone acetate|mesh-list
93125910|NCT03701698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93125911|NCT03701698|Prednisolone phosphate|prednisolone phosphate|mesh-list
93125912|NCT03701698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125913|NCT03701698|Antiemetics|antiemetics|mesh-ancestor
93125914|NCT03701698|Autonomic Agents|autonomic agents|mesh-ancestor
93125915|NCT03701698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125916|NCT03701698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125917|NCT03701698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125918|NCT03701698|Glucocorticoids|glucocorticoids|mesh-ancestor
93125919|NCT03701698|Hormones|hormones|mesh-ancestor
93125920|NCT03701698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125921|NCT03701698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93125922|NCT03701698|Protective Agents|protective agents|mesh-ancestor
93125923|NCT03701698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125924|NCT03701698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125925|NCT03734562|Amiodarone|amiodarone|mesh-list
93125926|NCT03734562|Sotalol|sotalol|mesh-list
93125927|NCT03734562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93125928|NCT03734562|Vasodilator Agents|vasodilator agents|mesh-ancestor
93125929|NCT03734562|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93125930|NCT03734562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93125931|NCT03734562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125932|NCT03734562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93125933|NCT03734562|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93125934|NCT03734562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93125935|NCT03734562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125936|NCT03734562|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93125937|NCT03734562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93125938|NCT03734562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93125939|NCT03734562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93125940|NCT03734562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93125941|NCT03734562|Adrenergic Agents|adrenergic agents|mesh-ancestor
93125942|NCT03734562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93125943|NCT03734562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125944|NCT03734562|Sympatholytics|sympatholytics|mesh-ancestor
93125945|NCT03734562|Autonomic Agents|autonomic agents|mesh-ancestor
93125946|NCT03734562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125947|NCT03034096|Propofol|propofol|mesh-list
93125948|NCT03034096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93125949|NCT03034096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93125950|NCT03034096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125951|NCT03034096|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93125952|NCT03034096|Anesthetics, General|anesthetics, general|mesh-ancestor
93125953|NCT03034096|Anesthetics|anesthetics|mesh-ancestor
93125954|NCT03722420|Imatinib Mesylate|imatinib mesylate|mesh-list
93125955|NCT03722420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125956|NCT03722420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93125957|NCT03722420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93125958|NCT03722420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125959|NCT03721874|Dapagliflozin|dapagliflozin|mesh-list
93125960|NCT03721874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93125961|NCT03721874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93125962|NCT03721874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93125963|NCT03721874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125964|NCT03807843|Vaccines|vaccines|mesh-list
93125965|NCT03807843|Immunologic Factors|immunologic factors|mesh-ancestor
93125966|NCT03807843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125967|NCT01094535|Secretin|secretin|mesh-list
93125968|NCT01094535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125969|NCT01094535|Hormones|hormones|mesh-ancestor
93125970|NCT01094535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125971|NCT01094535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125972|NCT02843074|Dexamethasone|dexamethasone|mesh-list
93125973|NCT02843074|Lenalidomide|lenalidomide|mesh-list
93125974|NCT02843074|Elotuzumab|elotuzumab|mesh-list
93125975|NCT02843074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93125976|NCT02843074|Antiemetics|antiemetics|mesh-ancestor
93125977|NCT02843074|Autonomic Agents|autonomic agents|mesh-ancestor
93125978|NCT02843074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125979|NCT02843074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125980|NCT02843074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93125981|NCT02843074|Glucocorticoids|glucocorticoids|mesh-ancestor
93125982|NCT02843074|Hormones|hormones|mesh-ancestor
93125983|NCT02843074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93125984|NCT02843074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93125985|NCT02843074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93125986|NCT02843074|Immunologic Factors|immunologic factors|mesh-ancestor
93125987|NCT02843074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93125988|NCT02843074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93125989|NCT02843074|Growth Substances|growth substances|mesh-ancestor
93125990|NCT02843074|Growth Inhibitors|growth inhibitors|mesh-ancestor
93125991|NCT00038103|Celecoxib|celecoxib|mesh-list
93125992|NCT00038103|Exemestane|exemestane|mesh-list
93125993|NCT00038103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93125994|NCT00038103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93125995|NCT00038103|Analgesics|analgesics|mesh-ancestor
93125996|NCT00038103|Sensory System Agents|sensory system agents|mesh-ancestor
93125997|NCT00038103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93125998|NCT00038103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93125999|NCT00038103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126000|NCT00038103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126001|NCT00038103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93126002|NCT00038103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93126003|NCT00038103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126004|NCT00038103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126005|NCT00038103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126006|NCT00038103|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93126007|NCT00038103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93126008|NCT00038103|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93126009|NCT00038103|Hormone Antagonists|hormone antagonists|mesh-ancestor
93126010|NCT00038103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126011|NCT03678870|Analgesics, Opioid|analgesics, opioid|mesh-list
93126012|NCT03678870|Narcotics|narcotics|mesh-ancestor
93126013|NCT03678870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126014|NCT03678870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126015|NCT03678870|Analgesics|analgesics|mesh-ancestor
93126016|NCT03678870|Sensory System Agents|sensory system agents|mesh-ancestor
93126017|NCT03678870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126018|NCT03032380|Meropenem|meropenem|mesh-list
93126019|NCT03032380|Linezolid|linezolid|mesh-list
93126020|NCT03032380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93126021|NCT03032380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126022|NCT03032380|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93126023|NCT03032380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126024|NCT03032380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126025|NCT03519854|Bromides|bromides|mesh-list
93126026|NCT03519854|Rocuronium|rocuronium|mesh-list
93126027|NCT03519854|Anticonvulsants|anticonvulsants|mesh-ancestor
93126028|NCT03519854|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93126029|NCT03519854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93126030|NCT03519854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93126031|NCT03519854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126032|NCT03519854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126033|NCT03703960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93126034|NCT03703960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126035|NCT03703960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126036|NCT03479216|Magnesium Sulfate|magnesium sulfate|mesh-list
93126037|NCT03479216|Dexmedetomidine|dexmedetomidine|mesh-list
93126038|NCT03479216|Bupivacaine|bupivacaine|mesh-list
93126039|NCT03479216|Anesthetics, Local|anesthetics, local|mesh-ancestor
93126040|NCT03479216|Anesthetics|anesthetics|mesh-ancestor
93126041|NCT03479216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126042|NCT03479216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126043|NCT03479216|Sensory System Agents|sensory system agents|mesh-ancestor
93126044|NCT03479216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126045|NCT03479216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93126046|NCT03479216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93126047|NCT03479216|Analgesics|analgesics|mesh-ancestor
93126048|NCT03479216|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93126049|NCT03479216|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93126050|NCT03479216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93126051|NCT03479216|Adrenergic Agents|adrenergic agents|mesh-ancestor
93126052|NCT03479216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126053|NCT03479216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126054|NCT03479216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93126055|NCT03479216|Anticonvulsants|anticonvulsants|mesh-ancestor
93126056|NCT03479216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93126057|NCT03479216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126058|NCT03479216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93126059|NCT03479216|Tocolytic Agents|tocolytic agents|mesh-ancestor
93126060|NCT03479216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93126061|NCT03717116|Parathyroid Hormone|parathyroid hormone|mesh-list
93126062|NCT03717116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93126063|NCT03717116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126064|NCT03717038|Trifluridine|trifluridine|mesh-list
93126065|NCT03717038|Antimetabolites|antimetabolites|mesh-ancestor
93126066|NCT03717038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126067|NCT03717038|Antiviral Agents|antiviral agents|mesh-ancestor
93126068|NCT03717038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126069|NCT00143182|Olanzapine|olanzapine|mesh-list
93126070|NCT00143182|Asenapine|asenapine|mesh-list
93126071|NCT00143182|Antiemetics|antiemetics|mesh-ancestor
93126072|NCT00143182|Autonomic Agents|autonomic agents|mesh-ancestor
93126073|NCT00143182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126074|NCT00143182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126075|NCT00143182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126076|NCT00143182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93126077|NCT00143182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93126078|NCT00143182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126079|NCT00143182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93126080|NCT00143182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93126081|NCT00143182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93126082|NCT00143182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126083|NCT00143182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126084|NCT00143182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126085|NCT00143182|Serotonin Agents|serotonin agents|mesh-ancestor
93126086|NCT03677934|Ranibizumab|ranibizumab|mesh-list
93126087|NCT03677934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93126088|NCT03677934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93126089|NCT03677934|Growth Substances|growth substances|mesh-ancestor
93126090|NCT03677934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126091|NCT03677934|Growth Inhibitors|growth inhibitors|mesh-ancestor
93126092|NCT03677934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126093|NCT03435692|Acetaminophen|acetaminophen|mesh-list
93126094|NCT03435692|Diphenhydramine|diphenhydramine|mesh-list
93126095|NCT03435692|Promethazine|promethazine|mesh-list
93126096|NCT03435692|Fentanyl|fentanyl|mesh-list
93126097|NCT03435692|Morphine|morphine|mesh-list
93126098|NCT03435692|Oxycodone|oxycodone|mesh-list
93126099|NCT03435692|Lorazepam|lorazepam|mesh-list
93126100|NCT03435692|Ondansetron|ondansetron|mesh-list
93126101|NCT03435692|Ropivacaine|ropivacaine|mesh-list
93126102|NCT03435692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93126103|NCT03435692|Narcotics|narcotics|mesh-ancestor
93126104|NCT03435692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126105|NCT03435692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126106|NCT03435692|Analgesics|analgesics|mesh-ancestor
93126107|NCT03435692|Sensory System Agents|sensory system agents|mesh-ancestor
93126108|NCT03435692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126109|NCT03435692|Anesthetics, Local|anesthetics, local|mesh-ancestor
93126110|NCT03435692|Anesthetics|anesthetics|mesh-ancestor
93126111|NCT03435692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93126112|NCT03435692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93126113|NCT03435692|Anesthetics, General|anesthetics, general|mesh-ancestor
93126114|NCT03435692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93126115|NCT03435692|Antipyretics|antipyretics|mesh-ancestor
93126116|NCT03435692|Antiemetics|antiemetics|mesh-ancestor
93126117|NCT03435692|Autonomic Agents|autonomic agents|mesh-ancestor
93126118|NCT03435692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126119|NCT03435692|Antipruritics|antipruritics|mesh-ancestor
93126120|NCT03435692|Dermatologic Agents|dermatologic agents|mesh-ancestor
93126121|NCT03435692|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93126122|NCT03435692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93126123|NCT03435692|Serotonin Agents|serotonin agents|mesh-ancestor
93126124|NCT03435692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126125|NCT03435692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126126|NCT03435692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93126127|NCT03435692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93126128|NCT03435692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93126129|NCT03435692|Histamine Antagonists|histamine antagonists|mesh-ancestor
93126130|NCT03435692|Histamine Agents|histamine agents|mesh-ancestor
93126131|NCT03435692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93126132|NCT03435692|Anticonvulsants|anticonvulsants|mesh-ancestor
93126133|NCT03435692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93126134|NCT03435692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93126135|NCT03435692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93126136|NCT03435692|GABA Modulators|gaba modulators|mesh-ancestor
93126137|NCT03435692|GABA Agents|gaba agents|mesh-ancestor
93126138|NCT03705442|Loperamide|loperamide|mesh-list
93126139|NCT03705442|Antidiarrheals|antidiarrheals|mesh-list
93126140|NCT03705442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126141|NCT04817410|Naltrexone|naltrexone|mesh-list
93126142|NCT04817410|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93126143|NCT04817410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93126144|NCT04817410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126145|NCT04817410|Sensory System Agents|sensory system agents|mesh-ancestor
93126146|NCT04817410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126147|NCT03673956|Vancomycin|vancomycin|mesh-list
93126148|NCT03673956|Levofloxacin|levofloxacin|mesh-list
93126149|NCT03673956|Tobramycin|tobramycin|mesh-list
93126150|NCT03673956|Mupirocin|mupirocin|mesh-list
93126151|NCT03673956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93126152|NCT03673956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126153|NCT03673956|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93126154|NCT03673956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93126155|NCT03673956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93126156|NCT03673956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126157|NCT03673956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126158|NCT03673956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126159|NCT03673956|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93126160|NCT03673956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93126161|NCT03673956|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93126163|NCT03716804|Cefuroxime|cefuroxime|mesh-list
93126164|NCT03716804|Cefuroxime axetil|cefuroxime axetil|mesh-list
93126165|NCT03716804|Nitrofurantoin|nitrofurantoin|mesh-list
93126166|NCT03716804|Cefixime|cefixime|mesh-list
93126167|NCT03716804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93126168|NCT03716804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126169|NCT03716804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93126170|NCT03716804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93126171|NCT03716804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126172|NCT03716804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126173|NCT03716804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126174|NCT03716804|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93126175|NCT03716804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93126176|NCT03716804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93126177|NCT01310166|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93126178|NCT01310166|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93126179|NCT01310166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126180|NCT01310166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126181|NCT01310166|Immunologic Factors|immunologic factors|mesh-ancestor
93126182|NCT01310166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126183|NCT03733860|Alprostadil|alprostadil|mesh-list
93126184|NCT03733860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93126185|NCT03733860|Vasodilator Agents|vasodilator agents|mesh-ancestor
93126186|NCT03733860|Urological Agents|urological agents|mesh-ancestor
93126187|NCT03605862|Nitazoxanide|nitazoxanide|mesh-list
93126188|NCT03605862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93126189|NCT03605862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126190|NCT01310244|Paclitaxel|paclitaxel|mesh-list
93126191|NCT01310244|Carboplatin|carboplatin|mesh-list
93126192|NCT01310244|Belinostat|belinostat|mesh-list
93126193|NCT01310244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93126194|NCT01310244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126195|NCT01310244|Tubulin Modulators|tubulin modulators|mesh-ancestor
93126196|NCT01310244|Antimitotic Agents|antimitotic agents|mesh-ancestor
93126197|NCT01310244|Mitosis Modulators|mitosis modulators|mesh-ancestor
93126198|NCT01310244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126199|NCT01310244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93126200|NCT01310244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126201|NCT03672006|Heparin|heparin|mesh-list
93126202|NCT03672006|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93126203|NCT03672006|Anticoagulants|anticoagulants|mesh-ancestor
93126204|NCT03672006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93126205|NCT03672006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93126206|NCT03672006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126207|NCT03621072|Fluconazole|fluconazole|mesh-list
93126208|NCT03621072|Antifungal Agents|antifungal agents|mesh-ancestor
93126209|NCT03621072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126210|NCT03621072|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93126211|NCT03621072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93126212|NCT03621072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126213|NCT03621072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126214|NCT03621072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93126215|NCT03621072|Hormone Antagonists|hormone antagonists|mesh-ancestor
93126216|NCT03621072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126217|NCT03621072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126218|NCT03621072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93126219|NCT03621072|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93126220|NCT03512288|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93126221|NCT03512288|Immunologic Factors|immunologic factors|mesh-ancestor
92798416|NCT00814801|Galantamine|galantamine|mesh-list
93126222|NCT03512288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126223|NCT01311050|Bevacizumab|bevacizumab|mesh-list
93126224|NCT01311050|Capecitabine|capecitabine|mesh-list
93126225|NCT01311050|Oxaliplatin|oxaliplatin|mesh-list
93126226|NCT01311050|Irinotecan|irinotecan|mesh-list
93126227|NCT01311050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126228|NCT01311050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126229|NCT01311050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93126230|NCT01311050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93126231|NCT01311050|Growth Substances|growth substances|mesh-ancestor
93126232|NCT01311050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126233|NCT01311050|Growth Inhibitors|growth inhibitors|mesh-ancestor
93126234|NCT01311050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93126235|NCT01311050|Antimetabolites|antimetabolites|mesh-ancestor
93126236|NCT01311050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126237|NCT01311050|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93126238|NCT01311050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93126239|NCT01311050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126240|NCT03700450|Cyclophosphamide|cyclophosphamide|mesh-list
93126241|NCT03700450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126242|NCT03700450|Immunologic Factors|immunologic factors|mesh-ancestor
93126243|NCT03700450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126244|NCT03700450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126245|NCT03700450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93126246|NCT03700450|Alkylating Agents|alkylating agents|mesh-ancestor
93126247|NCT03700450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126248|NCT03700450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126249|NCT03700450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93126250|NCT03702946|Oxytocin|oxytocin|mesh-list
93126251|NCT03702946|Oxytocics|oxytocics|mesh-ancestor
93126252|NCT03702946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93126253|NCT03702946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126254|NCT04491526|Tamsulosin|tamsulosin|mesh-list
93126255|NCT04491526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93126256|NCT04491526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93126257|NCT04491526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93126258|NCT04491526|Adrenergic Agents|adrenergic agents|mesh-ancestor
93126259|NCT04491526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126260|NCT04491526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126261|NCT04491526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126262|NCT04491526|Urological Agents|urological agents|mesh-ancestor
93126263|NCT04484350|Enalapril|enalapril|mesh-list
93126264|NCT04484350|Labetalol|labetalol|mesh-list
93126265|NCT04484350|Hydralazine|hydralazine|mesh-list
93126266|NCT04484350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93126267|NCT04484350|Protease Inhibitors|protease inhibitors|mesh-ancestor
93126268|NCT04484350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126269|NCT04484350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126270|NCT04484350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93126271|NCT04484350|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93126272|NCT04484350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93126273|NCT04484350|Adrenergic Agents|adrenergic agents|mesh-ancestor
93126274|NCT04484350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126275|NCT04484350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126276|NCT04484350|Sympathomimetics|sympathomimetics|mesh-ancestor
93126277|NCT04484350|Autonomic Agents|autonomic agents|mesh-ancestor
93126278|NCT04484350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126279|NCT04484350|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93126280|NCT04484350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93126281|NCT04484350|Vasodilator Agents|vasodilator agents|mesh-ancestor
93126282|NCT03699904|Valacyclovir|valacyclovir|mesh-list
93126283|NCT03699904|Antiviral Agents|antiviral agents|mesh-ancestor
93126284|NCT03699904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126285|NCT03697018|Lithium Carbonate|lithium carbonate|mesh-list
93126286|NCT03697018|Antidepressive Agents|antidepressive agents|mesh-ancestor
93126287|NCT03697018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93126288|NCT03697018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126289|NCT03697018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126290|NCT03697018|Antimanic Agents|antimanic agents|mesh-ancestor
93126291|NCT03697018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93126292|NCT03697018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126293|NCT03697018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126294|NCT03696940|Atorvastatin|atorvastatin|mesh-list
93126295|NCT03696940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93126296|NCT03696940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93126297|NCT03696940|Antimetabolites|antimetabolites|mesh-ancestor
93126298|NCT03696940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126299|NCT03696940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93126300|NCT03696940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93126301|NCT03696940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126302|NCT03731442|Paclitaxel|paclitaxel|mesh-list
93126303|NCT03731442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93126304|NCT03731442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126305|NCT03731442|Tubulin Modulators|tubulin modulators|mesh-ancestor
93126306|NCT03731442|Antimitotic Agents|antimitotic agents|mesh-ancestor
93126307|NCT03731442|Mitosis Modulators|mitosis modulators|mesh-ancestor
93126308|NCT03731442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126309|NCT03702400|Phenylephrine|phenylephrine|mesh-list
93126310|NCT03702400|Oxymetazoline|oxymetazoline|mesh-list
93126311|NCT03702400|Norepinephrine|norepinephrine|mesh-list
93126312|NCT03702400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93126313|NCT03702400|Mydriatics|mydriatics|mesh-ancestor
93126314|NCT03702400|Autonomic Agents|autonomic agents|mesh-ancestor
93126315|NCT03702400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126316|NCT03702400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126317|NCT03702400|Sympathomimetics|sympathomimetics|mesh-ancestor
93126318|NCT03702400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93126319|NCT03702400|Nasal Decongestants|nasal decongestants|mesh-ancestor
93126320|NCT03702400|Respiratory System Agents|respiratory system agents|mesh-ancestor
93126321|NCT03702400|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93126322|NCT03702400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93126323|NCT03702400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93126324|NCT03702400|Adrenergic Agents|adrenergic agents|mesh-ancestor
93126325|NCT03702400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126326|NCT03702400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126327|NCT03702400|Protective Agents|protective agents|mesh-ancestor
93126328|NCT03699202|Ziresovir|ziresovir|mesh-list
93126329|NCT03699202|Antiviral Agents|antiviral agents|mesh-ancestor
93126330|NCT03699202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126331|NCT03598140|Sildenafil Citrate|sildenafil citrate|mesh-list
93126332|NCT03598140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126333|NCT03598140|Vasodilator Agents|vasodilator agents|mesh-ancestor
93126334|NCT03598140|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93126335|NCT03598140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93126336|NCT03598140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126337|NCT03598140|Urological Agents|urological agents|mesh-ancestor
93126338|NCT04457596|Trastuzumab|trastuzumab|mesh-list
93126339|NCT04457596|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93126340|NCT04457596|Maytansine|maytansine|mesh-list
93126341|NCT04457596|Tucatinib|tucatinib|mesh-list
93126342|NCT04457596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126343|NCT04457596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126344|NCT04457596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93126345|NCT04457596|Tubulin Modulators|tubulin modulators|mesh-ancestor
93126346|NCT04457596|Antimitotic Agents|antimitotic agents|mesh-ancestor
93126347|NCT04457596|Mitosis Modulators|mitosis modulators|mesh-ancestor
93126348|NCT04457596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126349|NCT04457596|Immunotoxins|immunotoxins|mesh-ancestor
93126350|NCT04457596|Immunoconjugates|immunoconjugates|mesh-ancestor
93126351|NCT04457596|Immunologic Factors|immunologic factors|mesh-ancestor
93126352|NCT04457596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126353|NCT04457596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93126354|NCT04457596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126355|NCT03644550|Pembrolizumab|pembrolizumab|mesh-list
93126356|NCT03644550|LMB-100|lmb-100|mesh-list
93126357|NCT03644550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126358|NCT03644550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126359|NCT03644550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93126360|NCT03644550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126361|NCT03644550|Immunoconjugates|immunoconjugates|mesh-ancestor
93126362|NCT03644550|Immunologic Factors|immunologic factors|mesh-ancestor
93126363|NCT03644550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126364|NCT05668650|Pembrolizumab|pembrolizumab|mesh-list
93126365|NCT05668650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126366|NCT05668650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126367|NCT05668650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93126368|NCT05668650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126369|NCT03511664|177Lu-PSMA-617|177lu-psma-617|mesh-list
93126370|NCT03511664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92798570|NCT00652132|Antidotes|antidotes|mesh-ancestor
93126371|NCT03511664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126373|NCT00054717|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93126374|NCT00054717|Tipranavir|tipranavir|mesh-list
93126375|NCT00054717|Protease Inhibitors|protease inhibitors|mesh-list
93126376|NCT00054717|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93126377|NCT00054717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126378|NCT00054717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126379|NCT00054717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93126380|NCT00054717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93126381|NCT00054717|Antiviral Agents|antiviral agents|mesh-ancestor
93126382|NCT00054717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126383|NCT00054717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93126384|NCT00054717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93126385|NCT03430856|Insulin|insulin|mesh-list
93126386|NCT03430856|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93126387|NCT03430856|Insulin Aspart|insulin aspart|mesh-list
93126388|NCT03430856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93126389|NCT03430856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126390|NCT01097265|Capecitabine|capecitabine|mesh-list
93126391|NCT01097265|Oxaliplatin|oxaliplatin|mesh-list
93126392|NCT01097265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93126393|NCT01097265|Antimetabolites|antimetabolites|mesh-ancestor
93126394|NCT01097265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126395|NCT01097265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126396|NCT03731286|Caffeine|caffeine|mesh-list
93126397|NCT03731286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93126398|NCT03731286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126399|NCT03731286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93126400|NCT03731286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126401|NCT03731286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126402|NCT03731286|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93126403|NCT03731286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93126404|NCT03731286|Purinergic Agents|purinergic agents|mesh-ancestor
93126405|NCT03731286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126406|NCT00066807|Tamoxifen|tamoxifen|mesh-list
93126407|NCT00066807|Epirubicin|epirubicin|mesh-list
93126408|NCT00066807|Exemestane|exemestane|mesh-list
93126409|NCT00066807|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93126410|NCT00066807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93126411|NCT00066807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126412|NCT00066807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93126413|NCT00066807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93126414|NCT00066807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126415|NCT00066807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126416|NCT00066807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93126417|NCT00066807|Hormone Antagonists|hormone antagonists|mesh-ancestor
93126418|NCT00066807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126419|NCT00066807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126420|NCT00066807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93126421|NCT00066807|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93126422|NCT00066807|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93126423|NCT00066807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93126424|NCT00066807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93126425|NCT00066807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93126426|NCT00066807|Luteolytic Agents|luteolytic agents|mesh-ancestor
93126427|NCT00066807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93126428|NCT00066807|Contraceptive Agents|contraceptive agents|mesh-ancestor
93126429|NCT00066807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93126430|NCT00066807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93126431|NCT03619330|Liraglutide|liraglutide|mesh-list
93126432|NCT03619330|Testosterone|testosterone|mesh-list
93126433|NCT03619330|Androgens|androgens|mesh-ancestor
93126434|NCT03619330|Hormones|hormones|mesh-ancestor
93126435|NCT03619330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126436|NCT03619330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126437|NCT03619330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93126438|NCT03619330|Incretins|incretins|mesh-ancestor
93126439|NCT04457284|Nivolumab|nivolumab|mesh-list
93126440|NCT04457284|Temozolomide|temozolomide|mesh-list
93126441|NCT04457284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126442|NCT04457284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126443|NCT04457284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92798646|NCT00682318|Ethanol|ethanol|mesh-list
93126444|NCT04457284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126445|NCT04457284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93126446|NCT04457284|Alkylating Agents|alkylating agents|mesh-ancestor
93126447|NCT00054639|Rituximab|rituximab|mesh-list
93126448|NCT00054639|Oblimersen|oblimersen|mesh-list
93126449|NCT00054639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126450|NCT00054639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126451|NCT00054639|Immunologic Factors|immunologic factors|mesh-ancestor
93126452|NCT00054639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126453|NCT00054639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126454|NCT02530359|Pirfenidone|pirfenidone|mesh-list
93126455|NCT02530359|Analgesics|analgesics|mesh-ancestor
93126456|NCT02530359|Sensory System Agents|sensory system agents|mesh-ancestor
93126457|NCT02530359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126458|NCT02530359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126459|NCT02530359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93126460|NCT02530359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93126461|NCT02530359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126462|NCT02530359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126463|NCT02530359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126464|NCT03428360|Diazepam|diazepam|mesh-list
93126465|NCT03428360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93126466|NCT03428360|Anticonvulsants|anticonvulsants|mesh-ancestor
93126467|NCT03428360|Antiemetics|antiemetics|mesh-ancestor
93126468|NCT03428360|Autonomic Agents|autonomic agents|mesh-ancestor
93126469|NCT03428360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126470|NCT03428360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126471|NCT03428360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126472|NCT03428360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93126473|NCT03428360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126474|NCT03428360|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93126475|NCT03428360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93126476|NCT03428360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93126477|NCT03428360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93126478|NCT03428360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93126479|NCT03428360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93126480|NCT03428360|Anesthetics, General|anesthetics, general|mesh-ancestor
93126481|NCT03428360|Anesthetics|anesthetics|mesh-ancestor
93126482|NCT03428360|GABA Modulators|gaba modulators|mesh-ancestor
93126483|NCT03428360|GABA Agents|gaba agents|mesh-ancestor
93126484|NCT03428360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126485|NCT03428360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126486|NCT03427892|Brexpiprazole|brexpiprazole|mesh-list
93126487|NCT03427892|Serotonin Agents|serotonin agents|mesh-ancestor
93126488|NCT03427892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126489|NCT03427892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126490|NCT03427892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126491|NCT03427892|Dopamine Agonists|dopamine agonists|mesh-ancestor
93126492|NCT03427892|Dopamine Agents|dopamine agents|mesh-ancestor
93126493|NCT03466658|Anti-Infective Agents|anti-infective agents|mesh-list
93126494|NCT03466658|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93126495|NCT04867928|Azacitidine|azacitidine|mesh-list
93126496|NCT04867928|Venetoclax|venetoclax|mesh-list
93126497|NCT04867928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93126498|NCT04867928|Antimetabolites|antimetabolites|mesh-ancestor
93126499|NCT04867928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126500|NCT04867928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126501|NCT04867928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126502|NCT03425396|Nitrofurantoin|nitrofurantoin|mesh-list
93126503|NCT03425396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93126504|NCT03425396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126505|NCT03425396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93126506|NCT03698734|Evening primrose oil|evening primrose oil|mesh-list
93126507|NCT03698734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93126508|NCT03698734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93126509|NCT03698734|Analgesics|analgesics|mesh-ancestor
93126510|NCT03698734|Sensory System Agents|sensory system agents|mesh-ancestor
93126511|NCT03698734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126512|NCT03698734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126513|NCT03698734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126514|NCT03698734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126515|NCT03698734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93126516|NCT03698734|Antimetabolites|antimetabolites|mesh-ancestor
93126517|NCT03698734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126518|NCT03698734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93126519|NCT03698734|Dermatologic Agents|dermatologic agents|mesh-ancestor
93126521|NCT04070157|Clonidine|clonidine|mesh-list
93126522|NCT04070157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93126523|NCT04070157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93126524|NCT04070157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126525|NCT04070157|Sensory System Agents|sensory system agents|mesh-ancestor
93126526|NCT04070157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126527|NCT04070157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93126528|NCT04070157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93126529|NCT04070157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93126530|NCT04070157|Adrenergic Agents|adrenergic agents|mesh-ancestor
93126531|NCT04070157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126532|NCT04070157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126533|NCT04070157|Analgesics|analgesics|mesh-ancestor
93126534|NCT04070157|Sympatholytics|sympatholytics|mesh-ancestor
93126535|NCT04070157|Autonomic Agents|autonomic agents|mesh-ancestor
93126536|NCT01091337|Albuterol|albuterol|mesh-list
93126537|NCT01091337|Procaterol|procaterol|mesh-list
93126538|NCT01091337|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93126539|NCT01091337|Autonomic Agents|autonomic agents|mesh-ancestor
93126540|NCT01091337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126541|NCT01091337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126542|NCT01091337|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93126543|NCT01091337|Respiratory System Agents|respiratory system agents|mesh-ancestor
93126544|NCT01091337|Tocolytic Agents|tocolytic agents|mesh-ancestor
93126545|NCT01091337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93126546|NCT01091337|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93126547|NCT01091337|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93126548|NCT01091337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93126549|NCT01091337|Adrenergic Agents|adrenergic agents|mesh-ancestor
93126550|NCT01091337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126551|NCT01091337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126552|NCT01091337|Sympathomimetics|sympathomimetics|mesh-ancestor
93126553|NCT03955809|Ketamine|ketamine|mesh-list
93126554|NCT03955809|Analgesics|analgesics|mesh-ancestor
93126555|NCT03955809|Sensory System Agents|sensory system agents|mesh-ancestor
93126556|NCT03955809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126557|NCT03955809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126558|NCT03955809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93126559|NCT03955809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93126560|NCT03955809|Anesthetics, General|anesthetics, general|mesh-ancestor
93126561|NCT03955809|Anesthetics|anesthetics|mesh-ancestor
93126562|NCT03955809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126563|NCT03955809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93126564|NCT03955809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93126565|NCT03955809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126566|NCT03955809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126567|NCT01094613|Mercaptopurine|mercaptopurine|mesh-list
93126568|NCT01094613|Antimetabolites|antimetabolites|mesh-ancestor
93126569|NCT01094613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126570|NCT01094613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93126571|NCT01094613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126572|NCT01094613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126573|NCT01094613|Immunologic Factors|immunologic factors|mesh-ancestor
93126574|NCT01094613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126575|NCT01094613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93126576|NCT01094613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126577|NCT03953001|Lidocaine|lidocaine|mesh-list
93126578|NCT03953001|Epinephrine|epinephrine|mesh-list
93126579|NCT03953001|Anesthetics, Local|anesthetics, local|mesh-list
93126580|NCT03953001|Anesthetics|anesthetics|mesh-list
93126581|NCT03953001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126582|NCT03953001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126583|NCT03953001|Sensory System Agents|sensory system agents|mesh-ancestor
93126584|NCT03953001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126585|NCT03953001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93126586|NCT03953001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93126587|NCT03953001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93126588|NCT03953001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126589|NCT03953001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126590|NCT03953001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93126591|NCT03953001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93126592|NCT03953001|Adrenergic Agents|adrenergic agents|mesh-ancestor
92798804|NCT00885352|Metformin|metformin|mesh-list
93126593|NCT03953001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126594|NCT03953001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93126595|NCT03953001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93126596|NCT03953001|Autonomic Agents|autonomic agents|mesh-ancestor
93126597|NCT03953001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93126598|NCT03953001|Respiratory System Agents|respiratory system agents|mesh-ancestor
93126599|NCT03953001|Mydriatics|mydriatics|mesh-ancestor
93126600|NCT03953001|Sympathomimetics|sympathomimetics|mesh-ancestor
93126601|NCT03953001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93126603|NCT01094769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93126604|NCT01091415|Calcium|calcium|mesh-list
93126605|NCT01091415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93126606|NCT01091415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126607|NCT00032487|Metformin|metformin|mesh-list
93126608|NCT00032487|Glimepiride|glimepiride|mesh-list
93126609|NCT00032487|Rosiglitazone|rosiglitazone|mesh-list
93126610|NCT00032487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93126611|NCT00032487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126612|NCT00032487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93126613|NCT00032487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126614|NCT00032487|Immunologic Factors|immunologic factors|mesh-ancestor
93126615|NCT01091493|Moxifloxacin|moxifloxacin|mesh-list
93126616|NCT01091493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93126617|NCT01091493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126618|NCT01091493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93126619|NCT01091493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93126620|NCT01091493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126621|NCT01091493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126622|NCT01091493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126623|NCT03692416|Prednisone|prednisone|mesh-list
93126624|NCT03692416|Ibuprofen|ibuprofen|mesh-list
93126625|NCT03692416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93126626|NCT03692416|Methotrexate|methotrexate|mesh-list
93126627|NCT03692416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126628|NCT03692416|Glucocorticoids|glucocorticoids|mesh-ancestor
93126629|NCT03692416|Hormones|hormones|mesh-ancestor
93126630|NCT03692416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126631|NCT03692416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126632|NCT03692416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93126633|NCT03692416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126634|NCT03692416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93126635|NCT03692416|Abortifacient Agents|abortifacient agents|mesh-ancestor
93126636|NCT03692416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93126637|NCT03692416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93126638|NCT03692416|Antimetabolites|antimetabolites|mesh-ancestor
93126639|NCT03692416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126640|NCT03692416|Dermatologic Agents|dermatologic agents|mesh-ancestor
93126641|NCT03692416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126642|NCT03692416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93126643|NCT03692416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126644|NCT03692416|Immunologic Factors|immunologic factors|mesh-ancestor
93126645|NCT03692416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126646|NCT03692416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93126647|NCT03692416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93126648|NCT03692416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93126649|NCT03692416|Analgesics|analgesics|mesh-ancestor
93126650|NCT03692416|Sensory System Agents|sensory system agents|mesh-ancestor
93126651|NCT03692416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126652|NCT03692416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93126653|NCT03692416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93126654|NCT03692416|Protective Agents|protective agents|mesh-ancestor
93126655|NCT03594552|Baclofen|baclofen|mesh-list
93126656|NCT03594552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93126657|NCT03594552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126658|NCT03594552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93126659|NCT03594552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126660|NCT03594552|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93126661|NCT03594552|GABA Agonists|gaba agonists|mesh-ancestor
93126662|NCT03594552|GABA Agents|gaba agents|mesh-ancestor
93126663|NCT03594552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126664|NCT03594552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126665|NCT03641508|Dexamethasone|dexamethasone|mesh-list
93126666|NCT03641508|Triamcinolone|triamcinolone|mesh-list
93126667|NCT03641508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126668|NCT03641508|Antiemetics|antiemetics|mesh-ancestor
93126669|NCT03641508|Autonomic Agents|autonomic agents|mesh-ancestor
93126670|NCT03641508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126671|NCT03641508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126672|NCT03641508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126673|NCT03641508|Glucocorticoids|glucocorticoids|mesh-ancestor
93126674|NCT03641508|Hormones|hormones|mesh-ancestor
93126675|NCT03641508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126676|NCT03641508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93126677|NCT03641508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126678|NCT03624244|Letrozole|letrozole|mesh-list
93126679|NCT03624244|Exemestane|exemestane|mesh-list
93126680|NCT03624244|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93126681|NCT03624244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126682|NCT03624244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93126683|NCT03624244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126684|NCT03624244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126685|NCT03624244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93126686|NCT03624244|Hormone Antagonists|hormone antagonists|mesh-ancestor
93126687|NCT03624244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126688|NCT03624244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126689|NCT00066573|Anastrozole|anastrozole|mesh-list
93126690|NCT00066573|Exemestane|exemestane|mesh-list
93126691|NCT00066573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93126692|NCT00066573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126693|NCT00066573|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93126694|NCT00066573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93126695|NCT00066573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126696|NCT00066573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126697|NCT00066573|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93126698|NCT00066573|Hormone Antagonists|hormone antagonists|mesh-ancestor
93126699|NCT00066573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126700|NCT00066573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126701|NCT03465878|Insulin Lispro|insulin lispro|mesh-list
93126702|NCT03465878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93126703|NCT03465878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126704|NCT01091571|Dipyridamole|dipyridamole|mesh-list
93126705|NCT01091571|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93126706|NCT01091571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126707|NCT01091571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126708|NCT01091571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93126709|NCT01091571|Vasodilator Agents|vasodilator agents|mesh-ancestor
93126710|NCT01091649|Ritonavir|ritonavir|mesh-list
93126711|NCT01091649|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93126712|NCT01091649|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93126713|NCT01091649|Protease Inhibitors|protease inhibitors|mesh-ancestor
93126714|NCT01091649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126715|NCT01091649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126716|NCT01091649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93126717|NCT01091649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93126718|NCT01091649|Antiviral Agents|antiviral agents|mesh-ancestor
93126719|NCT01091649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126720|NCT01091649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93126721|NCT01091649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93126722|NCT01091727|Botulinum Toxins|botulinum toxins|mesh-list
93126723|NCT01091727|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93126724|NCT01091727|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93126725|NCT01091727|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93126726|NCT01091727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126727|NCT01091727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126728|NCT01091727|Cholinergic Agents|cholinergic agents|mesh-ancestor
93126729|NCT01091727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126730|NCT01091727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126731|NCT01091727|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93126732|NCT01091727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126733|NCT03421730|Budesonide|budesonide|mesh-list
93126734|NCT03421730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126735|NCT03421730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93126736|NCT03421730|Autonomic Agents|autonomic agents|mesh-ancestor
93126737|NCT03421730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126738|NCT03421730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126739|NCT03421730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93126740|NCT03421730|Respiratory System Agents|respiratory system agents|mesh-ancestor
93126741|NCT03421730|Glucocorticoids|glucocorticoids|mesh-ancestor
93126742|NCT03421730|Hormones|hormones|mesh-ancestor
93126743|NCT03421730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93126744|NCT01094925|Gabapentin|gabapentin|mesh-list
93126745|NCT01094925|Analgesics|analgesics|mesh-ancestor
93126746|NCT01094925|Sensory System Agents|sensory system agents|mesh-ancestor
93126747|NCT01094925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126748|NCT01094925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126749|NCT01094925|Anticonvulsants|anticonvulsants|mesh-ancestor
93126750|NCT01094925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93126751|NCT01094925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93126752|NCT01094925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126753|NCT01094925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93126754|NCT01094925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93126755|NCT01094925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93126756|NCT01094925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126757|NCT01094925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126758|NCT01094925|Antimanic Agents|antimanic agents|mesh-ancestor
93126759|NCT03718676|Pemetrexed|pemetrexed|mesh-list
93126760|NCT03718676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126761|NCT03718676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126762|NCT03718676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126763|NCT03718676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93126764|NCT03718676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93126765|NCT00054327|Cytarabine|cytarabine|mesh-list
93126766|NCT00054327|Cyclophosphamide|cyclophosphamide|mesh-list
93126767|NCT00054327|Busulfan|busulfan|mesh-list
93126768|NCT00054327|Etoposide|etoposide|mesh-list
93126769|NCT00054327|Etoposide phosphate|etoposide phosphate|mesh-list
93126770|NCT00054327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126771|NCT00054327|Immunologic Factors|immunologic factors|mesh-ancestor
93126772|NCT00054327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126773|NCT00054327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126774|NCT00054327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93126775|NCT00054327|Alkylating Agents|alkylating agents|mesh-ancestor
93126776|NCT00054327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126777|NCT00054327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126778|NCT00054327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93126779|NCT00054327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93126780|NCT00054327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93126781|NCT00054327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93126782|NCT00054327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126783|NCT00054327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93126784|NCT00054327|Antimetabolites|antimetabolites|mesh-ancestor
93126785|NCT00054327|Antiviral Agents|antiviral agents|mesh-ancestor
93126786|NCT00054327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126787|NCT03029650|Scopolamine|scopolamine|mesh-list
93126788|NCT03029650|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93126789|NCT03029650|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93126790|NCT03029650|Antiemetics|antiemetics|mesh-ancestor
93126791|NCT03029650|Autonomic Agents|autonomic agents|mesh-ancestor
93126792|NCT03029650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126793|NCT03029650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126794|NCT03029650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126795|NCT03029650|Mydriatics|mydriatics|mesh-ancestor
93126796|NCT03029650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93126797|NCT03029650|Cholinergic Agents|cholinergic agents|mesh-ancestor
93126798|NCT03029650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126799|NCT03029650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126800|NCT03029650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93126801|NCT03029650|Parasympatholytics|parasympatholytics|mesh-ancestor
93126802|NCT03462680|Niacin|niacin|mesh-list
93126803|NCT03462680|Vitamins|vitamins|mesh-ancestor
93126804|NCT03462680|Micronutrients|micronutrients|mesh-ancestor
93126805|NCT03462680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126806|NCT03462680|Vitamin B Complex|vitamin b complex|mesh-ancestor
93126807|NCT03462680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93126808|NCT03462680|Antimetabolites|antimetabolites|mesh-ancestor
93126809|NCT03462680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126810|NCT03462680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93126811|NCT03462680|Vasodilator Agents|vasodilator agents|mesh-ancestor
93126812|NCT03692026|Melatonin|melatonin|mesh-list
93126813|NCT03692026|Hyaluronic Acid|hyaluronic acid|mesh-list
93126814|NCT03692026|Antioxidants|antioxidants|mesh-ancestor
93126815|NCT03692026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126816|NCT03692026|Protective Agents|protective agents|mesh-ancestor
93126817|NCT03692026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126818|NCT03692026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126819|NCT03692026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93126820|NCT03692026|Immunologic Factors|immunologic factors|mesh-ancestor
93126821|NCT03692026|Viscosupplements|viscosupplements|mesh-ancestor
93126822|NCT03624322|Olanzapine|olanzapine|mesh-list
93126823|NCT03624322|Antiemetics|antiemetics|mesh-ancestor
93126824|NCT03624322|Autonomic Agents|autonomic agents|mesh-ancestor
93126825|NCT03624322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126826|NCT03624322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126827|NCT03624322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126828|NCT03624322|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93126829|NCT03624322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93126830|NCT03624322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126831|NCT03624322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93126832|NCT03624322|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93126833|NCT03624322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93126834|NCT03624322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126835|NCT03624322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126836|NCT03624322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126837|NCT03624322|Serotonin Agents|serotonin agents|mesh-ancestor
93126838|NCT01097811|Erythromycin|erythromycin|mesh-list
93126839|NCT01097811|Erythromycin Estolate|erythromycin estolate|mesh-list
93126840|NCT01097811|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93126841|NCT01097811|Erythromycin stearate|erythromycin stearate|mesh-list
93126842|NCT01097811|Neomycin|neomycin|mesh-list
93126843|NCT01097811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93126844|NCT01097811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126845|NCT01097811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126846|NCT01097811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93126847|NCT01097811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126848|NCT01097811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126849|NCT03418922|Nivolumab|nivolumab|mesh-list
93126850|NCT03418922|Lenvatinib|lenvatinib|mesh-list
93126851|NCT03418922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93126852|NCT03418922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126853|NCT03418922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93126854|NCT03418922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126855|NCT03418922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93126856|NCT03418922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126857|NCT03957291|Chlorhexidine|chlorhexidine|mesh-list
93126858|NCT03957291|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93126859|NCT03957291|Povidone-Iodine|povidone-iodine|mesh-list
93126860|NCT03957291|Povidone|povidone|mesh-list
93126861|NCT03957291|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93126862|NCT03957291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126863|NCT03957291|Disinfectants|disinfectants|mesh-ancestor
93126864|NCT03957291|Dermatologic Agents|dermatologic agents|mesh-ancestor
93126865|NCT03957291|Plasma Substitutes|plasma substitutes|mesh-ancestor
93126866|NCT03957291|Blood Substitutes|blood substitutes|mesh-ancestor
93126867|NCT04044976|Caffeine|caffeine|mesh-list
93126868|NCT04044976|Caffeine citrate|caffeine citrate|mesh-list
93126869|NCT04044976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126870|NCT04044976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93126871|NCT04044976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126872|NCT04044976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93126873|NCT04044976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126874|NCT04044976|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93126875|NCT04044976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93126876|NCT04044976|Purinergic Agents|purinergic agents|mesh-ancestor
93126877|NCT04044976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93126878|NCT03691636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93126879|NCT03691636|Lifitegrast|lifitegrast|mesh-list
93126880|NCT03691636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93126881|NCT04295902|Pyrithione zinc|pyrithione zinc|mesh-list
93126882|NCT04295902|Keratolytic Agents|keratolytic agents|mesh-ancestor
93126883|NCT04295902|Dermatologic Agents|dermatologic agents|mesh-ancestor
93126884|NCT03956121|Magnesium Sulfate|magnesium sulfate|mesh-list
93126885|NCT03956121|Analgesics|analgesics|mesh-ancestor
93126886|NCT03956121|Sensory System Agents|sensory system agents|mesh-ancestor
93126887|NCT03956121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126888|NCT03956121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126889|NCT03956121|Anesthetics|anesthetics|mesh-ancestor
93126890|NCT03956121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126891|NCT03956121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93126892|NCT03956121|Anticonvulsants|anticonvulsants|mesh-ancestor
92799099|NCT01079741|Poly I-C|poly i-c|mesh-list
93126893|NCT03956121|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93126894|NCT03956121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126895|NCT03956121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126896|NCT03956121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93126897|NCT03956121|Tocolytic Agents|tocolytic agents|mesh-ancestor
93126898|NCT03956121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93126899|NCT03636906|Vaccines|vaccines|mesh-list
93126900|NCT03636906|Immunologic Factors|immunologic factors|mesh-ancestor
93126901|NCT03636906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126902|NCT03028870|Naproxen|naproxen|mesh-list
93126903|NCT03028870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93126904|NCT03028870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93126905|NCT03028870|Analgesics|analgesics|mesh-ancestor
93126906|NCT03028870|Sensory System Agents|sensory system agents|mesh-ancestor
93126907|NCT03028870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126908|NCT03028870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126909|NCT03028870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126910|NCT03028870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126911|NCT03028870|Gout Suppressants|gout suppressants|mesh-ancestor
93126912|NCT03028870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93126913|NCT03028870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126914|NCT03028870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126915|NCT01098201|Certolizumab Pegol|certolizumab pegol|mesh-list
93126916|NCT01098201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93126917|NCT01098201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126918|NCT01098201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93126919|NCT01098201|Immunologic Factors|immunologic factors|mesh-ancestor
93126920|NCT01098201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126921|NCT01098201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93126922|NCT01092039|Lactoferrin|lactoferrin|mesh-list
93126923|NCT01092039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126924|NCT03663582|Teduglutide|teduglutide|mesh-list
93126925|NCT03663582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126926|NCT03663582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93126927|NCT03663582|Protective Agents|protective agents|mesh-ancestor
93126928|NCT03663582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126929|NCT01098357|Becaplermin|becaplermin|mesh-list
93126930|NCT01098357|Anticoagulants|anticoagulants|mesh-ancestor
93126931|NCT01098357|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93126932|NCT01098357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93126933|NCT01098357|Growth Substances|growth substances|mesh-ancestor
93126934|NCT01098357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126935|NCT03730740|Lenalidomide|lenalidomide|mesh-list
93126936|NCT03730740|Immunologic Factors|immunologic factors|mesh-ancestor
93126937|NCT03730740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126938|NCT03730740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93126939|NCT03730740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93126940|NCT03730740|Growth Substances|growth substances|mesh-ancestor
93126941|NCT03730740|Growth Inhibitors|growth inhibitors|mesh-ancestor
93126942|NCT03730740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93126943|NCT01098513|Dolutegravir|dolutegravir|mesh-list
93126944|NCT01098513|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93126945|NCT01098513|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93126946|NCT01098513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126947|NCT01098513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126948|NCT01098513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93126949|NCT01098513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93126950|NCT01098513|Antiviral Agents|antiviral agents|mesh-ancestor
93126951|NCT01098513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93126952|NCT03693976|Xylometazoline|xylometazoline|mesh-list
93126953|NCT03693976|Nasal Decongestants|nasal decongestants|mesh-ancestor
93126954|NCT03693976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93126955|NCT03693976|Respiratory System Agents|respiratory system agents|mesh-ancestor
93126956|NCT03730584|Ropivacaine|ropivacaine|mesh-list
93126957|NCT03730584|Anesthetics, Local|anesthetics, local|mesh-ancestor
93126958|NCT03730584|Anesthetics|anesthetics|mesh-ancestor
93126959|NCT03730584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126960|NCT03730584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126961|NCT03730584|Sensory System Agents|sensory system agents|mesh-ancestor
93126962|NCT03730584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126963|NCT03502616|Tofacitinib|tofacitinib|mesh-list
93126964|NCT03502616|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93126965|NCT03502616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93126966|NCT03502616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93126967|NCT03502616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126968|NCT04003012|Lidocaine|lidocaine|mesh-list
93126969|NCT04003012|Anesthetics, Local|anesthetics, local|mesh-ancestor
93126970|NCT04003012|Anesthetics|anesthetics|mesh-ancestor
93126971|NCT04003012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126972|NCT04003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126973|NCT04003012|Sensory System Agents|sensory system agents|mesh-ancestor
93126974|NCT04003012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126975|NCT04003012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93126976|NCT04003012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93126977|NCT04003012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93126978|NCT04003012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93126979|NCT04003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93126980|NCT05666076|Bupivacaine|bupivacaine|mesh-list
93126981|NCT05666076|Prilocaine|prilocaine|mesh-list
93126982|NCT05666076|Anesthetics, Local|anesthetics, local|mesh-ancestor
93126983|NCT05666076|Anesthetics|anesthetics|mesh-ancestor
93126984|NCT05666076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93126985|NCT05666076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126986|NCT05666076|Sensory System Agents|sensory system agents|mesh-ancestor
93126987|NCT05666076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126988|NCT03028012|Dexamethasone|dexamethasone|mesh-list
93126989|NCT03028012|Ketorolac|ketorolac|mesh-list
93126990|NCT03028012|Lidocaine|lidocaine|mesh-list
93126991|NCT03028012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93126992|NCT03028012|Antiemetics|antiemetics|mesh-ancestor
93126993|NCT03028012|Autonomic Agents|autonomic agents|mesh-ancestor
93126994|NCT03028012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93126995|NCT03028012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93126996|NCT03028012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93126997|NCT03028012|Glucocorticoids|glucocorticoids|mesh-ancestor
93126998|NCT03028012|Hormones|hormones|mesh-ancestor
93126999|NCT03028012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127000|NCT03028012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93127001|NCT03028012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127002|NCT03028012|Anesthetics, Local|anesthetics, local|mesh-ancestor
93127003|NCT03028012|Anesthetics|anesthetics|mesh-ancestor
93127004|NCT03028012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127005|NCT03028012|Sensory System Agents|sensory system agents|mesh-ancestor
93127006|NCT03028012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93127007|NCT03028012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93127008|NCT03028012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93127009|NCT03028012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127010|NCT03028012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127011|NCT03028012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93127012|NCT03028012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93127013|NCT03028012|Analgesics|analgesics|mesh-ancestor
93127014|NCT03028012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127015|NCT03028012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93127016|NCT03028012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127017|NCT03634800|Nivolumab|nivolumab|mesh-list
93127018|NCT03634800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93127019|NCT03634800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127020|NCT03634800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93127021|NCT03634800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127022|NCT03662334|Insulin, Short-Acting|insulin, short-acting|mesh-list
93127023|NCT03662334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93127024|NCT03662334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127025|NCT02955186|Saracatinib|saracatinib|mesh-list
93127026|NCT02955186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127027|NCT02955186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127028|NCT02955186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127029|NCT03693508|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93127030|NCT03693508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93127031|NCT03693508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93127032|NCT03693508|Antiviral Agents|antiviral agents|mesh-ancestor
93127033|NCT03693508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127034|NCT03690778|Metformin|metformin|mesh-list
93127035|NCT03690778|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93127036|NCT03690778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93127037|NCT03690778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127038|NCT03690778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93127039|NCT03690778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93127040|NCT03690778|Antimetabolites|antimetabolites|mesh-ancestor
92799248|NCT01076075|Metformin|metformin|mesh-list
93127041|NCT03690778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127042|NCT03690778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93127043|NCT03690778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93127044|NCT03690778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127045|NCT03715634|Buprenorphine|buprenorphine|mesh-list
93127046|NCT03715634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93127047|NCT03715634|Narcotics|narcotics|mesh-ancestor
93127048|NCT03715634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127049|NCT03715634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127050|NCT03715634|Analgesics|analgesics|mesh-ancestor
93127051|NCT03715634|Sensory System Agents|sensory system agents|mesh-ancestor
93127052|NCT03715634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127053|NCT03715634|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93127055|NCT03502070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127056|NCT03502070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127057|NCT04158934|Factor VIII|factor viii|mesh-list
93127058|NCT04158934|BAX 855|bax 855|mesh-list
93127059|NCT04158934|Coagulants|coagulants|mesh-ancestor
93127060|NCT03715556|Amiodarone|amiodarone|mesh-list
93127061|NCT03715556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93127062|NCT03715556|Vasodilator Agents|vasodilator agents|mesh-ancestor
93127063|NCT03715556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93127064|NCT03715556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127065|NCT03715556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127066|NCT03715556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93127067|NCT03715556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93127068|NCT03715556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93127069|NCT03715556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127070|NCT03715556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93127071|NCT03715556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93127072|NCT03715556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93127073|NCT03715478|Dexamethasone|dexamethasone|mesh-list
93127074|NCT03715478|Pomalidomide|pomalidomide|mesh-list
93127075|NCT03715478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127076|NCT03715478|Antiemetics|antiemetics|mesh-ancestor
93127077|NCT03715478|Autonomic Agents|autonomic agents|mesh-ancestor
93127078|NCT03715478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127079|NCT03715478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127080|NCT03715478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93127081|NCT03715478|Glucocorticoids|glucocorticoids|mesh-ancestor
93127082|NCT03715478|Hormones|hormones|mesh-ancestor
93127083|NCT03715478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127084|NCT03715478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93127085|NCT03715478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127086|NCT03715478|Immunologic Factors|immunologic factors|mesh-ancestor
93127087|NCT03715478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93127088|NCT03715478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93127089|NCT03715478|Growth Substances|growth substances|mesh-ancestor
93127090|NCT03715478|Growth Inhibitors|growth inhibitors|mesh-ancestor
93127091|NCT03730038|Pitavastatin|pitavastatin|mesh-list
93127092|NCT03730038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93127093|NCT03730038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93127094|NCT03730038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93127095|NCT03730038|Antimetabolites|antimetabolites|mesh-ancestor
93127096|NCT03730038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127097|NCT03730038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127098|NCT03730038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93127099|NCT03725904|Progesterone|progesterone|mesh-list
93127100|NCT03725904|Progestins|progestins|mesh-ancestor
93127101|NCT03725904|Hormones|hormones|mesh-ancestor
93127102|NCT03725904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127103|NCT03725904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127104|NCT03730272|Analgesics|analgesics|mesh-list
93127105|NCT03730272|Sensory System Agents|sensory system agents|mesh-ancestor
93127106|NCT03730272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127107|NCT03730272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127108|NCT03585504|Contraceptive Agents|contraceptive agents|mesh-list
93127109|NCT03585504|Etonogestrel|etonogestrel|mesh-list
93127110|NCT03585504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93127111|NCT03585504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127112|NCT03585504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93127113|NCT03585504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93127114|NCT03690622|Dexmedetomidine|dexmedetomidine|mesh-list
93127115|NCT03690622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93127116|NCT03690622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127117|NCT03690622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127118|NCT03690622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93127119|NCT03690622|Analgesics|analgesics|mesh-ancestor
93127120|NCT03690622|Sensory System Agents|sensory system agents|mesh-ancestor
93127121|NCT03690622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127122|NCT03690622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93127123|NCT03690622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93127124|NCT03690622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93127125|NCT03690622|Adrenergic Agents|adrenergic agents|mesh-ancestor
93127126|NCT03690622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127127|NCT03690622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127128|NCT03715322|Tobramycin|tobramycin|mesh-list
93127129|NCT03715322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127130|NCT03715322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127131|NCT03687268|Naloxone|naloxone|mesh-list
93127132|NCT03687268|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93127133|NCT03687268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127134|NCT03687268|Sensory System Agents|sensory system agents|mesh-ancestor
93127135|NCT03687268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127136|NCT03576066|Tenofovir|tenofovir|mesh-list
93127137|NCT03576066|Entecavir|entecavir|mesh-list
93127138|NCT03576066|Antiviral Agents|antiviral agents|mesh-ancestor
93127139|NCT03576066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127140|NCT03576066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93127141|NCT03576066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93127142|NCT03576066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127143|NCT03576066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127144|NCT03576066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93127145|NCT03576066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93127146|NCT03639480|Amlodipine|amlodipine|mesh-list
93127147|NCT03639480|Valsartan|valsartan|mesh-list
93127148|NCT03639480|Atorvastatin|atorvastatin|mesh-list
93127149|NCT03639480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93127150|NCT03639480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93127151|NCT03639480|Antimetabolites|antimetabolites|mesh-ancestor
93127152|NCT03639480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127153|NCT03639480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93127154|NCT03639480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93127155|NCT03639480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127156|NCT03639480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93127157|NCT03639480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93127158|NCT03639480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127159|NCT03639480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93127160|NCT03639480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127161|NCT03639480|Vasodilator Agents|vasodilator agents|mesh-ancestor
93127162|NCT03639480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93127163|NCT03639480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93127164|NCT03689998|Melatonin|melatonin|mesh-list
93127165|NCT03689998|Antioxidants|antioxidants|mesh-ancestor
93127166|NCT03689998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127167|NCT03689998|Protective Agents|protective agents|mesh-ancestor
93127168|NCT03689998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127169|NCT03689998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127170|NCT03948178|Simendan|simendan|mesh-list
93127171|NCT03948178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93127172|NCT03948178|Vasodilator Agents|vasodilator agents|mesh-ancestor
93127173|NCT03948178|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93127174|NCT03948178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93127175|NCT03948178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127176|NCT03948178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127177|NCT03948178|Protective Agents|protective agents|mesh-ancestor
93127178|NCT03948178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127179|NCT03687034|Temozolomide|temozolomide|mesh-list
93127180|NCT03687034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93127181|NCT03687034|Alkylating Agents|alkylating agents|mesh-ancestor
93127182|NCT03687034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127183|NCT03687034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127184|NCT03520920|Rituximab|rituximab|mesh-list
93127185|NCT03520920|Zanubrutinib|zanubrutinib|mesh-list
93127186|NCT03520920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93127187|NCT03520920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127188|NCT03520920|Immunologic Factors|immunologic factors|mesh-ancestor
93127189|NCT03520920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127190|NCT03520920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127191|NCT03520920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93127192|NCT03520920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127193|NCT03520920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127194|NCT03686878|Lifitegrast|lifitegrast|mesh-list
93127195|NCT03686878|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93127196|NCT03686878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93127197|NCT03682198|Phenylephrine|phenylephrine|mesh-list
93127198|NCT03682198|Oxymetazoline|oxymetazoline|mesh-list
93127199|NCT03682198|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93127200|NCT03682198|Mydriatics|mydriatics|mesh-ancestor
93127201|NCT03682198|Autonomic Agents|autonomic agents|mesh-ancestor
93127202|NCT03682198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127203|NCT03682198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127204|NCT03682198|Sympathomimetics|sympathomimetics|mesh-ancestor
93127205|NCT03682198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93127206|NCT03682198|Nasal Decongestants|nasal decongestants|mesh-ancestor
93127207|NCT03682198|Respiratory System Agents|respiratory system agents|mesh-ancestor
93127208|NCT03682198|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93127209|NCT03682198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93127210|NCT03682198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93127211|NCT03682198|Adrenergic Agents|adrenergic agents|mesh-ancestor
93127212|NCT03682198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127213|NCT03682198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127214|NCT03682198|Protective Agents|protective agents|mesh-ancestor
93127215|NCT02953340|Cyclophosphamide|cyclophosphamide|mesh-list
93127216|NCT02953340|Docetaxel|docetaxel|mesh-list
93127217|NCT02953340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93127218|NCT02953340|Immunologic Factors|immunologic factors|mesh-ancestor
93127219|NCT02953340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127220|NCT02953340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127221|NCT02953340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93127222|NCT02953340|Alkylating Agents|alkylating agents|mesh-ancestor
93127223|NCT02953340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127224|NCT02953340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127225|NCT02953340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93127226|NCT02953340|Tubulin Modulators|tubulin modulators|mesh-ancestor
93127227|NCT02953340|Antimitotic Agents|antimitotic agents|mesh-ancestor
93127228|NCT02953340|Mitosis Modulators|mitosis modulators|mesh-ancestor
93127229|NCT03554772|Celecoxib|celecoxib|mesh-list
93127230|NCT03554772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93127231|NCT03554772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93127232|NCT03554772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93127233|NCT03554772|Analgesics|analgesics|mesh-ancestor
93127234|NCT03554772|Sensory System Agents|sensory system agents|mesh-ancestor
93127235|NCT03554772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127236|NCT03554772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127237|NCT03554772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127238|NCT03554772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127239|NCT03554772|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93127240|NCT03554772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93127241|NCT03554772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127242|NCT03554772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127243|NCT03624010|Simendan|simendan|mesh-list
93127244|NCT03624010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93127245|NCT03624010|Vasodilator Agents|vasodilator agents|mesh-ancestor
93127246|NCT03624010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93127247|NCT03624010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93127248|NCT03624010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127249|NCT03624010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127250|NCT03624010|Protective Agents|protective agents|mesh-ancestor
93127251|NCT03624010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127252|NCT03686722|Metformin|metformin|mesh-list
93127253|NCT03686722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93127254|NCT03686722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127255|NCT04629976|Tenofovir|tenofovir|mesh-list
93127256|NCT04629976|Antiviral Agents|antiviral agents|mesh-ancestor
93127257|NCT04629976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127258|NCT04629976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93127259|NCT04629976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93127260|NCT04629976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127261|NCT04629976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127262|NCT04629976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93127263|NCT04629976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93127264|NCT03728946|Bupivacaine|bupivacaine|mesh-list
93127265|NCT03728946|Anesthetics, Local|anesthetics, local|mesh-ancestor
93127266|NCT03728946|Anesthetics|anesthetics|mesh-ancestor
93127267|NCT03728946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127268|NCT03728946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127269|NCT03728946|Sensory System Agents|sensory system agents|mesh-ancestor
93127270|NCT03728946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127271|NCT03553758|Ketamine|ketamine|mesh-list
93127272|NCT03553758|Analgesics|analgesics|mesh-ancestor
93127273|NCT03553758|Sensory System Agents|sensory system agents|mesh-ancestor
93127274|NCT03553758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127275|NCT03553758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127276|NCT03553758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93127277|NCT03553758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127278|NCT03553758|Anesthetics, General|anesthetics, general|mesh-ancestor
93127279|NCT03553758|Anesthetics|anesthetics|mesh-ancestor
93127280|NCT03553758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127281|NCT03553758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93127282|NCT03553758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93127283|NCT03553758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127284|NCT03553758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127285|NCT02954354|Oseltamivir|oseltamivir|mesh-list
93127286|NCT02954354|Baloxavir|baloxavir|mesh-list
93127287|NCT02954354|Antiviral Agents|antiviral agents|mesh-ancestor
93127288|NCT02954354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127289|NCT02954354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127290|NCT02954354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127291|NCT03519516|Ciprofloxacin|ciprofloxacin|mesh-list
93127292|NCT03519516|Levofloxacin|levofloxacin|mesh-list
93127293|NCT03519516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93127294|NCT03519516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93127295|NCT03519516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127296|NCT03519516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127297|NCT03519516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93127298|NCT03519516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93127299|NCT03519516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127300|NCT03519516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127301|NCT03519516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127302|NCT03519516|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93127303|NCT03519516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93127304|NCT03519516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93127305|NCT03681574|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
93127306|NCT03681574|GABA Agents|gaba agents|mesh-ancestor
93127307|NCT03681574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127308|NCT03681574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127309|NCT03681574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127310|NCT03519204|Lidocaine|lidocaine|mesh-list
93127311|NCT03519204|Anesthetics, Local|anesthetics, local|mesh-ancestor
93127312|NCT03519204|Anesthetics|anesthetics|mesh-ancestor
93127313|NCT03519204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127314|NCT03519204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127315|NCT03519204|Sensory System Agents|sensory system agents|mesh-ancestor
93127316|NCT03519204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127317|NCT03519204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93127318|NCT03519204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93127319|NCT03519204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93127320|NCT03519204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127321|NCT03519204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127322|NCT03624166|Ketamine|ketamine|mesh-list
93127323|NCT03624166|Anesthetics|anesthetics|mesh-list
93127324|NCT03624166|Anesthetics, General|anesthetics, general|mesh-list
93127325|NCT03624166|Analgesics|analgesics|mesh-ancestor
93127326|NCT03624166|Sensory System Agents|sensory system agents|mesh-ancestor
93127327|NCT03624166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127328|NCT03624166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127329|NCT03624166|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93127330|NCT03624166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127331|NCT03624166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127332|NCT03624166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93127333|NCT03624166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93127334|NCT03624166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127335|NCT03624166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799550|NCT00973674|Estrogens|estrogens|mesh-list
93127336|NCT03518112|Calcium, Dietary|calcium, dietary|mesh-list
93127337|NCT03518112|Leucovorin|leucovorin|mesh-list
93127338|NCT03518112|Folic Acid|folic acid|mesh-list
93127339|NCT03518112|Cytarabine|cytarabine|mesh-list
93127340|NCT03518112|Dexamethasone|dexamethasone|mesh-list
93127341|NCT03518112|Dexamethasone acetate|dexamethasone acetate|mesh-list
93127342|NCT03518112|Cyclophosphamide|cyclophosphamide|mesh-list
93127343|NCT03518112|Rituximab|rituximab|mesh-list
93127344|NCT03518112|Methotrexate|methotrexate|mesh-list
93127345|NCT03518112|Vincristine|vincristine|mesh-list
93127346|NCT03518112|Mercaptopurine|mercaptopurine|mesh-list
93127347|NCT03518112|Blinatumomab|blinatumomab|mesh-list
93127348|NCT03518112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93127349|NCT03518112|Muromonab-CD3|muromonab-cd3|mesh-list
93127350|NCT03518112|Antibodies|antibodies|mesh-list
93127351|NCT03518112|Immunoglobulins|immunoglobulins|mesh-list
93127352|NCT03518112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93127353|NCT03518112|Lenograstim|lenograstim|mesh-list
93127354|NCT03518112|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93127355|NCT03518112|BB 1101|bb 1101|mesh-list
93127356|NCT03518112|Calcium|calcium|mesh-list
93127357|NCT03518112|Levoleucovorin|levoleucovorin|mesh-list
93127358|NCT03518112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93127359|NCT03518112|Immunologic Factors|immunologic factors|mesh-ancestor
93127360|NCT03518112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127361|NCT03518112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127362|NCT03518112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93127363|NCT03518112|Alkylating Agents|alkylating agents|mesh-ancestor
93127364|NCT03518112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127365|NCT03518112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127366|NCT03518112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93127367|NCT03518112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127368|NCT03518112|Antiemetics|antiemetics|mesh-ancestor
93127369|NCT03518112|Autonomic Agents|autonomic agents|mesh-ancestor
93127370|NCT03518112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127371|NCT03518112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93127372|NCT03518112|Glucocorticoids|glucocorticoids|mesh-ancestor
93127373|NCT03518112|Hormones|hormones|mesh-ancestor
93127374|NCT03518112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127375|NCT03518112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93127376|NCT03518112|Protease Inhibitors|protease inhibitors|mesh-ancestor
93127377|NCT03518112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127378|NCT03518112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93127379|NCT03518112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93127380|NCT03518112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93127381|NCT03518112|Abortifacient Agents|abortifacient agents|mesh-ancestor
93127382|NCT03518112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93127383|NCT03518112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93127384|NCT03518112|Antimetabolites|antimetabolites|mesh-ancestor
93127385|NCT03518112|Dermatologic Agents|dermatologic agents|mesh-ancestor
93127386|NCT03518112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93127387|NCT03518112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93127388|NCT03518112|Antiviral Agents|antiviral agents|mesh-ancestor
93127389|NCT03518112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127390|NCT03518112|Antidotes|antidotes|mesh-ancestor
93127391|NCT03518112|Protective Agents|protective agents|mesh-ancestor
93127392|NCT03518112|Vitamin B Complex|vitamin b complex|mesh-ancestor
93127393|NCT03518112|Vitamins|vitamins|mesh-ancestor
93127394|NCT03518112|Micronutrients|micronutrients|mesh-ancestor
93127395|NCT03518112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93127396|NCT03518112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93127397|NCT03518112|Tubulin Modulators|tubulin modulators|mesh-ancestor
93127398|NCT03518112|Antimitotic Agents|antimitotic agents|mesh-ancestor
93127399|NCT03518112|Mitosis Modulators|mitosis modulators|mesh-ancestor
93127400|NCT03518112|Hematinics|hematinics|mesh-ancestor
93127401|NCT03686254|Bevacizumab|bevacizumab|mesh-list
93127402|NCT03686254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93127403|NCT03686254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127404|NCT03686254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93127405|NCT03686254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93127406|NCT03686254|Growth Substances|growth substances|mesh-ancestor
93127407|NCT03686254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127408|NCT03686254|Growth Inhibitors|growth inhibitors|mesh-ancestor
93127409|NCT03679780|Nitroprusside|nitroprusside|mesh-list
93127410|NCT03679780|BQ 788|bq 788|mesh-list
93127411|NCT03679780|Nitroarginine|nitroarginine|mesh-list
93127412|NCT03679780|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
93127413|NCT03679780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93127414|NCT03679780|Vasodilator Agents|vasodilator agents|mesh-ancestor
93127415|NCT03679780|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93127416|NCT03679780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127417|NCT03679780|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93127418|NCT03679780|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93127419|NCT03679780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127420|NCT03659734|Analgesics, Opioid|analgesics, opioid|mesh-list
93127421|NCT03659734|Narcotics|narcotics|mesh-ancestor
93127422|NCT03659734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127423|NCT03659734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127424|NCT03659734|Analgesics|analgesics|mesh-ancestor
93127425|NCT03659734|Sensory System Agents|sensory system agents|mesh-ancestor
93127426|NCT03659734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127427|NCT03680716|Ropivacaine|ropivacaine|mesh-list
93127428|NCT03680716|Anesthetics, Local|anesthetics, local|mesh-ancestor
93127429|NCT03680716|Anesthetics|anesthetics|mesh-ancestor
93127430|NCT03680716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127431|NCT03680716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127432|NCT03680716|Sensory System Agents|sensory system agents|mesh-ancestor
93127433|NCT03680716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127434|NCT03680638|Allopurinol|allopurinol|mesh-list
93127435|NCT03680638|Tempol|tempol|mesh-list
93127436|NCT03680638|Antimetabolites|antimetabolites|mesh-ancestor
93127437|NCT03680638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127438|NCT03680638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127439|NCT03680638|Gout Suppressants|gout suppressants|mesh-ancestor
93127440|NCT03680638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127441|NCT03680638|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93127442|NCT03680638|Antioxidants|antioxidants|mesh-ancestor
93127443|NCT03680638|Protective Agents|protective agents|mesh-ancestor
93127444|NCT03680638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127445|NCT03680638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93127446|NCT03680638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93127447|NCT03680638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93127448|NCT03680560|Trastuzumab|trastuzumab|mesh-list
93127449|NCT03680560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93127450|NCT03680560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127451|NCT03444298|Vitamin E|vitamin e|mesh-list
93127452|NCT03444298|Tocopherols|tocopherols|mesh-list
93127453|NCT03444298|Tocotrienols|tocotrienols|mesh-list
93127454|NCT03444298|alpha-Tocopherol|alpha-tocopherol|mesh-list
93127455|NCT03444298|gamma-Tocopherol|gamma-tocopherol|mesh-list
93127456|NCT03444298|Vitamins|vitamins|mesh-ancestor
93127457|NCT03444298|Micronutrients|micronutrients|mesh-ancestor
93127458|NCT03444298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127459|NCT03444298|Antioxidants|antioxidants|mesh-ancestor
93127460|NCT03444298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127461|NCT03444298|Protective Agents|protective agents|mesh-ancestor
93127462|NCT03640312|Candesartan|candesartan|mesh-list
93127463|NCT03640312|Candesartan cilexetil|candesartan cilexetil|mesh-list
93127464|NCT03640312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93127465|NCT03640312|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93127466|NCT03640312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93127467|NCT03640312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127468|NCT03639610|Dexamethasone|dexamethasone|mesh-list
93127469|NCT03639610|Melphalan|melphalan|mesh-list
93127470|NCT03639610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127471|NCT03639610|Antiemetics|antiemetics|mesh-ancestor
93127472|NCT03639610|Autonomic Agents|autonomic agents|mesh-ancestor
93127473|NCT03639610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127474|NCT03639610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127475|NCT03639610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93127476|NCT03639610|Glucocorticoids|glucocorticoids|mesh-ancestor
93127477|NCT03639610|Hormones|hormones|mesh-ancestor
93127478|NCT03639610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127479|NCT03639610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93127480|NCT03639610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127481|NCT03639610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93127482|NCT03639610|Alkylating Agents|alkylating agents|mesh-ancestor
93127483|NCT03639610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127484|NCT03639610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93127485|NCT03639610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93127486|NCT03639610|Immunologic Factors|immunologic factors|mesh-ancestor
93127487|NCT03680404|Allopurinol|allopurinol|mesh-list
93127488|NCT03680404|Phenylephrine|phenylephrine|mesh-list
93127489|NCT03680404|Oxymetazoline|oxymetazoline|mesh-list
93127490|NCT03680404|Tempol|tempol|mesh-list
93127491|NCT03680404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93127492|NCT03680404|Mydriatics|mydriatics|mesh-ancestor
93127493|NCT03680404|Autonomic Agents|autonomic agents|mesh-ancestor
93127494|NCT03680404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127495|NCT03680404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127496|NCT03680404|Sympathomimetics|sympathomimetics|mesh-ancestor
93127497|NCT03680404|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93127498|NCT03680404|Nasal Decongestants|nasal decongestants|mesh-ancestor
93127499|NCT03680404|Respiratory System Agents|respiratory system agents|mesh-ancestor
93127500|NCT03680404|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93127501|NCT03680404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93127502|NCT03680404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93127503|NCT03680404|Adrenergic Agents|adrenergic agents|mesh-ancestor
93127504|NCT03680404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127505|NCT03680404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127506|NCT03680404|Protective Agents|protective agents|mesh-ancestor
93127507|NCT03680404|Antimetabolites|antimetabolites|mesh-ancestor
93127508|NCT03680404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127509|NCT03680404|Gout Suppressants|gout suppressants|mesh-ancestor
93127510|NCT03680404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127511|NCT03680404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93127512|NCT03680404|Antioxidants|antioxidants|mesh-ancestor
93127513|NCT03680404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93127514|NCT03680404|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93127515|NCT03680404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93127516|NCT03685630|Brivaracetam|brivaracetam|mesh-list
93127517|NCT03685630|Anticonvulsants|anticonvulsants|mesh-ancestor
93127518|NCT02954406|Rituximab|rituximab|mesh-list
93127519|NCT02954406|Gemcitabine|gemcitabine|mesh-list
93127520|NCT02954406|Lenalidomide|lenalidomide|mesh-list
93127521|NCT02954406|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93127522|NCT02954406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93127523|NCT02954406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127524|NCT02954406|Immunologic Factors|immunologic factors|mesh-ancestor
93127525|NCT02954406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127526|NCT02954406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127527|NCT02954406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93127528|NCT02954406|Antimetabolites|antimetabolites|mesh-ancestor
93127529|NCT02954406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127530|NCT02954406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93127531|NCT02954406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93127532|NCT02954406|Growth Substances|growth substances|mesh-ancestor
93127533|NCT02954406|Growth Inhibitors|growth inhibitors|mesh-ancestor
93127534|NCT02954406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93127535|NCT02954406|Alkylating Agents|alkylating agents|mesh-ancestor
93127536|NCT01310478|Endostatins|endostatins|mesh-list
93127537|NCT01310478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93127538|NCT01310478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93127539|NCT01310478|Growth Substances|growth substances|mesh-ancestor
93127540|NCT01310478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127541|NCT01310478|Growth Inhibitors|growth inhibitors|mesh-ancestor
93127542|NCT01310478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127543|NCT03728244|Hyaluronic Acid|hyaluronic acid|mesh-list
93127544|NCT03728244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93127545|NCT03728244|Immunologic Factors|immunologic factors|mesh-ancestor
93127546|NCT03728244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127547|NCT03728244|Viscosupplements|viscosupplements|mesh-ancestor
93127548|NCT03728244|Protective Agents|protective agents|mesh-ancestor
93127549|NCT03511326|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93127550|NCT03511326|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93127551|NCT03511326|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93127552|NCT03511326|Dermatologic Agents|dermatologic agents|mesh-ancestor
93127553|NCT03721614|Sirolimus|sirolimus|mesh-list
93127554|NCT03721614|Everolimus|everolimus|mesh-list
93127555|NCT03721614|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93127556|NCT03721614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93127557|NCT03721614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127558|NCT03721614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127559|NCT03721614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93127560|NCT03721614|Immunologic Factors|immunologic factors|mesh-ancestor
93127561|NCT03721614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127562|NCT03721614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127563|NCT03721614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127564|NCT03721614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127565|NCT03721614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93127566|NCT03721614|Antifungal Agents|antifungal agents|mesh-ancestor
93127567|NCT03727620|Amoxicillin|amoxicillin|mesh-list
93127568|NCT03727620|Metronidazole|metronidazole|mesh-list
93127569|NCT03727620|Doxycycline|doxycycline|mesh-list
93127570|NCT03727620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127571|NCT03727620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127572|NCT03727620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93127573|NCT03727620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93127574|NCT03727620|Antimalarials|antimalarials|mesh-ancestor
93127575|NCT03727464|Propofol|propofol|mesh-list
93127576|NCT03727464|Sevoflurane|sevoflurane|mesh-list
93127577|NCT03727464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93127578|NCT03727464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127579|NCT03727464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127580|NCT03727464|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127581|NCT03727464|Anesthetics, General|anesthetics, general|mesh-ancestor
93127582|NCT03727464|Anesthetics|anesthetics|mesh-ancestor
93127583|NCT03727464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93127584|NCT03727464|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93127585|NCT03508830|Bupivacaine|bupivacaine|mesh-list
93127586|NCT03508830|Anesthetics, Local|anesthetics, local|mesh-ancestor
93127587|NCT03508830|Anesthetics|anesthetics|mesh-ancestor
93127588|NCT03508830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127589|NCT03508830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127590|NCT03508830|Sensory System Agents|sensory system agents|mesh-ancestor
93127591|NCT03508830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127592|NCT03569202|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93127593|NCT03569202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93127594|NCT03724578|Anti-Infective Agents|anti-infective agents|mesh-list
93127595|NCT03724578|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93127596|NCT03724578|Grape Seed Extract|grape seed extract|mesh-list
93127597|NCT03724578|Fluorides|fluorides|mesh-list
93127598|NCT03724578|Cariostatic Agents|cariostatic agents|mesh-ancestor
93127599|NCT03724578|Protective Agents|protective agents|mesh-ancestor
93127600|NCT03724578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127601|NCT03724578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93127602|NCT03724578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127603|NCT03724578|Antioxidants|antioxidants|mesh-ancestor
93127604|NCT03724578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127605|NCT03721380|Methadone|methadone|mesh-list
93127606|NCT03721380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93127607|NCT03721380|Narcotics|narcotics|mesh-ancestor
93127608|NCT03721380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127609|NCT03721380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127610|NCT03721380|Analgesics|analgesics|mesh-ancestor
93127611|NCT03721380|Sensory System Agents|sensory system agents|mesh-ancestor
93127612|NCT03721380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127613|NCT03721380|Antitussive Agents|antitussive agents|mesh-ancestor
93127614|NCT03721380|Respiratory System Agents|respiratory system agents|mesh-ancestor
93127615|NCT03568500|Olanzapine|olanzapine|mesh-list
93127616|NCT03568500|Risperidone|risperidone|mesh-list
93127617|NCT03568500|Aripiprazole|aripiprazole|mesh-list
93127618|NCT03568500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93127619|NCT03568500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93127620|NCT03568500|Serotonin Agents|serotonin agents|mesh-ancestor
93127621|NCT03568500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127622|NCT03568500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127623|NCT03568500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127624|NCT03568500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93127625|NCT03568500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93127626|NCT03568500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127627|NCT03568500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93127628|NCT03568500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93127629|NCT03568500|Dopamine Agents|dopamine agents|mesh-ancestor
93127630|NCT03568500|Antiemetics|antiemetics|mesh-ancestor
93127631|NCT03568500|Autonomic Agents|autonomic agents|mesh-ancestor
93127632|NCT03568500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127633|NCT03568500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93127634|NCT03568500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93127635|NCT03568500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93127636|NCT03568500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127637|NCT03568500|Antidepressive Agents|antidepressive agents|mesh-ancestor
93127638|NCT03568500|Dopamine Agonists|dopamine agonists|mesh-ancestor
93127639|NCT03568500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93127640|NCT03568500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93127641|NCT03568500|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93127642|NCT03568500|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93127643|NCT03910738|Methyltestosterone|methyltestosterone|mesh-list
93127644|NCT03910738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93127645|NCT03910738|Testosterone|testosterone|mesh-list
93127646|NCT03910738|Testosterone undecanoate|testosterone undecanoate|mesh-list
93127647|NCT03910738|Testosterone enanthate|testosterone enanthate|mesh-list
93127648|NCT03910738|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93127649|NCT03910738|Androgens|androgens|mesh-ancestor
93127651|NCT03910738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127652|NCT03910738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127653|NCT03910738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93127654|NCT03910738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127655|NCT03910738|Anabolic Agents|anabolic agents|mesh-ancestor
93127656|NCT03685084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93127657|NCT03685084|Piperacillin|piperacillin|mesh-list
93127658|NCT03685084|Cefepime|cefepime|mesh-list
93127659|NCT03685084|Lactams|lactams|mesh-list
93127660|NCT03685084|beta-Lactams|beta-lactams|mesh-list
93127661|NCT03685084|Enmetazobactam|enmetazobactam|mesh-list
93127662|NCT03685084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93127663|NCT03685084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127664|NCT03685084|Antitubercular Agents|antitubercular agents|mesh-ancestor
93127665|NCT03685084|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93127666|NCT03685084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127667|NCT03685084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127668|NCT03724266|Chitosan|chitosan|mesh-list
93127669|NCT03724266|Calcium|calcium|mesh-list
93127670|NCT03724266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93127671|NCT03724266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127672|NCT03724266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93127673|NCT03724266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93127674|NCT03724266|Antimetabolites|antimetabolites|mesh-ancestor
93127675|NCT03724266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127676|NCT03724266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93127677|NCT03724266|Chelating Agents|chelating agents|mesh-ancestor
93127678|NCT03724266|Sequestering Agents|sequestering agents|mesh-ancestor
93127679|NCT03724266|Hemostatics|hemostatics|mesh-ancestor
93127680|NCT03724266|Coagulants|coagulants|mesh-ancestor
93127681|NCT03679390|Ketamine|ketamine|mesh-list
93127682|NCT03679390|Analgesics|analgesics|mesh-ancestor
93127683|NCT03679390|Sensory System Agents|sensory system agents|mesh-ancestor
93127684|NCT03679390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127685|NCT03679390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127686|NCT03679390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93127687|NCT03679390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127688|NCT03679390|Anesthetics, General|anesthetics, general|mesh-ancestor
93127689|NCT03679390|Anesthetics|anesthetics|mesh-ancestor
93127690|NCT03679390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127691|NCT03679390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93127692|NCT03679390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93127693|NCT03679390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127694|NCT03679390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127695|NCT03684772|Digoxin|digoxin|mesh-list
93127696|NCT03684772|Furosemide|furosemide|mesh-list
93127697|NCT03684772|Diuretics|diuretics|mesh-ancestor
93127698|NCT03684772|Natriuretic Agents|natriuretic agents|mesh-ancestor
93127699|NCT03684772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127700|NCT03684772|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93127701|NCT03684772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127702|NCT03684772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127703|NCT03684772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93127704|NCT03684772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93127705|NCT03684772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127706|NCT03684772|Protective Agents|protective agents|mesh-ancestor
93127707|NCT03676114|Ketamine|ketamine|mesh-list
93127708|NCT03676114|Analgesics|analgesics|mesh-ancestor
93127709|NCT03676114|Sensory System Agents|sensory system agents|mesh-ancestor
93127710|NCT03676114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127711|NCT03676114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127712|NCT03676114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93127713|NCT03676114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127714|NCT03676114|Anesthetics, General|anesthetics, general|mesh-ancestor
93127715|NCT03676114|Anesthetics|anesthetics|mesh-ancestor
93127716|NCT03676114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127717|NCT03676114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93127718|NCT03676114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93127719|NCT03676114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127720|NCT03676114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127721|NCT03676036|Mometasone Furoate|mometasone furoate|mesh-list
93127722|NCT03676036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127723|NCT03676036|Dermatologic Agents|dermatologic agents|mesh-ancestor
93127724|NCT03676036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93127725|NCT03025828|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93127726|NCT03025828|Hormones|hormones|mesh-ancestor
93127727|NCT03025828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127728|NCT03025828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127729|NCT03546816|Serlopitant|serlopitant|mesh-list
93127730|NCT03546816|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93127731|NCT03546816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127732|NCT03546816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127733|NCT03546816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127734|NCT03675802|Misoprostol|misoprostol|mesh-list
93127735|NCT03675802|Dinoprostone|dinoprostone|mesh-list
93127736|NCT03675802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93127737|NCT03675802|Abortifacient Agents|abortifacient agents|mesh-ancestor
93127738|NCT03675802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93127739|NCT03675802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127740|NCT03675802|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93127741|NCT03675802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93127742|NCT03675802|Oxytocics|oxytocics|mesh-ancestor
93127743|NCT03678610|Ionomycin|ionomycin|mesh-list
93127744|NCT03678610|Calcium Ionophores|calcium ionophores|mesh-ancestor
93127745|NCT03678610|Ionophores|ionophores|mesh-ancestor
93127746|NCT03678610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93127747|NCT03678610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127748|NCT03675646|Morphine|morphine|mesh-list
93127749|NCT03675646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93127750|NCT03675646|Narcotics|narcotics|mesh-ancestor
93127751|NCT03675646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127752|NCT03675646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127753|NCT03675646|Analgesics|analgesics|mesh-ancestor
93127754|NCT03675646|Sensory System Agents|sensory system agents|mesh-ancestor
93127755|NCT03675646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127756|NCT03678532|Midazolam|midazolam|mesh-list
93127757|NCT03678532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93127758|NCT03678532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93127759|NCT03678532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127760|NCT03678532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127761|NCT03678532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93127762|NCT03678532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93127763|NCT03678532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93127764|NCT03678532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127765|NCT03678532|Anesthetics, General|anesthetics, general|mesh-ancestor
93127766|NCT03678532|Anesthetics|anesthetics|mesh-ancestor
93127767|NCT03678532|GABA Modulators|gaba modulators|mesh-ancestor
93127768|NCT03678532|GABA Agents|gaba agents|mesh-ancestor
93127769|NCT03678532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127770|NCT03678532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127771|NCT03675178|Ceftriaxone|ceftriaxone|mesh-list
93127772|NCT03675178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127773|NCT03675178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127774|NCT03678142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93127775|NCT03678142|Vancomycin|vancomycin|mesh-list
93127776|NCT03678142|Imipenem|imipenem|mesh-list
93127777|NCT03678142|Floxacillin|floxacillin|mesh-list
93127778|NCT03678142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127779|NCT03522298|GDC-0084|gdc-0084|mesh-list
93127780|NCT03522298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127781|NCT03522298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127782|NCT03674866|Insulin|insulin|mesh-list
93127783|NCT03674866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93127784|NCT03674866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127785|NCT03623776|Carboplatin|carboplatin|mesh-list
93127786|NCT03623776|Pemetrexed|pemetrexed|mesh-list
93127787|NCT03623776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127788|NCT03623776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127789|NCT03623776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127790|NCT03623776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93127791|NCT03623776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93127792|NCT03683914|Dinoprostone|dinoprostone|mesh-list
93127793|NCT03683914|Oxytocics|oxytocics|mesh-ancestor
93127794|NCT03683914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93127795|NCT03683914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127796|NCT03448406|Empagliflozin|empagliflozin|mesh-list
93127797|NCT03448406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93127798|NCT03448406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127799|NCT03448406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93127800|NCT03448406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127802|NCT00064701|Mycophenolic Acid|mycophenolic acid|mesh-list
93127803|NCT00064701|Tacrolimus|tacrolimus|mesh-list
93127804|NCT00064701|Cyclosporins|cyclosporins|mesh-list
93127805|NCT00064701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93127806|NCT00064701|Immunologic Factors|immunologic factors|mesh-ancestor
93127807|NCT00064701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127808|NCT00064701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93127809|NCT00064701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127810|NCT00064701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127811|NCT00064701|Antifungal Agents|antifungal agents|mesh-ancestor
93127812|NCT00064701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127813|NCT00064701|Dermatologic Agents|dermatologic agents|mesh-ancestor
93127814|NCT00064701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127815|NCT00064701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93127816|NCT00064701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127817|NCT00064701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93127818|NCT00064701|Antitubercular Agents|antitubercular agents|mesh-ancestor
93127819|NCT00064701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127820|NCT00064077|Paclitaxel|paclitaxel|mesh-list
93127821|NCT00064077|Vinorelbine|vinorelbine|mesh-list
93127822|NCT00064077|Cisplatin|cisplatin|mesh-list
93127823|NCT00064077|Gemcitabine|gemcitabine|mesh-list
93127824|NCT00064077|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93127825|NCT00064077|Topotecan|topotecan|mesh-list
93127826|NCT00064077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93127827|NCT00064077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127828|NCT00064077|Tubulin Modulators|tubulin modulators|mesh-ancestor
93127829|NCT00064077|Antimitotic Agents|antimitotic agents|mesh-ancestor
93127830|NCT00064077|Mitosis Modulators|mitosis modulators|mesh-ancestor
93127831|NCT00064077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127832|NCT00064077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93127833|NCT00064077|Antimetabolites|antimetabolites|mesh-ancestor
93127834|NCT00064077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93127835|NCT00064077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93127836|NCT00064077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127837|NCT03674008|Propofol|propofol|mesh-list
93127838|NCT03674008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93127839|NCT03674008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127840|NCT03674008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127841|NCT03674008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127842|NCT03674008|Anesthetics, General|anesthetics, general|mesh-ancestor
93127843|NCT03674008|Anesthetics|anesthetics|mesh-ancestor
93127844|NCT00063999|Paclitaxel|paclitaxel|mesh-list
93127845|NCT00063999|Cisplatin|cisplatin|mesh-list
93127846|NCT00063999|Carboplatin|carboplatin|mesh-list
93127847|NCT00063999|Doxorubicin|doxorubicin|mesh-list
93127848|NCT00063999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93127849|NCT00063999|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93127850|NCT00063999|Lenograstim|lenograstim|mesh-list
93127851|NCT00063999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93127852|NCT00063999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127853|NCT00063999|Tubulin Modulators|tubulin modulators|mesh-ancestor
93127854|NCT00063999|Antimitotic Agents|antimitotic agents|mesh-ancestor
93127855|NCT00063999|Mitosis Modulators|mitosis modulators|mesh-ancestor
93127856|NCT00063999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127857|NCT00063999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93127858|NCT00063999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93127859|NCT00063999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93127860|NCT00063999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93127861|NCT00063999|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93127862|NCT00063999|Immunologic Factors|immunologic factors|mesh-ancestor
93127863|NCT00063999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127864|NCT01092351|Nitrofurantoin|nitrofurantoin|mesh-list
93127865|NCT01092351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93127866|NCT01092351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93127867|NCT01092351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93127868|NCT02878798|Topiramate|topiramate|mesh-list
93127869|NCT02878798|Anticonvulsants|anticonvulsants|mesh-ancestor
93127870|NCT02878798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93127871|NCT02878798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127872|NCT03673384|Fluticasone|fluticasone|mesh-list
93127873|NCT03673384|Xhance|xhance|mesh-list
93127874|NCT03673384|Histamine|histamine|mesh-list
93127875|NCT03673384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127876|NCT03673384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93127877|NCT03673384|Autonomic Agents|autonomic agents|mesh-ancestor
93127878|NCT03673384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127879|NCT03673384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127880|NCT03673384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93127881|NCT03673384|Respiratory System Agents|respiratory system agents|mesh-ancestor
93127882|NCT03673384|Dermatologic Agents|dermatologic agents|mesh-ancestor
93127883|NCT03673384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93127884|NCT03673384|Histamine Agonists|histamine agonists|mesh-ancestor
93127885|NCT03673384|Histamine Agents|histamine agents|mesh-ancestor
93127886|NCT03673384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127887|NCT03673384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127888|NCT02915302|Vaccines|vaccines|mesh-list
93127889|NCT02915302|Immunologic Factors|immunologic factors|mesh-ancestor
93127890|NCT02915302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127891|NCT03023878|Dexamethasone|dexamethasone|mesh-list
93127892|NCT03023878|Blinatumomab|blinatumomab|mesh-list
93127893|NCT03023878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93127894|NCT03023878|Antiemetics|antiemetics|mesh-ancestor
93127895|NCT03023878|Autonomic Agents|autonomic agents|mesh-ancestor
93127896|NCT03023878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127897|NCT03023878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127898|NCT03023878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93127899|NCT03023878|Glucocorticoids|glucocorticoids|mesh-ancestor
93127900|NCT03023878|Hormones|hormones|mesh-ancestor
93127901|NCT03023878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93127902|NCT03023878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93127903|NCT03023878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127904|NCT03670888|Rituximab|rituximab|mesh-list
93127905|NCT03670888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93127906|NCT03670888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127907|NCT03670888|Immunologic Factors|immunologic factors|mesh-ancestor
93127908|NCT03670888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127909|NCT03670888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93127910|NCT03023722|Maytansine|maytansine|mesh-list
93127911|NCT03023722|Anetumab ravtansine|anetumab ravtansine|mesh-list
93127912|NCT03023722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93127913|NCT03023722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93127914|NCT03023722|Tubulin Modulators|tubulin modulators|mesh-ancestor
93127915|NCT03023722|Antimitotic Agents|antimitotic agents|mesh-ancestor
93127916|NCT03023722|Mitosis Modulators|mitosis modulators|mesh-ancestor
93127917|NCT03023722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127918|NCT03023722|Immunoconjugates|immunoconjugates|mesh-ancestor
93127919|NCT03023722|Immunologic Factors|immunologic factors|mesh-ancestor
93127920|NCT03023722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127921|NCT03623230|Bupivacaine|bupivacaine|mesh-list
93127922|NCT03623230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93127923|NCT03623230|Anesthetics, Local|anesthetics, local|mesh-ancestor
93127924|NCT03623230|Anesthetics|anesthetics|mesh-ancestor
93127925|NCT03623230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127926|NCT03623230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127927|NCT03623230|Sensory System Agents|sensory system agents|mesh-ancestor
93127928|NCT03623230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127929|NCT02624596|Midazolam|midazolam|mesh-list
93127930|NCT02624596|Ketamine|ketamine|mesh-list
93127931|NCT02624596|Analgesics|analgesics|mesh-ancestor
93127932|NCT02624596|Sensory System Agents|sensory system agents|mesh-ancestor
93127933|NCT02624596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127934|NCT02624596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127935|NCT02624596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93127936|NCT02624596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127937|NCT02624596|Anesthetics, General|anesthetics, general|mesh-ancestor
93127938|NCT02624596|Anesthetics|anesthetics|mesh-ancestor
93127939|NCT02624596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127940|NCT02624596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93127941|NCT02624596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93127942|NCT02624596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93127943|NCT02624596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93127944|NCT02624596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93127945|NCT02624596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93127946|NCT02624596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93127947|NCT02624596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93127948|NCT02624596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93127949|NCT02624596|GABA Modulators|gaba modulators|mesh-ancestor
93127950|NCT02624596|GABA Agents|gaba agents|mesh-ancestor
93127951|NCT03669562|Alprostadil|alprostadil|mesh-list
93127952|NCT03669562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93127954|NCT03669562|Urological Agents|urological agents|mesh-ancestor
93127955|NCT03669484|Fentanyl|fentanyl|mesh-list
93127956|NCT03669484|Bromides|bromides|mesh-list
93127957|NCT03669484|Propofol|propofol|mesh-list
93127958|NCT03669484|Rocuronium|rocuronium|mesh-list
93127959|NCT03669484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93127960|NCT03669484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93127961|NCT03669484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127962|NCT03669484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93127963|NCT03669484|Anesthetics, General|anesthetics, general|mesh-ancestor
93127964|NCT03669484|Anesthetics|anesthetics|mesh-ancestor
93127965|NCT03669484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93127966|NCT03669484|Narcotics|narcotics|mesh-ancestor
93127967|NCT03669484|Analgesics|analgesics|mesh-ancestor
93127968|NCT03669484|Sensory System Agents|sensory system agents|mesh-ancestor
93127969|NCT03669484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93127970|NCT03669484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93127971|NCT03669484|Anticonvulsants|anticonvulsants|mesh-ancestor
93127972|NCT03669484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93127973|NCT03669484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93127974|NCT03669484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93127975|NCT02159404|Immunomodulating Agents|immunomodulating agents|mesh-list
93127976|NCT02159404|Immunologic Factors|immunologic factors|mesh-ancestor
93127977|NCT02159404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93127978|NCT01979536|Cytarabine|cytarabine|mesh-list
93127979|NCT01979536|Dexamethasone|dexamethasone|mesh-list
93127980|NCT01979536|Dexamethasone acetate|dexamethasone acetate|mesh-list
93127981|NCT01979536|Cyclophosphamide|cyclophosphamide|mesh-list
93127982|NCT01979536|Ifosfamide|ifosfamide|mesh-list
93127983|NCT01979536|Isophosphamide mustard|isophosphamide mustard|mesh-list
93127984|NCT01979536|Doxorubicin|doxorubicin|mesh-list
93127985|NCT01979536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93127986|NCT01979536|Methotrexate|methotrexate|mesh-list
93127987|NCT01979536|Etoposide|etoposide|mesh-list
93127988|NCT01979536|Etoposide phosphate|etoposide phosphate|mesh-list
93127989|NCT01979536|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93127990|NCT01979536|Podophyllotoxin|podophyllotoxin|mesh-list
93127991|NCT01979536|Crizotinib|crizotinib|mesh-list
93127992|NCT01979536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93127993|NCT01979536|Antibodies|antibodies|mesh-list
93127994|NCT01979536|Immunoglobulins|immunoglobulins|mesh-list
93127995|NCT01979536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93127996|NCT01979536|BB 1101|bb 1101|mesh-list
93127997|NCT01979536|Immunoconjugates|immunoconjugates|mesh-list
93127998|NCT01979536|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93127999|NCT01979536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128000|NCT01979536|Immunologic Factors|immunologic factors|mesh-ancestor
93128001|NCT01979536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128002|NCT01979536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128003|NCT01979536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93128004|NCT01979536|Alkylating Agents|alkylating agents|mesh-ancestor
93128005|NCT01979536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128006|NCT01979536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128007|NCT01979536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93128008|NCT01979536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128009|NCT01979536|Antiemetics|antiemetics|mesh-ancestor
93128010|NCT01979536|Autonomic Agents|autonomic agents|mesh-ancestor
93128011|NCT01979536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128012|NCT01979536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128013|NCT01979536|Glucocorticoids|glucocorticoids|mesh-ancestor
93128014|NCT01979536|Hormones|hormones|mesh-ancestor
93128015|NCT01979536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128016|NCT01979536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128017|NCT01979536|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128018|NCT01979536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128019|NCT01979536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93128020|NCT01979536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93128021|NCT01979536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93128022|NCT01979536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93128023|NCT01979536|Abortifacient Agents|abortifacient agents|mesh-ancestor
93128024|NCT01979536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93128025|NCT01979536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128026|NCT01979536|Antimetabolites|antimetabolites|mesh-ancestor
93128027|NCT01979536|Dermatologic Agents|dermatologic agents|mesh-ancestor
93128028|NCT01979536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93128029|NCT01979536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93128030|NCT01979536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128032|NCT01979536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128033|NCT01979536|Immunotoxins|immunotoxins|mesh-ancestor
93128034|NCT01979536|Keratolytic Agents|keratolytic agents|mesh-ancestor
93128035|NCT01979536|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128036|NCT01979536|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128037|NCT01979536|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128038|NCT01979536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128039|NCT03496298|Efpeglenatide|efpeglenatide|mesh-list
93128040|NCT03496298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128041|NCT03496298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128042|NCT03668860|Dexamethasone|dexamethasone|mesh-list
93128043|NCT03668860|Dexamethasone acetate|dexamethasone acetate|mesh-list
93128044|NCT03668860|Betamethasone|betamethasone|mesh-list
93128045|NCT03668860|Betamethasone Valerate|betamethasone valerate|mesh-list
93128046|NCT03668860|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93128047|NCT03668860|Betamethasone benzoate|betamethasone benzoate|mesh-list
93128048|NCT03668860|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
93128049|NCT03668860|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93128050|NCT03668860|BB 1101|bb 1101|mesh-list
93128051|NCT03668860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128052|NCT03668860|Antiemetics|antiemetics|mesh-ancestor
93128053|NCT03668860|Autonomic Agents|autonomic agents|mesh-ancestor
93128054|NCT03668860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128055|NCT03668860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128056|NCT03668860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128057|NCT03668860|Glucocorticoids|glucocorticoids|mesh-ancestor
93128058|NCT03668860|Hormones|hormones|mesh-ancestor
93128059|NCT03668860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128060|NCT03668860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128061|NCT03668860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128062|NCT03668860|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128063|NCT03668860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128064|NCT03668860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128065|NCT03668860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93128066|NCT03668860|Respiratory System Agents|respiratory system agents|mesh-ancestor
93128067|NCT03668860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93128068|NCT00062751|Sirolimus|sirolimus|mesh-list
93128069|NCT00062751|Letrozole|letrozole|mesh-list
93128070|NCT00062751|Temsirolimus|temsirolimus|mesh-list
93128071|NCT00062751|MTOR Inhibitors|mtor inhibitors|mesh-list
93128072|NCT00062751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128073|NCT00062751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93128074|NCT00062751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93128075|NCT00062751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128076|NCT00062751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128077|NCT00062751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93128078|NCT00062751|Hormone Antagonists|hormone antagonists|mesh-ancestor
93128079|NCT00062751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128080|NCT00062751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128081|NCT00062751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128082|NCT00062751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128083|NCT00062751|Immunologic Factors|immunologic factors|mesh-ancestor
93128084|NCT00062751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128085|NCT00062751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128086|NCT00062751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93128087|NCT00062751|Antifungal Agents|antifungal agents|mesh-ancestor
93128088|NCT00945724|Cytarabine|cytarabine|mesh-list
93128089|NCT00945724|Prednisolone|prednisolone|mesh-list
93128090|NCT00945724|Cyclophosphamide|cyclophosphamide|mesh-list
93128091|NCT00945724|Rituximab|rituximab|mesh-list
93128092|NCT00945724|Doxorubicin|doxorubicin|mesh-list
93128093|NCT00945724|Methotrexate|methotrexate|mesh-list
93128094|NCT00945724|Vincristine|vincristine|mesh-list
93128095|NCT00945724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128096|NCT00945724|Immunologic Factors|immunologic factors|mesh-ancestor
93128097|NCT00945724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128098|NCT00945724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128099|NCT00945724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93128100|NCT00945724|Alkylating Agents|alkylating agents|mesh-ancestor
93128101|NCT00945724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128102|NCT00945724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128103|NCT00945724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93128104|NCT00945724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128105|NCT00945724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93128106|NCT00945724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93128107|NCT00945724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93128108|NCT00945724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128109|NCT00945724|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93128110|NCT00945724|Abortifacient Agents|abortifacient agents|mesh-ancestor
93128111|NCT00945724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93128112|NCT00945724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128113|NCT00945724|Antimetabolites|antimetabolites|mesh-ancestor
93128114|NCT00945724|Dermatologic Agents|dermatologic agents|mesh-ancestor
93128115|NCT00945724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93128116|NCT00945724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93128117|NCT00945724|Antiviral Agents|antiviral agents|mesh-ancestor
93128118|NCT00945724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128119|NCT00945724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128120|NCT00945724|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128121|NCT00945724|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128122|NCT00945724|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128123|NCT00945724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128124|NCT00945724|Glucocorticoids|glucocorticoids|mesh-ancestor
93128125|NCT00945724|Hormones|hormones|mesh-ancestor
93128126|NCT00945724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128127|NCT00945724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128128|NCT00258310|Capecitabine|capecitabine|mesh-list
93128129|NCT00258310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128130|NCT00258310|Antimetabolites|antimetabolites|mesh-ancestor
93128131|NCT00258310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128132|NCT00258310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128133|NCT00062439|Docetaxel|docetaxel|mesh-list
93128134|NCT00062439|Etoposide|etoposide|mesh-list
93128135|NCT00062439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128136|NCT00062439|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128137|NCT00062439|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128138|NCT00062439|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128139|NCT00062439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128140|NCT00062439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128141|NCT00062439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93128142|NCT00062439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93128143|NCT00062439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128144|NCT01099059|Amantadine|amantadine|mesh-list
93128145|NCT01099059|Methylphenidate|methylphenidate|mesh-list
93128146|NCT01099059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93128147|NCT01099059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128148|NCT01099059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93128149|NCT01099059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93128150|NCT01099059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93128151|NCT01099059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128152|NCT01099059|Dopamine Agents|dopamine agents|mesh-ancestor
93128153|NCT01099059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128154|NCT01099059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93128155|NCT01099059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93128156|NCT01099059|Antiviral Agents|antiviral agents|mesh-ancestor
93128157|NCT01099059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128158|NCT01099059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128159|NCT01099059|Analgesics|analgesics|mesh-ancestor
93128160|NCT01099059|Sensory System Agents|sensory system agents|mesh-ancestor
93128161|NCT01099059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128162|NCT01092741|Imatinib Mesylate|imatinib mesylate|mesh-list
93128163|NCT01092741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128164|NCT01092741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128165|NCT01092741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128166|NCT01092741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128167|NCT01095471|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93128168|NCT01095471|Immunologic Factors|immunologic factors|mesh-ancestor
93128169|NCT01095471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128170|NCT03955341|Chlorhexidine|chlorhexidine|mesh-list
93128171|NCT03955341|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93128172|NCT03955341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128173|NCT03955341|Disinfectants|disinfectants|mesh-ancestor
93128174|NCT00031551|Etanercept|etanercept|mesh-list
93128175|NCT00031551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93128176|NCT00031551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128177|NCT00031551|Analgesics|analgesics|mesh-ancestor
93128178|NCT00031551|Sensory System Agents|sensory system agents|mesh-ancestor
93128179|NCT00031551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128180|NCT00031551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128181|NCT00031551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128183|NCT00031551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128184|NCT00031551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128185|NCT00031551|Immunologic Factors|immunologic factors|mesh-ancestor
93128186|NCT01099137|Vildagliptin|vildagliptin|mesh-list
93128187|NCT01099137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128188|NCT01099137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128189|NCT01099137|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93128190|NCT01099137|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128191|NCT01099137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128192|NCT01099137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128193|NCT01092975|Phenylephrine|phenylephrine|mesh-list
93128194|NCT01092975|Oxymetazoline|oxymetazoline|mesh-list
93128195|NCT01092975|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93128196|NCT01092975|Mydriatics|mydriatics|mesh-ancestor
93128197|NCT01092975|Autonomic Agents|autonomic agents|mesh-ancestor
93128198|NCT01092975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128199|NCT01092975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128200|NCT01092975|Sympathomimetics|sympathomimetics|mesh-ancestor
93128201|NCT01092975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93128202|NCT01092975|Nasal Decongestants|nasal decongestants|mesh-ancestor
93128203|NCT01092975|Respiratory System Agents|respiratory system agents|mesh-ancestor
93128204|NCT01092975|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93128205|NCT01092975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93128206|NCT01092975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93128207|NCT01092975|Adrenergic Agents|adrenergic agents|mesh-ancestor
93128208|NCT01092975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128209|NCT01092975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128210|NCT01092975|Protective Agents|protective agents|mesh-ancestor
93128211|NCT01584297|Ketoconazole|ketoconazole|mesh-list
93128212|NCT01584297|Antifungal Agents|antifungal agents|mesh-ancestor
93128213|NCT01584297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128214|NCT01584297|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93128215|NCT01584297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93128216|NCT01584297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128217|NCT01584297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128218|NCT01584297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93128219|NCT01584297|Hormone Antagonists|hormone antagonists|mesh-ancestor
93128220|NCT01584297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128221|NCT01584297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128222|NCT01584297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93128223|NCT00049257|Paclitaxel|paclitaxel|mesh-list
93128224|NCT00049257|Carboplatin|carboplatin|mesh-list
93128225|NCT00049257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128226|NCT00049257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128227|NCT00049257|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128228|NCT00049257|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128229|NCT00049257|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128230|NCT00049257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128231|NCT03951987|Charcoal|charcoal|mesh-list
93128232|NCT03951987|Antidotes|antidotes|mesh-ancestor
93128233|NCT03951987|Protective Agents|protective agents|mesh-ancestor
93128234|NCT03951987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128235|NCT03668470|Dulaglutide|dulaglutide|mesh-list
93128236|NCT03668470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128237|NCT03668470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128238|NCT03020992|Certolizumab Pegol|certolizumab pegol|mesh-list
93128239|NCT03020992|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93128240|NCT03020992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128241|NCT03020992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128242|NCT03020992|Immunologic Factors|immunologic factors|mesh-ancestor
93128243|NCT03020992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128244|NCT03020992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128245|NCT03020914|Methamphetamine|methamphetamine|mesh-list
93128246|NCT03020914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93128247|NCT03020914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128248|NCT03020914|Sympathomimetics|sympathomimetics|mesh-ancestor
93128249|NCT03020914|Autonomic Agents|autonomic agents|mesh-ancestor
93128250|NCT03020914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128251|NCT03020914|Dopamine Agents|dopamine agents|mesh-ancestor
93128252|NCT03020914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800444|NCT04200651|Antiemetics|antiemetics|mesh-ancestor
93128253|NCT03020914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128254|NCT03020914|Adrenergic Agents|adrenergic agents|mesh-ancestor
93128255|NCT03020914|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93128256|NCT03020914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93128257|NCT03020914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93128258|NCT03020914|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93128259|NCT03018340|Pimavanserin|pimavanserin|mesh-list
93128260|NCT03018340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93128261|NCT03018340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93128262|NCT03018340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93128263|NCT03018340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93128264|NCT03018340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128265|NCT03018340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128266|NCT03018340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93128267|NCT03018340|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93128268|NCT03018340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93128269|NCT03018340|Serotonin Agents|serotonin agents|mesh-ancestor
93128270|NCT03018340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128271|NCT03018340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128272|NCT00048165|Cyclosporine|cyclosporine|mesh-list
93128273|NCT00048165|Mycophenolic Acid|mycophenolic acid|mesh-list
93128274|NCT00048165|Methylprednisolone|methylprednisolone|mesh-list
93128275|NCT00048165|Cyclosporins|cyclosporins|mesh-list
93128276|NCT00048165|Daclizumab|daclizumab|mesh-list
93128277|NCT00048165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128278|NCT00048165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128279|NCT00048165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128280|NCT00048165|Immunologic Factors|immunologic factors|mesh-ancestor
93128281|NCT00048165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128282|NCT00048165|Antifungal Agents|antifungal agents|mesh-ancestor
93128283|NCT00048165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128284|NCT00048165|Dermatologic Agents|dermatologic agents|mesh-ancestor
93128285|NCT00048165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128286|NCT00048165|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93128287|NCT00048165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93128288|NCT00048165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128289|NCT00048165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93128290|NCT00048165|Antitubercular Agents|antitubercular agents|mesh-ancestor
93128291|NCT00048165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128292|NCT00048165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128293|NCT00048165|Antiemetics|antiemetics|mesh-ancestor
93128294|NCT00048165|Autonomic Agents|autonomic agents|mesh-ancestor
93128295|NCT00048165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128296|NCT00048165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128297|NCT00048165|Glucocorticoids|glucocorticoids|mesh-ancestor
93128298|NCT00048165|Hormones|hormones|mesh-ancestor
93128299|NCT00048165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128300|NCT00048165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93128301|NCT00048165|Protective Agents|protective agents|mesh-ancestor
93128302|NCT01099527|Capecitabine|capecitabine|mesh-list
93128303|NCT01099527|Everolimus|everolimus|mesh-list
93128304|NCT01099527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128305|NCT01099527|Antimetabolites|antimetabolites|mesh-ancestor
93128306|NCT01099527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128307|NCT01099527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128308|NCT01099527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93128309|NCT01099527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128310|NCT01099527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128311|NCT01099527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128312|NCT01099527|Immunologic Factors|immunologic factors|mesh-ancestor
93128313|NCT01099527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128314|NCT01093365|Varenicline|varenicline|mesh-list
93128315|NCT01093365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93128316|NCT01093365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93128317|NCT01093365|Cholinergic Agents|cholinergic agents|mesh-ancestor
93128318|NCT01093365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128319|NCT01093365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128320|NCT01093365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128321|NCT03955497|Hyaluronic Acid|hyaluronic acid|mesh-list
93128322|NCT03955497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93128323|NCT03955497|Immunologic Factors|immunologic factors|mesh-ancestor
93128324|NCT03955497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128325|NCT03955497|Viscosupplements|viscosupplements|mesh-ancestor
93128326|NCT03955497|Protective Agents|protective agents|mesh-ancestor
92800525|NCT03871621|Metformin|metformin|mesh-list
93128327|NCT01099605|Bupivacaine|bupivacaine|mesh-list
93128328|NCT01099605|Anesthetics, Local|anesthetics, local|mesh-ancestor
93128329|NCT01099605|Anesthetics|anesthetics|mesh-ancestor
93128330|NCT01099605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128331|NCT01099605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128332|NCT01099605|Sensory System Agents|sensory system agents|mesh-ancestor
93128333|NCT01099605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128334|NCT00059787|Paclitaxel|paclitaxel|mesh-list
93128335|NCT00059787|Carboplatin|carboplatin|mesh-list
93128336|NCT00059787|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93128337|NCT00059787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128338|NCT00059787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128339|NCT00059787|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128340|NCT00059787|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128341|NCT00059787|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128342|NCT00059787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128343|NCT00059787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128344|NCT00059787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128345|NCT01099839|Ipragliflozin|ipragliflozin|mesh-list
93128346|NCT01099839|Miglitol|miglitol|mesh-list
93128347|NCT01099839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93128348|NCT01099839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128349|NCT01099839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128350|NCT01099839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128351|NCT01099839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128352|NCT01099839|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93128353|NCT00058539|Pertuzumab|pertuzumab|mesh-list
93128354|NCT00058539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128355|NCT00058539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128356|NCT03956823|Amlodipine|amlodipine|mesh-list
93128357|NCT03956823|Telmisartan|telmisartan|mesh-list
93128358|NCT03956823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93128359|NCT03956823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93128360|NCT03956823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93128361|NCT03956823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128362|NCT03956823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93128363|NCT03956823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128364|NCT03956823|Vasodilator Agents|vasodilator agents|mesh-ancestor
93128365|NCT03956823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93128366|NCT03956823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93128367|NCT03015532|Bupivacaine|bupivacaine|mesh-list
93128368|NCT03015532|Ropivacaine|ropivacaine|mesh-list
93128369|NCT03015532|Anesthetics, Local|anesthetics, local|mesh-ancestor
93128370|NCT03015532|Anesthetics|anesthetics|mesh-ancestor
93128371|NCT03015532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128372|NCT03015532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128373|NCT03015532|Sensory System Agents|sensory system agents|mesh-ancestor
93128374|NCT03015532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128375|NCT03954873|Glucagon|glucagon|mesh-list
93128376|NCT03954873|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93128377|NCT03954873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128378|NCT03954873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128379|NCT03954873|Hormones|hormones|mesh-ancestor
93128380|NCT03954873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128381|NCT03954873|Incretins|incretins|mesh-ancestor
93128382|NCT03951831|Docetaxel|docetaxel|mesh-list
93128383|NCT03951831|Leuprolide|leuprolide|mesh-list
93128384|NCT03951831|Cemiplimab|cemiplimab|mesh-list
93128385|NCT03951831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128386|NCT03951831|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128387|NCT03951831|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128388|NCT03951831|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128389|NCT03951831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128390|NCT03951831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93128391|NCT03951831|Fertility Agents|fertility agents|mesh-ancestor
93128392|NCT03951831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93128393|NCT03951831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128394|NCT03951831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128395|NCT03951831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128396|NCT03954639|Bupivacaine|bupivacaine|mesh-list
93128397|NCT03954639|Anesthetics, Local|anesthetics, local|mesh-ancestor
93128398|NCT03954639|Anesthetics|anesthetics|mesh-ancestor
93128399|NCT03954639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128400|NCT03954639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128401|NCT03954639|Sensory System Agents|sensory system agents|mesh-ancestor
92800597|NCT03640026|Tacrolimus|tacrolimus|mesh-list
93128402|NCT03954639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128403|NCT01095939|Benazepril|benazepril|mesh-list
93128404|NCT01095939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93128405|NCT01095939|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128406|NCT01095939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128407|NCT01095939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128408|NCT01095939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93128409|NCT03015220|Dulaglutide|dulaglutide|mesh-list
93128410|NCT03015220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128411|NCT03015220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128412|NCT00022659|Bevacizumab|bevacizumab|mesh-list
93128413|NCT00022659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93128414|NCT00022659|Antibodies|antibodies|mesh-list
93128415|NCT00022659|Immunoglobulins|immunoglobulins|mesh-list
93128416|NCT00022659|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93128417|NCT00022659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128418|NCT00022659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93128419|NCT00022659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93128420|NCT00022659|Growth Substances|growth substances|mesh-ancestor
93128421|NCT00022659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128422|NCT00022659|Growth Inhibitors|growth inhibitors|mesh-ancestor
93128423|NCT00022659|Immunologic Factors|immunologic factors|mesh-ancestor
93128424|NCT03018106|Estrogens|estrogens|mesh-list
93128425|NCT03018106|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93128426|NCT03018106|Hormones|hormones|mesh-ancestor
93128427|NCT03018106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128428|NCT03018106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128429|NCT03018028|Liraglutide|liraglutide|mesh-list
93128430|NCT03018028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128431|NCT03018028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128432|NCT03018028|Incretins|incretins|mesh-ancestor
93128433|NCT03018028|Hormones|hormones|mesh-ancestor
93128434|NCT03018028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128435|NCT03667222|Minocycline|minocycline|mesh-list
93128436|NCT03667222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128437|NCT03667222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128438|NCT03667300|Linagliptin|linagliptin|mesh-list
93128439|NCT03667300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128440|NCT03667300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128441|NCT03667300|Incretins|incretins|mesh-ancestor
93128442|NCT03667300|Hormones|hormones|mesh-ancestor
93128443|NCT03667300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128444|NCT03667300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93128445|NCT03667300|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128446|NCT03667300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128447|NCT03667300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128448|NCT03667066|Clopidogrel|clopidogrel|mesh-list
93128449|NCT03667066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93128450|NCT03667066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93128451|NCT03667066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93128452|NCT03667066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93128453|NCT03667066|Purinergic Agents|purinergic agents|mesh-ancestor
93128454|NCT03667066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128455|NCT03667066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128456|NCT03667066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128457|NCT00021255|Cyclophosphamide|cyclophosphamide|mesh-list
93128458|NCT00021255|Carboplatin|carboplatin|mesh-list
93128459|NCT00021255|Docetaxel|docetaxel|mesh-list
93128460|NCT00021255|Doxorubicin|doxorubicin|mesh-list
93128461|NCT00021255|Trastuzumab|trastuzumab|mesh-list
93128462|NCT00021255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128463|NCT00021255|Immunologic Factors|immunologic factors|mesh-ancestor
93128464|NCT00021255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128465|NCT00021255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128466|NCT00021255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93128467|NCT00021255|Alkylating Agents|alkylating agents|mesh-ancestor
93128468|NCT00021255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128469|NCT00021255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128470|NCT00021255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93128471|NCT00021255|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128472|NCT00021255|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128473|NCT00021255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800673|NCT03236987|Azithromycin|azithromycin|mesh-list
93128474|NCT00021255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93128475|NCT00021255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93128476|NCT00021255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93128477|NCT00021255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128478|NCT00021255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128479|NCT03012334|Alprazolam|alprazolam|mesh-list
93128480|NCT03012334|Lasmiditan|lasmiditan|mesh-list
93128481|NCT03012334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93128482|NCT03012334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128483|NCT03012334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128484|NCT03012334|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93128485|NCT03012334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93128486|NCT03012334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93128487|NCT03012334|GABA Modulators|gaba modulators|mesh-ancestor
93128488|NCT03012334|GABA Agents|gaba agents|mesh-ancestor
93128489|NCT03012334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128490|NCT03012334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128491|NCT03012334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93128492|NCT03012334|Serotonin Agents|serotonin agents|mesh-ancestor
93128493|NCT03951285|Niacinamide|niacinamide|mesh-list
93128494|NCT03951285|Vitamin B Complex|vitamin b complex|mesh-ancestor
93128495|NCT03951285|Vitamins|vitamins|mesh-ancestor
93128496|NCT03951285|Micronutrients|micronutrients|mesh-ancestor
93128497|NCT03951285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128498|NCT04571944|Suvorexant|suvorexant|mesh-list
93128499|NCT04571944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93128500|NCT04571944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93128501|NCT04571944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128502|NCT04571944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128503|NCT04571944|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93128504|NCT04571944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128505|NCT04571944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128506|NCT04052932|Allopurinol|allopurinol|mesh-list
93128507|NCT04052932|Antimetabolites|antimetabolites|mesh-ancestor
93128508|NCT04052932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128509|NCT04052932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128510|NCT04052932|Gout Suppressants|gout suppressants|mesh-ancestor
93128511|NCT04052932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128512|NCT04052932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93128513|NCT04052932|Antioxidants|antioxidants|mesh-ancestor
93128514|NCT04052932|Protective Agents|protective agents|mesh-ancestor
93128515|NCT04052932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128516|NCT03006562|Heparin|heparin|mesh-list
93128517|NCT03006562|Anticoagulants|anticoagulants|mesh-ancestor
93128518|NCT03006562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93128519|NCT03006562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93128520|NCT03006562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128521|NCT03666208|Sirolimus|sirolimus|mesh-list
93128522|NCT03666208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128523|NCT03666208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128524|NCT03666208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93128525|NCT03666208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128526|NCT03666208|Antifungal Agents|antifungal agents|mesh-ancestor
93128527|NCT03666208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128528|NCT03666208|Immunologic Factors|immunologic factors|mesh-ancestor
93128529|NCT03666208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128530|NCT03007966|Clonidine|clonidine|mesh-list
93128531|NCT03007966|Epinephrine|epinephrine|mesh-list
93128532|NCT03007966|Bupivacaine|bupivacaine|mesh-list
93128533|NCT03007966|Anesthetics, Local|anesthetics, local|mesh-ancestor
93128534|NCT03007966|Anesthetics|anesthetics|mesh-ancestor
93128535|NCT03007966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128536|NCT03007966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128537|NCT03007966|Sensory System Agents|sensory system agents|mesh-ancestor
93128538|NCT03007966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128539|NCT03007966|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93128540|NCT03007966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93128541|NCT03007966|Adrenergic Agents|adrenergic agents|mesh-ancestor
93128542|NCT03007966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128543|NCT03007966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128544|NCT03007966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93128545|NCT03007966|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93128546|NCT03007966|Autonomic Agents|autonomic agents|mesh-ancestor
93128547|NCT03007966|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92800740|NCT02789982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93128548|NCT03007966|Respiratory System Agents|respiratory system agents|mesh-ancestor
93128549|NCT03007966|Mydriatics|mydriatics|mesh-ancestor
93128550|NCT03007966|Sympathomimetics|sympathomimetics|mesh-ancestor
93128551|NCT03007966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93128552|NCT03007966|Analgesics|analgesics|mesh-ancestor
93128553|NCT03007966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93128554|NCT03007966|Sympatholytics|sympatholytics|mesh-ancestor
93128555|NCT03007966|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93128556|NCT03007888|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93128557|NCT03007888|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93128558|NCT03007888|Immunologic Factors|immunologic factors|mesh-ancestor
93128559|NCT03007888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128560|NCT03007888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93128561|NCT03007888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93128562|NCT03007888|Dopamine Agonists|dopamine agonists|mesh-ancestor
93128563|NCT03007888|Dopamine Agents|dopamine agents|mesh-ancestor
93128564|NCT03007888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128565|NCT03007888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128567|NCT03541044|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93128568|NCT03541044|Autonomic Agents|autonomic agents|mesh-ancestor
93128569|NCT03541044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128570|NCT03541044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128571|NCT03541044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93128572|NCT03541044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93128573|NCT03541044|Cholinergic Agents|cholinergic agents|mesh-ancestor
93128574|NCT03541044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128575|NCT03541044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128576|NCT00009945|Clodronic Acid|clodronic acid|mesh-list
93128577|NCT00009945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93128578|NCT00009945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128579|NCT03540030|Acetaminophen|acetaminophen|mesh-list
93128580|NCT03540030|Celecoxib|celecoxib|mesh-list
93128581|NCT03540030|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93128582|NCT03540030|Lidocaine|lidocaine|mesh-list
93128583|NCT03540030|Gabapentin|gabapentin|mesh-list
93128584|NCT03540030|Propofol|propofol|mesh-list
93128585|NCT03540030|Sevoflurane|sevoflurane|mesh-list
93128586|NCT03540030|Desflurane|desflurane|mesh-list
93128587|NCT03540030|Rocuronium|rocuronium|mesh-list
93128588|NCT03540030|Vecuronium Bromide|vecuronium bromide|mesh-list
93128589|NCT03540030|Anesthetics, Local|anesthetics, local|mesh-ancestor
93128590|NCT03540030|Anesthetics|anesthetics|mesh-ancestor
93128591|NCT03540030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128592|NCT03540030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128593|NCT03540030|Sensory System Agents|sensory system agents|mesh-ancestor
93128594|NCT03540030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128595|NCT03540030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93128596|NCT03540030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93128597|NCT03540030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93128598|NCT03540030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93128599|NCT03540030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128600|NCT03540030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93128601|NCT03540030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93128602|NCT03540030|Anesthetics, General|anesthetics, general|mesh-ancestor
93128603|NCT03540030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128604|NCT03540030|Analgesics|analgesics|mesh-ancestor
93128605|NCT03540030|Antipyretics|antipyretics|mesh-ancestor
93128606|NCT03540030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93128607|NCT03540030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93128608|NCT03540030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93128609|NCT03540030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128610|NCT03540030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128611|NCT03540030|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93128612|NCT03540030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93128613|NCT03540030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128614|NCT03540030|Anticonvulsants|anticonvulsants|mesh-ancestor
93128615|NCT03540030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93128616|NCT03540030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93128617|NCT03540030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93128618|NCT03540030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93128619|NCT03540030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93128620|NCT03540030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93128621|NCT03540030|Antimanic Agents|antimanic agents|mesh-ancestor
93128622|NCT03540030|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93128623|NCT03540030|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93128624|NCT03540030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93128625|NCT03540030|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93128626|NCT03540030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92800818|NCT02135133|Ofatumumab|ofatumumab|mesh-list
93128627|NCT03540030|Cholinergic Agents|cholinergic agents|mesh-ancestor
93128628|NCT03003676|Cyclophosphamide|cyclophosphamide|mesh-list
93128629|NCT03003676|Pembrolizumab|pembrolizumab|mesh-list
93128630|NCT03003676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128631|NCT03003676|Immunologic Factors|immunologic factors|mesh-ancestor
93128632|NCT03003676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128633|NCT03003676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128634|NCT03003676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93128635|NCT03003676|Alkylating Agents|alkylating agents|mesh-ancestor
93128636|NCT03003676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128637|NCT03003676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128638|NCT03003676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93128639|NCT03003676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128640|NCT03003676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93128641|NCT03665740|Resveratrol|resveratrol|mesh-list
93128642|NCT03665740|Antioxidants|antioxidants|mesh-ancestor
93128643|NCT03665740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128644|NCT03665740|Protective Agents|protective agents|mesh-ancestor
93128645|NCT03665740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128646|NCT03665740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128647|NCT03665740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93128648|NCT03665350|Insulin|insulin|mesh-list
93128649|NCT03665350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128650|NCT03665350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128651|NCT03665428|Bismuth|bismuth|mesh-list
93128652|NCT03665428|Antacids|antacids|mesh-ancestor
93128653|NCT03665428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128654|NCT03665428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128655|NCT03669328|Anesthetics|anesthetics|mesh-list
93128656|NCT03669328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128657|NCT03669328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128658|NCT02912650|Acetaminophen|acetaminophen|mesh-list
93128659|NCT02912650|Ibuprofen|ibuprofen|mesh-list
93128660|NCT02912650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128661|NCT02912650|Analgesics|analgesics|mesh-ancestor
93128662|NCT02912650|Sensory System Agents|sensory system agents|mesh-ancestor
93128663|NCT02912650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128664|NCT02912650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128665|NCT02912650|Antipyretics|antipyretics|mesh-ancestor
93128666|NCT02912650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93128667|NCT02912650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128668|NCT02912650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128669|NCT02912650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93128670|NCT02912650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128671|NCT02912650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128672|NCT03002038|Rituximab|rituximab|mesh-list
93128673|NCT03002038|Azathioprine|azathioprine|mesh-list
93128674|NCT03002038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128675|NCT03002038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128676|NCT03002038|Immunologic Factors|immunologic factors|mesh-ancestor
93128677|NCT03002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128678|NCT03002038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128679|NCT03002038|Antimetabolites|antimetabolites|mesh-ancestor
93128680|NCT03002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128681|NCT03002038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128682|NCT03002038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93128683|NCT03664414|Pentoxifylline|pentoxifylline|mesh-list
93128684|NCT03664414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93128685|NCT03664414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128686|NCT03664414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128687|NCT03664414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93128688|NCT03664414|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93128689|NCT03664414|Protective Agents|protective agents|mesh-ancestor
93128690|NCT03664414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128691|NCT03664414|Vasodilator Agents|vasodilator agents|mesh-ancestor
93128692|NCT03664414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93128693|NCT03664414|Antioxidants|antioxidants|mesh-ancestor
93128694|NCT02911948|Insulin|insulin|mesh-list
93128695|NCT02911948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93128696|NCT02911948|Liraglutide|liraglutide|mesh-list
93128697|NCT02911948|Insulin, Long-Acting|insulin, long-acting|mesh-list
93128698|NCT02911948|Xultophy|xultophy|mesh-list
93128699|NCT02911948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128700|NCT02911948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800900|NCT00408447|Busulfan|busulfan|mesh-list
93128701|NCT02911948|Incretins|incretins|mesh-ancestor
93128702|NCT02911948|Hormones|hormones|mesh-ancestor
93128703|NCT02911948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128704|NCT03622918|Rifampin|rifampin|mesh-list
93128705|NCT03622918|Colistin|colistin|mesh-list
93128706|NCT03622918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93128707|NCT03622918|Antitubercular Agents|antitubercular agents|mesh-ancestor
93128708|NCT03622918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128709|NCT03622918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128710|NCT03622918|Leprostatic Agents|leprostatic agents|mesh-ancestor
93128711|NCT03622918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93128712|NCT03622918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128713|NCT03622918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128714|NCT03622918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93128715|NCT03622918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93128716|NCT03622918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93128717|NCT03622918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93128718|NCT03622918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93128719|NCT03622918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93128720|NCT03487666|Capecitabine|capecitabine|mesh-list
93128721|NCT03487666|Nivolumab|nivolumab|mesh-list
93128722|NCT03487666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128723|NCT03487666|Antimetabolites|antimetabolites|mesh-ancestor
93128724|NCT03487666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128725|NCT03487666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128726|NCT03487666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128727|NCT03487666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93128728|NCT03376672|Dexamethasone|dexamethasone|mesh-list
93128729|NCT03376672|Lenalidomide|lenalidomide|mesh-list
93128730|NCT03376672|Ixazomib|ixazomib|mesh-list
93128731|NCT03376672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128732|NCT03376672|Antiemetics|antiemetics|mesh-ancestor
93128733|NCT03376672|Autonomic Agents|autonomic agents|mesh-ancestor
93128734|NCT03376672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128735|NCT03376672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128736|NCT03376672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93128737|NCT03376672|Glucocorticoids|glucocorticoids|mesh-ancestor
93128738|NCT03376672|Hormones|hormones|mesh-ancestor
93128739|NCT03376672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128740|NCT03376672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128741|NCT03376672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128742|NCT03376672|Immunologic Factors|immunologic factors|mesh-ancestor
93128743|NCT03376672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93128744|NCT03376672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93128745|NCT03376672|Growth Substances|growth substances|mesh-ancestor
93128746|NCT03376672|Growth Inhibitors|growth inhibitors|mesh-ancestor
93128747|NCT03376672|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128748|NCT03376672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128749|NCT03376672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128750|NCT03367312|Xenon|xenon|mesh-list
93128751|NCT03367312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93128752|NCT03367312|Anesthetics, General|anesthetics, general|mesh-ancestor
93128753|NCT03367312|Anesthetics|anesthetics|mesh-ancestor
93128754|NCT03367312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128755|NCT03367312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128756|NCT00027027|Pertuzumab|pertuzumab|mesh-list
93128757|NCT00027027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128758|NCT00027027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128759|NCT00046839|Celecoxib|celecoxib|mesh-list
93128760|NCT00046839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
93128761|NCT00046839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93128762|NCT00046839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128763|NCT00046839|Analgesics|analgesics|mesh-ancestor
93128764|NCT00046839|Sensory System Agents|sensory system agents|mesh-ancestor
93128765|NCT00046839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128766|NCT00046839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128767|NCT00046839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128768|NCT00046839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93128769|NCT00046839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93128770|NCT00046839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128771|NCT00046839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128772|NCT00006903|Fulvestrant|fulvestrant|mesh-list
93128773|NCT00006903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128774|NCT00006903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800963|NCT01131182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93128775|NCT00006903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93128776|NCT00006903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93128777|NCT00006903|Hormone Antagonists|hormone antagonists|mesh-ancestor
93128778|NCT00006903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128779|NCT00006903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128780|NCT03951597|Gemcitabine|gemcitabine|mesh-list
93128781|NCT03951597|Oxaliplatin|oxaliplatin|mesh-list
93128782|NCT03951597|Lenvatinib|lenvatinib|mesh-list
93128783|NCT03951597|Antibodies|antibodies|mesh-list
93128784|NCT03951597|Immunologic Factors|immunologic factors|mesh-ancestor
93128785|NCT03951597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128786|NCT03951597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93128787|NCT03951597|Antimetabolites|antimetabolites|mesh-ancestor
93128788|NCT03951597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128789|NCT03951597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128790|NCT03951597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128791|NCT03951597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128792|NCT03539484|Obinutuzumab|obinutuzumab|mesh-list
93128793|NCT03539484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128794|NCT03539484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128795|NCT01101009|Amlodipine|amlodipine|mesh-list
93128796|NCT01101009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93128797|NCT01101009|Olmesartan|olmesartan|mesh-list
93128798|NCT01101009|Perindopril|perindopril|mesh-list
93128799|NCT01101009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93128800|NCT01101009|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93128801|NCT01101009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93128802|NCT01101009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128803|NCT01101009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93128804|NCT01101009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128805|NCT01101009|Vasodilator Agents|vasodilator agents|mesh-ancestor
93128806|NCT01101009|Diuretics|diuretics|mesh-ancestor
93128807|NCT01101009|Natriuretic Agents|natriuretic agents|mesh-ancestor
93128808|NCT01101009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93128809|NCT01101009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93128810|NCT01101009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93128811|NCT01101009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93128812|NCT01101009|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128813|NCT01101009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128814|NCT02996500|Tofacitinib|tofacitinib|mesh-list
93128815|NCT02996500|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93128816|NCT02996500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93128817|NCT02996500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128818|NCT02996500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128819|NCT00006489|Naltrexone|naltrexone|mesh-list
93128820|NCT00006489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93128821|NCT00006489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93128822|NCT00006489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128823|NCT00006489|Sensory System Agents|sensory system agents|mesh-ancestor
93128824|NCT00006489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128825|NCT01096095|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93128826|NCT01096095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128827|NCT03720756|Nickel|nickel|mesh-list
93128828|NCT03720756|Trace Elements|trace elements|mesh-ancestor
93128829|NCT03720756|Micronutrients|micronutrients|mesh-ancestor
93128830|NCT03720756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128831|NCT00025233|Bevacizumab|bevacizumab|mesh-list
93128832|NCT00025233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93128833|NCT00025233|Antibodies|antibodies|mesh-list
93128834|NCT00025233|Immunoglobulins|immunoglobulins|mesh-list
93128835|NCT00025233|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93128836|NCT00025233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128837|NCT00025233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93128838|NCT00025233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93128839|NCT00025233|Growth Substances|growth substances|mesh-ancestor
93128840|NCT00025233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128841|NCT00025233|Growth Inhibitors|growth inhibitors|mesh-ancestor
93128842|NCT00025233|Immunologic Factors|immunologic factors|mesh-ancestor
93128843|NCT00025155|Epothilones|epothilones|mesh-list
93128844|NCT00025155|Epothilone B|epothilone b|mesh-list
93128845|NCT00025155|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128846|NCT00025155|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128847|NCT00025155|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128848|NCT00025155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128849|NCT00025155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128850|NCT02998996|Endocine|endocine|mesh-list
93128852|NCT02998996|Immunologic Factors|immunologic factors|mesh-ancestor
93128853|NCT02998996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128854|NCT03663478|Ropivacaine|ropivacaine|mesh-list
93128855|NCT03663478|Anesthetics, Local|anesthetics, local|mesh-ancestor
93128856|NCT03663478|Anesthetics|anesthetics|mesh-ancestor
93128857|NCT03663478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93128858|NCT03663478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128859|NCT03663478|Sensory System Agents|sensory system agents|mesh-ancestor
93128860|NCT03663478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128861|NCT02994940|Acetaminophen|acetaminophen|mesh-list
93128862|NCT02994940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128863|NCT02994940|Analgesics|analgesics|mesh-ancestor
93128864|NCT02994940|Sensory System Agents|sensory system agents|mesh-ancestor
93128865|NCT02994940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128866|NCT02994940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128867|NCT02994940|Antipyretics|antipyretics|mesh-ancestor
93128868|NCT04053322|Durvalumab|durvalumab|mesh-list
93128869|NCT04053322|Fulvestrant|fulvestrant|mesh-list
93128870|NCT04053322|Olaparib|olaparib|mesh-list
93128871|NCT04053322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93128872|NCT04053322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128873|NCT04053322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128874|NCT04053322|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93128875|NCT04053322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93128876|NCT04053322|Hormone Antagonists|hormone antagonists|mesh-ancestor
93128877|NCT04053322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128878|NCT04053322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128879|NCT04053322|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93128880|NCT04053322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128881|NCT04053322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128882|NCT02994394|Tolvaptan|tolvaptan|mesh-list
93128883|NCT02994394|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93128884|NCT02994394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128885|NCT02994394|Natriuretic Agents|natriuretic agents|mesh-ancestor
93128886|NCT02994394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128887|NCT01063270|Rifampin|rifampin|mesh-list
93128888|NCT01063270|Clindamycin|clindamycin|mesh-list
93128889|NCT01063270|Clindamycin palmitate|clindamycin palmitate|mesh-list
93069062|NCT03965624|Ixazomib|ixazomib|mesh-list
93128890|NCT01063270|Clindamycin phosphate|clindamycin phosphate|mesh-list
93128891|NCT01063270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93128892|NCT01063270|Antitubercular Agents|antitubercular agents|mesh-ancestor
93128893|NCT01063270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128894|NCT01063270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128895|NCT01063270|Leprostatic Agents|leprostatic agents|mesh-ancestor
93128896|NCT01063270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93128897|NCT01063270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128898|NCT01063270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128899|NCT01063270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93128900|NCT01063270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93128901|NCT01063270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93128902|NCT01063270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93128903|NCT01063270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93128904|NCT01063270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93128905|NCT01063270|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93128906|NCT00023673|Paclitaxel|paclitaxel|mesh-list
93128907|NCT00023673|Carboplatin|carboplatin|mesh-list
93128908|NCT00023673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128909|NCT00023673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128910|NCT00023673|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128911|NCT00023673|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128912|NCT00023673|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128913|NCT00023673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128914|NCT01069900|Amoxicillin|amoxicillin|mesh-list
93128915|NCT01069900|Moxifloxacin|moxifloxacin|mesh-list
93128916|NCT01069900|Clavulanic Acid|clavulanic acid|mesh-list
93128917|NCT01069900|Clavulanic Acids|clavulanic acids|mesh-list
93128918|NCT01069900|Ertapenem|ertapenem|mesh-list
93128919|NCT01069900|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93128920|NCT01069900|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93128921|NCT01069900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93128922|NCT01069900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801112|NCT01129622|Letrozole|letrozole|mesh-list
93128923|NCT01069900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93128924|NCT01069900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93128925|NCT01069900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128926|NCT01069900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128927|NCT01069900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128928|NCT01069900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93128929|NCT01069900|Contraceptive Agents|contraceptive agents|mesh-ancestor
93128930|NCT01069900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93128931|NCT01069900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128932|NCT01069900|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93128933|NCT01069900|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93128934|NCT01069900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93128935|NCT01069900|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93128936|NCT00006237|Interferons|interferons|mesh-list
93128937|NCT00006237|Interferon-alpha|interferon-alpha|mesh-list
93128938|NCT00006237|Aldesleukin|aldesleukin|mesh-list
93128939|NCT00006237|Interleukin-2|interleukin-2|mesh-list
93128940|NCT00006237|Dacarbazine|dacarbazine|mesh-list
93128941|NCT00006237|Vinblastine|vinblastine|mesh-list
93128942|NCT00006237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128943|NCT00006237|Antiviral Agents|antiviral agents|mesh-ancestor
93128944|NCT00006237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93128945|NCT00006237|Immunologic Factors|immunologic factors|mesh-ancestor
93128946|NCT00006237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128947|NCT00006237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93128948|NCT00006237|Analgesics|analgesics|mesh-ancestor
93128949|NCT00006237|Sensory System Agents|sensory system agents|mesh-ancestor
93128950|NCT00006237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93128951|NCT00006237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93128952|NCT00006237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93128953|NCT00006237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93128954|NCT00006237|Alkylating Agents|alkylating agents|mesh-ancestor
93128955|NCT00006237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128956|NCT00006237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93128957|NCT00006237|Tubulin Modulators|tubulin modulators|mesh-ancestor
93128958|NCT00006237|Antimitotic Agents|antimitotic agents|mesh-ancestor
93128959|NCT00006237|Mitosis Modulators|mitosis modulators|mesh-ancestor
93128960|NCT04056754|Prednisone|prednisone|mesh-list
93128961|NCT04056754|Abiraterone Acetate|abiraterone acetate|mesh-list
93128962|NCT04056754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128963|NCT04056754|Glucocorticoids|glucocorticoids|mesh-ancestor
93128964|NCT04056754|Hormones|hormones|mesh-ancestor
93128965|NCT04056754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128966|NCT04056754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128967|NCT04056754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128968|NCT04056754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128969|NCT04056754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93128970|NCT04056754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128971|NCT04056754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128972|NCT04056754|Hormone Antagonists|hormone antagonists|mesh-ancestor
93128973|NCT04056754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93128974|NCT04056442|Cannabidiol|cannabidiol|mesh-list
93128975|NCT04056442|Anticonvulsants|anticonvulsants|mesh-ancestor
93128976|NCT03661684|Prednisone|prednisone|mesh-list
93128977|NCT03661684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93128978|NCT03661684|Glucocorticoids|glucocorticoids|mesh-ancestor
93128979|NCT03661684|Hormones|hormones|mesh-ancestor
93128980|NCT03661684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93128981|NCT03661684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128982|NCT03661684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128983|NCT03661684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128984|NCT02993926|Leuprolide|leuprolide|mesh-list
93128985|NCT02993926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93128986|NCT02993926|Fertility Agents|fertility agents|mesh-ancestor
93128987|NCT02993926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93128988|NCT02993926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93128989|NCT02993926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93128990|NCT02993926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93128991|NCT04055506|Ritonavir|ritonavir|mesh-list
93128992|NCT04055506|Deucravacitinib|deucravacitinib|mesh-list
93128993|NCT04055506|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93128994|NCT04055506|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93128995|NCT04055506|Protease Inhibitors|protease inhibitors|mesh-ancestor
93128996|NCT04055506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93128997|NCT04055506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93128998|NCT04055506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93128999|NCT04055506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93129000|NCT04055506|Antiviral Agents|antiviral agents|mesh-ancestor
93129001|NCT04055506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129002|NCT04055506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93129003|NCT04055506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93129004|NCT04055506|Dermatologic Agents|dermatologic agents|mesh-ancestor
93129005|NCT04055506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93129006|NCT02993224|Deferasirox|deferasirox|mesh-list
93129007|NCT02993224|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93129008|NCT02993224|Chelating Agents|chelating agents|mesh-ancestor
93129009|NCT02993224|Sequestering Agents|sequestering agents|mesh-ancestor
93129010|NCT02993224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129011|NCT02992132|Pimavanserin|pimavanserin|mesh-list
93129012|NCT02992132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93129013|NCT02992132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93129014|NCT02992132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93129015|NCT02992132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93129016|NCT02992132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129017|NCT02992132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129018|NCT02992132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93129019|NCT02992132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93129020|NCT02992132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93129021|NCT02992132|Serotonin Agents|serotonin agents|mesh-ancestor
93129022|NCT02992132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129023|NCT02992132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129024|NCT03444584|Metformin|metformin|mesh-list
93129025|NCT03444584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129026|NCT03444584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129027|NCT03717740|Esomeprazole|esomeprazole|mesh-list
93129028|NCT03717740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93129029|NCT03717740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93129030|NCT03717740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93129031|NCT03717740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129032|NCT03717740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129033|NCT03411902|Risedronic Acid|risedronic acid|mesh-list
93129034|NCT03411902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93129035|NCT03411902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129036|NCT03411902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129037|NCT03411902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93129038|NCT03411902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129039|NCT03411902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93129040|NCT03717662|Nicotine|nicotine|mesh-list
93129041|NCT03717662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93129042|NCT03717662|Autonomic Agents|autonomic agents|mesh-ancestor
93129043|NCT03717662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129044|NCT03717662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129045|NCT03717662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93129046|NCT03717662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93129047|NCT03717662|Cholinergic Agents|cholinergic agents|mesh-ancestor
93129048|NCT03717662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129049|NCT03717662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129050|NCT03494816|Axitinib|axitinib|mesh-list
93129051|NCT03494816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129052|NCT03494816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93129053|NCT03494816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129054|NCT03494816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129055|NCT03713918|Lithium Carbonate|lithium carbonate|mesh-list
93129056|NCT03713918|Antidepressive Agents|antidepressive agents|mesh-ancestor
93129057|NCT03713918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93129058|NCT03713918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129059|NCT03713918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129060|NCT03713918|Antimanic Agents|antimanic agents|mesh-ancestor
93129061|NCT03713918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93129062|NCT03713918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129063|NCT03713918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129064|NCT03713762|Lidocaine|lidocaine|mesh-list
93129065|NCT03713762|Fentanyl|fentanyl|mesh-list
93129066|NCT03713762|Bupivacaine|bupivacaine|mesh-list
93129067|NCT03713762|Anesthetics, Local|anesthetics, local|mesh-ancestor
93129068|NCT03713762|Anesthetics|anesthetics|mesh-ancestor
93129069|NCT03713762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129070|NCT03713762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129071|NCT03713762|Sensory System Agents|sensory system agents|mesh-ancestor
93129072|NCT03713762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129073|NCT03713762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93129074|NCT03713762|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93129075|NCT03713762|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93129076|NCT03713762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129077|NCT03713762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129078|NCT03713762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93129079|NCT03713762|Narcotics|narcotics|mesh-ancestor
93129080|NCT03713762|Analgesics|analgesics|mesh-ancestor
93129081|NCT03713762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93129082|NCT03713762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93129083|NCT03713762|Anesthetics, General|anesthetics, general|mesh-ancestor
93129084|NCT02991118|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93129085|NCT02991118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129086|NCT02991118|Antimetabolites|antimetabolites|mesh-ancestor
93129087|NCT02991118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129088|NCT02991118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129089|NCT02991118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129090|NCT02991118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129091|NCT02991118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129092|NCT02991040|Lidocaine|lidocaine|mesh-list
93129093|NCT02991040|Anesthetics, Local|anesthetics, local|mesh-ancestor
93129094|NCT02991040|Anesthetics|anesthetics|mesh-ancestor
93129095|NCT02991040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129096|NCT02991040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129097|NCT02991040|Sensory System Agents|sensory system agents|mesh-ancestor
93129098|NCT02991040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129099|NCT02991040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93129100|NCT02991040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93129101|NCT02991040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93129102|NCT02991040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129103|NCT02991040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129104|NCT03660436|Mycophenolic Acid|mycophenolic acid|mesh-list
93129105|NCT03660436|Deucravacitinib|deucravacitinib|mesh-list
93129106|NCT03660436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93129107|NCT03660436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129108|NCT03660436|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93129109|NCT03660436|Antitubercular Agents|antitubercular agents|mesh-ancestor
93129110|NCT03660436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93129111|NCT03660436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129112|NCT03660436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129113|NCT03660436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129114|NCT03660436|Dermatologic Agents|dermatologic agents|mesh-ancestor
93129115|NCT03660436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93129116|NCT03662620|Amlodipine|amlodipine|mesh-list
93129117|NCT03662620|Telmisartan|telmisartan|mesh-list
93129118|NCT03662620|Chlorthalidone|chlorthalidone|mesh-list
93129119|NCT03662620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93129120|NCT03662620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93129121|NCT03662620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129122|NCT03662620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129123|NCT03662620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93129124|NCT03662620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129125|NCT03662620|Vasodilator Agents|vasodilator agents|mesh-ancestor
93129126|NCT03662620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93129127|NCT03662620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93129128|NCT03662620|Diuretics|diuretics|mesh-ancestor
93129129|NCT03662620|Natriuretic Agents|natriuretic agents|mesh-ancestor
93129130|NCT03662620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93129131|NCT03415178|Atorvastatin|atorvastatin|mesh-list
93129132|NCT03415178|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93129133|NCT03415178|Alirocumab|alirocumab|mesh-list
93129134|NCT03415178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93129135|NCT03415178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129136|NCT03415178|Antimetabolites|antimetabolites|mesh-ancestor
93129137|NCT03415178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129138|NCT03415178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129139|NCT03415178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93129140|NCT03415178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129141|NCT03415178|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93129142|NCT03415178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93129143|NCT03415178|Protease Inhibitors|protease inhibitors|mesh-ancestor
92801332|NCT02860962|Dextromethorphan|dextromethorphan|mesh-list
93129144|NCT01068730|Metformin|metformin|mesh-list
93129145|NCT01068730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129146|NCT01068730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129147|NCT01068652|Insulin|insulin|mesh-list
93129148|NCT01068652|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93129149|NCT01068652|Metformin|metformin|mesh-list
93129150|NCT01068652|Insulin Aspart|insulin aspart|mesh-list
93129151|NCT01068652|Insulin, Long-Acting|insulin, long-acting|mesh-list
93129152|NCT01068652|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93129153|NCT01068652|Insulin Detemir|insulin detemir|mesh-list
93129154|NCT01068652|Biphasic Insulins|biphasic insulins|mesh-list
93129155|NCT01068652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93129156|NCT01068652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129157|NCT01068652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129158|NCT03658720|Ibuprofen|ibuprofen|mesh-list
93129159|NCT03658720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93129160|NCT03658720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93129161|NCT03658720|Analgesics|analgesics|mesh-ancestor
93129162|NCT03658720|Sensory System Agents|sensory system agents|mesh-ancestor
93129163|NCT03658720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129164|NCT03658720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129165|NCT03658720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93129166|NCT03658720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129167|NCT03658720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93129168|NCT03658720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129169|NCT03658720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129170|NCT03658408|4-Aminopyridine|4-aminopyridine|mesh-list
93129171|NCT03658408|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93129172|NCT03658408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129173|NCT03658408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129174|NCT03658330|Naltrexone|naltrexone|mesh-list
93129175|NCT03658330|Ketamine|ketamine|mesh-list
93129176|NCT03658330|Analgesics|analgesics|mesh-ancestor
93129177|NCT03658330|Sensory System Agents|sensory system agents|mesh-ancestor
93129178|NCT03658330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129179|NCT03658330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129180|NCT03658330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93129181|NCT03658330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93129182|NCT03658330|Anesthetics, General|anesthetics, general|mesh-ancestor
93129183|NCT03658330|Anesthetics|anesthetics|mesh-ancestor
93129184|NCT03658330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129185|NCT03658330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93129186|NCT03658330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93129187|NCT03658330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129188|NCT03658330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129189|NCT03658330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93129190|NCT03658330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93129191|NCT02920528|Ketamine|ketamine|mesh-list
93129192|NCT02920528|Analgesics|analgesics|mesh-ancestor
93129193|NCT02920528|Sensory System Agents|sensory system agents|mesh-ancestor
93129194|NCT02920528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129195|NCT02920528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129196|NCT02920528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93129197|NCT02920528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93129198|NCT02920528|Anesthetics, General|anesthetics, general|mesh-ancestor
93129199|NCT02920528|Anesthetics|anesthetics|mesh-ancestor
93129200|NCT02920528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129201|NCT02920528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93129202|NCT02920528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93129203|NCT02920528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129204|NCT02920528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129205|NCT01068418|Vitamin D|vitamin d|mesh-list
93129206|NCT01068418|Cholecalciferol|cholecalciferol|mesh-list
93129207|NCT01068418|Vitamins|vitamins|mesh-ancestor
93129208|NCT01068418|Micronutrients|micronutrients|mesh-ancestor
93129209|NCT01068418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129210|NCT01068418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93129211|NCT01068418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93129212|NCT01100619|Rosiglitazone|rosiglitazone|mesh-list
93129213|NCT01100619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129214|NCT01100619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129215|NCT03657550|Niacin|niacin|mesh-list
93129216|NCT03657550|Amlodipine|amlodipine|mesh-list
93129217|NCT03657550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93129218|NCT03657550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93129219|NCT03657550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129220|NCT03657550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129221|NCT03657550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93129222|NCT03657550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129223|NCT03657550|Vasodilator Agents|vasodilator agents|mesh-ancestor
93129224|NCT03657550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129225|NCT03657550|Antimetabolites|antimetabolites|mesh-ancestor
93129226|NCT03657550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129227|NCT03657550|Vitamin B Complex|vitamin b complex|mesh-ancestor
93129228|NCT03657550|Vitamins|vitamins|mesh-ancestor
93129229|NCT03657550|Micronutrients|micronutrients|mesh-ancestor
93129230|NCT02920450|Paclitaxel|paclitaxel|mesh-list
93129231|NCT02920450|Carboplatin|carboplatin|mesh-list
93129232|NCT02920450|Gedatolisib|gedatolisib|mesh-list
93129233|NCT02920450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93129234|NCT02920450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129235|NCT02920450|Tubulin Modulators|tubulin modulators|mesh-ancestor
93129236|NCT02920450|Antimitotic Agents|antimitotic agents|mesh-ancestor
93129237|NCT02920450|Mitosis Modulators|mitosis modulators|mesh-ancestor
93129238|NCT02920450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129239|NCT02920450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93129240|NCT02920450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129241|NCT03622450|Ciprofloxacin|ciprofloxacin|mesh-list
93129242|NCT03622450|Levofloxacin|levofloxacin|mesh-list
93129243|NCT03622450|Gentamicins|gentamicins|mesh-list
93129244|NCT03622450|Meropenem|meropenem|mesh-list
93129245|NCT03622450|Amikacin|amikacin|mesh-list
93129246|NCT03622450|Colistin|colistin|mesh-list
93129247|NCT03622450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93129248|NCT03622450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129249|NCT03622450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93129250|NCT03622450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93129251|NCT03622450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129252|NCT03622450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129253|NCT03622450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129254|NCT03622450|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93129255|NCT03622450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93129256|NCT03622450|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93129257|NCT03622450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93129258|NCT03657862|Fluorides|fluorides|mesh-list
93129259|NCT03657862|Cariostatic Agents|cariostatic agents|mesh-ancestor
93129260|NCT03657862|Protective Agents|protective agents|mesh-ancestor
93129261|NCT03657862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129262|NCT02730130|Pembrolizumab|pembrolizumab|mesh-list
93129263|NCT02730130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129264|NCT02730130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129265|NCT02730130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93129266|NCT02730130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129267|NCT02919436|Tamsulosin|tamsulosin|mesh-list
93129268|NCT02919436|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93129269|NCT02919436|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93129270|NCT02919436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93129271|NCT02919436|Adrenergic Agents|adrenergic agents|mesh-ancestor
93129272|NCT02919436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129273|NCT02919436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129274|NCT02919436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129275|NCT02919436|Urological Agents|urological agents|mesh-ancestor
93129276|NCT03657472|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
93129277|NCT03657472|Atorvastatin|atorvastatin|mesh-list
93129278|NCT03657472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93129279|NCT03657472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129280|NCT03657472|Antimetabolites|antimetabolites|mesh-ancestor
93129281|NCT03657472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129282|NCT03657472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129283|NCT03657472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93129284|NCT03657472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129285|NCT03657472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93129286|NCT04440358|Carboplatin|carboplatin|mesh-list
93129287|NCT04440358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129288|NCT04438330|Nickel|nickel|mesh-list
93129289|NCT04438330|Trace Elements|trace elements|mesh-ancestor
93129290|NCT04438330|Micronutrients|micronutrients|mesh-ancestor
93129291|NCT04438330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129292|NCT03803475|Edetic Acid|edetic acid|mesh-list
93129293|NCT03803475|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92446539|NCT01669226|Taxane|taxane|mesh-list
93129294|NCT03803475|Chelating Agents|chelating agents|mesh-ancestor
93129295|NCT03803475|Sequestering Agents|sequestering agents|mesh-ancestor
93129296|NCT03803475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129297|NCT03803475|Anticoagulants|anticoagulants|mesh-ancestor
93129298|NCT03803475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93129299|NCT03803475|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93129300|NCT02682004|Serotonin|serotonin|mesh-list
93129301|NCT02682004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93129302|NCT02682004|Serotonin Agents|serotonin agents|mesh-ancestor
93129303|NCT02682004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129304|NCT02682004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129305|NCT02682004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129306|NCT00005937|Cyclosporine|cyclosporine|mesh-list
93129307|NCT00005937|Cyclosporins|cyclosporins|mesh-list
93129308|NCT00005937|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93129309|NCT00005937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129310|NCT00005937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129311|NCT00005937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129312|NCT00005937|Immunologic Factors|immunologic factors|mesh-ancestor
93129313|NCT00005937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129314|NCT00005937|Antifungal Agents|antifungal agents|mesh-ancestor
93129315|NCT00005937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129316|NCT00005937|Dermatologic Agents|dermatologic agents|mesh-ancestor
93129317|NCT00005937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129318|NCT00005937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93129319|NCT01096329|Methyltestosterone|methyltestosterone|mesh-list
93129320|NCT01096329|Testosterone|testosterone|mesh-list
93129321|NCT01096329|Testosterone undecanoate|testosterone undecanoate|mesh-list
93129322|NCT01096329|Testosterone enanthate|testosterone enanthate|mesh-list
93129323|NCT01096329|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93129324|NCT01096329|Androgens|androgens|mesh-ancestor
93129325|NCT01096329|Hormones|hormones|mesh-ancestor
93129326|NCT01096329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129327|NCT01096329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129328|NCT01096329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93129329|NCT01096329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129330|NCT01096329|Anabolic Agents|anabolic agents|mesh-ancestor
93129331|NCT02908516|Tranexamic Acid|tranexamic acid|mesh-list
93129332|NCT02908516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93129333|NCT02908516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93129334|NCT02908516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129335|NCT02908516|Hemostatics|hemostatics|mesh-ancestor
93129336|NCT02908516|Coagulants|coagulants|mesh-ancestor
93129337|NCT03717350|Meropenem|meropenem|mesh-list
93129338|NCT03717350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93129339|NCT03717350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129340|NCT03713372|Antibodies|antibodies|mesh-list
93129341|NCT03713372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93129342|NCT03713372|Immunologic Factors|immunologic factors|mesh-ancestor
93129343|NCT03713372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129344|NCT03656614|Neostigmine|neostigmine|mesh-list
93129345|NCT03656614|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93129346|NCT03656614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129347|NCT03656614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129348|NCT03656614|Cholinergic Agents|cholinergic agents|mesh-ancestor
93129349|NCT03656614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129350|NCT03656614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129351|NCT03656614|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93129352|NCT03656614|Autonomic Agents|autonomic agents|mesh-ancestor
93129353|NCT03656614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129354|NCT02906644|Nicotine|nicotine|mesh-list
93129355|NCT02906644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93129356|NCT02906644|Autonomic Agents|autonomic agents|mesh-ancestor
93129357|NCT02906644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129358|NCT02906644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129359|NCT02906644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93129360|NCT02906644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93129361|NCT02906644|Cholinergic Agents|cholinergic agents|mesh-ancestor
93129362|NCT02906644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129363|NCT02906644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129364|NCT02982772|Nicotine|nicotine|mesh-list
93129365|NCT02982772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93129366|NCT02982772|Autonomic Agents|autonomic agents|mesh-ancestor
93129367|NCT02982772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129368|NCT02982772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129369|NCT02982772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93129370|NCT02982772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93129371|NCT02982772|Cholinergic Agents|cholinergic agents|mesh-ancestor
93129372|NCT02982772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129373|NCT02982772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129375|NCT03713216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93129376|NCT03713216|Narcotics|narcotics|mesh-ancestor
93129377|NCT03713216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129378|NCT03713216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129379|NCT03713216|Analgesics|analgesics|mesh-ancestor
93129380|NCT03713216|Sensory System Agents|sensory system agents|mesh-ancestor
93129381|NCT03713216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129382|NCT02098954|Gemcitabine|gemcitabine|mesh-list
93129383|NCT02098954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93129384|NCT02098954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93129385|NCT02098954|Antimetabolites|antimetabolites|mesh-ancestor
93129386|NCT02098954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129387|NCT02098954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129388|NCT02098954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93129389|NCT02098954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129390|NCT03655834|Pemetrexed|pemetrexed|mesh-list
93129391|NCT03655834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129392|NCT03655834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129393|NCT03655834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129394|NCT03655834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93129395|NCT03655834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93129396|NCT03488108|Minoxidil|minoxidil|mesh-list
93129397|NCT03488108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93129398|NCT03488108|Vasodilator Agents|vasodilator agents|mesh-ancestor
93129399|NCT03712670|Pyranoprofen|pyranoprofen|mesh-list
93129400|NCT03712670|Aflibercept|aflibercept|mesh-list
93129401|NCT03712670|Carotenoids|carotenoids|mesh-list
93129402|NCT03712670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93129403|NCT03712670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93129404|NCT03712670|Growth Substances|growth substances|mesh-ancestor
93129405|NCT03712670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129406|NCT03712670|Growth Inhibitors|growth inhibitors|mesh-ancestor
93129407|NCT03712670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129408|NCT03712670|Antioxidants|antioxidants|mesh-ancestor
93129409|NCT03712670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129410|NCT03712670|Protective Agents|protective agents|mesh-ancestor
93129411|NCT03712670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93129412|NCT03712670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93129413|NCT03712670|Analgesics|analgesics|mesh-ancestor
93129414|NCT03712670|Sensory System Agents|sensory system agents|mesh-ancestor
93129415|NCT03712670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129416|NCT03712670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93129417|NCT03712670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129418|NCT03712670|Gout Suppressants|gout suppressants|mesh-ancestor
93129419|NCT03440918|Anti-Infective Agents|anti-infective agents|mesh-list
93129420|NCT03440918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93129421|NCT03486392|Liraglutide|liraglutide|mesh-list
93129422|NCT03486392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129423|NCT03486392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129424|NCT03486392|Incretins|incretins|mesh-ancestor
93129425|NCT03486392|Hormones|hormones|mesh-ancestor
93129426|NCT03486392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129427|NCT02981524|Cyclophosphamide|cyclophosphamide|mesh-list
93129428|NCT02981524|Pembrolizumab|pembrolizumab|mesh-list
93129429|NCT02981524|Immunologic Factors|immunologic factors|mesh-ancestor
93129430|NCT02981524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129431|NCT02981524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129432|NCT02981524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129433|NCT02981524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93129434|NCT02981524|Alkylating Agents|alkylating agents|mesh-ancestor
93129435|NCT02981524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129436|NCT02981524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129437|NCT02981524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93129438|NCT02981524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129439|NCT02981524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93129440|NCT04297150|Rivaroxaban|rivaroxaban|mesh-list
93129441|NCT04297150|Apixaban|apixaban|mesh-list
93129442|NCT04297150|Edoxaban|edoxaban|mesh-list
93129443|NCT04297150|Dabigatran|dabigatran|mesh-list
93129444|NCT04297150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93129445|NCT04297150|Antithrombins|antithrombins|mesh-ancestor
93129446|NCT04297150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93129447|NCT04297150|Protease Inhibitors|protease inhibitors|mesh-ancestor
93129448|NCT04297150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129449|NCT04297150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129450|NCT04297150|Anticoagulants|anticoagulants|mesh-ancestor
93129451|NCT03486314|Rifampin|rifampin|mesh-list
93129452|NCT03486314|Paclitaxel|paclitaxel|mesh-list
93129453|NCT03486314|Docetaxel|docetaxel|mesh-list
93129454|NCT03486314|Carboplatin|carboplatin|mesh-list
93129455|NCT03486314|Pevonedistat|pevonedistat|mesh-list
93129456|NCT03486314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93129457|NCT03486314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129458|NCT03486314|Tubulin Modulators|tubulin modulators|mesh-ancestor
93129459|NCT03486314|Antimitotic Agents|antimitotic agents|mesh-ancestor
93129460|NCT03486314|Mitosis Modulators|mitosis modulators|mesh-ancestor
93129461|NCT03486314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129462|NCT03486314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93129463|NCT03486314|Antitubercular Agents|antitubercular agents|mesh-ancestor
93129464|NCT03486314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93129465|NCT03486314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129466|NCT03486314|Leprostatic Agents|leprostatic agents|mesh-ancestor
93129467|NCT03486314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93129468|NCT03486314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129469|NCT03486314|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93129470|NCT03486314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93129471|NCT03486314|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93129472|NCT03486314|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93129473|NCT03486314|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93129474|NCT03486314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93129475|NCT02975206|Serlopitant|serlopitant|mesh-list
93129476|NCT02975206|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93129477|NCT02975206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129478|NCT02975206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129479|NCT02975206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129480|NCT03654820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93129481|NCT01066156|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93129482|NCT01066156|Antidepressive Agents|antidepressive agents|mesh-ancestor
93129483|NCT01066156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93129484|NCT01066156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93129485|NCT01066156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93129486|NCT01066156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129487|NCT01066156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129488|NCT02980042|Rituximab|rituximab|mesh-list
93129489|NCT02980042|Ocrelizumab|ocrelizumab|mesh-list
93129490|NCT02980042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129491|NCT02980042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129492|NCT02980042|Immunologic Factors|immunologic factors|mesh-ancestor
93129493|NCT02980042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129494|NCT02980042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129495|NCT01066000|Epoetin Alfa|epoetin alfa|mesh-list
93129496|NCT01066000|Hematinics|hematinics|mesh-ancestor
93129497|NCT01065844|Nelfinavir|nelfinavir|mesh-list
93129498|NCT01065844|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93129499|NCT01065844|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93129500|NCT01065844|Protease Inhibitors|protease inhibitors|mesh-ancestor
93129501|NCT01065844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129502|NCT01065844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129503|NCT01065844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93129504|NCT01065844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93129505|NCT01065844|Antiviral Agents|antiviral agents|mesh-ancestor
93129506|NCT01065844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129507|NCT00004635|Thalidomide|thalidomide|mesh-list
93129508|NCT00004635|Leuprolide|leuprolide|mesh-list
93129509|NCT00004635|Goserelin|goserelin|mesh-list
93129510|NCT00004635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129511|NCT00004635|Immunologic Factors|immunologic factors|mesh-ancestor
93129512|NCT00004635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129513|NCT00004635|Leprostatic Agents|leprostatic agents|mesh-ancestor
93129514|NCT00004635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93129515|NCT00004635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129516|NCT00004635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93129517|NCT00004635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93129518|NCT00004635|Growth Substances|growth substances|mesh-ancestor
93129519|NCT00004635|Growth Inhibitors|growth inhibitors|mesh-ancestor
93129520|NCT00004635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129521|NCT00004635|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93129523|NCT00004635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93129524|NCT00004635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93129525|NCT00004563|Cyclophosphamide|cyclophosphamide|mesh-list
93129526|NCT00004563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129527|NCT00004563|Immunologic Factors|immunologic factors|mesh-ancestor
93129528|NCT00004563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129529|NCT00004563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129530|NCT00004563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93129531|NCT00004563|Alkylating Agents|alkylating agents|mesh-ancestor
93129532|NCT00004563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129533|NCT00004563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129534|NCT00004563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93129535|NCT03951051|Olmesartan|olmesartan|mesh-list
93129536|NCT03951051|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93129537|NCT03951051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93129538|NCT03951051|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93129539|NCT03951051|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93129540|NCT03951051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129541|NCT01103115|Calcium, Dietary|calcium, dietary|mesh-list
93129542|NCT01103115|Vitamin D|vitamin d|mesh-list
93129543|NCT01103115|Calcium Carbonate|calcium carbonate|mesh-list
93129544|NCT01103115|Calcium|calcium|mesh-list
93129545|NCT01103115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93129546|NCT01103115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129547|NCT01103115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93129548|NCT01103115|Vitamins|vitamins|mesh-ancestor
93129549|NCT01103115|Micronutrients|micronutrients|mesh-ancestor
93129550|NCT01103115|Antacids|antacids|mesh-ancestor
93129551|NCT01103115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129552|NCT01103115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93129553|NCT01103193|Remifentanil|remifentanil|mesh-list
93129554|NCT01103193|Sevoflurane|sevoflurane|mesh-list
93129555|NCT01103193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93129556|NCT01103193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93129557|NCT01103193|Anesthetics, General|anesthetics, general|mesh-ancestor
93129558|NCT01103193|Anesthetics|anesthetics|mesh-ancestor
91931386|NCT04868409|Succinylcholine|succinylcholine|mesh-list
93129559|NCT01103193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129560|NCT01103193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129561|NCT01103193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93129562|NCT01103193|Narcotics|narcotics|mesh-ancestor
93129563|NCT01103193|Analgesics|analgesics|mesh-ancestor
93129564|NCT01103193|Sensory System Agents|sensory system agents|mesh-ancestor
93129565|NCT01103193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129566|NCT03949101|Atropine|atropine|mesh-list
93129567|NCT03949101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93129568|NCT03949101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93129569|NCT03949101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93129570|NCT03949101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93129571|NCT03949101|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93129572|NCT03949101|Autonomic Agents|autonomic agents|mesh-ancestor
93129573|NCT03949101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129574|NCT03949101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129575|NCT03949101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93129576|NCT03949101|Respiratory System Agents|respiratory system agents|mesh-ancestor
93129577|NCT03949101|Mydriatics|mydriatics|mesh-ancestor
93129578|NCT03949101|Parasympatholytics|parasympatholytics|mesh-ancestor
93129579|NCT03949101|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93129580|NCT03949101|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93129581|NCT03949101|Cholinergic Agents|cholinergic agents|mesh-ancestor
93129582|NCT03949101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129583|NCT03949101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129584|NCT01096485|Levonorgestrel|levonorgestrel|mesh-list
93129585|NCT01096485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93129586|NCT01096485|Contraceptive Agents|contraceptive agents|mesh-ancestor
93129587|NCT01096485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93129588|NCT01096485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129589|NCT01096485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93129590|NCT01096485|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93129591|NCT01096485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93129592|NCT00003645|Leuprolide|leuprolide|mesh-list
93129593|NCT00003645|Goserelin|goserelin|mesh-list
93129594|NCT00003645|Flutamide|flutamide|mesh-list
93129595|NCT00003645|Bicalutamide|bicalutamide|mesh-list
93129596|NCT00003645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93129597|NCT00003645|Fertility Agents|fertility agents|mesh-ancestor
93129598|NCT00003645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93129599|NCT00003645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129600|NCT00003645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93129601|NCT00003645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129602|NCT00003645|Androgen Antagonists|androgen antagonists|mesh-ancestor
93129603|NCT00003645|Hormone Antagonists|hormone antagonists|mesh-ancestor
93129604|NCT00003645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129605|NCT02918968|Flutamide|flutamide|mesh-list
93129606|NCT02918968|Androgens|androgens|mesh-list
93129607|NCT02918968|Hormones|hormones|mesh-ancestor
93129608|NCT02918968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129609|NCT02918968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129610|NCT02918968|Androgen Antagonists|androgen antagonists|mesh-ancestor
93129611|NCT02918968|Hormone Antagonists|hormone antagonists|mesh-ancestor
93129612|NCT02918968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93129613|NCT02918968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129614|NCT01065766|Metformin|metformin|mesh-list
93129615|NCT01065766|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93129616|NCT01065766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129617|NCT01065766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129618|NCT01065766|Incretins|incretins|mesh-ancestor
93129619|NCT01065766|Hormones|hormones|mesh-ancestor
93129620|NCT01065766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129621|NCT01065766|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93129622|NCT01065766|Protease Inhibitors|protease inhibitors|mesh-ancestor
93129623|NCT01065766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129624|NCT01065766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129625|NCT03653260|Lidocaine|lidocaine|mesh-list
93129626|NCT03653260|Anesthetics, Local|anesthetics, local|mesh-ancestor
93129627|NCT03653260|Anesthetics|anesthetics|mesh-ancestor
93129628|NCT03653260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129629|NCT03653260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129630|NCT03653260|Sensory System Agents|sensory system agents|mesh-ancestor
93129631|NCT03653260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129632|NCT03653260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93129633|NCT03653260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93129634|NCT03653260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93129635|NCT03653260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129636|NCT03653260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129637|NCT03652792|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93129638|NCT03652792|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93129639|NCT03652792|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93129640|NCT03652792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129641|NCT04054960|Levodopa|levodopa|mesh-list
93129642|NCT04054960|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93129643|NCT04054960|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93129644|NCT04054960|Dopamine Agents|dopamine agents|mesh-ancestor
93129645|NCT04054960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129646|NCT04054960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129647|NCT04054960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129648|NCT04055194|Tranexamic Acid|tranexamic acid|mesh-list
93129649|NCT04055194|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93129650|NCT04055194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93129651|NCT04055194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129652|NCT04055194|Hemostatics|hemostatics|mesh-ancestor
93129653|NCT04055194|Coagulants|coagulants|mesh-ancestor
93129654|NCT01103583|Hydroxyurea|hydroxyurea|mesh-list
93129655|NCT01103583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129656|NCT01103583|Antisickling Agents|antisickling agents|mesh-ancestor
93129657|NCT01103583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129658|NCT01103583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129659|NCT01103583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93129660|NCT02530047|Interferons|interferons|mesh-list
93129661|NCT02530047|Interferon-beta|interferon-beta|mesh-list
93129662|NCT02530047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129663|NCT02530047|Antiviral Agents|antiviral agents|mesh-ancestor
93129664|NCT02530047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129665|NCT02530047|Immunologic Factors|immunologic factors|mesh-ancestor
93129666|NCT02530047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129667|NCT02529969|Curcumin|curcumin|mesh-list
93129668|NCT02529969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93129669|NCT02529969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93129670|NCT02529969|Analgesics|analgesics|mesh-ancestor
93129671|NCT02529969|Sensory System Agents|sensory system agents|mesh-ancestor
93129672|NCT02529969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129673|NCT02529969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129674|NCT02529969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93129675|NCT02529969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129676|NCT02529969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129677|NCT02529969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129678|NCT02529969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129679|NCT01584687|Omalizumab|omalizumab|mesh-list
93129680|NCT01584687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93129681|NCT01584687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93129682|NCT01584687|Respiratory System Agents|respiratory system agents|mesh-ancestor
93129683|NCT01101789|Triclosan|triclosan|mesh-list
93129684|NCT01101789|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93129685|NCT01101789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129686|NCT01101789|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93129687|NCT01101789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129688|NCT01101789|Antimetabolites|antimetabolites|mesh-ancestor
93129689|NCT01101789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129690|NCT01101789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129691|NCT04185220|Mogamulizumab|mogamulizumab|mesh-list
93129692|NCT04185220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129693|NCT01103739|Simvastatin|simvastatin|mesh-list
93129694|NCT01103739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93129695|NCT01103739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129696|NCT01103739|Antimetabolites|antimetabolites|mesh-ancestor
93129697|NCT01103739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129698|NCT01103739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129699|NCT01103739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93129700|NCT01103739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129701|NCT04054024|Erenumab|erenumab|mesh-list
93129702|NCT04054024|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93129703|NCT04054024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129704|NCT04054024|Analgesics|analgesics|mesh-ancestor
93129705|NCT04054024|Sensory System Agents|sensory system agents|mesh-ancestor
93129706|NCT04054024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129707|NCT04054024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129708|NCT00002931|Paclitaxel|paclitaxel|mesh-list
93129709|NCT00002931|Etoposide|etoposide|mesh-list
93129710|NCT00002931|Carboplatin|carboplatin|mesh-list
93129711|NCT00002931|Ifosfamide|ifosfamide|mesh-list
93129712|NCT00002931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93129713|NCT00002931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129714|NCT00002931|Tubulin Modulators|tubulin modulators|mesh-ancestor
93129715|NCT00002931|Antimitotic Agents|antimitotic agents|mesh-ancestor
93129716|NCT00002931|Mitosis Modulators|mitosis modulators|mesh-ancestor
93129717|NCT00002931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129718|NCT00002931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93129719|NCT00002931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93129720|NCT00002931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129721|NCT00002931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93129722|NCT00002931|Alkylating Agents|alkylating agents|mesh-ancestor
93129723|NCT02918266|Scopolamine|scopolamine|mesh-list
93129724|NCT02918266|Donepezil|donepezil|mesh-list
93129725|NCT02918266|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93129726|NCT02918266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93129727|NCT02918266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129728|NCT02918266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129729|NCT02918266|Cholinergic Agents|cholinergic agents|mesh-ancestor
93129730|NCT02918266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129731|NCT02918266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129732|NCT02918266|Nootropic Agents|nootropic agents|mesh-ancestor
93129733|NCT02918266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93129734|NCT02918266|Antiemetics|antiemetics|mesh-ancestor
93129735|NCT02918266|Autonomic Agents|autonomic agents|mesh-ancestor
93129736|NCT02918266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129737|NCT02918266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93129738|NCT02918266|Mydriatics|mydriatics|mesh-ancestor
93129739|NCT02918266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93129740|NCT02918266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93129741|NCT02918266|Parasympatholytics|parasympatholytics|mesh-ancestor
93129742|NCT00041067|Docetaxel|docetaxel|mesh-list
92801924|NCT01076543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129743|NCT00041067|Trastuzumab|trastuzumab|mesh-list
93129744|NCT00041067|Vinorelbine|vinorelbine|mesh-list
93129745|NCT00041067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129746|NCT00041067|Tubulin Modulators|tubulin modulators|mesh-ancestor
93129747|NCT00041067|Antimitotic Agents|antimitotic agents|mesh-ancestor
93129748|NCT00041067|Mitosis Modulators|mitosis modulators|mesh-ancestor
93129749|NCT00041067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129750|NCT00041067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129751|NCT00041067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93129753|NCT01063036|Entecavir|entecavir|mesh-list
93129754|NCT01063036|Antiviral Agents|antiviral agents|mesh-ancestor
93129755|NCT01063036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129756|NCT01063036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93129757|NCT01063036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93129758|NCT01063036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129759|NCT01063036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129760|NCT01063036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93129761|NCT01063036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93129762|NCT03652480|Methylprednisolone|methylprednisolone|mesh-list
93129763|NCT03652480|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93129764|NCT03652480|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93129765|NCT03652480|Prednisolone|prednisolone|mesh-list
93129766|NCT03652480|Prednisolone acetate|prednisolone acetate|mesh-list
93129767|NCT03652480|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93129768|NCT03652480|Prednisolone phosphate|prednisolone phosphate|mesh-list
93129769|NCT03652480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93129770|NCT03652480|Antiemetics|antiemetics|mesh-ancestor
93129771|NCT03652480|Autonomic Agents|autonomic agents|mesh-ancestor
93129772|NCT03652480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129773|NCT03652480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129774|NCT03652480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93129775|NCT03652480|Glucocorticoids|glucocorticoids|mesh-ancestor
93129776|NCT03652480|Hormones|hormones|mesh-ancestor
93129777|NCT03652480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129778|NCT03652480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93129779|NCT03652480|Protective Agents|protective agents|mesh-ancestor
93129780|NCT03652480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93129781|NCT03652480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129782|NCT03622060|Nicardipine|nicardipine|mesh-list
93129783|NCT03622060|Nitroglycerin|nitroglycerin|mesh-list
93129784|NCT03622060|Vasodilator Agents|vasodilator agents|mesh-ancestor
93129785|NCT03622060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93129786|NCT03622060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93129787|NCT03622060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129788|NCT03622060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129789|NCT03622060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93129790|NCT03622060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129791|NCT00040365|Amifostine|amifostine|mesh-list
93129792|NCT00040365|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93129793|NCT00040365|Protective Agents|protective agents|mesh-ancestor
93129794|NCT00040365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129795|NCT02974114|Acetaminophen|acetaminophen|mesh-list
93129796|NCT02974114|Caffeine|caffeine|mesh-list
93129797|NCT02974114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93129798|NCT02974114|Analgesics|analgesics|mesh-ancestor
93129799|NCT02974114|Sensory System Agents|sensory system agents|mesh-ancestor
93129800|NCT02974114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129801|NCT02974114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129802|NCT02974114|Antipyretics|antipyretics|mesh-ancestor
93129803|NCT02974114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93129804|NCT02974114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93129805|NCT02974114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129806|NCT02974114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129807|NCT02974114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93129808|NCT02974114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93129809|NCT02974114|Purinergic Agents|purinergic agents|mesh-ancestor
93129810|NCT02974114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129811|NCT00001959|Pirfenidone|pirfenidone|mesh-list
93129812|NCT00001959|Analgesics|analgesics|mesh-ancestor
93129813|NCT00001959|Sensory System Agents|sensory system agents|mesh-ancestor
93129814|NCT00001959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129815|NCT00001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129816|NCT00001959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93129817|NCT00001959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93129818|NCT00001959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93129819|NCT00001959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93129820|NCT00001959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129821|NCT03950505|Pioglitazone|pioglitazone|mesh-list
93129822|NCT03950505|Alogliptin|alogliptin|mesh-list
93129823|NCT03950505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129824|NCT03950505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129825|NCT03950505|Incretins|incretins|mesh-ancestor
93129826|NCT03950505|Hormones|hormones|mesh-ancestor
93129827|NCT03950505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93129828|NCT03950505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93129829|NCT03950505|Protease Inhibitors|protease inhibitors|mesh-ancestor
93129830|NCT03950505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129831|NCT03950505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129832|NCT00001941|Daclizumab|daclizumab|mesh-list
93129833|NCT00001941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129834|NCT00001941|Immunologic Factors|immunologic factors|mesh-ancestor
93129835|NCT00001941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129836|NCT01061866|Thalidomide|thalidomide|mesh-list
93129837|NCT01061866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129838|NCT01061866|Immunologic Factors|immunologic factors|mesh-ancestor
93129839|NCT01061866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129840|NCT01061866|Leprostatic Agents|leprostatic agents|mesh-ancestor
93129841|NCT01061866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93129842|NCT01061866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129843|NCT01061866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93129844|NCT01061866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93129845|NCT01061866|Growth Substances|growth substances|mesh-ancestor
93129846|NCT01061866|Growth Inhibitors|growth inhibitors|mesh-ancestor
93129847|NCT01061866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129848|NCT03652714|Anesthetics|anesthetics|mesh-list
93129849|NCT03652714|Anesthetics, Local|anesthetics, local|mesh-list
93129850|NCT03652714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129851|NCT03652714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129852|NCT03652714|Sensory System Agents|sensory system agents|mesh-ancestor
93129853|NCT03652714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129854|NCT03948477|Pantoprazole|pantoprazole|mesh-list
93129855|NCT03948477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93129856|NCT03948477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93129857|NCT03948477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93129858|NCT03948477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129859|NCT03948477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129860|NCT03953781|Levetiracetam|levetiracetam|mesh-list
93129861|NCT03953781|Anticonvulsants|anticonvulsants|mesh-ancestor
93129862|NCT03953781|Nootropic Agents|nootropic agents|mesh-ancestor
93129863|NCT01103817|Vitamin D|vitamin d|mesh-list
93129864|NCT01103817|Vitamins|vitamins|mesh-ancestor
93129865|NCT01103817|Micronutrients|micronutrients|mesh-ancestor
93129866|NCT01103817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129867|NCT01103817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93129868|NCT01102101|Remifentanil|remifentanil|mesh-list
93129869|NCT01102101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93129870|NCT01102101|Narcotics|narcotics|mesh-ancestor
93129871|NCT01102101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129872|NCT01102101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129873|NCT01102101|Analgesics|analgesics|mesh-ancestor
93129874|NCT01102101|Sensory System Agents|sensory system agents|mesh-ancestor
93129875|NCT01102101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129876|NCT03950271|Capecitabine|capecitabine|mesh-list
93129877|NCT03950271|Oxaliplatin|oxaliplatin|mesh-list
93129878|NCT03950271|Trastuzumab|trastuzumab|mesh-list
93129879|NCT03950271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93129880|NCT03950271|Antimetabolites|antimetabolites|mesh-ancestor
93129881|NCT03950271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129882|NCT03950271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129883|NCT03950271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129884|NCT01102335|Telbivudine|telbivudine|mesh-list
93129885|NCT01102335|Antiviral Agents|antiviral agents|mesh-ancestor
93129886|NCT01102335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129887|NCT01102335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93129888|NCT01102335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129889|NCT01102335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129890|NCT02973100|Dulaglutide|dulaglutide|mesh-list
93129891|NCT02973100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129892|NCT02973100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129893|NCT01105611|Ritonavir|ritonavir|mesh-list
93129894|NCT01105611|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93129895|NCT01105611|Raltegravir Potassium|raltegravir potassium|mesh-list
93129896|NCT01105611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93129897|NCT01105611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93129898|NCT01105611|Protease Inhibitors|protease inhibitors|mesh-ancestor
93129899|NCT01105611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129900|NCT01105611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129901|NCT01105611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93129902|NCT01105611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93129903|NCT01105611|Antiviral Agents|antiviral agents|mesh-ancestor
93129904|NCT01105611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93129905|NCT01105611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93129906|NCT01105611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93129907|NCT01105611|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93129908|NCT01105611|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93129909|NCT05497557|Sotorasib|sotorasib|mesh-list
93129910|NCT05497557|Omeprazole|omeprazole|mesh-list
93129911|NCT05497557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93129912|NCT05497557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93129913|NCT05497557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93129914|NCT05497557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129915|NCT05497557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129916|NCT05497557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93129917|NCT05497557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129918|NCT05497557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129919|NCT03948321|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93129920|NCT03948321|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93129921|NCT03948321|Dermatologic Agents|dermatologic agents|mesh-ancestor
93129922|NCT05415267|Vaccines|vaccines|mesh-list
93129923|NCT05415267|Immunologic Factors|immunologic factors|mesh-ancestor
93129924|NCT05415267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129925|NCT01482286|Metformin|metformin|mesh-list
93129926|NCT01482286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93129927|NCT01482286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129928|NCT03651934|Iron|iron|mesh-list
93129929|NCT03651934|Selenium|selenium|mesh-list
93129930|NCT03651934|Trace Elements|trace elements|mesh-ancestor
93129931|NCT03651934|Micronutrients|micronutrients|mesh-ancestor
93129932|NCT03651934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129933|NCT03651934|Antioxidants|antioxidants|mesh-ancestor
91931542|NCT04059484|Fulvestrant|fulvestrant|mesh-list
93129934|NCT03651934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129935|NCT03651934|Protective Agents|protective agents|mesh-ancestor
93129936|NCT02972632|Vortioxetine|vortioxetine|mesh-list
93129937|NCT02972632|Antidepressive Agents|antidepressive agents|mesh-ancestor
93129938|NCT02972632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93129939|NCT02972632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93129940|NCT02972632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93129941|NCT02972632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129942|NCT02972632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129943|NCT02972632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93129944|NCT02972632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93129945|NCT02972632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93129946|NCT02972632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129947|NCT02972632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93129948|NCT02972632|Serotonin Agents|serotonin agents|mesh-ancestor
93129949|NCT02972632|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93129950|NCT02972632|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93129951|NCT02972632|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93129952|NCT02972632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93129953|NCT01106001|Levobupivacaine|levobupivacaine|mesh-list
93129954|NCT01106001|Anesthetics, Local|anesthetics, local|mesh-ancestor
93129955|NCT01106001|Anesthetics|anesthetics|mesh-ancestor
93129956|NCT01106001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93129957|NCT01106001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129958|NCT01106001|Sensory System Agents|sensory system agents|mesh-ancestor
93129959|NCT01106001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93129960|NCT01327521|Cisplatin|cisplatin|mesh-list
93129961|NCT01327521|Gemcitabine|gemcitabine|mesh-list
93129962|NCT01327521|Doxorubicin|doxorubicin|mesh-list
93129963|NCT01327521|Fluorouracil|fluorouracil|mesh-list
93129964|NCT01327521|Epirubicin|epirubicin|mesh-list
93129965|NCT01327521|Mitomycins|mitomycins|mesh-list
93129966|NCT01327521|Mitomycin|mitomycin|mesh-list
93129967|NCT01327521|Maleic acid|maleic acid|mesh-list
93129968|NCT01327521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129969|NCT01327521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93129970|NCT01327521|Antimetabolites|antimetabolites|mesh-ancestor
93129971|NCT01327521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129972|NCT01327521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93129973|NCT01327521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93129974|NCT01327521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93129975|NCT01327521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93129976|NCT01327521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93129977|NCT01327521|Immunologic Factors|immunologic factors|mesh-ancestor
93129978|NCT01327521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129979|NCT01327521|Alkylating Agents|alkylating agents|mesh-ancestor
93129980|NCT01327521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93129981|NCT04899921|Nivolumab|nivolumab|mesh-list
93129982|NCT04899921|Ipilimumab|ipilimumab|mesh-list
93129983|NCT04899921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93129984|NCT04899921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93129985|NCT04899921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93129986|NCT04899921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129987|NCT01104519|Niacin|niacin|mesh-list
93129988|NCT01104519|Nicotinic Acids|nicotinic acids|mesh-list
93129989|NCT01104519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93129990|NCT01104519|Antimetabolites|antimetabolites|mesh-ancestor
93129991|NCT01104519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93129992|NCT01104519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93129993|NCT01104519|Vasodilator Agents|vasodilator agents|mesh-ancestor
93129994|NCT01104519|Vitamin B Complex|vitamin b complex|mesh-ancestor
93129995|NCT01104519|Vitamins|vitamins|mesh-ancestor
93129996|NCT01104519|Micronutrients|micronutrients|mesh-ancestor
93129997|NCT01104519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93129998|NCT03944733|Iron|iron|mesh-list
93129999|NCT03944733|Trace Elements|trace elements|mesh-ancestor
93130000|NCT03944733|Micronutrients|micronutrients|mesh-ancestor
93130001|NCT03944733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130002|NCT01060384|Lenalidomide|lenalidomide|mesh-list
93130003|NCT01060384|Ofatumumab|ofatumumab|mesh-list
93130004|NCT01060384|Immunologic Factors|immunologic factors|mesh-ancestor
93130005|NCT01060384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130006|NCT01060384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93130007|NCT01060384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93130008|NCT01060384|Growth Substances|growth substances|mesh-ancestor
93070184|NCT00091026|Cetuximab|cetuximab|mesh-list
93130009|NCT01060384|Growth Inhibitors|growth inhibitors|mesh-ancestor
93130010|NCT01060384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130011|NCT01060150|Methylphenidate|methylphenidate|mesh-list
93130012|NCT01060150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93130013|NCT01060150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130014|NCT01060150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93130015|NCT01060150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93130016|NCT01060150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93130017|NCT01060150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130018|NCT01060150|Dopamine Agents|dopamine agents|mesh-ancestor
93130019|NCT01060150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130020|NCT03863223|Docetaxel|docetaxel|mesh-list
93130021|NCT03863223|Trastuzumab|trastuzumab|mesh-list
93130022|NCT03863223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130023|NCT03863223|Tubulin Modulators|tubulin modulators|mesh-ancestor
93130024|NCT03863223|Antimitotic Agents|antimitotic agents|mesh-ancestor
93130025|NCT03863223|Mitosis Modulators|mitosis modulators|mesh-ancestor
93130026|NCT03863223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130027|NCT03863223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130028|NCT01104597|Nitroglycerin|nitroglycerin|mesh-list
93130029|NCT01104597|Vasodilator Agents|vasodilator agents|mesh-ancestor
93130030|NCT02970292|Pimavanserin|pimavanserin|mesh-list
93130031|NCT02970292|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93130032|NCT02970292|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93130033|NCT02970292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93130034|NCT02970292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93130035|NCT02970292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130036|NCT02970292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130037|NCT02970292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93130038|NCT02970292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93130039|NCT02970292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93130040|NCT02970292|Serotonin Agents|serotonin agents|mesh-ancestor
93130041|NCT02970292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130042|NCT02970292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130043|NCT03944655|Anesthetics|anesthetics|mesh-list
93130044|NCT03944655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130045|NCT03944655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130046|NCT05276895|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
93130047|NCT05276895|Quercetin|quercetin|mesh-list
92802223|NCT04338165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93130048|NCT05276895|Antioxidants|antioxidants|mesh-ancestor
93130049|NCT05276895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130050|NCT05276895|Protective Agents|protective agents|mesh-ancestor
93130051|NCT05276895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130052|NCT05276895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130053|NCT02971228|Insulin Lispro|insulin lispro|mesh-list
93130054|NCT02971228|Glucagon|glucagon|mesh-list
93130055|NCT02971228|Pancrelipase|pancrelipase|mesh-list
93130056|NCT02971228|Pancreatin|pancreatin|mesh-list
93130057|NCT02971228|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93130058|NCT02971228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130059|NCT02971228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130060|NCT02971228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130061|NCT02971228|Hormones|hormones|mesh-ancestor
93130062|NCT02971228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130063|NCT02971228|Incretins|incretins|mesh-ancestor
93130064|NCT01060072|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93130065|NCT01060072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93130066|NCT03741075|Tranexamic Acid|tranexamic acid|mesh-list
93130067|NCT03741075|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93130068|NCT03741075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93130069|NCT03741075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130070|NCT03741075|Hemostatics|hemostatics|mesh-ancestor
93130071|NCT03741075|Coagulants|coagulants|mesh-ancestor
93130072|NCT01328223|Sorafenib|sorafenib|mesh-list
93130073|NCT01328223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130074|NCT01328223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130075|NCT01328223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130076|NCT01328223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130077|NCT01104987|Alendronate|alendronate|mesh-list
93130078|NCT01104987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93130079|NCT01104987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130080|NCT01106235|Aldesleukin|aldesleukin|mesh-list
93130081|NCT01106235|Cyclophosphamide|cyclophosphamide|mesh-list
93130082|NCT01106235|Interleukin-2|interleukin-2|mesh-list
93130083|NCT01106235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93130084|NCT01106235|Immunologic Factors|immunologic factors|mesh-ancestor
93130085|NCT01106235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130086|NCT01106235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130087|NCT01106235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93130088|NCT01106235|Alkylating Agents|alkylating agents|mesh-ancestor
93130089|NCT01106235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130090|NCT01106235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130091|NCT01106235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93130092|NCT01106235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93130093|NCT01106235|Analgesics|analgesics|mesh-ancestor
93130094|NCT01106235|Sensory System Agents|sensory system agents|mesh-ancestor
93130095|NCT01106235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130096|NCT01106235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93130097|NCT01106235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93130098|NCT01106235|Antiviral Agents|antiviral agents|mesh-ancestor
93130099|NCT01106235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130100|NCT02969590|Leuprolide|leuprolide|mesh-list
93130101|NCT02969590|Norethindrone|norethindrone|mesh-list
93130102|NCT02969590|Estradiol|estradiol|mesh-list
93130103|NCT02969590|Estrogens|estrogens|mesh-list
93130104|NCT02969590|Progesterone|progesterone|mesh-list
93130105|NCT02969590|Progestins|progestins|mesh-list
93130106|NCT02969590|Hormones|hormones|mesh-ancestor
93130107|NCT02969590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130108|NCT02969590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130109|NCT02969590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93130110|NCT02969590|Contraceptive Agents|contraceptive agents|mesh-ancestor
93130111|NCT02969590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130112|NCT02969590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93130113|NCT02969590|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93130114|NCT02969590|Fertility Agents|fertility agents|mesh-ancestor
93130115|NCT02969590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93130116|NCT02969590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130117|NCT02969590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93130118|NCT02969590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93130119|NCT02969590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93130120|NCT03650998|Ropivacaine|ropivacaine|mesh-list
93130121|NCT03650998|Anesthetics, Local|anesthetics, local|mesh-ancestor
93130122|NCT03650998|Anesthetics|anesthetics|mesh-ancestor
93130123|NCT03650998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130124|NCT03650998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130125|NCT03650998|Sensory System Agents|sensory system agents|mesh-ancestor
93130126|NCT03650998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130127|NCT04053400|Ketamine|ketamine|mesh-list
93130128|NCT04053400|Analgesics|analgesics|mesh-ancestor
93130129|NCT04053400|Sensory System Agents|sensory system agents|mesh-ancestor
93130130|NCT04053400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130131|NCT04053400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130132|NCT04053400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93130133|NCT04053400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93130134|NCT04053400|Anesthetics, General|anesthetics, general|mesh-ancestor
93130135|NCT04053400|Anesthetics|anesthetics|mesh-ancestor
93130136|NCT04053400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130137|NCT04053400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93130138|NCT04053400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93130139|NCT04053400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130140|NCT04053400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130141|NCT03345849|Upadacitinib|upadacitinib|mesh-list
93130142|NCT03345849|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93130143|NCT03345849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130144|NCT03345849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130145|NCT03345849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130146|NCT03345849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130147|NCT01109043|Bisoprolol|bisoprolol|mesh-list
93130148|NCT01109043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93130149|NCT01109043|Sympatholytics|sympatholytics|mesh-ancestor
93130150|NCT01109043|Autonomic Agents|autonomic agents|mesh-ancestor
93130151|NCT01109043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130152|NCT01109043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130153|NCT01109043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93130154|NCT01109043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93130155|NCT01109043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93130156|NCT01109043|Adrenergic Agents|adrenergic agents|mesh-ancestor
93130157|NCT01109043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130158|NCT01109043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130159|NCT01109121|Allopurinol|allopurinol|mesh-list
93130160|NCT01109121|Antimetabolites|antimetabolites|mesh-ancestor
93130161|NCT01109121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130162|NCT01109121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130163|NCT01109121|Gout Suppressants|gout suppressants|mesh-ancestor
93130164|NCT01109121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130165|NCT01109121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93130166|NCT01109121|Antioxidants|antioxidants|mesh-ancestor
93130167|NCT01109121|Protective Agents|protective agents|mesh-ancestor
93130168|NCT01109121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130169|NCT01106547|Methylprednisolone|methylprednisolone|mesh-list
93130170|NCT01106547|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93130171|NCT01106547|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93130172|NCT01106547|Prednisolone|prednisolone|mesh-list
93130173|NCT01106547|Prednisolone acetate|prednisolone acetate|mesh-list
93130174|NCT01106547|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93130175|NCT01106547|Prednisolone phosphate|prednisolone phosphate|mesh-list
93130176|NCT01106547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130177|NCT01106547|Antiemetics|antiemetics|mesh-ancestor
93130178|NCT01106547|Autonomic Agents|autonomic agents|mesh-ancestor
93130179|NCT01106547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130180|NCT01106547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130181|NCT01106547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130182|NCT01106547|Glucocorticoids|glucocorticoids|mesh-ancestor
93130183|NCT01106547|Hormones|hormones|mesh-ancestor
93130184|NCT01106547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130185|NCT01106547|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93130186|NCT01106547|Protective Agents|protective agents|mesh-ancestor
93130187|NCT01106547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93130188|NCT01106547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130189|NCT01105299|Anastrozole|anastrozole|mesh-list
93130190|NCT01105299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93130191|NCT01105299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130192|NCT01105299|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93130193|NCT01105299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93130194|NCT01105299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130195|NCT01105299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130196|NCT01105299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93130197|NCT01105299|Hormone Antagonists|hormone antagonists|mesh-ancestor
93130198|NCT01105299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130199|NCT01105299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130201|NCT03947229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93130202|NCT03947229|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93130203|NCT03947229|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93130204|NCT03947229|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93130205|NCT03947229|Purinergic Agents|purinergic agents|mesh-ancestor
93130206|NCT03947229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130207|NCT03947229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130208|NCT03947229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130209|NCT03011307|Oxytocin|oxytocin|mesh-list
93130210|NCT03011307|Oxytocics|oxytocics|mesh-ancestor
93130211|NCT03011307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130212|NCT03011307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130213|NCT01327755|Selenium|selenium|mesh-list
93130214|NCT01327755|Antioxidants|antioxidants|mesh-ancestor
93130215|NCT01327755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130216|NCT01327755|Protective Agents|protective agents|mesh-ancestor
93130217|NCT01327755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130218|NCT01327755|Trace Elements|trace elements|mesh-ancestor
93130219|NCT01327755|Micronutrients|micronutrients|mesh-ancestor
93130220|NCT01848639|Spironolactone|spironolactone|mesh-list
93130221|NCT01848639|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93130222|NCT01848639|Hormone Antagonists|hormone antagonists|mesh-ancestor
93130223|NCT01848639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130224|NCT01848639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130225|NCT01848639|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93130226|NCT01848639|Diuretics|diuretics|mesh-ancestor
93130227|NCT01848639|Natriuretic Agents|natriuretic agents|mesh-ancestor
93130228|NCT04537923|Insulin|insulin|mesh-list
93130229|NCT04537923|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93130230|NCT04537923|Insulin Glargine|insulin glargine|mesh-list
93130231|NCT04537923|Insulin Lispro|insulin lispro|mesh-list
93130232|NCT04537923|Tirzepatide|tirzepatide|mesh-list
93130233|NCT04537923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130234|NCT04537923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130235|NCT04537923|Incretins|incretins|mesh-ancestor
93130236|NCT04537923|Hormones|hormones|mesh-ancestor
93130237|NCT04537923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130238|NCT01107093|Ulipristal acetate|ulipristal acetate|mesh-list
93130239|NCT01107093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93130240|NCT01107093|Contraceptive Agents|contraceptive agents|mesh-ancestor
93130241|NCT01107093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130242|NCT01107093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130243|NCT01107093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93130244|NCT01118793|Clopidogrel|clopidogrel|mesh-list
93130245|NCT01118793|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93130246|NCT01118793|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93130247|NCT01118793|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93130248|NCT01118793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93130249|NCT01118793|Purinergic Agents|purinergic agents|mesh-ancestor
93130250|NCT01118793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130251|NCT01118793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130252|NCT01118793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130253|NCT00127335|Atorvastatin|atorvastatin|mesh-list
93130254|NCT00127335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93130255|NCT00127335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93130256|NCT00127335|Antimetabolites|antimetabolites|mesh-ancestor
93130257|NCT00127335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130258|NCT00127335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93130259|NCT00127335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93130260|NCT00127335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130261|NCT01109511|Oxycodone|oxycodone|mesh-list
93130262|NCT01109511|Naloxone|naloxone|mesh-list
93130263|NCT01109511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93130264|NCT01109511|Narcotics|narcotics|mesh-ancestor
93130265|NCT01109511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130266|NCT01109511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130267|NCT01109511|Analgesics|analgesics|mesh-ancestor
93130268|NCT01109511|Sensory System Agents|sensory system agents|mesh-ancestor
93130269|NCT01109511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130270|NCT01109511|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93130271|NCT01112085|Ranibizumab|ranibizumab|mesh-list
93130272|NCT01112085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93130273|NCT01112085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93130274|NCT01112085|Growth Substances|growth substances|mesh-ancestor
93130275|NCT01112085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130276|NCT01112085|Growth Inhibitors|growth inhibitors|mesh-ancestor
93130277|NCT01112085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130279|NCT01328301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93130280|NCT01328301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130281|NCT01328301|Sympathomimetics|sympathomimetics|mesh-ancestor
93130282|NCT01328301|Autonomic Agents|autonomic agents|mesh-ancestor
93130283|NCT01328301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130284|NCT01328301|Dopamine Agents|dopamine agents|mesh-ancestor
93130285|NCT01328301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130286|NCT01328301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130287|NCT01328301|Adrenergic Agents|adrenergic agents|mesh-ancestor
93130288|NCT01328301|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93130289|NCT01328301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93130290|NCT01328301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93130291|NCT01328301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93130292|NCT01328457|Paromomycin|paromomycin|mesh-list
93130293|NCT01328457|Neomycin|neomycin|mesh-list
93130294|NCT01328457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130295|NCT01328457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130296|NCT01328457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93130297|NCT01328457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130298|NCT01328457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93130299|NCT01328457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130300|NCT01328457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130301|NCT01109823|Levofloxacin|levofloxacin|mesh-list
93130302|NCT01109823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93130303|NCT01109823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130304|NCT01109823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130305|NCT01109823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93130306|NCT01109823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93130307|NCT01109823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130308|NCT01109823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130309|NCT01109823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130310|NCT01109823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93130311|NCT01109823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93130312|NCT03943407|Imiquimod|imiquimod|mesh-list
93130313|NCT03943407|Cinnamaldehyde|cinnamaldehyde|mesh-list
93130314|NCT03943407|Doxepin|doxepin|mesh-list
93130315|NCT03943407|Menthol|menthol|mesh-list
93130316|NCT03943407|Histamine|histamine|mesh-list
93130317|NCT03943407|Antipruritics|antipruritics|mesh-ancestor
93130318|NCT03943407|Dermatologic Agents|dermatologic agents|mesh-ancestor
93130319|NCT03943407|Histamine Agonists|histamine agonists|mesh-ancestor
93130320|NCT03943407|Histamine Agents|histamine agents|mesh-ancestor
93130321|NCT03943407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130322|NCT03943407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130323|NCT03943407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130324|NCT03943407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93130325|NCT03943407|Immunologic Factors|immunologic factors|mesh-ancestor
93130326|NCT03943407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130327|NCT03943407|Interferon Inducers|interferon inducers|mesh-ancestor
93130328|NCT03943407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93130329|NCT03943407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93130330|NCT03943407|Protective Agents|protective agents|mesh-ancestor
93130331|NCT03943407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93130332|NCT03943407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93130333|NCT03943407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130334|NCT03943407|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93130335|NCT03943407|Antidepressive Agents|antidepressive agents|mesh-ancestor
93130336|NCT03943407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93130337|NCT03943407|Histamine Antagonists|histamine antagonists|mesh-ancestor
93130338|NCT01209351|Teduglutide|teduglutide|mesh-list
93130339|NCT01209351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130340|NCT01209351|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93130341|NCT01209351|Protective Agents|protective agents|mesh-ancestor
93130342|NCT01209351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130343|NCT02529579|Gemcitabine|gemcitabine|mesh-list
93130344|NCT02529579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93130345|NCT02529579|Antimetabolites|antimetabolites|mesh-ancestor
93130346|NCT02529579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130347|NCT02529579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130348|NCT01209429|Hormones|hormones|mesh-list
93130349|NCT01209429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130350|NCT01209429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130351|NCT01110291|Docetaxel|docetaxel|mesh-list
93130352|NCT01110291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130353|NCT01110291|Tubulin Modulators|tubulin modulators|mesh-ancestor
93130354|NCT01110291|Antimitotic Agents|antimitotic agents|mesh-ancestor
93130355|NCT01110291|Mitosis Modulators|mitosis modulators|mesh-ancestor
93130356|NCT01110291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130357|NCT01207947|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93130358|NCT01207947|Vasodilator Agents|vasodilator agents|mesh-ancestor
93130359|NCT01207947|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93130360|NCT01207947|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93130361|NCT01207947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130362|NCT01207947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130363|NCT01207947|Urological Agents|urological agents|mesh-ancestor
93130364|NCT01107639|Docetaxel|docetaxel|mesh-list
93130365|NCT01107639|Cetuximab|cetuximab|mesh-list
93130366|NCT01107639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130367|NCT01107639|Tubulin Modulators|tubulin modulators|mesh-ancestor
93130368|NCT01107639|Antimitotic Agents|antimitotic agents|mesh-ancestor
93130369|NCT01107639|Mitosis Modulators|mitosis modulators|mesh-ancestor
93130370|NCT01107639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130371|NCT01107639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130372|NCT03942861|Methylprednisolone|methylprednisolone|mesh-list
93130373|NCT03942861|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93130374|NCT03942861|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93130375|NCT03942861|Prednisolone|prednisolone|mesh-list
93130376|NCT03942861|Prednisolone acetate|prednisolone acetate|mesh-list
93130377|NCT03942861|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93130378|NCT03942861|Prednisolone phosphate|prednisolone phosphate|mesh-list
93130379|NCT03942861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130380|NCT03942861|Antiemetics|antiemetics|mesh-ancestor
93130381|NCT03942861|Autonomic Agents|autonomic agents|mesh-ancestor
93130382|NCT03942861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130383|NCT03942861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130384|NCT03942861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130385|NCT03942861|Glucocorticoids|glucocorticoids|mesh-ancestor
93130386|NCT03942861|Hormones|hormones|mesh-ancestor
93130387|NCT03942861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130388|NCT03942861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93130389|NCT03942861|Protective Agents|protective agents|mesh-ancestor
93130390|NCT03942861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93130391|NCT03942861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130392|NCT01107951|Dexamethasone|dexamethasone|mesh-list
93130393|NCT01107951|Rituximab|rituximab|mesh-list
93130394|NCT01107951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130395|NCT01107951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130396|NCT01107951|Immunologic Factors|immunologic factors|mesh-ancestor
93130397|NCT01107951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130398|NCT01107951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130399|NCT01107951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130400|NCT01107951|Antiemetics|antiemetics|mesh-ancestor
93130401|NCT01107951|Autonomic Agents|autonomic agents|mesh-ancestor
93130402|NCT01107951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130403|NCT01107951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130404|NCT01107951|Glucocorticoids|glucocorticoids|mesh-ancestor
93130405|NCT01107951|Hormones|hormones|mesh-ancestor
93130406|NCT01107951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130407|NCT01107951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93130408|NCT01108029|Memantine|memantine|mesh-list
93130409|NCT01108029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93130410|NCT01108029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93130411|NCT01108029|Dopamine Agents|dopamine agents|mesh-ancestor
93130412|NCT01108029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130413|NCT01108029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130414|NCT01108029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130415|NCT01108029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93130416|NCT01108029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93130417|NCT03941925|Levan|levan|mesh-list
93130418|NCT03941925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130419|NCT01110603|Paclitaxel|paclitaxel|mesh-list
93130420|NCT01110603|Carboplatin|carboplatin|mesh-list
93130421|NCT01110603|Doxorubicin|doxorubicin|mesh-list
93130422|NCT01110603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93130423|NCT01110603|Niraparib|niraparib|mesh-list
93130424|NCT01110603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93130425|NCT01110603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130426|NCT01110603|Tubulin Modulators|tubulin modulators|mesh-ancestor
93130427|NCT01110603|Antimitotic Agents|antimitotic agents|mesh-ancestor
93130428|NCT01110603|Mitosis Modulators|mitosis modulators|mesh-ancestor
93130429|NCT01110603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130430|NCT01110603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93130431|NCT01110603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93130432|NCT01110603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93130433|NCT01110603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130434|NCT01110603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93130435|NCT04258683|Pembrolizumab|pembrolizumab|mesh-list
93130436|NCT04258683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130437|NCT04258683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130438|NCT04258683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93130439|NCT04258683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130440|NCT01112787|Tazarotene|tazarotene|mesh-list
93130441|NCT01112787|Dermatologic Agents|dermatologic agents|mesh-ancestor
93130442|NCT01112787|Keratolytic Agents|keratolytic agents|mesh-ancestor
93130443|NCT01108107|Capecitabine|capecitabine|mesh-list
93130444|NCT01108107|Oxaliplatin|oxaliplatin|mesh-list
93130445|NCT01108107|Panitumumab|panitumumab|mesh-list
93130446|NCT01108107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93130447|NCT01108107|Antimetabolites|antimetabolites|mesh-ancestor
93130448|NCT01108107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130449|NCT01108107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130450|NCT01108107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130451|NCT01111227|Propofol|propofol|mesh-list
93130452|NCT01111227|Isoflurane|isoflurane|mesh-list
93130453|NCT01111227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93130454|NCT01111227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130455|NCT01111227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130456|NCT01111227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93130457|NCT01111227|Anesthetics, General|anesthetics, general|mesh-ancestor
93130458|NCT01111227|Anesthetics|anesthetics|mesh-ancestor
93130459|NCT01111227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93130460|NCT01111383|Tobramycin|tobramycin|mesh-list
93130461|NCT01111383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130462|NCT01111383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130463|NCT01208649|Exenatide|exenatide|mesh-list
93130464|NCT01208649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130465|NCT01208649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130466|NCT01208649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93130467|NCT01208649|Incretins|incretins|mesh-ancestor
93130468|NCT01208649|Hormones|hormones|mesh-ancestor
93130469|NCT01208649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130470|NCT01211847|Diazoxide|diazoxide|mesh-list
93130471|NCT01211847|Choline|choline|mesh-list
93130472|NCT01211847|Lipotropic Agents|lipotropic agents|mesh-ancestor
93130473|NCT01211847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93130474|NCT01211847|Antimetabolites|antimetabolites|mesh-ancestor
93130475|NCT01211847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130476|NCT01211847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130477|NCT01211847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93130478|NCT01211847|Nootropic Agents|nootropic agents|mesh-ancestor
93130479|NCT01211847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93130480|NCT01211847|Vasodilator Agents|vasodilator agents|mesh-ancestor
93130481|NCT01210287|Lamivudine|lamivudine|mesh-list
93130482|NCT01210287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93130483|NCT01210287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93130484|NCT01210287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130485|NCT01210287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130486|NCT01210287|Antiviral Agents|antiviral agents|mesh-ancestor
93130487|NCT01210287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130488|NCT01210287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93130489|NCT01210287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93130490|NCT01211925|Aspirin|aspirin|mesh-list
93130491|NCT01211925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93130492|NCT01211925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93130493|NCT01211925|Analgesics|analgesics|mesh-ancestor
93130494|NCT01211925|Sensory System Agents|sensory system agents|mesh-ancestor
93130495|NCT01211925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130496|NCT01211925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130497|NCT01211925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130498|NCT01211925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130499|NCT01211925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93130500|NCT01211925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93130501|NCT01211925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130502|NCT01211925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93130503|NCT01211925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93130504|NCT01211925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130505|NCT01211925|Antipyretics|antipyretics|mesh-ancestor
93130506|NCT01114425|Raltegravir Potassium|raltegravir potassium|mesh-list
93130507|NCT01114425|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93130508|NCT01114425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93130509|NCT01114425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93130510|NCT01114425|Antiviral Agents|antiviral agents|mesh-ancestor
93130511|NCT01114425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130512|NCT01114425|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93130513|NCT01114425|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93130514|NCT01114425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130515|NCT01114425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130516|NCT01114425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93130517|NCT01114425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93130518|NCT01328145|Aspirin|aspirin|mesh-list
93130519|NCT01328145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93130520|NCT01328145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93130521|NCT01328145|Analgesics|analgesics|mesh-ancestor
93130522|NCT01328145|Sensory System Agents|sensory system agents|mesh-ancestor
93130523|NCT01328145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130524|NCT01328145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130525|NCT01328145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130526|NCT01328145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130527|NCT01328145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93130528|NCT01328145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93130529|NCT01328145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130530|NCT01328145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93130531|NCT01328145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93130532|NCT01328145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130533|NCT01328145|Antipyretics|antipyretics|mesh-ancestor
93130534|NCT01210521|Vitamin D|vitamin d|mesh-list
93130535|NCT01210521|Vitamins|vitamins|mesh-ancestor
93130536|NCT01210521|Micronutrients|micronutrients|mesh-ancestor
93130537|NCT01210521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130538|NCT01210521|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93130539|NCT01210599|Pamidronate|pamidronate|mesh-list
93130540|NCT01210599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93130541|NCT01210599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130542|NCT03944889|Capsaicin|capsaicin|mesh-list
93130543|NCT03944889|Antipruritics|antipruritics|mesh-ancestor
93130544|NCT03944889|Dermatologic Agents|dermatologic agents|mesh-ancestor
93130545|NCT03944889|Sensory System Agents|sensory system agents|mesh-ancestor
93130546|NCT03944889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130547|NCT03944889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130548|NCT01210677|Prednisone|prednisone|mesh-list
93130549|NCT01210677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130550|NCT01210677|Glucocorticoids|glucocorticoids|mesh-ancestor
93130551|NCT01210677|Hormones|hormones|mesh-ancestor
93130552|NCT01210677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130553|NCT01210677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130554|NCT01210677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93130555|NCT01210677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130556|NCT01210755|Rivaroxaban|rivaroxaban|mesh-list
93130557|NCT01210755|Dabigatran|dabigatran|mesh-list
93130558|NCT01210755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93130559|NCT01210755|Antithrombins|antithrombins|mesh-ancestor
93130560|NCT01210755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93130561|NCT01210755|Protease Inhibitors|protease inhibitors|mesh-ancestor
93130562|NCT01210755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130563|NCT01210755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130564|NCT01210755|Anticoagulants|anticoagulants|mesh-ancestor
93130565|NCT01210911|Metformin|metformin|mesh-list
93130566|NCT01210911|Gemcitabine|gemcitabine|mesh-list
93130567|NCT01210911|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93130568|NCT01210911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93130569|NCT01210911|Antimetabolites|antimetabolites|mesh-ancestor
93130570|NCT01210911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130571|NCT01210911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130572|NCT01210911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130573|NCT01210911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130574|NCT01210911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130575|NCT01210911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130576|NCT01115049|Chlorhexidine|chlorhexidine|mesh-list
93130577|NCT01115049|Hexetidine|hexetidine|mesh-list
93130578|NCT01115049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93130579|NCT01115049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130580|NCT01115049|Disinfectants|disinfectants|mesh-ancestor
93130581|NCT01115049|Antifungal Agents|antifungal agents|mesh-ancestor
93130582|NCT03941535|Vitamin K|vitamin k|mesh-list
93130583|NCT03941535|Vitamins|vitamins|mesh-ancestor
93130584|NCT03941535|Micronutrients|micronutrients|mesh-ancestor
93130585|NCT03941535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130586|NCT03941535|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93130587|NCT03941535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93130588|NCT03941535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130589|NCT03941535|Hemostatics|hemostatics|mesh-ancestor
93130590|NCT03941535|Coagulants|coagulants|mesh-ancestor
93130591|NCT01115127|Inositol|inositol|mesh-list
93130592|NCT01115127|Melatonin|melatonin|mesh-list
93130593|NCT01115127|Antioxidants|antioxidants|mesh-ancestor
93130594|NCT01115127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130595|NCT01115127|Protective Agents|protective agents|mesh-ancestor
93130596|NCT01115127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130597|NCT01115127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130598|NCT01115127|Vitamin B Complex|vitamin b complex|mesh-ancestor
93130599|NCT01115127|Vitamins|vitamins|mesh-ancestor
93130600|NCT01115127|Micronutrients|micronutrients|mesh-ancestor
93130601|NCT01211223|Amoxicillin|amoxicillin|mesh-list
93130602|NCT01211223|Metronidazole|metronidazole|mesh-list
93130603|NCT01211223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130604|NCT01211223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130605|NCT01211223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93130606|NCT01211223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130607|NCT01113489|Beclomethasone|beclomethasone|mesh-list
93130608|NCT01113489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130609|NCT01113489|Glucocorticoids|glucocorticoids|mesh-ancestor
93130610|NCT01113489|Hormones|hormones|mesh-ancestor
91931543|NCT04059484|Anastrozole|anastrozole|mesh-list
93130611|NCT01113489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130612|NCT01113489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130613|NCT01113489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93130614|NCT01113489|Respiratory System Agents|respiratory system agents|mesh-ancestor
93130615|NCT01115439|Artesunate|artesunate|mesh-list
93130616|NCT01115439|Pyrimethamine|pyrimethamine|mesh-list
93130617|NCT01115439|Sulfadoxine|sulfadoxine|mesh-list
93130618|NCT01115439|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93130619|NCT01115439|Antimalarials|antimalarials|mesh-ancestor
93130620|NCT01115439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93130621|NCT01115439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130622|NCT01115439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130623|NCT01115439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130624|NCT01115439|Antiviral Agents|antiviral agents|mesh-ancestor
93130625|NCT01115439|Schistosomicides|schistosomicides|mesh-ancestor
93130626|NCT01115439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93130627|NCT01115439|Anthelmintics|anthelmintics|mesh-ancestor
93130628|NCT01115439|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93130629|NCT01115439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130630|NCT01115439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130631|NCT01115439|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93130632|NCT01212315|Triclosan|triclosan|mesh-list
93130633|NCT01212315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93130634|NCT01212315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130635|NCT01212315|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93130636|NCT01212315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93130637|NCT01212315|Antimetabolites|antimetabolites|mesh-ancestor
93130638|NCT01212315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130639|NCT01212315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93130640|NCT03938259|Fentanyl|fentanyl|mesh-list
93130641|NCT03938259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93130642|NCT03938259|Narcotics|narcotics|mesh-ancestor
93130643|NCT03938259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130644|NCT03938259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130645|NCT03938259|Analgesics|analgesics|mesh-ancestor
93130646|NCT03938259|Sensory System Agents|sensory system agents|mesh-ancestor
93130647|NCT03938259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130648|NCT03938259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93130649|NCT03938259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93130650|NCT03938259|Anesthetics, General|anesthetics, general|mesh-ancestor
93130651|NCT03938259|Anesthetics|anesthetics|mesh-ancestor
93130652|NCT03939663|Misoprostol|misoprostol|mesh-list
93130653|NCT03939663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93130654|NCT03939663|Abortifacient Agents|abortifacient agents|mesh-ancestor
93130655|NCT03939663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130656|NCT03939663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130657|NCT03939663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93130658|NCT03939663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130659|NCT03939663|Oxytocics|oxytocics|mesh-ancestor
93130660|NCT01213407|Temozolomide|temozolomide|mesh-list
93130661|NCT01213407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93130662|NCT01213407|Alkylating Agents|alkylating agents|mesh-ancestor
93130663|NCT01213407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130664|NCT01213407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130665|NCT01211457|Decitabine|decitabine|mesh-list
93130666|NCT01211457|Venetoclax|venetoclax|mesh-list
93130667|NCT01211457|Sapacitabine|sapacitabine|mesh-list
93130668|NCT01211457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93130669|NCT01211457|Antimetabolites|antimetabolites|mesh-ancestor
93130670|NCT01211457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130671|NCT01211457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130672|NCT01211457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130673|NCT01213563|Insulin|insulin|mesh-list
93130674|NCT01213563|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93130675|NCT01213563|Insulin, neutral|insulin, neutral|mesh-list
93130676|NCT01213563|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
93130677|NCT01213563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130678|NCT01213563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130679|NCT01115985|Atorvastatin|atorvastatin|mesh-list
93130680|NCT01115985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93130681|NCT01115985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93130682|NCT01115985|Antimetabolites|antimetabolites|mesh-ancestor
93130683|NCT01115985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130684|NCT01115985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93130685|NCT01115985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93130686|NCT01115985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130687|NCT01116063|Iloprost|iloprost|mesh-list
93130688|NCT01116063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93130689|NCT01116063|Vasodilator Agents|vasodilator agents|mesh-ancestor
93130690|NCT01116219|Bevacizumab|bevacizumab|mesh-list
93130691|NCT01116219|Pemetrexed|pemetrexed|mesh-list
93130692|NCT01116219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93130693|NCT01116219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130694|NCT01116219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130695|NCT01116219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93130696|NCT01116219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93130697|NCT01116219|Growth Substances|growth substances|mesh-ancestor
93130698|NCT01116219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130699|NCT01116219|Growth Inhibitors|growth inhibitors|mesh-ancestor
93130700|NCT01116219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130701|NCT01116219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130702|NCT01116219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93130703|NCT01116219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93130704|NCT01116219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130705|NCT01213719|Betaine|betaine|mesh-list
93130706|NCT01213719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130707|NCT01213719|Lipotropic Agents|lipotropic agents|mesh-ancestor
93130708|NCT01213719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93130709|NCT01213719|Antimetabolites|antimetabolites|mesh-ancestor
93130710|NCT01213719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130711|NCT01213719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93130712|NCT01114191|Ketoconazole|ketoconazole|mesh-list
93130713|NCT01114191|Antifungal Agents|antifungal agents|mesh-ancestor
93130714|NCT01114191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130715|NCT01114191|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93130716|NCT01114191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93130717|NCT01114191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130718|NCT01114191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130719|NCT01114191|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93130720|NCT01114191|Hormone Antagonists|hormone antagonists|mesh-ancestor
93130721|NCT01114191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130722|NCT01114191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130723|NCT01114191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93130724|NCT01211691|Antibodies|antibodies|mesh-list
93130725|NCT01211691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92802896|NCT00678964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130726|NCT01211691|Immunologic Factors|immunologic factors|mesh-ancestor
93130727|NCT01211691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130728|NCT03937869|Secnidazole|secnidazole|mesh-list
93130729|NCT03937869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93130730|NCT03937869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130731|NCT03937869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130732|NCT01116531|Pregabalin|pregabalin|mesh-list
93130733|NCT01116531|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93130734|NCT01116531|Tramadol|tramadol|mesh-list
93130735|NCT01116531|Analgesics|analgesics|mesh-ancestor
93130736|NCT01116531|Sensory System Agents|sensory system agents|mesh-ancestor
93130737|NCT01116531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130738|NCT01116531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130739|NCT01116531|Anticonvulsants|anticonvulsants|mesh-ancestor
93130740|NCT01116531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93130741|NCT01116531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93130742|NCT01116531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130743|NCT01116531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93130744|NCT01116531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93130745|NCT01116531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93130746|NCT01116531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130747|NCT01116531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93130748|NCT01116531|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93130749|NCT01116531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93130750|NCT01116531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130751|NCT01116531|Antidepressive Agents|antidepressive agents|mesh-ancestor
93130752|NCT01116531|Dopamine Agents|dopamine agents|mesh-ancestor
93130753|NCT01116531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93130754|NCT01116531|Narcotics|narcotics|mesh-ancestor
93130755|NCT03939975|Pembrolizumab|pembrolizumab|mesh-list
93130756|NCT03939975|Nivolumab|nivolumab|mesh-list
93130757|NCT03939975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130758|NCT03939975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130759|NCT03939975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93130760|NCT03939975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130761|NCT01116609|Epinephrine|epinephrine|mesh-list
93130762|NCT01116609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93130763|NCT01116609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93130764|NCT01116609|Adrenergic Agents|adrenergic agents|mesh-ancestor
93130765|NCT01116609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130766|NCT01116609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130767|NCT01116609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130768|NCT01116609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93130769|NCT01116609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93130770|NCT01116609|Autonomic Agents|autonomic agents|mesh-ancestor
93130771|NCT01116609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130772|NCT01116609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93130773|NCT01116609|Respiratory System Agents|respiratory system agents|mesh-ancestor
93130774|NCT01116609|Mydriatics|mydriatics|mesh-ancestor
93130775|NCT01116609|Sympathomimetics|sympathomimetics|mesh-ancestor
93130776|NCT01116609|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93130777|NCT01118403|Ampicillin|ampicillin|mesh-list
93130778|NCT01118403|Sulbactam|sulbactam|mesh-list
93130779|NCT01118403|Sultamicillin|sultamicillin|mesh-list
93130780|NCT01118403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130781|NCT01118403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130782|NCT01118403|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93130783|NCT01118403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130784|NCT01118403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130785|NCT01121835|Insulin|insulin|mesh-list
93130786|NCT01121835|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93130787|NCT01121835|Insulin Glargine|insulin glargine|mesh-list
93130788|NCT01121835|Insulin glulisine|insulin glulisine|mesh-list
93130789|NCT01121835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130790|NCT01121835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130791|NCT03788967|Ertapenem|ertapenem|mesh-list
93130792|NCT03788967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130793|NCT03788967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130794|NCT01118559|Darexaban|darexaban|mesh-list
93130795|NCT01118559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93130796|NCT01118559|Antithrombins|antithrombins|mesh-ancestor
93130797|NCT01118559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93130798|NCT01118559|Protease Inhibitors|protease inhibitors|mesh-ancestor
92802972|NCT02627560|Hemostatics|hemostatics|mesh-ancestor
93130799|NCT01118559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130800|NCT01118559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130801|NCT01118559|Anticoagulants|anticoagulants|mesh-ancestor
93130802|NCT01216293|Esomeprazole|esomeprazole|mesh-list
93130803|NCT01216293|Dexlansoprazole|dexlansoprazole|mesh-list
93130804|NCT01216293|Lansoprazole|lansoprazole|mesh-list
93130805|NCT01216293|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93130806|NCT01216293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93130807|NCT01216293|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93130808|NCT01216293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130809|NCT01216293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130810|NCT01216371|Sunitinib|sunitinib|mesh-list
93130811|NCT01216371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130812|NCT01216371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93130813|NCT01216371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93130814|NCT01216371|Growth Substances|growth substances|mesh-ancestor
93130815|NCT01216371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130816|NCT01216371|Growth Inhibitors|growth inhibitors|mesh-ancestor
93130817|NCT01216371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130818|NCT01216371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130819|NCT01216371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130820|NCT01118871|Ritonavir|ritonavir|mesh-list
93130821|NCT01118871|Darunavir|darunavir|mesh-list
93130822|NCT01118871|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93130823|NCT01118871|Etravirine|etravirine|mesh-list
93130824|NCT01118871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93130825|NCT01118871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93130826|NCT01118871|Protease Inhibitors|protease inhibitors|mesh-ancestor
93130827|NCT01118871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130828|NCT01118871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130829|NCT01118871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93130830|NCT01118871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93130831|NCT01118871|Antiviral Agents|antiviral agents|mesh-ancestor
93130832|NCT01118871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130833|NCT01118871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93130834|NCT01118871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93130835|NCT01118871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93130836|NCT01118871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93130837|NCT01216449|Citalopram|citalopram|mesh-list
93130838|NCT01216449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93130839|NCT01216449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93130840|NCT01216449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93130841|NCT01216449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130842|NCT01216449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93130843|NCT01216449|Serotonin Agents|serotonin agents|mesh-ancestor
93130844|NCT01216449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130845|NCT01216449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93130846|NCT01216449|Antidepressive Agents|antidepressive agents|mesh-ancestor
93130847|NCT01216449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93130848|NCT03937401|Oxytocin|oxytocin|mesh-list
93130849|NCT03937401|Oxytocics|oxytocics|mesh-ancestor
93130850|NCT03937401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130851|NCT03937401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130852|NCT03939273|Metronidazole|metronidazole|mesh-list
93130853|NCT03939273|Vancomycin|vancomycin|mesh-list
93130854|NCT03939273|Ciprofloxacin|ciprofloxacin|mesh-list
93130855|NCT03939273|Fluconazole|fluconazole|mesh-list
93130856|NCT03939273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130857|NCT03939273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130858|NCT03939273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93130859|NCT03939273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130860|NCT03939273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93130861|NCT03939273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93130862|NCT03939273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130863|NCT03939273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130864|NCT03939273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130865|NCT03939273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93130866|NCT03939273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93130867|NCT03939273|Antifungal Agents|antifungal agents|mesh-ancestor
93130868|NCT03939273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93130869|NCT03939273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93130870|NCT03939273|Hormone Antagonists|hormone antagonists|mesh-ancestor
93130871|NCT03939273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130872|NCT03939273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130873|NCT03939273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93130874|NCT03939273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93130875|NCT01213017|Certolizumab Pegol|certolizumab pegol|mesh-list
93130876|NCT01213017|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93130877|NCT01213017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93130878|NCT01213017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93130879|NCT01213017|Immunologic Factors|immunologic factors|mesh-ancestor
93130880|NCT01213017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130881|NCT01213017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130882|NCT01119417|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
93130883|NCT01119417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93130884|NCT01119417|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93130885|NCT01119417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130886|NCT01216605|Oxytocin|oxytocin|mesh-list
93130887|NCT01216605|Oxytocics|oxytocics|mesh-ancestor
93130888|NCT01216605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130889|NCT01216605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130890|NCT01213095|Rituximab|rituximab|mesh-list
93130891|NCT01213095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93130892|NCT01213095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130893|NCT01213095|Immunologic Factors|immunologic factors|mesh-ancestor
93130894|NCT01213095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130895|NCT01213095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93130896|NCT03938883|Hyaluronic Acid|hyaluronic acid|mesh-list
93130897|NCT03938883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93130898|NCT03938883|Immunologic Factors|immunologic factors|mesh-ancestor
93130899|NCT03938883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130900|NCT03938883|Viscosupplements|viscosupplements|mesh-ancestor
93130901|NCT03938883|Protective Agents|protective agents|mesh-ancestor
93130902|NCT01216839|Everolimus|everolimus|mesh-list
93130903|NCT01216839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93130904|NCT01216839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130905|NCT01216839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130906|NCT01216839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071084|NCT03599362|Nivolumab|nivolumab|mesh-list
93130907|NCT01216839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93130908|NCT01216839|Immunologic Factors|immunologic factors|mesh-ancestor
93130909|NCT01216839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130910|NCT01216839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130911|NCT01119651|Tazarotene|tazarotene|mesh-list
93130912|NCT01119651|Dermatologic Agents|dermatologic agents|mesh-ancestor
93130913|NCT01119651|Keratolytic Agents|keratolytic agents|mesh-ancestor
93130914|NCT03971877|Polymyxins|polymyxins|mesh-list
93130915|NCT03971877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130916|NCT03971877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130917|NCT01328925|Nitazoxanide|nitazoxanide|mesh-list
93130918|NCT01328925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130919|NCT01328925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130920|NCT01119885|Fentanyl|fentanyl|mesh-list
93130921|NCT01119885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93130922|NCT01119885|Narcotics|narcotics|mesh-ancestor
93130923|NCT01119885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93130924|NCT01119885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130925|NCT01119885|Analgesics|analgesics|mesh-ancestor
93130926|NCT01119885|Sensory System Agents|sensory system agents|mesh-ancestor
93130927|NCT01119885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93130928|NCT01119885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93130929|NCT01119885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93130930|NCT01119885|Anesthetics, General|anesthetics, general|mesh-ancestor
93130931|NCT01119885|Anesthetics|anesthetics|mesh-ancestor
93130932|NCT03935217|Secnidazole|secnidazole|mesh-list
93130933|NCT03935217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93130934|NCT03935217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93130935|NCT03935217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130936|NCT01219023|Sildenafil Citrate|sildenafil citrate|mesh-list
93130937|NCT01219023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130938|NCT01219023|Vasodilator Agents|vasodilator agents|mesh-ancestor
93130939|NCT01219023|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93130940|NCT01219023|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93130941|NCT01219023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130942|NCT01219023|Urological Agents|urological agents|mesh-ancestor
93130943|NCT01124487|Insulin|insulin|mesh-list
93130944|NCT01124487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93130945|NCT01124487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130946|NCT01120119|Calcitriol|calcitriol|mesh-list
93130947|NCT01120119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93130948|NCT01120119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130949|NCT01120119|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93130950|NCT01120119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93130951|NCT01120119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130952|NCT01120119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93130954|NCT01120119|Micronutrients|micronutrients|mesh-ancestor
93130955|NCT01120119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93130956|NCT01219101|Citric Acid|citric acid|mesh-list
93130957|NCT01219101|Sodium Citrate|sodium citrate|mesh-list
93130958|NCT01219101|Clomiphene|clomiphene|mesh-list
93130959|NCT01219101|Enclomiphene|enclomiphene|mesh-list
93130960|NCT01219101|Zuclomiphene|zuclomiphene|mesh-list
93130961|NCT01219101|Anticoagulants|anticoagulants|mesh-ancestor
93130962|NCT01219101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93130963|NCT01219101|Chelating Agents|chelating agents|mesh-ancestor
93130964|NCT01219101|Sequestering Agents|sequestering agents|mesh-ancestor
93130965|NCT01219101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130966|NCT01219101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93130967|NCT01219101|Hormone Antagonists|hormone antagonists|mesh-ancestor
93130968|NCT01219101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93130969|NCT01219101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130970|NCT01219101|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93130971|NCT01219101|Fertility Agents|fertility agents|mesh-ancestor
93130972|NCT01219101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93130973|NCT01219101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93130974|NCT01219101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93130975|NCT01217619|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93130976|NCT01217619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130977|NCT01217619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130978|NCT01217619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130979|NCT01217619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130980|NCT01122615|Sirolimus|sirolimus|mesh-list
93130981|NCT01122615|Sunitinib|sunitinib|mesh-list
93130982|NCT01122615|Temsirolimus|temsirolimus|mesh-list
93130983|NCT01122615|MTOR Inhibitors|mtor inhibitors|mesh-list
93130984|NCT01122615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93130985|NCT01122615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93130986|NCT01122615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93130987|NCT01122615|Growth Substances|growth substances|mesh-ancestor
93130988|NCT01122615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93130989|NCT01122615|Growth Inhibitors|growth inhibitors|mesh-ancestor
93130990|NCT01122615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93130991|NCT01122615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93130992|NCT01122615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93130993|NCT01122615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93130994|NCT01122615|Immunologic Factors|immunologic factors|mesh-ancestor
93130995|NCT01122615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93130996|NCT01122615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93130997|NCT01122615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93130998|NCT01122615|Antifungal Agents|antifungal agents|mesh-ancestor
93130999|NCT01217697|Prednisone|prednisone|mesh-list
93131000|NCT01217697|Prednisolone|prednisolone|mesh-list
93131001|NCT01217697|Abiraterone Acetate|abiraterone acetate|mesh-list
93131002|NCT01217697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93131003|NCT01217697|Glucocorticoids|glucocorticoids|mesh-ancestor
93131004|NCT01217697|Hormones|hormones|mesh-ancestor
93131005|NCT01217697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131006|NCT01217697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131007|NCT01217697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93131008|NCT01217697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131009|NCT01217697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93131010|NCT01217697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131011|NCT01217697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131012|NCT01217697|Hormone Antagonists|hormone antagonists|mesh-ancestor
93131013|NCT01217697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93131014|NCT01214343|Sorafenib|sorafenib|mesh-list
93131015|NCT01214343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131016|NCT01214343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131017|NCT01214343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131018|NCT01214343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131019|NCT01120431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93131020|NCT01124799|Ciprofloxacin|ciprofloxacin|mesh-list
93131021|NCT01124799|Simeprevir|simeprevir|mesh-list
93131022|NCT01124799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131023|NCT01124799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131024|NCT01124799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92803195|NCT05745337|Metoprolol|metoprolol|mesh-list
93131025|NCT01124799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93131026|NCT01124799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131027|NCT01124799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131028|NCT01124799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131029|NCT01124799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93131030|NCT01124799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93131031|NCT01124799|Antiviral Agents|antiviral agents|mesh-ancestor
93131032|NCT01124799|Protease Inhibitors|protease inhibitors|mesh-ancestor
93131033|NCT01124877|Ziprasidone|ziprasidone|mesh-list
93131034|NCT01124877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93131035|NCT01124877|Serotonin Agents|serotonin agents|mesh-ancestor
93131036|NCT01124877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131037|NCT01124877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131038|NCT01124877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131039|NCT01124877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93131040|NCT01124877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93131041|NCT01124877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131042|NCT01124877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93131043|NCT01124877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93131044|NCT01124877|Dopamine Agents|dopamine agents|mesh-ancestor
93131045|NCT01219413|Perindopril|perindopril|mesh-list
93131046|NCT01219413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93131047|NCT01219413|Protease Inhibitors|protease inhibitors|mesh-ancestor
93131048|NCT01219413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131049|NCT01219413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131050|NCT01219413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131051|NCT03783039|Cellulose, Oxidized|cellulose, oxidized|mesh-list
93131052|NCT03783039|Hemostatics|hemostatics|mesh-ancestor
93131053|NCT03783039|Coagulants|coagulants|mesh-ancestor
93131054|NCT03933501|Amoxicillin|amoxicillin|mesh-list
93131055|NCT03933501|Metronidazole|metronidazole|mesh-list
93131056|NCT03933501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131057|NCT03933501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131058|NCT03933501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93131059|NCT03933501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93131060|NCT01122771|Amphotericin B|amphotericin b|mesh-list
93131061|NCT01122771|Paromomycin|paromomycin|mesh-list
93131062|NCT01122771|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93131063|NCT01122771|Miltefosine|miltefosine|mesh-list
93131064|NCT01122771|Amebicides|amebicides|mesh-ancestor
93131065|NCT01122771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93131066|NCT01122771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93131067|NCT01122771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131068|NCT01122771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131069|NCT01122771|Antifungal Agents|antifungal agents|mesh-ancestor
93131070|NCT01122771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131071|NCT01125033|Vitamins|vitamins|mesh-list
93131072|NCT01125033|Ascorbic Acid|ascorbic acid|mesh-list
93131073|NCT01125033|Vitamin E|vitamin e|mesh-list
93131074|NCT01125033|Tocopherols|tocopherols|mesh-list
93131075|NCT01125033|Tocotrienols|tocotrienols|mesh-list
93131076|NCT01125033|alpha-Tocopherol|alpha-tocopherol|mesh-list
93131077|NCT01125033|Micronutrients|micronutrients|mesh-ancestor
93131078|NCT01125033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131079|NCT01125033|Antioxidants|antioxidants|mesh-ancestor
93131080|NCT01125033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131081|NCT01125033|Protective Agents|protective agents|mesh-ancestor
93131082|NCT01120665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93131083|NCT01120665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93131084|NCT01120665|Estradiol|estradiol|mesh-list
93131085|NCT01120665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93131086|NCT01120665|Hormones|hormones|mesh-ancestor
93131087|NCT01120665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131088|NCT01120665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131089|NCT01120665|Estrogens|estrogens|mesh-ancestor
93131090|NCT01120665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93131091|NCT01120665|Contraceptive Agents|contraceptive agents|mesh-ancestor
93131092|NCT01120665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93131093|NCT01120665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93131094|NCT01120821|Imatinib Mesylate|imatinib mesylate|mesh-list
93131095|NCT01120821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131096|NCT01120821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131097|NCT01120821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131098|NCT01120821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131099|NCT01125423|Milnacipran|milnacipran|mesh-list
93131100|NCT01125423|Levomilnacipran|levomilnacipran|mesh-list
93131101|NCT01125423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93131102|NCT01125423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93131103|NCT01125423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131104|NCT01125423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131105|NCT01125423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131106|NCT01125423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131107|NCT01125423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93131108|NCT01125423|Analgesics|analgesics|mesh-ancestor
93131109|NCT01125423|Sensory System Agents|sensory system agents|mesh-ancestor
93131110|NCT01125423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131111|NCT01125423|Antidepressive Agents|antidepressive agents|mesh-ancestor
93131112|NCT01125423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93131114|NCT01219569|Sevoflurane|sevoflurane|mesh-list
93131115|NCT01219569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131116|NCT01219569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131117|NCT01219569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131118|NCT01219569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93131119|NCT01219569|Anesthetics, General|anesthetics, general|mesh-ancestor
93131120|NCT01219569|Anesthetics|anesthetics|mesh-ancestor
93131121|NCT01219569|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93131122|NCT01219569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93131123|NCT03933345|Naloxone|naloxone|mesh-list
93131124|NCT03933345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93131125|NCT03933345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131126|NCT03933345|Sensory System Agents|sensory system agents|mesh-ancestor
93131127|NCT03933345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131128|NCT01121055|Lorazepam|lorazepam|mesh-list
93131129|NCT01121055|Anticonvulsants|anticonvulsants|mesh-ancestor
93131130|NCT01121055|Antiemetics|antiemetics|mesh-ancestor
93131131|NCT01121055|Autonomic Agents|autonomic agents|mesh-ancestor
93131132|NCT01121055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131133|NCT01121055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131134|NCT01121055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93131135|NCT01121055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131136|NCT01121055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131137|NCT01121055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93131138|NCT01121055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93131139|NCT01121055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93131140|NCT01121055|GABA Modulators|gaba modulators|mesh-ancestor
93131141|NCT01121055|GABA Agents|gaba agents|mesh-ancestor
93131142|NCT01121055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131143|NCT01121055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131144|NCT01121133|Rifampin|rifampin|mesh-list
93131145|NCT01121133|Navitoclax|navitoclax|mesh-list
93131146|NCT01121133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93131147|NCT01121133|Antitubercular Agents|antitubercular agents|mesh-ancestor
93131148|NCT01121133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131149|NCT01121133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131150|NCT01121133|Leprostatic Agents|leprostatic agents|mesh-ancestor
93131151|NCT01121133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93131152|NCT01121133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131153|NCT01121133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131154|NCT01121133|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93131155|NCT01121133|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93131156|NCT01121133|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93131157|NCT01121133|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93131158|NCT01121133|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93131159|NCT01121133|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93131160|NCT01121133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131161|NCT01218321|Anticonvulsants|anticonvulsants|mesh-list
93131162|NCT01214889|Vaccines|vaccines|mesh-list
93131163|NCT01214889|Immunologic Factors|immunologic factors|mesh-ancestor
93131164|NCT01214889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131165|NCT01123317|Oxytocin|oxytocin|mesh-list
93131166|NCT01123317|Oxytocics|oxytocics|mesh-ancestor
93131167|NCT01123317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93131168|NCT01123317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131169|NCT01121289|Insulin Aspart|insulin aspart|mesh-list
93131170|NCT01121289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93131171|NCT01121289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131172|NCT01123473|Fluorouracil|fluorouracil|mesh-list
93131173|NCT01123473|Capecitabine|capecitabine|mesh-list
93131174|NCT01123473|Epirubicin|epirubicin|mesh-list
93131175|NCT01123473|Lapatinib|lapatinib|mesh-list
93131176|NCT01123473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803344|NCT05660473|Prednisone|prednisone|mesh-list
93131177|NCT01123473|Antimetabolites|antimetabolites|mesh-ancestor
93131178|NCT01123473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131179|NCT01123473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93131180|NCT01123473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93131181|NCT01123473|Immunologic Factors|immunologic factors|mesh-ancestor
93131182|NCT01123473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131183|NCT01123473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93131184|NCT01123473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93131185|NCT01123473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93131186|NCT01123473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131187|NCT01123473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131189|NCT01123551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93131190|NCT01123551|Narcotics|narcotics|mesh-ancestor
93131191|NCT01123551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131192|NCT01123551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131193|NCT01123551|Analgesics|analgesics|mesh-ancestor
93131194|NCT01123551|Sensory System Agents|sensory system agents|mesh-ancestor
93131195|NCT01123551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131196|NCT01125657|Darexaban|darexaban|mesh-list
93131197|NCT01125657|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93131198|NCT01125657|Antithrombins|antithrombins|mesh-ancestor
93131199|NCT01125657|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93131200|NCT01125657|Protease Inhibitors|protease inhibitors|mesh-ancestor
93131201|NCT01125657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131202|NCT01125657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131203|NCT01125657|Anticoagulants|anticoagulants|mesh-ancestor
93131204|NCT03934203|Moxifloxacin|moxifloxacin|mesh-list
93131205|NCT03934203|BI 409306|bi 409306|mesh-list
93131206|NCT03934203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131207|NCT03934203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131208|NCT03934203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93131209|NCT03934203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93131210|NCT03934203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071396|NCT00077636|Interferon-alpha|interferon-alpha|mesh-list
93131211|NCT03934203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131212|NCT03934203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131213|NCT03934203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93131214|NCT03934047|Tranexamic Acid|tranexamic acid|mesh-list
93131215|NCT03934047|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93131216|NCT03934047|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93131217|NCT03934047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131218|NCT03934047|Hemostatics|hemostatics|mesh-ancestor
93131219|NCT03934047|Coagulants|coagulants|mesh-ancestor
93131220|NCT01218711|Losartan|losartan|mesh-list
93131221|NCT01218711|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93131222|NCT01218711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93131223|NCT01218711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131224|NCT01218711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93131225|NCT01218711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93131226|NCT01218711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131227|NCT01218711|Diuretics|diuretics|mesh-ancestor
93131228|NCT01218711|Natriuretic Agents|natriuretic agents|mesh-ancestor
93131229|NCT01218711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131230|NCT01218711|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93131231|NCT01218711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131232|NCT01125891|Gemcitabine|gemcitabine|mesh-list
93131233|NCT01125891|ON 01910|on 01910|mesh-list
93131234|NCT01125891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93131235|NCT01125891|Antimetabolites|antimetabolites|mesh-ancestor
93131236|NCT01125891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131237|NCT01125891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131238|NCT01125891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131239|NCT01125891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131240|NCT01124253|Endostatins|endostatins|mesh-list
93131241|NCT01124253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93131242|NCT01124253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93131243|NCT01124253|Growth Substances|growth substances|mesh-ancestor
93131244|NCT01124253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131245|NCT01124253|Growth Inhibitors|growth inhibitors|mesh-ancestor
93131246|NCT01124253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131247|NCT01215669|Vaccines|vaccines|mesh-list
93131248|NCT01215669|Immunologic Factors|immunologic factors|mesh-ancestor
93131249|NCT01215669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131250|NCT01222221|Temozolomide|temozolomide|mesh-list
93131251|NCT01222221|Sargramostim|sargramostim|mesh-list
93131252|NCT01222221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93131253|NCT01222221|Alkylating Agents|alkylating agents|mesh-ancestor
93131254|NCT01222221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131255|NCT01222221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131256|NCT01222221|Immunologic Factors|immunologic factors|mesh-ancestor
93131257|NCT01222221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131258|NCT01220661|Cefotetan|cefotetan|mesh-list
93131259|NCT01220661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131260|NCT01220661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131261|NCT02903914|Pembrolizumab|pembrolizumab|mesh-list
93131262|NCT02903914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93131263|NCT02903914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131264|NCT02903914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93131265|NCT02903914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131266|NCT01222611|Fosamprenavir|fosamprenavir|mesh-list
93131267|NCT01222611|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93131268|NCT01222611|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93131269|NCT01222611|Protease Inhibitors|protease inhibitors|mesh-ancestor
93131270|NCT01222611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131271|NCT01222611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131272|NCT01222611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93131273|NCT01222611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93131274|NCT01222611|Antiviral Agents|antiviral agents|mesh-ancestor
93131275|NCT01222611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131276|NCT03928353|Ticagrelor|ticagrelor|mesh-list
93131277|NCT03928353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93131278|NCT03928353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93131279|NCT03928353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93131280|NCT03928353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93131281|NCT03928353|Purinergic Agents|purinergic agents|mesh-ancestor
93131282|NCT03928353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131283|NCT03928353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931544|NCT04059484|Exemestane|exemestane|mesh-list
93131284|NCT03928353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131285|NCT03931863|Ondansetron|ondansetron|mesh-list
93131286|NCT03931863|Antiemetics|antiemetics|mesh-ancestor
93131287|NCT03931863|Autonomic Agents|autonomic agents|mesh-ancestor
93131288|NCT03931863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131289|NCT03931863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131290|NCT03931863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93131291|NCT03931863|Antipruritics|antipruritics|mesh-ancestor
93131292|NCT03931863|Dermatologic Agents|dermatologic agents|mesh-ancestor
93131293|NCT03931863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93131294|NCT03931863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93131295|NCT03931863|Serotonin Agents|serotonin agents|mesh-ancestor
93131296|NCT03931863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131297|NCT03931863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131298|NCT03650608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93131299|NCT03650608|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93131300|NCT01226355|Sirolimus|sirolimus|mesh-list
93131301|NCT01226355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131302|NCT01226355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131303|NCT01226355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93131304|NCT01226355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131305|NCT01226355|Antifungal Agents|antifungal agents|mesh-ancestor
93131306|NCT01226355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93131307|NCT01226355|Immunologic Factors|immunologic factors|mesh-ancestor
93131308|NCT01226355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131309|NCT01129089|Micronutrients|micronutrients|mesh-list
93131310|NCT01129089|Trace Elements|trace elements|mesh-list
93131311|NCT01129089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131312|NCT01129323|Cyclophosphamide|cyclophosphamide|mesh-list
93131313|NCT01129323|Fludarabine|fludarabine|mesh-list
93131314|NCT01129323|Thymoglobulin|thymoglobulin|mesh-list
93131315|NCT01129323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93131316|NCT01129323|Immunologic Factors|immunologic factors|mesh-ancestor
93131317|NCT01129323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131318|NCT01129323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131319|NCT01129323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93131320|NCT01129323|Alkylating Agents|alkylating agents|mesh-ancestor
93131321|NCT01129323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131322|NCT01129323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131323|NCT01129323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93131324|NCT01221129|Zinc|zinc|mesh-list
93131325|NCT01221129|Trace Elements|trace elements|mesh-ancestor
93131326|NCT01221129|Micronutrients|micronutrients|mesh-ancestor
93131327|NCT01221129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131328|NCT01222923|Risperidone|risperidone|mesh-list
93131329|NCT01222923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93131330|NCT01222923|Serotonin Agents|serotonin agents|mesh-ancestor
93131331|NCT01222923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131332|NCT01222923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131333|NCT01222923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131334|NCT01222923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93131335|NCT01222923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93131336|NCT01222923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131337|NCT01222923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93131338|NCT01222923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93131339|NCT01222923|Dopamine Agents|dopamine agents|mesh-ancestor
93131340|NCT01223079|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93131341|NCT01223079|Hormones|hormones|mesh-ancestor
93131342|NCT01223079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131343|NCT01223079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131344|NCT03648970|Pravastatin|pravastatin|mesh-list
93131345|NCT03648970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93131346|NCT03648970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93131347|NCT03648970|Antimetabolites|antimetabolites|mesh-ancestor
93131348|NCT03648970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131349|NCT03648970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93131350|NCT03648970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93131351|NCT03648970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131352|NCT03927963|Dexmedetomidine|dexmedetomidine|mesh-list
93131353|NCT03927963|Propofol|propofol|mesh-list
93131354|NCT03927963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131355|NCT03927963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131356|NCT03927963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131357|NCT03927963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93131358|NCT03927963|Analgesics|analgesics|mesh-ancestor
93131359|NCT03927963|Sensory System Agents|sensory system agents|mesh-ancestor
93131360|NCT03927963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131361|NCT03927963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93131362|NCT03927963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93131363|NCT03927963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93131364|NCT03927963|Adrenergic Agents|adrenergic agents|mesh-ancestor
93131365|NCT03927963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131366|NCT03927963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131367|NCT03927963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93131368|NCT03927963|Anesthetics, General|anesthetics, general|mesh-ancestor
93131369|NCT03927963|Anesthetics|anesthetics|mesh-ancestor
93131370|NCT03648346|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93131371|NCT01127529|Protein C|protein c|mesh-list
93131372|NCT01127529|Anticoagulants|anticoagulants|mesh-ancestor
93131373|NCT01127529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93131374|NCT01127529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93131375|NCT01127529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131376|NCT01226667|Pregabalin|pregabalin|mesh-list
93131377|NCT01226667|Analgesics|analgesics|mesh-ancestor
93131378|NCT01226667|Sensory System Agents|sensory system agents|mesh-ancestor
93131379|NCT01226667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131380|NCT01226667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131381|NCT01226667|Anticonvulsants|anticonvulsants|mesh-ancestor
93131382|NCT01226667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93131383|NCT01226667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131384|NCT01226667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131385|NCT01226667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93131386|NCT01226667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93131387|NCT01226667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93131388|NCT01226667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131389|NCT01226667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93131390|NCT03927807|Misoprostol|misoprostol|mesh-list
93131391|NCT03927807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93131392|NCT03927807|Abortifacient Agents|abortifacient agents|mesh-ancestor
93131393|NCT03927807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93131394|NCT03927807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131395|NCT03927807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93131396|NCT03927807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93131397|NCT03927807|Oxytocics|oxytocics|mesh-ancestor
93131398|NCT05284942|Mycophenolic Acid|mycophenolic acid|mesh-list
92803571|NCT01123070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131399|NCT05284942|Prednisone|prednisone|mesh-list
93131400|NCT05284942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93131402|NCT05284942|Hormones|hormones|mesh-ancestor
93131403|NCT05284942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131404|NCT05284942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131405|NCT05284942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93131406|NCT05284942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131407|NCT05284942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93131408|NCT05284942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93131409|NCT05284942|Antitubercular Agents|antitubercular agents|mesh-ancestor
93131410|NCT05284942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131411|NCT05284942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131412|NCT05284942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131413|NCT05284942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131414|NCT03648034|Ropivacaine|ropivacaine|mesh-list
93131415|NCT03648034|Anesthetics, Local|anesthetics, local|mesh-ancestor
93131416|NCT03648034|Anesthetics|anesthetics|mesh-ancestor
93131417|NCT03648034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131418|NCT03648034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131419|NCT03648034|Sensory System Agents|sensory system agents|mesh-ancestor
93131420|NCT03648034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131421|NCT01129479|Galantamine|galantamine|mesh-list
93131422|NCT01129479|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93131423|NCT01129479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131424|NCT01129479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131425|NCT01129479|Cholinergic Agents|cholinergic agents|mesh-ancestor
93131426|NCT01129479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131427|NCT01129479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131428|NCT01129479|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93131429|NCT01129479|Autonomic Agents|autonomic agents|mesh-ancestor
93131430|NCT01129479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131431|NCT01129479|Nootropic Agents|nootropic agents|mesh-ancestor
93131432|NCT03647956|Bevacizumab|bevacizumab|mesh-list
93131433|NCT03647956|Atezolizumab|atezolizumab|mesh-list
93131434|NCT03647956|Carboplatin|carboplatin|mesh-list
93131435|NCT03647956|Pemetrexed|pemetrexed|mesh-list
93131436|NCT03647956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93131437|NCT03647956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131438|NCT03647956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93131439|NCT03647956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93131440|NCT03647956|Growth Substances|growth substances|mesh-ancestor
93131441|NCT03647956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131442|NCT03647956|Growth Inhibitors|growth inhibitors|mesh-ancestor
93131443|NCT03647956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131444|NCT03647956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131445|NCT03647956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93131446|NCT03647956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93131447|NCT03647956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93131448|NCT01221675|Antibodies|antibodies|mesh-list
93131449|NCT01221675|Immunologic Factors|immunologic factors|mesh-ancestor
93131450|NCT01221675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131451|NCT03927729|Methoxyflurane|methoxyflurane|mesh-list
93131452|NCT03927729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93131453|NCT03927729|Anesthetics, General|anesthetics, general|mesh-ancestor
93131454|NCT03927729|Anesthetics|anesthetics|mesh-ancestor
93131455|NCT03927729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131456|NCT03927729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131457|NCT01226823|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93131458|NCT01226823|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93131459|NCT01226823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93131460|NCT02968576|Tenofovir|tenofovir|mesh-list
93131461|NCT02968576|Emtricitabine|emtricitabine|mesh-list
93131462|NCT02968576|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93131463|NCT02968576|Antiviral Agents|antiviral agents|mesh-ancestor
93131464|NCT02968576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131465|NCT02968576|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93131466|NCT02968576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93131467|NCT02968576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131468|NCT02968576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131469|NCT02968576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93131470|NCT02968576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93131471|NCT01127217|Losartan|losartan|mesh-list
93131472|NCT01127217|Amlodipine|amlodipine|mesh-list
93131473|NCT01127217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131474|NCT01127217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93131475|NCT01127217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131476|NCT01127217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131477|NCT01127217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93131478|NCT01127217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131479|NCT01127217|Vasodilator Agents|vasodilator agents|mesh-ancestor
93131480|NCT01127217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93131481|NCT01127217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93131482|NCT01127217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93131483|NCT01226901|Niraparib|niraparib|mesh-list
93131484|NCT01226901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93131485|NCT01226901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131486|NCT01226901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131487|NCT01226901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131488|NCT03648658|Acetaminophen|acetaminophen|mesh-list
93131489|NCT03648658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93131490|NCT03648658|Analgesics|analgesics|mesh-ancestor
93131491|NCT03648658|Sensory System Agents|sensory system agents|mesh-ancestor
93131492|NCT03648658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131493|NCT03648658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131494|NCT03648658|Antipyretics|antipyretics|mesh-ancestor
93131495|NCT03931239|Vaccines|vaccines|mesh-list
93131496|NCT03931239|Immunologic Factors|immunologic factors|mesh-ancestor
93131497|NCT03931239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131498|NCT03927495|Paclitaxel|paclitaxel|mesh-list
93131499|NCT03927495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93131500|NCT03927495|Cisplatin|cisplatin|mesh-list
93131501|NCT03927495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93131502|NCT03927495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131503|NCT03927495|Tubulin Modulators|tubulin modulators|mesh-ancestor
93131504|NCT03927495|Antimitotic Agents|antimitotic agents|mesh-ancestor
93131505|NCT03927495|Mitosis Modulators|mitosis modulators|mesh-ancestor
93131506|NCT03927495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131507|NCT02966002|Aspirin|aspirin|mesh-list
93131508|NCT02966002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93131509|NCT02966002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93131510|NCT02966002|Analgesics|analgesics|mesh-ancestor
93131511|NCT02966002|Sensory System Agents|sensory system agents|mesh-ancestor
93131512|NCT02966002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131513|NCT02966002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131514|NCT02966002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93131515|NCT02966002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131516|NCT02966002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93131517|NCT02966002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93131518|NCT02966002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131519|NCT02966002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93131520|NCT02966002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93131521|NCT02966002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131522|NCT02966002|Antipyretics|antipyretics|mesh-ancestor
93131523|NCT01127295|Tamoxifen|tamoxifen|mesh-list
93131524|NCT01127295|Letrozole|letrozole|mesh-list
93131525|NCT01127295|Anastrozole|anastrozole|mesh-list
93131526|NCT01127295|Exemestane|exemestane|mesh-list
93131527|NCT01127295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131528|NCT01127295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93131529|NCT01127295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93131530|NCT01127295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131531|NCT01127295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131532|NCT01127295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93131533|NCT01127295|Hormone Antagonists|hormone antagonists|mesh-ancestor
93131534|NCT01127295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131535|NCT01127295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131536|NCT01127295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93131537|NCT01127295|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93131538|NCT01127295|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93131539|NCT01127295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93131540|NCT01129713|Esomeprazole|esomeprazole|mesh-list
93131541|NCT01129713|Omeprazole|omeprazole|mesh-list
93131542|NCT01129713|Lansoprazole|lansoprazole|mesh-list
93131543|NCT01129713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93131544|NCT01129713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93131545|NCT01129713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93131546|NCT01129713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131547|NCT01129713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131549|NCT01221831|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93131550|NCT01221831|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93131551|NCT01221831|Estradiol|estradiol|mesh-list
93131552|NCT01221831|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93131553|NCT01221831|Estrogens|estrogens|mesh-ancestor
93131554|NCT01221831|Hormones|hormones|mesh-ancestor
93131555|NCT01221831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131556|NCT01221831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131557|NCT01221831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93131558|NCT01221831|Contraceptive Agents|contraceptive agents|mesh-ancestor
93131559|NCT01221831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93131560|NCT01221831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93131561|NCT01221831|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93131562|NCT01221831|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93131563|NCT01221831|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93131564|NCT01221831|Hormone Antagonists|hormone antagonists|mesh-ancestor
93131565|NCT01221831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93131566|NCT01221831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131567|NCT03931317|Timolol|timolol|mesh-list
93131568|NCT03931317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131569|NCT03931317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93131570|NCT03931317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93131571|NCT03931317|Adrenergic Agents|adrenergic agents|mesh-ancestor
93131572|NCT03931317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131573|NCT03931317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131574|NCT03931317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93131575|NCT03931317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131576|NCT01221909|Tranexamic Acid|tranexamic acid|mesh-list
93131577|NCT01221909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93131578|NCT01221909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93131579|NCT01221909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131580|NCT01221909|Hemostatics|hemostatics|mesh-ancestor
93131581|NCT01221909|Coagulants|coagulants|mesh-ancestor
93131582|NCT02900092|Ganaxolone|ganaxolone|mesh-list
93131583|NCT02900092|Neurosteroids|neurosteroids|mesh-ancestor
93131584|NCT02900092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131585|NCT02900092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131586|NCT02900092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131587|NCT02900092|GABA Modulators|gaba modulators|mesh-ancestor
93131588|NCT02900092|GABA Agents|gaba agents|mesh-ancestor
93131589|NCT01130025|Tinzaparin|tinzaparin|mesh-list
93131590|NCT01130025|Warfarin|warfarin|mesh-list
93131591|NCT01130025|Anticoagulants|anticoagulants|mesh-ancestor
93131592|NCT01130025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93131593|NCT01130025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93131594|NCT01130025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131595|NCT03925155|Iodine|iodine|mesh-list
93131596|NCT03925155|Chlorhexidine|chlorhexidine|mesh-list
93131597|NCT03925155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93131598|NCT03925155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131599|NCT03925155|Disinfectants|disinfectants|mesh-ancestor
93131600|NCT03925155|Trace Elements|trace elements|mesh-ancestor
93131601|NCT03925155|Micronutrients|micronutrients|mesh-ancestor
93131602|NCT03925155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131603|NCT01131195|Paclitaxel|paclitaxel|mesh-list
93131604|NCT01131195|Cyclophosphamide|cyclophosphamide|mesh-list
93131605|NCT01131195|Bevacizumab|bevacizumab|mesh-list
93131606|NCT01131195|Capecitabine|capecitabine|mesh-list
93131607|NCT01131195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93131608|NCT01131195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131609|NCT01131195|Tubulin Modulators|tubulin modulators|mesh-ancestor
93131610|NCT01131195|Antimitotic Agents|antimitotic agents|mesh-ancestor
93131611|NCT01131195|Mitosis Modulators|mitosis modulators|mesh-ancestor
93131612|NCT01131195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131613|NCT01131195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93131614|NCT01131195|Immunologic Factors|immunologic factors|mesh-ancestor
93131615|NCT01131195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131616|NCT01131195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131617|NCT01131195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93131618|NCT01131195|Alkylating Agents|alkylating agents|mesh-ancestor
93131619|NCT01131195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93131620|NCT01131195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93131621|NCT01131195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93131622|NCT01131195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93131623|NCT01131195|Growth Substances|growth substances|mesh-ancestor
93131624|NCT01131195|Growth Inhibitors|growth inhibitors|mesh-ancestor
93131625|NCT01131195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93131626|NCT01131195|Antimetabolites|antimetabolites|mesh-ancestor
93131627|NCT01227135|Hydroxychloroquine|hydroxychloroquine|mesh-list
93131628|NCT01227135|Imatinib Mesylate|imatinib mesylate|mesh-list
93131629|NCT01227135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131630|NCT01227135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131631|NCT01227135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131632|NCT01227135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131633|NCT01227135|Antimalarials|antimalarials|mesh-ancestor
93131634|NCT01227135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93131635|NCT01227135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93131636|NCT01227135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131637|NCT01227135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131638|NCT01223625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93131639|NCT01223625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93131640|NCT01223625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93131641|NCT01223625|Antimetabolites|antimetabolites|mesh-ancestor
93131642|NCT01223625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131643|NCT01223625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93131644|NCT01223625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93131645|NCT01223625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131646|NCT01228227|Atorvastatin|atorvastatin|mesh-list
93131647|NCT01228227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93131648|NCT01228227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93131649|NCT01228227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93131650|NCT01228227|Antimetabolites|antimetabolites|mesh-ancestor
93131651|NCT01228227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131652|NCT01228227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93131653|NCT01228227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93131654|NCT01228227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131655|NCT04052854|Zanubrutinib|zanubrutinib|mesh-list
93131656|NCT04052854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131657|NCT04052854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131658|NCT04052854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131659|NCT04052854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131660|NCT03740373|Budesonide|budesonide|mesh-list
93131661|NCT03740373|Glycopyrrolate|glycopyrrolate|mesh-list
93131662|NCT03740373|Formoterol Fumarate|formoterol fumarate|mesh-list
93131663|NCT03740373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93131664|NCT03740373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93131665|NCT03740373|Autonomic Agents|autonomic agents|mesh-ancestor
93131666|NCT03740373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131667|NCT03740373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131668|NCT03740373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93131669|NCT03740373|Respiratory System Agents|respiratory system agents|mesh-ancestor
93131670|NCT03740373|Glucocorticoids|glucocorticoids|mesh-ancestor
93131671|NCT03740373|Hormones|hormones|mesh-ancestor
93131672|NCT03740373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131673|NCT03740373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93131674|NCT03740373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93131675|NCT03740373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93131676|NCT03740373|Adrenergic Agents|adrenergic agents|mesh-ancestor
93131677|NCT03740373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131678|NCT03740373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131679|NCT03740373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93131680|NCT03740373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93131681|NCT03740373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93131682|NCT03740373|Cholinergic Agents|cholinergic agents|mesh-ancestor
93131683|NCT01228305|Acetaminophen|acetaminophen|mesh-list
93131684|NCT01228305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93131685|NCT01228305|Analgesics|analgesics|mesh-ancestor
93131686|NCT01228305|Sensory System Agents|sensory system agents|mesh-ancestor
93131687|NCT01228305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131688|NCT01228305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131689|NCT01228305|Antipyretics|antipyretics|mesh-ancestor
93131690|NCT02902120|Grazoprevir|grazoprevir|mesh-list
93131691|NCT02902120|Antiviral Agents|antiviral agents|mesh-ancestor
93131692|NCT02902120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131693|NCT03646396|Sofosbuvir|sofosbuvir|mesh-list
93131694|NCT03646396|Antiviral Agents|antiviral agents|mesh-ancestor
93131695|NCT03646396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131696|NCT01131273|Buprenorphine|buprenorphine|mesh-list
93131697|NCT01131273|Methadone|methadone|mesh-list
93131698|NCT01131273|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93131699|NCT01131273|Naloxone|naloxone|mesh-list
93131700|NCT01131273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93131701|NCT01131273|Narcotics|narcotics|mesh-ancestor
93131702|NCT01131273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131703|NCT01131273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131704|NCT01131273|Analgesics|analgesics|mesh-ancestor
93131705|NCT01131273|Sensory System Agents|sensory system agents|mesh-ancestor
93131706|NCT01131273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131707|NCT01131273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93131708|NCT01131273|Antitussive Agents|antitussive agents|mesh-ancestor
93131709|NCT01131273|Respiratory System Agents|respiratory system agents|mesh-ancestor
93131711|NCT03646318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131712|NCT03646318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93131713|NCT03646318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93131714|NCT03646318|Serotonin Agents|serotonin agents|mesh-ancestor
93131715|NCT03646318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131716|NCT03646318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131717|NCT03646318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131718|NCT01130181|Cholecalciferol|cholecalciferol|mesh-list
93131719|NCT01130181|Vitamin D|vitamin d|mesh-list
93131720|NCT01130181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93131721|NCT01130181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131722|NCT01130181|Vitamins|vitamins|mesh-ancestor
93131723|NCT01130181|Micronutrients|micronutrients|mesh-ancestor
93131724|NCT01130181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93131725|NCT03621514|Lidocaine|lidocaine|mesh-list
93131726|NCT03621514|Anesthetics, Local|anesthetics, local|mesh-ancestor
93131727|NCT03621514|Anesthetics|anesthetics|mesh-ancestor
93131728|NCT03621514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131729|NCT03621514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131730|NCT03621514|Sensory System Agents|sensory system agents|mesh-ancestor
93131731|NCT03621514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131732|NCT03621514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93131733|NCT03621514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93131734|NCT03621514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93131735|NCT03621514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131736|NCT03621514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131737|NCT01127841|Rituximab|rituximab|mesh-list
93131738|NCT01127841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93131739|NCT01127841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93131740|NCT01127841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131741|NCT01127841|Immunologic Factors|immunologic factors|mesh-ancestor
93131742|NCT01127841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131743|NCT01127841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131744|NCT01127841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93131745|NCT01127841|Alkylating Agents|alkylating agents|mesh-ancestor
93131746|NCT01127841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131747|NCT01227603|Candesartan|candesartan|mesh-list
93131748|NCT01227603|Candesartan cilexetil|candesartan cilexetil|mesh-list
93131749|NCT01227603|Nifedipine|nifedipine|mesh-list
93131750|NCT01227603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131751|NCT01227603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93131752|NCT01227603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93131753|NCT01227603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131754|NCT01227603|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93131755|NCT01227603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131756|NCT01227603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93131757|NCT01227603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131758|NCT01227603|Vasodilator Agents|vasodilator agents|mesh-ancestor
93131759|NCT01227603|Tocolytic Agents|tocolytic agents|mesh-ancestor
93131760|NCT01227603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93131761|NCT01130259|Iniparib|iniparib|mesh-list
93131762|NCT01130259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93131763|NCT01130259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131764|NCT01130259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131765|NCT01130259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131766|NCT01585623|Metoprolol|metoprolol|mesh-list
93131767|NCT01585623|Midazolam|midazolam|mesh-list
93131768|NCT01585623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93131769|NCT01585623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131770|NCT01585623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131771|NCT01585623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803943|NCT00630708|Benazepril|benazepril|mesh-list
93131772|NCT01585623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93131773|NCT01585623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93131774|NCT01585623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93131775|NCT01585623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93131776|NCT01585623|Anesthetics, General|anesthetics, general|mesh-ancestor
93131778|NCT01585623|GABA Modulators|gaba modulators|mesh-ancestor
93131779|NCT01585623|GABA Agents|gaba agents|mesh-ancestor
93131780|NCT01585623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131781|NCT01585623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131782|NCT01585623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93131783|NCT01585623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131784|NCT01585623|Sympatholytics|sympatholytics|mesh-ancestor
93131785|NCT01585623|Autonomic Agents|autonomic agents|mesh-ancestor
93131786|NCT01585623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131787|NCT01585623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93131788|NCT01585623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93131789|NCT01585623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93131790|NCT01585623|Adrenergic Agents|adrenergic agents|mesh-ancestor
93131791|NCT03926559|Morphine|morphine|mesh-list
93131792|NCT03926559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93131793|NCT03926559|Narcotics|narcotics|mesh-ancestor
93131794|NCT03926559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131795|NCT03926559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131796|NCT03926559|Analgesics|analgesics|mesh-ancestor
93131797|NCT03926559|Sensory System Agents|sensory system agents|mesh-ancestor
93131798|NCT03926559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131799|NCT01228617|Nicotine|nicotine|mesh-list
93131800|NCT01228617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93131801|NCT01228617|Autonomic Agents|autonomic agents|mesh-ancestor
93131802|NCT01228617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131803|NCT01228617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131804|NCT01228617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93131805|NCT01228617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93131806|NCT01228617|Cholinergic Agents|cholinergic agents|mesh-ancestor
93131807|NCT01228617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131808|NCT01228617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131809|NCT01227759|Tyrothricin|tyrothricin|mesh-list
93131810|NCT01227759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93131811|NCT01227759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131812|NCT01227759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131813|NCT03923829|Zinc|zinc|mesh-list
93131814|NCT03923829|Zinc Sulfate|zinc sulfate|mesh-list
93131815|NCT03923829|Trace Elements|trace elements|mesh-ancestor
93131816|NCT03923829|Micronutrients|micronutrients|mesh-ancestor
93131817|NCT03923829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131818|NCT03923829|Astringents|astringents|mesh-ancestor
93131819|NCT03923829|Dermatologic Agents|dermatologic agents|mesh-ancestor
93131820|NCT01128075|Interferon beta-1a|interferon beta-1a|mesh-list
93131821|NCT01128075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93131822|NCT01128075|Immunologic Factors|immunologic factors|mesh-ancestor
93131823|NCT01128075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131824|NCT01128075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131825|NCT01128075|Antiviral Agents|antiviral agents|mesh-ancestor
93131826|NCT01128075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131827|NCT03923751|Anesthetics|anesthetics|mesh-list
93131828|NCT03923751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131829|NCT03923751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131830|NCT03923361|Propofol|propofol|mesh-list
93131831|NCT03923361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131832|NCT03923361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131833|NCT03923361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131834|NCT03923361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93131835|NCT03923361|Anesthetics, General|anesthetics, general|mesh-ancestor
93131836|NCT03923361|Anesthetics|anesthetics|mesh-ancestor
93131837|NCT03740295|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93131838|NCT03740295|Antioxidants|antioxidants|mesh-ancestor
93131839|NCT03740295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131840|NCT03740295|Protective Agents|protective agents|mesh-ancestor
93131841|NCT03740295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131842|NCT03740295|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93131843|NCT03740295|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93131844|NCT03740295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131845|NCT03740295|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93131846|NCT02965378|Docetaxel|docetaxel|mesh-list
93131847|NCT02965378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131848|NCT02965378|Tubulin Modulators|tubulin modulators|mesh-ancestor
93131849|NCT02965378|Antimitotic Agents|antimitotic agents|mesh-ancestor
93131850|NCT02965378|Mitosis Modulators|mitosis modulators|mesh-ancestor
93131851|NCT02965378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131852|NCT01224093|Rituximab|rituximab|mesh-list
93131853|NCT01224093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93131854|NCT01224093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131855|NCT01224093|Immunologic Factors|immunologic factors|mesh-ancestor
93131856|NCT01224093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131857|NCT01224093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93131858|NCT03772041|Tolvaptan|tolvaptan|mesh-list
93131859|NCT03772041|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93131860|NCT03772041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131861|NCT03772041|Natriuretic Agents|natriuretic agents|mesh-ancestor
93131862|NCT03772041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131863|NCT03922815|Fentanyl|fentanyl|mesh-list
93131864|NCT03922815|Propofol|propofol|mesh-list
93131865|NCT03922815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131866|NCT03922815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131867|NCT03922815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131868|NCT03922815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93131869|NCT03922815|Anesthetics, General|anesthetics, general|mesh-ancestor
93131870|NCT03922815|Anesthetics|anesthetics|mesh-ancestor
93131871|NCT03922815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93131872|NCT03922815|Narcotics|narcotics|mesh-ancestor
93131873|NCT03922815|Analgesics|analgesics|mesh-ancestor
93131874|NCT03922815|Sensory System Agents|sensory system agents|mesh-ancestor
93131875|NCT03922815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131876|NCT03922815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93131877|NCT01227915|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93131878|NCT01227915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93131879|NCT01227915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93131880|NCT01227915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131881|NCT01227915|Glucocorticoids|glucocorticoids|mesh-ancestor
93131882|NCT01227915|Hormones|hormones|mesh-ancestor
93131883|NCT01227915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93131884|NCT01227915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131885|NCT01227915|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93131886|NCT01227915|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93131887|NCT01224405|Docetaxel|docetaxel|mesh-list
93131888|NCT01224405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131889|NCT01224405|Tubulin Modulators|tubulin modulators|mesh-ancestor
93131890|NCT01224405|Antimitotic Agents|antimitotic agents|mesh-ancestor
93131891|NCT01224405|Mitosis Modulators|mitosis modulators|mesh-ancestor
93131892|NCT01224405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131893|NCT02899156|Flumazenil|flumazenil|mesh-list
93131894|NCT02899156|Antidotes|antidotes|mesh-ancestor
93131895|NCT02899156|Protective Agents|protective agents|mesh-ancestor
93131896|NCT02899156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131897|NCT02899156|GABA Modulators|gaba modulators|mesh-ancestor
93131898|NCT02899156|GABA Agents|gaba agents|mesh-ancestor
93131899|NCT02899156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131900|NCT02899156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131901|NCT01131429|Cisplatin|cisplatin|mesh-list
93131902|NCT01131429|Docetaxel|docetaxel|mesh-list
93131903|NCT01131429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93131904|NCT01131429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131905|NCT01131429|Tubulin Modulators|tubulin modulators|mesh-ancestor
93131906|NCT01131429|Antimitotic Agents|antimitotic agents|mesh-ancestor
93131907|NCT01131429|Mitosis Modulators|mitosis modulators|mesh-ancestor
93131908|NCT01131429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131909|NCT01131429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131910|NCT01131429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131911|NCT03645304|Ropivacaine|ropivacaine|mesh-list
93131912|NCT03645304|Anesthetics, Local|anesthetics, local|mesh-ancestor
93131913|NCT03645304|Anesthetics|anesthetics|mesh-ancestor
93131914|NCT03645304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131915|NCT03645304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131916|NCT03645304|Sensory System Agents|sensory system agents|mesh-ancestor
93131917|NCT03645304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131918|NCT03773133|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93131919|NCT03773133|Chelating Agents|chelating agents|mesh-ancestor
93131920|NCT03773133|Sequestering Agents|sequestering agents|mesh-ancestor
93131921|NCT03773133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131922|NCT02969356|Botulinum Toxins|botulinum toxins|mesh-list
93131923|NCT02969356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93131925|NCT02969356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93131926|NCT02969356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131927|NCT02969356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131928|NCT02969356|Cholinergic Agents|cholinergic agents|mesh-ancestor
93131929|NCT02969356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131930|NCT02969356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131931|NCT02969356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93131932|NCT02969356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131933|NCT03646006|Bupivacaine|bupivacaine|mesh-list
93131934|NCT03646006|Anesthetics, Local|anesthetics, local|mesh-ancestor
93131935|NCT03646006|Anesthetics|anesthetics|mesh-ancestor
93131936|NCT03646006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131937|NCT03646006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131938|NCT03646006|Sensory System Agents|sensory system agents|mesh-ancestor
93131939|NCT03646006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131940|NCT03854344|Lidocaine|lidocaine|mesh-list
93131941|NCT03854344|Bupivacaine|bupivacaine|mesh-list
93131942|NCT03854344|Anesthetics, Local|anesthetics, local|mesh-ancestor
93131943|NCT03854344|Anesthetics|anesthetics|mesh-ancestor
93131944|NCT03854344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131945|NCT03854344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131946|NCT03854344|Sensory System Agents|sensory system agents|mesh-ancestor
93131947|NCT03854344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131948|NCT03854344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93131949|NCT03854344|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93131950|NCT03854344|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93131951|NCT03854344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93131952|NCT03854344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131953|NCT05284318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93131954|NCT05284318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93131955|NCT03609424|Imatinib Mesylate|imatinib mesylate|mesh-list
93131956|NCT03609424|Spartalizumab|spartalizumab|mesh-list
93131957|NCT03609424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93131958|NCT03609424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93131959|NCT03609424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93131960|NCT03609424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131961|NCT03609424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93131962|NCT03609424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93131963|NCT03645850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93131964|NCT03645850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93131965|NCT03644446|Bisoprolol|bisoprolol|mesh-list
93131966|NCT03644446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93131967|NCT03644446|Sympatholytics|sympatholytics|mesh-ancestor
93131968|NCT03644446|Autonomic Agents|autonomic agents|mesh-ancestor
93131969|NCT03644446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131970|NCT03644446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131971|NCT03644446|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93131972|NCT03644446|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93131973|NCT03644446|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93131974|NCT03644446|Adrenergic Agents|adrenergic agents|mesh-ancestor
93131975|NCT03644446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93131976|NCT03644446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93131977|NCT02898454|Mometasone Furoate|mometasone furoate|mesh-list
93131978|NCT02898454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93131979|NCT02898454|Dermatologic Agents|dermatologic agents|mesh-ancestor
93131980|NCT02898454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93131981|NCT05283850|Calcium, Dietary|calcium, dietary|mesh-list
93131982|NCT05283850|Calcium|calcium|mesh-list
93131983|NCT05283850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93131984|NCT05283850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131985|NCT05283850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93131986|NCT03925779|Dexmedetomidine|dexmedetomidine|mesh-list
93131987|NCT03925779|Remifentanil|remifentanil|mesh-list
93131988|NCT03925779|Propofol|propofol|mesh-list
93131989|NCT03925779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93131990|NCT03925779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93131991|NCT03925779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93131992|NCT03925779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93131993|NCT03925779|Analgesics|analgesics|mesh-ancestor
93131994|NCT03925779|Sensory System Agents|sensory system agents|mesh-ancestor
93131995|NCT03925779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93131996|NCT03925779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93131997|NCT03925779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93131998|NCT03925779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93131999|NCT03925779|Adrenergic Agents|adrenergic agents|mesh-ancestor
93132000|NCT03925779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132001|NCT03925779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132002|NCT03925779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93132003|NCT03925779|Anesthetics, General|anesthetics, general|mesh-ancestor
93132005|NCT03925779|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93132006|NCT03925779|Narcotics|narcotics|mesh-ancestor
93132007|NCT05283694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93132008|NCT05283694|Immunologic Factors|immunologic factors|mesh-ancestor
93132009|NCT05283694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132010|NCT03925701|Metformin|metformin|mesh-list
93132011|NCT03925701|Vildagliptin|vildagliptin|mesh-list
93132012|NCT03925701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93132013|NCT03925701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132014|NCT03925701|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93132015|NCT03925701|Protease Inhibitors|protease inhibitors|mesh-ancestor
93132016|NCT03925701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132017|NCT03925701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132018|NCT01224717|Teriparatide|teriparatide|mesh-list
93132019|NCT01224717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132020|NCT01224717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132021|NCT01224717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93132022|NCT03925233|Tamoxifen|tamoxifen|mesh-list
93132023|NCT03925233|Toremifene|toremifene|mesh-list
93132024|NCT03925233|Vinorelbine|vinorelbine|mesh-list
93132025|NCT03925233|Cyclophosphamide|cyclophosphamide|mesh-list
93132026|NCT03925233|Bevacizumab|bevacizumab|mesh-list
93132027|NCT03925233|Carboplatin|carboplatin|mesh-list
93132028|NCT03925233|Gemcitabine|gemcitabine|mesh-list
93132029|NCT03925233|Doxorubicin|doxorubicin|mesh-list
93132030|NCT03925233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93132031|NCT03925233|Fluorouracil|fluorouracil|mesh-list
93132032|NCT03925233|Capecitabine|capecitabine|mesh-list
93132033|NCT03925233|Methotrexate|methotrexate|mesh-list
93132034|NCT03925233|Trastuzumab|trastuzumab|mesh-list
93132035|NCT03925233|Letrozole|letrozole|mesh-list
93132036|NCT03925233|Apatinib|apatinib|mesh-list
93132037|NCT03925233|Epirubicin|epirubicin|mesh-list
93132038|NCT03925233|Fulvestrant|fulvestrant|mesh-list
93132039|NCT03925233|Olaparib|olaparib|mesh-list
93132040|NCT03925233|Anastrozole|anastrozole|mesh-list
93132041|NCT03925233|Exemestane|exemestane|mesh-list
93132042|NCT03925233|Endostatins|endostatins|mesh-list
93132043|NCT03925233|Pirarubicin|pirarubicin|mesh-list
93132044|NCT03925233|Citric Acid|citric acid|mesh-list
93132045|NCT03925233|Sodium Citrate|sodium citrate|mesh-list
93132046|NCT03925233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132047|NCT03925233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132048|NCT03925233|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132049|NCT03925233|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132050|NCT03925233|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132051|NCT03925233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132052|NCT03925233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132053|NCT03925233|Immunologic Factors|immunologic factors|mesh-ancestor
93132054|NCT03925233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132055|NCT03925233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132056|NCT03925233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93132057|NCT03925233|Alkylating Agents|alkylating agents|mesh-ancestor
93132058|NCT03925233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93132059|NCT03925233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93132060|NCT03925233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93132061|NCT03925233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93132062|NCT03925233|Growth Substances|growth substances|mesh-ancestor
93132063|NCT03925233|Growth Inhibitors|growth inhibitors|mesh-ancestor
93132064|NCT03925233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93132065|NCT03925233|Antimetabolites|antimetabolites|mesh-ancestor
93132066|NCT03925233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93132067|NCT03925233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93132068|NCT03925233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93132069|NCT03925233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132070|NCT03925233|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93132071|NCT03925233|Abortifacient Agents|abortifacient agents|mesh-ancestor
93132072|NCT03925233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93132073|NCT03925233|Dermatologic Agents|dermatologic agents|mesh-ancestor
93132074|NCT03925233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93132075|NCT03925233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93132076|NCT03925233|Anticoagulants|anticoagulants|mesh-ancestor
93132077|NCT03925233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93132078|NCT03925233|Chelating Agents|chelating agents|mesh-ancestor
93132079|NCT03925233|Sequestering Agents|sequestering agents|mesh-ancestor
93132080|NCT03925233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93132081|NCT03925233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93132082|NCT03925233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93132083|NCT03925233|Hormone Antagonists|hormone antagonists|mesh-ancestor
93132084|NCT03925233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132085|NCT03925233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93132086|NCT03925233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93132087|NCT03925233|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93132088|NCT03925233|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93132089|NCT03925233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93132090|NCT03925233|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93132091|NCT03925233|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93132092|NCT01130805|Capecitabine|capecitabine|mesh-list
93132093|NCT01130805|Oxaliplatin|oxaliplatin|mesh-list
93132094|NCT01130805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93132095|NCT01130805|Antimetabolites|antimetabolites|mesh-ancestor
93132096|NCT01130805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132097|NCT01130805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132098|NCT01345162|Ketorolac|ketorolac|mesh-list
93132099|NCT01345162|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93132100|NCT01345162|Tramadol|tramadol|mesh-list
93132101|NCT01345162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93132102|NCT01345162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132103|NCT01345162|Analgesics|analgesics|mesh-ancestor
93132104|NCT01345162|Sensory System Agents|sensory system agents|mesh-ancestor
93132105|NCT01345162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132106|NCT01345162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132107|NCT01345162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132108|NCT01345162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132109|NCT01345162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93132110|NCT01345162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132111|NCT01345162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132112|NCT01345162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93132113|NCT01345162|Narcotics|narcotics|mesh-ancestor
93132114|NCT01345162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132115|NCT01131039|Bevacizumab|bevacizumab|mesh-list
93132116|NCT01131039|Gemcitabine|gemcitabine|mesh-list
93132117|NCT01131039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93132118|NCT01131039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132119|NCT01131039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93132120|NCT01131039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93132121|NCT01131039|Growth Substances|growth substances|mesh-ancestor
93132122|NCT01131039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132123|NCT01131039|Growth Inhibitors|growth inhibitors|mesh-ancestor
93132124|NCT01131039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93132125|NCT01131039|Antimetabolites|antimetabolites|mesh-ancestor
93132126|NCT01131039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132127|NCT01229085|Salicylic Acid|salicylic acid|mesh-list
93132128|NCT01229085|Salicylates|salicylates|mesh-list
93132129|NCT01229085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132130|NCT01229085|Antifungal Agents|antifungal agents|mesh-ancestor
93132131|NCT01229085|Keratolytic Agents|keratolytic agents|mesh-ancestor
93132132|NCT01229085|Dermatologic Agents|dermatologic agents|mesh-ancestor
93132133|NCT01229085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93132134|NCT01229085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132135|NCT01229085|Analgesics|analgesics|mesh-ancestor
93132136|NCT01229085|Sensory System Agents|sensory system agents|mesh-ancestor
93132137|NCT01229085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132138|NCT01229085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132139|NCT01229085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132140|NCT01229085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132141|NCT01229085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93132142|NCT01229085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132143|NCT01229085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132144|NCT03921645|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93132145|NCT03921645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132146|NCT03643666|Dexamethasone|dexamethasone|mesh-list
93132147|NCT03643666|Magnesium Sulfate|magnesium sulfate|mesh-list
93132148|NCT03643666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132149|NCT03643666|Antiemetics|antiemetics|mesh-ancestor
93132150|NCT03643666|Autonomic Agents|autonomic agents|mesh-ancestor
93132151|NCT03643666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132152|NCT03643666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132153|NCT03643666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93132154|NCT03643666|Glucocorticoids|glucocorticoids|mesh-ancestor
93132155|NCT03643666|Hormones|hormones|mesh-ancestor
93132156|NCT03643666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132157|NCT03643666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93132158|NCT03643666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132159|NCT03643666|Analgesics|analgesics|mesh-ancestor
93132160|NCT03643666|Sensory System Agents|sensory system agents|mesh-ancestor
93132161|NCT03643666|Anesthetics|anesthetics|mesh-ancestor
93132162|NCT03643666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132163|NCT03643666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93132164|NCT03643666|Anticonvulsants|anticonvulsants|mesh-ancestor
93132165|NCT03643666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93132166|NCT03643666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132167|NCT03643666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132168|NCT03643666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132169|NCT03643666|Tocolytic Agents|tocolytic agents|mesh-ancestor
93132170|NCT03643666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93132171|NCT03643588|Hyaluronic Acid|hyaluronic acid|mesh-list
93132172|NCT03643588|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93132173|NCT03643588|Immunologic Factors|immunologic factors|mesh-ancestor
93132174|NCT03643588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132175|NCT03643588|Viscosupplements|viscosupplements|mesh-ancestor
93132176|NCT03643588|Protective Agents|protective agents|mesh-ancestor
93132177|NCT01224951|Beclomethasone|beclomethasone|mesh-list
93132178|NCT01224951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132179|NCT01224951|Glucocorticoids|glucocorticoids|mesh-ancestor
93132180|NCT01224951|Hormones|hormones|mesh-ancestor
93132181|NCT01224951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132182|NCT01224951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132183|NCT01224951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93132184|NCT01224951|Respiratory System Agents|respiratory system agents|mesh-ancestor
93132185|NCT03641404|Ergothioneine|ergothioneine|mesh-list
93132186|NCT03641404|Antioxidants|antioxidants|mesh-ancestor
93132187|NCT03641404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132188|NCT03641404|Protective Agents|protective agents|mesh-ancestor
93132189|NCT03641404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132190|NCT01131741|Epinephrine|epinephrine|mesh-list
93132191|NCT01131741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93132192|NCT01131741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93132193|NCT01131741|Adrenergic Agents|adrenergic agents|mesh-ancestor
93132194|NCT01131741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132195|NCT01131741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132196|NCT01131741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132197|NCT01131741|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93132198|NCT01131741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93132199|NCT01131741|Autonomic Agents|autonomic agents|mesh-ancestor
93132200|NCT01131741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132201|NCT01131741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93132202|NCT01131741|Respiratory System Agents|respiratory system agents|mesh-ancestor
93132203|NCT01131741|Mydriatics|mydriatics|mesh-ancestor
93132204|NCT01131741|Sympathomimetics|sympathomimetics|mesh-ancestor
93132205|NCT01131741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93132206|NCT03919851|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93132207|NCT03919851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132208|NCT03921567|Lidocaine|lidocaine|mesh-list
93132209|NCT03921567|Ketamine|ketamine|mesh-list
93132210|NCT03921567|Anesthetics, Local|anesthetics, local|mesh-ancestor
93132211|NCT03921567|Anesthetics|anesthetics|mesh-ancestor
93132212|NCT03921567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132213|NCT03921567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132214|NCT03921567|Sensory System Agents|sensory system agents|mesh-ancestor
93132215|NCT03921567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132216|NCT03921567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93132217|NCT03921567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93132218|NCT03921567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93132219|NCT03921567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132220|NCT03921567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132221|NCT03921567|Analgesics|analgesics|mesh-ancestor
93132222|NCT03921567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93132223|NCT03921567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93132224|NCT03921567|Anesthetics, General|anesthetics, general|mesh-ancestor
93132225|NCT03921567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93132226|NCT03921567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93132227|NCT03921567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132228|NCT01229241|Anesthetics|anesthetics|mesh-list
93132229|NCT01229241|Anesthetics, Local|anesthetics, local|mesh-list
93132230|NCT01229241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132231|NCT01229241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132232|NCT01229241|Sensory System Agents|sensory system agents|mesh-ancestor
93132233|NCT01229241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132234|NCT05252884|Calcium, Dietary|calcium, dietary|mesh-list
93132235|NCT05252884|Calcitriol|calcitriol|mesh-list
93132236|NCT05252884|Calcium Carbonate|calcium carbonate|mesh-list
93132237|NCT05252884|Calcium|calcium|mesh-list
93132238|NCT05252884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132239|NCT05252884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132240|NCT05252884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93132241|NCT05252884|Antacids|antacids|mesh-ancestor
93132242|NCT05252884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132243|NCT05252884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93132244|NCT05252884|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93132245|NCT05252884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132246|NCT05252884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93132247|NCT05252884|Vitamins|vitamins|mesh-ancestor
93132248|NCT05252884|Micronutrients|micronutrients|mesh-ancestor
93132249|NCT03921177|Micronutrients|micronutrients|mesh-list
93132250|NCT03921177|Trace Elements|trace elements|mesh-list
93132251|NCT03921177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132252|NCT01229319|Imiquimod|imiquimod|mesh-list
93132253|NCT01229319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93132254|NCT01229319|Immunologic Factors|immunologic factors|mesh-ancestor
93132255|NCT01229319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132256|NCT01229319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132257|NCT01229319|Interferon Inducers|interferon inducers|mesh-ancestor
93132258|NCT03921099|Ascorbic Acid|ascorbic acid|mesh-list
93132259|NCT03921099|Vitamins|vitamins|mesh-ancestor
93132260|NCT03921099|Micronutrients|micronutrients|mesh-ancestor
93132261|NCT03921099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132262|NCT03921099|Antioxidants|antioxidants|mesh-ancestor
93072433|NCT04535713|Docetaxel|docetaxel|mesh-list
93132263|NCT03921099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132264|NCT03921099|Protective Agents|protective agents|mesh-ancestor
93132265|NCT02962648|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93132266|NCT02962648|Hematinics|hematinics|mesh-ancestor
93132267|NCT03920631|Nivolumab|nivolumab|mesh-list
93132268|NCT03920631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93132269|NCT03920631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132270|NCT03920631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93132271|NCT03920631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132272|NCT03930069|Vasopressins|vasopressins|mesh-list
93132273|NCT03930069|Arginine Vasopressin|arginine vasopressin|mesh-list
93132274|NCT03930069|Misoprostol|misoprostol|mesh-list
93132275|NCT03930069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93132276|NCT03930069|Abortifacient Agents|abortifacient agents|mesh-ancestor
93132277|NCT03930069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93132278|NCT03930069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132279|NCT03930069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93132280|NCT03930069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93132281|NCT03930069|Oxytocics|oxytocics|mesh-ancestor
93132282|NCT03930069|Hemostatics|hemostatics|mesh-ancestor
93132283|NCT03930069|Coagulants|coagulants|mesh-ancestor
93132284|NCT03930069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93132285|NCT03930069|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93132286|NCT03930069|Natriuretic Agents|natriuretic agents|mesh-ancestor
93132287|NCT01132443|Clindamycin|clindamycin|mesh-list
93132288|NCT01132443|Clindamycin palmitate|clindamycin palmitate|mesh-list
93132289|NCT01132443|Clindamycin phosphate|clindamycin phosphate|mesh-list
93132290|NCT01132443|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93132291|NCT01132443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132292|NCT01132443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132293|NCT01132443|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93132294|NCT01132443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132295|NCT01132443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132296|NCT01132443|Dermatologic Agents|dermatologic agents|mesh-ancestor
93132297|NCT01132521|Urinastatin|urinastatin|mesh-list
93132298|NCT01132521|Trypsin Inhibitors|trypsin inhibitors|mesh-list
93132299|NCT01132521|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93132300|NCT01132521|Protease Inhibitors|protease inhibitors|mesh-ancestor
93132301|NCT01132521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132302|NCT01132521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132303|NCT01132599|Choline|choline|mesh-list
93132304|NCT01132599|Lipotropic Agents|lipotropic agents|mesh-ancestor
93132305|NCT01132599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93132306|NCT01132599|Antimetabolites|antimetabolites|mesh-ancestor
93132307|NCT01132599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132308|NCT01132599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93132309|NCT01132599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93132310|NCT01132599|Nootropic Agents|nootropic agents|mesh-ancestor
93132311|NCT03929835|Chlorophyllin|chlorophyllin|mesh-list
93132312|NCT03929835|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93132313|NCT03929835|Protective Agents|protective agents|mesh-ancestor
93132314|NCT03929835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132315|NCT01132677|Methylprednisolone|methylprednisolone|mesh-list
93132316|NCT01132677|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93132317|NCT01132677|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93132318|NCT01132677|Prednisolone|prednisolone|mesh-list
93132319|NCT01132677|Prednisolone acetate|prednisolone acetate|mesh-list
93132320|NCT01132677|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93132321|NCT01132677|Prednisolone phosphate|prednisolone phosphate|mesh-list
93132322|NCT01132677|Hylan|hylan|mesh-list
93132323|NCT01132677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132324|NCT01132677|Antiemetics|antiemetics|mesh-ancestor
93132325|NCT01132677|Autonomic Agents|autonomic agents|mesh-ancestor
93132326|NCT01132677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132327|NCT01132677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132328|NCT01132677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93132329|NCT01132677|Glucocorticoids|glucocorticoids|mesh-ancestor
93132330|NCT01132677|Hormones|hormones|mesh-ancestor
93132331|NCT01132677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132332|NCT01132677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93132333|NCT01132677|Protective Agents|protective agents|mesh-ancestor
93132334|NCT01132677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93132335|NCT01132677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132336|NCT01132677|Viscosupplements|viscosupplements|mesh-ancestor
93132337|NCT02961790|Mandelic Acids|mandelic acids|mesh-list
93132338|NCT02961790|Oxybutynin|oxybutynin|mesh-list
93132339|NCT02961790|Parasympatholytics|parasympatholytics|mesh-ancestor
93132340|NCT02961790|Autonomic Agents|autonomic agents|mesh-ancestor
93132341|NCT02961790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132342|NCT02961790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132343|NCT02961790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93132344|NCT02961790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93132345|NCT02961790|Cholinergic Agents|cholinergic agents|mesh-ancestor
93132346|NCT02961790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132347|NCT02961790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132348|NCT02961790|Urological Agents|urological agents|mesh-ancestor
93132349|NCT02961790|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93132350|NCT02961790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132351|NCT01225341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93132352|NCT01225341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93132353|NCT01225341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93132354|NCT01225341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132355|NCT01225341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132356|NCT01225341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93132357|NCT01225341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132358|NCT01225341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132359|NCT01225341|Cholinergic Agents|cholinergic agents|mesh-ancestor
93132360|NCT01225341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132361|NCT03920553|Hyaluronic Acid|hyaluronic acid|mesh-list
93132362|NCT03920553|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93132363|NCT03920553|Immunologic Factors|immunologic factors|mesh-ancestor
93132364|NCT03920553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132365|NCT03920553|Viscosupplements|viscosupplements|mesh-ancestor
93132366|NCT03920553|Protective Agents|protective agents|mesh-ancestor
93132367|NCT03643900|Indomethacin|indomethacin|mesh-list
93132368|NCT03643900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93132369|NCT03643900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132370|NCT03643900|Analgesics|analgesics|mesh-ancestor
93132371|NCT03643900|Sensory System Agents|sensory system agents|mesh-ancestor
93132372|NCT03643900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132373|NCT03643900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132374|NCT03643900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132375|NCT03643900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132376|NCT03643900|Gout Suppressants|gout suppressants|mesh-ancestor
92804565|NCT02848209|Phenol|phenol|mesh-list
93132377|NCT03643900|Tocolytic Agents|tocolytic agents|mesh-ancestor
93132378|NCT03643900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93132379|NCT03643900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93132380|NCT03643900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132381|NCT03643900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132383|NCT03919383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132384|NCT03919383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93132385|NCT03919383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132386|NCT03919383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132387|NCT01131897|Levetiracetam|levetiracetam|mesh-list
93132388|NCT01131897|Anticonvulsants|anticonvulsants|mesh-ancestor
93132389|NCT01131897|Nootropic Agents|nootropic agents|mesh-ancestor
93132390|NCT01225419|Plerixafor|plerixafor|mesh-list
93132391|NCT01225419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93132392|NCT01225419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93132393|NCT01225419|Antiviral Agents|antiviral agents|mesh-ancestor
93132394|NCT01225419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132395|NCT03919461|Etodolac|etodolac|mesh-list
93132396|NCT03919461|Propranolol|propranolol|mesh-list
93132397|NCT03919461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93132398|NCT03919461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93132399|NCT03919461|Adrenergic Agents|adrenergic agents|mesh-ancestor
93132400|NCT03919461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132401|NCT03919461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132402|NCT03919461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132403|NCT03919461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93132404|NCT03919461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93132405|NCT03919461|Vasodilator Agents|vasodilator agents|mesh-ancestor
93132406|NCT03919461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93132407|NCT03919461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132408|NCT03919461|Analgesics|analgesics|mesh-ancestor
93132409|NCT03919461|Sensory System Agents|sensory system agents|mesh-ancestor
93132410|NCT03919461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132411|NCT03919461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132412|NCT03919461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132413|NCT03919461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91931813|NCT02195895|Micronutrients|micronutrients|mesh-ancestor
93132414|NCT03919461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93132415|NCT03919461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132416|NCT02528877|Sirolimus|sirolimus|mesh-list
93132417|NCT02528877|Fludarabine|fludarabine|mesh-list
93132418|NCT02528877|Fludarabine phosphate|fludarabine phosphate|mesh-list
93132419|NCT02528877|Melphalan|melphalan|mesh-list
93132420|NCT02528877|Mechlorethamine|mechlorethamine|mesh-list
93132421|NCT02528877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93132422|NCT02528877|Tacrolimus|tacrolimus|mesh-list
93132423|NCT02528877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132424|NCT02528877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93132425|NCT02528877|Antimetabolites|antimetabolites|mesh-ancestor
93132426|NCT02528877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132427|NCT02528877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132428|NCT02528877|Immunologic Factors|immunologic factors|mesh-ancestor
93132429|NCT02528877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132430|NCT02528877|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93132431|NCT02528877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132432|NCT02528877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132433|NCT02528877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132434|NCT02528877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93132435|NCT02528877|Antifungal Agents|antifungal agents|mesh-ancestor
93132436|NCT02528877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93132437|NCT02528877|Alkylating Agents|alkylating agents|mesh-ancestor
93132438|NCT02528877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93132439|NCT03918993|Tadalafil|tadalafil|mesh-list
93132440|NCT03918993|Vasodilator Agents|vasodilator agents|mesh-ancestor
93132441|NCT03918993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93132442|NCT03918993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93132443|NCT03918993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132444|NCT03918993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132445|NCT03918993|Urological Agents|urological agents|mesh-ancestor
93132446|NCT03920475|Sertraline|sertraline|mesh-list
93132447|NCT03920475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93132448|NCT03920475|Antidepressive Agents|antidepressive agents|mesh-ancestor
93132449|NCT03920475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93132450|NCT03920475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93132451|NCT03920475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92804633|NCT05337657|Letrozole|letrozole|mesh-list
93132452|NCT03920475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132453|NCT03920475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132454|NCT03920475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132455|NCT03920475|Serotonin Agents|serotonin agents|mesh-ancestor
93132456|NCT03920475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132457|NCT03920475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93132458|NCT03920475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93132459|NCT03920319|Bupropion|bupropion|mesh-list
93132460|NCT03920319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93132461|NCT03920319|Antidepressive Agents|antidepressive agents|mesh-ancestor
93132462|NCT03920319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93132463|NCT03920319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93132464|NCT03920319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93132465|NCT03920319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132466|NCT03920319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132467|NCT03920319|Dopamine Agents|dopamine agents|mesh-ancestor
93132468|NCT03920319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132469|NCT03920319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132470|NCT03920319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93132471|NCT03920319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93132472|NCT03920319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132473|NCT03920397|Cholecalciferol|cholecalciferol|mesh-list
93132474|NCT03920397|Vitamin D|vitamin d|mesh-list
93132475|NCT03920397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132476|NCT03920397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132477|NCT03920397|Vitamins|vitamins|mesh-ancestor
93132478|NCT03920397|Micronutrients|micronutrients|mesh-ancestor
93132479|NCT03920397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93132480|NCT01131975|Lamotrigine|lamotrigine|mesh-list
93132481|NCT01131975|Anticonvulsants|anticonvulsants|mesh-ancestor
93132482|NCT01131975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93132483|NCT01131975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132484|NCT01131975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132485|NCT01131975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132486|NCT01131975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132487|NCT01131975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93132488|NCT01131975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93132489|NCT01131975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132490|NCT01131975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93132491|NCT01131975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93132492|NCT01231737|Prulifloxacin|prulifloxacin|mesh-list
93132493|NCT01231737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132494|NCT01231737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132495|NCT01231737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93132496|NCT01231737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93132497|NCT01231737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132498|NCT01231737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132499|NCT01231737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132500|NCT01128699|Bevacizumab|bevacizumab|mesh-list
93132501|NCT01128699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93132502|NCT01128699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132503|NCT01128699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93132504|NCT01128699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93132505|NCT01128699|Growth Substances|growth substances|mesh-ancestor
93132506|NCT01128699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132507|NCT01128699|Growth Inhibitors|growth inhibitors|mesh-ancestor
93132508|NCT01329627|Paclitaxel|paclitaxel|mesh-list
93132509|NCT01329627|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93132510|NCT01329627|Cyclophosphamide|cyclophosphamide|mesh-list
93132511|NCT01329627|Doxorubicin|doxorubicin|mesh-list
93132512|NCT01329627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93132513|NCT01329627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132514|NCT01329627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132515|NCT01329627|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132516|NCT01329627|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132517|NCT01329627|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132518|NCT01329627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132519|NCT01329627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132520|NCT01329627|Immunologic Factors|immunologic factors|mesh-ancestor
93132521|NCT01329627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132522|NCT01329627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132523|NCT01329627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93132524|NCT01329627|Alkylating Agents|alkylating agents|mesh-ancestor
93132525|NCT01329627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93132526|NCT01329627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93132527|NCT01329627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93132528|NCT01329627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93132529|NCT01329627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132530|NCT03929211|Hydroxychloroquine|hydroxychloroquine|mesh-list
93132531|NCT03929211|Antimalarials|antimalarials|mesh-ancestor
93132532|NCT03929211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93132533|NCT03929211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93132534|NCT03929211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132535|NCT03929211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132536|NCT03929211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132537|NCT03929211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132538|NCT01132911|Bortezomib|bortezomib|mesh-list
93132539|NCT01132911|Vorinostat|vorinostat|mesh-list
93132540|NCT01132911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132541|NCT01132911|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93132542|NCT01132911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132543|NCT01132911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132544|NCT01132989|Lenalidomide|lenalidomide|mesh-list
93132545|NCT01132989|Immunologic Factors|immunologic factors|mesh-ancestor
93132546|NCT01132989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132547|NCT01132989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93132548|NCT01132989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93132549|NCT01132989|Growth Substances|growth substances|mesh-ancestor
93132550|NCT01132989|Growth Inhibitors|growth inhibitors|mesh-ancestor
93132551|NCT01132989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132552|NCT01225653|Latanoprost|latanoprost|mesh-list
93132553|NCT01225653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93132554|NCT01225653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93132555|NCT01134861|Cisplatin|cisplatin|mesh-list
93132556|NCT01134861|Etoposide|etoposide|mesh-list
93132557|NCT01134861|Vinblastine|vinblastine|mesh-list
93132558|NCT01134861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132559|NCT01134861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132560|NCT01134861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93132561|NCT01134861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93132562|NCT01134861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132563|NCT01134861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132564|NCT01134861|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132565|NCT01134861|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132566|NCT01134861|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132567|NCT01133223|Plasminogen|plasminogen|mesh-list
93132568|NCT01133223|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93132569|NCT01133223|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93132570|NCT01133223|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93132571|NCT01133223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132572|NCT01233219|Morphine|morphine|mesh-list
93132573|NCT01233219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93132574|NCT01233219|Narcotics|narcotics|mesh-ancestor
93132575|NCT01233219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132576|NCT01233219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132577|NCT01233219|Analgesics|analgesics|mesh-ancestor
93132578|NCT01233219|Sensory System Agents|sensory system agents|mesh-ancestor
93132579|NCT01233219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132580|NCT02960854|Nivolumab|nivolumab|mesh-list
93132581|NCT02960854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93132582|NCT02960854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132583|NCT02960854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93132584|NCT02960854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132585|NCT01133301|Naltrexone|naltrexone|mesh-list
93132586|NCT01133301|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93132587|NCT01133301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93132588|NCT01133301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132589|NCT01133301|Sensory System Agents|sensory system agents|mesh-ancestor
93132590|NCT01133301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132591|NCT03918135|Acetaminophen|acetaminophen|mesh-list
93132592|NCT03918135|Ibuprofen|ibuprofen|mesh-list
93132593|NCT03918135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93132594|NCT03918135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132595|NCT03918135|Analgesics|analgesics|mesh-ancestor
93132596|NCT03918135|Sensory System Agents|sensory system agents|mesh-ancestor
93132597|NCT03918135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132598|NCT03918135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132599|NCT03918135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132600|NCT03918135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132601|NCT03918135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93132602|NCT03918135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132603|NCT03918135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132604|NCT03918135|Antipyretics|antipyretics|mesh-ancestor
93132605|NCT05480475|Dabigatran|dabigatran|mesh-list
93132606|NCT05480475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93132607|NCT05480475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93132608|NCT05480475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93132609|NCT05480475|Antimetabolites|antimetabolites|mesh-ancestor
93132610|NCT05480475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132611|NCT05480475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93132612|NCT05480475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93132613|NCT05480475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132614|NCT05480475|Antithrombins|antithrombins|mesh-ancestor
93132615|NCT05480475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93132616|NCT05480475|Protease Inhibitors|protease inhibitors|mesh-ancestor
93132617|NCT05480475|Anticoagulants|anticoagulants|mesh-ancestor
93132618|NCT03642184|Empagliflozin|empagliflozin|mesh-list
93132619|NCT03642184|Linagliptin|linagliptin|mesh-list
93132620|NCT03642184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93132621|NCT03642184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132622|NCT03642184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93132623|NCT03642184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132624|NCT03642184|Incretins|incretins|mesh-ancestor
93132625|NCT03642184|Hormones|hormones|mesh-ancestor
93132626|NCT03642184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132627|NCT03642184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93132628|NCT03642184|Protease Inhibitors|protease inhibitors|mesh-ancestor
93132629|NCT03642184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132630|NCT01137591|Acetaminophen|acetaminophen|mesh-list
93132631|NCT01137591|Acetylcysteine|acetylcysteine|mesh-list
93132632|NCT01137591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132633|NCT01137591|Analgesics|analgesics|mesh-ancestor
93132634|NCT01137591|Sensory System Agents|sensory system agents|mesh-ancestor
93132635|NCT01137591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132636|NCT01137591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132637|NCT01137591|Antipyretics|antipyretics|mesh-ancestor
93132638|NCT01137591|Antiviral Agents|antiviral agents|mesh-ancestor
93132639|NCT01137591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132640|NCT01137591|Expectorants|expectorants|mesh-ancestor
93132641|NCT01137591|Respiratory System Agents|respiratory system agents|mesh-ancestor
93132642|NCT01137591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93132643|NCT01137591|Antioxidants|antioxidants|mesh-ancestor
93132644|NCT01137591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132645|NCT01137591|Protective Agents|protective agents|mesh-ancestor
93132646|NCT01133457|Finasteride|finasteride|mesh-list
93132647|NCT01133457|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93132648|NCT01133457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93132649|NCT01133457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132650|NCT01133457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132651|NCT01133457|Hormone Antagonists|hormone antagonists|mesh-ancestor
93132652|NCT01133457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132653|NCT01133457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132654|NCT01133457|Urological Agents|urological agents|mesh-ancestor
93132655|NCT01135563|Sirolimus|sirolimus|mesh-list
93132656|NCT01135563|Vinblastine|vinblastine|mesh-list
93132657|NCT01135563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132658|NCT01135563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132659|NCT01135563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93132660|NCT01135563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132661|NCT01135563|Antifungal Agents|antifungal agents|mesh-ancestor
93132662|NCT01135563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132663|NCT01135563|Immunologic Factors|immunologic factors|mesh-ancestor
93132664|NCT01135563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132665|NCT01135563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132666|NCT01135563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132667|NCT01135563|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132668|NCT01135563|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132669|NCT01135563|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132670|NCT03641950|Botulinum Toxins|botulinum toxins|mesh-list
93132671|NCT03641950|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93132672|NCT03641950|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93132673|NCT03641950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92804845|NCT00953706|Ivacaftor|ivacaftor|mesh-list
93132674|NCT03641950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132675|NCT03641950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132676|NCT03641950|Cholinergic Agents|cholinergic agents|mesh-ancestor
93132677|NCT03641950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132678|NCT03641950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132679|NCT03641950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93132680|NCT03641950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132681|NCT03764631|Empagliflozin|empagliflozin|mesh-list
93132682|NCT03764631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93132683|NCT03764631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93132684|NCT03764631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132685|NCT03764631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93132686|NCT03764631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132687|NCT03764631|Protease Inhibitors|protease inhibitors|mesh-ancestor
93132688|NCT03764631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132689|NCT01135641|Cyclosporine|cyclosporine|mesh-list
93132690|NCT01135641|Rituximab|rituximab|mesh-list
93132691|NCT01135641|Cyclosporins|cyclosporins|mesh-list
93132692|NCT01135641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93132693|NCT01135641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132694|NCT01135641|Immunologic Factors|immunologic factors|mesh-ancestor
93132695|NCT01135641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132696|NCT01135641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93132697|NCT01135641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132698|NCT01135641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132699|NCT01135641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132700|NCT01135641|Antifungal Agents|antifungal agents|mesh-ancestor
93132701|NCT01135641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132702|NCT01135641|Dermatologic Agents|dermatologic agents|mesh-ancestor
93132703|NCT01135641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93132704|NCT03640156|Oxytocin|oxytocin|mesh-list
93132705|NCT03640156|Oxytocics|oxytocics|mesh-ancestor
93132706|NCT03640156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93132707|NCT03640156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132708|NCT01230723|Everolimus|everolimus|mesh-list
93132709|NCT01230723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93132710|NCT01230723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93132711|NCT01230723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132712|NCT01230723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132713|NCT01230723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132714|NCT01230723|Immunologic Factors|immunologic factors|mesh-ancestor
93132715|NCT01230723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132716|NCT01230723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132717|NCT05401071|Rifapentine|rifapentine|mesh-list
93132718|NCT05401071|Rifampin|rifampin|mesh-list
93132719|NCT05401071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93132720|NCT05401071|Antitubercular Agents|antitubercular agents|mesh-ancestor
93132721|NCT05401071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132722|NCT05401071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132723|NCT05401071|Leprostatic Agents|leprostatic agents|mesh-ancestor
93132724|NCT05401071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93132725|NCT05401071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132726|NCT05401071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132727|NCT05401071|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93132728|NCT05401071|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93132729|NCT05401071|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93132730|NCT05401071|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93132731|NCT05401071|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93132732|NCT05401071|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93132733|NCT01135953|Cycloserine|cycloserine|mesh-list
93132734|NCT01135953|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93132735|NCT01135953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132736|NCT01135953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93132737|NCT01135953|Antitubercular Agents|antitubercular agents|mesh-ancestor
93132738|NCT01135953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132739|NCT01135953|Antimetabolites|antimetabolites|mesh-ancestor
93132740|NCT01135953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132741|NCT01136031|Paclitaxel|paclitaxel|mesh-list
93132742|NCT01136031|Irinotecan|irinotecan|mesh-list
93132743|NCT01136031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132744|NCT01136031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132745|NCT01136031|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132746|NCT01136031|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132747|NCT01136031|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132748|NCT01136031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132749|NCT01136031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93132750|NCT01136031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93132751|NCT01136031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132752|NCT05400915|Paclitaxel|paclitaxel|mesh-list
93132753|NCT05400915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132754|NCT05400915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132755|NCT05400915|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132756|NCT05400915|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132757|NCT05400915|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132758|NCT05400915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132759|NCT01137903|Amoxicillin|amoxicillin|mesh-list
93132760|NCT01137903|Ciprofloxacin|ciprofloxacin|mesh-list
93132761|NCT01137903|Clavulanic Acid|clavulanic acid|mesh-list
93132762|NCT01137903|Clavulanic Acids|clavulanic acids|mesh-list
93132763|NCT01137903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93132764|NCT01137903|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93132765|NCT01137903|Trimethoprim|trimethoprim|mesh-list
93132766|NCT01137903|Sulfamethoxazole|sulfamethoxazole|mesh-list
93132767|NCT01137903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132768|NCT01137903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132769|NCT01137903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93132770|NCT01137903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93132771|NCT01137903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132772|NCT01137903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132773|NCT01137903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132774|NCT01137903|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93132775|NCT01137903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93132776|NCT01137903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93132777|NCT01137903|Antimalarials|antimalarials|mesh-ancestor
93132778|NCT01137903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93132779|NCT01137903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93132780|NCT01137903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93132781|NCT01137903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93132782|NCT01137903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93132783|NCT01137903|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93132784|NCT03739671|Vitamin D|vitamin d|mesh-list
93132785|NCT03739671|Ergocalciferols|ergocalciferols|mesh-list
93132786|NCT03739671|Cholecalciferol|cholecalciferol|mesh-list
93132787|NCT03739671|Vitamins|vitamins|mesh-list
93132788|NCT03739671|Micronutrients|micronutrients|mesh-ancestor
93132789|NCT03739671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132790|NCT03739671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93132791|NCT03739671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132792|NCT01233453|Umirolimus|umirolimus|mesh-list
93132793|NCT01233453|Everolimus|everolimus|mesh-list
93132794|NCT01233453|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93132795|NCT01233453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93132796|NCT01233453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132797|NCT01233453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132798|NCT01233453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132799|NCT01233453|Immunologic Factors|immunologic factors|mesh-ancestor
93132800|NCT01233453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132801|NCT01233453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132802|NCT01233453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132803|NCT01133925|Sirolimus|sirolimus|mesh-list
93132804|NCT01133925|Paclitaxel|paclitaxel|mesh-list
93132805|NCT01133925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132806|NCT01133925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132807|NCT01133925|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132808|NCT01133925|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132809|NCT01133925|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132810|NCT01133925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132811|NCT01133925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132812|NCT01133925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132813|NCT01133925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93132814|NCT01133925|Antifungal Agents|antifungal agents|mesh-ancestor
93132815|NCT01133925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132816|NCT01133925|Immunologic Factors|immunologic factors|mesh-ancestor
93132817|NCT01133925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132818|NCT01232439|Aticaprant|aticaprant|mesh-list
93132819|NCT01232439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132820|NCT01232439|Sensory System Agents|sensory system agents|mesh-ancestor
93132821|NCT01232439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805004|NCT00937560|Paclitaxel|paclitaxel|mesh-list
93132822|NCT01232439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93132824|NCT01138137|Paclitaxel|paclitaxel|mesh-list
93132825|NCT01138137|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93132826|NCT01138137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93132827|NCT01138137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132828|NCT01138137|Tubulin Modulators|tubulin modulators|mesh-ancestor
93132829|NCT01138137|Antimitotic Agents|antimitotic agents|mesh-ancestor
93132830|NCT01138137|Mitosis Modulators|mitosis modulators|mesh-ancestor
93132831|NCT01138137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132832|NCT01138137|Antiviral Agents|antiviral agents|mesh-ancestor
93132833|NCT01138137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132834|NCT01138137|Expectorants|expectorants|mesh-ancestor
93132835|NCT01138137|Respiratory System Agents|respiratory system agents|mesh-ancestor
93132836|NCT01138137|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93132837|NCT01138137|Antioxidants|antioxidants|mesh-ancestor
93132838|NCT01138137|Protective Agents|protective agents|mesh-ancestor
93132839|NCT01138137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132840|NCT01138137|Antidotes|antidotes|mesh-ancestor
93132841|NCT01231113|Artesunate|artesunate|mesh-list
93132842|NCT01231113|Piperaquine|piperaquine|mesh-list
93132843|NCT01231113|Amodiaquine|amodiaquine|mesh-list
93132844|NCT01231113|Artenimol|artenimol|mesh-list
93132845|NCT01231113|Antimalarials|antimalarials|mesh-ancestor
93132846|NCT01231113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93132847|NCT01231113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93132848|NCT01231113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132849|NCT01231113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132850|NCT01231113|Antiviral Agents|antiviral agents|mesh-ancestor
93132851|NCT01231113|Schistosomicides|schistosomicides|mesh-ancestor
93132852|NCT01231113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93132853|NCT01231113|Anthelmintics|anthelmintics|mesh-ancestor
93132854|NCT01136421|Magnesium Sulfate|magnesium sulfate|mesh-list
93132855|NCT01136421|Bromides|bromides|mesh-list
93132856|NCT01136421|Ipratropium|ipratropium|mesh-list
93132857|NCT01136421|Anticonvulsants|anticonvulsants|mesh-ancestor
93132858|NCT01136421|Analgesics|analgesics|mesh-ancestor
93132859|NCT01136421|Sensory System Agents|sensory system agents|mesh-ancestor
93132860|NCT01136421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132861|NCT01136421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132862|NCT01136421|Anesthetics|anesthetics|mesh-ancestor
93132863|NCT01136421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132864|NCT01136421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93132865|NCT01136421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93132866|NCT01136421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132867|NCT01136421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132868|NCT01136421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93132869|NCT01136421|Tocolytic Agents|tocolytic agents|mesh-ancestor
93132870|NCT01136421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93132871|NCT01136421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93132872|NCT01136421|Autonomic Agents|autonomic agents|mesh-ancestor
93132873|NCT01136421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93132874|NCT01136421|Respiratory System Agents|respiratory system agents|mesh-ancestor
93132875|NCT01136421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93132876|NCT01136421|Cholinergic Agents|cholinergic agents|mesh-ancestor
93132877|NCT01136421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132878|NCT01136499|Panobinostat|panobinostat|mesh-list
93132879|NCT01136499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132880|NCT01136499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93132881|NCT01136499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132882|NCT01136499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132883|NCT01231191|Acetaminophen|acetaminophen|mesh-list
93132884|NCT01231191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93132885|NCT01231191|Analgesics|analgesics|mesh-ancestor
93132886|NCT01231191|Sensory System Agents|sensory system agents|mesh-ancestor
93132887|NCT01231191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132888|NCT01231191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132889|NCT01231191|Antipyretics|antipyretics|mesh-ancestor
93132890|NCT01138449|Vitamin A|vitamin a|mesh-list
93132891|NCT01138449|Vitamins|vitamins|mesh-ancestor
92805087|NCT02851212|Metformin|metformin|mesh-list
93132892|NCT01138449|Micronutrients|micronutrients|mesh-ancestor
93132893|NCT01138449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132894|NCT05402865|Denosumab|denosumab|mesh-list
93132895|NCT05402865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93132896|NCT05402865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132897|NCT01138605|Ritonavir|ritonavir|mesh-list
93132898|NCT01138605|Darunavir|darunavir|mesh-list
93132899|NCT01138605|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93132900|NCT01138605|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93132901|NCT01138605|Protease Inhibitors|protease inhibitors|mesh-ancestor
93132902|NCT01138605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132903|NCT01138605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132904|NCT01138605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93132905|NCT01138605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93132906|NCT01138605|Antiviral Agents|antiviral agents|mesh-ancestor
93132907|NCT01138605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132908|NCT01138605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93132909|NCT01138605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93132910|NCT01138683|Diuretics|diuretics|mesh-list
93132911|NCT01138683|Natriuretic Agents|natriuretic agents|mesh-ancestor
93132912|NCT01138683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132913|NCT04767243|Methamphetamine|methamphetamine|mesh-list
93132914|NCT04767243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93132915|NCT04767243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132916|NCT04767243|Sympathomimetics|sympathomimetics|mesh-ancestor
93132917|NCT04767243|Autonomic Agents|autonomic agents|mesh-ancestor
93132918|NCT04767243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132919|NCT04767243|Dopamine Agents|dopamine agents|mesh-ancestor
93132920|NCT04767243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93132921|NCT04767243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132922|NCT04767243|Adrenergic Agents|adrenergic agents|mesh-ancestor
93132923|NCT04767243|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93132924|NCT04767243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93132925|NCT04767243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93132926|NCT04767243|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93132927|NCT01138839|Dexamethasone|dexamethasone|mesh-list
93132928|NCT01138839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93132929|NCT01138839|Antiemetics|antiemetics|mesh-ancestor
93132930|NCT01138839|Autonomic Agents|autonomic agents|mesh-ancestor
93132931|NCT01138839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93132932|NCT01138839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132933|NCT01138839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93132934|NCT01138839|Glucocorticoids|glucocorticoids|mesh-ancestor
93132935|NCT01138839|Hormones|hormones|mesh-ancestor
93132936|NCT01138839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132937|NCT01138839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93132938|NCT01138839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132939|NCT01234623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93132940|NCT01234623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93132941|NCT01234701|Liver Extracts|liver extracts|mesh-list
93132942|NCT01234701|Hematinics|hematinics|mesh-ancestor
93132943|NCT05280717|Sotrovimab|sotrovimab|mesh-list
93132944|NCT05280717|Antiviral Agents|antiviral agents|mesh-ancestor
93132945|NCT05280717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132946|NCT04721613|Melatonin|melatonin|mesh-list
93132947|NCT04721613|Antioxidants|antioxidants|mesh-ancestor
93132948|NCT04721613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132949|NCT04721613|Protective Agents|protective agents|mesh-ancestor
93132950|NCT04721613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132951|NCT04721613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93132952|NCT05275179|Posaconazole|posaconazole|mesh-list
93132953|NCT05275179|Antifungal Agents|antifungal agents|mesh-ancestor
93132954|NCT05275179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132955|NCT05275179|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93132956|NCT05275179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93132957|NCT05275179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93132958|NCT05275179|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93132959|NCT05275179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93132960|NCT05275179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132961|NCT05275179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132962|NCT05275179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93132963|NCT05275179|Hormone Antagonists|hormone antagonists|mesh-ancestor
93132964|NCT05275179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132965|NCT05275179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132966|NCT01139151|Cytarabine|cytarabine|mesh-list
93132967|NCT01139151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93132968|NCT01139151|Antimetabolites|antimetabolites|mesh-ancestor
93132969|NCT01139151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132970|NCT01139151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132971|NCT01139151|Antiviral Agents|antiviral agents|mesh-ancestor
93132972|NCT01139151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805139|NCT00685672|Mydriatics|mydriatics|mesh-ancestor
93132973|NCT01139151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132974|NCT01139151|Immunologic Factors|immunologic factors|mesh-ancestor
93132975|NCT01139151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132977|NCT01234857|Exemestane|exemestane|mesh-list
93132978|NCT01234857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93132979|NCT01234857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132980|NCT01234857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93132981|NCT01234857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93132982|NCT01234857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93132983|NCT01234857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132984|NCT01234857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93132985|NCT01234857|Hormone Antagonists|hormone antagonists|mesh-ancestor
93132986|NCT01234857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93132987|NCT01234857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93132988|NCT01234857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93132989|NCT01234857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93132990|NCT01234857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93132991|NCT01234857|Antifungal Agents|antifungal agents|mesh-ancestor
93132992|NCT01234857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93132993|NCT01234857|Immunologic Factors|immunologic factors|mesh-ancestor
93132994|NCT01233843|Carboplatin|carboplatin|mesh-list
93132995|NCT01233843|Fluorouracil|fluorouracil|mesh-list
93132996|NCT01233843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93132997|NCT01233843|Antimetabolites|antimetabolites|mesh-ancestor
93132998|NCT01233843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93132999|NCT01233843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93133000|NCT01233843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133001|NCT01233843|Immunologic Factors|immunologic factors|mesh-ancestor
93133002|NCT01233843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133003|NCT01234935|Gemcitabine|gemcitabine|mesh-list
93133004|NCT01234935|Dasatinib|dasatinib|mesh-list
93133005|NCT01234935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93133006|NCT01234935|Antimetabolites|antimetabolites|mesh-ancestor
93073189|NCT05532358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133007|NCT01234935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133008|NCT01234935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133009|NCT01234935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133010|NCT01234935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133011|NCT03674541|Bromides|bromides|mesh-list
93133012|NCT03674541|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93133013|NCT03674541|Anticonvulsants|anticonvulsants|mesh-ancestor
93133014|NCT03674541|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93133015|NCT03674541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133016|NCT03674541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133017|NCT03674541|Cholinergic Agents|cholinergic agents|mesh-ancestor
93133018|NCT03674541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133019|NCT03674541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133020|NCT01235013|Maraviroc|maraviroc|mesh-list
93133021|NCT01235013|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93133022|NCT01235013|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93133023|NCT01235013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133024|NCT01235013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93133025|NCT01235013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93133026|NCT01235013|Antiviral Agents|antiviral agents|mesh-ancestor
93133027|NCT01235013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133028|NCT01235013|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93133029|NCT01236495|Morphine|morphine|mesh-list
93133030|NCT01236495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93133031|NCT01236495|Narcotics|narcotics|mesh-ancestor
93133032|NCT01236495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133033|NCT01236495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133034|NCT01236495|Analgesics|analgesics|mesh-ancestor
93133035|NCT01236495|Sensory System Agents|sensory system agents|mesh-ancestor
93133036|NCT01236495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133037|NCT01143129|Dexamethasone|dexamethasone|mesh-list
93133038|NCT01143129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133039|NCT01143129|Antiemetics|antiemetics|mesh-ancestor
93133040|NCT01143129|Autonomic Agents|autonomic agents|mesh-ancestor
93133041|NCT01143129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133042|NCT01143129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133043|NCT01143129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133044|NCT01143129|Glucocorticoids|glucocorticoids|mesh-ancestor
93133045|NCT01143129|Hormones|hormones|mesh-ancestor
93133046|NCT01143129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805210|NCT00940602|Deferasirox|deferasirox|mesh-list
93133047|NCT01143129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93133048|NCT01143129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133049|NCT01139463|Haloperidol|haloperidol|mesh-list
93133050|NCT01139463|Olanzapine|olanzapine|mesh-list
93133051|NCT01139463|Haloperidol decanoate|haloperidol decanoate|mesh-list
93133052|NCT01139463|Antiemetics|antiemetics|mesh-ancestor
93133053|NCT01139463|Autonomic Agents|autonomic agents|mesh-ancestor
93133054|NCT01139463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133055|NCT01139463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133056|NCT01139463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133057|NCT01139463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93133058|NCT01139463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93133059|NCT01139463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133060|NCT01139463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133061|NCT01139463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93133062|NCT01139463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93133063|NCT01139463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133064|NCT01139463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133065|NCT01139463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133066|NCT01139463|Serotonin Agents|serotonin agents|mesh-ancestor
93133067|NCT01139463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93133068|NCT01139463|Dopamine Agents|dopamine agents|mesh-ancestor
93133069|NCT01139463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93133070|NCT03640468|Lidocaine|lidocaine|mesh-list
93133071|NCT03640468|Midazolam|midazolam|mesh-list
93133072|NCT03640468|Ketamine|ketamine|mesh-list
93133073|NCT03640468|Anesthetics, Local|anesthetics, local|mesh-ancestor
93133074|NCT03640468|Anesthetics|anesthetics|mesh-ancestor
93133075|NCT03640468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133076|NCT03640468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133077|NCT03640468|Sensory System Agents|sensory system agents|mesh-ancestor
93133078|NCT03640468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133079|NCT03640468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93133080|NCT03640468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93133081|NCT03640468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93133082|NCT03640468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133083|NCT03640468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133084|NCT03640468|Analgesics|analgesics|mesh-ancestor
93133085|NCT03640468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93133086|NCT03640468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133087|NCT03640468|Anesthetics, General|anesthetics, general|mesh-ancestor
93133088|NCT03640468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93133089|NCT03640468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93133090|NCT03640468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133091|NCT03640468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93133092|NCT03640468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93133093|NCT03640468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93133094|NCT03640468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93133095|NCT03640468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133096|NCT03640468|GABA Modulators|gaba modulators|mesh-ancestor
93133097|NCT03640468|GABA Agents|gaba agents|mesh-ancestor
93133098|NCT03640390|Magnesium Sulfate|magnesium sulfate|mesh-list
93133099|NCT03640390|Dexmedetomidine|dexmedetomidine|mesh-list
93133100|NCT03640390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93133101|NCT03640390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133102|NCT03640390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133103|NCT03640390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93133104|NCT03640390|Analgesics|analgesics|mesh-ancestor
93133105|NCT03640390|Sensory System Agents|sensory system agents|mesh-ancestor
93133106|NCT03640390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133107|NCT03640390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93133108|NCT03640390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93133109|NCT03640390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93133110|NCT03640390|Adrenergic Agents|adrenergic agents|mesh-ancestor
93133111|NCT03640390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133112|NCT03640390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133113|NCT03640390|Anesthetics|anesthetics|mesh-ancestor
93133114|NCT03640390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93133115|NCT03640390|Anticonvulsants|anticonvulsants|mesh-ancestor
93133116|NCT03640390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93133117|NCT03640390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133118|NCT03640390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93133119|NCT03640390|Tocolytic Agents|tocolytic agents|mesh-ancestor
93133120|NCT03640390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93133121|NCT03618472|Metformin|metformin|mesh-list
93133123|NCT03618472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133124|NCT00001984|Alemtuzumab|alemtuzumab|mesh-list
93133125|NCT00001984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133126|NCT00001984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133127|NCT03618316|Cimetidine|cimetidine|mesh-list
93133128|NCT03618316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93133129|NCT03618316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133130|NCT03618316|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93133131|NCT03618316|Histamine Antagonists|histamine antagonists|mesh-ancestor
93133132|NCT03618316|Histamine Agents|histamine agents|mesh-ancestor
93133133|NCT03618316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133134|NCT03618316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133135|NCT03618316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133136|NCT03618316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93133137|NCT03618316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93133138|NCT03618316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133139|NCT03445533|Ipilimumab|ipilimumab|mesh-list
93133140|NCT03445533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133141|NCT03445533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133142|NCT03445533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93133143|NCT03445533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133144|NCT01336972|Tolvaptan|tolvaptan|mesh-list
93133145|NCT01336972|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93133146|NCT01336972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133147|NCT01336972|Natriuretic Agents|natriuretic agents|mesh-ancestor
93133148|NCT01336972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133149|NCT03537508|Vaccines|vaccines|mesh-list
93133150|NCT03537508|Immunologic Factors|immunologic factors|mesh-ancestor
93133151|NCT03537508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133152|NCT03618082|Desflurane|desflurane|mesh-list
93133153|NCT03618082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93133154|NCT03618082|Anesthetics, General|anesthetics, general|mesh-ancestor
93133155|NCT03618082|Anesthetics|anesthetics|mesh-ancestor
93133156|NCT03618082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133157|NCT03618082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133158|NCT01236651|Drotaverin|drotaverin|mesh-list
93133159|NCT01236651|Meperidine|meperidine|mesh-list
93133160|NCT01236651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93133161|NCT01236651|Narcotics|narcotics|mesh-ancestor
93133162|NCT01236651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133163|NCT01236651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133164|NCT01236651|Analgesics|analgesics|mesh-ancestor
93133165|NCT01236651|Sensory System Agents|sensory system agents|mesh-ancestor
93133166|NCT01236651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133167|NCT01236651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93133168|NCT01236651|Parasympatholytics|parasympatholytics|mesh-ancestor
93133169|NCT01236651|Autonomic Agents|autonomic agents|mesh-ancestor
93133170|NCT01236651|Vasodilator Agents|vasodilator agents|mesh-ancestor
93133171|NCT04484025|Ebselen|ebselen|mesh-list
93133172|NCT04484025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93133173|NCT04484025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93133174|NCT04484025|Analgesics|analgesics|mesh-ancestor
93133175|NCT04484025|Sensory System Agents|sensory system agents|mesh-ancestor
93133176|NCT04484025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133177|NCT04484025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133178|NCT04484025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133179|NCT04484025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93133180|NCT04484025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93133181|NCT04484025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133182|NCT04484025|Antioxidants|antioxidants|mesh-ancestor
93133183|NCT04484025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133184|NCT04484025|Protective Agents|protective agents|mesh-ancestor
93133185|NCT04484025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93133186|NCT04484025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133187|NCT04484025|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93133188|NCT01064518|Botulinum Toxins|botulinum toxins|mesh-list
93133189|NCT01064518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93133190|NCT01064518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93133191|NCT01064518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93133192|NCT01064518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133193|NCT01064518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133194|NCT01064518|Cholinergic Agents|cholinergic agents|mesh-ancestor
93133195|NCT01064518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133196|NCT01064518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133197|NCT01064518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93133198|NCT01064518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133199|NCT03616288|Thiamine|thiamine|mesh-list
93133200|NCT03616288|Vitamin B Complex|vitamin b complex|mesh-ancestor
93133201|NCT03616288|Vitamins|vitamins|mesh-ancestor
93133202|NCT03616288|Micronutrients|micronutrients|mesh-ancestor
93133203|NCT03616288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133204|NCT02873338|Cytarabine|cytarabine|mesh-list
93133205|NCT02873338|Idarubicin|idarubicin|mesh-list
93133206|NCT02873338|Heparin|heparin|mesh-list
93133207|NCT02873338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93133208|NCT02873338|Antimetabolites|antimetabolites|mesh-ancestor
93133209|NCT02873338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133210|NCT02873338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133211|NCT02873338|Antiviral Agents|antiviral agents|mesh-ancestor
93133212|NCT02873338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133213|NCT02873338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133214|NCT02873338|Immunologic Factors|immunologic factors|mesh-ancestor
93133215|NCT02873338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133216|NCT02873338|Anticoagulants|anticoagulants|mesh-ancestor
93133217|NCT02873338|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93133218|NCT02873338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93133219|NCT02873338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93133220|NCT02873338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93133221|NCT02873338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93133222|NCT02873338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133223|NCT03616132|Sirolimus|sirolimus|mesh-list
93133224|NCT03616132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93133225|NCT03616132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133226|NCT03616132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93133227|NCT03616132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133228|NCT03616132|Antifungal Agents|antifungal agents|mesh-ancestor
93133229|NCT03616132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133230|NCT03616132|Immunologic Factors|immunologic factors|mesh-ancestor
93133231|NCT03616132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133232|NCT02872012|Lidocaine|lidocaine|mesh-list
93133233|NCT02872012|Anesthetics, Local|anesthetics, local|mesh-ancestor
93133234|NCT02872012|Anesthetics|anesthetics|mesh-ancestor
93133235|NCT02872012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133236|NCT02872012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133237|NCT02872012|Sensory System Agents|sensory system agents|mesh-ancestor
93133238|NCT02872012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133239|NCT02872012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93133240|NCT02872012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93133241|NCT02872012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93133242|NCT02872012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133243|NCT02872012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133244|NCT03617224|Pembrolizumab|pembrolizumab|mesh-list
93133245|NCT03617224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133246|NCT03617224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133247|NCT03617224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93133248|NCT03617224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133249|NCT03615430|Anesthetics|anesthetics|mesh-list
93133250|NCT03615430|Anesthetics, Local|anesthetics, local|mesh-list
93133251|NCT03615430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133252|NCT03615430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133253|NCT03615430|Sensory System Agents|sensory system agents|mesh-ancestor
93133254|NCT03615430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133255|NCT01344226|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93133256|NCT01344226|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93133257|NCT01344226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93133258|NCT01344226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93133259|NCT03615196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93133260|NCT03615196|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93133261|NCT04837768|Progesterone|progesterone|mesh-list
93133262|NCT04837768|Progestins|progestins|mesh-ancestor
93133263|NCT04837768|Hormones|hormones|mesh-ancestor
93133264|NCT04837768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133265|NCT04837768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133266|NCT02869438|Benralizumab|benralizumab|mesh-list
93133267|NCT02869438|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93133268|NCT02869438|Respiratory System Agents|respiratory system agents|mesh-ancestor
93133269|NCT02868892|Pemetrexed|pemetrexed|mesh-list
93133270|NCT02868892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805448|NCT01093586|Busulfan|busulfan|mesh-list
93133272|NCT02868892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133273|NCT02868892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93133274|NCT02868892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93133275|NCT03613558|Dexmedetomidine|dexmedetomidine|mesh-list
93133276|NCT03613558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93133277|NCT03613558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133278|NCT03613558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133279|NCT03613558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93133280|NCT03613558|Analgesics|analgesics|mesh-ancestor
93133281|NCT03613558|Sensory System Agents|sensory system agents|mesh-ancestor
93133282|NCT03613558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133283|NCT03613558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93133284|NCT03613558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93133285|NCT03613558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93133286|NCT03613558|Adrenergic Agents|adrenergic agents|mesh-ancestor
93133287|NCT03613558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133288|NCT03613558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133289|NCT03310125|Colchicine|colchicine|mesh-list
93133290|NCT03310125|Gout Suppressants|gout suppressants|mesh-ancestor
93133291|NCT03310125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93133292|NCT03310125|Tubulin Modulators|tubulin modulators|mesh-ancestor
93133293|NCT03310125|Antimitotic Agents|antimitotic agents|mesh-ancestor
93133294|NCT03310125|Mitosis Modulators|mitosis modulators|mesh-ancestor
93133295|NCT03310125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133296|NCT03310125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133297|NCT03613168|Trastuzumab|trastuzumab|mesh-list
93133298|NCT03613168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133299|NCT03613168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133300|NCT01141881|Bevacizumab|bevacizumab|mesh-list
93133301|NCT01141881|Plasminogen|plasminogen|mesh-list
93133302|NCT01141881|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93133303|NCT01141881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133304|NCT01141881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133305|NCT01141881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93133306|NCT01141881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93133307|NCT01141881|Growth Substances|growth substances|mesh-ancestor
93133308|NCT01141881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133309|NCT01141881|Growth Inhibitors|growth inhibitors|mesh-ancestor
93133310|NCT01141881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93133311|NCT01141881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93133312|NCT01141881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133313|NCT04707430|Progesterone|progesterone|mesh-list
93133314|NCT04707430|Progestins|progestins|mesh-ancestor
93133315|NCT04707430|Hormones|hormones|mesh-ancestor
93133316|NCT04707430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133317|NCT04707430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133318|NCT03611920|Tetracycline|tetracycline|mesh-list
93133319|NCT03611920|Dexamethasone|dexamethasone|mesh-list
93133320|NCT03611920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133321|NCT03611920|Antiemetics|antiemetics|mesh-ancestor
93133322|NCT03611920|Autonomic Agents|autonomic agents|mesh-ancestor
93133323|NCT03611920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133324|NCT03611920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133325|NCT03611920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133326|NCT03611920|Glucocorticoids|glucocorticoids|mesh-ancestor
93133327|NCT03611920|Hormones|hormones|mesh-ancestor
93133328|NCT03611920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133329|NCT03611920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93133330|NCT03611920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133331|NCT03611920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93133332|NCT03611920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133333|NCT03611920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93133334|NCT03611920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133335|NCT03611920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133336|NCT03611530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93133337|NCT03611530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93133338|NCT02936752|Pembrolizumab|pembrolizumab|mesh-list
93133339|NCT02936752|Entinostat|entinostat|mesh-list
93133340|NCT02936752|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93133341|NCT02936752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133342|NCT02936752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133343|NCT02936752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93133344|NCT02936752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133345|NCT02936752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133346|NCT05383534|Propofol|propofol|mesh-list
93133347|NCT05383534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93133348|NCT05383534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133349|NCT05383534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133350|NCT05383534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133351|NCT05383534|Anesthetics, General|anesthetics, general|mesh-ancestor
93133352|NCT05383534|Anesthetics|anesthetics|mesh-ancestor
93133353|NCT01235325|Vitamin K|vitamin k|mesh-list
93133354|NCT01235325|Vitamin K 1|vitamin k 1|mesh-list
93133355|NCT01235325|Vitamins|vitamins|mesh-ancestor
93133356|NCT01235325|Micronutrients|micronutrients|mesh-ancestor
93133357|NCT01235325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133358|NCT01235325|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93133359|NCT01235325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93133360|NCT01235325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133361|NCT01235325|Hemostatics|hemostatics|mesh-ancestor
93133362|NCT01235325|Coagulants|coagulants|mesh-ancestor
93133363|NCT01140009|Vaccines|vaccines|mesh-list
93133364|NCT01140009|Immunologic Factors|immunologic factors|mesh-ancestor
93133365|NCT01140009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133366|NCT01235637|Sufentanil|sufentanil|mesh-list
93133367|NCT01235637|Alfentanil|alfentanil|mesh-list
93133368|NCT01235637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93133369|NCT01235637|Narcotics|narcotics|mesh-ancestor
93133370|NCT01235637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133371|NCT01235637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133372|NCT01235637|Analgesics|analgesics|mesh-ancestor
93133373|NCT01235637|Sensory System Agents|sensory system agents|mesh-ancestor
93133374|NCT01235637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133375|NCT01235637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93133376|NCT01235637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133377|NCT01235637|Anesthetics, General|anesthetics, general|mesh-ancestor
93133378|NCT01235637|Anesthetics|anesthetics|mesh-ancestor
93133379|NCT01143831|Vitamins|vitamins|mesh-list
93133380|NCT01143831|Vitamin K|vitamin k|mesh-list
93133381|NCT01143831|Vitamin K 2|vitamin k 2|mesh-list
93133382|NCT01143831|Menatetrenone|menatetrenone|mesh-list
93133383|NCT01143831|Micronutrients|micronutrients|mesh-ancestor
93133384|NCT01143831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133385|NCT01143831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93133386|NCT01143831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93133387|NCT01143831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133388|NCT01143831|Hemostatics|hemostatics|mesh-ancestor
93133389|NCT01143831|Coagulants|coagulants|mesh-ancestor
93133390|NCT04966299|Erythritol|erythritol|mesh-list
93133391|NCT04966299|Vasodilator Agents|vasodilator agents|mesh-ancestor
93133392|NCT01143987|Cinacalcet|cinacalcet|mesh-list
93133393|NCT01143987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93133394|NCT01143987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133395|NCT01143987|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93133396|NCT01143987|Hormone Antagonists|hormone antagonists|mesh-ancestor
93133397|NCT01143987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133398|NCT01144065|Hydrocortisone|hydrocortisone|mesh-list
93133399|NCT01144065|Testosterone|testosterone|mesh-list
93133400|NCT01144065|Androgens|androgens|mesh-ancestor
93133401|NCT01144065|Hormones|hormones|mesh-ancestor
93133402|NCT01144065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133403|NCT01144065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133404|NCT01144065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133405|NCT01142505|Mannitol|mannitol|mesh-list
93133406|NCT01142505|Montelukast|montelukast|mesh-list
93133407|NCT01142505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93133408|NCT01142505|Respiratory System Agents|respiratory system agents|mesh-ancestor
93133409|NCT01142505|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93133410|NCT01142505|Hormone Antagonists|hormone antagonists|mesh-ancestor
93133411|NCT01142505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133412|NCT01142505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133413|NCT01142505|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93133414|NCT01142505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93133415|NCT01142505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133416|NCT01142505|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93133417|NCT01142505|Diuretics|diuretics|mesh-ancestor
93133418|NCT01142505|Natriuretic Agents|natriuretic agents|mesh-ancestor
93133419|NCT01236963|Listerine|listerine|mesh-list
93133420|NCT01236963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93133421|NCT01236963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133422|NCT02908672|Atezolizumab|atezolizumab|mesh-list
93133423|NCT02908672|Vemurafenib|vemurafenib|mesh-list
93133424|NCT02908672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93133425|NCT02908672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93133426|NCT02908672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133427|NCT02908672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133428|NCT02908672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133429|NCT02908672|Immunologic Factors|immunologic factors|mesh-ancestor
93133430|NCT02908672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133431|NCT02908672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133432|NCT02908672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133433|NCT02572167|Nivolumab|nivolumab|mesh-list
93133434|NCT02572167|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93133435|NCT02572167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133436|NCT02572167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133437|NCT02572167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93133438|NCT02572167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133439|NCT02572167|Immunotoxins|immunotoxins|mesh-ancestor
93133440|NCT02572167|Immunoconjugates|immunoconjugates|mesh-ancestor
93133441|NCT02572167|Immunologic Factors|immunologic factors|mesh-ancestor
93133442|NCT02572167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133443|NCT01336738|Nicotinic Acids|nicotinic acids|mesh-list
93133444|NCT01336738|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93133445|NCT01336738|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93133446|NCT01336738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93133447|NCT01336738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133448|NCT01336738|Incretins|incretins|mesh-ancestor
93133449|NCT01336738|Hormones|hormones|mesh-ancestor
93133450|NCT01336738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133451|NCT01336738|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93133452|NCT01336738|Protease Inhibitors|protease inhibitors|mesh-ancestor
93133453|NCT01336738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931889|NCT01565499|Antimitotic Agents|antimitotic agents|mesh-ancestor
93133454|NCT01336738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133455|NCT01336738|Vitamin B Complex|vitamin b complex|mesh-ancestor
93133456|NCT01336738|Vitamins|vitamins|mesh-ancestor
93133457|NCT01336738|Micronutrients|micronutrients|mesh-ancestor
93133458|NCT01140399|Dopamine|dopamine|mesh-list
93133459|NCT01140399|Furosemide|furosemide|mesh-list
93133460|NCT01140399|Diuretics|diuretics|mesh-ancestor
92785103|NCT05298163|Calcitriol|calcitriol|mesh-list
92785247|NCT04125121|Anesthetics|anesthetics|mesh-ancestor
93133461|NCT01140399|Natriuretic Agents|natriuretic agents|mesh-ancestor
93133462|NCT01140399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232083|NCT03569696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785692|NCT04823052|GABA Agents|gaba agents|mesh-ancestor
92786139|NCT02771860|Calcium|calcium|mesh-list
92786439|NCT02617771|Vitamins|vitamins|mesh-ancestor
92786517|NCT01706692|Cyclosporine|cyclosporine|mesh-list
92786741|NCT02762656|Lidocaine|lidocaine|mesh-list
92786816|NCT00865189|Growth Substances|growth substances|mesh-ancestor
92786890|NCT01181726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92787182|NCT02758366|Doxorubicin|doxorubicin|mesh-list
93133463|NCT01140399|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93133464|NCT01140399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787554|NCT00939627|Cetuximab|cetuximab|mesh-list
92787628|NCT01135511|Immunologic Factors|immunologic factors|mesh-ancestor
93133465|NCT01140399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133466|NCT01140399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93133467|NCT01140399|Sympathomimetics|sympathomimetics|mesh-ancestor
93133468|NCT01140399|Autonomic Agents|autonomic agents|mesh-ancestor
92788303|NCT02874768|Analgesics|analgesics|mesh-ancestor
92788380|NCT01071096|Cholinergic Agents|cholinergic agents|mesh-ancestor
93133469|NCT01140399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788680|NCT01126541|Rituximab|rituximab|mesh-list
93133470|NCT01140399|Dopamine Agents|dopamine agents|mesh-ancestor
93133471|NCT01140399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133472|NCT01140399|Protective Agents|protective agents|mesh-ancestor
93133473|NCT02410317|Morphine|morphine|mesh-list
93133474|NCT02410317|Ropivacaine|ropivacaine|mesh-list
93133475|NCT02410317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92789280|NCT02718976|Mydriatics|mydriatics|mesh-ancestor
92789358|NCT04964284|Hormones|hormones|mesh-list
92789521|NCT00611416|Caffeine|caffeine|mesh-list
92789597|NCT02711176|Tinidazole|tinidazole|mesh-list
93133476|NCT02410317|Narcotics|narcotics|mesh-ancestor
92790188|NCT00607035|Diuretics|diuretics|mesh-ancestor
92790389|NCT04175626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93133477|NCT02410317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790535|NCT04303806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92790629|NCT03739840|Padsevonil|padsevonil|mesh-list
93133478|NCT02410317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133479|NCT02410317|Analgesics|analgesics|mesh-ancestor
92791277|NCT01114529|Cyclosporine|cyclosporine|mesh-list
93133480|NCT02410317|Sensory System Agents|sensory system agents|mesh-ancestor
93133481|NCT02410317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133482|NCT02410317|Anesthetics, Local|anesthetics, local|mesh-ancestor
93133483|NCT02410317|Anesthetics|anesthetics|mesh-ancestor
93133484|NCT02258451|Everolimus|everolimus|mesh-list
93133485|NCT02258451|Exemestane|exemestane|mesh-list
92791725|NCT03367156|Dexamethasone|dexamethasone|mesh-list
92791878|NCT05321602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133486|NCT02258451|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93133487|NCT02258451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92792024|NCT04907019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792324|NCT00854113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792544|NCT04300452|Ergonovine|ergonovine|mesh-list
92792626|NCT04252521|Dopamine Agents|dopamine agents|mesh-ancestor
92792771|NCT01019694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92792851|NCT04307069|Oxytocin|oxytocin|mesh-list
92792918|NCT04786275|Anesthetics|anesthetics|mesh-ancestor
93133488|NCT02258451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92793155|NCT00918333|Everolimus|everolimus|mesh-list
92793290|NCT04209478|Morphine|morphine|mesh-list
92793367|NCT04648540|Anesthetics|anesthetics|mesh-ancestor
93133489|NCT02258451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793514|NCT00621478|Diazepam|diazepam|mesh-list
93232084|NCT03569696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793663|NCT01006590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93133490|NCT02258451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133491|NCT02258451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133492|NCT02258451|Immunologic Factors|immunologic factors|mesh-ancestor
92794501|NCT02689024|Narcotics|narcotics|mesh-ancestor
92741063|NCT01012219|Niacin|niacin|mesh-list
92794727|NCT04182724|Mitosis Modulators|mitosis modulators|mesh-ancestor
93133493|NCT02258451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795025|NCT00996996|Iodine|iodine|mesh-list
92795176|NCT02675140|Anticestodal Agents|anticestodal agents|mesh-ancestor
92795254|NCT02676934|Anesthetics|anesthetics|mesh-list
93133494|NCT02258451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795711|NCT00998946|Vitamins|vitamins|mesh-list
93133495|NCT02258451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92795866|NCT04292886|Tamoxifen|tamoxifen|mesh-list
92805659|NCT00691912|Paclitaxel|paclitaxel|mesh-list
92796603|NCT00843193|Xhance|xhance|mesh-list
93133496|NCT02258451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92796755|NCT04117009|Remifentanil|remifentanil|mesh-list
93133497|NCT02258451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93133498|NCT02258451|Hormone Antagonists|hormone antagonists|mesh-ancestor
92797052|NCT00649948|Metformin|metformin|mesh-list
92797200|NCT00700921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93232085|NCT03569696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92797725|NCT00651586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797884|NCT00654160|Leucovorin|leucovorin|mesh-list
92798028|NCT02638870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93232235|NCT04377997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92798400|NCT02865564|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92798554|NCT01133678|Cetuximab|cetuximab|mesh-list
92798697|NCT00655408|Iron|iron|mesh-list
92798781|NCT02637466|Antidepressive Agents|antidepressive agents|mesh-ancestor
92799078|NCT00657982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92799161|NCT00879814|Vaccines|vaccines|mesh-list
92799307|NCT02877173|Alprostadil|alprostadil|mesh-list
93232086|NCT03569696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232087|NCT00092573|Ezetimibe|ezetimibe|mesh-list
92799761|NCT00974922|Vitamin D|vitamin d|mesh-list
92799829|NCT00970944|Analgesics|analgesics|mesh-ancestor
92799983|NCT05712265|Serotonin Agents|serotonin agents|mesh-ancestor
92800053|NCT05567068|Analgesics|analgesics|mesh-ancestor
92800126|NCT05355311|Acetylcarnitine|acetylcarnitine|mesh-list
92800280|NCT04897321|Fludarabine|fludarabine|mesh-list
93232088|NCT00092573|Fenofibrate|fenofibrate|mesh-list
92800576|NCT03657810|Analgesics|analgesics|mesh-ancestor
93232089|NCT00092573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93232090|NCT00092573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92800874|NCT01107717|Glyburide|glyburide|mesh-list
92800961|NCT01131182|Metformin|metformin|mesh-list
93232091|NCT00092573|Antimetabolites|antimetabolites|mesh-ancestor
92801319|NCT04646187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801475|NCT04155658|Fluorides|fluorides|mesh-list
92801541|NCT00666796|Ethanol|ethanol|mesh-list
92801615|NCT00663286|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93232092|NCT00092573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133499|NCT02258451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133500|NCT01237119|Liraglutide|liraglutide|mesh-list
93133501|NCT01237119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802359|NCT00811135|Bevacizumab|bevacizumab|mesh-list
92802746|NCT00680680|Dutasteride|dutasteride|mesh-list
93133502|NCT01237119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133503|NCT01237119|Incretins|incretins|mesh-ancestor
93133504|NCT01237119|Hormones|hormones|mesh-ancestor
92803106|NCT00805675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803483|NCT00906399|Interferons|interferons|mesh-list
93232093|NCT00092573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92803701|NCT02855502|Hormones|hormones|mesh-ancestor
93232094|NCT01342939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92803849|NCT00680134|Tavaborole|tavaborole|mesh-list
92804161|NCT02821923|Erythritol|erythritol|mesh-list
93232095|NCT01342939|Incretins|incretins|mesh-list
93232096|NCT01342939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93232097|NCT01342939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804522|NCT04956302|Antiemetics|antiemetics|mesh-ancestor
92804602|NCT02845713|Ivermectin|ivermectin|mesh-list
93232098|NCT01342939|Hormones|hormones|mesh-ancestor
92804819|NCT00140907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92450034|NCT05236608|Nivolumab|nivolumab|mesh-list
92805117|NCT00685594|Vitamin D|vitamin d|mesh-list
92805197|NCT04139824|Naproxen|naproxen|mesh-list
92805498|NCT00606450|Apremilast|apremilast|mesh-list
92805724|NCT00694252|Lapatinib|lapatinib|mesh-list
92450786|NCT04002518|Cimetidine|cimetidine|mesh-list
92805882|NCT00695032|Ifosfamide|ifosfamide|mesh-list
92805945|NCT02624440|Trimethoprim|trimethoprim|mesh-list
93232236|NCT04377997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232237|NCT01336049|Nimotuzumab|nimotuzumab|mesh-list
92806176|NCT01092182|Hormones|hormones|mesh-ancestor
92806468|NCT00864682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93133505|NCT01237119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133506|NCT03760263|Tacrolimus|tacrolimus|mesh-list
92806614|NCT01101308|Oxycodone|oxycodone|mesh-list
92806764|NCT00926328|Triclosan|triclosan|mesh-list
92806842|NCT02615782|Tadalafil|tadalafil|mesh-list
92806983|NCT04879134|Apomorphine|apomorphine|mesh-list
92807137|NCT02613676|Bilirubin|bilirubin|mesh-list
93133507|NCT03760263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133508|NCT03760263|Immunologic Factors|immunologic factors|mesh-ancestor
92807432|NCT01070888|Glucocorticoids|glucocorticoids|mesh-ancestor
93133509|NCT03760263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133510|NCT03760263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92807874|NCT00796315|Doxylamine|doxylamine|mesh-list
92808029|NCT02617654|Hormones|hormones|mesh-ancestor
93133511|NCT03760263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808180|NCT04117750|Vitamin D|vitamin d|mesh-list
93232238|NCT01336049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92808557|NCT01067144|Gabapentin|gabapentin|mesh-list
92808627|NCT04109833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232239|NCT01336049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232240|NCT04758949|Nivolumab|nivolumab|mesh-list
92808934|NCT02602483|Vitamins|vitamins|mesh-ancestor
92809146|NCT00848926|Immunologic Factors|immunologic factors|mesh-ancestor
93133512|NCT03760263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133513|NCT01237275|Sertraline|sertraline|mesh-list
93133514|NCT01237275|Fluoxetine|fluoxetine|mesh-list
93133515|NCT01237275|Paroxetine|paroxetine|mesh-list
93133516|NCT01237275|Antidepressive Agents|antidepressive agents|mesh-ancestor
93133517|NCT01237275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133518|NCT01237275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93133519|NCT01237275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93133520|NCT01237275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133521|NCT01237275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133522|NCT01237275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133523|NCT01237275|Serotonin Agents|serotonin agents|mesh-ancestor
93133524|NCT01237275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133525|NCT01237275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93133526|NCT01237275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93133527|NCT01237275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93133528|NCT01237275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133529|NCT01237977|Botulinum Toxins|botulinum toxins|mesh-list
93133530|NCT01237977|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93133531|NCT01237977|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93133532|NCT01237977|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93133533|NCT01237977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133534|NCT01237977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133535|NCT01237977|Cholinergic Agents|cholinergic agents|mesh-ancestor
93133536|NCT01237977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133537|NCT01237977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133538|NCT01237977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93133539|NCT01237977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133540|NCT02033434|Ketamine|ketamine|mesh-list
93133541|NCT02033434|Analgesics|analgesics|mesh-ancestor
93133542|NCT02033434|Sensory System Agents|sensory system agents|mesh-ancestor
93133543|NCT02033434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133544|NCT02033434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133545|NCT02033434|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93133546|NCT02033434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133547|NCT02033434|Anesthetics, General|anesthetics, general|mesh-ancestor
93133548|NCT02033434|Anesthetics|anesthetics|mesh-ancestor
93133549|NCT02033434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133550|NCT02033434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93133551|NCT02033434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93133552|NCT02033434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133553|NCT02033434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133554|NCT02033512|Hormones|hormones|mesh-list
93133555|NCT02033512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133556|NCT02033512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133557|NCT02712112|Imatinib Mesylate|imatinib mesylate|mesh-list
93133558|NCT02712112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133559|NCT02712112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133560|NCT02712112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133561|NCT02712112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133562|NCT02860546|Nivolumab|nivolumab|mesh-list
93133563|NCT02860546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133564|NCT02860546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133565|NCT02860546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92805742|NCT00673270|Hydrocortisone|hydrocortisone|mesh-list
93133566|NCT02860546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133568|NCT01982955|Pemetrexed|pemetrexed|mesh-list
93133569|NCT01982955|Gefitinib|gefitinib|mesh-list
93133570|NCT01982955|Tepotinib|tepotinib|mesh-list
93133571|NCT01982955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133572|NCT01982955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133573|NCT01982955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133574|NCT01982955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93133575|NCT01982955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93133576|NCT01982955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133577|NCT01144533|Hyaluronic Acid|hyaluronic acid|mesh-list
93133578|NCT01144533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93133579|NCT01144533|Immunologic Factors|immunologic factors|mesh-ancestor
93133580|NCT01144533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133581|NCT01144533|Viscosupplements|viscosupplements|mesh-ancestor
93133582|NCT01144533|Protective Agents|protective agents|mesh-ancestor
93133583|NCT01238055|Docetaxel|docetaxel|mesh-list
93133584|NCT01238055|Sunitinib|sunitinib|mesh-list
93133585|NCT01238055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133586|NCT01238055|Tubulin Modulators|tubulin modulators|mesh-ancestor
93133587|NCT01238055|Antimitotic Agents|antimitotic agents|mesh-ancestor
93133588|NCT01238055|Mitosis Modulators|mitosis modulators|mesh-ancestor
93133589|NCT01238055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133590|NCT01238055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93133591|NCT01238055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93133592|NCT01238055|Growth Substances|growth substances|mesh-ancestor
93133593|NCT01238055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133594|NCT01238055|Growth Inhibitors|growth inhibitors|mesh-ancestor
93133595|NCT01238055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133596|NCT01238055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133597|NCT01144923|Gabapentin|gabapentin|mesh-list
93133598|NCT01144923|Nortriptyline|nortriptyline|mesh-list
93133599|NCT01144923|Analgesics|analgesics|mesh-ancestor
93133600|NCT01144923|Sensory System Agents|sensory system agents|mesh-ancestor
93133601|NCT01144923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133602|NCT01144923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133603|NCT01144923|Anticonvulsants|anticonvulsants|mesh-ancestor
93133604|NCT01144923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93133605|NCT01144923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93133606|NCT01144923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133607|NCT01144923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133608|NCT01144923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93133609|NCT01144923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93133610|NCT01144923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133611|NCT01144923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133612|NCT01144923|Antimanic Agents|antimanic agents|mesh-ancestor
93133613|NCT01144923|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93133614|NCT01144923|Antidepressive Agents|antidepressive agents|mesh-ancestor
93133615|NCT01144923|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93133616|NCT01144923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93133617|NCT01144923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133618|NCT01144923|Adrenergic Agents|adrenergic agents|mesh-ancestor
93133619|NCT01329783|Maraviroc|maraviroc|mesh-list
93133620|NCT01329783|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93133621|NCT01329783|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93133622|NCT01329783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133623|NCT01329783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93133624|NCT01329783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93133625|NCT01329783|Antiviral Agents|antiviral agents|mesh-ancestor
93133626|NCT01329783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133627|NCT01329783|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93133628|NCT01238133|Paclitaxel|paclitaxel|mesh-list
93133629|NCT01238133|Carboplatin|carboplatin|mesh-list
93133630|NCT01238133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93133631|NCT01238133|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93133632|NCT01238133|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93133633|NCT01238133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93133634|NCT01238133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133635|NCT01238133|Tubulin Modulators|tubulin modulators|mesh-ancestor
93133636|NCT01238133|Antimitotic Agents|antimitotic agents|mesh-ancestor
93133637|NCT01238133|Mitosis Modulators|mitosis modulators|mesh-ancestor
93133638|NCT01238133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133639|NCT01238133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133640|NCT01145079|Sirolimus|sirolimus|mesh-list
93133641|NCT01145079|Everolimus|everolimus|mesh-list
93133642|NCT01145079|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93133643|NCT01145079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133644|NCT01145079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133645|NCT01145079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133646|NCT01145079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133647|NCT01145079|Immunologic Factors|immunologic factors|mesh-ancestor
93133648|NCT01145079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133649|NCT01145079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133650|NCT01145079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93133651|NCT01145079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133652|NCT01145079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93133653|NCT01145079|Antifungal Agents|antifungal agents|mesh-ancestor
93133654|NCT01146483|Pantoprazole|pantoprazole|mesh-list
93133655|NCT01146483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93133656|NCT01146483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93133657|NCT01146483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93133658|NCT01146483|Antimetabolites|antimetabolites|mesh-ancestor
93133659|NCT01146483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133660|NCT01146483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93133661|NCT01146483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93133662|NCT01146483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133663|NCT01146483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93133664|NCT01146483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133665|NCT01146483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93133666|NCT00396279|Vitamin D|vitamin d|mesh-list
93133667|NCT00396279|Denosumab|denosumab|mesh-list
93133668|NCT00396279|Calcium|calcium|mesh-list
93133669|NCT00396279|Vitamins|vitamins|mesh-ancestor
93133670|NCT00396279|Micronutrients|micronutrients|mesh-ancestor
93133671|NCT00396279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133672|NCT00396279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93133673|NCT00396279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93133674|NCT01238367|Factor VIII|factor viii|mesh-list
93133675|NCT01238367|Coagulants|coagulants|mesh-ancestor
93133676|NCT01347866|Irinotecan|irinotecan|mesh-list
93133677|NCT01347866|Gedatolisib|gedatolisib|mesh-list
93133678|NCT01347866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93133679|NCT01347866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93133680|NCT01347866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133681|NCT01347866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133682|NCT01347866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133683|NCT01347866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133684|NCT01347710|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
93133685|NCT01347710|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
93133686|NCT01347710|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93133687|NCT01347710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133688|NCT05470868|Naphazoline|naphazoline|mesh-list
93133689|NCT05470868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93133690|NCT05470868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93133691|NCT05470868|Adrenergic Agents|adrenergic agents|mesh-ancestor
93133692|NCT05470868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133693|NCT05470868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133694|NCT05470868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133695|NCT05470868|Nasal Decongestants|nasal decongestants|mesh-ancestor
93133696|NCT05470868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93133697|NCT05470868|Respiratory System Agents|respiratory system agents|mesh-ancestor
93133698|NCT03485222|Empagliflozin|empagliflozin|mesh-list
93133699|NCT03485222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93133700|NCT03485222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133701|NCT03485222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93133702|NCT03485222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133703|NCT01347554|Everolimus|everolimus|mesh-list
93133704|NCT01347554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93133705|NCT01347554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133706|NCT01347554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133707|NCT01347554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133708|NCT01347554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133709|NCT01347554|Immunologic Factors|immunologic factors|mesh-ancestor
93133710|NCT01347554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133711|NCT01347554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133712|NCT05567354|Oxycodone|oxycodone|mesh-list
93133713|NCT05567354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93133714|NCT05567354|Narcotics|narcotics|mesh-ancestor
93133715|NCT05567354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133716|NCT05567354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133717|NCT05567354|Analgesics|analgesics|mesh-ancestor
93133718|NCT05567354|Sensory System Agents|sensory system agents|mesh-ancestor
93133719|NCT05567354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133720|NCT03482882|Pimavanserin|pimavanserin|mesh-list
93133721|NCT03482882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93133722|NCT03482882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93133723|NCT03482882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93133724|NCT03482882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93133725|NCT03482882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133726|NCT03482882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133727|NCT03482882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133728|NCT03482882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93133729|NCT03482882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93133730|NCT03482882|Serotonin Agents|serotonin agents|mesh-ancestor
93133731|NCT03482882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133732|NCT03482882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133733|NCT03480932|Interferons|interferons|mesh-list
93133734|NCT03480932|Interferon-alpha|interferon-alpha|mesh-list
93133735|NCT03480932|Interferon alpha-2|interferon alpha-2|mesh-list
93133736|NCT03480932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93133737|NCT03480932|Sofosbuvir|sofosbuvir|mesh-list
93133738|NCT03480932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133739|NCT03480932|Antiviral Agents|antiviral agents|mesh-ancestor
93133740|NCT03480932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133741|NCT03480932|Immunologic Factors|immunologic factors|mesh-ancestor
93133742|NCT03480932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133743|NCT03387020|Everolimus|everolimus|mesh-list
93133744|NCT03387020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93133745|NCT03387020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93133746|NCT03387020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133747|NCT03387020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133748|NCT03387020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133749|NCT03387020|Immunologic Factors|immunologic factors|mesh-ancestor
93133750|NCT03387020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133751|NCT03387020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133752|NCT03386474|Aflibercept|aflibercept|mesh-list
93133753|NCT03386474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93133754|NCT03386474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93133755|NCT03386474|Growth Substances|growth substances|mesh-ancestor
93133756|NCT03386474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133757|NCT03386474|Growth Inhibitors|growth inhibitors|mesh-ancestor
93133758|NCT03386474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133759|NCT03405818|Tavaborole|tavaborole|mesh-list
93133760|NCT03405818|Antifungal Agents|antifungal agents|mesh-ancestor
93133761|NCT03405818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133762|NCT03403634|Interferons|interferons|mesh-list
93133763|NCT03403634|Interferon-alpha|interferon-alpha|mesh-list
93133764|NCT03403634|Interferon alpha-2|interferon alpha-2|mesh-list
93133765|NCT03403634|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
93133766|NCT03403634|Celecoxib|celecoxib|mesh-list
93133767|NCT03403634|Benzenesulfonamide|benzenesulfonamide|mesh-list
93133768|NCT03403634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133769|NCT03403634|Antiviral Agents|antiviral agents|mesh-ancestor
93133770|NCT03403634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133771|NCT03403634|Immunologic Factors|immunologic factors|mesh-ancestor
93133772|NCT03403634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133773|NCT03403634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93133774|NCT03403634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93133775|NCT03403634|Analgesics|analgesics|mesh-ancestor
93133776|NCT03403634|Sensory System Agents|sensory system agents|mesh-ancestor
93133777|NCT03403634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133778|NCT03403634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133779|NCT03403634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93133780|NCT03403634|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93133781|NCT03403634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93133782|NCT03403634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133783|NCT03403634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133784|NCT03403634|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93133785|NCT02863354|Aflibercept|aflibercept|mesh-list
93133786|NCT02863354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93133787|NCT02863354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93133788|NCT02863354|Growth Substances|growth substances|mesh-ancestor
93133789|NCT02863354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133790|NCT02863354|Growth Inhibitors|growth inhibitors|mesh-ancestor
93133791|NCT02863354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133792|NCT02859454|Avelumab|avelumab|mesh-list
93133793|NCT02859454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133794|NCT02859454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133795|NCT02862730|Pancrelipase|pancrelipase|mesh-list
93133796|NCT02862730|Pancreatin|pancreatin|mesh-list
93133797|NCT02862730|Hormones|hormones|mesh-list
93133798|NCT02862730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133799|NCT02862730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133800|NCT02862730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133801|NCT03609970|Vitamin D|vitamin d|mesh-list
93133802|NCT03609970|Vitamins|vitamins|mesh-ancestor
93133803|NCT03609970|Micronutrients|micronutrients|mesh-ancestor
93133804|NCT03609970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133805|NCT03609970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93133806|NCT03610282|Propofol|propofol|mesh-list
93133807|NCT03610282|Methylphenidate|methylphenidate|mesh-list
93133808|NCT03610282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93133809|NCT03610282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133810|NCT03610282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133811|NCT03610282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133812|NCT03610282|Anesthetics, General|anesthetics, general|mesh-ancestor
93133813|NCT03610282|Anesthetics|anesthetics|mesh-ancestor
93133814|NCT03610282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93133815|NCT03610282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93133816|NCT03610282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93133817|NCT03610282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133818|NCT03610282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133819|NCT03610282|Dopamine Agents|dopamine agents|mesh-ancestor
93133820|NCT03610282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133821|NCT02862574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93133822|NCT02862574|Methotrexate|methotrexate|mesh-list
93133823|NCT02862574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93133824|NCT02862574|Abortifacient Agents|abortifacient agents|mesh-ancestor
93133825|NCT02862574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93133826|NCT02862574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133827|NCT02862574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93133828|NCT02862574|Antimetabolites|antimetabolites|mesh-ancestor
93133829|NCT02862574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133830|NCT02862574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133831|NCT02862574|Dermatologic Agents|dermatologic agents|mesh-ancestor
93133832|NCT02862574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133833|NCT02862574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93133834|NCT02862574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133835|NCT02862574|Immunologic Factors|immunologic factors|mesh-ancestor
93133836|NCT02862574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93133837|NCT02862574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93133838|NCT02862574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133839|NCT05383300|Oxytocin|oxytocin|mesh-list
93133840|NCT05383300|Oxytocics|oxytocics|mesh-ancestor
93133841|NCT05383300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93133842|NCT05383300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133843|NCT03712046|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93133844|NCT03712046|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93133845|NCT03712046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133846|NCT02862106|Vaccines|vaccines|mesh-list
93133847|NCT02862106|Immunologic Factors|immunologic factors|mesh-ancestor
93133848|NCT02862106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133849|NCT03609892|Amoxicillin|amoxicillin|mesh-list
93133850|NCT03609892|Tetracycline|tetracycline|mesh-list
93133851|NCT03609892|Furazolidone|furazolidone|mesh-list
93133852|NCT03609892|Esomeprazole|esomeprazole|mesh-list
93133853|NCT03609892|Bismuth|bismuth|mesh-list
93133854|NCT03609892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93133855|NCT03609892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93133856|NCT03609892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93133857|NCT03609892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133858|NCT03609892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93133859|NCT03609892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133860|NCT03609892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133861|NCT03609892|Antacids|antacids|mesh-ancestor
93133862|NCT03609892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93133863|NCT03609892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93133864|NCT03609892|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93133865|NCT03609892|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93133866|NCT03609892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93133867|NCT03609892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93133868|NCT03609892|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93133869|NCT03609814|Fludarabine|fludarabine|mesh-list
93133870|NCT03609814|Clofarabine|clofarabine|mesh-list
93133871|NCT03609814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133872|NCT03609814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93133873|NCT03609814|Antimetabolites|antimetabolites|mesh-ancestor
93133874|NCT03609814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133875|NCT02457598|Obinutuzumab|obinutuzumab|mesh-list
93133876|NCT02457598|Idelalisib|idelalisib|mesh-list
93133877|NCT02457598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133878|NCT02457598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133879|NCT02457598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133880|NCT02457598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133881|NCT02859142|Nicotine|nicotine|mesh-list
93133882|NCT02859142|Varenicline|varenicline|mesh-list
93133883|NCT02859142|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93133884|NCT02859142|Autonomic Agents|autonomic agents|mesh-ancestor
93133885|NCT02859142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133886|NCT02859142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133887|NCT02859142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93133888|NCT02859142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93133889|NCT02859142|Cholinergic Agents|cholinergic agents|mesh-ancestor
93133890|NCT02859142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133891|NCT02859142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133892|NCT03351608|Atropine|atropine|mesh-list
93133893|NCT03351608|Glycopyrrolate|glycopyrrolate|mesh-list
93133894|NCT03351608|Neostigmine|neostigmine|mesh-list
93133895|NCT03351608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93133896|NCT03351608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93133897|NCT03351608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93133898|NCT03351608|Autonomic Agents|autonomic agents|mesh-ancestor
93133899|NCT03351608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133900|NCT03351608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133901|NCT03351608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93133902|NCT03351608|Respiratory System Agents|respiratory system agents|mesh-ancestor
93133903|NCT03351608|Mydriatics|mydriatics|mesh-ancestor
93133904|NCT03351608|Parasympatholytics|parasympatholytics|mesh-ancestor
93133905|NCT03351608|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93133906|NCT03351608|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93133907|NCT03351608|Cholinergic Agents|cholinergic agents|mesh-ancestor
93133908|NCT03351608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133909|NCT03351608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133910|NCT03351608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93133911|NCT03351608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133912|NCT03351608|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93133913|NCT03382418|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93133914|NCT03382418|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93133915|NCT03382418|Immunologic Factors|immunologic factors|mesh-ancestor
93133916|NCT03382418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133917|NCT03382418|Antacids|antacids|mesh-ancestor
93133918|NCT03382418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133919|NCT03382418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93133920|NCT03382262|Triamcinolone|triamcinolone|mesh-list
93133921|NCT03382262|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93133922|NCT03382262|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93133924|NCT03382262|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93133925|NCT03382262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93133926|NCT03382262|Glucocorticoids|glucocorticoids|mesh-ancestor
93133927|NCT03382262|Hormones|hormones|mesh-ancestor
93133928|NCT03382262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93133929|NCT03382262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133930|NCT03382262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93133931|NCT03382262|Immunologic Factors|immunologic factors|mesh-ancestor
93133932|NCT03382262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93133933|NCT03382262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133934|NCT02236936|Cetuximab|cetuximab|mesh-list
93133935|NCT02236936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133936|NCT02236936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133937|NCT03638960|Bupivacaine|bupivacaine|mesh-list
93133938|NCT03638960|Anesthetics, Local|anesthetics, local|mesh-ancestor
93133939|NCT03638960|Anesthetics|anesthetics|mesh-ancestor
93133940|NCT03638960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133941|NCT03638960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806119|NCT00696748|Hormones|hormones|mesh-ancestor
93133942|NCT03638960|Sensory System Agents|sensory system agents|mesh-ancestor
93133943|NCT03638960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133945|NCT02259790|Telmisartan|telmisartan|mesh-list
93133946|NCT02259790|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93133947|NCT02259790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93133948|NCT02259790|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93133949|NCT02259790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93133950|NCT02259790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133951|NCT02259790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93133952|NCT02259790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133953|NCT02259790|Vasodilator Agents|vasodilator agents|mesh-ancestor
93133954|NCT02259790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93133955|NCT02259790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93133956|NCT02857270|Paclitaxel|paclitaxel|mesh-list
93133957|NCT02857270|Gemcitabine|gemcitabine|mesh-list
93133958|NCT02857270|Cetuximab|cetuximab|mesh-list
93133959|NCT02857270|Midazolam|midazolam|mesh-list
93133960|NCT02857270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93133961|NCT02857270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93133962|NCT02857270|Tubulin Modulators|tubulin modulators|mesh-ancestor
93133963|NCT02857270|Antimitotic Agents|antimitotic agents|mesh-ancestor
93133964|NCT02857270|Mitosis Modulators|mitosis modulators|mesh-ancestor
93133965|NCT02857270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133966|NCT02857270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93133967|NCT02857270|Antimetabolites|antimetabolites|mesh-ancestor
93133968|NCT02857270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93133969|NCT02857270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93133970|NCT02857270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133971|NCT02857270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133972|NCT02857270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93133973|NCT02857270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93133974|NCT02857270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93133975|NCT02857270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133976|NCT02857270|Anesthetics, General|anesthetics, general|mesh-ancestor
93133977|NCT02857270|Anesthetics|anesthetics|mesh-ancestor
93133978|NCT02857270|GABA Modulators|gaba modulators|mesh-ancestor
93133979|NCT02857270|GABA Agents|gaba agents|mesh-ancestor
93133980|NCT02857270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133981|NCT02857270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93133982|NCT03609190|Ketamine|ketamine|mesh-list
93133983|NCT03609190|Analgesics|analgesics|mesh-ancestor
93133984|NCT03609190|Sensory System Agents|sensory system agents|mesh-ancestor
93133985|NCT03609190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93133986|NCT03609190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93133987|NCT03609190|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93133988|NCT03609190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93133989|NCT03609190|Anesthetics, General|anesthetics, general|mesh-ancestor
93133990|NCT03609190|Anesthetics|anesthetics|mesh-ancestor
93133991|NCT03609190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93133992|NCT03609190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93133993|NCT03609190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93133994|NCT03609190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93133995|NCT03609190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93133996|NCT02856880|Zinc|zinc|mesh-list
93133997|NCT02856880|Trace Elements|trace elements|mesh-ancestor
93133998|NCT02856880|Micronutrients|micronutrients|mesh-ancestor
93133999|NCT02856880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134000|NCT02856802|Sumatriptan|sumatriptan|mesh-list
93134001|NCT02856802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93134002|NCT02856802|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93134003|NCT02856802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93134004|NCT02856802|Serotonin Agents|serotonin agents|mesh-ancestor
93134005|NCT02856802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134006|NCT02856802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134007|NCT02856802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134008|NCT03381248|Hyaluronic Acid|hyaluronic acid|mesh-list
93134009|NCT03381248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93134010|NCT03381248|Immunologic Factors|immunologic factors|mesh-ancestor
93134011|NCT03381248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134012|NCT03381248|Viscosupplements|viscosupplements|mesh-ancestor
93134013|NCT03381248|Protective Agents|protective agents|mesh-ancestor
93134014|NCT02024230|Warfarin|warfarin|mesh-list
93134015|NCT02024230|Rivaroxaban|rivaroxaban|mesh-list
93134016|NCT02024230|Anticoagulants|anticoagulants|mesh-ancestor
93134017|NCT02024230|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93134018|NCT02024230|Antithrombins|antithrombins|mesh-ancestor
93134019|NCT02024230|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93134020|NCT02024230|Protease Inhibitors|protease inhibitors|mesh-ancestor
93134021|NCT02024230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134022|NCT02024230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134023|NCT03380390|Phenylephrine|phenylephrine|mesh-list
93134024|NCT03380390|Oxymetazoline|oxymetazoline|mesh-list
93134025|NCT03380390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93134026|NCT03380390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93134027|NCT03380390|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134028|NCT03380390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134029|NCT03380390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134030|NCT03380390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134031|NCT03380390|Sympathomimetics|sympathomimetics|mesh-ancestor
93134032|NCT03380390|Autonomic Agents|autonomic agents|mesh-ancestor
93134033|NCT03380390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134034|NCT03380390|Nasal Decongestants|nasal decongestants|mesh-ancestor
93134035|NCT03380390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93134036|NCT03380390|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134037|NCT03380390|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93134038|NCT03380390|Mydriatics|mydriatics|mesh-ancestor
93134039|NCT03380390|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93134040|NCT03380390|Protective Agents|protective agents|mesh-ancestor
93134041|NCT01935778|Docetaxel|docetaxel|mesh-list
93134042|NCT01935778|Capecitabine|capecitabine|mesh-list
93134043|NCT01935778|Oxaliplatin|oxaliplatin|mesh-list
93134044|NCT01935778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134045|NCT01935778|Tubulin Modulators|tubulin modulators|mesh-ancestor
93134046|NCT01935778|Antimitotic Agents|antimitotic agents|mesh-ancestor
93134047|NCT01935778|Mitosis Modulators|mitosis modulators|mesh-ancestor
93134048|NCT01935778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134049|NCT01935778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93134050|NCT01935778|Antimetabolites|antimetabolites|mesh-ancestor
93134051|NCT02034292|Aspirin|aspirin|mesh-list
93134052|NCT02034292|Clopidogrel|clopidogrel|mesh-list
93134053|NCT02034292|APD791|apd791|mesh-list
93134054|NCT02034292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93134055|NCT02034292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93134056|NCT02034292|Analgesics|analgesics|mesh-ancestor
93134057|NCT02034292|Sensory System Agents|sensory system agents|mesh-ancestor
93134058|NCT02034292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134059|NCT02034292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134060|NCT02034292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134061|NCT02034292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134062|NCT02034292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93134063|NCT02034292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93134064|NCT02034292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134065|NCT02034292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93134066|NCT02034292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93134067|NCT02034292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134068|NCT02034292|Antipyretics|antipyretics|mesh-ancestor
93134069|NCT02034292|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93134070|NCT02034292|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93134071|NCT02034292|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93134072|NCT02034292|Purinergic Agents|purinergic agents|mesh-ancestor
93134073|NCT02034292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134074|NCT02034292|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93134075|NCT02034292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93134076|NCT02034292|Serotonin Agents|serotonin agents|mesh-ancestor
93134077|NCT01758328|Fludarabine|fludarabine|mesh-list
93134078|NCT01758328|Melphalan|melphalan|mesh-list
93134079|NCT01758328|Busulfan|busulfan|mesh-list
93134080|NCT01758328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93134081|NCT01758328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134082|NCT01758328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134083|NCT01758328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93134084|NCT01758328|Immunologic Factors|immunologic factors|mesh-ancestor
93134085|NCT01758328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134086|NCT01758328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93134087|NCT01758328|Alkylating Agents|alkylating agents|mesh-ancestor
93134088|NCT01758328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93134089|NCT04125550|Propofol|propofol|mesh-list
93134090|NCT04125550|Sevoflurane|sevoflurane|mesh-list
93134091|NCT04125550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93134092|NCT04125550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134093|NCT04125550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134094|NCT04125550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93134096|NCT04125550|Anesthetics|anesthetics|mesh-ancestor
93134097|NCT04125550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93134098|NCT04125550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93134099|NCT02237326|Acetic Acid|acetic acid|mesh-list
93134100|NCT02237326|Retinol acetate|retinol acetate|mesh-list
93134101|NCT02237326|Lugol's solution|lugol's solution|mesh-list
93134102|NCT02237326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134103|NCT02237326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134104|NCT02237326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93134105|NCT02237326|Immunologic Factors|immunologic factors|mesh-ancestor
93134106|NCT02237326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134107|NCT02237326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93134108|NCT02237326|Protective Agents|protective agents|mesh-ancestor
93134109|NCT02237326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134110|NCT02237326|Hemostatics|hemostatics|mesh-ancestor
93134111|NCT02237326|Coagulants|coagulants|mesh-ancestor
93134112|NCT02034604|Tamsulosin|tamsulosin|mesh-list
93134113|NCT02034604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93134114|NCT02034604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93134115|NCT02034604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93134116|NCT02034604|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134117|NCT02034604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134118|NCT02034604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134119|NCT02034604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134120|NCT02034604|Urological Agents|urological agents|mesh-ancestor
93134121|NCT03608098|Oxymetazoline|oxymetazoline|mesh-list
93134122|NCT03608098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93134123|NCT03608098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93134124|NCT03608098|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134125|NCT03608098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134126|NCT03608098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134127|NCT03608098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134128|NCT03608098|Sympathomimetics|sympathomimetics|mesh-ancestor
93134129|NCT03608098|Autonomic Agents|autonomic agents|mesh-ancestor
93134130|NCT03608098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134131|NCT03608098|Nasal Decongestants|nasal decongestants|mesh-ancestor
93134132|NCT03608098|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93134133|NCT03608098|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134134|NCT02035072|Gemcitabine|gemcitabine|mesh-list
93134135|NCT02035072|Oxaliplatin|oxaliplatin|mesh-list
93134136|NCT02035072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93134137|NCT02035072|Antimetabolites|antimetabolites|mesh-ancestor
93134138|NCT02035072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134139|NCT02035072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134140|NCT00358215|Darbepoetin alfa|darbepoetin alfa|mesh-list
93134141|NCT00358215|Hematinics|hematinics|mesh-ancestor
93134142|NCT03605758|Ivermectin|ivermectin|mesh-list
93134143|NCT03605758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93134144|NCT03605758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134145|NCT03605056|Dexamethasone|dexamethasone|mesh-list
93134146|NCT03605056|Lenalidomide|lenalidomide|mesh-list
93134147|NCT03605056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134148|NCT03605056|Antiemetics|antiemetics|mesh-ancestor
93134149|NCT03605056|Autonomic Agents|autonomic agents|mesh-ancestor
93134150|NCT03605056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134151|NCT03605056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134152|NCT03605056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134153|NCT03605056|Glucocorticoids|glucocorticoids|mesh-ancestor
93134154|NCT03605056|Hormones|hormones|mesh-ancestor
93134155|NCT03605056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134156|NCT03605056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134157|NCT03605056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134158|NCT03605056|Immunologic Factors|immunologic factors|mesh-ancestor
93134159|NCT03605056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93134160|NCT03605056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93134161|NCT03605056|Growth Substances|growth substances|mesh-ancestor
93134162|NCT03605056|Growth Inhibitors|growth inhibitors|mesh-ancestor
93134163|NCT01002742|Mycophenolic Acid|mycophenolic acid|mesh-list
93134164|NCT01002742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93134165|NCT01002742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134166|NCT01002742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93134167|NCT01002742|Antitubercular Agents|antitubercular agents|mesh-ancestor
93134168|NCT01002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134169|NCT01002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134170|NCT01002742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134171|NCT01002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134172|NCT03604744|Psilocybin|psilocybin|mesh-list
93134173|NCT03604744|Hallucinogens|hallucinogens|mesh-ancestor
93134174|NCT03604744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134175|NCT03604744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93134176|NCT03604354|Pregabalin|pregabalin|mesh-list
93134177|NCT03604354|Tapentadol|tapentadol|mesh-list
93134178|NCT03604354|Analgesics|analgesics|mesh-ancestor
93134179|NCT03604354|Sensory System Agents|sensory system agents|mesh-ancestor
93134180|NCT03604354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134181|NCT03604354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134182|NCT03604354|Anticonvulsants|anticonvulsants|mesh-ancestor
93134183|NCT03604354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93134184|NCT03604354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134185|NCT03604354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134186|NCT03604354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93134187|NCT03604354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93134188|NCT03604354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93134189|NCT03604354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134190|NCT03604354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93134191|NCT03604354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93134192|NCT03604354|Narcotics|narcotics|mesh-ancestor
93134193|NCT03604354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93134194|NCT03604354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93134195|NCT03604354|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134196|NCT03604354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134197|NCT03603418|Dexamethasone|dexamethasone|mesh-list
93134198|NCT03603418|Dexamethasone acetate|dexamethasone acetate|mesh-list
93134199|NCT03603418|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93134200|NCT03603418|BB 1101|bb 1101|mesh-list
93134201|NCT03603418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134202|NCT03603418|Antiemetics|antiemetics|mesh-ancestor
93134203|NCT03603418|Autonomic Agents|autonomic agents|mesh-ancestor
93134204|NCT03603418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134205|NCT03603418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134206|NCT03603418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134207|NCT03603418|Glucocorticoids|glucocorticoids|mesh-ancestor
93134208|NCT03603418|Hormones|hormones|mesh-ancestor
93134209|NCT03603418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134210|NCT03603418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134211|NCT03603418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134212|NCT03603418|Protease Inhibitors|protease inhibitors|mesh-ancestor
93134213|NCT03603418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134214|NCT03603418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134215|NCT02034838|Ritonavir|ritonavir|mesh-list
93134216|NCT02034838|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93134217|NCT02034838|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93134218|NCT02034838|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93134219|NCT02034838|Protease Inhibitors|protease inhibitors|mesh-ancestor
93134220|NCT02034838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134221|NCT02034838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134222|NCT02034838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93134223|NCT02034838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93134224|NCT02034838|Antiviral Agents|antiviral agents|mesh-ancestor
93134225|NCT02034838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134226|NCT02034838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93134227|NCT02034838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93134228|NCT02852434|Lidocaine|lidocaine|mesh-list
93134229|NCT02852434|Anesthetics, Local|anesthetics, local|mesh-ancestor
93134230|NCT02852434|Anesthetics|anesthetics|mesh-ancestor
93134231|NCT02852434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134232|NCT02852434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134233|NCT02852434|Sensory System Agents|sensory system agents|mesh-ancestor
93134234|NCT02852434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134235|NCT02852434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93134236|NCT02852434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93134237|NCT02852434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93134238|NCT02852434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134239|NCT02852434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134240|NCT03606928|Leucovorin|leucovorin|mesh-list
93134241|NCT03606928|Docetaxel|docetaxel|mesh-list
93134242|NCT03606928|Oxaliplatin|oxaliplatin|mesh-list
93134243|NCT03606928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134245|NCT03606928|Antimitotic Agents|antimitotic agents|mesh-ancestor
93134246|NCT03606928|Mitosis Modulators|mitosis modulators|mesh-ancestor
93134247|NCT03606928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134248|NCT03606928|Antidotes|antidotes|mesh-ancestor
93134249|NCT03606928|Protective Agents|protective agents|mesh-ancestor
93134250|NCT03606928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134251|NCT03606928|Vitamin B Complex|vitamin b complex|mesh-ancestor
93134252|NCT03606928|Vitamins|vitamins|mesh-ancestor
93134253|NCT03606928|Micronutrients|micronutrients|mesh-ancestor
93134254|NCT03602248|Methamphetamine|methamphetamine|mesh-list
93134255|NCT03602248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93134256|NCT03602248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134257|NCT03602248|Sympathomimetics|sympathomimetics|mesh-ancestor
93134258|NCT03602248|Autonomic Agents|autonomic agents|mesh-ancestor
93134259|NCT03602248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134260|NCT03602248|Dopamine Agents|dopamine agents|mesh-ancestor
93134261|NCT03602248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134262|NCT03602248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134263|NCT03602248|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134264|NCT03602248|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93134265|NCT03602248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93134266|NCT03602248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134267|NCT03602248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93134268|NCT03602638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93134269|NCT03602638|Acarbose|acarbose|mesh-list
93134270|NCT03602638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93134271|NCT03602638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134272|NCT03602638|Incretins|incretins|mesh-ancestor
93134273|NCT03602638|Hormones|hormones|mesh-ancestor
93134274|NCT03602638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134275|NCT03602638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93134276|NCT03602638|Protease Inhibitors|protease inhibitors|mesh-ancestor
93134277|NCT03602638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134278|NCT03602638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134279|NCT03602638|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93134280|NCT02237560|Camphor|camphor|mesh-list
93134281|NCT02237560|Salicylates|salicylates|mesh-list
93134282|NCT02237560|Methyl salicylate|methyl salicylate|mesh-list
93134283|NCT02237560|Menthol|menthol|mesh-list
93134284|NCT02237560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93134285|NCT02237560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134286|NCT02237560|Antipruritics|antipruritics|mesh-ancestor
93134287|NCT02237560|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134288|NCT02237560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93134289|NCT02237560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93134290|NCT02237560|Analgesics|analgesics|mesh-ancestor
93134291|NCT02237560|Sensory System Agents|sensory system agents|mesh-ancestor
93134292|NCT02237560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134293|NCT02237560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134294|NCT02237560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134295|NCT02237560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134296|NCT02237560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93134297|NCT02237560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134298|NCT02237560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134299|NCT03601624|Dexamethasone|dexamethasone|mesh-list
93134300|NCT03601624|Cyclophosphamide|cyclophosphamide|mesh-list
93134301|NCT03601624|Pomalidomide|pomalidomide|mesh-list
93134302|NCT03601624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93134303|NCT03601624|Immunologic Factors|immunologic factors|mesh-ancestor
93134304|NCT03601624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134305|NCT03601624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134306|NCT03601624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93134307|NCT03601624|Alkylating Agents|alkylating agents|mesh-ancestor
93134308|NCT03601624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134309|NCT03601624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134310|NCT03601624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93134311|NCT03601624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134312|NCT03601624|Antiemetics|antiemetics|mesh-ancestor
93134313|NCT03601624|Autonomic Agents|autonomic agents|mesh-ancestor
93134314|NCT03601624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134315|NCT03601624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134316|NCT03601624|Glucocorticoids|glucocorticoids|mesh-ancestor
92806484|NCT02614456|Interferons|interferons|mesh-list
93134317|NCT03601624|Hormones|hormones|mesh-ancestor
93134318|NCT03601624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134319|NCT03601624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134320|NCT03601624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93134321|NCT03601624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93134322|NCT03601624|Growth Substances|growth substances|mesh-ancestor
93134323|NCT03601624|Growth Inhibitors|growth inhibitors|mesh-ancestor
93134324|NCT03899428|Sorafenib|sorafenib|mesh-list
93134325|NCT03899428|Durvalumab|durvalumab|mesh-list
93134326|NCT03899428|Lenvatinib|lenvatinib|mesh-list
93134327|NCT03899428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134328|NCT03899428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93134329|NCT03899428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134330|NCT03899428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134331|NCT03899428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134332|NCT02238418|Cholecalciferol|cholecalciferol|mesh-list
93134333|NCT02238418|Vitamin D|vitamin d|mesh-list
93134334|NCT02238418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93134335|NCT02238418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134336|NCT02238418|Vitamins|vitamins|mesh-ancestor
93134337|NCT02238418|Micronutrients|micronutrients|mesh-ancestor
93134338|NCT02238418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93134339|NCT02850016|Romidepsin|romidepsin|mesh-list
93134340|NCT02850016|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93134341|NCT02850016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93134342|NCT02850016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134343|NCT02850016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134344|NCT02850016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134345|NCT02849704|Pancrelipase|pancrelipase|mesh-list
93134346|NCT02849704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134347|NCT03600766|Mirabegron|mirabegron|mesh-list
93134348|NCT03600766|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93134349|NCT03600766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93134350|NCT03600766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93134351|NCT03600766|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134352|NCT03600766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134353|NCT03600766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134354|NCT03600766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134355|NCT03600766|Urological Agents|urological agents|mesh-ancestor
93134356|NCT03600454|Anesthetics|anesthetics|mesh-list
93134357|NCT03600454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134358|NCT03600454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134359|NCT03594604|Contraceptive Agents|contraceptive agents|mesh-list
93134360|NCT03594604|Norethindrone|norethindrone|mesh-list
93134361|NCT03594604|Norethindrone Acetate|norethindrone acetate|mesh-list
93134362|NCT03594604|Contraceptives, Oral|contraceptives, oral|mesh-list
93134363|NCT03594604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93134364|NCT03594604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93134365|NCT03594604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134366|NCT03594604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93134367|NCT03594604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93134368|NCT03594604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93134369|NCT03594604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93134370|NCT02689258|Bupivacaine|bupivacaine|mesh-list
93134371|NCT02689258|Anesthetics, Local|anesthetics, local|mesh-ancestor
93134372|NCT02689258|Anesthetics|anesthetics|mesh-ancestor
93134373|NCT02689258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134374|NCT02689258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134375|NCT02689258|Sensory System Agents|sensory system agents|mesh-ancestor
93134376|NCT02689258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134377|NCT02238184|Ipratropium|ipratropium|mesh-list
93134378|NCT02238184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93134379|NCT02238184|Autonomic Agents|autonomic agents|mesh-ancestor
93134380|NCT02238184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134381|NCT02238184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134382|NCT02238184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93134383|NCT02238184|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134384|NCT02238184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93134385|NCT02238184|Cholinergic Agents|cholinergic agents|mesh-ancestor
93134386|NCT02238184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134387|NCT02238184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134388|NCT03592498|Sulfadiazine|sulfadiazine|mesh-list
93134389|NCT03592498|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93134390|NCT03592498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806558|NCT04872218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134391|NCT03592498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134392|NCT03592498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93134393|NCT03592498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93134394|NCT03592498|Coccidiostats|coccidiostats|mesh-ancestor
93134395|NCT03592498|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93134396|NCT03600064|Misoprostol|misoprostol|mesh-list
93134397|NCT03600064|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93134398|NCT03600064|Abortifacient Agents|abortifacient agents|mesh-ancestor
93134399|NCT03600064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93134400|NCT03600064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134401|NCT03600064|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93134402|NCT03600064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134403|NCT03600064|Oxytocics|oxytocics|mesh-ancestor
93134404|NCT02721082|Nicotine|nicotine|mesh-list
93134405|NCT02721082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93134406|NCT02721082|Autonomic Agents|autonomic agents|mesh-ancestor
93134407|NCT02721082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134408|NCT02721082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134409|NCT02721082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93134410|NCT02721082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93134411|NCT02721082|Cholinergic Agents|cholinergic agents|mesh-ancestor
93134412|NCT02721082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134413|NCT02721082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134414|NCT02238106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93134415|NCT02238106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93134416|NCT02238106|Autonomic Agents|autonomic agents|mesh-ancestor
93134417|NCT02238106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134418|NCT02238106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134419|NCT02238106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93134420|NCT02238106|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134421|NCT02238106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93134422|NCT02238106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93134423|NCT02238106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93134424|NCT02238106|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134425|NCT02238106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134426|NCT02238106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134427|NCT03577912|Anesthetics|anesthetics|mesh-list
93134428|NCT03577912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134429|NCT03577912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134430|NCT02238262|Telmisartan|telmisartan|mesh-list
93134431|NCT02238262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93134432|NCT02238262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93134433|NCT02238262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93134434|NCT02238262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134435|NCT03577834|Acetic Acid|acetic acid|mesh-list
93134436|NCT03577834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134437|NCT03577834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134438|NCT03707678|Albuterol|albuterol|mesh-list
93134439|NCT03707678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93134440|NCT03707678|Autonomic Agents|autonomic agents|mesh-ancestor
93134441|NCT03707678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134442|NCT03707678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134443|NCT03707678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93134444|NCT03707678|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134445|NCT03707678|Tocolytic Agents|tocolytic agents|mesh-ancestor
93134446|NCT03707678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93134447|NCT03707678|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93134448|NCT03707678|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93134449|NCT03707678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93134450|NCT03707678|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134451|NCT03707678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134452|NCT03707678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134453|NCT03334448|Insulin Lispro|insulin lispro|mesh-list
93134454|NCT03334448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93134455|NCT03334448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134456|NCT04773002|Anesthetics|anesthetics|mesh-list
93134457|NCT04773002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134458|NCT04773002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134459|NCT02849080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93134460|NCT02849080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93134461|NCT02849080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134462|NCT02849080|Incretins|incretins|mesh-ancestor
93134463|NCT02849080|Hormones|hormones|mesh-ancestor
93134464|NCT02849080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134465|NCT02849080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93134466|NCT02849080|Protease Inhibitors|protease inhibitors|mesh-ancestor
93134467|NCT02849080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134468|NCT02849080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134469|NCT03346070|Glycopyrrolate|glycopyrrolate|mesh-list
93134470|NCT03346070|Rocuronium|rocuronium|mesh-list
93134471|NCT03346070|Vecuronium Bromide|vecuronium bromide|mesh-list
93134472|NCT03346070|Neostigmine|neostigmine|mesh-list
93134473|NCT03346070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93134474|NCT03346070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93134475|NCT03346070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93134476|NCT03346070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134477|NCT03346070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134478|NCT03346070|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93134479|NCT03346070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134480|NCT03346070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134481|NCT03346070|Cholinergic Agents|cholinergic agents|mesh-ancestor
93134482|NCT03346070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134483|NCT03346070|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93134484|NCT03346070|Autonomic Agents|autonomic agents|mesh-ancestor
93134485|NCT03346070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93134486|NCT03346070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93134487|NCT03346070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93134488|NCT03346070|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93134489|NCT03590626|Dulaglutide|dulaglutide|mesh-list
93134490|NCT03590626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93134491|NCT03590626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134492|NCT02238340|Ketoprofen|ketoprofen|mesh-list
93134493|NCT02238340|Morphine|morphine|mesh-list
93134494|NCT02238340|Oxycodone|oxycodone|mesh-list
93134495|NCT02238340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93134496|NCT02238340|Narcotics|narcotics|mesh-ancestor
93134497|NCT02238340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134498|NCT02238340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134499|NCT02238340|Analgesics|analgesics|mesh-ancestor
93134500|NCT02238340|Sensory System Agents|sensory system agents|mesh-ancestor
93134501|NCT02238340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134502|NCT02238340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93134503|NCT02238340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93134504|NCT02238340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134505|NCT02238340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134506|NCT02238340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93134507|NCT02238340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134508|NCT02238340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134509|NCT03577132|Atezolizumab|atezolizumab|mesh-list
93134510|NCT03577132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93134511|NCT03577132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134512|NCT03577132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134513|NCT03577132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134514|NCT05194124|alpha-MSH|alpha-msh|mesh-list
93134515|NCT05194124|Hormones|hormones|mesh-ancestor
93134516|NCT05194124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134517|NCT05194124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134518|NCT02250664|Nicotine|nicotine|mesh-list
93134519|NCT02250664|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93134520|NCT02250664|Autonomic Agents|autonomic agents|mesh-ancestor
93134521|NCT02250664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134522|NCT02250664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134523|NCT02250664|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93134524|NCT02250664|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93134525|NCT02250664|Cholinergic Agents|cholinergic agents|mesh-ancestor
93134526|NCT02250664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134527|NCT02250664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134528|NCT02239276|Stiripentol|stiripentol|mesh-list
93134529|NCT02239276|Anticonvulsants|anticonvulsants|mesh-ancestor
93134530|NCT03576820|Lidocaine|lidocaine|mesh-list
93134531|NCT03576820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93134532|NCT03576820|Anesthetics, Local|anesthetics, local|mesh-ancestor
93134533|NCT03576820|Anesthetics|anesthetics|mesh-ancestor
93134534|NCT03576820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134535|NCT03576820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134536|NCT03576820|Sensory System Agents|sensory system agents|mesh-ancestor
93134537|NCT03576820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134538|NCT03576820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92806703|NCT01079234|Insulin Glargine|insulin glargine|mesh-list
93134539|NCT03576820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93134540|NCT03576820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93134541|NCT03576820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134542|NCT03576820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134544|NCT03579082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93134545|NCT03579082|Antimetabolites|antimetabolites|mesh-ancestor
93134546|NCT03579082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134547|NCT03579082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134548|NCT03579082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134549|NCT03579004|Paclitaxel|paclitaxel|mesh-list
93134550|NCT03579004|Fluorouracil|fluorouracil|mesh-list
93134551|NCT03579004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93134552|NCT03579004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134553|NCT03579004|Tubulin Modulators|tubulin modulators|mesh-ancestor
93134554|NCT03579004|Antimitotic Agents|antimitotic agents|mesh-ancestor
93134555|NCT03579004|Mitosis Modulators|mitosis modulators|mesh-ancestor
93134556|NCT03579004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134557|NCT03579004|Antimetabolites|antimetabolites|mesh-ancestor
93134558|NCT03579004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93134559|NCT03579004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93134560|NCT03579004|Immunologic Factors|immunologic factors|mesh-ancestor
93134561|NCT03579004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134562|NCT03576508|Lidocaine|lidocaine|mesh-list
93134563|NCT03576508|Epinephrine|epinephrine|mesh-list
93134564|NCT03576508|Capsaicin|capsaicin|mesh-list
93134565|NCT03576508|Anesthetics, Local|anesthetics, local|mesh-ancestor
93134566|NCT03576508|Anesthetics|anesthetics|mesh-ancestor
93134567|NCT03576508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134568|NCT03576508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134569|NCT03576508|Sensory System Agents|sensory system agents|mesh-ancestor
93134570|NCT03576508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134571|NCT03576508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93134572|NCT03576508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93134573|NCT03576508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93134574|NCT03576508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134575|NCT03576508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134576|NCT03576508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93134577|NCT03576508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93134578|NCT03576508|Adrenergic Agents|adrenergic agents|mesh-ancestor
93134579|NCT03576508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134580|NCT03576508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93134581|NCT03576508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93134582|NCT03576508|Autonomic Agents|autonomic agents|mesh-ancestor
93134583|NCT03576508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93134584|NCT03576508|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134585|NCT03576508|Mydriatics|mydriatics|mesh-ancestor
93134586|NCT03576508|Sympathomimetics|sympathomimetics|mesh-ancestor
93134587|NCT03576508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93134588|NCT03576508|Antipruritics|antipruritics|mesh-ancestor
93134589|NCT03576508|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134590|NCT02646982|Candesartan|candesartan|mesh-list
93134591|NCT02646982|Candesartan cilexetil|candesartan cilexetil|mesh-list
93134592|NCT02646982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93134593|NCT02646982|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93134594|NCT02646982|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93134595|NCT02646982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134596|NCT03576040|Edotreotide|edotreotide|mesh-list
93134597|NCT03576040|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93134598|NCT03576040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134599|NCT03574246|Chlorhexidine|chlorhexidine|mesh-list
93134600|NCT03574246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93134601|NCT03574246|Benzydamine|benzydamine|mesh-list
93134602|NCT03574246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93134603|NCT03574246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134604|NCT03574246|Disinfectants|disinfectants|mesh-ancestor
93134605|NCT03574246|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134606|NCT03574246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134607|NCT02239900|Ipilimumab|ipilimumab|mesh-list
93134608|NCT02239900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134609|NCT02239900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134610|NCT02239900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93134611|NCT02239900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134612|NCT03573934|Glucagon|glucagon|mesh-list
93134613|NCT03573934|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93134614|NCT03573934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134615|NCT03573934|Hormones|hormones|mesh-ancestor
93134616|NCT03573934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134617|NCT03573934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134618|NCT03573934|Incretins|incretins|mesh-ancestor
93134619|NCT02229136|Prednisolone|prednisolone|mesh-list
93134620|NCT02229136|Hydrocortisone|hydrocortisone|mesh-list
93134621|NCT02229136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134622|NCT02229136|Glucocorticoids|glucocorticoids|mesh-ancestor
93134623|NCT02229136|Hormones|hormones|mesh-ancestor
93134624|NCT02229136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134625|NCT02229136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134626|NCT02229136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134627|NCT02229136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134628|NCT02523898|Metformin|metformin|mesh-list
93134629|NCT02523898|Clomiphene|clomiphene|mesh-list
93134630|NCT02523898|Enclomiphene|enclomiphene|mesh-list
93134631|NCT02523898|Zuclomiphene|zuclomiphene|mesh-list
93134632|NCT02523898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93134633|NCT02523898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134634|NCT02523898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93134635|NCT02523898|Hormone Antagonists|hormone antagonists|mesh-ancestor
93134636|NCT02523898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134637|NCT02523898|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93134638|NCT02523898|Fertility Agents|fertility agents|mesh-ancestor
93134639|NCT02523898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93134640|NCT02523898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93134641|NCT02523898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93134642|NCT02845336|Celecoxib|celecoxib|mesh-list
93134643|NCT02845336|Lubricant Eye Drops|lubricant eye drops|mesh-list
93134644|NCT02845336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93134645|NCT02845336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93134646|NCT02845336|Analgesics|analgesics|mesh-ancestor
93134647|NCT02845336|Sensory System Agents|sensory system agents|mesh-ancestor
93134648|NCT02845336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134649|NCT02845336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134650|NCT02845336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134651|NCT02845336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134652|NCT02845336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93134653|NCT02845336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93134654|NCT02845336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134655|NCT02845336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134656|NCT02845336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93134657|NCT02845336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93134658|NCT02244502|Paclitaxel|paclitaxel|mesh-list
92809499|NCT01077362|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134659|NCT02244502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93134660|NCT02244502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134661|NCT02244502|Tubulin Modulators|tubulin modulators|mesh-ancestor
93134662|NCT02244502|Antimitotic Agents|antimitotic agents|mesh-ancestor
93134663|NCT02244502|Mitosis Modulators|mitosis modulators|mesh-ancestor
93134664|NCT02244502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134665|NCT03573622|Sarpogrelate|sarpogrelate|mesh-list
93134666|NCT03573622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93134667|NCT03573622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93134668|NCT03573622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134669|NCT03573622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93134670|NCT03573622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93134671|NCT03573622|Serotonin Agents|serotonin agents|mesh-ancestor
93134672|NCT03573622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134673|NCT03573622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134674|NCT02951156|Rituximab|rituximab|mesh-list
93134675|NCT02951156|Avelumab|avelumab|mesh-list
93134676|NCT02951156|Gemcitabine|gemcitabine|mesh-list
93134677|NCT02951156|Oxaliplatin|oxaliplatin|mesh-list
93134678|NCT02951156|Azacitidine|azacitidine|mesh-list
93134679|NCT02951156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93134680|NCT02951156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134681|NCT02951156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134682|NCT02951156|Immunologic Factors|immunologic factors|mesh-ancestor
93134683|NCT02951156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134684|NCT02951156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134685|NCT02951156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93134686|NCT02951156|Antimetabolites|antimetabolites|mesh-ancestor
93134687|NCT02951156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134688|NCT02951156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134689|NCT02951156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93134690|NCT02951156|Alkylating Agents|alkylating agents|mesh-ancestor
93134691|NCT03571594|Octreotide|octreotide|mesh-list
93134692|NCT03571594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134693|NCT03571594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134694|NCT03571594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134695|NCT03571438|Sirolimus|sirolimus|mesh-list
93134696|NCT03571438|Sunitinib|sunitinib|mesh-list
93134697|NCT03571438|Temsirolimus|temsirolimus|mesh-list
93134698|NCT03571438|MTOR Inhibitors|mtor inhibitors|mesh-list
93134699|NCT03571438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134700|NCT03571438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93134701|NCT03571438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93134702|NCT03571438|Growth Substances|growth substances|mesh-ancestor
93134703|NCT03571438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134704|NCT03571438|Growth Inhibitors|growth inhibitors|mesh-ancestor
93134705|NCT03571438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93134706|NCT03571438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134707|NCT03571438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134708|NCT03571438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93134709|NCT03571438|Immunologic Factors|immunologic factors|mesh-ancestor
93134710|NCT03571438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134711|NCT03571438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134712|NCT03571438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93134713|NCT03571438|Antifungal Agents|antifungal agents|mesh-ancestor
93134714|NCT01874860|Doxycycline|doxycycline|mesh-list
93134715|NCT01874860|Clindamycin|clindamycin|mesh-list
93134716|NCT01874860|Clindamycin palmitate|clindamycin palmitate|mesh-list
93134717|NCT01874860|Clindamycin phosphate|clindamycin phosphate|mesh-list
93134718|NCT01874860|Hydrocortisone|hydrocortisone|mesh-list
93134719|NCT01874860|Methylprednisolone|methylprednisolone|mesh-list
93134720|NCT01874860|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93134721|NCT01874860|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93134722|NCT01874860|Prednisolone|prednisolone|mesh-list
93134723|NCT01874860|Prednisolone acetate|prednisolone acetate|mesh-list
93134724|NCT01874860|Sunscreening Agents|sunscreening agents|mesh-list
93134725|NCT01874860|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93134726|NCT01874860|Prednisolone phosphate|prednisolone phosphate|mesh-list
93134727|NCT01874860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134728|NCT01874860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134729|NCT01874860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134730|NCT01874860|Antimalarials|antimalarials|mesh-ancestor
93134731|NCT01874860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93134732|NCT01874860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93134733|NCT01874860|Antiemetics|antiemetics|mesh-ancestor
93134734|NCT01874860|Autonomic Agents|autonomic agents|mesh-ancestor
93134735|NCT01874860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134736|NCT01874860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134737|NCT01874860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134738|NCT01874860|Glucocorticoids|glucocorticoids|mesh-ancestor
93134739|NCT01874860|Hormones|hormones|mesh-ancestor
93134740|NCT01874860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134741|NCT01874860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93134742|NCT01874860|Protective Agents|protective agents|mesh-ancestor
93134743|NCT01874860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134744|NCT01874860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134745|NCT01874860|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93134746|NCT01874860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134747|NCT01874860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134748|NCT01874860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93134749|NCT01874860|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134750|NCT03570346|Hemay005|hemay005|mesh-list
93134751|NCT03570346|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134752|NCT03570346|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93134753|NCT03570346|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93134754|NCT03570346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134755|NCT03570346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134756|NCT03571126|Olanzapine|olanzapine|mesh-list
93134757|NCT03571126|Antiemetics|antiemetics|mesh-ancestor
93134758|NCT03571126|Autonomic Agents|autonomic agents|mesh-ancestor
93134759|NCT03571126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134760|NCT03571126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134761|NCT03571126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134762|NCT03571126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93134763|NCT03571126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93134764|NCT03571126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134765|NCT03571126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93134766|NCT03571126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93134767|NCT03571126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93134768|NCT03571126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134769|NCT03571126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134770|NCT03571126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134771|NCT03571126|Serotonin Agents|serotonin agents|mesh-ancestor
93134772|NCT03570112|Sofosbuvir|sofosbuvir|mesh-list
93134773|NCT03570112|Velpatasvir|velpatasvir|mesh-list
93134774|NCT03570112|Antiviral Agents|antiviral agents|mesh-ancestor
93134775|NCT03570112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134776|NCT03572686|Dexamethasone|dexamethasone|mesh-list
93134777|NCT03572686|Dexamethasone acetate|dexamethasone acetate|mesh-list
93134778|NCT03572686|Ropivacaine|ropivacaine|mesh-list
93134779|NCT03572686|BB 1101|bb 1101|mesh-list
93134780|NCT03572686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134781|NCT03572686|Antiemetics|antiemetics|mesh-ancestor
93134782|NCT03572686|Autonomic Agents|autonomic agents|mesh-ancestor
93134783|NCT03572686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134784|NCT03572686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134785|NCT03572686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134786|NCT03572686|Glucocorticoids|glucocorticoids|mesh-ancestor
93134787|NCT03572686|Hormones|hormones|mesh-ancestor
93134788|NCT03572686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134789|NCT03572686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93134790|NCT03572686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134791|NCT03572686|Protease Inhibitors|protease inhibitors|mesh-ancestor
93134792|NCT03572686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134793|NCT03572686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134794|NCT03572686|Anesthetics, Local|anesthetics, local|mesh-ancestor
93134795|NCT03572686|Anesthetics|anesthetics|mesh-ancestor
93134796|NCT03572686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134797|NCT03572686|Sensory System Agents|sensory system agents|mesh-ancestor
93134798|NCT02523820|Fluticasone|fluticasone|mesh-list
93134799|NCT02523820|Xhance|xhance|mesh-list
93134800|NCT02523820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93134801|NCT02523820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93134802|NCT02523820|Autonomic Agents|autonomic agents|mesh-ancestor
93134803|NCT02523820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134804|NCT02523820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134805|NCT02523820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93134806|NCT02523820|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134807|NCT02523820|Dermatologic Agents|dermatologic agents|mesh-ancestor
93134808|NCT02523820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93134809|NCT03369704|Omalizumab|omalizumab|mesh-list
93134810|NCT03369704|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91927245|NCT04265534|Micronutrients|micronutrients|mesh-ancestor
93134811|NCT03369704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93134812|NCT03369704|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134813|NCT03709160|Bumetanide|bumetanide|mesh-list
93134814|NCT03709160|Diuretics|diuretics|mesh-ancestor
93134815|NCT03709160|Natriuretic Agents|natriuretic agents|mesh-ancestor
93134816|NCT03709160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134817|NCT03709160|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93134818|NCT03709160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93134819|NCT03709160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134820|NCT05332496|Bevacizumab|bevacizumab|mesh-list
93134821|NCT05332496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93134822|NCT05332496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134823|NCT05332496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134824|NCT05332496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93134825|NCT05332496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93134826|NCT05332496|Growth Substances|growth substances|mesh-ancestor
93134827|NCT05332496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134828|NCT05332496|Growth Inhibitors|growth inhibitors|mesh-ancestor
93134829|NCT05332496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134830|NCT03567304|Rilpivirine|rilpivirine|mesh-list
93134831|NCT03567304|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93134832|NCT03567304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93134833|NCT03567304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134834|NCT03567304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134835|NCT03567304|Antiviral Agents|antiviral agents|mesh-ancestor
93134836|NCT03567304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134837|NCT03567304|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93134838|NCT03567304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93134839|NCT05356858|Zanubrutinib|zanubrutinib|mesh-list
93134840|NCT05356858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134841|NCT05356858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93134842|NCT05356858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134843|NCT05356858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134844|NCT03566914|Tadalafil|tadalafil|mesh-list
93134845|NCT03566914|Vasodilator Agents|vasodilator agents|mesh-ancestor
93134846|NCT03566914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93134847|NCT03566914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93134848|NCT03566914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134849|NCT03566914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134850|NCT03566914|Urological Agents|urological agents|mesh-ancestor
93134851|NCT03366428|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93134852|NCT03366428|Immunoconjugates|immunoconjugates|mesh-ancestor
93134853|NCT03366428|Immunologic Factors|immunologic factors|mesh-ancestor
93134854|NCT03366428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134855|NCT03709082|Trastuzumab|trastuzumab|mesh-list
93134856|NCT03709082|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93134857|NCT03709082|Letrozole|letrozole|mesh-list
93134858|NCT03709082|Palbociclib|palbociclib|mesh-list
93134859|NCT03709082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134860|NCT03709082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134861|NCT03709082|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93134862|NCT03709082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93134863|NCT03709082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134864|NCT03709082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134865|NCT03709082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93134866|NCT03709082|Hormone Antagonists|hormone antagonists|mesh-ancestor
93134867|NCT03709082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93134868|NCT03709082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134869|NCT03709082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93134870|NCT03709082|Tubulin Modulators|tubulin modulators|mesh-ancestor
93134871|NCT03709082|Antimitotic Agents|antimitotic agents|mesh-ancestor
93134872|NCT03709082|Mitosis Modulators|mitosis modulators|mesh-ancestor
93134873|NCT03709082|Immunotoxins|immunotoxins|mesh-ancestor
93134874|NCT03709082|Immunoconjugates|immunoconjugates|mesh-ancestor
93134875|NCT03709082|Immunologic Factors|immunologic factors|mesh-ancestor
93134876|NCT02839876|Acetaminophen|acetaminophen|mesh-list
93134877|NCT02839876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93134878|NCT02839876|Analgesics|analgesics|mesh-ancestor
93134879|NCT02839876|Sensory System Agents|sensory system agents|mesh-ancestor
93134880|NCT02839876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93134881|NCT02839876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134882|NCT02839876|Antipyretics|antipyretics|mesh-ancestor
93134883|NCT01312064|Rituximab|rituximab|mesh-list
93134884|NCT01312064|Everolimus|everolimus|mesh-list
93134885|NCT01312064|Tacrolimus|tacrolimus|mesh-list
93134886|NCT01312064|Thymoglobulin|thymoglobulin|mesh-list
93134887|NCT01312064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134888|NCT01312064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134889|NCT01312064|Immunologic Factors|immunologic factors|mesh-ancestor
93134890|NCT01312064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134891|NCT01312064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134892|NCT01312064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93134893|NCT01312064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93134894|NCT01312064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134895|NCT01312064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134896|NCT01312064|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93134897|NCT01312064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93134898|NCT05682716|Nitroglycerin|nitroglycerin|mesh-list
93134899|NCT05682716|Vasodilator Agents|vasodilator agents|mesh-ancestor
93134900|NCT03566134|Solifenacin Succinate|solifenacin succinate|mesh-list
93134901|NCT03566134|DA-8010|da-8010|mesh-list
93134902|NCT03566134|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93134903|NCT03566134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93134904|NCT03566134|Cholinergic Agents|cholinergic agents|mesh-ancestor
93134905|NCT03566134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93134906|NCT03566134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134907|NCT03566134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134908|NCT03566134|Urological Agents|urological agents|mesh-ancestor
93134909|NCT03101722|Huperzine A|huperzine a|mesh-list
93134910|NCT03101722|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
93134911|NCT03101722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134912|NCT03101722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134913|NCT03101722|Cholinergic Agents|cholinergic agents|mesh-ancestor
93134914|NCT03101722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807078|NCT00866788|Antiemetics|antiemetics|mesh-ancestor
93134915|NCT03101722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134916|NCT03101722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93134917|NCT03101722|Protective Agents|protective agents|mesh-ancestor
93134918|NCT03088852|Magnesium citrate|magnesium citrate|mesh-list
93134919|NCT03088852|Cathartics|cathartics|mesh-ancestor
93134920|NCT03088852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134921|NCT03568474|Fluorides|fluorides|mesh-list
93134922|NCT03568474|Cariostatic Agents|cariostatic agents|mesh-ancestor
93134923|NCT03568474|Protective Agents|protective agents|mesh-ancestor
93134924|NCT03568474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134925|NCT03345836|Upadacitinib|upadacitinib|mesh-list
93134926|NCT03345836|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93134927|NCT03345836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93134928|NCT03345836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134929|NCT03345836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134930|NCT03345836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93134931|NCT03708926|Abaloparatide|abaloparatide|mesh-list
93134932|NCT03708926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93134933|NCT03708926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134934|NCT03567928|Propofol|propofol|mesh-list
93134935|NCT03567928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93134936|NCT03567928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93134937|NCT03567928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134938|NCT03567928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93134939|NCT03567928|Anesthetics, General|anesthetics, general|mesh-ancestor
93134940|NCT03567928|Anesthetics|anesthetics|mesh-ancestor
93134941|NCT03565354|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93134942|NCT03565354|Hematinics|hematinics|mesh-ancestor
93134943|NCT03363776|Nivolumab|nivolumab|mesh-list
93134944|NCT03363776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93134945|NCT03363776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134946|NCT03363776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93134947|NCT03363776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134948|NCT03565276|Tranexamic Acid|tranexamic acid|mesh-list
93134949|NCT03565276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93134950|NCT03565276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93134951|NCT03565276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134952|NCT03565276|Hemostatics|hemostatics|mesh-ancestor
93134953|NCT03565276|Coagulants|coagulants|mesh-ancestor
93134954|NCT03564964|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
93134955|NCT03564964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93134956|NCT03564964|Serotonin Agents|serotonin agents|mesh-ancestor
93134957|NCT03564964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809500|NCT00846586|Tiotropium Bromide|tiotropium bromide|mesh-list
93134958|NCT03564964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134959|NCT03564964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134960|NCT03708848|Metronidazole|metronidazole|mesh-list
93134961|NCT03708848|Clarithromycin|clarithromycin|mesh-list
93134962|NCT03708848|Levofloxacin|levofloxacin|mesh-list
93134963|NCT03708848|Tetracycline|tetracycline|mesh-list
93134964|NCT03708848|Potassium Citrate|potassium citrate|mesh-list
93134965|NCT03708848|Esomeprazole|esomeprazole|mesh-list
93134966|NCT03708848|Bismuth|bismuth|mesh-list
93134967|NCT03708848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93134968|NCT03708848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134969|NCT03708848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134970|NCT03708848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93134971|NCT03708848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93134972|NCT03708848|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93134973|NCT03708848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93134974|NCT03708848|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93134975|NCT03708848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93134976|NCT03708848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93134977|NCT03708848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93134978|NCT03708848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93134979|NCT03708848|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93134980|NCT03708848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93134981|NCT03708848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93134982|NCT03708848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93134983|NCT03708848|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93134984|NCT03708848|Antacids|antacids|mesh-ancestor
93134985|NCT03708848|Diuretics|diuretics|mesh-ancestor
93134986|NCT03708848|Natriuretic Agents|natriuretic agents|mesh-ancestor
93134987|NCT03708848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93134988|NCT03708848|Expectorants|expectorants|mesh-ancestor
93134989|NCT03708848|Respiratory System Agents|respiratory system agents|mesh-ancestor
93134990|NCT03564652|Azithromycin|azithromycin|mesh-list
93134991|NCT03564652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93134992|NCT03564652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93134993|NCT03564574|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93134994|NCT03564574|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93134995|NCT03564574|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93134996|NCT03564574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93134997|NCT03710330|Tranexamic Acid|tranexamic acid|mesh-list
93134998|NCT03710330|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93134999|NCT03710330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93135000|NCT03710330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135001|NCT03710330|Hemostatics|hemostatics|mesh-ancestor
93135002|NCT03710330|Coagulants|coagulants|mesh-ancestor
93135003|NCT03710252|Ritonavir|ritonavir|mesh-list
93135004|NCT03710252|Ribavirin|ribavirin|mesh-list
93135005|NCT03710252|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93135006|NCT03710252|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93135007|NCT03710252|Protease Inhibitors|protease inhibitors|mesh-ancestor
93135008|NCT03710252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135009|NCT03710252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135010|NCT03710252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93135011|NCT03710252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93135012|NCT03710252|Antiviral Agents|antiviral agents|mesh-ancestor
93135013|NCT03710252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135014|NCT03710252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93135015|NCT03710252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93135016|NCT03710252|Antimetabolites|antimetabolites|mesh-ancestor
93135017|NCT02838628|Tirbanibulin|tirbanibulin|mesh-list
93135018|NCT02838628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135019|NCT02838628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135020|NCT03705884|Prednisolone|prednisolone|mesh-list
93135021|NCT03705884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135022|NCT03705884|Glucocorticoids|glucocorticoids|mesh-ancestor
93135023|NCT03705884|Hormones|hormones|mesh-ancestor
93135024|NCT03705884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135025|NCT03705884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135026|NCT03705884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93135027|NCT03705884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135028|NCT03359174|Tretinoin|tretinoin|mesh-list
93135029|NCT03359174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135030|NCT03359174|Keratolytic Agents|keratolytic agents|mesh-ancestor
93135031|NCT03359174|Dermatologic Agents|dermatologic agents|mesh-ancestor
93135032|NCT03564106|Methylprednisolone|methylprednisolone|mesh-list
93135033|NCT03564106|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93135034|NCT03564106|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93135035|NCT03564106|Prednisolone|prednisolone|mesh-list
93135036|NCT03564106|Prednisolone acetate|prednisolone acetate|mesh-list
93135037|NCT03564106|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93135038|NCT03564106|Prednisolone phosphate|prednisolone phosphate|mesh-list
93135039|NCT03564106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135040|NCT03564106|Antiemetics|antiemetics|mesh-ancestor
93135041|NCT03564106|Autonomic Agents|autonomic agents|mesh-ancestor
93135042|NCT03564106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135043|NCT03564106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135044|NCT03564106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135045|NCT03564106|Glucocorticoids|glucocorticoids|mesh-ancestor
93135046|NCT03564106|Hormones|hormones|mesh-ancestor
93135047|NCT03564106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135048|NCT03564106|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93135049|NCT03564106|Protective Agents|protective agents|mesh-ancestor
93135050|NCT03564106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93135051|NCT03564106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135052|NCT03710174|Salicylic Acid|salicylic acid|mesh-list
93135053|NCT03710174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135054|NCT03710174|Antifungal Agents|antifungal agents|mesh-ancestor
93135055|NCT03710174|Keratolytic Agents|keratolytic agents|mesh-ancestor
93135056|NCT03710174|Dermatologic Agents|dermatologic agents|mesh-ancestor
93135057|NCT00093015|Darbepoetin alfa|darbepoetin alfa|mesh-list
93135058|NCT00093015|Hematinics|hematinics|mesh-ancestor
93135059|NCT01145703|Vitamin D|vitamin d|mesh-list
93135060|NCT01145703|Ergocalciferols|ergocalciferols|mesh-list
93135061|NCT01145703|Cholecalciferol|cholecalciferol|mesh-list
93135062|NCT01145703|Vitamins|vitamins|mesh-list
93135063|NCT01145703|Micronutrients|micronutrients|mesh-ancestor
93135064|NCT01145703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135065|NCT01145703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93135066|NCT01145703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93135067|NCT05137587|Ketamine|ketamine|mesh-list
93135068|NCT05137587|Propofol|propofol|mesh-list
93135069|NCT05137587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135070|NCT05137587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135071|NCT05137587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135072|NCT05137587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93135073|NCT05137587|Anesthetics, General|anesthetics, general|mesh-ancestor
93135074|NCT05137587|Anesthetics|anesthetics|mesh-ancestor
93135075|NCT05137587|Analgesics|analgesics|mesh-ancestor
93135076|NCT05137587|Sensory System Agents|sensory system agents|mesh-ancestor
93135077|NCT05137587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135078|NCT05137587|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93135079|NCT05137587|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93135080|NCT05137587|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93135081|NCT05137587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135082|NCT05137587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135083|NCT01145859|Rivaroxaban|rivaroxaban|mesh-list
93135084|NCT01145859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93135085|NCT01145859|Antithrombins|antithrombins|mesh-ancestor
93135086|NCT01145859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93135087|NCT01145859|Protease Inhibitors|protease inhibitors|mesh-ancestor
93135088|NCT01145859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135089|NCT01145859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135090|NCT01145859|Anticoagulants|anticoagulants|mesh-ancestor
93135091|NCT01250847|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93135092|NCT01250847|Antidepressive Agents|antidepressive agents|mesh-ancestor
93135093|NCT01250847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135094|NCT01250847|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93135095|NCT01250847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135096|NCT01250847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135097|NCT01250847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135098|NCT03913455|Carboplatin|carboplatin|mesh-list
93135099|NCT03913455|Guadecitabine|guadecitabine|mesh-list
93135100|NCT03913455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135101|NCT03358472|Carboplatin|carboplatin|mesh-list
93135102|NCT03358472|Pembrolizumab|pembrolizumab|mesh-list
93135103|NCT03358472|Fluorouracil|fluorouracil|mesh-list
93135104|NCT03358472|Cetuximab|cetuximab|mesh-list
93135105|NCT03358472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135106|NCT03358472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93135107|NCT03358472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93135108|NCT03358472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135109|NCT03358472|Antimetabolites|antimetabolites|mesh-ancestor
93135110|NCT03358472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93135111|NCT03358472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93135112|NCT03358472|Immunologic Factors|immunologic factors|mesh-ancestor
93135113|NCT03358472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135114|NCT01238523|Calpastatin|calpastatin|mesh-list
93135115|NCT01238523|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93135116|NCT01238523|Protease Inhibitors|protease inhibitors|mesh-ancestor
93135117|NCT01238523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135118|NCT01238523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135119|NCT03708536|Bevacizumab|bevacizumab|mesh-list
93135120|NCT03708536|Capecitabine|capecitabine|mesh-list
93135121|NCT03708536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93135122|NCT03708536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135123|NCT03708536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93135124|NCT03708536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93135125|NCT03708536|Growth Substances|growth substances|mesh-ancestor
93135126|NCT03708536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135127|NCT03708536|Growth Inhibitors|growth inhibitors|mesh-ancestor
93135128|NCT03708536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93135129|NCT03708536|Antimetabolites|antimetabolites|mesh-ancestor
93135130|NCT03708536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135131|NCT03705728|Remifentanil|remifentanil|mesh-list
93135132|NCT03705728|Propofol|propofol|mesh-list
93135133|NCT03705728|Sevoflurane|sevoflurane|mesh-list
93135134|NCT03705728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135135|NCT03705728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135136|NCT03705728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135137|NCT03705728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93135138|NCT03705728|Anesthetics, General|anesthetics, general|mesh-ancestor
93135139|NCT03705728|Anesthetics|anesthetics|mesh-ancestor
93135140|NCT03705728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93135141|NCT03705728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93135142|NCT03705728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93135144|NCT03705728|Analgesics|analgesics|mesh-ancestor
93135145|NCT03705728|Sensory System Agents|sensory system agents|mesh-ancestor
93135146|NCT03705728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135147|NCT01147419|Blood Substitutes|blood substitutes|mesh-list
93135148|NCT05177666|Trastuzumab|trastuzumab|mesh-list
93135149|NCT05177666|Pertuzumab|pertuzumab|mesh-list
93135150|NCT05177666|Vemurafenib|vemurafenib|mesh-list
93135151|NCT05177666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93135152|NCT05177666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135153|NCT05177666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93135154|NCT05177666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135155|NCT05177666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135156|NCT03342638|Methylprednisolone|methylprednisolone|mesh-list
93135157|NCT03342638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93135158|NCT03342638|Cyclophosphamide|cyclophosphamide|mesh-list
93135159|NCT03342638|Thymoglobulin|thymoglobulin|mesh-list
93135160|NCT03342638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93135161|NCT03342638|Immunologic Factors|immunologic factors|mesh-ancestor
93135162|NCT03342638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135163|NCT03342638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135164|NCT03342638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93135165|NCT03342638|Alkylating Agents|alkylating agents|mesh-ancestor
93135166|NCT03342638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135167|NCT03342638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135168|NCT03342638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93135169|NCT03342638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135170|NCT03342638|Antiemetics|antiemetics|mesh-ancestor
93135171|NCT03342638|Autonomic Agents|autonomic agents|mesh-ancestor
93135172|NCT03342638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135173|NCT03342638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135174|NCT03342638|Glucocorticoids|glucocorticoids|mesh-ancestor
93135175|NCT03342638|Hormones|hormones|mesh-ancestor
93135176|NCT03342638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135177|NCT03342638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93135178|NCT03342638|Protective Agents|protective agents|mesh-ancestor
93135179|NCT03342638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93135180|NCT01246323|Fentanyl|fentanyl|mesh-list
93135181|NCT01246323|Morphine|morphine|mesh-list
93135182|NCT01246323|Anesthetics|anesthetics|mesh-ancestor
93135183|NCT01246323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135184|NCT01246323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135185|NCT01246323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93135186|NCT01246323|Narcotics|narcotics|mesh-ancestor
93135187|NCT01246323|Analgesics|analgesics|mesh-ancestor
93135188|NCT01246323|Sensory System Agents|sensory system agents|mesh-ancestor
93135189|NCT01246323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135190|NCT01246323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93135191|NCT01246323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93135192|NCT01246323|Anesthetics, General|anesthetics, general|mesh-ancestor
93135193|NCT05160363|Piperaquine|piperaquine|mesh-list
93135194|NCT05160363|Pyronaridine|pyronaridine|mesh-list
93135195|NCT05160363|Antimalarials|antimalarials|mesh-ancestor
93135196|NCT05160363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93135197|NCT05160363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135198|NCT05160363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135199|NCT05177276|Irinotecan|irinotecan|mesh-list
93135200|NCT05177276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93135201|NCT05177276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93135202|NCT05177276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135203|NCT05177276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135204|NCT05177276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135205|NCT02528175|Capecitabine|capecitabine|mesh-list
93135206|NCT02528175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93135207|NCT02528175|Antimetabolites|antimetabolites|mesh-ancestor
93135208|NCT02528175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135209|NCT02528175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135210|NCT03708458|Acetylcysteine|acetylcysteine|mesh-list
93135211|NCT03708458|Indomethacin|indomethacin|mesh-list
93135212|NCT03708458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93135213|NCT03708458|Antiviral Agents|antiviral agents|mesh-ancestor
93135214|NCT03708458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135215|NCT03708458|Expectorants|expectorants|mesh-ancestor
93135216|NCT03708458|Respiratory System Agents|respiratory system agents|mesh-ancestor
93135217|NCT03708458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93135218|NCT03708458|Antioxidants|antioxidants|mesh-ancestor
93135219|NCT03708458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135221|NCT03708458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135222|NCT03708458|Antidotes|antidotes|mesh-ancestor
93135223|NCT03708458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93135224|NCT03708458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135225|NCT03708458|Analgesics|analgesics|mesh-ancestor
93135226|NCT03708458|Sensory System Agents|sensory system agents|mesh-ancestor
93135227|NCT03708458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135228|NCT03708458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135229|NCT03708458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135230|NCT03708458|Gout Suppressants|gout suppressants|mesh-ancestor
93135231|NCT03708458|Tocolytic Agents|tocolytic agents|mesh-ancestor
93135232|NCT03708458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93135233|NCT03708458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93135234|NCT03708458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135235|NCT05625555|Midazolam|midazolam|mesh-list
93135236|NCT05625555|Ketamine|ketamine|mesh-list
93135237|NCT05625555|Analgesics|analgesics|mesh-ancestor
93135238|NCT05625555|Sensory System Agents|sensory system agents|mesh-ancestor
93135239|NCT05625555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135240|NCT05625555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135241|NCT05625555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93135242|NCT05625555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93135243|NCT05625555|Anesthetics, General|anesthetics, general|mesh-ancestor
93135244|NCT05625555|Anesthetics|anesthetics|mesh-ancestor
93135245|NCT05625555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135246|NCT05625555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93135247|NCT05625555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93135248|NCT05625555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135249|NCT05625555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135250|NCT05625555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93135251|NCT05625555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135252|NCT05625555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93135253|NCT05625555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135254|NCT05625555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135255|NCT05625555|GABA Modulators|gaba modulators|mesh-ancestor
93135256|NCT05625555|GABA Agents|gaba agents|mesh-ancestor
93135257|NCT01251471|Escitalopram|escitalopram|mesh-list
93135258|NCT01251471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93135259|NCT01251471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93135260|NCT01251471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135261|NCT01251471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135262|NCT01251471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135263|NCT01251471|Serotonin Agents|serotonin agents|mesh-ancestor
93135264|NCT01251471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135265|NCT01247805|Sildenafil Citrate|sildenafil citrate|mesh-list
93135266|NCT01247805|Citric Acid|citric acid|mesh-list
93135267|NCT01247805|Sodium Citrate|sodium citrate|mesh-list
93135268|NCT01247805|Anticoagulants|anticoagulants|mesh-ancestor
93135269|NCT01247805|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93135270|NCT01247805|Chelating Agents|chelating agents|mesh-ancestor
93135271|NCT01247805|Sequestering Agents|sequestering agents|mesh-ancestor
93135272|NCT01247805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135273|NCT01247805|Vasodilator Agents|vasodilator agents|mesh-ancestor
93135274|NCT01247805|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93135275|NCT01247805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93135276|NCT01247805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135277|NCT01247805|Urological Agents|urological agents|mesh-ancestor
93135278|NCT05631717|Aldesleukin|aldesleukin|mesh-list
93135279|NCT05631717|Interleukin-2|interleukin-2|mesh-list
93135280|NCT05631717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135281|NCT05631717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135282|NCT05631717|Analgesics|analgesics|mesh-ancestor
93135283|NCT05631717|Sensory System Agents|sensory system agents|mesh-ancestor
93135284|NCT05631717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135285|NCT05631717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135286|NCT05631717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93135287|NCT05631717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93135288|NCT05631717|Antiviral Agents|antiviral agents|mesh-ancestor
93135289|NCT05631717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135290|NCT01147731|Warfarin|warfarin|mesh-list
93135291|NCT01147731|rGLP-1 protein|rglp-1 protein|mesh-list
93135292|NCT01147731|Anticoagulants|anticoagulants|mesh-ancestor
93135293|NCT01147731|Incretins|incretins|mesh-ancestor
93135294|NCT01147731|Hormones|hormones|mesh-ancestor
93135295|NCT01147731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135296|NCT01147731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135297|NCT03912285|Losartan|losartan|mesh-list
93135298|NCT03912285|Amlodipine|amlodipine|mesh-list
93135299|NCT03912285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93135300|NCT03912285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93135301|NCT03912285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135302|NCT03912285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135303|NCT03912285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93135304|NCT03912285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135305|NCT03912285|Vasodilator Agents|vasodilator agents|mesh-ancestor
93135306|NCT03912285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93135307|NCT03912285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93135308|NCT03912285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93135309|NCT01251627|Decitabine|decitabine|mesh-list
93135310|NCT01251627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93135311|NCT01251627|Antimetabolites|antimetabolites|mesh-ancestor
93135312|NCT01251627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135313|NCT01251627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135314|NCT01251627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135315|NCT01146093|Pravastatin|pravastatin|mesh-list
93135316|NCT01146093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93135317|NCT01146093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93135318|NCT01146093|Antimetabolites|antimetabolites|mesh-ancestor
93135319|NCT01146093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135320|NCT01146093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93135321|NCT01146093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93135322|NCT01146093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135323|NCT02452983|Sertraline|sertraline|mesh-list
93135324|NCT02452983|Antidepressive Agents|antidepressive agents|mesh-ancestor
93135325|NCT02452983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135326|NCT02452983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93135327|NCT02452983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93135328|NCT02452983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135329|NCT02452983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135330|NCT02452983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135331|NCT02452983|Serotonin Agents|serotonin agents|mesh-ancestor
93135332|NCT02452983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135333|NCT03911817|Midodrine|midodrine|mesh-list
93135334|NCT03911817|Sympathomimetics|sympathomimetics|mesh-ancestor
93135335|NCT03911817|Autonomic Agents|autonomic agents|mesh-ancestor
93135336|NCT03911817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135337|NCT03911817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135338|NCT03911817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93135339|NCT03911817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93135340|NCT03911817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93135341|NCT03911817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93135342|NCT03911817|Adrenergic Agents|adrenergic agents|mesh-ancestor
93135343|NCT03911817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135344|NCT03911817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135345|NCT01239849|Atorvastatin|atorvastatin|mesh-list
93135346|NCT01239849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93135347|NCT01239849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93135348|NCT01239849|Antimetabolites|antimetabolites|mesh-ancestor
93135349|NCT01239849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135350|NCT01239849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93135351|NCT01239849|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93135352|NCT01239849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135353|NCT04896489|Hydrocortisone|hydrocortisone|mesh-list
93135354|NCT04896489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135355|NCT01148043|Hydroxychloroquine|hydroxychloroquine|mesh-list
93135356|NCT01148043|Antimalarials|antimalarials|mesh-ancestor
93135357|NCT01148043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93135358|NCT01148043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135359|NCT01148043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135360|NCT01148043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135361|NCT01148043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135362|NCT01148043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135363|NCT04880655|Bacitracin|bacitracin|mesh-list
93135364|NCT04880655|Petrolatum|petrolatum|mesh-list
93135365|NCT04880655|Emollients|emollients|mesh-ancestor
93135366|NCT04880655|Dermatologic Agents|dermatologic agents|mesh-ancestor
93135367|NCT04880655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93135368|NCT04880655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807536|NCT00857584|Serotonin Agents|serotonin agents|mesh-ancestor
93135369|NCT04880655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135370|NCT04865835|Metformin|metformin|mesh-list
93135371|NCT04865835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93135372|NCT04865835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135373|NCT03911271|Atropine|atropine|mesh-list
93135374|NCT03911271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93135375|NCT03911271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93135376|NCT03911271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93135377|NCT03911271|Autonomic Agents|autonomic agents|mesh-ancestor
93135378|NCT03911271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135379|NCT03911271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135380|NCT03911271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93135381|NCT03911271|Respiratory System Agents|respiratory system agents|mesh-ancestor
93135382|NCT03911271|Mydriatics|mydriatics|mesh-ancestor
93135383|NCT03911271|Parasympatholytics|parasympatholytics|mesh-ancestor
93135384|NCT03911271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93135385|NCT03911271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93135386|NCT03911271|Cholinergic Agents|cholinergic agents|mesh-ancestor
93135387|NCT03911271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135388|NCT03911271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135389|NCT01248195|Olanzapine|olanzapine|mesh-list
93135390|NCT01248195|Clozapine|clozapine|mesh-list
93135391|NCT01248195|Amisulpride|amisulpride|mesh-list
93135392|NCT01248195|Antiemetics|antiemetics|mesh-ancestor
93135393|NCT01248195|Autonomic Agents|autonomic agents|mesh-ancestor
93135394|NCT01248195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135395|NCT01248195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135396|NCT01248195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135397|NCT01248195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93135398|NCT01248195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135399|NCT01248195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135400|NCT01248195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135401|NCT01248195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93135402|NCT01248195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93135403|NCT01248195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135404|NCT01248195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135405|NCT01248195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135406|NCT01248195|Serotonin Agents|serotonin agents|mesh-ancestor
93135407|NCT01248195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93135408|NCT01248195|GABA Antagonists|gaba antagonists|mesh-ancestor
93135409|NCT01248195|GABA Agents|gaba agents|mesh-ancestor
93135410|NCT01248195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93135411|NCT01248195|Dopamine Agents|dopamine agents|mesh-ancestor
93135412|NCT01248195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93135413|NCT01248195|Antidepressive Agents|antidepressive agents|mesh-ancestor
93135414|NCT03910803|Brodalumab|brodalumab|mesh-list
93135415|NCT03910803|Dermatologic Agents|dermatologic agents|mesh-ancestor
93135416|NCT03910647|Pantoprazole|pantoprazole|mesh-list
93135417|NCT03910647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93135418|NCT03910647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135419|NCT03910647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93135420|NCT03910647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135421|NCT03910647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135422|NCT03709940|Methylphenidate|methylphenidate|mesh-list
93135423|NCT03709940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93135424|NCT03709940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135425|NCT03709940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93135426|NCT03709940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93135427|NCT03709940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135428|NCT03709940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135429|NCT03709940|Dopamine Agents|dopamine agents|mesh-ancestor
93135430|NCT03709940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135431|NCT05681312|Amoxicillin|amoxicillin|mesh-list
93135432|NCT05681312|Metronidazole|metronidazole|mesh-list
93135433|NCT05681312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135434|NCT05681312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135435|NCT05681312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93135436|NCT05681312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135437|NCT03341312|Insulin Lispro|insulin lispro|mesh-list
93135438|NCT03341312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93135439|NCT03341312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135440|NCT01147029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93135441|NCT01147029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93135442|NCT01147029|Growth Substances|growth substances|mesh-ancestor
93135443|NCT01147029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135444|NCT01147029|Growth Inhibitors|growth inhibitors|mesh-ancestor
93135445|NCT01147029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135446|NCT01239459|Teriflunomide|teriflunomide|mesh-list
93135447|NCT01239459|Cholestyramine Resin|cholestyramine resin|mesh-list
93135448|NCT01239459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93135449|NCT01239459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135450|NCT01239459|Analgesics|analgesics|mesh-ancestor
93135451|NCT01239459|Sensory System Agents|sensory system agents|mesh-ancestor
93135452|NCT01239459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135453|NCT01239459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135454|NCT01239459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135455|NCT01239459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135456|NCT01239459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93135457|NCT01239459|Immunologic Factors|immunologic factors|mesh-ancestor
93135458|NCT01239459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93135459|NCT01239459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93135460|NCT01239459|Antimetabolites|antimetabolites|mesh-ancestor
93135461|NCT01239459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135462|NCT01239459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93135463|NCT03915561|Parecoxib|parecoxib|mesh-list
93135464|NCT03915561|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93135465|NCT03915561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93135466|NCT03915561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135467|NCT03915561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135468|NCT03915561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93135469|NCT03915561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135470|NCT03915561|Analgesics|analgesics|mesh-ancestor
93135471|NCT03915561|Sensory System Agents|sensory system agents|mesh-ancestor
93135472|NCT03915561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135473|NCT03915561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135474|NCT03915561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135475|NCT03915561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135476|NCT01148277|Fentanyl|fentanyl|mesh-list
93135477|NCT01148277|Midazolam|midazolam|mesh-list
93135478|NCT01148277|Propofol|propofol|mesh-list
93135479|NCT01148277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135480|NCT01148277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135481|NCT01148277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135482|NCT01148277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93135483|NCT01148277|Anesthetics, General|anesthetics, general|mesh-ancestor
93135484|NCT01148277|Anesthetics|anesthetics|mesh-ancestor
93135485|NCT01148277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93135486|NCT01148277|Narcotics|narcotics|mesh-ancestor
93135487|NCT01148277|Analgesics|analgesics|mesh-ancestor
93135488|NCT01148277|Sensory System Agents|sensory system agents|mesh-ancestor
93135489|NCT01148277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135490|NCT01148277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93135491|NCT01148277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93135492|NCT01148277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135493|NCT01148277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135494|NCT01148277|GABA Modulators|gaba modulators|mesh-ancestor
93135495|NCT01148277|GABA Agents|gaba agents|mesh-ancestor
93135496|NCT01148277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135497|NCT01148277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135498|NCT03907371|Donepezil|donepezil|mesh-list
93135499|NCT03907371|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93135500|NCT03907371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135501|NCT03907371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135502|NCT03907371|Cholinergic Agents|cholinergic agents|mesh-ancestor
93135503|NCT03907371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135504|NCT03907371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135505|NCT03907371|Nootropic Agents|nootropic agents|mesh-ancestor
93135506|NCT03908619|Esomeprazole|esomeprazole|mesh-list
93135507|NCT03908619|Omeprazole|omeprazole|mesh-list
93135508|NCT03908619|Rabeprazole|rabeprazole|mesh-list
93135509|NCT03908619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93135510|NCT03908619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135511|NCT03908619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93135512|NCT03908619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135513|NCT03908619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135514|NCT01358734|Lenalidomide|lenalidomide|mesh-list
93135515|NCT01358734|Azacitidine|azacitidine|mesh-list
93135516|NCT01358734|Immunologic Factors|immunologic factors|mesh-ancestor
93135517|NCT01358734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135518|NCT01358734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807684|NCT04111159|Propofol|propofol|mesh-list
93135519|NCT01358734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93135520|NCT01358734|Growth Substances|growth substances|mesh-ancestor
93135522|NCT01358734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135523|NCT01358734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93135524|NCT01358734|Antimetabolites|antimetabolites|mesh-ancestor
93135525|NCT01358734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135526|NCT01358734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135527|NCT03907215|Citalopram|citalopram|mesh-list
93135528|NCT03907215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93135529|NCT03907215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93135530|NCT03907215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135531|NCT03907215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135532|NCT03907215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135533|NCT03907215|Serotonin Agents|serotonin agents|mesh-ancestor
93135534|NCT03907215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135535|NCT03907215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93135536|NCT03907215|Antidepressive Agents|antidepressive agents|mesh-ancestor
93135537|NCT03907215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135538|NCT05335954|Norepinephrine|norepinephrine|mesh-list
93135539|NCT05335954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93135540|NCT05335954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93135541|NCT05335954|Adrenergic Agents|adrenergic agents|mesh-ancestor
93135542|NCT05335954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135543|NCT05335954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135544|NCT05335954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135545|NCT05335954|Sympathomimetics|sympathomimetics|mesh-ancestor
93135546|NCT05335954|Autonomic Agents|autonomic agents|mesh-ancestor
93135547|NCT05335954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135548|NCT05335954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93135549|NCT01250457|Timolol|timolol|mesh-list
93135550|NCT01250457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93135551|NCT01250457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93135552|NCT01250457|Adrenergic Agents|adrenergic agents|mesh-ancestor
93135553|NCT01250457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135554|NCT01250457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135555|NCT01250457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135556|NCT01250457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93135557|NCT01250457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93135558|NCT03902925|Lidocaine|lidocaine|mesh-list
93135559|NCT03902925|Ropivacaine|ropivacaine|mesh-list
93135560|NCT03902925|Anesthetics, Local|anesthetics, local|mesh-ancestor
93135561|NCT03902925|Anesthetics|anesthetics|mesh-ancestor
93135562|NCT03902925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135563|NCT03902925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135564|NCT03902925|Sensory System Agents|sensory system agents|mesh-ancestor
93135565|NCT03902925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135566|NCT03902925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93135567|NCT03902925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93135568|NCT03902925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93135569|NCT03902925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135570|NCT03902925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135571|NCT01250535|Warfarin|warfarin|mesh-list
93135572|NCT01250535|Lovastatin|lovastatin|mesh-list
93135573|NCT01250535|L 647318|l 647318|mesh-list
93135574|NCT01250535|Dihydromevinolin|dihydromevinolin|mesh-list
93135575|NCT01250535|Anticoagulants|anticoagulants|mesh-ancestor
93135576|NCT01250535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93135577|NCT01250535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93135578|NCT01250535|Antimetabolites|antimetabolites|mesh-ancestor
93135579|NCT01250535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135580|NCT01250535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93135581|NCT01250535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93135582|NCT01250535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135583|NCT02527941|Metronidazole|metronidazole|mesh-list
93135584|NCT02527941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135585|NCT02527941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135586|NCT02527941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93135587|NCT02527941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135588|NCT03906669|Tamoxifen|tamoxifen|mesh-list
93135589|NCT03906669|Letrozole|letrozole|mesh-list
93135590|NCT03906669|Progesterone|progesterone|mesh-list
93135591|NCT03906669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135592|NCT03906669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93135593|NCT03906669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93135594|NCT03906669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135595|NCT03906669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135596|NCT03906669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93135597|NCT03906669|Hormone Antagonists|hormone antagonists|mesh-ancestor
93135598|NCT03906669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135599|NCT03906669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135600|NCT03906669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93135601|NCT03906669|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93135602|NCT03906669|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93135603|NCT03906669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93135604|NCT03906669|Progestins|progestins|mesh-ancestor
93135605|NCT03906669|Hormones|hormones|mesh-ancestor
93135606|NCT01254825|Ropivacaine|ropivacaine|mesh-list
93135607|NCT01254825|Anesthetics, Local|anesthetics, local|mesh-ancestor
93135608|NCT01254825|Anesthetics|anesthetics|mesh-ancestor
93135609|NCT01254825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135610|NCT01254825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135611|NCT01254825|Sensory System Agents|sensory system agents|mesh-ancestor
93135612|NCT01254825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135613|NCT03906123|3-n-butylphthalide|3-n-butylphthalide|mesh-list
93135614|NCT03906123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93135615|NCT03906123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93135616|NCT03906123|Protective Agents|protective agents|mesh-ancestor
93135617|NCT03906123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135618|NCT01341652|Molgramostim|molgramostim|mesh-list
93135619|NCT01341652|Sargramostim|sargramostim|mesh-list
93135620|NCT01341652|Immunologic Factors|immunologic factors|mesh-ancestor
93135621|NCT01341652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135622|NCT01341652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135623|NCT03563794|Insulin Lispro|insulin lispro|mesh-list
93135624|NCT03563794|Vildagliptin|vildagliptin|mesh-list
93135625|NCT03563794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93135626|NCT03563794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135627|NCT03563794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93135628|NCT03563794|Protease Inhibitors|protease inhibitors|mesh-ancestor
93135629|NCT03563794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135630|NCT03563794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135631|NCT03905967|Lenvatinib|lenvatinib|mesh-list
93135632|NCT03905967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135633|NCT03905967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93135634|NCT03905967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135635|NCT03905967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135636|NCT03563950|Rifampin|rifampin|mesh-list
93135637|NCT03563950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93135638|NCT03563950|Antitubercular Agents|antitubercular agents|mesh-ancestor
93135639|NCT03563950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135640|NCT03563950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135641|NCT03563950|Leprostatic Agents|leprostatic agents|mesh-ancestor
93135642|NCT03563950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93135643|NCT03563950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135644|NCT03563950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135645|NCT03563950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93135646|NCT03563950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93135647|NCT03563950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93135648|NCT03563950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93135649|NCT03563950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93135650|NCT03563950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93135651|NCT03905655|Nitazoxanide|nitazoxanide|mesh-list
93135652|NCT03905655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135653|NCT03905655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135654|NCT03914235|Lidocaine|lidocaine|mesh-list
93135655|NCT03914235|Anesthetics, Local|anesthetics, local|mesh-ancestor
93135656|NCT03914235|Anesthetics|anesthetics|mesh-ancestor
93135657|NCT03914235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135658|NCT03914235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135659|NCT03914235|Sensory System Agents|sensory system agents|mesh-ancestor
93135660|NCT03914235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135661|NCT03914235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93135662|NCT03914235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93135663|NCT03914235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93135664|NCT03914235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135665|NCT03914235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135666|NCT01148667|Caseins|caseins|mesh-list
93135667|NCT01148667|Chelating Agents|chelating agents|mesh-ancestor
93135668|NCT01148667|Sequestering Agents|sequestering agents|mesh-ancestor
93135669|NCT01148667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135670|NCT01254123|Exenatide|exenatide|mesh-list
93135671|NCT01254123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93135672|NCT01254123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135673|NCT01254123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93135674|NCT01254123|Incretins|incretins|mesh-ancestor
93135675|NCT01254123|Hormones|hormones|mesh-ancestor
93135676|NCT01254123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135677|NCT03898635|Linezolid|linezolid|mesh-list
93135678|NCT03898635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135679|NCT03898635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135680|NCT03898635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93135681|NCT03898635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135682|NCT03898635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135683|NCT05116917|Nivolumab|nivolumab|mesh-list
93135684|NCT05116917|Ipilimumab|ipilimumab|mesh-list
93135685|NCT05116917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93135686|NCT05116917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135687|NCT05116917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93135688|NCT05116917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135689|NCT02528019|Glimepiride|glimepiride|mesh-list
93135690|NCT02528019|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93135691|NCT02528019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93135692|NCT02528019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93135693|NCT02528019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135694|NCT02528019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93135695|NCT02528019|Immunologic Factors|immunologic factors|mesh-ancestor
93135696|NCT02528019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135697|NCT01255215|Nitric Oxide|nitric oxide|mesh-list
93135698|NCT01255215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93135699|NCT01255215|Autonomic Agents|autonomic agents|mesh-ancestor
93135700|NCT01255215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135701|NCT01255215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135702|NCT01255215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93135703|NCT01255215|Respiratory System Agents|respiratory system agents|mesh-ancestor
93135704|NCT01255215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93135705|NCT01255215|Antioxidants|antioxidants|mesh-ancestor
93135706|NCT01255215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135707|NCT01255215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135708|NCT01255215|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93135709|NCT01255215|Vasodilator Agents|vasodilator agents|mesh-ancestor
93135710|NCT01255215|Gasotransmitters|gasotransmitters|mesh-ancestor
93135711|NCT01255215|Protective Agents|protective agents|mesh-ancestor
93135712|NCT02527785|Oxaliplatin|oxaliplatin|mesh-list
93135713|NCT02527785|Irinotecan|irinotecan|mesh-list
93135714|NCT02527785|Tegafur|tegafur|mesh-list
93135715|NCT02527785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135716|NCT02527785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93135717|NCT02527785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93135718|NCT02527785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135719|NCT02527785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135720|NCT02527785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93135721|NCT02527785|Antimetabolites|antimetabolites|mesh-ancestor
93135722|NCT02527863|Tolvaptan|tolvaptan|mesh-list
93135723|NCT02527863|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93135724|NCT02527863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135725|NCT02527863|Natriuretic Agents|natriuretic agents|mesh-ancestor
93135726|NCT02527863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135727|NCT01256541|Lactulose|lactulose|mesh-list
93135728|NCT01256541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135729|NCT03904719|Vorolanib|vorolanib|mesh-list
93135730|NCT03904719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93135731|NCT03904719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135732|NCT03904719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135733|NCT01148901|Infliximab|infliximab|mesh-list
93135734|NCT01148901|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93135735|NCT01148901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135736|NCT01148901|Dermatologic Agents|dermatologic agents|mesh-ancestor
93135737|NCT01148901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135738|NCT01148901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135739|NCT01150617|Insulin|insulin|mesh-list
93135740|NCT01150617|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93135741|NCT01150617|Insulin Glargine|insulin glargine|mesh-list
93135742|NCT01150617|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93135743|NCT01150617|Insulin, Short-Acting|insulin, short-acting|mesh-list
93135744|NCT01150617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135746|NCT01256619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93135747|NCT01256619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93135748|NCT01256619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93135749|NCT01256619|Contraceptive Agents|contraceptive agents|mesh-ancestor
93135750|NCT01256619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93135751|NCT01256619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135752|NCT01256619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93135753|NCT01256619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93135754|NCT01256619|Progestins|progestins|mesh-ancestor
93135755|NCT01256619|Hormones|hormones|mesh-ancestor
93135756|NCT01256619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135757|NCT03898011|Lamotrigine|lamotrigine|mesh-list
93135758|NCT03898011|Anticonvulsants|anticonvulsants|mesh-ancestor
93135759|NCT03898011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93135760|NCT03898011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135761|NCT03898011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135762|NCT03898011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93135763|NCT03898011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135764|NCT03898011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93135765|NCT03898011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135766|NCT03898011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135767|NCT03898011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135768|NCT03898011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93135769|NCT01254513|Prednisone|prednisone|mesh-list
93135770|NCT01254513|Docetaxel|docetaxel|mesh-list
93135771|NCT01254513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135772|NCT01254513|Tubulin Modulators|tubulin modulators|mesh-ancestor
93135773|NCT01254513|Antimitotic Agents|antimitotic agents|mesh-ancestor
93135774|NCT01254513|Mitosis Modulators|mitosis modulators|mesh-ancestor
93135775|NCT01254513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135776|NCT01254513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135777|NCT01254513|Glucocorticoids|glucocorticoids|mesh-ancestor
93135778|NCT01254513|Hormones|hormones|mesh-ancestor
93135779|NCT01254513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135780|NCT01254513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135781|NCT01254513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93135782|NCT01254591|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93135783|NCT01254591|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93135784|NCT01254591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135785|NCT01149993|Mycophenolic Acid|mycophenolic acid|mesh-list
93135786|NCT01149993|Thymoglobulin|thymoglobulin|mesh-list
93135787|NCT01149993|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93135788|NCT01149993|Immunologic Factors|immunologic factors|mesh-ancestor
93135789|NCT01149993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135790|NCT01149993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93135791|NCT01149993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93135792|NCT01149993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135793|NCT01149993|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93135794|NCT01149993|Antitubercular Agents|antitubercular agents|mesh-ancestor
93135795|NCT01149993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135796|NCT01149993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135797|NCT01149993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135798|NCT01149993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135799|NCT01255371|Lopinavir|lopinavir|mesh-list
93135800|NCT01255371|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93135801|NCT01255371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93135802|NCT01255371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93135803|NCT01255371|Protease Inhibitors|protease inhibitors|mesh-ancestor
93135804|NCT01255371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135805|NCT01255371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135806|NCT01255371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93135807|NCT01255371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93135808|NCT01255371|Antiviral Agents|antiviral agents|mesh-ancestor
93135809|NCT01255371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135810|NCT01255371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93135811|NCT01255371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93135812|NCT03903783|Ceftriaxone|ceftriaxone|mesh-list
93135813|NCT03903783|Cefotaxime|cefotaxime|mesh-list
93135814|NCT03903783|Cefoxitin|cefoxitin|mesh-list
93135815|NCT03903783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807977|NCT01689909|GABA Agonists|gaba agonists|mesh-ancestor
93135816|NCT03903783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135817|NCT03899337|Prednisolone|prednisolone|mesh-list
93135818|NCT03899337|Cyclophosphamide|cyclophosphamide|mesh-list
93135819|NCT03899337|Rituximab|rituximab|mesh-list
93135820|NCT03899337|Doxorubicin|doxorubicin|mesh-list
93135821|NCT03899337|Vincristine|vincristine|mesh-list
93135822|NCT03899337|Acalabrutinib|acalabrutinib|mesh-list
93135823|NCT03899337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93135824|NCT03899337|Immunologic Factors|immunologic factors|mesh-ancestor
93135825|NCT03899337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135826|NCT03899337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135827|NCT03899337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93135828|NCT03899337|Alkylating Agents|alkylating agents|mesh-ancestor
93135829|NCT03899337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135830|NCT03899337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135831|NCT03899337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93135832|NCT03899337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93135833|NCT03899337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93135834|NCT03899337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93135835|NCT03899337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93135836|NCT03899337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135837|NCT03899337|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93135838|NCT03899337|Tubulin Modulators|tubulin modulators|mesh-ancestor
93135839|NCT03899337|Antimitotic Agents|antimitotic agents|mesh-ancestor
93135840|NCT03899337|Mitosis Modulators|mitosis modulators|mesh-ancestor
93135841|NCT03899337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135842|NCT03899337|Glucocorticoids|glucocorticoids|mesh-ancestor
93135843|NCT03899337|Hormones|hormones|mesh-ancestor
93135844|NCT03899337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93135845|NCT03899337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93135846|NCT01586169|Azithromycin|azithromycin|mesh-list
93135847|NCT01586169|Ivermectin|ivermectin|mesh-list
93135848|NCT01586169|Albendazole|albendazole|mesh-list
93135849|NCT01586169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93135850|NCT01586169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135851|NCT01586169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135852|NCT01586169|Anthelmintics|anthelmintics|mesh-ancestor
93135853|NCT01586169|Anticestodal Agents|anticestodal agents|mesh-ancestor
93135854|NCT01586169|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93135855|NCT01586169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93135856|NCT01586169|Tubulin Modulators|tubulin modulators|mesh-ancestor
93135857|NCT01586169|Antimitotic Agents|antimitotic agents|mesh-ancestor
93135858|NCT01586169|Mitosis Modulators|mitosis modulators|mesh-ancestor
93135859|NCT01586169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135860|NCT01586169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135861|NCT01256775|Aspirin|aspirin|mesh-list
93135862|NCT01256775|Nitroaspirin|nitroaspirin|mesh-list
93135863|NCT01256775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93135864|NCT01256775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135865|NCT01256775|Analgesics|analgesics|mesh-ancestor
93135866|NCT01256775|Sensory System Agents|sensory system agents|mesh-ancestor
93135867|NCT01256775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135868|NCT01256775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135869|NCT01256775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93135870|NCT01256775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93135871|NCT01256775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93135872|NCT01256775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93135873|NCT01256775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135874|NCT01256775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93135875|NCT01256775|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93135876|NCT01256775|Protease Inhibitors|protease inhibitors|mesh-ancestor
93135877|NCT01256775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135878|NCT01256775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93135879|NCT01256775|Antipyretics|antipyretics|mesh-ancestor
93135880|NCT03899571|Oseltamivir|oseltamivir|mesh-list
93135881|NCT03899571|Antiviral Agents|antiviral agents|mesh-ancestor
93135882|NCT03899571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135883|NCT03899571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135884|NCT03899571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135885|NCT01257009|Atorvastatin|atorvastatin|mesh-list
93135886|NCT01257009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93135887|NCT01257009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93135888|NCT01257009|Antimetabolites|antimetabolites|mesh-ancestor
93135889|NCT01257009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135890|NCT01257009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93135891|NCT01257009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93135892|NCT01257009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93135893|NCT01255527|Bortezomib|bortezomib|mesh-list
93135894|NCT01255527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135895|NCT01151787|Amitriptyline|amitriptyline|mesh-list
93135896|NCT01151787|Cyclobenzaprine|cyclobenzaprine|mesh-list
93135897|NCT01151787|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93135898|NCT01151787|Antidepressive Agents|antidepressive agents|mesh-ancestor
93135899|NCT01151787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135900|NCT01151787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93135901|NCT01151787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135902|NCT01151787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93135903|NCT01151787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135904|NCT01151787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135905|NCT01151787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135906|NCT01151787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135907|NCT01151787|Analgesics|analgesics|mesh-ancestor
93135908|NCT01151787|Sensory System Agents|sensory system agents|mesh-ancestor
93135909|NCT01151787|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93135910|NCT01151787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93135911|NCT01151787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93135912|NCT01151787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135913|NCT01151787|Adrenergic Agents|adrenergic agents|mesh-ancestor
93135914|NCT01151787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135915|NCT01151865|Dexmedetomidine|dexmedetomidine|mesh-list
93135916|NCT01151865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135917|NCT01151865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135918|NCT01151865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135919|NCT01151865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93135920|NCT01151865|Analgesics|analgesics|mesh-ancestor
93135921|NCT01151865|Sensory System Agents|sensory system agents|mesh-ancestor
93135922|NCT01151865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135923|NCT01151865|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93135924|NCT01151865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93135925|NCT01151865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93135926|NCT01151865|Adrenergic Agents|adrenergic agents|mesh-ancestor
93135927|NCT01151865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135928|NCT01151865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135929|NCT03893097|Artesunate|artesunate|mesh-list
93135930|NCT03893097|Mefloquine|mefloquine|mesh-list
93135931|NCT03893097|Praziquantel|praziquantel|mesh-list
93135932|NCT03893097|Antimalarials|antimalarials|mesh-ancestor
93135933|NCT03893097|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93135934|NCT03893097|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93135935|NCT03893097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135936|NCT03893097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93135937|NCT03893097|Antiviral Agents|antiviral agents|mesh-ancestor
93135938|NCT03893097|Schistosomicides|schistosomicides|mesh-ancestor
93135939|NCT03893097|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93135940|NCT03893097|Anthelmintics|anthelmintics|mesh-ancestor
93135941|NCT01258491|Nicotinic Acids|nicotinic acids|mesh-list
93135942|NCT01258491|Niacin|niacin|mesh-list
93135943|NCT01258491|Niacinamide|niacinamide|mesh-list
93135944|NCT01258491|Vitamin B Complex|vitamin b complex|mesh-ancestor
93135945|NCT01258491|Vitamins|vitamins|mesh-ancestor
93135946|NCT01258491|Micronutrients|micronutrients|mesh-ancestor
93135947|NCT01258491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135948|NCT01258491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93135949|NCT01258491|Antimetabolites|antimetabolites|mesh-ancestor
93135950|NCT01258491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135951|NCT01258491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93135952|NCT01258491|Vasodilator Agents|vasodilator agents|mesh-ancestor
93135953|NCT01257165|Ethanol|ethanol|mesh-list
93135954|NCT01257165|Zopiclone|zopiclone|mesh-list
93135955|NCT01257165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93135956|NCT01257165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93135957|NCT01257165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135958|NCT01257165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135959|NCT01257165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135960|NCT01151943|Anesthetics|anesthetics|mesh-list
93135961|NCT01151943|Anesthetics, Local|anesthetics, local|mesh-list
93135962|NCT01151943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135963|NCT01151943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135964|NCT01151943|Sensory System Agents|sensory system agents|mesh-ancestor
93135965|NCT01151943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135966|NCT01256151|Alprazolam|alprazolam|mesh-list
93135967|NCT01256151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93135968|NCT01256151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135969|NCT01256151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135970|NCT01256151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93135971|NCT01256151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135972|NCT01256151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135973|NCT01256151|GABA Modulators|gaba modulators|mesh-ancestor
93135974|NCT01256151|GABA Agents|gaba agents|mesh-ancestor
93135975|NCT01256151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135976|NCT01256151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135977|NCT01259973|Haloperidol|haloperidol|mesh-list
93135978|NCT01259973|Risperidone|risperidone|mesh-list
93135979|NCT01259973|Haloperidol decanoate|haloperidol decanoate|mesh-list
93135980|NCT01259973|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93135981|NCT01259973|Serotonin Agents|serotonin agents|mesh-ancestor
93135982|NCT01259973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93135983|NCT01259973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93135984|NCT01259973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93135985|NCT01259973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93135986|NCT01259973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93135987|NCT01259973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93135988|NCT01259973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93135989|NCT01259973|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93135990|NCT01259973|Dopamine Agents|dopamine agents|mesh-ancestor
93135991|NCT01259973|Antiemetics|antiemetics|mesh-ancestor
93135992|NCT01259973|Autonomic Agents|autonomic agents|mesh-ancestor
93135993|NCT01259973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93135994|NCT01259973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93135995|NCT01259973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93135996|NCT01257243|Potassium iodate|potassium iodate|mesh-list
93135997|NCT01257243|Phenylpropanolamine|phenylpropanolamine|mesh-list
93135998|NCT01257243|Guaifenesin|guaifenesin|mesh-list
93135999|NCT01257243|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93136000|NCT01257243|Expectorants|expectorants|mesh-ancestor
93136001|NCT01257243|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136002|NCT01257243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93136003|NCT01257243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93136004|NCT01257243|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136005|NCT01257243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136006|NCT01257243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136007|NCT01257243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136008|NCT01257243|Appetite Depressants|appetite depressants|mesh-ancestor
93136009|NCT01257243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93136010|NCT01257243|Sympathomimetics|sympathomimetics|mesh-ancestor
93136011|NCT01257243|Autonomic Agents|autonomic agents|mesh-ancestor
93136012|NCT01257243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136013|NCT01257243|Nasal Decongestants|nasal decongestants|mesh-ancestor
93136014|NCT01257243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93136015|NCT01257243|Antifungal Agents|antifungal agents|mesh-ancestor
93136016|NCT01257243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136017|NCT01258569|Alvimopan|alvimopan|mesh-list
93136018|NCT01258569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136019|NCT01257399|Mesalamine|mesalamine|mesh-list
93136020|NCT01257399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93136021|NCT01257399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93136022|NCT01257399|Analgesics|analgesics|mesh-ancestor
93136023|NCT01257399|Sensory System Agents|sensory system agents|mesh-ancestor
93136024|NCT01257399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136025|NCT01257399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136026|NCT01257399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136027|NCT01257399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136028|NCT01258959|Anesthetics|anesthetics|mesh-list
93136029|NCT01258959|Anesthetics, Local|anesthetics, local|mesh-list
93136030|NCT01258959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136031|NCT01258959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136032|NCT01258959|Sensory System Agents|sensory system agents|mesh-ancestor
93136033|NCT01258959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136034|NCT01153659|Esomeprazole|esomeprazole|mesh-list
93136035|NCT01153659|Rabeprazole|rabeprazole|mesh-list
93136036|NCT01153659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93136037|NCT01153659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136038|NCT01153659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93136039|NCT01153659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808200|NCT02840175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136040|NCT01153659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136041|NCT01260129|Silodosin|silodosin|mesh-list
93136042|NCT01260129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93136043|NCT01260129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93136044|NCT01260129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93136045|NCT01260129|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136046|NCT01260129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136047|NCT01260129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136048|NCT01260129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136049|NCT01260129|Urological Agents|urological agents|mesh-ancestor
93136050|NCT01260285|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93136051|NCT01260285|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136052|NCT01260285|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93136053|NCT01260285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93136054|NCT01260285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136055|NCT01260285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136056|NCT01260285|Urological Agents|urological agents|mesh-ancestor
93136057|NCT03888729|Velpatasvir|velpatasvir|mesh-list
93136058|NCT03888729|Antiviral Agents|antiviral agents|mesh-ancestor
93136059|NCT03888729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136060|NCT01151241|Anesthetics|anesthetics|mesh-list
93136061|NCT01151241|Anesthetics, Local|anesthetics, local|mesh-list
93136062|NCT01151241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136063|NCT01151241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136064|NCT01151241|Sensory System Agents|sensory system agents|mesh-ancestor
93136065|NCT01151241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136066|NCT02949362|Teduglutide|teduglutide|mesh-list
93136067|NCT02949362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136068|NCT02949362|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93136069|NCT02949362|Protective Agents|protective agents|mesh-ancestor
93136070|NCT02949362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136071|NCT03896217|Simvastatin|simvastatin|mesh-list
93136072|NCT03896217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93136073|NCT03896217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93136074|NCT03896217|Antimetabolites|antimetabolites|mesh-ancestor
93136075|NCT03896217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136076|NCT03896217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93136077|NCT03896217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93136078|NCT03896217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136079|NCT05220410|Psilocybin|psilocybin|mesh-list
93136080|NCT05220410|Hallucinogens|hallucinogens|mesh-ancestor
93136081|NCT05220410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136082|NCT05220410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136083|NCT03892161|Ritonavir|ritonavir|mesh-list
93136084|NCT03892161|Darunavir|darunavir|mesh-list
93136085|NCT03892161|Rifampin|rifampin|mesh-list
93136086|NCT03892161|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93136087|NCT03892161|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93136088|NCT03892161|Protease Inhibitors|protease inhibitors|mesh-ancestor
93136089|NCT03892161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136090|NCT03892161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136091|NCT03892161|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93136092|NCT03892161|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93136093|NCT03892161|Antiviral Agents|antiviral agents|mesh-ancestor
93136094|NCT03892161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136095|NCT03892161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93136096|NCT03892161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93136097|NCT03892161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93136098|NCT03892161|Antitubercular Agents|antitubercular agents|mesh-ancestor
93136099|NCT03892161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93136100|NCT03892161|Leprostatic Agents|leprostatic agents|mesh-ancestor
93136101|NCT03892161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93136102|NCT03892161|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93136103|NCT03892161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93136104|NCT03892161|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93136105|NCT03892161|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93136106|NCT03892161|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93136107|NCT03892161|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93136108|NCT01154361|Cortisone|cortisone|mesh-list
93136109|NCT01154361|Icatibant|icatibant|mesh-list
93136110|NCT01154361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136111|NCT01154361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93136112|NCT01154361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93136113|NCT01154361|Analgesics|analgesics|mesh-ancestor
93136114|NCT01154361|Sensory System Agents|sensory system agents|mesh-ancestor
93136115|NCT01154361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136116|NCT01154361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136117|NCT01154361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136118|NCT01154361|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
93136119|NCT01154361|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
93136120|NCT01154361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136121|NCT01154361|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93136122|NCT01154361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136123|NCT01154361|Immunologic Factors|immunologic factors|mesh-ancestor
93136124|NCT01260519|Heparin|heparin|mesh-list
93136125|NCT01260519|Calcium heparin|calcium heparin|mesh-list
93136126|NCT01260519|Anticoagulants|anticoagulants|mesh-ancestor
93136127|NCT01260519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93136128|NCT01260519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93136129|NCT01260519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136130|NCT03888183|Lubricant Eye Drops|lubricant eye drops|mesh-list
93136131|NCT03888183|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93136132|NCT03888183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93136133|NCT03891615|Niraparib|niraparib|mesh-list
93136134|NCT03891615|Osimertinib|osimertinib|mesh-list
93136135|NCT03891615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93136136|NCT03891615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136137|NCT03891615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136138|NCT03891615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136139|NCT03891615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136140|NCT02947022|Calcium, Dietary|calcium, dietary|mesh-list
93136141|NCT02947022|Zinc|zinc|mesh-list
93136142|NCT02947022|Edetic Acid|edetic acid|mesh-list
93136143|NCT02947022|Calcium|calcium|mesh-list
93136144|NCT02947022|Pentetic Acid|pentetic acid|mesh-list
93136145|NCT02947022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93136146|NCT02947022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136147|NCT02947022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93136148|NCT02947022|Trace Elements|trace elements|mesh-ancestor
93136149|NCT02947022|Micronutrients|micronutrients|mesh-ancestor
93136150|NCT02947022|Antidotes|antidotes|mesh-ancestor
93136151|NCT02947022|Protective Agents|protective agents|mesh-ancestor
93136152|NCT02947022|Chelating Agents|chelating agents|mesh-ancestor
93136153|NCT02947022|Sequestering Agents|sequestering agents|mesh-ancestor
93136154|NCT02947022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136155|NCT02947022|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93136156|NCT02947022|Anticoagulants|anticoagulants|mesh-ancestor
93136157|NCT02947022|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93136158|NCT01259193|Zoledronic Acid|zoledronic acid|mesh-list
93136159|NCT01259193|Sorafenib|sorafenib|mesh-list
93136160|NCT01259193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136161|NCT01259193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136162|NCT01259193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136163|NCT01259193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136164|NCT01259193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93136165|NCT01259193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136166|NCT05182892|Dopamine|dopamine|mesh-list
93136167|NCT05182892|Dopamine Agonists|dopamine agonists|mesh-list
93136168|NCT05182892|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93136169|NCT05182892|Sympathomimetics|sympathomimetics|mesh-ancestor
93136170|NCT05182892|Autonomic Agents|autonomic agents|mesh-ancestor
93136171|NCT05182892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136172|NCT05182892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136173|NCT05182892|Dopamine Agents|dopamine agents|mesh-ancestor
93136174|NCT05182892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136175|NCT05182892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136176|NCT05182892|Protective Agents|protective agents|mesh-ancestor
93136177|NCT01312376|Cyclophosphamide|cyclophosphamide|mesh-list
93136178|NCT01312376|Bevacizumab|bevacizumab|mesh-list
93136179|NCT01312376|Fludarabine|fludarabine|mesh-list
93136180|NCT01312376|Vaccines|vaccines|mesh-list
93136181|NCT01312376|Immunologic Factors|immunologic factors|mesh-ancestor
93136182|NCT01312376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136183|NCT01312376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136184|NCT01312376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136185|NCT01312376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93136186|NCT01312376|Alkylating Agents|alkylating agents|mesh-ancestor
93136187|NCT01312376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136188|NCT01312376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136189|NCT01312376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93136190|NCT01312376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93136191|NCT01312376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93136192|NCT01312376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93136193|NCT01312376|Growth Substances|growth substances|mesh-ancestor
93136194|NCT01312376|Growth Inhibitors|growth inhibitors|mesh-ancestor
93136195|NCT01260675|Buprenorphine|buprenorphine|mesh-list
93136196|NCT01260675|Naloxone|naloxone|mesh-list
93136197|NCT01260675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93136198|NCT01260675|Narcotics|narcotics|mesh-ancestor
93136199|NCT01260675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136200|NCT01260675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136201|NCT01260675|Analgesics|analgesics|mesh-ancestor
93136202|NCT01260675|Sensory System Agents|sensory system agents|mesh-ancestor
93136203|NCT01260675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136204|NCT01260675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93136205|NCT03887871|Tamsulosin|tamsulosin|mesh-list
93136206|NCT03887871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93136207|NCT03887871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93136208|NCT03887871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93136209|NCT03887871|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136210|NCT03887871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136211|NCT03887871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136212|NCT03887871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136213|NCT03887871|Urological Agents|urological agents|mesh-ancestor
93136214|NCT03708146|Zamicastat|zamicastat|mesh-list
93136215|NCT03708146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136216|NCT03708146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136217|NCT01260753|Fluticasone|fluticasone|mesh-list
93136218|NCT01260753|Xhance|xhance|mesh-list
93136219|NCT01260753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136220|NCT01260753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93136221|NCT01260753|Autonomic Agents|autonomic agents|mesh-ancestor
93136222|NCT01260753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136223|NCT01260753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136224|NCT01260753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93136225|NCT01260753|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136226|NCT01260753|Dermatologic Agents|dermatologic agents|mesh-ancestor
93136227|NCT01260753|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93136228|NCT03895671|Azacitidine|azacitidine|mesh-list
93136229|NCT03895671|Ponatinib|ponatinib|mesh-list
93136230|NCT03895671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93136231|NCT03895671|Antimetabolites|antimetabolites|mesh-ancestor
93136232|NCT03895671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136233|NCT03895671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136234|NCT03895671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136235|NCT03895671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136236|NCT01152723|Nicotine|nicotine|mesh-list
93136237|NCT01152723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93136238|NCT01152723|Autonomic Agents|autonomic agents|mesh-ancestor
93136239|NCT01152723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136240|NCT01152723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136241|NCT01152723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93136242|NCT01152723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93136243|NCT01152723|Cholinergic Agents|cholinergic agents|mesh-ancestor
93136244|NCT01152723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136245|NCT01152723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136246|NCT01261065|Carvedilol|carvedilol|mesh-list
93136247|NCT01261065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93136248|NCT01261065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93136249|NCT01261065|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136250|NCT01261065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136251|NCT01261065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136252|NCT01261065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136253|NCT01261065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93136254|NCT01261065|Antioxidants|antioxidants|mesh-ancestor
93136255|NCT01261065|Protective Agents|protective agents|mesh-ancestor
93136256|NCT01261065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93136257|NCT01261065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93136258|NCT01261065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93136259|NCT01261065|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136260|NCT01261065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93136261|NCT01261065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93136262|NCT01257867|Lithium Carbonate|lithium carbonate|mesh-list
93136263|NCT01257867|Antidepressive Agents|antidepressive agents|mesh-ancestor
93136264|NCT01257867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136265|NCT01257867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136266|NCT01257867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136267|NCT01257867|Antimanic Agents|antimanic agents|mesh-ancestor
93136268|NCT01257867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93136269|NCT01257867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136270|NCT01257867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136272|NCT03338972|Fludarabine|fludarabine|mesh-list
93136273|NCT03338972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136274|NCT03338972|Immunologic Factors|immunologic factors|mesh-ancestor
93136275|NCT03338972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136276|NCT03338972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136277|NCT03338972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93136278|NCT03338972|Alkylating Agents|alkylating agents|mesh-ancestor
93136279|NCT03338972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136280|NCT03338972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136281|NCT03338972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93136282|NCT01151397|Vitamin D|vitamin d|mesh-list
93136283|NCT01151397|Ribavirin|ribavirin|mesh-list
93136284|NCT01151397|Vitamins|vitamins|mesh-ancestor
93136285|NCT01151397|Micronutrients|micronutrients|mesh-ancestor
93136286|NCT01151397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136287|NCT01151397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93136288|NCT01151397|Antimetabolites|antimetabolites|mesh-ancestor
93136289|NCT01151397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136290|NCT01151397|Antiviral Agents|antiviral agents|mesh-ancestor
93136291|NCT01151397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136292|NCT01152801|Everolimus|everolimus|mesh-list
93136293|NCT01152801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93136294|NCT01152801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136295|NCT01152801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136296|NCT01152801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136297|NCT01152801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136298|NCT01152801|Immunologic Factors|immunologic factors|mesh-ancestor
93136299|NCT01152801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136300|NCT01152801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136301|NCT03887169|Vitamin B 12|vitamin b 12|mesh-list
93136302|NCT03887169|Hydroxocobalamin|hydroxocobalamin|mesh-list
93136303|NCT03887169|Vitamins|vitamins|mesh-ancestor
93136304|NCT03887169|Micronutrients|micronutrients|mesh-ancestor
93136305|NCT03887169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136306|NCT03887169|Vitamin B Complex|vitamin b complex|mesh-ancestor
93136307|NCT03887169|Hematinics|hematinics|mesh-ancestor
93136308|NCT03886779|Nepafenac|nepafenac|mesh-list
93136309|NCT03886779|Bromfenac|bromfenac|mesh-list
93136310|NCT03886779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93136311|NCT03886779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93136312|NCT03886779|Analgesics|analgesics|mesh-ancestor
93136313|NCT03886779|Sensory System Agents|sensory system agents|mesh-ancestor
93136314|NCT03886779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136315|NCT03886779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136316|NCT03886779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136317|NCT03886779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136318|NCT03887013|Trimetazidine|trimetazidine|mesh-list
93136319|NCT03887013|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136320|NCT01261299|Carboplatin|carboplatin|mesh-list
93136321|NCT01261299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136322|NCT01154829|Aripiprazole|aripiprazole|mesh-list
93136323|NCT01154829|Amisulpride|amisulpride|mesh-list
93136324|NCT01154829|Antidepressive Agents|antidepressive agents|mesh-ancestor
93136325|NCT01154829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136326|NCT01154829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93136327|NCT01154829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93136328|NCT01154829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136329|NCT01154829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136330|NCT01154829|Dopamine Agonists|dopamine agonists|mesh-ancestor
93136331|NCT01154829|Dopamine Agents|dopamine agents|mesh-ancestor
93136332|NCT01154829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136333|NCT01154829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136334|NCT01154829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93136335|NCT01154829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93136336|NCT01154829|Serotonin Agents|serotonin agents|mesh-ancestor
93136337|NCT01154829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93136338|NCT01154829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93136339|NCT01154829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93136340|NCT01154829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93136341|NCT01154829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93136342|NCT01153191|Gentamicins|gentamicins|mesh-list
93136343|NCT01153191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93136344|NCT01153191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136345|NCT01153191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93136346|NCT01153191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136347|NCT01153191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136348|NCT01259817|Aspirin|aspirin|mesh-list
93136349|NCT01259817|Interferons|interferons|mesh-list
93136350|NCT01259817|Interferon-alpha|interferon-alpha|mesh-list
93136351|NCT01259817|Interferon alpha-2|interferon alpha-2|mesh-list
93136352|NCT01259817|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93136353|NCT01259817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136354|NCT01259817|Antiviral Agents|antiviral agents|mesh-ancestor
93136355|NCT01259817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136356|NCT01259817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93136357|NCT01259817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93136358|NCT01259817|Analgesics|analgesics|mesh-ancestor
93136359|NCT01259817|Sensory System Agents|sensory system agents|mesh-ancestor
93136360|NCT01259817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136361|NCT01259817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136362|NCT01259817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136363|NCT01259817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136364|NCT01259817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93136365|NCT01259817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93136366|NCT01259817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136367|NCT01259817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93136368|NCT01259817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93136369|NCT01259817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136370|NCT01259817|Antipyretics|antipyretics|mesh-ancestor
93136371|NCT01259817|Immunologic Factors|immunologic factors|mesh-ancestor
93136372|NCT01261689|Sufentanil|sufentanil|mesh-list
93136373|NCT01261689|Dsuvia|dsuvia|mesh-list
93136374|NCT01261689|Ropivacaine|ropivacaine|mesh-list
93136375|NCT01261689|Anesthetics, Local|anesthetics, local|mesh-ancestor
93136376|NCT01261689|Anesthetics|anesthetics|mesh-ancestor
93136377|NCT01261689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136378|NCT01261689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136379|NCT01261689|Sensory System Agents|sensory system agents|mesh-ancestor
93136380|NCT01261689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136381|NCT01261689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93136382|NCT01261689|Narcotics|narcotics|mesh-ancestor
93136383|NCT01261689|Analgesics|analgesics|mesh-ancestor
93136384|NCT01261689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93136385|NCT01261689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93136386|NCT01261689|Anesthetics, General|anesthetics, general|mesh-ancestor
93136387|NCT01154907|Praziquantel|praziquantel|mesh-list
93136388|NCT01154907|Anthelmintics|anthelmintics|mesh-ancestor
93136389|NCT01154907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93136390|NCT01154907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432176|NCT04182672|Hormones|hormones|mesh-ancestor
93136391|NCT01261923|Alitretinoin|alitretinoin|mesh-list
93136392|NCT01261923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136393|NCT01261923|Dermatologic Agents|dermatologic agents|mesh-ancestor
93136394|NCT01157247|Fentanyl|fentanyl|mesh-list
93136395|NCT01157247|Anesthetics|anesthetics|mesh-list
93136396|NCT01157247|Anesthetics, Local|anesthetics, local|mesh-list
93136397|NCT01157247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93136398|NCT01157247|Narcotics|narcotics|mesh-ancestor
93136399|NCT01157247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136400|NCT01157247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136401|NCT01157247|Analgesics|analgesics|mesh-ancestor
93136402|NCT01157247|Sensory System Agents|sensory system agents|mesh-ancestor
93136403|NCT01157247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136404|NCT01157247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93136405|NCT01157247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93136406|NCT01157247|Anesthetics, General|anesthetics, general|mesh-ancestor
93136407|NCT03881787|Cetuximab|cetuximab|mesh-list
93136408|NCT03881787|Antibodies|antibodies|mesh-list
93136409|NCT03881787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93136410|NCT03881787|Immunologic Factors|immunologic factors|mesh-ancestor
93136411|NCT03881787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136412|NCT03881787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93136413|NCT03881787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136414|NCT01157481|Nifedipine|nifedipine|mesh-list
93136415|NCT01157481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93136416|NCT01157481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93136417|NCT01157481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136418|NCT01157481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93136419|NCT01157481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136420|NCT01157481|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136421|NCT01157481|Tocolytic Agents|tocolytic agents|mesh-ancestor
93136422|NCT01157481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93136424|NCT03894189|Doxapram|doxapram|mesh-list
93136425|NCT03894189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93136426|NCT03894189|Autonomic Agents|autonomic agents|mesh-ancestor
93136427|NCT03894189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136428|NCT03894189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136429|NCT03894189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93136430|NCT03894189|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136431|NCT03894189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93136432|NCT03894189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136433|NCT03894189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136434|NCT03894189|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136435|NCT03894189|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93136436|NCT03894189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93136437|NCT03894189|Purinergic Agents|purinergic agents|mesh-ancestor
93136438|NCT03894189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136439|NCT03894189|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93136440|NCT03886311|Nivolumab|nivolumab|mesh-list
93136441|NCT03886311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93136442|NCT03886311|Trabectedin|trabectedin|mesh-list
93136443|NCT03886311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93136444|NCT03886311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136445|NCT03886311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93136446|NCT03886311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136447|NCT03886311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93136448|NCT03886311|Alkylating Agents|alkylating agents|mesh-ancestor
93136449|NCT01155453|Trametinib|trametinib|mesh-list
93136450|NCT01155453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136451|NCT01155453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136452|NCT01155453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136453|NCT01155453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136454|NCT03886233|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93136455|NCT03886233|Immunologic Factors|immunologic factors|mesh-ancestor
93136456|NCT03886233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136457|NCT03885219|Paclitaxel|paclitaxel|mesh-list
93136458|NCT03885219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93136459|NCT03885219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136460|NCT03885219|Tubulin Modulators|tubulin modulators|mesh-ancestor
93136461|NCT03885219|Antimitotic Agents|antimitotic agents|mesh-ancestor
93136462|NCT03885219|Mitosis Modulators|mitosis modulators|mesh-ancestor
93136463|NCT03885219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136464|NCT01157559|Ziprasidone|ziprasidone|mesh-list
93136465|NCT01157559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93136466|NCT01157559|Serotonin Agents|serotonin agents|mesh-ancestor
93136467|NCT01157559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136468|NCT01157559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136469|NCT01157559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136470|NCT01157559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93136471|NCT01157559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93136472|NCT01157559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136473|NCT01157559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136474|NCT01157559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93136475|NCT01157559|Dopamine Agents|dopamine agents|mesh-ancestor
93136476|NCT01263951|Everolimus|everolimus|mesh-list
93136477|NCT01263951|Sorafenib|sorafenib|mesh-list
93136478|NCT01263951|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93136479|NCT01263951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136480|NCT01263951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136481|NCT01263951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136482|NCT01263951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136483|NCT01263951|Immunologic Factors|immunologic factors|mesh-ancestor
93136484|NCT01263951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136485|NCT01263951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136486|NCT01265433|Molgramostim|molgramostim|mesh-list
93136487|NCT01265433|Sargramostim|sargramostim|mesh-list
93136488|NCT01265433|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93136489|NCT01265433|Immunologic Factors|immunologic factors|mesh-ancestor
93136490|NCT01265433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136491|NCT01265433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136492|NCT01265433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93136493|NCT01265589|Vitamin A|vitamin a|mesh-list
93136494|NCT01265589|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93136495|NCT01265589|Vitamins|vitamins|mesh-ancestor
93136496|NCT01265589|Micronutrients|micronutrients|mesh-ancestor
93136497|NCT01265589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136498|NCT01265589|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136499|NCT01159587|Factor VIII|factor viii|mesh-list
93136500|NCT01159587|Coagulants|coagulants|mesh-ancestor
93136501|NCT03885297|Liraglutide|liraglutide|mesh-list
93136502|NCT03885297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93136503|NCT03885297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136504|NCT03885297|Incretins|incretins|mesh-ancestor
93136505|NCT03885297|Hormones|hormones|mesh-ancestor
93136506|NCT03885297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93136507|NCT01159821|Paroxetine|paroxetine|mesh-list
93136508|NCT01159821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93136509|NCT01159821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93136510|NCT01159821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93136511|NCT01159821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136512|NCT01159821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136513|NCT01159821|Serotonin Agents|serotonin agents|mesh-ancestor
93136514|NCT01159821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136515|NCT01159821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93136516|NCT01159821|Antidepressive Agents|antidepressive agents|mesh-ancestor
93136517|NCT01159821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136518|NCT01159821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93136519|NCT01159821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93136520|NCT01159821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136521|NCT03881319|Contraceptive Agents|contraceptive agents|mesh-list
93136522|NCT03881319|Contraceptives, Oral|contraceptives, oral|mesh-list
93136523|NCT03881319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93136524|NCT03881319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136525|NCT03881319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93136526|NCT03885141|Zolpidem|zolpidem|mesh-list
93136527|NCT03885141|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93136528|NCT03885141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93136529|NCT03885141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136530|NCT03885141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136531|NCT03885141|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93136532|NCT03885141|GABA Agonists|gaba agonists|mesh-ancestor
93136533|NCT03885141|GABA Agents|gaba agents|mesh-ancestor
93136534|NCT03885141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136535|NCT03885141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136536|NCT03879057|Antibodies|antibodies|mesh-list
93136537|NCT03879057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93136538|NCT03879057|Immunologic Factors|immunologic factors|mesh-ancestor
93136539|NCT03879057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136540|NCT01266057|Sirolimus|sirolimus|mesh-list
93136541|NCT01266057|Hydroxychloroquine|hydroxychloroquine|mesh-list
93136542|NCT01266057|Vorinostat|vorinostat|mesh-list
93136543|NCT01266057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93136544|NCT01266057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136545|NCT01266057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93136546|NCT01266057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136547|NCT01266057|Antifungal Agents|antifungal agents|mesh-ancestor
93136548|NCT01266057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136549|NCT01266057|Immunologic Factors|immunologic factors|mesh-ancestor
93136550|NCT01266057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136551|NCT01266057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136552|NCT01266057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136553|NCT01266057|Antimalarials|antimalarials|mesh-ancestor
93136554|NCT01266057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93136555|NCT01266057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93136556|NCT01266057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93136557|NCT01266057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93136558|NCT01266213|Fulvestrant|fulvestrant|mesh-list
93136559|NCT01266213|Anastrozole|anastrozole|mesh-list
93136560|NCT01266213|Goserelin|goserelin|mesh-list
93136561|NCT01266213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93136562|NCT01266213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136563|NCT01266213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93136564|NCT01266213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93136565|NCT01266213|Hormone Antagonists|hormone antagonists|mesh-ancestor
93136566|NCT01266213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93136567|NCT01266213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136568|NCT01266213|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93136569|NCT01266213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93136570|NCT01266213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136571|NCT01266213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136572|NCT01262391|Solifenacin Succinate|solifenacin succinate|mesh-list
93136573|NCT01262391|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93136574|NCT01262391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93136575|NCT01262391|Cholinergic Agents|cholinergic agents|mesh-ancestor
93136576|NCT01262391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136577|NCT01262391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136578|NCT01262391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136579|NCT01262391|Urological Agents|urological agents|mesh-ancestor
93136580|NCT03880695|Doxorubicin|doxorubicin|mesh-list
93136581|NCT03880695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93136582|NCT03880695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93136583|NCT03880695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136584|NCT03880695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93136585|NCT03880695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93136586|NCT03880695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136587|NCT03880695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136588|NCT01155765|Clopidogrel|clopidogrel|mesh-list
93136589|NCT01155765|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93136590|NCT01155765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93136591|NCT01155765|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93136592|NCT01155765|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93136593|NCT01155765|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93136594|NCT01155765|Purinergic Agents|purinergic agents|mesh-ancestor
93136595|NCT01155765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136596|NCT01155765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136597|NCT01155765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136598|NCT01264341|Sirolimus|sirolimus|mesh-list
93136599|NCT01264341|Bevacizumab|bevacizumab|mesh-list
93136600|NCT01264341|Temsirolimus|temsirolimus|mesh-list
93136601|NCT01264341|MTOR Inhibitors|mtor inhibitors|mesh-list
93136602|NCT01264341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93136603|NCT01264341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136604|NCT01264341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93136605|NCT01264341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93136606|NCT01264341|Growth Substances|growth substances|mesh-ancestor
93136607|NCT01264341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136608|NCT01264341|Growth Inhibitors|growth inhibitors|mesh-ancestor
93136609|NCT01264341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136610|NCT01264341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136611|NCT01264341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136612|NCT01264341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136613|NCT01264341|Immunologic Factors|immunologic factors|mesh-ancestor
93136614|NCT01264341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93136615|NCT01264341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136616|NCT01264341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93136617|NCT01264341|Antifungal Agents|antifungal agents|mesh-ancestor
93136618|NCT01264497|Tesamorelin|tesamorelin|mesh-list
93136619|NCT01264497|Growth Substances|growth substances|mesh-ancestor
93136620|NCT01264497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136621|NCT01157949|Thymoglobulin|thymoglobulin|mesh-list
93136622|NCT01157949|Immunologic Factors|immunologic factors|mesh-ancestor
93136623|NCT01157949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136624|NCT01157949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136625|NCT01262469|Capecitabine|capecitabine|mesh-list
93136626|NCT01262469|Lapatinib|lapatinib|mesh-list
93136627|NCT01262469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93136628|NCT01262469|Antimetabolites|antimetabolites|mesh-ancestor
93136629|NCT01262469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136630|NCT01262469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136631|NCT01262469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136632|NCT01262469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136633|NCT01155921|Risperidone|risperidone|mesh-list
93136634|NCT01155921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93136635|NCT01155921|Serotonin Agents|serotonin agents|mesh-ancestor
93136636|NCT01155921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136637|NCT01155921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136638|NCT01155921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136639|NCT01155921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93136640|NCT01155921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93136641|NCT01155921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136642|NCT01155921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136643|NCT01155921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93136644|NCT01155921|Dopamine Agents|dopamine agents|mesh-ancestor
93136645|NCT03884127|Orlistat|orlistat|mesh-list
93136646|NCT03884127|Ezetimibe|ezetimibe|mesh-list
93136647|NCT03884127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93136648|NCT03884127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93136649|NCT03884127|Antimetabolites|antimetabolites|mesh-ancestor
93136650|NCT03884127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136651|NCT03884127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93136652|NCT03884127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136653|NCT03884127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93136655|NCT01158105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136656|NCT03337490|Ivermectin|ivermectin|mesh-list
93136657|NCT03337490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93136658|NCT03337490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136659|NCT01158183|Interferons|interferons|mesh-list
93136660|NCT01158183|Interferon-beta|interferon-beta|mesh-list
93136661|NCT01158183|Interferon beta-1b|interferon beta-1b|mesh-list
93136662|NCT01158183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136663|NCT01158183|Antiviral Agents|antiviral agents|mesh-ancestor
93136664|NCT01158183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136665|NCT01158183|Immunologic Factors|immunologic factors|mesh-ancestor
93136666|NCT01158183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136667|NCT01158183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93136668|NCT01264575|Epinephrine|epinephrine|mesh-list
93136669|NCT01264575|Racepinephrine|racepinephrine|mesh-list
93136670|NCT01264575|Bupivacaine|bupivacaine|mesh-list
93136671|NCT01264575|Epinephryl borate|epinephryl borate|mesh-list
93136672|NCT01264575|Anesthetics, Local|anesthetics, local|mesh-ancestor
93136673|NCT01264575|Anesthetics|anesthetics|mesh-ancestor
93136674|NCT01264575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136675|NCT01264575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136676|NCT01264575|Sensory System Agents|sensory system agents|mesh-ancestor
93136677|NCT01264575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136678|NCT01264575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93136679|NCT01264575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93136680|NCT01264575|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136681|NCT01264575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136682|NCT01264575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136683|NCT01264575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93136684|NCT01264575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93136685|NCT01264575|Autonomic Agents|autonomic agents|mesh-ancestor
93136686|NCT01264575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93136687|NCT01264575|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136688|NCT01264575|Mydriatics|mydriatics|mesh-ancestor
93136689|NCT01264575|Sympathomimetics|sympathomimetics|mesh-ancestor
93136690|NCT01264575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93136691|NCT04992260|Vaccines|vaccines|mesh-list
93136692|NCT04992260|Immunologic Factors|immunologic factors|mesh-ancestor
93136693|NCT04992260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136694|NCT01266681|Amiodarone|amiodarone|mesh-list
93136695|NCT01266681|Dronedarone|dronedarone|mesh-list
93136696|NCT01266681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93136697|NCT01266681|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136698|NCT01266681|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93136699|NCT01266681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93136700|NCT01266681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136701|NCT01266681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93136702|NCT01266681|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93136703|NCT01266681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93136704|NCT01266681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136705|NCT01266681|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93136706|NCT01266681|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93136707|NCT01266681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93136708|NCT03638648|Capecitabine|capecitabine|mesh-list
93136709|NCT03638648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93136710|NCT03638648|Antimetabolites|antimetabolites|mesh-ancestor
93136711|NCT03638648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136712|NCT03638648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136713|NCT01266759|NuvaRing|nuvaring|mesh-list
93136714|NCT01266759|Norethindrone|norethindrone|mesh-list
93136715|NCT01266759|Norethindrone Acetate|norethindrone acetate|mesh-list
93136716|NCT01266759|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93136717|NCT01266759|Contraceptive Agents|contraceptive agents|mesh-ancestor
93136718|NCT01266759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93136719|NCT01266759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136720|NCT01266759|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93136721|NCT01266759|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92808880|NCT00928434|Leuprolide|leuprolide|mesh-list
93136722|NCT01266759|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93136723|NCT01266759|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93136724|NCT03512223|Dexamethasone|dexamethasone|mesh-list
93136725|NCT03512223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136726|NCT03512223|Antiemetics|antiemetics|mesh-ancestor
93136727|NCT03512223|Autonomic Agents|autonomic agents|mesh-ancestor
93136728|NCT03512223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136729|NCT03512223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136730|NCT03512223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136731|NCT03512223|Glucocorticoids|glucocorticoids|mesh-ancestor
93136732|NCT03512223|Hormones|hormones|mesh-ancestor
93136733|NCT03512223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93136734|NCT03512223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93136735|NCT03512223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136736|NCT03878667|Calcium, Dietary|calcium, dietary|mesh-list
93136737|NCT03878667|Calcium Carbonate|calcium carbonate|mesh-list
93136738|NCT03878667|Calcium|calcium|mesh-list
93136739|NCT03878667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93136740|NCT03878667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136741|NCT03878667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93136742|NCT03878667|Antacids|antacids|mesh-ancestor
93136743|NCT03878667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136744|NCT03878667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136745|NCT01264653|Epinephrine|epinephrine|mesh-list
93136746|NCT01264653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93136747|NCT01264653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93136748|NCT01264653|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136749|NCT01264653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136750|NCT01264653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136751|NCT01264653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136752|NCT01264653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93136753|NCT01264653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93136754|NCT01264653|Autonomic Agents|autonomic agents|mesh-ancestor
93136755|NCT01264653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136756|NCT01264653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93136757|NCT01264653|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136758|NCT01264653|Mydriatics|mydriatics|mesh-ancestor
93136759|NCT01264653|Sympathomimetics|sympathomimetics|mesh-ancestor
93136760|NCT01264653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93136761|NCT01266837|Everolimus|everolimus|mesh-list
93136762|NCT01266837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93136763|NCT01266837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93136764|NCT01266837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136765|NCT01266837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136766|NCT01266837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136767|NCT01266837|Immunologic Factors|immunologic factors|mesh-ancestor
93136768|NCT01266837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136769|NCT01266837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136770|NCT01264731|Imiquimod|imiquimod|mesh-list
93136771|NCT01264731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93136772|NCT01264731|Immunologic Factors|immunologic factors|mesh-ancestor
93136773|NCT01264731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136774|NCT01264731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136775|NCT01264731|Interferon Inducers|interferon inducers|mesh-ancestor
93136776|NCT03879837|Fluticasone|fluticasone|mesh-list
93136778|NCT03879837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93136779|NCT03879837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93136780|NCT03879837|Autonomic Agents|autonomic agents|mesh-ancestor
93136781|NCT03879837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136782|NCT03879837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136783|NCT03879837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93136784|NCT03879837|Respiratory System Agents|respiratory system agents|mesh-ancestor
93136785|NCT03879837|Dermatologic Agents|dermatologic agents|mesh-ancestor
93136786|NCT03879837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93136787|NCT05308628|Complement C3|complement c3|mesh-list
93136788|NCT05308628|Immunologic Factors|immunologic factors|mesh-ancestor
93136789|NCT05308628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136790|NCT01156077|Tedizolid phosphate|tedizolid phosphate|mesh-list
93136791|NCT01156077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93136792|NCT01156077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136793|NCT01158729|Antithrombins|antithrombins|mesh-list
92808946|NCT04260360|Tubulin Modulators|tubulin modulators|mesh-ancestor
93136794|NCT01158729|Antithrombin III|antithrombin iii|mesh-list
93136795|NCT01158729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93136796|NCT01158729|Protease Inhibitors|protease inhibitors|mesh-ancestor
93136797|NCT01158729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136798|NCT01158729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136799|NCT01158729|Anticoagulants|anticoagulants|mesh-ancestor
93136800|NCT05303324|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
93136801|NCT05303324|Choline|choline|mesh-list
93136802|NCT05303324|Lipotropic Agents|lipotropic agents|mesh-ancestor
93136803|NCT05303324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93136804|NCT05303324|Antimetabolites|antimetabolites|mesh-ancestor
93136805|NCT05303324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136806|NCT05303324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136807|NCT05303324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93136808|NCT05303324|Nootropic Agents|nootropic agents|mesh-ancestor
93136809|NCT05303324|Chelating Agents|chelating agents|mesh-ancestor
93136810|NCT05303324|Sequestering Agents|sequestering agents|mesh-ancestor
93136811|NCT05303324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136812|NCT05303324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93136813|NCT05303324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93136814|NCT05303324|Growth Substances|growth substances|mesh-ancestor
93136815|NCT05303324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136816|NCT05303324|Growth Inhibitors|growth inhibitors|mesh-ancestor
93136817|NCT05303324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136818|NCT01262859|Bevacizumab|bevacizumab|mesh-list
93136819|NCT01262859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93136820|NCT01262859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136821|NCT01262859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93136822|NCT01262859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93136823|NCT01262859|Growth Substances|growth substances|mesh-ancestor
93136824|NCT01262859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136825|NCT01262859|Growth Inhibitors|growth inhibitors|mesh-ancestor
93136826|NCT02527083|Ketamine|ketamine|mesh-list
93136827|NCT02527083|Remifentanil|remifentanil|mesh-list
93136828|NCT02527083|Propofol|propofol|mesh-list
93136829|NCT02527083|Sevoflurane|sevoflurane|mesh-list
93136830|NCT02527083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93136831|NCT02527083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136832|NCT02527083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136833|NCT02527083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93136834|NCT02527083|Anesthetics, General|anesthetics, general|mesh-ancestor
93136835|NCT02527083|Anesthetics|anesthetics|mesh-ancestor
93136836|NCT02527083|Analgesics|analgesics|mesh-ancestor
93136837|NCT02527083|Sensory System Agents|sensory system agents|mesh-ancestor
93136838|NCT02527083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136839|NCT02527083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93136840|NCT02527083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93136841|NCT02527083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92432619|NCT01570088|Folic Acid|folic acid|mesh-list
93136842|NCT02527083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136843|NCT02527083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136844|NCT02527083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93136845|NCT02527083|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93136846|NCT02527083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93136847|NCT02527083|Narcotics|narcotics|mesh-ancestor
93136848|NCT05156684|Zinc|zinc|mesh-list
93136849|NCT05156684|Pentoxifylline|pentoxifylline|mesh-list
93136850|NCT05156684|Zinc Sulfate|zinc sulfate|mesh-list
93136851|NCT05156684|Trace Elements|trace elements|mesh-ancestor
93136852|NCT05156684|Micronutrients|micronutrients|mesh-ancestor
93136853|NCT05156684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136854|NCT05156684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93136855|NCT05156684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136856|NCT05156684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136857|NCT05156684|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93136858|NCT05156684|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93136859|NCT05156684|Protective Agents|protective agents|mesh-ancestor
93136860|NCT05156684|Vasodilator Agents|vasodilator agents|mesh-ancestor
93136861|NCT05156684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93136862|NCT05156684|Antioxidants|antioxidants|mesh-ancestor
93136863|NCT05156684|Astringents|astringents|mesh-ancestor
93136864|NCT05156684|Dermatologic Agents|dermatologic agents|mesh-ancestor
93136865|NCT03883347|Dexmedetomidine|dexmedetomidine|mesh-list
93136866|NCT03883347|Remifentanil|remifentanil|mesh-list
93136867|NCT03883347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93136868|NCT03883347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136869|NCT03883347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136870|NCT03883347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93136871|NCT03883347|Analgesics|analgesics|mesh-ancestor
93136872|NCT03883347|Sensory System Agents|sensory system agents|mesh-ancestor
93136873|NCT03883347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136874|NCT03883347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93136875|NCT03883347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93136876|NCT03883347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93136877|NCT03883347|Adrenergic Agents|adrenergic agents|mesh-ancestor
93136878|NCT03883347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136879|NCT03883347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136880|NCT03883347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93136882|NCT01159275|Lopinavir|lopinavir|mesh-list
93136883|NCT01159275|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93136884|NCT01159275|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93136885|NCT01159275|Protease Inhibitors|protease inhibitors|mesh-ancestor
93136886|NCT01159275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136887|NCT01159275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136888|NCT01159275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93136889|NCT01159275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93136890|NCT01159275|Antiviral Agents|antiviral agents|mesh-ancestor
93136891|NCT01159275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136892|NCT01159275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93136893|NCT01159275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93136894|NCT01159353|Insulin|insulin|mesh-list
93136895|NCT01159353|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93136896|NCT01159353|Insulin Aspart|insulin aspart|mesh-list
93136897|NCT01159353|Insulin glulisine|insulin glulisine|mesh-list
93136898|NCT01159353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93136899|NCT01159353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136900|NCT02943668|Deferasirox|deferasirox|mesh-list
93136901|NCT02943668|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93136902|NCT02943668|Chelating Agents|chelating agents|mesh-ancestor
93136903|NCT02943668|Sequestering Agents|sequestering agents|mesh-ancestor
93136904|NCT02943668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136905|NCT01265199|Cytarabine|cytarabine|mesh-list
93136906|NCT01265199|Daunorubicin|daunorubicin|mesh-list
93136907|NCT01265199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93136908|NCT01265199|Antimetabolites|antimetabolites|mesh-ancestor
93136909|NCT01265199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136910|NCT01265199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136911|NCT01265199|Antiviral Agents|antiviral agents|mesh-ancestor
93136912|NCT01265199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136913|NCT01265199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136914|NCT01265199|Immunologic Factors|immunologic factors|mesh-ancestor
93136915|NCT01265199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136916|NCT01265199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93136917|NCT01265199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93136918|NCT01265199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93136919|NCT01265199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136920|NCT01263171|Leucovorin|leucovorin|mesh-list
93136921|NCT01263171|Fluorouracil|fluorouracil|mesh-list
93136922|NCT01263171|Oxaliplatin|oxaliplatin|mesh-list
93136923|NCT01263171|Calcium|calcium|mesh-list
93136924|NCT01263171|Levoleucovorin|levoleucovorin|mesh-list
93136925|NCT01263171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93136926|NCT01263171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136927|NCT01263171|Antimetabolites|antimetabolites|mesh-ancestor
93136928|NCT01263171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136929|NCT01263171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93136930|NCT01263171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93136931|NCT01263171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93136932|NCT01263171|Immunologic Factors|immunologic factors|mesh-ancestor
93136933|NCT01263171|Antidotes|antidotes|mesh-ancestor
93136934|NCT01263171|Protective Agents|protective agents|mesh-ancestor
93136935|NCT01263171|Vitamin B Complex|vitamin b complex|mesh-ancestor
93136936|NCT01263171|Vitamins|vitamins|mesh-ancestor
93136937|NCT01263171|Micronutrients|micronutrients|mesh-ancestor
93136938|NCT01156233|Anesthetics|anesthetics|mesh-list
93136939|NCT01156233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136940|NCT01156233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136941|NCT03883269|Ethanol|ethanol|mesh-list
93136942|NCT03883269|Clindamycin|clindamycin|mesh-list
93136943|NCT03883269|Clindamycin palmitate|clindamycin palmitate|mesh-list
93136944|NCT03883269|Clindamycin phosphate|clindamycin phosphate|mesh-list
93136945|NCT03883269|Erythromycin|erythromycin|mesh-list
93136946|NCT03883269|Erythromycin Estolate|erythromycin estolate|mesh-list
93136947|NCT03883269|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93136948|NCT03883269|Erythromycin stearate|erythromycin stearate|mesh-list
93136949|NCT03883269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93136950|NCT03883269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93136951|NCT03883269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136952|NCT03883269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136953|NCT03883269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93136954|NCT03883269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93136955|NCT03883269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136956|NCT03883269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136957|NCT03883269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136958|NCT01267305|Calcium, Dietary|calcium, dietary|mesh-list
93136959|NCT01267305|PENTA|penta|mesh-list
93136960|NCT01267305|Nadroparin|nadroparin|mesh-list
93136961|NCT01267305|Fondaparinux|fondaparinux|mesh-list
93136962|NCT01267305|Calcium|calcium|mesh-list
93136963|NCT01267305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93136964|NCT01267305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136965|NCT01267305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93136966|NCT01267305|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93136967|NCT01267305|Antithrombins|antithrombins|mesh-ancestor
93136968|NCT01267305|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93136969|NCT01267305|Protease Inhibitors|protease inhibitors|mesh-ancestor
93136970|NCT01267305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136971|NCT01267305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136972|NCT01267305|Anticoagulants|anticoagulants|mesh-ancestor
93136973|NCT01267305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93136974|NCT01267305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93136975|NCT02891408|Fenofibrate|fenofibrate|mesh-list
93136976|NCT02891408|Firsocostat|firsocostat|mesh-list
93136977|NCT02891408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93136978|NCT02891408|Antimetabolites|antimetabolites|mesh-ancestor
93136979|NCT02891408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136980|NCT02891408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93136981|NCT02891408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93136982|NCT01160991|Olanzapine|olanzapine|mesh-list
93136983|NCT01160991|Amisulpride|amisulpride|mesh-list
93136984|NCT01160991|Antiemetics|antiemetics|mesh-ancestor
93136985|NCT01160991|Autonomic Agents|autonomic agents|mesh-ancestor
93136986|NCT01160991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136987|NCT01160991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93136988|NCT01160991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93136989|NCT01160991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93136990|NCT01160991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93136991|NCT01160991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93136992|NCT01160991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93136993|NCT01160991|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92809503|NCT00846586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93136994|NCT01160991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93136995|NCT01160991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93136996|NCT01160991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93136997|NCT01160991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93136998|NCT01160991|Serotonin Agents|serotonin agents|mesh-ancestor
93136999|NCT01160991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93137000|NCT01160991|Dopamine Agents|dopamine agents|mesh-ancestor
93137001|NCT01160991|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93137002|NCT01160991|Antidepressive Agents|antidepressive agents|mesh-ancestor
93137003|NCT05498480|Nivolumab|nivolumab|mesh-list
93137004|NCT05498480|Relatlimab|relatlimab|mesh-list
93137005|NCT05498480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93137006|NCT05498480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137007|NCT05498480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93137008|NCT05498480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137009|NCT01161069|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
93137010|NCT01161069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93137011|NCT01161069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93137012|NCT01161069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137013|NCT01161069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137014|NCT01161147|Meloxicam|meloxicam|mesh-list
93137015|NCT01161147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137016|NCT01161147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137017|NCT01161147|Analgesics|analgesics|mesh-ancestor
93137018|NCT01161147|Sensory System Agents|sensory system agents|mesh-ancestor
93137019|NCT01161147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137020|NCT01161147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137021|NCT01161147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137022|NCT01161147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137023|NCT01161147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93137024|NCT01161147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137025|NCT01161147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137026|NCT01161147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137027|NCT01161927|Nizatidine|nizatidine|mesh-list
93137028|NCT01161927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93137029|NCT01161927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93137030|NCT01161927|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93137031|NCT01161927|Histamine Antagonists|histamine antagonists|mesh-ancestor
93137032|NCT01161927|Histamine Agents|histamine agents|mesh-ancestor
93137033|NCT01161927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137034|NCT01161927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137035|NCT01161927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137036|NCT01267383|Sertraline|sertraline|mesh-list
93137037|NCT01267383|Antidepressive Agents|antidepressive agents|mesh-ancestor
93137038|NCT01267383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137039|NCT01267383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93137040|NCT01267383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93137041|NCT01267383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93137042|NCT01267383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137043|NCT01267383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137044|NCT01267383|Serotonin Agents|serotonin agents|mesh-ancestor
93137045|NCT01267383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137046|NCT03283670|Nitrous Oxide|nitrous oxide|mesh-list
93137047|NCT03283670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93137048|NCT03283670|Anesthetics, General|anesthetics, general|mesh-ancestor
93137049|NCT03283670|Anesthetics|anesthetics|mesh-ancestor
93137050|NCT03283670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137051|NCT03283670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137052|NCT03283670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137053|NCT03283670|Analgesics|analgesics|mesh-ancestor
93137054|NCT03283670|Sensory System Agents|sensory system agents|mesh-ancestor
93137055|NCT03283670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137056|NCT03110432|Nicotinic Acids|nicotinic acids|mesh-list
93137057|NCT03110432|Niacin|niacin|mesh-list
93137058|NCT03110432|Ezetimibe|ezetimibe|mesh-list
93137059|NCT03110432|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93137060|NCT03110432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
93137061|NCT03110432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93137062|NCT03110432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137063|NCT03110432|Antimetabolites|antimetabolites|mesh-ancestor
93137064|NCT03110432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137065|NCT03110432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137066|NCT03110432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93137067|NCT03110432|Protease Inhibitors|protease inhibitors|mesh-ancestor
93137068|NCT03110432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137069|NCT03110432|Vitamin B Complex|vitamin b complex|mesh-ancestor
93137070|NCT03110432|Vitamins|vitamins|mesh-ancestor
93137071|NCT03110432|Micronutrients|micronutrients|mesh-ancestor
93137072|NCT03110432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137073|NCT03110432|Vasodilator Agents|vasodilator agents|mesh-ancestor
93137074|NCT03205358|Vaccines|vaccines|mesh-list
93137075|NCT03205358|Immunologic Factors|immunologic factors|mesh-ancestor
93137076|NCT03205358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137077|NCT01358578|Etanercept|etanercept|mesh-list
93137078|NCT01358578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137079|NCT01358578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137080|NCT01358578|Analgesics|analgesics|mesh-ancestor
93137081|NCT01358578|Sensory System Agents|sensory system agents|mesh-ancestor
93137082|NCT01358578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137083|NCT01358578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137084|NCT01358578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137085|NCT01358578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137086|NCT01358578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93137087|NCT01358578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137088|NCT01358578|Immunologic Factors|immunologic factors|mesh-ancestor
93137089|NCT01161459|Prednisone|prednisone|mesh-list
93137090|NCT01161459|Tacrolimus|tacrolimus|mesh-list
93137091|NCT01161459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137092|NCT01161459|Glucocorticoids|glucocorticoids|mesh-ancestor
93137093|NCT01161459|Hormones|hormones|mesh-ancestor
93137094|NCT01161459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137095|NCT01161459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137096|NCT01161459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93137097|NCT01161459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137098|NCT01161459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137099|NCT01161459|Immunologic Factors|immunologic factors|mesh-ancestor
93137100|NCT01161459|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93137102|NCT01161459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137103|NCT03882489|Chloroprocaine|chloroprocaine|mesh-list
93137104|NCT03882489|Anesthetics, Local|anesthetics, local|mesh-ancestor
93137105|NCT03882489|Anesthetics|anesthetics|mesh-ancestor
93137106|NCT03882489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137107|NCT03882489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137108|NCT03882489|Sensory System Agents|sensory system agents|mesh-ancestor
93137109|NCT03882489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137110|NCT03882099|Vitamin D|vitamin d|mesh-list
93137111|NCT03882099|Vitamins|vitamins|mesh-ancestor
93137112|NCT03882099|Micronutrients|micronutrients|mesh-ancestor
93137113|NCT03882099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137114|NCT03882099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93137115|NCT01268163|Docetaxel|docetaxel|mesh-list
93137116|NCT01268163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137117|NCT01268163|Tubulin Modulators|tubulin modulators|mesh-ancestor
93137118|NCT01268163|Antimitotic Agents|antimitotic agents|mesh-ancestor
93137119|NCT01268163|Mitosis Modulators|mitosis modulators|mesh-ancestor
93137120|NCT01268163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137121|NCT04745780|Inositol|inositol|mesh-list
93137122|NCT04745780|Vitamin B Complex|vitamin b complex|mesh-ancestor
93137123|NCT04745780|Vitamins|vitamins|mesh-ancestor
93137124|NCT04745780|Micronutrients|micronutrients|mesh-ancestor
93137125|NCT04745780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137126|NCT02833948|Aspirin|aspirin|mesh-list
93137127|NCT02833948|Rivaroxaban|rivaroxaban|mesh-list
93137128|NCT02833948|Clopidogrel|clopidogrel|mesh-list
93137129|NCT02833948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93137130|NCT02833948|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93137131|NCT02833948|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93137132|NCT02833948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93137133|NCT02833948|Purinergic Agents|purinergic agents|mesh-ancestor
93137134|NCT02833948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137135|NCT02833948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137136|NCT02833948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137137|NCT02833948|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93137138|NCT02833948|Antithrombins|antithrombins|mesh-ancestor
93137139|NCT02833948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93137140|NCT02833948|Protease Inhibitors|protease inhibitors|mesh-ancestor
93137141|NCT02833948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137142|NCT02833948|Anticoagulants|anticoagulants|mesh-ancestor
93137143|NCT02833948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137144|NCT02833948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137145|NCT02833948|Analgesics|analgesics|mesh-ancestor
93137146|NCT02833948|Sensory System Agents|sensory system agents|mesh-ancestor
93137147|NCT02833948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137148|NCT02833948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137149|NCT02833948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137150|NCT02833948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93137151|NCT02833948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93137152|NCT02833948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137153|NCT02833948|Antipyretics|antipyretics|mesh-ancestor
93137154|NCT02527005|Azithromycin|azithromycin|mesh-list
93137155|NCT02527005|Pyrimethamine|pyrimethamine|mesh-list
93137156|NCT02527005|Sulfadoxine|sulfadoxine|mesh-list
93137157|NCT02527005|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93137158|NCT02527005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93137159|NCT02527005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137160|NCT02527005|Antimalarials|antimalarials|mesh-ancestor
93137161|NCT02527005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93137162|NCT02527005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93137163|NCT02527005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93137164|NCT02527005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137165|NCT02527005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137166|NCT02527005|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93137167|NCT01267695|Imatinib Mesylate|imatinib mesylate|mesh-list
93137168|NCT01267695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137169|NCT01267695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137170|NCT01267695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137171|NCT01267695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137172|NCT02404688|Ethanol|ethanol|mesh-list
93137173|NCT02404688|Dronabinol|dronabinol|mesh-list
93137174|NCT02404688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93137175|NCT02404688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137176|NCT02404688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137177|NCT02404688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137178|NCT02404688|Hallucinogens|hallucinogens|mesh-ancestor
93137179|NCT02404688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137180|NCT02404688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137181|NCT02404688|Analgesics|analgesics|mesh-ancestor
93137182|NCT02404688|Sensory System Agents|sensory system agents|mesh-ancestor
93137183|NCT02404688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137184|NCT02404688|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93137185|NCT02404688|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93137186|NCT02404688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137187|NCT02404688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137188|NCT02404688|Hormones|hormones|mesh-ancestor
93137189|NCT02404688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137190|NCT04704518|Hyaluronic Acid|hyaluronic acid|mesh-list
93137191|NCT04704518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93137192|NCT04704518|Immunologic Factors|immunologic factors|mesh-ancestor
93137193|NCT04704518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137194|NCT04704518|Viscosupplements|viscosupplements|mesh-ancestor
93137195|NCT04704518|Protective Agents|protective agents|mesh-ancestor
93137196|NCT02624102|Antidepressive Agents|antidepressive agents|mesh-list
93137197|NCT02624102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137198|NCT01162941|Prednisolone|prednisolone|mesh-list
93137199|NCT01162941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137200|NCT01162941|Glucocorticoids|glucocorticoids|mesh-ancestor
93137201|NCT01162941|Hormones|hormones|mesh-ancestor
93137202|NCT01162941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137203|NCT01162941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137204|NCT01162941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93137205|NCT01162941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137206|NCT00161044|Galantamine|galantamine|mesh-list
92809505|NCT00846586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92809743|NCT04244097|Autonomic Agents|autonomic agents|mesh-ancestor
92809815|NCT00784927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809887|NCT00631722|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92809961|NCT00776659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93137207|NCT00161044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93137208|NCT00161044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810186|NCT01059812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92810261|NCT04241523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232241|NCT04758949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810406|NCT04099771|Ketamine|ketamine|mesh-list
93137209|NCT00161044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137210|NCT00161044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92810556|NCT02822937|Triazolam|triazolam|mesh-list
93137211|NCT00161044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137212|NCT00161044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810877|NCT02817477|Ketamine|ketamine|mesh-list
93137213|NCT00161044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92811010|NCT02815449|Iron|iron|mesh-list
93137214|NCT00161044|Autonomic Agents|autonomic agents|mesh-ancestor
93137215|NCT00161044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137216|NCT00161044|Nootropic Agents|nootropic agents|mesh-ancestor
93137217|NCT01156779|Exenatide|exenatide|mesh-list
93137218|NCT01156779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811441|NCT00819052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137219|NCT01156779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137220|NCT01156779|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93137221|NCT01156779|Incretins|incretins|mesh-ancestor
93137222|NCT01156779|Hormones|hormones|mesh-ancestor
93137223|NCT01156779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811809|NCT04235985|Chlorhexidine|chlorhexidine|mesh-list
92811893|NCT05804591|Pregabalin|pregabalin|mesh-list
93137224|NCT01156857|Ulipristal acetate|ulipristal acetate|mesh-list
92812043|NCT05802888|Amoxicillin|amoxicillin|mesh-list
93137225|NCT01156857|Progestins|progestins|mesh-list
92812110|NCT05752734|Antiemetics|antiemetics|mesh-ancestor
92812186|NCT05646693|Antacids|antacids|mesh-ancestor
92812263|NCT05494593|gamma-Globulins|gamma-globulins|mesh-list
93137226|NCT01156857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92812424|NCT05101122|Analgesics|analgesics|mesh-ancestor
92812505|NCT04952389|Budesonide|budesonide|mesh-list
93137227|NCT01156857|Contraceptive Agents|contraceptive agents|mesh-ancestor
93137228|NCT01156857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93137229|NCT01156857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812783|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
92812858|NCT03503058|Analgesics|analgesics|mesh-ancestor
92813006|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813084|NCT01968460|Rasagiline|rasagiline|mesh-list
93137230|NCT01156857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93137231|NCT01156857|Hormones|hormones|mesh-ancestor
93232242|NCT04758949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137232|NCT01156857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137233|NCT01269333|Fluvoxamine|fluvoxamine|mesh-list
93137234|NCT01269333|Omeprazole|omeprazole|mesh-list
93137235|NCT01269333|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92813681|NCT00905034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137236|NCT01269333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813758|NCT01038752|Suramin|suramin|mesh-list
93137237|NCT01269333|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93137238|NCT01269333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232243|NCT04758949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92814132|NCT02690922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814212|NCT00913666|Interferons|interferons|mesh-list
92814283|NCT00902304|Amlodipine|amlodipine|mesh-list
93137239|NCT01269333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137240|NCT01269333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93137241|NCT01269333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92814656|NCT00903006|Dasatinib|dasatinib|mesh-list
93137242|NCT01269333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814803|NCT05325489|Hormones|hormones|mesh-ancestor
92815029|NCT01022762|Repaglinide|repaglinide|mesh-list
93137243|NCT01269333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815403|NCT01034462|Analgesics|analgesics|mesh-ancestor
92815477|NCT02774187|Antidotes|antidotes|mesh-ancestor
93137244|NCT01269333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815629|NCT02767401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93137245|NCT01269333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92815705|NCT02766855|Cysteamine|cysteamine|mesh-list
92815773|NCT00746785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137246|NCT01269333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93137247|NCT01269333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815919|NCT02760615|Losartan|losartan|mesh-list
93137248|NCT01269333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809399|NCT04203186|Lumefantrine|lumefantrine|mesh-list
93137249|NCT01269333|Serotonin Agents|serotonin agents|mesh-ancestor
92816214|NCT02752113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93137250|NCT01269333|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92816363|NCT02754687|Androgens|androgens|mesh-ancestor
93137251|NCT01269333|Antidepressive Agents|antidepressive agents|mesh-ancestor
93137252|NCT01269333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93137253|NCT01269333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93137254|NCT01269333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92816733|NCT02740803|Listerine|listerine|mesh-list
92816734|NCT02740803|Fluorides|fluorides|mesh-list
92816809|NCT02612116|Ticagrelor|ticagrelor|mesh-list
92816886|NCT00812812|Paroxetine|paroxetine|mesh-list
93232099|NCT01342939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817177|NCT02737059|Narcotics|narcotics|mesh-ancestor
92817251|NCT02731287|Adrenergic Agents|adrenergic agents|mesh-ancestor
93232100|NCT01342939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93232101|NCT01342939|Protease Inhibitors|protease inhibitors|mesh-ancestor
93232102|NCT01342939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817541|NCT02610088|Gliclazide|gliclazide|mesh-list
93232103|NCT01342939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817696|NCT02609152|Esmolol|esmolol|mesh-list
93232104|NCT03569540|Glyburide|glyburide|mesh-list
93232105|NCT03569540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93232106|NCT03569540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817919|NCT02725359|Tizanidine|tizanidine|mesh-list
93232107|NCT05708690|Tranexamic Acid|tranexamic acid|mesh-list
92818059|NCT02717871|Ofloxacin|ofloxacin|mesh-list
92818136|NCT00736645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232108|NCT05708690|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93232109|NCT05708690|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92818285|NCT04227093|Diuretics|diuretics|mesh-ancestor
92818358|NCT00729859|Testosterone enanthate|testosterone enanthate|mesh-list
92818587|NCT02777229|Tenofovir|tenofovir|mesh-list
93232110|NCT05708690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232111|NCT05708690|Hemostatics|hemostatics|mesh-ancestor
93232112|NCT05708690|Coagulants|coagulants|mesh-ancestor
93232113|NCT04851821|Quercetin|quercetin|mesh-list
93232114|NCT04851821|Antioxidants|antioxidants|mesh-ancestor
93232115|NCT04851821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819108|NCT05737342|Red yeast rice|red yeast rice|mesh-list
93232116|NCT04851821|Protective Agents|protective agents|mesh-ancestor
92819476|NCT00796822|Pentoxifylline|pentoxifylline|mesh-list
92819548|NCT00724711|Abacavir|abacavir|mesh-list
92819630|NCT03481959|Dopamine Agents|dopamine agents|mesh-ancestor
93232117|NCT04851821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232118|NCT03379727|Midostaurin|midostaurin|mesh-list
92819770|NCT00720109|Antimetabolites|antimetabolites|mesh-ancestor
93232119|NCT03379727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232120|NCT03379727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93232121|NCT03379727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820147|NCT00722137|Prednisone|prednisone|mesh-list
92820220|NCT00588640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820300|NCT04115410|Alkylating Agents|alkylating agents|mesh-ancestor
92820519|NCT00718315|Erythromycin Estolate|erythromycin estolate|mesh-list
93232122|NCT03379727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232123|NCT02247128|Aspirin|aspirin|mesh-list
93232124|NCT02247128|Clopidogrel|clopidogrel|mesh-list
92820961|NCT02704923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93232125|NCT02247128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232126|NCT02247128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93232127|NCT02247128|Analgesics|analgesics|mesh-ancestor
93232128|NCT02247128|Sensory System Agents|sensory system agents|mesh-ancestor
92821342|NCT02960763|Bupropion|bupropion|mesh-list
93232129|NCT02247128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232130|NCT02247128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232131|NCT02247128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232132|NCT02247128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232133|NCT02247128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92821939|NCT02584543|Vaccines|vaccines|mesh-list
92822020|NCT04426669|Analgesics|analgesics|mesh-ancestor
93232134|NCT02247128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92822089|NCT02583217|Narcotics|narcotics|mesh-ancestor
93232135|NCT02247128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822177|NCT00782626|Everolimus|everolimus|mesh-list
92822234|NCT01071083|Hormones|hormones|mesh-ancestor
92822320|NCT03862495|Azithromycin|azithromycin|mesh-list
92822385|NCT00618111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822459|NCT01009580|Insulin Aspart|insulin aspart|mesh-list
93232136|NCT02247128|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92822610|NCT00618501|Methotrexate|methotrexate|mesh-list
92822684|NCT00618579|Warfarin|warfarin|mesh-list
93232137|NCT02247128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232138|NCT02247128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232139|NCT02247128|Antipyretics|antipyretics|mesh-ancestor
93232140|NCT02247128|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93232141|NCT02247128|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93232142|NCT02247128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93232143|NCT02247128|Purinergic Agents|purinergic agents|mesh-ancestor
92823435|NCT02575729|Glucocorticoids|glucocorticoids|mesh-list
93232144|NCT02247128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232145|NCT01339481|Abatacept|abatacept|mesh-list
92823733|NCT03548805|Alkylating Agents|alkylating agents|mesh-ancestor
93232146|NCT01339481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93232147|NCT01339481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232148|NCT01339481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824032|NCT00998738|Calcium, Dietary|calcium, dietary|mesh-list
92824177|NCT01020305|Immunologic Factors|immunologic factors|mesh-ancestor
92824247|NCT01018511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92824323|NCT01385059|Axitinib|axitinib|mesh-list
92824469|NCT02576353|Fentanyl|fentanyl|mesh-list
93232149|NCT01339481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824562|NCT00714649|Cetuximab|cetuximab|mesh-list
92824625|NCT01014767|Leucovorin|leucovorin|mesh-list
92824695|NCT01014533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824769|NCT00715039|Antidepressive Agents|antidepressive agents|mesh-ancestor
93232150|NCT01339481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232151|NCT01339481|Immunologic Factors|immunologic factors|mesh-ancestor
93232152|NCT01339481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825000|NCT00713011|Nifedipine|nifedipine|mesh-list
93232153|NCT01339481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232154|NCT01344031|Fulvestrant|fulvestrant|mesh-list
93232155|NCT01344031|Anastrozole|anastrozole|mesh-list
92825143|NCT00778102|Leucovorin|leucovorin|mesh-list
92825217|NCT00716911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92825293|NCT00639483|Celecoxib|celecoxib|mesh-list
93232156|NCT01344031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93232157|NCT01344031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232158|NCT01344031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92825594|NCT03565783|Cemiplimab|cemiplimab|mesh-list
92825819|NCT00723385|Vitamin D|vitamin d|mesh-list
93232159|NCT01344031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93232160|NCT01344031|Hormone Antagonists|hormone antagonists|mesh-ancestor
92825967|NCT04019288|Immunoglobulin G|immunoglobulin g|mesh-list
92826119|NCT00577993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92826197|NCT02866370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826274|NCT00603525|Ofatumumab|ofatumumab|mesh-list
93232161|NCT01344031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826418|NCT02683005|Sofosbuvir|sofosbuvir|mesh-list
93232162|NCT01344031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232163|NCT01344031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93232164|NCT01344031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93232165|NCT01344031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826860|NCT02681913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92826938|NCT05663775|Analgesics|analgesics|mesh-ancestor
92827011|NCT00734773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92472071|NCT01842087|Iproplatin|iproplatin|mesh-list
93232166|NCT01344031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232167|NCT01332929|Bevacizumab|bevacizumab|mesh-list
93232168|NCT01332929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92827307|NCT02717455|Panobinostat|panobinostat|mesh-list
92827388|NCT00731575|Hormones|hormones|mesh-ancestor
92827459|NCT05273775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93232169|NCT01332929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827620|NCT02671227|Bupivacaine|bupivacaine|mesh-list
93232170|NCT01332929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93232171|NCT01332929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92827841|NCT02666703|Hormones|hormones|mesh-ancestor
93232172|NCT01332929|Growth Substances|growth substances|mesh-ancestor
93232173|NCT01332929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232174|NCT01332929|Growth Inhibitors|growth inhibitors|mesh-ancestor
93232175|NCT03566966|Antiviral Agents|antiviral agents|mesh-list
92828207|NCT02654379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828282|NCT00737971|Bevacizumab|bevacizumab|mesh-list
93232176|NCT03566966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828354|NCT02652585|Naltrexone|naltrexone|mesh-list
93232177|NCT02247986|Methylphenidate|methylphenidate|mesh-list
92828433|NCT00650325|Sertraline|sertraline|mesh-list
93232178|NCT02247986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93232179|NCT02247986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828652|NCT05740657|Fentanyl|fentanyl|mesh-list
92828801|NCT00968708|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828874|NCT00967616|Vitamin B Complex|vitamin b complex|mesh-ancestor
93046906|NCT00350636|Mandelic Acids|mandelic acids|mesh-list
93232180|NCT02247986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92829229|NCT00705679|Antiviral Agents|antiviral agents|mesh-ancestor
93232181|NCT02247986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92829449|NCT02597140|Anesthetics, General|anesthetics, general|mesh-ancestor
92829599|NCT04827979|Immunologic Factors|immunologic factors|mesh-ancestor
93232182|NCT02247986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232183|NCT02247986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232184|NCT02247986|Dopamine Agents|dopamine agents|mesh-ancestor
92829819|NCT02565979|Protective Agents|protective agents|mesh-ancestor
92829984|NCT00733954|Clobetasol|clobetasol|mesh-list
93232185|NCT02247986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232186|NCT03567434|Ethanol|ethanol|mesh-list
93232187|NCT03567434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93232188|NCT03567434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830190|NCT00958568|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93137255|NCT01269411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92830563|NCT02857946|Protease Inhibitors|protease inhibitors|mesh-ancestor
92830783|NCT00948194|Vasodilator Agents|vasodilator agents|mesh-ancestor
92830857|NCT00631124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137256|NCT01269411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93137257|NCT01269411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831229|NCT00749359|Serotonin Agents|serotonin agents|mesh-ancestor
93137258|NCT01269411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137259|NCT03882255|Propranolol|propranolol|mesh-list
93137260|NCT03882255|Ponesimod|ponesimod|mesh-list
93137261|NCT03882255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93137262|NCT03882255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92831905|NCT05381168|Antacids|antacids|mesh-ancestor
93137263|NCT03882255|Adrenergic Agents|adrenergic agents|mesh-ancestor
93137264|NCT03882255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832280|NCT04614545|Appetite Depressants|appetite depressants|mesh-ancestor
92832354|NCT00748891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832427|NCT02559973|Analgesics|analgesics|mesh-ancestor
93232189|NCT03567434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137265|NCT03882255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832652|NCT00585052|Antimetabolites|antimetabolites|mesh-ancestor
93137266|NCT03882255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137267|NCT03882255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92832872|NCT00754819|Colchicine|colchicine|mesh-list
93137268|NCT03882255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93137269|NCT03882255|Vasodilator Agents|vasodilator agents|mesh-ancestor
92833023|NCT05291221|Lidocaine|lidocaine|mesh-list
93137270|NCT03882255|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92833252|NCT04935034|Vitamin D|vitamin d|mesh-list
92833392|NCT04049227|Letrozole|letrozole|mesh-list
93137271|NCT03882255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833543|NCT04674514|Hormones|hormones|mesh-ancestor
93137272|NCT03882255|Immunologic Factors|immunologic factors|mesh-ancestor
93137273|NCT05433272|Vaccines|vaccines|mesh-list
93137274|NCT05433272|Immunologic Factors|immunologic factors|mesh-ancestor
92833842|NCT00583102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92833915|NCT05857202|Narcotics|narcotics|mesh-ancestor
92833988|NCT05850611|Coagulants|coagulants|mesh-ancestor
93137275|NCT05433272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834289|NCT05147558|Pembrolizumab|pembrolizumab|mesh-list
92834362|NCT04983940|Testosterone|testosterone|mesh-list
93137276|NCT01268631|Pregabalin|pregabalin|mesh-list
93137277|NCT01268631|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93137278|NCT01268631|Analgesics|analgesics|mesh-ancestor
93137279|NCT01268631|Sensory System Agents|sensory system agents|mesh-ancestor
93137280|NCT01268631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137281|NCT01268631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137282|NCT01268631|Anticonvulsants|anticonvulsants|mesh-ancestor
93137283|NCT01268631|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93137284|NCT01268631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93137285|NCT01268631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137286|NCT01268631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93137287|NCT01268631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93137288|NCT01268631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93137289|NCT01268631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137290|NCT01268631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137291|NCT01268631|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93137292|NCT01268631|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93137293|NCT01268631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137294|NCT01268631|Antidepressive Agents|antidepressive agents|mesh-ancestor
93137295|NCT01268631|Dopamine Agents|dopamine agents|mesh-ancestor
93137296|NCT05430230|Naproxen|naproxen|mesh-list
93137297|NCT05430230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93137298|NCT05430230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93137299|NCT05430230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137300|NCT05430230|Analgesics|analgesics|mesh-ancestor
93137301|NCT05430230|Sensory System Agents|sensory system agents|mesh-ancestor
93137302|NCT05430230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137303|NCT05430230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137304|NCT05430230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137305|NCT05430230|Gout Suppressants|gout suppressants|mesh-ancestor
93137306|NCT05430230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137307|NCT05430230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137308|NCT05430230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137309|NCT01268709|Doxepin|doxepin|mesh-list
93137310|NCT01268709|Nortriptyline|nortriptyline|mesh-list
93137311|NCT01268709|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93137312|NCT01268709|Antidepressive Agents|antidepressive agents|mesh-ancestor
93137313|NCT01268709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137314|NCT01268709|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93137315|NCT01268709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93137316|NCT01268709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93137317|NCT01268709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809471|NCT04303598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137318|NCT01268709|Adrenergic Agents|adrenergic agents|mesh-ancestor
93137319|NCT01268709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137320|NCT01268709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137321|NCT01268709|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92834511|NCT04626791|Doxorubicin|doxorubicin|mesh-list
92834563|NCT04544111|Trametinib|trametinib|mesh-list
92834612|NCT04379596|Antimetabolites|antimetabolites|mesh-ancestor
92834759|NCT03841201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93137322|NCT01268709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92834908|NCT03232918|Oxytocin|oxytocin|mesh-list
93137323|NCT01268709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835205|NCT04080310|Ezetimibe|ezetimibe|mesh-list
92835276|NCT02584738|Prednisolone|prednisolone|mesh-list
93137324|NCT01268709|Histamine Antagonists|histamine antagonists|mesh-ancestor
93137325|NCT01268709|Histamine Agents|histamine agents|mesh-ancestor
92835422|NCT00770263|MTOR Inhibitors|mtor inhibitors|mesh-list
92835499|NCT00607958|Ritonavir|ritonavir|mesh-list
93137326|NCT03881943|Aspirin|aspirin|mesh-list
93137327|NCT03881943|Ticagrelor|ticagrelor|mesh-list
93232190|NCT03567434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232191|NCT05708534|Abatacept|abatacept|mesh-list
93232192|NCT05708534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92835947|NCT03913702|Prednisolone|prednisolone|mesh-list
92836173|NCT00772681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836327|NCT02635191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93137328|NCT03881943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836632|NCT00779389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137329|NCT03881943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137330|NCT03881943|Analgesics|analgesics|mesh-ancestor
92836776|NCT02633007|Levodopa|levodopa|mesh-list
92836850|NCT00790075|Risperidone|risperidone|mesh-list
93137331|NCT03881943|Sensory System Agents|sensory system agents|mesh-ancestor
92836998|NCT00662805|Dermatologic Agents|dermatologic agents|mesh-ancestor
93137332|NCT03881943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837071|NCT00663195|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837144|NCT00663741|Sorafenib|sorafenib|mesh-list
93137333|NCT03881943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137334|NCT03881943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137335|NCT03881943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837378|NCT00595413|Adalimumab|adalimumab|mesh-list
93137336|NCT03881943|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93137337|NCT03881943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92837512|NCT00999713|Calfactant|calfactant|mesh-list
93137338|NCT03881943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837589|NCT00792181|Anesthetics|anesthetics|mesh-ancestor
92837654|NCT00787501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137339|NCT03881943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92838189|NCT04151823|Vitamin D|vitamin d|mesh-list
92838345|NCT00629135|Tazobactam|tazobactam|mesh-list
93137340|NCT03881943|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137341|NCT03881943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137342|NCT03881943|Antipyretics|antipyretics|mesh-ancestor
92838853|NCT00685425|Albuterol|albuterol|mesh-list
93137343|NCT03881943|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93137344|NCT03881943|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92839307|NCT00690105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93137345|NCT03881943|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93137346|NCT03881943|Purinergic Agents|purinergic agents|mesh-ancestor
93137347|NCT03881943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839687|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
93137348|NCT03760185|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93137349|NCT03760185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92839828|NCT05485519|Analgesics|analgesics|mesh-ancestor
92839906|NCT05243147|Hemostatics|hemostatics|mesh-ancestor
93137350|NCT03760185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93137351|NCT03760185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93137352|NCT03760185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93137353|NCT03760185|Adrenergic Agents|adrenergic agents|mesh-ancestor
92840504|NCT01971489|Cisplatin|cisplatin|mesh-list
92840568|NCT01147016|Mitosis Modulators|mitosis modulators|mesh-ancestor
93137354|NCT03760185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137355|NCT03760185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137356|NCT03760185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137357|NCT01164969|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92840939|NCT04134897|Capecitabine|capecitabine|mesh-list
92841016|NCT02619669|Letrozole|letrozole|mesh-list
92841088|NCT03853187|Immunologic Factors|immunologic factors|mesh-ancestor
93137358|NCT01164969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137359|NCT04722848|Imatinib Mesylate|imatinib mesylate|mesh-list
93137360|NCT04722848|Blinatumomab|blinatumomab|mesh-list
93137361|NCT04722848|Ponatinib|ponatinib|mesh-list
93137362|NCT04722848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841455|NCT00798343|Vaccines|vaccines|mesh-list
92841534|NCT00804115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137363|NCT04722848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137364|NCT04722848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841767|NCT00657709|Vaccines|vaccines|mesh-list
93137365|NCT04722848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137366|NCT01157013|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93137367|NCT01157013|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92841982|NCT00701493|Topiramate|topiramate|mesh-list
92842139|NCT00654355|Tacrolimus|tacrolimus|mesh-list
92842208|NCT00814723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137368|NCT01157013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842281|NCT00844857|Antiemetics|antiemetics|mesh-ancestor
93137369|NCT01584466|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93137370|NCT01584466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93137371|NCT01584466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92842573|NCT00702975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137372|NCT01584466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137373|NCT01584466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137374|NCT01584466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842793|NCT00911300|Vitamin K|vitamin k|mesh-list
92842883|NCT00644059|Vaccines|vaccines|mesh-list
92842951|NCT00816205|Nifedipine|nifedipine|mesh-list
92843095|NCT05332106|Estradiol|estradiol|mesh-list
93137375|NCT01584466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93137376|NCT01584466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93137377|NCT01584466|Serotonin Agents|serotonin agents|mesh-ancestor
93137378|NCT01584466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843386|NCT00640393|Analgesics|analgesics|mesh-ancestor
92843460|NCT00822133|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93137379|NCT01584466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843608|NCT04381429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93137380|NCT01584466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93137381|NCT01584466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93137382|NCT01584466|Dopamine Agents|dopamine agents|mesh-ancestor
93137383|NCT05363384|Metformin|metformin|mesh-list
93137384|NCT05363384|Alogliptin|alogliptin|mesh-list
93137385|NCT05363384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844450|NCT02845388|Estradiol|estradiol|mesh-list
92844573|NCT02839668|Acetaminophen|acetaminophen|mesh-list
92844726|NCT02839122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137386|NCT05363384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137387|NCT05363384|Incretins|incretins|mesh-ancestor
93137388|NCT05363384|Hormones|hormones|mesh-ancestor
92844949|NCT05878353|Antimalarials|antimalarials|mesh-ancestor
92844968|NCT05878249|Eusol|eusol|mesh-list
92845026|NCT05877807|Baclofen|baclofen|mesh-list
92845247|NCT05597722|Adderall|adderall|mesh-list
93137389|NCT05363384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845322|NCT05462613|Antipyretics|antipyretics|mesh-ancestor
93137390|NCT05363384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93137391|NCT05363384|Protease Inhibitors|protease inhibitors|mesh-ancestor
92845620|NCT04385290|Cytarabine|cytarabine|mesh-list
93137392|NCT05363384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845699|NCT04213794|Antioxidants|antioxidants|mesh-ancestor
93137393|NCT05363384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137394|NCT01165125|Ketoconazole|ketoconazole|mesh-list
93137395|NCT01165125|Antifungal Agents|antifungal agents|mesh-ancestor
93137396|NCT01165125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846065|NCT02115282|Exemestane|exemestane|mesh-list
92846138|NCT01596621|Alkylating Agents|alkylating agents|mesh-ancestor
92846212|NCT00837213|Doxycycline|doxycycline|mesh-list
92846290|NCT00633438|Celecoxib|celecoxib|mesh-list
93137397|NCT01165125|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93137398|NCT01165125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92846660|NCT02832726|Vitamin B 12|vitamin b 12|mesh-list
92846736|NCT02832336|Caffeine|caffeine|mesh-list
92846815|NCT00891930|Irinotecan|irinotecan|mesh-list
93137399|NCT01165125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847030|NCT03223220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92847105|NCT00887484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93137400|NCT01165125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137401|NCT01165125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92847252|NCT04321746|Ketamine|ketamine|mesh-list
93137402|NCT01165125|Hormone Antagonists|hormone antagonists|mesh-ancestor
93137403|NCT01165125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847547|NCT00839683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137404|NCT01165125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137405|NCT01165125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93137406|NCT01163799|Alefacept|alefacept|mesh-list
93137407|NCT01163799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847928|NCT00829179|Omalizumab|omalizumab|mesh-list
92847999|NCT05659212|Lidocaine|lidocaine|mesh-list
93137408|NCT01163799|Immunologic Factors|immunologic factors|mesh-ancestor
92848074|NCT02820948|Vitamins|vitamins|mesh-list
92848142|NCT00620815|Immunologic Factors|immunologic factors|mesh-ancestor
92848290|NCT00619957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92848366|NCT00836485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848436|NCT02545777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848510|NCT00852163|Antimetabolites|antimetabolites|mesh-ancestor
92848585|NCT02812602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137409|NCT01163799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137410|NCT02274662|Cyclosporine|cyclosporine|mesh-list
93137411|NCT02274662|Tacrolimus|tacrolimus|mesh-list
92848805|NCT04041349|Mitogens|mitogens|mesh-list
93137412|NCT02274662|Cyclosporins|cyclosporins|mesh-list
93137413|NCT02274662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93137414|NCT02274662|Thymoglobulin|thymoglobulin|mesh-list
93137415|NCT02274662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137416|NCT02274662|Immunologic Factors|immunologic factors|mesh-ancestor
93137417|NCT02274662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137418|NCT02274662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93137419|NCT02274662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137420|NCT02274662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137421|NCT02274662|Antifungal Agents|antifungal agents|mesh-ancestor
92849730|NCT00863239|Ribavirin|ribavirin|mesh-list
93137422|NCT02274662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849771|NCT00865657|Alprazolam|alprazolam|mesh-list
93137423|NCT02274662|Dermatologic Agents|dermatologic agents|mesh-ancestor
93137424|NCT02274662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137425|NCT02891174|Acetaminophen|acetaminophen|mesh-list
93137426|NCT02891174|Ibuprofen|ibuprofen|mesh-list
92850014|NCT02795754|Ritonavir|ritonavir|mesh-list
93137427|NCT02891174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137428|NCT02891174|Analgesics|analgesics|mesh-ancestor
93137429|NCT02891174|Sensory System Agents|sensory system agents|mesh-ancestor
92850294|NCT02794584|Sufentanil|sufentanil|mesh-list
92850364|NCT04233294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850445|NCT02789202|Fluorides|fluorides|mesh-list
93137430|NCT02891174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850517|NCT02609919|Chelating Agents|chelating agents|mesh-ancestor
93137431|NCT02891174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850598|NCT00876889|Riluzole|riluzole|mesh-list
92850658|NCT00615901|Cyclophosphamide|cyclophosphamide|mesh-list
93137432|NCT02891174|Antipyretics|antipyretics|mesh-ancestor
92850735|NCT00953615|Thalidomide|thalidomide|mesh-list
92850881|NCT00874003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92850957|NCT00874315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137433|NCT02891174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137434|NCT02891174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851259|NCT02785068|Antidotes|antidotes|mesh-ancestor
93137435|NCT02891174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137436|NCT02891174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92851569|NCT00881179|Clarithromycin|clarithromycin|mesh-list
93137437|NCT02891174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137438|NCT02891174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137439|NCT01280175|Charcoal|charcoal|mesh-list
92851867|NCT02543671|Vitamin D|vitamin d|mesh-list
93137440|NCT01280175|Antidotes|antidotes|mesh-ancestor
92852011|NCT00803361|Dopamine Agents|dopamine agents|mesh-ancestor
93137441|NCT01280175|Protective Agents|protective agents|mesh-ancestor
93137442|NCT01280175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852236|NCT02854787|Phenylephrine|phenylephrine|mesh-list
93137443|NCT01588431|Bevacizumab|bevacizumab|mesh-list
93137444|NCT01588431|Cetuximab|cetuximab|mesh-list
93137445|NCT01588431|Cisplatin|cisplatin|mesh-list
93137446|NCT01588431|Docetaxel|docetaxel|mesh-list
92852538|NCT02772354|Verapamil|verapamil|mesh-list
92852676|NCT02542813|Oxytocin|oxytocin|mesh-list
92852756|NCT00609973|Ciprofloxacin|ciprofloxacin|mesh-list
92852825|NCT00888901|Protective Agents|protective agents|mesh-ancestor
93137447|NCT01588431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93137448|NCT01588431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852973|NCT02766192|Ketamine|ketamine|mesh-list
93137449|NCT01588431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93137450|NCT01588431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93137451|NCT01588431|Growth Substances|growth substances|mesh-ancestor
92853417|NCT00891163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93137452|NCT01588431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137453|NCT01588431|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853732|NCT04113915|Hormones|hormones|mesh-ancestor
93137454|NCT01588431|Tubulin Modulators|tubulin modulators|mesh-ancestor
93137455|NCT01588431|Antimitotic Agents|antimitotic agents|mesh-ancestor
93137456|NCT01588431|Mitosis Modulators|mitosis modulators|mesh-ancestor
92853899|NCT00894283|PENTA|penta|mesh-list
92853951|NCT02762838|Folic Acid|folic acid|mesh-list
92854087|NCT01082393|Pimecrolimus|pimecrolimus|mesh-list
92854243|NCT02751918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137457|NCT01588431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854313|NCT02756598|Sufentanil|sufentanil|mesh-list
92854389|NCT00631085|Vitamins|vitamins|mesh-ancestor
93137458|NCT01583283|Dexamethasone|dexamethasone|mesh-list
93137459|NCT01583283|Lenalidomide|lenalidomide|mesh-list
93137460|NCT01583283|Ricolinostat|ricolinostat|mesh-list
92854538|NCT02540785|Dexamethasone|dexamethasone|mesh-list
93137461|NCT01583283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93137462|NCT01583283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137463|NCT01583283|Antiemetics|antiemetics|mesh-ancestor
93137464|NCT01583283|Autonomic Agents|autonomic agents|mesh-ancestor
93137465|NCT01583283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137466|NCT01583283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137467|NCT01583283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93137469|NCT01583283|Hormones|hormones|mesh-ancestor
93137470|NCT01583283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137471|NCT01583283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93137472|NCT01583283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137473|NCT01583283|Immunologic Factors|immunologic factors|mesh-ancestor
93137474|NCT01583283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93137475|NCT01583283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93137476|NCT01583283|Growth Substances|growth substances|mesh-ancestor
93137477|NCT01583283|Growth Inhibitors|growth inhibitors|mesh-ancestor
93137478|NCT01583283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137479|NCT01583283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137480|NCT02076620|Doxorubicin|doxorubicin|mesh-list
93137481|NCT02076620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93137482|NCT02076620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137483|NCT02076620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93137484|NCT02076620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93137485|NCT02076620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137486|NCT02076620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137487|NCT01270737|Daidzein|daidzein|mesh-list
93137488|NCT01270737|Phytoestrogens|phytoestrogens|mesh-ancestor
93137489|NCT01270737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93137490|NCT01270737|Estrogens|estrogens|mesh-ancestor
93137491|NCT01270737|Hormones|hormones|mesh-ancestor
93137492|NCT01270737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137493|NCT01270737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137494|NCT01270815|Pregabalin|pregabalin|mesh-list
93137495|NCT01270815|Analgesics|analgesics|mesh-ancestor
93137496|NCT01270815|Sensory System Agents|sensory system agents|mesh-ancestor
93137497|NCT01270815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137498|NCT01270815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137499|NCT01270815|Anticonvulsants|anticonvulsants|mesh-ancestor
93137500|NCT01270815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93137501|NCT01270815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93137502|NCT01270815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137503|NCT01270815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93137504|NCT01270815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93137505|NCT01270815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93137506|NCT01270815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137507|NCT01270815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93137508|NCT01751984|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93137509|NCT01751984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137510|NCT01751984|Antimetabolites|antimetabolites|mesh-ancestor
93137511|NCT01751984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854692|NCT00939029|Nicotine|nicotine|mesh-list
93137512|NCT01751984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137513|NCT01751984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137514|NCT01751984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93137515|NCT01751984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137516|NCT03330236|Anesthetics|anesthetics|mesh-list
93137517|NCT03330236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137518|NCT03330236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137519|NCT02831764|Tenofovir|tenofovir|mesh-list
93137520|NCT02831764|Lamivudine|lamivudine|mesh-list
93137521|NCT02831764|Emtricitabine|emtricitabine|mesh-list
93137522|NCT02831764|Dolutegravir|dolutegravir|mesh-list
93137523|NCT02831764|Antiviral Agents|antiviral agents|mesh-ancestor
93137524|NCT02831764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137525|NCT02831764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93137526|NCT02831764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93137527|NCT02831764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137528|NCT02831764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137529|NCT02831764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93137530|NCT02831764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93137531|NCT02831764|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93137532|NCT02831764|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93137533|NCT01271361|Sirolimus|sirolimus|mesh-list
93137534|NCT01271361|Umirolimus|umirolimus|mesh-list
93137535|NCT01271361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137536|NCT01271361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137537|NCT01271361|Immunologic Factors|immunologic factors|mesh-ancestor
93137538|NCT01271361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137539|NCT01271361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93137540|NCT01271361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809697|NCT02829333|Anesthetics|anesthetics|mesh-list
93137541|NCT01271361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93137542|NCT01271361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137543|NCT01271361|Antifungal Agents|antifungal agents|mesh-ancestor
93137544|NCT03638726|Atropine|atropine|mesh-list
93137545|NCT03638726|Phenylephrine|phenylephrine|mesh-list
93137546|NCT03638726|Epinephrine|epinephrine|mesh-list
93137547|NCT03638726|Racepinephrine|racepinephrine|mesh-list
93137548|NCT03638726|Oxymetazoline|oxymetazoline|mesh-list
93137549|NCT03638726|Cyclopentolate|cyclopentolate|mesh-list
93137550|NCT03638726|Epinephryl borate|epinephryl borate|mesh-list
93137551|NCT03638726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93137552|NCT03638726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93137553|NCT03638726|Adrenergic Agents|adrenergic agents|mesh-ancestor
93137554|NCT03638726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137555|NCT03638726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137556|NCT03638726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137557|NCT03638726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93137558|NCT03638726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93137559|NCT03638726|Autonomic Agents|autonomic agents|mesh-ancestor
93137560|NCT03638726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137561|NCT03638726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93137562|NCT03638726|Respiratory System Agents|respiratory system agents|mesh-ancestor
93137563|NCT03638726|Mydriatics|mydriatics|mesh-ancestor
93137564|NCT03638726|Sympathomimetics|sympathomimetics|mesh-ancestor
93137565|NCT03638726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93137566|NCT03638726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93137567|NCT03638726|Nasal Decongestants|nasal decongestants|mesh-ancestor
93137568|NCT03638726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93137569|NCT03638726|Protective Agents|protective agents|mesh-ancestor
93137570|NCT03638726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93137571|NCT03638726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93137572|NCT03638726|Parasympatholytics|parasympatholytics|mesh-ancestor
93137573|NCT03638726|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93137574|NCT03638726|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93137575|NCT03638726|Cholinergic Agents|cholinergic agents|mesh-ancestor
93137576|NCT01164189|Bevacizumab|bevacizumab|mesh-list
93137577|NCT01164189|Temozolomide|temozolomide|mesh-list
93137578|NCT01164189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93137579|NCT01164189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137580|NCT01164189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93137581|NCT01164189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93137582|NCT01164189|Growth Substances|growth substances|mesh-ancestor
93137583|NCT01164189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137584|NCT01164189|Growth Inhibitors|growth inhibitors|mesh-ancestor
93137585|NCT01164189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93137586|NCT01164189|Alkylating Agents|alkylating agents|mesh-ancestor
93137587|NCT01164189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137588|NCT01164267|Everolimus|everolimus|mesh-list
93137589|NCT01164267|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93137590|NCT01164267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137591|NCT01164267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137592|NCT01164267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137593|NCT01164267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137594|NCT01164267|Immunologic Factors|immunologic factors|mesh-ancestor
93137595|NCT01164267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137596|NCT01164267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137597|NCT01164345|Plerixafor|plerixafor|mesh-list
93137598|NCT01164345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93137599|NCT01164345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93137600|NCT01164345|Antiviral Agents|antiviral agents|mesh-ancestor
93137601|NCT01164345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137602|NCT02948582|Glycopyrrolate|glycopyrrolate|mesh-list
93137603|NCT02948582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93137604|NCT02948582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93137605|NCT02948582|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93137606|NCT02948582|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93137607|NCT02948582|Cholinergic Agents|cholinergic agents|mesh-ancestor
93137608|NCT02948582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137609|NCT02948582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137610|NCT02948582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137611|NCT02259868|Ritonavir|ritonavir|mesh-list
93137612|NCT02259868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93137613|NCT02259868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93137614|NCT02259868|Protease Inhibitors|protease inhibitors|mesh-ancestor
93137615|NCT02259868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809769|NCT00915733|Antipyretics|antipyretics|mesh-ancestor
93137616|NCT02259868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137617|NCT02259868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93137618|NCT02259868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93137619|NCT02259868|Antiviral Agents|antiviral agents|mesh-ancestor
93137620|NCT02259868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137621|NCT02259868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93137622|NCT02259868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93137623|NCT01167231|Acarbose|acarbose|mesh-list
93137624|NCT01167231|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93137625|NCT01167231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137626|NCT01167231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137627|NCT01167231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93137628|NCT01167231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137629|NCT03871803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93137630|NCT03871803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93137631|NCT03871803|Adrenergic Agents|adrenergic agents|mesh-ancestor
93137632|NCT03871803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137633|NCT03871803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137634|NCT03871803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137635|NCT00135226|Aspirin|aspirin|mesh-list
93137636|NCT00135226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137637|NCT00135226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137638|NCT00135226|Analgesics|analgesics|mesh-ancestor
93137639|NCT00135226|Sensory System Agents|sensory system agents|mesh-ancestor
93137640|NCT00135226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137641|NCT00135226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137642|NCT00135226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137643|NCT00135226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137644|NCT00135226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93137645|NCT00135226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93137646|NCT00135226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137647|NCT00135226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93137648|NCT00135226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137649|NCT00135226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137650|NCT00135226|Antipyretics|antipyretics|mesh-ancestor
93137651|NCT01587261|Ascorbic Acid|ascorbic acid|mesh-list
93137652|NCT01587261|Vitamins|vitamins|mesh-ancestor
93137653|NCT01587261|Micronutrients|micronutrients|mesh-ancestor
93137654|NCT01587261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137655|NCT01587261|Antioxidants|antioxidants|mesh-ancestor
93137656|NCT01587261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137657|NCT01587261|Protective Agents|protective agents|mesh-ancestor
93137658|NCT01269021|Mycophenolic Acid|mycophenolic acid|mesh-list
93137659|NCT01269021|Prednisone|prednisone|mesh-list
93137660|NCT01269021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137661|NCT01269021|Glucocorticoids|glucocorticoids|mesh-ancestor
93137662|NCT01269021|Hormones|hormones|mesh-ancestor
93137663|NCT01269021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137664|NCT01269021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137665|NCT01269021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93137666|NCT01269021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137667|NCT01269021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93137668|NCT01269021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93137669|NCT01269021|Antitubercular Agents|antitubercular agents|mesh-ancestor
93137670|NCT01269021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93137671|NCT01269021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137672|NCT01269021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137673|NCT01269021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137674|NCT01269099|Fentanyl|fentanyl|mesh-list
93137675|NCT01269099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93137676|NCT01269099|Narcotics|narcotics|mesh-ancestor
93137677|NCT01269099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137678|NCT01269099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137679|NCT01269099|Analgesics|analgesics|mesh-ancestor
93137680|NCT01269099|Sensory System Agents|sensory system agents|mesh-ancestor
93137681|NCT01269099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137682|NCT01269099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93137683|NCT01269099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93137684|NCT01269099|Anesthetics, General|anesthetics, general|mesh-ancestor
93137685|NCT01269099|Anesthetics|anesthetics|mesh-ancestor
93137686|NCT01164813|Nabumetone|nabumetone|mesh-list
93137687|NCT01164813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137688|NCT01164813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137689|NCT01164813|Analgesics|analgesics|mesh-ancestor
93137690|NCT01164813|Sensory System Agents|sensory system agents|mesh-ancestor
93137691|NCT01164813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137692|NCT01164813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137693|NCT01164813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137694|NCT01164813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137695|NCT01164813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93137696|NCT01164813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137697|NCT01164813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137698|NCT01164813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137699|NCT01165905|Gemcitabine|gemcitabine|mesh-list
93137701|NCT01165905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93137702|NCT01165905|Antimetabolites|antimetabolites|mesh-ancestor
93137703|NCT01165905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137704|NCT01165905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137705|NCT01165905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137706|NCT01165905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137707|NCT01339000|Vaccines|vaccines|mesh-list
93137708|NCT01339000|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93137709|NCT01339000|Immunologic Factors|immunologic factors|mesh-ancestor
93137710|NCT01339000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137711|NCT01269255|Cisplatin|cisplatin|mesh-list
93137712|NCT01269255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137713|NCT03563170|Leucovorin|leucovorin|mesh-list
93137714|NCT03563170|Paclitaxel|paclitaxel|mesh-list
93137715|NCT03563170|Cyclophosphamide|cyclophosphamide|mesh-list
93137716|NCT03563170|Fluorouracil|fluorouracil|mesh-list
93137717|NCT03563170|Capecitabine|capecitabine|mesh-list
93137718|NCT03563170|Cetuximab|cetuximab|mesh-list
93137719|NCT03563170|Sorafenib|sorafenib|mesh-list
93137720|NCT03563170|Avelumab|avelumab|mesh-list
93137721|NCT03563170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93137722|NCT03563170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137723|NCT03563170|Tubulin Modulators|tubulin modulators|mesh-ancestor
93137724|NCT03563170|Antimitotic Agents|antimitotic agents|mesh-ancestor
93137725|NCT03563170|Mitosis Modulators|mitosis modulators|mesh-ancestor
93137726|NCT03563170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137727|NCT03563170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137728|NCT03563170|Immunologic Factors|immunologic factors|mesh-ancestor
93137729|NCT03563170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137730|NCT03563170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137731|NCT03563170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93137732|NCT03563170|Alkylating Agents|alkylating agents|mesh-ancestor
93137733|NCT03563170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93137734|NCT03563170|Antimetabolites|antimetabolites|mesh-ancestor
93137735|NCT03563170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93137736|NCT03563170|Antidotes|antidotes|mesh-ancestor
93137737|NCT03563170|Protective Agents|protective agents|mesh-ancestor
93137738|NCT03563170|Vitamin B Complex|vitamin b complex|mesh-ancestor
93137739|NCT03563170|Vitamins|vitamins|mesh-ancestor
93137740|NCT03563170|Micronutrients|micronutrients|mesh-ancestor
93137741|NCT03563170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93137742|NCT03563170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137743|NCT03563170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137744|NCT01281111|Aspirin|aspirin|mesh-list
93137745|NCT01281111|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93137746|NCT01281111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137747|NCT01281111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137748|NCT01281111|Analgesics|analgesics|mesh-ancestor
93137749|NCT01281111|Sensory System Agents|sensory system agents|mesh-ancestor
93137750|NCT01281111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137751|NCT01281111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137752|NCT01281111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137753|NCT01281111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137754|NCT01281111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93137755|NCT01281111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93137756|NCT01281111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137757|NCT01281111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93137758|NCT01281111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137759|NCT01281111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137760|NCT01281111|Antipyretics|antipyretics|mesh-ancestor
93137761|NCT01281111|Dermatologic Agents|dermatologic agents|mesh-ancestor
93137762|NCT01281111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137763|NCT01281111|Immunologic Factors|immunologic factors|mesh-ancestor
93137764|NCT03869931|Fenofibrate|fenofibrate|mesh-list
93137765|NCT03869931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137766|NCT03869931|Antimetabolites|antimetabolites|mesh-ancestor
93137767|NCT03869931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137768|NCT03869931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137769|NCT04876066|Ketamine|ketamine|mesh-list
93137770|NCT04876066|Analgesics|analgesics|mesh-ancestor
93137771|NCT04876066|Sensory System Agents|sensory system agents|mesh-ancestor
93137772|NCT04876066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137773|NCT04876066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137774|NCT04876066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93137775|NCT04876066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93137776|NCT04876066|Anesthetics, General|anesthetics, general|mesh-ancestor
93137777|NCT04876066|Anesthetics|anesthetics|mesh-ancestor
93137778|NCT04876066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137779|NCT04876066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93137780|NCT04876066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93137781|NCT04876066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137782|NCT04876066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137783|NCT01169805|Ondansetron|ondansetron|mesh-list
93137784|NCT01169805|Palonosetron|palonosetron|mesh-list
93137785|NCT01169805|Ramosetron|ramosetron|mesh-list
93137786|NCT01169805|Antiemetics|antiemetics|mesh-ancestor
93137787|NCT01169805|Autonomic Agents|autonomic agents|mesh-ancestor
93137788|NCT01169805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137789|NCT01169805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137790|NCT01169805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93137791|NCT01169805|Antipruritics|antipruritics|mesh-ancestor
93137792|NCT01169805|Dermatologic Agents|dermatologic agents|mesh-ancestor
93137793|NCT01169805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93137794|NCT01169805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93137795|NCT01169805|Serotonin Agents|serotonin agents|mesh-ancestor
93137796|NCT01169805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137797|NCT01169805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137798|NCT01283061|Zafirlukast|zafirlukast|mesh-list
93137799|NCT01283061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93137800|NCT01283061|Respiratory System Agents|respiratory system agents|mesh-ancestor
93137801|NCT01283061|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93137802|NCT01283061|Hormone Antagonists|hormone antagonists|mesh-ancestor
93137803|NCT01283061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93137804|NCT01283061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137805|NCT03563014|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93137806|NCT03563014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137807|NCT01167465|Zinc Oxide|zinc oxide|mesh-list
93137808|NCT01167465|Dermatologic Agents|dermatologic agents|mesh-ancestor
93137809|NCT01167465|Sunscreening Agents|sunscreening agents|mesh-ancestor
93137810|NCT01167465|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93137811|NCT01167465|Protective Agents|protective agents|mesh-ancestor
91927321|NCT00744367|Metformin|metformin|mesh-list
93137812|NCT01167465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137813|NCT01283217|Cisplatin|cisplatin|mesh-list
93137814|NCT01283217|Docetaxel|docetaxel|mesh-list
93137815|NCT01283217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137816|NCT01283217|Tubulin Modulators|tubulin modulators|mesh-ancestor
93137817|NCT01283217|Antimitotic Agents|antimitotic agents|mesh-ancestor
93137818|NCT01283217|Mitosis Modulators|mitosis modulators|mesh-ancestor
93137819|NCT01283217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137820|NCT01276431|Buprenorphine|buprenorphine|mesh-list
93137821|NCT01276431|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93137822|NCT01276431|Narcotics|narcotics|mesh-ancestor
93137823|NCT01276431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137824|NCT01276431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137825|NCT01276431|Analgesics|analgesics|mesh-ancestor
93137826|NCT01276431|Sensory System Agents|sensory system agents|mesh-ancestor
93137827|NCT01276431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137828|NCT01276431|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93137829|NCT01281579|Canagliflozin|canagliflozin|mesh-list
93137830|NCT01281579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93137831|NCT01281579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137832|NCT01281579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93137833|NCT01281579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137834|NCT01281657|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93137835|NCT01281657|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93137836|NCT01281657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137837|NCT01281657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137838|NCT01281657|Immunologic Factors|immunologic factors|mesh-ancestor
93137839|NCT01281657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137840|NCT01166451|Iron|iron|mesh-list
93137841|NCT01166451|Trace Elements|trace elements|mesh-ancestor
93137842|NCT01166451|Micronutrients|micronutrients|mesh-ancestor
93137843|NCT01166451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137844|NCT02526615|Metformin|metformin|mesh-list
93137845|NCT02526615|Rosiglitazone|rosiglitazone|mesh-list
93137846|NCT02526615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93137847|NCT02526615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137848|NCT01283763|Imiquimod|imiquimod|mesh-list
93137849|NCT01283763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93137850|NCT01283763|Immunologic Factors|immunologic factors|mesh-ancestor
93137851|NCT01283763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137852|NCT01283763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137853|NCT01283763|Interferon Inducers|interferon inducers|mesh-ancestor
93137854|NCT01283841|Mycophenolic Acid|mycophenolic acid|mesh-list
93137855|NCT01283841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93137856|NCT01283841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137857|NCT01283841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93137858|NCT01283841|Antitubercular Agents|antitubercular agents|mesh-ancestor
93137859|NCT01283841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93137860|NCT01283841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137861|NCT01283841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137862|NCT01283841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137863|NCT03872661|Bevacizumab|bevacizumab|mesh-list
93137864|NCT03872661|Carboplatin|carboplatin|mesh-list
93137865|NCT03872661|Pemetrexed|pemetrexed|mesh-list
93137866|NCT03872661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93137867|NCT03872661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137868|NCT03872661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93137869|NCT03872661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93137870|NCT03872661|Growth Substances|growth substances|mesh-ancestor
93137871|NCT03872661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137872|NCT03872661|Growth Inhibitors|growth inhibitors|mesh-ancestor
93137873|NCT03872661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137874|NCT03872661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137875|NCT03872661|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93137876|NCT03872661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93137877|NCT01167699|Oxycodone|oxycodone|mesh-list
93137878|NCT01167699|Naloxone|naloxone|mesh-list
93137879|NCT01167699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93137880|NCT01167699|Narcotics|narcotics|mesh-ancestor
93137881|NCT01167699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93137882|NCT01167699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137883|NCT01167699|Analgesics|analgesics|mesh-ancestor
93137884|NCT01167699|Sensory System Agents|sensory system agents|mesh-ancestor
93137885|NCT01167699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137886|NCT01167699|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93137887|NCT02526303|Nadroparin|nadroparin|mesh-list
93137888|NCT02526303|Warfarin|warfarin|mesh-list
93137889|NCT02526303|Calcium|calcium|mesh-list
93137890|NCT02526303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93137891|NCT02526303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137892|NCT02526303|Anticoagulants|anticoagulants|mesh-ancestor
93137893|NCT02526303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93137894|NCT02526303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93137895|NCT02526303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137896|NCT03869073|Evolocumab|evolocumab|mesh-list
93137897|NCT03869073|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93137898|NCT03869073|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93137899|NCT03869073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137900|NCT03869073|Antimetabolites|antimetabolites|mesh-ancestor
93137901|NCT03869073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137902|NCT03869073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93137903|NCT03869073|Protease Inhibitors|protease inhibitors|mesh-ancestor
93137904|NCT03869073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137905|NCT03869073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137906|NCT01587495|Ertapenem|ertapenem|mesh-list
93137907|NCT01587495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93137908|NCT01587495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137909|NCT01170351|Cyclosporine|cyclosporine|mesh-list
93137910|NCT01170351|Cyclosporins|cyclosporins|mesh-list
93137911|NCT01170351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137912|NCT01170351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137913|NCT01170351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93137914|NCT01170351|Immunologic Factors|immunologic factors|mesh-ancestor
93137915|NCT01170351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137916|NCT01170351|Antifungal Agents|antifungal agents|mesh-ancestor
93137917|NCT01170351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137918|NCT01170351|Dermatologic Agents|dermatologic agents|mesh-ancestor
93137919|NCT01170351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137920|NCT01170351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93137921|NCT01170429|Procaterol|procaterol|mesh-list
93137922|NCT01170429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93137923|NCT01170429|Autonomic Agents|autonomic agents|mesh-ancestor
93137924|NCT01170429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137925|NCT01170429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137926|NCT01170429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93137927|NCT01170429|Respiratory System Agents|respiratory system agents|mesh-ancestor
93137928|NCT01170429|Sympathomimetics|sympathomimetics|mesh-ancestor
93137929|NCT01170429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93137930|NCT01170429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93137931|NCT01170429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93137932|NCT01170429|Adrenergic Agents|adrenergic agents|mesh-ancestor
93137933|NCT01170429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93137934|NCT01170429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137935|NCT01170507|Vitamin D|vitamin d|mesh-list
93137936|NCT01170507|Ergocalciferols|ergocalciferols|mesh-list
93137937|NCT01170507|Cholecalciferol|cholecalciferol|mesh-list
93137938|NCT01170507|Vitamins|vitamins|mesh-list
93137939|NCT01170507|Micronutrients|micronutrients|mesh-ancestor
93137940|NCT01170507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137941|NCT01170507|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93137942|NCT01170507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93137943|NCT01170585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93137944|NCT01170585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93137945|NCT01170585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137946|NCT01170585|Antimetabolites|antimetabolites|mesh-ancestor
93137947|NCT01170585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137948|NCT01170585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137949|NCT01170585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93137950|NCT01170585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137951|NCT01170819|Dinoprostone|dinoprostone|mesh-list
93137952|NCT01170819|Oxytocics|oxytocics|mesh-ancestor
93137953|NCT01170819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93137954|NCT01170819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137955|NCT03868137|Ibuprofen|ibuprofen|mesh-list
93137956|NCT03868137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93137957|NCT03868137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93137958|NCT03868137|Analgesics|analgesics|mesh-ancestor
93137959|NCT03868137|Sensory System Agents|sensory system agents|mesh-ancestor
93137960|NCT03868137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93137961|NCT03868137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137962|NCT03868137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93137963|NCT03868137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93137964|NCT03868137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93137965|NCT03868137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137966|NCT03868137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137967|NCT01283919|Pantoprazole|pantoprazole|mesh-list
93137968|NCT01283919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93137969|NCT01283919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93137970|NCT01283919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93137971|NCT01283919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137972|NCT01283919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137973|NCT01167933|Simvastatin|simvastatin|mesh-list
93137974|NCT01167933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93137975|NCT01167933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93137976|NCT01167933|Antimetabolites|antimetabolites|mesh-ancestor
93137977|NCT01167933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137978|NCT01167933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93137979|NCT01167933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93137980|NCT01167933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137981|NCT01168011|ON 01910|on 01910|mesh-list
93137982|NCT01168011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137983|NCT01168011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137984|NCT01168011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93137985|NCT01168011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93137986|NCT01171209|Interferons|interferons|mesh-list
93137987|NCT01171209|Interferon-beta|interferon-beta|mesh-list
93137988|NCT01171209|Interferon-alpha|interferon-alpha|mesh-list
93137989|NCT01171209|Interferon beta-1b|interferon beta-1b|mesh-list
93137990|NCT01171209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93137991|NCT01171209|Antiviral Agents|antiviral agents|mesh-ancestor
93137992|NCT01171209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93137993|NCT01171209|Immunologic Factors|immunologic factors|mesh-ancestor
93137994|NCT01171209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93137995|NCT01171209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93137996|NCT01166685|Everolimus|everolimus|mesh-list
93137997|NCT01166685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93137998|NCT01166685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93137999|NCT01166685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138000|NCT01166685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138001|NCT01166685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138002|NCT01166685|Immunologic Factors|immunologic factors|mesh-ancestor
93138003|NCT01166685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138004|NCT01166685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138005|NCT03870711|Lidocaine|lidocaine|mesh-list
93138006|NCT03870711|Anesthetics, Local|anesthetics, local|mesh-ancestor
93138007|NCT03870711|Anesthetics|anesthetics|mesh-ancestor
93138008|NCT03870711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138009|NCT03870711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138010|NCT03870711|Sensory System Agents|sensory system agents|mesh-ancestor
93138011|NCT03870711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138012|NCT03870711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93138013|NCT03870711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93138014|NCT03870711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93138015|NCT03870711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93138016|NCT03870711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138017|NCT03872505|Paclitaxel|paclitaxel|mesh-list
93138018|NCT03872505|Carboplatin|carboplatin|mesh-list
93138019|NCT03872505|Durvalumab|durvalumab|mesh-list
93138020|NCT03872505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93138021|NCT03872505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138022|NCT03872505|Tubulin Modulators|tubulin modulators|mesh-ancestor
93138023|NCT03872505|Antimitotic Agents|antimitotic agents|mesh-ancestor
93138024|NCT03872505|Mitosis Modulators|mitosis modulators|mesh-ancestor
93138025|NCT03872505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138026|NCT03872505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93138027|NCT01171365|Ciclesonide|ciclesonide|mesh-list
93138028|NCT01171365|Glucocorticoids|glucocorticoids|mesh-ancestor
93138029|NCT01171365|Hormones|hormones|mesh-ancestor
93138030|NCT01171365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138031|NCT01171365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138032|NCT01171365|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93138033|NCT01281891|Morphine|morphine|mesh-list
93138034|NCT01281891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93138035|NCT01281891|Narcotics|narcotics|mesh-ancestor
93138036|NCT01281891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927322|NCT00744367|Pioglitazone|pioglitazone|mesh-list
93138037|NCT01281891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138038|NCT01281891|Analgesics|analgesics|mesh-ancestor
93138039|NCT01281891|Sensory System Agents|sensory system agents|mesh-ancestor
93138040|NCT01281891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138041|NCT01282047|Lenalidomide|lenalidomide|mesh-list
93138042|NCT01282047|Immunologic Factors|immunologic factors|mesh-ancestor
93138043|NCT01282047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138044|NCT01282047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93138045|NCT01282047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93138046|NCT01282047|Growth Substances|growth substances|mesh-ancestor
93138047|NCT01282047|Growth Inhibitors|growth inhibitors|mesh-ancestor
93138048|NCT01282047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138049|NCT02525991|Loxapine|loxapine|mesh-list
93138050|NCT02525991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93138051|NCT02525991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93138052|NCT02525991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138053|NCT02525991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138054|NCT02525991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93138055|NCT02525991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93138056|NCT02525991|Dopamine Agents|dopamine agents|mesh-ancestor
93138057|NCT02525991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138058|NCT02525991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138059|NCT01171755|Gemcitabine|gemcitabine|mesh-list
93138060|NCT01171755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93138061|NCT01171755|Antimetabolites|antimetabolites|mesh-ancestor
93138062|NCT01171755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138063|NCT01171755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138064|NCT01172691|Nitric Oxide|nitric oxide|mesh-list
93138065|NCT01172691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93138066|NCT01172691|Autonomic Agents|autonomic agents|mesh-ancestor
93138067|NCT01172691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138068|NCT01172691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138070|NCT01172691|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138071|NCT01172691|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93138072|NCT01172691|Antioxidants|antioxidants|mesh-ancestor
93138073|NCT01172691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138074|NCT01172691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138075|NCT01172691|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93138076|NCT01172691|Vasodilator Agents|vasodilator agents|mesh-ancestor
93138077|NCT01172691|Gasotransmitters|gasotransmitters|mesh-ancestor
93138078|NCT01172691|Protective Agents|protective agents|mesh-ancestor
93138079|NCT01171833|Sevoflurane|sevoflurane|mesh-list
93138080|NCT01171833|Desflurane|desflurane|mesh-list
93138081|NCT01171833|Isoflurane|isoflurane|mesh-list
93138082|NCT01171833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93138083|NCT01171833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93138084|NCT01171833|Anesthetics, General|anesthetics, general|mesh-ancestor
93138085|NCT01171833|Anesthetics|anesthetics|mesh-ancestor
93138086|NCT01171833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138087|NCT01171833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138088|NCT01172769|Sirolimus|sirolimus|mesh-list
93138089|NCT01172769|Temsirolimus|temsirolimus|mesh-list
93138090|NCT01172769|MTOR Inhibitors|mtor inhibitors|mesh-list
93138091|NCT01172769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
93138092|NCT01172769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138093|NCT01172769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138094|NCT01172769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138095|NCT01172769|Immunologic Factors|immunologic factors|mesh-ancestor
93138096|NCT01172769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138097|NCT01172769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138098|NCT01172769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93138099|NCT01172769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138100|NCT01172769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138101|NCT01172769|Antifungal Agents|antifungal agents|mesh-ancestor
93138102|NCT01584531|ON 01910|on 01910|mesh-list
93138103|NCT01584531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138104|NCT01584531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138105|NCT01584531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138106|NCT01584531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138107|NCT01171911|Nicardipine|nicardipine|mesh-list
93138108|NCT01171911|Calcium Channel Blockers|calcium channel blockers|mesh-list
93138109|NCT01171911|Esmolol|esmolol|mesh-list
93138110|NCT01171911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93138111|NCT01171911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138112|NCT01171911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93138113|NCT01171911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93138114|NCT01171911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93138115|NCT01171911|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138116|NCT01171911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138117|NCT01171911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138118|NCT01171911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93138119|NCT01171911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93138120|NCT01171911|Vasodilator Agents|vasodilator agents|mesh-ancestor
93138121|NCT01172925|Tiotropium Bromide|tiotropium bromide|mesh-list
93138122|NCT01172925|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93138123|NCT01172925|Autonomic Agents|autonomic agents|mesh-ancestor
93138124|NCT01172925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138125|NCT01172925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138126|NCT01172925|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93138127|NCT01172925|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138128|NCT01172925|Parasympatholytics|parasympatholytics|mesh-ancestor
93138129|NCT01172925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93138130|NCT01172925|Cholinergic Agents|cholinergic agents|mesh-ancestor
93138131|NCT01172925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138132|NCT01172925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138133|NCT01173003|Misoprostol|misoprostol|mesh-list
93138134|NCT01173003|Mifepristone|mifepristone|mesh-list
93138135|NCT01173003|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93138136|NCT01173003|Abortifacient Agents|abortifacient agents|mesh-ancestor
93138137|NCT01173003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93138138|NCT01173003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138139|NCT01173003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93138140|NCT01173003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93138141|NCT01173003|Oxytocics|oxytocics|mesh-ancestor
93138142|NCT01173003|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93138143|NCT01173003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93138144|NCT01173003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93138145|NCT01173003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93138146|NCT01173003|Contraceptive Agents|contraceptive agents|mesh-ancestor
93138147|NCT01173003|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93138148|NCT01173003|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93138149|NCT01173003|Hormone Antagonists|hormone antagonists|mesh-ancestor
93138150|NCT01173003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138151|NCT01173003|Luteolytic Agents|luteolytic agents|mesh-ancestor
93138152|NCT01173003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93138153|NCT01173003|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93138154|NCT03435003|Dexamethasone|dexamethasone|mesh-list
93138155|NCT03435003|Fentanyl|fentanyl|mesh-list
93138156|NCT03435003|Scopolamine|scopolamine|mesh-list
93138157|NCT03435003|Dexmedetomidine|dexmedetomidine|mesh-list
93138158|NCT03435003|Ondansetron|ondansetron|mesh-list
93138159|NCT03435003|Aprepitant|aprepitant|mesh-list
93138160|NCT03435003|Metoclopramide|metoclopramide|mesh-list
93138161|NCT03435003|Prochlorperazine|prochlorperazine|mesh-list
93138162|NCT03435003|Propofol|propofol|mesh-list
93138163|NCT03435003|Sevoflurane|sevoflurane|mesh-list
93138164|NCT03435003|Desflurane|desflurane|mesh-list
93138165|NCT03435003|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93138166|NCT03435003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138167|NCT03435003|Antiemetics|antiemetics|mesh-ancestor
93138168|NCT03435003|Autonomic Agents|autonomic agents|mesh-ancestor
93138169|NCT03435003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138170|NCT03435003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138171|NCT03435003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93138172|NCT03435003|Glucocorticoids|glucocorticoids|mesh-ancestor
93138173|NCT03435003|Hormones|hormones|mesh-ancestor
93138174|NCT03435003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138175|NCT03435003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93138176|NCT03435003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138177|NCT03435003|Anesthetics|anesthetics|mesh-ancestor
93138178|NCT03435003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138179|NCT03435003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93138180|NCT03435003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93138181|NCT03435003|Analgesics|analgesics|mesh-ancestor
93138182|NCT03435003|Sensory System Agents|sensory system agents|mesh-ancestor
93138183|NCT03435003|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93138184|NCT03435003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93138185|NCT03435003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93138186|NCT03435003|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138187|NCT03435003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138188|NCT03435003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138189|NCT03435003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93138190|NCT03435003|Anesthetics, General|anesthetics, general|mesh-ancestor
93138191|NCT03435003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93138192|NCT03435003|Narcotics|narcotics|mesh-ancestor
93138193|NCT03435003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93138194|NCT03435003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93138195|NCT03435003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93138196|NCT03435003|Antipruritics|antipruritics|mesh-ancestor
93138197|NCT03435003|Dermatologic Agents|dermatologic agents|mesh-ancestor
93138198|NCT03435003|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93138199|NCT03435003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93138200|NCT03435003|Serotonin Agents|serotonin agents|mesh-ancestor
93138201|NCT03435003|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93138202|NCT03435003|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93138203|NCT03435003|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93138204|NCT03435003|Dopamine Agents|dopamine agents|mesh-ancestor
93138205|NCT03435003|Mydriatics|mydriatics|mesh-ancestor
93138206|NCT03435003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93138207|NCT03435003|Cholinergic Agents|cholinergic agents|mesh-ancestor
93138208|NCT03435003|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93138209|NCT03435003|Parasympatholytics|parasympatholytics|mesh-ancestor
93138210|NCT03435003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93138211|NCT03435003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93138212|NCT03435003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93138213|NCT01172223|Paclitaxel|paclitaxel|mesh-list
92810380|NCT00832000|Mexiletine|mexiletine|mesh-list
93138214|NCT01172223|Doxorubicin|doxorubicin|mesh-list
93138215|NCT01172223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93138216|NCT01172223|Lapatinib|lapatinib|mesh-list
93138217|NCT01172223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93138218|NCT01172223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138219|NCT01172223|Tubulin Modulators|tubulin modulators|mesh-ancestor
93138220|NCT01172223|Antimitotic Agents|antimitotic agents|mesh-ancestor
93138221|NCT01172223|Mitosis Modulators|mitosis modulators|mesh-ancestor
93138222|NCT01172223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138223|NCT01172223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138224|NCT01172223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93138225|NCT01172223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93138226|NCT01172223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138227|NCT01172223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138228|NCT01173081|Teriparatide|teriparatide|mesh-list
93138229|NCT01173081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93138230|NCT01173081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138231|NCT01173081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93138232|NCT03866733|Narcotics|narcotics|mesh-list
93138233|NCT03866733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138234|NCT03866733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138235|NCT03866733|Analgesics|analgesics|mesh-ancestor
93138236|NCT03866733|Sensory System Agents|sensory system agents|mesh-ancestor
93138237|NCT03866733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138238|NCT01168791|Doxorubicin|doxorubicin|mesh-list
93138239|NCT01168791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93138240|NCT01168791|Isophosphamide mustard|isophosphamide mustard|mesh-list
93138241|NCT01168791|Ifosfamide|ifosfamide|mesh-list
93138242|NCT01168791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138243|NCT01168791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138244|NCT01168791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93138245|NCT01168791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93138246|NCT01168791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138247|NCT01168791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138248|NCT01168791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93138249|NCT01168791|Alkylating Agents|alkylating agents|mesh-ancestor
93138250|NCT01284309|Mirabegron|mirabegron|mesh-list
93138251|NCT01284309|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93138252|NCT01284309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93138253|NCT01284309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93138254|NCT01284309|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138255|NCT01284309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138256|NCT01284309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138257|NCT01284309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138258|NCT01284309|Urological Agents|urological agents|mesh-ancestor
93138259|NCT01173237|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93138260|NCT01173237|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138261|NCT01169025|Fentanyl|fentanyl|mesh-list
93138262|NCT01169025|Ketamine|ketamine|mesh-list
93138263|NCT01169025|Analgesics|analgesics|mesh-ancestor
93138264|NCT01169025|Sensory System Agents|sensory system agents|mesh-ancestor
93138265|NCT01169025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138266|NCT01169025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138267|NCT01169025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93138268|NCT01169025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93138269|NCT01169025|Anesthetics, General|anesthetics, general|mesh-ancestor
93138270|NCT01169025|Anesthetics|anesthetics|mesh-ancestor
93138271|NCT01169025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138272|NCT01169025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93138273|NCT01169025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93138274|NCT01169025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138275|NCT01169025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138276|NCT01169025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93138277|NCT01169025|Narcotics|narcotics|mesh-ancestor
93138278|NCT01169025|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93138279|NCT01582347|Buprenorphine|buprenorphine|mesh-list
93138280|NCT01582347|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93138281|NCT01582347|Naloxone|naloxone|mesh-list
93138282|NCT01582347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93138283|NCT01582347|Narcotics|narcotics|mesh-ancestor
93138284|NCT01582347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138285|NCT01582347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138286|NCT01582347|Analgesics|analgesics|mesh-ancestor
93138287|NCT01582347|Sensory System Agents|sensory system agents|mesh-ancestor
93138288|NCT01582347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138289|NCT01582347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93138290|NCT01336634|Trametinib|trametinib|mesh-list
93138291|NCT01336634|Dabrafenib|dabrafenib|mesh-list
93138292|NCT01336634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138293|NCT01336634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138294|NCT01336634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138295|NCT01336634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138297|NCT01284855|Immunologic Factors|immunologic factors|mesh-ancestor
93138298|NCT01284855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138299|NCT00785798|Doxorubicin|doxorubicin|mesh-list
93138300|NCT00785798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93138301|NCT00785798|Vorinostat|vorinostat|mesh-list
93138302|NCT00785798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138303|NCT00785798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138304|NCT00785798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93138305|NCT00785798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93138306|NCT00785798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138307|NCT00785798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138308|NCT00785798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93138309|NCT01175109|Imatinib Mesylate|imatinib mesylate|mesh-list
93138310|NCT01175109|Panobinostat|panobinostat|mesh-list
93138311|NCT01175109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138312|NCT01175109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138313|NCT01175109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138314|NCT01175109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138315|NCT01175109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93138316|NCT01282515|Clobetasol|clobetasol|mesh-list
93138317|NCT01282515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138318|NCT01282515|Glucocorticoids|glucocorticoids|mesh-ancestor
93138319|NCT01282515|Hormones|hormones|mesh-ancestor
93138320|NCT01282515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138321|NCT01282515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138322|NCT04732910|Ivacaftor|ivacaftor|mesh-list
93138323|NCT04732910|Elexacaftor|elexacaftor|mesh-list
93138324|NCT04732910|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93138325|NCT04732910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93138326|NCT04732910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138327|NCT03329846|Nivolumab|nivolumab|mesh-list
93138328|NCT03329846|Linrodostat|linrodostat|mesh-list
93138329|NCT03329846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93138330|NCT03329846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138331|NCT03329846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93138332|NCT03329846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138333|NCT03329846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138334|NCT04020848|Melatonin|melatonin|mesh-list
93138335|NCT04020848|Antioxidants|antioxidants|mesh-ancestor
93138336|NCT04020848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138337|NCT04020848|Protective Agents|protective agents|mesh-ancestor
93138338|NCT04020848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138339|NCT04020848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138340|NCT01338610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93138341|NCT01338610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93138342|NCT01355302|Capecitabine|capecitabine|mesh-list
93138343|NCT01355302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138344|NCT01355302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93138345|NCT01355302|Antimetabolites|antimetabolites|mesh-ancestor
93138346|NCT01355302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138347|NCT01355068|Phenytoin|phenytoin|mesh-list
93138348|NCT01355068|Anticonvulsants|anticonvulsants|mesh-ancestor
93138349|NCT01355068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93138350|NCT01355068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93138351|NCT01355068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93138352|NCT01355068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138353|NCT01355068|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93138354|NCT01355068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93138355|NCT03562780|Acetaminophen|acetaminophen|mesh-list
93138356|NCT03562780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93138357|NCT03562780|Analgesics|analgesics|mesh-ancestor
93138358|NCT03562780|Sensory System Agents|sensory system agents|mesh-ancestor
93138359|NCT03562780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138360|NCT03562780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138361|NCT03562780|Antipyretics|antipyretics|mesh-ancestor
93138362|NCT02259946|Bromides|bromides|mesh-list
93138363|NCT02259946|Tiotropium Bromide|tiotropium bromide|mesh-list
93138364|NCT02259946|Olodaterol|olodaterol|mesh-list
93138365|NCT02259946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93138366|NCT02259946|Autonomic Agents|autonomic agents|mesh-ancestor
93138367|NCT02259946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138368|NCT02259946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138369|NCT02259946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93138370|NCT02259946|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138371|NCT02259946|Parasympatholytics|parasympatholytics|mesh-ancestor
93138372|NCT02259946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93138373|NCT02259946|Cholinergic Agents|cholinergic agents|mesh-ancestor
93138374|NCT02259946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138375|NCT02259946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138376|NCT02259946|Anticonvulsants|anticonvulsants|mesh-ancestor
93138377|NCT03756129|Ketamine|ketamine|mesh-list
93138378|NCT03756129|Analgesics|analgesics|mesh-ancestor
93138379|NCT03756129|Sensory System Agents|sensory system agents|mesh-ancestor
93138380|NCT03756129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138381|NCT03756129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138382|NCT03756129|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93138383|NCT03756129|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93138384|NCT03756129|Anesthetics, General|anesthetics, general|mesh-ancestor
93138385|NCT03756129|Anesthetics|anesthetics|mesh-ancestor
93138386|NCT03756129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138387|NCT03756129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93138388|NCT03756129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93138389|NCT03756129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138390|NCT03756129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138391|NCT03863691|Amisulpride|amisulpride|mesh-list
93138392|NCT03863691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93138393|NCT03863691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93138394|NCT03863691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138395|NCT03863691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138396|NCT03863691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93138397|NCT03863691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93138398|NCT03863691|Dopamine Agents|dopamine agents|mesh-ancestor
93138399|NCT03863691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138400|NCT03863691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138401|NCT03863691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93138402|NCT03863691|Antidepressive Agents|antidepressive agents|mesh-ancestor
93138403|NCT02822794|Ribavirin|ribavirin|mesh-list
93138404|NCT02822794|Sofosbuvir|sofosbuvir|mesh-list
93138405|NCT02822794|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93138406|NCT02822794|Velpatasvir|velpatasvir|mesh-list
93138407|NCT02822794|Antimetabolites|antimetabolites|mesh-ancestor
93138408|NCT02822794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138409|NCT02822794|Antiviral Agents|antiviral agents|mesh-ancestor
93138410|NCT02822794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138411|NCT01173315|Vitamins|vitamins|mesh-list
93138412|NCT01173315|Micronutrients|micronutrients|mesh-ancestor
93138413|NCT01173315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138414|NCT01173549|Canagliflozin|canagliflozin|mesh-list
93138415|NCT01173549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93138416|NCT01173549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138417|NCT01173549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93138418|NCT01173549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138419|NCT01338298|Aripiprazole|aripiprazole|mesh-list
93138420|NCT01338298|Antidepressive Agents|antidepressive agents|mesh-ancestor
93138421|NCT01338298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93138422|NCT01338298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93138423|NCT01338298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93138424|NCT01338298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138425|NCT01338298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138426|NCT01338298|Dopamine Agonists|dopamine agonists|mesh-ancestor
93138427|NCT01338298|Dopamine Agents|dopamine agents|mesh-ancestor
93138428|NCT01338298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138429|NCT01338298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138430|NCT01338298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93138431|NCT01338298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93138432|NCT01338298|Serotonin Agents|serotonin agents|mesh-ancestor
93138433|NCT01338298|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93138434|NCT01338298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93138435|NCT01338298|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93138436|NCT01338298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93138437|NCT01169415|Dexamethasone|dexamethasone|mesh-list
93138438|NCT01169415|Dexamethasone acetate|dexamethasone acetate|mesh-list
93138439|NCT01169415|BB 1101|bb 1101|mesh-list
93138440|NCT01169415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138441|NCT01169415|Antiemetics|antiemetics|mesh-ancestor
93138442|NCT01169415|Autonomic Agents|autonomic agents|mesh-ancestor
93138443|NCT01169415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138444|NCT01169415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138445|NCT01169415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93138446|NCT01169415|Glucocorticoids|glucocorticoids|mesh-ancestor
93138447|NCT01169415|Hormones|hormones|mesh-ancestor
93138448|NCT01169415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138449|NCT01169415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93138450|NCT01169415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138451|NCT01169415|Protease Inhibitors|protease inhibitors|mesh-ancestor
93138452|NCT01169415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138453|NCT01169415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138454|NCT01173627|Fentanyl|fentanyl|mesh-list
93138455|NCT01173627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93138456|NCT01173627|Narcotics|narcotics|mesh-ancestor
93138457|NCT01173627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138458|NCT01173627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138459|NCT01173627|Analgesics|analgesics|mesh-ancestor
93138460|NCT01173627|Sensory System Agents|sensory system agents|mesh-ancestor
93138461|NCT01173627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138462|NCT01173627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93138463|NCT01173627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93138464|NCT01173627|Anesthetics, General|anesthetics, general|mesh-ancestor
93138465|NCT01173627|Anesthetics|anesthetics|mesh-ancestor
93138466|NCT01169571|Dexmedetomidine|dexmedetomidine|mesh-list
93138467|NCT01169571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93138468|NCT01169571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138469|NCT01169571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138470|NCT01169571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93138471|NCT01169571|Analgesics|analgesics|mesh-ancestor
93138472|NCT01169571|Sensory System Agents|sensory system agents|mesh-ancestor
93138473|NCT01169571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138474|NCT01169571|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93138475|NCT01169571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93138476|NCT01169571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93138477|NCT01169571|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138478|NCT01169571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138479|NCT01169571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138480|NCT01354132|Acetylcysteine|acetylcysteine|mesh-list
93138481|NCT01354132|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93138482|NCT01354132|Antiviral Agents|antiviral agents|mesh-ancestor
93138483|NCT01354132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138484|NCT01354132|Expectorants|expectorants|mesh-ancestor
93138485|NCT01354132|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138486|NCT01354132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93138487|NCT01354132|Antioxidants|antioxidants|mesh-ancestor
93138488|NCT01354132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138489|NCT01354132|Protective Agents|protective agents|mesh-ancestor
93138490|NCT01354132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138491|NCT01354132|Antidotes|antidotes|mesh-ancestor
93138492|NCT05707936|Heparin|heparin|mesh-list
93138493|NCT05707936|Anticoagulants|anticoagulants|mesh-ancestor
93138494|NCT05707936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93138495|NCT05707936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93138496|NCT05707936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138497|NCT03863613|Progesterone|progesterone|mesh-list
93138498|NCT03863613|Progestins|progestins|mesh-ancestor
93138499|NCT03863613|Hormones|hormones|mesh-ancestor
93138500|NCT03863613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138501|NCT03863613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138502|NCT01372150|Fluoxetine|fluoxetine|mesh-list
93138503|NCT01372150|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93138504|NCT01372150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93138505|NCT01372150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93138506|NCT01372150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93138507|NCT01372150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138508|NCT01372150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138509|NCT01372150|Serotonin Agents|serotonin agents|mesh-ancestor
93138510|NCT01372150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138511|NCT01372150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93138512|NCT01372150|Antidepressive Agents|antidepressive agents|mesh-ancestor
93138513|NCT01372150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93138514|NCT01372150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92810684|NCT02818803|Propolis|propolis|mesh-list
93138515|NCT01372150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93138516|NCT01372150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138517|NCT01372150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93138518|NCT01285245|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93138519|NCT01285245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93138520|NCT01175577|Carotenoids|carotenoids|mesh-list
93138521|NCT01175577|Antioxidants|antioxidants|mesh-ancestor
93138522|NCT01175577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138523|NCT01175577|Protective Agents|protective agents|mesh-ancestor
93138524|NCT01175577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138525|NCT01175733|Panitumumab|panitumumab|mesh-list
93138526|NCT01175733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93138527|NCT01175733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138528|NCT02035930|Dexmedetomidine|dexmedetomidine|mesh-list
93138529|NCT02035930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93138530|NCT02035930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138531|NCT02035930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138532|NCT02035930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93138533|NCT02035930|Analgesics|analgesics|mesh-ancestor
93138534|NCT02035930|Sensory System Agents|sensory system agents|mesh-ancestor
93138535|NCT02035930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138536|NCT02035930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93138537|NCT02035930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93138538|NCT02035930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93138539|NCT02035930|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138540|NCT02035930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138541|NCT02035930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138542|NCT01173939|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93138543|NCT01173939|Pravastatin|pravastatin|mesh-list
93138544|NCT01173939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93138545|NCT01173939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93138546|NCT01173939|Antimetabolites|antimetabolites|mesh-ancestor
93138547|NCT01173939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138548|NCT01173939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93138549|NCT01173939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93138550|NCT01173939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138551|NCT01174017|Iodine|iodine|mesh-list
93138552|NCT01174017|Cadexomer iodine|cadexomer iodine|mesh-list
93138553|NCT01174017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93138554|NCT01174017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138555|NCT01174017|Trace Elements|trace elements|mesh-ancestor
93138556|NCT01174017|Micronutrients|micronutrients|mesh-ancestor
93138557|NCT01174017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138558|NCT01288131|Cyclosporine|cyclosporine|mesh-list
93138559|NCT01288131|Mycophenolic Acid|mycophenolic acid|mesh-list
93138560|NCT01288131|Cyclophosphamide|cyclophosphamide|mesh-list
93138561|NCT01288131|Cyclosporins|cyclosporins|mesh-list
93138562|NCT01288131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138563|NCT01288131|Immunologic Factors|immunologic factors|mesh-ancestor
93138564|NCT01288131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138565|NCT01288131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93138566|NCT01288131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93138567|NCT01288131|Alkylating Agents|alkylating agents|mesh-ancestor
93138568|NCT01288131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138569|NCT01288131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138570|NCT01288131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93138571|NCT01288131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138572|NCT01288131|Antifungal Agents|antifungal agents|mesh-ancestor
93138573|NCT01288131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138574|NCT01288131|Dermatologic Agents|dermatologic agents|mesh-ancestor
93138575|NCT01288131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93138576|NCT01288131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138577|NCT01288131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93138578|NCT01288131|Antitubercular Agents|antitubercular agents|mesh-ancestor
93138579|NCT01288131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93138580|NCT02525211|Ropivacaine|ropivacaine|mesh-list
93138581|NCT02525211|Anesthetics, Local|anesthetics, local|mesh-ancestor
93138582|NCT02525211|Anesthetics|anesthetics|mesh-ancestor
93138583|NCT02525211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138584|NCT02525211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138585|NCT02525211|Sensory System Agents|sensory system agents|mesh-ancestor
93138586|NCT02525211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138587|NCT03865563|Gemcitabine|gemcitabine|mesh-list
93138588|NCT03865563|Ethiodized Oil|ethiodized oil|mesh-list
92810763|NCT00766363|Donepezil|donepezil|mesh-list
93138589|NCT03865563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93138591|NCT03865563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138592|NCT03865563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138593|NCT01178151|Everolimus|everolimus|mesh-list
93138594|NCT01178151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93138595|NCT01178151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138596|NCT01178151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138597|NCT01178151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138598|NCT01178151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138599|NCT01178151|Immunologic Factors|immunologic factors|mesh-ancestor
93138600|NCT01178151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138601|NCT01178151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138602|NCT03862287|Lidocaine|lidocaine|mesh-list
93138603|NCT03862287|Bupivacaine|bupivacaine|mesh-list
93138604|NCT03862287|Anesthetics, Local|anesthetics, local|mesh-ancestor
93138605|NCT03862287|Anesthetics|anesthetics|mesh-ancestor
93138606|NCT03862287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138607|NCT03862287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138608|NCT03862287|Sensory System Agents|sensory system agents|mesh-ancestor
93138609|NCT03862287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138610|NCT03862287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93138611|NCT03862287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93138612|NCT03862287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93138613|NCT03862287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93138614|NCT03862287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138615|NCT03862053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93138616|NCT03862053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93138617|NCT03749109|Quinagolide|quinagolide|mesh-list
93138618|NCT03749109|Dopamine Agonists|dopamine agonists|mesh-ancestor
93138619|NCT03749109|Dopamine Agents|dopamine agents|mesh-ancestor
93138620|NCT03749109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138621|NCT03749109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138622|NCT03749109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138623|NCT01287351|Fluticasone|fluticasone|mesh-list
93138624|NCT01287351|Xhance|xhance|mesh-list
93138625|NCT01287351|Beclomethasone|beclomethasone|mesh-list
93138626|NCT01287351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138627|NCT01287351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93138628|NCT01287351|Autonomic Agents|autonomic agents|mesh-ancestor
93138629|NCT01287351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138630|NCT01287351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138631|NCT01287351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93138632|NCT01287351|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138633|NCT01287351|Dermatologic Agents|dermatologic agents|mesh-ancestor
93138634|NCT01287351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93138635|NCT01287351|Glucocorticoids|glucocorticoids|mesh-ancestor
93138636|NCT01287351|Hormones|hormones|mesh-ancestor
93138637|NCT01287351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138638|NCT03864783|Curcumin|curcumin|mesh-list
93138639|NCT03864783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93138640|NCT03864783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93138641|NCT03864783|Analgesics|analgesics|mesh-ancestor
93138642|NCT03864783|Sensory System Agents|sensory system agents|mesh-ancestor
93138643|NCT03864783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138644|NCT03864783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138645|NCT03864783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138646|NCT03864783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93138647|NCT03864783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138648|NCT03864783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138649|NCT03864783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138650|NCT01287507|Lactoferrin|lactoferrin|mesh-list
93138651|NCT01287507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138652|NCT03864705|Metformin|metformin|mesh-list
93138653|NCT03864705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93138654|NCT03864705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138655|NCT01287663|Permethrin|permethrin|mesh-list
93138656|NCT01287663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138657|NCT01287663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138658|NCT01176669|Apatinib|apatinib|mesh-list
93138659|NCT01176669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138660|NCT01176669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138661|NCT01176669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138662|NCT01176669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138664|NCT01176747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93138665|NCT01176747|Autonomic Agents|autonomic agents|mesh-ancestor
93138666|NCT01176747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138667|NCT01176747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138668|NCT01176747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93138669|NCT01176747|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138670|NCT01176747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93138671|NCT01176747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93138672|NCT01176747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93138673|NCT01176747|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138674|NCT01176747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138675|NCT01176747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138676|NCT01174953|Finasteride|finasteride|mesh-list
93138677|NCT01174953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93138678|NCT01174953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93138679|NCT01174953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138680|NCT01174953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138681|NCT01174953|Hormone Antagonists|hormone antagonists|mesh-ancestor
93138682|NCT01174953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138683|NCT01174953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138684|NCT01174953|Urological Agents|urological agents|mesh-ancestor
93138685|NCT01286103|Canagliflozin|canagliflozin|mesh-list
93138686|NCT01286103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93138687|NCT01286103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138688|NCT01286103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93138689|NCT01286103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138690|NCT01176903|Glycopyrrolate|glycopyrrolate|mesh-list
93138691|NCT01176903|Tiotropium Bromide|tiotropium bromide|mesh-list
93138692|NCT01176903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93138693|NCT01176903|Autonomic Agents|autonomic agents|mesh-ancestor
93138694|NCT01176903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138695|NCT01176903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138696|NCT01176903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93138697|NCT01176903|Respiratory System Agents|respiratory system agents|mesh-ancestor
93138698|NCT01176903|Parasympatholytics|parasympatholytics|mesh-ancestor
93138699|NCT01176903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93138700|NCT01176903|Cholinergic Agents|cholinergic agents|mesh-ancestor
93138701|NCT01176903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138702|NCT01176903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138703|NCT01176903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93138704|NCT01176903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93138705|NCT03863925|Propofol|propofol|mesh-list
93138706|NCT03863925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93138707|NCT03863925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138708|NCT03863925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138709|NCT03863925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93138710|NCT03863925|Anesthetics, General|anesthetics, general|mesh-ancestor
93138711|NCT03863925|Anesthetics|anesthetics|mesh-ancestor
93138712|NCT01178697|Triamcinolone|triamcinolone|mesh-list
93138713|NCT01178697|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93138714|NCT01178697|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93138715|NCT01178697|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93138716|NCT01178697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138717|NCT01178697|Glucocorticoids|glucocorticoids|mesh-ancestor
93138718|NCT01178697|Hormones|hormones|mesh-ancestor
93138719|NCT01178697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138720|NCT01178697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138721|NCT01178697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138722|NCT01178697|Immunologic Factors|immunologic factors|mesh-ancestor
93138723|NCT01178697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138724|NCT01178697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138725|NCT03329690|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93138726|NCT03329690|Immunoconjugates|immunoconjugates|mesh-ancestor
93138727|NCT03329690|Immunologic Factors|immunologic factors|mesh-ancestor
93138728|NCT03329690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138729|NCT03328832|Tranylcypromine|tranylcypromine|mesh-list
93138730|NCT03328832|Rivaroxaban|rivaroxaban|mesh-list
93138731|NCT03328832|Tranexamic Acid|tranexamic acid|mesh-list
93138732|NCT03328832|Thrombin|thrombin|mesh-list
93138733|NCT03328832|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93138734|NCT03328832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92810890|NCT02817477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138735|NCT03328832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138736|NCT03328832|Hemostatics|hemostatics|mesh-ancestor
93138737|NCT03328832|Coagulants|coagulants|mesh-ancestor
93138738|NCT03328832|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93138739|NCT03328832|Antithrombins|antithrombins|mesh-ancestor
93138740|NCT03328832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93138741|NCT03328832|Protease Inhibitors|protease inhibitors|mesh-ancestor
93138742|NCT03328832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138743|NCT03328832|Anticoagulants|anticoagulants|mesh-ancestor
93138744|NCT03328832|Antidepressive Agents|antidepressive agents|mesh-ancestor
93138745|NCT03328832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93138746|NCT03328832|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93138747|NCT03328832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93138748|NCT03328832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93138749|NCT03328832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138750|NCT03328832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138751|NCT02820844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93138752|NCT02820844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138753|NCT02942576|Warfarin|warfarin|mesh-list
93138754|NCT02942576|Edoxaban|edoxaban|mesh-list
93138755|NCT02942576|Acenocoumarol|acenocoumarol|mesh-list
93138756|NCT02942576|Phenprocoumon|phenprocoumon|mesh-list
93138757|NCT02942576|Fluindione|fluindione|mesh-list
93138758|NCT02942576|Anticoagulants|anticoagulants|mesh-ancestor
93138759|NCT02942576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93138760|NCT02942576|Antithrombins|antithrombins|mesh-ancestor
93138761|NCT02942576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93138762|NCT02942576|Protease Inhibitors|protease inhibitors|mesh-ancestor
93138763|NCT02942576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138764|NCT02942576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138765|NCT02820298|Bexagliflozin|bexagliflozin|mesh-list
93138766|NCT02820298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93138767|NCT02820298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138768|NCT02036008|Liver Extracts|liver extracts|mesh-list
93138769|NCT02036008|Hematinics|hematinics|mesh-ancestor
93138770|NCT02819440|Tadalafil|tadalafil|mesh-list
93138771|NCT02819440|Vasodilator Agents|vasodilator agents|mesh-ancestor
93138772|NCT02819440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93138773|NCT02819440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93138774|NCT02819440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138775|NCT02819440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138776|NCT02819440|Urological Agents|urological agents|mesh-ancestor
93138777|NCT03562468|Niacinamide|niacinamide|mesh-list
93138778|NCT03562468|Niacin|niacin|mesh-list
93138779|NCT03562468|Nicotinic Acids|nicotinic acids|mesh-list
93138780|NCT03562468|Vitamin B Complex|vitamin b complex|mesh-ancestor
93138781|NCT03562468|Vitamins|vitamins|mesh-ancestor
93138782|NCT03562468|Micronutrients|micronutrients|mesh-ancestor
93138783|NCT03562468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138784|NCT03562468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93138785|NCT03562468|Antimetabolites|antimetabolites|mesh-ancestor
93138786|NCT03562468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138787|NCT03562468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93138788|NCT03562468|Vasodilator Agents|vasodilator agents|mesh-ancestor
93138789|NCT02036164|Paclitaxel|paclitaxel|mesh-list
93138790|NCT02036164|Cisplatin|cisplatin|mesh-list
93138791|NCT02036164|Carboplatin|carboplatin|mesh-list
93138792|NCT02036164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93138793|NCT02036164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138794|NCT02036164|Tubulin Modulators|tubulin modulators|mesh-ancestor
93138795|NCT02036164|Antimitotic Agents|antimitotic agents|mesh-ancestor
93138796|NCT02036164|Mitosis Modulators|mitosis modulators|mesh-ancestor
93138797|NCT02036164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138798|NCT02818036|Naltrexone|naltrexone|mesh-list
93138799|NCT02818036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93138800|NCT02818036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93138801|NCT02818036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138802|NCT02818036|Sensory System Agents|sensory system agents|mesh-ancestor
93138803|NCT02818036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138804|NCT01287741|Prednisone|prednisone|mesh-list
93138805|NCT01287741|Cyclophosphamide|cyclophosphamide|mesh-list
93138806|NCT01287741|Rituximab|rituximab|mesh-list
93138807|NCT01287741|Doxorubicin|doxorubicin|mesh-list
93138808|NCT01287741|Vincristine|vincristine|mesh-list
93138809|NCT01287741|Obinutuzumab|obinutuzumab|mesh-list
93138810|NCT01287741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138811|NCT01287741|Immunologic Factors|immunologic factors|mesh-ancestor
93138812|NCT01287741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138813|NCT01287741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93138814|NCT01287741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93138815|NCT01287741|Alkylating Agents|alkylating agents|mesh-ancestor
93138816|NCT01287741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138817|NCT01287741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138818|NCT01287741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93138819|NCT01287741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93138820|NCT01287741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138821|NCT01287741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93138822|NCT01287741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93138823|NCT01287741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138824|NCT01287741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138825|NCT01287741|Glucocorticoids|glucocorticoids|mesh-ancestor
93138827|NCT01287741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138828|NCT01287741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93138829|NCT01287741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93138830|NCT01287741|Tubulin Modulators|tubulin modulators|mesh-ancestor
93138831|NCT01287741|Antimitotic Agents|antimitotic agents|mesh-ancestor
93138832|NCT01287741|Mitosis Modulators|mitosis modulators|mesh-ancestor
93138833|NCT01180959|Bevacizumab|bevacizumab|mesh-list
93138834|NCT01180959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93138835|NCT01180959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93138836|NCT01180959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138837|NCT01180959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93138838|NCT01180959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93138839|NCT01180959|Growth Substances|growth substances|mesh-ancestor
93138840|NCT01180959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138841|NCT01180959|Growth Inhibitors|growth inhibitors|mesh-ancestor
93138842|NCT01180959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138843|NCT01180959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138844|NCT01180959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138845|NCT01177371|Cyclosporine|cyclosporine|mesh-list
93138846|NCT01177371|Methylprednisolone|methylprednisolone|mesh-list
93138847|NCT01177371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93138848|NCT01177371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93138849|NCT01177371|Prednisolone|prednisolone|mesh-list
93138850|NCT01177371|Prednisolone acetate|prednisolone acetate|mesh-list
93138851|NCT01177371|Cyclophosphamide|cyclophosphamide|mesh-list
93138852|NCT01177371|Busulfan|busulfan|mesh-list
93138853|NCT01177371|Methotrexate|methotrexate|mesh-list
93138854|NCT01177371|Cyclosporins|cyclosporins|mesh-list
93138855|NCT01177371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93138856|NCT01177371|Prednisolone phosphate|prednisolone phosphate|mesh-list
93138857|NCT01177371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93138858|NCT01177371|Immunologic Factors|immunologic factors|mesh-ancestor
93138859|NCT01177371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138860|NCT01177371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93138861|NCT01177371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93138862|NCT01177371|Alkylating Agents|alkylating agents|mesh-ancestor
93138863|NCT01177371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138864|NCT01177371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138865|NCT01177371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93138866|NCT01177371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93138867|NCT01177371|Abortifacient Agents|abortifacient agents|mesh-ancestor
93138868|NCT01177371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93138869|NCT01177371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93138870|NCT01177371|Antimetabolites|antimetabolites|mesh-ancestor
93138871|NCT01177371|Dermatologic Agents|dermatologic agents|mesh-ancestor
93138872|NCT01177371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138873|NCT01177371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93138874|NCT01177371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93138875|NCT01177371|Antifungal Agents|antifungal agents|mesh-ancestor
93138876|NCT01177371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138877|NCT01177371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93138878|NCT01177371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93138879|NCT01177371|Antiemetics|antiemetics|mesh-ancestor
93138880|NCT01177371|Autonomic Agents|autonomic agents|mesh-ancestor
93138881|NCT01177371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138882|NCT01177371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93138883|NCT01177371|Glucocorticoids|glucocorticoids|mesh-ancestor
93138884|NCT01177371|Hormones|hormones|mesh-ancestor
93138885|NCT01177371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138886|NCT01177371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93138887|NCT01177371|Protective Agents|protective agents|mesh-ancestor
93138888|NCT01177371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93138889|NCT01178931|Dydrogesterone|dydrogesterone|mesh-list
93138890|NCT01178931|Progesterone|progesterone|mesh-list
93138891|NCT01178931|Progestins|progestins|mesh-ancestor
93138892|NCT01178931|Hormones|hormones|mesh-ancestor
93138893|NCT01178931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93138894|NCT01178931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138895|NCT01181115|Interferon beta-1a|interferon beta-1a|mesh-list
93138896|NCT01181115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93138897|NCT01181115|Immunologic Factors|immunologic factors|mesh-ancestor
93138898|NCT01181115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138899|NCT01181115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138900|NCT01181115|Antiviral Agents|antiviral agents|mesh-ancestor
93138901|NCT01181115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93138902|NCT01181193|Vitamin D|vitamin d|mesh-list
93138903|NCT01181193|Cholecalciferol|cholecalciferol|mesh-list
93138904|NCT01181193|Temozolomide|temozolomide|mesh-list
93138905|NCT01181193|Vitamins|vitamins|mesh-ancestor
93138906|NCT01181193|Micronutrients|micronutrients|mesh-ancestor
93138907|NCT01181193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138908|NCT01181193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93138909|NCT01181193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93138910|NCT01181193|Alkylating Agents|alkylating agents|mesh-ancestor
93138911|NCT01181193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138912|NCT01181193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138913|NCT01181193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93138914|NCT01177683|Doxorubicin|doxorubicin|mesh-list
93138915|NCT01177683|Bortezomib|bortezomib|mesh-list
93138916|NCT01177683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93138917|NCT01177683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93138918|NCT01177683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138919|NCT01177683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93138920|NCT01177683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93138921|NCT01177683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138922|NCT01177683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138923|NCT01177683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93138924|NCT01177683|Alkylating Agents|alkylating agents|mesh-ancestor
93138925|NCT01181427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-list
93138926|NCT01181427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138927|NCT01181427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138928|NCT03855579|Simendan|simendan|mesh-list
93138929|NCT03855579|Milrinone|milrinone|mesh-list
93138930|NCT03855579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93138931|NCT03855579|Vasodilator Agents|vasodilator agents|mesh-ancestor
93138932|NCT03855579|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93138933|NCT03855579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93138934|NCT03855579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138935|NCT03855579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138936|NCT03855579|Protective Agents|protective agents|mesh-ancestor
93138937|NCT03855579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138938|NCT03855579|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93138939|NCT03855423|Tocotrienols|tocotrienols|mesh-list
93138940|NCT03855423|Vitamin E|vitamin e|mesh-list
93138941|NCT03855423|Tocopherols|tocopherols|mesh-list
93138942|NCT03855423|Tocovid|tocovid|mesh-list
93138943|NCT03855423|Antioxidants|antioxidants|mesh-ancestor
93138944|NCT03855423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138945|NCT03855423|Protective Agents|protective agents|mesh-ancestor
93138946|NCT03855423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138947|NCT03855423|Vitamins|vitamins|mesh-ancestor
93138948|NCT03855423|Micronutrients|micronutrients|mesh-ancestor
93138949|NCT01181505|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93138950|NCT01181505|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93138951|NCT01181505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93138952|NCT01181505|Cholinergic Agents|cholinergic agents|mesh-ancestor
93138953|NCT01181505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138954|NCT01181505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138955|NCT01181505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138956|NCT01181505|Urological Agents|urological agents|mesh-ancestor
93138957|NCT01290783|Irinotecan|irinotecan|mesh-list
93138958|NCT01290783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93138959|NCT01290783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92811111|NCT02812641|Bevacizumab|bevacizumab|mesh-list
93138960|NCT01290783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138961|NCT01290783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138962|NCT01290783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138963|NCT03857763|Paclitaxel|paclitaxel|mesh-list
93138964|NCT03857763|Apatinib|apatinib|mesh-list
93138965|NCT03857763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93138966|NCT03857763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93138967|NCT03857763|Tubulin Modulators|tubulin modulators|mesh-ancestor
93138968|NCT03857763|Antimitotic Agents|antimitotic agents|mesh-ancestor
93138969|NCT03857763|Mitosis Modulators|mitosis modulators|mesh-ancestor
93138970|NCT03857763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138971|NCT03857763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93138972|NCT03857763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93138973|NCT01289769|Dexmedetomidine|dexmedetomidine|mesh-list
93138974|NCT01289769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93138975|NCT01289769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93138976|NCT01289769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138977|NCT01289769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93138978|NCT01289769|Analgesics|analgesics|mesh-ancestor
93138979|NCT01289769|Sensory System Agents|sensory system agents|mesh-ancestor
93138980|NCT01289769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93138981|NCT01289769|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93138982|NCT01289769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93138983|NCT01289769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93138984|NCT01289769|Adrenergic Agents|adrenergic agents|mesh-ancestor
93138985|NCT01289769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93138986|NCT01289769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138987|NCT01185015|Nicorandil|nicorandil|mesh-list
93138988|NCT01185015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93138989|NCT01185015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93138990|NCT01185015|Vasodilator Agents|vasodilator agents|mesh-ancestor
93138991|NCT01185015|Vitamin B Complex|vitamin b complex|mesh-ancestor
93138992|NCT01185015|Vitamins|vitamins|mesh-ancestor
93138993|NCT01185015|Micronutrients|micronutrients|mesh-ancestor
93138994|NCT01185015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93138995|NCT01289925|Selenium|selenium|mesh-list
93138996|NCT01289925|Antioxidants|antioxidants|mesh-ancestor
93138997|NCT01289925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93138998|NCT01289925|Protective Agents|protective agents|mesh-ancestor
93138999|NCT01289925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139000|NCT01289925|Trace Elements|trace elements|mesh-ancestor
93139001|NCT01289925|Micronutrients|micronutrients|mesh-ancestor
93139002|NCT01290939|Bevacizumab|bevacizumab|mesh-list
93139003|NCT01290939|Lomustine|lomustine|mesh-list
93139004|NCT01290939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93139005|NCT01290939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139006|NCT01290939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93139007|NCT01290939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93139008|NCT01290939|Growth Substances|growth substances|mesh-ancestor
93139009|NCT01290939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139010|NCT01290939|Growth Inhibitors|growth inhibitors|mesh-ancestor
93139011|NCT01290939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93139012|NCT01290939|Alkylating Agents|alkylating agents|mesh-ancestor
93139013|NCT01290939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139014|NCT01288755|Raltegravir Potassium|raltegravir potassium|mesh-list
93139015|NCT01288755|Rilpivirine|rilpivirine|mesh-list
93139016|NCT01288755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93139017|NCT01288755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93139018|NCT01288755|Antiviral Agents|antiviral agents|mesh-ancestor
93139019|NCT01288755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139020|NCT01288755|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93139021|NCT01288755|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93139022|NCT01288755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139023|NCT01288755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139024|NCT01288755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93139025|NCT01288755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93139026|NCT01290003|Tazobactam|tazobactam|mesh-list
93139027|NCT01290003|Piperacillin|piperacillin|mesh-list
93139028|NCT01290003|Amikacin|amikacin|mesh-list
93139029|NCT01290003|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93139030|NCT01290003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139031|NCT01290003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139032|NCT01290003|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93139033|NCT01290003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139034|NCT01290003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139035|NCT01291095|Cisplatin|cisplatin|mesh-list
93139036|NCT01291095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139037|NCT03739203|Cariprazine|cariprazine|mesh-list
93139038|NCT03739203|Antidepressive Agents|antidepressive agents|mesh-list
93139039|NCT03739203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139040|NCT03739203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93139041|NCT03739203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139042|NCT03739203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139043|NCT03739203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139044|NCT01185405|Voriconazole|voriconazole|mesh-list
93139045|NCT01185405|Antifungal Agents|antifungal agents|mesh-ancestor
93139046|NCT01185405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139047|NCT01185405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93139048|NCT01185405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93139049|NCT01185405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139050|NCT01185405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139051|NCT01185405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93139052|NCT01185405|Hormone Antagonists|hormone antagonists|mesh-ancestor
93139053|NCT01185405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93139054|NCT01185405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139055|NCT01185405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93139056|NCT01182129|Nicotine|nicotine|mesh-list
93139057|NCT01182129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93139058|NCT01182129|Autonomic Agents|autonomic agents|mesh-ancestor
93139059|NCT01182129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139060|NCT01182129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139061|NCT01182129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93139062|NCT01182129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93139063|NCT01182129|Cholinergic Agents|cholinergic agents|mesh-ancestor
93139064|NCT01182129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139065|NCT01182129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139066|NCT01587729|Antidepressive Agents|antidepressive agents|mesh-list
93139067|NCT01587729|Serotonin|serotonin|mesh-list
93139068|NCT01587729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93139069|NCT01587729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139070|NCT01587729|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93139071|NCT01587729|Serotonin Agents|serotonin agents|mesh-ancestor
93139072|NCT01587729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139073|NCT01587729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139074|NCT01587729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139075|NCT01587729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93139076|NCT01587729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93139077|NCT03855267|Propofol|propofol|mesh-list
93139078|NCT03855267|Etomidate|etomidate|mesh-list
93139079|NCT03855267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93139080|NCT03855267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139081|NCT03855267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139082|NCT03855267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93139083|NCT03855267|Anesthetics, General|anesthetics, general|mesh-ancestor
93139084|NCT03855267|Anesthetics|anesthetics|mesh-ancestor
93139085|NCT01185873|Ritonavir|ritonavir|mesh-list
93139086|NCT01185873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93139087|NCT01185873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93139088|NCT01185873|Protease Inhibitors|protease inhibitors|mesh-ancestor
93139089|NCT01185873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139090|NCT01185873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139091|NCT01185873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93139092|NCT01185873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93139093|NCT01185873|Antiviral Agents|antiviral agents|mesh-ancestor
93139094|NCT01185873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139095|NCT01185873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93139096|NCT01185873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93139097|NCT01182597|Pantoprazole|pantoprazole|mesh-list
93139098|NCT01182597|Lansoprazole|lansoprazole|mesh-list
93139099|NCT01182597|Dexlansoprazole|dexlansoprazole|mesh-list
93139100|NCT01182597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93139101|NCT01182597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139102|NCT01182597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93139103|NCT01182597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139104|NCT01182597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139105|NCT01185951|Polidocanol|polidocanol|mesh-list
93139106|NCT01185951|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93139107|NCT01185951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93139108|NCT01186029|Aprepitant|aprepitant|mesh-list
93139109|NCT01186029|Antiemetics|antiemetics|mesh-ancestor
93139110|NCT01186029|Autonomic Agents|autonomic agents|mesh-ancestor
93139111|NCT01186029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139112|NCT01186029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139113|NCT01186029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139115|NCT01186029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139116|NCT01186029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139117|NCT01587807|Dimercaprol|dimercaprol|mesh-list
93139118|NCT01587807|Chelating Agents|chelating agents|mesh-ancestor
93139119|NCT01587807|Sequestering Agents|sequestering agents|mesh-ancestor
93139120|NCT01587807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139121|NCT01186185|Fludrocortisone|fludrocortisone|mesh-list
93139122|NCT01186185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139123|NCT01180179|Lansoprazole|lansoprazole|mesh-list
93139124|NCT01180179|Dexlansoprazole|dexlansoprazole|mesh-list
93139125|NCT01180179|Famotidine|famotidine|mesh-list
93139126|NCT01180179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93139127|NCT01180179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139128|NCT01180179|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93139129|NCT01180179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139130|NCT01180179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139131|NCT01180179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93139132|NCT01180179|Histamine Antagonists|histamine antagonists|mesh-ancestor
93139133|NCT01180179|Histamine Agents|histamine agents|mesh-ancestor
93139134|NCT01180179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139135|NCT01180179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139136|NCT01289223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93139137|NCT01289223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93139138|NCT01289223|Alkylating Agents|alkylating agents|mesh-ancestor
93139139|NCT01289223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139140|NCT01289223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139141|NCT01186497|Rabeprazole|rabeprazole|mesh-list
93139142|NCT01186497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93139143|NCT01186497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139144|NCT01186497|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93139145|NCT01186497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139146|NCT01186497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139147|NCT03854409|Aripiprazole|aripiprazole|mesh-list
93139148|NCT03854409|Antidepressive Agents|antidepressive agents|mesh-ancestor
93139149|NCT03854409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139150|NCT03854409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93139151|NCT03854409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139152|NCT03854409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139153|NCT03854409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139154|NCT03854409|Dopamine Agonists|dopamine agonists|mesh-ancestor
93139155|NCT03854409|Dopamine Agents|dopamine agents|mesh-ancestor
93139156|NCT03854409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139157|NCT03854409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139158|NCT03854409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93139159|NCT03854409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93139160|NCT03854409|Serotonin Agents|serotonin agents|mesh-ancestor
93139161|NCT03854409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93139162|NCT03854409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93139163|NCT03854409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93139164|NCT03854409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93139165|NCT01186653|Fluticasone|fluticasone|mesh-list
93139166|NCT01186653|Budesonide|budesonide|mesh-list
93139167|NCT01186653|Formoterol Fumarate|formoterol fumarate|mesh-list
93139168|NCT01186653|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93139169|NCT01186653|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93139170|NCT01186653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139171|NCT01186653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93139172|NCT01186653|Autonomic Agents|autonomic agents|mesh-ancestor
93139173|NCT01186653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139174|NCT01186653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139175|NCT01186653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93139176|NCT01186653|Respiratory System Agents|respiratory system agents|mesh-ancestor
93139177|NCT01186653|Dermatologic Agents|dermatologic agents|mesh-ancestor
93139178|NCT01186653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93139179|NCT01186653|Glucocorticoids|glucocorticoids|mesh-ancestor
93139180|NCT01186653|Hormones|hormones|mesh-ancestor
93139181|NCT01186653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93139182|NCT01186653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93139183|NCT01186653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93139184|NCT01186653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93139185|NCT01186653|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139186|NCT01186653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139187|NCT01186653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139188|NCT01186653|Sympathomimetics|sympathomimetics|mesh-ancestor
93139189|NCT01186731|Docetaxel|docetaxel|mesh-list
93139190|NCT01186731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139191|NCT01186731|Tubulin Modulators|tubulin modulators|mesh-ancestor
93139192|NCT01186731|Antimitotic Agents|antimitotic agents|mesh-ancestor
93139193|NCT01186731|Mitosis Modulators|mitosis modulators|mesh-ancestor
93139194|NCT01186731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139195|NCT01186887|Celecoxib|celecoxib|mesh-list
93139196|NCT01186887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93139197|NCT01186887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93139198|NCT01186887|Analgesics|analgesics|mesh-ancestor
93139199|NCT01186887|Sensory System Agents|sensory system agents|mesh-ancestor
93139200|NCT01186887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139201|NCT01186887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139202|NCT01186887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139203|NCT01186887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93139204|NCT01186887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93139205|NCT01186887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93139206|NCT01186887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139207|NCT01186887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139208|NCT01180413|Losartan|losartan|mesh-list
93139209|NCT01180413|Amlodipine|amlodipine|mesh-list
93139210|NCT01180413|Ramipril|ramipril|mesh-list
93139211|NCT01180413|Lercanidipine|lercanidipine|mesh-list
93139212|NCT01180413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93139213|NCT01180413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93139214|NCT01180413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93139215|NCT01180413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139216|NCT01180413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139217|NCT01180413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139218|NCT01180413|Vasodilator Agents|vasodilator agents|mesh-ancestor
93139219|NCT01180413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93139220|NCT01180413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93139221|NCT01180413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93139222|NCT01180413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93139223|NCT01180413|Protease Inhibitors|protease inhibitors|mesh-ancestor
93139224|NCT01180413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139225|NCT03858387|Meropenem|meropenem|mesh-list
93139226|NCT03858387|Imipenem|imipenem|mesh-list
93139227|NCT03858387|Cilastatin|cilastatin|mesh-list
93139228|NCT03858387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139229|NCT03858387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139230|NCT03858387|Protease Inhibitors|protease inhibitors|mesh-ancestor
93139231|NCT03858387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139232|NCT03858387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139233|NCT01289301|Cyclosporine|cyclosporine|mesh-list
93139234|NCT01289301|Sirolimus|sirolimus|mesh-list
93139235|NCT01289301|Everolimus|everolimus|mesh-list
93139236|NCT01289301|MTOR Inhibitors|mtor inhibitors|mesh-list
93139237|NCT01289301|Temsirolimus|temsirolimus|mesh-list
93139238|NCT01289301|Tacrolimus|tacrolimus|mesh-list
93139239|NCT01289301|Cyclosporins|cyclosporins|mesh-list
93139240|NCT01289301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93139241|NCT01289301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93139242|NCT01289301|Immunologic Factors|immunologic factors|mesh-ancestor
93139243|NCT01289301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139244|NCT01289301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139245|NCT01289301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139246|NCT01289301|Antifungal Agents|antifungal agents|mesh-ancestor
93139247|NCT01289301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139248|NCT01289301|Dermatologic Agents|dermatologic agents|mesh-ancestor
93139249|NCT01289301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93139250|NCT01289301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93139251|NCT01289301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139252|NCT01289301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139253|NCT01289301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93139254|NCT02524899|Guanfacine|guanfacine|mesh-list
93139255|NCT02524899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93139256|NCT02524899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93139257|NCT02524899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93139258|NCT02524899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93139259|NCT02524899|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139260|NCT02524899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139261|NCT02524899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139262|NCT02524899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139263|NCT02524821|Metformin|metformin|mesh-list
93139264|NCT02524821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93139265|NCT02524821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139266|NCT01183455|Protease Inhibitors|protease inhibitors|mesh-list
93139267|NCT01183455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93139268|NCT01183455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139269|NCT01183455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139270|NCT01183455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93139271|NCT01183455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93139272|NCT03854175|Sildenafil Citrate|sildenafil citrate|mesh-list
93139273|NCT03854175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93139274|NCT03854175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93139275|NCT03854175|Estradiol|estradiol|mesh-list
93139276|NCT03854175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93139277|NCT03854175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139278|NCT03854175|Estrogens|estrogens|mesh-ancestor
93139279|NCT03854175|Hormones|hormones|mesh-ancestor
93139280|NCT03854175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93139281|NCT03854175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139282|NCT03854175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93139283|NCT03854175|Contraceptive Agents|contraceptive agents|mesh-ancestor
93139284|NCT03854175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139285|NCT03854175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93139286|NCT03854175|Vasodilator Agents|vasodilator agents|mesh-ancestor
93139287|NCT03854175|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93139288|NCT03854175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93139289|NCT03854175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139290|NCT03854175|Urological Agents|urological agents|mesh-ancestor
93139291|NCT01183611|Vaccines|vaccines|mesh-list
93139292|NCT01183611|Immunologic Factors|immunologic factors|mesh-ancestor
93139293|NCT01183611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139294|NCT01180569|Lenalidomide|lenalidomide|mesh-list
93139295|NCT01180569|Immunologic Factors|immunologic factors|mesh-ancestor
93139296|NCT01180569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139297|NCT01180569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93139298|NCT01180569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93139299|NCT01180569|Growth Substances|growth substances|mesh-ancestor
93139300|NCT01180569|Growth Inhibitors|growth inhibitors|mesh-ancestor
93139301|NCT01180569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139302|NCT02942264|Temozolomide|temozolomide|mesh-list
93139303|NCT02942264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93139304|NCT02942264|Alkylating Agents|alkylating agents|mesh-ancestor
93139305|NCT02942264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139306|NCT02942264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139307|NCT01180725|Psyllium|psyllium|mesh-list
93139308|NCT01180725|Cathartics|cathartics|mesh-ancestor
93139309|NCT01180725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139310|NCT01183767|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93139311|NCT01183767|Antioxidants|antioxidants|mesh-ancestor
93139312|NCT01183767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139313|NCT01183767|Protective Agents|protective agents|mesh-ancestor
93139314|NCT01183767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139315|NCT01183767|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93139316|NCT01183767|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93139317|NCT01183767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139318|NCT01183767|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93139319|NCT03853785|Podophyllin|podophyllin|mesh-list
93139320|NCT03853785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93139321|NCT03853785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139322|NCT03853785|Keratolytic Agents|keratolytic agents|mesh-ancestor
93139323|NCT03853785|Dermatologic Agents|dermatologic agents|mesh-ancestor
93139324|NCT01290471|U3-1565|u3-1565|mesh-list
93139325|NCT01290471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93139326|NCT01290471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139327|NCT01291563|Moxifloxacin|moxifloxacin|mesh-list
93139328|NCT01291563|Bedaquiline|bedaquiline|mesh-list
93139329|NCT01291563|Diarylquinolines|diarylquinolines|mesh-list
93139330|NCT01291563|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93139331|NCT01291563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139332|NCT01291563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139333|NCT01291563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93139334|NCT01291563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93139335|NCT01291563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139336|NCT01291563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811485|NCT05549115|Ofloxacin|ofloxacin|mesh-list
93139338|NCT01291563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93139339|NCT01291563|Contraceptive Agents|contraceptive agents|mesh-ancestor
93139340|NCT01291563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139341|NCT01291563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139342|NCT01291563|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93139343|NCT01291563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93139344|NCT01291563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93139345|NCT01291563|Antitubercular Agents|antitubercular agents|mesh-ancestor
93139346|NCT01187589|Albuterol|albuterol|mesh-list
93139347|NCT01187589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93139348|NCT01187589|Autonomic Agents|autonomic agents|mesh-ancestor
93139349|NCT01187589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139350|NCT01187589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139351|NCT01187589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93139352|NCT01187589|Respiratory System Agents|respiratory system agents|mesh-ancestor
93139353|NCT01187589|Tocolytic Agents|tocolytic agents|mesh-ancestor
93139354|NCT01187589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139355|NCT01187589|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93139356|NCT01187589|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93139357|NCT01187589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93139358|NCT01187589|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139359|NCT01187589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139360|NCT01187589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139361|NCT01290549|Rituximab|rituximab|mesh-list
93139362|NCT01290549|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93139363|NCT01290549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93139364|NCT01290549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139365|NCT01290549|Immunologic Factors|immunologic factors|mesh-ancestor
93139366|NCT01290549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139367|NCT01290549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93139368|NCT01290549|Immunoconjugates|immunoconjugates|mesh-ancestor
93139369|NCT01184235|Antipsychotic Agents|antipsychotic agents|mesh-list
93139370|NCT01184235|Antidepressive Agents|antidepressive agents|mesh-list
93139371|NCT01184235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139372|NCT01184235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139373|NCT01184235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139374|NCT01184235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139375|NCT04951947|Lenvatinib|lenvatinib|mesh-list
93139376|NCT04951947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139377|NCT04951947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93139378|NCT04951947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139379|NCT04951947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139380|NCT01184391|Valproic Acid|valproic acid|mesh-list
93139381|NCT01184391|Anticonvulsants|anticonvulsants|mesh-ancestor
93139382|NCT01184391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139383|NCT01184391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139384|NCT01184391|GABA Agents|gaba agents|mesh-ancestor
93139385|NCT01184391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139386|NCT01184391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139387|NCT01184391|Antimanic Agents|antimanic agents|mesh-ancestor
93139388|NCT01184391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139389|NCT01184391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139390|NCT01184391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139391|NCT02524743|Acetaminophen|acetaminophen|mesh-list
93139392|NCT02524743|Lidocaine|lidocaine|mesh-list
93139393|NCT02524743|Anesthetics, Local|anesthetics, local|mesh-ancestor
93139394|NCT02524743|Anesthetics|anesthetics|mesh-ancestor
93139395|NCT02524743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139396|NCT02524743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139397|NCT02524743|Sensory System Agents|sensory system agents|mesh-ancestor
93139398|NCT02524743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139399|NCT02524743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93139400|NCT02524743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93139401|NCT02524743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93139402|NCT02524743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93139403|NCT02524743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139404|NCT02524743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93139405|NCT02524743|Analgesics|analgesics|mesh-ancestor
93139406|NCT02524743|Antipyretics|antipyretics|mesh-ancestor
93139407|NCT01188057|Alprazolam|alprazolam|mesh-list
93139408|NCT01188057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92811557|NCT05472753|Micronutrients|micronutrients|mesh-ancestor
93139409|NCT01188057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139410|NCT01188057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139411|NCT01188057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93139412|NCT01188057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139413|NCT01188057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139414|NCT01188057|GABA Modulators|gaba modulators|mesh-ancestor
93139415|NCT01188057|GABA Agents|gaba agents|mesh-ancestor
93139416|NCT01188057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139417|NCT01188057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139418|NCT01291641|Cilostazol|cilostazol|mesh-list
93139419|NCT01291641|Probucol|probucol|mesh-list
93139420|NCT01291641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93139421|NCT01291641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93139422|NCT01291641|Autonomic Agents|autonomic agents|mesh-ancestor
93139423|NCT01291641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139424|NCT01291641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139425|NCT01291641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93139426|NCT01291641|Respiratory System Agents|respiratory system agents|mesh-ancestor
93139427|NCT01291641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93139428|NCT01291641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93139429|NCT01291641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139430|NCT01291641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93139431|NCT01291641|Vasodilator Agents|vasodilator agents|mesh-ancestor
93139432|NCT01291641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93139433|NCT01291641|Protective Agents|protective agents|mesh-ancestor
93139434|NCT01291641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93139435|NCT01291641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93139436|NCT01291641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139437|NCT01291641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93139438|NCT01291641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93139439|NCT01291641|Antimetabolites|antimetabolites|mesh-ancestor
93139440|NCT01291641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93139441|NCT01291641|Antioxidants|antioxidants|mesh-ancestor
93139442|NCT03855501|Calcium|calcium|mesh-list
93139443|NCT03855501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139444|NCT03855501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139445|NCT01588587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93139446|NCT01588587|Vildagliptin|vildagliptin|mesh-list
93139447|NCT01588587|Alogliptin|alogliptin|mesh-list
93139448|NCT01588587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93139449|NCT01588587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139450|NCT01588587|Incretins|incretins|mesh-ancestor
93139451|NCT01588587|Hormones|hormones|mesh-ancestor
93139452|NCT01588587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93139453|NCT01588587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93139454|NCT01588587|Protease Inhibitors|protease inhibitors|mesh-ancestor
93139455|NCT01588587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139456|NCT01588587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139457|NCT03325712|Midazolam|midazolam|mesh-list
93139458|NCT03325712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93139459|NCT03325712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93139460|NCT03325712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139461|NCT03325712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139462|NCT03325712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93139463|NCT03325712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139464|NCT03325712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139465|NCT03325712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93139466|NCT03325712|Anesthetics, General|anesthetics, general|mesh-ancestor
93139467|NCT03325712|Anesthetics|anesthetics|mesh-ancestor
93139468|NCT03325712|GABA Modulators|gaba modulators|mesh-ancestor
93139469|NCT03325712|GABA Agents|gaba agents|mesh-ancestor
93139470|NCT03325712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139471|NCT03325712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139472|NCT01293747|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93139473|NCT01293747|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93139474|NCT01293747|Estradiol|estradiol|mesh-list
93139475|NCT01293747|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93139476|NCT01293747|Progesterone|progesterone|mesh-list
93139477|NCT01293747|Estrogens|estrogens|mesh-ancestor
93139478|NCT01293747|Hormones|hormones|mesh-ancestor
93139479|NCT01293747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93139480|NCT01293747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139481|NCT01293747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93139482|NCT01293747|Contraceptive Agents|contraceptive agents|mesh-ancestor
93139483|NCT01293747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139484|NCT01293747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93139485|NCT01293747|Progestins|progestins|mesh-ancestor
93139486|NCT03849729|Phentermine|phentermine|mesh-list
93139487|NCT03849729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93139488|NCT03849729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139489|NCT03849729|Appetite Depressants|appetite depressants|mesh-ancestor
93139490|NCT03849729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93139491|NCT03849729|Sympathomimetics|sympathomimetics|mesh-ancestor
93139492|NCT03849729|Autonomic Agents|autonomic agents|mesh-ancestor
93139493|NCT03849729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139494|NCT03849729|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139495|NCT03849729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139496|NCT03849729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139497|NCT03325556|Pimavanserin|pimavanserin|mesh-list
93139498|NCT03325556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93139499|NCT03325556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93139500|NCT03325556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93139501|NCT03325556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139502|NCT03325556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139503|NCT03325556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139504|NCT03325556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139505|NCT03325556|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93139506|NCT03325556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93139507|NCT03325556|Serotonin Agents|serotonin agents|mesh-ancestor
93139508|NCT03325556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139509|NCT03325556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139510|NCT01188213|Dimethyl sulfone|dimethyl sulfone|mesh-list
93139511|NCT01188213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139512|NCT03320564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93139513|NCT03320564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93139514|NCT03320564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139515|NCT03852303|Ivermectin|ivermectin|mesh-list
93139516|NCT03852303|Anticonvulsants|anticonvulsants|mesh-list
93139517|NCT03852303|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93139518|NCT03852303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139519|NCT03325166|Pembrolizumab|pembrolizumab|mesh-list
93139520|NCT03325166|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93139521|NCT03325166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93139522|NCT03325166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139523|NCT03325166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93139524|NCT03325166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139525|NCT03325166|Hematinics|hematinics|mesh-ancestor
93139526|NCT03325166|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93139527|NCT03325166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93139528|NCT03847623|Curcumin|curcumin|mesh-list
93139529|NCT03847623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93139530|NCT03847623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93139531|NCT03847623|Analgesics|analgesics|mesh-ancestor
93139532|NCT03847623|Sensory System Agents|sensory system agents|mesh-ancestor
93139533|NCT03847623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139534|NCT03847623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139535|NCT03847623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139536|NCT03847623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93139537|NCT03847623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139538|NCT03847623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139539|NCT03847623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139540|NCT01294059|Milnacipran|milnacipran|mesh-list
93139541|NCT01294059|Levomilnacipran|levomilnacipran|mesh-list
93139542|NCT01294059|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93139543|NCT01294059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93139544|NCT01294059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93139545|NCT01294059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139546|NCT01294059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139547|NCT01294059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139548|NCT01294059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93139549|NCT01294059|Analgesics|analgesics|mesh-ancestor
93139550|NCT01294059|Sensory System Agents|sensory system agents|mesh-ancestor
93139551|NCT01294059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139552|NCT01294059|Antidepressive Agents|antidepressive agents|mesh-ancestor
93139553|NCT01294059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139554|NCT03847155|Nicotine|nicotine|mesh-list
93139555|NCT03847155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93139556|NCT03847155|Autonomic Agents|autonomic agents|mesh-ancestor
93139557|NCT03847155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139558|NCT03847155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811705|NCT00818662|gamma-Globulins|gamma-globulins|mesh-list
93139560|NCT03847155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93139561|NCT03847155|Cholinergic Agents|cholinergic agents|mesh-ancestor
93139562|NCT03847155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139563|NCT03847155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139564|NCT01294215|Nifedipine|nifedipine|mesh-list
93139565|NCT01294215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93139566|NCT01294215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93139567|NCT01294215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139568|NCT01294215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139569|NCT01294215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139570|NCT01294215|Vasodilator Agents|vasodilator agents|mesh-ancestor
93139571|NCT01294215|Tocolytic Agents|tocolytic agents|mesh-ancestor
93139572|NCT01294215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139573|NCT01296555|Letrozole|letrozole|mesh-list
93139574|NCT01296555|Fulvestrant|fulvestrant|mesh-list
93139575|NCT01296555|Midazolam|midazolam|mesh-list
93139576|NCT01296555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93139577|NCT01296555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93139578|NCT01296555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139579|NCT01296555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139580|NCT01296555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93139581|NCT01296555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93139582|NCT01296555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93139583|NCT01296555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93139584|NCT01296555|Anesthetics, General|anesthetics, general|mesh-ancestor
93139585|NCT01296555|Anesthetics|anesthetics|mesh-ancestor
93139586|NCT01296555|GABA Modulators|gaba modulators|mesh-ancestor
93139587|NCT01296555|GABA Agents|gaba agents|mesh-ancestor
93139588|NCT01296555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139589|NCT01296555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139590|NCT01296555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139591|NCT01296555|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93139592|NCT01296555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93139593|NCT01296555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139594|NCT01296555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93139595|NCT01296555|Hormone Antagonists|hormone antagonists|mesh-ancestor
93139596|NCT01296555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93139597|NCT01296555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93139598|NCT01296555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93139599|NCT01294293|Paclitaxel|paclitaxel|mesh-list
93139600|NCT01294293|Doxorubicin|doxorubicin|mesh-list
93139601|NCT01294293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93139602|NCT01294293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93139603|NCT01294293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139604|NCT01294293|Tubulin Modulators|tubulin modulators|mesh-ancestor
93139605|NCT01294293|Antimitotic Agents|antimitotic agents|mesh-ancestor
93139606|NCT01294293|Mitosis Modulators|mitosis modulators|mesh-ancestor
93139607|NCT01294293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139608|NCT01294293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93139609|NCT01294293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93139610|NCT01294293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93139611|NCT01294293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139612|NCT01294605|Edetic Acid|edetic acid|mesh-list
93139613|NCT01294605|Pentetic Acid|pentetic acid|mesh-list
93139614|NCT01294605|Antidotes|antidotes|mesh-ancestor
93139615|NCT01294605|Protective Agents|protective agents|mesh-ancestor
93139616|NCT01294605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139617|NCT01294605|Chelating Agents|chelating agents|mesh-ancestor
93139618|NCT01294605|Sequestering Agents|sequestering agents|mesh-ancestor
93139619|NCT01294605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139620|NCT01294605|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93139621|NCT01294605|Anticoagulants|anticoagulants|mesh-ancestor
93139622|NCT01294605|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93139623|NCT01294761|Raltegravir Potassium|raltegravir potassium|mesh-list
93139624|NCT01294761|Darunavir|darunavir|mesh-list
93139625|NCT01294761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93139626|NCT01294761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93139627|NCT01294761|Antiviral Agents|antiviral agents|mesh-ancestor
93139628|NCT01294761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139629|NCT01294761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93139630|NCT01294761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93139631|NCT01294761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139632|NCT01294761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139633|NCT01294761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93139634|NCT01294761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93139635|NCT01294761|Protease Inhibitors|protease inhibitors|mesh-ancestor
93139636|NCT03849183|Nitroglycerin|nitroglycerin|mesh-list
93139637|NCT03849183|Vasodilator Agents|vasodilator agents|mesh-ancestor
93139638|NCT03305666|Bupivacaine|bupivacaine|mesh-list
93139639|NCT03305666|Anesthetics, Local|anesthetics, local|mesh-ancestor
93139640|NCT03305666|Anesthetics|anesthetics|mesh-ancestor
93139641|NCT03305666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139642|NCT03305666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139643|NCT03305666|Sensory System Agents|sensory system agents|mesh-ancestor
93139644|NCT03305666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139645|NCT01194843|Ropivacaine|ropivacaine|mesh-list
93139646|NCT01194843|Anesthetics, Local|anesthetics, local|mesh-ancestor
93139647|NCT01194843|Anesthetics|anesthetics|mesh-ancestor
93139648|NCT01194843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139649|NCT01194843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139650|NCT01194843|Sensory System Agents|sensory system agents|mesh-ancestor
93139651|NCT01194843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139652|NCT01297023|Calcium, Dietary|calcium, dietary|mesh-list
93139653|NCT01297023|Vitamin D|vitamin d|mesh-list
93139654|NCT01297023|Ergocalciferols|ergocalciferols|mesh-list
93139655|NCT01297023|Cholecalciferol|cholecalciferol|mesh-list
93139656|NCT01297023|Vitamins|vitamins|mesh-list
93139657|NCT01297023|Calcium|calcium|mesh-list
93139658|NCT01297023|Micronutrients|micronutrients|mesh-ancestor
93139659|NCT01297023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139660|NCT01297023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139661|NCT01297023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93139662|NCT03846843|Phenylacetic acid|phenylacetic acid|mesh-list
93139663|NCT03846843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93139664|NCT03846843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93139665|NCT03846843|Antimetabolites|antimetabolites|mesh-ancestor
93139666|NCT03846843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139667|NCT03846843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139668|NCT01297101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93139669|NCT01297101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139670|NCT01297101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93139671|NCT01297101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139672|NCT01297101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139673|NCT04781426|Tenofovir|tenofovir|mesh-list
93139674|NCT04781426|Lamivudine|lamivudine|mesh-list
93139675|NCT04781426|Antiviral Agents|antiviral agents|mesh-ancestor
93139676|NCT04781426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139677|NCT04781426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93139678|NCT04781426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93139679|NCT04781426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139680|NCT04781426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139681|NCT04781426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93139682|NCT04781426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93139683|NCT01292031|Meropenem|meropenem|mesh-list
93139684|NCT01292031|Colistin|colistin|mesh-list
93139685|NCT01292031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139686|NCT01292031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139687|NCT04633226|Vaccines|vaccines|mesh-list
93139688|NCT04633226|Immunologic Factors|immunologic factors|mesh-ancestor
93139689|NCT04633226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139690|NCT03849027|Methoxyflurane|methoxyflurane|mesh-list
93139691|NCT03849027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93139692|NCT03849027|Anesthetics, General|anesthetics, general|mesh-ancestor
93139693|NCT03849027|Anesthetics|anesthetics|mesh-ancestor
93139694|NCT03849027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139695|NCT03849027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139696|NCT01188759|Voriconazole|voriconazole|mesh-list
93139697|NCT01188759|Anidulafungin|anidulafungin|mesh-list
93139698|NCT01188759|Antifungal Agents|antifungal agents|mesh-ancestor
93139699|NCT01188759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139700|NCT01188759|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93139701|NCT01188759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93139702|NCT01188759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139703|NCT01188759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139704|NCT01188759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93139705|NCT01188759|Hormone Antagonists|hormone antagonists|mesh-ancestor
93139706|NCT01188759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811854|NCT05804734|Anticoagulants|anticoagulants|mesh-list
93139707|NCT01188759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139708|NCT01188759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93139709|NCT01295073|Trientine|trientine|mesh-list
93139710|NCT01295073|Chelating Agents|chelating agents|mesh-ancestor
93139711|NCT01295073|Sequestering Agents|sequestering agents|mesh-ancestor
93139712|NCT01295073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139713|NCT01292109|Picosulfate sodium|picosulfate sodium|mesh-list
93139714|NCT01292109|Cathartics|cathartics|mesh-ancestor
93139715|NCT01292109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139716|NCT01191645|Remifentanil|remifentanil|mesh-list
93139717|NCT01191645|Metoclopramide|metoclopramide|mesh-list
93139718|NCT01191645|Naloxone|naloxone|mesh-list
93139719|NCT01191645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93139720|NCT01191645|Narcotics|narcotics|mesh-ancestor
93139721|NCT01191645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139722|NCT01191645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139723|NCT01191645|Analgesics|analgesics|mesh-ancestor
93139724|NCT01191645|Sensory System Agents|sensory system agents|mesh-ancestor
93139725|NCT01191645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139726|NCT01191645|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93139727|NCT01191645|Antiemetics|antiemetics|mesh-ancestor
93139728|NCT01191645|Autonomic Agents|autonomic agents|mesh-ancestor
93139729|NCT01191645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139730|NCT01191645|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93139731|NCT01191645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93139732|NCT01191645|Dopamine Agents|dopamine agents|mesh-ancestor
93139733|NCT01191645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139734|NCT01191645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139735|NCT03736785|Insulin|insulin|mesh-list
93139736|NCT03736785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93139737|NCT03736785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139738|NCT03734991|Ibrexafungerp|ibrexafungerp|mesh-list
93139739|NCT03734991|Antifungal Agents|antifungal agents|mesh-ancestor
93139740|NCT03734991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139741|NCT01295151|Adalimumab|adalimumab|mesh-list
93139742|NCT01295151|Infliximab|infliximab|mesh-list
93139743|NCT01295151|Golimumab|golimumab|mesh-list
93139744|NCT01295151|Certolizumab Pegol|certolizumab pegol|mesh-list
93139745|NCT01295151|Etanercept|etanercept|mesh-list
93139746|NCT01295151|Rituximab|rituximab|mesh-list
93139747|NCT01295151|Abatacept|abatacept|mesh-list
93139748|NCT01295151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93139749|NCT01295151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139750|NCT01295151|Immunologic Factors|immunologic factors|mesh-ancestor
93139751|NCT01295151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139752|NCT01295151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93139753|NCT01295151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93139754|NCT01295151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139755|NCT01295151|Dermatologic Agents|dermatologic agents|mesh-ancestor
93139756|NCT01295151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139757|NCT01295151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93139758|NCT01295151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93139759|NCT01295151|Analgesics|analgesics|mesh-ancestor
93139760|NCT01295151|Sensory System Agents|sensory system agents|mesh-ancestor
93139761|NCT01295151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139762|NCT01295151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93139763|NCT01295151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93139764|NCT01295151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139765|NCT01295307|Clofarabine|clofarabine|mesh-list
93139766|NCT01295307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93139767|NCT01295307|Antimetabolites|antimetabolites|mesh-ancestor
93139768|NCT01295307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139769|NCT01295307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139770|NCT01292343|Listerine|listerine|mesh-list
93139771|NCT01292343|Triclosan|triclosan|mesh-list
93139772|NCT01292343|Fluorides|fluorides|mesh-list
93139773|NCT01292343|Sodium Fluoride|sodium fluoride|mesh-list
93139774|NCT01292343|Cariostatic Agents|cariostatic agents|mesh-ancestor
93139775|NCT01292343|Protective Agents|protective agents|mesh-ancestor
93139776|NCT01292343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139777|NCT01292343|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93139778|NCT01292343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139779|NCT01292343|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93139780|NCT01292343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93139781|NCT01292343|Antimetabolites|antimetabolites|mesh-ancestor
93139782|NCT01292343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139783|NCT01292343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93139784|NCT01192113|Vitamin B 12|vitamin b 12|mesh-list
93139785|NCT01192113|Vitamin B Complex|vitamin b complex|mesh-ancestor
93139786|NCT01192113|Vitamins|vitamins|mesh-ancestor
93139787|NCT01192113|Micronutrients|micronutrients|mesh-ancestor
93139788|NCT01192113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139789|NCT05671029|Moxifloxacin|moxifloxacin|mesh-list
93139790|NCT05671029|Pritelivir|pritelivir|mesh-list
93139791|NCT05671029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93139792|NCT05671029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139793|NCT05671029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139794|NCT05671029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93139795|NCT05671029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93139796|NCT05671029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139797|NCT05671029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139798|NCT05671029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139799|NCT05671029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93139800|NCT05671029|Contraceptive Agents|contraceptive agents|mesh-ancestor
93139801|NCT05671029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139802|NCT05671029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139803|NCT05671029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93139804|NCT05671029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93139805|NCT05671029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93139806|NCT05671029|Antiviral Agents|antiviral agents|mesh-ancestor
93139807|NCT03303092|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93139808|NCT03303092|Immunologic Factors|immunologic factors|mesh-ancestor
93139809|NCT03303092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139810|NCT03851679|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93139811|NCT03851679|Natriuretic Agents|natriuretic agents|mesh-ancestor
93139812|NCT03851679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139813|NCT01192503|Rasagiline|rasagiline|mesh-list
93139814|NCT01192503|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93139815|NCT01192503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139816|NCT01192503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139817|NCT01192503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93139818|NCT01192503|Protective Agents|protective agents|mesh-ancestor
93139819|NCT01192503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139820|NCT01192581|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93139821|NCT01192581|Plasma Substitutes|plasma substitutes|mesh-ancestor
93139822|NCT01192581|Blood Substitutes|blood substitutes|mesh-ancestor
93139823|NCT03851289|Calcium|calcium|mesh-list
93139824|NCT03851289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139825|NCT03851289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139826|NCT03733899|Anesthetics|anesthetics|mesh-list
93139827|NCT03733899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139828|NCT03733899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139829|NCT01196013|Clofarabine|clofarabine|mesh-list
93139830|NCT01196013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93139831|NCT01196013|Antimetabolites|antimetabolites|mesh-ancestor
93139832|NCT01196013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139833|NCT01196013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139834|NCT01196169|Vancomycin|vancomycin|mesh-list
93139835|NCT01196169|Daptomycin|daptomycin|mesh-list
93139836|NCT01196169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139837|NCT01196169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139838|NCT01196481|Carvedilol|carvedilol|mesh-list
93139839|NCT01196481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93139840|NCT01196481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93139841|NCT01196481|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139842|NCT01196481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139843|NCT01196481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139844|NCT01196481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139845|NCT01196481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93139846|NCT01196481|Antioxidants|antioxidants|mesh-ancestor
93139847|NCT01196481|Protective Agents|protective agents|mesh-ancestor
93139848|NCT01196481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93139849|NCT01196481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93139850|NCT01196481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139851|NCT01196481|Vasodilator Agents|vasodilator agents|mesh-ancestor
93139852|NCT01196481|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93139853|NCT01196481|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93139854|NCT05283057|Empagliflozin|empagliflozin|mesh-list
93139855|NCT05283057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93139856|NCT05283057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139857|NCT05283057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93139858|NCT05283057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139859|NCT01193595|Bevacizumab|bevacizumab|mesh-list
93139860|NCT01193595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93139861|NCT01193595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139862|NCT01193595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93139863|NCT01193595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93139864|NCT01193595|Growth Substances|growth substances|mesh-ancestor
93139865|NCT01193595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139866|NCT01193595|Growth Inhibitors|growth inhibitors|mesh-ancestor
93139867|NCT01196559|Gemcitabine|gemcitabine|mesh-list
93139868|NCT01196559|Vinorelbine|vinorelbine|mesh-list
93139869|NCT01196559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93139870|NCT01196559|Antimetabolites|antimetabolites|mesh-ancestor
93139871|NCT01196559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139872|NCT01196559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139873|NCT01196559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93139874|NCT01196559|Tubulin Modulators|tubulin modulators|mesh-ancestor
93139875|NCT01196559|Antimitotic Agents|antimitotic agents|mesh-ancestor
93139876|NCT01196559|Mitosis Modulators|mitosis modulators|mesh-ancestor
93139877|NCT01295775|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
93139878|NCT01295775|Anticoagulants|anticoagulants|mesh-ancestor
93139879|NCT01295775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93139880|NCT01295775|Antimetabolites|antimetabolites|mesh-ancestor
93139881|NCT01295775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139882|NCT01295775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93139883|NCT01295775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93139884|NCT01295775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93139885|NCT01295775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93139886|NCT01295775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139887|NCT01581177|Albuterol|albuterol|mesh-list
93139888|NCT01581177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93139889|NCT01581177|Autonomic Agents|autonomic agents|mesh-ancestor
93139890|NCT01581177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139891|NCT01581177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139892|NCT01581177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93139893|NCT01581177|Respiratory System Agents|respiratory system agents|mesh-ancestor
93139894|NCT01581177|Tocolytic Agents|tocolytic agents|mesh-ancestor
93139895|NCT01581177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139896|NCT01581177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93139897|NCT01581177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93139898|NCT01581177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93139899|NCT01581177|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139900|NCT01581177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139901|NCT01581177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139902|NCT01580007|Cholecalciferol|cholecalciferol|mesh-list
93139903|NCT01580007|Vitamin D|vitamin d|mesh-list
93139904|NCT01580007|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93139905|NCT01580007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93139906|NCT01580007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139907|NCT01580007|Vitamins|vitamins|mesh-ancestor
93139908|NCT01580007|Micronutrients|micronutrients|mesh-ancestor
93139909|NCT01580007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93139910|NCT01580007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139911|NCT01189695|Ritonavir|ritonavir|mesh-list
93139912|NCT01189695|Lopinavir|lopinavir|mesh-list
93139913|NCT01189695|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93139914|NCT01189695|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93139915|NCT01189695|Protease Inhibitors|protease inhibitors|mesh-ancestor
93139916|NCT01189695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139917|NCT01189695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139918|NCT01189695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93139919|NCT01189695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93139920|NCT01189695|Antiviral Agents|antiviral agents|mesh-ancestor
93139921|NCT01189695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139922|NCT01189695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93139923|NCT01189695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93139924|NCT01196715|Darbepoetin alfa|darbepoetin alfa|mesh-list
93139925|NCT01196715|Hematinics|hematinics|mesh-ancestor
93139926|NCT03848091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93139927|NCT03848091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139928|NCT01189773|Ibuprofen|ibuprofen|mesh-list
93139929|NCT01189773|Codeine|codeine|mesh-list
93139930|NCT01189773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93139931|NCT01189773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93139932|NCT01189773|Analgesics|analgesics|mesh-ancestor
93139933|NCT01189773|Sensory System Agents|sensory system agents|mesh-ancestor
93139934|NCT01189773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93139935|NCT01189773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812082|NCT05766670|Vancomycin|vancomycin|mesh-list
93139936|NCT01189773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93139937|NCT01189773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93139938|NCT01189773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93139939|NCT01189773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139940|NCT01189773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139941|NCT01189773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93139943|NCT01189773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93139944|NCT01189773|Antitussive Agents|antitussive agents|mesh-ancestor
93139945|NCT01189773|Respiratory System Agents|respiratory system agents|mesh-ancestor
93139946|NCT01189929|Gemcitabine|gemcitabine|mesh-list
93139947|NCT01189929|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93139948|NCT01189929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93139949|NCT01189929|Antimetabolites|antimetabolites|mesh-ancestor
93139950|NCT01189929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139951|NCT01189929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139952|NCT03845673|Psyllium|psyllium|mesh-list
93139953|NCT03845673|Cathartics|cathartics|mesh-ancestor
93139954|NCT03845673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93139955|NCT01190163|Oxytocin|oxytocin|mesh-list
93139956|NCT01190163|Dinoprostone|dinoprostone|mesh-list
93139957|NCT01190163|Oxytocics|oxytocics|mesh-ancestor
93139958|NCT01190163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93139959|NCT01190163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139960|NCT01199445|Vitamin A|vitamin a|mesh-list
93139961|NCT01199445|Vitamins|vitamins|mesh-ancestor
93139962|NCT01199445|Micronutrients|micronutrients|mesh-ancestor
93139963|NCT01199445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139964|NCT01199523|Moxifloxacin|moxifloxacin|mesh-list
93139965|NCT01199523|Mirabegron|mirabegron|mesh-list
93139966|NCT01199523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93139967|NCT01199523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93139968|NCT01199523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93139969|NCT01199523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93139970|NCT01199523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139971|NCT01199523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139972|NCT01199523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139973|NCT01199523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139974|NCT01199523|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93139975|NCT01199523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93139976|NCT01199523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93139977|NCT01199523|Adrenergic Agents|adrenergic agents|mesh-ancestor
93139978|NCT01199523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93139979|NCT01199523|Urological Agents|urological agents|mesh-ancestor
93139980|NCT01190241|Everolimus|everolimus|mesh-list
93139981|NCT01190241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93139982|NCT01190241|Sorafenib|sorafenib|mesh-list
93139983|NCT01190241|Sunitinib|sunitinib|mesh-list
93139984|NCT01190241|Lapatinib|lapatinib|mesh-list
93139985|NCT01190241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93139986|NCT01190241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93139987|NCT01190241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93139988|NCT01190241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93139989|NCT01190241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93139990|NCT01190241|Immunologic Factors|immunologic factors|mesh-ancestor
93139991|NCT01190241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93139992|NCT01190241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93139993|NCT01190241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93139994|NCT01190241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93139995|NCT01190241|Growth Substances|growth substances|mesh-ancestor
93139996|NCT01190241|Growth Inhibitors|growth inhibitors|mesh-ancestor
93139997|NCT01197261|Oxycodone|oxycodone|mesh-list
93139998|NCT01197261|Naloxone|naloxone|mesh-list
93139999|NCT01197261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93140000|NCT01197261|Narcotics|narcotics|mesh-ancestor
93140001|NCT01197261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140002|NCT01197261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140003|NCT01197261|Analgesics|analgesics|mesh-ancestor
93140004|NCT01197261|Sensory System Agents|sensory system agents|mesh-ancestor
93140005|NCT01197261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140006|NCT01197261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93140007|NCT01190553|Amantadine|amantadine|mesh-list
93140008|NCT01190553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93140009|NCT01190553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93140010|NCT01190553|Antiviral Agents|antiviral agents|mesh-ancestor
93140011|NCT01190553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140012|NCT01190553|Dopamine Agents|dopamine agents|mesh-ancestor
93140013|NCT01190553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140014|NCT01190553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140015|NCT01190553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140016|NCT01190553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140017|NCT01190553|Analgesics|analgesics|mesh-ancestor
93140018|NCT01190553|Sensory System Agents|sensory system agents|mesh-ancestor
93140019|NCT01190553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140020|NCT01199757|Fluticasone|fluticasone|mesh-list
93140021|NCT01199757|Xhance|xhance|mesh-list
93140022|NCT01199757|Mometasone Furoate|mometasone furoate|mesh-list
93140023|NCT01199757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140024|NCT01199757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93140025|NCT01199757|Autonomic Agents|autonomic agents|mesh-ancestor
93140026|NCT01199757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140027|NCT01199757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140028|NCT01199757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93140029|NCT01199757|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140030|NCT01199757|Dermatologic Agents|dermatologic agents|mesh-ancestor
93140031|NCT01199757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93140032|NCT03302234|Pembrolizumab|pembrolizumab|mesh-list
93140033|NCT03302234|Ipilimumab|ipilimumab|mesh-list
93140034|NCT03302234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140035|NCT03302234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140036|NCT03302234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93140037|NCT03302234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140038|NCT03843879|Lidocaine|lidocaine|mesh-list
93140039|NCT03843879|Anesthetics, Local|anesthetics, local|mesh-ancestor
93140040|NCT03843879|Anesthetics|anesthetics|mesh-ancestor
93140041|NCT03843879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140042|NCT03843879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140043|NCT03843879|Sensory System Agents|sensory system agents|mesh-ancestor
93140044|NCT03843879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140045|NCT03843879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140046|NCT03843879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93140047|NCT03843879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93140048|NCT03843879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140049|NCT03843879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140050|NCT03850587|Celecoxib|celecoxib|mesh-list
93140051|NCT03850587|Tramadol|tramadol|mesh-list
93140052|NCT03850587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93140053|NCT03850587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140054|NCT03850587|Analgesics|analgesics|mesh-ancestor
93140055|NCT03850587|Sensory System Agents|sensory system agents|mesh-ancestor
93140056|NCT03850587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140057|NCT03850587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140058|NCT03850587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140059|NCT03850587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140060|NCT03850587|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93140061|NCT03850587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93140062|NCT03850587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140063|NCT03850587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140064|NCT03850587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93140065|NCT03850587|Narcotics|narcotics|mesh-ancestor
93140066|NCT03850587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140067|NCT01199835|Calcium|calcium|mesh-list
93140068|NCT01199835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93140069|NCT01199835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140070|NCT05671497|Antirheumatic Agents|antirheumatic agents|mesh-list
93140071|NCT05671497|Cilostazol|cilostazol|mesh-list
93140072|NCT05671497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93140073|NCT05671497|Autonomic Agents|autonomic agents|mesh-ancestor
93140074|NCT05671497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140075|NCT05671497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140076|NCT05671497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93140077|NCT05671497|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140078|NCT05671497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93140079|NCT05671497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93140080|NCT05671497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140081|NCT05671497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93140082|NCT05671497|Vasodilator Agents|vasodilator agents|mesh-ancestor
93140083|NCT05671497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93140084|NCT05671497|Protective Agents|protective agents|mesh-ancestor
93140085|NCT05671497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93140086|NCT05671497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92812235|NCT05519579|Methotrexate|methotrexate|mesh-list
93140087|NCT05671497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140088|NCT03915626|Rivastigmine|rivastigmine|mesh-list
93140089|NCT03915626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93140090|NCT03915626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140091|NCT03915626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140092|NCT03915626|Cholinergic Agents|cholinergic agents|mesh-ancestor
93140093|NCT03915626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140094|NCT03915626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140095|NCT03915626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93140096|NCT03915626|Protective Agents|protective agents|mesh-ancestor
93140097|NCT04491968|Methadone|methadone|mesh-list
93140098|NCT04491968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93140099|NCT04491968|Narcotics|narcotics|mesh-ancestor
93140100|NCT04491968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140101|NCT04491968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140102|NCT04491968|Analgesics|analgesics|mesh-ancestor
93140103|NCT04491968|Sensory System Agents|sensory system agents|mesh-ancestor
93140104|NCT04491968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140105|NCT04491968|Antitussive Agents|antitussive agents|mesh-ancestor
93140106|NCT04491968|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140107|NCT05668455|Dexamethasone|dexamethasone|mesh-list
93140108|NCT05668455|Hydrocortisone|hydrocortisone|mesh-list
93140109|NCT05668455|Povidone|povidone|mesh-list
93140110|NCT05668455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140111|NCT05668455|Antiemetics|antiemetics|mesh-ancestor
93140112|NCT05668455|Autonomic Agents|autonomic agents|mesh-ancestor
93140113|NCT05668455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435844|NCT01597531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93140114|NCT05668455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140115|NCT05668455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93140116|NCT05668455|Glucocorticoids|glucocorticoids|mesh-ancestor
93140117|NCT05668455|Hormones|hormones|mesh-ancestor
93140118|NCT05668455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140119|NCT05668455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93140120|NCT05668455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140121|NCT05668455|Plasma Substitutes|plasma substitutes|mesh-ancestor
93140122|NCT05668455|Blood Substitutes|blood substitutes|mesh-ancestor
93140123|NCT03313076|Vitamin D|vitamin d|mesh-list
93140124|NCT03313076|Ergocalciferols|ergocalciferols|mesh-list
93140125|NCT03313076|Cholecalciferol|cholecalciferol|mesh-list
93140126|NCT03313076|Vitamins|vitamins|mesh-list
93140127|NCT03313076|Micronutrients|micronutrients|mesh-ancestor
93140128|NCT03313076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140129|NCT03313076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93140130|NCT03313076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93140131|NCT01191021|Propofol|propofol|mesh-list
93140132|NCT01191021|Anesthetics|anesthetics|mesh-ancestor
93140133|NCT01191021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140134|NCT01191021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140135|NCT01191021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93140136|NCT01191021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93140137|NCT01191021|Anesthetics, General|anesthetics, general|mesh-ancestor
93140138|NCT01200537|Norinyl|norinyl|mesh-list
93140139|NCT01200537|Contraceptive Agents|contraceptive agents|mesh-list
93140140|NCT01200537|Contraceptives, Oral|contraceptives, oral|mesh-list
93140141|NCT01200537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93140142|NCT01200537|Estradiol|estradiol|mesh-list
93140143|NCT01200537|Estrogens|estrogens|mesh-ancestor
93140144|NCT01200537|Hormones|hormones|mesh-ancestor
93140145|NCT01200537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140146|NCT01200537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140147|NCT01200537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93140148|NCT01200537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93140149|NCT01200537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93140150|NCT01200537|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93140151|NCT01198353|Ziprasidone|ziprasidone|mesh-list
93140152|NCT01198353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93140153|NCT01198353|Serotonin Agents|serotonin agents|mesh-ancestor
93140154|NCT01198353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140155|NCT01198353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140156|NCT01198353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140157|NCT01198353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93140158|NCT01198353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93140159|NCT01198353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140160|NCT01198353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140161|NCT01198353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93140162|NCT01198353|Dopamine Agents|dopamine agents|mesh-ancestor
92812312|NCT05438264|Donepezil|donepezil|mesh-list
93140163|NCT01200693|Sirolimus|sirolimus|mesh-list
93140164|NCT01200693|Everolimus|everolimus|mesh-list
93140165|NCT01200693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93140166|NCT01200693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93140167|NCT01200693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140168|NCT01200693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140169|NCT01200693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93140170|NCT01200693|Immunologic Factors|immunologic factors|mesh-ancestor
93140171|NCT01200693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140172|NCT01200693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140173|NCT01200693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93140174|NCT01200693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140175|NCT01200693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93140176|NCT01200693|Antifungal Agents|antifungal agents|mesh-ancestor
93140177|NCT03844581|Propiverine|propiverine|mesh-list
93140178|NCT03844581|Parasympatholytics|parasympatholytics|mesh-ancestor
93140179|NCT03844581|Autonomic Agents|autonomic agents|mesh-ancestor
93140180|NCT03844581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140181|NCT03844581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140182|NCT03844581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93140183|NCT03844581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93140184|NCT03844581|Cholinergic Agents|cholinergic agents|mesh-ancestor
93140185|NCT03844581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140186|NCT03844581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140187|NCT03844581|Urological Agents|urological agents|mesh-ancestor
93140188|NCT01202097|Fluticasone|fluticasone|mesh-list
93140189|NCT01202097|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93140190|NCT01202097|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93140191|NCT01202097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140192|NCT01202097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93140193|NCT01202097|Autonomic Agents|autonomic agents|mesh-ancestor
93140194|NCT01202097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140195|NCT01202097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140196|NCT01202097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93140197|NCT01202097|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140198|NCT01202097|Dermatologic Agents|dermatologic agents|mesh-ancestor
93140199|NCT01202097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93140200|NCT01202097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93140201|NCT01202097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93140202|NCT01202097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93140203|NCT01202097|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140204|NCT01202097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140205|NCT01202097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140206|NCT01202097|Glucocorticoids|glucocorticoids|mesh-ancestor
93140207|NCT01202097|Hormones|hormones|mesh-ancestor
93140208|NCT01202097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140209|NCT01202097|Sympathomimetics|sympathomimetics|mesh-ancestor
93140210|NCT05670015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93140211|NCT05670015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93140212|NCT01201005|Hydroxocobalamin|hydroxocobalamin|mesh-list
93140213|NCT01201005|Vitamin B 12|vitamin b 12|mesh-list
93140214|NCT01201005|Hematinics|hematinics|mesh-ancestor
93140215|NCT01201005|Vitamin B Complex|vitamin b complex|mesh-ancestor
93140216|NCT01201005|Vitamins|vitamins|mesh-ancestor
93140217|NCT01201005|Micronutrients|micronutrients|mesh-ancestor
93140218|NCT01201005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140219|NCT01198665|Prednisolone|prednisolone|mesh-list
93140220|NCT01198665|Doxorubicin|doxorubicin|mesh-list
93140221|NCT01198665|Vincristine|vincristine|mesh-list
93140222|NCT01198665|Everolimus|everolimus|mesh-list
93140223|NCT01198665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93140224|NCT01198665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140225|NCT01198665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93140226|NCT01198665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93140227|NCT01198665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140228|NCT01198665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140229|NCT01198665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140230|NCT01198665|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140231|NCT01198665|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140232|NCT01198665|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140233|NCT01198665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93140234|NCT01198665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93140235|NCT01198665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93140236|NCT01198665|Immunologic Factors|immunologic factors|mesh-ancestor
93140237|NCT01198665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140238|NCT01198665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140240|NCT01198665|Hormones|hormones|mesh-ancestor
93140241|NCT01198665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140242|NCT01198665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93140243|NCT05030415|Ixekizumab|ixekizumab|mesh-list
93140244|NCT05030415|Dermatologic Agents|dermatologic agents|mesh-ancestor
93140245|NCT01198821|Gemcitabine|gemcitabine|mesh-list
93140246|NCT01198821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93140247|NCT01198821|Antimetabolites|antimetabolites|mesh-ancestor
93140248|NCT01198821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140249|NCT01198821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140250|NCT05013801|Hydroquinone|hydroquinone|mesh-list
93140251|NCT05013801|Antioxidants|antioxidants|mesh-ancestor
93140252|NCT05013801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140253|NCT05013801|Protective Agents|protective agents|mesh-ancestor
93140254|NCT05013801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140255|NCT05013801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93140256|NCT01566669|Parecoxib|parecoxib|mesh-list
93140257|NCT01566669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93140258|NCT01566669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93140259|NCT01566669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140260|NCT01566669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140261|NCT01566669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435998|NCT01598259|Melatonin|melatonin|mesh-list
93140262|NCT01566669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140263|NCT01566669|Analgesics|analgesics|mesh-ancestor
93140264|NCT01566669|Sensory System Agents|sensory system agents|mesh-ancestor
93140265|NCT01566669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140266|NCT01566669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140267|NCT01566669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140268|NCT01566669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140269|NCT03841773|Cyclobenzaprine|cyclobenzaprine|mesh-list
93140270|NCT03841773|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93140271|NCT03841773|Antidepressive Agents|antidepressive agents|mesh-ancestor
93140272|NCT03841773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140273|NCT03841773|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93140274|NCT03841773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140275|NCT03841773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93140276|NCT03841773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140277|NCT03841773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93140278|NCT03841773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140279|NCT01201161|Ranibizumab|ranibizumab|mesh-list
93140280|NCT01201161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93140281|NCT01201161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93140282|NCT01201161|Growth Substances|growth substances|mesh-ancestor
93140283|NCT01201161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140284|NCT01201161|Growth Inhibitors|growth inhibitors|mesh-ancestor
93140285|NCT01201161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140286|NCT03841383|Dipyridamole|dipyridamole|mesh-list
93140287|NCT03841383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93140288|NCT03841383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140289|NCT03841383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140290|NCT03841383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93140291|NCT03841383|Vasodilator Agents|vasodilator agents|mesh-ancestor
93140292|NCT05667987|Lidocaine|lidocaine|mesh-list
93140293|NCT05667987|Anesthetics, Local|anesthetics, local|mesh-ancestor
93140294|NCT05667987|Anesthetics|anesthetics|mesh-ancestor
93140295|NCT05667987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140296|NCT05667987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140297|NCT05667987|Sensory System Agents|sensory system agents|mesh-ancestor
93140298|NCT05667987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140299|NCT05667987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140300|NCT05667987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93140301|NCT05667987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93140302|NCT05667987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140303|NCT05667987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140304|NCT01201239|Raltegravir Potassium|raltegravir potassium|mesh-list
93140305|NCT01201239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93140306|NCT01201239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93140307|NCT01201239|Antiviral Agents|antiviral agents|mesh-ancestor
93140308|NCT01201239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140309|NCT01201239|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93140310|NCT01201239|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93140311|NCT01201239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140312|NCT01201239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140313|NCT01199367|Letrozole|letrozole|mesh-list
93140314|NCT01199367|Lapatinib|lapatinib|mesh-list
93140315|NCT01199367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140316|NCT01199367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93140317|NCT01199367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93140318|NCT01199367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140319|NCT01199367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140320|NCT01199367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93140321|NCT01199367|Hormone Antagonists|hormone antagonists|mesh-ancestor
93140322|NCT01199367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140323|NCT01199367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140324|NCT01199367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93140325|NCT01203735|Valproic Acid|valproic acid|mesh-list
93140326|NCT01203735|Anticonvulsants|anticonvulsants|mesh-ancestor
93140327|NCT01203735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140328|NCT01203735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140329|NCT01203735|GABA Agents|gaba agents|mesh-ancestor
93140330|NCT01203735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140331|NCT01203735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140332|NCT01203735|Antimanic Agents|antimanic agents|mesh-ancestor
93140333|NCT01203735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91927473|NCT00833521|GABA Agents|gaba agents|mesh-ancestor
93140334|NCT01203735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140335|NCT01203735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140336|NCT03842631|Timolol|timolol|mesh-list
93140337|NCT03842631|Maleic acid|maleic acid|mesh-list
93140338|NCT03842631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140339|NCT03842631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140340|NCT03842631|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93140341|NCT03842631|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93140342|NCT03842631|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140343|NCT03842631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140344|NCT03842631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140345|NCT03842631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140346|NCT03842631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93140347|NCT05669781|Metoclopramide|metoclopramide|mesh-list
93140348|NCT05669781|Antiemetics|antiemetics|mesh-ancestor
93140349|NCT05669781|Autonomic Agents|autonomic agents|mesh-ancestor
93140350|NCT05669781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140351|NCT05669781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140352|NCT05669781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93140353|NCT05669781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93140354|NCT05669781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93140355|NCT05669781|Dopamine Agents|dopamine agents|mesh-ancestor
93140356|NCT05669781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140357|NCT05669781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140358|NCT01202331|Azithromycin|azithromycin|mesh-list
93140359|NCT01202331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93140360|NCT01202331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140361|NCT01201551|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93140362|NCT01201551|Latanoprost|latanoprost|mesh-list
93140363|NCT01201551|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93140364|NCT01201551|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93140365|NCT01201551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93140366|NCT01201551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93140367|NCT01201551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93140368|NCT01201551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93140369|NCT01201551|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140370|NCT01201551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140371|NCT01201551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140372|NCT01201551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140373|NCT01204125|Paclitaxel|paclitaxel|mesh-list
93140374|NCT01204125|Iniparib|iniparib|mesh-list
93140375|NCT01204125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140376|NCT01204125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140377|NCT01204125|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140378|NCT01204125|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140379|NCT01204125|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140380|NCT01204125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140381|NCT01204125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93140382|NCT01204125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140383|NCT03074240|Anesthetics|anesthetics|mesh-list
93140384|NCT03074240|Anesthetics, General|anesthetics, general|mesh-list
93140385|NCT03074240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140387|NCT03725085|Guaifenesin|guaifenesin|mesh-list
93140388|NCT03725085|Expectorants|expectorants|mesh-ancestor
93140389|NCT03725085|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140390|NCT03755804|Prednisone|prednisone|mesh-list
93140391|NCT03755804|Prednisolone|prednisolone|mesh-list
93140392|NCT03755804|Cyclophosphamide|cyclophosphamide|mesh-list
93140393|NCT03755804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93140394|NCT03755804|Dacarbazine|dacarbazine|mesh-list
93140395|NCT03755804|Doxorubicin|doxorubicin|mesh-list
93140396|NCT03755804|Etoposide|etoposide|mesh-list
93140397|NCT03755804|Vincristine|vincristine|mesh-list
93140398|NCT03755804|Bleomycin|bleomycin|mesh-list
93140399|NCT03755804|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93140400|NCT03755804|Vinblastine|vinblastine|mesh-list
93140401|NCT03755804|Imidazole|imidazole|mesh-list
93140402|NCT03755804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93140403|NCT03755804|Immunologic Factors|immunologic factors|mesh-ancestor
93140404|NCT03755804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140405|NCT03755804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140406|NCT03755804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93140407|NCT03755804|Alkylating Agents|alkylating agents|mesh-ancestor
93140408|NCT03755804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140409|NCT03755804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140410|NCT03755804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93140411|NCT03755804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93140412|NCT03755804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93140413|NCT03755804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93140414|NCT03755804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140415|NCT03755804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140416|NCT03755804|Glucocorticoids|glucocorticoids|mesh-ancestor
93140417|NCT03755804|Hormones|hormones|mesh-ancestor
93140418|NCT03755804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140419|NCT03755804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93140420|NCT03755804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140421|NCT03755804|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140422|NCT03755804|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140423|NCT03755804|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140424|NCT03755804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140425|NCT03755804|Immunotoxins|immunotoxins|mesh-ancestor
93140426|NCT03755804|Immunoconjugates|immunoconjugates|mesh-ancestor
93140427|NCT01566825|Amitriptyline|amitriptyline|mesh-list
93140428|NCT01566825|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93140429|NCT01566825|Antidepressive Agents|antidepressive agents|mesh-ancestor
93140430|NCT01566825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140431|NCT01566825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140432|NCT01566825|Analgesics|analgesics|mesh-ancestor
93140433|NCT01566825|Sensory System Agents|sensory system agents|mesh-ancestor
93140434|NCT01566825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140435|NCT01566825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140436|NCT01566825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93140437|NCT01566825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93140438|NCT01566825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140439|NCT01566825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140440|NCT01566825|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140441|NCT01566825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140442|NCT03559010|Norgestrel|norgestrel|mesh-list
93140443|NCT03559010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93140444|NCT03559010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93140445|NCT03559010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93140446|NCT03559010|Contraceptive Agents|contraceptive agents|mesh-ancestor
93140447|NCT03559010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93140448|NCT03559010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140449|NCT03559010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93140450|NCT03559010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93140451|NCT03298412|Blinatumomab|blinatumomab|mesh-list
93140452|NCT03298412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140453|NCT03297398|Ascorbic Acid|ascorbic acid|mesh-list
93140454|NCT03297398|Methyltestosterone|methyltestosterone|mesh-list
93140455|NCT03297398|Androgens|androgens|mesh-list
93140456|NCT03297398|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93140457|NCT03297398|Hormones|hormones|mesh-ancestor
93140458|NCT03297398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140459|NCT03297398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812609|NCT04460872|Testosterone enanthate|testosterone enanthate|mesh-list
93140460|NCT03297398|Antioxidants|antioxidants|mesh-ancestor
93140461|NCT03297398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140462|NCT03297398|Protective Agents|protective agents|mesh-ancestor
93140464|NCT03297398|Micronutrients|micronutrients|mesh-ancestor
93140465|NCT03297398|Estrogens|estrogens|mesh-ancestor
93140466|NCT03297398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93140467|NCT03297398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140468|NCT03297398|Anabolic Agents|anabolic agents|mesh-ancestor
93140469|NCT03293654|Bevacizumab|bevacizumab|mesh-list
93140470|NCT03293654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140471|NCT03293654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140472|NCT03293654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93140473|NCT03293654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93140474|NCT03293654|Growth Substances|growth substances|mesh-ancestor
93140475|NCT03293654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140476|NCT03293654|Growth Inhibitors|growth inhibitors|mesh-ancestor
93140477|NCT03930615|Letermovir|letermovir|mesh-list
93140478|NCT03930615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93140479|NCT03930615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140480|NCT03930615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140481|NCT03930615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140482|NCT03930615|Antiviral Agents|antiviral agents|mesh-ancestor
93140483|NCT03930615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140484|NCT03838029|Etodolac|etodolac|mesh-list
93140485|NCT03838029|Propranolol|propranolol|mesh-list
93140486|NCT03838029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93140487|NCT03838029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93140488|NCT03838029|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140489|NCT03838029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140490|NCT03838029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140491|NCT03838029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140492|NCT03838029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140493|NCT03838029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93140494|NCT03838029|Vasodilator Agents|vasodilator agents|mesh-ancestor
93140495|NCT03838029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93140496|NCT03838029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140497|NCT03838029|Analgesics|analgesics|mesh-ancestor
93140498|NCT03838029|Sensory System Agents|sensory system agents|mesh-ancestor
93140499|NCT03838029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140500|NCT03838029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140501|NCT03838029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140502|NCT03838029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93140503|NCT03838029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93140504|NCT03838029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140505|NCT04708340|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
93140506|NCT04708340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140507|NCT04708340|Antioxidants|antioxidants|mesh-ancestor
93140508|NCT04708340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140509|NCT04708340|Protective Agents|protective agents|mesh-ancestor
93140510|NCT04708340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140511|NCT03292640|Nicotinic Acids|nicotinic acids|mesh-list
93140512|NCT03292640|Tazarotene|tazarotene|mesh-list
93140513|NCT03292640|Dermatologic Agents|dermatologic agents|mesh-ancestor
93140514|NCT03292640|Keratolytic Agents|keratolytic agents|mesh-ancestor
93140515|NCT03292640|Vitamin B Complex|vitamin b complex|mesh-ancestor
93140516|NCT03292640|Vitamins|vitamins|mesh-ancestor
93140517|NCT03292640|Micronutrients|micronutrients|mesh-ancestor
93140518|NCT03292640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140519|NCT01567215|Ethanol|ethanol|mesh-list
93140520|NCT01567215|Silver Nitrate|silver nitrate|mesh-list
93140521|NCT01567215|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93140522|NCT01567215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140523|NCT01567215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140524|NCT01567215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140525|NCT02871141|Antidepressive Agents|antidepressive agents|mesh-list
93140526|NCT02871141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140527|NCT01202487|Lidocaine|lidocaine|mesh-list
93140528|NCT01202487|Epinephrine|epinephrine|mesh-list
93140529|NCT01202487|Tetracaine|tetracaine|mesh-list
93140530|NCT01202487|Anesthetics, Local|anesthetics, local|mesh-ancestor
93140531|NCT01202487|Anesthetics|anesthetics|mesh-ancestor
93140532|NCT01202487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140533|NCT01202487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140534|NCT01202487|Sensory System Agents|sensory system agents|mesh-ancestor
93140535|NCT01202487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140536|NCT01202487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140537|NCT01202487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93140538|NCT01202487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93140539|NCT01202487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140540|NCT01202487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140541|NCT01202487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93140542|NCT01202487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93140543|NCT01202487|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140544|NCT01202487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140545|NCT01202487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93140546|NCT01202487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93140547|NCT01202487|Autonomic Agents|autonomic agents|mesh-ancestor
93140548|NCT01202487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93140549|NCT01202487|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140550|NCT01202487|Mydriatics|mydriatics|mesh-ancestor
93140551|NCT01202487|Sympathomimetics|sympathomimetics|mesh-ancestor
93140552|NCT01202487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93140554|NCT01204437|Cyclophosphamide|cyclophosphamide|mesh-list
93140555|NCT01204437|Capecitabine|capecitabine|mesh-list
93140556|NCT01204437|Methotrexate|methotrexate|mesh-list
93140557|NCT01204437|Epirubicin|epirubicin|mesh-list
93140558|NCT01204437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140559|NCT01204437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140560|NCT01204437|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140561|NCT01204437|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140562|NCT01204437|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140563|NCT01204437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140564|NCT01204437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93140565|NCT01204437|Immunologic Factors|immunologic factors|mesh-ancestor
93140566|NCT01204437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140567|NCT01204437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140568|NCT01204437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93140569|NCT01204437|Alkylating Agents|alkylating agents|mesh-ancestor
93140570|NCT01204437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93140571|NCT01204437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93140572|NCT01204437|Antimetabolites|antimetabolites|mesh-ancestor
93140573|NCT01204437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93140574|NCT01204437|Abortifacient Agents|abortifacient agents|mesh-ancestor
93140575|NCT01204437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93140576|NCT01204437|Dermatologic Agents|dermatologic agents|mesh-ancestor
93140577|NCT01204437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140578|NCT01204437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93140579|NCT01204437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93140580|NCT01204437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93140581|NCT01204437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93140582|NCT01204437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93140583|NCT02633241|Dexmedetomidine|dexmedetomidine|mesh-list
93140584|NCT02633241|Propofol|propofol|mesh-list
93140585|NCT02633241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93140586|NCT02633241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140587|NCT02633241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140588|NCT02633241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140589|NCT02633241|Analgesics|analgesics|mesh-ancestor
93140590|NCT02633241|Sensory System Agents|sensory system agents|mesh-ancestor
93140591|NCT02633241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140592|NCT02633241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93140593|NCT02633241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93140594|NCT02633241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93140595|NCT02633241|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140596|NCT02633241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140597|NCT02633241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140598|NCT02633241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93140599|NCT02633241|Anesthetics, General|anesthetics, general|mesh-ancestor
93140600|NCT02633241|Anesthetics|anesthetics|mesh-ancestor
93140601|NCT03292016|Apomorphine|apomorphine|mesh-list
93140602|NCT03292016|Emetics|emetics|mesh-ancestor
93140603|NCT03292016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140604|NCT03292016|Autonomic Agents|autonomic agents|mesh-ancestor
93140605|NCT03292016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140606|NCT03292016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93140607|NCT03292016|Dopamine Agonists|dopamine agonists|mesh-ancestor
93140608|NCT03292016|Dopamine Agents|dopamine agents|mesh-ancestor
93140609|NCT03292016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140610|NCT03292016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140611|NCT05669391|Antidepressive Agents|antidepressive agents|mesh-list
93140612|NCT05669391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140613|NCT01206075|Plerixafor|plerixafor|mesh-list
93140614|NCT01206075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93140615|NCT01206075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93140616|NCT01206075|Antiviral Agents|antiviral agents|mesh-ancestor
93140617|NCT01206075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140618|NCT03289676|Nicotine|nicotine|mesh-list
93140619|NCT03289676|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93140620|NCT03289676|Autonomic Agents|autonomic agents|mesh-ancestor
93140621|NCT03289676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140622|NCT03289676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140623|NCT03289676|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93140624|NCT03289676|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93140625|NCT03289676|Cholinergic Agents|cholinergic agents|mesh-ancestor
93140626|NCT03289676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140627|NCT03289676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140628|NCT03834831|Selenium|selenium|mesh-list
93140629|NCT03834831|Ubiquinone|ubiquinone|mesh-list
93140630|NCT03834831|Coenzyme Q10|coenzyme q10|mesh-list
93140631|NCT03834831|Antioxidants|antioxidants|mesh-ancestor
92854730|NCT00587847|Alemtuzumab|alemtuzumab|mesh-list
93140632|NCT03834831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140633|NCT03834831|Protective Agents|protective agents|mesh-ancestor
93140634|NCT03834831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140635|NCT03834831|Trace Elements|trace elements|mesh-ancestor
93140636|NCT03834831|Micronutrients|micronutrients|mesh-ancestor
93140637|NCT03834831|Vitamins|vitamins|mesh-ancestor
93140638|NCT01206153|Metformin|metformin|mesh-list
93140639|NCT01206153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93140640|NCT01206153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140641|NCT01298271|Propranolol|propranolol|mesh-list
93140642|NCT01298271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93140643|NCT01298271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93140644|NCT01298271|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140645|NCT01298271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140646|NCT01298271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140647|NCT01298271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140648|NCT01298271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140649|NCT01298271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93140650|NCT01298271|Vasodilator Agents|vasodilator agents|mesh-ancestor
93140651|NCT05281965|Tretinoin|tretinoin|mesh-list
93140652|NCT05281965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140653|NCT05281965|Keratolytic Agents|keratolytic agents|mesh-ancestor
93140654|NCT05281965|Dermatologic Agents|dermatologic agents|mesh-ancestor
93140655|NCT04251884|Ropivacaine|ropivacaine|mesh-list
93140656|NCT04251884|Anesthetics, Local|anesthetics, local|mesh-list
93140657|NCT04251884|Anesthetics|anesthetics|mesh-list
93140658|NCT04251884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140659|NCT04251884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140660|NCT04251884|Sensory System Agents|sensory system agents|mesh-ancestor
93140661|NCT04251884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140662|NCT01202799|Diclofenac|diclofenac|mesh-list
93140663|NCT01202799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93140664|NCT01202799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140665|NCT01202799|Analgesics|analgesics|mesh-ancestor
93140666|NCT01202799|Sensory System Agents|sensory system agents|mesh-ancestor
93140667|NCT01202799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140668|NCT01202799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140669|NCT01202799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140670|NCT01202799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140671|NCT01202799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93140672|NCT01202799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140673|NCT01202799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140674|NCT03829605|Hydrogen Sulfide|hydrogen sulfide|mesh-list
93140675|NCT03829605|Gasotransmitters|gasotransmitters|mesh-ancestor
93140676|NCT03829605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140677|NCT03829605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140678|NCT03829605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140679|NCT01298505|Fexofenadine|fexofenadine|mesh-list
93140680|NCT01298505|Terfenadine|terfenadine|mesh-list
93140681|NCT01298505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93140682|NCT01298505|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93140683|NCT01298505|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93140684|NCT01298505|Histamine Antagonists|histamine antagonists|mesh-ancestor
93140685|NCT01298505|Histamine Agents|histamine agents|mesh-ancestor
93140686|NCT01298505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140687|NCT01298505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140688|NCT01298505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140690|NCT01204593|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93140691|NCT01204593|Insulin Glargine|insulin glargine|mesh-list
93140692|NCT01204593|Insulin glulisine|insulin glulisine|mesh-list
93140693|NCT01204593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93140694|NCT01204593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140695|NCT03310970|Lidocaine|lidocaine|mesh-list
93140696|NCT03310970|Anesthetics, Local|anesthetics, local|mesh-ancestor
93140697|NCT03310970|Anesthetics|anesthetics|mesh-ancestor
93140698|NCT03310970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140699|NCT03310970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140700|NCT03310970|Sensory System Agents|sensory system agents|mesh-ancestor
93140701|NCT03310970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140702|NCT03310970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140703|NCT03310970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93140704|NCT03310970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93140705|NCT03310970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436443|NCT05191797|Immunoglobulin G|immunoglobulin g|mesh-list
93140706|NCT03310970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140707|NCT03427814|Pamiparib|pamiparib|mesh-list
93140708|NCT03427814|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93140709|NCT03427814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140710|NCT03427814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140711|NCT03427814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140712|NCT05281419|Triamcinolone|triamcinolone|mesh-list
93140713|NCT05281419|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93140714|NCT05281419|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93140715|NCT05281419|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93140716|NCT05281419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140717|NCT05281419|Glucocorticoids|glucocorticoids|mesh-ancestor
93140718|NCT05281419|Hormones|hormones|mesh-ancestor
93140719|NCT05281419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140720|NCT05281419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140721|NCT05281419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93140722|NCT05281419|Immunologic Factors|immunologic factors|mesh-ancestor
93140723|NCT05281419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140724|NCT05281419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140725|NCT04427072|Docetaxel|docetaxel|mesh-list
93140726|NCT04427072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140727|NCT04427072|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140728|NCT04427072|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140729|NCT04427072|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140730|NCT04427072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140731|NCT03537651|Ivacaftor|ivacaftor|mesh-list
93140732|NCT03537651|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93140733|NCT03537651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140734|NCT03537651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140735|NCT01203111|Insulin|insulin|mesh-list
93140736|NCT01203111|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93140737|NCT01203111|Insulin Glargine|insulin glargine|mesh-list
93140738|NCT01203111|Insulin glulisine|insulin glulisine|mesh-list
93140739|NCT01203111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93140740|NCT01203111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140741|NCT02722941|Panobinostat|panobinostat|mesh-list
93140742|NCT02722941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140743|NCT02722941|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93140744|NCT02722941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140745|NCT02722941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140746|NCT03420339|Adderall|adderall|mesh-list
93140747|NCT03420339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93140748|NCT03420339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140749|NCT01297179|Levonorgestrel|levonorgestrel|mesh-list
93140750|NCT01297179|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93140751|NCT01297179|Mirabegron|mirabegron|mesh-list
93140752|NCT01297179|Estradiol|estradiol|mesh-list
93140753|NCT01297179|Estrogens|estrogens|mesh-ancestor
93140754|NCT01297179|Hormones|hormones|mesh-ancestor
93140755|NCT01297179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140756|NCT01297179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140757|NCT01297179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93140758|NCT01297179|Contraceptive Agents|contraceptive agents|mesh-ancestor
92812918|NCT03098836|Prednisone|prednisone|mesh-list
93140759|NCT01297179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93140760|NCT01297179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93140761|NCT01297179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93140762|NCT01297179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93140763|NCT01297179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93140764|NCT01297179|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93140765|NCT01297179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93140766|NCT01297179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93140767|NCT01297179|Adrenergic Agents|adrenergic agents|mesh-ancestor
93140768|NCT01297179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140769|NCT01297179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140770|NCT01297179|Urological Agents|urological agents|mesh-ancestor
93140772|NCT01205139|Rilpivirine|rilpivirine|mesh-list
93140773|NCT01205139|Antiviral Agents|antiviral agents|mesh-ancestor
93140774|NCT01205139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140775|NCT01205139|Protease Inhibitors|protease inhibitors|mesh-ancestor
93140776|NCT01205139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140777|NCT01205139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140778|NCT01205139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92436521|NCT04873557|Copper|copper|mesh-list
93140779|NCT01205139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93140780|NCT01205139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93140781|NCT01205139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93140782|NCT01205217|Paclitaxel|paclitaxel|mesh-list
93140783|NCT01205217|Cyclophosphamide|cyclophosphamide|mesh-list
93140784|NCT01205217|Trastuzumab|trastuzumab|mesh-list
93140785|NCT01205217|Epirubicin|epirubicin|mesh-list
93140786|NCT01205217|Lapatinib|lapatinib|mesh-list
93140787|NCT01205217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140788|NCT01205217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140789|NCT01205217|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140790|NCT01205217|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140791|NCT01205217|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140792|NCT01205217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140793|NCT01205217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93140794|NCT01205217|Immunologic Factors|immunologic factors|mesh-ancestor
93140795|NCT01205217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140796|NCT01205217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140797|NCT01205217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93140798|NCT01205217|Alkylating Agents|alkylating agents|mesh-ancestor
93140799|NCT01205217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93140800|NCT01205217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140801|NCT01205217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93140802|NCT01205217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93140803|NCT01205217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93140804|NCT01205217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140805|NCT01205217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93140806|NCT01203267|Paclitaxel|paclitaxel|mesh-list
93140807|NCT01203267|Carboplatin|carboplatin|mesh-list
93140808|NCT01203267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140809|NCT01203267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140810|NCT01203267|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140811|NCT01203267|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140812|NCT01203267|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140813|NCT01203267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140814|NCT01207245|Tobramycin|tobramycin|mesh-list
93140815|NCT01207245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93140816|NCT01207245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140817|NCT01297569|Ranibizumab|ranibizumab|mesh-list
93140818|NCT01297569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93140819|NCT01297569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93140820|NCT01297569|Growth Substances|growth substances|mesh-ancestor
93140821|NCT01297569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140822|NCT01297569|Growth Inhibitors|growth inhibitors|mesh-ancestor
93140823|NCT01297569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140824|NCT01203345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93140825|NCT01203345|Immunologic Factors|immunologic factors|mesh-ancestor
93140826|NCT01203345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140827|NCT01299597|Atorvastatin|atorvastatin|mesh-list
93140828|NCT01299597|Simvastatin|simvastatin|mesh-list
93140829|NCT01299597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93140830|NCT01299597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93140831|NCT01299597|Antimetabolites|antimetabolites|mesh-ancestor
93140832|NCT01299597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140833|NCT01299597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93140834|NCT01299597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93140835|NCT01299597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140837|NCT03723915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140838|NCT03723915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140839|NCT03723915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93140840|NCT03723915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140841|NCT03840057|Azithromycin|azithromycin|mesh-list
93140842|NCT03840057|Metoclopramide|metoclopramide|mesh-list
93140843|NCT03840057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93140844|NCT03840057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140845|NCT03840057|Antiemetics|antiemetics|mesh-ancestor
93140846|NCT03840057|Autonomic Agents|autonomic agents|mesh-ancestor
93140847|NCT03840057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140848|NCT03840057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140849|NCT03840057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93140850|NCT03840057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93140851|NCT03840057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93140852|NCT03840057|Dopamine Agents|dopamine agents|mesh-ancestor
93140853|NCT03840057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140854|NCT03840057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140855|NCT01297803|Mitomycins|mitomycins|mesh-list
93140856|NCT01297803|Mitomycin|mitomycin|mesh-list
93140857|NCT01297803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93140858|NCT01297803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140859|NCT01297803|Alkylating Agents|alkylating agents|mesh-ancestor
93140860|NCT01297803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140861|NCT01297803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93140862|NCT01297803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140863|NCT03824691|Durvalumab|durvalumab|mesh-list
93140864|NCT03824691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140865|NCT03824691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140866|NCT01299831|Hormones|hormones|mesh-list
93140867|NCT01299831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140868|NCT01299831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140869|NCT01205997|Magnesium Sulfate|magnesium sulfate|mesh-list
93140870|NCT01205997|Fentanyl|fentanyl|mesh-list
93140871|NCT01205997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93140872|NCT01205997|Narcotics|narcotics|mesh-ancestor
93140873|NCT01205997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140874|NCT01205997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140875|NCT01205997|Analgesics|analgesics|mesh-ancestor
93140876|NCT01205997|Sensory System Agents|sensory system agents|mesh-ancestor
93140877|NCT01205997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140878|NCT01205997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93140879|NCT01205997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93140880|NCT01205997|Anesthetics, General|anesthetics, general|mesh-ancestor
93140881|NCT01205997|Anesthetics|anesthetics|mesh-ancestor
93140882|NCT01205997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140883|NCT01205997|Anticonvulsants|anticonvulsants|mesh-ancestor
93140884|NCT01205997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93140885|NCT01205997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140886|NCT01205997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140887|NCT01205997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93140888|NCT01205997|Tocolytic Agents|tocolytic agents|mesh-ancestor
93140889|NCT01205997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93140890|NCT03818997|Paclitaxel|paclitaxel|mesh-list
93140891|NCT03818997|Atezolizumab|atezolizumab|mesh-list
93140892|NCT03818997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93140893|NCT03818997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93140894|NCT03818997|Tubulin Modulators|tubulin modulators|mesh-ancestor
93140895|NCT03818997|Antimitotic Agents|antimitotic agents|mesh-ancestor
93140896|NCT03818997|Mitosis Modulators|mitosis modulators|mesh-ancestor
93140897|NCT03818997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140898|NCT03818997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93140899|NCT03818997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93140900|NCT03818919|Acetaminophen|acetaminophen|mesh-list
93140901|NCT03818919|Celecoxib|celecoxib|mesh-list
93140902|NCT03818919|Ketorolac|ketorolac|mesh-list
93140903|NCT03818919|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93140904|NCT03818919|Diazepam|diazepam|mesh-list
93140905|NCT03818919|Gabapentin|gabapentin|mesh-list
93140906|NCT03818919|Hydrocodone|hydrocodone|mesh-list
93140907|NCT03818919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93140908|NCT03818919|Analgesics|analgesics|mesh-ancestor
93140909|NCT03818919|Sensory System Agents|sensory system agents|mesh-ancestor
93140910|NCT03818919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140911|NCT03818919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140913|NCT03818919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93140914|NCT03818919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93140915|NCT03818919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93140916|NCT03818919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93140917|NCT03818919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93140918|NCT03818919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140919|NCT03818919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140920|NCT03818919|Anticonvulsants|anticonvulsants|mesh-ancestor
93140921|NCT03818919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93140922|NCT03818919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93140923|NCT03818919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140924|NCT03818919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93140925|NCT03818919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93140926|NCT03818919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93140927|NCT03818919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93140928|NCT03818919|Antimanic Agents|antimanic agents|mesh-ancestor
93140929|NCT03818919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93140930|NCT03818919|Narcotics|narcotics|mesh-ancestor
93140931|NCT03818919|Antitussive Agents|antitussive agents|mesh-ancestor
93140932|NCT03818919|Respiratory System Agents|respiratory system agents|mesh-ancestor
93140933|NCT03818919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93140934|NCT03818919|Antiemetics|antiemetics|mesh-ancestor
93140935|NCT03818919|Autonomic Agents|autonomic agents|mesh-ancestor
93140936|NCT03818919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93140937|NCT03818919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93140938|NCT03818919|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93140939|NCT03818919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93140940|NCT03818919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93140941|NCT03818919|Anesthetics, General|anesthetics, general|mesh-ancestor
93140942|NCT03818919|Anesthetics|anesthetics|mesh-ancestor
93140943|NCT03818919|GABA Modulators|gaba modulators|mesh-ancestor
93140944|NCT03818919|GABA Agents|gaba agents|mesh-ancestor
93140945|NCT03821493|Itraconazole|itraconazole|mesh-list
93140946|NCT03821493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93140947|NCT03821493|Antifungal Agents|antifungal agents|mesh-ancestor
93140948|NCT03821493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140949|NCT03821493|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93140950|NCT03821493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93140951|NCT03821493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93140952|NCT03821493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140953|NCT03821493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93140954|NCT03821493|Hormone Antagonists|hormone antagonists|mesh-ancestor
93140955|NCT03821493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93140956|NCT03821493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140957|NCT03821493|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93140958|NCT01301937|Meglumine Antimoniate|meglumine antimoniate|mesh-list
93140959|NCT01301937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93140960|NCT01301937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93140961|NCT01301937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93140962|NCT05618223|Dapagliflozin|dapagliflozin|mesh-list
93140963|NCT05618223|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93140964|NCT05618223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140965|NCT05618223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93140966|NCT05618223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140967|NCT03814629|Vitamins|vitamins|mesh-list
93140968|NCT03814629|Micronutrients|micronutrients|mesh-ancestor
93140969|NCT03814629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140970|NCT01585935|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93140971|NCT01585935|SMOFlipid|smoflipid|mesh-list
93140972|NCT01585935|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93140973|NCT01585935|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93140974|NCT01585935|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93140975|NCT01300377|Lidocaine|lidocaine|mesh-list
93140976|NCT01300377|Bupivacaine|bupivacaine|mesh-list
93140977|NCT01300377|Anesthetics, Local|anesthetics, local|mesh-ancestor
93140978|NCT01300377|Anesthetics|anesthetics|mesh-ancestor
93140979|NCT01300377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93140980|NCT01300377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140981|NCT01300377|Sensory System Agents|sensory system agents|mesh-ancestor
93140982|NCT01300377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93140983|NCT01300377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93140984|NCT01300377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93140985|NCT01300377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93140986|NCT01300377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93140987|NCT01300377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140988|NCT03814707|Hyaluronic Acid|hyaluronic acid|mesh-list
93140989|NCT03814707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93140990|NCT03814707|Immunologic Factors|immunologic factors|mesh-ancestor
93140991|NCT03814707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93140992|NCT03814707|Viscosupplements|viscosupplements|mesh-ancestor
93140993|NCT03814707|Protective Agents|protective agents|mesh-ancestor
93140994|NCT03818295|Praliciguat|praliciguat|mesh-list
93140995|NCT03818295|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93140996|NCT03818295|Enzyme Activators|enzyme activators|mesh-ancestor
93140997|NCT03818295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93140998|NCT03818295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93140999|NCT01300611|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93141000|NCT01300611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93141001|NCT01300611|Vasodilator Agents|vasodilator agents|mesh-ancestor
93141002|NCT01301313|Simendan|simendan|mesh-list
93141003|NCT01301313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93141004|NCT01301313|Vasodilator Agents|vasodilator agents|mesh-ancestor
93141005|NCT01301313|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93141006|NCT01301313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93141007|NCT01301313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141008|NCT01301313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141009|NCT01301313|Protective Agents|protective agents|mesh-ancestor
93141010|NCT01301313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141011|NCT03817359|Remifentanil|remifentanil|mesh-list
93141012|NCT03817359|Propofol|propofol|mesh-list
93141013|NCT03817359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93141014|NCT03817359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141015|NCT03817359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141016|NCT03817359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141017|NCT03817359|Anesthetics, General|anesthetics, general|mesh-ancestor
93141018|NCT03817359|Anesthetics|anesthetics|mesh-ancestor
93141019|NCT03817359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141020|NCT03817359|Narcotics|narcotics|mesh-ancestor
93141021|NCT03817359|Analgesics|analgesics|mesh-ancestor
93141022|NCT03817359|Sensory System Agents|sensory system agents|mesh-ancestor
93141023|NCT03817359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141024|NCT03813927|Vitamin D|vitamin d|mesh-list
93141025|NCT03813927|Vitamins|vitamins|mesh-ancestor
93141026|NCT03813927|Micronutrients|micronutrients|mesh-ancestor
93141027|NCT03813927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141028|NCT03813927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93141029|NCT02819518|Paclitaxel|paclitaxel|mesh-list
93141030|NCT02819518|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93141031|NCT02819518|Carboplatin|carboplatin|mesh-list
93141032|NCT02819518|Gemcitabine|gemcitabine|mesh-list
93141033|NCT02819518|Pembrolizumab|pembrolizumab|mesh-list
93141034|NCT02819518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93141035|NCT02819518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141036|NCT02819518|Tubulin Modulators|tubulin modulators|mesh-ancestor
93141037|NCT02819518|Antimitotic Agents|antimitotic agents|mesh-ancestor
93141038|NCT02819518|Mitosis Modulators|mitosis modulators|mesh-ancestor
93141039|NCT02819518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141040|NCT02819518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93141041|NCT02819518|Antimetabolites|antimetabolites|mesh-ancestor
93141042|NCT02819518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93141043|NCT02819518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93141044|NCT03310580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93141045|NCT03310580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93141046|NCT03813771|Hydroxychloroquine|hydroxychloroquine|mesh-list
93141047|NCT03813771|Sulfasalazine|sulfasalazine|mesh-list
93141048|NCT03813771|Etanercept|etanercept|mesh-list
93141049|NCT03813771|Methotrexate|methotrexate|mesh-list
93141050|NCT03813771|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93141051|NCT03813771|Abortifacient Agents|abortifacient agents|mesh-ancestor
93141052|NCT03813771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93141053|NCT03813771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141054|NCT03813771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93141055|NCT03813771|Antimetabolites|antimetabolites|mesh-ancestor
93141056|NCT03813771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141057|NCT03813771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813218|NCT02796183|Bevacizumab|bevacizumab|mesh-list
93141058|NCT03813771|Dermatologic Agents|dermatologic agents|mesh-ancestor
93141059|NCT03813771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141060|NCT03813771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93141061|NCT03813771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93141062|NCT03813771|Immunologic Factors|immunologic factors|mesh-ancestor
93141063|NCT03813771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93141064|NCT03813771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93141065|NCT03813771|Antimalarials|antimalarials|mesh-ancestor
93141066|NCT03813771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93141067|NCT03813771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93141068|NCT03813771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141069|NCT03813771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93141070|NCT03813771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93141071|NCT03813771|Analgesics|analgesics|mesh-ancestor
93141072|NCT03813771|Sensory System Agents|sensory system agents|mesh-ancestor
93141073|NCT03813771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141074|NCT03813771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93141075|NCT03813771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141076|NCT03813693|Chlorhexidine|chlorhexidine|mesh-list
93141077|NCT03813693|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93141078|NCT03813693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93141079|NCT03813693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141080|NCT03813693|Disinfectants|disinfectants|mesh-ancestor
93141081|NCT03813693|Dermatologic Agents|dermatologic agents|mesh-ancestor
93141082|NCT02036242|Sufentanil|sufentanil|mesh-list
93141083|NCT02036242|Ropivacaine|ropivacaine|mesh-list
93141084|NCT02036242|Anesthetics, Local|anesthetics, local|mesh-list
93141085|NCT02036242|Anesthetics|anesthetics|mesh-list
93141086|NCT02036242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141087|NCT02036242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141088|NCT02036242|Sensory System Agents|sensory system agents|mesh-ancestor
93141089|NCT02036242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141090|NCT02036242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141091|NCT02036242|Narcotics|narcotics|mesh-ancestor
93141092|NCT02036242|Analgesics|analgesics|mesh-ancestor
93141093|NCT02036242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93141094|NCT02036242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141095|NCT02036242|Anesthetics, General|anesthetics, general|mesh-ancestor
93141096|NCT05281107|Calcium, Dietary|calcium, dietary|mesh-list
93141097|NCT05281107|Vitamin D|vitamin d|mesh-list
93141098|NCT05281107|Ergocalciferols|ergocalciferols|mesh-list
93141099|NCT05281107|Cholecalciferol|cholecalciferol|mesh-list
93141100|NCT05281107|Vitamins|vitamins|mesh-list
93141101|NCT05281107|Calcium|calcium|mesh-list
93141102|NCT05281107|Micronutrients|micronutrients|mesh-ancestor
93141103|NCT05281107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141104|NCT05281107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93141105|NCT05281107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93141106|NCT02812186|Rocuronium|rocuronium|mesh-list
93141107|NCT02812186|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93141108|NCT02812186|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93141109|NCT02812186|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93141110|NCT02812186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141111|NCT02812186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141112|NCT03310268|Listerine|listerine|mesh-list
93141113|NCT03310268|Fluorides|fluorides|mesh-list
93141114|NCT03310268|Sodium Fluoride|sodium fluoride|mesh-list
93141115|NCT03310268|Tin Fluorides|tin fluorides|mesh-list
93141116|NCT03310268|Fluorophosphate|fluorophosphate|mesh-list
93141117|NCT03310268|Cariostatic Agents|cariostatic agents|mesh-ancestor
93141118|NCT03310268|Protective Agents|protective agents|mesh-ancestor
93141119|NCT03310268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141120|NCT03310268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93141121|NCT03310268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141122|NCT01301469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93141123|NCT02810392|Insulin|insulin|mesh-list
93141124|NCT02810392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93141125|NCT02810392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93141126|NCT02810392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141127|NCT03805035|Chlorpheniramine|chlorpheniramine|mesh-list
93141128|NCT03805035|Maleic acid|maleic acid|mesh-list
93141129|NCT03805035|Histamine Antagonists|histamine antagonists|mesh-list
93141130|NCT03805035|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93141131|NCT03805035|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93141132|NCT03805035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141133|NCT03805035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141134|NCT03805035|Histamine Agents|histamine agents|mesh-ancestor
93141135|NCT03805035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141136|NCT03805035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141137|NCT03805035|Antipruritics|antipruritics|mesh-ancestor
93141138|NCT03805035|Dermatologic Agents|dermatologic agents|mesh-ancestor
93141139|NCT03805035|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93141141|NCT02815540|Anticonvulsants|anticonvulsants|mesh-ancestor
93141142|NCT03816267|Albuterol|albuterol|mesh-list
93141143|NCT03816267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93141144|NCT03816267|Autonomic Agents|autonomic agents|mesh-ancestor
93141145|NCT03816267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141146|NCT03816267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141147|NCT03816267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93141148|NCT03816267|Respiratory System Agents|respiratory system agents|mesh-ancestor
93141149|NCT03816267|Tocolytic Agents|tocolytic agents|mesh-ancestor
93141150|NCT03816267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93141151|NCT03816267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93141152|NCT03816267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93141153|NCT03816267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93141154|NCT03816267|Adrenergic Agents|adrenergic agents|mesh-ancestor
93141155|NCT03816267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141156|NCT03816267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141157|NCT03280550|Omalizumab|omalizumab|mesh-list
93141158|NCT03280550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93141159|NCT03280550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93141160|NCT03280550|Respiratory System Agents|respiratory system agents|mesh-ancestor
93141161|NCT02036554|Mycophenolic Acid|mycophenolic acid|mesh-list
93141162|NCT02036554|Everolimus|everolimus|mesh-list
93141163|NCT02036554|Tacrolimus|tacrolimus|mesh-list
93141164|NCT02036554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93141165|NCT02036554|Immunologic Factors|immunologic factors|mesh-ancestor
93141166|NCT02036554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141167|NCT02036554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93141168|NCT02036554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141169|NCT02036554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141170|NCT02036554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93141171|NCT02036554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93141172|NCT02036554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141173|NCT02036554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93141174|NCT02036554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93141175|NCT02036554|Antitubercular Agents|antitubercular agents|mesh-ancestor
93141176|NCT02036554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93141177|NCT02036554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141178|NCT05577117|Fentanyl|fentanyl|mesh-list
93141179|NCT05577117|Dexmedetomidine|dexmedetomidine|mesh-list
93141180|NCT05577117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93141181|NCT05577117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141182|NCT05577117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141183|NCT05577117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93141184|NCT05577117|Analgesics|analgesics|mesh-ancestor
93141185|NCT05577117|Sensory System Agents|sensory system agents|mesh-ancestor
93141186|NCT05577117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141187|NCT05577117|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93141188|NCT05577117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93141189|NCT05577117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93141190|NCT05577117|Adrenergic Agents|adrenergic agents|mesh-ancestor
93141191|NCT05577117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141192|NCT05577117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141193|NCT05577117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141194|NCT05577117|Narcotics|narcotics|mesh-ancestor
93141195|NCT05577117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93141196|NCT05577117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141197|NCT05577117|Anesthetics, General|anesthetics, general|mesh-ancestor
93141198|NCT05577117|Anesthetics|anesthetics|mesh-ancestor
93141199|NCT03813303|Fentanyl|fentanyl|mesh-list
93141200|NCT03813303|Midazolam|midazolam|mesh-list
93141201|NCT03813303|Propofol|propofol|mesh-list
93141202|NCT03813303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93141203|NCT03813303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141204|NCT03813303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141205|NCT03813303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141206|NCT03813303|Anesthetics, General|anesthetics, general|mesh-ancestor
93141207|NCT03813303|Anesthetics|anesthetics|mesh-ancestor
93141208|NCT03813303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141209|NCT03813303|Narcotics|narcotics|mesh-ancestor
93141210|NCT03813303|Analgesics|analgesics|mesh-ancestor
93141211|NCT03813303|Sensory System Agents|sensory system agents|mesh-ancestor
93141212|NCT03813303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141213|NCT03813303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93141214|NCT03813303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93141215|NCT03813303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93141216|NCT03813303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93141217|NCT03813303|GABA Modulators|gaba modulators|mesh-ancestor
93141219|NCT03813303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141220|NCT03813303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141221|NCT05562063|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93141222|NCT05562063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93141223|NCT05562063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141224|NCT05562063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93141225|NCT05562063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141226|NCT03637790|Rifampin|rifampin|mesh-list
93141227|NCT03637790|Abrocitinib|abrocitinib|mesh-list
93141228|NCT03637790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93141229|NCT03637790|Antitubercular Agents|antitubercular agents|mesh-ancestor
93141230|NCT03637790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93141231|NCT03637790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141232|NCT03637790|Leprostatic Agents|leprostatic agents|mesh-ancestor
93141233|NCT03637790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93141234|NCT03637790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141235|NCT03637790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141236|NCT03637790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93141237|NCT03637790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93141238|NCT03637790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93141239|NCT03637790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93141240|NCT03637790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93141241|NCT03637790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93141242|NCT03637790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93141243|NCT03813069|Permethrin|permethrin|mesh-list
93141244|NCT03813069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141245|NCT03813069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141246|NCT03276026|Neostigmine|neostigmine|mesh-list
93141247|NCT03276026|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93141248|NCT03276026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141249|NCT03276026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141250|NCT03276026|Cholinergic Agents|cholinergic agents|mesh-ancestor
93141251|NCT03276026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141252|NCT03276026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141253|NCT03276026|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93141254|NCT03276026|Autonomic Agents|autonomic agents|mesh-ancestor
93141255|NCT03276026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141256|NCT01303497|Paclitaxel|paclitaxel|mesh-list
93141257|NCT01303497|Bevacizumab|bevacizumab|mesh-list
93141258|NCT01303497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93141259|NCT01303497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141260|NCT01303497|Tubulin Modulators|tubulin modulators|mesh-ancestor
93141261|NCT01303497|Antimitotic Agents|antimitotic agents|mesh-ancestor
93141262|NCT01303497|Mitosis Modulators|mitosis modulators|mesh-ancestor
93141263|NCT01303497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141264|NCT01303497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93141265|NCT01303497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93141266|NCT01303497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93141267|NCT01303497|Growth Substances|growth substances|mesh-ancestor
93141268|NCT01303497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141269|NCT01303497|Growth Inhibitors|growth inhibitors|mesh-ancestor
93141270|NCT01589523|Cholic Acids|cholic acids|mesh-list
93141271|NCT01589523|Glycocholic Acid|glycocholic acid|mesh-list
93141272|NCT01589523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141273|NCT01589523|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93141274|NCT03804177|Ascorbic Acid|ascorbic acid|mesh-list
93141275|NCT03804177|Melatonin|melatonin|mesh-list
93141276|NCT03804177|Hyaluronic Acid|hyaluronic acid|mesh-list
93141277|NCT03804177|Antioxidants|antioxidants|mesh-ancestor
93141278|NCT03804177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141279|NCT03804177|Protective Agents|protective agents|mesh-ancestor
93141280|NCT03804177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141281|NCT03804177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141282|NCT03804177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93141283|NCT03804177|Immunologic Factors|immunologic factors|mesh-ancestor
93141284|NCT03804177|Viscosupplements|viscosupplements|mesh-ancestor
93141285|NCT03804177|Vitamins|vitamins|mesh-ancestor
93141287|NCT03277352|Pembrolizumab|pembrolizumab|mesh-list
93141288|NCT03277352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93141289|NCT03277352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141290|NCT03277352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93141291|NCT03277352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141292|NCT01302093|Racecadotril|racecadotril|mesh-list
93141293|NCT01302093|Thiorphan|thiorphan|mesh-list
93141294|NCT01302093|Antidiarrheals|antidiarrheals|mesh-ancestor
93141295|NCT01302093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141296|NCT01302093|Protease Inhibitors|protease inhibitors|mesh-ancestor
93141297|NCT01302093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141298|NCT01302093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141299|NCT03803007|Glenzocimab|glenzocimab|mesh-list
93141300|NCT03803007|Anticoagulants|anticoagulants|mesh-ancestor
93141301|NCT03802149|Ulipristal acetate|ulipristal acetate|mesh-list
93141302|NCT03802149|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93141303|NCT03802149|Contraceptive Agents|contraceptive agents|mesh-ancestor
93141304|NCT03802149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93141305|NCT03802149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141306|NCT03802149|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93141307|NCT02047552|Iron|iron|mesh-list
91927846|NCT02274259|Growth Inhibitors|growth inhibitors|mesh-ancestor
93141308|NCT02047552|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93141309|NCT02047552|Oxandrolone|oxandrolone|mesh-list
93141310|NCT02047552|Trace Elements|trace elements|mesh-ancestor
93141311|NCT02047552|Micronutrients|micronutrients|mesh-ancestor
93141312|NCT02047552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141313|NCT02047552|Hematinics|hematinics|mesh-ancestor
93141314|NCT02047552|Androgens|androgens|mesh-ancestor
93141315|NCT02047552|Hormones|hormones|mesh-ancestor
93141316|NCT02047552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141317|NCT02047552|Anabolic Agents|anabolic agents|mesh-ancestor
93141318|NCT01303731|Fentanyl|fentanyl|mesh-list
93141319|NCT01303731|Bupivacaine|bupivacaine|mesh-list
93141320|NCT01303731|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141321|NCT01303731|Anesthetics|anesthetics|mesh-ancestor
93141322|NCT01303731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141323|NCT01303731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141324|NCT01303731|Sensory System Agents|sensory system agents|mesh-ancestor
93141325|NCT01303731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141326|NCT01303731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141327|NCT01303731|Narcotics|narcotics|mesh-ancestor
93141328|NCT01303731|Analgesics|analgesics|mesh-ancestor
93141329|NCT01303731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93141330|NCT01303731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141331|NCT01303731|Anesthetics, General|anesthetics, general|mesh-ancestor
93141332|NCT03815487|Insulin|insulin|mesh-list
93141333|NCT03815487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93141334|NCT03815487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93141335|NCT03815487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141336|NCT03815422|Anesthetics|anesthetics|mesh-list
93141337|NCT03815422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141338|NCT03815422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141339|NCT02260024|Pramipexole|pramipexole|mesh-list
93141340|NCT02260024|Antioxidants|antioxidants|mesh-ancestor
93141341|NCT02260024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141342|NCT02260024|Protective Agents|protective agents|mesh-ancestor
93141343|NCT02260024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141344|NCT02260024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93141345|NCT02260024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93141346|NCT02260024|Dopamine Agonists|dopamine agonists|mesh-ancestor
93141347|NCT02260024|Dopamine Agents|dopamine agents|mesh-ancestor
93141348|NCT02260024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141349|NCT03800667|Ascorbic Acid|ascorbic acid|mesh-list
93141350|NCT03800667|Antioxidants|antioxidants|mesh-ancestor
93141351|NCT03800667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141352|NCT03800667|Protective Agents|protective agents|mesh-ancestor
93141353|NCT03800667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141354|NCT03800667|Vitamins|vitamins|mesh-ancestor
93141355|NCT03800667|Micronutrients|micronutrients|mesh-ancestor
93141356|NCT01302171|Lenograstim|lenograstim|mesh-list
93141357|NCT01302171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93141358|NCT01302171|Immunologic Factors|immunologic factors|mesh-ancestor
93141359|NCT01302171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141360|NCT02047630|Latanoprost|latanoprost|mesh-list
93141361|NCT02047630|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93141362|NCT02047630|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93141363|NCT04305470|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93141365|NCT04305470|Dermatologic Agents|dermatologic agents|mesh-ancestor
93141366|NCT03799809|Voriconazole|voriconazole|mesh-list
93141367|NCT03799809|Antifungal Agents|antifungal agents|mesh-ancestor
93141368|NCT03799809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141369|NCT03799809|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93141370|NCT03799809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93141371|NCT03799809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141372|NCT03799809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141373|NCT03799809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93141374|NCT03799809|Hormone Antagonists|hormone antagonists|mesh-ancestor
93141375|NCT03799809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141376|NCT03799809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141377|NCT03799809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93141378|NCT03812523|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93141379|NCT03812523|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93141380|NCT03812523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93141381|NCT03812523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93141382|NCT03812523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141383|NCT03812523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141384|NCT03812523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141385|NCT03812523|Analgesics|analgesics|mesh-ancestor
93141386|NCT03812523|Sensory System Agents|sensory system agents|mesh-ancestor
93141387|NCT03812523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141388|NCT03812523|Antidepressive Agents|antidepressive agents|mesh-ancestor
93141389|NCT03812523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93141390|NCT03812523|Dopamine Agents|dopamine agents|mesh-ancestor
93141391|NCT04216251|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93141392|NCT04216251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93141393|NCT04216251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93141394|NCT02049970|Dexmedetomidine|dexmedetomidine|mesh-list
93141395|NCT02049970|Bupivacaine|bupivacaine|mesh-list
93141396|NCT02049970|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141397|NCT02049970|Anesthetics|anesthetics|mesh-ancestor
93141398|NCT02049970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141399|NCT02049970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141400|NCT02049970|Sensory System Agents|sensory system agents|mesh-ancestor
93141401|NCT02049970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141402|NCT02049970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93141403|NCT02049970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93141404|NCT02049970|Analgesics|analgesics|mesh-ancestor
93141405|NCT02049970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93141406|NCT02049970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93141407|NCT02049970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93141408|NCT02049970|Adrenergic Agents|adrenergic agents|mesh-ancestor
93141409|NCT02049970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141410|NCT02049970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141411|NCT02048020|Paclitaxel|paclitaxel|mesh-list
93141412|NCT02048020|Carboplatin|carboplatin|mesh-list
93141413|NCT02048020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93141414|NCT02048020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141415|NCT02048020|Tubulin Modulators|tubulin modulators|mesh-ancestor
93141416|NCT02048020|Antimitotic Agents|antimitotic agents|mesh-ancestor
93141417|NCT02048020|Mitosis Modulators|mitosis modulators|mesh-ancestor
93141418|NCT02048020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141419|NCT03562390|Irinotecan|irinotecan|mesh-list
93141420|NCT03562390|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93141421|NCT03562390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93141422|NCT03562390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141423|NCT03562390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141424|NCT03562390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141425|NCT02048098|Misoprostol|misoprostol|mesh-list
93141426|NCT02048098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93141427|NCT02048098|Abortifacient Agents|abortifacient agents|mesh-ancestor
93141428|NCT02048098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93141429|NCT02048098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141430|NCT02048098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93141431|NCT02048098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141432|NCT02048098|Oxytocics|oxytocics|mesh-ancestor
93141433|NCT02050360|Sildenafil Citrate|sildenafil citrate|mesh-list
93141434|NCT02050360|Vasodilator Agents|vasodilator agents|mesh-ancestor
92813588|NCT02788851|Adderall|adderall|mesh-list
93141435|NCT02050360|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93141436|NCT02050360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93141437|NCT02050360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141438|NCT02050360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141439|NCT02050360|Urological Agents|urological agents|mesh-ancestor
93141440|NCT02940860|Iron|iron|mesh-list
93141441|NCT02940860|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93141442|NCT02940860|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93141443|NCT02940860|Trace Elements|trace elements|mesh-ancestor
93141444|NCT02940860|Micronutrients|micronutrients|mesh-ancestor
93141445|NCT02940860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141446|NCT02940860|Hematinics|hematinics|mesh-ancestor
93141447|NCT01303887|Prednisolone|prednisolone|mesh-list
93141448|NCT01303887|Cyclophosphamide|cyclophosphamide|mesh-list
93141449|NCT01303887|Rituximab|rituximab|mesh-list
93141450|NCT01303887|Fludarabine|fludarabine|mesh-list
93141451|NCT01303887|Vincristine|vincristine|mesh-list
93141452|NCT01303887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93141453|NCT01303887|Immunologic Factors|immunologic factors|mesh-ancestor
93141454|NCT01303887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141455|NCT01303887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93141456|NCT01303887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93141457|NCT01303887|Alkylating Agents|alkylating agents|mesh-ancestor
93141458|NCT01303887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141459|NCT01303887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141460|NCT01303887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93141461|NCT01303887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93141462|NCT01303887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93141463|NCT01303887|Tubulin Modulators|tubulin modulators|mesh-ancestor
93141464|NCT01303887|Antimitotic Agents|antimitotic agents|mesh-ancestor
93141465|NCT01303887|Mitosis Modulators|mitosis modulators|mesh-ancestor
93141466|NCT01303887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93141467|NCT01303887|Glucocorticoids|glucocorticoids|mesh-ancestor
93141468|NCT01303887|Hormones|hormones|mesh-ancestor
93141469|NCT01303887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141470|NCT01303887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93141471|NCT02050594|Ipilimumab|ipilimumab|mesh-list
93141472|NCT02050594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93141473|NCT02050594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141474|NCT02050594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93141475|NCT02050594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141476|NCT02806960|Glucagon|glucagon|mesh-list
93141477|NCT02806960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141478|NCT02806960|Hormones|hormones|mesh-ancestor
93141479|NCT02806960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141480|NCT02806960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141481|NCT03718143|Adavosertib|adavosertib|mesh-list
93141482|NCT03718143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141483|NCT03718143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141484|NCT02955134|Hydrotalcite|hydrotalcite|mesh-list
93141485|NCT02955134|Antacids|antacids|mesh-ancestor
93141486|NCT02955134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141487|NCT02955134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141488|NCT02048488|Belizatinib|belizatinib|mesh-list
93141489|NCT02048488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93141490|NCT02048488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141491|NCT02048488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141492|NCT02050672|Inositol|inositol|mesh-list
93141493|NCT02050672|Vitamin B Complex|vitamin b complex|mesh-ancestor
93141494|NCT02050672|Vitamins|vitamins|mesh-ancestor
93141495|NCT02050672|Micronutrients|micronutrients|mesh-ancestor
93141496|NCT02050672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141497|NCT03811366|Prednisone|prednisone|mesh-list
93141498|NCT03811366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93141499|NCT03811366|Glucocorticoids|glucocorticoids|mesh-ancestor
93141500|NCT03811366|Hormones|hormones|mesh-ancestor
93141501|NCT03811366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141502|NCT03811366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141503|NCT03811366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93141504|NCT03811366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141505|NCT03274466|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93141506|NCT03274466|Laxatives|laxatives|mesh-ancestor
93141507|NCT03274466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141508|NCT02037802|Fentanyl|fentanyl|mesh-list
93141509|NCT02037802|Meperidine|meperidine|mesh-list
93141510|NCT02037802|Bupivacaine|bupivacaine|mesh-list
93141512|NCT02037802|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141513|NCT02037802|Anesthetics|anesthetics|mesh-ancestor
93141514|NCT02037802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141515|NCT02037802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141516|NCT02037802|Sensory System Agents|sensory system agents|mesh-ancestor
93141517|NCT02037802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141518|NCT02037802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93141519|NCT02037802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141520|NCT02037802|Anesthetics, General|anesthetics, general|mesh-ancestor
93141521|NCT02037802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141522|NCT02037802|Narcotics|narcotics|mesh-ancestor
93141523|NCT02037802|Analgesics|analgesics|mesh-ancestor
93141524|NCT02037802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93141525|NCT02051530|Tryptophan|tryptophan|mesh-list
93141526|NCT02051530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93141527|NCT02051530|Antidepressive Agents|antidepressive agents|mesh-ancestor
93141528|NCT02051530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93141529|NCT03797703|Lidocaine|lidocaine|mesh-list
93141530|NCT03797703|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141531|NCT03797703|Anesthetics|anesthetics|mesh-ancestor
93141532|NCT03797703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141533|NCT03797703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141534|NCT03797703|Sensory System Agents|sensory system agents|mesh-ancestor
93141535|NCT03797703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141536|NCT03797703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93141537|NCT03797703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93141538|NCT03797703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93141539|NCT03797703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93141540|NCT03797703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141541|NCT02048644|Beclomethasone|beclomethasone|mesh-list
93141542|NCT02048644|Formoterol Fumarate|formoterol fumarate|mesh-list
93141543|NCT02048644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93141544|NCT02048644|Autonomic Agents|autonomic agents|mesh-ancestor
93141545|NCT02048644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141546|NCT02048644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141547|NCT02048644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93141548|NCT02048644|Respiratory System Agents|respiratory system agents|mesh-ancestor
93141549|NCT02048644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93141550|NCT02048644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93141551|NCT02048644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93141552|NCT02048644|Adrenergic Agents|adrenergic agents|mesh-ancestor
93141553|NCT02048644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141554|NCT02048644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141555|NCT02048644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93141556|NCT02048644|Glucocorticoids|glucocorticoids|mesh-ancestor
93141557|NCT02048644|Hormones|hormones|mesh-ancestor
93141558|NCT02048644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141559|NCT02048800|Treosulfan|treosulfan|mesh-list
93141560|NCT02048800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93141561|NCT02048800|Alkylating Agents|alkylating agents|mesh-ancestor
93141562|NCT02048800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141563|NCT02048800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141564|NCT03797625|Cisplatin|cisplatin|mesh-list
93141565|NCT03797625|Irinotecan|irinotecan|mesh-list
93141566|NCT03797625|Endostar protein|endostar protein|mesh-list
93141567|NCT03797625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141568|NCT03797625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93141569|NCT03797625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93141570|NCT03797625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141571|NCT03797625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141572|NCT03797625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93141573|NCT03797625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93141574|NCT03797625|Growth Substances|growth substances|mesh-ancestor
93141575|NCT03797625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141576|NCT03797625|Growth Inhibitors|growth inhibitors|mesh-ancestor
93141577|NCT02051842|Metadoxine|metadoxine|mesh-list
93141578|NCT02051842|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93141579|NCT02806414|Ivermectin|ivermectin|mesh-list
93141580|NCT02806414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93141581|NCT02806414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141582|NCT02049034|Lixisenatide|lixisenatide|mesh-list
93141583|NCT02049034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93141584|NCT02049034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141585|NCT02049190|Onapristone|onapristone|mesh-list
93141586|NCT02049190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141587|NCT02049190|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93141588|NCT02049190|Fertility Agents|fertility agents|mesh-ancestor
93141589|NCT02049190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93141590|NCT02049190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141591|NCT02049190|Hormone Antagonists|hormone antagonists|mesh-ancestor
93141592|NCT02049190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141594|NCT03811509|Diphosphonates|diphosphonates|mesh-list
93141595|NCT03811509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93141596|NCT03811509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141597|NCT02037412|Clopidogrel|clopidogrel|mesh-list
93141598|NCT02037412|Ticagrelor|ticagrelor|mesh-list
93141599|NCT02037412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93141600|NCT02037412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93141601|NCT02037412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93141602|NCT02037412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93141603|NCT02037412|Purinergic Agents|purinergic agents|mesh-ancestor
93141604|NCT02037412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141605|NCT02037412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141606|NCT02037412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437338|NCT03476642|Mydriatics|mydriatics|mesh-ancestor
93141607|NCT02052154|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93141608|NCT02052154|Immunologic Factors|immunologic factors|mesh-ancestor
93141609|NCT02052154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141610|NCT03797079|Bupivacaine|bupivacaine|mesh-list
93141611|NCT03797079|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141612|NCT03797079|Anesthetics|anesthetics|mesh-ancestor
93141613|NCT03797079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141614|NCT03797079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141615|NCT03797079|Sensory System Agents|sensory system agents|mesh-ancestor
93141616|NCT03797079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141617|NCT02049268|Ethanol|ethanol|mesh-list
93141618|NCT02049268|Nicotine|nicotine|mesh-list
93141619|NCT02049268|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93141620|NCT02049268|Autonomic Agents|autonomic agents|mesh-ancestor
93141621|NCT02049268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141622|NCT02049268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141623|NCT02049268|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93141624|NCT02049268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93141625|NCT02049268|Cholinergic Agents|cholinergic agents|mesh-ancestor
93141626|NCT02049268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141627|NCT02049268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141628|NCT02049268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93141629|NCT02049268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141630|NCT02049268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141631|NCT02049346|Epoetin Alfa|epoetin alfa|mesh-list
93141632|NCT02049346|Darbepoetin alfa|darbepoetin alfa|mesh-list
93141633|NCT02049346|Hematinics|hematinics|mesh-ancestor
93141634|NCT03564873|Azacitidine|azacitidine|mesh-list
93141635|NCT03564873|Homoharringtonine|homoharringtonine|mesh-list
93141636|NCT03564873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93141637|NCT03564873|Antimetabolites|antimetabolites|mesh-ancestor
93141638|NCT03564873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141639|NCT03564873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141640|NCT03564873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141641|NCT03564873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93141642|NCT03564873|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93141643|NCT02806024|Tranexamic Acid|tranexamic acid|mesh-list
93141644|NCT02806024|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93141645|NCT02806024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93141646|NCT02806024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141647|NCT02806024|Hemostatics|hemostatics|mesh-ancestor
93141648|NCT02806024|Coagulants|coagulants|mesh-ancestor
93141649|NCT03811197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93141650|NCT03811197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141651|NCT03811197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141652|NCT02049580|Cyclophosphamide|cyclophosphamide|mesh-list
93141653|NCT02049580|Thiotepa|thiotepa|mesh-list
93141654|NCT02049580|Fludarabine|fludarabine|mesh-list
93141655|NCT02049580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93141656|NCT02049580|Immunologic Factors|immunologic factors|mesh-ancestor
93141657|NCT02049580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141658|NCT02049580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93141659|NCT02049580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93141660|NCT02049580|Alkylating Agents|alkylating agents|mesh-ancestor
93141661|NCT02049580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141662|NCT02049580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141663|NCT02049580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93141664|NCT01302951|Moxifloxacin|moxifloxacin|mesh-list
93141665|NCT01302951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93141666|NCT01302951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141667|NCT01302951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93141668|NCT01302951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93141669|NCT01302951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141670|NCT01302951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141671|NCT01302951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141672|NCT03796533|Posaconazole|posaconazole|mesh-list
93141673|NCT03796533|Antifungal Agents|antifungal agents|mesh-ancestor
93141674|NCT03796533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141675|NCT03796533|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93141676|NCT03796533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93141677|NCT03796533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93141678|NCT03796533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93141679|NCT03796533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93141680|NCT03796533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117821|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93141681|NCT03796533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141682|NCT03796533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93141683|NCT03796533|Hormone Antagonists|hormone antagonists|mesh-ancestor
93141684|NCT03796533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141685|NCT03796533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141686|NCT03796377|Rivaroxaban|rivaroxaban|mesh-list
93141687|NCT03796377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93141688|NCT03796377|Antithrombins|antithrombins|mesh-ancestor
93141689|NCT03796377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93141690|NCT03796377|Protease Inhibitors|protease inhibitors|mesh-ancestor
93141691|NCT03796377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141692|NCT03796377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141693|NCT03796377|Anticoagulants|anticoagulants|mesh-ancestor
93141694|NCT02049736|Telbivudine|telbivudine|mesh-list
93141695|NCT02049736|Antiviral Agents|antiviral agents|mesh-ancestor
93141696|NCT02049736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141697|NCT02049736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93141698|NCT02049736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141699|NCT02049736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141700|NCT01303029|Gemcitabine|gemcitabine|mesh-list
93141701|NCT01303029|Capecitabine|capecitabine|mesh-list
93141702|NCT01303029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93141703|NCT01303029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93141704|NCT01303029|Antimetabolites|antimetabolites|mesh-ancestor
93141705|NCT01303029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141706|NCT01303029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141707|NCT01303029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93141708|NCT01303029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141709|NCT02052388|Daptomycin|daptomycin|mesh-list
93141710|NCT02052388|Brilacidin|brilacidin|mesh-list
93141711|NCT02052388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93141712|NCT02052388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141713|NCT01303107|Bupivacaine|bupivacaine|mesh-list
93141714|NCT01303107|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141715|NCT01303107|Anesthetics|anesthetics|mesh-ancestor
93141716|NCT01303107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141717|NCT01303107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141718|NCT01303107|Sensory System Agents|sensory system agents|mesh-ancestor
93141719|NCT01303107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141720|NCT03795909|Dexamethasone|dexamethasone|mesh-list
93141721|NCT03795909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93141722|NCT03795909|Antiemetics|antiemetics|mesh-ancestor
93141723|NCT03795909|Autonomic Agents|autonomic agents|mesh-ancestor
93141724|NCT03795909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141725|NCT03795909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141726|NCT03795909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141727|NCT03795909|Glucocorticoids|glucocorticoids|mesh-ancestor
93141728|NCT03795909|Hormones|hormones|mesh-ancestor
93141729|NCT03795909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141730|NCT03795909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93141731|NCT03795909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141732|NCT03795597|Melphalan|melphalan|mesh-list
93141733|NCT03795597|Busulfan|busulfan|mesh-list
93141734|NCT03795597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93141735|NCT03795597|Alkylating Agents|alkylating agents|mesh-ancestor
93141736|NCT03795597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141737|NCT03795597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141738|NCT03795597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93141739|NCT03795597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93141740|NCT03795597|Immunologic Factors|immunologic factors|mesh-ancestor
93141741|NCT03795597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141742|NCT02802592|Epoetin Alfa|epoetin alfa|mesh-list
93141743|NCT02802592|Hematinics|hematinics|mesh-ancestor
93141744|NCT03637972|Nicotine|nicotine|mesh-list
93141745|NCT03637972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93141746|NCT03637972|Autonomic Agents|autonomic agents|mesh-ancestor
93141747|NCT03637972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141748|NCT03637972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141749|NCT03637972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93141750|NCT03637972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93141751|NCT03637972|Cholinergic Agents|cholinergic agents|mesh-ancestor
93141752|NCT03637972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141753|NCT03637972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141754|NCT03383679|Capecitabine|capecitabine|mesh-list
92437480|NCT02229084|Paclitaxel|paclitaxel|mesh-list
93141755|NCT03383679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93141756|NCT03383679|Antimetabolites|antimetabolites|mesh-ancestor
93141757|NCT03383679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141758|NCT03383679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141759|NCT02037958|Chlorhexidine|chlorhexidine|mesh-list
93141760|NCT02037958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93141761|NCT02037958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141762|NCT02037958|Disinfectants|disinfectants|mesh-ancestor
93141763|NCT02053402|Vitamin D|vitamin d|mesh-list
93141764|NCT02053402|Cholecalciferol|cholecalciferol|mesh-list
93141765|NCT02053402|Vitamins|vitamins|mesh-ancestor
93141766|NCT02053402|Micronutrients|micronutrients|mesh-ancestor
93141767|NCT02053402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141768|NCT02053402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93141769|NCT02053402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93141770|NCT04639011|Norepinephrine|norepinephrine|mesh-list
93141771|NCT04639011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93141772|NCT04639011|Serotonin|serotonin|mesh-list
93141773|NCT04639011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93141774|NCT04639011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93141775|NCT04639011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93141776|NCT04639011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141777|NCT04639011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141778|NCT04639011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141779|NCT04639011|Analgesics|analgesics|mesh-ancestor
93141780|NCT04639011|Sensory System Agents|sensory system agents|mesh-ancestor
93141781|NCT04639011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141782|NCT04639011|Antidepressive Agents|antidepressive agents|mesh-ancestor
93141783|NCT04639011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93141784|NCT04639011|Dopamine Agents|dopamine agents|mesh-ancestor
93141785|NCT04639011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93141786|NCT04639011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93141787|NCT04639011|Adrenergic Agents|adrenergic agents|mesh-ancestor
93141788|NCT04639011|Sympathomimetics|sympathomimetics|mesh-ancestor
93141789|NCT04639011|Autonomic Agents|autonomic agents|mesh-ancestor
93141790|NCT04639011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93141791|NCT04639011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93141792|NCT04639011|Serotonin Agents|serotonin agents|mesh-ancestor
93141793|NCT02053558|Lidocaine|lidocaine|mesh-list
93141794|NCT02053558|Ropivacaine|ropivacaine|mesh-list
93141795|NCT02053558|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141796|NCT02053558|Anesthetics|anesthetics|mesh-ancestor
93141797|NCT02053558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141798|NCT02053558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141799|NCT02053558|Sensory System Agents|sensory system agents|mesh-ancestor
93141800|NCT02053558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141801|NCT02053558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93141802|NCT02053558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93141803|NCT02053558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93141804|NCT02053558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93141805|NCT02053558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141806|NCT03809949|Fentanyl|fentanyl|mesh-list
93141807|NCT03809949|Anesthetics|anesthetics|mesh-list
93141808|NCT03809949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141809|NCT03809949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141810|NCT03809949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93141811|NCT03809949|Narcotics|narcotics|mesh-ancestor
93141812|NCT03809949|Analgesics|analgesics|mesh-ancestor
93141813|NCT03809949|Sensory System Agents|sensory system agents|mesh-ancestor
93141814|NCT03809949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141815|NCT03809949|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93141816|NCT03809949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93141817|NCT03809949|Anesthetics, General|anesthetics, general|mesh-ancestor
93141819|NCT02052934|Immunologic Factors|immunologic factors|mesh-ancestor
93141820|NCT02052934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141821|NCT03810261|Vitamin D|vitamin d|mesh-list
93141822|NCT03810261|Ergocalciferols|ergocalciferols|mesh-list
93141823|NCT03810261|Cholecalciferol|cholecalciferol|mesh-list
93141824|NCT03810261|Vitamins|vitamins|mesh-list
93141825|NCT03810261|Micronutrients|micronutrients|mesh-ancestor
93141826|NCT03810261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141827|NCT03810261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93141828|NCT03810261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93141829|NCT02037724|Iron|iron|mesh-list
93141830|NCT02037724|Trace Elements|trace elements|mesh-ancestor
93141831|NCT02037724|Micronutrients|micronutrients|mesh-ancestor
93141832|NCT02037724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141833|NCT03327675|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93141834|NCT03327675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93141835|NCT03327675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141836|NCT01569633|Erythromycin|erythromycin|mesh-list
93141837|NCT01569633|Erythromycin Estolate|erythromycin estolate|mesh-list
93141838|NCT01569633|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93141839|NCT01569633|Erythromycin stearate|erythromycin stearate|mesh-list
93141840|NCT01569633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93141841|NCT01569633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141842|NCT01569633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141843|NCT01569633|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93141844|NCT01569633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141845|NCT01569633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141846|NCT02054182|Vitamin D|vitamin d|mesh-list
93141847|NCT02054182|Cholecalciferol|cholecalciferol|mesh-list
93141848|NCT02054182|Vitamins|vitamins|mesh-ancestor
93141849|NCT02054182|Micronutrients|micronutrients|mesh-ancestor
93141850|NCT02054182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141851|NCT02054182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93141852|NCT02054182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93141853|NCT03323151|Ixazomib|ixazomib|mesh-list
93141854|NCT03323151|Glycine|glycine|mesh-list
93141855|NCT03323151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141856|NCT03323151|Protease Inhibitors|protease inhibitors|mesh-ancestor
93141857|NCT03323151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141858|NCT03323151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141859|NCT03323151|Glycine Agents|glycine agents|mesh-ancestor
93141860|NCT03323151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93141861|NCT03323151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141862|NCT02803138|Ritonavir|ritonavir|mesh-list
93141863|NCT02803138|Ribavirin|ribavirin|mesh-list
93141864|NCT02803138|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93141865|NCT02803138|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93141866|NCT02803138|Protease Inhibitors|protease inhibitors|mesh-ancestor
93141867|NCT02803138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141868|NCT02803138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141869|NCT02803138|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93141870|NCT02803138|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93141871|NCT02803138|Antiviral Agents|antiviral agents|mesh-ancestor
93141872|NCT02803138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141873|NCT02803138|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93141874|NCT02803138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93141875|NCT02803138|Antimetabolites|antimetabolites|mesh-ancestor
93141876|NCT03795207|Durvalumab|durvalumab|mesh-list
93141877|NCT03795207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93141878|NCT03795207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141879|NCT02056210|Plerixafor|plerixafor|mesh-list
93141880|NCT02056210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93141881|NCT02056210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93141882|NCT02056210|Antiviral Agents|antiviral agents|mesh-ancestor
93141883|NCT02056210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141884|NCT00131235|Azithromycin|azithromycin|mesh-list
93141885|NCT00131235|Pyrimethamine|pyrimethamine|mesh-list
93141886|NCT00131235|Sulfadoxine|sulfadoxine|mesh-list
93141887|NCT00131235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93141888|NCT00131235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93141889|NCT00131235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93141890|NCT00131235|Antimalarials|antimalarials|mesh-ancestor
93141891|NCT00131235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93141892|NCT00131235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93141893|NCT00131235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93141894|NCT00131235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141895|NCT00131235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141896|NCT00131235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93141897|NCT03794505|Methylprednisolone|methylprednisolone|mesh-list
93141898|NCT03794505|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93141899|NCT03794505|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93141900|NCT03794505|Prednisolone|prednisolone|mesh-list
93141901|NCT03794505|Prednisolone acetate|prednisolone acetate|mesh-list
93141903|NCT03794505|Ropivacaine|ropivacaine|mesh-list
93141904|NCT03794505|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93141905|NCT03794505|Prednisolone phosphate|prednisolone phosphate|mesh-list
93141906|NCT03794505|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141907|NCT03794505|Anesthetics|anesthetics|mesh-ancestor
93141908|NCT03794505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141909|NCT03794505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141910|NCT03794505|Sensory System Agents|sensory system agents|mesh-ancestor
93141911|NCT03794505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141912|NCT03794505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93141913|NCT03794505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93141914|NCT03794505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93141915|NCT03794505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93141916|NCT03794505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141917|NCT03794505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93141918|NCT03794505|Antiemetics|antiemetics|mesh-ancestor
93141919|NCT03794505|Autonomic Agents|autonomic agents|mesh-ancestor
93141920|NCT03794505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93141921|NCT03794505|Glucocorticoids|glucocorticoids|mesh-ancestor
93141922|NCT03794505|Hormones|hormones|mesh-ancestor
93141923|NCT03794505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141924|NCT03794505|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93141925|NCT03794505|Protective Agents|protective agents|mesh-ancestor
93141926|NCT03794505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93141927|NCT03794505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141928|NCT05625243|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
93141929|NCT05625243|Vasodilator Agents|vasodilator agents|mesh-ancestor
93141930|NCT05625243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93141931|NCT05625243|Protective Agents|protective agents|mesh-ancestor
93141932|NCT05625243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141933|NCT03023007|Anesthetics|anesthetics|mesh-list
93141934|NCT03023007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141935|NCT03023007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141936|NCT01304901|Montelukast|montelukast|mesh-list
93141937|NCT01304901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93141938|NCT01304901|Respiratory System Agents|respiratory system agents|mesh-ancestor
93141939|NCT01304901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93141940|NCT01304901|Hormone Antagonists|hormone antagonists|mesh-ancestor
93141941|NCT01304901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141942|NCT01304901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141943|NCT01304901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93141944|NCT01304901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93141945|NCT01304901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141946|NCT05624853|Pregabalin|pregabalin|mesh-list
93141947|NCT05624853|Analgesics|analgesics|mesh-ancestor
93141948|NCT05624853|Sensory System Agents|sensory system agents|mesh-ancestor
93141949|NCT05624853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141950|NCT05624853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141951|NCT05624853|Anticonvulsants|anticonvulsants|mesh-ancestor
93141952|NCT05624853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93141953|NCT05624853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93141954|NCT05624853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141955|NCT05624853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93141956|NCT05624853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93141957|NCT05624853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93141958|NCT05624853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141959|NCT05624853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93141960|NCT03794271|Anesthetics|anesthetics|mesh-list
93141961|NCT03794271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141962|NCT03794271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141963|NCT03792321|Methyltestosterone|methyltestosterone|mesh-list
93141964|NCT03792321|Testosterone|testosterone|mesh-list
93141965|NCT03792321|Testosterone undecanoate|testosterone undecanoate|mesh-list
93141966|NCT03792321|Testosterone enanthate|testosterone enanthate|mesh-list
93141967|NCT03792321|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93141968|NCT03792321|Androgens|androgens|mesh-ancestor
93141969|NCT03792321|Hormones|hormones|mesh-ancestor
93141970|NCT03792321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93141971|NCT03792321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141972|NCT03792321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93141973|NCT03792321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141974|NCT03792321|Anabolic Agents|anabolic agents|mesh-ancestor
93141975|NCT01305057|Pyridoxine|pyridoxine|mesh-list
93141976|NCT01305057|Vitamin B Complex|vitamin b complex|mesh-ancestor
93141977|NCT01305057|Vitamins|vitamins|mesh-ancestor
93141978|NCT01305057|Micronutrients|micronutrients|mesh-ancestor
93141979|NCT01305057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141980|NCT03792009|Bupivacaine|bupivacaine|mesh-list
93141981|NCT03792009|Anesthetics, Local|anesthetics, local|mesh-ancestor
93141982|NCT03792009|Anesthetics|anesthetics|mesh-ancestor
93141983|NCT03792009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93141984|NCT03792009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93141985|NCT03792009|Sensory System Agents|sensory system agents|mesh-ancestor
93141986|NCT03792009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93141987|NCT01305135|Azacitidine|azacitidine|mesh-list
93141988|NCT01305135|Idarubicin|idarubicin|mesh-list
93141989|NCT01305135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93141990|NCT01305135|Antimetabolites|antimetabolites|mesh-ancestor
93141991|NCT01305135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93141992|NCT01305135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93141993|NCT01305135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93141994|NCT01305135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93141995|NCT01305135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93141996|NCT01305135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93141997|NCT01305603|Bupivacaine|bupivacaine|mesh-list
93141998|NCT01305603|Anesthetics, Local|anesthetics, local|mesh-list
93141999|NCT01305603|Anesthetics|anesthetics|mesh-list
93142000|NCT01305603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142001|NCT01305603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142002|NCT01305603|Sensory System Agents|sensory system agents|mesh-ancestor
93142003|NCT01305603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142004|NCT03793725|Apatinib|apatinib|mesh-list
93142005|NCT03793725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142006|NCT03793725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142007|NCT03793725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142008|NCT03793725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142009|NCT01305369|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93142010|NCT01305369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93142011|NCT02056366|Thioctic Acid|thioctic acid|mesh-list
93142012|NCT02056366|Antioxidants|antioxidants|mesh-ancestor
93142013|NCT02056366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142014|NCT02056366|Protective Agents|protective agents|mesh-ancestor
93142015|NCT02056366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142016|NCT02056366|Vitamin B Complex|vitamin b complex|mesh-ancestor
93142017|NCT02056366|Vitamins|vitamins|mesh-ancestor
93142018|NCT02056366|Micronutrients|micronutrients|mesh-ancestor
93142019|NCT02056444|Tranexamic Acid|tranexamic acid|mesh-list
93142020|NCT02056444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93142021|NCT02056444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93142022|NCT02056444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142023|NCT02056444|Hemostatics|hemostatics|mesh-ancestor
93142024|NCT02056444|Coagulants|coagulants|mesh-ancestor
93142025|NCT02665234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93142026|NCT02665234|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93142027|NCT05624229|Esomeprazole|esomeprazole|mesh-list
93142028|NCT05624229|Omeprazole|omeprazole|mesh-list
93142029|NCT05624229|Rabeprazole|rabeprazole|mesh-list
93142030|NCT05624229|Pantoprazole|pantoprazole|mesh-list
93142031|NCT05624229|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93142032|NCT05624229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93142033|NCT05624229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142034|NCT05624229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142035|NCT05624229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142036|NCT05622370|Brivaracetam|brivaracetam|mesh-list
93142037|NCT05622370|Anticonvulsants|anticonvulsants|mesh-ancestor
93142038|NCT03791775|Polidocanol|polidocanol|mesh-list
93142039|NCT03791775|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93142040|NCT03791775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93142041|NCT03789123|Dienogest|dienogest|mesh-list
93142042|NCT03789123|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93142043|NCT03789123|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93142044|NCT03789123|Estradiol|estradiol|mesh-list
93142045|NCT03789123|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93142046|NCT03789123|Nandrolone|nandrolone|mesh-list
93142047|NCT03789123|Estrogens|estrogens|mesh-ancestor
93142048|NCT03789123|Hormones|hormones|mesh-ancestor
93142049|NCT03789123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142050|NCT03789123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142051|NCT03789123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93142052|NCT03789123|Contraceptive Agents|contraceptive agents|mesh-ancestor
93142053|NCT03789123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142054|NCT03789123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93142055|NCT03789123|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93142056|NCT03789123|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93142057|NCT03789123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93142058|NCT03789123|Hormone Antagonists|hormone antagonists|mesh-ancestor
93142059|NCT03789123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93142060|NCT03789123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142061|NCT03789123|Androgens|androgens|mesh-ancestor
93142062|NCT03789123|Anabolic Agents|anabolic agents|mesh-ancestor
93142063|NCT05471817|Dabigatran|dabigatran|mesh-list
93142064|NCT05471817|Antithrombins|antithrombins|mesh-ancestor
93142065|NCT05471817|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93142066|NCT05471817|Protease Inhibitors|protease inhibitors|mesh-ancestor
93142067|NCT05471817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142068|NCT05471817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142069|NCT05471817|Anticoagulants|anticoagulants|mesh-ancestor
93142070|NCT03788889|Ketamine|ketamine|mesh-list
93142071|NCT03788889|Lorazepam|lorazepam|mesh-list
93142072|NCT03788889|Phenobarbital|phenobarbital|mesh-list
93142073|NCT03788889|Analgesics|analgesics|mesh-ancestor
93142074|NCT03788889|Sensory System Agents|sensory system agents|mesh-ancestor
93142075|NCT03788889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142076|NCT03788889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142077|NCT03788889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93142078|NCT03788889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93142079|NCT03788889|Anesthetics, General|anesthetics, general|mesh-ancestor
93142080|NCT03788889|Anesthetics|anesthetics|mesh-ancestor
93142081|NCT03788889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142082|NCT03788889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93142083|NCT03788889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93142084|NCT03788889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142085|NCT03788889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142086|NCT03788889|Anticonvulsants|anticonvulsants|mesh-ancestor
93142087|NCT03788889|Antiemetics|antiemetics|mesh-ancestor
93142088|NCT03788889|Autonomic Agents|autonomic agents|mesh-ancestor
93142089|NCT03788889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142090|NCT03788889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93142091|NCT03788889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93142092|NCT03788889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93142093|NCT03788889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93142094|NCT03788889|GABA Modulators|gaba modulators|mesh-ancestor
93142095|NCT03788889|GABA Agents|gaba agents|mesh-ancestor
93142096|NCT03788889|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93142097|NCT03788889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93142098|NCT03788889|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93142099|NCT03788733|Melatonin|melatonin|mesh-list
93142100|NCT03788733|Antioxidants|antioxidants|mesh-ancestor
93142101|NCT03788733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142102|NCT03788733|Protective Agents|protective agents|mesh-ancestor
93142103|NCT03788733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142104|NCT03788733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142105|NCT03791463|Salvianolic acid A|salvianolic acid a|mesh-list
93142106|NCT03791463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142107|NCT03791463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142108|NCT03791463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142109|NCT03791463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93142110|NCT04753515|Midazolam|midazolam|mesh-list
93142111|NCT04753515|Dexmedetomidine|dexmedetomidine|mesh-list
93142112|NCT04753515|Remifentanil|remifentanil|mesh-list
92814273|NCT02601157|Purinergic Agents|purinergic agents|mesh-ancestor
93142113|NCT04753515|Propofol|propofol|mesh-list
93142114|NCT04753515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93142115|NCT04753515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142116|NCT04753515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142117|NCT04753515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142118|NCT04753515|Analgesics|analgesics|mesh-ancestor
93142119|NCT04753515|Sensory System Agents|sensory system agents|mesh-ancestor
93142120|NCT04753515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142121|NCT04753515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93142122|NCT04753515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93142123|NCT04753515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93142124|NCT04753515|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142125|NCT04753515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142126|NCT04753515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142127|NCT04753515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93142128|NCT04753515|Anesthetics, General|anesthetics, general|mesh-ancestor
93142129|NCT04753515|Anesthetics|anesthetics|mesh-ancestor
93142130|NCT04753515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93142131|NCT04753515|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93142132|NCT04753515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93142133|NCT04753515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93142134|NCT04753515|GABA Modulators|gaba modulators|mesh-ancestor
93142135|NCT04753515|GABA Agents|gaba agents|mesh-ancestor
93142136|NCT04753515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93142137|NCT04753515|Narcotics|narcotics|mesh-ancestor
93142138|NCT01306461|Timolol|timolol|mesh-list
93142139|NCT01306461|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93142140|NCT01306461|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93142141|NCT01306461|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142142|NCT01306461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142143|NCT01306461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142144|NCT01306461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142145|NCT01306461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93142146|NCT01306461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93142147|NCT01305837|Methylprednisolone|methylprednisolone|mesh-list
93142148|NCT01305837|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93142149|NCT01305837|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93142150|NCT01305837|Prednisolone|prednisolone|mesh-list
93142151|NCT01305837|Prednisolone acetate|prednisolone acetate|mesh-list
93142152|NCT01305837|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93142153|NCT01305837|Prednisolone phosphate|prednisolone phosphate|mesh-list
93142154|NCT01305837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93142155|NCT01305837|Antiemetics|antiemetics|mesh-ancestor
93142156|NCT01305837|Autonomic Agents|autonomic agents|mesh-ancestor
93142157|NCT01305837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142158|NCT01305837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142159|NCT01305837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142160|NCT01305837|Glucocorticoids|glucocorticoids|mesh-ancestor
93142161|NCT01305837|Hormones|hormones|mesh-ancestor
93142162|NCT01305837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142163|NCT01305837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93142164|NCT01305837|Protective Agents|protective agents|mesh-ancestor
93142165|NCT01305837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93142166|NCT01305837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142167|NCT01306773|Oseltamivir|oseltamivir|mesh-list
93142168|NCT01306773|Antiviral Agents|antiviral agents|mesh-ancestor
93142169|NCT01306773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142170|NCT01306773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142171|NCT01306773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142172|NCT03790605|Curcumin|curcumin|mesh-list
93142173|NCT03790605|Iproplatin|iproplatin|mesh-list
93142174|NCT03790605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93142175|NCT03790605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142176|NCT03790605|Analgesics|analgesics|mesh-ancestor
93142177|NCT03790605|Sensory System Agents|sensory system agents|mesh-ancestor
93142178|NCT03790605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142179|NCT03790605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142180|NCT03790605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93142181|NCT03790605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142182|NCT03790605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142183|NCT03790605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142184|NCT03790605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142185|NCT03787953|Antibodies|antibodies|mesh-list
93142186|NCT03787953|Immunologic Factors|immunologic factors|mesh-ancestor
93142187|NCT03787953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142188|NCT05590689|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93142189|NCT05590689|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93142190|NCT05590689|Dermatologic Agents|dermatologic agents|mesh-ancestor
93142191|NCT01306851|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93142192|NCT01306851|Hemostatics|hemostatics|mesh-ancestor
93142193|NCT01306851|Coagulants|coagulants|mesh-ancestor
93142194|NCT03790215|Dydrogesterone|dydrogesterone|mesh-list
93142195|NCT03790215|Progestins|progestins|mesh-ancestor
93142196|NCT03790215|Hormones|hormones|mesh-ancestor
93142197|NCT03790215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142198|NCT03790215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142199|NCT03790371|Misoprostol|misoprostol|mesh-list
93142200|NCT03790371|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93142201|NCT03790371|Abortifacient Agents|abortifacient agents|mesh-ancestor
93142202|NCT03790371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142203|NCT03790371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142204|NCT03790371|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93142205|NCT03790371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142206|NCT03790371|Oxytocics|oxytocics|mesh-ancestor
93142207|NCT01307475|Adenosine|adenosine|mesh-list
93142208|NCT01307475|Analgesics|analgesics|mesh-ancestor
93142209|NCT01307475|Sensory System Agents|sensory system agents|mesh-ancestor
93142210|NCT01307475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142211|NCT01307475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142212|NCT01307475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93142213|NCT01307475|Vasodilator Agents|vasodilator agents|mesh-ancestor
93142214|NCT01307475|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93142215|NCT01307475|Purinergic Agonists|purinergic agonists|mesh-ancestor
93142216|NCT01307475|Purinergic Agents|purinergic agents|mesh-ancestor
93142217|NCT01307475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142218|NCT01307475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142219|NCT03787641|Protamines|protamines|mesh-list
93142220|NCT03787641|Heparin Antagonists|heparin antagonists|mesh-ancestor
93142221|NCT03787641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142222|NCT03787641|Coagulants|coagulants|mesh-ancestor
93142223|NCT03790293|Rituximab|rituximab|mesh-list
93142224|NCT03790293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93142225|NCT03790293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142226|NCT03790293|Immunologic Factors|immunologic factors|mesh-ancestor
93142227|NCT03790293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142228|NCT03790293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142229|NCT03245450|Irinotecan|irinotecan|mesh-list
93142230|NCT03245450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93142231|NCT03245450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93142232|NCT03245450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142233|NCT03245450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142234|NCT03245450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142235|NCT05694585|Esmolol|esmolol|mesh-list
93142236|NCT05694585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93142237|NCT05694585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93142238|NCT05694585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93142239|NCT05694585|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142240|NCT05694585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142241|NCT05694585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142242|NCT05694585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142243|NCT03712917|Topiramate|topiramate|mesh-list
93142244|NCT03712917|Flunarizine|flunarizine|mesh-list
93142245|NCT03712917|Anticonvulsants|anticonvulsants|mesh-ancestor
93142246|NCT03712917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93142247|NCT03712917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142248|NCT03712917|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93142249|NCT03712917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93142250|NCT03712917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142251|NCT03712917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142252|NCT03712917|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93142253|NCT03712917|Histamine Antagonists|histamine antagonists|mesh-ancestor
93142254|NCT03712917|Histamine Agents|histamine agents|mesh-ancestor
93142255|NCT03712917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142256|NCT03712917|Vasodilator Agents|vasodilator agents|mesh-ancestor
93142257|NCT03787017|Metformin|metformin|mesh-list
93142258|NCT03787017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93142259|NCT03787017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142260|NCT01307865|Mannitol|mannitol|mesh-list
93142261|NCT01307865|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93142262|NCT01307865|Diuretics|diuretics|mesh-ancestor
93142263|NCT01307865|Natriuretic Agents|natriuretic agents|mesh-ancestor
93142264|NCT01307865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142266|NCT01308177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142267|NCT01308177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93142268|NCT01308177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142269|NCT01308177|Protease Inhibitors|protease inhibitors|mesh-ancestor
93142270|NCT01308177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142271|NCT01308177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142272|NCT01308177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93142273|NCT01308177|Protective Agents|protective agents|mesh-ancestor
93142274|NCT01308177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142275|NCT01308177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142276|NCT01308255|Vitamins|vitamins|mesh-list
93142277|NCT01308255|Folic Acid|folic acid|mesh-list
93142278|NCT01308255|Methylprednisolone|methylprednisolone|mesh-list
93142279|NCT01308255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93142280|NCT01308255|Infliximab|infliximab|mesh-list
93142281|NCT01308255|Methotrexate|methotrexate|mesh-list
93142282|NCT01308255|Micronutrients|micronutrients|mesh-ancestor
92438003|NCT01602874|Metronidazole|metronidazole|mesh-list
93142283|NCT01308255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142284|NCT01308255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93142285|NCT01308255|Abortifacient Agents|abortifacient agents|mesh-ancestor
93142286|NCT01308255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142287|NCT01308255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93142288|NCT01308255|Antimetabolites|antimetabolites|mesh-ancestor
93142289|NCT01308255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142290|NCT01308255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142291|NCT01308255|Dermatologic Agents|dermatologic agents|mesh-ancestor
93142292|NCT01308255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142293|NCT01308255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93142294|NCT01308255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93142295|NCT01308255|Immunologic Factors|immunologic factors|mesh-ancestor
93142296|NCT01308255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142297|NCT01308255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93142298|NCT01308255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93142299|NCT01308255|Antiemetics|antiemetics|mesh-ancestor
93142300|NCT01308255|Autonomic Agents|autonomic agents|mesh-ancestor
93142301|NCT01308255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142302|NCT01308255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142303|NCT01308255|Glucocorticoids|glucocorticoids|mesh-ancestor
93142304|NCT01308255|Hormones|hormones|mesh-ancestor
93142305|NCT01308255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142306|NCT01308255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93142307|NCT01308255|Protective Agents|protective agents|mesh-ancestor
93142308|NCT01308255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93142309|NCT01308255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93142310|NCT01308255|Hematinics|hematinics|mesh-ancestor
93142311|NCT01308255|Vitamin B Complex|vitamin b complex|mesh-ancestor
93142312|NCT03782025|Vitamin K 1|vitamin k 1|mesh-list
93142313|NCT03782025|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93142314|NCT03782025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93142315|NCT03782025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142316|NCT03782025|Hemostatics|hemostatics|mesh-ancestor
93142317|NCT03782025|Coagulants|coagulants|mesh-ancestor
93142318|NCT03782025|Vitamins|vitamins|mesh-ancestor
93142319|NCT03782025|Micronutrients|micronutrients|mesh-ancestor
93142320|NCT03782025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142321|NCT03781947|Antarelix|antarelix|mesh-list
93142322|NCT03781947|Hormone Antagonists|hormone antagonists|mesh-ancestor
93142323|NCT03781947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142324|NCT03781947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142325|NCT03781869|Cisplatin|cisplatin|mesh-list
93142326|NCT03781869|Etoposide|etoposide|mesh-list
93142327|NCT03781869|Etoposide phosphate|etoposide phosphate|mesh-list
93142328|NCT03781869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142329|NCT03781869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93142330|NCT03781869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93142331|NCT03781869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93142332|NCT03781869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142333|NCT03781869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142334|NCT01311765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93142335|NCT01311765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142336|NCT03781635|Ketamine|ketamine|mesh-list
93142337|NCT03781635|Analgesics|analgesics|mesh-ancestor
93142338|NCT03781635|Sensory System Agents|sensory system agents|mesh-ancestor
93142339|NCT03781635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142340|NCT03781635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814503|NCT05242926|Docetaxel|docetaxel|mesh-list
93142341|NCT03781635|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93142342|NCT03781635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93142343|NCT03781635|Anesthetics, General|anesthetics, general|mesh-ancestor
93142344|NCT03781635|Anesthetics|anesthetics|mesh-ancestor
93142345|NCT03781635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142346|NCT03781635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93142347|NCT03781635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93142348|NCT03781635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142349|NCT03781635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142350|NCT03781713|Anti-Infective Agents|anti-infective agents|mesh-list
93142351|NCT03781713|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93142352|NCT03781011|Choline|choline|mesh-list
93142353|NCT03781011|Lipotropic Agents|lipotropic agents|mesh-ancestor
93142354|NCT03781011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93142355|NCT03781011|Antimetabolites|antimetabolites|mesh-ancestor
93142356|NCT03781011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142357|NCT03781011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93142358|NCT03781011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93142359|NCT03781011|Nootropic Agents|nootropic agents|mesh-ancestor
93142360|NCT03785613|Buprenorphine|buprenorphine|mesh-list
93142361|NCT03785613|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93142362|NCT03785613|Narcotics|narcotics|mesh-ancestor
93142363|NCT03785613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142364|NCT03785613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142365|NCT03785613|Analgesics|analgesics|mesh-ancestor
93142366|NCT03785613|Sensory System Agents|sensory system agents|mesh-ancestor
93142367|NCT03785613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142368|NCT03785613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93142369|NCT03785223|Methylphenidate|methylphenidate|mesh-list
93142370|NCT03785223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93142371|NCT03785223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142372|NCT03785223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93142373|NCT03785223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93142374|NCT03785223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93142375|NCT03785223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142376|NCT03785223|Dopamine Agents|dopamine agents|mesh-ancestor
93142377|NCT03785223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142378|NCT01308723|Sorafenib|sorafenib|mesh-list
93142379|NCT01308723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93142380|NCT01308723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142381|NCT01308723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142382|NCT01308723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142383|NCT01308723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142384|NCT01308723|Immunologic Factors|immunologic factors|mesh-ancestor
93142385|NCT01308723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142386|NCT01561131|Calcium|calcium|mesh-list
93142387|NCT01561131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142388|NCT01561131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142389|NCT01313403|Antidepressive Agents|antidepressive agents|mesh-list
93142390|NCT01313403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93142391|NCT03780621|Andrographolide|andrographolide|mesh-list
93142392|NCT03780621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93142393|NCT03780621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93142394|NCT03780621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142395|NCT03780621|Analgesics|analgesics|mesh-ancestor
93142396|NCT03780621|Sensory System Agents|sensory system agents|mesh-ancestor
93142397|NCT03780621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142398|NCT03780621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142399|NCT03780621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142400|NCT03780621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93142401|NCT03780621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93142402|NCT03780621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142403|NCT03780621|Antiviral Agents|antiviral agents|mesh-ancestor
93142404|NCT03780621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93142405|NCT03785067|Amlodipine|amlodipine|mesh-list
93142406|NCT03785067|Telmisartan|telmisartan|mesh-list
93142407|NCT03785067|Indapamide|indapamide|mesh-list
93142408|NCT03785067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93142409|NCT03785067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93142410|NCT03785067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93142411|NCT03785067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142412|NCT03785067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142413|NCT03785067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142414|NCT03785067|Vasodilator Agents|vasodilator agents|mesh-ancestor
93142415|NCT03785067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93142416|NCT03785067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93142418|NCT03785067|Natriuretic Agents|natriuretic agents|mesh-ancestor
93142419|NCT03785067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93142420|NCT05688111|Tranexamic Acid|tranexamic acid|mesh-list
93142421|NCT05688111|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93142422|NCT05688111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93142423|NCT05688111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142424|NCT05688111|Hemostatics|hemostatics|mesh-ancestor
93142425|NCT05688111|Coagulants|coagulants|mesh-ancestor
93142426|NCT02059018|Diclofenac|diclofenac|mesh-list
93142427|NCT02059018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
93142428|NCT02059018|Nitroglycerin|nitroglycerin|mesh-list
93142429|NCT02059018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93142430|NCT02059018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93142431|NCT02059018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93142432|NCT02059018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142433|NCT02059018|Analgesics|analgesics|mesh-ancestor
93142434|NCT02059018|Sensory System Agents|sensory system agents|mesh-ancestor
93142435|NCT02059018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142436|NCT02059018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142437|NCT02059018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93142438|NCT02059018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142439|NCT02059018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142440|NCT02059018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142441|NCT02059018|Vasodilator Agents|vasodilator agents|mesh-ancestor
93142442|NCT01561209|Amitriptyline|amitriptyline|mesh-list
93142443|NCT01561209|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93142444|NCT01561209|Antidepressive Agents|antidepressive agents|mesh-ancestor
93142445|NCT01561209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93142446|NCT01561209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142447|NCT01561209|Analgesics|analgesics|mesh-ancestor
93142448|NCT01561209|Sensory System Agents|sensory system agents|mesh-ancestor
93142449|NCT01561209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142450|NCT01561209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142451|NCT01561209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93142452|NCT01561209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93142453|NCT01561209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93142454|NCT01561209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142455|NCT01561209|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142456|NCT01561209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142457|NCT02800642|Aflibercept|aflibercept|mesh-list
93142458|NCT02800642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93142459|NCT02800642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93142460|NCT02800642|Growth Substances|growth substances|mesh-ancestor
93142461|NCT02800642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142462|NCT02800642|Growth Inhibitors|growth inhibitors|mesh-ancestor
93142463|NCT02800642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142464|NCT02056600|Metformin|metformin|mesh-list
93142465|NCT02056600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93142466|NCT02056600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142467|NCT02056678|Acetaminophen|acetaminophen|mesh-list
93142468|NCT02056678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142469|NCT02056678|Analgesics|analgesics|mesh-ancestor
93142470|NCT02056678|Sensory System Agents|sensory system agents|mesh-ancestor
93142471|NCT02056678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142472|NCT02056678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142473|NCT02056678|Antipyretics|antipyretics|mesh-ancestor
93142474|NCT04662567|Acetaminophen|acetaminophen|mesh-list
93142475|NCT04662567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142476|NCT04662567|Analgesics|analgesics|mesh-ancestor
93142477|NCT04662567|Sensory System Agents|sensory system agents|mesh-ancestor
93142478|NCT04662567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142479|NCT04662567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142480|NCT04662567|Antipyretics|antipyretics|mesh-ancestor
93142481|NCT02799784|Albuterol|albuterol|mesh-list
93142482|NCT02799784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93142483|NCT02799784|Autonomic Agents|autonomic agents|mesh-ancestor
93142484|NCT02799784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142485|NCT02799784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142486|NCT02799784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93142487|NCT02799784|Respiratory System Agents|respiratory system agents|mesh-ancestor
93142488|NCT02799784|Tocolytic Agents|tocolytic agents|mesh-ancestor
93142489|NCT02799784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142490|NCT02799784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93142491|NCT02799784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93142492|NCT02799784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93142493|NCT02799784|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142494|NCT02799784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142495|NCT02799784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142496|NCT03779685|Anesthetics|anesthetics|mesh-list
93142497|NCT03779685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142498|NCT03779685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142499|NCT03779451|Progesterone|progesterone|mesh-list
93142500|NCT03779451|Progestins|progestins|mesh-ancestor
93142501|NCT03779451|Hormones|hormones|mesh-ancestor
93142502|NCT03779451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142503|NCT03779451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142504|NCT02059330|Palbociclib|palbociclib|mesh-list
93142505|NCT02059330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142506|NCT02059330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142507|NCT02059330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142508|NCT02059330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142509|NCT03784443|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93142510|NCT03784443|Ranibizumab|ranibizumab|mesh-list
93142511|NCT03784443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93142512|NCT03784443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93142513|NCT03784443|Growth Substances|growth substances|mesh-ancestor
93142514|NCT03784443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142515|NCT03784443|Growth Inhibitors|growth inhibitors|mesh-ancestor
93142516|NCT03784443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142517|NCT03784443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93142518|NCT03784443|Glucocorticoids|glucocorticoids|mesh-ancestor
93142519|NCT03784443|Hormones|hormones|mesh-ancestor
93142520|NCT03784443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142521|NCT02054806|Pembrolizumab|pembrolizumab|mesh-list
93142522|NCT02054806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93142523|NCT02054806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142524|NCT02054806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93142525|NCT02054806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142526|NCT02054884|Paclitaxel|paclitaxel|mesh-list
93142527|NCT02054884|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93142528|NCT02054884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93142529|NCT02054884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142530|NCT02054884|Tubulin Modulators|tubulin modulators|mesh-ancestor
93142531|NCT02054884|Antimitotic Agents|antimitotic agents|mesh-ancestor
93142532|NCT02054884|Mitosis Modulators|mitosis modulators|mesh-ancestor
93142533|NCT02054884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142534|NCT01333072|Risperidone|risperidone|mesh-list
93142535|NCT01333072|Aripiprazole|aripiprazole|mesh-list
93142536|NCT01333072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93142537|NCT01333072|Serotonin Agents|serotonin agents|mesh-ancestor
93142538|NCT01333072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142539|NCT01333072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142540|NCT01333072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142541|NCT01333072|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93142542|NCT01333072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93142543|NCT01333072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142544|NCT01333072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93142545|NCT01333072|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93142546|NCT01333072|Dopamine Agents|dopamine agents|mesh-ancestor
93142547|NCT01333072|Antidepressive Agents|antidepressive agents|mesh-ancestor
93142548|NCT01333072|Dopamine Agonists|dopamine agonists|mesh-ancestor
93142549|NCT01333072|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93142550|NCT01333072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93142551|NCT01333072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93142552|NCT01333072|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93142553|NCT01560663|Carboplatin|carboplatin|mesh-list
93142554|NCT01560663|Docetaxel|docetaxel|mesh-list
93142555|NCT01560663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142556|NCT01560663|Tubulin Modulators|tubulin modulators|mesh-ancestor
93142557|NCT01560663|Antimitotic Agents|antimitotic agents|mesh-ancestor
93142558|NCT01560663|Mitosis Modulators|mitosis modulators|mesh-ancestor
93142559|NCT01560663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142560|NCT02059564|Liraglutide|liraglutide|mesh-list
93142561|NCT02059564|Exenatide|exenatide|mesh-list
93142562|NCT02059564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93142563|NCT02059564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142564|NCT02059564|Incretins|incretins|mesh-ancestor
93142565|NCT02059564|Hormones|hormones|mesh-ancestor
93142566|NCT02059564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142567|NCT02059564|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93142568|NCT05622058|Cyclophosphamide|cyclophosphamide|mesh-list
93142569|NCT05622058|Docetaxel|docetaxel|mesh-list
93142570|NCT05622058|Doxorubicin|doxorubicin|mesh-list
93142571|NCT05622058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93142572|NCT05622058|Immunologic Factors|immunologic factors|mesh-ancestor
93142573|NCT05622058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142574|NCT05622058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142575|NCT05622058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93142576|NCT05622058|Alkylating Agents|alkylating agents|mesh-ancestor
93142577|NCT05622058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142578|NCT05622058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142579|NCT05622058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93142580|NCT05622058|Tubulin Modulators|tubulin modulators|mesh-ancestor
93142581|NCT05622058|Antimitotic Agents|antimitotic agents|mesh-ancestor
93142582|NCT05622058|Mitosis Modulators|mitosis modulators|mesh-ancestor
93142583|NCT05622058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93142584|NCT05622058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93142585|NCT05622058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93142586|NCT05622058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142587|NCT02055196|Irinotecan|irinotecan|mesh-list
93142588|NCT02055196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93142589|NCT02055196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93142590|NCT02055196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142591|NCT02055196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142592|NCT02055196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142593|NCT02055274|Rotigotine|rotigotine|mesh-list
93142594|NCT02055274|Dopamine Agonists|dopamine agonists|mesh-ancestor
93142595|NCT02055274|Dopamine Agents|dopamine agents|mesh-ancestor
93142596|NCT02055274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142597|NCT02055274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142598|NCT02055274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142599|NCT03783897|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93142600|NCT03783897|Norgestimate|norgestimate|mesh-list
93142601|NCT03783897|Contraceptive Agents|contraceptive agents|mesh-list
93142602|NCT03783897|Contraceptives, Oral|contraceptives, oral|mesh-list
93142603|NCT03783897|Estradiol|estradiol|mesh-list
93142604|NCT03783897|Estrogens|estrogens|mesh-ancestor
93142605|NCT03783897|Hormones|hormones|mesh-ancestor
93142606|NCT03783897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142607|NCT03783897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142608|NCT03783897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93142609|NCT03783897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142610|NCT03783897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93142611|NCT03783897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93142612|NCT03783897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93142613|NCT03779061|Propofol|propofol|mesh-list
93142614|NCT03779061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93142615|NCT03779061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142616|NCT03779061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142617|NCT03779061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93142618|NCT03779061|Anesthetics, General|anesthetics, general|mesh-ancestor
93142619|NCT03779061|Anesthetics|anesthetics|mesh-ancestor
93142620|NCT01316445|Midazolam|midazolam|mesh-list
93142621|NCT01316445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93142622|NCT01316445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93142623|NCT01316445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142624|NCT01316445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142625|NCT01316445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93142626|NCT01316445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93142627|NCT01316445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93142628|NCT01316445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93142629|NCT01316445|Anesthetics, General|anesthetics, general|mesh-ancestor
93142630|NCT01316445|Anesthetics|anesthetics|mesh-ancestor
93142631|NCT01316445|GABA Modulators|gaba modulators|mesh-ancestor
93142632|NCT01316445|GABA Agents|gaba agents|mesh-ancestor
93142633|NCT01316445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142634|NCT01316445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142635|NCT03712449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93142636|NCT03712449|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93142637|NCT03712449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93142638|NCT03712449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142639|NCT03712449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142640|NCT03712449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93142641|NCT03712449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91927929|NCT02170805|Anticoagulants|anticoagulants|mesh-ancestor
93142642|NCT03712449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142643|NCT03712449|Cholinergic Agents|cholinergic agents|mesh-ancestor
93142644|NCT03712449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142645|NCT03517540|Cenicriviroc|cenicriviroc|mesh-list
93142646|NCT03517540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93142647|NCT03517540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142648|NCT03517540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93142649|NCT03517540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93142650|NCT03517540|Antiviral Agents|antiviral agents|mesh-ancestor
93142651|NCT03517540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142652|NCT03778359|Leuprolide|leuprolide|mesh-list
93142653|NCT03778359|Dienogest|dienogest|mesh-list
93142654|NCT03778359|Levonorgestrel|levonorgestrel|mesh-list
93142655|NCT03778359|Progestins|progestins|mesh-list
93142656|NCT03778359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93142657|NCT03778359|Contraceptive Agents|contraceptive agents|mesh-ancestor
93142658|NCT03778359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142659|NCT03778359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142660|NCT03778359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93142661|NCT03778359|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93142662|NCT03778359|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93142663|NCT03778359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93142664|NCT03778359|Fertility Agents|fertility agents|mesh-ancestor
93142665|NCT03778359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93142666|NCT03778359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142667|NCT03778359|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93142668|NCT03778359|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93142669|NCT03778359|Hormone Antagonists|hormone antagonists|mesh-ancestor
93142670|NCT03778359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93142671|NCT03778359|Hormones|hormones|mesh-ancestor
93142672|NCT03560908|Dasatinib|dasatinib|mesh-list
93142673|NCT03560908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142674|NCT03560908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142675|NCT03560908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142676|NCT03560908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142677|NCT02057770|Cyclophosphamide|cyclophosphamide|mesh-list
93142678|NCT02057770|Busulfan|busulfan|mesh-list
93142679|NCT02057770|Fludarabine|fludarabine|mesh-list
93142680|NCT02057770|Fludarabine phosphate|fludarabine phosphate|mesh-list
93142681|NCT02057770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93142682|NCT02057770|Immunologic Factors|immunologic factors|mesh-ancestor
93142683|NCT02057770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142684|NCT02057770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142685|NCT02057770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93142686|NCT02057770|Alkylating Agents|alkylating agents|mesh-ancestor
93142687|NCT02057770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142688|NCT02057770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142689|NCT02057770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93142690|NCT02057770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93142691|NCT02057770|Antimetabolites|antimetabolites|mesh-ancestor
93142692|NCT03778281|Baclofen|baclofen|mesh-list
93142693|NCT03778281|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93142694|NCT03778281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142695|NCT03778281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93142696|NCT03778281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142697|NCT03778281|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93142698|NCT03778281|GABA Agonists|gaba agonists|mesh-ancestor
93142699|NCT03778281|GABA Agents|gaba agents|mesh-ancestor
93142700|NCT03778281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142701|NCT03778281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142702|NCT02055586|Alovudine|alovudine|mesh-list
93142703|NCT02055586|Fluorides|fluorides|mesh-list
93142704|NCT02055586|Cariostatic Agents|cariostatic agents|mesh-ancestor
93142705|NCT02055586|Protective Agents|protective agents|mesh-ancestor
93142706|NCT02055586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142707|NCT02055586|Antiviral Agents|antiviral agents|mesh-ancestor
93142708|NCT02055586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142709|NCT03778593|Leucovorin|leucovorin|mesh-list
93142710|NCT03778593|Fluorouracil|fluorouracil|mesh-list
93142711|NCT03778593|Oxaliplatin|oxaliplatin|mesh-list
93142712|NCT03778593|Irinotecan|irinotecan|mesh-list
93142713|NCT03778593|Antimetabolites|antimetabolites|mesh-ancestor
93142714|NCT03778593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142715|NCT03778593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93142716|NCT03778593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142717|NCT03778593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93142718|NCT03778593|Immunologic Factors|immunologic factors|mesh-ancestor
93142719|NCT03778593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142720|NCT03778593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93142721|NCT03778593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93142722|NCT03778593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142723|NCT03778593|Antidotes|antidotes|mesh-ancestor
93142724|NCT03778593|Protective Agents|protective agents|mesh-ancestor
93142725|NCT03778593|Vitamin B Complex|vitamin b complex|mesh-ancestor
93142726|NCT03778593|Vitamins|vitamins|mesh-ancestor
93142727|NCT03778593|Micronutrients|micronutrients|mesh-ancestor
93142728|NCT02055664|Ropivacaine|ropivacaine|mesh-list
93142729|NCT02055664|Anesthetics, Local|anesthetics, local|mesh-ancestor
93142730|NCT02055664|Anesthetics|anesthetics|mesh-ancestor
93142731|NCT02055664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142732|NCT02055664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142733|NCT02055664|Sensory System Agents|sensory system agents|mesh-ancestor
93142734|NCT02055664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142735|NCT01309425|Tapentadol|tapentadol|mesh-list
93142736|NCT01309425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93142737|NCT01309425|Narcotics|narcotics|mesh-ancestor
93142738|NCT01309425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93142739|NCT01309425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142740|NCT01309425|Analgesics|analgesics|mesh-ancestor
93142741|NCT01309425|Sensory System Agents|sensory system agents|mesh-ancestor
93142742|NCT01309425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142743|NCT01309425|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93142744|NCT01309425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93142745|NCT01309425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93142746|NCT01309425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142747|NCT01309425|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142748|NCT01309425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142749|NCT03561298|Zanubrutinib|zanubrutinib|mesh-list
93142750|NCT03561298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142751|NCT03561298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142752|NCT03561298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142753|NCT03561298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142754|NCT05648422|Nitazoxanide|nitazoxanide|mesh-list
93142755|NCT05648422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93142756|NCT05648422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142757|NCT02057926|Tetracycline|tetracycline|mesh-list
93142758|NCT02057926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93142759|NCT02057926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142760|NCT02057926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93142761|NCT02057926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142762|NCT02057926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142763|NCT03777579|Paclitaxel|paclitaxel|mesh-list
93142764|NCT03777579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93142765|NCT03777579|Antibodies|antibodies|mesh-list
93142766|NCT03777579|Immunoglobulins|immunoglobulins|mesh-list
93142767|NCT03777579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93142768|NCT03777579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142769|NCT03777579|Tubulin Modulators|tubulin modulators|mesh-ancestor
93142770|NCT03777579|Antimitotic Agents|antimitotic agents|mesh-ancestor
93142771|NCT03777579|Mitosis Modulators|mitosis modulators|mesh-ancestor
93142772|NCT03777579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142773|NCT03777579|Immunologic Factors|immunologic factors|mesh-ancestor
93142774|NCT03777579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142775|NCT02059876|Paclitaxel|paclitaxel|mesh-list
93142776|NCT02059876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93142777|NCT02059876|Carboplatin|carboplatin|mesh-list
93142778|NCT02059876|Trastuzumab|trastuzumab|mesh-list
93142779|NCT02059876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93142780|NCT02059876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142781|NCT02059876|Tubulin Modulators|tubulin modulators|mesh-ancestor
93142782|NCT02059876|Antimitotic Agents|antimitotic agents|mesh-ancestor
93142783|NCT02059876|Mitosis Modulators|mitosis modulators|mesh-ancestor
93142784|NCT02059876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142785|NCT02059876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93142786|NCT03777423|Cobalt|cobalt|mesh-list
93142787|NCT03777423|Chromium|chromium|mesh-list
93142788|NCT03777423|Trace Elements|trace elements|mesh-ancestor
93142789|NCT03777423|Micronutrients|micronutrients|mesh-ancestor
93142790|NCT03777423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814948|NCT00751218|Histamine Antagonists|histamine antagonists|mesh-ancestor
93142791|NCT05654662|Listerine|listerine|mesh-list
93142792|NCT05654662|Chlorhexidine|chlorhexidine|mesh-list
93142793|NCT05654662|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93142795|NCT05654662|Cariostatic Agents|cariostatic agents|mesh-ancestor
93142796|NCT05654662|Protective Agents|protective agents|mesh-ancestor
93142797|NCT05654662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142798|NCT05654662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93142799|NCT05654662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142800|NCT05654662|Disinfectants|disinfectants|mesh-ancestor
93142801|NCT05654662|Dermatologic Agents|dermatologic agents|mesh-ancestor
93142802|NCT03777033|Alfacalcidol|alfacalcidol|mesh-list
93142803|NCT03777033|Calcium|calcium|mesh-list
93142804|NCT03777033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142805|NCT03777033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142806|NCT03777033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93142807|NCT02060032|Atorvastatin|atorvastatin|mesh-list
93142808|NCT02060032|Simvastatin|simvastatin|mesh-list
93142809|NCT02060032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93142810|NCT02060032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93142811|NCT02060032|Antimetabolites|antimetabolites|mesh-ancestor
93142812|NCT02060032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142813|NCT02060032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93142814|NCT02060032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93142815|NCT02060032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142816|NCT03783273|Vitamin D|vitamin d|mesh-list
93142817|NCT03783273|Cholecalciferol|cholecalciferol|mesh-list
93142818|NCT03783273|Vitamins|vitamins|mesh-ancestor
93142819|NCT03783273|Micronutrients|micronutrients|mesh-ancestor
93142820|NCT03783273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142821|NCT03783273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93142822|NCT03783273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142823|NCT03777345|Cobalt|cobalt|mesh-list
93142824|NCT03777345|Chromium|chromium|mesh-list
93142825|NCT03777345|Trace Elements|trace elements|mesh-ancestor
93142826|NCT03777345|Micronutrients|micronutrients|mesh-ancestor
93142827|NCT03777345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142828|NCT01318005|Contraceptive Agents|contraceptive agents|mesh-list
93142829|NCT01318005|Norinyl|norinyl|mesh-list
93142830|NCT01318005|Contraceptives, Oral|contraceptives, oral|mesh-list
93142831|NCT01318005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93142832|NCT01318005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142833|NCT01318005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93142834|NCT01318005|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93142835|NCT01318005|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93142836|NCT01318005|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93142837|NCT02799082|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93142838|NCT02799082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93142839|NCT02799082|Dermatologic Agents|dermatologic agents|mesh-ancestor
93142840|NCT03710889|Abaloparatide|abaloparatide|mesh-list
93142841|NCT03710889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93142842|NCT03710889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142843|NCT02061124|Sevelamer|sevelamer|mesh-list
93142844|NCT02061124|Chelating Agents|chelating agents|mesh-ancestor
93142845|NCT02061124|Sequestering Agents|sequestering agents|mesh-ancestor
93142846|NCT02061124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142847|NCT01318941|Ranibizumab|ranibizumab|mesh-list
93142848|NCT01318941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93142849|NCT01318941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93142850|NCT01318941|Growth Substances|growth substances|mesh-ancestor
93142851|NCT01318941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142852|NCT01318941|Growth Inhibitors|growth inhibitors|mesh-ancestor
93142853|NCT01318941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142854|NCT03560440|Vancomycin|vancomycin|mesh-list
93142855|NCT03560440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93142856|NCT03560440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142857|NCT03776955|Carvedilol|carvedilol|mesh-list
93142858|NCT03776955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93142859|NCT03776955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93142860|NCT03776955|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142861|NCT03776955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142862|NCT03776955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142863|NCT03776955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142864|NCT03776955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93142865|NCT03776955|Antioxidants|antioxidants|mesh-ancestor
93142866|NCT03776955|Protective Agents|protective agents|mesh-ancestor
92438587|NCT01613209|Olmesartan|olmesartan|mesh-list
93142867|NCT03776955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93142868|NCT03776955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93142869|NCT03776955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142870|NCT03776955|Vasodilator Agents|vasodilator agents|mesh-ancestor
93142871|NCT03776955|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93142872|NCT03776955|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93142873|NCT05102721|Avelumab|avelumab|mesh-list
93142874|NCT05102721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93142875|NCT05102721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142876|NCT03308942|Pembrolizumab|pembrolizumab|mesh-list
93142877|NCT03308942|Niraparib|niraparib|mesh-list
93142878|NCT03308942|Dostarlimab|dostarlimab|mesh-list
93142879|NCT03308942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93142880|NCT03308942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142881|NCT03308942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93142882|NCT03308942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142883|NCT03308942|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93142884|NCT03308942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142885|NCT01319019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93142886|NCT01319019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93142887|NCT01319019|Autonomic Agents|autonomic agents|mesh-ancestor
93142888|NCT01319019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142889|NCT01319019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142890|NCT01319019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93142891|NCT01319019|Respiratory System Agents|respiratory system agents|mesh-ancestor
93142892|NCT01319019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93142893|NCT01319019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93142894|NCT01319019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93142895|NCT01319019|Adrenergic Agents|adrenergic agents|mesh-ancestor
93142896|NCT01319019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93142897|NCT01319019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142898|NCT03308786|Aldesleukin|aldesleukin|mesh-list
93142899|NCT03308786|Interleukin-2|interleukin-2|mesh-list
93142900|NCT03308786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142901|NCT03308786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93142902|NCT03308786|Analgesics|analgesics|mesh-ancestor
93142903|NCT03308786|Sensory System Agents|sensory system agents|mesh-ancestor
93142904|NCT03308786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93142905|NCT03308786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142906|NCT03308786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93142907|NCT03308786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93142908|NCT03308786|Antiviral Agents|antiviral agents|mesh-ancestor
93142909|NCT03308786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142910|NCT03776409|Vancomycin|vancomycin|mesh-list
93142911|NCT03776409|Tazobactam|tazobactam|mesh-list
93142912|NCT03776409|Piperacillin|piperacillin|mesh-list
93142913|NCT03776409|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93142914|NCT03776409|Lactams|lactams|mesh-list
93142915|NCT03776409|beta-Lactams|beta-lactams|mesh-list
93142916|NCT03776409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93142917|NCT03776409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142918|NCT03776409|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93142919|NCT03776409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142920|NCT03776409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142921|NCT03782805|Cholecalciferol|cholecalciferol|mesh-list
93142922|NCT03782805|Vitamin D|vitamin d|mesh-list
93142923|NCT03782805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93142924|NCT03782805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142925|NCT03782805|Vitamins|vitamins|mesh-ancestor
93142926|NCT03782805|Micronutrients|micronutrients|mesh-ancestor
93142927|NCT03782805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93142928|NCT03775863|Liver Extracts|liver extracts|mesh-list
93142929|NCT03775863|Hematinics|hematinics|mesh-ancestor
93142930|NCT03274076|Tofacitinib|tofacitinib|mesh-list
93142931|NCT03274076|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93142932|NCT03274076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142933|NCT03274076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142934|NCT03274076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142935|NCT03775707|Lenvatinib|lenvatinib|mesh-list
93142936|NCT03775707|Antibodies|antibodies|mesh-list
93142937|NCT03775707|Immunologic Factors|immunologic factors|mesh-ancestor
93142938|NCT03775707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142939|NCT03775707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142940|NCT03775707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142941|NCT03775707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142942|NCT03775707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142943|NCT01320501|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93142944|NCT01320501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142945|NCT01320501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142946|NCT01320501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142947|NCT01320501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142949|NCT02764268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142950|NCT02764268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142951|NCT02764268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142952|NCT02764268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142953|NCT01320111|Paclitaxel|paclitaxel|mesh-list
93142954|NCT01320111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93142955|NCT01320111|Sorafenib|sorafenib|mesh-list
93142956|NCT01320111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93142957|NCT01320111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142958|NCT01320111|Tubulin Modulators|tubulin modulators|mesh-ancestor
93142959|NCT01320111|Antimitotic Agents|antimitotic agents|mesh-ancestor
93142960|NCT01320111|Mitosis Modulators|mitosis modulators|mesh-ancestor
93142961|NCT01320111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142962|NCT01320111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142963|NCT01320111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142964|NCT01320579|Tacrolimus|tacrolimus|mesh-list
93142965|NCT01320579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93142966|NCT01320579|Immunologic Factors|immunologic factors|mesh-ancestor
93142967|NCT01320579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142968|NCT01320579|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93142969|NCT01320579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142970|NCT01320579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142971|NCT05669001|Mycophenolic Acid|mycophenolic acid|mesh-list
93142972|NCT05669001|Abatacept|abatacept|mesh-list
93142973|NCT05669001|Tacrolimus|tacrolimus|mesh-list
93142974|NCT05669001|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93142975|NCT05669001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93142976|NCT05669001|Immunologic Factors|immunologic factors|mesh-ancestor
93142977|NCT05669001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93142978|NCT05669001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93142979|NCT05669001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142980|NCT05669001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142981|NCT05669001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93142982|NCT05669001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93142983|NCT05669001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142984|NCT05669001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93142985|NCT05669001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93142986|NCT05669001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93142987|NCT05669001|Antitubercular Agents|antitubercular agents|mesh-ancestor
93142988|NCT05669001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93142989|NCT05669001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93142990|NCT03775395|Sorafenib|sorafenib|mesh-list
93142991|NCT03775395|Lenvatinib|lenvatinib|mesh-list
93142992|NCT03775395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93142993|NCT03775395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93142994|NCT03775395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93142995|NCT03775395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93142996|NCT02797522|Acetaminophen|acetaminophen|mesh-list
93142997|NCT02797522|Tenofovir|tenofovir|mesh-list
93142998|NCT02797522|Entecavir|entecavir|mesh-list
93142999|NCT02797522|Histamine Antagonists|histamine antagonists|mesh-list
93143000|NCT02797522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93143001|NCT02797522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143002|NCT02797522|Analgesics|analgesics|mesh-ancestor
93143003|NCT02797522|Sensory System Agents|sensory system agents|mesh-ancestor
93143004|NCT02797522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143005|NCT02797522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143006|NCT02797522|Antipyretics|antipyretics|mesh-ancestor
93143007|NCT02797522|Antiviral Agents|antiviral agents|mesh-ancestor
93143008|NCT02797522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143009|NCT02797522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93143010|NCT02797522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143011|NCT02797522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143012|NCT02797522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143013|NCT02797522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93143014|NCT02797522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93143015|NCT02797522|Histamine Agents|histamine agents|mesh-ancestor
93143016|NCT02797522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143017|NCT03773367|Fluorouracil|fluorouracil|mesh-list
93143018|NCT03773367|Oxaliplatin|oxaliplatin|mesh-list
93143019|NCT03773367|Irinotecan|irinotecan|mesh-list
93143020|NCT03773367|Antimetabolites|antimetabolites|mesh-ancestor
93143021|NCT03773367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143022|NCT03773367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93143023|NCT03773367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143024|NCT03773367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93143025|NCT03773367|Immunologic Factors|immunologic factors|mesh-ancestor
93143026|NCT03773367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143027|NCT03773367|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93143028|NCT03773367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93143029|NCT03773367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143030|NCT02060656|Methylprednisolone|methylprednisolone|mesh-list
93143031|NCT02060656|Rituximab|rituximab|mesh-list
93143032|NCT02060656|Gemcitabine|gemcitabine|mesh-list
93143033|NCT02060656|Lenalidomide|lenalidomide|mesh-list
93143034|NCT02060656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143035|NCT02060656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143036|NCT02060656|Immunologic Factors|immunologic factors|mesh-ancestor
93143037|NCT02060656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143038|NCT02060656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143039|NCT02060656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93143040|NCT02060656|Antimetabolites|antimetabolites|mesh-ancestor
93143041|NCT02060656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143042|NCT02060656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93143043|NCT02060656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93143044|NCT02060656|Growth Substances|growth substances|mesh-ancestor
93143045|NCT02060656|Growth Inhibitors|growth inhibitors|mesh-ancestor
93143046|NCT02060656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143047|NCT02060656|Antiemetics|antiemetics|mesh-ancestor
93143048|NCT02060656|Autonomic Agents|autonomic agents|mesh-ancestor
93143049|NCT02060656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143050|NCT02060656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143051|NCT02060656|Glucocorticoids|glucocorticoids|mesh-ancestor
93143052|NCT02060656|Hormones|hormones|mesh-ancestor
93143053|NCT02060656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143054|NCT02060656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93143055|NCT02060656|Protective Agents|protective agents|mesh-ancestor
93143056|NCT03774771|Cinacalcet|cinacalcet|mesh-list
93143057|NCT03774771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143058|NCT03774771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143059|NCT03774771|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93143060|NCT03774771|Hormone Antagonists|hormone antagonists|mesh-ancestor
93143061|NCT03774771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143062|NCT03774693|Fentanyl|fentanyl|mesh-list
93143063|NCT03774693|Anesthetics|anesthetics|mesh-ancestor
93143064|NCT03774693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143065|NCT03774693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143066|NCT03774693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93143067|NCT03774693|Narcotics|narcotics|mesh-ancestor
93143068|NCT03774693|Analgesics|analgesics|mesh-ancestor
93143069|NCT03774693|Sensory System Agents|sensory system agents|mesh-ancestor
93143070|NCT03774693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143071|NCT03774693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93143072|NCT03774693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93143073|NCT03774693|Anesthetics, General|anesthetics, general|mesh-ancestor
93143074|NCT03774615|Ferric maltol|ferric maltol|mesh-list
93143075|NCT03774615|Hematinics|hematinics|mesh-ancestor
93143076|NCT01321047|Propofol|propofol|mesh-list
93143077|NCT01321047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93143078|NCT01321047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143079|NCT01321047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143080|NCT01321047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93143081|NCT01321047|Anesthetics, General|anesthetics, general|mesh-ancestor
93143082|NCT01321047|Anesthetics|anesthetics|mesh-ancestor
93143083|NCT01321125|Chlorhexidine|chlorhexidine|mesh-list
93143084|NCT01321125|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93143085|NCT01321125|Povidone-Iodine|povidone-iodine|mesh-list
93143086|NCT01321125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93143087|NCT01321125|Povidone|povidone|mesh-list
93143088|NCT01321125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143089|NCT01321125|Disinfectants|disinfectants|mesh-ancestor
93143090|NCT01321125|Dermatologic Agents|dermatologic agents|mesh-ancestor
93143091|NCT01321125|Plasma Substitutes|plasma substitutes|mesh-ancestor
93143092|NCT01321125|Blood Substitutes|blood substitutes|mesh-ancestor
93143093|NCT03773991|Nitric Oxide|nitric oxide|mesh-list
92815252|NCT01027754|Varenicline|varenicline|mesh-list
93143094|NCT03773991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93143095|NCT03773991|Autonomic Agents|autonomic agents|mesh-ancestor
93143096|NCT03773991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143097|NCT03773991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143098|NCT03773991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93143099|NCT03773991|Respiratory System Agents|respiratory system agents|mesh-ancestor
93143100|NCT03773991|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93143101|NCT03773991|Antioxidants|antioxidants|mesh-ancestor
93143102|NCT03773991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143103|NCT03773991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143104|NCT03773991|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93143105|NCT03773991|Vasodilator Agents|vasodilator agents|mesh-ancestor
93143106|NCT03773991|Gasotransmitters|gasotransmitters|mesh-ancestor
93143107|NCT03773991|Protective Agents|protective agents|mesh-ancestor
93143108|NCT05435313|Oxaliplatin|oxaliplatin|mesh-list
93143109|NCT05435313|Irinotecan|irinotecan|mesh-list
93143110|NCT05435313|Tislelizumab|tislelizumab|mesh-list
93143111|NCT05435313|Raltitrexed|raltitrexed|mesh-list
93143112|NCT05435313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143113|NCT05435313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93143114|NCT05435313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93143115|NCT05435313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143116|NCT05435313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143117|NCT05435313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143118|NCT05435313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93143119|NCT05435313|Antimetabolites|antimetabolites|mesh-ancestor
93143120|NCT05435313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93143121|NCT05472675|Bupivacaine|bupivacaine|mesh-list
93143122|NCT05472675|Botulinum Toxins|botulinum toxins|mesh-list
93143123|NCT05472675|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143124|NCT05472675|Anesthetics|anesthetics|mesh-ancestor
93143125|NCT05472675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143126|NCT05472675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143127|NCT05472675|Sensory System Agents|sensory system agents|mesh-ancestor
93143128|NCT05472675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143129|NCT05472675|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93143130|NCT05472675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143131|NCT05472675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143132|NCT05472675|Cholinergic Agents|cholinergic agents|mesh-ancestor
93143133|NCT05472675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143134|NCT01321905|Vitamin D|vitamin d|mesh-list
93143135|NCT01321905|Ergocalciferols|ergocalciferols|mesh-list
93143136|NCT01321905|Vitamins|vitamins|mesh-ancestor
93143137|NCT01321905|Micronutrients|micronutrients|mesh-ancestor
93143138|NCT01321905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143139|NCT01321905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93143140|NCT01321905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143141|NCT04570670|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93143142|NCT04570670|Dermatologic Agents|dermatologic agents|mesh-ancestor
93143143|NCT04570670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93143144|NCT04570670|Immunologic Factors|immunologic factors|mesh-ancestor
93143145|NCT04570670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143146|NCT03763227|Ranibizumab|ranibizumab|mesh-list
93143147|NCT03763227|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-list
93143148|NCT03763227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93143149|NCT03763227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93143150|NCT03763227|Growth Substances|growth substances|mesh-ancestor
93143151|NCT03763227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143152|NCT03763227|Growth Inhibitors|growth inhibitors|mesh-ancestor
93143153|NCT03763227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143154|NCT03763227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143155|NCT03763227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143156|NCT04929548|Maleic acid|maleic acid|mesh-list
93143157|NCT04929548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143158|NCT04929548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143159|NCT04150029|Azacitidine|azacitidine|mesh-list
93143160|NCT04150029|Venetoclax|venetoclax|mesh-list
93143161|NCT04150029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93143162|NCT04150029|Antimetabolites|antimetabolites|mesh-ancestor
93143163|NCT04150029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143164|NCT04150029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143165|NCT04150029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143166|NCT02060734|Lidocaine|lidocaine|mesh-list
93143167|NCT02060734|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143168|NCT02060734|Anesthetics|anesthetics|mesh-ancestor
93143169|NCT02060734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143170|NCT02060734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143171|NCT02060734|Sensory System Agents|sensory system agents|mesh-ancestor
93143172|NCT02060734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143173|NCT02060734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93143174|NCT02060734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93143175|NCT02060734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93143176|NCT02060734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143177|NCT02060734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143178|NCT03270644|Propranolol|propranolol|mesh-list
93143179|NCT03270644|Lasmiditan|lasmiditan|mesh-list
93143180|NCT03270644|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93143181|NCT03270644|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93143182|NCT03270644|Adrenergic Agents|adrenergic agents|mesh-ancestor
93143183|NCT03270644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143184|NCT03270644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143185|NCT03270644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143186|NCT03270644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93143187|NCT03270644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143188|NCT03270644|Vasodilator Agents|vasodilator agents|mesh-ancestor
93143189|NCT03270644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93143190|NCT03270644|Serotonin Agents|serotonin agents|mesh-ancestor
93143191|NCT04535102|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93143192|NCT04535102|Immunoconjugates|immunoconjugates|mesh-ancestor
93143193|NCT04535102|Immunologic Factors|immunologic factors|mesh-ancestor
93143194|NCT04535102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143195|NCT04529720|Vaccines|vaccines|mesh-list
93143196|NCT04529720|Immunologic Factors|immunologic factors|mesh-ancestor
93143197|NCT04529720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143198|NCT03768609|Cyclosporine|cyclosporine|mesh-list
93143199|NCT03768609|Cyclosporins|cyclosporins|mesh-list
93143200|NCT03768609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143201|NCT03768609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143202|NCT03768609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93143203|NCT03768609|Immunologic Factors|immunologic factors|mesh-ancestor
93143204|NCT03768609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143205|NCT03768609|Antifungal Agents|antifungal agents|mesh-ancestor
93143206|NCT03768609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143207|NCT03768609|Dermatologic Agents|dermatologic agents|mesh-ancestor
93143208|NCT03768609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143209|NCT03768609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93143210|NCT03269552|Rituximab|rituximab|mesh-list
93143211|NCT03269552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93143212|NCT03269552|Antibodies|antibodies|mesh-list
93143213|NCT03269552|Immunoglobulins|immunoglobulins|mesh-list
93143214|NCT03269552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93143215|NCT03269552|Immunologic Factors|immunologic factors|mesh-ancestor
93143216|NCT03269552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143217|NCT03269552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143218|NCT03269552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143219|NCT03771729|Valsartan|valsartan|mesh-list
93143220|NCT03771729|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93143221|NCT03771729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143222|NCT03771729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93143223|NCT03771729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93143224|NCT03771729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143225|NCT03560362|Epinephrine|epinephrine|mesh-list
93143226|NCT03560362|Bupivacaine|bupivacaine|mesh-list
93143227|NCT03560362|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143228|NCT03560362|Anesthetics|anesthetics|mesh-ancestor
93143229|NCT03560362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143230|NCT03560362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143231|NCT03560362|Sensory System Agents|sensory system agents|mesh-ancestor
93143232|NCT03560362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143233|NCT03560362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93143234|NCT03560362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93143235|NCT03560362|Adrenergic Agents|adrenergic agents|mesh-ancestor
93143236|NCT03560362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143237|NCT03560362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143238|NCT03560362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93143239|NCT03560362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93143240|NCT03560362|Autonomic Agents|autonomic agents|mesh-ancestor
93143241|NCT03560362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93143242|NCT03560362|Respiratory System Agents|respiratory system agents|mesh-ancestor
93143243|NCT03560362|Mydriatics|mydriatics|mesh-ancestor
93143244|NCT03560362|Sympathomimetics|sympathomimetics|mesh-ancestor
93143245|NCT03560362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93143246|NCT03768531|Nivolumab|nivolumab|mesh-list
93143247|NCT03768531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143248|NCT03768531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143249|NCT03768531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93143250|NCT03768531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143251|NCT01322061|Ascorbic Acid|ascorbic acid|mesh-list
93143252|NCT01322061|Vitamins|vitamins|mesh-ancestor
93143253|NCT01322061|Micronutrients|micronutrients|mesh-ancestor
93143254|NCT01322061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143255|NCT01322061|Antioxidants|antioxidants|mesh-ancestor
93143256|NCT01322061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143257|NCT01322061|Protective Agents|protective agents|mesh-ancestor
93143258|NCT02062996|Phenylephrine|phenylephrine|mesh-list
93143259|NCT02062996|Oxymetazoline|oxymetazoline|mesh-list
93143260|NCT02062996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93143261|NCT02062996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93143262|NCT02062996|Adrenergic Agents|adrenergic agents|mesh-ancestor
93143263|NCT02062996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143264|NCT02062996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143265|NCT02062996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143266|NCT02062996|Sympathomimetics|sympathomimetics|mesh-ancestor
93143267|NCT02062996|Autonomic Agents|autonomic agents|mesh-ancestor
93143268|NCT02062996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143269|NCT02062996|Nasal Decongestants|nasal decongestants|mesh-ancestor
93143270|NCT02062996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93143271|NCT02062996|Respiratory System Agents|respiratory system agents|mesh-ancestor
93143272|NCT02062996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93143273|NCT02062996|Mydriatics|mydriatics|mesh-ancestor
93143274|NCT02062996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93143275|NCT02062996|Protective Agents|protective agents|mesh-ancestor
93143276|NCT03762369|Latanoprost|latanoprost|mesh-list
93143277|NCT03762369|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93143278|NCT03762369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93143279|NCT01321515|Famciclovir|famciclovir|mesh-list
93143280|NCT01321515|Antiviral Agents|antiviral agents|mesh-ancestor
93143281|NCT01321515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143282|NCT01321515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143283|NCT01321515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143284|NCT01321515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143285|NCT02065414|Chlorhexidine|chlorhexidine|mesh-list
93143286|NCT02065414|Listerine|listerine|mesh-list
93143287|NCT02065414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93143288|NCT02065414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143289|NCT02065414|Disinfectants|disinfectants|mesh-ancestor
93143290|NCT04233879|Tenofovir|tenofovir|mesh-list
93143291|NCT04233879|Emtricitabine|emtricitabine|mesh-list
93143292|NCT04233879|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93143293|NCT04233879|Islatravir|islatravir|mesh-list
93143294|NCT04233879|Antiviral Agents|antiviral agents|mesh-ancestor
93143295|NCT04233879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143296|NCT04233879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93143297|NCT04233879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143298|NCT04233879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143299|NCT04233879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143300|NCT04233879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93143301|NCT04233879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93143302|NCT01370356|Varenicline|varenicline|mesh-list
93143303|NCT01370356|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93143304|NCT01370356|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93143305|NCT01370356|Cholinergic Agents|cholinergic agents|mesh-ancestor
93143306|NCT01370356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143307|NCT01370356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143308|NCT01370356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143309|NCT03792334|Anesthetics|anesthetics|mesh-list
93143310|NCT03792334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143311|NCT03792334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143312|NCT04545411|Dapagliflozin|dapagliflozin|mesh-list
93143313|NCT04545411|Volagidemab|volagidemab|mesh-list
92439025|NCT01615913|Hormone Antagonists|hormone antagonists|mesh-ancestor
93143314|NCT04545411|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93143315|NCT04545411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143316|NCT04545411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93143317|NCT04545411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143318|NCT02065492|Amlodipine|amlodipine|mesh-list
93143319|NCT02065492|Calcium Channel Blockers|calcium channel blockers|mesh-list
93143320|NCT02065492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143321|NCT02065492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143322|NCT02065492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143323|NCT02065492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143324|NCT02065492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143325|NCT02065492|Vasodilator Agents|vasodilator agents|mesh-ancestor
93143326|NCT02063620|Ketamine|ketamine|mesh-list
93143327|NCT02063620|Analgesics|analgesics|mesh-ancestor
93143328|NCT02063620|Sensory System Agents|sensory system agents|mesh-ancestor
93143329|NCT02063620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143330|NCT02063620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143331|NCT02063620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93143332|NCT02063620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93143333|NCT02063620|Anesthetics, General|anesthetics, general|mesh-ancestor
93143334|NCT02063620|Anesthetics|anesthetics|mesh-ancestor
93143335|NCT02063620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143336|NCT02063620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93143337|NCT02063620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93143338|NCT02063620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143339|NCT02063620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143340|NCT03767439|Nivolumab|nivolumab|mesh-list
93143341|NCT03767439|Ipilimumab|ipilimumab|mesh-list
93143342|NCT03767439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143343|NCT03767439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143344|NCT03767439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93143345|NCT03767439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143346|NCT04539405|Sevoflurane|sevoflurane|mesh-list
93143347|NCT04539405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93143348|NCT04539405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93143349|NCT04539405|Anesthetics, General|anesthetics, general|mesh-ancestor
93143350|NCT04539405|Anesthetics|anesthetics|mesh-ancestor
93143351|NCT04539405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143352|NCT04539405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143353|NCT02065804|Bupivacaine|bupivacaine|mesh-list
93143354|NCT02065804|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143355|NCT02065804|Anesthetics|anesthetics|mesh-ancestor
93143356|NCT02065804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143357|NCT02065804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143358|NCT02065804|Sensory System Agents|sensory system agents|mesh-ancestor
93143359|NCT02065804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143360|NCT02064010|Calcium, Dietary|calcium, dietary|mesh-list
93143361|NCT02064010|Acamprosate|acamprosate|mesh-list
93143362|NCT02064010|Calcium|calcium|mesh-list
93143363|NCT02064010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143364|NCT02064010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143365|NCT02064010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93143366|NCT02064010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93143367|NCT02064088|Levobupivacaine|levobupivacaine|mesh-list
93143368|NCT02064088|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143369|NCT02064088|Anesthetics|anesthetics|mesh-ancestor
93143370|NCT02064088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143371|NCT02064088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143372|NCT02064088|Sensory System Agents|sensory system agents|mesh-ancestor
93143373|NCT02064088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143374|NCT02066038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93143375|NCT02066038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143376|NCT02066038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93143377|NCT02066038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143378|NCT02066038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143379|NCT03766893|Naltrexone|naltrexone|mesh-list
93143380|NCT03766893|Buprenorphine|buprenorphine|mesh-list
93143381|NCT03766893|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93143382|NCT03766893|Naloxone|naloxone|mesh-list
93143383|NCT03766893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93143384|NCT03766893|Narcotics|narcotics|mesh-ancestor
93143385|NCT03766893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143386|NCT03766893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143387|NCT03766893|Analgesics|analgesics|mesh-ancestor
93143388|NCT03766893|Sensory System Agents|sensory system agents|mesh-ancestor
93143389|NCT03766893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143390|NCT03766893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93143391|NCT03766893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93143392|NCT03760809|Dexmedetomidine|dexmedetomidine|mesh-list
93143393|NCT03760809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93143394|NCT03760809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815546|NCT02773407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93143395|NCT03760809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143396|NCT03760809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143397|NCT03760809|Analgesics|analgesics|mesh-ancestor
93143398|NCT03760809|Sensory System Agents|sensory system agents|mesh-ancestor
93143399|NCT03760809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143400|NCT03760809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93143401|NCT03760809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93143402|NCT03760809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93143403|NCT03760809|Adrenergic Agents|adrenergic agents|mesh-ancestor
93143404|NCT03760809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143405|NCT03760809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143406|NCT01370590|Atorvastatin|atorvastatin|mesh-list
93143407|NCT01370590|Ezetimibe|ezetimibe|mesh-list
93143408|NCT01370590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93143409|NCT01370590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93143410|NCT01370590|Antimetabolites|antimetabolites|mesh-ancestor
93143411|NCT01370590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143412|NCT01370590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93143413|NCT01370590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93143414|NCT01370590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143415|NCT01567683|Imiquimod|imiquimod|mesh-list
93143416|NCT01567683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93143417|NCT01567683|Immunologic Factors|immunologic factors|mesh-ancestor
93143418|NCT01567683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143419|NCT01567683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143420|NCT01567683|Interferon Inducers|interferon inducers|mesh-ancestor
93143421|NCT03766425|Aflibercept|aflibercept|mesh-list
93143422|NCT03766425|Mitomycins|mitomycins|mesh-list
93143423|NCT03766425|Mitomycin|mitomycin|mesh-list
93143424|NCT03766425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93143425|NCT03766425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93143426|NCT03766425|Growth Substances|growth substances|mesh-ancestor
93143427|NCT03766425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143428|NCT03766425|Growth Inhibitors|growth inhibitors|mesh-ancestor
93143429|NCT03766425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143430|NCT03766425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93143431|NCT03766425|Alkylating Agents|alkylating agents|mesh-ancestor
93143432|NCT03766425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143433|NCT03766425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143434|NCT03766425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143435|NCT01561911|Antibodies|antibodies|mesh-list
93143436|NCT01561911|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93143437|NCT01561911|Immunologic Factors|immunologic factors|mesh-ancestor
93143438|NCT01561911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143439|NCT03770637|Glucagon|glucagon|mesh-list
93143440|NCT03770637|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93143441|NCT03770637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143442|NCT03770637|Hormones|hormones|mesh-ancestor
93143443|NCT03770637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143444|NCT03770637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143445|NCT03770637|Incretins|incretins|mesh-ancestor
93143446|NCT03766269|Dronabinol|dronabinol|mesh-list
93143447|NCT03766269|Hallucinogens|hallucinogens|mesh-ancestor
93143448|NCT03766269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143449|NCT03766269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93143450|NCT03766269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143451|NCT03766269|Analgesics|analgesics|mesh-ancestor
93143452|NCT03766269|Sensory System Agents|sensory system agents|mesh-ancestor
93143453|NCT03766269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143454|NCT03766269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93143455|NCT03766269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93143456|NCT03766269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143457|NCT03766269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143458|NCT03766269|Hormones|hormones|mesh-ancestor
93143459|NCT03766269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143460|NCT03894891|Docetaxel|docetaxel|mesh-list
93143461|NCT03894891|Nivolumab|nivolumab|mesh-list
93143462|NCT03894891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143463|NCT03894891|Tubulin Modulators|tubulin modulators|mesh-ancestor
93143464|NCT03894891|Antimitotic Agents|antimitotic agents|mesh-ancestor
93143465|NCT03894891|Mitosis Modulators|mitosis modulators|mesh-ancestor
93143466|NCT03894891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143467|NCT03894891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143468|NCT03894891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93143469|NCT03878979|Nivolumab|nivolumab|mesh-list
93143470|NCT03878979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143471|NCT03878979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143472|NCT03878979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93143473|NCT03878979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143475|NCT03765645|Piperacillin|piperacillin|mesh-list
93143476|NCT03765645|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93143477|NCT03765645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93143478|NCT03765645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143479|NCT03765645|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93143480|NCT03765645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143481|NCT03765645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143482|NCT01321671|Pregabalin|pregabalin|mesh-list
93143483|NCT01321671|Analgesics|analgesics|mesh-ancestor
93143484|NCT01321671|Sensory System Agents|sensory system agents|mesh-ancestor
93143485|NCT01321671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143486|NCT01321671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143487|NCT01321671|Anticonvulsants|anticonvulsants|mesh-ancestor
93143488|NCT01321671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93143489|NCT01321671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143490|NCT01321671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143491|NCT01321671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143492|NCT01321671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93143493|NCT01321671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93143494|NCT01321671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143495|NCT01321671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93143496|NCT03770013|Clonidine|clonidine|mesh-list
93143497|NCT03770013|Dexmedetomidine|dexmedetomidine|mesh-list
93143498|NCT03770013|Bupivacaine|bupivacaine|mesh-list
93143499|NCT03770013|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143500|NCT03770013|Anesthetics|anesthetics|mesh-ancestor
93143501|NCT03770013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143502|NCT03770013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143503|NCT03770013|Sensory System Agents|sensory system agents|mesh-ancestor
93143504|NCT03770013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143505|NCT03770013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93143506|NCT03770013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143507|NCT03770013|Analgesics|analgesics|mesh-ancestor
93143508|NCT03770013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93143509|NCT03770013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93143510|NCT03770013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93143511|NCT03770013|Adrenergic Agents|adrenergic agents|mesh-ancestor
93143512|NCT03770013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143513|NCT03770013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143514|NCT03770013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143515|NCT03770013|Sympatholytics|sympatholytics|mesh-ancestor
93143516|NCT03770013|Autonomic Agents|autonomic agents|mesh-ancestor
93143517|NCT03769935|Etoposide|etoposide|mesh-list
93143518|NCT03769935|Cisplatin|cisplatin|mesh-list
93143519|NCT03769935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93143520|NCT03769935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143521|NCT03769935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93143522|NCT03769935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93143523|NCT03769935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143524|NCT03769935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143525|NCT03765021|Tranexamic Acid|tranexamic acid|mesh-list
93143526|NCT03765021|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93143527|NCT03765021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93143528|NCT03765021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143529|NCT03765021|Hemostatics|hemostatics|mesh-ancestor
93143530|NCT03765021|Coagulants|coagulants|mesh-ancestor
93143531|NCT05418699|Insulin|insulin|mesh-list
93143532|NCT05418699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93143533|NCT05418699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143534|NCT03758859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93143535|NCT03758859|Hyaluronic Acid|hyaluronic acid|mesh-list
93143536|NCT03758859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93143537|NCT03758859|Immunologic Factors|immunologic factors|mesh-ancestor
93143538|NCT03758859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143539|NCT03758859|Viscosupplements|viscosupplements|mesh-ancestor
93143540|NCT03758859|Protective Agents|protective agents|mesh-ancestor
93143541|NCT03758859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93143542|NCT03759093|Thalidomide|thalidomide|mesh-list
93143543|NCT03759093|Dexamethasone|dexamethasone|mesh-list
93143544|NCT03759093|Dexamethasone acetate|dexamethasone acetate|mesh-list
93143545|NCT03759093|Cyclophosphamide|cyclophosphamide|mesh-list
93143546|NCT03759093|Bortezomib|bortezomib|mesh-list
93143547|NCT03759093|BB 1101|bb 1101|mesh-list
93143548|NCT03759093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93143549|NCT03759093|Immunologic Factors|immunologic factors|mesh-ancestor
93143550|NCT03759093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143551|NCT03759093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143552|NCT03759093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93143553|NCT03759093|Alkylating Agents|alkylating agents|mesh-ancestor
93143554|NCT03759093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143555|NCT03759093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143556|NCT03759093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93143557|NCT03759093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143558|NCT03759093|Antiemetics|antiemetics|mesh-ancestor
93143559|NCT03759093|Autonomic Agents|autonomic agents|mesh-ancestor
93143560|NCT03759093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143561|NCT03759093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143562|NCT03759093|Glucocorticoids|glucocorticoids|mesh-ancestor
93143563|NCT03759093|Hormones|hormones|mesh-ancestor
93143564|NCT03759093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143565|NCT03759093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93143566|NCT03759093|Protease Inhibitors|protease inhibitors|mesh-ancestor
93143567|NCT03759093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143568|NCT03759093|Leprostatic Agents|leprostatic agents|mesh-ancestor
93143569|NCT03759093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93143570|NCT03759093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143571|NCT03759093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93143572|NCT03759093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93143573|NCT03759093|Growth Substances|growth substances|mesh-ancestor
93143574|NCT03759093|Growth Inhibitors|growth inhibitors|mesh-ancestor
93143575|NCT03764241|Vitamin K|vitamin k|mesh-list
93143576|NCT03764241|Rivaroxaban|rivaroxaban|mesh-list
93143577|NCT03764241|Vitamins|vitamins|mesh-ancestor
93143578|NCT03764241|Micronutrients|micronutrients|mesh-ancestor
93143579|NCT03764241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143580|NCT03764241|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93143581|NCT03764241|Antithrombins|antithrombins|mesh-ancestor
93143582|NCT03764241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93143583|NCT03764241|Protease Inhibitors|protease inhibitors|mesh-ancestor
93143584|NCT03764241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143585|NCT03764241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143586|NCT03764241|Anticoagulants|anticoagulants|mesh-ancestor
93143587|NCT03764241|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93143588|NCT03764241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93143589|NCT03764241|Hemostatics|hemostatics|mesh-ancestor
93143590|NCT03764241|Coagulants|coagulants|mesh-ancestor
93143591|NCT03764163|Xenon|xenon|mesh-list
93143592|NCT03764163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93143593|NCT03764163|Anesthetics, General|anesthetics, general|mesh-ancestor
93143594|NCT03764163|Anesthetics|anesthetics|mesh-ancestor
93143595|NCT03764163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143596|NCT03764163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143597|NCT02556099|Hydroxyurea|hydroxyurea|mesh-list
93143598|NCT02556099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143599|NCT02556099|Antisickling Agents|antisickling agents|mesh-ancestor
93143600|NCT02556099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143601|NCT02556099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143602|NCT02556099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143603|NCT01321827|Itraconazole|itraconazole|mesh-list
93143604|NCT01321827|Prednisolone|prednisolone|mesh-list
93143605|NCT01321827|Glucocorticoids|glucocorticoids|mesh-list
93143606|NCT01321827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143607|NCT01321827|Hormones|hormones|mesh-ancestor
93143608|NCT01321827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143609|NCT01321827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143610|NCT01321827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93143611|NCT01321827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143612|NCT01321827|Antifungal Agents|antifungal agents|mesh-ancestor
93143613|NCT01321827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143614|NCT01321827|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93143615|NCT01321827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93143616|NCT01321827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143617|NCT01321827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143618|NCT01321827|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93143619|NCT01321827|Hormone Antagonists|hormone antagonists|mesh-ancestor
93143620|NCT01321827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93143621|NCT03753477|Amlodipine|amlodipine|mesh-list
93143622|NCT03753477|Olmesartan|olmesartan|mesh-list
93143623|NCT03753477|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93143624|NCT03753477|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
93143625|NCT03753477|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93143626|NCT03753477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143627|NCT03753477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93143628|NCT03753477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143629|NCT03753477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143630|NCT03753477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143631|NCT03753477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143632|NCT03753477|Vasodilator Agents|vasodilator agents|mesh-ancestor
93143633|NCT03753477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93143634|NCT03753477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93143635|NCT03753477|Antimetabolites|antimetabolites|mesh-ancestor
93143636|NCT03753477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93143637|NCT03753477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93143638|NCT03753477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143639|NCT03753477|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93143640|NCT03753477|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93143641|NCT05236647|Morphine|morphine|mesh-list
93143642|NCT05236647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93143643|NCT05236647|Narcotics|narcotics|mesh-ancestor
93143644|NCT05236647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143645|NCT05236647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143646|NCT05236647|Analgesics|analgesics|mesh-ancestor
93143647|NCT05236647|Sensory System Agents|sensory system agents|mesh-ancestor
93143648|NCT05236647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143649|NCT03758469|Rifampin|rifampin|mesh-list
93143650|NCT03758469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93143651|NCT03758469|Antitubercular Agents|antitubercular agents|mesh-ancestor
93143652|NCT03758469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93143653|NCT03758469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143654|NCT03758469|Leprostatic Agents|leprostatic agents|mesh-ancestor
93143655|NCT03758469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143656|NCT03758469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143657|NCT03758469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143658|NCT03758469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93143659|NCT03758469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93143660|NCT03758469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93143661|NCT03758469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93143662|NCT03758469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93143663|NCT03758469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93143664|NCT04646109|Azithromycin|azithromycin|mesh-list
93143665|NCT04646109|Hydroxychloroquine|hydroxychloroquine|mesh-list
93143666|NCT04646109|Ivermectin|ivermectin|mesh-list
93143667|NCT04646109|Favipiravir|favipiravir|mesh-list
93143668|NCT04646109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93143669|NCT04646109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143670|NCT04646109|Antimalarials|antimalarials|mesh-ancestor
93143671|NCT04646109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93143672|NCT04646109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93143673|NCT04646109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143674|NCT04646109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143675|NCT04646109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143676|NCT04646109|Antiviral Agents|antiviral agents|mesh-ancestor
93143677|NCT05320107|Ketamine|ketamine|mesh-list
93143678|NCT05320107|Analgesics|analgesics|mesh-ancestor
93143679|NCT05320107|Sensory System Agents|sensory system agents|mesh-ancestor
93143680|NCT05320107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143681|NCT05320107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143682|NCT05320107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93143683|NCT05320107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93143684|NCT05320107|Anesthetics, General|anesthetics, general|mesh-ancestor
93143685|NCT05320107|Anesthetics|anesthetics|mesh-ancestor
93143686|NCT05320107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143687|NCT05320107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93143688|NCT05320107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93143689|NCT05320107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143690|NCT05320107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143691|NCT03752931|Celiprolol|celiprolol|mesh-list
93143692|NCT03752931|Diltiazem|diltiazem|mesh-list
93143693|NCT03752931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143694|NCT03752931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93143695|NCT03752931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143696|NCT03752931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143697|NCT03752931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143698|NCT03752931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143699|NCT03752931|Vasodilator Agents|vasodilator agents|mesh-ancestor
93143700|NCT03752931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93143701|NCT03752931|Sympathomimetics|sympathomimetics|mesh-ancestor
93143702|NCT03752931|Autonomic Agents|autonomic agents|mesh-ancestor
93143703|NCT03752931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143704|NCT03752931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93143705|NCT03752931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93143706|NCT03752931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93143707|NCT03752931|Adrenergic Agents|adrenergic agents|mesh-ancestor
93143708|NCT03752931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143709|NCT03758235|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93143710|NCT03758235|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93143711|NCT03758235|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93143712|NCT03758235|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93143713|NCT03758235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143714|NCT03758235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143715|NCT03758235|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93143716|NCT03758235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143717|NCT03758235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143718|NCT03758235|Cholinergic Agents|cholinergic agents|mesh-ancestor
93143719|NCT03758235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143720|NCT02066350|Pancrelipase|pancrelipase|mesh-list
93143721|NCT02066350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143722|NCT02064946|Vitamin D|vitamin d|mesh-list
93143723|NCT02064946|Vitamins|vitamins|mesh-ancestor
93143724|NCT02064946|Micronutrients|micronutrients|mesh-ancestor
93143725|NCT02064946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143726|NCT02064946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93143727|NCT02064556|Amlodipine|amlodipine|mesh-list
93143728|NCT02064556|Candesartan|candesartan|mesh-list
93143729|NCT02064556|Candesartan cilexetil|candesartan cilexetil|mesh-list
93143730|NCT02064556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93143731|NCT02064556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93143732|NCT02064556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143733|NCT02064556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143734|NCT02064556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93143735|NCT02064556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143736|NCT02064556|Vasodilator Agents|vasodilator agents|mesh-ancestor
93143737|NCT02064556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93143738|NCT02064556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93143739|NCT05041647|Dronabinol|dronabinol|mesh-list
93143740|NCT05041647|Hallucinogens|hallucinogens|mesh-ancestor
93143741|NCT05041647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143742|NCT05041647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93143743|NCT05041647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143744|NCT05041647|Analgesics|analgesics|mesh-ancestor
93143745|NCT05041647|Sensory System Agents|sensory system agents|mesh-ancestor
93143746|NCT05041647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143747|NCT05041647|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93143748|NCT05041647|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93143749|NCT05041647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143750|NCT05041647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143751|NCT05041647|Hormones|hormones|mesh-ancestor
93143752|NCT05041647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143753|NCT03752229|Diazepam|diazepam|mesh-list
93143754|NCT03752229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93143755|NCT03752229|Anticonvulsants|anticonvulsants|mesh-ancestor
93143756|NCT03752229|Antiemetics|antiemetics|mesh-ancestor
93143757|NCT03752229|Autonomic Agents|autonomic agents|mesh-ancestor
93143758|NCT03752229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143759|NCT03752229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143760|NCT03752229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143761|NCT03752229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93143762|NCT03752229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143763|NCT03752229|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93143764|NCT03752229|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93143765|NCT03752229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93143766|NCT03752229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93143767|NCT03752229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93143769|NCT03752229|Anesthetics, General|anesthetics, general|mesh-ancestor
93143770|NCT03752229|Anesthetics|anesthetics|mesh-ancestor
93143771|NCT03752229|GABA Modulators|gaba modulators|mesh-ancestor
93143772|NCT03752229|GABA Agents|gaba agents|mesh-ancestor
93143773|NCT03752229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143774|NCT03752229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143775|NCT05359731|Dexamethasone|dexamethasone|mesh-list
93143776|NCT05359731|Bupivacaine|bupivacaine|mesh-list
93143777|NCT05359731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143778|NCT05359731|Antiemetics|antiemetics|mesh-ancestor
93143779|NCT05359731|Autonomic Agents|autonomic agents|mesh-ancestor
93143780|NCT05359731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143781|NCT05359731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143782|NCT05359731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143783|NCT05359731|Glucocorticoids|glucocorticoids|mesh-ancestor
93143784|NCT05359731|Hormones|hormones|mesh-ancestor
93143785|NCT05359731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143786|NCT05359731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93143787|NCT05359731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143788|NCT05359731|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143789|NCT05359731|Anesthetics|anesthetics|mesh-ancestor
93143790|NCT05359731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143791|NCT05359731|Sensory System Agents|sensory system agents|mesh-ancestor
93143792|NCT03695367|Acetaminophen|acetaminophen|mesh-list
93143793|NCT03695367|Ibuprofen|ibuprofen|mesh-list
93143794|NCT03695367|Ketorolac|ketorolac|mesh-list
93143795|NCT03695367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143796|NCT03695367|Analgesics|analgesics|mesh-ancestor
93143797|NCT03695367|Sensory System Agents|sensory system agents|mesh-ancestor
93143798|NCT03695367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143799|NCT03695367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143800|NCT03695367|Antipyretics|antipyretics|mesh-ancestor
93143801|NCT03695367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93143802|NCT03695367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143803|NCT03695367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143804|NCT03695367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93143805|NCT03695367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143806|NCT03695367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143807|NCT03755427|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93143808|NCT03755427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93143809|NCT03755427|Immunologic Factors|immunologic factors|mesh-ancestor
93143810|NCT03755427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143811|NCT03755427|Antacids|antacids|mesh-ancestor
93143812|NCT03755427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143813|NCT03755427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143814|NCT03758079|Gabapentin|gabapentin|mesh-list
93143815|NCT03758079|Doxepin|doxepin|mesh-list
93143816|NCT03758079|Analgesics|analgesics|mesh-ancestor
93143817|NCT03758079|Sensory System Agents|sensory system agents|mesh-ancestor
93143818|NCT03758079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143819|NCT03758079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143820|NCT03758079|Anticonvulsants|anticonvulsants|mesh-ancestor
93143821|NCT03758079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93143822|NCT03758079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93143823|NCT03758079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143824|NCT03758079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93143825|NCT03758079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93143826|NCT03758079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93143827|NCT03758079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143828|NCT03758079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143829|NCT03758079|Antimanic Agents|antimanic agents|mesh-ancestor
93143830|NCT03758079|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93143831|NCT03758079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93143832|NCT03758079|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93143833|NCT03758079|Antidepressive Agents|antidepressive agents|mesh-ancestor
93143834|NCT03758079|Histamine Antagonists|histamine antagonists|mesh-ancestor
93143835|NCT03758079|Histamine Agents|histamine agents|mesh-ancestor
93143836|NCT02067910|Abatacept|abatacept|mesh-list
93143837|NCT02067910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93143838|NCT02067910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143839|NCT02067910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93143840|NCT02067910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143841|NCT02067910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93143842|NCT02067910|Immunologic Factors|immunologic factors|mesh-ancestor
93143843|NCT02067910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143844|NCT02067910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143846|NCT02066662|Phenprocoumon|phenprocoumon|mesh-list
93143847|NCT02066662|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93143848|NCT02066662|Antithrombins|antithrombins|mesh-ancestor
93143849|NCT02066662|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93143850|NCT02066662|Protease Inhibitors|protease inhibitors|mesh-ancestor
93143851|NCT02066662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143852|NCT02066662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143853|NCT02066662|Anticoagulants|anticoagulants|mesh-ancestor
93143854|NCT05280873|Methylprednisolone|methylprednisolone|mesh-list
93143855|NCT05280873|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93143856|NCT05280873|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93143857|NCT05280873|Prednisolone|prednisolone|mesh-list
93143858|NCT05280873|Prednisolone acetate|prednisolone acetate|mesh-list
93143859|NCT05280873|Pirfenidone|pirfenidone|mesh-list
93143860|NCT05280873|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93143861|NCT05280873|Prednisolone phosphate|prednisolone phosphate|mesh-list
93143862|NCT05280873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143863|NCT05280873|Antiemetics|antiemetics|mesh-ancestor
93143864|NCT05280873|Autonomic Agents|autonomic agents|mesh-ancestor
93143865|NCT05280873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143866|NCT05280873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143867|NCT05280873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143868|NCT05280873|Glucocorticoids|glucocorticoids|mesh-ancestor
93143869|NCT05280873|Hormones|hormones|mesh-ancestor
93143870|NCT05280873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93143871|NCT05280873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93143872|NCT05280873|Protective Agents|protective agents|mesh-ancestor
93143873|NCT05280873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93143874|NCT05280873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143875|NCT05280873|Analgesics|analgesics|mesh-ancestor
93143876|NCT05280873|Sensory System Agents|sensory system agents|mesh-ancestor
93143877|NCT05280873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93143878|NCT05280873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143879|NCT05280873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143880|NCT02066818|Lidocaine|lidocaine|mesh-list
93143881|NCT02066818|Tetracaine|tetracaine|mesh-list
93143882|NCT02066818|Anesthetics, Local|anesthetics, local|mesh-ancestor
93143883|NCT02066818|Anesthetics|anesthetics|mesh-ancestor
93143884|NCT02066818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143885|NCT02066818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143886|NCT02066818|Sensory System Agents|sensory system agents|mesh-ancestor
93143887|NCT02066818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143888|NCT02066818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93143889|NCT02066818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93143890|NCT02066818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93143891|NCT02066818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93143892|NCT02066818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143893|NCT04558125|Heparin|heparin|mesh-list
93143894|NCT04558125|Calcium heparin|calcium heparin|mesh-list
93143895|NCT04558125|Enoxaparin|enoxaparin|mesh-list
93143896|NCT04558125|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93143897|NCT04558125|Tinzaparin|tinzaparin|mesh-list
93143898|NCT04558125|Dalteparin|dalteparin|mesh-list
93143899|NCT04558125|Tenecteplase|tenecteplase|mesh-list
93143900|NCT04558125|Enoxaparin sodium|enoxaparin sodium|mesh-list
93143901|NCT04558125|Anticoagulants|anticoagulants|mesh-ancestor
93143902|NCT04558125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93143903|NCT04558125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93143904|NCT04558125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143905|NCT05460195|Immunomodulating Agents|immunomodulating agents|mesh-list
93143906|NCT05460195|Immunologic Factors|immunologic factors|mesh-list
93143907|NCT05460195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143908|NCT02793622|Pyrimethamine|pyrimethamine|mesh-list
93143909|NCT02793622|Piperaquine|piperaquine|mesh-list
93143910|NCT02793622|Sulfadoxine|sulfadoxine|mesh-list
93143911|NCT02793622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93143912|NCT02793622|Artenimol|artenimol|mesh-list
93143913|NCT02793622|Antimalarials|antimalarials|mesh-ancestor
93143914|NCT02793622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93143915|NCT02793622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93143916|NCT02793622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143917|NCT02793622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93143918|NCT02793622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143919|NCT02793622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143920|NCT02793622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93143921|NCT04493931|Rifampin|rifampin|mesh-list
93143922|NCT04493931|Gepotidacin|gepotidacin|mesh-list
93143923|NCT04493931|Digoxin|digoxin|mesh-list
93143924|NCT04493931|Midazolam|midazolam|mesh-list
93143925|NCT04493931|Cimetidine|cimetidine|mesh-list
93143926|NCT04493931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93143927|NCT04493931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93143928|NCT04493931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93143929|NCT04493931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143930|NCT04493931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93143931|NCT04493931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93143932|NCT04493931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93143933|NCT04493931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93143934|NCT04493931|Anesthetics, General|anesthetics, general|mesh-ancestor
93143935|NCT04493931|Anesthetics|anesthetics|mesh-ancestor
93143936|NCT04493931|GABA Modulators|gaba modulators|mesh-ancestor
93143937|NCT04493931|GABA Agents|gaba agents|mesh-ancestor
93143938|NCT04493931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93143939|NCT04493931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143940|NCT04493931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93143941|NCT04493931|Antitubercular Agents|antitubercular agents|mesh-ancestor
93143942|NCT04493931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93143943|NCT04493931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143944|NCT04493931|Leprostatic Agents|leprostatic agents|mesh-ancestor
93143945|NCT04493931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93143946|NCT04493931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143947|NCT04493931|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93143948|NCT04493931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93143949|NCT04493931|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93143950|NCT04493931|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93143951|NCT04493931|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93143952|NCT04493931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93143953|NCT04493931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93143954|NCT04493931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93143955|NCT04493931|Protective Agents|protective agents|mesh-ancestor
93143956|NCT04493931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93143957|NCT04493931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93143958|NCT04493931|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93143959|NCT04493931|Histamine Antagonists|histamine antagonists|mesh-ancestor
93143960|NCT04493931|Histamine Agents|histamine agents|mesh-ancestor
93143961|NCT04493931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93143962|NCT04493931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93143963|NCT04493931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93143964|NCT04493931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143965|NCT02260336|Celecoxib|celecoxib|mesh-list
93143966|NCT02260336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93143967|NCT02260336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93143968|NCT02260336|Analgesics|analgesics|mesh-ancestor
93143969|NCT02260336|Sensory System Agents|sensory system agents|mesh-ancestor
93143970|NCT02260336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93143971|NCT02260336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143972|NCT02260336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93143973|NCT02260336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93143974|NCT02260336|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93143975|NCT02260336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93143976|NCT02260336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143977|NCT02260336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143978|NCT04948203|Sirolimus|sirolimus|mesh-list
93143979|NCT04948203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93143980|NCT04948203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93143981|NCT04948203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93143982|NCT04948203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143983|NCT04948203|Antifungal Agents|antifungal agents|mesh-ancestor
93143984|NCT04948203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93143985|NCT04948203|Immunologic Factors|immunologic factors|mesh-ancestor
93143986|NCT04948203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143987|NCT03755193|Diphosphonates|diphosphonates|mesh-list
93143988|NCT03755193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93143989|NCT03755193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93143990|NCT03755115|Epirubicin|epirubicin|mesh-list
93143991|NCT03755115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93143992|NCT03755115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93143993|NCT03755115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93143994|NCT03755115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93143995|NCT03755115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93143996|NCT03755115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93143997|NCT03755037|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93143998|NCT03755037|Estradiol|estradiol|mesh-list
93143999|NCT03755037|Estrogens|estrogens|mesh-ancestor
93144000|NCT03755037|Hormones|hormones|mesh-ancestor
93144001|NCT03755037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144002|NCT03755037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144003|NCT03755037|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93144004|NCT03755037|Contraceptive Agents|contraceptive agents|mesh-ancestor
93144005|NCT03755037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93144006|NCT03755037|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93144007|NCT03755037|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93144008|NCT03755037|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93144009|NCT03751917|Arsenic Trioxide|arsenic trioxide|mesh-list
93144010|NCT03751917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144011|NCT04490499|Vaccines|vaccines|mesh-list
93144012|NCT04490499|Immunologic Factors|immunologic factors|mesh-ancestor
93144013|NCT04490499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144014|NCT01332994|Rituximab|rituximab|mesh-list
93144015|NCT01332994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93144016|NCT01332994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144017|NCT01332994|Immunologic Factors|immunologic factors|mesh-ancestor
93144018|NCT01332994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144019|NCT01332994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144020|NCT03754959|Midazolam|midazolam|mesh-list
93144021|NCT03754959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93144022|NCT03754959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93144023|NCT03754959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144024|NCT03754959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144025|NCT03754959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93144026|NCT03754959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93144027|NCT03754959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93144028|NCT03754959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93144029|NCT03754959|Anesthetics, General|anesthetics, general|mesh-ancestor
93144030|NCT03754959|Anesthetics|anesthetics|mesh-ancestor
93144031|NCT03754959|GABA Modulators|gaba modulators|mesh-ancestor
93144032|NCT03754959|GABA Agents|gaba agents|mesh-ancestor
93144033|NCT03754959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144034|NCT03754959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144035|NCT02068690|BI 425809|bi 425809|mesh-list
93144036|NCT02068690|Nootropic Agents|nootropic agents|mesh-ancestor
93144037|NCT02067442|Acetaminophen|acetaminophen|mesh-list
93144038|NCT02067442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144039|NCT02067442|Analgesics|analgesics|mesh-ancestor
93144040|NCT02067442|Sensory System Agents|sensory system agents|mesh-ancestor
93144041|NCT02067442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144042|NCT02067442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144043|NCT02067442|Antipyretics|antipyretics|mesh-ancestor
93144044|NCT02067520|Hydromorphone|hydromorphone|mesh-list
93144045|NCT02067520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93144046|NCT02067520|Narcotics|narcotics|mesh-ancestor
93144047|NCT02067520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144048|NCT02067520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144049|NCT02067520|Analgesics|analgesics|mesh-ancestor
93144050|NCT02067520|Sensory System Agents|sensory system agents|mesh-ancestor
93144051|NCT02067520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144052|NCT03757923|Metformin|metformin|mesh-list
93144053|NCT03757923|Pioglitazone|pioglitazone|mesh-list
93144054|NCT03757923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93144055|NCT03757923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144056|NCT02071888|Dexamethasone|dexamethasone|mesh-list
93144057|NCT02071888|Dexamethasone acetate|dexamethasone acetate|mesh-list
93144058|NCT02071888|Pomalidomide|pomalidomide|mesh-list
93144059|NCT02071888|BB 1101|bb 1101|mesh-list
93144060|NCT02071888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144061|NCT02071888|Antiemetics|antiemetics|mesh-ancestor
93144062|NCT02071888|Autonomic Agents|autonomic agents|mesh-ancestor
93144063|NCT02071888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144064|NCT02071888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144065|NCT02071888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144066|NCT02071888|Glucocorticoids|glucocorticoids|mesh-ancestor
93144067|NCT02071888|Hormones|hormones|mesh-ancestor
93144068|NCT02071888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816224|NCT02756715|Propofol|propofol|mesh-list
93144069|NCT02071888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144070|NCT02071888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144071|NCT02071888|Protease Inhibitors|protease inhibitors|mesh-ancestor
93144072|NCT02071888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144073|NCT02071888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144074|NCT02071888|Immunologic Factors|immunologic factors|mesh-ancestor
93144075|NCT02071888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93144076|NCT02071888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93144077|NCT02071888|Growth Substances|growth substances|mesh-ancestor
93144078|NCT02071888|Growth Inhibitors|growth inhibitors|mesh-ancestor
93144079|NCT02071966|Clopidogrel|clopidogrel|mesh-list
93144080|NCT02071966|Ticagrelor|ticagrelor|mesh-list
93144081|NCT02071966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93144082|NCT02071966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93144083|NCT02071966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93144084|NCT02071966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93144085|NCT02071966|Purinergic Agents|purinergic agents|mesh-ancestor
93144086|NCT02071966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144087|NCT02071966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144088|NCT02071966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144089|NCT02072278|Vortioxetine|vortioxetine|mesh-list
93144090|NCT02072278|Escitalopram|escitalopram|mesh-list
93144091|NCT02072278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93144092|NCT02072278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93144093|NCT02072278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93144094|NCT02072278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144095|NCT02072278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144096|NCT02072278|Serotonin Agents|serotonin agents|mesh-ancestor
93144097|NCT02072278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144098|NCT02072278|Antidepressive Agents|antidepressive agents|mesh-ancestor
93144099|NCT02072278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93144100|NCT02072278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93144101|NCT02072278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93144102|NCT02072278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144103|NCT02072278|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93144104|NCT02072278|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93144105|NCT02072278|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93144106|NCT02072278|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93144107|NCT02072512|Fulvestrant|fulvestrant|mesh-list
93144108|NCT02072512|Anastrozole|anastrozole|mesh-list
93144109|NCT02072512|Goserelin|goserelin|mesh-list
93144110|NCT02072512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144111|NCT02072512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144112|NCT02072512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93144113|NCT02072512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93144114|NCT02072512|Hormone Antagonists|hormone antagonists|mesh-ancestor
93144115|NCT02072512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144116|NCT02072512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144117|NCT02072512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93144118|NCT02072512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93144119|NCT02072512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144120|NCT02072512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144121|NCT04534491|Oxybutynin|oxybutynin|mesh-list
93144122|NCT04534491|Parasympatholytics|parasympatholytics|mesh-ancestor
93144123|NCT04534491|Autonomic Agents|autonomic agents|mesh-ancestor
93144124|NCT04534491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144125|NCT04534491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144126|NCT04534491|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93144127|NCT04534491|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93144128|NCT04534491|Cholinergic Agents|cholinergic agents|mesh-ancestor
93144129|NCT04534491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144130|NCT04534491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144131|NCT04534491|Urological Agents|urological agents|mesh-ancestor
93144132|NCT02069080|Plerixafor|plerixafor|mesh-list
93144133|NCT02069080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93144134|NCT02069080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93144135|NCT02069080|Antiviral Agents|antiviral agents|mesh-ancestor
93144136|NCT02069080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144137|NCT02077348|Hormones|hormones|mesh-list
93144138|NCT02077348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144139|NCT02077348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144140|NCT03694821|Methylprednisolone|methylprednisolone|mesh-list
93144141|NCT03694821|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93144142|NCT03694821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93144143|NCT03694821|Prednisolone|prednisolone|mesh-list
93144144|NCT03694821|Prednisolone acetate|prednisolone acetate|mesh-list
93144145|NCT03694821|Ketorolac|ketorolac|mesh-list
93144146|NCT03694821|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93144147|NCT03694821|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93144148|NCT03694821|Prednisolone phosphate|prednisolone phosphate|mesh-list
93144149|NCT03694821|Hylan|hylan|mesh-list
93144150|NCT03694821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144151|NCT03694821|Antiemetics|antiemetics|mesh-ancestor
93144152|NCT03694821|Autonomic Agents|autonomic agents|mesh-ancestor
93144153|NCT03694821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144154|NCT03694821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144155|NCT03694821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144156|NCT03694821|Glucocorticoids|glucocorticoids|mesh-ancestor
93144157|NCT03694821|Hormones|hormones|mesh-ancestor
93144158|NCT03694821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144159|NCT03694821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93144160|NCT03694821|Protective Agents|protective agents|mesh-ancestor
93144161|NCT03694821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144162|NCT03694821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144163|NCT03694821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93144164|NCT03694821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144165|NCT03694821|Analgesics|analgesics|mesh-ancestor
93144166|NCT03694821|Sensory System Agents|sensory system agents|mesh-ancestor
93144167|NCT03694821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144168|NCT03694821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93144169|NCT03694821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144170|NCT03694821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144171|NCT03694821|Viscosupplements|viscosupplements|mesh-ancestor
93144172|NCT02069158|Paclitaxel|paclitaxel|mesh-list
93144173|NCT02069158|Carboplatin|carboplatin|mesh-list
93144174|NCT02069158|Gedatolisib|gedatolisib|mesh-list
93144175|NCT02069158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93144176|NCT02069158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144177|NCT02069158|Tubulin Modulators|tubulin modulators|mesh-ancestor
93144178|NCT02069158|Antimitotic Agents|antimitotic agents|mesh-ancestor
93144179|NCT02069158|Mitosis Modulators|mitosis modulators|mesh-ancestor
93144180|NCT02069158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144181|NCT02069158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144182|NCT02069158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144183|NCT04531527|Butenafine|butenafine|mesh-list
93144184|NCT04531527|Antifungal Agents|antifungal agents|mesh-ancestor
93144185|NCT04531527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144186|NCT02078440|Bromocriptine|bromocriptine|mesh-list
93144187|NCT02078440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93144188|NCT02078440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93144189|NCT02078440|Hormone Antagonists|hormone antagonists|mesh-ancestor
93144190|NCT02078440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144191|NCT02078440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144192|NCT02078440|Dopamine Agonists|dopamine agonists|mesh-ancestor
93144193|NCT02078440|Dopamine Agents|dopamine agents|mesh-ancestor
93144194|NCT02078440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144195|NCT02078440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144196|NCT02070406|Aldesleukin|aldesleukin|mesh-list
93144197|NCT02070406|Cyclophosphamide|cyclophosphamide|mesh-list
93144198|NCT02070406|Fludarabine|fludarabine|mesh-list
93144199|NCT02070406|Fludarabine phosphate|fludarabine phosphate|mesh-list
93144200|NCT02070406|Interleukin-2|interleukin-2|mesh-list
93144201|NCT02070406|Vaccines|vaccines|mesh-list
93144202|NCT02070406|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93144203|NCT02070406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144204|NCT02070406|Immunologic Factors|immunologic factors|mesh-ancestor
93144205|NCT02070406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144206|NCT02070406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144207|NCT02070406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93144208|NCT02070406|Alkylating Agents|alkylating agents|mesh-ancestor
93144209|NCT02070406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144210|NCT02070406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144211|NCT02070406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93144212|NCT02070406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93144213|NCT02070406|Antimetabolites|antimetabolites|mesh-ancestor
93144214|NCT02070406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144215|NCT02070406|Analgesics|analgesics|mesh-ancestor
93144216|NCT02070406|Sensory System Agents|sensory system agents|mesh-ancestor
93144217|NCT02070406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144218|NCT02070406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93144219|NCT02070406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93144220|NCT02070406|Antiviral Agents|antiviral agents|mesh-ancestor
93144221|NCT02070406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144222|NCT02070406|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93144224|NCT02078596|Anticonvulsants|anticonvulsants|mesh-ancestor
93144225|NCT02078596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144226|NCT02078596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144227|NCT02078596|GABA Agents|gaba agents|mesh-ancestor
93144228|NCT02078596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144229|NCT02078596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144230|NCT02078596|Antimanic Agents|antimanic agents|mesh-ancestor
93144231|NCT02078596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93144232|NCT02078596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144233|NCT02078596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93144234|NCT02070718|Pentazocine|pentazocine|mesh-list
93144235|NCT02070718|Naloxone|naloxone|mesh-list
93144236|NCT02070718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93144237|NCT02070718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144238|NCT02070718|Sensory System Agents|sensory system agents|mesh-ancestor
93144239|NCT02070718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144240|NCT02070718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93144241|NCT02070718|Narcotics|narcotics|mesh-ancestor
93144242|NCT02070718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144243|NCT02070718|Analgesics|analgesics|mesh-ancestor
93144244|NCT02070718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93144245|NCT02070796|Rotigotine|rotigotine|mesh-list
93144246|NCT02070796|Dopamine Agonists|dopamine agonists|mesh-ancestor
93144247|NCT02070796|Dopamine Agents|dopamine agents|mesh-ancestor
93144248|NCT02070796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144249|NCT02070796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144250|NCT02070796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144251|NCT02079064|Propofol|propofol|mesh-list
93144252|NCT02079064|Desflurane|desflurane|mesh-list
93144253|NCT02079064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93144254|NCT02079064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144255|NCT02079064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144256|NCT02079064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93144257|NCT02079064|Anesthetics, General|anesthetics, general|mesh-ancestor
93144258|NCT02079064|Anesthetics|anesthetics|mesh-ancestor
93144259|NCT02079064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93144260|NCT02079220|Capecitabine|capecitabine|mesh-list
93144261|NCT02079220|Oxaliplatin|oxaliplatin|mesh-list
93144262|NCT02079220|Aflibercept|aflibercept|mesh-list
93144263|NCT02079220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93144264|NCT02079220|Antimetabolites|antimetabolites|mesh-ancestor
93144265|NCT02079220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144266|NCT02079220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144267|NCT02079220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93144268|NCT02079220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93144269|NCT02079220|Growth Substances|growth substances|mesh-ancestor
93144270|NCT02079220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144271|NCT02079220|Growth Inhibitors|growth inhibitors|mesh-ancestor
93144272|NCT02079298|Fluconazole|fluconazole|mesh-list
93144273|NCT02079298|Ibuprofen|ibuprofen|mesh-list
93144274|NCT02079298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93144275|NCT02079298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144276|NCT02079298|Analgesics|analgesics|mesh-ancestor
93144277|NCT02079298|Sensory System Agents|sensory system agents|mesh-ancestor
93144278|NCT02079298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144279|NCT02079298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144280|NCT02079298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144281|NCT02079298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854764|NCT02540395|Antiemetics|antiemetics|mesh-ancestor
93144282|NCT02079298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93144283|NCT02079298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144284|NCT02079298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144285|NCT02079298|Antifungal Agents|antifungal agents|mesh-ancestor
93144286|NCT02079298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144287|NCT02079298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93144288|NCT02079298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93144289|NCT02079298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93144290|NCT02079298|Hormone Antagonists|hormone antagonists|mesh-ancestor
93144291|NCT02079298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144292|NCT02079298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93144293|NCT02079298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93144294|NCT02071342|Everolimus|everolimus|mesh-list
93144295|NCT02071342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92816445|NCT02695641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93144296|NCT02071342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144298|NCT02071342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144299|NCT02071342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144300|NCT02071342|Immunologic Factors|immunologic factors|mesh-ancestor
93144301|NCT02071342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144302|NCT02071342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144303|NCT02080078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93144304|NCT02080078|Theophylline|theophylline|mesh-list
93144305|NCT02080078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144306|NCT02080078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144307|NCT02080078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144308|NCT02080078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144309|NCT02080078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93144310|NCT02080078|Autonomic Agents|autonomic agents|mesh-ancestor
93144311|NCT02080078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144312|NCT02080078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144313|NCT02080078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93144314|NCT02080078|Respiratory System Agents|respiratory system agents|mesh-ancestor
93144315|NCT02080078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93144316|NCT02080078|Vasodilator Agents|vasodilator agents|mesh-ancestor
93144317|NCT02080078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93144318|NCT02080078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93144319|NCT02080078|Purinergic Agents|purinergic agents|mesh-ancestor
93144320|NCT02080078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144321|NCT02083276|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
93144322|NCT02083276|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93144323|NCT02083276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144324|NCT02083276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144325|NCT03559504|Sevoflurane|sevoflurane|mesh-list
93144326|NCT03559504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93144327|NCT03559504|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93144328|NCT03559504|Anesthetics, General|anesthetics, general|mesh-ancestor
93144329|NCT03559504|Anesthetics|anesthetics|mesh-ancestor
93144330|NCT03559504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144331|NCT03559504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144332|NCT02080234|Gemcitabine|gemcitabine|mesh-list
93144333|NCT02080234|Oxaliplatin|oxaliplatin|mesh-list
93144334|NCT02080234|Asparaginase|asparaginase|mesh-list
93144335|NCT02080234|Pegaspargase|pegaspargase|mesh-list
93144336|NCT02080234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93144337|NCT02080234|Antimetabolites|antimetabolites|mesh-ancestor
93144338|NCT02080234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144339|NCT02080234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144340|NCT05070039|Antibodies|antibodies|mesh-list
93144341|NCT05070039|Immunologic Factors|immunologic factors|mesh-ancestor
93144342|NCT05070039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144343|NCT05459649|Cyclosporine|cyclosporine|mesh-list
93144344|NCT05459649|Prednisone|prednisone|mesh-list
93144345|NCT05459649|Cyclosporins|cyclosporins|mesh-list
93144346|NCT05459649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144347|NCT05459649|Glucocorticoids|glucocorticoids|mesh-ancestor
93144348|NCT05459649|Hormones|hormones|mesh-ancestor
93144349|NCT05459649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144350|NCT05459649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144351|NCT05459649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144352|NCT05459649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144353|NCT05459649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144354|NCT05459649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144355|NCT05459649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144356|NCT05459649|Immunologic Factors|immunologic factors|mesh-ancestor
93144357|NCT05459649|Antifungal Agents|antifungal agents|mesh-ancestor
93144358|NCT05459649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144359|NCT05459649|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144360|NCT05459649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144361|NCT05459649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93144362|NCT04461795|Erenumab|erenumab|mesh-list
93144363|NCT04461795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93144364|NCT04461795|Immunologic Factors|immunologic factors|mesh-ancestor
93144365|NCT04461795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144366|NCT04461795|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92816521|NCT04036929|Hormone Antagonists|hormone antagonists|mesh-ancestor
93144367|NCT04461795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144368|NCT04461795|Analgesics|analgesics|mesh-ancestor
93144369|NCT04461795|Sensory System Agents|sensory system agents|mesh-ancestor
93144370|NCT04461795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144372|NCT04461015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93144373|NCT04461015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93144374|NCT04461015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144375|NCT03754179|Hydroxychloroquine|hydroxychloroquine|mesh-list
93144376|NCT03754179|Trametinib|trametinib|mesh-list
93144377|NCT03754179|Dabrafenib|dabrafenib|mesh-list
93144378|NCT03754179|Antimalarials|antimalarials|mesh-ancestor
93144379|NCT03754179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93144380|NCT03754179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93144381|NCT03754179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144382|NCT03754179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144383|NCT03754179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144384|NCT03754179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144385|NCT03754179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144386|NCT03754179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144387|NCT03753867|Acitretin|acitretin|mesh-list
93144388|NCT03753867|Keratolytic Agents|keratolytic agents|mesh-ancestor
93144389|NCT03753867|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144390|NCT04439253|Crizotinib|crizotinib|mesh-list
93144391|NCT04439253|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93144392|NCT04439253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144393|NCT04439253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144394|NCT04439253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144395|NCT04439253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144396|NCT03750669|Folic Acid|folic acid|mesh-list
93144397|NCT03750669|Paclitaxel|paclitaxel|mesh-list
93144398|NCT03750669|Gemcitabine|gemcitabine|mesh-list
93144399|NCT03750669|Fluorouracil|fluorouracil|mesh-list
93144400|NCT03750669|Oxaliplatin|oxaliplatin|mesh-list
93144401|NCT03750669|Irinotecan|irinotecan|mesh-list
93144402|NCT03750669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93144403|NCT03750669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144404|NCT03750669|Tubulin Modulators|tubulin modulators|mesh-ancestor
93144405|NCT03750669|Antimitotic Agents|antimitotic agents|mesh-ancestor
93144406|NCT03750669|Mitosis Modulators|mitosis modulators|mesh-ancestor
93144407|NCT03750669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144408|NCT03750669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93144409|NCT03750669|Antimetabolites|antimetabolites|mesh-ancestor
93144410|NCT03750669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144411|NCT03750669|Immunologic Factors|immunologic factors|mesh-ancestor
93144412|NCT03750669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144413|NCT03750669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93144414|NCT03750669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93144415|NCT03750669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144416|NCT03750669|Hematinics|hematinics|mesh-ancestor
93144417|NCT03750669|Vitamin B Complex|vitamin b complex|mesh-ancestor
93144418|NCT03750669|Vitamins|vitamins|mesh-ancestor
93144419|NCT03750669|Micronutrients|micronutrients|mesh-ancestor
93144420|NCT03757221|Daratumumab|daratumumab|mesh-list
93144421|NCT03757221|Ixazomib|ixazomib|mesh-list
93144422|NCT03757221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144423|NCT03757221|Protease Inhibitors|protease inhibitors|mesh-ancestor
93144424|NCT03757221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144425|NCT03757221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144426|NCT03757143|Ethanol|ethanol|mesh-list
93144427|NCT03757143|Chlorhexidine|chlorhexidine|mesh-list
93144428|NCT03757143|Povidone-Iodine|povidone-iodine|mesh-list
93144429|NCT03757143|Povidone|povidone|mesh-list
93144430|NCT03757143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93144431|NCT03757143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144432|NCT03757143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144433|NCT03757143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144434|NCT03757143|Disinfectants|disinfectants|mesh-ancestor
93144435|NCT03757143|Plasma Substitutes|plasma substitutes|mesh-ancestor
93144436|NCT03757143|Blood Substitutes|blood substitutes|mesh-ancestor
93144437|NCT04428411|Etanercept|etanercept|mesh-list
93144438|NCT04428411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93144439|NCT04428411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144440|NCT04428411|Analgesics|analgesics|mesh-ancestor
93144441|NCT04428411|Sensory System Agents|sensory system agents|mesh-ancestor
93144442|NCT04428411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144443|NCT04428411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144444|NCT04428411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144445|NCT04428411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816598|NCT04217733|Mebeverine|mebeverine|mesh-list
93144446|NCT04428411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144447|NCT04428411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144448|NCT04428411|Immunologic Factors|immunologic factors|mesh-ancestor
93144449|NCT03751059|Dexamethasone|dexamethasone|mesh-list
93144450|NCT03751059|Bromfenac|bromfenac|mesh-list
93144451|NCT03751059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144452|NCT03751059|Antiemetics|antiemetics|mesh-ancestor
93144453|NCT03751059|Autonomic Agents|autonomic agents|mesh-ancestor
93144454|NCT03751059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144455|NCT03751059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144456|NCT03751059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144457|NCT03751059|Glucocorticoids|glucocorticoids|mesh-ancestor
93144458|NCT03751059|Hormones|hormones|mesh-ancestor
93144459|NCT03751059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144460|NCT03751059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144461|NCT03751059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144462|NCT03751059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93144463|NCT03751059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144464|NCT03751059|Analgesics|analgesics|mesh-ancestor
93144465|NCT03751059|Sensory System Agents|sensory system agents|mesh-ancestor
93144466|NCT03751059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144467|NCT04422561|Ivermectin|ivermectin|mesh-list
93144468|NCT04422561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93144469|NCT04422561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144470|NCT03756987|Ropivacaine|ropivacaine|mesh-list
93144471|NCT03756987|Anesthetics, Local|anesthetics, local|mesh-ancestor
93144472|NCT03756987|Anesthetics|anesthetics|mesh-ancestor
93144473|NCT03756987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144474|NCT03756987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144475|NCT03756987|Sensory System Agents|sensory system agents|mesh-ancestor
93144476|NCT03756987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144477|NCT02072746|Zinc|zinc|mesh-list
93144478|NCT02072746|Zinc Sulfate|zinc sulfate|mesh-list
93144479|NCT02072746|Trace Elements|trace elements|mesh-ancestor
93144480|NCT02072746|Micronutrients|micronutrients|mesh-ancestor
93144481|NCT02072746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144482|NCT02072746|Astringents|astringents|mesh-ancestor
93144483|NCT02072746|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144484|NCT04940338|Dexamethasone|dexamethasone|mesh-list
93144485|NCT04940338|Dexamethasone acetate|dexamethasone acetate|mesh-list
93144486|NCT04940338|Bromfenac|bromfenac|mesh-list
93144487|NCT04940338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93144488|NCT04940338|BB 1101|bb 1101|mesh-list
93144489|NCT04940338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144490|NCT04940338|Antiemetics|antiemetics|mesh-ancestor
93144491|NCT04940338|Autonomic Agents|autonomic agents|mesh-ancestor
93144492|NCT04940338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144493|NCT04940338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144494|NCT04940338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144495|NCT04940338|Glucocorticoids|glucocorticoids|mesh-ancestor
93144496|NCT04940338|Hormones|hormones|mesh-ancestor
93144497|NCT04940338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144498|NCT04940338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144499|NCT04940338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144500|NCT04940338|Protease Inhibitors|protease inhibitors|mesh-ancestor
93144501|NCT04940338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144502|NCT04940338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144503|NCT04940338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93144504|NCT04940338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93144505|NCT04940338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144506|NCT04940338|Analgesics|analgesics|mesh-ancestor
93144507|NCT04940338|Sensory System Agents|sensory system agents|mesh-ancestor
93144508|NCT04940338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144509|NCT02083510|Colchicine|colchicine|mesh-list
93144510|NCT02083510|Gout Suppressants|gout suppressants|mesh-ancestor
93144511|NCT02083510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144512|NCT02083510|Tubulin Modulators|tubulin modulators|mesh-ancestor
93144513|NCT02083510|Antimitotic Agents|antimitotic agents|mesh-ancestor
93144514|NCT02083510|Mitosis Modulators|mitosis modulators|mesh-ancestor
93144515|NCT02083510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144516|NCT02083510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144517|NCT04407507|Ivermectin|ivermectin|mesh-list
93144518|NCT04407507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93144519|NCT04407507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144520|NCT02080624|Sirolimus|sirolimus|mesh-list
93144521|NCT02080624|Temsirolimus|temsirolimus|mesh-list
93144522|NCT02080624|MTOR Inhibitors|mtor inhibitors|mesh-list
93144523|NCT02080624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144524|NCT02080624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144525|NCT02080624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93144526|NCT02080624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144527|NCT02080624|Antifungal Agents|antifungal agents|mesh-ancestor
93144528|NCT02080624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144529|NCT02080624|Immunologic Factors|immunologic factors|mesh-ancestor
93144530|NCT02080624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144531|NCT02080624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144532|NCT02080624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144533|NCT02080624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144534|NCT02080858|Apixaban|apixaban|mesh-list
93144535|NCT02080858|Ticagrelor|ticagrelor|mesh-list
93144536|NCT02080858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93144537|NCT02080858|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93144538|NCT02080858|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93144539|NCT02080858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93144540|NCT02080858|Purinergic Agents|purinergic agents|mesh-ancestor
93144541|NCT02080858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144542|NCT02080858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144543|NCT02080858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144544|NCT02080858|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93144545|NCT02080858|Antithrombins|antithrombins|mesh-ancestor
93144546|NCT02080858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93144547|NCT02080858|Protease Inhibitors|protease inhibitors|mesh-ancestor
93144548|NCT02080858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144549|NCT02080858|Anticoagulants|anticoagulants|mesh-ancestor
93144550|NCT02073526|Adalimumab|adalimumab|mesh-list
93144551|NCT02073526|Infliximab|infliximab|mesh-list
93144552|NCT02073526|Certolizumab Pegol|certolizumab pegol|mesh-list
93144553|NCT02073526|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93144554|NCT02073526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144555|NCT02073526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144556|NCT02073526|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144557|NCT02073526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144558|NCT02073526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144559|NCT02073526|Immunologic Factors|immunologic factors|mesh-ancestor
93144560|NCT02073526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144561|NCT02073916|Paclitaxel|paclitaxel|mesh-list
93144562|NCT02073916|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93144563|NCT02073916|Trastuzumab|trastuzumab|mesh-list
93144564|NCT02073916|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93144565|NCT02073916|Lapatinib|lapatinib|mesh-list
93144566|NCT02073916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93144567|NCT02073916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144568|NCT02073916|Tubulin Modulators|tubulin modulators|mesh-ancestor
93144569|NCT02073916|Antimitotic Agents|antimitotic agents|mesh-ancestor
93144570|NCT02073916|Mitosis Modulators|mitosis modulators|mesh-ancestor
93144571|NCT02073916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144572|NCT02073916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93144573|NCT02073916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144574|NCT02073916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144575|NCT02073916|Immunotoxins|immunotoxins|mesh-ancestor
93144576|NCT02073916|Immunoconjugates|immunoconjugates|mesh-ancestor
93144577|NCT02073916|Immunologic Factors|immunologic factors|mesh-ancestor
93144578|NCT02073916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144579|NCT02084368|Bupivacaine|bupivacaine|mesh-list
93144580|NCT02084368|Ropivacaine|ropivacaine|mesh-list
93144581|NCT02084368|Anesthetics, Local|anesthetics, local|mesh-ancestor
93144582|NCT02084368|Anesthetics|anesthetics|mesh-ancestor
93144583|NCT02084368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144584|NCT02084368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144585|NCT02084368|Sensory System Agents|sensory system agents|mesh-ancestor
93144586|NCT02084368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144587|NCT02084446|Mycophenolic Acid|mycophenolic acid|mesh-list
93144588|NCT02084446|Prednisone|prednisone|mesh-list
93144589|NCT02084446|Methylprednisolone|methylprednisolone|mesh-list
93144590|NCT02084446|Everolimus|everolimus|mesh-list
93144591|NCT02084446|Tacrolimus|tacrolimus|mesh-list
93144592|NCT02084446|Thymoglobulin|thymoglobulin|mesh-list
93144593|NCT02084446|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93144594|NCT02084446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144595|NCT02084446|Glucocorticoids|glucocorticoids|mesh-ancestor
93144596|NCT02084446|Hormones|hormones|mesh-ancestor
93144597|NCT02084446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144598|NCT02084446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816743|NCT02740647|Amoxicillin|amoxicillin|mesh-list
93144599|NCT02084446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144600|NCT02084446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144601|NCT02084446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144602|NCT02084446|Immunologic Factors|immunologic factors|mesh-ancestor
93144603|NCT02084446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93144604|NCT02084446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144605|NCT02084446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144606|NCT02084446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93144607|NCT02084446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144608|NCT02084446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93144609|NCT02084446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93144610|NCT02084446|Antitubercular Agents|antitubercular agents|mesh-ancestor
93144611|NCT02084446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144612|NCT02084446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144613|NCT02084446|Antiemetics|antiemetics|mesh-ancestor
93144614|NCT02084446|Autonomic Agents|autonomic agents|mesh-ancestor
93144615|NCT02084446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144616|NCT02084446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144617|NCT02084446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93144618|NCT02084446|Protective Agents|protective agents|mesh-ancestor
93144619|NCT02801656|Vancomycin|vancomycin|mesh-list
93144620|NCT02801656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144621|NCT02801656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144622|NCT02081482|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93144623|NCT02081482|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93144624|NCT02081482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144625|NCT02084602|Artesunate|artesunate|mesh-list
93144626|NCT02084602|Mefloquine|mefloquine|mesh-list
93144627|NCT02084602|Antimalarials|antimalarials|mesh-ancestor
93144628|NCT02084602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93144629|NCT02084602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93144630|NCT02084602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144631|NCT02084602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144632|NCT02084602|Antiviral Agents|antiviral agents|mesh-ancestor
93144633|NCT02084602|Schistosomicides|schistosomicides|mesh-ancestor
93144634|NCT02084602|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93144635|NCT02084602|Anthelmintics|anthelmintics|mesh-ancestor
93144636|NCT02081560|Colistin|colistin|mesh-list
93144637|NCT02081560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144638|NCT02081560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144639|NCT02074150|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93144640|NCT02074150|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93144641|NCT02074150|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93144642|NCT02074150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144643|NCT02074150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144644|NCT02074150|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93144645|NCT02074150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93144646|NCT02074150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144647|NCT02074150|Cholinergic Agents|cholinergic agents|mesh-ancestor
93144648|NCT02074150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144649|NCT02074228|Methylphenidate|methylphenidate|mesh-list
93144650|NCT02074228|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93144651|NCT02074228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144652|NCT02074228|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93144653|NCT02074228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93144654|NCT02074228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93144655|NCT02074228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144656|NCT02074228|Dopamine Agents|dopamine agents|mesh-ancestor
93144657|NCT02074228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144658|NCT04346199|Acalabrutinib|acalabrutinib|mesh-list
93144659|NCT04346199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144660|NCT03558490|Immunomodulating Agents|immunomodulating agents|mesh-list
93144661|NCT03558490|Immunologic Factors|immunologic factors|mesh-ancestor
93144662|NCT03558490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144663|NCT04345653|Hydroxychloroquine|hydroxychloroquine|mesh-list
93144664|NCT04345653|Antimalarials|antimalarials|mesh-ancestor
93144665|NCT04345653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93144666|NCT04345653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93144667|NCT04345653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144668|NCT04345653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144669|NCT04345653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144670|NCT04345653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144671|NCT02085304|Temozolomide|temozolomide|mesh-list
93144672|NCT02085304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93144673|NCT02085304|Alkylating Agents|alkylating agents|mesh-ancestor
93144674|NCT02085304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144675|NCT02085304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816818|NCT00813748|Omalizumab|omalizumab|mesh-list
93144676|NCT02260414|Tinzaparin|tinzaparin|mesh-list
93144677|NCT02260414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93144678|NCT02260414|Dalteparin|dalteparin|mesh-list
93144679|NCT02260414|Anticoagulants|anticoagulants|mesh-ancestor
93144680|NCT02260414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93144681|NCT02260414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93144682|NCT02260414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144683|NCT02085538|Palbociclib|palbociclib|mesh-list
93144684|NCT02085538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144685|NCT02085538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93144686|NCT02085538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144687|NCT02085538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144688|NCT04169061|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93144689|NCT04169061|Hormones|hormones|mesh-ancestor
93144690|NCT04169061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144691|NCT04169061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144692|NCT01562691|Petrolatum|petrolatum|mesh-list
93144693|NCT01562691|Emollients|emollients|mesh-ancestor
93144694|NCT01562691|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144695|NCT04681677|Bevacizumab|bevacizumab|mesh-list
93144696|NCT04681677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93144697|NCT04681677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144698|NCT04681677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93144699|NCT04681677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93144700|NCT04681677|Growth Substances|growth substances|mesh-ancestor
93144701|NCT04681677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144702|NCT04681677|Growth Inhibitors|growth inhibitors|mesh-ancestor
93144703|NCT02792218|Teriflunomide|teriflunomide|mesh-list
93144704|NCT02792218|Ofatumumab|ofatumumab|mesh-list
93144705|NCT02792218|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93144706|NCT02792218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144707|NCT02792218|Immunologic Factors|immunologic factors|mesh-ancestor
93144708|NCT02792218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144709|NCT02792218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93144710|NCT02792218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93144711|NCT02792218|Analgesics|analgesics|mesh-ancestor
93144712|NCT02792218|Sensory System Agents|sensory system agents|mesh-ancestor
93144713|NCT02792218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144714|NCT02792218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144715|NCT02792218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144716|NCT02792218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144717|NCT02075086|Bevacizumab|bevacizumab|mesh-list
93144718|NCT02075086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93144719|NCT02075086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144720|NCT02075086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93144721|NCT02075086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93144722|NCT02075086|Growth Substances|growth substances|mesh-ancestor
93144723|NCT02075086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144724|NCT02075086|Growth Inhibitors|growth inhibitors|mesh-ancestor
93144725|NCT02082418|Caseins|caseins|mesh-list
93144726|NCT02082418|Chelating Agents|chelating agents|mesh-ancestor
93144727|NCT02082418|Sequestering Agents|sequestering agents|mesh-ancestor
93144728|NCT02082418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144729|NCT02082496|Liraglutide|liraglutide|mesh-list
93144730|NCT02082496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93144731|NCT02082496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144732|NCT02082496|Incretins|incretins|mesh-ancestor
93144733|NCT02082496|Hormones|hormones|mesh-ancestor
93144734|NCT02082496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144735|NCT02075242|Mycophenolic Acid|mycophenolic acid|mesh-list
93144736|NCT02075242|Tacrolimus|tacrolimus|mesh-list
93144737|NCT02075242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144738|NCT02075242|Immunologic Factors|immunologic factors|mesh-ancestor
93144739|NCT02075242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144740|NCT02075242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93144741|NCT02075242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144742|NCT02075242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144743|NCT02075242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93144744|NCT02075242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144745|NCT02075242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93144746|NCT02075242|Antitubercular Agents|antitubercular agents|mesh-ancestor
93144747|NCT02075242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144748|NCT02075242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144749|NCT02082652|Etonogestrel|etonogestrel|mesh-list
93144750|NCT02082652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93144751|NCT02082652|Contraceptive Agents|contraceptive agents|mesh-ancestor
93144752|NCT02082652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93144753|NCT02082652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144754|NCT02082652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93144755|NCT00153101|Telmisartan|telmisartan|mesh-list
93144756|NCT00153101|Ramipril|ramipril|mesh-list
93144757|NCT00153101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93144758|NCT00153101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93144759|NCT00153101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93144760|NCT00153101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144761|NCT00153101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93144762|NCT00153101|Protease Inhibitors|protease inhibitors|mesh-ancestor
93144763|NCT00153101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144764|NCT03558412|Decitabine|decitabine|mesh-list
93144765|NCT03558412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93144766|NCT03558412|Antimetabolites|antimetabolites|mesh-ancestor
93144767|NCT03558412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144768|NCT03558412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144769|NCT03558412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144770|NCT04401579|Remdesivir|remdesivir|mesh-list
93144771|NCT04401579|Antimetabolites|antimetabolites|mesh-ancestor
93144772|NCT04401579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144773|NCT04401579|Antiviral Agents|antiviral agents|mesh-ancestor
93144774|NCT04401579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144775|NCT03558880|Anesthetics|anesthetics|mesh-list
93144776|NCT03558880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144777|NCT03558880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144778|NCT04401423|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93144779|NCT04401423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93144780|NCT04401423|Vasodilator Agents|vasodilator agents|mesh-ancestor
93144781|NCT03749733|Megestrol|megestrol|mesh-list
93144782|NCT03749733|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93144783|NCT03749733|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93144784|NCT03749733|Estradiol|estradiol|mesh-list
93144785|NCT03749733|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93144786|NCT03749733|Estrogens|estrogens|mesh-ancestor
93144787|NCT03749733|Hormones|hormones|mesh-ancestor
93144788|NCT03749733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144789|NCT03749733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144790|NCT03749733|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93144791|NCT03749733|Contraceptive Agents|contraceptive agents|mesh-ancestor
93144792|NCT03749733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93144793|NCT03749733|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93144794|NCT03749733|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93144795|NCT03749733|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93144796|NCT03749733|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93144797|NCT03749733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144798|NCT03749733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144799|NCT04399161|Chlorhexidine|chlorhexidine|mesh-list
93144800|NCT04399161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93144801|NCT04399161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144802|NCT04399161|Disinfectants|disinfectants|mesh-ancestor
93144804|NCT04160091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144805|NCT04160091|Glucocorticoids|glucocorticoids|mesh-ancestor
93144806|NCT04160091|Hormones|hormones|mesh-ancestor
93144807|NCT04160091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144808|NCT04160091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144809|NCT04160091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144810|NCT04160091|Immunologic Factors|immunologic factors|mesh-ancestor
93144811|NCT01582607|Fentanyl|fentanyl|mesh-list
93144812|NCT01582607|Bupivacaine|bupivacaine|mesh-list
93144813|NCT01582607|Ropivacaine|ropivacaine|mesh-list
93144814|NCT01582607|Levobupivacaine|levobupivacaine|mesh-list
93144815|NCT01582607|Anesthetics, Local|anesthetics, local|mesh-ancestor
93144816|NCT01582607|Anesthetics|anesthetics|mesh-ancestor
93144817|NCT01582607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144818|NCT01582607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144819|NCT01582607|Sensory System Agents|sensory system agents|mesh-ancestor
93144820|NCT01582607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144821|NCT01582607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93144822|NCT01582607|Narcotics|narcotics|mesh-ancestor
93144823|NCT01582607|Analgesics|analgesics|mesh-ancestor
93144824|NCT01582607|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92816965|NCT00748189|Ofatumumab|ofatumumab|mesh-list
93144825|NCT01582607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93144826|NCT01582607|Anesthetics, General|anesthetics, general|mesh-ancestor
93144827|NCT00149825|Dexetimide|dexetimide|mesh-list
93144828|NCT00149825|Citalopram|citalopram|mesh-list
93144829|NCT00149825|Escitalopram|escitalopram|mesh-list
93144830|NCT00149825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93144831|NCT00149825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93144832|NCT00149825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93144833|NCT00149825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144834|NCT00149825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144835|NCT00149825|Serotonin Agents|serotonin agents|mesh-ancestor
93144836|NCT00149825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144837|NCT00149825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93144838|NCT00149825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93144839|NCT00149825|Parasympatholytics|parasympatholytics|mesh-ancestor
93144840|NCT00149825|Autonomic Agents|autonomic agents|mesh-ancestor
93144841|NCT00149825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144842|NCT00149825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93144843|NCT00149825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93144844|NCT00149825|Cholinergic Agents|cholinergic agents|mesh-ancestor
93144845|NCT00149825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93144846|NCT00149825|Antidepressive Agents|antidepressive agents|mesh-ancestor
93144847|NCT00149825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93144848|NCT02792062|Relugolix|relugolix|mesh-list
93144849|NCT02792062|Androgen Antagonists|androgen antagonists|mesh-ancestor
93144850|NCT02792062|Hormone Antagonists|hormone antagonists|mesh-ancestor
93144851|NCT02792062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144852|NCT02792062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144853|NCT05027295|Riboflavin|riboflavin|mesh-list
93144854|NCT05027295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93144855|NCT05027295|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93144856|NCT05027295|Vitamin B Complex|vitamin b complex|mesh-ancestor
93144857|NCT05027295|Vitamins|vitamins|mesh-ancestor
93144858|NCT05027295|Micronutrients|micronutrients|mesh-ancestor
93144859|NCT05027295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144860|NCT05027295|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93144861|NCT05027295|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144862|NCT02090920|Nifedipine|nifedipine|mesh-list
93144863|NCT02090920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93144864|NCT02090920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93144865|NCT02090920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144866|NCT02090920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93144867|NCT02090920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144868|NCT02090920|Vasodilator Agents|vasodilator agents|mesh-ancestor
93144869|NCT02090920|Tocolytic Agents|tocolytic agents|mesh-ancestor
93144870|NCT02090920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93144871|NCT02086474|Bupivacaine|bupivacaine|mesh-list
93144872|NCT02086474|Hyaluronic Acid|hyaluronic acid|mesh-list
93144873|NCT02086474|Anesthetics, Local|anesthetics, local|mesh-ancestor
93144874|NCT02086474|Anesthetics|anesthetics|mesh-ancestor
93144875|NCT02086474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144876|NCT02086474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144877|NCT02086474|Sensory System Agents|sensory system agents|mesh-ancestor
93144878|NCT02086474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144879|NCT02086474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93144880|NCT02086474|Immunologic Factors|immunologic factors|mesh-ancestor
93144881|NCT02086474|Viscosupplements|viscosupplements|mesh-ancestor
93144882|NCT02086474|Protective Agents|protective agents|mesh-ancestor
93144883|NCT02091310|Moxifloxacin|moxifloxacin|mesh-list
93144884|NCT02091310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93144885|NCT02091310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144886|NCT02091310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93144887|NCT02091310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93144888|NCT02091310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93144889|NCT02091310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144890|NCT02091310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144891|NCT02621398|Paclitaxel|paclitaxel|mesh-list
93144892|NCT02621398|Carboplatin|carboplatin|mesh-list
93144893|NCT02621398|Pembrolizumab|pembrolizumab|mesh-list
93144894|NCT02621398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93144895|NCT02621398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93144896|NCT02621398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144897|NCT02621398|Tubulin Modulators|tubulin modulators|mesh-ancestor
93144898|NCT02621398|Antimitotic Agents|antimitotic agents|mesh-ancestor
93144899|NCT02621398|Mitosis Modulators|mitosis modulators|mesh-ancestor
93144900|NCT02621398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144901|NCT02621398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93144902|NCT02621398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93144903|NCT04397445|Ranitidine|ranitidine|mesh-list
93144904|NCT04397445|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93144905|NCT04397445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93144906|NCT04397445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144907|NCT04397445|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93144908|NCT04397445|Histamine Antagonists|histamine antagonists|mesh-ancestor
93144909|NCT04397445|Histamine Agents|histamine agents|mesh-ancestor
93144910|NCT04397445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144911|NCT04397445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144912|NCT04397445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144913|NCT02091388|Risperidone|risperidone|mesh-list
93144914|NCT02091388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93144915|NCT02091388|Serotonin Agents|serotonin agents|mesh-ancestor
93144916|NCT02091388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144917|NCT02091388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144918|NCT02091388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144919|NCT02091388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93144920|NCT02091388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93144921|NCT02091388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93144922|NCT02091388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93144923|NCT02091388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93144924|NCT02091388|Dopamine Agents|dopamine agents|mesh-ancestor
93144925|NCT02086942|Dexamethasone|dexamethasone|mesh-list
93144926|NCT02086942|Cyclophosphamide|cyclophosphamide|mesh-list
93144927|NCT02086942|Bortezomib|bortezomib|mesh-list
93144928|NCT02086942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93144929|NCT02086942|Immunologic Factors|immunologic factors|mesh-ancestor
93144930|NCT02086942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144931|NCT02086942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93144932|NCT02086942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93144933|NCT02086942|Alkylating Agents|alkylating agents|mesh-ancestor
93144934|NCT02086942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144935|NCT02086942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144936|NCT02086942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93144937|NCT02086942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93144938|NCT02086942|Antiemetics|antiemetics|mesh-ancestor
93144939|NCT02086942|Autonomic Agents|autonomic agents|mesh-ancestor
93144940|NCT02086942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144941|NCT02086942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93144942|NCT02086942|Glucocorticoids|glucocorticoids|mesh-ancestor
93144943|NCT02086942|Hormones|hormones|mesh-ancestor
93144944|NCT02086942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93144945|NCT02086942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93144946|NCT02088424|Insulin|insulin|mesh-list
93144947|NCT02088424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93144948|NCT02088424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144949|NCT00191945|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93144950|NCT00191945|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93144951|NCT00191945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93144952|NCT00191945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93144953|NCT00191945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144954|NCT00191945|Adrenergic Agents|adrenergic agents|mesh-ancestor
93144955|NCT00191945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144956|NCT00191945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144957|NCT02087020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93144958|NCT02087020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144959|NCT02088502|Acetylcysteine|acetylcysteine|mesh-list
93144960|NCT02088502|Theophylline|theophylline|mesh-list
93144961|NCT02088502|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93144962|NCT02088502|Antiviral Agents|antiviral agents|mesh-ancestor
93144963|NCT02088502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93144964|NCT02088502|Expectorants|expectorants|mesh-ancestor
93144965|NCT02088502|Respiratory System Agents|respiratory system agents|mesh-ancestor
93144966|NCT02088502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93144967|NCT02088502|Antioxidants|antioxidants|mesh-ancestor
93144968|NCT02088502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144969|NCT02088502|Protective Agents|protective agents|mesh-ancestor
93144970|NCT02088502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144971|NCT02088502|Antidotes|antidotes|mesh-ancestor
93144972|NCT02088502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93144973|NCT02088502|Autonomic Agents|autonomic agents|mesh-ancestor
93144974|NCT02088502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93144975|NCT02088502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93144976|NCT02088502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93144978|NCT02088502|Vasodilator Agents|vasodilator agents|mesh-ancestor
93144979|NCT02088502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93144980|NCT02088502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93144981|NCT02088502|Purinergic Agents|purinergic agents|mesh-ancestor
93144982|NCT02088502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144983|NCT02087098|Solifenacin Succinate|solifenacin succinate|mesh-list
93144984|NCT02087098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93144985|NCT02087098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93144986|NCT02087098|Cholinergic Agents|cholinergic agents|mesh-ancestor
93144987|NCT02087098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93144988|NCT02087098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144989|NCT02087098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93144990|NCT02087098|Urological Agents|urological agents|mesh-ancestor
93144991|NCT01369342|Ustekinumab|ustekinumab|mesh-list
93144992|NCT01369342|Dermatologic Agents|dermatologic agents|mesh-ancestor
93144993|NCT00191477|Gemcitabine|gemcitabine|mesh-list
93144994|NCT00191477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93144995|NCT00191477|Antimetabolites|antimetabolites|mesh-ancestor
93144996|NCT00191477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93144997|NCT00191477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93144998|NCT02087332|Torsemide|torsemide|mesh-list
93144999|NCT02087332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93145000|NCT02087332|Diuretics|diuretics|mesh-ancestor
93145001|NCT02087332|Natriuretic Agents|natriuretic agents|mesh-ancestor
93145002|NCT02087332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145003|NCT02087332|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93145004|NCT02087332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145005|NCT02087332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145006|NCT02092012|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93145007|NCT02092012|Dexmedetomidine|dexmedetomidine|mesh-list
93145008|NCT02092012|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93145009|NCT02092012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145010|NCT02092012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145011|NCT02092012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145012|NCT02092012|Analgesics|analgesics|mesh-ancestor
93145013|NCT02092012|Sensory System Agents|sensory system agents|mesh-ancestor
93145014|NCT02092012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145015|NCT02092012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93145016|NCT02092012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93145017|NCT02092012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93145018|NCT02092012|Adrenergic Agents|adrenergic agents|mesh-ancestor
93145019|NCT02092012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145020|NCT02092012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145021|NCT02092012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93145022|NCT02092012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145023|NCT02092012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145024|NCT00187889|Eplerenone|eplerenone|mesh-list
93145025|NCT00187889|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93145026|NCT00187889|Hormone Antagonists|hormone antagonists|mesh-ancestor
93145027|NCT00187889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145028|NCT00187889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145029|NCT00187889|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93145030|NCT00187889|Diuretics|diuretics|mesh-ancestor
93145031|NCT00187889|Natriuretic Agents|natriuretic agents|mesh-ancestor
93145032|NCT00187889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93145033|NCT02087488|Eszopiclone|eszopiclone|mesh-list
93145034|NCT02087488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93145035|NCT02087488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145036|NCT02087488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145037|NCT02087566|Linezolid|linezolid|mesh-list
93145038|NCT02087566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145039|NCT02087566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145040|NCT02087566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93145041|NCT02087566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145042|NCT02087566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145043|NCT00148109|Cetuximab|cetuximab|mesh-list
93145044|NCT00148109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145045|NCT00148109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145046|NCT03746223|Rituximab|rituximab|mesh-list
93145047|NCT03746223|Methotrexate|methotrexate|mesh-list
93145048|NCT03746223|Lenalidomide|lenalidomide|mesh-list
92817186|NCT02731911|Dexamethasone|dexamethasone|mesh-list
93145049|NCT03746223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145050|NCT03746223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145051|NCT03746223|Immunologic Factors|immunologic factors|mesh-ancestor
93145052|NCT03746223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145053|NCT03746223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145054|NCT03746223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93145055|NCT03746223|Abortifacient Agents|abortifacient agents|mesh-ancestor
93145056|NCT03746223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93145057|NCT03746223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93145058|NCT03746223|Antimetabolites|antimetabolites|mesh-ancestor
93145059|NCT03746223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145060|NCT03746223|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145061|NCT03746223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145062|NCT03746223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93145063|NCT03746223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145064|NCT03746223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145065|NCT03746223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93145066|NCT03746223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93145067|NCT03746223|Growth Substances|growth substances|mesh-ancestor
93145068|NCT03746223|Growth Inhibitors|growth inhibitors|mesh-ancestor
93145069|NCT03969017|Interferons|interferons|mesh-list
93145070|NCT03969017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145071|NCT03969017|Antiviral Agents|antiviral agents|mesh-ancestor
93145072|NCT03969017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145073|NCT04596033|Cyclophosphamide|cyclophosphamide|mesh-list
93145074|NCT04596033|Fludarabine|fludarabine|mesh-list
93145075|NCT04596033|Interleukin-2|interleukin-2|mesh-list
93145076|NCT04596033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145077|NCT04596033|Immunologic Factors|immunologic factors|mesh-ancestor
93145078|NCT04596033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145079|NCT04596033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145080|NCT04596033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93145081|NCT04596033|Alkylating Agents|alkylating agents|mesh-ancestor
93145082|NCT04596033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145083|NCT04596033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145084|NCT04596033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93145085|NCT04596033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145086|NCT04596033|Analgesics|analgesics|mesh-ancestor
93145087|NCT04596033|Sensory System Agents|sensory system agents|mesh-ancestor
93145088|NCT04596033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145089|NCT02092558|Nitrofurantoin|nitrofurantoin|mesh-list
93145090|NCT02092558|Cephalosporins|cephalosporins|mesh-list
93145091|NCT02092558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93145092|NCT02092558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145093|NCT02092558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145094|NCT01074359|Tocopherylquinone|tocopherylquinone|mesh-list
93145095|NCT01074359|Anticoagulants|anticoagulants|mesh-ancestor
93145096|NCT01074359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93145097|NCT01074359|Antioxidants|antioxidants|mesh-ancestor
93145098|NCT01074359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145099|NCT01074359|Protective Agents|protective agents|mesh-ancestor
93145100|NCT01074359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145101|NCT02087722|Melatonin|melatonin|mesh-list
93145102|NCT02087722|Antioxidants|antioxidants|mesh-ancestor
93145103|NCT02087722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145104|NCT02087722|Protective Agents|protective agents|mesh-ancestor
93145105|NCT02087722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145106|NCT02087722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145107|NCT01326221|Tenofovir|tenofovir|mesh-list
93145108|NCT01326221|Emtricitabine|emtricitabine|mesh-list
93145109|NCT01326221|Antiviral Agents|antiviral agents|mesh-ancestor
93145110|NCT01326221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145111|NCT01326221|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93145112|NCT01326221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145113|NCT01326221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145114|NCT01326221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145115|NCT01326221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93145116|NCT01326221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93145117|NCT04311177|Losartan|losartan|mesh-list
93145118|NCT04311177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93145119|NCT04311177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93145120|NCT04311177|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93145121|NCT04311177|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93145122|NCT04311177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145123|NCT02088892|BCG Vaccine|bcg vaccine|mesh-list
93145124|NCT02088892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93145125|NCT02088892|Immunologic Factors|immunologic factors|mesh-ancestor
93145126|NCT02088892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145127|NCT01074593|Interferons|interferons|mesh-list
93145128|NCT01074593|Interferon-beta|interferon-beta|mesh-list
93145129|NCT01074593|Interferon beta-1a|interferon beta-1a|mesh-list
93145130|NCT01074593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145131|NCT01074593|Antiviral Agents|antiviral agents|mesh-ancestor
93145132|NCT01074593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145133|NCT01074593|Immunologic Factors|immunologic factors|mesh-ancestor
93145134|NCT01074593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145135|NCT01074593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93145136|NCT02088970|Riboflavin|riboflavin|mesh-list
93145137|NCT02088970|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93145138|NCT02088970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145139|NCT02088970|Vitamin B Complex|vitamin b complex|mesh-ancestor
93145140|NCT02088970|Vitamins|vitamins|mesh-ancestor
93145141|NCT02088970|Micronutrients|micronutrients|mesh-ancestor
93145142|NCT02088970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145143|NCT02088970|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93145144|NCT02088970|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145145|NCT03968861|Xenon|xenon|mesh-list
93145146|NCT03968861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93145147|NCT03968861|Anesthetics, General|anesthetics, general|mesh-ancestor
93145148|NCT03968861|Anesthetics|anesthetics|mesh-ancestor
93145149|NCT03968861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145150|NCT03968861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145151|NCT04292535|Insulin|insulin|mesh-list
93145152|NCT04292535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93145153|NCT04292535|Insulin Aspart|insulin aspart|mesh-list
93145154|NCT04292535|Insulin, Long-Acting|insulin, long-acting|mesh-list
93145155|NCT04292535|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93145156|NCT04292535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145157|NCT04292535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145158|NCT03747081|Warfarin|warfarin|mesh-list
93145159|NCT03747081|Rivaroxaban|rivaroxaban|mesh-list
93145160|NCT03747081|Anticoagulants|anticoagulants|mesh-ancestor
93145161|NCT03747081|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93145162|NCT03747081|Antithrombins|antithrombins|mesh-ancestor
93145163|NCT03747081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93145164|NCT03747081|Protease Inhibitors|protease inhibitors|mesh-ancestor
93145165|NCT03747081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145166|NCT03747081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145167|NCT01075841|Cetuximab|cetuximab|mesh-list
93145168|NCT01075841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145169|NCT01075841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145170|NCT01313390|Docetaxel|docetaxel|mesh-list
93145171|NCT01313390|Everolimus|everolimus|mesh-list
93145172|NCT01313390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145173|NCT01313390|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145174|NCT01313390|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145175|NCT01313390|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145176|NCT01313390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145177|NCT01313390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93145178|NCT01313390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93145179|NCT01313390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145180|NCT01313390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145181|NCT01313390|Immunologic Factors|immunologic factors|mesh-ancestor
93145182|NCT01313390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145183|NCT05571332|Cyclosporine|cyclosporine|mesh-list
93145184|NCT05571332|Cyclosporins|cyclosporins|mesh-list
93145185|NCT05571332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145186|NCT05571332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145187|NCT05571332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145188|NCT05571332|Immunologic Factors|immunologic factors|mesh-ancestor
93145189|NCT05571332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145190|NCT05571332|Antifungal Agents|antifungal agents|mesh-ancestor
93145191|NCT05571332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145192|NCT05571332|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145193|NCT05571332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145194|NCT05571332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93145195|NCT02791438|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93145196|NCT02791438|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93145197|NCT02791438|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93145198|NCT02791438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145199|NCT02089048|Auranofin|auranofin|mesh-list
93145200|NCT02089048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145202|NCT02089126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93145203|NCT02089126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145204|NCT02089126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145205|NCT02089126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145206|NCT02089126|Immunologic Factors|immunologic factors|mesh-ancestor
93145207|NCT05571176|Ketamine|ketamine|mesh-list
93145208|NCT05571176|Esketamine|esketamine|mesh-list
93145209|NCT05571176|Analgesics|analgesics|mesh-ancestor
93145210|NCT05571176|Sensory System Agents|sensory system agents|mesh-ancestor
93145211|NCT05571176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145212|NCT05571176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145213|NCT05571176|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93145214|NCT05571176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93145215|NCT05571176|Anesthetics, General|anesthetics, general|mesh-ancestor
93145216|NCT05571176|Anesthetics|anesthetics|mesh-ancestor
93145217|NCT05571176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145218|NCT05571176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93145219|NCT05571176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93145220|NCT05571176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145221|NCT05571176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145222|NCT05571176|Antidepressive Agents|antidepressive agents|mesh-ancestor
93145223|NCT05571176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93145224|NCT03689582|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93145225|NCT03689582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93145226|NCT03689582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145227|NCT02095834|Dexamethasone|dexamethasone|mesh-list
93145228|NCT02095834|Dexamethasone acetate|dexamethasone acetate|mesh-list
93145229|NCT02095834|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93145230|NCT02095834|Ichthammol|ichthammol|mesh-list
93145231|NCT02095834|BB 1101|bb 1101|mesh-list
93145232|NCT02095834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145233|NCT02095834|Antiemetics|antiemetics|mesh-ancestor
93145234|NCT02095834|Autonomic Agents|autonomic agents|mesh-ancestor
93145235|NCT02095834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145236|NCT02095834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145237|NCT02095834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145238|NCT02095834|Glucocorticoids|glucocorticoids|mesh-ancestor
93145239|NCT02095834|Hormones|hormones|mesh-ancestor
93145240|NCT02095834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145241|NCT02095834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93145242|NCT02095834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145243|NCT02095834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93145244|NCT02095834|Alkylating Agents|alkylating agents|mesh-ancestor
93145245|NCT02095834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145246|NCT02095834|Protease Inhibitors|protease inhibitors|mesh-ancestor
93145247|NCT02095834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145248|NCT02095834|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145249|NCT03556852|Misoprostol|misoprostol|mesh-list
93145250|NCT03556852|Carbetocin|carbetocin|mesh-list
93145251|NCT03556852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93145252|NCT03556852|Abortifacient Agents|abortifacient agents|mesh-ancestor
93145253|NCT03556852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93145254|NCT03556852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145255|NCT03556852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93145256|NCT03556852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145257|NCT03556852|Oxytocics|oxytocics|mesh-ancestor
93145258|NCT02808572|Mitogens|mitogens|mesh-list
93145259|NCT02808572|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145260|NCT02808572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145261|NCT02093728|Itraconazole|itraconazole|mesh-list
93145262|NCT02093728|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93145263|NCT02093728|Fluconazole|fluconazole|mesh-list
93145264|NCT02093728|Antifungal Agents|antifungal agents|mesh-ancestor
93145265|NCT02093728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145266|NCT02093728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93145267|NCT02093728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93145268|NCT02093728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145269|NCT02093728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145270|NCT02093728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93145271|NCT02093728|Hormone Antagonists|hormone antagonists|mesh-ancestor
93145272|NCT02093728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145273|NCT02093728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145274|NCT02093728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93145275|NCT02093728|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93145276|NCT02093728|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93145277|NCT03692871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93145278|NCT03692871|Immunologic Factors|immunologic factors|mesh-ancestor
93145279|NCT03692871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145280|NCT02089204|Deoxyglucose|deoxyglucose|mesh-list
93145281|NCT02089204|Fluorides|fluorides|mesh-list
93145282|NCT02089204|Cariostatic Agents|cariostatic agents|mesh-ancestor
93145283|NCT02089204|Protective Agents|protective agents|mesh-ancestor
93145284|NCT02089204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145285|NCT02089204|Antimetabolites|antimetabolites|mesh-ancestor
93145286|NCT02089204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145287|NCT02089204|Antiviral Agents|antiviral agents|mesh-ancestor
93145288|NCT02089204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145289|NCT02095990|Hydroquinone|hydroquinone|mesh-list
93145290|NCT02095990|Antioxidants|antioxidants|mesh-ancestor
93145291|NCT02095990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145292|NCT02095990|Protective Agents|protective agents|mesh-ancestor
93145293|NCT02095990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145294|NCT02095990|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93145295|NCT02096068|Dexmedetomidine|dexmedetomidine|mesh-list
93145296|NCT02096068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93145297|NCT02096068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145298|NCT02096068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145299|NCT02096068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145300|NCT02096068|Analgesics|analgesics|mesh-ancestor
93145301|NCT02096068|Sensory System Agents|sensory system agents|mesh-ancestor
93145302|NCT02096068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145303|NCT02096068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93145304|NCT02096068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93145305|NCT02096068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93145306|NCT02096068|Adrenergic Agents|adrenergic agents|mesh-ancestor
93145307|NCT02096068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145308|NCT02096068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145309|NCT02089438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93145310|NCT02089438|Vildagliptin|vildagliptin|mesh-list
93145311|NCT02089438|Saxagliptin|saxagliptin|mesh-list
93145312|NCT02089438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145313|NCT02089438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145314|NCT02089438|Incretins|incretins|mesh-ancestor
93145315|NCT02089438|Hormones|hormones|mesh-ancestor
93145316|NCT02089438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145317|NCT02089438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93145318|NCT02089438|Protease Inhibitors|protease inhibitors|mesh-ancestor
93145319|NCT02089438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145320|NCT02089438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145321|NCT05471674|Nivolumab|nivolumab|mesh-list
93145322|NCT05471674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145323|NCT05471674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145324|NCT05471674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93145325|NCT05471674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145326|NCT02096224|Sevoflurane|sevoflurane|mesh-list
93145327|NCT02096224|Desflurane|desflurane|mesh-list
93145328|NCT02096224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93145329|NCT02096224|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93145330|NCT02096224|Anesthetics, General|anesthetics, general|mesh-ancestor
93145331|NCT02096224|Anesthetics|anesthetics|mesh-ancestor
93145332|NCT02096224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145333|NCT02096224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145334|NCT02096380|Cisplatin|cisplatin|mesh-list
93145335|NCT02096380|Docetaxel|docetaxel|mesh-list
93145336|NCT02096380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145337|NCT02096380|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145338|NCT02096380|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145339|NCT02096380|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145340|NCT02096380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145341|NCT04384107|Vaccines|vaccines|mesh-list
93145342|NCT04384107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93145343|NCT04384107|Immunologic Factors|immunologic factors|mesh-ancestor
93145344|NCT04384107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145345|NCT02250118|Bevacizumab|bevacizumab|mesh-list
93145346|NCT02250118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145347|NCT02250118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145348|NCT02250118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93145349|NCT02250118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93145350|NCT02250118|Growth Substances|growth substances|mesh-ancestor
93145351|NCT02250118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145352|NCT02250118|Growth Inhibitors|growth inhibitors|mesh-ancestor
93145353|NCT03060772|Pioglitazone|pioglitazone|mesh-list
93145354|NCT03060772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145355|NCT03060772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145356|NCT02096536|Vancomycin|vancomycin|mesh-list
93145357|NCT02096536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145358|NCT02096536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145359|NCT02096614|Cyclophosphamide|cyclophosphamide|mesh-list
93145360|NCT02096614|Fludarabine|fludarabine|mesh-list
93145361|NCT02096614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145362|NCT02096614|Immunologic Factors|immunologic factors|mesh-ancestor
93145363|NCT02096614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145364|NCT02096614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145365|NCT02096614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93145366|NCT02096614|Alkylating Agents|alkylating agents|mesh-ancestor
93145367|NCT02096614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145368|NCT02096614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145369|NCT02096614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93145370|NCT02094196|Ethanol|ethanol|mesh-list
93145371|NCT02094196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93145372|NCT02094196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145373|NCT02094196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145374|NCT02094196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145375|NCT02094274|Fluticasone|fluticasone|mesh-list
93145376|NCT02094274|Xhance|xhance|mesh-list
93145377|NCT02094274|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93145378|NCT02094274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145379|NCT02094274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93145380|NCT02094274|Autonomic Agents|autonomic agents|mesh-ancestor
93145381|NCT02094274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145382|NCT02094274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145383|NCT02094274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93145384|NCT02094274|Respiratory System Agents|respiratory system agents|mesh-ancestor
93145385|NCT02094274|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145386|NCT02094274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93145387|NCT02094274|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93145388|NCT02094274|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93145389|NCT02094274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93145390|NCT02094274|Adrenergic Agents|adrenergic agents|mesh-ancestor
93145391|NCT02094274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145392|NCT02094274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145393|NCT02096926|Ibuprofen|ibuprofen|mesh-list
93145394|NCT02096926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93145395|NCT02096926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145396|NCT02096926|Analgesics|analgesics|mesh-ancestor
93145397|NCT02096926|Sensory System Agents|sensory system agents|mesh-ancestor
93145398|NCT02096926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145399|NCT02096926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145400|NCT02096926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145401|NCT02096926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145402|NCT02096926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93145403|NCT02096926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145404|NCT02096926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145405|NCT02097004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93145406|NCT02097004|Entecavir|entecavir|mesh-list
93145407|NCT02097004|Antiviral Agents|antiviral agents|mesh-ancestor
93145408|NCT02097004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145409|NCT02090296|Hydroxyurea|hydroxyurea|mesh-list
93145410|NCT02090296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145411|NCT02090296|Antisickling Agents|antisickling agents|mesh-ancestor
93145412|NCT02090296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145413|NCT02090296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145414|NCT02090296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145415|NCT03691779|Ivacaftor|ivacaftor|mesh-list
93145416|NCT03691779|Elexacaftor|elexacaftor|mesh-list
93145417|NCT03691779|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93145418|NCT03691779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145419|NCT03691779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145420|NCT02095054|Cetuximab|cetuximab|mesh-list
93145421|NCT02095054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145422|NCT02095054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145423|NCT03555994|Liraglutide|liraglutide|mesh-list
93145424|NCT03555994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145425|NCT03555994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145426|NCT03555994|Incretins|incretins|mesh-ancestor
93145427|NCT03555994|Hormones|hormones|mesh-ancestor
93145428|NCT03555994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145429|NCT02095366|Sufentanil|sufentanil|mesh-list
93145430|NCT02095366|Morphine|morphine|mesh-list
93145431|NCT02095366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93145432|NCT02095366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93145433|NCT02095366|Narcotics|narcotics|mesh-ancestor
93145434|NCT02095366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145435|NCT02095366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145436|NCT02095366|Analgesics|analgesics|mesh-ancestor
93145437|NCT02095366|Sensory System Agents|sensory system agents|mesh-ancestor
93145438|NCT02095366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145439|NCT02095366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93145440|NCT02095366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93145441|NCT02095366|Anesthetics, General|anesthetics, general|mesh-ancestor
93145442|NCT02095366|Anesthetics|anesthetics|mesh-ancestor
93145443|NCT02097082|Paclitaxel|paclitaxel|mesh-list
93145444|NCT02097082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93145445|NCT02097082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145446|NCT02097082|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145447|NCT02097082|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145448|NCT02097082|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145449|NCT02097082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145450|NCT02097160|Vitamin D|vitamin d|mesh-list
93145451|NCT02097160|Vitamins|vitamins|mesh-ancestor
93145452|NCT02097160|Micronutrients|micronutrients|mesh-ancestor
93145453|NCT02097160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145454|NCT02097160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93145455|NCT01562223|Motexafin gadolinium|motexafin gadolinium|mesh-list
93145456|NCT01562223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145457|NCT01562223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93145458|NCT01562223|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145459|NCT02097316|Insulin|insulin|mesh-list
93145460|NCT02097316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145461|NCT02097316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145462|NCT02095522|Colchicine|colchicine|mesh-list
93145463|NCT02095522|Gout Suppressants|gout suppressants|mesh-ancestor
93145464|NCT02095522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145465|NCT02095522|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145466|NCT02095522|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145467|NCT02095522|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145468|NCT02095522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145469|NCT02095522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145470|NCT02097394|Pancreatin|pancreatin|mesh-list
93145471|NCT02097394|Pancrelipase|pancrelipase|mesh-list
93145472|NCT02097394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145473|NCT04123665|Fluorides|fluorides|mesh-list
93145474|NCT04123665|Tin Fluorides|tin fluorides|mesh-list
93145475|NCT04123665|Fluorophosphate|fluorophosphate|mesh-list
93145476|NCT04123665|Cariostatic Agents|cariostatic agents|mesh-ancestor
93145477|NCT04123665|Protective Agents|protective agents|mesh-ancestor
93145478|NCT04123665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145479|NCT02250508|Factor VIII|factor viii|mesh-list
93145480|NCT02250508|Coagulants|coagulants|mesh-ancestor
93145481|NCT03555526|Amoxicillin|amoxicillin|mesh-list
93145482|NCT03555526|Metronidazole|metronidazole|mesh-list
93145483|NCT03555526|Clarithromycin|clarithromycin|mesh-list
93145484|NCT03555526|Levofloxacin|levofloxacin|mesh-list
93145485|NCT03555526|Tetracycline|tetracycline|mesh-list
93145486|NCT03555526|Esomeprazole|esomeprazole|mesh-list
93145487|NCT03555526|Bismuth|bismuth|mesh-list
93145488|NCT03555526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145489|NCT03555526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145490|NCT03555526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93145491|NCT03555526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93145492|NCT03555526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93145493|NCT03555526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145494|NCT03555526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92817630|NCT02597257|Anesthetics, Local|anesthetics, local|mesh-ancestor
93145495|NCT03555526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145496|NCT03555526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145497|NCT03555526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93145498|NCT03555526|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93145499|NCT03555526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93145500|NCT03555526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93145501|NCT03555526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93145502|NCT03555526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93145503|NCT03555526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145504|NCT03555526|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93145506|NCT02102620|Lidocaine|lidocaine|mesh-list
93145507|NCT02102620|Anesthetics, Local|anesthetics, local|mesh-ancestor
93145508|NCT02102620|Anesthetics|anesthetics|mesh-ancestor
93145509|NCT02102620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145510|NCT02102620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145511|NCT02102620|Sensory System Agents|sensory system agents|mesh-ancestor
93145512|NCT02102620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145513|NCT02102620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93145514|NCT02102620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93145515|NCT02102620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93145516|NCT02102620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145517|NCT02102620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145518|NCT02102698|Ecopipam|ecopipam|mesh-list
93145519|NCT02102698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93145520|NCT02102698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93145521|NCT02102698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145522|NCT02102698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145523|NCT02102698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93145524|NCT02102698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93145525|NCT02102698|Dopamine Agents|dopamine agents|mesh-ancestor
93145526|NCT02102698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145527|NCT02102698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145528|NCT02102776|Mitomycins|mitomycins|mesh-list
93145529|NCT02102776|Mitomycin|mitomycin|mesh-list
93145530|NCT02102776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93145531|NCT02102776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145532|NCT02102776|Alkylating Agents|alkylating agents|mesh-ancestor
93145533|NCT02102776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145534|NCT02102776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145535|NCT02102776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145536|NCT02102854|Thymoglobulin|thymoglobulin|mesh-list
93145537|NCT02102854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93145538|NCT02102854|Immunologic Factors|immunologic factors|mesh-ancestor
93145539|NCT02102854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145540|NCT02102854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93145541|NCT02670044|Venetoclax|venetoclax|mesh-list
93145542|NCT02670044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145543|NCT02307656|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93145544|NCT02307656|Cobicistat|cobicistat|mesh-list
93145545|NCT02307656|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93145546|NCT02307656|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93145547|NCT02307656|Protease Inhibitors|protease inhibitors|mesh-ancestor
93145548|NCT02307656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145549|NCT02307656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145550|NCT02307656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93145551|NCT02307656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93145552|NCT02307656|Antiviral Agents|antiviral agents|mesh-ancestor
93145553|NCT02307656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145554|NCT02307656|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93145555|NCT02307656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93145556|NCT04232943|Vaccines|vaccines|mesh-list
93145557|NCT04232943|Immunologic Factors|immunologic factors|mesh-ancestor
93145558|NCT04232943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145559|NCT02098330|Methylprednisolone|methylprednisolone|mesh-list
93145560|NCT02098330|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93145561|NCT02098330|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93145562|NCT02098330|Prednisolone|prednisolone|mesh-list
93145563|NCT02098330|Prednisolone acetate|prednisolone acetate|mesh-list
93145564|NCT02098330|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93145565|NCT02098330|Prednisolone phosphate|prednisolone phosphate|mesh-list
93145566|NCT02098330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145567|NCT02098330|Antiemetics|antiemetics|mesh-ancestor
93145568|NCT02098330|Autonomic Agents|autonomic agents|mesh-ancestor
93145569|NCT02098330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145570|NCT02098330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145571|NCT02098330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145572|NCT02098330|Glucocorticoids|glucocorticoids|mesh-ancestor
93145573|NCT02098330|Hormones|hormones|mesh-ancestor
93145574|NCT02098330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145575|NCT02098330|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93145576|NCT02098330|Protective Agents|protective agents|mesh-ancestor
93145577|NCT02098330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93145578|NCT02098330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145580|NCT02103166|Bromides|bromides|mesh-list
93145581|NCT02103166|Anticonvulsants|anticonvulsants|mesh-ancestor
93145582|NCT02103166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93145583|NCT02103166|Antiemetics|antiemetics|mesh-ancestor
93145584|NCT02103166|Autonomic Agents|autonomic agents|mesh-ancestor
93145585|NCT02103166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145586|NCT02103166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145587|NCT02103166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145588|NCT02103166|Mydriatics|mydriatics|mesh-ancestor
93145589|NCT02103166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93145590|NCT02103166|Cholinergic Agents|cholinergic agents|mesh-ancestor
93145591|NCT02103166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145592|NCT02103166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145593|NCT02103166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93145594|NCT02103244|Carboplatin|carboplatin|mesh-list
93145595|NCT02103244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145596|NCT02098486|Moxifloxacin|moxifloxacin|mesh-list
93145597|NCT02098486|Ceftriaxone|ceftriaxone|mesh-list
93145598|NCT02098486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145599|NCT02098486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145600|NCT02098486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93145601|NCT02098486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93145602|NCT02098486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145603|NCT02098486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145604|NCT02098486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145605|NCT02250820|Pentobarbital|pentobarbital|mesh-list
93145606|NCT02250820|Dexmedetomidine|dexmedetomidine|mesh-list
93145607|NCT02250820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93145608|NCT02250820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145609|NCT02250820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145610|NCT02250820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145611|NCT02250820|Analgesics|analgesics|mesh-ancestor
93145612|NCT02250820|Sensory System Agents|sensory system agents|mesh-ancestor
93145613|NCT02250820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145614|NCT02250820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93145615|NCT02250820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93145616|NCT02250820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93145617|NCT02250820|Adrenergic Agents|adrenergic agents|mesh-ancestor
93145618|NCT02250820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854784|NCT04547166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145619|NCT02250820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145620|NCT02250820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93145621|NCT02250820|GABA Modulators|gaba modulators|mesh-ancestor
93145622|NCT02250820|GABA Agents|gaba agents|mesh-ancestor
93145623|NCT04292457|Propofol|propofol|mesh-list
93145624|NCT04292457|Sevoflurane|sevoflurane|mesh-list
93145625|NCT04292457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93145626|NCT04292457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145627|NCT04292457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145628|NCT04292457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93145629|NCT04292457|Anesthetics, General|anesthetics, general|mesh-ancestor
93145630|NCT04292457|Anesthetics|anesthetics|mesh-ancestor
93145631|NCT04292457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93145632|NCT04292457|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93145633|NCT02100046|Ethosuximide|ethosuximide|mesh-list
93145634|NCT02100046|Anticonvulsants|anticonvulsants|mesh-ancestor
93145635|NCT02100202|Turmeric extract|turmeric extract|mesh-list
93145636|NCT02100202|Antioxidants|antioxidants|mesh-ancestor
93145637|NCT02100202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145638|NCT02100202|Protective Agents|protective agents|mesh-ancestor
93145639|NCT02100202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145640|NCT05423392|Lidocaine|lidocaine|mesh-list
93145641|NCT05423392|Carticaine|carticaine|mesh-list
93145642|NCT05423392|Anesthetics|anesthetics|mesh-list
93145643|NCT05423392|Anesthetics, Local|anesthetics, local|mesh-ancestor
93145644|NCT05423392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145645|NCT05423392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145646|NCT05423392|Sensory System Agents|sensory system agents|mesh-ancestor
93145647|NCT05423392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145648|NCT05423392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93145649|NCT05423392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93145650|NCT05423392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817776|NCT05755204|Cabotegravir|cabotegravir|mesh-list
93145651|NCT05423392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145652|NCT05423392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145653|NCT02103556|Mineral Oil|mineral oil|mesh-list
93145654|NCT02103556|Emollients|emollients|mesh-ancestor
93145655|NCT02103556|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145656|NCT02099890|Curcumin|curcumin|mesh-list
93145657|NCT02099890|Antioxidants|antioxidants|mesh-list
93145658|NCT02099890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93145659|NCT02099890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145660|NCT02099890|Analgesics|analgesics|mesh-ancestor
93145661|NCT02099890|Sensory System Agents|sensory system agents|mesh-ancestor
93145662|NCT02099890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145663|NCT02099890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145664|NCT02099890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145665|NCT02099890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145666|NCT02099890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145667|NCT02099890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145668|NCT02099890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145669|NCT02099890|Protective Agents|protective agents|mesh-ancestor
93145670|NCT03555136|Vortioxetine|vortioxetine|mesh-list
93145671|NCT03555136|Antidepressive Agents|antidepressive agents|mesh-ancestor
93145672|NCT03555136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93145673|NCT03555136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93145674|NCT03555136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93145675|NCT03555136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145676|NCT03555136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145677|NCT03555136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93145678|NCT03555136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93145679|NCT03555136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145680|NCT03555136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145681|NCT03555136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145682|NCT03555136|Serotonin Agents|serotonin agents|mesh-ancestor
93145683|NCT03555136|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93145684|NCT03555136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93145685|NCT03555136|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93145686|NCT03555136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93145687|NCT03554980|Listerine|listerine|mesh-list
93145688|NCT03554980|Fluorides|fluorides|mesh-list
93145689|NCT03554980|Sodium Fluoride|sodium fluoride|mesh-list
93145690|NCT03554980|Fluorides, Topical|fluorides, topical|mesh-list
93145691|NCT03554980|Cariostatic Agents|cariostatic agents|mesh-ancestor
93145692|NCT03554980|Protective Agents|protective agents|mesh-ancestor
93145693|NCT03554980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145694|NCT03554980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93145695|NCT03554980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145696|NCT04230213|Adalimumab|adalimumab|mesh-list
93145697|NCT04230213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93145698|NCT04230213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145699|NCT04230213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145700|NCT03746691|Citalopram|citalopram|mesh-list
93145701|NCT03746691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93145702|NCT03746691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93145703|NCT03746691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145704|NCT03746691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145705|NCT03746691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145706|NCT03746691|Serotonin Agents|serotonin agents|mesh-ancestor
93145707|NCT03746691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145708|NCT03746691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93145709|NCT03746691|Antidepressive Agents|antidepressive agents|mesh-ancestor
93145710|NCT03746691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93145711|NCT04222725|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93145712|NCT04222725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93145713|NCT03745911|Paclitaxel|paclitaxel|mesh-list
93145714|NCT03745911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93145715|NCT03745911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145716|NCT03745911|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145717|NCT03745911|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145718|NCT03745911|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145719|NCT03745911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145720|NCT03242252|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93145721|NCT03242252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93145722|NCT03242252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817852|NCT02720601|Capecitabine|capecitabine|mesh-list
93145723|NCT03242252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145724|NCT03242252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145725|NCT03554590|Insulin|insulin|mesh-list
93145726|NCT03554590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145727|NCT03554590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145728|NCT02106286|Bisoprolol|bisoprolol|mesh-list
93145729|NCT02106286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93145730|NCT02106286|Sympatholytics|sympatholytics|mesh-ancestor
93145731|NCT02106286|Autonomic Agents|autonomic agents|mesh-ancestor
93145732|NCT02106286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145733|NCT02106286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145734|NCT02106286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93145735|NCT02106286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93145736|NCT02106286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93145737|NCT02106286|Adrenergic Agents|adrenergic agents|mesh-ancestor
93145738|NCT02106286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145739|NCT02106286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145740|NCT04109391|Trastuzumab|trastuzumab|mesh-list
93145741|NCT04109391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145742|NCT04109391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145743|NCT02106364|Insulin|insulin|mesh-list
93145744|NCT02106364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93145745|NCT02106364|Insulin Glargine|insulin glargine|mesh-list
93145746|NCT02106364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145747|NCT02106364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145748|NCT04077866|Temozolomide|temozolomide|mesh-list
93145749|NCT04077866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93145750|NCT04077866|Alkylating Agents|alkylating agents|mesh-ancestor
93145751|NCT04077866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145752|NCT04077866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145753|NCT02101138|Pramipexole|pramipexole|mesh-list
93145754|NCT02101138|Antioxidants|antioxidants|mesh-ancestor
93145755|NCT02101138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145756|NCT02101138|Protective Agents|protective agents|mesh-ancestor
93145757|NCT02101138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145758|NCT02101138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93145759|NCT02101138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93145760|NCT02101138|Dopamine Agonists|dopamine agonists|mesh-ancestor
93145761|NCT02101138|Dopamine Agents|dopamine agents|mesh-ancestor
93145762|NCT02101138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145763|NCT02106520|Bevacizumab|bevacizumab|mesh-list
93145764|NCT02106520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93145765|NCT02106520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145766|NCT02106520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93145767|NCT02106520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93145768|NCT02106520|Growth Substances|growth substances|mesh-ancestor
93145769|NCT02106520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145770|NCT02106520|Growth Inhibitors|growth inhibitors|mesh-ancestor
93145771|NCT02101216|Abacavir|abacavir|mesh-list
93145772|NCT02101216|Dideoxynucleosides|dideoxynucleosides|mesh-list
93145773|NCT02101216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93145774|NCT02101216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145775|NCT02101216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145776|NCT02101216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145777|NCT02101216|Antiviral Agents|antiviral agents|mesh-ancestor
93145778|NCT02101216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145779|NCT02101216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93145780|NCT02101216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93145781|NCT02101216|Antimetabolites|antimetabolites|mesh-ancestor
93145782|NCT04097925|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93145783|NCT04097925|Antiviral Agents|antiviral agents|mesh-ancestor
93145784|NCT04097925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145785|NCT04097925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93145786|NCT04097925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145787|NCT04097925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145788|NCT04097925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145789|NCT04097925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93145790|NCT04097925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93145791|NCT02104648|Moxifloxacin|moxifloxacin|mesh-list
93145792|NCT02104648|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93145793|NCT02104648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145794|NCT02104648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145795|NCT02104648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93145796|NCT02104648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93145797|NCT02104648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145798|NCT02104648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145799|NCT02104648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145800|NCT02104648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93145801|NCT02104648|Contraceptive Agents|contraceptive agents|mesh-ancestor
93145802|NCT02104648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93145803|NCT02104648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145804|NCT02104648|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93145805|NCT02104648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93145806|NCT02104648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93145807|NCT01562301|Carboplatin|carboplatin|mesh-list
93145808|NCT01562301|Docetaxel|docetaxel|mesh-list
93145809|NCT01562301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145810|NCT01562301|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145811|NCT01562301|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145812|NCT01562301|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145813|NCT01562301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145814|NCT02104960|Dermatologic Agents|dermatologic agents|mesh-list
93145815|NCT04094883|Vaccines|vaccines|mesh-list
93145816|NCT04094883|Immunologic Factors|immunologic factors|mesh-ancestor
93145817|NCT04094883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145818|NCT02101606|Tenecteplase|tenecteplase|mesh-list
93145819|NCT02101606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93145820|NCT02101606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93145821|NCT02101606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145822|NCT02101840|Oxycodone|oxycodone|mesh-list
93145823|NCT02101840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93145824|NCT02101840|Narcotics|narcotics|mesh-ancestor
93145825|NCT02101840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145826|NCT02101840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145827|NCT02101840|Analgesics|analgesics|mesh-ancestor
93145828|NCT02101840|Sensory System Agents|sensory system agents|mesh-ancestor
93145829|NCT02101840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145830|NCT02107378|Paclitaxel|paclitaxel|mesh-list
93145831|NCT02107378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93145832|NCT02107378|Doxorubicin|doxorubicin|mesh-list
93145833|NCT02107378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93145834|NCT02107378|Topotecan|topotecan|mesh-list
93145835|NCT02107378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93145836|NCT02107378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145837|NCT02107378|Tubulin Modulators|tubulin modulators|mesh-ancestor
93145838|NCT02107378|Antimitotic Agents|antimitotic agents|mesh-ancestor
93145839|NCT02107378|Mitosis Modulators|mitosis modulators|mesh-ancestor
93145840|NCT02107378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145841|NCT02107378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93145842|NCT02107378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93145843|NCT02107378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93145844|NCT02107378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145845|NCT02107378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93145846|NCT02105350|Gemcitabine|gemcitabine|mesh-list
93145847|NCT02105350|Oxaliplatin|oxaliplatin|mesh-list
93145848|NCT02105350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93145849|NCT02105350|Antimetabolites|antimetabolites|mesh-ancestor
93145850|NCT02105350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145851|NCT02105350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145852|NCT02102152|Tobramycin|tobramycin|mesh-list
93145853|NCT02102152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145854|NCT02102152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145855|NCT01368562|Methylnaltrexone|methylnaltrexone|mesh-list
93145856|NCT01368562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93145857|NCT01368562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145858|NCT01368562|Sensory System Agents|sensory system agents|mesh-ancestor
93145859|NCT01368562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145860|NCT03242018|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93145861|NCT03242018|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93145862|NCT03242018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145863|NCT03242018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145864|NCT03242018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145865|NCT02107690|Lidocaine|lidocaine|mesh-list
93145866|NCT02107690|Anesthetics, Local|anesthetics, local|mesh-ancestor
93145867|NCT02107690|Anesthetics|anesthetics|mesh-ancestor
93145868|NCT02107690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145869|NCT02107690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145870|NCT02107690|Sensory System Agents|sensory system agents|mesh-ancestor
93145871|NCT02107690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145872|NCT02107690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93145873|NCT02107690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93145874|NCT02107690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93145875|NCT02107690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93145876|NCT02107690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145877|NCT05568836|Vitamin D|vitamin d|mesh-list
93145878|NCT05568836|Vitamins|vitamins|mesh-ancestor
93145879|NCT05568836|Micronutrients|micronutrients|mesh-ancestor
93145880|NCT05568836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145881|NCT05568836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93145882|NCT03259490|Metformin|metformin|mesh-list
93145883|NCT03259490|Empagliflozin|empagliflozin|mesh-list
93145884|NCT03259490|Linagliptin|linagliptin|mesh-list
93145885|NCT03259490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93145886|NCT03259490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145887|NCT03259490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93145888|NCT03259490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145889|NCT03259490|Incretins|incretins|mesh-ancestor
93145890|NCT03259490|Hormones|hormones|mesh-ancestor
93145891|NCT03259490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145892|NCT03259490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93145893|NCT03259490|Protease Inhibitors|protease inhibitors|mesh-ancestor
93145894|NCT03259490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145895|NCT02106130|Rebamipide|rebamipide|mesh-list
93145896|NCT02106130|Mosapride|mosapride|mesh-list
93145897|NCT02106130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145898|NCT02106130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93145899|NCT02106130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145900|NCT02106130|Antioxidants|antioxidants|mesh-ancestor
93145901|NCT02106130|Protective Agents|protective agents|mesh-ancestor
93145902|NCT02106130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145903|NCT02106130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145904|NCT02106130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93145905|NCT02106130|Serotonin Agents|serotonin agents|mesh-ancestor
93145906|NCT02106130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93145907|NCT02251132|Ritonavir|ritonavir|mesh-list
93145908|NCT02251132|Erythromycin|erythromycin|mesh-list
93145909|NCT02251132|Erythromycin Estolate|erythromycin estolate|mesh-list
93145910|NCT02251132|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93145911|NCT02251132|Erythromycin stearate|erythromycin stearate|mesh-list
93145912|NCT02251132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93145913|NCT02251132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93145914|NCT02251132|Protease Inhibitors|protease inhibitors|mesh-ancestor
93145915|NCT02251132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145916|NCT02251132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145917|NCT02251132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93145918|NCT02251132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93145919|NCT02251132|Antiviral Agents|antiviral agents|mesh-ancestor
93145920|NCT02251132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145921|NCT02251132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93145922|NCT02251132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93145923|NCT02251132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145924|NCT02251132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93145925|NCT02251132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93145926|NCT01331824|Amrubicin|amrubicin|mesh-list
93145927|NCT01331824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145928|NCT02113774|Anti-Infective Agents|anti-infective agents|mesh-list
93145929|NCT02113774|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93145930|NCT05571722|Vancomycin|vancomycin|mesh-list
93145931|NCT05571722|Linezolid|linezolid|mesh-list
93145932|NCT05571722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145933|NCT05571722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145934|NCT05571722|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93145935|NCT05571722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145936|NCT05571722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145937|NCT02110654|Mometasone Furoate|mometasone furoate|mesh-list
93145938|NCT02110654|Montelukast|montelukast|mesh-list
93145939|NCT02110654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93145940|NCT02110654|Respiratory System Agents|respiratory system agents|mesh-ancestor
93145941|NCT02110654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93145942|NCT02110654|Hormone Antagonists|hormone antagonists|mesh-ancestor
93145943|NCT02110654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145944|NCT02110654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145945|NCT02110654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93145946|NCT02110654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93145947|NCT02110654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145948|NCT02110654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145949|NCT02110654|Dermatologic Agents|dermatologic agents|mesh-ancestor
93145950|NCT02110654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93145951|NCT03258710|Tenofovir|tenofovir|mesh-list
93145952|NCT03258710|Antiviral Agents|antiviral agents|mesh-ancestor
93145953|NCT03258710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145954|NCT03258710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93145955|NCT03258710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93145956|NCT03258710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145957|NCT03258710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145958|NCT03258710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93145959|NCT03258710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93145960|NCT02110810|Indomethacin|indomethacin|mesh-list
93145961|NCT02110810|Glycerol|glycerol|mesh-list
93145962|NCT02110810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93145963|NCT02110810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93145964|NCT02110810|Analgesics|analgesics|mesh-ancestor
93145965|NCT02110810|Sensory System Agents|sensory system agents|mesh-ancestor
93145966|NCT02110810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93145967|NCT02110810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145968|NCT02110810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93145969|NCT02110810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93145970|NCT02110810|Gout Suppressants|gout suppressants|mesh-ancestor
93145971|NCT02110810|Tocolytic Agents|tocolytic agents|mesh-ancestor
93145972|NCT02110810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93145973|NCT02110810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93145974|NCT02110810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145975|NCT02110810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145976|NCT02110810|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93145977|NCT02110810|Protective Agents|protective agents|mesh-ancestor
93145978|NCT02107924|Vancomycin|vancomycin|mesh-list
93145979|NCT02107924|Tobramycin|tobramycin|mesh-list
93145980|NCT02107924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93145981|NCT02107924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93145982|NCT02108002|Vorinostat|vorinostat|mesh-list
93145983|NCT02108002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93145984|NCT02108002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93145985|NCT02108002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93145986|NCT02108002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93145987|NCT02114476|Progestins|progestins|mesh-list
93145988|NCT02114476|Hormones|hormones|mesh-ancestor
93145989|NCT02114476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93145990|NCT02114476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145991|NCT02110966|Tramadol|tramadol|mesh-list
93145992|NCT02110966|Mepivacaine|mepivacaine|mesh-list
93145993|NCT02110966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93145994|NCT02110966|Narcotics|narcotics|mesh-ancestor
93145995|NCT02110966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93145996|NCT02110966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93145997|NCT02110966|Analgesics|analgesics|mesh-ancestor
93145998|NCT02110966|Sensory System Agents|sensory system agents|mesh-ancestor
93145999|NCT02110966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146000|NCT02110966|Anesthetics, Local|anesthetics, local|mesh-ancestor
93146001|NCT02110966|Anesthetics|anesthetics|mesh-ancestor
93146002|NCT02937740|Methyltestosterone|methyltestosterone|mesh-list
93146003|NCT02937740|Testosterone|testosterone|mesh-list
93146004|NCT02937740|Testosterone undecanoate|testosterone undecanoate|mesh-list
93146005|NCT02937740|Testosterone enanthate|testosterone enanthate|mesh-list
93146006|NCT02937740|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93146007|NCT02937740|Androgens|androgens|mesh-ancestor
93146008|NCT02937740|Hormones|hormones|mesh-ancestor
93146009|NCT02937740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146010|NCT02937740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146011|NCT02937740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93146012|NCT02937740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146013|NCT02937740|Anabolic Agents|anabolic agents|mesh-ancestor
93146014|NCT02111044|Octreotide|octreotide|mesh-list
93146015|NCT02111044|Somatostatin|somatostatin|mesh-list
93146016|NCT02111044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146017|NCT02111044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93146018|NCT02111044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818151|NCT00736489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146019|NCT02111044|Hormones|hormones|mesh-ancestor
93146020|NCT02111044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146021|NCT02111044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146022|NCT02114710|Hydrocortisone|hydrocortisone|mesh-list
93146023|NCT02114710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146025|NCT02108548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93146026|NCT02108548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146027|NCT02108548|Analgesics|analgesics|mesh-ancestor
93146028|NCT02108548|Sensory System Agents|sensory system agents|mesh-ancestor
93146029|NCT02108548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146030|NCT02108548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146031|NCT02108548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146032|NCT02108548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146033|NCT02108548|Gout Suppressants|gout suppressants|mesh-ancestor
93146034|NCT02108548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93146035|NCT02108548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146036|NCT02108548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146037|NCT02111122|Sodium Oxybate|sodium oxybate|mesh-list
93146038|NCT02111122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93146039|NCT02111122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93146040|NCT02111122|Anesthetics, General|anesthetics, general|mesh-ancestor
93146041|NCT02111122|Anesthetics|anesthetics|mesh-ancestor
93146042|NCT02111122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146043|NCT02111122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146044|NCT02108626|Nicotine|nicotine|mesh-list
93146045|NCT02108626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93146046|NCT02108626|Autonomic Agents|autonomic agents|mesh-ancestor
93146047|NCT02108626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146048|NCT02108626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146049|NCT02108626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93146050|NCT02108626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93146051|NCT02108626|Cholinergic Agents|cholinergic agents|mesh-ancestor
93146052|NCT02108626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146053|NCT02108626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146054|NCT05431322|Dexmedetomidine|dexmedetomidine|mesh-list
93146055|NCT05431322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93146056|NCT05431322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854786|NCT00602693|Sirolimus|sirolimus|mesh-list
93146057|NCT05431322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146058|NCT05431322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146059|NCT05431322|Analgesics|analgesics|mesh-ancestor
93146060|NCT05431322|Sensory System Agents|sensory system agents|mesh-ancestor
93146061|NCT05431322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146062|NCT05431322|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93146063|NCT05431322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93146064|NCT05431322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93146065|NCT05431322|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146066|NCT05431322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146067|NCT05431322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146068|NCT03745599|Diclofenac|diclofenac|mesh-list
93146069|NCT03745599|Flurbiprofen|flurbiprofen|mesh-list
93146070|NCT03745599|Benzydamine|benzydamine|mesh-list
93146071|NCT03745599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93146072|NCT03745599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146073|NCT03745599|Analgesics|analgesics|mesh-ancestor
93146074|NCT03745599|Sensory System Agents|sensory system agents|mesh-ancestor
93146075|NCT03745599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146076|NCT03745599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146077|NCT03745599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146078|NCT03745599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146079|NCT03745599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93146080|NCT03745599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146081|NCT03745599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146082|NCT02108782|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93146083|NCT02108782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93146084|NCT02108782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146085|NCT02108782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146086|NCT02111434|Testosterone|testosterone|mesh-list
93146087|NCT02111434|Androgens|androgens|mesh-ancestor
93146088|NCT02111434|Hormones|hormones|mesh-ancestor
93146089|NCT02111434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146090|NCT02111434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146091|NCT03230864|Olanzapine|olanzapine|mesh-list
93146092|NCT03230864|Risperidone|risperidone|mesh-list
93146093|NCT03230864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93146094|NCT03230864|Serotonin Agents|serotonin agents|mesh-ancestor
93146095|NCT03230864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146096|NCT03230864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146097|NCT03230864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146098|NCT03230864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93146099|NCT03230864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146100|NCT03230864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146101|NCT03230864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146102|NCT03230864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93146103|NCT03230864|Dopamine Agents|dopamine agents|mesh-ancestor
93146104|NCT03230864|Antiemetics|antiemetics|mesh-ancestor
93146105|NCT03230864|Autonomic Agents|autonomic agents|mesh-ancestor
93146106|NCT03230864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146107|NCT03230864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146108|NCT03230864|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93146109|NCT03230864|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93146110|NCT03230864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93146111|NCT02111590|Immunoglobulins|immunoglobulins|mesh-list
93146112|NCT02111590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93146113|NCT02111590|Antibodies|antibodies|mesh-list
93146114|NCT02111590|Immunologic Factors|immunologic factors|mesh-ancestor
93146115|NCT02111590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146116|NCT02937350|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93146117|NCT02937350|Calcifediol|calcifediol|mesh-list
93146118|NCT02937350|Vitamins|vitamins|mesh-ancestor
93146119|NCT02937350|Micronutrients|micronutrients|mesh-ancestor
93146120|NCT02937350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146121|NCT02937350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93146122|NCT02109328|Paclitaxel|paclitaxel|mesh-list
93146123|NCT02109328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93146124|NCT02109328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146125|NCT02109328|Tubulin Modulators|tubulin modulators|mesh-ancestor
93146126|NCT02109328|Antimitotic Agents|antimitotic agents|mesh-ancestor
93146127|NCT02109328|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146128|NCT02109328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146129|NCT02115490|Diphosphonates|diphosphonates|mesh-list
92854787|NCT00602693|Cyclophosphamide|cyclophosphamide|mesh-list
93146130|NCT02115490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93146131|NCT02115490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146132|NCT02251288|Vaccines|vaccines|mesh-list
93146133|NCT02251288|Immunologic Factors|immunologic factors|mesh-ancestor
93146134|NCT02251288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146135|NCT02109718|Sulfadiazine|sulfadiazine|mesh-list
93146136|NCT02109718|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93146137|NCT02109718|Petrolatum|petrolatum|mesh-list
93146138|NCT02109718|Emollients|emollients|mesh-ancestor
93146139|NCT02109718|Dermatologic Agents|dermatologic agents|mesh-ancestor
93146140|NCT02109718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146141|NCT02109718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146142|NCT02109718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93146143|NCT02109718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93146144|NCT02109718|Coccidiostats|coccidiostats|mesh-ancestor
93146145|NCT02109718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93146146|NCT03744897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93146147|NCT03744897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146148|NCT03744897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146149|NCT02112214|Bismuth|bismuth|mesh-list
93146150|NCT02112214|Antacids|antacids|mesh-ancestor
93146151|NCT02112214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146152|NCT02112214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146153|NCT02112292|Dronabinol|dronabinol|mesh-list
93146154|NCT02112292|Cannabidiol|cannabidiol|mesh-list
93146155|NCT02112292|Anticonvulsants|anticonvulsants|mesh-ancestor
93146156|NCT02112292|Hallucinogens|hallucinogens|mesh-ancestor
93146157|NCT02112292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146158|NCT02112292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146159|NCT02112292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146160|NCT02112292|Analgesics|analgesics|mesh-ancestor
93146161|NCT02112292|Sensory System Agents|sensory system agents|mesh-ancestor
93146162|NCT02112292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146163|NCT02112292|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93146164|NCT02112292|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93146165|NCT02112292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146166|NCT02112292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146167|NCT02112292|Hormones|hormones|mesh-ancestor
93146168|NCT02112292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146169|NCT02116036|Rivaroxaban|rivaroxaban|mesh-list
93146170|NCT02116036|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93146171|NCT02116036|Antithrombins|antithrombins|mesh-ancestor
93146172|NCT02116036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93146173|NCT02116036|Protease Inhibitors|protease inhibitors|mesh-ancestor
93146174|NCT02116036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146175|NCT02116036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146176|NCT02116036|Anticoagulants|anticoagulants|mesh-ancestor
93146177|NCT04011735|Tiotropium Bromide|tiotropium bromide|mesh-list
93146178|NCT04011735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93146179|NCT04011735|Autonomic Agents|autonomic agents|mesh-ancestor
93146180|NCT04011735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146181|NCT04011735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146182|NCT04011735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93146183|NCT04011735|Respiratory System Agents|respiratory system agents|mesh-ancestor
93146184|NCT04011735|Parasympatholytics|parasympatholytics|mesh-ancestor
93146185|NCT04011735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93146186|NCT04011735|Cholinergic Agents|cholinergic agents|mesh-ancestor
93146187|NCT04011735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146188|NCT04011735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146190|NCT02118844|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93146191|NCT02118844|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93146192|NCT02118844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93146193|NCT02118844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146194|NCT02118844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146195|NCT02116348|Cerebrolysin|cerebrolysin|mesh-list
93146196|NCT02116348|Mitogens|mitogens|mesh-list
93146197|NCT02116348|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146198|NCT02116348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146199|NCT02116348|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93146200|NCT02116348|Protective Agents|protective agents|mesh-ancestor
93146201|NCT02116348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146202|NCT02116348|Nootropic Agents|nootropic agents|mesh-ancestor
93146203|NCT02119000|Bisacodyl|bisacodyl|mesh-list
93146204|NCT02119000|Cathartics|cathartics|mesh-ancestor
93146205|NCT02119000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146206|NCT02119000|Laxatives|laxatives|mesh-ancestor
93146207|NCT02119234|Beclomethasone|beclomethasone|mesh-list
93146208|NCT02119234|Glycopyrrolate|glycopyrrolate|mesh-list
93146209|NCT02119234|Formoterol Fumarate|formoterol fumarate|mesh-list
93146210|NCT02119234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93146211|NCT02119234|Autonomic Agents|autonomic agents|mesh-ancestor
93146212|NCT02119234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146213|NCT02119234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146214|NCT02119234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93146215|NCT02119234|Respiratory System Agents|respiratory system agents|mesh-ancestor
93146216|NCT02119234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93146217|NCT02119234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93146218|NCT02119234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93146219|NCT02119234|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146220|NCT02119234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146221|NCT02119234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146222|NCT02119234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93146223|NCT02119234|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93146224|NCT02119234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93146225|NCT02119234|Cholinergic Agents|cholinergic agents|mesh-ancestor
93146226|NCT02119234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146227|NCT02119234|Glucocorticoids|glucocorticoids|mesh-ancestor
93146228|NCT02119234|Hormones|hormones|mesh-ancestor
93146229|NCT02119234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146230|NCT02112604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93146231|NCT02112604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146232|NCT02112604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146233|NCT03694197|Alirocumab|alirocumab|mesh-list
93146234|NCT03694197|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93146235|NCT03694197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93146236|NCT03694197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146237|NCT03694197|Antimetabolites|antimetabolites|mesh-ancestor
93146238|NCT03694197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146239|NCT03694197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93146240|NCT03694197|Protease Inhibitors|protease inhibitors|mesh-ancestor
93146241|NCT03694197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146242|NCT03694197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146243|NCT04480424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92818389|NCT00736255|Nicotine|nicotine|mesh-list
93146244|NCT04480424|Immunologic Factors|immunologic factors|mesh-ancestor
93146245|NCT04480424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146247|NCT04473716|Cisplatin|cisplatin|mesh-list
93146248|NCT04473716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93146249|NCT04473716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146250|NCT04473716|Tubulin Modulators|tubulin modulators|mesh-ancestor
93146251|NCT04473716|Antimitotic Agents|antimitotic agents|mesh-ancestor
93146252|NCT04473716|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146253|NCT04473716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146254|NCT04000815|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
93146255|NCT04000815|Natriuretic Agents|natriuretic agents|mesh-ancestor
93146256|NCT04000815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146257|NCT03919617|Volagidemab|volagidemab|mesh-list
93146258|NCT03919617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93146259|NCT03919617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146260|NCT03748173|Calfactant|calfactant|mesh-list
93146261|NCT03748173|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93146262|NCT03748173|Respiratory System Agents|respiratory system agents|mesh-ancestor
93146263|NCT03848403|Ixekizumab|ixekizumab|mesh-list
93146264|NCT03848403|Dermatologic Agents|dermatologic agents|mesh-ancestor
93146265|NCT04054011|Deoxycholic Acid|deoxycholic acid|mesh-list
93146266|NCT04054011|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93146267|NCT04054011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146268|NCT03743883|Aspirin|aspirin|mesh-list
93146269|NCT03743883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93146270|NCT03743883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146271|NCT03743883|Analgesics|analgesics|mesh-ancestor
93146272|NCT03743883|Sensory System Agents|sensory system agents|mesh-ancestor
93146273|NCT03743883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146274|NCT03743883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146275|NCT03743883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146276|NCT03743883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146277|NCT03743883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93146278|NCT03743883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93146279|NCT03743883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146280|NCT03743883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93146281|NCT03743883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93146282|NCT03743883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146283|NCT03743883|Antipyretics|antipyretics|mesh-ancestor
93146284|NCT03988803|Memantine|memantine|mesh-list
93146285|NCT03988803|BI 425809|bi 425809|mesh-list
93146286|NCT03988803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93146287|NCT03988803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93146288|NCT03988803|Dopamine Agents|dopamine agents|mesh-ancestor
93146289|NCT03988803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146290|NCT03988803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146291|NCT03988803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146292|NCT03988803|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93146293|NCT03988803|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93146294|NCT03988803|Nootropic Agents|nootropic agents|mesh-ancestor
93146295|NCT00181883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93146296|NCT00181883|Antidepressive Agents|antidepressive agents|mesh-ancestor
93146297|NCT00181883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146298|NCT00181883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93146299|NCT00181883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146300|NCT00181883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146301|NCT00181883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146302|NCT00180713|Simvastatin|simvastatin|mesh-list
93146303|NCT00180713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93146304|NCT00180713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146305|NCT00180713|Antimetabolites|antimetabolites|mesh-ancestor
93146306|NCT00180713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146307|NCT00180713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146308|NCT00180713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93146309|NCT00180713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146310|NCT02531477|Propofol|propofol|mesh-list
93146311|NCT02531477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93146312|NCT02531477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146313|NCT02531477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146314|NCT02531477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93146315|NCT02531477|Anesthetics, General|anesthetics, general|mesh-ancestor
93146316|NCT02531477|Anesthetics|anesthetics|mesh-ancestor
93146317|NCT04052139|Naltrexone|naltrexone|mesh-list
93146318|NCT04052139|Gabapentin|gabapentin|mesh-list
93146319|NCT04052139|Analgesics|analgesics|mesh-ancestor
92818447|NCT02609698|Antipyretics|antipyretics|mesh-ancestor
93146320|NCT04052139|Sensory System Agents|sensory system agents|mesh-ancestor
93146321|NCT04052139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146322|NCT04052139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146324|NCT04052139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93146325|NCT04052139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146326|NCT04052139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146327|NCT04052139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146328|NCT04052139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93146329|NCT04052139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93146330|NCT04052139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146331|NCT04052139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146332|NCT04052139|Antimanic Agents|antimanic agents|mesh-ancestor
93146333|NCT04052139|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93146334|NCT04052139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93146335|NCT03743805|Naloxone|naloxone|mesh-list
93146336|NCT03743805|Flumazenil|flumazenil|mesh-list
93146337|NCT03743805|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93146338|NCT03743805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146339|NCT03743805|Sensory System Agents|sensory system agents|mesh-ancestor
93146340|NCT03743805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146341|NCT03743805|Antidotes|antidotes|mesh-ancestor
93146342|NCT03743805|Protective Agents|protective agents|mesh-ancestor
93146343|NCT03743805|GABA Modulators|gaba modulators|mesh-ancestor
93146344|NCT03743805|GABA Agents|gaba agents|mesh-ancestor
93146345|NCT03743805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146346|NCT03743805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146347|NCT03743727|Sofosbuvir|sofosbuvir|mesh-list
93146348|NCT03743727|Ledipasvir|ledipasvir|mesh-list
93146349|NCT03743727|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93146350|NCT03743727|Antiviral Agents|antiviral agents|mesh-ancestor
93146351|NCT03743727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146352|NCT03981861|Metformin|metformin|mesh-list
93146353|NCT03981861|Spironolactone|spironolactone|mesh-list
93146354|NCT03981861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93146355|NCT03981861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146356|NCT03981861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93146357|NCT03981861|Hormone Antagonists|hormone antagonists|mesh-ancestor
93146358|NCT03981861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146359|NCT03981861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93146360|NCT03981861|Diuretics|diuretics|mesh-ancestor
93146361|NCT03981861|Natriuretic Agents|natriuretic agents|mesh-ancestor
93146362|NCT03743649|Lorazepam|lorazepam|mesh-list
93146363|NCT03743649|Haloperidol|haloperidol|mesh-list
93146364|NCT03743649|Haloperidol decanoate|haloperidol decanoate|mesh-list
93146365|NCT03743649|Antiemetics|antiemetics|mesh-ancestor
93146366|NCT03743649|Autonomic Agents|autonomic agents|mesh-ancestor
93146367|NCT03743649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146368|NCT03743649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146369|NCT03743649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146370|NCT03743649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93146371|NCT03743649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146372|NCT03743649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146373|NCT03743649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146374|NCT03743649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93146375|NCT03743649|Dopamine Agents|dopamine agents|mesh-ancestor
93146376|NCT03743649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146377|NCT03743649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146378|NCT03743649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93146379|NCT03743649|Anticonvulsants|anticonvulsants|mesh-ancestor
93146380|NCT03743649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93146381|NCT03743649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93146382|NCT03743649|GABA Modulators|gaba modulators|mesh-ancestor
93146383|NCT03743649|GABA Agents|gaba agents|mesh-ancestor
93146384|NCT01332266|Cetuximab|cetuximab|mesh-list
93146385|NCT01332266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146386|NCT01332266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146387|NCT03255824|Fentanyl|fentanyl|mesh-list
93146388|NCT03255824|Midazolam|midazolam|mesh-list
93146389|NCT03255824|Dexmedetomidine|dexmedetomidine|mesh-list
93146390|NCT03255824|Propofol|propofol|mesh-list
93146391|NCT03255824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93146392|NCT03255824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146393|NCT03255824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146394|NCT03255824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146395|NCT03255824|Analgesics|analgesics|mesh-ancestor
93146396|NCT03255824|Sensory System Agents|sensory system agents|mesh-ancestor
93146397|NCT03255824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146398|NCT03255824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93146399|NCT03255824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93146400|NCT03255824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93146401|NCT03255824|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146402|NCT03255824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146403|NCT03255824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146404|NCT03255824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93146405|NCT03255824|Anesthetics, General|anesthetics, general|mesh-ancestor
93146406|NCT03255824|Anesthetics|anesthetics|mesh-ancestor
93146407|NCT03255824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93146408|NCT03255824|Narcotics|narcotics|mesh-ancestor
93146409|NCT03255824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93146410|NCT03255824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93146411|NCT03255824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146412|NCT03255824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146413|NCT03255824|GABA Modulators|gaba modulators|mesh-ancestor
93146414|NCT03255824|GABA Agents|gaba agents|mesh-ancestor
93146416|NCT03238352|Fluorides|fluorides|mesh-list
93146417|NCT03238352|Sodium Fluoride|sodium fluoride|mesh-list
93146418|NCT03238352|Cariostatic Agents|cariostatic agents|mesh-ancestor
93146419|NCT03238352|Protective Agents|protective agents|mesh-ancestor
93146420|NCT03238352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146421|NCT03238352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93146422|NCT03238352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146423|NCT01222754|Lenalidomide|lenalidomide|mesh-list
93146424|NCT01222754|Immunologic Factors|immunologic factors|mesh-ancestor
93146425|NCT01222754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146426|NCT01222754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93146427|NCT01222754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93146428|NCT01222754|Growth Substances|growth substances|mesh-ancestor
93146429|NCT01222754|Growth Inhibitors|growth inhibitors|mesh-ancestor
93146430|NCT01222754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146431|NCT03850418|Azacitidine|azacitidine|mesh-list
93146432|NCT03850418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93146433|NCT03850418|Antimetabolites|antimetabolites|mesh-ancestor
93146434|NCT03850418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146435|NCT03850418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146436|NCT03850418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146437|NCT05256914|Chlorhexidine|chlorhexidine|mesh-list
93146438|NCT05256914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93146439|NCT05256914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146440|NCT05256914|Disinfectants|disinfectants|mesh-ancestor
93146441|NCT00180479|Paclitaxel|paclitaxel|mesh-list
93146442|NCT00180479|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93146443|NCT00180479|Everolimus|everolimus|mesh-list
93146444|NCT00180479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93146445|NCT00180479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146446|NCT00180479|Tubulin Modulators|tubulin modulators|mesh-ancestor
93146447|NCT00180479|Antimitotic Agents|antimitotic agents|mesh-ancestor
93146448|NCT00180479|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146449|NCT00180479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146450|NCT00180479|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93146451|NCT00180479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93146452|NCT00180479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146453|NCT00180479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146454|NCT00180479|Immunologic Factors|immunologic factors|mesh-ancestor
93146455|NCT00180479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146456|NCT05169944|Magrolimab|magrolimab|mesh-list
93146457|NCT05169944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146458|NCT05169944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146459|NCT02955069|Spartalizumab|spartalizumab|mesh-list
93146460|NCT02955069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93146461|NCT02955069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146462|NCT02955069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146463|NCT02955069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146464|NCT03254108|Tolvaptan|tolvaptan|mesh-list
93146465|NCT03254108|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93146466|NCT03254108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146467|NCT03254108|Natriuretic Agents|natriuretic agents|mesh-ancestor
93146468|NCT03254108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146469|NCT02585895|Evolocumab|evolocumab|mesh-list
93146470|NCT02585895|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93146471|NCT02585895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93146472|NCT02585895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146473|NCT02585895|Antimetabolites|antimetabolites|mesh-ancestor
93146474|NCT02585895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146475|NCT02585895|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93146476|NCT02585895|Protease Inhibitors|protease inhibitors|mesh-ancestor
93146477|NCT02585895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146478|NCT02585895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146479|NCT03736161|Methotrexate|methotrexate|mesh-list
93146480|NCT03736161|Tofacitinib|tofacitinib|mesh-list
93146481|NCT03736161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93146482|NCT03736161|Abortifacient Agents|abortifacient agents|mesh-ancestor
93146483|NCT03736161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93146484|NCT03736161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146485|NCT03736161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93146486|NCT03736161|Antimetabolites|antimetabolites|mesh-ancestor
93146487|NCT03736161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146488|NCT03736161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146489|NCT03736161|Dermatologic Agents|dermatologic agents|mesh-ancestor
93146490|NCT03736161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146491|NCT03736161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93146492|NCT03736161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146493|NCT03736161|Immunologic Factors|immunologic factors|mesh-ancestor
93146494|NCT03736161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146495|NCT03736161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93146496|NCT03736161|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93146497|NCT03736161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93146498|NCT03253796|Golimumab|golimumab|mesh-list
93146499|NCT03253796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93146500|NCT03253796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146501|NCT03253796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146502|NCT03253796|Immunologic Factors|immunologic factors|mesh-ancestor
93146503|NCT03253796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146504|NCT02956005|Tacrolimus|tacrolimus|mesh-list
93146505|NCT02956005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146506|NCT02956005|Immunologic Factors|immunologic factors|mesh-ancestor
93146507|NCT02956005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146508|NCT02956005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93146509|NCT02956005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146510|NCT02956005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146511|NCT02579499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93146512|NCT02579499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93146513|NCT02579499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146514|NCT02579499|Antimetabolites|antimetabolites|mesh-ancestor
93146515|NCT02579499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146516|NCT02579499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146517|NCT02579499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146518|NCT03253094|Fluconazole|fluconazole|mesh-list
93146519|NCT03253094|Ibrexafungerp|ibrexafungerp|mesh-list
93146520|NCT03253094|Antifungal Agents|antifungal agents|mesh-ancestor
93146521|NCT03253094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146522|NCT03253094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93146523|NCT03253094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93146524|NCT03253094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146525|NCT03253094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146526|NCT03253094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93146527|NCT03253094|Hormone Antagonists|hormone antagonists|mesh-ancestor
93146528|NCT03253094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146529|NCT03253094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146530|NCT03253094|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93146531|NCT03253094|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93146532|NCT05179070|Carvedilol|carvedilol|mesh-list
93146533|NCT05179070|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93146534|NCT05179070|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93146535|NCT05179070|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146536|NCT05179070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146537|NCT05179070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146538|NCT05179070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146539|NCT05179070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93146540|NCT05179070|Antioxidants|antioxidants|mesh-ancestor
93146541|NCT05179070|Protective Agents|protective agents|mesh-ancestor
93146542|NCT05179070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93146543|NCT05179070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93146544|NCT05179070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93146545|NCT05179070|Vasodilator Agents|vasodilator agents|mesh-ancestor
93146546|NCT05179070|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93146547|NCT05179070|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93146548|NCT03477500|Cyclophosphamide|cyclophosphamide|mesh-list
93146549|NCT03477500|Alemtuzumab|alemtuzumab|mesh-list
93146550|NCT03477500|Cladribine|cladribine|mesh-list
93146551|NCT03477500|Ocrelizumab|ocrelizumab|mesh-list
93146552|NCT03477500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146553|NCT03477500|Immunologic Factors|immunologic factors|mesh-ancestor
93146554|NCT03477500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146555|NCT03477500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146556|NCT03477500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93146557|NCT03477500|Alkylating Agents|alkylating agents|mesh-ancestor
93146558|NCT03477500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146559|NCT03477500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146560|NCT03477500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93146561|NCT03477500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146562|NCT00179621|Lenalidomide|lenalidomide|mesh-list
93146563|NCT00179621|Immunologic Factors|immunologic factors|mesh-ancestor
93146564|NCT00179621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146565|NCT00179621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93146566|NCT00179621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93146567|NCT00179621|Growth Substances|growth substances|mesh-ancestor
93146568|NCT00179621|Growth Inhibitors|growth inhibitors|mesh-ancestor
93146569|NCT00179621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146570|NCT04862780|Osimertinib|osimertinib|mesh-list
93146571|NCT04862780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146572|NCT04862780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93146573|NCT04862780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146574|NCT04862780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146575|NCT00179309|Docetaxel|docetaxel|mesh-list
93146576|NCT00179309|Sargramostim|sargramostim|mesh-list
93146577|NCT00179309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146578|NCT00179309|Tubulin Modulators|tubulin modulators|mesh-ancestor
93146579|NCT00179309|Antimitotic Agents|antimitotic agents|mesh-ancestor
93146580|NCT00179309|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146581|NCT00179309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146582|NCT00179309|Immunologic Factors|immunologic factors|mesh-ancestor
93146583|NCT00179309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146584|NCT00177671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93146585|NCT00177671|Donepezil|donepezil|mesh-list
93146586|NCT00177671|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93146587|NCT00177671|Escitalopram|escitalopram|mesh-list
93146588|NCT00177671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93146589|NCT00177671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93146590|NCT00177671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93146591|NCT00177671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146592|NCT00177671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146593|NCT00177671|Serotonin Agents|serotonin agents|mesh-ancestor
93146594|NCT00177671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146595|NCT00177671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146596|NCT00177671|Cholinergic Agents|cholinergic agents|mesh-ancestor
93146597|NCT00177671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93146598|NCT00177671|Antidepressive Agents|antidepressive agents|mesh-ancestor
93146599|NCT00177671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146600|NCT00177671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93146601|NCT00177671|Analgesics|analgesics|mesh-ancestor
93146602|NCT00177671|Sensory System Agents|sensory system agents|mesh-ancestor
93146603|NCT00177671|Dopamine Agents|dopamine agents|mesh-ancestor
93146604|NCT00177671|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93146605|NCT00177671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146606|NCT00177671|Nootropic Agents|nootropic agents|mesh-ancestor
93146607|NCT03235154|Sofosbuvir|sofosbuvir|mesh-list
93146608|NCT03235154|Velpatasvir|velpatasvir|mesh-list
93146609|NCT03235154|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93146610|NCT03235154|Antiviral Agents|antiviral agents|mesh-ancestor
93146611|NCT03235154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146612|NCT03233438|Dalbavancin|dalbavancin|mesh-list
93146613|NCT03233438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146614|NCT03233438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146615|NCT02251600|Deflazacort|deflazacort|mesh-list
93146616|NCT02251600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146617|NCT02251600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146618|NCT02251600|Immunologic Factors|immunologic factors|mesh-ancestor
93146619|NCT02251600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146621|NCT02113072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146622|NCT02113072|Glucocorticoids|glucocorticoids|mesh-ancestor
93146623|NCT02113072|Hormones|hormones|mesh-ancestor
93146624|NCT02113072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146625|NCT02113072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146626|NCT02113072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93146627|NCT02113072|Respiratory System Agents|respiratory system agents|mesh-ancestor
93146628|NCT02113150|Ketamine|ketamine|mesh-list
93146629|NCT02113150|Remifentanil|remifentanil|mesh-list
93146630|NCT02113150|Analgesics|analgesics|mesh-ancestor
93146631|NCT02113150|Sensory System Agents|sensory system agents|mesh-ancestor
93146632|NCT02113150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146633|NCT02113150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146634|NCT02113150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93146635|NCT02113150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93146636|NCT02113150|Anesthetics, General|anesthetics, general|mesh-ancestor
93146637|NCT02113150|Anesthetics|anesthetics|mesh-ancestor
93146638|NCT02113150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146639|NCT02113150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93146640|NCT02113150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93146641|NCT02113150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146642|NCT02113150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146643|NCT02113150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93146644|NCT02113150|Narcotics|narcotics|mesh-ancestor
93146645|NCT04647500|Methylphenidate|methylphenidate|mesh-list
93146646|NCT04647500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93146647|NCT04647500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146648|NCT04647500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93146649|NCT04647500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93146650|NCT04647500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92854794|NCT00602693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146651|NCT04647500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146652|NCT04647500|Dopamine Agents|dopamine agents|mesh-ancestor
93146653|NCT04647500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146654|NCT03553108|Olaparib|olaparib|mesh-list
93146655|NCT03553108|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93146656|NCT03553108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146657|NCT03553108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146658|NCT03553108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146659|NCT02119858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93146660|NCT02117128|Tranexamic Acid|tranexamic acid|mesh-list
93146661|NCT02117128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93146662|NCT02117128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93146663|NCT02117128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146664|NCT02117128|Hemostatics|hemostatics|mesh-ancestor
93146665|NCT02117128|Coagulants|coagulants|mesh-ancestor
93146666|NCT00175877|Certolizumab Pegol|certolizumab pegol|mesh-list
93146667|NCT00175877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93146668|NCT00175877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146669|NCT00175877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146670|NCT00175877|Immunologic Factors|immunologic factors|mesh-ancestor
93146671|NCT00175877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146672|NCT00175877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146673|NCT02117362|Ipilimumab|ipilimumab|mesh-list
93146674|NCT02117362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146675|NCT02117362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146676|NCT02117362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93146677|NCT02117362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146678|NCT02113540|Atorvastatin|atorvastatin|mesh-list
93146679|NCT02113540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93146680|NCT02113540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146681|NCT02113540|Antimetabolites|antimetabolites|mesh-ancestor
93146682|NCT02113540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146683|NCT02113540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146684|NCT02113540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93146685|NCT02113540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146686|NCT02123056|Metoprolol|metoprolol|mesh-list
93146687|NCT02123056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93146688|NCT02123056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93146689|NCT02123056|Sympatholytics|sympatholytics|mesh-ancestor
93146690|NCT02123056|Autonomic Agents|autonomic agents|mesh-ancestor
93146691|NCT02123056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146692|NCT02123056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146693|NCT02123056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93146694|NCT02123056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93146695|NCT02123056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93146696|NCT02123056|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146697|NCT02123056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146698|NCT02123056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146699|NCT02120092|Clopidogrel|clopidogrel|mesh-list
93146700|NCT02120092|Ticagrelor|ticagrelor|mesh-list
93146701|NCT02120092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93146702|NCT02120092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93146703|NCT02120092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93146704|NCT02120092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93146705|NCT02120092|Purinergic Agents|purinergic agents|mesh-ancestor
93146706|NCT02120092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146707|NCT02120092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146708|NCT02120092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146709|NCT02117596|Sirolimus|sirolimus|mesh-list
93146710|NCT02117596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146711|NCT02117596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146712|NCT02117596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93146713|NCT02117596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146714|NCT02117596|Antifungal Agents|antifungal agents|mesh-ancestor
93146715|NCT02117596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146716|NCT02117596|Immunologic Factors|immunologic factors|mesh-ancestor
93146717|NCT02117596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146718|NCT02117752|Dapsone|dapsone|mesh-list
93146719|NCT02117752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146720|NCT02117752|Antimalarials|antimalarials|mesh-ancestor
93146721|NCT02117752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93146722|NCT02117752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93146723|NCT02117752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93146724|NCT02117752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146725|NCT02117752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146726|NCT02117752|Leprostatic Agents|leprostatic agents|mesh-ancestor
93146727|NCT02117752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146728|NCT02117830|Moxifloxacin|moxifloxacin|mesh-list
93146729|NCT02117830|Enclomiphene|enclomiphene|mesh-list
93146730|NCT02117830|Clomiphene|clomiphene|mesh-list
93146731|NCT02117830|Zuclomiphene|zuclomiphene|mesh-list
93146732|NCT02117830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146733|NCT02117830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146734|NCT02117830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93146735|NCT02117830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93146736|NCT02117830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146737|NCT02117830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146738|NCT02117830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146739|NCT02117830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93146740|NCT02117830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146741|NCT02117830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93146742|NCT02117830|Hormone Antagonists|hormone antagonists|mesh-ancestor
93146743|NCT02117830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146744|NCT02117830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93146745|NCT02117830|Fertility Agents|fertility agents|mesh-ancestor
93146746|NCT02117830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93146747|NCT02117830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93146748|NCT02120638|Pyrazinamide|pyrazinamide|mesh-list
93146749|NCT02120638|Antitubercular Agents|antitubercular agents|mesh-ancestor
93146750|NCT02120638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146751|NCT02120638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146752|NCT03552406|Cetuximab|cetuximab|mesh-list
93146753|NCT03552406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146754|NCT03552406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146755|NCT02123368|Hyaluronic Acid|hyaluronic acid|mesh-list
93146756|NCT02123368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93146757|NCT02123368|Immunologic Factors|immunologic factors|mesh-ancestor
93146758|NCT02123368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146759|NCT02123368|Viscosupplements|viscosupplements|mesh-ancestor
93146760|NCT02123368|Protective Agents|protective agents|mesh-ancestor
93146761|NCT02123524|Rivaroxaban|rivaroxaban|mesh-list
93146762|NCT02123524|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93146763|NCT02123524|Antithrombins|antithrombins|mesh-ancestor
93146764|NCT02123524|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93146765|NCT02123524|Protease Inhibitors|protease inhibitors|mesh-ancestor
93146766|NCT02123524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146767|NCT02123524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146768|NCT02123524|Anticoagulants|anticoagulants|mesh-ancestor
93146770|NCT02117986|Polymyxins|polymyxins|mesh-list
93146771|NCT02117986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146772|NCT02117986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146773|NCT02118064|Irinotecan|irinotecan|mesh-list
93146774|NCT02118064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93146775|NCT02118064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93146776|NCT02118064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146777|NCT02118064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146778|NCT02118064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146779|NCT02120872|Simvastatin|simvastatin|mesh-list
93146780|NCT02120872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93146781|NCT02120872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146782|NCT02120872|Antimetabolites|antimetabolites|mesh-ancestor
93146783|NCT02120872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146784|NCT02120872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146785|NCT02120872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93146786|NCT02120872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146787|NCT03552016|Riboflavin|riboflavin|mesh-list
93146788|NCT03552016|Vitamins|vitamins|mesh-ancestor
93146789|NCT03552016|Micronutrients|micronutrients|mesh-ancestor
93146790|NCT03552016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146791|NCT03552016|Vitamin B Complex|vitamin b complex|mesh-ancestor
93146792|NCT03552016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93146793|NCT03552016|Dermatologic Agents|dermatologic agents|mesh-ancestor
93146794|NCT02788474|Nintedanib|nintedanib|mesh-list
93146795|NCT02788474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146796|NCT02788474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93146797|NCT02788474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146798|NCT02788474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146799|NCT02118142|Betaine|betaine|mesh-list
93146800|NCT02118142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93146801|NCT02118142|Lipotropic Agents|lipotropic agents|mesh-ancestor
93146802|NCT02118142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93146803|NCT02118142|Antimetabolites|antimetabolites|mesh-ancestor
93146804|NCT02118142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146805|NCT02118142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146806|NCT02118376|Exenatide|exenatide|mesh-list
93146807|NCT02118376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93146808|NCT02118376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146809|NCT02118376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93146810|NCT02118376|Incretins|incretins|mesh-ancestor
93146811|NCT02118376|Hormones|hormones|mesh-ancestor
93146812|NCT02118376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146813|NCT02124070|Hormones|hormones|mesh-list
93146814|NCT02124070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146815|NCT02124070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146816|NCT02118532|Paclitaxel|paclitaxel|mesh-list
93146817|NCT02118532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93146818|NCT02118532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146819|NCT02118532|Tubulin Modulators|tubulin modulators|mesh-ancestor
93146820|NCT02118532|Antimitotic Agents|antimitotic agents|mesh-ancestor
93146821|NCT02118532|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146822|NCT02118532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146823|NCT02118688|Risperidone|risperidone|mesh-list
93146824|NCT02118688|Trazodone|trazodone|mesh-list
93146825|NCT02118688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93146826|NCT02118688|Serotonin Agents|serotonin agents|mesh-ancestor
93146827|NCT02118688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146828|NCT02118688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146829|NCT02118688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146830|NCT02118688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93146831|NCT02118688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146832|NCT02118688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146833|NCT02118688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146834|NCT02118688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93146835|NCT02118688|Dopamine Agents|dopamine agents|mesh-ancestor
93146836|NCT02118688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93146837|NCT02118688|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93146838|NCT02118688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93146839|NCT02118688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93146840|NCT02118688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93146841|NCT02118688|Antidepressive Agents|antidepressive agents|mesh-ancestor
93146842|NCT03248492|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93146843|NCT03248492|Immunoconjugates|immunoconjugates|mesh-ancestor
93146844|NCT03248492|Immunologic Factors|immunologic factors|mesh-ancestor
93146845|NCT03248492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146847|NCT02126956|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93146848|NCT02126956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146849|NCT02126956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146850|NCT02126956|Immunologic Factors|immunologic factors|mesh-ancestor
93146851|NCT02126956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146852|NCT02124148|Leucovorin|leucovorin|mesh-list
93146853|NCT02124148|Fluorouracil|fluorouracil|mesh-list
93146854|NCT02124148|Pemetrexed|pemetrexed|mesh-list
93146855|NCT02124148|Cetuximab|cetuximab|mesh-list
93146856|NCT02124148|Prexasertib|prexasertib|mesh-list
93146857|NCT02124148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146858|NCT02124148|Antimetabolites|antimetabolites|mesh-ancestor
93146859|NCT02124148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146860|NCT02124148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93146861|NCT02124148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146862|NCT02124148|Immunologic Factors|immunologic factors|mesh-ancestor
93146863|NCT02124148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146864|NCT02124148|Antidotes|antidotes|mesh-ancestor
93146865|NCT02124148|Protective Agents|protective agents|mesh-ancestor
93146866|NCT02124148|Vitamin B Complex|vitamin b complex|mesh-ancestor
93146867|NCT02124148|Vitamins|vitamins|mesh-ancestor
93146868|NCT02124148|Micronutrients|micronutrients|mesh-ancestor
93146869|NCT02124148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146870|NCT02124148|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93146871|NCT02124148|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93146872|NCT02124148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93146873|NCT02124148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93146874|NCT02124226|Methotrexate|methotrexate|mesh-list
93146875|NCT02124226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93146876|NCT02124226|Abortifacient Agents|abortifacient agents|mesh-ancestor
93146877|NCT02124226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93146878|NCT02124226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146879|NCT02124226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93146880|NCT02124226|Antimetabolites|antimetabolites|mesh-ancestor
93146881|NCT02124226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146882|NCT02124226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146883|NCT02124226|Dermatologic Agents|dermatologic agents|mesh-ancestor
93146884|NCT02124226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146885|NCT02124226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93146886|NCT02124226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146887|NCT02124226|Immunologic Factors|immunologic factors|mesh-ancestor
93146888|NCT02124226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146889|NCT02124226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93146890|NCT02127034|Digoxin|digoxin|mesh-list
93146891|NCT02127034|Solifenacin Succinate|solifenacin succinate|mesh-list
93146892|NCT02127034|Mirabegron|mirabegron|mesh-list
93146893|NCT02127034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93146894|NCT02127034|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93146895|NCT02127034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146896|NCT02127034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146897|NCT02127034|Protective Agents|protective agents|mesh-ancestor
93146898|NCT02127034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146899|NCT02127034|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93146900|NCT02127034|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93146901|NCT02127034|Cholinergic Agents|cholinergic agents|mesh-ancestor
93146902|NCT02127034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146903|NCT02127034|Urological Agents|urological agents|mesh-ancestor
93146904|NCT02127034|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93146905|NCT02127034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93146906|NCT02127034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93146907|NCT02127034|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146908|NCT02787304|Volixibat|volixibat|mesh-list
93146909|NCT02787304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93146910|NCT00574496|Cyclosporine|cyclosporine|mesh-list
93146911|NCT00574496|Mycophenolic Acid|mycophenolic acid|mesh-list
93146912|NCT00574496|Prednisone|prednisone|mesh-list
93146913|NCT00574496|Cyclophosphamide|cyclophosphamide|mesh-list
93146914|NCT00574496|Melphalan|melphalan|mesh-list
93146915|NCT00574496|Ifosfamide|ifosfamide|mesh-list
93146916|NCT00574496|Mechlorethamine|mechlorethamine|mesh-list
93146917|NCT00574496|Gemcitabine|gemcitabine|mesh-list
93146918|NCT00574496|Methotrexate|methotrexate|mesh-list
93146919|NCT00574496|Fludarabine|fludarabine|mesh-list
93146920|NCT00574496|Fludarabine phosphate|fludarabine phosphate|mesh-list
93146922|NCT00574496|Vinorelbine|vinorelbine|mesh-list
93146923|NCT00574496|Procarbazine|procarbazine|mesh-list
93146924|NCT00574496|Cyclosporins|cyclosporins|mesh-list
93146925|NCT00574496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93146926|NCT00574496|Immunologic Factors|immunologic factors|mesh-ancestor
93146927|NCT00574496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146928|NCT00574496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93146929|NCT00574496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93146930|NCT00574496|Alkylating Agents|alkylating agents|mesh-ancestor
93146931|NCT00574496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146932|NCT00574496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93146933|NCT00574496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93146934|NCT00574496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93146935|NCT00574496|Antimetabolites|antimetabolites|mesh-ancestor
93146936|NCT00574496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146937|NCT00574496|Glucocorticoids|glucocorticoids|mesh-ancestor
93146938|NCT00574496|Hormones|hormones|mesh-ancestor
93146939|NCT00574496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93146940|NCT00574496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93146941|NCT00574496|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93146942|NCT00574496|Abortifacient Agents|abortifacient agents|mesh-ancestor
93146943|NCT00574496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93146944|NCT00574496|Dermatologic Agents|dermatologic agents|mesh-ancestor
93146945|NCT00574496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146946|NCT00574496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93146947|NCT00574496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93146948|NCT00574496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93146949|NCT00574496|Tubulin Modulators|tubulin modulators|mesh-ancestor
93146950|NCT00574496|Antimitotic Agents|antimitotic agents|mesh-ancestor
93146951|NCT00574496|Mitosis Modulators|mitosis modulators|mesh-ancestor
93146952|NCT00574496|Antifungal Agents|antifungal agents|mesh-ancestor
93146953|NCT00574496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93146954|NCT00574496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93146955|NCT00574496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93146956|NCT00574496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93146957|NCT00574496|Antitubercular Agents|antitubercular agents|mesh-ancestor
93146958|NCT00574496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93146959|NCT02127190|CXA-10|cxa-10|mesh-list
93146960|NCT02127190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93146961|NCT02932904|Vortioxetine|vortioxetine|mesh-list
93146962|NCT02932904|Paroxetine|paroxetine|mesh-list
93146963|NCT02932904|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93146964|NCT02932904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93146965|NCT02932904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93146966|NCT02932904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146967|NCT02932904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146968|NCT02932904|Serotonin Agents|serotonin agents|mesh-ancestor
93146969|NCT02932904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146970|NCT02932904|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93146971|NCT02932904|Antidepressive Agents|antidepressive agents|mesh-ancestor
93146972|NCT02932904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146973|NCT02932904|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93146974|NCT02932904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93146975|NCT02932904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93146976|NCT02932904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93146977|NCT02932904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93146978|NCT02932904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93146979|NCT02932904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93146980|NCT02932904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93146981|NCT02932904|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93146982|NCT02932904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93146983|NCT02127736|Amitriptyline|amitriptyline|mesh-list
93146984|NCT02127736|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93146985|NCT02127736|Antidepressive Agents|antidepressive agents|mesh-ancestor
93146986|NCT02127736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93146987|NCT02127736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93146988|NCT02127736|Analgesics|analgesics|mesh-ancestor
93146989|NCT02127736|Sensory System Agents|sensory system agents|mesh-ancestor
93146990|NCT02127736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93146991|NCT02127736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93146992|NCT02127736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92819129|NCT04188483|Trace Elements|trace elements|mesh-ancestor
93146993|NCT02127736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93146994|NCT02127736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93146995|NCT02127736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93146996|NCT02127736|Adrenergic Agents|adrenergic agents|mesh-ancestor
93146997|NCT02127736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93146998|NCT02124850|Nivolumab|nivolumab|mesh-list
93146999|NCT02124850|Cetuximab|cetuximab|mesh-list
93147000|NCT02124850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147001|NCT02124850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147002|NCT02124850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93147003|NCT02124850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147004|NCT02125084|Everolimus|everolimus|mesh-list
93147005|NCT02125084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93147006|NCT02125084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93147007|NCT02125084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147008|NCT02125084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147009|NCT02125084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147010|NCT02125084|Immunologic Factors|immunologic factors|mesh-ancestor
93147011|NCT02125084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147012|NCT02125084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147013|NCT02122510|Dexmedetomidine|dexmedetomidine|mesh-list
93147014|NCT02122510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93147015|NCT02122510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927931|NCT00606697|Vestipitant|vestipitant|mesh-list
93147016|NCT02122510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147017|NCT02122510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147018|NCT02122510|Analgesics|analgesics|mesh-ancestor
93147019|NCT02122510|Sensory System Agents|sensory system agents|mesh-ancestor
93147020|NCT02122510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147021|NCT02122510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93147022|NCT02122510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93147023|NCT02122510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93147024|NCT02122510|Adrenergic Agents|adrenergic agents|mesh-ancestor
93147025|NCT02122510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147026|NCT02122510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147027|NCT02125318|Anagrelide|anagrelide|mesh-list
93147028|NCT02125318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93147029|NCT02125318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93147030|NCT02125318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147031|NCT02125318|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93147032|NCT02128126|Vaccines|vaccines|mesh-list
93147033|NCT02128126|Immunologic Factors|immunologic factors|mesh-ancestor
93147034|NCT02128126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147035|NCT02128204|Lidocaine|lidocaine|mesh-list
93147036|NCT02128204|Anesthetics, Local|anesthetics, local|mesh-ancestor
93147037|NCT02128204|Anesthetics|anesthetics|mesh-ancestor
93147038|NCT02128204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147039|NCT02128204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147040|NCT02128204|Sensory System Agents|sensory system agents|mesh-ancestor
93147041|NCT02128204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147042|NCT02128204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147043|NCT02128204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93147044|NCT02128204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93147045|NCT02128204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147046|NCT02128204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147047|NCT02128282|Gemcitabine|gemcitabine|mesh-list
93147048|NCT02128282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147049|NCT02128282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93147050|NCT02128282|Antimetabolites|antimetabolites|mesh-ancestor
93147051|NCT02128282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147052|NCT02125630|Hormones|hormones|mesh-list
93147053|NCT02125630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147054|NCT02125630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147055|NCT03551548|Spironolactone|spironolactone|mesh-list
93147056|NCT03551548|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93147057|NCT03551548|Hormone Antagonists|hormone antagonists|mesh-ancestor
93147058|NCT03551548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147059|NCT03551548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147060|NCT03551548|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93147061|NCT03551548|Diuretics|diuretics|mesh-ancestor
93147062|NCT03551548|Natriuretic Agents|natriuretic agents|mesh-ancestor
93147063|NCT02128360|Letrozole|letrozole|mesh-list
93147064|NCT02128360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147065|NCT02128360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93147066|NCT02128360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93147067|NCT02128360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147068|NCT02128360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147069|NCT02128360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93147070|NCT02128360|Hormone Antagonists|hormone antagonists|mesh-ancestor
93147071|NCT02128360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147072|NCT02128360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147073|NCT02126020|Infliximab|infliximab|mesh-list
93147074|NCT02126020|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93147075|NCT02126020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147076|NCT02126020|Dermatologic Agents|dermatologic agents|mesh-ancestor
93147077|NCT02126020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93147078|NCT02126020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147079|NCT00688376|Donepezil|donepezil|mesh-list
93147080|NCT00688376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93147081|NCT00688376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147082|NCT00688376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147083|NCT00688376|Cholinergic Agents|cholinergic agents|mesh-ancestor
93147084|NCT00688376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147085|NCT00688376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147086|NCT00688376|Nootropic Agents|nootropic agents|mesh-ancestor
93147087|NCT02126332|Acetaminophen|acetaminophen|mesh-list
93147088|NCT02126332|Sufentanil|sufentanil|mesh-list
93147089|NCT02126332|Nefopam|nefopam|mesh-list
93147090|NCT02126332|Tramadol|tramadol|mesh-list
93147091|NCT02126332|Ropivacaine|ropivacaine|mesh-list
93147092|NCT02126332|Anesthetics, Local|anesthetics, local|mesh-ancestor
93147093|NCT02126332|Anesthetics|anesthetics|mesh-ancestor
93147094|NCT02126332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147095|NCT02126332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147096|NCT02126332|Sensory System Agents|sensory system agents|mesh-ancestor
93147097|NCT02126332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147098|NCT02126332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147099|NCT02126332|Analgesics|analgesics|mesh-ancestor
93147100|NCT02126332|Antipyretics|antipyretics|mesh-ancestor
93147101|NCT02126332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147102|NCT02126332|Narcotics|narcotics|mesh-ancestor
93147103|NCT02126332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93147104|NCT02126332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93147105|NCT02126332|Anesthetics, General|anesthetics, general|mesh-ancestor
93147106|NCT02131246|Insulin|insulin|mesh-list
93147107|NCT02131246|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93147108|NCT02131246|Insulin Aspart|insulin aspart|mesh-list
93147109|NCT02131246|Insulin, Long-Acting|insulin, long-acting|mesh-list
93147110|NCT02131246|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93147111|NCT02131246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93147112|NCT02131246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147113|NCT02126644|Glycolic acid|glycolic acid|mesh-list
93147114|NCT02126644|Keratolytic Agents|keratolytic agents|mesh-ancestor
93147115|NCT02126644|Dermatologic Agents|dermatologic agents|mesh-ancestor
93147116|NCT03550534|Calcium Carbonate|calcium carbonate|mesh-list
93147117|NCT03550534|Calcium|calcium|mesh-list
93147118|NCT03550534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93147119|NCT03550534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147120|NCT03550534|Antacids|antacids|mesh-ancestor
93147121|NCT03550534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147122|NCT03550534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93147123|NCT02131480|Doxorubicin|doxorubicin|mesh-list
93147124|NCT02131480|Trabectedin|trabectedin|mesh-list
93147125|NCT02131480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93147126|NCT02131480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147127|NCT02131480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93147128|NCT02131480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93147129|NCT02131480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147130|NCT02131480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147131|NCT02131480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93147132|NCT02131480|Alkylating Agents|alkylating agents|mesh-ancestor
93147133|NCT02128906|Docetaxel|docetaxel|mesh-list
93147134|NCT02128906|Cetuximab|cetuximab|mesh-list
93147135|NCT02128906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147136|NCT02128906|Tubulin Modulators|tubulin modulators|mesh-ancestor
93147137|NCT02128906|Antimitotic Agents|antimitotic agents|mesh-ancestor
93147138|NCT02128906|Mitosis Modulators|mitosis modulators|mesh-ancestor
93147139|NCT02128906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147140|NCT02128906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147141|NCT02128984|Antioxidants|antioxidants|mesh-list
93147142|NCT02128984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147143|NCT02128984|Protective Agents|protective agents|mesh-ancestor
93147144|NCT02128984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147145|NCT02252302|Albuterol|albuterol|mesh-list
93147146|NCT02252302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93147147|NCT02252302|Autonomic Agents|autonomic agents|mesh-ancestor
93147148|NCT02252302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147149|NCT02252302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147150|NCT02252302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93147151|NCT02252302|Respiratory System Agents|respiratory system agents|mesh-ancestor
93147152|NCT02252302|Tocolytic Agents|tocolytic agents|mesh-ancestor
93147153|NCT02252302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93147154|NCT02252302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93147155|NCT02252302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93147156|NCT02252302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93147157|NCT02252302|Adrenergic Agents|adrenergic agents|mesh-ancestor
93147158|NCT02252302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147159|NCT02252302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147160|NCT02252614|Acetaminophen|acetaminophen|mesh-list
93147161|NCT02252614|Naproxen|naproxen|mesh-list
93147162|NCT02252614|Codeine|codeine|mesh-list
93147163|NCT02252614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147164|NCT02252614|Analgesics|analgesics|mesh-ancestor
93147165|NCT02252614|Sensory System Agents|sensory system agents|mesh-ancestor
93147166|NCT02252614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147167|NCT02252614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147168|NCT02252614|Antipyretics|antipyretics|mesh-ancestor
93147169|NCT02252614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93147170|NCT02252614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147171|NCT02252614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147172|NCT02252614|Gout Suppressants|gout suppressants|mesh-ancestor
93147173|NCT02252614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93147174|NCT02252614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147175|NCT02252614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147176|NCT02252614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147177|NCT02252614|Narcotics|narcotics|mesh-ancestor
93147178|NCT02252614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147179|NCT02252614|Antitussive Agents|antitussive agents|mesh-ancestor
93147180|NCT02252614|Respiratory System Agents|respiratory system agents|mesh-ancestor
93147181|NCT02260570|Tolcapone|tolcapone|mesh-list
93147182|NCT02260570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93147183|NCT02260570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93147184|NCT02260570|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93147185|NCT02260570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147186|NCT02260570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147187|NCT03681951|Pembrolizumab|pembrolizumab|mesh-list
93147188|NCT03681951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147189|NCT03681951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147190|NCT03681951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93147191|NCT03681951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147192|NCT02131948|Insulin|insulin|mesh-list
93147193|NCT02131948|Insulin Lispro|insulin lispro|mesh-list
93147194|NCT02131948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93147195|NCT02131948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147196|NCT02132026|Denosumab|denosumab|mesh-list
93147197|NCT02132026|Alendronate|alendronate|mesh-list
93147198|NCT02132026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93147199|NCT02132026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147200|NCT03735771|Bupivacaine|bupivacaine|mesh-list
93147201|NCT03735771|Anesthetics, Local|anesthetics, local|mesh-ancestor
93147202|NCT03735771|Anesthetics|anesthetics|mesh-ancestor
93147203|NCT03735771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147204|NCT03735771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147205|NCT03735771|Sensory System Agents|sensory system agents|mesh-ancestor
93147206|NCT03735771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147207|NCT02132104|Hormones|hormones|mesh-list
93147208|NCT02132104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147209|NCT02132104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147210|NCT00174785|Dronedarone|dronedarone|mesh-list
93147211|NCT00174785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147212|NCT03681093|Indoleacetic Acids|indoleacetic acids|mesh-list
93147213|NCT03681093|Plant Growth Regulators|plant growth regulators|mesh-ancestor
93147214|NCT03681093|Growth Substances|growth substances|mesh-ancestor
93147215|NCT03681093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147216|NCT00166439|Cytarabine|cytarabine|mesh-list
93147217|NCT00166439|Dexamethasone|dexamethasone|mesh-list
93147218|NCT00166439|Oxaliplatin|oxaliplatin|mesh-list
93147219|NCT00166439|Rituximab|rituximab|mesh-list
93147220|NCT00166439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147221|NCT00166439|Antiemetics|antiemetics|mesh-ancestor
93147222|NCT00166439|Autonomic Agents|autonomic agents|mesh-ancestor
93147223|NCT00166439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147224|NCT00166439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147225|NCT00166439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93147226|NCT00166439|Glucocorticoids|glucocorticoids|mesh-ancestor
93147227|NCT00166439|Hormones|hormones|mesh-ancestor
93147228|NCT00166439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147229|NCT00166439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93147230|NCT00166439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147231|NCT00166439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147232|NCT00166439|Immunologic Factors|immunologic factors|mesh-ancestor
93147233|NCT00166439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147234|NCT00166439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93147235|NCT00166439|Antimetabolites|antimetabolites|mesh-ancestor
93147236|NCT00166439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147237|NCT00166439|Antiviral Agents|antiviral agents|mesh-ancestor
93147238|NCT00166439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147239|NCT00166439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366260|NCT05636501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366261|NCT05636501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366262|NCT05636501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93366263|NCT05636501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366264|NCT02058173|Chloroquine|chloroquine|mesh-list
93366265|NCT02058173|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93366266|NCT02058173|Amebicides|amebicides|mesh-ancestor
93366267|NCT02058173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93366268|NCT02058173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93366269|NCT02058173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366270|NCT02058173|Antimalarials|antimalarials|mesh-ancestor
93366271|NCT02058173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366272|NCT02058173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93366273|NCT02058173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366274|NCT02058173|Analgesics|analgesics|mesh-ancestor
93366275|NCT02058173|Sensory System Agents|sensory system agents|mesh-ancestor
93366276|NCT02058173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366277|NCT02058173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366278|NCT02058173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366279|NCT02058173|Filaricides|filaricides|mesh-ancestor
93366280|NCT02058173|Antinematodal Agents|antinematodal agents|mesh-ancestor
93366281|NCT02058173|Anthelmintics|anthelmintics|mesh-ancestor
93366282|NCT02060201|Dapagliflozin|dapagliflozin|mesh-list
93366283|NCT02060201|Saxagliptin|saxagliptin|mesh-list
93366284|NCT02060201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93366285|NCT02060201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366286|NCT02060201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93366287|NCT02060201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366288|NCT02060201|Incretins|incretins|mesh-ancestor
93366289|NCT02060201|Hormones|hormones|mesh-ancestor
93366290|NCT02060201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366291|NCT02060201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93366292|NCT02060201|Protease Inhibitors|protease inhibitors|mesh-ancestor
93366293|NCT02060201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366294|NCT03561233|Omeprazole|omeprazole|mesh-list
93366295|NCT03561233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93366296|NCT03561233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93366297|NCT03561233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93366298|NCT03561233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366299|NCT03561233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366300|NCT02058407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93366301|NCT02058485|Midazolam|midazolam|mesh-list
93366302|NCT02058485|Dexmedetomidine|dexmedetomidine|mesh-list
93366303|NCT02058485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93366304|NCT02058485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366305|NCT02058485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366306|NCT02058485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366307|NCT02058485|Analgesics|analgesics|mesh-ancestor
93366308|NCT02058485|Sensory System Agents|sensory system agents|mesh-ancestor
93366309|NCT02058485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366310|NCT02058485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93366311|NCT02058485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93147240|NCT01074905|Artesunate|artesunate|mesh-list
93147241|NCT01074905|Chloroquine|chloroquine|mesh-list
93147242|NCT01074905|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93147243|NCT01074905|Primaquine|primaquine|mesh-list
93147244|NCT01074905|Antimalarials|antimalarials|mesh-ancestor
93147245|NCT01074905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93147246|NCT01074905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93147247|NCT01074905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147248|NCT01074905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147249|NCT01074905|Antiviral Agents|antiviral agents|mesh-ancestor
93147250|NCT01074905|Schistosomicides|schistosomicides|mesh-ancestor
93147251|NCT01074905|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93147252|NCT01074905|Anthelmintics|anthelmintics|mesh-ancestor
93147253|NCT01074905|Amebicides|amebicides|mesh-ancestor
93147254|NCT01074905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147255|NCT01074905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93147256|NCT01074905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147257|NCT01074905|Analgesics|analgesics|mesh-ancestor
93147258|NCT01074905|Sensory System Agents|sensory system agents|mesh-ancestor
93147259|NCT01074905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147260|NCT01074905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147261|NCT01074905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147262|NCT01074905|Filaricides|filaricides|mesh-ancestor
93147263|NCT01074905|Antinematodal Agents|antinematodal agents|mesh-ancestor
93147264|NCT03968237|Buprenorphine|buprenorphine|mesh-list
93147265|NCT03968237|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93147266|NCT03968237|Naloxone|naloxone|mesh-list
93147267|NCT03968237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147268|NCT03968237|Narcotics|narcotics|mesh-ancestor
93147269|NCT03968237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147270|NCT03968237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147271|NCT03968237|Analgesics|analgesics|mesh-ancestor
93147272|NCT03968237|Sensory System Agents|sensory system agents|mesh-ancestor
93147273|NCT03968237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147274|NCT03968237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93147275|NCT00138671|Insulin|insulin|mesh-list
93147276|NCT00138671|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93147277|NCT00138671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93147278|NCT00138671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147279|NCT01367158|Vaccines|vaccines|mesh-list
93147280|NCT01367158|Immunologic Factors|immunologic factors|mesh-ancestor
93147281|NCT01367158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147282|NCT00130637|Daclizumab|daclizumab|mesh-list
93147283|NCT00130637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147284|NCT00130637|Immunologic Factors|immunologic factors|mesh-ancestor
93147285|NCT00130637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147286|NCT01077479|Metformin|metformin|mesh-list
93147287|NCT01077479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93147288|NCT01077479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147289|NCT02136784|Morphine|morphine|mesh-list
93147290|NCT02136784|Oxycodone|oxycodone|mesh-list
93147291|NCT02136784|Buprenorphine|buprenorphine|mesh-list
93147292|NCT02136784|Hydromorphone|hydromorphone|mesh-list
93147293|NCT02136784|Hydrocodone|hydrocodone|mesh-list
93147294|NCT02136784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147295|NCT02136784|Narcotics|narcotics|mesh-ancestor
93147296|NCT02136784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147297|NCT02136784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147298|NCT02136784|Analgesics|analgesics|mesh-ancestor
93147299|NCT02136784|Sensory System Agents|sensory system agents|mesh-ancestor
93147300|NCT02136784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147301|NCT02136784|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93147302|NCT02136784|Antitussive Agents|antitussive agents|mesh-ancestor
93147303|NCT02136784|Respiratory System Agents|respiratory system agents|mesh-ancestor
93147304|NCT02129764|Prednisone|prednisone|mesh-list
93147305|NCT02129764|Allopurinol|allopurinol|mesh-list
93147306|NCT02129764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147307|NCT02129764|Glucocorticoids|glucocorticoids|mesh-ancestor
93147308|NCT02129764|Hormones|hormones|mesh-ancestor
93147309|NCT02129764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147310|NCT02129764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147311|NCT02129764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93147312|NCT02129764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147313|NCT02129764|Antimetabolites|antimetabolites|mesh-ancestor
93147314|NCT02129764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147315|NCT02129764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147316|NCT02129764|Gout Suppressants|gout suppressants|mesh-ancestor
93147317|NCT02129764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147318|NCT02129764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93147319|NCT02129764|Antioxidants|antioxidants|mesh-ancestor
93147320|NCT02129764|Protective Agents|protective agents|mesh-ancestor
93147321|NCT00130247|Rifampin|rifampin|mesh-list
93147322|NCT00130247|Isoniazid|isoniazid|mesh-list
93147323|NCT00130247|Pyrazinamide|pyrazinamide|mesh-list
93147324|NCT00130247|Ethambutol|ethambutol|mesh-list
93147325|NCT00130247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93147326|NCT00130247|Antitubercular Agents|antitubercular agents|mesh-ancestor
93147327|NCT00130247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93147328|NCT00130247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147329|NCT00130247|Leprostatic Agents|leprostatic agents|mesh-ancestor
93147330|NCT00130247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93147331|NCT00130247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147332|NCT00130247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147333|NCT00130247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93147334|NCT00130247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93147335|NCT00130247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93147336|NCT00130247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93147337|NCT00130247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93147338|NCT00130247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93147339|NCT00130247|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93147340|NCT00130247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93147341|NCT00130247|Antimetabolites|antimetabolites|mesh-ancestor
93147342|NCT00130247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93147343|NCT02252926|Acetaminophen|acetaminophen|mesh-list
93147344|NCT02252926|Lidocaine|lidocaine|mesh-list
93147345|NCT02252926|Morphine|morphine|mesh-list
93147346|NCT02252926|Gabapentin|gabapentin|mesh-list
93147347|NCT02252926|Bupivacaine|bupivacaine|mesh-list
93147348|NCT02252926|Anesthetics, Local|anesthetics, local|mesh-ancestor
93147349|NCT02252926|Anesthetics|anesthetics|mesh-ancestor
93147350|NCT02252926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147351|NCT02252926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147352|NCT02252926|Sensory System Agents|sensory system agents|mesh-ancestor
93147353|NCT02252926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147354|NCT02252926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147355|NCT02252926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93147356|NCT02252926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93147357|NCT02252926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147358|NCT02252926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147359|NCT02252926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147360|NCT02252926|Narcotics|narcotics|mesh-ancestor
93147361|NCT02252926|Analgesics|analgesics|mesh-ancestor
93147362|NCT02252926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147363|NCT02252926|Antipyretics|antipyretics|mesh-ancestor
93147364|NCT02252926|Anticonvulsants|anticonvulsants|mesh-ancestor
93147365|NCT02252926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93147366|NCT02252926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93147367|NCT02252926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93147368|NCT02252926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93147369|NCT02252926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93147370|NCT02252926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147371|NCT02252926|Antimanic Agents|antimanic agents|mesh-ancestor
93147372|NCT02253004|Cilostazol|cilostazol|mesh-list
93147373|NCT02253004|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93147374|NCT02253004|Autonomic Agents|autonomic agents|mesh-ancestor
93147375|NCT02253004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147376|NCT02253004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147377|NCT02253004|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93147378|NCT02253004|Respiratory System Agents|respiratory system agents|mesh-ancestor
93147379|NCT02253004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93147380|NCT02253004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93147381|NCT02253004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147382|NCT02253004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93147383|NCT02253004|Vasodilator Agents|vasodilator agents|mesh-ancestor
93147384|NCT02253004|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93147385|NCT02253004|Protective Agents|protective agents|mesh-ancestor
93147386|NCT02253004|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93147387|NCT02253004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93147388|NCT02253004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147389|NCT02252458|Fentanyl|fentanyl|mesh-list
93147390|NCT02252458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147391|NCT02252458|Narcotics|narcotics|mesh-ancestor
93147392|NCT02252458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147393|NCT02252458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147394|NCT02252458|Analgesics|analgesics|mesh-ancestor
93147395|NCT02252458|Sensory System Agents|sensory system agents|mesh-ancestor
93147396|NCT02252458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147397|NCT02252458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93147398|NCT02252458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93147399|NCT02252458|Anesthetics, General|anesthetics, general|mesh-ancestor
93147400|NCT02252458|Anesthetics|anesthetics|mesh-ancestor
93147401|NCT04032171|Interferon beta-1a|interferon beta-1a|mesh-list
93147402|NCT04032171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93147403|NCT04032171|Immunologic Factors|immunologic factors|mesh-ancestor
93147404|NCT04032171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147405|NCT04032171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147406|NCT04032171|Antiviral Agents|antiviral agents|mesh-ancestor
93147407|NCT04032171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147408|NCT02130154|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93147409|NCT02130154|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93147410|NCT02130154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147411|NCT02132260|Naftifine|naftifine|mesh-list
93147412|NCT02132260|Antifungal Agents|antifungal agents|mesh-ancestor
93147413|NCT02132260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147414|NCT02137564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93147415|NCT02137564|Nirogacestat|nirogacestat|mesh-list
93147416|NCT02137564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147417|NCT02137564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147418|NCT02132416|Acetaminophen|acetaminophen|mesh-list
93147419|NCT02132416|Ibuprofen|ibuprofen|mesh-list
93147420|NCT02132416|Diclofenac|diclofenac|mesh-list
93147421|NCT02132416|Morphine|morphine|mesh-list
93147422|NCT02132416|Oxycodone|oxycodone|mesh-list
93147423|NCT02132416|Tramadol|tramadol|mesh-list
93147424|NCT02132416|Anesthetics|anesthetics|mesh-list
93147425|NCT02132416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147426|NCT02132416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147427|NCT02132416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147428|NCT02132416|Narcotics|narcotics|mesh-ancestor
93147429|NCT02132416|Analgesics|analgesics|mesh-ancestor
93147430|NCT02132416|Sensory System Agents|sensory system agents|mesh-ancestor
93147431|NCT02132416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147432|NCT02132416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93147433|NCT02132416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147434|NCT02132416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147435|NCT02132416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147436|NCT02132416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93147437|NCT02132416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147438|NCT02132416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147439|NCT02132416|Antipyretics|antipyretics|mesh-ancestor
93147440|NCT00137423|Sunitinib|sunitinib|mesh-list
93147441|NCT00137423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147442|NCT00137423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93147443|NCT00137423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93147444|NCT00137423|Growth Substances|growth substances|mesh-ancestor
93147445|NCT00137423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147446|NCT00137423|Growth Inhibitors|growth inhibitors|mesh-ancestor
93147447|NCT00137423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93147448|NCT00137423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147449|NCT00137423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147450|NCT01077557|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93147451|NCT01077557|Antiviral Agents|antiviral agents|mesh-ancestor
93147452|NCT01077557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147453|NCT02130700|Seviteronel|seviteronel|mesh-list
93147454|NCT02130700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147455|NCT02130700|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93147456|NCT02130700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147457|NCT02130700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147458|NCT02137954|Lidocaine|lidocaine|mesh-list
93147459|NCT02137954|Anesthetics, Local|anesthetics, local|mesh-ancestor
93147460|NCT02137954|Anesthetics|anesthetics|mesh-ancestor
93147461|NCT02137954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147462|NCT02137954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147463|NCT02137954|Sensory System Agents|sensory system agents|mesh-ancestor
93147464|NCT02137954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147465|NCT02137954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147466|NCT02137954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93147467|NCT02137954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93147468|NCT02137954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147469|NCT02137954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147470|NCT02131012|Celecoxib|celecoxib|mesh-list
93366312|NCT02058485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93147471|NCT02131012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93147472|NCT02131012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147473|NCT02131012|Analgesics|analgesics|mesh-ancestor
93147474|NCT02131012|Sensory System Agents|sensory system agents|mesh-ancestor
93147475|NCT02131012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147476|NCT02131012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147477|NCT02131012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147478|NCT02131012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147479|NCT02131012|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93147480|NCT02131012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93147481|NCT02131012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147482|NCT02131012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147483|NCT02138500|PF-06372865|pf-06372865|mesh-list
93147484|NCT02138500|GABA Modulators|gaba modulators|mesh-ancestor
93147485|NCT02138500|GABA Agents|gaba agents|mesh-ancestor
93147486|NCT02138500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147487|NCT02138500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854807|NCT00602693|Gout Suppressants|gout suppressants|mesh-ancestor
93147488|NCT02138500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147489|NCT01561768|Vaccines|vaccines|mesh-list
93147490|NCT01561768|Immunologic Factors|immunologic factors|mesh-ancestor
93147491|NCT01561768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147492|NCT00137111|Cytarabine|cytarabine|mesh-list
93147493|NCT00137111|Dexamethasone|dexamethasone|mesh-list
93147494|NCT00137111|Prednisone|prednisone|mesh-list
93147495|NCT00137111|Cyclophosphamide|cyclophosphamide|mesh-list
93147496|NCT00137111|Doxorubicin|doxorubicin|mesh-list
93147497|NCT00137111|Methotrexate|methotrexate|mesh-list
93147498|NCT00137111|Etoposide|etoposide|mesh-list
93147499|NCT00137111|Vincristine|vincristine|mesh-list
93147500|NCT00137111|Daunorubicin|daunorubicin|mesh-list
93147501|NCT00137111|Asparaginase|asparaginase|mesh-list
93147502|NCT00137111|Mercaptopurine|mercaptopurine|mesh-list
93147503|NCT00137111|Pegaspargase|pegaspargase|mesh-list
93147504|NCT00137111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147505|NCT00137111|Immunologic Factors|immunologic factors|mesh-ancestor
93147506|NCT00137111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147507|NCT00137111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147508|NCT00137111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93147509|NCT00137111|Alkylating Agents|alkylating agents|mesh-ancestor
93147510|NCT00137111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147511|NCT00137111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147512|NCT00137111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93147513|NCT00137111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147514|NCT00137111|Antiemetics|antiemetics|mesh-ancestor
93147515|NCT00137111|Autonomic Agents|autonomic agents|mesh-ancestor
93147516|NCT00137111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147517|NCT00137111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93147518|NCT00137111|Glucocorticoids|glucocorticoids|mesh-ancestor
93147519|NCT00137111|Hormones|hormones|mesh-ancestor
93147520|NCT00137111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147521|NCT00137111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93147522|NCT00137111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93147523|NCT00137111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93147524|NCT00137111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93147525|NCT00137111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147526|NCT00137111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93147527|NCT00137111|Abortifacient Agents|abortifacient agents|mesh-ancestor
93147528|NCT00137111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93147529|NCT00137111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93147530|NCT00137111|Antimetabolites|antimetabolites|mesh-ancestor
93147531|NCT00137111|Dermatologic Agents|dermatologic agents|mesh-ancestor
93147532|NCT00137111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93147533|NCT00137111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93147534|NCT00137111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93147535|NCT00137111|Antiviral Agents|antiviral agents|mesh-ancestor
93147536|NCT00137111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147537|NCT00137111|Tubulin Modulators|tubulin modulators|mesh-ancestor
93147538|NCT00137111|Antimitotic Agents|antimitotic agents|mesh-ancestor
93147539|NCT00137111|Mitosis Modulators|mitosis modulators|mesh-ancestor
93147540|NCT02133118|Pioglitazone|pioglitazone|mesh-list
93147541|NCT02133118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93147542|NCT02133118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147543|NCT02138812|Paclitaxel|paclitaxel|mesh-list
93147544|NCT02138812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93147545|NCT02138812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147546|NCT02138812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819715|NCT00720109|Methylprednisolone|methylprednisolone|mesh-list
93147547|NCT02138812|Antimitotic Agents|antimitotic agents|mesh-ancestor
93147548|NCT02138812|Mitosis Modulators|mitosis modulators|mesh-ancestor
93147549|NCT02138812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147550|NCT00136955|Irinotecan|irinotecan|mesh-list
93147551|NCT00136955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93147552|NCT00136955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93147553|NCT00136955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147554|NCT00136955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147555|NCT00136955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147556|NCT00135707|Vitamins|vitamins|mesh-list
93147557|NCT00135707|Ascorbic Acid|ascorbic acid|mesh-list
93147558|NCT00135707|Vitamin E|vitamin e|mesh-list
93147559|NCT00135707|alpha-Tocopherol|alpha-tocopherol|mesh-list
93147560|NCT00135707|Micronutrients|micronutrients|mesh-ancestor
93147561|NCT00135707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147562|NCT00135707|Antioxidants|antioxidants|mesh-ancestor
93147563|NCT00135707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147564|NCT00135707|Protective Agents|protective agents|mesh-ancestor
93147565|NCT03548818|Interferons|interferons|mesh-list
93147566|NCT03548818|Interferon-gamma|interferon-gamma|mesh-list
93147567|NCT03548818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147568|NCT03548818|Antiviral Agents|antiviral agents|mesh-ancestor
93147569|NCT03548818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147570|NCT02252692|Enalapril|enalapril|mesh-list
93147571|NCT02252692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93147572|NCT02252692|Protease Inhibitors|protease inhibitors|mesh-ancestor
93147573|NCT02252692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147574|NCT02252692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147575|NCT02252692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93147576|NCT03548662|Hyaluronic Acid|hyaluronic acid|mesh-list
93147577|NCT03548662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93147578|NCT03548662|Immunologic Factors|immunologic factors|mesh-ancestor
93147579|NCT03548662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147580|NCT03548662|Viscosupplements|viscosupplements|mesh-ancestor
93147581|NCT03548662|Protective Agents|protective agents|mesh-ancestor
93147582|NCT03966209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93147583|NCT03966209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147584|NCT03966209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147585|NCT03966209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147586|NCT02252770|Nitric Oxide|nitric oxide|mesh-list
93147587|NCT02252770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93147588|NCT02252770|Autonomic Agents|autonomic agents|mesh-ancestor
93147589|NCT02252770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147590|NCT02252770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147591|NCT02252770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93147592|NCT02252770|Respiratory System Agents|respiratory system agents|mesh-ancestor
93147593|NCT02252770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93147594|NCT02252770|Antioxidants|antioxidants|mesh-ancestor
93147595|NCT02252770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147596|NCT02252770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147597|NCT02252770|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93147598|NCT02252770|Vasodilator Agents|vasodilator agents|mesh-ancestor
93147599|NCT02252770|Gasotransmitters|gasotransmitters|mesh-ancestor
93147600|NCT02252770|Protective Agents|protective agents|mesh-ancestor
93147601|NCT05578456|Aspirin|aspirin|mesh-list
93147602|NCT05578456|Prednisone|prednisone|mesh-list
93147603|NCT05578456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147604|NCT05578456|Glucocorticoids|glucocorticoids|mesh-ancestor
93147605|NCT05578456|Hormones|hormones|mesh-ancestor
93147606|NCT05578456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147607|NCT05578456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147608|NCT05578456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93147609|NCT05578456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147610|NCT05578456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93147611|NCT05578456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147612|NCT05578456|Analgesics|analgesics|mesh-ancestor
93147613|NCT05578456|Sensory System Agents|sensory system agents|mesh-ancestor
93147614|NCT05578456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147615|NCT05578456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147616|NCT05578456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93147617|NCT05578456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93147618|NCT05578456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147619|NCT05578456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93147620|NCT05578456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93147621|NCT05578456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147622|NCT05578456|Antipyretics|antipyretics|mesh-ancestor
93147623|NCT02133820|Analgesics|analgesics|mesh-list
93147624|NCT02133820|Sensory System Agents|sensory system agents|mesh-ancestor
93147625|NCT02133820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147626|NCT02133820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147627|NCT05578378|Cytarabine|cytarabine|mesh-list
93147628|NCT05578378|Methotrexate|methotrexate|mesh-list
93147629|NCT05578378|Fludarabine|fludarabine|mesh-list
93147630|NCT05578378|Cladribine|cladribine|mesh-list
93147631|NCT05578378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93147632|NCT05578378|Abortifacient Agents|abortifacient agents|mesh-ancestor
93147633|NCT05578378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93147634|NCT05578378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147635|NCT05578378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93147636|NCT05578378|Antimetabolites|antimetabolites|mesh-ancestor
93147637|NCT05578378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147638|NCT05578378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147639|NCT05578378|Dermatologic Agents|dermatologic agents|mesh-ancestor
93147640|NCT05578378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147641|NCT05578378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93147642|NCT05578378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147643|NCT05578378|Immunologic Factors|immunologic factors|mesh-ancestor
93147644|NCT05578378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147645|NCT05578378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93147646|NCT05578378|Antiviral Agents|antiviral agents|mesh-ancestor
93147647|NCT05578378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147648|NCT00129623|Ibandronic Acid|ibandronic acid|mesh-list
93147649|NCT00129623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93147650|NCT00129623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147651|NCT02139904|Vinorelbine|vinorelbine|mesh-list
93147652|NCT02139904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93147653|NCT02139904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147654|NCT02139904|Tubulin Modulators|tubulin modulators|mesh-ancestor
93147655|NCT02139904|Antimitotic Agents|antimitotic agents|mesh-ancestor
93147656|NCT02139904|Mitosis Modulators|mitosis modulators|mesh-ancestor
93147657|NCT02139904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147658|NCT05578222|Pembrolizumab|pembrolizumab|mesh-list
93147659|NCT05578222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147660|NCT05578222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147661|NCT05578222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93147662|NCT05578222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147663|NCT05201638|Calcium, Dietary|calcium, dietary|mesh-list
93147664|NCT05201638|Calcium|calcium|mesh-list
93147665|NCT05201638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93147666|NCT05201638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854844|NCT00905905|Ezetimibe|ezetimibe|mesh-list
93147667|NCT05201638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93147668|NCT00129545|Warfarin|warfarin|mesh-list
93147669|NCT00129545|Anticoagulants|anticoagulants|mesh-ancestor
93147670|NCT02134288|Everolimus|everolimus|mesh-list
93147671|NCT02134288|Abatacept|abatacept|mesh-list
93147672|NCT02134288|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93147673|NCT02134288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93147674|NCT02134288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147675|NCT02134288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147676|NCT02134288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147677|NCT02134288|Immunologic Factors|immunologic factors|mesh-ancestor
93147678|NCT02134288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147679|NCT02134288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147680|NCT02134288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93147681|NCT02134288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147682|NCT02134288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147683|NCT00129467|Methylphenidate|methylphenidate|mesh-list
93147684|NCT00129467|Serotonin|serotonin|mesh-list
93147685|NCT00129467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93147686|NCT00129467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93147687|NCT00129467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147688|NCT00129467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93147689|NCT00129467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93147690|NCT00129467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147691|NCT00129467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147692|NCT00129467|Dopamine Agents|dopamine agents|mesh-ancestor
93147693|NCT00129467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147694|NCT00129467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93147695|NCT00129467|Serotonin Agents|serotonin agents|mesh-ancestor
93147696|NCT00129311|Selegiline|selegiline|mesh-list
93147697|NCT00129311|Antidepressive Agents|antidepressive agents|mesh-ancestor
93147698|NCT00129311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93147699|NCT00129311|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93147700|NCT00129311|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93147701|NCT00129311|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93147702|NCT00129311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147703|NCT00129311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147704|NCT00129311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93147705|NCT00129311|Protective Agents|protective agents|mesh-ancestor
93147706|NCT00129311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147707|NCT01076621|Norethindrone|norethindrone|mesh-list
93147708|NCT01076621|Norethindrone Acetate|norethindrone acetate|mesh-list
93147709|NCT01076621|Estradiol|estradiol|mesh-list
93147710|NCT01076621|Estrogens|estrogens|mesh-ancestor
93147711|NCT01076621|Hormones|hormones|mesh-ancestor
93147712|NCT01076621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147713|NCT01076621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147714|NCT01076621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93147715|NCT01076621|Contraceptive Agents|contraceptive agents|mesh-ancestor
93147716|NCT01076621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93147717|NCT01076621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93147718|NCT01076621|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93147719|NCT01076621|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93147720|NCT01076621|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93147721|NCT03965819|Acetaminophen|acetaminophen|mesh-list
93147722|NCT03965819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147723|NCT03965819|Analgesics|analgesics|mesh-ancestor
93147724|NCT03965819|Sensory System Agents|sensory system agents|mesh-ancestor
93147725|NCT03965819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147726|NCT03965819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147727|NCT03965819|Antipyretics|antipyretics|mesh-ancestor
93147728|NCT02134366|Lorazepam|lorazepam|mesh-list
93147729|NCT02134366|Clonazepam|clonazepam|mesh-list
93147730|NCT02134366|Clobazam|clobazam|mesh-list
93147731|NCT02134366|Anticonvulsants|anticonvulsants|mesh-ancestor
93147732|NCT02134366|Antiemetics|antiemetics|mesh-ancestor
93147733|NCT02134366|Autonomic Agents|autonomic agents|mesh-ancestor
93147734|NCT02134366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147735|NCT02134366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147736|NCT02134366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93147737|NCT02134366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93147738|NCT02134366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147739|NCT02134366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93147740|NCT02134366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93147741|NCT02134366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93147742|NCT02134366|GABA Modulators|gaba modulators|mesh-ancestor
93147743|NCT02134366|GABA Agents|gaba agents|mesh-ancestor
93147744|NCT02134366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147745|NCT02134366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147746|NCT02134366|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93147747|NCT02134366|GABA Agonists|gaba agonists|mesh-ancestor
93147748|NCT01077947|Anesthetics|anesthetics|mesh-list
93147749|NCT01077947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147750|NCT01077947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147751|NCT00133991|Leucovorin|leucovorin|mesh-list
93147752|NCT00133991|Cytarabine|cytarabine|mesh-list
93147753|NCT00133991|Prednisone|prednisone|mesh-list
93147754|NCT00133991|Hydrocortisone|hydrocortisone|mesh-list
93147755|NCT00133991|Cyclophosphamide|cyclophosphamide|mesh-list
93147756|NCT00133991|Rituximab|rituximab|mesh-list
93147757|NCT00133991|Methotrexate|methotrexate|mesh-list
93147758|NCT00133991|Vincristine|vincristine|mesh-list
93147759|NCT00133991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147760|NCT00133991|Immunologic Factors|immunologic factors|mesh-ancestor
93147761|NCT00133991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147762|NCT00133991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147763|NCT00133991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93147764|NCT00133991|Alkylating Agents|alkylating agents|mesh-ancestor
93147765|NCT00133991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147766|NCT00133991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147767|NCT00133991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93147768|NCT00133991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147769|NCT00133991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147770|NCT00133991|Glucocorticoids|glucocorticoids|mesh-ancestor
93147771|NCT00133991|Hormones|hormones|mesh-ancestor
93147772|NCT00133991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147773|NCT00133991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93147774|NCT00133991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93147775|NCT00133991|Abortifacient Agents|abortifacient agents|mesh-ancestor
93147776|NCT00133991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93147777|NCT00133991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93147778|NCT00133991|Antimetabolites|antimetabolites|mesh-ancestor
93147779|NCT00133991|Dermatologic Agents|dermatologic agents|mesh-ancestor
93147780|NCT00133991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147781|NCT00133991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93147782|NCT00133991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93147783|NCT00133991|Antiviral Agents|antiviral agents|mesh-ancestor
93147784|NCT00133991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147785|NCT00133991|Antidotes|antidotes|mesh-ancestor
93147786|NCT00133991|Protective Agents|protective agents|mesh-ancestor
93147787|NCT00133991|Vitamin B Complex|vitamin b complex|mesh-ancestor
93147788|NCT00133991|Vitamins|vitamins|mesh-ancestor
93147789|NCT00133991|Micronutrients|micronutrients|mesh-ancestor
93147790|NCT00133991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93147791|NCT00133991|Tubulin Modulators|tubulin modulators|mesh-ancestor
93147792|NCT00133991|Antimitotic Agents|antimitotic agents|mesh-ancestor
93147793|NCT00133991|Mitosis Modulators|mitosis modulators|mesh-ancestor
93147794|NCT03549208|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93147795|NCT03549208|Immunologic Factors|immunologic factors|mesh-ancestor
93147796|NCT03549208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147797|NCT02140450|Timolol|timolol|mesh-list
93147798|NCT02140450|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93147799|NCT02140450|Mannitol|mannitol|mesh-list
93147800|NCT02140450|Acetazolamide|acetazolamide|mesh-list
93147801|NCT02140450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93147802|NCT02140450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93147803|NCT02140450|Adrenergic Agents|adrenergic agents|mesh-ancestor
93147804|NCT02140450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147805|NCT02140450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147806|NCT02140450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147807|NCT02140450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147808|NCT02140450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93147809|NCT02140450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93147810|NCT02140450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93147811|NCT02140450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93147812|NCT02140450|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93147813|NCT02140450|Diuretics|diuretics|mesh-ancestor
93147814|NCT02140450|Natriuretic Agents|natriuretic agents|mesh-ancestor
93147815|NCT02140450|Anticonvulsants|anticonvulsants|mesh-ancestor
92443578|NCT01651988|Propofol|propofol|mesh-list
93147816|NCT02140450|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93147817|NCT02140450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147818|NCT05577676|Triamcinolone|triamcinolone|mesh-list
93147819|NCT05577676|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93147820|NCT05577676|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93147821|NCT05577676|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93147822|NCT05577676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147823|NCT05577676|Glucocorticoids|glucocorticoids|mesh-ancestor
93147824|NCT05577676|Hormones|hormones|mesh-ancestor
93147825|NCT05577676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93147826|NCT05577676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147827|NCT05577676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147828|NCT05577676|Immunologic Factors|immunologic factors|mesh-ancestor
93147829|NCT05577676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147830|NCT05577676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147831|NCT03549832|Ritonavir|ritonavir|mesh-list
93147832|NCT03549832|Ribavirin|ribavirin|mesh-list
93147833|NCT03549832|Sofosbuvir|sofosbuvir|mesh-list
93147834|NCT03549832|Simeprevir|simeprevir|mesh-list
93147835|NCT03549832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93147836|NCT03549832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93147837|NCT03549832|Protease Inhibitors|protease inhibitors|mesh-ancestor
93147838|NCT03549832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147839|NCT03549832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147840|NCT03549832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93147841|NCT03549832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93147842|NCT03549832|Antiviral Agents|antiviral agents|mesh-ancestor
93147843|NCT03549832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147844|NCT03549832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93147845|NCT03549832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93147846|NCT03549832|Antimetabolites|antimetabolites|mesh-ancestor
93147847|NCT02134990|Docetaxel|docetaxel|mesh-list
93147848|NCT02134990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147849|NCT02134990|Tubulin Modulators|tubulin modulators|mesh-ancestor
93147850|NCT02134990|Antimitotic Agents|antimitotic agents|mesh-ancestor
93147851|NCT02134990|Mitosis Modulators|mitosis modulators|mesh-ancestor
93147852|NCT02134990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147853|NCT02135224|Fentanyl|fentanyl|mesh-list
93147854|NCT02135224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93147855|NCT02135224|Narcotics|narcotics|mesh-ancestor
93147856|NCT02135224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147857|NCT02135224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147858|NCT02135224|Analgesics|analgesics|mesh-ancestor
93147859|NCT02135224|Sensory System Agents|sensory system agents|mesh-ancestor
93147860|NCT02135224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147861|NCT02135224|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93147862|NCT02135224|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93147863|NCT02135224|Anesthetics, General|anesthetics, general|mesh-ancestor
93147864|NCT02135224|Anesthetics|anesthetics|mesh-ancestor
93147865|NCT02785900|Azacitidine|azacitidine|mesh-list
93147866|NCT02785900|Decitabine|decitabine|mesh-list
93147867|NCT02785900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93147868|NCT02785900|Antimetabolites|antimetabolites|mesh-ancestor
93147869|NCT02785900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147870|NCT02785900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147871|NCT02785900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147872|NCT00127205|Zoledronic Acid|zoledronic acid|mesh-list
93147873|NCT00127205|Ibandronic Acid|ibandronic acid|mesh-list
93147874|NCT00127205|Clodronic Acid|clodronic acid|mesh-list
93147875|NCT00127205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93147876|NCT00127205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147877|NCT02135770|Heparin|heparin|mesh-list
93147878|NCT02135770|Calcium heparin|calcium heparin|mesh-list
93147879|NCT02135770|Anticoagulants|anticoagulants|mesh-ancestor
93147880|NCT02135770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93147881|NCT02135770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93147882|NCT02135770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147883|NCT05478850|Anesthetics|anesthetics|mesh-list
93147884|NCT05478850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147885|NCT05478850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147886|NCT05575180|Acetazolamide|acetazolamide|mesh-list
93147887|NCT05575180|Methazolamide|methazolamide|mesh-list
93147888|NCT05575180|Anticonvulsants|anticonvulsants|mesh-ancestor
93147889|NCT05575180|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93147890|NCT05575180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147891|NCT05575180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147892|NCT05575180|Diuretics|diuretics|mesh-ancestor
93147893|NCT05575180|Natriuretic Agents|natriuretic agents|mesh-ancestor
93147894|NCT05575180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147895|NCT01560754|Nicotine|nicotine|mesh-list
93147896|NCT01560754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93147897|NCT01560754|Autonomic Agents|autonomic agents|mesh-ancestor
93147898|NCT01560754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147899|NCT01560754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147900|NCT01560754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93147901|NCT01560754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93147902|NCT01560754|Cholinergic Agents|cholinergic agents|mesh-ancestor
93147903|NCT01560754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147904|NCT01560754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147905|NCT03547804|Apatinib|apatinib|mesh-list
93147906|NCT03547804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147907|NCT03547804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93147908|NCT03547804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147909|NCT03547804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147910|NCT02217267|Lidocaine|lidocaine|mesh-list
93147911|NCT02217267|Anesthetics, Local|anesthetics, local|mesh-ancestor
93147912|NCT02217267|Anesthetics|anesthetics|mesh-ancestor
93147913|NCT02217267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147914|NCT02217267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147915|NCT02217267|Sensory System Agents|sensory system agents|mesh-ancestor
93147916|NCT02217267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147917|NCT02217267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147918|NCT02217267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93147919|NCT02217267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93147920|NCT02217267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147921|NCT02217267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147922|NCT03670641|Insulin Glargine|insulin glargine|mesh-list
93147923|NCT03670641|Insulin Lispro|insulin lispro|mesh-list
92820107|NCT01010750|Amphetamine|amphetamine|mesh-list
93147924|NCT03670641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93147925|NCT03670641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147926|NCT03546400|Methylphenidate|methylphenidate|mesh-list
93147927|NCT03546400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93147928|NCT03546400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147929|NCT03546400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93147930|NCT03546400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93147931|NCT03546400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147932|NCT03546400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147933|NCT03546400|Dopamine Agents|dopamine agents|mesh-ancestor
93147934|NCT03546400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93147935|NCT03669861|Abatacept|abatacept|mesh-list
93147936|NCT03669861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93147937|NCT03669861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147938|NCT03669861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93147939|NCT03669861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147940|NCT03669861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93147941|NCT03669861|Immunologic Factors|immunologic factors|mesh-ancestor
93147942|NCT03669861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147943|NCT03669861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147944|NCT00127127|Vorinostat|vorinostat|mesh-list
93147945|NCT00127127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147946|NCT00127127|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93147947|NCT00127127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147948|NCT00127127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147949|NCT00126659|Sorafenib|sorafenib|mesh-list
93147950|NCT00126659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93147951|NCT00126659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93147952|NCT00126659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147953|NCT00126659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147954|NCT03669081|Ketorolac|ketorolac|mesh-list
93147955|NCT03669081|Pregabalin|pregabalin|mesh-list
93147956|NCT03669081|Analgesics|analgesics|mesh-ancestor
93147957|NCT03669081|Sensory System Agents|sensory system agents|mesh-ancestor
93147958|NCT03669081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93147959|NCT03669081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93147960|NCT03669081|Anticonvulsants|anticonvulsants|mesh-ancestor
93147961|NCT03669081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93147962|NCT03669081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93147963|NCT03669081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147964|NCT03669081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93147965|NCT03669081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93147966|NCT03669081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93147967|NCT03669081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93147968|NCT03669081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93147969|NCT03669081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93147970|NCT03669081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93147971|NCT03669081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93147972|NCT03669081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93147973|NCT03669081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93147974|NCT03669081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147975|NCT02253940|Ritonavir|ritonavir|mesh-list
93147976|NCT02253940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93147977|NCT02253940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93147978|NCT02253940|Protease Inhibitors|protease inhibitors|mesh-ancestor
93147979|NCT02253940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147980|NCT02253940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147981|NCT02253940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93147982|NCT02253940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93147983|NCT02253940|Antiviral Agents|antiviral agents|mesh-ancestor
93147984|NCT02253940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147985|NCT02253940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93147986|NCT02253940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93147987|NCT02253550|Sofosbuvir|sofosbuvir|mesh-list
93147988|NCT02253550|Simeprevir|simeprevir|mesh-list
93147989|NCT02253550|Antiviral Agents|antiviral agents|mesh-ancestor
93147990|NCT02253550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93147991|NCT02253550|Protease Inhibitors|protease inhibitors|mesh-ancestor
93147992|NCT02253550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93147993|NCT02253550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93147994|NCT05203432|Atropine|atropine|mesh-list
93147995|NCT05203432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93147996|NCT05203432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93147997|NCT05203432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93147998|NCT05203432|Autonomic Agents|autonomic agents|mesh-ancestor
93366313|NCT02058485|Adrenergic Agents|adrenergic agents|mesh-ancestor
93147999|NCT05203432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148000|NCT05203432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148001|NCT05203432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93148002|NCT05203432|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148003|NCT05203432|Mydriatics|mydriatics|mesh-ancestor
93148004|NCT05203432|Parasympatholytics|parasympatholytics|mesh-ancestor
93148005|NCT05203432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93148006|NCT05203432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93148007|NCT05203432|Cholinergic Agents|cholinergic agents|mesh-ancestor
93148008|NCT05203432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148009|NCT05203432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148010|NCT03667053|Glucagon|glucagon|mesh-list
93148011|NCT03667053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148012|NCT03667053|Hormones|hormones|mesh-ancestor
93148013|NCT03667053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148014|NCT03667053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148015|NCT04589728|Venetoclax|venetoclax|mesh-list
93148016|NCT04589728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148017|NCT05557240|Poly I-C|poly i-c|mesh-list
93148018|NCT05557240|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93148019|NCT05557240|Vaccines|vaccines|mesh-list
93148020|NCT05557240|Poly ICLC|poly iclc|mesh-list
93148021|NCT05557240|Immunologic Factors|immunologic factors|mesh-ancestor
93148022|NCT05557240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148023|NCT05557240|Interferon Inducers|interferon inducers|mesh-ancestor
93148024|NCT05557240|Laxatives|laxatives|mesh-ancestor
93148025|NCT05557240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148026|NCT05557240|Antiviral Agents|antiviral agents|mesh-ancestor
93148027|NCT05557240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148028|NCT03631407|Pembrolizumab|pembrolizumab|mesh-list
93148029|NCT03631407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148030|NCT03631407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148031|NCT03631407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93148032|NCT03631407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148033|NCT03547024|Midazolam|midazolam|mesh-list
93148034|NCT03547024|Dextromethorphan|dextromethorphan|mesh-list
93148035|NCT03547024|Omeprazole|omeprazole|mesh-list
93148036|NCT03547024|Levonorgestrel|levonorgestrel|mesh-list
93148037|NCT03547024|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93148038|NCT03547024|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93148039|NCT03547024|JNJ-55308942|jnj-55308942|mesh-list
93148040|NCT03547024|Estradiol|estradiol|mesh-list
93148041|NCT03547024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93148042|NCT03547024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93148043|NCT03547024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148044|NCT03547024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148045|NCT03547024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93148046|NCT03547024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93148047|NCT03547024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93148048|NCT03547024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93148049|NCT03547024|Anesthetics, General|anesthetics, general|mesh-ancestor
93148050|NCT03547024|Anesthetics|anesthetics|mesh-ancestor
93148051|NCT03547024|GABA Modulators|gaba modulators|mesh-ancestor
93148052|NCT03547024|GABA Agents|gaba agents|mesh-ancestor
93148053|NCT03547024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148054|NCT03547024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148055|NCT03547024|Estrogens|estrogens|mesh-ancestor
93148056|NCT03547024|Hormones|hormones|mesh-ancestor
93148057|NCT03547024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148058|NCT03547024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93148059|NCT03547024|Contraceptive Agents|contraceptive agents|mesh-ancestor
93148060|NCT03547024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93148061|NCT03547024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93148062|NCT03547024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93148063|NCT03547024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148064|NCT03547024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93148065|NCT03547024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148066|NCT03547024|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93148067|NCT03547024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93148068|NCT03547024|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93148069|NCT03547024|Antitussive Agents|antitussive agents|mesh-ancestor
93148070|NCT03547024|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148071|NCT03547024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93148072|NCT03547024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93148073|NCT03547024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92820248|NCT02605798|Sofosbuvir|sofosbuvir|mesh-list
93148074|NCT03547024|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
93148075|NCT03547024|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93148076|NCT03547024|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93148077|NCT03547024|Purinergic Agents|purinergic agents|mesh-ancestor
93148078|NCT05115994|Antihypertensive Agents|antihypertensive agents|mesh-list
93148079|NCT04012996|Meloxicam|meloxicam|mesh-list
93148080|NCT04012996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93148081|NCT04012996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93148082|NCT04012996|Analgesics|analgesics|mesh-ancestor
93148083|NCT04012996|Sensory System Agents|sensory system agents|mesh-ancestor
93148084|NCT04012996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148085|NCT04012996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148086|NCT04012996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148087|NCT04012996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148088|NCT04012996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93148089|NCT04012996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93148090|NCT04012996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148091|NCT04012996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148092|NCT02253784|Dexamethasone|dexamethasone|mesh-list
93148093|NCT02253784|Bupivacaine|bupivacaine|mesh-list
93148094|NCT02253784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148095|NCT02253784|Antiemetics|antiemetics|mesh-ancestor
93148096|NCT02253784|Autonomic Agents|autonomic agents|mesh-ancestor
93148097|NCT02253784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148098|NCT02253784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148099|NCT02253784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148100|NCT02253784|Glucocorticoids|glucocorticoids|mesh-ancestor
93148101|NCT02253784|Hormones|hormones|mesh-ancestor
93148102|NCT02253784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148103|NCT02253784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93148104|NCT02253784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148105|NCT02253784|Anesthetics, Local|anesthetics, local|mesh-ancestor
93148106|NCT02253784|Anesthetics|anesthetics|mesh-ancestor
93148107|NCT02253784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148108|NCT02253784|Sensory System Agents|sensory system agents|mesh-ancestor
93148109|NCT03734445|Vitamins|vitamins|mesh-list
93148110|NCT03734445|Micronutrients|micronutrients|mesh-ancestor
93148111|NCT03734445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148112|NCT04538092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93148113|NCT04538092|Analgesics|analgesics|mesh-list
93148114|NCT04538092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148115|NCT04538092|Sensory System Agents|sensory system agents|mesh-ancestor
93148116|NCT04538092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148117|NCT04538092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148118|NCT03546088|Anesthetics|anesthetics|mesh-list
93148119|NCT03546088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148120|NCT03546088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148121|NCT03866980|Carboplatin|carboplatin|mesh-list
93148122|NCT03866980|Pemetrexed|pemetrexed|mesh-list
93148123|NCT03866980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148124|NCT03866980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148125|NCT03866980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148126|NCT03866980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93148127|NCT03866980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93148128|NCT02253862|Ritonavir|ritonavir|mesh-list
93148129|NCT02253862|Tipranavir|tipranavir|mesh-list
93148130|NCT02253862|Tadalafil|tadalafil|mesh-list
93148131|NCT02253862|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93148132|NCT02253862|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93148133|NCT02253862|Protease Inhibitors|protease inhibitors|mesh-ancestor
93148134|NCT02253862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148135|NCT02253862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148136|NCT02253862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93148137|NCT02253862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93148138|NCT02253862|Antiviral Agents|antiviral agents|mesh-ancestor
93148139|NCT02253862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148140|NCT02253862|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93148141|NCT02253862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93148142|NCT02253862|Vasodilator Agents|vasodilator agents|mesh-ancestor
93148143|NCT02253862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93148144|NCT02253862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93148145|NCT02253862|Urological Agents|urological agents|mesh-ancestor
93148146|NCT03627195|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93148147|NCT03627195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93148148|NCT03627195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93148149|NCT03627195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148150|NCT03627195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148151|NCT03627195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93148152|NCT03627195|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93148153|NCT03627195|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93148154|NCT03627195|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93148155|NCT03627195|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148156|NCT03627195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148157|NCT03627195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148158|NCT03627195|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93148159|NCT03627195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93148160|NCT03627195|Serotonin Agents|serotonin agents|mesh-ancestor
93148161|NCT03627195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93148162|NCT03627195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93148163|NCT03627195|Dopamine Agents|dopamine agents|mesh-ancestor
93148164|NCT03776656|Allopurinol|allopurinol|mesh-list
93148165|NCT03776656|Antimetabolites|antimetabolites|mesh-ancestor
93148166|NCT03776656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148167|NCT03776656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148168|NCT03776656|Gout Suppressants|gout suppressants|mesh-ancestor
93148169|NCT03776656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148170|NCT03776656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93148171|NCT03776656|Antioxidants|antioxidants|mesh-ancestor
93148172|NCT03776656|Protective Agents|protective agents|mesh-ancestor
93148173|NCT03776656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148174|NCT03733587|Cyclophosphamide|cyclophosphamide|mesh-list
93148175|NCT03733587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93148176|NCT03733587|Immunologic Factors|immunologic factors|mesh-ancestor
93148177|NCT03733587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148178|NCT03733587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148179|NCT03733587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93148180|NCT03733587|Alkylating Agents|alkylating agents|mesh-ancestor
92854863|NCT04104789|Anesthetics|anesthetics|mesh-ancestor
93148181|NCT03733587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148182|NCT03733587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148183|NCT03733587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93148184|NCT00126581|Paclitaxel|paclitaxel|mesh-list
93148185|NCT00126581|Carboplatin|carboplatin|mesh-list
93148186|NCT00126581|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93148187|NCT00126581|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93148188|NCT00126581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148189|NCT00126581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148190|NCT00126581|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148191|NCT00126581|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148192|NCT00126581|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148193|NCT00126581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148194|NCT00126581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148195|NCT00126581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148196|NCT03704584|Methylprednisolone|methylprednisolone|mesh-list
93148197|NCT03704584|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93148198|NCT03704584|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93148199|NCT03704584|Prednisolone|prednisolone|mesh-list
93148200|NCT03704584|Prednisolone acetate|prednisolone acetate|mesh-list
93148201|NCT03704584|Lidocaine|lidocaine|mesh-list
93148202|NCT03704584|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93148203|NCT03704584|Prednisolone phosphate|prednisolone phosphate|mesh-list
93148204|NCT03704584|Anesthetics, Local|anesthetics, local|mesh-ancestor
93148205|NCT03704584|Anesthetics|anesthetics|mesh-ancestor
93148206|NCT03704584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148207|NCT03704584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148208|NCT03704584|Sensory System Agents|sensory system agents|mesh-ancestor
93148209|NCT03704584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148210|NCT03704584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93148211|NCT03704584|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93148212|NCT03704584|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93148213|NCT03704584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93148214|NCT03704584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148215|NCT03704584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148216|NCT03704584|Antiemetics|antiemetics|mesh-ancestor
93148217|NCT03704584|Autonomic Agents|autonomic agents|mesh-ancestor
93148218|NCT03704584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148219|NCT03704584|Glucocorticoids|glucocorticoids|mesh-ancestor
93148220|NCT03704584|Hormones|hormones|mesh-ancestor
93148221|NCT03704584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148222|NCT03704584|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93148223|NCT03704584|Protective Agents|protective agents|mesh-ancestor
93148224|NCT03704584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93148225|NCT03704584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148226|NCT03737721|Avelumab|avelumab|mesh-list
93148227|NCT03737721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148228|NCT03737721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148229|NCT03647709|Analgesics, Opioid|analgesics, opioid|mesh-list
93148230|NCT03647709|Narcotics|narcotics|mesh-ancestor
93148231|NCT03647709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148232|NCT03647709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148233|NCT03647709|Analgesics|analgesics|mesh-ancestor
93148234|NCT03647709|Sensory System Agents|sensory system agents|mesh-ancestor
93148235|NCT03647709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148236|NCT03546634|Vaccines|vaccines|mesh-list
93148237|NCT03546634|Immunologic Factors|immunologic factors|mesh-ancestor
93148238|NCT03546634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148239|NCT03661983|Aripiprazole|aripiprazole|mesh-list
93148240|NCT03661983|Antidepressive Agents|antidepressive agents|mesh-ancestor
93148241|NCT03661983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93148242|NCT03661983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93148243|NCT03661983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93148244|NCT03661983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148245|NCT03661983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148246|NCT03661983|Dopamine Agonists|dopamine agonists|mesh-ancestor
93148247|NCT03661983|Dopamine Agents|dopamine agents|mesh-ancestor
93148248|NCT03661983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148249|NCT03661983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148250|NCT03661983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93148251|NCT03661983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93148252|NCT03661983|Serotonin Agents|serotonin agents|mesh-ancestor
93148253|NCT03661983|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93148254|NCT03661983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93148255|NCT03661983|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93148256|NCT03661983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93148257|NCT02783170|Vaccines|vaccines|mesh-list
93148258|NCT02783170|Immunologic Factors|immunologic factors|mesh-ancestor
93148259|NCT02783170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148260|NCT04307134|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93148261|NCT04307134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148262|NCT04307134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148263|NCT04307134|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93148264|NCT04307134|Immunotoxins|immunotoxins|mesh-ancestor
93148265|NCT04307134|Immunoconjugates|immunoconjugates|mesh-ancestor
93148266|NCT04307134|Immunologic Factors|immunologic factors|mesh-ancestor
93148267|NCT04307134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148268|NCT02254018|Maytansine|maytansine|mesh-list
93148269|NCT02254018|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
93148270|NCT02254018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148271|NCT02254018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148272|NCT02254018|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148273|NCT02254018|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148274|NCT02254018|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148275|NCT02254018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148276|NCT02254018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148277|NCT02254018|Immunotoxins|immunotoxins|mesh-ancestor
93148278|NCT02254018|Immunoconjugates|immunoconjugates|mesh-ancestor
93148279|NCT02254018|Immunologic Factors|immunologic factors|mesh-ancestor
93148280|NCT02254018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148281|NCT04249882|Naltrexone|naltrexone|mesh-list
93148282|NCT04249882|Varenicline|varenicline|mesh-list
93148283|NCT04249882|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93148284|NCT04249882|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93148285|NCT04249882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148286|NCT04249882|Sensory System Agents|sensory system agents|mesh-ancestor
93148287|NCT04249882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148288|NCT04249882|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93148289|NCT04249882|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93148290|NCT04249882|Cholinergic Agents|cholinergic agents|mesh-ancestor
93148291|NCT04249882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148292|NCT04249882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148293|NCT03396952|Aspirin|aspirin|mesh-list
93148294|NCT03396952|Pembrolizumab|pembrolizumab|mesh-list
93148295|NCT03396952|Ipilimumab|ipilimumab|mesh-list
93148296|NCT03396952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148297|NCT03396952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148298|NCT03396952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93148299|NCT03396952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148300|NCT03396952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93148301|NCT03396952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93148302|NCT03396952|Analgesics|analgesics|mesh-ancestor
93148303|NCT03396952|Sensory System Agents|sensory system agents|mesh-ancestor
93148304|NCT03396952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148305|NCT03396952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148306|NCT03396952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148307|NCT03396952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148308|NCT03396952|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93148309|NCT03396952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93148310|NCT03396952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93148311|NCT03396952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93148312|NCT03396952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148313|NCT03396952|Antipyretics|antipyretics|mesh-ancestor
93148314|NCT03378934|Aspirin|aspirin|mesh-list
93148315|NCT03378934|Clopidogrel|clopidogrel|mesh-list
93148316|NCT03378934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93148317|NCT03378934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93148318|NCT03378934|Analgesics|analgesics|mesh-ancestor
93148319|NCT03378934|Sensory System Agents|sensory system agents|mesh-ancestor
93148320|NCT03378934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148321|NCT03378934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148322|NCT03378934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148323|NCT03378934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148324|NCT03378934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93148325|NCT03378934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93148326|NCT03378934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148327|NCT03378934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93148328|NCT03378934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93148329|NCT03378934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148330|NCT03378934|Antipyretics|antipyretics|mesh-ancestor
93148331|NCT03378934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93148332|NCT03378934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93148333|NCT03378934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93148334|NCT03378934|Purinergic Agents|purinergic agents|mesh-ancestor
93148335|NCT03378934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148336|NCT00126503|Bevacizumab|bevacizumab|mesh-list
93148337|NCT00126503|Sorafenib|sorafenib|mesh-list
93148338|NCT00126503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148339|NCT00126503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148340|NCT00126503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93148341|NCT00126503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93148342|NCT00126503|Growth Substances|growth substances|mesh-ancestor
93148343|NCT00126503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148344|NCT00126503|Growth Inhibitors|growth inhibitors|mesh-ancestor
93148345|NCT00126503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148346|NCT00126503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148347|NCT00126503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148348|NCT00126425|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93148349|NCT00126425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148350|NCT00126425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148351|NCT00126425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148352|NCT00126425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93148353|NCT00126191|Leucovorin|leucovorin|mesh-list
93148354|NCT00126191|Cytarabine|cytarabine|mesh-list
93148355|NCT00126191|Cyclophosphamide|cyclophosphamide|mesh-list
93148356|NCT00126191|Ifosfamide|ifosfamide|mesh-list
93148357|NCT00126191|Rituximab|rituximab|mesh-list
93148358|NCT00126191|Doxorubicin|doxorubicin|mesh-list
93148359|NCT00126191|Methotrexate|methotrexate|mesh-list
93148360|NCT00126191|Etoposide|etoposide|mesh-list
93148361|NCT00126191|Vincristine|vincristine|mesh-list
93148362|NCT00126191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93148363|NCT00126191|Immunologic Factors|immunologic factors|mesh-ancestor
93148364|NCT00126191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148365|NCT00126191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148366|NCT00126191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93148367|NCT00126191|Alkylating Agents|alkylating agents|mesh-ancestor
93148368|NCT00126191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148369|NCT00126191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148370|NCT00126191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93148371|NCT00126191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93148372|NCT00126191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93148373|NCT00126191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93148374|NCT00126191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93148376|NCT00126191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93148377|NCT00126191|Abortifacient Agents|abortifacient agents|mesh-ancestor
93148378|NCT00126191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93148379|NCT00126191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93148380|NCT00126191|Antimetabolites|antimetabolites|mesh-ancestor
93148381|NCT00126191|Dermatologic Agents|dermatologic agents|mesh-ancestor
93148382|NCT00126191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93148383|NCT00126191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93148384|NCT00126191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148385|NCT00126191|Antiviral Agents|antiviral agents|mesh-ancestor
93148386|NCT00126191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148387|NCT00126191|Antidotes|antidotes|mesh-ancestor
93148388|NCT00126191|Protective Agents|protective agents|mesh-ancestor
93148389|NCT00126191|Vitamin B Complex|vitamin b complex|mesh-ancestor
93148390|NCT00126191|Vitamins|vitamins|mesh-ancestor
93148391|NCT00126191|Micronutrients|micronutrients|mesh-ancestor
93148392|NCT00126191|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148393|NCT00126191|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148394|NCT00126191|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148395|NCT03207958|Belimumab|belimumab|mesh-list
93148396|NCT03207958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93148397|NCT03207958|Immunologic Factors|immunologic factors|mesh-ancestor
93148398|NCT03207958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148399|NCT00124943|Paclitaxel|paclitaxel|mesh-list
93148400|NCT00124943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93148401|NCT00124943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148402|NCT00124943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148403|NCT00124943|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148404|NCT00124943|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148405|NCT00124943|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148406|NCT00124943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148407|NCT00124709|Pimecrolimus|pimecrolimus|mesh-list
93148408|NCT00124709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93148409|NCT00124709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93148410|NCT00124709|Analgesics|analgesics|mesh-ancestor
93148411|NCT00124709|Sensory System Agents|sensory system agents|mesh-ancestor
93148412|NCT00124709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148413|NCT00124709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148414|NCT00124709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148415|NCT00124709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148416|NCT00124709|Dermatologic Agents|dermatologic agents|mesh-ancestor
93148417|NCT00124709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93148418|NCT00124709|Immunologic Factors|immunologic factors|mesh-ancestor
93148419|NCT00124709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93148420|NCT00124709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148421|NCT00124709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148422|NCT04139434|Azacitidine|azacitidine|mesh-list
93148423|NCT04139434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93148424|NCT04139434|Antimetabolites|antimetabolites|mesh-ancestor
93148425|NCT04139434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148426|NCT04139434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148427|NCT04139434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148428|NCT04130464|Ketorolac|ketorolac|mesh-list
93148429|NCT04130464|Ropivacaine|ropivacaine|mesh-list
93148430|NCT04130464|Anesthetics, Local|anesthetics, local|mesh-ancestor
93148431|NCT04130464|Anesthetics|anesthetics|mesh-ancestor
93148432|NCT04130464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148433|NCT04130464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148434|NCT04130464|Sensory System Agents|sensory system agents|mesh-ancestor
93148435|NCT04130464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148436|NCT04130464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93148437|NCT04130464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93148438|NCT04130464|Analgesics|analgesics|mesh-ancestor
93148439|NCT04130464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148440|NCT04130464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148441|NCT04130464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93148442|NCT04130464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148443|NCT04130464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148444|NCT03058354|Propofol|propofol|mesh-list
93148445|NCT03058354|Anesthetics|anesthetics|mesh-ancestor
93148446|NCT03058354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148447|NCT03058354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148448|NCT03058354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93148449|NCT03058354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93148450|NCT03058354|Anesthetics, General|anesthetics, general|mesh-ancestor
93148451|NCT02911792|Metformin|metformin|mesh-list
93148452|NCT02911792|Dapagliflozin|dapagliflozin|mesh-list
93148453|NCT02911792|Glipizide|glipizide|mesh-list
93148454|NCT02911792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93148455|NCT02911792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148456|NCT02911792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93148457|NCT02911792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148458|NCT02143570|Darifenacin|darifenacin|mesh-list
93148459|NCT02143570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93148460|NCT02143570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93148461|NCT02143570|Cholinergic Agents|cholinergic agents|mesh-ancestor
93148462|NCT02143570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148463|NCT02143570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148464|NCT02143570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148465|NCT02143570|Urological Agents|urological agents|mesh-ancestor
93148466|NCT02143804|Molgramostim|molgramostim|mesh-list
93148467|NCT02143804|Sargramostim|sargramostim|mesh-list
93148468|NCT02143804|Immunologic Factors|immunologic factors|mesh-ancestor
93148469|NCT02143804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148470|NCT02143804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148471|NCT03544996|Insulin|insulin|mesh-list
93148472|NCT03544996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93148473|NCT03544996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148474|NCT00564850|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93148475|NCT00564850|Luteolytic Agents|luteolytic agents|mesh-ancestor
93148476|NCT00564850|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93148477|NCT00564850|Contraceptive Agents|contraceptive agents|mesh-ancestor
93148478|NCT00564850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93148479|NCT00564850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148480|NCT00564850|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93148481|NCT00564850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93148482|NCT00564850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148483|NCT02144194|Docetaxel|docetaxel|mesh-list
93148484|NCT02144194|Vinorelbine|vinorelbine|mesh-list
93148485|NCT02144194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148486|NCT02144194|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148487|NCT02144194|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148488|NCT02144194|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148489|NCT02144194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148490|NCT02144194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148491|NCT02140840|Trametinib|trametinib|mesh-list
93148492|NCT02140840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148493|NCT02140840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148494|NCT02140840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148495|NCT02140840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148496|NCT02140918|Fludrocortisone|fludrocortisone|mesh-list
93148497|NCT02140918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148498|NCT00108160|Mupirocin|mupirocin|mesh-list
93148499|NCT00108160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93148500|NCT00108160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148501|NCT00108160|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93148502|NCT00108160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148503|NCT00108160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148504|NCT02254174|Tiotropium Bromide|tiotropium bromide|mesh-list
93148505|NCT02254174|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93148506|NCT02254174|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93148507|NCT02254174|Autonomic Agents|autonomic agents|mesh-ancestor
93148508|NCT02254174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148509|NCT02254174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148510|NCT02254174|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93148511|NCT02254174|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148512|NCT02254174|Parasympatholytics|parasympatholytics|mesh-ancestor
93148513|NCT02254174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93148514|NCT02254174|Cholinergic Agents|cholinergic agents|mesh-ancestor
93148515|NCT02254174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148516|NCT02254174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148517|NCT02254174|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93148518|NCT02254174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93148519|NCT02254174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93148520|NCT02254174|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148521|NCT03545308|Rocuronium|rocuronium|mesh-list
93148522|NCT03545308|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93148523|NCT03545308|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93148524|NCT03545308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93148525|NCT03545308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148526|NCT03545308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148527|NCT00108082|Atenolol|atenolol|mesh-list
93148528|NCT00108082|Carvedilol|carvedilol|mesh-list
93148529|NCT00108082|Lisinopril|lisinopril|mesh-list
93148530|NCT00108082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93148531|NCT00108082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93148532|NCT00108082|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148533|NCT00108082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148534|NCT00108082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148535|NCT00108082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148536|NCT00108082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93148537|NCT00108082|Antioxidants|antioxidants|mesh-ancestor
93148538|NCT00108082|Protective Agents|protective agents|mesh-ancestor
93148539|NCT00108082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93148540|NCT00108082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93148541|NCT00108082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93148542|NCT00108082|Vasodilator Agents|vasodilator agents|mesh-ancestor
93148543|NCT00108082|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93148544|NCT00108082|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93148545|NCT00108082|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93148546|NCT00108082|Protease Inhibitors|protease inhibitors|mesh-ancestor
93148547|NCT00108082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148548|NCT00108082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93148549|NCT00108082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93148550|NCT00108082|Sympatholytics|sympatholytics|mesh-ancestor
93148551|NCT00108082|Autonomic Agents|autonomic agents|mesh-ancestor
93148552|NCT00108082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148553|NCT00108082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93148554|NCT02144662|Ranibizumab|ranibizumab|mesh-list
93148555|NCT02144662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93148556|NCT02144662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93148557|NCT02144662|Growth Substances|growth substances|mesh-ancestor
93148558|NCT02144662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148559|NCT02144662|Growth Inhibitors|growth inhibitors|mesh-ancestor
93148560|NCT02144662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148561|NCT02141698|Esomeprazole|esomeprazole|mesh-list
93148562|NCT02141698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93148563|NCT02141698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148564|NCT02141698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93148565|NCT02141698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148566|NCT02141698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148567|NCT02144818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93148568|NCT02144818|Luteolytic Agents|luteolytic agents|mesh-ancestor
93148569|NCT02144818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93148570|NCT02144818|Contraceptive Agents|contraceptive agents|mesh-ancestor
93148571|NCT02144818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93148572|NCT02144818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148573|NCT02144818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93148574|NCT02144818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93148575|NCT02144818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148576|NCT02147938|Tacrolimus|tacrolimus|mesh-list
93148577|NCT02147938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93148578|NCT02147938|Immunologic Factors|immunologic factors|mesh-ancestor
93148579|NCT02147938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148580|NCT02147938|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93148581|NCT02147938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148582|NCT02147938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148583|NCT02148016|Levofloxacin|levofloxacin|mesh-list
93148584|NCT02148016|Betamethasone|betamethasone|mesh-list
93148585|NCT02148016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93148586|NCT02148016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148587|NCT02148016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93148588|NCT02148016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93148589|NCT02148016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93148590|NCT02148016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148591|NCT02148016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148592|NCT02148016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148593|NCT02148016|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93148594|NCT02148016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93148595|NCT02148016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148596|NCT02148016|Glucocorticoids|glucocorticoids|mesh-ancestor
93148597|NCT02148016|Hormones|hormones|mesh-ancestor
93148598|NCT02148016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148599|NCT02148016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148600|NCT02148016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93148601|NCT02148016|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148602|NCT02148094|Tenofovir|tenofovir|mesh-list
93148603|NCT02148094|Emtricitabine|emtricitabine|mesh-list
93148604|NCT02148094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93148605|NCT02148094|Antiviral Agents|antiviral agents|mesh-ancestor
93148606|NCT02148094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148607|NCT02148094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93148608|NCT02148094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93148609|NCT02148094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148610|NCT02148094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148611|NCT02148094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93148612|NCT02148094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93148613|NCT02148328|Vaccines|vaccines|mesh-list
93148614|NCT02148328|Immunologic Factors|immunologic factors|mesh-ancestor
93148615|NCT02148328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148616|NCT02142010|Paclitaxel|paclitaxel|mesh-list
93148617|NCT02142010|Cisplatin|cisplatin|mesh-list
93148618|NCT02142010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148619|NCT02142010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148620|NCT02142010|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148621|NCT02142010|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148622|NCT02142010|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148623|NCT02142010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148624|NCT02142166|Dialysis Solutions|dialysis solutions|mesh-list
93148625|NCT02142166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93148626|NCT05054140|Calcium|calcium|mesh-list
93148627|NCT05054140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93148628|NCT05054140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148629|NCT03543826|Rocuronium|rocuronium|mesh-list
93148630|NCT03543826|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93148631|NCT03543826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93148632|NCT03543826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93148633|NCT03543826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148634|NCT03543826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148635|NCT02148640|Infliximab|infliximab|mesh-list
93148636|NCT02148640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93148637|NCT02148640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148638|NCT02148640|Dermatologic Agents|dermatologic agents|mesh-ancestor
93148639|NCT02148640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148640|NCT02148640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93148641|NCT02142556|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93148642|NCT02142556|Antidepressive Agents|antidepressive agents|mesh-ancestor
93148643|NCT02142556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93148644|NCT02142556|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93148645|NCT02142556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93148646|NCT02142556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148647|NCT02142556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148648|NCT02142634|Budesonide|budesonide|mesh-list
93148649|NCT02142634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148650|NCT02142634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93148651|NCT02142634|Autonomic Agents|autonomic agents|mesh-ancestor
93148652|NCT02142634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148653|NCT02142634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148654|NCT02142634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93148655|NCT02142634|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148656|NCT02142634|Glucocorticoids|glucocorticoids|mesh-ancestor
93148657|NCT02142634|Hormones|hormones|mesh-ancestor
93148658|NCT02142634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148659|NCT02142790|Paclitaxel|paclitaxel|mesh-list
93148660|NCT02142790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93148661|NCT02142790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148662|NCT02142790|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148663|NCT02142790|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148664|NCT02142790|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148665|NCT02142790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148666|NCT02142868|Letrozole|letrozole|mesh-list
93148667|NCT02142868|Palbociclib|palbociclib|mesh-list
93148668|NCT02142868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148669|NCT02142868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92820867|NCT02588287|Tenofovir|tenofovir|mesh-list
93148670|NCT02142868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93148671|NCT02142868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148672|NCT02142868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148673|NCT02142868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93148674|NCT02142868|Hormone Antagonists|hormone antagonists|mesh-ancestor
93148675|NCT02142868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148676|NCT02142868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148677|NCT02142868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148678|NCT02145520|Magnesium Sulfate|magnesium sulfate|mesh-list
93148679|NCT02145520|Analgesics|analgesics|mesh-ancestor
93148680|NCT02145520|Sensory System Agents|sensory system agents|mesh-ancestor
93148681|NCT02145520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148682|NCT02145520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148683|NCT02145520|Anesthetics|anesthetics|mesh-ancestor
93148684|NCT02145520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148685|NCT02145520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93148686|NCT02145520|Anticonvulsants|anticonvulsants|mesh-ancestor
93148687|NCT02145520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93148688|NCT02145520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93148689|NCT02145520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148690|NCT02145520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93148691|NCT02145520|Tocolytic Agents|tocolytic agents|mesh-ancestor
93148692|NCT02145520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93148693|NCT02145598|Lenalidomide|lenalidomide|mesh-list
93148694|NCT02145598|Immunologic Factors|immunologic factors|mesh-ancestor
93148695|NCT02145598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148696|NCT02145598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93148697|NCT02145598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93148698|NCT02145598|Growth Substances|growth substances|mesh-ancestor
93148699|NCT02145598|Growth Inhibitors|growth inhibitors|mesh-ancestor
93148700|NCT02145598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148701|NCT02145832|Fluconazole|fluconazole|mesh-list
93148702|NCT02145832|Micafungin|micafungin|mesh-list
93148703|NCT02145832|Antifungal Agents|antifungal agents|mesh-list
93148704|NCT02145832|Clotrimazole|clotrimazole|mesh-list
93148705|NCT02145832|Miconazole|miconazole|mesh-list
93148706|NCT02145832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93148707|NCT02145832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93148708|NCT02145832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93148709|NCT02145832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148710|NCT02145832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148711|NCT02145832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93148712|NCT02145832|Hormone Antagonists|hormone antagonists|mesh-ancestor
93148713|NCT02145832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148714|NCT02145832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148715|NCT02145832|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93148716|NCT02145832|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93148717|NCT02145832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93148718|NCT02145832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93148719|NCT00104728|Gefitinib|gefitinib|mesh-list
93148720|NCT00104728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148721|NCT00104728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148722|NCT00104728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148723|NCT00104728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148724|NCT02145910|Vemurafenib|vemurafenib|mesh-list
93148725|NCT02145910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148726|NCT02145910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148727|NCT02145910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148728|NCT02145910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148729|NCT02146222|Docetaxel|docetaxel|mesh-list
93148730|NCT02146222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148731|NCT02146222|Tubulin Modulators|tubulin modulators|mesh-ancestor
93148732|NCT02146222|Antimitotic Agents|antimitotic agents|mesh-ancestor
93148733|NCT02146222|Mitosis Modulators|mitosis modulators|mesh-ancestor
93148734|NCT02146222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148735|NCT02146300|Xylometazoline|xylometazoline|mesh-list
93148736|NCT02146300|Nasal Decongestants|nasal decongestants|mesh-ancestor
93148737|NCT02146300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93148738|NCT02146300|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148739|NCT02146456|Tranexamic Acid|tranexamic acid|mesh-list
93148740|NCT02146456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93148741|NCT02146456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93148742|NCT02146456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148743|NCT02146456|Hemostatics|hemostatics|mesh-ancestor
93148744|NCT02146456|Coagulants|coagulants|mesh-ancestor
93148745|NCT02146534|4-Aminopyridine|4-aminopyridine|mesh-list
93148746|NCT02146534|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93148747|NCT02146534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93148748|NCT02146534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148749|NCT02151916|Fluorides|fluorides|mesh-list
93148750|NCT02151916|Fluorides, Topical|fluorides, topical|mesh-list
93148751|NCT02151916|Cariostatic Agents|cariostatic agents|mesh-ancestor
92854883|NCT00905983|Gemcitabine|gemcitabine|mesh-list
93148752|NCT02151916|Protective Agents|protective agents|mesh-ancestor
93148753|NCT02151916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148754|NCT02146846|Imatinib Mesylate|imatinib mesylate|mesh-list
93148755|NCT02146846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148756|NCT02146846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148757|NCT02146846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148758|NCT02146846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148759|NCT02152228|Teriparatide|teriparatide|mesh-list
93148760|NCT02152228|Hormones|hormones|mesh-list
93148761|NCT02152228|Parathyroid Hormone|parathyroid hormone|mesh-list
93148762|NCT02152228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93148763|NCT02152228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148764|NCT02152228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93148765|NCT02152228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93148766|NCT02152306|Amlodipine|amlodipine|mesh-list
93148767|NCT02152306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93148768|NCT02152306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93148769|NCT02152306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93148770|NCT02152306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148771|NCT02152306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93148772|NCT02152306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148773|NCT02152306|Vasodilator Agents|vasodilator agents|mesh-ancestor
93148774|NCT02261116|Telmisartan|telmisartan|mesh-list
93148775|NCT02261116|Candesartan|candesartan|mesh-list
93148776|NCT02261116|Candesartan cilexetil|candesartan cilexetil|mesh-list
93148777|NCT02261116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93148778|NCT02261116|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93148779|NCT02261116|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93148780|NCT02261116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148781|NCT02254720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93148782|NCT02147548|Lorazepam|lorazepam|mesh-list
93148783|NCT02147548|Etifoxine|etifoxine|mesh-list
93148784|NCT02147548|Anticonvulsants|anticonvulsants|mesh-ancestor
93148785|NCT02147548|Antiemetics|antiemetics|mesh-ancestor
93148786|NCT02147548|Autonomic Agents|autonomic agents|mesh-ancestor
93148787|NCT02147548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148788|NCT02147548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148789|NCT02147548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93148790|NCT02147548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93148791|NCT02147548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148792|NCT02147548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93148793|NCT02147548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93148794|NCT02147548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93148795|NCT02147548|GABA Modulators|gaba modulators|mesh-ancestor
93148796|NCT02147548|GABA Agents|gaba agents|mesh-ancestor
93148797|NCT02147548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148798|NCT02147548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148799|NCT00122681|Vaccines|vaccines|mesh-list
93148800|NCT00122681|Immunologic Factors|immunologic factors|mesh-ancestor
93148801|NCT00122681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148802|NCT02774278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93148803|NCT02774278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148804|NCT02774278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148805|NCT02774278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148806|NCT02774278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148807|NCT05666349|Niraparib|niraparib|mesh-list
93148808|NCT05666349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93148809|NCT05666349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148810|NCT05666349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148811|NCT05666349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148812|NCT03733275|Lidocaine|lidocaine|mesh-list
93148813|NCT03733275|Bupivacaine|bupivacaine|mesh-list
93148814|NCT03733275|Anesthetics, Local|anesthetics, local|mesh-ancestor
93148815|NCT03733275|Anesthetics|anesthetics|mesh-ancestor
93148816|NCT03733275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148817|NCT03733275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148818|NCT03733275|Sensory System Agents|sensory system agents|mesh-ancestor
93148819|NCT03733275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148820|NCT03733275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93148821|NCT03733275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93148822|NCT03733275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93148823|NCT03733275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93148824|NCT03733275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148825|NCT03542422|Apatinib|apatinib|mesh-list
93148826|NCT03542422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148827|NCT03542422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148828|NCT03542422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148829|NCT03542422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148830|NCT01077011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93148831|NCT01077011|Lubricant Eye Drops|lubricant eye drops|mesh-list
93148832|NCT01077011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93148833|NCT02153866|Vaccines|vaccines|mesh-list
93148834|NCT02153866|Immunologic Factors|immunologic factors|mesh-ancestor
93148835|NCT02153866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148836|NCT03645057|Tacrolimus|tacrolimus|mesh-list
93148837|NCT03645057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93148838|NCT03645057|Immunologic Factors|immunologic factors|mesh-ancestor
93148839|NCT03645057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148840|NCT03645057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93148841|NCT03645057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148842|NCT03645057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148843|NCT04863430|Oxaliplatin|oxaliplatin|mesh-list
93148844|NCT04863430|Apatinib|apatinib|mesh-list
93148845|NCT04863430|Tegafur|tegafur|mesh-list
93148846|NCT04863430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148847|NCT04863430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148848|NCT04863430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148849|NCT04863430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148850|NCT04863430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93148851|NCT04863430|Antimetabolites|antimetabolites|mesh-ancestor
93148852|NCT05665881|Phenylephrine|phenylephrine|mesh-list
93148853|NCT05665881|Oxymetazoline|oxymetazoline|mesh-list
93148854|NCT05665881|Norepinephrine|norepinephrine|mesh-list
93148855|NCT05665881|Ephedrine|ephedrine|mesh-list
93148856|NCT05665881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93148857|NCT05665881|Mydriatics|mydriatics|mesh-ancestor
93148858|NCT05665881|Autonomic Agents|autonomic agents|mesh-ancestor
93148859|NCT05665881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148860|NCT05665881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148861|NCT05665881|Sympathomimetics|sympathomimetics|mesh-ancestor
93148862|NCT05665881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93148863|NCT05665881|Nasal Decongestants|nasal decongestants|mesh-ancestor
93148864|NCT05665881|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148865|NCT05665881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93148866|NCT05665881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93148867|NCT05665881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93148868|NCT05665881|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148869|NCT05665881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148870|NCT05665881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148871|NCT05665881|Protective Agents|protective agents|mesh-ancestor
93148872|NCT05665881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93148873|NCT03643575|Phenylpropanolamine|phenylpropanolamine|mesh-list
93148874|NCT03643575|Guaifenesin|guaifenesin|mesh-list
93148875|NCT03643575|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93148876|NCT03643575|Expectorants|expectorants|mesh-ancestor
93148877|NCT03643575|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148878|NCT03643575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93148879|NCT03643575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93148880|NCT03643575|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148881|NCT03643575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148882|NCT03643575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148883|NCT03643575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148884|NCT03643575|Appetite Depressants|appetite depressants|mesh-ancestor
93148885|NCT03643575|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93148886|NCT03643575|Sympathomimetics|sympathomimetics|mesh-ancestor
93148887|NCT03643575|Autonomic Agents|autonomic agents|mesh-ancestor
93148888|NCT03643575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148889|NCT03643575|Nasal Decongestants|nasal decongestants|mesh-ancestor
93148890|NCT03643575|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93148891|NCT02768194|Fluorides|fluorides|mesh-list
93148892|NCT02768194|Tin Fluorides|tin fluorides|mesh-list
93148893|NCT02768194|Fluorophosphate|fluorophosphate|mesh-list
93148894|NCT02768194|Cariostatic Agents|cariostatic agents|mesh-ancestor
93148895|NCT02768194|Protective Agents|protective agents|mesh-ancestor
93148896|NCT02768194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148897|NCT02254954|Temozolomide|temozolomide|mesh-list
93148898|NCT02254954|Macitentan|macitentan|mesh-list
93148899|NCT02254954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93148900|NCT02254954|Alkylating Agents|alkylating agents|mesh-ancestor
93148901|NCT02254954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148902|NCT02254954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148903|NCT02254954|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93148904|NCT02254954|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93148905|NCT02254954|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93148906|NCT00130793|Vaccines|vaccines|mesh-list
93148907|NCT00130793|Immunologic Factors|immunologic factors|mesh-ancestor
93148908|NCT00130793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148909|NCT03732105|Apatinib|apatinib|mesh-list
93148910|NCT03732105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93148911|NCT03732105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148912|NCT03732105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148913|NCT03732105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148914|NCT03732105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148915|NCT03732105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93148916|NCT03732105|Growth Substances|growth substances|mesh-ancestor
93148917|NCT03732105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148918|NCT03732105|Growth Inhibitors|growth inhibitors|mesh-ancestor
93148919|NCT02154334|Mometasone Furoate|mometasone furoate|mesh-list
93148920|NCT02154334|Phenylephrine|phenylephrine|mesh-list
93148921|NCT02154334|Oxymetazoline|oxymetazoline|mesh-list
93148922|NCT02154334|Esketamine|esketamine|mesh-list
93148923|NCT02154334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93148924|NCT02154334|Dermatologic Agents|dermatologic agents|mesh-ancestor
93148925|NCT02154334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93148926|NCT02154334|Antidepressive Agents|antidepressive agents|mesh-ancestor
93148927|NCT02154334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93148928|NCT02154334|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93148929|NCT02154334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93148930|NCT02154334|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148931|NCT02154334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148932|NCT02154334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148933|NCT02154334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148934|NCT02154334|Sympathomimetics|sympathomimetics|mesh-ancestor
93148935|NCT02154334|Autonomic Agents|autonomic agents|mesh-ancestor
93148936|NCT02154334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148937|NCT02154334|Nasal Decongestants|nasal decongestants|mesh-ancestor
93148938|NCT02154334|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93148939|NCT02154334|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148940|NCT02154334|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93148941|NCT02154334|Mydriatics|mydriatics|mesh-ancestor
93148942|NCT02154334|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93148943|NCT02154334|Protective Agents|protective agents|mesh-ancestor
93148944|NCT01078961|Bortezomib|bortezomib|mesh-list
93148945|NCT01078961|Sorafenib|sorafenib|mesh-list
93148946|NCT01078961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148947|NCT01078961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93148948|NCT01078961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148949|NCT01078961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148950|NCT03818399|Buprenorphine|buprenorphine|mesh-list
93148951|NCT03818399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93148952|NCT03818399|Narcotics|narcotics|mesh-ancestor
93148953|NCT03818399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148954|NCT03818399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148955|NCT03818399|Analgesics|analgesics|mesh-ancestor
93148956|NCT03818399|Sensory System Agents|sensory system agents|mesh-ancestor
93148957|NCT03818399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148958|NCT03818399|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93148959|NCT02154646|Gemcitabine|gemcitabine|mesh-list
93148960|NCT02154646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93148961|NCT02154646|Antimetabolites|antimetabolites|mesh-ancestor
93148962|NCT02154646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148963|NCT02154646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93148964|NCT03642873|Phenylpropanolamine|phenylpropanolamine|mesh-list
93148965|NCT03642873|Hydrocodone|hydrocodone|mesh-list
93148966|NCT03642873|Guaifenesin|guaifenesin|mesh-list
93148967|NCT03642873|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93148968|NCT03642873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93148969|NCT03642873|Narcotics|narcotics|mesh-ancestor
92821145|NCT02702739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148970|NCT03642873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148971|NCT03642873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148972|NCT03642873|Analgesics|analgesics|mesh-ancestor
93148973|NCT03642873|Sensory System Agents|sensory system agents|mesh-ancestor
93148974|NCT03642873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93148975|NCT03642873|Antitussive Agents|antitussive agents|mesh-ancestor
93148976|NCT03642873|Respiratory System Agents|respiratory system agents|mesh-ancestor
93148977|NCT03642873|Expectorants|expectorants|mesh-ancestor
93148978|NCT03642873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93148979|NCT03642873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93148980|NCT03642873|Adrenergic Agents|adrenergic agents|mesh-ancestor
93148981|NCT03642873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93148982|NCT03642873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148983|NCT03642873|Appetite Depressants|appetite depressants|mesh-ancestor
93148984|NCT03642873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93148985|NCT03642873|Sympathomimetics|sympathomimetics|mesh-ancestor
93148986|NCT03642873|Autonomic Agents|autonomic agents|mesh-ancestor
93148987|NCT03642873|Nasal Decongestants|nasal decongestants|mesh-ancestor
93148988|NCT03642873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93148989|NCT01079819|BMS 708163|bms 708163|mesh-list
93148990|NCT01079819|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93148991|NCT01079819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93148992|NCT01079819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93148993|NCT02156596|Ketoprofen|ketoprofen|mesh-list
93148994|NCT02156596|Morphine|morphine|mesh-list
93148995|NCT02156596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93148996|NCT02156596|Narcotics|narcotics|mesh-ancestor
93148997|NCT02156596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93148998|NCT02156596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93148999|NCT02156596|Analgesics|analgesics|mesh-ancestor
93149000|NCT02156596|Sensory System Agents|sensory system agents|mesh-ancestor
93149001|NCT02156596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149002|NCT02156596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149003|NCT02156596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149004|NCT02156596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149005|NCT02156596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149006|NCT02156596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93149007|NCT02156596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149008|NCT02156596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149009|NCT01079117|Morphine|morphine|mesh-list
93149010|NCT01079117|Methadone|methadone|mesh-list
93149011|NCT01079117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93149012|NCT01079117|Narcotics|narcotics|mesh-ancestor
93149013|NCT01079117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149014|NCT01079117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149015|NCT01079117|Analgesics|analgesics|mesh-ancestor
93149016|NCT01079117|Sensory System Agents|sensory system agents|mesh-ancestor
93149017|NCT01079117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149018|NCT01079117|Antitussive Agents|antitussive agents|mesh-ancestor
93149019|NCT01079117|Respiratory System Agents|respiratory system agents|mesh-ancestor
93149020|NCT03732963|Melatonin|melatonin|mesh-list
93149021|NCT03732963|Antioxidants|antioxidants|mesh-ancestor
93149022|NCT03732963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149023|NCT03732963|Protective Agents|protective agents|mesh-ancestor
93149024|NCT03732963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149025|NCT03732963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149026|NCT03729687|Capecitabine|capecitabine|mesh-list
93149027|NCT03729687|Oxaliplatin|oxaliplatin|mesh-list
93149028|NCT03729687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93149029|NCT03729687|Antimetabolites|antimetabolites|mesh-ancestor
93149030|NCT03729687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149031|NCT03729687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149032|NCT03818321|Methenamine|methenamine|mesh-list
93149033|NCT03818321|Methenamine hippurate|methenamine hippurate|mesh-list
93149034|NCT03818321|Methenamine mandelate|methenamine mandelate|mesh-list
93149035|NCT03818321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93149036|NCT03818321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149037|NCT03818321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149038|NCT03616977|Insulin Lispro|insulin lispro|mesh-list
93149039|NCT03616977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149040|NCT03616977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149041|NCT04996719|Sirolimus|sirolimus|mesh-list
93149042|NCT04996719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149043|NCT04996719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149044|NCT04996719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93149045|NCT04996719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149046|NCT04996719|Antifungal Agents|antifungal agents|mesh-ancestor
93149047|NCT04996719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149048|NCT04996719|Immunologic Factors|immunologic factors|mesh-ancestor
93149049|NCT04996719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149050|NCT03816761|Insulin Aspart|insulin aspart|mesh-list
93149051|NCT03816761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149052|NCT03816761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149053|NCT02770612|Analgesics, Opioid|analgesics, opioid|mesh-list
93149054|NCT02770612|Narcotics|narcotics|mesh-ancestor
93149055|NCT02770612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149056|NCT02770612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149057|NCT02770612|Analgesics|analgesics|mesh-ancestor
93149058|NCT02770612|Sensory System Agents|sensory system agents|mesh-ancestor
93149059|NCT02770612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149060|NCT03542110|Alirocumab|alirocumab|mesh-list
93149061|NCT03542110|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93149062|NCT03542110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93149063|NCT03542110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93149064|NCT03542110|Antimetabolites|antimetabolites|mesh-ancestor
93149065|NCT03542110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149066|NCT03542110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93149067|NCT03542110|Protease Inhibitors|protease inhibitors|mesh-ancestor
93149068|NCT03542110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149069|NCT03542110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93149070|NCT03575871|Abrocitinib|abrocitinib|mesh-list
93149071|NCT03575871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149072|NCT03575871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149073|NCT03575871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149074|NCT02155504|Itraconazole|itraconazole|mesh-list
93149075|NCT02155504|Antifungal Agents|antifungal agents|mesh-ancestor
93149076|NCT02155504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149077|NCT02155504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93149078|NCT02155504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93149079|NCT02155504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149080|NCT02155504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149081|NCT02155504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93149082|NCT02155504|Hormone Antagonists|hormone antagonists|mesh-ancestor
93149083|NCT02155504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149084|NCT02155504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149085|NCT02155504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93149086|NCT03642717|Empagliflozin|empagliflozin|mesh-list
93149087|NCT03642717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93149088|NCT03642717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149089|NCT03642717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149090|NCT03642717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149091|NCT02766478|Genistein|genistein|mesh-list
93149092|NCT02766478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93149093|NCT02766478|Protective Agents|protective agents|mesh-ancestor
93149094|NCT02766478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149095|NCT02766478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149096|NCT02766478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149097|NCT02766478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149098|NCT02766478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149099|NCT02766478|Phytoestrogens|phytoestrogens|mesh-ancestor
93149100|NCT02766478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93149101|NCT02766478|Estrogens|estrogens|mesh-ancestor
93149102|NCT02766478|Hormones|hormones|mesh-ancestor
93149103|NCT02766478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149104|NCT03729375|Bupivacaine|bupivacaine|mesh-list
93149105|NCT03729375|Anesthetics, Local|anesthetics, local|mesh-ancestor
93149106|NCT03729375|Anesthetics|anesthetics|mesh-ancestor
93149107|NCT03729375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149108|NCT03729375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149109|NCT03729375|Sensory System Agents|sensory system agents|mesh-ancestor
93149110|NCT03729375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149111|NCT02159326|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93149112|NCT02159326|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93149113|NCT02159326|Riociguat|riociguat|mesh-list
93149114|NCT02159326|Enzyme Activators|enzyme activators|mesh-ancestor
93149115|NCT02159326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149116|NCT02159326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92821298|NCT02586259|Budesonide|budesonide|mesh-list
93149117|NCT02159326|Contraceptive Agents|contraceptive agents|mesh-ancestor
93149118|NCT02159326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93149119|NCT02159326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149120|NCT02159326|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93149121|NCT02159326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93149122|NCT02159326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93149123|NCT02159326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93149124|NCT02159326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93149125|NCT02159326|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93149126|NCT02159326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93149127|NCT02159326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93149128|NCT02255266|Liraglutide|liraglutide|mesh-list
93149129|NCT02255266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149130|NCT02255266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149131|NCT02255266|Incretins|incretins|mesh-ancestor
93149132|NCT02255266|Hormones|hormones|mesh-ancestor
93149133|NCT02255266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149134|NCT00104650|Diphosphonates|diphosphonates|mesh-list
93149135|NCT00104650|Denosumab|denosumab|mesh-list
93149136|NCT00104650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93149137|NCT00104650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149138|NCT02158078|Insulin|insulin|mesh-list
93149139|NCT02158078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149140|NCT02158078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149141|NCT00104416|Lamotrigine|lamotrigine|mesh-list
93149142|NCT00104416|Anticonvulsants|anticonvulsants|mesh-ancestor
93149143|NCT00104416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93149144|NCT00104416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93149145|NCT00104416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149146|NCT00104416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93149147|NCT00104416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149148|NCT00104416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93149149|NCT00104416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93149150|NCT00104416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149151|NCT00104416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93149152|NCT00104416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93149153|NCT04817254|Nivolumab|nivolumab|mesh-list
93149154|NCT04817254|Ipilimumab|ipilimumab|mesh-list
93149155|NCT04817254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149156|NCT04817254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149157|NCT04817254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93149158|NCT04817254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149159|NCT02149888|Tenofovir|tenofovir|mesh-list
93149160|NCT02149888|Emtricitabine|emtricitabine|mesh-list
93149161|NCT02149888|Antiviral Agents|antiviral agents|mesh-ancestor
93149162|NCT02149888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149163|NCT02149888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93149164|NCT02149888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93149165|NCT02149888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149166|NCT02149888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149167|NCT02149888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93149168|NCT02149888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93149169|NCT03639675|Aflibercept|aflibercept|mesh-list
93149170|NCT03639675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149171|NCT03639675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149172|NCT03639675|Growth Substances|growth substances|mesh-ancestor
93149173|NCT03639675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149174|NCT03639675|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149175|NCT03639675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149176|NCT03543436|Meropenem|meropenem|mesh-list
93149177|NCT03543436|Imipenem|imipenem|mesh-list
93149178|NCT03543436|Temocillin|temocillin|mesh-list
93149179|NCT03543436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149180|NCT03543436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149181|NCT02149966|Mitapivat|mitapivat|mesh-list
93149182|NCT02149966|Enzyme Activators|enzyme activators|mesh-ancestor
93149183|NCT02149966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149184|NCT03729063|Carbon Monoxide|carbon monoxide|mesh-list
93149185|NCT03729063|Antimetabolites|antimetabolites|mesh-ancestor
93149186|NCT03729063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149187|NCT03729063|Gasotransmitters|gasotransmitters|mesh-ancestor
93149188|NCT03729063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149189|NCT03729063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149190|NCT01310361|Amoxicillin|amoxicillin|mesh-list
93149191|NCT01310361|Penicillins|penicillins|mesh-list
93149192|NCT01310361|Penicillin G|penicillin g|mesh-list
93149193|NCT01310361|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93149194|NCT01310361|Penicillin G Procaine|penicillin g procaine|mesh-list
93149195|NCT01310361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149196|NCT01310361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149197|NCT03541798|Anesthetics|anesthetics|mesh-list
93149198|NCT03541798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149199|NCT03541798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149200|NCT02150122|Vitamin D|vitamin d|mesh-list
93149201|NCT02150122|Cholecalciferol|cholecalciferol|mesh-list
93149202|NCT02150122|Vitamins|vitamins|mesh-ancestor
93149203|NCT02150122|Micronutrients|micronutrients|mesh-ancestor
93149204|NCT02150122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149205|NCT02150122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93149206|NCT02150122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93149207|NCT03728829|Carboplatin|carboplatin|mesh-list
93149208|NCT03728829|Docetaxel|docetaxel|mesh-list
93149209|NCT03728829|Trastuzumab|trastuzumab|mesh-list
93149210|NCT03728829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149211|NCT03728829|Tubulin Modulators|tubulin modulators|mesh-ancestor
93149212|NCT03728829|Antimitotic Agents|antimitotic agents|mesh-ancestor
93149213|NCT03728829|Mitosis Modulators|mitosis modulators|mesh-ancestor
93149214|NCT03728829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149215|NCT03728829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149216|NCT00121667|Metformin|metformin|mesh-list
93149217|NCT00121667|Pioglitazone|pioglitazone|mesh-list
93149218|NCT00121667|Saxagliptin|saxagliptin|mesh-list
93149219|NCT00121667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149220|NCT00121667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149221|NCT00121667|Incretins|incretins|mesh-ancestor
93149222|NCT00121667|Hormones|hormones|mesh-ancestor
93149223|NCT00121667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149224|NCT00121667|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93149225|NCT00121667|Protease Inhibitors|protease inhibitors|mesh-ancestor
93149226|NCT00121667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149227|NCT00121667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149228|NCT02954601|Insulin|insulin|mesh-list
93149229|NCT02954601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93149230|NCT02954601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149231|NCT02954601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149232|NCT00121199|Prednisone|prednisone|mesh-list
93149233|NCT00121199|Cyclophosphamide|cyclophosphamide|mesh-list
93149234|NCT00121199|Bevacizumab|bevacizumab|mesh-list
93149235|NCT00121199|Rituximab|rituximab|mesh-list
93149236|NCT00121199|Doxorubicin|doxorubicin|mesh-list
93149237|NCT00121199|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93149238|NCT00121199|Vincristine|vincristine|mesh-list
93149239|NCT00121199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93149240|NCT00121199|Antibodies|antibodies|mesh-list
93149241|NCT00121199|Immunoglobulins|immunoglobulins|mesh-list
93149242|NCT00121199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93149243|NCT00121199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149244|NCT00121199|Immunologic Factors|immunologic factors|mesh-ancestor
93149245|NCT00121199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149246|NCT00121199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149247|NCT00121199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93149248|NCT00121199|Alkylating Agents|alkylating agents|mesh-ancestor
93149249|NCT00121199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149250|NCT00121199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149251|NCT00121199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93149252|NCT00121199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149253|NCT00121199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149254|NCT00121199|Growth Substances|growth substances|mesh-ancestor
93149255|NCT00121199|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149256|NCT00121199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93149257|NCT00121199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93149258|NCT00121199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93149259|NCT00121199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149260|NCT00121199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149261|NCT00121199|Glucocorticoids|glucocorticoids|mesh-ancestor
93149262|NCT00121199|Hormones|hormones|mesh-ancestor
93149263|NCT00121199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149264|NCT00121199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93149265|NCT00121199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93149266|NCT00121199|Tubulin Modulators|tubulin modulators|mesh-ancestor
93149267|NCT00121199|Antimitotic Agents|antimitotic agents|mesh-ancestor
93149268|NCT00121199|Mitosis Modulators|mitosis modulators|mesh-ancestor
92821443|NCT04215159|Irinotecan|irinotecan|mesh-list
93149269|NCT01079897|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
93149270|NCT01079897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149271|NCT00119015|Fluticasone|fluticasone|mesh-list
93149272|NCT00119015|Xhance|xhance|mesh-list
93149273|NCT00119015|Montelukast|montelukast|mesh-list
93149274|NCT00119015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149275|NCT00119015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93149276|NCT00119015|Autonomic Agents|autonomic agents|mesh-ancestor
93149277|NCT00119015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149278|NCT00119015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149279|NCT00119015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93149280|NCT00119015|Respiratory System Agents|respiratory system agents|mesh-ancestor
93149281|NCT00119015|Dermatologic Agents|dermatologic agents|mesh-ancestor
93149282|NCT00119015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93149283|NCT00119015|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93149284|NCT00119015|Hormone Antagonists|hormone antagonists|mesh-ancestor
93149285|NCT00119015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149286|NCT00119015|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93149287|NCT00119015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93149288|NCT00119015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149289|NCT03557307|Benralizumab|benralizumab|mesh-list
93149290|NCT03557307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93149291|NCT03557307|Respiratory System Agents|respiratory system agents|mesh-ancestor
93149292|NCT01079351|Carbamazepine|carbamazepine|mesh-list
93149293|NCT01079351|Anticonvulsants|anticonvulsants|mesh-ancestor
93149294|NCT01079351|Antimanic Agents|antimanic agents|mesh-ancestor
93149295|NCT01079351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93149296|NCT01079351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149297|NCT01079351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149298|NCT01079351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93149299|NCT01079351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149300|NCT01079351|Analgesics|analgesics|mesh-ancestor
93149301|NCT01079351|Sensory System Agents|sensory system agents|mesh-ancestor
93149302|NCT01079351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149303|NCT01079351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93149304|NCT01079351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93149305|NCT01079351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149306|NCT01079351|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93149307|NCT01079351|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93149308|NCT00104104|Zoledronic Acid|zoledronic acid|mesh-list
93149309|NCT00104104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93149310|NCT00104104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149311|NCT02158624|Ranibizumab|ranibizumab|mesh-list
93149312|NCT02158624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149313|NCT02158624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149314|NCT02158624|Growth Substances|growth substances|mesh-ancestor
93149315|NCT02158624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149316|NCT02158624|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149317|NCT02158624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149318|NCT00115739|Imatinib Mesylate|imatinib mesylate|mesh-list
93149319|NCT00115739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149320|NCT00115739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149321|NCT00115739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149322|NCT00115739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149323|NCT03639519|Ascorbic Acid|ascorbic acid|mesh-list
93149324|NCT03639519|Antioxidants|antioxidants|mesh-ancestor
93149325|NCT03639519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149326|NCT03639519|Protective Agents|protective agents|mesh-ancestor
93149327|NCT03639519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149328|NCT03639519|Vitamins|vitamins|mesh-ancestor
93149329|NCT03639519|Micronutrients|micronutrients|mesh-ancestor
93149330|NCT02158702|Dexamethasone|dexamethasone|mesh-list
93149331|NCT02158702|Pomalidomide|pomalidomide|mesh-list
93149332|NCT02158702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149333|NCT02158702|Antiemetics|antiemetics|mesh-ancestor
93149334|NCT02158702|Autonomic Agents|autonomic agents|mesh-ancestor
93149335|NCT02158702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149336|NCT02158702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149337|NCT02158702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93149338|NCT02158702|Glucocorticoids|glucocorticoids|mesh-ancestor
93149339|NCT02158702|Hormones|hormones|mesh-ancestor
93149340|NCT02158702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149341|NCT02158702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93149342|NCT02158702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149343|NCT02158702|Immunologic Factors|immunologic factors|mesh-ancestor
93149344|NCT02158702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149345|NCT02158702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149346|NCT02158702|Growth Substances|growth substances|mesh-ancestor
93149347|NCT02158702|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149348|NCT03725709|Anesthetics|anesthetics|mesh-list
93149349|NCT03725709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149350|NCT03725709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149351|NCT01761890|Dasatinib|dasatinib|mesh-list
93149352|NCT01761890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149353|NCT01761890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149354|NCT01761890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149355|NCT01761890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149356|NCT02160028|Anesthetics|anesthetics|mesh-list
93149357|NCT02160028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149358|NCT02160028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149359|NCT03246152|Bevacizumab|bevacizumab|mesh-list
93149360|NCT03246152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149361|NCT03246152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149362|NCT03246152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149363|NCT03246152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149364|NCT03246152|Growth Substances|growth substances|mesh-ancestor
93149365|NCT03246152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149366|NCT03246152|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149367|NCT03541564|Moxifloxacin|moxifloxacin|mesh-list
93149368|NCT03541564|Deucravacitinib|deucravacitinib|mesh-list
93149369|NCT03541564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149370|NCT03541564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149371|NCT03541564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93149372|NCT03541564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93149373|NCT03541564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149374|NCT03541564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149375|NCT03541564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149376|NCT03541564|Dermatologic Agents|dermatologic agents|mesh-ancestor
93149377|NCT03541564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149378|NCT00115349|Deferiprone|deferiprone|mesh-list
93149379|NCT00115349|Deferoxamine|deferoxamine|mesh-list
93149380|NCT00115349|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93149381|NCT00115349|Chelating Agents|chelating agents|mesh-ancestor
93149382|NCT00115349|Sequestering Agents|sequestering agents|mesh-ancestor
93149383|NCT00115349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149384|NCT00115349|Siderophores|siderophores|mesh-ancestor
93149385|NCT04804696|Paclitaxel|paclitaxel|mesh-list
93149386|NCT04804696|Cisplatin|cisplatin|mesh-list
93149387|NCT04804696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93149388|NCT04804696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149389|NCT04804696|Tubulin Modulators|tubulin modulators|mesh-ancestor
93149390|NCT04804696|Antimitotic Agents|antimitotic agents|mesh-ancestor
93149391|NCT04804696|Mitosis Modulators|mitosis modulators|mesh-ancestor
93149392|NCT04804696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149393|NCT00115037|Naltrexone|naltrexone|mesh-list
93149394|NCT00115037|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93149395|NCT00115037|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93149396|NCT00115037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149397|NCT00115037|Sensory System Agents|sensory system agents|mesh-ancestor
93149398|NCT00115037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149399|NCT02160106|Vactosertib|vactosertib|mesh-list
93149400|NCT02160106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149401|NCT02160106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149402|NCT02160106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149403|NCT02160184|Pancrelipase|pancrelipase|mesh-list
93149404|NCT02160184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93149405|NCT03725553|Vasopressins|vasopressins|mesh-list
93149406|NCT03725553|Arginine Vasopressin|arginine vasopressin|mesh-list
93149407|NCT03725553|Hemostatics|hemostatics|mesh-ancestor
93149408|NCT03725553|Coagulants|coagulants|mesh-ancestor
93149409|NCT03725553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93149410|NCT03725553|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93149411|NCT03725553|Natriuretic Agents|natriuretic agents|mesh-ancestor
93149412|NCT03725553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149413|NCT03213626|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93149414|NCT03213626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821594|NCT02586649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93149415|NCT03213626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149416|NCT03213626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149417|NCT03213626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149418|NCT03604341|Dronabinol|dronabinol|mesh-list
93149419|NCT03604341|Hallucinogens|hallucinogens|mesh-ancestor
93149420|NCT03604341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149421|NCT03604341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93149422|NCT03604341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149423|NCT03604341|Analgesics|analgesics|mesh-ancestor
93149424|NCT03604341|Sensory System Agents|sensory system agents|mesh-ancestor
93149425|NCT03604341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149426|NCT03604341|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93149427|NCT03604341|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93149428|NCT03604341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149429|NCT03604341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149430|NCT03604341|Hormones|hormones|mesh-ancestor
93149431|NCT03604341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149432|NCT02160574|Chlorhexidine|chlorhexidine|mesh-list
93149433|NCT02160574|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93149434|NCT02160574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93149435|NCT02160574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149436|NCT02160574|Disinfectants|disinfectants|mesh-ancestor
93149437|NCT02160574|Dermatologic Agents|dermatologic agents|mesh-ancestor
93149438|NCT03560960|Pramlintide|pramlintide|mesh-list
93149439|NCT03560960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149440|NCT03560960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149441|NCT01186640|Cyclophosphamide|cyclophosphamide|mesh-list
93149442|NCT01186640|Fludarabine|fludarabine|mesh-list
93149443|NCT01186640|Fludarabine phosphate|fludarabine phosphate|mesh-list
93149444|NCT01186640|Mitoxantrone|mitoxantrone|mesh-list
93149445|NCT01186640|Alemtuzumab|alemtuzumab|mesh-list
93149446|NCT01186640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149447|NCT01186640|Immunologic Factors|immunologic factors|mesh-ancestor
93149448|NCT01186640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149449|NCT01186640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149450|NCT01186640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93149451|NCT01186640|Alkylating Agents|alkylating agents|mesh-ancestor
93149452|NCT01186640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149453|NCT01186640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149454|NCT01186640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93149455|NCT01186640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93149456|NCT01186640|Antimetabolites|antimetabolites|mesh-ancestor
93149457|NCT01186640|Analgesics|analgesics|mesh-ancestor
93149458|NCT01186640|Sensory System Agents|sensory system agents|mesh-ancestor
93149459|NCT01186640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149460|NCT01186640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93149461|NCT01186640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93149462|NCT01186640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149463|NCT01186640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149464|NCT04949516|Aspirin|aspirin|mesh-list
93149465|NCT04949516|Colchicine|colchicine|mesh-list
93149466|NCT04949516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149467|NCT04949516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149468|NCT04949516|Analgesics|analgesics|mesh-ancestor
93149469|NCT04949516|Sensory System Agents|sensory system agents|mesh-ancestor
93149470|NCT04949516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149471|NCT04949516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149472|NCT04949516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149473|NCT04949516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149474|NCT04949516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93149475|NCT04949516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93149476|NCT04949516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149477|NCT04949516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93149478|NCT04949516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93149479|NCT04949516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149480|NCT04949516|Antipyretics|antipyretics|mesh-ancestor
93149481|NCT04949516|Gout Suppressants|gout suppressants|mesh-ancestor
93149482|NCT04949516|Tubulin Modulators|tubulin modulators|mesh-ancestor
93149483|NCT04949516|Antimitotic Agents|antimitotic agents|mesh-ancestor
93149484|NCT04949516|Mitosis Modulators|mitosis modulators|mesh-ancestor
93149485|NCT04949516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149486|NCT00114959|Imatinib Mesylate|imatinib mesylate|mesh-list
93149487|NCT00114959|Homoharringtonine|homoharringtonine|mesh-list
93149488|NCT00114959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149489|NCT00114959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149490|NCT00114959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928157|NCT02178761|Everolimus|everolimus|mesh-list
93149491|NCT00114959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149492|NCT00114959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92821675|NCT00617253|Sunitinib|sunitinib|mesh-list
93149493|NCT00114959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93149494|NCT02778100|Phenylephrine|phenylephrine|mesh-list
93149495|NCT02778100|Oxymetazoline|oxymetazoline|mesh-list
93149496|NCT02778100|Glucagon|glucagon|mesh-list
93149497|NCT02778100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93149498|NCT02778100|Hormones|hormones|mesh-ancestor
93149499|NCT02778100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149500|NCT02778100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149501|NCT02778100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93149502|NCT02778100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93149503|NCT02778100|Adrenergic Agents|adrenergic agents|mesh-ancestor
93149504|NCT02778100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149505|NCT02778100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149506|NCT02778100|Sympathomimetics|sympathomimetics|mesh-ancestor
93149507|NCT02778100|Autonomic Agents|autonomic agents|mesh-ancestor
93149508|NCT02778100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149509|NCT02778100|Nasal Decongestants|nasal decongestants|mesh-ancestor
93149510|NCT02778100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93149511|NCT02778100|Respiratory System Agents|respiratory system agents|mesh-ancestor
93149512|NCT02778100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93149513|NCT02778100|Mydriatics|mydriatics|mesh-ancestor
93149514|NCT02778100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93149515|NCT02778100|Protective Agents|protective agents|mesh-ancestor
93149516|NCT02159248|Tolfenamic acid|tolfenamic acid|mesh-list
93149517|NCT02159248|Gemcitabine|gemcitabine|mesh-list
93149518|NCT02159248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93149519|NCT02159248|Antimetabolites|antimetabolites|mesh-ancestor
93149520|NCT02159248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149521|NCT02159248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149522|NCT02159248|Analgesics|analgesics|mesh-ancestor
93149523|NCT02159248|Sensory System Agents|sensory system agents|mesh-ancestor
93149524|NCT02159248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149525|NCT02159248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149526|NCT02159248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149527|NCT02159248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149528|NCT02159248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149529|NCT02159248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149530|NCT02159248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93149531|NCT02159248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93149532|NCT02159248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93149533|NCT02159248|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
93149534|NCT02159248|Hormone Antagonists|hormone antagonists|mesh-ancestor
93149535|NCT02159248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149536|NCT02159248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93149537|NCT02159248|Serotonin Agents|serotonin agents|mesh-ancestor
93149538|NCT02159248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149539|NCT00118157|Tamoxifen|tamoxifen|mesh-list
93149540|NCT00118157|Lapatinib|lapatinib|mesh-list
93149541|NCT00118157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149542|NCT00118157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93149543|NCT00118157|Hormone Antagonists|hormone antagonists|mesh-ancestor
93149544|NCT00118157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149545|NCT00118157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149546|NCT00118157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93149547|NCT00118157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149548|NCT00118157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93149549|NCT00118157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93149550|NCT00118157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93149551|NCT00118157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149552|NCT00118157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149553|NCT03543202|Anesthetics|anesthetics|mesh-list
93149554|NCT03543202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149555|NCT03543202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149556|NCT03552549|Interferons|interferons|mesh-list
93149557|NCT03552549|Interferon-alpha|interferon-alpha|mesh-list
93149558|NCT03552549|Interferon alpha-2|interferon alpha-2|mesh-list
93149559|NCT03552549|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93149560|NCT03552549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149561|NCT03552549|Antiviral Agents|antiviral agents|mesh-ancestor
93149562|NCT03552549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149563|NCT03552549|Immunologic Factors|immunologic factors|mesh-ancestor
93149564|NCT03552549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149565|NCT00117845|Denileukin diftitox|denileukin diftitox|mesh-list
92821741|NCT04904965|Anesthetics|anesthetics|mesh-ancestor
93149566|NCT00117845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149568|NCT02761642|Hematinics|hematinics|mesh-ancestor
93149569|NCT03731403|Fluorides|fluorides|mesh-list
93149570|NCT03731403|Cariostatic Agents|cariostatic agents|mesh-ancestor
93149571|NCT03731403|Protective Agents|protective agents|mesh-ancestor
93149572|NCT03731403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149573|NCT03189524|Zanubrutinib|zanubrutinib|mesh-list
93149574|NCT03189524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149575|NCT03189524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149576|NCT03189524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149577|NCT03189524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149578|NCT03600909|Cyclophosphamide|cyclophosphamide|mesh-list
93149579|NCT03600909|Busulfan|busulfan|mesh-list
93149580|NCT03600909|Fludarabine|fludarabine|mesh-list
93149581|NCT03600909|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93149582|NCT03600909|Thymoglobulin|thymoglobulin|mesh-list
93149583|NCT03600909|Lenograstim|lenograstim|mesh-list
93149584|NCT03600909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149585|NCT03600909|Immunologic Factors|immunologic factors|mesh-ancestor
93149586|NCT03600909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149587|NCT03600909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149588|NCT03600909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93149589|NCT03600909|Alkylating Agents|alkylating agents|mesh-ancestor
93149590|NCT03600909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149591|NCT03600909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149592|NCT03600909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93149593|NCT03600909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93149594|NCT03189446|Paclitaxel|paclitaxel|mesh-list
93149595|NCT03189446|Carboplatin|carboplatin|mesh-list
93149596|NCT03189446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93149597|NCT03189446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149598|NCT03189446|Tubulin Modulators|tubulin modulators|mesh-ancestor
93149599|NCT03189446|Antimitotic Agents|antimitotic agents|mesh-ancestor
93149600|NCT03189446|Mitosis Modulators|mitosis modulators|mesh-ancestor
93149601|NCT03189446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149602|NCT03568461|Tisagenlecleucel|tisagenlecleucel|mesh-list
93149603|NCT03568461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149604|NCT03568461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149605|NCT01314482|Minocycline|minocycline|mesh-list
93149606|NCT01314482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149607|NCT01314482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149608|NCT03188120|Tiotropium Bromide|tiotropium bromide|mesh-list
93149609|NCT03188120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93149610|NCT03188120|Autonomic Agents|autonomic agents|mesh-ancestor
93149611|NCT03188120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149612|NCT03188120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149613|NCT03188120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93149614|NCT03188120|Respiratory System Agents|respiratory system agents|mesh-ancestor
93149615|NCT03188120|Parasympatholytics|parasympatholytics|mesh-ancestor
93149616|NCT03188120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93149617|NCT03188120|Cholinergic Agents|cholinergic agents|mesh-ancestor
93149618|NCT03188120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149619|NCT03188120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149620|NCT02895945|Factor VIII|factor viii|mesh-list
93149621|NCT02895945|Coagulants|coagulants|mesh-ancestor
93149622|NCT02777554|Thalidomide|thalidomide|mesh-list
93149623|NCT02777554|Apremilast|apremilast|mesh-list
93149624|NCT02777554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149625|NCT02777554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149626|NCT02777554|Analgesics|analgesics|mesh-ancestor
93149627|NCT02777554|Sensory System Agents|sensory system agents|mesh-ancestor
93149628|NCT02777554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149629|NCT02777554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149630|NCT02777554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149631|NCT02777554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149632|NCT02777554|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93149633|NCT02777554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93149634|NCT02777554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149635|NCT02777554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149636|NCT02777554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149637|NCT02777554|Immunologic Factors|immunologic factors|mesh-ancestor
93149638|NCT02777554|Leprostatic Agents|leprostatic agents|mesh-ancestor
93149639|NCT02777554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149640|NCT02777554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149641|NCT02777554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149642|NCT02777554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149643|NCT02777554|Growth Substances|growth substances|mesh-ancestor
93149644|NCT02777554|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149645|NCT02777554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149646|NCT03220178|Letrozole|letrozole|mesh-list
93149647|NCT03220178|Fulvestrant|fulvestrant|mesh-list
93149648|NCT03220178|Palbociclib|palbociclib|mesh-list
93149649|NCT03220178|Anastrozole|anastrozole|mesh-list
93149650|NCT03220178|Exemestane|exemestane|mesh-list
93149651|NCT03220178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149652|NCT03220178|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93149653|NCT03220178|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93149654|NCT03220178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149655|NCT03220178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149656|NCT03220178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93149657|NCT03220178|Hormone Antagonists|hormone antagonists|mesh-ancestor
93149658|NCT03220178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149659|NCT03220178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149660|NCT03220178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93149661|NCT03220178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93149662|NCT03220178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149663|NCT03032510|Levofloxacin|levofloxacin|mesh-list
93149664|NCT03032510|Ertapenem|ertapenem|mesh-list
93149665|NCT03032510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93149666|NCT03032510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149667|NCT03032510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149668|NCT03032510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93149669|NCT03032510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93149670|NCT03032510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149671|NCT03032510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149672|NCT03032510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149673|NCT03032510|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93149674|NCT03032510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93149675|NCT03022292|Aflibercept|aflibercept|mesh-list
93149676|NCT03022292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149677|NCT03022292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149678|NCT03022292|Growth Substances|growth substances|mesh-ancestor
93149679|NCT03022292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149680|NCT03022292|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149681|NCT03022292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149682|NCT03599193|Nicotinic Acids|nicotinic acids|mesh-list
93149683|NCT03599193|Tazarotene|tazarotene|mesh-list
93149684|NCT03599193|Dermatologic Agents|dermatologic agents|mesh-ancestor
93149685|NCT03599193|Keratolytic Agents|keratolytic agents|mesh-ancestor
93149686|NCT03599193|Vitamin B Complex|vitamin b complex|mesh-ancestor
93149687|NCT03599193|Vitamins|vitamins|mesh-ancestor
93149688|NCT03599193|Micronutrients|micronutrients|mesh-ancestor
93149689|NCT03599193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149690|NCT02161354|Buprenorphine|buprenorphine|mesh-list
93149691|NCT02161354|Naloxone|naloxone|mesh-list
93149692|NCT02161354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93149693|NCT02161354|Narcotics|narcotics|mesh-ancestor
93149694|NCT02161354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149695|NCT02161354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149696|NCT02161354|Analgesics|analgesics|mesh-ancestor
93149697|NCT02161354|Sensory System Agents|sensory system agents|mesh-ancestor
93149698|NCT02161354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149699|NCT02161354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93149700|NCT03166124|Insulin Lispro|insulin lispro|mesh-list
93149701|NCT03166124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149702|NCT03166124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149703|NCT02777242|Methyltestosterone|methyltestosterone|mesh-list
93149704|NCT02777242|Testosterone|testosterone|mesh-list
93149705|NCT02777242|Testosterone undecanoate|testosterone undecanoate|mesh-list
93149706|NCT02777242|Testosterone enanthate|testosterone enanthate|mesh-list
93149707|NCT02777242|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93149708|NCT02777242|Androgens|androgens|mesh-ancestor
93149709|NCT02777242|Hormones|hormones|mesh-ancestor
93149710|NCT02777242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149711|NCT02777242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149712|NCT02777242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93149713|NCT02777242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149714|NCT02777242|Anabolic Agents|anabolic agents|mesh-ancestor
93149715|NCT02163070|Vitamins|vitamins|mesh-list
93149716|NCT02163070|Vitamin E|vitamin e|mesh-list
93149717|NCT02163070|Micronutrients|micronutrients|mesh-ancestor
93149718|NCT02163070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149720|NCT02163070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149721|NCT02163070|Protective Agents|protective agents|mesh-ancestor
93149722|NCT03484520|Venetoclax|venetoclax|mesh-list
93149723|NCT03484520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149724|NCT03566979|Naproxen|naproxen|mesh-list
93149725|NCT03566979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149726|NCT03566979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149727|NCT03566979|Analgesics|analgesics|mesh-ancestor
93149728|NCT03566979|Sensory System Agents|sensory system agents|mesh-ancestor
93149729|NCT03566979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149730|NCT03566979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149731|NCT03566979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149732|NCT03566979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149733|NCT03566979|Gout Suppressants|gout suppressants|mesh-ancestor
93149734|NCT03566979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93149735|NCT03566979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149736|NCT03566979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149737|NCT00116831|Rosiglitazone|rosiglitazone|mesh-list
93149738|NCT00116831|Glipizide|glipizide|mesh-list
93149739|NCT00116831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93149740|NCT00116831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149741|NCT02784704|Meropenem|meropenem|mesh-list
93149742|NCT02784704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149743|NCT02784704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149744|NCT03540472|Tacrolimus|tacrolimus|mesh-list
93149745|NCT03540472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149746|NCT03540472|Immunologic Factors|immunologic factors|mesh-ancestor
93149747|NCT03540472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149748|NCT03540472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93149749|NCT03540472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149750|NCT03540472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149751|NCT02166814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93149752|NCT02166814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93149753|NCT02166814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93149754|NCT02166814|Antimetabolites|antimetabolites|mesh-ancestor
93149755|NCT02166814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149756|NCT02166814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93149757|NCT02166814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93149758|NCT02166814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149759|NCT01310283|Fluorides|fluorides|mesh-list
93149760|NCT01310283|Fluorides, Topical|fluorides, topical|mesh-list
93149761|NCT01310283|Cariostatic Agents|cariostatic agents|mesh-ancestor
93149762|NCT01310283|Protective Agents|protective agents|mesh-ancestor
93149763|NCT01310283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149764|NCT02161822|Simvastatin|simvastatin|mesh-list
93149765|NCT02161822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93149766|NCT02161822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93149767|NCT02161822|Antimetabolites|antimetabolites|mesh-ancestor
93149768|NCT02161822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149769|NCT02161822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93149770|NCT02161822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93149771|NCT02161822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149772|NCT03183908|Vaccines|vaccines|mesh-list
93149773|NCT03183908|Immunologic Factors|immunologic factors|mesh-ancestor
93149774|NCT03183908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149775|NCT03724851|Vactosertib|vactosertib|mesh-list
93149776|NCT03724851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93149777|NCT03724851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149778|NCT03724851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149779|NCT03565887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93149780|NCT03565887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93149781|NCT00113399|Paclitaxel|paclitaxel|mesh-list
93149782|NCT00113399|Docetaxel|docetaxel|mesh-list
93149783|NCT00113399|Fluorouracil|fluorouracil|mesh-list
93149784|NCT00113399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93149785|NCT00113399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149786|NCT00113399|Tubulin Modulators|tubulin modulators|mesh-ancestor
93149787|NCT00113399|Antimitotic Agents|antimitotic agents|mesh-ancestor
93149788|NCT00113399|Mitosis Modulators|mitosis modulators|mesh-ancestor
93149789|NCT00113399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149790|NCT00113399|Antimetabolites|antimetabolites|mesh-ancestor
93149791|NCT00113399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93149792|NCT00113399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149793|NCT00113399|Immunologic Factors|immunologic factors|mesh-ancestor
93149794|NCT00113399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149795|NCT01326611|Clarithromycin|clarithromycin|mesh-list
93149796|NCT01326611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149797|NCT01326611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149798|NCT01326611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93149799|NCT01326611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149800|NCT01326611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149801|NCT01326611|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93149802|NCT01326611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93149803|NCT00113087|Enalapril|enalapril|mesh-list
93149804|NCT00113087|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93149805|NCT00113087|Protease Inhibitors|protease inhibitors|mesh-ancestor
93149806|NCT00113087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149807|NCT00113087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149808|NCT00113087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93149809|NCT00112463|Romidepsin|romidepsin|mesh-list
93149810|NCT00112463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93149811|NCT00112463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149812|NCT00112463|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93149813|NCT00112463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149814|NCT00112463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149815|NCT01083017|Chlorthalidone|chlorthalidone|mesh-list
93149816|NCT01083017|Antihypertensive Agents|antihypertensive agents|mesh-list
93149817|NCT01083017|Diuretics|diuretics|mesh-ancestor
93149818|NCT01083017|Natriuretic Agents|natriuretic agents|mesh-ancestor
93149819|NCT01083017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149820|NCT01083017|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93149821|NCT01083017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93149822|NCT01083017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149823|NCT00112385|Etanercept|etanercept|mesh-list
93149824|NCT00112385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149825|NCT00112385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149826|NCT00112385|Analgesics|analgesics|mesh-ancestor
93149827|NCT00112385|Sensory System Agents|sensory system agents|mesh-ancestor
93149828|NCT00112385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149829|NCT00112385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149830|NCT00112385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149831|NCT00112385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149832|NCT00112385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93149833|NCT00112385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149834|NCT00112385|Immunologic Factors|immunologic factors|mesh-ancestor
93149835|NCT03731169|Voriconazole|voriconazole|mesh-list
93149836|NCT03731169|Antifungal Agents|antifungal agents|mesh-ancestor
93149837|NCT03731169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149838|NCT03731169|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93149839|NCT03731169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93149840|NCT03731169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149841|NCT03731169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149842|NCT03731169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93149843|NCT03731169|Hormone Antagonists|hormone antagonists|mesh-ancestor
93149844|NCT03731169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149845|NCT03731169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149846|NCT03731169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93149847|NCT03731091|Calcitriol|calcitriol|mesh-list
93149848|NCT03731091|Betamethasone|betamethasone|mesh-list
93149849|NCT03731091|Betamethasone Valerate|betamethasone valerate|mesh-list
93149850|NCT03731091|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93149851|NCT03731091|Betamethasone benzoate|betamethasone benzoate|mesh-list
93149852|NCT03731091|Calcipotriene|calcipotriene|mesh-list
93149853|NCT03731091|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93149854|NCT03731091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149855|NCT03731091|Glucocorticoids|glucocorticoids|mesh-ancestor
93149856|NCT03731091|Hormones|hormones|mesh-ancestor
93149857|NCT03731091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93149858|NCT03731091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149859|NCT03731091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93149860|NCT03731091|Respiratory System Agents|respiratory system agents|mesh-ancestor
93149861|NCT03731091|Dermatologic Agents|dermatologic agents|mesh-ancestor
93149862|NCT03731091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93149863|NCT03731091|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93149864|NCT03731091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366314|NCT02058485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149865|NCT03731091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149866|NCT03731091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93149867|NCT03731091|Vitamins|vitamins|mesh-ancestor
93149868|NCT03731091|Micronutrients|micronutrients|mesh-ancestor
93149869|NCT03731091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93149870|NCT03547167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93149871|NCT03547167|Immunologic Factors|immunologic factors|mesh-ancestor
93149872|NCT03547167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149873|NCT03560739|Ofatumumab|ofatumumab|mesh-list
93149874|NCT03560739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93149875|NCT03560739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149876|NCT03560739|Immunologic Factors|immunologic factors|mesh-ancestor
93149877|NCT03560739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149878|NCT01310673|Allopurinol|allopurinol|mesh-list
93149879|NCT01310673|Antimetabolites|antimetabolites|mesh-ancestor
93149880|NCT01310673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149881|NCT01310673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149882|NCT01310673|Gout Suppressants|gout suppressants|mesh-ancestor
93149883|NCT01310673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149884|NCT01310673|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93149885|NCT01310673|Antioxidants|antioxidants|mesh-ancestor
93149886|NCT01310673|Protective Agents|protective agents|mesh-ancestor
93149887|NCT01310673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149888|NCT00101686|Bevacizumab|bevacizumab|mesh-list
93149889|NCT00101686|Capecitabine|capecitabine|mesh-list
93149890|NCT00101686|Irinotecan|irinotecan|mesh-list
93149891|NCT00101686|Fluorouracil|fluorouracil|mesh-list
93149892|NCT00101686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149893|NCT00101686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149894|NCT00101686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93149895|NCT00101686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93149896|NCT00101686|Growth Substances|growth substances|mesh-ancestor
93149897|NCT00101686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149898|NCT00101686|Growth Inhibitors|growth inhibitors|mesh-ancestor
93149899|NCT00101686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93149900|NCT00101686|Antimetabolites|antimetabolites|mesh-ancestor
93149901|NCT00101686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149902|NCT00101686|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93149903|NCT00101686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93149904|NCT00101686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149905|NCT00101686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93149906|NCT00101686|Immunologic Factors|immunologic factors|mesh-ancestor
93149907|NCT02163616|Misoprostol|misoprostol|mesh-list
93149908|NCT02163616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93149909|NCT02163616|Abortifacient Agents|abortifacient agents|mesh-ancestor
93149910|NCT02163616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93149911|NCT02163616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149912|NCT02163616|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93149913|NCT02163616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93149914|NCT02163616|Oxytocics|oxytocics|mesh-ancestor
93149915|NCT00101452|Escitalopram|escitalopram|mesh-list
93149916|NCT00101452|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93149917|NCT00101452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93149918|NCT00101452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93149919|NCT00101452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149920|NCT00101452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149921|NCT00101452|Serotonin Agents|serotonin agents|mesh-ancestor
93149922|NCT00101452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149923|NCT02162134|Cefuroxime|cefuroxime|mesh-list
93149924|NCT02162134|Cefuroxime axetil|cefuroxime axetil|mesh-list
93149925|NCT02162134|Ketorolac|ketorolac|mesh-list
93149926|NCT02162134|Midazolam|midazolam|mesh-list
93149927|NCT02162134|Propofol|propofol|mesh-list
93149928|NCT02162134|Sevoflurane|sevoflurane|mesh-list
93149929|NCT02162134|Atracurium|atracurium|mesh-list
93149930|NCT02162134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93149931|NCT02162134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149932|NCT02162134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149933|NCT02162134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93149934|NCT02162134|Anesthetics, General|anesthetics, general|mesh-ancestor
93149935|NCT02162134|Anesthetics|anesthetics|mesh-ancestor
93149936|NCT02162134|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93149937|NCT02162134|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93149938|NCT02162134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93149939|NCT02162134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93149940|NCT02162134|GABA Modulators|gaba modulators|mesh-ancestor
93149941|NCT02162134|GABA Agents|gaba agents|mesh-ancestor
93149942|NCT02162134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149943|NCT02162134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149944|NCT02162134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93149945|NCT02162134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93149946|NCT02162134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93149947|NCT02162134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93149948|NCT02162134|Analgesics|analgesics|mesh-ancestor
93149949|NCT02162134|Sensory System Agents|sensory system agents|mesh-ancestor
93149950|NCT02162134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149951|NCT02162134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93149952|NCT02162134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93149953|NCT02162134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93149954|NCT02162134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149955|NCT02162134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93149956|NCT02162134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149957|NCT02162134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93149958|NCT02162134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93149959|NCT02162134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93149960|NCT02162134|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93149961|NCT02162134|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93149962|NCT02162134|Cholinergic Agents|cholinergic agents|mesh-ancestor
93149963|NCT02164006|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93149964|NCT02164006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93149965|NCT02164006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149966|NCT02164006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149967|NCT02164006|Immunotoxins|immunotoxins|mesh-ancestor
93149968|NCT02164006|Immunoconjugates|immunoconjugates|mesh-ancestor
93149969|NCT02164006|Immunologic Factors|immunologic factors|mesh-ancestor
93149970|NCT02164006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149971|NCT02167360|Tisagenlecleucel|tisagenlecleucel|mesh-list
93149972|NCT02167360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93149973|NCT02167360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93149974|NCT03546621|Tenofovir|tenofovir|mesh-list
93149975|NCT03546621|Antiviral Agents|antiviral agents|mesh-ancestor
93149976|NCT03546621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93149977|NCT03546621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93149978|NCT03546621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93149979|NCT03546621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93149980|NCT03546621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149981|NCT03546621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93149982|NCT03546621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93149983|NCT02761330|Ketamine|ketamine|mesh-list
93149984|NCT02761330|Analgesics|analgesics|mesh-ancestor
93149985|NCT02761330|Sensory System Agents|sensory system agents|mesh-ancestor
93149986|NCT02761330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93149987|NCT02761330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93149988|NCT02761330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93149989|NCT02761330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93149990|NCT02761330|Anesthetics, General|anesthetics, general|mesh-ancestor
93149991|NCT02761330|Anesthetics|anesthetics|mesh-ancestor
93149992|NCT02761330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93149993|NCT02761330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93149994|NCT02761330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93149995|NCT02761330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93149996|NCT02761330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93149997|NCT03730857|Olanzapine|olanzapine|mesh-list
93149998|NCT03730857|Risperidone|risperidone|mesh-list
93149999|NCT03730857|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93150000|NCT03730857|Antipsychotic Agents|antipsychotic agents|mesh-list
93150001|NCT03730857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93150002|NCT03730857|Serotonin Agents|serotonin agents|mesh-ancestor
93150003|NCT03730857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150004|NCT03730857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150005|NCT03730857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150006|NCT03730857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150007|NCT03730857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150008|NCT03730857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150009|NCT03730857|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93150010|NCT03730857|Dopamine Agents|dopamine agents|mesh-ancestor
93150011|NCT03730857|Antiemetics|antiemetics|mesh-ancestor
93150012|NCT03730857|Autonomic Agents|autonomic agents|mesh-ancestor
93150013|NCT03730857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150014|NCT03730857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150015|NCT03730857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93150016|NCT03730857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93150017|NCT03730857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150018|NCT03730857|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93150019|NCT03730857|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93150021|NCT03726177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93150022|NCT03726177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150023|NCT03726177|Analgesics|analgesics|mesh-ancestor
93150024|NCT03726177|Sensory System Agents|sensory system agents|mesh-ancestor
93150025|NCT03726177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150026|NCT03726177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150027|NCT03726177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93150028|NCT03726177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150029|NCT03726177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93150030|NCT03726177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93150031|NCT03726177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150032|NCT03726177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93150033|NCT03726177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93150034|NCT03726177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150035|NCT03726177|Antipyretics|antipyretics|mesh-ancestor
93150036|NCT03726099|Amoxicillin|amoxicillin|mesh-list
93150037|NCT03726099|Tetracycline|tetracycline|mesh-list
93150038|NCT03726099|Furazolidone|furazolidone|mesh-list
93150039|NCT03726099|Esomeprazole|esomeprazole|mesh-list
93150040|NCT03726099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93150041|NCT03726099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150042|NCT03726099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93150043|NCT03726099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150044|NCT03726099|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93150045|NCT03726099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150046|NCT03726099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150047|NCT03726099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93150048|NCT03726099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93150049|NCT03726099|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93150050|NCT03726099|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93150051|NCT03726099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93150052|NCT03726099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93150053|NCT03726099|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93150054|NCT03723759|Insulin Aspart|insulin aspart|mesh-list
93150055|NCT03723759|Insulin, Long-Acting|insulin, long-acting|mesh-list
93150056|NCT03723759|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93150057|NCT03723759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150058|NCT03723759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150059|NCT03558555|Acetaminophen|acetaminophen|mesh-list
93150060|NCT03558555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150061|NCT03558555|Analgesics|analgesics|mesh-ancestor
93150062|NCT03558555|Sensory System Agents|sensory system agents|mesh-ancestor
93150063|NCT03558555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150064|NCT03558555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150065|NCT03558555|Antipyretics|antipyretics|mesh-ancestor
93150066|NCT03726021|Oxaliplatin|oxaliplatin|mesh-list
93150067|NCT03726021|Irinotecan|irinotecan|mesh-list
93150068|NCT03726021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150069|NCT03726021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93150070|NCT03726021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150071|NCT03726021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150072|NCT03726021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150073|NCT05665023|Bevacizumab|bevacizumab|mesh-list
93150074|NCT05665023|Folfirinox|folfirinox|mesh-list
93150075|NCT05665023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93150076|NCT05665023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150077|NCT05665023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93150078|NCT05665023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93150079|NCT05665023|Growth Substances|growth substances|mesh-ancestor
93150080|NCT05665023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150081|NCT05665023|Growth Inhibitors|growth inhibitors|mesh-ancestor
93150082|NCT03557931|Olanzapine|olanzapine|mesh-list
93150083|NCT03557931|Risperidone|risperidone|mesh-list
93150084|NCT03557931|Aripiprazole|aripiprazole|mesh-list
93150085|NCT03557931|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93150086|NCT03557931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93150087|NCT03557931|Ziprasidone|ziprasidone|mesh-list
93150088|NCT03557931|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93150089|NCT03557931|Brexpiprazole|brexpiprazole|mesh-list
93150090|NCT03557931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93150091|NCT03557931|Serotonin Agents|serotonin agents|mesh-ancestor
93150092|NCT03557931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150093|NCT03557931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150094|NCT03557931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150095|NCT03557931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93150096|NCT03557931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150097|NCT03557931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150098|NCT03557931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150099|NCT03557931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93150100|NCT03557931|Dopamine Agents|dopamine agents|mesh-ancestor
93150101|NCT03557931|Antiemetics|antiemetics|mesh-ancestor
93150102|NCT03557931|Autonomic Agents|autonomic agents|mesh-ancestor
93150103|NCT03557931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150104|NCT03557931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150105|NCT03557931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93150106|NCT03557931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93150107|NCT03557931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150108|NCT03557931|Antidepressive Agents|antidepressive agents|mesh-ancestor
93150109|NCT03557931|Dopamine Agonists|dopamine agonists|mesh-ancestor
93150110|NCT03557931|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93150111|NCT03557931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93150112|NCT03557931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93150113|NCT03557931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93150114|NCT03557931|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93150115|NCT03557931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93150116|NCT03557931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93150117|NCT03557931|Adrenergic Agents|adrenergic agents|mesh-ancestor
93150118|NCT03977675|Ketamine|ketamine|mesh-list
93150119|NCT03977675|Analgesics|analgesics|mesh-ancestor
93150120|NCT03977675|Sensory System Agents|sensory system agents|mesh-ancestor
93150121|NCT03977675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150122|NCT03977675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150123|NCT03977675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93150124|NCT03977675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93150125|NCT03977675|Anesthetics, General|anesthetics, general|mesh-ancestor
93150126|NCT03977675|Anesthetics|anesthetics|mesh-ancestor
93150127|NCT03977675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150128|NCT03977675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93150129|NCT03977675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93150130|NCT03977675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150131|NCT03977675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150132|NCT01066559|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
93150133|NCT01066559|Vasodilator Agents|vasodilator agents|mesh-ancestor
93150134|NCT01066559|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93150135|NCT01066559|Protective Agents|protective agents|mesh-ancestor
93150136|NCT01066559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150137|NCT00293813|Denosumab|denosumab|mesh-list
93150138|NCT00293813|Alendronate|alendronate|mesh-list
93150139|NCT00293813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93150140|NCT00293813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150141|NCT00293579|Pemetrexed|pemetrexed|mesh-list
93150142|NCT00293579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150143|NCT00293579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150144|NCT00293579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150145|NCT00293579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93150146|NCT00293579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93150147|NCT00293423|polysaccharide-K|polysaccharide-k|mesh-list
93150148|NCT00293423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93150149|NCT00293423|Immunologic Factors|immunologic factors|mesh-ancestor
93150150|NCT00293423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150151|NCT00293423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93150152|NCT00293423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150153|NCT00293423|Antiviral Agents|antiviral agents|mesh-ancestor
93150154|NCT00293423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150155|NCT00293423|Interferon Inducers|interferon inducers|mesh-ancestor
93150156|NCT00293423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93150157|NCT00293423|Protective Agents|protective agents|mesh-ancestor
93150158|NCT03521817|Ethanol|ethanol|mesh-list
93150159|NCT03521817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93150160|NCT03521817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150161|NCT03521817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150162|NCT03521817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150163|NCT03538431|Buspirone|buspirone|mesh-list
93150164|NCT03538431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92822358|NCT05674201|Propofol|propofol|mesh-list
93150165|NCT03538431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150166|NCT03538431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150167|NCT03538431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150168|NCT03538431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150169|NCT03538431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93150170|NCT03538431|Serotonin Agents|serotonin agents|mesh-ancestor
93150171|NCT03538431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150172|NCT03538431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150173|NCT03521193|Aspirin|aspirin|mesh-list
93150174|NCT03521193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93150175|NCT03521193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150176|NCT03521193|Analgesics|analgesics|mesh-ancestor
93150177|NCT03521193|Sensory System Agents|sensory system agents|mesh-ancestor
93150178|NCT03521193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150179|NCT03521193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150180|NCT03521193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93150181|NCT03521193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150182|NCT03521193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93150183|NCT03521193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93150184|NCT03521193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150185|NCT03521193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93150186|NCT03521193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93150187|NCT03521193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150188|NCT03521193|Antipyretics|antipyretics|mesh-ancestor
93150189|NCT00293267|Raltegravir Potassium|raltegravir potassium|mesh-list
93150190|NCT00293267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93150191|NCT00293267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93150192|NCT00293267|Antiviral Agents|antiviral agents|mesh-ancestor
93150193|NCT00293267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150194|NCT00293267|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93150195|NCT00293267|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93150196|NCT00293267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150197|NCT00293267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150198|NCT03977441|Pramipexole|pramipexole|mesh-list
93150199|NCT03977441|Agomelatine|agomelatine|mesh-list
93150200|NCT03977441|Antioxidants|antioxidants|mesh-ancestor
93150201|NCT03977441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150202|NCT03977441|Protective Agents|protective agents|mesh-ancestor
93150203|NCT03977441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150204|NCT03977441|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93150205|NCT03977441|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93150206|NCT03977441|Dopamine Agonists|dopamine agonists|mesh-ancestor
93150207|NCT03977441|Dopamine Agents|dopamine agents|mesh-ancestor
93150208|NCT03977441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150209|NCT03977441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93150210|NCT03977441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150211|NCT03536949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93150212|NCT03536949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93150213|NCT01080443|Mycophenolic Acid|mycophenolic acid|mesh-list
93150214|NCT01080443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93150215|NCT01080443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150216|NCT01080443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93150217|NCT01080443|Antitubercular Agents|antitubercular agents|mesh-ancestor
93150218|NCT01080443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93150219|NCT01080443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150220|NCT01080443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150221|NCT01080443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150222|NCT00111917|Infliximab|infliximab|mesh-list
93150223|NCT00111917|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93150224|NCT00111917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93150225|NCT00111917|Dermatologic Agents|dermatologic agents|mesh-ancestor
93150226|NCT00111917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150227|NCT00111917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150228|NCT01067417|Hydroxychloroquine|hydroxychloroquine|mesh-list
93150229|NCT01067417|Antimalarials|antimalarials|mesh-ancestor
93150230|NCT01067417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93150231|NCT01067417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93150232|NCT01067417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150233|NCT01067417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150234|NCT01067417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150235|NCT01067417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150236|NCT03520569|Octreotide|octreotide|mesh-list
93150237|NCT03520569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150238|NCT03520569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93150239|NCT03520569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150240|NCT00111839|Pemetrexed|pemetrexed|mesh-list
93150241|NCT00111839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150242|NCT00111839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150243|NCT00111839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150244|NCT00111839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93150245|NCT00111839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93150246|NCT03723291|Tocopherols|tocopherols|mesh-list
93150247|NCT03723291|Vitamin E|vitamin e|mesh-list
93150248|NCT03723291|Tocotrienols|tocotrienols|mesh-list
93150249|NCT03723291|alpha-Tocopherol|alpha-tocopherol|mesh-list
93150250|NCT03723291|Pentoxifylline|pentoxifylline|mesh-list
93150251|NCT03723291|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93150252|NCT03723291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150253|NCT03723291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150254|NCT03723291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93150255|NCT03723291|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93150256|NCT03723291|Protective Agents|protective agents|mesh-ancestor
93150257|NCT03723291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150258|NCT03723291|Vasodilator Agents|vasodilator agents|mesh-ancestor
93150259|NCT03723291|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93150260|NCT03723291|Antioxidants|antioxidants|mesh-ancestor
93150261|NCT03723291|Vitamins|vitamins|mesh-ancestor
93150262|NCT03723291|Micronutrients|micronutrients|mesh-ancestor
93150263|NCT00111761|Leucovorin|leucovorin|mesh-list
93150264|NCT00111761|Fluorouracil|fluorouracil|mesh-list
93150265|NCT00111761|Irinotecan|irinotecan|mesh-list
93150266|NCT00111761|Panitumumab|panitumumab|mesh-list
93150267|NCT00111761|Antimetabolites|antimetabolites|mesh-ancestor
93150268|NCT00111761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150269|NCT00111761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93150270|NCT00111761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150271|NCT00111761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93150272|NCT00111761|Immunologic Factors|immunologic factors|mesh-ancestor
93150273|NCT00111761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150274|NCT00111761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93150275|NCT00111761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150276|NCT00111761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150277|NCT00111761|Antidotes|antidotes|mesh-ancestor
93150278|NCT00111761|Protective Agents|protective agents|mesh-ancestor
93150279|NCT00111761|Vitamin B Complex|vitamin b complex|mesh-ancestor
93150280|NCT00111761|Vitamins|vitamins|mesh-ancestor
93150281|NCT00111761|Micronutrients|micronutrients|mesh-ancestor
93150282|NCT00111761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93150283|NCT03519867|Bromides|bromides|mesh-list
93150284|NCT03519867|Rocuronium|rocuronium|mesh-list
93150285|NCT03519867|Anticonvulsants|anticonvulsants|mesh-ancestor
93150286|NCT03519867|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93150287|NCT03519867|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93150288|NCT03519867|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93150289|NCT03519867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150290|NCT03519867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150291|NCT03977285|Chlorhexidine|chlorhexidine|mesh-list
93150292|NCT03977285|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93150293|NCT03977285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150294|NCT03977285|Disinfectants|disinfectants|mesh-ancestor
93150295|NCT03730311|Elsulfavirine|elsulfavirine|mesh-list
93150296|NCT03730311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93150297|NCT03730311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93150298|NCT03730311|Antiviral Agents|antiviral agents|mesh-ancestor
93150299|NCT03730311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150300|NCT02763046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93150301|NCT02763046|Immunologic Factors|immunologic factors|mesh-ancestor
93150302|NCT02763046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150303|NCT02164552|Vitamin D|vitamin d|mesh-list
93150304|NCT02164552|Ergocalciferols|ergocalciferols|mesh-list
93150305|NCT02164552|Cholecalciferol|cholecalciferol|mesh-list
93150306|NCT02164552|Vitamins|vitamins|mesh-list
93150307|NCT02164552|Micronutrients|micronutrients|mesh-ancestor
93150308|NCT02164552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150309|NCT02164552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93150310|NCT02164552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93150311|NCT03723135|Azacitidine|azacitidine|mesh-list
93150312|NCT03723135|Cc-486|cc-486|mesh-list
93150313|NCT03723135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93150314|NCT03723135|Antimetabolites|antimetabolites|mesh-ancestor
93150315|NCT03723135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150316|NCT03723135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150317|NCT03723135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150318|NCT02762578|Insulin|insulin|mesh-list
93150320|NCT02762578|Insulin Aspart|insulin aspart|mesh-list
93150321|NCT02762578|Insulin, Long-Acting|insulin, long-acting|mesh-list
93150322|NCT02762578|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93150323|NCT02762578|Biphasic Insulins|biphasic insulins|mesh-list
93150324|NCT02762578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150325|NCT02762578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150326|NCT03540628|Thiamine|thiamine|mesh-list
93150327|NCT03540628|Vitamins|vitamins|mesh-ancestor
93150328|NCT03540628|Micronutrients|micronutrients|mesh-ancestor
93150329|NCT03540628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150330|NCT03540628|Vitamin B Complex|vitamin b complex|mesh-ancestor
93150331|NCT02170948|Dexmedetomidine|dexmedetomidine|mesh-list
93150332|NCT02170948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93150333|NCT02170948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150334|NCT02170948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150335|NCT02170948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150336|NCT02170948|Analgesics|analgesics|mesh-ancestor
93150337|NCT02170948|Sensory System Agents|sensory system agents|mesh-ancestor
93150338|NCT02170948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150339|NCT02170948|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93150340|NCT02170948|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93150341|NCT02170948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93150342|NCT02170948|Adrenergic Agents|adrenergic agents|mesh-ancestor
93150343|NCT02170948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150344|NCT02170948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150345|NCT02171026|Amiodarone|amiodarone|mesh-list
93150346|NCT02171026|Dabigatran|dabigatran|mesh-list
93150347|NCT02171026|Antithrombins|antithrombins|mesh-ancestor
93150348|NCT02171026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93150349|NCT02171026|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150350|NCT02171026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150351|NCT02171026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150352|NCT02171026|Anticoagulants|anticoagulants|mesh-ancestor
93150353|NCT02171026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93150354|NCT02171026|Vasodilator Agents|vasodilator agents|mesh-ancestor
93150355|NCT02171026|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93150356|NCT02171026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150357|NCT02171026|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93150358|NCT02171026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93150359|NCT02171026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93150360|NCT02171026|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93150361|NCT02171026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93150362|NCT02171026|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93150363|NCT02165020|Hyaluronic Acid|hyaluronic acid|mesh-list
93150364|NCT02165020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93150365|NCT02165020|Immunologic Factors|immunologic factors|mesh-ancestor
93150366|NCT02165020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150367|NCT02165020|Viscosupplements|viscosupplements|mesh-ancestor
93150368|NCT02165020|Protective Agents|protective agents|mesh-ancestor
93150369|NCT03514641|Bexagliflozin|bexagliflozin|mesh-list
93150370|NCT03514641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150371|NCT03514641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150372|NCT03539224|Lamivudine|lamivudine|mesh-list
93150373|NCT03539224|Dolutegravir|dolutegravir|mesh-list
93150374|NCT03539224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93150375|NCT03539224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93150376|NCT03539224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150377|NCT03539224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150378|NCT03539224|Antiviral Agents|antiviral agents|mesh-ancestor
93150379|NCT03539224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150380|NCT03539224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93150381|NCT03539224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93150382|NCT03539224|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93150383|NCT03539224|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93150384|NCT02171182|Capsaicin|capsaicin|mesh-list
93150385|NCT02171182|Antipruritics|antipruritics|mesh-ancestor
93150386|NCT02171182|Dermatologic Agents|dermatologic agents|mesh-ancestor
93150387|NCT02171182|Sensory System Agents|sensory system agents|mesh-ancestor
93150388|NCT02171182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150389|NCT02171182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150390|NCT00100828|Irinotecan|irinotecan|mesh-list
93150391|NCT00100828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93150392|NCT00100828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150393|NCT00100828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150394|NCT00100828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150396|NCT02165098|Cariprazine|cariprazine|mesh-list
93150397|NCT02165098|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93150398|NCT02165098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150399|NCT02165098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150400|NCT02165098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150401|NCT02165098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150402|NCT02171338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93150403|NCT02171338|Azithromycin|azithromycin|mesh-list
93150404|NCT02171338|Clarithromycin|clarithromycin|mesh-list
93150405|NCT02171338|Ciprofloxacin|ciprofloxacin|mesh-list
93150406|NCT02171338|Tazobactam|tazobactam|mesh-list
93150407|NCT02171338|Piperacillin|piperacillin|mesh-list
93150408|NCT02171338|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93150409|NCT02171338|Penicillin G|penicillin g|mesh-list
93150410|NCT02171338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150411|NCT02171338|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93150412|NCT02171338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150413|NCT02171338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150414|NCT02171338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93150415|NCT02171338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93150416|NCT02171338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93150417|NCT02171338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150418|NCT02171338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150419|NCT02171338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93150420|NCT02171338|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93150421|NCT02171416|Rilonacept|rilonacept|mesh-list
93150422|NCT02171416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93150423|NCT02171494|Warfarin|warfarin|mesh-list
93150424|NCT02171494|Anticoagulants|anticoagulants|mesh-ancestor
93150425|NCT02165332|Moxifloxacin|moxifloxacin|mesh-list
93150426|NCT02165332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93150427|NCT02165332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93150428|NCT02165332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150429|NCT02165332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93150430|NCT02165332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150431|NCT02165332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150432|NCT02165332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150433|NCT02165332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150434|NCT02165332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93150435|NCT02165332|Contraceptive Agents|contraceptive agents|mesh-ancestor
93150436|NCT02165332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93150437|NCT02165332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150438|NCT02165332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93150439|NCT02165332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93150440|NCT02165332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93150441|NCT02171572|Dabigatran|dabigatran|mesh-list
93150442|NCT02171572|Antithrombins|antithrombins|mesh-ancestor
93150443|NCT02171572|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93150444|NCT02171572|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150445|NCT02171572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150446|NCT02171572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150447|NCT02171572|Anticoagulants|anticoagulants|mesh-ancestor
93150448|NCT02255578|Clomiphene|clomiphene|mesh-list
93150449|NCT02255578|Enclomiphene|enclomiphene|mesh-list
93150450|NCT02255578|Zuclomiphene|zuclomiphene|mesh-list
93150451|NCT02255578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93150452|NCT02255578|Hormone Antagonists|hormone antagonists|mesh-ancestor
93150453|NCT02255578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93150454|NCT02255578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150455|NCT02255578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93150456|NCT02255578|Fertility Agents|fertility agents|mesh-ancestor
93150457|NCT02255578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93150458|NCT02255578|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93150459|NCT02255578|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93150460|NCT02169154|Diclofenac|diclofenac|mesh-list
93150461|NCT02169154|Menthol|menthol|mesh-list
93150462|NCT02169154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93150463|NCT02169154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150464|NCT02169154|Analgesics|analgesics|mesh-ancestor
93150465|NCT02169154|Sensory System Agents|sensory system agents|mesh-ancestor
93150466|NCT02169154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822653|NCT00772954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150467|NCT02169154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150468|NCT02169154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93150469|NCT02169154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150470|NCT02169154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93150471|NCT02169154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150472|NCT02169154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150473|NCT02169154|Antipruritics|antipruritics|mesh-ancestor
93150474|NCT02169154|Dermatologic Agents|dermatologic agents|mesh-ancestor
93150475|NCT00100048|Tenofovir|tenofovir|mesh-list
93150476|NCT00100048|Lamivudine|lamivudine|mesh-list
93150477|NCT00100048|Efavirenz|efavirenz|mesh-list
93150478|NCT00100048|Raltegravir Potassium|raltegravir potassium|mesh-list
93150479|NCT00100048|Antiviral Agents|antiviral agents|mesh-ancestor
93150480|NCT00100048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150481|NCT00100048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93150482|NCT00100048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93150483|NCT00100048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150484|NCT00100048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150485|NCT00100048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93150486|NCT00100048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93150487|NCT00100048|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93150488|NCT00100048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93150489|NCT00100048|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93150490|NCT00100048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93150491|NCT00100048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93150492|NCT00100048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93150493|NCT00100048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93150494|NCT00100048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93150495|NCT02171650|Afatinib|afatinib|mesh-list
93150496|NCT02171650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150497|NCT02171650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93150498|NCT02171650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150499|NCT02171650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150500|NCT02165566|Insulin|insulin|mesh-list
93150501|NCT02165566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93150502|NCT02165566|Insulin Lispro|insulin lispro|mesh-list
93150503|NCT02165566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150504|NCT02165566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150505|NCT02171728|Afatinib|afatinib|mesh-list
93150506|NCT02171728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150507|NCT02171728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93150508|NCT02171728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150509|NCT02171728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150510|NCT02165644|Nimodipine|nimodipine|mesh-list
93150511|NCT02165644|Acetazolamide|acetazolamide|mesh-list
93150512|NCT02165644|Anticonvulsants|anticonvulsants|mesh-ancestor
93150513|NCT02165644|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93150514|NCT02165644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150515|NCT02165644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150516|NCT02165644|Diuretics|diuretics|mesh-ancestor
93150517|NCT02165644|Natriuretic Agents|natriuretic agents|mesh-ancestor
93150518|NCT02165644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150519|NCT02165644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93150520|NCT02165644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93150521|NCT02165644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150522|NCT02165644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93150523|NCT02165644|Vasodilator Agents|vasodilator agents|mesh-ancestor
93150524|NCT02171806|Olodaterol|olodaterol|mesh-list
93150525|NCT02171806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93150526|NCT02171806|Autonomic Agents|autonomic agents|mesh-ancestor
93150527|NCT02171806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150528|NCT02171806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150529|NCT02171806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93150530|NCT02171806|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150531|NCT02169544|Abatacept|abatacept|mesh-list
93150532|NCT02169544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93150533|NCT02169544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150534|NCT02169544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93150535|NCT02169544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150536|NCT02169544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93150537|NCT02169544|Immunologic Factors|immunologic factors|mesh-ancestor
93150538|NCT02169544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150539|NCT02169544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150540|NCT02169856|Cefuroxime|cefuroxime|mesh-list
93150541|NCT02169856|Cefuroxime axetil|cefuroxime axetil|mesh-list
93150542|NCT02169856|Ketorolac|ketorolac|mesh-list
93150543|NCT02169856|Midazolam|midazolam|mesh-list
93150544|NCT02169856|Propofol|propofol|mesh-list
93150545|NCT02169856|Sevoflurane|sevoflurane|mesh-list
93150546|NCT02169856|Atracurium|atracurium|mesh-list
93150547|NCT02169856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93150548|NCT02169856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150549|NCT02169856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150550|NCT02169856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93150551|NCT02169856|Anesthetics, General|anesthetics, general|mesh-ancestor
93150552|NCT02169856|Anesthetics|anesthetics|mesh-ancestor
93150553|NCT02169856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93150554|NCT02169856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93150555|NCT02169856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150556|NCT02169856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150557|NCT02169856|GABA Modulators|gaba modulators|mesh-ancestor
93150558|NCT02169856|GABA Agents|gaba agents|mesh-ancestor
93150559|NCT02169856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150560|NCT02169856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150561|NCT02169856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93150562|NCT02169856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93150563|NCT02169856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93150564|NCT02169856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150565|NCT02169856|Analgesics|analgesics|mesh-ancestor
93150566|NCT02169856|Sensory System Agents|sensory system agents|mesh-ancestor
93150567|NCT02169856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150568|NCT02169856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93150569|NCT02169856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93150570|NCT02169856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93150571|NCT02169856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150572|NCT02169856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93150573|NCT02169856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150574|NCT02169856|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93150575|NCT02169856|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93150576|NCT02169856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93150577|NCT02169856|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93150578|NCT02169856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93150579|NCT02169856|Cholinergic Agents|cholinergic agents|mesh-ancestor
93150580|NCT02170246|Telmisartan|telmisartan|mesh-list
93150581|NCT02170246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93150582|NCT02170246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93150583|NCT02170246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93150584|NCT02170246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150585|NCT02170324|Exenatide|exenatide|mesh-list
93150586|NCT02170324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150587|NCT02170324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150588|NCT02170324|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93150589|NCT02170324|Incretins|incretins|mesh-ancestor
93150590|NCT02170324|Hormones|hormones|mesh-ancestor
93150591|NCT02170324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93150592|NCT02170402|Factor VIII|factor viii|mesh-list
93150593|NCT02170402|Coagulants|coagulants|mesh-ancestor
93150594|NCT02172196|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93150595|NCT02172196|Empagliflozin|empagliflozin|mesh-list
93150596|NCT02172196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150597|NCT02172196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150598|NCT02172196|Incretins|incretins|mesh-ancestor
93150599|NCT02172196|Hormones|hormones|mesh-ancestor
93150600|NCT02172196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93150601|NCT02172196|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93150602|NCT02172196|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150603|NCT02172196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150604|NCT02172196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150605|NCT02172196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93150606|NCT02172274|Empagliflozin|empagliflozin|mesh-list
93150607|NCT02172274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92446332|NCT01667718|Antacids|antacids|mesh-ancestor
93150608|NCT02172274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150609|NCT02172274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150610|NCT02172274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150611|NCT02172352|Tiotropium Bromide|tiotropium bromide|mesh-list
93150612|NCT02172352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93150613|NCT02172352|Autonomic Agents|autonomic agents|mesh-ancestor
93150614|NCT02172352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150615|NCT02172352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150616|NCT02172352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93150617|NCT02172352|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150618|NCT02172352|Parasympatholytics|parasympatholytics|mesh-ancestor
93150619|NCT02172352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93150620|NCT02172352|Cholinergic Agents|cholinergic agents|mesh-ancestor
93150621|NCT02172352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150622|NCT02172352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150623|NCT02757352|Ixekizumab|ixekizumab|mesh-list
93150624|NCT02757352|Dermatologic Agents|dermatologic agents|mesh-ancestor
93150625|NCT02172430|Tiotropium Bromide|tiotropium bromide|mesh-list
93150626|NCT02172430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93150627|NCT02172430|Autonomic Agents|autonomic agents|mesh-ancestor
93150628|NCT02172430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150629|NCT02172430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150630|NCT02172430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93150631|NCT02172430|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150632|NCT02172430|Parasympatholytics|parasympatholytics|mesh-ancestor
93150633|NCT02172430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93150634|NCT02172430|Cholinergic Agents|cholinergic agents|mesh-ancestor
93150635|NCT02172430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150636|NCT02172430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150637|NCT02172508|Tiotropium Bromide|tiotropium bromide|mesh-list
93150638|NCT02172508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93150639|NCT02172508|Autonomic Agents|autonomic agents|mesh-ancestor
93150640|NCT02172508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150641|NCT02172508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150642|NCT02172508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93150643|NCT02172508|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150644|NCT02172508|Parasympatholytics|parasympatholytics|mesh-ancestor
93150645|NCT02172508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93150646|NCT02172508|Cholinergic Agents|cholinergic agents|mesh-ancestor
93150647|NCT02172508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150648|NCT02172508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150649|NCT02172586|Losartan|losartan|mesh-list
93150650|NCT02172586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93150651|NCT02172586|Telmisartan|telmisartan|mesh-list
93150652|NCT02172586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93150653|NCT02172586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93150654|NCT02172586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93150655|NCT02172586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93150656|NCT02172586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150657|NCT02172586|Diuretics|diuretics|mesh-ancestor
93150658|NCT02172586|Natriuretic Agents|natriuretic agents|mesh-ancestor
93150659|NCT02172586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150660|NCT02172586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93150661|NCT02172586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150662|NCT02170636|Pantoprazole|pantoprazole|mesh-list
93150663|NCT02170636|Dabigatran|dabigatran|mesh-list
93150664|NCT02170636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93150665|NCT02170636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150666|NCT02170636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93150667|NCT02170636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150668|NCT02170636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150669|NCT02170636|Antithrombins|antithrombins|mesh-ancestor
93150670|NCT02170636|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93150671|NCT02170636|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150672|NCT02170636|Anticoagulants|anticoagulants|mesh-ancestor
93150673|NCT02255734|Acyclovir|acyclovir|mesh-list
93150674|NCT02255734|Antiviral Agents|antiviral agents|mesh-ancestor
93150675|NCT02255734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150676|NCT02170792|Ranitidine|ranitidine|mesh-list
93150677|NCT02170792|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93150678|NCT02170792|Dabigatran|dabigatran|mesh-list
93150679|NCT02170792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93150680|NCT02170792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150681|NCT02170792|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93150682|NCT02170792|Histamine Antagonists|histamine antagonists|mesh-ancestor
93150683|NCT02170792|Histamine Agents|histamine agents|mesh-ancestor
93150684|NCT02170792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150685|NCT02170792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150686|NCT02170792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150687|NCT02170792|Antithrombins|antithrombins|mesh-ancestor
93150688|NCT02170792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93150689|NCT02170792|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150690|NCT02170792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150691|NCT02170792|Anticoagulants|anticoagulants|mesh-ancestor
93150692|NCT02172976|Gemcitabine|gemcitabine|mesh-list
93150693|NCT02172976|Fluorouracil|fluorouracil|mesh-list
93150694|NCT02172976|Oxaliplatin|oxaliplatin|mesh-list
93150695|NCT02172976|Irinotecan|irinotecan|mesh-list
93150696|NCT02172976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93150697|NCT02172976|Antimetabolites|antimetabolites|mesh-ancestor
93150698|NCT02172976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150699|NCT02172976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150700|NCT02172976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93150701|NCT02172976|Immunologic Factors|immunologic factors|mesh-ancestor
93150702|NCT02172976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150703|NCT02172976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93150704|NCT02172976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150705|NCT02172976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150706|NCT02173132|Acetylcarnitine|acetylcarnitine|mesh-list
93150707|NCT02173132|Vitamin B Complex|vitamin b complex|mesh-ancestor
93150708|NCT02173132|Vitamins|vitamins|mesh-ancestor
93150709|NCT02173132|Micronutrients|micronutrients|mesh-ancestor
93150710|NCT02173132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150711|NCT02173132|Nootropic Agents|nootropic agents|mesh-ancestor
93150712|NCT02173288|Furosemide|furosemide|mesh-list
93150713|NCT02173288|Spironolactone|spironolactone|mesh-list
93150714|NCT02173288|Tolvaptan|tolvaptan|mesh-list
93150715|NCT02173288|Midodrine|midodrine|mesh-list
93150716|NCT02173288|Diuretics|diuretics|mesh-ancestor
93150717|NCT02173288|Natriuretic Agents|natriuretic agents|mesh-ancestor
93150718|NCT02173288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150719|NCT02173288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93150720|NCT02173288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150721|NCT02173288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150722|NCT02173288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93150723|NCT02173288|Hormone Antagonists|hormone antagonists|mesh-ancestor
93150724|NCT02173288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93150725|NCT02173288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93150726|NCT02173288|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93150727|NCT02173288|Sympathomimetics|sympathomimetics|mesh-ancestor
93150728|NCT02173288|Autonomic Agents|autonomic agents|mesh-ancestor
93150729|NCT02173288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150730|NCT02173288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93150731|NCT02173288|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93150732|NCT02173288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93150733|NCT02173288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93150734|NCT02173288|Adrenergic Agents|adrenergic agents|mesh-ancestor
93150735|NCT02173288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150736|NCT02175394|Linagliptin|linagliptin|mesh-list
93150737|NCT02175394|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93150738|NCT02175394|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93150739|NCT02175394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150740|NCT02175394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150741|NCT02175394|Incretins|incretins|mesh-ancestor
93150742|NCT02175394|Hormones|hormones|mesh-ancestor
93150743|NCT02175394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93150744|NCT02175394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93150745|NCT02175394|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150746|NCT02175394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150747|NCT02175394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150748|NCT02175394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93150749|NCT02175394|Contraceptive Agents|contraceptive agents|mesh-ancestor
93150750|NCT02175394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93150751|NCT02175394|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93150752|NCT02175394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93150753|NCT02175394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93150754|NCT02175394|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93150755|NCT02175394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93150756|NCT02175394|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93150757|NCT02175394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93150758|NCT02175394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93150759|NCT02256124|Lamotrigine|lamotrigine|mesh-list
93150760|NCT02256124|Anticonvulsants|anticonvulsants|mesh-ancestor
93150761|NCT02256124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93150762|NCT02256124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150763|NCT02256124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150764|NCT02256124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93150765|NCT02256124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150766|NCT02256124|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93150767|NCT02256124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150768|NCT02256124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150769|NCT02256124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150770|NCT02256124|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93150771|NCT02173756|Morphine|morphine|mesh-list
93150772|NCT02173756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93150773|NCT02173756|Narcotics|narcotics|mesh-ancestor
93150774|NCT02173756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150775|NCT02173756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150776|NCT02173756|Analgesics|analgesics|mesh-ancestor
93150777|NCT02173756|Sensory System Agents|sensory system agents|mesh-ancestor
93150778|NCT02173756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150779|NCT00102466|Metformin|metformin|mesh-list
93150780|NCT00102466|Vildagliptin|vildagliptin|mesh-list
93150781|NCT00102466|Gliclazide|gliclazide|mesh-list
93150782|NCT00102466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150783|NCT00102466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150784|NCT00102466|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93150785|NCT00102466|Protease Inhibitors|protease inhibitors|mesh-ancestor
93150786|NCT00102466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150787|NCT00102466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150788|NCT02173834|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93150789|NCT02173834|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93150790|NCT02173834|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93150791|NCT02173834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150792|NCT02173834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150793|NCT02173834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150794|NCT02173912|Amlodipine|amlodipine|mesh-list
93150795|NCT02173912|Candesartan|candesartan|mesh-list
93150796|NCT02173912|Candesartan cilexetil|candesartan cilexetil|mesh-list
93150797|NCT02173912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93150798|NCT02173912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93150799|NCT02173912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93150800|NCT02173912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150801|NCT02173912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93150802|NCT02173912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150803|NCT02173912|Vasodilator Agents|vasodilator agents|mesh-ancestor
93150804|NCT02173912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93150805|NCT02173912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93150806|NCT02173990|Aflibercept|aflibercept|mesh-list
93150807|NCT02173990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93150808|NCT02173990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93150809|NCT02173990|Growth Substances|growth substances|mesh-ancestor
93150810|NCT02173990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150811|NCT02173990|Growth Inhibitors|growth inhibitors|mesh-ancestor
93150812|NCT02173990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150813|NCT02255812|Quinine|quinine|mesh-list
93150814|NCT02255812|Citric Acid|citric acid|mesh-list
93150815|NCT02255812|Sodium Citrate|sodium citrate|mesh-list
93150816|NCT02255812|Antimalarials|antimalarials|mesh-ancestor
93150817|NCT02255812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93150818|NCT02255812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93150819|NCT02255812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150820|NCT02255812|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93150821|NCT02255812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150822|NCT02255812|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93150823|NCT02255812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150824|NCT02255812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150825|NCT02255812|Analgesics|analgesics|mesh-ancestor
93150826|NCT02255812|Sensory System Agents|sensory system agents|mesh-ancestor
93150827|NCT02255812|Anticoagulants|anticoagulants|mesh-ancestor
93150828|NCT02255812|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93150829|NCT02255812|Chelating Agents|chelating agents|mesh-ancestor
93150830|NCT02255812|Sequestering Agents|sequestering agents|mesh-ancestor
93150831|NCT02255812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150832|NCT02175784|Ipragliflozin|ipragliflozin|mesh-list
93150833|NCT02175784|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93150834|NCT02175784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150835|NCT02175784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93150836|NCT02175784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150837|NCT02256280|Neostigmine|neostigmine|mesh-list
93150838|NCT02256280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93150839|NCT02256280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150840|NCT02256280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150841|NCT02256280|Cholinergic Agents|cholinergic agents|mesh-ancestor
93150842|NCT02256280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150843|NCT02256280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150844|NCT02256280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93150845|NCT02256280|Autonomic Agents|autonomic agents|mesh-ancestor
93150846|NCT02256280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150847|NCT02174068|Acetaminophen|acetaminophen|mesh-list
93150849|NCT02174068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93150850|NCT02174068|Analgesics|analgesics|mesh-ancestor
93150851|NCT02174068|Sensory System Agents|sensory system agents|mesh-ancestor
93150852|NCT02174068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150853|NCT02174068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150854|NCT02174068|Antipyretics|antipyretics|mesh-ancestor
93150855|NCT02179294|Meperidine|meperidine|mesh-list
93150856|NCT02179294|Remifentanil|remifentanil|mesh-list
93150857|NCT02179294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93150858|NCT02179294|Narcotics|narcotics|mesh-ancestor
93150859|NCT02179294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150860|NCT02179294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150861|NCT02179294|Analgesics|analgesics|mesh-ancestor
93150862|NCT02179294|Sensory System Agents|sensory system agents|mesh-ancestor
93150863|NCT02179294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150864|NCT02179294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93150865|NCT02179528|Etoposide|etoposide|mesh-list
93150866|NCT02179528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93150867|NCT02179528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150868|NCT02179528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93150869|NCT02179528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93150870|NCT02179528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150871|NCT02179528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150872|NCT02176564|Bronchodilator Agents|bronchodilator agents|mesh-list
93150873|NCT02176564|Autonomic Agents|autonomic agents|mesh-ancestor
93150874|NCT02176564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150875|NCT02176564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150876|NCT02176564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93150877|NCT02176564|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150878|NCT02182102|Pemetrexed|pemetrexed|mesh-list
93150879|NCT02182102|Nintedanib|nintedanib|mesh-list
93150880|NCT02182102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150881|NCT02182102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150882|NCT02182102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150883|NCT02182102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93150884|NCT02182102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93150885|NCT02182102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93150886|NCT02176720|Fluorides|fluorides|mesh-list
93150887|NCT02176720|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
93150888|NCT02176720|Cariostatic Agents|cariostatic agents|mesh-ancestor
93150889|NCT02176720|Protective Agents|protective agents|mesh-ancestor
93150890|NCT02176720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150891|NCT02176720|Dopamine Agents|dopamine agents|mesh-ancestor
93150892|NCT02176720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150893|NCT02176720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150894|NCT02176876|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93150895|NCT02176876|Immunologic Factors|immunologic factors|mesh-ancestor
93150896|NCT02176876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150897|NCT03537196|Ribavirin|ribavirin|mesh-list
93150898|NCT03537196|Sofosbuvir|sofosbuvir|mesh-list
93150899|NCT03537196|Antimetabolites|antimetabolites|mesh-ancestor
93150900|NCT03537196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150901|NCT03537196|Antiviral Agents|antiviral agents|mesh-ancestor
92854901|NCT02602509|Rifampin|rifampin|mesh-list
93150902|NCT03537196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93150903|NCT02182258|Nintedanib|nintedanib|mesh-list
93150904|NCT02182258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93150905|NCT02182258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93150906|NCT02182258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150907|NCT02182258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150908|NCT02182336|Vitamin K|vitamin k|mesh-list
93150909|NCT02182336|Digoxin|digoxin|mesh-list
93150910|NCT02182336|Midazolam|midazolam|mesh-list
93150911|NCT02182336|Dextromethorphan|dextromethorphan|mesh-list
93150912|NCT02182336|Caffeine|caffeine|mesh-list
92823106|NCT01000610|Prednisolone|prednisolone|mesh-list
93150913|NCT02182336|Omeprazole|omeprazole|mesh-list
93150914|NCT02182336|Warfarin|warfarin|mesh-list
93150915|NCT02182336|Vitamins|vitamins|mesh-ancestor
93150916|NCT02182336|Micronutrients|micronutrients|mesh-ancestor
93150917|NCT02182336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150918|NCT02182336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93150919|NCT02182336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93150920|NCT02182336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150921|NCT02182336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93150922|NCT02182336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93150923|NCT02182336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93150924|NCT02182336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93150925|NCT02182336|Anesthetics, General|anesthetics, general|mesh-ancestor
93150926|NCT02182336|Anesthetics|anesthetics|mesh-ancestor
93150927|NCT02182336|GABA Modulators|gaba modulators|mesh-ancestor
93150928|NCT02182336|GABA Agents|gaba agents|mesh-ancestor
93150929|NCT02182336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150930|NCT02182336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150931|NCT02182336|Anticoagulants|anticoagulants|mesh-ancestor
93150932|NCT02182336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93150933|NCT02182336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93150934|NCT02182336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93150935|NCT02182336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93150936|NCT02182336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93150937|NCT02182336|Purinergic Agents|purinergic agents|mesh-ancestor
93150938|NCT02182336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93150939|NCT02182336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93150940|NCT02182336|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93150941|NCT02182336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93150942|NCT02182336|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93150943|NCT02182336|Protective Agents|protective agents|mesh-ancestor
93150944|NCT02182336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93150945|NCT02182336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93150946|NCT02182336|Hemostatics|hemostatics|mesh-ancestor
93150947|NCT02182336|Coagulants|coagulants|mesh-ancestor
93150948|NCT02182336|Antitussive Agents|antitussive agents|mesh-ancestor
93150949|NCT02182336|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150950|NCT02182336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93150951|NCT02182336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93150952|NCT02182570|Epinastine|epinastine|mesh-list
93150953|NCT02182570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93150954|NCT02182570|Histamine Antagonists|histamine antagonists|mesh-ancestor
93150955|NCT02182570|Histamine Agents|histamine agents|mesh-ancestor
93150956|NCT02182570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150957|NCT02182570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150958|NCT02182570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150959|NCT02182648|Propofol|propofol|mesh-list
93150960|NCT02182648|Etomidate|etomidate|mesh-list
93150961|NCT02182648|Sevoflurane|sevoflurane|mesh-list
93150962|NCT02182648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93150963|NCT02182648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93150964|NCT02182648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150965|NCT02182648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93150966|NCT02182648|Anesthetics, General|anesthetics, general|mesh-ancestor
93150967|NCT02182648|Anesthetics|anesthetics|mesh-ancestor
93150968|NCT02182648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93150969|NCT02182648|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93150970|NCT02179996|Vaccines|vaccines|mesh-list
93150971|NCT02179996|Immunologic Factors|immunologic factors|mesh-ancestor
93150972|NCT02179996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150973|NCT02177344|Bromides|bromides|mesh-list
93150974|NCT02177344|Ipratropium|ipratropium|mesh-list
93150975|NCT02177344|Anticonvulsants|anticonvulsants|mesh-ancestor
93150976|NCT02177344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93150977|NCT02177344|Autonomic Agents|autonomic agents|mesh-ancestor
93150978|NCT02177344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93150979|NCT02177344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150980|NCT02177344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93150981|NCT02177344|Respiratory System Agents|respiratory system agents|mesh-ancestor
93150982|NCT02177344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93150983|NCT02177344|Cholinergic Agents|cholinergic agents|mesh-ancestor
93150984|NCT02177344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150985|NCT02177344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150986|NCT03536494|Mirabegron|mirabegron|mesh-list
93150987|NCT03536494|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93150988|NCT03536494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93150989|NCT03536494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93150990|NCT03536494|Adrenergic Agents|adrenergic agents|mesh-ancestor
93150991|NCT03536494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93150992|NCT03536494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93150993|NCT03536494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93150994|NCT03536494|Urological Agents|urological agents|mesh-ancestor
93150995|NCT02177422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93150996|NCT02177422|Telmisartan|telmisartan|mesh-list
93150997|NCT02177422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93150998|NCT02177422|Diuretics|diuretics|mesh-ancestor
93150999|NCT02177422|Natriuretic Agents|natriuretic agents|mesh-ancestor
93151000|NCT02177422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151001|NCT02177422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93151002|NCT02177422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93151003|NCT02177422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151004|NCT02177422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93151005|NCT02177422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93151006|NCT02182960|Ibuprofen|ibuprofen|mesh-list
93151007|NCT02182960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151008|NCT02182960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151009|NCT02182960|Analgesics|analgesics|mesh-ancestor
93151010|NCT02182960|Sensory System Agents|sensory system agents|mesh-ancestor
93151011|NCT02182960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151012|NCT02182960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151013|NCT02182960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151014|NCT02182960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151015|NCT02182960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151016|NCT02182960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151017|NCT02182960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151018|NCT05141968|Vitamin D|vitamin d|mesh-list
93151019|NCT05141968|Vitamins|vitamins|mesh-ancestor
93151020|NCT05141968|Micronutrients|micronutrients|mesh-ancestor
93151021|NCT05141968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151022|NCT05141968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93151023|NCT00110357|Irinotecan|irinotecan|mesh-list
93151024|NCT00110357|Cetuximab|cetuximab|mesh-list
93151025|NCT00110357|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93151026|NCT00110357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93151027|NCT00110357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151028|NCT00110357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151029|NCT00110357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151030|NCT00110357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93151031|NCT02183038|Naproxen|naproxen|mesh-list
93151032|NCT02183038|Meloxicam|meloxicam|mesh-list
93151033|NCT02183038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151034|NCT02183038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151035|NCT02183038|Analgesics|analgesics|mesh-ancestor
93151036|NCT02183038|Sensory System Agents|sensory system agents|mesh-ancestor
93151037|NCT02183038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151038|NCT02183038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151039|NCT02183038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151040|NCT02183038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151041|NCT02183038|Gout Suppressants|gout suppressants|mesh-ancestor
93151042|NCT02183038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151043|NCT02183038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151044|NCT02183038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151045|NCT02183038|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93151046|NCT02752906|Vaccines|vaccines|mesh-list
93151047|NCT02752906|Immunologic Factors|immunologic factors|mesh-ancestor
93151048|NCT02752906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151049|NCT00293033|Fentanyl|fentanyl|mesh-list
93151050|NCT00293033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93151051|NCT00293033|Narcotics|narcotics|mesh-ancestor
93151052|NCT00293033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151053|NCT00293033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151054|NCT00293033|Analgesics|analgesics|mesh-ancestor
93151055|NCT00293033|Sensory System Agents|sensory system agents|mesh-ancestor
93151056|NCT00293033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151057|NCT00293033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93151058|NCT00293033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151059|NCT00293033|Anesthetics, General|anesthetics, general|mesh-ancestor
93151060|NCT00293033|Anesthetics|anesthetics|mesh-ancestor
93151061|NCT02183116|Meloxicam|meloxicam|mesh-list
93151062|NCT02183116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151063|NCT02183116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151064|NCT02183116|Analgesics|analgesics|mesh-ancestor
93151065|NCT02183116|Sensory System Agents|sensory system agents|mesh-ancestor
93151066|NCT02183116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151067|NCT02183116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151068|NCT02183116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151069|NCT02183116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151070|NCT02183116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93151071|NCT02183116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151072|NCT02183116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151073|NCT02183116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151075|NCT02183194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93151076|NCT02183194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151077|NCT02183194|Tubulin Modulators|tubulin modulators|mesh-ancestor
93151078|NCT02183194|Antimitotic Agents|antimitotic agents|mesh-ancestor
93151079|NCT02183194|Mitosis Modulators|mitosis modulators|mesh-ancestor
93151080|NCT02183194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151081|NCT02183272|Ketamine|ketamine|mesh-list
93151082|NCT02183272|Analgesics|analgesics|mesh-ancestor
93151083|NCT02183272|Sensory System Agents|sensory system agents|mesh-ancestor
93151084|NCT02183272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151085|NCT02183272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151086|NCT02183272|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93151087|NCT02183272|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151088|NCT02183272|Anesthetics, General|anesthetics, general|mesh-ancestor
93151089|NCT02183272|Anesthetics|anesthetics|mesh-ancestor
93151090|NCT02183272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151091|NCT02183272|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93151092|NCT02183272|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93151093|NCT02183272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151094|NCT02183272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151095|NCT02177500|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93151096|NCT02177500|Telmisartan|telmisartan|mesh-list
93151097|NCT02177500|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
93151098|NCT02177500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93151099|NCT02177500|Diuretics|diuretics|mesh-ancestor
93151100|NCT02177500|Natriuretic Agents|natriuretic agents|mesh-ancestor
93151101|NCT02177500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151102|NCT02177500|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93151103|NCT02177500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93151104|NCT02177500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151105|NCT02177500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93151106|NCT02177500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93151107|NCT02183350|Linagliptin|linagliptin|mesh-list
93151108|NCT02183350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151109|NCT02183350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151110|NCT02183350|Incretins|incretins|mesh-ancestor
93151111|NCT02183350|Hormones|hormones|mesh-ancestor
93151112|NCT02183350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151113|NCT02183350|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93151114|NCT02183350|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151115|NCT02183350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151116|NCT02183350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151117|NCT03537898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93151118|NCT03537898|Plasma-lyte 148|plasma-lyte 148|mesh-list
93151119|NCT03537898|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93151120|NCT02183428|Glyburide|glyburide|mesh-list
93151121|NCT02183428|Linagliptin|linagliptin|mesh-list
93151122|NCT02183428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151123|NCT02183428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151124|NCT02183428|Incretins|incretins|mesh-ancestor
93151125|NCT02183428|Hormones|hormones|mesh-ancestor
93151126|NCT02183428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151127|NCT02183428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93151128|NCT02183428|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151129|NCT02183428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151130|NCT02183428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151131|NCT01080911|Morphine|morphine|mesh-list
93151132|NCT01080911|Analgesics, Opioid|analgesics, opioid|mesh-list
93151133|NCT01080911|Narcotics|narcotics|mesh-ancestor
93151134|NCT01080911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151135|NCT01080911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151136|NCT01080911|Analgesics|analgesics|mesh-ancestor
93151137|NCT01080911|Sensory System Agents|sensory system agents|mesh-ancestor
93151138|NCT01080911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151139|NCT02183506|Metformin|metformin|mesh-list
92823332|NCT04676867|Dalcetrapib|dalcetrapib|mesh-list
93151140|NCT02183506|Linagliptin|linagliptin|mesh-list
93151141|NCT02183506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151142|NCT02183506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151143|NCT02183506|Incretins|incretins|mesh-ancestor
93151144|NCT02183506|Hormones|hormones|mesh-ancestor
93151145|NCT02183506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151146|NCT02183506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93151147|NCT02183506|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151148|NCT02183506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151149|NCT02183506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151150|NCT02177734|Vaccines|vaccines|mesh-list
93151151|NCT02177734|Immunologic Factors|immunologic factors|mesh-ancestor
93151152|NCT02177734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151153|NCT02183584|Linagliptin|linagliptin|mesh-list
93151154|NCT02183584|Rifampin|rifampin|mesh-list
93151155|NCT02183584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151156|NCT02183584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151157|NCT02183584|Incretins|incretins|mesh-ancestor
93151158|NCT02183584|Hormones|hormones|mesh-ancestor
93151159|NCT02183584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151160|NCT02183584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93151161|NCT02183584|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151162|NCT02183584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151163|NCT02183584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151164|NCT02183584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93151165|NCT02183584|Antitubercular Agents|antitubercular agents|mesh-ancestor
93151166|NCT02183584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151167|NCT02183584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151168|NCT02183584|Leprostatic Agents|leprostatic agents|mesh-ancestor
93151169|NCT02183584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93151170|NCT02183584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93151171|NCT02183584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93151172|NCT02183584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93151173|NCT02183584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93151174|NCT02183584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93151175|NCT02183584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93151176|NCT03964493|Vancomycin|vancomycin|mesh-list
93151177|NCT03964493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151178|NCT03964493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151179|NCT01068353|Etanercept|etanercept|mesh-list
93151180|NCT01068353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151181|NCT01068353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151182|NCT01068353|Analgesics|analgesics|mesh-ancestor
93151183|NCT01068353|Sensory System Agents|sensory system agents|mesh-ancestor
93151184|NCT01068353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151185|NCT01068353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151186|NCT01068353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151187|NCT01068353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151188|NCT01068353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93151189|NCT01068353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93151190|NCT01068353|Immunologic Factors|immunologic factors|mesh-ancestor
93151191|NCT01083251|Vitamin D|vitamin d|mesh-list
93151192|NCT01083251|Ergocalciferols|ergocalciferols|mesh-list
93151193|NCT01083251|Cholecalciferol|cholecalciferol|mesh-list
93151194|NCT01083251|Vitamins|vitamins|mesh-list
93151195|NCT01083251|Entecavir|entecavir|mesh-list
93151196|NCT01083251|Micronutrients|micronutrients|mesh-ancestor
93151197|NCT01083251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151198|NCT01083251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93151199|NCT01083251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93151200|NCT01083251|Antiviral Agents|antiviral agents|mesh-ancestor
93151201|NCT01083251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151202|NCT02184052|Meloxicam|meloxicam|mesh-list
93151203|NCT02184052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151204|NCT02184052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151205|NCT02184052|Analgesics|analgesics|mesh-ancestor
93151206|NCT02184052|Sensory System Agents|sensory system agents|mesh-ancestor
93151207|NCT02184052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151208|NCT02184052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151209|NCT02184052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151210|NCT02184052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151211|NCT02184052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93151212|NCT02184052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151213|NCT02184052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823407|NCT02389465|Antidepressive Agents|antidepressive agents|mesh-ancestor
93151214|NCT02184052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151215|NCT01083329|Nicotinic Acids|nicotinic acids|mesh-list
93151216|NCT01083329|Niacin|niacin|mesh-list
93151217|NCT01083329|Niacinamide|niacinamide|mesh-list
93151218|NCT01083329|Vitamin B Complex|vitamin b complex|mesh-ancestor
93151219|NCT01083329|Vitamins|vitamins|mesh-ancestor
93151220|NCT01083329|Micronutrients|micronutrients|mesh-ancestor
93151221|NCT01083329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151222|NCT01083329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93151223|NCT01083329|Antimetabolites|antimetabolites|mesh-ancestor
93151224|NCT01083329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151225|NCT01083329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93151226|NCT01083329|Vasodilator Agents|vasodilator agents|mesh-ancestor
93151227|NCT01083407|Chlorhexidine|chlorhexidine|mesh-list
93151228|NCT01083407|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93151229|NCT01083407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93151230|NCT01083407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151231|NCT01083407|Disinfectants|disinfectants|mesh-ancestor
93151232|NCT01083407|Dermatologic Agents|dermatologic agents|mesh-ancestor
93151233|NCT02181322|Meloxicam|meloxicam|mesh-list
93151234|NCT02181322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151235|NCT02181322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151236|NCT02181322|Analgesics|analgesics|mesh-ancestor
93151237|NCT02181322|Sensory System Agents|sensory system agents|mesh-ancestor
93151238|NCT02181322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151239|NCT02181322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151240|NCT02181322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151241|NCT02181322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151242|NCT02181322|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93151243|NCT02181322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151244|NCT02181322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151245|NCT02181322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151246|NCT02184286|Nevirapine|nevirapine|mesh-list
93151247|NCT02184286|Saquinavir|saquinavir|mesh-list
93151248|NCT02184286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93151249|NCT02184286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93151250|NCT02184286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151251|NCT02184286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151252|NCT02184286|Antiviral Agents|antiviral agents|mesh-ancestor
93151253|NCT02184286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151254|NCT02184286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93151255|NCT02184286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93151256|NCT02184286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93151257|NCT02184286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93151258|NCT02184286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93151259|NCT02184286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93151260|NCT02184286|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151261|NCT02184286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93151262|NCT02184286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93151263|NCT02178124|Donepezil|donepezil|mesh-list
93151264|NCT02178124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93151265|NCT02178124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446954|NCT05596669|Ketamine|ketamine|mesh-list
93151266|NCT02178124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151267|NCT02178124|Cholinergic Agents|cholinergic agents|mesh-ancestor
93151268|NCT02178124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151269|NCT02178124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151270|NCT02178124|Nootropic Agents|nootropic agents|mesh-ancestor
93151271|NCT02030314|Chlorthalidone|chlorthalidone|mesh-list
93151272|NCT02030314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93151273|NCT02030314|Diuretics|diuretics|mesh-ancestor
93151274|NCT02030314|Natriuretic Agents|natriuretic agents|mesh-ancestor
93151275|NCT02030314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151276|NCT02030314|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93151277|NCT02030314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93151278|NCT02030314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151279|NCT02184364|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93151280|NCT02184364|Estrogens|estrogens|mesh-ancestor
93151281|NCT02184364|Hormones|hormones|mesh-ancestor
93151282|NCT02184364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151283|NCT02184364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151284|NCT02181478|Cyclosporine|cyclosporine|mesh-list
93151285|NCT02181478|Mycophenolic Acid|mycophenolic acid|mesh-list
93151286|NCT02181478|Cyclophosphamide|cyclophosphamide|mesh-list
93151287|NCT02181478|Fludarabine|fludarabine|mesh-list
93151288|NCT02181478|Fludarabine phosphate|fludarabine phosphate|mesh-list
93151289|NCT02181478|Cyclosporins|cyclosporins|mesh-list
93151290|NCT02181478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93151291|NCT02181478|Immunologic Factors|immunologic factors|mesh-ancestor
93151292|NCT02181478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151293|NCT02181478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151294|NCT02181478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93151295|NCT02181478|Alkylating Agents|alkylating agents|mesh-ancestor
93151296|NCT02181478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151297|NCT02181478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151298|NCT02181478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93151299|NCT02181478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93151300|NCT02181478|Antimetabolites|antimetabolites|mesh-ancestor
93151301|NCT02181478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151302|NCT02181478|Antifungal Agents|antifungal agents|mesh-ancestor
93151303|NCT02181478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151304|NCT02181478|Dermatologic Agents|dermatologic agents|mesh-ancestor
93151305|NCT02181478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93151306|NCT02181478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93151307|NCT02181478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93151308|NCT02181478|Antitubercular Agents|antitubercular agents|mesh-ancestor
93151309|NCT02181478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151310|NCT02755090|Nitrous Oxide|nitrous oxide|mesh-list
93151311|NCT02755090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93151312|NCT02755090|Anesthetics, General|anesthetics, general|mesh-ancestor
93151313|NCT02755090|Anesthetics|anesthetics|mesh-ancestor
93151314|NCT02755090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151315|NCT02755090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151316|NCT02755090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151317|NCT02755090|Analgesics|analgesics|mesh-ancestor
93151318|NCT02755090|Sensory System Agents|sensory system agents|mesh-ancestor
93151319|NCT02755090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151320|NCT00109343|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93151321|NCT00109343|Immunologic Factors|immunologic factors|mesh-ancestor
93151322|NCT00109343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151323|NCT02185690|Carboplatin|carboplatin|mesh-list
93151324|NCT02185690|Pemetrexed|pemetrexed|mesh-list
93151325|NCT02185690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151326|NCT02185690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151327|NCT02185690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151328|NCT02185690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93151329|NCT02185690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93151330|NCT03536806|Canrenone|canrenone|mesh-list
93151331|NCT03536806|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93151332|NCT03536806|Hormone Antagonists|hormone antagonists|mesh-ancestor
93151333|NCT03536806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151334|NCT03536806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151335|NCT03536806|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93151336|NCT03536806|Diuretics|diuretics|mesh-ancestor
93151337|NCT03536806|Natriuretic Agents|natriuretic agents|mesh-ancestor
93151339|NCT00108485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93151340|NCT00108485|Antimetabolites|antimetabolites|mesh-ancestor
93151341|NCT00108485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151342|NCT00108485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93151343|NCT00108485|Vasodilator Agents|vasodilator agents|mesh-ancestor
93151344|NCT00108485|Vitamin B Complex|vitamin b complex|mesh-ancestor
93151345|NCT00108485|Vitamins|vitamins|mesh-ancestor
93151346|NCT00108485|Micronutrients|micronutrients|mesh-ancestor
93151347|NCT00108485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151348|NCT01068587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93151349|NCT01068587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151350|NCT01068587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93151351|NCT01068587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151352|NCT01068587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151353|NCT02181946|Fluconazole|fluconazole|mesh-list
93151354|NCT02181946|Nevirapine|nevirapine|mesh-list
93151355|NCT02181946|Antifungal Agents|antifungal agents|mesh-ancestor
93151356|NCT02181946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151357|NCT02181946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93151358|NCT02181946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93151359|NCT02181946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151360|NCT02181946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151361|NCT02181946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93151362|NCT02181946|Hormone Antagonists|hormone antagonists|mesh-ancestor
93151363|NCT02181946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151364|NCT02181946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151365|NCT02181946|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93151366|NCT02181946|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93151367|NCT02181946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93151368|NCT02181946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93151369|NCT02181946|Antiviral Agents|antiviral agents|mesh-ancestor
93151370|NCT02181946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93151371|NCT02181946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93151372|NCT02181946|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93151373|NCT02181946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93151375|NCT00107783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151376|NCT00107783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151377|NCT02185768|Idarubicin|idarubicin|mesh-list
93151378|NCT02185768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93151379|NCT02185768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151380|NCT02185768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93151381|NCT02185768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93151382|NCT02185768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151383|NCT02185768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151384|NCT02182024|Dabigatran|dabigatran|mesh-list
93151385|NCT02182024|Antithrombins|antithrombins|mesh-ancestor
93151386|NCT02182024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93151387|NCT02182024|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151388|NCT02182024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151389|NCT02182024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151390|NCT02182024|Anticoagulants|anticoagulants|mesh-ancestor
93151391|NCT02185846|Dirithromycin|dirithromycin|mesh-list
93151392|NCT02185846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151393|NCT02185846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151394|NCT02184832|Metformin|metformin|mesh-list
93151395|NCT02184832|Tryptophan|tryptophan|mesh-list
93151396|NCT02184832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151397|NCT02184832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151398|NCT02184832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93151399|NCT02184832|Antidepressive Agents|antidepressive agents|mesh-ancestor
93151400|NCT02184832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93151401|NCT01083797|Dexmedetomidine|dexmedetomidine|mesh-list
93151402|NCT01083797|Chloral Hydrate|chloral hydrate|mesh-list
93151403|NCT01083797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93151404|NCT01083797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151405|NCT01083797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151406|NCT01083797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151407|NCT01083797|Analgesics|analgesics|mesh-ancestor
93151408|NCT01083797|Sensory System Agents|sensory system agents|mesh-ancestor
93151409|NCT01083797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151410|NCT01083797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93151411|NCT01083797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93151412|NCT01083797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93151413|NCT01083797|Adrenergic Agents|adrenergic agents|mesh-ancestor
93151414|NCT01083797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151415|NCT01083797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151416|NCT01083875|Amlexanox|amlexanox|mesh-list
93151417|NCT01083875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93151418|NCT01068977|Bevacizumab|bevacizumab|mesh-list
93151419|NCT01068977|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93151420|NCT01068977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93151421|NCT01068977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151422|NCT01068977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93151423|NCT01068977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93151424|NCT01068977|Growth Substances|growth substances|mesh-ancestor
93151425|NCT01068977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151426|NCT01068977|Growth Inhibitors|growth inhibitors|mesh-ancestor
93151427|NCT01068977|Immunologic Factors|immunologic factors|mesh-ancestor
93151428|NCT02184910|Gastrins|gastrins|mesh-list
93151429|NCT02184910|Hormones|hormones|mesh-ancestor
93151430|NCT02184910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151431|NCT02184910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151432|NCT02185924|Parecoxib|parecoxib|mesh-list
93151433|NCT02185924|Ropivacaine|ropivacaine|mesh-list
93151434|NCT02185924|Anesthetics, Local|anesthetics, local|mesh-ancestor
93151435|NCT02185924|Anesthetics|anesthetics|mesh-ancestor
93151436|NCT02185924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151437|NCT02185924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151438|NCT02185924|Sensory System Agents|sensory system agents|mesh-ancestor
93151439|NCT02185924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151440|NCT02185924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93151441|NCT02185924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151442|NCT02185924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151443|NCT02185924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151444|NCT02185924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151445|NCT02185924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151446|NCT02185924|Analgesics|analgesics|mesh-ancestor
93151447|NCT02185924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151448|NCT02185924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151449|NCT02185066|Metformin|metformin|mesh-list
93151450|NCT02185066|Atorvastatin|atorvastatin|mesh-list
93151451|NCT02185066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151452|NCT02185066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151453|NCT02185066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93151454|NCT02185066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93151455|NCT02185066|Antimetabolites|antimetabolites|mesh-ancestor
93151456|NCT02185066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151457|NCT02185066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93151458|NCT02185066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93151459|NCT02185066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151460|NCT01081223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
93151461|NCT01081223|Immunologic Factors|immunologic factors|mesh-ancestor
93151462|NCT01081223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151463|NCT01069055|Acetaminophen|acetaminophen|mesh-list
93151464|NCT01069055|Lornoxicam|lornoxicam|mesh-list
93151465|NCT01069055|Piroxicam|piroxicam|mesh-list
93151466|NCT01069055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151467|NCT01069055|Analgesics|analgesics|mesh-ancestor
93151468|NCT01069055|Sensory System Agents|sensory system agents|mesh-ancestor
93151469|NCT01069055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151470|NCT01069055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151471|NCT01069055|Antipyretics|antipyretics|mesh-ancestor
93151472|NCT01069055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151473|NCT01069055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151474|NCT01069055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151475|NCT01069055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151476|NCT01069055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151477|NCT01069055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151478|NCT01083953|Sevoflurane|sevoflurane|mesh-list
93151479|NCT01083953|Desflurane|desflurane|mesh-list
93151480|NCT01083953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93151481|NCT01083953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93151482|NCT01083953|Anesthetics, General|anesthetics, general|mesh-ancestor
93151483|NCT01083953|Anesthetics|anesthetics|mesh-ancestor
93151484|NCT01083953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151485|NCT01083953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151486|NCT02190526|Mesalamine|mesalamine|mesh-list
93151487|NCT02190526|Amitriptyline|amitriptyline|mesh-list
93151488|NCT02190526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151489|NCT02190526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151490|NCT02190526|Analgesics|analgesics|mesh-ancestor
93151491|NCT02190526|Sensory System Agents|sensory system agents|mesh-ancestor
93151492|NCT02190526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151493|NCT02190526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151494|NCT02190526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151495|NCT02190526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151496|NCT02190526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93151497|NCT02190526|Antidepressive Agents|antidepressive agents|mesh-ancestor
93151498|NCT02190526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93151499|NCT02190526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93151500|NCT02190526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93151501|NCT02190526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93151502|NCT02190526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151503|NCT02190526|Adrenergic Agents|adrenergic agents|mesh-ancestor
93151504|NCT02190526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151505|NCT01084031|Propofol|propofol|mesh-list
93151506|NCT01084031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93151507|NCT01084031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151508|NCT01084031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151509|NCT01084031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151510|NCT01084031|Anesthetics, General|anesthetics, general|mesh-ancestor
93151511|NCT01084031|Anesthetics|anesthetics|mesh-ancestor
93151512|NCT02185222|Cholecalciferol|cholecalciferol|mesh-list
93151513|NCT02185222|Vitamin D|vitamin d|mesh-list
93151514|NCT02185222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93151515|NCT02185222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151516|NCT02185222|Vitamins|vitamins|mesh-ancestor
93151517|NCT02185222|Micronutrients|micronutrients|mesh-ancestor
93151518|NCT02185222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93151519|NCT01084187|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93151520|NCT01084187|Vasodilator Agents|vasodilator agents|mesh-ancestor
93151521|NCT01084187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93151522|NCT01084187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93151523|NCT01084187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151524|NCT01084187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151525|NCT01084187|Urological Agents|urological agents|mesh-ancestor
93151526|NCT02185300|Dolutegravir|dolutegravir|mesh-list
93151527|NCT02185300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93151528|NCT02185300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93151529|NCT02185300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151530|NCT02185300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151531|NCT02185300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93151532|NCT02185300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93151533|NCT02185300|Antiviral Agents|antiviral agents|mesh-ancestor
93151534|NCT02185300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151535|NCT02190760|Dexamethasone|dexamethasone|mesh-list
93151536|NCT02190760|Bupivacaine|bupivacaine|mesh-list
93151537|NCT02190760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151538|NCT02190760|Antiemetics|antiemetics|mesh-ancestor
93151539|NCT02190760|Autonomic Agents|autonomic agents|mesh-ancestor
93151540|NCT02190760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151541|NCT02190760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151542|NCT02190760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93151543|NCT02190760|Glucocorticoids|glucocorticoids|mesh-ancestor
93151544|NCT02190760|Hormones|hormones|mesh-ancestor
93151545|NCT02190760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151546|NCT02190760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93151547|NCT02190760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151548|NCT02190760|Anesthetics, Local|anesthetics, local|mesh-ancestor
93151549|NCT02190760|Anesthetics|anesthetics|mesh-ancestor
93151550|NCT02190760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151551|NCT02190760|Sensory System Agents|sensory system agents|mesh-ancestor
93151552|NCT02190838|Metformin|metformin|mesh-list
93151553|NCT02190838|Dacarbazine|dacarbazine|mesh-list
93151554|NCT02190838|Melatonin|melatonin|mesh-list
93151555|NCT02190838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151556|NCT02190838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151557|NCT02190838|Antioxidants|antioxidants|mesh-ancestor
93151558|NCT02190838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151559|NCT02190838|Protective Agents|protective agents|mesh-ancestor
93151560|NCT02190838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151561|NCT02190838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93151562|NCT02190838|Alkylating Agents|alkylating agents|mesh-ancestor
93151563|NCT02190838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151564|NCT02185456|Metronidazole|metronidazole|mesh-list
93151565|NCT02185456|Miconazole|miconazole|mesh-list
93151566|NCT02185456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151567|NCT02185456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151568|NCT02185456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93151569|NCT02185456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93151570|NCT02185456|Antifungal Agents|antifungal agents|mesh-ancestor
93151571|NCT02185456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93151572|NCT02185456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93151573|NCT02185456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151574|NCT02185456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151575|NCT02185456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93151576|NCT02185456|Hormone Antagonists|hormone antagonists|mesh-ancestor
93151577|NCT02185456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151578|NCT02185456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151579|NCT02185456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93151580|NCT02185456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93151581|NCT02190994|Prednisone|prednisone|mesh-list
93151582|NCT02190994|Hydrocortisone|hydrocortisone|mesh-list
93151583|NCT02190994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151584|NCT02190994|Glucocorticoids|glucocorticoids|mesh-ancestor
93151585|NCT02190994|Hormones|hormones|mesh-ancestor
92823779|NCT04314219|Dermatologic Agents|dermatologic agents|mesh-ancestor
93151586|NCT02190994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151587|NCT02190994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151588|NCT02190994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93151589|NCT02190994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151590|NCT02193568|Anesthetics|anesthetics|mesh-list
93151591|NCT02193568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151592|NCT02193568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151593|NCT02191072|Omalizumab|omalizumab|mesh-list
93151594|NCT02191072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93151595|NCT02191072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93151596|NCT02191072|Respiratory System Agents|respiratory system agents|mesh-ancestor
93151597|NCT02191228|Linagliptin|linagliptin|mesh-list
93151598|NCT02191228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151599|NCT02191228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151600|NCT02191228|Incretins|incretins|mesh-ancestor
93151601|NCT02191228|Hormones|hormones|mesh-ancestor
93151602|NCT02191228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151603|NCT02191228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93151604|NCT02191228|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151605|NCT02191228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151606|NCT02191228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151607|NCT02186782|Citric Acid|citric acid|mesh-list
93151608|NCT02186782|Sodium Citrate|sodium citrate|mesh-list
93151609|NCT02186782|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93151610|NCT02186782|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93151611|NCT02186782|Clomiphene|clomiphene|mesh-list
93151612|NCT02186782|Enclomiphene|enclomiphene|mesh-list
93151613|NCT02186782|Zuclomiphene|zuclomiphene|mesh-list
93151614|NCT02186782|Estradiol|estradiol|mesh-list
93151615|NCT02186782|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93151616|NCT02186782|Anticoagulants|anticoagulants|mesh-ancestor
93151617|NCT02186782|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93151618|NCT02186782|Chelating Agents|chelating agents|mesh-ancestor
93151619|NCT02186782|Sequestering Agents|sequestering agents|mesh-ancestor
93151620|NCT02186782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151621|NCT02186782|Estrogens|estrogens|mesh-ancestor
93151622|NCT02186782|Hormones|hormones|mesh-ancestor
93151623|NCT02186782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151624|NCT02186782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151625|NCT02186782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93151626|NCT02186782|Contraceptive Agents|contraceptive agents|mesh-ancestor
93151627|NCT02186782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93151628|NCT02186782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93151629|NCT02186782|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93151630|NCT02186782|Hormone Antagonists|hormone antagonists|mesh-ancestor
93151631|NCT02186782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93151632|NCT02186782|Fertility Agents|fertility agents|mesh-ancestor
93151633|NCT02186782|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93151634|NCT02186782|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93151635|NCT02187250|Metformin|metformin|mesh-list
93151636|NCT02187250|Liraglutide|liraglutide|mesh-list
93151637|NCT02187250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151638|NCT02187250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151639|NCT02187250|Incretins|incretins|mesh-ancestor
93151640|NCT02187250|Hormones|hormones|mesh-ancestor
93151641|NCT02187250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151642|NCT03535480|Lenograstim|lenograstim|mesh-list
93151643|NCT03535480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93151644|NCT03535480|Immunologic Factors|immunologic factors|mesh-ancestor
93151645|NCT03535480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151646|NCT02187484|Telmisartan|telmisartan|mesh-list
93151647|NCT02187484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93151648|NCT02187484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93151649|NCT02187484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93151650|NCT02187484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151651|NCT02256748|Midazolam|midazolam|mesh-list
93151652|NCT02256748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93151653|NCT02256748|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93151654|NCT02256748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151655|NCT02256748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151656|NCT02256748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93151657|NCT02256748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93151658|NCT02256748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93151659|NCT02256748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151660|NCT02256748|Anesthetics, General|anesthetics, general|mesh-ancestor
93151662|NCT02256748|GABA Modulators|gaba modulators|mesh-ancestor
93151663|NCT02256748|GABA Agents|gaba agents|mesh-ancestor
93151664|NCT02256748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151665|NCT02256748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151666|NCT02187562|Aspirin|aspirin|mesh-list
93151667|NCT02187562|Meloxicam|meloxicam|mesh-list
93151668|NCT02187562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151669|NCT02187562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151670|NCT02187562|Analgesics|analgesics|mesh-ancestor
93151671|NCT02187562|Sensory System Agents|sensory system agents|mesh-ancestor
93151672|NCT02187562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151673|NCT02187562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151674|NCT02187562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151675|NCT02187562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151676|NCT02187562|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93151677|NCT02187562|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93151678|NCT02187562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151679|NCT02187562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93151680|NCT02187562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93151681|NCT02187562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151682|NCT02187562|Antipyretics|antipyretics|mesh-ancestor
93151683|NCT02187562|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93151684|NCT02187718|Anesthetics|anesthetics|mesh-list
93151685|NCT02187718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151686|NCT02187718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151687|NCT03535168|Midazolam|midazolam|mesh-list
93151688|NCT03535168|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93151689|NCT03535168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93151690|NCT03535168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151691|NCT03535168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151692|NCT03535168|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93151693|NCT03535168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93151694|NCT03535168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93151695|NCT03535168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151696|NCT03535168|Anesthetics, General|anesthetics, general|mesh-ancestor
93151697|NCT03535168|Anesthetics|anesthetics|mesh-ancestor
93151698|NCT03535168|GABA Modulators|gaba modulators|mesh-ancestor
93151699|NCT03535168|GABA Agents|gaba agents|mesh-ancestor
93151700|NCT03535168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151701|NCT03535168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151702|NCT02192320|Dexamethasone|dexamethasone|mesh-list
93151703|NCT02192320|Atorvastatin|atorvastatin|mesh-list
93151704|NCT02192320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151705|NCT02192320|Antiemetics|antiemetics|mesh-ancestor
93151706|NCT02192320|Autonomic Agents|autonomic agents|mesh-ancestor
93151707|NCT02192320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151708|NCT02192320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151709|NCT02192320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93151710|NCT02192320|Glucocorticoids|glucocorticoids|mesh-ancestor
93151711|NCT02192320|Hormones|hormones|mesh-ancestor
93151712|NCT02192320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151713|NCT02192320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93151714|NCT02192320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151715|NCT02192320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93151716|NCT02192320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93151717|NCT02192320|Antimetabolites|antimetabolites|mesh-ancestor
93151718|NCT02192320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151719|NCT02192320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93151720|NCT02192320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93151721|NCT02192320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151722|NCT02187874|Oxytocin|oxytocin|mesh-list
93151723|NCT02187874|Oxytocics|oxytocics|mesh-ancestor
93151724|NCT02187874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93151725|NCT02187874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151726|NCT04870138|Azithromycin|azithromycin|mesh-list
93151727|NCT04870138|Ciprofloxacin|ciprofloxacin|mesh-list
93151728|NCT04870138|Ceftriaxone|ceftriaxone|mesh-list
93151729|NCT04870138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151730|NCT04870138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151731|NCT04870138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93151732|NCT04870138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93151733|NCT04870138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151734|NCT04870138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151735|NCT04870138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151736|NCT04870138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93151737|NCT04870138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93151738|NCT02188186|Metformin|metformin|mesh-list
93151739|NCT02188186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93151740|NCT02188186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151741|NCT02188186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151742|NCT02188186|Incretins|incretins|mesh-ancestor
93151743|NCT02188186|Hormones|hormones|mesh-ancestor
93151744|NCT02188186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151745|NCT02188186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93151746|NCT02188186|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151747|NCT02188186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151748|NCT02188186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151749|NCT02192632|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
93151750|NCT02192632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93151751|NCT02192632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151752|NCT02192632|Analgesics|analgesics|mesh-ancestor
93151753|NCT02192632|Sensory System Agents|sensory system agents|mesh-ancestor
93151754|NCT02192632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151755|NCT02192632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151756|NCT02192632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151757|NCT02192632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151758|NCT02192632|Dermatologic Agents|dermatologic agents|mesh-ancestor
93151759|NCT03535090|Methylprednisolone|methylprednisolone|mesh-list
93151760|NCT03535090|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93151761|NCT03535090|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93151762|NCT03535090|Prednisolone|prednisolone|mesh-list
93151763|NCT03535090|Prednisolone acetate|prednisolone acetate|mesh-list
93151764|NCT03535090|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93151765|NCT03535090|Prednisolone phosphate|prednisolone phosphate|mesh-list
93151766|NCT03535090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151767|NCT03535090|Antiemetics|antiemetics|mesh-ancestor
93151768|NCT03535090|Autonomic Agents|autonomic agents|mesh-ancestor
93151769|NCT03535090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151770|NCT03535090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151771|NCT03535090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93151772|NCT03535090|Glucocorticoids|glucocorticoids|mesh-ancestor
93151773|NCT03535090|Hormones|hormones|mesh-ancestor
93151774|NCT03535090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151775|NCT03535090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93151776|NCT03535090|Protective Agents|protective agents|mesh-ancestor
93151777|NCT03535090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93151778|NCT03535090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151779|NCT03535870|Fluticasone|fluticasone|mesh-list
93151780|NCT03535870|Xhance|xhance|mesh-list
93151781|NCT03535870|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93151782|NCT03535870|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93151783|NCT03535870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151784|NCT03535870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93151785|NCT03535870|Autonomic Agents|autonomic agents|mesh-ancestor
93151786|NCT03535870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151787|NCT03535870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151788|NCT03535870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93151789|NCT03535870|Respiratory System Agents|respiratory system agents|mesh-ancestor
93151790|NCT03535870|Dermatologic Agents|dermatologic agents|mesh-ancestor
93151791|NCT03535870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93151792|NCT03535870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93151793|NCT03535870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93151794|NCT03535870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93151795|NCT03535870|Adrenergic Agents|adrenergic agents|mesh-ancestor
93151796|NCT03535870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151797|NCT03535870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151798|NCT03535870|Glucocorticoids|glucocorticoids|mesh-ancestor
93151799|NCT03535870|Hormones|hormones|mesh-ancestor
93151800|NCT03535870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151801|NCT03535870|Sympathomimetics|sympathomimetics|mesh-ancestor
93151802|NCT02192710|Midazolam|midazolam|mesh-list
93151803|NCT02192710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93151804|NCT02192710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93151805|NCT02192710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151806|NCT02192710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151807|NCT02192710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93151808|NCT02192710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93151809|NCT02192710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93151810|NCT02192710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151811|NCT02192710|Anesthetics, General|anesthetics, general|mesh-ancestor
93151812|NCT02192710|Anesthetics|anesthetics|mesh-ancestor
93151813|NCT02192710|GABA Modulators|gaba modulators|mesh-ancestor
93151814|NCT02192710|GABA Agents|gaba agents|mesh-ancestor
93151815|NCT02192710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151816|NCT02192710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151817|NCT02188654|Metformin|metformin|mesh-list
93151818|NCT02188654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93151819|NCT02188654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151820|NCT02192944|Chloroquine|chloroquine|mesh-list
93151821|NCT02192944|Piperaquine|piperaquine|mesh-list
93151822|NCT02192944|Artenimol|artenimol|mesh-list
93151823|NCT02192944|Amebicides|amebicides|mesh-ancestor
93151824|NCT02192944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93151825|NCT02192944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93151826|NCT02192944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151827|NCT02192944|Antimalarials|antimalarials|mesh-ancestor
93151828|NCT02192944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93151829|NCT02193022|Miltefosine|miltefosine|mesh-list
93151830|NCT02193022|Antifungal Agents|antifungal agents|mesh-ancestor
93151831|NCT02193022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151832|NCT02193022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151833|NCT02193022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93151834|NCT02193022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93151835|NCT02188810|Vaccines|vaccines|mesh-list
93151836|NCT02188810|Immunologic Factors|immunologic factors|mesh-ancestor
93151837|NCT02188810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151838|NCT02188888|Esmolol|esmolol|mesh-list
93151839|NCT02188888|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93151840|NCT02188888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93151841|NCT02188888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93151842|NCT02188888|Adrenergic Agents|adrenergic agents|mesh-ancestor
93151843|NCT02188888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151844|NCT02188888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151845|NCT02188888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151846|NCT02256826|Ritonavir|ritonavir|mesh-list
93151847|NCT02256826|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93151848|NCT02256826|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93151849|NCT02256826|Protease Inhibitors|protease inhibitors|mesh-ancestor
93151850|NCT02256826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151851|NCT02256826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151852|NCT02256826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93151853|NCT02256826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93151854|NCT02256826|Antiviral Agents|antiviral agents|mesh-ancestor
93151855|NCT02256826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151856|NCT02256826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93151857|NCT02256826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93151858|NCT03535792|Fentanyl|fentanyl|mesh-list
93151859|NCT03535792|Nalbuphine|nalbuphine|mesh-list
93151860|NCT03535792|Bupivacaine|bupivacaine|mesh-list
93151861|NCT03535792|Anesthetics, Local|anesthetics, local|mesh-ancestor
93151862|NCT03535792|Anesthetics|anesthetics|mesh-ancestor
93151863|NCT03535792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151864|NCT03535792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151865|NCT03535792|Sensory System Agents|sensory system agents|mesh-ancestor
93151866|NCT03535792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151867|NCT03535792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93151868|NCT03535792|Narcotics|narcotics|mesh-ancestor
93151869|NCT03535792|Analgesics|analgesics|mesh-ancestor
93151870|NCT03535792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93151871|NCT03535792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93151872|NCT03535792|Anesthetics, General|anesthetics, general|mesh-ancestor
93151873|NCT02193256|Prazosin|prazosin|mesh-list
93151874|NCT02193256|Varenicline|varenicline|mesh-list
93151875|NCT02193256|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93151876|NCT02193256|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93151877|NCT02193256|Cholinergic Agents|cholinergic agents|mesh-ancestor
93151878|NCT02193256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151879|NCT02193256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151880|NCT02193256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151881|NCT02193256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93151882|NCT02193256|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93151883|NCT02193256|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93151884|NCT02193256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93151885|NCT02193256|Adrenergic Agents|adrenergic agents|mesh-ancestor
93151886|NCT03535558|Azithromycin|azithromycin|mesh-list
93151887|NCT03535558|Fluoroquinolones|fluoroquinolones|mesh-list
93151888|NCT03535558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93151889|NCT03535558|Trimethoprim|trimethoprim|mesh-list
93151890|NCT03535558|Sulfamethoxazole|sulfamethoxazole|mesh-list
93151891|NCT03535558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93151892|NCT03535558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151893|NCT03535558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93151894|NCT03535558|Antimalarials|antimalarials|mesh-ancestor
93151895|NCT03535558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93151896|NCT03535558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93151897|NCT03535558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93151898|NCT03535558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93151899|NCT03535558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151900|NCT03535558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93151901|NCT03535558|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93151902|NCT03535558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93151903|NCT03535558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93151904|NCT02193334|Mitogens|mitogens|mesh-list
93151905|NCT02193334|Mitosis Modulators|mitosis modulators|mesh-ancestor
93151906|NCT02193334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151907|NCT02194192|Ephedrine|ephedrine|mesh-list
93151908|NCT02194192|Ondansetron|ondansetron|mesh-list
93151909|NCT02194192|Antiemetics|antiemetics|mesh-ancestor
93151910|NCT02194192|Autonomic Agents|autonomic agents|mesh-ancestor
93151911|NCT02194192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151912|NCT02194192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151913|NCT02194192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93151914|NCT02194192|Antipruritics|antipruritics|mesh-ancestor
93151915|NCT02194192|Dermatologic Agents|dermatologic agents|mesh-ancestor
93151916|NCT02194192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93151917|NCT02194192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93151918|NCT02194192|Serotonin Agents|serotonin agents|mesh-ancestor
93151919|NCT02194192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93151920|NCT02194192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151921|NCT02194192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93151922|NCT02194192|Sympathomimetics|sympathomimetics|mesh-ancestor
93151923|NCT02194192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93151924|NCT02194192|Adrenergic Agents|adrenergic agents|mesh-ancestor
93151925|NCT02194270|Ambroxol|ambroxol|mesh-list
93151926|NCT02194270|Expectorants|expectorants|mesh-ancestor
93151927|NCT02194270|Respiratory System Agents|respiratory system agents|mesh-ancestor
93151928|NCT02190058|DS-1971a|ds-1971a|mesh-list
93151929|NCT02190058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93151930|NCT02190058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93151931|NCT02190058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93151932|NCT02190058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151933|NCT02194348|Olcegepant|olcegepant|mesh-list
93151934|NCT02194348|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93151935|NCT02194348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151936|NCT02194348|Analgesics|analgesics|mesh-ancestor
93151937|NCT02194348|Sensory System Agents|sensory system agents|mesh-ancestor
93151938|NCT02194348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151939|NCT02194348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151940|NCT02195908|Antiemetics|antiemetics|mesh-list
93151941|NCT02195908|Autonomic Agents|autonomic agents|mesh-ancestor
93151942|NCT02195908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151943|NCT02195908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151944|NCT02195908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93151945|NCT02197000|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
93151946|NCT02197000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93151947|NCT02197000|Protective Agents|protective agents|mesh-ancestor
93151948|NCT02197000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151949|NCT02197000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93151950|NCT02196142|Hydrocortisone|hydrocortisone|mesh-list
93151951|NCT02196142|Mannitol|mannitol|mesh-list
93151952|NCT02196142|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93151953|NCT02196142|Diuretics|diuretics|mesh-ancestor
93151954|NCT02196142|Natriuretic Agents|natriuretic agents|mesh-ancestor
93151955|NCT02196142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151956|NCT02196142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93151957|NCT02257294|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93151958|NCT02257294|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93151959|NCT02257294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93151960|NCT02257294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93151961|NCT03534388|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93151962|NCT03534388|Eusol|eusol|mesh-list
93151963|NCT03534388|Disinfectants|disinfectants|mesh-ancestor
93151964|NCT03534388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151965|NCT04308694|Methadone|methadone|mesh-list
93151966|NCT04308694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93151967|NCT04308694|Narcotics|narcotics|mesh-ancestor
93151968|NCT04308694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93151969|NCT04308694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151970|NCT04308694|Analgesics|analgesics|mesh-ancestor
93151971|NCT04308694|Sensory System Agents|sensory system agents|mesh-ancestor
93151972|NCT04308694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151973|NCT04308694|Antitussive Agents|antitussive agents|mesh-ancestor
93151974|NCT04308694|Respiratory System Agents|respiratory system agents|mesh-ancestor
93151975|NCT03534310|Liraglutide|liraglutide|mesh-list
93151976|NCT03534310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928158|NCT02178761|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93151977|NCT03534310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151978|NCT03534310|Incretins|incretins|mesh-ancestor
93151979|NCT03534310|Hormones|hormones|mesh-ancestor
93151980|NCT03534310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93151981|NCT02194894|Acetaminophen|acetaminophen|mesh-list
93151982|NCT02194894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93151983|NCT02194894|Analgesics|analgesics|mesh-ancestor
93151984|NCT02194894|Sensory System Agents|sensory system agents|mesh-ancestor
93151985|NCT02194894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93151986|NCT02194894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151987|NCT02194894|Antipyretics|antipyretics|mesh-ancestor
93151988|NCT03534622|Delafloxacin|delafloxacin|mesh-list
93151989|NCT03534622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93151990|NCT02197702|Vitamin D|vitamin d|mesh-list
93151991|NCT02197702|Cholecalciferol|cholecalciferol|mesh-list
93151992|NCT02197702|Vitamins|vitamins|mesh-ancestor
93151993|NCT02197702|Micronutrients|micronutrients|mesh-ancestor
93151994|NCT02197702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93151995|NCT02197702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93151996|NCT02197702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93151997|NCT02031016|Fentanyl|fentanyl|mesh-list
93151998|NCT02031016|Remifentanil|remifentanil|mesh-list
93151999|NCT02031016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93152000|NCT02031016|Narcotics|narcotics|mesh-ancestor
93152001|NCT02031016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152002|NCT02031016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152003|NCT02031016|Analgesics|analgesics|mesh-ancestor
93152004|NCT02031016|Sensory System Agents|sensory system agents|mesh-ancestor
93152005|NCT02031016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152006|NCT02031016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93152007|NCT02031016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152008|NCT02031016|Anesthetics, General|anesthetics, general|mesh-ancestor
93152009|NCT02031016|Anesthetics|anesthetics|mesh-ancestor
93152010|NCT00095147|Infliximab|infliximab|mesh-list
93152011|NCT00095147|Methotrexate|methotrexate|mesh-list
93152012|NCT00095147|Abatacept|abatacept|mesh-list
93152013|NCT00095147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93152014|NCT00095147|Abortifacient Agents|abortifacient agents|mesh-ancestor
93152015|NCT00095147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93152016|NCT00095147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152017|NCT00095147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93152018|NCT00095147|Antimetabolites|antimetabolites|mesh-ancestor
93152019|NCT00095147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152020|NCT00095147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152021|NCT00095147|Dermatologic Agents|dermatologic agents|mesh-ancestor
93152022|NCT00095147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152023|NCT00095147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93152024|NCT00095147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93152025|NCT00095147|Immunologic Factors|immunologic factors|mesh-ancestor
93152026|NCT00095147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152027|NCT00095147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93152028|NCT00095147|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93152029|NCT00095147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152030|NCT00095147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93152031|NCT00095147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93152032|NCT00095147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152033|NCT02198170|Ketoconazole|ketoconazole|mesh-list
93152034|NCT02198170|Lenvatinib|lenvatinib|mesh-list
93152035|NCT02198170|Antifungal Agents|antifungal agents|mesh-ancestor
93152036|NCT02198170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152037|NCT02198170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92824237|NCT01018511|Tamsulosin|tamsulosin|mesh-list
93152038|NCT02198170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93152039|NCT02198170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152040|NCT02198170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152041|NCT02198170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93152042|NCT02198170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93152043|NCT02198170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152044|NCT02198170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152045|NCT02198170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93152046|NCT02198170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152047|NCT02198170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152048|NCT02198248|Prednisolone|prednisolone|mesh-list
93152049|NCT02198248|Rituximab|rituximab|mesh-list
93152050|NCT02198248|Glucocorticoids|glucocorticoids|mesh-list
93152051|NCT02198248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152052|NCT02198248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152053|NCT02198248|Immunologic Factors|immunologic factors|mesh-ancestor
93152054|NCT02198248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152055|NCT02198248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152056|NCT02198248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152057|NCT02198248|Hormones|hormones|mesh-ancestor
93152058|NCT02198248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152059|NCT02198248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93152060|NCT01069133|Rifaximin|rifaximin|mesh-list
93152061|NCT01069133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93152062|NCT01069133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152063|NCT01069133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93152064|NCT02198326|Olcegepant|olcegepant|mesh-list
93152065|NCT02198326|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93152066|NCT02198326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152067|NCT02198326|Analgesics|analgesics|mesh-ancestor
93152068|NCT02198326|Sensory System Agents|sensory system agents|mesh-ancestor
93152069|NCT02198326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152070|NCT02198326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152071|NCT02198404|Propofol|propofol|mesh-list
93152072|NCT02198404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93152073|NCT02198404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152074|NCT02198404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152075|NCT02198404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152076|NCT02198404|Anesthetics, General|anesthetics, general|mesh-ancestor
93152077|NCT02198404|Anesthetics|anesthetics|mesh-ancestor
93152078|NCT02198482|Cytarabine|cytarabine|mesh-list
93152079|NCT02198482|Daunorubicin|daunorubicin|mesh-list
93152080|NCT02198482|Mitoxantrone|mitoxantrone|mesh-list
93152081|NCT02198482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93152082|NCT02198482|Antimetabolites|antimetabolites|mesh-ancestor
93152083|NCT02198482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152084|NCT02198482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152085|NCT02198482|Antiviral Agents|antiviral agents|mesh-ancestor
93152086|NCT02198482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152087|NCT02198482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93152088|NCT02198482|Immunologic Factors|immunologic factors|mesh-ancestor
93152089|NCT02198482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152090|NCT02198482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93152091|NCT02198482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93152092|NCT02198482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93152093|NCT02198482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152094|NCT02198482|Analgesics|analgesics|mesh-ancestor
93152095|NCT02198482|Sensory System Agents|sensory system agents|mesh-ancestor
93152096|NCT02198482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152097|NCT03961841|Oxaliplatin|oxaliplatin|mesh-list
93152098|NCT03961841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152099|NCT02201134|Sevoflurane|sevoflurane|mesh-list
93152100|NCT02201134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93152101|NCT02201134|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93152102|NCT02201134|Anesthetics, General|anesthetics, general|mesh-ancestor
93152103|NCT02201134|Anesthetics|anesthetics|mesh-ancestor
93152104|NCT02201134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152105|NCT02201134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152106|NCT02201602|Gliclazide|gliclazide|mesh-list
93152107|NCT02201602|Glyburide|glyburide|mesh-list
93152108|NCT02201602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93152109|NCT02201602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152110|NCT02201914|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93152111|NCT02201914|Clomiphene|clomiphene|mesh-list
93152112|NCT02201914|Enclomiphene|enclomiphene|mesh-list
93152113|NCT02201914|Zuclomiphene|zuclomiphene|mesh-list
93152114|NCT02201914|Cetrorelix|cetrorelix|mesh-list
93152115|NCT02201914|Luteolytic Agents|luteolytic agents|mesh-ancestor
93152116|NCT02201914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93152117|NCT02201914|Contraceptive Agents|contraceptive agents|mesh-ancestor
93152118|NCT02201914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93152119|NCT02201914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152120|NCT02201914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93152121|NCT02201914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93152122|NCT02201914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152123|NCT02201914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93152124|NCT02201914|Hormone Antagonists|hormone antagonists|mesh-ancestor
93152125|NCT02201914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152126|NCT02201914|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93152127|NCT02201914|Fertility Agents|fertility agents|mesh-ancestor
93152128|NCT02201914|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93152129|NCT02201914|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93152130|NCT02202070|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93152131|NCT02202070|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93152132|NCT02202070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93152133|NCT02202070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152134|NCT02202070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152135|NCT02202070|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93152136|NCT02202070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152137|NCT02202070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152138|NCT02202070|Cholinergic Agents|cholinergic agents|mesh-ancestor
93152139|NCT02202070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152140|NCT02202304|Chlorhexidine|chlorhexidine|mesh-list
93152141|NCT02202304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93152142|NCT02202304|Thymol|thymol|mesh-list
93152143|NCT02202304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93152144|NCT02202304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152145|NCT02202304|Disinfectants|disinfectants|mesh-ancestor
93152146|NCT02202304|Dermatologic Agents|dermatologic agents|mesh-ancestor
93152147|NCT02202304|Antifungal Agents|antifungal agents|mesh-ancestor
93152148|NCT02207452|Albuterol|albuterol|mesh-list
93152149|NCT02207452|Ipratropium|ipratropium|mesh-list
93152150|NCT02207452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93152151|NCT02207452|Autonomic Agents|autonomic agents|mesh-ancestor
93152152|NCT02207452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152153|NCT02207452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152154|NCT02207452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93152155|NCT02207452|Respiratory System Agents|respiratory system agents|mesh-ancestor
93152156|NCT02207452|Tocolytic Agents|tocolytic agents|mesh-ancestor
93152157|NCT02207452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93152158|NCT02207452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93152159|NCT02207452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93152160|NCT02207452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93152161|NCT02207452|Adrenergic Agents|adrenergic agents|mesh-ancestor
93152162|NCT02207452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152163|NCT02207452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152164|NCT02207452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93152165|NCT02207452|Cholinergic Agents|cholinergic agents|mesh-ancestor
93152166|NCT03533062|Botulinum Toxins|botulinum toxins|mesh-list
93152167|NCT03533062|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93152168|NCT03533062|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93152169|NCT03533062|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93152170|NCT03533062|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93152171|NCT03533062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152172|NCT03533062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152173|NCT03533062|Cholinergic Agents|cholinergic agents|mesh-ancestor
93152174|NCT03533062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152175|NCT03533062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152176|NCT03533062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93152177|NCT03533062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152178|NCT02207920|Vaccines|vaccines|mesh-list
93152179|NCT02207920|Immunologic Factors|immunologic factors|mesh-ancestor
93152180|NCT02207920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152181|NCT02208154|Chlorhexidine|chlorhexidine|mesh-list
93152182|NCT02208154|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93152183|NCT02208154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93152184|NCT02208154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152185|NCT02208154|Disinfectants|disinfectants|mesh-ancestor
93152186|NCT02208154|Dermatologic Agents|dermatologic agents|mesh-ancestor
93152187|NCT03532906|Bupivacaine|bupivacaine|mesh-list
92824377|NCT04292990|Morphine|morphine|mesh-list
93152188|NCT03532906|Anesthetics, Local|anesthetics, local|mesh-ancestor
93152189|NCT03532906|Anesthetics|anesthetics|mesh-ancestor
93152190|NCT03532906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152191|NCT03532906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152192|NCT03532906|Sensory System Agents|sensory system agents|mesh-ancestor
93152193|NCT03532906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152194|NCT02199418|Paclitaxel|paclitaxel|mesh-list
93152195|NCT02199418|Cisplatin|cisplatin|mesh-list
93152196|NCT02199418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93152197|NCT02199418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152198|NCT02199418|Tubulin Modulators|tubulin modulators|mesh-ancestor
93152199|NCT02199418|Antimitotic Agents|antimitotic agents|mesh-ancestor
93152200|NCT02199418|Mitosis Modulators|mitosis modulators|mesh-ancestor
93152201|NCT02199418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152202|NCT02208778|Remifentanil|remifentanil|mesh-list
93152203|NCT02208778|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93152204|NCT02208778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93152205|NCT02208778|Narcotics|narcotics|mesh-ancestor
93152206|NCT02208778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152207|NCT02208778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152208|NCT02208778|Analgesics|analgesics|mesh-ancestor
93152209|NCT02208778|Sensory System Agents|sensory system agents|mesh-ancestor
93152210|NCT02208778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152211|NCT02208778|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93152212|NCT02208778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93152213|NCT02208778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152214|NCT02208778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152215|NCT02208778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152216|NCT02208778|Antidepressive Agents|antidepressive agents|mesh-ancestor
93152217|NCT02208778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93152218|NCT02208778|Dopamine Agents|dopamine agents|mesh-ancestor
93152219|NCT02203396|Cyclosporine|cyclosporine|mesh-list
93152220|NCT02203396|Levamisole|levamisole|mesh-list
93152221|NCT02203396|Cyclosporins|cyclosporins|mesh-list
93152222|NCT02203396|Thymoglobulin|thymoglobulin|mesh-list
93152223|NCT02203396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152224|NCT02203396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152225|NCT02203396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93152226|NCT02203396|Immunologic Factors|immunologic factors|mesh-ancestor
93152227|NCT02203396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152228|NCT02203396|Antifungal Agents|antifungal agents|mesh-ancestor
93152229|NCT02203396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152230|NCT02203396|Dermatologic Agents|dermatologic agents|mesh-ancestor
93152231|NCT02203396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152232|NCT02203396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93152233|NCT02203396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93152234|NCT02203396|Antinematodal Agents|antinematodal agents|mesh-ancestor
93152235|NCT02203396|Anthelmintics|anthelmintics|mesh-ancestor
93152236|NCT02203396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93152237|NCT02203552|Minocycline|minocycline|mesh-list
93152238|NCT02203552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93152239|NCT02203552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152240|NCT02209012|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93152241|NCT02209012|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93152242|NCT02209012|Dermatologic Agents|dermatologic agents|mesh-ancestor
93152243|NCT02200354|Bevacizumab|bevacizumab|mesh-list
93152244|NCT02200354|Pemetrexed|pemetrexed|mesh-list
93152245|NCT02200354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152246|NCT02200354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152247|NCT02200354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93152248|NCT02200354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93152249|NCT02200354|Growth Substances|growth substances|mesh-ancestor
93152250|NCT02200354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152251|NCT02200354|Growth Inhibitors|growth inhibitors|mesh-ancestor
93152252|NCT02200354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152253|NCT02200354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152254|NCT02200354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93152255|NCT02200354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93152256|NCT02204020|Azacitidine|azacitidine|mesh-list
93152257|NCT02204020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93152258|NCT02204020|Antimetabolites|antimetabolites|mesh-ancestor
93152259|NCT02204020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152260|NCT02204020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152261|NCT02204020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152262|NCT02200822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93152263|NCT02200822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93152264|NCT02200822|Adrenergic Agents|adrenergic agents|mesh-ancestor
93152265|NCT02200822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152266|NCT02200822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152267|NCT02200822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152268|NCT02220634|Regadenoson|regadenoson|mesh-list
93152269|NCT02220634|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93152270|NCT02220634|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93152271|NCT02220634|Purinergic Agonists|purinergic agonists|mesh-ancestor
93152272|NCT02220634|Purinergic Agents|purinergic agents|mesh-ancestor
93152273|NCT02220634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152274|NCT02220634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152275|NCT02220634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152276|NCT02204644|Imatinib Mesylate|imatinib mesylate|mesh-list
93152277|NCT02204644|Flumatinib|flumatinib|mesh-list
93152278|NCT02204644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152279|NCT02204644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152280|NCT02204644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152281|NCT02204644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152282|NCT02204722|Imatinib Mesylate|imatinib mesylate|mesh-list
93152283|NCT02204722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152284|NCT02204722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152285|NCT02204722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152286|NCT02204722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152287|NCT02204878|Parecoxib|parecoxib|mesh-list
93152288|NCT02204878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93152289|NCT02204878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93152290|NCT02204878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152291|NCT02204878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152292|NCT02204878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152293|NCT02204878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152294|NCT02204878|Analgesics|analgesics|mesh-ancestor
93152295|NCT02204878|Sensory System Agents|sensory system agents|mesh-ancestor
93152296|NCT02204878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152297|NCT02204878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152298|NCT02204878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152299|NCT02204878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152300|NCT02205034|Oxytocin|oxytocin|mesh-list
93152301|NCT02205034|Oxytocics|oxytocics|mesh-ancestor
93152302|NCT02205034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93152303|NCT02205034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152304|NCT02210728|Methylphenidate|methylphenidate|mesh-list
93152305|NCT02210728|Amphetamine|amphetamine|mesh-list
93152306|NCT02210728|Adderall|adderall|mesh-list
93152307|NCT02210728|Dextroamphetamine|dextroamphetamine|mesh-list
93152308|NCT02210728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93152309|NCT02210728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152310|NCT02210728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93152311|NCT02210728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93152312|NCT02210728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152313|NCT02210728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152314|NCT02210728|Dopamine Agents|dopamine agents|mesh-ancestor
93152315|NCT02210728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152316|NCT02210728|Sympathomimetics|sympathomimetics|mesh-ancestor
93152317|NCT02210728|Autonomic Agents|autonomic agents|mesh-ancestor
93152318|NCT02210728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152319|NCT02210728|Adrenergic Agents|adrenergic agents|mesh-ancestor
93152320|NCT02210728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93152321|NCT02220868|Ribavirin|ribavirin|mesh-list
93152322|NCT02220868|Sofosbuvir|sofosbuvir|mesh-list
93152323|NCT02220868|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93152324|NCT02220868|Antimetabolites|antimetabolites|mesh-ancestor
93152325|NCT02220868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152326|NCT02220868|Antiviral Agents|antiviral agents|mesh-ancestor
93152327|NCT02220868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152328|NCT02220868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93152329|NCT02220868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93152330|NCT02221024|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93152331|NCT02221102|Aspirin|aspirin|mesh-list
93152332|NCT02221102|Edoxaban|edoxaban|mesh-list
93152333|NCT02221102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152334|NCT02221102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152335|NCT02221102|Analgesics|analgesics|mesh-ancestor
93152336|NCT02221102|Sensory System Agents|sensory system agents|mesh-ancestor
92824548|NCT01017029|Everolimus|everolimus|mesh-list
93152337|NCT02221102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152338|NCT02221102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152339|NCT02221102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152340|NCT02221102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152341|NCT02221102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93152342|NCT02221102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93152343|NCT02221102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152344|NCT02221102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93152345|NCT02221102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93152346|NCT02221102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152347|NCT02221102|Antipyretics|antipyretics|mesh-ancestor
93152348|NCT02221102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93152349|NCT02221102|Antithrombins|antithrombins|mesh-ancestor
93152350|NCT02221102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93152351|NCT02221102|Protease Inhibitors|protease inhibitors|mesh-ancestor
93152352|NCT02221102|Anticoagulants|anticoagulants|mesh-ancestor
93152353|NCT02213302|Midazolam|midazolam|mesh-list
93152354|NCT02213302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93152355|NCT02213302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93152356|NCT02213302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152357|NCT02213302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152358|NCT02213302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93152359|NCT02213302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93152360|NCT02213302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93152361|NCT02213302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152362|NCT02213302|Anesthetics, General|anesthetics, general|mesh-ancestor
93152363|NCT02213302|Anesthetics|anesthetics|mesh-ancestor
93152364|NCT02213302|GABA Modulators|gaba modulators|mesh-ancestor
93152365|NCT02213302|GABA Agents|gaba agents|mesh-ancestor
93152366|NCT02213302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152367|NCT02213302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152368|NCT02221180|Metformin|metformin|mesh-list
93152369|NCT02221180|Canagliflozin|canagliflozin|mesh-list
93152370|NCT02221180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93152371|NCT02221180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152372|NCT02221180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93152373|NCT02221180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152374|NCT02205112|Levofloxacin|levofloxacin|mesh-list
93152375|NCT02205112|Nemonoxacin|nemonoxacin|mesh-list
93152376|NCT02205112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93152377|NCT02205112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152378|NCT02205112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93152379|NCT02205112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93152380|NCT02205112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93152381|NCT02205112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152382|NCT02205112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152383|NCT02205112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152384|NCT02205112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93152385|NCT02205112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93152386|NCT02205190|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93152387|NCT02205190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93152388|NCT02205190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93152389|NCT02205190|Antimetabolites|antimetabolites|mesh-ancestor
93152390|NCT02205190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152391|NCT02205190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93152392|NCT02205190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93152393|NCT02205190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152394|NCT02257918|Ceftriaxone|ceftriaxone|mesh-list
93152395|NCT02257918|Zoliflodacin|zoliflodacin|mesh-list
93152396|NCT02257918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93152397|NCT02257918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152398|NCT02257918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93152399|NCT02257918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93152400|NCT02257918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152401|NCT02257918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152402|NCT02257918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152403|NCT02221414|Metformin|metformin|mesh-list
93152404|NCT02221414|Linagliptin|linagliptin|mesh-list
93152405|NCT02221414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93152406|NCT02221414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152407|NCT02221414|Incretins|incretins|mesh-ancestor
93152408|NCT02221414|Hormones|hormones|mesh-ancestor
93152409|NCT02221414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152410|NCT02221414|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93152411|NCT02221414|Protease Inhibitors|protease inhibitors|mesh-ancestor
93152412|NCT02221414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152413|NCT02221414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152414|NCT02221492|Plerixafor|plerixafor|mesh-list
93152415|NCT02221492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93152416|NCT02221492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93152417|NCT02221492|Antiviral Agents|antiviral agents|mesh-ancestor
93152418|NCT02221492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152419|NCT05164978|Antibodies|antibodies|mesh-list
93152420|NCT05164978|Immunologic Factors|immunologic factors|mesh-ancestor
93152421|NCT05164978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152422|NCT02221570|Baclofen|baclofen|mesh-list
93152423|NCT02221570|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93152424|NCT02221570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152425|NCT02221570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93152426|NCT02221570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152427|NCT02221570|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93152428|NCT02221570|GABA Agonists|gaba agonists|mesh-ancestor
93152429|NCT02221570|GABA Agents|gaba agents|mesh-ancestor
93152430|NCT02221570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152431|NCT02221570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152432|NCT02205502|Lidocaine|lidocaine|mesh-list
93152433|NCT02205502|Anesthetics, Local|anesthetics, local|mesh-ancestor
93152434|NCT02205502|Anesthetics|anesthetics|mesh-ancestor
93152435|NCT02205502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152436|NCT02205502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152437|NCT02205502|Sensory System Agents|sensory system agents|mesh-ancestor
93152438|NCT02205502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152439|NCT02205502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93152440|NCT02205502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93152441|NCT02205502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93152442|NCT02205502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152443|NCT02205502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152444|NCT02219698|Acetaminophen|acetaminophen|mesh-list
93152445|NCT02219698|Ibuprofen|ibuprofen|mesh-list
93152446|NCT02219698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152447|NCT02219698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152448|NCT02219698|Analgesics|analgesics|mesh-ancestor
93152449|NCT02219698|Sensory System Agents|sensory system agents|mesh-ancestor
93152450|NCT02219698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152451|NCT02219698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152452|NCT02219698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152453|NCT02219698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152454|NCT02219698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93152455|NCT02219698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152456|NCT02219698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152457|NCT02219698|Antipyretics|antipyretics|mesh-ancestor
93152458|NCT02205580|Sufentanil|sufentanil|mesh-list
93152459|NCT02205580|Dsuvia|dsuvia|mesh-list
93152460|NCT02205580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93152461|NCT02205580|Narcotics|narcotics|mesh-ancestor
93152462|NCT02205580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152463|NCT02205580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152464|NCT02205580|Analgesics|analgesics|mesh-ancestor
93152465|NCT02205580|Sensory System Agents|sensory system agents|mesh-ancestor
93152466|NCT02205580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152467|NCT02205580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93152468|NCT02205580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152469|NCT02205580|Anesthetics, General|anesthetics, general|mesh-ancestor
93152470|NCT02205580|Anesthetics|anesthetics|mesh-ancestor
93152471|NCT02221960|Durvalumab|durvalumab|mesh-list
93152472|NCT02221960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152473|NCT02221960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152474|NCT02220088|Leucovorin|leucovorin|mesh-list
93152475|NCT02220088|Fluorouracil|fluorouracil|mesh-list
93152476|NCT02220088|Oxaliplatin|oxaliplatin|mesh-list
93152477|NCT02220088|Sorafenib|sorafenib|mesh-list
93152478|NCT02220088|Antimetabolites|antimetabolites|mesh-ancestor
93152479|NCT02220088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152480|NCT02220088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93152481|NCT02220088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152482|NCT02220088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93152483|NCT02220088|Immunologic Factors|immunologic factors|mesh-ancestor
93152484|NCT02220088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152485|NCT02220088|Antidotes|antidotes|mesh-ancestor
93152486|NCT02220088|Protective Agents|protective agents|mesh-ancestor
93152487|NCT02220088|Vitamin B Complex|vitamin b complex|mesh-ancestor
93152488|NCT02220088|Vitamins|vitamins|mesh-ancestor
93152489|NCT02220088|Micronutrients|micronutrients|mesh-ancestor
93152490|NCT02220088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152491|NCT02220088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152492|NCT02220400|Ketamine|ketamine|mesh-list
93152493|NCT02220400|Analgesics|analgesics|mesh-ancestor
93152494|NCT02220400|Sensory System Agents|sensory system agents|mesh-ancestor
93152495|NCT02220400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152496|NCT02220400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152497|NCT02220400|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93152498|NCT02220400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152499|NCT02220400|Anesthetics, General|anesthetics, general|mesh-ancestor
93152500|NCT02220400|Anesthetics|anesthetics|mesh-ancestor
93152501|NCT02220400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152502|NCT02220400|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93152503|NCT02220400|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93152504|NCT02220400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152505|NCT02220400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152506|NCT02205892|Lupeol|lupeol|mesh-list
93152507|NCT02205892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152508|NCT02224768|Ipilimumab|ipilimumab|mesh-list
93152509|NCT02224768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152510|NCT02224768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152511|NCT02224768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93152512|NCT02224768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152513|NCT05262166|Dexmedetomidine|dexmedetomidine|mesh-list
93152514|NCT05262166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93152515|NCT05262166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152516|NCT05262166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152517|NCT05262166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152518|NCT05262166|Analgesics|analgesics|mesh-ancestor
93152519|NCT05262166|Sensory System Agents|sensory system agents|mesh-ancestor
93152520|NCT05262166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152521|NCT05262166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93152522|NCT05262166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93152523|NCT05262166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93152524|NCT05262166|Adrenergic Agents|adrenergic agents|mesh-ancestor
93152525|NCT05262166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152526|NCT05262166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152527|NCT02206204|Moxifloxacin|moxifloxacin|mesh-list
93152528|NCT02206204|Selexipag|selexipag|mesh-list
93152529|NCT02206204|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93152530|NCT02206204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93152531|NCT02206204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152532|NCT02206204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93152533|NCT02206204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93152534|NCT02206204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152535|NCT02206204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152536|NCT02206204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152537|NCT02206204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93152538|NCT02206204|Contraceptive Agents|contraceptive agents|mesh-ancestor
93152539|NCT02206204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93152540|NCT02206204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152541|NCT02206204|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93152542|NCT02206204|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93152543|NCT02206204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93152544|NCT02206204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93152545|NCT02230930|Hydrocortisone|hydrocortisone|mesh-list
93152546|NCT02230930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93152547|NCT02230930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93152548|NCT02230930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93152549|NCT02230930|Apomorphine|apomorphine|mesh-list
93152550|NCT02230930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152551|NCT02230930|Emetics|emetics|mesh-ancestor
93152552|NCT02230930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152553|NCT02230930|Autonomic Agents|autonomic agents|mesh-ancestor
93152554|NCT02230930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152555|NCT02230930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93152556|NCT02230930|Dopamine Agonists|dopamine agonists|mesh-ancestor
93152557|NCT02230930|Dopamine Agents|dopamine agents|mesh-ancestor
93152558|NCT02230930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152559|NCT02230930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152560|NCT02222350|Firuglipel|firuglipel|mesh-list
93152561|NCT02222350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93152562|NCT02222350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152564|NCT02222428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93152565|NCT02222428|Autonomic Agents|autonomic agents|mesh-ancestor
93152566|NCT02222428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152567|NCT02222428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152568|NCT02222428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93152569|NCT02222428|Respiratory System Agents|respiratory system agents|mesh-ancestor
93152570|NCT02231320|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93152571|NCT02231320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93152572|NCT02231320|Autonomic Agents|autonomic agents|mesh-ancestor
93152573|NCT02231320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152574|NCT02231320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152575|NCT02231320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93152576|NCT02231320|Respiratory System Agents|respiratory system agents|mesh-ancestor
93152577|NCT02225470|Vinorelbine|vinorelbine|mesh-list
93152578|NCT02225470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93152579|NCT02225470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152580|NCT02225470|Tubulin Modulators|tubulin modulators|mesh-ancestor
93152581|NCT02225470|Antimitotic Agents|antimitotic agents|mesh-ancestor
93152582|NCT02225470|Mitosis Modulators|mitosis modulators|mesh-ancestor
93152583|NCT02225470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152584|NCT02225548|Tadalafil|tadalafil|mesh-list
93152585|NCT02225548|Selegiline|selegiline|mesh-list
93152586|NCT02225548|Vasodilator Agents|vasodilator agents|mesh-ancestor
93152587|NCT02225548|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93152588|NCT02225548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93152589|NCT02225548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152590|NCT02225548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152591|NCT02225548|Urological Agents|urological agents|mesh-ancestor
93152592|NCT02225548|Antidepressive Agents|antidepressive agents|mesh-ancestor
93152593|NCT02225548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93152594|NCT02225548|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93152595|NCT02225548|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93152596|NCT02225548|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93152597|NCT02225548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93152598|NCT02225548|Protective Agents|protective agents|mesh-ancestor
93152599|NCT02225548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152600|NCT02223052|Azacitidine|azacitidine|mesh-list
93152601|NCT02223052|Cc-486|cc-486|mesh-list
93152602|NCT02223052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93152603|NCT02223052|Antimetabolites|antimetabolites|mesh-ancestor
93152604|NCT02223052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152605|NCT02223052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152606|NCT02223052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152607|NCT02231632|Vaccines|vaccines|mesh-list
93152608|NCT02231632|Immunologic Factors|immunologic factors|mesh-ancestor
93152609|NCT02231632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152610|NCT02225782|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93152611|NCT02225782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93152612|NCT02225782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93152613|NCT02225782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152614|NCT02231788|Amlodipine|amlodipine|mesh-list
93152615|NCT02231788|Telmisartan|telmisartan|mesh-list
93152616|NCT02231788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93152617|NCT02231788|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93152618|NCT02231788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152619|NCT02231788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152620|NCT02231788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93152621|NCT02231788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152622|NCT02231788|Vasodilator Agents|vasodilator agents|mesh-ancestor
93152623|NCT02231788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93152624|NCT02231788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93152625|NCT02258620|Isosorbide|isosorbide|mesh-list
93152626|NCT02258620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93152627|NCT02258620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93152628|NCT02258620|Nitroglycerin|nitroglycerin|mesh-list
93152629|NCT02258620|Vasodilator Agents|vasodilator agents|mesh-ancestor
93152630|NCT02258620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93152631|NCT02258620|Diuretics|diuretics|mesh-ancestor
93152632|NCT02258620|Natriuretic Agents|natriuretic agents|mesh-ancestor
93152633|NCT02258620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152634|NCT02258620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92824829|NCT00715273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93152635|NCT02258620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152636|NCT02223598|Dexamethasone|dexamethasone|mesh-list
93152637|NCT02223598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152638|NCT02223598|Antiemetics|antiemetics|mesh-ancestor
93152639|NCT02223598|Autonomic Agents|autonomic agents|mesh-ancestor
93152640|NCT02223598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152641|NCT02223598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928310|NCT02387619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93152642|NCT02223598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93152643|NCT02223598|Glucocorticoids|glucocorticoids|mesh-ancestor
93152644|NCT02223598|Hormones|hormones|mesh-ancestor
93152645|NCT02223598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152646|NCT02223598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93152647|NCT02223598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152648|NCT00094835|Paclitaxel|paclitaxel|mesh-list
93152649|NCT00094835|Carboplatin|carboplatin|mesh-list
93152650|NCT00094835|Panitumumab|panitumumab|mesh-list
93152651|NCT00094835|Motesanib diphosphate|motesanib diphosphate|mesh-list
93152652|NCT00094835|Imetelstat|imetelstat|mesh-list
93152653|NCT00094835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93152654|NCT00094835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152655|NCT00094835|Tubulin Modulators|tubulin modulators|mesh-ancestor
93152656|NCT00094835|Antimitotic Agents|antimitotic agents|mesh-ancestor
93152657|NCT00094835|Mitosis Modulators|mitosis modulators|mesh-ancestor
93152658|NCT00094835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152659|NCT00094835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152660|NCT00094835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152661|NCT00094835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152662|NCT02226328|Fentanyl|fentanyl|mesh-list
93152663|NCT02226328|Midazolam|midazolam|mesh-list
93152664|NCT02226328|Propofol|propofol|mesh-list
93152665|NCT02226328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93152666|NCT02226328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152667|NCT02226328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152668|NCT02226328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152669|NCT02226328|Anesthetics, General|anesthetics, general|mesh-ancestor
93152670|NCT02226328|Anesthetics|anesthetics|mesh-ancestor
93152671|NCT02226328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93152672|NCT02226328|Narcotics|narcotics|mesh-ancestor
93152673|NCT02226328|Analgesics|analgesics|mesh-ancestor
93152674|NCT02226328|Sensory System Agents|sensory system agents|mesh-ancestor
93152675|NCT02226328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152676|NCT02226328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93152677|NCT02226328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93152678|NCT02226328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93152679|NCT02226328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93152680|NCT02226328|GABA Modulators|gaba modulators|mesh-ancestor
93152681|NCT02226328|GABA Agents|gaba agents|mesh-ancestor
93152682|NCT02226328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152683|NCT02226328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152684|NCT03962777|Chlorhexidine|chlorhexidine|mesh-list
93152685|NCT03962777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93152686|NCT03962777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152687|NCT03962777|Disinfectants|disinfectants|mesh-ancestor
93152688|NCT02226484|Quercetin|quercetin|mesh-list
93152689|NCT02226484|Antioxidants|antioxidants|mesh-ancestor
93152690|NCT02226484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152691|NCT02226484|Protective Agents|protective agents|mesh-ancestor
93152692|NCT02226484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152693|NCT04453852|Vaccines|vaccines|mesh-list
93152694|NCT04453852|Immunologic Factors|immunologic factors|mesh-ancestor
93152695|NCT04453852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152696|NCT00094757|Pioglitazone|pioglitazone|mesh-list
93152697|NCT00094757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93152698|NCT00094757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93152699|NCT00094757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152700|NCT00094757|Incretins|incretins|mesh-ancestor
93152701|NCT00094757|Hormones|hormones|mesh-ancestor
93152702|NCT00094757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152703|NCT00094757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93152704|NCT00094757|Protease Inhibitors|protease inhibitors|mesh-ancestor
93152705|NCT00094757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152706|NCT00094757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152707|NCT02223832|Ponesimod|ponesimod|mesh-list
93152708|NCT02223832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93152709|NCT02223832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152710|NCT02223832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93152711|NCT02223832|Immunologic Factors|immunologic factors|mesh-ancestor
93152712|NCT02223832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152713|NCT02224066|Aspirin|aspirin|mesh-list
93152714|NCT02224066|Clopidogrel|clopidogrel|mesh-list
93152715|NCT02224066|Ticagrelor|ticagrelor|mesh-list
93152716|NCT02224066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152717|NCT02224066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152718|NCT02224066|Analgesics|analgesics|mesh-ancestor
93152719|NCT02224066|Sensory System Agents|sensory system agents|mesh-ancestor
93152720|NCT02224066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152721|NCT02224066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152722|NCT02224066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152723|NCT02224066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152724|NCT02224066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93152725|NCT02224066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93152726|NCT02224066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152727|NCT02224066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93152728|NCT02224066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93152729|NCT02224066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152730|NCT02224066|Antipyretics|antipyretics|mesh-ancestor
93152731|NCT02224066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93152732|NCT02224066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93152733|NCT02224066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93152734|NCT02224066|Purinergic Agents|purinergic agents|mesh-ancestor
93152735|NCT02224066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152736|NCT02227030|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93152737|NCT04378114|Acetaminophen|acetaminophen|mesh-list
93152738|NCT04378114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152739|NCT04378114|Analgesics|analgesics|mesh-ancestor
93152740|NCT04378114|Sensory System Agents|sensory system agents|mesh-ancestor
93152741|NCT04378114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152742|NCT04378114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152743|NCT04378114|Antipyretics|antipyretics|mesh-ancestor
93152744|NCT00082433|Capecitabine|capecitabine|mesh-list
93152745|NCT00082433|Epothilones|epothilones|mesh-list
93152746|NCT00082433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93152747|NCT00082433|Antimetabolites|antimetabolites|mesh-ancestor
93152748|NCT00082433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152749|NCT00082433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152750|NCT00082433|Tubulin Modulators|tubulin modulators|mesh-ancestor
93152751|NCT00082433|Antimitotic Agents|antimitotic agents|mesh-ancestor
93152752|NCT00082433|Mitosis Modulators|mitosis modulators|mesh-ancestor
93152753|NCT00094445|Curcumin|curcumin|mesh-list
93152754|NCT00094445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152755|NCT00094445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152756|NCT00094445|Analgesics|analgesics|mesh-ancestor
93152757|NCT00094445|Sensory System Agents|sensory system agents|mesh-ancestor
93152758|NCT00094445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152759|NCT00094445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152760|NCT00094445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152761|NCT00094445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152762|NCT00094445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152763|NCT00094445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152764|NCT00094445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152765|NCT01081535|Ketorolac|ketorolac|mesh-list
93152766|NCT01081535|Fentanyl|fentanyl|mesh-list
93152767|NCT01081535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93152768|NCT01081535|Narcotics|narcotics|mesh-ancestor
93152769|NCT01081535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152770|NCT01081535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152771|NCT01081535|Analgesics|analgesics|mesh-ancestor
93152772|NCT01081535|Sensory System Agents|sensory system agents|mesh-ancestor
93152773|NCT01081535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152774|NCT01081535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93152775|NCT01081535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152776|NCT01081535|Anesthetics, General|anesthetics, general|mesh-ancestor
93152777|NCT01081535|Anesthetics|anesthetics|mesh-ancestor
93152778|NCT01081535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152779|NCT01081535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152780|NCT01081535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152781|NCT01081535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152782|NCT01081535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93152783|NCT01081535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152784|NCT01081535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152785|NCT01087229|Nitrous Oxide|nitrous oxide|mesh-list
92824979|NCT00712855|Sorafenib|sorafenib|mesh-list
93152786|NCT01087229|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93152787|NCT01087229|Anesthetics, General|anesthetics, general|mesh-ancestor
93152789|NCT01087229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152790|NCT01087229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152791|NCT01087229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152792|NCT01087229|Analgesics|analgesics|mesh-ancestor
92448502|NCT02720068|Fluorouracil|fluorouracil|mesh-list
93152793|NCT01087229|Sensory System Agents|sensory system agents|mesh-ancestor
93152794|NCT01087229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152795|NCT00082355|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93152796|NCT00082355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93152797|NCT00082355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93152798|NCT00082355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152799|NCT01084577|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93152800|NCT01084577|Laxatives|laxatives|mesh-ancestor
93152801|NCT01084577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93152802|NCT00094055|Axitinib|axitinib|mesh-list
93152803|NCT00094055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152804|NCT00094055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152805|NCT00094055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152806|NCT00094055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152807|NCT02531165|Aspirin|aspirin|mesh-list
93152808|NCT02531165|Heparin|heparin|mesh-list
93152809|NCT02531165|Fentanyl|fentanyl|mesh-list
93152810|NCT02531165|Morphine|morphine|mesh-list
93152811|NCT02531165|Ticagrelor|ticagrelor|mesh-list
93152812|NCT02531165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152813|NCT02531165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152814|NCT02531165|Analgesics|analgesics|mesh-ancestor
93152815|NCT02531165|Sensory System Agents|sensory system agents|mesh-ancestor
93152816|NCT02531165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152817|NCT02531165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152818|NCT02531165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152819|NCT02531165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152820|NCT02531165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93152821|NCT02531165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93152822|NCT02531165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152823|NCT02531165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93152824|NCT02531165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93152825|NCT02531165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152826|NCT02531165|Antipyretics|antipyretics|mesh-ancestor
93152827|NCT02531165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93152828|NCT02531165|Narcotics|narcotics|mesh-ancestor
93152829|NCT02531165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152830|NCT02531165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93152831|NCT02531165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93152832|NCT02531165|Anesthetics, General|anesthetics, general|mesh-ancestor
93152833|NCT02531165|Anesthetics|anesthetics|mesh-ancestor
93152834|NCT02531165|Anticoagulants|anticoagulants|mesh-ancestor
93152835|NCT02531165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93152836|NCT02531165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93152837|NCT02531165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93152838|NCT02531165|Purinergic Agents|purinergic agents|mesh-ancestor
93152839|NCT02531165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152840|NCT00099983|Risperidone|risperidone|mesh-list
93152841|NCT00099983|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93152842|NCT00099983|Serotonin Agents|serotonin agents|mesh-ancestor
93152843|NCT00099983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152844|NCT00099983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152845|NCT00099983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152846|NCT00099983|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93152847|NCT00099983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93152848|NCT00099983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93152849|NCT00099983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93152850|NCT00099983|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93152851|NCT00099983|Dopamine Agents|dopamine agents|mesh-ancestor
93152852|NCT00099359|Lamivudine|lamivudine|mesh-list
93152853|NCT00099359|Zidovudine|zidovudine|mesh-list
93152854|NCT00099359|Nevirapine|nevirapine|mesh-list
93152855|NCT00099359|Nelfinavir|nelfinavir|mesh-list
93152856|NCT00099359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93152857|NCT00099359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93152858|NCT00099359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152859|NCT00099359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152860|NCT00099359|Antiviral Agents|antiviral agents|mesh-ancestor
93152861|NCT00099359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152862|NCT00099359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93152863|NCT00099359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93152864|NCT00099359|Antimetabolites|antimetabolites|mesh-ancestor
93152865|NCT00099359|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93152866|NCT00099359|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93152867|NCT00099359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92448578|NCT02066636|Nivolumab|nivolumab|mesh-list
93152868|NCT00099359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93152869|NCT00099359|Protease Inhibitors|protease inhibitors|mesh-ancestor
93152870|NCT00092417|Vaccines|vaccines|mesh-list
93152871|NCT00092417|Immunologic Factors|immunologic factors|mesh-ancestor
93152872|NCT00092417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152873|NCT00091949|Pioglitazone|pioglitazone|mesh-list
93152874|NCT00091949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93152875|NCT00091949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152876|NCT02258542|Benralizumab|benralizumab|mesh-list
93152877|NCT02258542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93152878|NCT02258542|Respiratory System Agents|respiratory system agents|mesh-ancestor
93152879|NCT00091793|Denosumab|denosumab|mesh-list
93152880|NCT00091793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93152881|NCT00091793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152882|NCT00098813|Romidepsin|romidepsin|mesh-list
93152883|NCT00098813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93152884|NCT00098813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152885|NCT00098813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93152886|NCT00098813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152887|NCT00098813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152888|NCT01081613|Bevacizumab|bevacizumab|mesh-list
93152889|NCT01081613|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
93152890|NCT01081613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152891|NCT01081613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152892|NCT01081613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93152893|NCT01081613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93152894|NCT01081613|Growth Substances|growth substances|mesh-ancestor
93152895|NCT01081613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152896|NCT01081613|Growth Inhibitors|growth inhibitors|mesh-ancestor
93152897|NCT01081613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93152898|NCT01081613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152899|NCT02227264|Parathyroid Hormone|parathyroid hormone|mesh-list
93152900|NCT02227264|Cinacalcet|cinacalcet|mesh-list
93152901|NCT02227264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93152902|NCT02227264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152903|NCT02227264|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93152904|NCT02227264|Hormone Antagonists|hormone antagonists|mesh-ancestor
93152905|NCT02227264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152906|NCT02227420|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93152907|NCT02227420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152908|NCT04772248|Adalimumab|adalimumab|mesh-list
93152909|NCT04772248|Infliximab|infliximab|mesh-list
93152910|NCT04772248|Golimumab|golimumab|mesh-list
93152911|NCT04772248|Certolizumab Pegol|certolizumab pegol|mesh-list
93152912|NCT04772248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93152913|NCT04772248|Etanercept|etanercept|mesh-list
93152914|NCT04772248|Tofacitinib|tofacitinib|mesh-list
93152915|NCT04772248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93152916|NCT04772248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93152917|NCT04772248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93152918|NCT04772248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93152919|NCT04772248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93152920|NCT04772248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93152921|NCT04772248|Analgesics|analgesics|mesh-ancestor
93152922|NCT04772248|Sensory System Agents|sensory system agents|mesh-ancestor
93152923|NCT04772248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152924|NCT04772248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152925|NCT04772248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93152926|NCT04772248|Immunologic Factors|immunologic factors|mesh-ancestor
93152927|NCT04772248|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93152928|NCT04772248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93152929|NCT04772248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152930|NCT04772248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152931|NCT00090857|Letrozole|letrozole|mesh-list
93152932|NCT00090857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152933|NCT00090857|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93152934|NCT00090857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93152935|NCT00090857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152936|NCT00090857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152937|NCT00090857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93152938|NCT00090857|Hormone Antagonists|hormone antagonists|mesh-ancestor
93152939|NCT00090857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93152940|NCT00090857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152941|NCT01775644|Bevacizumab|bevacizumab|mesh-list
93152942|NCT01775644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93152943|NCT01775644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93152944|NCT01775644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93152945|NCT01775644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93152946|NCT01775644|Growth Substances|growth substances|mesh-ancestor
93152947|NCT01775644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152948|NCT01775644|Growth Inhibitors|growth inhibitors|mesh-ancestor
93152949|NCT04259086|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93152950|NCT04259086|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93152951|NCT04259086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93152952|NCT04259086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93152953|NCT04259086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152954|NCT04259086|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93152955|NCT04259086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93152956|NCT04259086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152957|NCT04259086|Cholinergic Agents|cholinergic agents|mesh-ancestor
93152958|NCT04259086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93152959|NCT04229368|Vitamin D|vitamin d|mesh-list
93152960|NCT04229368|Cholecalciferol|cholecalciferol|mesh-list
93152961|NCT04229368|Vitamins|vitamins|mesh-ancestor
93152962|NCT04229368|Micronutrients|micronutrients|mesh-ancestor
93152963|NCT04229368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152964|NCT04229368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93152965|NCT04229368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93152966|NCT00090779|Ritonavir|ritonavir|mesh-list
93152967|NCT00090779|Lopinavir|lopinavir|mesh-list
93152968|NCT00090779|Tenofovir|tenofovir|mesh-list
93152969|NCT00090779|Emtricitabine|emtricitabine|mesh-list
93152970|NCT00090779|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93152971|NCT00090779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93152972|NCT00090779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93152973|NCT00090779|Protease Inhibitors|protease inhibitors|mesh-ancestor
93152974|NCT00090779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93152975|NCT00090779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93152976|NCT00090779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93152977|NCT00090779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93152978|NCT00090779|Antiviral Agents|antiviral agents|mesh-ancestor
93152979|NCT00090779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152980|NCT00090779|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93152981|NCT00090779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93152982|NCT00090779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93152983|NCT00090779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93152984|NCT01081691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93152985|NCT01081691|Immunologic Factors|immunologic factors|mesh-ancestor
93152986|NCT01081691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152987|NCT01081847|Mannitol|mannitol|mesh-list
93152988|NCT01081847|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93152989|NCT01081847|Freund's Adjuvant|freund's adjuvant|mesh-list
93152990|NCT01081847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93152991|NCT01081847|Immunologic Factors|immunologic factors|mesh-ancestor
93152992|NCT01081847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93152993|NCT01081847|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93152994|NCT01081847|Diuretics|diuretics|mesh-ancestor
93152995|NCT01081847|Natriuretic Agents|natriuretic agents|mesh-ancestor
93152996|NCT02224456|Tenofovir|tenofovir|mesh-list
93152997|NCT02224456|Antiviral Agents|antiviral agents|mesh-ancestor
93152998|NCT02224456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93152999|NCT02224456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93153000|NCT02224456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93153001|NCT02224456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153002|NCT02224456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153003|NCT02224456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93153004|NCT02224456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93153005|NCT02224534|Clopidogrel|clopidogrel|mesh-list
93153006|NCT02224534|Ticagrelor|ticagrelor|mesh-list
93153007|NCT02224534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93153008|NCT02224534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93153009|NCT02224534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93153010|NCT02224534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93153011|NCT02224534|Purinergic Agents|purinergic agents|mesh-ancestor
93153012|NCT02224534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153013|NCT02224534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153014|NCT02224534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153015|NCT04174612|Cytarabine|cytarabine|mesh-list
93153016|NCT04174612|Daunorubicin|daunorubicin|mesh-list
93153017|NCT04174612|Midostaurin|midostaurin|mesh-list
93153018|NCT04174612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153019|NCT04174612|Antimetabolites|antimetabolites|mesh-ancestor
93153020|NCT04174612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153021|NCT04174612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153022|NCT04174612|Antiviral Agents|antiviral agents|mesh-ancestor
93153023|NCT04174612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153024|NCT04174612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153025|NCT04174612|Immunologic Factors|immunologic factors|mesh-ancestor
93153026|NCT04174612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153027|NCT04174612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93153028|NCT04174612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93153029|NCT04174612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93153030|NCT04174612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153031|NCT04174612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153032|NCT01082003|Pentoxifylline|pentoxifylline|mesh-list
93153033|NCT01082003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93153034|NCT01082003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153035|NCT01082003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153036|NCT01082003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93153037|NCT01082003|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93153038|NCT01082003|Protective Agents|protective agents|mesh-ancestor
93153039|NCT01082003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153040|NCT01082003|Vasodilator Agents|vasodilator agents|mesh-ancestor
93153041|NCT01082003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93153042|NCT01082003|Antioxidants|antioxidants|mesh-ancestor
93153043|NCT01082237|Escitalopram|escitalopram|mesh-list
93153044|NCT01082237|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93153045|NCT01082237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93153046|NCT01082237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153047|NCT01082237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153048|NCT01082237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153049|NCT01082237|Serotonin Agents|serotonin agents|mesh-ancestor
93153050|NCT01082237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153051|NCT02228122|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93153052|NCT02228122|Laxatives|laxatives|mesh-ancestor
93153053|NCT02228122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93153054|NCT01082315|Cetuximab|cetuximab|mesh-list
93153055|NCT01082315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153056|NCT01082315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153057|NCT01082471|Morphine|morphine|mesh-list
93153058|NCT01082471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93153059|NCT01082471|Narcotics|narcotics|mesh-ancestor
93153060|NCT01082471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153061|NCT01082471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153062|NCT01082471|Analgesics|analgesics|mesh-ancestor
93153063|NCT01082471|Sensory System Agents|sensory system agents|mesh-ancestor
93153064|NCT01082471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153065|NCT03553498|Acetaminophen|acetaminophen|mesh-list
93153066|NCT03553498|Hydromorphone|hydromorphone|mesh-list
93153067|NCT03553498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93153068|NCT03553498|Analgesics|analgesics|mesh-ancestor
93153069|NCT03553498|Sensory System Agents|sensory system agents|mesh-ancestor
93153070|NCT03553498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153071|NCT03553498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153072|NCT03553498|Antipyretics|antipyretics|mesh-ancestor
93153073|NCT03553498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93153074|NCT03553498|Narcotics|narcotics|mesh-ancestor
93153075|NCT03553498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153076|NCT01589393|Enoxaparin|enoxaparin|mesh-list
93153077|NCT01589393|Anticoagulants|anticoagulants|mesh-ancestor
93153078|NCT01589393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93153079|NCT01589393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93153080|NCT01589393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153081|NCT01589471|Botulinum Toxins|botulinum toxins|mesh-list
93153082|NCT01589471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93153083|NCT01589471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93153084|NCT01589471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93153085|NCT01589471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153086|NCT01589471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153087|NCT01589471|Cholinergic Agents|cholinergic agents|mesh-ancestor
93153088|NCT01589471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153089|NCT01589471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153090|NCT01589471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93153091|NCT01589471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153092|NCT00096941|Pertuzumab|pertuzumab|mesh-list
93153093|NCT00096941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153094|NCT00096941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153095|NCT00096785|Entecavir|entecavir|mesh-list
93153096|NCT00096785|Adefovir|adefovir|mesh-list
93153097|NCT00096785|Antiviral Agents|antiviral agents|mesh-ancestor
93153098|NCT00096785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153099|NCT00096785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93153100|NCT00096785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93153101|NCT00096785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153102|NCT00096785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153103|NCT01326767|Paclitaxel|paclitaxel|mesh-list
93153104|NCT01326767|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93153105|NCT01326767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153106|NCT01326767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153107|NCT01326767|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153108|NCT01326767|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153109|NCT01326767|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153110|NCT01326767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153111|NCT03963479|Vitamin B 6|vitamin b 6|mesh-list
93153112|NCT03963479|Pyridoxal|pyridoxal|mesh-list
93153113|NCT03963479|Pyridoxine|pyridoxine|mesh-list
93153114|NCT03963479|Vitamins|vitamins|mesh-ancestor
93153115|NCT03963479|Micronutrients|micronutrients|mesh-ancestor
93153116|NCT03963479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153117|NCT03963479|Vitamin B Complex|vitamin b complex|mesh-ancestor
93153118|NCT02228512|Prednisone|prednisone|mesh-list
93153119|NCT02228512|Cyclophosphamide|cyclophosphamide|mesh-list
93153120|NCT02228512|Rituximab|rituximab|mesh-list
93153121|NCT02228512|Doxorubicin|doxorubicin|mesh-list
93153122|NCT02228512|Etoposide|etoposide|mesh-list
93153123|NCT02228512|Vincristine|vincristine|mesh-list
93153124|NCT02228512|Pomalidomide|pomalidomide|mesh-list
93153125|NCT02228512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153126|NCT02228512|Immunologic Factors|immunologic factors|mesh-ancestor
93153127|NCT02228512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153128|NCT02228512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153129|NCT02228512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93153130|NCT02228512|Alkylating Agents|alkylating agents|mesh-ancestor
93153131|NCT02228512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153132|NCT02228512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153133|NCT02228512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93153134|NCT02228512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153135|NCT02228512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93153136|NCT02228512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93153137|NCT02228512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93153138|NCT02228512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153139|NCT02228512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153140|NCT02228512|Glucocorticoids|glucocorticoids|mesh-ancestor
93153141|NCT02228512|Hormones|hormones|mesh-ancestor
93153142|NCT02228512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153143|NCT02228512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93153144|NCT02228512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153145|NCT02228512|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153146|NCT02228512|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153147|NCT02228512|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153148|NCT02228512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153149|NCT02228512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153150|NCT02228512|Growth Substances|growth substances|mesh-ancestor
93153151|NCT02228512|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153152|NCT01082627|Somatostatin|somatostatin|mesh-list
93153153|NCT01082627|Hormones|hormones|mesh-ancestor
93153154|NCT01082627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153155|NCT01082627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153156|NCT03515044|Rifaximin|rifaximin|mesh-list
93153157|NCT03515044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153158|NCT03515044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153159|NCT03515044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93153160|NCT01082705|Lumefantrine|lumefantrine|mesh-list
93153161|NCT01082705|Artemether|artemether|mesh-list
93153162|NCT01082705|Piperaquine|piperaquine|mesh-list
93153163|NCT01082705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93153164|NCT01082705|Artenimol|artenimol|mesh-list
93153165|NCT01082705|Antimalarials|antimalarials|mesh-ancestor
93153166|NCT01082705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93153167|NCT01082705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93153168|NCT01082705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153169|NCT01582997|Dabrafenib|dabrafenib|mesh-list
93153170|NCT01582997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153171|NCT01582997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153172|NCT01582997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153173|NCT01582997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153174|NCT01090505|Oxaliplatin|oxaliplatin|mesh-list
93153175|NCT01090505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153176|NCT01085981|Niacin|niacin|mesh-list
93153177|NCT01085981|Niacinamide|niacinamide|mesh-list
93153178|NCT01085981|Nicotinic Acids|nicotinic acids|mesh-list
93153179|NCT01085981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93153180|NCT01085981|Antimetabolites|antimetabolites|mesh-ancestor
93153181|NCT01085981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153182|NCT01085981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93153183|NCT01085981|Vasodilator Agents|vasodilator agents|mesh-ancestor
93153184|NCT01085981|Vitamin B Complex|vitamin b complex|mesh-ancestor
93153185|NCT01085981|Vitamins|vitamins|mesh-ancestor
93153186|NCT01085981|Micronutrients|micronutrients|mesh-ancestor
93153187|NCT01085981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153188|NCT03345082|Ranibizumab|ranibizumab|mesh-list
93153189|NCT03345082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153190|NCT03345082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153191|NCT03345082|Growth Substances|growth substances|mesh-ancestor
93153192|NCT03345082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153193|NCT03345082|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153194|NCT03345082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153195|NCT02228902|Ferrous fumarate|ferrous fumarate|mesh-list
93153196|NCT02228902|Ferrous gluconate|ferrous gluconate|mesh-list
93153197|NCT02228902|Trace Elements|trace elements|mesh-ancestor
93153198|NCT02228902|Micronutrients|micronutrients|mesh-ancestor
93153199|NCT02228902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153200|NCT02228902|Hematinics|hematinics|mesh-ancestor
93153201|NCT03288454|Apixaban|apixaban|mesh-list
93153202|NCT03288454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93153203|NCT03288454|Antithrombins|antithrombins|mesh-ancestor
93153204|NCT03288454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93153205|NCT03288454|Protease Inhibitors|protease inhibitors|mesh-ancestor
93153206|NCT03288454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153207|NCT03288454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153208|NCT03288454|Anticoagulants|anticoagulants|mesh-ancestor
93153209|NCT00090545|Sorafenib|sorafenib|mesh-list
93153210|NCT00090545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153211|NCT00090545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153212|NCT00090545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153213|NCT00090545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153214|NCT02829814|Cyclobenzaprine|cyclobenzaprine|mesh-list
93153215|NCT02829814|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93153216|NCT02829814|Antidepressive Agents|antidepressive agents|mesh-ancestor
93153217|NCT02829814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93153218|NCT02829814|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93153219|NCT02829814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153220|NCT02829814|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93153221|NCT02829814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153222|NCT02829814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93153223|NCT02829814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153224|NCT03916042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93153225|NCT03916042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93153226|NCT02229058|Paclitaxel|paclitaxel|mesh-list
93153227|NCT02229058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93153228|NCT02229058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153229|NCT02229058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153230|NCT02229058|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153231|NCT02229058|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153232|NCT02229058|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153233|NCT02229058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153234|NCT02229292|Tranexamic Acid|tranexamic acid|mesh-list
93153235|NCT02229292|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93153236|NCT02229292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93153237|NCT02229292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153238|NCT02229292|Hemostatics|hemostatics|mesh-ancestor
93153239|NCT02229292|Coagulants|coagulants|mesh-ancestor
93153240|NCT00070109|Trabectedin|trabectedin|mesh-list
93153241|NCT00070109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93153242|NCT00070109|Alkylating Agents|alkylating agents|mesh-ancestor
93153243|NCT00070109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153244|NCT00070109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153245|NCT00069953|Paclitaxel|paclitaxel|mesh-list
93153246|NCT00069953|Fluorouracil|fluorouracil|mesh-list
93153247|NCT00069953|Lenograstim|lenograstim|mesh-list
93153248|NCT00069953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153249|NCT00069953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153250|NCT00069953|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153251|NCT00069953|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153252|NCT00069953|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153253|NCT00069953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153254|NCT00069953|Antimetabolites|antimetabolites|mesh-ancestor
93153255|NCT00069953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153256|NCT00069953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153257|NCT00069953|Immunologic Factors|immunologic factors|mesh-ancestor
93153258|NCT00069953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153259|NCT00069953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93153260|NCT02750800|Adalimumab|adalimumab|mesh-list
93153261|NCT02750800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93153262|NCT02750800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153263|NCT02750800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153264|NCT02229760|Ritonavir|ritonavir|mesh-list
93153265|NCT02229760|Tipranavir|tipranavir|mesh-list
93153266|NCT02229760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93153267|NCT02229760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93153268|NCT02229760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93153269|NCT02229760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153270|NCT02229760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153271|NCT02229760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93153272|NCT02229760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93153273|NCT02229760|Antiviral Agents|antiviral agents|mesh-ancestor
93153274|NCT02229760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153275|NCT02229760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93153276|NCT02229760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93153277|NCT03662542|Golimumab|golimumab|mesh-list
93153278|NCT03662542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93153279|NCT03662542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93153280|NCT03662542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153281|NCT03662542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153282|NCT03662542|Immunologic Factors|immunologic factors|mesh-ancestor
93153283|NCT03662542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153284|NCT01329562|Naproxen|naproxen|mesh-list
93153285|NCT01329562|Sumatriptan|sumatriptan|mesh-list
93153286|NCT01329562|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93153287|NCT01329562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93153288|NCT01329562|Analgesics|analgesics|mesh-ancestor
93153289|NCT01329562|Sensory System Agents|sensory system agents|mesh-ancestor
93153290|NCT01329562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153291|NCT01329562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153292|NCT01329562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153293|NCT01329562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153294|NCT01329562|Gout Suppressants|gout suppressants|mesh-ancestor
93153295|NCT01329562|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93153296|NCT01329562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153297|NCT01329562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153298|NCT01329562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93153299|NCT01329562|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93153300|NCT01329562|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93153301|NCT01329562|Serotonin Agents|serotonin agents|mesh-ancestor
93153302|NCT01329562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153303|NCT02230228|Vitamin A|vitamin a|mesh-list
93153304|NCT02230228|Retinol acetate|retinol acetate|mesh-list
93153305|NCT02230228|Vitamins|vitamins|mesh-ancestor
93153306|NCT02230228|Micronutrients|micronutrients|mesh-ancestor
93153307|NCT02230228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153308|NCT02230228|Protective Agents|protective agents|mesh-ancestor
93153309|NCT02230228|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93153310|NCT02230228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153311|NCT02230228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93153312|NCT02230228|Immunologic Factors|immunologic factors|mesh-ancestor
93153313|NCT01090661|Moxifloxacin|moxifloxacin|mesh-list
93153314|NCT01090661|Mipomersen|mipomersen|mesh-list
93153315|NCT01090661|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93153316|NCT01090661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153317|NCT01090661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153318|NCT01090661|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93153319|NCT01090661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93153320|NCT01090661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153321|NCT01090661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153322|NCT01090661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153323|NCT01090661|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93153324|NCT01090661|Contraceptive Agents|contraceptive agents|mesh-ancestor
93153325|NCT01090661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93153326|NCT01090661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153327|NCT01090661|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93153328|NCT01090661|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93153329|NCT01090661|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93153330|NCT01090661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93153331|NCT01090661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93153332|NCT01090661|Antimetabolites|antimetabolites|mesh-ancestor
93153333|NCT01090661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93153334|NCT05563480|Cisplatin|cisplatin|mesh-list
93153335|NCT05563480|Gemcitabine|gemcitabine|mesh-list
93153336|NCT05563480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153337|NCT05563480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153338|NCT05563480|Antimetabolites|antimetabolites|mesh-ancestor
93153339|NCT05563480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153340|NCT05546398|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93153341|NCT05546398|Ezetimibe|ezetimibe|mesh-list
93153342|NCT05546398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93153343|NCT05546398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93153344|NCT05546398|Antimetabolites|antimetabolites|mesh-ancestor
93153345|NCT05546398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153346|NCT05546398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93153347|NCT05546398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153348|NCT05546398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93153349|NCT05546398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153350|NCT05472766|Anticoagulants|anticoagulants|mesh-list
93153351|NCT05472766|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
93153352|NCT05472766|Antithrombins|antithrombins|mesh-ancestor
93153353|NCT05472766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93153354|NCT05472766|Protease Inhibitors|protease inhibitors|mesh-ancestor
93153355|NCT05472766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153356|NCT05472766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153357|NCT03653026|Upadacitinib|upadacitinib|mesh-list
93153358|NCT03653026|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93153359|NCT03653026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153360|NCT03653026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153361|NCT03653026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153362|NCT03653026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153363|NCT02232724|Choline|choline|mesh-list
93153364|NCT02232724|Lipotropic Agents|lipotropic agents|mesh-ancestor
93153365|NCT02232724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93153366|NCT02232724|Antimetabolites|antimetabolites|mesh-ancestor
93153367|NCT02232724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153368|NCT02232724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93153369|NCT02232724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93153370|NCT02232724|Nootropic Agents|nootropic agents|mesh-ancestor
93153371|NCT02234440|Metformin|metformin|mesh-list
93153372|NCT02234440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93153373|NCT02234440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153374|NCT04981678|Buprenorphine|buprenorphine|mesh-list
93153375|NCT04981678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93153376|NCT04981678|Narcotics|narcotics|mesh-ancestor
93153377|NCT04981678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153378|NCT04981678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153379|NCT04981678|Analgesics|analgesics|mesh-ancestor
93153380|NCT04981678|Sensory System Agents|sensory system agents|mesh-ancestor
93153381|NCT04981678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153382|NCT04981678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93153383|NCT02230618|Insulin|insulin|mesh-list
93153384|NCT02230618|Insulin Aspart|insulin aspart|mesh-list
93153385|NCT02230618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93153386|NCT02230618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153387|NCT01337986|4-Aminopyridine|4-aminopyridine|mesh-list
93153388|NCT01337986|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93153389|NCT01337986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153390|NCT01337986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153391|NCT04669288|Azithromycin|azithromycin|mesh-list
93153392|NCT04669288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153393|NCT04669288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153394|NCT02262520|Digoxin|digoxin|mesh-list
93153395|NCT02262520|Apixaban|apixaban|mesh-list
93153396|NCT02262520|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93153397|NCT02262520|Antithrombins|antithrombins|mesh-ancestor
93153398|NCT02262520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93153399|NCT02262520|Protease Inhibitors|protease inhibitors|mesh-ancestor
93153400|NCT02262520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153401|NCT02262520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153402|NCT02262520|Anticoagulants|anticoagulants|mesh-ancestor
93153403|NCT02262520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93153404|NCT02262520|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93153405|NCT02262520|Protective Agents|protective agents|mesh-ancestor
93153406|NCT02262520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153407|NCT02233504|Deferasirox|deferasirox|mesh-list
93153408|NCT02233504|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93153409|NCT02233504|Chelating Agents|chelating agents|mesh-ancestor
93153410|NCT02233504|Sequestering Agents|sequestering agents|mesh-ancestor
93153411|NCT02233504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153412|NCT02262598|Telmisartan|telmisartan|mesh-list
93153413|NCT02262598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93153414|NCT02262598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93153415|NCT02262598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93153416|NCT02262598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93153417|NCT02262598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153418|NCT02262598|Diuretics|diuretics|mesh-ancestor
93153419|NCT02262598|Natriuretic Agents|natriuretic agents|mesh-ancestor
93153420|NCT02262598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153421|NCT02262598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93153422|NCT02262598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153423|NCT04542382|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93153424|NCT04542382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93153425|NCT04542382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93153426|NCT04542382|Antimetabolites|antimetabolites|mesh-ancestor
93153427|NCT04542382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153428|NCT04542382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93153429|NCT04542382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93153430|NCT04542382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153431|NCT03723538|Dexmedetomidine|dexmedetomidine|mesh-list
93153432|NCT03723538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93153433|NCT03723538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153434|NCT03723538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153435|NCT03723538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93153436|NCT03723538|Analgesics|analgesics|mesh-ancestor
93153437|NCT03723538|Sensory System Agents|sensory system agents|mesh-ancestor
93153438|NCT03723538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153439|NCT03723538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93153440|NCT03723538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93153441|NCT03723538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93153442|NCT03723538|Adrenergic Agents|adrenergic agents|mesh-ancestor
93153443|NCT03723538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153444|NCT03723538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153445|NCT01337674|Metoprolol|metoprolol|mesh-list
93153446|NCT01337674|Amlodipine|amlodipine|mesh-list
93153447|NCT01337674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93153448|NCT01337674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93153449|NCT01337674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153450|NCT01337674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153451|NCT01337674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93153452|NCT01337674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153453|NCT01337674|Vasodilator Agents|vasodilator agents|mesh-ancestor
93153454|NCT01337674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93153455|NCT01337674|Sympatholytics|sympatholytics|mesh-ancestor
93153456|NCT01337674|Autonomic Agents|autonomic agents|mesh-ancestor
93153457|NCT01337674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153458|NCT01337674|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93153459|NCT01337674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93153460|NCT01337674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93153461|NCT01337674|Adrenergic Agents|adrenergic agents|mesh-ancestor
93153462|NCT01337674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153463|NCT02262676|Rivaroxaban|rivaroxaban|mesh-list
93153464|NCT02262676|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93153465|NCT02262676|Antithrombins|antithrombins|mesh-ancestor
93153466|NCT02262676|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93153467|NCT02262676|Protease Inhibitors|protease inhibitors|mesh-ancestor
93153468|NCT02262676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153469|NCT02262676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153470|NCT02262676|Anticoagulants|anticoagulants|mesh-ancestor
93153471|NCT02233582|Ibuprofen|ibuprofen|mesh-list
93153472|NCT02233582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93153473|NCT02233582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93153474|NCT02233582|Analgesics|analgesics|mesh-ancestor
93153475|NCT02233582|Sensory System Agents|sensory system agents|mesh-ancestor
93153476|NCT02233582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153477|NCT02233582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153478|NCT02233582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153479|NCT02233582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153480|NCT02233582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93153481|NCT02233582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153482|NCT02233582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153483|NCT02580370|Botulinum Toxins|botulinum toxins|mesh-list
93153484|NCT02580370|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93153485|NCT02580370|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93153486|NCT02580370|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93153487|NCT02580370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153488|NCT02580370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153489|NCT02580370|Cholinergic Agents|cholinergic agents|mesh-ancestor
93153490|NCT02580370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153491|NCT02580370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153492|NCT02580370|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93153493|NCT02580370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153494|NCT02233816|Vaccines|vaccines|mesh-list
93153495|NCT02233816|Immunologic Factors|immunologic factors|mesh-ancestor
93153496|NCT02233816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153497|NCT02750410|Dulaglutide|dulaglutide|mesh-list
93153498|NCT02750410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93153499|NCT02750410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153500|NCT02750332|Nitisinone|nitisinone|mesh-list
93153501|NCT02750332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153502|NCT02750332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153503|NCT02233894|Ipratropium|ipratropium|mesh-list
93153504|NCT02233894|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93153505|NCT02233894|Autonomic Agents|autonomic agents|mesh-ancestor
93153506|NCT02233894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153507|NCT02233894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153508|NCT02233894|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93153509|NCT02233894|Respiratory System Agents|respiratory system agents|mesh-ancestor
93153510|NCT02233894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93153511|NCT02233894|Cholinergic Agents|cholinergic agents|mesh-ancestor
93153512|NCT02233894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153513|NCT02233894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153514|NCT02233972|Midazolam|midazolam|mesh-list
93153515|NCT02233972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93153516|NCT02233972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93153517|NCT02233972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153518|NCT02233972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153519|NCT02233972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93153520|NCT02233972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93153521|NCT02233972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93153522|NCT02233972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93153523|NCT02233972|Anesthetics, General|anesthetics, general|mesh-ancestor
93153524|NCT02233972|Anesthetics|anesthetics|mesh-ancestor
93153525|NCT02233972|GABA Modulators|gaba modulators|mesh-ancestor
93153526|NCT02233972|GABA Agents|gaba agents|mesh-ancestor
93153527|NCT02233972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153528|NCT02233972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153529|NCT02234050|Trabectedin|trabectedin|mesh-list
93153530|NCT02234050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93153531|NCT02234050|Alkylating Agents|alkylating agents|mesh-ancestor
93153532|NCT02234050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153533|NCT02234050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153534|NCT02263066|Factor VIII|factor viii|mesh-list
93153535|NCT02263066|Coagulants|coagulants|mesh-ancestor
93153536|NCT02235532|Fluorides|fluorides|mesh-list
93153537|NCT02235532|Cariostatic Agents|cariostatic agents|mesh-ancestor
93153538|NCT02235532|Protective Agents|protective agents|mesh-ancestor
93153539|NCT02235532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153540|NCT00069095|Leucovorin|leucovorin|mesh-list
93153541|NCT00069095|Bevacizumab|bevacizumab|mesh-list
93153542|NCT00069095|Fluorouracil|fluorouracil|mesh-list
93153543|NCT00069095|Capecitabine|capecitabine|mesh-list
93153544|NCT00069095|Oxaliplatin|oxaliplatin|mesh-list
93153545|NCT00069095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153546|NCT00069095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153547|NCT00069095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153548|NCT00069095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153549|NCT00069095|Growth Substances|growth substances|mesh-ancestor
93153550|NCT00069095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153551|NCT00069095|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153552|NCT00069095|Antimetabolites|antimetabolites|mesh-ancestor
93153553|NCT00069095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153554|NCT00069095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153555|NCT00069095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153556|NCT00069095|Immunologic Factors|immunologic factors|mesh-ancestor
93153557|NCT00069095|Antidotes|antidotes|mesh-ancestor
93153558|NCT00069095|Protective Agents|protective agents|mesh-ancestor
93153559|NCT00069095|Vitamin B Complex|vitamin b complex|mesh-ancestor
93153560|NCT00069095|Vitamins|vitamins|mesh-ancestor
93153561|NCT00069095|Micronutrients|micronutrients|mesh-ancestor
93153562|NCT00086411|Bupropion|bupropion|mesh-list
93153563|NCT00086411|Nicotine|nicotine|mesh-list
93153564|NCT00086411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93153565|NCT00086411|Autonomic Agents|autonomic agents|mesh-ancestor
93153566|NCT00086411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153567|NCT00086411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153568|NCT00086411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93153569|NCT00086411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93153570|NCT00086411|Cholinergic Agents|cholinergic agents|mesh-ancestor
93153571|NCT00086411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153572|NCT00086411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153573|NCT00086411|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93153574|NCT00086411|Antidepressive Agents|antidepressive agents|mesh-ancestor
93153575|NCT00086411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93153576|NCT00086411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93153577|NCT00086411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93153578|NCT00086411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153579|NCT00086411|Dopamine Agents|dopamine agents|mesh-ancestor
93153580|NCT00086411|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93153581|NCT00086411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93153582|NCT00086411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153583|NCT01086527|Montelukast|montelukast|mesh-list
93153584|NCT01086527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93153585|NCT01086527|Respiratory System Agents|respiratory system agents|mesh-ancestor
93153586|NCT01086527|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93153587|NCT01086527|Hormone Antagonists|hormone antagonists|mesh-ancestor
93153588|NCT01086527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153589|NCT01086527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153590|NCT01086527|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93153591|NCT01086527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93153592|NCT01086527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153593|NCT01093937|Varenicline|varenicline|mesh-list
93153594|NCT01093937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93153595|NCT01093937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93153596|NCT01093937|Cholinergic Agents|cholinergic agents|mesh-ancestor
93153597|NCT01093937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153598|NCT01093937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153599|NCT01093937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153600|NCT01094015|Lidocaine|lidocaine|mesh-list
93153601|NCT01094015|Prilocaine|prilocaine|mesh-list
93153602|NCT01094015|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93153603|NCT01094015|Anesthetics, Local|anesthetics, local|mesh-ancestor
93153604|NCT01094015|Anesthetics|anesthetics|mesh-ancestor
93153605|NCT01094015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153606|NCT01094015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153607|NCT01094015|Sensory System Agents|sensory system agents|mesh-ancestor
93153608|NCT01094015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153609|NCT01094015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93153610|NCT01094015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93153611|NCT01094015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93153612|NCT01094015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153613|NCT01094015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153614|NCT01094015|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93153615|NCT01090895|Ascorbic Acid|ascorbic acid|mesh-list
93153617|NCT01090895|Micronutrients|micronutrients|mesh-ancestor
93153618|NCT01090895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153619|NCT01090895|Antioxidants|antioxidants|mesh-ancestor
93153620|NCT01090895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153621|NCT01090895|Protective Agents|protective agents|mesh-ancestor
93153622|NCT03956303|Levobupivacaine|levobupivacaine|mesh-list
93153623|NCT03956303|Anesthetics, Local|anesthetics, local|mesh-ancestor
93153624|NCT03956303|Anesthetics|anesthetics|mesh-ancestor
93153625|NCT03956303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153626|NCT03956303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153627|NCT03956303|Sensory System Agents|sensory system agents|mesh-ancestor
93153628|NCT03956303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153629|NCT01094249|Valproic Acid|valproic acid|mesh-list
93153630|NCT01094249|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93153631|NCT01094249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93153632|NCT01094249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93153633|NCT01094249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153634|NCT01094249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153635|NCT01094249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93153636|NCT01094249|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93153637|NCT01094249|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93153638|NCT01094249|Serotonin Agents|serotonin agents|mesh-ancestor
93153639|NCT01094249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153640|NCT01094249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153641|NCT01094249|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93153642|NCT01094249|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93153643|NCT01094249|Dopamine Agents|dopamine agents|mesh-ancestor
93153644|NCT01094249|Anticonvulsants|anticonvulsants|mesh-ancestor
93153645|NCT01094249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153646|NCT01094249|GABA Agents|gaba agents|mesh-ancestor
93153647|NCT01094249|Antimanic Agents|antimanic agents|mesh-ancestor
93153648|NCT00055601|Paclitaxel|paclitaxel|mesh-list
93153649|NCT00055601|Gemcitabine|gemcitabine|mesh-list
93153650|NCT00055601|Fluorouracil|fluorouracil|mesh-list
93153651|NCT00055601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153652|NCT00055601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153653|NCT00055601|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153654|NCT00055601|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153655|NCT00055601|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153656|NCT00055601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153657|NCT00055601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153658|NCT00055601|Antimetabolites|antimetabolites|mesh-ancestor
93153659|NCT00055601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153660|NCT00055601|Immunologic Factors|immunologic factors|mesh-ancestor
93153661|NCT00055601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153662|NCT01583621|Cholecalciferol|cholecalciferol|mesh-list
93153663|NCT01583621|Vitamin D|vitamin d|mesh-list
93153664|NCT01583621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93153665|NCT01583621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153666|NCT01583621|Vitamins|vitamins|mesh-ancestor
93153667|NCT01583621|Micronutrients|micronutrients|mesh-ancestor
93153668|NCT01583621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93153669|NCT03806231|Dinoprostone|dinoprostone|mesh-list
93153670|NCT03806231|Oxytocics|oxytocics|mesh-ancestor
93153671|NCT03806231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93153672|NCT03806231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153673|NCT01091051|Ustekinumab|ustekinumab|mesh-list
93153674|NCT01091051|Dermatologic Agents|dermatologic agents|mesh-ancestor
93153675|NCT01327079|Methadone|methadone|mesh-list
93153676|NCT01327079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93153677|NCT01327079|Narcotics|narcotics|mesh-ancestor
93153678|NCT01327079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153679|NCT01327079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153680|NCT01327079|Analgesics|analgesics|mesh-ancestor
93153681|NCT01327079|Sensory System Agents|sensory system agents|mesh-ancestor
93153682|NCT01327079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153683|NCT01327079|Antitussive Agents|antitussive agents|mesh-ancestor
93153684|NCT01327079|Respiratory System Agents|respiratory system agents|mesh-ancestor
93153685|NCT01091207|Sorafenib|sorafenib|mesh-list
93153686|NCT01091207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153687|NCT01091207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153688|NCT01091207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153689|NCT01091207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153690|NCT00054275|Docetaxel|docetaxel|mesh-list
93153691|NCT00054275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93153692|NCT00054275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153693|NCT00054275|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153694|NCT00054275|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153695|NCT00054275|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153696|NCT00054275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153697|NCT00054275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153698|NCT00054275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153700|NCT01095185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93153701|NCT01095185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93153702|NCT01095185|Antimetabolites|antimetabolites|mesh-ancestor
93153703|NCT01095185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153704|NCT01095185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93153705|NCT01095185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93153706|NCT01095185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153707|NCT01583777|Belinostat|belinostat|mesh-list
93153708|NCT01583777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153709|NCT01583777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93153710|NCT01583777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153711|NCT01583777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153712|NCT00053417|4-Aminopyridine|4-aminopyridine|mesh-list
93153713|NCT00053417|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93153714|NCT00053417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153715|NCT00053417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153716|NCT00052715|Poly ICLC|poly iclc|mesh-list
93153717|NCT00052715|Interferon Inducers|interferon inducers|mesh-ancestor
93153718|NCT00052715|Immunologic Factors|immunologic factors|mesh-ancestor
93153719|NCT00052715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153720|NCT03955601|Cyclophosphamide|cyclophosphamide|mesh-list
93153721|NCT03955601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153722|NCT03955601|Immunologic Factors|immunologic factors|mesh-ancestor
93153723|NCT03955601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153724|NCT03955601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153725|NCT03955601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93153726|NCT03955601|Alkylating Agents|alkylating agents|mesh-ancestor
93153727|NCT03955601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153728|NCT03955601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153729|NCT03955601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93153730|NCT00051311|Cyclosporine|cyclosporine|mesh-list
93153731|NCT00051311|Prednisone|prednisone|mesh-list
93153732|NCT00051311|Cyclophosphamide|cyclophosphamide|mesh-list
93153733|NCT00051311|Doxorubicin|doxorubicin|mesh-list
93153734|NCT00051311|Methotrexate|methotrexate|mesh-list
93153735|NCT00051311|Fludarabine|fludarabine|mesh-list
93153736|NCT00051311|Etoposide|etoposide|mesh-list
93153737|NCT00051311|Vincristine|vincristine|mesh-list
93153738|NCT00051311|Cyclosporins|cyclosporins|mesh-list
93153739|NCT00051311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153740|NCT00051311|Immunologic Factors|immunologic factors|mesh-ancestor
93153741|NCT00051311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153742|NCT00051311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153743|NCT00051311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93153744|NCT00051311|Alkylating Agents|alkylating agents|mesh-ancestor
93153745|NCT00051311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153746|NCT00051311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153747|NCT00051311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93153748|NCT00051311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93153749|NCT00051311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93153750|NCT00051311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93153751|NCT00051311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153752|NCT00051311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153753|NCT00051311|Glucocorticoids|glucocorticoids|mesh-ancestor
93153754|NCT00051311|Hormones|hormones|mesh-ancestor
93153755|NCT00051311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153756|NCT00051311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93153757|NCT00051311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93153758|NCT00051311|Abortifacient Agents|abortifacient agents|mesh-ancestor
93153759|NCT00051311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93153760|NCT00051311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153761|NCT00051311|Antimetabolites|antimetabolites|mesh-ancestor
93153762|NCT00051311|Dermatologic Agents|dermatologic agents|mesh-ancestor
93153763|NCT00051311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93153764|NCT00051311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93153765|NCT00051311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153766|NCT00051311|Tubulin Modulators|tubulin modulators|mesh-ancestor
93153767|NCT00051311|Antimitotic Agents|antimitotic agents|mesh-ancestor
93153768|NCT00051311|Mitosis Modulators|mitosis modulators|mesh-ancestor
93153769|NCT00051311|Antifungal Agents|antifungal agents|mesh-ancestor
93153770|NCT00051311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153771|NCT00051311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93153772|NCT01091753|Amlodipine|amlodipine|mesh-list
93153773|NCT01091753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93153774|NCT01091753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93153775|NCT01091753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93153776|NCT01091753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153777|NCT01091753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93153778|NCT01091753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153779|NCT01091753|Vasodilator Agents|vasodilator agents|mesh-ancestor
93153780|NCT00049673|Thalidomide|thalidomide|mesh-list
93153781|NCT00049673|Prednisone|prednisone|mesh-list
93153782|NCT00049673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153783|NCT00049673|Glucocorticoids|glucocorticoids|mesh-ancestor
93153784|NCT00049673|Hormones|hormones|mesh-ancestor
93153785|NCT00049673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153786|NCT00049673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153787|NCT00049673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93153788|NCT00049673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153789|NCT00049673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153790|NCT00049673|Immunologic Factors|immunologic factors|mesh-ancestor
93153791|NCT00049673|Leprostatic Agents|leprostatic agents|mesh-ancestor
93153792|NCT00049673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153793|NCT00049673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153794|NCT00049673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153795|NCT00049673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153796|NCT00049673|Growth Substances|growth substances|mesh-ancestor
93153797|NCT00049673|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153798|NCT00049127|Imatinib Mesylate|imatinib mesylate|mesh-list
93153799|NCT00049127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153800|NCT00049127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93153801|NCT00049127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153802|NCT00049127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153803|NCT00066365|Molgramostim|molgramostim|mesh-list
93153804|NCT00066365|Sargramostim|sargramostim|mesh-list
93153805|NCT00066365|Immunologic Factors|immunologic factors|mesh-ancestor
93153806|NCT00066365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153807|NCT00066365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153808|NCT00048581|Abatacept|abatacept|mesh-list
93153809|NCT00048581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93153810|NCT00048581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153811|NCT00048581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153812|NCT00048581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153813|NCT00048581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153814|NCT00048581|Immunologic Factors|immunologic factors|mesh-ancestor
93153815|NCT00048581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153816|NCT00048581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153817|NCT00048347|Interferon beta-1a|interferon beta-1a|mesh-list
93153818|NCT00048347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93153819|NCT00048347|Immunologic Factors|immunologic factors|mesh-ancestor
93153820|NCT00048347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153821|NCT00048347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153822|NCT00048347|Antiviral Agents|antiviral agents|mesh-ancestor
93153823|NCT00048347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153824|NCT03957629|Interferons|interferons|mesh-list
93153825|NCT03957629|Tenofovir|tenofovir|mesh-list
93153826|NCT03957629|Interferon-alpha|interferon-alpha|mesh-list
93153827|NCT03957629|Interferon alpha-2|interferon alpha-2|mesh-list
93153828|NCT03957629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93153829|NCT03957629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153830|NCT03957629|Antiviral Agents|antiviral agents|mesh-ancestor
93153831|NCT03957629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153832|NCT03957629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93153833|NCT03957629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93153834|NCT03957629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153835|NCT03957629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153836|NCT03957629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93153837|NCT03957629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93153838|NCT03957629|Immunologic Factors|immunologic factors|mesh-ancestor
93153839|NCT03957629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153840|NCT00065507|Entecavir|entecavir|mesh-list
93153841|NCT00065507|Adefovir|adefovir|mesh-list
93153842|NCT00065507|Antiviral Agents|antiviral agents|mesh-ancestor
93153843|NCT00065507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153844|NCT00065507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93153845|NCT00065507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93153846|NCT00065507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153847|NCT00065507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153848|NCT01095575|Morphine|morphine|mesh-list
93153849|NCT01095575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93153850|NCT01095575|Narcotics|narcotics|mesh-ancestor
93153851|NCT01095575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93153852|NCT01095575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153853|NCT01095575|Analgesics|analgesics|mesh-ancestor
93153854|NCT01095575|Sensory System Agents|sensory system agents|mesh-ancestor
93153855|NCT01095575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153856|NCT00065429|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
93153857|NCT00065429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153858|NCT00065429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153859|NCT00065429|Immunotoxins|immunotoxins|mesh-ancestor
93153860|NCT00065429|Immunoconjugates|immunoconjugates|mesh-ancestor
93153861|NCT00065429|Immunologic Factors|immunologic factors|mesh-ancestor
93153862|NCT00065429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153863|NCT00065429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93153864|NCT01095731|Acetic Acid|acetic acid|mesh-list
93153865|NCT01095731|Retinol acetate|retinol acetate|mesh-list
93153866|NCT01095731|Glycine|glycine|mesh-list
93153867|NCT01095731|Glycine Agents|glycine agents|mesh-ancestor
93153868|NCT01095731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93153869|NCT01095731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153870|NCT01095731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153871|NCT01095731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153872|NCT01095731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153873|NCT01095731|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93153874|NCT01095731|Immunologic Factors|immunologic factors|mesh-ancestor
93153875|NCT01095731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93153876|NCT01095731|Protective Agents|protective agents|mesh-ancestor
93153877|NCT01095731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153878|NCT01095809|Triamcinolone|triamcinolone|mesh-list
93153879|NCT01095809|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93153880|NCT01095809|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93153881|NCT01095809|Bevacizumab|bevacizumab|mesh-list
93153882|NCT01095809|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93153883|NCT01095809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93153884|NCT01095809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153885|NCT01095809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153886|NCT01095809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153887|NCT01095809|Growth Substances|growth substances|mesh-ancestor
93153888|NCT01095809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153889|NCT01095809|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153890|NCT01095809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153891|NCT01095809|Glucocorticoids|glucocorticoids|mesh-ancestor
93153892|NCT01095809|Hormones|hormones|mesh-ancestor
93153893|NCT01095809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153894|NCT01095809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153895|NCT01095809|Immunologic Factors|immunologic factors|mesh-ancestor
93153896|NCT01095809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153897|NCT01095809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153898|NCT00048035|Epoetin Alfa|epoetin alfa|mesh-list
93153899|NCT00048035|Hematinics|hematinics|mesh-ancestor
93153900|NCT01092221|Allopurinol|allopurinol|mesh-list
93153901|NCT01092221|Antimetabolites|antimetabolites|mesh-ancestor
93153902|NCT01092221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153903|NCT01092221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153904|NCT01092221|Gout Suppressants|gout suppressants|mesh-ancestor
93153905|NCT01092221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153906|NCT01092221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93153907|NCT01092221|Antioxidants|antioxidants|mesh-ancestor
93153908|NCT01092221|Protective Agents|protective agents|mesh-ancestor
93153909|NCT01092221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153910|NCT00047879|Interferons|interferons|mesh-list
93153911|NCT00047879|Interferon-alpha|interferon-alpha|mesh-list
93153912|NCT00047879|Interferon alpha-2|interferon alpha-2|mesh-list
93153913|NCT00047879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93153914|NCT00047879|Thalidomide|thalidomide|mesh-list
93153915|NCT00047879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153916|NCT00047879|Antiviral Agents|antiviral agents|mesh-ancestor
93153917|NCT00047879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153918|NCT00047879|Immunologic Factors|immunologic factors|mesh-ancestor
93153919|NCT00047879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153920|NCT00047879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153921|NCT00047879|Leprostatic Agents|leprostatic agents|mesh-ancestor
93153922|NCT00047879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153923|NCT00047879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153924|NCT00047879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153925|NCT00047879|Growth Substances|growth substances|mesh-ancestor
93153926|NCT00047879|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153927|NCT00064337|Thalidomide|thalidomide|mesh-list
93153928|NCT00064337|Dexamethasone|dexamethasone|mesh-list
93153929|NCT00064337|Cyclophosphamide|cyclophosphamide|mesh-list
93153930|NCT00064337|Melphalan|melphalan|mesh-list
93153931|NCT00064337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153932|NCT00064337|Immunologic Factors|immunologic factors|mesh-ancestor
93153933|NCT00064337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153934|NCT00064337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93153935|NCT00064337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93153936|NCT00064337|Alkylating Agents|alkylating agents|mesh-ancestor
93153937|NCT00064337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153938|NCT00064337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153939|NCT00064337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93153940|NCT00064337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93153941|NCT00064337|Antiemetics|antiemetics|mesh-ancestor
93153942|NCT00064337|Autonomic Agents|autonomic agents|mesh-ancestor
93153943|NCT00064337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93153944|NCT00064337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93153945|NCT00064337|Glucocorticoids|glucocorticoids|mesh-ancestor
93153946|NCT00064337|Hormones|hormones|mesh-ancestor
93153947|NCT00064337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153948|NCT00064337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93153949|NCT00064337|Leprostatic Agents|leprostatic agents|mesh-ancestor
93153950|NCT00064337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93153951|NCT00064337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93153952|NCT00064337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93153953|NCT00064337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93153954|NCT00064337|Growth Substances|growth substances|mesh-ancestor
93153955|NCT00064337|Growth Inhibitors|growth inhibitors|mesh-ancestor
93153956|NCT01096121|Enalapril|enalapril|mesh-list
93153957|NCT01096121|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93153958|NCT01096121|Protease Inhibitors|protease inhibitors|mesh-ancestor
93153959|NCT01096121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93153960|NCT01096121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153961|NCT01096121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93153962|NCT00064259|Fluorouracil|fluorouracil|mesh-list
93153963|NCT00064259|Oblimersen|oblimersen|mesh-list
93153964|NCT00064259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93153965|NCT00064259|Antimetabolites|antimetabolites|mesh-ancestor
93153966|NCT00064259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153967|NCT00064259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93153968|NCT00064259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93153969|NCT00064259|Immunologic Factors|immunologic factors|mesh-ancestor
93153970|NCT00064259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153971|NCT03954197|Hormones|hormones|mesh-list
93153972|NCT03954197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93153973|NCT03954197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153974|NCT00044213|Vitamins|vitamins|mesh-list
93153975|NCT00044213|Edetic Acid|edetic acid|mesh-list
93153976|NCT00044213|Pentetic Acid|pentetic acid|mesh-list
93153977|NCT00044213|Micronutrients|micronutrients|mesh-ancestor
93153978|NCT00044213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153979|NCT00044213|Anticoagulants|anticoagulants|mesh-ancestor
93153980|NCT00044213|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93153981|NCT00044213|Chelating Agents|chelating agents|mesh-ancestor
93153982|NCT00044213|Sequestering Agents|sequestering agents|mesh-ancestor
93153983|NCT00044213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93153984|NCT00044213|Antidotes|antidotes|mesh-ancestor
93153985|NCT00044213|Protective Agents|protective agents|mesh-ancestor
93153986|NCT00044213|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93153987|NCT00064025|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93153988|NCT00064025|Medroxyprogesterone|medroxyprogesterone|mesh-list
93153989|NCT00064025|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93153990|NCT00064025|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92826200|NCT00978068|Ritonavir|ritonavir|mesh-list
93153991|NCT00064025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93153993|NCT00064025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93153994|NCT00064025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93153995|NCT00064025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93153996|NCT00064025|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93153997|NCT00064025|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93153998|NCT00064025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93153999|NCT00064025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154000|NCT01096199|Cisplatin|cisplatin|mesh-list
93154001|NCT01096199|Everolimus|everolimus|mesh-list
93154002|NCT01096199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154003|NCT01096199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93154004|NCT01096199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93154005|NCT01096199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154006|NCT01096199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154007|NCT01096199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154008|NCT01096199|Immunologic Factors|immunologic factors|mesh-ancestor
93154009|NCT01096199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154010|NCT01096277|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93154011|NCT01096277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93154012|NCT01096277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154013|NCT01096277|Incretins|incretins|mesh-ancestor
93154014|NCT01096277|Hormones|hormones|mesh-ancestor
93154015|NCT01096277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154016|NCT01096277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93154017|NCT01096277|Protease Inhibitors|protease inhibitors|mesh-ancestor
93154018|NCT01096277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154019|NCT01096277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154020|NCT01096355|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93154021|NCT01096355|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93154022|NCT01096355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154023|NCT01096355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154024|NCT01096511|Moxifloxacin|moxifloxacin|mesh-list
93154025|NCT01096511|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93154026|NCT01096511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154027|NCT01096511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154028|NCT01096511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93154029|NCT01096511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154030|NCT01096511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154031|NCT01096511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154032|NCT01096511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154033|NCT01096511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93154034|NCT01096511|Contraceptive Agents|contraceptive agents|mesh-ancestor
93154035|NCT01096511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93154036|NCT01096511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154037|NCT01096511|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93154038|NCT01096511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93154039|NCT01096511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93154040|NCT01092455|Heparin|heparin|mesh-list
93154041|NCT01092455|Calcium heparin|calcium heparin|mesh-list
93154042|NCT01092455|Anticoagulants|anticoagulants|mesh-ancestor
93154043|NCT01092455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93154044|NCT01092455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93154045|NCT01092455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154046|NCT02264938|Antioxidants|antioxidants|mesh-list
93154047|NCT02264938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154048|NCT02264938|Protective Agents|protective agents|mesh-ancestor
93154049|NCT02264938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154050|NCT02511886|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
93154051|NCT02511886|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93154052|NCT02511886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154053|NCT02511886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93154054|NCT02511886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154055|NCT02511886|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93154056|NCT02511886|GABA Agonists|gaba agonists|mesh-ancestor
93154057|NCT02511886|GABA Agents|gaba agents|mesh-ancestor
93154058|NCT02511886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154059|NCT02511886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154060|NCT04235140|Ivacaftor|ivacaftor|mesh-list
93154061|NCT04235140|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93154062|NCT04235140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93154063|NCT04235140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154064|NCT00043979|Cyclosporine|cyclosporine|mesh-list
93154065|NCT00043979|Sirolimus|sirolimus|mesh-list
93154066|NCT00043979|Prednisone|prednisone|mesh-list
93154067|NCT00043979|Cyclophosphamide|cyclophosphamide|mesh-list
93154068|NCT00043979|Melphalan|melphalan|mesh-list
93154069|NCT00043979|Doxorubicin|doxorubicin|mesh-list
93154070|NCT00043979|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93154071|NCT00043979|Fludarabine|fludarabine|mesh-list
93154072|NCT00043979|Fludarabine phosphate|fludarabine phosphate|mesh-list
93154073|NCT00043979|Etoposide|etoposide|mesh-list
93154074|NCT00043979|Vincristine|vincristine|mesh-list
93154075|NCT00043979|Tacrolimus|tacrolimus|mesh-list
93154076|NCT00043979|Cyclosporins|cyclosporins|mesh-list
93154077|NCT00043979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93154078|NCT00043979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154079|NCT00043979|Immunologic Factors|immunologic factors|mesh-ancestor
93154080|NCT00043979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154081|NCT00043979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154082|NCT00043979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93154083|NCT00043979|Alkylating Agents|alkylating agents|mesh-ancestor
93154084|NCT00043979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154085|NCT00043979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154086|NCT00043979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93154087|NCT00043979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93154088|NCT00043979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93154089|NCT00043979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154090|NCT00043979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154091|NCT00043979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154092|NCT00043979|Glucocorticoids|glucocorticoids|mesh-ancestor
93154093|NCT00043979|Hormones|hormones|mesh-ancestor
93154094|NCT00043979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154095|NCT00043979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93154096|NCT00043979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154097|NCT00043979|Antimetabolites|antimetabolites|mesh-ancestor
93154098|NCT00043979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93154099|NCT00043979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93154100|NCT00043979|Tubulin Modulators|tubulin modulators|mesh-ancestor
93154101|NCT00043979|Antimitotic Agents|antimitotic agents|mesh-ancestor
93154102|NCT00043979|Mitosis Modulators|mitosis modulators|mesh-ancestor
93154103|NCT00043979|Antifungal Agents|antifungal agents|mesh-ancestor
93154104|NCT00043979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154105|NCT00043979|Dermatologic Agents|dermatologic agents|mesh-ancestor
93154106|NCT00043979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154107|NCT00043979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93154108|NCT01436032|Ketorolac|ketorolac|mesh-list
93154109|NCT01436032|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93154110|NCT01436032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93154111|NCT01436032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93154112|NCT01436032|Analgesics|analgesics|mesh-ancestor
93154113|NCT01436032|Sensory System Agents|sensory system agents|mesh-ancestor
93154114|NCT01436032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154115|NCT01436032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154116|NCT01436032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154117|NCT01436032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154118|NCT01436032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93154119|NCT01436032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154120|NCT01436032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154121|NCT01092533|Mycophenolic Acid|mycophenolic acid|mesh-list
93154122|NCT01092533|Prednisolone|prednisolone|mesh-list
93154123|NCT01092533|Prednisone|prednisone|mesh-list
93154124|NCT01092533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93154125|NCT01092533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154126|NCT01092533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93154127|NCT01092533|Antitubercular Agents|antitubercular agents|mesh-ancestor
93154128|NCT01092533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154129|NCT01092533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154130|NCT01092533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154131|NCT01092533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154132|NCT01092533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154133|NCT01092533|Glucocorticoids|glucocorticoids|mesh-ancestor
93154134|NCT01092533|Hormones|hormones|mesh-ancestor
93154135|NCT01092533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154136|NCT01092533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154137|NCT01092533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93154138|NCT01431820|Luliconazole|luliconazole|mesh-list
93154139|NCT01431820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93154140|NCT01431820|Antifungal Agents|antifungal agents|mesh-ancestor
93154141|NCT01431820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154142|NCT01425970|Interferons|interferons|mesh-list
93154143|NCT01425970|Ribavirin|ribavirin|mesh-list
93154144|NCT01425970|Interferon-alpha|interferon-alpha|mesh-list
93154145|NCT01425970|Interferon alpha-2|interferon alpha-2|mesh-list
93154146|NCT01425970|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93154147|NCT01425970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154148|NCT01425970|Antiviral Agents|antiviral agents|mesh-ancestor
93154149|NCT01425970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154150|NCT01425970|Antimetabolites|antimetabolites|mesh-ancestor
93154151|NCT01425970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154152|NCT01425970|Immunologic Factors|immunologic factors|mesh-ancestor
93154153|NCT01425970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154154|NCT01619332|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93154155|NCT01619332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93154156|NCT01619332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154157|NCT01619332|Incretins|incretins|mesh-ancestor
93154158|NCT01619332|Hormones|hormones|mesh-ancestor
93154159|NCT01619332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154160|NCT01619332|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93154161|NCT01619332|Protease Inhibitors|protease inhibitors|mesh-ancestor
93154162|NCT01619332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154163|NCT01619332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154164|NCT01616524|Interferons|interferons|mesh-list
93154165|NCT01616524|Ribavirin|ribavirin|mesh-list
93154166|NCT01616524|Interferon-alpha|interferon-alpha|mesh-list
93154167|NCT01616524|Interferon alpha-2|interferon alpha-2|mesh-list
93154168|NCT01616524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93154169|NCT01616524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154170|NCT01616524|Antiviral Agents|antiviral agents|mesh-ancestor
93154171|NCT01616524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154172|NCT01616524|Antimetabolites|antimetabolites|mesh-ancestor
93154173|NCT01616524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154174|NCT01616524|Immunologic Factors|immunologic factors|mesh-ancestor
93154175|NCT01616524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154176|NCT02265328|Prednisolone|prednisolone|mesh-list
93154177|NCT02265328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154178|NCT02265328|Glucocorticoids|glucocorticoids|mesh-ancestor
93154179|NCT02265328|Hormones|hormones|mesh-ancestor
93154180|NCT02265328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154181|NCT02265328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154182|NCT02265328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93154183|NCT02265328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154184|NCT02265406|Anti-Infective Agents|anti-infective agents|mesh-list
93154185|NCT01421056|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
93154186|NCT01421056|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93154187|NCT01421056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154188|NCT01421056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154189|NCT01416064|Molindone|molindone|mesh-list
93154190|NCT01416064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93154191|NCT01416064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93154192|NCT01416064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154193|NCT01416064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154194|NCT01416064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93154195|NCT01594216|Exemestane|exemestane|mesh-list
93154196|NCT01594216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154197|NCT01594216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93154198|NCT01594216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93154199|NCT01594216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154200|NCT01594216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154201|NCT01594216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93154202|NCT01594216|Hormone Antagonists|hormone antagonists|mesh-ancestor
93154203|NCT01594216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154204|NCT01594216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154205|NCT02263690|Lidocaine|lidocaine|mesh-list
93154206|NCT02263690|Anesthetics, Local|anesthetics, local|mesh-ancestor
93154207|NCT02263690|Anesthetics|anesthetics|mesh-ancestor
93154208|NCT02263690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154209|NCT02263690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154210|NCT02263690|Sensory System Agents|sensory system agents|mesh-ancestor
93154211|NCT02263690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154212|NCT02263690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93154213|NCT02263690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93154214|NCT02263690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93154215|NCT02263690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93154216|NCT02263690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154217|NCT02265562|Alprostadil|alprostadil|mesh-list
93154218|NCT02265562|Misoprostol|misoprostol|mesh-list
93154219|NCT02265562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93154220|NCT02265562|Abortifacient Agents|abortifacient agents|mesh-ancestor
93154221|NCT02265562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93154222|NCT02265562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154223|NCT02265562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93154224|NCT02265562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93154225|NCT02265562|Oxytocics|oxytocics|mesh-ancestor
93154226|NCT02265562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93154227|NCT02265562|Vasodilator Agents|vasodilator agents|mesh-ancestor
93154228|NCT02265562|Urological Agents|urological agents|mesh-ancestor
93154229|NCT01399684|Leucovorin|leucovorin|mesh-list
93154230|NCT01399684|Folic Acid|folic acid|mesh-list
93154231|NCT01399684|Bevacizumab|bevacizumab|mesh-list
93154232|NCT01399684|Fluorouracil|fluorouracil|mesh-list
93154233|NCT01399684|Oxaliplatin|oxaliplatin|mesh-list
93154234|NCT01399684|Levoleucovorin|levoleucovorin|mesh-list
93154235|NCT01399684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93154236|NCT01399684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154237|NCT01399684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93154238|NCT01399684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93154239|NCT01399684|Growth Substances|growth substances|mesh-ancestor
93154240|NCT01399684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154241|NCT01399684|Growth Inhibitors|growth inhibitors|mesh-ancestor
93154242|NCT01399684|Antimetabolites|antimetabolites|mesh-ancestor
93154243|NCT01399684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154244|NCT01399684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154245|NCT01399684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154246|NCT01399684|Immunologic Factors|immunologic factors|mesh-ancestor
93154247|NCT01399684|Antidotes|antidotes|mesh-ancestor
93154248|NCT01399684|Protective Agents|protective agents|mesh-ancestor
93154249|NCT01399684|Vitamin B Complex|vitamin b complex|mesh-ancestor
93154250|NCT01399684|Vitamins|vitamins|mesh-ancestor
93154251|NCT01399684|Micronutrients|micronutrients|mesh-ancestor
93154252|NCT01399684|Hematinics|hematinics|mesh-ancestor
93154253|NCT01397968|Cenobamate|cenobamate|mesh-list
93154254|NCT01397968|Anticonvulsants|anticonvulsants|mesh-ancestor
93154255|NCT01397578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93154256|NCT01397578|Immunologic Factors|immunologic factors|mesh-ancestor
93154257|NCT01397578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154258|NCT02265718|Methylphenidate|methylphenidate|mesh-list
93154259|NCT02265718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93154260|NCT02265718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154261|NCT02265718|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93154262|NCT02265718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93154263|NCT02265718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93154264|NCT02265718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154265|NCT02265718|Dopamine Agents|dopamine agents|mesh-ancestor
93154266|NCT02265718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154267|NCT01381666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93154268|NCT02266030|Aspirin|aspirin|mesh-list
93154269|NCT02266030|Cilostazol|cilostazol|mesh-list
93154270|NCT02266030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93154271|NCT02266030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93154272|NCT02266030|Analgesics|analgesics|mesh-ancestor
93154273|NCT02266030|Sensory System Agents|sensory system agents|mesh-ancestor
93154274|NCT02266030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154275|NCT02266030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154276|NCT02266030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154277|NCT02266030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154278|NCT02266030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93154279|NCT02266030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93154280|NCT02266030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154281|NCT02266030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93154282|NCT02266030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93154283|NCT02266030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154284|NCT02266030|Antipyretics|antipyretics|mesh-ancestor
93154285|NCT02266030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93154286|NCT02266030|Autonomic Agents|autonomic agents|mesh-ancestor
93154287|NCT02266030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93154288|NCT02266030|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154289|NCT02266030|Vasodilator Agents|vasodilator agents|mesh-ancestor
93154290|NCT02266030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93154291|NCT02266030|Protective Agents|protective agents|mesh-ancestor
93154292|NCT02266030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93154293|NCT02266030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93154294|NCT01527916|Donepezil|donepezil|mesh-list
93154295|NCT01527916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93154296|NCT01527916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154297|NCT01527916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154298|NCT01527916|Cholinergic Agents|cholinergic agents|mesh-ancestor
93154299|NCT01527916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154300|NCT01527916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154301|NCT01527916|Nootropic Agents|nootropic agents|mesh-ancestor
93154302|NCT01373086|Eplerenone|eplerenone|mesh-list
93154303|NCT01373086|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93154304|NCT01373086|Hormone Antagonists|hormone antagonists|mesh-ancestor
93154305|NCT01373086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154306|NCT01373086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154307|NCT01373086|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93154308|NCT01373086|Diuretics|diuretics|mesh-ancestor
93154309|NCT01373086|Natriuretic Agents|natriuretic agents|mesh-ancestor
93154310|NCT01373086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93154311|NCT01519804|Paclitaxel|paclitaxel|mesh-list
93154312|NCT01519804|Carboplatin|carboplatin|mesh-list
93154313|NCT01519804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93154314|NCT01519804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154315|NCT01519804|Tubulin Modulators|tubulin modulators|mesh-ancestor
93154316|NCT01519804|Antimitotic Agents|antimitotic agents|mesh-ancestor
93154317|NCT01519804|Mitosis Modulators|mitosis modulators|mesh-ancestor
93154318|NCT01519804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154319|NCT02263924|Tocotrienols|tocotrienols|mesh-list
93154320|NCT02263924|Vitamin E|vitamin e|mesh-list
93154321|NCT02263924|Tocopherols|tocopherols|mesh-list
93154322|NCT02263924|Antioxidants|antioxidants|mesh-ancestor
93154323|NCT02263924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154324|NCT02263924|Protective Agents|protective agents|mesh-ancestor
93154325|NCT02263924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154326|NCT02263924|Vitamins|vitamins|mesh-ancestor
93154327|NCT02263924|Micronutrients|micronutrients|mesh-ancestor
93154328|NCT02264002|Metoprolol|metoprolol|mesh-list
93154329|NCT02264002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93154330|NCT02264002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93154331|NCT02264002|Sympatholytics|sympatholytics|mesh-ancestor
93154332|NCT02264002|Autonomic Agents|autonomic agents|mesh-ancestor
93154333|NCT02264002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154334|NCT02264002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154335|NCT02264002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93154336|NCT02264002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93154337|NCT02264002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93154338|NCT02264002|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154339|NCT02264002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154340|NCT02264002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154341|NCT01517776|Temozolomide|temozolomide|mesh-list
93154342|NCT01517776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93154343|NCT01517776|Alkylating Agents|alkylating agents|mesh-ancestor
93154344|NCT01517776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154345|NCT01517776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154346|NCT02266264|Hydrocortisone|hydrocortisone|mesh-list
93154347|NCT02266264|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93154348|NCT02266264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154349|NCT01516918|Ribavirin|ribavirin|mesh-list
93154350|NCT01516918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93154351|NCT01516918|Antimetabolites|antimetabolites|mesh-ancestor
93154352|NCT01516918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154353|NCT01516918|Antiviral Agents|antiviral agents|mesh-ancestor
93154354|NCT01516918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154355|NCT01508026|Valsartan|valsartan|mesh-list
93154356|NCT01508026|Nebivolol|nebivolol|mesh-list
93154357|NCT01508026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93154358|NCT01508026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93154359|NCT01508026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93154360|NCT01508026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154361|NCT01508026|Vasodilator Agents|vasodilator agents|mesh-ancestor
93154362|NCT01508026|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93154363|NCT01508026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93154364|NCT01508026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93154365|NCT01508026|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154366|NCT01508026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154367|NCT01508026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154368|NCT01357642|Epinephrine|epinephrine|mesh-list
93154369|NCT01357642|Racepinephrine|racepinephrine|mesh-list
93154370|NCT01357642|Epinephryl borate|epinephryl borate|mesh-list
93154371|NCT01357642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93154372|NCT01357642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93154373|NCT01357642|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154374|NCT01357642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154375|NCT01357642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154376|NCT01357642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154377|NCT01357642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93154378|NCT01357642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93154379|NCT01357642|Autonomic Agents|autonomic agents|mesh-ancestor
93154380|NCT01357642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154381|NCT01357642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93154382|NCT01357642|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154383|NCT01357642|Mydriatics|mydriatics|mesh-ancestor
93154384|NCT01357642|Sympathomimetics|sympathomimetics|mesh-ancestor
93154385|NCT01357642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93154386|NCT03135340|Anesthetics|anesthetics|mesh-list
93154387|NCT03135340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154388|NCT03135340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154389|NCT01356160|Ribavirin|ribavirin|mesh-list
93154390|NCT01356160|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93154391|NCT01356160|Ledipasvir|ledipasvir|mesh-list
93154392|NCT01356160|Antimetabolites|antimetabolites|mesh-ancestor
93154393|NCT01356160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154394|NCT01356160|Antiviral Agents|antiviral agents|mesh-ancestor
93154395|NCT01356160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154396|NCT02264158|Telmisartan|telmisartan|mesh-list
93154397|NCT02264158|Lacidipine|lacidipine|mesh-list
93154398|NCT02264158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93154399|NCT02264158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93154400|NCT02264158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93154401|NCT02264158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154402|NCT02264158|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93154403|NCT02264158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93154404|NCT02264158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93154405|NCT02264158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154406|NCT02264236|Vaccines|vaccines|mesh-list
93154407|NCT02264236|Immunologic Factors|immunologic factors|mesh-ancestor
93154408|NCT02264236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154409|NCT01476904|Epinephrine|epinephrine|mesh-list
93154410|NCT01476904|Racepinephrine|racepinephrine|mesh-list
93154411|NCT01476904|Epinephryl borate|epinephryl borate|mesh-list
93154412|NCT01476904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93154413|NCT01476904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93154414|NCT01476904|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154415|NCT01476904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154416|NCT01476904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154417|NCT01476904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154418|NCT01476904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93154419|NCT01476904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93154420|NCT01476904|Autonomic Agents|autonomic agents|mesh-ancestor
93154421|NCT01476904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154422|NCT01476904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93154423|NCT01476904|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154424|NCT01476904|Mydriatics|mydriatics|mesh-ancestor
93154425|NCT01476904|Sympathomimetics|sympathomimetics|mesh-ancestor
93154426|NCT01476904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93154427|NCT01337752|Dexamethasone|dexamethasone|mesh-list
93154428|NCT01337752|Bortezomib|bortezomib|mesh-list
93154429|NCT01337752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93154430|NCT01337752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154431|NCT01337752|Antiemetics|antiemetics|mesh-ancestor
93154432|NCT01337752|Autonomic Agents|autonomic agents|mesh-ancestor
93154433|NCT01337752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154434|NCT01337752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154435|NCT01337752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93154436|NCT01337752|Glucocorticoids|glucocorticoids|mesh-ancestor
93154437|NCT01337752|Hormones|hormones|mesh-ancestor
93154438|NCT01337752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154440|NCT01337752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154441|NCT01337752|Immunologic Factors|immunologic factors|mesh-ancestor
93154442|NCT01318642|Gemcitabine|gemcitabine|mesh-list
93154443|NCT01318642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154444|NCT01318642|Antimetabolites|antimetabolites|mesh-ancestor
93154445|NCT01318642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154446|NCT01318642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154447|NCT01318252|Latanoprost|latanoprost|mesh-list
93154448|NCT01318252|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93154449|NCT01318252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93154450|NCT01313572|Adenosine|adenosine|mesh-list
93154451|NCT01313572|Analgesics|analgesics|mesh-ancestor
93154452|NCT01313572|Sensory System Agents|sensory system agents|mesh-ancestor
93154453|NCT01313572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154454|NCT01313572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154455|NCT01313572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93154456|NCT01313572|Vasodilator Agents|vasodilator agents|mesh-ancestor
93154457|NCT01313572|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93154458|NCT01313572|Purinergic Agonists|purinergic agonists|mesh-ancestor
93154459|NCT01313572|Purinergic Agents|purinergic agents|mesh-ancestor
93154460|NCT01313572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154461|NCT01313572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154462|NCT02265484|Rifaximin|rifaximin|mesh-list
93154463|NCT02265484|Bromocriptine|bromocriptine|mesh-list
93154464|NCT02265484|Lactulose|lactulose|mesh-list
93154465|NCT02265484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154466|NCT02265484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154467|NCT02265484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93154468|NCT02265484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93154469|NCT02265484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93154470|NCT02265484|Hormone Antagonists|hormone antagonists|mesh-ancestor
93154471|NCT02265484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154472|NCT02265484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154473|NCT02265484|Dopamine Agonists|dopamine agonists|mesh-ancestor
93154474|NCT02265484|Dopamine Agents|dopamine agents|mesh-ancestor
93154475|NCT02265484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154476|NCT02265484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154477|NCT02264626|Remifentanil|remifentanil|mesh-list
93154478|NCT02264626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93154479|NCT02264626|Narcotics|narcotics|mesh-ancestor
93154480|NCT02264626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154481|NCT02264626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154482|NCT02264626|Analgesics|analgesics|mesh-ancestor
93154483|NCT02264626|Sensory System Agents|sensory system agents|mesh-ancestor
93154484|NCT02264626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154485|NCT03993262|Bortezomib|bortezomib|mesh-list
93154486|NCT03993262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154487|NCT02267044|Ropivacaine|ropivacaine|mesh-list
93154488|NCT02267044|Anesthetics, Local|anesthetics, local|mesh-ancestor
93154489|NCT02267044|Anesthetics|anesthetics|mesh-ancestor
93154490|NCT02267044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154491|NCT02267044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154492|NCT02267044|Sensory System Agents|sensory system agents|mesh-ancestor
93154493|NCT02267044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154494|NCT02267122|Mupirocin|mupirocin|mesh-list
93154495|NCT02267122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154496|NCT02267122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154497|NCT02267122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93154498|NCT02267122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154499|NCT02267122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154500|NCT01261312|Guadecitabine|guadecitabine|mesh-list
93154501|NCT01261312|Azacitidine|azacitidine|mesh-list
93154502|NCT01261312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154503|NCT01261312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154504|NCT01261312|Antimetabolites|antimetabolites|mesh-ancestor
93154505|NCT01261312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154506|NCT01261312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154507|NCT01254370|Travoprost|travoprost|mesh-list
93154508|NCT01254370|Latanoprost|latanoprost|mesh-list
93154509|NCT01254370|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93154510|NCT01254370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93154511|NCT01254370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92826720|NCT01632657|Sumatriptan|sumatriptan|mesh-list
93154512|NCT01254136|Trastuzumab|trastuzumab|mesh-list
93154513|NCT01254136|Vinorelbine|vinorelbine|mesh-list
93154514|NCT01254136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93154515|NCT01254136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154516|NCT01254136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93154517|NCT01254136|Tubulin Modulators|tubulin modulators|mesh-ancestor
93154518|NCT01254136|Antimitotic Agents|antimitotic agents|mesh-ancestor
93154519|NCT01254136|Mitosis Modulators|mitosis modulators|mesh-ancestor
93154520|NCT01254136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154521|NCT02268370|Dasatinib|dasatinib|mesh-list
93154522|NCT02268370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154523|NCT02268370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93154524|NCT02268370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154525|NCT02268370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154526|NCT00039377|Leucovorin|leucovorin|mesh-list
93154527|NCT00039377|Cytarabine|cytarabine|mesh-list
93154528|NCT00039377|Cyclophosphamide|cyclophosphamide|mesh-list
93154529|NCT00039377|Methotrexate|methotrexate|mesh-list
93154530|NCT00039377|Etoposide|etoposide|mesh-list
93154531|NCT00039377|Vincristine|vincristine|mesh-list
93154532|NCT00039377|Etoposide phosphate|etoposide phosphate|mesh-list
93154533|NCT00039377|Imatinib Mesylate|imatinib mesylate|mesh-list
93154534|NCT00039377|Tacrolimus|tacrolimus|mesh-list
93154535|NCT00039377|Levoleucovorin|levoleucovorin|mesh-list
93154536|NCT00039377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154537|NCT00039377|Immunologic Factors|immunologic factors|mesh-ancestor
93154538|NCT00039377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154539|NCT00039377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154540|NCT00039377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93154541|NCT00039377|Alkylating Agents|alkylating agents|mesh-ancestor
93154542|NCT00039377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154543|NCT00039377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154544|NCT00039377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93154545|NCT00039377|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93154546|NCT00039377|Abortifacient Agents|abortifacient agents|mesh-ancestor
93154547|NCT00039377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93154548|NCT00039377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154549|NCT00039377|Antimetabolites|antimetabolites|mesh-ancestor
93154550|NCT00039377|Dermatologic Agents|dermatologic agents|mesh-ancestor
93154551|NCT00039377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154552|NCT00039377|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93154553|NCT00039377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93154554|NCT00039377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93154555|NCT00039377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93154556|NCT00039377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154557|NCT00039377|Antiviral Agents|antiviral agents|mesh-ancestor
93154558|NCT00039377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154559|NCT00039377|Antidotes|antidotes|mesh-ancestor
93154560|NCT00039377|Protective Agents|protective agents|mesh-ancestor
93154561|NCT00039377|Vitamin B Complex|vitamin b complex|mesh-ancestor
93154562|NCT00039377|Vitamins|vitamins|mesh-ancestor
93154563|NCT00039377|Micronutrients|micronutrients|mesh-ancestor
93154564|NCT00039377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93154565|NCT00039377|Tubulin Modulators|tubulin modulators|mesh-ancestor
93154566|NCT00039377|Antimitotic Agents|antimitotic agents|mesh-ancestor
93154567|NCT00039377|Mitosis Modulators|mitosis modulators|mesh-ancestor
93154568|NCT00039377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93154569|NCT01096745|Cisplatin|cisplatin|mesh-list
93154570|NCT01096745|Gemcitabine|gemcitabine|mesh-list
93154571|NCT01096745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154572|NCT01096745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154573|NCT01096745|Antimetabolites|antimetabolites|mesh-ancestor
93154574|NCT01096745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154575|NCT03953729|Ibuprofen|ibuprofen|mesh-list
93154576|NCT03953729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93154577|NCT03953729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93154578|NCT03953729|Analgesics|analgesics|mesh-ancestor
93154579|NCT03953729|Sensory System Agents|sensory system agents|mesh-ancestor
93154580|NCT03953729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154581|NCT03953729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154582|NCT03953729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154583|NCT03953729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154584|NCT03953729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93154585|NCT03953729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154586|NCT03953729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154587|NCT01097213|Ethanol|ethanol|mesh-list
93154588|NCT01097213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93154589|NCT01097213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826790|NCT04183491|Interferons|interferons|mesh-list
93154590|NCT01097213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154591|NCT01097213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154593|NCT00154102|Folic Acid|folic acid|mesh-list
93154594|NCT00154102|Fluorouracil|fluorouracil|mesh-list
93154595|NCT00154102|Irinotecan|irinotecan|mesh-list
93154596|NCT00154102|Cetuximab|cetuximab|mesh-list
93154597|NCT00154102|Levoleucovorin|levoleucovorin|mesh-list
93154598|NCT00154102|Antimetabolites|antimetabolites|mesh-ancestor
93154599|NCT00154102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154600|NCT00154102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154601|NCT00154102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154602|NCT00154102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154603|NCT00154102|Immunologic Factors|immunologic factors|mesh-ancestor
93154604|NCT00154102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154605|NCT00154102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93154606|NCT00154102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154607|NCT00154102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154608|NCT00154102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93154609|NCT00154102|Antidotes|antidotes|mesh-ancestor
93154610|NCT00154102|Protective Agents|protective agents|mesh-ancestor
93154611|NCT00154102|Vitamin B Complex|vitamin b complex|mesh-ancestor
93154612|NCT00154102|Vitamins|vitamins|mesh-ancestor
93154613|NCT00154102|Micronutrients|micronutrients|mesh-ancestor
93154614|NCT00154102|Hematinics|hematinics|mesh-ancestor
93154615|NCT01269658|Azithromycin|azithromycin|mesh-list
93154616|NCT01269658|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93154617|NCT01269658|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93154618|NCT01269658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154619|NCT01269658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154620|NCT01229644|Crenolanib|crenolanib|mesh-list
93154621|NCT01229644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154622|NCT02267980|Ketamine|ketamine|mesh-list
93154623|NCT02267980|Sevoflurane|sevoflurane|mesh-list
93154624|NCT02267980|Analgesics|analgesics|mesh-ancestor
93154625|NCT02267980|Sensory System Agents|sensory system agents|mesh-ancestor
93154626|NCT02267980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154627|NCT02267980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154628|NCT02267980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93154629|NCT02267980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93154630|NCT02267980|Anesthetics, General|anesthetics, general|mesh-ancestor
93154631|NCT02267980|Anesthetics|anesthetics|mesh-ancestor
93154632|NCT02267980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154633|NCT02267980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93154634|NCT02267980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93154635|NCT02267980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154636|NCT02267980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154637|NCT02267980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93154638|NCT02267980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93154639|NCT01224262|Vaccines|vaccines|mesh-list
93154640|NCT01224262|Immunologic Factors|immunologic factors|mesh-ancestor
93154641|NCT01224262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154642|NCT01222702|Vancomycin|vancomycin|mesh-list
93154643|NCT01222702|Oxazolidinones|oxazolidinones|mesh-list
93154644|NCT01222702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154645|NCT01222702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154646|NCT01222702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93154647|NCT01222702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154648|NCT01222702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154649|NCT01204762|Entecavir|entecavir|mesh-list
93154650|NCT01204762|Antiviral Agents|antiviral agents|mesh-ancestor
93154651|NCT01204762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154652|NCT02236078|Isoniazid|isoniazid|mesh-list
93154653|NCT02236078|Antitubercular Agents|antitubercular agents|mesh-ancestor
93154654|NCT02236078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154655|NCT02236078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154656|NCT02236078|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93154657|NCT02236078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93154658|NCT02236078|Antimetabolites|antimetabolites|mesh-ancestor
93154659|NCT02236078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450369|NCT04671082|Tolperisone|tolperisone|mesh-list
93154660|NCT02236078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93154661|NCT01198834|Etodolac|etodolac|mesh-list
93154662|NCT01198834|Lidocaine|lidocaine|mesh-list
93154663|NCT01198834|Anesthetics, Local|anesthetics, local|mesh-ancestor
93154664|NCT01198834|Anesthetics|anesthetics|mesh-ancestor
93154665|NCT01198834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93154666|NCT01198834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826867|NCT02681679|Bromfenac|bromfenac|mesh-list
93154667|NCT01198834|Sensory System Agents|sensory system agents|mesh-ancestor
93154668|NCT01198834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154669|NCT01198834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93154670|NCT01198834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93154671|NCT01198834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93154672|NCT01198834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93154673|NCT01198834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154674|NCT01198834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93154675|NCT01198834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93154676|NCT01198834|Analgesics|analgesics|mesh-ancestor
93154677|NCT01198834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154678|NCT01198834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154679|NCT01198834|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93154680|NCT01198834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93154681|NCT01198834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154682|NCT01193140|Temozolomide|temozolomide|mesh-list
93154684|NCT01193140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93154685|NCT01193140|Alkylating Agents|alkylating agents|mesh-ancestor
93154686|NCT01193140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154687|NCT01193140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154688|NCT01193140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93154689|NCT01193140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154690|NCT01189396|Albuterol|albuterol|mesh-list
93154691|NCT01189396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93154692|NCT01189396|Autonomic Agents|autonomic agents|mesh-ancestor
93154693|NCT01189396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154694|NCT01189396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154695|NCT01189396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93154696|NCT01189396|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154697|NCT01189396|Tocolytic Agents|tocolytic agents|mesh-ancestor
93154698|NCT01189396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93154699|NCT01189396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93154700|NCT01189396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93154701|NCT01189396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93154702|NCT01189396|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154703|NCT01189396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154704|NCT01189396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154705|NCT05626972|Tenecteplase|tenecteplase|mesh-list
93154706|NCT05626972|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93154707|NCT05626972|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93154708|NCT05626972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154709|NCT01174732|Albuterol|albuterol|mesh-list
93154710|NCT01174732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93154711|NCT01174732|Autonomic Agents|autonomic agents|mesh-ancestor
93154712|NCT01174732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154713|NCT01174732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154714|NCT01174732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93154715|NCT01174732|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154716|NCT01174732|Tocolytic Agents|tocolytic agents|mesh-ancestor
93154717|NCT01174732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93154718|NCT01174732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93154719|NCT01174732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93154720|NCT01174732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93154721|NCT01174732|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154722|NCT01174732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154723|NCT01174732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154724|NCT01076764|Heparin|heparin|mesh-list
93154725|NCT01076764|Calcium heparin|calcium heparin|mesh-list
93154726|NCT01076764|Otamixaban|otamixaban|mesh-list
93154727|NCT01076764|Eptifibatide|eptifibatide|mesh-list
93154728|NCT01076764|Anticoagulants|anticoagulants|mesh-ancestor
93154729|NCT01076764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93154730|NCT01076764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93154731|NCT01076764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154732|NCT01076764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93154733|NCT01076764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93154734|NCT01076764|Antithrombins|antithrombins|mesh-ancestor
93154735|NCT01076764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93154736|NCT01076764|Protease Inhibitors|protease inhibitors|mesh-ancestor
93154737|NCT01076764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154738|NCT02269072|Anastrozole|anastrozole|mesh-list
93154739|NCT02269072|Leuprolide|leuprolide|mesh-list
93154740|NCT02269072|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93154741|NCT02269072|Testosterone|testosterone|mesh-list
93154742|NCT02269072|Androgens|androgens|mesh-ancestor
93154743|NCT02269072|Hormones|hormones|mesh-ancestor
93154744|NCT02269072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154745|NCT02269072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154746|NCT02269072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93154747|NCT02269072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154748|NCT02269072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93154749|NCT02269072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93154750|NCT02269072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154751|NCT02269072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154752|NCT02269072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93154753|NCT02269072|Hormone Antagonists|hormone antagonists|mesh-ancestor
93154754|NCT02269072|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93154755|NCT02269072|Fertility Agents|fertility agents|mesh-ancestor
93154756|NCT02269072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93154757|NCT02269072|Natriuretic Agents|natriuretic agents|mesh-ancestor
93154758|NCT01071850|Metformin|metformin|mesh-list
93154759|NCT01071850|Ipragliflozin|ipragliflozin|mesh-list
93154760|NCT01071850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93154761|NCT01071850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154762|NCT01071850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93154763|NCT01071850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154764|NCT02269228|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
93154765|NCT02269228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93154766|NCT01037062|Entecavir|entecavir|mesh-list
93154767|NCT01037062|Antiviral Agents|antiviral agents|mesh-ancestor
93154768|NCT01037062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154769|NCT01167166|ON 01910|on 01910|mesh-list
93154770|NCT01167166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154771|NCT01167166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93154772|NCT01167166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154773|NCT01167166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154774|NCT01035502|Idarubicin|idarubicin|mesh-list
93154775|NCT01035502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93154776|NCT01035502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154777|NCT01035502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93154778|NCT01035502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154779|NCT01035502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154780|NCT01035502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154781|NCT01030432|Ribavirin|ribavirin|mesh-list
93154782|NCT01030432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93154783|NCT01030432|Interferon-alpha|interferon-alpha|mesh-list
93154784|NCT01030432|Asunaprevir|asunaprevir|mesh-list
93154785|NCT01030432|Antimetabolites|antimetabolites|mesh-ancestor
93154786|NCT01030432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154787|NCT01030432|Antiviral Agents|antiviral agents|mesh-ancestor
93154788|NCT01030432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154789|NCT01030432|Immunologic Factors|immunologic factors|mesh-ancestor
93154790|NCT01030432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154791|NCT01030432|Protease Inhibitors|protease inhibitors|mesh-ancestor
93154792|NCT01030432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154793|NCT02269462|Efavirenz|efavirenz|mesh-list
93154794|NCT02269462|Nevirapine|nevirapine|mesh-list
93154795|NCT02269462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93154796|NCT02269462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93154797|NCT02269462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154798|NCT02269462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154799|NCT02269462|Antiviral Agents|antiviral agents|mesh-ancestor
93154800|NCT02269462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154801|NCT02269462|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93154802|NCT02269462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93154803|NCT02269462|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93154804|NCT02269462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93154805|NCT02269462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93154806|NCT02269462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93154807|NCT02269462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93154808|NCT02269462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93154809|NCT02261506|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93154810|NCT02261506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93154811|NCT02261506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154812|NCT02261506|Antitubercular Agents|antitubercular agents|mesh-ancestor
93154813|NCT02269540|Acetylcysteine|acetylcysteine|mesh-list
93154814|NCT02269540|Sertraline|sertraline|mesh-list
93154815|NCT02269540|Citalopram|citalopram|mesh-list
93154817|NCT02269540|Antiviral Agents|antiviral agents|mesh-ancestor
93154818|NCT02269540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154819|NCT02269540|Expectorants|expectorants|mesh-ancestor
93154820|NCT02269540|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154821|NCT02269540|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93154822|NCT02269540|Antioxidants|antioxidants|mesh-ancestor
93154823|NCT02269540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154824|NCT02269540|Protective Agents|protective agents|mesh-ancestor
93154825|NCT02269540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154826|NCT02269540|Antidotes|antidotes|mesh-ancestor
93154827|NCT02269540|Antidepressive Agents|antidepressive agents|mesh-ancestor
93154828|NCT02269540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93154829|NCT02269540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93154830|NCT02269540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93154831|NCT02269540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93154832|NCT02269540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154833|NCT02269540|Serotonin Agents|serotonin agents|mesh-ancestor
93154834|NCT02269540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93154835|NCT01023880|Delanzomib|delanzomib|mesh-list
93154836|NCT01023880|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
93154837|NCT01023880|Protease Inhibitors|protease inhibitors|mesh-ancestor
93154838|NCT01023880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154839|NCT01023880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154840|NCT02650804|Coenzyme Q10|coenzyme q10|mesh-list
93154841|NCT02650804|Gemcitabine|gemcitabine|mesh-list
93154842|NCT02650804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154843|NCT02650804|Antimetabolites|antimetabolites|mesh-ancestor
93154844|NCT02650804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154845|NCT02650804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154846|NCT02650804|Vitamins|vitamins|mesh-ancestor
93154847|NCT02650804|Micronutrients|micronutrients|mesh-ancestor
93154848|NCT02650804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154849|NCT02269696|Metoprolol|metoprolol|mesh-list
93154850|NCT02269696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93154851|NCT02269696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93154852|NCT02269696|Sympatholytics|sympatholytics|mesh-ancestor
93154853|NCT02269696|Autonomic Agents|autonomic agents|mesh-ancestor
93154854|NCT02269696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154855|NCT02269696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154856|NCT02269696|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93154857|NCT02269696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93154858|NCT02269696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93154859|NCT02269696|Adrenergic Agents|adrenergic agents|mesh-ancestor
93154860|NCT02269696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93154861|NCT02269696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154862|NCT03135184|Coal Tar|coal tar|mesh-list
93154863|NCT03135184|Keratolytic Agents|keratolytic agents|mesh-ancestor
93154864|NCT03135184|Dermatologic Agents|dermatologic agents|mesh-ancestor
93154865|NCT05613400|Simvastatin|simvastatin|mesh-list
93154866|NCT05613400|Ezetimibe|ezetimibe|mesh-list
93154867|NCT05613400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93154868|NCT05613400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93154869|NCT05613400|Antimetabolites|antimetabolites|mesh-ancestor
93154870|NCT05613400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154871|NCT05613400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93154872|NCT05613400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93154873|NCT05613400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154874|NCT02261662|Ribavirin|ribavirin|mesh-list
93154875|NCT02261662|Betamethasone|betamethasone|mesh-list
93154876|NCT02261662|Antimetabolites|antimetabolites|mesh-ancestor
93154877|NCT02261662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154878|NCT02261662|Antiviral Agents|antiviral agents|mesh-ancestor
93154879|NCT02261662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154880|NCT02261662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154881|NCT02261662|Glucocorticoids|glucocorticoids|mesh-ancestor
93154882|NCT02261662|Hormones|hormones|mesh-ancestor
93154883|NCT02261662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154884|NCT02261662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154885|NCT02261662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93154886|NCT02261662|Respiratory System Agents|respiratory system agents|mesh-ancestor
93154887|NCT02261896|Ciprofloxacin|ciprofloxacin|mesh-list
93154888|NCT02261896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154889|NCT02261896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827099|NCT02678949|Xhance|xhance|mesh-list
93154890|NCT02261896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93154891|NCT02261896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154892|NCT02261896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154893|NCT02261896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154894|NCT02261896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154895|NCT02261896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93154896|NCT02261896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93154897|NCT00035555|Cyclosporine|cyclosporine|mesh-list
93154898|NCT00035555|Mycophenolic Acid|mycophenolic acid|mesh-list
93154899|NCT00035555|Abatacept|abatacept|mesh-list
93154900|NCT00035555|Cyclosporins|cyclosporins|mesh-list
93154901|NCT00035555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154902|NCT00035555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154903|NCT00035555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154904|NCT00035555|Immunologic Factors|immunologic factors|mesh-ancestor
93154905|NCT00035555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154906|NCT00035555|Antifungal Agents|antifungal agents|mesh-ancestor
93154907|NCT00035555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154908|NCT00035555|Dermatologic Agents|dermatologic agents|mesh-ancestor
93154909|NCT00035555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154910|NCT00035555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93154911|NCT00035555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93154912|NCT00035555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154913|NCT00035555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93154914|NCT00035555|Antitubercular Agents|antitubercular agents|mesh-ancestor
93154915|NCT00035555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154916|NCT00035555|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93154917|NCT00035555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93154918|NCT01093157|Hormones|hormones|mesh-list
93154919|NCT01093157|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93154920|NCT01093157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154921|NCT01093157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154922|NCT01093235|Cyclophosphamide|cyclophosphamide|mesh-list
93154923|NCT01093235|Bevacizumab|bevacizumab|mesh-list
93154924|NCT01093235|Docetaxel|docetaxel|mesh-list
93154925|NCT01093235|Fluorouracil|fluorouracil|mesh-list
93154926|NCT01093235|Epirubicin|epirubicin|mesh-list
93154927|NCT01093235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93154928|NCT01093235|Immunologic Factors|immunologic factors|mesh-ancestor
93154929|NCT01093235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154930|NCT01093235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154931|NCT01093235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93154932|NCT01093235|Alkylating Agents|alkylating agents|mesh-ancestor
93154933|NCT01093235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154934|NCT01093235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93154935|NCT01093235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93154936|NCT01093235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93154937|NCT01093235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93154938|NCT01093235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93154939|NCT01093235|Growth Substances|growth substances|mesh-ancestor
93154940|NCT01093235|Growth Inhibitors|growth inhibitors|mesh-ancestor
93154941|NCT01093235|Tubulin Modulators|tubulin modulators|mesh-ancestor
93154942|NCT01093235|Antimitotic Agents|antimitotic agents|mesh-ancestor
93154943|NCT01093235|Mitosis Modulators|mitosis modulators|mesh-ancestor
93154944|NCT01093235|Antimetabolites|antimetabolites|mesh-ancestor
93154945|NCT01093235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93154946|NCT01093235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93154947|NCT01093235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93154948|NCT01093235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93154949|NCT01093235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154950|NCT01097681|Ipragliflozin|ipragliflozin|mesh-list
93154951|NCT01097681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93154952|NCT01097681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154953|NCT01097681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93154954|NCT01097681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154955|NCT01088009|Lamivudine|lamivudine|mesh-list
93154956|NCT01088009|Adefovir|adefovir|mesh-list
93154957|NCT01088009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93154958|NCT01088009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93154959|NCT01088009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154960|NCT01088009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154961|NCT01088009|Antiviral Agents|antiviral agents|mesh-ancestor
93154962|NCT01088009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154963|NCT01088009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93154964|NCT01088009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93154965|NCT03894046|Imipenem|imipenem|mesh-list
93154966|NCT03894046|Colistin|colistin|mesh-list
93154967|NCT03894046|Sulbactam|sulbactam|mesh-list
93154968|NCT03894046|Durlobactam|durlobactam|mesh-list
93154969|NCT03894046|Cilastatin|cilastatin|mesh-list
93154970|NCT03894046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93154971|NCT03894046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93154972|NCT03894046|Protease Inhibitors|protease inhibitors|mesh-ancestor
93154973|NCT03894046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154974|NCT03894046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154975|NCT03894046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93154976|NCT04475614|Vitamin B Complex|vitamin b complex|mesh-list
93154977|NCT04475614|Vitamins|vitamins|mesh-ancestor
93154978|NCT04475614|Micronutrients|micronutrients|mesh-ancestor
93154979|NCT04475614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154980|NCT01143064|Progesterone|progesterone|mesh-list
93154981|NCT01143064|Progestins|progestins|mesh-ancestor
93154982|NCT01143064|Hormones|hormones|mesh-ancestor
93154983|NCT01143064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93154984|NCT01143064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154985|NCT00033371|Eflornithine|eflornithine|mesh-list
93154986|NCT00033371|Celecoxib|celecoxib|mesh-list
93154987|NCT00033371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93154988|NCT00033371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93154989|NCT00033371|Analgesics|analgesics|mesh-ancestor
93154990|NCT00033371|Sensory System Agents|sensory system agents|mesh-ancestor
93154991|NCT00033371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93154992|NCT00033371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93154993|NCT00033371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93154994|NCT00033371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93154995|NCT00033371|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93154996|NCT00033371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93154997|NCT00033371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93154998|NCT00033371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93154999|NCT00033371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155000|NCT00033371|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93155001|NCT00033371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93155002|NCT00033371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93155003|NCT00033371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155004|NCT00033371|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93155005|NCT01001338|Allopurinol|allopurinol|mesh-list
93155006|NCT01001338|Lesinurad|lesinurad|mesh-list
93155007|NCT01001338|Antimetabolites|antimetabolites|mesh-ancestor
93155008|NCT01001338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155009|NCT01001338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155010|NCT01001338|Gout Suppressants|gout suppressants|mesh-ancestor
93155011|NCT01001338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155012|NCT01001338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93155013|NCT01001338|Antioxidants|antioxidants|mesh-ancestor
93155014|NCT01001338|Protective Agents|protective agents|mesh-ancestor
93155015|NCT01001338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155016|NCT01001338|Uricosuric Agents|uricosuric agents|mesh-ancestor
93155017|NCT03952715|Ibuprofen|ibuprofen|mesh-list
93155018|NCT03952715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93155019|NCT03952715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155020|NCT03952715|Analgesics|analgesics|mesh-ancestor
93155021|NCT03952715|Sensory System Agents|sensory system agents|mesh-ancestor
93155022|NCT03952715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155023|NCT03952715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155024|NCT03952715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155025|NCT03952715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155026|NCT03952715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93155027|NCT03952715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155028|NCT03952715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155029|NCT01137526|Donepezil|donepezil|mesh-list
93155030|NCT01137526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93155031|NCT01137526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155032|NCT01137526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155033|NCT01137526|Cholinergic Agents|cholinergic agents|mesh-ancestor
93155034|NCT01137526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155035|NCT01137526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155036|NCT01137526|Nootropic Agents|nootropic agents|mesh-ancestor
93155037|NCT00993382|Amiodarone|amiodarone|mesh-list
93155038|NCT00993382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93155039|NCT00993382|Vasodilator Agents|vasodilator agents|mesh-ancestor
93155040|NCT00993382|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93155041|NCT00993382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155042|NCT00993382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155043|NCT00993382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93155044|NCT00993382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93155045|NCT00993382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93155046|NCT00993382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155047|NCT00993382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93155048|NCT00993382|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93155049|NCT00993382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93155050|NCT00081731|Candesartan cilexetil|candesartan cilexetil|mesh-list
93155051|NCT00081731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93155052|NCT00081731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93155053|NCT00081731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93155054|NCT00081731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155055|NCT05628610|Paclitaxel|paclitaxel|mesh-list
93155056|NCT05628610|Carboplatin|carboplatin|mesh-list
93155057|NCT05628610|Tislelizumab|tislelizumab|mesh-list
93155058|NCT05628610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93155059|NCT05628610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155060|NCT05628610|Tubulin Modulators|tubulin modulators|mesh-ancestor
93155061|NCT05628610|Antimitotic Agents|antimitotic agents|mesh-ancestor
93155062|NCT05628610|Mitosis Modulators|mitosis modulators|mesh-ancestor
93155063|NCT05628610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155064|NCT05628610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155065|NCT00079937|Fluticasone|fluticasone|mesh-list
93155066|NCT00079937|Omalizumab|omalizumab|mesh-list
93155067|NCT00079937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155068|NCT00079937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93155069|NCT00079937|Autonomic Agents|autonomic agents|mesh-ancestor
93155070|NCT00079937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155071|NCT00079937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155072|NCT00079937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93155073|NCT00079937|Respiratory System Agents|respiratory system agents|mesh-ancestor
93155074|NCT00079937|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155075|NCT00079937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93155076|NCT00909610|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93155077|NCT00909610|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93155078|NCT00909610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155079|NCT03961607|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93155080|NCT03961607|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93155081|NCT03961607|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155082|NCT03126110|Nivolumab|nivolumab|mesh-list
93155083|NCT03126110|Ipilimumab|ipilimumab|mesh-list
93155084|NCT03126110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155085|NCT03126110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155086|NCT03126110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155087|NCT03126110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155088|NCT00908128|Mycophenolic Acid|mycophenolic acid|mesh-list
93155089|NCT00908128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93155090|NCT00908128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155091|NCT00908128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93155092|NCT00908128|Antitubercular Agents|antitubercular agents|mesh-ancestor
93155093|NCT00908128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155094|NCT00908128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155095|NCT00908128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155096|NCT00908128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155097|NCT00906334|ON 01910|on 01910|mesh-list
93155098|NCT00906334|Glycine|glycine|mesh-list
93155099|NCT00906334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155100|NCT00906334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93155101|NCT00906334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155102|NCT00906334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155103|NCT00906334|Glycine Agents|glycine agents|mesh-ancestor
93155104|NCT00906334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155105|NCT00906334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155106|NCT00905164|Topiramate|topiramate|mesh-list
93155107|NCT00905164|Anticonvulsants|anticonvulsants|mesh-ancestor
93155108|NCT00905164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155109|NCT00905164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155110|NCT00978016|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
93155111|NCT00978016|Baclofen|baclofen|mesh-list
93155112|NCT00978016|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93155113|NCT00978016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827313|NCT02674581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93155114|NCT00978016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155115|NCT00978016|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93155116|NCT00978016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155117|NCT00978016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93155118|NCT00978016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155119|NCT00978016|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93155120|NCT00978016|GABA Agonists|gaba agonists|mesh-ancestor
93155121|NCT00978016|GABA Agents|gaba agents|mesh-ancestor
93155122|NCT00978016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155123|NCT01129648|Allopurinol|allopurinol|mesh-list
93155124|NCT01129648|Antimetabolites|antimetabolites|mesh-ancestor
93155125|NCT01129648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155126|NCT01129648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155127|NCT01129648|Gout Suppressants|gout suppressants|mesh-ancestor
93155128|NCT01129648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155129|NCT01129648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93155130|NCT01129648|Antioxidants|antioxidants|mesh-ancestor
93155131|NCT01129648|Protective Agents|protective agents|mesh-ancestor
93155132|NCT01129648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155133|NCT04438720|Nifedipine|nifedipine|mesh-list
93155134|NCT04438720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93155135|NCT04438720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155136|NCT04438720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155137|NCT04438720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93155138|NCT04438720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155139|NCT04438720|Vasodilator Agents|vasodilator agents|mesh-ancestor
93155140|NCT04438720|Tocolytic Agents|tocolytic agents|mesh-ancestor
93155141|NCT04438720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93155142|NCT05464810|Letrozole|letrozole|mesh-list
93155143|NCT05464810|Simvastatin|simvastatin|mesh-list
93155144|NCT05464810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93155145|NCT05464810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93155146|NCT05464810|Antimetabolites|antimetabolites|mesh-ancestor
93155147|NCT05464810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155148|NCT05464810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93155149|NCT05464810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93155150|NCT05464810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155151|NCT05464810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155152|NCT05464810|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93155153|NCT05464810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93155154|NCT05464810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93155155|NCT05464810|Hormone Antagonists|hormone antagonists|mesh-ancestor
93155156|NCT05464810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155157|NCT05464810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155158|NCT03176966|Vitamin E|vitamin e|mesh-list
93155159|NCT03176966|Ropinirole|ropinirole|mesh-list
93155160|NCT03176966|Vitamins|vitamins|mesh-ancestor
93155161|NCT03176966|Micronutrients|micronutrients|mesh-ancestor
93155162|NCT03176966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155163|NCT03176966|Antioxidants|antioxidants|mesh-ancestor
92854979|NCT00906139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93155164|NCT03176966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155165|NCT03176966|Protective Agents|protective agents|mesh-ancestor
93155166|NCT03176966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93155167|NCT03176966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93155168|NCT03176966|Dopamine Agonists|dopamine agonists|mesh-ancestor
93155169|NCT03176966|Dopamine Agents|dopamine agents|mesh-ancestor
93155170|NCT03176966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155171|NCT03209570|Zinc Oxide|zinc oxide|mesh-list
93155172|NCT03209570|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155173|NCT03209570|Sunscreening Agents|sunscreening agents|mesh-ancestor
93155174|NCT03209570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93155175|NCT03209570|Protective Agents|protective agents|mesh-ancestor
93155176|NCT03209570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155177|NCT04405102|Ozanimod|ozanimod|mesh-list
93155178|NCT04405102|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93155179|NCT04405102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155180|NCT04405102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93155181|NCT04405102|Immunologic Factors|immunologic factors|mesh-ancestor
93155182|NCT04405102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155183|NCT03209492|Leuprolide|leuprolide|mesh-list
93155184|NCT03209492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93155185|NCT03209492|Fertility Agents|fertility agents|mesh-ancestor
93155186|NCT03209492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93155187|NCT03209492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827393|NCT00731575|Antiemetics|antiemetics|mesh-ancestor
93155188|NCT03209492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155190|NCT00894868|Vildagliptin|vildagliptin|mesh-list
93155191|NCT00894868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155192|NCT00894868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155193|NCT00894868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93155194|NCT00894868|Protease Inhibitors|protease inhibitors|mesh-ancestor
93155195|NCT00894868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155196|NCT00894868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155197|NCT01122784|Vaccines|vaccines|mesh-list
93155198|NCT01122784|Immunologic Factors|immunologic factors|mesh-ancestor
93155199|NCT01122784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155200|NCT03208244|Antiviral Agents|antiviral agents|mesh-list
93155201|NCT03208244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155202|NCT01088165|Adalimumab|adalimumab|mesh-list
93155203|NCT01088165|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93155204|NCT01088165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155205|NCT01088165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155206|NCT00892762|Travoprost|travoprost|mesh-list
93155207|NCT00892762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93155208|NCT00892762|Latanoprost|latanoprost|mesh-list
93155209|NCT00892762|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93155210|NCT00892762|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93155211|NCT00890968|Triamcinolone|triamcinolone|mesh-list
93155212|NCT00890968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93155213|NCT00890968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93155214|NCT00890968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93155215|NCT00890968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155216|NCT00890968|Glucocorticoids|glucocorticoids|mesh-ancestor
93155217|NCT00890968|Hormones|hormones|mesh-ancestor
93155218|NCT00890968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155219|NCT00890968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155220|NCT00890968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93155221|NCT00890968|Immunologic Factors|immunologic factors|mesh-ancestor
93155222|NCT00890968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155223|NCT00890968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155224|NCT01098383|Acetylcholine|acetylcholine|mesh-list
93155225|NCT01098383|Donepezil|donepezil|mesh-list
93155226|NCT01098383|Choline|choline|mesh-list
93155227|NCT01098383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93155228|NCT01098383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155229|NCT01098383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155230|NCT01098383|Cholinergic Agents|cholinergic agents|mesh-ancestor
93155231|NCT01098383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155232|NCT01098383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155233|NCT01098383|Nootropic Agents|nootropic agents|mesh-ancestor
93155234|NCT01098383|Lipotropic Agents|lipotropic agents|mesh-ancestor
93155235|NCT01098383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93155236|NCT01098383|Antimetabolites|antimetabolites|mesh-ancestor
93155237|NCT01098383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155238|NCT01098383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93155239|NCT01098383|Vasodilator Agents|vasodilator agents|mesh-ancestor
93155240|NCT01098383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93155241|NCT00890890|BMS 708163|bms 708163|mesh-list
93155242|NCT00890890|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93155243|NCT00890890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155244|NCT00890890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155245|NCT03175172|Pembrolizumab|pembrolizumab|mesh-list
93155246|NCT03175172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155247|NCT03175172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155248|NCT03175172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155249|NCT03175172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155250|NCT00961090|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93155251|NCT00961090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93155252|NCT00961090|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155253|NCT01088477|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93155254|NCT01088477|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93155255|NCT01088477|Estradiol|estradiol|mesh-list
93155256|NCT01088477|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93155257|NCT01088477|Estrogens|estrogens|mesh-ancestor
93155258|NCT01088477|Hormones|hormones|mesh-ancestor
93155259|NCT01088477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155260|NCT01088477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155261|NCT01088477|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93155262|NCT01088477|Contraceptive Agents|contraceptive agents|mesh-ancestor
93155263|NCT01088477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93155264|NCT01088477|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93155265|NCT01088555|Sodium thiosulfate|sodium thiosulfate|mesh-list
93155266|NCT01088555|Antidotes|antidotes|mesh-ancestor
93155267|NCT01088555|Protective Agents|protective agents|mesh-ancestor
93155268|NCT01088555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155269|NCT01088555|Antioxidants|antioxidants|mesh-ancestor
93155270|NCT01088555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155271|NCT01088555|Antitubercular Agents|antitubercular agents|mesh-ancestor
93155272|NCT01088555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155273|NCT01088555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155274|NCT01088555|Chelating Agents|chelating agents|mesh-ancestor
93155275|NCT01088555|Sequestering Agents|sequestering agents|mesh-ancestor
93155276|NCT04474210|JNJ-56136379|jnj-56136379|mesh-list
93155277|NCT04474210|Antiviral Agents|antiviral agents|mesh-ancestor
93155278|NCT04474210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155279|NCT00078767|Sertraline|sertraline|mesh-list
93155280|NCT00078767|Antidepressive Agents|antidepressive agents|mesh-ancestor
93155281|NCT00078767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155282|NCT00078767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93155283|NCT00078767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93155284|NCT00078767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155285|NCT00078767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155286|NCT00078767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155287|NCT00078767|Serotonin Agents|serotonin agents|mesh-ancestor
93155288|NCT00078767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155289|NCT04474288|Antibodies|antibodies|mesh-list
93155290|NCT04474288|Immunologic Factors|immunologic factors|mesh-ancestor
93155291|NCT04474288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155292|NCT00078377|Modafinil|modafinil|mesh-list
93155293|NCT00078377|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93155294|NCT00078377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155295|NCT00078377|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93155296|NCT00078377|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93155297|NCT00078377|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93155298|NCT00078377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155299|NCT01107496|Viloxazine|viloxazine|mesh-list
93155300|NCT01107496|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93155301|NCT01107496|Antidepressive Agents|antidepressive agents|mesh-ancestor
93155302|NCT01107496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155303|NCT01107496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93155304|NCT01107496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93155305|NCT01107496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155306|NCT01107496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155307|NCT01107496|Adrenergic Agents|adrenergic agents|mesh-ancestor
93155308|NCT01107496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155309|NCT01107496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155310|NCT00886600|Losartan|losartan|mesh-list
93155311|NCT00886600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93155312|NCT00886600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93155313|NCT00886600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93155314|NCT00886600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93155315|NCT00886600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93155316|NCT00886600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155317|NCT00886600|Diuretics|diuretics|mesh-ancestor
93155318|NCT00886600|Natriuretic Agents|natriuretic agents|mesh-ancestor
93155319|NCT00886600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155320|NCT00886600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93155321|NCT00886600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155322|NCT02591654|Pembrolizumab|pembrolizumab|mesh-list
93155323|NCT02591654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155324|NCT02591654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155325|NCT02591654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155326|NCT02591654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155327|NCT03134872|Carboplatin|carboplatin|mesh-list
93155328|NCT03134872|Pemetrexed|pemetrexed|mesh-list
93155329|NCT03134872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155330|NCT03134872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155331|NCT03134872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155332|NCT03134872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93155333|NCT03134872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93155334|NCT03952481|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93155335|NCT03952481|Lifitegrast|lifitegrast|mesh-list
93155336|NCT03952481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93155337|NCT05135312|Etanercept|etanercept|mesh-list
93155338|NCT05135312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93155339|NCT05135312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155340|NCT05135312|Analgesics|analgesics|mesh-ancestor
93155341|NCT05135312|Sensory System Agents|sensory system agents|mesh-ancestor
93155342|NCT05135312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155343|NCT05135312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155344|NCT05135312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155345|NCT05135312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155346|NCT05135312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155347|NCT05135312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93155348|NCT05135312|Immunologic Factors|immunologic factors|mesh-ancestor
93155349|NCT00881452|Citric Acid|citric acid|mesh-list
93155350|NCT00881452|Anticoagulants|anticoagulants|mesh-ancestor
93155351|NCT00881452|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93155352|NCT00881452|Chelating Agents|chelating agents|mesh-ancestor
93155353|NCT00881452|Sequestering Agents|sequestering agents|mesh-ancestor
93155354|NCT00881452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155355|NCT03952325|Pembrolizumab|pembrolizumab|mesh-list
93155356|NCT03952325|Nivolumab|nivolumab|mesh-list
93155357|NCT03952325|Atezolizumab|atezolizumab|mesh-list
93155358|NCT03952325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155359|NCT03952325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155360|NCT03952325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155361|NCT03952325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155362|NCT00948142|Linezolid|linezolid|mesh-list
93155363|NCT00948142|Fusidic Acid|fusidic acid|mesh-list
93155364|NCT00948142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155365|NCT00948142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155366|NCT00948142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93155367|NCT00948142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155368|NCT00948142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155369|NCT00947518|Chlorhexidine|chlorhexidine|mesh-list
93155370|NCT00947518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93155371|NCT00947518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155372|NCT00947518|Disinfectants|disinfectants|mesh-ancestor
93155373|NCT00945802|Ciprofloxacin|ciprofloxacin|mesh-list
93155374|NCT00945802|Dexamethasone|dexamethasone|mesh-list
93155375|NCT00945802|Dexamethasone acetate|dexamethasone acetate|mesh-list
93155376|NCT00945802|BB 1101|bb 1101|mesh-list
93155377|NCT00945802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155378|NCT00945802|Antiemetics|antiemetics|mesh-ancestor
93155379|NCT00945802|Autonomic Agents|autonomic agents|mesh-ancestor
93155380|NCT00945802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155381|NCT00945802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155382|NCT00945802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155383|NCT00945802|Glucocorticoids|glucocorticoids|mesh-ancestor
93155384|NCT00945802|Hormones|hormones|mesh-ancestor
93155385|NCT00945802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155386|NCT00945802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155387|NCT00945802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155388|NCT00945802|Protease Inhibitors|protease inhibitors|mesh-ancestor
93155389|NCT00945802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155390|NCT00945802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155391|NCT00945802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155392|NCT00945802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155393|NCT00945802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93155394|NCT00945802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93155395|NCT00945802|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93155396|NCT00945802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93155397|NCT01105624|Azithromycin|azithromycin|mesh-list
93155398|NCT01105624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93155399|NCT01105624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93155400|NCT01105624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155401|NCT01105624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155402|NCT01102660|Naproxen|naproxen|mesh-list
93155403|NCT01102660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93155404|NCT01102660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155405|NCT01102660|Analgesics|analgesics|mesh-ancestor
93155406|NCT01102660|Sensory System Agents|sensory system agents|mesh-ancestor
93155407|NCT01102660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155408|NCT01102660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155409|NCT01102660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155410|NCT01102660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155411|NCT01102660|Gout Suppressants|gout suppressants|mesh-ancestor
93155412|NCT01102660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93155413|NCT01102660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155414|NCT01102660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155415|NCT03135106|Itraconazole|itraconazole|mesh-list
93155416|NCT03135106|Fluconazole|fluconazole|mesh-list
93155417|NCT03135106|Antifungal Agents|antifungal agents|mesh-ancestor
93155418|NCT03135106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155419|NCT03135106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93155420|NCT03135106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93155421|NCT03135106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155422|NCT03135106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155423|NCT03135106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93155424|NCT03135106|Hormone Antagonists|hormone antagonists|mesh-ancestor
93155425|NCT03135106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155426|NCT03135106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155427|NCT03135106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93155428|NCT03135106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93155429|NCT03135106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93155430|NCT00872014|Sorafenib|sorafenib|mesh-list
93155431|NCT00872014|Trebananib|trebananib|mesh-list
93155432|NCT00872014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155433|NCT00872014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93155434|NCT00872014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155435|NCT00872014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155436|NCT00872014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93155437|NCT00872014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93155438|NCT00872014|Growth Substances|growth substances|mesh-ancestor
93155439|NCT00872014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155440|NCT00872014|Growth Inhibitors|growth inhibitors|mesh-ancestor
93155441|NCT00871936|Metformin|metformin|mesh-list
93155442|NCT00871936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155443|NCT00871936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155444|NCT00870688|Valproic Acid|valproic acid|mesh-list
93155445|NCT00870688|Anticonvulsants|anticonvulsants|mesh-ancestor
93155446|NCT00870688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155447|NCT00870688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155448|NCT00870688|GABA Agents|gaba agents|mesh-ancestor
93155449|NCT00870688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155450|NCT00870688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155451|NCT00870688|Antimanic Agents|antimanic agents|mesh-ancestor
93155452|NCT00870688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93155453|NCT00870688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93155454|NCT00870688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155455|NCT00870454|Pregabalin|pregabalin|mesh-list
93155456|NCT00870454|Analgesics|analgesics|mesh-ancestor
93155457|NCT00870454|Sensory System Agents|sensory system agents|mesh-ancestor
93155458|NCT00870454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155459|NCT00870454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155460|NCT00870454|Anticonvulsants|anticonvulsants|mesh-ancestor
93155461|NCT00870454|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93155462|NCT00870454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155463|NCT00870454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155464|NCT00870454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93155465|NCT00870454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93155466|NCT00870454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93155467|NCT00870454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93155468|NCT00870454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155469|NCT05096962|Antibodies|antibodies|mesh-list
93155470|NCT05096962|Immunologic Factors|immunologic factors|mesh-ancestor
93155471|NCT05096962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155472|NCT00869128|Melatonin|melatonin|mesh-list
93155473|NCT00869128|Antioxidants|antioxidants|mesh-ancestor
93155474|NCT00869128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155475|NCT00869128|Protective Agents|protective agents|mesh-ancestor
93155476|NCT00869128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155477|NCT00869128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93155478|NCT00945646|Dexamethasone|dexamethasone|mesh-list
93155479|NCT00945646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155480|NCT00945646|Antiemetics|antiemetics|mesh-ancestor
93155481|NCT00945646|Autonomic Agents|autonomic agents|mesh-ancestor
93155482|NCT00945646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155483|NCT00945646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827691|NCT00737113|Hormones|hormones|mesh-list
93155484|NCT00945646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155485|NCT00945646|Glucocorticoids|glucocorticoids|mesh-ancestor
93155486|NCT00945646|Hormones|hormones|mesh-ancestor
93155487|NCT00945646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155488|NCT00945646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155489|NCT00945646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155490|NCT00077675|Vancomycin|vancomycin|mesh-list
93155491|NCT00077675|Penicillins|penicillins|mesh-list
93155492|NCT00077675|Telavancin|telavancin|mesh-list
93155493|NCT00077675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155494|NCT00077675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155495|NCT00934180|Ondansetron|ondansetron|mesh-list
93155496|NCT00934180|Antiemetics|antiemetics|mesh-ancestor
93155497|NCT00934180|Autonomic Agents|autonomic agents|mesh-ancestor
93155498|NCT00934180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155499|NCT00934180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155500|NCT00934180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155501|NCT00934180|Antipruritics|antipruritics|mesh-ancestor
93155502|NCT00934180|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155503|NCT00934180|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93155504|NCT00934180|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93155505|NCT00934180|Serotonin Agents|serotonin agents|mesh-ancestor
93155506|NCT00934180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155507|NCT00934180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155508|NCT02576444|Olaparib|olaparib|mesh-list
93155509|NCT02576444|Adavosertib|adavosertib|mesh-list
93155510|NCT02576444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93155511|NCT02576444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155512|NCT02576444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155513|NCT02576444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155514|NCT00929968|Fluticasone|fluticasone|mesh-list
93155515|NCT00929968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155516|NCT00929968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93155517|NCT00929968|Autonomic Agents|autonomic agents|mesh-ancestor
93155518|NCT00929968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155519|NCT00929968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155520|NCT00929968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93155521|NCT00929968|Respiratory System Agents|respiratory system agents|mesh-ancestor
93155522|NCT00929968|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155523|NCT00929968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93155524|NCT03957083|Oxytocin|oxytocin|mesh-list
93155525|NCT03957083|Oxytocics|oxytocics|mesh-ancestor
93155526|NCT03957083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93155527|NCT03957083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155528|NCT04945616|Aspirin|aspirin|mesh-list
93155529|NCT04945616|Clopidogrel|clopidogrel|mesh-list
93155530|NCT04945616|Ticagrelor|ticagrelor|mesh-list
92451241|NCT05601154|Fluorides|fluorides|mesh-list
93155531|NCT04945616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93155532|NCT04945616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155533|NCT04945616|Analgesics|analgesics|mesh-ancestor
93155534|NCT04945616|Sensory System Agents|sensory system agents|mesh-ancestor
93155535|NCT04945616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155536|NCT04945616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155537|NCT04945616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155538|NCT04945616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155539|NCT04945616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93155540|NCT04945616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93155541|NCT04945616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155542|NCT04945616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93155543|NCT04945616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93155544|NCT04945616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155545|NCT04945616|Antipyretics|antipyretics|mesh-ancestor
93155546|NCT04945616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93155547|NCT04945616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93155548|NCT04945616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93155549|NCT04945616|Purinergic Agents|purinergic agents|mesh-ancestor
93155550|NCT04945616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155551|NCT04473820|Lidocaine|lidocaine|mesh-list
93155552|NCT04473820|Prilocaine|prilocaine|mesh-list
93155553|NCT04473820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93155554|NCT04473820|Anesthetics, Local|anesthetics, local|mesh-ancestor
93155555|NCT04473820|Anesthetics|anesthetics|mesh-ancestor
93155556|NCT04473820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93155557|NCT04473820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155558|NCT04473820|Sensory System Agents|sensory system agents|mesh-ancestor
93155559|NCT04473820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155560|NCT04473820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93155561|NCT04473820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93155562|NCT04473820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93155563|NCT04473820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155564|NCT04473820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155565|NCT04473820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93155567|NCT05064332|Contraceptive Agents|contraceptive agents|mesh-list
93155568|NCT05064332|Contraceptives, Oral|contraceptives, oral|mesh-list
93155569|NCT05064332|Estradiol|estradiol|mesh-list
93155570|NCT05064332|Estrogens|estrogens|mesh-ancestor
93155571|NCT05064332|Hormones|hormones|mesh-ancestor
93155572|NCT05064332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155573|NCT05064332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155574|NCT05064332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93155575|NCT05064332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93155576|NCT05064332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93155577|NCT05064332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93155578|NCT00855712|Cardioplegic Solutions|cardioplegic solutions|mesh-list
93155579|NCT00855712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93155580|NCT00850174|Oxcarbazepine|oxcarbazepine|mesh-list
93155581|NCT00850174|Anticonvulsants|anticonvulsants|mesh-ancestor
93155582|NCT00850174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93155583|NCT00850174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93155584|NCT00850174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155585|NCT00850174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155586|NCT00850174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93155587|NCT00850174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93155588|NCT00849862|Levetiracetam|levetiracetam|mesh-list
93155589|NCT00849862|Anticonvulsants|anticonvulsants|mesh-ancestor
93155590|NCT00849862|Nootropic Agents|nootropic agents|mesh-ancestor
93155591|NCT00077207|Carboplatin|carboplatin|mesh-list
93155592|NCT00077207|Vincristine|vincristine|mesh-list
93155593|NCT00077207|Temozolomide|temozolomide|mesh-list
93155594|NCT00077207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155595|NCT00077207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93155596|NCT00077207|Tubulin Modulators|tubulin modulators|mesh-ancestor
93155597|NCT00077207|Antimitotic Agents|antimitotic agents|mesh-ancestor
93155598|NCT00077207|Mitosis Modulators|mitosis modulators|mesh-ancestor
93155599|NCT00077207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155600|NCT00077207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93155601|NCT00077207|Alkylating Agents|alkylating agents|mesh-ancestor
93155602|NCT01099085|Simvastatin|simvastatin|mesh-list
93155603|NCT01099085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93155604|NCT01099085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93155605|NCT01099085|Antimetabolites|antimetabolites|mesh-ancestor
93155606|NCT01099085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155607|NCT01099085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93155608|NCT01099085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93155609|NCT01099085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155610|NCT03206918|Zanubrutinib|zanubrutinib|mesh-list
93155611|NCT03206918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155612|NCT03206918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93155613|NCT03206918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155614|NCT03206918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155615|NCT05095064|Irinotecan|irinotecan|mesh-list
93155616|NCT05095064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93155617|NCT05095064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93155618|NCT05095064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155619|NCT05095064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155620|NCT05095064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155621|NCT03169244|Bupropion|bupropion|mesh-list
93155622|NCT03169244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93155623|NCT03169244|Antidepressive Agents|antidepressive agents|mesh-ancestor
93155624|NCT03169244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155625|NCT03169244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93155626|NCT03169244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93155627|NCT03169244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155628|NCT03169244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155629|NCT03169244|Dopamine Agents|dopamine agents|mesh-ancestor
93155630|NCT03169244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827839|NCT02666703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155631|NCT03169244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155632|NCT03169244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93155633|NCT03169244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93155634|NCT03169244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155635|NCT02486042|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93155636|NCT02486042|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93155637|NCT02486042|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93155638|NCT02486042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93155639|NCT00920764|Atrasentan|atrasentan|mesh-list
93155640|NCT00920764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155641|NCT00920764|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93155642|NCT00920764|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93155643|NCT00920764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155644|NCT05376046|Thrombin|thrombin|mesh-list
93155645|NCT05376046|Hemostatics|hemostatics|mesh-ancestor
93155646|NCT05376046|Coagulants|coagulants|mesh-ancestor
93155647|NCT03034304|Carboplatin|carboplatin|mesh-list
93155648|NCT03034304|Gemcitabine|gemcitabine|mesh-list
93155649|NCT03034304|Doxorubicin|doxorubicin|mesh-list
93155650|NCT03034304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93155651|NCT03034304|Ifosfamide|ifosfamide|mesh-list
93155652|NCT03034304|Antibodies|antibodies|mesh-list
93155653|NCT03034304|Immunologic Factors|immunologic factors|mesh-ancestor
93155654|NCT03034304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155655|NCT03034304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155656|NCT03034304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93155657|NCT03034304|Antimetabolites|antimetabolites|mesh-ancestor
93155658|NCT03034304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155659|NCT03034304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93155660|NCT03034304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93155661|NCT03034304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93155662|NCT03034304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155663|NCT03034304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93155664|NCT03034304|Alkylating Agents|alkylating agents|mesh-ancestor
93155665|NCT00914602|Levodopa|levodopa|mesh-list
93155666|NCT00914602|Carbidopa|carbidopa|mesh-list
93155667|NCT00914602|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93155668|NCT00914602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93155669|NCT00914602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93155670|NCT00914602|Dopamine Agents|dopamine agents|mesh-ancestor
93155671|NCT00914602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155672|NCT00914602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155673|NCT00914602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155674|NCT00914602|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93155675|NCT00914602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155676|NCT00914602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93155677|NCT00914602|Immunologic Factors|immunologic factors|mesh-ancestor
93155678|NCT00914602|Dopamine Agonists|dopamine agonists|mesh-ancestor
93155679|NCT00914290|Baclofen|baclofen|mesh-list
93155680|NCT00914290|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93155681|NCT00914290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155682|NCT00914290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93155683|NCT00914290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155684|NCT00914290|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93155685|NCT00914290|GABA Agonists|gaba agonists|mesh-ancestor
93155686|NCT00914290|GABA Agents|gaba agents|mesh-ancestor
93155687|NCT00914290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155688|NCT00914290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155689|NCT00057941|Fulvestrant|fulvestrant|mesh-list
93155690|NCT00057941|Anastrozole|anastrozole|mesh-list
93155691|NCT00057941|Gefitinib|gefitinib|mesh-list
93155692|NCT00057941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155693|NCT00057941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155694|NCT00057941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93155695|NCT00057941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93155696|NCT00057941|Hormone Antagonists|hormone antagonists|mesh-ancestor
93155697|NCT00057941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155698|NCT00057941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155699|NCT00057941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93155700|NCT00057941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155701|NCT00057941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155702|NCT00057941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93155703|NCT00057941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93155704|NCT03005522|Dexamethasone|dexamethasone|mesh-list
92827914|NCT02665845|Mesalamine|mesalamine|mesh-list
93155705|NCT03005522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155706|NCT03005522|Antiemetics|antiemetics|mesh-ancestor
93155707|NCT03005522|Autonomic Agents|autonomic agents|mesh-ancestor
93155708|NCT03005522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155709|NCT03005522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155710|NCT03005522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155711|NCT03005522|Glucocorticoids|glucocorticoids|mesh-ancestor
93155712|NCT03005522|Hormones|hormones|mesh-ancestor
93155713|NCT03005522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155714|NCT03005522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155715|NCT03005522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155716|NCT02998736|Tadalafil|tadalafil|mesh-list
93155717|NCT02998736|Vasodilator Agents|vasodilator agents|mesh-ancestor
93155718|NCT02998736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93155719|NCT02998736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93155720|NCT02998736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155721|NCT02998736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155722|NCT02998736|Urological Agents|urological agents|mesh-ancestor
93155723|NCT00075881|Bortezomib|bortezomib|mesh-list
93155724|NCT00075881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155725|NCT00838630|Cilostazol|cilostazol|mesh-list
93155726|NCT00838630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93155727|NCT00838630|Autonomic Agents|autonomic agents|mesh-ancestor
93155728|NCT00838630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155729|NCT00838630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155730|NCT00838630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93155731|NCT00838630|Respiratory System Agents|respiratory system agents|mesh-ancestor
93155732|NCT00838630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93155733|NCT00838630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93155734|NCT00838630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155735|NCT00838630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93155736|NCT00838630|Vasodilator Agents|vasodilator agents|mesh-ancestor
93155737|NCT00838630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93155738|NCT00838630|Protective Agents|protective agents|mesh-ancestor
93155739|NCT00838630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93155740|NCT00838630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93155741|NCT00838630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155742|NCT02996474|Pembrolizumab|pembrolizumab|mesh-list
93155743|NCT02996474|Decitabine|decitabine|mesh-list
93155744|NCT02996474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155745|NCT02996474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155746|NCT02996474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155747|NCT02996474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155748|NCT02996474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93155749|NCT02996474|Antimetabolites|antimetabolites|mesh-ancestor
93155750|NCT02996474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155751|NCT00821002|Latanoprost|latanoprost|mesh-list
93155752|NCT00821002|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93155753|NCT00821002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93155754|NCT00820924|Lapatinib|lapatinib|mesh-list
93155755|NCT00820924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155756|NCT00820924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93155757|NCT00820924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155758|NCT00820924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155759|NCT00820300|Latanoprost|latanoprost|mesh-list
93155760|NCT00820300|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93155761|NCT00820300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93155762|NCT00814372|Metformin|metformin|mesh-list
93155763|NCT00814372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155764|NCT00814372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155765|NCT03134638|Carboplatin|carboplatin|mesh-list
93155766|NCT03134638|Fulvestrant|fulvestrant|mesh-list
93155767|NCT03134638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155768|NCT03134638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155769|NCT03134638|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93155770|NCT03134638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93155771|NCT03134638|Hormone Antagonists|hormone antagonists|mesh-ancestor
93155772|NCT03134638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155773|NCT03134638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155774|NCT03205046|Acalabrutinib|acalabrutinib|mesh-list
93155775|NCT03205046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155776|NCT04855526|Dronabinol|dronabinol|mesh-list
93155777|NCT04855526|Hallucinogens|hallucinogens|mesh-ancestor
93155778|NCT04855526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827989|NCT00648531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155779|NCT04855526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155780|NCT04855526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155781|NCT04855526|Analgesics|analgesics|mesh-ancestor
93155782|NCT04855526|Sensory System Agents|sensory system agents|mesh-ancestor
93155783|NCT04855526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155784|NCT04855526|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93155785|NCT04855526|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93155786|NCT04855526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155787|NCT04855526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155788|NCT04855526|Hormones|hormones|mesh-ancestor
93155789|NCT04855526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155790|NCT03204812|Durvalumab|durvalumab|mesh-list
93155791|NCT03204812|Ipilimumab|ipilimumab|mesh-list
93155792|NCT03204812|Tremelimumab|tremelimumab|mesh-list
93155793|NCT03204812|Immunoglobulins|immunoglobulins|mesh-list
93155794|NCT03204812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93155795|NCT03204812|Immunoglobulin G|immunoglobulin g|mesh-list
93155796|NCT03204812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155797|NCT03204812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155798|NCT03204812|Immunologic Factors|immunologic factors|mesh-ancestor
93155799|NCT03204812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155800|NCT03204812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155801|NCT03204812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155802|NCT02339090|Hormones|hormones|mesh-list
93155803|NCT02339090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155804|NCT02339090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155805|NCT05442008|Erenumab|erenumab|mesh-list
93155806|NCT05442008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93155807|NCT05442008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155808|NCT05442008|Analgesics|analgesics|mesh-ancestor
93155809|NCT05442008|Sensory System Agents|sensory system agents|mesh-ancestor
93155810|NCT05442008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155811|NCT05442008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155812|NCT03524092|Mirikizumab|mirikizumab|mesh-list
93155813|NCT03524092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93155814|NCT03524092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93155815|NCT03524092|Analgesics|analgesics|mesh-ancestor
93155816|NCT03524092|Sensory System Agents|sensory system agents|mesh-ancestor
93155817|NCT03524092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155818|NCT03524092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155819|NCT03524092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155820|NCT03524092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93155821|NCT03524092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93155822|NCT03524092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155823|NCT03331562|Ergocalciferols|ergocalciferols|mesh-list
93155824|NCT03331562|Pembrolizumab|pembrolizumab|mesh-list
93155825|NCT03331562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93155826|NCT03331562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155827|NCT03331562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93155828|NCT03331562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155829|NCT03331562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93155830|NCT03331562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155831|NCT03331562|Vitamins|vitamins|mesh-ancestor
93155832|NCT03331562|Micronutrients|micronutrients|mesh-ancestor
93155833|NCT03331562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93155834|NCT00814294|Insulin|insulin|mesh-list
93155835|NCT00814294|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93155836|NCT00814294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155837|NCT00814294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155838|NCT02038634|Betamethasone|betamethasone|mesh-list
93155839|NCT02038634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155840|NCT02038634|Glucocorticoids|glucocorticoids|mesh-ancestor
93155841|NCT02038634|Hormones|hormones|mesh-ancestor
93155842|NCT02038634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155843|NCT02038634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155844|NCT02038634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93155845|NCT02038634|Respiratory System Agents|respiratory system agents|mesh-ancestor
93155846|NCT00808288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93155847|NCT00808288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93155848|NCT00808288|Autonomic Agents|autonomic agents|mesh-ancestor
93155849|NCT00808288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155850|NCT00808288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828065|NCT00648999|Ritonavir|ritonavir|mesh-list
93155851|NCT00808288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93155852|NCT00808288|Respiratory System Agents|respiratory system agents|mesh-ancestor
93155853|NCT00808288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93155854|NCT00808288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93155855|NCT00808288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93155856|NCT00808288|Adrenergic Agents|adrenergic agents|mesh-ancestor
93155857|NCT00808288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155858|NCT00808288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155859|NCT03636308|Paclitaxel|paclitaxel|mesh-list
93155860|NCT03636308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93155861|NCT03636308|Gemcitabine|gemcitabine|mesh-list
93155862|NCT03636308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93155863|NCT03636308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155864|NCT03636308|Tubulin Modulators|tubulin modulators|mesh-ancestor
93155865|NCT03636308|Antimitotic Agents|antimitotic agents|mesh-ancestor
93155866|NCT03636308|Mitosis Modulators|mitosis modulators|mesh-ancestor
93155867|NCT03636308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155868|NCT03636308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93155869|NCT03636308|Antimetabolites|antimetabolites|mesh-ancestor
93155870|NCT00836056|Clindamycin|clindamycin|mesh-list
93155871|NCT00836056|Clindamycin palmitate|clindamycin palmitate|mesh-list
93155872|NCT00836056|Clindamycin phosphate|clindamycin phosphate|mesh-list
93155873|NCT00836056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93155874|NCT00836056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155875|NCT00836056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93155876|NCT00836056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155877|NCT00836056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155878|NCT00835666|Finasteride|finasteride|mesh-list
93155879|NCT00835666|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93155880|NCT00835666|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93155881|NCT00835666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155882|NCT00835666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155883|NCT00835666|Hormone Antagonists|hormone antagonists|mesh-ancestor
93155884|NCT00835666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155885|NCT00835666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155886|NCT00835666|Urological Agents|urological agents|mesh-ancestor
93155887|NCT00835588|Pantoprazole|pantoprazole|mesh-list
93155888|NCT00835588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93155889|NCT00835588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155890|NCT00835588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93155891|NCT00835588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928311|NCT02387619|Antimetabolites|antimetabolites|mesh-ancestor
93155892|NCT00835588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155893|NCT00713518|Ranibizumab|ranibizumab|mesh-list
93155894|NCT00713518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93155895|NCT00713518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93155896|NCT00713518|Growth Substances|growth substances|mesh-ancestor
93155897|NCT00713518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155898|NCT00713518|Growth Inhibitors|growth inhibitors|mesh-ancestor
93155899|NCT00713518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155900|NCT04468958|Immunoglobulins|immunoglobulins|mesh-list
93155901|NCT04468958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93155902|NCT04468958|Immunologic Factors|immunologic factors|mesh-ancestor
93155903|NCT04468958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155904|NCT00708292|Dexamethasone|dexamethasone|mesh-list
93155905|NCT00708292|Bortezomib|bortezomib|mesh-list
93155906|NCT00708292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93155907|NCT00708292|Antiemetics|antiemetics|mesh-ancestor
93155908|NCT00708292|Autonomic Agents|autonomic agents|mesh-ancestor
93155909|NCT00708292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93155910|NCT00708292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155911|NCT00708292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155912|NCT00708292|Glucocorticoids|glucocorticoids|mesh-ancestor
93155913|NCT00708292|Hormones|hormones|mesh-ancestor
93155914|NCT00708292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93155915|NCT00708292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93155916|NCT00708292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155917|NCT00790660|Ipragliflozin|ipragliflozin|mesh-list
93155918|NCT00790660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93155919|NCT00790660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155920|NCT00790660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155921|NCT00790660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155922|NCT01330082|Photosensitizing Agents|photosensitizing agents|mesh-list
93155923|NCT01330082|Dermatologic Agents|dermatologic agents|mesh-ancestor
93155924|NCT00835354|Cefprozil|cefprozil|mesh-list
93155926|NCT00835354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93155927|NCT04874480|Decitabine|decitabine|mesh-list
93155928|NCT04874480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93155929|NCT04874480|Antimetabolites|antimetabolites|mesh-ancestor
93155930|NCT04874480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155931|NCT04874480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93155932|NCT04874480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155933|NCT00698230|Metformin|metformin|mesh-list
93155934|NCT00698230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93155935|NCT00698230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155936|NCT01330238|Zoledronic Acid|zoledronic acid|mesh-list
93155937|NCT01330238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93155938|NCT01330238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155939|NCT01330472|Alprazolam|alprazolam|mesh-list
93155940|NCT01330472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93155941|NCT01330472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93155942|NCT01330472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155943|NCT01330472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93155944|NCT01330472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93155945|NCT01330472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155946|NCT01330472|GABA Modulators|gaba modulators|mesh-ancestor
93155947|NCT01330472|GABA Agents|gaba agents|mesh-ancestor
93155948|NCT01330472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155949|NCT01330472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155950|NCT00835276|Fexofenadine|fexofenadine|mesh-list
93155951|NCT00835276|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93155952|NCT00835276|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93155953|NCT00835276|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93155954|NCT00835276|Histamine Antagonists|histamine antagonists|mesh-ancestor
93155955|NCT00835276|Histamine Agents|histamine agents|mesh-ancestor
93155956|NCT00835276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155957|NCT00835276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155958|NCT00835276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155959|NCT04718740|Vitamin K|vitamin k|mesh-list
93155960|NCT04718740|Repaglinide|repaglinide|mesh-list
93155961|NCT04718740|Fluzoparib|fluzoparib|mesh-list
93155962|NCT04718740|Midazolam|midazolam|mesh-list
93155963|NCT04718740|Caffeine|caffeine|mesh-list
93155964|NCT04718740|Bupropion|bupropion|mesh-list
93155965|NCT04718740|Omeprazole|omeprazole|mesh-list
93155966|NCT04718740|Warfarin|warfarin|mesh-list
93155967|NCT04718740|Vitamins|vitamins|mesh-ancestor
93155968|NCT04718740|Micronutrients|micronutrients|mesh-ancestor
93155969|NCT04718740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93155970|NCT04718740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93155971|NCT04718740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93155972|NCT04718740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93155973|NCT04718740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93155974|NCT04718740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93155975|NCT04718740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93155976|NCT04718740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93155977|NCT04718740|Anesthetics, General|anesthetics, general|mesh-ancestor
93155978|NCT04718740|Anesthetics|anesthetics|mesh-ancestor
93155979|NCT04718740|GABA Modulators|gaba modulators|mesh-ancestor
93155980|NCT04718740|GABA Agents|gaba agents|mesh-ancestor
93155981|NCT04718740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93155982|NCT04718740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93155983|NCT04718740|Anticoagulants|anticoagulants|mesh-ancestor
93155984|NCT04718740|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93155985|NCT04718740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93155986|NCT04718740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93155987|NCT04718740|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93155988|NCT04718740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93155989|NCT04718740|Purinergic Agents|purinergic agents|mesh-ancestor
93155990|NCT04718740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93155991|NCT04718740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93155992|NCT04718740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93155993|NCT04718740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93155994|NCT04718740|Antidepressive Agents|antidepressive agents|mesh-ancestor
93155995|NCT04718740|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93155996|NCT04718740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93155997|NCT04718740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93155998|NCT04718740|Dopamine Agents|dopamine agents|mesh-ancestor
92828213|NCT04341129|Sequestering Agents|sequestering agents|mesh-ancestor
93155999|NCT04718740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93156000|NCT04718740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93156001|NCT04718740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93156002|NCT04718740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93156004|NCT04718740|Coagulants|coagulants|mesh-ancestor
93156005|NCT04718740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156006|NCT04718740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93156007|NCT04718740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156008|NCT03344536|Fulvestrant|fulvestrant|mesh-list
93156009|NCT03344536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156010|NCT03344536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156011|NCT03344536|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93156012|NCT03344536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93156013|NCT03344536|Hormone Antagonists|hormone antagonists|mesh-ancestor
93156014|NCT03344536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156015|NCT03344536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156016|NCT01759238|Bevacizumab|bevacizumab|mesh-list
93156017|NCT01759238|Capecitabine|capecitabine|mesh-list
93156018|NCT01759238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156019|NCT01759238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156020|NCT01759238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93156021|NCT01759238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93156022|NCT01759238|Growth Substances|growth substances|mesh-ancestor
93156023|NCT01759238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156024|NCT01759238|Growth Inhibitors|growth inhibitors|mesh-ancestor
93156025|NCT01759238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93156026|NCT01759238|Antimetabolites|antimetabolites|mesh-ancestor
93156027|NCT01759238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156028|NCT00835042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93156029|NCT00835042|Moexipril|moexipril|mesh-list
93156030|NCT00835042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156031|NCT00835042|Diuretics|diuretics|mesh-ancestor
93156032|NCT00835042|Natriuretic Agents|natriuretic agents|mesh-ancestor
93156033|NCT00835042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156034|NCT00835042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93156035|NCT00835042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156036|NCT00835042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156037|NCT00835042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93156038|NCT00835042|Protease Inhibitors|protease inhibitors|mesh-ancestor
93156039|NCT00835042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156040|NCT00834964|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92854989|NCT00906295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93156041|NCT00834964|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93156042|NCT00834964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93156043|NCT00834964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156044|NCT00834964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156045|NCT00834964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156046|NCT00834964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156047|NCT00834964|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93156048|NCT00834964|Antidepressive Agents|antidepressive agents|mesh-ancestor
93156049|NCT00834964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93156050|NCT03070522|Prednisone|prednisone|mesh-list
93156051|NCT03070522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156052|NCT03070522|Glucocorticoids|glucocorticoids|mesh-ancestor
93156053|NCT03070522|Hormones|hormones|mesh-ancestor
93156054|NCT03070522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156055|NCT03070522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156056|NCT03070522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156057|NCT03070522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156058|NCT00834574|Cefdinir|cefdinir|mesh-list
93156059|NCT00834574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156060|NCT00834574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156061|NCT04879966|Infliximab|infliximab|mesh-list
93156062|NCT04879966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93156063|NCT04879966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156064|NCT04879966|Dermatologic Agents|dermatologic agents|mesh-ancestor
93156065|NCT04879966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93156066|NCT04879966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156067|NCT00834418|Leflunomide|leflunomide|mesh-list
93156068|NCT00834418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156069|NCT00834418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156070|NCT00834418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156071|NCT00834418|Immunologic Factors|immunologic factors|mesh-ancestor
93156072|NCT00834418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156074|NCT04621318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93156075|NCT04621318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156076|NCT00834340|Glimepiride|glimepiride|mesh-list
93156077|NCT00834340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93156078|NCT00834340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156079|NCT00834340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156080|NCT00834340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156081|NCT00834340|Immunologic Factors|immunologic factors|mesh-ancestor
93156082|NCT00683722|Remestemcel-l|remestemcel-l|mesh-list
93156083|NCT00683722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156084|NCT00683722|Antiviral Agents|antiviral agents|mesh-ancestor
93156085|NCT00683722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156086|NCT04473274|Pioglitazone|pioglitazone|mesh-list
93156087|NCT04473274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156088|NCT04473274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156089|NCT00679588|Enoxaparin|enoxaparin|mesh-list
93156090|NCT00679588|Semuloparin|semuloparin|mesh-list
93156091|NCT00679588|Enoxaparin sodium|enoxaparin sodium|mesh-list
93156092|NCT00679588|Anticoagulants|anticoagulants|mesh-ancestor
93156093|NCT00679588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93156094|NCT00679588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93156095|NCT00679588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156096|NCT00151996|Guanfacine|guanfacine|mesh-list
93156097|NCT00151996|Methylphenidate|methylphenidate|mesh-list
93156098|NCT00151996|Amphetamine|amphetamine|mesh-list
93156099|NCT00151996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93156100|NCT00151996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156101|NCT00151996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93156102|NCT00151996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93156103|NCT00151996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156104|NCT00151996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156105|NCT00151996|Dopamine Agents|dopamine agents|mesh-ancestor
93156106|NCT00151996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156107|NCT00151996|Sympathomimetics|sympathomimetics|mesh-ancestor
93156108|NCT00151996|Autonomic Agents|autonomic agents|mesh-ancestor
93156109|NCT00151996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156110|NCT00151996|Adrenergic Agents|adrenergic agents|mesh-ancestor
93156111|NCT00151996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93156112|NCT00151996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156113|NCT00151996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93156114|NCT00151996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93156115|NCT00151996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93156116|NCT00830206|Azithromycin|azithromycin|mesh-list
93156117|NCT00830206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156118|NCT00830206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156119|NCT04464070|Aspirin|aspirin|mesh-list
93156120|NCT04464070|Niacin|niacin|mesh-list
93156121|NCT04464070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93156122|NCT04464070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93156123|NCT04464070|Analgesics|analgesics|mesh-ancestor
93156124|NCT04464070|Sensory System Agents|sensory system agents|mesh-ancestor
93156125|NCT04464070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156126|NCT04464070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156127|NCT04464070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156128|NCT04464070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156129|NCT04464070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93156130|NCT04464070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93156131|NCT04464070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156132|NCT04464070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93156133|NCT04464070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93156134|NCT04464070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156135|NCT04464070|Antipyretics|antipyretics|mesh-ancestor
93156136|NCT04464070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93156137|NCT04464070|Antimetabolites|antimetabolites|mesh-ancestor
93156138|NCT04464070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93156139|NCT04464070|Vasodilator Agents|vasodilator agents|mesh-ancestor
93156140|NCT04464070|Vitamin B Complex|vitamin b complex|mesh-ancestor
93156141|NCT04464070|Vitamins|vitamins|mesh-ancestor
93156142|NCT04464070|Micronutrients|micronutrients|mesh-ancestor
93156143|NCT00829504|Ropinirole|ropinirole|mesh-list
93156144|NCT00829504|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93156145|NCT00829504|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93156146|NCT00829504|Dopamine Agonists|dopamine agonists|mesh-ancestor
93156147|NCT00829504|Dopamine Agents|dopamine agents|mesh-ancestor
93156148|NCT00829504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156149|NCT00829504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156150|NCT00829504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156151|NCT00829426|Alprazolam|alprazolam|mesh-list
93156152|NCT00829426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93156153|NCT00829426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93156154|NCT00829426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156155|NCT00829426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93156156|NCT00829426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93156157|NCT00829426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93156158|NCT00829426|GABA Modulators|gaba modulators|mesh-ancestor
93156159|NCT00829426|GABA Agents|gaba agents|mesh-ancestor
93156160|NCT00829426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156161|NCT00829426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156162|NCT00152464|Levocetirizine|levocetirizine|mesh-list
93156163|NCT00152464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93156164|NCT00152464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93156165|NCT00152464|Histamine Antagonists|histamine antagonists|mesh-ancestor
93156166|NCT00152464|Histamine Agents|histamine agents|mesh-ancestor
93156167|NCT00152464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156168|NCT00152464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156169|NCT00152464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156170|NCT00675844|Dexelvucitabine|dexelvucitabine|mesh-list
93156171|NCT00675844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93156172|NCT00675844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93156173|NCT00675844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156174|NCT00675844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156175|NCT00675844|Antiviral Agents|antiviral agents|mesh-ancestor
93156176|NCT00675844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156177|NCT00675844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93156178|NCT00675844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93156179|NCT04472806|Endostar protein|endostar protein|mesh-list
93156180|NCT04472806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93156181|NCT04472806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93156182|NCT04472806|Growth Substances|growth substances|mesh-ancestor
93156183|NCT04472806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156184|NCT04472806|Growth Inhibitors|growth inhibitors|mesh-ancestor
93156185|NCT04472806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156186|NCT00674440|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
93156187|NCT00674440|Dopamine Agents|dopamine agents|mesh-ancestor
93156188|NCT00674440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156189|NCT00674440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156190|NCT00674440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156191|NCT01858948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93156192|NCT01858948|Antidepressive Agents|antidepressive agents|mesh-ancestor
93156193|NCT01858948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93156194|NCT01858948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93156195|NCT01858948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93156196|NCT01858948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93156197|NCT01858948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156198|NCT00770848|Prednisone|prednisone|mesh-list
93156199|NCT00770848|Mitoxantrone|mitoxantrone|mesh-list
93156200|NCT00770848|Rilotumumab|rilotumumab|mesh-list
93156201|NCT00770848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93156202|NCT00770848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156203|NCT00770848|Glucocorticoids|glucocorticoids|mesh-ancestor
93156204|NCT00770848|Hormones|hormones|mesh-ancestor
93156205|NCT00770848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156206|NCT00770848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156207|NCT00770848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156208|NCT00770848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156209|NCT00770848|Analgesics|analgesics|mesh-ancestor
93156210|NCT00770848|Sensory System Agents|sensory system agents|mesh-ancestor
93156211|NCT00770848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156212|NCT00770848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156213|NCT00770848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156214|NCT00770848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156215|NCT00770848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156216|NCT00770848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156217|NCT00770848|Immunologic Factors|immunologic factors|mesh-ancestor
93156218|NCT00672412|Lamivudine|lamivudine|mesh-list
93156219|NCT00672412|Zidovudine|zidovudine|mesh-list
93156220|NCT00672412|Nevirapine|nevirapine|mesh-list
93156221|NCT00672412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93156222|NCT00672412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93156223|NCT00672412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156224|NCT00672412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156225|NCT00672412|Antiviral Agents|antiviral agents|mesh-ancestor
93156226|NCT00672412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156227|NCT00672412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93156228|NCT00672412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93156229|NCT00672412|Antimetabolites|antimetabolites|mesh-ancestor
93156230|NCT00672412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93156231|NCT00672412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93156232|NCT01315262|Sildenafil Citrate|sildenafil citrate|mesh-list
93156233|NCT01315262|Vasodilator Agents|vasodilator agents|mesh-ancestor
93156234|NCT01315262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93156235|NCT01315262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93156236|NCT01315262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156237|NCT01315262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156238|NCT01315262|Urological Agents|urological agents|mesh-ancestor
93156239|NCT03197324|Bexagliflozin|bexagliflozin|mesh-list
93156240|NCT03197324|Digoxin|digoxin|mesh-list
93156241|NCT03197324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93156242|NCT03197324|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93156243|NCT03197324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156244|NCT03197324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156245|NCT03197324|Protective Agents|protective agents|mesh-ancestor
93156246|NCT03197324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156247|NCT03197324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156248|NCT01330706|Polihexanide|polihexanide|mesh-list
93156249|NCT01330706|Disinfectants|disinfectants|mesh-ancestor
93156250|NCT01330706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156251|NCT01156220|Furosemide|furosemide|mesh-list
93156252|NCT01156220|Diuretics|diuretics|mesh-ancestor
93156253|NCT01156220|Natriuretic Agents|natriuretic agents|mesh-ancestor
93156254|NCT01156220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156255|NCT01156220|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93156256|NCT01156220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156257|NCT01156220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156258|NCT03192488|Cetirizine|cetirizine|mesh-list
93156259|NCT03192488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93156260|NCT03192488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93156261|NCT03192488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93156262|NCT03192488|Histamine Antagonists|histamine antagonists|mesh-ancestor
93156263|NCT03192488|Histamine Agents|histamine agents|mesh-ancestor
93156264|NCT03192488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156265|NCT03192488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156266|NCT03192488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156267|NCT01642004|Docetaxel|docetaxel|mesh-list
93156268|NCT01642004|Nivolumab|nivolumab|mesh-list
93156269|NCT01642004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156270|NCT01642004|Tubulin Modulators|tubulin modulators|mesh-ancestor
93156271|NCT01642004|Antimitotic Agents|antimitotic agents|mesh-ancestor
93156272|NCT01642004|Mitosis Modulators|mitosis modulators|mesh-ancestor
93156273|NCT01642004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156274|NCT01642004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156275|NCT01642004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93156276|NCT03907826|Antibodies|antibodies|mesh-list
93156277|NCT03907826|Antibodies, Blocking|antibodies, blocking|mesh-list
93156278|NCT03907826|Immunologic Factors|immunologic factors|mesh-ancestor
93156279|NCT03907826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156280|NCT00042289|Ritonavir|ritonavir|mesh-list
93156281|NCT00042289|Lopinavir|lopinavir|mesh-list
93156282|NCT00042289|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93156283|NCT00042289|Darunavir|darunavir|mesh-list
93156284|NCT00042289|Nelfinavir|nelfinavir|mesh-list
93156285|NCT00042289|Indinavir|indinavir|mesh-list
93156286|NCT00042289|Fosamprenavir|fosamprenavir|mesh-list
93156287|NCT00042289|Amprenavir|amprenavir|mesh-list
93156288|NCT00042289|Tenofovir|tenofovir|mesh-list
93156289|NCT00042289|Emtricitabine|emtricitabine|mesh-list
93156290|NCT00042289|Raltegravir Potassium|raltegravir potassium|mesh-list
93156291|NCT00042289|Nevirapine|nevirapine|mesh-list
93156292|NCT00042289|Dolutegravir|dolutegravir|mesh-list
93156293|NCT00042289|Maraviroc|maraviroc|mesh-list
93156294|NCT00042289|Abacavir|abacavir|mesh-list
93156295|NCT00042289|Didanosine|didanosine|mesh-list
92828508|NCT05551897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156296|NCT00042289|Cobicistat|cobicistat|mesh-list
93156297|NCT00042289|Rilpivirine|rilpivirine|mesh-list
93156298|NCT00042289|Tipranavir|tipranavir|mesh-list
93156299|NCT00042289|Elvitegravir|elvitegravir|mesh-list
93156300|NCT00042289|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
93156301|NCT00042289|Moxifloxacin|moxifloxacin|mesh-list
93156302|NCT00042289|Efavirenz|efavirenz|mesh-list
93156303|NCT00042289|Rifampin|rifampin|mesh-list
93156304|NCT00042289|Isoniazid|isoniazid|mesh-list
93156305|NCT00042289|Linezolid|linezolid|mesh-list
93156306|NCT00042289|Cycloserine|cycloserine|mesh-list
93156307|NCT00042289|Amikacin|amikacin|mesh-list
93156308|NCT00042289|Pyrazinamide|pyrazinamide|mesh-list
93156309|NCT00042289|Ethambutol|ethambutol|mesh-list
93156310|NCT00042289|Bedaquiline|bedaquiline|mesh-list
93156311|NCT00042289|Etravirine|etravirine|mesh-list
93156312|NCT00042289|Clofazimine|clofazimine|mesh-list
93156313|NCT00042289|Ofloxacin|ofloxacin|mesh-list
93156314|NCT00042289|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93156315|NCT00042289|Ethionamide|ethionamide|mesh-list
93156316|NCT00042289|Kanamycin|kanamycin|mesh-list
93156317|NCT00042289|Capreomycin|capreomycin|mesh-list
93156318|NCT00042289|Prothionamide|prothionamide|mesh-list
93156319|NCT00042289|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93156320|NCT00042289|Etonogestrel|etonogestrel|mesh-list
93156321|NCT00042289|Estradiol|estradiol|mesh-list
93156322|NCT00042289|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93156323|NCT00042289|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93156324|NCT00042289|Protease Inhibitors|protease inhibitors|mesh-ancestor
93156325|NCT00042289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156326|NCT00042289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156327|NCT00042289|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93156328|NCT00042289|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93156329|NCT00042289|Antiviral Agents|antiviral agents|mesh-ancestor
93156330|NCT00042289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156331|NCT00042289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93156332|NCT00042289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93156333|NCT00042289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93156334|NCT00042289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93156335|NCT00042289|Estrogens|estrogens|mesh-ancestor
93156336|NCT00042289|Hormones|hormones|mesh-ancestor
93156337|NCT00042289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156338|NCT00042289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156339|NCT00042289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93156340|NCT00042289|Contraceptive Agents|contraceptive agents|mesh-ancestor
93156341|NCT00042289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93156342|NCT00042289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93156343|NCT00042289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156344|NCT00042289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156345|NCT00042289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156346|NCT00042289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156347|NCT00042289|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93156348|NCT00042289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93156349|NCT00042289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93156350|NCT00042289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93156351|NCT00042289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93156352|NCT00042289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93156353|NCT00042289|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93156354|NCT00042289|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93156355|NCT00042289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93156356|NCT00042289|Antitubercular Agents|antitubercular agents|mesh-ancestor
93156357|NCT00042289|Leprostatic Agents|leprostatic agents|mesh-ancestor
93156358|NCT00042289|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93156359|NCT00042289|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93156360|NCT00042289|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93156361|NCT00042289|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93156362|NCT00042289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93156363|NCT00042289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93156364|NCT00042289|Antimetabolites|antimetabolites|mesh-ancestor
93156365|NCT00042289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93156366|NCT00042289|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93156367|NCT00042289|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93156368|NCT00042289|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93156369|NCT00042289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93156370|NCT00042289|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93156371|NCT00042289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156372|NCT00042289|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93156373|NCT00039871|Ribavirin|ribavirin|mesh-list
93156374|NCT00039871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93156375|NCT00039871|Interferon-alpha|interferon-alpha|mesh-list
93156376|NCT00039871|Antimetabolites|antimetabolites|mesh-ancestor
93156377|NCT00039871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156378|NCT00039871|Antiviral Agents|antiviral agents|mesh-ancestor
93156379|NCT00039871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156381|NCT00039871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156382|NCT01096693|Substance P|substance p|mesh-list
93156383|NCT01096693|Neurokinin A|neurokinin a|mesh-list
93156384|NCT01096693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156385|NCT01096693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156386|NCT01096693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156387|NCT00015457|Amlodipine|amlodipine|mesh-list
93156388|NCT00015457|Botulinum Toxins|botulinum toxins|mesh-list
93156389|NCT00015457|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93156390|NCT00015457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156391|NCT00015457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156392|NCT00015457|Cholinergic Agents|cholinergic agents|mesh-ancestor
93156393|NCT00015457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156394|NCT00015457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156395|NCT00015457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156396|NCT00015457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93156397|NCT00015457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93156398|NCT00015457|Vasodilator Agents|vasodilator agents|mesh-ancestor
93156399|NCT03564470|Dasatinib|dasatinib|mesh-list
93156400|NCT03564470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156401|NCT03564470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93156402|NCT03564470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156403|NCT03564470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156404|NCT03191396|Liraglutide|liraglutide|mesh-list
93156405|NCT03191396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156406|NCT03191396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156407|NCT03191396|Incretins|incretins|mesh-ancestor
93156408|NCT03191396|Hormones|hormones|mesh-ancestor
93156409|NCT03191396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156410|NCT03509636|Fluzoparib|fluzoparib|mesh-list
93156411|NCT03509636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93156412|NCT03509636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156413|NCT03509636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156414|NCT03509636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156415|NCT01333670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93156416|NCT00007345|Romidepsin|romidepsin|mesh-list
93156417|NCT00007345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93156418|NCT00007345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156419|NCT00007345|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93156420|NCT00007345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156421|NCT00007345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156422|NCT01584271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93156423|NCT01584271|Carbamide Peroxide|carbamide peroxide|mesh-list
93156424|NCT01584271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156425|NCT01584271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93156426|NCT00031447|Acyclovir|acyclovir|mesh-list
93156427|NCT00031447|Antiviral Agents|antiviral agents|mesh-ancestor
93156428|NCT00031447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156429|NCT00006721|Prednisone|prednisone|mesh-list
93156430|NCT00006721|Cyclophosphamide|cyclophosphamide|mesh-list
93156431|NCT00006721|Rituximab|rituximab|mesh-list
93156432|NCT00006721|Doxorubicin|doxorubicin|mesh-list
93156433|NCT00006721|Vincristine|vincristine|mesh-list
93156434|NCT00006721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156435|NCT00006721|Immunologic Factors|immunologic factors|mesh-ancestor
93156436|NCT00006721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156437|NCT00006721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156438|NCT00006721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93156439|NCT00006721|Alkylating Agents|alkylating agents|mesh-ancestor
93156440|NCT00006721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156441|NCT00006721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156442|NCT00006721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93156443|NCT00006721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156444|NCT00006721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93156445|NCT00006721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156446|NCT00006721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156447|NCT00006721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156448|NCT00006721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156449|NCT00006721|Glucocorticoids|glucocorticoids|mesh-ancestor
93156450|NCT00006721|Hormones|hormones|mesh-ancestor
93156451|NCT00006721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828658|NCT05740657|Alfentanil|alfentanil|mesh-list
93156452|NCT00006721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156453|NCT00006721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93156454|NCT00006721|Tubulin Modulators|tubulin modulators|mesh-ancestor
93156455|NCT00006721|Antimitotic Agents|antimitotic agents|mesh-ancestor
93156456|NCT00006721|Mitosis Modulators|mitosis modulators|mesh-ancestor
93156457|NCT00006289|Neurotropin|neurotropin|mesh-list
93156458|NCT00006289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93156459|NCT00006289|Immunologic Factors|immunologic factors|mesh-ancestor
93156460|NCT00006289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156461|NCT00006289|Analgesics|analgesics|mesh-ancestor
93156462|NCT00006289|Sensory System Agents|sensory system agents|mesh-ancestor
93156463|NCT00006289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156464|NCT00006289|Anticonvulsants|anticonvulsants|mesh-ancestor
93156465|NCT05625841|Propolis|propolis|mesh-list
93156466|NCT05625841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156467|NCT01103401|Tobramycin|tobramycin|mesh-list
93156468|NCT01103401|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93156469|NCT01103401|Dexamethasone|dexamethasone|mesh-list
93156470|NCT01103401|Dexamethasone acetate|dexamethasone acetate|mesh-list
93156471|NCT01103401|Ketorolac|ketorolac|mesh-list
93156472|NCT01103401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93156473|NCT01103401|BB 1101|bb 1101|mesh-list
93156474|NCT01103401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156475|NCT01103401|Antiemetics|antiemetics|mesh-ancestor
93156476|NCT01103401|Autonomic Agents|autonomic agents|mesh-ancestor
93156477|NCT01103401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156478|NCT01103401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156479|NCT01103401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93156480|NCT01103401|Glucocorticoids|glucocorticoids|mesh-ancestor
93156481|NCT01103401|Hormones|hormones|mesh-ancestor
93156482|NCT01103401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156483|NCT01103401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156484|NCT01103401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156485|NCT01103401|Protease Inhibitors|protease inhibitors|mesh-ancestor
93156486|NCT01103401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156487|NCT01103401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156488|NCT01103401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93156489|NCT01103401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93156490|NCT01103401|Analgesics|analgesics|mesh-ancestor
93156491|NCT01103401|Sensory System Agents|sensory system agents|mesh-ancestor
93156492|NCT01103401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156493|NCT01103401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93156494|NCT01103401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156495|NCT01103401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156496|NCT01103401|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93156497|NCT01103401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93156498|NCT00005047|Doxorubicin|doxorubicin|mesh-list
93156499|NCT00005047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93156500|NCT00005047|Methotrexate|methotrexate|mesh-list
93156501|NCT00005047|Vinblastine|vinblastine|mesh-list
93156502|NCT00005047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156503|NCT00005047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93156504|NCT00005047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156505|NCT00005047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156506|NCT00005047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156507|NCT00005047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156508|NCT00005047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93156509|NCT00005047|Abortifacient Agents|abortifacient agents|mesh-ancestor
93156510|NCT00005047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93156511|NCT00005047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156512|NCT00005047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93156513|NCT00005047|Antimetabolites|antimetabolites|mesh-ancestor
93156514|NCT00005047|Dermatologic Agents|dermatologic agents|mesh-ancestor
93156515|NCT00005047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93156516|NCT00005047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156517|NCT00005047|Immunologic Factors|immunologic factors|mesh-ancestor
93156518|NCT00005047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156519|NCT00005047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93156520|NCT00005047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93156521|NCT00005047|Tubulin Modulators|tubulin modulators|mesh-ancestor
93156522|NCT00005047|Antimitotic Agents|antimitotic agents|mesh-ancestor
93156523|NCT00005047|Mitosis Modulators|mitosis modulators|mesh-ancestor
93156524|NCT01103635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93156525|NCT01103635|Ipilimumab|ipilimumab|mesh-list
93156526|NCT01103635|Tremelimumab|tremelimumab|mesh-list
93156527|NCT01103635|Antibodies|antibodies|mesh-list
93156528|NCT01103635|Immunoglobulins|immunoglobulins|mesh-list
93156529|NCT01103635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93156530|NCT01103635|Immunologic Factors|immunologic factors|mesh-ancestor
93156531|NCT01103635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156532|NCT01103635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156533|NCT01103635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93156534|NCT01103635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156535|NCT03949075|Enalapril|enalapril|mesh-list
93156536|NCT03949075|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93156537|NCT03949075|Protease Inhibitors|protease inhibitors|mesh-ancestor
93156538|NCT03949075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156539|NCT03949075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156540|NCT03949075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156541|NCT01101529|Aprepitant|aprepitant|mesh-list
93156542|NCT01101529|Antiemetics|antiemetics|mesh-ancestor
93156543|NCT01101529|Autonomic Agents|autonomic agents|mesh-ancestor
93156544|NCT01101529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156545|NCT01101529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156546|NCT01101529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93156547|NCT01101529|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93156548|NCT01101529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156549|NCT01101529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156550|NCT01100125|Insulin|insulin|mesh-list
93156551|NCT01100125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93156552|NCT01100125|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93156553|NCT01100125|Insulin, Long-Acting|insulin, long-acting|mesh-list
93156554|NCT01100125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156555|NCT01100125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156556|NCT01100125|Incretins|incretins|mesh-ancestor
93156557|NCT01100125|Hormones|hormones|mesh-ancestor
93156558|NCT01100125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156559|NCT01100125|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93156560|NCT01100125|Protease Inhibitors|protease inhibitors|mesh-ancestor
93156561|NCT01100125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156562|NCT01100125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156563|NCT01100203|Eplerenone|eplerenone|mesh-list
93156564|NCT01100203|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93156565|NCT01100203|Hormone Antagonists|hormone antagonists|mesh-ancestor
93156566|NCT01100203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156567|NCT01100203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156568|NCT01100203|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93156569|NCT01100203|Diuretics|diuretics|mesh-ancestor
93156570|NCT01100203|Natriuretic Agents|natriuretic agents|mesh-ancestor
93156571|NCT01100203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156572|NCT03948685|Carvedilol|carvedilol|mesh-list
93156573|NCT03948685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93156574|NCT03948685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93156575|NCT03948685|Adrenergic Agents|adrenergic agents|mesh-ancestor
93156576|NCT03948685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156577|NCT03948685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156578|NCT03948685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156579|NCT03948685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156580|NCT03948685|Antioxidants|antioxidants|mesh-ancestor
93156581|NCT03948685|Protective Agents|protective agents|mesh-ancestor
93156582|NCT03948685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93156583|NCT03948685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156584|NCT03948685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93156585|NCT03948685|Vasodilator Agents|vasodilator agents|mesh-ancestor
93156586|NCT03948685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93156587|NCT03948685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93156588|NCT01585051|Vitamin D|vitamin d|mesh-list
93156589|NCT01585051|Vitamins|vitamins|mesh-ancestor
93156590|NCT01585051|Micronutrients|micronutrients|mesh-ancestor
93156591|NCT01585051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156592|NCT01585051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93156593|NCT01103791|Docetaxel|docetaxel|mesh-list
93156594|NCT01103791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156595|NCT01103791|Tubulin Modulators|tubulin modulators|mesh-ancestor
93156596|NCT01103791|Antimitotic Agents|antimitotic agents|mesh-ancestor
93156597|NCT01103791|Mitosis Modulators|mitosis modulators|mesh-ancestor
93156598|NCT01103791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156599|NCT03800173|Galidesivir|galidesivir|mesh-list
93156600|NCT03800173|Antiviral Agents|antiviral agents|mesh-ancestor
93156601|NCT03800173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156602|NCT00003631|Cytarabine|cytarabine|mesh-list
93156603|NCT00003631|Cyclophosphamide|cyclophosphamide|mesh-list
93156604|NCT00003631|Melphalan|melphalan|mesh-list
93156605|NCT00003631|Ifosfamide|ifosfamide|mesh-list
93156606|NCT00003631|Carmustine|carmustine|mesh-list
93156607|NCT00003631|Carboplatin|carboplatin|mesh-list
93156608|NCT00003631|Etoposide|etoposide|mesh-list
93156609|NCT00003631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156610|NCT00003631|Immunologic Factors|immunologic factors|mesh-ancestor
93156611|NCT00003631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156612|NCT00003631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156613|NCT00003631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93156614|NCT00003631|Alkylating Agents|alkylating agents|mesh-ancestor
93156615|NCT00003631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156616|NCT00003631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156617|NCT00003631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93156618|NCT00003631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93156619|NCT00003631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156620|NCT00003631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156621|NCT00003631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156622|NCT00003631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93156623|NCT00003631|Antimetabolites|antimetabolites|mesh-ancestor
93156624|NCT00003631|Antiviral Agents|antiviral agents|mesh-ancestor
93156625|NCT00003631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156626|NCT01101685|Escitalopram|escitalopram|mesh-list
93156627|NCT01101685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93156628|NCT01101685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93156629|NCT01101685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156630|NCT01101685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156631|NCT01101685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156632|NCT01101685|Serotonin Agents|serotonin agents|mesh-ancestor
93156633|NCT01101685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156634|NCT00030901|Selenium|selenium|mesh-list
93156635|NCT00030901|Antioxidants|antioxidants|mesh-ancestor
93156636|NCT00030901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156637|NCT00030901|Protective Agents|protective agents|mesh-ancestor
93156638|NCT00030901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156639|NCT00030901|Trace Elements|trace elements|mesh-ancestor
93156640|NCT00030901|Micronutrients|micronutrients|mesh-ancestor
93156641|NCT01104259|Vinorelbine|vinorelbine|mesh-list
93156642|NCT01104259|Veliparib|veliparib|mesh-list
93156643|NCT01104259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156644|NCT01104259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93156645|NCT01104259|Tubulin Modulators|tubulin modulators|mesh-ancestor
93156646|NCT01104259|Antimitotic Agents|antimitotic agents|mesh-ancestor
93156647|NCT01104259|Mitosis Modulators|mitosis modulators|mesh-ancestor
93156648|NCT01104259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156649|NCT01104259|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93156650|NCT01104259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156651|NCT01104337|Acetaminophen|acetaminophen|mesh-list
93156652|NCT01104337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93156653|NCT01104337|Analgesics|analgesics|mesh-ancestor
93156654|NCT01104337|Sensory System Agents|sensory system agents|mesh-ancestor
93156655|NCT01104337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156656|NCT01104337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156657|NCT01104337|Antipyretics|antipyretics|mesh-ancestor
93156658|NCT01100359|Carboplatin|carboplatin|mesh-list
93156659|NCT01100359|Doxorubicin|doxorubicin|mesh-list
93156660|NCT01100359|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93156661|NCT01100359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156662|NCT01100359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93156663|NCT01100359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156664|NCT01100359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156665|NCT01100359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156666|NCT01100359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156667|NCT00003199|Tamoxifen|tamoxifen|mesh-list
93156668|NCT00003199|Aldesleukin|aldesleukin|mesh-list
93156669|NCT00003199|Melphalan|melphalan|mesh-list
93156670|NCT00003199|Busulfan|busulfan|mesh-list
93156671|NCT00003199|Thiotepa|thiotepa|mesh-list
93156672|NCT00003199|Interleukin-2|interleukin-2|mesh-list
93156673|NCT00003199|Sargramostim|sargramostim|mesh-list
93156674|NCT00003199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156675|NCT00003199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93156676|NCT00003199|Alkylating Agents|alkylating agents|mesh-ancestor
93156677|NCT00003199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156678|NCT00003199|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92828884|NCT02864264|Interferons|interferons|mesh-list
93156679|NCT00003199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156680|NCT00003199|Immunologic Factors|immunologic factors|mesh-ancestor
93156681|NCT00003199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156682|NCT00003199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93156683|NCT00003199|Analgesics|analgesics|mesh-ancestor
93156684|NCT00003199|Sensory System Agents|sensory system agents|mesh-ancestor
93156685|NCT00003199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156686|NCT00003199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93156687|NCT00003199|Hormone Antagonists|hormone antagonists|mesh-ancestor
93156688|NCT00003199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156689|NCT00003199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156690|NCT00003199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93156691|NCT00003199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93156692|NCT00003199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93156693|NCT00003199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93156694|NCT00003199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93156695|NCT00003199|Antiviral Agents|antiviral agents|mesh-ancestor
93156696|NCT00003199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156697|NCT01327261|Levodopa|levodopa|mesh-list
93156698|NCT01327261|Benserazide|benserazide|mesh-list
93156699|NCT01327261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93156700|NCT01327261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93156701|NCT01327261|Dopamine Agents|dopamine agents|mesh-ancestor
93156702|NCT01327261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156703|NCT01327261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156704|NCT01327261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156705|NCT01327261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156706|NCT01101919|Tofacitinib|tofacitinib|mesh-list
93156707|NCT01101919|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93156708|NCT01101919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93156709|NCT01101919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156710|NCT01101919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156711|NCT03951415|Durvalumab|durvalumab|mesh-list
93156712|NCT03951415|Olaparib|olaparib|mesh-list
93156713|NCT03951415|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93156714|NCT03951415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156715|NCT03951415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156716|NCT03951415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117822|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156717|NCT03951415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156718|NCT00001849|Edetic Acid|edetic acid|mesh-list
93156719|NCT00001849|Pentetic Acid|pentetic acid|mesh-list
93156720|NCT00001849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156721|NCT00001849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156722|NCT00001849|Antidotes|antidotes|mesh-ancestor
93156723|NCT00001849|Protective Agents|protective agents|mesh-ancestor
93156724|NCT00001849|Chelating Agents|chelating agents|mesh-ancestor
93156725|NCT00001849|Sequestering Agents|sequestering agents|mesh-ancestor
93156726|NCT00001849|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93156727|NCT00001849|Anticoagulants|anticoagulants|mesh-ancestor
93156728|NCT00001849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93156729|NCT01104571|Trastuzumab|trastuzumab|mesh-list
93156730|NCT01104571|Lapatinib|lapatinib|mesh-list
93156731|NCT01104571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156732|NCT01104571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156733|NCT01104571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93156734|NCT01104571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156735|NCT01104571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156736|NCT01104649|Riluzole|riluzole|mesh-list
93156737|NCT01104649|Anticonvulsants|anticonvulsants|mesh-ancestor
93156738|NCT01104649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93156739|NCT01104649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93156740|NCT01104649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156741|NCT01104649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156742|NCT01104649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156743|NCT01104649|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93156744|NCT01104649|Protective Agents|protective agents|mesh-ancestor
93156745|NCT01327729|Interferons|interferons|mesh-list
93156746|NCT01327729|Interferon-alpha|interferon-alpha|mesh-list
93156747|NCT01327729|Interferon alpha-2|interferon alpha-2|mesh-list
93156748|NCT01327729|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93156749|NCT01327729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156750|NCT01327729|Antiviral Agents|antiviral agents|mesh-ancestor
93156751|NCT01327729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156752|NCT01327729|Immunologic Factors|immunologic factors|mesh-ancestor
93156753|NCT01327729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156755|NCT01342952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156756|NCT01104883|Iodine|iodine|mesh-list
93156757|NCT01104883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93156758|NCT01104883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156759|NCT01104883|Trace Elements|trace elements|mesh-ancestor
93156760|NCT01104883|Micronutrients|micronutrients|mesh-ancestor
93156761|NCT01104883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156762|NCT01104961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93156763|NCT04371380|Rilpivirine|rilpivirine|mesh-list
93156764|NCT04371380|Cabotegravir|cabotegravir|mesh-list
93156765|NCT04371380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93156766|NCT04371380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93156767|NCT04371380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156768|NCT04371380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156769|NCT04371380|Antiviral Agents|antiviral agents|mesh-ancestor
93156770|NCT04371380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156771|NCT04371380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93156772|NCT04371380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93156773|NCT04371380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93156774|NCT04371380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93156775|NCT01341080|Varenicline|varenicline|mesh-list
93156776|NCT01341080|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93156777|NCT01341080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93156778|NCT01341080|Cholinergic Agents|cholinergic agents|mesh-ancestor
93156779|NCT01341080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156780|NCT01341080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156781|NCT01341080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156782|NCT01333982|Amoxicillin|amoxicillin|mesh-list
93156783|NCT01333982|Gentamicins|gentamicins|mesh-list
93156784|NCT01333982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156785|NCT01333982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156786|NCT01333982|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93156787|NCT01333982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156788|NCT01333982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156789|NCT01334060|Vaccines|vaccines|mesh-list
93156790|NCT01334060|Immunologic Factors|immunologic factors|mesh-ancestor
93156791|NCT01334060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156792|NCT04130828|Ferrous fumarate|ferrous fumarate|mesh-list
93156793|NCT04130828|Trace Elements|trace elements|mesh-ancestor
93156794|NCT04130828|Micronutrients|micronutrients|mesh-ancestor
93156795|NCT04130828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156796|NCT01332344|Fluticasone|fluticasone|mesh-list
93156797|NCT01332344|Xhance|xhance|mesh-list
93156798|NCT01332344|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93156799|NCT01332344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156800|NCT01332344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93156801|NCT01332344|Autonomic Agents|autonomic agents|mesh-ancestor
93156802|NCT01332344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156803|NCT01332344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156804|NCT01332344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93156805|NCT01332344|Respiratory System Agents|respiratory system agents|mesh-ancestor
93156806|NCT01332344|Dermatologic Agents|dermatologic agents|mesh-ancestor
93156807|NCT01332344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93156808|NCT01332344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93156809|NCT01332344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93156810|NCT01332344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93156811|NCT01332344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93156812|NCT01332344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156813|NCT01332344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156814|NCT01112306|Selexipag|selexipag|mesh-list
93156815|NCT01112306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93156816|NCT01332422|Fluticasone|fluticasone|mesh-list
93156817|NCT01332422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93156818|NCT01332422|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93156819|NCT01332422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156820|NCT01332422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93156821|NCT01332422|Autonomic Agents|autonomic agents|mesh-ancestor
93156822|NCT01332422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156823|NCT01332422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156824|NCT01332422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93156825|NCT01332422|Respiratory System Agents|respiratory system agents|mesh-ancestor
93156826|NCT01332422|Dermatologic Agents|dermatologic agents|mesh-ancestor
93156827|NCT01332422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93156828|NCT01332422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93156829|NCT01332422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93156830|NCT01332422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93156831|NCT01332422|Adrenergic Agents|adrenergic agents|mesh-ancestor
93156832|NCT01332422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156833|NCT01332422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156835|NCT01332422|Hormones|hormones|mesh-ancestor
93156836|NCT01332422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156837|NCT01332422|Sympathomimetics|sympathomimetics|mesh-ancestor
93156838|NCT03162224|Durvalumab|durvalumab|mesh-list
93156839|NCT03162224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156840|NCT03162224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156841|NCT00904046|Pioglitazone|pioglitazone|mesh-list
93156842|NCT00904046|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93156843|NCT00904046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156844|NCT00904046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156845|NCT01332734|Magnesium Sulfate|magnesium sulfate|mesh-list
93156846|NCT01332734|Analgesics|analgesics|mesh-ancestor
93156847|NCT01332734|Sensory System Agents|sensory system agents|mesh-ancestor
93156848|NCT01332734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156849|NCT01332734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156850|NCT01332734|Anesthetics|anesthetics|mesh-ancestor
93156851|NCT01332734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93156852|NCT01332734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93156853|NCT01332734|Anticonvulsants|anticonvulsants|mesh-ancestor
93156854|NCT01332734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93156855|NCT01332734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156856|NCT01332734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156857|NCT01332734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93156858|NCT01332734|Tocolytic Agents|tocolytic agents|mesh-ancestor
93156859|NCT01332734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93156860|NCT03326492|Antivenins|antivenins|mesh-list
93156861|NCT03326492|Immunologic Factors|immunologic factors|mesh-ancestor
93156862|NCT03326492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156863|NCT01524536|Prednisone|prednisone|mesh-list
93156864|NCT01524536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156865|NCT01524536|Glucocorticoids|glucocorticoids|mesh-ancestor
93156866|NCT01524536|Hormones|hormones|mesh-ancestor
92854995|NCT00906295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156867|NCT01524536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156868|NCT01524536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156869|NCT01524536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156870|NCT01524536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156871|NCT00533468|Lidocaine|lidocaine|mesh-list
93156872|NCT00533468|Anesthetics, Local|anesthetics, local|mesh-ancestor
93156873|NCT00533468|Anesthetics|anesthetics|mesh-ancestor
93156874|NCT00533468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93156875|NCT00533468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156876|NCT00533468|Sensory System Agents|sensory system agents|mesh-ancestor
93156877|NCT00533468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156878|NCT00533468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93156879|NCT00533468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93156880|NCT00533468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93156881|NCT00533468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93156882|NCT00533468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156883|NCT01333124|Gemcitabine|gemcitabine|mesh-list
93156884|NCT01333124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93156885|NCT01333124|Antimetabolites|antimetabolites|mesh-ancestor
93156886|NCT01333124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156887|NCT01333124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156888|NCT03035630|Sunitinib|sunitinib|mesh-list
93156889|NCT03035630|Avelumab|avelumab|mesh-list
93156890|NCT03035630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156891|NCT03035630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93156892|NCT03035630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93156893|NCT03035630|Growth Substances|growth substances|mesh-ancestor
93156894|NCT03035630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156895|NCT03035630|Growth Inhibitors|growth inhibitors|mesh-ancestor
93156896|NCT03035630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93156897|NCT03035630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156898|NCT03035630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156899|NCT03035630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156900|NCT00004124|Prednisone|prednisone|mesh-list
93156901|NCT00004124|Goserelin|goserelin|mesh-list
93156902|NCT00004124|Mitoxantrone|mitoxantrone|mesh-list
93156903|NCT00004124|Bicalutamide|bicalutamide|mesh-list
93156904|NCT00004124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156905|NCT00004124|Glucocorticoids|glucocorticoids|mesh-ancestor
93156906|NCT00004124|Hormones|hormones|mesh-ancestor
93156907|NCT00004124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156908|NCT00004124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156909|NCT00004124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93156910|NCT00004124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156911|NCT00004124|Analgesics|analgesics|mesh-ancestor
93156912|NCT00004124|Sensory System Agents|sensory system agents|mesh-ancestor
93156913|NCT00004124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156914|NCT00004124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93156915|NCT00004124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93156916|NCT00004124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156917|NCT00004124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156918|NCT00004124|Androgen Antagonists|androgen antagonists|mesh-ancestor
93156919|NCT00004124|Hormone Antagonists|hormone antagonists|mesh-ancestor
93156920|NCT01333358|Alemtuzumab|alemtuzumab|mesh-list
93156921|NCT01333358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93156922|NCT01333358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156923|NCT01334684|Metformin|metformin|mesh-list
93156924|NCT01334684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93156925|NCT01334684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156926|NCT01334762|Letrozole|letrozole|mesh-list
93156927|NCT01334762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156928|NCT01334762|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93156929|NCT01334762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93156930|NCT01334762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156931|NCT01334762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156932|NCT01334762|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93156933|NCT01334762|Hormone Antagonists|hormone antagonists|mesh-ancestor
93156934|NCT01334762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93156935|NCT01334762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156936|NCT00383552|Mometasone Furoate|mometasone furoate|mesh-list
93156937|NCT00383552|Formoterol Fumarate|formoterol fumarate|mesh-list
93156938|NCT00383552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93156939|NCT00383552|Autonomic Agents|autonomic agents|mesh-ancestor
93156940|NCT00383552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156941|NCT00383552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156942|NCT00383552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93156943|NCT00383552|Respiratory System Agents|respiratory system agents|mesh-ancestor
93156944|NCT00383552|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93156945|NCT00383552|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93156946|NCT00383552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93156947|NCT00383552|Adrenergic Agents|adrenergic agents|mesh-ancestor
93156948|NCT00383552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93156949|NCT00383552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156950|NCT00383552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156951|NCT00383552|Dermatologic Agents|dermatologic agents|mesh-ancestor
93156952|NCT00383552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93156953|NCT01335074|Sirolimus|sirolimus|mesh-list
93156954|NCT01335074|Sorafenib|sorafenib|mesh-list
93156955|NCT01335074|Temsirolimus|temsirolimus|mesh-list
93156956|NCT01335074|MTOR Inhibitors|mtor inhibitors|mesh-list
93156957|NCT01335074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156958|NCT01335074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93156959|NCT01335074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156960|NCT01335074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156961|NCT01335074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93156962|NCT01335074|Immunologic Factors|immunologic factors|mesh-ancestor
93156963|NCT01335074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156964|NCT01335074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93156965|NCT01335074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156966|NCT01335074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93156967|NCT01335074|Antifungal Agents|antifungal agents|mesh-ancestor
93156968|NCT01337492|Sorafenib|sorafenib|mesh-list
93156969|NCT01337492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93156970|NCT01337492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93156971|NCT01337492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156972|NCT01337492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156973|NCT01337570|Dapivirine|dapivirine|mesh-list
93156974|NCT01337570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93156975|NCT01337570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92829163|NCT04283240|Urological Agents|urological agents|mesh-ancestor
93156976|NCT01337570|Antiviral Agents|antiviral agents|mesh-ancestor
93156977|NCT01337570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93156979|NCT01337804|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
93156980|NCT01337804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93156981|NCT01337804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93156982|NCT01337804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93156983|NCT01337804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93156984|NCT01337804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156985|NCT01776424|Aspirin|aspirin|mesh-list
93156986|NCT01776424|Pantoprazole|pantoprazole|mesh-list
93156987|NCT01776424|Rivaroxaban|rivaroxaban|mesh-list
93156988|NCT01776424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93156989|NCT01776424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93156990|NCT01776424|Analgesics|analgesics|mesh-ancestor
93156991|NCT01776424|Sensory System Agents|sensory system agents|mesh-ancestor
93156992|NCT01776424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93156993|NCT01776424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93156994|NCT01776424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93156995|NCT01776424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93156996|NCT01776424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93156997|NCT01776424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93156998|NCT01776424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93156999|NCT01776424|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93157000|NCT01776424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93157001|NCT01776424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157002|NCT01776424|Antipyretics|antipyretics|mesh-ancestor
93157003|NCT01776424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93157004|NCT01776424|Antithrombins|antithrombins|mesh-ancestor
93157005|NCT01776424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93157006|NCT01776424|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157007|NCT01776424|Anticoagulants|anticoagulants|mesh-ancestor
93157008|NCT01776424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93157009|NCT01776424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93157010|NCT01776424|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93157011|NCT00642148|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93157012|NCT00642148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157013|NCT00642148|Autonomic Agents|autonomic agents|mesh-ancestor
93157014|NCT00642148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157015|NCT00642148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157016|NCT00642148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157017|NCT00642148|Respiratory System Agents|respiratory system agents|mesh-ancestor
93157018|NCT00642148|Glucocorticoids|glucocorticoids|mesh-ancestor
93157019|NCT00642148|Hormones|hormones|mesh-ancestor
93157020|NCT00642148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157021|NCT00642148|Sympathomimetics|sympathomimetics|mesh-ancestor
93157022|NCT00629980|Azithromycin|azithromycin|mesh-list
93157023|NCT00629980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157024|NCT00629980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157025|NCT00629590|Azithromycin|azithromycin|mesh-list
93157026|NCT00629590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157027|NCT00629590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157028|NCT00626704|Doxorubicin|doxorubicin|mesh-list
93157029|NCT00626704|Conatumumab|conatumumab|mesh-list
93157030|NCT00626704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93157031|NCT00626704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157032|NCT00626704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93157033|NCT00626704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93157034|NCT00626704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157035|NCT00626704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157036|NCT00626704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93157037|NCT00765700|Ketoprofen|ketoprofen|mesh-list
93157038|NCT00765700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93157039|NCT00765700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93157040|NCT00765700|Analgesics|analgesics|mesh-ancestor
93157041|NCT00765700|Sensory System Agents|sensory system agents|mesh-ancestor
93157042|NCT00765700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157043|NCT00765700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157044|NCT00765700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157045|NCT00765700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157046|NCT00765700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93157047|NCT00765700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157048|NCT00765700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157049|NCT02280694|Celecoxib|celecoxib|mesh-list
93157050|NCT02280694|Cyclophosphamide|cyclophosphamide|mesh-list
93157051|NCT02280694|Capecitabine|capecitabine|mesh-list
93157052|NCT02280694|Methotrexate|methotrexate|mesh-list
93157053|NCT02280694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157054|NCT02280694|Immunologic Factors|immunologic factors|mesh-ancestor
93157055|NCT02280694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157056|NCT02280694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157057|NCT02280694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93157058|NCT02280694|Alkylating Agents|alkylating agents|mesh-ancestor
93157059|NCT02280694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157060|NCT02280694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157061|NCT02280694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93157062|NCT02280694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93157063|NCT02280694|Antimetabolites|antimetabolites|mesh-ancestor
93157064|NCT02280694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93157065|NCT02280694|Abortifacient Agents|abortifacient agents|mesh-ancestor
93157066|NCT02280694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93157067|NCT02280694|Dermatologic Agents|dermatologic agents|mesh-ancestor
93157068|NCT02280694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157069|NCT02280694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93157070|NCT02280694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93157071|NCT02280694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93157072|NCT02280694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93157073|NCT02280694|Analgesics|analgesics|mesh-ancestor
93157074|NCT02280694|Sensory System Agents|sensory system agents|mesh-ancestor
93157075|NCT02280694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157076|NCT02280694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157077|NCT02280694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93157078|NCT02280694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93157079|NCT02280772|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93157080|NCT02280772|Cathartics|cathartics|mesh-ancestor
93157081|NCT02280772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93157082|NCT02280850|Nitroglycerin|nitroglycerin|mesh-list
93157083|NCT02280850|Vasodilator Agents|vasodilator agents|mesh-ancestor
93157084|NCT00799864|Tenofovir|tenofovir|mesh-list
93157085|NCT00799864|Lamivudine|lamivudine|mesh-list
93157086|NCT00799864|Emtricitabine|emtricitabine|mesh-list
93157087|NCT00799864|Zidovudine|zidovudine|mesh-list
93157088|NCT00799864|Abacavir|abacavir|mesh-list
93157089|NCT00799864|Rilpivirine|rilpivirine|mesh-list
93157090|NCT00799864|Antiviral Agents|antiviral agents|mesh-ancestor
93157091|NCT00799864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157092|NCT00799864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93157093|NCT00799864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93157094|NCT00799864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157095|NCT00799864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157096|NCT00799864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93157097|NCT00799864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93157098|NCT00799864|Antimetabolites|antimetabolites|mesh-ancestor
93157099|NCT02281006|Sodium thiosulfate|sodium thiosulfate|mesh-list
93157100|NCT02281006|Antidotes|antidotes|mesh-ancestor
93157101|NCT02281006|Protective Agents|protective agents|mesh-ancestor
93157102|NCT02281006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157103|NCT02281006|Antioxidants|antioxidants|mesh-ancestor
93157104|NCT02281006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157105|NCT02281006|Antitubercular Agents|antitubercular agents|mesh-ancestor
93157106|NCT02281006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157107|NCT02281006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157108|NCT02281006|Chelating Agents|chelating agents|mesh-ancestor
93157109|NCT02281006|Sequestering Agents|sequestering agents|mesh-ancestor
93157110|NCT00758290|Triclosan|triclosan|mesh-list
93157111|NCT00758290|Fluorides|fluorides|mesh-list
93157112|NCT00758290|Cariostatic Agents|cariostatic agents|mesh-ancestor
93157113|NCT00758290|Protective Agents|protective agents|mesh-ancestor
93157114|NCT00758290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157115|NCT00758290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93157116|NCT00758290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157117|NCT00758290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93157118|NCT00758290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93157119|NCT00758290|Antimetabolites|antimetabolites|mesh-ancestor
93157120|NCT00758290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157121|NCT00758290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93157122|NCT03799627|Epoetin Alfa|epoetin alfa|mesh-list
93157123|NCT03799627|Glycine|glycine|mesh-list
93157124|NCT03799627|Hematinics|hematinics|mesh-ancestor
93157125|NCT03799627|Glycine Agents|glycine agents|mesh-ancestor
93157126|NCT03799627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157127|NCT03799627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157128|NCT03799627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157129|NCT02274142|Methamphetamine|methamphetamine|mesh-list
93157130|NCT02274142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93157131|NCT02274142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157132|NCT02274142|Sympathomimetics|sympathomimetics|mesh-ancestor
93157133|NCT02274142|Autonomic Agents|autonomic agents|mesh-ancestor
93157134|NCT02274142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157135|NCT02274142|Dopamine Agents|dopamine agents|mesh-ancestor
93157136|NCT02274142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157137|NCT02274142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157138|NCT02274142|Adrenergic Agents|adrenergic agents|mesh-ancestor
93157139|NCT02274142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93157140|NCT02274142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93157141|NCT02274142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157142|NCT02274142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93157143|NCT00752050|Botulinum Toxins|botulinum toxins|mesh-list
93157144|NCT00752050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93157145|NCT00752050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93157146|NCT00752050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93157147|NCT00752050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157148|NCT00752050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157149|NCT00752050|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157150|NCT00752050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157151|NCT00752050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157152|NCT00752050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93157153|NCT00752050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157154|NCT02276014|Beta Carotene|beta carotene|mesh-list
93157155|NCT02276014|Carotenoids|carotenoids|mesh-list
93157156|NCT02276014|Antioxidants|antioxidants|mesh-ancestor
93157157|NCT02276014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157158|NCT02276014|Protective Agents|protective agents|mesh-ancestor
93157159|NCT02276014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157160|NCT02276014|Provitamins|provitamins|mesh-ancestor
93157161|NCT02276014|Vitamins|vitamins|mesh-ancestor
93157162|NCT02276014|Micronutrients|micronutrients|mesh-ancestor
93157163|NCT01102387|Octenidine|octenidine|mesh-list
93157164|NCT01102387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157165|NCT01102387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93157166|NCT02277808|Amikacin|amikacin|mesh-list
93157167|NCT02277808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157168|NCT02277808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157169|NCT02281240|Oprelvekin|oprelvekin|mesh-list
93157170|NCT02281240|Heparin|heparin|mesh-list
93157171|NCT02281240|Anticoagulants|anticoagulants|mesh-ancestor
93157172|NCT02281240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93157173|NCT02281240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93157174|NCT02281240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157175|NCT02281240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157176|NCT01102465|Losartan|losartan|mesh-list
93157177|NCT01102465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93157178|NCT01102465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93157179|NCT01102465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93157180|NCT01102465|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93157181|NCT01102465|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93157182|NCT01102465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157183|NCT01102465|Diuretics|diuretics|mesh-ancestor
93157184|NCT01102465|Natriuretic Agents|natriuretic agents|mesh-ancestor
93157185|NCT01102465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157186|NCT01102465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93157187|NCT01102465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157188|NCT01105819|Chlorhexidine|chlorhexidine|mesh-list
93157189|NCT01105819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93157190|NCT01105819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157191|NCT01105819|Disinfectants|disinfectants|mesh-ancestor
93157192|NCT00749632|Mandelic Acids|mandelic acids|mesh-list
93157193|NCT00749632|Oxybutynin|oxybutynin|mesh-list
93157194|NCT00749632|Parasympatholytics|parasympatholytics|mesh-ancestor
93157195|NCT00749632|Autonomic Agents|autonomic agents|mesh-ancestor
93157196|NCT00749632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157197|NCT00749632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157198|NCT00749632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93157199|NCT00749632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93157200|NCT00749632|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157201|NCT00749632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157202|NCT00749632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157203|NCT00749632|Urological Agents|urological agents|mesh-ancestor
93157204|NCT00749632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93157205|NCT00749632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157206|NCT01105273|Cyclophosphamide|cyclophosphamide|mesh-list
93157207|NCT01105273|Fludarabine|fludarabine|mesh-list
93157208|NCT01105273|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93157209|NCT01105273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157210|NCT01105273|Immunologic Factors|immunologic factors|mesh-ancestor
93157211|NCT01105273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157212|NCT01105273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157213|NCT01105273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93157214|NCT01105273|Alkylating Agents|alkylating agents|mesh-ancestor
93157215|NCT01105273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157216|NCT01105273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157217|NCT01105273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93157218|NCT05215327|Vaccines|vaccines|mesh-list
93157219|NCT05215327|Immunologic Factors|immunologic factors|mesh-ancestor
93157220|NCT05215327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157221|NCT00743938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93157222|NCT00743938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157223|NCT00743938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93157224|NCT00743938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157225|NCT00743938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157226|NCT00662740|Tiotropium Bromide|tiotropium bromide|mesh-list
93157227|NCT00662740|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93157228|NCT00662740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157229|NCT00662740|Autonomic Agents|autonomic agents|mesh-ancestor
93157230|NCT00662740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157231|NCT00662740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157232|NCT00662740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157233|NCT00662740|Respiratory System Agents|respiratory system agents|mesh-ancestor
93157234|NCT00662740|Parasympatholytics|parasympatholytics|mesh-ancestor
93157235|NCT00662740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93157236|NCT00662740|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157237|NCT00662740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157238|NCT00662740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157239|NCT00662740|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93157240|NCT00662740|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93157241|NCT00662740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93157242|NCT00662740|Adrenergic Agents|adrenergic agents|mesh-ancestor
93157243|NCT01105351|Folic Acid|folic acid|mesh-list
93157244|NCT01105351|Vitamin B Complex|vitamin b complex|mesh-list
93157245|NCT01105351|Hematinics|hematinics|mesh-ancestor
93157246|NCT01105351|Vitamins|vitamins|mesh-ancestor
93157247|NCT01105351|Micronutrients|micronutrients|mesh-ancestor
93157248|NCT01105351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157249|NCT00662506|Deoxyglucose|deoxyglucose|mesh-list
93157250|NCT00662506|Temozolomide|temozolomide|mesh-list
93157251|NCT00662506|Cediranib|cediranib|mesh-list
93157252|NCT00662506|Maleic acid|maleic acid|mesh-list
93157253|NCT00662506|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93157254|NCT00662506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93157255|NCT00662506|Alkylating Agents|alkylating agents|mesh-ancestor
93157256|NCT00662506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157257|NCT00662506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157258|NCT00662506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157259|NCT00662506|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93157260|NCT00662506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93157261|NCT00662506|Antimetabolites|antimetabolites|mesh-ancestor
93157262|NCT00662506|Antiviral Agents|antiviral agents|mesh-ancestor
93157263|NCT00662506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157264|NCT03947125|Buprenorphine|buprenorphine|mesh-list
93157265|NCT03947125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93157266|NCT03947125|Narcotics|narcotics|mesh-ancestor
93157267|NCT03947125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157268|NCT03947125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157269|NCT03947125|Analgesics|analgesics|mesh-ancestor
93157270|NCT03947125|Sensory System Agents|sensory system agents|mesh-ancestor
93157271|NCT03947125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157272|NCT03947125|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93157273|NCT00658762|Paroxetine|paroxetine|mesh-list
93157274|NCT00658762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93157275|NCT00658762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93157276|NCT00658762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157277|NCT00658762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157278|NCT00658762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157279|NCT00658762|Serotonin Agents|serotonin agents|mesh-ancestor
93157280|NCT00658762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157281|NCT00658762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93157282|NCT00658762|Antidepressive Agents|antidepressive agents|mesh-ancestor
93157283|NCT00658762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93157284|NCT00658762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93157285|NCT00658762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93157286|NCT00658762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157287|NCT00658372|Paroxetine|paroxetine|mesh-list
93157288|NCT00658372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93157289|NCT00658372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93157290|NCT00658372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157291|NCT00658372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157292|NCT00658372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157293|NCT00658372|Serotonin Agents|serotonin agents|mesh-ancestor
93157294|NCT00658372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157295|NCT00658372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93157296|NCT00658372|Antidepressive Agents|antidepressive agents|mesh-ancestor
93157297|NCT00658372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93157298|NCT00658372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93157299|NCT00658372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93157300|NCT00658372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157301|NCT03946657|Anesthetics|anesthetics|mesh-list
93157302|NCT03946657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
93157303|NCT03946657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157304|NCT03946657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157305|NCT03946657|Anesthetics, General|anesthetics, general|mesh-ancestor
93157306|NCT00616798|Antipsychotic Agents|antipsychotic agents|mesh-list
93157307|NCT00616798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93157308|NCT00616798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157309|NCT00616798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157310|NCT00616798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93157311|NCT01106053|Pramipexole|pramipexole|mesh-list
93157312|NCT01106053|Antioxidants|antioxidants|mesh-ancestor
93157313|NCT01106053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157314|NCT01106053|Protective Agents|protective agents|mesh-ancestor
93157315|NCT01106053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157316|NCT01106053|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93157317|NCT01106053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93157318|NCT01106053|Dopamine Agonists|dopamine agonists|mesh-ancestor
93157319|NCT01106053|Dopamine Agents|dopamine agents|mesh-ancestor
93157320|NCT01106053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157321|NCT00616330|Clindamycin|clindamycin|mesh-list
93157322|NCT00616330|Clindamycin palmitate|clindamycin palmitate|mesh-list
93157323|NCT00616330|Clindamycin phosphate|clindamycin phosphate|mesh-list
93157324|NCT00616330|Butoconazole|butoconazole|mesh-list
93157325|NCT00616330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157326|NCT00616330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157327|NCT00616330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93157328|NCT00616330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157329|NCT00616330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157330|NCT00616330|Antifungal Agents|antifungal agents|mesh-ancestor
93157331|NCT00612820|Fluticasone|fluticasone|mesh-list
93157332|NCT00612820|Xhance|xhance|mesh-list
93157333|NCT00612820|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
93157334|NCT00612820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157335|NCT00612820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157336|NCT00612820|Autonomic Agents|autonomic agents|mesh-ancestor
93157337|NCT00612820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157338|NCT00612820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157339|NCT00612820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157340|NCT00612820|Respiratory System Agents|respiratory system agents|mesh-ancestor
93157341|NCT00612820|Dermatologic Agents|dermatologic agents|mesh-ancestor
93157342|NCT00612820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93157343|NCT00612820|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93157344|NCT00612820|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93157345|NCT00612820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157346|NCT00612820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157347|NCT00612742|Testosterone|testosterone|mesh-list
93157348|NCT00612742|Androgens|androgens|mesh-ancestor
93157349|NCT00612742|Hormones|hormones|mesh-ancestor
93157350|NCT00612742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157351|NCT00612742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157352|NCT05016895|Azithromycin|azithromycin|mesh-list
93157353|NCT05016895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157354|NCT05016895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157355|NCT01106131|Pioglitazone|pioglitazone|mesh-list
93157356|NCT01106131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93157357|NCT01106131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157358|NCT00612118|Azelastine|azelastine|mesh-list
93157359|NCT00612118|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
93157360|NCT00612118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157361|NCT00612118|Autonomic Agents|autonomic agents|mesh-ancestor
93157362|NCT00612118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157363|NCT00612118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157364|NCT00612118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157365|NCT00612118|Respiratory System Agents|respiratory system agents|mesh-ancestor
93157366|NCT00612118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93157367|NCT00612118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157368|NCT00612118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157369|NCT00612118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93157370|NCT00612118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93157371|NCT00612118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93157372|NCT00612118|Histamine Antagonists|histamine antagonists|mesh-ancestor
93157373|NCT00612118|Histamine Agents|histamine agents|mesh-ancestor
93157374|NCT00612118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157375|NCT00612118|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93157376|NCT00612118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93157377|NCT00743002|Metformin|metformin|mesh-list
93157378|NCT00743002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93157379|NCT00743002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157380|NCT03944863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93157381|NCT03944863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157382|NCT01102699|Lenograstim|lenograstim|mesh-list
93157383|NCT01102699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93157384|NCT01102699|Immunologic Factors|immunologic factors|mesh-ancestor
93157385|NCT01102699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157386|NCT00603616|Rifaximin|rifaximin|mesh-list
93157387|NCT00603616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157388|NCT00603616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157389|NCT00603616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93157390|NCT02280070|Leucovorin|leucovorin|mesh-list
93157391|NCT02280070|Fluorouracil|fluorouracil|mesh-list
93157392|NCT02280070|Tegafur|tegafur|mesh-list
93157393|NCT02280070|Oxaliplatin|oxaliplatin|mesh-list
93157394|NCT02280070|Antibodies|antibodies|mesh-list
93157395|NCT02280070|Immunoglobulins|immunoglobulins|mesh-list
93157396|NCT02280070|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
93157397|NCT02280070|Immunologic Factors|immunologic factors|mesh-ancestor
93157398|NCT02280070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157399|NCT02280070|Antimetabolites|antimetabolites|mesh-ancestor
93157400|NCT02280070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157401|NCT02280070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93157402|NCT02280070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157403|NCT02280070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157404|NCT02280070|Antidotes|antidotes|mesh-ancestor
93157405|NCT02280070|Protective Agents|protective agents|mesh-ancestor
93157406|NCT02280070|Vitamin B Complex|vitamin b complex|mesh-ancestor
93157407|NCT02280070|Vitamins|vitamins|mesh-ancestor
93157408|NCT02280070|Micronutrients|micronutrients|mesh-ancestor
93157409|NCT01108783|Desloratadine|desloratadine|mesh-list
93157410|NCT01108783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93157411|NCT01108783|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157412|NCT01108783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157413|NCT01108783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157414|NCT01108783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157415|NCT01108783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93157416|NCT01108783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93157417|NCT01108783|Histamine Antagonists|histamine antagonists|mesh-ancestor
93157418|NCT01108783|Histamine Agents|histamine agents|mesh-ancestor
93157419|NCT02743780|MGV354|mgv354|mesh-list
93157420|NCT02743780|Enzyme Activators|enzyme activators|mesh-ancestor
93157421|NCT02743780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157422|NCT02280148|Propofol|propofol|mesh-list
93157423|NCT02280148|Anesthetics|anesthetics|mesh-ancestor
93157424|NCT02280148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157425|NCT02280148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157426|NCT02280148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93157427|NCT02280148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93157428|NCT02280148|Anesthetics, General|anesthetics, general|mesh-ancestor
93157429|NCT00602602|Bevacizumab|bevacizumab|mesh-list
93157430|NCT00602602|Gemcitabine|gemcitabine|mesh-list
93157431|NCT00602602|Fluorouracil|fluorouracil|mesh-list
93157432|NCT00602602|Oxaliplatin|oxaliplatin|mesh-list
93157433|NCT00602602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93157434|NCT00602602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157435|NCT00602602|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93157436|NCT00602602|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93157437|NCT00602602|Growth Substances|growth substances|mesh-ancestor
93157438|NCT00602602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157439|NCT00602602|Growth Inhibitors|growth inhibitors|mesh-ancestor
93157440|NCT00602602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93157441|NCT00602602|Antimetabolites|antimetabolites|mesh-ancestor
93157442|NCT00602602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157443|NCT00602602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157444|NCT00602602|Immunologic Factors|immunologic factors|mesh-ancestor
93157445|NCT04177654|Albendazole|albendazole|mesh-list
93157446|NCT04177654|Mebendazole|mebendazole|mesh-list
93157447|NCT04177654|Benzimidazole|benzimidazole|mesh-list
93157448|NCT04177654|Anthelmintics|anthelmintics|mesh-ancestor
93157449|NCT04177654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93157450|NCT04177654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157451|NCT04177654|Anticestodal Agents|anticestodal agents|mesh-ancestor
93157452|NCT04177654|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93157453|NCT04177654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93157454|NCT04177654|Tubulin Modulators|tubulin modulators|mesh-ancestor
93157455|NCT04177654|Antimitotic Agents|antimitotic agents|mesh-ancestor
93157456|NCT04177654|Mitosis Modulators|mitosis modulators|mesh-ancestor
92855001|NCT00134303|Metformin|metformin|mesh-list
93157457|NCT04177654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157458|NCT04177654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157459|NCT04177654|Antinematodal Agents|antinematodal agents|mesh-ancestor
93157460|NCT02281396|Vaccines|vaccines|mesh-list
93157461|NCT02281396|Immunologic Factors|immunologic factors|mesh-ancestor
93157462|NCT02281396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157463|NCT04471480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93157464|NCT04471480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157465|NCT04471480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93157466|NCT04471480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157467|NCT02880956|Tilavonemab|tilavonemab|mesh-list
93157468|NCT02880956|Nootropic Agents|nootropic agents|mesh-ancestor
93157469|NCT01111513|Analgesics|analgesics|mesh-list
93157470|NCT01111513|Ropivacaine|ropivacaine|mesh-list
93157471|NCT01111513|Anesthetics, Local|anesthetics, local|mesh-ancestor
93157472|NCT01111513|Anesthetics|anesthetics|mesh-ancestor
93157473|NCT01111513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157474|NCT01111513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157475|NCT01111513|Sensory System Agents|sensory system agents|mesh-ancestor
93157476|NCT01111513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157477|NCT01111591|Celecoxib|celecoxib|mesh-list
93157478|NCT01111591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
93157479|NCT01111591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93157480|NCT01111591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93157481|NCT01111591|Analgesics|analgesics|mesh-ancestor
93157482|NCT01111591|Sensory System Agents|sensory system agents|mesh-ancestor
93157483|NCT01111591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157484|NCT01111591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157485|NCT01111591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157486|NCT01111591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157487|NCT01111591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93157488|NCT01111591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157489|NCT01111591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157490|NCT01111669|Tranexamic Acid|tranexamic acid|mesh-list
93157491|NCT01111669|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93157492|NCT01111669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93157493|NCT01111669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157494|NCT01111669|Hemostatics|hemostatics|mesh-ancestor
93157495|NCT01111669|Coagulants|coagulants|mesh-ancestor
93157496|NCT01108939|Antimalarials|antimalarials|mesh-list
93157497|NCT01108939|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93157498|NCT01108939|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93157499|NCT01108939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157500|NCT00654706|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93157501|NCT00654706|Sertindole|sertindole|mesh-list
93157502|NCT00654706|Antidepressive Agents|antidepressive agents|mesh-ancestor
93157503|NCT00654706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93157504|NCT00654706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93157505|NCT00654706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93157506|NCT00654706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157507|NCT00654706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157508|NCT03944473|Neostigmine|neostigmine|mesh-list
93157509|NCT03944473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93157510|NCT03944473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157511|NCT03944473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157512|NCT03944473|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157513|NCT03944473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157514|NCT03944473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157515|NCT03944473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93157516|NCT03944473|Autonomic Agents|autonomic agents|mesh-ancestor
93157517|NCT03944473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157518|NCT03944317|Azithromycin|azithromycin|mesh-list
93157519|NCT03944317|Pyrimethamine|pyrimethamine|mesh-list
93157520|NCT03944317|Sulfadoxine|sulfadoxine|mesh-list
93157521|NCT03944317|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93157522|NCT03944317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157523|NCT03944317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157524|NCT03944317|Antimalarials|antimalarials|mesh-ancestor
92855004|NCT00902941|Rasagiline|rasagiline|mesh-list
93157525|NCT03944317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93157526|NCT03944317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93157527|NCT03944317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93157528|NCT03944317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157529|NCT03944317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157530|NCT03944317|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93157531|NCT02280538|Hyaluronic Acid|hyaluronic acid|mesh-list
93157532|NCT02280538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93157533|NCT02280538|Immunologic Factors|immunologic factors|mesh-ancestor
93157534|NCT02280538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157535|NCT02280538|Viscosupplements|viscosupplements|mesh-ancestor
93157536|NCT02280538|Protective Agents|protective agents|mesh-ancestor
93157537|NCT01111747|Mitogens|mitogens|mesh-list
93157538|NCT01111747|Mitosis Modulators|mitosis modulators|mesh-ancestor
93157539|NCT01111747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157540|NCT02281708|Cisplatin|cisplatin|mesh-list
93157541|NCT02281708|Vinorelbine|vinorelbine|mesh-list
93157542|NCT02281708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157543|NCT02281708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93157544|NCT02281708|Tubulin Modulators|tubulin modulators|mesh-ancestor
93157545|NCT02281708|Antimitotic Agents|antimitotic agents|mesh-ancestor
93157546|NCT02281708|Mitosis Modulators|mitosis modulators|mesh-ancestor
93157547|NCT02281708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157548|NCT01111903|Lenalidomide|lenalidomide|mesh-list
93157549|NCT01111903|Immunologic Factors|immunologic factors|mesh-ancestor
93157550|NCT01111903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157551|NCT01111903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93157552|NCT01111903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93157553|NCT01111903|Growth Substances|growth substances|mesh-ancestor
93157554|NCT01111903|Growth Inhibitors|growth inhibitors|mesh-ancestor
93157555|NCT01111903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157556|NCT02280616|Budesonide|budesonide|mesh-list
93157557|NCT02280616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157558|NCT02280616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157559|NCT02280616|Autonomic Agents|autonomic agents|mesh-ancestor
93157560|NCT02280616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157561|NCT02280616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157562|NCT02280616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157563|NCT02280616|Respiratory System Agents|respiratory system agents|mesh-ancestor
93157564|NCT02280616|Glucocorticoids|glucocorticoids|mesh-ancestor
93157565|NCT02280616|Hormones|hormones|mesh-ancestor
93157566|NCT02280616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157567|NCT01111981|Clobetasol|clobetasol|mesh-list
93157568|NCT01111981|Emollients|emollients|mesh-list
93157569|NCT01111981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157570|NCT01111981|Glucocorticoids|glucocorticoids|mesh-ancestor
93157571|NCT01111981|Hormones|hormones|mesh-ancestor
93157572|NCT01111981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157573|NCT01111981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157574|NCT01111981|Dermatologic Agents|dermatologic agents|mesh-ancestor
93157575|NCT02283424|Carboplatin|carboplatin|mesh-list
93157576|NCT02283424|Docetaxel|docetaxel|mesh-list
93157577|NCT02283424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157578|NCT02283424|Tubulin Modulators|tubulin modulators|mesh-ancestor
93157579|NCT02283424|Antimitotic Agents|antimitotic agents|mesh-ancestor
93157580|NCT02283424|Mitosis Modulators|mitosis modulators|mesh-ancestor
93157581|NCT02283424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157583|NCT03942601|Dexamethasone|dexamethasone|mesh-list
93157584|NCT03942601|Dexamethasone acetate|dexamethasone acetate|mesh-list
93157585|NCT03942601|Temsirolimus|temsirolimus|mesh-list
93157586|NCT03942601|MTOR Inhibitors|mtor inhibitors|mesh-list
93157587|NCT03942601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93157588|NCT03942601|BB 1101|bb 1101|mesh-list
93157589|NCT03942601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157590|NCT03942601|Antiemetics|antiemetics|mesh-ancestor
93157591|NCT03942601|Autonomic Agents|autonomic agents|mesh-ancestor
93157592|NCT03942601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157593|NCT03942601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157594|NCT03942601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93157595|NCT03942601|Glucocorticoids|glucocorticoids|mesh-ancestor
93157596|NCT03942601|Hormones|hormones|mesh-ancestor
93157597|NCT03942601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157598|NCT03942601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93157599|NCT03942601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157600|NCT03942601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93157601|NCT03942601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157602|NCT03942601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157603|NCT03942601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157604|NCT03942601|Immunologic Factors|immunologic factors|mesh-ancestor
93157605|NCT03942601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157606|NCT03942601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157607|NCT03942601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93157608|NCT03942601|Antifungal Agents|antifungal agents|mesh-ancestor
93157609|NCT03942601|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157610|NCT00598312|Leuprolide|leuprolide|mesh-list
93157611|NCT00598312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93157612|NCT00598312|Fertility Agents|fertility agents|mesh-ancestor
93157613|NCT00598312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93157614|NCT00598312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157615|NCT00598312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93157616|NCT00598312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157617|NCT00595426|Warfarin|warfarin|mesh-list
93157618|NCT00595426|Anticoagulants|anticoagulants|mesh-ancestor
93157619|NCT01112137|Clopidogrel|clopidogrel|mesh-list
93157620|NCT01112137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93157621|NCT01112137|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93157622|NCT01112137|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93157623|NCT01112137|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93157624|NCT01112137|Purinergic Agents|purinergic agents|mesh-ancestor
93157625|NCT01112137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157626|NCT01112137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157627|NCT01112137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157628|NCT02282098|Colchicine|colchicine|mesh-list
93157629|NCT02282098|Gout Suppressants|gout suppressants|mesh-ancestor
93157630|NCT02282098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157631|NCT02282098|Tubulin Modulators|tubulin modulators|mesh-ancestor
93157632|NCT02282098|Antimitotic Agents|antimitotic agents|mesh-ancestor
93157633|NCT02282098|Mitosis Modulators|mitosis modulators|mesh-ancestor
93157634|NCT02282098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157635|NCT02282098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157636|NCT01208935|Nicotine|nicotine|mesh-list
93157637|NCT01208935|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93157638|NCT01208935|Autonomic Agents|autonomic agents|mesh-ancestor
93157639|NCT01208935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157640|NCT01208935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157641|NCT01208935|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93157642|NCT01208935|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93157643|NCT01208935|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157644|NCT01208935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157645|NCT01208935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157646|NCT00584974|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93157647|NCT00584974|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93157648|NCT00584974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93157649|NCT00584974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157650|NCT00584974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157651|NCT00584974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157652|NCT00584974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157653|NCT00584974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93157654|NCT00584974|Antidepressive Agents|antidepressive agents|mesh-ancestor
92829878|NCT04342975|Niacin|niacin|mesh-list
93157655|NCT00584974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93157656|NCT01107067|Testosterone|testosterone|mesh-list
93157657|NCT01107067|Androgens|androgens|mesh-ancestor
93157658|NCT01107067|Hormones|hormones|mesh-ancestor
93157659|NCT01107067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157660|NCT01107067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157661|NCT02282176|Azithromycin|azithromycin|mesh-list
93157662|NCT02282176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157663|NCT02282176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157664|NCT00580216|Biotin|biotin|mesh-list
93157665|NCT00580216|Warfarin|warfarin|mesh-list
93157666|NCT00580216|Idraparinux|idraparinux|mesh-list
93157667|NCT00580216|Idrabiotaparinux|idrabiotaparinux|mesh-list
93157668|NCT00580216|Anticoagulants|anticoagulants|mesh-ancestor
93157669|NCT00580216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93157670|NCT00580216|Antithrombins|antithrombins|mesh-ancestor
93157671|NCT00580216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93157672|NCT00580216|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157673|NCT00580216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157674|NCT00580216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157675|NCT00580216|Vitamin B Complex|vitamin b complex|mesh-ancestor
93157676|NCT00580216|Vitamins|vitamins|mesh-ancestor
93157677|NCT00580216|Micronutrients|micronutrients|mesh-ancestor
93157678|NCT00580216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157679|NCT01107145|Artesunate|artesunate|mesh-list
93157680|NCT01107145|Lumefantrine|lumefantrine|mesh-list
93157681|NCT01107145|Chloroquine|chloroquine|mesh-list
93157682|NCT01107145|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93157683|NCT01107145|Artemether|artemether|mesh-list
93157684|NCT01107145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93157685|NCT01107145|Mefloquine|mefloquine|mesh-list
93157686|NCT01107145|Antimalarials|antimalarials|mesh-ancestor
93157687|NCT01107145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93157688|NCT01107145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93157689|NCT01107145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157690|NCT01107145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157691|NCT01107145|Antiviral Agents|antiviral agents|mesh-ancestor
93157692|NCT01107145|Schistosomicides|schistosomicides|mesh-ancestor
93157693|NCT01107145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93157694|NCT01107145|Anthelmintics|anthelmintics|mesh-ancestor
93157695|NCT01107145|Amebicides|amebicides|mesh-ancestor
93157696|NCT01107145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157697|NCT01107145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93157698|NCT01107145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93157699|NCT01107145|Analgesics|analgesics|mesh-ancestor
93157700|NCT01107145|Sensory System Agents|sensory system agents|mesh-ancestor
93157701|NCT01107145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157702|NCT01107145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157703|NCT01107145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157704|NCT01107145|Filaricides|filaricides|mesh-ancestor
93157705|NCT01107145|Antinematodal Agents|antinematodal agents|mesh-ancestor
93157706|NCT03944005|Anesthetics|anesthetics|mesh-list
93157707|NCT03944005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157708|NCT03944005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157709|NCT01209403|Insulin|insulin|mesh-list
93157710|NCT01209403|Insulin Aspart|insulin aspart|mesh-list
93157711|NCT01209403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93157712|NCT01209403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157713|NCT01112215|Mycophenolic Acid|mycophenolic acid|mesh-list
93157714|NCT01112215|Azathioprine|azathioprine|mesh-list
93157715|NCT01112215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93157716|NCT01112215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157717|NCT01112215|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93157718|NCT01112215|Antitubercular Agents|antitubercular agents|mesh-ancestor
93157719|NCT01112215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157720|NCT01112215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157721|NCT01112215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157722|NCT01112215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157723|NCT01112215|Antimetabolites|antimetabolites|mesh-ancestor
93157724|NCT01112215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93157725|NCT01112215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157726|NCT01112215|Immunologic Factors|immunologic factors|mesh-ancestor
93157727|NCT01112215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157728|NCT01112215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157729|NCT01107223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93157730|NCT01107223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93157731|NCT01107223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157732|NCT01107223|Antitubercular Agents|antitubercular agents|mesh-ancestor
93157733|NCT02286388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93157734|NCT02286388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157735|NCT02286544|Atorvastatin|atorvastatin|mesh-list
93157736|NCT02286544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93157737|NCT02286544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93157738|NCT02286544|Antimetabolites|antimetabolites|mesh-ancestor
93157739|NCT02286544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157740|NCT02286544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93157741|NCT02286544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93157742|NCT02286544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157743|NCT01338116|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93157744|NCT01338116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157745|NCT00384904|Ritonavir|ritonavir|mesh-list
93157746|NCT00384904|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93157747|NCT00384904|Tenofovir|tenofovir|mesh-list
93157748|NCT00384904|Famotidine|famotidine|mesh-list
93157749|NCT00384904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93157750|NCT00384904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93157751|NCT00384904|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157752|NCT00384904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157753|NCT00384904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157754|NCT00384904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93157755|NCT00384904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93157756|NCT00384904|Antiviral Agents|antiviral agents|mesh-ancestor
93157757|NCT00384904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157758|NCT00384904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93157759|NCT00384904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93157760|NCT00384904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93157761|NCT00384904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93157762|NCT00384904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93157763|NCT00384904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93157764|NCT00384904|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93157765|NCT00384904|Histamine Antagonists|histamine antagonists|mesh-ancestor
93157766|NCT00384904|Histamine Agents|histamine agents|mesh-ancestor
93157767|NCT00384904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157768|NCT00384904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157769|NCT01335386|Glycerol|glycerol|mesh-list
93157770|NCT01335386|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93157771|NCT01335386|Protective Agents|protective agents|mesh-ancestor
93157772|NCT01335386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157773|NCT00383578|Metformin|metformin|mesh-list
93157774|NCT00383578|Vildagliptin|vildagliptin|mesh-list
93157775|NCT00383578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93157776|NCT00383578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157777|NCT00383578|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93157778|NCT00383578|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157779|NCT00383578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157780|NCT00383578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157781|NCT00383422|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93157782|NCT00383422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93157783|NCT00383422|Hormone Antagonists|hormone antagonists|mesh-ancestor
93157784|NCT00383422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157785|NCT00383422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157786|NCT00383422|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93157787|NCT00383422|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93157788|NCT00383422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93157789|NCT02286622|Deflazacort|deflazacort|mesh-list
93157790|NCT02286622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157791|NCT02286622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157792|NCT02286622|Immunologic Factors|immunologic factors|mesh-ancestor
93157793|NCT02286622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157794|NCT00564226|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93157795|NCT00564226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93157796|NCT00564226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93157797|NCT00564226|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157798|NCT00564226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157799|NCT00564226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157800|NCT00564226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157801|NCT00564226|Urological Agents|urological agents|mesh-ancestor
93157802|NCT03635684|Acetaminophen|acetaminophen|mesh-list
93157803|NCT03635684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93157804|NCT03635684|Analgesics|analgesics|mesh-ancestor
93157805|NCT03635684|Sensory System Agents|sensory system agents|mesh-ancestor
93157806|NCT03635684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157807|NCT03635684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157808|NCT03635684|Antipyretics|antipyretics|mesh-ancestor
93157809|NCT00092690|Atorvastatin|atorvastatin|mesh-list
93157810|NCT00092690|Simvastatin|simvastatin|mesh-list
93157811|NCT00092690|Ezetimibe|ezetimibe|mesh-list
93157812|NCT00092690|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93157813|NCT00092690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93157814|NCT00092690|Antimetabolites|antimetabolites|mesh-ancestor
93157815|NCT00092690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157816|NCT00092690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93157817|NCT00092690|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93157818|NCT00092690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157819|NCT02286700|Desonide|desonide|mesh-list
93157820|NCT02286700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157821|NCT01338896|Rotigotine|rotigotine|mesh-list
93157822|NCT01338896|Dopamine Agonists|dopamine agonists|mesh-ancestor
93157823|NCT01338896|Dopamine Agents|dopamine agents|mesh-ancestor
93157824|NCT01338896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157825|NCT01338896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157826|NCT01338896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157827|NCT05185544|Pemetrexed|pemetrexed|mesh-list
93157828|NCT05185544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157829|NCT05185544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157830|NCT05185544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157831|NCT05185544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93157832|NCT05185544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93157833|NCT00382096|Metformin|metformin|mesh-list
93157834|NCT00382096|Vildagliptin|vildagliptin|mesh-list
93157835|NCT00382096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93157836|NCT00382096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157837|NCT00382096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93157838|NCT00382096|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157839|NCT00382096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157840|NCT00382096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157841|NCT00482092|Remestemcel-l|remestemcel-l|mesh-list
93157842|NCT00482092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157843|NCT00482092|Antiviral Agents|antiviral agents|mesh-ancestor
93157844|NCT00482092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157845|NCT00379990|Prednisolone|prednisolone|mesh-list
93157846|NCT00379990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157847|NCT00379990|Glucocorticoids|glucocorticoids|mesh-ancestor
93157848|NCT00379990|Hormones|hormones|mesh-ancestor
93157849|NCT00379990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157850|NCT00379990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157851|NCT00379990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93157852|NCT00379990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157853|NCT00377182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93157854|NCT00377182|Antiviral Agents|antiviral agents|mesh-ancestor
93157855|NCT00377182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157856|NCT01341938|Nicotine|nicotine|mesh-list
93157857|NCT01341938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93157858|NCT01341938|Autonomic Agents|autonomic agents|mesh-ancestor
93157859|NCT01341938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157860|NCT01341938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157861|NCT01341938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93157862|NCT01341938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93157863|NCT01341938|Cholinergic Agents|cholinergic agents|mesh-ancestor
93157864|NCT01341938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157865|NCT01341938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157866|NCT02284048|Ticagrelor|ticagrelor|mesh-list
93157867|NCT02284048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93157868|NCT02284048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93157869|NCT02284048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93157870|NCT02284048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93157871|NCT02284048|Purinergic Agents|purinergic agents|mesh-ancestor
93157872|NCT02284048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157873|NCT02284048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157874|NCT02284048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157875|NCT00374296|Mocetinostat|mocetinostat|mesh-list
93157876|NCT00374296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93157877|NCT00374296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157878|NCT00374296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157879|NCT00547066|Veltuzumab|veltuzumab|mesh-list
93157880|NCT00547066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157881|NCT01315496|Immunoglobulins|immunoglobulins|mesh-list
93157882|NCT01315496|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93157883|NCT01315496|Antibodies|antibodies|mesh-list
93157884|NCT01315496|Immunoglobulin G|immunoglobulin g|mesh-list
93157885|NCT01315496|Immunologic Factors|immunologic factors|mesh-ancestor
93157886|NCT01315496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157887|NCT00544960|Docetaxel|docetaxel|mesh-list
93157888|NCT00544960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157889|NCT00544960|Tubulin Modulators|tubulin modulators|mesh-ancestor
93157890|NCT00544960|Antimitotic Agents|antimitotic agents|mesh-ancestor
93157891|NCT00544960|Mitosis Modulators|mitosis modulators|mesh-ancestor
93157892|NCT00544960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157893|NCT01339286|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93157894|NCT01339286|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93157895|NCT01339286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93157896|NCT01339286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157897|NCT01339286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157898|NCT01339286|Adrenergic Agents|adrenergic agents|mesh-ancestor
93157899|NCT01339286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157900|NCT01339286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157901|NCT00468442|Sirolimus|sirolimus|mesh-list
93157902|NCT00468442|Rituximab|rituximab|mesh-list
93157903|NCT00468442|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93157904|NCT00468442|Daclizumab|daclizumab|mesh-list
93157905|NCT00468442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93157906|NCT00468442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157907|NCT00468442|Immunologic Factors|immunologic factors|mesh-ancestor
93157908|NCT00468442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157909|NCT00468442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93157910|NCT00468442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93157911|NCT00468442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93157912|NCT00468442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93157913|NCT00468442|Antifungal Agents|antifungal agents|mesh-ancestor
93157914|NCT00468442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93157915|NCT01339442|Fulvestrant|fulvestrant|mesh-list
93157916|NCT01339442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93157917|NCT01339442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157918|NCT01339442|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93157919|NCT01339442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93157920|NCT01339442|Hormone Antagonists|hormone antagonists|mesh-ancestor
93157921|NCT01339442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93157922|NCT01339442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157923|NCT02286934|Carvedilol|carvedilol|mesh-list
93157924|NCT02286934|Isoproterenol|isoproterenol|mesh-list
93157925|NCT02286934|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93157926|NCT02286934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93157927|NCT02286934|Adrenergic Agents|adrenergic agents|mesh-ancestor
93157928|NCT02286934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93157929|NCT02286934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157930|NCT02286934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157931|NCT02286934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93157932|NCT02286934|Antioxidants|antioxidants|mesh-ancestor
93157933|NCT02286934|Protective Agents|protective agents|mesh-ancestor
93157934|NCT02286934|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93157935|NCT02286934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93157936|NCT02286934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93157937|NCT02286934|Vasodilator Agents|vasodilator agents|mesh-ancestor
93157938|NCT02286934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93157939|NCT02286934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93157940|NCT02286934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93157941|NCT02286934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93157942|NCT02286934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157943|NCT02286934|Autonomic Agents|autonomic agents|mesh-ancestor
93157944|NCT02286934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157945|NCT02286934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157946|NCT02286934|Respiratory System Agents|respiratory system agents|mesh-ancestor
93157947|NCT02286934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93157948|NCT02286934|Sympathomimetics|sympathomimetics|mesh-ancestor
93157949|NCT02282410|Factor VIII|factor viii|mesh-list
93157950|NCT02282410|Coagulants|coagulants|mesh-ancestor
93157951|NCT00092612|Ezetimibe|ezetimibe|mesh-list
93157952|NCT00092612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93157953|NCT00092612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93157954|NCT00092612|Antimetabolites|antimetabolites|mesh-ancestor
93157955|NCT00092612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157956|NCT00092612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93157957|NCT00540358|Carboplatin|carboplatin|mesh-list
93157958|NCT00540358|Gemcitabine|gemcitabine|mesh-list
93157959|NCT00540358|Iniparib|iniparib|mesh-list
93157960|NCT00540358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93157961|NCT00540358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93157962|NCT00540358|Antimetabolites|antimetabolites|mesh-ancestor
93157963|NCT00540358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157964|NCT00540358|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93157965|NCT00540358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157966|NCT00462202|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
93157967|NCT00462202|Anticoagulants|anticoagulants|mesh-ancestor
93157968|NCT00462202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93157969|NCT00462202|Antimetabolites|antimetabolites|mesh-ancestor
93157970|NCT00462202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157971|NCT00462202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93157972|NCT00462202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93157973|NCT00462202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93157974|NCT00462202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93157975|NCT00462202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157976|NCT02287246|Bupivacaine|bupivacaine|mesh-list
93157977|NCT02287246|Anesthetics, Local|anesthetics, local|mesh-ancestor
93157978|NCT02287246|Anesthetics|anesthetics|mesh-ancestor
93157979|NCT02287246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93157980|NCT02287246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157981|NCT02287246|Sensory System Agents|sensory system agents|mesh-ancestor
93157982|NCT02287246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157983|NCT04470544|Camostat|camostat|mesh-list
93157984|NCT04470544|Protease Inhibitors|protease inhibitors|mesh-ancestor
93157985|NCT04470544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93157986|NCT04470544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93157987|NCT04470544|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93157988|NCT04470544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93157989|NCT00535366|Fluticasone|fluticasone|mesh-list
93157990|NCT00535366|Ciclesonide|ciclesonide|mesh-list
93157991|NCT00535366|Tiotropium Bromide|tiotropium bromide|mesh-list
93157992|NCT00535366|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93157993|NCT00535366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93157994|NCT00535366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93157995|NCT00535366|Autonomic Agents|autonomic agents|mesh-ancestor
93157996|NCT00535366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93157997|NCT00535366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93157998|NCT00535366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93157999|NCT00535366|Respiratory System Agents|respiratory system agents|mesh-ancestor
93158000|NCT00535366|Dermatologic Agents|dermatologic agents|mesh-ancestor
93158001|NCT00535366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93158002|NCT00535366|Parasympatholytics|parasympatholytics|mesh-ancestor
93158003|NCT00535366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93158004|NCT00535366|Cholinergic Agents|cholinergic agents|mesh-ancestor
93158005|NCT00535366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158006|NCT00535366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158007|NCT00535366|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93158008|NCT00535366|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93158009|NCT00535366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93158010|NCT00535366|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158011|NCT00535366|Glucocorticoids|glucocorticoids|mesh-ancestor
93158012|NCT00535366|Hormones|hormones|mesh-ancestor
93158013|NCT00535366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158014|NCT00369070|Paclitaxel|paclitaxel|mesh-list
93158015|NCT00369070|Bevacizumab|bevacizumab|mesh-list
93158016|NCT00369070|Carboplatin|carboplatin|mesh-list
93158017|NCT00369070|Motesanib diphosphate|motesanib diphosphate|mesh-list
93158018|NCT00369070|Imetelstat|imetelstat|mesh-list
93158019|NCT00369070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93158020|NCT00369070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158021|NCT00369070|Tubulin Modulators|tubulin modulators|mesh-ancestor
93158022|NCT00369070|Antimitotic Agents|antimitotic agents|mesh-ancestor
93158023|NCT00369070|Mitosis Modulators|mitosis modulators|mesh-ancestor
93158024|NCT00369070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158025|NCT00369070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158026|NCT00369070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93158027|NCT00369070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93158028|NCT00369070|Growth Substances|growth substances|mesh-ancestor
93158029|NCT00369070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158030|NCT00369070|Growth Inhibitors|growth inhibitors|mesh-ancestor
93158031|NCT00369070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93158032|NCT00369070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158034|NCT02284204|Ketamine|ketamine|mesh-list
93158035|NCT02284204|Sevoflurane|sevoflurane|mesh-list
93158036|NCT02284204|Analgesics|analgesics|mesh-ancestor
93158037|NCT02284204|Sensory System Agents|sensory system agents|mesh-ancestor
93158038|NCT02284204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158039|NCT02284204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158040|NCT02284204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93158041|NCT02284204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93158042|NCT02284204|Anesthetics, General|anesthetics, general|mesh-ancestor
93158043|NCT02284204|Anesthetics|anesthetics|mesh-ancestor
93158044|NCT02284204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158045|NCT02284204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93158046|NCT02284204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93158047|NCT02284204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158048|NCT02284204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158049|NCT02284204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93158050|NCT02284204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93158051|NCT02284204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93158052|NCT02284204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93158053|NCT02284204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93158054|NCT02284204|GABA Modulators|gaba modulators|mesh-ancestor
93158055|NCT02284204|GABA Agents|gaba agents|mesh-ancestor
93158056|NCT02284204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93158057|NCT02284204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93158058|NCT01352416|Ranolazine|ranolazine|mesh-list
93158059|NCT01352416|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93158060|NCT01352416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158061|NCT01352416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158062|NCT00531622|Escitalopram|escitalopram|mesh-list
93158063|NCT00531622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93158064|NCT00531622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93158065|NCT00531622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158066|NCT00531622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158067|NCT00531622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158068|NCT00531622|Serotonin Agents|serotonin agents|mesh-ancestor
93158069|NCT00531622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158070|NCT00364546|Tapentadol|tapentadol|mesh-list
93158071|NCT00364546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93158072|NCT00364546|Narcotics|narcotics|mesh-ancestor
93158073|NCT00364546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158074|NCT00364546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158075|NCT00364546|Analgesics|analgesics|mesh-ancestor
93158076|NCT00364546|Sensory System Agents|sensory system agents|mesh-ancestor
93158077|NCT00364546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158078|NCT00364546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93158079|NCT00364546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93158080|NCT00364546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158081|NCT00364546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158082|NCT00364546|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158083|NCT00364546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158084|NCT00361582|Tapentadol|tapentadol|mesh-list
93158085|NCT00361582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93158086|NCT00361582|Narcotics|narcotics|mesh-ancestor
93158087|NCT00361582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158088|NCT00361582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158089|NCT00361582|Analgesics|analgesics|mesh-ancestor
93158090|NCT00361582|Sensory System Agents|sensory system agents|mesh-ancestor
93158091|NCT00361582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158092|NCT00361582|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93158093|NCT00361582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93158094|NCT00361582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158095|NCT00361582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158096|NCT00361582|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158097|NCT00361582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158098|NCT00450970|Satraplatin|satraplatin|mesh-list
93158099|NCT00450970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158100|NCT02282800|Vitamin D|vitamin d|mesh-list
93158101|NCT02282800|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93158102|NCT02282800|Vitamins|vitamins|mesh-ancestor
93158103|NCT02282800|Micronutrients|micronutrients|mesh-ancestor
93158104|NCT02282800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158105|NCT02282800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93158106|NCT05208034|Methotrexate|methotrexate|mesh-list
93158107|NCT05208034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93158108|NCT05208034|Abortifacient Agents|abortifacient agents|mesh-ancestor
93158109|NCT05208034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93158110|NCT05208034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158111|NCT05208034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158112|NCT05208034|Antimetabolites|antimetabolites|mesh-ancestor
93158113|NCT05208034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158114|NCT05208034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158115|NCT05208034|Dermatologic Agents|dermatologic agents|mesh-ancestor
93158116|NCT05208034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158117|NCT05208034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93158118|NCT05208034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158119|NCT05208034|Immunologic Factors|immunologic factors|mesh-ancestor
93158120|NCT05208034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158121|NCT05208034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93158123|NCT02284282|Morphine|morphine|mesh-list
93158124|NCT02284282|Bupivacaine|bupivacaine|mesh-list
93158125|NCT02284282|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158126|NCT02284282|Anesthetics|anesthetics|mesh-ancestor
93158127|NCT02284282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158128|NCT02284282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158129|NCT02284282|Sensory System Agents|sensory system agents|mesh-ancestor
93158130|NCT02284282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158131|NCT02284282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93158132|NCT02284282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93158133|NCT02284282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93158134|NCT02284282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158135|NCT02284282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158136|NCT02284282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93158137|NCT02284282|Narcotics|narcotics|mesh-ancestor
93158138|NCT02284282|Analgesics|analgesics|mesh-ancestor
93158139|NCT00359086|Mocetinostat|mocetinostat|mesh-list
93158140|NCT00359086|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93158141|NCT00359086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158142|NCT00359086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158143|NCT03133780|Midazolam|midazolam|mesh-list
93158144|NCT03133780|Ketamine|ketamine|mesh-list
93158145|NCT03133780|Analgesics|analgesics|mesh-ancestor
93158146|NCT03133780|Sensory System Agents|sensory system agents|mesh-ancestor
93158147|NCT03133780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158148|NCT03133780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158149|NCT03133780|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93158150|NCT03133780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93158151|NCT03133780|Anesthetics, General|anesthetics, general|mesh-ancestor
93158152|NCT03133780|Anesthetics|anesthetics|mesh-ancestor
93158153|NCT03133780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158154|NCT03133780|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93158155|NCT03133780|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93158156|NCT03133780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158157|NCT03133780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158158|NCT03133780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93158159|NCT03133780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93158160|NCT03133780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93158161|NCT03133780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93158162|NCT03133780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93158163|NCT03133780|GABA Modulators|gaba modulators|mesh-ancestor
93158164|NCT03133780|GABA Agents|gaba agents|mesh-ancestor
93158165|NCT02282956|Droperidol|droperidol|mesh-list
93158166|NCT02282956|Morphine|morphine|mesh-list
93158167|NCT02282956|Ropivacaine|ropivacaine|mesh-list
93158168|NCT02282956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93158169|NCT02282956|Narcotics|narcotics|mesh-ancestor
93158170|NCT02282956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158171|NCT02282956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158172|NCT02282956|Analgesics|analgesics|mesh-ancestor
93158173|NCT02282956|Sensory System Agents|sensory system agents|mesh-ancestor
93158174|NCT02282956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158175|NCT02282956|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158176|NCT02282956|Anesthetics|anesthetics|mesh-ancestor
93158177|NCT02282956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93158178|NCT02282956|Antiemetics|antiemetics|mesh-ancestor
93158179|NCT02282956|Autonomic Agents|autonomic agents|mesh-ancestor
93158180|NCT02282956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93158181|NCT02282956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93158182|NCT02282956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93158183|NCT02282956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93158184|NCT02282956|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93158185|NCT02282956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93158186|NCT02282956|Dopamine Agents|dopamine agents|mesh-ancestor
93158187|NCT02282956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158188|NCT02282956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158189|NCT02287558|Pomalidomide|pomalidomide|mesh-list
93158190|NCT02287558|Immunologic Factors|immunologic factors|mesh-ancestor
93158191|NCT02287558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158192|NCT02287558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93158193|NCT02287558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93158194|NCT02287558|Growth Substances|growth substances|mesh-ancestor
93158195|NCT02287558|Growth Inhibitors|growth inhibitors|mesh-ancestor
93158196|NCT02287558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158197|NCT04470076|Carboplatin|carboplatin|mesh-list
93158198|NCT04470076|Gemcitabine|gemcitabine|mesh-list
93158199|NCT04470076|Pemetrexed|pemetrexed|mesh-list
93158200|NCT04470076|Afatinib|afatinib|mesh-list
93158201|NCT04470076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158202|NCT04470076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158203|NCT04470076|Antimetabolites|antimetabolites|mesh-ancestor
93158204|NCT04470076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158205|NCT04470076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158206|NCT04470076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93158207|NCT04470076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93158208|NCT04470076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93158209|NCT00445198|Navitoclax|navitoclax|mesh-list
93158210|NCT00445198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158211|NCT00345748|Abatacept|abatacept|mesh-list
93158212|NCT00345748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93158213|NCT00345748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158214|NCT00345748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158215|NCT00345748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158216|NCT00345748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158217|NCT00345748|Immunologic Factors|immunologic factors|mesh-ancestor
93158218|NCT00345748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158219|NCT00345748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158220|NCT00439738|Amlodipine|amlodipine|mesh-list
93158221|NCT00439738|Valsartan|valsartan|mesh-list
93158222|NCT00439738|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93158223|NCT00439738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158224|NCT00439738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93158225|NCT00439738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158226|NCT00439738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158227|NCT00439738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93158228|NCT00439738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158229|NCT00439738|Vasodilator Agents|vasodilator agents|mesh-ancestor
93158230|NCT00439738|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93158231|NCT00439738|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93158232|NCT00439738|Diuretics|diuretics|mesh-ancestor
93158233|NCT00439738|Natriuretic Agents|natriuretic agents|mesh-ancestor
93158234|NCT00439738|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93158235|NCT00435916|Dacetuzumab|dacetuzumab|mesh-list
93158236|NCT00435916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158237|NCT00435916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158238|NCT00523042|Insulin|insulin|mesh-list
93158239|NCT00523042|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93158240|NCT00523042|Insulin Aspart|insulin aspart|mesh-list
93158241|NCT00523042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158242|NCT00523042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158243|NCT00338104|Insulin|insulin|mesh-list
93158244|NCT00338104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93158245|NCT00338104|Insulin Glargine|insulin glargine|mesh-list
93158246|NCT00338104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158247|NCT00338104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158248|NCT00519142|Mitiglinide|mitiglinide|mesh-list
93158249|NCT00519142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158250|NCT00519142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158251|NCT02284672|Dexmedetomidine|dexmedetomidine|mesh-list
93158252|NCT02284672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93158253|NCT02284672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158254|NCT02284672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158255|NCT02284672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93158256|NCT02284672|Analgesics|analgesics|mesh-ancestor
93158257|NCT02284672|Sensory System Agents|sensory system agents|mesh-ancestor
93158258|NCT02284672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158259|NCT02284672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93158260|NCT02284672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93158261|NCT02284672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93158262|NCT02284672|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158263|NCT02284672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158264|NCT02284672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158265|NCT02283190|Asparaginase|asparaginase|mesh-list
93158266|NCT02283190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158267|NCT00333502|Camptothecin|camptothecin|mesh-list
93158268|NCT00333502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93158269|NCT00333502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158270|NCT00333502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93158271|NCT00333502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93158272|NCT00333502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158273|NCT00333502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158274|NCT00332956|Vaccines|vaccines|mesh-list
93158275|NCT00332956|Immunologic Factors|immunologic factors|mesh-ancestor
93158276|NCT00332956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158277|NCT00324220|Mocetinostat|mocetinostat|mesh-list
93158278|NCT00324220|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93158279|NCT00324220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158280|NCT00324220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158281|NCT02287792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93158282|NCT02287792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93158283|NCT02287792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158284|NCT00417118|Escitalopram|escitalopram|mesh-list
93158285|NCT00417118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93158286|NCT00417118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93158287|NCT00417118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158288|NCT00417118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158289|NCT00417118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158290|NCT00417118|Serotonin Agents|serotonin agents|mesh-ancestor
93158291|NCT00417118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158292|NCT02883452|Infliximab|infliximab|mesh-list
93158293|NCT02883452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93158294|NCT02883452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158295|NCT02883452|Dermatologic Agents|dermatologic agents|mesh-ancestor
93158296|NCT02883452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93158297|NCT02883452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158298|NCT00508066|Bupivacaine|bupivacaine|mesh-list
93158299|NCT00508066|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158300|NCT00508066|Anesthetics|anesthetics|mesh-ancestor
93158301|NCT00508066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158302|NCT00508066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158303|NCT00508066|Sensory System Agents|sensory system agents|mesh-ancestor
93158304|NCT00508066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158305|NCT01336010|Ribavirin|ribavirin|mesh-list
93158306|NCT01336010|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93158307|NCT01336010|Antimetabolites|antimetabolites|mesh-ancestor
93158308|NCT01336010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158309|NCT01336010|Antiviral Agents|antiviral agents|mesh-ancestor
93158310|NCT01336010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158311|NCT02207504|Crizotinib|crizotinib|mesh-list
93158312|NCT02207504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158313|NCT02207504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93158314|NCT02207504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158315|NCT02207504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158316|NCT01342016|Prednisone|prednisone|mesh-list
93158317|NCT01342016|Tacrolimus|tacrolimus|mesh-list
93158318|NCT01342016|Leflunomide|leflunomide|mesh-list
93158319|NCT01342016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158320|NCT01342016|Glucocorticoids|glucocorticoids|mesh-ancestor
93158321|NCT01342016|Hormones|hormones|mesh-ancestor
93158322|NCT01342016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158323|NCT01342016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158324|NCT01342016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93158325|NCT01342016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158326|NCT01342016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158327|NCT01342016|Immunologic Factors|immunologic factors|mesh-ancestor
93158328|NCT01342016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93158329|NCT01342016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158330|NCT01342016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158331|NCT01336166|Vaccines|vaccines|mesh-list
93158332|NCT01336166|Immunologic Factors|immunologic factors|mesh-ancestor
93158334|NCT04470310|Pioglitazone|pioglitazone|mesh-list
93158335|NCT04470310|Glimepiride|glimepiride|mesh-list
93158336|NCT04470310|Alogliptin|alogliptin|mesh-list
93158337|NCT04470310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158338|NCT04470310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158339|NCT04470310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93158340|NCT04470310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158341|NCT04470310|Immunologic Factors|immunologic factors|mesh-ancestor
93158342|NCT04470310|Incretins|incretins|mesh-ancestor
93158343|NCT04470310|Hormones|hormones|mesh-ancestor
93158344|NCT04470310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158345|NCT04470310|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93158346|NCT04470310|Protease Inhibitors|protease inhibitors|mesh-ancestor
93158347|NCT04470310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158348|NCT04470310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158349|NCT02083250|Fludarabine|fludarabine|mesh-list
93158350|NCT02083250|Fludarabine phosphate|fludarabine phosphate|mesh-list
93158351|NCT02083250|Busulfan|busulfan|mesh-list
93158352|NCT02083250|Vorinostat|vorinostat|mesh-list
93158353|NCT02083250|Clofarabine|clofarabine|mesh-list
93158354|NCT02083250|Thymoglobulin|thymoglobulin|mesh-list
93158355|NCT02083250|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93158356|NCT02083250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158357|NCT02083250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158358|NCT02083250|Antimetabolites|antimetabolites|mesh-ancestor
93158359|NCT02083250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158360|NCT02083250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158361|NCT02083250|Immunologic Factors|immunologic factors|mesh-ancestor
93158362|NCT02083250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158363|NCT02083250|Alkylating Agents|alkylating agents|mesh-ancestor
93158364|NCT02083250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93158365|NCT02083250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93158366|NCT02083250|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93158367|NCT02083250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158368|NCT00412828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
93158369|NCT00412828|Immunoconjugates|immunoconjugates|mesh-ancestor
93158370|NCT00412828|Immunologic Factors|immunologic factors|mesh-ancestor
93158371|NCT00412828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158372|NCT00412828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158373|NCT00412828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158374|NCT00315640|Hydrocortisone|hydrocortisone|mesh-list
93158375|NCT00315640|Anecortave|anecortave|mesh-list
93158376|NCT00315640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93158377|NCT00315640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93158378|NCT00315640|Growth Substances|growth substances|mesh-ancestor
93158379|NCT00315640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158380|NCT00315640|Growth Inhibitors|growth inhibitors|mesh-ancestor
93158381|NCT00315640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158382|NCT00315640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158383|NCT00411892|Insulin|insulin|mesh-list
93158384|NCT00411892|Pioglitazone|pioglitazone|mesh-list
93158385|NCT00411892|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93158386|NCT00411892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158387|NCT00411892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158388|NCT01336322|Metformin|metformin|mesh-list
93158389|NCT01336322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93158390|NCT01336322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158391|NCT01336322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158392|NCT01336322|Incretins|incretins|mesh-ancestor
93158393|NCT01336322|Hormones|hormones|mesh-ancestor
93158394|NCT01336322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158395|NCT01336322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93158396|NCT01336322|Protease Inhibitors|protease inhibitors|mesh-ancestor
93158397|NCT01336322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158398|NCT01336322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158399|NCT01339676|Vitamin D|vitamin d|mesh-list
93158400|NCT01339676|Cholecalciferol|cholecalciferol|mesh-list
93158401|NCT01339676|Vitamins|vitamins|mesh-ancestor
93158402|NCT01339676|Micronutrients|micronutrients|mesh-ancestor
93158403|NCT01339676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158404|NCT01339676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93158405|NCT01339676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93158406|NCT01339754|Trabectedin|trabectedin|mesh-list
93158407|NCT01339754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93158408|NCT01339754|Alkylating Agents|alkylating agents|mesh-ancestor
93158409|NCT01339754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158410|NCT01339754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158412|NCT00313768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93158413|NCT00313768|Bevacizumab|bevacizumab|mesh-list
93158414|NCT00313768|Carboplatin|carboplatin|mesh-list
93158415|NCT00313768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93158416|NCT00313768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158417|NCT00313768|Tubulin Modulators|tubulin modulators|mesh-ancestor
93158418|NCT00313768|Antimitotic Agents|antimitotic agents|mesh-ancestor
93158419|NCT00313768|Mitosis Modulators|mitosis modulators|mesh-ancestor
93158420|NCT00313768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158421|NCT00313768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158422|NCT00313768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93158423|NCT00313768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93158424|NCT00313768|Growth Substances|growth substances|mesh-ancestor
93158425|NCT00313768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158426|NCT00313768|Growth Inhibitors|growth inhibitors|mesh-ancestor
93158427|NCT01339988|Cyclophosphamide|cyclophosphamide|mesh-list
93158428|NCT01339988|Busulfan|busulfan|mesh-list
93158429|NCT01339988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158430|NCT01339988|Immunologic Factors|immunologic factors|mesh-ancestor
93158431|NCT01339988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158432|NCT01339988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158433|NCT01339988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93158434|NCT01339988|Alkylating Agents|alkylating agents|mesh-ancestor
93158435|NCT01339988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158436|NCT01339988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158437|NCT01339988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93158438|NCT00406588|Levodopa|levodopa|mesh-list
93158439|NCT00406588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93158440|NCT00406588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93158441|NCT00406588|Dopamine Agents|dopamine agents|mesh-ancestor
93158442|NCT00406588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158443|NCT00406588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158444|NCT00406588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158445|NCT01342328|Dexmedetomidine|dexmedetomidine|mesh-list
93158446|NCT01342328|Propofol|propofol|mesh-list
93158447|NCT01342328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93158448|NCT01342328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158449|NCT01342328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158450|NCT01342328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93158451|NCT01342328|Analgesics|analgesics|mesh-ancestor
93158452|NCT01342328|Sensory System Agents|sensory system agents|mesh-ancestor
93158453|NCT01342328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158454|NCT01342328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93158455|NCT01342328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93158456|NCT01342328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93158457|NCT01342328|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158458|NCT01342328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158459|NCT01342328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158460|NCT01342328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93158461|NCT01342328|Anesthetics, General|anesthetics, general|mesh-ancestor
93158462|NCT01342328|Anesthetics|anesthetics|mesh-ancestor
93158463|NCT00313222|Bosentan|bosentan|mesh-list
93158464|NCT00313222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158465|NCT00313222|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93158466|NCT00313222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158467|NCT05184530|Evolocumab|evolocumab|mesh-list
93158468|NCT05184530|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93158469|NCT05184530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93158470|NCT05184530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93158471|NCT05184530|Antimetabolites|antimetabolites|mesh-ancestor
93158472|NCT05184530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158473|NCT05184530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93158474|NCT05184530|Protease Inhibitors|protease inhibitors|mesh-ancestor
93158475|NCT05184530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158476|NCT05184530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93158477|NCT05184374|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93158478|NCT05184374|Hormones|hormones|mesh-ancestor
93158479|NCT05184374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158480|NCT05184374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158481|NCT05187494|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93158482|NCT05187494|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158483|NCT05187494|Anesthetics|anesthetics|mesh-ancestor
93158484|NCT05187494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158485|NCT05187494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928462|NCT02403687|Diclofenac|diclofenac|mesh-list
93158486|NCT05187494|Sensory System Agents|sensory system agents|mesh-ancestor
93158487|NCT05187494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158488|NCT05187494|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93158489|NCT01342562|Anesthetics|anesthetics|mesh-list
93158490|NCT01342562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158491|NCT01342562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158492|NCT00116116|Lamivudine|lamivudine|mesh-list
93158493|NCT00116116|Efavirenz|efavirenz|mesh-list
93158494|NCT00116116|Stavudine|stavudine|mesh-list
93158495|NCT00116116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93158496|NCT00116116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93158497|NCT00116116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158498|NCT00116116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158499|NCT00116116|Antiviral Agents|antiviral agents|mesh-ancestor
93158500|NCT00116116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158501|NCT00116116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93158502|NCT00116116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93158503|NCT00116116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93158504|NCT00116116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93158505|NCT00116116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93158506|NCT00116116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93158507|NCT00116116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93158508|NCT00116116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93158509|NCT00116116|Antimetabolites|antimetabolites|mesh-ancestor
93158510|NCT02287870|Lidocaine|lidocaine|mesh-list
93158511|NCT02287870|Chloroprocaine|chloroprocaine|mesh-list
93158512|NCT02287870|Procaine|procaine|mesh-list
93158513|NCT02287870|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158514|NCT02287870|Anesthetics|anesthetics|mesh-ancestor
93158515|NCT02287870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158516|NCT02287870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158517|NCT02287870|Sensory System Agents|sensory system agents|mesh-ancestor
93158518|NCT02287870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158519|NCT02287870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93158520|NCT02287870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93158521|NCT02287870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93158522|NCT02287870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158523|NCT02287870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158524|NCT01340456|Rifampin|rifampin|mesh-list
93158525|NCT01340456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93158526|NCT01340456|Antitubercular Agents|antitubercular agents|mesh-ancestor
93158527|NCT01340456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93158528|NCT01340456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158529|NCT01340456|Leprostatic Agents|leprostatic agents|mesh-ancestor
93158530|NCT01340456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93158531|NCT01340456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158532|NCT01340456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158533|NCT01340456|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93158534|NCT01340456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93158535|NCT01340456|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93158536|NCT01340456|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93158537|NCT01340456|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93158538|NCT01340456|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93158539|NCT00110422|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93158540|NCT00110422|Irbesartan|irbesartan|mesh-list
93158541|NCT00110422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158542|NCT00110422|Diuretics|diuretics|mesh-ancestor
93158543|NCT00110422|Natriuretic Agents|natriuretic agents|mesh-ancestor
93158544|NCT00110422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158545|NCT00110422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93158546|NCT00110422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158547|NCT00110422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158548|NCT00110422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93158549|NCT00110422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93158550|NCT00305656|Cediranib|cediranib|mesh-list
93158551|NCT00305656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158552|NCT00305656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158553|NCT00305656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158554|NCT00305656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93158556|NCT02284984|Belimumab|belimumab|mesh-list
93158557|NCT02284984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158558|NCT02284984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158559|NCT02284984|Immunologic Factors|immunologic factors|mesh-ancestor
93158560|NCT02284984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158561|NCT02284984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158562|NCT02284984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158563|NCT00305188|Leucovorin|leucovorin|mesh-list
93158564|NCT00305188|Fluorouracil|fluorouracil|mesh-list
93158565|NCT00305188|Oxaliplatin|oxaliplatin|mesh-list
93158566|NCT00305188|Xaliproden|xaliproden|mesh-list
93158567|NCT00305188|Antimetabolites|antimetabolites|mesh-ancestor
93158568|NCT00305188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158569|NCT00305188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158570|NCT00305188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158571|NCT00305188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158572|NCT00305188|Immunologic Factors|immunologic factors|mesh-ancestor
93158573|NCT00305188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158574|NCT00305188|Antidotes|antidotes|mesh-ancestor
93158575|NCT00305188|Protective Agents|protective agents|mesh-ancestor
93158576|NCT00305188|Vitamin B Complex|vitamin b complex|mesh-ancestor
93158577|NCT00305188|Vitamins|vitamins|mesh-ancestor
93158578|NCT00305188|Micronutrients|micronutrients|mesh-ancestor
93158579|NCT00305188|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93158580|NCT00305188|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93158581|NCT00305188|Serotonin Agents|serotonin agents|mesh-ancestor
93158582|NCT00305188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158583|NCT00297310|Tacrolimus|tacrolimus|mesh-list
93158584|NCT00297310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93158585|NCT00297310|Immunologic Factors|immunologic factors|mesh-ancestor
93158586|NCT00297310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158587|NCT00297310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93158588|NCT00297310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158589|NCT00297310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158590|NCT00095290|Ramipril|ramipril|mesh-list
93158591|NCT00095290|Irbesartan|irbesartan|mesh-list
93158592|NCT00095290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93158593|NCT00095290|Protease Inhibitors|protease inhibitors|mesh-ancestor
93158594|NCT00095290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158595|NCT00095290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158596|NCT00095290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158597|NCT00095290|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93158598|NCT00095290|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93158599|NCT01340846|Ketoconazole|ketoconazole|mesh-list
93158600|NCT01340846|Dabrafenib|dabrafenib|mesh-list
93158601|NCT01340846|Warfarin|warfarin|mesh-list
93158602|NCT01340846|Gemfibrozil|gemfibrozil|mesh-list
93158603|NCT01340846|Anticoagulants|anticoagulants|mesh-ancestor
93158604|NCT01340846|Antifungal Agents|antifungal agents|mesh-ancestor
93158605|NCT01340846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158606|NCT01340846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93158607|NCT01340846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93158608|NCT01340846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158609|NCT01340846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158610|NCT01340846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93158611|NCT01340846|Hormone Antagonists|hormone antagonists|mesh-ancestor
93158612|NCT01340846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158613|NCT01340846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158614|NCT01340846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93158615|NCT01340846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158616|NCT01340846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93158617|NCT01340846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93158618|NCT01340846|Antimetabolites|antimetabolites|mesh-ancestor
93158619|NCT01340846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93158620|NCT01340846|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93158621|NCT01342874|Inositol|inositol|mesh-list
93158622|NCT01342874|Vitamin B Complex|vitamin b complex|mesh-ancestor
93158623|NCT01342874|Vitamins|vitamins|mesh-ancestor
93158624|NCT01342874|Micronutrients|micronutrients|mesh-ancestor
93158625|NCT01342874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158626|NCT01337258|Dutasteride|dutasteride|mesh-list
93158627|NCT01337258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93158628|NCT01337258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93158629|NCT01337258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158630|NCT01337258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158631|NCT01337258|Hormone Antagonists|hormone antagonists|mesh-ancestor
93158632|NCT01337258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158633|NCT01337258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158634|NCT02603809|Lisinopril|lisinopril|mesh-list
93158635|NCT02603809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93158636|NCT02603809|Protease Inhibitors|protease inhibitors|mesh-ancestor
93158637|NCT02603809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158638|NCT02603809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158639|NCT02603809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158640|NCT02603809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93158641|NCT02603809|Protective Agents|protective agents|mesh-ancestor
93158642|NCT02603809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158643|NCT01341158|Interferons|interferons|mesh-list
93158644|NCT01341158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158645|NCT01341158|Antiviral Agents|antiviral agents|mesh-ancestor
93158646|NCT01341158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158647|NCT00393952|Fluticasone|fluticasone|mesh-list
93158648|NCT00393952|Xhance|xhance|mesh-list
93158649|NCT00393952|Formoterol Fumarate|formoterol fumarate|mesh-list
93158650|NCT00393952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158651|NCT00393952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93158652|NCT00393952|Autonomic Agents|autonomic agents|mesh-ancestor
93158653|NCT00393952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158654|NCT00393952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158655|NCT00393952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93158656|NCT00393952|Respiratory System Agents|respiratory system agents|mesh-ancestor
93158657|NCT00393952|Dermatologic Agents|dermatologic agents|mesh-ancestor
93158658|NCT00393952|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93158659|NCT00393952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93158660|NCT00393952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93158661|NCT00393952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93158662|NCT00393952|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158663|NCT00393952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158664|NCT00393952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158665|NCT02285374|Tenofovir|tenofovir|mesh-list
93158666|NCT02285374|Emtricitabine|emtricitabine|mesh-list
93158667|NCT02285374|Efavirenz|efavirenz|mesh-list
93158668|NCT02285374|Dolutegravir|dolutegravir|mesh-list
93158669|NCT02285374|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93158670|NCT02285374|Antiviral Agents|antiviral agents|mesh-ancestor
93158671|NCT02285374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158672|NCT02285374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93158673|NCT02285374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93158674|NCT02285374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158675|NCT02285374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158676|NCT02285374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93158677|NCT02285374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93158678|NCT02285374|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93158679|NCT02285374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93158680|NCT02285374|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93158681|NCT02285374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93158682|NCT02285374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93158683|NCT02285374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93158684|NCT02285374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93158685|NCT02285374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93158686|NCT01112449|Selenium|selenium|mesh-list
93158687|NCT01112449|Antioxidants|antioxidants|mesh-ancestor
93158688|NCT01112449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158689|NCT01112449|Protective Agents|protective agents|mesh-ancestor
93158690|NCT01112449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158691|NCT01112449|Trace Elements|trace elements|mesh-ancestor
93158692|NCT01112449|Micronutrients|micronutrients|mesh-ancestor
93158693|NCT01341392|Amlodipine|amlodipine|mesh-list
93158694|NCT01341392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158695|NCT01341392|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93158696|NCT01341392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158697|NCT01341392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158698|NCT01341392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93158699|NCT01341392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158700|NCT01341392|Vasodilator Agents|vasodilator agents|mesh-ancestor
93158701|NCT04390958|Paclitaxel|paclitaxel|mesh-list
93158702|NCT04390958|Capecitabine|capecitabine|mesh-list
93158703|NCT04390958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93158704|NCT04390958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158705|NCT04390958|Tubulin Modulators|tubulin modulators|mesh-ancestor
93158706|NCT04390958|Antimitotic Agents|antimitotic agents|mesh-ancestor
93158707|NCT04390958|Mitosis Modulators|mitosis modulators|mesh-ancestor
93158708|NCT04390958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158709|NCT04390958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158710|NCT04390958|Antimetabolites|antimetabolites|mesh-ancestor
93158711|NCT03943459|Atorvastatin|atorvastatin|mesh-list
93158712|NCT03943459|Quercetin|quercetin|mesh-list
93158713|NCT03943459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93158714|NCT03943459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93158715|NCT03943459|Antimetabolites|antimetabolites|mesh-ancestor
93158716|NCT03943459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158717|NCT03943459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93158718|NCT03943459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93158719|NCT03943459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158720|NCT03943459|Antioxidants|antioxidants|mesh-ancestor
93158721|NCT03943459|Protective Agents|protective agents|mesh-ancestor
93158722|NCT03943459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158723|NCT04832438|Carboplatin|carboplatin|mesh-list
93158724|NCT04832438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158725|NCT05182970|Metformin|metformin|mesh-list
93158726|NCT05182970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158727|NCT05182970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158728|NCT01315886|Fentanyl|fentanyl|mesh-list
93158729|NCT01315886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93158730|NCT01315886|Narcotics|narcotics|mesh-ancestor
93158731|NCT01315886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158732|NCT01315886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158733|NCT01315886|Analgesics|analgesics|mesh-ancestor
93158734|NCT01315886|Sensory System Agents|sensory system agents|mesh-ancestor
93158735|NCT01315886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158736|NCT01315886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93158737|NCT01315886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93158738|NCT01315886|Anesthetics, General|anesthetics, general|mesh-ancestor
93158739|NCT01315886|Anesthetics|anesthetics|mesh-ancestor
93158740|NCT00065728|Anecortave|anecortave|mesh-list
93158741|NCT00065728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93158742|NCT00065728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93158743|NCT00065728|Growth Substances|growth substances|mesh-ancestor
93158744|NCT00065728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158745|NCT00065728|Growth Inhibitors|growth inhibitors|mesh-ancestor
93158746|NCT00065728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158747|NCT00064714|Exenatide|exenatide|mesh-list
93158748|NCT00064714|Daclizumab|daclizumab|mesh-list
93158749|NCT00064714|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93158750|NCT00064714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158751|NCT00064714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158752|NCT00064714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93158753|NCT00064714|Incretins|incretins|mesh-ancestor
93158754|NCT00064714|Hormones|hormones|mesh-ancestor
93158755|NCT00064714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158756|NCT00064714|Immunologic Factors|immunologic factors|mesh-ancestor
93158757|NCT01109485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93158758|NCT01109485|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93158759|NCT01109485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93158760|NCT01109485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93158761|NCT01109485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93158762|NCT01109485|Analgesics|analgesics|mesh-ancestor
93158763|NCT01109485|Sensory System Agents|sensory system agents|mesh-ancestor
93158764|NCT01109485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158765|NCT01109485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158766|NCT01109485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158767|NCT01109485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158768|NCT01109485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93158769|NCT01109485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93158770|NCT01109485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93158771|NCT01109485|Histamine Antagonists|histamine antagonists|mesh-ancestor
93158772|NCT01109485|Histamine Agents|histamine agents|mesh-ancestor
93158773|NCT01109485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158774|NCT01109485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158775|NCT00292396|Antibodies|antibodies|mesh-list
93158776|NCT00292396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93158777|NCT00292396|Immunologic Factors|immunologic factors|mesh-ancestor
93158778|NCT00292396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158780|NCT03942289|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93158781|NCT03942289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93158782|NCT03942289|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158783|NCT03942289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158784|NCT03942289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158785|NCT03942289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158786|NCT03942289|Sympathomimetics|sympathomimetics|mesh-ancestor
93158787|NCT03942289|Autonomic Agents|autonomic agents|mesh-ancestor
93158788|NCT03942289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158789|NCT03942289|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93158790|NCT00284128|Losartan|losartan|mesh-list
93158791|NCT00284128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93158792|NCT00284128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93158793|NCT00284128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93158794|NCT00284128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93158795|NCT00284128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158796|NCT00035542|Metformin|metformin|mesh-list
93158797|NCT00035542|Glyburide|glyburide|mesh-list
93158798|NCT00035542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93158799|NCT00035542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158800|NCT01209715|Fluticasone|fluticasone|mesh-list
93158801|NCT01209715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93158802|NCT01209715|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93158803|NCT01209715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158804|NCT01209715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93158805|NCT01209715|Autonomic Agents|autonomic agents|mesh-ancestor
93158806|NCT01209715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158807|NCT01209715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158808|NCT01209715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93158809|NCT01209715|Respiratory System Agents|respiratory system agents|mesh-ancestor
93158810|NCT01209715|Dermatologic Agents|dermatologic agents|mesh-ancestor
93158811|NCT01209715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93158812|NCT01209715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93158813|NCT01209715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93158814|NCT01209715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93158815|NCT01209715|Adrenergic Agents|adrenergic agents|mesh-ancestor
93158816|NCT01209715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158817|NCT01209715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158818|NCT01209715|Glucocorticoids|glucocorticoids|mesh-ancestor
93158819|NCT01209715|Hormones|hormones|mesh-ancestor
93158820|NCT01209715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93158821|NCT01209715|Sympathomimetics|sympathomimetics|mesh-ancestor
93158822|NCT03740893|Durvalumab|durvalumab|mesh-list
93158823|NCT03740893|Olaparib|olaparib|mesh-list
93158824|NCT03740893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158825|NCT03740893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158826|NCT03740893|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93158827|NCT03740893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158828|NCT03740893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158829|NCT00005788|Aldesleukin|aldesleukin|mesh-list
93158830|NCT00005788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158831|NCT00005788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93158832|NCT00005788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93158833|NCT00005788|Antiviral Agents|antiviral agents|mesh-ancestor
93158834|NCT00005788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158835|NCT03945955|Melatonin|melatonin|mesh-list
93158836|NCT03945955|Antioxidants|antioxidants|mesh-ancestor
93158837|NCT03945955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158838|NCT03945955|Protective Agents|protective agents|mesh-ancestor
93158839|NCT03945955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158840|NCT03945955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158841|NCT00005608|Leucovorin|leucovorin|mesh-list
93158842|NCT00005608|Tegafur|tegafur|mesh-list
93158843|NCT00005608|Calcium|calcium|mesh-list
93158844|NCT00005608|Levoleucovorin|levoleucovorin|mesh-list
93158845|NCT00005608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93158846|NCT00005608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158847|NCT00005608|Antidotes|antidotes|mesh-ancestor
93158848|NCT00005608|Protective Agents|protective agents|mesh-ancestor
93158849|NCT00005608|Vitamin B Complex|vitamin b complex|mesh-ancestor
93158850|NCT00005608|Vitamins|vitamins|mesh-ancestor
93158851|NCT00005608|Micronutrients|micronutrients|mesh-ancestor
93158852|NCT00005608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158853|NCT00005608|Antimetabolites|antimetabolites|mesh-ancestor
93158854|NCT00005608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158855|NCT00005608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158857|NCT02288338|Ezetimibe|ezetimibe|mesh-list
92454600|NCT01700608|Antiviral Agents|antiviral agents|mesh-ancestor
93158858|NCT02288338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93158859|NCT02288338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93158860|NCT02288338|Antimetabolites|antimetabolites|mesh-ancestor
93158861|NCT02288338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158862|NCT02288338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93158863|NCT02288338|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93158864|NCT02288338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158865|NCT00388960|Etoposide|etoposide|mesh-list
93158866|NCT00388960|Amrubicin|amrubicin|mesh-list
93158867|NCT00388960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158868|NCT00388960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93158869|NCT00388960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93158870|NCT00388960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93158871|NCT00388960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158872|NCT00388960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158873|NCT03941899|Levobupivacaine|levobupivacaine|mesh-list
93158874|NCT03941899|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158875|NCT03941899|Anesthetics|anesthetics|mesh-ancestor
93158876|NCT03941899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158877|NCT03941899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158878|NCT03941899|Sensory System Agents|sensory system agents|mesh-ancestor
93158879|NCT03941899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158880|NCT00004912|Megestrol|megestrol|mesh-list
93158881|NCT00004912|Megestrol Acetate|megestrol acetate|mesh-list
93158882|NCT00004912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93158883|NCT00004912|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93158884|NCT00004912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93158885|NCT00004912|Contraceptive Agents|contraceptive agents|mesh-ancestor
93158886|NCT00004912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93158887|NCT00004912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158888|NCT00004912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93158889|NCT00004912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93158890|NCT00004912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93158891|NCT00004912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158892|NCT00004912|Appetite Stimulants|appetite stimulants|mesh-ancestor
93158893|NCT00004912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93158894|NCT02529787|Dexlansoprazole|dexlansoprazole|mesh-list
93158895|NCT02529787|Lansoprazole|lansoprazole|mesh-list
93158896|NCT02529787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93158897|NCT02529787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93158898|NCT02529787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93158899|NCT02529787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158900|NCT02529787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158901|NCT00267592|Temozolomide|temozolomide|mesh-list
93158902|NCT00267592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93158903|NCT00267592|Alkylating Agents|alkylating agents|mesh-ancestor
93158904|NCT00267592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158905|NCT00267592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158906|NCT00267280|Atorvastatin|atorvastatin|mesh-list
93158907|NCT00267280|Simvastatin|simvastatin|mesh-list
93158908|NCT00267280|Torcetrapib|torcetrapib|mesh-list
93158909|NCT00267280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93158910|NCT00267280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93158911|NCT00267280|Antimetabolites|antimetabolites|mesh-ancestor
93158912|NCT00267280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158913|NCT00267280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93158914|NCT00267280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93158915|NCT00267280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158916|NCT03530488|Lidocaine|lidocaine|mesh-list
93158917|NCT03530488|Anesthetics, Local|anesthetics, local|mesh-ancestor
93158918|NCT03530488|Anesthetics|anesthetics|mesh-ancestor
93158919|NCT03530488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93158920|NCT03530488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158921|NCT03530488|Sensory System Agents|sensory system agents|mesh-ancestor
93158922|NCT03530488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93158923|NCT03530488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93158924|NCT03530488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93158925|NCT03530488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93158926|NCT03530488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93158927|NCT03530488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158928|NCT00262990|Doxorubicin|doxorubicin|mesh-list
93158929|NCT00262990|Epothilone B|epothilone b|mesh-list
93158930|NCT00262990|Epothilones|epothilones|mesh-list
93158931|NCT00262990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93158932|NCT00262990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158933|NCT00262990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93158934|NCT00262990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93158935|NCT00262990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158936|NCT00262990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158937|NCT00262990|Tubulin Modulators|tubulin modulators|mesh-ancestor
93158938|NCT00262990|Antimitotic Agents|antimitotic agents|mesh-ancestor
93158939|NCT00262990|Mitosis Modulators|mitosis modulators|mesh-ancestor
93158940|NCT01110031|Ofatumumab|ofatumumab|mesh-list
93158941|NCT01110031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158942|NCT02741596|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93158943|NCT02741596|Immunologic Factors|immunologic factors|mesh-ancestor
93158944|NCT02741596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158945|NCT01210339|Esomeprazole|esomeprazole|mesh-list
93158946|NCT01210339|Clopidogrel|clopidogrel|mesh-list
93158947|NCT01210339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93158948|NCT01210339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93158949|NCT01210339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93158950|NCT01210339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93158951|NCT01210339|Purinergic Agents|purinergic agents|mesh-ancestor
93158952|NCT01210339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93158953|NCT01210339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158954|NCT01210339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93158955|NCT01210339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93158956|NCT01210339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93158957|NCT01210339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93158958|NCT01210339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158959|NCT03684694|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93158960|NCT03684694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93158961|NCT03684694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158962|NCT03147248|Infliximab|infliximab|mesh-list
93158963|NCT03147248|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93158964|NCT03147248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93158965|NCT03147248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93158966|NCT03147248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93158967|NCT03147248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93158968|NCT00250822|Gemcitabine|gemcitabine|mesh-list
93158969|NCT00250822|Oxaliplatin|oxaliplatin|mesh-list
93158970|NCT00250822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93158971|NCT00250822|Antimetabolites|antimetabolites|mesh-ancestor
93158972|NCT00250822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158973|NCT00250822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158974|NCT00004096|Carboplatin|carboplatin|mesh-list
93158975|NCT00004096|Vinorelbine|vinorelbine|mesh-list
93158976|NCT00004096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93158977|NCT00004096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93158978|NCT00004096|Tubulin Modulators|tubulin modulators|mesh-ancestor
93158979|NCT00004096|Antimitotic Agents|antimitotic agents|mesh-ancestor
93158980|NCT00004096|Mitosis Modulators|mitosis modulators|mesh-ancestor
93158981|NCT00004096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158982|NCT00002224|Nelfinavir|nelfinavir|mesh-list
93158983|NCT00002224|Didanosine|didanosine|mesh-list
93158984|NCT00002224|Stavudine|stavudine|mesh-list
93158985|NCT00002224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93158986|NCT00002224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93158987|NCT00002224|Protease Inhibitors|protease inhibitors|mesh-ancestor
93158988|NCT00002224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93158989|NCT00002224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93158990|NCT00002224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93158991|NCT00002224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93158992|NCT00002224|Antiviral Agents|antiviral agents|mesh-ancestor
93158993|NCT00002224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93158994|NCT00002224|Antimetabolites|antimetabolites|mesh-ancestor
93158995|NCT00002224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93158996|NCT00002224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93158997|NCT01207921|Lenalidomide|lenalidomide|mesh-list
93158998|NCT01207921|Immunologic Factors|immunologic factors|mesh-ancestor
93158999|NCT01207921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159000|NCT01207921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93159001|NCT01207921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93159002|NCT01207921|Growth Substances|growth substances|mesh-ancestor
93159003|NCT01207921|Growth Inhibitors|growth inhibitors|mesh-ancestor
93159004|NCT01207921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159005|NCT01108393|Agomelatine|agomelatine|mesh-list
93159006|NCT01108393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93159007|NCT01108393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159008|NCT01108393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159009|NCT01113229|Misoprostol|misoprostol|mesh-list
93159010|NCT01113229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93159011|NCT01113229|Abortifacient Agents|abortifacient agents|mesh-ancestor
93159012|NCT01113229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93159013|NCT01113229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159014|NCT01113229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93159015|NCT01113229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159016|NCT01113229|Oxytocics|oxytocics|mesh-ancestor
93159017|NCT03530176|Listerine|listerine|mesh-list
93159018|NCT03530176|Fluorides|fluorides|mesh-list
93159019|NCT03530176|Sodium Fluoride|sodium fluoride|mesh-list
93159020|NCT03530176|Cariostatic Agents|cariostatic agents|mesh-ancestor
93159021|NCT03530176|Protective Agents|protective agents|mesh-ancestor
93159022|NCT03530176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159023|NCT03530176|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93159024|NCT03530176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159025|NCT03151304|Azacitidine|azacitidine|mesh-list
93159026|NCT03151304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93159027|NCT03151304|Antimetabolites|antimetabolites|mesh-ancestor
93159028|NCT03151304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159029|NCT03151304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159030|NCT03151304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159031|NCT03530020|Lithium Carbonate|lithium carbonate|mesh-list
93159032|NCT03530020|Antidepressive Agents|antidepressive agents|mesh-ancestor
93159033|NCT03530020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93159034|NCT03530020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159035|NCT03530020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159036|NCT03530020|Antimanic Agents|antimanic agents|mesh-ancestor
93159037|NCT03530020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93159038|NCT03530020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159039|NCT03530020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159040|NCT02288962|Cabergoline|cabergoline|mesh-list
93159041|NCT02288962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93159042|NCT02288962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93159043|NCT02288962|Dopamine Agonists|dopamine agonists|mesh-ancestor
93159044|NCT02288962|Dopamine Agents|dopamine agents|mesh-ancestor
93159045|NCT02288962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159046|NCT02288962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159047|NCT02288962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159048|NCT03942991|Carticaine|carticaine|mesh-list
93159049|NCT03942991|Mepivacaine|mepivacaine|mesh-list
93159050|NCT03942991|Anesthetics, Local|anesthetics, local|mesh-ancestor
93159051|NCT03942991|Anesthetics|anesthetics|mesh-ancestor
93159052|NCT03942991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159053|NCT03942991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159054|NCT03942991|Sensory System Agents|sensory system agents|mesh-ancestor
93159055|NCT03942991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159056|NCT00162292|Methotrexate|methotrexate|mesh-list
93159057|NCT00162292|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93159058|NCT00162292|Abortifacient Agents|abortifacient agents|mesh-ancestor
93159059|NCT00162292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93159060|NCT00162292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159061|NCT00162292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93159062|NCT00162292|Antimetabolites|antimetabolites|mesh-ancestor
93159063|NCT00162292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159064|NCT00162292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159065|NCT00162292|Dermatologic Agents|dermatologic agents|mesh-ancestor
93159066|NCT00162292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159067|NCT00162292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93159068|NCT00162292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159069|NCT00162292|Immunologic Factors|immunologic factors|mesh-ancestor
93159070|NCT00162292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159071|NCT00162292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93159072|NCT00135382|Efavirenz|efavirenz|mesh-list
93159073|NCT00135382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93159074|NCT00135382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93159075|NCT00135382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159076|NCT00135382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159077|NCT00135382|Antiviral Agents|antiviral agents|mesh-ancestor
93159078|NCT00135382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159079|NCT00135382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93159080|NCT00135382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92454833|NCT01702038|Rituximab|rituximab|mesh-list
93159081|NCT00135382|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93159082|NCT00135382|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93159083|NCT00135382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93159084|NCT00135382|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93159085|NCT03531970|Dexamethasone|dexamethasone|mesh-list
93159086|NCT03531970|Dexamethasone acetate|dexamethasone acetate|mesh-list
93159087|NCT03531970|Lidocaine|lidocaine|mesh-list
93159088|NCT03531970|Epinephrine|epinephrine|mesh-list
93159089|NCT03531970|BB 1101|bb 1101|mesh-list
93159090|NCT03531970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159091|NCT03531970|Antiemetics|antiemetics|mesh-ancestor
93159092|NCT03531970|Autonomic Agents|autonomic agents|mesh-ancestor
93159093|NCT03531970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159094|NCT03531970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159095|NCT03531970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159096|NCT03531970|Glucocorticoids|glucocorticoids|mesh-ancestor
93159097|NCT03531970|Hormones|hormones|mesh-ancestor
93159098|NCT03531970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159099|NCT03531970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93159100|NCT03531970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159101|NCT03531970|Protease Inhibitors|protease inhibitors|mesh-ancestor
93159102|NCT03531970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159103|NCT03531970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159104|NCT03531970|Anesthetics, Local|anesthetics, local|mesh-ancestor
93159105|NCT03531970|Anesthetics|anesthetics|mesh-ancestor
93159106|NCT03531970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159107|NCT03531970|Sensory System Agents|sensory system agents|mesh-ancestor
93159108|NCT03531970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93159109|NCT03531970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93159110|NCT03531970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93159111|NCT03531970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93159112|NCT03531970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93159113|NCT03531970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93159114|NCT03531970|Adrenergic Agents|adrenergic agents|mesh-ancestor
93159115|NCT03531970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159116|NCT03531970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93159117|NCT03531970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93159118|NCT03531970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93159119|NCT03531970|Respiratory System Agents|respiratory system agents|mesh-ancestor
93159120|NCT03531970|Mydriatics|mydriatics|mesh-ancestor
93159121|NCT03531970|Sympathomimetics|sympathomimetics|mesh-ancestor
93159122|NCT03531970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93159123|NCT01211821|Metoprolol|metoprolol|mesh-list
93159124|NCT01211821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93159125|NCT01211821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93159126|NCT01211821|Sympatholytics|sympatholytics|mesh-ancestor
93159127|NCT01211821|Autonomic Agents|autonomic agents|mesh-ancestor
93159128|NCT01211821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159129|NCT01211821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159130|NCT01211821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93159131|NCT01211821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93159132|NCT01211821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93159133|NCT01211821|Adrenergic Agents|adrenergic agents|mesh-ancestor
93159134|NCT01211821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159135|NCT01211821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159136|NCT03527836|Lidocaine|lidocaine|mesh-list
93159137|NCT03527836|Bupivacaine|bupivacaine|mesh-list
93159138|NCT03527836|Anesthetics, Local|anesthetics, local|mesh-ancestor
93159139|NCT03527836|Anesthetics|anesthetics|mesh-ancestor
93159140|NCT03527836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159141|NCT03527836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159142|NCT03527836|Sensory System Agents|sensory system agents|mesh-ancestor
93159143|NCT03527836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159144|NCT03527836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93159145|NCT03527836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93159146|NCT03527836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93159147|NCT03527836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93159148|NCT03527836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159149|NCT05724862|Anesthetics|anesthetics|mesh-list
93159150|NCT05724862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831337|NCT00941330|Docetaxel|docetaxel|mesh-list
93159151|NCT05724862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159152|NCT03940651|Anesthetics|anesthetics|mesh-list
93159153|NCT03940651|Anesthetics, General|anesthetics, general|mesh-list
93159154|NCT03940651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159155|NCT03940651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159156|NCT03152552|Empagliflozin|empagliflozin|mesh-list
93159157|NCT03152552|Licogliflozin|licogliflozin|mesh-list
93159158|NCT03152552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93159159|NCT03152552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159160|NCT03152552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159161|NCT03152552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159162|NCT01211275|Cisplatin|cisplatin|mesh-list
93159163|NCT01211275|Pemetrexed|pemetrexed|mesh-list
93159164|NCT01211275|Axitinib|axitinib|mesh-list
93159165|NCT01211275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159166|NCT01211275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159167|NCT01211275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159168|NCT01211275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93159169|NCT01211275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93159170|NCT01211275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159171|NCT03529084|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93159172|NCT03529084|Gefitinib|gefitinib|mesh-list
93159173|NCT03529084|Nazartinib|nazartinib|mesh-list
93159174|NCT03529084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159175|NCT03529084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159176|NCT03529084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159177|NCT03529084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159178|NCT03942757|Bilirubin|bilirubin|mesh-list
93159179|NCT03942757|Antioxidants|antioxidants|mesh-ancestor
93159180|NCT03942757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159181|NCT03942757|Protective Agents|protective agents|mesh-ancestor
93159182|NCT03942757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159183|NCT05724628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93159184|NCT05724628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159185|NCT01208701|Atorvastatin|atorvastatin|mesh-list
93159186|NCT01208701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93159187|NCT01208701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93159188|NCT01208701|Antimetabolites|antimetabolites|mesh-ancestor
93159189|NCT01208701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159190|NCT01208701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93159191|NCT01208701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93159192|NCT01208701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159193|NCT03528772|Minoxidil|minoxidil|mesh-list
93159194|NCT03528772|Nitroglycerin|nitroglycerin|mesh-list
93159195|NCT03528772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93159196|NCT03528772|Vasodilator Agents|vasodilator agents|mesh-ancestor
93159197|NCT01316744|Ketamine|ketamine|mesh-list
93159198|NCT01316744|Analgesics|analgesics|mesh-ancestor
93159199|NCT01316744|Sensory System Agents|sensory system agents|mesh-ancestor
93159200|NCT01316744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159201|NCT01316744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159202|NCT01316744|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93159203|NCT01316744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93159204|NCT01316744|Anesthetics, General|anesthetics, general|mesh-ancestor
93159205|NCT01316744|Anesthetics|anesthetics|mesh-ancestor
93159206|NCT01316744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159207|NCT01316744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93159208|NCT01316744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93159209|NCT01316744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159210|NCT01316744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159211|NCT01213381|Carboplatin|carboplatin|mesh-list
93159212|NCT01213381|Gemcitabine|gemcitabine|mesh-list
93159213|NCT01213381|Iniparib|iniparib|mesh-list
93159214|NCT01213381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159215|NCT01213381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93159216|NCT01213381|Antimetabolites|antimetabolites|mesh-ancestor
93159217|NCT01213381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159218|NCT01213381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93159219|NCT01213381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159220|NCT01316978|Ibuprofen|ibuprofen|mesh-list
93159221|NCT01316978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93159222|NCT01316978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159223|NCT01316978|Analgesics|analgesics|mesh-ancestor
93159224|NCT01316978|Sensory System Agents|sensory system agents|mesh-ancestor
93159225|NCT01316978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159226|NCT01316978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159227|NCT01316978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159228|NCT01316978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159229|NCT01316978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93159230|NCT01316978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159231|NCT01316978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159232|NCT01317212|Carboplatin|carboplatin|mesh-list
93159233|NCT01317212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159234|NCT05250752|Dapagliflozin|dapagliflozin|mesh-list
93159235|NCT05250752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93159236|NCT05250752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159237|NCT05250752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159238|NCT05250752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159239|NCT01211509|Montelukast|montelukast|mesh-list
93159240|NCT01211509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93159241|NCT01211509|Respiratory System Agents|respiratory system agents|mesh-ancestor
93159242|NCT01211509|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93159243|NCT01211509|Hormone Antagonists|hormone antagonists|mesh-ancestor
93159244|NCT01211509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159245|NCT01211509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159246|NCT01211509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93159247|NCT01211509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93159248|NCT01211509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159249|NCT04791176|Lenvatinib|lenvatinib|mesh-list
93159250|NCT04791176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159251|NCT04791176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159252|NCT04791176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159253|NCT04791176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159254|NCT05072600|Pembrolizumab|pembrolizumab|mesh-list
93159255|NCT05072600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93159256|NCT05072600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159257|NCT05072600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159258|NCT05072600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159259|NCT04441528|Hyaluronic Acid|hyaluronic acid|mesh-list
93159260|NCT04441528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93159261|NCT04441528|Immunologic Factors|immunologic factors|mesh-ancestor
93159262|NCT04441528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159263|NCT04441528|Viscosupplements|viscosupplements|mesh-ancestor
93159264|NCT04441528|Protective Agents|protective agents|mesh-ancestor
93159265|NCT01344512|Ciprofloxacin|ciprofloxacin|mesh-list
93159266|NCT01344512|Ceftazidime|ceftazidime|mesh-list
93159267|NCT01344512|Voriconazole|voriconazole|mesh-list
93159268|NCT01344512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93159269|NCT01344512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159270|NCT01344512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93159271|NCT01344512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93159272|NCT01344512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159273|NCT01344512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159274|NCT01344512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159275|NCT01344512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93159276|NCT01344512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93159277|NCT01344512|Antifungal Agents|antifungal agents|mesh-ancestor
93159278|NCT01344512|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93159279|NCT01344512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93159280|NCT01344512|Hormone Antagonists|hormone antagonists|mesh-ancestor
93159281|NCT01344512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159282|NCT01344512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159283|NCT01344512|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93159284|NCT05064488|Metformin|metformin|mesh-list
93159285|NCT05064488|Digoxin|digoxin|mesh-list
93159286|NCT05064488|Sumatriptan|sumatriptan|mesh-list
93159287|NCT05064488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93159288|NCT05064488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159289|NCT05064488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159290|NCT05064488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93159291|NCT05064488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93159292|NCT05064488|Antimetabolites|antimetabolites|mesh-ancestor
93159293|NCT05064488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159294|NCT05064488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93159295|NCT05064488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93159296|NCT05064488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831504|NCT02563327|Pyridoxine|pyridoxine|mesh-list
93159297|NCT05064488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93159298|NCT05064488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93159299|NCT05064488|Protective Agents|protective agents|mesh-ancestor
93159300|NCT05064488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93159301|NCT05064488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93159302|NCT05064488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93159303|NCT05064488|Serotonin Agents|serotonin agents|mesh-ancestor
93159304|NCT05064488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159305|NCT01344590|Ethanol|ethanol|mesh-list
93159306|NCT01344590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93159307|NCT01344590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159308|NCT01344590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159309|NCT01344590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159310|NCT01114087|Imatinib Mesylate|imatinib mesylate|mesh-list
93159311|NCT01114087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159312|NCT01114087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159313|NCT01114087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159314|NCT01114087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159315|NCT01212133|Liraglutide|liraglutide|mesh-list
93159316|NCT01212133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159317|NCT01212133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159318|NCT01212133|Incretins|incretins|mesh-ancestor
93159319|NCT01212133|Hormones|hormones|mesh-ancestor
93159320|NCT01212133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159321|NCT04269356|Magnesium Oxide|magnesium oxide|mesh-list
93159322|NCT04269356|Magnesium Hydroxide|magnesium hydroxide|mesh-list
93159323|NCT04269356|Antacids|antacids|mesh-ancestor
93159324|NCT04269356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159325|NCT04269356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159326|NCT05214820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93159327|NCT05214820|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93159328|NCT05214820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159329|NCT01118065|Everolimus|everolimus|mesh-list
93159330|NCT01118065|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93159331|NCT01118065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159332|NCT01118065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159333|NCT01118065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159334|NCT01118065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159335|NCT01118065|Immunologic Factors|immunologic factors|mesh-ancestor
93159336|NCT01118065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159337|NCT01118065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159338|NCT03528616|Propranolol|propranolol|mesh-list
93159339|NCT03528616|Digoxin|digoxin|mesh-list
93159340|NCT03528616|Adenosine|adenosine|mesh-list
93159341|NCT03528616|Amiodarone|amiodarone|mesh-list
93159342|NCT03528616|Flecainide|flecainide|mesh-list
93159343|NCT03528616|Procainamide|procainamide|mesh-list
93159344|NCT03528616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93159345|NCT03528616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93159346|NCT03528616|Adrenergic Agents|adrenergic agents|mesh-ancestor
93159347|NCT03528616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159348|NCT03528616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159349|NCT03528616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159350|NCT03528616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93159351|NCT03528616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93159352|NCT03528616|Vasodilator Agents|vasodilator agents|mesh-ancestor
93159353|NCT03528616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93159354|NCT03528616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159355|NCT03528616|Protective Agents|protective agents|mesh-ancestor
93159356|NCT03528616|Analgesics|analgesics|mesh-ancestor
93159357|NCT03528616|Sensory System Agents|sensory system agents|mesh-ancestor
93159358|NCT03528616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159359|NCT03528616|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93159360|NCT03528616|Purinergic Agonists|purinergic agonists|mesh-ancestor
93159361|NCT03528616|Purinergic Agents|purinergic agents|mesh-ancestor
93159362|NCT03528616|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93159363|NCT03528616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93159364|NCT03528616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93159365|NCT03528616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93159366|NCT03528616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93159367|NCT03528616|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93159368|NCT03528616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92855029|NCT02852681|Hormone Antagonists|hormone antagonists|mesh-ancestor
93159369|NCT03528616|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93159370|NCT03528616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93159371|NCT02529631|Orlistat|orlistat|mesh-list
93159372|NCT02529631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159373|NCT02529631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159374|NCT02529631|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93159375|NCT02529631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93159376|NCT04469062|Mirikizumab|mirikizumab|mesh-list
93159377|NCT04469062|Vedolizumab|vedolizumab|mesh-list
93159378|NCT04469062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159379|NCT04469062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93159380|NCT04469062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159381|NCT04469062|Analgesics|analgesics|mesh-ancestor
93159382|NCT04469062|Sensory System Agents|sensory system agents|mesh-ancestor
93159383|NCT04469062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159384|NCT04469062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159385|NCT04469062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159386|NCT04469062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159387|NCT04469062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93159388|NCT03528538|Fenugreek seed meal|fenugreek seed meal|mesh-list
93159389|NCT03528538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159390|NCT03528538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159391|NCT03145766|Immunoglobulins|immunoglobulins|mesh-list
93159392|NCT03145766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93159393|NCT03145766|Antibodies|antibodies|mesh-list
93159394|NCT03145766|Immunologic Factors|immunologic factors|mesh-ancestor
93159395|NCT03145766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159396|NCT01115179|Propofol|propofol|mesh-list
93159397|NCT01115179|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93159398|NCT01115179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93159399|NCT01115179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159400|NCT01115179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159401|NCT01115179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93159402|NCT01115179|Anesthetics, General|anesthetics, general|mesh-ancestor
93159403|NCT01115179|Anesthetics|anesthetics|mesh-ancestor
93159404|NCT01115179|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93159405|NCT01115179|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93159406|NCT01115179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93159407|NCT04468438|Estrogens|estrogens|mesh-list
93159408|NCT04468438|Hormones|hormones|mesh-ancestor
93159409|NCT04468438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159410|NCT04468438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159411|NCT04468282|Vigabatrin|vigabatrin|mesh-list
93159412|NCT04468282|Anticonvulsants|anticonvulsants|mesh-ancestor
93159413|NCT04468282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159414|NCT04468282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159415|NCT04468282|GABA Agents|gaba agents|mesh-ancestor
93159416|NCT04468282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159417|NCT04468282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159418|NCT01121731|Interferons|interferons|mesh-list
93159419|NCT01121731|Interferon alpha-2|interferon alpha-2|mesh-list
93159420|NCT01121731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159421|NCT01121731|Antiviral Agents|antiviral agents|mesh-ancestor
93159422|NCT01121731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159423|NCT01215799|Bafetinib|bafetinib|mesh-list
93159424|NCT01215799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159425|NCT01215799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159426|NCT01215799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159427|NCT03145064|Zanubrutinib|zanubrutinib|mesh-list
93159428|NCT03145064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159429|NCT03145064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159430|NCT03145064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159431|NCT03145064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159432|NCT03527134|Amantadine|amantadine|mesh-list
93159433|NCT03527134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93159434|NCT03527134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93159435|NCT03527134|Antiviral Agents|antiviral agents|mesh-ancestor
93159436|NCT03527134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159437|NCT03527134|Dopamine Agents|dopamine agents|mesh-ancestor
93159438|NCT03527134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159439|NCT03527134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159440|NCT03527134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159441|NCT03527134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159442|NCT03527134|Analgesics|analgesics|mesh-ancestor
93159443|NCT03527134|Sensory System Agents|sensory system agents|mesh-ancestor
93159444|NCT03527134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159445|NCT01213693|Fluticasone|fluticasone|mesh-list
93159446|NCT01213693|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92831638|NCT04055233|Biguanides|biguanides|mesh-list
93159447|NCT01213693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159448|NCT01213693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93159449|NCT01213693|Autonomic Agents|autonomic agents|mesh-ancestor
93159450|NCT01213693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159451|NCT01213693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159452|NCT01213693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93159453|NCT01213693|Respiratory System Agents|respiratory system agents|mesh-ancestor
93159454|NCT01213693|Dermatologic Agents|dermatologic agents|mesh-ancestor
93159455|NCT01213693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93159456|NCT01213693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93159457|NCT01213693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93159458|NCT01213693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93159459|NCT01213693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93159460|NCT01213693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159461|NCT01213693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159462|NCT01213849|Fluticasone|fluticasone|mesh-list
93159464|NCT01213849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159465|NCT01213849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93159466|NCT01213849|Autonomic Agents|autonomic agents|mesh-ancestor
93159467|NCT01213849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159468|NCT01213849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159469|NCT01213849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93159470|NCT01213849|Respiratory System Agents|respiratory system agents|mesh-ancestor
93159471|NCT01213849|Dermatologic Agents|dermatologic agents|mesh-ancestor
93159472|NCT01213849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93159473|NCT01121809|Raltegravir Potassium|raltegravir potassium|mesh-list
93159474|NCT01121809|Etravirine|etravirine|mesh-list
93159475|NCT01121809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93159476|NCT01121809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93159477|NCT01121809|Antiviral Agents|antiviral agents|mesh-ancestor
93159478|NCT01121809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159479|NCT01121809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93159480|NCT01121809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93159481|NCT01121809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159482|NCT01121809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159483|NCT01121809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93159484|NCT01121809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93159485|NCT03937687|Caffeine|caffeine|mesh-list
93159486|NCT03937687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93159487|NCT03937687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159488|NCT03937687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93159489|NCT03937687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159490|NCT03937687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159491|NCT03937687|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93159492|NCT03937687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93159493|NCT03937687|Purinergic Agents|purinergic agents|mesh-ancestor
93159494|NCT03937687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159495|NCT05110144|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93159496|NCT05110144|Amitriptyline|amitriptyline|mesh-list
93159497|NCT05110144|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93159498|NCT05110144|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93159499|NCT05110144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93159500|NCT05110144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159501|NCT05110144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159502|NCT05110144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159503|NCT05110144|Analgesics|analgesics|mesh-ancestor
93159504|NCT05110144|Sensory System Agents|sensory system agents|mesh-ancestor
93159505|NCT05110144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159506|NCT05110144|Antidepressive Agents|antidepressive agents|mesh-ancestor
93159507|NCT05110144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93159508|NCT05110144|Dopamine Agents|dopamine agents|mesh-ancestor
93159509|NCT05110144|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93159510|NCT05110144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159511|NCT05110144|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93159512|NCT05110144|Adrenergic Agents|adrenergic agents|mesh-ancestor
93159513|NCT01212367|Interferons|interferons|mesh-list
93159514|NCT01212367|Interferon-alpha|interferon-alpha|mesh-list
93159515|NCT01212367|Interferon alpha-2|interferon alpha-2|mesh-list
93159516|NCT01212367|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93159517|NCT01212367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159518|NCT01212367|Antiviral Agents|antiviral agents|mesh-ancestor
93159519|NCT01212367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159520|NCT01212367|Immunologic Factors|immunologic factors|mesh-ancestor
93159521|NCT01212367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159522|NCT01216111|Paclitaxel|paclitaxel|mesh-list
93159523|NCT01216111|Docetaxel|docetaxel|mesh-list
93159524|NCT01216111|Cyclophosphamide|cyclophosphamide|mesh-list
93159525|NCT01216111|Fluorouracil|fluorouracil|mesh-list
93159526|NCT01216111|Epirubicin|epirubicin|mesh-list
93159527|NCT01216111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93159528|NCT01216111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159529|NCT01216111|Tubulin Modulators|tubulin modulators|mesh-ancestor
93159530|NCT01216111|Antimitotic Agents|antimitotic agents|mesh-ancestor
93159531|NCT01216111|Mitosis Modulators|mitosis modulators|mesh-ancestor
93159532|NCT01216111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159533|NCT01216111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159534|NCT01216111|Immunologic Factors|immunologic factors|mesh-ancestor
93159535|NCT01216111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159536|NCT01216111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159537|NCT01216111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93159538|NCT01216111|Alkylating Agents|alkylating agents|mesh-ancestor
93159539|NCT01216111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93159540|NCT01216111|Antimetabolites|antimetabolites|mesh-ancestor
93159541|NCT01216111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93159542|NCT01216111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93159543|NCT01216111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93159544|NCT01216111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93159545|NCT01216111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159546|NCT01216267|Lansoprazole|lansoprazole|mesh-list
93159547|NCT01216267|Dexlansoprazole|dexlansoprazole|mesh-list
93159548|NCT01216267|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93159549|NCT01216267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159550|NCT01216267|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93159551|NCT01216267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159552|NCT01216267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159553|NCT01216345|Gemcitabine|gemcitabine|mesh-list
93159554|NCT01216345|Oxaliplatin|oxaliplatin|mesh-list
93159555|NCT01216345|Cetuximab|cetuximab|mesh-list
93159556|NCT01216345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93159557|NCT01216345|Antimetabolites|antimetabolites|mesh-ancestor
93159558|NCT01216345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159559|NCT01216345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159560|NCT01216345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159561|NCT01118533|Pyrithione zinc|pyrithione zinc|mesh-list
93159562|NCT01118533|Keratolytic Agents|keratolytic agents|mesh-ancestor
93159563|NCT01118533|Dermatologic Agents|dermatologic agents|mesh-ancestor
93159564|NCT01118611|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93159565|NCT01118611|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93159566|NCT01118611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159567|NCT01212523|Propofol|propofol|mesh-list
93159568|NCT01212523|Isoflurane|isoflurane|mesh-list
93159569|NCT01212523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93159570|NCT01212523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159571|NCT01212523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159572|NCT01212523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93159573|NCT01212523|Anesthetics, General|anesthetics, general|mesh-ancestor
93159574|NCT01212523|Anesthetics|anesthetics|mesh-ancestor
93159575|NCT01212523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93159576|NCT01122121|Leuprolide|leuprolide|mesh-list
93159577|NCT01122121|Flutamide|flutamide|mesh-list
93159578|NCT01122121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93159579|NCT01122121|Fertility Agents|fertility agents|mesh-ancestor
93159580|NCT01122121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93159581|NCT01122121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159582|NCT01122121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93159583|NCT01122121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159584|NCT01122121|Androgen Antagonists|androgen antagonists|mesh-ancestor
93159585|NCT01122121|Hormone Antagonists|hormone antagonists|mesh-ancestor
93159586|NCT01122121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159587|NCT01115725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93159588|NCT01115725|Hormones|hormones|mesh-ancestor
93159589|NCT01115725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159590|NCT01115725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159591|NCT01122199|Everolimus|everolimus|mesh-list
93159592|NCT01122199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93159593|NCT01122199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159594|NCT01122199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159595|NCT01122199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159596|NCT01122199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159597|NCT01122199|Immunologic Factors|immunologic factors|mesh-ancestor
93159598|NCT01122199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159599|NCT01122199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159600|NCT01118923|Magnesium Hydroxide|magnesium hydroxide|mesh-list
93159601|NCT01118923|Antacids|antacids|mesh-ancestor
93159602|NCT01118923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159603|NCT01118923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159604|NCT01119079|Anesthetics|anesthetics|mesh-list
93159605|NCT01119079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159606|NCT01119079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159607|NCT04503616|Cyclophosphamide|cyclophosphamide|mesh-list
93159608|NCT04503616|Abatacept|abatacept|mesh-list
93159609|NCT04503616|Tacrolimus|tacrolimus|mesh-list
93159610|NCT04503616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159611|NCT04503616|Immunologic Factors|immunologic factors|mesh-ancestor
93159612|NCT04503616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159613|NCT04503616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159614|NCT04503616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93159615|NCT04503616|Alkylating Agents|alkylating agents|mesh-ancestor
93159616|NCT04503616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159617|NCT04503616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159618|NCT04503616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93159619|NCT04503616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93159620|NCT04503616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159621|NCT04503616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93159622|NCT04503616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159623|NCT01119157|Vaccines|vaccines|mesh-list
93159624|NCT01119157|Immunologic Factors|immunologic factors|mesh-ancestor
93159625|NCT01119157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159626|NCT01120015|Diacerein|diacerein|mesh-list
93159627|NCT01120015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159628|NCT05405452|Ethyl Chloride|ethyl chloride|mesh-list
93159629|NCT05405452|Anesthetics|anesthetics|mesh-ancestor
93159630|NCT05405452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159631|NCT05405452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159632|NCT05405452|Anesthetics, Local|anesthetics, local|mesh-ancestor
93159633|NCT05405452|Sensory System Agents|sensory system agents|mesh-ancestor
93159634|NCT05405452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159635|NCT01216579|Mannitol|mannitol|mesh-list
93159636|NCT01216579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93159637|NCT01216579|Diuretics|diuretics|mesh-ancestor
93159638|NCT01216579|Natriuretic Agents|natriuretic agents|mesh-ancestor
93159639|NCT01216579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159640|NCT03528070|Tranilast|tranilast|mesh-list
93159641|NCT03528070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93159642|NCT03528070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159643|NCT03528070|Analgesics|analgesics|mesh-ancestor
93159644|NCT03528070|Sensory System Agents|sensory system agents|mesh-ancestor
93159645|NCT03528070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159646|NCT03528070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159647|NCT03528070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159648|NCT03528070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159649|NCT03528070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93159650|NCT03528070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93159651|NCT03528070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159652|NCT03528070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93159653|NCT03528070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93159654|NCT03528070|Histamine Antagonists|histamine antagonists|mesh-ancestor
93159655|NCT03528070|Histamine Agents|histamine agents|mesh-ancestor
93159656|NCT03528070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159657|NCT03528070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93159658|NCT03528070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93159659|NCT03935815|Ropivacaine|ropivacaine|mesh-list
93159660|NCT03935815|Anesthetics, Local|anesthetics, local|mesh-ancestor
93159661|NCT03935815|Anesthetics|anesthetics|mesh-ancestor
93159662|NCT03935815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159663|NCT03935815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159664|NCT03935815|Sensory System Agents|sensory system agents|mesh-ancestor
93159665|NCT03935815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159666|NCT01216657|Sunitinib|sunitinib|mesh-list
93159667|NCT01216657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159668|NCT01216657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93159669|NCT01216657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93159670|NCT01216657|Growth Substances|growth substances|mesh-ancestor
93159671|NCT01216657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159672|NCT01216657|Growth Inhibitors|growth inhibitors|mesh-ancestor
93159673|NCT01216657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159674|NCT01216657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159675|NCT01216657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159676|NCT04400188|Temozolomide|temozolomide|mesh-list
93159677|NCT04400188|Fluzoparib|fluzoparib|mesh-list
93159678|NCT04400188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93159679|NCT04400188|Alkylating Agents|alkylating agents|mesh-ancestor
93159680|NCT04400188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159681|NCT04400188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159682|NCT04400188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93159683|NCT04400188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159684|NCT04163458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93159685|NCT04163458|Menotropins|menotropins|mesh-list
93159686|NCT04163458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93159687|NCT04163458|Fertility Agents|fertility agents|mesh-ancestor
93159688|NCT04163458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93159689|NCT04163458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159690|NCT04902040|Pembrolizumab|pembrolizumab|mesh-list
93159691|NCT04902040|Nivolumab|nivolumab|mesh-list
93159692|NCT04902040|Atezolizumab|atezolizumab|mesh-list
93159693|NCT04902040|Durvalumab|durvalumab|mesh-list
93159694|NCT04902040|Avelumab|avelumab|mesh-list
93159695|NCT04902040|Immunoglobulins|immunoglobulins|mesh-list
93159696|NCT04902040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93159697|NCT04902040|Immunoglobulin G|immunoglobulin g|mesh-list
93159698|NCT04902040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159699|NCT04902040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159700|NCT04902040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93159701|NCT04902040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159702|NCT04902040|Immunologic Factors|immunologic factors|mesh-ancestor
93159703|NCT04902040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159704|NCT01115959|Valproic Acid|valproic acid|mesh-list
93159705|NCT01115959|Anticonvulsants|anticonvulsants|mesh-ancestor
93159706|NCT01115959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159707|NCT01115959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159708|NCT01115959|GABA Agents|gaba agents|mesh-ancestor
93159709|NCT01115959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159710|NCT01115959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159711|NCT01115959|Antimanic Agents|antimanic agents|mesh-ancestor
93159712|NCT01115959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93159713|NCT01115959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159714|NCT01115959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93159715|NCT03936907|Nabiximols|nabiximols|mesh-list
93159716|NCT03936907|Analgesics|analgesics|mesh-ancestor
93159717|NCT03936907|Sensory System Agents|sensory system agents|mesh-ancestor
93159718|NCT03936907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159719|NCT03936907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159720|NCT01116115|Palmitic Acid|palmitic acid|mesh-list
93159721|NCT01116115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159722|NCT01116115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159723|NCT01217203|Lenalidomide|lenalidomide|mesh-list
93159724|NCT01217203|Immunologic Factors|immunologic factors|mesh-ancestor
93159725|NCT01217203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159726|NCT01217203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93159727|NCT01217203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93159728|NCT01217203|Growth Substances|growth substances|mesh-ancestor
93159729|NCT01217203|Growth Inhibitors|growth inhibitors|mesh-ancestor
93159730|NCT01217203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159731|NCT01120171|Cyclophosphamide|cyclophosphamide|mesh-list
93159732|NCT01120171|Doxorubicin|doxorubicin|mesh-list
93159733|NCT01120171|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93159734|NCT01120171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159735|NCT01120171|Immunologic Factors|immunologic factors|mesh-ancestor
93159736|NCT01120171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159737|NCT01120171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159738|NCT01120171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93159739|NCT01120171|Alkylating Agents|alkylating agents|mesh-ancestor
93159740|NCT01120171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159741|NCT01120171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159742|NCT01120171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93159743|NCT01120171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93159744|NCT01120171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93159745|NCT01120171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93159746|NCT01120171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831938|NCT00685945|Bradykinin|bradykinin|mesh-list
93159747|NCT01116193|Dexamethasone|dexamethasone|mesh-list
93159748|NCT01116193|Lenalidomide|lenalidomide|mesh-list
93159749|NCT01116193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159750|NCT01116193|Antiemetics|antiemetics|mesh-ancestor
93159751|NCT01116193|Autonomic Agents|autonomic agents|mesh-ancestor
93159752|NCT01116193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159753|NCT01116193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159754|NCT01116193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159755|NCT01116193|Glucocorticoids|glucocorticoids|mesh-ancestor
93159756|NCT01116193|Hormones|hormones|mesh-ancestor
93159757|NCT01116193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159758|NCT01116193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93159759|NCT01116193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159760|NCT01116193|Immunologic Factors|immunologic factors|mesh-ancestor
93159761|NCT01116193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93159762|NCT01116193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93159763|NCT01116193|Growth Substances|growth substances|mesh-ancestor
93159764|NCT01116193|Growth Inhibitors|growth inhibitors|mesh-ancestor
93159765|NCT01120327|Amlodipine|amlodipine|mesh-list
93159766|NCT01120327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93159767|NCT01120327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93159768|NCT01120327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93159769|NCT01120327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159770|NCT01120327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93159771|NCT01120327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159772|NCT01120327|Vasodilator Agents|vasodilator agents|mesh-ancestor
93159773|NCT01116271|Irinotecan|irinotecan|mesh-list
93159774|NCT01116271|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93159775|NCT01116271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93159776|NCT01116271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159777|NCT01116271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159778|NCT01116271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159779|NCT01217359|Interferons|interferons|mesh-list
93159780|NCT01217359|Interferon-alpha|interferon-alpha|mesh-list
93159781|NCT01217359|Interferon alpha-2|interferon alpha-2|mesh-list
93159782|NCT01217359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159783|NCT01217359|Antiviral Agents|antiviral agents|mesh-ancestor
93159784|NCT01217359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159785|NCT01217359|Immunologic Factors|immunologic factors|mesh-ancestor
93159786|NCT01217359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159787|NCT03225664|Pembrolizumab|pembrolizumab|mesh-list
93159788|NCT03225664|Trametinib|trametinib|mesh-list
93159789|NCT03225664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159790|NCT03225664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159791|NCT03225664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93159792|NCT03225664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159793|NCT03225664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93159794|NCT03225664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159795|NCT01212679|Mitogens|mitogens|mesh-list
93159796|NCT01212679|Mitosis Modulators|mitosis modulators|mesh-ancestor
93159797|NCT01212679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159798|NCT03193684|Empagliflozin|empagliflozin|mesh-list
93159799|NCT03193684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93159800|NCT03193684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159801|NCT03193684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159802|NCT03193684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159803|NCT01217671|Protease Inhibitors|protease inhibitors|mesh-list
93159804|NCT01217671|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93159805|NCT01217671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159806|NCT01217671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159807|NCT01217671|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93159808|NCT01217671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93159809|NCT01116583|Gabapentin|gabapentin|mesh-list
93159810|NCT01116583|Analgesics|analgesics|mesh-ancestor
93159811|NCT01116583|Sensory System Agents|sensory system agents|mesh-ancestor
93159812|NCT01116583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159813|NCT01116583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159814|NCT01116583|Anticonvulsants|anticonvulsants|mesh-ancestor
93159815|NCT01116583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93159816|NCT01116583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93159817|NCT01116583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159818|NCT01116583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93159819|NCT01116583|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93159820|NCT01116583|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93159821|NCT01116583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159822|NCT01116583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159823|NCT01116583|Antimanic Agents|antimanic agents|mesh-ancestor
93159824|NCT04299490|Analgesics|analgesics|mesh-list
93159825|NCT04299490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159826|NCT04299490|Sensory System Agents|sensory system agents|mesh-ancestor
93159827|NCT04299490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159828|NCT03935347|Vidarabine|vidarabine|mesh-list
93159829|NCT03935347|Aldesleukin|aldesleukin|mesh-list
93159830|NCT03935347|Cyclophosphamide|cyclophosphamide|mesh-list
93159831|NCT03935347|Pembrolizumab|pembrolizumab|mesh-list
93159832|NCT03935347|Fludarabine|fludarabine|mesh-list
93159833|NCT03935347|Fludarabine phosphate|fludarabine phosphate|mesh-list
93159834|NCT03935347|Interleukin-2|interleukin-2|mesh-list
93159835|NCT03935347|Immunoglobulins|immunoglobulins|mesh-list
93159836|NCT03935347|Immunoglobulin G|immunoglobulin g|mesh-list
93159837|NCT03935347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159838|NCT03935347|Immunologic Factors|immunologic factors|mesh-ancestor
93159839|NCT03935347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159840|NCT03935347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93159841|NCT03935347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93159842|NCT03935347|Alkylating Agents|alkylating agents|mesh-ancestor
93159843|NCT03935347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159844|NCT03935347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159845|NCT03935347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93159846|NCT03935347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159847|NCT03935347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93159848|NCT03935347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93159849|NCT03935347|Antimetabolites|antimetabolites|mesh-ancestor
93159850|NCT03935347|Antiviral Agents|antiviral agents|mesh-ancestor
93159851|NCT03935347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159852|NCT03935347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159853|NCT03935347|Analgesics|analgesics|mesh-ancestor
93159854|NCT03935347|Sensory System Agents|sensory system agents|mesh-ancestor
93159855|NCT03935347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159856|NCT03935347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93159857|NCT03935347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93159858|NCT04467346|Temozolomide|temozolomide|mesh-list
93159859|NCT04467346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93159860|NCT04467346|Alkylating Agents|alkylating agents|mesh-ancestor
93159861|NCT04467346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159862|NCT04467346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159863|NCT03939871|Vinorelbine|vinorelbine|mesh-list
93159864|NCT03939871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93159865|NCT03939871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159866|NCT03939871|Tubulin Modulators|tubulin modulators|mesh-ancestor
93159867|NCT03939871|Antimitotic Agents|antimitotic agents|mesh-ancestor
93159868|NCT03939871|Mitosis Modulators|mitosis modulators|mesh-ancestor
93159869|NCT03939871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159870|NCT01122667|Anacetrapib|anacetrapib|mesh-list
93159871|NCT01122667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93159872|NCT01122667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93159873|NCT01122667|Antimetabolites|antimetabolites|mesh-ancestor
93159874|NCT01122667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159875|NCT01122667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93159876|NCT01120561|Trastuzumab|trastuzumab|mesh-list
93159877|NCT01120561|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93159878|NCT01120561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159879|NCT01120561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159880|NCT01120561|Immunotoxins|immunotoxins|mesh-ancestor
93159881|NCT01120561|Immunoconjugates|immunoconjugates|mesh-ancestor
93159882|NCT01120561|Immunologic Factors|immunologic factors|mesh-ancestor
93159883|NCT01120561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159884|NCT01120561|Tubulin Modulators|tubulin modulators|mesh-ancestor
93159885|NCT01120561|Antimitotic Agents|antimitotic agents|mesh-ancestor
93159886|NCT01120561|Mitosis Modulators|mitosis modulators|mesh-ancestor
92855034|NCT02852681|Natriuretic Agents|natriuretic agents|mesh-ancestor
93159887|NCT01120561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159888|NCT01217125|Sirolimus|sirolimus|mesh-list
93159889|NCT01217125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93159890|NCT01217125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159891|NCT01217125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93159892|NCT01217125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159893|NCT01217125|Antifungal Agents|antifungal agents|mesh-ancestor
93159894|NCT01217125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93159895|NCT01217125|Immunologic Factors|immunologic factors|mesh-ancestor
93159896|NCT01217125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159897|NCT03936517|Prednisolone|prednisolone|mesh-list
93159898|NCT03936517|Hydrocortisone|hydrocortisone|mesh-list
93159899|NCT03936517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159900|NCT03936517|Glucocorticoids|glucocorticoids|mesh-ancestor
93159901|NCT03936517|Hormones|hormones|mesh-ancestor
93159902|NCT03936517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159903|NCT03936517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159904|NCT03936517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93159905|NCT03936517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159906|NCT03635372|Sucralfate|sucralfate|mesh-list
93159907|NCT03635372|Hydrotalcite|hydrotalcite|mesh-list
93159908|NCT03635372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93159909|NCT03635372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159910|NCT03635372|Antacids|antacids|mesh-ancestor
93159911|NCT03635372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159912|NCT01116817|Ritonavir|ritonavir|mesh-list
93159913|NCT01116817|Lopinavir|lopinavir|mesh-list
93159914|NCT01116817|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93159915|NCT01116817|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93159916|NCT01116817|Protease Inhibitors|protease inhibitors|mesh-ancestor
93159917|NCT01116817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93159918|NCT01116817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159919|NCT01116817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93159920|NCT01116817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93159921|NCT01116817|Antiviral Agents|antiviral agents|mesh-ancestor
93159922|NCT01116817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159923|NCT01116817|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93159924|NCT01116817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93159925|NCT01120795|Interferons|interferons|mesh-list
93159926|NCT01120795|Ribavirin|ribavirin|mesh-list
93159927|NCT01120795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93159928|NCT01120795|Interferon-alpha|interferon-alpha|mesh-list
93159929|NCT01120795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159930|NCT01120795|Antiviral Agents|antiviral agents|mesh-ancestor
93159931|NCT01120795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93159932|NCT01120795|Antimetabolites|antimetabolites|mesh-ancestor
93159933|NCT01120795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159934|NCT01120795|Immunologic Factors|immunologic factors|mesh-ancestor
93159935|NCT01120795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159936|NCT04467892|Methylprednisolone|methylprednisolone|mesh-list
93159937|NCT04467892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93159938|NCT04467892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93159939|NCT04467892|Prednisolone|prednisolone|mesh-list
93159940|NCT04467892|Prednisolone acetate|prednisolone acetate|mesh-list
93159941|NCT04467892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93159942|NCT04467892|Prednisolone phosphate|prednisolone phosphate|mesh-list
93159943|NCT04467892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93159944|NCT04467892|Antiemetics|antiemetics|mesh-ancestor
93159945|NCT04467892|Autonomic Agents|autonomic agents|mesh-ancestor
93159946|NCT04467892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159947|NCT04467892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159948|NCT04467892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93159949|NCT04467892|Glucocorticoids|glucocorticoids|mesh-ancestor
93159950|NCT04467892|Hormones|hormones|mesh-ancestor
93159951|NCT04467892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93159952|NCT04467892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93159953|NCT04467892|Protective Agents|protective agents|mesh-ancestor
93159954|NCT04467892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93159955|NCT04467892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159956|NCT01122979|Insulin|insulin|mesh-list
93159957|NCT01122979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93159958|NCT01122979|Insulin Glargine|insulin glargine|mesh-list
93159959|NCT01122979|Insulin glulisine|insulin glulisine|mesh-list
93159960|NCT01122979|Insulin, Isophane|insulin, isophane|mesh-list
93159961|NCT01122979|Isophane Insulin, Human|isophane insulin, human|mesh-list
93159962|NCT01122979|Isophane insulin, beef|isophane insulin, beef|mesh-list
93159963|NCT01122979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93159964|NCT01122979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159965|NCT04179110|Pembrolizumab|pembrolizumab|mesh-list
93159966|NCT04179110|Ramucirumab|ramucirumab|mesh-list
93159967|NCT04179110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93159968|NCT04179110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159969|NCT04179110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93159970|NCT04179110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832164|NCT00752479|Hormones|hormones|mesh-ancestor
93159971|NCT01123057|Riboflavin|riboflavin|mesh-list
93159972|NCT01123057|Vitamin B Complex|vitamin b complex|mesh-ancestor
93159973|NCT01123057|Vitamins|vitamins|mesh-ancestor
93159975|NCT01123057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159976|NCT01123057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93159977|NCT01123057|Dermatologic Agents|dermatologic agents|mesh-ancestor
93159978|NCT03524950|Dexmedetomidine|dexmedetomidine|mesh-list
93159979|NCT03524950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93159980|NCT03524950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93159981|NCT03524950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93159982|NCT03524950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93159983|NCT03524950|Analgesics|analgesics|mesh-ancestor
93159984|NCT03524950|Sensory System Agents|sensory system agents|mesh-ancestor
93159985|NCT03524950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93159986|NCT03524950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93159987|NCT03524950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93159988|NCT03524950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93159989|NCT03524950|Adrenergic Agents|adrenergic agents|mesh-ancestor
93159990|NCT03524950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93159991|NCT03524950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93159992|NCT04714190|Paclitaxel|paclitaxel|mesh-list
93159993|NCT04714190|Irinotecan|irinotecan|mesh-list
93159994|NCT04714190|Apatinib|apatinib|mesh-list
93159995|NCT04714190|Trastuzumab|trastuzumab|mesh-list
93159996|NCT04714190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93159997|NCT04714190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93159998|NCT04714190|Tubulin Modulators|tubulin modulators|mesh-ancestor
93159999|NCT04714190|Antimitotic Agents|antimitotic agents|mesh-ancestor
93160000|NCT04714190|Mitosis Modulators|mitosis modulators|mesh-ancestor
93160001|NCT04714190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160002|NCT04714190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93160003|NCT04714190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93160004|NCT04714190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160005|NCT04714190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160006|NCT04714190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160007|NCT03524872|Analgesics|analgesics|mesh-list
93160008|NCT03524872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160009|NCT03524872|Sensory System Agents|sensory system agents|mesh-ancestor
93160010|NCT03524872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160011|NCT04143724|Luspatercept|luspatercept|mesh-list
93160012|NCT04143724|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93160013|NCT04143724|Hematinics|hematinics|mesh-ancestor
93160014|NCT04143724|Immunologic Factors|immunologic factors|mesh-ancestor
93160015|NCT04143724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160016|NCT01345370|Temozolomide|temozolomide|mesh-list
93160017|NCT01345370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93160018|NCT01345370|Alkylating Agents|alkylating agents|mesh-ancestor
93160019|NCT01345370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160020|NCT01345370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160021|NCT04702802|Hyaluronic Acid|hyaluronic acid|mesh-list
93160022|NCT04702802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93160023|NCT04702802|Immunologic Factors|immunologic factors|mesh-ancestor
93160024|NCT04702802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160025|NCT04702802|Viscosupplements|viscosupplements|mesh-ancestor
93160026|NCT04702802|Protective Agents|protective agents|mesh-ancestor
93160027|NCT01214941|Itraconazole|itraconazole|mesh-list
93160028|NCT01214941|Ticlopidine|ticlopidine|mesh-list
93160029|NCT01214941|Antifungal Agents|antifungal agents|mesh-ancestor
93160030|NCT01214941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160031|NCT01214941|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93160032|NCT01214941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93160033|NCT01214941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160034|NCT01214941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160035|NCT01214941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93160036|NCT01214941|Hormone Antagonists|hormone antagonists|mesh-ancestor
92855035|NCT02754180|Gemcitabine|gemcitabine|mesh-list
93160037|NCT01214941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160038|NCT01214941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160039|NCT01214941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93160040|NCT01214941|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93160041|NCT01214941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93160042|NCT01214941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93160043|NCT01214941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93160044|NCT01214941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93160045|NCT01214941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93160046|NCT01214941|Purinergic Agents|purinergic agents|mesh-ancestor
93160047|NCT01214941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160048|NCT01214941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93160049|NCT05301634|Bupivacaine|bupivacaine|mesh-list
93160050|NCT05301634|Anesthetics, Local|anesthetics, local|mesh-ancestor
93160051|NCT05301634|Anesthetics|anesthetics|mesh-ancestor
93160052|NCT05301634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160053|NCT05301634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160054|NCT05301634|Sensory System Agents|sensory system agents|mesh-ancestor
93160055|NCT05301634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160056|NCT01328821|Pentoxifylline|pentoxifylline|mesh-list
93160057|NCT01328821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93160058|NCT01328821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160059|NCT01328821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160060|NCT01328821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93160061|NCT01328821|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93160062|NCT01328821|Protective Agents|protective agents|mesh-ancestor
93160063|NCT01328821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160064|NCT01328821|Vasodilator Agents|vasodilator agents|mesh-ancestor
93160065|NCT01328821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93160066|NCT01328821|Antioxidants|antioxidants|mesh-ancestor
93160067|NCT04082572|Pembrolizumab|pembrolizumab|mesh-list
93160068|NCT04082572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160069|NCT04082572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160070|NCT04082572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93160071|NCT04082572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160072|NCT01345448|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93160073|NCT01345448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93160074|NCT01345448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93160075|NCT01345448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93160076|NCT01345448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93160077|NCT01345448|Adrenergic Agents|adrenergic agents|mesh-ancestor
93160078|NCT01345448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160079|NCT01345448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160080|NCT01345448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160081|NCT04072822|Prednisone|prednisone|mesh-list
93160082|NCT04072822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93160083|NCT04072822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160084|NCT04072822|Glucocorticoids|glucocorticoids|mesh-ancestor
93160085|NCT04072822|Hormones|hormones|mesh-ancestor
93160086|NCT04072822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160087|NCT04072822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160088|NCT04072822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160089|NCT04072822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160090|NCT04072822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160091|NCT04001894|Clopidogrel|clopidogrel|mesh-list
93160092|NCT04001894|Ticagrelor|ticagrelor|mesh-list
93160093|NCT04001894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93160094|NCT04001894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93160095|NCT04001894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93160096|NCT04001894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93160097|NCT04001894|Purinergic Agents|purinergic agents|mesh-ancestor
93160098|NCT04001894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160099|NCT04001894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160100|NCT04001894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160101|NCT04066114|Mycophenolic Acid|mycophenolic acid|mesh-list
93160102|NCT04066114|Prednisone|prednisone|mesh-list
93160103|NCT04066114|Methylprednisolone|methylprednisolone|mesh-list
93160104|NCT04066114|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93160105|NCT04066114|Everolimus|everolimus|mesh-list
93160106|NCT04066114|Abatacept|abatacept|mesh-list
93160107|NCT04066114|Thymoglobulin|thymoglobulin|mesh-list
93160108|NCT04066114|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93160109|NCT04066114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160110|NCT04066114|Glucocorticoids|glucocorticoids|mesh-ancestor
93160111|NCT04066114|Hormones|hormones|mesh-ancestor
93160112|NCT04066114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160113|NCT04066114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160114|NCT04066114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160115|NCT04066114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160116|NCT04066114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93160117|NCT04066114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160118|NCT04066114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160119|NCT04066114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160120|NCT04066114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160121|NCT04066114|Immunologic Factors|immunologic factors|mesh-ancestor
93160122|NCT04066114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93160123|NCT04066114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93160124|NCT04066114|Antitubercular Agents|antitubercular agents|mesh-ancestor
93160125|NCT04066114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93160126|NCT04066114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160127|NCT04066114|Antiemetics|antiemetics|mesh-ancestor
93160128|NCT04066114|Autonomic Agents|autonomic agents|mesh-ancestor
93160129|NCT04066114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160130|NCT04066114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93160131|NCT04066114|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93160132|NCT04066114|Protective Agents|protective agents|mesh-ancestor
93160133|NCT04066114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93160134|NCT04066114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160135|NCT04066114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160136|NCT01212913|Insulin|insulin|mesh-list
93160137|NCT01212913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93160138|NCT01212913|Insulin Glargine|insulin glargine|mesh-list
93160139|NCT01212913|Insulin Aspart|insulin aspart|mesh-list
93160140|NCT01212913|Insulin glulisine|insulin glulisine|mesh-list
93160141|NCT01212913|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93160142|NCT01212913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93160143|NCT01212913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160144|NCT01345604|Ropivacaine|ropivacaine|mesh-list
93160145|NCT01345604|Anesthetics, Local|anesthetics, local|mesh-ancestor
93160146|NCT01345604|Anesthetics|anesthetics|mesh-ancestor
93160147|NCT01345604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160148|NCT01345604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160149|NCT01345604|Sensory System Agents|sensory system agents|mesh-ancestor
93160150|NCT01345604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160151|NCT01218217|Rifampin|rifampin|mesh-list
93160152|NCT01218217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93160153|NCT01218217|Antitubercular Agents|antitubercular agents|mesh-ancestor
93160154|NCT01218217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93160155|NCT01218217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160156|NCT01218217|Leprostatic Agents|leprostatic agents|mesh-ancestor
93160157|NCT01218217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93160158|NCT01218217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160159|NCT01218217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160160|NCT01218217|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93160161|NCT01218217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93160162|NCT01218217|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93160163|NCT01218217|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93160164|NCT01218217|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93160165|NCT01218217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93160166|NCT03522532|Zinc|zinc|mesh-list
93160167|NCT03522532|Trace Elements|trace elements|mesh-ancestor
93160168|NCT03522532|Micronutrients|micronutrients|mesh-ancestor
93160169|NCT03522532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160170|NCT01215019|Mannitol|mannitol|mesh-list
93160171|NCT01215019|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93160172|NCT01215019|Diuretics|diuretics|mesh-ancestor
93160173|NCT01215019|Natriuretic Agents|natriuretic agents|mesh-ancestor
93160174|NCT01215019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160175|NCT03795428|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
93160176|NCT03795428|Vasodilator Agents|vasodilator agents|mesh-ancestor
93160177|NCT01215331|Insulin|insulin|mesh-list
93160178|NCT01215331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93160179|NCT01215331|Metformin|metformin|mesh-list
93160180|NCT01215331|Glyburide|glyburide|mesh-list
93160181|NCT01215331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928463|NCT02403687|Meloxicam|meloxicam|mesh-list
93160182|NCT01215331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160183|NCT03526276|Fluorides|fluorides|mesh-list
93160184|NCT03526276|Cariostatic Agents|cariostatic agents|mesh-ancestor
93160185|NCT03526276|Protective Agents|protective agents|mesh-ancestor
93160186|NCT03526276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160187|NCT04466254|Cetuximab|cetuximab|mesh-list
93160188|NCT04466254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160189|NCT04466254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160190|NCT04466176|Fluticasone|fluticasone|mesh-list
93160191|NCT04466176|Xhance|xhance|mesh-list
93160192|NCT04466176|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93160193|NCT04466176|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93160194|NCT04466176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160195|NCT04466176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93160196|NCT04466176|Autonomic Agents|autonomic agents|mesh-ancestor
93160197|NCT04466176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160198|NCT04466176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160199|NCT04466176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93160200|NCT04466176|Respiratory System Agents|respiratory system agents|mesh-ancestor
93160201|NCT04466176|Dermatologic Agents|dermatologic agents|mesh-ancestor
93160202|NCT04466176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93160203|NCT04466176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93160204|NCT04466176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93160205|NCT04466176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93160206|NCT04466176|Adrenergic Agents|adrenergic agents|mesh-ancestor
93160207|NCT04466176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160208|NCT04466176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160209|NCT04466176|Glucocorticoids|glucocorticoids|mesh-ancestor
93160210|NCT04466176|Hormones|hormones|mesh-ancestor
93160211|NCT04466176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160212|NCT04466176|Sympathomimetics|sympathomimetics|mesh-ancestor
93160213|NCT01215409|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93160214|NCT01215409|Vasodilator Agents|vasodilator agents|mesh-ancestor
93160215|NCT01215409|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93160216|NCT01215409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93160217|NCT01215409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160218|NCT01215409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160219|NCT01215409|Urological Agents|urological agents|mesh-ancestor
93160220|NCT03936205|Dexmedetomidine|dexmedetomidine|mesh-list
93160221|NCT03936205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93160222|NCT03936205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160223|NCT03936205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160224|NCT03936205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93160225|NCT03936205|Analgesics|analgesics|mesh-ancestor
93160226|NCT03936205|Sensory System Agents|sensory system agents|mesh-ancestor
93160227|NCT03936205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160228|NCT03936205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93160229|NCT03936205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93160230|NCT03936205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93160231|NCT03936205|Adrenergic Agents|adrenergic agents|mesh-ancestor
93160232|NCT03936205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160233|NCT03936205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160234|NCT04674020|Erenumab|erenumab|mesh-list
93160235|NCT04674020|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93160236|NCT04674020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160237|NCT04674020|Analgesics|analgesics|mesh-ancestor
93160238|NCT04674020|Sensory System Agents|sensory system agents|mesh-ancestor
93160239|NCT04674020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160240|NCT04674020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160241|NCT01123525|Adenosine|adenosine|mesh-list
93160242|NCT01123525|Analgesics|analgesics|mesh-ancestor
93160243|NCT01123525|Sensory System Agents|sensory system agents|mesh-ancestor
93160244|NCT01123525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160245|NCT01123525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160246|NCT01123525|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93160247|NCT01123525|Vasodilator Agents|vasodilator agents|mesh-ancestor
93160248|NCT01123525|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93160249|NCT01123525|Purinergic Agonists|purinergic agonists|mesh-ancestor
93160250|NCT01123525|Purinergic Agents|purinergic agents|mesh-ancestor
93160251|NCT01123525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160252|NCT01123525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160253|NCT01215565|Sunitinib|sunitinib|mesh-list
93160254|NCT01215565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160255|NCT01215565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93160256|NCT01215565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93160257|NCT01215565|Growth Substances|growth substances|mesh-ancestor
93160258|NCT01215565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160259|NCT01215565|Growth Inhibitors|growth inhibitors|mesh-ancestor
93160260|NCT01215565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160261|NCT01215565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160262|NCT01215565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160263|NCT01121497|Physostigmine|physostigmine|mesh-list
93160264|NCT01121497|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93160265|NCT01121497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160266|NCT01121497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160267|NCT01121497|Cholinergic Agents|cholinergic agents|mesh-ancestor
93160268|NCT01121497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160269|NCT01121497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160271|NCT01121497|Autonomic Agents|autonomic agents|mesh-ancestor
93160272|NCT01121497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160273|NCT01213147|Clomiphene|clomiphene|mesh-list
93160274|NCT01213147|Enclomiphene|enclomiphene|mesh-list
93160275|NCT01213147|Zuclomiphene|zuclomiphene|mesh-list
93160276|NCT01213147|Buserelin|buserelin|mesh-list
93160277|NCT01213147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93160278|NCT01213147|Hormone Antagonists|hormone antagonists|mesh-ancestor
93160279|NCT01213147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160280|NCT01213147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160281|NCT01213147|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93160282|NCT01213147|Fertility Agents|fertility agents|mesh-ancestor
93160283|NCT01213147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160284|NCT01213147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93160285|NCT01213147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93160286|NCT03143816|Insulin|insulin|mesh-list
93160287|NCT03143816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93160288|NCT03143816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160289|NCT01117129|Rituximab|rituximab|mesh-list
93160290|NCT01117129|Methotrexate|methotrexate|mesh-list
93160291|NCT01117129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160292|NCT01117129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160293|NCT01117129|Immunologic Factors|immunologic factors|mesh-ancestor
93160294|NCT01117129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160295|NCT01117129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160296|NCT01117129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93160297|NCT01117129|Abortifacient Agents|abortifacient agents|mesh-ancestor
93160298|NCT01117129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160299|NCT01117129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93160300|NCT01117129|Antimetabolites|antimetabolites|mesh-ancestor
93160301|NCT01117129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160302|NCT01117129|Dermatologic Agents|dermatologic agents|mesh-ancestor
93160303|NCT01117129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160304|NCT01117129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93160305|NCT01117129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160306|NCT01117129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93160307|NCT03133988|Margetuximab|margetuximab|mesh-list
93160308|NCT03133988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160309|NCT03934411|Tramadol|tramadol|mesh-list
93160310|NCT03934411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93160311|NCT03934411|Narcotics|narcotics|mesh-ancestor
93160312|NCT03934411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160313|NCT03934411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160314|NCT03934411|Analgesics|analgesics|mesh-ancestor
93160315|NCT03934411|Sensory System Agents|sensory system agents|mesh-ancestor
93160316|NCT03934411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160317|NCT01218451|Vaccines|vaccines|mesh-list
93160318|NCT01218451|Immunologic Factors|immunologic factors|mesh-ancestor
93160319|NCT01218451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160320|NCT01346930|Macitentan|macitentan|mesh-list
93160321|NCT01346930|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93160322|NCT01346930|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93160323|NCT01346930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160324|NCT01346930|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93160325|NCT01219153|Letrozole|letrozole|mesh-list
93160326|NCT01219153|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
93160327|NCT01219153|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93160328|NCT01219153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160329|NCT01219153|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93160330|NCT01219153|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93160331|NCT01219153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160332|NCT01219153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160333|NCT01219153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93160334|NCT01219153|Hormone Antagonists|hormone antagonists|mesh-ancestor
93160335|NCT01219153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160336|NCT01219153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160337|NCT01219153|Hormones|hormones|mesh-ancestor
93160338|NCT03526042|Losartan|losartan|mesh-list
93160339|NCT03526042|Enalapril|enalapril|mesh-list
93160340|NCT03526042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93160341|NCT03526042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93160342|NCT03526042|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93160343|NCT03526042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93160344|NCT03526042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93160345|NCT03526042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93160346|NCT03526042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160347|NCT03526042|Protease Inhibitors|protease inhibitors|mesh-ancestor
93160348|NCT01124539|Camptothecin|camptothecin|mesh-list
93160349|NCT01124539|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
93160350|NCT01124539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93160351|NCT01124539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160352|NCT01124539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93160353|NCT01124539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93160354|NCT01124539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160355|NCT01124539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160356|NCT03781375|Etanercept|etanercept|mesh-list
93160357|NCT03781375|Methotrexate|methotrexate|mesh-list
93160358|NCT03781375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93160359|NCT03781375|Abortifacient Agents|abortifacient agents|mesh-ancestor
93160360|NCT03781375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160361|NCT03781375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160362|NCT03781375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93160363|NCT03781375|Antimetabolites|antimetabolites|mesh-ancestor
93160364|NCT03781375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160365|NCT03781375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160366|NCT03781375|Dermatologic Agents|dermatologic agents|mesh-ancestor
93160367|NCT03781375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160368|NCT03781375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93160369|NCT03781375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160370|NCT03781375|Immunologic Factors|immunologic factors|mesh-ancestor
93160371|NCT03781375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160372|NCT03781375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93160373|NCT03781375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93160374|NCT03781375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93160375|NCT03781375|Analgesics|analgesics|mesh-ancestor
93160376|NCT03781375|Sensory System Agents|sensory system agents|mesh-ancestor
93160377|NCT03781375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160378|NCT03781375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160379|NCT03781375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93160380|NCT01123915|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93160381|NCT01123915|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93160382|NCT01123915|Protective Agents|protective agents|mesh-ancestor
93160383|NCT01123915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160384|NCT01123915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93160385|NCT01123915|Antioxidants|antioxidants|mesh-ancestor
93160386|NCT01123915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160387|NCT01218529|Lapatinib|lapatinib|mesh-list
93160388|NCT01218529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160389|NCT01218529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160390|NCT01218529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160391|NCT01218529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160392|NCT03938467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93160393|NCT03938467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160394|NCT01218607|Bosentan|bosentan|mesh-list
93160395|NCT01218607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93160396|NCT01218607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93160397|NCT01218607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160398|NCT03933787|Saxagliptin|saxagliptin|mesh-list
93160399|NCT03933787|Incretins|incretins|mesh-ancestor
93160400|NCT03933787|Hormones|hormones|mesh-ancestor
93160401|NCT03933787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160402|NCT03933787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160403|NCT03933787|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93160404|NCT03933787|Protease Inhibitors|protease inhibitors|mesh-ancestor
93160405|NCT03933787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160406|NCT03933787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160407|NCT03933787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93160408|NCT03934333|Budesonide|budesonide|mesh-list
93160409|NCT03934333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160410|NCT03934333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93160411|NCT03934333|Autonomic Agents|autonomic agents|mesh-ancestor
93160412|NCT03934333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160413|NCT03934333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160414|NCT03934333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93160416|NCT03934333|Glucocorticoids|glucocorticoids|mesh-ancestor
93160417|NCT03934333|Hormones|hormones|mesh-ancestor
93160418|NCT03934333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160419|NCT01124227|Icodextrin|icodextrin|mesh-list
93160420|NCT01124227|Dialysis Solutions|dialysis solutions|mesh-ancestor
93160421|NCT01124227|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93160422|NCT03931915|Leuprolide|leuprolide|mesh-list
93160423|NCT03931915|Relugolix|relugolix|mesh-list
93160424|NCT03931915|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93160425|NCT03931915|Fertility Agents|fertility agents|mesh-ancestor
93160426|NCT03931915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160427|NCT03931915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160428|NCT03931915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160429|NCT03931915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160430|NCT03931915|Androgen Antagonists|androgen antagonists|mesh-ancestor
93160431|NCT03931915|Hormone Antagonists|hormone antagonists|mesh-ancestor
93160432|NCT03931915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160433|NCT03932071|Zoledronic Acid|zoledronic acid|mesh-list
93160434|NCT03932071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93160435|NCT03932071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160436|NCT01124383|Lidocaine|lidocaine|mesh-list
93160437|NCT01124383|Ephedrine|ephedrine|mesh-list
93160438|NCT01124383|Midazolam|midazolam|mesh-list
93160439|NCT01124383|Sufentanil|sufentanil|mesh-list
93160440|NCT01124383|Dsuvia|dsuvia|mesh-list
93160441|NCT01124383|Anesthetics|anesthetics|mesh-list
93160442|NCT01124383|Propofol|propofol|mesh-list
93160443|NCT01124383|Sevoflurane|sevoflurane|mesh-list
93160444|NCT01124383|Rocuronium|rocuronium|mesh-list
93160445|NCT01124383|Anesthetics, Local|anesthetics, local|mesh-ancestor
93160446|NCT01124383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160447|NCT01124383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160448|NCT01124383|Sensory System Agents|sensory system agents|mesh-ancestor
93160449|NCT01124383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160450|NCT01124383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93160451|NCT01124383|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93160452|NCT01124383|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93160453|NCT01124383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93160454|NCT01124383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160455|NCT01124383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93160456|NCT01124383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93160457|NCT01124383|Anesthetics, General|anesthetics, general|mesh-ancestor
93160458|NCT01124383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93160459|NCT01124383|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93160460|NCT01124383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93160461|NCT01124383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93160462|NCT01124383|GABA Modulators|gaba modulators|mesh-ancestor
93160463|NCT01124383|GABA Agents|gaba agents|mesh-ancestor
93160464|NCT01124383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160465|NCT01124383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93160466|NCT01124383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93160467|NCT01124383|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93160468|NCT01124383|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93160469|NCT01124383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93160470|NCT01124383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93160471|NCT01124383|Narcotics|narcotics|mesh-ancestor
93160472|NCT01124383|Analgesics|analgesics|mesh-ancestor
93160473|NCT01124383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93160474|NCT01124383|Sympathomimetics|sympathomimetics|mesh-ancestor
93160475|NCT01124383|Autonomic Agents|autonomic agents|mesh-ancestor
93160476|NCT01124383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93160477|NCT01124383|Adrenergic Agents|adrenergic agents|mesh-ancestor
93160478|NCT01226017|Oxytocin|oxytocin|mesh-list
93160479|NCT01226017|Oxytocics|oxytocics|mesh-ancestor
93160480|NCT01226017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160481|NCT01226017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160482|NCT01222819|Lenograstim|lenograstim|mesh-list
93160483|NCT01222819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93160484|NCT01222819|Immunologic Factors|immunologic factors|mesh-ancestor
93160485|NCT01222819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160486|NCT01222897|Valacyclovir|valacyclovir|mesh-list
93160487|NCT01222897|Antiviral Agents|antiviral agents|mesh-ancestor
93160488|NCT01222897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160489|NCT03150056|Prednisone|prednisone|mesh-list
93160490|NCT03150056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160491|NCT03150056|Glucocorticoids|glucocorticoids|mesh-ancestor
93160492|NCT03150056|Hormones|hormones|mesh-ancestor
93160493|NCT03150056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160494|NCT03150056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160495|NCT03150056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160496|NCT03150056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160497|NCT01329367|Antioxidants|antioxidants|mesh-list
93160498|NCT01329367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160499|NCT01329367|Protective Agents|protective agents|mesh-ancestor
93160500|NCT01329367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160501|NCT01222975|Risperidone|risperidone|mesh-list
93160502|NCT01222975|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93160503|NCT01222975|Serotonin Agents|serotonin agents|mesh-ancestor
93160504|NCT01222975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160505|NCT01222975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160506|NCT01222975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160507|NCT01222975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93160508|NCT01222975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93160509|NCT01222975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160510|NCT01222975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93160511|NCT01222975|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93160512|NCT01222975|Dopamine Agents|dopamine agents|mesh-ancestor
93160513|NCT01129063|Clopidogrel|clopidogrel|mesh-list
93160514|NCT01129063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93160515|NCT01129063|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93160516|NCT01129063|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93160517|NCT01129063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93160518|NCT01129063|Purinergic Agents|purinergic agents|mesh-ancestor
93160519|NCT01129063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160520|NCT01129063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160521|NCT01129063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160522|NCT01317368|Ropivacaine|ropivacaine|mesh-list
93160523|NCT01317368|Anesthetics, Local|anesthetics, local|mesh-ancestor
93160524|NCT01317368|Anesthetics|anesthetics|mesh-ancestor
93160525|NCT01317368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160526|NCT01317368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160527|NCT01317368|Sensory System Agents|sensory system agents|mesh-ancestor
93160528|NCT01317368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160529|NCT01219699|Fulvestrant|fulvestrant|mesh-list
93160530|NCT01219699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160531|NCT01219699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160532|NCT01219699|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93160533|NCT01219699|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93160534|NCT01219699|Hormone Antagonists|hormone antagonists|mesh-ancestor
93160535|NCT01219699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160536|NCT01219699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160537|NCT03933319|Doxorubicin|doxorubicin|mesh-list
93160538|NCT03933319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93160539|NCT03933319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93160540|NCT03933319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160541|NCT03933319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93160542|NCT03933319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93160543|NCT03933319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160544|NCT03933319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160545|NCT01223053|Ketoprofen|ketoprofen|mesh-list
93160546|NCT01223053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93160547|NCT01223053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93160548|NCT01223053|Analgesics|analgesics|mesh-ancestor
93160549|NCT01223053|Sensory System Agents|sensory system agents|mesh-ancestor
93160550|NCT01223053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160551|NCT01223053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160552|NCT01223053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160553|NCT01223053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160554|NCT01223053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93160555|NCT01223053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160556|NCT01223053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160557|NCT01223131|Insulin|insulin|mesh-list
93160558|NCT01223131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93160559|NCT01223131|Insulin Glargine|insulin glargine|mesh-list
93160560|NCT01223131|Insulin, Isophane|insulin, isophane|mesh-list
93160561|NCT01223131|Isophane Insulin, Human|isophane insulin, human|mesh-list
93160562|NCT01223131|Isophane insulin, beef|isophane insulin, beef|mesh-list
93160563|NCT01223131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93160564|NCT01223131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832761|NCT04085770|Vitamins|vitamins|mesh-ancestor
93160565|NCT01125553|Insulin|insulin|mesh-list
93160566|NCT01125553|Insulin Aspart|insulin aspart|mesh-list
93160567|NCT01125553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93160568|NCT01125553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160569|NCT02640664|Ranibizumab|ranibizumab|mesh-list
93160570|NCT02640664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93160571|NCT02640664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93160572|NCT02640664|Growth Substances|growth substances|mesh-ancestor
93160573|NCT02640664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160574|NCT02640664|Growth Inhibitors|growth inhibitors|mesh-ancestor
93160575|NCT02640664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160576|NCT01317446|Fluorides|fluorides|mesh-list
93160577|NCT01317446|Tin Fluorides|tin fluorides|mesh-list
93160578|NCT01317446|Cariostatic Agents|cariostatic agents|mesh-ancestor
93160579|NCT01317446|Protective Agents|protective agents|mesh-ancestor
93160580|NCT01317446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160581|NCT02529241|Delpazolid|delpazolid|mesh-list
93160582|NCT02529241|Oxazolidinones|oxazolidinones|mesh-list
93160583|NCT02529241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93160584|NCT02529241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160585|NCT02529241|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93160586|NCT02529241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160587|NCT02529241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160588|NCT02456012|Esomeprazole|esomeprazole|mesh-list
93160589|NCT02456012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93160590|NCT02456012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93160591|NCT02456012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93160592|NCT02456012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160593|NCT02456012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160594|NCT00812006|Rizatriptan|rizatriptan|mesh-list
93160595|NCT00812006|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93160596|NCT00812006|Serotonin Agents|serotonin agents|mesh-ancestor
93160597|NCT00812006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160598|NCT00812006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160599|NCT00812006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160600|NCT03133234|Osimertinib|osimertinib|mesh-list
93160601|NCT03133234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160602|NCT03133234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160603|NCT03133234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160604|NCT03133234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160605|NCT01125787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93160606|NCT01125787|Ofatumumab|ofatumumab|mesh-list
93160607|NCT01125787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93160608|NCT01125787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93160609|NCT01125787|Alkylating Agents|alkylating agents|mesh-ancestor
93160610|NCT01125787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160611|NCT01125787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160612|NCT01125787|Immunologic Factors|immunologic factors|mesh-ancestor
93160613|NCT01125787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160614|NCT02457442|Remifentanil|remifentanil|mesh-list
93160615|NCT02457442|Propofol|propofol|mesh-list
93160616|NCT02457442|Sevoflurane|sevoflurane|mesh-list
93160617|NCT02457442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93160618|NCT02457442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160619|NCT02457442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160620|NCT02457442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93160621|NCT02457442|Anesthetics, General|anesthetics, general|mesh-ancestor
93160622|NCT02457442|Anesthetics|anesthetics|mesh-ancestor
93160623|NCT02457442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92456395|NCT01711671|Antiemetics|antiemetics|mesh-ancestor
93160624|NCT02457442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93160625|NCT02457442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93160626|NCT02457442|Narcotics|narcotics|mesh-ancestor
93160627|NCT02457442|Analgesics|analgesics|mesh-ancestor
93160628|NCT02457442|Sensory System Agents|sensory system agents|mesh-ancestor
93160629|NCT02457442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160630|NCT03132038|Nivolumab|nivolumab|mesh-list
93160631|NCT03132038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160632|NCT03132038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160633|NCT03132038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93160634|NCT03132038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160635|NCT01129375|Omeprazole|omeprazole|mesh-list
93160636|NCT01129375|Clopidogrel|clopidogrel|mesh-list
93160637|NCT01129375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93160638|NCT01129375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93160639|NCT01129375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93160640|NCT01129375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93160641|NCT01129375|Purinergic Agents|purinergic agents|mesh-ancestor
93160642|NCT01129375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160643|NCT01129375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160644|NCT01129375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160645|NCT01129375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93160646|NCT01129375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93160647|NCT01129375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93160648|NCT01129375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160649|NCT01352702|Dabigatran|dabigatran|mesh-list
93160650|NCT01352702|Phenprocoumon|phenprocoumon|mesh-list
93160651|NCT01352702|Antithrombins|antithrombins|mesh-ancestor
93160652|NCT01352702|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93160653|NCT01352702|Protease Inhibitors|protease inhibitors|mesh-ancestor
93160654|NCT01352702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160655|NCT01352702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160656|NCT01352702|Anticoagulants|anticoagulants|mesh-ancestor
93160657|NCT03525730|Pyrimethamine|pyrimethamine|mesh-list
93160658|NCT03525730|Valproic Acid|valproic acid|mesh-list
93160659|NCT03525730|Antimalarials|antimalarials|mesh-ancestor
93160660|NCT03525730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93160661|NCT03525730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93160662|NCT03525730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160663|NCT03525730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93160664|NCT03525730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160665|NCT03525730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160666|NCT03525730|Anticonvulsants|anticonvulsants|mesh-ancestor
93160667|NCT03525730|GABA Agents|gaba agents|mesh-ancestor
93160668|NCT03525730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160669|NCT03525730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160670|NCT03525730|Antimanic Agents|antimanic agents|mesh-ancestor
93160671|NCT03525730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93160672|NCT03525730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160673|NCT03525730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93160674|NCT01223443|Paclitaxel|paclitaxel|mesh-list
93160675|NCT01223443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93160676|NCT01223443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160677|NCT01223443|Tubulin Modulators|tubulin modulators|mesh-ancestor
93160678|NCT01223443|Antimitotic Agents|antimitotic agents|mesh-ancestor
93160679|NCT01223443|Mitosis Modulators|mitosis modulators|mesh-ancestor
93160680|NCT01223443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160681|NCT03525652|Vaccines|vaccines|mesh-list
93160682|NCT03525652|Immunologic Factors|immunologic factors|mesh-ancestor
93160683|NCT03525652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160684|NCT02290054|Anesthetics|anesthetics|mesh-list
93160685|NCT02290054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160686|NCT02290054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160687|NCT01347944|Lenalidomide|lenalidomide|mesh-list
93160688|NCT01347944|Immunologic Factors|immunologic factors|mesh-ancestor
93160689|NCT01347944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160690|NCT01347944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93160691|NCT01347944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93160692|NCT01347944|Growth Substances|growth substances|mesh-ancestor
93160693|NCT01347944|Growth Inhibitors|growth inhibitors|mesh-ancestor
93160694|NCT01347944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160695|NCT02290132|Thymoglobulin|thymoglobulin|mesh-list
93160696|NCT02290132|Immunologic Factors|immunologic factors|mesh-ancestor
93160697|NCT02290132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160698|NCT02290132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160699|NCT01220245|Heparin|heparin|mesh-list
93160700|NCT01220245|Anticoagulants|anticoagulants|mesh-ancestor
93160701|NCT01220245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93160702|NCT01220245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93160703|NCT01220245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160704|NCT03931135|Dexamethasone|dexamethasone|mesh-list
93160705|NCT03931135|Morphine|morphine|mesh-list
93160706|NCT03931135|Cyclizine|cyclizine|mesh-list
93160707|NCT03931135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160708|NCT03931135|Antiemetics|antiemetics|mesh-ancestor
93160709|NCT03931135|Autonomic Agents|autonomic agents|mesh-ancestor
93160710|NCT03931135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160711|NCT03931135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160712|NCT03931135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93160713|NCT03931135|Glucocorticoids|glucocorticoids|mesh-ancestor
92832911|NCT00679627|Nootropic Agents|nootropic agents|mesh-ancestor
93160714|NCT03931135|Hormones|hormones|mesh-ancestor
93160715|NCT03931135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160716|NCT03931135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160717|NCT03931135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160718|NCT03931135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93160719|NCT03931135|Narcotics|narcotics|mesh-ancestor
93160720|NCT03931135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160721|NCT03931135|Analgesics|analgesics|mesh-ancestor
93160722|NCT03931135|Sensory System Agents|sensory system agents|mesh-ancestor
93160723|NCT03931135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93160724|NCT03931135|Histamine Antagonists|histamine antagonists|mesh-ancestor
93160725|NCT03931135|Histamine Agents|histamine agents|mesh-ancestor
93160726|NCT03931135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160727|NCT03931135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160728|NCT01353170|Dialysis Solutions|dialysis solutions|mesh-list
93160729|NCT01353170|Calcium|calcium|mesh-list
93160730|NCT01353170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93160731|NCT01353170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160732|NCT01353170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93160733|NCT03620318|Crenolanib|crenolanib|mesh-list
93160734|NCT03620318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160735|NCT01125943|Bevacizumab|bevacizumab|mesh-list
93160736|NCT01125943|Nitroprusside|nitroprusside|mesh-list
93160737|NCT01125943|Acetylcholine|acetylcholine|mesh-list
93160738|NCT01125943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160739|NCT01125943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160740|NCT01125943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93160741|NCT01125943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93160742|NCT01125943|Growth Substances|growth substances|mesh-ancestor
93160743|NCT01125943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160744|NCT01125943|Growth Inhibitors|growth inhibitors|mesh-ancestor
93160745|NCT01125943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93160746|NCT01125943|Vasodilator Agents|vasodilator agents|mesh-ancestor
93160747|NCT01125943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93160748|NCT01125943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160749|NCT01125943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93160750|NCT01125943|Cholinergic Agents|cholinergic agents|mesh-ancestor
93160751|NCT01125943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160752|NCT01223755|Sirolimus|sirolimus|mesh-list
93160753|NCT01223755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93160754|NCT01223755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160755|NCT01223755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93160756|NCT01223755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160757|NCT01223755|Antifungal Agents|antifungal agents|mesh-ancestor
93160758|NCT01223755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160759|NCT01223755|Immunologic Factors|immunologic factors|mesh-ancestor
93160760|NCT01223755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160761|NCT01126177|Interferons|interferons|mesh-list
93160762|NCT01126177|Interferon-beta|interferon-beta|mesh-list
93160763|NCT01126177|Interferon beta-1a|interferon beta-1a|mesh-list
93160764|NCT01126177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160765|NCT01126177|Antiviral Agents|antiviral agents|mesh-ancestor
93160766|NCT01126177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160767|NCT01126177|Immunologic Factors|immunologic factors|mesh-ancestor
93160768|NCT01126177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160769|NCT01126177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93160770|NCT03680092|Cyclophosphamide|cyclophosphamide|mesh-list
93160771|NCT03680092|Methotrexate|methotrexate|mesh-list
93160772|NCT03680092|Abatacept|abatacept|mesh-list
93160773|NCT03680092|Tacrolimus|tacrolimus|mesh-list
93160774|NCT03680092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160775|NCT03680092|Immunologic Factors|immunologic factors|mesh-ancestor
93160776|NCT03680092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160777|NCT03680092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160778|NCT03680092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93160779|NCT03680092|Alkylating Agents|alkylating agents|mesh-ancestor
93160780|NCT03680092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160781|NCT03680092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160782|NCT03680092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93160783|NCT03680092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93160784|NCT03680092|Abortifacient Agents|abortifacient agents|mesh-ancestor
93160785|NCT03680092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160786|NCT03680092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93160787|NCT03680092|Antimetabolites|antimetabolites|mesh-ancestor
93160788|NCT03680092|Dermatologic Agents|dermatologic agents|mesh-ancestor
93160789|NCT03680092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160790|NCT03680092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93160791|NCT03680092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92832984|NCT00755209|Hemostatics|hemostatics|mesh-ancestor
93160792|NCT03680092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93160793|NCT03680092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93160794|NCT03680092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93160795|NCT03671044|Docetaxel|docetaxel|mesh-list
93160796|NCT03671044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160797|NCT03671044|Tubulin Modulators|tubulin modulators|mesh-ancestor
93160798|NCT03671044|Antimitotic Agents|antimitotic agents|mesh-ancestor
93160799|NCT03671044|Mitosis Modulators|mitosis modulators|mesh-ancestor
93160800|NCT03671044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160801|NCT05790070|Betaine|betaine|mesh-list
93160802|NCT05790070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93160803|NCT05790070|Lipotropic Agents|lipotropic agents|mesh-ancestor
93160804|NCT05790070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93160805|NCT05790070|Antimetabolites|antimetabolites|mesh-ancestor
93160806|NCT05790070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160807|NCT05790070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93160808|NCT05790044|Clonidine|clonidine|mesh-list
93160809|NCT05790044|Bupivacaine|bupivacaine|mesh-list
93160810|NCT05790044|Anesthetics, Local|anesthetics, local|mesh-ancestor
93160811|NCT05790044|Anesthetics|anesthetics|mesh-ancestor
93160812|NCT05790044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93160813|NCT05790044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160814|NCT05790044|Sensory System Agents|sensory system agents|mesh-ancestor
93160815|NCT05790044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160816|NCT05790044|Analgesics|analgesics|mesh-ancestor
93160817|NCT05790044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93160818|NCT05790044|Sympatholytics|sympatholytics|mesh-ancestor
93160819|NCT05790044|Autonomic Agents|autonomic agents|mesh-ancestor
93160820|NCT05790044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93160821|NCT05790044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93160822|NCT05790044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93160823|NCT05790044|Adrenergic Agents|adrenergic agents|mesh-ancestor
93160824|NCT05790044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160825|NCT05790044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160826|NCT05789680|Parathyroid Hormone|parathyroid hormone|mesh-list
93160827|NCT05789680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93160828|NCT05789680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160829|NCT05789667|Lenvatinib|lenvatinib|mesh-list
93160830|NCT05789667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160831|NCT05789667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160832|NCT05789667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160833|NCT05789667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160834|NCT05789537|Protein C|protein c|mesh-list
93160835|NCT05789537|Anticoagulants|anticoagulants|mesh-ancestor
93160836|NCT05789537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93160837|NCT05789537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93160838|NCT05789537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160839|NCT05789342|Itraconazole|itraconazole|mesh-list
93160840|NCT05789342|Oseltamivir|oseltamivir|mesh-list
93160841|NCT05789342|Digoxin|digoxin|mesh-list
93160842|NCT05789342|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93160843|NCT05789342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93160844|NCT05789342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93160845|NCT05789342|Antimetabolites|antimetabolites|mesh-ancestor
92855042|NCT00602849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93160846|NCT05789342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160847|NCT05789342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93160848|NCT05789342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93160849|NCT05789342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160850|NCT05789342|Antifungal Agents|antifungal agents|mesh-ancestor
93160851|NCT05789342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160852|NCT05789342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93160853|NCT05789342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93160854|NCT05789342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93160855|NCT05789342|Hormone Antagonists|hormone antagonists|mesh-ancestor
93160856|NCT05789342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160857|NCT05789342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160858|NCT05789342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93160859|NCT05789342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93160860|NCT05789342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93160861|NCT05789342|Protective Agents|protective agents|mesh-ancestor
93160862|NCT05789342|Antiviral Agents|antiviral agents|mesh-ancestor
93160863|NCT05789186|Fluoxetine|fluoxetine|mesh-list
93160864|NCT05789186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93160865|NCT05789186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93160866|NCT05789186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93160867|NCT05789186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160868|NCT05789186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160870|NCT05789186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160871|NCT05789186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93160872|NCT05789186|Antidepressive Agents|antidepressive agents|mesh-ancestor
93160873|NCT05789186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93160874|NCT05789186|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93160875|NCT05789186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93160876|NCT05789186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160877|NCT05789043|Apatinib|apatinib|mesh-list
93160878|NCT05789043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160879|NCT05789043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160880|NCT05789043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160881|NCT05789043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160882|NCT05789030|Prednisone|prednisone|mesh-list
93160883|NCT05789030|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
93160884|NCT05789030|Betamethasone|betamethasone|mesh-list
93160885|NCT05789030|Leflunomide|leflunomide|mesh-list
93160886|NCT05789030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160887|NCT05789030|Glucocorticoids|glucocorticoids|mesh-ancestor
93160888|NCT05789030|Hormones|hormones|mesh-ancestor
93160889|NCT05789030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160890|NCT05789030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160891|NCT05789030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160892|NCT05789030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160893|NCT05789030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160894|NCT05789030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160895|NCT05789030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160896|NCT05789030|Immunologic Factors|immunologic factors|mesh-ancestor
93160897|NCT05789030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93160898|NCT05789030|Respiratory System Agents|respiratory system agents|mesh-ancestor
93160899|NCT05789017|Mycophenolic Acid|mycophenolic acid|mesh-list
93160900|NCT05789017|Prednisone|prednisone|mesh-list
93160901|NCT05789017|Leflunomide|leflunomide|mesh-list
93160902|NCT05789017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160903|NCT05789017|Glucocorticoids|glucocorticoids|mesh-ancestor
93160904|NCT05789017|Hormones|hormones|mesh-ancestor
93160905|NCT05789017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160906|NCT05789017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160907|NCT05789017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160908|NCT05789017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160909|NCT05789017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93160910|NCT05789017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93160911|NCT05789017|Antitubercular Agents|antitubercular agents|mesh-ancestor
93160912|NCT05789017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93160913|NCT05789017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160914|NCT05789017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160915|NCT05789017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160916|NCT05789017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93160917|NCT05789017|Immunologic Factors|immunologic factors|mesh-ancestor
93160918|NCT05788991|Metronidazole|metronidazole|mesh-list
93160919|NCT05788991|Dequalinium|dequalinium|mesh-list
93160920|NCT05788991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160921|NCT05788991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93160922|NCT05788991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93160923|NCT05788991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93160924|NCT05788991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93160925|NCT05788913|Heparin|heparin|mesh-list
93160926|NCT05788913|Anticoagulants|anticoagulants|mesh-ancestor
93160927|NCT05788913|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93160928|NCT05788913|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93160929|NCT05788913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160930|NCT05788900|Heparin|heparin|mesh-list
93160931|NCT05788900|Anticoagulants|anticoagulants|mesh-ancestor
93160932|NCT05788900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93160933|NCT05788900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93160934|NCT05788900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160935|NCT05788835|Chlorotrianisene|chlorotrianisene|mesh-list
93160936|NCT05788835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93160937|NCT05788835|Estrogens|estrogens|mesh-ancestor
93160938|NCT05788835|Hormones|hormones|mesh-ancestor
93160939|NCT05788835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160940|NCT05788835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160941|NCT05788835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160942|NCT05788835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160943|NCT05788705|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
93160944|NCT05788705|Boswellic acid|boswellic acid|mesh-list
93160945|NCT05788705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93160946|NCT05788705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93160947|NCT05788705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93160948|NCT05788705|Analgesics|analgesics|mesh-ancestor
93160949|NCT05788705|Sensory System Agents|sensory system agents|mesh-ancestor
93160950|NCT05788705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160951|NCT05788705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160952|NCT05788705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93160953|NCT05788679|Azacitidine|azacitidine|mesh-list
93160954|NCT05788679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93160955|NCT05788679|Antimetabolites|antimetabolites|mesh-ancestor
93160956|NCT05788679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160957|NCT05788679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160958|NCT05788679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160959|NCT05770544|Entrectinib|entrectinib|mesh-list
93160960|NCT05770544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93160961|NCT05770544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93160962|NCT05770544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160963|NCT05767086|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93160964|NCT05767086|Medroxyprogesterone|medroxyprogesterone|mesh-list
93160965|NCT05767086|Cetrorelix|cetrorelix|mesh-list
93160966|NCT05767086|Hormones|hormones|mesh-list
93160967|NCT05767086|Dydrogesterone|dydrogesterone|mesh-list
93160968|NCT05767086|Hormone Antagonists|hormone antagonists|mesh-list
93160969|NCT05767086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93160970|NCT05767086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160971|NCT05767086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93160972|NCT05767086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93160973|NCT05767086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93160974|NCT05767086|Contraceptive Agents|contraceptive agents|mesh-ancestor
93160975|NCT05767086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93160976|NCT05767086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93160977|NCT05767086|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93160978|NCT05767086|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93160979|NCT05767086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93160980|NCT05767086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93160981|NCT05767086|Progestins|progestins|mesh-ancestor
93160982|NCT05767086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93160983|NCT05767086|Fertility Agents|fertility agents|mesh-ancestor
93160984|NCT05755282|Hand Sanitizers|hand sanitizers|mesh-list
93160985|NCT05755282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93160986|NCT05755282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93160987|NCT05755282|Disinfectants|disinfectants|mesh-ancestor
93160988|NCT05732077|Dopamine|dopamine|mesh-list
93160989|NCT05732077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93160990|NCT05732077|Sympathomimetics|sympathomimetics|mesh-ancestor
93160991|NCT05732077|Autonomic Agents|autonomic agents|mesh-ancestor
93160992|NCT05732077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93160993|NCT05732077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93160994|NCT05732077|Dopamine Agents|dopamine agents|mesh-ancestor
93160995|NCT05732077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93160996|NCT05732077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93160997|NCT05732077|Protective Agents|protective agents|mesh-ancestor
93160998|NCT05722886|Trastuzumab|trastuzumab|mesh-list
93160999|NCT05722886|Atezolizumab|atezolizumab|mesh-list
93161000|NCT05722886|Pertuzumab|pertuzumab|mesh-list
93161001|NCT05722886|Vemurafenib|vemurafenib|mesh-list
93161002|NCT05722886|Entrectinib|entrectinib|mesh-list
93161003|NCT05722886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161004|NCT05722886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161005|NCT05722886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161006|NCT05722886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161007|NCT05722886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161008|NCT05722886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161009|NCT05702905|Metformin|metformin|mesh-list
93161010|NCT05702905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93161011|NCT05702905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161012|NCT05697471|Dienogest|dienogest|mesh-list
93161013|NCT05697471|Danazol|danazol|mesh-list
93161014|NCT05697471|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93161015|NCT05697471|Contraceptive Agents|contraceptive agents|mesh-ancestor
93161016|NCT05697471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93161017|NCT05697471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161018|NCT05697471|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93161019|NCT05697471|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93161020|NCT05697471|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93161021|NCT05697471|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93161022|NCT05697471|Hormone Antagonists|hormone antagonists|mesh-ancestor
93161023|NCT05697471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93161024|NCT05697471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93161025|NCT05697471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161026|NCT05697471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93161027|NCT05670561|Sufentanil|sufentanil|mesh-list
93161028|NCT05670561|Esketamine|esketamine|mesh-list
93161029|NCT05670561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93161030|NCT05670561|Narcotics|narcotics|mesh-ancestor
93161031|NCT05670561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93161032|NCT05670561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161033|NCT05670561|Analgesics|analgesics|mesh-ancestor
93161034|NCT05670561|Sensory System Agents|sensory system agents|mesh-ancestor
93161035|NCT05670561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161036|NCT05670561|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93161037|NCT05670561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93161038|NCT05670561|Anesthetics, General|anesthetics, general|mesh-ancestor
93161039|NCT05670561|Anesthetics|anesthetics|mesh-ancestor
93161040|NCT05670561|Antidepressive Agents|antidepressive agents|mesh-ancestor
93161041|NCT05670561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93161042|NCT05635877|Esmolol|esmolol|mesh-list
93161043|NCT05635877|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93161044|NCT05635877|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93161045|NCT05635877|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93161046|NCT05635877|Adrenergic Agents|adrenergic agents|mesh-ancestor
93161047|NCT05635877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161048|NCT05635877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161049|NCT05635877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161050|NCT05630183|Paclitaxel|paclitaxel|mesh-list
93161051|NCT05630183|Gemcitabine|gemcitabine|mesh-list
93161052|NCT05630183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93161053|NCT05630183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161054|NCT05630183|Tubulin Modulators|tubulin modulators|mesh-ancestor
93161055|NCT05630183|Antimitotic Agents|antimitotic agents|mesh-ancestor
93161056|NCT05630183|Mitosis Modulators|mitosis modulators|mesh-ancestor
93161057|NCT05630183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161058|NCT05630183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161059|NCT05630183|Antimetabolites|antimetabolites|mesh-ancestor
93161060|NCT05629546|Nivolumab|nivolumab|mesh-list
93161061|NCT05629546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161062|NCT05629546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161063|NCT05629546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161064|NCT05629546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161065|NCT05603702|Lacosamide|lacosamide|mesh-list
92456843|NCT01714089|RNS60|rns60|mesh-list
93161066|NCT05603702|Anticonvulsants|anticonvulsants|mesh-ancestor
93161067|NCT05603702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93161068|NCT05603702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93161069|NCT05603702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93161070|NCT05603702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161071|NCT05596006|Domperidone|domperidone|mesh-list
93161072|NCT05596006|Antiemetics|antiemetics|mesh-ancestor
93161073|NCT05596006|Autonomic Agents|autonomic agents|mesh-ancestor
93161074|NCT05596006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161075|NCT05596006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161076|NCT05596006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93161077|NCT05596006|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93161078|NCT05596006|Dopamine Agents|dopamine agents|mesh-ancestor
93161079|NCT05596006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161080|NCT05596006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161081|NCT05587374|Gemcitabine|gemcitabine|mesh-list
93161082|NCT05587374|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93161083|NCT05587374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161084|NCT05587374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161085|NCT05587374|Antimetabolites|antimetabolites|mesh-ancestor
93161086|NCT05587374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161087|NCT05587374|Immunologic Factors|immunologic factors|mesh-ancestor
93161088|NCT05587374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161089|NCT05586529|Cholecalciferol|cholecalciferol|mesh-list
93161091|NCT05586529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93161092|NCT05586529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161093|NCT05586529|Vitamins|vitamins|mesh-ancestor
93161094|NCT05586529|Micronutrients|micronutrients|mesh-ancestor
93161095|NCT05586529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93161096|NCT05558280|Dinutuximab|dinutuximab|mesh-list
93161097|NCT05558280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161098|NCT05555303|Amikacin|amikacin|mesh-list
93161099|NCT05555303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161100|NCT05555303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161101|NCT05549752|Amiodarone|amiodarone|mesh-list
93161102|NCT05549752|Flecainide|flecainide|mesh-list
93161103|NCT05549752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93161104|NCT05549752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93161105|NCT05549752|Vasodilator Agents|vasodilator agents|mesh-ancestor
93161106|NCT05549752|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93161107|NCT05549752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93161108|NCT05549752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161109|NCT05549752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93161110|NCT05549752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93161111|NCT05549752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93161112|NCT05549752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161113|NCT05549752|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93161114|NCT05549752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93161115|NCT05549752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93161116|NCT05549752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93161117|NCT05538091|Atezolizumab|atezolizumab|mesh-list
93161118|NCT05538091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161119|NCT05538091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161120|NCT05538091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161121|NCT05538091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161122|NCT05524935|Pembrolizumab|pembrolizumab|mesh-list
93161123|NCT05524935|Olaparib|olaparib|mesh-list
93161124|NCT05524935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161125|NCT05524935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161126|NCT05524935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161127|NCT05524935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161128|NCT05524935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93161129|NCT05524935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161130|NCT05515029|Cyclophosphamide|cyclophosphamide|mesh-list
93161131|NCT05515029|Abatacept|abatacept|mesh-list
93161132|NCT05515029|Vedolizumab|vedolizumab|mesh-list
93161133|NCT05515029|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93161134|NCT05515029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161135|NCT05515029|Immunologic Factors|immunologic factors|mesh-ancestor
93161136|NCT05515029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161137|NCT05515029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161138|NCT05515029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93161139|NCT05515029|Alkylating Agents|alkylating agents|mesh-ancestor
93161140|NCT05515029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161141|NCT05515029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161142|NCT05515029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93161143|NCT05515029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161144|NCT05515029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161145|NCT05515029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93161146|NCT05515029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161147|NCT05499832|Tenecteplase|tenecteplase|mesh-list
93161148|NCT05499832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93161149|NCT05499832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93161150|NCT05499832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161151|NCT05461755|Tretinoin|tretinoin|mesh-list
93161152|NCT05461755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161153|NCT05461755|Keratolytic Agents|keratolytic agents|mesh-ancestor
93161154|NCT05461755|Dermatologic Agents|dermatologic agents|mesh-ancestor
93161155|NCT05461456|Fexofenadine|fexofenadine|mesh-list
93161156|NCT05461456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93161157|NCT05461456|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93161158|NCT05461456|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93161159|NCT05461456|Histamine Antagonists|histamine antagonists|mesh-ancestor
93161160|NCT05461456|Histamine Agents|histamine agents|mesh-ancestor
93161161|NCT05461456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161162|NCT05461456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161163|NCT05461456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161164|NCT05441930|Levofloxacin|levofloxacin|mesh-list
93161165|NCT05441930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93161166|NCT05441930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161167|NCT05441930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161168|NCT05441930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93161169|NCT05441930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93161170|NCT05441930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161171|NCT05441930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161172|NCT05441930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161173|NCT05441930|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93161174|NCT05441930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93161176|NCT05394727|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93161177|NCT05394727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93161178|NCT05394727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161179|NCT05350501|Nivolumab|nivolumab|mesh-list
93161180|NCT05350501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161181|NCT05350501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161182|NCT05350501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161183|NCT05350501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161184|NCT05322512|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93161185|NCT05322512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93161186|NCT05322512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161187|NCT05268926|Dapagliflozin|dapagliflozin|mesh-list
93161188|NCT05268926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93161189|NCT05268926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161190|NCT05268926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93161191|NCT05268926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161192|NCT05267366|Bevacizumab|bevacizumab|mesh-list
93161193|NCT05267366|Carboplatin|carboplatin|mesh-list
93161194|NCT05267366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93161195|NCT05267366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161196|NCT05267366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161197|NCT05267366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93161198|NCT05267366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93161199|NCT05267366|Growth Substances|growth substances|mesh-ancestor
93161200|NCT05267366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161201|NCT05267366|Growth Inhibitors|growth inhibitors|mesh-ancestor
93161202|NCT05267366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161203|NCT05267288|Afatinib|afatinib|mesh-list
93161204|NCT05267288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161205|NCT05267288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161206|NCT05267288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161207|NCT05267288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161208|NCT05218629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93161209|NCT05218629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161210|NCT05218629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161211|NCT05218629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161212|NCT05191667|Paclitaxel|paclitaxel|mesh-list
93161213|NCT05191667|Carboplatin|carboplatin|mesh-list
93161214|NCT05191667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93161215|NCT05191667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161216|NCT05191667|Tubulin Modulators|tubulin modulators|mesh-ancestor
93161217|NCT05191667|Antimitotic Agents|antimitotic agents|mesh-ancestor
93161218|NCT05191667|Mitosis Modulators|mitosis modulators|mesh-ancestor
93161219|NCT05191667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161220|NCT05112263|Cyclosporine|cyclosporine|mesh-list
93161221|NCT05112263|Cyclosporins|cyclosporins|mesh-list
93161222|NCT05112263|Tofacitinib|tofacitinib|mesh-list
93161223|NCT05112263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161224|NCT05112263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161225|NCT05112263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161226|NCT05112263|Immunologic Factors|immunologic factors|mesh-ancestor
93161227|NCT05112263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161228|NCT05112263|Antifungal Agents|antifungal agents|mesh-ancestor
93161229|NCT05112263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161230|NCT05112263|Dermatologic Agents|dermatologic agents|mesh-ancestor
93161231|NCT05112263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161232|NCT05112263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93161233|NCT05112263|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93161234|NCT05112263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161235|NCT05104281|Osimertinib|osimertinib|mesh-list
93161236|NCT05104281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161237|NCT05104281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161238|NCT05104281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161239|NCT05104281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161240|NCT05096884|Metoprolol|metoprolol|mesh-list
93161241|NCT05096884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93161242|NCT05096884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93161243|NCT05096884|Sympatholytics|sympatholytics|mesh-ancestor
93161244|NCT05096884|Autonomic Agents|autonomic agents|mesh-ancestor
93161245|NCT05096884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161246|NCT05096884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161247|NCT05096884|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93161248|NCT05096884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93161249|NCT05096884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93161250|NCT05096884|Adrenergic Agents|adrenergic agents|mesh-ancestor
93161251|NCT05096884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161252|NCT05096884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161253|NCT05084378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93161254|NCT05084378|Chlorhexidine|chlorhexidine|mesh-list
93161255|NCT05084378|Povidone-Iodine|povidone-iodine|mesh-list
93161256|NCT05084378|Povidone|povidone|mesh-list
93161257|NCT05084378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93161258|NCT05084378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161259|NCT05084378|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93161260|NCT05084378|Disinfectants|disinfectants|mesh-ancestor
93161261|NCT05084378|Plasma Substitutes|plasma substitutes|mesh-ancestor
93161262|NCT05084378|Blood Substitutes|blood substitutes|mesh-ancestor
93161263|NCT05072249|Naloxone|naloxone|mesh-list
93161264|NCT05072249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93161265|NCT05072249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161266|NCT05072249|Sensory System Agents|sensory system agents|mesh-ancestor
93161267|NCT05072249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161268|NCT05065918|Ethanol|ethanol|mesh-list
93161269|NCT05065918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93161270|NCT05065918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161271|NCT05065918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93161272|NCT05065918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161273|NCT05048017|Pembrolizumab|pembrolizumab|mesh-list
93161274|NCT05048017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93161275|NCT05048017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161276|NCT05048017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161277|NCT05048017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161278|NCT05040984|Solifenacin Succinate|solifenacin succinate|mesh-list
93161279|NCT05040984|Mirabegron|mirabegron|mesh-list
93161280|NCT05040984|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93161281|NCT05040984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93161282|NCT05040984|Cholinergic Agents|cholinergic agents|mesh-ancestor
93161283|NCT05040984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161284|NCT05040984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161285|NCT05040984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161286|NCT05040984|Urological Agents|urological agents|mesh-ancestor
93161287|NCT05040984|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93161288|NCT05040984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93161289|NCT05040984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93161290|NCT05040984|Adrenergic Agents|adrenergic agents|mesh-ancestor
93161291|NCT05017272|Analgesics, Opioid|analgesics, opioid|mesh-list
93161292|NCT05017272|Narcotics|narcotics|mesh-ancestor
93161293|NCT05017272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93161294|NCT05017272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161295|NCT05017272|Analgesics|analgesics|mesh-ancestor
93161296|NCT05017272|Sensory System Agents|sensory system agents|mesh-ancestor
93161297|NCT05017272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161298|NCT04981912|Rituximab|rituximab|mesh-list
93161299|NCT04981912|Venetoclax|venetoclax|mesh-list
93161300|NCT04981912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161301|NCT04981912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161302|NCT04981912|Immunologic Factors|immunologic factors|mesh-ancestor
93161303|NCT04981912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161304|NCT04981912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161305|NCT04974879|Osimertinib|osimertinib|mesh-list
93161306|NCT04974879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161307|NCT04974879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161308|NCT04974879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161309|NCT04974879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161310|NCT04933058|Acetaminophen|acetaminophen|mesh-list
93161311|NCT04933058|Fentanyl|fentanyl|mesh-list
93161312|NCT04933058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93161313|NCT04933058|Narcotics|narcotics|mesh-ancestor
93161314|NCT04933058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93161315|NCT04933058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161316|NCT04933058|Analgesics|analgesics|mesh-ancestor
93161317|NCT04933058|Sensory System Agents|sensory system agents|mesh-ancestor
93161318|NCT04933058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161319|NCT04933058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93161320|NCT04933058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93161321|NCT04933058|Anesthetics, General|anesthetics, general|mesh-ancestor
93161322|NCT04933058|Anesthetics|anesthetics|mesh-ancestor
93161323|NCT04933058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93161324|NCT04933058|Antipyretics|antipyretics|mesh-ancestor
93161325|NCT04918810|Docetaxel|docetaxel|mesh-list
93161326|NCT04918810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161327|NCT04918810|Tubulin Modulators|tubulin modulators|mesh-ancestor
93161328|NCT04918810|Antimitotic Agents|antimitotic agents|mesh-ancestor
93161329|NCT04918810|Mitosis Modulators|mitosis modulators|mesh-ancestor
93161330|NCT04918810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161331|NCT04894864|Analgesics, Opioid|analgesics, opioid|mesh-list
93161332|NCT04894864|Anesthetics|anesthetics|mesh-list
93161333|NCT04894864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93161334|NCT04894864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161335|NCT04894864|Narcotics|narcotics|mesh-ancestor
93161336|NCT04894864|Analgesics|analgesics|mesh-ancestor
93161337|NCT04894864|Sensory System Agents|sensory system agents|mesh-ancestor
93161338|NCT04894864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161339|NCT04880395|Lamivudine|lamivudine|mesh-list
93161340|NCT04880395|Emtricitabine|emtricitabine|mesh-list
93161341|NCT04880395|Dolutegravir|dolutegravir|mesh-list
93161342|NCT04880395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93161343|NCT04880395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93161344|NCT04880395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161345|NCT04880395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161346|NCT04880395|Antiviral Agents|antiviral agents|mesh-ancestor
93161347|NCT04880395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161348|NCT04880395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93161349|NCT04880395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93161350|NCT04880395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93161351|NCT04880395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93161352|NCT04849013|Ketanserin|ketanserin|mesh-list
93161353|NCT04849013|Mescaline|mescaline|mesh-list
93161354|NCT04849013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93161355|NCT04849013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93161356|NCT04849013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93161357|NCT04849013|Serotonin Agents|serotonin agents|mesh-ancestor
93161358|NCT04849013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161359|NCT04849013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161360|NCT04849013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161361|NCT04849013|Hallucinogens|hallucinogens|mesh-ancestor
93161362|NCT04849013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93161363|NCT04849013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93161364|NCT04808245|Atezolizumab|atezolizumab|mesh-list
93161365|NCT04808245|Imiquimod|imiquimod|mesh-list
93161366|NCT04808245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161367|NCT04808245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161368|NCT04808245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161369|NCT04808245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161370|NCT04808245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93161371|NCT04808245|Immunologic Factors|immunologic factors|mesh-ancestor
93161372|NCT04808245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161373|NCT04808245|Interferon Inducers|interferon inducers|mesh-ancestor
93161374|NCT04790513|Evolocumab|evolocumab|mesh-list
93161375|NCT04790513|Alirocumab|alirocumab|mesh-list
93161376|NCT04790513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93161377|NCT04790513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93161378|NCT04790513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161379|NCT04790513|Antimetabolites|antimetabolites|mesh-ancestor
93161380|NCT04790513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161381|NCT04790513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93161382|NCT04790513|Protease Inhibitors|protease inhibitors|mesh-ancestor
93161383|NCT04790513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161384|NCT04790513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161385|NCT04777071|Edetic Acid|edetic acid|mesh-list
93161386|NCT04777071|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93161387|NCT04777071|Chelating Agents|chelating agents|mesh-ancestor
93161388|NCT04777071|Sequestering Agents|sequestering agents|mesh-ancestor
93161389|NCT04777071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161390|NCT04777071|Anticoagulants|anticoagulants|mesh-ancestor
93161391|NCT04777071|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93161392|NCT04777071|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93161393|NCT04747847|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93161394|NCT04747847|Atorvastatin|atorvastatin|mesh-list
93161395|NCT04747847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93161396|NCT04747847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161397|NCT04747847|Antimetabolites|antimetabolites|mesh-ancestor
93161398|NCT04747847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161399|NCT04747847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161400|NCT04747847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93161401|NCT04747847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161402|NCT04747847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161403|NCT04646837|Paclitaxel|paclitaxel|mesh-list
93161404|NCT04646837|Carboplatin|carboplatin|mesh-list
93161405|NCT04646837|Durvalumab|durvalumab|mesh-list
93161406|NCT04646837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93161407|NCT04646837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161408|NCT04646837|Tubulin Modulators|tubulin modulators|mesh-ancestor
93161409|NCT04646837|Antimitotic Agents|antimitotic agents|mesh-ancestor
93161410|NCT04646837|Mitosis Modulators|mitosis modulators|mesh-ancestor
93161411|NCT04646837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161412|NCT04646837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161413|NCT04640636|Midazolam|midazolam|mesh-list
93161414|NCT04640636|Ketamine|ketamine|mesh-list
93161415|NCT04640636|Analgesics|analgesics|mesh-ancestor
93161416|NCT04640636|Sensory System Agents|sensory system agents|mesh-ancestor
93161417|NCT04640636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161418|NCT04640636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161419|NCT04640636|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93161420|NCT04640636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93161421|NCT04640636|Anesthetics, General|anesthetics, general|mesh-ancestor
93161422|NCT04640636|Anesthetics|anesthetics|mesh-ancestor
93161423|NCT04640636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93161424|NCT04640636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93161425|NCT04640636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93161426|NCT04640636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161427|NCT04640636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161428|NCT04640636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93161429|NCT04640636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93161430|NCT04640636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93161431|NCT04640636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93161432|NCT04640636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93161433|NCT04640636|GABA Modulators|gaba modulators|mesh-ancestor
93161434|NCT04640636|GABA Agents|gaba agents|mesh-ancestor
93161435|NCT04600167|Isoniazid|isoniazid|mesh-list
93161436|NCT04600167|Rifapentine|rifapentine|mesh-list
93161437|NCT04600167|Antitubercular Agents|antitubercular agents|mesh-ancestor
93161438|NCT04600167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161439|NCT04600167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161440|NCT04600167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93161441|NCT04600167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161442|NCT04600167|Antimetabolites|antimetabolites|mesh-ancestor
93161443|NCT04600167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161444|NCT04600167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161445|NCT04600167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93161446|NCT04600167|Leprostatic Agents|leprostatic agents|mesh-ancestor
93161447|NCT04560725|Choline|choline|mesh-list
93161448|NCT04560725|Lipotropic Agents|lipotropic agents|mesh-ancestor
93161449|NCT04560725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161450|NCT04560725|Antimetabolites|antimetabolites|mesh-ancestor
93161451|NCT04560725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161452|NCT04560725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93161453|NCT04560725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161454|NCT04560725|Nootropic Agents|nootropic agents|mesh-ancestor
93161455|NCT04522284|Capecitabine|capecitabine|mesh-list
93161456|NCT04522284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161457|NCT04522284|Antimetabolites|antimetabolites|mesh-ancestor
93161458|NCT04522284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161459|NCT04522284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161460|NCT04489888|Paclitaxel|paclitaxel|mesh-list
93161461|NCT04489888|Carboplatin|carboplatin|mesh-list
93161462|NCT04489888|Pembrolizumab|pembrolizumab|mesh-list
93161463|NCT04489888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93161465|NCT04489888|Tubulin Modulators|tubulin modulators|mesh-ancestor
93161466|NCT04489888|Antimitotic Agents|antimitotic agents|mesh-ancestor
93161467|NCT04489888|Mitosis Modulators|mitosis modulators|mesh-ancestor
93161468|NCT04489888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161469|NCT04489888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161470|NCT04489888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161471|NCT04443309|Lenvatinib|lenvatinib|mesh-list
93161472|NCT04443309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161473|NCT04443309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161474|NCT04443309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161475|NCT04443309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161476|NCT04401800|Lenvatinib|lenvatinib|mesh-list
93161477|NCT04401800|Tislelizumab|tislelizumab|mesh-list
93161478|NCT04401800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161479|NCT04401800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161480|NCT04401800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161481|NCT04401800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161482|NCT04401800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161483|NCT04400110|Amoxicillin|amoxicillin|mesh-list
93161484|NCT04400110|Clavulanic Acids|clavulanic acids|mesh-list
93161485|NCT04400110|Clavulanic Acid|clavulanic acid|mesh-list
93161486|NCT04400110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161487|NCT04400110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161488|NCT04400110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161489|NCT04400110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161490|NCT04400110|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93161491|NCT04387227|Carboplatin|carboplatin|mesh-list
93161492|NCT04387227|Pembrolizumab|pembrolizumab|mesh-list
93161493|NCT04387227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161494|NCT04387227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161495|NCT04387227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161496|NCT04387227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161497|NCT04368078|Lenvatinib|lenvatinib|mesh-list
93161498|NCT04368078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161499|NCT04368078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161500|NCT04368078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161501|NCT04368078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161502|NCT04350463|Nivolumab|nivolumab|mesh-list
93161503|NCT04350463|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
93161504|NCT04350463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161505|NCT04350463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161506|NCT04350463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161507|NCT04350463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161508|NCT04350463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161509|NCT04347616|Aldesleukin|aldesleukin|mesh-list
93161510|NCT04347616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161511|NCT04347616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93161512|NCT04347616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93161513|NCT04347616|Antiviral Agents|antiviral agents|mesh-ancestor
93161514|NCT04347616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161515|NCT04338763|Gemcitabine|gemcitabine|mesh-list
93161516|NCT04338763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161517|NCT04338763|Antimetabolites|antimetabolites|mesh-ancestor
93161518|NCT04338763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161519|NCT04338763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161520|NCT04329728|Dexamethasone|dexamethasone|mesh-list
93161521|NCT04329728|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93161522|NCT04329728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161523|NCT04329728|Antiemetics|antiemetics|mesh-ancestor
93161524|NCT04329728|Autonomic Agents|autonomic agents|mesh-ancestor
93161525|NCT04329728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161526|NCT04329728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161527|NCT04329728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93161528|NCT04329728|Glucocorticoids|glucocorticoids|mesh-ancestor
93161529|NCT04329728|Hormones|hormones|mesh-ancestor
93161530|NCT04329728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93161531|NCT04329728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93161532|NCT04329728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161533|NCT04265950|Vaccines|vaccines|mesh-list
92833741|NCT02586610|Antimetabolites|antimetabolites|mesh-ancestor
93161534|NCT04265950|Immunologic Factors|immunologic factors|mesh-ancestor
93161535|NCT04265950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161536|NCT04249778|Dapagliflozin|dapagliflozin|mesh-list
93161537|NCT04249778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93161538|NCT04249778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161539|NCT04249778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93161540|NCT04249778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161541|NCT04247815|Methotrexate|methotrexate|mesh-list
93161542|NCT04247815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93161543|NCT04247815|Abortifacient Agents|abortifacient agents|mesh-ancestor
93161544|NCT04247815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93161545|NCT04247815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161546|NCT04247815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161547|NCT04247815|Antimetabolites|antimetabolites|mesh-ancestor
93161548|NCT04247815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161549|NCT04247815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161550|NCT04247815|Dermatologic Agents|dermatologic agents|mesh-ancestor
93161551|NCT04247815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161552|NCT04247815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93161553|NCT04247815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161554|NCT04247815|Immunologic Factors|immunologic factors|mesh-ancestor
93161555|NCT04247815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161556|NCT04247815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93161558|NCT04227522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93161559|NCT04227522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161560|NCT04227522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161561|NCT04227522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161562|NCT04216953|Atezolizumab|atezolizumab|mesh-list
93161563|NCT04216953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161564|NCT04216953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161565|NCT04216953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161566|NCT04216953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161567|NCT04211168|Lenvatinib|lenvatinib|mesh-list
93161568|NCT04211168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161569|NCT04211168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161570|NCT04211168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161571|NCT04211168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161572|NCT04196257|Paclitaxel|paclitaxel|mesh-list
93161573|NCT04196257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93161574|NCT04196257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161575|NCT04196257|Tubulin Modulators|tubulin modulators|mesh-ancestor
93161576|NCT04196257|Antimitotic Agents|antimitotic agents|mesh-ancestor
93161577|NCT04196257|Mitosis Modulators|mitosis modulators|mesh-ancestor
93161578|NCT04196257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161579|NCT04193553|Lenvatinib|lenvatinib|mesh-list
93161580|NCT04193553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161581|NCT04193553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161582|NCT04193553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161583|NCT04193553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161584|NCT04188548|Trastuzumab|trastuzumab|mesh-list
93161585|NCT04188548|Pertuzumab|pertuzumab|mesh-list
93161586|NCT04188548|Everolimus|everolimus|mesh-list
93161587|NCT04188548|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93161588|NCT04188548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161589|NCT04188548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161590|NCT04188548|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93161591|NCT04188548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161592|NCT04188548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161593|NCT04188548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161594|NCT04188548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161595|NCT04188548|Immunologic Factors|immunologic factors|mesh-ancestor
93161596|NCT04188548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161597|NCT04188548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93161598|NCT04188548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93161599|NCT04188548|Hormone Antagonists|hormone antagonists|mesh-ancestor
93161600|NCT04188548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93161601|NCT04183101|Enalapril|enalapril|mesh-list
93161602|NCT04183101|Enalaprilat|enalaprilat|mesh-list
93161603|NCT04183101|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93161604|NCT04183101|Protease Inhibitors|protease inhibitors|mesh-ancestor
93161605|NCT04183101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161606|NCT04183101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161607|NCT04183101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92833807|NCT00764413|Prednisolone|prednisolone|mesh-list
93161608|NCT04165772|Capecitabine|capecitabine|mesh-list
93161609|NCT04165772|Dostarlimab|dostarlimab|mesh-list
93161610|NCT04165772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161611|NCT04165772|Antimetabolites|antimetabolites|mesh-ancestor
93161612|NCT04165772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161613|NCT04165772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161614|NCT04155632|Acetylcysteine|acetylcysteine|mesh-list
93161615|NCT04155632|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93161616|NCT04155632|Antiviral Agents|antiviral agents|mesh-ancestor
93161617|NCT04155632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161618|NCT04155632|Expectorants|expectorants|mesh-ancestor
93161619|NCT04155632|Respiratory System Agents|respiratory system agents|mesh-ancestor
93161620|NCT04155632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93161621|NCT04155632|Antioxidants|antioxidants|mesh-ancestor
93161622|NCT04155632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161623|NCT04155632|Protective Agents|protective agents|mesh-ancestor
93161624|NCT04155632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161625|NCT04155632|Antidotes|antidotes|mesh-ancestor
93161626|NCT04088630|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93161627|NCT04088630|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93161628|NCT04088630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161629|NCT04088630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161630|NCT04088630|Immunologic Factors|immunologic factors|mesh-ancestor
93161631|NCT04088630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161632|NCT04073134|Evolocumab|evolocumab|mesh-list
93161633|NCT04073134|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93161634|NCT04073134|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93161635|NCT04073134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161636|NCT04073134|Antimetabolites|antimetabolites|mesh-ancestor
93161637|NCT04073134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161638|NCT04073134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93161639|NCT04073134|Protease Inhibitors|protease inhibitors|mesh-ancestor
93161640|NCT04073134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161641|NCT04073134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161642|NCT04034485|Evolocumab|evolocumab|mesh-list
93161643|NCT04034485|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93161644|NCT04034485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93161645|NCT04034485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161646|NCT04034485|Antimetabolites|antimetabolites|mesh-ancestor
93161647|NCT04034485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161648|NCT04034485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93161649|NCT04034485|Protease Inhibitors|protease inhibitors|mesh-ancestor
93161650|NCT04034485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161651|NCT04034485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161652|NCT04010071|Axitinib|axitinib|mesh-list
93161653|NCT04010071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161654|NCT04010071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93161655|NCT04010071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161656|NCT04010071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161657|NCT03988920|Sevelamer|sevelamer|mesh-list
93161658|NCT03988920|Chelating Agents|chelating agents|mesh-ancestor
93161659|NCT03988920|Sequestering Agents|sequestering agents|mesh-ancestor
93161660|NCT03988920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161661|NCT03925402|Ertapenem|ertapenem|mesh-list
93161662|NCT03925402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161663|NCT03925402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161664|NCT03892577|Immunomodulating Agents|immunomodulating agents|mesh-list
93161665|NCT03892577|Immunologic Factors|immunologic factors|mesh-ancestor
93161666|NCT03892577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161667|NCT03875079|Pembrolizumab|pembrolizumab|mesh-list
93161668|NCT03875079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161669|NCT03875079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161670|NCT03875079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161671|NCT03875079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161672|NCT03866252|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93161673|NCT03866252|Hallucinogens|hallucinogens|mesh-ancestor
93161674|NCT03866252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161675|NCT03866252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93161676|NCT03866252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93161677|NCT03866252|Serotonin Agents|serotonin agents|mesh-ancestor
93161678|NCT03866252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161679|NCT03866252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161680|NCT03866252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93161681|NCT03769298|Tacrolimus|tacrolimus|mesh-list
93161682|NCT03769298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161683|NCT03769298|Immunologic Factors|immunologic factors|mesh-ancestor
93161684|NCT03769298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161685|NCT03769298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93161686|NCT03769298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161687|NCT03769298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161688|NCT03688451|Rituximab|rituximab|mesh-list
93161689|NCT03688451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161690|NCT03688451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161691|NCT03688451|Immunologic Factors|immunologic factors|mesh-ancestor
93161692|NCT03688451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161693|NCT03688451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161694|NCT03626064|Nicotine|nicotine|mesh-list
93161695|NCT03626064|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93161696|NCT03626064|Autonomic Agents|autonomic agents|mesh-ancestor
93161697|NCT03626064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161698|NCT03626064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161699|NCT03626064|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93161700|NCT03626064|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93161701|NCT03626064|Cholinergic Agents|cholinergic agents|mesh-ancestor
93161702|NCT03626064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161703|NCT03626064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161704|NCT03613532|Fludarabine|fludarabine|mesh-list
93161705|NCT03613532|Azacitidine|azacitidine|mesh-list
93161706|NCT03613532|Busulfan|busulfan|mesh-list
93161707|NCT03613532|Decitabine|decitabine|mesh-list
93161708|NCT03613532|Venetoclax|venetoclax|mesh-list
93161709|NCT03613532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161710|NCT03613532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161711|NCT03613532|Antimetabolites|antimetabolites|mesh-ancestor
93161712|NCT03613532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161713|NCT03613532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161714|NCT03613532|Immunologic Factors|immunologic factors|mesh-ancestor
93161715|NCT03613532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161716|NCT03613532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161717|NCT03613532|Alkylating Agents|alkylating agents|mesh-ancestor
93161718|NCT03613532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93161719|NCT03613532|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93161720|NCT03593018|Gemcitabine|gemcitabine|mesh-list
93161721|NCT03593018|Azacitidine|azacitidine|mesh-list
93161722|NCT03593018|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93161723|NCT03593018|Romidepsin|romidepsin|mesh-list
93161724|NCT03593018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161725|NCT03593018|Antimetabolites|antimetabolites|mesh-ancestor
93161726|NCT03593018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161727|NCT03593018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161728|NCT03593018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161729|NCT03593018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93161730|NCT03593018|Alkylating Agents|alkylating agents|mesh-ancestor
93161731|NCT03593018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93161732|NCT03593018|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93161733|NCT03570099|Naloxone|naloxone|mesh-list
93161734|NCT03570099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93161735|NCT03570099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161736|NCT03570099|Sensory System Agents|sensory system agents|mesh-ancestor
93161737|NCT03570099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161738|NCT03550391|Memantine|memantine|mesh-list
93161739|NCT03550391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93161740|NCT03550391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93161741|NCT03550391|Dopamine Agents|dopamine agents|mesh-ancestor
93161742|NCT03550391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161743|NCT03550391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161744|NCT03550391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161745|NCT03550391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93161746|NCT03550391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93161747|NCT03529396|Chloroquine|chloroquine|mesh-list
93161748|NCT03529396|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93161749|NCT03529396|Primaquine|primaquine|mesh-list
93161750|NCT03529396|Amebicides|amebicides|mesh-ancestor
93161751|NCT03529396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93161752|NCT03529396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93161753|NCT03529396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161754|NCT03529396|Antimalarials|antimalarials|mesh-ancestor
93161755|NCT03529396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161756|NCT03529396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93161757|NCT03529396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93161758|NCT03529396|Analgesics|analgesics|mesh-ancestor
93161759|NCT03529396|Sensory System Agents|sensory system agents|mesh-ancestor
93161760|NCT03529396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161761|NCT03529396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161762|NCT03529396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161763|NCT03529396|Filaricides|filaricides|mesh-ancestor
93161764|NCT03529396|Antinematodal Agents|antinematodal agents|mesh-ancestor
93161765|NCT03529396|Anthelmintics|anthelmintics|mesh-ancestor
93161766|NCT03515837|Carboplatin|carboplatin|mesh-list
93161767|NCT03515837|Pembrolizumab|pembrolizumab|mesh-list
93161768|NCT03515837|Pemetrexed|pemetrexed|mesh-list
93161769|NCT03515837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93161770|NCT03515837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161771|NCT03515837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161772|NCT03515837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161773|NCT03515837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161774|NCT03515837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161775|NCT03515837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93161776|NCT03515837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93161777|NCT03436563|Atezolizumab|atezolizumab|mesh-list
93161778|NCT03436563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161779|NCT03436563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161780|NCT03436563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161781|NCT03436563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161782|NCT03426254|Talazoparib|talazoparib|mesh-list
93161783|NCT03426254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93161784|NCT03426254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161785|NCT03426254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161786|NCT03426254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161787|NCT03411031|Thalidomide|thalidomide|mesh-list
93161788|NCT03411031|Dexamethasone|dexamethasone|mesh-list
93161789|NCT03411031|Lenalidomide|lenalidomide|mesh-list
93161790|NCT03411031|Elotuzumab|elotuzumab|mesh-list
93161791|NCT03411031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161792|NCT03411031|Antiemetics|antiemetics|mesh-ancestor
93161793|NCT03411031|Autonomic Agents|autonomic agents|mesh-ancestor
93161794|NCT03411031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161795|NCT03411031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161796|NCT03411031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93161797|NCT03411031|Glucocorticoids|glucocorticoids|mesh-ancestor
93161798|NCT03411031|Hormones|hormones|mesh-ancestor
93161799|NCT03411031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93161800|NCT03411031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93161801|NCT03411031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161802|NCT03411031|Immunologic Factors|immunologic factors|mesh-ancestor
93161803|NCT03411031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93161804|NCT03411031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93161805|NCT03411031|Growth Substances|growth substances|mesh-ancestor
93161806|NCT03411031|Growth Inhibitors|growth inhibitors|mesh-ancestor
93161807|NCT03411031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93161808|NCT03411031|Leprostatic Agents|leprostatic agents|mesh-ancestor
93161809|NCT03411031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161810|NCT03411031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161811|NCT03358017|Zoledronic Acid|zoledronic acid|mesh-list
93161812|NCT03358017|Atorvastatin|atorvastatin|mesh-list
93161813|NCT03358017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93161814|NCT03358017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93161815|NCT03358017|Antimetabolites|antimetabolites|mesh-ancestor
93161816|NCT03358017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161817|NCT03358017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93161818|NCT03358017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93161819|NCT03358017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161820|NCT03358017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93161821|NCT03358017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161822|NCT03289351|Tazobactam|tazobactam|mesh-list
93161823|NCT03289351|Piperacillin|piperacillin|mesh-list
93161824|NCT03289351|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93161825|NCT03289351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93161826|NCT03289351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161827|NCT03289351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93161828|NCT03289351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161829|NCT03289351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161830|NCT03280667|Denosumab|denosumab|mesh-list
93161831|NCT03280667|Pembrolizumab|pembrolizumab|mesh-list
93161832|NCT03280667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161833|NCT03280667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161834|NCT03280667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161835|NCT03280667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161836|NCT03280667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93161837|NCT03280667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161838|NCT03272347|Tenofovir|tenofovir|mesh-list
93161839|NCT03272347|Lamivudine|lamivudine|mesh-list
93161840|NCT03272347|Islatravir|islatravir|mesh-list
93161841|NCT03272347|Antiviral Agents|antiviral agents|mesh-ancestor
93161842|NCT03272347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161843|NCT03272347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93161844|NCT03272347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93161845|NCT03272347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161846|NCT03272347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161847|NCT03272347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93161848|NCT03272347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93161849|NCT03251300|Mirabegron|mirabegron|mesh-list
93161850|NCT03251300|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93161851|NCT03251300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93161852|NCT03251300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93161853|NCT03251300|Adrenergic Agents|adrenergic agents|mesh-ancestor
93161854|NCT03251300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161855|NCT03251300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161856|NCT03251300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161857|NCT03251300|Urological Agents|urological agents|mesh-ancestor
93161858|NCT03228693|Triamcinolone|triamcinolone|mesh-list
93161859|NCT03228693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161860|NCT03228693|Glucocorticoids|glucocorticoids|mesh-ancestor
93161861|NCT03228693|Hormones|hormones|mesh-ancestor
93161862|NCT03228693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93161863|NCT03228693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161864|NCT03108690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93161865|NCT03108690|Meropenem|meropenem|mesh-list
93161866|NCT03108690|Tazobactam|tazobactam|mesh-list
93161867|NCT03108690|Piperacillin|piperacillin|mesh-list
93161868|NCT03108690|Ampicillin|ampicillin|mesh-list
93161869|NCT03108690|Cefuroxime|cefuroxime|mesh-list
93161870|NCT03108690|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93161871|NCT03108690|Lactams|lactams|mesh-list
93161872|NCT03108690|beta-Lactams|beta-lactams|mesh-list
93161873|NCT03108690|Penicillin G|penicillin g|mesh-list
93161874|NCT03108690|Dicloxacillin|dicloxacillin|mesh-list
93161875|NCT03108690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93161876|NCT03108690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161877|NCT03108690|Antitubercular Agents|antitubercular agents|mesh-ancestor
93161878|NCT03108690|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93161879|NCT03108690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161880|NCT03108690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161881|NCT03103152|Aspirin|aspirin|mesh-list
93161882|NCT03103152|Vitamin D|vitamin d|mesh-list
93161883|NCT03103152|Ergocalciferols|ergocalciferols|mesh-list
93161884|NCT03103152|Cholecalciferol|cholecalciferol|mesh-list
93161885|NCT03103152|Vitamins|vitamins|mesh-list
93161886|NCT03103152|Micronutrients|micronutrients|mesh-ancestor
93161887|NCT03103152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161888|NCT03103152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93161889|NCT03103152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93161890|NCT03103152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93161891|NCT03103152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93161892|NCT03103152|Analgesics|analgesics|mesh-ancestor
93161893|NCT03103152|Sensory System Agents|sensory system agents|mesh-ancestor
93161894|NCT03103152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161895|NCT03103152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161896|NCT03103152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161897|NCT03103152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93161898|NCT03103152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93161899|NCT03103152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161900|NCT03103152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93161901|NCT03103152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93161902|NCT03103152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161903|NCT03103152|Antipyretics|antipyretics|mesh-ancestor
93161904|NCT02988297|RNS60|rns60|mesh-list
93161905|NCT02988297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93161906|NCT02988297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93161907|NCT02988297|Analgesics|analgesics|mesh-ancestor
92834109|NCT05641324|Hormones|hormones|mesh-ancestor
93161908|NCT02988297|Sensory System Agents|sensory system agents|mesh-ancestor
93161909|NCT02988297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161910|NCT02988297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161911|NCT02988297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161912|NCT02988297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93161913|NCT02988297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93161914|NCT02937285|Interferons|interferons|mesh-list
93161915|NCT02937285|Interferon-beta|interferon-beta|mesh-list
93161916|NCT02937285|Interferon beta-1a|interferon beta-1a|mesh-list
93161917|NCT02937285|Mitoxantrone|mitoxantrone|mesh-list
93161918|NCT02937285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161919|NCT02937285|Antiviral Agents|antiviral agents|mesh-ancestor
93161920|NCT02937285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93161921|NCT02937285|Analgesics|analgesics|mesh-ancestor
93161922|NCT02937285|Sensory System Agents|sensory system agents|mesh-ancestor
93161923|NCT02937285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161924|NCT02937285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161925|NCT02937285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93161926|NCT02937285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93161927|NCT02937285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161928|NCT02937285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161929|NCT02937285|Immunologic Factors|immunologic factors|mesh-ancestor
93161930|NCT02937285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93161931|NCT02878785|Decitabine|decitabine|mesh-list
93161932|NCT02878785|Talazoparib|talazoparib|mesh-list
93161933|NCT02878785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93161934|NCT02878785|Antimetabolites|antimetabolites|mesh-ancestor
93161935|NCT02878785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161936|NCT02878785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161937|NCT02878785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161938|NCT02878785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93161939|NCT02825576|Glycopyrrolate|glycopyrrolate|mesh-list
93161940|NCT02825576|Neostigmine|neostigmine|mesh-list
93161941|NCT02825576|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93161942|NCT02825576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161943|NCT02825576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161944|NCT02825576|Cholinergic Agents|cholinergic agents|mesh-ancestor
93161945|NCT02825576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93161946|NCT02825576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161947|NCT02825576|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93161948|NCT02825576|Autonomic Agents|autonomic agents|mesh-ancestor
93161949|NCT02825576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161950|NCT02825576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93161951|NCT02825576|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93161952|NCT02825576|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93161953|NCT02719613|Dexamethasone|dexamethasone|mesh-list
93161954|NCT02719613|Dexamethasone acetate|dexamethasone acetate|mesh-list
93161955|NCT02719613|Nivolumab|nivolumab|mesh-list
93161956|NCT02719613|Lenalidomide|lenalidomide|mesh-list
93161957|NCT02719613|Bortezomib|bortezomib|mesh-list
93161958|NCT02719613|Pomalidomide|pomalidomide|mesh-list
93161959|NCT02719613|Elotuzumab|elotuzumab|mesh-list
93161960|NCT02719613|BB 1101|bb 1101|mesh-list
93161961|NCT02719613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93161962|NCT02719613|Antiemetics|antiemetics|mesh-ancestor
93161963|NCT02719613|Autonomic Agents|autonomic agents|mesh-ancestor
93161964|NCT02719613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93161965|NCT02719613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93161966|NCT02719613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93161967|NCT02719613|Glucocorticoids|glucocorticoids|mesh-ancestor
93161968|NCT02719613|Hormones|hormones|mesh-ancestor
93161969|NCT02719613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93161970|NCT02719613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93161971|NCT02719613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161972|NCT02719613|Protease Inhibitors|protease inhibitors|mesh-ancestor
93161973|NCT02719613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93161974|NCT02719613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161975|NCT02719613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161976|NCT02719613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161977|NCT02719613|Immunologic Factors|immunologic factors|mesh-ancestor
93161978|NCT02719613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93161979|NCT02719613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93161980|NCT02719613|Growth Substances|growth substances|mesh-ancestor
93161981|NCT02719613|Growth Inhibitors|growth inhibitors|mesh-ancestor
93161982|NCT02660645|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93161983|NCT02660645|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93161984|NCT02660645|Dermatologic Agents|dermatologic agents|mesh-ancestor
93161985|NCT02603887|Pembrolizumab|pembrolizumab|mesh-list
93161986|NCT02603887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161987|NCT02603887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161988|NCT02603887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93161989|NCT02603887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161990|NCT02475681|Obinutuzumab|obinutuzumab|mesh-list
93161991|NCT02475681|Acalabrutinib|acalabrutinib|mesh-list
93161992|NCT02475681|Chlorambucil|chlorambucil|mesh-list
93161993|NCT02475681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93161994|NCT02475681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93161995|NCT02475681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93161996|NCT02475681|Alkylating Agents|alkylating agents|mesh-ancestor
93161997|NCT02475681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93161998|NCT02315196|Paclitaxel|paclitaxel|mesh-list
93161999|NCT02315196|Carboplatin|carboplatin|mesh-list
93162000|NCT02315196|Doxorubicin|doxorubicin|mesh-list
93162001|NCT02315196|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93162002|NCT02315196|Epirubicin|epirubicin|mesh-list
93162003|NCT02315196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93162004|NCT02315196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162005|NCT02315196|Tubulin Modulators|tubulin modulators|mesh-ancestor
93162006|NCT02315196|Antimitotic Agents|antimitotic agents|mesh-ancestor
93162007|NCT02315196|Mitosis Modulators|mitosis modulators|mesh-ancestor
93162008|NCT02315196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162009|NCT02315196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93162010|NCT02315196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93162011|NCT02315196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93162012|NCT02315196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162013|NCT02273375|Durvalumab|durvalumab|mesh-list
93162014|NCT02273375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162015|NCT02273375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162016|NCT02207712|Ranibizumab|ranibizumab|mesh-list
93162017|NCT02207712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93162018|NCT02207712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93162019|NCT02207712|Growth Substances|growth substances|mesh-ancestor
93162020|NCT02207712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162021|NCT02207712|Growth Inhibitors|growth inhibitors|mesh-ancestor
93162022|NCT02207712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162023|NCT02179853|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93162024|NCT02179853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162025|NCT02133573|Progesterone|progesterone|mesh-list
93162026|NCT02133573|Progestins|progestins|mesh-ancestor
93162027|NCT02133573|Hormones|hormones|mesh-ancestor
93162028|NCT02133573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162029|NCT02133573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162030|NCT01917877|Dexamethasone|dexamethasone|mesh-list
93162031|NCT01917877|Bevacizumab|bevacizumab|mesh-list
93162032|NCT01917877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162033|NCT01917877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162034|NCT01917877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93162035|NCT01917877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93162036|NCT01917877|Growth Substances|growth substances|mesh-ancestor
93162037|NCT01917877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162038|NCT01917877|Growth Inhibitors|growth inhibitors|mesh-ancestor
93162039|NCT01917877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162040|NCT01917877|Antiemetics|antiemetics|mesh-ancestor
93162041|NCT01917877|Autonomic Agents|autonomic agents|mesh-ancestor
93162042|NCT01917877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162043|NCT01917877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93162044|NCT01917877|Glucocorticoids|glucocorticoids|mesh-ancestor
93162045|NCT01917877|Hormones|hormones|mesh-ancestor
93162046|NCT01917877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162047|NCT01917877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93162048|NCT01698840|Vitamin D|vitamin d|mesh-list
93162049|NCT01698840|Vitamins|vitamins|mesh-ancestor
93162050|NCT01698840|Micronutrients|micronutrients|mesh-ancestor
93162051|NCT01698840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162052|NCT01698840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93162053|NCT01570296|Gefitinib|gefitinib|mesh-list
93162054|NCT01570296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162055|NCT01570296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93162056|NCT01570296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162057|NCT01570296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162058|NCT01199575|Rituximab|rituximab|mesh-list
93162059|NCT01199575|Lenalidomide|lenalidomide|mesh-list
93162060|NCT01199575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162061|NCT01199575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162062|NCT01199575|Immunologic Factors|immunologic factors|mesh-ancestor
93162063|NCT01199575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162064|NCT01199575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162065|NCT01199575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93162066|NCT01199575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93162067|NCT01199575|Growth Substances|growth substances|mesh-ancestor
93162068|NCT01199575|Growth Inhibitors|growth inhibitors|mesh-ancestor
93162069|NCT01087619|Parathyroid Hormone|parathyroid hormone|mesh-list
93162070|NCT01087619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162071|NCT01087619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162072|NCT00496873|Cyclophosphamide|cyclophosphamide|mesh-list
93162073|NCT00496873|Rituximab|rituximab|mesh-list
93162074|NCT00496873|Pentostatin|pentostatin|mesh-list
93162075|NCT00496873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93162076|NCT00496873|Immunologic Factors|immunologic factors|mesh-ancestor
93162077|NCT00496873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162078|NCT00496873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162079|NCT00496873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93162080|NCT00496873|Alkylating Agents|alkylating agents|mesh-ancestor
93162081|NCT00496873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162082|NCT00496873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162083|NCT00496873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93162084|NCT00496873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162085|NCT00496873|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93162086|NCT00496873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162087|NCT00492778|Cisplatin|cisplatin|mesh-list
93162088|NCT00492778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162089|NCT03931369|Tolvaptan|tolvaptan|mesh-list
93162090|NCT03931369|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93162091|NCT03931369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162092|NCT03931369|Natriuretic Agents|natriuretic agents|mesh-ancestor
93162093|NCT03931369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162094|NCT00359216|Mometasone Furoate|mometasone furoate|mesh-list
93162095|NCT00359216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162096|NCT00359216|Dermatologic Agents|dermatologic agents|mesh-ancestor
93162097|NCT00359216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93162098|NCT01239550|Insulin Detemir|insulin detemir|mesh-list
93162099|NCT01239550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162100|NCT01239550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162101|NCT03721328|Vancomycin|vancomycin|mesh-list
93162102|NCT03721328|Tobramycin|tobramycin|mesh-list
93162103|NCT03721328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93162104|NCT03721328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162105|NCT01220791|Progesterone|progesterone|mesh-list
93162106|NCT01220791|Progestins|progestins|mesh-ancestor
93162107|NCT01220791|Hormones|hormones|mesh-ancestor
93162108|NCT01220791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162109|NCT01220791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162110|NCT01353482|Pemetrexed|pemetrexed|mesh-list
93162111|NCT01353482|Vorinostat|vorinostat|mesh-list
93162112|NCT01353482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162113|NCT01353482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162114|NCT01353482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162115|NCT01353482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93162116|NCT01353482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93162117|NCT01353482|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93162118|NCT02291380|Botulinum Toxins|botulinum toxins|mesh-list
93162119|NCT02291380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93162120|NCT02291380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93162121|NCT02291380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93162122|NCT02291380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162123|NCT02291380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162124|NCT02291380|Cholinergic Agents|cholinergic agents|mesh-ancestor
93162125|NCT02291380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162126|NCT02291380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162127|NCT02291380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93162128|NCT02291380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162129|NCT01353716|Dolutegravir|dolutegravir|mesh-list
93162130|NCT01353716|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93162131|NCT01353716|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93162132|NCT01353716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162133|NCT01353716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162134|NCT01353716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93162135|NCT01353716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93162136|NCT01353716|Antiviral Agents|antiviral agents|mesh-ancestor
93162137|NCT01353716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162138|NCT04481672|Magnesium Sulfate|magnesium sulfate|mesh-list
93162139|NCT04481672|Analgesics|analgesics|mesh-ancestor
93162140|NCT04481672|Sensory System Agents|sensory system agents|mesh-ancestor
93162141|NCT04481672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162142|NCT04481672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162143|NCT04481672|Anesthetics|anesthetics|mesh-ancestor
93162144|NCT04481672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162145|NCT04481672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93162146|NCT04481672|Anticonvulsants|anticonvulsants|mesh-ancestor
93162147|NCT04481672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93162148|NCT04481672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162149|NCT04481672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162150|NCT04481672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162151|NCT04481672|Tocolytic Agents|tocolytic agents|mesh-ancestor
93162152|NCT04481672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93162153|NCT01224067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93162154|NCT01224067|Antidepressive Agents|antidepressive agents|mesh-ancestor
93162155|NCT01224067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93162156|NCT01224067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93162157|NCT01224067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93162158|NCT01224067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162159|NCT01224067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162160|NCT04465942|Paclitaxel|paclitaxel|mesh-list
93162161|NCT04465942|Pembrolizumab|pembrolizumab|mesh-list
93162162|NCT04465942|Nivolumab|nivolumab|mesh-list
93162163|NCT04465942|Pemetrexed|pemetrexed|mesh-list
93162164|NCT04465942|Atezolizumab|atezolizumab|mesh-list
93162165|NCT04465942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93162166|NCT04465942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162167|NCT04465942|Tubulin Modulators|tubulin modulators|mesh-ancestor
93162168|NCT04465942|Antimitotic Agents|antimitotic agents|mesh-ancestor
93162169|NCT04465942|Mitosis Modulators|mitosis modulators|mesh-ancestor
93162170|NCT04465942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162171|NCT04465942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162172|NCT04465942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93162173|NCT04465942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162174|NCT04465942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93162175|NCT04465942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93162176|NCT01126645|Sorafenib|sorafenib|mesh-list
93162177|NCT01126645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162178|NCT01126645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93162179|NCT01126645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162180|NCT01126645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162181|NCT01343186|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93162182|NCT01343186|Interferon-alpha|interferon-alpha|mesh-list
93162183|NCT01343186|Antiviral Agents|antiviral agents|mesh-ancestor
93162184|NCT01343186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162185|NCT01343186|Immunologic Factors|immunologic factors|mesh-ancestor
93162186|NCT01343186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162187|NCT01329289|Dexamethasone|dexamethasone|mesh-list
93162188|NCT01329289|Dexamethasone acetate|dexamethasone acetate|mesh-list
93162189|NCT01329289|Bortezomib|bortezomib|mesh-list
93162190|NCT01329289|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93162191|NCT01329289|Pasireotide|pasireotide|mesh-list
93162192|NCT01329289|BB 1101|bb 1101|mesh-list
93162193|NCT01329289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162194|NCT01329289|Antiemetics|antiemetics|mesh-ancestor
93162195|NCT01329289|Autonomic Agents|autonomic agents|mesh-ancestor
93162196|NCT01329289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162197|NCT01329289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162198|NCT01329289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93162199|NCT01329289|Glucocorticoids|glucocorticoids|mesh-ancestor
93162200|NCT01329289|Hormones|hormones|mesh-ancestor
93162201|NCT01329289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162202|NCT01329289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93162203|NCT01329289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162204|NCT01329289|Protease Inhibitors|protease inhibitors|mesh-ancestor
93162205|NCT01329289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162206|NCT01329289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162207|NCT02291536|Dronabinol|dronabinol|mesh-list
93162208|NCT02291536|Cannabidiol|cannabidiol|mesh-list
93162209|NCT02291536|Anticonvulsants|anticonvulsants|mesh-ancestor
93162210|NCT02291536|Hallucinogens|hallucinogens|mesh-ancestor
93162211|NCT02291536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162212|NCT02291536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93162213|NCT02291536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93162214|NCT02291536|Analgesics|analgesics|mesh-ancestor
93162215|NCT02291536|Sensory System Agents|sensory system agents|mesh-ancestor
93162216|NCT02291536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162217|NCT02291536|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93162218|NCT02291536|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93162219|NCT02291536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162220|NCT02291536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162221|NCT02291536|Hormones|hormones|mesh-ancestor
93162222|NCT02291536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162223|NCT01317992|Ibudilast|ibudilast|mesh-list
93162224|NCT01317992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93162225|NCT01317992|Autonomic Agents|autonomic agents|mesh-ancestor
93162226|NCT01317992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162227|NCT01317992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162228|NCT01317992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93162229|NCT01317992|Respiratory System Agents|respiratory system agents|mesh-ancestor
93162230|NCT01317992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93162231|NCT01317992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162232|NCT01317992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162233|NCT01317992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93162234|NCT01317992|Vasodilator Agents|vasodilator agents|mesh-ancestor
93162235|NCT03635788|Rilpivirine|rilpivirine|mesh-list
93162236|NCT03635788|Cabotegravir|cabotegravir|mesh-list
93162237|NCT03635788|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93162238|NCT03635788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93162239|NCT03635788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162240|NCT03635788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162241|NCT03635788|Antiviral Agents|antiviral agents|mesh-ancestor
93162242|NCT03635788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162243|NCT03635788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93162244|NCT03635788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93162245|NCT03635788|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93162246|NCT03635788|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93162247|NCT01348412|Oxaliplatin|oxaliplatin|mesh-list
93162248|NCT01348412|Raltitrexed|raltitrexed|mesh-list
93162249|NCT01348412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162250|NCT01348412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93162251|NCT01348412|Antimetabolites|antimetabolites|mesh-ancestor
93162252|NCT01348412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162253|NCT01348412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93162254|NCT01348412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162255|NCT01353794|Sorafenib|sorafenib|mesh-list
93162256|NCT01353794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162257|NCT01353794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93162258|NCT01353794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162259|NCT01353794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162260|NCT01224301|Vaccines|vaccines|mesh-list
93162261|NCT01224301|Immunologic Factors|immunologic factors|mesh-ancestor
93162262|NCT01224301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162263|NCT01221025|Parecoxib|parecoxib|mesh-list
93162264|NCT01221025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93162265|NCT01221025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93162266|NCT01221025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162267|NCT01221025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162268|NCT01221025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93162269|NCT01221025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93162270|NCT01221025|Analgesics|analgesics|mesh-ancestor
93162271|NCT01221025|Sensory System Agents|sensory system agents|mesh-ancestor
93162272|NCT01221025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162273|NCT01221025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162274|NCT01221025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162275|NCT01221025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162276|NCT03523390|Avelumab|avelumab|mesh-list
93162277|NCT03523390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162278|NCT03523390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162279|NCT01221103|Dexamethasone|dexamethasone|mesh-list
93162280|NCT01221103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93162281|NCT01221103|Ofatumumab|ofatumumab|mesh-list
93162282|NCT01221103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93162283|NCT01221103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162284|NCT01221103|Antiemetics|antiemetics|mesh-ancestor
93162285|NCT01221103|Autonomic Agents|autonomic agents|mesh-ancestor
93162286|NCT01221103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162287|NCT01221103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162288|NCT01221103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93162289|NCT01221103|Glucocorticoids|glucocorticoids|mesh-ancestor
93162290|NCT01221103|Hormones|hormones|mesh-ancestor
93162291|NCT01221103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162292|NCT01221103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93162293|NCT01221103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162294|NCT01221103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93162295|NCT01221103|Alkylating Agents|alkylating agents|mesh-ancestor
93162296|NCT01221103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162297|NCT01221103|Immunologic Factors|immunologic factors|mesh-ancestor
93162298|NCT03706898|Sofosbuvir|sofosbuvir|mesh-list
93162299|NCT03706898|Dolutegravir|dolutegravir|mesh-list
93162300|NCT03706898|Elsulfavirine|elsulfavirine|mesh-list
93162301|NCT03706898|Antiviral Agents|antiviral agents|mesh-ancestor
93162302|NCT03706898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162303|NCT03706898|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93162304|NCT03706898|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93162305|NCT03706898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162306|NCT03706898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162307|NCT03706898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93162308|NCT03706898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93162309|NCT03927313|Aspirin|aspirin|mesh-list
93162310|NCT03927313|Rifampin|rifampin|mesh-list
93162311|NCT03927313|Linezolid|linezolid|mesh-list
93162312|NCT03927313|Dexamethasone|dexamethasone|mesh-list
93162313|NCT03927313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162314|NCT03927313|Antiemetics|antiemetics|mesh-ancestor
93162315|NCT03927313|Autonomic Agents|autonomic agents|mesh-ancestor
93162316|NCT03927313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162317|NCT03927313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162318|NCT03927313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93162319|NCT03927313|Glucocorticoids|glucocorticoids|mesh-ancestor
93162320|NCT03927313|Hormones|hormones|mesh-ancestor
93162321|NCT03927313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162322|NCT03927313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93162323|NCT03927313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162324|NCT03927313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93162325|NCT03927313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93162326|NCT03927313|Analgesics|analgesics|mesh-ancestor
93162327|NCT03927313|Sensory System Agents|sensory system agents|mesh-ancestor
93162328|NCT03927313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162329|NCT03927313|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93162330|NCT03927313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93162331|NCT03927313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162332|NCT03927313|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93162333|NCT03927313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93162334|NCT03927313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162335|NCT03927313|Antipyretics|antipyretics|mesh-ancestor
93162336|NCT03927313|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93162337|NCT03927313|Antitubercular Agents|antitubercular agents|mesh-ancestor
93162338|NCT03927313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93162339|NCT03927313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162340|NCT03927313|Leprostatic Agents|leprostatic agents|mesh-ancestor
93162341|NCT03927313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93162342|NCT03927313|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93162343|NCT03927313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93162344|NCT03927313|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93162345|NCT03927313|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93162346|NCT03927313|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93162347|NCT03927313|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93162348|NCT03927313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93162349|NCT01224457|Phenobarbital|phenobarbital|mesh-list
93162350|NCT01224457|Anticonvulsants|anticonvulsants|mesh-ancestor
93162351|NCT01224457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93162352|NCT01224457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162353|NCT01224457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162354|NCT01224457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93162355|NCT01224457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93162356|NCT01224457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162357|NCT01224457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162358|NCT01224457|GABA Modulators|gaba modulators|mesh-ancestor
93162359|NCT01224457|GABA Agents|gaba agents|mesh-ancestor
93162360|NCT01224457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93162361|NCT01224457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93162362|NCT01224457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93162363|NCT03133312|Chlorhexidine|chlorhexidine|mesh-list
93162364|NCT03133312|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93162365|NCT03133312|Povidone-Iodine|povidone-iodine|mesh-list
93162366|NCT03133312|Povidone|povidone|mesh-list
93162367|NCT03133312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93162368|NCT03133312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162369|NCT03133312|Disinfectants|disinfectants|mesh-ancestor
93162370|NCT03133312|Dermatologic Agents|dermatologic agents|mesh-ancestor
93162371|NCT03133312|Plasma Substitutes|plasma substitutes|mesh-ancestor
93162372|NCT03133312|Blood Substitutes|blood substitutes|mesh-ancestor
93162373|NCT01318148|Caspofungin|caspofungin|mesh-list
93162374|NCT01318148|Antifungal Agents|antifungal agents|mesh-ancestor
93162375|NCT01318148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162376|NCT01318148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162377|NCT01318148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162378|NCT01354262|Vitamin D|vitamin d|mesh-list
93162379|NCT01354262|Ergocalciferols|ergocalciferols|mesh-list
93162380|NCT01354262|Cholecalciferol|cholecalciferol|mesh-list
93162381|NCT01354262|Vitamins|vitamins|mesh-list
93162382|NCT01354262|Micronutrients|micronutrients|mesh-ancestor
93162383|NCT01354262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162384|NCT01354262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93162385|NCT01354262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162386|NCT01343498|Dactolisib|dactolisib|mesh-list
93162387|NCT01343498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162388|NCT01221337|Heparin|heparin|mesh-list
93162389|NCT01221337|Anticoagulants|anticoagulants|mesh-ancestor
93162390|NCT01221337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93162391|NCT01221337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93162392|NCT01221337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162393|NCT01354418|Phenylephrine|phenylephrine|mesh-list
93162394|NCT01354418|Oxymetazoline|oxymetazoline|mesh-list
93162395|NCT01354418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93162396|NCT01354418|Mydriatics|mydriatics|mesh-ancestor
93162397|NCT01354418|Autonomic Agents|autonomic agents|mesh-ancestor
93162398|NCT01354418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162399|NCT01354418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162400|NCT01354418|Sympathomimetics|sympathomimetics|mesh-ancestor
93162401|NCT01354418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93162402|NCT01354418|Nasal Decongestants|nasal decongestants|mesh-ancestor
93162403|NCT01354418|Respiratory System Agents|respiratory system agents|mesh-ancestor
93162404|NCT01354418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93162405|NCT01354418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93162406|NCT01354418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93162407|NCT01354418|Adrenergic Agents|adrenergic agents|mesh-ancestor
93162408|NCT01354418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162409|NCT01354418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162410|NCT01354418|Protective Agents|protective agents|mesh-ancestor
93162411|NCT02818868|Apixaban|apixaban|mesh-list
93162412|NCT02818868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93162413|NCT02818868|Antithrombins|antithrombins|mesh-ancestor
93162414|NCT02818868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93162415|NCT02818868|Protease Inhibitors|protease inhibitors|mesh-ancestor
93162416|NCT02818868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162417|NCT02818868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162418|NCT02818868|Anticoagulants|anticoagulants|mesh-ancestor
93162419|NCT01224535|Micronutrients|micronutrients|mesh-list
93162420|NCT01224535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162421|NCT02289274|Aceclofenac|aceclofenac|mesh-list
93162422|NCT02289274|Eperisone|eperisone|mesh-list
93162423|NCT02289274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93162424|NCT02289274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93162425|NCT02289274|Analgesics|analgesics|mesh-ancestor
93162426|NCT02289274|Sensory System Agents|sensory system agents|mesh-ancestor
93162427|NCT02289274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162428|NCT02289274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162429|NCT02289274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162430|NCT02289274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162431|NCT02289274|Anticonvulsants|anticonvulsants|mesh-ancestor
93162432|NCT02289274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93162433|NCT02289274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162434|NCT02289274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162435|NCT02289274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162436|NCT02289274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93162437|NCT02289274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93162438|NCT02289274|Parasympatholytics|parasympatholytics|mesh-ancestor
93162439|NCT02289274|Autonomic Agents|autonomic agents|mesh-ancestor
93162440|NCT02289274|Vasodilator Agents|vasodilator agents|mesh-ancestor
93162441|NCT01224613|Vaccines|vaccines|mesh-list
93162442|NCT01224613|Immunologic Factors|immunologic factors|mesh-ancestor
93162443|NCT01224613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162444|NCT03930433|Nebivolol|nebivolol|mesh-list
93162445|NCT03930433|Diltiazem|diltiazem|mesh-list
93162446|NCT03930433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93162447|NCT03930433|Vasodilator Agents|vasodilator agents|mesh-ancestor
93162448|NCT03930433|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93162449|NCT03930433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93162450|NCT03930433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93162451|NCT03930433|Adrenergic Agents|adrenergic agents|mesh-ancestor
93162452|NCT03930433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162453|NCT03930433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162454|NCT03930433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162455|NCT03930433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93162456|NCT03930433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162457|NCT03930433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162458|NCT01224769|Rituximab|rituximab|mesh-list
93162459|NCT01224769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93162460|NCT01224769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162461|NCT01224769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162462|NCT01224769|Immunologic Factors|immunologic factors|mesh-ancestor
93162463|NCT01224769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162464|NCT01224769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162465|NCT01224769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93162466|NCT01224769|Alkylating Agents|alkylating agents|mesh-ancestor
93162467|NCT01224769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162468|NCT02289430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93162469|NCT02289430|Ezetimibe|ezetimibe|mesh-list
93162470|NCT02289430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93162471|NCT02289430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93162472|NCT02289430|Antimetabolites|antimetabolites|mesh-ancestor
93162473|NCT02289430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162474|NCT02289430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93162475|NCT02289430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93162476|NCT02289430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162477|NCT01224847|Lidocaine|lidocaine|mesh-list
93162478|NCT01224847|Cocaine|cocaine|mesh-list
93162479|NCT01224847|Tetracaine|tetracaine|mesh-list
93162480|NCT01224847|Anesthetics, Local|anesthetics, local|mesh-ancestor
93162481|NCT01224847|Anesthetics|anesthetics|mesh-ancestor
93162482|NCT01224847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162483|NCT01224847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162484|NCT01224847|Sensory System Agents|sensory system agents|mesh-ancestor
93162485|NCT01224847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162486|NCT01224847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93162487|NCT01224847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93162488|NCT01224847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93162489|NCT01224847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162490|NCT01224847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162491|NCT01224847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93162492|NCT01224847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93162493|NCT01224847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93162494|NCT01224847|Dopamine Agents|dopamine agents|mesh-ancestor
93162495|NCT01224847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162496|NCT02289586|Fentanyl|fentanyl|mesh-list
93162497|NCT02289586|Midazolam|midazolam|mesh-list
93162498|NCT02289586|Remifentanil|remifentanil|mesh-list
93162499|NCT02289586|Dezocine|dezocine|mesh-list
93162500|NCT02289586|Propofol|propofol|mesh-list
93162501|NCT02289586|Rocuronium|rocuronium|mesh-list
93162502|NCT02289586|Anesthetics|anesthetics|mesh-ancestor
93162503|NCT02289586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162504|NCT02289586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162505|NCT02289586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93162506|NCT02289586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93162507|NCT02289586|Anesthetics, General|anesthetics, general|mesh-ancestor
93162508|NCT02289586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93162509|NCT02289586|Narcotics|narcotics|mesh-ancestor
93162510|NCT02289586|Analgesics|analgesics|mesh-ancestor
93162511|NCT02289586|Sensory System Agents|sensory system agents|mesh-ancestor
93162512|NCT02289586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162513|NCT02289586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93162514|NCT02289586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93162515|NCT02289586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93162516|NCT02289586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93162517|NCT02289586|GABA Modulators|gaba modulators|mesh-ancestor
93162518|NCT02289586|GABA Agents|gaba agents|mesh-ancestor
93162519|NCT02289586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162520|NCT02289586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162521|NCT02289586|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93162522|NCT02289586|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93162523|NCT02289586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93162524|NCT03740581|Insulin|insulin|mesh-list
93162525|NCT03740581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162526|NCT03740581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162527|NCT03874897|Antibodies|antibodies|mesh-list
93162528|NCT03874897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93162529|NCT03874897|Immunologic Factors|immunologic factors|mesh-ancestor
93162530|NCT03874897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162531|NCT01127035|Immunomodulating Agents|immunomodulating agents|mesh-list
93162532|NCT01127035|Immunologic Factors|immunologic factors|mesh-ancestor
93162533|NCT01127035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162534|NCT02294266|Ethanol|ethanol|mesh-list
93162535|NCT02294266|Methamphetamine|methamphetamine|mesh-list
93162536|NCT02294266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93162537|NCT02294266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162538|NCT02294266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162539|NCT02294266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162540|NCT02294266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93162541|NCT02294266|Sympathomimetics|sympathomimetics|mesh-ancestor
93162542|NCT02294266|Autonomic Agents|autonomic agents|mesh-ancestor
93162543|NCT02294266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162544|NCT02294266|Dopamine Agents|dopamine agents|mesh-ancestor
93162545|NCT02294266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162546|NCT02294266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162547|NCT02294266|Adrenergic Agents|adrenergic agents|mesh-ancestor
93162548|NCT02294266|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93162549|NCT02294266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93162550|NCT02294266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162551|NCT02294266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93162552|NCT02294344|Cyclophosphamide|cyclophosphamide|mesh-list
93162553|NCT02294344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93162554|NCT02294344|Immunologic Factors|immunologic factors|mesh-ancestor
93162555|NCT02294344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162556|NCT02294344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162557|NCT02294344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93162558|NCT02294344|Alkylating Agents|alkylating agents|mesh-ancestor
93162559|NCT02294344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162560|NCT02294344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162561|NCT02294344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93162562|NCT01130311|Vitamin D|vitamin d|mesh-list
93162563|NCT01130311|Cholecalciferol|cholecalciferol|mesh-list
93162564|NCT01130311|Vitamins|vitamins|mesh-ancestor
93162565|NCT01130311|Micronutrients|micronutrients|mesh-ancestor
93162566|NCT01130311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162567|NCT01130311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93162568|NCT01130311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162569|NCT03926377|Clobetasol|clobetasol|mesh-list
93162570|NCT03926377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162571|NCT03926377|Glucocorticoids|glucocorticoids|mesh-ancestor
93162572|NCT03926377|Hormones|hormones|mesh-ancestor
93162573|NCT03926377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162574|NCT03926377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162575|NCT03132688|Propofol|propofol|mesh-list
93162576|NCT03132688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93162577|NCT03132688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162578|NCT03132688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162579|NCT03132688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93162580|NCT03132688|Anesthetics, General|anesthetics, general|mesh-ancestor
93162581|NCT03132688|Anesthetics|anesthetics|mesh-ancestor
93162582|NCT01227811|Darifenacin|darifenacin|mesh-list
93162583|NCT01227811|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93162584|NCT01227811|Cholinergic Agents|cholinergic agents|mesh-list
93162585|NCT01227811|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93162586|NCT01227811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162587|NCT01227811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162588|NCT01227811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162589|NCT01227811|Urological Agents|urological agents|mesh-ancestor
93162590|NCT01225081|Pioglitazone|pioglitazone|mesh-list
93162591|NCT01225081|Ipragliflozin|ipragliflozin|mesh-list
93162592|NCT01225081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162593|NCT01225081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162594|NCT01225081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93162595|NCT01225081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162596|NCT02298166|Cytarabine|cytarabine|mesh-list
93162597|NCT02298166|Mitoxantrone|mitoxantrone|mesh-list
93162598|NCT02298166|Crenolanib|crenolanib|mesh-list
93162599|NCT02298166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93162600|NCT02298166|Antimetabolites|antimetabolites|mesh-ancestor
93162601|NCT02298166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162602|NCT02298166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162603|NCT02298166|Antiviral Agents|antiviral agents|mesh-ancestor
93162604|NCT02298166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162605|NCT02298166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93162606|NCT02298166|Immunologic Factors|immunologic factors|mesh-ancestor
93162607|NCT02298166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162608|NCT02298166|Analgesics|analgesics|mesh-ancestor
93162609|NCT02298166|Sensory System Agents|sensory system agents|mesh-ancestor
93162610|NCT02298166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162611|NCT02298166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93162612|NCT02298166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93162613|NCT02298166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162614|NCT01127269|Insulin Glargine|insulin glargine|mesh-list
93162615|NCT01127269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162616|NCT01127269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162617|NCT01221883|Diazepam|diazepam|mesh-list
93162618|NCT01221883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93162619|NCT01221883|Anticonvulsants|anticonvulsants|mesh-ancestor
93162620|NCT01221883|Antiemetics|antiemetics|mesh-ancestor
93162621|NCT01221883|Autonomic Agents|autonomic agents|mesh-ancestor
93162622|NCT01221883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162623|NCT01221883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162624|NCT01221883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93162625|NCT01221883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93162626|NCT01221883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162627|NCT01221883|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93162628|NCT01221883|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93162629|NCT01221883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93162630|NCT01221883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93162631|NCT01221883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93162632|NCT01221883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93162633|NCT01221883|Anesthetics, General|anesthetics, general|mesh-ancestor
93162634|NCT01221883|Anesthetics|anesthetics|mesh-ancestor
93162635|NCT01221883|GABA Modulators|gaba modulators|mesh-ancestor
93162636|NCT01221883|GABA Agents|gaba agents|mesh-ancestor
93162637|NCT01221883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162638|NCT01221883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162639|NCT02294656|Triamcinolone|triamcinolone|mesh-list
93162640|NCT02294656|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93162641|NCT02294656|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93162642|NCT02294656|Ranibizumab|ranibizumab|mesh-list
93162643|NCT02294656|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93162644|NCT02294656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93162645|NCT02294656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93162646|NCT02294656|Growth Substances|growth substances|mesh-ancestor
93162647|NCT02294656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162648|NCT02294656|Growth Inhibitors|growth inhibitors|mesh-ancestor
93162649|NCT02294656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162650|NCT02294656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162651|NCT02294656|Glucocorticoids|glucocorticoids|mesh-ancestor
93162652|NCT02294656|Hormones|hormones|mesh-ancestor
93162653|NCT02294656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162654|NCT02294656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93162655|NCT02294656|Immunologic Factors|immunologic factors|mesh-ancestor
93162656|NCT02294656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162657|NCT02294656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162658|NCT01225237|Ramosetron|ramosetron|mesh-list
93162659|NCT01225237|Antiemetics|antiemetics|mesh-ancestor
93162660|NCT01225237|Autonomic Agents|autonomic agents|mesh-ancestor
93162661|NCT01225237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162662|NCT01225237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162663|NCT01225237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834872|NCT03393741|Paclitaxel|paclitaxel|mesh-list
93162664|NCT01225237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93162665|NCT01225237|Serotonin Agents|serotonin agents|mesh-ancestor
93162666|NCT01225237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162667|NCT01225237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162668|NCT03517930|Loratadine|loratadine|mesh-list
93162669|NCT03517930|Pseudoephedrine|pseudoephedrine|mesh-list
93162670|NCT03517930|Ephedrine|ephedrine|mesh-list
93162671|NCT03517930|Antipruritics|antipruritics|mesh-ancestor
93162672|NCT03517930|Dermatologic Agents|dermatologic agents|mesh-ancestor
93162673|NCT03517930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93162674|NCT03517930|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93162675|NCT03517930|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93162676|NCT03517930|Histamine Antagonists|histamine antagonists|mesh-ancestor
93162677|NCT03517930|Histamine Agents|histamine agents|mesh-ancestor
93162678|NCT03517930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162679|NCT03517930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162680|NCT03517930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162681|NCT03517930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93162682|NCT03517930|Autonomic Agents|autonomic agents|mesh-ancestor
93162683|NCT03517930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162684|NCT03517930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93162685|NCT03517930|Respiratory System Agents|respiratory system agents|mesh-ancestor
93162686|NCT03517930|Nasal Decongestants|nasal decongestants|mesh-ancestor
93162687|NCT03517930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93162688|NCT03517930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93162689|NCT03517930|Sympathomimetics|sympathomimetics|mesh-ancestor
93162690|NCT03517930|Adrenergic Agents|adrenergic agents|mesh-ancestor
93162691|NCT01130467|Methylphenidate|methylphenidate|mesh-list
93162692|NCT01130467|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93162693|NCT01130467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93162694|NCT01130467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162695|NCT01130467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93162696|NCT01130467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93162697|NCT01130467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162698|NCT01130467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162699|NCT01130467|Dopamine Agents|dopamine agents|mesh-ancestor
93162700|NCT01130467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162701|NCT01130467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92458489|NCT01732367|Lamivudine|lamivudine|mesh-list
93162702|NCT01130467|Adrenergic Agents|adrenergic agents|mesh-ancestor
93162703|NCT02295046|Amlodipine|amlodipine|mesh-list
93162704|NCT02295046|Atorvastatin|atorvastatin|mesh-list
93162705|NCT02295046|Calcium|calcium|mesh-list
93162706|NCT02295046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162707|NCT02295046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162708|NCT02295046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93162709|NCT02295046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93162710|NCT02295046|Antimetabolites|antimetabolites|mesh-ancestor
93162711|NCT02295046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162712|NCT02295046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93162713|NCT02295046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93162714|NCT02295046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162715|NCT02295046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93162716|NCT02295046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93162717|NCT02295046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162718|NCT02295046|Vasodilator Agents|vasodilator agents|mesh-ancestor
93162719|NCT03517618|Leucovorin|leucovorin|mesh-list
93162720|NCT03517618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162721|NCT03517618|Antidotes|antidotes|mesh-ancestor
93162722|NCT03517618|Protective Agents|protective agents|mesh-ancestor
93162723|NCT03517618|Vitamin B Complex|vitamin b complex|mesh-ancestor
93162724|NCT03517618|Vitamins|vitamins|mesh-ancestor
93162725|NCT03517618|Micronutrients|micronutrients|mesh-ancestor
93162726|NCT02295124|Oxycodone|oxycodone|mesh-list
93162727|NCT02295124|Hydromorphone|hydromorphone|mesh-list
93162728|NCT02295124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93162729|NCT02295124|Narcotics|narcotics|mesh-ancestor
93162730|NCT02295124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162731|NCT02295124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162732|NCT02295124|Analgesics|analgesics|mesh-ancestor
93162733|NCT02295124|Sensory System Agents|sensory system agents|mesh-ancestor
93162734|NCT02295124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162735|NCT03925051|Denosumab|denosumab|mesh-list
93162736|NCT03925051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93162737|NCT03925051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162738|NCT03514576|Pasireotide|pasireotide|mesh-list
93162739|NCT03514576|Hormones|hormones|mesh-ancestor
93162740|NCT03514576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93162741|NCT03514576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162742|NCT02299024|Analgesics, Opioid|analgesics, opioid|mesh-list
93162743|NCT02299024|Narcotics|narcotics|mesh-ancestor
93162744|NCT02299024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162745|NCT02299024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162746|NCT02299024|Analgesics|analgesics|mesh-ancestor
93162747|NCT02299024|Sensory System Agents|sensory system agents|mesh-ancestor
93162748|NCT02299024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162749|NCT03929419|Insulin|insulin|mesh-list
93162750|NCT03929419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162751|NCT03929419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162752|NCT01228279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93162753|NCT01228279|Icodextrin|icodextrin|mesh-list
93162754|NCT01228279|Dialysis Solutions|dialysis solutions|mesh-ancestor
93162755|NCT03514342|Ropivacaine|ropivacaine|mesh-list
93162756|NCT03514342|Anesthetics, Local|anesthetics, local|mesh-ancestor
93162757|NCT03514342|Anesthetics|anesthetics|mesh-ancestor
93162758|NCT03514342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162759|NCT03514342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162760|NCT03514342|Sensory System Agents|sensory system agents|mesh-ancestor
93162761|NCT03514342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162762|NCT01228045|Trastuzumab|trastuzumab|mesh-list
93162763|NCT01228045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162764|NCT01228045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162765|NCT03514030|Antibodies|antibodies|mesh-list
93162766|NCT03514030|Immunologic Factors|immunologic factors|mesh-ancestor
93162767|NCT03514030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162768|NCT03517462|Ivermectin|ivermectin|mesh-list
93162769|NCT03517462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93162770|NCT03517462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162771|NCT03929575|Calcium|calcium|mesh-list
93162772|NCT03929575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162773|NCT03929575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162774|NCT02292472|Botulinum Toxins|botulinum toxins|mesh-list
93162775|NCT02292472|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93162776|NCT02292472|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93162777|NCT02292472|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93162778|NCT02292472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162779|NCT02292472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162780|NCT02292472|Cholinergic Agents|cholinergic agents|mesh-ancestor
93162781|NCT02292472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162782|NCT02292472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162783|NCT02292472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93162784|NCT02292472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162785|NCT01131247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93162786|NCT01131247|Ofatumumab|ofatumumab|mesh-list
93162787|NCT01131247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93162788|NCT01131247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93162789|NCT01131247|Alkylating Agents|alkylating agents|mesh-ancestor
93162790|NCT01131247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162791|NCT01131247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162792|NCT01131247|Immunologic Factors|immunologic factors|mesh-ancestor
93162793|NCT01131247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162794|NCT03513874|Metformin|metformin|mesh-list
93162795|NCT03513874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162796|NCT03513874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162797|NCT01228357|Milnacipran|milnacipran|mesh-list
93162798|NCT01228357|Mirtazapine|mirtazapine|mesh-list
93162799|NCT01228357|Sertraline|sertraline|mesh-list
93162800|NCT01228357|Fluoxetine|fluoxetine|mesh-list
93162801|NCT01228357|Paroxetine|paroxetine|mesh-list
93162802|NCT01228357|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93162803|NCT01228357|Nortriptyline|nortriptyline|mesh-list
93162804|NCT01228357|Antidepressive Agents|antidepressive agents|mesh-ancestor
93162805|NCT01228357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93162806|NCT01228357|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93162807|NCT01228357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93162808|NCT01228357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162809|NCT01228357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162810|NCT01228357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162811|NCT01228357|Serotonin Agents|serotonin agents|mesh-ancestor
93162812|NCT01228357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162813|NCT01228357|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93162814|NCT01228357|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92835007|NCT02706054|Meloxicam|meloxicam|mesh-list
93162815|NCT01228357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93162816|NCT01228357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162817|NCT01228357|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93162818|NCT01228357|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93162819|NCT01228357|Histamine Antagonists|histamine antagonists|mesh-ancestor
93162820|NCT01228357|Histamine Agents|histamine agents|mesh-ancestor
93162821|NCT01228357|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93162822|NCT01228357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93162823|NCT01228357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162824|NCT01228357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93162825|NCT01228357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93162826|NCT01228357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93162827|NCT01228357|Adrenergic Agents|adrenergic agents|mesh-ancestor
93162828|NCT01228357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93162829|NCT01228357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93162830|NCT01228357|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93162831|NCT01228357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93162832|NCT01228357|Analgesics|analgesics|mesh-ancestor
93162833|NCT01228357|Sensory System Agents|sensory system agents|mesh-ancestor
93162834|NCT01228357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162835|NCT01228357|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93162836|NCT01228357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93162837|NCT01130701|Capecitabine|capecitabine|mesh-list
93162838|NCT01130701|Panitumumab|panitumumab|mesh-list
93162839|NCT01130701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93162840|NCT01130701|Antimetabolites|antimetabolites|mesh-ancestor
93162841|NCT01130701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162842|NCT01130701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162843|NCT01130701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162844|NCT02292550|Ceritinib|ceritinib|mesh-list
93162845|NCT02292550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162846|NCT02292550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93162847|NCT02292550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162848|NCT02292550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162849|NCT03925285|Bevacizumab|bevacizumab|mesh-list
92458681|NCT01733979|Iron|iron|mesh-list
93162850|NCT03925285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162851|NCT03925285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162852|NCT03925285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93162853|NCT03925285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93162854|NCT03925285|Growth Substances|growth substances|mesh-ancestor
93162855|NCT03925285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162856|NCT03925285|Growth Inhibitors|growth inhibitors|mesh-ancestor
93162857|NCT04464694|Ranibizumab|ranibizumab|mesh-list
93162858|NCT04464694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93162859|NCT04464694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93162860|NCT04464694|Growth Substances|growth substances|mesh-ancestor
93162861|NCT04464694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162862|NCT04464694|Growth Inhibitors|growth inhibitors|mesh-ancestor
93162863|NCT04464694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162864|NCT01130779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93162865|NCT01130779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162866|NCT01130779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93162867|NCT01130779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162868|NCT01130779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162869|NCT03513484|Azacitidine|azacitidine|mesh-list
93162870|NCT03513484|Nintedanib|nintedanib|mesh-list
93162871|NCT03513484|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93162872|NCT03513484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93162873|NCT03513484|Antimetabolites|antimetabolites|mesh-ancestor
93162874|NCT03513484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162875|NCT03513484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162876|NCT03513484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162877|NCT03513484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93162878|NCT03519724|Neostigmine|neostigmine|mesh-list
93162879|NCT03519724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93162880|NCT03519724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162881|NCT03519724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162882|NCT03519724|Cholinergic Agents|cholinergic agents|mesh-ancestor
93162883|NCT03519724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162884|NCT03519724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162885|NCT03519724|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93162886|NCT03519724|Autonomic Agents|autonomic agents|mesh-ancestor
93162887|NCT03519724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162888|NCT03920449|Botulinum Toxins|botulinum toxins|mesh-list
92835080|NCT01996436|Verapamil|verapamil|mesh-list
93162889|NCT03920449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93162890|NCT03920449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162891|NCT03920449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162892|NCT03920449|Cholinergic Agents|cholinergic agents|mesh-ancestor
93162893|NCT03920449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162894|NCT03920449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162895|NCT03920059|Mycophenolic Acid|mycophenolic acid|mesh-list
93162896|NCT03920059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93162897|NCT03920059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162898|NCT03920059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93162899|NCT03920059|Antitubercular Agents|antitubercular agents|mesh-ancestor
93162900|NCT03920059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93162901|NCT03920059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93162902|NCT03920059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162903|NCT03920059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162904|NCT01132027|Tacrolimus|tacrolimus|mesh-list
93162905|NCT01132027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93162906|NCT01132027|Immunologic Factors|immunologic factors|mesh-ancestor
93162907|NCT01132027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162908|NCT01132027|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93162909|NCT01132027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162910|NCT01132027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162911|NCT03136484|Canagliflozin|canagliflozin|mesh-list
93162912|NCT03136484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93162913|NCT03136484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162914|NCT03136484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93162915|NCT03136484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162916|NCT01132183|Valproic Acid|valproic acid|mesh-list
93162917|NCT01132183|Anticonvulsants|anticonvulsants|mesh-ancestor
93162918|NCT01132183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162919|NCT01132183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162920|NCT01132183|GABA Agents|gaba agents|mesh-ancestor
93162921|NCT01132183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162922|NCT01132183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162923|NCT01132183|Antimanic Agents|antimanic agents|mesh-ancestor
93162924|NCT01132183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93162925|NCT01132183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162926|NCT01132183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93162927|NCT03923881|Cetuximab|cetuximab|mesh-list
93162928|NCT03923881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93162929|NCT03923881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162930|NCT02295748|Deflazacort|deflazacort|mesh-list
93162931|NCT02295748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162932|NCT02295748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93162933|NCT02295748|Immunologic Factors|immunologic factors|mesh-ancestor
93162934|NCT02295748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162935|NCT03923803|Calcitonin|calcitonin|mesh-list
93162936|NCT03923803|Salmon calcitonin|salmon calcitonin|mesh-list
93162937|NCT03923803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93162938|NCT03923803|Katacalcin|katacalcin|mesh-list
93162939|NCT03923803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93162940|NCT03923803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162941|NCT03923803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93162942|NCT03923803|Vasodilator Agents|vasodilator agents|mesh-ancestor
93162943|NCT02295826|Aspirin|aspirin|mesh-list
93162944|NCT02295826|Dabigatran|dabigatran|mesh-list
93162945|NCT02295826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93162946|NCT02295826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93162947|NCT02295826|Analgesics|analgesics|mesh-ancestor
93162948|NCT02295826|Sensory System Agents|sensory system agents|mesh-ancestor
93162949|NCT02295826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162950|NCT02295826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162951|NCT02295826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93162952|NCT02295826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93162953|NCT02295826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93162954|NCT02295826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93162955|NCT02295826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162956|NCT02295826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93162957|NCT02295826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93162958|NCT02295826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93162959|NCT02295826|Antipyretics|antipyretics|mesh-ancestor
93162960|NCT02295826|Antithrombins|antithrombins|mesh-ancestor
93162961|NCT02295826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93162962|NCT02295826|Protease Inhibitors|protease inhibitors|mesh-ancestor
93162963|NCT02295826|Anticoagulants|anticoagulants|mesh-ancestor
93162964|NCT01348724|Naloxegol|naloxegol|mesh-list
93162965|NCT01348724|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93162966|NCT01348724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162967|NCT01348724|Sensory System Agents|sensory system agents|mesh-ancestor
93162968|NCT01348724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162969|NCT03519022|Cocaine|cocaine|mesh-list
93162970|NCT03519022|Methylphenidate|methylphenidate|mesh-list
93162971|NCT03519022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93162972|NCT03519022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162973|NCT03519022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93162974|NCT03519022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93162975|NCT03519022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93162976|NCT03519022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162977|NCT03519022|Dopamine Agents|dopamine agents|mesh-ancestor
93162978|NCT03519022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93162979|NCT03519022|Anesthetics, Local|anesthetics, local|mesh-ancestor
93162980|NCT03519022|Anesthetics|anesthetics|mesh-ancestor
93162981|NCT03519022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93162982|NCT03519022|Sensory System Agents|sensory system agents|mesh-ancestor
93162983|NCT03519022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93162984|NCT03519022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93162985|NCT03923257|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93162986|NCT03923257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93162987|NCT03923257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93162988|NCT03516526|Natalizumab|natalizumab|mesh-list
93162989|NCT03516526|Immunologic Factors|immunologic factors|mesh-ancestor
93162990|NCT03516526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93162991|NCT02730416|Paclitaxel|paclitaxel|mesh-list
93162992|NCT02730416|Carboplatin|carboplatin|mesh-list
93162993|NCT02730416|Nintedanib|nintedanib|mesh-list
93162994|NCT02730416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93162995|NCT02730416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93162996|NCT02730416|Tubulin Modulators|tubulin modulators|mesh-ancestor
93162997|NCT02730416|Antimitotic Agents|antimitotic agents|mesh-ancestor
93162998|NCT02730416|Mitosis Modulators|mitosis modulators|mesh-ancestor
93162999|NCT02730416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163000|NCT02730416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93163001|NCT02730416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163002|NCT02293330|Levobupivacaine|levobupivacaine|mesh-list
93163003|NCT02293330|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163004|NCT02293330|Anesthetics|anesthetics|mesh-ancestor
93163005|NCT02293330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163006|NCT02293330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163007|NCT02293330|Sensory System Agents|sensory system agents|mesh-ancestor
93163008|NCT02293330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163009|NCT01348880|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93163010|NCT01348880|Vasodilator Agents|vasodilator agents|mesh-ancestor
93163011|NCT01348880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93163012|NCT01348880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93163013|NCT01348880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163014|NCT01348880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163015|NCT01348880|Urological Agents|urological agents|mesh-ancestor
93163016|NCT03923179|Etoposide|etoposide|mesh-list
93163017|NCT03923179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93163018|NCT03923179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163019|NCT03923179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163020|NCT03923179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163021|NCT03923179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163022|NCT03923179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163023|NCT01318460|Simendan|simendan|mesh-list
93163024|NCT01318460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93163025|NCT01318460|Vasodilator Agents|vasodilator agents|mesh-ancestor
93163026|NCT01318460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93163027|NCT01318460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93163028|NCT01318460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163029|NCT01318460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163030|NCT01318460|Protective Agents|protective agents|mesh-ancestor
93163031|NCT01318460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163032|NCT02299726|Spironolactone|spironolactone|mesh-list
93163033|NCT02299726|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93163034|NCT02299726|Hormone Antagonists|hormone antagonists|mesh-ancestor
93163035|NCT02299726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163036|NCT02299726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163037|NCT02299726|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93163038|NCT02299726|Diuretics|diuretics|mesh-ancestor
93163039|NCT02299726|Natriuretic Agents|natriuretic agents|mesh-ancestor
93163040|NCT03647852|Methylprednisolone|methylprednisolone|mesh-list
93163041|NCT03647852|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93163042|NCT03647852|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93163043|NCT03647852|Prednisolone|prednisolone|mesh-list
93163044|NCT03647852|Prednisolone acetate|prednisolone acetate|mesh-list
93163045|NCT03647852|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93163046|NCT03647852|Prednisolone phosphate|prednisolone phosphate|mesh-list
93163047|NCT03647852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163048|NCT03647852|Antiemetics|antiemetics|mesh-ancestor
93163049|NCT03647852|Autonomic Agents|autonomic agents|mesh-ancestor
93163050|NCT03647852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163051|NCT03647852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163052|NCT03647852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93163053|NCT03647852|Glucocorticoids|glucocorticoids|mesh-ancestor
93163054|NCT03647852|Hormones|hormones|mesh-ancestor
93163055|NCT03647852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163056|NCT03647852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93163057|NCT03647852|Protective Agents|protective agents|mesh-ancestor
93163058|NCT03647852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93163059|NCT03647852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163060|NCT01354886|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93163061|NCT01354886|Hormones|hormones|mesh-ancestor
93163062|NCT01354886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163063|NCT01354886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163064|NCT02299882|Vancomycin|vancomycin|mesh-list
93163065|NCT02299882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163066|NCT02299882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163067|NCT01355120|Ipilimumab|ipilimumab|mesh-list
93163068|NCT01355120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93163069|NCT01355120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163070|NCT01355120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93163071|NCT01355120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163072|NCT02300038|Lidocaine|lidocaine|mesh-list
93163073|NCT02300038|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163074|NCT02300038|Anesthetics|anesthetics|mesh-ancestor
93163075|NCT02300038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163076|NCT02300038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163077|NCT02300038|Sensory System Agents|sensory system agents|mesh-ancestor
93163078|NCT02300038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163079|NCT02300038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93163080|NCT02300038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93163081|NCT02300038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93163082|NCT02300038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163083|NCT02300038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163084|NCT01355198|Acetylcysteine|acetylcysteine|mesh-list
93163085|NCT01355198|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93163086|NCT01355198|Glycine|glycine|mesh-list
93163087|NCT01355198|Antiviral Agents|antiviral agents|mesh-ancestor
93163088|NCT01355198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163089|NCT01355198|Expectorants|expectorants|mesh-ancestor
93163090|NCT01355198|Respiratory System Agents|respiratory system agents|mesh-ancestor
93163091|NCT01355198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93163092|NCT01355198|Antioxidants|antioxidants|mesh-ancestor
93163093|NCT01355198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163094|NCT01355198|Protective Agents|protective agents|mesh-ancestor
93163095|NCT01355198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163096|NCT01355198|Antidotes|antidotes|mesh-ancestor
93163097|NCT01355198|Glycine Agents|glycine agents|mesh-ancestor
93163098|NCT01355198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163099|NCT01355276|Domperidone|domperidone|mesh-list
93163100|NCT01355276|Cinitapride|cinitapride|mesh-list
93163101|NCT01355276|Antiemetics|antiemetics|mesh-ancestor
93163102|NCT01355276|Autonomic Agents|autonomic agents|mesh-ancestor
93163103|NCT01355276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163104|NCT01355276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163105|NCT01355276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93163106|NCT01355276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93163107|NCT01355276|Dopamine Agents|dopamine agents|mesh-ancestor
93163108|NCT01355276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163109|NCT01355276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163110|NCT01355276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93163111|NCT02589860|Melphalan|melphalan|mesh-list
93163112|NCT02589860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93163113|NCT02589860|Alkylating Agents|alkylating agents|mesh-ancestor
93163114|NCT02589860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163115|NCT02589860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163116|NCT02589860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93163117|NCT02589860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163118|NCT02589860|Immunologic Factors|immunologic factors|mesh-ancestor
93163119|NCT02589860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163120|NCT01355354|Digoxin|digoxin|mesh-list
93163121|NCT01355354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93163122|NCT01355354|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93163123|NCT01355354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163124|NCT01355354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163125|NCT01355354|Protective Agents|protective agents|mesh-ancestor
93163126|NCT01355354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163127|NCT03513172|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93163128|NCT03513172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93163129|NCT03513172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93163130|NCT03513172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93163131|NCT03513172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93163132|NCT03513172|Adrenergic Agents|adrenergic agents|mesh-ancestor
93163133|NCT03513172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163134|NCT03513172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163135|NCT03513172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163136|NCT01349270|Prednisone|prednisone|mesh-list
93163137|NCT01349270|Immunoglobulins|immunoglobulins|mesh-list
93163138|NCT01349270|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93163139|NCT01349270|Antibodies|antibodies|mesh-list
93163140|NCT01349270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163141|NCT01349270|Glucocorticoids|glucocorticoids|mesh-ancestor
93163142|NCT01349270|Hormones|hormones|mesh-ancestor
93163143|NCT01349270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163144|NCT01349270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163145|NCT01349270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93163146|NCT01349270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163147|NCT01349270|Immunologic Factors|immunologic factors|mesh-ancestor
93163148|NCT01132417|Tigecycline|tigecycline|mesh-list
93163149|NCT01132417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163150|NCT01132417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163151|NCT01132417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93163152|NCT01132417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163153|NCT01132417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163154|NCT02300194|Morphine|morphine|mesh-list
93163155|NCT02300194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93163156|NCT02300194|Narcotics|narcotics|mesh-ancestor
93163157|NCT02300194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163158|NCT02300194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163159|NCT02300194|Analgesics|analgesics|mesh-ancestor
93163160|NCT02300194|Sensory System Agents|sensory system agents|mesh-ancestor
93163161|NCT02300194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163162|NCT01225705|Ritonavir|ritonavir|mesh-list
93163163|NCT01225705|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93163164|NCT01225705|Raltegravir Potassium|raltegravir potassium|mesh-list
93163165|NCT01225705|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93163166|NCT01225705|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93163167|NCT01225705|Protease Inhibitors|protease inhibitors|mesh-ancestor
93163168|NCT01225705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163169|NCT01225705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163170|NCT01225705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93163171|NCT01225705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93163172|NCT01225705|Antiviral Agents|antiviral agents|mesh-ancestor
93163173|NCT01225705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163174|NCT01225705|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93163175|NCT01225705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93163176|NCT01225705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93163177|NCT01225705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93163178|NCT01128985|Canagliflozin|canagliflozin|mesh-list
93163179|NCT01128985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93163180|NCT01128985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163181|NCT01128985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163182|NCT01128985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163183|NCT03922555|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93163184|NCT03922555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93163185|NCT03922555|Antimetabolites|antimetabolites|mesh-ancestor
93163186|NCT03922555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163187|NCT03922555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163188|NCT03512860|Valproic Acid|valproic acid|mesh-list
93163189|NCT03512860|Anticonvulsants|anticonvulsants|mesh-ancestor
93163190|NCT03512860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163191|NCT03512860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163192|NCT03512860|GABA Agents|gaba agents|mesh-ancestor
93163193|NCT03512860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163194|NCT03512860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163195|NCT03512860|Antimanic Agents|antimanic agents|mesh-ancestor
93163196|NCT03512860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93163197|NCT03512860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163198|NCT03512860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93163199|NCT01357694|Psychotropic Drugs|psychotropic drugs|mesh-list
93163200|NCT02528695|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93163201|NCT02528695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163202|NCT02296762|Sirolimus|sirolimus|mesh-list
93163203|NCT02296762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163204|NCT02296762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163205|NCT02296762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93163206|NCT02296762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163207|NCT02296762|Antifungal Agents|antifungal agents|mesh-ancestor
93163208|NCT02296762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163209|NCT02296762|Immunologic Factors|immunologic factors|mesh-ancestor
93163210|NCT02296762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163211|NCT01132573|Clofarabine|clofarabine|mesh-list
93163212|NCT01132573|Entinostat|entinostat|mesh-list
93163213|NCT01132573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93163214|NCT01132573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93163215|NCT01132573|Antimetabolites|antimetabolites|mesh-ancestor
93163216|NCT01132573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163217|NCT01132573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163218|NCT01132573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163219|NCT01131559|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93163220|NCT01131559|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93163221|NCT01131559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163222|NCT01131559|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93163223|NCT01131559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93163224|NCT01131559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163225|NCT01131559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163226|NCT01131559|Dopamine Agents|dopamine agents|mesh-ancestor
93163227|NCT01131559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163228|NCT03518320|Gemcitabine|gemcitabine|mesh-list
93163229|NCT03518320|Nivolumab|nivolumab|mesh-list
93163230|NCT03518320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93163231|NCT03518320|Antimetabolites|antimetabolites|mesh-ancestor
93163232|NCT03518320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163233|NCT03518320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163234|NCT03518320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93163235|NCT03518320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93163236|NCT01134289|Bupivacaine|bupivacaine|mesh-list
93163237|NCT01134289|Levobupivacaine|levobupivacaine|mesh-list
93163238|NCT01134289|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163239|NCT01134289|Anesthetics|anesthetics|mesh-ancestor
93163240|NCT01134289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163241|NCT01134289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163242|NCT01134289|Sensory System Agents|sensory system agents|mesh-ancestor
93163243|NCT01134289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163244|NCT02300350|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93163245|NCT02300350|Digoxin|digoxin|mesh-list
93163246|NCT02300350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93163247|NCT02300350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93163248|NCT02300350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163249|NCT02300350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163250|NCT02300350|Protective Agents|protective agents|mesh-ancestor
93163251|NCT02300350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163252|NCT02300350|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93163253|NCT02300350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163254|NCT01349348|Tolvaptan|tolvaptan|mesh-list
93163255|NCT01349348|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93163256|NCT01349348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163257|NCT01349348|Natriuretic Agents|natriuretic agents|mesh-ancestor
93163258|NCT01349348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163259|NCT02300428|Ferrous fumarate|ferrous fumarate|mesh-list
93163260|NCT02300428|Ferrous gluconate|ferrous gluconate|mesh-list
93163261|NCT02300428|Trace Elements|trace elements|mesh-ancestor
93163262|NCT02300428|Micronutrients|micronutrients|mesh-ancestor
93163263|NCT02300428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163264|NCT02300428|Hematinics|hematinics|mesh-ancestor
93163265|NCT02293876|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93163266|NCT02293876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93163268|NCT02296996|Dabrafenib|dabrafenib|mesh-list
93163269|NCT02296996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163270|NCT02296996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93163271|NCT02296996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163272|NCT02296996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163273|NCT01132729|Valacyclovir|valacyclovir|mesh-list
93163274|NCT01132729|Antiviral Agents|antiviral agents|mesh-ancestor
93163275|NCT01132729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163276|NCT02294110|Anesthetics|anesthetics|mesh-list
93163277|NCT02294110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163278|NCT02294110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163279|NCT03512548|Itraconazole|itraconazole|mesh-list
93163280|NCT03512548|Antifungal Agents|antifungal agents|mesh-ancestor
93163281|NCT03512548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163282|NCT03512548|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93163283|NCT03512548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93163284|NCT03512548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163285|NCT03512548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163286|NCT03512548|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93163287|NCT03512548|Hormone Antagonists|hormone antagonists|mesh-ancestor
93163288|NCT03512548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163289|NCT03512548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163290|NCT03512548|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93163291|NCT03515668|Methylphenidate|methylphenidate|mesh-list
93163292|NCT03515668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93163293|NCT03515668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163294|NCT03515668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93163295|NCT03515668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93163296|NCT03515668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163297|NCT03515668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163298|NCT03515668|Dopamine Agents|dopamine agents|mesh-ancestor
93163299|NCT03515668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163300|NCT01356212|Ketorolac|ketorolac|mesh-list
93163301|NCT01356212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93163302|NCT01356212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163303|NCT01356212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163304|NCT01356212|Analgesics|analgesics|mesh-ancestor
93163305|NCT01356212|Sensory System Agents|sensory system agents|mesh-ancestor
93163306|NCT01356212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163307|NCT01356212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163308|NCT01356212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163309|NCT01356212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163310|NCT01356212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93163311|NCT01356212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163312|NCT01356212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163313|NCT02302378|Bupivacaine|bupivacaine|mesh-list
93163314|NCT02302378|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163315|NCT02302378|Anesthetics|anesthetics|mesh-ancestor
93163316|NCT02302378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163317|NCT02302378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163318|NCT02302378|Sensory System Agents|sensory system agents|mesh-ancestor
93163319|NCT02302378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163320|NCT01356368|Docetaxel|docetaxel|mesh-list
93163321|NCT01356368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163322|NCT01356368|Tubulin Modulators|tubulin modulators|mesh-ancestor
93163323|NCT01356368|Antimitotic Agents|antimitotic agents|mesh-ancestor
93163324|NCT01356368|Mitosis Modulators|mitosis modulators|mesh-ancestor
93163325|NCT01356368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163326|NCT02302456|Tranexamic Acid|tranexamic acid|mesh-list
93163327|NCT02302456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93163328|NCT02302456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93163329|NCT02302456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163330|NCT02302456|Hemostatics|hemostatics|mesh-ancestor
93163331|NCT02302456|Coagulants|coagulants|mesh-ancestor
93163332|NCT01356524|Progesterone|progesterone|mesh-list
93163333|NCT01356524|Progestins|progestins|mesh-ancestor
93163334|NCT01356524|Hormones|hormones|mesh-ancestor
93163335|NCT01356524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163336|NCT01356524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163337|NCT01232023|Indobufen|indobufen|mesh-list
93163338|NCT01232023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93163339|NCT01232023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93163340|NCT01232023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163341|NCT01232023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163342|NCT01232023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163343|NCT01232023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163344|NCT01232023|Analgesics|analgesics|mesh-ancestor
93163345|NCT01232023|Sensory System Agents|sensory system agents|mesh-ancestor
93163346|NCT01232023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163347|NCT01232023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163348|NCT01232023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163349|NCT01232023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163350|NCT02300740|Niacinamide|niacinamide|mesh-list
93163351|NCT02300740|Niacin|niacin|mesh-list
93163352|NCT02300740|Nicotinic Acids|nicotinic acids|mesh-list
93163353|NCT02300740|Vitamin B Complex|vitamin b complex|mesh-ancestor
93163354|NCT02300740|Vitamins|vitamins|mesh-ancestor
93163355|NCT02300740|Micronutrients|micronutrients|mesh-ancestor
93163356|NCT02300740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163357|NCT02300740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93163358|NCT02300740|Antimetabolites|antimetabolites|mesh-ancestor
93163359|NCT02300740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163360|NCT02300740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93163361|NCT02300740|Vasodilator Agents|vasodilator agents|mesh-ancestor
93163362|NCT02300818|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93163363|NCT02300818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93163364|NCT02297386|Testosterone|testosterone|mesh-list
93163365|NCT02297386|Dihydrotestosterone|dihydrotestosterone|mesh-list
93163366|NCT02297386|Androgens|androgens|mesh-ancestor
93163367|NCT02297386|Hormones|hormones|mesh-ancestor
93163368|NCT02297386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163369|NCT02297386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163370|NCT04464616|Anesthetics|anesthetics|mesh-list
93163371|NCT04464616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163372|NCT04464616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163373|NCT01356680|Prednisone|prednisone|mesh-list
93163374|NCT01356680|Cyclophosphamide|cyclophosphamide|mesh-list
93163375|NCT01356680|Dacarbazine|dacarbazine|mesh-list
93163376|NCT01356680|Etoposide|etoposide|mesh-list
93163377|NCT01356680|Vincristine|vincristine|mesh-list
93163378|NCT01356680|Doxorubicin|doxorubicin|mesh-list
93163379|NCT01356680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93163380|NCT01356680|Bleomycin|bleomycin|mesh-list
93163381|NCT01356680|Vinblastine|vinblastine|mesh-list
93163382|NCT01356680|Procarbazine|procarbazine|mesh-list
93163383|NCT01356680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163384|NCT01356680|Immunologic Factors|immunologic factors|mesh-ancestor
93163385|NCT01356680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163386|NCT01356680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163387|NCT01356680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93163388|NCT01356680|Alkylating Agents|alkylating agents|mesh-ancestor
93163389|NCT01356680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163390|NCT01356680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163391|NCT01356680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93163392|NCT01356680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163393|NCT01356680|Glucocorticoids|glucocorticoids|mesh-ancestor
93163394|NCT01356680|Hormones|hormones|mesh-ancestor
93163395|NCT01356680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163396|NCT01356680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93163397|NCT01356680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93163398|NCT01356680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163399|NCT01356680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163400|NCT01356680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163401|NCT01356680|Tubulin Modulators|tubulin modulators|mesh-ancestor
93163402|NCT01356680|Antimitotic Agents|antimitotic agents|mesh-ancestor
93163403|NCT01356680|Mitosis Modulators|mitosis modulators|mesh-ancestor
93163404|NCT01356680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93163405|NCT04464850|Iron|iron|mesh-list
92835601|NCT04378426|Analgesics|analgesics|mesh-ancestor
93163406|NCT04464850|Ferrous fumarate|ferrous fumarate|mesh-list
93163407|NCT04464850|Folic Acid|folic acid|mesh-list
93163408|NCT04464850|Trace Elements|trace elements|mesh-ancestor
93163409|NCT04464850|Micronutrients|micronutrients|mesh-ancestor
93163410|NCT04464850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163411|NCT04464850|Hematinics|hematinics|mesh-ancestor
93163412|NCT04464850|Vitamin B Complex|vitamin b complex|mesh-ancestor
93163413|NCT04464850|Vitamins|vitamins|mesh-ancestor
93163414|NCT01356758|Adalimumab|adalimumab|mesh-list
93163415|NCT01356758|Infliximab|infliximab|mesh-list
93163416|NCT01356758|Etanercept|etanercept|mesh-list
93163417|NCT01356758|Ustekinumab|ustekinumab|mesh-list
93163418|NCT01356758|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93163419|NCT01356758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163420|NCT01356758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163421|NCT01356758|Dermatologic Agents|dermatologic agents|mesh-ancestor
93163422|NCT01356758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93163423|NCT01356758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163424|NCT01356758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163425|NCT01356758|Analgesics|analgesics|mesh-ancestor
93163426|NCT01356758|Sensory System Agents|sensory system agents|mesh-ancestor
93163427|NCT01356758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163428|NCT01356758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163429|NCT01356758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163430|NCT01356758|Immunologic Factors|immunologic factors|mesh-ancestor
93163431|NCT01134523|Paclitaxel|paclitaxel|mesh-list
93163432|NCT01134523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93163433|NCT01134523|Epirubicin|epirubicin|mesh-list
93163434|NCT01134523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93163435|NCT01134523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163436|NCT01134523|Tubulin Modulators|tubulin modulators|mesh-ancestor
93163437|NCT01134523|Antimitotic Agents|antimitotic agents|mesh-ancestor
93163438|NCT01134523|Mitosis Modulators|mitosis modulators|mesh-ancestor
93163439|NCT01134523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163440|NCT01134523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93163441|NCT01134523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163442|NCT01134523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163443|NCT01134523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163444|NCT01349738|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93163445|NCT01349738|Ciprofloxacin|ciprofloxacin|mesh-list
93163446|NCT01349738|Levofloxacin|levofloxacin|mesh-list
93163447|NCT01349738|Ofloxacin|ofloxacin|mesh-list
93163448|NCT01349738|Gentamicins|gentamicins|mesh-list
93163449|NCT01349738|Cefazolin|cefazolin|mesh-list
93163450|NCT01349738|Tobramycin|tobramycin|mesh-list
93163451|NCT01349738|Ampicillin|ampicillin|mesh-list
93163452|NCT01349738|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93163453|NCT01349738|Nitrofurantoin|nitrofurantoin|mesh-list
93163454|NCT01349738|Sulbactam|sulbactam|mesh-list
93163455|NCT01349738|Trimethoprim|trimethoprim|mesh-list
93163456|NCT01349738|Sulfamethoxazole|sulfamethoxazole|mesh-list
93163457|NCT01349738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163458|NCT01349738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163459|NCT01349738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163460|NCT01349738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163461|NCT01349738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163462|NCT01349738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163463|NCT01349738|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93163464|NCT01349738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93163465|NCT01349738|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93163466|NCT01349738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93163467|NCT01349738|Antimalarials|antimalarials|mesh-ancestor
93163468|NCT01349738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93163469|NCT01349738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93163470|NCT01349738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93163471|NCT01349738|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93163472|NCT01349738|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93163473|NCT01349738|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93163474|NCT02302768|Selenium|selenium|mesh-list
93163475|NCT02302768|Antioxidants|antioxidants|mesh-ancestor
93163476|NCT02302768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163477|NCT02302768|Protective Agents|protective agents|mesh-ancestor
93163478|NCT02302768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163479|NCT02302768|Trace Elements|trace elements|mesh-ancestor
93163480|NCT02302768|Micronutrients|micronutrients|mesh-ancestor
93163481|NCT03921775|Propofol|propofol|mesh-list
93163482|NCT03921775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93163483|NCT03921775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163484|NCT03921775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163485|NCT03921775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93163486|NCT03921775|Anesthetics, General|anesthetics, general|mesh-ancestor
93163487|NCT03921775|Anesthetics|anesthetics|mesh-ancestor
93163488|NCT01356992|Enoxaparin|enoxaparin|mesh-list
93163489|NCT01356992|Anticoagulants|anticoagulants|mesh-ancestor
93163490|NCT01356992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93163491|NCT01356992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93163492|NCT01356992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163493|NCT01350050|Carticaine|carticaine|mesh-list
93163494|NCT01350050|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163495|NCT01350050|Anesthetics|anesthetics|mesh-ancestor
93163496|NCT01350050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163497|NCT01350050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163498|NCT01350050|Sensory System Agents|sensory system agents|mesh-ancestor
93163499|NCT01350050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163500|NCT03918889|Midazolam|midazolam|mesh-list
93163501|NCT03918889|Dexmedetomidine|dexmedetomidine|mesh-list
93163502|NCT03918889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93163503|NCT03918889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163504|NCT03918889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163505|NCT03918889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163506|NCT03918889|Analgesics|analgesics|mesh-ancestor
93163507|NCT03918889|Sensory System Agents|sensory system agents|mesh-ancestor
93163508|NCT03918889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163509|NCT03918889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93163510|NCT03918889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93163511|NCT03918889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93163512|NCT03918889|Adrenergic Agents|adrenergic agents|mesh-ancestor
93163513|NCT03918889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163514|NCT03918889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163515|NCT03918889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93163516|NCT03918889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93163517|NCT03918889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93163518|NCT03918889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93163519|NCT03918889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93163520|NCT03918889|Anesthetics, General|anesthetics, general|mesh-ancestor
93163521|NCT03918889|Anesthetics|anesthetics|mesh-ancestor
93163522|NCT03918889|GABA Modulators|gaba modulators|mesh-ancestor
93163523|NCT03918889|GABA Agents|gaba agents|mesh-ancestor
93163524|NCT02297620|Ipragliflozin|ipragliflozin|mesh-list
93163525|NCT02297620|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93163526|NCT02297620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163527|NCT02297620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163528|NCT02297620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163529|NCT03739801|Irinotecan|irinotecan|mesh-list
93163530|NCT03739801|Ramucirumab|ramucirumab|mesh-list
93163531|NCT03739801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93163532|NCT03739801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163533|NCT03739801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163534|NCT03739801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163535|NCT03739801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163536|NCT03512236|Insulin Lispro|insulin lispro|mesh-list
93163537|NCT03512236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163538|NCT03512236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163539|NCT02303002|Botulinum Toxins|botulinum toxins|mesh-list
93163540|NCT02303002|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93163541|NCT02303002|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93163542|NCT02303002|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93163543|NCT02303002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163544|NCT02303002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163545|NCT02303002|Cholinergic Agents|cholinergic agents|mesh-ancestor
93163546|NCT02303002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163547|NCT02303002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163548|NCT02303002|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93163549|NCT02303002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163550|NCT02297854|Valganciclovir|valganciclovir|mesh-list
93163551|NCT02297854|Antiviral Agents|antiviral agents|mesh-ancestor
93163552|NCT02297854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163553|NCT03511768|Octreotide|octreotide|mesh-list
93163554|NCT03511768|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
93163555|NCT03511768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93163556|NCT03511768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93163557|NCT03511768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835754|NCT02582476|Natriuretic Agents|natriuretic agents|mesh-ancestor
93163558|NCT03511768|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93163559|NCT03511768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163560|NCT01134991|Minocycline|minocycline|mesh-list
93163561|NCT01134991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163562|NCT01134991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163564|NCT03515200|Dexamethasone|dexamethasone|mesh-list
93163565|NCT03515200|Hydrocortisone|hydrocortisone|mesh-list
93163566|NCT03515200|Doxorubicin|doxorubicin|mesh-list
93163567|NCT03515200|Methotrexate|methotrexate|mesh-list
93163568|NCT03515200|Bortezomib|bortezomib|mesh-list
93163569|NCT03515200|Dasatinib|dasatinib|mesh-list
93163570|NCT03515200|Palbociclib|palbociclib|mesh-list
93163571|NCT03515200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163572|NCT03515200|Antiemetics|antiemetics|mesh-ancestor
93163573|NCT03515200|Autonomic Agents|autonomic agents|mesh-ancestor
93163574|NCT03515200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163575|NCT03515200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163576|NCT03515200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93163577|NCT03515200|Glucocorticoids|glucocorticoids|mesh-ancestor
93163578|NCT03515200|Hormones|hormones|mesh-ancestor
93163579|NCT03515200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163580|NCT03515200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93163581|NCT03515200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163582|NCT03515200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93163583|NCT03515200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163584|NCT03515200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163585|NCT03515200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163586|NCT03515200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163587|NCT03515200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93163588|NCT03515200|Abortifacient Agents|abortifacient agents|mesh-ancestor
93163589|NCT03515200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93163590|NCT03515200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93163591|NCT03515200|Antimetabolites|antimetabolites|mesh-ancestor
93163592|NCT03515200|Dermatologic Agents|dermatologic agents|mesh-ancestor
93163593|NCT03515200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93163594|NCT03515200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163595|NCT03515200|Immunologic Factors|immunologic factors|mesh-ancestor
93163596|NCT03515200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163597|NCT03515200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93163598|NCT03515200|Antiviral Agents|antiviral agents|mesh-ancestor
93163599|NCT03515200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163600|NCT03515200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93163601|NCT03918265|Tacrolimus|tacrolimus|mesh-list
93163602|NCT03918265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163603|NCT03918265|Immunologic Factors|immunologic factors|mesh-ancestor
93163604|NCT03918265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163605|NCT03918265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93163606|NCT03918265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163607|NCT03918265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163608|NCT03920839|Paclitaxel|paclitaxel|mesh-list
93163609|NCT03920839|Carboplatin|carboplatin|mesh-list
93163610|NCT03920839|Gemcitabine|gemcitabine|mesh-list
93163611|NCT03920839|Pemetrexed|pemetrexed|mesh-list
93163612|NCT03920839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93163613|NCT03920839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163614|NCT03920839|Tubulin Modulators|tubulin modulators|mesh-ancestor
93163615|NCT03920839|Antimitotic Agents|antimitotic agents|mesh-ancestor
93163616|NCT03920839|Mitosis Modulators|mitosis modulators|mesh-ancestor
93163617|NCT03920839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163618|NCT03920839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93163619|NCT03920839|Antimetabolites|antimetabolites|mesh-ancestor
93163620|NCT03920839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163621|NCT03920839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93163622|NCT03920839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93163623|NCT02301130|Durvalumab|durvalumab|mesh-list
93163624|NCT02301130|Tremelimumab|tremelimumab|mesh-list
93163625|NCT02301130|Mogamulizumab|mogamulizumab|mesh-list
93163626|NCT02301130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93163627|NCT02301130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93163628|NCT02301130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163629|NCT02301130|Immunologic Factors|immunologic factors|mesh-ancestor
93163630|NCT02301130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163631|NCT03920605|Tenofovir|tenofovir|mesh-list
93163632|NCT03920605|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93163633|NCT03920605|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93163634|NCT03920605|Antiviral Agents|antiviral agents|mesh-ancestor
93163635|NCT03920605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163636|NCT03920605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93163637|NCT03920605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93163638|NCT03920605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163639|NCT03920605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163640|NCT03920605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93163641|NCT03920605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93163642|NCT02301208|Nedaplatin|nedaplatin|mesh-list
93163643|NCT02301208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163644|NCT02298010|Capecitabine|capecitabine|mesh-list
93163645|NCT02298010|Oxaliplatin|oxaliplatin|mesh-list
93163646|NCT02298010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93163647|NCT02298010|Antimetabolites|antimetabolites|mesh-ancestor
93163648|NCT02298010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163649|NCT02298010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163650|NCT01229605|Cyclophosphamide|cyclophosphamide|mesh-list
93163651|NCT01229605|Docetaxel|docetaxel|mesh-list
93163652|NCT01229605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163653|NCT01229605|Immunologic Factors|immunologic factors|mesh-ancestor
93163654|NCT01229605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163655|NCT01229605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163656|NCT01229605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93163657|NCT01229605|Alkylating Agents|alkylating agents|mesh-ancestor
93163658|NCT01229605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163659|NCT01229605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163660|NCT01229605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93163661|NCT01229605|Tubulin Modulators|tubulin modulators|mesh-ancestor
93163662|NCT01229605|Antimitotic Agents|antimitotic agents|mesh-ancestor
93163663|NCT01229605|Mitosis Modulators|mitosis modulators|mesh-ancestor
93163664|NCT01319006|Glycine|glycine|mesh-list
93163665|NCT01319006|Glycine Agents|glycine agents|mesh-ancestor
93163666|NCT01319006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163667|NCT01319006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163668|NCT01319006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163669|NCT01358240|Econazole|econazole|mesh-list
93163670|NCT01358240|Antifungal Agents|antifungal agents|mesh-ancestor
93163671|NCT01358240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163672|NCT01358240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93163673|NCT01358240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93163674|NCT01358240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163675|NCT01358240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163676|NCT01358240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93163677|NCT01358240|Hormone Antagonists|hormone antagonists|mesh-ancestor
93163678|NCT01358240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93163679|NCT01358240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163680|NCT01131949|Lamotrigine|lamotrigine|mesh-list
93163681|NCT01131949|Anticonvulsants|anticonvulsants|mesh-ancestor
93163682|NCT01131949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93163683|NCT01131949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163684|NCT01131949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163685|NCT01131949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93163686|NCT01131949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163687|NCT01131949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93163688|NCT01131949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93163689|NCT01131949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163690|NCT01131949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93163691|NCT01131949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93163692|NCT03511222|Pembrolizumab|pembrolizumab|mesh-list
93163693|NCT03511222|Nivolumab|nivolumab|mesh-list
93163694|NCT03511222|Vorolanib|vorolanib|mesh-list
93163695|NCT03511222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93163696|NCT03511222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163697|NCT03511222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93163698|NCT03511222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163699|NCT03511222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93163700|NCT03511222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163701|NCT01230463|Ketorolac|ketorolac|mesh-list
93163702|NCT01230463|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93163703|NCT01230463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163704|NCT01230463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163705|NCT01230463|Analgesics|analgesics|mesh-ancestor
93163706|NCT01230463|Sensory System Agents|sensory system agents|mesh-ancestor
93163707|NCT01230463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163708|NCT01230463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163709|NCT01230463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163710|NCT01230463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835901|NCT00570739|Metformin|metformin|mesh-list
93163711|NCT01230463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93163712|NCT01230463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163713|NCT01230463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163715|NCT01358396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163716|NCT01358396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163717|NCT01358396|Analgesics|analgesics|mesh-ancestor
93163718|NCT01358396|Sensory System Agents|sensory system agents|mesh-ancestor
93163719|NCT01358396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163720|NCT01358396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163721|NCT01358396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163722|NCT01358396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163723|NCT01135615|Calcium|calcium|mesh-list
93163724|NCT01135615|Sevelamer|sevelamer|mesh-list
93163725|NCT01135615|Calcium acetate|calcium acetate|mesh-list
93163726|NCT01135615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93163727|NCT01135615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163728|NCT01135615|Chelating Agents|chelating agents|mesh-ancestor
93163729|NCT01135615|Sequestering Agents|sequestering agents|mesh-ancestor
93163730|NCT01135615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163731|NCT01361516|Anesthetics|anesthetics|mesh-list
93163732|NCT01361516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163733|NCT01361516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163734|NCT03920137|Nicotine|nicotine|mesh-list
93163735|NCT03920137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93163736|NCT03920137|Autonomic Agents|autonomic agents|mesh-ancestor
93163737|NCT03920137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163738|NCT03920137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163739|NCT03920137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93163740|NCT03920137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93163741|NCT03920137|Cholinergic Agents|cholinergic agents|mesh-ancestor
93163742|NCT03920137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163743|NCT03920137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163744|NCT03132610|Andrographolide|andrographolide|mesh-list
93163745|NCT03132610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163746|NCT03132610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163747|NCT03132610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163748|NCT03132610|Analgesics|analgesics|mesh-ancestor
93163749|NCT03132610|Sensory System Agents|sensory system agents|mesh-ancestor
93163750|NCT03132610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163751|NCT03132610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163752|NCT03132610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163753|NCT03132610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93163754|NCT03132610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93163755|NCT03132610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163756|NCT03132610|Antiviral Agents|antiviral agents|mesh-ancestor
93163757|NCT03132610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93163758|NCT02298088|Clopidogrel|clopidogrel|mesh-list
93163759|NCT02298088|Ticagrelor|ticagrelor|mesh-list
93163760|NCT02298088|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93163761|NCT02298088|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93163762|NCT02298088|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93163763|NCT02298088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93163764|NCT02298088|Purinergic Agents|purinergic agents|mesh-ancestor
93163765|NCT02298088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163766|NCT02298088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163767|NCT02298088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163768|NCT01133119|Bupivacaine|bupivacaine|mesh-list
93163769|NCT01133119|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163770|NCT01133119|Anesthetics|anesthetics|mesh-ancestor
93163771|NCT01133119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163772|NCT01133119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163773|NCT01133119|Sensory System Agents|sensory system agents|mesh-ancestor
93163774|NCT01133119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163775|NCT01230541|Udenafil|udenafil|mesh-list
93163776|NCT01230541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93163777|NCT01230541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93163778|NCT01230541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163779|NCT01230541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163780|NCT01229761|Trimethoprim|trimethoprim|mesh-list
93163781|NCT01229761|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93163782|NCT01229761|Sulfamethoxazole|sulfamethoxazole|mesh-list
93163783|NCT01229761|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93163785|NCT01229761|Antimalarials|antimalarials|mesh-ancestor
93163786|NCT01229761|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93163787|NCT01229761|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93163788|NCT01229761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93163789|NCT01229761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163790|NCT01229761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163791|NCT01229761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93163792|NCT01229761|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93163793|NCT01229761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93163794|NCT01229761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163795|NCT01229839|Ethiodized Oil|ethiodized oil|mesh-list
93163796|NCT01229839|Antineoplastic Agents|antineoplastic agents|mesh-list
93163797|NCT03514810|Ketoprofen|ketoprofen|mesh-list
93163798|NCT03514810|Sertraline|sertraline|mesh-list
93163799|NCT03514810|Antidepressive Agents|antidepressive agents|mesh-ancestor
93163800|NCT03514810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93163801|NCT03514810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93163802|NCT03514810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93163803|NCT03514810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163804|NCT03514810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163805|NCT03514810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163806|NCT03514810|Serotonin Agents|serotonin agents|mesh-ancestor
93163807|NCT03514810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163808|NCT03514810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93163809|NCT03514810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163810|NCT03514810|Analgesics|analgesics|mesh-ancestor
93163811|NCT03514810|Sensory System Agents|sensory system agents|mesh-ancestor
93163812|NCT03514810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163813|NCT03514810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93163814|NCT03514810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93163815|NCT03514810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93163816|NCT03514810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163817|NCT02301676|Dexmedetomidine|dexmedetomidine|mesh-list
93163818|NCT02301676|Propofol|propofol|mesh-list
93163819|NCT02301676|Sevoflurane|sevoflurane|mesh-list
93163820|NCT02301676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93163821|NCT02301676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163822|NCT02301676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163823|NCT02301676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163824|NCT02301676|Analgesics|analgesics|mesh-ancestor
93163825|NCT02301676|Sensory System Agents|sensory system agents|mesh-ancestor
93163826|NCT02301676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163827|NCT02301676|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93163828|NCT02301676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93163829|NCT02301676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93163830|NCT02301676|Adrenergic Agents|adrenergic agents|mesh-ancestor
93163831|NCT02301676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163832|NCT02301676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163833|NCT02301676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93163834|NCT02301676|Anesthetics, General|anesthetics, general|mesh-ancestor
93163835|NCT02301676|Anesthetics|anesthetics|mesh-ancestor
93163836|NCT02301676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93163837|NCT02301676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93163838|NCT01135771|Insulin|insulin|mesh-list
93163839|NCT01135771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163840|NCT01135771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163841|NCT01133353|Tetrabenazine|tetrabenazine|mesh-list
93163842|NCT01133353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93163843|NCT01133353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93163844|NCT01133353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163845|NCT01133353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163846|NCT01133353|Adrenergic Agents|adrenergic agents|mesh-ancestor
93163847|NCT01133353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163848|NCT01133353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163849|NCT01135927|Insulin|insulin|mesh-list
93163850|NCT01135927|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93163851|NCT01135927|Insulin Detemir|insulin detemir|mesh-list
93163852|NCT01135927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163853|NCT01135927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163854|NCT02301910|Tenecteplase|tenecteplase|mesh-list
93163855|NCT02301910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93163856|NCT02301910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92836054|NCT00669955|Antacids|antacids|mesh-ancestor
93163857|NCT02301910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163858|NCT01585753|Maraviroc|maraviroc|mesh-list
93163859|NCT01585753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93163860|NCT01585753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93163861|NCT01585753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163862|NCT01585753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93163863|NCT01585753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93163864|NCT01585753|Antiviral Agents|antiviral agents|mesh-ancestor
93163865|NCT01585753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163866|NCT01585753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93163867|NCT01136005|Provitamins|provitamins|mesh-list
93163868|NCT01136005|Vitamins|vitamins|mesh-ancestor
93163869|NCT01136005|Micronutrients|micronutrients|mesh-ancestor
93163870|NCT01136005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163871|NCT03509740|Acetaminophen|acetaminophen|mesh-list
93163872|NCT03509740|Tramadol|tramadol|mesh-list
93163873|NCT03509740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163874|NCT03509740|Analgesics|analgesics|mesh-ancestor
93163875|NCT03509740|Sensory System Agents|sensory system agents|mesh-ancestor
93163876|NCT03509740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163877|NCT03509740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163878|NCT03509740|Antipyretics|antipyretics|mesh-ancestor
93163879|NCT03509740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93163880|NCT03509740|Narcotics|narcotics|mesh-ancestor
93163881|NCT03509740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163882|NCT03918187|Midazolam|midazolam|mesh-list
93163883|NCT03918187|Nalbuphine|nalbuphine|mesh-list
93163884|NCT03918187|Bupivacaine|bupivacaine|mesh-list
93163885|NCT03918187|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163886|NCT03918187|Anesthetics|anesthetics|mesh-ancestor
93163887|NCT03918187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163888|NCT03918187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163889|NCT03918187|Sensory System Agents|sensory system agents|mesh-ancestor
93163890|NCT03918187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163891|NCT03918187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93163892|NCT03918187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93163893|NCT03918187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93163894|NCT03918187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93163895|NCT03918187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93163896|NCT03918187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93163897|NCT03918187|Anesthetics, General|anesthetics, general|mesh-ancestor
93163898|NCT03918187|GABA Modulators|gaba modulators|mesh-ancestor
93163899|NCT03918187|GABA Agents|gaba agents|mesh-ancestor
93163900|NCT03918187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163901|NCT03918187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163902|NCT03918187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93163903|NCT03918187|Narcotics|narcotics|mesh-ancestor
93163904|NCT03918187|Analgesics|analgesics|mesh-ancestor
93163905|NCT03507634|Lidocaine|lidocaine|mesh-list
93163906|NCT03507634|Fentanyl|fentanyl|mesh-list
93163907|NCT03507634|Dexmedetomidine|dexmedetomidine|mesh-list
93163908|NCT03507634|Remifentanil|remifentanil|mesh-list
93163909|NCT03507634|Analgesics, Opioid|analgesics, opioid|mesh-list
93163910|NCT03507634|Anesthetics|anesthetics|mesh-list
93163911|NCT03507634|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163912|NCT03507634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163913|NCT03507634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163914|NCT03507634|Sensory System Agents|sensory system agents|mesh-ancestor
93163915|NCT03507634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163916|NCT03507634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93163917|NCT03507634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93163918|NCT03507634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93163919|NCT03507634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93163920|NCT03507634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163921|NCT03507634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93163922|NCT03507634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93163923|NCT03507634|Analgesics|analgesics|mesh-ancestor
93163924|NCT03507634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93163925|NCT03507634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93163926|NCT03507634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93163927|NCT03507634|Adrenergic Agents|adrenergic agents|mesh-ancestor
93163928|NCT03507634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93163929|NCT03507634|Narcotics|narcotics|mesh-ancestor
93163930|NCT03507634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93163931|NCT03507634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93163932|NCT03507634|Anesthetics, General|anesthetics, general|mesh-ancestor
93163933|NCT03507556|Metronidazole|metronidazole|mesh-list
93163934|NCT03507556|Ciprofloxacin|ciprofloxacin|mesh-list
93163936|NCT03507556|Zinc Oxide|zinc oxide|mesh-list
93163937|NCT03507556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163938|NCT03507556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163939|NCT03507556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93163940|NCT03507556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93163941|NCT03507556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163942|NCT03507556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163943|NCT03507556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163944|NCT03507556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163945|NCT03507556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163946|NCT03507556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93163947|NCT03507556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93163948|NCT03507556|Dermatologic Agents|dermatologic agents|mesh-ancestor
93163949|NCT03507556|Sunscreening Agents|sunscreening agents|mesh-ancestor
93163950|NCT03507556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93163951|NCT03507556|Protective Agents|protective agents|mesh-ancestor
93163952|NCT03507556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163953|NCT01232257|Acetylcysteine|acetylcysteine|mesh-list
93163954|NCT01232257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93163955|NCT01232257|Antiviral Agents|antiviral agents|mesh-ancestor
93163956|NCT01232257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163957|NCT01232257|Expectorants|expectorants|mesh-ancestor
93163958|NCT01232257|Respiratory System Agents|respiratory system agents|mesh-ancestor
93163959|NCT01232257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93163960|NCT01232257|Antioxidants|antioxidants|mesh-ancestor
93163961|NCT01232257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163962|NCT01232257|Protective Agents|protective agents|mesh-ancestor
93163963|NCT01232257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163964|NCT01232257|Antidotes|antidotes|mesh-ancestor
93163965|NCT03509662|Ascorbic Acid|ascorbic acid|mesh-list
93163966|NCT03509662|Thiamine|thiamine|mesh-list
93163967|NCT03509662|Vitamins|vitamins|mesh-ancestor
93163968|NCT03509662|Micronutrients|micronutrients|mesh-ancestor
93163969|NCT03509662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163970|NCT03509662|Antioxidants|antioxidants|mesh-ancestor
93163971|NCT03509662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163972|NCT03509662|Protective Agents|protective agents|mesh-ancestor
93163973|NCT03509662|Vitamin B Complex|vitamin b complex|mesh-ancestor
93163974|NCT03504982|Moxifloxacin|moxifloxacin|mesh-list
93163975|NCT03504982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163976|NCT03504982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163977|NCT03504982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93163978|NCT03504982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93163979|NCT03504982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93163980|NCT03504982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93163981|NCT03504982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93163982|NCT01133431|Glimepiride|glimepiride|mesh-list
93163983|NCT01133431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93163984|NCT01133431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93163985|NCT01133431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163986|NCT01133431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93163987|NCT01133431|Immunologic Factors|immunologic factors|mesh-ancestor
93163988|NCT05610007|Prilocaine|prilocaine|mesh-list
93163989|NCT05610007|Anesthetics, Local|anesthetics, local|mesh-ancestor
93163990|NCT05610007|Anesthetics|anesthetics|mesh-ancestor
93163991|NCT05610007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93163992|NCT05610007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93163993|NCT05610007|Sensory System Agents|sensory system agents|mesh-ancestor
93163994|NCT05610007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93163995|NCT01232413|Ipragliflozin|ipragliflozin|mesh-list
93163996|NCT01232413|Moxifloxacin|moxifloxacin|mesh-list
93163997|NCT01232413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93163998|NCT01232413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93163999|NCT01232413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93164000|NCT01232413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93164001|NCT01232413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164002|NCT01232413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164003|NCT01232413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164004|NCT01232413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164005|NCT01232413|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93164006|NCT01232413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93164007|NCT02303782|Azacitidine|azacitidine|mesh-list
93164008|NCT02303782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92836205|NCT00773149|Alemtuzumab|alemtuzumab|mesh-list
93164009|NCT02303782|Antimetabolites|antimetabolites|mesh-ancestor
93164010|NCT02303782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164011|NCT02303782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164012|NCT02303782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164013|NCT01233505|Capecitabine|capecitabine|mesh-list
93164014|NCT01233505|Oxaliplatin|oxaliplatin|mesh-list
93164016|NCT01233505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93164017|NCT01233505|Antimetabolites|antimetabolites|mesh-ancestor
93164018|NCT01233505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164019|NCT01233505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164020|NCT01233505|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93164021|NCT01233505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164022|NCT04925180|Cyproterone Acetate|cyproterone acetate|mesh-list
93164023|NCT04925180|Cyproterone|cyproterone|mesh-list
93164024|NCT04925180|Androgen Antagonists|androgen antagonists|mesh-ancestor
93164025|NCT04925180|Hormone Antagonists|hormone antagonists|mesh-ancestor
93164026|NCT04925180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164027|NCT04925180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164028|NCT04925180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164029|NCT04925180|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93164030|NCT04925180|Contraceptive Agents|contraceptive agents|mesh-ancestor
93164031|NCT04925180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93164032|NCT01133509|Vaccines|vaccines|mesh-list
93164033|NCT01133509|Immunologic Factors|immunologic factors|mesh-ancestor
93164034|NCT01133509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164035|NCT02306902|Fenofibrate|fenofibrate|mesh-list
93164036|NCT02306902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93164037|NCT02306902|Antimetabolites|antimetabolites|mesh-ancestor
93164038|NCT02306902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164039|NCT02306902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93164040|NCT01230697|Sorafenib|sorafenib|mesh-list
93164041|NCT01230697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164042|NCT01230697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93164043|NCT01230697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164044|NCT01230697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164045|NCT01361984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93164046|NCT01361984|Formoterol Fumarate|formoterol fumarate|mesh-list
93164047|NCT01361984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93164048|NCT01361984|Autonomic Agents|autonomic agents|mesh-ancestor
93164049|NCT01361984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164050|NCT01361984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164051|NCT01361984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93164052|NCT01361984|Respiratory System Agents|respiratory system agents|mesh-ancestor
93164053|NCT01361984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93164054|NCT01361984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93164055|NCT01361984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93164056|NCT01361984|Adrenergic Agents|adrenergic agents|mesh-ancestor
93164057|NCT01361984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164058|NCT01361984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164059|NCT01230775|Anagrelide|anagrelide|mesh-list
93164060|NCT01230775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93164061|NCT01230775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164062|NCT01230775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164063|NCT01230775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93164064|NCT01136317|Omeprazole|omeprazole|mesh-list
93164065|NCT01136317|Rabeprazole|rabeprazole|mesh-list
93164066|NCT01136317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93164067|NCT01136317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164068|NCT01136317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93164069|NCT01136317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164070|NCT01136317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164071|NCT03507244|Dexamethasone|dexamethasone|mesh-list
93164072|NCT03507244|Pemetrexed|pemetrexed|mesh-list
93164073|NCT03507244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164074|NCT03507244|Antiemetics|antiemetics|mesh-ancestor
93164075|NCT03507244|Autonomic Agents|autonomic agents|mesh-ancestor
93164076|NCT03507244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164077|NCT03507244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164078|NCT03507244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164079|NCT03507244|Glucocorticoids|glucocorticoids|mesh-ancestor
93164080|NCT03507244|Hormones|hormones|mesh-ancestor
93164081|NCT03507244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164082|NCT03507244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164083|NCT03507244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164084|NCT03507244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164085|NCT03507244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164086|NCT03507244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93164087|NCT03507244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93164088|NCT01136395|Rituximab|rituximab|mesh-list
93164089|NCT01136395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164090|NCT01136395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164091|NCT01136395|Immunologic Factors|immunologic factors|mesh-ancestor
93164092|NCT01136395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164093|NCT01136395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164094|NCT02304094|Methylprednisolone|methylprednisolone|mesh-list
93164095|NCT02304094|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93164096|NCT02304094|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93164097|NCT02304094|Prednisolone|prednisolone|mesh-list
93164098|NCT02304094|Prednisolone acetate|prednisolone acetate|mesh-list
93164099|NCT02304094|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93164100|NCT02304094|Prednisolone phosphate|prednisolone phosphate|mesh-list
93164101|NCT02304094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164102|NCT02304094|Antiemetics|antiemetics|mesh-ancestor
93164103|NCT02304094|Autonomic Agents|autonomic agents|mesh-ancestor
93164104|NCT02304094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164105|NCT02304094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164106|NCT02304094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164107|NCT02304094|Glucocorticoids|glucocorticoids|mesh-ancestor
93164108|NCT02304094|Hormones|hormones|mesh-ancestor
93164109|NCT02304094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164110|NCT02304094|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93164111|NCT02304094|Protective Agents|protective agents|mesh-ancestor
93164112|NCT02304094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164113|NCT02304094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164114|NCT03507166|Trastuzumab|trastuzumab|mesh-list
93164115|NCT03507166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164116|NCT03507166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164117|NCT01233583|Adalimumab|adalimumab|mesh-list
93164118|NCT01233583|Infliximab|infliximab|mesh-list
93164119|NCT01233583|Etanercept|etanercept|mesh-list
93164120|NCT01233583|Acitretin|acitretin|mesh-list
93164121|NCT01233583|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93164122|NCT01233583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164123|NCT01233583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164124|NCT01233583|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164125|NCT01233583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164126|NCT01233583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164127|NCT01233583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164128|NCT01233583|Analgesics|analgesics|mesh-ancestor
93164129|NCT01233583|Sensory System Agents|sensory system agents|mesh-ancestor
93164130|NCT01233583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164131|NCT01233583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164132|NCT01233583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164133|NCT01233583|Immunologic Factors|immunologic factors|mesh-ancestor
93164134|NCT01233583|Keratolytic Agents|keratolytic agents|mesh-ancestor
93164135|NCT02304250|Dexamethasone|dexamethasone|mesh-list
93164136|NCT02304250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164137|NCT02304250|Antiemetics|antiemetics|mesh-ancestor
93164138|NCT02304250|Autonomic Agents|autonomic agents|mesh-ancestor
93164139|NCT02304250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164140|NCT02304250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164141|NCT02304250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164142|NCT02304250|Glucocorticoids|glucocorticoids|mesh-ancestor
93164143|NCT02304250|Hormones|hormones|mesh-ancestor
93164144|NCT02304250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164145|NCT02304250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164146|NCT02304250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164147|NCT01136551|Huperzine A|huperzine a|mesh-list
93164148|NCT01136551|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93164149|NCT01136551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164150|NCT01136551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164151|NCT01136551|Cholinergic Agents|cholinergic agents|mesh-ancestor
93164152|NCT01136551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164153|NCT01136551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164154|NCT01136551|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93164155|NCT01136551|Protective Agents|protective agents|mesh-ancestor
93164156|NCT03132142|Cinnamaldehyde|cinnamaldehyde|mesh-list
93164157|NCT03132142|Capsaicin|capsaicin|mesh-list
93164158|NCT03132142|Menthol|menthol|mesh-list
93164159|NCT03132142|Antipruritics|antipruritics|mesh-ancestor
93164160|NCT03132142|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164161|NCT03132142|Sensory System Agents|sensory system agents|mesh-ancestor
93164162|NCT03132142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164163|NCT03132142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164164|NCT03132142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93164165|NCT03132142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164166|NCT03132142|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93164167|NCT03132142|Protective Agents|protective agents|mesh-ancestor
93164169|NCT01232647|Vitamin K|vitamin k|mesh-list
93164170|NCT01232647|Vitamin K 2|vitamin k 2|mesh-list
93164171|NCT01232647|Vitamin K 1|vitamin k 1|mesh-list
93164172|NCT01232647|Menatetrenone|menatetrenone|mesh-list
93164173|NCT01232647|Micronutrients|micronutrients|mesh-ancestor
93164174|NCT01232647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164175|NCT01232647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93164176|NCT01232647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164177|NCT01232647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164178|NCT01232647|Hemostatics|hemostatics|mesh-ancestor
93164179|NCT01232647|Coagulants|coagulants|mesh-ancestor
93164180|NCT03917095|Mesalamine|mesalamine|mesh-list
93164181|NCT03917095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164182|NCT03917095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164183|NCT03917095|Analgesics|analgesics|mesh-ancestor
93164184|NCT03917095|Sensory System Agents|sensory system agents|mesh-ancestor
93164185|NCT03917095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164186|NCT03917095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164187|NCT03917095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164188|NCT03917095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164189|NCT01133743|Thalidomide|thalidomide|mesh-list
93164190|NCT01133743|Dexamethasone|dexamethasone|mesh-list
93164191|NCT01133743|Lenalidomide|lenalidomide|mesh-list
93164192|NCT01133743|Immunomodulating Agents|immunomodulating agents|mesh-list
93164193|NCT01133743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164194|NCT01133743|Antiemetics|antiemetics|mesh-ancestor
93164195|NCT01133743|Autonomic Agents|autonomic agents|mesh-ancestor
93164196|NCT01133743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164197|NCT01133743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164198|NCT01133743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164199|NCT01133743|Glucocorticoids|glucocorticoids|mesh-ancestor
93164200|NCT01133743|Hormones|hormones|mesh-ancestor
93164201|NCT01133743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164202|NCT01133743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164203|NCT01133743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164204|NCT01133743|Immunologic Factors|immunologic factors|mesh-ancestor
93164205|NCT01133743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93164206|NCT01133743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93164207|NCT01133743|Growth Substances|growth substances|mesh-ancestor
93164208|NCT01133743|Growth Inhibitors|growth inhibitors|mesh-ancestor
93164209|NCT01133743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164210|NCT01133743|Leprostatic Agents|leprostatic agents|mesh-ancestor
93164211|NCT01133743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93164212|NCT01133743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164213|NCT01138423|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93164214|NCT01138423|Moxonidine|moxonidine|mesh-list
93164215|NCT01138423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93164216|NCT01138423|Diuretics|diuretics|mesh-ancestor
93164217|NCT01138423|Natriuretic Agents|natriuretic agents|mesh-ancestor
93164218|NCT01138423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164219|NCT01138423|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93164220|NCT01138423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164221|NCT01138423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164222|NCT01136863|Felodipine|felodipine|mesh-list
93164223|NCT01136863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93164224|NCT01136863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93164225|NCT01136863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93164226|NCT01136863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164227|NCT01136863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164228|NCT01136863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93164229|NCT01136863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164230|NCT01136863|Vasodilator Agents|vasodilator agents|mesh-ancestor
93164231|NCT03961516|Pancrelipase|pancrelipase|mesh-list
93164232|NCT03961516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164233|NCT03508882|Botulinum Toxins|botulinum toxins|mesh-list
93164234|NCT03508882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93164235|NCT03508882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92836432|NCT00582790|Zoledronic Acid|zoledronic acid|mesh-list
93164236|NCT03508882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93164237|NCT03508882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164238|NCT03508882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164239|NCT03508882|Cholinergic Agents|cholinergic agents|mesh-ancestor
93164240|NCT03508882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164241|NCT03508882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164242|NCT03508882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93164243|NCT03508882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164244|NCT05553145|Antibodies|antibodies|mesh-list
93164245|NCT05553145|Autoantibodies|autoantibodies|mesh-list
93164246|NCT05553145|Immunologic Factors|immunologic factors|mesh-ancestor
93164247|NCT05553145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164248|NCT03504280|Cholecalciferol|cholecalciferol|mesh-list
93164249|NCT03504280|Vitamin D|vitamin d|mesh-list
93164250|NCT03504280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93164251|NCT03504280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164252|NCT03504280|Vitamins|vitamins|mesh-ancestor
93164253|NCT03504280|Micronutrients|micronutrients|mesh-ancestor
93164254|NCT03504280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93164255|NCT03504202|Trimetazidine|trimetazidine|mesh-list
93164256|NCT03504202|Vasodilator Agents|vasodilator agents|mesh-ancestor
93164257|NCT01136941|Zileuton|zileuton|mesh-list
93164258|NCT01136941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164259|NCT01136941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164260|NCT01136941|Analgesics|analgesics|mesh-ancestor
93164261|NCT01136941|Sensory System Agents|sensory system agents|mesh-ancestor
93164262|NCT01136941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164263|NCT01136941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164264|NCT01136941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164265|NCT01136941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164266|NCT01136941|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93164267|NCT01136941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164268|NCT01136941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164269|NCT01136941|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93164270|NCT01136941|Hormone Antagonists|hormone antagonists|mesh-ancestor
93164271|NCT01136941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164272|NCT01232803|Tenofovir|tenofovir|mesh-list
93164273|NCT01232803|Antiviral Agents|antiviral agents|mesh-ancestor
93164274|NCT01232803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164275|NCT01232803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93164276|NCT01232803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93164277|NCT01232803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164278|NCT01232803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164279|NCT01232803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93164280|NCT01232803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93164281|NCT03504046|Pancrelipase|pancrelipase|mesh-list
93164282|NCT03504046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164283|NCT01139203|Lamivudine|lamivudine|mesh-list
93164284|NCT01139203|Adefovir|adefovir|mesh-list
93164285|NCT01139203|Entecavir|entecavir|mesh-list
93164286|NCT01139203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93164287|NCT01139203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93164288|NCT01139203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164289|NCT01139203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164290|NCT01139203|Antiviral Agents|antiviral agents|mesh-ancestor
93164291|NCT01139203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164292|NCT01139203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93164293|NCT01139203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93164294|NCT05187715|Simvastatin|simvastatin|mesh-list
93164295|NCT05187715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93164296|NCT05187715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93164297|NCT05187715|Antimetabolites|antimetabolites|mesh-ancestor
93164298|NCT05187715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164299|NCT05187715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93164300|NCT05187715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93164301|NCT05187715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164302|NCT02312440|Tranexamic Acid|tranexamic acid|mesh-list
93164303|NCT02312440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93164304|NCT02312440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164305|NCT02312440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164306|NCT02312440|Hemostatics|hemostatics|mesh-ancestor
93164307|NCT02312440|Coagulants|coagulants|mesh-ancestor
93164308|NCT01137019|Everolimus|everolimus|mesh-list
93164309|NCT01137019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93164310|NCT01137019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93164311|NCT01137019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164312|NCT01137019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164313|NCT01137019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164314|NCT01137019|Immunologic Factors|immunologic factors|mesh-ancestor
93164315|NCT01137019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164316|NCT01137019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164317|NCT03508804|Lidocaine|lidocaine|mesh-list
93164318|NCT03508804|Prilocaine|prilocaine|mesh-list
93164319|NCT03508804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93164320|NCT03508804|Anesthetics, Local|anesthetics, local|mesh-ancestor
93164321|NCT03508804|Anesthetics|anesthetics|mesh-ancestor
93164322|NCT03508804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164323|NCT03508804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164324|NCT03508804|Sensory System Agents|sensory system agents|mesh-ancestor
93164325|NCT03508804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164326|NCT03508804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93164327|NCT03508804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93164328|NCT03508804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93164329|NCT03508804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164330|NCT03508804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164331|NCT03508804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93164332|NCT01231165|Aspirin|aspirin|mesh-list
93164333|NCT01231165|Amiloride|amiloride|mesh-list
93164334|NCT01231165|Clopidogrel|clopidogrel|mesh-list
93164335|NCT01231165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92855060|NCT00898417|Carboplatin|carboplatin|mesh-list
93164336|NCT01231165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164337|NCT01231165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164338|NCT01231165|Analgesics|analgesics|mesh-ancestor
93164339|NCT01231165|Sensory System Agents|sensory system agents|mesh-ancestor
93164340|NCT01231165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164341|NCT01231165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164342|NCT01231165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164343|NCT01231165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164344|NCT01231165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93164345|NCT01231165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164346|NCT01231165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164347|NCT01231165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93164348|NCT01231165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164349|NCT01231165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164350|NCT01231165|Antipyretics|antipyretics|mesh-ancestor
93164351|NCT01231165|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93164352|NCT01231165|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93164353|NCT01231165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93164354|NCT01231165|Purinergic Agents|purinergic agents|mesh-ancestor
93164355|NCT01231165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164356|NCT01231165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93164357|NCT01231165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93164358|NCT01231165|Antimetabolites|antimetabolites|mesh-ancestor
93164359|NCT01231165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93164360|NCT01231165|Diuretics|diuretics|mesh-ancestor
93164361|NCT01231165|Natriuretic Agents|natriuretic agents|mesh-ancestor
93164362|NCT01231165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93164363|NCT01231165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93164364|NCT01231165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164365|NCT01231165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93164366|NCT01231165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93164367|NCT01231243|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93164368|NCT01231243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93164369|NCT01231243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164370|NCT03503890|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
93164371|NCT03503890|Immunoconjugates|immunoconjugates|mesh-ancestor
93164372|NCT03503890|Immunologic Factors|immunologic factors|mesh-ancestor
93164373|NCT03503890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164374|NCT01233895|Bortezomib|bortezomib|mesh-list
93164375|NCT01233895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164376|NCT05221645|Rituximab|rituximab|mesh-list
93164377|NCT05221645|Pembrolizumab|pembrolizumab|mesh-list
93164378|NCT05221645|Carboplatin|carboplatin|mesh-list
93164379|NCT05221645|Etoposide|etoposide|mesh-list
93164380|NCT05221645|Ifosfamide|ifosfamide|mesh-list
93164381|NCT05221645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164382|NCT05221645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164383|NCT05221645|Immunologic Factors|immunologic factors|mesh-ancestor
93164384|NCT05221645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164385|NCT05221645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164386|NCT05221645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93164387|NCT05221645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164388|NCT05221645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93164389|NCT05221645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93164390|NCT05221645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93164391|NCT05221645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164392|NCT05221645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93164393|NCT05221645|Alkylating Agents|alkylating agents|mesh-ancestor
93164394|NCT03506620|Ropivacaine|ropivacaine|mesh-list
93164395|NCT03506620|Anesthetics, Local|anesthetics, local|mesh-ancestor
93164396|NCT03506620|Anesthetics|anesthetics|mesh-ancestor
93164397|NCT03506620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164398|NCT03506620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164399|NCT03506620|Sensory System Agents|sensory system agents|mesh-ancestor
93164400|NCT03506620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164401|NCT02305030|Opicapone|opicapone|mesh-list
93164402|NCT02305030|Warfarin|warfarin|mesh-list
93164403|NCT02305030|Anticoagulants|anticoagulants|mesh-ancestor
93164404|NCT02305030|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93164405|NCT02305030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164406|NCT02305030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164407|NCT02305030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93164408|NCT02305030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93164409|NCT01139437|Vaccines|vaccines|mesh-list
93164410|NCT01139437|Immunologic Factors|immunologic factors|mesh-ancestor
93164411|NCT01139437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164412|NCT01137253|Trimethaphan|trimethaphan|mesh-list
93164413|NCT01137253|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
93164414|NCT01137253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93164415|NCT01137253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93164416|NCT01137253|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
93164417|NCT01137253|Autonomic Agents|autonomic agents|mesh-ancestor
93164418|NCT01137253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164419|NCT01137253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164420|NCT01137253|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93164421|NCT01137253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93164422|NCT01137253|Cholinergic Agents|cholinergic agents|mesh-ancestor
93164423|NCT01137253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164424|NCT01137253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164425|NCT01137253|Vasodilator Agents|vasodilator agents|mesh-ancestor
93164426|NCT05493163|Fibrinolytic Agents|fibrinolytic agents|mesh-list
93164427|NCT05493163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164428|NCT05493163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164429|NCT03506542|Mitomycins|mitomycins|mesh-list
93164430|NCT03506542|Mitomycin|mitomycin|mesh-list
93164431|NCT03506542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93164432|NCT03506542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164433|NCT03506542|Alkylating Agents|alkylating agents|mesh-ancestor
93164434|NCT03506542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164435|NCT03506542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93164436|NCT03506542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164437|NCT02305186|Pembrolizumab|pembrolizumab|mesh-list
93164438|NCT02305186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164439|NCT02305186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164440|NCT02305186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93164441|NCT02305186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164442|NCT02312908|Clonazepam|clonazepam|mesh-list
93164443|NCT02312908|Anticonvulsants|anticonvulsants|mesh-ancestor
93164444|NCT02312908|GABA Modulators|gaba modulators|mesh-ancestor
93164445|NCT02312908|GABA Agents|gaba agents|mesh-ancestor
93164446|NCT02312908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164447|NCT02312908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164448|NCT02312908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164449|NCT02308930|Vitamin D|vitamin d|mesh-list
93164450|NCT02308930|Vitamins|vitamins|mesh-list
93164451|NCT02308930|Vitamin A|vitamin a|mesh-list
93164452|NCT02308930|Retinol palmitate|retinol palmitate|mesh-list
93164453|NCT02308930|Micronutrients|micronutrients|mesh-ancestor
93164454|NCT02308930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164455|NCT02308930|Antioxidants|antioxidants|mesh-ancestor
93164456|NCT02308930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164457|NCT02308930|Protective Agents|protective agents|mesh-ancestor
93164458|NCT02308930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93164459|NCT02308930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164460|NCT02308930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93164461|NCT01139671|Remifentanil|remifentanil|mesh-list
93164462|NCT01139671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93164463|NCT01139671|Narcotics|narcotics|mesh-ancestor
93164464|NCT01139671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164465|NCT01139671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164466|NCT01139671|Analgesics|analgesics|mesh-ancestor
93164467|NCT01139671|Sensory System Agents|sensory system agents|mesh-ancestor
93164468|NCT01139671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164469|NCT02313064|CXA-10|cxa-10|mesh-list
93164470|NCT02313064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164471|NCT05088889|Nivolumab|nivolumab|mesh-list
93164472|NCT05088889|Ipilimumab|ipilimumab|mesh-list
93164473|NCT05088889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164474|NCT05088889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164475|NCT05088889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93164476|NCT05088889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164477|NCT01234051|Docetaxel|docetaxel|mesh-list
93164478|NCT01234051|Oxaliplatin|oxaliplatin|mesh-list
93164479|NCT01234051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164480|NCT01234051|Tubulin Modulators|tubulin modulators|mesh-ancestor
93164481|NCT01234051|Antimitotic Agents|antimitotic agents|mesh-ancestor
93164482|NCT01234051|Mitosis Modulators|mitosis modulators|mesh-ancestor
93164483|NCT01234051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164484|NCT03341962|Calcium|calcium|mesh-list
93164485|NCT03341962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93164486|NCT03341962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164487|NCT01234597|Insulin|insulin|mesh-list
93164488|NCT01234597|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93164489|NCT01234597|Insulin Glargine|insulin glargine|mesh-list
93164490|NCT01234597|Insulin glulisine|insulin glulisine|mesh-list
93164491|NCT01234597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93164492|NCT01234597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164493|NCT02313220|Dapagliflozin|dapagliflozin|mesh-list
93164494|NCT02313220|Exenatide|exenatide|mesh-list
93164495|NCT02313220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93164496|NCT02313220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164497|NCT02313220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93164498|NCT02313220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164499|NCT02313220|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93164500|NCT02313220|Incretins|incretins|mesh-ancestor
93164501|NCT02313220|Hormones|hormones|mesh-ancestor
93164502|NCT02313220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164503|NCT02309320|Gontivimab|gontivimab|mesh-list
93164504|NCT02309320|Antiviral Agents|antiviral agents|mesh-ancestor
93164505|NCT02309320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164506|NCT01139749|Salicylic Acid|salicylic acid|mesh-list
93164507|NCT01139749|Ciclopirox|ciclopirox|mesh-list
93164508|NCT01139749|Salicylates|salicylates|mesh-list
93164509|NCT01139749|Isotretinoin|isotretinoin|mesh-list
93164510|NCT01139749|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164511|NCT01139749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164512|NCT01139749|Antifungal Agents|antifungal agents|mesh-ancestor
93164513|NCT01139749|Keratolytic Agents|keratolytic agents|mesh-ancestor
93164514|NCT01139749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164515|NCT01139749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164516|NCT01139749|Analgesics|analgesics|mesh-ancestor
93164517|NCT01139749|Sensory System Agents|sensory system agents|mesh-ancestor
93164518|NCT01139749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164519|NCT01139749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164520|NCT01139749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164521|NCT01139749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164522|NCT01139749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164523|NCT01139749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164524|NCT01139749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164525|NCT02305810|Everolimus|everolimus|mesh-list
93164526|NCT02305810|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93164527|NCT02305810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93164528|NCT02305810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164529|NCT02305810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164530|NCT02305810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164531|NCT02305810|Immunologic Factors|immunologic factors|mesh-ancestor
93164532|NCT02305810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164533|NCT02305810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164534|NCT01142869|Cetuximab|cetuximab|mesh-list
93164535|NCT01142869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164536|NCT01142869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164537|NCT01139905|Ritonavir|ritonavir|mesh-list
93164538|NCT01139905|Lopinavir|lopinavir|mesh-list
93164539|NCT01139905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93164540|NCT01139905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93164541|NCT01139905|Protease Inhibitors|protease inhibitors|mesh-ancestor
93164542|NCT01139905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164543|NCT01139905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164544|NCT01139905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93164545|NCT01139905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93164546|NCT01139905|Antiviral Agents|antiviral agents|mesh-ancestor
93164547|NCT01139905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164548|NCT01139905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93164549|NCT01139905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93164551|NCT05044429|Anesthetics, Local|anesthetics, local|mesh-ancestor
93164552|NCT05044429|Anesthetics|anesthetics|mesh-ancestor
93164553|NCT05044429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164554|NCT05044429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164555|NCT05044429|Sensory System Agents|sensory system agents|mesh-ancestor
93164556|NCT05044429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164557|NCT05044429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93164558|NCT05044429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93164559|NCT05044429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93164560|NCT05044429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164561|NCT05044429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164562|NCT02309554|Nonoxynol|nonoxynol|mesh-list
93164563|NCT02309554|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
93164564|NCT02309554|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
93164565|NCT02309554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164566|NCT02309554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93164567|NCT02309554|Contraceptive Agents|contraceptive agents|mesh-ancestor
93164568|NCT02309554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93164569|NCT02309554|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93164570|NCT01143025|Ropivacaine|ropivacaine|mesh-list
93164571|NCT01143025|Anesthetics, Local|anesthetics, local|mesh-ancestor
93164572|NCT01143025|Anesthetics|anesthetics|mesh-ancestor
93164573|NCT01143025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164574|NCT01143025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164575|NCT01143025|Sensory System Agents|sensory system agents|mesh-ancestor
93164576|NCT01143025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164577|NCT03502642|Morphine|morphine|mesh-list
93164578|NCT03502642|Ropivacaine|ropivacaine|mesh-list
93164579|NCT03502642|Anesthetics|anesthetics|mesh-ancestor
93164580|NCT03502642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164581|NCT03502642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164582|NCT03502642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93164583|NCT03502642|Narcotics|narcotics|mesh-ancestor
93164584|NCT03502642|Analgesics|analgesics|mesh-ancestor
93164585|NCT03502642|Sensory System Agents|sensory system agents|mesh-ancestor
93164586|NCT03502642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164587|NCT03502642|Anesthetics, Local|anesthetics, local|mesh-ancestor
93164588|NCT02306278|Gabapentin|gabapentin|mesh-list
93164589|NCT02306278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164590|NCT02306278|Analgesics|analgesics|mesh-ancestor
93164591|NCT02306278|Sensory System Agents|sensory system agents|mesh-ancestor
93164592|NCT02306278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164593|NCT02306278|Anticonvulsants|anticonvulsants|mesh-ancestor
93164594|NCT02306278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93164595|NCT02306278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93164596|NCT02306278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164597|NCT02306278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93164598|NCT02306278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93164599|NCT02306278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93164600|NCT02306278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164601|NCT02306278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164602|NCT02306278|Antimanic Agents|antimanic agents|mesh-ancestor
93164603|NCT01234129|Zoledronic Acid|zoledronic acid|mesh-list
93164604|NCT01234129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93164605|NCT01234129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164606|NCT02313922|Etanercept|etanercept|mesh-list
93164607|NCT02313922|Methotrexate|methotrexate|mesh-list
93164608|NCT02313922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93164609|NCT02313922|Abortifacient Agents|abortifacient agents|mesh-ancestor
93164610|NCT02313922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93164611|NCT02313922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164612|NCT02313922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93164613|NCT02313922|Antimetabolites|antimetabolites|mesh-ancestor
93164614|NCT02313922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164615|NCT02313922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164616|NCT02313922|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164617|NCT02313922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164618|NCT02313922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93164619|NCT02313922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164620|NCT02313922|Immunologic Factors|immunologic factors|mesh-ancestor
93164621|NCT02313922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164622|NCT02313922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93164623|NCT02313922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164624|NCT02313922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164625|NCT02313922|Analgesics|analgesics|mesh-ancestor
93164626|NCT02313922|Sensory System Agents|sensory system agents|mesh-ancestor
93164627|NCT02313922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164628|NCT02313922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164629|NCT02313922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164630|NCT03627013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93164631|NCT03508102|Remifentanil|remifentanil|mesh-list
93164632|NCT03508102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93164633|NCT03508102|Narcotics|narcotics|mesh-ancestor
92855062|NCT00898417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164634|NCT03508102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164635|NCT03508102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164636|NCT03508102|Analgesics|analgesics|mesh-ancestor
93164637|NCT03508102|Sensory System Agents|sensory system agents|mesh-ancestor
93164638|NCT03508102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164639|NCT03505528|Paclitaxel|paclitaxel|mesh-list
93164640|NCT03505528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93164641|NCT03505528|Phenelzine|phenelzine|mesh-list
93164642|NCT03505528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93164643|NCT03505528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164644|NCT03505528|Tubulin Modulators|tubulin modulators|mesh-ancestor
93164645|NCT03505528|Antimitotic Agents|antimitotic agents|mesh-ancestor
93164646|NCT03505528|Mitosis Modulators|mitosis modulators|mesh-ancestor
93164647|NCT03505528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164648|NCT03505528|Antidepressive Agents|antidepressive agents|mesh-ancestor
93164649|NCT03505528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93164650|NCT03505528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93164651|NCT03505528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164652|NCT01234285|Heparin|heparin|mesh-list
93164653|NCT01234285|Calcium heparin|calcium heparin|mesh-list
93164654|NCT01234285|Anticoagulants|anticoagulants|mesh-ancestor
93164655|NCT01234285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93164656|NCT01234285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164657|NCT01234285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164658|NCT02314312|Cyclosporine|cyclosporine|mesh-list
93164659|NCT02314312|Prednisolone|prednisolone|mesh-list
93164660|NCT02314312|Everolimus|everolimus|mesh-list
93164661|NCT02314312|Cyclosporins|cyclosporins|mesh-list
93164662|NCT02314312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164663|NCT02314312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164664|NCT02314312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164665|NCT02314312|Immunologic Factors|immunologic factors|mesh-ancestor
93164666|NCT02314312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164667|NCT02314312|Antifungal Agents|antifungal agents|mesh-ancestor
93164668|NCT02314312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164669|NCT02314312|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164670|NCT02314312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164671|NCT02314312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93164672|NCT02314312|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93164673|NCT02314312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93164674|NCT02314312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164675|NCT02314312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164676|NCT02314312|Glucocorticoids|glucocorticoids|mesh-ancestor
93164677|NCT02314312|Hormones|hormones|mesh-ancestor
93164678|NCT02314312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164679|NCT02314312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164680|NCT02316340|Hydroxychloroquine|hydroxychloroquine|mesh-list
93164681|NCT02316340|Vorinostat|vorinostat|mesh-list
93164682|NCT02316340|Antimalarials|antimalarials|mesh-ancestor
93164683|NCT02316340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93164684|NCT02316340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93164685|NCT02316340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164686|NCT02316340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164687|NCT02316340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836881|NCT02631603|Prednisolone|prednisolone|mesh-list
93164688|NCT02316340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164689|NCT02316340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164690|NCT02316340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93164691|NCT01140997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93164692|NCT01140997|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93164693|NCT01140997|Antiviral Agents|antiviral agents|mesh-ancestor
93164694|NCT01140997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164695|NCT02310490|Mannitol|mannitol|mesh-list
93164696|NCT02310490|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93164697|NCT02310490|Diuretics|diuretics|mesh-ancestor
93164698|NCT02310490|Natriuretic Agents|natriuretic agents|mesh-ancestor
93164699|NCT02310490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164700|NCT02316496|Irinotecan|irinotecan|mesh-list
93164701|NCT02316496|Cetuximab|cetuximab|mesh-list
93164702|NCT02316496|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93164703|NCT02316496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93164704|NCT02316496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164705|NCT02316496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164706|NCT02316496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164707|NCT02316496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164708|NCT01140529|Dexmedetomidine|dexmedetomidine|mesh-list
93164709|NCT01140529|Haloperidol|haloperidol|mesh-list
93164710|NCT01140529|Haloperidol decanoate|haloperidol decanoate|mesh-list
93164711|NCT01140529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93164712|NCT01140529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164713|NCT01140529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164714|NCT01140529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164715|NCT01140529|Analgesics|analgesics|mesh-ancestor
93164716|NCT01140529|Sensory System Agents|sensory system agents|mesh-ancestor
93164717|NCT01140529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164718|NCT01140529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93164719|NCT01140529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93164720|NCT01140529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93164721|NCT01140529|Adrenergic Agents|adrenergic agents|mesh-ancestor
93164722|NCT01140529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164723|NCT01140529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164724|NCT01140529|Antiemetics|antiemetics|mesh-ancestor
93164725|NCT01140529|Autonomic Agents|autonomic agents|mesh-ancestor
93164726|NCT01140529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164727|NCT01140529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93164728|NCT01140529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93164729|NCT01140529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93164730|NCT01140529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93164731|NCT01140529|Dopamine Agents|dopamine agents|mesh-ancestor
93164732|NCT01140529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93164733|NCT01141153|Aspirin|aspirin|mesh-list
93164734|NCT01141153|Acenocoumarol|acenocoumarol|mesh-list
93164735|NCT01141153|Clopidogrel|clopidogrel|mesh-list
93164736|NCT01141153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93164737|NCT01141153|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93164738|NCT01141153|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93164739|NCT01141153|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93164740|NCT01141153|Purinergic Agents|purinergic agents|mesh-ancestor
93164741|NCT01141153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164742|NCT01141153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164743|NCT01141153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164744|NCT01141153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164745|NCT01141153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164746|NCT01141153|Analgesics|analgesics|mesh-ancestor
93164747|NCT01141153|Sensory System Agents|sensory system agents|mesh-ancestor
93164748|NCT01141153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164749|NCT01141153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164750|NCT01141153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164751|NCT01141153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93164752|NCT01141153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164753|NCT01141153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164754|NCT01141153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164755|NCT01141153|Antipyretics|antipyretics|mesh-ancestor
93164756|NCT01141153|Anticoagulants|anticoagulants|mesh-ancestor
93164757|NCT01235143|Sevoflurane|sevoflurane|mesh-list
93164758|NCT01235143|Desflurane|desflurane|mesh-list
93164759|NCT01235143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93164760|NCT01235143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93164761|NCT01235143|Anesthetics, General|anesthetics, general|mesh-ancestor
93164762|NCT01235143|Anesthetics|anesthetics|mesh-ancestor
93164763|NCT01235143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164764|NCT01235143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164765|NCT01238029|Capecitabine|capecitabine|mesh-list
93164767|NCT01238029|Lapatinib|lapatinib|mesh-list
93164768|NCT01238029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93164769|NCT01238029|Antimetabolites|antimetabolites|mesh-ancestor
93164770|NCT01238029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164771|NCT01238029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164772|NCT01238029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93164773|NCT01238029|Tubulin Modulators|tubulin modulators|mesh-ancestor
93164774|NCT01238029|Antimitotic Agents|antimitotic agents|mesh-ancestor
93164775|NCT01238029|Mitosis Modulators|mitosis modulators|mesh-ancestor
93164776|NCT01238029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93164777|NCT01238029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164778|NCT01235221|4-Aminopyridine|4-aminopyridine|mesh-list
93164779|NCT01235221|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93164780|NCT01235221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164781|NCT01235221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164782|NCT03139604|Prednisone|prednisone|mesh-list
93164783|NCT03139604|Methylprednisolone|methylprednisolone|mesh-list
93164784|NCT03139604|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93164785|NCT03139604|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93164786|NCT03139604|Prednisolone|prednisolone|mesh-list
93164787|NCT03139604|Prednisolone acetate|prednisolone acetate|mesh-list
93164788|NCT03139604|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93164789|NCT03139604|Prednisolone phosphate|prednisolone phosphate|mesh-list
93164790|NCT03139604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164791|NCT03139604|Glucocorticoids|glucocorticoids|mesh-ancestor
93164792|NCT03139604|Hormones|hormones|mesh-ancestor
93164793|NCT03139604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164794|NCT03139604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164795|NCT03139604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164796|NCT03139604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164797|NCT03139604|Antiemetics|antiemetics|mesh-ancestor
93164798|NCT03139604|Autonomic Agents|autonomic agents|mesh-ancestor
93164799|NCT03139604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164800|NCT03139604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164801|NCT03139604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93164802|NCT03139604|Protective Agents|protective agents|mesh-ancestor
93164803|NCT01350596|Ibuprofen|ibuprofen|mesh-list
93164804|NCT01350596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164805|NCT01350596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164806|NCT01350596|Analgesics|analgesics|mesh-ancestor
93164807|NCT01350596|Sensory System Agents|sensory system agents|mesh-ancestor
93164808|NCT01350596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164809|NCT01350596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164810|NCT01350596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164811|NCT01350596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164812|NCT01350596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164813|NCT01350596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164814|NCT01350596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164815|NCT04462588|Metronidazole|metronidazole|mesh-list
93164816|NCT04462588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164817|NCT04462588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93164818|NCT04462588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93164819|NCT04462588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93164820|NCT04462822|Fluticasone|fluticasone|mesh-list
93164821|NCT04462822|Xhance|xhance|mesh-list
93164822|NCT04462822|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93164823|NCT04462822|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93164824|NCT04462822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164825|NCT04462822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93164826|NCT04462822|Autonomic Agents|autonomic agents|mesh-ancestor
93164827|NCT04462822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164828|NCT04462822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164829|NCT04462822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93164830|NCT04462822|Respiratory System Agents|respiratory system agents|mesh-ancestor
93164831|NCT04462822|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164832|NCT04462822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93164833|NCT04462822|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93164834|NCT04462822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93164835|NCT04462822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93164836|NCT04462822|Adrenergic Agents|adrenergic agents|mesh-ancestor
93164837|NCT04462822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164838|NCT04462822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164839|NCT04462822|Glucocorticoids|glucocorticoids|mesh-ancestor
93164840|NCT04462822|Hormones|hormones|mesh-ancestor
93164841|NCT04462822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164842|NCT04462822|Sympathomimetics|sympathomimetics|mesh-ancestor
93164843|NCT01362218|Aspirin|aspirin|mesh-list
93164844|NCT01362218|Ramipril|ramipril|mesh-list
93164845|NCT01362218|Simvastatin|simvastatin|mesh-list
93164846|NCT01362218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93164847|NCT01362218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93164848|NCT01362218|Antimetabolites|antimetabolites|mesh-ancestor
93164849|NCT01362218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164850|NCT01362218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93164851|NCT01362218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93164852|NCT01362218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164853|NCT01362218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164854|NCT01362218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164855|NCT01362218|Analgesics|analgesics|mesh-ancestor
93164856|NCT01362218|Sensory System Agents|sensory system agents|mesh-ancestor
93164857|NCT01362218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164858|NCT01362218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164859|NCT01362218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164860|NCT01362218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164861|NCT01362218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93164862|NCT01362218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93164863|NCT01362218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93164864|NCT01362218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164865|NCT01362218|Antipyretics|antipyretics|mesh-ancestor
93164866|NCT01362218|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93164867|NCT01362218|Protease Inhibitors|protease inhibitors|mesh-ancestor
93164868|NCT01362218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93164869|NCT02316964|Aldesleukin|aldesleukin|mesh-list
93164870|NCT02316964|Decitabine|decitabine|mesh-list
93164871|NCT02316964|Azacitidine|azacitidine|mesh-list
93164872|NCT02316964|Interleukin-2|interleukin-2|mesh-list
93164873|NCT02316964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93164874|NCT02316964|Antimetabolites|antimetabolites|mesh-ancestor
93164875|NCT02316964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164876|NCT02316964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164877|NCT02316964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164878|NCT02316964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164879|NCT02316964|Analgesics|analgesics|mesh-ancestor
93164880|NCT02316964|Sensory System Agents|sensory system agents|mesh-ancestor
93164881|NCT02316964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164882|NCT02316964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164883|NCT02316964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93164884|NCT02316964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93164885|NCT02316964|Antiviral Agents|antiviral agents|mesh-ancestor
93164886|NCT02316964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164887|NCT02875340|Risperidone|risperidone|mesh-list
93164888|NCT02875340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93164889|NCT02875340|Serotonin Agents|serotonin agents|mesh-ancestor
93164890|NCT02875340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164891|NCT02875340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164892|NCT02875340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164893|NCT02875340|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93164894|NCT02875340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93164895|NCT02875340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93164896|NCT02875340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93164897|NCT02875340|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93164898|NCT02875340|Dopamine Agents|dopamine agents|mesh-ancestor
93164899|NCT04462666|Etoricoxib|etoricoxib|mesh-list
93164900|NCT04462666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164901|NCT04462666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164902|NCT04462666|Analgesics|analgesics|mesh-ancestor
93164903|NCT04462666|Sensory System Agents|sensory system agents|mesh-ancestor
93164904|NCT04462666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164905|NCT04462666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164906|NCT04462666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164907|NCT04462666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164908|NCT04462666|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93164909|NCT04462666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164910|NCT04462666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164911|NCT04462666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164912|NCT01359020|Acetaminophen|acetaminophen|mesh-list
93164913|NCT01359020|Dipyrone|dipyrone|mesh-list
93164914|NCT01359020|Ibuprofen|ibuprofen|mesh-list
93164915|NCT01359020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93164916|NCT01359020|Analgesics|analgesics|mesh-ancestor
93164917|NCT01359020|Sensory System Agents|sensory system agents|mesh-ancestor
93164918|NCT01359020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164919|NCT01359020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164920|NCT01359020|Antipyretics|antipyretics|mesh-ancestor
93164921|NCT01359020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93164922|NCT01359020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164923|NCT01359020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93164924|NCT01359020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93164925|NCT01359020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164926|NCT01359020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164927|NCT01359098|Ciprofloxacin|ciprofloxacin|mesh-list
93164928|NCT01359098|Dexamethasone|dexamethasone|mesh-list
93164929|NCT01359098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164930|NCT01359098|Antiemetics|antiemetics|mesh-ancestor
93164931|NCT01359098|Autonomic Agents|autonomic agents|mesh-ancestor
93164932|NCT01359098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460721|NCT01747044|Analgesics|analgesics|mesh-ancestor
93164933|NCT01359098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164934|NCT01359098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93164935|NCT01359098|Glucocorticoids|glucocorticoids|mesh-ancestor
93164936|NCT01359098|Hormones|hormones|mesh-ancestor
93164937|NCT01359098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164938|NCT01359098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93164939|NCT01359098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164940|NCT01359098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164941|NCT01359098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164942|NCT01359098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93164943|NCT01359098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93164944|NCT01359098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93164945|NCT01359098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93164946|NCT01359098|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93164947|NCT01359098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93164948|NCT01319240|Insulin|insulin|mesh-list
93164949|NCT01319240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93164950|NCT01319240|Liraglutide|liraglutide|mesh-list
93164951|NCT01319240|Insulin, Long-Acting|insulin, long-acting|mesh-list
93164952|NCT01319240|Xultophy|xultophy|mesh-list
93164953|NCT01319240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93164954|NCT01319240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164955|NCT01319240|Incretins|incretins|mesh-ancestor
93164956|NCT01319240|Hormones|hormones|mesh-ancestor
93164957|NCT01319240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164958|NCT04463056|Eculizumab|eculizumab|mesh-list
93164959|NCT04463056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93164960|NCT04463056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93164961|NCT04463056|Immunologic Factors|immunologic factors|mesh-ancestor
93164962|NCT04463056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164963|NCT02315950|Botulinum Toxins|botulinum toxins|mesh-list
93164964|NCT02315950|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93164965|NCT02315950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93164966|NCT02315950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164967|NCT02315950|Cholinergic Agents|cholinergic agents|mesh-ancestor
93164968|NCT02315950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93164969|NCT02315950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164970|NCT03319316|Durvalumab|durvalumab|mesh-list
93164971|NCT03319316|Tremelimumab|tremelimumab|mesh-list
93164972|NCT03319316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93164973|NCT03319316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164974|NCT02316028|Decitabine|decitabine|mesh-list
93164975|NCT02316028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93164976|NCT02316028|Antimetabolites|antimetabolites|mesh-ancestor
93164977|NCT02316028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93164978|NCT02316028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93164979|NCT02316028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93164980|NCT01359488|Hormones|hormones|mesh-list
93164981|NCT01359488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
93164982|NCT01359488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93164983|NCT01359488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164984|NCT01141465|Fluticasone|fluticasone|mesh-list
93164985|NCT01141465|Xhance|xhance|mesh-list
93164986|NCT01141465|Budesonide|budesonide|mesh-list
93164987|NCT01141465|Formoterol Fumarate|formoterol fumarate|mesh-list
93164988|NCT01141465|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93164989|NCT01141465|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93164990|NCT01141465|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93164991|NCT01141465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93164992|NCT01141465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93164993|NCT01141465|Autonomic Agents|autonomic agents|mesh-ancestor
93164994|NCT01141465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93164995|NCT01141465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93164996|NCT01141465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93164997|NCT01141465|Respiratory System Agents|respiratory system agents|mesh-ancestor
93164998|NCT01141465|Dermatologic Agents|dermatologic agents|mesh-ancestor
93164999|NCT01141465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93165000|NCT01141465|Glucocorticoids|glucocorticoids|mesh-ancestor
93165001|NCT01141465|Hormones|hormones|mesh-ancestor
93165002|NCT01141465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165003|NCT01141465|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93165004|NCT01141465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93165005|NCT01141465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93165006|NCT01141465|Adrenergic Agents|adrenergic agents|mesh-ancestor
93165007|NCT01141465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165008|NCT01141465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165009|NCT01141465|Sympathomimetics|sympathomimetics|mesh-ancestor
93165010|NCT01141543|Plerixafor|plerixafor|mesh-list
93165011|NCT01141543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93165012|NCT01141543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93165013|NCT01141543|Antiviral Agents|antiviral agents|mesh-ancestor
93165014|NCT01141543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165015|NCT03300518|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93165016|NCT03300518|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93165017|NCT03300518|Estradiol|estradiol|mesh-list
93165018|NCT03300518|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93165019|NCT03300518|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93165020|NCT03300518|Ganirelix|ganirelix|mesh-list
93165021|NCT03300518|Estrogens|estrogens|mesh-ancestor
93165022|NCT03300518|Hormones|hormones|mesh-ancestor
93165023|NCT03300518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165024|NCT03300518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165025|NCT03300518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93165026|NCT03300518|Contraceptive Agents|contraceptive agents|mesh-ancestor
93165027|NCT03300518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93165028|NCT03300518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93165029|NCT03300518|Hormone Antagonists|hormone antagonists|mesh-ancestor
93165030|NCT02317198|Clopidogrel|clopidogrel|mesh-list
93165031|NCT02317198|Ticagrelor|ticagrelor|mesh-list
93165032|NCT02317198|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93165033|NCT02317198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93165034|NCT02317198|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93165035|NCT02317198|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93165036|NCT02317198|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93165037|NCT02317198|Purinergic Agents|purinergic agents|mesh-ancestor
93165038|NCT02317198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165039|NCT02317198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165040|NCT02317198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165041|NCT01359722|Acetylcysteine|acetylcysteine|mesh-list
93165042|NCT01359722|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93165043|NCT01359722|Antiviral Agents|antiviral agents|mesh-ancestor
93165044|NCT01359722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165045|NCT01359722|Expectorants|expectorants|mesh-ancestor
93165046|NCT01359722|Respiratory System Agents|respiratory system agents|mesh-ancestor
93165047|NCT01359722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93165048|NCT01359722|Antioxidants|antioxidants|mesh-ancestor
93165049|NCT01359722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165050|NCT01359722|Protective Agents|protective agents|mesh-ancestor
93165051|NCT01359722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165052|NCT01359722|Antidotes|antidotes|mesh-ancestor
93165053|NCT01238185|Aspirin|aspirin|mesh-list
93165054|NCT01238185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93165055|NCT01238185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93165056|NCT01238185|Analgesics|analgesics|mesh-ancestor
93165057|NCT01238185|Sensory System Agents|sensory system agents|mesh-ancestor
93165058|NCT01238185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165059|NCT01238185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165060|NCT01238185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165061|NCT01238185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93165062|NCT01238185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93165063|NCT01238185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93165064|NCT01238185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165065|NCT01238185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93165067|NCT01238185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165068|NCT01238185|Antipyretics|antipyretics|mesh-ancestor
93165069|NCT01143805|Tofacitinib|tofacitinib|mesh-list
93165070|NCT01143805|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93165071|NCT01143805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93165072|NCT01143805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165073|NCT01143805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165074|NCT01362764|Abiraterone Acetate|abiraterone acetate|mesh-list
93165075|NCT01362764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165076|NCT01362764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93165077|NCT01362764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165078|NCT01362764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165079|NCT01362764|Hormone Antagonists|hormone antagonists|mesh-ancestor
93165080|NCT01362764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460876|NCT01747993|Tamsulosin|tamsulosin|mesh-list
93165081|NCT01362764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165082|NCT01362764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93165083|NCT03498118|Bupivacaine|bupivacaine|mesh-list
93165084|NCT03498118|Anesthetics, Local|anesthetics, local|mesh-ancestor
93165085|NCT03498118|Anesthetics|anesthetics|mesh-ancestor
93165086|NCT03498118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165087|NCT03498118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165088|NCT03498118|Sensory System Agents|sensory system agents|mesh-ancestor
93165089|NCT03498118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165090|NCT05188742|Mirabegron|mirabegron|mesh-list
93165091|NCT05188742|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93165092|NCT05188742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93165093|NCT05188742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93165094|NCT05188742|Adrenergic Agents|adrenergic agents|mesh-ancestor
93165095|NCT05188742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165096|NCT05188742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165097|NCT05188742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165098|NCT05188742|Urological Agents|urological agents|mesh-ancestor
93165099|NCT02324452|Fluorouracil|fluorouracil|mesh-list
93165100|NCT02324452|Capecitabine|capecitabine|mesh-list
93165101|NCT02324452|Antimetabolites|antimetabolites|mesh-ancestor
93165102|NCT02324452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165103|NCT02324452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93165104|NCT02324452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165105|NCT02324452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165106|NCT02324452|Immunologic Factors|immunologic factors|mesh-ancestor
93165107|NCT02324452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165108|NCT02321176|Resveratrol|resveratrol|mesh-list
93165109|NCT02321176|Antioxidants|antioxidants|mesh-ancestor
93165110|NCT02321176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165111|NCT02321176|Protective Agents|protective agents|mesh-ancestor
93165112|NCT02321176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165113|NCT02321176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165114|NCT02321176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93165115|NCT01351298|Lidocaine|lidocaine|mesh-list
93165116|NCT01351298|Xylometazoline|xylometazoline|mesh-list
93165117|NCT01351298|Anesthetics, Local|anesthetics, local|mesh-ancestor
93165118|NCT01351298|Anesthetics|anesthetics|mesh-ancestor
93165119|NCT01351298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165120|NCT01351298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165121|NCT01351298|Sensory System Agents|sensory system agents|mesh-ancestor
93165122|NCT01351298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165123|NCT01351298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93165124|NCT01351298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93165125|NCT01351298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93165126|NCT01351298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165127|NCT01351298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165128|NCT01351298|Nasal Decongestants|nasal decongestants|mesh-ancestor
93165129|NCT01351298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93165130|NCT01351298|Respiratory System Agents|respiratory system agents|mesh-ancestor
93165131|NCT02324686|Vitamin K|vitamin k|mesh-list
93165132|NCT02324686|Vitamin K 1|vitamin k 1|mesh-list
93165133|NCT02324686|Vitamins|vitamins|mesh-ancestor
93165134|NCT02324686|Micronutrients|micronutrients|mesh-ancestor
93165135|NCT02324686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165136|NCT02324686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93165137|NCT02324686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92837336|NCT00671697|Decitabine|decitabine|mesh-list
93165138|NCT02324686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165140|NCT02324686|Coagulants|coagulants|mesh-ancestor
93165141|NCT01360034|Indomethacin|indomethacin|mesh-list
93165142|NCT01360034|Nifedipine|nifedipine|mesh-list
93165143|NCT01360034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93165144|NCT01360034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165145|NCT01360034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165146|NCT01360034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93165147|NCT01360034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165148|NCT01360034|Vasodilator Agents|vasodilator agents|mesh-ancestor
93165149|NCT01360034|Tocolytic Agents|tocolytic agents|mesh-ancestor
93165150|NCT01360034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93165151|NCT01360034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93165152|NCT01360034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93165153|NCT01360034|Analgesics|analgesics|mesh-ancestor
93165154|NCT01360034|Sensory System Agents|sensory system agents|mesh-ancestor
93165155|NCT01360034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165156|NCT01360034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165157|NCT01360034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93165158|NCT01360034|Gout Suppressants|gout suppressants|mesh-ancestor
93165159|NCT01360034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93165160|NCT01360034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165161|NCT01363310|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93165162|NCT01363310|Escitalopram|escitalopram|mesh-list
93165163|NCT01363310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93165164|NCT01363310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93165165|NCT01363310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165166|NCT01363310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165167|NCT01363310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165168|NCT01363310|Serotonin Agents|serotonin agents|mesh-ancestor
93165169|NCT01363310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165170|NCT01363310|Antidepressive Agents|antidepressive agents|mesh-ancestor
93165171|NCT01363310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93165172|NCT01363310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93165173|NCT01363310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93165174|NCT01363310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165175|NCT01363544|Methylphenidate|methylphenidate|mesh-list
93165176|NCT01363544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93165177|NCT01363544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165178|NCT01363544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93165179|NCT01363544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93165180|NCT01363544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165181|NCT01363544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165182|NCT01363544|Dopamine Agents|dopamine agents|mesh-ancestor
93165183|NCT01363544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165184|NCT03257618|Temozolomide|temozolomide|mesh-list
93165185|NCT03257618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93165186|NCT03257618|Alkylating Agents|alkylating agents|mesh-ancestor
93165187|NCT03257618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165188|NCT03257618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165189|NCT01363778|Tivozanib|tivozanib|mesh-list
93165190|NCT01363778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93165191|NCT01363778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165192|NCT01363778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165193|NCT04175834|Cetirizine|cetirizine|mesh-list
93165194|NCT04175834|Histamine Antagonists|histamine antagonists|mesh-list
93165195|NCT04175834|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93165196|NCT04175834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93165197|NCT04175834|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93165198|NCT04175834|Histamine Agents|histamine agents|mesh-ancestor
93165199|NCT04175834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165200|NCT04175834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165201|NCT04175834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165202|NCT02324998|Olaparib|olaparib|mesh-list
93165203|NCT02324998|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93165204|NCT02324998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165205|NCT02324998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165206|NCT02324998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165207|NCT03500848|Mycophenolic Acid|mycophenolic acid|mesh-list
93165208|NCT03500848|Sirolimus|sirolimus|mesh-list
93165209|NCT03500848|Tacrolimus|tacrolimus|mesh-list
93165210|NCT03500848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165211|NCT03500848|Immunologic Factors|immunologic factors|mesh-ancestor
93165212|NCT03500848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165213|NCT03500848|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93165214|NCT03500848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165215|NCT03500848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165216|NCT03500848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93165217|NCT03500848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165218|NCT03500848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93165219|NCT03500848|Antitubercular Agents|antitubercular agents|mesh-ancestor
93165220|NCT03500848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93165221|NCT03500848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165222|NCT03500848|Antifungal Agents|antifungal agents|mesh-ancestor
93165223|NCT01360190|Fluoxetine|fluoxetine|mesh-list
93165224|NCT01360190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93165225|NCT01360190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93165226|NCT01360190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165227|NCT01360190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165228|NCT01360190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165229|NCT01360190|Serotonin Agents|serotonin agents|mesh-ancestor
93165230|NCT01360190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165231|NCT01360190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93165232|NCT01360190|Antidepressive Agents|antidepressive agents|mesh-ancestor
93165233|NCT01360190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93165234|NCT01360190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93165235|NCT01360190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93165236|NCT01360190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165237|NCT01363934|Darbepoetin alfa|darbepoetin alfa|mesh-list
93165238|NCT01363934|Hematinics|hematinics|mesh-ancestor
93165239|NCT03132376|Caseins|caseins|mesh-list
93165240|NCT03132376|Chelating Agents|chelating agents|mesh-ancestor
93165241|NCT03132376|Sequestering Agents|sequestering agents|mesh-ancestor
93165242|NCT03132376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165243|NCT01364012|Paclitaxel|paclitaxel|mesh-list
93165244|NCT01364012|Bevacizumab|bevacizumab|mesh-list
93165245|NCT01364012|Carboplatin|carboplatin|mesh-list
93165246|NCT01364012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93165247|NCT01364012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165248|NCT01364012|Tubulin Modulators|tubulin modulators|mesh-ancestor
93165249|NCT01364012|Antimitotic Agents|antimitotic agents|mesh-ancestor
93165250|NCT01364012|Mitosis Modulators|mitosis modulators|mesh-ancestor
93165251|NCT01364012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165252|NCT01364012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165253|NCT01364012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93165254|NCT01364012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93165255|NCT01364012|Growth Substances|growth substances|mesh-ancestor
93165256|NCT01364012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165257|NCT01364012|Growth Inhibitors|growth inhibitors|mesh-ancestor
93165258|NCT02318056|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93165259|NCT02318056|Bacitracin|bacitracin|mesh-list
93165260|NCT02318056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93165261|NCT02318056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165262|NCT02318056|Laxatives|laxatives|mesh-ancestor
93165263|NCT02318056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165264|NCT02318056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93165265|NCT01360424|Teriparatide|teriparatide|mesh-list
93165266|NCT01360424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93165267|NCT01360424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165268|NCT01360424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93165269|NCT01364324|Antitubercular Agents|antitubercular agents|mesh-list
93165270|NCT01364324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93165271|NCT01364324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165272|NCT01364402|Epoetin Alfa|epoetin alfa|mesh-list
93165273|NCT01364402|Hematinics|hematinics|mesh-ancestor
93165274|NCT03552380|Nivolumab|nivolumab|mesh-list
93165275|NCT03552380|Ipilimumab|ipilimumab|mesh-list
93165276|NCT03552380|Entinostat|entinostat|mesh-list
93165277|NCT03552380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165278|NCT03552380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165279|NCT03552380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93165280|NCT03552380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165281|NCT03552380|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93165282|NCT03552380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165283|NCT02318290|Analgesics|analgesics|mesh-list
93165284|NCT02318290|Narcotics|narcotics|mesh-list
93165285|NCT02318290|Sensory System Agents|sensory system agents|mesh-ancestor
93165286|NCT02318290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165287|NCT02318290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165288|NCT02318290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165289|NCT03467360|Etoposide|etoposide|mesh-list
93165290|NCT03467360|Acetazolamide|acetazolamide|mesh-list
93165291|NCT03467360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93165292|NCT03467360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165293|NCT03467360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93165294|NCT03467360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93165295|NCT03467360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165296|NCT03467360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165297|NCT03467360|Anticonvulsants|anticonvulsants|mesh-ancestor
93165298|NCT03467360|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93165299|NCT03467360|Diuretics|diuretics|mesh-ancestor
93165300|NCT03467360|Natriuretic Agents|natriuretic agents|mesh-ancestor
93165301|NCT03467360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165302|NCT03452072|Timolol|timolol|mesh-list
93165303|NCT03452072|Petrolatum|petrolatum|mesh-list
93165304|NCT03452072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93165305|NCT03452072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93165306|NCT03452072|Adrenergic Agents|adrenergic agents|mesh-ancestor
93165307|NCT03452072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165308|NCT03452072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165309|NCT03452072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165310|NCT03452072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93165311|NCT03452072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93165312|NCT03452072|Emollients|emollients|mesh-ancestor
93165313|NCT03452072|Dermatologic Agents|dermatologic agents|mesh-ancestor
93165314|NCT03433040|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93165315|NCT03433040|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93165316|NCT03433040|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93165317|NCT03433040|Hormone Antagonists|hormone antagonists|mesh-ancestor
93165318|NCT03433040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165319|NCT03433040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165320|NCT03433040|Progestins|progestins|mesh-ancestor
93165321|NCT03433040|Hormones|hormones|mesh-ancestor
93165322|NCT02318446|Folic Acid|folic acid|mesh-list
93165323|NCT02318446|Hematinics|hematinics|mesh-ancestor
93165324|NCT02318446|Vitamin B Complex|vitamin b complex|mesh-ancestor
93165325|NCT02318446|Vitamins|vitamins|mesh-ancestor
93165326|NCT02318446|Micronutrients|micronutrients|mesh-ancestor
93165327|NCT02318446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165328|NCT02325934|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93165329|NCT02325934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93165330|NCT02325934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93165331|NCT02325934|Antiviral Agents|antiviral agents|mesh-ancestor
93165332|NCT02325934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165333|NCT01360658|Immunoglobulins|immunoglobulins|mesh-list
93165334|NCT01360658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93165335|NCT01360658|Antibodies|antibodies|mesh-list
93165336|NCT01360658|gamma-Globulins|gamma-globulins|mesh-list
93165337|NCT01360658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93165338|NCT01360658|Immunologic Factors|immunologic factors|mesh-ancestor
93165339|NCT01360658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165340|NCT02318758|Ethanol|ethanol|mesh-list
93165341|NCT02318758|Treprostinil|treprostinil|mesh-list
93165342|NCT02318758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93165343|NCT02318758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165344|NCT02318758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165345|NCT02318758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165346|NCT02318758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93165347|NCT02441686|Dexamethasone|dexamethasone|mesh-list
93165348|NCT02441686|Lenalidomide|lenalidomide|mesh-list
93165349|NCT02441686|Bortezomib|bortezomib|mesh-list
93165350|NCT02441686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165351|NCT02441686|Antiemetics|antiemetics|mesh-ancestor
93165352|NCT02441686|Autonomic Agents|autonomic agents|mesh-ancestor
93165353|NCT02441686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165354|NCT02441686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165355|NCT02441686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165356|NCT02441686|Glucocorticoids|glucocorticoids|mesh-ancestor
93165357|NCT02441686|Hormones|hormones|mesh-ancestor
93165358|NCT02441686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165359|NCT02441686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93165360|NCT02441686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165361|NCT02441686|Immunologic Factors|immunologic factors|mesh-ancestor
93165362|NCT02441686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93165363|NCT02441686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93165364|NCT02441686|Growth Substances|growth substances|mesh-ancestor
93165365|NCT02441686|Growth Inhibitors|growth inhibitors|mesh-ancestor
93165366|NCT03500146|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93165367|NCT03500146|Cholinergic Agents|cholinergic agents|mesh-ancestor
93165368|NCT03500146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165369|NCT03500146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165370|NCT03500146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165371|NCT01352234|Aspirin|aspirin|mesh-list
93165372|NCT01352234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93165373|NCT01352234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93165374|NCT01352234|Analgesics|analgesics|mesh-ancestor
92461179|NCT01749319|Baclofen|baclofen|mesh-list
93165375|NCT01352234|Sensory System Agents|sensory system agents|mesh-ancestor
93165376|NCT01352234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165377|NCT01352234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165378|NCT01352234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165379|NCT01352234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93165380|NCT01352234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93165381|NCT01352234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93165382|NCT01352234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165383|NCT01352234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93165384|NCT01352234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93165385|NCT01352234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165386|NCT01352234|Antipyretics|antipyretics|mesh-ancestor
93165387|NCT01364792|Valacyclovir|valacyclovir|mesh-list
93165388|NCT01364792|Antiviral Agents|antiviral agents|mesh-ancestor
93165389|NCT01364792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165390|NCT02318836|Lofexidine|lofexidine|mesh-list
93165391|NCT02318836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93165392|NCT02318836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93165393|NCT02318836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165394|NCT02318836|Sensory System Agents|sensory system agents|mesh-ancestor
93165395|NCT02318836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165396|NCT02318836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93165397|NCT02318836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93165398|NCT02318836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93165399|NCT02318836|Adrenergic Agents|adrenergic agents|mesh-ancestor
93165400|NCT02318836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165401|NCT02318836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165402|NCT01352312|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93165403|NCT01352312|Ofatumumab|ofatumumab|mesh-list
93165404|NCT01352312|Pentostatin|pentostatin|mesh-list
93165405|NCT01352312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93165406|NCT01352312|Alkylating Agents|alkylating agents|mesh-ancestor
93165407|NCT01352312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165408|NCT01352312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165409|NCT01352312|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93165410|NCT01352312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165411|NCT02939209|Hydromorphone|hydromorphone|mesh-list
93165412|NCT02939209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93165413|NCT02939209|Narcotics|narcotics|mesh-ancestor
93165414|NCT02939209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165415|NCT02939209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165416|NCT02939209|Analgesics|analgesics|mesh-ancestor
93165417|NCT02939209|Sensory System Agents|sensory system agents|mesh-ancestor
93165418|NCT02939209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165419|NCT01141855|Varenicline|varenicline|mesh-list
93165420|NCT01141855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93165421|NCT01141855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93165422|NCT01141855|Cholinergic Agents|cholinergic agents|mesh-ancestor
93165423|NCT01141855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165424|NCT01141855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165425|NCT01141855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165426|NCT01236859|Gabapentin|gabapentin|mesh-list
93165427|NCT01236859|Analgesics|analgesics|mesh-ancestor
93165428|NCT01236859|Sensory System Agents|sensory system agents|mesh-ancestor
93165429|NCT01236859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165430|NCT01236859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165431|NCT01236859|Anticonvulsants|anticonvulsants|mesh-ancestor
93165432|NCT01236859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93165433|NCT01236859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93165434|NCT01236859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165435|NCT01236859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93165436|NCT01236859|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93165437|NCT01236859|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93165438|NCT01236859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165439|NCT01236859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165440|NCT01236859|Antimanic Agents|antimanic agents|mesh-ancestor
93165441|NCT01145365|Anesthetics|anesthetics|mesh-list
93165442|NCT01145365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165443|NCT01145365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165444|NCT04967092|Anti-Allergic Agents|anti-allergic agents|mesh-list
93165445|NCT01365104|Deferoxamine|deferoxamine|mesh-list
93165446|NCT01365104|Siderophores|siderophores|mesh-ancestor
93165447|NCT01365104|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93165448|NCT01365104|Chelating Agents|chelating agents|mesh-ancestor
93165449|NCT01365104|Sequestering Agents|sequestering agents|mesh-ancestor
93165450|NCT01365104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165451|NCT03492970|Melatonin|melatonin|mesh-list
93165452|NCT03492970|Antioxidants|antioxidants|mesh-ancestor
93165453|NCT03492970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165454|NCT03492970|Protective Agents|protective agents|mesh-ancestor
93165455|NCT03492970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165456|NCT03492970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165457|NCT01362374|Leucovorin|leucovorin|mesh-list
93165458|NCT01362374|Paclitaxel|paclitaxel|mesh-list
93165459|NCT01362374|Docetaxel|docetaxel|mesh-list
93165460|NCT01362374|Oxaliplatin|oxaliplatin|mesh-list
93165461|NCT01362374|Ipatasertib|ipatasertib|mesh-list
93165462|NCT01362374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93165463|NCT01362374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165464|NCT01362374|Tubulin Modulators|tubulin modulators|mesh-ancestor
93165465|NCT01362374|Antimitotic Agents|antimitotic agents|mesh-ancestor
93165466|NCT01362374|Mitosis Modulators|mitosis modulators|mesh-ancestor
93165467|NCT01362374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165468|NCT01362374|Antidotes|antidotes|mesh-ancestor
93165469|NCT01362374|Protective Agents|protective agents|mesh-ancestor
93165470|NCT01362374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165471|NCT01362374|Vitamin B Complex|vitamin b complex|mesh-ancestor
93165472|NCT01362374|Vitamins|vitamins|mesh-ancestor
93165473|NCT01362374|Micronutrients|micronutrients|mesh-ancestor
93165474|NCT01362374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93165475|NCT01362374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165476|NCT01142011|Belimumab|belimumab|mesh-list
93165477|NCT01142011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165478|NCT01142011|Immunologic Factors|immunologic factors|mesh-ancestor
93165479|NCT01142011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165480|NCT02319460|Thrombin|thrombin|mesh-list
93165481|NCT02319460|Hemostatics|hemostatics|mesh-ancestor
93165482|NCT02319460|Coagulants|coagulants|mesh-ancestor
93165483|NCT04722952|Cytarabine|cytarabine|mesh-list
93165484|NCT04722952|Azacitidine|azacitidine|mesh-list
93165485|NCT04722952|Homoharringtonine|homoharringtonine|mesh-list
93165486|NCT04722952|Visilizumab|visilizumab|mesh-list
93165487|NCT04722952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93165488|NCT04722952|Antimetabolites|antimetabolites|mesh-ancestor
93165489|NCT04722952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165490|NCT04722952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165491|NCT04722952|Antiviral Agents|antiviral agents|mesh-ancestor
93165492|NCT04722952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165493|NCT04722952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165494|NCT04722952|Immunologic Factors|immunologic factors|mesh-ancestor
93165495|NCT04722952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165496|NCT04722952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165497|NCT04722952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93165498|NCT04722952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93165499|NCT01365260|Hyaluronic Acid|hyaluronic acid|mesh-list
93165500|NCT01365260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93165501|NCT01365260|Immunologic Factors|immunologic factors|mesh-ancestor
93165502|NCT01365260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165503|NCT01365260|Viscosupplements|viscosupplements|mesh-ancestor
93165504|NCT01365260|Protective Agents|protective agents|mesh-ancestor
93165505|NCT01235455|Interferons|interferons|mesh-list
93165506|NCT01235455|Interferon-beta|interferon-beta|mesh-list
93165507|NCT01235455|Interferon beta-1b|interferon beta-1b|mesh-list
93165508|NCT01235455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165509|NCT01235455|Antiviral Agents|antiviral agents|mesh-ancestor
93165510|NCT01235455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165511|NCT01235455|Immunologic Factors|immunologic factors|mesh-ancestor
93165512|NCT01235455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165513|NCT01235455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93165515|NCT01145677|Anticonvulsants|anticonvulsants|mesh-ancestor
93165516|NCT01145677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93165517|NCT01145677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165518|NCT02319616|Clobetasol|clobetasol|mesh-list
93165519|NCT02319616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165520|NCT02319616|Glucocorticoids|glucocorticoids|mesh-ancestor
93165521|NCT02319616|Hormones|hormones|mesh-ancestor
93165522|NCT02319616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165523|NCT02319616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165524|NCT01142245|Esomeprazole|esomeprazole|mesh-list
93165525|NCT01142245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93165526|NCT01142245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165527|NCT01142245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93165528|NCT01142245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165529|NCT01142245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165530|NCT02319772|Galidesivir|galidesivir|mesh-list
93165531|NCT02319772|Antiviral Agents|antiviral agents|mesh-ancestor
93165532|NCT02319772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165533|NCT03499132|Anesthetics|anesthetics|mesh-list
93165534|NCT03499132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165535|NCT03499132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165536|NCT01142401|Bortezomib|bortezomib|mesh-list
93165537|NCT01142401|Fulvestrant|fulvestrant|mesh-list
93165538|NCT01142401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165539|NCT01142401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93165540|NCT01142401|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93165541|NCT01142401|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93165542|NCT01142401|Hormone Antagonists|hormone antagonists|mesh-ancestor
93165543|NCT01142401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165544|NCT01142401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165545|NCT03498898|Adrenergic Agents|adrenergic agents|mesh-list
93165546|NCT03498898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165547|NCT03498898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165548|NCT03498898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165549|NCT03498820|Remifentanil|remifentanil|mesh-list
93165550|NCT03498820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93165551|NCT03498820|Narcotics|narcotics|mesh-ancestor
93165552|NCT03498820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165553|NCT03498820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165554|NCT03498820|Analgesics|analgesics|mesh-ancestor
93165555|NCT03498820|Sensory System Agents|sensory system agents|mesh-ancestor
93165556|NCT03498820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165557|NCT05158309|Capsaicin|capsaicin|mesh-list
93165558|NCT05158309|Antipruritics|antipruritics|mesh-ancestor
93165559|NCT05158309|Dermatologic Agents|dermatologic agents|mesh-ancestor
93165560|NCT05158309|Sensory System Agents|sensory system agents|mesh-ancestor
93165561|NCT05158309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165562|NCT05158309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165563|NCT02320084|Nitisinone|nitisinone|mesh-list
93165564|NCT02320084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165565|NCT02320084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165566|NCT02320240|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93165567|NCT02320240|Fluvoxamine|fluvoxamine|mesh-list
93165568|NCT02320240|Citalopram|citalopram|mesh-list
93165569|NCT02320240|Fluoxetine|fluoxetine|mesh-list
93165570|NCT02320240|Paroxetine|paroxetine|mesh-list
93165571|NCT02320240|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93165572|NCT02320240|Sertraline|sertraline|mesh-list
93165573|NCT02320240|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93165574|NCT02320240|Escitalopram|escitalopram|mesh-list
93165575|NCT02320240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93165576|NCT02320240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93165577|NCT02320240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165578|NCT02320240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165579|NCT02320240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165580|NCT02320240|Serotonin Agents|serotonin agents|mesh-ancestor
93165581|NCT02320240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165582|NCT02320240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165583|NCT02320240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93165584|NCT02320240|Antidepressive Agents|antidepressive agents|mesh-ancestor
93165585|NCT02320240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837790|NCT02535273|Lidocaine|lidocaine|mesh-list
93165586|NCT02320240|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93165587|NCT02320240|Analgesics|analgesics|mesh-ancestor
93165588|NCT02320240|Sensory System Agents|sensory system agents|mesh-ancestor
93165589|NCT02320240|Dopamine Agents|dopamine agents|mesh-ancestor
93165590|NCT02320240|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93165591|NCT02320240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93165592|NCT02320240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165593|NCT02320240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93165594|NCT02320240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93165595|NCT02320240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165596|NCT02320240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93165597|NCT02320240|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93165598|NCT03492736|Melatonin|melatonin|mesh-list
93165599|NCT03492736|Antioxidants|antioxidants|mesh-ancestor
93165600|NCT03492736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165601|NCT03492736|Protective Agents|protective agents|mesh-ancestor
93165602|NCT03492736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165603|NCT03492736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165604|NCT02320474|Aflibercept|aflibercept|mesh-list
93165605|NCT02320474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93165606|NCT02320474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93165607|NCT02320474|Growth Substances|growth substances|mesh-ancestor
93165608|NCT02320474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165609|NCT02320474|Growth Inhibitors|growth inhibitors|mesh-ancestor
93165610|NCT02320474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165611|NCT03492580|Dapagliflozin|dapagliflozin|mesh-list
93165612|NCT03492580|Empagliflozin|empagliflozin|mesh-list
93165613|NCT03492580|Canagliflozin|canagliflozin|mesh-list
93165614|NCT03492580|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93165615|NCT03492580|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93165616|NCT03492580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93165617|NCT03492580|Glucagon|glucagon|mesh-list
93165618|NCT03492580|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93165619|NCT03492580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165620|NCT03492580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93165621|NCT03492580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165622|NCT03492580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165623|NCT03492580|Hormones|hormones|mesh-ancestor
93165624|NCT03492580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165625|NCT03492580|Incretins|incretins|mesh-ancestor
93165626|NCT03492580|Protease Inhibitors|protease inhibitors|mesh-ancestor
93165627|NCT03492580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165628|NCT01238965|Calcium, Dietary|calcium, dietary|mesh-list
93165629|NCT01238965|Leucovorin|leucovorin|mesh-list
93165630|NCT01238965|Fluorouracil|fluorouracil|mesh-list
93165631|NCT01238965|Panobinostat|panobinostat|mesh-list
93165632|NCT01238965|Calcium|calcium|mesh-list
93165633|NCT01238965|Levoleucovorin|levoleucovorin|mesh-list
93165634|NCT01238965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93165635|NCT01238965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93165636|NCT01238965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165637|NCT01238965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93165638|NCT01238965|Antimetabolites|antimetabolites|mesh-ancestor
93165639|NCT01238965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165640|NCT01238965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93165641|NCT01238965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165642|NCT01238965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165643|NCT01238965|Immunologic Factors|immunologic factors|mesh-ancestor
93165644|NCT01238965|Antidotes|antidotes|mesh-ancestor
93165645|NCT01238965|Protective Agents|protective agents|mesh-ancestor
93165646|NCT01238965|Vitamin B Complex|vitamin b complex|mesh-ancestor
93165647|NCT01238965|Vitamins|vitamins|mesh-ancestor
93165648|NCT01238965|Micronutrients|micronutrients|mesh-ancestor
93165649|NCT01238965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165650|NCT01142557|Interferons|interferons|mesh-list
93165651|NCT01142557|Interferon-beta|interferon-beta|mesh-list
93165652|NCT01142557|Interferon beta-1a|interferon beta-1a|mesh-list
93165653|NCT01142557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165654|NCT01142557|Antiviral Agents|antiviral agents|mesh-ancestor
93165655|NCT01142557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165656|NCT01142557|Immunologic Factors|immunologic factors|mesh-ancestor
93165657|NCT01142557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165658|NCT01142557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93165659|NCT04496908|Misoprostol|misoprostol|mesh-list
93165660|NCT04496908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93165661|NCT04496908|Abortifacient Agents|abortifacient agents|mesh-ancestor
93165662|NCT04496908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93165663|NCT04496908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165664|NCT04496908|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93165665|NCT04496908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165666|NCT04496908|Oxytocics|oxytocics|mesh-ancestor
93165667|NCT01144117|Epoetin Alfa|epoetin alfa|mesh-list
93165668|NCT01144117|Hematinics|hematinics|mesh-ancestor
93165670|NCT04371640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93165671|NCT04371640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165672|NCT04371640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93165673|NCT04371640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165674|NCT04371640|Antifungal Agents|antifungal agents|mesh-ancestor
93165675|NCT04371640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165676|NCT04371640|Immunologic Factors|immunologic factors|mesh-ancestor
93165677|NCT04371640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165678|NCT04356196|Verapamil|verapamil|mesh-list
93165679|NCT04356196|Bisoprolol|bisoprolol|mesh-list
93165680|NCT04356196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93165681|NCT04356196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93165682|NCT04356196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165683|NCT04356196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165684|NCT04356196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93165685|NCT04356196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165686|NCT04356196|Vasodilator Agents|vasodilator agents|mesh-ancestor
93165687|NCT04356196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93165688|NCT04356196|Sympatholytics|sympatholytics|mesh-ancestor
93165689|NCT04356196|Autonomic Agents|autonomic agents|mesh-ancestor
93165690|NCT04356196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165691|NCT04356196|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93165692|NCT04356196|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93165693|NCT04356196|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93165694|NCT04356196|Adrenergic Agents|adrenergic agents|mesh-ancestor
93165695|NCT04356196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165696|NCT02115139|Ipilimumab|ipilimumab|mesh-list
93165697|NCT02115139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165698|NCT02115139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165699|NCT02115139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93165700|NCT02115139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165701|NCT02047981|Azithromycin|azithromycin|mesh-list
93165702|NCT02047981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93165703|NCT02047981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165704|NCT04802356|Dexamethasone|dexamethasone|mesh-list
93165705|NCT04802356|Lenalidomide|lenalidomide|mesh-list
93165706|NCT04802356|Bortezomib|bortezomib|mesh-list
93165707|NCT04802356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165708|NCT04802356|Antiemetics|antiemetics|mesh-ancestor
93165709|NCT04802356|Autonomic Agents|autonomic agents|mesh-ancestor
93165710|NCT04802356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165711|NCT04802356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165712|NCT04802356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165713|NCT04802356|Glucocorticoids|glucocorticoids|mesh-ancestor
93165714|NCT04802356|Hormones|hormones|mesh-ancestor
93165715|NCT04802356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165716|NCT04802356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93165717|NCT04802356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165718|NCT04802356|Immunologic Factors|immunologic factors|mesh-ancestor
93165719|NCT04802356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93165720|NCT04802356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93165721|NCT04802356|Growth Substances|growth substances|mesh-ancestor
93165722|NCT04802356|Growth Inhibitors|growth inhibitors|mesh-ancestor
93165723|NCT01142635|Bromides|bromides|mesh-list
93165724|NCT01142635|Rocuronium|rocuronium|mesh-list
93165725|NCT01142635|Anticonvulsants|anticonvulsants|mesh-ancestor
93165726|NCT01142635|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93165727|NCT01142635|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93165728|NCT01142635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93165729|NCT01142635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165730|NCT01142635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165731|NCT01144195|Panitumumab|panitumumab|mesh-list
93165732|NCT01144195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165733|NCT01144195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165734|NCT05631769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93165735|NCT02528383|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93165736|NCT02528383|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92837925|NCT00929708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93165737|NCT02528383|Estradiol|estradiol|mesh-list
93165738|NCT02528383|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93165739|NCT02528383|Estrogens|estrogens|mesh-ancestor
93165740|NCT02528383|Hormones|hormones|mesh-ancestor
93165741|NCT02528383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165742|NCT02528383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165743|NCT02528383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93165744|NCT02528383|Contraceptive Agents|contraceptive agents|mesh-ancestor
93165745|NCT02528383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93165746|NCT02528383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93165747|NCT01146067|Rivastigmine|rivastigmine|mesh-list
93165748|NCT01146067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93165749|NCT01146067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165750|NCT01146067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165751|NCT01146067|Cholinergic Agents|cholinergic agents|mesh-ancestor
93165752|NCT01146067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165753|NCT01146067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165754|NCT01146067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93165755|NCT01146067|Protective Agents|protective agents|mesh-ancestor
93165756|NCT01237249|Dexamethasone|dexamethasone|mesh-list
93165757|NCT01237249|Prednisone|prednisone|mesh-list
93165758|NCT01237249|Melphalan|melphalan|mesh-list
93165759|NCT01237249|Lenalidomide|lenalidomide|mesh-list
93165760|NCT01237249|Bortezomib|bortezomib|mesh-list
93165761|NCT01237249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165762|NCT01237249|Antiemetics|antiemetics|mesh-ancestor
93165763|NCT01237249|Autonomic Agents|autonomic agents|mesh-ancestor
93165764|NCT01237249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165765|NCT01237249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165766|NCT01237249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165767|NCT01237249|Glucocorticoids|glucocorticoids|mesh-ancestor
93165768|NCT01237249|Hormones|hormones|mesh-ancestor
93165769|NCT01237249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165770|NCT01237249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93165771|NCT01237249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165772|NCT01237249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93165773|NCT01237249|Alkylating Agents|alkylating agents|mesh-ancestor
93165774|NCT01237249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165775|NCT01237249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93165776|NCT01237249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165777|NCT01237249|Immunologic Factors|immunologic factors|mesh-ancestor
93165778|NCT01237249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93165779|NCT01237249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93165780|NCT01237249|Growth Substances|growth substances|mesh-ancestor
93165781|NCT01237249|Growth Inhibitors|growth inhibitors|mesh-ancestor
93165782|NCT03646162|Zuclomiphene|zuclomiphene|mesh-list
93165783|NCT03646162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93165784|NCT03646162|Hormone Antagonists|hormone antagonists|mesh-ancestor
93165785|NCT03646162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165786|NCT03646162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165787|NCT03646162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93165788|NCT03646162|Fertility Agents|fertility agents|mesh-ancestor
93165789|NCT03646162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93165790|NCT03646162|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93165791|NCT03646162|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93165792|NCT01244347|Folic Acid|folic acid|mesh-list
93165793|NCT01244347|Vitamin B Complex|vitamin b complex|mesh-list
93165794|NCT01244347|Hematinics|hematinics|mesh-ancestor
93165795|NCT01244347|Vitamins|vitamins|mesh-ancestor
93165796|NCT01244347|Micronutrients|micronutrients|mesh-ancestor
93165797|NCT01244347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165798|NCT01763827|Ezetimibe|ezetimibe|mesh-list
93165799|NCT01763827|Evolocumab|evolocumab|mesh-list
93165800|NCT01763827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93165801|NCT01763827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93165802|NCT01763827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93165803|NCT01763827|Antimetabolites|antimetabolites|mesh-ancestor
93165804|NCT01763827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165805|NCT01763827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93165806|NCT01763827|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93165807|NCT01763827|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93165808|NCT01763827|Protease Inhibitors|protease inhibitors|mesh-ancestor
93165809|NCT01763827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165810|NCT01763827|Immunologic Factors|immunologic factors|mesh-ancestor
93165811|NCT01763827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165812|NCT01146145|Ketamine|ketamine|mesh-list
93165813|NCT01146145|Morphine|morphine|mesh-list
93165814|NCT01146145|Analgesics|analgesics|mesh-ancestor
92838003|NCT00789763|Gemcitabine|gemcitabine|mesh-list
93165816|NCT01146145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165817|NCT01146145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165818|NCT01146145|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93165819|NCT01146145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93165820|NCT01146145|Anesthetics, General|anesthetics, general|mesh-ancestor
93165821|NCT01146145|Anesthetics|anesthetics|mesh-ancestor
93165822|NCT01146145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165823|NCT01146145|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93165824|NCT01146145|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93165825|NCT01146145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165826|NCT01146145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165827|NCT01146145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93165828|NCT01146145|Narcotics|narcotics|mesh-ancestor
93165829|NCT01146535|Interferons|interferons|mesh-list
93165830|NCT01146535|Interferon-alpha|interferon-alpha|mesh-list
93165831|NCT01146535|Oseltamivir|oseltamivir|mesh-list
93165832|NCT01146535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165833|NCT01146535|Antiviral Agents|antiviral agents|mesh-ancestor
93165834|NCT01146535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165835|NCT01146535|Immunologic Factors|immunologic factors|mesh-ancestor
93165836|NCT01146535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165837|NCT01146535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165838|NCT01146535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165839|NCT01732783|Panitumumab|panitumumab|mesh-list
93165840|NCT01732783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165841|NCT01732783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165842|NCT04355728|Heparin|heparin|mesh-list
93165843|NCT04355728|Calcium heparin|calcium heparin|mesh-list
93165844|NCT04355728|Anticoagulants|anticoagulants|mesh-ancestor
93165845|NCT04355728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93165846|NCT04355728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93165847|NCT04355728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165848|NCT01693783|Ipilimumab|ipilimumab|mesh-list
93165849|NCT01693783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165850|NCT01693783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165851|NCT01693783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93165852|NCT01693783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165853|NCT02528461|Sofosbuvir|sofosbuvir|mesh-list
93165854|NCT02528461|Liver Extracts|liver extracts|mesh-list
93165855|NCT02528461|Hematinics|hematinics|mesh-ancestor
93165856|NCT02528461|Antiviral Agents|antiviral agents|mesh-ancestor
93165857|NCT02528461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93165858|NCT01237483|Cetuximab|cetuximab|mesh-list
93165859|NCT01237483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165860|NCT01237483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165861|NCT01240213|Vitamin D|vitamin d|mesh-list
93165862|NCT01240213|Vitamins|vitamins|mesh-ancestor
93165863|NCT01240213|Micronutrients|micronutrients|mesh-ancestor
93165864|NCT01240213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165865|NCT01240213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93165866|NCT01375777|Ezetimibe|ezetimibe|mesh-list
93165867|NCT01375777|Evolocumab|evolocumab|mesh-list
93165868|NCT01375777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93165869|NCT01375777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93165870|NCT01375777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93165871|NCT01375777|Antimetabolites|antimetabolites|mesh-ancestor
93165872|NCT01375777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165873|NCT01375777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93165874|NCT01375777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93165875|NCT01375777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93165876|NCT01375777|Protease Inhibitors|protease inhibitors|mesh-ancestor
93165877|NCT01375777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165878|NCT01375777|Immunologic Factors|immunologic factors|mesh-ancestor
93165879|NCT01375777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165880|NCT02431702|Haloperidol|haloperidol|mesh-list
93165881|NCT02431702|Olanzapine|olanzapine|mesh-list
93165882|NCT02431702|Risperidone|risperidone|mesh-list
93165883|NCT02431702|Aripiprazole|aripiprazole|mesh-list
93165884|NCT02431702|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93165885|NCT02431702|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93165886|NCT02431702|Haloperidol decanoate|haloperidol decanoate|mesh-list
93165887|NCT02431702|Perphenazine|perphenazine|mesh-list
93165888|NCT02431702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93165889|NCT02431702|Serotonin Agents|serotonin agents|mesh-ancestor
93165890|NCT02431702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165891|NCT02431702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165892|NCT02431702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165893|NCT02431702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93165894|NCT02431702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93165895|NCT02431702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165896|NCT02431702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93165897|NCT02431702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93165898|NCT02431702|Dopamine Agents|dopamine agents|mesh-ancestor
93165899|NCT02431702|Antiemetics|antiemetics|mesh-ancestor
93165900|NCT02431702|Autonomic Agents|autonomic agents|mesh-ancestor
93165901|NCT02431702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165902|NCT02431702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93165903|NCT02431702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93165904|NCT02431702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93165905|NCT02431702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93165906|NCT02431702|Antidepressive Agents|antidepressive agents|mesh-ancestor
93165907|NCT02431702|Dopamine Agonists|dopamine agonists|mesh-ancestor
93165908|NCT02431702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93165909|NCT02431702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93165910|NCT02431702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93165911|NCT02431702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93165912|NCT02431702|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93165913|NCT01145209|Cyclophosphamide|cyclophosphamide|mesh-list
93165914|NCT01145209|Fludarabine|fludarabine|mesh-list
93165915|NCT01145209|Fludarabine phosphate|fludarabine phosphate|mesh-list
93165916|NCT01145209|Ofatumumab|ofatumumab|mesh-list
93165917|NCT01145209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165918|NCT01145209|Immunologic Factors|immunologic factors|mesh-ancestor
93165919|NCT01145209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165920|NCT01145209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93165921|NCT01145209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93165922|NCT01145209|Alkylating Agents|alkylating agents|mesh-ancestor
93165923|NCT01145209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165924|NCT01145209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165925|NCT01145209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93165926|NCT01145209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93165927|NCT01145209|Antimetabolites|antimetabolites|mesh-ancestor
93165928|NCT02086552|Lenalidomide|lenalidomide|mesh-list
93165929|NCT02086552|Immunologic Factors|immunologic factors|mesh-ancestor
93165930|NCT02086552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165931|NCT02086552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93165932|NCT02086552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93165933|NCT02086552|Growth Substances|growth substances|mesh-ancestor
93165934|NCT02086552|Growth Inhibitors|growth inhibitors|mesh-ancestor
93165935|NCT02086552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165936|NCT02321878|Liraglutide|liraglutide|mesh-list
93165937|NCT02321878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93165938|NCT02321878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165939|NCT02321878|Incretins|incretins|mesh-ancestor
93165940|NCT02321878|Hormones|hormones|mesh-ancestor
93165941|NCT02321878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93165942|NCT03625141|Atezolizumab|atezolizumab|mesh-list
93165943|NCT03625141|Vemurafenib|vemurafenib|mesh-list
93165944|NCT03625141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93165945|NCT03625141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165946|NCT03625141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93165947|NCT03625141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165948|NCT03625141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93165949|NCT03625141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165950|NCT03491410|Aspirin|aspirin|mesh-list
93165951|NCT03491410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93165952|NCT03491410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93165953|NCT03491410|Analgesics|analgesics|mesh-ancestor
93165954|NCT03491410|Sensory System Agents|sensory system agents|mesh-ancestor
93165955|NCT03491410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165956|NCT03491410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165957|NCT03491410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93165958|NCT03491410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93165959|NCT03491410|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93165960|NCT03491410|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93165961|NCT03491410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165962|NCT03491410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93165963|NCT03491410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93165964|NCT03491410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165965|NCT03491410|Antipyretics|antipyretics|mesh-ancestor
93165966|NCT00876031|Etoposide|etoposide|mesh-list
93165967|NCT00876031|Idarubicin|idarubicin|mesh-list
93165968|NCT00876031|Trofosfamide|trofosfamide|mesh-list
93165969|NCT00876031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93165970|NCT00876031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93165971|NCT00876031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93165972|NCT00876031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93165973|NCT00876031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93165974|NCT00876031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165975|NCT00876031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93165976|NCT00876031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93165977|NCT00876031|Immunologic Factors|immunologic factors|mesh-ancestor
93165978|NCT00876031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165979|NCT00876031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93165980|NCT00876031|Alkylating Agents|alkylating agents|mesh-ancestor
93165981|NCT02322346|Levobupivacaine|levobupivacaine|mesh-list
93165982|NCT02322346|Anesthetics, Local|anesthetics, local|mesh-ancestor
93165983|NCT02322346|Anesthetics|anesthetics|mesh-ancestor
93165984|NCT02322346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93165985|NCT02322346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165986|NCT02322346|Sensory System Agents|sensory system agents|mesh-ancestor
93165987|NCT02322346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93165988|NCT01146301|Clopidogrel|clopidogrel|mesh-list
93165989|NCT01146301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93165990|NCT01146301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93165991|NCT01146301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93165992|NCT01146301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93165993|NCT01146301|Purinergic Agents|purinergic agents|mesh-ancestor
93165994|NCT01146301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93165995|NCT01146301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93165996|NCT01146301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93165997|NCT00807859|Paclitaxel|paclitaxel|mesh-list
93165998|NCT00807859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93165999|NCT00807859|Capecitabine|capecitabine|mesh-list
93166000|NCT00807859|Trastuzumab|trastuzumab|mesh-list
93166001|NCT00807859|Lapatinib|lapatinib|mesh-list
93166002|NCT00807859|Trebananib|trebananib|mesh-list
93166003|NCT00807859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93166004|NCT00807859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166005|NCT00807859|Tubulin Modulators|tubulin modulators|mesh-ancestor
93166006|NCT00807859|Antimitotic Agents|antimitotic agents|mesh-ancestor
93166007|NCT00807859|Mitosis Modulators|mitosis modulators|mesh-ancestor
93166008|NCT00807859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166009|NCT00807859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93166010|NCT00807859|Antimetabolites|antimetabolites|mesh-ancestor
93166011|NCT00807859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166012|NCT00807859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93166013|NCT00807859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166014|NCT00807859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93166015|NCT00807859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93166016|NCT00807859|Growth Substances|growth substances|mesh-ancestor
93166017|NCT00807859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166018|NCT00807859|Growth Inhibitors|growth inhibitors|mesh-ancestor
93166019|NCT01246453|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93166020|NCT01246453|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93166021|NCT01246453|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93166022|NCT01246453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166023|NCT03491098|Mometasone Furoate|mometasone furoate|mesh-list
93166024|NCT03491098|Prednisolone|prednisolone|mesh-list
93166025|NCT03491098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93166026|NCT03491098|Methylprednisolone|methylprednisolone|mesh-list
93166027|NCT03491098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93166028|NCT03491098|Prednisolone acetate|prednisolone acetate|mesh-list
93166029|NCT03491098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93166030|NCT03491098|Prednisolone phosphate|prednisolone phosphate|mesh-list
93166031|NCT03491098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166032|NCT03491098|Glucocorticoids|glucocorticoids|mesh-ancestor
93166033|NCT03491098|Hormones|hormones|mesh-ancestor
93166034|NCT03491098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166035|NCT03491098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166036|NCT03491098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93166037|NCT03491098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166038|NCT03491098|Antiemetics|antiemetics|mesh-ancestor
93166039|NCT03491098|Autonomic Agents|autonomic agents|mesh-ancestor
92838225|NCT04031703|Paclitaxel|paclitaxel|mesh-list
93166040|NCT03491098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166041|NCT03491098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166042|NCT03491098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93166044|NCT03491098|Dermatologic Agents|dermatologic agents|mesh-ancestor
93166045|NCT03491098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93166046|NCT02322502|Propofol|propofol|mesh-list
93166047|NCT02322502|Sevoflurane|sevoflurane|mesh-list
93166048|NCT02322502|Desflurane|desflurane|mesh-list
93166049|NCT02322502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93166050|NCT02322502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166051|NCT02322502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166052|NCT02322502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93166053|NCT02322502|Anesthetics, General|anesthetics, general|mesh-ancestor
93166054|NCT02322502|Anesthetics|anesthetics|mesh-ancestor
93166055|NCT02322502|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166056|NCT02322502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93166057|NCT02322580|Etanercept|etanercept|mesh-list
93166058|NCT02322580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93166059|NCT02322580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166060|NCT02322580|Analgesics|analgesics|mesh-ancestor
93166061|NCT02322580|Sensory System Agents|sensory system agents|mesh-ancestor
93166062|NCT02322580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166063|NCT02322580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166064|NCT02322580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166065|NCT02322580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166066|NCT02322580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166067|NCT02322580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166068|NCT02322580|Immunologic Factors|immunologic factors|mesh-ancestor
93166069|NCT03190174|Sirolimus|sirolimus|mesh-list
93166070|NCT03190174|Nivolumab|nivolumab|mesh-list
93166071|NCT03190174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166072|NCT03190174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166073|NCT03190174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93166074|NCT03190174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166075|NCT03190174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93166076|NCT03190174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166077|NCT03190174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93166078|NCT03190174|Antifungal Agents|antifungal agents|mesh-ancestor
93166079|NCT03190174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166080|NCT03190174|Immunologic Factors|immunologic factors|mesh-ancestor
93166081|NCT03190174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166082|NCT03490708|Tranilast|tranilast|mesh-list
93166083|NCT03490708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93166084|NCT03490708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166085|NCT03490708|Analgesics|analgesics|mesh-ancestor
93166086|NCT03490708|Sensory System Agents|sensory system agents|mesh-ancestor
93166087|NCT03490708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166088|NCT03490708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166089|NCT03490708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166090|NCT03490708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166091|NCT03490708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93166092|NCT03490708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166093|NCT03490708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166094|NCT03490708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93166095|NCT03490708|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93166096|NCT03490708|Histamine Antagonists|histamine antagonists|mesh-ancestor
93166097|NCT03490708|Histamine Agents|histamine agents|mesh-ancestor
93166098|NCT03490708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166099|NCT03490708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166100|NCT03490708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93166101|NCT00924326|Vidarabine|vidarabine|mesh-list
93166102|NCT00924326|Aldesleukin|aldesleukin|mesh-list
93166103|NCT00924326|Cyclophosphamide|cyclophosphamide|mesh-list
93166104|NCT00924326|Fludarabine|fludarabine|mesh-list
93166105|NCT00924326|Fludarabine phosphate|fludarabine phosphate|mesh-list
93166106|NCT00924326|Interleukin-2|interleukin-2|mesh-list
93166107|NCT00924326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166108|NCT00924326|Immunologic Factors|immunologic factors|mesh-ancestor
93166109|NCT00924326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166110|NCT00924326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166111|NCT00924326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93166112|NCT00924326|Alkylating Agents|alkylating agents|mesh-ancestor
93166113|NCT00924326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166114|NCT00924326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166115|NCT00924326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93166116|NCT00924326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93166117|NCT00924326|Antimetabolites|antimetabolites|mesh-ancestor
93166118|NCT00924326|Antiviral Agents|antiviral agents|mesh-ancestor
93166119|NCT00924326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166120|NCT00924326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166121|NCT00924326|Analgesics|analgesics|mesh-ancestor
93166122|NCT00924326|Sensory System Agents|sensory system agents|mesh-ancestor
93166123|NCT00924326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166124|NCT00924326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93166125|NCT00924326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93166126|NCT03496870|Levodopa|levodopa|mesh-list
93166127|NCT03496870|Carbidopa|carbidopa|mesh-list
93166128|NCT03496870|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93166129|NCT03496870|Opicapone|opicapone|mesh-list
93166130|NCT03496870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93166131|NCT03496870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93166132|NCT03496870|Dopamine Agents|dopamine agents|mesh-ancestor
93166133|NCT03496870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166134|NCT03496870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166135|NCT03496870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166136|NCT03496870|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93166137|NCT03496870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166138|NCT03496870|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93166139|NCT03496870|Immunologic Factors|immunologic factors|mesh-ancestor
93166140|NCT03496870|Dopamine Agonists|dopamine agonists|mesh-ancestor
93166141|NCT03496870|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93166142|NCT01370096|Epoprostenol|epoprostenol|mesh-list
93166143|NCT01370096|Vasopressins|vasopressins|mesh-list
93166144|NCT01370096|Arginine Vasopressin|arginine vasopressin|mesh-list
93166145|NCT01370096|Tezosentan|tezosentan|mesh-list
93166146|NCT01370096|Hemostatics|hemostatics|mesh-ancestor
93166147|NCT01370096|Coagulants|coagulants|mesh-ancestor
93166148|NCT01370096|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93166149|NCT01370096|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93166150|NCT01370096|Natriuretic Agents|natriuretic agents|mesh-ancestor
93166151|NCT01370096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166152|NCT01370096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166153|NCT01370096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166154|NCT01370096|Vasodilator Agents|vasodilator agents|mesh-ancestor
93166155|NCT03131570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93166156|NCT03131570|Immunologic Factors|immunologic factors|mesh-ancestor
93166157|NCT03131570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166158|NCT01370876|Oxaliplatin|oxaliplatin|mesh-list
93166159|NCT01370876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166160|NCT02875028|Vorapaxar|vorapaxar|mesh-list
93166161|NCT02875028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166162|NCT01371344|Tacrolimus|tacrolimus|mesh-list
93166163|NCT01371344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166164|NCT01371344|Immunologic Factors|immunologic factors|mesh-ancestor
93166165|NCT01371344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166166|NCT01371344|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93166167|NCT01371344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166168|NCT01371344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166169|NCT03631004|Olanzapine|olanzapine|mesh-list
93166170|NCT03631004|Antiemetics|antiemetics|mesh-ancestor
93166171|NCT03631004|Autonomic Agents|autonomic agents|mesh-ancestor
93166172|NCT03631004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166173|NCT03631004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166174|NCT03631004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166175|NCT03631004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93166176|NCT03631004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92855081|NCT00783705|Inositol|inositol|mesh-list
93166177|NCT03631004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166178|NCT03631004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93166179|NCT03631004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93166180|NCT03631004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93166181|NCT03631004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166182|NCT03631004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166183|NCT03631004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166184|NCT03631004|Serotonin Agents|serotonin agents|mesh-ancestor
93166185|NCT01366118|Oxaliplatin|oxaliplatin|mesh-list
93166186|NCT01366118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166187|NCT00943618|Bupropion|bupropion|mesh-list
93166188|NCT00943618|Varenicline|varenicline|mesh-list
92838381|NCT00801151|Vinorelbine|vinorelbine|mesh-list
93166189|NCT00943618|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93166190|NCT00943618|Antidepressive Agents|antidepressive agents|mesh-ancestor
93166191|NCT00943618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93166192|NCT00943618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93166193|NCT00943618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93166194|NCT00943618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166195|NCT00943618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166196|NCT00943618|Dopamine Agents|dopamine agents|mesh-ancestor
93166197|NCT00943618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166198|NCT00943618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166199|NCT00943618|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93166200|NCT00943618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93166201|NCT00943618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166202|NCT00943618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93166203|NCT00943618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93166204|NCT00943618|Cholinergic Agents|cholinergic agents|mesh-ancestor
93166205|NCT01372670|Hydroxyzine|hydroxyzine|mesh-list
93166206|NCT01372670|Antipruritics|antipruritics|mesh-ancestor
93166207|NCT01372670|Dermatologic Agents|dermatologic agents|mesh-ancestor
93166208|NCT01372670|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93166209|NCT01372670|Histamine Antagonists|histamine antagonists|mesh-ancestor
93166210|NCT01372670|Histamine Agents|histamine agents|mesh-ancestor
93166211|NCT01372670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166212|NCT01372670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166213|NCT01372670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166214|NCT02322658|Eszopiclone|eszopiclone|mesh-list
93166215|NCT02322658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93166216|NCT02322658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166217|NCT02322658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166218|NCT04218656|Rivaroxaban|rivaroxaban|mesh-list
93166219|NCT04218656|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93166220|NCT04218656|Antithrombins|antithrombins|mesh-ancestor
93166221|NCT04218656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93166222|NCT04218656|Protease Inhibitors|protease inhibitors|mesh-ancestor
93166223|NCT04218656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166224|NCT04218656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166225|NCT04218656|Anticoagulants|anticoagulants|mesh-ancestor
93166226|NCT03229382|Obinutuzumab|obinutuzumab|mesh-list
93166227|NCT03229382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166228|NCT03229382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166229|NCT02710084|Oxytocin|oxytocin|mesh-list
93166230|NCT02710084|Oxytocics|oxytocics|mesh-ancestor
93166231|NCT02710084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166232|NCT02710084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166233|NCT02849990|Prednisone|prednisone|mesh-list
93166234|NCT02849990|Cortisone|cortisone|mesh-list
93166235|NCT02849990|Indomethacin|indomethacin|mesh-list
93166236|NCT02849990|Abiraterone Acetate|abiraterone acetate|mesh-list
93166237|NCT02849990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166238|NCT02849990|Glucocorticoids|glucocorticoids|mesh-ancestor
93166239|NCT02849990|Hormones|hormones|mesh-ancestor
93166240|NCT02849990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166241|NCT02849990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166242|NCT02849990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93166243|NCT02849990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166244|NCT02849990|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93166245|NCT02849990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462048|NCT01754792|Inositol|inositol|mesh-list
93166246|NCT02849990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166247|NCT02849990|Hormone Antagonists|hormone antagonists|mesh-ancestor
93166248|NCT02849990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93166249|NCT02849990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93166250|NCT02849990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166251|NCT02849990|Analgesics|analgesics|mesh-ancestor
93166252|NCT02849990|Sensory System Agents|sensory system agents|mesh-ancestor
93166253|NCT02849990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166254|NCT02849990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166255|NCT02849990|Gout Suppressants|gout suppressants|mesh-ancestor
93166256|NCT02849990|Tocolytic Agents|tocolytic agents|mesh-ancestor
93166257|NCT02849990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166258|NCT02849990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93166259|NCT01366352|Methylnaltrexone|methylnaltrexone|mesh-list
93166260|NCT01366352|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93166261|NCT01366352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166262|NCT01366352|Sensory System Agents|sensory system agents|mesh-ancestor
93166263|NCT01366352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166264|NCT03490396|Povidone|povidone|mesh-list
92838459|NCT00793663|Dexamethasone|dexamethasone|mesh-list
93166265|NCT03490396|Hyaluronic Acid|hyaluronic acid|mesh-list
93166266|NCT03490396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93166267|NCT03490396|Immunologic Factors|immunologic factors|mesh-ancestor
93166268|NCT03490396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166269|NCT03490396|Viscosupplements|viscosupplements|mesh-ancestor
93166270|NCT03490396|Protective Agents|protective agents|mesh-ancestor
93166271|NCT03490396|Plasma Substitutes|plasma substitutes|mesh-ancestor
93166272|NCT03490396|Blood Substitutes|blood substitutes|mesh-ancestor
93166273|NCT05136040|Bupivacaine|bupivacaine|mesh-list
93166274|NCT05136040|Anesthetics, Local|anesthetics, local|mesh-ancestor
93166275|NCT05136040|Anesthetics|anesthetics|mesh-ancestor
93166276|NCT05136040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166277|NCT05136040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166278|NCT05136040|Sensory System Agents|sensory system agents|mesh-ancestor
93166279|NCT05136040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166280|NCT03496246|Vitamin D|vitamin d|mesh-list
93166281|NCT03496246|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93166282|NCT03496246|Alfacalcidol|alfacalcidol|mesh-list
93166283|NCT03496246|Calcifediol|calcifediol|mesh-list
93166284|NCT03496246|Calcium|calcium|mesh-list
93166285|NCT03496246|Vitamins|vitamins|mesh-ancestor
93166286|NCT03496246|Micronutrients|micronutrients|mesh-ancestor
93166287|NCT03496246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166288|NCT03496246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93166289|NCT03496246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93166290|NCT02017964|Cyclophosphamide|cyclophosphamide|mesh-list
93166291|NCT02017964|Carboplatin|carboplatin|mesh-list
93166292|NCT02017964|Methotrexate|methotrexate|mesh-list
93166293|NCT02017964|Etoposide|etoposide|mesh-list
93166294|NCT02017964|Vincristine|vincristine|mesh-list
93166295|NCT02017964|Etoposide phosphate|etoposide phosphate|mesh-list
93166296|NCT02017964|Podophyllotoxin|podophyllotoxin|mesh-list
93166297|NCT02017964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166298|NCT02017964|Immunologic Factors|immunologic factors|mesh-ancestor
93166299|NCT02017964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166300|NCT02017964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166301|NCT02017964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93166302|NCT02017964|Alkylating Agents|alkylating agents|mesh-ancestor
93166303|NCT02017964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166304|NCT02017964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166305|NCT02017964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93166306|NCT02017964|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93166307|NCT02017964|Abortifacient Agents|abortifacient agents|mesh-ancestor
93166308|NCT02017964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166309|NCT02017964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93166310|NCT02017964|Antimetabolites|antimetabolites|mesh-ancestor
93166311|NCT02017964|Dermatologic Agents|dermatologic agents|mesh-ancestor
93166312|NCT02017964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166313|NCT02017964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93166314|NCT02017964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93166315|NCT02017964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93166316|NCT02017964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93166317|NCT02017964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93166318|NCT02017964|Tubulin Modulators|tubulin modulators|mesh-ancestor
93166319|NCT02017964|Antimitotic Agents|antimitotic agents|mesh-ancestor
93166320|NCT02017964|Mitosis Modulators|mitosis modulators|mesh-ancestor
93166321|NCT02017964|Keratolytic Agents|keratolytic agents|mesh-ancestor
93166322|NCT05121298|Upadacitinib|upadacitinib|mesh-list
93166323|NCT05121298|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93166324|NCT05121298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93166325|NCT05121298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166326|NCT05121298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166327|NCT05121298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166328|NCT01956110|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93166329|NCT01956110|Hormones|hormones|mesh-ancestor
93166330|NCT01956110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166331|NCT01956110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166332|NCT03489928|Misoprostol|misoprostol|mesh-list
93166333|NCT03489928|Dinoprostone|dinoprostone|mesh-list
93166334|NCT03489928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93166335|NCT03489928|Abortifacient Agents|abortifacient agents|mesh-ancestor
93166336|NCT03489928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166337|NCT03489928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166338|NCT03489928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93166339|NCT03489928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166340|NCT03489928|Oxytocics|oxytocics|mesh-ancestor
93166341|NCT02323282|Ropivacaine|ropivacaine|mesh-list
93166343|NCT02323282|Anesthetics|anesthetics|mesh-ancestor
93166344|NCT02323282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166345|NCT02323282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166346|NCT02323282|Sensory System Agents|sensory system agents|mesh-ancestor
93166347|NCT02323282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166348|NCT01802086|Lidocaine|lidocaine|mesh-list
93166349|NCT01802086|Prilocaine|prilocaine|mesh-list
93166350|NCT01802086|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93166351|NCT01802086|Anesthetics, Local|anesthetics, local|mesh-ancestor
93166352|NCT01802086|Anesthetics|anesthetics|mesh-ancestor
93166353|NCT01802086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166354|NCT01802086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166355|NCT01802086|Sensory System Agents|sensory system agents|mesh-ancestor
93166356|NCT01802086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166357|NCT01802086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93166358|NCT01802086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93166359|NCT01802086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93166360|NCT01802086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166361|NCT01802086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166362|NCT01802086|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93166363|NCT05347316|Colchicine|colchicine|mesh-list
93166364|NCT05347316|Gout Suppressants|gout suppressants|mesh-ancestor
93166365|NCT05347316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166366|NCT05347316|Tubulin Modulators|tubulin modulators|mesh-ancestor
93166367|NCT05347316|Antimitotic Agents|antimitotic agents|mesh-ancestor
93166368|NCT05347316|Mitosis Modulators|mitosis modulators|mesh-ancestor
93166369|NCT05347316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166370|NCT05347316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166371|NCT03495466|Anesthetics|anesthetics|mesh-list
93166372|NCT03495466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166373|NCT03495466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166374|NCT01372826|Naloxegol|naloxegol|mesh-list
93166375|NCT01372826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93166376|NCT01372826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166377|NCT01372826|Sensory System Agents|sensory system agents|mesh-ancestor
93166378|NCT01372826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166379|NCT01371968|Alfentanil|alfentanil|mesh-list
93166380|NCT01371968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93166381|NCT01371968|Narcotics|narcotics|mesh-ancestor
93166382|NCT01371968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166383|NCT01371968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166384|NCT01371968|Analgesics|analgesics|mesh-ancestor
93166385|NCT01371968|Sensory System Agents|sensory system agents|mesh-ancestor
93166386|NCT01371968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166387|NCT01371968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93166388|NCT01371968|Anesthetics, General|anesthetics, general|mesh-ancestor
93166389|NCT01371968|Anesthetics|anesthetics|mesh-ancestor
93166390|NCT04989322|Carboplatin|carboplatin|mesh-list
93166391|NCT04989322|Pembrolizumab|pembrolizumab|mesh-list
93166392|NCT04989322|Pemetrexed|pemetrexed|mesh-list
93166393|NCT04989322|Lenvatinib|lenvatinib|mesh-list
93166394|NCT04989322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166395|NCT04989322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166396|NCT04989322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91928464|NCT02403687|Flurbiprofen|flurbiprofen|mesh-list
93166397|NCT04989322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166398|NCT04989322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166399|NCT04989322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93166400|NCT04989322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93166401|NCT04989322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93166402|NCT01367054|Metformin|metformin|mesh-list
93166403|NCT01367054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93166404|NCT01367054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166405|NCT03634514|Hormones|hormones|mesh-list
93166406|NCT03634514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166407|NCT03634514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166408|NCT02323438|Menthol|menthol|mesh-list
93166409|NCT02323438|Nicotine|nicotine|mesh-list
93166410|NCT02323438|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93166411|NCT02323438|Autonomic Agents|autonomic agents|mesh-ancestor
93166412|NCT02323438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166413|NCT02323438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166414|NCT02323438|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93166415|NCT02323438|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93166416|NCT02323438|Cholinergic Agents|cholinergic agents|mesh-ancestor
93166417|NCT02323438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166418|NCT02323438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166419|NCT02323438|Antipruritics|antipruritics|mesh-ancestor
93166420|NCT02323438|Dermatologic Agents|dermatologic agents|mesh-ancestor
93166421|NCT01372904|Dexamethasone|dexamethasone|mesh-list
93166422|NCT01372904|Dexamethasone acetate|dexamethasone acetate|mesh-list
93166423|NCT01372904|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93166424|NCT01372904|BB 1101|bb 1101|mesh-list
93166425|NCT01372904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166426|NCT01372904|Antiemetics|antiemetics|mesh-ancestor
93166427|NCT01372904|Autonomic Agents|autonomic agents|mesh-ancestor
93166428|NCT01372904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166429|NCT01372904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166430|NCT01372904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166431|NCT01372904|Glucocorticoids|glucocorticoids|mesh-ancestor
93166432|NCT01372904|Hormones|hormones|mesh-ancestor
93166433|NCT01372904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166434|NCT01372904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93166435|NCT01372904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166436|NCT01372904|Protease Inhibitors|protease inhibitors|mesh-ancestor
93166437|NCT01372904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166438|NCT01372904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166439|NCT01372982|Letrozole|letrozole|mesh-list
93166440|NCT01372982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166441|NCT01372982|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93166442|NCT01372982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93166443|NCT01372982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166444|NCT01372982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166445|NCT01372982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93166446|NCT01372982|Hormone Antagonists|hormone antagonists|mesh-ancestor
93166447|NCT01372982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166448|NCT01372982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166449|NCT02323516|Aspirin|aspirin|mesh-list
93166450|NCT02323516|Loperamide|loperamide|mesh-list
93166451|NCT02323516|Antidiarrheals|antidiarrheals|mesh-list
93166452|NCT02323516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93166453|NCT02323516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166454|NCT02323516|Analgesics|analgesics|mesh-ancestor
93166455|NCT02323516|Sensory System Agents|sensory system agents|mesh-ancestor
93166456|NCT02323516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166457|NCT02323516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166458|NCT02323516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166459|NCT02323516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166460|NCT02323516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93166461|NCT02323516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93166462|NCT02323516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166463|NCT02323516|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166464|NCT02323516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93166465|NCT02323516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166466|NCT02323516|Antipyretics|antipyretics|mesh-ancestor
93166467|NCT02323516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166468|NCT01367210|Maraviroc|maraviroc|mesh-list
93166469|NCT01367210|Darunavir|darunavir|mesh-list
93166470|NCT01367210|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93166471|NCT01367210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93166472|NCT01367210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93166473|NCT01367210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166474|NCT01367210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93166475|NCT01367210|Antiviral Agents|antiviral agents|mesh-ancestor
93166476|NCT01367210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166477|NCT01367210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93166478|NCT01367210|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93166479|NCT01367210|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93166480|NCT01367210|Protease Inhibitors|protease inhibitors|mesh-ancestor
93166481|NCT01367210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166482|NCT02323594|Asunaprevir|asunaprevir|mesh-list
93166483|NCT02323594|Protease Inhibitors|protease inhibitors|mesh-ancestor
93166484|NCT02323594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166485|NCT02323594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166486|NCT01372280|Galantamine|galantamine|mesh-list
93166487|NCT01372280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93166488|NCT01372280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166489|NCT01372280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166490|NCT01372280|Cholinergic Agents|cholinergic agents|mesh-ancestor
93166491|NCT01372280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166493|NCT01372280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93166494|NCT01372280|Autonomic Agents|autonomic agents|mesh-ancestor
93166495|NCT01372280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166496|NCT01372280|Nootropic Agents|nootropic agents|mesh-ancestor
93166497|NCT01373060|Ipragliflozin|ipragliflozin|mesh-list
93166498|NCT01373060|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93166499|NCT01373060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166500|NCT01373060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93166501|NCT01373060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166502|NCT04742140|Magnesium Sulfate|magnesium sulfate|mesh-list
93166503|NCT04742140|Analgesics|analgesics|mesh-ancestor
93166504|NCT04742140|Sensory System Agents|sensory system agents|mesh-ancestor
93166505|NCT04742140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166506|NCT04742140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166507|NCT04742140|Anesthetics|anesthetics|mesh-ancestor
93166508|NCT04742140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166509|NCT04742140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93166510|NCT04742140|Anticonvulsants|anticonvulsants|mesh-ancestor
93166511|NCT04742140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93166512|NCT04742140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166513|NCT04742140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166514|NCT04742140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93166515|NCT04742140|Tocolytic Agents|tocolytic agents|mesh-ancestor
93166516|NCT04742140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166517|NCT04580992|Ajmaline|ajmaline|mesh-list
93166518|NCT04580992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93166519|NCT04580992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93166520|NCT04580992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93166521|NCT04580992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166522|NCT04580992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166523|NCT04590274|Azithromycin|azithromycin|mesh-list
93166524|NCT04590274|Hydroxychloroquine|hydroxychloroquine|mesh-list
93166525|NCT04590274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93166526|NCT04590274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166527|NCT04590274|Antimalarials|antimalarials|mesh-ancestor
93166528|NCT04590274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93166529|NCT04590274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93166530|NCT04590274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166531|NCT04590274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166532|NCT04590274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166533|NCT01367288|Zoledronic Acid|zoledronic acid|mesh-list
93166534|NCT01367288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93166535|NCT01367288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166536|NCT04455178|Indapamide|indapamide|mesh-list
93166537|NCT04455178|Spironolactone|spironolactone|mesh-list
93166538|NCT04455178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93166539|NCT04455178|Hormone Antagonists|hormone antagonists|mesh-ancestor
93166540|NCT04455178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166541|NCT04455178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166542|NCT04455178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93166543|NCT04455178|Diuretics|diuretics|mesh-ancestor
93166544|NCT04455178|Natriuretic Agents|natriuretic agents|mesh-ancestor
93166545|NCT04455178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166546|NCT04455178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93166547|NCT04455178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166548|NCT04455178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166549|NCT01367522|Methylnaltrexone|methylnaltrexone|mesh-list
93166550|NCT01367522|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93166551|NCT01367522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166552|NCT01367522|Sensory System Agents|sensory system agents|mesh-ancestor
93166553|NCT01367522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166554|NCT02446834|Metformin|metformin|mesh-list
93166555|NCT02446834|Acarbose|acarbose|mesh-list
93166556|NCT02446834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93166557|NCT02446834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166558|NCT02446834|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93166559|NCT02446834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166560|NCT02446834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166561|NCT03489616|Pemetrexed|pemetrexed|mesh-list
93166562|NCT03489616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166563|NCT03489616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166564|NCT03489616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166565|NCT03489616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93166566|NCT03489616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93166567|NCT02323906|Sorafenib|sorafenib|mesh-list
93166568|NCT02323906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166569|NCT02323906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93166570|NCT02323906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166571|NCT02323906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166572|NCT03116828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
93166573|NCT03116828|Anticonvulsants|anticonvulsants|mesh-ancestor
93166574|NCT03116828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93166575|NCT03116828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93166576|NCT03116828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166577|NCT03116828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166578|NCT01319942|Sorafenib|sorafenib|mesh-list
93166579|NCT01319942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166580|NCT01319942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93166581|NCT01319942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166582|NCT01319942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166583|NCT01373138|Pseudoephedrine|pseudoephedrine|mesh-list
93166584|NCT01373138|Ephedrine|ephedrine|mesh-list
93166585|NCT01373138|Desloratadine|desloratadine|mesh-list
93166586|NCT01373138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93166587|NCT01373138|Cholinergic Agents|cholinergic agents|mesh-ancestor
93166588|NCT01373138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166589|NCT01373138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166590|NCT01373138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166591|NCT01373138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93166592|NCT01373138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93166593|NCT01373138|Histamine Antagonists|histamine antagonists|mesh-ancestor
93166594|NCT01373138|Histamine Agents|histamine agents|mesh-ancestor
93166595|NCT01373138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93166596|NCT01373138|Autonomic Agents|autonomic agents|mesh-ancestor
93166597|NCT01373138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166598|NCT01373138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93166599|NCT01373138|Respiratory System Agents|respiratory system agents|mesh-ancestor
93166600|NCT01373138|Nasal Decongestants|nasal decongestants|mesh-ancestor
93166601|NCT01373138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93166602|NCT01373138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93166603|NCT01373138|Sympathomimetics|sympathomimetics|mesh-ancestor
93166604|NCT01373138|Adrenergic Agents|adrenergic agents|mesh-ancestor
93166605|NCT01373216|Exenatide|exenatide|mesh-list
93166606|NCT01373216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93166607|NCT01373216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166608|NCT01373216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93166609|NCT01373216|Incretins|incretins|mesh-ancestor
93166610|NCT01373216|Hormones|hormones|mesh-ancestor
93166611|NCT01373216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166612|NCT03487354|Misoprostol|misoprostol|mesh-list
93166613|NCT03487354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93166614|NCT03487354|Abortifacient Agents|abortifacient agents|mesh-ancestor
93166615|NCT03487354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462406|NCT01757639|Ipilimumab|ipilimumab|mesh-list
93166616|NCT03487354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166617|NCT03487354|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93166618|NCT03487354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166619|NCT03487354|Oxytocics|oxytocics|mesh-ancestor
93166620|NCT04461340|Sirolimus|sirolimus|mesh-list
93166621|NCT04461340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93166622|NCT04461340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166623|NCT04461340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93166624|NCT04461340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166625|NCT04461340|Antifungal Agents|antifungal agents|mesh-ancestor
93166626|NCT04461340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166627|NCT04461340|Immunologic Factors|immunologic factors|mesh-ancestor
93166628|NCT04461340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166629|NCT05154968|Mannitol|mannitol|mesh-list
93166630|NCT05154968|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93166631|NCT05154968|Diuretics|diuretics|mesh-ancestor
93166632|NCT05154968|Natriuretic Agents|natriuretic agents|mesh-ancestor
93166633|NCT05154968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166634|NCT01373372|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
93166635|NCT01373372|Hormones|hormones|mesh-ancestor
93166636|NCT01373372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166637|NCT01373372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166638|NCT04146142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93166639|NCT04146142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166640|NCT02324296|Cisplatin|cisplatin|mesh-list
93166641|NCT02324296|Etoposide|etoposide|mesh-list
93166642|NCT02324296|Ifosfamide|ifosfamide|mesh-list
93166643|NCT02324296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166644|NCT02324296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93166645|NCT02324296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93166646|NCT02324296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93166647|NCT02324296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166648|NCT02324296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166649|NCT02324296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93166650|NCT02324296|Alkylating Agents|alkylating agents|mesh-ancestor
93166651|NCT03494686|Anesthetics|anesthetics|mesh-list
93166652|NCT03494686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166653|NCT03494686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166654|NCT03487198|Brexpiprazole|brexpiprazole|mesh-list
93166655|NCT03487198|Serotonin Agents|serotonin agents|mesh-ancestor
93166656|NCT03487198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166657|NCT03487198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166658|NCT03487198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166659|NCT03487198|Dopamine Agonists|dopamine agonists|mesh-ancestor
93166660|NCT03487198|Dopamine Agents|dopamine agents|mesh-ancestor
93166661|NCT02565914|Ivacaftor|ivacaftor|mesh-list
93166662|NCT02565914|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93166663|NCT02565914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166664|NCT02565914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166665|NCT03881020|Fluorides|fluorides|mesh-list
93166666|NCT03881020|Cariostatic Agents|cariostatic agents|mesh-ancestor
93166667|NCT03881020|Protective Agents|protective agents|mesh-ancestor
93166668|NCT03881020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166669|NCT01367600|Methylnaltrexone|methylnaltrexone|mesh-list
93166670|NCT01367600|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93166671|NCT01367600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166672|NCT01367600|Sensory System Agents|sensory system agents|mesh-ancestor
93166673|NCT01367600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166674|NCT01367678|Chlorhexidine|chlorhexidine|mesh-list
93166675|NCT01367678|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93166676|NCT01367678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166677|NCT01367678|Disinfectants|disinfectants|mesh-ancestor
93166678|NCT03487042|Bimatoprost|bimatoprost|mesh-list
93166679|NCT03487042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93166680|NCT03487042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93166681|NCT03487042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166682|NCT03115294|Theophylline|theophylline|mesh-list
93166683|NCT03115294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93166684|NCT03115294|Autonomic Agents|autonomic agents|mesh-ancestor
93166685|NCT03115294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166686|NCT03115294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166687|NCT03115294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93166688|NCT03115294|Respiratory System Agents|respiratory system agents|mesh-ancestor
93166689|NCT03115294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93166690|NCT03115294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117976|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93166691|NCT03115294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166692|NCT03115294|Vasodilator Agents|vasodilator agents|mesh-ancestor
93166693|NCT03115294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93166694|NCT03115294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93166695|NCT03115294|Purinergic Agents|purinergic agents|mesh-ancestor
93166696|NCT03115294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166697|NCT01367756|Citalopram|citalopram|mesh-list
93166698|NCT01367756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93166699|NCT01367756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93166700|NCT01367756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93166701|NCT01367756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166702|NCT01367756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166703|NCT01367756|Serotonin Agents|serotonin agents|mesh-ancestor
93166704|NCT01367756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166705|NCT01367756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93166706|NCT01367756|Antidepressive Agents|antidepressive agents|mesh-ancestor
93166707|NCT01367756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93166708|NCT04624958|Rituximab|rituximab|mesh-list
93166709|NCT04624958|Zanubrutinib|zanubrutinib|mesh-list
93166710|NCT04624958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166711|NCT04624958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838929|NCT00797017|Fentanyl|fentanyl|mesh-list
93166712|NCT04624958|Immunologic Factors|immunologic factors|mesh-ancestor
93166713|NCT04624958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166714|NCT04624958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166715|NCT04624958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93166716|NCT04624958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166717|NCT04624958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166719|NCT03485482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166720|NCT03485482|Sympatholytics|sympatholytics|mesh-ancestor
93166721|NCT03485482|Autonomic Agents|autonomic agents|mesh-ancestor
93166722|NCT03485482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166723|NCT03485482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166724|NCT03485482|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93166725|NCT03485482|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93166726|NCT03485482|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93166727|NCT03485482|Adrenergic Agents|adrenergic agents|mesh-ancestor
93166728|NCT03485482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166729|NCT03485482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166730|NCT02946424|Simvastatin|simvastatin|mesh-list
93166731|NCT02946424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93166732|NCT02946424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93166733|NCT02946424|Antimetabolites|antimetabolites|mesh-ancestor
93166734|NCT02946424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166735|NCT02946424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93166736|NCT02946424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93166737|NCT02946424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166738|NCT00783536|Etanercept|etanercept|mesh-list
93166739|NCT00783536|Methotrexate|methotrexate|mesh-list
93166740|NCT00783536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93166741|NCT00783536|Abortifacient Agents|abortifacient agents|mesh-ancestor
93166742|NCT00783536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166743|NCT00783536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166744|NCT00783536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93166745|NCT00783536|Antimetabolites|antimetabolites|mesh-ancestor
93166746|NCT00783536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166747|NCT00783536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166748|NCT00783536|Dermatologic Agents|dermatologic agents|mesh-ancestor
93166749|NCT00783536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166750|NCT00783536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93166751|NCT00783536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166752|NCT00783536|Immunologic Factors|immunologic factors|mesh-ancestor
93166753|NCT00783536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166754|NCT00783536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93166755|NCT00783536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93166756|NCT00783536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166757|NCT00783536|Analgesics|analgesics|mesh-ancestor
93166758|NCT00783536|Sensory System Agents|sensory system agents|mesh-ancestor
93166759|NCT00783536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166760|NCT00783536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166761|NCT00783536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166762|NCT01367912|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93166763|NCT01367912|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93166764|NCT01367912|Estradiol|estradiol|mesh-list
93166765|NCT01367912|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93166766|NCT01367912|Estrogens|estrogens|mesh-ancestor
93166767|NCT01367912|Hormones|hormones|mesh-ancestor
93166768|NCT01367912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166769|NCT01367912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166770|NCT01367912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93166771|NCT01367912|Contraceptive Agents|contraceptive agents|mesh-ancestor
93166772|NCT01367912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166773|NCT01367912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93166774|NCT03115112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93166775|NCT03115112|Bexagliflozin|bexagliflozin|mesh-list
93166776|NCT03115112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93166777|NCT03115112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166778|NCT03115112|Incretins|incretins|mesh-ancestor
93166779|NCT03115112|Hormones|hormones|mesh-ancestor
93166780|NCT03115112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166781|NCT03115112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93166782|NCT03115112|Protease Inhibitors|protease inhibitors|mesh-ancestor
93166783|NCT03115112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838971|NCT00924950|Micronutrients|micronutrients|mesh-ancestor
93166784|NCT03115112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166786|NCT01373528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166787|NCT01373528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93166788|NCT01373528|Autonomic Agents|autonomic agents|mesh-ancestor
93166789|NCT01373528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166790|NCT01373528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166791|NCT01373528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93166792|NCT01373528|Respiratory System Agents|respiratory system agents|mesh-ancestor
93166793|NCT01373528|Glucocorticoids|glucocorticoids|mesh-ancestor
93166794|NCT01373528|Hormones|hormones|mesh-ancestor
93166795|NCT01373528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166796|NCT03634202|Capecitabine|capecitabine|mesh-list
93166797|NCT03634202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93166798|NCT03634202|Antimetabolites|antimetabolites|mesh-ancestor
93166799|NCT03634202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166800|NCT03634202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166801|NCT05019560|Sevoflurane|sevoflurane|mesh-list
93166802|NCT05019560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166803|NCT05019560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93166804|NCT05019560|Anesthetics, General|anesthetics, general|mesh-ancestor
93166805|NCT05019560|Anesthetics|anesthetics|mesh-ancestor
93166806|NCT05019560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166807|NCT05019560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166808|NCT01373606|Terlipressin|terlipressin|mesh-list
93166809|NCT01373606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166810|NCT01373606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93166811|NCT01367990|Norepinephrine|norepinephrine|mesh-list
93166812|NCT01367990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93166813|NCT01367990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93166814|NCT01367990|Adrenergic Agents|adrenergic agents|mesh-ancestor
93166815|NCT01367990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166816|NCT01367990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166817|NCT01367990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166818|NCT01367990|Sympathomimetics|sympathomimetics|mesh-ancestor
93166819|NCT01367990|Autonomic Agents|autonomic agents|mesh-ancestor
93166820|NCT01367990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166821|NCT01367990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93166822|NCT03556358|Paclitaxel|paclitaxel|mesh-list
93166823|NCT03556358|Cyclophosphamide|cyclophosphamide|mesh-list
93166824|NCT03556358|Trastuzumab|trastuzumab|mesh-list
93166825|NCT03556358|Epirubicin|epirubicin|mesh-list
93166826|NCT03556358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93166827|NCT03556358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166828|NCT03556358|Tubulin Modulators|tubulin modulators|mesh-ancestor
93166829|NCT03556358|Antimitotic Agents|antimitotic agents|mesh-ancestor
93166830|NCT03556358|Mitosis Modulators|mitosis modulators|mesh-ancestor
93166831|NCT03556358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166832|NCT03556358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166833|NCT03556358|Immunologic Factors|immunologic factors|mesh-ancestor
93166834|NCT03556358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166835|NCT03556358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166836|NCT03556358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93166837|NCT03556358|Alkylating Agents|alkylating agents|mesh-ancestor
93166838|NCT03556358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93166839|NCT03556358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166840|NCT03556358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93166841|NCT03556358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93166842|NCT03556358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93166843|NCT03556358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166844|NCT01374308|Interferons|interferons|mesh-list
93166845|NCT01374308|Interferon-alpha|interferon-alpha|mesh-list
93166846|NCT01374308|Interferon alpha-2|interferon alpha-2|mesh-list
93166847|NCT01374308|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93166848|NCT01374308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166849|NCT01374308|Antiviral Agents|antiviral agents|mesh-ancestor
93166850|NCT01374308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166851|NCT01374308|Immunologic Factors|immunologic factors|mesh-ancestor
93166852|NCT01374308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166853|NCT01368068|Tibolone|tibolone|mesh-list
93166854|NCT01368068|Escitalopram|escitalopram|mesh-list
93166855|NCT01368068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93166856|NCT01368068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93166857|NCT01368068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839062|NCT00797485|Vitamins|vitamins|mesh-ancestor
93166858|NCT01368068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166859|NCT01368068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166860|NCT01368068|Serotonin Agents|serotonin agents|mesh-ancestor
93166861|NCT01368068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166862|NCT01368068|Androgen Antagonists|androgen antagonists|mesh-ancestor
93166863|NCT01368068|Hormone Antagonists|hormone antagonists|mesh-ancestor
93166864|NCT01368068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166865|NCT01368068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166866|NCT01368068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93166867|NCT01368068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166868|NCT01368068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93166869|NCT01368068|Anabolic Agents|anabolic agents|mesh-ancestor
93166870|NCT01368068|Hormones|hormones|mesh-ancestor
93166871|NCT03228680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93166872|NCT03228680|Hormones|hormones|mesh-ancestor
93166873|NCT03228680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166874|NCT03228680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166875|NCT01373684|Tenofovir|tenofovir|mesh-list
93166876|NCT01373684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93166877|NCT01373684|Entecavir|entecavir|mesh-list
93166878|NCT01373684|Adefovir|adefovir|mesh-list
93166879|NCT01373684|Antiviral Agents|antiviral agents|mesh-ancestor
93166880|NCT01373684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166881|NCT01373684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93166882|NCT01373684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93166883|NCT01373684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166884|NCT01373684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166885|NCT01373684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93166886|NCT01373684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93166887|NCT04490018|Vaccines|vaccines|mesh-list
93166888|NCT04490018|Immunologic Factors|immunologic factors|mesh-ancestor
93166889|NCT04490018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166890|NCT02891798|Dexamethasone|dexamethasone|mesh-list
93166891|NCT02891798|Dexamethasone acetate|dexamethasone acetate|mesh-list
93166892|NCT02891798|Clonidine|clonidine|mesh-list
93166893|NCT02891798|Buprenorphine|buprenorphine|mesh-list
93166894|NCT02891798|Bupivacaine|bupivacaine|mesh-list
93166895|NCT02891798|BB 1101|bb 1101|mesh-list
93166896|NCT02891798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166897|NCT02891798|Antiemetics|antiemetics|mesh-ancestor
93166898|NCT02891798|Autonomic Agents|autonomic agents|mesh-ancestor
93166899|NCT02891798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166900|NCT02891798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166901|NCT02891798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93166902|NCT02891798|Glucocorticoids|glucocorticoids|mesh-ancestor
93166903|NCT02891798|Hormones|hormones|mesh-ancestor
93166904|NCT02891798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93166905|NCT02891798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93166906|NCT02891798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166907|NCT02891798|Protease Inhibitors|protease inhibitors|mesh-ancestor
93166908|NCT02891798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166909|NCT02891798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166910|NCT02891798|Anesthetics, Local|anesthetics, local|mesh-ancestor
93166911|NCT02891798|Anesthetics|anesthetics|mesh-ancestor
93166912|NCT02891798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166913|NCT02891798|Sensory System Agents|sensory system agents|mesh-ancestor
93166914|NCT02891798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93166915|NCT02891798|Narcotics|narcotics|mesh-ancestor
93166916|NCT02891798|Analgesics|analgesics|mesh-ancestor
93166917|NCT02891798|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93166918|NCT02891798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93166919|NCT02891798|Sympatholytics|sympatholytics|mesh-ancestor
93166920|NCT02891798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93166921|NCT02891798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93166922|NCT02891798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93166923|NCT02891798|Adrenergic Agents|adrenergic agents|mesh-ancestor
93166924|NCT02891798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166925|NCT01374464|Levobupivacaine|levobupivacaine|mesh-list
93166926|NCT01374464|Anesthetics, Local|anesthetics, local|mesh-ancestor
93166927|NCT01374464|Anesthetics|anesthetics|mesh-ancestor
93166928|NCT01374464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166929|NCT01374464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166930|NCT01374464|Sensory System Agents|sensory system agents|mesh-ancestor
93166931|NCT01374464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166932|NCT01374620|Paclitaxel|paclitaxel|mesh-list
93166933|NCT01374620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93166934|NCT01374620|Cyclophosphamide|cyclophosphamide|mesh-list
93166935|NCT01374620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93166936|NCT01374620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166937|NCT01374620|Tubulin Modulators|tubulin modulators|mesh-ancestor
93166938|NCT01374620|Antimitotic Agents|antimitotic agents|mesh-ancestor
93166939|NCT01374620|Mitosis Modulators|mitosis modulators|mesh-ancestor
93166940|NCT01374620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166941|NCT01374620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93166942|NCT01374620|Immunologic Factors|immunologic factors|mesh-ancestor
93166943|NCT01374620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166944|NCT01374620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166945|NCT01374620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93166946|NCT01374620|Alkylating Agents|alkylating agents|mesh-ancestor
93166947|NCT01374620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93166948|NCT01374698|Aspirin|aspirin|mesh-list
93166949|NCT01374698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93166950|NCT01374698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93166951|NCT01374698|Analgesics|analgesics|mesh-ancestor
93166952|NCT01374698|Sensory System Agents|sensory system agents|mesh-ancestor
93166953|NCT01374698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93166954|NCT01374698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166955|NCT01374698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93166956|NCT01374698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93166957|NCT01374698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93166958|NCT01374698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93166959|NCT01374698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166960|NCT01374698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93166961|NCT01374698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93166962|NCT01374698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93166963|NCT01374698|Antipyretics|antipyretics|mesh-ancestor
93166964|NCT01368458|Antipsychotic Agents|antipsychotic agents|mesh-list
93166965|NCT01368458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92855120|NCT02602197|Acetaminophen|acetaminophen|mesh-list
93166966|NCT01368458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93166967|NCT01368458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166968|NCT01368458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93166969|NCT05197088|Tamsulosin|tamsulosin|mesh-list
93166970|NCT05197088|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93166971|NCT05197088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93166972|NCT05197088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93166973|NCT05197088|Adrenergic Agents|adrenergic agents|mesh-ancestor
93166974|NCT05197088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93166975|NCT05197088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166976|NCT05197088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166977|NCT05197088|Urological Agents|urological agents|mesh-ancestor
93166978|NCT01375088|Propolis|propolis|mesh-list
93166979|NCT01375088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93166980|NCT01368848|Bevacizumab|bevacizumab|mesh-list
93166981|NCT01368848|Docetaxel|docetaxel|mesh-list
93166982|NCT01368848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93166983|NCT01368848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93166984|NCT01368848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93166985|NCT01368848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93166986|NCT01368848|Growth Substances|growth substances|mesh-ancestor
93166987|NCT01368848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166988|NCT01368848|Growth Inhibitors|growth inhibitors|mesh-ancestor
93166989|NCT01368848|Tubulin Modulators|tubulin modulators|mesh-ancestor
93166990|NCT01368848|Antimitotic Agents|antimitotic agents|mesh-ancestor
93166991|NCT01368848|Mitosis Modulators|mitosis modulators|mesh-ancestor
93166992|NCT01368848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93166993|NCT03604874|Oxytocin|oxytocin|mesh-list
93166994|NCT03604874|Oxytocics|oxytocics|mesh-ancestor
93166995|NCT03604874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93166996|NCT03604874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93166997|NCT01369082|Cyclosporine|cyclosporine|mesh-list
93166998|NCT01369082|Sirolimus|sirolimus|mesh-list
93166999|NCT01369082|Mycophenolic Acid|mycophenolic acid|mesh-list
93167000|NCT01369082|Tacrolimus|tacrolimus|mesh-list
93167001|NCT01369082|Cyclosporins|cyclosporins|mesh-list
93167002|NCT01369082|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93167003|NCT01369082|Immunologic Factors|immunologic factors|mesh-ancestor
93167004|NCT01369082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167005|NCT01369082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93167006|NCT01369082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167007|NCT01369082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167008|NCT01369082|Antifungal Agents|antifungal agents|mesh-ancestor
93167009|NCT01369082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167011|NCT01369082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167012|NCT01369082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93167013|NCT01369082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167014|NCT01369082|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93167015|NCT01369082|Antitubercular Agents|antitubercular agents|mesh-ancestor
93167016|NCT01369082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167017|NCT03382730|Chlorhexidine|chlorhexidine|mesh-list
93167018|NCT03382730|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93167019|NCT03382730|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93167020|NCT03382730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167021|NCT03382730|Disinfectants|disinfectants|mesh-ancestor
93167022|NCT03382730|Dermatologic Agents|dermatologic agents|mesh-ancestor
93167023|NCT03135262|Rituximab|rituximab|mesh-list
93167024|NCT03135262|Obinutuzumab|obinutuzumab|mesh-list
93167025|NCT03135262|Venetoclax|venetoclax|mesh-list
93167026|NCT03135262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93167027|NCT03135262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167028|NCT03135262|Immunologic Factors|immunologic factors|mesh-ancestor
93167029|NCT03135262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167030|NCT03135262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167031|NCT01375244|Lisinopril|lisinopril|mesh-list
93167032|NCT01375244|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93167033|NCT01375244|Protease Inhibitors|protease inhibitors|mesh-ancestor
93167034|NCT01375244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167035|NCT01375244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167036|NCT01375244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93167037|NCT01375244|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93167038|NCT01375244|Protective Agents|protective agents|mesh-ancestor
93167039|NCT01375244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167040|NCT01375322|Amlodipine|amlodipine|mesh-list
93167041|NCT01375322|Valsartan|valsartan|mesh-list
93167042|NCT01375322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93167043|NCT01375322|Benazepril|benazepril|mesh-list
93167044|NCT01375322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93167045|NCT01375322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93167046|NCT01375322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167047|NCT01375322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167048|NCT01375322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93167049|NCT01375322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167050|NCT01375322|Vasodilator Agents|vasodilator agents|mesh-ancestor
93167051|NCT01375322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93167052|NCT01375322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93167053|NCT01375322|Diuretics|diuretics|mesh-ancestor
93167054|NCT01375322|Natriuretic Agents|natriuretic agents|mesh-ancestor
93167055|NCT01375322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93167056|NCT01375322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93167057|NCT01375322|Protease Inhibitors|protease inhibitors|mesh-ancestor
93167058|NCT01375322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167059|NCT01369238|Pyranoprofen|pyranoprofen|mesh-list
93167060|NCT01369238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167061|NCT01369238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167062|NCT01369238|Analgesics|analgesics|mesh-ancestor
93167063|NCT01369238|Sensory System Agents|sensory system agents|mesh-ancestor
93167064|NCT01369238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167065|NCT01369238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167066|NCT01369238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167067|NCT01369238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167068|NCT01369238|Gout Suppressants|gout suppressants|mesh-ancestor
93167069|NCT03485404|Vitamins|vitamins|mesh-list
93167070|NCT03485404|Folic Acid|folic acid|mesh-list
93167071|NCT03485404|Vitamin B 12|vitamin b 12|mesh-list
93167072|NCT03485404|Vitamin B Complex|vitamin b complex|mesh-list
93167073|NCT03485404|Micronutrients|micronutrients|mesh-ancestor
93167074|NCT03485404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167075|NCT03485404|Hematinics|hematinics|mesh-ancestor
93167076|NCT05195294|Lenvatinib|lenvatinib|mesh-list
93167077|NCT05195294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167078|NCT05195294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93167079|NCT05195294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167080|NCT05195294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167081|NCT03072628|Nicotine|nicotine|mesh-list
93167082|NCT03072628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93167083|NCT03072628|Autonomic Agents|autonomic agents|mesh-ancestor
93167084|NCT03072628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839272|NCT00689715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93167085|NCT03072628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167086|NCT03072628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93167087|NCT03072628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93167088|NCT03072628|Cholinergic Agents|cholinergic agents|mesh-ancestor
93167089|NCT03072628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167090|NCT03072628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167091|NCT05195060|Sotrovimab|sotrovimab|mesh-list
93167092|NCT05195060|Molnupiravir|molnupiravir|mesh-list
93167093|NCT05195060|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
93167094|NCT05195060|Antiviral Agents|antiviral agents|mesh-ancestor
93167095|NCT05195060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167096|NCT03535194|Mirikizumab|mirikizumab|mesh-list
93167097|NCT03535194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167098|NCT03535194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167099|NCT03535194|Analgesics|analgesics|mesh-ancestor
93167100|NCT03535194|Sensory System Agents|sensory system agents|mesh-ancestor
93167101|NCT03535194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167102|NCT03535194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167103|NCT03535194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167104|NCT03535194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167105|NCT03535194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93167106|NCT03535194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167107|NCT03633812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93167108|NCT03633812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93167109|NCT03633812|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167110|NCT03633812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167111|NCT03633812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167112|NCT03633812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167113|NCT05194904|Ketorolac|ketorolac|mesh-list
93167114|NCT05194904|Dexmedetomidine|dexmedetomidine|mesh-list
93167115|NCT05194904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93167116|NCT05194904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167117|NCT05194904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167118|NCT05194904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167119|NCT05194904|Analgesics|analgesics|mesh-ancestor
93167120|NCT05194904|Sensory System Agents|sensory system agents|mesh-ancestor
93167121|NCT05194904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167122|NCT05194904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93167123|NCT05194904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93167124|NCT05194904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93167125|NCT05194904|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167126|NCT05194904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167127|NCT05194904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167128|NCT05194904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167129|NCT05194904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167130|NCT05194904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167131|NCT05194904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93167132|NCT05194904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167133|NCT01375400|Aspirin|aspirin|mesh-list
93167134|NCT01375400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167135|NCT01375400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167136|NCT01375400|Analgesics|analgesics|mesh-ancestor
93167137|NCT01375400|Sensory System Agents|sensory system agents|mesh-ancestor
93167138|NCT01375400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167139|NCT01375400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167140|NCT01375400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167141|NCT01375400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167142|NCT01375400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93167143|NCT01375400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93167144|NCT01375400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167145|NCT01375400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93167146|NCT01375400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93167147|NCT01375400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167148|NCT01375400|Antipyretics|antipyretics|mesh-ancestor
93167149|NCT01319864|Plerixafor|plerixafor|mesh-list
93167150|NCT01319864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93167151|NCT01319864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93167152|NCT01319864|Antiviral Agents|antiviral agents|mesh-ancestor
93167153|NCT01319864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167154|NCT05194046|Amoxicillin|amoxicillin|mesh-list
93167155|NCT05194046|Clarithromycin|clarithromycin|mesh-list
93167156|NCT05194046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167157|NCT05194046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167158|NCT05194046|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93167159|NCT05194046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167160|NCT05194046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167161|NCT05194046|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93167162|NCT05194046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93167163|NCT01369472|Carvedilol|carvedilol|mesh-list
93167164|NCT01369472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93167165|NCT01369472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93167166|NCT01369472|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167167|NCT01369472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167168|NCT01369472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167169|NCT01369472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167170|NCT01369472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93167171|NCT01369472|Antioxidants|antioxidants|mesh-ancestor
93167172|NCT01369472|Protective Agents|protective agents|mesh-ancestor
93167173|NCT01369472|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93167174|NCT01369472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167175|NCT01369472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93167176|NCT01369472|Vasodilator Agents|vasodilator agents|mesh-ancestor
93167177|NCT01369472|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93167178|NCT01369472|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93167179|NCT03559530|Anti-Infective Agents|anti-infective agents|mesh-list
93167180|NCT03559530|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93167181|NCT05193734|Hemagglutinins|hemagglutinins|mesh-list
93167182|NCT05193734|Agglutinins|agglutinins|mesh-ancestor
93167183|NCT05193734|Immunologic Factors|immunologic factors|mesh-ancestor
93167184|NCT05193734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167185|NCT05193734|Coagulants|coagulants|mesh-ancestor
93167186|NCT01375556|Ethanol|ethanol|mesh-list
93167187|NCT01375556|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93167188|NCT01375556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167189|NCT01375556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855123|NCT02602197|Analgesics|analgesics|mesh-ancestor
93167190|NCT01375556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167191|NCT03486496|Gefitinib|gefitinib|mesh-list
93167192|NCT03486496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167193|NCT03486496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93167194|NCT03486496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167195|NCT03486496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167196|NCT02091934|Dipivefrin|dipivefrin|mesh-list
93167197|NCT02091934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93167198|NCT02091934|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167199|NCT02091934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167200|NCT02091934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167201|NCT02091934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167202|NCT01375634|Midazolam|midazolam|mesh-list
93167203|NCT01375634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93167204|NCT01375634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93167205|NCT01375634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167206|NCT01375634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167207|NCT01375634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93167208|NCT01375634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93167209|NCT01375634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167210|NCT01375634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93167211|NCT01375634|Anesthetics, General|anesthetics, general|mesh-ancestor
93167212|NCT01375634|Anesthetics|anesthetics|mesh-ancestor
93167213|NCT01375634|GABA Modulators|gaba modulators|mesh-ancestor
93167214|NCT01375634|GABA Agents|gaba agents|mesh-ancestor
93167215|NCT01375634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167216|NCT01375634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167217|NCT05388448|Amoxicillin|amoxicillin|mesh-list
93167218|NCT05388448|Rifampin|rifampin|mesh-list
93167219|NCT05388448|Clavulanic Acids|clavulanic acids|mesh-list
93167220|NCT05388448|Clavulanic Acid|clavulanic acid|mesh-list
93167221|NCT05388448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167222|NCT05388448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167223|NCT05388448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93167224|NCT05388448|Antitubercular Agents|antitubercular agents|mesh-ancestor
93167225|NCT05388448|Leprostatic Agents|leprostatic agents|mesh-ancestor
93167226|NCT05388448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93167227|NCT05388448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167228|NCT05388448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167229|NCT05388448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93167230|NCT05388448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93167231|NCT05388448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93167232|NCT05388448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93167233|NCT05388448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93167235|NCT05388448|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93167236|NCT05108740|Everolimus|everolimus|mesh-list
93167237|NCT05108740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93167238|NCT05108740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93167239|NCT05108740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167240|NCT05108740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167241|NCT05108740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93167242|NCT05108740|Immunologic Factors|immunologic factors|mesh-ancestor
93167243|NCT05108740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167244|NCT05108740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167245|NCT05105750|Aspirin|aspirin|mesh-list
93167246|NCT05105750|Indobufen|indobufen|mesh-list
93167247|NCT05105750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167248|NCT05105750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167249|NCT05105750|Analgesics|analgesics|mesh-ancestor
93167250|NCT05105750|Sensory System Agents|sensory system agents|mesh-ancestor
93167251|NCT05105750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167252|NCT05105750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167253|NCT05105750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167254|NCT05105750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167255|NCT05105750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93167256|NCT05105750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93167257|NCT05105750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167258|NCT05105750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93167259|NCT05105750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93167260|NCT05105750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167261|NCT05105750|Antipyretics|antipyretics|mesh-ancestor
93167262|NCT03485170|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93167263|NCT03485170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92463042|NCT01760694|Leucovorin|leucovorin|mesh-list
93167264|NCT03485170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167265|NCT05152264|Analgesics|analgesics|mesh-list
93167266|NCT05152264|Sensory System Agents|sensory system agents|mesh-ancestor
93167267|NCT05152264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167268|NCT05152264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167269|NCT02286154|Hydroxyurea|hydroxyurea|mesh-list
93167270|NCT02286154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167271|NCT02286154|Antisickling Agents|antisickling agents|mesh-ancestor
93167272|NCT02286154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167273|NCT02286154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167274|NCT02286154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93167275|NCT05152186|Disinfectants|disinfectants|mesh-list
93167276|NCT05152186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167277|NCT03485092|Empagliflozin|empagliflozin|mesh-list
93167278|NCT03485092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93167279|NCT03485092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167280|NCT03485092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93167281|NCT03485092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167282|NCT03481582|Nitroglycerin|nitroglycerin|mesh-list
93167283|NCT03481582|Vasodilator Agents|vasodilator agents|mesh-ancestor
93167284|NCT01376102|Ibandronic Acid|ibandronic acid|mesh-list
93167285|NCT01376102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93167286|NCT01376102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167287|NCT05064800|Ritonavir|ritonavir|mesh-list
93167288|NCT05064800|Nirmatrelvir|nirmatrelvir|mesh-list
93167289|NCT05064800|Dabigatran|dabigatran|mesh-list
93167290|NCT05064800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93167291|NCT05064800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93167292|NCT05064800|Protease Inhibitors|protease inhibitors|mesh-ancestor
93167293|NCT05064800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167294|NCT05064800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167295|NCT05064800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93167296|NCT05064800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93167297|NCT05064800|Antiviral Agents|antiviral agents|mesh-ancestor
93167298|NCT05064800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167299|NCT05064800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93167300|NCT05064800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93167301|NCT05064800|Antithrombins|antithrombins|mesh-ancestor
93167302|NCT05064800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93167303|NCT05064800|Anticoagulants|anticoagulants|mesh-ancestor
93167304|NCT01376180|Lamotrigine|lamotrigine|mesh-list
93167305|NCT01376180|Anticonvulsants|anticonvulsants|mesh-ancestor
93167306|NCT01376180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93167307|NCT01376180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167308|NCT01376180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167309|NCT01376180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93167310|NCT01376180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167311|NCT01376180|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93167312|NCT01376180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93167313|NCT01376180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167314|NCT01376180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167315|NCT01376180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93167316|NCT03633734|Folfirinox|folfirinox|mesh-list
93167317|NCT03633734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167318|NCT01376258|Finasteride|finasteride|mesh-list
93167319|NCT01376258|Dutasteride|dutasteride|mesh-list
93167320|NCT01376258|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93167321|NCT01376258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93167322|NCT01376258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167323|NCT01376258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167324|NCT01376258|Hormone Antagonists|hormone antagonists|mesh-ancestor
93167325|NCT01376258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167326|NCT01376258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167327|NCT01376258|Urological Agents|urological agents|mesh-ancestor
93167328|NCT05151874|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93167329|NCT05151874|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93167330|NCT05151874|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93167331|NCT05151874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167332|NCT05151874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167333|NCT05151874|Cholinergic Agents|cholinergic agents|mesh-ancestor
93167334|NCT05151874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167335|NCT05151874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167336|NCT05151874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93167337|NCT05151874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167338|NCT03531840|Olaparib|olaparib|mesh-list
93167339|NCT03531840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93167340|NCT03531840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167341|NCT03531840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167342|NCT03531840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167343|NCT05151796|Aspirin|aspirin|mesh-list
93167344|NCT05151796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167345|NCT05151796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167346|NCT05151796|Analgesics|analgesics|mesh-ancestor
93167347|NCT05151796|Sensory System Agents|sensory system agents|mesh-ancestor
93167348|NCT05151796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167349|NCT05151796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167350|NCT05151796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167351|NCT05151796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167352|NCT05151796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93167353|NCT05151796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93167354|NCT05151796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167355|NCT05151796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93167356|NCT05151796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93167357|NCT05151796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167358|NCT05151796|Antipyretics|antipyretics|mesh-ancestor
93167359|NCT04460092|Insulin|insulin|mesh-list
93167360|NCT04460092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93167361|NCT04460092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93167362|NCT04460092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167363|NCT03110900|Lorazepam|lorazepam|mesh-list
93167364|NCT03110900|Haloperidol|haloperidol|mesh-list
93167365|NCT03110900|Haloperidol decanoate|haloperidol decanoate|mesh-list
93167366|NCT03110900|Loxapine|loxapine|mesh-list
93167367|NCT03110900|Antiemetics|antiemetics|mesh-ancestor
93167368|NCT03110900|Autonomic Agents|autonomic agents|mesh-ancestor
93167369|NCT03110900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167370|NCT03110900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167371|NCT03110900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167372|NCT03110900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93167373|NCT03110900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93167374|NCT03110900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167375|NCT03110900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167376|NCT03110900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93167377|NCT03110900|Dopamine Agents|dopamine agents|mesh-ancestor
93167378|NCT03110900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167379|NCT03110900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167380|NCT03110900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93167381|NCT03110900|Anticonvulsants|anticonvulsants|mesh-ancestor
93167382|NCT03110900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93167383|NCT03110900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93167384|NCT03110900|GABA Modulators|gaba modulators|mesh-ancestor
93167385|NCT03110900|GABA Agents|gaba agents|mesh-ancestor
93167386|NCT03486184|Cystatins|cystatins|mesh-list
93167387|NCT03486184|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93167388|NCT03486184|Protease Inhibitors|protease inhibitors|mesh-ancestor
93167389|NCT03486184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167390|NCT03486184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167391|NCT03109756|Gaboxadol|gaboxadol|mesh-list
93167392|NCT03109756|Analgesics|analgesics|mesh-ancestor
93167393|NCT03109756|Sensory System Agents|sensory system agents|mesh-ancestor
93167394|NCT03109756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167395|NCT03109756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167396|NCT03109756|Anticonvulsants|anticonvulsants|mesh-ancestor
93167397|NCT03109756|GABA Agonists|gaba agonists|mesh-ancestor
93167398|NCT03109756|GABA Agents|gaba agents|mesh-ancestor
93167399|NCT03109756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167400|NCT03109756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167401|NCT03867734|Aztreonam|aztreonam|mesh-list
93167402|NCT03867734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167403|NCT03867734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167404|NCT05759546|Fulvestrant|fulvestrant|mesh-list
93167405|NCT05759546|Fluzoparib|fluzoparib|mesh-list
93167406|NCT05759546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93167407|NCT05759546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167408|NCT05759546|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93167409|NCT05759546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93167410|NCT05759546|Hormone Antagonists|hormone antagonists|mesh-ancestor
92855124|NCT02602197|Sensory System Agents|sensory system agents|mesh-ancestor
93167411|NCT05759546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167412|NCT05759546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167413|NCT05759546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93167414|NCT05759546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167415|NCT05759546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167416|NCT05151016|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93167417|NCT05151016|Mifepristone|mifepristone|mesh-list
93167418|NCT05151016|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93167419|NCT05151016|Abortifacient Agents|abortifacient agents|mesh-ancestor
93167420|NCT05151016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167421|NCT05151016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167422|NCT05151016|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93167423|NCT05151016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93167424|NCT05151016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93167425|NCT05151016|Contraceptive Agents|contraceptive agents|mesh-ancestor
93167426|NCT05151016|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93167427|NCT05151016|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93167428|NCT05151016|Hormone Antagonists|hormone antagonists|mesh-ancestor
93167429|NCT05151016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167430|NCT05151016|Luteolytic Agents|luteolytic agents|mesh-ancestor
93167431|NCT05151016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93167432|NCT05151016|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93167433|NCT05151016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93167434|NCT05151016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167435|NCT04459312|Antibodies|antibodies|mesh-list
93167436|NCT04459312|Immunologic Factors|immunologic factors|mesh-ancestor
93167437|NCT04459312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167438|NCT04871360|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93167439|NCT04871360|Laxatives|laxatives|mesh-ancestor
93167440|NCT04871360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167441|NCT05153200|Adalimumab|adalimumab|mesh-list
93167442|NCT05153200|Upadacitinib|upadacitinib|mesh-list
93167443|NCT05153200|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93167444|NCT05153200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167445|NCT05153200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167446|NCT05153200|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93167447|NCT05153200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93167448|NCT05153200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167449|NCT05153200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167450|NCT03481036|Antiviral Agents|antiviral agents|mesh-list
93167451|NCT03481036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167452|NCT03477136|Vitamin D|vitamin d|mesh-list
93167453|NCT03477136|Vitamins|vitamins|mesh-ancestor
93167454|NCT03477136|Micronutrients|micronutrients|mesh-ancestor
93167455|NCT03477136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167456|NCT03477136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93167457|NCT03552068|Clonidine|clonidine|mesh-list
93167458|NCT03552068|Analgesics|analgesics|mesh-ancestor
93167459|NCT03552068|Sensory System Agents|sensory system agents|mesh-ancestor
93167460|NCT03552068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167461|NCT03552068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167462|NCT03552068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93167463|NCT03552068|Sympatholytics|sympatholytics|mesh-ancestor
93167464|NCT03552068|Autonomic Agents|autonomic agents|mesh-ancestor
93167465|NCT03552068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93167466|NCT03552068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93167467|NCT03552068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93167468|NCT03552068|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167469|NCT03552068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167470|NCT03552068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167471|NCT00702988|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93167472|NCT00702988|Hormones|hormones|mesh-ancestor
93167473|NCT00702988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167474|NCT00702988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167475|NCT05759312|Metformin|metformin|mesh-list
93167476|NCT05759312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93167477|NCT05759312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167478|NCT03446456|Vasopressins|vasopressins|mesh-list
93167479|NCT03446456|Arginine Vasopressin|arginine vasopressin|mesh-list
93167480|NCT03446456|Hemostatics|hemostatics|mesh-ancestor
93167481|NCT03446456|Coagulants|coagulants|mesh-ancestor
91928465|NCT02403687|Lidocaine|lidocaine|mesh-list
93167482|NCT03446456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93167483|NCT03446456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93167484|NCT03446456|Natriuretic Agents|natriuretic agents|mesh-ancestor
93167485|NCT03446456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167486|NCT03396692|Morphine|morphine|mesh-list
93167487|NCT03396692|Ropivacaine|ropivacaine|mesh-list
93167488|NCT03396692|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93167489|NCT03396692|Narcotics|narcotics|mesh-ancestor
93167490|NCT03396692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167491|NCT03396692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167492|NCT03396692|Analgesics|analgesics|mesh-ancestor
93167493|NCT03396692|Sensory System Agents|sensory system agents|mesh-ancestor
93167494|NCT03396692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167495|NCT03396692|Anesthetics, Local|anesthetics, local|mesh-ancestor
93167496|NCT03396692|Anesthetics|anesthetics|mesh-ancestor
93167497|NCT04796948|Leucovorin|leucovorin|mesh-list
93167498|NCT04796948|Fluorouracil|fluorouracil|mesh-list
93167499|NCT04796948|Oxaliplatin|oxaliplatin|mesh-list
93167500|NCT04796948|Irinotecan|irinotecan|mesh-list
93167501|NCT04796948|Calcium|calcium|mesh-list
93167502|NCT04796948|Levoleucovorin|levoleucovorin|mesh-list
93167503|NCT04796948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93167504|NCT04796948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167505|NCT04796948|Antimetabolites|antimetabolites|mesh-ancestor
93167506|NCT04796948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167507|NCT04796948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93167508|NCT04796948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167509|NCT04796948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93167510|NCT04796948|Immunologic Factors|immunologic factors|mesh-ancestor
93167511|NCT04796948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93167512|NCT04796948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93167513|NCT04796948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167514|NCT04796948|Antidotes|antidotes|mesh-ancestor
93167515|NCT04796948|Protective Agents|protective agents|mesh-ancestor
93167516|NCT04796948|Vitamin B Complex|vitamin b complex|mesh-ancestor
93167517|NCT04796948|Vitamins|vitamins|mesh-ancestor
93167518|NCT04796948|Micronutrients|micronutrients|mesh-ancestor
93167519|NCT03480958|Morphine|morphine|mesh-list
93167520|NCT03480958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93167521|NCT03480958|Narcotics|narcotics|mesh-ancestor
93167522|NCT03480958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167523|NCT03480958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167524|NCT03480958|Analgesics|analgesics|mesh-ancestor
93167525|NCT03480958|Sensory System Agents|sensory system agents|mesh-ancestor
93167526|NCT03480958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167527|NCT03495102|Dulaglutide|dulaglutide|mesh-list
93167528|NCT03495102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93167529|NCT03495102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167530|NCT04859608|Eculizumab|eculizumab|mesh-list
93167531|NCT04859608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93167532|NCT04859608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93167533|NCT04859608|Immunologic Factors|immunologic factors|mesh-ancestor
93167534|NCT04859608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167535|NCT04754386|Antibodies|antibodies|mesh-list
93167537|NCT04754386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167538|NCT05198180|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93167539|NCT05198180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93167540|NCT05198180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93167541|NCT05198180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167542|NCT03253172|Potassium Citrate|potassium citrate|mesh-list
93167543|NCT03253172|Diuretics|diuretics|mesh-ancestor
93167544|NCT03253172|Natriuretic Agents|natriuretic agents|mesh-ancestor
93167545|NCT03253172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167546|NCT03253172|Expectorants|expectorants|mesh-ancestor
93167547|NCT03253172|Respiratory System Agents|respiratory system agents|mesh-ancestor
93167548|NCT03483376|Anti-Infective Agents|anti-infective agents|mesh-list
93167549|NCT03483376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93167550|NCT03480646|Prednisone|prednisone|mesh-list
93167551|NCT03480646|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
93167552|NCT03480646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167553|NCT03480646|Glucocorticoids|glucocorticoids|mesh-ancestor
93167554|NCT03480646|Hormones|hormones|mesh-ancestor
93167555|NCT03480646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167556|NCT03480646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855127|NCT02602197|Antipyretics|antipyretics|mesh-ancestor
93167557|NCT03480646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93167558|NCT03480646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167559|NCT03480646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167560|NCT03480646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167561|NCT03483142|Misoprostol|misoprostol|mesh-list
93167562|NCT03483142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93167563|NCT03483142|Abortifacient Agents|abortifacient agents|mesh-ancestor
93167564|NCT03483142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167565|NCT03483142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167566|NCT03483142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93167567|NCT03483142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167568|NCT03483142|Oxytocics|oxytocics|mesh-ancestor
93167569|NCT03726372|Bromides|bromides|mesh-list
93167570|NCT03726372|Rocuronium|rocuronium|mesh-list
93167571|NCT03726372|Anticonvulsants|anticonvulsants|mesh-ancestor
93167572|NCT03726372|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93167573|NCT03726372|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93167574|NCT03726372|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93167575|NCT03726372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167576|NCT03726372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167577|NCT03104816|Acetaminophen|acetaminophen|mesh-list
93167578|NCT03104816|Hydromorphone|hydromorphone|mesh-list
93167579|NCT03104816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167580|NCT03104816|Analgesics|analgesics|mesh-ancestor
93167581|NCT03104816|Sensory System Agents|sensory system agents|mesh-ancestor
93167582|NCT03104816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167583|NCT03104816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167584|NCT03104816|Antipyretics|antipyretics|mesh-ancestor
93167585|NCT03104816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93167586|NCT03104816|Narcotics|narcotics|mesh-ancestor
93167587|NCT03104816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167588|NCT04720976|Pembrolizumab|pembrolizumab|mesh-list
93167589|NCT04720976|Sotorasib|sotorasib|mesh-list
93167590|NCT04720976|Osimertinib|osimertinib|mesh-list
93167591|NCT04720976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93167592|NCT04720976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167593|NCT04720976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93167594|NCT04720976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167595|NCT04720976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93167596|NCT04720976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167597|NCT03480568|Alirocumab|alirocumab|mesh-list
93167598|NCT03480568|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93167599|NCT03480568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93167600|NCT03480568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93167601|NCT03480568|Antimetabolites|antimetabolites|mesh-ancestor
93167602|NCT03480568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167603|NCT03480568|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93167604|NCT03480568|Protease Inhibitors|protease inhibitors|mesh-ancestor
93167605|NCT03480568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167606|NCT03480568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93167607|NCT04707326|Lamivudine|lamivudine|mesh-list
93167608|NCT04707326|Dolutegravir|dolutegravir|mesh-list
93167609|NCT04707326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93167610|NCT04707326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93167611|NCT04707326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167612|NCT04707326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167613|NCT04707326|Antiviral Agents|antiviral agents|mesh-ancestor
93167614|NCT04707326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167615|NCT04707326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93167616|NCT04707326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93167617|NCT04707326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93167618|NCT04707326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93167619|NCT03559062|Ivacaftor|ivacaftor|mesh-list
93167620|NCT03559062|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93167621|NCT03559062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167622|NCT03559062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167623|NCT05759000|Dapagliflozin|dapagliflozin|mesh-list
93167624|NCT05759000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93167625|NCT05759000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167626|NCT05759000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93167627|NCT05759000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167628|NCT03726216|Dalbavancin|dalbavancin|mesh-list
93167629|NCT03726216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167630|NCT03726216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167631|NCT00089791|Denosumab|denosumab|mesh-list
91928466|NCT02403687|Clonidine|clonidine|mesh-list
93167632|NCT00089791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93167633|NCT00089791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167634|NCT02876510|Aldesleukin|aldesleukin|mesh-list
93167635|NCT02876510|Cyclophosphamide|cyclophosphamide|mesh-list
93167636|NCT02876510|Fludarabine|fludarabine|mesh-list
93167637|NCT02876510|Fludarabine phosphate|fludarabine phosphate|mesh-list
93167638|NCT02876510|Atezolizumab|atezolizumab|mesh-list
93167639|NCT02876510|Interleukin-2|interleukin-2|mesh-list
93167640|NCT02876510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93167641|NCT02876510|Immunologic Factors|immunologic factors|mesh-ancestor
93167642|NCT02876510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167643|NCT02876510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167644|NCT02876510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93167645|NCT02876510|Alkylating Agents|alkylating agents|mesh-ancestor
93167646|NCT02876510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167647|NCT02876510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167648|NCT02876510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93167649|NCT02876510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93167650|NCT02876510|Antimetabolites|antimetabolites|mesh-ancestor
93167651|NCT02876510|Antiviral Agents|antiviral agents|mesh-ancestor
93167652|NCT02876510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167653|NCT02876510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93167654|NCT02876510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93167655|NCT02876510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167656|NCT02876510|Analgesics|analgesics|mesh-ancestor
93167657|NCT02876510|Sensory System Agents|sensory system agents|mesh-ancestor
93167658|NCT02876510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167659|NCT02876510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93167660|NCT02876510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93167661|NCT03380455|Cimetidine|cimetidine|mesh-list
93167662|NCT03380455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93167663|NCT03380455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167664|NCT03380455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93167665|NCT03380455|Histamine Antagonists|histamine antagonists|mesh-ancestor
93167666|NCT03380455|Histamine Agents|histamine agents|mesh-ancestor
93167667|NCT03380455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167668|NCT03380455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167669|NCT03380455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167670|NCT03380455|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93167671|NCT03380455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93167672|NCT03380455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167673|NCT02815280|Minocycline|minocycline|mesh-list
93167674|NCT02815280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167675|NCT02815280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167676|NCT03482752|Molgramostim|molgramostim|mesh-list
93167677|NCT03482752|Sargramostim|sargramostim|mesh-list
93167678|NCT03482752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167679|NCT03482752|Immunologic Factors|immunologic factors|mesh-ancestor
93167680|NCT03482752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167681|NCT04729543|Azacitidine|azacitidine|mesh-list
93167682|NCT04729543|Interleukin-2|interleukin-2|mesh-list
92839878|NCT05359627|Polymyxins|polymyxins|mesh-list
93167683|NCT04729543|Valproic Acid|valproic acid|mesh-list
93167684|NCT04729543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93167685|NCT04729543|Antimetabolites|antimetabolites|mesh-ancestor
93167686|NCT04729543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167687|NCT04729543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167688|NCT04729543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167689|NCT04729543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167690|NCT04729543|Analgesics|analgesics|mesh-ancestor
93167691|NCT04729543|Sensory System Agents|sensory system agents|mesh-ancestor
93167692|NCT04729543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167693|NCT04729543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167694|NCT04729543|Anticonvulsants|anticonvulsants|mesh-ancestor
93167695|NCT04729543|GABA Agents|gaba agents|mesh-ancestor
93167696|NCT04729543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167697|NCT04729543|Antimanic Agents|antimanic agents|mesh-ancestor
93167698|NCT04729543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93167699|NCT04729543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167700|NCT04729543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167701|NCT01310712|Oxybutynin|oxybutynin|mesh-list
93167702|NCT01310712|Parasympatholytics|parasympatholytics|mesh-ancestor
93167703|NCT01310712|Autonomic Agents|autonomic agents|mesh-ancestor
93167704|NCT01310712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167705|NCT01310712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167706|NCT01310712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93167707|NCT01310712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93167708|NCT01310712|Cholinergic Agents|cholinergic agents|mesh-ancestor
93167709|NCT01310712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167710|NCT01310712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167711|NCT01310712|Urological Agents|urological agents|mesh-ancestor
93167712|NCT02737930|Fluoxetine|fluoxetine|mesh-list
93167713|NCT02737930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93167714|NCT02737930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93167715|NCT02737930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167716|NCT02737930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167717|NCT02737930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167718|NCT02737930|Serotonin Agents|serotonin agents|mesh-ancestor
93167719|NCT02737930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167720|NCT02737930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93167721|NCT02737930|Antidepressive Agents|antidepressive agents|mesh-ancestor
93167722|NCT02737930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167723|NCT02737930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93167724|NCT02737930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93167725|NCT02737930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167726|NCT01242787|Entecavir|entecavir|mesh-list
93167727|NCT01242787|Antiviral Agents|antiviral agents|mesh-ancestor
93167728|NCT01242787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167729|NCT03476356|Clomiphene|clomiphene|mesh-list
93167730|NCT03476356|Enclomiphene|enclomiphene|mesh-list
93167731|NCT03476356|Zuclomiphene|zuclomiphene|mesh-list
93167732|NCT03476356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93167733|NCT03476356|Hormone Antagonists|hormone antagonists|mesh-ancestor
93167734|NCT03476356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167735|NCT03476356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167736|NCT03476356|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93167737|NCT03476356|Fertility Agents|fertility agents|mesh-ancestor
93167738|NCT03476356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167739|NCT03476356|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93167740|NCT03476356|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93167741|NCT03723096|Pomalidomide|pomalidomide|mesh-list
93167742|NCT03723096|Immunologic Factors|immunologic factors|mesh-ancestor
93167743|NCT03723096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167744|NCT03723096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93167745|NCT03723096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93167746|NCT03723096|Growth Substances|growth substances|mesh-ancestor
93167747|NCT03723096|Growth Inhibitors|growth inhibitors|mesh-ancestor
93167748|NCT03723096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167749|NCT02534012|Anesthetics|anesthetics|mesh-list
93167750|NCT02534012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167751|NCT02534012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167752|NCT05626387|Mycophenolic Acid|mycophenolic acid|mesh-list
93167753|NCT05626387|Prednisolone|prednisolone|mesh-list
93167754|NCT05626387|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93167755|NCT05626387|Methylprednisolone|methylprednisolone|mesh-list
93167756|NCT05626387|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93167757|NCT05626387|Prednisolone acetate|prednisolone acetate|mesh-list
93167758|NCT05626387|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92839952|NCT05114590|Lixisenatide|lixisenatide|mesh-list
93167759|NCT05626387|Prednisolone phosphate|prednisolone phosphate|mesh-list
93167760|NCT05626387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93167761|NCT05626387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167762|NCT05626387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93167763|NCT05626387|Antitubercular Agents|antitubercular agents|mesh-ancestor
93167764|NCT05626387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167765|NCT05626387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167766|NCT05626387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167767|NCT05626387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167768|NCT05626387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167769|NCT05626387|Glucocorticoids|glucocorticoids|mesh-ancestor
93167770|NCT05626387|Hormones|hormones|mesh-ancestor
93167771|NCT05626387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167772|NCT05626387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167773|NCT05626387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93167774|NCT05626387|Antiemetics|antiemetics|mesh-ancestor
93167775|NCT05626387|Autonomic Agents|autonomic agents|mesh-ancestor
93167776|NCT05626387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167777|NCT05626387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167778|NCT05626387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93167779|NCT05626387|Protective Agents|protective agents|mesh-ancestor
93167780|NCT03722940|Magnesium Sulfate|magnesium sulfate|mesh-list
93167781|NCT03722940|Analgesics|analgesics|mesh-ancestor
93167782|NCT03722940|Sensory System Agents|sensory system agents|mesh-ancestor
93167783|NCT03722940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167784|NCT03722940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167785|NCT03722940|Anesthetics|anesthetics|mesh-ancestor
93167786|NCT03722940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167787|NCT03722940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93167788|NCT03722940|Anticonvulsants|anticonvulsants|mesh-ancestor
93167789|NCT03722940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93167790|NCT03722940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93167791|NCT03722940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167792|NCT03722940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93167793|NCT03722940|Tocolytic Agents|tocolytic agents|mesh-ancestor
93167794|NCT03722940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167795|NCT01146925|Deferiprone|deferiprone|mesh-list
93167796|NCT01146925|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93167797|NCT01146925|Chelating Agents|chelating agents|mesh-ancestor
93167798|NCT01146925|Sequestering Agents|sequestering agents|mesh-ancestor
93167799|NCT01146925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167800|NCT04635254|Histamine|histamine|mesh-list
93167801|NCT04635254|Histamine Agonists|histamine agonists|mesh-ancestor
93167802|NCT04635254|Histamine Agents|histamine agents|mesh-ancestor
93167803|NCT04635254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167804|NCT04635254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167805|NCT04635254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167806|NCT03476044|Selenium|selenium|mesh-list
93167807|NCT03476044|Antioxidants|antioxidants|mesh-ancestor
93167808|NCT03476044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167809|NCT03476044|Protective Agents|protective agents|mesh-ancestor
93167810|NCT03476044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167811|NCT03476044|Trace Elements|trace elements|mesh-ancestor
93167812|NCT03476044|Micronutrients|micronutrients|mesh-ancestor
93167813|NCT01250821|Menotropins|menotropins|mesh-list
93167814|NCT01250821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93167815|NCT01250821|Fertility Agents|fertility agents|mesh-ancestor
93167816|NCT01250821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167817|NCT01250821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167818|NCT03493698|Midazolam|midazolam|mesh-list
93167819|NCT03493698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93167820|NCT03493698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93167821|NCT03493698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167822|NCT03493698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167823|NCT03493698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93167824|NCT03493698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93167825|NCT03493698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167826|NCT03493698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93167827|NCT03493698|Anesthetics, General|anesthetics, general|mesh-ancestor
93167828|NCT03493698|Anesthetics|anesthetics|mesh-ancestor
93167829|NCT03493698|GABA Modulators|gaba modulators|mesh-ancestor
93167830|NCT03493698|GABA Agents|gaba agents|mesh-ancestor
93167831|NCT03493698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167832|NCT03493698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167833|NCT01148173|Ifosfamide|ifosfamide|mesh-list
93167834|NCT01148173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93167835|NCT01148173|Alkylating Agents|alkylating agents|mesh-ancestor
93167836|NCT01148173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167837|NCT01148173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167838|NCT01898312|Mifepristone|mifepristone|mesh-list
93167839|NCT01898312|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93167840|NCT01898312|Abortifacient Agents|abortifacient agents|mesh-ancestor
93167841|NCT01898312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167842|NCT01898312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167843|NCT01898312|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93167844|NCT01898312|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93167845|NCT01898312|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93167846|NCT01898312|Contraceptive Agents|contraceptive agents|mesh-ancestor
93167847|NCT01898312|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93167848|NCT01898312|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93167849|NCT01898312|Hormone Antagonists|hormone antagonists|mesh-ancestor
93167850|NCT01898312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167851|NCT01898312|Luteolytic Agents|luteolytic agents|mesh-ancestor
93167852|NCT01898312|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93167853|NCT01898312|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93167854|NCT03528174|Pancrelipase|pancrelipase|mesh-list
93167855|NCT03528174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93167856|NCT05756660|Sodium thiosulfate|sodium thiosulfate|mesh-list
93167857|NCT05756660|Cisplatin|cisplatin|mesh-list
93167858|NCT05756660|Vorinostat|vorinostat|mesh-list
93167859|NCT05756660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167860|NCT05756660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93167861|NCT05756660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167862|NCT05756660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167863|NCT05756660|Antidotes|antidotes|mesh-ancestor
93167864|NCT05756660|Protective Agents|protective agents|mesh-ancestor
93167865|NCT05756660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167866|NCT05756660|Antioxidants|antioxidants|mesh-ancestor
93167867|NCT05756660|Antitubercular Agents|antitubercular agents|mesh-ancestor
93167868|NCT05756660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93167869|NCT05756660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93167870|NCT05756660|Chelating Agents|chelating agents|mesh-ancestor
93167871|NCT05756660|Sequestering Agents|sequestering agents|mesh-ancestor
93167872|NCT03482440|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
93167873|NCT03482440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167874|NCT03482440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167875|NCT03482440|Analgesics|analgesics|mesh-ancestor
93167876|NCT03482440|Sensory System Agents|sensory system agents|mesh-ancestor
93167877|NCT03482440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167878|NCT03482440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167879|NCT03482440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167880|NCT03482440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167881|NCT04638634|Immunoglobulins|immunoglobulins|mesh-list
93167882|NCT04638634|Immunologic Factors|immunologic factors|mesh-ancestor
93167883|NCT04638634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167884|NCT01253473|Budesonide|budesonide|mesh-list
93167885|NCT01253473|Albuterol|albuterol|mesh-list
93167886|NCT01253473|Formoterol Fumarate|formoterol fumarate|mesh-list
93167887|NCT01253473|Ipratropium|ipratropium|mesh-list
93167888|NCT01253473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167889|NCT01253473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93167890|NCT01253473|Autonomic Agents|autonomic agents|mesh-ancestor
93167891|NCT01253473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167892|NCT01253473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167893|NCT01253473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93167894|NCT01253473|Respiratory System Agents|respiratory system agents|mesh-ancestor
93167895|NCT01253473|Glucocorticoids|glucocorticoids|mesh-ancestor
93167896|NCT01253473|Hormones|hormones|mesh-ancestor
93167897|NCT01253473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167898|NCT01253473|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93167899|NCT01253473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93167900|NCT01253473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93167901|NCT01253473|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167902|NCT01253473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167903|NCT01253473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167904|NCT01253473|Tocolytic Agents|tocolytic agents|mesh-ancestor
93167905|NCT01253473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93167906|NCT01253473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93167907|NCT01253473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92840097|NCT04472611|Colchicine|colchicine|mesh-list
93167909|NCT01883804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93167910|NCT01883804|Sympatholytics|sympatholytics|mesh-ancestor
93167911|NCT01883804|Autonomic Agents|autonomic agents|mesh-ancestor
93167912|NCT01883804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167913|NCT01883804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167914|NCT01883804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93167915|NCT01883804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93167916|NCT01883804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93167917|NCT01883804|Adrenergic Agents|adrenergic agents|mesh-ancestor
93167918|NCT01883804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167919|NCT01883804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167920|NCT01247935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93167921|NCT01247935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167922|NCT01247935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167923|NCT03475810|Midazolam|midazolam|mesh-list
93167924|NCT03475810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93167925|NCT03475810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93167926|NCT03475810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93167927|NCT03475810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167928|NCT03475810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93167929|NCT03475810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93167930|NCT03475810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93167931|NCT03475810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93167932|NCT03475810|Anesthetics, General|anesthetics, general|mesh-ancestor
93167933|NCT03475810|Anesthetics|anesthetics|mesh-ancestor
93167934|NCT03475810|GABA Modulators|gaba modulators|mesh-ancestor
93167935|NCT03475810|GABA Agents|gaba agents|mesh-ancestor
93167936|NCT03475810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167937|NCT03475810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167938|NCT03480100|Xylometazoline|xylometazoline|mesh-list
93167939|NCT03480100|Nasal Decongestants|nasal decongestants|mesh-ancestor
93167940|NCT03480100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93167941|NCT03480100|Respiratory System Agents|respiratory system agents|mesh-ancestor
93167942|NCT02348203|Aspirin|aspirin|mesh-list
93167943|NCT02348203|Zileuton|zileuton|mesh-list
93167944|NCT02348203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167945|NCT02348203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93167946|NCT02348203|Analgesics|analgesics|mesh-ancestor
93167947|NCT02348203|Sensory System Agents|sensory system agents|mesh-ancestor
93167948|NCT02348203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167949|NCT02348203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167950|NCT02348203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167951|NCT02348203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167952|NCT02348203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93167953|NCT02348203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93167954|NCT02348203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167955|NCT02348203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93167956|NCT02348203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93167957|NCT02348203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167958|NCT02348203|Antipyretics|antipyretics|mesh-ancestor
93167959|NCT02348203|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93167960|NCT02348203|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93167961|NCT02348203|Hormone Antagonists|hormone antagonists|mesh-ancestor
93167962|NCT02348203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93167963|NCT03493542|Vaccines|vaccines|mesh-list
93167964|NCT03493542|Immunologic Factors|immunologic factors|mesh-ancestor
93167965|NCT03493542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167966|NCT04365088|Deflazacort|deflazacort|mesh-list
93167967|NCT04365088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167968|NCT04365088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93167969|NCT04365088|Immunologic Factors|immunologic factors|mesh-ancestor
93167970|NCT04365088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167971|NCT03482362|Vinorelbine|vinorelbine|mesh-list
93167972|NCT03482362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93167973|NCT03482362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93167974|NCT03482362|Tubulin Modulators|tubulin modulators|mesh-ancestor
93167975|NCT03482362|Antimitotic Agents|antimitotic agents|mesh-ancestor
93167976|NCT03482362|Mitosis Modulators|mitosis modulators|mesh-ancestor
93167977|NCT03482362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167978|NCT04500470|Ketoprofen|ketoprofen|mesh-list
93167979|NCT04500470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93167980|NCT04500470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840176|NCT04078295|Nivolumab|nivolumab|mesh-list
93167981|NCT04500470|Analgesics|analgesics|mesh-ancestor
93167982|NCT04500470|Sensory System Agents|sensory system agents|mesh-ancestor
93167983|NCT04500470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93167984|NCT04500470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167985|NCT04500470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93167986|NCT04500470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93167987|NCT04500470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93167988|NCT04500470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93167989|NCT04500470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167990|NCT03493386|Glycine|glycine|mesh-list
93167991|NCT03493386|Glycine Agents|glycine agents|mesh-ancestor
93167992|NCT03493386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93167993|NCT03493386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167994|NCT03493386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93167995|NCT04937816|Empagliflozin|empagliflozin|mesh-list
93167996|NCT04937816|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93167997|NCT04937816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93167998|NCT04937816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93167999|NCT04937816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168000|NCT01366898|Methotrexate|methotrexate|mesh-list
93168001|NCT01366898|Idarubicin|idarubicin|mesh-list
93168002|NCT01366898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93168003|NCT01366898|Abortifacient Agents|abortifacient agents|mesh-ancestor
93168004|NCT01366898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93168005|NCT01366898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168006|NCT01366898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93168007|NCT01366898|Antimetabolites|antimetabolites|mesh-ancestor
93168008|NCT01366898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168009|NCT01366898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168010|NCT01366898|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168011|NCT01366898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168012|NCT01366898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93168013|NCT01366898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168014|NCT01366898|Immunologic Factors|immunologic factors|mesh-ancestor
93168015|NCT01366898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168016|NCT01366898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93168017|NCT01366898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93168018|NCT01366898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93168019|NCT01366898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93168020|NCT01248871|Sufentanil|sufentanil|mesh-list
93168021|NCT01248871|Remifentanil|remifentanil|mesh-list
93168023|NCT01248871|Propofol|propofol|mesh-list
93168024|NCT01248871|Sevoflurane|sevoflurane|mesh-list
93168025|NCT01248871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93168026|NCT01248871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168027|NCT01248871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168028|NCT01248871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93168029|NCT01248871|Anesthetics, General|anesthetics, general|mesh-ancestor
93168030|NCT01248871|Anesthetics|anesthetics|mesh-ancestor
93168031|NCT01248871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93168032|NCT01248871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93168033|NCT01248871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93168034|NCT01248871|Narcotics|narcotics|mesh-ancestor
93168035|NCT01248871|Analgesics|analgesics|mesh-ancestor
93168036|NCT01248871|Sensory System Agents|sensory system agents|mesh-ancestor
93168037|NCT01248871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168038|NCT01248871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93168039|NCT01251133|Vaccines|vaccines|mesh-list
93168040|NCT01251133|Immunologic Factors|immunologic factors|mesh-ancestor
93168041|NCT01251133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168042|NCT03720288|Acetazolamide|acetazolamide|mesh-list
93168043|NCT03720288|Anticonvulsants|anticonvulsants|mesh-ancestor
93168044|NCT03720288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93168045|NCT03720288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168046|NCT03720288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168047|NCT03720288|Diuretics|diuretics|mesh-ancestor
93168048|NCT03720288|Natriuretic Agents|natriuretic agents|mesh-ancestor
93168049|NCT03720288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168050|NCT03907813|Bupivacaine|bupivacaine|mesh-list
93168051|NCT03907813|Anesthetics, Local|anesthetics, local|mesh-ancestor
93168052|NCT03907813|Anesthetics|anesthetics|mesh-ancestor
93168053|NCT03907813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168054|NCT03907813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168055|NCT03907813|Sensory System Agents|sensory system agents|mesh-ancestor
93168056|NCT03907813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168057|NCT00938912|Lacosamide|lacosamide|mesh-list
93168058|NCT00938912|Anticonvulsants|anticonvulsants|mesh-ancestor
93168059|NCT00938912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93168060|NCT00938912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93168061|NCT00938912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168062|NCT00938912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168063|NCT01251211|Botulinum Toxins|botulinum toxins|mesh-list
93168064|NCT01251211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93168065|NCT01251211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93168066|NCT01251211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93168067|NCT01251211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168068|NCT01251211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168069|NCT01251211|Cholinergic Agents|cholinergic agents|mesh-ancestor
93168070|NCT01251211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168071|NCT01251211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168072|NCT01251211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93168073|NCT01251211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168074|NCT03473340|Pirfenidone|pirfenidone|mesh-list
93168075|NCT03473340|Analgesics|analgesics|mesh-ancestor
93168076|NCT03473340|Sensory System Agents|sensory system agents|mesh-ancestor
93168077|NCT03473340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168078|NCT03473340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168079|NCT03473340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168080|NCT03473340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168081|NCT03473340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168082|NCT03473340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168083|NCT03473340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168084|NCT01147705|Allopurinol|allopurinol|mesh-list
93168085|NCT01147705|Antimetabolites|antimetabolites|mesh-ancestor
93168086|NCT01147705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168087|NCT01147705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168088|NCT01147705|Gout Suppressants|gout suppressants|mesh-ancestor
93168089|NCT01147705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168090|NCT01147705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93168091|NCT01147705|Antioxidants|antioxidants|mesh-ancestor
93168092|NCT01147705|Protective Agents|protective agents|mesh-ancestor
93168093|NCT01147705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168094|NCT03907111|Chitosan|chitosan|mesh-list
93168095|NCT03907111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93168096|NCT03907111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93168097|NCT03907111|Antimetabolites|antimetabolites|mesh-ancestor
93168098|NCT03907111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168099|NCT03907111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93168100|NCT03907111|Chelating Agents|chelating agents|mesh-ancestor
93168101|NCT03907111|Sequestering Agents|sequestering agents|mesh-ancestor
93168102|NCT03907111|Hemostatics|hemostatics|mesh-ancestor
93168103|NCT03907111|Coagulants|coagulants|mesh-ancestor
93168104|NCT03912727|Thioctic Acid|thioctic acid|mesh-list
93168105|NCT03912727|Antioxidants|antioxidants|mesh-ancestor
93168106|NCT03912727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168107|NCT03912727|Protective Agents|protective agents|mesh-ancestor
93168108|NCT03912727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168109|NCT03912727|Vitamin B Complex|vitamin b complex|mesh-ancestor
93168110|NCT03912727|Vitamins|vitamins|mesh-ancestor
93168111|NCT03912727|Micronutrients|micronutrients|mesh-ancestor
93168112|NCT03661567|Methylprednisolone|methylprednisolone|mesh-list
93168113|NCT03661567|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93168114|NCT03661567|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93168115|NCT03661567|Prednisolone|prednisolone|mesh-list
93168116|NCT03661567|Prednisolone acetate|prednisolone acetate|mesh-list
93168117|NCT03661567|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93168118|NCT03661567|Prednisolone phosphate|prednisolone phosphate|mesh-list
93168119|NCT03661567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168120|NCT03661567|Antiemetics|antiemetics|mesh-ancestor
93168121|NCT03661567|Autonomic Agents|autonomic agents|mesh-ancestor
93168122|NCT03661567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168123|NCT03661567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168124|NCT03661567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93168125|NCT03661567|Glucocorticoids|glucocorticoids|mesh-ancestor
93168126|NCT03661567|Hormones|hormones|mesh-ancestor
93168127|NCT03661567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168128|NCT03661567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93168129|NCT03661567|Protective Agents|protective agents|mesh-ancestor
93168130|NCT03661567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93168131|NCT03661567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840320|NCT03067051|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168132|NCT03739138|Pembrolizumab|pembrolizumab|mesh-list
93168133|NCT03739138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168134|NCT03739138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168135|NCT03739138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93168136|NCT03739138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168137|NCT03472326|GS-9131|gs-9131|mesh-list
93168138|NCT03472326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168139|NCT03472326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168140|NCT03472326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93168141|NCT03472326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93168142|NCT03472326|Antiviral Agents|antiviral agents|mesh-ancestor
93168143|NCT03472326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168144|NCT03472326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93168145|NCT03472326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93168146|NCT03472014|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93168147|NCT03472014|Antiviral Agents|antiviral agents|mesh-ancestor
92855132|NCT02753712|Xhance|xhance|mesh-list
93168148|NCT03472014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168149|NCT04182100|Aspirin|aspirin|mesh-list
93168150|NCT04182100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168151|NCT04182100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168152|NCT04182100|Analgesics|analgesics|mesh-ancestor
93168153|NCT04182100|Sensory System Agents|sensory system agents|mesh-ancestor
93168154|NCT04182100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168155|NCT04182100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168156|NCT04182100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168157|NCT04182100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168158|NCT04182100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93168159|NCT04182100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93168160|NCT04182100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168161|NCT04182100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93168162|NCT04182100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93168163|NCT04182100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168164|NCT04182100|Antipyretics|antipyretics|mesh-ancestor
93168165|NCT03479320|Lidocaine|lidocaine|mesh-list
93168166|NCT03479320|Anesthetics, Local|anesthetics, local|mesh-ancestor
93168167|NCT03479320|Anesthetics|anesthetics|mesh-ancestor
93168168|NCT03479320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168169|NCT03479320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168170|NCT03479320|Sensory System Agents|sensory system agents|mesh-ancestor
93168171|NCT03479320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168172|NCT03479320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168173|NCT03479320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93168174|NCT03479320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93168175|NCT03479320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168176|NCT03479320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168177|NCT03912415|Paclitaxel|paclitaxel|mesh-list
93168178|NCT03912415|Bevacizumab|bevacizumab|mesh-list
93168179|NCT03912415|Carboplatin|carboplatin|mesh-list
93168180|NCT03912415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93168181|NCT03912415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168182|NCT03912415|Tubulin Modulators|tubulin modulators|mesh-ancestor
93168183|NCT03912415|Antimitotic Agents|antimitotic agents|mesh-ancestor
93168184|NCT03912415|Mitosis Modulators|mitosis modulators|mesh-ancestor
93168185|NCT03912415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168186|NCT03912415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168187|NCT03912415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93168188|NCT03912415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93168189|NCT03912415|Growth Substances|growth substances|mesh-ancestor
93168190|NCT03912415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168191|NCT03912415|Growth Inhibitors|growth inhibitors|mesh-ancestor
93168192|NCT03525834|Everolimus|everolimus|mesh-list
93168193|NCT03525834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93168194|NCT03525834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93168195|NCT03525834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168196|NCT03525834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168197|NCT03525834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168198|NCT03525834|Immunologic Factors|immunologic factors|mesh-ancestor
93168199|NCT03525834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168200|NCT03525834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168201|NCT00925652|Cyclophosphamide|cyclophosphamide|mesh-list
93168202|NCT00925652|Bevacizumab|bevacizumab|mesh-list
93168203|NCT00925652|Methotrexate|methotrexate|mesh-list
93168204|NCT00925652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168205|NCT00925652|Immunologic Factors|immunologic factors|mesh-ancestor
93168206|NCT00925652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168207|NCT00925652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168208|NCT00925652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93168209|NCT00925652|Alkylating Agents|alkylating agents|mesh-ancestor
93168210|NCT00925652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168211|NCT00925652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168212|NCT00925652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93168213|NCT00925652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168214|NCT00925652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93168215|NCT00925652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93168216|NCT00925652|Growth Substances|growth substances|mesh-ancestor
93168217|NCT00925652|Growth Inhibitors|growth inhibitors|mesh-ancestor
93168218|NCT00925652|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93168219|NCT00925652|Abortifacient Agents|abortifacient agents|mesh-ancestor
92855135|NCT02753712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93168220|NCT00925652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93168221|NCT00925652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93168222|NCT00925652|Antimetabolites|antimetabolites|mesh-ancestor
93168223|NCT00925652|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168224|NCT00925652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168225|NCT00925652|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93168226|NCT00925652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93168227|NCT04872686|Povidone-Iodine|povidone-iodine|mesh-list
93168228|NCT04872686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93168229|NCT04872686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168230|NCT03954106|Defibrotide|defibrotide|mesh-list
93168231|NCT03954106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93168232|NCT03954106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93168233|NCT03954106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168234|NCT03954106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93168235|NCT03525444|Ivacaftor|ivacaftor|mesh-list
93168236|NCT03525444|Elexacaftor|elexacaftor|mesh-list
93168237|NCT03525444|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93168238|NCT03525444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168239|NCT03525444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168240|NCT01251835|Rifampin|rifampin|mesh-list
93168241|NCT01251835|Sitaxsentan|sitaxsentan|mesh-list
93168242|NCT01251835|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93168243|NCT01251835|Antitubercular Agents|antitubercular agents|mesh-ancestor
93168244|NCT01251835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93168245|NCT01251835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168246|NCT01251835|Leprostatic Agents|leprostatic agents|mesh-ancestor
93168247|NCT01251835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93168248|NCT01251835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168249|NCT01251835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168250|NCT01251835|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93168251|NCT01251835|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93168252|NCT01251835|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93168253|NCT01251835|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93168254|NCT01251835|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93168255|NCT01251835|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93168256|NCT01251835|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93168257|NCT03632876|Vitamin A|vitamin a|mesh-list
93168258|NCT03632876|Retinol palmitate|retinol palmitate|mesh-list
93168259|NCT03632876|Antioxidants|antioxidants|mesh-ancestor
93168260|NCT03632876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168261|NCT03632876|Protective Agents|protective agents|mesh-ancestor
93168262|NCT03632876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168263|NCT03632876|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93168264|NCT03632876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168265|NCT03632876|Vitamins|vitamins|mesh-ancestor
93168266|NCT03632876|Micronutrients|micronutrients|mesh-ancestor
93168267|NCT03914755|Tucatinib|tucatinib|mesh-list
93168268|NCT03914755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168269|NCT03914755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93168270|NCT03914755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168271|NCT03914755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168272|NCT03905317|Bevacizumab|bevacizumab|mesh-list
93168273|NCT03905317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168274|NCT03905317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168275|NCT03905317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93168276|NCT03905317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92840467|NCT02393794|Nivolumab|nivolumab|mesh-list
93168277|NCT03905317|Growth Substances|growth substances|mesh-ancestor
93168278|NCT03905317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168279|NCT03905317|Growth Inhibitors|growth inhibitors|mesh-ancestor
93168280|NCT03487848|Sofosbuvir|sofosbuvir|mesh-list
93168281|NCT03487848|Antiviral Agents|antiviral agents|mesh-ancestor
93168282|NCT03487848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168283|NCT01251991|Psyllium|psyllium|mesh-list
93168284|NCT01251991|Calcium polycarbophil|calcium polycarbophil|mesh-list
93168285|NCT01251991|Cathartics|cathartics|mesh-ancestor
93168286|NCT01251991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93168287|NCT01251991|Antidiarrheals|antidiarrheals|mesh-ancestor
93168288|NCT04458454|Methocarbamol|methocarbamol|mesh-list
93168289|NCT04458454|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93168290|NCT04458454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168291|NCT04458454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93168292|NCT04458454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168293|NCT03914677|Mecamylamine|mecamylamine|mesh-list
93168294|NCT03914677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93168295|NCT03914677|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
93168296|NCT03914677|Autonomic Agents|autonomic agents|mesh-ancestor
93168297|NCT03914677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168298|NCT03914677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168299|NCT03914677|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93168300|NCT03914677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93168301|NCT03914677|Cholinergic Agents|cholinergic agents|mesh-ancestor
93168302|NCT03914677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168303|NCT03914677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168304|NCT03479086|Topiramate|topiramate|mesh-list
93168305|NCT03479086|Naltrexone|naltrexone|mesh-list
93168306|NCT03479086|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93168307|NCT03479086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93168308|NCT03479086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168309|NCT03479086|Sensory System Agents|sensory system agents|mesh-ancestor
93168310|NCT03479086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168311|NCT03479086|Anticonvulsants|anticonvulsants|mesh-ancestor
93168312|NCT03479086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93168313|NCT01252069|Ulipristal acetate|ulipristal acetate|mesh-list
93168314|NCT01252069|Progestins|progestins|mesh-list
93168315|NCT01252069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93168316|NCT01252069|Contraceptive Agents|contraceptive agents|mesh-ancestor
93168317|NCT01252069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93168318|NCT01252069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168319|NCT01252069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93168320|NCT01252069|Hormones|hormones|mesh-ancestor
93168321|NCT01252069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168322|NCT01252225|Lidocaine|lidocaine|mesh-list
93168323|NCT01252225|Anesthetics, Local|anesthetics, local|mesh-ancestor
93168324|NCT01252225|Anesthetics|anesthetics|mesh-ancestor
93168325|NCT01252225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168326|NCT01252225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168327|NCT01252225|Sensory System Agents|sensory system agents|mesh-ancestor
93168328|NCT01252225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168329|NCT01252225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168330|NCT01252225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93168331|NCT01252225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93168332|NCT01252225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168333|NCT01252225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168334|NCT04459702|Ritonavir|ritonavir|mesh-list
93168335|NCT04459702|Lopinavir|lopinavir|mesh-list
93168336|NCT04459702|Azithromycin|azithromycin|mesh-list
93168337|NCT04459702|Hydroxychloroquine|hydroxychloroquine|mesh-list
93168338|NCT04459702|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93168339|NCT04459702|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93168340|NCT04459702|Protease Inhibitors|protease inhibitors|mesh-ancestor
93168341|NCT04459702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168342|NCT04459702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168343|NCT04459702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93168344|NCT04459702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93168345|NCT04459702|Antiviral Agents|antiviral agents|mesh-ancestor
93168346|NCT04459702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168347|NCT04459702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93168348|NCT04459702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93168349|NCT04459702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93168350|NCT04459702|Antimalarials|antimalarials|mesh-ancestor
93168351|NCT04459702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92840542|NCT01743131|Abatacept|abatacept|mesh-list
93168352|NCT04459702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93168353|NCT04459702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168355|NCT03574792|Methadone|methadone|mesh-list
93168356|NCT03574792|Gabapentin|gabapentin|mesh-list
93168357|NCT03574792|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93168358|NCT03574792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93168359|NCT03574792|Narcotics|narcotics|mesh-ancestor
93168360|NCT03574792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168361|NCT03574792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168362|NCT03574792|Analgesics|analgesics|mesh-ancestor
93168363|NCT03574792|Sensory System Agents|sensory system agents|mesh-ancestor
93168364|NCT03574792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168365|NCT03574792|Anticonvulsants|anticonvulsants|mesh-ancestor
93168366|NCT03574792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93168367|NCT03574792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93168368|NCT03574792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93168369|NCT03574792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93168370|NCT03574792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93168371|NCT03574792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168372|NCT03574792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168373|NCT03574792|Antimanic Agents|antimanic agents|mesh-ancestor
93168374|NCT03574792|Antitussive Agents|antitussive agents|mesh-ancestor
93168375|NCT03574792|Respiratory System Agents|respiratory system agents|mesh-ancestor
93168376|NCT03574792|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93168377|NCT03574792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93168378|NCT03574792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168379|NCT03574792|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93168380|NCT03574792|Antidepressive Agents|antidepressive agents|mesh-ancestor
93168381|NCT03904849|Cannabidiol|cannabidiol|mesh-list
93168382|NCT03904849|Anticonvulsants|anticonvulsants|mesh-ancestor
93168383|NCT01250743|Vitamins|vitamins|mesh-list
93168384|NCT01250743|Ascorbic Acid|ascorbic acid|mesh-list
93168385|NCT01250743|Micronutrients|micronutrients|mesh-ancestor
93168386|NCT01250743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168387|NCT01250743|Antioxidants|antioxidants|mesh-ancestor
93168388|NCT01250743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168389|NCT01250743|Protective Agents|protective agents|mesh-ancestor
93168390|NCT01254175|Vaccines|vaccines|mesh-list
93168391|NCT01254175|Immunologic Factors|immunologic factors|mesh-ancestor
93168392|NCT01254175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168393|NCT04377620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
93168394|NCT04377620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93168395|NCT04377620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168396|NCT04377620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168397|NCT03478540|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93168398|NCT03478540|Antiviral Agents|antiviral agents|mesh-ancestor
93168399|NCT03478540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168400|NCT03903367|Fentanyl|fentanyl|mesh-list
93168401|NCT03903367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93168402|NCT03903367|Narcotics|narcotics|mesh-ancestor
93168403|NCT03903367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168404|NCT03903367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168405|NCT03903367|Analgesics|analgesics|mesh-ancestor
93168406|NCT03903367|Sensory System Agents|sensory system agents|mesh-ancestor
93168407|NCT03903367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168408|NCT03903367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93168409|NCT03903367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93168410|NCT03903367|Anesthetics, General|anesthetics, general|mesh-ancestor
93168411|NCT03903367|Anesthetics|anesthetics|mesh-ancestor
93168412|NCT03486834|Vaccines|vaccines|mesh-list
93168413|NCT03486834|Immunologic Factors|immunologic factors|mesh-ancestor
93168414|NCT03486834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168415|NCT02523664|Hydrocortisone|hydrocortisone|mesh-list
93168416|NCT02523664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168417|NCT03177460|Daratumumab|daratumumab|mesh-list
93168418|NCT03177460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168419|NCT03717168|Hormones|hormones|mesh-list
93168420|NCT03717168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168421|NCT03717168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168422|NCT00708448|Bevacizumab|bevacizumab|mesh-list
93168423|NCT00708448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93168424|NCT00708448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168425|NCT00708448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168426|NCT00708448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93168427|NCT00708448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93168428|NCT00708448|Growth Substances|growth substances|mesh-ancestor
93168429|NCT00708448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168430|NCT00708448|Growth Inhibitors|growth inhibitors|mesh-ancestor
93168431|NCT00708448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93168432|NCT00708448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168433|NCT00708448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168434|NCT02892604|Insulin|insulin|mesh-list
93168435|NCT02892604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93168436|NCT02892604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168437|NCT03478306|Melatonin|melatonin|mesh-list
93168438|NCT03478306|Antioxidants|antioxidants|mesh-ancestor
93168439|NCT03478306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168440|NCT03478306|Protective Agents|protective agents|mesh-ancestor
93168441|NCT03478306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464226|NCT01767428|Sensory System Agents|sensory system agents|mesh-ancestor
93168442|NCT03478306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168443|NCT03103100|Lidocaine|lidocaine|mesh-list
93168444|NCT03103100|Bupivacaine|bupivacaine|mesh-list
93168445|NCT03103100|Anesthetics, Local|anesthetics, local|mesh-ancestor
93168446|NCT03103100|Anesthetics|anesthetics|mesh-ancestor
93168447|NCT03103100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168448|NCT03103100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168449|NCT03103100|Sensory System Agents|sensory system agents|mesh-ancestor
93168450|NCT03103100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168451|NCT03103100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168452|NCT03103100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93168453|NCT03103100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93168454|NCT03103100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168455|NCT03103100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168456|NCT02940496|Ribavirin|ribavirin|mesh-list
93168457|NCT02940496|Grazoprevir|grazoprevir|mesh-list
93168458|NCT02940496|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93168459|NCT02940496|Pembrolizumab|pembrolizumab|mesh-list
93168460|NCT02940496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168461|NCT02940496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168462|NCT02940496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93168463|NCT02940496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168464|NCT02940496|Antimetabolites|antimetabolites|mesh-ancestor
93168465|NCT02940496|Antiviral Agents|antiviral agents|mesh-ancestor
93168466|NCT02940496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168467|NCT03639168|Cisplatin|cisplatin|mesh-list
93168468|NCT03639168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168469|NCT03131050|Scopolamine|scopolamine|mesh-list
93168470|NCT03131050|Escitalopram|escitalopram|mesh-list
93168471|NCT03131050|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93168472|NCT03131050|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93168473|NCT03131050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93168474|NCT03131050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168475|NCT03131050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168476|NCT03131050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168477|NCT03131050|Serotonin Agents|serotonin agents|mesh-ancestor
93168478|NCT03131050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168479|NCT03131050|Parasympatholytics|parasympatholytics|mesh-ancestor
93168480|NCT03131050|Autonomic Agents|autonomic agents|mesh-ancestor
93168481|NCT03131050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168482|NCT03131050|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93168483|NCT03131050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93168484|NCT03131050|Cholinergic Agents|cholinergic agents|mesh-ancestor
93168485|NCT03131050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93168486|NCT03131050|Antiemetics|antiemetics|mesh-ancestor
93168487|NCT03131050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93168488|NCT03131050|Mydriatics|mydriatics|mesh-ancestor
93168489|NCT03719820|Clopidogrel|clopidogrel|mesh-list
93168490|NCT03719820|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93168491|NCT03719820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168492|NCT03719820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168493|NCT03719820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93168494|NCT03719820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168495|NCT03719820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93168496|NCT03719820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93168497|NCT03719820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93168498|NCT03719820|Purinergic Agents|purinergic agents|mesh-ancestor
93168499|NCT03719820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168500|NCT03719820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93168501|NCT03719820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92840697|NCT02623569|Atenolol|atenolol|mesh-list
93168502|NCT03719820|Antimetabolites|antimetabolites|mesh-ancestor
93168503|NCT03719820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93168504|NCT03719820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93168505|NCT04206020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93168506|NCT04206020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93168507|NCT03466086|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93168508|NCT03466086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93168509|NCT01254799|Doxycycline|doxycycline|mesh-list
93168510|NCT01254799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93168511|NCT01254799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168512|NCT01254799|Antimalarials|antimalarials|mesh-ancestor
93168513|NCT01254799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93168514|NCT01254799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93168515|NCT05553938|Empagliflozin|empagliflozin|mesh-list
93168516|NCT05553938|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93168517|NCT05553938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168518|NCT05553938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93168519|NCT05553938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168520|NCT03718884|Mirikizumab|mirikizumab|mesh-list
93168521|NCT03718884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168522|NCT03718884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168523|NCT03718884|Analgesics|analgesics|mesh-ancestor
93168524|NCT03718884|Sensory System Agents|sensory system agents|mesh-ancestor
93168525|NCT03718884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168526|NCT03718884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168527|NCT03718884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168528|NCT03718884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168529|NCT03718884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93168530|NCT03718884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93168531|NCT03718806|Zoliflodacin|zoliflodacin|mesh-list
93168532|NCT03718806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93168533|NCT03718806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93168534|NCT03718806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168535|NCT03718806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168536|NCT03718806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168537|NCT03716856|Cyclophosphamide|cyclophosphamide|mesh-list
93168538|NCT03716856|Fludarabine|fludarabine|mesh-list
93168539|NCT03716856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168540|NCT03716856|Immunologic Factors|immunologic factors|mesh-ancestor
93168541|NCT03716856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168542|NCT03716856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168543|NCT03716856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93168544|NCT03716856|Alkylating Agents|alkylating agents|mesh-ancestor
93168545|NCT03716856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168546|NCT03716856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168547|NCT03716856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93168548|NCT03910543|Tofacitinib|tofacitinib|mesh-list
93168549|NCT03910543|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93168550|NCT03910543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93168551|NCT03910543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168552|NCT03910543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168553|NCT03101462|Vaccines|vaccines|mesh-list
93168554|NCT03101462|Immunologic Factors|immunologic factors|mesh-ancestor
93168555|NCT03101462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168556|NCT03904537|Antibodies|antibodies|mesh-list
93168557|NCT03904537|Immunologic Factors|immunologic factors|mesh-ancestor
93168558|NCT03904537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168559|NCT03904225|Tegafur|tegafur|mesh-list
93168560|NCT03904225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93168561|NCT03904225|Antimetabolites|antimetabolites|mesh-ancestor
93168562|NCT03904225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168563|NCT03904225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168564|NCT03910231|Tolvaptan|tolvaptan|mesh-list
93168565|NCT03910231|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93168566|NCT03910231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168567|NCT03910231|Natriuretic Agents|natriuretic agents|mesh-ancestor
93168568|NCT03910231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168569|NCT01149109|Temozolomide|temozolomide|mesh-list
93168570|NCT01149109|Lomustine|lomustine|mesh-list
93168571|NCT01149109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93168572|NCT01149109|Alkylating Agents|alkylating agents|mesh-ancestor
93168573|NCT01149109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168574|NCT01149109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168575|NCT05667415|Cisplatin|cisplatin|mesh-list
93168576|NCT05667415|Disulfiram|disulfiram|mesh-list
93168577|NCT05667415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168578|NCT05667415|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93168579|NCT05667415|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93168580|NCT05667415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168581|NCT05667415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168582|NCT01586143|Acetaminophen|acetaminophen|mesh-list
93168583|NCT01586143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168584|NCT01586143|Analgesics|analgesics|mesh-ancestor
93168585|NCT01586143|Sensory System Agents|sensory system agents|mesh-ancestor
93168586|NCT01586143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168587|NCT01586143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168588|NCT01586143|Antipyretics|antipyretics|mesh-ancestor
93168589|NCT01256359|Docetaxel|docetaxel|mesh-list
93168590|NCT01256359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168591|NCT01256359|Tubulin Modulators|tubulin modulators|mesh-ancestor
93168592|NCT01256359|Antimitotic Agents|antimitotic agents|mesh-ancestor
93168593|NCT01256359|Mitosis Modulators|mitosis modulators|mesh-ancestor
93168594|NCT01256359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168595|NCT02527993|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93168596|NCT02527993|Liraglutide|liraglutide|mesh-list
93168597|NCT02527993|Acarbose|acarbose|mesh-list
93168598|NCT02527993|Verapamil|verapamil|mesh-list
93168599|NCT02527993|Pasireotide|pasireotide|mesh-list
93168600|NCT02527993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93168601|NCT02527993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168602|NCT02527993|Incretins|incretins|mesh-ancestor
93168603|NCT02527993|Hormones|hormones|mesh-ancestor
93168604|NCT02527993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168605|NCT02527993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93168606|NCT02527993|Protease Inhibitors|protease inhibitors|mesh-ancestor
93168607|NCT02527993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168608|NCT02527993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168609|NCT02527993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168610|NCT02527993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93168611|NCT02527993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168612|NCT02527993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93168613|NCT02527993|Vasodilator Agents|vasodilator agents|mesh-ancestor
93168614|NCT02527993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93168615|NCT04927052|Lidocaine|lidocaine|mesh-list
93168616|NCT04927052|Anesthetics, Local|anesthetics, local|mesh-ancestor
93168617|NCT04927052|Anesthetics|anesthetics|mesh-ancestor
93168618|NCT04927052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168619|NCT04927052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168620|NCT04927052|Sensory System Agents|sensory system agents|mesh-ancestor
93168621|NCT04927052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168622|NCT04927052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168623|NCT04927052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93168624|NCT04927052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93168625|NCT04927052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168626|NCT04927052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168627|NCT01149499|Valacyclovir|valacyclovir|mesh-list
93168628|NCT01149499|Antiviral Agents|antiviral agents|mesh-ancestor
93168629|NCT01149499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168630|NCT03900871|Aspirin|aspirin|mesh-list
93168631|NCT03900871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168632|NCT03900871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168633|NCT03900871|Analgesics|analgesics|mesh-ancestor
93168634|NCT03900871|Sensory System Agents|sensory system agents|mesh-ancestor
93168635|NCT03900871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168636|NCT03900871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168637|NCT03900871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168638|NCT03900871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168639|NCT03900871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93168640|NCT03900871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93168641|NCT03900871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168642|NCT03900871|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93168643|NCT03900871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93168644|NCT03900871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168645|NCT03900871|Antipyretics|antipyretics|mesh-ancestor
93168646|NCT01149577|Olanzapine|olanzapine|mesh-list
93168647|NCT01149577|Antiemetics|antiemetics|mesh-ancestor
93168648|NCT01149577|Autonomic Agents|autonomic agents|mesh-ancestor
93168649|NCT01149577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168650|NCT01149577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168651|NCT01149577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93168652|NCT01149577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93168653|NCT01149577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93168654|NCT01149577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168655|NCT01149577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93168656|NCT01149577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93168657|NCT01149577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93168658|NCT01149577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168659|NCT01149577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168660|NCT01149577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168662|NCT03894007|Maytansine|maytansine|mesh-list
93168663|NCT03894007|Docetaxel|docetaxel|mesh-list
93168664|NCT03894007|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93168665|NCT03894007|Cyclophosphamide|cyclophosphamide|mesh-list
93168666|NCT03894007|Carboplatin|carboplatin|mesh-list
93168667|NCT03894007|Trastuzumab|trastuzumab|mesh-list
93168668|NCT03894007|Atezolizumab|atezolizumab|mesh-list
93168669|NCT03894007|Epirubicin|epirubicin|mesh-list
93168670|NCT03894007|Pertuzumab|pertuzumab|mesh-list
93168671|NCT03894007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93168672|NCT03894007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168673|NCT03894007|Tubulin Modulators|tubulin modulators|mesh-ancestor
93168674|NCT03894007|Antimitotic Agents|antimitotic agents|mesh-ancestor
93168675|NCT03894007|Mitosis Modulators|mitosis modulators|mesh-ancestor
93168676|NCT03894007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168677|NCT03894007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168678|NCT03894007|Immunologic Factors|immunologic factors|mesh-ancestor
93168679|NCT03894007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168680|NCT03894007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168681|NCT03894007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93168682|NCT03894007|Alkylating Agents|alkylating agents|mesh-ancestor
93168683|NCT03894007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93168684|NCT03894007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168685|NCT03894007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93168686|NCT03894007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93168687|NCT03894007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93168688|NCT03894007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93168689|NCT03894007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168690|NCT03894007|Immunotoxins|immunotoxins|mesh-ancestor
93168691|NCT03894007|Immunoconjugates|immunoconjugates|mesh-ancestor
93168692|NCT01150747|Azithromycin|azithromycin|mesh-list
93168693|NCT01150747|Ceftriaxone|ceftriaxone|mesh-list
93168694|NCT01150747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93168695|NCT01150747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168696|NCT03893695|Nivolumab|nivolumab|mesh-list
93168697|NCT03893695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168698|NCT03893695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168699|NCT03893695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93168700|NCT03893695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168701|NCT01258309|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93168702|NCT01258309|Ketorolac|ketorolac|mesh-list
93168703|NCT01258309|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93168704|NCT01258309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93168705|NCT01258309|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93168706|NCT01258309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168707|NCT01258309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168708|NCT01258309|Analgesics|analgesics|mesh-ancestor
93168709|NCT01258309|Sensory System Agents|sensory system agents|mesh-ancestor
93168710|NCT01258309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168711|NCT01258309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168712|NCT01258309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168713|NCT01258309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168714|NCT01258309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93168715|NCT01258309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168716|NCT01258309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168717|NCT01258309|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93168718|NCT01258309|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93168719|NCT01258309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93168720|NCT01258309|Histamine Antagonists|histamine antagonists|mesh-ancestor
93168721|NCT01258309|Histamine Agents|histamine agents|mesh-ancestor
93168722|NCT01258309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168723|NCT01256905|Modafinil|modafinil|mesh-list
93168724|NCT01256905|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92840916|NCT00975689|Antidotes|antidotes|mesh-ancestor
93168725|NCT01256905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168726|NCT01256905|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93168727|NCT01256905|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93168728|NCT01256905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93168729|NCT01256905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168730|NCT01586299|Acetaminophen|acetaminophen|mesh-list
93168731|NCT01586299|Ibuprofen|ibuprofen|mesh-list
93168732|NCT01586299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168733|NCT01586299|Analgesics|analgesics|mesh-ancestor
93168734|NCT01586299|Sensory System Agents|sensory system agents|mesh-ancestor
93168735|NCT01586299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168736|NCT01586299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168737|NCT01586299|Antipyretics|antipyretics|mesh-ancestor
93168738|NCT01586299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168739|NCT01586299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168740|NCT01586299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168741|NCT01586299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93168742|NCT01586299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168743|NCT01586299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168744|NCT02874794|Valsartan|valsartan|mesh-list
93168745|NCT02874794|Enalapril|enalapril|mesh-list
93168746|NCT02874794|Enalaprilat|enalaprilat|mesh-list
93168747|NCT02874794|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93168748|NCT02874794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93168749|NCT02874794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93168750|NCT02874794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93168751|NCT02874794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168752|NCT02874794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93168753|NCT02874794|Protease Inhibitors|protease inhibitors|mesh-ancestor
93168754|NCT02874794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168755|NCT03102710|Lidocaine|lidocaine|mesh-list
93168756|NCT03102710|Capsaicin|capsaicin|mesh-list
93168757|NCT03102710|Anesthetics, Local|anesthetics, local|mesh-ancestor
93168758|NCT03102710|Anesthetics|anesthetics|mesh-ancestor
93168759|NCT03102710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168760|NCT03102710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168761|NCT03102710|Sensory System Agents|sensory system agents|mesh-ancestor
93168762|NCT03102710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168763|NCT03102710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168764|NCT03102710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93168765|NCT03102710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93168766|NCT03102710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168767|NCT03102710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168768|NCT03102710|Antipruritics|antipruritics|mesh-ancestor
93168769|NCT03102710|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168770|NCT01149967|Dexetimide|dexetimide|mesh-list
93168771|NCT01149967|Citalopram|citalopram|mesh-list
93168772|NCT01149967|Escitalopram|escitalopram|mesh-list
93168773|NCT01149967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93168774|NCT01149967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93168775|NCT01149967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168776|NCT01149967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168777|NCT01149967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168778|NCT01149967|Serotonin Agents|serotonin agents|mesh-ancestor
93168779|NCT01149967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168780|NCT01149967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93168781|NCT01149967|Antidepressive Agents|antidepressive agents|mesh-ancestor
93168782|NCT01149967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93168783|NCT01149967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93168784|NCT01149967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93168785|NCT01149967|Parasympatholytics|parasympatholytics|mesh-ancestor
93168786|NCT01149967|Autonomic Agents|autonomic agents|mesh-ancestor
93168787|NCT01149967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168788|NCT01149967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93168789|NCT01149967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93168790|NCT01149967|Cholinergic Agents|cholinergic agents|mesh-ancestor
93168791|NCT05505409|Pirfenidone|pirfenidone|mesh-list
93168792|NCT05505409|Glucocorticoids|glucocorticoids|mesh-list
93168793|NCT05505409|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93168794|NCT05505409|Hormones|hormones|mesh-ancestor
93168795|NCT05505409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168796|NCT05505409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168797|NCT05505409|Analgesics|analgesics|mesh-ancestor
93168798|NCT05505409|Sensory System Agents|sensory system agents|mesh-ancestor
93168799|NCT05505409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168800|NCT05505409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168801|NCT05505409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168802|NCT05505409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168803|NCT05505409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168804|NCT05505409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168805|NCT05505409|Immunologic Factors|immunologic factors|mesh-ancestor
93168806|NCT04770740|Vitamin K|vitamin k|mesh-list
93168807|NCT04770740|Vitamin K 2|vitamin k 2|mesh-list
93168808|NCT04770740|Menaquinone 7|menaquinone 7|mesh-list
93168809|NCT04770740|Vitamins|vitamins|mesh-ancestor
93168810|NCT04770740|Micronutrients|micronutrients|mesh-ancestor
93168811|NCT04770740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168812|NCT04770740|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93168813|NCT04770740|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93168814|NCT04770740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168815|NCT04770740|Hemostatics|hemostatics|mesh-ancestor
93168816|NCT04770740|Coagulants|coagulants|mesh-ancestor
93168817|NCT03896971|Cyclosporine|cyclosporine|mesh-list
93168818|NCT03896971|Cyclosporins|cyclosporins|mesh-list
93168819|NCT03896971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168820|NCT03896971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168821|NCT03896971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168822|NCT03896971|Immunologic Factors|immunologic factors|mesh-ancestor
93168823|NCT03896971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168824|NCT03896971|Antifungal Agents|antifungal agents|mesh-ancestor
93168825|NCT03896971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168826|NCT03896971|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168827|NCT03896971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168828|NCT03896971|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93168829|NCT01258777|Golimumab|golimumab|mesh-list
93168830|NCT01258777|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93168831|NCT01258777|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93168832|NCT01258777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168833|NCT01258777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168834|NCT01258777|Immunologic Factors|immunologic factors|mesh-ancestor
93168835|NCT01258777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168836|NCT03896893|Emollients|emollients|mesh-list
93168837|NCT03896893|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168838|NCT01257373|Cobalt|cobalt|mesh-list
93168839|NCT01257373|Chromium|chromium|mesh-list
93168840|NCT01257373|Sirolimus|sirolimus|mesh-list
93168841|NCT01257373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93168842|NCT01257373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93168843|NCT01257373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93168844|NCT01257373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168845|NCT01257373|Antifungal Agents|antifungal agents|mesh-ancestor
93168846|NCT01257373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93168847|NCT01257373|Immunologic Factors|immunologic factors|mesh-ancestor
93168848|NCT01257373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168849|NCT01257373|Trace Elements|trace elements|mesh-ancestor
93168850|NCT01257373|Micronutrients|micronutrients|mesh-ancestor
93168851|NCT03899233|Tranexamic Acid|tranexamic acid|mesh-list
93168852|NCT03899233|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93168853|NCT03899233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93168854|NCT03899233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168855|NCT03899233|Hemostatics|hemostatics|mesh-ancestor
93168856|NCT03899233|Coagulants|coagulants|mesh-ancestor
93168857|NCT03101150|Vitamin D|vitamin d|mesh-list
93168858|NCT03101150|Ergocalciferols|ergocalciferols|mesh-list
93168859|NCT03101150|Cholecalciferol|cholecalciferol|mesh-list
93168860|NCT03101150|Vitamins|vitamins|mesh-list
93168861|NCT03101150|Micronutrients|micronutrients|mesh-ancestor
93168862|NCT03101150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168863|NCT03101150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93168864|NCT03101150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93168865|NCT03899077|Goserelin|goserelin|mesh-list
93168866|NCT03899077|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93168867|NCT03899077|Leuprolide|leuprolide|mesh-list
93168868|NCT03899077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93168869|NCT03899077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168870|NCT03899077|Luteolytic Agents|luteolytic agents|mesh-ancestor
93168871|NCT03899077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93168872|NCT03899077|Contraceptive Agents|contraceptive agents|mesh-ancestor
93168873|NCT03899077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93168874|NCT03899077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168875|NCT03899077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93168876|NCT03899077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93168878|NCT01255579|Fluticasone|fluticasone|mesh-list
93168879|NCT01255579|Beclomethasone|beclomethasone|mesh-list
93168880|NCT01255579|Formoterol Fumarate|formoterol fumarate|mesh-list
93168881|NCT01255579|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93168882|NCT01255579|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93168883|NCT01255579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168884|NCT01255579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93168885|NCT01255579|Autonomic Agents|autonomic agents|mesh-ancestor
93168886|NCT01255579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168887|NCT01255579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168888|NCT01255579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93168889|NCT01255579|Respiratory System Agents|respiratory system agents|mesh-ancestor
93168890|NCT01255579|Dermatologic Agents|dermatologic agents|mesh-ancestor
93168891|NCT01255579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93168892|NCT01255579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93168893|NCT01255579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93168894|NCT01255579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93168895|NCT01255579|Adrenergic Agents|adrenergic agents|mesh-ancestor
93168896|NCT01255579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93168897|NCT01255579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168898|NCT01255579|Glucocorticoids|glucocorticoids|mesh-ancestor
93168899|NCT01255579|Hormones|hormones|mesh-ancestor
93168900|NCT01255579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168901|NCT01255579|Sympathomimetics|sympathomimetics|mesh-ancestor
93168902|NCT03101930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93168903|NCT03101930|Liraglutide|liraglutide|mesh-list
93168904|NCT03101930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93168905|NCT03101930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168906|NCT03101930|Incretins|incretins|mesh-ancestor
93168907|NCT03101930|Hormones|hormones|mesh-ancestor
93168908|NCT03101930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93168909|NCT03101930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93168910|NCT03101930|Protease Inhibitors|protease inhibitors|mesh-ancestor
93168911|NCT03101930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168912|NCT03101930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168913|NCT04239950|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93168914|NCT04239950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93168915|NCT04239950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93168916|NCT05415254|Calcitriol|calcitriol|mesh-list
93168917|NCT05415254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93168918|NCT05415254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168919|NCT05415254|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93168920|NCT05415254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168921|NCT05415254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168922|NCT05415254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93168923|NCT05415254|Vitamins|vitamins|mesh-ancestor
93168924|NCT05415254|Micronutrients|micronutrients|mesh-ancestor
93168925|NCT05415254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93168926|NCT01150201|Losartan|losartan|mesh-list
93168927|NCT01150201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93168928|NCT01150201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93168929|NCT01150201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93168930|NCT01150201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93168931|NCT01150201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168932|NCT01257451|Vildagliptin|vildagliptin|mesh-list
93168933|NCT01257451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93168934|NCT01257451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168935|NCT01257451|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93168936|NCT01257451|Protease Inhibitors|protease inhibitors|mesh-ancestor
93168937|NCT01257451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168938|NCT01257451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168939|NCT01257529|Pregabalin|pregabalin|mesh-list
93168940|NCT01257529|Analgesics|analgesics|mesh-ancestor
93168941|NCT01257529|Sensory System Agents|sensory system agents|mesh-ancestor
93168942|NCT01257529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168943|NCT01257529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168944|NCT01257529|Anticonvulsants|anticonvulsants|mesh-ancestor
93168945|NCT01257529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93168946|NCT01257529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168947|NCT01257529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168948|NCT01257529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93168949|NCT01257529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93168950|NCT01257529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93168951|NCT01257529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93168952|NCT01257529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93168953|NCT03896113|Celecoxib|celecoxib|mesh-list
93168954|NCT03896113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93168955|NCT03896113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93168956|NCT03896113|Analgesics|analgesics|mesh-ancestor
93168957|NCT03896113|Sensory System Agents|sensory system agents|mesh-ancestor
93168958|NCT03896113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93168959|NCT03896113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168960|NCT03896113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93168961|NCT03896113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93168962|NCT03896113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93168963|NCT03896113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93168964|NCT03896113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168965|NCT03896113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168966|NCT03100838|Nifedipine|nifedipine|mesh-list
93168967|NCT03100838|Omeprazole|omeprazole|mesh-list
93168968|NCT03100838|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
93168969|NCT03100838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93168970|NCT03100838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93168971|NCT03100838|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93168972|NCT03100838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93168973|NCT03100838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168974|NCT03100838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93168975|NCT03100838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93168976|NCT03100838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93168977|NCT03100838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168978|NCT03100838|Vasodilator Agents|vasodilator agents|mesh-ancestor
93168979|NCT03100838|Tocolytic Agents|tocolytic agents|mesh-ancestor
93168980|NCT03100838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93168981|NCT01260025|Endostatins|endostatins|mesh-list
93168982|NCT01260025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168983|NCT01260025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93168984|NCT01260025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93168985|NCT01260025|Growth Substances|growth substances|mesh-ancestor
93168986|NCT01260025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93168987|NCT01260025|Growth Inhibitors|growth inhibitors|mesh-ancestor
93168988|NCT03984578|Pembrolizumab|pembrolizumab|mesh-list
93168989|NCT03984578|Capecitabine|capecitabine|mesh-list
93168990|NCT03984578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93168991|NCT03984578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93168992|NCT03984578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93168993|NCT03984578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168994|NCT03984578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93168995|NCT03984578|Antimetabolites|antimetabolites|mesh-ancestor
93168996|NCT03892525|Atezolizumab|atezolizumab|mesh-list
93168997|NCT03892525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93168998|NCT03892525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93168999|NCT03892525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169000|NCT03892525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169001|NCT05418452|Metformin|metformin|mesh-list
93169002|NCT05418452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93169003|NCT05418452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169004|NCT01260103|Temozolomide|temozolomide|mesh-list
93169005|NCT01260103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93169006|NCT01260103|Alkylating Agents|alkylating agents|mesh-ancestor
93169007|NCT01260103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169008|NCT01260103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169009|NCT03480750|Carboplatin|carboplatin|mesh-list
93169010|NCT03480750|Doxorubicin|doxorubicin|mesh-list
93169011|NCT03480750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93169012|NCT03480750|Trientine|trientine|mesh-list
93169013|NCT03480750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169014|NCT03480750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93169015|NCT03480750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93169016|NCT03480750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93169017|NCT03480750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169018|NCT03480750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169019|NCT03480750|Chelating Agents|chelating agents|mesh-ancestor
93169020|NCT03480750|Sequestering Agents|sequestering agents|mesh-ancestor
93169021|NCT03892447|Ferulic acid|ferulic acid|mesh-list
93169022|NCT03892447|Dopamine|dopamine|mesh-list
93169023|NCT03892447|Alprostadil|alprostadil|mesh-list
93169024|NCT03892447|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93169025|NCT03892447|Sympathomimetics|sympathomimetics|mesh-ancestor
93169026|NCT03892447|Autonomic Agents|autonomic agents|mesh-ancestor
93169027|NCT03892447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169028|NCT03892447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169029|NCT03892447|Dopamine Agents|dopamine agents|mesh-ancestor
93169030|NCT03892447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169031|NCT03892447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169032|NCT03892447|Protective Agents|protective agents|mesh-ancestor
93169033|NCT03892447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93169034|NCT03892447|Vasodilator Agents|vasodilator agents|mesh-ancestor
93169035|NCT03892447|Urological Agents|urological agents|mesh-ancestor
93169036|NCT03892447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169037|NCT03892447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169038|NCT03892447|Analgesics|analgesics|mesh-ancestor
93169039|NCT03892447|Sensory System Agents|sensory system agents|mesh-ancestor
93169040|NCT03892447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169041|NCT03892447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169042|NCT03892447|Anticoagulants|anticoagulants|mesh-ancestor
93169043|NCT03892447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93169044|NCT03892447|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93169045|NCT03892447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93169046|NCT03892447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93169047|NCT03892447|Antioxidants|antioxidants|mesh-ancestor
93169048|NCT03716700|Immunoglobulins|immunoglobulins|mesh-list
93169049|NCT03716700|gamma-Globulins|gamma-globulins|mesh-list
93169050|NCT03716700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93169051|NCT03716700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93169052|NCT03716700|Immunologic Factors|immunologic factors|mesh-ancestor
93169053|NCT03716700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169054|NCT05250596|Colchicine|colchicine|mesh-list
93169055|NCT05250596|Atorvastatin|atorvastatin|mesh-list
93169056|NCT05250596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93169057|NCT05250596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93169058|NCT05250596|Antimetabolites|antimetabolites|mesh-ancestor
93169059|NCT05250596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169060|NCT05250596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93169061|NCT05250596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93169062|NCT05250596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169063|NCT05250596|Gout Suppressants|gout suppressants|mesh-ancestor
93169064|NCT05250596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169065|NCT05250596|Tubulin Modulators|tubulin modulators|mesh-ancestor
93169066|NCT05250596|Antimitotic Agents|antimitotic agents|mesh-ancestor
93169067|NCT05250596|Mitosis Modulators|mitosis modulators|mesh-ancestor
93169068|NCT05250596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169069|NCT04788914|Charcoal|charcoal|mesh-list
93169070|NCT04788914|Antidotes|antidotes|mesh-ancestor
93169071|NCT04788914|Protective Agents|protective agents|mesh-ancestor
93169072|NCT04788914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169073|NCT03716622|Clarithromycin|clarithromycin|mesh-list
93169074|NCT03716622|Furazolidone|furazolidone|mesh-list
93169075|NCT03716622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169076|NCT03716622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169077|NCT03716622|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93169078|NCT03716622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169079|NCT03716622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169080|NCT03716622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93169081|NCT03716622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93169082|NCT03716622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93169083|NCT03716622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93169084|NCT03716622|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93169085|NCT03716622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93169086|NCT03716622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93169087|NCT03716622|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93169088|NCT03892213|Benzonidazole|benzonidazole|mesh-list
93169089|NCT03892213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93169090|NCT03892213|Immunologic Factors|immunologic factors|mesh-ancestor
93169091|NCT03892213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169092|NCT03892213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93169093|NCT03892213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93169094|NCT03892213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92841286|NCT04289207|Danazol|danazol|mesh-list
93169095|NCT03892213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169096|NCT03412734|Chlorhexidine|chlorhexidine|mesh-list
93169097|NCT03412734|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93169098|NCT03412734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169099|NCT03412734|Disinfectants|disinfectants|mesh-ancestor
93169100|NCT04881032|Temozolomide|temozolomide|mesh-list
93169101|NCT04881032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93169102|NCT04881032|Alkylating Agents|alkylating agents|mesh-ancestor
93169103|NCT04881032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169104|NCT04881032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169105|NCT03891979|Metronidazole|metronidazole|mesh-list
93169106|NCT03891979|Ciprofloxacin|ciprofloxacin|mesh-list
93169107|NCT03891979|Pembrolizumab|pembrolizumab|mesh-list
93169108|NCT03891979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169109|NCT03891979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169110|NCT03891979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93169111|NCT03891979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169112|NCT03891979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169113|NCT03891979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169114|NCT03891979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93169115|NCT03891979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93169116|NCT03891979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93169117|NCT03891979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93169118|NCT03891979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169119|NCT03891979|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93169120|NCT03891979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93169121|NCT01260415|Oxaliplatin|oxaliplatin|mesh-list
93169122|NCT01260415|Panitumumab|panitumumab|mesh-list
93169123|NCT01260415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169124|NCT01260415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169125|NCT04608344|Atorvastatin|atorvastatin|mesh-list
93169126|NCT04608344|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93169127|NCT04608344|Pravastatin|pravastatin|mesh-list
93169128|NCT04608344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93169129|NCT04608344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93169130|NCT04608344|Antimetabolites|antimetabolites|mesh-ancestor
93169131|NCT04608344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169132|NCT04608344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93169133|NCT04608344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93169134|NCT04608344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169135|NCT03891433|Meropenem|meropenem|mesh-list
93169136|NCT03891433|Tazobactam|tazobactam|mesh-list
93169137|NCT03891433|Piperacillin|piperacillin|mesh-list
93169138|NCT03891433|Ertapenem|ertapenem|mesh-list
93169139|NCT03891433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169140|NCT03891433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169141|NCT03891433|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93169142|NCT03891433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169143|NCT03891433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169144|NCT03895411|Sotalol|sotalol|mesh-list
93169145|NCT03895411|Propafenone|propafenone|mesh-list
93169146|NCT03895411|Metoprolol|metoprolol|mesh-list
93169147|NCT03895411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93169148|NCT03895411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93169149|NCT03895411|Adrenergic Agents|adrenergic agents|mesh-ancestor
93169150|NCT03895411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169151|NCT03895411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169152|NCT03895411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169153|NCT03895411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93169154|NCT03895411|Sympatholytics|sympatholytics|mesh-ancestor
93169155|NCT03895411|Autonomic Agents|autonomic agents|mesh-ancestor
93169156|NCT03895411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169157|NCT03895411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93169158|NCT03895411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93169159|NCT03895411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169160|NCT03895411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93169161|NCT03895411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93169162|NCT01259323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93169163|NCT01259323|Immunologic Factors|immunologic factors|mesh-ancestor
93169164|NCT01259323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169165|NCT03891277|Ferrous succinate|ferrous succinate|mesh-list
93169166|NCT03891277|Hematinics|hematinics|mesh-ancestor
93169167|NCT03888157|Liraglutide|liraglutide|mesh-list
93169168|NCT03888157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93169169|NCT03888157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169170|NCT03888157|Incretins|incretins|mesh-ancestor
93169171|NCT03888157|Hormones|hormones|mesh-ancestor
93169172|NCT03888157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169173|NCT01154491|Epoetin Alfa|epoetin alfa|mesh-list
93169174|NCT01154491|Hematinics|hematinics|mesh-ancestor
93169175|NCT01260571|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93169176|NCT01260571|Dermatologic Agents|dermatologic agents|mesh-ancestor
93169177|NCT02527603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93169178|NCT02527603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93169179|NCT02527603|Analgesics|analgesics|mesh-ancestor
93169180|NCT02527603|Sensory System Agents|sensory system agents|mesh-ancestor
93169181|NCT02527603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169182|NCT02527603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169183|NCT02527603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169184|NCT02527603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169185|NCT01259479|Satraplatin|satraplatin|mesh-list
93169186|NCT01259479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169187|NCT01260727|Vaccines|vaccines|mesh-list
93169188|NCT01260727|Immunologic Factors|immunologic factors|mesh-ancestor
93169189|NCT01260727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169190|NCT03890809|Deucravacitinib|deucravacitinib|mesh-list
93169191|NCT03890809|Dermatologic Agents|dermatologic agents|mesh-ancestor
93169192|NCT03890809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93169193|NCT03890809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169194|NCT03890809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169195|NCT03891121|Botulinum Toxins|botulinum toxins|mesh-list
93169196|NCT03891121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93169197|NCT03891121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93169198|NCT03891121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93169199|NCT03891121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169200|NCT03891121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169201|NCT03891121|Cholinergic Agents|cholinergic agents|mesh-ancestor
93169202|NCT03891121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169203|NCT03891121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169204|NCT03891121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93169205|NCT03891121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169206|NCT01154569|Azithromycin|azithromycin|mesh-list
93169207|NCT01154569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169208|NCT01154569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169209|NCT03891043|Selenium|selenium|mesh-list
93169210|NCT03891043|Antioxidants|antioxidants|mesh-ancestor
93169211|NCT03891043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169212|NCT03891043|Protective Agents|protective agents|mesh-ancestor
93169213|NCT03891043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169214|NCT03891043|Trace Elements|trace elements|mesh-ancestor
93169215|NCT03891043|Micronutrients|micronutrients|mesh-ancestor
93169216|NCT03890341|Drospirenone|drospirenone|mesh-list
93169217|NCT03890341|Midazolam|midazolam|mesh-list
93169218|NCT03890341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93169219|NCT03890341|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93169220|NCT03890341|Betadex|betadex|mesh-list
93169221|NCT03890341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93169222|NCT03890341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93169223|NCT03890341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169224|NCT03890341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169225|NCT03890341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93169226|NCT03890341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93169227|NCT03890341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93169228|NCT03890341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93169229|NCT03890341|Anesthetics, General|anesthetics, general|mesh-ancestor
93169230|NCT03890341|Anesthetics|anesthetics|mesh-ancestor
93169231|NCT03890341|GABA Modulators|gaba modulators|mesh-ancestor
93169232|NCT03890341|GABA Agents|gaba agents|mesh-ancestor
93169233|NCT03890341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169234|NCT03890341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169235|NCT03890341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93169236|NCT03890341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93169237|NCT03890341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93169238|NCT03890341|Contraceptive Agents|contraceptive agents|mesh-ancestor
93169239|NCT03890341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93169240|NCT03890341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93169241|NCT03890341|Estrogens|estrogens|mesh-ancestor
93169242|NCT03890341|Hormones|hormones|mesh-ancestor
93169243|NCT03890341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169244|NCT03890341|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93169245|NCT03890341|Hormone Antagonists|hormone antagonists|mesh-ancestor
93169246|NCT03890341|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93169247|NCT03890341|Diuretics|diuretics|mesh-ancestor
93169248|NCT03890341|Natriuretic Agents|natriuretic agents|mesh-ancestor
93169249|NCT03890341|Sequestering Agents|sequestering agents|mesh-ancestor
92841434|NCT00803335|Hormones|hormones|mesh-ancestor
93169250|NCT01259557|Botulinum Toxins|botulinum toxins|mesh-list
93169251|NCT01259557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93169252|NCT01259557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93169253|NCT01259557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93169254|NCT01259557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169255|NCT01259557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169256|NCT01259557|Cholinergic Agents|cholinergic agents|mesh-ancestor
93169257|NCT01259557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169258|NCT01259557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169259|NCT01259557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93169260|NCT01259557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169261|NCT03894085|Paroxetine|paroxetine|mesh-list
93169262|NCT03894085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93169263|NCT03894085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93169264|NCT03894085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169265|NCT03894085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169266|NCT03894085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169267|NCT03894085|Serotonin Agents|serotonin agents|mesh-ancestor
93169268|NCT03894085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169269|NCT03894085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93169270|NCT03894085|Antidepressive Agents|antidepressive agents|mesh-ancestor
93169271|NCT03894085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93169272|NCT03894085|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93169273|NCT03894085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93169274|NCT03894085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169275|NCT01152931|Vitamins|vitamins|mesh-list
93169276|NCT01152931|Vitamin E|vitamin e|mesh-list
93169277|NCT01152931|Tocopherols|tocopherols|mesh-list
93169278|NCT01152931|Tocotrienols|tocotrienols|mesh-list
93169279|NCT01152931|alpha-Tocopherol|alpha-tocopherol|mesh-list
93169280|NCT01152931|Vitamin A|vitamin a|mesh-list
93169281|NCT01152931|Zinc|zinc|mesh-list
93169282|NCT01152931|Selenium|selenium|mesh-list
93169283|NCT01152931|Artesunate|artesunate|mesh-list
93169284|NCT01152931|Lumefantrine|lumefantrine|mesh-list
93169285|NCT01152931|Artemether|artemether|mesh-list
93169286|NCT01152931|Amodiaquine|amodiaquine|mesh-list
93169287|NCT01152931|Retinol palmitate|retinol palmitate|mesh-list
93169288|NCT01152931|Micronutrients|micronutrients|mesh-ancestor
93169289|NCT01152931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169290|NCT01152931|Trace Elements|trace elements|mesh-ancestor
93169291|NCT01152931|Antioxidants|antioxidants|mesh-ancestor
93169292|NCT01152931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169293|NCT01152931|Protective Agents|protective agents|mesh-ancestor
93169294|NCT01152931|Antimalarials|antimalarials|mesh-ancestor
93169295|NCT01152931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93169296|NCT01152931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93169297|NCT01152931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169298|NCT01152931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169299|NCT01152931|Antiviral Agents|antiviral agents|mesh-ancestor
93169300|NCT01152931|Schistosomicides|schistosomicides|mesh-ancestor
93169301|NCT01152931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93169302|NCT01152931|Anthelmintics|anthelmintics|mesh-ancestor
93169303|NCT01152931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93169304|NCT01261117|Ibuprofen|ibuprofen|mesh-list
93169305|NCT01261117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169306|NCT01261117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169307|NCT01261117|Analgesics|analgesics|mesh-ancestor
93169308|NCT01261117|Sensory System Agents|sensory system agents|mesh-ancestor
93169309|NCT01261117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169310|NCT01261117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169311|NCT01261117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169312|NCT01261117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169313|NCT01261117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93169314|NCT01261117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169315|NCT01261117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169316|NCT03889717|Vitamin D|vitamin d|mesh-list
93169317|NCT03889717|Vitamins|vitamins|mesh-ancestor
93169318|NCT03889717|Micronutrients|micronutrients|mesh-ancestor
93169319|NCT03889717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169320|NCT03889717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93169321|NCT03885895|Tranexamic Acid|tranexamic acid|mesh-list
93169322|NCT03885895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93169323|NCT03885895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93169324|NCT03885895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169325|NCT03885895|Hemostatics|hemostatics|mesh-ancestor
93169326|NCT03885895|Coagulants|coagulants|mesh-ancestor
93169327|NCT01154647|Citalopram|citalopram|mesh-list
93169328|NCT01154647|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93169329|NCT01154647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93169330|NCT01154647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169331|NCT01154647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169332|NCT01154647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169333|NCT01154647|Serotonin Agents|serotonin agents|mesh-ancestor
93169334|NCT01154647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169335|NCT01154647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93169336|NCT01154647|Antidepressive Agents|antidepressive agents|mesh-ancestor
93169337|NCT01154647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93169339|NCT01153165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93169340|NCT01153165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93169341|NCT01153165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169342|NCT01153165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169343|NCT01153165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169344|NCT01153165|Serotonin Agents|serotonin agents|mesh-ancestor
93169345|NCT01153165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169346|NCT01153165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93169347|NCT01153165|Antidepressive Agents|antidepressive agents|mesh-ancestor
93169348|NCT01153165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93169349|NCT01155505|Lenalidomide|lenalidomide|mesh-list
93169350|NCT01155505|Immunologic Factors|immunologic factors|mesh-ancestor
93169351|NCT01155505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169352|NCT01155505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93169353|NCT01155505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93169354|NCT01155505|Growth Substances|growth substances|mesh-ancestor
93169355|NCT01155505|Growth Inhibitors|growth inhibitors|mesh-ancestor
93169356|NCT01155505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169357|NCT01153243|Vitamin D|vitamin d|mesh-list
93169358|NCT01153243|Ergocalciferols|ergocalciferols|mesh-list
93169359|NCT01153243|Vitamins|vitamins|mesh-ancestor
93169360|NCT01153243|Micronutrients|micronutrients|mesh-ancestor
93169361|NCT01153243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169362|NCT01153243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93169363|NCT01153243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93169364|NCT03432858|Vancomycin|vancomycin|mesh-list
93169365|NCT03432858|Cefazolin|cefazolin|mesh-list
93169366|NCT03432858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169367|NCT03432858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169368|NCT05659914|Durvalumab|durvalumab|mesh-list
93169369|NCT05659914|Olaparib|olaparib|mesh-list
93169370|NCT05659914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169371|NCT05659914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169372|NCT05659914|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93169373|NCT05659914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169374|NCT05659914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169375|NCT01154803|Micronutrients|micronutrients|mesh-list
93169376|NCT01154803|Trace Elements|trace elements|mesh-list
93169377|NCT01154803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169378|NCT03885427|Ketamine|ketamine|mesh-list
93169379|NCT03885427|Analgesics|analgesics|mesh-ancestor
93169380|NCT03885427|Sensory System Agents|sensory system agents|mesh-ancestor
93169381|NCT03885427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169382|NCT03885427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169383|NCT03885427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93169384|NCT03885427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93169385|NCT03885427|Anesthetics, General|anesthetics, general|mesh-ancestor
93169386|NCT03885427|Anesthetics|anesthetics|mesh-ancestor
93169387|NCT03885427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169388|NCT03885427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93169389|NCT03885427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93169390|NCT03885427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169391|NCT03885427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169392|NCT03456960|Aspirin|aspirin|mesh-list
93169393|NCT03456960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169394|NCT03456960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169395|NCT03456960|Analgesics|analgesics|mesh-ancestor
93169396|NCT03456960|Sensory System Agents|sensory system agents|mesh-ancestor
93169397|NCT03456960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169398|NCT03456960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169399|NCT03456960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169400|NCT03456960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169401|NCT03456960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93169402|NCT03456960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92855147|NCT02753712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169403|NCT03456960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169404|NCT03456960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93169405|NCT03456960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93169406|NCT03456960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169407|NCT03456960|Antipyretics|antipyretics|mesh-ancestor
93169408|NCT03716388|Mesalamine|mesalamine|mesh-list
93169409|NCT03716388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169410|NCT03716388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169411|NCT03716388|Analgesics|analgesics|mesh-ancestor
93169412|NCT03716388|Sensory System Agents|sensory system agents|mesh-ancestor
93169413|NCT03716388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169414|NCT03716388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169415|NCT03716388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169416|NCT03716388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169417|NCT01311336|Loratadine|loratadine|mesh-list
93169418|NCT01311336|Antipruritics|antipruritics|mesh-ancestor
93169419|NCT01311336|Dermatologic Agents|dermatologic agents|mesh-ancestor
93169420|NCT01311336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93169421|NCT01311336|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93169422|NCT01311336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93169423|NCT01311336|Histamine Antagonists|histamine antagonists|mesh-ancestor
93169424|NCT01311336|Histamine Agents|histamine agents|mesh-ancestor
93169425|NCT01311336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169426|NCT01311336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169427|NCT01311336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169428|NCT03430986|Lidocaine|lidocaine|mesh-list
93169429|NCT03430986|Anesthetics, Local|anesthetics, local|mesh-ancestor
93169430|NCT03430986|Anesthetics|anesthetics|mesh-ancestor
93169431|NCT03430986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169432|NCT03430986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169433|NCT03430986|Sensory System Agents|sensory system agents|mesh-ancestor
93169434|NCT03430986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169435|NCT03430986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93169436|NCT03430986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93169437|NCT03430986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93169438|NCT03430986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169439|NCT03430986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169440|NCT01261741|Memantine|memantine|mesh-list
93169441|NCT01261741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93169442|NCT01261741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93169443|NCT01261741|Dopamine Agents|dopamine agents|mesh-ancestor
93169444|NCT01261741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169445|NCT01261741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169446|NCT01261741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169447|NCT01261741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93169448|NCT01261741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93169449|NCT01157455|Aspirin|aspirin|mesh-list
93169450|NCT01157455|Everolimus|everolimus|mesh-list
93169451|NCT01157455|Heparin|heparin|mesh-list
93169452|NCT01157455|Bivalirudin|bivalirudin|mesh-list
93169453|NCT01157455|Clopidogrel|clopidogrel|mesh-list
93169454|NCT01157455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169455|NCT01157455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169456|NCT01157455|Analgesics|analgesics|mesh-ancestor
93169457|NCT01157455|Sensory System Agents|sensory system agents|mesh-ancestor
93169458|NCT01157455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169459|NCT01157455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169460|NCT01157455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169461|NCT01157455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169462|NCT01157455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93169463|NCT01157455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93169464|NCT01157455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169465|NCT01157455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93169466|NCT01157455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93169467|NCT01157455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169468|NCT01157455|Antipyretics|antipyretics|mesh-ancestor
93169469|NCT01157455|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93169470|NCT01157455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93169471|NCT01157455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93169472|NCT01157455|Immunologic Factors|immunologic factors|mesh-ancestor
93169473|NCT01157455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169474|NCT01157455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93169475|NCT01157455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93169476|NCT01157455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93169477|NCT01157455|Purinergic Agents|purinergic agents|mesh-ancestor
93169478|NCT01157455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169479|NCT01157455|Anticoagulants|anticoagulants|mesh-ancestor
93169480|NCT01157455|Antithrombins|antithrombins|mesh-ancestor
93169481|NCT01157455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93169482|NCT01157455|Protease Inhibitors|protease inhibitors|mesh-ancestor
93169483|NCT03713892|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93169484|NCT03713892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169485|NCT03713892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169486|NCT03884881|Meropenem|meropenem|mesh-list
93169487|NCT03884881|Imipenem|imipenem|mesh-list
93169488|NCT03884881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169489|NCT03884881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169490|NCT01154881|Insulin|insulin|mesh-list
93169491|NCT01154881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93169492|NCT01154881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169493|NCT03886441|Beclomethasone|beclomethasone|mesh-list
93169494|NCT03886441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169495|NCT03886441|Glucocorticoids|glucocorticoids|mesh-ancestor
93169496|NCT03886441|Hormones|hormones|mesh-ancestor
93169497|NCT03886441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169498|NCT03886441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169499|NCT03886441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93169500|NCT03886441|Respiratory System Agents|respiratory system agents|mesh-ancestor
93169501|NCT03713346|Caseins|caseins|mesh-list
93169502|NCT03713346|Chelating Agents|chelating agents|mesh-ancestor
93169503|NCT03713346|Sequestering Agents|sequestering agents|mesh-ancestor
93169504|NCT03713346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169505|NCT01154959|Moxifloxacin|moxifloxacin|mesh-list
93169506|NCT01154959|Rifampin|rifampin|mesh-list
93169507|NCT01154959|Isoniazid|isoniazid|mesh-list
93169508|NCT01154959|Pyrazinamide|pyrazinamide|mesh-list
93169509|NCT01154959|Ethambutol|ethambutol|mesh-list
93169510|NCT01154959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169511|NCT01154959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169512|NCT01154959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93169513|NCT01154959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93169514|NCT01154959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169515|NCT01154959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169516|NCT01154959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169517|NCT01154959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93169518|NCT01154959|Antitubercular Agents|antitubercular agents|mesh-ancestor
93169519|NCT01154959|Leprostatic Agents|leprostatic agents|mesh-ancestor
93169520|NCT01154959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93169521|NCT01154959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93169522|NCT01154959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93169523|NCT01154959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93169524|NCT01154959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93169525|NCT01154959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93169526|NCT01154959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93169527|NCT01154959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93169528|NCT01154959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93169529|NCT01154959|Antimetabolites|antimetabolites|mesh-ancestor
93169530|NCT01154959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93169531|NCT03881293|Lidocaine|lidocaine|mesh-list
93169532|NCT03881293|Anesthetics, Local|anesthetics, local|mesh-ancestor
93169533|NCT03881293|Anesthetics|anesthetics|mesh-ancestor
93169534|NCT03881293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169535|NCT03881293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169536|NCT03881293|Sensory System Agents|sensory system agents|mesh-ancestor
93169537|NCT03881293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169538|NCT03881293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93169539|NCT03881293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93169540|NCT03881293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93169541|NCT03881293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169542|NCT03881293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169543|NCT01155037|Vaccines|vaccines|mesh-list
93169544|NCT01155037|Immunologic Factors|immunologic factors|mesh-ancestor
93169545|NCT01155037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169546|NCT01261897|Ropivacaine|ropivacaine|mesh-list
93169547|NCT01261897|Anesthetics, Local|anesthetics, local|mesh-ancestor
93169548|NCT01261897|Anesthetics|anesthetics|mesh-ancestor
93169549|NCT01261897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169550|NCT01261897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169551|NCT01261897|Sensory System Agents|sensory system agents|mesh-ancestor
93169552|NCT01261897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169553|NCT03448536|Acetaminophen|acetaminophen|mesh-list
93169555|NCT03448536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169556|NCT03448536|Analgesics|analgesics|mesh-ancestor
93169557|NCT03448536|Sensory System Agents|sensory system agents|mesh-ancestor
93169558|NCT03448536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169559|NCT03448536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169560|NCT03448536|Antipyretics|antipyretics|mesh-ancestor
93169561|NCT03448536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169562|NCT03448536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169563|NCT03448536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169564|NCT03448536|Gout Suppressants|gout suppressants|mesh-ancestor
93169565|NCT03448536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93169566|NCT03448536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169567|NCT03448536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169568|NCT01155115|Nitric Oxide|nitric oxide|mesh-list
93169569|NCT01155115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93169570|NCT01155115|Autonomic Agents|autonomic agents|mesh-ancestor
93169571|NCT01155115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169572|NCT01155115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169573|NCT01155115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93169574|NCT01155115|Respiratory System Agents|respiratory system agents|mesh-ancestor
93169575|NCT01155115|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93169576|NCT01155115|Antioxidants|antioxidants|mesh-ancestor
93169577|NCT01155115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169578|NCT01155115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169579|NCT01155115|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93169580|NCT01155115|Vasodilator Agents|vasodilator agents|mesh-ancestor
93169581|NCT01155115|Gasotransmitters|gasotransmitters|mesh-ancestor
93169582|NCT01155115|Protective Agents|protective agents|mesh-ancestor
93169583|NCT03713190|Empagliflozin|empagliflozin|mesh-list
93169584|NCT03713190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93169585|NCT03713190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169586|NCT03713190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93169587|NCT03713190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169588|NCT03718182|Cholecalciferol|cholecalciferol|mesh-list
93169589|NCT03718182|Vitamin D|vitamin d|mesh-list
93169590|NCT03718182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93169591|NCT03718182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169592|NCT03718182|Vitamins|vitamins|mesh-ancestor
93169593|NCT03718182|Micronutrients|micronutrients|mesh-ancestor
93169594|NCT03718182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93169595|NCT03881449|Aripiprazole|aripiprazole|mesh-list
93169596|NCT03881449|Antidepressive Agents|antidepressive agents|mesh-ancestor
93169597|NCT03881449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93169598|NCT03881449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93169599|NCT03881449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93169600|NCT03881449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169601|NCT03881449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169602|NCT03881449|Dopamine Agonists|dopamine agonists|mesh-ancestor
93169603|NCT03881449|Dopamine Agents|dopamine agents|mesh-ancestor
93169604|NCT03881449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169605|NCT03881449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169606|NCT03881449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93169607|NCT03881449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93169608|NCT03881449|Serotonin Agents|serotonin agents|mesh-ancestor
93169609|NCT03881449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93169610|NCT03881449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93169611|NCT03881449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93169612|NCT03881449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93169613|NCT03884491|Vortioxetine|vortioxetine|mesh-list
93169614|NCT03884491|Antidepressive Agents|antidepressive agents|mesh-ancestor
93169615|NCT03884491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93169616|NCT03884491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93169617|NCT03884491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93169618|NCT03884491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93169619|NCT03884491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169620|NCT03884491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93169621|NCT03884491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93169622|NCT03884491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169623|NCT03884491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169624|NCT03884491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169625|NCT03884491|Serotonin Agents|serotonin agents|mesh-ancestor
93169626|NCT03884491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93169627|NCT03884491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93169628|NCT03884491|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93169629|NCT03884491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93169630|NCT03712956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93169631|NCT03712956|Doxorubicin|doxorubicin|mesh-list
93169632|NCT03712956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93169633|NCT03712956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169634|NCT03712956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93169635|NCT03712956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93169636|NCT03712956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169637|NCT03712956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169638|NCT03880981|Acetaminophen|acetaminophen|mesh-list
93169639|NCT03880981|Ibuprofen|ibuprofen|mesh-list
93169640|NCT03880981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169641|NCT03880981|Analgesics|analgesics|mesh-ancestor
93169642|NCT03880981|Sensory System Agents|sensory system agents|mesh-ancestor
93169643|NCT03880981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169644|NCT03880981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169645|NCT03880981|Antipyretics|antipyretics|mesh-ancestor
93169646|NCT03880981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169647|NCT03880981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169648|NCT03880981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169649|NCT03880981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93169650|NCT03880981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169651|NCT03880981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169652|NCT03424044|Glucagon|glucagon|mesh-list
93169653|NCT03424044|Pancrelipase|pancrelipase|mesh-list
93169654|NCT03424044|Pancreatin|pancreatin|mesh-list
93169655|NCT03424044|Hormones|hormones|mesh-list
93169656|NCT03424044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169657|NCT03424044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169658|NCT03424044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93169659|NCT03880903|Albuterol|albuterol|mesh-list
93169660|NCT03880903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93169661|NCT03880903|Autonomic Agents|autonomic agents|mesh-ancestor
93169662|NCT03880903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169663|NCT03880903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169664|NCT03880903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93169665|NCT03880903|Respiratory System Agents|respiratory system agents|mesh-ancestor
93169666|NCT03880903|Tocolytic Agents|tocolytic agents|mesh-ancestor
93169667|NCT03880903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93169668|NCT03880903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93169669|NCT03880903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93169670|NCT03880903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93169671|NCT03880903|Adrenergic Agents|adrenergic agents|mesh-ancestor
93169672|NCT03880903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169673|NCT03880903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169674|NCT01155895|Amlodipine|amlodipine|mesh-list
93169675|NCT01155895|Benazepril|benazepril|mesh-list
93169676|NCT01155895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93169677|NCT01155895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93169678|NCT01155895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169679|NCT01155895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169680|NCT01155895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93169681|NCT01155895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169682|NCT01155895|Vasodilator Agents|vasodilator agents|mesh-ancestor
93169683|NCT01155895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93169684|NCT01155895|Protease Inhibitors|protease inhibitors|mesh-ancestor
93169685|NCT01155895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169686|NCT01265641|Moxifloxacin|moxifloxacin|mesh-list
93169687|NCT01265641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169688|NCT01265641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169689|NCT01265641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93169690|NCT01265641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93169691|NCT01265641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169692|NCT01265641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169693|NCT01265641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169694|NCT01589809|Niacinamide|niacinamide|mesh-list
93169695|NCT01589809|Niacin|niacin|mesh-list
93169696|NCT01589809|Nicotinic Acids|nicotinic acids|mesh-list
93169697|NCT01589809|Vitamins|vitamins|mesh-ancestor
93169698|NCT01589809|Micronutrients|micronutrients|mesh-ancestor
93169699|NCT01589809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169700|NCT01589809|Vitamin B Complex|vitamin b complex|mesh-ancestor
93169701|NCT01589809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93169702|NCT01589809|Antimetabolites|antimetabolites|mesh-ancestor
93169703|NCT01589809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169704|NCT01589809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93169705|NCT01589809|Vasodilator Agents|vasodilator agents|mesh-ancestor
93169706|NCT01264237|Etoricoxib|etoricoxib|mesh-list
93169707|NCT01264237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169708|NCT01264237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169709|NCT01264237|Analgesics|analgesics|mesh-ancestor
93169710|NCT01264237|Sensory System Agents|sensory system agents|mesh-ancestor
93169711|NCT01264237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169712|NCT01264237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169713|NCT01264237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169714|NCT01264237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169715|NCT01264237|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93169716|NCT01264237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93169717|NCT01264237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169718|NCT01264237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169719|NCT03880825|Metformin|metformin|mesh-list
93169720|NCT03880825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93169721|NCT03880825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169722|NCT01159639|Clopidogrel|clopidogrel|mesh-list
93169723|NCT01159639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93169724|NCT01159639|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93169725|NCT01159639|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93169726|NCT01159639|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93169727|NCT01159639|Purinergic Agents|purinergic agents|mesh-ancestor
93169728|NCT01159639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169729|NCT01159639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169730|NCT01159639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169731|NCT03880357|Betamethasone|betamethasone|mesh-list
93169732|NCT03880357|Betamethasone Valerate|betamethasone valerate|mesh-list
93169733|NCT03880357|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93169734|NCT03880357|Betamethasone benzoate|betamethasone benzoate|mesh-list
93169735|NCT03880357|Calcipotriene|calcipotriene|mesh-list
93169736|NCT03880357|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93169737|NCT03880357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169738|NCT03880357|Glucocorticoids|glucocorticoids|mesh-ancestor
93169739|NCT03880357|Hormones|hormones|mesh-ancestor
93169740|NCT03880357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169741|NCT03880357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169742|NCT03880357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93169743|NCT03880357|Respiratory System Agents|respiratory system agents|mesh-ancestor
93169744|NCT03880357|Dermatologic Agents|dermatologic agents|mesh-ancestor
93169745|NCT01266031|Bevacizumab|bevacizumab|mesh-list
93169746|NCT01266031|Vorinostat|vorinostat|mesh-list
93169747|NCT01266031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169748|NCT01266031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169749|NCT01266031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93169750|NCT01266031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93169751|NCT01266031|Growth Substances|growth substances|mesh-ancestor
93169752|NCT01266031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169753|NCT01266031|Growth Inhibitors|growth inhibitors|mesh-ancestor
93169754|NCT01266031|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93169755|NCT01266031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169756|NCT01266031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169757|NCT03880045|Vasopressins|vasopressins|mesh-list
93169758|NCT03880045|Arginine Vasopressin|arginine vasopressin|mesh-list
93169759|NCT03880045|Hemostatics|hemostatics|mesh-ancestor
93169760|NCT03880045|Coagulants|coagulants|mesh-ancestor
93169761|NCT03880045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93169762|NCT03880045|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93169763|NCT03880045|Natriuretic Agents|natriuretic agents|mesh-ancestor
93169764|NCT03880045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169765|NCT03879889|Nicotine|nicotine|mesh-list
93169766|NCT03879889|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93169767|NCT03879889|Autonomic Agents|autonomic agents|mesh-ancestor
93169768|NCT03879889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855150|NCT04220892|Pemetrexed|pemetrexed|mesh-list
93169769|NCT03879889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169770|NCT03879889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92841968|NCT00701337|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93169771|NCT03879889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93169772|NCT03879889|Cholinergic Agents|cholinergic agents|mesh-ancestor
93169773|NCT03879889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169774|NCT03879889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169775|NCT01266187|Leucovorin|leucovorin|mesh-list
93169776|NCT01266187|Cetuximab|cetuximab|mesh-list
93169777|NCT01266187|Fluorouracil|fluorouracil|mesh-list
93169778|NCT01266187|Oxaliplatin|oxaliplatin|mesh-list
93169779|NCT01266187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169780|NCT01266187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169781|NCT01266187|Antimetabolites|antimetabolites|mesh-ancestor
93169782|NCT01266187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169783|NCT01266187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93169784|NCT01266187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93169785|NCT01266187|Immunologic Factors|immunologic factors|mesh-ancestor
93169786|NCT01266187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169787|NCT01266187|Antidotes|antidotes|mesh-ancestor
93169788|NCT01266187|Protective Agents|protective agents|mesh-ancestor
93169789|NCT01266187|Vitamin B Complex|vitamin b complex|mesh-ancestor
93169790|NCT01266187|Vitamins|vitamins|mesh-ancestor
93169791|NCT01266187|Micronutrients|micronutrients|mesh-ancestor
93169792|NCT01586533|Mesalamine|mesalamine|mesh-list
93169793|NCT01586533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169794|NCT01586533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169795|NCT01586533|Analgesics|analgesics|mesh-ancestor
93169796|NCT01586533|Sensory System Agents|sensory system agents|mesh-ancestor
93169797|NCT01586533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169798|NCT01586533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169799|NCT01586533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169800|NCT01586533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169801|NCT03880123|Ixazomib|ixazomib|mesh-list
93169802|NCT03880123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169803|NCT03880123|Protease Inhibitors|protease inhibitors|mesh-ancestor
93169804|NCT03880123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169805|NCT03880123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169806|NCT01266499|Colistin|colistin|mesh-list
93169807|NCT01266499|Polymyxins|polymyxins|mesh-list
93169808|NCT01266499|Gentamicins|gentamicins|mesh-list
93169809|NCT01266499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169810|NCT01266499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169811|NCT01266499|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93169812|NCT01266499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169813|NCT01266499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169814|NCT00075725|Calcium, Dietary|calcium, dietary|mesh-list
93169815|NCT00075725|Leucovorin|leucovorin|mesh-list
93169816|NCT00075725|Folic Acid|folic acid|mesh-list
93169817|NCT00075725|Cytarabine|cytarabine|mesh-list
93169818|NCT00075725|Dexamethasone|dexamethasone|mesh-list
93169819|NCT00075725|Dexamethasone acetate|dexamethasone acetate|mesh-list
93169820|NCT00075725|Prednisone|prednisone|mesh-list
93169821|NCT00075725|Cortisone|cortisone|mesh-list
93169822|NCT00075725|Cyclophosphamide|cyclophosphamide|mesh-list
93169823|NCT00075725|Doxorubicin|doxorubicin|mesh-list
93169824|NCT00075725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93169825|NCT00075725|Methotrexate|methotrexate|mesh-list
93169826|NCT00075725|Vincristine|vincristine|mesh-list
93169827|NCT00075725|Daunorubicin|daunorubicin|mesh-list
93169828|NCT00075725|Asparaginase|asparaginase|mesh-list
93169829|NCT00075725|Mercaptopurine|mercaptopurine|mesh-list
93169830|NCT00075725|Pegaspargase|pegaspargase|mesh-list
93169831|NCT00075725|Thioguanine|thioguanine|mesh-list
93169832|NCT00075725|BB 1101|bb 1101|mesh-list
93169833|NCT00075725|Calcium|calcium|mesh-list
93169834|NCT00075725|2-Aminopurine|2-aminopurine|mesh-list
93169835|NCT00075725|Levoleucovorin|levoleucovorin|mesh-list
93169836|NCT00075725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93169837|NCT00075725|Immunologic Factors|immunologic factors|mesh-ancestor
93169838|NCT00075725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169839|NCT00075725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169840|NCT00075725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93169841|NCT00075725|Alkylating Agents|alkylating agents|mesh-ancestor
93169842|NCT00075725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169843|NCT00075725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169844|NCT00075725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93169845|NCT00075725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92842057|NCT00807625|Copper|copper|mesh-list
93169846|NCT00075725|Antiemetics|antiemetics|mesh-ancestor
93169847|NCT00075725|Autonomic Agents|autonomic agents|mesh-ancestor
93169848|NCT00075725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169849|NCT00075725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93169850|NCT00075725|Glucocorticoids|glucocorticoids|mesh-ancestor
93169851|NCT00075725|Hormones|hormones|mesh-ancestor
93169852|NCT00075725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169853|NCT00075725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93169854|NCT00075725|Protease Inhibitors|protease inhibitors|mesh-ancestor
93169855|NCT00075725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93169856|NCT00075725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93169857|NCT00075725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93169858|NCT00075725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93169859|NCT00075725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93169860|NCT00075725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93169861|NCT00075725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93169862|NCT00075725|Abortifacient Agents|abortifacient agents|mesh-ancestor
93169863|NCT00075725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93169864|NCT00075725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93169865|NCT00075725|Antimetabolites|antimetabolites|mesh-ancestor
93169866|NCT00075725|Dermatologic Agents|dermatologic agents|mesh-ancestor
93169867|NCT00075725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93169868|NCT00075725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93169869|NCT00075725|Antiviral Agents|antiviral agents|mesh-ancestor
93169870|NCT00075725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169871|NCT00075725|Antidotes|antidotes|mesh-ancestor
93169872|NCT00075725|Protective Agents|protective agents|mesh-ancestor
93169873|NCT00075725|Vitamin B Complex|vitamin b complex|mesh-ancestor
93169874|NCT00075725|Vitamins|vitamins|mesh-ancestor
93169875|NCT00075725|Micronutrients|micronutrients|mesh-ancestor
93169876|NCT00075725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93169877|NCT00075725|Tubulin Modulators|tubulin modulators|mesh-ancestor
93169878|NCT00075725|Antimitotic Agents|antimitotic agents|mesh-ancestor
93169879|NCT00075725|Mitosis Modulators|mitosis modulators|mesh-ancestor
93169880|NCT00075725|Hematinics|hematinics|mesh-ancestor
93169881|NCT02953782|Cetuximab|cetuximab|mesh-list
93169882|NCT02953782|Magrolimab|magrolimab|mesh-list
93169883|NCT02953782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169884|NCT02953782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169885|NCT01264783|RNS60|rns60|mesh-list
93169886|NCT01264783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93169887|NCT01264783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93169888|NCT01264783|Analgesics|analgesics|mesh-ancestor
93169889|NCT01264783|Sensory System Agents|sensory system agents|mesh-ancestor
93169890|NCT01264783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169891|NCT01264783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169892|NCT01264783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169893|NCT01264783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93169894|NCT01264783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93169895|NCT01156129|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
93169896|NCT01156129|Antidiarrheals|antidiarrheals|mesh-ancestor
93169897|NCT01156129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93169898|NCT01160029|Nateglinide|nateglinide|mesh-list
93169899|NCT01160029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93169900|NCT01160029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169901|NCT00057863|Paclitaxel|paclitaxel|mesh-list
93169902|NCT00057863|Oxaliplatin|oxaliplatin|mesh-list
93169903|NCT00057863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93169904|NCT00057863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169905|NCT00057863|Tubulin Modulators|tubulin modulators|mesh-ancestor
93169906|NCT00057863|Antimitotic Agents|antimitotic agents|mesh-ancestor
93169907|NCT00057863|Mitosis Modulators|mitosis modulators|mesh-ancestor
93169908|NCT00057863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169909|NCT01266655|Baclofen|baclofen|mesh-list
93169910|NCT01266655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93169911|NCT01266655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169912|NCT01266655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93169913|NCT01266655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93169914|NCT01266655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93169915|NCT01266655|GABA Agonists|gaba agonists|mesh-ancestor
93169916|NCT01266655|GABA Agents|gaba agents|mesh-ancestor
93169917|NCT01266655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93169918|NCT01266655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169919|NCT00075023|Thalidomide|thalidomide|mesh-list
93169920|NCT00075023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93169921|NCT00075023|Immunologic Factors|immunologic factors|mesh-ancestor
93169922|NCT00075023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169923|NCT00075023|Leprostatic Agents|leprostatic agents|mesh-ancestor
93169924|NCT00075023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169925|NCT00075023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169926|NCT00075023|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93169927|NCT00075023|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93169928|NCT00075023|Growth Substances|growth substances|mesh-ancestor
93169929|NCT00075023|Growth Inhibitors|growth inhibitors|mesh-ancestor
93169930|NCT00075023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169931|NCT01100801|Cisplatin|cisplatin|mesh-list
93169932|NCT01100801|Oxaliplatin|oxaliplatin|mesh-list
93169933|NCT01100801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169934|NCT01263145|Paclitaxel|paclitaxel|mesh-list
93169935|NCT01263145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93169936|NCT01263145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169937|NCT01263145|Tubulin Modulators|tubulin modulators|mesh-ancestor
93169938|NCT01263145|Antimitotic Agents|antimitotic agents|mesh-ancestor
93169939|NCT01263145|Mitosis Modulators|mitosis modulators|mesh-ancestor
93169940|NCT01263145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169941|NCT03717558|Ivermectin|ivermectin|mesh-list
93169942|NCT03717558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93169943|NCT03717558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169944|NCT00074711|Calcium, Dietary|calcium, dietary|mesh-list
93169945|NCT00074711|Calcium Carbonate|calcium carbonate|mesh-list
93169946|NCT00074711|Calcium|calcium|mesh-list
93169947|NCT00074711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93169948|NCT00074711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169949|NCT00074711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93169950|NCT00074711|Antacids|antacids|mesh-ancestor
93169951|NCT00074711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169952|NCT00074711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93169953|NCT03960905|Meropenem|meropenem|mesh-list
93169954|NCT03960905|Ceftazidime|ceftazidime|mesh-list
93169955|NCT03960905|Cefepime|cefepime|mesh-list
93169956|NCT03960905|Anti-Infective Agents|anti-infective agents|mesh-list
93169957|NCT03960905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93169958|NCT05619120|Mexiletine|mexiletine|mesh-list
93169959|NCT05619120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93169960|NCT05619120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93169961|NCT05619120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93169962|NCT05619120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93169963|NCT05619120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169964|NCT01265017|Hydrocortisone|hydrocortisone|mesh-list
93169965|NCT01265017|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93169966|NCT01265017|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93169967|NCT01265017|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93169968|NCT01265017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93169969|NCT01265017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93169970|NCT01265017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93169971|NCT01265017|Medroxyprogesterone|medroxyprogesterone|mesh-list
93169972|NCT01265017|Estradiol|estradiol|mesh-list
93169973|NCT01265017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93169974|NCT01265017|Hormones|hormones|mesh-ancestor
93169975|NCT01265017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93169976|NCT01265017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93169977|NCT01265017|Estrogens|estrogens|mesh-ancestor
93169978|NCT01265017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93169979|NCT01265017|Contraceptive Agents|contraceptive agents|mesh-ancestor
93169980|NCT01265017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93169981|NCT01265017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93169982|NCT01265017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93169983|NCT01265017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93169984|NCT01265017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93169985|NCT01265017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93169986|NCT01265017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93169987|NCT01265017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93169988|NCT01265017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169989|NCT03420300|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93169990|NCT03420300|Antiviral Agents|antiviral agents|mesh-ancestor
93169991|NCT03420300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93169992|NCT03879811|Nivolumab|nivolumab|mesh-list
93169993|NCT03879811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93169994|NCT03879811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93169995|NCT03879811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93169996|NCT03879811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93169997|NCT01158859|Pregabalin|pregabalin|mesh-list
93169998|NCT01158859|Analgesics|analgesics|mesh-ancestor
93169999|NCT01158859|Sensory System Agents|sensory system agents|mesh-ancestor
93170000|NCT01158859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170001|NCT01158859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842196|NCT00808327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93170002|NCT01158859|Anticonvulsants|anticonvulsants|mesh-ancestor
93170003|NCT01158859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93170004|NCT01158859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93170005|NCT01158859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170006|NCT01158859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93170007|NCT01158859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93170008|NCT01158859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93170009|NCT01158859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170010|NCT01158859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170012|NCT01100021|Tamsulosin|tamsulosin|mesh-list
93170013|NCT01100021|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93170014|NCT01100021|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93170015|NCT01100021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93170016|NCT01100021|Adrenergic Agents|adrenergic agents|mesh-ancestor
93170017|NCT01100021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170018|NCT01100021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170019|NCT01100021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170020|NCT01100021|Urological Agents|urological agents|mesh-ancestor
93170021|NCT01100021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93170022|NCT03407430|Pregabalin|pregabalin|mesh-list
93170023|NCT03407430|Analgesics|analgesics|mesh-ancestor
93170024|NCT03407430|Sensory System Agents|sensory system agents|mesh-ancestor
93170025|NCT03407430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170026|NCT03407430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170027|NCT03407430|Anticonvulsants|anticonvulsants|mesh-ancestor
93170028|NCT03407430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93170029|NCT03407430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93170030|NCT03407430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170031|NCT03407430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93170032|NCT03407430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93170033|NCT03407430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93170034|NCT03407430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170035|NCT03407430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170036|NCT01266811|Dexamethasone|dexamethasone|mesh-list
93170037|NCT01266811|Dexamethasone acetate|dexamethasone acetate|mesh-list
93170038|NCT01266811|Bortezomib|bortezomib|mesh-list
93170039|NCT01266811|Siltuximab|siltuximab|mesh-list
93170040|NCT01266811|BB 1101|bb 1101|mesh-list
93170041|NCT01266811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170042|NCT01266811|Antiemetics|antiemetics|mesh-ancestor
93170043|NCT01266811|Autonomic Agents|autonomic agents|mesh-ancestor
93170044|NCT01266811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170045|NCT01266811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170046|NCT01266811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170047|NCT01266811|Glucocorticoids|glucocorticoids|mesh-ancestor
93170048|NCT01266811|Hormones|hormones|mesh-ancestor
93170049|NCT01266811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170050|NCT01266811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93170051|NCT01266811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170052|NCT01266811|Protease Inhibitors|protease inhibitors|mesh-ancestor
93170053|NCT01266811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170054|NCT01266811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170055|NCT01158937|Meropenem|meropenem|mesh-list
93170056|NCT01158937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93170057|NCT01158937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170058|NCT03407118|Insulin Lispro|insulin lispro|mesh-list
93170059|NCT03407118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93170060|NCT03407118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170061|NCT01100177|Sunitinib|sunitinib|mesh-list
93170062|NCT01100177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170063|NCT01100177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170064|NCT01100177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170065|NCT01100177|Growth Substances|growth substances|mesh-ancestor
93170066|NCT01100177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170067|NCT01100177|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170068|NCT01100177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170069|NCT01100177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855153|NCT04220892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93170070|NCT01100177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170071|NCT01100333|Hormones|hormones|mesh-list
93170072|NCT01100333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93170073|NCT01100333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170074|NCT01100333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170075|NCT01327235|Cisplatin|cisplatin|mesh-list
93170076|NCT01327235|Endostar protein|endostar protein|mesh-list
93170077|NCT01327235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170078|NCT01327235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170079|NCT01327235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170080|NCT01327235|Growth Substances|growth substances|mesh-ancestor
93170081|NCT01327235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170082|NCT01327235|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170083|NCT03406260|Lasmiditan|lasmiditan|mesh-list
93170084|NCT03406260|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93170085|NCT03406260|Serotonin Agents|serotonin agents|mesh-ancestor
93170086|NCT03406260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170087|NCT03406260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170088|NCT03406260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170089|NCT01089179|Metformin|metformin|mesh-list
93170090|NCT01089179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93170091|NCT01089179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170092|NCT01160185|Paclitaxel|paclitaxel|mesh-list
93170093|NCT01160185|Topotecan|topotecan|mesh-list
93170094|NCT01160185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93170095|NCT01160185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170096|NCT01160185|Tubulin Modulators|tubulin modulators|mesh-ancestor
93170097|NCT01160185|Antimitotic Agents|antimitotic agents|mesh-ancestor
93170098|NCT01160185|Mitosis Modulators|mitosis modulators|mesh-ancestor
93170099|NCT01160185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170100|NCT01160185|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93170101|NCT01160185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93170102|NCT01160185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170103|NCT03419364|Niacinamide|niacinamide|mesh-list
93170104|NCT03419364|Niacin|niacin|mesh-list
93170105|NCT03419364|Nicotinic Acids|nicotinic acids|mesh-list
93170106|NCT03419364|Vitamin B Complex|vitamin b complex|mesh-ancestor
93170107|NCT03419364|Vitamins|vitamins|mesh-ancestor
93170108|NCT03419364|Micronutrients|micronutrients|mesh-ancestor
93170109|NCT03419364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170110|NCT03419364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93170111|NCT03419364|Antimetabolites|antimetabolites|mesh-ancestor
93170112|NCT03419364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170113|NCT03419364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93170114|NCT03419364|Vasodilator Agents|vasodilator agents|mesh-ancestor
93170115|NCT01265173|Ciprofloxacin|ciprofloxacin|mesh-list
93170116|NCT01265173|Ceftriaxone|ceftriaxone|mesh-list
93170117|NCT01265173|Cefotaxime|cefotaxime|mesh-list
93170118|NCT01265173|Cefoxitin|cefoxitin|mesh-list
93170119|NCT01265173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93170120|NCT01265173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170121|NCT01265173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93170122|NCT01265173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93170123|NCT01265173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170124|NCT01265173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170125|NCT01265173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170126|NCT01265173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93170127|NCT01265173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93170128|NCT01159327|Sorafenib|sorafenib|mesh-list
93170129|NCT01159327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170130|NCT01159327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170131|NCT01159327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170132|NCT01159327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170133|NCT01160341|Methyltestosterone|methyltestosterone|mesh-list
93170134|NCT01160341|Testosterone|testosterone|mesh-list
93170135|NCT01160341|Testosterone undecanoate|testosterone undecanoate|mesh-list
93170136|NCT01160341|Testosterone enanthate|testosterone enanthate|mesh-list
93170137|NCT01160341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93170138|NCT01160341|Androgens|androgens|mesh-ancestor
93170139|NCT01160341|Hormones|hormones|mesh-ancestor
93170140|NCT01160341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170141|NCT01160341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170142|NCT01160341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93170143|NCT01160341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170144|NCT01160341|Anabolic Agents|anabolic agents|mesh-ancestor
93170145|NCT03882775|Heparin|heparin|mesh-list
93170146|NCT03882775|Bivalirudin|bivalirudin|mesh-list
93170147|NCT03882775|Anticoagulants|anticoagulants|mesh-ancestor
93170148|NCT03882775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93170149|NCT03882775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93170150|NCT03882775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170151|NCT03882775|Antithrombins|antithrombins|mesh-ancestor
93170152|NCT03882775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93170153|NCT03882775|Protease Inhibitors|protease inhibitors|mesh-ancestor
93170154|NCT03882775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170156|NCT03877705|Sodium Fluoride|sodium fluoride|mesh-list
93170157|NCT03877705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93170158|NCT03877705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170159|NCT03877705|Cariostatic Agents|cariostatic agents|mesh-ancestor
93170160|NCT03877705|Protective Agents|protective agents|mesh-ancestor
93170161|NCT03877705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170162|NCT01160419|Leucovorin|leucovorin|mesh-list
93170163|NCT01160419|Folic Acid|folic acid|mesh-list
93170164|NCT01160419|Docetaxel|docetaxel|mesh-list
93170165|NCT01160419|Oxaliplatin|oxaliplatin|mesh-list
93170166|NCT01160419|Levoleucovorin|levoleucovorin|mesh-list
93170167|NCT01160419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170168|NCT01160419|Tubulin Modulators|tubulin modulators|mesh-ancestor
93170169|NCT01160419|Antimitotic Agents|antimitotic agents|mesh-ancestor
93170170|NCT01160419|Mitosis Modulators|mitosis modulators|mesh-ancestor
93170171|NCT01160419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170172|NCT01160419|Antidotes|antidotes|mesh-ancestor
93170173|NCT01160419|Protective Agents|protective agents|mesh-ancestor
93170174|NCT01160419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170175|NCT01160419|Vitamin B Complex|vitamin b complex|mesh-ancestor
93170176|NCT01160419|Vitamins|vitamins|mesh-ancestor
93170177|NCT01160419|Micronutrients|micronutrients|mesh-ancestor
93170178|NCT01160419|Hematinics|hematinics|mesh-ancestor
93170179|NCT02954172|Paclitaxel|paclitaxel|mesh-list
93170180|NCT02954172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93170181|NCT02954172|Bevacizumab|bevacizumab|mesh-list
93170182|NCT02954172|Carboplatin|carboplatin|mesh-list
93170183|NCT02954172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93170184|NCT02954172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170185|NCT02954172|Tubulin Modulators|tubulin modulators|mesh-ancestor
93170186|NCT02954172|Antimitotic Agents|antimitotic agents|mesh-ancestor
93170187|NCT02954172|Mitosis Modulators|mitosis modulators|mesh-ancestor
93170188|NCT02954172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170189|NCT02954172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93170190|NCT02954172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170191|NCT02954172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170192|NCT02954172|Growth Substances|growth substances|mesh-ancestor
93170193|NCT02954172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170194|NCT02954172|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170195|NCT01156519|Hydrocortisone|hydrocortisone|mesh-list
93170196|NCT01156519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170197|NCT02953938|Ranibizumab|ranibizumab|mesh-list
93170198|NCT02953938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170199|NCT02953938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170200|NCT02953938|Growth Substances|growth substances|mesh-ancestor
93170201|NCT02953938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170202|NCT02953938|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170203|NCT02953938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170204|NCT01161667|Naratriptan|naratriptan|mesh-list
93170205|NCT01161667|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93170206|NCT01161667|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93170207|NCT01161667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93170208|NCT01161667|Serotonin Agents|serotonin agents|mesh-ancestor
93170209|NCT01161667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170210|NCT01161667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170211|NCT01161667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170212|NCT02526979|Mirabegron|mirabegron|mesh-list
93170213|NCT02526979|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93170214|NCT02526979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93170215|NCT02526979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93170216|NCT02526979|Adrenergic Agents|adrenergic agents|mesh-ancestor
93170217|NCT02526979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170218|NCT02526979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170219|NCT02526979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170220|NCT02526979|Urological Agents|urological agents|mesh-ancestor
93170221|NCT03882541|Midazolam|midazolam|mesh-list
93170222|NCT03882541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93170223|NCT03882541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93170224|NCT03882541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170225|NCT03882541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170226|NCT03882541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93170227|NCT03882541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93170228|NCT03882541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170229|NCT03882541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93170230|NCT03882541|Anesthetics, General|anesthetics, general|mesh-ancestor
93170231|NCT03882541|Anesthetics|anesthetics|mesh-ancestor
93170232|NCT03882541|GABA Modulators|gaba modulators|mesh-ancestor
93170233|NCT03882541|GABA Agents|gaba agents|mesh-ancestor
93170234|NCT03882541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170235|NCT03882541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170236|NCT01267903|Vaccines|vaccines|mesh-list
93170237|NCT01267903|Immunologic Factors|immunologic factors|mesh-ancestor
93170238|NCT01267903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170239|NCT03576313|Ivermectin|ivermectin|mesh-list
93170240|NCT03576313|Piperaquine|piperaquine|mesh-list
93170241|NCT03576313|Artenimol|artenimol|mesh-list
93170242|NCT03576313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93170243|NCT03576313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170244|NCT03576313|Antimalarials|antimalarials|mesh-ancestor
93170245|NCT03576313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93170246|NCT01161979|Zonisamide|zonisamide|mesh-list
93170247|NCT01161979|Anticonvulsants|anticonvulsants|mesh-ancestor
93170248|NCT01161979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93170249|NCT01161979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93170250|NCT01161979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170251|NCT01161979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93170252|NCT01161979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170253|NCT01160731|Etoposide|etoposide|mesh-list
93170254|NCT01160731|Panobinostat|panobinostat|mesh-list
93170255|NCT01160731|Etoposide phosphate|etoposide phosphate|mesh-list
93170256|NCT01160731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170257|NCT01160731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93170258|NCT01160731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93170259|NCT01160731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93170260|NCT01160731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170261|NCT01160731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170262|NCT01160731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93170263|NCT01160965|Ropivacaine|ropivacaine|mesh-list
93170264|NCT01160965|Levobupivacaine|levobupivacaine|mesh-list
93170265|NCT01160965|Anesthetics, Local|anesthetics, local|mesh-ancestor
93170266|NCT01160965|Anesthetics|anesthetics|mesh-ancestor
93170267|NCT01160965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170268|NCT01160965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170269|NCT01160965|Sensory System Agents|sensory system agents|mesh-ancestor
93170270|NCT01160965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170271|NCT01156909|Rituximab|rituximab|mesh-list
93170272|NCT01156909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93170273|NCT01156909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170274|NCT01156909|Immunologic Factors|immunologic factors|mesh-ancestor
93170275|NCT01156909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170276|NCT01156909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93170277|NCT01162603|Latanoprost|latanoprost|mesh-list
93170278|NCT01162603|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93170279|NCT01162603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93170280|NCT03881995|Insulin Glargine|insulin glargine|mesh-list
93170281|NCT03881995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93170282|NCT03881995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170283|NCT02527213|Sodium thiosulfate|sodium thiosulfate|mesh-list
93170284|NCT02527213|Antidotes|antidotes|mesh-ancestor
93170285|NCT02527213|Protective Agents|protective agents|mesh-ancestor
93170286|NCT02527213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170287|NCT02527213|Antioxidants|antioxidants|mesh-ancestor
93170288|NCT02527213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170289|NCT02527213|Antitubercular Agents|antitubercular agents|mesh-ancestor
93170290|NCT02527213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93170291|NCT02527213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170292|NCT02527213|Chelating Agents|chelating agents|mesh-ancestor
93170293|NCT02527213|Sequestering Agents|sequestering agents|mesh-ancestor
93170294|NCT01161277|Haloperidol|haloperidol|mesh-list
93170295|NCT01161277|Aripiprazole|aripiprazole|mesh-list
93170296|NCT01161277|Haloperidol decanoate|haloperidol decanoate|mesh-list
93170297|NCT01161277|Antidepressive Agents|antidepressive agents|mesh-ancestor
93170298|NCT01161277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170299|NCT01161277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93170300|NCT01161277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93170301|NCT01161277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170302|NCT01161277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170303|NCT01161277|Dopamine Agonists|dopamine agonists|mesh-ancestor
93170304|NCT01161277|Dopamine Agents|dopamine agents|mesh-ancestor
93170305|NCT01161277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170306|NCT01161277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170307|NCT01161277|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93170308|NCT01161277|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93170309|NCT01161277|Serotonin Agents|serotonin agents|mesh-ancestor
93170310|NCT01161277|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93170311|NCT01161277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93170312|NCT01161277|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93170313|NCT01161277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93170314|NCT01161277|Antiemetics|antiemetics|mesh-ancestor
93170315|NCT01161277|Autonomic Agents|autonomic agents|mesh-ancestor
93170316|NCT01161277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170317|NCT01161277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170318|NCT01161277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93170319|NCT01268215|Budesonide|budesonide|mesh-list
93170320|NCT01268215|Calfactant|calfactant|mesh-list
93170321|NCT01268215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170322|NCT01268215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93170323|NCT01268215|Autonomic Agents|autonomic agents|mesh-ancestor
93170324|NCT01268215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170325|NCT01268215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170326|NCT01268215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93170327|NCT01268215|Respiratory System Agents|respiratory system agents|mesh-ancestor
93170328|NCT01268215|Glucocorticoids|glucocorticoids|mesh-ancestor
93170329|NCT01268215|Hormones|hormones|mesh-ancestor
93170330|NCT01268215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170331|NCT01268215|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93170332|NCT01269307|Ketamine|ketamine|mesh-list
93170333|NCT01269307|Propofol|propofol|mesh-list
93170334|NCT01269307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93170335|NCT01269307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170336|NCT01269307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170337|NCT01269307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93170338|NCT01269307|Anesthetics, General|anesthetics, general|mesh-ancestor
93170339|NCT01269307|Anesthetics|anesthetics|mesh-ancestor
93170340|NCT01269307|Analgesics|analgesics|mesh-ancestor
93170341|NCT01269307|Sensory System Agents|sensory system agents|mesh-ancestor
93170342|NCT01269307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170343|NCT01269307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93170344|NCT01269307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93170345|NCT01269307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93170346|NCT01269307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170347|NCT01269307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170348|NCT03874585|Nicotine|nicotine|mesh-list
93170349|NCT03874585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93170350|NCT03874585|Autonomic Agents|autonomic agents|mesh-ancestor
93170351|NCT03874585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170352|NCT03874585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170353|NCT03874585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93170354|NCT03874585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93170355|NCT03874585|Cholinergic Agents|cholinergic agents|mesh-ancestor
93170356|NCT03874585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170357|NCT03874585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170358|NCT01268371|Everolimus|everolimus|mesh-list
93170359|NCT01268371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93170360|NCT01268371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170361|NCT01268371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170362|NCT01268371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170363|NCT01268371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93170364|NCT01268371|Immunologic Factors|immunologic factors|mesh-ancestor
93170365|NCT01268371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170366|NCT01268371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170367|NCT01267669|Somatostatin|somatostatin|mesh-list
93170368|NCT01267669|Hormones|hormones|mesh-ancestor
93170369|NCT01267669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170370|NCT01267669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170371|NCT05666869|Esketamine|esketamine|mesh-list
93170372|NCT05666869|Antidepressive Agents|antidepressive agents|mesh-ancestor
93170373|NCT05666869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170374|NCT01164943|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93170375|NCT01164943|Hormones|hormones|mesh-ancestor
93170376|NCT01164943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170377|NCT01164943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170378|NCT01269541|Rifampin|rifampin|mesh-list
93170379|NCT01269541|Mupirocin|mupirocin|mesh-list
93170380|NCT01269541|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93170381|NCT01269541|Antitubercular Agents|antitubercular agents|mesh-ancestor
93170382|NCT01269541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93170383|NCT01269541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170384|NCT01269541|Leprostatic Agents|leprostatic agents|mesh-ancestor
93170385|NCT01269541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93170386|NCT01269541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170387|NCT01269541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170388|NCT01269541|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93170389|NCT01269541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93170390|NCT01269541|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93170391|NCT01269541|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93170392|NCT01269541|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93170393|NCT01269541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93170394|NCT01269541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93170395|NCT03877003|Choline|choline|mesh-list
93170396|NCT03877003|Lipotropic Agents|lipotropic agents|mesh-ancestor
93170397|NCT03877003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93170398|NCT03877003|Antimetabolites|antimetabolites|mesh-ancestor
93170399|NCT03877003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170400|NCT03877003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170401|NCT03877003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93170402|NCT03877003|Nootropic Agents|nootropic agents|mesh-ancestor
93170403|NCT01280149|Substance P|substance p|mesh-list
93170404|NCT01280149|Neurokinin A|neurokinin a|mesh-list
93170405|NCT01280149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170406|NCT01280149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170407|NCT01280149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170408|NCT01165255|Bupropion|bupropion|mesh-list
93170409|NCT01165255|Antidepressive Agents|antidepressive agents|mesh-list
93170410|NCT01165255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93170411|NCT01165255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170412|NCT01165255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93170413|NCT01165255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93170414|NCT01165255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93170415|NCT01165255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170416|NCT01165255|Dopamine Agents|dopamine agents|mesh-ancestor
93170417|NCT01165255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170418|NCT01165255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170419|NCT01165255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93170420|NCT01165255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93170421|NCT01165255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170422|NCT01167049|Capecitabine|capecitabine|mesh-list
93170423|NCT01167049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93170424|NCT01167049|Antimetabolites|antimetabolites|mesh-ancestor
93170425|NCT01167049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170426|NCT01167049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170427|NCT01311414|Urapidil|urapidil|mesh-list
93170428|NCT01311414|Cafedrine|cafedrine|mesh-list
93170429|NCT01311414|Theodrenaline|theodrenaline|mesh-list
93170430|NCT01311414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93170431|NCT01311414|Vasodilator Agents|vasodilator agents|mesh-ancestor
93170432|NCT01311414|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93170433|NCT01311414|Serotonin Agents|serotonin agents|mesh-ancestor
93170434|NCT01311414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170435|NCT01311414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170436|NCT01311414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170437|NCT01311414|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93170438|NCT01311414|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93170439|NCT01311414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93170440|NCT01311414|Adrenergic Agents|adrenergic agents|mesh-ancestor
93170441|NCT03715296|Lenalidomide|lenalidomide|mesh-list
93170442|NCT03715296|Immunologic Factors|immunologic factors|mesh-ancestor
93170443|NCT03715296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170444|NCT03715296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170445|NCT03715296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170446|NCT03715296|Growth Substances|growth substances|mesh-ancestor
93170447|NCT03715296|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170448|NCT03715296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170449|NCT01347762|Nabilone|nabilone|mesh-list
93170450|NCT01347762|Antiemetics|antiemetics|mesh-ancestor
93170451|NCT01347762|Autonomic Agents|autonomic agents|mesh-ancestor
93170452|NCT01347762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170453|NCT01347762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170454|NCT01347762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170456|NCT01347762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93170457|NCT01347762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170458|NCT01347762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170459|NCT03874273|Crizotinib|crizotinib|mesh-list
93170460|NCT03874273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170461|NCT03874273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170462|NCT03874273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170463|NCT03874273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170464|NCT05657652|Cytarabine|cytarabine|mesh-list
93170465|NCT05657652|Venetoclax|venetoclax|mesh-list
93170466|NCT05657652|Cladribine|cladribine|mesh-list
93170467|NCT05657652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93170468|NCT05657652|Antimetabolites|antimetabolites|mesh-ancestor
93170469|NCT05657652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170470|NCT05657652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170471|NCT05657652|Antiviral Agents|antiviral agents|mesh-ancestor
93170472|NCT05657652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170473|NCT05657652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93170474|NCT05657652|Immunologic Factors|immunologic factors|mesh-ancestor
93170475|NCT05657652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170476|NCT01167127|Oxycodone|oxycodone|mesh-list
93170477|NCT01167127|Naloxone|naloxone|mesh-list
93170478|NCT01167127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93170479|NCT01167127|Narcotics|narcotics|mesh-ancestor
93170480|NCT01167127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170481|NCT01167127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170482|NCT01167127|Analgesics|analgesics|mesh-ancestor
93170483|NCT01167127|Sensory System Agents|sensory system agents|mesh-ancestor
93170484|NCT01167127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170485|NCT01167127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93170486|NCT01280305|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93170487|NCT01280305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93170488|NCT01280305|Hormone Antagonists|hormone antagonists|mesh-ancestor
93170489|NCT01280305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170490|NCT01280305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170491|NCT01280305|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93170492|NCT01280305|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93170493|NCT01280305|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93170494|NCT03872011|Vitamins|vitamins|mesh-list
93170495|NCT03872011|Ascorbic Acid|ascorbic acid|mesh-list
93170496|NCT03872011|Thiamine|thiamine|mesh-list
93170497|NCT03872011|Hydrocortisone|hydrocortisone|mesh-list
93170498|NCT03872011|Micronutrients|micronutrients|mesh-ancestor
93170499|NCT03872011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170500|NCT03872011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170501|NCT03872011|Antioxidants|antioxidants|mesh-ancestor
93170502|NCT03872011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170503|NCT03872011|Protective Agents|protective agents|mesh-ancestor
93170504|NCT03872011|Vitamin B Complex|vitamin b complex|mesh-ancestor
93170505|NCT03438396|Tisotumab vedotin|tisotumab vedotin|mesh-list
93170506|NCT03438396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93170507|NCT03438396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170508|NCT03876067|Cardioplegic Solutions|cardioplegic solutions|mesh-list
93170509|NCT03876067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93170510|NCT01163929|Paclitaxel|paclitaxel|mesh-list
93170511|NCT01163929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93170512|NCT01163929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170513|NCT01163929|Tubulin Modulators|tubulin modulators|mesh-ancestor
93170514|NCT01163929|Antimitotic Agents|antimitotic agents|mesh-ancestor
93170515|NCT01163929|Mitosis Modulators|mitosis modulators|mesh-ancestor
93170516|NCT01163929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170517|NCT03871777|Chlorhexidine|chlorhexidine|mesh-list
93170518|NCT03871777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93170519|NCT03871777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170520|NCT03871777|Disinfectants|disinfectants|mesh-ancestor
93170521|NCT00073307|Sorafenib|sorafenib|mesh-list
93170522|NCT00073307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170523|NCT00073307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170524|NCT00073307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170525|NCT00073307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170526|NCT01270789|Liraglutide|liraglutide|mesh-list
93170527|NCT01270789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93170528|NCT01270789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170529|NCT01270789|Incretins|incretins|mesh-ancestor
93170530|NCT01270789|Hormones|hormones|mesh-ancestor
93170531|NCT01270789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170532|NCT01164085|Ketorolac|ketorolac|mesh-list
93170533|NCT01164085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93170534|NCT01164085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93170535|NCT01164085|Analgesics|analgesics|mesh-ancestor
93170536|NCT01164085|Sensory System Agents|sensory system agents|mesh-ancestor
93170537|NCT01164085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170538|NCT01164085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170539|NCT01164085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170540|NCT01164085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93170541|NCT01164085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93170542|NCT01164085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170543|NCT01164085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170544|NCT01271179|Insulin|insulin|mesh-list
93170545|NCT01271179|Allopurinol|allopurinol|mesh-list
93170546|NCT01271179|Adenosine|adenosine|mesh-list
93170547|NCT01271179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93170548|NCT01271179|Analgesics|analgesics|mesh-ancestor
93170549|NCT01271179|Sensory System Agents|sensory system agents|mesh-ancestor
93170550|NCT01271179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170551|NCT01271179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170552|NCT01271179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93170553|NCT01271179|Vasodilator Agents|vasodilator agents|mesh-ancestor
93170554|NCT01271179|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93170555|NCT01271179|Purinergic Agonists|purinergic agonists|mesh-ancestor
93170556|NCT01271179|Purinergic Agents|purinergic agents|mesh-ancestor
93170557|NCT01271179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170558|NCT01271179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170559|NCT01271179|Antimetabolites|antimetabolites|mesh-ancestor
93170560|NCT01271179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170561|NCT01271179|Gout Suppressants|gout suppressants|mesh-ancestor
93170562|NCT01271179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93170563|NCT01271179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93170564|NCT01271179|Antioxidants|antioxidants|mesh-ancestor
93170565|NCT01271179|Protective Agents|protective agents|mesh-ancestor
93170566|NCT01271179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93170567|NCT03388164|Dexetimide|dexetimide|mesh-list
93170568|NCT03388164|Citalopram|citalopram|mesh-list
93170569|NCT03388164|Escitalopram|escitalopram|mesh-list
93170570|NCT03388164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93170571|NCT03388164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93170572|NCT03388164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93170573|NCT03388164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170574|NCT03388164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170575|NCT03388164|Serotonin Agents|serotonin agents|mesh-ancestor
93170576|NCT03388164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170577|NCT03388164|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93170578|NCT03388164|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93170579|NCT03388164|Parasympatholytics|parasympatholytics|mesh-ancestor
93170580|NCT03388164|Autonomic Agents|autonomic agents|mesh-ancestor
93170581|NCT03388164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170582|NCT03388164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93170583|NCT03388164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93170584|NCT03388164|Cholinergic Agents|cholinergic agents|mesh-ancestor
93170585|NCT03388164|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93170586|NCT03388164|Antidepressive Agents|antidepressive agents|mesh-ancestor
93170587|NCT03388164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170588|NCT01268761|Cetrorelix|cetrorelix|mesh-list
93170589|NCT01268761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93170590|NCT01268761|Fertility Agents|fertility agents|mesh-ancestor
93170591|NCT01268761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93170592|NCT01268761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170593|NCT01268761|Hormone Antagonists|hormone antagonists|mesh-ancestor
93170594|NCT01268761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170595|NCT01268839|Efavirenz|efavirenz|mesh-list
93170596|NCT01268839|Rilpivirine|rilpivirine|mesh-list
93170597|NCT01268839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93170598|NCT01268839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93170599|NCT01268839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170600|NCT01268839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170601|NCT01268839|Antiviral Agents|antiviral agents|mesh-ancestor
93170602|NCT01268839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170603|NCT01268839|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93170604|NCT01268839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93170605|NCT01268839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93170606|NCT01268839|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93170607|NCT01268839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93170608|NCT01268839|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93170609|NCT01268839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93170610|NCT01268839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93170611|NCT03403374|Evolocumab|evolocumab|mesh-list
93170612|NCT03403374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93170613|NCT03403374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93170614|NCT03403374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93170615|NCT03403374|Antimetabolites|antimetabolites|mesh-ancestor
93170616|NCT03403374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170617|NCT03403374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93170618|NCT03403374|Protease Inhibitors|protease inhibitors|mesh-ancestor
93170619|NCT03403374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170620|NCT03403374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93170621|NCT01165567|Sarpogrelate|sarpogrelate|mesh-list
93170622|NCT01165567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93170623|NCT01165567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93170624|NCT01165567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170625|NCT01165567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93170626|NCT01165567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93170627|NCT01165567|Serotonin Agents|serotonin agents|mesh-ancestor
93170628|NCT01165567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170629|NCT01165567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170630|NCT03387462|Tenofovir|tenofovir|mesh-list
93170631|NCT03387462|Emtricitabine|emtricitabine|mesh-list
93170632|NCT03387462|Antiviral Agents|antiviral agents|mesh-ancestor
93170633|NCT03387462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170634|NCT03387462|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93170635|NCT03387462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93170636|NCT03387462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170637|NCT03387462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170638|NCT03387462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93170639|NCT03387462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93170640|NCT03756883|Fluticasone|fluticasone|mesh-list
93170641|NCT03756883|Xhance|xhance|mesh-list
93170642|NCT03756883|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93170643|NCT03756883|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93170644|NCT03756883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170645|NCT03756883|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93170646|NCT03756883|Autonomic Agents|autonomic agents|mesh-ancestor
93170647|NCT03756883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170648|NCT03756883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170649|NCT03756883|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93170650|NCT03756883|Respiratory System Agents|respiratory system agents|mesh-ancestor
93170651|NCT03756883|Dermatologic Agents|dermatologic agents|mesh-ancestor
93170652|NCT03756883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93170653|NCT03756883|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93170654|NCT03756883|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93170655|NCT03756883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93170656|NCT03756883|Adrenergic Agents|adrenergic agents|mesh-ancestor
93170657|NCT03756883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170658|NCT03756883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170659|NCT03756883|Glucocorticoids|glucocorticoids|mesh-ancestor
93170660|NCT03756883|Hormones|hormones|mesh-ancestor
93170661|NCT03756883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170662|NCT03756883|Sympathomimetics|sympathomimetics|mesh-ancestor
93170663|NCT01586611|Leucovorin|leucovorin|mesh-list
93170664|NCT01586611|Gemcitabine|gemcitabine|mesh-list
93170665|NCT01586611|Oxaliplatin|oxaliplatin|mesh-list
93170666|NCT01586611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93170667|NCT01586611|Antimetabolites|antimetabolites|mesh-ancestor
93170668|NCT01586611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170669|NCT01586611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170670|NCT01586611|Antidotes|antidotes|mesh-ancestor
93170671|NCT01586611|Protective Agents|protective agents|mesh-ancestor
93170672|NCT01586611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170673|NCT01586611|Vitamin B Complex|vitamin b complex|mesh-ancestor
93170674|NCT01586611|Vitamins|vitamins|mesh-ancestor
93170675|NCT01586611|Micronutrients|micronutrients|mesh-ancestor
93170676|NCT03386448|Scopolamine|scopolamine|mesh-list
93170677|NCT03386448|Naltrexone|naltrexone|mesh-list
93170678|NCT03386448|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93170679|NCT03386448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93170680|NCT03386448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93170681|NCT03386448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170682|NCT03386448|Sensory System Agents|sensory system agents|mesh-ancestor
93170683|NCT03386448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170684|NCT03386448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93170685|NCT03386448|Antiemetics|antiemetics|mesh-ancestor
93170686|NCT03386448|Autonomic Agents|autonomic agents|mesh-ancestor
93170687|NCT03386448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170688|NCT03386448|Mydriatics|mydriatics|mesh-ancestor
93170689|NCT03386448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93170690|NCT03386448|Cholinergic Agents|cholinergic agents|mesh-ancestor
93170691|NCT03386448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170692|NCT03386448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170693|NCT03386448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93170694|NCT03386448|Parasympatholytics|parasympatholytics|mesh-ancestor
93170695|NCT01280929|Ranibizumab|ranibizumab|mesh-list
93170696|NCT01280929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170697|NCT01280929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170698|NCT01280929|Growth Substances|growth substances|mesh-ancestor
93170699|NCT01280929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170700|NCT01280929|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170701|NCT01280929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170702|NCT01268917|Aspirin|aspirin|mesh-list
93170703|NCT01268917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93170704|NCT01268917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93170705|NCT01268917|Analgesics|analgesics|mesh-ancestor
93170706|NCT01268917|Sensory System Agents|sensory system agents|mesh-ancestor
93170707|NCT01268917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170708|NCT01268917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170709|NCT01268917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170710|NCT01268917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93170711|NCT01268917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93170712|NCT01268917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93170713|NCT01268917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170714|NCT01268917|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93170715|NCT01268917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93170716|NCT01268917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170717|NCT01268917|Antipyretics|antipyretics|mesh-ancestor
93170718|NCT01281163|Lapatinib|lapatinib|mesh-list
93170719|NCT01281163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170720|NCT01281163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170721|NCT01281163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170722|NCT01281163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170723|NCT01268995|Cyclosporine|cyclosporine|mesh-list
93170724|NCT01268995|Tacrolimus|tacrolimus|mesh-list
93170725|NCT01268995|Cyclosporins|cyclosporins|mesh-list
93170726|NCT01268995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93170727|NCT01268995|Immunologic Factors|immunologic factors|mesh-ancestor
93170728|NCT01268995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170729|NCT01268995|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93170730|NCT01268995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170731|NCT01268995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170732|NCT01268995|Antifungal Agents|antifungal agents|mesh-ancestor
93170733|NCT01268995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170734|NCT01268995|Dermatologic Agents|dermatologic agents|mesh-ancestor
93170735|NCT01268995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93170736|NCT00009737|Leucovorin|leucovorin|mesh-list
93170737|NCT00009737|Fluorouracil|fluorouracil|mesh-list
93170738|NCT00009737|Capecitabine|capecitabine|mesh-list
93170739|NCT00009737|Antimetabolites|antimetabolites|mesh-ancestor
93170740|NCT00009737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170741|NCT00009737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93170742|NCT00009737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170743|NCT00009737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93170744|NCT00009737|Immunologic Factors|immunologic factors|mesh-ancestor
93170745|NCT00009737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170746|NCT00009737|Antidotes|antidotes|mesh-ancestor
93170747|NCT00009737|Protective Agents|protective agents|mesh-ancestor
93170748|NCT00009737|Vitamin B Complex|vitamin b complex|mesh-ancestor
93170749|NCT00009737|Vitamins|vitamins|mesh-ancestor
93170750|NCT00009737|Micronutrients|micronutrients|mesh-ancestor
93170751|NCT03711240|Leucovorin|leucovorin|mesh-list
93170752|NCT03711240|Bevacizumab|bevacizumab|mesh-list
93170753|NCT03711240|Oxaliplatin|oxaliplatin|mesh-list
93170754|NCT03711240|Irinotecan|irinotecan|mesh-list
93170755|NCT03711240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93170756|NCT03711240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170757|NCT03711240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170758|NCT03711240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170759|NCT03711240|Growth Substances|growth substances|mesh-ancestor
93170760|NCT03711240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170761|NCT03711240|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170762|NCT03711240|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93170763|NCT03711240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93170764|NCT03711240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170765|NCT03711240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170766|NCT03711240|Antidotes|antidotes|mesh-ancestor
93170767|NCT03711240|Protective Agents|protective agents|mesh-ancestor
93170768|NCT03711240|Vitamin B Complex|vitamin b complex|mesh-ancestor
93170769|NCT03711240|Vitamins|vitamins|mesh-ancestor
93170770|NCT03711240|Micronutrients|micronutrients|mesh-ancestor
93170771|NCT01271881|Heparin|heparin|mesh-list
93170772|NCT01271881|Anticoagulants|anticoagulants|mesh-ancestor
93170773|NCT01271881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93170774|NCT01271881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93170775|NCT01271881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170776|NCT05459844|Octreotide|octreotide|mesh-list
93170777|NCT05459844|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93170778|NCT05459844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170779|NCT05459844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93170780|NCT05459844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170781|NCT05459844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93170782|NCT05459844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170783|NCT03874975|Vitamin D|vitamin d|mesh-list
93170784|NCT03874975|Vitamins|vitamins|mesh-ancestor
93170785|NCT03874975|Micronutrients|micronutrients|mesh-ancestor
93170786|NCT03874975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170787|NCT03874975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93170788|NCT01164709|Nelfinavir|nelfinavir|mesh-list
93170789|NCT01164709|Bortezomib|bortezomib|mesh-list
93170790|NCT01164709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170791|NCT01164709|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93170792|NCT01164709|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93170793|NCT01164709|Protease Inhibitors|protease inhibitors|mesh-ancestor
93170794|NCT01164709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170795|NCT01164709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170796|NCT01164709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93170797|NCT01164709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93170798|NCT01164709|Antiviral Agents|antiviral agents|mesh-ancestor
93170799|NCT01164709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170800|NCT03960671|Midazolam|midazolam|mesh-list
93170801|NCT03960671|Diazepam|diazepam|mesh-list
93170802|NCT03960671|Propofol|propofol|mesh-list
93170803|NCT03960671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93170804|NCT03960671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170805|NCT03960671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170806|NCT03960671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93170807|NCT03960671|Anesthetics, General|anesthetics, general|mesh-ancestor
93170808|NCT03960671|Anesthetics|anesthetics|mesh-ancestor
93170809|NCT03960671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93170810|NCT03960671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93170811|NCT03960671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93170812|NCT03960671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93170813|NCT03960671|GABA Modulators|gaba modulators|mesh-ancestor
93170814|NCT03960671|GABA Agents|gaba agents|mesh-ancestor
93170815|NCT03960671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170816|NCT03960671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170817|NCT03960671|Anticonvulsants|anticonvulsants|mesh-ancestor
93170818|NCT03960671|Antiemetics|antiemetics|mesh-ancestor
93170819|NCT03960671|Autonomic Agents|autonomic agents|mesh-ancestor
93170820|NCT03960671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170821|NCT03960671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170822|NCT03960671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93170823|NCT03960671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93170824|NCT01281553|Cisapride|cisapride|mesh-list
93170825|NCT01281553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93170826|NCT01281553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170827|NCT01281553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93170828|NCT01281553|Serotonin Agents|serotonin agents|mesh-ancestor
93170829|NCT01281553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170830|NCT01281553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170831|NCT01281553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170832|NCT01164787|Trandolapril|trandolapril|mesh-list
92843019|NCT04236830|Fluorides|fluorides|mesh-list
93170833|NCT01164787|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93170834|NCT01164787|Protease Inhibitors|protease inhibitors|mesh-ancestor
93170835|NCT01164787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170836|NCT01164787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170837|NCT01164787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93170839|NCT01269151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170840|NCT01269151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170841|NCT01269151|Growth Substances|growth substances|mesh-ancestor
93170842|NCT01269151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170843|NCT01269151|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170844|NCT01269151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170845|NCT00028769|Paclitaxel|paclitaxel|mesh-list
93170846|NCT00028769|Etoposide|etoposide|mesh-list
93170847|NCT00028769|Leuprolide|leuprolide|mesh-list
93170848|NCT00028769|Goserelin|goserelin|mesh-list
93170849|NCT00028769|Bicalutamide|bicalutamide|mesh-list
93170850|NCT00028769|Flutamide|flutamide|mesh-list
93170851|NCT00028769|Estramustine|estramustine|mesh-list
93170852|NCT00028769|Nilutamide|nilutamide|mesh-list
93170853|NCT00028769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93170854|NCT00028769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170855|NCT00028769|Tubulin Modulators|tubulin modulators|mesh-ancestor
93170856|NCT00028769|Antimitotic Agents|antimitotic agents|mesh-ancestor
93170857|NCT00028769|Mitosis Modulators|mitosis modulators|mesh-ancestor
93170858|NCT00028769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170859|NCT00028769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93170860|NCT00028769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93170861|NCT00028769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170862|NCT00028769|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93170863|NCT00028769|Fertility Agents|fertility agents|mesh-ancestor
93170864|NCT00028769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93170865|NCT00028769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170866|NCT00028769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93170867|NCT00028769|Androgen Antagonists|androgen antagonists|mesh-ancestor
93170868|NCT00028769|Hormone Antagonists|hormone antagonists|mesh-ancestor
93170869|NCT00028769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93170870|NCT00028769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93170871|NCT00028769|Alkylating Agents|alkylating agents|mesh-ancestor
93170872|NCT01281787|Losartan|losartan|mesh-list
93170873|NCT01281787|Metoprolol|metoprolol|mesh-list
93170874|NCT01281787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93170875|NCT01281787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93170876|NCT01281787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93170877|NCT01281787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93170878|NCT01281787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170879|NCT01281787|Sympatholytics|sympatholytics|mesh-ancestor
93170880|NCT01281787|Autonomic Agents|autonomic agents|mesh-ancestor
93170881|NCT01281787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170882|NCT01281787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170883|NCT01281787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93170884|NCT01281787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93170885|NCT01281787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93170886|NCT01281787|Adrenergic Agents|adrenergic agents|mesh-ancestor
93170887|NCT01281787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170888|NCT02953314|Ivacaftor|ivacaftor|mesh-list
93170889|NCT02953314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93170890|NCT02953314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93170891|NCT02953314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170892|NCT00007475|Cyclophosphamide|cyclophosphamide|mesh-list
93170893|NCT00007475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93170894|NCT00007475|Immunologic Factors|immunologic factors|mesh-ancestor
93170895|NCT00007475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170896|NCT00007475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93170897|NCT00007475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93170898|NCT00007475|Alkylating Agents|alkylating agents|mesh-ancestor
93170899|NCT00007475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170900|NCT00007475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170901|NCT00007475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93170902|NCT01273441|Amoxicillin|amoxicillin|mesh-list
93170903|NCT01273441|Metronidazole|metronidazole|mesh-list
93170904|NCT01273441|Clarithromycin|clarithromycin|mesh-list
93170905|NCT01273441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93170906|NCT01273441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170907|NCT01273441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93170908|NCT01273441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92843092|NCT05332106|Dienogest|dienogest|mesh-list
93170909|NCT01273441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93170910|NCT01273441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170911|NCT01273441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170912|NCT01273441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93170913|NCT01273441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93170914|NCT03714360|Tranexamic Acid|tranexamic acid|mesh-list
93170915|NCT03714360|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93170916|NCT03714360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93170917|NCT03714360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170918|NCT03714360|Hemostatics|hemostatics|mesh-ancestor
93170919|NCT03714360|Coagulants|coagulants|mesh-ancestor
93170920|NCT01169857|Bortezomib|bortezomib|mesh-list
93170921|NCT01169857|Proteasome Inhibitors|proteasome inhibitors|mesh-list
93170922|NCT01169857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170923|NCT01169857|Protease Inhibitors|protease inhibitors|mesh-ancestor
93170924|NCT01169857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170925|NCT01169857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170926|NCT01169935|Dextrans|dextrans|mesh-list
93170927|NCT01169935|Anticoagulants|anticoagulants|mesh-ancestor
93170928|NCT01169935|Plasma Substitutes|plasma substitutes|mesh-ancestor
93170929|NCT01169935|Blood Substitutes|blood substitutes|mesh-ancestor
93170930|NCT01168063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93170931|NCT01168063|Amoxicillin|amoxicillin|mesh-list
93170932|NCT01168063|Metronidazole|metronidazole|mesh-list
93170933|NCT01168063|Clarithromycin|clarithromycin|mesh-list
93170934|NCT01168063|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93170935|NCT01168063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170936|NCT01168063|Antitubercular Agents|antitubercular agents|mesh-ancestor
93170937|NCT01168063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93170938|NCT01168063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93170939|NCT01168063|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93170940|NCT01168063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170941|NCT01168063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170942|NCT01168063|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93170943|NCT01168063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93170944|NCT01166035|Lenalidomide|lenalidomide|mesh-list
93170945|NCT01166035|Cetuximab|cetuximab|mesh-list
93170946|NCT01166035|Immunologic Factors|immunologic factors|mesh-ancestor
93170947|NCT01166035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170948|NCT01166035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93170949|NCT01166035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93170950|NCT01166035|Growth Substances|growth substances|mesh-ancestor
93170951|NCT01166035|Growth Inhibitors|growth inhibitors|mesh-ancestor
93170952|NCT01166035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170953|NCT01166035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93170954|NCT01168375|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93170955|NCT01168375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93170956|NCT03869281|Pancrelipase|pancrelipase|mesh-list
93170957|NCT03869281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93170958|NCT01281943|Sirolimus|sirolimus|mesh-list
93170959|NCT01281943|Doxorubicin|doxorubicin|mesh-list
93170960|NCT01281943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93170961|NCT01281943|Temsirolimus|temsirolimus|mesh-list
93170962|NCT01281943|MTOR Inhibitors|mtor inhibitors|mesh-list
93170963|NCT01281943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93170964|NCT01281943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93170965|NCT01281943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93170966|NCT01281943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93170967|NCT01281943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93170968|NCT01281943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170969|NCT01281943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93170970|NCT01281943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93170971|NCT01281943|Immunologic Factors|immunologic factors|mesh-ancestor
93170972|NCT01281943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170973|NCT01281943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93170974|NCT01281943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93170975|NCT01281943|Antifungal Agents|antifungal agents|mesh-ancestor
93170976|NCT03869047|Dexmedetomidine|dexmedetomidine|mesh-list
93170977|NCT03869047|Bupivacaine|bupivacaine|mesh-list
93170978|NCT03869047|Anesthetics, Local|anesthetics, local|mesh-ancestor
93170979|NCT03869047|Anesthetics|anesthetics|mesh-ancestor
93170980|NCT03869047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93170981|NCT03869047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93170982|NCT03869047|Sensory System Agents|sensory system agents|mesh-ancestor
93170983|NCT03869047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170984|NCT03869047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93170985|NCT03869047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93170986|NCT03869047|Analgesics|analgesics|mesh-ancestor
93170987|NCT03869047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93170988|NCT03869047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93170989|NCT03869047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93170990|NCT03869047|Adrenergic Agents|adrenergic agents|mesh-ancestor
93170991|NCT03869047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93170992|NCT03869047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93170993|NCT01168531|Dexamethasone|dexamethasone|mesh-list
93170994|NCT01168531|Pregabalin|pregabalin|mesh-list
93170995|NCT01168531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93170996|NCT01168531|Antiemetics|antiemetics|mesh-ancestor
93170997|NCT01168531|Autonomic Agents|autonomic agents|mesh-ancestor
93170998|NCT01168531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93170999|NCT01168531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171000|NCT01168531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171001|NCT01168531|Glucocorticoids|glucocorticoids|mesh-ancestor
93171002|NCT01168531|Hormones|hormones|mesh-ancestor
93171003|NCT01168531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171004|NCT01168531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93171005|NCT01168531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171006|NCT01168531|Analgesics|analgesics|mesh-ancestor
93171007|NCT01168531|Sensory System Agents|sensory system agents|mesh-ancestor
93171008|NCT01168531|Anticonvulsants|anticonvulsants|mesh-ancestor
93171009|NCT01168531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93171010|NCT01168531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171011|NCT01168531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171012|NCT01168531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93171013|NCT01168531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93171014|NCT01168531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93171015|NCT01168531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171016|NCT01168531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93171017|NCT01170169|Omeprazole|omeprazole|mesh-list
93171018|NCT01170169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93171019|NCT01170169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171020|NCT01170169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93171021|NCT01170169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171022|NCT01170169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171023|NCT01587313|Hydralazine|hydralazine|mesh-list
93171024|NCT01587313|Isosorbide|isosorbide|mesh-list
93171025|NCT01587313|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93171026|NCT01587313|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93171027|NCT01587313|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93171028|NCT01587313|Diuretics|diuretics|mesh-ancestor
93171029|NCT01587313|Natriuretic Agents|natriuretic agents|mesh-ancestor
93171030|NCT01587313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171031|NCT01587313|Vasodilator Agents|vasodilator agents|mesh-ancestor
93171032|NCT01587313|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93171033|NCT01587313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171034|NCT01587313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93171035|NCT01282333|Gemcitabine|gemcitabine|mesh-list
93171036|NCT01282333|Veliparib|veliparib|mesh-list
93171037|NCT01282333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171038|NCT01282333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93171039|NCT01282333|Antimetabolites|antimetabolites|mesh-ancestor
93171040|NCT01282333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171041|NCT01282333|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93171042|NCT01282333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171043|NCT01166425|Lithium Carbonate|lithium carbonate|mesh-list
93171044|NCT01166425|Antidepressive Agents|antidepressive agents|mesh-ancestor
93171045|NCT01166425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93171046|NCT01166425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171047|NCT01166425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171048|NCT01166425|Antimanic Agents|antimanic agents|mesh-ancestor
93171049|NCT01166425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93171050|NCT01166425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171051|NCT01166425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171052|NCT03868969|Fosfomycin|fosfomycin|mesh-list
93171053|NCT03868969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93171054|NCT03868969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171055|NCT01311570|Buprenorphine|buprenorphine|mesh-list
93171056|NCT01311570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93171057|NCT01311570|Narcotics|narcotics|mesh-ancestor
93171058|NCT01311570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171059|NCT01311570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171061|NCT01311570|Sensory System Agents|sensory system agents|mesh-ancestor
93171062|NCT01311570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171063|NCT01311570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93171064|NCT01170325|Valproic Acid|valproic acid|mesh-list
93171065|NCT01170325|Anticonvulsants|anticonvulsants|mesh-ancestor
93171066|NCT01170325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171067|NCT01170325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171068|NCT01170325|GABA Agents|gaba agents|mesh-ancestor
93171069|NCT01170325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171070|NCT01170325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171071|NCT01170325|Antimanic Agents|antimanic agents|mesh-ancestor
93171072|NCT01170325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93171073|NCT01170325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171074|NCT01170325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93171075|NCT05542446|Colistin|colistin|mesh-list
93171076|NCT05542446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93171077|NCT05542446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171078|NCT03355326|Glycerol|glycerol|mesh-list
93171079|NCT03355326|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93171080|NCT03355326|Protective Agents|protective agents|mesh-ancestor
93171081|NCT03355326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171082|NCT01170637|Ibuprofen|ibuprofen|mesh-list
93171083|NCT01170637|Pseudoephedrine|pseudoephedrine|mesh-list
93171084|NCT01170637|Ephedrine|ephedrine|mesh-list
93171085|NCT01170637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93171086|NCT01170637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93171087|NCT01170637|Analgesics|analgesics|mesh-ancestor
93171088|NCT01170637|Sensory System Agents|sensory system agents|mesh-ancestor
93171089|NCT01170637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171090|NCT01170637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171091|NCT01170637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171092|NCT01170637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171093|NCT01170637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93171094|NCT01170637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171095|NCT01170637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171096|NCT01170637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93171097|NCT01170637|Autonomic Agents|autonomic agents|mesh-ancestor
93171098|NCT01170637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93171099|NCT01170637|Respiratory System Agents|respiratory system agents|mesh-ancestor
93171100|NCT01170637|Nasal Decongestants|nasal decongestants|mesh-ancestor
93171101|NCT01170637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93171102|NCT01170637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93171103|NCT01170637|Sympathomimetics|sympathomimetics|mesh-ancestor
93171104|NCT01170637|Adrenergic Agents|adrenergic agents|mesh-ancestor
93171105|NCT01170637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171106|NCT03873025|Pembrolizumab|pembrolizumab|mesh-list
93171107|NCT03873025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171108|NCT03873025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171109|NCT03873025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93171110|NCT03873025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171111|NCT02526745|Vaccines|vaccines|mesh-list
93171112|NCT02526745|Immunologic Factors|immunologic factors|mesh-ancestor
93171113|NCT02526745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171114|NCT01169389|Bupivacaine|bupivacaine|mesh-list
93171115|NCT01169389|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171116|NCT01169389|Anesthetics|anesthetics|mesh-ancestor
93171117|NCT01169389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171118|NCT01169389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171119|NCT01169389|Sensory System Agents|sensory system agents|mesh-ancestor
93171120|NCT01169389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171121|NCT01170871|Pemetrexed|pemetrexed|mesh-list
93171122|NCT01170871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171123|NCT01170871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171124|NCT01170871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171125|NCT01170871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93171126|NCT01170871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93171127|NCT03868111|Sufentanil|sufentanil|mesh-list
93171128|NCT03868111|Remifentanil|remifentanil|mesh-list
93171129|NCT03868111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93171130|NCT03868111|Narcotics|narcotics|mesh-ancestor
93171131|NCT03868111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843314|NCT00648037|Rituximab|rituximab|mesh-list
93171132|NCT03868111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171133|NCT03868111|Analgesics|analgesics|mesh-ancestor
93171134|NCT03868111|Sensory System Agents|sensory system agents|mesh-ancestor
93171135|NCT03868111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171136|NCT03868111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93171137|NCT03868111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93171138|NCT03868111|Anesthetics, General|anesthetics, general|mesh-ancestor
93171139|NCT03868111|Anesthetics|anesthetics|mesh-ancestor
93171140|NCT01282879|Itraconazole|itraconazole|mesh-list
93171141|NCT01282879|Antifungal Agents|antifungal agents|mesh-ancestor
93171142|NCT01282879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171143|NCT01282879|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93171144|NCT01282879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93171145|NCT01282879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171146|NCT01282879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171147|NCT01282879|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93171148|NCT01282879|Hormone Antagonists|hormone antagonists|mesh-ancestor
93171149|NCT01282879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171150|NCT01282879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171151|NCT01282879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93171152|NCT03868033|Zoledronic Acid|zoledronic acid|mesh-list
93171153|NCT03868033|Denosumab|denosumab|mesh-list
93171154|NCT03868033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93171155|NCT03868033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171156|NCT01166815|Zinc Sulfate|zinc sulfate|mesh-list
93171157|NCT01166815|Astringents|astringents|mesh-ancestor
93171158|NCT01166815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171159|NCT01166815|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171160|NCT03751657|Insulin|insulin|mesh-list
93171161|NCT03751657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93171162|NCT03751657|Metformin|metformin|mesh-list
93171163|NCT03751657|Insulin Glargine|insulin glargine|mesh-list
93171164|NCT03751657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93171165|NCT03751657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93171166|NCT03751657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171167|NCT03751657|Protease Inhibitors|protease inhibitors|mesh-ancestor
93171168|NCT03751657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171169|NCT03751657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171170|NCT03873415|Deucravacitinib|deucravacitinib|mesh-list
93171171|NCT03873415|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171172|NCT03873415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93171173|NCT03873415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171174|NCT03873415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171175|NCT00025259|Cytarabine|cytarabine|mesh-list
93171176|NCT00025259|Dexamethasone|dexamethasone|mesh-list
93171177|NCT00025259|Prednisone|prednisone|mesh-list
93171178|NCT00025259|Dexamethasone acetate|dexamethasone acetate|mesh-list
93171179|NCT00025259|Cortisone|cortisone|mesh-list
93171180|NCT00025259|Cyclophosphamide|cyclophosphamide|mesh-list
93171181|NCT00025259|Cisplatin|cisplatin|mesh-list
93171182|NCT00025259|Doxorubicin|doxorubicin|mesh-list
93171183|NCT00025259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93171184|NCT00025259|Etoposide|etoposide|mesh-list
93171185|NCT00025259|Vincristine|vincristine|mesh-list
93171186|NCT00025259|Etoposide phosphate|etoposide phosphate|mesh-list
93171187|NCT00025259|Bleomycin|bleomycin|mesh-list
93171188|NCT00025259|Podophyllotoxin|podophyllotoxin|mesh-list
93171189|NCT00025259|Lenograstim|lenograstim|mesh-list
93171190|NCT00025259|BB 1101|bb 1101|mesh-list
93171191|NCT00025259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93171192|NCT00025259|Immunologic Factors|immunologic factors|mesh-ancestor
93171193|NCT00025259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171194|NCT00025259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171195|NCT00025259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93171196|NCT00025259|Alkylating Agents|alkylating agents|mesh-ancestor
93171197|NCT00025259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171198|NCT00025259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171199|NCT00025259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93171200|NCT00025259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171201|NCT00025259|Antiemetics|antiemetics|mesh-ancestor
93171202|NCT00025259|Autonomic Agents|autonomic agents|mesh-ancestor
93171203|NCT00025259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171204|NCT00025259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171205|NCT00025259|Glucocorticoids|glucocorticoids|mesh-ancestor
93171206|NCT00025259|Hormones|hormones|mesh-ancestor
93171207|NCT00025259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171208|NCT00025259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93171209|NCT00025259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93171210|NCT00025259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93171211|NCT00025259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93171212|NCT00025259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171213|NCT00025259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93171214|NCT00025259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93171215|NCT00025259|Antimetabolites|antimetabolites|mesh-ancestor
93171216|NCT00025259|Antiviral Agents|antiviral agents|mesh-ancestor
93171217|NCT00025259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171218|NCT00025259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171219|NCT00025259|Tubulin Modulators|tubulin modulators|mesh-ancestor
93171220|NCT00025259|Antimitotic Agents|antimitotic agents|mesh-ancestor
93171221|NCT00025259|Mitosis Modulators|mitosis modulators|mesh-ancestor
93171222|NCT00025259|Protease Inhibitors|protease inhibitors|mesh-ancestor
93171223|NCT00025259|Keratolytic Agents|keratolytic agents|mesh-ancestor
93171224|NCT00025259|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171225|NCT01171651|Sorafenib|sorafenib|mesh-list
93171226|NCT01171651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171227|NCT01171651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93171228|NCT01171651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171229|NCT01171651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171230|NCT03866629|Lifitegrast|lifitegrast|mesh-list
93171231|NCT03866629|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93171232|NCT03866629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93171233|NCT01280071|Aminophylline|aminophylline|mesh-list
93171234|NCT01280071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93171235|NCT01280071|Autonomic Agents|autonomic agents|mesh-ancestor
93171236|NCT01280071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171237|NCT01280071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171238|NCT01280071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93171239|NCT01280071|Respiratory System Agents|respiratory system agents|mesh-ancestor
93171240|NCT01280071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93171241|NCT01280071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93171242|NCT01280071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171243|NCT01280071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171244|NCT01280071|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93171245|NCT01280071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93171246|NCT01280071|Purinergic Agents|purinergic agents|mesh-ancestor
93171247|NCT01280071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171248|NCT01280071|Protective Agents|protective agents|mesh-ancestor
93171249|NCT02526199|Dexamethasone|dexamethasone|mesh-list
93171250|NCT02526199|Epinephrine|epinephrine|mesh-list
93171251|NCT02526199|Bupivacaine|bupivacaine|mesh-list
93171252|NCT02526199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171253|NCT02526199|Antiemetics|antiemetics|mesh-ancestor
93171254|NCT02526199|Autonomic Agents|autonomic agents|mesh-ancestor
93171255|NCT02526199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171256|NCT02526199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171257|NCT02526199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171258|NCT02526199|Glucocorticoids|glucocorticoids|mesh-ancestor
93171259|NCT02526199|Hormones|hormones|mesh-ancestor
93171260|NCT02526199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171261|NCT02526199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93171262|NCT02526199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171263|NCT02526199|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171264|NCT02526199|Anesthetics|anesthetics|mesh-ancestor
93171265|NCT02526199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171266|NCT02526199|Sensory System Agents|sensory system agents|mesh-ancestor
93171267|NCT02526199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93171268|NCT02526199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93171269|NCT02526199|Adrenergic Agents|adrenergic agents|mesh-ancestor
93171270|NCT02526199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171271|NCT02526199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171272|NCT02526199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93171273|NCT02526199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93171274|NCT02526199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93171275|NCT02526199|Respiratory System Agents|respiratory system agents|mesh-ancestor
93171276|NCT02526199|Mydriatics|mydriatics|mesh-ancestor
93171277|NCT02526199|Sympathomimetics|sympathomimetics|mesh-ancestor
93171278|NCT02526199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93171279|NCT01284049|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93171280|NCT01284049|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93171281|NCT01284049|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93171282|NCT01284049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93171283|NCT03863977|Dexamethasone|dexamethasone|mesh-list
93171284|NCT03863977|Dexamethasone acetate|dexamethasone acetate|mesh-list
93171285|NCT03863977|Bupivacaine|bupivacaine|mesh-list
93171286|NCT03863977|BB 1101|bb 1101|mesh-list
93171287|NCT03863977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171288|NCT03863977|Antiemetics|antiemetics|mesh-ancestor
93171289|NCT03863977|Autonomic Agents|autonomic agents|mesh-ancestor
93171290|NCT03863977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171291|NCT03863977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171292|NCT03863977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171293|NCT03863977|Glucocorticoids|glucocorticoids|mesh-ancestor
93171295|NCT03863977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171296|NCT03863977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93171297|NCT03863977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171298|NCT03863977|Protease Inhibitors|protease inhibitors|mesh-ancestor
93171299|NCT03863977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171300|NCT03863977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171301|NCT03863977|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171302|NCT03863977|Anesthetics|anesthetics|mesh-ancestor
93171303|NCT03863977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171304|NCT03863977|Sensory System Agents|sensory system agents|mesh-ancestor
93171305|NCT01171807|Dexamethasone|dexamethasone|mesh-list
93171306|NCT01171807|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93171307|NCT01171807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171308|NCT01171807|Antiemetics|antiemetics|mesh-ancestor
93171309|NCT01171807|Autonomic Agents|autonomic agents|mesh-ancestor
93171310|NCT01171807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171311|NCT01171807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171312|NCT01171807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171313|NCT01171807|Glucocorticoids|glucocorticoids|mesh-ancestor
93171314|NCT01171807|Hormones|hormones|mesh-ancestor
93171315|NCT01171807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171316|NCT01171807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93171317|NCT01171807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171318|NCT05445648|Tislelizumab|tislelizumab|mesh-list
93171319|NCT05445648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171320|NCT05445648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171321|NCT01171885|Ropivacaine|ropivacaine|mesh-list
93171322|NCT01171885|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171323|NCT01171885|Anesthetics|anesthetics|mesh-ancestor
93171324|NCT01171885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171325|NCT01171885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171326|NCT01171885|Sensory System Agents|sensory system agents|mesh-ancestor
93171327|NCT01171885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171328|NCT01286233|Metformin|metformin|mesh-list
93171329|NCT01286233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93171330|NCT01286233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171331|NCT01175161|Copper|copper|mesh-list
93171332|NCT01175161|Trace Elements|trace elements|mesh-ancestor
93171333|NCT01175161|Micronutrients|micronutrients|mesh-ancestor
93171334|NCT01175161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171335|NCT01172041|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93171336|NCT01172041|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93171337|NCT01172041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171338|NCT01284205|BCG Vaccine|bcg vaccine|mesh-list
93171339|NCT01284205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171340|NCT01284205|Immunologic Factors|immunologic factors|mesh-ancestor
93171341|NCT01284205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171342|NCT00024167|Ketoconazole|ketoconazole|mesh-list
93171343|NCT00024167|Dexamethasone|dexamethasone|mesh-list
93171344|NCT00024167|Prednisone|prednisone|mesh-list
93171345|NCT00024167|Estramustine|estramustine|mesh-list
93171346|NCT00024167|Docetaxel|docetaxel|mesh-list
93171347|NCT00024167|Doxorubicin|doxorubicin|mesh-list
93171348|NCT00024167|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93171349|NCT00024167|Vinblastine|vinblastine|mesh-list
93171350|NCT00024167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171351|NCT00024167|Antiemetics|antiemetics|mesh-ancestor
93171352|NCT00024167|Autonomic Agents|autonomic agents|mesh-ancestor
93171353|NCT00024167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171354|NCT00024167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171355|NCT00024167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171356|NCT00024167|Glucocorticoids|glucocorticoids|mesh-ancestor
93171357|NCT00024167|Hormones|hormones|mesh-ancestor
93171358|NCT00024167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171359|NCT00024167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93171360|NCT00024167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171361|NCT00024167|Tubulin Modulators|tubulin modulators|mesh-ancestor
92843533|NCT00826969|Ciclesonide|ciclesonide|mesh-list
93171362|NCT00024167|Antimitotic Agents|antimitotic agents|mesh-ancestor
93171363|NCT00024167|Mitosis Modulators|mitosis modulators|mesh-ancestor
93171364|NCT00024167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171366|NCT00024167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93171367|NCT00024167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93171368|NCT00024167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171369|NCT00024167|Antifungal Agents|antifungal agents|mesh-ancestor
93171370|NCT00024167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171371|NCT00024167|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93171372|NCT00024167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93171373|NCT00024167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93171374|NCT00024167|Hormone Antagonists|hormone antagonists|mesh-ancestor
93171375|NCT00024167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93171376|NCT00024167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93171377|NCT00024167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93171378|NCT00024167|Alkylating Agents|alkylating agents|mesh-ancestor
93171379|NCT03867097|Iloprost|iloprost|mesh-list
93171380|NCT03867097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93171381|NCT03867097|Vasodilator Agents|vasodilator agents|mesh-ancestor
93171382|NCT00022763|Enfuvirtide|enfuvirtide|mesh-list
93171383|NCT00022763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93171384|NCT00022763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93171385|NCT00022763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171386|NCT00022763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93171387|NCT00022763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93171388|NCT00022763|Antiviral Agents|antiviral agents|mesh-ancestor
93171389|NCT00022763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171390|NCT01285141|polysaccharide-K|polysaccharide-k|mesh-list
93171391|NCT01285141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171392|NCT01285141|Immunologic Factors|immunologic factors|mesh-ancestor
93171393|NCT01285141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171394|NCT01285141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93171395|NCT01285141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171396|NCT01285141|Antiviral Agents|antiviral agents|mesh-ancestor
93171397|NCT01285141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171398|NCT01285141|Interferon Inducers|interferon inducers|mesh-ancestor
93171399|NCT01285141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93171400|NCT01285141|Protective Agents|protective agents|mesh-ancestor
93171401|NCT01285219|Lenograstim|lenograstim|mesh-list
93171402|NCT01285219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171403|NCT01285219|Immunologic Factors|immunologic factors|mesh-ancestor
93171404|NCT01285219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171405|NCT01284439|Hyaluronic Acid|hyaluronic acid|mesh-list
93171406|NCT01284439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171407|NCT01284439|Immunologic Factors|immunologic factors|mesh-ancestor
93171408|NCT01284439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171409|NCT01284439|Viscosupplements|viscosupplements|mesh-ancestor
93171410|NCT01284439|Protective Agents|protective agents|mesh-ancestor
93171411|NCT01172431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93171412|NCT01172431|Indapamide|indapamide|mesh-list
93171413|NCT01172431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93171414|NCT01172431|Diuretics|diuretics|mesh-ancestor
93171415|NCT01172431|Natriuretic Agents|natriuretic agents|mesh-ancestor
93171416|NCT01172431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171417|NCT01172431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93171418|NCT01172431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171419|NCT01172431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171420|NCT01172509|Baclofen|baclofen|mesh-list
93171421|NCT01172509|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93171422|NCT01172509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171423|NCT01172509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93171424|NCT01172509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171425|NCT01172509|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93171426|NCT01172509|GABA Agonists|gaba agonists|mesh-ancestor
93171427|NCT01172509|GABA Agents|gaba agents|mesh-ancestor
93171428|NCT01172509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171429|NCT01172509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171430|NCT01089959|Esomeprazole|esomeprazole|mesh-list
93171431|NCT01089959|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93171432|NCT01089959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171433|NCT01089959|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93171434|NCT01089959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171435|NCT01089959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171436|NCT01090037|Epoprostenol|epoprostenol|mesh-list
93171437|NCT01090037|Beraprost|beraprost|mesh-list
93171438|NCT01090037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93171439|NCT01090037|Vasodilator Agents|vasodilator agents|mesh-ancestor
93171440|NCT01090037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93171441|NCT01285375|Curcumin|curcumin|mesh-list
93171442|NCT01285375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93171443|NCT01285375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93171444|NCT01285375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93171445|NCT01285375|Analgesics|analgesics|mesh-ancestor
93171446|NCT01285375|Sensory System Agents|sensory system agents|mesh-ancestor
93171447|NCT01285375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171448|NCT01285375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171449|NCT01285375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171450|NCT01285375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171451|NCT01285375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171452|NCT01285375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171453|NCT01285375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171454|NCT05625893|Bevacizumab|bevacizumab|mesh-list
93171455|NCT05625893|Atezolizumab|atezolizumab|mesh-list
93171456|NCT05625893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171457|NCT05625893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171458|NCT05625893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93171459|NCT05625893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93171460|NCT05625893|Growth Substances|growth substances|mesh-ancestor
93171461|NCT05625893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171462|NCT05625893|Growth Inhibitors|growth inhibitors|mesh-ancestor
93171463|NCT05625893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93171464|NCT05625893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171465|NCT01178047|Rasagiline|rasagiline|mesh-list
93171466|NCT01178047|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93171467|NCT01178047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171468|NCT01178047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171469|NCT01178047|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93171470|NCT01178047|Protective Agents|protective agents|mesh-ancestor
93171471|NCT01178047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171472|NCT01101113|Cinacalcet|cinacalcet|mesh-list
93171473|NCT01101113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93171474|NCT01101113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171475|NCT01101113|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93171476|NCT01101113|Hormone Antagonists|hormone antagonists|mesh-ancestor
93171477|NCT01101113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171478|NCT01288261|Paclitaxel|paclitaxel|mesh-list
93171479|NCT01288261|Bavituximab|bavituximab|mesh-list
93171480|NCT01288261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93171481|NCT01288261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171482|NCT01288261|Tubulin Modulators|tubulin modulators|mesh-ancestor
93171483|NCT01288261|Antimitotic Agents|antimitotic agents|mesh-ancestor
93171484|NCT01288261|Mitosis Modulators|mitosis modulators|mesh-ancestor
93171485|NCT01288261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171486|NCT01288261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171487|NCT01174303|Insulin|insulin|mesh-list
93171488|NCT01174303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93171489|NCT01174303|Insulin Aspart|insulin aspart|mesh-list
93171490|NCT01174303|Insulin, Long-Acting|insulin, long-acting|mesh-list
93171491|NCT01174303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93171492|NCT01174303|Biphasic Insulins|biphasic insulins|mesh-list
93171493|NCT01174303|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93171494|NCT01174303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93171495|NCT01174303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171496|NCT01285453|Vadimezan|vadimezan|mesh-list
93171497|NCT01285453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171498|NCT01288339|Leucovorin|leucovorin|mesh-list
93171499|NCT01288339|Fluorouracil|fluorouracil|mesh-list
93171500|NCT01288339|Oxaliplatin|oxaliplatin|mesh-list
93171501|NCT01288339|Panitumumab|panitumumab|mesh-list
93171502|NCT01288339|Antimetabolites|antimetabolites|mesh-ancestor
93171503|NCT01288339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171504|NCT01288339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93171505|NCT01288339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171506|NCT01288339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93171507|NCT01288339|Immunologic Factors|immunologic factors|mesh-ancestor
93171508|NCT01288339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171509|NCT01288339|Antidotes|antidotes|mesh-ancestor
93171510|NCT01288339|Protective Agents|protective agents|mesh-ancestor
93171511|NCT01288339|Vitamin B Complex|vitamin b complex|mesh-ancestor
93171512|NCT01288339|Vitamins|vitamins|mesh-ancestor
93171513|NCT01288339|Micronutrients|micronutrients|mesh-ancestor
93171514|NCT01288339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171515|NCT00006389|Bryostatin 1|bryostatin 1|mesh-list
93171516|NCT00006389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171517|NCT00006389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171518|NCT00006389|Immunologic Factors|immunologic factors|mesh-ancestor
93171519|NCT00006389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171520|NCT04965311|Botulinum Toxins|botulinum toxins|mesh-list
93171521|NCT04965311|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93171522|NCT04965311|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93171523|NCT04965311|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93171524|NCT04965311|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93171525|NCT04965311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171526|NCT04965311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171527|NCT04965311|Cholinergic Agents|cholinergic agents|mesh-ancestor
93171528|NCT04965311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171529|NCT04965311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171530|NCT04965311|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93171531|NCT04965311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171532|NCT01105481|Amisulpride|amisulpride|mesh-list
93171533|NCT01105481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93171534|NCT01105481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93171535|NCT01105481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171536|NCT01105481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171537|NCT01105481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93171538|NCT01105481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93171539|NCT01105481|Dopamine Agents|dopamine agents|mesh-ancestor
93171540|NCT01105481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171541|NCT01105481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171542|NCT01105481|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93171543|NCT01105481|Antidepressive Agents|antidepressive agents|mesh-ancestor
93171544|NCT01178203|Naproxen|naproxen|mesh-list
93171545|NCT01178203|Tramadol|tramadol|mesh-list
93171546|NCT01178203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93171547|NCT01178203|Narcotics|narcotics|mesh-ancestor
93171548|NCT01178203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171549|NCT01178203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171550|NCT01178203|Analgesics|analgesics|mesh-ancestor
93171551|NCT01178203|Sensory System Agents|sensory system agents|mesh-ancestor
93171552|NCT01178203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171553|NCT01178203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93171554|NCT01178203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93171555|NCT01178203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171556|NCT01178203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171557|NCT01178203|Gout Suppressants|gout suppressants|mesh-ancestor
93171558|NCT01178203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93171559|NCT01178203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171560|NCT01178203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171561|NCT01286701|Terbinafine|terbinafine|mesh-list
93171562|NCT01286701|Antifungal Agents|antifungal agents|mesh-ancestor
93171563|NCT01286701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171564|NCT01286701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171565|NCT01286701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171566|NCT00006305|Biguanides|biguanides|mesh-list
93171567|NCT00006305|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93171568|NCT00006305|Calcium Channel Blockers|calcium channel blockers|mesh-list
93171569|NCT00006305|Calcium|calcium|mesh-list
93171570|NCT00006305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93171571|NCT00006305|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93171572|NCT00006305|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93171573|NCT00006305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93171574|NCT00006305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171575|NCT00006305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93171576|NCT00006305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93171577|NCT00006305|Adrenergic Agents|adrenergic agents|mesh-ancestor
93171578|NCT00006305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171579|NCT00006305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171580|NCT00006305|Protease Inhibitors|protease inhibitors|mesh-ancestor
93171581|NCT00006305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171582|NCT00006305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171583|NCT01284907|Vitamin D|vitamin d|mesh-list
93171584|NCT01284907|Cholecalciferol|cholecalciferol|mesh-list
93171585|NCT01284907|Vitamins|vitamins|mesh-ancestor
93171586|NCT01284907|Micronutrients|micronutrients|mesh-ancestor
93171587|NCT01284907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171588|NCT01284907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93171589|NCT01284907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93171590|NCT01286857|Silicon|silicon|mesh-list
93171591|NCT01286857|Trace Elements|trace elements|mesh-ancestor
93171592|NCT01286857|Micronutrients|micronutrients|mesh-ancestor
93171593|NCT01286857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171594|NCT01101269|Lisinopril|lisinopril|mesh-list
93171595|NCT01101269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93171596|NCT01101269|Protease Inhibitors|protease inhibitors|mesh-ancestor
93171597|NCT01101269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171598|NCT01101269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171599|NCT01101269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93171600|NCT01101269|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93171601|NCT01101269|Protective Agents|protective agents|mesh-ancestor
93171602|NCT01101269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171603|NCT01103375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93171604|NCT01103375|Isotretinoin|isotretinoin|mesh-list
93171605|NCT01103375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171606|NCT01103375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93171607|NCT01103375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171608|NCT01103375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171609|NCT01103375|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171610|NCT03949049|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93171611|NCT03949049|Nootropic Agents|nootropic agents|mesh-ancestor
93171612|NCT01288417|Raltegravir Potassium|raltegravir potassium|mesh-list
93171613|NCT01288417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93171614|NCT01288417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93171615|NCT01288417|Antiviral Agents|antiviral agents|mesh-ancestor
93171616|NCT01288417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171617|NCT01288417|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93171618|NCT01288417|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93171619|NCT01288417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171620|NCT01288417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171621|NCT01285765|Rituximab|rituximab|mesh-list
93171622|NCT01285765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171623|NCT01285765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171624|NCT01285765|Immunologic Factors|immunologic factors|mesh-ancestor
93171625|NCT01285765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171626|NCT01285765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171627|NCT03864913|Testosterone|testosterone|mesh-list
93171628|NCT03864913|Androgens|androgens|mesh-ancestor
93171629|NCT03864913|Hormones|hormones|mesh-ancestor
93171630|NCT03864913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171631|NCT03864913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171632|NCT03865147|Acetaminophen|acetaminophen|mesh-list
93171633|NCT03865147|Cetrimonium|cetrimonium|mesh-list
93171634|NCT03865147|Ibuprofen|ibuprofen|mesh-list
93171635|NCT03865147|Lidocaine|lidocaine|mesh-list
93171636|NCT03865147|Epinephrine|epinephrine|mesh-list
93171637|NCT03865147|Racepinephrine|racepinephrine|mesh-list
93171638|NCT03865147|Bupivacaine|bupivacaine|mesh-list
93171639|NCT03865147|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93171640|NCT03865147|Epinephryl borate|epinephryl borate|mesh-list
93171641|NCT03865147|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171642|NCT03865147|Anesthetics|anesthetics|mesh-ancestor
93171643|NCT03865147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171644|NCT03865147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171645|NCT03865147|Sensory System Agents|sensory system agents|mesh-ancestor
93171646|NCT03865147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171647|NCT03865147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93171648|NCT03865147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93171649|NCT03865147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93171650|NCT03865147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171651|NCT03865147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171652|NCT03865147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93171653|NCT03865147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93171654|NCT03865147|Analgesics|analgesics|mesh-ancestor
93171655|NCT03865147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93171656|NCT03865147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171657|NCT03865147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93171658|NCT03865147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171659|NCT03865147|Antipyretics|antipyretics|mesh-ancestor
93171660|NCT03865147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93171661|NCT03865147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93171662|NCT03865147|Adrenergic Agents|adrenergic agents|mesh-ancestor
93171663|NCT03865147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171664|NCT03865147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93171665|NCT03865147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93171666|NCT03865147|Autonomic Agents|autonomic agents|mesh-ancestor
93171667|NCT03865147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93171668|NCT03865147|Respiratory System Agents|respiratory system agents|mesh-ancestor
93171669|NCT03865147|Mydriatics|mydriatics|mesh-ancestor
93171670|NCT03865147|Sympathomimetics|sympathomimetics|mesh-ancestor
93171671|NCT03865147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93171672|NCT03865147|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93171673|NCT03865147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93171674|NCT03865147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171675|NCT03722823|Tucatinib|tucatinib|mesh-list
93171676|NCT03722823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171677|NCT03722823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93171678|NCT03722823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171679|NCT03722823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171680|NCT03862651|Cangrelor|cangrelor|mesh-list
93171681|NCT03862651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93171682|NCT03862651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93171683|NCT03862651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93171684|NCT03862651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93171685|NCT03862651|Purinergic Agents|purinergic agents|mesh-ancestor
93171686|NCT03862651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171687|NCT03862651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171688|NCT03862651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171689|NCT03349710|Nivolumab|nivolumab|mesh-list
93171690|NCT03349710|Cetuximab|cetuximab|mesh-list
93171691|NCT03349710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171692|NCT03349710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171693|NCT03349710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93171694|NCT03349710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171695|NCT01288495|Psyllium|psyllium|mesh-list
93171696|NCT01288495|Cathartics|cathartics|mesh-ancestor
93171697|NCT01288495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93171698|NCT01105793|Danazol|danazol|mesh-list
93171699|NCT01105793|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93171700|NCT01105793|Hormone Antagonists|hormone antagonists|mesh-ancestor
93171701|NCT01105793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171702|NCT01105793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171703|NCT04934579|Rituximab|rituximab|mesh-list
93171704|NCT04934579|Methotrexate|methotrexate|mesh-list
93171705|NCT04934579|Lenalidomide|lenalidomide|mesh-list
93171706|NCT04934579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93171707|NCT04934579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171708|NCT04934579|Immunologic Factors|immunologic factors|mesh-ancestor
93171709|NCT04934579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171710|NCT04934579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171711|NCT04934579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93171712|NCT04934579|Abortifacient Agents|abortifacient agents|mesh-ancestor
93171713|NCT04934579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93171714|NCT04934579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93171715|NCT04934579|Antimetabolites|antimetabolites|mesh-ancestor
93171716|NCT04934579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171717|NCT04934579|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171718|NCT04934579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171719|NCT04934579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93171720|NCT04934579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93171721|NCT04934579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93171722|NCT04934579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93171723|NCT04934579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93171724|NCT04934579|Growth Substances|growth substances|mesh-ancestor
93171725|NCT04934579|Growth Inhibitors|growth inhibitors|mesh-ancestor
93171726|NCT03134131|TIC10 compound|tic10 compound|mesh-list
93171727|NCT03134131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171728|NCT01103609|Warfarin|warfarin|mesh-list
93171729|NCT01103609|Anticoagulants|anticoagulants|mesh-ancestor
93171730|NCT03528369|Capsaicin|capsaicin|mesh-list
93171731|NCT03528369|Antipruritics|antipruritics|mesh-ancestor
93171732|NCT03528369|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171733|NCT03528369|Sensory System Agents|sensory system agents|mesh-ancestor
93171734|NCT03528369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171735|NCT03528369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171736|NCT01288573|Plerixafor|plerixafor|mesh-list
93171737|NCT01288573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93171738|NCT01288573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93171739|NCT01288573|Antiviral Agents|antiviral agents|mesh-ancestor
93171740|NCT01288573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171741|NCT01174693|Clopidogrel|clopidogrel|mesh-list
93171742|NCT01174693|Triflusal|triflusal|mesh-list
93171743|NCT01174693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93171744|NCT01174693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93171745|NCT01174693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93171746|NCT01174693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93171747|NCT01174693|Purinergic Agents|purinergic agents|mesh-ancestor
93171748|NCT01174693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171749|NCT01174693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171750|NCT01174693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171751|NCT00006011|Paclitaxel|paclitaxel|mesh-list
93171752|NCT00006011|Doxorubicin|doxorubicin|mesh-list
93171753|NCT00006011|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93171754|NCT00006011|Lenograstim|lenograstim|mesh-list
93171755|NCT00006011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93171756|NCT00006011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171757|NCT00006011|Tubulin Modulators|tubulin modulators|mesh-ancestor
93171758|NCT00006011|Antimitotic Agents|antimitotic agents|mesh-ancestor
93171759|NCT00006011|Mitosis Modulators|mitosis modulators|mesh-ancestor
93171760|NCT00006011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171761|NCT00006011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93171762|NCT00006011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93171763|NCT00006011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93171764|NCT00006011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171765|NCT00006011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93171766|NCT00006011|Immunologic Factors|immunologic factors|mesh-ancestor
93171767|NCT00006011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171768|NCT01105871|Naloxone|naloxone|mesh-list
93171769|NCT01105871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93171770|NCT01105871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171771|NCT01105871|Sensory System Agents|sensory system agents|mesh-ancestor
93171772|NCT01105871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171773|NCT03377556|Talazoparib|talazoparib|mesh-list
93171774|NCT03377556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93171775|NCT03377556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171776|NCT03377556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171777|NCT03377556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171778|NCT05625581|Cyclophosphamide|cyclophosphamide|mesh-list
93171779|NCT05625581|Tofacitinib|tofacitinib|mesh-list
93171780|NCT05625581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93171781|NCT05625581|Immunologic Factors|immunologic factors|mesh-ancestor
93171782|NCT05625581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171783|NCT05625581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93171784|NCT05625581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93171785|NCT05625581|Alkylating Agents|alkylating agents|mesh-ancestor
93171786|NCT05625581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171787|NCT05625581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171788|NCT05625581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93171789|NCT05625581|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93171790|NCT05625581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93171791|NCT05625581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171792|NCT05625503|Verapamil|verapamil|mesh-list
93171793|NCT05625503|Nicardipine|nicardipine|mesh-list
93171794|NCT05625503|Calcium Channel Blockers|calcium channel blockers|mesh-list
92977227|NCT00809744|Vitamins|vitamins|mesh-ancestor
93171795|NCT05625503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93171796|NCT05625503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171797|NCT05625503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93171798|NCT05625503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171799|NCT05625503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171800|NCT05625503|Vasodilator Agents|vasodilator agents|mesh-ancestor
93171801|NCT05625503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93171802|NCT01176175|Progesterone|progesterone|mesh-list
93171803|NCT01176175|Progestins|progestins|mesh-ancestor
93171804|NCT01176175|Hormones|hormones|mesh-ancestor
93171805|NCT01176175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93171806|NCT01176175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171807|NCT05624099|Paclitaxel|paclitaxel|mesh-list
93171808|NCT05624099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93171809|NCT05624099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171810|NCT05624099|Tubulin Modulators|tubulin modulators|mesh-ancestor
93171811|NCT05624099|Antimitotic Agents|antimitotic agents|mesh-ancestor
93171812|NCT05624099|Mitosis Modulators|mitosis modulators|mesh-ancestor
93171813|NCT05624099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171814|NCT03864601|JNJ-56136379|jnj-56136379|mesh-list
93171815|NCT03864601|Antiviral Agents|antiviral agents|mesh-ancestor
93171816|NCT03864601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171817|NCT03864523|Pioglitazone|pioglitazone|mesh-list
93171818|NCT03864523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93171819|NCT03864523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171820|NCT01174849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93171821|NCT01174849|Immunologic Factors|immunologic factors|mesh-ancestor
93171822|NCT01174849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171823|NCT03583359|Lidocaine|lidocaine|mesh-list
93171824|NCT03583359|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171825|NCT03583359|Anesthetics|anesthetics|mesh-ancestor
93171826|NCT03583359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171827|NCT03583359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171828|NCT03583359|Sensory System Agents|sensory system agents|mesh-ancestor
93171829|NCT03583359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171830|NCT03583359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93171831|NCT03583359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93171832|NCT03583359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93171833|NCT03583359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171834|NCT03583359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171835|NCT05619887|Fentanyl|fentanyl|mesh-list
93171836|NCT05619887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93171837|NCT05619887|Narcotics|narcotics|mesh-ancestor
93171838|NCT05619887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171839|NCT05619887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171840|NCT05619887|Analgesics|analgesics|mesh-ancestor
93171841|NCT05619887|Sensory System Agents|sensory system agents|mesh-ancestor
93171842|NCT05619887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171843|NCT05619887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93171844|NCT05619887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93171845|NCT05619887|Anesthetics, General|anesthetics, general|mesh-ancestor
93171846|NCT05619887|Anesthetics|anesthetics|mesh-ancestor
93171847|NCT01174927|Heroin|heroin|mesh-list
93171848|NCT01174927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93171849|NCT01174927|Narcotics|narcotics|mesh-ancestor
93171850|NCT01174927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171851|NCT01174927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171852|NCT01174927|Analgesics|analgesics|mesh-ancestor
93171853|NCT01174927|Sensory System Agents|sensory system agents|mesh-ancestor
93171854|NCT01174927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171855|NCT03510663|Moxifloxacin|moxifloxacin|mesh-list
93171856|NCT03510663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93171857|NCT03510663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171858|NCT03510663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93171859|NCT03510663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93171860|NCT03510663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171861|NCT03510663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171862|NCT03510663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171863|NCT03948737|Tocopherols|tocopherols|mesh-list
93171864|NCT03948737|Vitamin E|vitamin e|mesh-list
93171865|NCT03948737|Tocotrienols|tocotrienols|mesh-list
93171866|NCT03948737|alpha-Tocopherol|alpha-tocopherol|mesh-list
93171867|NCT03948737|Antioxidants|antioxidants|mesh-ancestor
93171868|NCT03948737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171869|NCT03948737|Protective Agents|protective agents|mesh-ancestor
93171870|NCT03948737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171871|NCT03948737|Vitamins|vitamins|mesh-ancestor
93171872|NCT03948737|Micronutrients|micronutrients|mesh-ancestor
93171873|NCT01287247|Botulinum Toxins|botulinum toxins|mesh-list
93171874|NCT01287247|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93171875|NCT01287247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93171876|NCT01287247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171877|NCT01287247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171878|NCT01287247|Cholinergic Agents|cholinergic agents|mesh-ancestor
93171879|NCT01287247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171880|NCT01287247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171881|NCT01287247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93171882|NCT01287247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171883|NCT01327859|Donepezil|donepezil|mesh-list
93171884|NCT01327859|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93171885|NCT01327859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171886|NCT01327859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171887|NCT01327859|Cholinergic Agents|cholinergic agents|mesh-ancestor
93171888|NCT01327859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171889|NCT01327859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171890|NCT01327859|Nootropic Agents|nootropic agents|mesh-ancestor
93171891|NCT01176409|Valacyclovir|valacyclovir|mesh-list
93171892|NCT01176409|Antiviral Agents|antiviral agents|mesh-ancestor
93171893|NCT01176409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171895|NCT03480009|Dextromethorphan|dextromethorphan|mesh-list
93171896|NCT03480009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93171897|NCT03480009|Narcotics|narcotics|mesh-ancestor
93171898|NCT03480009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171899|NCT03480009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171900|NCT03480009|Analgesics|analgesics|mesh-ancestor
93171901|NCT03480009|Sensory System Agents|sensory system agents|mesh-ancestor
93171902|NCT03480009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171903|NCT03480009|Antitussive Agents|antitussive agents|mesh-ancestor
93171904|NCT03480009|Respiratory System Agents|respiratory system agents|mesh-ancestor
93171905|NCT03480009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93171906|NCT03480009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93171907|NCT03480009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171908|NCT03480009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171909|NCT03859375|Disinfectants|disinfectants|mesh-list
93171910|NCT03859375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171911|NCT01310751|Iloprost|iloprost|mesh-list
93171912|NCT01310751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93171913|NCT01310751|Vasodilator Agents|vasodilator agents|mesh-ancestor
93171914|NCT01180933|Folic Acid|folic acid|mesh-list
93171915|NCT01180933|Vitamin B Complex|vitamin b complex|mesh-list
93171916|NCT01180933|Hematinics|hematinics|mesh-ancestor
93171917|NCT01180933|Vitamins|vitamins|mesh-ancestor
93171918|NCT01180933|Micronutrients|micronutrients|mesh-ancestor
93171919|NCT01180933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171920|NCT03639363|Chlorhexidine|chlorhexidine|mesh-list
93171921|NCT03639363|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93171922|NCT03639363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93171923|NCT03639363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171924|NCT03639363|Disinfectants|disinfectants|mesh-ancestor
93171925|NCT03639363|Dermatologic Agents|dermatologic agents|mesh-ancestor
93171926|NCT03859141|Vaccines|vaccines|mesh-list
93171927|NCT03859141|Immunologic Factors|immunologic factors|mesh-ancestor
93171928|NCT03859141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171929|NCT03859219|Rozanolixizumab|rozanolixizumab|mesh-list
93171930|NCT03859219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93171931|NCT03859219|Immunologic Factors|immunologic factors|mesh-ancestor
93171932|NCT03859219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171933|NCT03374358|Raltegravir Potassium|raltegravir potassium|mesh-list
93171934|NCT03374358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93171935|NCT03374358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93171936|NCT03374358|Antiviral Agents|antiviral agents|mesh-ancestor
93171937|NCT03374358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171938|NCT03374358|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93171939|NCT03374358|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93171940|NCT03374358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171941|NCT03374358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171942|NCT03711708|Sertraline|sertraline|mesh-list
93171943|NCT03711708|Antidepressive Agents|antidepressive agents|mesh-ancestor
93171944|NCT03711708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93171945|NCT03711708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93171946|NCT03711708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93171947|NCT03711708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171948|NCT03711708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171949|NCT03711708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93171950|NCT03711708|Serotonin Agents|serotonin agents|mesh-ancestor
93171951|NCT03711708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171952|NCT01179529|Omalizumab|omalizumab|mesh-list
93171953|NCT01179529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93171954|NCT01179529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93171955|NCT01179529|Respiratory System Agents|respiratory system agents|mesh-ancestor
93171956|NCT00004859|Thalidomide|thalidomide|mesh-list
93171957|NCT00004859|Paclitaxel|paclitaxel|mesh-list
93171958|NCT00004859|Carboplatin|carboplatin|mesh-list
93171959|NCT00004859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93171960|NCT00004859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93171961|NCT00004859|Tubulin Modulators|tubulin modulators|mesh-ancestor
93171962|NCT00004859|Antimitotic Agents|antimitotic agents|mesh-ancestor
93171963|NCT00004859|Mitosis Modulators|mitosis modulators|mesh-ancestor
93171964|NCT00004859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171965|NCT00004859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93171966|NCT00004859|Immunologic Factors|immunologic factors|mesh-ancestor
93171967|NCT00004859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171968|NCT00004859|Leprostatic Agents|leprostatic agents|mesh-ancestor
93171969|NCT00004859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93171970|NCT00004859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93171971|NCT00004859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93171972|NCT00004859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93171973|NCT00004859|Growth Substances|growth substances|mesh-ancestor
93171974|NCT00004859|Growth Inhibitors|growth inhibitors|mesh-ancestor
93171975|NCT03348930|Tolcapone|tolcapone|mesh-list
93171976|NCT03348930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93171977|NCT03348930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93171978|NCT03348930|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93171979|NCT03348930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93171980|NCT03348930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171981|NCT03500211|Lidocaine|lidocaine|mesh-list
93171982|NCT03500211|Anesthetics, Local|anesthetics, local|mesh-ancestor
93171983|NCT03500211|Anesthetics|anesthetics|mesh-ancestor
93171984|NCT03500211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93171985|NCT03500211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171986|NCT03500211|Sensory System Agents|sensory system agents|mesh-ancestor
93171987|NCT03500211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93171988|NCT03500211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93171989|NCT03500211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93171990|NCT03500211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93171991|NCT03500211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93171992|NCT03500211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171993|NCT01288885|Ipragliflozin|ipragliflozin|mesh-list
93171994|NCT01288885|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93171995|NCT01288885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93171996|NCT01288885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93171997|NCT01288885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93171998|NCT04760717|Spironolactone|spironolactone|mesh-list
93171999|NCT04760717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93172000|NCT04760717|Hormone Antagonists|hormone antagonists|mesh-ancestor
93172001|NCT04760717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93172002|NCT04760717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172003|NCT04760717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93172004|NCT04760717|Diuretics|diuretics|mesh-ancestor
93172005|NCT04760717|Natriuretic Agents|natriuretic agents|mesh-ancestor
93172006|NCT03478683|Budesonide|budesonide|mesh-list
93172007|NCT03478683|Albuterol|albuterol|mesh-list
93172008|NCT03478683|Formoterol Fumarate|formoterol fumarate|mesh-list
93172009|NCT03478683|Tiotropium Bromide|tiotropium bromide|mesh-list
93172010|NCT03478683|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93172011|NCT03478683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172012|NCT03478683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93172013|NCT03478683|Autonomic Agents|autonomic agents|mesh-ancestor
93172014|NCT03478683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172015|NCT03478683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172016|NCT03478683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93172017|NCT03478683|Respiratory System Agents|respiratory system agents|mesh-ancestor
93172018|NCT03478683|Glucocorticoids|glucocorticoids|mesh-ancestor
93172019|NCT03478683|Hormones|hormones|mesh-ancestor
93172020|NCT03478683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93172021|NCT03478683|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93172022|NCT03478683|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93172023|NCT03478683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93172024|NCT03478683|Adrenergic Agents|adrenergic agents|mesh-ancestor
93172025|NCT03478683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172026|NCT03478683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172027|NCT03478683|Parasympatholytics|parasympatholytics|mesh-ancestor
93172028|NCT03478683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93172029|NCT03478683|Cholinergic Agents|cholinergic agents|mesh-ancestor
93172030|NCT03478683|Tocolytic Agents|tocolytic agents|mesh-ancestor
93172031|NCT03478683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93172032|NCT04744883|Naloxone|naloxone|mesh-list
93172033|NCT04744883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93172034|NCT04744883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172035|NCT04744883|Sensory System Agents|sensory system agents|mesh-ancestor
93172036|NCT04744883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172037|NCT01176799|Cyclophosphamide|cyclophosphamide|mesh-list
93172038|NCT01176799|Doxorubicin|doxorubicin|mesh-list
93172039|NCT01176799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93172040|NCT01176799|Sunitinib|sunitinib|mesh-list
93172041|NCT01176799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172042|NCT01176799|Immunologic Factors|immunologic factors|mesh-ancestor
93172043|NCT01176799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172044|NCT01176799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172045|NCT01176799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172046|NCT01176799|Alkylating Agents|alkylating agents|mesh-ancestor
93172047|NCT01176799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172048|NCT01176799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172049|NCT01176799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93172050|NCT01176799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93172051|NCT01176799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93172052|NCT01176799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93172053|NCT01176799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172054|NCT01176799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93172055|NCT01176799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93172056|NCT01176799|Growth Substances|growth substances|mesh-ancestor
93172057|NCT01176799|Growth Inhibitors|growth inhibitors|mesh-ancestor
93172058|NCT01176799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93172059|NCT03861403|Cyclophosphamide|cyclophosphamide|mesh-list
93172060|NCT03861403|Avelumab|avelumab|mesh-list
93172061|NCT03861403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172062|NCT03861403|Immunologic Factors|immunologic factors|mesh-ancestor
93172063|NCT03861403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172064|NCT03861403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172065|NCT03861403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172066|NCT03861403|Alkylating Agents|alkylating agents|mesh-ancestor
93172067|NCT03861403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172068|NCT03861403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172069|NCT03861403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93172070|NCT03861403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172071|NCT03477903|Metoclopramide|metoclopramide|mesh-list
93172072|NCT03477903|Antiemetics|antiemetics|mesh-ancestor
93172073|NCT03477903|Autonomic Agents|autonomic agents|mesh-ancestor
93172074|NCT03477903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172075|NCT03477903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172076|NCT03477903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172077|NCT03477903|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93172078|NCT03477903|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93172079|NCT03477903|Dopamine Agents|dopamine agents|mesh-ancestor
93172080|NCT03477903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172081|NCT03477903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172082|NCT04728425|Immunoglobulins|immunoglobulins|mesh-list
93172083|NCT04728425|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93172084|NCT04728425|Antibodies|antibodies|mesh-list
93172085|NCT04728425|gamma-Globulins|gamma-globulins|mesh-list
93172086|NCT04728425|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93172087|NCT04728425|Immunoglobulin G|immunoglobulin g|mesh-list
93172088|NCT04728425|Immunologic Factors|immunologic factors|mesh-ancestor
93172089|NCT04728425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172090|NCT01181401|Cisplatin|cisplatin|mesh-list
93172091|NCT01181401|Docetaxel|docetaxel|mesh-list
93172092|NCT01181401|Cetuximab|cetuximab|mesh-list
93172093|NCT01181401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172094|NCT01181401|Tubulin Modulators|tubulin modulators|mesh-ancestor
93172095|NCT01181401|Antimitotic Agents|antimitotic agents|mesh-ancestor
93172096|NCT01181401|Mitosis Modulators|mitosis modulators|mesh-ancestor
93172097|NCT01181401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172098|NCT01181401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172099|NCT01287715|Etanercept|etanercept|mesh-list
93172100|NCT01287715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93172101|NCT01287715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172102|NCT01287715|Analgesics|analgesics|mesh-ancestor
93172103|NCT01287715|Sensory System Agents|sensory system agents|mesh-ancestor
93172104|NCT01287715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172105|NCT01287715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172106|NCT01287715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172107|NCT01287715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172108|NCT01287715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172109|NCT01287715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172110|NCT01287715|Immunologic Factors|immunologic factors|mesh-ancestor
93172111|NCT03474081|Albuterol|albuterol|mesh-list
93172112|NCT03474081|Tiotropium Bromide|tiotropium bromide|mesh-list
93172113|NCT03474081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93172114|NCT03474081|Autonomic Agents|autonomic agents|mesh-ancestor
93172115|NCT03474081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172116|NCT03474081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172117|NCT03474081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93172118|NCT03474081|Respiratory System Agents|respiratory system agents|mesh-ancestor
93172119|NCT03474081|Parasympatholytics|parasympatholytics|mesh-ancestor
93172120|NCT03474081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93172121|NCT03474081|Cholinergic Agents|cholinergic agents|mesh-ancestor
93172122|NCT03474081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172123|NCT03474081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172124|NCT03474081|Tocolytic Agents|tocolytic agents|mesh-ancestor
93172125|NCT03474081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93172126|NCT03474081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93172127|NCT03474081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93172128|NCT03474081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93172129|NCT03474081|Adrenergic Agents|adrenergic agents|mesh-ancestor
93172131|NCT03393000|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
93172132|NCT03393000|Antioxidants|antioxidants|mesh-ancestor
93172133|NCT03393000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172134|NCT03393000|Protective Agents|protective agents|mesh-ancestor
93172135|NCT03393000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172136|NCT03393000|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93172137|NCT03393000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172138|NCT03393000|Vitamins|vitamins|mesh-ancestor
93172139|NCT03393000|Micronutrients|micronutrients|mesh-ancestor
93172140|NCT01311804|Parecoxib|parecoxib|mesh-list
93172141|NCT01311804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93172142|NCT01311804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93172143|NCT01311804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172144|NCT01311804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172145|NCT01311804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93172146|NCT01311804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172147|NCT01311804|Analgesics|analgesics|mesh-ancestor
93172148|NCT01311804|Sensory System Agents|sensory system agents|mesh-ancestor
93172149|NCT01311804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172150|NCT01311804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172151|NCT01311804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172152|NCT01311804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172153|NCT03370770|Osimertinib|osimertinib|mesh-list
93172154|NCT03370770|Afatinib|afatinib|mesh-list
93172155|NCT03370770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172156|NCT03370770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93172157|NCT03370770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172158|NCT03370770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172159|NCT01180075|Ritonavir|ritonavir|mesh-list
93172160|NCT01180075|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93172161|NCT01180075|Tenofovir|tenofovir|mesh-list
93172162|NCT01180075|Emtricitabine|emtricitabine|mesh-list
93172163|NCT01180075|Efavirenz|efavirenz|mesh-list
93172164|NCT01180075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93172165|NCT01180075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93172166|NCT01180075|Protease Inhibitors|protease inhibitors|mesh-ancestor
93172167|NCT01180075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172168|NCT01180075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172169|NCT01180075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93172170|NCT01180075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93172171|NCT01180075|Antiviral Agents|antiviral agents|mesh-ancestor
93172172|NCT01180075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172173|NCT01180075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93172174|NCT01180075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93172175|NCT01180075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93172176|NCT01180075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93172177|NCT01180075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93172178|NCT01180075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93172179|NCT01180075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93172180|NCT01180075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93172181|NCT01180075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93172182|NCT01311882|Zopiclone|zopiclone|mesh-list
93172183|NCT01311882|Suvorexant|suvorexant|mesh-list
93172184|NCT01311882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93172185|NCT01311882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172186|NCT01311882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172187|NCT01311882|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93172188|NCT01311882|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93172189|NCT01311882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172190|NCT01311882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172191|NCT01287793|Moxifloxacin|moxifloxacin|mesh-list
93172192|NCT01287793|Tigecycline|tigecycline|mesh-list
93172193|NCT01287793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93172194|NCT01287793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172195|NCT01287793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93172196|NCT01287793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93172197|NCT01287793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172198|NCT01287793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172199|NCT01287793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172200|NCT01287793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93172201|NCT03391284|Acetaminophen|acetaminophen|mesh-list
93172202|NCT03391284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172203|NCT03391284|Analgesics|analgesics|mesh-ancestor
93172204|NCT03391284|Sensory System Agents|sensory system agents|mesh-ancestor
93172205|NCT03391284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172206|NCT03391284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172207|NCT03391284|Antipyretics|antipyretics|mesh-ancestor
93172208|NCT01180153|Oxaliplatin|oxaliplatin|mesh-list
93172209|NCT01180153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172210|NCT03719625|Norepinephrine|norepinephrine|mesh-list
93172211|NCT03719625|Ephedrine|ephedrine|mesh-list
93172212|NCT03719625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93172213|NCT03719625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93172214|NCT03719625|Adrenergic Agents|adrenergic agents|mesh-ancestor
93172215|NCT03719625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172216|NCT03719625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172217|NCT03719625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172218|NCT03719625|Sympathomimetics|sympathomimetics|mesh-ancestor
93172219|NCT03719625|Autonomic Agents|autonomic agents|mesh-ancestor
93172220|NCT03719625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172221|NCT03719625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93172222|NCT03719625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93172223|NCT01289743|Etanercept|etanercept|mesh-list
93172224|NCT01289743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93172225|NCT01289743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172226|NCT01289743|Analgesics|analgesics|mesh-ancestor
93172227|NCT01289743|Sensory System Agents|sensory system agents|mesh-ancestor
93172228|NCT01289743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172229|NCT01289743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172230|NCT01289743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172231|NCT01289743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172232|NCT01289743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172233|NCT01289743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172234|NCT01289743|Immunologic Factors|immunologic factors|mesh-ancestor
93172235|NCT03390426|Anesthetics|anesthetics|mesh-list
93172236|NCT03390426|Mepivacaine|mepivacaine|mesh-list
93172237|NCT03390426|Anesthetics, Local|anesthetics, local|mesh-list
93172238|NCT03390426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172239|NCT03390426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172240|NCT03390426|Sensory System Agents|sensory system agents|mesh-ancestor
93172241|NCT03390426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172242|NCT03472521|Gabapentin|gabapentin|mesh-list
93172243|NCT03472521|Analgesics|analgesics|mesh-ancestor
93172244|NCT03472521|Sensory System Agents|sensory system agents|mesh-ancestor
93172245|NCT03472521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172246|NCT03472521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172247|NCT03472521|Anticonvulsants|anticonvulsants|mesh-ancestor
93172248|NCT03472521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93172249|NCT03472521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93172250|NCT03472521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172251|NCT03472521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93172252|NCT03472521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93172253|NCT03472521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93172254|NCT03472521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172255|NCT03472521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172256|NCT03472521|Antimanic Agents|antimanic agents|mesh-ancestor
93172257|NCT02906020|Venglustat|venglustat|mesh-list
93172258|NCT02906020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844433|NCT01341600|Omeprazole|omeprazole|mesh-list
93172259|NCT02906020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172260|NCT01177423|Anesthetics|anesthetics|mesh-list
93172261|NCT01177423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172262|NCT01177423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172264|NCT01180231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93172265|NCT01177501|Topotecan|topotecan|mesh-list
93172266|NCT01177501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93172267|NCT01177501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93172268|NCT01177501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172269|NCT01177501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172270|NCT01177501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172271|NCT03478150|Zinc Oxide|zinc oxide|mesh-list
93172272|NCT03478150|Dermatologic Agents|dermatologic agents|mesh-ancestor
93172273|NCT03478150|Sunscreening Agents|sunscreening agents|mesh-ancestor
93172274|NCT03478150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93172275|NCT03478150|Protective Agents|protective agents|mesh-ancestor
93172276|NCT03478150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172277|NCT03499353|Talazoparib|talazoparib|mesh-list
93172278|NCT03499353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93172279|NCT03499353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172280|NCT03499353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172281|NCT03499353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172282|NCT03368664|Interferons|interferons|mesh-list
93172283|NCT03368664|Acyclovir|acyclovir|mesh-list
93172284|NCT03368664|Interferon-beta|interferon-beta|mesh-list
93172285|NCT03368664|Methylprednisolone|methylprednisolone|mesh-list
93172286|NCT03368664|Prednisolone|prednisolone|mesh-list
93172287|NCT03368664|Alemtuzumab|alemtuzumab|mesh-list
93172288|NCT03368664|Glatiramer Acetate|glatiramer acetate|mesh-list
93172289|NCT03368664|Ranitidine|ranitidine|mesh-list
93172290|NCT03368664|(T,G)-A-L|(t,g)-a-l|mesh-list
93172291|NCT03368664|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93172292|NCT03368664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172293|NCT03368664|Antiviral Agents|antiviral agents|mesh-ancestor
93172294|NCT03368664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172295|NCT03368664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172296|NCT03368664|Antiemetics|antiemetics|mesh-ancestor
93172297|NCT03368664|Autonomic Agents|autonomic agents|mesh-ancestor
93172298|NCT03368664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172299|NCT03368664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172300|NCT03368664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172301|NCT03368664|Glucocorticoids|glucocorticoids|mesh-ancestor
93172302|NCT03368664|Hormones|hormones|mesh-ancestor
93172303|NCT03368664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93172304|NCT03368664|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93172305|NCT03368664|Protective Agents|protective agents|mesh-ancestor
93172306|NCT03368664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93172307|NCT03368664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172308|NCT03368664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93172309|NCT03368664|Immunologic Factors|immunologic factors|mesh-ancestor
93172310|NCT03368664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172311|NCT03368664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172312|NCT03368664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93172313|NCT03368664|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93172314|NCT03368664|Histamine Antagonists|histamine antagonists|mesh-ancestor
93172315|NCT03368664|Histamine Agents|histamine agents|mesh-ancestor
93172316|NCT03368664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855168|NCT00887198|Hormones|hormones|mesh-ancestor
93172317|NCT03368664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172318|NCT03368664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93172319|NCT00004259|Carmustine|carmustine|mesh-list
93172320|NCT00004259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172321|NCT00004259|Alkylating Agents|alkylating agents|mesh-ancestor
93172322|NCT00004259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172323|NCT00004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172324|NCT01177579|Copper|copper|mesh-list
93172325|NCT01177579|Trace Elements|trace elements|mesh-ancestor
93172326|NCT01177579|Micronutrients|micronutrients|mesh-ancestor
93172327|NCT01177579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172328|NCT03722355|Carmustine|carmustine|mesh-list
93172329|NCT03722355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172330|NCT03722355|Alkylating Agents|alkylating agents|mesh-ancestor
93172331|NCT03722355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172332|NCT03722355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172333|NCT03857815|Antibodies|antibodies|mesh-list
93172334|NCT03857815|Immunologic Factors|immunologic factors|mesh-ancestor
93172335|NCT03857815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172336|NCT03365934|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93172337|NCT03365934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172338|NCT04682405|Melphalan|melphalan|mesh-list
93172339|NCT04682405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172340|NCT04682405|Alkylating Agents|alkylating agents|mesh-ancestor
93172341|NCT04682405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172342|NCT04682405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172343|NCT04682405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93172344|NCT04682405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172345|NCT04682405|Immunologic Factors|immunologic factors|mesh-ancestor
93172346|NCT04682405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172347|NCT03477994|Clonidine|clonidine|mesh-list
93172348|NCT03477994|Dexmedetomidine|dexmedetomidine|mesh-list
93172349|NCT03477994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93172350|NCT03477994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172351|NCT03477994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172352|NCT03477994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172353|NCT03477994|Analgesics|analgesics|mesh-ancestor
93172354|NCT03477994|Sensory System Agents|sensory system agents|mesh-ancestor
93172355|NCT03477994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172356|NCT03477994|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93172357|NCT03477994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93172358|NCT03477994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93172359|NCT03477994|Adrenergic Agents|adrenergic agents|mesh-ancestor
93172360|NCT03477994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172361|NCT03477994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172362|NCT03477994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93172363|NCT03477994|Sympatholytics|sympatholytics|mesh-ancestor
93172364|NCT03477994|Autonomic Agents|autonomic agents|mesh-ancestor
93172365|NCT04668131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93172366|NCT04668131|Lubricant Eye Drops|lubricant eye drops|mesh-list
93172367|NCT04668131|Hyaluronic Acid|hyaluronic acid|mesh-list
93172368|NCT04668131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93172369|NCT04668131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93172370|NCT04668131|Immunologic Factors|immunologic factors|mesh-ancestor
93172371|NCT04668131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172372|NCT04668131|Viscosupplements|viscosupplements|mesh-ancestor
93172373|NCT04668131|Protective Agents|protective agents|mesh-ancestor
93172374|NCT03857581|Olanzapine|olanzapine|mesh-list
93172375|NCT03857581|Clozapine|clozapine|mesh-list
93172376|NCT03857581|Antiemetics|antiemetics|mesh-ancestor
93172377|NCT03857581|Autonomic Agents|autonomic agents|mesh-ancestor
93172378|NCT03857581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172379|NCT03857581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172380|NCT03857581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172381|NCT03857581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93172382|NCT03857581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93172383|NCT03857581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172384|NCT03857581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93172385|NCT03857581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93172386|NCT03857581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93172387|NCT03857581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93172388|NCT03857581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172389|NCT03857581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172390|NCT03857581|Serotonin Agents|serotonin agents|mesh-ancestor
93172391|NCT03857581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93172392|NCT03857581|GABA Antagonists|gaba antagonists|mesh-ancestor
93172393|NCT03857581|GABA Agents|gaba agents|mesh-ancestor
93172394|NCT01103843|Clopidogrel|clopidogrel|mesh-list
93172395|NCT01103843|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93172396|NCT01103843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93172397|NCT01103843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93172398|NCT01103843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93172399|NCT01103843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93172400|NCT01103843|Purinergic Agents|purinergic agents|mesh-ancestor
93172401|NCT01103843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172402|NCT01103843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172403|NCT01103843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172404|NCT03738865|Glucagon|glucagon|mesh-list
93172405|NCT03738865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93172406|NCT03738865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172407|NCT03738865|Hormones|hormones|mesh-ancestor
93172408|NCT03738865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93172409|NCT03738865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172410|NCT03738865|Incretins|incretins|mesh-ancestor
93172411|NCT03524157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93172412|NCT03524157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93172413|NCT03524157|Hyaluronic Acid|hyaluronic acid|mesh-list
93172414|NCT03524157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93172415|NCT03524157|Immunologic Factors|immunologic factors|mesh-ancestor
93172416|NCT03524157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172417|NCT03524157|Viscosupplements|viscosupplements|mesh-ancestor
93172418|NCT03524157|Protective Agents|protective agents|mesh-ancestor
93172419|NCT03719391|Nicotine|nicotine|mesh-list
93172420|NCT03719391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93172421|NCT03719391|Autonomic Agents|autonomic agents|mesh-ancestor
93172422|NCT03719391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172423|NCT03719391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172424|NCT03719391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93172425|NCT03719391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93172426|NCT03719391|Cholinergic Agents|cholinergic agents|mesh-ancestor
93172427|NCT03719391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172428|NCT03719391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172429|NCT03468543|Memantine|memantine|mesh-list
93172430|NCT03468543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93172431|NCT03468543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93172432|NCT03468543|Dopamine Agents|dopamine agents|mesh-ancestor
93172433|NCT03468543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172434|NCT03468543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172435|NCT03468543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172436|NCT03468543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93172437|NCT03468543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93172438|NCT03467763|Metformin|metformin|mesh-list
93172439|NCT03467763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93172440|NCT03467763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172441|NCT00004031|Prednisone|prednisone|mesh-list
93172442|NCT00004031|Cyclophosphamide|cyclophosphamide|mesh-list
93172443|NCT00004031|Carmustine|carmustine|mesh-list
93172444|NCT00004031|Rituximab|rituximab|mesh-list
93172445|NCT00004031|Doxorubicin|doxorubicin|mesh-list
93172446|NCT00004031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93172447|NCT00004031|Etoposide|etoposide|mesh-list
93172448|NCT00004031|Vincristine|vincristine|mesh-list
93172449|NCT00004031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172450|NCT00004031|Immunologic Factors|immunologic factors|mesh-ancestor
93172451|NCT00004031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172452|NCT00004031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172453|NCT00004031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172454|NCT00004031|Alkylating Agents|alkylating agents|mesh-ancestor
93172455|NCT00004031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172456|NCT00004031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172457|NCT00004031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93172458|NCT00004031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172459|NCT00004031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93172460|NCT00004031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93172461|NCT00004031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93172462|NCT00004031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172463|NCT00004031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172464|NCT00004031|Glucocorticoids|glucocorticoids|mesh-ancestor
93172465|NCT00004031|Hormones|hormones|mesh-ancestor
93172466|NCT00004031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93172467|NCT00004031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93172468|NCT00004031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93172469|NCT00004031|Tubulin Modulators|tubulin modulators|mesh-ancestor
93172470|NCT00004031|Antimitotic Agents|antimitotic agents|mesh-ancestor
93172471|NCT00004031|Mitosis Modulators|mitosis modulators|mesh-ancestor
93172472|NCT01184443|Olanzapine|olanzapine|mesh-list
93172473|NCT01184443|Antiemetics|antiemetics|mesh-ancestor
93172474|NCT01184443|Autonomic Agents|autonomic agents|mesh-ancestor
93172475|NCT01184443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172476|NCT01184443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172477|NCT01184443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172478|NCT01184443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93172479|NCT01184443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93172480|NCT01184443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172481|NCT01184443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93172482|NCT01184443|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93172483|NCT01184443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93172484|NCT01184443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93172485|NCT01184443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172486|NCT01184443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172487|NCT01184443|Serotonin Agents|serotonin agents|mesh-ancestor
93172488|NCT01180621|Vaccines|vaccines|mesh-list
93172489|NCT01180621|Immunologic Factors|immunologic factors|mesh-ancestor
93172490|NCT01180621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172491|NCT01290133|Vestipitant|vestipitant|mesh-list
93172492|NCT01290133|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93172493|NCT01290133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172494|NCT01290133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172495|NCT01290133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172496|NCT03467217|Losartan|losartan|mesh-list
93172497|NCT03467217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93172498|NCT03467217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93172499|NCT03467217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93172500|NCT03467217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93172501|NCT03467217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172502|NCT00003875|Aldesleukin|aldesleukin|mesh-list
93172503|NCT00003875|Etoposide|etoposide|mesh-list
93172504|NCT00003875|Etoposide phosphate|etoposide phosphate|mesh-list
93172505|NCT00003875|Busulfan|busulfan|mesh-list
93172506|NCT00003875|Interleukin-2|interleukin-2|mesh-list
93172507|NCT00003875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93172508|NCT00003875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172509|NCT00003875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93172510|NCT00003875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93172511|NCT00003875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172512|NCT00003875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172513|NCT00003875|Alkylating Agents|alkylating agents|mesh-ancestor
93172514|NCT00003875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172515|NCT00003875|Immunologic Factors|immunologic factors|mesh-ancestor
93172516|NCT00003875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172517|NCT00003875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172518|NCT00003875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93172519|NCT00003875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172520|NCT00003875|Analgesics|analgesics|mesh-ancestor
93172521|NCT00003875|Sensory System Agents|sensory system agents|mesh-ancestor
93172522|NCT00003875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172523|NCT00003875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93172524|NCT00003875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93172525|NCT00003875|Antiviral Agents|antiviral agents|mesh-ancestor
93172526|NCT00003875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172527|NCT01327625|Azithromycin|azithromycin|mesh-list
93172528|NCT01327625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93172529|NCT01327625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172530|NCT01290211|Ritonavir|ritonavir|mesh-list
93172531|NCT01290211|Fosamprenavir|fosamprenavir|mesh-list
93172532|NCT01290211|Maraviroc|maraviroc|mesh-list
93172533|NCT01290211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93172534|NCT01290211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93172535|NCT01290211|Protease Inhibitors|protease inhibitors|mesh-ancestor
93172536|NCT01290211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172537|NCT01290211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172538|NCT01290211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93172539|NCT01290211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92977230|NCT00246337|Rizatriptan|rizatriptan|mesh-list
93172540|NCT01290211|Antiviral Agents|antiviral agents|mesh-ancestor
93172541|NCT01290211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172542|NCT01290211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93172543|NCT01290211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93172544|NCT01290211|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93172545|NCT01290211|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93172546|NCT01290211|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93172547|NCT03720873|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93172548|NCT03720873|Gefitinib|gefitinib|mesh-list
93172549|NCT03720873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172550|NCT03720873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93172551|NCT03720873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172552|NCT03720873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172553|NCT01311960|Bevacizumab|bevacizumab|mesh-list
93172554|NCT01311960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93172555|NCT01311960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172556|NCT01311960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172557|NCT01311960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93172558|NCT01311960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93172559|NCT01311960|Growth Substances|growth substances|mesh-ancestor
93172560|NCT01311960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172561|NCT01311960|Growth Inhibitors|growth inhibitors|mesh-ancestor
93172562|NCT01311960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93172563|NCT03709056|Propofol|propofol|mesh-list
93172564|NCT03709056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93172565|NCT03709056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172566|NCT03709056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172567|NCT03709056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93172568|NCT03709056|Anesthetics, General|anesthetics, general|mesh-ancestor
93172569|NCT03709056|Anesthetics|anesthetics|mesh-ancestor
93172570|NCT05663307|Aspirin|aspirin|mesh-list
93172571|NCT05663307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93172572|NCT05663307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172573|NCT05663307|Analgesics|analgesics|mesh-ancestor
93172574|NCT05663307|Sensory System Agents|sensory system agents|mesh-ancestor
93172575|NCT05663307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172576|NCT05663307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172577|NCT05663307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172578|NCT05663307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172579|NCT05663307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93172580|NCT05663307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93172581|NCT05663307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172582|NCT05663307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93172583|NCT05663307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93172584|NCT05663307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172585|NCT05663307|Antipyretics|antipyretics|mesh-ancestor
93172586|NCT01106495|Simvastatin|simvastatin|mesh-list
93172587|NCT01106495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93172588|NCT01106495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93172589|NCT01106495|Antimetabolites|antimetabolites|mesh-ancestor
93172590|NCT01106495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172591|NCT01106495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93172592|NCT01106495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93172593|NCT01106495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172594|NCT01184833|Interferons|interferons|mesh-list
93172595|NCT01184833|Interferon-beta|interferon-beta|mesh-list
93172596|NCT01184833|Interferon beta-1b|interferon beta-1b|mesh-list
93172597|NCT01184833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172598|NCT01184833|Antiviral Agents|antiviral agents|mesh-ancestor
93172599|NCT01184833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172600|NCT01184833|Immunologic Factors|immunologic factors|mesh-ancestor
93172601|NCT01184833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172602|NCT01184833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93172603|NCT01184911|Pyrimethamine|pyrimethamine|mesh-list
93172604|NCT01184911|Sulfadoxine|sulfadoxine|mesh-list
93172605|NCT01184911|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93172606|NCT01184911|Antimalarials|antimalarials|mesh-ancestor
93172607|NCT01184911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93172608|NCT01184911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93172609|NCT01184911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172610|NCT01184911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93172611|NCT01184911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172612|NCT01184911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172613|NCT01184911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93172614|NCT01185067|Grape Seed Extract|grape seed extract|mesh-list
93172615|NCT01185067|Resveratrol|resveratrol|mesh-list
93172616|NCT01185067|Antioxidants|antioxidants|mesh-list
93172617|NCT01185067|Quercetin|quercetin|mesh-list
93172618|NCT01185067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172619|NCT01185067|Protective Agents|protective agents|mesh-ancestor
93172620|NCT01185067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172621|NCT01185067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172622|NCT01185067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93172623|NCT01185067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93172624|NCT01185067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172625|NCT03364686|Biotin|biotin|mesh-list
93172626|NCT03364686|Vitamin B Complex|vitamin b complex|mesh-ancestor
93172627|NCT03364686|Vitamins|vitamins|mesh-ancestor
93172628|NCT03364686|Micronutrients|micronutrients|mesh-ancestor
93172629|NCT03364686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172630|NCT03437577|Tacrolimus|tacrolimus|mesh-list
93172631|NCT03437577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172632|NCT03437577|Immunologic Factors|immunologic factors|mesh-ancestor
93172633|NCT03437577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172634|NCT03437577|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93172635|NCT03437577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172636|NCT03437577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172637|NCT03336528|Insulin Glargine|insulin glargine|mesh-list
93172638|NCT03336528|Insulin Aspart|insulin aspart|mesh-list
93172639|NCT03336528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93172640|NCT03336528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172641|NCT03364608|Albuterol|albuterol|mesh-list
93172642|NCT03364608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93172643|NCT03364608|Autonomic Agents|autonomic agents|mesh-ancestor
93172644|NCT03364608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172645|NCT03364608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172646|NCT03364608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93172647|NCT03364608|Respiratory System Agents|respiratory system agents|mesh-ancestor
93172648|NCT03364608|Tocolytic Agents|tocolytic agents|mesh-ancestor
93172649|NCT03364608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93172650|NCT03364608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93172651|NCT03364608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93172652|NCT03364608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93172653|NCT03364608|Adrenergic Agents|adrenergic agents|mesh-ancestor
93172654|NCT03364608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172655|NCT03364608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172656|NCT03719157|Anesthetics|anesthetics|mesh-list
93172657|NCT03719157|Anesthetics, Local|anesthetics, local|mesh-list
93172658|NCT03719157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172659|NCT03719157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172660|NCT03719157|Sensory System Agents|sensory system agents|mesh-ancestor
93172661|NCT03719157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172662|NCT01185223|Valganciclovir|valganciclovir|mesh-list
93172663|NCT01185223|Ganciclovir|ganciclovir|mesh-list
93172664|NCT01185223|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93172665|NCT01185223|Antiviral Agents|antiviral agents|mesh-ancestor
93172666|NCT01185223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172667|NCT01185223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93172668|NCT01185223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172669|NCT01185223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172670|NCT03852979|Paclitaxel|paclitaxel|mesh-list
93172671|NCT03852979|Carboplatin|carboplatin|mesh-list
93172672|NCT03852979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93172673|NCT03852979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172674|NCT03852979|Tubulin Modulators|tubulin modulators|mesh-ancestor
93172675|NCT03852979|Antimitotic Agents|antimitotic agents|mesh-ancestor
93172676|NCT03852979|Mitosis Modulators|mitosis modulators|mesh-ancestor
93172677|NCT03852979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172678|NCT01188031|Alprazolam|alprazolam|mesh-list
93172679|NCT01188031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93172680|NCT01188031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172681|NCT01188031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172682|NCT01188031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93172683|NCT01188031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93172684|NCT01188031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93172685|NCT01188031|GABA Modulators|gaba modulators|mesh-ancestor
93172686|NCT01188031|GABA Agents|gaba agents|mesh-ancestor
93172687|NCT01188031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172688|NCT01188031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172689|NCT01182883|Sirolimus|sirolimus|mesh-list
93172690|NCT01182883|Temsirolimus|temsirolimus|mesh-list
93172691|NCT01182883|MTOR Inhibitors|mtor inhibitors|mesh-list
93172692|NCT01182883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93172693|NCT01182883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172694|NCT01182883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172695|NCT01182883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172696|NCT01182883|Immunologic Factors|immunologic factors|mesh-ancestor
93172697|NCT01182883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172698|NCT01182883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172699|NCT01182883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93172700|NCT01182883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172701|NCT01182883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93172702|NCT01182883|Antifungal Agents|antifungal agents|mesh-ancestor
93172703|NCT01188265|Valproic Acid|valproic acid|mesh-list
93172704|NCT01188265|Dextromethorphan|dextromethorphan|mesh-list
93172705|NCT01188265|Antitussive Agents|antitussive agents|mesh-ancestor
93172706|NCT01188265|Respiratory System Agents|respiratory system agents|mesh-ancestor
93172707|NCT01188265|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93172708|NCT01188265|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93172709|NCT01188265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172710|NCT01188265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172711|NCT01188265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172712|NCT01188265|Anticonvulsants|anticonvulsants|mesh-ancestor
93172713|NCT01188265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172714|NCT01188265|GABA Agents|gaba agents|mesh-ancestor
93172715|NCT01188265|Antimanic Agents|antimanic agents|mesh-ancestor
93172716|NCT01188265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93172717|NCT01188265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172718|NCT01188265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93172720|NCT01291069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172721|NCT01291069|Vasodilator Agents|vasodilator agents|mesh-ancestor
93172722|NCT01291069|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93172723|NCT01291069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93172724|NCT01291069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172725|NCT01291069|Urological Agents|urological agents|mesh-ancestor
93172726|NCT00003869|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
93172727|NCT00003869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172728|NCT00003869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93172729|NCT00003869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93172730|NCT00003869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172731|NCT00003869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93172732|NCT00003869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172733|NCT01588639|Insulin|insulin|mesh-list
93172734|NCT01588639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93172735|NCT01588639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93172736|NCT01588639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172737|NCT02524639|Sirolimus|sirolimus|mesh-list
93172738|NCT02524639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93172739|NCT02524639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172740|NCT02524639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93172741|NCT02524639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172742|NCT02524639|Antifungal Agents|antifungal agents|mesh-ancestor
93172743|NCT02524639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172744|NCT02524639|Immunologic Factors|immunologic factors|mesh-ancestor
93172745|NCT02524639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172746|NCT01185535|Anesthetics|anesthetics|mesh-list
91928467|NCT02403687|Sumatriptan|sumatriptan|mesh-list
93172747|NCT01185535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172748|NCT01185535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172749|NCT00003659|Cyclophosphamide|cyclophosphamide|mesh-list
93172750|NCT00003659|Rituximab|rituximab|mesh-list
93172751|NCT00003659|Fludarabine|fludarabine|mesh-list
93172752|NCT00003659|Fludarabine phosphate|fludarabine phosphate|mesh-list
93172753|NCT00003659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172754|NCT00003659|Immunologic Factors|immunologic factors|mesh-ancestor
93172755|NCT00003659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172756|NCT00003659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172757|NCT00003659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93172758|NCT00003659|Alkylating Agents|alkylating agents|mesh-ancestor
93172759|NCT00003659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172760|NCT00003659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172761|NCT00003659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93172762|NCT00003659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172763|NCT00003659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93172764|NCT00003659|Antimetabolites|antimetabolites|mesh-ancestor
93172765|NCT01101581|Epratuzumab|epratuzumab|mesh-list
93172766|NCT01101581|Veltuzumab|veltuzumab|mesh-list
93172767|NCT01101581|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93172768|NCT01101581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172769|NCT01101581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172770|NCT01101581|Chelating Agents|chelating agents|mesh-ancestor
93172771|NCT01101581|Sequestering Agents|sequestering agents|mesh-ancestor
93172772|NCT01101581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172773|NCT01183585|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93172774|NCT01183585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93172775|NCT01183585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93172776|NCT01183585|Antimetabolites|antimetabolites|mesh-ancestor
93172777|NCT01183585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172778|NCT01183585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93172779|NCT01183585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93172780|NCT01183585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172781|NCT03494985|Muramidase|muramidase|mesh-list
93172782|NCT03494985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172783|NCT01185769|Tocotrienols|tocotrienols|mesh-list
93172784|NCT01185769|Vitamin E|vitamin e|mesh-list
93172785|NCT01185769|Tocopherols|tocopherols|mesh-list
93172786|NCT01185769|Antioxidants|antioxidants|mesh-ancestor
93172787|NCT01185769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172788|NCT01185769|Protective Agents|protective agents|mesh-ancestor
93172789|NCT01185769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172791|NCT01185769|Micronutrients|micronutrients|mesh-ancestor
93172792|NCT01185847|Gemcitabine|gemcitabine|mesh-list
93172793|NCT01185847|Pemetrexed|pemetrexed|mesh-list
93172794|NCT01185847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172795|NCT01185847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93172796|NCT01185847|Antimetabolites|antimetabolites|mesh-ancestor
93172797|NCT01185847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172798|NCT01185847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172799|NCT01185847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93172800|NCT01185847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93172801|NCT03720483|Acetylcysteine|acetylcysteine|mesh-list
93172802|NCT03720483|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93172803|NCT03720483|Antiviral Agents|antiviral agents|mesh-ancestor
93172804|NCT03720483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172805|NCT03720483|Expectorants|expectorants|mesh-ancestor
93172806|NCT03720483|Respiratory System Agents|respiratory system agents|mesh-ancestor
93172807|NCT03720483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93172808|NCT03720483|Antioxidants|antioxidants|mesh-ancestor
93172809|NCT03720483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172810|NCT03720483|Protective Agents|protective agents|mesh-ancestor
93172811|NCT03720483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172812|NCT03720483|Antidotes|antidotes|mesh-ancestor
93172813|NCT01183663|Leucovorin|leucovorin|mesh-list
93172814|NCT01183663|Sirolimus|sirolimus|mesh-list
93172815|NCT01183663|Bevacizumab|bevacizumab|mesh-list
93172816|NCT01183663|Lenalidomide|lenalidomide|mesh-list
93172817|NCT01183663|Fluorouracil|fluorouracil|mesh-list
93172818|NCT01183663|Oxaliplatin|oxaliplatin|mesh-list
93172819|NCT01183663|Sorafenib|sorafenib|mesh-list
93172820|NCT01183663|Temsirolimus|temsirolimus|mesh-list
93172821|NCT01183663|MTOR Inhibitors|mtor inhibitors|mesh-list
93172822|NCT01183663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172823|NCT01183663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468610|NCT01809392|Decitabine|decitabine|mesh-list
93172824|NCT01183663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93172825|NCT01183663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93172826|NCT01183663|Growth Substances|growth substances|mesh-ancestor
93172827|NCT01183663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172828|NCT01183663|Growth Inhibitors|growth inhibitors|mesh-ancestor
93172829|NCT01183663|Antimetabolites|antimetabolites|mesh-ancestor
93172830|NCT01183663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172831|NCT01183663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93172832|NCT01183663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172833|NCT01183663|Immunologic Factors|immunologic factors|mesh-ancestor
93172834|NCT01183663|Antidotes|antidotes|mesh-ancestor
93172835|NCT01183663|Protective Agents|protective agents|mesh-ancestor
93172836|NCT01183663|Vitamin B Complex|vitamin b complex|mesh-ancestor
93172837|NCT01183663|Vitamins|vitamins|mesh-ancestor
93172838|NCT01183663|Micronutrients|micronutrients|mesh-ancestor
93172839|NCT01183663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93172840|NCT01183663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172841|NCT01183663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93172842|NCT01183663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172843|NCT01183663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93172844|NCT01183663|Antifungal Agents|antifungal agents|mesh-ancestor
93172845|NCT01291927|Pancrelipase|pancrelipase|mesh-list
93172846|NCT01291927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172847|NCT03344172|Hydroxychloroquine|hydroxychloroquine|mesh-list
93172848|NCT03344172|Paclitaxel|paclitaxel|mesh-list
93172849|NCT03344172|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93172850|NCT03344172|Gemcitabine|gemcitabine|mesh-list
93172851|NCT03344172|Avelumab|avelumab|mesh-list
93172852|NCT03344172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93172853|NCT03344172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172854|NCT03344172|Tubulin Modulators|tubulin modulators|mesh-ancestor
93172855|NCT03344172|Antimitotic Agents|antimitotic agents|mesh-ancestor
93172856|NCT03344172|Mitosis Modulators|mitosis modulators|mesh-ancestor
93172857|NCT03344172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172858|NCT03344172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93172859|NCT03344172|Antimetabolites|antimetabolites|mesh-ancestor
93172860|NCT03344172|Antimalarials|antimalarials|mesh-ancestor
93172861|NCT03344172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93172862|NCT03344172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93172863|NCT03344172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93172864|NCT03344172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172865|NCT03344172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172866|NCT03344172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172867|NCT01188733|Octreotide|octreotide|mesh-list
93172868|NCT01188733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172869|NCT01188733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93172870|NCT01188733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172872|NCT01101659|Analgesics|analgesics|mesh-ancestor
93172873|NCT01101659|Sensory System Agents|sensory system agents|mesh-ancestor
93172874|NCT01101659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172875|NCT01101659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172876|NCT01101659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93172877|NCT01101659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93172878|NCT01101659|Anesthetics, General|anesthetics, general|mesh-ancestor
93172879|NCT01101659|Anesthetics|anesthetics|mesh-ancestor
93172880|NCT01101659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172881|NCT01101659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93172882|NCT01101659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93172883|NCT01101659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172884|NCT01101659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172885|NCT03855865|Vortioxetine|vortioxetine|mesh-list
93172886|NCT03855865|Antidepressive Agents|antidepressive agents|mesh-ancestor
93172887|NCT03855865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93172888|NCT03855865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93172889|NCT03855865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93172890|NCT03855865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93172891|NCT03855865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172892|NCT03855865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93172893|NCT03855865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93172894|NCT03855865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93172895|NCT03855865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172896|NCT03855865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93172897|NCT03855865|Serotonin Agents|serotonin agents|mesh-ancestor
93172898|NCT03855865|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93172899|NCT03855865|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93172900|NCT03855865|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93172901|NCT03855865|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93172902|NCT01290367|Hyaluronic Acid|hyaluronic acid|mesh-list
93172903|NCT01290367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93172904|NCT01290367|Immunologic Factors|immunologic factors|mesh-ancestor
93172905|NCT01290367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172906|NCT01290367|Viscosupplements|viscosupplements|mesh-ancestor
93172907|NCT01290367|Protective Agents|protective agents|mesh-ancestor
93172908|NCT03465891|Atezolizumab|atezolizumab|mesh-list
93172909|NCT03465891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93172910|NCT03465891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172911|NCT03465891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93172912|NCT03465891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172913|NCT03363906|Dulaglutide|dulaglutide|mesh-list
93172914|NCT03363906|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93172915|NCT03363906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93172916|NCT03363906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172917|NCT03363906|Immunologic Factors|immunologic factors|mesh-ancestor
93172918|NCT03948191|Methylene diphosphonate|methylene diphosphonate|mesh-list
93172919|NCT03948191|Methylprednisolone|methylprednisolone|mesh-list
93172920|NCT03948191|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93172921|NCT03948191|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93172922|NCT03948191|Prednisolone|prednisolone|mesh-list
93172923|NCT03948191|Prednisolone acetate|prednisolone acetate|mesh-list
93172924|NCT03948191|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93172925|NCT03948191|Prednisolone phosphate|prednisolone phosphate|mesh-list
93172926|NCT03948191|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
93172927|NCT03948191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172928|NCT03948191|Antiemetics|antiemetics|mesh-ancestor
93172929|NCT03948191|Autonomic Agents|autonomic agents|mesh-ancestor
93172930|NCT03948191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172931|NCT03948191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172932|NCT03948191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93172933|NCT03948191|Glucocorticoids|glucocorticoids|mesh-ancestor
93172934|NCT03948191|Hormones|hormones|mesh-ancestor
93172935|NCT03948191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93172936|NCT03948191|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93172937|NCT03948191|Protective Agents|protective agents|mesh-ancestor
93172938|NCT03948191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93172939|NCT03948191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845118|NCT05859009|Propranolol|propranolol|mesh-list
93172940|NCT03948191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93172941|NCT03948191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93172942|NCT03948191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172943|NCT01292083|Azacitidine|azacitidine|mesh-list
93172944|NCT01292083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93172945|NCT01292083|Antimetabolites|antimetabolites|mesh-ancestor
93172946|NCT01292083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172947|NCT01292083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172948|NCT01292083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172949|NCT01104467|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
93172950|NCT01104467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93172951|NCT01104467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93172952|NCT01104467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172953|NCT01292161|Silymarin|silymarin|mesh-list
93172954|NCT01292161|Antioxidants|antioxidants|mesh-ancestor
93172955|NCT01292161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172956|NCT01292161|Protective Agents|protective agents|mesh-ancestor
93172957|NCT01292161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172958|NCT01185925|Sildenafil Citrate|sildenafil citrate|mesh-list
93172959|NCT01185925|Vasodilator Agents|vasodilator agents|mesh-ancestor
93172960|NCT01185925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93172961|NCT01185925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93172962|NCT01185925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172963|NCT01185925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172964|NCT01185925|Urological Agents|urological agents|mesh-ancestor
93172965|NCT01188889|Imatinib Mesylate|imatinib mesylate|mesh-list
93172966|NCT01188889|Everolimus|everolimus|mesh-list
93172967|NCT01188889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172968|NCT01188889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93172969|NCT01188889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172970|NCT01188889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172971|NCT01188889|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91928468|NCT02403687|Ketamine|ketamine|mesh-list
93172972|NCT01188889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93172973|NCT01188889|Immunologic Factors|immunologic factors|mesh-ancestor
93172974|NCT01188889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172975|NCT01184287|Ranpirnase|ranpirnase|mesh-list
93172976|NCT01184287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93172977|NCT01184287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93172978|NCT01184287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172979|NCT01184287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172980|NCT01107431|Chromium|chromium|mesh-list
93172981|NCT01107431|Trace Elements|trace elements|mesh-ancestor
93172982|NCT01107431|Micronutrients|micronutrients|mesh-ancestor
93172983|NCT01107431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172984|NCT01186159|Parecoxib|parecoxib|mesh-list
93172985|NCT01186159|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93172986|NCT01186159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93172987|NCT01186159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93172988|NCT01186159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93172989|NCT01186159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93172990|NCT01186159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93172991|NCT01186159|Analgesics|analgesics|mesh-ancestor
93172992|NCT01186159|Sensory System Agents|sensory system agents|mesh-ancestor
93172993|NCT01186159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93172994|NCT01186159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93172995|NCT01186159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93172996|NCT01186159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93172997|NCT01107509|Everolimus|everolimus|mesh-list
93172998|NCT01107509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93172999|NCT01107509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93173000|NCT01107509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173001|NCT01107509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173002|NCT01107509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93173003|NCT01107509|Immunologic Factors|immunologic factors|mesh-ancestor
93173004|NCT01107509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173005|NCT01107509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173006|NCT01101815|Naltrexone|naltrexone|mesh-list
93173007|NCT01101815|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93173008|NCT01101815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93173009|NCT01101815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173010|NCT01101815|Sensory System Agents|sensory system agents|mesh-ancestor
93173011|NCT01101815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173012|NCT01104935|Trastuzumab|trastuzumab|mesh-list
92845192|NCT05663658|Morphine|morphine|mesh-list
93173013|NCT01104935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173014|NCT01104935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173015|NCT01293643|Clindamycin|clindamycin|mesh-list
93173016|NCT01293643|Clindamycin palmitate|clindamycin palmitate|mesh-list
93173017|NCT01293643|Clindamycin phosphate|clindamycin phosphate|mesh-list
93173018|NCT01293643|Amphotericin B|amphotericin b|mesh-list
93173019|NCT01293643|Tetracycline|tetracycline|mesh-list
93173020|NCT01293643|Ketoconazole|ketoconazole|mesh-list
93173021|NCT01293643|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93173022|NCT01293643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173023|NCT01293643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173024|NCT01293643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93173025|NCT01293643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173026|NCT01293643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173027|NCT01293643|Antifungal Agents|antifungal agents|mesh-ancestor
93173028|NCT01293643|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93173029|NCT01293643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173030|NCT01293643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93173031|NCT01293643|Hormone Antagonists|hormone antagonists|mesh-ancestor
93173032|NCT01293643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173033|NCT01293643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173034|NCT01293643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93173035|NCT01293643|Amebicides|amebicides|mesh-ancestor
93173036|NCT01293643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93173037|NCT01293643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93173038|NCT01105013|Clotrimazole|clotrimazole|mesh-list
93173039|NCT01105013|Miconazole|miconazole|mesh-list
93173040|NCT01105013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93173041|NCT01105013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173042|NCT01105013|Antifungal Agents|antifungal agents|mesh-ancestor
93173043|NCT01105013|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93173044|NCT01105013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173045|NCT01105013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173046|NCT01105013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173047|NCT01105013|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93173048|NCT01105013|Hormone Antagonists|hormone antagonists|mesh-ancestor
93173049|NCT01105013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173050|NCT01105013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173051|NCT01105013|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93173052|NCT01105013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93173053|NCT03851731|Naltrexone|naltrexone|mesh-list
93173054|NCT03851731|Naloxone|naloxone|mesh-list
93173055|NCT03851731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93173056|NCT03851731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93173057|NCT03851731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173058|NCT03851731|Sensory System Agents|sensory system agents|mesh-ancestor
93173059|NCT03851731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173060|NCT03707652|Vitamins|vitamins|mesh-list
93173061|NCT03707652|Niacinamide|niacinamide|mesh-list
93173062|NCT03707652|Niacin|niacin|mesh-list
93173063|NCT03707652|Nicotinic Acids|nicotinic acids|mesh-list
93173064|NCT03707652|Vitamin B Complex|vitamin b complex|mesh-list
93173065|NCT03707652|Micronutrients|micronutrients|mesh-ancestor
93173066|NCT03707652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173067|NCT03707652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93173068|NCT03707652|Antimetabolites|antimetabolites|mesh-ancestor
93173069|NCT03707652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173070|NCT03707652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93173071|NCT03707652|Vasodilator Agents|vasodilator agents|mesh-ancestor
93173072|NCT01588093|Mecasermin|mecasermin|mesh-list
93173073|NCT01588093|Growth Substances|growth substances|mesh-ancestor
93173074|NCT01588093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173075|NCT01186471|Nicotine|nicotine|mesh-list
93173076|NCT01186471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93173077|NCT01186471|Autonomic Agents|autonomic agents|mesh-ancestor
93173078|NCT01186471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173079|NCT01186471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173080|NCT01186471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93173081|NCT01186471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93173082|NCT01186471|Cholinergic Agents|cholinergic agents|mesh-ancestor
93173083|NCT01186471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173084|NCT01186471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173085|NCT01292551|Bosentan|bosentan|mesh-list
93173086|NCT01292551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93173087|NCT01292551|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93173088|NCT01292551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173090|NCT03854383|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93173091|NCT03854383|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93173092|NCT03854383|Misoprostol|misoprostol|mesh-list
93173093|NCT03854383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93173094|NCT03854383|Abortifacient Agents|abortifacient agents|mesh-ancestor
93173095|NCT03854383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93173096|NCT03854383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173097|NCT03854383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93173098|NCT03854383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173099|NCT03854383|Oxytocics|oxytocics|mesh-ancestor
93173100|NCT03854383|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93173101|NCT03854383|Diuretics|diuretics|mesh-ancestor
93173102|NCT03854383|Natriuretic Agents|natriuretic agents|mesh-ancestor
93173103|NCT03854383|Vasodilator Agents|vasodilator agents|mesh-ancestor
93173104|NCT03854383|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93173105|NCT03854383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173106|NCT03854617|Vinorelbine|vinorelbine|mesh-list
93173107|NCT03854617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93173108|NCT03854617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173109|NCT03854617|Tubulin Modulators|tubulin modulators|mesh-ancestor
93173110|NCT03854617|Antimitotic Agents|antimitotic agents|mesh-ancestor
93173111|NCT03854617|Mitosis Modulators|mitosis modulators|mesh-ancestor
93173112|NCT03854617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173113|NCT01186549|Lidocaine|lidocaine|mesh-list
93173114|NCT01186549|Ephedrine|ephedrine|mesh-list
93173115|NCT01186549|Pseudoephedrine|pseudoephedrine|mesh-list
93173116|NCT01186549|Anesthetics, Local|anesthetics, local|mesh-ancestor
93173117|NCT01186549|Anesthetics|anesthetics|mesh-ancestor
93173118|NCT01186549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173119|NCT01186549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173120|NCT01186549|Sensory System Agents|sensory system agents|mesh-ancestor
93173121|NCT01186549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928469|NCT02403687|Gabapentin|gabapentin|mesh-list
93173122|NCT01186549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93173123|NCT01186549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93173124|NCT01186549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93173125|NCT01186549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173126|NCT01186549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173127|NCT01186549|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93173128|NCT01186549|Sympathomimetics|sympathomimetics|mesh-ancestor
93173129|NCT01186549|Autonomic Agents|autonomic agents|mesh-ancestor
93173130|NCT01186549|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93173131|NCT01186549|Adrenergic Agents|adrenergic agents|mesh-ancestor
93173132|NCT01186549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173133|NCT01186549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93173134|NCT01186549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93173135|NCT01186549|Respiratory System Agents|respiratory system agents|mesh-ancestor
93173136|NCT01186549|Nasal Decongestants|nasal decongestants|mesh-ancestor
93173137|NCT03851341|Metformin|metformin|mesh-list
93173138|NCT03851341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93173139|NCT03851341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93173140|NCT03851341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173141|NCT03851341|Incretins|incretins|mesh-ancestor
93173142|NCT03851341|Hormones|hormones|mesh-ancestor
93173143|NCT03851341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173144|NCT03851341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93173145|NCT03851341|Protease Inhibitors|protease inhibitors|mesh-ancestor
93173146|NCT03851341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173147|NCT03851341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173148|NCT04788108|Dydrogesterone|dydrogesterone|mesh-list
93173149|NCT04788108|Progestins|progestins|mesh-ancestor
93173150|NCT04788108|Hormones|hormones|mesh-ancestor
93173151|NCT04788108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173152|NCT04788108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173153|NCT03362190|Ranibizumab|ranibizumab|mesh-list
93173154|NCT03362190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93173155|NCT03362190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93173156|NCT03362190|Growth Substances|growth substances|mesh-ancestor
93173157|NCT03362190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173158|NCT03362190|Growth Inhibitors|growth inhibitors|mesh-ancestor
93173159|NCT03362190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173160|NCT01292785|Hormones|hormones|mesh-list
93173161|NCT01292785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173162|NCT01292785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173163|NCT02323126|Nivolumab|nivolumab|mesh-list
93173164|NCT02323126|Nazartinib|nazartinib|mesh-list
93173165|NCT02323126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173166|NCT02323126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173167|NCT02323126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93173168|NCT02323126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173169|NCT01291459|Tenofovir|tenofovir|mesh-list
93173170|NCT01291459|Emtricitabine|emtricitabine|mesh-list
93173171|NCT01291459|Raltegravir Potassium|raltegravir potassium|mesh-list
93173172|NCT01291459|Maraviroc|maraviroc|mesh-list
93173173|NCT01291459|Antiviral Agents|antiviral agents|mesh-ancestor
93173174|NCT01291459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173175|NCT01291459|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93173176|NCT01291459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93173177|NCT01291459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173178|NCT01291459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173179|NCT01291459|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93173180|NCT01291459|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93173181|NCT01291459|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93173182|NCT01291459|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93173183|NCT01291459|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93173184|NCT01291459|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93173185|NCT01291459|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93173186|NCT00003377|Paclitaxel|paclitaxel|mesh-list
93173187|NCT00003377|Cisplatin|cisplatin|mesh-list
93173188|NCT00003377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93173189|NCT00003377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173190|NCT00003377|Tubulin Modulators|tubulin modulators|mesh-ancestor
93173191|NCT00003377|Antimitotic Agents|antimitotic agents|mesh-ancestor
93173192|NCT00003377|Mitosis Modulators|mitosis modulators|mesh-ancestor
93173193|NCT00003377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173194|NCT01291537|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93173195|NCT01291537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93173196|NCT01291537|Immunologic Factors|immunologic factors|mesh-ancestor
93173197|NCT01291537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173198|NCT01291537|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93173199|NCT01291537|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93173200|NCT01291537|Dopamine Agonists|dopamine agonists|mesh-ancestor
93173201|NCT01291537|Dopamine Agents|dopamine agents|mesh-ancestor
93173202|NCT01291537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173203|NCT01291537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173204|NCT01328015|Oxybutynin|oxybutynin|mesh-list
93173205|NCT01328015|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93173206|NCT01328015|Parasympatholytics|parasympatholytics|mesh-ancestor
93173207|NCT01328015|Autonomic Agents|autonomic agents|mesh-ancestor
93173208|NCT01328015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173209|NCT01328015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173210|NCT01328015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93173211|NCT01328015|Cholinergic Agents|cholinergic agents|mesh-ancestor
93173212|NCT01328015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173213|NCT01328015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173214|NCT01328015|Urological Agents|urological agents|mesh-ancestor
93173215|NCT01101893|Raltegravir Potassium|raltegravir potassium|mesh-list
93173216|NCT01101893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93173217|NCT01101893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93173218|NCT01101893|Antiviral Agents|antiviral agents|mesh-ancestor
93173219|NCT01101893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173220|NCT01101893|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93173221|NCT01101893|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93173222|NCT01101893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173223|NCT01101893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173224|NCT01292863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93173225|NCT01292863|Dialysis Solutions|dialysis solutions|mesh-list
93173226|NCT00002651|Goserelin|goserelin|mesh-list
93173227|NCT00002651|Bicalutamide|bicalutamide|mesh-list
93173228|NCT00002651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93173229|NCT00002651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173230|NCT00002651|Androgen Antagonists|androgen antagonists|mesh-ancestor
93173231|NCT00002651|Hormone Antagonists|hormone antagonists|mesh-ancestor
93173232|NCT00002651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173233|NCT00002651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173234|NCT03853993|Vaccines|vaccines|mesh-list
93173235|NCT03853993|Immunologic Factors|immunologic factors|mesh-ancestor
93173236|NCT03853993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173237|NCT03473626|Alicaforsen|alicaforsen|mesh-list
93173238|NCT03473626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173239|NCT03473626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93173240|NCT03473626|Immunologic Factors|immunologic factors|mesh-ancestor
93173241|NCT03473626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173242|NCT05154682|Acetaminophen|acetaminophen|mesh-list
93173243|NCT05154682|Naproxen|naproxen|mesh-list
93173244|NCT05154682|Oxycodone|oxycodone|mesh-list
93173245|NCT05154682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93173246|NCT05154682|Analgesics|analgesics|mesh-ancestor
93173247|NCT05154682|Sensory System Agents|sensory system agents|mesh-ancestor
93173248|NCT05154682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173249|NCT05154682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173250|NCT05154682|Antipyretics|antipyretics|mesh-ancestor
93173251|NCT05154682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93173252|NCT05154682|Narcotics|narcotics|mesh-ancestor
93173253|NCT05154682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173254|NCT05154682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93173255|NCT05154682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93173256|NCT05154682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93173257|NCT05154682|Gout Suppressants|gout suppressants|mesh-ancestor
93173258|NCT05154682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93173259|NCT05154682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173260|NCT05154682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173261|NCT04312841|Acetic Acid|acetic acid|mesh-list
93173262|NCT04312841|Letermovir|letermovir|mesh-list
93173263|NCT04312841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173264|NCT04312841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173265|NCT04312841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173266|NCT04312841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173267|NCT04312841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173268|NCT04312841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93173269|NCT04312841|Antiviral Agents|antiviral agents|mesh-ancestor
93173270|NCT01294735|Temozolomide|temozolomide|mesh-list
93173271|NCT01294735|Niraparib|niraparib|mesh-list
93173272|NCT01294735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93173273|NCT01294735|Alkylating Agents|alkylating agents|mesh-ancestor
93173274|NCT01294735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173275|NCT01294735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173276|NCT01294735|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93173277|NCT01294735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173278|NCT03851263|Evolocumab|evolocumab|mesh-list
93173279|NCT03851263|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93173280|NCT03851263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93173281|NCT03851263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93173282|NCT03851263|Antimetabolites|antimetabolites|mesh-ancestor
93173283|NCT03851263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173284|NCT03851263|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93173285|NCT03851263|Protease Inhibitors|protease inhibitors|mesh-ancestor
93173286|NCT03851263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173287|NCT03851263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93173288|NCT03849235|Glucagon|glucagon|mesh-list
93173289|NCT03849235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173290|NCT03849235|Hormones|hormones|mesh-ancestor
93173291|NCT03849235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173292|NCT03849235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173293|NCT03477448|Bleomycin|bleomycin|mesh-list
93173294|NCT03477448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93173295|NCT03477448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173296|NCT01187485|Methyltestosterone|methyltestosterone|mesh-list
93173297|NCT01187485|Testosterone|testosterone|mesh-list
93173298|NCT01187485|Testosterone undecanoate|testosterone undecanoate|mesh-list
93173299|NCT01187485|Testosterone enanthate|testosterone enanthate|mesh-list
93173300|NCT01187485|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93173301|NCT01187485|Androgens|androgens|mesh-ancestor
93173302|NCT01187485|Hormones|hormones|mesh-ancestor
93173303|NCT01187485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173304|NCT01187485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173305|NCT01187485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93173306|NCT01187485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173307|NCT01187485|Anabolic Agents|anabolic agents|mesh-ancestor
93173308|NCT00002597|Leuprolide|leuprolide|mesh-list
93173309|NCT00002597|Goserelin|goserelin|mesh-list
93173310|NCT00002597|Flutamide|flutamide|mesh-list
93173311|NCT00002597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93173312|NCT00002597|Fertility Agents|fertility agents|mesh-ancestor
93173313|NCT00002597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93173314|NCT00002597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173315|NCT00002597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93173316|NCT00002597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173317|NCT00002597|Androgen Antagonists|androgen antagonists|mesh-ancestor
93173318|NCT00002597|Hormone Antagonists|hormone antagonists|mesh-ancestor
93173319|NCT00002597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173320|NCT03853525|Petrolatum|petrolatum|mesh-list
93173321|NCT03853525|Emollients|emollients|mesh-ancestor
93173322|NCT03853525|Dermatologic Agents|dermatologic agents|mesh-ancestor
93173323|NCT03716583|Melatonin|melatonin|mesh-list
93173324|NCT03716583|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93173325|NCT03716583|Antioxidants|antioxidants|mesh-ancestor
93173326|NCT03716583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173327|NCT03716583|Protective Agents|protective agents|mesh-ancestor
93173328|NCT03716583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173329|NCT03716583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173330|NCT03716583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93173331|NCT03716583|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93173332|NCT02738008|Tenofovir|tenofovir|mesh-list
93173333|NCT02738008|Entecavir|entecavir|mesh-list
93173334|NCT02738008|Histamine Antagonists|histamine antagonists|mesh-list
93173335|NCT02738008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93173336|NCT02738008|Antiviral Agents|antiviral agents|mesh-ancestor
93173337|NCT02738008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173338|NCT02738008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93173339|NCT02738008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93173340|NCT02738008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173341|NCT02738008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173342|NCT02738008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93173343|NCT02738008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93173344|NCT02738008|Histamine Agents|histamine agents|mesh-ancestor
93173345|NCT02738008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855186|NCT00782067|Midostaurin|midostaurin|mesh-list
93173346|NCT02738008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173347|NCT03720249|Vitamins|vitamins|mesh-list
93173348|NCT03720249|Vitamin B 12|vitamin b 12|mesh-list
93173349|NCT03720249|Vitamin B 6|vitamin b 6|mesh-list
93173350|NCT03720249|Vitamin B Complex|vitamin b complex|mesh-list
93173351|NCT03720249|Betaine|betaine|mesh-list
93173352|NCT03720249|Micronutrients|micronutrients|mesh-ancestor
93173353|NCT03720249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173354|NCT03720249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173355|NCT03720249|Lipotropic Agents|lipotropic agents|mesh-ancestor
93173356|NCT03720249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93173357|NCT03720249|Antimetabolites|antimetabolites|mesh-ancestor
93173358|NCT03720249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173359|NCT03720249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93173360|NCT01294969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93173361|NCT01294969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93173362|NCT01294969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93173363|NCT01294969|Analgesics|analgesics|mesh-ancestor
93173364|NCT01294969|Sensory System Agents|sensory system agents|mesh-ancestor
93173365|NCT01294969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173366|NCT01294969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173367|NCT01294969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93173368|NCT01294969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93173369|NCT01294969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93173370|NCT01294969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93173371|NCT01294969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93173372|NCT01294969|Histamine Antagonists|histamine antagonists|mesh-ancestor
93173373|NCT01294969|Histamine Agents|histamine agents|mesh-ancestor
93173374|NCT01294969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173375|NCT01294969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173376|NCT03850561|Ubiquinone|ubiquinone|mesh-list
93173377|NCT03850561|Coenzyme Q10|coenzyme q10|mesh-list
93173378|NCT03850561|Micronutrients|micronutrients|mesh-ancestor
93173379|NCT03850561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173380|NCT03850561|Vitamins|vitamins|mesh-ancestor
93173381|NCT01190137|Cholecalciferol|cholecalciferol|mesh-list
93173382|NCT01190137|Vitamin D|vitamin d|mesh-list
93173383|NCT01190137|Ergocalciferols|ergocalciferols|mesh-list
93173384|NCT01190137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93173385|NCT01190137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173386|NCT01190137|Vitamins|vitamins|mesh-ancestor
93173387|NCT01190137|Micronutrients|micronutrients|mesh-ancestor
93173388|NCT01190137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93173389|NCT02529839|Cyclophosphamide|cyclophosphamide|mesh-list
93173390|NCT02529839|Fludarabine|fludarabine|mesh-list
93173391|NCT02529839|Alemtuzumab|alemtuzumab|mesh-list
93173392|NCT02529839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93173393|NCT02529839|Immunologic Factors|immunologic factors|mesh-ancestor
93173394|NCT02529839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173395|NCT02529839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93173396|NCT02529839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93173397|NCT02529839|Alkylating Agents|alkylating agents|mesh-ancestor
93173398|NCT02529839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173399|NCT02529839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173400|NCT02529839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93173401|NCT02529839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173402|NCT03473314|Nitric Oxide|nitric oxide|mesh-list
93173403|NCT03473314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93173404|NCT03473314|Autonomic Agents|autonomic agents|mesh-ancestor
93173405|NCT03473314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173406|NCT03473314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173407|NCT03473314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93173408|NCT03473314|Respiratory System Agents|respiratory system agents|mesh-ancestor
93173409|NCT03473314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93173410|NCT03473314|Antioxidants|antioxidants|mesh-ancestor
93173411|NCT03473314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173412|NCT03473314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173413|NCT03473314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93173414|NCT03473314|Vasodilator Agents|vasodilator agents|mesh-ancestor
93173415|NCT03473314|Gasotransmitters|gasotransmitters|mesh-ancestor
93173416|NCT03473314|Protective Agents|protective agents|mesh-ancestor
93173417|NCT03945539|Itraconazole|itraconazole|mesh-list
93173418|NCT03945539|JNJ-56136379|jnj-56136379|mesh-list
93173419|NCT03945539|Antifungal Agents|antifungal agents|mesh-ancestor
93173420|NCT03945539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173421|NCT03945539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93173422|NCT03945539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173423|NCT03945539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173424|NCT03945539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173425|NCT03945539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93173426|NCT03945539|Hormone Antagonists|hormone antagonists|mesh-ancestor
93173427|NCT03945539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173428|NCT03945539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173429|NCT03945539|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93173430|NCT03945539|Antiviral Agents|antiviral agents|mesh-ancestor
93173431|NCT01190293|Efavirenz|efavirenz|mesh-list
93173432|NCT01190293|Maraviroc|maraviroc|mesh-list
93173433|NCT01190293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93173434|NCT01190293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93173435|NCT01190293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173436|NCT01190293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173437|NCT01190293|Antiviral Agents|antiviral agents|mesh-ancestor
93173438|NCT01190293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173439|NCT01190293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93173440|NCT01190293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173441|NCT01190293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93173442|NCT01190293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93173443|NCT01190293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93173444|NCT01190293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93173445|NCT01190293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93173446|NCT01190293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93173447|NCT01190293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93173448|NCT01190293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93173449|NCT01190293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93173450|NCT03945227|Spartalizumab|spartalizumab|mesh-list
93173451|NCT03945227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93173452|NCT03945227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173453|NCT03945227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173454|NCT03945227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173455|NCT01108133|Dexamethasone|dexamethasone|mesh-list
93173456|NCT01108133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93173457|NCT01108133|Antiemetics|antiemetics|mesh-ancestor
93173458|NCT01108133|Autonomic Agents|autonomic agents|mesh-ancestor
93173459|NCT01108133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173460|NCT01108133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173461|NCT01108133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92845642|NCT04324463|Aspirin|aspirin|mesh-list
93173462|NCT01108133|Glucocorticoids|glucocorticoids|mesh-ancestor
93173463|NCT01108133|Hormones|hormones|mesh-ancestor
93173464|NCT01108133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173465|NCT01108133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93173466|NCT01108133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173467|NCT01108289|Oxytocin|oxytocin|mesh-list
93173468|NCT01108289|Oxytocics|oxytocics|mesh-ancestor
93173469|NCT01108289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93173470|NCT01108289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173471|NCT03947489|Sarpogrelate|sarpogrelate|mesh-list
93173472|NCT03947489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93173473|NCT03947489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93173474|NCT03947489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173475|NCT03947489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93173476|NCT03947489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93173477|NCT03947489|Serotonin Agents|serotonin agents|mesh-ancestor
93173478|NCT03947489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173479|NCT03947489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173480|NCT03947411|Oseltamivir|oseltamivir|mesh-list
93173481|NCT03947411|Antiviral Agents|antiviral agents|mesh-ancestor
93173482|NCT03947411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173483|NCT03947411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173484|NCT03947411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173485|NCT03257254|Polidocanol|polidocanol|mesh-list
93173486|NCT03257254|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93173487|NCT03257254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93173488|NCT01327469|Albendazole|albendazole|mesh-list
93173489|NCT01327469|Mebendazole|mebendazole|mesh-list
93173490|NCT01327469|Piperazine|piperazine|mesh-list
93173491|NCT01327469|Piperazine citrate|piperazine citrate|mesh-list
93173492|NCT01327469|Pyrantel|pyrantel|mesh-list
93173493|NCT01327469|Oxantel|oxantel|mesh-list
93173494|NCT01327469|DMP 777|dmp 777|mesh-list
93173495|NCT01327469|Anthelmintics|anthelmintics|mesh-ancestor
93173496|NCT01327469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93173497|NCT01327469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173498|NCT01327469|Anticestodal Agents|anticestodal agents|mesh-ancestor
93173499|NCT01327469|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93173500|NCT01327469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93173501|NCT01327469|Tubulin Modulators|tubulin modulators|mesh-ancestor
93173502|NCT01327469|Antimitotic Agents|antimitotic agents|mesh-ancestor
93173503|NCT01327469|Mitosis Modulators|mitosis modulators|mesh-ancestor
93173504|NCT01327469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173505|NCT01327469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173506|NCT01327469|Antinematodal Agents|antinematodal agents|mesh-ancestor
93173507|NCT01327469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173508|NCT01327469|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93173509|NCT01327469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93173510|NCT01327469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93173511|NCT01327469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173512|NCT01327469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173513|NCT03950141|Apatinib|apatinib|mesh-list
93173514|NCT03950141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173515|NCT03950141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93173516|NCT03950141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173517|NCT03950141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173518|NCT01108601|Ciprofloxacin|ciprofloxacin|mesh-list
93173519|NCT01108601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173520|NCT01108601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173521|NCT01108601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93173522|NCT01108601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93173523|NCT01108601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173524|NCT01108601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173525|NCT01108601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173526|NCT01108601|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93173527|NCT01108601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173528|NCT03084718|Beclomethasone|beclomethasone|mesh-list
93173529|NCT03084718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93173530|NCT03084718|Glucocorticoids|glucocorticoids|mesh-ancestor
93173531|NCT03084718|Hormones|hormones|mesh-ancestor
93173532|NCT03084718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173533|NCT03084718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173534|NCT03084718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93173535|NCT03084718|Respiratory System Agents|respiratory system agents|mesh-ancestor
93173536|NCT02938624|Pembrolizumab|pembrolizumab|mesh-list
92845711|NCT04083170|Vidarabine|vidarabine|mesh-list
93173537|NCT02938624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173538|NCT02938624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173539|NCT02938624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93173540|NCT02938624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173541|NCT03469804|Pembrolizumab|pembrolizumab|mesh-list
93173542|NCT03469804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173543|NCT03469804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173544|NCT03469804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93173545|NCT03469804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173546|NCT03944291|Bupivacaine|bupivacaine|mesh-list
93173547|NCT03944291|Anesthetics, Local|anesthetics, local|mesh-ancestor
93173548|NCT03944291|Anesthetics|anesthetics|mesh-ancestor
93173549|NCT03944291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173550|NCT03944291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173551|NCT03944291|Sensory System Agents|sensory system agents|mesh-ancestor
93173552|NCT03944291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173553|NCT03067571|Daratumumab|daratumumab|mesh-list
93173554|NCT03067571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173555|NCT01102439|Aspirin|aspirin|mesh-list
93173556|NCT01102439|Clopidogrel|clopidogrel|mesh-list
93173557|NCT01102439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93173558|NCT01102439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93173559|NCT01102439|Analgesics|analgesics|mesh-ancestor
93173560|NCT01102439|Sensory System Agents|sensory system agents|mesh-ancestor
93173561|NCT01102439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173562|NCT01102439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173563|NCT01102439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93173564|NCT01102439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93173565|NCT01102439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93173566|NCT01102439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93173567|NCT01102439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173568|NCT01102439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93173569|NCT01102439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93173570|NCT01102439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173571|NCT01102439|Antipyretics|antipyretics|mesh-ancestor
93173572|NCT01102439|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93173573|NCT01102439|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93173574|NCT01102439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93173575|NCT01102439|Purinergic Agents|purinergic agents|mesh-ancestor
93173576|NCT01102439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173577|NCT03949985|Hemostatics|hemostatics|mesh-list
93173578|NCT03949985|Contraceptive Agents|contraceptive agents|mesh-list
93173579|NCT03949985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93173580|NCT03949985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173581|NCT03949985|Coagulants|coagulants|mesh-ancestor
93173582|NCT01584791|Aspirin|aspirin|mesh-list
93173583|NCT01584791|Clopidogrel|clopidogrel|mesh-list
93173584|NCT01584791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93173585|NCT01584791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93173586|NCT01584791|Analgesics|analgesics|mesh-ancestor
93173587|NCT01584791|Sensory System Agents|sensory system agents|mesh-ancestor
93173588|NCT01584791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173589|NCT01584791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173590|NCT01584791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93173591|NCT01584791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93173592|NCT01584791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93173593|NCT01584791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93173594|NCT01584791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173595|NCT01584791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93173596|NCT01584791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93173597|NCT01584791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173598|NCT01584791|Antipyretics|antipyretics|mesh-ancestor
93173599|NCT01584791|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93173600|NCT01584791|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93173601|NCT01584791|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93173602|NCT01584791|Purinergic Agents|purinergic agents|mesh-ancestor
93173603|NCT01584791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173604|NCT04285684|Ketamine|ketamine|mesh-list
93173605|NCT04285684|Analgesics|analgesics|mesh-ancestor
93173606|NCT04285684|Sensory System Agents|sensory system agents|mesh-ancestor
93173607|NCT04285684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173608|NCT04285684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173609|NCT04285684|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93173610|NCT04285684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93173611|NCT04285684|Anesthetics, General|anesthetics, general|mesh-ancestor
93173612|NCT04285684|Anesthetics|anesthetics|mesh-ancestor
93173613|NCT04285684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173614|NCT04285684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93173615|NCT04285684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93173616|NCT04285684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173617|NCT04285684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173618|NCT01310985|Capecitabine|capecitabine|mesh-list
93173619|NCT01310985|Cetuximab|cetuximab|mesh-list
93173620|NCT01310985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93173621|NCT01310985|Antimetabolites|antimetabolites|mesh-ancestor
93173622|NCT01310985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173623|NCT01310985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173624|NCT01310985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173625|NCT03433677|Insulin Lispro|insulin lispro|mesh-list
93173626|NCT03433677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93173627|NCT03433677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173628|NCT02492711|Trastuzumab|trastuzumab|mesh-list
93173629|NCT02492711|Margetuximab|margetuximab|mesh-list
93173630|NCT02492711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173631|NCT02492711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173632|NCT03716427|Tolbutamide|tolbutamide|mesh-list
93173633|NCT03716427|Midazolam|midazolam|mesh-list
93173634|NCT03716427|Dextromethorphan|dextromethorphan|mesh-list
93173635|NCT03716427|Omeprazole|omeprazole|mesh-list
93173636|NCT03716427|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93173637|NCT03716427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93173638|NCT03716427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173639|NCT03716427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173640|NCT03716427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93173641|NCT03716427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93173642|NCT03716427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93173643|NCT03716427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93173644|NCT03716427|Anesthetics, General|anesthetics, general|mesh-ancestor
93173645|NCT03716427|Anesthetics|anesthetics|mesh-ancestor
93173646|NCT03716427|GABA Modulators|gaba modulators|mesh-ancestor
93173647|NCT03716427|GABA Agents|gaba agents|mesh-ancestor
93173648|NCT03716427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173649|NCT03716427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173650|NCT03716427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93173651|NCT03716427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173652|NCT03716427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93173653|NCT03716427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173654|NCT03716427|Antitussive Agents|antitussive agents|mesh-ancestor
93173655|NCT03716427|Respiratory System Agents|respiratory system agents|mesh-ancestor
93173656|NCT03716427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93173657|NCT03716427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93173658|NCT03716427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93173659|NCT01147822|Sunitinib|sunitinib|mesh-list
93173660|NCT01147822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173661|NCT01147822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93173662|NCT01147822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93173663|NCT01147822|Growth Substances|growth substances|mesh-ancestor
93173664|NCT01147822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173665|NCT01147822|Growth Inhibitors|growth inhibitors|mesh-ancestor
93173666|NCT01147822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93173667|NCT01147822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173668|NCT01147822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173669|NCT03431337|Amoxicillin|amoxicillin|mesh-list
93173670|NCT03431337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173671|NCT03431337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173672|NCT01293097|Atorvastatin|atorvastatin|mesh-list
93173673|NCT01293097|Pravastatin|pravastatin|mesh-list
93173674|NCT01293097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93173675|NCT01293097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93173676|NCT01293097|Antimetabolites|antimetabolites|mesh-ancestor
93173677|NCT01293097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173678|NCT01293097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93173679|NCT01293097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93173680|NCT01293097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173681|NCT03516292|Mitogens|mitogens|mesh-list
93173682|NCT03516292|Mitosis Modulators|mitosis modulators|mesh-ancestor
93173683|NCT03516292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173684|NCT01291615|Gemcitabine|gemcitabine|mesh-list
93173685|NCT01291615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93173686|NCT01291615|Antimetabolites|antimetabolites|mesh-ancestor
93173687|NCT01291615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173688|NCT01291615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173690|NCT01295047|Verapamil|verapamil|mesh-list
93173691|NCT01295047|Perindopril|perindopril|mesh-list
93173692|NCT01295047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93173693|NCT01295047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93173694|NCT01295047|Sympatholytics|sympatholytics|mesh-ancestor
93173695|NCT01295047|Autonomic Agents|autonomic agents|mesh-ancestor
93173696|NCT01295047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173697|NCT01295047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173698|NCT01295047|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93173699|NCT01295047|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93173700|NCT01295047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93173701|NCT01295047|Adrenergic Agents|adrenergic agents|mesh-ancestor
93173702|NCT01295047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173703|NCT01295047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173704|NCT01295047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93173705|NCT01295047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173706|NCT01295047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93173707|NCT01295047|Vasodilator Agents|vasodilator agents|mesh-ancestor
93173708|NCT01295047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93173709|NCT01295047|Protease Inhibitors|protease inhibitors|mesh-ancestor
93173710|NCT01295047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173711|NCT03472846|Teriparatide|teriparatide|mesh-list
93173712|NCT03472846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93173713|NCT03472846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173714|NCT03472846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93173715|NCT01190371|Artesunate|artesunate|mesh-list
93173716|NCT01190371|Antimalarials|antimalarials|mesh-ancestor
93173717|NCT01190371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93173718|NCT01190371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93173719|NCT01190371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173720|NCT01190371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173721|NCT01190371|Antiviral Agents|antiviral agents|mesh-ancestor
93173722|NCT01190371|Schistosomicides|schistosomicides|mesh-ancestor
93173723|NCT01190371|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93173724|NCT01190371|Anthelmintics|anthelmintics|mesh-ancestor
93173725|NCT05158426|Propofol|propofol|mesh-list
93173726|NCT05158426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93173727|NCT05158426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173728|NCT05158426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173729|NCT05158426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93173730|NCT05158426|Anesthetics, General|anesthetics, general|mesh-ancestor
93173731|NCT05158426|Anesthetics|anesthetics|mesh-ancestor
93173732|NCT03853369|Nifekalant|nifekalant|mesh-list
93173733|NCT03853369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93173734|NCT05158348|Lidocaine|lidocaine|mesh-list
93173735|NCT05158348|Dexmedetomidine|dexmedetomidine|mesh-list
93173736|NCT05158348|Anesthetics, Local|anesthetics, local|mesh-ancestor
93173737|NCT05158348|Anesthetics|anesthetics|mesh-ancestor
93173738|NCT05158348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173739|NCT05158348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173740|NCT05158348|Sensory System Agents|sensory system agents|mesh-ancestor
93173741|NCT05158348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173742|NCT05158348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93173743|NCT05158348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93173744|NCT05158348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93173745|NCT05158348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173746|NCT05158348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173747|NCT05158348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93173748|NCT05158348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93173749|NCT05158348|Analgesics|analgesics|mesh-ancestor
93173750|NCT05158348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93173751|NCT05158348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93173752|NCT05158348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93173753|NCT05158348|Adrenergic Agents|adrenergic agents|mesh-ancestor
93173754|NCT05158348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173755|NCT01187719|Phenytoin|phenytoin|mesh-list
93173756|NCT01187719|Anticonvulsants|anticonvulsants|mesh-ancestor
93173757|NCT01187719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93173758|NCT01187719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93173759|NCT01187719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173760|NCT01187719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173761|NCT01187719|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93173762|NCT01187719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93173764|NCT01102595|Temozolomide|temozolomide|mesh-list
93173765|NCT01102595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173766|NCT01102595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173767|NCT01102595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93173768|NCT01102595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93173769|NCT01102595|Growth Substances|growth substances|mesh-ancestor
93173770|NCT01102595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173771|NCT01102595|Growth Inhibitors|growth inhibitors|mesh-ancestor
93173772|NCT01102595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93173773|NCT01102595|Alkylating Agents|alkylating agents|mesh-ancestor
93173774|NCT01102595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173775|NCT03949517|Piperidine|piperidine|mesh-list
93173776|NCT03949517|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93173777|NCT03949517|Bombesin|bombesin|mesh-list
93173778|NCT03949517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173779|NCT03949517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93173780|NCT03949517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173781|NCT03949517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173782|NCT03949517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93173783|NCT03949517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173784|NCT03949517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93173785|NCT03848611|Vorolanib|vorolanib|mesh-list
93173786|NCT03848611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93173787|NCT03848611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173788|NCT03848611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173789|NCT01584947|Bupivacaine|bupivacaine|mesh-list
93173790|NCT01584947|Anesthetics, Local|anesthetics, local|mesh-ancestor
93173791|NCT01584947|Anesthetics|anesthetics|mesh-ancestor
93173792|NCT01584947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173793|NCT01584947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173794|NCT01584947|Sensory System Agents|sensory system agents|mesh-ancestor
93173795|NCT01584947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173796|NCT03848767|Insulin Lispro|insulin lispro|mesh-list
93173797|NCT03848767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93173798|NCT03848767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173799|NCT01109615|Gemcitabine|gemcitabine|mesh-list
93173800|NCT01109615|Pemetrexed|pemetrexed|mesh-list
93173801|NCT01109615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93173802|NCT01109615|Antimetabolites|antimetabolites|mesh-ancestor
93173803|NCT01109615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173804|NCT01109615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173805|NCT01109615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173806|NCT01109615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93173807|NCT01109615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93173808|NCT01209065|Ritonavir|ritonavir|mesh-list
93173809|NCT01209065|Fosamprenavir|fosamprenavir|mesh-list
93173810|NCT01209065|Dolutegravir|dolutegravir|mesh-list
93173811|NCT01209065|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93173812|NCT01209065|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93173813|NCT01209065|Protease Inhibitors|protease inhibitors|mesh-ancestor
93173814|NCT01209065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173815|NCT01209065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173816|NCT01209065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93173817|NCT01209065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93173818|NCT01209065|Antiviral Agents|antiviral agents|mesh-ancestor
93173819|NCT01209065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173820|NCT01209065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93173821|NCT01209065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173822|NCT01209065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93173823|NCT01209065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93173824|NCT02782702|Botulinum Toxins|botulinum toxins|mesh-list
93173825|NCT02782702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93173826|NCT02782702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173827|NCT02782702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173828|NCT02782702|Cholinergic Agents|cholinergic agents|mesh-ancestor
93173829|NCT02782702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173830|NCT02782702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173831|NCT01102673|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93173832|NCT01102673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173833|NCT01102673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173835|NCT03481725|Keratolytic Agents|keratolytic agents|mesh-ancestor
93173836|NCT03481725|Dermatologic Agents|dermatologic agents|mesh-ancestor
93173837|NCT03472456|Eugenol|eugenol|mesh-list
93173838|NCT03472456|Carticaine|carticaine|mesh-list
93173839|NCT03472456|Anesthetics, Local|anesthetics, local|mesh-ancestor
93173840|NCT03472456|Anesthetics|anesthetics|mesh-ancestor
93173841|NCT03472456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173842|NCT03472456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173843|NCT03472456|Sensory System Agents|sensory system agents|mesh-ancestor
93173844|NCT03472456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173845|NCT03472456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173846|NCT01193881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93173847|NCT01193881|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93173848|NCT01193881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93173849|NCT01193881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173850|NCT01193881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93173851|NCT01193881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173852|NCT01193881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173853|NCT01194037|Interferons|interferons|mesh-list
93173854|NCT01194037|Interferon-alpha|interferon-alpha|mesh-list
93173855|NCT01194037|Interferon alpha-2|interferon alpha-2|mesh-list
93173856|NCT01194037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93173857|NCT01194037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173858|NCT01194037|Antiviral Agents|antiviral agents|mesh-ancestor
93173859|NCT01194037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173860|NCT01194037|Immunologic Factors|immunologic factors|mesh-ancestor
93173861|NCT01194037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173862|NCT03480243|Erythromycin|erythromycin|mesh-list
93173863|NCT03480243|Erythromycin Estolate|erythromycin estolate|mesh-list
93173864|NCT03480243|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93173865|NCT03480243|Erythromycin stearate|erythromycin stearate|mesh-list
93173866|NCT03480243|Padsevonil|padsevonil|mesh-list
93173867|NCT03480243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173868|NCT03480243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173869|NCT03480243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173870|NCT03480243|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93173871|NCT03480243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173872|NCT03480243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173873|NCT03480243|Anticonvulsants|anticonvulsants|mesh-ancestor
93173874|NCT01109693|Mirtazapine|mirtazapine|mesh-list
93173875|NCT01109693|Sertraline|sertraline|mesh-list
93173876|NCT01109693|Antidepressive Agents|antidepressive agents|mesh-ancestor
93173877|NCT01109693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93173878|NCT01109693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93173879|NCT01109693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93173880|NCT01109693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93173881|NCT01109693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173882|NCT01109693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173883|NCT01109693|Serotonin Agents|serotonin agents|mesh-ancestor
93173884|NCT01109693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173885|NCT01109693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93173886|NCT01109693|Histamine Antagonists|histamine antagonists|mesh-ancestor
93173887|NCT01109693|Histamine Agents|histamine agents|mesh-ancestor
93173888|NCT01109693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93173889|NCT01109693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93173890|NCT01109693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173891|NCT01109693|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93173892|NCT01109693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93173893|NCT01109693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93173894|NCT01109693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93173895|NCT01109693|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93173896|NCT01109693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93173897|NCT01109693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93173898|NCT01190683|Calcium, Dietary|calcium, dietary|mesh-list
93173899|NCT01190683|Vitamin D|vitamin d|mesh-list
93173900|NCT01190683|Ergocalciferols|ergocalciferols|mesh-list
93173901|NCT01190683|Cholecalciferol|cholecalciferol|mesh-list
93173902|NCT01190683|Vitamins|vitamins|mesh-list
93173903|NCT01190683|Calcium Carbonate|calcium carbonate|mesh-list
93173904|NCT01190683|Calcium|calcium|mesh-list
93173905|NCT01190683|Micronutrients|micronutrients|mesh-ancestor
93173906|NCT01190683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173907|NCT01190683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93173908|NCT01190683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93173910|NCT01190683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173911|NCT01190683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173912|NCT01190761|Galantamine|galantamine|mesh-list
93173913|NCT01190761|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93173914|NCT01190761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173915|NCT01190761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173916|NCT01190761|Cholinergic Agents|cholinergic agents|mesh-ancestor
93173917|NCT01190761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173918|NCT01190761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173919|NCT01190761|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93173920|NCT01190761|Autonomic Agents|autonomic agents|mesh-ancestor
93173921|NCT01190761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173922|NCT01190761|Nootropic Agents|nootropic agents|mesh-ancestor
93173923|NCT01209455|Acetaminophen|acetaminophen|mesh-list
93173924|NCT01209455|Chlorpheniramine|chlorpheniramine|mesh-list
93173925|NCT01209455|Ranitidine|ranitidine|mesh-list
93173926|NCT01209455|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93173927|NCT01209455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93173928|NCT01209455|Analgesics|analgesics|mesh-ancestor
93173929|NCT01209455|Sensory System Agents|sensory system agents|mesh-ancestor
93173930|NCT01209455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93173931|NCT01209455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173932|NCT01209455|Antipyretics|antipyretics|mesh-ancestor
93173933|NCT01209455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93173934|NCT01209455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93173935|NCT01209455|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93173936|NCT01209455|Histamine Antagonists|histamine antagonists|mesh-ancestor
93173937|NCT01209455|Histamine Agents|histamine agents|mesh-ancestor
93173938|NCT01209455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93173939|NCT01209455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173940|NCT01209455|Antipruritics|antipruritics|mesh-ancestor
93173941|NCT01209455|Dermatologic Agents|dermatologic agents|mesh-ancestor
93173942|NCT01209455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93173943|NCT01209455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93173944|NCT01194115|Metronidazole|metronidazole|mesh-list
93173945|NCT01194115|Cephalexin|cephalexin|mesh-list
93173946|NCT01194115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173947|NCT01194115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173948|NCT01194115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93173949|NCT01194115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93173950|NCT01209533|Iloprost|iloprost|mesh-list
93173951|NCT01209533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93173952|NCT01209533|Vasodilator Agents|vasodilator agents|mesh-ancestor
93173953|NCT03847363|Anesthetics|anesthetics|mesh-list
93173954|NCT03847363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93173955|NCT03847363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173956|NCT01207739|Hydroxychloroquine|hydroxychloroquine|mesh-list
93173957|NCT01207739|Doxycycline|doxycycline|mesh-list
93173958|NCT01207739|Clarithromycin|clarithromycin|mesh-list
93173959|NCT01207739|Antimalarials|antimalarials|mesh-ancestor
93173960|NCT01207739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93173961|NCT01207739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93173962|NCT01207739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173963|NCT01207739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173964|NCT01207739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173965|NCT01207739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93173966|NCT01207739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93173967|NCT01207739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93173968|NCT01207739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93173969|NCT01207739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173970|NCT03941951|Anti-Infective Agents|anti-infective agents|mesh-list
93173971|NCT03941951|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93173972|NCT03847207|Pasireotide|pasireotide|mesh-list
93173973|NCT03847207|Hormones|hormones|mesh-ancestor
93173974|NCT03847207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173975|NCT03847207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173976|NCT01192087|Cetuximab|cetuximab|mesh-list
93173977|NCT01192087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93173978|NCT01192087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93173979|NCT03942029|Fluconazole|fluconazole|mesh-list
93173980|NCT03942029|Antifungal Agents|antifungal agents|mesh-ancestor
93173981|NCT03942029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93173982|NCT03942029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93173983|NCT03942029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93173984|NCT03942029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93173985|NCT03942029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93173986|NCT03942029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93173987|NCT03942029|Hormone Antagonists|hormone antagonists|mesh-ancestor
93173988|NCT03942029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93173989|NCT03942029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173990|NCT03942029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93173991|NCT03942029|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93173992|NCT03740945|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93173993|NCT03740945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93173994|NCT03740945|Immunologic Factors|immunologic factors|mesh-ancestor
93173995|NCT03740945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93173996|NCT01192165|Paclitaxel|paclitaxel|mesh-list
93173997|NCT01192165|Docetaxel|docetaxel|mesh-list
93173998|NCT01192165|Carboplatin|carboplatin|mesh-list
93173999|NCT01192165|Pemetrexed|pemetrexed|mesh-list
93174000|NCT01192165|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93174001|NCT01192165|Trametinib|trametinib|mesh-list
93174002|NCT01192165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93174003|NCT01192165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174004|NCT01192165|Tubulin Modulators|tubulin modulators|mesh-ancestor
93174005|NCT01192165|Antimitotic Agents|antimitotic agents|mesh-ancestor
93174006|NCT01192165|Mitosis Modulators|mitosis modulators|mesh-ancestor
93174007|NCT01192165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174008|NCT01192165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174009|NCT01192165|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93174010|NCT01192165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93174011|NCT01192165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174012|NCT01192243|Carboplatin|carboplatin|mesh-list
93174013|NCT01192243|Pemetrexed|pemetrexed|mesh-list
93174014|NCT01192243|Gefitinib|gefitinib|mesh-list
93174015|NCT01192243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174016|NCT01192243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174017|NCT01192243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174018|NCT01192243|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93174019|NCT01192243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93174020|NCT01192243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174021|NCT01209845|Ketamine|ketamine|mesh-list
93174022|NCT01209845|Analgesics|analgesics|mesh-ancestor
93174023|NCT01209845|Sensory System Agents|sensory system agents|mesh-ancestor
93174024|NCT01209845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174025|NCT01209845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174026|NCT01209845|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93174027|NCT01209845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93174028|NCT01209845|Anesthetics, General|anesthetics, general|mesh-ancestor
93174029|NCT01209845|Anesthetics|anesthetics|mesh-ancestor
93174030|NCT01209845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174031|NCT01209845|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93174032|NCT01209845|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93174033|NCT01209845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174034|NCT01209845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174035|NCT01112813|Lithium Carbonate|lithium carbonate|mesh-list
93174036|NCT01112813|Antidepressive Agents|antidepressive agents|mesh-ancestor
93174037|NCT01112813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93174038|NCT01112813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174039|NCT01112813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174040|NCT01112813|Antimanic Agents|antimanic agents|mesh-ancestor
93174041|NCT01112813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93174042|NCT01112813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174043|NCT01112813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174044|NCT01196767|Ropivacaine|ropivacaine|mesh-list
93174045|NCT01196767|Anesthetics, Local|anesthetics, local|mesh-ancestor
93174046|NCT01196767|Anesthetics|anesthetics|mesh-ancestor
93174047|NCT01196767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174048|NCT01196767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174049|NCT01196767|Sensory System Agents|sensory system agents|mesh-ancestor
93174050|NCT01196767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174051|NCT03451773|Gemcitabine|gemcitabine|mesh-list
93174052|NCT03451773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93174053|NCT03451773|Antimetabolites|antimetabolites|mesh-ancestor
93174054|NCT03451773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174055|NCT03451773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174056|NCT01112891|Vitamin D|vitamin d|mesh-list
93174057|NCT01112891|Ergocalciferols|ergocalciferols|mesh-list
93174058|NCT01112891|Cholecalciferol|cholecalciferol|mesh-list
93174059|NCT01112891|Vitamins|vitamins|mesh-list
93174060|NCT01112891|Micronutrients|micronutrients|mesh-ancestor
93174061|NCT01112891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174062|NCT01112891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93174063|NCT01112891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174064|NCT03847441|Vitamin D|vitamin d|mesh-list
93174065|NCT03847441|Cholecalciferol|cholecalciferol|mesh-list
93174066|NCT03847441|Calcipotriene|calcipotriene|mesh-list
93174067|NCT03847441|Vitamins|vitamins|mesh-ancestor
93174068|NCT03847441|Micronutrients|micronutrients|mesh-ancestor
93174069|NCT03847441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174070|NCT03847441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93174071|NCT03847441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174072|NCT03847441|Dermatologic Agents|dermatologic agents|mesh-ancestor
93174073|NCT02529683|NuvaRing|nuvaring|mesh-list
93174074|NCT02529683|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93174075|NCT02529683|Contraceptive Agents|contraceptive agents|mesh-ancestor
93174076|NCT02529683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93174077|NCT02529683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174078|NCT05406895|Lidocaine|lidocaine|mesh-list
93174079|NCT05406895|Epinephrine|epinephrine|mesh-list
93174080|NCT05406895|Anesthetics, Local|anesthetics, local|mesh-ancestor
93174081|NCT05406895|Anesthetics|anesthetics|mesh-ancestor
93174082|NCT05406895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174083|NCT05406895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174084|NCT05406895|Sensory System Agents|sensory system agents|mesh-ancestor
93174085|NCT05406895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174086|NCT05406895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93174087|NCT05406895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93174088|NCT05406895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93174089|NCT05406895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174090|NCT05406895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174091|NCT05406895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93174092|NCT05406895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93174093|NCT05406895|Adrenergic Agents|adrenergic agents|mesh-ancestor
93174094|NCT05406895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174095|NCT05406895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93174096|NCT05406895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93174097|NCT05406895|Autonomic Agents|autonomic agents|mesh-ancestor
93174098|NCT05406895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93174099|NCT05406895|Respiratory System Agents|respiratory system agents|mesh-ancestor
93174100|NCT05406895|Mydriatics|mydriatics|mesh-ancestor
93174101|NCT05406895|Sympathomimetics|sympathomimetics|mesh-ancestor
93174102|NCT05406895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93174103|NCT03425253|Lidocaine|lidocaine|mesh-list
93174104|NCT03425253|Anesthetics, Local|anesthetics, local|mesh-ancestor
93174105|NCT03425253|Anesthetics|anesthetics|mesh-ancestor
93174106|NCT03425253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174107|NCT03425253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174108|NCT03425253|Sensory System Agents|sensory system agents|mesh-ancestor
93174109|NCT03425253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174110|NCT03425253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93174111|NCT03425253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93174112|NCT03425253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93174113|NCT03425253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174114|NCT03425253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174115|NCT03941561|Tegafur|tegafur|mesh-list
93174116|NCT03941561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93174117|NCT03941561|Antimetabolites|antimetabolites|mesh-ancestor
93174118|NCT03941561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174119|NCT03941561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174120|NCT05403229|Topiramate|topiramate|mesh-list
93174121|NCT05403229|Anticonvulsants|anticonvulsants|mesh-ancestor
93174122|NCT05403229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174123|NCT05403229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174124|NCT03424239|Vitamin D|vitamin d|mesh-list
93174125|NCT03424239|Ergocalciferols|ergocalciferols|mesh-list
93174126|NCT03424239|Cholecalciferol|cholecalciferol|mesh-list
93174127|NCT03424239|Zoledronic Acid|zoledronic acid|mesh-list
93174128|NCT03424239|Vitamins|vitamins|mesh-list
93174129|NCT03424239|Micronutrients|micronutrients|mesh-ancestor
93174130|NCT03424239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174131|NCT03424239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174132|NCT03424239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93174133|NCT03941795|Axitinib|axitinib|mesh-list
93174134|NCT03941795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174135|NCT03941795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174136|NCT03941795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174137|NCT03941795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174138|NCT01197001|Losartan|losartan|mesh-list
93174139|NCT01197001|Amlodipine|amlodipine|mesh-list
93174140|NCT01197001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93174141|NCT01197001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93174142|NCT01197001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174143|NCT01197001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174144|NCT01197001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174145|NCT01197001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174146|NCT01197001|Vasodilator Agents|vasodilator agents|mesh-ancestor
93174147|NCT01197001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93174148|NCT01197001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93174149|NCT01197001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93174150|NCT01113047|Amlodipine|amlodipine|mesh-list
93174151|NCT01113047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93174152|NCT01113047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93174153|NCT01113047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174154|NCT01113047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174155|NCT01113047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174156|NCT01113047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174157|NCT01113047|Vasodilator Agents|vasodilator agents|mesh-ancestor
93174158|NCT01113125|Fusidic Acid|fusidic acid|mesh-list
93174159|NCT01113125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93174160|NCT01113125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174161|NCT01113125|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93174162|NCT01113125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174163|NCT01113125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174164|NCT01210391|Caseins|caseins|mesh-list
93174165|NCT01210391|Chelating Agents|chelating agents|mesh-ancestor
93174166|NCT01210391|Sequestering Agents|sequestering agents|mesh-ancestor
93174167|NCT01210391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174168|NCT03846739|Oxytocin|oxytocin|mesh-list
93174169|NCT03846739|Oxytocics|oxytocics|mesh-ancestor
93174170|NCT03846739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93174171|NCT03846739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174172|NCT03716115|Budesonide|budesonide|mesh-list
93174173|NCT03716115|Teduglutide|teduglutide|mesh-list
93174174|NCT03716115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174175|NCT03716115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93174176|NCT03716115|Autonomic Agents|autonomic agents|mesh-ancestor
93174177|NCT03716115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174178|NCT03716115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174179|NCT03716115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93174180|NCT03716115|Respiratory System Agents|respiratory system agents|mesh-ancestor
93174181|NCT03716115|Glucocorticoids|glucocorticoids|mesh-ancestor
93174182|NCT03716115|Hormones|hormones|mesh-ancestor
93174183|NCT03716115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174184|NCT03716115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93174185|NCT03716115|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93174186|NCT03716115|Protective Agents|protective agents|mesh-ancestor
93174187|NCT01113281|Vaccines|vaccines|mesh-list
93174188|NCT01113281|Immunologic Factors|immunologic factors|mesh-ancestor
93174189|NCT01113281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174190|NCT01295593|Cladribine|cladribine|mesh-list
93174191|NCT01295593|Valproic Acid|valproic acid|mesh-list
93174192|NCT01295593|Anticonvulsants|anticonvulsants|mesh-ancestor
93174193|NCT01295593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174194|NCT01295593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174195|NCT01295593|GABA Agents|gaba agents|mesh-ancestor
93174196|NCT01295593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174197|NCT01295593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174198|NCT01295593|Antimanic Agents|antimanic agents|mesh-ancestor
93174199|NCT01295593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93174200|NCT01295593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174201|NCT01295593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93174202|NCT01295593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174203|NCT01295593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93174204|NCT01295593|Immunologic Factors|immunologic factors|mesh-ancestor
93174205|NCT03845881|Oxycodone|oxycodone|mesh-list
93174206|NCT03845881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93174207|NCT03845881|Narcotics|narcotics|mesh-ancestor
93174208|NCT03845881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174209|NCT03845881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174210|NCT03845881|Analgesics|analgesics|mesh-ancestor
93174211|NCT03845881|Sensory System Agents|sensory system agents|mesh-ancestor
93174212|NCT03845881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174213|NCT01197157|Nitazoxanide|nitazoxanide|mesh-list
93174214|NCT01197157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93174215|NCT01197157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174216|NCT01296997|Calcium|calcium|mesh-list
93174217|NCT01296997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174218|NCT01296997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174219|NCT01114841|Tazarotene|tazarotene|mesh-list
93174220|NCT01114841|Dermatologic Agents|dermatologic agents|mesh-ancestor
93174221|NCT01114841|Keratolytic Agents|keratolytic agents|mesh-ancestor
93174222|NCT01113437|Omalizumab|omalizumab|mesh-list
93174223|NCT01113437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93174224|NCT01113437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93174225|NCT01113437|Respiratory System Agents|respiratory system agents|mesh-ancestor
93174226|NCT01197235|Darbepoetin alfa|darbepoetin alfa|mesh-list
93174227|NCT01197235|Hematinics|hematinics|mesh-ancestor
93174228|NCT01192789|Amoxicillin|amoxicillin|mesh-list
93174229|NCT01192789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93174230|NCT01192789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174231|NCT01211171|Telmisartan|telmisartan|mesh-list
93174232|NCT01211171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93174233|NCT01211171|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93174234|NCT01211171|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93174235|NCT01211171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174236|NCT03846973|Tranexamic Acid|tranexamic acid|mesh-list
93174237|NCT03846973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93174238|NCT03846973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93174239|NCT03846973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174240|NCT03846973|Hemostatics|hemostatics|mesh-ancestor
93174241|NCT03846973|Coagulants|coagulants|mesh-ancestor
93174242|NCT01113515|Esmolol|esmolol|mesh-list
93174243|NCT01113515|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93174244|NCT01113515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93174245|NCT01113515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93174246|NCT01113515|Adrenergic Agents|adrenergic agents|mesh-ancestor
93174247|NCT01113515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174248|NCT01113515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174249|NCT01113515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174250|NCT01211327|Cyclosporine|cyclosporine|mesh-list
93174251|NCT01211327|Dexamethasone|dexamethasone|mesh-list
93174252|NCT01211327|Cyclosporins|cyclosporins|mesh-list
93174253|NCT01211327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174254|NCT01211327|Antiemetics|antiemetics|mesh-ancestor
93174255|NCT01211327|Autonomic Agents|autonomic agents|mesh-ancestor
93174256|NCT01211327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174257|NCT01211327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174258|NCT01211327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93174259|NCT01211327|Glucocorticoids|glucocorticoids|mesh-ancestor
93174260|NCT01211327|Hormones|hormones|mesh-ancestor
93174261|NCT01211327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174262|NCT01211327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93174263|NCT01211327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174264|NCT01211327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174265|NCT01211327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174266|NCT01211327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93174267|NCT01211327|Immunologic Factors|immunologic factors|mesh-ancestor
93174268|NCT01211327|Antifungal Agents|antifungal agents|mesh-ancestor
93174269|NCT01211327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174270|NCT01211327|Dermatologic Agents|dermatologic agents|mesh-ancestor
93174271|NCT01211327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93174272|NCT01211327|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93174273|NCT05601895|Sorafenib|sorafenib|mesh-list
93174274|NCT05601895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174275|NCT05601895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174276|NCT05601895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174277|NCT05601895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174278|NCT01113671|Vitamin E|vitamin e|mesh-list
93174279|NCT01113671|Tocopherols|tocopherols|mesh-list
93174280|NCT01113671|alpha-Tocopherol|alpha-tocopherol|mesh-list
93174281|NCT01113671|Vitamins|vitamins|mesh-ancestor
93174282|NCT01113671|Micronutrients|micronutrients|mesh-ancestor
93174283|NCT01113671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174284|NCT01113671|Antioxidants|antioxidants|mesh-ancestor
93174285|NCT01113671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174287|NCT03943043|Paclitaxel|paclitaxel|mesh-list
93174288|NCT03943043|Gemcitabine|gemcitabine|mesh-list
93174289|NCT03943043|Oxaliplatin|oxaliplatin|mesh-list
93174290|NCT03943043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93174291|NCT03943043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174292|NCT03943043|Tubulin Modulators|tubulin modulators|mesh-ancestor
93174293|NCT03943043|Antimitotic Agents|antimitotic agents|mesh-ancestor
93174294|NCT03943043|Mitosis Modulators|mitosis modulators|mesh-ancestor
93174295|NCT03943043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174296|NCT03943043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93174297|NCT03943043|Antimetabolites|antimetabolites|mesh-ancestor
93174298|NCT01109927|Insulin|insulin|mesh-list
93174299|NCT01109927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174300|NCT01109927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174301|NCT01211795|Ketoprofen|ketoprofen|mesh-list
93174302|NCT01211795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93174303|NCT01211795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93174304|NCT01211795|Analgesics|analgesics|mesh-ancestor
93174305|NCT01211795|Sensory System Agents|sensory system agents|mesh-ancestor
93174306|NCT01211795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174307|NCT01211795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174308|NCT01211795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174309|NCT01211795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93174310|NCT01211795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93174311|NCT01211795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174312|NCT01211795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174313|NCT01193491|Geldanamycin|geldanamycin|mesh-list
93174314|NCT01193491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93174315|NCT01193491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174316|NCT01193491|Antiviral Agents|antiviral agents|mesh-ancestor
93174317|NCT01193491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174318|NCT01193491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174319|NCT01193491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174320|NCT01193491|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93174321|NCT01193491|Protease Inhibitors|protease inhibitors|mesh-ancestor
93174322|NCT01110317|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93174323|NCT01110317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93174324|NCT01110317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93174325|NCT01110317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174326|NCT01110317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174327|NCT01110317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93174328|NCT01110317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93174329|NCT01110317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93174330|NCT01110317|Serotonin Agents|serotonin agents|mesh-ancestor
93174331|NCT01110317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174332|NCT01110317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174333|NCT01110317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93174334|NCT01110317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93174335|NCT01110317|Dopamine Agents|dopamine agents|mesh-ancestor
93174336|NCT01208285|Ivacaftor|ivacaftor|mesh-list
93174337|NCT01208285|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93174338|NCT01208285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174339|NCT01208285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174340|NCT01208363|Fe(III)-EDTA|fe(iii)-edta|mesh-list
93174341|NCT01208363|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93174342|NCT01208363|Chelating Agents|chelating agents|mesh-ancestor
93174343|NCT01208363|Sequestering Agents|sequestering agents|mesh-ancestor
93174344|NCT01208363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174345|NCT01208441|Letrozole|letrozole|mesh-list
93174346|NCT01208441|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93174347|NCT01208441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174348|NCT01208441|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93174349|NCT01208441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93174350|NCT01208441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174351|NCT01208441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174352|NCT01208441|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93174353|NCT01208441|Hormone Antagonists|hormone antagonists|mesh-ancestor
93174354|NCT01208441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174355|NCT01208441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174356|NCT01208441|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93174357|NCT03718377|Anesthetics|anesthetics|mesh-list
93174358|NCT03718377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174359|NCT03718377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174360|NCT01197469|Tadalafil|tadalafil|mesh-list
93174361|NCT01197469|Vasodilator Agents|vasodilator agents|mesh-ancestor
93174362|NCT01197469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93174363|NCT01197469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93174364|NCT01197469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174365|NCT01197469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174366|NCT01197469|Urological Agents|urological agents|mesh-ancestor
93174367|NCT01211561|Selenium|selenium|mesh-list
93174368|NCT01211561|Antioxidants|antioxidants|mesh-ancestor
93174369|NCT01211561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174370|NCT01211561|Protective Agents|protective agents|mesh-ancestor
93174371|NCT01211561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174372|NCT01211561|Trace Elements|trace elements|mesh-ancestor
93174373|NCT01211561|Micronutrients|micronutrients|mesh-ancestor
93174374|NCT05358535|Propofol|propofol|mesh-list
93174375|NCT05358535|Etomidate|etomidate|mesh-list
93174376|NCT05358535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93174377|NCT05358535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174378|NCT05358535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174379|NCT05358535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93174380|NCT05358535|Anesthetics, General|anesthetics, general|mesh-ancestor
93174381|NCT05358535|Anesthetics|anesthetics|mesh-ancestor
93174382|NCT01213355|Scopolamine|scopolamine|mesh-list
93174383|NCT01213355|Donepezil|donepezil|mesh-list
93174384|NCT01213355|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93174385|NCT01213355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93174386|NCT01213355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174387|NCT01213355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174388|NCT01213355|Cholinergic Agents|cholinergic agents|mesh-ancestor
93174389|NCT01213355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174390|NCT01213355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174391|NCT01213355|Nootropic Agents|nootropic agents|mesh-ancestor
93174392|NCT01213355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93174393|NCT01213355|Antiemetics|antiemetics|mesh-ancestor
93174394|NCT01213355|Autonomic Agents|autonomic agents|mesh-ancestor
93174395|NCT01213355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174396|NCT01213355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93174397|NCT01213355|Mydriatics|mydriatics|mesh-ancestor
93174398|NCT01213355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93174399|NCT01213355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93174400|NCT01213355|Parasympatholytics|parasympatholytics|mesh-ancestor
93174401|NCT03938363|Botulinum Toxins|botulinum toxins|mesh-list
93174402|NCT03938363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93174403|NCT03938363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174404|NCT03938363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174405|NCT03938363|Cholinergic Agents|cholinergic agents|mesh-ancestor
93174406|NCT03938363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174407|NCT03938363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174408|NCT03848065|Vaccines|vaccines|mesh-list
93174409|NCT03848065|Immunologic Factors|immunologic factors|mesh-ancestor
93174410|NCT03848065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174411|NCT01110473|Azacitidine|azacitidine|mesh-list
93174412|NCT01110473|Ilorasertib|ilorasertib|mesh-list
93174413|NCT01110473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93174414|NCT01110473|Antimetabolites|antimetabolites|mesh-ancestor
93174415|NCT01110473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174416|NCT01110473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174417|NCT01110473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174418|NCT01110473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174419|NCT05558761|Pentoxifylline|pentoxifylline|mesh-list
93174420|NCT05558761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93174421|NCT05558761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174422|NCT05558761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174423|NCT05558761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93174424|NCT05558761|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93174425|NCT05558761|Protective Agents|protective agents|mesh-ancestor
93174426|NCT05558761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174427|NCT05558761|Vasodilator Agents|vasodilator agents|mesh-ancestor
93174428|NCT05558761|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93174429|NCT05558761|Antioxidants|antioxidants|mesh-ancestor
93174430|NCT03940391|Chlorpheniramine|chlorpheniramine|mesh-list
93174431|NCT03940391|Midazolam|midazolam|mesh-list
93174433|NCT03940391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93174434|NCT03940391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174435|NCT03940391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174436|NCT03940391|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93174437|NCT03940391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93174438|NCT03940391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93174439|NCT03940391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93174440|NCT03940391|Anesthetics, General|anesthetics, general|mesh-ancestor
93174441|NCT03940391|Anesthetics|anesthetics|mesh-ancestor
93174442|NCT03940391|GABA Modulators|gaba modulators|mesh-ancestor
93174443|NCT03940391|GABA Agents|gaba agents|mesh-ancestor
93174444|NCT03940391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174445|NCT03940391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174446|NCT03940391|Antipruritics|antipruritics|mesh-ancestor
93174447|NCT03940391|Dermatologic Agents|dermatologic agents|mesh-ancestor
93174448|NCT03940391|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93174449|NCT03940391|Histamine Antagonists|histamine antagonists|mesh-ancestor
93174450|NCT03940391|Histamine Agents|histamine agents|mesh-ancestor
93174451|NCT03940391|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93174452|NCT03715881|Prednisolone|prednisolone|mesh-list
93174453|NCT03715881|Epoetin Alfa|epoetin alfa|mesh-list
93174454|NCT03715881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174455|NCT03715881|Glucocorticoids|glucocorticoids|mesh-ancestor
93174456|NCT03715881|Hormones|hormones|mesh-ancestor
93174457|NCT03715881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174458|NCT03715881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470254|NCT01820442|Lofexidine|lofexidine|mesh-list
93174459|NCT03715881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93174460|NCT03715881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174461|NCT03715881|Hematinics|hematinics|mesh-ancestor
93174462|NCT01197781|Verapamil|verapamil|mesh-list
93174463|NCT01197781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93174464|NCT01197781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93174465|NCT01197781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174466|NCT01197781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174467|NCT01197781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174468|NCT01197781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174469|NCT01197781|Vasodilator Agents|vasodilator agents|mesh-ancestor
93174470|NCT01110551|Vaccines|vaccines|mesh-list
93174471|NCT01110551|Immunologic Factors|immunologic factors|mesh-ancestor
93174472|NCT01110551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174473|NCT01296139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93174474|NCT01296139|Hematinics|hematinics|mesh-ancestor
93174475|NCT01296139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93174476|NCT01296139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93174477|NCT03940469|Dexamethasone|dexamethasone|mesh-list
93174478|NCT03940469|Dexamethasone acetate|dexamethasone acetate|mesh-list
93174479|NCT03940469|Dexmedetomidine|dexmedetomidine|mesh-list
93174480|NCT03940469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174481|NCT03940469|Antiemetics|antiemetics|mesh-ancestor
93174482|NCT03940469|Autonomic Agents|autonomic agents|mesh-ancestor
93174483|NCT03940469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174484|NCT03940469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174485|NCT03940469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93174486|NCT03940469|Glucocorticoids|glucocorticoids|mesh-ancestor
93174487|NCT03940469|Hormones|hormones|mesh-ancestor
93174488|NCT03940469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174489|NCT03940469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93174490|NCT03940469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174491|NCT03940469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93174492|NCT03940469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174493|NCT03940469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93174494|NCT03940469|Analgesics|analgesics|mesh-ancestor
93174495|NCT03940469|Sensory System Agents|sensory system agents|mesh-ancestor
93174496|NCT03940469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93174497|NCT03940469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93174498|NCT03940469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93174499|NCT03940469|Adrenergic Agents|adrenergic agents|mesh-ancestor
93174500|NCT03940469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174501|NCT03940469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174502|NCT01110785|Panitumumab|panitumumab|mesh-list
93174503|NCT01110785|Simvastatin|simvastatin|mesh-list
93174504|NCT01110785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93174505|NCT01110785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93174506|NCT01110785|Antimetabolites|antimetabolites|mesh-ancestor
93174507|NCT01110785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174508|NCT01110785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93174509|NCT01110785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93174510|NCT01110785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174511|NCT01110785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93174512|NCT01110785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174513|NCT03846271|Oxytocin|oxytocin|mesh-list
93174514|NCT03846271|Oxytocics|oxytocics|mesh-ancestor
93174515|NCT03846271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93174516|NCT03846271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174517|NCT01110941|Leucovorin|leucovorin|mesh-list
93174518|NCT01110941|Oxaliplatin|oxaliplatin|mesh-list
93174519|NCT01110941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174520|NCT01110941|Antidotes|antidotes|mesh-ancestor
93174521|NCT01110941|Protective Agents|protective agents|mesh-ancestor
93174522|NCT01110941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174523|NCT01110941|Vitamin B Complex|vitamin b complex|mesh-ancestor
93174524|NCT01110941|Vitamins|vitamins|mesh-ancestor
93174525|NCT01110941|Micronutrients|micronutrients|mesh-ancestor
93174526|NCT03448419|Empagliflozin|empagliflozin|mesh-list
93174527|NCT03448419|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93174528|NCT03448419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174529|NCT03448419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174530|NCT03448419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174531|NCT01118039|Sunitinib|sunitinib|mesh-list
93174532|NCT01118039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174533|NCT01118039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93174534|NCT01118039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93174535|NCT01118039|Growth Substances|growth substances|mesh-ancestor
93174536|NCT01118039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174537|NCT01118039|Growth Inhibitors|growth inhibitors|mesh-ancestor
93174538|NCT01118039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174539|NCT01118039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174540|NCT01118039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174541|NCT01213433|Artesunate|artesunate|mesh-list
93174542|NCT01213433|Amodiaquine|amodiaquine|mesh-list
93174543|NCT01213433|Antimalarials|antimalarials|mesh-ancestor
93174544|NCT01213433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93174545|NCT01213433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93174546|NCT01213433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174547|NCT01213433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174548|NCT01213433|Antiviral Agents|antiviral agents|mesh-ancestor
93174549|NCT01213433|Schistosomicides|schistosomicides|mesh-ancestor
93174550|NCT01213433|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93174551|NCT01213433|Anthelmintics|anthelmintics|mesh-ancestor
93174552|NCT03848533|Metformin|metformin|mesh-list
93174553|NCT03848533|Melatonin|melatonin|mesh-list
93174554|NCT03848533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174555|NCT03848533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174556|NCT03848533|Antioxidants|antioxidants|mesh-ancestor
93174557|NCT03848533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174558|NCT03848533|Protective Agents|protective agents|mesh-ancestor
93174559|NCT03848533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174560|NCT01111253|Amoxicillin|amoxicillin|mesh-list
93174561|NCT01111253|Clavulanic Acid|clavulanic acid|mesh-list
93174562|NCT01111253|Clavulanic Acids|clavulanic acids|mesh-list
93174563|NCT01111253|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93174564|NCT01111253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93174565|NCT01111253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174566|NCT01111253|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93174567|NCT01111253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174568|NCT01111253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174569|NCT01213667|Ranibizumab|ranibizumab|mesh-list
93174570|NCT01213667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93174571|NCT01213667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93174572|NCT01213667|Growth Substances|growth substances|mesh-ancestor
93174573|NCT01213667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174574|NCT01213667|Growth Inhibitors|growth inhibitors|mesh-ancestor
93174575|NCT01213667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174576|NCT01196065|Memantine|memantine|mesh-list
93174577|NCT01196065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93174578|NCT01196065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93174579|NCT01196065|Dopamine Agents|dopamine agents|mesh-ancestor
93174580|NCT01196065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174581|NCT01196065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846763|NCT02690792|Vitamin E|vitamin e|mesh-list
93174582|NCT01196065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174583|NCT01196065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93174584|NCT01196065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93174585|NCT05258773|Azasetron|azasetron|mesh-list
93174586|NCT05258773|Antiemetics|antiemetics|mesh-ancestor
93174587|NCT05258773|Autonomic Agents|autonomic agents|mesh-ancestor
93174588|NCT05258773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174589|NCT05258773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174590|NCT05258773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93174591|NCT05258773|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93174592|NCT05258773|Serotonin Agents|serotonin agents|mesh-ancestor
93174593|NCT05258773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174594|NCT05258773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174595|NCT03845179|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93174596|NCT03845179|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93174597|NCT03845179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174598|NCT03845179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174599|NCT03845179|Incretins|incretins|mesh-ancestor
93174600|NCT03845179|Hormones|hormones|mesh-ancestor
93174601|NCT03845179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174602|NCT03845179|Protease Inhibitors|protease inhibitors|mesh-ancestor
93174603|NCT03845179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174604|NCT03845179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174605|NCT03936023|Saxagliptin|saxagliptin|mesh-list
93174606|NCT03936023|Incretins|incretins|mesh-ancestor
93174607|NCT03936023|Hormones|hormones|mesh-ancestor
93174608|NCT03936023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174609|NCT03936023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174610|NCT03936023|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93174611|NCT03936023|Protease Inhibitors|protease inhibitors|mesh-ancestor
93174612|NCT03936023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174613|NCT03936023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174614|NCT03936023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174615|NCT01121705|Interferons|interferons|mesh-list
93174616|NCT01121705|Ribavirin|ribavirin|mesh-list
93174617|NCT01121705|Interferon-alpha|interferon-alpha|mesh-list
93174618|NCT01121705|Interferon alpha-2|interferon alpha-2|mesh-list
93174619|NCT01121705|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93174620|NCT01121705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174621|NCT01121705|Antiviral Agents|antiviral agents|mesh-ancestor
93174622|NCT01121705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174623|NCT01121705|Antimetabolites|antimetabolites|mesh-ancestor
93174624|NCT01121705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174625|NCT01121705|Immunologic Factors|immunologic factors|mesh-ancestor
93174626|NCT01121705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174627|NCT01196455|Capecitabine|capecitabine|mesh-list
93174628|NCT01196455|Mitomycins|mitomycins|mesh-list
93174629|NCT01196455|Mitomycin|mitomycin|mesh-list
93174630|NCT01196455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93174631|NCT01196455|Antimetabolites|antimetabolites|mesh-ancestor
93174632|NCT01196455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174633|NCT01196455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174634|NCT01196455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93174635|NCT01196455|Alkylating Agents|alkylating agents|mesh-ancestor
93174636|NCT01196455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93174637|NCT01196455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174638|NCT03846583|Trastuzumab|trastuzumab|mesh-list
93174639|NCT03846583|Tucatinib|tucatinib|mesh-list
93174640|NCT03846583|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93174641|NCT03846583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93174642|NCT03846583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174643|NCT03846583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93174644|NCT03846583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174645|NCT03846583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174646|NCT03846583|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93174647|NCT03846583|Hormone Antagonists|hormone antagonists|mesh-ancestor
93174648|NCT03846583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174649|NCT03846583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174650|NCT03846583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174651|NCT01115543|Calcitriol|calcitriol|mesh-list
93174652|NCT01115543|Alfacalcidol|alfacalcidol|mesh-list
93174653|NCT01115543|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93174654|NCT01115543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174655|NCT01115543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174656|NCT01115543|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93174657|NCT01115543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174658|NCT01115543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174659|NCT01115543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93174661|NCT01115543|Micronutrients|micronutrients|mesh-ancestor
93174662|NCT01115543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93174663|NCT01216007|Propofol|propofol|mesh-list
93174664|NCT01216007|Sevoflurane|sevoflurane|mesh-list
93174665|NCT01216007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93174666|NCT01216007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174667|NCT01216007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174668|NCT01216007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93174669|NCT01216007|Anesthetics, General|anesthetics, general|mesh-ancestor
93174670|NCT01216007|Anesthetics|anesthetics|mesh-ancestor
93174671|NCT01216007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93174672|NCT01216007|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93174673|NCT01198249|Losartan|losartan|mesh-list
93174674|NCT01198249|Amlodipine|amlodipine|mesh-list
93174675|NCT01198249|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93174676|NCT01198249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93174677|NCT01198249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93174678|NCT01198249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174679|NCT01198249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174680|NCT01198249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174681|NCT01198249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174682|NCT01198249|Vasodilator Agents|vasodilator agents|mesh-ancestor
93174683|NCT01198249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93174684|NCT01198249|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93174685|NCT01198249|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93174686|NCT01198249|Diuretics|diuretics|mesh-ancestor
93174687|NCT01198249|Natriuretic Agents|natriuretic agents|mesh-ancestor
93174688|NCT01198249|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93174689|NCT02529761|Sorafenib|sorafenib|mesh-list
93174690|NCT02529761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174691|NCT02529761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174692|NCT02529761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174693|NCT02529761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174694|NCT03844243|Mitogens|mitogens|mesh-list
93174695|NCT03844243|Mitosis Modulators|mitosis modulators|mesh-ancestor
93174696|NCT03844243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174697|NCT05479591|Xultophy|xultophy|mesh-list
93174698|NCT05479591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174699|NCT05479591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174700|NCT05479591|Incretins|incretins|mesh-ancestor
93174701|NCT05479591|Hormones|hormones|mesh-ancestor
93174702|NCT05479591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174703|NCT01119209|Ropivacaine|ropivacaine|mesh-list
93174704|NCT01119209|Anesthetics, Local|anesthetics, local|mesh-ancestor
93174705|NCT01119209|Anesthetics|anesthetics|mesh-ancestor
93174706|NCT01119209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174707|NCT01119209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174708|NCT01119209|Sensory System Agents|sensory system agents|mesh-ancestor
93174709|NCT01119209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174710|NCT01213901|Insulin Lispro|insulin lispro|mesh-list
93174711|NCT01213901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174712|NCT01213901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174713|NCT01116167|Letrozole|letrozole|mesh-list
93174714|NCT01116167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174715|NCT01116167|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93174716|NCT01116167|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93174717|NCT01116167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174718|NCT01116167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174719|NCT01116167|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93174720|NCT01116167|Hormone Antagonists|hormone antagonists|mesh-ancestor
93174721|NCT01116167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174722|NCT01116167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174723|NCT01119521|Isoniazid|isoniazid|mesh-list
93174724|NCT01119521|Antitubercular Agents|antitubercular agents|mesh-ancestor
93174725|NCT01119521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93174726|NCT01119521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174727|NCT01119521|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93174728|NCT01119521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93174729|NCT01119521|Antimetabolites|antimetabolites|mesh-ancestor
93174730|NCT01119521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174731|NCT01119521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93174732|NCT03939923|Glycopyrrolate|glycopyrrolate|mesh-list
93174733|NCT03939923|Rocuronium|rocuronium|mesh-list
93174734|NCT03939923|Neostigmine|neostigmine|mesh-list
93174735|NCT03939923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93174736|NCT03939923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93174737|NCT03939923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93174738|NCT03939923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174739|NCT03939923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174740|NCT03939923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93174741|NCT03939923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174742|NCT03939923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174743|NCT03939923|Cholinergic Agents|cholinergic agents|mesh-ancestor
93174744|NCT03939923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174745|NCT03939923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93174746|NCT03939923|Autonomic Agents|autonomic agents|mesh-ancestor
93174747|NCT03939923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93174748|NCT03939923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93174749|NCT03939923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93174750|NCT01119599|Temozolomide|temozolomide|mesh-list
93174751|NCT01119599|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93174752|NCT01119599|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93174753|NCT01119599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93174754|NCT01119599|Alkylating Agents|alkylating agents|mesh-ancestor
93174755|NCT01119599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174756|NCT01119599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174757|NCT01119599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174758|NCT03419403|Temozolomide|temozolomide|mesh-list
93174759|NCT03419403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93174760|NCT03419403|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93174761|NCT03419403|ABT-414|abt-414|mesh-list
93174762|NCT03419403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93174763|NCT03419403|Alkylating Agents|alkylating agents|mesh-ancestor
93174764|NCT03419403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174765|NCT03419403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174766|NCT03419403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93174767|NCT03419403|Immunoconjugates|immunoconjugates|mesh-ancestor
93174768|NCT03419403|Immunologic Factors|immunologic factors|mesh-ancestor
93174769|NCT03419403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174770|NCT05156437|Amoxicillin|amoxicillin|mesh-list
93174771|NCT05156437|Vancomycin|vancomycin|mesh-list
93174772|NCT05156437|Levofloxacin|levofloxacin|mesh-list
93174773|NCT05156437|Rifampin|rifampin|mesh-list
93174774|NCT05156437|Ceftriaxone|ceftriaxone|mesh-list
93174775|NCT05156437|Linezolid|linezolid|mesh-list
93174776|NCT05156437|Daptomycin|daptomycin|mesh-list
93174777|NCT05156437|Cephalexin|cephalexin|mesh-list
93174778|NCT05156437|Ampicillin|ampicillin|mesh-list
93174779|NCT05156437|Cefepime|cefepime|mesh-list
93174780|NCT05156437|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93174781|NCT05156437|Oxacillin|oxacillin|mesh-list
93174782|NCT05156437|Dicloxacillin|dicloxacillin|mesh-list
93174783|NCT05156437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93174784|NCT05156437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174785|NCT05156437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93174786|NCT05156437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93174787|NCT05156437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93174788|NCT05156437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174789|NCT05156437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174790|NCT05156437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174791|NCT05156437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93174792|NCT05156437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93174793|NCT05156437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93174794|NCT05156437|Antitubercular Agents|antitubercular agents|mesh-ancestor
93174795|NCT05156437|Leprostatic Agents|leprostatic agents|mesh-ancestor
93174796|NCT05156437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93174797|NCT05156437|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93174798|NCT05156437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93174799|NCT05156437|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93174800|NCT05156437|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93174801|NCT05156437|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93174802|NCT05156437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93174803|NCT05156437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93174804|NCT01119677|Interferon beta-1a|interferon beta-1a|mesh-list
93174805|NCT01119677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93174806|NCT01119677|Immunologic Factors|immunologic factors|mesh-ancestor
93174807|NCT01119677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174808|NCT01119677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174809|NCT01119677|Antiviral Agents|antiviral agents|mesh-ancestor
93174810|NCT01119677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174812|NCT03715725|Rivaroxaban|rivaroxaban|mesh-list
93174813|NCT03715725|Dabigatran|dabigatran|mesh-list
93174814|NCT03715725|Apixaban|apixaban|mesh-list
93174815|NCT03715725|Anticoagulants|anticoagulants|mesh-ancestor
93174816|NCT03715725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93174817|NCT03715725|Antithrombins|antithrombins|mesh-ancestor
93174818|NCT03715725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93174819|NCT03715725|Protease Inhibitors|protease inhibitors|mesh-ancestor
93174820|NCT03715725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174821|NCT03715725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174822|NCT01212653|Golimumab|golimumab|mesh-list
93174823|NCT01212653|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93174824|NCT01212653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174825|NCT01212653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93174826|NCT01212653|Immunologic Factors|immunologic factors|mesh-ancestor
93174827|NCT01212653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174828|NCT01213979|Iron|iron|mesh-list
93174829|NCT01213979|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93174830|NCT01213979|Ferric Compounds|ferric compounds|mesh-list
93174831|NCT01213979|Trace Elements|trace elements|mesh-ancestor
93174832|NCT01213979|Micronutrients|micronutrients|mesh-ancestor
93174833|NCT01213979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174834|NCT01213979|Hematinics|hematinics|mesh-ancestor
93174835|NCT05282719|Azacitidine|azacitidine|mesh-list
93174836|NCT05282719|Venetoclax|venetoclax|mesh-list
93174837|NCT05282719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93174838|NCT05282719|Antimetabolites|antimetabolites|mesh-ancestor
93174839|NCT05282719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174840|NCT05282719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174841|NCT05282719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174842|NCT01118429|Oxybutynin|oxybutynin|mesh-list
93174843|NCT01118429|Parasympatholytics|parasympatholytics|mesh-ancestor
93174844|NCT01118429|Autonomic Agents|autonomic agents|mesh-ancestor
93174845|NCT01118429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174846|NCT01118429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174847|NCT01118429|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93174848|NCT01118429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93174849|NCT01118429|Cholinergic Agents|cholinergic agents|mesh-ancestor
93174850|NCT01118429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174851|NCT01118429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174852|NCT01118429|Urological Agents|urological agents|mesh-ancestor
93174853|NCT03447249|Ivacaftor|ivacaftor|mesh-list
93174854|NCT03447249|VX-659|vx-659|mesh-list
93174855|NCT03447249|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93174856|NCT03447249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174857|NCT03447249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174858|NCT04156555|Amoxicillin|amoxicillin|mesh-list
93174859|NCT04156555|Clavulanic Acid|clavulanic acid|mesh-list
93174860|NCT04156555|Clavulanic Acids|clavulanic acids|mesh-list
93174861|NCT04156555|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93174862|NCT04156555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93174863|NCT04156555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174864|NCT04156555|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93174865|NCT04156555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174866|NCT04156555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174867|NCT01200121|Bevacizumab|bevacizumab|mesh-list
93174868|NCT01200121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93174869|NCT01200121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174870|NCT01200121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93174871|NCT01200121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93174872|NCT01200121|Growth Substances|growth substances|mesh-ancestor
93174873|NCT01200121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174874|NCT01200121|Growth Inhibitors|growth inhibitors|mesh-ancestor
93174875|NCT01214291|Toremifene|toremifene|mesh-list
93174876|NCT01214291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93174877|NCT01214291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847075|NCT02827578|Tamsulosin|tamsulosin|mesh-list
93174878|NCT01214291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93174879|NCT01214291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93174880|NCT01214291|Hormone Antagonists|hormone antagonists|mesh-ancestor
93174881|NCT01214291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174882|NCT01214291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174883|NCT01214291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93174884|NCT01116635|Doxorubicin|doxorubicin|mesh-list
93174885|NCT01116635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93174886|NCT01116635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174887|NCT01116635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93174888|NCT01116635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93174889|NCT01116635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174890|NCT01116635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174891|NCT01566799|Metformin|metformin|mesh-list
93174892|NCT01566799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93174893|NCT01566799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174894|NCT04642807|Calpastatin|calpastatin|mesh-list
93174895|NCT04642807|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93174896|NCT04642807|Protease Inhibitors|protease inhibitors|mesh-ancestor
93174897|NCT04642807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174898|NCT04642807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174899|NCT01216085|Imatinib Mesylate|imatinib mesylate|mesh-list
93174900|NCT01216085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174901|NCT01216085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93174902|NCT01216085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174903|NCT01216085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174904|NCT01198639|Remifentanil|remifentanil|mesh-list
93174905|NCT01198639|Propofol|propofol|mesh-list
93174906|NCT01198639|Anesthetics|anesthetics|mesh-list
93174907|NCT01198639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93174908|NCT01198639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174909|NCT01198639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174910|NCT01198639|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93174911|NCT01198639|Anesthetics, General|anesthetics, general|mesh-ancestor
93174912|NCT01198639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93174913|NCT01198639|Narcotics|narcotics|mesh-ancestor
93174914|NCT01198639|Analgesics|analgesics|mesh-ancestor
93174915|NCT01198639|Sensory System Agents|sensory system agents|mesh-ancestor
93174916|NCT01198639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174917|NCT01116713|Dexamethasone|dexamethasone|mesh-list
93174918|NCT01116713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174919|NCT01116713|Antiemetics|antiemetics|mesh-ancestor
93174920|NCT01116713|Autonomic Agents|autonomic agents|mesh-ancestor
93174921|NCT01116713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174922|NCT01116713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174923|NCT01116713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93174924|NCT01116713|Glucocorticoids|glucocorticoids|mesh-ancestor
93174925|NCT01116713|Hormones|hormones|mesh-ancestor
93174926|NCT01116713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174927|NCT01116713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93174928|NCT01116713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174929|NCT01202149|Pimecrolimus|pimecrolimus|mesh-list
93174930|NCT01202149|Emollients|emollients|mesh-list
93174931|NCT01202149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93174932|NCT01202149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93174933|NCT01202149|Analgesics|analgesics|mesh-ancestor
93174934|NCT01202149|Sensory System Agents|sensory system agents|mesh-ancestor
93174935|NCT01202149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174936|NCT01202149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174937|NCT01202149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174938|NCT01202149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93174939|NCT01202149|Dermatologic Agents|dermatologic agents|mesh-ancestor
93174940|NCT01202149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93174941|NCT01202149|Immunologic Factors|immunologic factors|mesh-ancestor
93174942|NCT01202149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93174943|NCT01202149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174944|NCT01202149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174945|NCT01116791|Cisplatin|cisplatin|mesh-list
93174946|NCT01116791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174947|NCT03717909|Valproic Acid|valproic acid|mesh-list
93174948|NCT03717909|Anticonvulsants|anticonvulsants|mesh-ancestor
93174949|NCT03717909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93174950|NCT03717909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174951|NCT03717909|GABA Agents|gaba agents|mesh-ancestor
93174952|NCT03717909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93174953|NCT03717909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174954|NCT03717909|Antimanic Agents|antimanic agents|mesh-ancestor
93174955|NCT03717909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93174956|NCT03717909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93174957|NCT03717909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93174958|NCT03940001|Paclitaxel|paclitaxel|mesh-list
93174959|NCT03940001|Carboplatin|carboplatin|mesh-list
93174960|NCT03940001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93174961|NCT03940001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174962|NCT03940001|Tubulin Modulators|tubulin modulators|mesh-ancestor
93174963|NCT03940001|Antimitotic Agents|antimitotic agents|mesh-ancestor
93174964|NCT03940001|Mitosis Modulators|mitosis modulators|mesh-ancestor
93174965|NCT03940001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174966|NCT01120769|Acetaminophen|acetaminophen|mesh-list
93174967|NCT01120769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93174968|NCT01120769|Analgesics|analgesics|mesh-ancestor
93174969|NCT01120769|Sensory System Agents|sensory system agents|mesh-ancestor
93174970|NCT01120769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93174971|NCT01120769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174972|NCT01120769|Antipyretics|antipyretics|mesh-ancestor
93174973|NCT03715413|Tamoxifen|tamoxifen|mesh-list
93174974|NCT03715413|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93174975|NCT03715413|Hormone Antagonists|hormone antagonists|mesh-ancestor
93174976|NCT03715413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93174977|NCT03715413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174978|NCT03715413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93174979|NCT03715413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93174980|NCT03715413|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93174981|NCT03715413|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93174982|NCT03715413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93174983|NCT01122251|Valsartan|valsartan|mesh-list
93174984|NCT01122251|Lercanidipine|lercanidipine|mesh-list
93174985|NCT01122251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93174986|NCT01122251|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93174987|NCT01122251|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93174988|NCT01122251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93174989|NCT01122251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93174990|NCT01122251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93174991|NCT01122251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93174992|NCT01122251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93174993|NCT04600999|Favipiravir|favipiravir|mesh-list
93174994|NCT04600999|Antiviral Agents|antiviral agents|mesh-ancestor
93174995|NCT04600999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93174996|NCT01199029|Prednisone|prednisone|mesh-list
93174997|NCT01199029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93174998|NCT01199029|Glucocorticoids|glucocorticoids|mesh-ancestor
93174999|NCT01199029|Hormones|hormones|mesh-ancestor
93175000|NCT01199029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175001|NCT01199029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175002|NCT01199029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93175003|NCT01199029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175004|NCT01200745|Capsaicin|capsaicin|mesh-list
93175005|NCT01200745|Antipruritics|antipruritics|mesh-ancestor
93175006|NCT01200745|Dermatologic Agents|dermatologic agents|mesh-ancestor
93175007|NCT01200745|Sensory System Agents|sensory system agents|mesh-ancestor
93175008|NCT01200745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175009|NCT01200745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175010|NCT01585415|Aldesleukin|aldesleukin|mesh-list
93175011|NCT01585415|Cyclophosphamide|cyclophosphamide|mesh-list
93175012|NCT01585415|Fludarabine|fludarabine|mesh-list
93175013|NCT01585415|Vemurafenib|vemurafenib|mesh-list
93175014|NCT01585415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175015|NCT01585415|Immunologic Factors|immunologic factors|mesh-ancestor
93175016|NCT01585415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175017|NCT01585415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175018|NCT01585415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175019|NCT01585415|Alkylating Agents|alkylating agents|mesh-ancestor
93175020|NCT01585415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175021|NCT01585415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175022|NCT01585415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93175023|NCT01585415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93175024|NCT01585415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93175025|NCT01585415|Antiviral Agents|antiviral agents|mesh-ancestor
93175026|NCT01585415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175027|NCT01585415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93175028|NCT01585415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175029|NCT01566643|Metronidazole|metronidazole|mesh-list
93175030|NCT01566643|Rabeprazole|rabeprazole|mesh-list
93175031|NCT01566643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175032|NCT01566643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93175033|NCT01566643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93175034|NCT01566643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93175035|NCT01566643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93175036|NCT01566643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93175037|NCT01566643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93175038|NCT01566643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175039|NCT01566643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175040|NCT03841747|Paclitaxel|paclitaxel|mesh-list
93175041|NCT03841747|Pembrolizumab|pembrolizumab|mesh-list
93175042|NCT03841747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93175043|NCT03841747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175044|NCT03841747|Tubulin Modulators|tubulin modulators|mesh-ancestor
93175045|NCT03841747|Antimitotic Agents|antimitotic agents|mesh-ancestor
93175046|NCT03841747|Mitosis Modulators|mitosis modulators|mesh-ancestor
93175047|NCT03841747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175048|NCT03841747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175049|NCT03841747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93175050|NCT01121237|Epoetin Alfa|epoetin alfa|mesh-list
93175051|NCT01121237|Hematinics|hematinics|mesh-ancestor
93175052|NCT03841591|Metformin|metformin|mesh-list
93175053|NCT03841591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175054|NCT03841591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175055|NCT05667727|Epinephrine|epinephrine|mesh-list
93175056|NCT05667727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93175057|NCT05667727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93175058|NCT05667727|Adrenergic Agents|adrenergic agents|mesh-ancestor
93175059|NCT05667727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175060|NCT05667727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175061|NCT05667727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175062|NCT05667727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93175063|NCT05667727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93175064|NCT05667727|Autonomic Agents|autonomic agents|mesh-ancestor
93175065|NCT05667727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175066|NCT05667727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93175067|NCT05667727|Respiratory System Agents|respiratory system agents|mesh-ancestor
93175068|NCT05667727|Mydriatics|mydriatics|mesh-ancestor
93175069|NCT05667727|Sympathomimetics|sympathomimetics|mesh-ancestor
93175070|NCT05667727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93175071|NCT01200901|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93175072|NCT01200901|Antidepressive Agents|antidepressive agents|mesh-ancestor
93175073|NCT01200901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175074|NCT01200901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93175075|NCT01200901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175076|NCT01200901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175077|NCT01200901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175078|NCT01212809|Hyaluronic Acid|hyaluronic acid|mesh-list
93175079|NCT01212809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93175080|NCT01212809|Immunologic Factors|immunologic factors|mesh-ancestor
93175081|NCT01212809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175082|NCT01212809|Viscosupplements|viscosupplements|mesh-ancestor
93175083|NCT01212809|Protective Agents|protective agents|mesh-ancestor
93175084|NCT01214993|Dolutegravir|dolutegravir|mesh-list
93175085|NCT01214993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93175086|NCT01214993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93175087|NCT01214993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175088|NCT01214993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175089|NCT01214993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93175090|NCT01214993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93175091|NCT01214993|Antiviral Agents|antiviral agents|mesh-ancestor
93175092|NCT01214993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175093|NCT03843229|Bufanolides|bufanolides|mesh-list
93175094|NCT03843229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93175095|NCT03843229|Protective Agents|protective agents|mesh-ancestor
93175096|NCT03843229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175097|NCT01212887|Aldesleukin|aldesleukin|mesh-list
93175098|NCT01212887|Cyclophosphamide|cyclophosphamide|mesh-list
93175099|NCT01212887|Fludarabine|fludarabine|mesh-list
93175100|NCT01212887|Fludarabine phosphate|fludarabine phosphate|mesh-list
93175101|NCT01212887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175102|NCT01212887|Immunologic Factors|immunologic factors|mesh-ancestor
93175103|NCT01212887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175104|NCT01212887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175105|NCT01212887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175106|NCT01212887|Alkylating Agents|alkylating agents|mesh-ancestor
93175107|NCT01212887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175108|NCT01212887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175109|NCT01212887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93175110|NCT01212887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175112|NCT01212887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93175113|NCT01212887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93175114|NCT01212887|Antiviral Agents|antiviral agents|mesh-ancestor
93175115|NCT01212887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175116|NCT01215149|Vaccines|vaccines|mesh-list
93175117|NCT01215149|Immunologic Factors|immunologic factors|mesh-ancestor
93175118|NCT01215149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175119|NCT03843307|Immunologic Factors|immunologic factors|mesh-list
93175120|NCT03843307|Immunomodulating Agents|immunomodulating agents|mesh-list
93175121|NCT03843307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175122|NCT04961281|Triamcinolone|triamcinolone|mesh-list
93175123|NCT04961281|Dexmedetomidine|dexmedetomidine|mesh-list
93175124|NCT04961281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93175125|NCT04961281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175126|NCT04961281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175127|NCT04961281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93175128|NCT04961281|Analgesics|analgesics|mesh-ancestor
93175129|NCT04961281|Sensory System Agents|sensory system agents|mesh-ancestor
93175130|NCT04961281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175131|NCT04961281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93175132|NCT04961281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93175133|NCT04961281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93175134|NCT04961281|Adrenergic Agents|adrenergic agents|mesh-ancestor
93175135|NCT04961281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175136|NCT04961281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175137|NCT04961281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175138|NCT04961281|Glucocorticoids|glucocorticoids|mesh-ancestor
93175139|NCT04961281|Hormones|hormones|mesh-ancestor
93175140|NCT04961281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175141|NCT01212965|Selenium|selenium|mesh-list
93175142|NCT01212965|Antioxidants|antioxidants|mesh-ancestor
93175143|NCT01212965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175144|NCT01212965|Protective Agents|protective agents|mesh-ancestor
93175145|NCT01212965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175146|NCT01212965|Trace Elements|trace elements|mesh-ancestor
93175147|NCT01212965|Micronutrients|micronutrients|mesh-ancestor
93175148|NCT02529449|Ipragliflozin|ipragliflozin|mesh-list
93175149|NCT02529449|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93175150|NCT02529449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175151|NCT02529449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175152|NCT02529449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175153|NCT01216709|Iron|iron|mesh-list
93175154|NCT01216709|Trace Elements|trace elements|mesh-ancestor
93175155|NCT01216709|Micronutrients|micronutrients|mesh-ancestor
93175156|NCT01216709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175157|NCT01216787|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93175158|NCT01216787|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93175159|NCT01216787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175160|NCT01216787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175161|NCT05282251|Bupivacaine|bupivacaine|mesh-list
93175162|NCT05282251|Anesthetics, Local|anesthetics, local|mesh-ancestor
93175163|NCT05282251|Anesthetics|anesthetics|mesh-ancestor
93175164|NCT05282251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175165|NCT05282251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175166|NCT05282251|Sensory System Agents|sensory system agents|mesh-ancestor
93175167|NCT05282251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175168|NCT01199341|Warfarin|warfarin|mesh-list
93175169|NCT01199341|Anticoagulants|anticoagulants|mesh-ancestor
93175170|NCT01215539|Panitumumab|panitumumab|mesh-list
93175171|NCT01215539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175172|NCT01215539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175173|NCT01203709|Mycophenolic Acid|mycophenolic acid|mesh-list
93175174|NCT01203709|Tacrolimus|tacrolimus|mesh-list
93175175|NCT01203709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175176|NCT01203709|Immunologic Factors|immunologic factors|mesh-ancestor
93175177|NCT01203709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175178|NCT01203709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93175179|NCT01203709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175180|NCT01203709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175181|NCT01203709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93175182|NCT01203709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175183|NCT01203709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93175184|NCT01203709|Antitubercular Agents|antitubercular agents|mesh-ancestor
93175185|NCT01203709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93175186|NCT01203709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175187|NCT01122407|Trimethaphan|trimethaphan|mesh-list
93175188|NCT01122407|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
93175189|NCT01122407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175190|NCT01122407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93175191|NCT01122407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93175192|NCT01122407|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
93175193|NCT01122407|Autonomic Agents|autonomic agents|mesh-ancestor
93175194|NCT01122407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175195|NCT01122407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175196|NCT01122407|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93175197|NCT01122407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93175198|NCT01122407|Cholinergic Agents|cholinergic agents|mesh-ancestor
93175199|NCT01122407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175200|NCT01122407|Vasodilator Agents|vasodilator agents|mesh-ancestor
93175201|NCT01213121|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93175202|NCT01213121|Antidepressive Agents|antidepressive agents|mesh-ancestor
93175203|NCT01213121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175204|NCT01213121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93175205|NCT01213121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175206|NCT01213121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175207|NCT01213121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175208|NCT01124435|Celecoxib|celecoxib|mesh-list
93175209|NCT01124435|Carboplatin|carboplatin|mesh-list
93175210|NCT01124435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175211|NCT01124435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93175212|NCT01124435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93175213|NCT01124435|Analgesics|analgesics|mesh-ancestor
93175214|NCT01124435|Sensory System Agents|sensory system agents|mesh-ancestor
93175215|NCT01124435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175216|NCT01124435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175217|NCT01124435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175218|NCT01124435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175219|NCT01124435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93175220|NCT01124435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93175221|NCT01124435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175222|NCT01124435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175223|NCT03294304|Gemcitabine|gemcitabine|mesh-list
93175224|NCT03294304|Nivolumab|nivolumab|mesh-list
93175225|NCT03294304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175226|NCT03294304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175227|NCT03294304|Antimetabolites|antimetabolites|mesh-ancestor
93175228|NCT03294304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175229|NCT03294304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175230|NCT03294304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93175231|NCT01201213|Anesthetics|anesthetics|mesh-list
93175232|NCT01201213|Anesthetics, Local|anesthetics, local|mesh-list
93175233|NCT01201213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175234|NCT01201213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175235|NCT01201213|Sensory System Agents|sensory system agents|mesh-ancestor
93175236|NCT01201213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175237|NCT03472378|Celecoxib|celecoxib|mesh-list
93175238|NCT03472378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93175239|NCT03472378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93175240|NCT03472378|Analgesics|analgesics|mesh-ancestor
93175241|NCT03472378|Sensory System Agents|sensory system agents|mesh-ancestor
93175242|NCT03472378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175243|NCT03472378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175244|NCT03472378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175245|NCT03472378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175246|NCT03472378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93175247|NCT03472378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93175248|NCT03472378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175249|NCT03472378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175250|NCT03408873|Aripiprazole|aripiprazole|mesh-list
93175251|NCT03408873|Antidepressive Agents|antidepressive agents|mesh-ancestor
93175252|NCT03408873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175253|NCT03408873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93175255|NCT03408873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175256|NCT03408873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175257|NCT03408873|Dopamine Agonists|dopamine agonists|mesh-ancestor
93175258|NCT03408873|Dopamine Agents|dopamine agents|mesh-ancestor
93175259|NCT03408873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175260|NCT03408873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175261|NCT03408873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93175262|NCT03408873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93175263|NCT03408873|Serotonin Agents|serotonin agents|mesh-ancestor
93175264|NCT03408873|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93175265|NCT03408873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93175266|NCT03408873|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93175267|NCT03408873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93175268|NCT03715101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93175269|NCT03715101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93175270|NCT03715101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93175271|NCT03715101|Antimetabolites|antimetabolites|mesh-ancestor
93175272|NCT03715101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175273|NCT03715101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93175274|NCT03715101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93175275|NCT03715101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175276|NCT03780959|Etanercept|etanercept|mesh-list
93175277|NCT03780959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93175278|NCT03780959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93175279|NCT03780959|Analgesics|analgesics|mesh-ancestor
93175280|NCT03780959|Sensory System Agents|sensory system agents|mesh-ancestor
93175281|NCT03780959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175282|NCT03780959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175283|NCT03780959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175284|NCT03780959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175285|NCT03780959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93175286|NCT03780959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175287|NCT03780959|Immunologic Factors|immunologic factors|mesh-ancestor
93175288|NCT03838783|Insulin|insulin|mesh-list
93175289|NCT03838783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175290|NCT03838783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175291|NCT03408639|Vitamin B 12|vitamin b 12|mesh-list
93175292|NCT03408639|Hydroxocobalamin|hydroxocobalamin|mesh-list
93175293|NCT03408639|Epoetin Alfa|epoetin alfa|mesh-list
93175294|NCT03408639|Vitamins|vitamins|mesh-ancestor
93175295|NCT03408639|Micronutrients|micronutrients|mesh-ancestor
93175296|NCT03408639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175297|NCT03408639|Vitamin B Complex|vitamin b complex|mesh-ancestor
93175298|NCT03408639|Hematinics|hematinics|mesh-ancestor
93175299|NCT01219205|Bevacizumab|bevacizumab|mesh-list
93175300|NCT01219205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175301|NCT01219205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175302|NCT01219205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93175303|NCT01219205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93175304|NCT01219205|Growth Substances|growth substances|mesh-ancestor
93175305|NCT01219205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175306|NCT01219205|Growth Inhibitors|growth inhibitors|mesh-ancestor
93175307|NCT03810235|Lidocaine|lidocaine|mesh-list
93175308|NCT03810235|Anesthetics, Local|anesthetics, local|mesh-ancestor
93175309|NCT03810235|Anesthetics|anesthetics|mesh-ancestor
93175310|NCT03810235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175311|NCT03810235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175312|NCT03810235|Sensory System Agents|sensory system agents|mesh-ancestor
93175313|NCT03810235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175314|NCT03810235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93175315|NCT03810235|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93175316|NCT03810235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93175317|NCT03810235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93175318|NCT03810235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175319|NCT03408483|Epinephrine|epinephrine|mesh-list
93175320|NCT03408483|Analgesics, Opioid|analgesics, opioid|mesh-list
93175321|NCT03408483|Bupivacaine|bupivacaine|mesh-list
93175322|NCT03408483|Anesthetics, Local|anesthetics, local|mesh-ancestor
93175323|NCT03408483|Anesthetics|anesthetics|mesh-ancestor
93175324|NCT03408483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175325|NCT03408483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175326|NCT03408483|Sensory System Agents|sensory system agents|mesh-ancestor
93175327|NCT03408483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175328|NCT03408483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93175329|NCT03408483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93175330|NCT03408483|Adrenergic Agents|adrenergic agents|mesh-ancestor
93175331|NCT03408483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175332|NCT03408483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175333|NCT03408483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93175334|NCT03408483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93175335|NCT03408483|Autonomic Agents|autonomic agents|mesh-ancestor
93175336|NCT03408483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93175337|NCT03408483|Respiratory System Agents|respiratory system agents|mesh-ancestor
93175338|NCT03408483|Mydriatics|mydriatics|mesh-ancestor
93175339|NCT03408483|Sympathomimetics|sympathomimetics|mesh-ancestor
93175340|NCT03408483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93175341|NCT03408483|Narcotics|narcotics|mesh-ancestor
93175342|NCT03408483|Analgesics|analgesics|mesh-ancestor
93175343|NCT03777917|Hyaluronic Acid|hyaluronic acid|mesh-list
93175344|NCT03777917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93175345|NCT03777917|Immunologic Factors|immunologic factors|mesh-ancestor
93175346|NCT03777917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175347|NCT03777917|Viscosupplements|viscosupplements|mesh-ancestor
93175348|NCT03777917|Protective Agents|protective agents|mesh-ancestor
93175349|NCT03715023|PC-786|pc-786|mesh-list
93175350|NCT03715023|Antiviral Agents|antiviral agents|mesh-ancestor
93175351|NCT03715023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175352|NCT03715023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175353|NCT03715023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175354|NCT03714867|Pregabalin|pregabalin|mesh-list
93175355|NCT03714867|Analgesics|analgesics|mesh-ancestor
93175356|NCT03714867|Sensory System Agents|sensory system agents|mesh-ancestor
93175357|NCT03714867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175358|NCT03714867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175359|NCT03714867|Anticonvulsants|anticonvulsants|mesh-ancestor
93175360|NCT03714867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93175361|NCT03714867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93175362|NCT03714867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175363|NCT03714867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93175364|NCT03714867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93175365|NCT03714867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175366|NCT03714867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175367|NCT03714867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175368|NCT01204177|Sorafenib|sorafenib|mesh-list
93175369|NCT01204177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175370|NCT01204177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93175371|NCT01204177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175372|NCT01204177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175373|NCT01217099|Azithromycin|azithromycin|mesh-list
93175374|NCT01217099|Methylprednisolone|methylprednisolone|mesh-list
93175375|NCT01217099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93175376|NCT01217099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93175377|NCT01217099|Prednisolone|prednisolone|mesh-list
93175378|NCT01217099|Prednisolone acetate|prednisolone acetate|mesh-list
93175379|NCT01217099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93175380|NCT01217099|Prednisolone phosphate|prednisolone phosphate|mesh-list
93175381|NCT01217099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175382|NCT01217099|Antiemetics|antiemetics|mesh-ancestor
93175383|NCT01217099|Autonomic Agents|autonomic agents|mesh-ancestor
93175384|NCT01217099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175385|NCT01217099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175386|NCT01217099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93175387|NCT01217099|Glucocorticoids|glucocorticoids|mesh-ancestor
93175388|NCT01217099|Hormones|hormones|mesh-ancestor
93175389|NCT01217099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175390|NCT01217099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93175391|NCT01217099|Protective Agents|protective agents|mesh-ancestor
93175392|NCT01217099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93175393|NCT01217099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175394|NCT01217099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93175395|NCT01217099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175396|NCT04305457|Nitric Oxide|nitric oxide|mesh-list
93175397|NCT04305457|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93175398|NCT04305457|Autonomic Agents|autonomic agents|mesh-ancestor
93175399|NCT04305457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175400|NCT04305457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175401|NCT04305457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93175402|NCT04305457|Respiratory System Agents|respiratory system agents|mesh-ancestor
93175403|NCT04305457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93175404|NCT04305457|Antioxidants|antioxidants|mesh-ancestor
93175405|NCT04305457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175406|NCT04305457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175407|NCT04305457|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93175408|NCT04305457|Vasodilator Agents|vasodilator agents|mesh-ancestor
93175409|NCT04305457|Gasotransmitters|gasotransmitters|mesh-ancestor
93175410|NCT04305457|Protective Agents|protective agents|mesh-ancestor
93175411|NCT01122563|Solifenacin Succinate|solifenacin succinate|mesh-list
93175412|NCT01122563|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93175413|NCT01122563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93175414|NCT01122563|Cholinergic Agents|cholinergic agents|mesh-ancestor
93175415|NCT01122563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175416|NCT01122563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175417|NCT01122563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175418|NCT01122563|Urological Agents|urological agents|mesh-ancestor
93175419|NCT01217177|Everolimus|everolimus|mesh-list
93175420|NCT01217177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93175421|NCT01217177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93175422|NCT01217177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175423|NCT01217177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175424|NCT01217177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175425|NCT01217177|Immunologic Factors|immunologic factors|mesh-ancestor
92855200|NCT02826746|Magnesium Sulfate|magnesium sulfate|mesh-list
93175426|NCT01217177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175427|NCT01217177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175428|NCT01204333|Heparin|heparin|mesh-list
93175429|NCT01204333|Anticoagulants|anticoagulants|mesh-ancestor
93175430|NCT01204333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93175431|NCT01204333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93175432|NCT01204333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175433|NCT02529059|Tenofovir|tenofovir|mesh-list
93175434|NCT02529059|Emtricitabine|emtricitabine|mesh-list
93175435|NCT02529059|Rilpivirine|rilpivirine|mesh-list
93175436|NCT02529059|Antiviral Agents|antiviral agents|mesh-ancestor
93175437|NCT02529059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175438|NCT02529059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93175439|NCT02529059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93175440|NCT02529059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175441|NCT02529059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175442|NCT02529059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93175443|NCT02529059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93175444|NCT03100058|Licogliflozin|licogliflozin|mesh-list
93175445|NCT03100058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93175446|NCT03100058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175447|NCT03100058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175448|NCT03100058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175449|NCT03933761|Pamiparib|pamiparib|mesh-list
93175450|NCT03933761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93175451|NCT03933761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175452|NCT03933761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175453|NCT03933761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175454|NCT03932123|Vancomycin|vancomycin|mesh-list
93175455|NCT03932123|Meropenem|meropenem|mesh-list
93175456|NCT03932123|Tazobactam|tazobactam|mesh-list
93175457|NCT03932123|Piperacillin|piperacillin|mesh-list
93175458|NCT03932123|Cefotaxime|cefotaxime|mesh-list
93175459|NCT03932123|Cefoxitin|cefoxitin|mesh-list
93175460|NCT03932123|Azlocillin|azlocillin|mesh-list
93175461|NCT03932123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93175462|NCT03932123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175463|NCT03932123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93175464|NCT03932123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175465|NCT03932123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175466|NCT02866279|Contraceptive Agents|contraceptive agents|mesh-list
93175467|NCT02866279|Etonogestrel|etonogestrel|mesh-list
93175468|NCT02866279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93175469|NCT02866279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175470|NCT02866279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93175471|NCT02866279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93175472|NCT01222169|Propofol|propofol|mesh-list
93175473|NCT01222169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93175474|NCT01222169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175475|NCT01222169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175476|NCT01222169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93175477|NCT01222169|Anesthetics, General|anesthetics, general|mesh-ancestor
93175478|NCT01222169|Anesthetics|anesthetics|mesh-ancestor
93175479|NCT02871778|Ivacaftor|ivacaftor|mesh-list
93175480|NCT02871778|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93175481|NCT02871778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93175482|NCT02871778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175483|NCT04947592|Fluconazole|fluconazole|mesh-list
93175484|NCT04947592|Antifungal Agents|antifungal agents|mesh-ancestor
93175485|NCT04947592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175486|NCT04947592|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93175487|NCT04947592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93175488|NCT04947592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175489|NCT04947592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175490|NCT04947592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93175491|NCT04947592|Hormone Antagonists|hormone antagonists|mesh-ancestor
93175492|NCT04947592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175493|NCT04947592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175494|NCT04947592|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93175495|NCT04947592|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93175496|NCT02735473|Choline|choline|mesh-list
93175497|NCT02735473|Lipotropic Agents|lipotropic agents|mesh-ancestor
93175498|NCT02735473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93175499|NCT02735473|Antimetabolites|antimetabolites|mesh-ancestor
91928470|NCT02403687|Amitriptyline|amitriptyline|mesh-list
93175500|NCT02735473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175501|NCT02735473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93175502|NCT02735473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93175503|NCT02735473|Nootropic Agents|nootropic agents|mesh-ancestor
93175504|NCT05156788|Lenvatinib|lenvatinib|mesh-list
93175505|NCT05156788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175506|NCT05156788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93175507|NCT05156788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175508|NCT05156788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175509|NCT04199767|Insulin|insulin|mesh-list
93175510|NCT04199767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93175511|NCT04199767|Insulin, Isophane|insulin, isophane|mesh-list
93175512|NCT04199767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175513|NCT04199767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175514|NCT01125059|Methadone|methadone|mesh-list
93175515|NCT01125059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93175516|NCT01125059|Narcotics|narcotics|mesh-ancestor
93175517|NCT01125059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175518|NCT01125059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175519|NCT01125059|Analgesics|analgesics|mesh-ancestor
93175520|NCT01125059|Sensory System Agents|sensory system agents|mesh-ancestor
93175521|NCT01125059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175522|NCT01125059|Antitussive Agents|antitussive agents|mesh-ancestor
93175523|NCT01125059|Respiratory System Agents|respiratory system agents|mesh-ancestor
93175524|NCT01204411|Artesunate|artesunate|mesh-list
93175525|NCT01204411|Amodiaquine|amodiaquine|mesh-list
93175526|NCT01204411|Antimalarials|antimalarials|mesh-ancestor
93175527|NCT01204411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93175528|NCT01204411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93175529|NCT01204411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175530|NCT01204411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175531|NCT01204411|Antiviral Agents|antiviral agents|mesh-ancestor
93175532|NCT01204411|Schistosomicides|schistosomicides|mesh-ancestor
93175533|NCT01204411|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93175534|NCT01204411|Anthelmintics|anthelmintics|mesh-ancestor
93175535|NCT01471444|Methotrexate|methotrexate|mesh-list
93175536|NCT01471444|Fludarabine phosphate|fludarabine phosphate|mesh-list
93175537|NCT01471444|Clofarabine|clofarabine|mesh-list
93175538|NCT01471444|Fludarabine|fludarabine|mesh-list
93175539|NCT01471444|Busulfan|busulfan|mesh-list
93175540|NCT01471444|Tacrolimus|tacrolimus|mesh-list
93175541|NCT01471444|Thymoglobulin|thymoglobulin|mesh-list
93175542|NCT01471444|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93175543|NCT01471444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93175544|NCT01471444|Abortifacient Agents|abortifacient agents|mesh-ancestor
93175545|NCT01471444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93175546|NCT01471444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175547|NCT01471444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175548|NCT01471444|Antimetabolites|antimetabolites|mesh-ancestor
93175549|NCT01471444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175550|NCT01471444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175551|NCT01471444|Dermatologic Agents|dermatologic agents|mesh-ancestor
93175552|NCT01471444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175553|NCT01471444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93175554|NCT01471444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175555|NCT01471444|Immunologic Factors|immunologic factors|mesh-ancestor
93175556|NCT01471444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175557|NCT01471444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93175558|NCT01471444|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93175559|NCT01471444|Alkylating Agents|alkylating agents|mesh-ancestor
93175560|NCT01471444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175561|NCT01471444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93175562|NCT05282407|Tenofovir|tenofovir|mesh-list
93175563|NCT05282407|Antiviral Agents|antiviral agents|mesh-ancestor
93175564|NCT05282407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175565|NCT05282407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93175566|NCT05282407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93175567|NCT05282407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175568|NCT05282407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175569|NCT05282407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93175570|NCT05282407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93175571|NCT04209686|Paclitaxel|paclitaxel|mesh-list
93175572|NCT04209686|Pembrolizumab|pembrolizumab|mesh-list
93175573|NCT04209686|Olaparib|olaparib|mesh-list
93175574|NCT04209686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93175575|NCT04209686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175576|NCT04209686|Tubulin Modulators|tubulin modulators|mesh-ancestor
93175577|NCT04209686|Antimitotic Agents|antimitotic agents|mesh-ancestor
93175578|NCT04209686|Mitosis Modulators|mitosis modulators|mesh-ancestor
93175579|NCT04209686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175580|NCT04209686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175581|NCT04209686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93175582|NCT04209686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93175583|NCT04209686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175584|NCT01125215|Capsaicin|capsaicin|mesh-list
93175585|NCT01125215|Antipruritics|antipruritics|mesh-ancestor
93175586|NCT01125215|Dermatologic Agents|dermatologic agents|mesh-ancestor
93175587|NCT01125215|Sensory System Agents|sensory system agents|mesh-ancestor
93175588|NCT01125215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175589|NCT01125215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175590|NCT01217723|Thymoglobulin|thymoglobulin|mesh-list
93175591|NCT01217723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93175592|NCT01217723|Immunologic Factors|immunologic factors|mesh-ancestor
93175593|NCT01217723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175594|NCT01217723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175595|NCT05162872|Niraparib|niraparib|mesh-list
93175596|NCT05162872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93175597|NCT05162872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175598|NCT05162872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175599|NCT05162872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175600|NCT01567111|Metomidate|metomidate|mesh-list
93175601|NCT01567111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93175602|NCT01567111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175603|NCT01567111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175604|NCT03955211|Acetaminophen|acetaminophen|mesh-list
93175605|NCT03955211|Ibuprofen|ibuprofen|mesh-list
93175606|NCT03955211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93175607|NCT03955211|Analgesics|analgesics|mesh-ancestor
93175608|NCT03955211|Sensory System Agents|sensory system agents|mesh-ancestor
93175609|NCT03955211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175610|NCT03955211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175611|NCT03955211|Antipyretics|antipyretics|mesh-ancestor
93175612|NCT03955211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93175613|NCT03955211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175614|NCT03955211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175615|NCT03955211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93175616|NCT03955211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175617|NCT03955211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175618|NCT03933605|Midazolam|midazolam|mesh-list
93175619|NCT03933605|Palonosetron|palonosetron|mesh-list
93175620|NCT03933605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93175621|NCT03933605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93175622|NCT03933605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175623|NCT03933605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175624|NCT03933605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93175625|NCT03933605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175626|NCT03933605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175627|NCT03933605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93175628|NCT03933605|Anesthetics, General|anesthetics, general|mesh-ancestor
93175629|NCT03933605|Anesthetics|anesthetics|mesh-ancestor
93175630|NCT03933605|GABA Modulators|gaba modulators|mesh-ancestor
93175631|NCT03933605|GABA Agents|gaba agents|mesh-ancestor
93175632|NCT03933605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175633|NCT03933605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175634|NCT03933605|Antiemetics|antiemetics|mesh-ancestor
93175635|NCT03933605|Autonomic Agents|autonomic agents|mesh-ancestor
93175636|NCT03933605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175637|NCT03933605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93175638|NCT03933605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93175639|NCT03933605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93175640|NCT03933605|Serotonin Agents|serotonin agents|mesh-ancestor
93175641|NCT03714789|Dialysis Solutions|dialysis solutions|mesh-list
93175642|NCT03714789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93175643|NCT01127477|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93175644|NCT01127477|Plasma Substitutes|plasma substitutes|mesh-ancestor
93175645|NCT01127477|Blood Substitutes|blood substitutes|mesh-ancestor
93175646|NCT05281861|Lithium Carbonate|lithium carbonate|mesh-list
93175647|NCT05281861|Antidepressive Agents|antidepressive agents|mesh-ancestor
93175648|NCT05281861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175649|NCT05281861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175650|NCT05281861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175651|NCT05281861|Antimanic Agents|antimanic agents|mesh-ancestor
93175652|NCT05281861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175653|NCT05281861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175654|NCT05281861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175655|NCT01311141|Doripenem|doripenem|mesh-list
93175656|NCT01311141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93175657|NCT01311141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175658|NCT01122641|Vildagliptin|vildagliptin|mesh-list
93175659|NCT01122641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175660|NCT01122641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175661|NCT01122641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93175662|NCT01122641|Protease Inhibitors|protease inhibitors|mesh-ancestor
93175663|NCT01122641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175664|NCT01122641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175665|NCT03714555|Copper|copper|mesh-list
93175666|NCT03714555|Paclitaxel|paclitaxel|mesh-list
93175667|NCT03714555|Gemcitabine|gemcitabine|mesh-list
93175668|NCT03714555|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93175669|NCT03714555|Folfirinox|folfirinox|mesh-list
93175670|NCT03714555|Disulfiram|disulfiram|mesh-list
93175671|NCT03714555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93175672|NCT03714555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175673|NCT03714555|Tubulin Modulators|tubulin modulators|mesh-ancestor
93175674|NCT03714555|Antimitotic Agents|antimitotic agents|mesh-ancestor
93175675|NCT03714555|Mitosis Modulators|mitosis modulators|mesh-ancestor
93175676|NCT03714555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175677|NCT03714555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175678|NCT03714555|Antimetabolites|antimetabolites|mesh-ancestor
93175679|NCT03714555|Trace Elements|trace elements|mesh-ancestor
93175680|NCT03714555|Micronutrients|micronutrients|mesh-ancestor
93175681|NCT03714555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175682|NCT03714555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93175683|NCT03714555|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93175684|NCT03714555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175685|NCT01125449|Ascorbic Acid|ascorbic acid|mesh-list
93175686|NCT01125449|Vitamins|vitamins|mesh-ancestor
93175687|NCT01125449|Micronutrients|micronutrients|mesh-ancestor
93175688|NCT01125449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175689|NCT01125449|Antioxidants|antioxidants|mesh-ancestor
93175690|NCT01125449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175691|NCT01125449|Protective Agents|protective agents|mesh-ancestor
93175692|NCT01206049|Bevacizumab|bevacizumab|mesh-list
93175693|NCT01206049|Panitumumab|panitumumab|mesh-list
93175694|NCT01206049|Gemcitabine|gemcitabine|mesh-list
93175695|NCT01206049|Capecitabine|capecitabine|mesh-list
93175696|NCT01206049|Oxaliplatin|oxaliplatin|mesh-list
93175697|NCT01206049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175698|NCT01206049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175699|NCT01206049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93175700|NCT01206049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93175701|NCT01206049|Growth Substances|growth substances|mesh-ancestor
93175702|NCT01206049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175703|NCT01206049|Growth Inhibitors|growth inhibitors|mesh-ancestor
93175704|NCT01206049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175705|NCT01206049|Antimetabolites|antimetabolites|mesh-ancestor
93175706|NCT01206049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847886|NCT02823912|Antacids|antacids|mesh-ancestor
93175707|NCT03931889|Vitamin D|vitamin d|mesh-list
93175708|NCT03931889|Cholecalciferol|cholecalciferol|mesh-list
93175709|NCT03931889|Vitamins|vitamins|mesh-ancestor
93175710|NCT03931889|Micronutrients|micronutrients|mesh-ancestor
93175711|NCT03931889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175712|NCT03931889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93175713|NCT03931889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93175714|NCT02953821|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93175715|NCT02953821|Hormones|hormones|mesh-ancestor
93175716|NCT02953821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175717|NCT02953821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175718|NCT01206205|Lenalidomide|lenalidomide|mesh-list
93175719|NCT01206205|Bortezomib|bortezomib|mesh-list
93175720|NCT01206205|Immunologic Factors|immunologic factors|mesh-ancestor
93175721|NCT01206205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175722|NCT01206205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93175723|NCT01206205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93175724|NCT01206205|Growth Substances|growth substances|mesh-ancestor
93175725|NCT01206205|Growth Inhibitors|growth inhibitors|mesh-ancestor
93175726|NCT01206205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175727|NCT03783923|Deflazacort|deflazacort|mesh-list
93175728|NCT03783923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175729|NCT03783923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175730|NCT03783923|Immunologic Factors|immunologic factors|mesh-ancestor
93175731|NCT03783923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175732|NCT03472144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93175733|NCT03472144|Levofloxacin|levofloxacin|mesh-list
93175734|NCT03472144|Ofloxacin|ofloxacin|mesh-list
93175735|NCT03472144|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93175736|NCT03472144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175737|NCT03472144|Antitubercular Agents|antitubercular agents|mesh-ancestor
93175738|NCT03472144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93175739|NCT03472144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93175740|NCT03472144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93175741|NCT03472144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175742|NCT03472144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175743|NCT03472144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175744|NCT03472144|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93175745|NCT03472144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93175746|NCT03417141|Mechlorethamine|mechlorethamine|mesh-list
93175747|NCT03417141|Alkylating Agents|alkylating agents|mesh-ancestor
93175748|NCT03417141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175749|NCT03417141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175750|NCT03417141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175751|NCT01219751|Sunitinib|sunitinib|mesh-list
93175752|NCT01219751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175753|NCT01219751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93175754|NCT01219751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93175755|NCT01219751|Growth Substances|growth substances|mesh-ancestor
93175756|NCT01219751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175757|NCT01219751|Growth Inhibitors|growth inhibitors|mesh-ancestor
93175758|NCT01219751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93175759|NCT01219751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175760|NCT01219751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175761|NCT04823091|Cyclophosphamide|cyclophosphamide|mesh-list
93175762|NCT04823091|Fludarabine|fludarabine|mesh-list
93175763|NCT04823091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175764|NCT04823091|Immunologic Factors|immunologic factors|mesh-ancestor
93175765|NCT04823091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175766|NCT04823091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175767|NCT04823091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175768|NCT04823091|Alkylating Agents|alkylating agents|mesh-ancestor
93175769|NCT04823091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175770|NCT04823091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175771|NCT04823091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93175772|NCT01125527|Vaccines|vaccines|mesh-list
93175773|NCT01125527|Immunologic Factors|immunologic factors|mesh-ancestor
93175774|NCT01125527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175775|NCT01298401|Gemcitabine|gemcitabine|mesh-list
93175776|NCT01298401|Capecitabine|capecitabine|mesh-list
93175777|NCT01298401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175778|NCT01298401|Antimetabolites|antimetabolites|mesh-ancestor
93175779|NCT01298401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175780|NCT01298401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175781|NCT03931343|Epinephrine|epinephrine|mesh-list
93175782|NCT03931343|Racepinephrine|racepinephrine|mesh-list
93175783|NCT03931343|Bupivacaine|bupivacaine|mesh-list
93175784|NCT03931343|Epinephryl borate|epinephryl borate|mesh-list
93175785|NCT03931343|Anesthetics, Local|anesthetics, local|mesh-ancestor
93175786|NCT03931343|Anesthetics|anesthetics|mesh-ancestor
93175787|NCT03931343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175788|NCT03931343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175789|NCT03931343|Sensory System Agents|sensory system agents|mesh-ancestor
93175790|NCT03931343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175791|NCT03931343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93175792|NCT03931343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93175793|NCT03931343|Adrenergic Agents|adrenergic agents|mesh-ancestor
93175794|NCT03931343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175795|NCT03931343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175796|NCT03931343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93175797|NCT03931343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93175798|NCT03931343|Autonomic Agents|autonomic agents|mesh-ancestor
93175799|NCT03931343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93175800|NCT03931343|Respiratory System Agents|respiratory system agents|mesh-ancestor
93175801|NCT03931343|Mydriatics|mydriatics|mesh-ancestor
93175802|NCT03931343|Sympathomimetics|sympathomimetics|mesh-ancestor
93175803|NCT03931343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93175804|NCT04867798|Tenofovir|tenofovir|mesh-list
93175805|NCT04867798|Lamivudine|lamivudine|mesh-list
93175806|NCT04867798|Antiviral Agents|antiviral agents|mesh-ancestor
93175807|NCT04867798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175808|NCT04867798|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93175809|NCT04867798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93175810|NCT04867798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175811|NCT04867798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175812|NCT04867798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93175813|NCT04867798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93175814|NCT01122953|Phenytoin|phenytoin|mesh-list
93175815|NCT01122953|Anticonvulsants|anticonvulsants|mesh-ancestor
93175816|NCT01122953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93175817|NCT01122953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93175818|NCT01122953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93175819|NCT01122953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175820|NCT01122953|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93175821|NCT01122953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93175822|NCT01125683|Donepezil|donepezil|mesh-list
93175823|NCT01125683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93175824|NCT01125683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175825|NCT01125683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175826|NCT01125683|Cholinergic Agents|cholinergic agents|mesh-ancestor
93175827|NCT01125683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175828|NCT01125683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175829|NCT01125683|Nootropic Agents|nootropic agents|mesh-ancestor
93175830|NCT01127555|Leucovorin|leucovorin|mesh-list
93175831|NCT01127555|Fluorouracil|fluorouracil|mesh-list
93175832|NCT01127555|Oxaliplatin|oxaliplatin|mesh-list
93175833|NCT01127555|Antimetabolites|antimetabolites|mesh-ancestor
93175834|NCT01127555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175835|NCT01127555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175836|NCT01127555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175837|NCT01127555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175838|NCT01127555|Immunologic Factors|immunologic factors|mesh-ancestor
93175839|NCT01127555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175840|NCT01127555|Antidotes|antidotes|mesh-ancestor
93175841|NCT01127555|Protective Agents|protective agents|mesh-ancestor
93175842|NCT01127555|Vitamin B Complex|vitamin b complex|mesh-ancestor
93175843|NCT01127555|Vitamins|vitamins|mesh-ancestor
93175844|NCT01127555|Micronutrients|micronutrients|mesh-ancestor
93175845|NCT01219907|Cyclophosphamide|cyclophosphamide|mesh-list
93175846|NCT01219907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175847|NCT01219907|Immunologic Factors|immunologic factors|mesh-ancestor
93175848|NCT01219907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175849|NCT01219907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175850|NCT01219907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175851|NCT01219907|Alkylating Agents|alkylating agents|mesh-ancestor
93175852|NCT01219907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175853|NCT01219907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175854|NCT01219907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93175855|NCT03471988|Voriconazole|voriconazole|mesh-list
93175856|NCT03471988|Antifungal Agents|antifungal agents|mesh-ancestor
93175857|NCT03471988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175858|NCT03471988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93175859|NCT03471988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93175860|NCT03471988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175861|NCT03471988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175862|NCT03471988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93175863|NCT03471988|Hormone Antagonists|hormone antagonists|mesh-ancestor
93175864|NCT03471988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175865|NCT03471988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175866|NCT03471988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93175867|NCT03724981|Dulaglutide|dulaglutide|mesh-list
93175868|NCT03724981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175869|NCT03724981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175870|NCT03442569|Nivolumab|nivolumab|mesh-list
93175871|NCT03442569|Ipilimumab|ipilimumab|mesh-list
93175872|NCT03442569|Panitumumab|panitumumab|mesh-list
93175873|NCT03442569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93175874|NCT03442569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175875|NCT03442569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93175876|NCT03442569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175877|NCT01123031|Esomeprazole|esomeprazole|mesh-list
93175878|NCT01123031|Lansoprazole|lansoprazole|mesh-list
93175879|NCT01123031|Dexlansoprazole|dexlansoprazole|mesh-list
93175880|NCT01123031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93175881|NCT01123031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93175882|NCT01123031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93175883|NCT01123031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175884|NCT01123031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175885|NCT01220063|Irinotecan|irinotecan|mesh-list
93175886|NCT01220063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93175887|NCT01220063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93175888|NCT01220063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175889|NCT01220063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175890|NCT01220063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175891|NCT01298713|Tamoxifen|tamoxifen|mesh-list
93175892|NCT01298713|Everolimus|everolimus|mesh-list
93175893|NCT01298713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93175894|NCT01298713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93175895|NCT01298713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93175896|NCT01298713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175897|NCT01298713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175898|NCT01298713|Immunologic Factors|immunologic factors|mesh-ancestor
93175899|NCT01298713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175900|NCT01298713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175901|NCT01298713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93175902|NCT01298713|Hormone Antagonists|hormone antagonists|mesh-ancestor
93175903|NCT01298713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175904|NCT01298713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93175905|NCT01298713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93175906|NCT01298713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93175907|NCT01298713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93175908|NCT01223339|Ertugliflozin|ertugliflozin|mesh-list
93175909|NCT01223339|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93175910|NCT01223339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175911|NCT01223339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93175912|NCT01223339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175913|NCT01217879|Telmisartan|telmisartan|mesh-list
93175914|NCT01217879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93175915|NCT01217879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93175916|NCT01217879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93175917|NCT01217879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175918|NCT01218035|Zoledronic Acid|zoledronic acid|mesh-list
93175919|NCT01218035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93175920|NCT01218035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175921|NCT04249310|Tiotropium Bromide|tiotropium bromide|mesh-list
93175922|NCT04249310|Olodaterol|olodaterol|mesh-list
93175923|NCT04249310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93175924|NCT04249310|Autonomic Agents|autonomic agents|mesh-ancestor
93175925|NCT04249310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175926|NCT04249310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175927|NCT04249310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93175928|NCT04249310|Respiratory System Agents|respiratory system agents|mesh-ancestor
93175929|NCT04249310|Parasympatholytics|parasympatholytics|mesh-ancestor
93175931|NCT04249310|Cholinergic Agents|cholinergic agents|mesh-ancestor
93175932|NCT04249310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93175933|NCT04249310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175934|NCT05665075|Cytarabine|cytarabine|mesh-list
93175935|NCT05665075|Cyclophosphamide|cyclophosphamide|mesh-list
93175936|NCT05665075|Fludarabine|fludarabine|mesh-list
93175937|NCT05665075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93175938|NCT05665075|Immunologic Factors|immunologic factors|mesh-ancestor
93175939|NCT05665075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175940|NCT05665075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93175941|NCT05665075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175942|NCT05665075|Alkylating Agents|alkylating agents|mesh-ancestor
93175943|NCT05665075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175944|NCT05665075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175945|NCT05665075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93175946|NCT05665075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93175947|NCT05665075|Antimetabolites|antimetabolites|mesh-ancestor
93175948|NCT05665075|Antiviral Agents|antiviral agents|mesh-ancestor
93175949|NCT05665075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175950|NCT03714165|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93175951|NCT03714165|alpha-Defensins|alpha-defensins|mesh-list
93175952|NCT03714165|Defensins|defensins|mesh-list
93175953|NCT03714165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93175954|NCT03442101|Antipsychotic Agents|antipsychotic agents|mesh-list
93175955|NCT03442101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175956|NCT03442101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175957|NCT03442101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175958|NCT03442101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175959|NCT03932825|Nitrous Oxide|nitrous oxide|mesh-list
93175960|NCT03932825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93175961|NCT03932825|Anesthetics, General|anesthetics, general|mesh-ancestor
93175962|NCT03932825|Anesthetics|anesthetics|mesh-ancestor
93175963|NCT03932825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175964|NCT03932825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175965|NCT03932825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93175966|NCT03932825|Analgesics|analgesics|mesh-ancestor
93175967|NCT03932825|Sensory System Agents|sensory system agents|mesh-ancestor
93175968|NCT03932825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175969|NCT03932981|Temozolomide|temozolomide|mesh-list
93175970|NCT03932981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93175971|NCT03932981|Alkylating Agents|alkylating agents|mesh-ancestor
93175972|NCT03932981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175973|NCT03932981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93175974|NCT01220219|Pregabalin|pregabalin|mesh-list
93175975|NCT01220219|Analgesics|analgesics|mesh-ancestor
93175976|NCT01220219|Sensory System Agents|sensory system agents|mesh-ancestor
93175977|NCT01220219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93175978|NCT01220219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175979|NCT01220219|Anticonvulsants|anticonvulsants|mesh-ancestor
93175980|NCT01220219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93175981|NCT01220219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93175982|NCT01220219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93175983|NCT01220219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93175984|NCT01220219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93175985|NCT01220219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93175986|NCT01220219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93175987|NCT01220219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93175988|NCT03441789|Betamethasone|betamethasone|mesh-list
93175989|NCT03441789|Betamethasone Valerate|betamethasone valerate|mesh-list
93175990|NCT03441789|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93175991|NCT03441789|Betamethasone benzoate|betamethasone benzoate|mesh-list
93175992|NCT03441789|Calcipotriene|calcipotriene|mesh-list
93175993|NCT03441789|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93175994|NCT03441789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93175995|NCT03441789|Glucocorticoids|glucocorticoids|mesh-ancestor
93175996|NCT03441789|Hormones|hormones|mesh-ancestor
93175997|NCT03441789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93175998|NCT03441789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93175999|NCT03441789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93176000|NCT03441789|Respiratory System Agents|respiratory system agents|mesh-ancestor
93176001|NCT03441789|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176002|NCT03359005|Vincristine|vincristine|mesh-list
93176003|NCT03359005|Temozolomide|temozolomide|mesh-list
92848216|NCT00634140|Ezetimibe|ezetimibe|mesh-list
93176004|NCT03359005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93176005|NCT03359005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176006|NCT03359005|Tubulin Modulators|tubulin modulators|mesh-ancestor
93176007|NCT03359005|Antimitotic Agents|antimitotic agents|mesh-ancestor
93176008|NCT03359005|Mitosis Modulators|mitosis modulators|mesh-ancestor
93176009|NCT03359005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176010|NCT03359005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93176011|NCT03359005|Alkylating Agents|alkylating agents|mesh-ancestor
93176013|NCT04321174|Lopinavir|lopinavir|mesh-list
93176014|NCT04321174|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93176015|NCT04321174|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93176016|NCT04321174|Protease Inhibitors|protease inhibitors|mesh-ancestor
93176017|NCT04321174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176018|NCT04321174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176019|NCT04321174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93176020|NCT04321174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93176021|NCT04321174|Antiviral Agents|antiviral agents|mesh-ancestor
93176022|NCT04321174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176023|NCT04321174|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93176024|NCT04321174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93176025|NCT01123265|Methotrexate|methotrexate|mesh-list
93176026|NCT01123265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93176027|NCT01123265|Abortifacient Agents|abortifacient agents|mesh-ancestor
93176028|NCT01123265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93176029|NCT01123265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176030|NCT01123265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93176031|NCT01123265|Antimetabolites|antimetabolites|mesh-ancestor
93176032|NCT01123265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176033|NCT01123265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176034|NCT01123265|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176035|NCT01123265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176036|NCT01123265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93176037|NCT01123265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176038|NCT01123265|Immunologic Factors|immunologic factors|mesh-ancestor
93176039|NCT01123265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176040|NCT01123265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93176041|NCT01204723|Aprepitant|aprepitant|mesh-list
93176042|NCT01204723|Fosaprepitant|fosaprepitant|mesh-list
93176043|NCT01204723|Antiemetics|antiemetics|mesh-ancestor
93176044|NCT01204723|Autonomic Agents|autonomic agents|mesh-ancestor
93176045|NCT01204723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176046|NCT01204723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176047|NCT01204723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176048|NCT01204723|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93176049|NCT01204723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176050|NCT01204723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176051|NCT01204801|Doxorubicin|doxorubicin|mesh-list
93176052|NCT01204801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93176053|NCT01204801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93176054|NCT01204801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176055|NCT01204801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93176056|NCT01204801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93176057|NCT01204801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176058|NCT01204801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176059|NCT04194814|Betamethasone|betamethasone|mesh-list
93176060|NCT04194814|Betamethasone Valerate|betamethasone valerate|mesh-list
93176061|NCT04194814|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93176062|NCT04194814|Betamethasone benzoate|betamethasone benzoate|mesh-list
93176063|NCT04194814|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93176064|NCT04194814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176065|NCT04194814|Glucocorticoids|glucocorticoids|mesh-ancestor
93176066|NCT04194814|Hormones|hormones|mesh-ancestor
93176067|NCT04194814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176068|NCT04194814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176069|NCT04194814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93176070|NCT04194814|Respiratory System Agents|respiratory system agents|mesh-ancestor
93176071|NCT03832621|Nivolumab|nivolumab|mesh-list
93176072|NCT03832621|Ipilimumab|ipilimumab|mesh-list
93176073|NCT03832621|Temozolomide|temozolomide|mesh-list
93176074|NCT03832621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176075|NCT03832621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176076|NCT03832621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92848272|NCT02817750|Zolpidem|zolpidem|mesh-list
93176077|NCT03832621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176078|NCT03832621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93176079|NCT03832621|Alkylating Agents|alkylating agents|mesh-ancestor
93176080|NCT01220375|Plerixafor|plerixafor|mesh-list
93176081|NCT01220375|Vinorelbine|vinorelbine|mesh-list
93176082|NCT01220375|Lenograstim|lenograstim|mesh-list
93176083|NCT01220375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93176084|NCT01220375|Immunologic Factors|immunologic factors|mesh-ancestor
93176085|NCT01220375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176086|NCT01220375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93176087|NCT01220375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176088|NCT01220375|Tubulin Modulators|tubulin modulators|mesh-ancestor
93176089|NCT01220375|Antimitotic Agents|antimitotic agents|mesh-ancestor
93176090|NCT01220375|Mitosis Modulators|mitosis modulators|mesh-ancestor
93176091|NCT01220375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176092|NCT01220375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93176093|NCT01220375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93176094|NCT01220375|Antiviral Agents|antiviral agents|mesh-ancestor
93176095|NCT01220375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176096|NCT01223729|Acetylcarnitine|acetylcarnitine|mesh-list
93176097|NCT01223729|Vitamin B Complex|vitamin b complex|mesh-ancestor
93176098|NCT01223729|Vitamins|vitamins|mesh-ancestor
93176099|NCT01223729|Micronutrients|micronutrients|mesh-ancestor
93176100|NCT01223729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176101|NCT01223729|Nootropic Agents|nootropic agents|mesh-ancestor
93176103|NCT01126073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93176104|NCT01126073|Antimetabolites|antimetabolites|mesh-ancestor
93176105|NCT01126073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176106|NCT01126073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93176107|NCT01126073|Vasodilator Agents|vasodilator agents|mesh-ancestor
93176108|NCT01126073|Vitamin B Complex|vitamin b complex|mesh-ancestor
93176109|NCT01126073|Vitamins|vitamins|mesh-ancestor
93176110|NCT01126073|Micronutrients|micronutrients|mesh-ancestor
93176111|NCT01126073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176112|NCT03287050|Pembrolizumab|pembrolizumab|mesh-list
93176113|NCT03287050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176114|NCT03287050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176115|NCT03287050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93176116|NCT03287050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176117|NCT05470881|Atropine|atropine|mesh-list
93176118|NCT05470881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93176119|NCT05470881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93176120|NCT05470881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93176121|NCT05470881|Autonomic Agents|autonomic agents|mesh-ancestor
93176122|NCT05470881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176123|NCT05470881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176124|NCT05470881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93176125|NCT05470881|Respiratory System Agents|respiratory system agents|mesh-ancestor
93176126|NCT05470881|Mydriatics|mydriatics|mesh-ancestor
93176127|NCT05470881|Parasympatholytics|parasympatholytics|mesh-ancestor
93176128|NCT05470881|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93176129|NCT05470881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93176130|NCT05470881|Cholinergic Agents|cholinergic agents|mesh-ancestor
93176131|NCT05470881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176132|NCT05470881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176133|NCT03130504|Progesterone|progesterone|mesh-list
93176134|NCT03130504|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93176135|NCT03130504|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93176136|NCT03130504|Progestins|progestins|mesh-ancestor
93176137|NCT03130504|Hormones|hormones|mesh-ancestor
93176138|NCT03130504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176139|NCT03130504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176140|NCT03130504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93176141|NCT03130504|Hormone Antagonists|hormone antagonists|mesh-ancestor
93176142|NCT03819127|Metformin|metformin|mesh-list
93176143|NCT03819127|Vildagliptin|vildagliptin|mesh-list
93176144|NCT03819127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93176145|NCT03819127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176146|NCT03819127|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93176147|NCT03819127|Protease Inhibitors|protease inhibitors|mesh-ancestor
93176148|NCT03819127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176149|NCT03819127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176150|NCT02908789|Anti-Infective Agents|anti-infective agents|mesh-list
93176151|NCT02908789|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93176152|NCT05607550|Aflutinib|aflutinib|mesh-list
93176153|NCT05607550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93176155|NCT05607550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176156|NCT01299181|Atorvastatin|atorvastatin|mesh-list
93176157|NCT01299181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93176158|NCT01299181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93176159|NCT01299181|Antimetabolites|antimetabolites|mesh-ancestor
93176160|NCT01299181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176161|NCT01299181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93176162|NCT01299181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93176163|NCT01299181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176164|NCT03930875|Aspirin|aspirin|mesh-list
93176165|NCT03930875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93176166|NCT03930875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93176167|NCT03930875|Analgesics|analgesics|mesh-ancestor
93176168|NCT03930875|Sensory System Agents|sensory system agents|mesh-ancestor
93176169|NCT03930875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176170|NCT03930875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176171|NCT03930875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176172|NCT03930875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176173|NCT03930875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93176174|NCT03930875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93176175|NCT03930875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176176|NCT03930875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93176177|NCT03930875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93176178|NCT03930875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176179|NCT03930875|Antipyretics|antipyretics|mesh-ancestor
93176180|NCT01206907|Oxymorphone|oxymorphone|mesh-list
93176181|NCT01206907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93176182|NCT01206907|Narcotics|narcotics|mesh-ancestor
93176183|NCT01206907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93176184|NCT01206907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176185|NCT01206907|Analgesics|analgesics|mesh-ancestor
93176186|NCT01206907|Sensory System Agents|sensory system agents|mesh-ancestor
93176187|NCT01206907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176188|NCT01206907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93176189|NCT03925246|Nivolumab|nivolumab|mesh-list
93176190|NCT03925246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176191|NCT03925246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176192|NCT03925246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93176193|NCT03925246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176194|NCT01218347|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93176195|NCT01218347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93176196|NCT01218347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93176197|NCT01218347|Antimetabolites|antimetabolites|mesh-ancestor
93176198|NCT01218347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176199|NCT01218347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93176200|NCT01218347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93176201|NCT01218347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176202|NCT01126229|Resveratrol|resveratrol|mesh-list
93176203|NCT01126229|Antioxidants|antioxidants|mesh-ancestor
93176204|NCT01126229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176205|NCT01126229|Protective Agents|protective agents|mesh-ancestor
93176206|NCT01126229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176207|NCT01126229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176208|NCT01126229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93176209|NCT03474640|Antibodies|antibodies|mesh-list
93176210|NCT03474640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93176211|NCT03474640|Immunologic Factors|immunologic factors|mesh-ancestor
93176212|NCT03474640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176213|NCT01126307|Verapamil|verapamil|mesh-list
93176214|NCT01126307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93176215|NCT01126307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93176216|NCT01126307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176217|NCT01126307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176218|NCT01126307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93176219|NCT01126307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176220|NCT01126307|Vasodilator Agents|vasodilator agents|mesh-ancestor
93176221|NCT03439137|Darbepoetin alfa|darbepoetin alfa|mesh-list
93176222|NCT03439137|Hematinics|hematinics|mesh-ancestor
93176223|NCT04173338|Pemetrexed|pemetrexed|mesh-list
93176224|NCT04173338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176225|NCT04173338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176226|NCT04173338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176227|NCT04173338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93176228|NCT04173338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93176229|NCT03936491|Methylphenidate|methylphenidate|mesh-list
93176230|NCT03936491|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93176231|NCT03936491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93176232|NCT03936491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176233|NCT03936491|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93176234|NCT03936491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93176235|NCT03936491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176236|NCT03936491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176237|NCT03936491|Dopamine Agents|dopamine agents|mesh-ancestor
93176238|NCT03936491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176239|NCT03936491|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93176240|NCT03936491|Adrenergic Agents|adrenergic agents|mesh-ancestor
93176241|NCT00890617|Prednisone|prednisone|mesh-list
93176242|NCT00890617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176243|NCT00890617|Glucocorticoids|glucocorticoids|mesh-ancestor
93176244|NCT00890617|Hormones|hormones|mesh-ancestor
93176245|NCT00890617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176246|NCT00890617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176247|NCT00890617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93176248|NCT00890617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176249|NCT03468946|Caffeine|caffeine|mesh-list
93176250|NCT03468946|Citric Acid|citric acid|mesh-list
93176251|NCT03468946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93176252|NCT03468946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176253|NCT03468946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93176254|NCT03468946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176255|NCT03468946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176256|NCT03468946|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93176257|NCT03468946|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93176258|NCT03468946|Purinergic Agents|purinergic agents|mesh-ancestor
93176259|NCT03468946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176260|NCT03468946|Anticoagulants|anticoagulants|mesh-ancestor
93176261|NCT03468946|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93176262|NCT03468946|Chelating Agents|chelating agents|mesh-ancestor
93176263|NCT03468946|Sequestering Agents|sequestering agents|mesh-ancestor
93176264|NCT01218425|Levodopa|levodopa|mesh-list
93176265|NCT01218425|Carbidopa|carbidopa|mesh-list
93176266|NCT01218425|Domperidone|domperidone|mesh-list
93176267|NCT01218425|Methylphenidate|methylphenidate|mesh-list
93176268|NCT01218425|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93176269|NCT01218425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176270|NCT01218425|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93176271|NCT01218425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93176272|NCT01218425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176273|NCT01218425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176274|NCT01218425|Dopamine Agents|dopamine agents|mesh-ancestor
93176275|NCT01218425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176276|NCT01218425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93176277|NCT01218425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93176278|NCT01218425|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93176279|NCT01218425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176280|NCT01218425|Antiemetics|antiemetics|mesh-ancestor
93176281|NCT01218425|Autonomic Agents|autonomic agents|mesh-ancestor
93176282|NCT01218425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176283|NCT01218425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176284|NCT01218425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93176285|NCT05621005|Rifaximin|rifaximin|mesh-list
93176286|NCT05621005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93176287|NCT05621005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176288|NCT05621005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176289|NCT01224041|Tacrolimus|tacrolimus|mesh-list
93176290|NCT01224041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176291|NCT01224041|Immunologic Factors|immunologic factors|mesh-ancestor
93176292|NCT01224041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176293|NCT01224041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93176294|NCT01224041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176295|NCT01224041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176296|NCT03181828|Acetohydroxamic acid|acetohydroxamic acid|mesh-list
93176297|NCT03181828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176298|NCT03181828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176299|NCT01123811|Cetuximab|cetuximab|mesh-list
93176300|NCT01123811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176301|NCT01123811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176302|NCT01128101|Spironolactone|spironolactone|mesh-list
93176303|NCT01128101|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93176304|NCT01128101|Hormone Antagonists|hormone antagonists|mesh-ancestor
93176305|NCT01128101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176306|NCT01128101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176307|NCT01128101|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93176308|NCT01128101|Diuretics|diuretics|mesh-ancestor
93176309|NCT01128101|Natriuretic Agents|natriuretic agents|mesh-ancestor
93176310|NCT01299415|Vadimezan|vadimezan|mesh-list
93176311|NCT01299415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176312|NCT01123967|Nicotine|nicotine|mesh-list
93176313|NCT01123967|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93176314|NCT01123967|Autonomic Agents|autonomic agents|mesh-ancestor
93176315|NCT01123967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176316|NCT01123967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176317|NCT01123967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93176318|NCT01123967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93176319|NCT01123967|Cholinergic Agents|cholinergic agents|mesh-ancestor
93176320|NCT01123967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176321|NCT01123967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176322|NCT01126463|Ethiodized Oil|ethiodized oil|mesh-list
93176323|NCT01126463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176324|NCT01126697|Ubiquinone|ubiquinone|mesh-list
93176325|NCT01126697|Coenzyme Q10|coenzyme q10|mesh-list
93176326|NCT01126697|Lisinopril|lisinopril|mesh-list
93176327|NCT01126697|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93176328|NCT01126697|Protease Inhibitors|protease inhibitors|mesh-ancestor
93176329|NCT01126697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176330|NCT01126697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176331|NCT01126697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93176332|NCT01126697|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93176333|NCT01126697|Protective Agents|protective agents|mesh-ancestor
93176334|NCT01126697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176335|NCT01126697|Micronutrients|micronutrients|mesh-ancestor
93176336|NCT01126697|Vitamins|vitamins|mesh-ancestor
93176337|NCT01220843|Sevelamer|sevelamer|mesh-list
93176338|NCT01220843|Chelating Agents|chelating agents|mesh-ancestor
93176339|NCT01220843|Sequestering Agents|sequestering agents|mesh-ancestor
93176340|NCT01220843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176341|NCT02804932|Methamphetamine|methamphetamine|mesh-list
93176342|NCT02804932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93176343|NCT02804932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176344|NCT02804932|Sympathomimetics|sympathomimetics|mesh-ancestor
93176345|NCT02804932|Autonomic Agents|autonomic agents|mesh-ancestor
93176346|NCT02804932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176347|NCT02804932|Dopamine Agents|dopamine agents|mesh-ancestor
93176348|NCT02804932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176349|NCT02804932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176350|NCT02804932|Adrenergic Agents|adrenergic agents|mesh-ancestor
93176351|NCT02804932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93176352|NCT02804932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93176353|NCT02804932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176354|NCT02804932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93176355|NCT03468790|Fluticasone|fluticasone|mesh-list
93176356|NCT03468790|Xhance|xhance|mesh-list
93176357|NCT03468790|Budesonide|budesonide|mesh-list
93176358|NCT03468790|Albuterol|albuterol|mesh-list
93176359|NCT03468790|Formoterol Fumarate|formoterol fumarate|mesh-list
93176360|NCT03468790|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93176361|NCT03468790|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93176362|NCT03468790|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93176363|NCT03468790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176364|NCT03468790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93176365|NCT03468790|Autonomic Agents|autonomic agents|mesh-ancestor
93176366|NCT03468790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176367|NCT03468790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176368|NCT03468790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93176369|NCT03468790|Respiratory System Agents|respiratory system agents|mesh-ancestor
93176370|NCT03468790|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176371|NCT03468790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93176372|NCT03468790|Glucocorticoids|glucocorticoids|mesh-ancestor
93176373|NCT03468790|Hormones|hormones|mesh-ancestor
93366315|NCT02058485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176374|NCT03468790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176375|NCT03468790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93176376|NCT03468790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93176377|NCT03468790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93176378|NCT03468790|Adrenergic Agents|adrenergic agents|mesh-ancestor
93176379|NCT03468790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176380|NCT03468790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176381|NCT03468790|Tocolytic Agents|tocolytic agents|mesh-ancestor
93176382|NCT03468790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93176383|NCT03468790|Sympathomimetics|sympathomimetics|mesh-ancestor
93176384|NCT01224197|Simeprevir|simeprevir|mesh-list
93176385|NCT01224197|Antiviral Agents|antiviral agents|mesh-ancestor
93176386|NCT01224197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176387|NCT01224197|Protease Inhibitors|protease inhibitors|mesh-ancestor
93176388|NCT01224197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176389|NCT01224197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176390|NCT01224353|Thioctic Acid|thioctic acid|mesh-list
93176391|NCT01224353|Antioxidants|antioxidants|mesh-ancestor
93176392|NCT01224353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176393|NCT01224353|Protective Agents|protective agents|mesh-ancestor
93176394|NCT01224353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176395|NCT01224353|Vitamin B Complex|vitamin b complex|mesh-ancestor
93176396|NCT01224353|Vitamins|vitamins|mesh-ancestor
93176397|NCT01224353|Micronutrients|micronutrients|mesh-ancestor
93176398|NCT01207297|Cyclophosphamide|cyclophosphamide|mesh-list
93176399|NCT01207297|Tacrolimus|tacrolimus|mesh-list
93176400|NCT01207297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176401|NCT01207297|Immunologic Factors|immunologic factors|mesh-ancestor
93176402|NCT01207297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176403|NCT01207297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176404|NCT01207297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93176405|NCT01207297|Alkylating Agents|alkylating agents|mesh-ancestor
93176406|NCT01207297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176407|NCT01207297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176408|NCT01207297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93176409|NCT01207297|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93176410|NCT01207297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176411|NCT03932435|Bepotastine besilate|bepotastine besilate|mesh-list
93176412|NCT03932435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93176413|NCT03720847|Estradiol|estradiol|mesh-list
93176414|NCT03720847|Progesterone|progesterone|mesh-list
93176415|NCT03720847|Estrogens|estrogens|mesh-ancestor
93176416|NCT03720847|Hormones|hormones|mesh-ancestor
93176417|NCT03720847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176418|NCT03720847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176419|NCT03720847|Progestins|progestins|mesh-ancestor
93176420|NCT01128257|Alendronate|alendronate|mesh-list
93176421|NCT01128257|Ibandronic Acid|ibandronic acid|mesh-list
93176422|NCT01128257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93176423|NCT01128257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176424|NCT01205347|Simvastatin|simvastatin|mesh-list
93176425|NCT01205347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93176426|NCT01205347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93176427|NCT01205347|Antimetabolites|antimetabolites|mesh-ancestor
93176428|NCT01205347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176429|NCT01205347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93176430|NCT01205347|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93176431|NCT01205347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176432|NCT01218737|Gatifloxacin|gatifloxacin|mesh-list
93176433|NCT01218737|Prednisolone|prednisolone|mesh-list
93176434|NCT01218737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93176435|NCT01218737|Methylprednisolone|methylprednisolone|mesh-list
93176436|NCT01218737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93176437|NCT01218737|Prednisolone acetate|prednisolone acetate|mesh-list
93176438|NCT01218737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93176439|NCT01218737|Prednisolone phosphate|prednisolone phosphate|mesh-list
93176440|NCT01218737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176441|NCT01218737|Glucocorticoids|glucocorticoids|mesh-ancestor
93176442|NCT01218737|Hormones|hormones|mesh-ancestor
93176443|NCT01218737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176444|NCT01218737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176445|NCT01218737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93176446|NCT01218737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176447|NCT01218737|Antiemetics|antiemetics|mesh-ancestor
93176448|NCT01218737|Autonomic Agents|autonomic agents|mesh-ancestor
93176449|NCT01218737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176450|NCT01218737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176451|NCT01218737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93176452|NCT01218737|Protective Agents|protective agents|mesh-ancestor
93176453|NCT01218737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93176454|NCT01218737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176455|NCT01218737|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93176456|NCT01218737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93176457|NCT01218737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93176458|NCT01218737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93176459|NCT01218737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176460|NCT01218737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176461|NCT03818113|Cardioplegic Solutions|cardioplegic solutions|mesh-list
93176462|NCT03818113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93176463|NCT01224509|Mifepristone|mifepristone|mesh-list
93176464|NCT01224509|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93176465|NCT01224509|Abortifacient Agents|abortifacient agents|mesh-ancestor
93176466|NCT01224509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93176467|NCT01224509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176468|NCT01224509|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93176469|NCT01224509|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93176470|NCT01224509|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93176471|NCT01224509|Contraceptive Agents|contraceptive agents|mesh-ancestor
93176472|NCT01224509|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93176473|NCT01224509|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93176474|NCT01224509|Hormone Antagonists|hormone antagonists|mesh-ancestor
93176475|NCT01224509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176476|NCT01224509|Luteolytic Agents|luteolytic agents|mesh-ancestor
93176477|NCT01224509|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93176478|NCT01224509|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93176479|NCT01301053|Insulin|insulin|mesh-list
93176480|NCT01301053|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93176481|NCT01301053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93176482|NCT01301053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176483|NCT01218581|Letrozole|letrozole|mesh-list
93176484|NCT01218581|Goserelin|goserelin|mesh-list
93176485|NCT01218581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176486|NCT01218581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93176487|NCT01218581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93176488|NCT01218581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176489|NCT01218581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176490|NCT01218581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93176491|NCT01218581|Hormone Antagonists|hormone antagonists|mesh-ancestor
93176492|NCT01218581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176493|NCT01218581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176494|NCT01218581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93176495|NCT03825133|Hyaluronic Acid|hyaluronic acid|mesh-list
93176496|NCT03825133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93176497|NCT03825133|Immunologic Factors|immunologic factors|mesh-ancestor
93176498|NCT03825133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176499|NCT03825133|Viscosupplements|viscosupplements|mesh-ancestor
93176500|NCT03825133|Protective Agents|protective agents|mesh-ancestor
93176501|NCT03817567|Antibodies|antibodies|mesh-list
93176502|NCT03817567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93176503|NCT03817567|Immunologic Factors|immunologic factors|mesh-ancestor
93176504|NCT03817567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176505|NCT01127009|Cytarabine|cytarabine|mesh-list
93176506|NCT01127009|Etoposide|etoposide|mesh-list
93176507|NCT01127009|Podophyllotoxin|podophyllotoxin|mesh-list
93176508|NCT01127009|Mitoxantrone|mitoxantrone|mesh-list
93176509|NCT01127009|Etoposide phosphate|etoposide phosphate|mesh-list
93176510|NCT01127009|Bortezomib|bortezomib|mesh-list
93176511|NCT01127009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93176512|NCT01127009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176513|NCT01127009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93176514|NCT01127009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93176515|NCT01127009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176516|NCT01127009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176517|NCT01127009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93176518|NCT01127009|Antimetabolites|antimetabolites|mesh-ancestor
93176519|NCT01127009|Antiviral Agents|antiviral agents|mesh-ancestor
93176520|NCT01127009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176521|NCT01127009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176522|NCT01127009|Immunologic Factors|immunologic factors|mesh-ancestor
93176523|NCT01127009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176524|NCT01127009|Analgesics|analgesics|mesh-ancestor
93176525|NCT01127009|Sensory System Agents|sensory system agents|mesh-ancestor
93176526|NCT01127009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176527|NCT01127009|Keratolytic Agents|keratolytic agents|mesh-ancestor
93176528|NCT01127009|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176529|NCT01127009|Tubulin Modulators|tubulin modulators|mesh-ancestor
93176530|NCT01127009|Antimitotic Agents|antimitotic agents|mesh-ancestor
93176531|NCT01127009|Mitosis Modulators|mitosis modulators|mesh-ancestor
93176533|NCT03817411|Oxaliplatin|oxaliplatin|mesh-list
93176534|NCT03817411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93176535|NCT03817411|Antimetabolites|antimetabolites|mesh-ancestor
93176536|NCT03817411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176537|NCT03817411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176538|NCT01205737|Rituximab|rituximab|mesh-list
93176539|NCT01205737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176540|NCT01205737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176541|NCT01205737|Immunologic Factors|immunologic factors|mesh-ancestor
93176542|NCT01205737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176543|NCT01205737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176544|NCT01218893|Chloroquine|chloroquine|mesh-list
93176545|NCT01218893|Proguanil|proguanil|mesh-list
93176546|NCT01218893|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93176547|NCT01218893|Amebicides|amebicides|mesh-ancestor
93176548|NCT01218893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93176549|NCT01218893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93176550|NCT01218893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176551|NCT01218893|Antimalarials|antimalarials|mesh-ancestor
93176552|NCT01218893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176553|NCT01218893|Antimetabolites|antimetabolites|mesh-ancestor
93176554|NCT01218893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176555|NCT03824119|Ibuprofen|ibuprofen|mesh-list
93176556|NCT03824119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93176557|NCT03824119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93176558|NCT03824119|Analgesics|analgesics|mesh-ancestor
93176559|NCT03824119|Sensory System Agents|sensory system agents|mesh-ancestor
93176560|NCT03824119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176561|NCT03824119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176562|NCT03824119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176563|NCT03824119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176564|NCT03824119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93176565|NCT03824119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176566|NCT03824119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176567|NCT03823417|Tranexamic Acid|tranexamic acid|mesh-list
93176568|NCT03823417|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93176569|NCT03823417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93176570|NCT03823417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176571|NCT03823417|Hemostatics|hemostatics|mesh-ancestor
93176572|NCT03823417|Coagulants|coagulants|mesh-ancestor
93176573|NCT01297777|Imatinib Mesylate|imatinib mesylate|mesh-list
93176574|NCT01297777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176575|NCT01297777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93176576|NCT01297777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176577|NCT01297777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176578|NCT01225913|Fluticasone|fluticasone|mesh-list
93176579|NCT01225913|Xhance|xhance|mesh-list
93176580|NCT01225913|Budesonide|budesonide|mesh-list
93176581|NCT01225913|Formoterol Fumarate|formoterol fumarate|mesh-list
93176582|NCT01225913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93176583|NCT01225913|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93176584|NCT01225913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93176585|NCT01225913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176586|NCT01225913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93176587|NCT01225913|Autonomic Agents|autonomic agents|mesh-ancestor
93176588|NCT01225913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176589|NCT01225913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176590|NCT01225913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93176591|NCT01225913|Respiratory System Agents|respiratory system agents|mesh-ancestor
93176592|NCT01225913|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176593|NCT01225913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93176594|NCT01225913|Glucocorticoids|glucocorticoids|mesh-ancestor
93176595|NCT01225913|Hormones|hormones|mesh-ancestor
93176596|NCT01225913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176597|NCT01225913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93176598|NCT01225913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93176599|NCT01225913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93176600|NCT01225913|Adrenergic Agents|adrenergic agents|mesh-ancestor
93176601|NCT01225913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176602|NCT01225913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176603|NCT01225913|Sympathomimetics|sympathomimetics|mesh-ancestor
93176605|NCT01224977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93176606|NCT01224977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176607|NCT01226069|Magnesium Sulfate|magnesium sulfate|mesh-list
93176608|NCT01226069|Glycerol|glycerol|mesh-list
93176609|NCT01226069|Analgesics|analgesics|mesh-ancestor
93176610|NCT01226069|Sensory System Agents|sensory system agents|mesh-ancestor
93176611|NCT01226069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176612|NCT01226069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176613|NCT01226069|Anesthetics|anesthetics|mesh-ancestor
93176614|NCT01226069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93176615|NCT01226069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93176616|NCT01226069|Anticonvulsants|anticonvulsants|mesh-ancestor
93176617|NCT01226069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93176618|NCT01226069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176619|NCT01226069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176620|NCT01226069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93176621|NCT01226069|Tocolytic Agents|tocolytic agents|mesh-ancestor
93176622|NCT01226069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93176623|NCT01226069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93176624|NCT01226069|Protective Agents|protective agents|mesh-ancestor
93176625|NCT03928691|Magnesium Sulfate|magnesium sulfate|mesh-list
93176626|NCT03928691|Analgesics|analgesics|mesh-ancestor
93176627|NCT03928691|Sensory System Agents|sensory system agents|mesh-ancestor
93176628|NCT03928691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176629|NCT03928691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176630|NCT03928691|Anesthetics|anesthetics|mesh-ancestor
93176631|NCT03928691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93176632|NCT03928691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93176633|NCT03928691|Anticonvulsants|anticonvulsants|mesh-ancestor
93176634|NCT03928691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93176635|NCT03928691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176636|NCT03928691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176637|NCT03928691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93176638|NCT03928691|Tocolytic Agents|tocolytic agents|mesh-ancestor
93176639|NCT03928691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93176640|NCT01297855|Rifampin|rifampin|mesh-list
93176641|NCT01297855|Colistin|colistin|mesh-list
93176642|NCT01297855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93176643|NCT01297855|Antitubercular Agents|antitubercular agents|mesh-ancestor
93176644|NCT01297855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93176645|NCT01297855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176646|NCT01297855|Leprostatic Agents|leprostatic agents|mesh-ancestor
93176647|NCT01297855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93176648|NCT01297855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176649|NCT01297855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176650|NCT01297855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93176651|NCT01297855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93176652|NCT01297855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93176653|NCT01297855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93176654|NCT01297855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93176655|NCT01297855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93176656|NCT02631070|Luspatercept|luspatercept|mesh-list
93176657|NCT02631070|Hematinics|hematinics|mesh-ancestor
93176658|NCT01298011|Paclitaxel|paclitaxel|mesh-list
93176659|NCT01298011|Gemcitabine|gemcitabine|mesh-list
93176660|NCT01298011|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93176661|NCT01298011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93176662|NCT01298011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176663|NCT01298011|Tubulin Modulators|tubulin modulators|mesh-ancestor
93176664|NCT01298011|Antimitotic Agents|antimitotic agents|mesh-ancestor
93176665|NCT01298011|Mitosis Modulators|mitosis modulators|mesh-ancestor
93176666|NCT01298011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176667|NCT01298011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93176668|NCT01298011|Antimetabolites|antimetabolites|mesh-ancestor
93176669|NCT01221935|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93176670|NCT01221935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93176671|NCT01221935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
92848864|NCT00924079|Nalbuphine|nalbuphine|mesh-list
93176672|NCT01221935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93176673|NCT01221935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176674|NCT01221935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176675|NCT01221935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176676|NCT01221935|Serotonin Agents|serotonin agents|mesh-ancestor
93176677|NCT01221935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176678|NCT01221935|Antidepressive Agents|antidepressive agents|mesh-ancestor
93176679|NCT01221935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93176680|NCT05137678|Glyburide|glyburide|mesh-list
93176681|NCT05137678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93176682|NCT05137678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176683|NCT01226303|Tretinoin|tretinoin|mesh-list
93176684|NCT01226303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176685|NCT01226303|Keratolytic Agents|keratolytic agents|mesh-ancestor
93176686|NCT01226303|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176687|NCT03814759|Cisplatin|cisplatin|mesh-list
93176688|NCT03814759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176689|NCT05101018|Denosumab|denosumab|mesh-list
91928471|NCT02403687|Tizanidine|tizanidine|mesh-list
93176690|NCT05101018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93176691|NCT05101018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176692|NCT03929861|Fluconazole|fluconazole|mesh-list
93176693|NCT03929861|Antifungal Agents|antifungal agents|mesh-ancestor
93176694|NCT03929861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176695|NCT03929861|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93176696|NCT03929861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93176697|NCT03929861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176698|NCT03929861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176699|NCT03929861|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93176700|NCT03929861|Hormone Antagonists|hormone antagonists|mesh-ancestor
93176701|NCT03929861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176702|NCT03929861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176703|NCT03929861|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93176704|NCT03929861|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93176705|NCT03821623|Niacinamide|niacinamide|mesh-list
93176706|NCT03821623|Niacin|niacin|mesh-list
93176707|NCT03821623|Nicotinic Acids|nicotinic acids|mesh-list
93176708|NCT03821623|Vitamin B Complex|vitamin b complex|mesh-ancestor
93176709|NCT03821623|Vitamins|vitamins|mesh-ancestor
93176710|NCT03821623|Micronutrients|micronutrients|mesh-ancestor
93176711|NCT03821623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176712|NCT03821623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93176713|NCT03821623|Antimetabolites|antimetabolites|mesh-ancestor
93176714|NCT03821623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176715|NCT03821623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93176716|NCT03821623|Vasodilator Agents|vasodilator agents|mesh-ancestor
93176717|NCT03928145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93176718|NCT03928145|Chlorthalidone|chlorthalidone|mesh-list
93176719|NCT03928145|Amiloride|amiloride|mesh-list
93176720|NCT03928145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93176721|NCT03928145|Diuretics|diuretics|mesh-ancestor
93176722|NCT03928145|Natriuretic Agents|natriuretic agents|mesh-ancestor
93176723|NCT03928145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176724|NCT03928145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93176725|NCT03928145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93176726|NCT03928145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176727|NCT03928145|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93176728|NCT03928145|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93176729|NCT03928145|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93176730|NCT03928145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93176731|NCT01129271|Clopidogrel|clopidogrel|mesh-list
93176732|NCT01129271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93176733|NCT01129271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93176734|NCT01129271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93176735|NCT01129271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93176736|NCT01129271|Purinergic Agents|purinergic agents|mesh-ancestor
93176737|NCT01129271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176738|NCT01129271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176739|NCT01129271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176740|NCT01222013|Imatinib Mesylate|imatinib mesylate|mesh-list
93176741|NCT01222013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176742|NCT01222013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93176743|NCT01222013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176744|NCT01222013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176746|NCT00741988|Carboplatin|carboplatin|mesh-list
93176747|NCT00741988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176748|NCT00741988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176749|NCT00741988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93176750|NCT00741988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93176751|NCT00741988|Growth Substances|growth substances|mesh-ancestor
93176752|NCT00741988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176753|NCT00741988|Growth Inhibitors|growth inhibitors|mesh-ancestor
93176754|NCT01131377|Acetazolamide|acetazolamide|mesh-list
93176755|NCT01131377|Anticonvulsants|anticonvulsants|mesh-ancestor
93176756|NCT01131377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93176757|NCT01131377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176758|NCT01131377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176759|NCT01131377|Diuretics|diuretics|mesh-ancestor
93176760|NCT01131377|Natriuretic Agents|natriuretic agents|mesh-ancestor
93176761|NCT01131377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176762|NCT04457050|Ribavirin|ribavirin|mesh-list
93176763|NCT04457050|Sofosbuvir|sofosbuvir|mesh-list
93176764|NCT04457050|Ledipasvir|ledipasvir|mesh-list
93176765|NCT04457050|Antimetabolites|antimetabolites|mesh-ancestor
93176766|NCT04457050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176767|NCT04457050|Antiviral Agents|antiviral agents|mesh-ancestor
93176768|NCT04457050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176769|NCT01228409|Acitretin|acitretin|mesh-list
93176770|NCT01228409|Keratolytic Agents|keratolytic agents|mesh-ancestor
93176771|NCT01228409|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176772|NCT03470350|Capecitabine|capecitabine|mesh-list
93176773|NCT03470350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93176774|NCT03470350|Antimetabolites|antimetabolites|mesh-ancestor
93176775|NCT03470350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176776|NCT03470350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176777|NCT04565392|Famotidine|famotidine|mesh-list
93176778|NCT04565392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93176779|NCT04565392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176780|NCT04565392|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93176781|NCT04565392|Histamine Antagonists|histamine antagonists|mesh-ancestor
93176782|NCT04565392|Histamine Agents|histamine agents|mesh-ancestor
93176783|NCT04565392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176784|NCT04565392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176785|NCT04565392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176786|NCT05654233|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
93176787|NCT05654233|Anticoagulants|anticoagulants|mesh-ancestor
93176788|NCT05654233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93176789|NCT05654233|Antimetabolites|antimetabolites|mesh-ancestor
93176790|NCT05654233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176791|NCT05654233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93176792|NCT05654233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93176793|NCT05654233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93176794|NCT05654233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93176795|NCT05654233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176796|NCT01226771|Ribavirin|ribavirin|mesh-list
93176797|NCT01226771|Antimetabolites|antimetabolites|mesh-ancestor
93176798|NCT01226771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176799|NCT01226771|Antiviral Agents|antiviral agents|mesh-ancestor
93176800|NCT01226771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176801|NCT03814447|Cyclophosphamide|cyclophosphamide|mesh-list
93176802|NCT03814447|Fludarabine|fludarabine|mesh-list
93176803|NCT03814447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176804|NCT03814447|Immunologic Factors|immunologic factors|mesh-ancestor
93176805|NCT03814447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176806|NCT03814447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176807|NCT03814447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93176808|NCT03814447|Alkylating Agents|alkylating agents|mesh-ancestor
93176809|NCT03814447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176810|NCT03814447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176811|NCT03814447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93176812|NCT01129427|Pantoprazole|pantoprazole|mesh-list
93176813|NCT01129427|Clopidogrel|clopidogrel|mesh-list
93176814|NCT01129427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93176815|NCT01129427|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93176816|NCT01129427|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93176817|NCT01129427|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93176818|NCT01129427|Purinergic Agents|purinergic agents|mesh-ancestor
93176819|NCT01129427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176820|NCT01129427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176821|NCT01129427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176822|NCT01129427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93176823|NCT01129427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176824|NCT01129427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93176825|NCT01129427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176826|NCT03814291|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93176827|NCT03814291|Immunologic Factors|immunologic factors|mesh-ancestor
93176828|NCT03814291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176830|NCT03354429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93176831|NCT03354429|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93176832|NCT03354429|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93176833|NCT03354429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93176834|NCT03354429|Purinergic Agents|purinergic agents|mesh-ancestor
93176835|NCT03354429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176836|NCT03354429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176837|NCT03354429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176838|NCT05164198|Adalimumab|adalimumab|mesh-list
93176839|NCT05164198|Infliximab|infliximab|mesh-list
93176840|NCT05164198|Golimumab|golimumab|mesh-list
93176841|NCT05164198|Etanercept|etanercept|mesh-list
93176842|NCT05164198|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93176843|NCT05164198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93176844|NCT05164198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176845|NCT05164198|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176846|NCT05164198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93176847|NCT05164198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93176848|NCT05164198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93176849|NCT05164198|Analgesics|analgesics|mesh-ancestor
93176850|NCT05164198|Sensory System Agents|sensory system agents|mesh-ancestor
93176851|NCT05164198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176852|NCT05164198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176853|NCT05164198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176854|NCT05164198|Immunologic Factors|immunologic factors|mesh-ancestor
93176855|NCT03740399|Anesthetics|anesthetics|mesh-list
93176856|NCT03740399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93176857|NCT03740399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176858|NCT05160220|Psilocybin|psilocybin|mesh-list
93176859|NCT05160220|Hallucinogens|hallucinogens|mesh-ancestor
93176860|NCT05160220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176861|NCT05160220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93176862|NCT03924245|Olaparib|olaparib|mesh-list
93176863|NCT03924245|Entinostat|entinostat|mesh-list
93176864|NCT03924245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93176865|NCT03924245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176866|NCT03924245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176867|NCT03924245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176868|NCT03924245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93176869|NCT05647447|SR 142801|sr 142801|mesh-list
93176870|NCT05647447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93176871|NCT05647447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93176872|NCT05647447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93176873|NCT05647447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176874|NCT05647447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93176875|NCT01225445|Ramipril|ramipril|mesh-list
93176876|NCT01225445|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93176877|NCT01225445|Protease Inhibitors|protease inhibitors|mesh-ancestor
93176878|NCT01225445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176879|NCT01225445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176880|NCT01225445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93176881|NCT05555329|Thalidomide|thalidomide|mesh-list
93176882|NCT05555329|Pomalidomide|pomalidomide|mesh-list
93176883|NCT05555329|Immunologic Factors|immunologic factors|mesh-ancestor
93176884|NCT05555329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176885|NCT05555329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93176886|NCT05555329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93176887|NCT05555329|Growth Substances|growth substances|mesh-ancestor
93176888|NCT05555329|Growth Inhibitors|growth inhibitors|mesh-ancestor
93176889|NCT05555329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176890|NCT05555329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176891|NCT05555329|Leprostatic Agents|leprostatic agents|mesh-ancestor
93176892|NCT05555329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93176893|NCT05555329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176894|NCT05390710|Paclitaxel|paclitaxel|mesh-list
93176895|NCT05390710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93176896|NCT05390710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93176897|NCT05390710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176898|NCT05390710|Tubulin Modulators|tubulin modulators|mesh-ancestor
93176899|NCT05390710|Antimitotic Agents|antimitotic agents|mesh-ancestor
93176900|NCT05390710|Mitosis Modulators|mitosis modulators|mesh-ancestor
93176901|NCT05390710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176902|NCT01228565|Cetuximab|cetuximab|mesh-list
93176903|NCT01228565|OTD70DERM|otd70derm|mesh-list
93176904|NCT01228565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176905|NCT01228565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176906|NCT01228565|Protective Agents|protective agents|mesh-ancestor
93176907|NCT01228565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176908|NCT01226849|Rituximab|rituximab|mesh-list
93176909|NCT01226849|Carboplatin|carboplatin|mesh-list
93176910|NCT01226849|Etoposide|etoposide|mesh-list
93176911|NCT01226849|Bortezomib|bortezomib|mesh-list
93176912|NCT01226849|Ifosfamide|ifosfamide|mesh-list
93176913|NCT01226849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176914|NCT01226849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176915|NCT01226849|Immunologic Factors|immunologic factors|mesh-ancestor
93176916|NCT01226849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176917|NCT01226849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176918|NCT01226849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93176919|NCT01226849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93176920|NCT01226849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93176921|NCT01226849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176922|NCT01226849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176923|NCT01226849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93176924|NCT01226849|Alkylating Agents|alkylating agents|mesh-ancestor
93176925|NCT05159674|Dexmedetomidine|dexmedetomidine|mesh-list
93176926|NCT05159674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93176927|NCT05159674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176928|NCT05159674|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93176929|NCT05159674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93176930|NCT05159674|Analgesics|analgesics|mesh-ancestor
93176931|NCT05159674|Sensory System Agents|sensory system agents|mesh-ancestor
93176932|NCT05159674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93176933|NCT05159674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93176934|NCT05159674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93176935|NCT05159674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93176936|NCT05159674|Adrenergic Agents|adrenergic agents|mesh-ancestor
93176937|NCT05159674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176938|NCT05159674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176939|NCT03813979|Dolutegravir|dolutegravir|mesh-list
93176940|NCT03813979|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93176941|NCT03813979|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93176942|NCT03813979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176943|NCT03813979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176944|NCT03813979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93176945|NCT03813979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93176946|NCT03813979|Antiviral Agents|antiviral agents|mesh-ancestor
93176947|NCT03813979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176948|NCT05555121|Progesterone|progesterone|mesh-list
93176949|NCT05555121|Progestins|progestins|mesh-ancestor
93176950|NCT05555121|Hormones|hormones|mesh-ancestor
93176951|NCT05555121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176952|NCT05555121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176953|NCT05446467|Pembrolizumab|pembrolizumab|mesh-list
93176954|NCT05446467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93176955|NCT05446467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93176956|NCT05446467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93176957|NCT05446467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176958|NCT05553613|Clopidogrel|clopidogrel|mesh-list
93176959|NCT05553613|Ticagrelor|ticagrelor|mesh-list
93176960|NCT05553613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93176961|NCT05553613|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93176962|NCT05553613|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93176963|NCT05553613|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93176964|NCT05553613|Purinergic Agents|purinergic agents|mesh-ancestor
93176965|NCT05553613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176966|NCT05553613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176967|NCT05553613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176968|NCT03901144|Glycerol|glycerol|mesh-list
93176970|NCT03901144|Protective Agents|protective agents|mesh-ancestor
93176971|NCT03901144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176972|NCT01129739|Cyclosporine|cyclosporine|mesh-list
93176973|NCT01129739|Cyclosporins|cyclosporins|mesh-list
93176974|NCT01129739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176975|NCT01129739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176976|NCT01129739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93176977|NCT01129739|Immunologic Factors|immunologic factors|mesh-ancestor
93176978|NCT01129739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176979|NCT01129739|Antifungal Agents|antifungal agents|mesh-ancestor
93176980|NCT01129739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93176981|NCT01129739|Dermatologic Agents|dermatologic agents|mesh-ancestor
93176982|NCT01129739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93176983|NCT01129739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93176984|NCT01301599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
93176985|NCT01301599|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
93176986|NCT01301599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93176987|NCT01301599|Adrenergic Agents|adrenergic agents|mesh-ancestor
93176988|NCT01301599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93176989|NCT01301599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176990|NCT01301599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93176991|NCT01301599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93176992|NCT01301599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93176993|NCT01301599|Hormone Antagonists|hormone antagonists|mesh-ancestor
93176994|NCT01301599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93176995|NCT03384693|Defibrotide|defibrotide|mesh-list
93176996|NCT03384693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93176997|NCT03384693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93176998|NCT03384693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93176999|NCT03384693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93177000|NCT05533281|Dexamethasone|dexamethasone|mesh-list
93177001|NCT05533281|Metoclopramide|metoclopramide|mesh-list
93177002|NCT05533281|Tropisetron|tropisetron|mesh-list
93177003|NCT05533281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177004|NCT05533281|Antiemetics|antiemetics|mesh-ancestor
93177005|NCT05533281|Autonomic Agents|autonomic agents|mesh-ancestor
93177006|NCT05533281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177007|NCT05533281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177008|NCT05533281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177009|NCT05533281|Glucocorticoids|glucocorticoids|mesh-ancestor
93177010|NCT05533281|Hormones|hormones|mesh-ancestor
93177011|NCT05533281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93177012|NCT05533281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93177013|NCT05533281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177014|NCT05533281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93177015|NCT05533281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93177016|NCT05533281|Dopamine Agents|dopamine agents|mesh-ancestor
93177017|NCT05533281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177018|NCT05533281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177019|NCT05533281|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93177020|NCT05533281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93177021|NCT05533281|Serotonin Agents|serotonin agents|mesh-ancestor
93177022|NCT03923075|Dexmedetomidine|dexmedetomidine|mesh-list
93177023|NCT03923075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177024|NCT03923075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177025|NCT03923075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177026|NCT03923075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93177027|NCT03923075|Analgesics|analgesics|mesh-ancestor
93177028|NCT03923075|Sensory System Agents|sensory system agents|mesh-ancestor
93177029|NCT03923075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177030|NCT03923075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93177031|NCT03923075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93177032|NCT03923075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93177033|NCT03923075|Adrenergic Agents|adrenergic agents|mesh-ancestor
93177034|NCT03923075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177035|NCT03923075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177036|NCT03923231|Ritonavir|ritonavir|mesh-list
93177037|NCT03923231|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93177038|NCT03923231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93177039|NCT03923231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93177040|NCT03923231|Protease Inhibitors|protease inhibitors|mesh-ancestor
93177041|NCT03923231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177042|NCT03923231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177043|NCT03923231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93177044|NCT03923231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93177045|NCT03923231|Antiviral Agents|antiviral agents|mesh-ancestor
93177046|NCT03923231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177047|NCT03923231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93177048|NCT03923231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93177049|NCT01227239|Oxaliplatin|oxaliplatin|mesh-list
93177050|NCT01227239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177051|NCT01301677|Hydrocortisone|hydrocortisone|mesh-list
93177052|NCT01301677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177053|NCT02618980|Hemostatics|hemostatics|mesh-list
93177054|NCT02618980|Coagulants|coagulants|mesh-ancestor
93177055|NCT02613598|Bortezomib|bortezomib|mesh-list
93177056|NCT02613598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177057|NCT03718429|Rivaroxaban|rivaroxaban|mesh-list
93177058|NCT03718429|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93177059|NCT03718429|Antithrombins|antithrombins|mesh-ancestor
93177060|NCT03718429|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93177061|NCT03718429|Protease Inhibitors|protease inhibitors|mesh-ancestor
93177062|NCT03718429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177063|NCT03718429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177064|NCT03718429|Anticoagulants|anticoagulants|mesh-ancestor
93177065|NCT01225523|Paclitaxel|paclitaxel|mesh-list
93177066|NCT01225523|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93177067|NCT01225523|Cisplatin|cisplatin|mesh-list
93177068|NCT01225523|Fluorouracil|fluorouracil|mesh-list
93177069|NCT01225523|Capecitabine|capecitabine|mesh-list
93177070|NCT01225523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93177071|NCT01225523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177072|NCT01225523|Tubulin Modulators|tubulin modulators|mesh-ancestor
93177073|NCT01225523|Antimitotic Agents|antimitotic agents|mesh-ancestor
93177074|NCT01225523|Mitosis Modulators|mitosis modulators|mesh-ancestor
93177075|NCT01225523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177076|NCT01225523|Antimetabolites|antimetabolites|mesh-ancestor
93177077|NCT01225523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93177078|NCT01225523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93177079|NCT01225523|Immunologic Factors|immunologic factors|mesh-ancestor
93177080|NCT01225523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177081|NCT03815539|Hyaluronic Acid|hyaluronic acid|mesh-list
93177082|NCT03815539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93177083|NCT03815539|Immunologic Factors|immunologic factors|mesh-ancestor
93177084|NCT03815539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177085|NCT03815539|Viscosupplements|viscosupplements|mesh-ancestor
93177086|NCT03815539|Protective Agents|protective agents|mesh-ancestor
93177087|NCT03922919|Ceftriaxone|ceftriaxone|mesh-list
93177088|NCT03922919|Cefotaxime|cefotaxime|mesh-list
93177089|NCT03922919|Cefoxitin|cefoxitin|mesh-list
93177090|NCT03922919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93177091|NCT03922919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177092|NCT03813277|Dexmedetomidine|dexmedetomidine|mesh-list
93177093|NCT03813277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177094|NCT03813277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177095|NCT03813277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177096|NCT03813277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93177097|NCT03813277|Analgesics|analgesics|mesh-ancestor
93177098|NCT03813277|Sensory System Agents|sensory system agents|mesh-ancestor
93177099|NCT03813277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177100|NCT03813277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93177101|NCT03813277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93177102|NCT03813277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93177103|NCT03813277|Adrenergic Agents|adrenergic agents|mesh-ancestor
93177104|NCT03813277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177105|NCT03813277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177106|NCT03815461|Paclitaxel|paclitaxel|mesh-list
93177107|NCT03815461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93177108|NCT03815461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177109|NCT03815461|Tubulin Modulators|tubulin modulators|mesh-ancestor
93177110|NCT03815461|Antimitotic Agents|antimitotic agents|mesh-ancestor
93177111|NCT03815461|Mitosis Modulators|mitosis modulators|mesh-ancestor
93177112|NCT03815461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177113|NCT01285102|Irinotecan|irinotecan|mesh-list
93177114|NCT01285102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93177115|NCT01285102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93177116|NCT01285102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177117|NCT01285102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177118|NCT01285102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177119|NCT03740243|Buprenorphine|buprenorphine|mesh-list
93177120|NCT03740243|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93177121|NCT03740243|Naloxone|naloxone|mesh-list
93177122|NCT03740243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177123|NCT03740243|Narcotics|narcotics|mesh-ancestor
93177124|NCT03740243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177125|NCT03740243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177126|NCT03740243|Analgesics|analgesics|mesh-ancestor
93177127|NCT03740243|Sensory System Agents|sensory system agents|mesh-ancestor
93177128|NCT03740243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177129|NCT03740243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93177130|NCT03813043|Midazolam|midazolam|mesh-list
93177131|NCT03813043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93177132|NCT03813043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177133|NCT03813043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177134|NCT03813043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177135|NCT03813043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93177136|NCT03813043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93177137|NCT03813043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93177138|NCT03813043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177139|NCT03813043|Anesthetics, General|anesthetics, general|mesh-ancestor
93177140|NCT03813043|Anesthetics|anesthetics|mesh-ancestor
93177141|NCT03813043|GABA Modulators|gaba modulators|mesh-ancestor
93177142|NCT03813043|GABA Agents|gaba agents|mesh-ancestor
93177143|NCT03813043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177144|NCT03813043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177145|NCT03382899|Pembrolizumab|pembrolizumab|mesh-list
93177146|NCT03382899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177147|NCT03382899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177148|NCT03382899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93177149|NCT03382899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177150|NCT03815305|Petrolatum|petrolatum|mesh-list
93177151|NCT03815305|Emollients|emollients|mesh-ancestor
93177152|NCT03815305|Dermatologic Agents|dermatologic agents|mesh-ancestor
93177153|NCT01560013|Naltrexone|naltrexone|mesh-list
93177154|NCT01560013|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93177155|NCT01560013|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93177156|NCT01560013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177157|NCT01560013|Sensory System Agents|sensory system agents|mesh-ancestor
93177158|NCT01560013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177159|NCT01302145|Metformin|metformin|mesh-list
93177160|NCT01302145|Ipragliflozin|ipragliflozin|mesh-list
93177161|NCT01302145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177162|NCT01302145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177163|NCT01302145|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93177164|NCT01302145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177165|NCT01560091|Tamsulosin|tamsulosin|mesh-list
93177166|NCT01560091|Silodosin|silodosin|mesh-list
93177167|NCT01560091|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93177168|NCT01560091|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93177169|NCT01560091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93177170|NCT01560091|Adrenergic Agents|adrenergic agents|mesh-ancestor
93177171|NCT01560091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177172|NCT01560091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177173|NCT01560091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177174|NCT01560091|Urological Agents|urological agents|mesh-ancestor
93177175|NCT03382041|Carbon Fiber|carbon fiber|mesh-list
93177176|NCT03382041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93177177|NCT03382041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177178|NCT03807271|Anesthetics|anesthetics|mesh-list
93177179|NCT03807271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177180|NCT03807271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177181|NCT03812731|Fentanyl|fentanyl|mesh-list
93177182|NCT03812731|Ropivacaine|ropivacaine|mesh-list
93177183|NCT03812731|Anesthetics, Local|anesthetics, local|mesh-ancestor
93177184|NCT03812731|Anesthetics|anesthetics|mesh-ancestor
93177185|NCT03812731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177186|NCT03812731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177187|NCT03812731|Sensory System Agents|sensory system agents|mesh-ancestor
93177188|NCT03812731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177189|NCT03812731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177190|NCT03812731|Narcotics|narcotics|mesh-ancestor
93177191|NCT03812731|Analgesics|analgesics|mesh-ancestor
93177192|NCT03812731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93177193|NCT03812731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177194|NCT03812731|Anesthetics, General|anesthetics, general|mesh-ancestor
93177195|NCT03351231|Nivolumab|nivolumab|mesh-list
93177196|NCT03351231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177197|NCT03351231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177198|NCT03351231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93177199|NCT03351231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177200|NCT03922373|Benzonatate|benzonatate|mesh-list
93177201|NCT03922373|Antitussive Agents|antitussive agents|mesh-ancestor
93177202|NCT03922373|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177203|NCT03709719|Blinatumomab|blinatumomab|mesh-list
93177204|NCT03709719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177205|NCT03926663|Dexmedetomidine|dexmedetomidine|mesh-list
93177206|NCT03926663|Bupivacaine|bupivacaine|mesh-list
93177207|NCT03926663|Anesthetics, Local|anesthetics, local|mesh-ancestor
93177208|NCT03926663|Anesthetics|anesthetics|mesh-ancestor
93177209|NCT03926663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177210|NCT03926663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177211|NCT03926663|Sensory System Agents|sensory system agents|mesh-ancestor
93177212|NCT03926663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177213|NCT03926663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177214|NCT03926663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93177215|NCT03926663|Analgesics|analgesics|mesh-ancestor
93177216|NCT03926663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93177217|NCT03926663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93177218|NCT03926663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93177219|NCT03926663|Adrenergic Agents|adrenergic agents|mesh-ancestor
93177220|NCT03926663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177221|NCT03926663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177222|NCT05481775|Immunomodulating Agents|immunomodulating agents|mesh-list
93177223|NCT05481775|Immunologic Factors|immunologic factors|mesh-ancestor
93177224|NCT05481775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177225|NCT05165914|Midazolam|midazolam|mesh-list
93177226|NCT05165914|Anesthetics|anesthetics|mesh-list
93177227|NCT05165914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177228|NCT05165914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177229|NCT05165914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93177230|NCT05165914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177231|NCT05165914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93177232|NCT05165914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93177233|NCT05165914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93177234|NCT05165914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177235|NCT05165914|Anesthetics, General|anesthetics, general|mesh-ancestor
93177236|NCT05165914|GABA Modulators|gaba modulators|mesh-ancestor
93177237|NCT05165914|GABA Agents|gaba agents|mesh-ancestor
93177238|NCT05165914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177239|NCT05165914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177240|NCT04420975|Nivolumab|nivolumab|mesh-list
93177241|NCT04420975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177242|NCT04420975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177243|NCT04420975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93177244|NCT04420975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177245|NCT01132157|Propofol|propofol|mesh-list
93177246|NCT01132157|Desflurane|desflurane|mesh-list
93177247|NCT01132157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177248|NCT01132157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177249|NCT01132157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177250|NCT01132157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177251|NCT01132157|Anesthetics, General|anesthetics, general|mesh-ancestor
93177252|NCT01132157|Anesthetics|anesthetics|mesh-ancestor
93177253|NCT01132157|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93177254|NCT05389150|Pregabalin|pregabalin|mesh-list
93177255|NCT05389150|Tramadol|tramadol|mesh-list
93177256|NCT05389150|Analgesics|analgesics|mesh-ancestor
93177257|NCT05389150|Sensory System Agents|sensory system agents|mesh-ancestor
93177258|NCT05389150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177259|NCT05389150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177260|NCT05389150|Anticonvulsants|anticonvulsants|mesh-ancestor
93177261|NCT05389150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93177262|NCT05389150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93177263|NCT05389150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177264|NCT05389150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93177265|NCT05389150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93177266|NCT05389150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93177267|NCT05389150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177268|NCT05389150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93177269|NCT05389150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177270|NCT05389150|Narcotics|narcotics|mesh-ancestor
93177271|NCT03806101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93177272|NCT03806101|Abrocitinib|abrocitinib|mesh-list
93177273|NCT03806101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93177274|NCT03806101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93177275|NCT03806101|Antimetabolites|antimetabolites|mesh-ancestor
93177276|NCT03806101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177277|NCT03806101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93177278|NCT03806101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93177279|NCT03806101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177280|NCT03806101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177281|NCT03812419|Esomeprazole|esomeprazole|mesh-list
93177282|NCT03812419|Pantoprazole|pantoprazole|mesh-list
93177283|NCT03812419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93177284|NCT03812419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177285|NCT03812419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93177286|NCT03812419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177287|NCT03812419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177288|NCT01132235|Etanercept|etanercept|mesh-list
93177289|NCT01132235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93177290|NCT01132235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93177291|NCT01132235|Analgesics|analgesics|mesh-ancestor
93177292|NCT01132235|Sensory System Agents|sensory system agents|mesh-ancestor
93177293|NCT01132235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177294|NCT01132235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177295|NCT01132235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177296|NCT01132235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93177297|NCT01132235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177298|NCT01132235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93177299|NCT01132235|Immunologic Factors|immunologic factors|mesh-ancestor
93177300|NCT01131689|Sorafenib|sorafenib|mesh-list
93177301|NCT01131689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177302|NCT01131689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177303|NCT01131689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177304|NCT01131689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177305|NCT03401229|Mometasone Furoate|mometasone furoate|mesh-list
93177306|NCT03401229|Benralizumab|benralizumab|mesh-list
93177307|NCT03401229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177308|NCT03401229|Dermatologic Agents|dermatologic agents|mesh-ancestor
93177309|NCT03401229|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93177310|NCT03401229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93177311|NCT03401229|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177312|NCT05435053|Nivolumab|nivolumab|mesh-list
93177313|NCT05435053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177314|NCT05435053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177315|NCT05435053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93177316|NCT05435053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177317|NCT01132391|Nitroglycerin|nitroglycerin|mesh-list
93177318|NCT01132391|Vasodilator Agents|vasodilator agents|mesh-ancestor
93177319|NCT05281081|Morphine|morphine|mesh-list
93177320|NCT05281081|Levobupivacaine|levobupivacaine|mesh-list
93177321|NCT05281081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177322|NCT05281081|Narcotics|narcotics|mesh-ancestor
93177323|NCT05281081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177324|NCT05281081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177325|NCT05281081|Analgesics|analgesics|mesh-ancestor
93177326|NCT05281081|Sensory System Agents|sensory system agents|mesh-ancestor
93177327|NCT05281081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177328|NCT05281081|Anesthetics, Local|anesthetics, local|mesh-ancestor
93177329|NCT05281081|Anesthetics|anesthetics|mesh-ancestor
93177330|NCT03812965|Botulinum Toxins|botulinum toxins|mesh-list
93177331|NCT03812965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93177332|NCT03812965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93177333|NCT03812965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93177334|NCT03812965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93177335|NCT03812965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177336|NCT03812965|Cholinergic Agents|cholinergic agents|mesh-ancestor
93177337|NCT03812965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177338|NCT03812965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177339|NCT03812965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93177340|NCT03812965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177341|NCT01303237|Cetuximab|cetuximab|mesh-list
93177342|NCT01303237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177343|NCT01303237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177344|NCT01227863|Dexamethasone, neomycin, polymyxin B drug combination|dexamethasone, neomycin, polymyxin b drug combination|mesh-list
93177345|NCT01227863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93177346|NCT01227863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177347|NCT03349515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93177348|NCT01227941|Doxorubicin|doxorubicin|mesh-list
93177349|NCT01227941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93177350|NCT01227941|Niraparib|niraparib|mesh-list
93177351|NCT01227941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93177352|NCT01227941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177353|NCT01227941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93177354|NCT01227941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93177355|NCT01227941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177356|NCT01227941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177357|NCT01227941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93177358|NCT03919565|Tenofovir|tenofovir|mesh-list
93177359|NCT03919565|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93177360|NCT03919565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93177361|NCT03919565|Antiviral Agents|antiviral agents|mesh-ancestor
93177362|NCT03919565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177363|NCT03919565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93177364|NCT03919565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93177365|NCT03919565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177366|NCT03919565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177367|NCT03919565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93177368|NCT03919565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93177369|NCT03380091|Vitamin D|vitamin d|mesh-list
93177370|NCT03380091|Cholecalciferol|cholecalciferol|mesh-list
93177371|NCT03380091|Metformin|metformin|mesh-list
93177372|NCT03380091|Vitamins|vitamins|mesh-ancestor
93177373|NCT03380091|Micronutrients|micronutrients|mesh-ancestor
93177374|NCT03380091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177375|NCT03380091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177376|NCT03380091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93177377|NCT03380091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93177378|NCT02529293|Insulin Lispro|insulin lispro|mesh-list
93177379|NCT02529293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177380|NCT02529293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177381|NCT03919253|Paclitaxel|paclitaxel|mesh-list
93177382|NCT03919253|Maleic acid|maleic acid|mesh-list
93177383|NCT03919253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93177384|NCT03919253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177385|NCT03919253|Tubulin Modulators|tubulin modulators|mesh-ancestor
93177386|NCT03919253|Antimitotic Agents|antimitotic agents|mesh-ancestor
93177387|NCT03919253|Mitosis Modulators|mitosis modulators|mesh-ancestor
93177388|NCT03919253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177389|NCT03919253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177390|NCT05165290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93177391|NCT05165290|Latanoprost|latanoprost|mesh-list
93177392|NCT05165290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93177393|NCT01132703|Glyburide|glyburide|mesh-list
93177394|NCT01132703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177395|NCT01132703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177396|NCT01377922|Amifampridine|amifampridine|mesh-list
93177397|NCT01377922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93177398|NCT01377922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177399|NCT01377922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177400|NCT01377922|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93177401|NCT01377922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93177402|NCT01377922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177403|NCT03919175|Rituximab|rituximab|mesh-list
93177404|NCT03919175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177405|NCT03919175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177406|NCT03919175|Immunologic Factors|immunologic factors|mesh-ancestor
93177407|NCT03919175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177408|NCT03919175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93177409|NCT01303471|Remifentanil|remifentanil|mesh-list
93177410|NCT01303471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177411|NCT01303471|Narcotics|narcotics|mesh-ancestor
93177412|NCT01303471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177413|NCT01303471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177414|NCT01303471|Analgesics|analgesics|mesh-ancestor
93177415|NCT01303471|Sensory System Agents|sensory system agents|mesh-ancestor
93177416|NCT01303471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177417|NCT03804541|Ensartinib|ensartinib|mesh-list
93177418|NCT03804541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177419|NCT03804541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177420|NCT03804541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177421|NCT03804541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177422|NCT01377844|Bexagliflozin|bexagliflozin|mesh-list
93177423|NCT01377844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177424|NCT01377844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177425|NCT03710811|Insulin|insulin|mesh-list
93177426|NCT03710811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177427|NCT03710811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177428|NCT01303549|Amphotericin B|amphotericin b|mesh-list
93177429|NCT01303549|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93177430|NCT01303549|Anidulafungin|anidulafungin|mesh-list
93177431|NCT01303549|Amebicides|amebicides|mesh-ancestor
93177432|NCT01303549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93177433|NCT01303549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93177434|NCT01303549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177435|NCT01303549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93177436|NCT01303549|Antifungal Agents|antifungal agents|mesh-ancestor
93177437|NCT03796975|Metformin|metformin|mesh-list
93177438|NCT03796975|Pioglitazone|pioglitazone|mesh-list
93177439|NCT03796975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177440|NCT03796975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177441|NCT01130753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93177442|NCT01130753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177443|NCT01130753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177444|NCT01130753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177445|NCT01130753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177446|NCT05400070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93177447|NCT05400070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177448|NCT05400070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177449|NCT05400070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177450|NCT01302613|Leucovorin|leucovorin|mesh-list
93177451|NCT01302613|Capecitabine|capecitabine|mesh-list
93177452|NCT01302613|Oxaliplatin|oxaliplatin|mesh-list
93177453|NCT01302613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93177454|NCT01302613|Antimetabolites|antimetabolites|mesh-ancestor
93177455|NCT01302613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177456|NCT01302613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177457|NCT01302613|Antidotes|antidotes|mesh-ancestor
93177458|NCT01302613|Protective Agents|protective agents|mesh-ancestor
93177459|NCT01302613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177460|NCT01302613|Vitamin B Complex|vitamin b complex|mesh-ancestor
93177461|NCT01302613|Vitamins|vitamins|mesh-ancestor
93177462|NCT01302613|Micronutrients|micronutrients|mesh-ancestor
93177463|NCT03803371|Acetaminophen|acetaminophen|mesh-list
93177464|NCT03803371|Tramadol|tramadol|mesh-list
93177465|NCT03803371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93177466|NCT03803371|Analgesics|analgesics|mesh-ancestor
93177467|NCT03803371|Sensory System Agents|sensory system agents|mesh-ancestor
93177468|NCT03803371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177469|NCT03803371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177470|NCT03803371|Antipyretics|antipyretics|mesh-ancestor
93177471|NCT03803371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177472|NCT03803371|Narcotics|narcotics|mesh-ancestor
93177473|NCT03803371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177474|NCT01130909|Ketamine|ketamine|mesh-list
93177475|NCT01130909|Analgesics|analgesics|mesh-ancestor
93177476|NCT01130909|Sensory System Agents|sensory system agents|mesh-ancestor
93177477|NCT01130909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177478|NCT01130909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177479|NCT01130909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93177480|NCT01130909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177481|NCT01130909|Anesthetics, General|anesthetics, general|mesh-ancestor
93177482|NCT01130909|Anesthetics|anesthetics|mesh-ancestor
93177483|NCT01130909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177484|NCT01130909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93177485|NCT01130909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93177486|NCT01130909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177487|NCT01130909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177488|NCT03918551|Febuxostat|febuxostat|mesh-list
93177489|NCT03918551|Gout Suppressants|gout suppressants|mesh-ancestor
93177490|NCT03918551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93177491|NCT04453930|Irinotecan|irinotecan|mesh-list
93177492|NCT04453930|Apatinib|apatinib|mesh-list
93177493|NCT04453930|Antibodies|antibodies|mesh-list
93177494|NCT04453930|Immunologic Factors|immunologic factors|mesh-ancestor
93177495|NCT04453930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177496|NCT04453930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93177497|NCT04453930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93177498|NCT04453930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177499|NCT04453930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177500|NCT04453930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177501|NCT04453930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177503|NCT03796507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93177504|NCT03796507|Alkylating Agents|alkylating agents|mesh-ancestor
93177505|NCT03796507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177506|NCT03796507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177507|NCT04586062|Plasminogen|plasminogen|mesh-list
93177508|NCT04586062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93177509|NCT04586062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93177510|NCT04586062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177511|NCT01132781|Theophylline|theophylline|mesh-list
93177512|NCT01132781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93177513|NCT01132781|Autonomic Agents|autonomic agents|mesh-ancestor
93177514|NCT01132781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177515|NCT01132781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177516|NCT01132781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93177517|NCT01132781|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177518|NCT01132781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93177519|NCT01132781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177520|NCT01132781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177521|NCT01132781|Vasodilator Agents|vasodilator agents|mesh-ancestor
93177522|NCT01132781|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93177523|NCT01132781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93177524|NCT01132781|Purinergic Agents|purinergic agents|mesh-ancestor
93177525|NCT01132781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177526|NCT03497767|Osimertinib|osimertinib|mesh-list
93177527|NCT03497767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177528|NCT03497767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177529|NCT03497767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177530|NCT03497767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177531|NCT01303705|Cyclophosphamide|cyclophosphamide|mesh-list
93177532|NCT01303705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93177533|NCT01303705|Immunologic Factors|immunologic factors|mesh-ancestor
93177534|NCT01303705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177535|NCT01303705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93177536|NCT01303705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93177537|NCT01303705|Alkylating Agents|alkylating agents|mesh-ancestor
93177538|NCT01303705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177539|NCT01303705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177540|NCT01303705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93177541|NCT01134341|Vitamins|vitamins|mesh-list
93177542|NCT01134341|Folic Acid|folic acid|mesh-list
93177543|NCT01134341|Vitamin B 12|vitamin b 12|mesh-list
93177544|NCT01134341|Vitamin B Complex|vitamin b complex|mesh-list
93177545|NCT01134341|Bexarotene|bexarotene|mesh-list
93177546|NCT01134341|10-deazaaminopterin|10-deazaaminopterin|mesh-list
93177547|NCT01134341|Aminopterin|aminopterin|mesh-list
93177548|NCT01134341|Micronutrients|micronutrients|mesh-ancestor
93177549|NCT01134341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177550|NCT01134341|Hematinics|hematinics|mesh-ancestor
93177551|NCT01134341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177552|NCT01134341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93177553|NCT01134341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177554|NCT01134341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177555|NCT04308304|Donepezil|donepezil|mesh-list
93177556|NCT04308304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93177557|NCT04308304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177558|NCT04308304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177559|NCT04308304|Cholinergic Agents|cholinergic agents|mesh-ancestor
93177560|NCT04308304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177561|NCT04308304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177562|NCT04308304|Nootropic Agents|nootropic agents|mesh-ancestor
93177563|NCT05397262|Fluorouracil|fluorouracil|mesh-list
93177564|NCT05397262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177565|NCT05397262|Antimetabolites|antimetabolites|mesh-ancestor
93177566|NCT05397262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177567|NCT05397262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93177568|NCT05397262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93177569|NCT05397262|Immunologic Factors|immunologic factors|mesh-ancestor
93177570|NCT05397262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177571|NCT01230359|Pyridoxine|pyridoxine|mesh-list
93177572|NCT01230359|Vitamin B 6|vitamin b 6|mesh-list
93177573|NCT01230359|Vitamins|vitamins|mesh-ancestor
93177574|NCT01230359|Micronutrients|micronutrients|mesh-ancestor
93177575|NCT01230359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177576|NCT01230359|Vitamin B Complex|vitamin b complex|mesh-ancestor
93177577|NCT05591677|Cycloserine|cycloserine|mesh-list
93177578|NCT05591677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93177579|NCT05591677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177580|NCT05591677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93177581|NCT05591677|Antitubercular Agents|antitubercular agents|mesh-ancestor
93177582|NCT05591677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93177583|NCT05591677|Antimetabolites|antimetabolites|mesh-ancestor
93177584|NCT05591677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177585|NCT05396326|Oxaliplatin|oxaliplatin|mesh-list
93177586|NCT05396326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177587|NCT03795571|Dexamethasone|dexamethasone|mesh-list
93177588|NCT03795571|Rituximab|rituximab|mesh-list
93177589|NCT03795571|Gemcitabine|gemcitabine|mesh-list
93177590|NCT03795571|Oxaliplatin|oxaliplatin|mesh-list
93177591|NCT03795571|Lenalidomide|lenalidomide|mesh-list
93177592|NCT03795571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177593|NCT03795571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177594|NCT03795571|Immunologic Factors|immunologic factors|mesh-ancestor
93177595|NCT03795571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177596|NCT03795571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93177597|NCT03795571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177598|NCT03795571|Antiemetics|antiemetics|mesh-ancestor
93177599|NCT03795571|Autonomic Agents|autonomic agents|mesh-ancestor
93177600|NCT03795571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177601|NCT03795571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177602|NCT03795571|Glucocorticoids|glucocorticoids|mesh-ancestor
93177603|NCT03795571|Hormones|hormones|mesh-ancestor
93177604|NCT03795571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93177605|NCT03795571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93177606|NCT03795571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93177607|NCT03795571|Antimetabolites|antimetabolites|mesh-ancestor
93177608|NCT03795571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177609|NCT03795571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93177610|NCT03795571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93177611|NCT03795571|Growth Substances|growth substances|mesh-ancestor
93177612|NCT03795571|Growth Inhibitors|growth inhibitors|mesh-ancestor
93177613|NCT04280848|Temozolomide|temozolomide|mesh-list
93177614|NCT04280848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93177615|NCT04280848|Alkylating Agents|alkylating agents|mesh-ancestor
93177616|NCT04280848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177617|NCT04280848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177618|NCT03795649|Tranexamic Acid|tranexamic acid|mesh-list
93177619|NCT03795649|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93177620|NCT03795649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93177621|NCT03795649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177622|NCT03795649|Hemostatics|hemostatics|mesh-ancestor
93177623|NCT03795649|Coagulants|coagulants|mesh-ancestor
93177624|NCT04211272|Sildenafil Citrate|sildenafil citrate|mesh-list
93177625|NCT04211272|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93177626|NCT04211272|Macitentan|macitentan|mesh-list
93177627|NCT04211272|Riociguat|riociguat|mesh-list
93177628|NCT04211272|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93177629|NCT04211272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93177630|NCT04211272|Antimetabolites|antimetabolites|mesh-ancestor
93177631|NCT04211272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177632|NCT04211272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93177633|NCT04211272|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93177634|NCT04211272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177635|NCT04211272|Vasodilator Agents|vasodilator agents|mesh-ancestor
93177636|NCT04211272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93177637|NCT04211272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93177638|NCT04211272|Urological Agents|urological agents|mesh-ancestor
93177639|NCT04211272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93177640|NCT04211272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93177641|NCT04211272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93177642|NCT04211272|Enzyme Activators|enzyme activators|mesh-ancestor
93177643|NCT05402189|Fentanyl|fentanyl|mesh-list
93177644|NCT05402189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177645|NCT05402189|Narcotics|narcotics|mesh-ancestor
93177646|NCT05402189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177647|NCT05402189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177648|NCT05402189|Analgesics|analgesics|mesh-ancestor
93177649|NCT05402189|Sensory System Agents|sensory system agents|mesh-ancestor
92849829|NCT00860899|Clonidine|clonidine|mesh-list
93177650|NCT05402189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177651|NCT05402189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93177652|NCT05402189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177653|NCT05402189|Anesthetics, General|anesthetics, general|mesh-ancestor
93177654|NCT05402189|Anesthetics|anesthetics|mesh-ancestor
93177655|NCT01304563|Vaccines|vaccines|mesh-list
93177656|NCT01304563|Immunologic Factors|immunologic factors|mesh-ancestor
93177657|NCT01304563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177658|NCT01231997|Udenafil|udenafil|mesh-list
93177659|NCT01231997|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93177660|NCT01231997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93177661|NCT01231997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177662|NCT01231997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177663|NCT03795805|Lidocaine|lidocaine|mesh-list
93177664|NCT03795805|Anesthetics, Local|anesthetics, local|mesh-ancestor
93177665|NCT03795805|Anesthetics|anesthetics|mesh-ancestor
93177666|NCT03795805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177667|NCT03795805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177668|NCT03795805|Sensory System Agents|sensory system agents|mesh-ancestor
93177669|NCT03795805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177670|NCT03795805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93177671|NCT03795805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93177672|NCT03795805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93177673|NCT03795805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93177674|NCT03795805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177675|NCT04072042|Apatinib|apatinib|mesh-list
93177676|NCT04072042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177677|NCT04072042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177678|NCT04072042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177679|NCT04072042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177680|NCT03799315|Nicotine|nicotine|mesh-list
93177681|NCT03799315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93177682|NCT03799315|Autonomic Agents|autonomic agents|mesh-ancestor
93177683|NCT03799315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177684|NCT03799315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177685|NCT03799315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93177686|NCT03799315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93177687|NCT03799315|Cholinergic Agents|cholinergic agents|mesh-ancestor
93177688|NCT03799315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177689|NCT03799315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177690|NCT05387200|Alendronate|alendronate|mesh-list
93177691|NCT05387200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93177692|NCT05387200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177693|NCT05386810|Vaccines|vaccines|mesh-list
93177694|NCT05386810|Immunologic Factors|immunologic factors|mesh-ancestor
93177695|NCT05386810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177696|NCT04910269|Immunoglobulins|immunoglobulins|mesh-list
93177697|NCT04910269|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93177698|NCT04910269|Antibodies|antibodies|mesh-list
93177699|NCT04910269|Immunologic Factors|immunologic factors|mesh-ancestor
93177700|NCT04910269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177701|NCT03442972|Teduglutide|teduglutide|mesh-list
93177702|NCT03442972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177703|NCT03442972|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93177704|NCT03442972|Protective Agents|protective agents|mesh-ancestor
93177705|NCT03442972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177706|NCT03921671|Paclitaxel|paclitaxel|mesh-list
93177707|NCT03921671|Carboplatin|carboplatin|mesh-list
93177708|NCT03921671|Ramucirumab|ramucirumab|mesh-list
93177709|NCT03921671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93177710|NCT03921671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177711|NCT03921671|Tubulin Modulators|tubulin modulators|mesh-ancestor
93177712|NCT03921671|Antimitotic Agents|antimitotic agents|mesh-ancestor
93177713|NCT03921671|Mitosis Modulators|mitosis modulators|mesh-ancestor
93177714|NCT03921671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177715|NCT03921593|Pancrelipase|pancrelipase|mesh-list
93177716|NCT03921593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177717|NCT03369951|Minocycline|minocycline|mesh-list
93177718|NCT03369951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93177719|NCT03369951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177720|NCT01131767|Naproxen|naproxen|mesh-list
93177721|NCT01131767|Pseudoephedrine|pseudoephedrine|mesh-list
93177722|NCT01131767|Ephedrine|ephedrine|mesh-list
93177723|NCT01131767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93177724|NCT01131767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93177725|NCT01131767|Analgesics|analgesics|mesh-ancestor
93177726|NCT01131767|Sensory System Agents|sensory system agents|mesh-ancestor
93177727|NCT01131767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177728|NCT01131767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177729|NCT01131767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177730|NCT01131767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93177731|NCT01131767|Gout Suppressants|gout suppressants|mesh-ancestor
93177732|NCT01131767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93177733|NCT01131767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177734|NCT01131767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177735|NCT01131767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93177736|NCT01131767|Autonomic Agents|autonomic agents|mesh-ancestor
93177737|NCT01131767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93177738|NCT01131767|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177739|NCT01131767|Nasal Decongestants|nasal decongestants|mesh-ancestor
93177740|NCT01131767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93177741|NCT01131767|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93177742|NCT01131767|Sympathomimetics|sympathomimetics|mesh-ancestor
93177743|NCT01131767|Adrenergic Agents|adrenergic agents|mesh-ancestor
93177744|NCT01131767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177745|NCT03795259|Rocuronium|rocuronium|mesh-list
93177746|NCT03795259|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93177747|NCT03795259|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93177748|NCT03795259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93177749|NCT03795259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177750|NCT03795259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177751|NCT01229189|Vitamin D|vitamin d|mesh-list
93177752|NCT01229189|Vitamins|vitamins|mesh-ancestor
93177753|NCT01229189|Micronutrients|micronutrients|mesh-ancestor
93177754|NCT01229189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177755|NCT01229189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93177756|NCT05481489|Atropine|atropine|mesh-list
93177757|NCT05481489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93177758|NCT05481489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93177759|NCT05481489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93177760|NCT05481489|Autonomic Agents|autonomic agents|mesh-ancestor
93177761|NCT05481489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177762|NCT05481489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177763|NCT05481489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93177764|NCT05481489|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177765|NCT05481489|Mydriatics|mydriatics|mesh-ancestor
93177766|NCT05481489|Parasympatholytics|parasympatholytics|mesh-ancestor
93177767|NCT05481489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93177768|NCT05481489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93177769|NCT05481489|Cholinergic Agents|cholinergic agents|mesh-ancestor
93177770|NCT05481489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177771|NCT05481489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177772|NCT05341180|Lactulose|lactulose|mesh-list
93177773|NCT05341180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93177774|NCT05341180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93177775|NCT01133483|Fexofenadine|fexofenadine|mesh-list
93177776|NCT01133483|Pseudoephedrine|pseudoephedrine|mesh-list
93177777|NCT01133483|Ephedrine|ephedrine|mesh-list
93177778|NCT01133483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93177779|NCT01133483|Autonomic Agents|autonomic agents|mesh-ancestor
93177780|NCT01133483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177781|NCT01133483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177782|NCT01133483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93177783|NCT01133483|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177784|NCT01133483|Nasal Decongestants|nasal decongestants|mesh-ancestor
93177785|NCT01133483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93177786|NCT01133483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93177787|NCT01133483|Sympathomimetics|sympathomimetics|mesh-ancestor
93177788|NCT01133483|Adrenergic Agents|adrenergic agents|mesh-ancestor
93177789|NCT01133483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177790|NCT01133483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177791|NCT01133483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93177792|NCT01133483|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93177793|NCT01133483|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93177794|NCT01133483|Histamine Antagonists|histamine antagonists|mesh-ancestor
93177795|NCT01133483|Histamine Agents|histamine agents|mesh-ancestor
93177796|NCT05401721|Arginine Vasopressin|arginine vasopressin|mesh-list
93177797|NCT05401721|Hemostatics|hemostatics|mesh-ancestor
92849982|NCT00866437|Progestins|progestins|mesh-ancestor
93177798|NCT05401721|Coagulants|coagulants|mesh-ancestor
93177799|NCT05401721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93177800|NCT05401721|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93177801|NCT05401721|Natriuretic Agents|natriuretic agents|mesh-ancestor
93177802|NCT05401721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177804|NCT01560481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177805|NCT01560481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177806|NCT04795531|Insulin|insulin|mesh-list
93177807|NCT04795531|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93177808|NCT04795531|Insulin, Long-Acting|insulin, long-acting|mesh-list
93177809|NCT04795531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177810|NCT04795531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177811|NCT05238844|Tenofovir|tenofovir|mesh-list
93177812|NCT05238844|Antiviral Agents|antiviral agents|mesh-ancestor
93177813|NCT05238844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177814|NCT05238844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93177815|NCT05238844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93177816|NCT05238844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177817|NCT05238844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177818|NCT05238844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93177819|NCT05238844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93177820|NCT04785625|Bupivacaine|bupivacaine|mesh-list
93177821|NCT04785625|Anesthetics, Local|anesthetics, local|mesh-ancestor
93177822|NCT04785625|Anesthetics|anesthetics|mesh-ancestor
93177823|NCT04785625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177824|NCT04785625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177825|NCT04785625|Sensory System Agents|sensory system agents|mesh-ancestor
93177826|NCT04785625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177827|NCT03368859|Leucovorin|leucovorin|mesh-list
93177828|NCT03368859|Bevacizumab|bevacizumab|mesh-list
93177829|NCT03368859|Fluorouracil|fluorouracil|mesh-list
93177830|NCT03368859|Irinotecan|irinotecan|mesh-list
93177831|NCT03368859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177832|NCT03368859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177833|NCT03368859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93177834|NCT03368859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93177835|NCT03368859|Growth Substances|growth substances|mesh-ancestor
93177836|NCT03368859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177837|NCT03368859|Growth Inhibitors|growth inhibitors|mesh-ancestor
93177838|NCT03368859|Antimetabolites|antimetabolites|mesh-ancestor
93177839|NCT03368859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177840|NCT03368859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93177841|NCT03368859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93177842|NCT03368859|Immunologic Factors|immunologic factors|mesh-ancestor
93177843|NCT03368859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93177844|NCT03368859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93177845|NCT03368859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177846|NCT03368859|Antidotes|antidotes|mesh-ancestor
93177847|NCT03368859|Protective Agents|protective agents|mesh-ancestor
93177848|NCT03368859|Vitamin B Complex|vitamin b complex|mesh-ancestor
93177849|NCT03368859|Vitamins|vitamins|mesh-ancestor
93177850|NCT03368859|Micronutrients|micronutrients|mesh-ancestor
93177851|NCT01134965|Digoxin|digoxin|mesh-list
93177852|NCT01134965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93177853|NCT01134965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93177854|NCT01134965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177855|NCT01134965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177856|NCT01134965|Protective Agents|protective agents|mesh-ancestor
93177857|NCT01134965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177858|NCT03810547|Ketamine|ketamine|mesh-list
93177859|NCT03810547|Propofol|propofol|mesh-list
93177860|NCT03810547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93177861|NCT03810547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177862|NCT03810547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177863|NCT03810547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93177864|NCT03810547|Anesthetics, General|anesthetics, general|mesh-ancestor
93177865|NCT03810547|Anesthetics|anesthetics|mesh-ancestor
93177866|NCT03810547|Analgesics|analgesics|mesh-ancestor
93177867|NCT03810547|Sensory System Agents|sensory system agents|mesh-ancestor
93177868|NCT03810547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177869|NCT03810547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93177870|NCT03810547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93177871|NCT03810547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93177872|NCT03810547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177873|NCT03810547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177874|NCT03096314|Vitamin D|vitamin d|mesh-list
93177875|NCT03096314|Cholecalciferol|cholecalciferol|mesh-list
93177876|NCT03096314|Vitamins|vitamins|mesh-ancestor
93177877|NCT03096314|Micronutrients|micronutrients|mesh-ancestor
93177878|NCT03096314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177879|NCT03096314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93177880|NCT03096314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93177881|NCT03917459|Enalapril|enalapril|mesh-list
93177882|NCT03917459|Enalaprilat|enalaprilat|mesh-list
93177883|NCT03917459|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93177884|NCT03917459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93177885|NCT03917459|Protease Inhibitors|protease inhibitors|mesh-ancestor
93177886|NCT03917459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177887|NCT03917459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177888|NCT03917459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93177889|NCT03917459|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93177890|NCT03129646|Paromomycin|paromomycin|mesh-list
93177891|NCT03129646|Miltefosine|miltefosine|mesh-list
93177892|NCT03129646|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
93177893|NCT03129646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93177894|NCT03129646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93177895|NCT03129646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93177896|NCT03129646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93177897|NCT03129646|Antifungal Agents|antifungal agents|mesh-ancestor
93177898|NCT03129646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177899|NCT03129646|Schistosomicides|schistosomicides|mesh-ancestor
93177900|NCT03129646|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93177901|NCT03129646|Anthelmintics|anthelmintics|mesh-ancestor
93177902|NCT03710655|Histamine|histamine|mesh-list
93177903|NCT03710655|Histamine Agonists|histamine agonists|mesh-ancestor
93177904|NCT03710655|Histamine Agents|histamine agents|mesh-ancestor
93177905|NCT03710655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93177906|NCT03710655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177907|NCT03710655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177908|NCT01135199|Pomalidomide|pomalidomide|mesh-list
93177909|NCT01135199|Immunologic Factors|immunologic factors|mesh-ancestor
93177910|NCT01135199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177911|NCT01135199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93177912|NCT01135199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93177913|NCT01135199|Growth Substances|growth substances|mesh-ancestor
93177914|NCT01135199|Growth Inhibitors|growth inhibitors|mesh-ancestor
93177915|NCT01135199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177916|NCT03917537|Nivolumab|nivolumab|mesh-list
93177917|NCT03917537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177918|NCT03917537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177919|NCT03917537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93177920|NCT03917537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177921|NCT03335163|Topiramate|topiramate|mesh-list
93177922|NCT03335163|Anticonvulsants|anticonvulsants|mesh-ancestor
93177923|NCT03335163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93177924|NCT03335163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177925|NCT04749602|Nivolumab|nivolumab|mesh-list
93177926|NCT04749602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93177927|NCT04749602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177928|NCT04749602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93177929|NCT04749602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177930|NCT03461302|Coal Tar|coal tar|mesh-list
93177931|NCT03461302|Keratolytic Agents|keratolytic agents|mesh-ancestor
93177932|NCT03461302|Dermatologic Agents|dermatologic agents|mesh-ancestor
93177933|NCT01232075|Letrozole|letrozole|mesh-list
93177934|NCT01232075|Citric Acid|citric acid|mesh-list
93177935|NCT01232075|Sodium Citrate|sodium citrate|mesh-list
93177936|NCT01232075|Clomiphene|clomiphene|mesh-list
93177937|NCT01232075|Enclomiphene|enclomiphene|mesh-list
93177938|NCT01232075|Zuclomiphene|zuclomiphene|mesh-list
93177939|NCT01232075|Anticoagulants|anticoagulants|mesh-ancestor
93177940|NCT01232075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93177941|NCT01232075|Chelating Agents|chelating agents|mesh-ancestor
93177942|NCT01232075|Sequestering Agents|sequestering agents|mesh-ancestor
93177943|NCT01232075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177944|NCT01232075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177945|NCT01232075|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93177946|NCT01232075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93177947|NCT01232075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177948|NCT01232075|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93177949|NCT01232075|Hormone Antagonists|hormone antagonists|mesh-ancestor
93177950|NCT01232075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93177951|NCT01232075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177952|NCT01232075|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93177953|NCT01232075|Fertility Agents|fertility agents|mesh-ancestor
93177954|NCT01232075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93177955|NCT01232075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93177956|NCT01232075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93177957|NCT03773822|Hydrocortisone|hydrocortisone|mesh-list
93177958|NCT03773822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93177959|NCT01131845|Treprostinil|treprostinil|mesh-list
93177960|NCT01131845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93177961|NCT03711422|Afatinib|afatinib|mesh-list
93177962|NCT03711422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177963|NCT03711422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177964|NCT03711422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177965|NCT03711422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177966|NCT03460678|Pemetrexed|pemetrexed|mesh-list
93177967|NCT03460678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93177968|NCT03460678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93177969|NCT03460678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93177970|NCT03460678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177971|NCT03460678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93177972|NCT03460678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93177973|NCT03460678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93177974|NCT03810391|Butorphanol|butorphanol|mesh-list
93177975|NCT03810391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93177976|NCT03810391|Narcotics|narcotics|mesh-ancestor
93177977|NCT03810391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93177978|NCT03810391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177979|NCT03810391|Analgesics|analgesics|mesh-ancestor
93177980|NCT03810391|Sensory System Agents|sensory system agents|mesh-ancestor
93177981|NCT03810391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93177982|NCT03810391|Antitussive Agents|antitussive agents|mesh-ancestor
93177983|NCT03810391|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177984|NCT03810391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93177985|NCT01229579|Zinc Sulfate|zinc sulfate|mesh-list
93177986|NCT01229579|Astringents|astringents|mesh-ancestor
93177987|NCT01229579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177988|NCT01229579|Dermatologic Agents|dermatologic agents|mesh-ancestor
93177989|NCT01131923|Amlodipine|amlodipine|mesh-list
93177990|NCT01131923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93177991|NCT01131923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93177992|NCT01131923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93177993|NCT01131923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93177994|NCT01131923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92855245|NCT00605215|Interferon beta-1a|interferon beta-1a|mesh-list
93177995|NCT01131923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93177996|NCT01131923|Vasodilator Agents|vasodilator agents|mesh-ancestor
93177997|NCT03794557|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
93177998|NCT03794557|Respiratory System Agents|respiratory system agents|mesh-ancestor
93177999|NCT01230983|Leucovorin|leucovorin|mesh-list
93178000|NCT01230983|Cytarabine|cytarabine|mesh-list
93178001|NCT01230983|Prednisone|prednisone|mesh-list
93178002|NCT01230983|Hydrocortisone|hydrocortisone|mesh-list
93178003|NCT01230983|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93178004|NCT01230983|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93178005|NCT01230983|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93178006|NCT01230983|Doxorubicin|doxorubicin|mesh-list
93178007|NCT01230983|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93178008|NCT01230983|Dexrazoxane|dexrazoxane|mesh-list
93178009|NCT01230983|Methotrexate|methotrexate|mesh-list
93178010|NCT01230983|Vincristine|vincristine|mesh-list
93178011|NCT01230983|Asparaginase|asparaginase|mesh-list
93178012|NCT01230983|Mercaptopurine|mercaptopurine|mesh-list
93178013|NCT01230983|Razoxane|razoxane|mesh-list
93178014|NCT01230983|Levoleucovorin|levoleucovorin|mesh-list
93178015|NCT01230983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93178016|NCT01230983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178017|NCT01230983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93178018|NCT01230983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93178019|NCT01230983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178020|NCT01230983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178021|NCT01230983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178022|NCT01230983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178023|NCT01230983|Glucocorticoids|glucocorticoids|mesh-ancestor
93178024|NCT01230983|Hormones|hormones|mesh-ancestor
93178025|NCT01230983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178026|NCT01230983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93178027|NCT01230983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92850207|NCT00871039|Midazolam|midazolam|mesh-list
93178028|NCT01230983|Abortifacient Agents|abortifacient agents|mesh-ancestor
93178029|NCT01230983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93178030|NCT01230983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178031|NCT01230983|Antimetabolites|antimetabolites|mesh-ancestor
93178032|NCT01230983|Dermatologic Agents|dermatologic agents|mesh-ancestor
93178033|NCT01230983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93178034|NCT01230983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178035|NCT01230983|Immunologic Factors|immunologic factors|mesh-ancestor
93178036|NCT01230983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178037|NCT01230983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93178038|NCT01230983|Antiviral Agents|antiviral agents|mesh-ancestor
93178039|NCT01230983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178040|NCT01230983|Antidotes|antidotes|mesh-ancestor
93178041|NCT01230983|Protective Agents|protective agents|mesh-ancestor
93178042|NCT01230983|Vitamin B Complex|vitamin b complex|mesh-ancestor
93178043|NCT01230983|Vitamins|vitamins|mesh-ancestor
93178044|NCT01230983|Micronutrients|micronutrients|mesh-ancestor
93178045|NCT01230983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178046|NCT01230983|Tubulin Modulators|tubulin modulators|mesh-ancestor
93178047|NCT01230983|Antimitotic Agents|antimitotic agents|mesh-ancestor
93178048|NCT01230983|Mitosis Modulators|mitosis modulators|mesh-ancestor
93178049|NCT01230983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93178050|NCT01304797|Cyclophosphamide|cyclophosphamide|mesh-list
93178051|NCT01304797|Trastuzumab|trastuzumab|mesh-list
93178052|NCT01304797|Doxorubicin|doxorubicin|mesh-list
93178053|NCT01304797|Gancotamab|gancotamab|mesh-list
93178054|NCT01304797|Immunoconjugates|immunoconjugates|mesh-list
93178055|NCT01304797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178056|NCT01304797|Immunologic Factors|immunologic factors|mesh-ancestor
93178057|NCT01304797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178058|NCT01304797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178059|NCT01304797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93178060|NCT01304797|Alkylating Agents|alkylating agents|mesh-ancestor
93178061|NCT01304797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178062|NCT01304797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178063|NCT01304797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93178064|NCT01304797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93178065|NCT01304797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93178066|NCT01304797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93178067|NCT01304797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93178068|NCT01304797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178069|NCT03707535|Infliximab|infliximab|mesh-list
93178070|NCT03707535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93178071|NCT03707535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178072|NCT03707535|Dermatologic Agents|dermatologic agents|mesh-ancestor
93178073|NCT03707535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178074|NCT03707535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178075|NCT01133795|Midodrine|midodrine|mesh-list
93178076|NCT01133795|Sympathomimetics|sympathomimetics|mesh-ancestor
93178077|NCT01133795|Autonomic Agents|autonomic agents|mesh-ancestor
93178078|NCT01133795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178079|NCT01133795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178080|NCT01133795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93178081|NCT01133795|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93178082|NCT01133795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93178083|NCT01133795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93178084|NCT01133795|Adrenergic Agents|adrenergic agents|mesh-ancestor
93178085|NCT01133795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178086|NCT01133795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178087|NCT01133873|Dextropropoxyphene|dextropropoxyphene|mesh-list
93178088|NCT01133873|Levopropoxyphene|levopropoxyphene|mesh-list
93178089|NCT01133873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93178090|NCT01133873|Narcotics|narcotics|mesh-ancestor
93178091|NCT01133873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178092|NCT01133873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178093|NCT01133873|Analgesics|analgesics|mesh-ancestor
93178094|NCT01133873|Sensory System Agents|sensory system agents|mesh-ancestor
93178095|NCT01133873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178096|NCT01133873|Antitussive Agents|antitussive agents|mesh-ancestor
93178097|NCT01133873|Respiratory System Agents|respiratory system agents|mesh-ancestor
93178098|NCT01229813|Bevacizumab|bevacizumab|mesh-list
93178099|NCT01229813|Capecitabine|capecitabine|mesh-list
93178100|NCT01229813|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93178101|NCT01229813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93178102|NCT01229813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178103|NCT01229813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93178104|NCT01229813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93178105|NCT01229813|Growth Substances|growth substances|mesh-ancestor
93178106|NCT01229813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178108|NCT01229813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178109|NCT01229813|Antimetabolites|antimetabolites|mesh-ancestor
93178110|NCT01229813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178111|NCT01229813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178112|NCT01229813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178113|NCT03920813|Mercaptopurine|mercaptopurine|mesh-list
93178114|NCT03920813|Antimetabolites|antimetabolites|mesh-ancestor
93178115|NCT03920813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178116|NCT03920813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178117|NCT03920813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178118|NCT03920813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178119|NCT03920813|Immunologic Factors|immunologic factors|mesh-ancestor
93178120|NCT03920813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178121|NCT03920813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93178122|NCT03920813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178123|NCT01649947|Hydroxychloroquine|hydroxychloroquine|mesh-list
93178124|NCT01649947|Paclitaxel|paclitaxel|mesh-list
93178125|NCT01649947|Bevacizumab|bevacizumab|mesh-list
93178126|NCT01649947|Carboplatin|carboplatin|mesh-list
93178127|NCT01649947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178128|NCT01649947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178129|NCT01649947|Tubulin Modulators|tubulin modulators|mesh-ancestor
93178130|NCT01649947|Antimitotic Agents|antimitotic agents|mesh-ancestor
93178131|NCT01649947|Mitosis Modulators|mitosis modulators|mesh-ancestor
93178132|NCT01649947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178133|NCT01649947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855269|NCT00604279|Risperidone|risperidone|mesh-list
93178134|NCT01649947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93178135|NCT01649947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93178136|NCT01649947|Growth Substances|growth substances|mesh-ancestor
93178137|NCT01649947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178138|NCT01649947|Growth Inhibitors|growth inhibitors|mesh-ancestor
93178139|NCT01649947|Antimalarials|antimalarials|mesh-ancestor
93178140|NCT01649947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93178141|NCT01649947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93178142|NCT01649947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178143|NCT01649947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178144|NCT01649947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178145|NCT03793075|Ketamine|ketamine|mesh-list
93178146|NCT03793075|Propofol|propofol|mesh-list
93178147|NCT03793075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93178148|NCT03793075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178149|NCT03793075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178150|NCT03793075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93178151|NCT03793075|Anesthetics, General|anesthetics, general|mesh-ancestor
93178152|NCT03793075|Anesthetics|anesthetics|mesh-ancestor
93178153|NCT03793075|Analgesics|analgesics|mesh-ancestor
93178154|NCT03793075|Sensory System Agents|sensory system agents|mesh-ancestor
93178155|NCT03793075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178156|NCT03793075|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93178157|NCT03793075|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93178158|NCT03793075|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93178159|NCT03793075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178160|NCT03793075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178161|NCT01233167|Clopidogrel|clopidogrel|mesh-list
93178162|NCT01233167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93178163|NCT01233167|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93178164|NCT01233167|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93178165|NCT01233167|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93178166|NCT01233167|Purinergic Agents|purinergic agents|mesh-ancestor
93178167|NCT01233167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178168|NCT01233167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178169|NCT01233167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178170|NCT01304095|Ranolazine|ranolazine|mesh-list
93178171|NCT01304095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93178172|NCT01304095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93178173|NCT01304095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178174|NCT03707457|Nivolumab|nivolumab|mesh-list
93178175|NCT03707457|Ipilimumab|ipilimumab|mesh-list
93178176|NCT03707457|MK-4166|mk-4166|mesh-list
93178177|NCT03707457|Antibodies|antibodies|mesh-list
93178178|NCT03707457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93178179|NCT03707457|Immunologic Factors|immunologic factors|mesh-ancestor
93178180|NCT03707457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178181|NCT03707457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93178182|NCT03707457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178183|NCT03707457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93178184|NCT03707457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178185|NCT01568294|Pomalidomide|pomalidomide|mesh-list
93178186|NCT01568294|Immunologic Factors|immunologic factors|mesh-ancestor
93178187|NCT01568294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178188|NCT01568294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93178189|NCT01568294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93178190|NCT01568294|Growth Substances|growth substances|mesh-ancestor
93178191|NCT01568294|Growth Inhibitors|growth inhibitors|mesh-ancestor
93178192|NCT01568294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178193|NCT03422666|Teduglutide|teduglutide|mesh-list
93178194|NCT03422666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178195|NCT03422666|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93178196|NCT03422666|Protective Agents|protective agents|mesh-ancestor
93178197|NCT03422666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178198|NCT03453190|Apremilast|apremilast|mesh-list
93178199|NCT03453190|Clobetasol|clobetasol|mesh-list
93178200|NCT03453190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93178201|NCT03453190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93178202|NCT03453190|Analgesics|analgesics|mesh-ancestor
93178203|NCT03453190|Sensory System Agents|sensory system agents|mesh-ancestor
93178204|NCT03453190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178205|NCT03453190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178206|NCT03453190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178207|NCT03453190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178208|NCT03453190|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93178209|NCT03453190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93178210|NCT03453190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178211|NCT03453190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178212|NCT03453190|Glucocorticoids|glucocorticoids|mesh-ancestor
93178213|NCT03453190|Hormones|hormones|mesh-ancestor
93178214|NCT03453190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178215|NCT01231139|Acetaminophen|acetaminophen|mesh-list
93178216|NCT01231139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93178217|NCT01231139|Analgesics|analgesics|mesh-ancestor
93178218|NCT01231139|Sensory System Agents|sensory system agents|mesh-ancestor
93178219|NCT01231139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178220|NCT01231139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178221|NCT01231139|Antipyretics|antipyretics|mesh-ancestor
93178222|NCT03382574|Denosumab|denosumab|mesh-list
93178223|NCT03382574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93178224|NCT03382574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178225|NCT01137695|Pramlintide|pramlintide|mesh-list
93178226|NCT01137695|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
93178227|NCT01137695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93178228|NCT01137695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178229|NCT01137695|Appetite Depressants|appetite depressants|mesh-ancestor
93178230|NCT01137695|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93178231|NCT01137695|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
93178232|NCT01137695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178233|NCT03451396|Lifitegrast|lifitegrast|mesh-list
93178234|NCT03451396|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93178235|NCT03451396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93178236|NCT02528825|Remifentanil|remifentanil|mesh-list
93178237|NCT02528825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93178238|NCT02528825|Narcotics|narcotics|mesh-ancestor
93178239|NCT02528825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178240|NCT02528825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178241|NCT02528825|Analgesics|analgesics|mesh-ancestor
93178242|NCT02528825|Sensory System Agents|sensory system agents|mesh-ancestor
93178243|NCT02528825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178244|NCT01233245|Interferons|interferons|mesh-list
93178245|NCT01233245|Interferon-beta|interferon-beta|mesh-list
93178246|NCT01233245|Interferon beta-1b|interferon beta-1b|mesh-list
93178247|NCT01233245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178248|NCT01233245|Antiviral Agents|antiviral agents|mesh-ancestor
93178249|NCT01233245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178250|NCT01233245|Immunologic Factors|immunologic factors|mesh-ancestor
93178251|NCT01233245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178252|NCT01233245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93178253|NCT03776812|Paclitaxel|paclitaxel|mesh-list
92850435|NCT02792712|Clopidogrel|clopidogrel|mesh-list
93178254|NCT03776812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93178255|NCT03776812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178256|NCT03776812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178257|NCT03776812|Tubulin Modulators|tubulin modulators|mesh-ancestor
93178258|NCT03776812|Antimitotic Agents|antimitotic agents|mesh-ancestor
93178259|NCT03776812|Mitosis Modulators|mitosis modulators|mesh-ancestor
93178260|NCT03776812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178261|NCT03361605|Propofol|propofol|mesh-list
93178262|NCT03361605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93178263|NCT03361605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178264|NCT03361605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178265|NCT03361605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93178266|NCT03361605|Anesthetics, General|anesthetics, general|mesh-ancestor
93178267|NCT03361605|Anesthetics|anesthetics|mesh-ancestor
93178268|NCT03794167|Cyclophosphamide|cyclophosphamide|mesh-list
93178269|NCT03794167|Melphalan|melphalan|mesh-list
93178270|NCT03794167|Busulfan|busulfan|mesh-list
93178271|NCT03794167|Etoposide|etoposide|mesh-list
93178272|NCT03794167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178273|NCT03794167|Immunologic Factors|immunologic factors|mesh-ancestor
93178274|NCT03794167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178275|NCT03794167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178276|NCT03794167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93178277|NCT03794167|Alkylating Agents|alkylating agents|mesh-ancestor
93178278|NCT03794167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178279|NCT03794167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178280|NCT03794167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93178281|NCT03794167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178282|NCT03794167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93178283|NCT03794167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93178284|NCT03794167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178285|NCT05332821|Bevacizumab|bevacizumab|mesh-list
93178286|NCT05332821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93178287|NCT05332821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93178288|NCT05332821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178289|NCT05332821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93178290|NCT05332821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93178291|NCT05332821|Growth Substances|growth substances|mesh-ancestor
93178292|NCT05332821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178293|NCT05332821|Growth Inhibitors|growth inhibitors|mesh-ancestor
93178294|NCT05332821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178295|NCT05331651|Glycopyrrolate|glycopyrrolate|mesh-list
93178296|NCT05331651|Tropisetron|tropisetron|mesh-list
93178297|NCT05331651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93178298|NCT05331651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93178299|NCT05331651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93178300|NCT05331651|Cholinergic Agents|cholinergic agents|mesh-ancestor
93178301|NCT05331651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178302|NCT05331651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178303|NCT05331651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178304|NCT05331651|Antiemetics|antiemetics|mesh-ancestor
93178305|NCT05331651|Autonomic Agents|autonomic agents|mesh-ancestor
93178306|NCT05331651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178307|NCT05331651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178308|NCT05331651|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93178309|NCT05331651|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93178310|NCT05331651|Serotonin Agents|serotonin agents|mesh-ancestor
93178311|NCT01134185|Prucalopride|prucalopride|mesh-list
93178312|NCT01134185|Laxatives|laxatives|mesh-ancestor
93178313|NCT01134185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178314|NCT01134185|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93178315|NCT01134185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93178316|NCT01134185|Serotonin Agents|serotonin agents|mesh-ancestor
93178317|NCT01134185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178318|NCT01134185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178319|NCT01134185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178320|NCT03829046|Evolocumab|evolocumab|mesh-list
93178321|NCT03829046|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93178322|NCT03829046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93178323|NCT03829046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93178324|NCT03829046|Antimetabolites|antimetabolites|mesh-ancestor
93178325|NCT03829046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178326|NCT03829046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93178327|NCT03829046|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850504|NCT02609997|Glucocorticoids|glucocorticoids|mesh-ancestor
93178328|NCT03829046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178329|NCT03829046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93178330|NCT05320588|Pembrolizumab|pembrolizumab|mesh-list
93178331|NCT05320588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93178332|NCT05320588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178333|NCT05320588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93178334|NCT05320588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178335|NCT01231529|Dolutegravir|dolutegravir|mesh-list
93178336|NCT01231529|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93178337|NCT01231529|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93178338|NCT01231529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178339|NCT01231529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178340|NCT01231529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93178341|NCT01231529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93178342|NCT01231529|Antiviral Agents|antiviral agents|mesh-ancestor
93178343|NCT01231529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178344|NCT05306704|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93178345|NCT05306704|Calcifediol|calcifediol|mesh-list
93178346|NCT05306704|Vitamins|vitamins|mesh-ancestor
93178347|NCT05306704|Micronutrients|micronutrients|mesh-ancestor
93178348|NCT05306704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178349|NCT05306704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93178350|NCT01231685|Ritonavir|ritonavir|mesh-list
93178351|NCT01231685|Lopinavir|lopinavir|mesh-list
93178352|NCT01231685|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93178353|NCT01231685|Darunavir|darunavir|mesh-list
93178354|NCT01231685|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93178355|NCT01231685|Raltegravir Potassium|raltegravir potassium|mesh-list
93178356|NCT01231685|Protease Inhibitors|protease inhibitors|mesh-list
93178357|NCT01231685|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93178358|NCT01231685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178359|NCT01231685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178360|NCT01231685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93178361|NCT01231685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93178362|NCT01231685|Antiviral Agents|antiviral agents|mesh-ancestor
93178363|NCT01231685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178364|NCT01231685|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93178365|NCT01231685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93178366|NCT01231685|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93178367|NCT01231685|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93178368|NCT05402735|Uric Acid|uric acid|mesh-list
93178369|NCT05402735|Antioxidants|antioxidants|mesh-ancestor
93178370|NCT05402735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178371|NCT05402735|Protective Agents|protective agents|mesh-ancestor
93178372|NCT05402735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178373|NCT01138085|Trametinib|trametinib|mesh-list
93178374|NCT01138085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178375|NCT01138085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178376|NCT01138085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178377|NCT01138085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178378|NCT05278858|Triamcinolone|triamcinolone|mesh-list
93178379|NCT05278858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178380|NCT05278858|Glucocorticoids|glucocorticoids|mesh-ancestor
93178381|NCT05278858|Hormones|hormones|mesh-ancestor
93178382|NCT05278858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178383|NCT05278858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178384|NCT03792217|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93178385|NCT03792217|Eusol|eusol|mesh-list
93178386|NCT03792217|Disinfectants|disinfectants|mesh-ancestor
93178387|NCT03792217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178388|NCT03359811|Bupivacaine|bupivacaine|mesh-list
93178389|NCT03359811|Anesthetics, Local|anesthetics, local|mesh-list
93178390|NCT03359811|Anesthetics|anesthetics|mesh-list
93178391|NCT03359811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178392|NCT03359811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178393|NCT03359811|Sensory System Agents|sensory system agents|mesh-ancestor
93178394|NCT03359811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178395|NCT03728426|Letermovir|letermovir|mesh-list
93178396|NCT03728426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93178397|NCT03728426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178398|NCT03728426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178399|NCT03728426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178400|NCT03728426|Antiviral Agents|antiviral agents|mesh-ancestor
93178401|NCT03728426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178402|NCT01140581|Dronedarone|dronedarone|mesh-list
93178403|NCT01140581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93178404|NCT03792139|Itraconazole|itraconazole|mesh-list
93178405|NCT03792139|Antifungal Agents|antifungal agents|mesh-ancestor
93178406|NCT03792139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178407|NCT03792139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93178408|NCT03792139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93178409|NCT03792139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178410|NCT03792139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178411|NCT03792139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93178412|NCT03792139|Hormone Antagonists|hormone antagonists|mesh-ancestor
93178413|NCT03792139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178414|NCT03792139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178415|NCT03792139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93178416|NCT04664738|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93178417|NCT04664738|Hemostatics|hemostatics|mesh-ancestor
93178418|NCT04664738|Coagulants|coagulants|mesh-ancestor
93178419|NCT03792295|Acetaminophen|acetaminophen|mesh-list
93178420|NCT03792295|Ibuprofen|ibuprofen|mesh-list
93178421|NCT03792295|Oxycodone|oxycodone|mesh-list
93178422|NCT03792295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93178423|NCT03792295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93178424|NCT03792295|Analgesics|analgesics|mesh-ancestor
93178425|NCT03792295|Sensory System Agents|sensory system agents|mesh-ancestor
93178426|NCT03792295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178427|NCT03792295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178428|NCT03792295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178429|NCT03792295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178430|NCT03792295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93178431|NCT03792295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178432|NCT03792295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178433|NCT03792295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93178434|NCT03792295|Narcotics|narcotics|mesh-ancestor
93178435|NCT03792295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178436|NCT03792295|Antipyretics|antipyretics|mesh-ancestor
93178437|NCT03449056|Albuterol|albuterol|mesh-list
93178438|NCT03449056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93178439|NCT03449056|Autonomic Agents|autonomic agents|mesh-ancestor
93178440|NCT03449056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178441|NCT03449056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178442|NCT03449056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93178443|NCT03449056|Respiratory System Agents|respiratory system agents|mesh-ancestor
93178444|NCT03449056|Tocolytic Agents|tocolytic agents|mesh-ancestor
93178445|NCT03449056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93178446|NCT03449056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93178447|NCT03449056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93178448|NCT03449056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93178449|NCT03449056|Adrenergic Agents|adrenergic agents|mesh-ancestor
93178450|NCT03449056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178451|NCT03449056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178452|NCT01135433|Metformin|metformin|mesh-list
93178453|NCT01135433|Ipragliflozin|ipragliflozin|mesh-list
93178454|NCT01135433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93178455|NCT01135433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178456|NCT01135433|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93178457|NCT01135433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178458|NCT04745273|Ondansetron|ondansetron|mesh-list
93178459|NCT04745273|Antiemetics|antiemetics|mesh-ancestor
93178460|NCT04745273|Autonomic Agents|autonomic agents|mesh-ancestor
93178461|NCT04745273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178462|NCT04745273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178463|NCT04745273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178464|NCT04745273|Antipruritics|antipruritics|mesh-ancestor
93178465|NCT04745273|Dermatologic Agents|dermatologic agents|mesh-ancestor
93178466|NCT04745273|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93178467|NCT04745273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93178468|NCT04745273|Serotonin Agents|serotonin agents|mesh-ancestor
93178469|NCT04745273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178470|NCT04745273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178471|NCT01305187|Hyaluronic Acid|hyaluronic acid|mesh-list
93178472|NCT01305187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93178473|NCT01305187|Immunologic Factors|immunologic factors|mesh-ancestor
93178474|NCT01305187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178475|NCT01305187|Viscosupplements|viscosupplements|mesh-ancestor
93178476|NCT01305187|Protective Agents|protective agents|mesh-ancestor
93178477|NCT01138397|Vaccines|vaccines|mesh-list
93178478|NCT01138397|Immunologic Factors|immunologic factors|mesh-ancestor
93178479|NCT01138397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178481|NCT03448744|Thymalfasin|thymalfasin|mesh-list
93178482|NCT03448744|Antiviral Agents|antiviral agents|mesh-ancestor
93178483|NCT03448744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178484|NCT03448744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93178485|NCT03448744|Immunologic Factors|immunologic factors|mesh-ancestor
93178486|NCT03448744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178487|NCT03448588|Selenium|selenium|mesh-list
93178488|NCT03448588|Antioxidants|antioxidants|mesh-ancestor
93178489|NCT03448588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178490|NCT03448588|Protective Agents|protective agents|mesh-ancestor
93178491|NCT03448588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178492|NCT03448588|Trace Elements|trace elements|mesh-ancestor
93178493|NCT03448588|Micronutrients|micronutrients|mesh-ancestor
93178494|NCT03797443|Ascorbic Acid|ascorbic acid|mesh-list
93178495|NCT03797443|Paclitaxel|paclitaxel|mesh-list
93178496|NCT03797443|Gemcitabine|gemcitabine|mesh-list
93178497|NCT03797443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178498|NCT03797443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178499|NCT03797443|Tubulin Modulators|tubulin modulators|mesh-ancestor
93178500|NCT03797443|Antimitotic Agents|antimitotic agents|mesh-ancestor
93178501|NCT03797443|Mitosis Modulators|mitosis modulators|mesh-ancestor
93178502|NCT03797443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178503|NCT03797443|Vitamins|vitamins|mesh-ancestor
93178504|NCT03797443|Micronutrients|micronutrients|mesh-ancestor
93178505|NCT03797443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178506|NCT03797443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178507|NCT03797443|Antimetabolites|antimetabolites|mesh-ancestor
93178508|NCT03797443|Antioxidants|antioxidants|mesh-ancestor
93178509|NCT03797443|Protective Agents|protective agents|mesh-ancestor
93178510|NCT01135589|Micafungin|micafungin|mesh-list
93178511|NCT01135589|Antifungal Agents|antifungal agents|mesh-ancestor
93178512|NCT01135589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178513|NCT01915810|Nicotine|nicotine|mesh-list
93178514|NCT01915810|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93178515|NCT01915810|Autonomic Agents|autonomic agents|mesh-ancestor
93178516|NCT01915810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178517|NCT01915810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178518|NCT01915810|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93178519|NCT01915810|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93178520|NCT01915810|Cholinergic Agents|cholinergic agents|mesh-ancestor
93178521|NCT01915810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178522|NCT01915810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178523|NCT01140737|Axitinib|axitinib|mesh-list
93178524|NCT01140737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178525|NCT01140737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178526|NCT01140737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178527|NCT01140737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178528|NCT05594095|Everolimus|everolimus|mesh-list
93178529|NCT05594095|Fulvestrant|fulvestrant|mesh-list
93178530|NCT05594095|Goserelin|goserelin|mesh-list
93178531|NCT05594095|Fluzoparib|fluzoparib|mesh-list
93178532|NCT05594095|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93178533|NCT05594095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93178534|NCT05594095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178535|NCT05594095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178536|NCT05594095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178537|NCT05594095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178538|NCT05594095|Immunologic Factors|immunologic factors|mesh-ancestor
93178539|NCT05594095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178540|NCT05594095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178541|NCT05594095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93178542|NCT05594095|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93178543|NCT05594095|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93178544|NCT05594095|Hormone Antagonists|hormone antagonists|mesh-ancestor
93178545|NCT05594095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178546|NCT05594095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93178547|NCT05594095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93178548|NCT04951063|Immunomodulating Agents|immunomodulating agents|mesh-list
93178549|NCT04951063|Immunologic Factors|immunologic factors|mesh-ancestor
93178550|NCT04951063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178551|NCT05624671|Fentanyl|fentanyl|mesh-list
93178552|NCT05624671|Bupivacaine|bupivacaine|mesh-list
92850727|NCT02790528|Atorvastatin|atorvastatin|mesh-list
93178553|NCT05624671|Anesthetics, Local|anesthetics, local|mesh-ancestor
93178554|NCT05624671|Anesthetics|anesthetics|mesh-ancestor
93178555|NCT05624671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178556|NCT05624671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178557|NCT05624671|Sensory System Agents|sensory system agents|mesh-ancestor
93178558|NCT05624671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178559|NCT05624671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93178560|NCT05624671|Narcotics|narcotics|mesh-ancestor
93178561|NCT05624671|Analgesics|analgesics|mesh-ancestor
93178562|NCT05624671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93178563|NCT05624671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93178564|NCT05624671|Anesthetics, General|anesthetics, general|mesh-ancestor
93178565|NCT03578965|Cefazolin|cefazolin|mesh-list
93178566|NCT03578965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93178567|NCT03578965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178568|NCT03791905|Leucovorin|leucovorin|mesh-list
93178569|NCT03791905|Paclitaxel|paclitaxel|mesh-list
93178570|NCT03791905|Fluorouracil|fluorouracil|mesh-list
93178571|NCT03791905|Oxaliplatin|oxaliplatin|mesh-list
93178572|NCT03791905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178573|NCT03791905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178574|NCT03791905|Tubulin Modulators|tubulin modulators|mesh-ancestor
93178575|NCT03791905|Antimitotic Agents|antimitotic agents|mesh-ancestor
93178576|NCT03791905|Mitosis Modulators|mitosis modulators|mesh-ancestor
93178577|NCT03791905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178578|NCT03791905|Antimetabolites|antimetabolites|mesh-ancestor
93178579|NCT03791905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178580|NCT03791905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178581|NCT03791905|Immunologic Factors|immunologic factors|mesh-ancestor
93178582|NCT03791905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178583|NCT03791905|Antidotes|antidotes|mesh-ancestor
93178584|NCT03791905|Protective Agents|protective agents|mesh-ancestor
93178585|NCT03791905|Vitamin B Complex|vitamin b complex|mesh-ancestor
93178586|NCT03791905|Vitamins|vitamins|mesh-ancestor
93178587|NCT03791905|Micronutrients|micronutrients|mesh-ancestor
93178588|NCT01138553|Mifepristone|mifepristone|mesh-list
93178589|NCT01138553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93178590|NCT01138553|Abortifacient Agents|abortifacient agents|mesh-ancestor
93178591|NCT01138553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93178592|NCT01138553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178593|NCT01138553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93178594|NCT01138553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93178595|NCT01138553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93178596|NCT01138553|Contraceptive Agents|contraceptive agents|mesh-ancestor
93178597|NCT01138553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93178598|NCT01138553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93178599|NCT01138553|Hormone Antagonists|hormone antagonists|mesh-ancestor
93178600|NCT01138553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178601|NCT01138553|Luteolytic Agents|luteolytic agents|mesh-ancestor
93178602|NCT01138553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93178603|NCT01138553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93178604|NCT05171374|Trametinib|trametinib|mesh-list
93178605|NCT05171374|Dabrafenib|dabrafenib|mesh-list
93178606|NCT05171374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178607|NCT05171374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178608|NCT05171374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178609|NCT05171374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178610|NCT03447184|Androgens|androgens|mesh-list
93178611|NCT03447184|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93178612|NCT03447184|Hormones|hormones|mesh-ancestor
93178613|NCT03447184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178614|NCT03447184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178615|NCT03447184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93178616|NCT03447184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178617|NCT03447184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178618|NCT03447184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93178619|NCT03447184|Hormone Antagonists|hormone antagonists|mesh-ancestor
93178620|NCT03739541|Benzonidazole|benzonidazole|mesh-list
93178621|NCT03739541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178622|NCT03739541|Immunologic Factors|immunologic factors|mesh-ancestor
93178623|NCT03739541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178624|NCT03739541|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93178625|NCT03739541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93178626|NCT03739541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93178627|NCT03739541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178628|NCT01135667|Clopidogrel|clopidogrel|mesh-list
93178629|NCT01135667|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93178630|NCT01135667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93178631|NCT01135667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93178632|NCT01135667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93178633|NCT01135667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93178634|NCT01135667|Purinergic Agents|purinergic agents|mesh-ancestor
93178635|NCT01135667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178636|NCT01135667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178637|NCT01135667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178638|NCT03446872|Leucovorin|leucovorin|mesh-list
93178639|NCT03446872|Fluorouracil|fluorouracil|mesh-list
93178640|NCT03446872|Antimetabolites|antimetabolites|mesh-ancestor
93178641|NCT03446872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178642|NCT03446872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178643|NCT03446872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178644|NCT03446872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178645|NCT03446872|Immunologic Factors|immunologic factors|mesh-ancestor
93178646|NCT03446872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178647|NCT03446872|Antidotes|antidotes|mesh-ancestor
93178648|NCT03446872|Protective Agents|protective agents|mesh-ancestor
93178649|NCT03446872|Vitamin B Complex|vitamin b complex|mesh-ancestor
93178650|NCT03446872|Vitamins|vitamins|mesh-ancestor
93178651|NCT03446872|Micronutrients|micronutrients|mesh-ancestor
93178652|NCT03446638|Cytarabine|cytarabine|mesh-list
93178653|NCT03446638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178654|NCT03446638|Antimetabolites|antimetabolites|mesh-ancestor
93178655|NCT03446638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178656|NCT03446638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178657|NCT03446638|Antiviral Agents|antiviral agents|mesh-ancestor
93178658|NCT03446638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178659|NCT03446638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178660|NCT03446638|Immunologic Factors|immunologic factors|mesh-ancestor
93178661|NCT03446638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178662|NCT05401019|Pramipexole|pramipexole|mesh-list
93178663|NCT05401019|Risperidone|risperidone|mesh-list
93178664|NCT05401019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93178665|NCT05401019|Serotonin Agents|serotonin agents|mesh-ancestor
93178666|NCT05401019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178667|NCT05401019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178668|NCT05401019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178669|NCT05401019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93178670|NCT05401019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93178671|NCT05401019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178672|NCT05401019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93178673|NCT05401019|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93178674|NCT05401019|Dopamine Agents|dopamine agents|mesh-ancestor
93178675|NCT05401019|Antioxidants|antioxidants|mesh-ancestor
93178676|NCT05401019|Protective Agents|protective agents|mesh-ancestor
93178677|NCT05401019|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93178678|NCT05401019|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93178679|NCT05401019|Dopamine Agonists|dopamine agonists|mesh-ancestor
93178680|NCT03788863|Diflucortolone|diflucortolone|mesh-list
93178681|NCT03788863|Diflucortolone valerate|diflucortolone valerate|mesh-list
93178682|NCT03788863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178683|NCT03788863|Glucocorticoids|glucocorticoids|mesh-ancestor
93178684|NCT03788863|Hormones|hormones|mesh-ancestor
93178685|NCT03788863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178686|NCT03788863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178687|NCT04659161|Xanomeline|xanomeline|mesh-list
93178688|NCT04659161|Trospium chloride|trospium chloride|mesh-list
93178689|NCT04659161|Parasympatholytics|parasympatholytics|mesh-ancestor
93178690|NCT04659161|Autonomic Agents|autonomic agents|mesh-ancestor
93178691|NCT04659161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178692|NCT04659161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178693|NCT04659161|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93178694|NCT04659161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93178695|NCT04659161|Cholinergic Agents|cholinergic agents|mesh-ancestor
93178696|NCT04659161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178697|NCT04659161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178698|NCT04659161|Urological Agents|urological agents|mesh-ancestor
93178699|NCT04659161|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93178700|NCT04659161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93178701|NCT04659161|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93178702|NCT04659161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93178703|NCT03129256|Apatinib|apatinib|mesh-list
93178704|NCT03129256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178705|NCT03129256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178706|NCT03129256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178707|NCT03129256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178708|NCT05682807|Caffeine|caffeine|mesh-list
93178709|NCT05682807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93178710|NCT05682807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178711|NCT05682807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93178712|NCT05682807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178713|NCT05682807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178714|NCT05682807|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93178715|NCT05682807|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93178716|NCT05682807|Purinergic Agents|purinergic agents|mesh-ancestor
93178717|NCT05682807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178718|NCT03445780|Ethyl Chloride|ethyl chloride|mesh-list
93178719|NCT03445780|Anesthetics, Local|anesthetics, local|mesh-ancestor
93178720|NCT03445780|Anesthetics|anesthetics|mesh-ancestor
93178721|NCT03445780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178722|NCT03445780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178723|NCT03445780|Sensory System Agents|sensory system agents|mesh-ancestor
93178724|NCT03445780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178725|NCT05364099|Triamcinolone|triamcinolone|mesh-list
93178726|NCT05364099|Lidocaine|lidocaine|mesh-list
93178727|NCT05364099|Anesthetics, Local|anesthetics, local|mesh-ancestor
93178728|NCT05364099|Anesthetics|anesthetics|mesh-ancestor
93178729|NCT05364099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178730|NCT05364099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178731|NCT05364099|Sensory System Agents|sensory system agents|mesh-ancestor
93178732|NCT05364099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178733|NCT05364099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93178734|NCT05364099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93178735|NCT05364099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93178736|NCT05364099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93178737|NCT05364099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178738|NCT05364099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178739|NCT05364099|Glucocorticoids|glucocorticoids|mesh-ancestor
93178740|NCT05364099|Hormones|hormones|mesh-ancestor
93178741|NCT05364099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178742|NCT03445702|Metformin|metformin|mesh-list
93178743|NCT03445702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93178744|NCT03445702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178745|NCT03445624|Infliximab|infliximab|mesh-list
93178746|NCT03445624|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93178747|NCT03445624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178748|NCT03445624|Dermatologic Agents|dermatologic agents|mesh-ancestor
93178749|NCT03445624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178750|NCT03445624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178751|NCT01312077|Morphine|morphine|mesh-list
93178752|NCT01312077|Levobupivacaine|levobupivacaine|mesh-list
93178753|NCT01312077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93178754|NCT01312077|Narcotics|narcotics|mesh-ancestor
93178755|NCT01312077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178756|NCT01312077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178757|NCT01312077|Analgesics|analgesics|mesh-ancestor
93178758|NCT01312077|Sensory System Agents|sensory system agents|mesh-ancestor
93178759|NCT01312077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178760|NCT01312077|Anesthetics, Local|anesthetics, local|mesh-ancestor
93178761|NCT01312077|Anesthetics|anesthetics|mesh-ancestor
93178762|NCT03793309|Vitamin D|vitamin d|mesh-list
93178763|NCT03793309|Ergocalciferols|ergocalciferols|mesh-list
93178764|NCT03793309|Cholecalciferol|cholecalciferol|mesh-list
93178765|NCT03793309|Vitamins|vitamins|mesh-list
93178766|NCT03793309|Micronutrients|micronutrients|mesh-ancestor
93178767|NCT03793309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178768|NCT03793309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93178769|NCT03793309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93178770|NCT01140893|Exenatide|exenatide|mesh-list
93178771|NCT01140893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93178772|NCT01140893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178773|NCT01140893|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93178774|NCT01140893|Incretins|incretins|mesh-ancestor
93178775|NCT01140893|Hormones|hormones|mesh-ancestor
93178776|NCT01140893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178777|NCT03445468|Vaccines|vaccines|mesh-list
93178778|NCT03445468|Immunologic Factors|immunologic factors|mesh-ancestor
93178779|NCT03445468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178780|NCT03791827|Cyclosporine|cyclosporine|mesh-list
93178781|NCT03791827|Mycophenolic Acid|mycophenolic acid|mesh-list
93178782|NCT03791827|Hydroxychloroquine|hydroxychloroquine|mesh-list
93178783|NCT03791827|Prednisone|prednisone|mesh-list
93178784|NCT03791827|Prednisolone|prednisolone|mesh-list
93178785|NCT03791827|Cyclophosphamide|cyclophosphamide|mesh-list
93178786|NCT03791827|Rituximab|rituximab|mesh-list
93178787|NCT03791827|Azathioprine|azathioprine|mesh-list
93178788|NCT03791827|Tacrolimus|tacrolimus|mesh-list
93178789|NCT03791827|Cyclosporins|cyclosporins|mesh-list
93178790|NCT03791827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178791|NCT03791827|Immunologic Factors|immunologic factors|mesh-ancestor
93178792|NCT03791827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178793|NCT03791827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178794|NCT03791827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93178795|NCT03791827|Alkylating Agents|alkylating agents|mesh-ancestor
93178796|NCT03791827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178797|NCT03791827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178798|NCT03791827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93178799|NCT03791827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93178800|NCT03791827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178801|NCT03791827|Glucocorticoids|glucocorticoids|mesh-ancestor
93178802|NCT03791827|Hormones|hormones|mesh-ancestor
93178803|NCT03791827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178804|NCT03791827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93178805|NCT03791827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93178806|NCT03791827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178807|NCT03791827|Antifungal Agents|antifungal agents|mesh-ancestor
93178808|NCT03791827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178809|NCT03791827|Dermatologic Agents|dermatologic agents|mesh-ancestor
93178810|NCT03791827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93178811|NCT03791827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93178812|NCT03791827|Antitubercular Agents|antitubercular agents|mesh-ancestor
93178813|NCT03791827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93178814|NCT03791827|Antimalarials|antimalarials|mesh-ancestor
93178815|NCT03791827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93178816|NCT03791827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93178817|NCT03791827|Antimetabolites|antimetabolites|mesh-ancestor
93178818|NCT03791827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178819|NCT03708861|Ritonavir|ritonavir|mesh-list
93178820|NCT03708861|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93178821|NCT03708861|Maraviroc|maraviroc|mesh-list
93178822|NCT03708861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93178823|NCT03708861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93178824|NCT03708861|Protease Inhibitors|protease inhibitors|mesh-ancestor
93178825|NCT03708861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178826|NCT03708861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178827|NCT03708861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93178828|NCT03708861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93178829|NCT03708861|Antiviral Agents|antiviral agents|mesh-ancestor
93178830|NCT03708861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178831|NCT03708861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93178832|NCT03708861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93178833|NCT03708861|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93178834|NCT03708861|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93178835|NCT03708861|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93178836|NCT04798755|Adalimumab|adalimumab|mesh-list
93178837|NCT04798755|Methotrexate|methotrexate|mesh-list
93178838|NCT04798755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93178839|NCT04798755|Abortifacient Agents|abortifacient agents|mesh-ancestor
93178840|NCT04798755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93178841|NCT04798755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178842|NCT04798755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93178843|NCT04798755|Antimetabolites|antimetabolites|mesh-ancestor
93178844|NCT04798755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178845|NCT04798755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178846|NCT04798755|Dermatologic Agents|dermatologic agents|mesh-ancestor
93178847|NCT04798755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178848|NCT04798755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93178849|NCT04798755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93178850|NCT04798755|Immunologic Factors|immunologic factors|mesh-ancestor
93178851|NCT04798755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178852|NCT04798755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93178853|NCT04798755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93178854|NCT04798755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178855|NCT01308229|Paclitaxel|paclitaxel|mesh-list
93178856|NCT01308229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93178857|NCT01308229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178858|NCT01308229|Tubulin Modulators|tubulin modulators|mesh-ancestor
93178859|NCT01308229|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851037|NCT02066220|Lomustine|lomustine|mesh-list
93178860|NCT01308229|Mitosis Modulators|mitosis modulators|mesh-ancestor
93178861|NCT01308229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178862|NCT03445078|Selenium|selenium|mesh-list
93178863|NCT03445078|Antioxidants|antioxidants|mesh-ancestor
93178864|NCT03445078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178865|NCT03445078|Protective Agents|protective agents|mesh-ancestor
93178866|NCT03445078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178867|NCT03445078|Trace Elements|trace elements|mesh-ancestor
93178868|NCT03445078|Micronutrients|micronutrients|mesh-ancestor
93178869|NCT01233791|Diazepam|diazepam|mesh-list
93178870|NCT01233791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93178871|NCT01233791|Anticonvulsants|anticonvulsants|mesh-ancestor
93178872|NCT01233791|Antiemetics|antiemetics|mesh-ancestor
93178873|NCT01233791|Autonomic Agents|autonomic agents|mesh-ancestor
93178874|NCT01233791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178875|NCT01233791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178876|NCT01233791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178877|NCT01233791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93178878|NCT01233791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178879|NCT01233791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93178880|NCT01233791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93178881|NCT01233791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93178882|NCT01233791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93178883|NCT01233791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93178884|NCT01233791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93178885|NCT01233791|Anesthetics, General|anesthetics, general|mesh-ancestor
93178886|NCT01233791|Anesthetics|anesthetics|mesh-ancestor
93178887|NCT01233791|GABA Modulators|gaba modulators|mesh-ancestor
93178888|NCT01233791|GABA Agents|gaba agents|mesh-ancestor
93178889|NCT01233791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178890|NCT01233791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178891|NCT01140971|Misoprostol|misoprostol|mesh-list
93178892|NCT01140971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93178893|NCT01140971|Abortifacient Agents|abortifacient agents|mesh-ancestor
93178894|NCT01140971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93178895|NCT01140971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178896|NCT01140971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93178897|NCT01140971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93178898|NCT01140971|Oxytocics|oxytocics|mesh-ancestor
93178899|NCT01306357|Hormones|hormones|mesh-list
93178900|NCT01306357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178901|NCT01306357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178902|NCT03129022|Anesthetics|anesthetics|mesh-list
93178903|NCT03129022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178904|NCT03129022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178905|NCT03342963|Aripiprazole|aripiprazole|mesh-list
93178906|NCT03342963|Sertraline|sertraline|mesh-list
93178907|NCT03342963|Antidepressive Agents|antidepressive agents|mesh-ancestor
93178908|NCT03342963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93178909|NCT03342963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93178910|NCT03342963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93178911|NCT03342963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178912|NCT03342963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178913|NCT03342963|Dopamine Agonists|dopamine agonists|mesh-ancestor
93178914|NCT03342963|Dopamine Agents|dopamine agents|mesh-ancestor
93178915|NCT03342963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178916|NCT03342963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178917|NCT03342963|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93178918|NCT03342963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93178919|NCT03342963|Serotonin Agents|serotonin agents|mesh-ancestor
93178920|NCT03342963|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93178921|NCT03342963|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93178922|NCT03342963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93178923|NCT03342963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93178924|NCT03342963|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93178925|NCT03342963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93178926|NCT03342963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93178927|NCT03706755|Norepinephrine|norepinephrine|mesh-list
93178928|NCT03706755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93178929|NCT03706755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93178930|NCT03706755|Adrenergic Agents|adrenergic agents|mesh-ancestor
93178931|NCT03706755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178932|NCT03706755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178933|NCT03706755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178934|NCT03706755|Sympathomimetics|sympathomimetics|mesh-ancestor
93178935|NCT03706755|Autonomic Agents|autonomic agents|mesh-ancestor
93178936|NCT03706755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178937|NCT03706755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93178939|NCT03791515|Salmon calcitonin|salmon calcitonin|mesh-list
93178940|NCT03791515|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93178941|NCT03791515|Katacalcin|katacalcin|mesh-list
93178942|NCT03791515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93178943|NCT03791515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178944|NCT03791515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93178945|NCT03791515|Vasodilator Agents|vasodilator agents|mesh-ancestor
93178946|NCT03361956|JNJ-56136379|jnj-56136379|mesh-list
93178947|NCT03361956|Antiviral Agents|antiviral agents|mesh-ancestor
93178948|NCT03361956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93178949|NCT04595591|Remifentanil|remifentanil|mesh-list
93178950|NCT04595591|Rocuronium|rocuronium|mesh-list
93178951|NCT04595591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93178952|NCT04595591|Narcotics|narcotics|mesh-ancestor
93178953|NCT04595591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178954|NCT04595591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178955|NCT04595591|Analgesics|analgesics|mesh-ancestor
93178956|NCT04595591|Sensory System Agents|sensory system agents|mesh-ancestor
93178957|NCT04595591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178958|NCT04595591|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93178959|NCT04595591|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93178960|NCT04595591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93178961|NCT03709953|Apatinib|apatinib|mesh-list
93178962|NCT03709953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93178963|NCT03709953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93178964|NCT03709953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178965|NCT03709953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178966|NCT03444142|Exenatide|exenatide|mesh-list
93178967|NCT03444142|Dulaglutide|dulaglutide|mesh-list
93178968|NCT03444142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93178969|NCT03444142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178970|NCT03444142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93178971|NCT03444142|Incretins|incretins|mesh-ancestor
93178972|NCT03444142|Hormones|hormones|mesh-ancestor
93178973|NCT03444142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93178974|NCT01305733|Ketorolac|ketorolac|mesh-list
93178975|NCT01305733|Epinephrine|epinephrine|mesh-list
93178976|NCT01305733|Racepinephrine|racepinephrine|mesh-list
93178977|NCT01305733|Levobupivacaine|levobupivacaine|mesh-list
93178978|NCT01305733|Epinephryl borate|epinephryl borate|mesh-list
93178979|NCT01305733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93178980|NCT01305733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93178981|NCT01305733|Analgesics|analgesics|mesh-ancestor
93178982|NCT01305733|Sensory System Agents|sensory system agents|mesh-ancestor
93178983|NCT01305733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93178984|NCT01305733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93178985|NCT01305733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93178986|NCT01305733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93178987|NCT01305733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93178988|NCT01305733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93178989|NCT01305733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93178990|NCT01305733|Anesthetics, Local|anesthetics, local|mesh-ancestor
93178991|NCT01305733|Anesthetics|anesthetics|mesh-ancestor
93178992|NCT01305733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93178993|NCT01305733|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93178994|NCT01305733|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93178995|NCT01305733|Adrenergic Agents|adrenergic agents|mesh-ancestor
93178996|NCT01305733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93178997|NCT01305733|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93178998|NCT01305733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93178999|NCT01305733|Autonomic Agents|autonomic agents|mesh-ancestor
93179000|NCT01305733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93179001|NCT01305733|Respiratory System Agents|respiratory system agents|mesh-ancestor
93179002|NCT01305733|Mydriatics|mydriatics|mesh-ancestor
93179003|NCT01305733|Sympathomimetics|sympathomimetics|mesh-ancestor
93179004|NCT01305733|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93179005|NCT05210153|Sertraline|sertraline|mesh-list
93179006|NCT05210153|Antidepressive Agents|antidepressive agents|mesh-ancestor
93179007|NCT05210153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93179008|NCT05210153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92851184|NCT02783586|Anesthetics|anesthetics|mesh-ancestor
93179009|NCT05210153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93179010|NCT05210153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93179011|NCT05210153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179012|NCT05210153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179013|NCT05210153|Serotonin Agents|serotonin agents|mesh-ancestor
93179014|NCT05210153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179015|NCT04749459|Sunscreening Agents|sunscreening agents|mesh-list
93179016|NCT04749459|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93179017|NCT04749459|Protective Agents|protective agents|mesh-ancestor
93179018|NCT04749459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179019|NCT04749459|Dermatologic Agents|dermatologic agents|mesh-ancestor
93179020|NCT04585295|Betaine|betaine|mesh-list
93179021|NCT04585295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179022|NCT04585295|Lipotropic Agents|lipotropic agents|mesh-ancestor
93179023|NCT04585295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93179024|NCT04585295|Antimetabolites|antimetabolites|mesh-ancestor
93179025|NCT04585295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179026|NCT04585295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93179027|NCT01136213|Fluoxetine|fluoxetine|mesh-list
93179028|NCT01136213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93179029|NCT01136213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93179030|NCT01136213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93179031|NCT01136213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179032|NCT01136213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179033|NCT01136213|Serotonin Agents|serotonin agents|mesh-ancestor
93179034|NCT01136213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179035|NCT01136213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93179036|NCT01136213|Antidepressive Agents|antidepressive agents|mesh-ancestor
93179037|NCT01136213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93179038|NCT01136213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93179039|NCT01136213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93179040|NCT01136213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179041|NCT03361176|Triamcinolone|triamcinolone|mesh-list
93179042|NCT03361176|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93179043|NCT03361176|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93179044|NCT03361176|Deoxycholic Acid|deoxycholic acid|mesh-list
93179045|NCT03361176|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93179046|NCT03361176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179047|NCT03361176|Glucocorticoids|glucocorticoids|mesh-ancestor
93179048|NCT03361176|Hormones|hormones|mesh-ancestor
93179049|NCT03361176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179050|NCT03361176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179051|NCT03361176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179052|NCT03361176|Immunologic Factors|immunologic factors|mesh-ancestor
93179053|NCT03361176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179054|NCT03361176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179055|NCT03361176|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93179056|NCT03361176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179057|NCT03438214|Vancomycin|vancomycin|mesh-list
93179058|NCT03438214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93179059|NCT03438214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179060|NCT01141127|Tranexamic Acid|tranexamic acid|mesh-list
93179061|NCT01141127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93179062|NCT01141127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93179063|NCT01141127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179064|NCT01141127|Hemostatics|hemostatics|mesh-ancestor
93179065|NCT01141127|Coagulants|coagulants|mesh-ancestor
93179066|NCT03708822|Docetaxel|docetaxel|mesh-list
93179067|NCT03708822|Nimotuzumab|nimotuzumab|mesh-list
93179068|NCT03708822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179069|NCT03708822|Tubulin Modulators|tubulin modulators|mesh-ancestor
93179070|NCT03708822|Antimitotic Agents|antimitotic agents|mesh-ancestor
93179071|NCT03708822|Mitosis Modulators|mitosis modulators|mesh-ancestor
93179072|NCT03708822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179073|NCT03708822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179074|NCT05280444|Idarubicin|idarubicin|mesh-list
93179075|NCT05280444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93179076|NCT05280444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179077|NCT05280444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93179078|NCT05280444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93179079|NCT05280444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179080|NCT05280444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179081|NCT01308541|Propofol|propofol|mesh-list
93179082|NCT01308541|Fospropofol|fospropofol|mesh-list
93179083|NCT01308541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93179084|NCT01308541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179085|NCT01308541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179086|NCT01308541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93179087|NCT01308541|Anesthetics, General|anesthetics, general|mesh-ancestor
93179088|NCT01308541|Anesthetics|anesthetics|mesh-ancestor
93179089|NCT05679765|Dexamethasone|dexamethasone|mesh-list
93179090|NCT05679765|Dexamethasone acetate|dexamethasone acetate|mesh-list
93179091|NCT05679765|Lidocaine|lidocaine|mesh-list
93179092|NCT05679765|BB 1101|bb 1101|mesh-list
93179093|NCT05679765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179094|NCT05679765|Antiemetics|antiemetics|mesh-ancestor
93179095|NCT05679765|Autonomic Agents|autonomic agents|mesh-ancestor
93179096|NCT05679765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179097|NCT05679765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179098|NCT05679765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179099|NCT05679765|Glucocorticoids|glucocorticoids|mesh-ancestor
93179100|NCT05679765|Hormones|hormones|mesh-ancestor
93179101|NCT05679765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179102|NCT05679765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93179103|NCT05679765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179104|NCT05679765|Protease Inhibitors|protease inhibitors|mesh-ancestor
93179105|NCT05679765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179106|NCT05679765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179107|NCT05679765|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179108|NCT05679765|Anesthetics|anesthetics|mesh-ancestor
93179109|NCT05679765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179110|NCT05679765|Sensory System Agents|sensory system agents|mesh-ancestor
93179111|NCT05679765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93179112|NCT05679765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93179113|NCT05679765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93179114|NCT05679765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93179115|NCT03437980|Propofol|propofol|mesh-list
93179116|NCT03437980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93179117|NCT03437980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179118|NCT03437980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179119|NCT03437980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93179120|NCT03437980|Anesthetics, General|anesthetics, general|mesh-ancestor
93179121|NCT03437980|Anesthetics|anesthetics|mesh-ancestor
93179122|NCT05176119|Ketamine|ketamine|mesh-list
93179123|NCT05176119|Nalbuphine|nalbuphine|mesh-list
93179124|NCT05176119|Analgesics|analgesics|mesh-ancestor
93179125|NCT05176119|Sensory System Agents|sensory system agents|mesh-ancestor
93179126|NCT05176119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179127|NCT05176119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179128|NCT05176119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93179129|NCT05176119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93179130|NCT05176119|Anesthetics, General|anesthetics, general|mesh-ancestor
93179131|NCT05176119|Anesthetics|anesthetics|mesh-ancestor
93179132|NCT05176119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179133|NCT05176119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93179134|NCT05176119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93179135|NCT05176119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179136|NCT05176119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179137|NCT05176119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93179138|NCT05176119|Narcotics|narcotics|mesh-ancestor
93179139|NCT03437902|Vitamins|vitamins|mesh-list
93179140|NCT03437902|Ascorbic Acid|ascorbic acid|mesh-list
93179141|NCT03437902|Micronutrients|micronutrients|mesh-ancestor
93179142|NCT03437902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179143|NCT03437902|Antioxidants|antioxidants|mesh-ancestor
93179144|NCT03437902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179145|NCT03437902|Protective Agents|protective agents|mesh-ancestor
93179146|NCT05283499|Analgesics, Opioid|analgesics, opioid|mesh-list
93179147|NCT05283499|Analgesics|analgesics|mesh-list
93179148|NCT05283499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
93179149|NCT05283499|Narcotics|narcotics|mesh-ancestor
92855303|NCT05660720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179150|NCT05283499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179151|NCT05283499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179152|NCT05283499|Sensory System Agents|sensory system agents|mesh-ancestor
93179153|NCT05283499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179154|NCT03437824|Vitamin B 12|vitamin b 12|mesh-list
93179155|NCT03437824|Hydroxocobalamin|hydroxocobalamin|mesh-list
93179156|NCT03437824|Vitamins|vitamins|mesh-ancestor
93179157|NCT03437824|Micronutrients|micronutrients|mesh-ancestor
93179158|NCT03437824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179159|NCT03437824|Vitamin B Complex|vitamin b complex|mesh-ancestor
93179160|NCT03437824|Hematinics|hematinics|mesh-ancestor
93179162|NCT03437590|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
93179163|NCT03437590|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93179164|NCT03437590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93179165|NCT03437590|Purinergic Agents|purinergic agents|mesh-ancestor
93179166|NCT03437590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179167|NCT03437590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179168|NCT03437590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179169|NCT01136525|Valacyclovir|valacyclovir|mesh-list
93179170|NCT01136525|Antiviral Agents|antiviral agents|mesh-ancestor
93179171|NCT01136525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179172|NCT05632445|Apixaban|apixaban|mesh-list
93179173|NCT05632445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93179174|NCT05632445|Antithrombins|antithrombins|mesh-ancestor
93179175|NCT05632445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93179176|NCT05632445|Protease Inhibitors|protease inhibitors|mesh-ancestor
93179177|NCT05632445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179178|NCT05632445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179179|NCT05632445|Anticoagulants|anticoagulants|mesh-ancestor
93179180|NCT04422652|Bupropion|bupropion|mesh-list
93179181|NCT04422652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93179182|NCT04422652|Antidepressive Agents|antidepressive agents|mesh-ancestor
93179183|NCT04422652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93179184|NCT04422652|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93179185|NCT04422652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93179186|NCT04422652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93179187|NCT04422652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179188|NCT04422652|Dopamine Agents|dopamine agents|mesh-ancestor
93179189|NCT04422652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179190|NCT04422652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179191|NCT04422652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93179192|NCT04422652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93179193|NCT04422652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179194|NCT01235117|Azacitidine|azacitidine|mesh-list
93179195|NCT01235117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93179196|NCT01235117|Antimetabolites|antimetabolites|mesh-ancestor
93179197|NCT01235117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179198|NCT01235117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179199|NCT01235117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179200|NCT01306591|Bevacizumab|bevacizumab|mesh-list
93179201|NCT01306591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179202|NCT01306591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179203|NCT01306591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93179204|NCT01306591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93179205|NCT01306591|Growth Substances|growth substances|mesh-ancestor
93179206|NCT01306591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179207|NCT01306591|Growth Inhibitors|growth inhibitors|mesh-ancestor
93179208|NCT03098030|Irinotecan|irinotecan|mesh-list
93179209|NCT03098030|Topotecan|topotecan|mesh-list
93179210|NCT03098030|Dinutuximab|dinutuximab|mesh-list
93179211|NCT03098030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93179212|NCT03098030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93179213|NCT03098030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179214|NCT03098030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179215|NCT03098030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179216|NCT01233947|Fulvestrant|fulvestrant|mesh-list
93179217|NCT01233947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93179218|NCT01233947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179219|NCT01233947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93179220|NCT01233947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93179221|NCT01233947|Hormone Antagonists|hormone antagonists|mesh-ancestor
93179222|NCT01233947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179223|NCT01233947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179224|NCT01139645|Esomeprazole|esomeprazole|mesh-list
93179225|NCT01139645|Rabeprazole|rabeprazole|mesh-list
93179226|NCT01139645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93179227|NCT01139645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179228|NCT01139645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93179229|NCT01139645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179230|NCT01139645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179231|NCT03706287|Cisplatin|cisplatin|mesh-list
93179232|NCT03706287|Carboplatin|carboplatin|mesh-list
93179233|NCT03706287|Pemetrexed|pemetrexed|mesh-list
92851411|NCT05188170|Niclosamide|niclosamide|mesh-list
93179234|NCT03706287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179235|NCT03706287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179236|NCT03706287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179237|NCT03706287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93179238|NCT03706287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93179239|NCT05115201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93179240|NCT05115201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179241|NCT05107193|Afatinib|afatinib|mesh-list
93179242|NCT05107193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179243|NCT05107193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93179244|NCT05107193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179245|NCT05107193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179246|NCT03788395|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93179247|NCT03788395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93179248|NCT03788395|Respiratory System Agents|respiratory system agents|mesh-ancestor
93179249|NCT02522650|Amiloride|amiloride|mesh-list
93179250|NCT02522650|Triamterene|triamterene|mesh-list
93179251|NCT02522650|Diuretics|diuretics|mesh-ancestor
93179252|NCT02522650|Natriuretic Agents|natriuretic agents|mesh-ancestor
93179253|NCT02522650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179254|NCT02522650|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93179255|NCT02522650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93179256|NCT02522650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93179257|NCT02522650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179258|NCT02522650|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93179259|NCT02522650|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93179260|NCT05681871|Folic Acid|folic acid|mesh-list
93179261|NCT05681871|Ferrous fumarate|ferrous fumarate|mesh-list
93179262|NCT05681871|Ferrous gluconate|ferrous gluconate|mesh-list
93179263|NCT05681871|Hematinics|hematinics|mesh-ancestor
93179264|NCT05681871|Vitamin B Complex|vitamin b complex|mesh-ancestor
93179265|NCT05681871|Vitamins|vitamins|mesh-ancestor
93179266|NCT05681871|Micronutrients|micronutrients|mesh-ancestor
93179267|NCT05681871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179268|NCT05681871|Trace Elements|trace elements|mesh-ancestor
93179269|NCT04455958|Ritonavir|ritonavir|mesh-list
93179270|NCT04455958|Lopinavir|lopinavir|mesh-list
93179271|NCT04455958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93179272|NCT04455958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93179273|NCT04455958|Protease Inhibitors|protease inhibitors|mesh-ancestor
93179274|NCT04455958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179275|NCT04455958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179276|NCT04455958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93179277|NCT04455958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93179278|NCT04455958|Antiviral Agents|antiviral agents|mesh-ancestor
93179279|NCT04455958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179280|NCT04455958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93179281|NCT04455958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93179282|NCT03791125|Salvianolic acid A|salvianolic acid a|mesh-list
93179283|NCT03791125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179284|NCT03791125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179285|NCT03791125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179286|NCT03791125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93179287|NCT03788317|Botulinum Toxins|botulinum toxins|mesh-list
93179288|NCT03788317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93179289|NCT03788317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93179290|NCT03788317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93179291|NCT03788317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93179292|NCT03788317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179293|NCT03788317|Cholinergic Agents|cholinergic agents|mesh-ancestor
93179294|NCT03788317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179295|NCT03788317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179296|NCT03788317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93179297|NCT03788317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179298|NCT01378858|Varenicline|varenicline|mesh-list
93179299|NCT01378858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93179300|NCT01378858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93179301|NCT01378858|Cholinergic Agents|cholinergic agents|mesh-ancestor
93179302|NCT01378858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179303|NCT01378858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179304|NCT01378858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179305|NCT02891850|Sildenafil Citrate|sildenafil citrate|mesh-list
93179306|NCT02891850|Tadalafil|tadalafil|mesh-list
93179307|NCT02891850|Riociguat|riociguat|mesh-list
92851497|NCT00880867|Poly ICLC|poly iclc|mesh-list
93179308|NCT02891850|Vasodilator Agents|vasodilator agents|mesh-ancestor
93179309|NCT02891850|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93179310|NCT02891850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93179311|NCT02891850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179312|NCT02891850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179313|NCT02891850|Urological Agents|urological agents|mesh-ancestor
93179314|NCT02891850|Enzyme Activators|enzyme activators|mesh-ancestor
93179315|NCT05175027|Povidone-Iodine|povidone-iodine|mesh-list
93179316|NCT05175027|Povidone|povidone|mesh-list
93179317|NCT05175027|Plasma Substitutes|plasma substitutes|mesh-ancestor
93179318|NCT05175027|Blood Substitutes|blood substitutes|mesh-ancestor
93179319|NCT05175027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93179320|NCT05175027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179321|NCT05089630|Vaccines|vaccines|mesh-list
93179322|NCT05089630|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
93179323|NCT05089630|Immunologic Factors|immunologic factors|mesh-ancestor
93179324|NCT05089630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179325|NCT05089630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93179326|NCT03707418|Heparin|heparin|mesh-list
93179327|NCT03707418|Calcium heparin|calcium heparin|mesh-list
93179328|NCT03707418|Bivalirudin|bivalirudin|mesh-list
93179329|NCT03707418|Anticoagulants|anticoagulants|mesh-ancestor
93179330|NCT03707418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93179331|NCT03707418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93179332|NCT03707418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179333|NCT03707418|Antithrombins|antithrombins|mesh-ancestor
93179334|NCT03707418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93179335|NCT03707418|Protease Inhibitors|protease inhibitors|mesh-ancestor
93179336|NCT03707418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179337|NCT03785041|Tramadol|tramadol|mesh-list
93179338|NCT03785041|Levobupivacaine|levobupivacaine|mesh-list
93179339|NCT03785041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93179340|NCT03785041|Narcotics|narcotics|mesh-ancestor
93179341|NCT03785041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179342|NCT03785041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179343|NCT03785041|Analgesics|analgesics|mesh-ancestor
93179344|NCT03785041|Sensory System Agents|sensory system agents|mesh-ancestor
93179345|NCT03785041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179346|NCT03785041|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179347|NCT03785041|Anesthetics|anesthetics|mesh-ancestor
93179348|NCT03710304|Misoprostol|misoprostol|mesh-list
93179349|NCT03710304|Tranexamic Acid|tranexamic acid|mesh-list
93179350|NCT03710304|Oxytocin|oxytocin|mesh-list
93179351|NCT03710304|Oxytocics|oxytocics|mesh-ancestor
93179352|NCT03710304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93179353|NCT03710304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179354|NCT03710304|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93179355|NCT03710304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93179356|NCT03710304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179357|NCT03710304|Hemostatics|hemostatics|mesh-ancestor
93179358|NCT03710304|Coagulants|coagulants|mesh-ancestor
93179359|NCT03710304|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93179360|NCT03710304|Abortifacient Agents|abortifacient agents|mesh-ancestor
93179361|NCT03710304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93179362|NCT03710304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179363|NCT05605639|Bupivacaine|bupivacaine|mesh-list
93179364|NCT05605639|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179365|NCT05605639|Anesthetics|anesthetics|mesh-ancestor
93179366|NCT05605639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179367|NCT05605639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179368|NCT05605639|Sensory System Agents|sensory system agents|mesh-ancestor
93179369|NCT05605639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179370|NCT03790345|Vitamins|vitamins|mesh-list
93179371|NCT03790345|Vitamin B 12|vitamin b 12|mesh-list
93179372|NCT03790345|Pyridoxine|pyridoxine|mesh-list
93179373|NCT03790345|Vitamin B 6|vitamin b 6|mesh-list
93179374|NCT03790345|Vitamin B Complex|vitamin b complex|mesh-list
93179375|NCT03790345|Micronutrients|micronutrients|mesh-ancestor
93179376|NCT03790345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179377|NCT05416190|Anticoagulants|anticoagulants|mesh-list
93179378|NCT05416190|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
93179379|NCT05416190|Immunologic Factors|immunologic factors|mesh-ancestor
93179380|NCT05416190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179381|NCT04454788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92851562|NCT03955861|Analgesics|analgesics|mesh-ancestor
93179382|NCT04454788|Tenecteplase|tenecteplase|mesh-list
93179383|NCT04454788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93179384|NCT04454788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93179385|NCT04454788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179387|NCT04862650|Carboplatin|carboplatin|mesh-list
93179388|NCT04862650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93179389|NCT04862650|Cemiplimab|cemiplimab|mesh-list
93179390|NCT04862650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93179391|NCT04862650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179392|NCT04862650|Tubulin Modulators|tubulin modulators|mesh-ancestor
93179393|NCT04862650|Antimitotic Agents|antimitotic agents|mesh-ancestor
93179394|NCT04862650|Mitosis Modulators|mitosis modulators|mesh-ancestor
93179395|NCT04862650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179396|NCT04862650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179397|NCT05163561|Vaccines|vaccines|mesh-list
93179398|NCT05163561|Immunologic Factors|immunologic factors|mesh-ancestor
93179399|NCT05163561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179400|NCT05681403|Cytarabine|cytarabine|mesh-list
93179401|NCT05681403|Carmustine|carmustine|mesh-list
93179402|NCT05681403|Melphalan|melphalan|mesh-list
93179403|NCT05681403|Etoposide|etoposide|mesh-list
93179404|NCT05681403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93179405|NCT05681403|Alkylating Agents|alkylating agents|mesh-ancestor
93179406|NCT05681403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179407|NCT05681403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179408|NCT05681403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93179409|NCT05681403|Antimetabolites|antimetabolites|mesh-ancestor
93179410|NCT05681403|Antiviral Agents|antiviral agents|mesh-ancestor
93179411|NCT05681403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179412|NCT05681403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179413|NCT05681403|Immunologic Factors|immunologic factors|mesh-ancestor
93179414|NCT05681403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179415|NCT05681403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93179416|NCT05681403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93179417|NCT05681403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93179418|NCT05681403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179419|NCT05681403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93179420|NCT01309009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93179421|NCT01309009|MEN 11420|men 11420|mesh-list
93179422|NCT01309009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93179423|NCT01309009|Autonomic Agents|autonomic agents|mesh-ancestor
93179424|NCT01309009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179425|NCT01309009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179426|NCT01309009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93179427|NCT01309009|Respiratory System Agents|respiratory system agents|mesh-ancestor
93179428|NCT03339453|Glucagon|glucagon|mesh-list
93179429|NCT03339453|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93179430|NCT03339453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179431|NCT03339453|Hormones|hormones|mesh-ancestor
93179432|NCT03339453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179433|NCT03339453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179434|NCT03339453|Incretins|incretins|mesh-ancestor
93179435|NCT05418686|Colchicine|colchicine|mesh-list
93179436|NCT05418686|Gout Suppressants|gout suppressants|mesh-ancestor
93179437|NCT05418686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93179438|NCT05418686|Tubulin Modulators|tubulin modulators|mesh-ancestor
93179439|NCT05418686|Antimitotic Agents|antimitotic agents|mesh-ancestor
93179440|NCT05418686|Mitosis Modulators|mitosis modulators|mesh-ancestor
93179441|NCT05418686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179442|NCT05418686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179443|NCT01306981|Ranibizumab|ranibizumab|mesh-list
93179444|NCT01306981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93179445|NCT01306981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93179446|NCT01306981|Growth Substances|growth substances|mesh-ancestor
93179447|NCT01306981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179448|NCT01306981|Growth Inhibitors|growth inhibitors|mesh-ancestor
93179449|NCT01306981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475239|NCT01862003|Leucovorin|leucovorin|mesh-list
93179450|NCT05552157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93179451|NCT05552157|Immunologic Factors|immunologic factors|mesh-ancestor
93179452|NCT05552157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179453|NCT05076799|Lactulose|lactulose|mesh-list
93179454|NCT05076799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179455|NCT03784495|Melatonin|melatonin|mesh-list
93179456|NCT03784495|Antioxidants|antioxidants|mesh-ancestor
93179457|NCT03784495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179458|NCT03784495|Protective Agents|protective agents|mesh-ancestor
93179459|NCT03784495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179460|NCT03784495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179461|NCT04120246|Acetic Acid|acetic acid|mesh-list
93179462|NCT04120246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93179463|NCT04120246|Trastuzumab|trastuzumab|mesh-list
93179464|NCT04120246|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93179465|NCT04120246|Antibodies|antibodies|mesh-list
93179466|NCT04120246|Immunoglobulins|immunoglobulins|mesh-list
93179467|NCT04120246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93179468|NCT04120246|Immunologic Factors|immunologic factors|mesh-ancestor
93179469|NCT04120246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179470|NCT04120246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179471|NCT04120246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93179472|NCT04120246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179473|NCT05659147|Secretin|secretin|mesh-list
93179474|NCT05659147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179475|NCT05659147|Hormones|hormones|mesh-ancestor
93179476|NCT05659147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179477|NCT05659147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179478|NCT05234697|Remifentanil|remifentanil|mesh-list
93179479|NCT05234697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93179480|NCT05234697|Narcotics|narcotics|mesh-ancestor
93179481|NCT05234697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179482|NCT05234697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179483|NCT05234697|Analgesics|analgesics|mesh-ancestor
93179484|NCT05234697|Sensory System Agents|sensory system agents|mesh-ancestor
93179485|NCT05234697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179486|NCT03490760|Durvalumab|durvalumab|mesh-list
93179487|NCT03490760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179488|NCT03490760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179489|NCT02133404|Cinacalcet|cinacalcet|mesh-list
93179490|NCT02133404|ASP7991|asp7991|mesh-list
93179491|NCT02133404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93179492|NCT02133404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179493|NCT02133404|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93179494|NCT02133404|Hormone Antagonists|hormone antagonists|mesh-ancestor
93179495|NCT02133404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179496|NCT01307215|Ropivacaine|ropivacaine|mesh-list
93179497|NCT01307215|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179498|NCT01307215|Anesthetics|anesthetics|mesh-ancestor
93179499|NCT01307215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179500|NCT01307215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179501|NCT01307215|Sensory System Agents|sensory system agents|mesh-ancestor
93179502|NCT01307215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179503|NCT05177601|Cycloserine|cycloserine|mesh-list
93179504|NCT05177601|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93179505|NCT05177601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179506|NCT05177601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93179507|NCT05177601|Antitubercular Agents|antitubercular agents|mesh-ancestor
93179508|NCT05177601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93179509|NCT05177601|Antimetabolites|antimetabolites|mesh-ancestor
93179510|NCT05177601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179511|NCT03420794|Analgesics|analgesics|mesh-list
93179512|NCT03420794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
93179513|NCT03420794|Sensory System Agents|sensory system agents|mesh-ancestor
93179514|NCT03420794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179515|NCT03420794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179516|NCT01568450|Oxycodone|oxycodone|mesh-list
93179517|NCT01568450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93179518|NCT01568450|Narcotics|narcotics|mesh-ancestor
93179519|NCT01568450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179520|NCT01568450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179521|NCT01568450|Analgesics|analgesics|mesh-ancestor
93179522|NCT01568450|Sensory System Agents|sensory system agents|mesh-ancestor
93179523|NCT01568450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179524|NCT05410496|Tenofovir|tenofovir|mesh-list
93179525|NCT05410496|Antiviral Agents|antiviral agents|mesh-ancestor
93179526|NCT05410496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179527|NCT05410496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93179528|NCT05410496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93179529|NCT05410496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179530|NCT05410496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179531|NCT05410496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93179532|NCT05410496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92851711|NCT05339646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93179533|NCT03784105|Codeine|codeine|mesh-list
93179534|NCT03784105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93179535|NCT03784105|Narcotics|narcotics|mesh-ancestor
93179536|NCT03784105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179537|NCT03784105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179538|NCT03784105|Analgesics|analgesics|mesh-ancestor
93179539|NCT03784105|Sensory System Agents|sensory system agents|mesh-ancestor
93179540|NCT03784105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179541|NCT03784105|Antitussive Agents|antitussive agents|mesh-ancestor
93179542|NCT03784105|Respiratory System Agents|respiratory system agents|mesh-ancestor
93179543|NCT03784261|Abatacept|abatacept|mesh-list
93179544|NCT03784261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93179545|NCT03784261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179546|NCT03784261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179547|NCT03784261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179548|NCT03784261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179549|NCT03784261|Immunologic Factors|immunologic factors|mesh-ancestor
93179550|NCT03784261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179551|NCT03784261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93179552|NCT02989402|Rivastigmine|rivastigmine|mesh-list
93179553|NCT02989402|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93179554|NCT02989402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179555|NCT02989402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179556|NCT02989402|Cholinergic Agents|cholinergic agents|mesh-ancestor
93179557|NCT02989402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179558|NCT02989402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179559|NCT02989402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93179560|NCT02989402|Protective Agents|protective agents|mesh-ancestor
93179561|NCT03783949|Paclitaxel|paclitaxel|mesh-list
93179562|NCT03783949|Carboplatin|carboplatin|mesh-list
93179563|NCT03783949|Gemcitabine|gemcitabine|mesh-list
93179564|NCT03783949|Niraparib|niraparib|mesh-list
93179565|NCT03783949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93179566|NCT03783949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179567|NCT03783949|Tubulin Modulators|tubulin modulators|mesh-ancestor
93179568|NCT03783949|Antimitotic Agents|antimitotic agents|mesh-ancestor
93179569|NCT03783949|Mitosis Modulators|mitosis modulators|mesh-ancestor
93179570|NCT03783949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179571|NCT03783949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93179572|NCT03783949|Antimetabolites|antimetabolites|mesh-ancestor
93179573|NCT03783949|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93179574|NCT03783949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179575|NCT02861950|Bupivacaine|bupivacaine|mesh-list
93179576|NCT02861950|Ropivacaine|ropivacaine|mesh-list
93179577|NCT02861950|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179578|NCT02861950|Anesthetics|anesthetics|mesh-ancestor
93179579|NCT02861950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179580|NCT02861950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179581|NCT02861950|Sensory System Agents|sensory system agents|mesh-ancestor
93179582|NCT02861950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179583|NCT05681247|Ezetimibe|ezetimibe|mesh-list
93179584|NCT05681247|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93179585|NCT05681247|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93179586|NCT05681247|Antimetabolites|antimetabolites|mesh-ancestor
93179587|NCT05681247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179588|NCT05681247|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93179589|NCT03787927|Aspirin|aspirin|mesh-list
93179590|NCT03787927|Clopidogrel|clopidogrel|mesh-list
93179591|NCT03787927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93179592|NCT03787927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93179593|NCT03787927|Analgesics|analgesics|mesh-ancestor
93179594|NCT03787927|Sensory System Agents|sensory system agents|mesh-ancestor
93179595|NCT03787927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179596|NCT03787927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179597|NCT03787927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179598|NCT03787927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93179599|NCT03787927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93179600|NCT03787927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93179601|NCT03787927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179602|NCT03787927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93179603|NCT03787927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93179604|NCT03787927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179605|NCT03787927|Antipyretics|antipyretics|mesh-ancestor
93179606|NCT03787927|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93179607|NCT03787927|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93179608|NCT03787927|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93179609|NCT03787927|Purinergic Agents|purinergic agents|mesh-ancestor
93179610|NCT03787927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179611|NCT00602576|Temozolomide|temozolomide|mesh-list
93179612|NCT00602576|Sorafenib|sorafenib|mesh-list
93179613|NCT00602576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93179614|NCT00602576|Alkylating Agents|alkylating agents|mesh-ancestor
93179615|NCT00602576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179616|NCT00602576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179617|NCT00602576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93179618|NCT00602576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179619|NCT04807972|Folfirinox|folfirinox|mesh-list
93179620|NCT04807972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179621|NCT05694871|Palbociclib|palbociclib|mesh-list
93179622|NCT05694871|Cemiplimab|cemiplimab|mesh-list
93179623|NCT05694871|Immunoglobulins|immunoglobulins|mesh-list
93179624|NCT05694871|Immunoglobulin G|immunoglobulin g|mesh-list
93179625|NCT05694871|Immunologic Factors|immunologic factors|mesh-ancestor
93179626|NCT05694871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179627|NCT05694871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179628|NCT05694871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93179629|NCT05694871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179630|NCT05694871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179631|NCT05694871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179632|NCT03359850|Niraparib|niraparib|mesh-list
93179633|NCT03359850|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93179634|NCT03359850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179635|NCT03359850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179636|NCT03359850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179637|NCT01306123|Vitamin B 12|vitamin b 12|mesh-list
93179638|NCT01306123|Hydroxocobalamin|hydroxocobalamin|mesh-list
93179639|NCT01306123|Vitamins|vitamins|mesh-ancestor
93179640|NCT01306123|Micronutrients|micronutrients|mesh-ancestor
93179641|NCT01306123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179642|NCT01306123|Vitamin B Complex|vitamin b complex|mesh-ancestor
93179643|NCT01306123|Hematinics|hematinics|mesh-ancestor
93179644|NCT04803994|Bevacizumab|bevacizumab|mesh-list
93179645|NCT04803994|Atezolizumab|atezolizumab|mesh-list
93179646|NCT04803994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179647|NCT04803994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179648|NCT04803994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93179649|NCT04803994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93179650|NCT04803994|Growth Substances|growth substances|mesh-ancestor
93179651|NCT04803994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179652|NCT04803994|Growth Inhibitors|growth inhibitors|mesh-ancestor
93179653|NCT04803994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93179654|NCT04803994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179655|NCT03130426|Insulin|insulin|mesh-list
93179656|NCT03130426|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93179657|NCT03130426|Metformin|metformin|mesh-list
93179658|NCT03130426|Insulin Glargine|insulin glargine|mesh-list
93179659|NCT03130426|Lixisenatide|lixisenatide|mesh-list
93179660|NCT03130426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93179661|NCT03130426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179662|NCT00114140|Temozolomide|temozolomide|mesh-list
93179663|NCT00114140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93179664|NCT00114140|Alkylating Agents|alkylating agents|mesh-ancestor
93179665|NCT00114140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179666|NCT00114140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179667|NCT03130582|Etoposide|etoposide|mesh-list
93179668|NCT03130582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93179669|NCT03130582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179670|NCT03130582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93179671|NCT03130582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93179672|NCT03130582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179673|NCT03130582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179674|NCT04752540|Olorofim|olorofim|mesh-list
93179675|NCT04752540|Antifungal Agents|antifungal agents|mesh-ancestor
93179676|NCT04752540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179677|NCT04341454|Fexuprazan|fexuprazan|mesh-list
93179678|NCT04341454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179679|NCT03712345|Vilobelimab|vilobelimab|mesh-list
93179680|NCT03712345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93179681|NCT03712345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179682|NCT03712345|Immunologic Factors|immunologic factors|mesh-ancestor
93179683|NCT03712345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179684|NCT03130348|Dexamethasone|dexamethasone|mesh-list
93179685|NCT03130348|Dexamethasone acetate|dexamethasone acetate|mesh-list
93179686|NCT03130348|Bortezomib|bortezomib|mesh-list
92851861|NCT02779608|Docetaxel|docetaxel|mesh-list
93179687|NCT03130348|Ichthammol|ichthammol|mesh-list
93179688|NCT03130348|BB 1101|bb 1101|mesh-list
93179689|NCT03130348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179690|NCT03130348|Antiemetics|antiemetics|mesh-ancestor
93179691|NCT03130348|Autonomic Agents|autonomic agents|mesh-ancestor
93179692|NCT03130348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179693|NCT03130348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179694|NCT03130348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179695|NCT03130348|Glucocorticoids|glucocorticoids|mesh-ancestor
93179696|NCT03130348|Hormones|hormones|mesh-ancestor
93179697|NCT03130348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179698|NCT03130348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93179699|NCT03130348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179700|NCT03130348|Protease Inhibitors|protease inhibitors|mesh-ancestor
93179701|NCT03130348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179702|NCT03130348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179703|NCT03130348|Dermatologic Agents|dermatologic agents|mesh-ancestor
93179704|NCT01307527|Riboflavin|riboflavin|mesh-list
93179705|NCT01307527|Vitamin B Complex|vitamin b complex|mesh-ancestor
93179706|NCT01307527|Vitamins|vitamins|mesh-ancestor
93179707|NCT01307527|Micronutrients|micronutrients|mesh-ancestor
93179708|NCT01307527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179709|NCT01307527|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93179710|NCT01307527|Dermatologic Agents|dermatologic agents|mesh-ancestor
93179711|NCT03789799|Titanium dioxide|titanium dioxide|mesh-list
93179712|NCT03789799|Sunscreening Agents|sunscreening agents|mesh-ancestor
93179713|NCT03789799|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93179714|NCT03789799|Protective Agents|protective agents|mesh-ancestor
93179715|NCT03789799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179716|NCT03789799|Dermatologic Agents|dermatologic agents|mesh-ancestor
93179717|NCT03789799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93179718|NCT05439772|Ondansetron|ondansetron|mesh-list
93179719|NCT05439772|Antiemetics|antiemetics|mesh-ancestor
93179720|NCT05439772|Autonomic Agents|autonomic agents|mesh-ancestor
93179721|NCT05439772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179722|NCT05439772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179723|NCT05439772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179724|NCT05439772|Antipruritics|antipruritics|mesh-ancestor
93179725|NCT05439772|Dermatologic Agents|dermatologic agents|mesh-ancestor
93179726|NCT05439772|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93179727|NCT05439772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93179728|NCT05439772|Serotonin Agents|serotonin agents|mesh-ancestor
93179729|NCT05439772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179730|NCT05439772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179731|NCT05694715|Irinotecan|irinotecan|mesh-list
93179732|NCT05694715|Niraparib|niraparib|mesh-list
93179733|NCT05694715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93179734|NCT05694715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93179735|NCT05694715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179736|NCT05694715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179737|NCT05694715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179738|NCT05694715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93179739|NCT01309399|Teriparatide|teriparatide|mesh-list
93179740|NCT01309399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93179741|NCT01309399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179742|NCT01309399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93179743|NCT03311828|Daratumumab|daratumumab|mesh-list
93179744|NCT03311828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179745|NCT01309477|Tacrolimus|tacrolimus|mesh-list
93179746|NCT01309477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179747|NCT01309477|Immunologic Factors|immunologic factors|mesh-ancestor
93179748|NCT01309477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179749|NCT01309477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93179750|NCT01309477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179751|NCT01309477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179752|NCT03709992|Tamsulosin|tamsulosin|mesh-list
93179753|NCT03709992|Trospium chloride|trospium chloride|mesh-list
93179754|NCT03709992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93179755|NCT03709992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93179756|NCT03709992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93179757|NCT03709992|Adrenergic Agents|adrenergic agents|mesh-ancestor
93179758|NCT03709992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179759|NCT03709992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179760|NCT03709992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179761|NCT03709992|Urological Agents|urological agents|mesh-ancestor
93179762|NCT03709992|Parasympatholytics|parasympatholytics|mesh-ancestor
93179763|NCT03709992|Autonomic Agents|autonomic agents|mesh-ancestor
93179764|NCT03709992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179765|NCT03709992|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93179766|NCT03709992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93179767|NCT03709992|Cholinergic Agents|cholinergic agents|mesh-ancestor
93179768|NCT05438992|Bupivacaine|bupivacaine|mesh-list
93179769|NCT05438992|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179770|NCT05438992|Anesthetics|anesthetics|mesh-ancestor
93179771|NCT05438992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179772|NCT05438992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179773|NCT05438992|Sensory System Agents|sensory system agents|mesh-ancestor
93179774|NCT05438992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179776|NCT05361486|Tafenoquine|tafenoquine|mesh-list
93179777|NCT05361486|Antimalarials|antimalarials|mesh-ancestor
93179778|NCT05361486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93179779|NCT05361486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93179780|NCT05361486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179781|NCT03089216|Calcium Carbonate|calcium carbonate|mesh-list
93179782|NCT03089216|Calcium|calcium|mesh-list
93179783|NCT03089216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93179784|NCT03089216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179785|NCT03089216|Antacids|antacids|mesh-ancestor
93179786|NCT03089216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179787|NCT03089216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179788|NCT03339726|Phenylephrine|phenylephrine|mesh-list
93179789|NCT03339726|Oxymetazoline|oxymetazoline|mesh-list
93179790|NCT03339726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93179791|NCT03339726|Mydriatics|mydriatics|mesh-ancestor
93179792|NCT03339726|Autonomic Agents|autonomic agents|mesh-ancestor
93179793|NCT03339726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179794|NCT03339726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179795|NCT03339726|Sympathomimetics|sympathomimetics|mesh-ancestor
93179796|NCT03339726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93179797|NCT03339726|Nasal Decongestants|nasal decongestants|mesh-ancestor
93179798|NCT03339726|Respiratory System Agents|respiratory system agents|mesh-ancestor
93179799|NCT03339726|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93179800|NCT03339726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93179801|NCT03339726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93179802|NCT03339726|Adrenergic Agents|adrenergic agents|mesh-ancestor
93179803|NCT03339726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179804|NCT03339726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179805|NCT03339726|Protective Agents|protective agents|mesh-ancestor
93179806|NCT03339297|Defibrotide|defibrotide|mesh-list
93179807|NCT03339297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93179808|NCT03339297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93179809|NCT03339297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179810|NCT03339297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93179811|NCT05434624|Midazolam|midazolam|mesh-list
93179812|NCT05434624|Propofol|propofol|mesh-list
93179813|NCT05434624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93179814|NCT05434624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179815|NCT05434624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179816|NCT05434624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93179817|NCT05434624|Anesthetics, General|anesthetics, general|mesh-ancestor
93179818|NCT05434624|Anesthetics|anesthetics|mesh-ancestor
93179819|NCT05434624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93179820|NCT05434624|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93179821|NCT05434624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93179822|NCT05434624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93179823|NCT05434624|GABA Modulators|gaba modulators|mesh-ancestor
93179824|NCT05434624|GABA Agents|gaba agents|mesh-ancestor
93179825|NCT05434624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179826|NCT05434624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179827|NCT01309633|Bevacizumab|bevacizumab|mesh-list
93179828|NCT01309633|Sunitinib|sunitinib|mesh-list
93179829|NCT01309633|Cisplatin|cisplatin|mesh-list
93179830|NCT01309633|Gemcitabine|gemcitabine|mesh-list
93179831|NCT01309633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179832|NCT01309633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179833|NCT01309633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93179834|NCT01309633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93179835|NCT01309633|Growth Substances|growth substances|mesh-ancestor
93179836|NCT01309633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179837|NCT01309633|Growth Inhibitors|growth inhibitors|mesh-ancestor
92852006|NCT00803361|Analgesics|analgesics|mesh-ancestor
93179838|NCT01309633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93179839|NCT01309633|Antimetabolites|antimetabolites|mesh-ancestor
93179840|NCT01309633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179841|NCT01309633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93179842|NCT01309633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179843|NCT05215431|Antioxidants|antioxidants|mesh-list
93179844|NCT05215431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179845|NCT05215431|Protective Agents|protective agents|mesh-ancestor
93179846|NCT05215431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179847|NCT03706950|Elsulfavirine|elsulfavirine|mesh-list
93179848|NCT03706950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93179849|NCT03706950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93179850|NCT03706950|Antiviral Agents|antiviral agents|mesh-ancestor
93179851|NCT03706950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93179852|NCT01310647|Estradiol|estradiol|mesh-list
93179853|NCT01310647|Testosterone|testosterone|mesh-list
93179854|NCT01310647|Estrogens|estrogens|mesh-ancestor
93179855|NCT01310647|Hormones|hormones|mesh-ancestor
93179856|NCT01310647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179857|NCT01310647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179858|NCT01310647|Androgens|androgens|mesh-ancestor
93179859|NCT05560399|Dexamethasone|dexamethasone|mesh-list
93179860|NCT05560399|Elotuzumab|elotuzumab|mesh-list
93179861|NCT05560399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179862|NCT05560399|Antiemetics|antiemetics|mesh-ancestor
93179863|NCT05560399|Autonomic Agents|autonomic agents|mesh-ancestor
93179864|NCT05560399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179865|NCT05560399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179866|NCT05560399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179867|NCT05560399|Glucocorticoids|glucocorticoids|mesh-ancestor
93179868|NCT05560399|Hormones|hormones|mesh-ancestor
93179869|NCT05560399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179870|NCT05560399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93179871|NCT05560399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179872|NCT02949024|Triamcinolone|triamcinolone|mesh-list
93179873|NCT02949024|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93179874|NCT02949024|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93179875|NCT02949024|Aflibercept|aflibercept|mesh-list
93179876|NCT02949024|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93179877|NCT02949024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179878|NCT02949024|Glucocorticoids|glucocorticoids|mesh-ancestor
93179879|NCT02949024|Hormones|hormones|mesh-ancestor
93179880|NCT02949024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179881|NCT02949024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179882|NCT02949024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179883|NCT02949024|Immunologic Factors|immunologic factors|mesh-ancestor
93179884|NCT02949024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179885|NCT02949024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179886|NCT02949024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93179887|NCT02949024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93179888|NCT02949024|Growth Substances|growth substances|mesh-ancestor
93179889|NCT02949024|Growth Inhibitors|growth inhibitors|mesh-ancestor
93179890|NCT02949024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179891|NCT04394481|Dexamethasone|dexamethasone|mesh-list
93179892|NCT04394481|Dexmedetomidine|dexmedetomidine|mesh-list
93179893|NCT04394481|Ropivacaine|ropivacaine|mesh-list
93179894|NCT04394481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179895|NCT04394481|Antiemetics|antiemetics|mesh-ancestor
93179896|NCT04394481|Autonomic Agents|autonomic agents|mesh-ancestor
93179897|NCT04394481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179898|NCT04394481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179899|NCT04394481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179900|NCT04394481|Glucocorticoids|glucocorticoids|mesh-ancestor
93179901|NCT04394481|Hormones|hormones|mesh-ancestor
93179902|NCT04394481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179903|NCT04394481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93179904|NCT04394481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179905|NCT04394481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93179906|NCT04394481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179907|NCT04394481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93179908|NCT04394481|Analgesics|analgesics|mesh-ancestor
93179909|NCT04394481|Sensory System Agents|sensory system agents|mesh-ancestor
93179910|NCT04394481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93179911|NCT04394481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93179912|NCT04394481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93179913|NCT04394481|Adrenergic Agents|adrenergic agents|mesh-ancestor
93179914|NCT04394481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852080|NCT05333744|Prednisone|prednisone|mesh-list
93179915|NCT04394481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179916|NCT04394481|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179917|NCT04394481|Anesthetics|anesthetics|mesh-ancestor
93179918|NCT03782935|Choline|choline|mesh-list
93179919|NCT03782935|Lipotropic Agents|lipotropic agents|mesh-ancestor
93179920|NCT03782935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93179921|NCT03782935|Antimetabolites|antimetabolites|mesh-ancestor
93179922|NCT03782935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179923|NCT03782935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93179924|NCT03782935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93179925|NCT03782935|Nootropic Agents|nootropic agents|mesh-ancestor
93179926|NCT04370847|Ephedrine|ephedrine|mesh-list
93179927|NCT04370847|Fentanyl|fentanyl|mesh-list
93179928|NCT04370847|Bupivacaine|bupivacaine|mesh-list
93179929|NCT04370847|Oxytocin|oxytocin|mesh-list
93179930|NCT04370847|Anesthetics, Local|anesthetics, local|mesh-ancestor
93179931|NCT04370847|Anesthetics|anesthetics|mesh-ancestor
93179932|NCT04370847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93179933|NCT04370847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179934|NCT04370847|Sensory System Agents|sensory system agents|mesh-ancestor
93179935|NCT04370847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93179936|NCT04370847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93179937|NCT04370847|Narcotics|narcotics|mesh-ancestor
93179938|NCT04370847|Analgesics|analgesics|mesh-ancestor
93179939|NCT04370847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93179940|NCT04370847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93179941|NCT04370847|Anesthetics, General|anesthetics, general|mesh-ancestor
93179942|NCT04370847|Oxytocics|oxytocics|mesh-ancestor
93179943|NCT04370847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93179944|NCT04370847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93179945|NCT04370847|Sympathomimetics|sympathomimetics|mesh-ancestor
93179946|NCT04370847|Autonomic Agents|autonomic agents|mesh-ancestor
93179947|NCT04370847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93179948|NCT04370847|Adrenergic Agents|adrenergic agents|mesh-ancestor
93179949|NCT04370847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93179950|NCT04370847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179951|NCT03708120|Insect Repellents|insect repellents|mesh-list
93179952|NCT03708120|Protective Agents|protective agents|mesh-ancestor
93179953|NCT03708120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179954|NCT03093428|Pembrolizumab|pembrolizumab|mesh-list
93179955|NCT03093428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179956|NCT03093428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855326|NCT05381207|Fluticasone|fluticasone|mesh-list
93179957|NCT03093428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93179958|NCT03093428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179959|NCT02735980|Prexasertib|prexasertib|mesh-list
93179960|NCT02735980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93179961|NCT02735980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179962|NCT02735980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179963|NCT01309789|Prednisone|prednisone|mesh-list
93179964|NCT01309789|Cyclophosphamide|cyclophosphamide|mesh-list
93179965|NCT01309789|Doxorubicin|doxorubicin|mesh-list
93179966|NCT01309789|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93179967|NCT01309789|Vincristine|vincristine|mesh-list
93179968|NCT01309789|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93179969|NCT01309789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93179970|NCT01309789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93179971|NCT01309789|Immunologic Factors|immunologic factors|mesh-ancestor
93179972|NCT01309789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93179973|NCT01309789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93179974|NCT01309789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93179975|NCT01309789|Alkylating Agents|alkylating agents|mesh-ancestor
93179976|NCT01309789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93179977|NCT01309789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179978|NCT01309789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93179979|NCT01309789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93179980|NCT01309789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93179981|NCT01309789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93179982|NCT01309789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93179983|NCT01309789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93179984|NCT01309789|Glucocorticoids|glucocorticoids|mesh-ancestor
93179985|NCT01309789|Hormones|hormones|mesh-ancestor
93179986|NCT01309789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93179987|NCT01309789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852155|NCT02857361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93179988|NCT01309789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93179989|NCT01309789|Tubulin Modulators|tubulin modulators|mesh-ancestor
93179990|NCT01309789|Antimitotic Agents|antimitotic agents|mesh-ancestor
93179991|NCT01309789|Mitosis Modulators|mitosis modulators|mesh-ancestor
93179992|NCT01309789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93179994|NCT01309789|Immunoconjugates|immunoconjugates|mesh-ancestor
93179995|NCT03707847|Etoposide|etoposide|mesh-list
93179996|NCT03707847|Crizotinib|crizotinib|mesh-list
93179997|NCT03707847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93179998|NCT03707847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93179999|NCT03707847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93180000|NCT03707847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93180001|NCT03707847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180002|NCT03707847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180003|NCT03707847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93180004|NCT03338400|Dexamethasone|dexamethasone|mesh-list
93180005|NCT03338400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180006|NCT03338400|Antiemetics|antiemetics|mesh-ancestor
93180007|NCT03338400|Autonomic Agents|autonomic agents|mesh-ancestor
93180008|NCT03338400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180009|NCT03338400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180010|NCT03338400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180011|NCT03338400|Glucocorticoids|glucocorticoids|mesh-ancestor
93180012|NCT03338400|Hormones|hormones|mesh-ancestor
93180013|NCT03338400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180014|NCT03338400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93180015|NCT03338400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180016|NCT03787147|Lidocaine|lidocaine|mesh-list
93180017|NCT03787147|Bupivacaine|bupivacaine|mesh-list
93180018|NCT03787147|Anesthetics, Local|anesthetics, local|mesh-ancestor
93180019|NCT03787147|Anesthetics|anesthetics|mesh-ancestor
93180020|NCT03787147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180021|NCT03787147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180022|NCT03787147|Sensory System Agents|sensory system agents|mesh-ancestor
93180023|NCT03787147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180024|NCT03787147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93180025|NCT03787147|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93180026|NCT03787147|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93180027|NCT03787147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180028|NCT03787147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180029|NCT02620306|Losartan|losartan|mesh-list
93180030|NCT02620306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93180031|NCT02620306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93180032|NCT02620306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93180033|NCT02620306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93180034|NCT02620306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180035|NCT03781843|Lidocaine|lidocaine|mesh-list
93180036|NCT03781843|Anesthetics, Local|anesthetics, local|mesh-ancestor
93180037|NCT03781843|Anesthetics|anesthetics|mesh-ancestor
93180038|NCT03781843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180039|NCT03781843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180040|NCT03781843|Sensory System Agents|sensory system agents|mesh-ancestor
93180041|NCT03781843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180042|NCT03781843|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93180043|NCT03781843|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93180044|NCT03781843|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93180045|NCT03781843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180046|NCT03781843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180047|NCT05205447|Itraconazole|itraconazole|mesh-list
93180048|NCT05205447|Carbamazepine|carbamazepine|mesh-list
93180049|NCT05205447|Antifungal Agents|antifungal agents|mesh-ancestor
93180050|NCT05205447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180051|NCT05205447|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93180052|NCT05205447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93180053|NCT05205447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180054|NCT05205447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180055|NCT05205447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93180056|NCT05205447|Hormone Antagonists|hormone antagonists|mesh-ancestor
93180057|NCT05205447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180058|NCT05205447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180059|NCT05205447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93180060|NCT05205447|Anticonvulsants|anticonvulsants|mesh-ancestor
92852233|NCT04227912|Analgesics|analgesics|mesh-ancestor
93180061|NCT05205447|Antimanic Agents|antimanic agents|mesh-ancestor
93180062|NCT05205447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93180063|NCT05205447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180064|NCT05205447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93180065|NCT05205447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180066|NCT05205447|Analgesics|analgesics|mesh-ancestor
93180067|NCT05205447|Sensory System Agents|sensory system agents|mesh-ancestor
93180068|NCT05205447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180069|NCT05205447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93180070|NCT05205447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180071|NCT05205447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93180072|NCT05205447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93180073|NCT03781687|Morphine|morphine|mesh-list
93180074|NCT03781687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93180075|NCT03781687|Narcotics|narcotics|mesh-ancestor
93180076|NCT03781687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180077|NCT03781687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180078|NCT03781687|Analgesics|analgesics|mesh-ancestor
93180079|NCT03781687|Sensory System Agents|sensory system agents|mesh-ancestor
93180080|NCT03781687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180081|NCT03092726|ASP8062|asp8062|mesh-list
93180082|NCT03092726|Analgesics|analgesics|mesh-ancestor
93180083|NCT03092726|Sensory System Agents|sensory system agents|mesh-ancestor
93180084|NCT03092726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180085|NCT03092726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180086|NCT03092726|GABA Modulators|gaba modulators|mesh-ancestor
93180087|NCT03092726|GABA Agents|gaba agents|mesh-ancestor
93180088|NCT03092726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180089|NCT03092726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180090|NCT03786757|Rivaroxaban|rivaroxaban|mesh-list
93180091|NCT03786757|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93180092|NCT03786757|Antithrombins|antithrombins|mesh-ancestor
93180093|NCT03786757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93180094|NCT03786757|Protease Inhibitors|protease inhibitors|mesh-ancestor
93180095|NCT03786757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180096|NCT03786757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180097|NCT03786757|Anticoagulants|anticoagulants|mesh-ancestor
93180098|NCT05126511|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93180099|NCT05126511|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93180100|NCT05126511|beta-Endorphin|beta-endorphin|mesh-list
93180101|NCT05126511|Hormones|hormones|mesh-ancestor
93180102|NCT05126511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180103|NCT05126511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180104|NCT05126511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180105|NCT05126511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180106|NCT05598242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93180107|NCT05598242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93180108|NCT04494789|Fludrocortisone|fludrocortisone|mesh-list
93180109|NCT04494789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180110|NCT05598164|Botulinum Toxins|botulinum toxins|mesh-list
93180111|NCT05598164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93180112|NCT05598164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93180113|NCT05598164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93180114|NCT05598164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180115|NCT05598164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180116|NCT05598164|Cholinergic Agents|cholinergic agents|mesh-ancestor
93180117|NCT05598164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180118|NCT05598164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180119|NCT05598164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93180120|NCT05598164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180121|NCT03787069|Lidocaine|lidocaine|mesh-list
93180122|NCT03787069|Anesthetics, Local|anesthetics, local|mesh-ancestor
93180123|NCT03787069|Anesthetics|anesthetics|mesh-ancestor
93180124|NCT03787069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180125|NCT03787069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180126|NCT03787069|Sensory System Agents|sensory system agents|mesh-ancestor
93180127|NCT03787069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180128|NCT03787069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93180129|NCT03787069|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93180130|NCT03787069|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93180131|NCT03787069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180132|NCT03787069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180133|NCT04447118|Docetaxel|docetaxel|mesh-list
93180134|NCT04447118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180135|NCT04447118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180136|NCT04447118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180137|NCT04447118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180138|NCT04447118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180139|NCT05532319|Lenvatinib|lenvatinib|mesh-list
93180140|NCT05532319|Tislelizumab|tislelizumab|mesh-list
93180141|NCT05532319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180142|NCT05532319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93180143|NCT05532319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180144|NCT05532319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180145|NCT05532319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180146|NCT01553032|Cetuximab|cetuximab|mesh-list
93180147|NCT01553032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180148|NCT01553032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180149|NCT05181124|Naproxen|naproxen|mesh-list
93180150|NCT05181124|Meloxicam|meloxicam|mesh-list
93180151|NCT05181124|Aceclofenac|aceclofenac|mesh-list
93180152|NCT05181124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93180153|NCT05181124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180154|NCT05181124|Analgesics|analgesics|mesh-ancestor
93180155|NCT05181124|Sensory System Agents|sensory system agents|mesh-ancestor
93180156|NCT05181124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180157|NCT05181124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180158|NCT05181124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180159|NCT05181124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180160|NCT05181124|Gout Suppressants|gout suppressants|mesh-ancestor
93180161|NCT05181124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93180162|NCT05181124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180163|NCT05181124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180164|NCT05181124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93180165|NCT02897648|Lactams|lactams|mesh-list
93180166|NCT02897648|beta-Lactams|beta-lactams|mesh-list
93180167|NCT02897648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93180168|NCT02897648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180169|NCT03338010|Insulin Glargine|insulin glargine|mesh-list
93180170|NCT03338010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180171|NCT03338010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180172|NCT04959591|Acetaminophen|acetaminophen|mesh-list
93180173|NCT04959591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180174|NCT04959591|Analgesics|analgesics|mesh-ancestor
93180175|NCT04959591|Sensory System Agents|sensory system agents|mesh-ancestor
93180176|NCT04959591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180177|NCT04959591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180178|NCT04959591|Antipyretics|antipyretics|mesh-ancestor
93180179|NCT05598086|Tranexamic Acid|tranexamic acid|mesh-list
93180180|NCT05598086|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93180181|NCT05598086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93180182|NCT05598086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180183|NCT05598086|Hemostatics|hemostatics|mesh-ancestor
93180184|NCT05598086|Coagulants|coagulants|mesh-ancestor
93180185|NCT00753532|Vitamin E|vitamin e|mesh-list
93180186|NCT00753532|Tocopherols|tocopherols|mesh-list
93180187|NCT00753532|Tocotrienols|tocotrienols|mesh-list
93180188|NCT00753532|Tocovid|tocovid|mesh-list
93180189|NCT00753532|Vitamins|vitamins|mesh-ancestor
93180190|NCT00753532|Micronutrients|micronutrients|mesh-ancestor
93180191|NCT00753532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180192|NCT00753532|Antioxidants|antioxidants|mesh-ancestor
93180193|NCT00753532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180194|NCT00753532|Protective Agents|protective agents|mesh-ancestor
93180195|NCT03632408|Zopiclone|zopiclone|mesh-list
93180196|NCT03632408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93180197|NCT03632408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180198|NCT03632408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180199|NCT01307839|Lidocaine|lidocaine|mesh-list
93180200|NCT01307839|Anesthetics, Local|anesthetics, local|mesh-ancestor
93180201|NCT01307839|Anesthetics|anesthetics|mesh-ancestor
93180202|NCT01307839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180203|NCT01307839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180204|NCT01307839|Sensory System Agents|sensory system agents|mesh-ancestor
93180205|NCT01307839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180206|NCT01307839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93180207|NCT01307839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93180208|NCT01307839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93180209|NCT01307839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180210|NCT01307839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180211|NCT03777085|Rituximab|rituximab|mesh-list
93180212|NCT03777085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180213|NCT03777085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180214|NCT03777085|Immunologic Factors|immunologic factors|mesh-ancestor
93180215|NCT03777085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180216|NCT03777085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180217|NCT01328548|Vaccines|vaccines|mesh-list
93180218|NCT01328548|Immunologic Factors|immunologic factors|mesh-ancestor
93180219|NCT01328548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180220|NCT04453306|Topiramate|topiramate|mesh-list
93180221|NCT04453306|Anticonvulsants|anticonvulsants|mesh-ancestor
93180222|NCT04453306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180223|NCT04453306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180224|NCT03777163|Vaccines|vaccines|mesh-list
93180225|NCT03777163|Immunologic Factors|immunologic factors|mesh-ancestor
93180226|NCT03777163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180227|NCT03786289|Epoetin Alfa|epoetin alfa|mesh-list
93180228|NCT03786289|Hematinics|hematinics|mesh-ancestor
93180229|NCT05597540|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93180230|NCT05597540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93180231|NCT05597540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180232|NCT05597540|Antitubercular Agents|antitubercular agents|mesh-ancestor
93180233|NCT03776851|Epoetin Alfa|epoetin alfa|mesh-list
93180234|NCT03776851|Hematinics|hematinics|mesh-ancestor
93180235|NCT03337308|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93180236|NCT03337308|Ezetimibe|ezetimibe|mesh-list
93180237|NCT03337308|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93180238|NCT03337308|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93180239|NCT03337308|Antimetabolites|antimetabolites|mesh-ancestor
93180240|NCT03337308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180241|NCT03337308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93180242|NCT03337308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180243|NCT03337308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180244|NCT03337308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180245|NCT03631862|Apatinib|apatinib|mesh-list
93180246|NCT03631862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180247|NCT03631862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93180248|NCT03631862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180249|NCT03631862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180250|NCT03468010|Paclitaxel|paclitaxel|mesh-list
93180251|NCT03468010|Cisplatin|cisplatin|mesh-list
93180252|NCT03468010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93180253|NCT03468010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180254|NCT03468010|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180255|NCT03468010|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180256|NCT03468010|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180257|NCT03468010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180258|NCT03337152|Chloroquine|chloroquine|mesh-list
93180259|NCT03337152|Primaquine|primaquine|mesh-list
93180260|NCT03337152|Amebicides|amebicides|mesh-ancestor
93180261|NCT03337152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93180262|NCT03337152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93180263|NCT03337152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180264|NCT03337152|Antimalarials|antimalarials|mesh-ancestor
93180265|NCT03337152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180266|NCT03467620|Cannabidiol|cannabidiol|mesh-list
93180267|NCT03467620|Anticonvulsants|anticonvulsants|mesh-ancestor
93180268|NCT03780205|Methamphetamine|methamphetamine|mesh-list
93180269|NCT03780205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93180270|NCT03780205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180271|NCT03780205|Sympathomimetics|sympathomimetics|mesh-ancestor
93180272|NCT03780205|Autonomic Agents|autonomic agents|mesh-ancestor
93180273|NCT03780205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180274|NCT03780205|Dopamine Agents|dopamine agents|mesh-ancestor
93180275|NCT03780205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180276|NCT03780205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180277|NCT03780205|Adrenergic Agents|adrenergic agents|mesh-ancestor
93180278|NCT03780205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93180279|NCT03780205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93180280|NCT03780205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180281|NCT03780205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93180282|NCT04751500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93180283|NCT04751500|Metronidazole|metronidazole|mesh-list
93180284|NCT04751500|Clindamycin|clindamycin|mesh-list
93180285|NCT04751500|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93180286|NCT04751500|Misoprostol|misoprostol|mesh-list
93180287|NCT04751500|Mifepristone|mifepristone|mesh-list
93180288|NCT04751500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180289|NCT04751500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93180291|NCT04751500|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93180292|NCT04751500|Abortifacient Agents|abortifacient agents|mesh-ancestor
93180293|NCT04751500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93180294|NCT04751500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180295|NCT04751500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93180296|NCT04751500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180297|NCT04751500|Oxytocics|oxytocics|mesh-ancestor
93180298|NCT04751500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93180299|NCT04751500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180300|NCT04751500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180301|NCT04751500|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93180302|NCT04751500|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93180303|NCT04751500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93180304|NCT04751500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93180305|NCT04751500|Contraceptive Agents|contraceptive agents|mesh-ancestor
93180306|NCT04751500|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93180307|NCT04751500|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93180308|NCT04751500|Hormone Antagonists|hormone antagonists|mesh-ancestor
93180309|NCT04751500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180310|NCT04751500|Luteolytic Agents|luteolytic agents|mesh-ancestor
93180311|NCT04751500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93180312|NCT04751500|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93180313|NCT04751500|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93180314|NCT04305249|Nivolumab|nivolumab|mesh-list
93180315|NCT04305249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180316|NCT04305249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180317|NCT04305249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93180318|NCT04305249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180319|NCT03710161|Vitamin D|vitamin d|mesh-list
93180320|NCT03710161|Vitamins|vitamins|mesh-ancestor
93180321|NCT03710161|Micronutrients|micronutrients|mesh-ancestor
93180322|NCT03710161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180323|NCT03710161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93180324|NCT02719574|Cytarabine|cytarabine|mesh-list
93180325|NCT02719574|Azacitidine|azacitidine|mesh-list
93180326|NCT02719574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93180327|NCT02719574|Antimetabolites|antimetabolites|mesh-ancestor
93180328|NCT02719574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180329|NCT02719574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180330|NCT02719574|Antiviral Agents|antiviral agents|mesh-ancestor
93180331|NCT02719574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180332|NCT02719574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180333|NCT02719574|Immunologic Factors|immunologic factors|mesh-ancestor
93180334|NCT02719574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180335|NCT02719574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180336|NCT04947501|Cyclophosphamide|cyclophosphamide|mesh-list
93180337|NCT04947501|Ifosfamide|ifosfamide|mesh-list
93180338|NCT04947501|Carboplatin|carboplatin|mesh-list
93180339|NCT04947501|Doxorubicin|doxorubicin|mesh-list
93180340|NCT04947501|Etoposide|etoposide|mesh-list
93180341|NCT04947501|Vincristine|vincristine|mesh-list
93180342|NCT04947501|Topotecan|topotecan|mesh-list
93180343|NCT04947501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180344|NCT04947501|Immunologic Factors|immunologic factors|mesh-ancestor
93180345|NCT04947501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180346|NCT04947501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180347|NCT04947501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93180348|NCT04947501|Alkylating Agents|alkylating agents|mesh-ancestor
93180349|NCT04947501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180350|NCT04947501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180351|NCT04947501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93180352|NCT04947501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93180353|NCT04947501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93180354|NCT04947501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93180355|NCT04947501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180356|NCT04947501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93180357|NCT04947501|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180358|NCT04947501|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180359|NCT04947501|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180360|NCT04947501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93180361|NCT03707808|Nivolumab|nivolumab|mesh-list
93180362|NCT03707808|Ipilimumab|ipilimumab|mesh-list
93180363|NCT03707808|Avelumab|avelumab|mesh-list
92852537|NCT02772354|Metoprolol|metoprolol|mesh-list
93180364|NCT03707808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180365|NCT03707808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180366|NCT03707808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93180367|NCT03707808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180368|NCT03091400|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93180369|NCT03091400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93180370|NCT03091400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93180371|NCT03091400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180372|NCT03091400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180373|NCT03091400|Adrenergic Agents|adrenergic agents|mesh-ancestor
93180374|NCT03091400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180375|NCT03091400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180377|NCT04716634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180378|NCT04716634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180379|NCT02761070|Bevacizumab|bevacizumab|mesh-list
93180380|NCT02761070|Temozolomide|temozolomide|mesh-list
93180381|NCT02761070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180382|NCT02761070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180383|NCT02761070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93180384|NCT02761070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93180385|NCT02761070|Growth Substances|growth substances|mesh-ancestor
93180386|NCT02761070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180387|NCT02761070|Growth Inhibitors|growth inhibitors|mesh-ancestor
93180388|NCT02761070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93180389|NCT02761070|Alkylating Agents|alkylating agents|mesh-ancestor
93180390|NCT02761070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180391|NCT03090152|Bupivacaine|bupivacaine|mesh-list
93180392|NCT03090152|Anesthetics, Local|anesthetics, local|mesh-ancestor
93180393|NCT03090152|Anesthetics|anesthetics|mesh-ancestor
93180394|NCT03090152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180395|NCT03090152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180396|NCT03090152|Sensory System Agents|sensory system agents|mesh-ancestor
93180397|NCT03090152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180398|NCT03466528|Thiamine|thiamine|mesh-list
93180399|NCT03466528|Vitamin B Complex|vitamin b complex|mesh-list
93180400|NCT03466528|Magnesium Sulfate|magnesium sulfate|mesh-list
93180401|NCT03466528|Vitamins|vitamins|mesh-ancestor
93180402|NCT03466528|Micronutrients|micronutrients|mesh-ancestor
93180403|NCT03466528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180404|NCT03466528|Analgesics|analgesics|mesh-ancestor
93180405|NCT03466528|Sensory System Agents|sensory system agents|mesh-ancestor
93180406|NCT03466528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180407|NCT03466528|Anesthetics|anesthetics|mesh-ancestor
93180408|NCT03466528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180409|NCT03466528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93180410|NCT03466528|Anticonvulsants|anticonvulsants|mesh-ancestor
93180411|NCT03466528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93180412|NCT03466528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180413|NCT03466528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180414|NCT03466528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93180415|NCT03466528|Tocolytic Agents|tocolytic agents|mesh-ancestor
93180416|NCT03466528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93180417|NCT03466216|Octreotide|octreotide|mesh-list
93180418|NCT03466216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180419|NCT03466216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93180420|NCT03466216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180421|NCT03098654|Metformin|metformin|mesh-list
93180422|NCT03098654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180423|NCT03098654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180424|NCT05175066|Bisoprolol|bisoprolol|mesh-list
93180425|NCT05175066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93180426|NCT05175066|Sympatholytics|sympatholytics|mesh-ancestor
93180427|NCT05175066|Autonomic Agents|autonomic agents|mesh-ancestor
93180428|NCT05175066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180429|NCT05175066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180430|NCT05175066|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93180431|NCT05175066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93180432|NCT05175066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93180433|NCT05175066|Adrenergic Agents|adrenergic agents|mesh-ancestor
93180434|NCT05175066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180435|NCT05175066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180436|NCT03130114|Azithromycin|azithromycin|mesh-list
93180437|NCT03130114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93180438|NCT03130114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180439|NCT03130270|Apatinib|apatinib|mesh-list
93180440|NCT03130270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180441|NCT03130270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93180442|NCT03130270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180443|NCT03130270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180444|NCT03780361|Aflibercept|aflibercept|mesh-list
93180445|NCT03780361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93180446|NCT03780361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93180447|NCT03780361|Growth Substances|growth substances|mesh-ancestor
93180448|NCT03780361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180449|NCT03780361|Growth Inhibitors|growth inhibitors|mesh-ancestor
93180450|NCT03780361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180451|NCT05183646|Propagermanium|propagermanium|mesh-list
93180452|NCT05183646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180453|NCT05183646|Interferon Inducers|interferon inducers|mesh-ancestor
93180454|NCT05183646|Immunologic Factors|immunologic factors|mesh-ancestor
93180455|NCT05183646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180456|NCT04943445|Paclitaxel|paclitaxel|mesh-list
93180457|NCT04943445|Carboplatin|carboplatin|mesh-list
93180458|NCT04943445|Pembrolizumab|pembrolizumab|mesh-list
93180459|NCT04943445|Immunomodulating Agents|immunomodulating agents|mesh-list
93180460|NCT04943445|Immunologic Factors|immunologic factors|mesh-list
93180461|NCT04943445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93180462|NCT04943445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180463|NCT04943445|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180464|NCT04943445|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180465|NCT04943445|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180466|NCT04943445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180467|NCT04943445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180468|NCT04943445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93180469|NCT04943445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180470|NCT02522572|Plerixafor|plerixafor|mesh-list
93180471|NCT02522572|Bortezomib|bortezomib|mesh-list
93180472|NCT02522572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180473|NCT02522572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93180474|NCT02522572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93180475|NCT02522572|Antiviral Agents|antiviral agents|mesh-ancestor
93180476|NCT02522572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180477|NCT04602507|Ivermectin|ivermectin|mesh-list
93180478|NCT04602507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93180479|NCT04602507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180480|NCT04645966|Acetaminophen|acetaminophen|mesh-list
93180481|NCT04645966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180482|NCT04645966|Analgesics|analgesics|mesh-ancestor
93180483|NCT04645966|Sensory System Agents|sensory system agents|mesh-ancestor
93180484|NCT04645966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180485|NCT04645966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180486|NCT04645966|Antipyretics|antipyretics|mesh-ancestor
93180487|NCT03773809|Vitamin D|vitamin d|mesh-list
93180488|NCT03773809|Ergocalciferols|ergocalciferols|mesh-list
93180489|NCT03773809|Cholecalciferol|cholecalciferol|mesh-list
93180490|NCT03773809|Vitamins|vitamins|mesh-list
93180491|NCT03773809|Micronutrients|micronutrients|mesh-ancestor
93180492|NCT03773809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180493|NCT03773809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93180494|NCT03773809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93180495|NCT01313611|Rituximab|rituximab|mesh-list
93180496|NCT01313611|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93180497|NCT01313611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180498|NCT01313611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180499|NCT01313611|Immunologic Factors|immunologic factors|mesh-ancestor
93180500|NCT01313611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180501|NCT01313611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180502|NCT01313611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93180503|NCT01313611|Alkylating Agents|alkylating agents|mesh-ancestor
93180504|NCT01313611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180505|NCT03776383|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93180506|NCT03776383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180507|NCT04534582|Denosumab|denosumab|mesh-list
93180508|NCT04534582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93180509|NCT04534582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180510|NCT03780049|Leucovorin|leucovorin|mesh-list
93180511|NCT03780049|Fluorouracil|fluorouracil|mesh-list
93180512|NCT03780049|Oxaliplatin|oxaliplatin|mesh-list
93180513|NCT03780049|Antimetabolites|antimetabolites|mesh-ancestor
93366316|NCT02058485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93180514|NCT03780049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180515|NCT03780049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93180516|NCT03780049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180517|NCT03780049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180518|NCT03780049|Immunologic Factors|immunologic factors|mesh-ancestor
93180519|NCT03780049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180520|NCT03780049|Antidotes|antidotes|mesh-ancestor
93180521|NCT03780049|Protective Agents|protective agents|mesh-ancestor
93180522|NCT03780049|Vitamin B Complex|vitamin b complex|mesh-ancestor
93180523|NCT03780049|Vitamins|vitamins|mesh-ancestor
93180524|NCT03780049|Micronutrients|micronutrients|mesh-ancestor
93180525|NCT04252287|Canagliflozin|canagliflozin|mesh-list
93180526|NCT04252287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93180527|NCT04252287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180528|NCT04252287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180529|NCT04252287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180530|NCT05681754|Calcium, Dietary|calcium, dietary|mesh-list
93180531|NCT05681754|Calcium|calcium|mesh-list
93180532|NCT05681754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93180533|NCT05681754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180534|NCT05681754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93180535|NCT03465202|Capecitabine|capecitabine|mesh-list
93180536|NCT03465202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93180537|NCT03465202|Antimetabolites|antimetabolites|mesh-ancestor
93180538|NCT03465202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180539|NCT03465202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180540|NCT04195958|Omalizumab|omalizumab|mesh-list
93180541|NCT04195958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93180542|NCT04195958|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93180543|NCT04195958|Respiratory System Agents|respiratory system agents|mesh-ancestor
93180544|NCT05540262|Edaravone|edaravone|mesh-list
93180545|NCT05540262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93180546|NCT05540262|Antioxidants|antioxidants|mesh-ancestor
93180547|NCT05540262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180548|NCT05540262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93180549|NCT05540262|Protective Agents|protective agents|mesh-ancestor
93180550|NCT05540262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180551|NCT04245423|Analgesics, Opioid|analgesics, opioid|mesh-list
93180552|NCT04245423|Narcotics|narcotics|mesh-ancestor
93180553|NCT04245423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180554|NCT04245423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180555|NCT04245423|Analgesics|analgesics|mesh-ancestor
93180556|NCT04245423|Sensory System Agents|sensory system agents|mesh-ancestor
93180557|NCT04245423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180558|NCT02735200|Vitamin D|vitamin d|mesh-list
93180559|NCT02735200|Ergocalciferols|ergocalciferols|mesh-list
93180560|NCT02735200|Cholecalciferol|cholecalciferol|mesh-list
93180561|NCT02735200|Vitamins|vitamins|mesh-list
93180562|NCT02735200|Micronutrients|micronutrients|mesh-ancestor
93180563|NCT02735200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180564|NCT02735200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93180565|NCT02735200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93180566|NCT01312311|Docetaxel|docetaxel|mesh-list
93180567|NCT01312311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180568|NCT01312311|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180569|NCT01312311|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180570|NCT01312311|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180571|NCT01312311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180572|NCT03464968|Leucovorin|leucovorin|mesh-list
93180573|NCT03464968|Oxaliplatin|oxaliplatin|mesh-list
93180574|NCT03464968|Irinotecan|irinotecan|mesh-list
93180575|NCT03464968|Fluorouracil|fluorouracil|mesh-list
93180576|NCT03464968|Levoleucovorin|levoleucovorin|mesh-list
93180577|NCT03464968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180578|NCT03464968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93180579|NCT03464968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93180580|NCT03464968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180581|NCT03464968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180582|NCT03464968|Antidotes|antidotes|mesh-ancestor
93180583|NCT03464968|Protective Agents|protective agents|mesh-ancestor
93180584|NCT03464968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180585|NCT03464968|Vitamin B Complex|vitamin b complex|mesh-ancestor
93180586|NCT03464968|Vitamins|vitamins|mesh-ancestor
93180587|NCT03464968|Micronutrients|micronutrients|mesh-ancestor
93180588|NCT03464968|Antimetabolites|antimetabolites|mesh-ancestor
93180589|NCT03464968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93180590|NCT03464968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180591|NCT03464968|Immunologic Factors|immunologic factors|mesh-ancestor
93180592|NCT05073744|Morphine|morphine|mesh-list
93180593|NCT05073744|Nalbuphine|nalbuphine|mesh-list
93180594|NCT05073744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93180595|NCT05073744|Narcotics|narcotics|mesh-ancestor
93180596|NCT05073744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180597|NCT05073744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180598|NCT05073744|Analgesics|analgesics|mesh-ancestor
93180599|NCT05073744|Sensory System Agents|sensory system agents|mesh-ancestor
93180600|NCT05073744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180601|NCT05681598|Hydroxyurea|hydroxyurea|mesh-list
93180602|NCT05681598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180603|NCT05681598|Antisickling Agents|antisickling agents|mesh-ancestor
93180604|NCT05681598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180605|NCT05681598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180606|NCT05681598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93180607|NCT01312350|Docetaxel|docetaxel|mesh-list
93180608|NCT01312350|Fluorouracil|fluorouracil|mesh-list
93180609|NCT01312350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180610|NCT01312350|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180611|NCT01312350|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180612|NCT01312350|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180613|NCT01312350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180614|NCT01312350|Antimetabolites|antimetabolites|mesh-ancestor
93180615|NCT01312350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93180616|NCT01312350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180617|NCT01312350|Immunologic Factors|immunologic factors|mesh-ancestor
93180618|NCT01312350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180619|NCT03464656|Antioxidants|antioxidants|mesh-list
93180620|NCT03464656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180621|NCT03464656|Protective Agents|protective agents|mesh-ancestor
93180622|NCT03464656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180623|NCT04343248|Nitazoxanide|nitazoxanide|mesh-list
93180624|NCT04343248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93180625|NCT04343248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180626|NCT03705858|Lintuzumab|lintuzumab|mesh-list
93180627|NCT03705858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180628|NCT03705858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180629|NCT05156658|Etonogestrel|etonogestrel|mesh-list
93180630|NCT05156658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93180631|NCT05156658|Contraceptive Agents|contraceptive agents|mesh-ancestor
93180632|NCT05156658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93180633|NCT05156658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180634|NCT05156658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93180635|NCT03463642|Vitamin D|vitamin d|mesh-list
93180636|NCT03463642|Cholecalciferol|cholecalciferol|mesh-list
93180637|NCT03463642|Mineral Oil|mineral oil|mesh-list
93180638|NCT03463642|Vitamins|vitamins|mesh-ancestor
93180639|NCT03463642|Micronutrients|micronutrients|mesh-ancestor
93180640|NCT03463642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180641|NCT03463642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93180642|NCT03463642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93180643|NCT03463642|Emollients|emollients|mesh-ancestor
93180644|NCT03463642|Dermatologic Agents|dermatologic agents|mesh-ancestor
93180645|NCT03463564|Insulin|insulin|mesh-list
93180646|NCT03463564|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93180647|NCT03463564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180648|NCT03463564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180649|NCT05092386|Vaccines|vaccines|mesh-list
93180650|NCT05092386|Immunologic Factors|immunologic factors|mesh-ancestor
93180651|NCT05092386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180652|NCT03463252|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93180653|NCT03463252|Medroxyprogesterone|medroxyprogesterone|mesh-list
93180654|NCT03463252|Progesterone|progesterone|mesh-list
93180655|NCT03463252|Progestins|progestins|mesh-ancestor
93180656|NCT03463252|Hormones|hormones|mesh-ancestor
93180657|NCT03463252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180658|NCT03463252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180659|NCT03463252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93180660|NCT03463252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93180661|NCT03463252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93180662|NCT03463252|Contraceptive Agents|contraceptive agents|mesh-ancestor
93180663|NCT03463252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93180664|NCT03463252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93180665|NCT03463252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93180666|NCT03463252|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93366317|NCT02058485|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93180667|NCT03463252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93180668|NCT03463252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180669|NCT05309538|Betahistine|betahistine|mesh-list
93180670|NCT05309538|Vasodilator Agents|vasodilator agents|mesh-ancestor
93180671|NCT05309538|Histamine Agonists|histamine agonists|mesh-ancestor
93180672|NCT05309538|Histamine Agents|histamine agents|mesh-ancestor
93180673|NCT05309538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180674|NCT05309538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180675|NCT05309538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180676|NCT03462940|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
93180677|NCT03462940|Antiviral Agents|antiviral agents|mesh-ancestor
93180678|NCT03462940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180679|NCT03462940|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93180680|NCT03462940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180681|NCT03011450|Fenofibrate|fenofibrate|mesh-list
93180682|NCT03011450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93180683|NCT03011450|Antimetabolites|antimetabolites|mesh-ancestor
93180684|NCT03011450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180685|NCT03011450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93180686|NCT03638856|Misoprostol|misoprostol|mesh-list
93180687|NCT03638856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93180688|NCT03638856|Abortifacient Agents|abortifacient agents|mesh-ancestor
93180689|NCT03638856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93180690|NCT03638856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180691|NCT03638856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93180692|NCT03638856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180693|NCT03638856|Oxytocics|oxytocics|mesh-ancestor
93180694|NCT03705780|Fentanyl|fentanyl|mesh-list
93180695|NCT03705780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93180696|NCT03705780|Narcotics|narcotics|mesh-ancestor
93180697|NCT03705780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93180698|NCT03705780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180699|NCT03705780|Analgesics|analgesics|mesh-ancestor
93180700|NCT03705780|Sensory System Agents|sensory system agents|mesh-ancestor
93180701|NCT03705780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180702|NCT03705780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93180703|NCT03705780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93180704|NCT03705780|Anesthetics, General|anesthetics, general|mesh-ancestor
93180705|NCT03705780|Anesthetics|anesthetics|mesh-ancestor
93180706|NCT04976790|Flurbiprofen|flurbiprofen|mesh-list
93180707|NCT04976790|Analgesics|analgesics|mesh-ancestor
93180708|NCT04976790|Sensory System Agents|sensory system agents|mesh-ancestor
93180709|NCT04976790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180710|NCT04976790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180711|NCT04976790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93180712|NCT04976790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180713|NCT04976790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180714|NCT04976790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180715|NCT04976790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93180716|NCT04976790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180717|NCT04976790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180718|NCT04452838|Fesoterodine|fesoterodine|mesh-list
93180719|NCT04452838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93180720|NCT04452838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93180721|NCT04452838|Cholinergic Agents|cholinergic agents|mesh-ancestor
93180722|NCT04452838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180723|NCT04452838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180724|NCT04452838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180725|NCT04452838|Urological Agents|urological agents|mesh-ancestor
93180726|NCT02967848|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
93180727|NCT02967848|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93180728|NCT02967848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180729|NCT04188860|Paclitaxel|paclitaxel|mesh-list
93180730|NCT04188860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93180731|NCT04188860|Antibodies|antibodies|mesh-list
93180732|NCT04188860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93180733|NCT04188860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180734|NCT04188860|Tubulin Modulators|tubulin modulators|mesh-ancestor
93180735|NCT04188860|Antimitotic Agents|antimitotic agents|mesh-ancestor
93180736|NCT04188860|Mitosis Modulators|mitosis modulators|mesh-ancestor
93180737|NCT04188860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180738|NCT04188860|Immunologic Factors|immunologic factors|mesh-ancestor
93180739|NCT04188860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180740|NCT05425862|Talazoparib|talazoparib|mesh-list
93180741|NCT05425862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93180742|NCT05425862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180743|NCT05425862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180744|NCT05425862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180745|NCT01383668|Sirolimus|sirolimus|mesh-list
93180746|NCT01383668|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
93180747|NCT01383668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93180748|NCT01383668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180749|NCT01383668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93180750|NCT01383668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180751|NCT01383668|Antifungal Agents|antifungal agents|mesh-ancestor
93180752|NCT01383668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180753|NCT01383668|Immunologic Factors|immunologic factors|mesh-ancestor
93180754|NCT01383668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180755|NCT01383668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180756|NCT03656068|Nitazoxanide|nitazoxanide|mesh-list
93180757|NCT03656068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93180758|NCT03656068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180759|NCT01381796|Sumatriptan|sumatriptan|mesh-list
93180760|NCT01381796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93180761|NCT01381796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93180762|NCT01381796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93180763|NCT01381796|Serotonin Agents|serotonin agents|mesh-ancestor
93180764|NCT01381796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180765|NCT01381796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180766|NCT01381796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180767|NCT04375228|Rituximab|rituximab|mesh-list
93180768|NCT04375228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180769|NCT04375228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180770|NCT04375228|Immunologic Factors|immunologic factors|mesh-ancestor
93180771|NCT04375228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180772|NCT04375228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180773|NCT02521714|Lenalidomide|lenalidomide|mesh-list
93180774|NCT02521714|Immunologic Factors|immunologic factors|mesh-ancestor
93180775|NCT02521714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180776|NCT02521714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93180777|NCT02521714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93180778|NCT02521714|Growth Substances|growth substances|mesh-ancestor
93180779|NCT02521714|Growth Inhibitors|growth inhibitors|mesh-ancestor
93180780|NCT02521714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180781|NCT03768089|Ivacaftor|ivacaftor|mesh-list
93180782|NCT03768089|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93180783|NCT03768089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180784|NCT03768089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180785|NCT03548584|Brexpiprazole|brexpiprazole|mesh-list
93180786|NCT03548584|Serotonin Agents|serotonin agents|mesh-ancestor
93180787|NCT03548584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180788|NCT03548584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180789|NCT03548584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180790|NCT03548584|Dopamine Agonists|dopamine agonists|mesh-ancestor
93180791|NCT03548584|Dopamine Agents|dopamine agents|mesh-ancestor
93180792|NCT01381640|Acetaminophen|acetaminophen|mesh-list
93180793|NCT01381640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180794|NCT01381640|Analgesics|analgesics|mesh-ancestor
93180795|NCT01381640|Sensory System Agents|sensory system agents|mesh-ancestor
93180796|NCT01381640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180797|NCT01381640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180798|NCT01381640|Antipyretics|antipyretics|mesh-ancestor
93180799|NCT04483973|Ebselen|ebselen|mesh-list
93180800|NCT04483973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93180801|NCT04483973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93180802|NCT04483973|Analgesics|analgesics|mesh-ancestor
93180803|NCT04483973|Sensory System Agents|sensory system agents|mesh-ancestor
93180804|NCT04483973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180805|NCT04483973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180806|NCT04483973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180807|NCT04483973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93180808|NCT04483973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93180809|NCT04483973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180810|NCT04483973|Antioxidants|antioxidants|mesh-ancestor
93180811|NCT04483973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180812|NCT04483973|Protective Agents|protective agents|mesh-ancestor
93180813|NCT04483973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93180814|NCT04483973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180815|NCT04483973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93180816|NCT04283890|Nivolumab|nivolumab|mesh-list
93180817|NCT04283890|Ipilimumab|ipilimumab|mesh-list
93180818|NCT04283890|Melphalan|melphalan|mesh-list
93180819|NCT04283890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180820|NCT04283890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180821|NCT04283890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93180822|NCT04283890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180823|NCT04283890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93180824|NCT04283890|Alkylating Agents|alkylating agents|mesh-ancestor
93180825|NCT04283890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93180826|NCT04283890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93180827|NCT04283890|Immunologic Factors|immunologic factors|mesh-ancestor
93180828|NCT04283890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180829|NCT01139723|Bevacizumab|bevacizumab|mesh-list
93180830|NCT01139723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180831|NCT01139723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180832|NCT01139723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93180833|NCT01139723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93180834|NCT01139723|Growth Substances|growth substances|mesh-ancestor
93180835|NCT01139723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180836|NCT01139723|Growth Inhibitors|growth inhibitors|mesh-ancestor
93180837|NCT05068037|Antiemetics|antiemetics|mesh-list
93180838|NCT05068037|Autonomic Agents|autonomic agents|mesh-ancestor
93180839|NCT05068037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180840|NCT05068037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180841|NCT05068037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93180842|NCT01136759|Tenofovir|tenofovir|mesh-list
93180843|NCT01136759|Antiviral Agents|antiviral agents|mesh-ancestor
93180844|NCT01136759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180845|NCT01136759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93180846|NCT01136759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93180847|NCT01136759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180848|NCT01136759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180849|NCT01136759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93180850|NCT01136759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93180851|NCT01141439|Fluticasone|fluticasone|mesh-list
93180852|NCT01141439|Xhance|xhance|mesh-list
93180853|NCT01141439|Beclomethasone|beclomethasone|mesh-list
93180854|NCT01141439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180855|NCT01141439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93180856|NCT01141439|Autonomic Agents|autonomic agents|mesh-ancestor
93180857|NCT01141439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180858|NCT01141439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180859|NCT01141439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93180860|NCT01141439|Respiratory System Agents|respiratory system agents|mesh-ancestor
93180861|NCT01141439|Dermatologic Agents|dermatologic agents|mesh-ancestor
93180862|NCT01141439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93180863|NCT01141439|Glucocorticoids|glucocorticoids|mesh-ancestor
93180864|NCT01141439|Hormones|hormones|mesh-ancestor
93180865|NCT01141439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180866|NCT05549531|Itraconazole|itraconazole|mesh-list
93180867|NCT05549531|Antifungal Agents|antifungal agents|mesh-ancestor
93180868|NCT05549531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180869|NCT05549531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93180870|NCT05549531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93180871|NCT05549531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180872|NCT05549531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180873|NCT05549531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93180874|NCT05549531|Hormone Antagonists|hormone antagonists|mesh-ancestor
93180875|NCT05549531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180876|NCT05549531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180877|NCT05549531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93180878|NCT04452370|Etoposide|etoposide|mesh-list
93180879|NCT04452370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93180880|NCT04452370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180881|NCT04452370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93180882|NCT04452370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93180883|NCT04452370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180884|NCT04452370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180885|NCT03819088|Zinc|zinc|mesh-list
93180886|NCT03819088|Zinc Sulfate|zinc sulfate|mesh-list
93180887|NCT03819088|Trace Elements|trace elements|mesh-ancestor
93180888|NCT03819088|Micronutrients|micronutrients|mesh-ancestor
93180889|NCT03819088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180890|NCT03819088|Astringents|astringents|mesh-ancestor
93180891|NCT03819088|Dermatologic Agents|dermatologic agents|mesh-ancestor
93180892|NCT01232777|Bevacizumab|bevacizumab|mesh-list
93180893|NCT01232777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180894|NCT01232777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180895|NCT01232777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93180896|NCT01232777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93180897|NCT01232777|Growth Substances|growth substances|mesh-ancestor
93180898|NCT01232777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180899|NCT01232777|Growth Inhibitors|growth inhibitors|mesh-ancestor
93180900|NCT03248271|Insulin Lispro|insulin lispro|mesh-list
93180901|NCT03248271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180902|NCT03248271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180903|NCT04213677|Dapagliflozin|dapagliflozin|mesh-list
93180904|NCT04213677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93180905|NCT04213677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180906|NCT04213677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180907|NCT04213677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180908|NCT03247036|Fibrinolytic Agents|fibrinolytic agents|mesh-list
93180909|NCT03247036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93180910|NCT03247036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180911|NCT04921995|Tislelizumab|tislelizumab|mesh-list
93180912|NCT04921995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93180913|NCT04921995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180914|NCT03129867|Ticagrelor|ticagrelor|mesh-list
93180915|NCT03129867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93180916|NCT03129867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93180917|NCT03129867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93180918|NCT03129867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93180919|NCT03129867|Purinergic Agents|purinergic agents|mesh-ancestor
93180920|NCT03129867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180921|NCT03129867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180922|NCT03129867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180923|NCT01235273|Hormones|hormones|mesh-list
93180924|NCT01235273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180925|NCT01235273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180926|NCT01140035|Insulin|insulin|mesh-list
93180927|NCT01140035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93180928|NCT01140035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180929|NCT02525692|TIC10 compound|tic10 compound|mesh-list
93180930|NCT02525692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180931|NCT00872950|Amifampridine|amifampridine|mesh-list
93180932|NCT00872950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93180933|NCT00872950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180934|NCT00872950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180935|NCT00872950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93180936|NCT00872950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180937|NCT00872950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180938|NCT03233217|Vaccines|vaccines|mesh-list
93180939|NCT03233217|Immunologic Factors|immunologic factors|mesh-ancestor
93180940|NCT03233217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180941|NCT01568996|Sulforaphane|sulforaphane|mesh-list
93180942|NCT01568996|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93180943|NCT01568996|Protective Agents|protective agents|mesh-ancestor
93180944|NCT01568996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180945|NCT01568996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180946|NCT02943993|Edoxaban|edoxaban|mesh-list
93180947|NCT02943993|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93180948|NCT02943993|Antithrombins|antithrombins|mesh-ancestor
93180949|NCT02943993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93180950|NCT02943993|Protease Inhibitors|protease inhibitors|mesh-ancestor
93180951|NCT02943993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180952|NCT02943993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180953|NCT02943993|Anticoagulants|anticoagulants|mesh-ancestor
93180954|NCT02620150|Escitalopram|escitalopram|mesh-list
93180955|NCT02620150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93180956|NCT02620150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93180957|NCT02620150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93180958|NCT02620150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180959|NCT02620150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93180960|NCT02620150|Serotonin Agents|serotonin agents|mesh-ancestor
93180961|NCT02620150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180962|NCT04098302|Dutasteride|dutasteride|mesh-list
93180963|NCT04098302|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93180964|NCT04098302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93180965|NCT04098302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180966|NCT04098302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180967|NCT04098302|Hormone Antagonists|hormone antagonists|mesh-ancestor
93180968|NCT04098302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93180969|NCT04098302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180970|NCT02596126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93180971|NCT05488613|Midostaurin|midostaurin|mesh-list
93180972|NCT05488613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180973|NCT05488613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93180974|NCT05488613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93180975|NCT05488613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180976|NCT05420168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93180977|NCT05420168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180978|NCT01137383|Interferons|interferons|mesh-list
93180979|NCT01137383|Ribavirin|ribavirin|mesh-list
93180980|NCT01137383|Interferon-alpha|interferon-alpha|mesh-list
93180981|NCT01137383|Interferon alpha-2|interferon alpha-2|mesh-list
93180982|NCT01137383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93180983|NCT01137383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93180984|NCT01137383|Antiviral Agents|antiviral agents|mesh-ancestor
93180985|NCT01137383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93180986|NCT01137383|Antimetabolites|antimetabolites|mesh-ancestor
93180987|NCT01137383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93180988|NCT01137383|Immunologic Factors|immunologic factors|mesh-ancestor
93180989|NCT01137383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180990|NCT03449836|Fluticasone|fluticasone|mesh-list
93180991|NCT03449836|Mometasone Furoate|mometasone furoate|mesh-list
93180992|NCT03449836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93180993|NCT03449836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93180994|NCT03449836|Autonomic Agents|autonomic agents|mesh-ancestor
93180995|NCT03449836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93180996|NCT03449836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93180997|NCT03449836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93180998|NCT03449836|Respiratory System Agents|respiratory system agents|mesh-ancestor
93180999|NCT03449836|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181000|NCT03449836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93181001|NCT03449524|CXA-10|cxa-10|mesh-list
93181002|NCT03449524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181003|NCT03961256|Exenatide|exenatide|mesh-list
93181004|NCT03961256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93181005|NCT03961256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181006|NCT03961256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93181007|NCT03961256|Incretins|incretins|mesh-ancestor
93181008|NCT03961256|Hormones|hormones|mesh-ancestor
93181009|NCT03961256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181010|NCT03443518|Remifentanil|remifentanil|mesh-list
93181011|NCT03443518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181012|NCT03443518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181013|NCT03443518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93181014|NCT03443518|Narcotics|narcotics|mesh-ancestor
93181015|NCT03443518|Analgesics|analgesics|mesh-ancestor
93181016|NCT03443518|Sensory System Agents|sensory system agents|mesh-ancestor
93181017|NCT03443518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181018|NCT01142843|Propolis|propolis|mesh-list
93181019|NCT01142843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181020|NCT04330625|Volagidemab|volagidemab|mesh-list
93181021|NCT04330625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93181022|NCT04330625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181023|NCT03747497|Linezolid|linezolid|mesh-list
93181024|NCT03747497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93181025|NCT03747497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181026|NCT03747497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93181027|NCT03747497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181028|NCT03747497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181029|NCT03109600|Vaccines|vaccines|mesh-list
93181030|NCT03109600|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93181031|NCT03109600|Immunologic Factors|immunologic factors|mesh-ancestor
93181032|NCT03109600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181033|NCT03679013|Acetaminophen|acetaminophen|mesh-list
93181034|NCT03679013|Gabapentin|gabapentin|mesh-list
93181035|NCT03679013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181036|NCT03679013|Analgesics|analgesics|mesh-ancestor
93181037|NCT03679013|Sensory System Agents|sensory system agents|mesh-ancestor
93181038|NCT03679013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181039|NCT03679013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181040|NCT03679013|Antipyretics|antipyretics|mesh-ancestor
92853208|NCT00887107|Sorafenib|sorafenib|mesh-list
93181041|NCT03679013|Anticonvulsants|anticonvulsants|mesh-ancestor
93181042|NCT03679013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93181043|NCT03679013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93181044|NCT03679013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181045|NCT03679013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93181046|NCT03679013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93181047|NCT03679013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93181048|NCT03679013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181049|NCT03679013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181050|NCT03679013|Antimanic Agents|antimanic agents|mesh-ancestor
93181051|NCT01140425|Moxifloxacin|moxifloxacin|mesh-list
93181052|NCT01140425|PF 232798|pf 232798|mesh-list
93181053|NCT01140425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93181054|NCT01140425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181055|NCT01140425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93181056|NCT01140425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93181057|NCT01140425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181058|NCT01140425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181059|NCT01140425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181060|NCT01140425|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93181061|NCT01140425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93181062|NCT01140425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93181063|NCT01140425|Antiviral Agents|antiviral agents|mesh-ancestor
93181064|NCT04884412|Anesthetics|anesthetics|mesh-list
93181065|NCT04884412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181066|NCT04884412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181067|NCT03991013|Dolutegravir|dolutegravir|mesh-list
93181068|NCT03991013|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93181069|NCT03991013|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93181070|NCT03991013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181071|NCT03991013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181072|NCT03991013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93181073|NCT03991013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93181074|NCT03991013|Antiviral Agents|antiviral agents|mesh-ancestor
93181075|NCT03991013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181076|NCT03441412|Metoprolol|metoprolol|mesh-list
93181077|NCT03441412|Epinephrine|epinephrine|mesh-list
93181078|NCT03441412|Ticagrelor|ticagrelor|mesh-list
93181079|NCT03441412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93181080|NCT03441412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93181081|NCT03441412|Adrenergic Agents|adrenergic agents|mesh-ancestor
93181082|NCT03441412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181083|NCT03441412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181084|NCT03441412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181085|NCT03441412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93181086|NCT03441412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93181087|NCT03441412|Autonomic Agents|autonomic agents|mesh-ancestor
93181088|NCT03441412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181089|NCT03441412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93181090|NCT03441412|Respiratory System Agents|respiratory system agents|mesh-ancestor
93181091|NCT03441412|Mydriatics|mydriatics|mesh-ancestor
93181092|NCT03441412|Sympathomimetics|sympathomimetics|mesh-ancestor
93181093|NCT03441412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93181094|NCT03441412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93181095|NCT03441412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93181096|NCT03441412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93181097|NCT03441412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93181098|NCT03441412|Purinergic Agents|purinergic agents|mesh-ancestor
93181099|NCT03441412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181100|NCT03441412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93181101|NCT03441412|Sympatholytics|sympatholytics|mesh-ancestor
93181102|NCT03441412|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93181103|NCT03441412|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93181104|NCT03441412|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93181105|NCT01235819|Insulin|insulin|mesh-list
93181106|NCT01235819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93181107|NCT01235819|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93181108|NCT01235819|Exenatide|exenatide|mesh-list
93181109|NCT01235819|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93181110|NCT01235819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93181111|NCT01235819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181112|NCT01235819|Incretins|incretins|mesh-ancestor
93181113|NCT01235819|Hormones|hormones|mesh-ancestor
93181114|NCT01235819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181115|NCT01235819|Protease Inhibitors|protease inhibitors|mesh-ancestor
92476912|NCT01872728|Anesthetics|anesthetics|mesh-list
93181116|NCT01235819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181117|NCT01235819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181118|NCT01235819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93181119|NCT05275569|Antiemetics|antiemetics|mesh-list
93181120|NCT05275569|Autonomic Agents|autonomic agents|mesh-ancestor
93181121|NCT05275569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181122|NCT05275569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181123|NCT05275569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93181124|NCT04599933|Pilocarpine|pilocarpine|mesh-list
93181125|NCT04599933|Miotics|miotics|mesh-ancestor
93181126|NCT04599933|Autonomic Agents|autonomic agents|mesh-ancestor
93181127|NCT04599933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181128|NCT04599933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181129|NCT04599933|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93181130|NCT04599933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93181131|NCT04599933|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181132|NCT04599933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181133|NCT04599933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181134|NCT03440788|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93181135|NCT03440788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181136|NCT03440788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181137|NCT03440788|Immunotoxins|immunotoxins|mesh-ancestor
93181138|NCT03440788|Immunoconjugates|immunoconjugates|mesh-ancestor
93181139|NCT03440788|Immunologic Factors|immunologic factors|mesh-ancestor
93181140|NCT03440788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181141|NCT02824575|Paclitaxel|paclitaxel|mesh-list
93181142|NCT02824575|Rebastinib|rebastinib|mesh-list
93181143|NCT02824575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93181144|NCT02824575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181145|NCT02824575|Tubulin Modulators|tubulin modulators|mesh-ancestor
93181146|NCT02824575|Antimitotic Agents|antimitotic agents|mesh-ancestor
93181147|NCT02824575|Mitosis Modulators|mitosis modulators|mesh-ancestor
93181148|NCT02824575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181149|NCT02824575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93181150|NCT02824575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181151|NCT03780608|Durvalumab|durvalumab|mesh-list
93181152|NCT03780608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181153|NCT03780608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181154|NCT03631316|Valganciclovir|valganciclovir|mesh-list
93181155|NCT03631316|Antiviral Agents|antiviral agents|mesh-ancestor
93181156|NCT03631316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181157|NCT03608865|Durvalumab|durvalumab|mesh-list
93181158|NCT03608865|Tremelimumab|tremelimumab|mesh-list
93181159|NCT03608865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181160|NCT03608865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181161|NCT03532451|Nivolumab|nivolumab|mesh-list
93181162|NCT03532451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181163|NCT03532451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181164|NCT03532451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93181165|NCT03532451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181166|NCT04704531|Hyaluronic Acid|hyaluronic acid|mesh-list
93181167|NCT04704531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93181168|NCT04704531|Immunologic Factors|immunologic factors|mesh-ancestor
93181169|NCT04704531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181170|NCT04704531|Viscosupplements|viscosupplements|mesh-ancestor
93181171|NCT04704531|Protective Agents|protective agents|mesh-ancestor
93181172|NCT02637531|Nivolumab|nivolumab|mesh-list
93181173|NCT02637531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181174|NCT02637531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181175|NCT02637531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93181176|NCT02637531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181177|NCT01237925|Chlorpheniramine|chlorpheniramine|mesh-list
93181178|NCT01237925|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93181179|NCT01237925|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93181180|NCT01237925|Histamine Antagonists|histamine antagonists|mesh-ancestor
93181181|NCT01237925|Histamine Agents|histamine agents|mesh-ancestor
93181182|NCT01237925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181183|NCT01237925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181184|NCT01237925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181185|NCT01237925|Antipruritics|antipruritics|mesh-ancestor
93181186|NCT01237925|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181187|NCT01237925|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93181188|NCT01380548|Iron|iron|mesh-list
93181189|NCT01380548|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93181190|NCT01380548|Trace Elements|trace elements|mesh-ancestor
93181191|NCT01380548|Micronutrients|micronutrients|mesh-ancestor
93181192|NCT01380548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181193|NCT01380548|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93181194|NCT01380548|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181195|NCT01313247|Acetaminophen|acetaminophen|mesh-list
93181196|NCT01313247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181197|NCT01313247|Analgesics|analgesics|mesh-ancestor
93181198|NCT01313247|Sensory System Agents|sensory system agents|mesh-ancestor
93181199|NCT01313247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181200|NCT01313247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181201|NCT01313247|Antipyretics|antipyretics|mesh-ancestor
93181202|NCT01142453|Interferons|interferons|mesh-list
93181203|NCT01142453|Interferon-beta|interferon-beta|mesh-list
93181204|NCT01142453|Interferon beta-1a|interferon beta-1a|mesh-list
93181205|NCT01142453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181206|NCT01142453|Antiviral Agents|antiviral agents|mesh-ancestor
93181207|NCT01142453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181208|NCT01142453|Immunologic Factors|immunologic factors|mesh-ancestor
93181209|NCT01142453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181210|NCT01142453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93181211|NCT04701424|Insulin|insulin|mesh-list
93181212|NCT04701424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93181213|NCT04701424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181214|NCT03560193|Chlorhexidine|chlorhexidine|mesh-list
93181215|NCT03560193|Ethanol|ethanol|mesh-list
93181216|NCT03560193|Povidone-Iodine|povidone-iodine|mesh-list
93181217|NCT03560193|Povidone|povidone|mesh-list
93181218|NCT03560193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93181219|NCT03560193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181220|NCT03560193|Disinfectants|disinfectants|mesh-ancestor
93181221|NCT03560193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181222|NCT03560193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181223|NCT03560193|Plasma Substitutes|plasma substitutes|mesh-ancestor
93181224|NCT03560193|Blood Substitutes|blood substitutes|mesh-ancestor
93181225|NCT04451200|Busulfan|busulfan|mesh-list
93181226|NCT04451200|Alkylating Agents|alkylating agents|mesh-ancestor
93181227|NCT04451200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181228|NCT04451200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181229|NCT04451200|Immunologic Factors|immunologic factors|mesh-ancestor
93181230|NCT04451200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181231|NCT04451200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93181232|NCT04451200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181233|NCT04451200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93181234|NCT04678479|Ganaxolone|ganaxolone|mesh-list
93181235|NCT04678479|Neurosteroids|neurosteroids|mesh-ancestor
93181236|NCT04678479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181237|NCT04678479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181238|NCT04678479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181239|NCT04678479|GABA Modulators|gaba modulators|mesh-ancestor
93181240|NCT04678479|GABA Agents|gaba agents|mesh-ancestor
93181241|NCT04668118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93181242|NCT04668118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93181243|NCT02251821|Mycophenolic Acid|mycophenolic acid|mesh-list
93181244|NCT02251821|Cyclophosphamide|cyclophosphamide|mesh-list
93181245|NCT02251821|Melphalan|melphalan|mesh-list
93181246|NCT02251821|Busulfan|busulfan|mesh-list
93181247|NCT02251821|Mechlorethamine|mechlorethamine|mesh-list
93181248|NCT02251821|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93181249|NCT02251821|Methotrexate|methotrexate|mesh-list
93181250|NCT02251821|Fludarabine|fludarabine|mesh-list
93181251|NCT02251821|Fludarabine phosphate|fludarabine phosphate|mesh-list
93181252|NCT02251821|Tacrolimus|tacrolimus|mesh-list
93181253|NCT02251821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181254|NCT02251821|Immunologic Factors|immunologic factors|mesh-ancestor
93181255|NCT02251821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181256|NCT02251821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181257|NCT02251821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93181258|NCT02251821|Alkylating Agents|alkylating agents|mesh-ancestor
93181259|NCT02251821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181260|NCT02251821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181261|NCT02251821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93181262|NCT02251821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93181263|NCT02251821|Abortifacient Agents|abortifacient agents|mesh-ancestor
93181264|NCT02251821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93181265|NCT02251821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181266|NCT02251821|Antimetabolites|antimetabolites|mesh-ancestor
93181267|NCT02251821|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181268|NCT02251821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181269|NCT02251821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93181270|NCT02251821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93181271|NCT02251821|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93181272|NCT02251821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93181273|NCT02251821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93181274|NCT02251821|Antitubercular Agents|antitubercular agents|mesh-ancestor
93181275|NCT02251821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93181276|NCT02251821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181277|NCT03784781|Dimercaprol|dimercaprol|mesh-list
93181278|NCT03784781|Chelating Agents|chelating agents|mesh-ancestor
93181279|NCT03784781|Sequestering Agents|sequestering agents|mesh-ancestor
93181280|NCT03784781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181281|NCT03428477|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93181282|NCT03428477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93181283|NCT03428477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93181284|NCT03425201|Niraparib|niraparib|mesh-list
93181285|NCT03425201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93181286|NCT03425201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181287|NCT03425201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181288|NCT03425201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181289|NCT03438604|Donepezil|donepezil|mesh-list
93181290|NCT03438604|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93181291|NCT03438604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181292|NCT03438604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181293|NCT03438604|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181294|NCT03438604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181295|NCT03438604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181296|NCT03438604|Nootropic Agents|nootropic agents|mesh-ancestor
93181297|NCT03433378|Tretinoin|tretinoin|mesh-list
93181298|NCT03433378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181299|NCT03433378|Keratolytic Agents|keratolytic agents|mesh-ancestor
93181300|NCT03433378|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181301|NCT03433222|Coal Tar|coal tar|mesh-list
93181302|NCT03433222|Keratolytic Agents|keratolytic agents|mesh-ancestor
93181303|NCT03433222|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181304|NCT05016076|Dexamethasone|dexamethasone|mesh-list
93181305|NCT05016076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181306|NCT05016076|Antiemetics|antiemetics|mesh-ancestor
93181307|NCT05016076|Autonomic Agents|autonomic agents|mesh-ancestor
93181308|NCT05016076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181309|NCT05016076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181310|NCT05016076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93181311|NCT05016076|Glucocorticoids|glucocorticoids|mesh-ancestor
93181312|NCT05016076|Hormones|hormones|mesh-ancestor
93181313|NCT05016076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181314|NCT05016076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93181315|NCT05016076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181316|NCT03319953|Antipsychotic Agents|antipsychotic agents|mesh-list
93181317|NCT03319953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93181318|NCT03319953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181319|NCT03319953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181320|NCT03319953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93181321|NCT03433144|Tranexamic Acid|tranexamic acid|mesh-list
93181322|NCT03433144|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93181323|NCT03433144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93181324|NCT03433144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181325|NCT03433144|Hemostatics|hemostatics|mesh-ancestor
93181326|NCT03433144|Coagulants|coagulants|mesh-ancestor
93181327|NCT01384214|Botulinum Toxins|botulinum toxins|mesh-list
93181328|NCT01384214|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93181329|NCT01384214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93181330|NCT01384214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93181331|NCT01384214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93181332|NCT01384214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181333|NCT01384214|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181334|NCT01384214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181335|NCT01384214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181336|NCT01384214|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93181337|NCT01384214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181338|NCT02927834|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93181339|NCT02927834|Prednisone|prednisone|mesh-list
93181340|NCT02927834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181341|NCT02927834|Glucocorticoids|glucocorticoids|mesh-ancestor
93181342|NCT02927834|Hormones|hormones|mesh-ancestor
93181343|NCT02927834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181344|NCT02927834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181345|NCT02927834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93181346|NCT02927834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181347|NCT02927834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93181348|NCT02927834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181349|NCT02927834|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93181350|NCT02927834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181351|NCT02927834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181352|NCT03170180|Sunitinib|sunitinib|mesh-list
93181353|NCT03170180|Imatinib Mesylate|imatinib mesylate|mesh-list
93181354|NCT03170180|Gefitinib|gefitinib|mesh-list
93181355|NCT03170180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181356|NCT03170180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93181357|NCT03170180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93181358|NCT03170180|Growth Substances|growth substances|mesh-ancestor
93181359|NCT03170180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181360|NCT03170180|Growth Inhibitors|growth inhibitors|mesh-ancestor
93181361|NCT03170180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93181362|NCT03170180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181363|NCT03170180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181364|NCT03319667|Dexamethasone|dexamethasone|mesh-list
93181365|NCT03319667|Lenalidomide|lenalidomide|mesh-list
93181366|NCT03319667|Bortezomib|bortezomib|mesh-list
93181367|NCT03319667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181368|NCT03319667|Antiemetics|antiemetics|mesh-ancestor
93181369|NCT03319667|Autonomic Agents|autonomic agents|mesh-ancestor
93181370|NCT03319667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181371|NCT03319667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181372|NCT03319667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93181373|NCT03319667|Glucocorticoids|glucocorticoids|mesh-ancestor
93181374|NCT03319667|Hormones|hormones|mesh-ancestor
93181375|NCT03319667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181376|NCT03319667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93181377|NCT03319667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181378|NCT03319667|Immunologic Factors|immunologic factors|mesh-ancestor
93181379|NCT03319667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93181380|NCT03319667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93181381|NCT03319667|Growth Substances|growth substances|mesh-ancestor
93181382|NCT03319667|Growth Inhibitors|growth inhibitors|mesh-ancestor
93181383|NCT03432676|Pembrolizumab|pembrolizumab|mesh-list
93181384|NCT03432676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181385|NCT03432676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181386|NCT03432676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93181387|NCT03432676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181388|NCT03432598|Paclitaxel|paclitaxel|mesh-list
93181389|NCT03432598|Etoposide|etoposide|mesh-list
93181390|NCT03432598|Carboplatin|carboplatin|mesh-list
93181391|NCT03432598|Gemcitabine|gemcitabine|mesh-list
93181392|NCT03432598|Pemetrexed|pemetrexed|mesh-list
93181393|NCT03432598|Tislelizumab|tislelizumab|mesh-list
93181394|NCT03432598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93181395|NCT03432598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181396|NCT03432598|Tubulin Modulators|tubulin modulators|mesh-ancestor
93181397|NCT03432598|Antimitotic Agents|antimitotic agents|mesh-ancestor
93181398|NCT03432598|Mitosis Modulators|mitosis modulators|mesh-ancestor
93181399|NCT03432598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181400|NCT03432598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181401|NCT03432598|Antimetabolites|antimetabolites|mesh-ancestor
93181402|NCT03432598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93181403|NCT03432598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93181404|NCT03432598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181405|NCT03432598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93181406|NCT03432598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93181407|NCT03432598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181408|NCT03432442|Ivermectin|ivermectin|mesh-list
93181409|NCT03432442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93181410|NCT03432442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181411|NCT01964547|Nabiximols|nabiximols|mesh-list
93181412|NCT01964547|Analgesics|analgesics|mesh-ancestor
93181413|NCT01964547|Sensory System Agents|sensory system agents|mesh-ancestor
93181414|NCT01964547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181415|NCT01964547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181416|NCT01380314|Miltefosine|miltefosine|mesh-list
93181417|NCT01380314|Imiquimod|imiquimod|mesh-list
93181418|NCT01380314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93181419|NCT01380314|Immunologic Factors|immunologic factors|mesh-ancestor
92853580|NCT02768220|Incretins|incretins|mesh-ancestor
93181420|NCT01380314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181421|NCT01380314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181422|NCT01380314|Interferon Inducers|interferon inducers|mesh-ancestor
93181423|NCT01380314|Antifungal Agents|antifungal agents|mesh-ancestor
93181424|NCT01380314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181425|NCT01380314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93181426|NCT01380314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93181427|NCT03110510|Leucovorin|leucovorin|mesh-list
93181428|NCT03110510|Fluorouracil|fluorouracil|mesh-list
93181429|NCT03110510|Irinotecan|irinotecan|mesh-list
93181430|NCT03110510|Calcium|calcium|mesh-list
93181431|NCT03110510|Levoleucovorin|levoleucovorin|mesh-list
93181432|NCT03110510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93181433|NCT03110510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181434|NCT03110510|Antimetabolites|antimetabolites|mesh-ancestor
93181435|NCT03110510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181436|NCT03110510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181437|NCT03110510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181438|NCT03110510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181439|NCT03110510|Immunologic Factors|immunologic factors|mesh-ancestor
93181440|NCT03110510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93181441|NCT03110510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93181442|NCT03110510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181443|NCT03110510|Antidotes|antidotes|mesh-ancestor
93181444|NCT03110510|Protective Agents|protective agents|mesh-ancestor
93181445|NCT03110510|Vitamin B Complex|vitamin b complex|mesh-ancestor
93181446|NCT03110510|Vitamins|vitamins|mesh-ancestor
93181447|NCT03110510|Micronutrients|micronutrients|mesh-ancestor
93181448|NCT01238237|Cetuximab|cetuximab|mesh-list
93181449|NCT01238237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181450|NCT01238237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181451|NCT03319719|Lidocaine|lidocaine|mesh-list
93181452|NCT03319719|Hyaluronic Acid|hyaluronic acid|mesh-list
93181453|NCT03319719|Anesthetics, Local|anesthetics, local|mesh-ancestor
93181454|NCT03319719|Anesthetics|anesthetics|mesh-ancestor
93181455|NCT03319719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181456|NCT03319719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181457|NCT03319719|Sensory System Agents|sensory system agents|mesh-ancestor
93181458|NCT03319719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181459|NCT03319719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181460|NCT03319719|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93181461|NCT03319719|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93181462|NCT03319719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93181463|NCT03319719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181464|NCT03319719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93181465|NCT03319719|Immunologic Factors|immunologic factors|mesh-ancestor
93181466|NCT03319719|Viscosupplements|viscosupplements|mesh-ancestor
93181467|NCT03319719|Protective Agents|protective agents|mesh-ancestor
93181468|NCT03128242|Oxytocin|oxytocin|mesh-list
93181469|NCT03128242|Oxytocics|oxytocics|mesh-ancestor
93181470|NCT03128242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93181471|NCT03128242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181472|NCT01313689|Ofatumumab|ofatumumab|mesh-list
93181473|NCT01313689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181474|NCT03431272|Lifitegrast|lifitegrast|mesh-list
93181475|NCT03431272|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93181476|NCT03431272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93181477|NCT02528513|Fentanyl|fentanyl|mesh-list
93181478|NCT02528513|Midazolam|midazolam|mesh-list
93181479|NCT02528513|Dexmedetomidine|dexmedetomidine|mesh-list
93181480|NCT02528513|Propofol|propofol|mesh-list
93181481|NCT02528513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93181482|NCT02528513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181483|NCT02528513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181484|NCT02528513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181485|NCT02528513|Analgesics|analgesics|mesh-ancestor
93181486|NCT02528513|Sensory System Agents|sensory system agents|mesh-ancestor
93181487|NCT02528513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181488|NCT02528513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93181489|NCT02528513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93181490|NCT02528513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93181491|NCT02528513|Adrenergic Agents|adrenergic agents|mesh-ancestor
93181492|NCT02528513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181493|NCT02528513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181494|NCT02528513|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93181495|NCT02528513|Anesthetics, General|anesthetics, general|mesh-ancestor
93181496|NCT02528513|Anesthetics|anesthetics|mesh-ancestor
93181497|NCT02528513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92853663|NCT02767596|Lixisenatide|lixisenatide|mesh-list
93181498|NCT02528513|Narcotics|narcotics|mesh-ancestor
93181499|NCT02528513|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93181500|NCT02528513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93181501|NCT02528513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93181502|NCT02528513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93181503|NCT02528513|GABA Modulators|gaba modulators|mesh-ancestor
93181504|NCT02528513|GABA Agents|gaba agents|mesh-ancestor
93181505|NCT01320007|Furosemide|furosemide|mesh-list
93181506|NCT01320007|Diuretics|diuretics|mesh-ancestor
93181507|NCT01320007|Natriuretic Agents|natriuretic agents|mesh-ancestor
93181508|NCT01320007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181509|NCT01320007|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93181510|NCT01320007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93181511|NCT01320007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181512|NCT03318315|Vaccines|vaccines|mesh-list
93181513|NCT03318315|Immunologic Factors|immunologic factors|mesh-ancestor
93181514|NCT03318315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181515|NCT04460183|Nitric Oxide|nitric oxide|mesh-list
93181516|NCT04460183|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93181517|NCT04460183|Autonomic Agents|autonomic agents|mesh-ancestor
93181518|NCT04460183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181519|NCT04460183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181520|NCT04460183|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93181521|NCT04460183|Respiratory System Agents|respiratory system agents|mesh-ancestor
93181522|NCT04460183|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93181523|NCT04460183|Antioxidants|antioxidants|mesh-ancestor
93181524|NCT04460183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181525|NCT04460183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181526|NCT04460183|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93181527|NCT04460183|Vasodilator Agents|vasodilator agents|mesh-ancestor
93181528|NCT04460183|Gasotransmitters|gasotransmitters|mesh-ancestor
93181529|NCT04460183|Protective Agents|protective agents|mesh-ancestor
93181530|NCT01243697|Desogestrel|desogestrel|mesh-list
93181531|NCT01243697|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93181532|NCT01243697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93181533|NCT01243697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93181534|NCT01243697|Contraceptive Agents|contraceptive agents|mesh-ancestor
93181535|NCT01243697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93181536|NCT01243697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181537|NCT01243697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93181538|NCT01243697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93181539|NCT01243697|Progestins|progestins|mesh-ancestor
93181540|NCT01243697|Hormones|hormones|mesh-ancestor
93181541|NCT01243697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181542|NCT04703101|Leucovorin|leucovorin|mesh-list
93181543|NCT04703101|Fluorouracil|fluorouracil|mesh-list
93181544|NCT04703101|Capecitabine|capecitabine|mesh-list
93181545|NCT04703101|Oxaliplatin|oxaliplatin|mesh-list
93181546|NCT04703101|Antimetabolites|antimetabolites|mesh-ancestor
93181547|NCT04703101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181548|NCT04703101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181549|NCT04703101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181550|NCT04703101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181551|NCT04703101|Immunologic Factors|immunologic factors|mesh-ancestor
93181552|NCT04703101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181553|NCT04703101|Antidotes|antidotes|mesh-ancestor
93181554|NCT04703101|Protective Agents|protective agents|mesh-ancestor
93181555|NCT04703101|Vitamin B Complex|vitamin b complex|mesh-ancestor
93181556|NCT04703101|Vitamins|vitamins|mesh-ancestor
93181557|NCT04703101|Micronutrients|micronutrients|mesh-ancestor
93181558|NCT01145573|Calcium|calcium|mesh-list
93181559|NCT01145573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93181560|NCT01145573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181561|NCT01320709|Piroxicam|piroxicam|mesh-list
93181562|NCT01320709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93181563|NCT01320709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181564|NCT01320709|Analgesics|analgesics|mesh-ancestor
93181565|NCT01320709|Sensory System Agents|sensory system agents|mesh-ancestor
93181566|NCT01320709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181567|NCT01320709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181568|NCT01320709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181569|NCT01320709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181570|NCT01320709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93181571|NCT01320709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181572|NCT01320709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181573|NCT01238393|Ranibizumab|ranibizumab|mesh-list
93181574|NCT01238393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93181575|NCT01238393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93181576|NCT01238393|Growth Substances|growth substances|mesh-ancestor
93181577|NCT01238393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181578|NCT01238393|Growth Inhibitors|growth inhibitors|mesh-ancestor
93181579|NCT01238393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181580|NCT03776305|Imipenem|imipenem|mesh-list
93181581|NCT03776305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93181582|NCT03776305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181583|NCT01146509|Donepezil|donepezil|mesh-list
93181584|NCT01146509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93181585|NCT01146509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181586|NCT01146509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181587|NCT01146509|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181588|NCT01146509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181589|NCT01146509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181590|NCT01146509|Nootropic Agents|nootropic agents|mesh-ancestor
93181591|NCT03775993|Hormones|hormones|mesh-list
93181592|NCT03775993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181593|NCT03775993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181594|NCT03316131|Dapagliflozin|dapagliflozin|mesh-list
93181595|NCT03316131|Febuxostat|febuxostat|mesh-list
93181596|NCT03316131|Verinurad|verinurad|mesh-list
93181597|NCT03316131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93181598|NCT03316131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181599|NCT03316131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93181600|NCT03316131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181601|NCT03316131|Gout Suppressants|gout suppressants|mesh-ancestor
93181602|NCT03316131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181603|NCT03779659|Anesthetics|anesthetics|mesh-list
93181604|NCT03779659|Benzocaine|benzocaine|mesh-list
93181605|NCT03779659|Anesthetics, Local|anesthetics, local|mesh-list
93181606|NCT03779659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181607|NCT03779659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181608|NCT03779659|Sensory System Agents|sensory system agents|mesh-ancestor
93181609|NCT03779659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181610|NCT01145807|Terbinafine|terbinafine|mesh-list
93181611|NCT01145807|Antifungal Agents|antifungal agents|mesh-ancestor
93181612|NCT01145807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181613|NCT01145807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181614|NCT01145807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181615|NCT03898895|Antibodies|antibodies|mesh-list
93181616|NCT03898895|Immunologic Factors|immunologic factors|mesh-ancestor
93181617|NCT03898895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181618|NCT01245569|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93181619|NCT01245569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93181620|NCT01245569|Autonomic Agents|autonomic agents|mesh-ancestor
93181621|NCT01245569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181622|NCT01245569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181623|NCT01245569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93181624|NCT01245569|Respiratory System Agents|respiratory system agents|mesh-ancestor
93181625|NCT01245569|Glucocorticoids|glucocorticoids|mesh-ancestor
93181626|NCT01245569|Hormones|hormones|mesh-ancestor
93181627|NCT01245569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181628|NCT01245569|Sympathomimetics|sympathomimetics|mesh-ancestor
93181629|NCT01314859|Nifedipine|nifedipine|mesh-list
93181630|NCT01314859|Atosiban|atosiban|mesh-list
93181631|NCT01314859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93181632|NCT01314859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93181633|NCT01314859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181634|NCT01314859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93181635|NCT01314859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181636|NCT01314859|Vasodilator Agents|vasodilator agents|mesh-ancestor
93181637|NCT01314859|Tocolytic Agents|tocolytic agents|mesh-ancestor
93181638|NCT01314859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93181639|NCT01314859|Hormone Antagonists|hormone antagonists|mesh-ancestor
93181640|NCT01314859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181641|NCT02528279|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93181642|NCT02528279|Antimalarials|antimalarials|mesh-ancestor
93181643|NCT02528279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93181644|NCT02528279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93181645|NCT02528279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181646|NCT01238627|Nicotine|nicotine|mesh-list
93366318|NCT02058485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92853815|NCT00887354|Vitamin D|vitamin d|mesh-list
93181647|NCT01238627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93181648|NCT01238627|Autonomic Agents|autonomic agents|mesh-ancestor
93181649|NCT01238627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181650|NCT01238627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181651|NCT01238627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93181652|NCT01238627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93181653|NCT01238627|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181654|NCT01238627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181655|NCT01238627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181656|NCT01321021|Diphenhydramine|diphenhydramine|mesh-list
93181657|NCT01321021|Promethazine|promethazine|mesh-list
93181658|NCT01321021|Losartan|losartan|mesh-list
93181659|NCT01321021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181660|NCT01321021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93181661|NCT01321021|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93181662|NCT01321021|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93181663|NCT01321021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181664|NCT01321021|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93181665|NCT01321021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93181666|NCT01321021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181667|NCT01321021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181668|NCT01321021|Anesthetics, Local|anesthetics, local|mesh-ancestor
93181669|NCT01321021|Anesthetics|anesthetics|mesh-ancestor
93181670|NCT01321021|Sensory System Agents|sensory system agents|mesh-ancestor
93181671|NCT01321021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181672|NCT01321021|Antiemetics|antiemetics|mesh-ancestor
93181673|NCT01321021|Autonomic Agents|autonomic agents|mesh-ancestor
93181674|NCT01321021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93181675|NCT01321021|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93181676|NCT01321021|Histamine Antagonists|histamine antagonists|mesh-ancestor
93181677|NCT01321021|Histamine Agents|histamine agents|mesh-ancestor
93181678|NCT01321021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181679|NCT01321021|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93181680|NCT01321021|Antipruritics|antipruritics|mesh-ancestor
93181681|NCT01321021|Dermatologic Agents|dermatologic agents|mesh-ancestor
93181682|NCT01238705|Metoprolol|metoprolol|mesh-list
93181683|NCT01238705|Felodipine|felodipine|mesh-list
93181684|NCT01238705|Irbesartan|irbesartan|mesh-list
93181685|NCT01238705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181686|NCT01238705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93181687|NCT01238705|Sympatholytics|sympatholytics|mesh-ancestor
93181688|NCT01238705|Autonomic Agents|autonomic agents|mesh-ancestor
93181689|NCT01238705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181690|NCT01238705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181691|NCT01238705|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93181692|NCT01238705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93181693|NCT01238705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93181694|NCT01238705|Adrenergic Agents|adrenergic agents|mesh-ancestor
93181695|NCT01238705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181696|NCT01238705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181697|NCT01238705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93181698|NCT01238705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93181699|NCT01238705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93181700|NCT01238705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93181701|NCT01238705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93181702|NCT01238705|Vasodilator Agents|vasodilator agents|mesh-ancestor
93181703|NCT03779347|Praziquantel|praziquantel|mesh-list
93181704|NCT03779347|Anthelmintics|anthelmintics|mesh-ancestor
93181705|NCT03779347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93181706|NCT03779347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181707|NCT01321099|Fe(III)-EDTA|fe(iii)-edta|mesh-list
93181708|NCT01321099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181709|NCT01321099|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93181710|NCT01321099|Chelating Agents|chelating agents|mesh-ancestor
93181711|NCT01321099|Sequestering Agents|sequestering agents|mesh-ancestor
93181712|NCT01245725|Tirofiban|tirofiban|mesh-list
93181713|NCT01245725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93181714|NCT01245725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93181715|NCT01245725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928472|NCT02403687|Bupivacaine|bupivacaine|mesh-list
93181716|NCT01245725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93181717|NCT01143545|Celecoxib|celecoxib|mesh-list
93181718|NCT01143545|Cyclophosphamide|cyclophosphamide|mesh-list
93181719|NCT01143545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181720|NCT01143545|Immunologic Factors|immunologic factors|mesh-ancestor
93181721|NCT01143545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181722|NCT01143545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181723|NCT01143545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93181724|NCT01143545|Alkylating Agents|alkylating agents|mesh-ancestor
93181725|NCT01143545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181726|NCT01143545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181727|NCT01143545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93181728|NCT01143545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93181729|NCT01143545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181730|NCT01143545|Analgesics|analgesics|mesh-ancestor
93181731|NCT01143545|Sensory System Agents|sensory system agents|mesh-ancestor
93181732|NCT01143545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181733|NCT01143545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181734|NCT01143545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93181735|NCT01143545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93181736|NCT01143545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181737|NCT03779035|Gemcitabine|gemcitabine|mesh-list
93181738|NCT03779035|Capecitabine|capecitabine|mesh-list
93181739|NCT03779035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181740|NCT03779035|Antimetabolites|antimetabolites|mesh-ancestor
93181741|NCT03779035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181742|NCT03779035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181743|NCT01586117|Amifostine|amifostine|mesh-list
93181744|NCT01586117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93181745|NCT01586117|Protective Agents|protective agents|mesh-ancestor
93181746|NCT01586117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181747|NCT03301415|Valganciclovir|valganciclovir|mesh-list
93181748|NCT03301415|Antiviral Agents|antiviral agents|mesh-ancestor
93181749|NCT03301415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181750|NCT05449015|Atropine|atropine|mesh-list
93181751|NCT05449015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93181752|NCT05449015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181753|NCT05449015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93181754|NCT05449015|Autonomic Agents|autonomic agents|mesh-ancestor
93181755|NCT05449015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181756|NCT05449015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181757|NCT05449015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93181758|NCT05449015|Respiratory System Agents|respiratory system agents|mesh-ancestor
93181759|NCT05449015|Mydriatics|mydriatics|mesh-ancestor
93181760|NCT05449015|Parasympatholytics|parasympatholytics|mesh-ancestor
93181761|NCT05449015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93181762|NCT05449015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93181763|NCT05449015|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181764|NCT05449015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181765|NCT05449015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181766|NCT01239017|Fasinumab|fasinumab|mesh-list
93181767|NCT01239017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181768|NCT01239017|Analgesics|analgesics|mesh-ancestor
93181769|NCT01239017|Sensory System Agents|sensory system agents|mesh-ancestor
93181770|NCT01239017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181771|NCT01239017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181772|NCT02732938|Paclitaxel|paclitaxel|mesh-list
93181773|NCT02732938|Gemcitabine|gemcitabine|mesh-list
93181774|NCT02732938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93181775|NCT02732938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181776|NCT02732938|Tubulin Modulators|tubulin modulators|mesh-ancestor
93181777|NCT02732938|Antimitotic Agents|antimitotic agents|mesh-ancestor
93181778|NCT02732938|Mitosis Modulators|mitosis modulators|mesh-ancestor
93181779|NCT02732938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181780|NCT02732938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181781|NCT02732938|Antimetabolites|antimetabolites|mesh-ancestor
93181782|NCT03778723|Fentanyl|fentanyl|mesh-list
93181783|NCT03778723|Anesthetics|anesthetics|mesh-list
93181784|NCT03778723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181785|NCT03778723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181786|NCT03778723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93181787|NCT03778723|Narcotics|narcotics|mesh-ancestor
93181788|NCT03778723|Analgesics|analgesics|mesh-ancestor
93181789|NCT03778723|Sensory System Agents|sensory system agents|mesh-ancestor
93181790|NCT03778723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181791|NCT03778723|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93181792|NCT03778723|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93181793|NCT03778723|Anesthetics, General|anesthetics, general|mesh-ancestor
93181794|NCT01245959|Cisplatin|cisplatin|mesh-list
93181795|NCT01245959|Docetaxel|docetaxel|mesh-list
93181796|NCT01245959|Fluorouracil|fluorouracil|mesh-list
93181797|NCT01245959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181798|NCT01245959|Tubulin Modulators|tubulin modulators|mesh-ancestor
93181799|NCT01245959|Antimitotic Agents|antimitotic agents|mesh-ancestor
93181800|NCT01245959|Mitosis Modulators|mitosis modulators|mesh-ancestor
93181801|NCT01245959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181802|NCT01245959|Antimetabolites|antimetabolites|mesh-ancestor
93181803|NCT01245959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181804|NCT01245959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181805|NCT01245959|Immunologic Factors|immunologic factors|mesh-ancestor
93181806|NCT01245959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181807|NCT03778645|Epinephrine|epinephrine|mesh-list
93181808|NCT03778645|Racepinephrine|racepinephrine|mesh-list
93181809|NCT03778645|Epinephryl borate|epinephryl borate|mesh-list
93181810|NCT03778645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93181811|NCT03778645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93181812|NCT03778645|Adrenergic Agents|adrenergic agents|mesh-ancestor
93181813|NCT03778645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181814|NCT03778645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181815|NCT03778645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181816|NCT03778645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93181817|NCT03778645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93181818|NCT03778645|Autonomic Agents|autonomic agents|mesh-ancestor
93181819|NCT03778645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181820|NCT03778645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93181821|NCT03778645|Respiratory System Agents|respiratory system agents|mesh-ancestor
93181822|NCT03778645|Mydriatics|mydriatics|mesh-ancestor
93181823|NCT03778645|Sympathomimetics|sympathomimetics|mesh-ancestor
93181824|NCT03778645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93181825|NCT04326478|Azithromycin|azithromycin|mesh-list
93181826|NCT04326478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93181827|NCT04326478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181828|NCT04647721|Hyaluronic Acid|hyaluronic acid|mesh-list
93181829|NCT04647721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181830|NCT04647721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93181831|NCT04647721|Immunologic Factors|immunologic factors|mesh-ancestor
93181832|NCT04647721|Viscosupplements|viscosupplements|mesh-ancestor
93181833|NCT04647721|Protective Agents|protective agents|mesh-ancestor
93181834|NCT03470038|Mitogens|mitogens|mesh-list
93181835|NCT03470038|Mitosis Modulators|mitosis modulators|mesh-ancestor
93181836|NCT03470038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181837|NCT03250325|Cyclophosphamide|cyclophosphamide|mesh-list
93181838|NCT03250325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93181839|NCT03250325|Immunologic Factors|immunologic factors|mesh-ancestor
93181840|NCT03250325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181841|NCT03250325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181842|NCT03250325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93181843|NCT03250325|Alkylating Agents|alkylating agents|mesh-ancestor
93181844|NCT03250325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181845|NCT03250325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181846|NCT03250325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93181847|NCT03778567|Lamivudine|lamivudine|mesh-list
93181848|NCT03778567|Telbivudine|telbivudine|mesh-list
93181849|NCT03778567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93181850|NCT03778567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93181851|NCT03778567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181852|NCT03778567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181853|NCT03778567|Antiviral Agents|antiviral agents|mesh-ancestor
93181854|NCT03778567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181855|NCT03778567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93181856|NCT03778567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93181857|NCT03784066|Durvalumab|durvalumab|mesh-list
93181858|NCT03784066|Tremelimumab|tremelimumab|mesh-list
93181859|NCT03784066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93181860|NCT03784066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181861|NCT03784066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181862|NCT03784066|Immunologic Factors|immunologic factors|mesh-ancestor
93181863|NCT03784066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181864|NCT05168683|Rasburicase|rasburicase|mesh-list
93181865|NCT05168683|Uric Acid|uric acid|mesh-list
93181866|NCT05168683|Antioxidants|antioxidants|mesh-ancestor
93181867|NCT05168683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181868|NCT05168683|Protective Agents|protective agents|mesh-ancestor
93181869|NCT05168683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181870|NCT05168683|Gout Suppressants|gout suppressants|mesh-ancestor
93181871|NCT05168683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181872|NCT03113123|Tenofovir|tenofovir|mesh-list
93181873|NCT03113123|Emtricitabine|emtricitabine|mesh-list
93181874|NCT03113123|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93181875|NCT03113123|Antiviral Agents|antiviral agents|mesh-ancestor
93181876|NCT03113123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181877|NCT03113123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93181878|NCT03113123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93181879|NCT03113123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181880|NCT03113123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181881|NCT03113123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93181882|NCT03113123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93181883|NCT04451122|Tea Tree Oil|tea tree oil|mesh-list
93181884|NCT04451122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93181885|NCT04451122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181886|NCT01143857|Varenicline|varenicline|mesh-list
93181887|NCT01143857|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93181888|NCT01143857|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93181889|NCT01143857|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181890|NCT01143857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181891|NCT01143857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181892|NCT01143857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181893|NCT05159284|Hydrocortisone|hydrocortisone|mesh-list
93181894|NCT05159284|Lubricant Eye Drops|lubricant eye drops|mesh-list
93181895|NCT05159284|Hyaluronic Acid|hyaluronic acid|mesh-list
93181896|NCT05159284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181897|NCT05159284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93181898|NCT05159284|Immunologic Factors|immunologic factors|mesh-ancestor
93181899|NCT05159284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181900|NCT05159284|Viscosupplements|viscosupplements|mesh-ancestor
93181901|NCT05159284|Protective Agents|protective agents|mesh-ancestor
93181902|NCT05159284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93181903|NCT05159284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93181904|NCT01239173|Propranolol|propranolol|mesh-list
93181905|NCT01239173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93181906|NCT01239173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93181907|NCT01239173|Adrenergic Agents|adrenergic agents|mesh-ancestor
93181908|NCT01239173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181909|NCT01239173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181910|NCT01239173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181911|NCT01239173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181912|NCT01239173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93181913|NCT01239173|Vasodilator Agents|vasodilator agents|mesh-ancestor
93181914|NCT03063203|Decitabine|decitabine|mesh-list
93181915|NCT03063203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93181916|NCT03063203|Antimetabolites|antimetabolites|mesh-ancestor
93181917|NCT03063203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181918|NCT03063203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181919|NCT03063203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181920|NCT03435094|Alendronate|alendronate|mesh-list
93181921|NCT03435094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93181922|NCT03435094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181923|NCT03772483|Anesthetics|anesthetics|mesh-list
93181924|NCT03772483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93181925|NCT03772483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181926|NCT01236911|Calcium|calcium|mesh-list
93181927|NCT01236911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93181928|NCT01236911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181929|NCT03772561|Durvalumab|durvalumab|mesh-list
93181930|NCT03772561|Olaparib|olaparib|mesh-list
93181931|NCT03772561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93181932|NCT03772561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181933|NCT03772561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93181934|NCT03772561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181935|NCT03772561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181936|NCT01239485|Irinotecan|irinotecan|mesh-list
93181937|NCT01239485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93181938|NCT01239485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93181939|NCT01239485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181940|NCT01239485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181941|NCT01239485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181942|NCT01146041|Rivastigmine|rivastigmine|mesh-list
93181943|NCT01146041|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93181944|NCT01146041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93181945|NCT01146041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181946|NCT01146041|Cholinergic Agents|cholinergic agents|mesh-ancestor
93181947|NCT01146041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93181948|NCT01146041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181949|NCT01146041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93181950|NCT01146041|Protective Agents|protective agents|mesh-ancestor
93181951|NCT04450576|Chrysarobin|chrysarobin|mesh-list
93181952|NCT04450576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93181953|NCT04450576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93181954|NCT04450576|Analgesics|analgesics|mesh-ancestor
93181955|NCT04450576|Sensory System Agents|sensory system agents|mesh-ancestor
93181956|NCT04450576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181957|NCT04450576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181958|NCT04450576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93181959|NCT04450576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93181960|NCT03430180|Naloxone|naloxone|mesh-list
93181961|NCT03430180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93181962|NCT03430180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181963|NCT03430180|Sensory System Agents|sensory system agents|mesh-ancestor
93181964|NCT03430180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181965|NCT03777787|Denatonium|denatonium|mesh-list
93181966|NCT03777787|Aversive Agents|aversive agents|mesh-ancestor
93181967|NCT03777787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181968|NCT03777787|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
93181969|NCT03777787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181970|NCT03777787|Sensory System Agents|sensory system agents|mesh-ancestor
93181971|NCT03777787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93181972|NCT03430024|Estrogens|estrogens|mesh-list
93181973|NCT03430024|Hormones|hormones|mesh-ancestor
93181974|NCT03430024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93181975|NCT03430024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181976|NCT03434782|Listerine|listerine|mesh-list
93181977|NCT03434782|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93181978|NCT03434782|Fluorides|fluorides|mesh-list
93181979|NCT03434782|Sodium Fluoride|sodium fluoride|mesh-list
93181980|NCT03434782|Cariostatic Agents|cariostatic agents|mesh-ancestor
93181981|NCT03434782|Protective Agents|protective agents|mesh-ancestor
93181982|NCT03434782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93181983|NCT03434782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93181984|NCT03434782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93181985|NCT01320397|Losartan|losartan|mesh-list
93181986|NCT01320397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93181987|NCT01320397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93181988|NCT01320397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93181989|NCT01320397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93181990|NCT01320397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181991|NCT03434704|Antifungal Agents|antifungal agents|mesh-list
93181992|NCT03434704|Clotrimazole|clotrimazole|mesh-list
93181993|NCT03434704|Miconazole|miconazole|mesh-list
93181994|NCT03434704|Fludarabine|fludarabine|mesh-list
93181995|NCT03434704|Thiotepa|thiotepa|mesh-list
93181996|NCT03434704|Treosulfan|treosulfan|mesh-list
93181997|NCT03434704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93181998|NCT03434704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93181999|NCT03434704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182000|NCT03434704|Immunologic Factors|immunologic factors|mesh-ancestor
93182001|NCT03434704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182002|NCT03434704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93182003|NCT03434704|Alkylating Agents|alkylating agents|mesh-ancestor
93182004|NCT03434704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93182005|NCT03434704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182006|NCT03434704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93182007|NCT03434704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93182008|NCT03434704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93182009|NCT03434704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182010|NCT03434704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93182011|NCT03434704|Hormone Antagonists|hormone antagonists|mesh-ancestor
93182012|NCT03434704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182013|NCT03434704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93182014|NCT03434704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93182015|NCT02521636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93182016|NCT02521636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182017|NCT04779151|Niraparib|niraparib|mesh-list
93182018|NCT04779151|Dostarlimab|dostarlimab|mesh-list
93182019|NCT04779151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93182020|NCT04779151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182021|NCT04779151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366319|NCT02058485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92854198|NCT00792909|Vaccines|vaccines|mesh-list
93182022|NCT04779151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182023|NCT02891226|Mirikizumab|mirikizumab|mesh-list
93182024|NCT02891226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93182025|NCT02891226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93182026|NCT02891226|Analgesics|analgesics|mesh-ancestor
93182027|NCT02891226|Sensory System Agents|sensory system agents|mesh-ancestor
93182028|NCT02891226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182029|NCT02891226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182030|NCT02891226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182031|NCT02891226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182032|NCT02891226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93182033|NCT02891226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93182034|NCT03771781|Empagliflozin|empagliflozin|mesh-list
93182035|NCT03771781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93182036|NCT03771781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182037|NCT03771781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93182038|NCT03771781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182039|NCT04140721|Moxonidine|moxonidine|mesh-list
93182040|NCT04140721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93182041|NCT03224104|Temozolomide|temozolomide|mesh-list
93182042|NCT03224104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93182043|NCT03224104|Alkylating Agents|alkylating agents|mesh-ancestor
93182044|NCT03224104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182045|NCT03224104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182046|NCT01320475|Sufentanil|sufentanil|mesh-list
93182047|NCT01320475|Ketamine|ketamine|mesh-list
93182048|NCT01320475|Analgesics|analgesics|mesh-ancestor
93182049|NCT01320475|Sensory System Agents|sensory system agents|mesh-ancestor
93182050|NCT01320475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182051|NCT01320475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182052|NCT01320475|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93182053|NCT01320475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93182054|NCT01320475|Anesthetics, General|anesthetics, general|mesh-ancestor
93182055|NCT01320475|Anesthetics|anesthetics|mesh-ancestor
93182056|NCT01320475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182057|NCT01320475|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93182058|NCT01320475|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93182059|NCT01320475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182060|NCT01320475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182061|NCT01320475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93182062|NCT01320475|Narcotics|narcotics|mesh-ancestor
93182063|NCT01320475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93182064|NCT05177406|Erenumab|erenumab|mesh-list
93182065|NCT05177406|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93182066|NCT05177406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182067|NCT05177406|Analgesics|analgesics|mesh-ancestor
93182068|NCT05177406|Sensory System Agents|sensory system agents|mesh-ancestor
93182069|NCT05177406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182070|NCT05177406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182071|NCT02521246|Losartan|losartan|mesh-list
93182072|NCT02521246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93182073|NCT02521246|Candesartan|candesartan|mesh-list
93182074|NCT02521246|Candesartan cilexetil|candesartan cilexetil|mesh-list
93182075|NCT02521246|Chlorthalidone|chlorthalidone|mesh-list
93182076|NCT02521246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93182077|NCT02521246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93182078|NCT02521246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93182079|NCT02521246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93182080|NCT02521246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182081|NCT02521246|Diuretics|diuretics|mesh-ancestor
93182082|NCT02521246|Natriuretic Agents|natriuretic agents|mesh-ancestor
93182083|NCT02521246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182084|NCT02521246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93182085|NCT02521246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93182086|NCT05309070|Acetylcysteine|acetylcysteine|mesh-list
93182087|NCT05309070|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93182088|NCT05309070|Antiviral Agents|antiviral agents|mesh-ancestor
93182089|NCT05309070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182090|NCT05309070|Expectorants|expectorants|mesh-ancestor
93182091|NCT05309070|Respiratory System Agents|respiratory system agents|mesh-ancestor
93182092|NCT05309070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93182093|NCT05309070|Antioxidants|antioxidants|mesh-ancestor
93182094|NCT05309070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182095|NCT05309070|Protective Agents|protective agents|mesh-ancestor
93182096|NCT05309070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182098|NCT04763928|Decitabine|decitabine|mesh-list
93182099|NCT04763928|Venetoclax|venetoclax|mesh-list
93182100|NCT04763928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93182101|NCT04763928|Antimetabolites|antimetabolites|mesh-ancestor
93182102|NCT04763928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182103|NCT04763928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182104|NCT04763928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182105|NCT01567501|Cetirizine|cetirizine|mesh-list
93182106|NCT01567501|Levocetirizine|levocetirizine|mesh-list
93182107|NCT01567501|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93182108|NCT01567501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93182109|NCT01567501|Histamine Antagonists|histamine antagonists|mesh-ancestor
93182110|NCT01567501|Histamine Agents|histamine agents|mesh-ancestor
93182111|NCT01567501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182112|NCT01567501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182113|NCT01567501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182114|NCT01567501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93182115|NCT01321957|Bevacizumab|bevacizumab|mesh-list
93182116|NCT01321957|Oxaliplatin|oxaliplatin|mesh-list
93182117|NCT01321957|Irinotecan|irinotecan|mesh-list
93182118|NCT01321957|Fluorouracil|fluorouracil|mesh-list
93182119|NCT01321957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182120|NCT01321957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182121|NCT01321957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93182122|NCT01321957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93182123|NCT01321957|Growth Substances|growth substances|mesh-ancestor
93182124|NCT01321957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182125|NCT01321957|Growth Inhibitors|growth inhibitors|mesh-ancestor
93182126|NCT01321957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93182127|NCT01321957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93182128|NCT01321957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182129|NCT01321957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182130|NCT01321957|Antimetabolites|antimetabolites|mesh-ancestor
93182131|NCT01321957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93182132|NCT01321957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182133|NCT01321957|Immunologic Factors|immunologic factors|mesh-ancestor
93182134|NCT05363592|Metformin|metformin|mesh-list
93182135|NCT05363592|Alogliptin|alogliptin|mesh-list
93182136|NCT05363592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93182137|NCT05363592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182138|NCT05363592|Incretins|incretins|mesh-ancestor
93182139|NCT05363592|Hormones|hormones|mesh-ancestor
93182140|NCT05363592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182141|NCT05363592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93182142|NCT05363592|Protease Inhibitors|protease inhibitors|mesh-ancestor
93182143|NCT05363592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182144|NCT05363592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182145|NCT03708211|Esomeprazole|esomeprazole|mesh-list
93182146|NCT03708211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93182147|NCT03708211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93182148|NCT03708211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93182149|NCT03708211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182150|NCT03708211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182151|NCT03770923|Montelukast|montelukast|mesh-list
93182152|NCT03770923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93182153|NCT03770923|Respiratory System Agents|respiratory system agents|mesh-ancestor
93182154|NCT03770923|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93182155|NCT03770923|Hormone Antagonists|hormone antagonists|mesh-ancestor
93182156|NCT03770923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182157|NCT03770923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182158|NCT03770923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93182159|NCT03770923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93182160|NCT03770923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182161|NCT03433534|Nivolumab|nivolumab|mesh-list
93182162|NCT03433534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182163|NCT03433534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182164|NCT03433534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93182165|NCT03433534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182166|NCT05445895|Clopidogrel|clopidogrel|mesh-list
93182167|NCT05445895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93182168|NCT05445895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93182169|NCT05445895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93182170|NCT05445895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93182171|NCT05445895|Purinergic Agents|purinergic agents|mesh-ancestor
93182172|NCT05445895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182173|NCT05445895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182174|NCT05445895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182175|NCT03367299|Blinatumomab|blinatumomab|mesh-list
93182176|NCT03367299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182177|NCT04449952|Listerine|listerine|mesh-list
93182178|NCT04449952|Sodium Fluoride|sodium fluoride|mesh-list
93182179|NCT04449952|Cariostatic Agents|cariostatic agents|mesh-ancestor
93182180|NCT04449952|Protective Agents|protective agents|mesh-ancestor
93182181|NCT04449952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182182|NCT04449952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93182183|NCT04449952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182184|NCT03705793|Mometasone Furoate|mometasone furoate|mesh-list
93182185|NCT03705793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182186|NCT03705793|Dermatologic Agents|dermatologic agents|mesh-ancestor
93182187|NCT03705793|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93182188|NCT04449718|Vitamin D|vitamin d|mesh-list
93182189|NCT04449718|Vitamins|vitamins|mesh-ancestor
93182190|NCT04449718|Micronutrients|micronutrients|mesh-ancestor
93182191|NCT04449718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182192|NCT04449718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93182193|NCT03763279|Triclosan|triclosan|mesh-list
93182194|NCT03763279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93182195|NCT03763279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182196|NCT03763279|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93182197|NCT03763279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93182198|NCT03763279|Antimetabolites|antimetabolites|mesh-ancestor
93182199|NCT03763279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182200|NCT03763279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93182201|NCT03638037|Vitamin D|vitamin d|mesh-list
93182202|NCT03638037|Vitamins|vitamins|mesh-ancestor
93182203|NCT03638037|Micronutrients|micronutrients|mesh-ancestor
93182204|NCT03638037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182205|NCT03638037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93182206|NCT03763123|Paclitaxel|paclitaxel|mesh-list
93182207|NCT03763123|Topotecan|topotecan|mesh-list
93182208|NCT03763123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93182209|NCT03763123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182210|NCT03763123|Tubulin Modulators|tubulin modulators|mesh-ancestor
93182211|NCT03763123|Antimitotic Agents|antimitotic agents|mesh-ancestor
93182212|NCT03763123|Mitosis Modulators|mitosis modulators|mesh-ancestor
93182213|NCT03763123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182214|NCT03763123|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93182215|NCT03763123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93182216|NCT03763123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182217|NCT03429400|Morphine|morphine|mesh-list
93182218|NCT03429400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93182219|NCT03429400|Narcotics|narcotics|mesh-ancestor
93182220|NCT03429400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182221|NCT03429400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182222|NCT03429400|Analgesics|analgesics|mesh-ancestor
93182223|NCT03429400|Sensory System Agents|sensory system agents|mesh-ancestor
93182224|NCT03429400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182225|NCT03429010|Anesthetics|anesthetics|mesh-list
93182226|NCT03429010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182227|NCT03429010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182228|NCT02944656|Gabapentin|gabapentin|mesh-list
93182229|NCT02944656|Analgesics|analgesics|mesh-ancestor
93182230|NCT02944656|Sensory System Agents|sensory system agents|mesh-ancestor
93182231|NCT02944656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182232|NCT02944656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182233|NCT02944656|Anticonvulsants|anticonvulsants|mesh-ancestor
93182234|NCT02944656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93182235|NCT02944656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93182236|NCT02944656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182237|NCT02944656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182238|NCT02944656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93182239|NCT02944656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93182240|NCT02944656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182241|NCT02944656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182242|NCT02944656|Antimanic Agents|antimanic agents|mesh-ancestor
93182243|NCT02713529|Pembrolizumab|pembrolizumab|mesh-list
93182244|NCT02713529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182245|NCT02713529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182246|NCT02713529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93182247|NCT02713529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182248|NCT03763045|Sildenafil Citrate|sildenafil citrate|mesh-list
93182249|NCT03763045|Vasodilator Agents|vasodilator agents|mesh-ancestor
93182250|NCT03763045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93182251|NCT03763045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93182252|NCT03763045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182253|NCT03763045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182254|NCT03763045|Urological Agents|urological agents|mesh-ancestor
93182255|NCT01321489|Sildenafil Citrate|sildenafil citrate|mesh-list
93182256|NCT01321489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182257|NCT01321489|Vasodilator Agents|vasodilator agents|mesh-ancestor
93182258|NCT01321489|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93182259|NCT01321489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93182260|NCT01321489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182261|NCT01321489|Urological Agents|urological agents|mesh-ancestor
93182262|NCT04800627|Pembrolizumab|pembrolizumab|mesh-list
93182263|NCT04800627|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93182264|NCT04800627|Pevonedistat|pevonedistat|mesh-list
93182265|NCT04800627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182266|NCT04800627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182267|NCT04800627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93182268|NCT04800627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182269|NCT05308602|Vaccines|vaccines|mesh-list
93182270|NCT05308602|Immunologic Factors|immunologic factors|mesh-ancestor
93182271|NCT05308602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182272|NCT03768037|Pemetrexed|pemetrexed|mesh-list
93182273|NCT03768037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182274|NCT03768037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182275|NCT03768037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182276|NCT03768037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93182277|NCT03768037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93182278|NCT01146977|Cytarabine|cytarabine|mesh-list
93182279|NCT01146977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93182280|NCT01146977|Antimetabolites|antimetabolites|mesh-ancestor
93182281|NCT01146977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182282|NCT01146977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182283|NCT01146977|Antiviral Agents|antiviral agents|mesh-ancestor
93182284|NCT01146977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182285|NCT01146977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182286|NCT01146977|Immunologic Factors|immunologic factors|mesh-ancestor
93182287|NCT01146977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182288|NCT03762967|Hormones|hormones|mesh-list
93182289|NCT03762967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182290|NCT03762967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182291|NCT03762889|Anesthetics|anesthetics|mesh-list
93182292|NCT03762889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182293|NCT03762889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182294|NCT03746041|Abaloparatide|abaloparatide|mesh-list
93182295|NCT03746041|Bevacizumab|bevacizumab|mesh-list
93182296|NCT03746041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182297|NCT03746041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182298|NCT03746041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93182299|NCT03746041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93182300|NCT03746041|Growth Substances|growth substances|mesh-ancestor
93182301|NCT03746041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182302|NCT03746041|Growth Inhibitors|growth inhibitors|mesh-ancestor
93182303|NCT03746041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93182304|NCT01236989|Liver Extracts|liver extracts|mesh-list
93182305|NCT01236989|Hematinics|hematinics|mesh-ancestor
93182306|NCT03423472|Vitamin A|vitamin a|mesh-list
93182307|NCT03423472|Vitamins|vitamins|mesh-ancestor
93182308|NCT03423472|Micronutrients|micronutrients|mesh-ancestor
93182309|NCT03423472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182310|NCT01239563|Thymoglobulin|thymoglobulin|mesh-list
93182311|NCT01239563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93182312|NCT01239563|Basiliximab|basiliximab|mesh-list
93182313|NCT01239563|Immunologic Factors|immunologic factors|mesh-ancestor
93182314|NCT01239563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182315|NCT01239563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182316|NCT01321255|Aspirin|aspirin|mesh-list
93182317|NCT01321255|Ramipril|ramipril|mesh-list
93182318|NCT01321255|Simvastatin|simvastatin|mesh-list
93182319|NCT01321255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93182321|NCT01321255|Analgesics|analgesics|mesh-ancestor
93182322|NCT01321255|Sensory System Agents|sensory system agents|mesh-ancestor
93182323|NCT01321255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182324|NCT01321255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182325|NCT01321255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182326|NCT01321255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182327|NCT01321255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93182328|NCT01321255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93182329|NCT01321255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182330|NCT01321255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93182331|NCT01321255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93182332|NCT01321255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182333|NCT01321255|Antipyretics|antipyretics|mesh-ancestor
93182334|NCT01321255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93182335|NCT01321255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93182336|NCT01321255|Antimetabolites|antimetabolites|mesh-ancestor
93182337|NCT01321255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93182338|NCT01321255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93182339|NCT01321255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93182340|NCT01321255|Protease Inhibitors|protease inhibitors|mesh-ancestor
93182341|NCT01321255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93182342|NCT01883297|Aldesleukin|aldesleukin|mesh-list
93182343|NCT01883297|Cyclophosphamide|cyclophosphamide|mesh-list
93182344|NCT01883297|Interleukin-2|interleukin-2|mesh-list
93182345|NCT01883297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182346|NCT01883297|Immunologic Factors|immunologic factors|mesh-ancestor
93182347|NCT01883297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182348|NCT01883297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182349|NCT01883297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93182350|NCT01883297|Alkylating Agents|alkylating agents|mesh-ancestor
93182351|NCT01883297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182352|NCT01883297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182353|NCT01883297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93182354|NCT01883297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93182355|NCT01883297|Analgesics|analgesics|mesh-ancestor
93182356|NCT01883297|Sensory System Agents|sensory system agents|mesh-ancestor
93182357|NCT01883297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182358|NCT01883297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93182359|NCT01883297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93182360|NCT01883297|Antiviral Agents|antiviral agents|mesh-ancestor
93182361|NCT01883297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182362|NCT04546581|Remdesivir|remdesivir|mesh-list
93182363|NCT04546581|Immunoglobulins|immunoglobulins|mesh-list
93182364|NCT04546581|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93182365|NCT04546581|Antibodies|antibodies|mesh-list
93182366|NCT04546581|Immunologic Factors|immunologic factors|mesh-ancestor
93182367|NCT04546581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182368|NCT04546581|Antimetabolites|antimetabolites|mesh-ancestor
93182369|NCT04546581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182370|NCT04546581|Antiviral Agents|antiviral agents|mesh-ancestor
93182371|NCT04546581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182372|NCT02204254|Doxycycline|doxycycline|mesh-list
93182373|NCT02204254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93182374|NCT02204254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182375|NCT02204254|Antimalarials|antimalarials|mesh-ancestor
93182376|NCT02204254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93182377|NCT02204254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93182378|NCT03417076|Bexagliflozin|bexagliflozin|mesh-list
93182379|NCT03417076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93182380|NCT03417076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182381|NCT05294172|Cisplatin|cisplatin|mesh-list
93182382|NCT05294172|Gemcitabine|gemcitabine|mesh-list
93182383|NCT05294172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182384|NCT05294172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93182385|NCT05294172|Antimetabolites|antimetabolites|mesh-ancestor
93182386|NCT05294172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182387|NCT03164655|Leucovorin|leucovorin|mesh-list
93182388|NCT03164655|Bevacizumab|bevacizumab|mesh-list
93182389|NCT03164655|Cetuximab|cetuximab|mesh-list
93182390|NCT03164655|Panitumumab|panitumumab|mesh-list
93182391|NCT03164655|Fluorouracil|fluorouracil|mesh-list
93182392|NCT03164655|Oxaliplatin|oxaliplatin|mesh-list
93182393|NCT03164655|Irinotecan|irinotecan|mesh-list
93182394|NCT03164655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182395|NCT03164655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182396|NCT03164655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93182397|NCT03164655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93182398|NCT03164655|Growth Substances|growth substances|mesh-ancestor
93182399|NCT03164655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182400|NCT03164655|Growth Inhibitors|growth inhibitors|mesh-ancestor
93182401|NCT03164655|Antimetabolites|antimetabolites|mesh-ancestor
93182402|NCT03164655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182403|NCT03164655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93182404|NCT03164655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182405|NCT03164655|Immunologic Factors|immunologic factors|mesh-ancestor
93182406|NCT03164655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93182407|NCT03164655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93182408|NCT03164655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182409|NCT03164655|Antidotes|antidotes|mesh-ancestor
93182410|NCT03164655|Protective Agents|protective agents|mesh-ancestor
93182411|NCT03164655|Vitamin B Complex|vitamin b complex|mesh-ancestor
93182412|NCT03164655|Vitamins|vitamins|mesh-ancestor
93182413|NCT03164655|Micronutrients|micronutrients|mesh-ancestor
93182414|NCT02561273|Prednisone|prednisone|mesh-list
93182415|NCT02561273|Cortisone|cortisone|mesh-list
93182416|NCT02561273|Cyclophosphamide|cyclophosphamide|mesh-list
93182417|NCT02561273|Doxorubicin|doxorubicin|mesh-list
93182418|NCT02561273|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93182419|NCT02561273|Etoposide|etoposide|mesh-list
93182420|NCT02561273|Vincristine|vincristine|mesh-list
93182421|NCT02561273|Lenalidomide|lenalidomide|mesh-list
93182422|NCT02561273|Etoposide phosphate|etoposide phosphate|mesh-list
93182423|NCT02561273|Podophyllotoxin|podophyllotoxin|mesh-list
93182424|NCT02561273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182425|NCT02561273|Immunologic Factors|immunologic factors|mesh-ancestor
93182426|NCT02561273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182427|NCT02561273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182428|NCT02561273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93182429|NCT02561273|Alkylating Agents|alkylating agents|mesh-ancestor
93182430|NCT02561273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182431|NCT02561273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182432|NCT02561273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93182433|NCT02561273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93182434|NCT02561273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93182435|NCT02561273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93182436|NCT02561273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182437|NCT02561273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182438|NCT02561273|Glucocorticoids|glucocorticoids|mesh-ancestor
93182439|NCT02561273|Hormones|hormones|mesh-ancestor
93182440|NCT02561273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182441|NCT02561273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93182442|NCT02561273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93182443|NCT02561273|Tubulin Modulators|tubulin modulators|mesh-ancestor
93182444|NCT02561273|Antimitotic Agents|antimitotic agents|mesh-ancestor
93182445|NCT02561273|Mitosis Modulators|mitosis modulators|mesh-ancestor
93182446|NCT02561273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93182447|NCT02561273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93182448|NCT02561273|Growth Substances|growth substances|mesh-ancestor
93182449|NCT02561273|Growth Inhibitors|growth inhibitors|mesh-ancestor
93182450|NCT02561273|Keratolytic Agents|keratolytic agents|mesh-ancestor
93182451|NCT02561273|Dermatologic Agents|dermatologic agents|mesh-ancestor
93182452|NCT02521012|Vitamin D|vitamin d|mesh-list
93182453|NCT02521012|Ergocalciferols|ergocalciferols|mesh-list
93182454|NCT02521012|Cholecalciferol|cholecalciferol|mesh-list
93182455|NCT02521012|Vitamins|vitamins|mesh-list
93182456|NCT02521012|Micronutrients|micronutrients|mesh-ancestor
93182457|NCT02521012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182458|NCT02521012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93182459|NCT02521012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93182460|NCT04756128|Colchicine|colchicine|mesh-list
93182461|NCT04756128|Naltrexone|naltrexone|mesh-list
93182462|NCT04756128|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93182463|NCT04756128|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93182464|NCT04756128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182465|NCT04756128|Sensory System Agents|sensory system agents|mesh-ancestor
93182466|NCT04756128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182467|NCT04756128|Gout Suppressants|gout suppressants|mesh-ancestor
93182468|NCT04756128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182469|NCT04756128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854643|NCT04268927|Hormones|hormones|mesh-ancestor
93182470|NCT04756128|Antimitotic Agents|antimitotic agents|mesh-ancestor
93182471|NCT04756128|Mitosis Modulators|mitosis modulators|mesh-ancestor
93182472|NCT04756128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182473|NCT04756128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182474|NCT03427216|Diazepam|diazepam|mesh-list
93182475|NCT03427216|Baclofen|baclofen|mesh-list
93182476|NCT03427216|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93182477|NCT03427216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182478|NCT03427216|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93182479|NCT03427216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182480|NCT03427216|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93182481|NCT03427216|GABA Agonists|gaba agonists|mesh-ancestor
93182482|NCT03427216|GABA Agents|gaba agents|mesh-ancestor
93182483|NCT03427216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182484|NCT03427216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182485|NCT03427216|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93182486|NCT03427216|Anticonvulsants|anticonvulsants|mesh-ancestor
93182487|NCT03427216|Antiemetics|antiemetics|mesh-ancestor
93182488|NCT03427216|Autonomic Agents|autonomic agents|mesh-ancestor
93182489|NCT03427216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93182490|NCT03427216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93182491|NCT03427216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182492|NCT03427216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93182493|NCT03427216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93182494|NCT03427216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182495|NCT03427216|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93182496|NCT03427216|Anesthetics, General|anesthetics, general|mesh-ancestor
93182497|NCT03427216|Anesthetics|anesthetics|mesh-ancestor
93182498|NCT03427216|GABA Modulators|gaba modulators|mesh-ancestor
93182499|NCT01144091|Pentoxifylline|pentoxifylline|mesh-list
93182500|NCT01144091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93182501|NCT01144091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182502|NCT01144091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182503|NCT01144091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93182504|NCT01144091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93182505|NCT01144091|Protective Agents|protective agents|mesh-ancestor
93182506|NCT01144091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182507|NCT01144091|Vasodilator Agents|vasodilator agents|mesh-ancestor
93182508|NCT01144091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93182509|NCT01144091|Antioxidants|antioxidants|mesh-ancestor
93182510|NCT02392559|Evolocumab|evolocumab|mesh-list
93182511|NCT02392559|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93182512|NCT02392559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93182513|NCT02392559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93182514|NCT02392559|Antimetabolites|antimetabolites|mesh-ancestor
93182515|NCT02392559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182516|NCT02392559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93182517|NCT02392559|Protease Inhibitors|protease inhibitors|mesh-ancestor
93182518|NCT02392559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182519|NCT02392559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93182520|NCT03332589|Dabrafenib|dabrafenib|mesh-list
93182521|NCT03332589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182522|NCT03332589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93182523|NCT03332589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182524|NCT03332589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182525|NCT03767569|Folic Acid|folic acid|mesh-list
93182526|NCT03767569|Inositol|inositol|mesh-list
93182527|NCT03767569|Hematinics|hematinics|mesh-ancestor
93182528|NCT03767569|Vitamin B Complex|vitamin b complex|mesh-ancestor
93182529|NCT03767569|Vitamins|vitamins|mesh-ancestor
93182530|NCT03767569|Micronutrients|micronutrients|mesh-ancestor
93182531|NCT03767569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182532|NCT03620916|Morphine|morphine|mesh-list
93182533|NCT03620916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93182534|NCT03620916|Narcotics|narcotics|mesh-ancestor
93182535|NCT03620916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182536|NCT03620916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182537|NCT03620916|Analgesics|analgesics|mesh-ancestor
93182538|NCT03620916|Sensory System Agents|sensory system agents|mesh-ancestor
93182539|NCT03620916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182540|NCT01237067|Carboplatin|carboplatin|mesh-list
93182541|NCT01237067|Olaparib|olaparib|mesh-list
93182542|NCT01237067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182543|NCT01237067|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93182544|NCT01237067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182545|NCT01237067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182546|NCT03426982|Heparin|heparin|mesh-list
93182547|NCT03426982|Calcium heparin|calcium heparin|mesh-list
93182548|NCT03426982|Anticoagulants|anticoagulants|mesh-ancestor
93182549|NCT03426982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93182550|NCT03426982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93182551|NCT03426982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182552|NCT01546948|Methadone|methadone|mesh-list
93182553|NCT01546948|Hydromorphone|hydromorphone|mesh-list
93182554|NCT01546948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93182555|NCT01546948|Narcotics|narcotics|mesh-ancestor
93182556|NCT01546948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182557|NCT01546948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182558|NCT01546948|Analgesics|analgesics|mesh-ancestor
93182559|NCT01546948|Sensory System Agents|sensory system agents|mesh-ancestor
93182560|NCT01546948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182561|NCT01546948|Antitussive Agents|antitussive agents|mesh-ancestor
93182562|NCT01546948|Respiratory System Agents|respiratory system agents|mesh-ancestor
93182563|NCT00458003|Phenylephrine|phenylephrine|mesh-list
93182564|NCT00458003|Oxymetazoline|oxymetazoline|mesh-list
93182565|NCT00458003|Ephedrine|ephedrine|mesh-list
93182566|NCT00458003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93182567|NCT00458003|Mydriatics|mydriatics|mesh-ancestor
93182568|NCT00458003|Autonomic Agents|autonomic agents|mesh-ancestor
93182569|NCT00458003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182570|NCT00458003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182571|NCT00458003|Sympathomimetics|sympathomimetics|mesh-ancestor
93182572|NCT00458003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93182573|NCT00458003|Nasal Decongestants|nasal decongestants|mesh-ancestor
93182574|NCT00458003|Respiratory System Agents|respiratory system agents|mesh-ancestor
93182575|NCT00458003|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93182576|NCT00458003|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93182577|NCT00458003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93182578|NCT00458003|Adrenergic Agents|adrenergic agents|mesh-ancestor
93182579|NCT00458003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182580|NCT00458003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182581|NCT00458003|Protective Agents|protective agents|mesh-ancestor
93182582|NCT00458003|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93182583|NCT04599972|Pilocarpine|pilocarpine|mesh-list
93182584|NCT04599972|Miotics|miotics|mesh-ancestor
93182585|NCT04599972|Autonomic Agents|autonomic agents|mesh-ancestor
93182586|NCT04599972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182587|NCT04599972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182588|NCT04599972|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93182589|NCT04599972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93182590|NCT04599972|Cholinergic Agents|cholinergic agents|mesh-ancestor
93182591|NCT04599972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182592|NCT04599972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182593|NCT03008616|Digoxin|digoxin|mesh-list
93182594|NCT03008616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93182595|NCT03008616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93182596|NCT03008616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182597|NCT03008616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182598|NCT03008616|Protective Agents|protective agents|mesh-ancestor
93182599|NCT03008616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182600|NCT03422146|Tea Tree Oil|tea tree oil|mesh-list
93182601|NCT03422146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93182602|NCT03422146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182603|NCT03426592|Vitamin D|vitamin d|mesh-list
93182604|NCT03426592|Cholecalciferol|cholecalciferol|mesh-list
93182605|NCT03426592|Vitamins|vitamins|mesh-ancestor
93182606|NCT03426592|Micronutrients|micronutrients|mesh-ancestor
93182607|NCT03426592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182608|NCT03426592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93182609|NCT03426592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93182610|NCT01567657|Midazolam|midazolam|mesh-list
93182611|NCT01567657|Meperidine|meperidine|mesh-list
93182612|NCT01567657|Propofol|propofol|mesh-list
93182613|NCT01567657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93182614|NCT01567657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478403|NCT01900574|Golimumab|golimumab|mesh-list
93182615|NCT01567657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182616|NCT01567657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93182617|NCT01567657|Anesthetics, General|anesthetics, general|mesh-ancestor
93182618|NCT01567657|Anesthetics|anesthetics|mesh-ancestor
93182619|NCT01567657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93182620|NCT01567657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93182621|NCT01567657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93182622|NCT01567657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182623|NCT01567657|GABA Modulators|gaba modulators|mesh-ancestor
93182624|NCT01567657|GABA Agents|gaba agents|mesh-ancestor
93182625|NCT01567657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182626|NCT01567657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182627|NCT01567657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93182628|NCT01567657|Narcotics|narcotics|mesh-ancestor
93182629|NCT01567657|Analgesics|analgesics|mesh-ancestor
93182630|NCT01567657|Sensory System Agents|sensory system agents|mesh-ancestor
93182631|NCT01567657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182632|NCT03416062|Niacinamide|niacinamide|mesh-list
93182633|NCT03416062|Vitamin B Complex|vitamin b complex|mesh-ancestor
93182634|NCT03416062|Vitamins|vitamins|mesh-ancestor
93182635|NCT03416062|Micronutrients|micronutrients|mesh-ancestor
93182636|NCT03416062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182637|NCT03761485|Fluorides|fluorides|mesh-list
93182638|NCT03761485|Cariostatic Agents|cariostatic agents|mesh-ancestor
93182639|NCT03761485|Protective Agents|protective agents|mesh-ancestor
93182640|NCT03761485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182641|NCT03766867|Vortioxetine|vortioxetine|mesh-list
93182642|NCT03766867|Antidepressive Agents|antidepressive agents|mesh-ancestor
93182643|NCT03766867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182644|NCT03766867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93182645|NCT03766867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93182646|NCT03766867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182647|NCT03766867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182648|NCT03766867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93182649|NCT03766867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93182650|NCT03766867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93182651|NCT03766867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182652|NCT03766867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182653|NCT03766867|Serotonin Agents|serotonin agents|mesh-ancestor
93182654|NCT03766867|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93182655|NCT03766867|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93182656|NCT03766867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93182657|NCT03766867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93182658|NCT02061293|Diphenhydramine|diphenhydramine|mesh-list
93182659|NCT02061293|Promethazine|promethazine|mesh-list
93182660|NCT02061293|Psilocybin|psilocybin|mesh-list
93182661|NCT02061293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93182662|NCT02061293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93182663|NCT02061293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182664|NCT02061293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182665|NCT02061293|Anesthetics, Local|anesthetics, local|mesh-ancestor
93182666|NCT02061293|Anesthetics|anesthetics|mesh-ancestor
93182667|NCT02061293|Sensory System Agents|sensory system agents|mesh-ancestor
93182668|NCT02061293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182669|NCT02061293|Antiemetics|antiemetics|mesh-ancestor
93182670|NCT02061293|Autonomic Agents|autonomic agents|mesh-ancestor
93182671|NCT02061293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93182672|NCT02061293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93182673|NCT02061293|Histamine Antagonists|histamine antagonists|mesh-ancestor
93182674|NCT02061293|Histamine Agents|histamine agents|mesh-ancestor
93182675|NCT02061293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182676|NCT02061293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182677|NCT02061293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93182678|NCT02061293|Antipruritics|antipruritics|mesh-ancestor
93182679|NCT02061293|Dermatologic Agents|dermatologic agents|mesh-ancestor
93182680|NCT02061293|Hallucinogens|hallucinogens|mesh-ancestor
93182681|NCT02061293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182682|NCT03761329|Lidocaine|lidocaine|mesh-list
93182683|NCT03761329|Anesthetics|anesthetics|mesh-list
93182684|NCT03761329|Anesthetics, Local|anesthetics, local|mesh-ancestor
93182685|NCT03761329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182686|NCT03761329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182687|NCT03761329|Sensory System Agents|sensory system agents|mesh-ancestor
93182688|NCT03761329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182689|NCT03761329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93182690|NCT03761329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93182691|NCT03761329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93182692|NCT03761329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93182693|NCT03761329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182694|NCT03415906|Valsartan|valsartan|mesh-list
93182695|NCT03415906|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93182696|NCT03415906|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93182697|NCT03415906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93182698|NCT03415906|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93182699|NCT03415906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182700|NCT03415750|Mycophenolic Acid|mycophenolic acid|mesh-list
93182701|NCT03415750|Everolimus|everolimus|mesh-list
93182702|NCT03415750|Tacrolimus|tacrolimus|mesh-list
93182703|NCT03415750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182704|NCT03415750|Immunologic Factors|immunologic factors|mesh-ancestor
93182705|NCT03415750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182706|NCT03415750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93182707|NCT03415750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182708|NCT03415750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182709|NCT03415750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93182710|NCT03415750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93182711|NCT03415750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182712|NCT03415750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93182713|NCT03415750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93182714|NCT03415750|Antitubercular Agents|antitubercular agents|mesh-ancestor
93182715|NCT03415750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93182716|NCT03415750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182717|NCT01239719|Clemastine|clemastine|mesh-list
93182718|NCT01239719|Dexamethasone|dexamethasone|mesh-list
93182719|NCT01239719|Dexamethasone acetate|dexamethasone acetate|mesh-list
93182720|NCT01239719|BB 1101|bb 1101|mesh-list
93182721|NCT01239719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182722|NCT01239719|Antiemetics|antiemetics|mesh-ancestor
93182723|NCT01239719|Autonomic Agents|autonomic agents|mesh-ancestor
93182724|NCT01239719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182725|NCT01239719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182726|NCT01239719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93182727|NCT01239719|Glucocorticoids|glucocorticoids|mesh-ancestor
93182728|NCT01239719|Hormones|hormones|mesh-ancestor
93182729|NCT01239719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182730|NCT01239719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93182731|NCT01239719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182732|NCT01239719|Protease Inhibitors|protease inhibitors|mesh-ancestor
93182733|NCT01239719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182734|NCT01239719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182735|NCT01239719|Antipruritics|antipruritics|mesh-ancestor
93182736|NCT01239719|Dermatologic Agents|dermatologic agents|mesh-ancestor
93182737|NCT01239719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93182738|NCT01239719|Histamine Antagonists|histamine antagonists|mesh-ancestor
93182739|NCT01239719|Histamine Agents|histamine agents|mesh-ancestor
93182740|NCT01239719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182741|NCT01239719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93182742|NCT03916679|Cyclophosphamide|cyclophosphamide|mesh-list
93182743|NCT03916679|Fludarabine|fludarabine|mesh-list
93182744|NCT03916679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182745|NCT03916679|Immunologic Factors|immunologic factors|mesh-ancestor
93182746|NCT03916679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182747|NCT03916679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182748|NCT03916679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93182749|NCT03916679|Alkylating Agents|alkylating agents|mesh-ancestor
93182750|NCT03916679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182751|NCT03916679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182752|NCT03916679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93182753|NCT03421990|Anesthetics|anesthetics|mesh-list
93182754|NCT03421990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182755|NCT03421990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182756|NCT02913612|Timolol|timolol|mesh-list
93182757|NCT02913612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93182758|NCT02913612|Maleic acid|maleic acid|mesh-list
93182759|NCT02913612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182760|NCT02913612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182761|NCT02913612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93182762|NCT02913612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93182763|NCT02913612|Adrenergic Agents|adrenergic agents|mesh-ancestor
93182764|NCT02913612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182765|NCT02913612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182766|NCT02913612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93182767|NCT02913612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93182768|NCT03426202|Modafinil|modafinil|mesh-list
93182769|NCT03426202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93182770|NCT03426202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182771|NCT03426202|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93182772|NCT03426202|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93182773|NCT03426202|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93182774|NCT03426202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182775|NCT01248299|Cisplatin|cisplatin|mesh-list
93182776|NCT01248299|Docetaxel|docetaxel|mesh-list
93182777|NCT01248299|Oxaliplatin|oxaliplatin|mesh-list
92854931|NCT00897871|Carboplatin|carboplatin|mesh-list
93182778|NCT01248299|Fluorouracil|fluorouracil|mesh-list
93182779|NCT01248299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182780|NCT01248299|Tubulin Modulators|tubulin modulators|mesh-ancestor
93182781|NCT01248299|Antimitotic Agents|antimitotic agents|mesh-ancestor
93182782|NCT01248299|Mitosis Modulators|mitosis modulators|mesh-ancestor
93182783|NCT01248299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182784|NCT01248299|Antimetabolites|antimetabolites|mesh-ancestor
93182785|NCT01248299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93182786|NCT01248299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182787|NCT01248299|Immunologic Factors|immunologic factors|mesh-ancestor
93182788|NCT01248299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182789|NCT01239875|Vaccines|vaccines|mesh-list
93182790|NCT01239875|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93182791|NCT01239875|Immunologic Factors|immunologic factors|mesh-ancestor
93182792|NCT01239875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182793|NCT03415594|Glucagon|glucagon|mesh-list
93182794|NCT03415594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93182795|NCT03415594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93182796|NCT03415594|Hormones|hormones|mesh-ancestor
93182797|NCT03415594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182798|NCT03415594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182799|NCT03415594|Incretins|incretins|mesh-ancestor
93182800|NCT04219254|Pembrolizumab|pembrolizumab|mesh-list
93182801|NCT04219254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93182802|NCT04219254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182803|NCT04219254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93182804|NCT04219254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182805|NCT01144169|Hydroxychloroquine|hydroxychloroquine|mesh-list
93182806|NCT01144169|Antimalarials|antimalarials|mesh-ancestor
93182807|NCT01144169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93182808|NCT01144169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93182809|NCT01144169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182810|NCT01144169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182811|NCT01144169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182812|NCT01144169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182813|NCT02709954|Ethanol|ethanol|mesh-list
93182814|NCT02709954|Dronabinol|dronabinol|mesh-list
93182815|NCT02709954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93182816|NCT02709954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182817|NCT02709954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182818|NCT02709954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182819|NCT02709954|Hallucinogens|hallucinogens|mesh-ancestor
93182820|NCT02709954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182821|NCT02709954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93182822|NCT02709954|Analgesics|analgesics|mesh-ancestor
93182823|NCT02709954|Sensory System Agents|sensory system agents|mesh-ancestor
93182824|NCT02709954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182825|NCT02709954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93182826|NCT02709954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93182827|NCT02709954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182828|NCT02709954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182829|NCT02709954|Hormones|hormones|mesh-ancestor
93182830|NCT02709954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182831|NCT03620838|Contraceptive Agents|contraceptive agents|mesh-list
93182832|NCT03620838|Contraceptives, Oral|contraceptives, oral|mesh-list
93182833|NCT03620838|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93182834|NCT03620838|Progesterone|progesterone|mesh-list
93182835|NCT03620838|Progestins|progestins|mesh-ancestor
93182836|NCT03620838|Hormones|hormones|mesh-ancestor
93182837|NCT03620838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182838|NCT03620838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182839|NCT03620838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93182840|NCT03620838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93182841|NCT01239953|Paclitaxel|paclitaxel|mesh-list
93182842|NCT01239953|Everolimus|everolimus|mesh-list
93182843|NCT01239953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93182844|NCT01239953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182845|NCT01239953|Tubulin Modulators|tubulin modulators|mesh-ancestor
93182846|NCT01239953|Antimitotic Agents|antimitotic agents|mesh-ancestor
93182847|NCT01239953|Mitosis Modulators|mitosis modulators|mesh-ancestor
93182848|NCT01239953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182849|NCT01239953|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92855020|NCT04267991|Tacrolimus|tacrolimus|mesh-list
93182850|NCT01239953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93182851|NCT01239953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182852|NCT01239953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93182853|NCT01239953|Immunologic Factors|immunologic factors|mesh-ancestor
93182854|NCT01239953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182856|NCT01322191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93182857|NCT01322191|Narcotics|narcotics|mesh-ancestor
93182858|NCT01322191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182859|NCT01322191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182860|NCT01322191|Analgesics|analgesics|mesh-ancestor
93182861|NCT01322191|Sensory System Agents|sensory system agents|mesh-ancestor
93182862|NCT01322191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182863|NCT03620760|Aspirin|aspirin|mesh-list
93182864|NCT03620760|Ticagrelor|ticagrelor|mesh-list
93182865|NCT03620760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93182866|NCT03620760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93182867|NCT03620760|Analgesics|analgesics|mesh-ancestor
93182868|NCT03620760|Sensory System Agents|sensory system agents|mesh-ancestor
93182869|NCT03620760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182870|NCT03620760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182871|NCT03620760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182872|NCT03620760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93182873|NCT03620760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93182874|NCT03620760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93182875|NCT03620760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182876|NCT03620760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93182877|NCT03620760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93182878|NCT03620760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182879|NCT03620760|Antipyretics|antipyretics|mesh-ancestor
93182880|NCT03620760|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93182881|NCT03620760|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93182882|NCT03620760|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93182883|NCT03620760|Purinergic Agents|purinergic agents|mesh-ancestor
93182884|NCT03620760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182885|NCT03765931|Amoxicillin|amoxicillin|mesh-list
93182886|NCT03765931|Doxycycline|doxycycline|mesh-list
93182887|NCT03765931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93182888|NCT03765931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182889|NCT03765931|Antimalarials|antimalarials|mesh-ancestor
93182890|NCT03765931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93182891|NCT03765931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93182892|NCT01240265|Vitamin D|vitamin d|mesh-list
93182893|NCT01240265|Ergocalciferols|ergocalciferols|mesh-list
93182894|NCT01240265|Cholecalciferol|cholecalciferol|mesh-list
93182895|NCT01240265|Vitamins|vitamins|mesh-list
93182896|NCT01240265|Micronutrients|micronutrients|mesh-ancestor
93182897|NCT01240265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182898|NCT01240265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93182899|NCT01240265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93182900|NCT02327455|Dobutamine|dobutamine|mesh-list
93182901|NCT02327455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93182902|NCT02327455|Sympathomimetics|sympathomimetics|mesh-ancestor
93182903|NCT02327455|Autonomic Agents|autonomic agents|mesh-ancestor
93182904|NCT02327455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182905|NCT02327455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182906|NCT02327455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93182907|NCT02327455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93182908|NCT02327455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93182909|NCT02327455|Adrenergic Agents|adrenergic agents|mesh-ancestor
93182910|NCT02327455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182911|NCT02327455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182912|NCT02327455|Protective Agents|protective agents|mesh-ancestor
93182913|NCT03638076|Ritonavir|ritonavir|mesh-list
93182914|NCT03638076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93182915|NCT03638076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93182916|NCT03638076|Protease Inhibitors|protease inhibitors|mesh-ancestor
93182917|NCT03638076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182918|NCT03638076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182919|NCT03638076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93182920|NCT03638076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93182921|NCT03638076|Antiviral Agents|antiviral agents|mesh-ancestor
93182922|NCT03638076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182923|NCT03638076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93182924|NCT03638076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93182925|NCT01329731|Olaflur|olaflur|mesh-list
93182926|NCT01329731|Cariostatic Agents|cariostatic agents|mesh-ancestor
93182927|NCT01329731|Protective Agents|protective agents|mesh-ancestor
93182928|NCT01329731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182929|NCT03765697|Lidocaine|lidocaine|mesh-list
93182930|NCT03765697|Anesthetics, Local|anesthetics, local|mesh-ancestor
93182931|NCT03765697|Anesthetics|anesthetics|mesh-ancestor
93182932|NCT03765697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182933|NCT03765697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182934|NCT03765697|Sensory System Agents|sensory system agents|mesh-ancestor
93182935|NCT03765697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93182936|NCT03765697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93182937|NCT03765697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93182938|NCT03765697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93182939|NCT03765697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93182940|NCT03765697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182941|NCT03311841|Rifampin|rifampin|mesh-list
93182942|NCT03311841|Midazolam|midazolam|mesh-list
93182943|NCT03311841|Dabigatran|dabigatran|mesh-list
93182944|NCT03311841|Atorvastatin|atorvastatin|mesh-list
93182945|NCT03311841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93182946|NCT03311841|Pitavastatin|pitavastatin|mesh-list
93182947|NCT03311841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93182948|NCT03311841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93182949|NCT03311841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93182950|NCT03311841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93182951|NCT03311841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182952|NCT03311841|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93182953|NCT03311841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93182954|NCT03311841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93182955|NCT03311841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93182956|NCT03311841|Anesthetics, General|anesthetics, general|mesh-ancestor
93182957|NCT03311841|Anesthetics|anesthetics|mesh-ancestor
93182958|NCT03311841|GABA Modulators|gaba modulators|mesh-ancestor
93182959|NCT03311841|GABA Agents|gaba agents|mesh-ancestor
93182960|NCT03311841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93182961|NCT03311841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93182962|NCT03311841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93182963|NCT03311841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93182964|NCT03311841|Antimetabolites|antimetabolites|mesh-ancestor
93182965|NCT03311841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93182966|NCT03311841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93182967|NCT03311841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93182968|NCT03311841|Antithrombins|antithrombins|mesh-ancestor
93182969|NCT03311841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93182970|NCT03311841|Protease Inhibitors|protease inhibitors|mesh-ancestor
93182971|NCT03311841|Anticoagulants|anticoagulants|mesh-ancestor
93182972|NCT03311841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93182973|NCT03311841|Antitubercular Agents|antitubercular agents|mesh-ancestor
93182974|NCT03311841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93182975|NCT03311841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93182976|NCT03311841|Leprostatic Agents|leprostatic agents|mesh-ancestor
93182977|NCT03311841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93182978|NCT03311841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93182979|NCT03311841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93182980|NCT03311841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93182981|NCT03311841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93182982|NCT03311841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93182983|NCT03311841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93182984|NCT01249937|Triamcinolone|triamcinolone|mesh-list
93182985|NCT01249937|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93182986|NCT01249937|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93182987|NCT01249937|Ranibizumab|ranibizumab|mesh-list
93182988|NCT01249937|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93182989|NCT01249937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93182990|NCT01249937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93182991|NCT01249937|Growth Substances|growth substances|mesh-ancestor
93182992|NCT01249937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93182993|NCT01249937|Growth Inhibitors|growth inhibitors|mesh-ancestor
93182994|NCT01249937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93182995|NCT01249937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93182996|NCT01249937|Glucocorticoids|glucocorticoids|mesh-ancestor
93182997|NCT01249937|Hormones|hormones|mesh-ancestor
93182998|NCT01249937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93182999|NCT01249937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183000|NCT01249937|Immunologic Factors|immunologic factors|mesh-ancestor
93183001|NCT01249937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366320|NCT02058485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93183002|NCT01249937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183003|NCT02528201|Celecoxib|celecoxib|mesh-list
93183004|NCT02528201|Diclofenac|diclofenac|mesh-list
93183005|NCT02528201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183006|NCT02528201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183007|NCT02528201|Analgesics|analgesics|mesh-ancestor
93183008|NCT02528201|Sensory System Agents|sensory system agents|mesh-ancestor
93183009|NCT02528201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183010|NCT02528201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183011|NCT02528201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183012|NCT02528201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183013|NCT02528201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93183014|NCT02528201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183015|NCT02528201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183016|NCT02528201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183017|NCT03758677|Gemcitabine|gemcitabine|mesh-list
93183018|NCT03758677|Docetaxel|docetaxel|mesh-list
93183019|NCT03758677|Pemetrexed|pemetrexed|mesh-list
93183020|NCT03758677|Apatinib|apatinib|mesh-list
93183021|NCT03758677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93183022|NCT03758677|Antimetabolites|antimetabolites|mesh-ancestor
93183023|NCT03758677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183024|NCT03758677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183025|NCT03758677|Tubulin Modulators|tubulin modulators|mesh-ancestor
93183026|NCT03758677|Antimitotic Agents|antimitotic agents|mesh-ancestor
93183027|NCT03758677|Mitosis Modulators|mitosis modulators|mesh-ancestor
93183028|NCT03758677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183029|NCT03758677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93183030|NCT03758677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93183031|NCT03758677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93183032|NCT03764683|Suvorexant|suvorexant|mesh-list
93183033|NCT03764683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93183034|NCT03764683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93183035|NCT03764683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183036|NCT03764683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183037|NCT03764683|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93183038|NCT03764683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183039|NCT03764683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183040|NCT03414892|Globalagliatin|globalagliatin|mesh-list
93183041|NCT03414892|Enzyme Activators|enzyme activators|mesh-ancestor
93183042|NCT03414892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183043|NCT01242605|Gemcitabine|gemcitabine|mesh-list
93183044|NCT01242605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183045|NCT01242605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93183046|NCT01242605|Antimetabolites|antimetabolites|mesh-ancestor
93183047|NCT01242605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183048|NCT03414814|Osimertinib|osimertinib|mesh-list
93183049|NCT03414814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183050|NCT03414814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93183051|NCT03414814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183052|NCT03414814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183053|NCT03421366|Posaconazole|posaconazole|mesh-list
93183054|NCT03421366|Antifungal Agents|antifungal agents|mesh-ancestor
93183055|NCT03421366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183056|NCT03421366|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93183057|NCT03421366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93183058|NCT03421366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93183059|NCT03421366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93183060|NCT03421366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93183061|NCT03421366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183062|NCT03421366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183063|NCT03421366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93183064|NCT03421366|Hormone Antagonists|hormone antagonists|mesh-ancestor
93183065|NCT03421366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93183066|NCT03421366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183067|NCT03764605|Metformin|metformin|mesh-list
93183068|NCT03764605|Tolvaptan|tolvaptan|mesh-list
93183069|NCT03764605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93183070|NCT03764605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183071|NCT03764605|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93183072|NCT03764605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183073|NCT03764605|Natriuretic Agents|natriuretic agents|mesh-ancestor
92855263|NCT02750748|Naltrexone|naltrexone|mesh-list
93183074|NCT03764527|Artesunate|artesunate|mesh-list
93183075|NCT03764527|Lumefantrine|lumefantrine|mesh-list
93183076|NCT03764527|Artemether|artemether|mesh-list
93183077|NCT03764527|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93183078|NCT03764527|Amodiaquine|amodiaquine|mesh-list
93183079|NCT03764527|Antimalarials|antimalarials|mesh-ancestor
93183080|NCT03764527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93183081|NCT03764527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93183082|NCT03764527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183083|NCT03764527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183084|NCT03764527|Antiviral Agents|antiviral agents|mesh-ancestor
93183085|NCT03764527|Schistosomicides|schistosomicides|mesh-ancestor
93183086|NCT03764527|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93183087|NCT03764527|Anthelmintics|anthelmintics|mesh-ancestor
93183088|NCT01321801|Pregabalin|pregabalin|mesh-list
93183089|NCT01321801|Analgesics|analgesics|mesh-ancestor
93183090|NCT01321801|Sensory System Agents|sensory system agents|mesh-ancestor
93183091|NCT01321801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183092|NCT01321801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183093|NCT01321801|Anticonvulsants|anticonvulsants|mesh-ancestor
93183094|NCT01321801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93183095|NCT01321801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183096|NCT01321801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183097|NCT01321801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93183098|NCT01321801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93183099|NCT01321801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93183100|NCT01321801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183101|NCT01321801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93183102|NCT01155375|Ferrous fumarate|ferrous fumarate|mesh-list
93183103|NCT01155375|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93183104|NCT01155375|Hematinics|hematinics|mesh-ancestor
93183105|NCT01155375|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93183106|NCT01155375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93183107|NCT01155375|Trace Elements|trace elements|mesh-ancestor
93183108|NCT01155375|Micronutrients|micronutrients|mesh-ancestor
93183109|NCT01155375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183110|NCT03759301|Cetrorelix|cetrorelix|mesh-list
93183111|NCT03759301|Hormones|hormones|mesh-list
93183112|NCT03759301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93183113|NCT03759301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183114|NCT03759301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93183115|NCT03759301|Fertility Agents|fertility agents|mesh-ancestor
93183116|NCT03759301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93183117|NCT03759301|Hormone Antagonists|hormone antagonists|mesh-ancestor
93183118|NCT03764059|Chlorhexidine|chlorhexidine|mesh-list
93183119|NCT03764059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93183120|NCT03764059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183121|NCT03764059|Disinfectants|disinfectants|mesh-ancestor
93183122|NCT02260102|Temocillin|temocillin|mesh-list
93183123|NCT02260102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93183124|NCT02260102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183125|NCT03425734|Dexmedetomidine|dexmedetomidine|mesh-list
93183126|NCT03425734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93183127|NCT03425734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183128|NCT03425734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183129|NCT03425734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183130|NCT03425734|Analgesics|analgesics|mesh-ancestor
93183131|NCT03425734|Sensory System Agents|sensory system agents|mesh-ancestor
93183132|NCT03425734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183133|NCT03425734|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93183134|NCT03425734|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93183135|NCT03425734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93183136|NCT03425734|Adrenergic Agents|adrenergic agents|mesh-ancestor
93183137|NCT03425734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183138|NCT03425734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183139|NCT03420586|Nitrous Oxide|nitrous oxide|mesh-list
93183140|NCT03420586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93183141|NCT03420586|Anesthetics, General|anesthetics, general|mesh-ancestor
93183142|NCT03420586|Anesthetics|anesthetics|mesh-ancestor
93183143|NCT03420586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183144|NCT03420586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183145|NCT03420586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183146|NCT03420586|Analgesics|analgesics|mesh-ancestor
93183147|NCT03420586|Sensory System Agents|sensory system agents|mesh-ancestor
93183148|NCT03420586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183149|NCT03759067|Clopidogrel|clopidogrel|mesh-list
93183150|NCT03759067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93183151|NCT03759067|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93183152|NCT03759067|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93183153|NCT03759067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93183154|NCT03759067|Purinergic Agents|purinergic agents|mesh-ancestor
93183155|NCT03759067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183156|NCT03759067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183157|NCT03759067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183158|NCT03425656|Cyclophosphamide|cyclophosphamide|mesh-list
93183159|NCT03425656|Docetaxel|docetaxel|mesh-list
93183160|NCT03425656|Doxorubicin|doxorubicin|mesh-list
93183161|NCT03425656|Trastuzumab|trastuzumab|mesh-list
93183162|NCT03425656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183163|NCT03425656|Immunologic Factors|immunologic factors|mesh-ancestor
93183164|NCT03425656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183165|NCT03425656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183166|NCT03425656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93183167|NCT03425656|Alkylating Agents|alkylating agents|mesh-ancestor
93183168|NCT03425656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183169|NCT03425656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183170|NCT03425656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93183171|NCT03425656|Tubulin Modulators|tubulin modulators|mesh-ancestor
93183172|NCT03425656|Antimitotic Agents|antimitotic agents|mesh-ancestor
93183173|NCT03425656|Mitosis Modulators|mitosis modulators|mesh-ancestor
93183174|NCT03425656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93183175|NCT03425656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93183176|NCT03425656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93183177|NCT03425656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183178|NCT03425656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183179|NCT03413722|Everolimus|everolimus|mesh-list
93183180|NCT03413722|Tacrolimus|tacrolimus|mesh-list
93183181|NCT03413722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183182|NCT03413722|Immunologic Factors|immunologic factors|mesh-ancestor
93183183|NCT03413722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183184|NCT03413722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93183185|NCT03413722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183186|NCT03413722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183187|NCT03413722|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93183188|NCT03413722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93183189|NCT03413722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183190|NCT04843462|Esketamine|esketamine|mesh-list
93183191|NCT04843462|Antidepressive Agents|antidepressive agents|mesh-ancestor
93183192|NCT04843462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93183193|NCT03420040|Insulin Glargine|insulin glargine|mesh-list
93183194|NCT03420040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93183195|NCT03420040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183196|NCT03413410|Metoprolol|metoprolol|mesh-list
93183197|NCT03413410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93183198|NCT03413410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93183199|NCT03413410|Sympatholytics|sympatholytics|mesh-ancestor
93183200|NCT03413410|Autonomic Agents|autonomic agents|mesh-ancestor
93183201|NCT03413410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183202|NCT03413410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183203|NCT03413410|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93183204|NCT03413410|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93183205|NCT03413410|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93183206|NCT03413410|Adrenergic Agents|adrenergic agents|mesh-ancestor
93183207|NCT03413410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183208|NCT03413410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183209|NCT03419806|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93183210|NCT03419806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93183211|NCT03419806|Immunologic Factors|immunologic factors|mesh-ancestor
93183212|NCT03419806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183213|NCT03419806|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93183214|NCT03419806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93183215|NCT03419806|Dopamine Agonists|dopamine agonists|mesh-ancestor
93183216|NCT03419806|Dopamine Agents|dopamine agents|mesh-ancestor
93183217|NCT03419806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183218|NCT03419806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183219|NCT03424876|Sunitinib|sunitinib|mesh-list
93183220|NCT03424876|Imatinib Mesylate|imatinib mesylate|mesh-list
93183221|NCT03424876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183222|NCT03424876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92855375|NCT05122208|Famotidine|famotidine|mesh-list
93183223|NCT03424876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93183224|NCT03424876|Growth Substances|growth substances|mesh-ancestor
93183225|NCT03424876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183226|NCT03424876|Growth Inhibitors|growth inhibitors|mesh-ancestor
93183227|NCT03424876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93183228|NCT03424876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183229|NCT03424876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183230|NCT03476577|Ibuprofen|ibuprofen|mesh-list
93183231|NCT03476577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183232|NCT03476577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183233|NCT03476577|Analgesics|analgesics|mesh-ancestor
93183234|NCT03476577|Sensory System Agents|sensory system agents|mesh-ancestor
93183235|NCT03476577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183236|NCT03476577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183237|NCT03476577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183238|NCT03476577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183239|NCT03476577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183240|NCT03476577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183241|NCT03476577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183242|NCT03419650|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93183243|NCT03419650|Hormones|hormones|mesh-ancestor
93183244|NCT03419650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93183245|NCT03419650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183246|NCT04893915|Cyclophosphamide|cyclophosphamide|mesh-list
93183247|NCT04893915|Fludarabine|fludarabine|mesh-list
93183248|NCT04893915|Interleukin-2|interleukin-2|mesh-list
93183249|NCT04893915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183250|NCT04893915|Immunologic Factors|immunologic factors|mesh-ancestor
93183251|NCT04893915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183252|NCT04893915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183253|NCT04893915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93183254|NCT04893915|Alkylating Agents|alkylating agents|mesh-ancestor
93183255|NCT04893915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183256|NCT04893915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183257|NCT04893915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93183258|NCT04893915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183259|NCT04893915|Analgesics|analgesics|mesh-ancestor
93183260|NCT04893915|Sensory System Agents|sensory system agents|mesh-ancestor
93183261|NCT04893915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183262|NCT03419494|Doxorubicin|doxorubicin|mesh-list
93183263|NCT03419494|Daunorubicin|daunorubicin|mesh-list
93183264|NCT03419494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93183265|NCT03419494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93183266|NCT03419494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183267|NCT03419494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93183268|NCT03419494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93183269|NCT03419494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183270|NCT03419494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183271|NCT03413020|Amoxicillin|amoxicillin|mesh-list
93183272|NCT03413020|Metronidazole|metronidazole|mesh-list
93183273|NCT03413020|Clarithromycin|clarithromycin|mesh-list
93183274|NCT03413020|Levofloxacin|levofloxacin|mesh-list
93183275|NCT03413020|Potassium Citrate|potassium citrate|mesh-list
93183276|NCT03413020|Esomeprazole|esomeprazole|mesh-list
93183277|NCT03413020|Bismuth|bismuth|mesh-list
92479070|NCT01876641|Decitabine|decitabine|mesh-list
93183278|NCT03413020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183279|NCT03413020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93183280|NCT03413020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183281|NCT03413020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93183282|NCT03413020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93183283|NCT03413020|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93183284|NCT03413020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93183285|NCT03413020|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93183286|NCT03413020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183287|NCT03413020|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93183288|NCT03413020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93183289|NCT03413020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93183290|NCT03413020|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93183291|NCT03413020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93183292|NCT03413020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93183293|NCT03413020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183294|NCT03413020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93183295|NCT03413020|Antacids|antacids|mesh-ancestor
93183296|NCT03413020|Diuretics|diuretics|mesh-ancestor
93183297|NCT03413020|Natriuretic Agents|natriuretic agents|mesh-ancestor
93183298|NCT03413020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183299|NCT03413020|Expectorants|expectorants|mesh-ancestor
93183300|NCT03413020|Respiratory System Agents|respiratory system agents|mesh-ancestor
93183301|NCT03424408|Aspirin|aspirin|mesh-list
93183302|NCT03424408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183303|NCT03424408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183304|NCT03424408|Analgesics|analgesics|mesh-ancestor
93183305|NCT03424408|Sensory System Agents|sensory system agents|mesh-ancestor
93183306|NCT03424408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183307|NCT03424408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183308|NCT03424408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183309|NCT03424408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183310|NCT03424408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93183311|NCT03424408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93183312|NCT03424408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183313|NCT03424408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93183314|NCT03424408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183315|NCT03424408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183316|NCT03424408|Antipyretics|antipyretics|mesh-ancestor
93183317|NCT03305055|Fentanyl|fentanyl|mesh-list
93183318|NCT03305055|Ketamine|ketamine|mesh-list
93183319|NCT03305055|Analgesics|analgesics|mesh-ancestor
93183320|NCT03305055|Sensory System Agents|sensory system agents|mesh-ancestor
93183321|NCT03305055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183322|NCT03305055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183323|NCT03305055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93183324|NCT03305055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93183325|NCT03305055|Anesthetics, General|anesthetics, general|mesh-ancestor
93183326|NCT03305055|Anesthetics|anesthetics|mesh-ancestor
93183327|NCT03305055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183328|NCT03305055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93183329|NCT03305055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93183330|NCT03305055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183331|NCT03305055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183332|NCT03305055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93183333|NCT03305055|Narcotics|narcotics|mesh-ancestor
93183334|NCT03305055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93183335|NCT04547985|Naltrexone|naltrexone|mesh-list
93183336|NCT04547985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93183337|NCT04547985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93183338|NCT04547985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183339|NCT04547985|Sensory System Agents|sensory system agents|mesh-ancestor
93183340|NCT04547985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183341|NCT03412552|Magnesium Sulfate|magnesium sulfate|mesh-list
93183342|NCT03412552|Analgesics|analgesics|mesh-ancestor
93183343|NCT03412552|Sensory System Agents|sensory system agents|mesh-ancestor
93183344|NCT03412552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183345|NCT03412552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183346|NCT03412552|Anesthetics|anesthetics|mesh-ancestor
93183347|NCT03412552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183348|NCT03412552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93183349|NCT03412552|Anticonvulsants|anticonvulsants|mesh-ancestor
93183350|NCT03412552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93183351|NCT03412552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183352|NCT03412552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183353|NCT03412552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93183354|NCT03412552|Tocolytic Agents|tocolytic agents|mesh-ancestor
93183355|NCT03412552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93183356|NCT03412474|Acetaminophen|acetaminophen|mesh-list
93183357|NCT03412474|Dexmedetomidine|dexmedetomidine|mesh-list
93183358|NCT03412474|Bupivacaine|bupivacaine|mesh-list
93183359|NCT03412474|Anesthetics, Local|anesthetics, local|mesh-ancestor
93183360|NCT03412474|Anesthetics|anesthetics|mesh-ancestor
93183361|NCT03412474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183362|NCT03412474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183363|NCT03412474|Sensory System Agents|sensory system agents|mesh-ancestor
93183364|NCT03412474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183365|NCT03412474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93183366|NCT03412474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183367|NCT03412474|Analgesics|analgesics|mesh-ancestor
93183368|NCT03412474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93183369|NCT03412474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93183370|NCT03412474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93183371|NCT03412474|Adrenergic Agents|adrenergic agents|mesh-ancestor
93183372|NCT03412474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855526|NCT04242914|GABA Agents|gaba agents|mesh-ancestor
93183373|NCT03412474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183374|NCT03412474|Antipyretics|antipyretics|mesh-ancestor
93183375|NCT03273387|Trimetazidine|trimetazidine|mesh-list
93183376|NCT03273387|Vasodilator Agents|vasodilator agents|mesh-ancestor
93183377|NCT04527003|Cannabidiol|cannabidiol|mesh-list
93183378|NCT04527003|Norethindrone|norethindrone|mesh-list
93183379|NCT04527003|Norethindrone Acetate|norethindrone acetate|mesh-list
93183380|NCT04527003|Anticonvulsants|anticonvulsants|mesh-ancestor
93183381|NCT04527003|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93183382|NCT04527003|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93183383|NCT04527003|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93183384|NCT04527003|Contraceptive Agents|contraceptive agents|mesh-ancestor
93183385|NCT04527003|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93183386|NCT04527003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183387|NCT04527003|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93183388|NCT04527003|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93183389|NCT04447612|Gemcitabine|gemcitabine|mesh-list
93183390|NCT04447612|Durvalumab|durvalumab|mesh-list
93183391|NCT04447612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183392|NCT04447612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93183393|NCT04447612|Antimetabolites|antimetabolites|mesh-ancestor
93183394|NCT04447612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183395|NCT04447612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183396|NCT03418558|Trastuzumab|trastuzumab|mesh-list
93183397|NCT03418558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93183398|NCT03418558|Maytansine|maytansine|mesh-list
93183399|NCT03418558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183400|NCT03418558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183401|NCT03418558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93183402|NCT03418558|Tubulin Modulators|tubulin modulators|mesh-ancestor
93183403|NCT03418558|Antimitotic Agents|antimitotic agents|mesh-ancestor
93183404|NCT03418558|Mitosis Modulators|mitosis modulators|mesh-ancestor
93183405|NCT03418558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183406|NCT03418558|Immunotoxins|immunotoxins|mesh-ancestor
93183407|NCT03418558|Immunoconjugates|immunoconjugates|mesh-ancestor
93183408|NCT03418558|Immunologic Factors|immunologic factors|mesh-ancestor
93183409|NCT03418558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183410|NCT05170828|Mycophenolic Acid|mycophenolic acid|mesh-list
93183411|NCT05170828|Sirolimus|sirolimus|mesh-list
93183412|NCT05170828|Cyclophosphamide|cyclophosphamide|mesh-list
93183413|NCT05170828|Busulfan|busulfan|mesh-list
93183414|NCT05170828|Fludarabine|fludarabine|mesh-list
93183415|NCT05170828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183416|NCT05170828|Immunologic Factors|immunologic factors|mesh-ancestor
93183417|NCT05170828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183418|NCT05170828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183419|NCT05170828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93183420|NCT05170828|Alkylating Agents|alkylating agents|mesh-ancestor
93183421|NCT05170828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183422|NCT05170828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183423|NCT05170828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93183424|NCT05170828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93183425|NCT05170828|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93183426|NCT05170828|Antitubercular Agents|antitubercular agents|mesh-ancestor
93183427|NCT05170828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93183428|NCT05170828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183429|NCT05170828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183430|NCT05170828|Antifungal Agents|antifungal agents|mesh-ancestor
93183431|NCT03412006|Fulacimstat|fulacimstat|mesh-list
93183432|NCT03412006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183433|NCT03412006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183434|NCT03418246|Calcium|calcium|mesh-list
93183435|NCT03418246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93183436|NCT03418246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183437|NCT03411850|Abatacept|abatacept|mesh-list
93183438|NCT03411850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93183439|NCT03411850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183440|NCT03411850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183441|NCT03411850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183442|NCT03411850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183443|NCT03411850|Immunologic Factors|immunologic factors|mesh-ancestor
93183444|NCT03411850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183445|NCT03411850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183446|NCT05170594|Bevacizumab|bevacizumab|mesh-list
93183447|NCT05170594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93183448|NCT05170594|Fluzoparib|fluzoparib|mesh-list
93183449|NCT05170594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183450|NCT05170594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183451|NCT05170594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93183452|NCT05170594|Growth Substances|growth substances|mesh-ancestor
93183453|NCT05170594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183454|NCT05170594|Growth Inhibitors|growth inhibitors|mesh-ancestor
93183455|NCT05170594|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93183456|NCT05170594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183457|NCT05170594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183458|NCT03410836|Lidocaine|lidocaine|mesh-list
93183459|NCT03410836|Anesthetics, Local|anesthetics, local|mesh-ancestor
93183460|NCT03410836|Anesthetics|anesthetics|mesh-ancestor
93183461|NCT03410836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183462|NCT03410836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183463|NCT03410836|Sensory System Agents|sensory system agents|mesh-ancestor
93183464|NCT03410836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183465|NCT03410836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93183466|NCT03410836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93183467|NCT03410836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93183468|NCT03410836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183469|NCT03410836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183470|NCT03273153|Pembrolizumab|pembrolizumab|mesh-list
93183471|NCT03273153|Atezolizumab|atezolizumab|mesh-list
93183472|NCT03273153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183473|NCT03273153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183474|NCT03273153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93183475|NCT03273153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183476|NCT03418090|Xenon|xenon|mesh-list
93183477|NCT03418090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93183478|NCT03418090|Anesthetics, General|anesthetics, general|mesh-ancestor
93183479|NCT03418090|Anesthetics|anesthetics|mesh-ancestor
93183480|NCT03418090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183481|NCT03418090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183482|NCT03323034|Irinotecan|irinotecan|mesh-list
93183483|NCT03323034|Temozolomide|temozolomide|mesh-list
93183484|NCT03323034|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93183485|NCT03323034|Pevonedistat|pevonedistat|mesh-list
93183486|NCT03323034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93183487|NCT03323034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93183488|NCT03323034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183489|NCT03323034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183490|NCT03323034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93183491|NCT03323034|Alkylating Agents|alkylating agents|mesh-ancestor
93183492|NCT02520934|Miglustat|miglustat|mesh-list
93183493|NCT02520934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183494|NCT02520934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183495|NCT02520934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93183496|NCT02520934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93183497|NCT02520934|Antiviral Agents|antiviral agents|mesh-ancestor
93183498|NCT02520934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183499|NCT02520934|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93183500|NCT02520934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93183501|NCT02520934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183502|NCT02749968|Bupivacaine|bupivacaine|mesh-list
93183503|NCT02749968|Anesthetics, Local|anesthetics, local|mesh-ancestor
93183504|NCT02749968|Anesthetics|anesthetics|mesh-ancestor
93183505|NCT02749968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183506|NCT02749968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183507|NCT02749968|Sensory System Agents|sensory system agents|mesh-ancestor
93183508|NCT02749968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183509|NCT04787250|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93183510|NCT04787250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93183511|NCT04787250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183512|NCT04787250|Antitubercular Agents|antitubercular agents|mesh-ancestor
93183513|NCT03417700|Vitamin D|vitamin d|mesh-list
93183514|NCT03417700|Vitamins|vitamins|mesh-ancestor
93183515|NCT03417700|Micronutrients|micronutrients|mesh-ancestor
93183516|NCT03417700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183517|NCT03417700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93183518|NCT03410524|Simethicone|simethicone|mesh-list
93183519|NCT03410524|Antifoaming Agents|antifoaming agents|mesh-ancestor
93183520|NCT03410524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183521|NCT03410524|Emollients|emollients|mesh-ancestor
93183522|NCT03410524|Dermatologic Agents|dermatologic agents|mesh-ancestor
93183523|NCT02713776|Pasireotide|pasireotide|mesh-list
92855671|NCT00900445|Prednisone|prednisone|mesh-list
93183524|NCT02713776|Somatostatin|somatostatin|mesh-list
93183525|NCT02713776|Hormones|hormones|mesh-ancestor
93183526|NCT02713776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93183527|NCT02713776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183528|NCT05215990|Metformin|metformin|mesh-list
93183529|NCT05215990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93183530|NCT05215990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183531|NCT03268941|Metoclopramide|metoclopramide|mesh-list
93183532|NCT03268941|Maleic acid|maleic acid|mesh-list
93183533|NCT03268941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183534|NCT03268941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183535|NCT03268941|Antiemetics|antiemetics|mesh-ancestor
93183536|NCT03268941|Autonomic Agents|autonomic agents|mesh-ancestor
93183537|NCT03268941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183538|NCT03268941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183539|NCT03268941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93183540|NCT03268941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93183541|NCT03268941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93183542|NCT03268941|Dopamine Agents|dopamine agents|mesh-ancestor
93183543|NCT03268941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183544|NCT05215834|Remifentanil|remifentanil|mesh-list
93183545|NCT05215834|Propofol|propofol|mesh-list
93183546|NCT05215834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93183547|NCT05215834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183548|NCT05215834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183549|NCT05215834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93183550|NCT05215834|Anesthetics, General|anesthetics, general|mesh-ancestor
93183551|NCT05215834|Anesthetics|anesthetics|mesh-ancestor
93183552|NCT05215834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93183553|NCT05215834|Narcotics|narcotics|mesh-ancestor
93183554|NCT05215834|Analgesics|analgesics|mesh-ancestor
93183555|NCT05215834|Sensory System Agents|sensory system agents|mesh-ancestor
93183556|NCT05215834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183557|NCT03394144|Durvalumab|durvalumab|mesh-list
93183558|NCT03394144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183559|NCT03394144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183560|NCT05011149|Ibuprofen|ibuprofen|mesh-list
93183561|NCT05011149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183562|NCT05011149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183563|NCT05011149|Analgesics|analgesics|mesh-ancestor
93183564|NCT05011149|Sensory System Agents|sensory system agents|mesh-ancestor
93183565|NCT05011149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183566|NCT05011149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183567|NCT05011149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183568|NCT05011149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183569|NCT05011149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183570|NCT05011149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183571|NCT05011149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183572|NCT03393988|Fentanyl|fentanyl|mesh-list
93183573|NCT03393988|Dexmedetomidine|dexmedetomidine|mesh-list
93183574|NCT03393988|Sympathomimetics|sympathomimetics|mesh-list
93183575|NCT03393988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93183576|NCT03393988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183577|NCT03393988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183578|NCT03393988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183579|NCT03393988|Analgesics|analgesics|mesh-ancestor
93183580|NCT03393988|Sensory System Agents|sensory system agents|mesh-ancestor
93183581|NCT03393988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183582|NCT03393988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93183583|NCT03393988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93183584|NCT03393988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93183585|NCT03393988|Adrenergic Agents|adrenergic agents|mesh-ancestor
93183586|NCT03393988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183587|NCT03393988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183588|NCT03393988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93183589|NCT03393988|Narcotics|narcotics|mesh-ancestor
93183590|NCT03393988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93183591|NCT03393988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93183592|NCT03393988|Anesthetics, General|anesthetics, general|mesh-ancestor
93183593|NCT03393988|Anesthetics|anesthetics|mesh-ancestor
93183594|NCT03393988|Autonomic Agents|autonomic agents|mesh-ancestor
93183595|NCT03410212|Ketorolac|ketorolac|mesh-list
93183596|NCT03410212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93183597|NCT03410212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92855744|NCT00905047|Antimetabolites|antimetabolites|mesh-ancestor
93183598|NCT03410212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183599|NCT03410212|Analgesics|analgesics|mesh-ancestor
93183600|NCT03410212|Sensory System Agents|sensory system agents|mesh-ancestor
93183601|NCT03410212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183602|NCT03410212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183603|NCT03410212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183604|NCT03410212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183605|NCT03410212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183606|NCT03410212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183607|NCT03410212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183608|NCT03397264|Aflibercept|aflibercept|mesh-list
93183609|NCT03397264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93183610|NCT03397264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93183611|NCT03397264|Growth Substances|growth substances|mesh-ancestor
93183612|NCT03397264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183613|NCT03397264|Growth Inhibitors|growth inhibitors|mesh-ancestor
93183614|NCT03397264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183615|NCT03397186|Trabectedin|trabectedin|mesh-list
93183616|NCT03397186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93183617|NCT03397186|Alkylating Agents|alkylating agents|mesh-ancestor
93183618|NCT03397186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183619|NCT03397186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183620|NCT03393364|Ketorolac|ketorolac|mesh-list
93183621|NCT03393364|Oxycodone|oxycodone|mesh-list
93183622|NCT03393364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93183623|NCT03393364|Narcotics|narcotics|mesh-ancestor
93183624|NCT03393364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183625|NCT03393364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183626|NCT03393364|Analgesics|analgesics|mesh-ancestor
93183627|NCT03393364|Sensory System Agents|sensory system agents|mesh-ancestor
93183628|NCT03393364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183629|NCT03393364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183630|NCT03393364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183631|NCT03393364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183632|NCT03393364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183633|NCT03393364|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183634|NCT03393364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183635|NCT03393364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183636|NCT04632706|Ivermectin|ivermectin|mesh-list
93183637|NCT04632706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93183638|NCT04632706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183639|NCT03405454|Durvalumab|durvalumab|mesh-list
93183640|NCT03405454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183641|NCT03405454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183642|NCT05168176|Dolutegravir|dolutegravir|mesh-list
93183643|NCT05168176|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93183644|NCT05168176|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93183645|NCT05168176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183646|NCT05168176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183647|NCT05168176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93183648|NCT05168176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93183649|NCT05168176|Antiviral Agents|antiviral agents|mesh-ancestor
93183650|NCT05168176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183651|NCT04539730|Bupivacaine|bupivacaine|mesh-list
93183652|NCT04539730|Ropivacaine|ropivacaine|mesh-list
93183653|NCT04539730|Anesthetics, Local|anesthetics, local|mesh-ancestor
93183654|NCT04539730|Anesthetics|anesthetics|mesh-ancestor
93183655|NCT04539730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183656|NCT04539730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183657|NCT04539730|Sensory System Agents|sensory system agents|mesh-ancestor
93183658|NCT04539730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183659|NCT03396484|Methyldopa|methyldopa|mesh-list
93183660|NCT03396484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93183661|NCT03396484|Sympatholytics|sympatholytics|mesh-ancestor
93183662|NCT03396484|Autonomic Agents|autonomic agents|mesh-ancestor
93183663|NCT03396484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183664|NCT03396484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183665|NCT03396484|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93183666|NCT03396484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93183667|NCT03396484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93183668|NCT03396484|Adrenergic Agents|adrenergic agents|mesh-ancestor
93183669|NCT03396484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183670|NCT03396484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183671|NCT03321396|Calcium|calcium|mesh-list
93183672|NCT03321396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92855821|NCT04242758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93183673|NCT03321396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183674|NCT04809376|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
93183675|NCT04809376|Anticoagulants|anticoagulants|mesh-ancestor
93183676|NCT03321006|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93183677|NCT03321006|Escitalopram|escitalopram|mesh-list
93183678|NCT03321006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93183679|NCT03321006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93183680|NCT03321006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183681|NCT03321006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183682|NCT03321006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183683|NCT03321006|Serotonin Agents|serotonin agents|mesh-ancestor
93183684|NCT03321006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183685|NCT03321006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183686|NCT03321006|Antidepressive Agents|antidepressive agents|mesh-ancestor
93183687|NCT03321006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93183688|NCT03321006|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93183689|NCT03321006|Analgesics|analgesics|mesh-ancestor
93183690|NCT03321006|Sensory System Agents|sensory system agents|mesh-ancestor
93183691|NCT03321006|Dopamine Agents|dopamine agents|mesh-ancestor
93183692|NCT04760626|Insulin|insulin|mesh-list
93183693|NCT04760626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93183694|NCT04760626|Insulin Glargine|insulin glargine|mesh-list
93183695|NCT04760626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93183696|NCT04760626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183697|NCT01974609|Acetaminophen|acetaminophen|mesh-list
93183698|NCT01974609|Ibuprofen|ibuprofen|mesh-list
93183699|NCT01974609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93183700|NCT01974609|Hydrocodone|hydrocodone|mesh-list
93183701|NCT01974609|Narcotics|narcotics|mesh-list
93183702|NCT01974609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183703|NCT01974609|Analgesics|analgesics|mesh-ancestor
93183704|NCT01974609|Sensory System Agents|sensory system agents|mesh-ancestor
93183705|NCT01974609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183706|NCT01974609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183707|NCT01974609|Antipyretics|antipyretics|mesh-ancestor
93183708|NCT01974609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183709|NCT01974609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183710|NCT01974609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183711|NCT01974609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183712|NCT01974609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183713|NCT01974609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183714|NCT01974609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93183715|NCT01974609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183716|NCT01974609|Antitussive Agents|antitussive agents|mesh-ancestor
93183717|NCT01974609|Respiratory System Agents|respiratory system agents|mesh-ancestor
93183718|NCT02593123|Mycophenolic Acid|mycophenolic acid|mesh-list
93183719|NCT02593123|Molgramostim|molgramostim|mesh-list
93183720|NCT02593123|Lenograstim|lenograstim|mesh-list
93183721|NCT02593123|Sargramostim|sargramostim|mesh-list
93183722|NCT02593123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93183723|NCT02593123|Immunologic Factors|immunologic factors|mesh-ancestor
93183724|NCT02593123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183725|NCT02593123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93183726|NCT02593123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183727|NCT02593123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93183728|NCT02593123|Antitubercular Agents|antitubercular agents|mesh-ancestor
93183729|NCT02593123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93183730|NCT02593123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183731|NCT02593123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183732|NCT02593123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183733|NCT03396250|Diphenhydramine|diphenhydramine|mesh-list
93183734|NCT03396250|Promethazine|promethazine|mesh-list
93183735|NCT03396250|Naproxen|naproxen|mesh-list
93183736|NCT03396250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183737|NCT03396250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183738|NCT03396250|Analgesics|analgesics|mesh-ancestor
93183739|NCT03396250|Sensory System Agents|sensory system agents|mesh-ancestor
93183740|NCT03396250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183741|NCT03396250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183742|NCT03396250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183743|NCT03396250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183744|NCT03396250|Gout Suppressants|gout suppressants|mesh-ancestor
93183745|NCT03396250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183746|NCT03396250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183747|NCT03396250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183748|NCT03396250|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93183749|NCT03396250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93183750|NCT03396250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93183751|NCT03396250|Anesthetics, Local|anesthetics, local|mesh-ancestor
93183752|NCT03396250|Anesthetics|anesthetics|mesh-ancestor
93183753|NCT03396250|Antiemetics|antiemetics|mesh-ancestor
93183754|NCT03396250|Autonomic Agents|autonomic agents|mesh-ancestor
93183755|NCT03396250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93183756|NCT03396250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93183757|NCT03396250|Histamine Antagonists|histamine antagonists|mesh-ancestor
93183758|NCT03396250|Histamine Agents|histamine agents|mesh-ancestor
93183759|NCT03396250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183760|NCT03396250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93183761|NCT03396250|Antipruritics|antipruritics|mesh-ancestor
93183762|NCT03396250|Dermatologic Agents|dermatologic agents|mesh-ancestor
93183763|NCT03302559|Vitamin A|vitamin a|mesh-list
93183764|NCT03302559|Retinol palmitate|retinol palmitate|mesh-list
93183765|NCT03302559|Sunscreening Agents|sunscreening agents|mesh-list
93183766|NCT03302559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93183767|NCT03302559|Protective Agents|protective agents|mesh-ancestor
93183768|NCT03302559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183769|NCT03302559|Dermatologic Agents|dermatologic agents|mesh-ancestor
93183770|NCT03302559|Vitamins|vitamins|mesh-ancestor
93183771|NCT03302559|Micronutrients|micronutrients|mesh-ancestor
93183772|NCT03302559|Antioxidants|antioxidants|mesh-ancestor
93183773|NCT03302559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183774|NCT03302559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93183775|NCT03302559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183776|NCT03763669|Folic Acid|folic acid|mesh-list
93183777|NCT03763669|Vitamin B Complex|vitamin b complex|mesh-list
93183778|NCT03763669|Inositol|inositol|mesh-list
93183779|NCT03763669|Hematinics|hematinics|mesh-ancestor
93183780|NCT03763669|Vitamins|vitamins|mesh-ancestor
93183781|NCT03763669|Micronutrients|micronutrients|mesh-ancestor
93183782|NCT03763669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183783|NCT03302247|Gemcitabine|gemcitabine|mesh-list
93183784|NCT03302247|Nivolumab|nivolumab|mesh-list
93183785|NCT03302247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93183786|NCT03302247|Antimetabolites|antimetabolites|mesh-ancestor
93183787|NCT03302247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183788|NCT03302247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183789|NCT03302247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183790|NCT03302247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93183791|NCT01758081|Vitamin D|vitamin d|mesh-list
93183792|NCT01758081|Ergocalciferols|ergocalciferols|mesh-list
93183793|NCT01758081|Cholecalciferol|cholecalciferol|mesh-list
93183794|NCT01758081|Vitamins|vitamins|mesh-list
93183795|NCT01758081|Micronutrients|micronutrients|mesh-ancestor
93183796|NCT01758081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183797|NCT01758081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93183798|NCT01758081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93183799|NCT04363840|Aspirin|aspirin|mesh-list
93183800|NCT04363840|Vitamin D|vitamin d|mesh-list
93183801|NCT04363840|Vitamins|vitamins|mesh-ancestor
93183802|NCT04363840|Micronutrients|micronutrients|mesh-ancestor
93183803|NCT04363840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183804|NCT04363840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93183805|NCT04363840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93183806|NCT04363840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93183807|NCT04363840|Analgesics|analgesics|mesh-ancestor
93183808|NCT04363840|Sensory System Agents|sensory system agents|mesh-ancestor
93183809|NCT04363840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183810|NCT04363840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183811|NCT04363840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183812|NCT04363840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93183813|NCT04363840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93183814|NCT04363840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183815|NCT04363840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93183816|NCT04363840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93183817|NCT04363840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183818|NCT04363840|Antipyretics|antipyretics|mesh-ancestor
93183819|NCT04981665|Tislelizumab|tislelizumab|mesh-list
93183820|NCT04981665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183821|NCT04981665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183822|NCT03392740|Lisinopril|lisinopril|mesh-list
93183823|NCT03392740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93183824|NCT03392740|Protease Inhibitors|protease inhibitors|mesh-ancestor
93183825|NCT03392740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183826|NCT03392740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183827|NCT03392740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93183828|NCT03392740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93183829|NCT03392740|Protective Agents|protective agents|mesh-ancestor
93183830|NCT03392740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183831|NCT04919317|Dexamethasone|dexamethasone|mesh-list
93183832|NCT04919317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183833|NCT04919317|Antiemetics|antiemetics|mesh-ancestor
93183834|NCT04919317|Autonomic Agents|autonomic agents|mesh-ancestor
93183835|NCT04919317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183836|NCT04919317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183837|NCT04919317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93183838|NCT04919317|Glucocorticoids|glucocorticoids|mesh-ancestor
93183839|NCT04919317|Hormones|hormones|mesh-ancestor
93183840|NCT04919317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93183841|NCT04919317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93183842|NCT04919317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183843|NCT02818023|Pembrolizumab|pembrolizumab|mesh-list
93183844|NCT02818023|Vemurafenib|vemurafenib|mesh-list
93183845|NCT02818023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183846|NCT02818023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183847|NCT02818023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93183848|NCT02818023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183849|NCT02818023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93183850|NCT02818023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183851|NCT03262389|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93183852|NCT03262389|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93183853|NCT03262389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183854|NCT04631536|Folic Acid|folic acid|mesh-list
93183855|NCT04631536|Vitamin B Complex|vitamin b complex|mesh-list
93183856|NCT04631536|Nicorandil|nicorandil|mesh-list
93183857|NCT04631536|Nebivolol|nebivolol|mesh-list
93183858|NCT04631536|Atorvastatin|atorvastatin|mesh-list
93183859|NCT04631536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93183860|NCT04631536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93183861|NCT04631536|Antimetabolites|antimetabolites|mesh-ancestor
93183862|NCT04631536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183863|NCT04631536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93183864|NCT04631536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93183865|NCT04631536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183866|NCT04631536|Hematinics|hematinics|mesh-ancestor
93183867|NCT04631536|Vitamins|vitamins|mesh-ancestor
93183868|NCT04631536|Micronutrients|micronutrients|mesh-ancestor
93183869|NCT04631536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183870|NCT04631536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93183871|NCT04631536|Vasodilator Agents|vasodilator agents|mesh-ancestor
93183872|NCT04631536|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93183873|NCT04631536|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93183874|NCT04631536|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93183875|NCT04631536|Adrenergic Agents|adrenergic agents|mesh-ancestor
93183876|NCT04631536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183877|NCT04631536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93183878|NCT03262233|Nicotine|nicotine|mesh-list
93183879|NCT03262233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93183880|NCT03262233|Autonomic Agents|autonomic agents|mesh-ancestor
93183881|NCT03262233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183882|NCT03262233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183883|NCT03262233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93183884|NCT03262233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93183885|NCT03262233|Cholinergic Agents|cholinergic agents|mesh-ancestor
93183886|NCT03262233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183887|NCT03262233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183888|NCT05166538|Clopidogrel|clopidogrel|mesh-list
93183889|NCT05166538|Ticagrelor|ticagrelor|mesh-list
93183890|NCT05166538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93183891|NCT05166538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93183892|NCT05166538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93183893|NCT05166538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93183894|NCT05166538|Purinergic Agents|purinergic agents|mesh-ancestor
93183895|NCT05166538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183896|NCT05166538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183897|NCT05166538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183898|NCT03260205|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93183899|NCT03260205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93183900|NCT03260205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183901|NCT03260205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93183902|NCT03260205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93183903|NCT03260205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183904|NCT03260205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183905|NCT03260205|Dopamine Agents|dopamine agents|mesh-ancestor
93183906|NCT03260205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183907|NCT04666441|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
93183908|NCT04666441|Antiviral Agents|antiviral agents|mesh-ancestor
93183909|NCT04666441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183910|NCT03320850|Botulinum Toxins|botulinum toxins|mesh-list
93183911|NCT03320850|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93183912|NCT03320850|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93183913|NCT03320850|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93183914|NCT03320850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183915|NCT03320850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183916|NCT03320850|Cholinergic Agents|cholinergic agents|mesh-ancestor
93183917|NCT03320850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93183918|NCT03320850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183919|NCT03320850|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93183920|NCT03320850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93183921|NCT04447378|PENTA|penta|mesh-list
93183922|NCT04447378|Fondaparinux|fondaparinux|mesh-list
93183923|NCT04447378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93183924|NCT04447378|Antithrombins|antithrombins|mesh-ancestor
93183925|NCT04447378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93183926|NCT04447378|Protease Inhibitors|protease inhibitors|mesh-ancestor
93183927|NCT04447378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183928|NCT04447378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183929|NCT04447378|Anticoagulants|anticoagulants|mesh-ancestor
93183930|NCT04447378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93183931|NCT04447378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93183932|NCT03125980|Capecitabine|capecitabine|mesh-list
93183933|NCT03125980|Oxaliplatin|oxaliplatin|mesh-list
93183934|NCT03125980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93183935|NCT03125980|Antimetabolites|antimetabolites|mesh-ancestor
93183936|NCT03125980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183937|NCT03125980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183938|NCT03399604|Treprostinil|treprostinil|mesh-list
93183939|NCT03399604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93183940|NCT03399526|Calcitriol|calcitriol|mesh-list
93183941|NCT03399526|Betamethasone|betamethasone|mesh-list
93183942|NCT03399526|Betamethasone Valerate|betamethasone valerate|mesh-list
93183943|NCT03399526|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93183944|NCT03399526|Betamethasone benzoate|betamethasone benzoate|mesh-list
93183945|NCT03399526|Clobetasol|clobetasol|mesh-list
93183946|NCT03399526|Prednicarbate|prednicarbate|mesh-list
93183947|NCT03399526|Calcipotriene|calcipotriene|mesh-list
93183948|NCT03399526|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93183949|NCT03399526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93183950|NCT03399526|Glucocorticoids|glucocorticoids|mesh-ancestor
93183951|NCT03399526|Hormones|hormones|mesh-ancestor
93183952|NCT03399526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93183953|NCT03399526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183954|NCT03399526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93183955|NCT03399526|Respiratory System Agents|respiratory system agents|mesh-ancestor
93183956|NCT03399526|Dermatologic Agents|dermatologic agents|mesh-ancestor
93183957|NCT03399526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93183958|NCT03399526|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93183959|NCT03399526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93183960|NCT03399526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183961|NCT03399526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93183962|NCT03399526|Vitamins|vitamins|mesh-ancestor
93183963|NCT03399526|Micronutrients|micronutrients|mesh-ancestor
93183964|NCT03399526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93183965|NCT03392272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93183966|NCT03392272|Hemostatics|hemostatics|mesh-ancestor
93183967|NCT03392272|Coagulants|coagulants|mesh-ancestor
93183968|NCT03905902|Vaccines|vaccines|mesh-list
93183969|NCT03905902|Immunologic Factors|immunologic factors|mesh-ancestor
93183970|NCT03905902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183971|NCT03638310|Gentamicins|gentamicins|mesh-list
93183972|NCT03638310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93183973|NCT03638310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183974|NCT03638310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93183975|NCT03638310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93183976|NCT03638310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183977|NCT04656691|Bamlanivimab|bamlanivimab|mesh-list
93183978|NCT04656691|Antiviral Agents|antiviral agents|mesh-ancestor
93183979|NCT04656691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93183980|NCT03399448|Cyclophosphamide|cyclophosphamide|mesh-list
93183981|NCT03399448|Fludarabine|fludarabine|mesh-list
93183982|NCT03399448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93183983|NCT03399448|Immunologic Factors|immunologic factors|mesh-ancestor
93183984|NCT03399448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93183985|NCT03399448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93183986|NCT03399448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93183987|NCT03399448|Alkylating Agents|alkylating agents|mesh-ancestor
93183988|NCT03399448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93183989|NCT03399448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183990|NCT03399448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93183991|NCT03755947|Venetoclax|venetoclax|mesh-list
93183992|NCT03755947|Obinutuzumab|obinutuzumab|mesh-list
93183993|NCT03755947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93183994|NCT03755947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93183995|NCT03395470|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93183996|NCT03395470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93183997|NCT03395470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93183998|NCT03395470|Antimetabolites|antimetabolites|mesh-ancestor
93183999|NCT03395470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184000|NCT03395470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93184001|NCT03395470|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93184002|NCT03395470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184003|NCT03257865|Brexpiprazole|brexpiprazole|mesh-list
93184004|NCT03257865|Serotonin Agents|serotonin agents|mesh-ancestor
93184005|NCT03257865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184006|NCT03257865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184007|NCT03257865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184008|NCT03257865|Dopamine Agonists|dopamine agonists|mesh-ancestor
93184009|NCT03257865|Dopamine Agents|dopamine agents|mesh-ancestor
93184010|NCT01610700|Nabiximols|nabiximols|mesh-list
93184011|NCT01610700|Analgesics|analgesics|mesh-ancestor
93184012|NCT01610700|Sensory System Agents|sensory system agents|mesh-ancestor
93184013|NCT01610700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184014|NCT01610700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184015|NCT04632459|Pembrolizumab|pembrolizumab|mesh-list
93184016|NCT04632459|Ramucirumab|ramucirumab|mesh-list
93184017|NCT04632459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184018|NCT04632459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184019|NCT04632459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93184020|NCT04632459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184021|NCT03985371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93184022|NCT03985371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93184023|NCT03316872|Pembrolizumab|pembrolizumab|mesh-list
93184024|NCT03316872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184025|NCT03316872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184026|NCT03316872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93184027|NCT03316872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184028|NCT03256695|Albuterol|albuterol|mesh-list
93184029|NCT03256695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184030|NCT03256695|Autonomic Agents|autonomic agents|mesh-ancestor
93184031|NCT03256695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184032|NCT03256695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184033|NCT03256695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184034|NCT03256695|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184035|NCT03256695|Tocolytic Agents|tocolytic agents|mesh-ancestor
93184036|NCT03256695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93184037|NCT03256695|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93184038|NCT03256695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93184039|NCT03256695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93184040|NCT03256695|Adrenergic Agents|adrenergic agents|mesh-ancestor
93184041|NCT03256695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184042|NCT03256695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184043|NCT04623684|Phenylephrine|phenylephrine|mesh-list
93184044|NCT04623684|Oxymetazoline|oxymetazoline|mesh-list
93184045|NCT04623684|Tropicamide|tropicamide|mesh-list
93184046|NCT04623684|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93184047|NCT04623684|Mydriatics|mydriatics|mesh-ancestor
93184048|NCT04623684|Autonomic Agents|autonomic agents|mesh-ancestor
93184049|NCT04623684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184050|NCT04623684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184051|NCT04623684|Sympathomimetics|sympathomimetics|mesh-ancestor
93184052|NCT04623684|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93184053|NCT04623684|Nasal Decongestants|nasal decongestants|mesh-ancestor
93184054|NCT04623684|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184055|NCT04623684|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93184056|NCT04623684|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93184057|NCT04623684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93184058|NCT04623684|Adrenergic Agents|adrenergic agents|mesh-ancestor
93184059|NCT04623684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184060|NCT04623684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184061|NCT04623684|Protective Agents|protective agents|mesh-ancestor
93184062|NCT04623684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93184063|NCT04623684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93184064|NCT04623684|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184065|NCT03297021|Ondansetron|ondansetron|mesh-list
93184066|NCT03297021|Antiemetics|antiemetics|mesh-ancestor
93184067|NCT03297021|Autonomic Agents|autonomic agents|mesh-ancestor
93184068|NCT03297021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184069|NCT03297021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184070|NCT03297021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93184071|NCT03297021|Antipruritics|antipruritics|mesh-ancestor
93184072|NCT03297021|Dermatologic Agents|dermatologic agents|mesh-ancestor
93184073|NCT03297021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93184074|NCT03297021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93184075|NCT03297021|Serotonin Agents|serotonin agents|mesh-ancestor
93184076|NCT03297021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184077|NCT03297021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184078|NCT03752749|Prednisolone|prednisolone|mesh-list
93184079|NCT03752749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184080|NCT03752749|Glucocorticoids|glucocorticoids|mesh-ancestor
93184082|NCT03752749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184083|NCT03752749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184084|NCT03752749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93184085|NCT03752749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184086|NCT01988571|Atorvastatin|atorvastatin|mesh-list
93184087|NCT01988571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93184088|NCT01988571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93184089|NCT01988571|Antimetabolites|antimetabolites|mesh-ancestor
93184090|NCT01988571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184091|NCT01988571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93184092|NCT01988571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93184093|NCT01988571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184094|NCT00536172|Escitalopram|escitalopram|mesh-list
93184095|NCT00536172|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93184096|NCT00536172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93184097|NCT00536172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184098|NCT00536172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184099|NCT00536172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184100|NCT00536172|Serotonin Agents|serotonin agents|mesh-ancestor
93184101|NCT00536172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184102|NCT03755557|Budesonide|budesonide|mesh-list
93184103|NCT03755557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184104|NCT03755557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184105|NCT03755557|Autonomic Agents|autonomic agents|mesh-ancestor
93184106|NCT03755557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184107|NCT03755557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184108|NCT03755557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184109|NCT03755557|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184110|NCT03755557|Glucocorticoids|glucocorticoids|mesh-ancestor
93184111|NCT03755557|Hormones|hormones|mesh-ancestor
93184112|NCT03755557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184113|NCT03511599|Cycloserine|cycloserine|mesh-list
93184114|NCT03511599|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93184115|NCT03511599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184116|NCT03511599|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93184117|NCT03511599|Antitubercular Agents|antitubercular agents|mesh-ancestor
93184118|NCT03511599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93184119|NCT03511599|Antimetabolites|antimetabolites|mesh-ancestor
93184120|NCT03511599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184121|NCT01140867|Zonisamide|zonisamide|mesh-list
93184122|NCT01140867|Anticonvulsants|anticonvulsants|mesh-ancestor
93184123|NCT01140867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93184124|NCT01140867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856269|NCT00908713|Antiemetics|antiemetics|mesh-ancestor
93184125|NCT01140867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184126|NCT01140867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93184127|NCT01140867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184128|NCT04572997|Apremilast|apremilast|mesh-list
93184129|NCT04572997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93184130|NCT04572997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184131|NCT04572997|Analgesics|analgesics|mesh-ancestor
93184132|NCT04572997|Sensory System Agents|sensory system agents|mesh-ancestor
93184133|NCT04572997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184134|NCT04572997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184135|NCT04572997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184136|NCT04572997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184137|NCT04572997|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93184138|NCT04572997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93184139|NCT04572997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184140|NCT04572997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184141|NCT03292653|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93184142|NCT03292653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93184143|NCT03292653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184144|NCT03292653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93184145|NCT03292653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184146|NCT02891070|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93184147|NCT02891070|Hemostatics|hemostatics|mesh-ancestor
93184148|NCT02891070|Coagulants|coagulants|mesh-ancestor
93184149|NCT00381381|Donepezil|donepezil|mesh-list
93184150|NCT00381381|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93184151|NCT00381381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184152|NCT00381381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184153|NCT00381381|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184154|NCT00381381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184155|NCT00381381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184156|NCT00381381|Nootropic Agents|nootropic agents|mesh-ancestor
93184157|NCT03637335|Carboplatin|carboplatin|mesh-list
93184158|NCT03637335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184159|NCT02939937|Phenytoin|phenytoin|mesh-list
93184160|NCT02939937|Anticonvulsants|anticonvulsants|mesh-ancestor
93184161|NCT02939937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93184162|NCT02939937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93184163|NCT02939937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184164|NCT02939937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184165|NCT02939937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93184166|NCT02939937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93184167|NCT02939079|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93184168|NCT02939079|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93184169|NCT02939079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184170|NCT02939079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93184171|NCT02939079|Immunologic Factors|immunologic factors|mesh-ancestor
93184172|NCT02939079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184173|NCT02774265|Aspirin|aspirin|mesh-list
93184174|NCT02774265|Heparin|heparin|mesh-list
93184175|NCT02774265|Enoxaparin|enoxaparin|mesh-list
93184176|NCT02774265|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93184177|NCT02774265|Tinzaparin|tinzaparin|mesh-list
93184178|NCT02774265|Dalteparin|dalteparin|mesh-list
93184179|NCT02774265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93184180|NCT02774265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184181|NCT02774265|Analgesics|analgesics|mesh-ancestor
93184182|NCT02774265|Sensory System Agents|sensory system agents|mesh-ancestor
93184183|NCT02774265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184184|NCT02774265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184185|NCT02774265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184186|NCT02774265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184187|NCT02774265|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93184188|NCT02774265|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93184189|NCT02774265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184190|NCT02774265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93184191|NCT02774265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93184192|NCT02774265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184193|NCT02774265|Antipyretics|antipyretics|mesh-ancestor
93184194|NCT02774265|Anticoagulants|anticoagulants|mesh-ancestor
93184195|NCT04755595|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93184196|NCT04755595|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93184197|NCT04755595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93184198|NCT04755595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184199|NCT04755595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184200|NCT04755595|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93184201|NCT04755595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184202|NCT04755595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184203|NCT04755595|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184204|NCT04755595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184206|NCT03755479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93184207|NCT03755479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184208|NCT05239390|Dronabinol|dronabinol|mesh-list
93184209|NCT05239390|Hallucinogens|hallucinogens|mesh-ancestor
93184210|NCT05239390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184211|NCT05239390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93184212|NCT05239390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184213|NCT05239390|Analgesics|analgesics|mesh-ancestor
93184214|NCT05239390|Sensory System Agents|sensory system agents|mesh-ancestor
93184215|NCT05239390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184216|NCT05239390|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92855398|NCT04919096|Aflibercept|aflibercept|mesh-list
93184217|NCT05239390|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93184218|NCT05239390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184219|NCT05239390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184220|NCT05239390|Hormones|hormones|mesh-ancestor
93184221|NCT05239390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184222|NCT03752437|Heparin|heparin|mesh-list
93184223|NCT03752437|Anticoagulants|anticoagulants|mesh-ancestor
93184224|NCT03752437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93184225|NCT03752437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93184226|NCT03752437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184227|NCT05239312|Anti-Infective Agents|anti-infective agents|mesh-list
93184228|NCT05239312|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93184229|NCT04748341|Benzocaine|benzocaine|mesh-list
93184230|NCT04748341|Anesthetics, Local|anesthetics, local|mesh-ancestor
93184231|NCT04748341|Anesthetics|anesthetics|mesh-ancestor
93184232|NCT04748341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184233|NCT04748341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184234|NCT04748341|Sensory System Agents|sensory system agents|mesh-ancestor
93184235|NCT04748341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184236|NCT01328002|Milnacipran|milnacipran|mesh-list
93184237|NCT01328002|Levomilnacipran|levomilnacipran|mesh-list
93184238|NCT01328002|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93184239|NCT01328002|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93184240|NCT01328002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184241|NCT01328002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184242|NCT01328002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184243|NCT01328002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184244|NCT01328002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184245|NCT01328002|Analgesics|analgesics|mesh-ancestor
93184246|NCT01328002|Sensory System Agents|sensory system agents|mesh-ancestor
93184247|NCT01328002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184248|NCT01328002|Antidepressive Agents|antidepressive agents|mesh-ancestor
93184249|NCT01328002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93184250|NCT05239078|Anesthetics|anesthetics|mesh-list
93184251|NCT05239078|Anesthetics, Local|anesthetics, local|mesh-list
93184252|NCT05239078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184253|NCT05239078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184254|NCT05239078|Sensory System Agents|sensory system agents|mesh-ancestor
93184255|NCT05239078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184256|NCT02579265|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93184257|NCT02579265|SMOFlipid|smoflipid|mesh-list
93184258|NCT02579265|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
93184259|NCT02579265|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93184260|NCT02579265|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93184261|NCT05238220|Valganciclovir|valganciclovir|mesh-list
93184262|NCT05238220|Antiviral Agents|antiviral agents|mesh-ancestor
93184263|NCT05238220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184264|NCT04446598|Tadalafil|tadalafil|mesh-list
93184265|NCT04446598|Vasodilator Agents|vasodilator agents|mesh-ancestor
93184266|NCT04446598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93184267|NCT04446598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93184268|NCT04446598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184269|NCT04446598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184270|NCT04446598|Urological Agents|urological agents|mesh-ancestor
93184271|NCT03391570|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
93184272|NCT03391570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93184273|NCT03391570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184274|NCT03391570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184275|NCT03391570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93184276|NCT03391570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184278|NCT03391570|Sensory System Agents|sensory system agents|mesh-ancestor
93184279|NCT03391570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184280|NCT03391570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184281|NCT03391570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184282|NCT03391570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184283|NCT03755089|Lidocaine|lidocaine|mesh-list
93184284|NCT03755089|Anesthetics, Local|anesthetics, local|mesh-ancestor
93184285|NCT03755089|Anesthetics|anesthetics|mesh-ancestor
93184286|NCT03755089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184287|NCT03755089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184288|NCT03755089|Sensory System Agents|sensory system agents|mesh-ancestor
93184289|NCT03755089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184290|NCT03755089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93184291|NCT03755089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93184292|NCT03755089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93184293|NCT03755089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184294|NCT03755089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184295|NCT03757117|Hormones|hormones|mesh-list
93184296|NCT03757117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184297|NCT03757117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184298|NCT03752125|Caffeine|caffeine|mesh-list
93184299|NCT03752125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93184300|NCT03752125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184301|NCT03752125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93184302|NCT03752125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184303|NCT03752125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184304|NCT03752125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93184305|NCT03752125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93184306|NCT03752125|Purinergic Agents|purinergic agents|mesh-ancestor
93184307|NCT03752125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184308|NCT03289533|Avelumab|avelumab|mesh-list
93184309|NCT03289533|Axitinib|axitinib|mesh-list
93184310|NCT03289533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184311|NCT03289533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184312|NCT03289533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93184313|NCT03289533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184314|NCT03289533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184315|NCT03395002|Fluticasone|fluticasone|mesh-list
93184316|NCT03395002|Xhance|xhance|mesh-list
93184317|NCT03395002|Tiotropium Bromide|tiotropium bromide|mesh-list
93184318|NCT03395002|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93184319|NCT03395002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184320|NCT03395002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184321|NCT03395002|Autonomic Agents|autonomic agents|mesh-ancestor
93184322|NCT03395002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184323|NCT03395002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184324|NCT03395002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184325|NCT03395002|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184326|NCT03395002|Dermatologic Agents|dermatologic agents|mesh-ancestor
93184327|NCT03395002|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93184328|NCT03395002|Parasympatholytics|parasympatholytics|mesh-ancestor
93184329|NCT03395002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93184330|NCT03395002|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184331|NCT03395002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184332|NCT03395002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184333|NCT03395002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93184334|NCT03395002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93184335|NCT03395002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93184336|NCT03395002|Adrenergic Agents|adrenergic agents|mesh-ancestor
93184337|NCT05238064|Cyclophosphamide|cyclophosphamide|mesh-list
93184338|NCT05238064|Doxorubicin|doxorubicin|mesh-list
93184339|NCT05238064|Vincristine|vincristine|mesh-list
93184340|NCT05238064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93184341|NCT05238064|Immunologic Factors|immunologic factors|mesh-ancestor
93184342|NCT05238064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184343|NCT05238064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184344|NCT05238064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93184345|NCT05238064|Alkylating Agents|alkylating agents|mesh-ancestor
93184346|NCT05238064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184347|NCT05238064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184348|NCT05238064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93184349|NCT05238064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93184350|NCT05238064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93184351|NCT05238064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93184352|NCT05238064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184353|NCT05238064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93184354|NCT05238064|Tubulin Modulators|tubulin modulators|mesh-ancestor
93184355|NCT05238064|Antimitotic Agents|antimitotic agents|mesh-ancestor
93184356|NCT05238064|Mitosis Modulators|mitosis modulators|mesh-ancestor
93184357|NCT03390790|Lidocaine|lidocaine|mesh-list
93184358|NCT03390790|Anesthetics, Local|anesthetics, local|mesh-ancestor
93184359|NCT03390790|Anesthetics|anesthetics|mesh-ancestor
93184360|NCT03390790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184361|NCT03390790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928473|NCT02403687|Prilocaine|prilocaine|mesh-list
93184362|NCT03390790|Sensory System Agents|sensory system agents|mesh-ancestor
93184363|NCT03390790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184364|NCT03390790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93184365|NCT03390790|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93184366|NCT03390790|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93184367|NCT03390790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184368|NCT03390790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184369|NCT03697993|Levofloxacin|levofloxacin|mesh-list
93184370|NCT03697993|Fosfomycin|fosfomycin|mesh-list
93184371|NCT03697993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93184372|NCT03697993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184373|NCT03697993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93184374|NCT03697993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93184375|NCT03697993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93184376|NCT03697993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184377|NCT03697993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184378|NCT03697993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184379|NCT03697993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93184380|NCT03697993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93184381|NCT05393245|Tiotropium Bromide|tiotropium bromide|mesh-list
93184382|NCT05393245|Olodaterol|olodaterol|mesh-list
93184383|NCT05393245|Cholinergic Agents|cholinergic agents|mesh-list
93184384|NCT05393245|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93184385|NCT05393245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184386|NCT05393245|Autonomic Agents|autonomic agents|mesh-ancestor
93184387|NCT05393245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184388|NCT05393245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184389|NCT05393245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184390|NCT05393245|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184391|NCT05393245|Parasympatholytics|parasympatholytics|mesh-ancestor
93184392|NCT05393245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93184393|NCT05393245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184394|NCT05393245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184395|NCT04544995|Niraparib|niraparib|mesh-list
93184396|NCT04544995|Dostarlimab|dostarlimab|mesh-list
93184397|NCT04544995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93184398|NCT04544995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184399|NCT04544995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184400|NCT04544995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184401|NCT03390712|Risperidone|risperidone|mesh-list
93184402|NCT03390712|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93184403|NCT03390712|Antipsychotic Agents|antipsychotic agents|mesh-list
93184404|NCT03390712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93184405|NCT03390712|Serotonin Agents|serotonin agents|mesh-ancestor
93184406|NCT03390712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184407|NCT03390712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184408|NCT03390712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184409|NCT03390712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93184410|NCT03390712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184411|NCT03390712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93184412|NCT03390712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93184413|NCT03390712|Dopamine Agents|dopamine agents|mesh-ancestor
93184414|NCT03390712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93184415|NCT03390712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93184416|NCT03756727|Ascorbic Acid|ascorbic acid|mesh-list
93184417|NCT03756727|Vitamins|vitamins|mesh-ancestor
93184418|NCT03756727|Micronutrients|micronutrients|mesh-ancestor
93184419|NCT03756727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184420|NCT03756727|Antioxidants|antioxidants|mesh-ancestor
93184421|NCT03756727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184422|NCT03756727|Protective Agents|protective agents|mesh-ancestor
93184423|NCT04962724|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93184424|NCT03398434|Apixaban|apixaban|mesh-list
93184425|NCT03398434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93184426|NCT03398434|Antithrombins|antithrombins|mesh-ancestor
93184427|NCT03398434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93184428|NCT03398434|Protease Inhibitors|protease inhibitors|mesh-ancestor
93184429|NCT03398434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184430|NCT03398434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184431|NCT03398434|Anticoagulants|anticoagulants|mesh-ancestor
93184432|NCT03398122|Apatinib|apatinib|mesh-list
93184433|NCT03398122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184434|NCT03398122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93184435|NCT03398122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184436|NCT03398122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184437|NCT05459857|Menthol|menthol|mesh-list
93184438|NCT05459857|Antipruritics|antipruritics|mesh-ancestor
93184439|NCT05459857|Dermatologic Agents|dermatologic agents|mesh-ancestor
93184440|NCT03394222|Budesonide|budesonide|mesh-list
93184441|NCT03394222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184442|NCT03394222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184443|NCT03394222|Autonomic Agents|autonomic agents|mesh-ancestor
93184444|NCT03394222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184445|NCT03394222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184446|NCT03394222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184447|NCT03394222|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184448|NCT03394222|Glucocorticoids|glucocorticoids|mesh-ancestor
93184449|NCT03394222|Hormones|hormones|mesh-ancestor
93184450|NCT03394222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184451|NCT03398044|Dexamethasone|dexamethasone|mesh-list
93184452|NCT03398044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184453|NCT03398044|Antiemetics|antiemetics|mesh-ancestor
93184454|NCT03398044|Autonomic Agents|autonomic agents|mesh-ancestor
93184455|NCT03398044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184456|NCT03398044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184457|NCT03398044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93184458|NCT03398044|Glucocorticoids|glucocorticoids|mesh-ancestor
93184459|NCT03398044|Hormones|hormones|mesh-ancestor
93184460|NCT03398044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184461|NCT03398044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93184462|NCT03398044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184463|NCT03389776|Anesthetics|anesthetics|mesh-list
93184464|NCT03389776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184465|NCT03389776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184466|NCT02813200|Tiotropium Bromide|tiotropium bromide|mesh-list
93184467|NCT02813200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93184468|NCT02813200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184469|NCT02813200|Autonomic Agents|autonomic agents|mesh-ancestor
93184470|NCT02813200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184471|NCT02813200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184472|NCT02813200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184473|NCT02813200|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184474|NCT02813200|Parasympatholytics|parasympatholytics|mesh-ancestor
93184475|NCT02813200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93184476|NCT02813200|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184477|NCT02813200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184478|NCT02813200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184479|NCT02813200|Glucocorticoids|glucocorticoids|mesh-ancestor
93184480|NCT02813200|Hormones|hormones|mesh-ancestor
93184481|NCT02813200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184482|NCT02813200|Sympathomimetics|sympathomimetics|mesh-ancestor
93184483|NCT04535947|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93184484|NCT04535947|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93184485|NCT03750721|Rifampin|rifampin|mesh-list
93184486|NCT03750721|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93184487|NCT03750721|Antitubercular Agents|antitubercular agents|mesh-ancestor
93184488|NCT03750721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93184489|NCT03750721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184490|NCT03750721|Leprostatic Agents|leprostatic agents|mesh-ancestor
93366321|NCT02058485|Anesthetics, General|anesthetics, general|mesh-ancestor
93184491|NCT03750721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93184492|NCT03750721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184493|NCT03750721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184494|NCT03750721|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93184495|NCT03750721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93184496|NCT03750721|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93184497|NCT03750721|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93184498|NCT03750721|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93184499|NCT03750721|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93184500|NCT01481272|Leucovorin|leucovorin|mesh-list
93184501|NCT01481272|Cytarabine|cytarabine|mesh-list
93184502|NCT01481272|Methotrexate|methotrexate|mesh-list
93184503|NCT01481272|Etoposide|etoposide|mesh-list
93184504|NCT01481272|Ofatumumab|ofatumumab|mesh-list
93184505|NCT01481272|Lenograstim|lenograstim|mesh-list
93184506|NCT01481272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93184507|NCT01481272|Abortifacient Agents|abortifacient agents|mesh-ancestor
93184508|NCT01481272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93184509|NCT01481272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184510|NCT01481272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93184511|NCT01481272|Antimetabolites|antimetabolites|mesh-ancestor
93184512|NCT01481272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184513|NCT01481272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184514|NCT01481272|Dermatologic Agents|dermatologic agents|mesh-ancestor
93184515|NCT01481272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184516|NCT01481272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93184517|NCT01481272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93184518|NCT01481272|Immunologic Factors|immunologic factors|mesh-ancestor
93184519|NCT01481272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184520|NCT01481272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93184521|NCT01481272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93184522|NCT01481272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93184523|NCT01481272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93184524|NCT01481272|Antiviral Agents|antiviral agents|mesh-ancestor
93184525|NCT01481272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184526|NCT01481272|Antidotes|antidotes|mesh-ancestor
93184527|NCT01481272|Protective Agents|protective agents|mesh-ancestor
93184528|NCT01481272|Vitamin B Complex|vitamin b complex|mesh-ancestor
93184529|NCT01481272|Vitamins|vitamins|mesh-ancestor
93184530|NCT01481272|Micronutrients|micronutrients|mesh-ancestor
93184531|NCT01481272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93184532|NCT04478695|Pembrolizumab|pembrolizumab|mesh-list
93184533|NCT04478695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184534|NCT04478695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184535|NCT04478695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93184536|NCT04478695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184537|NCT02687386|Mitoxantrone|mitoxantrone|mesh-list
93184538|NCT02687386|Analgesics|analgesics|mesh-ancestor
93184539|NCT02687386|Sensory System Agents|sensory system agents|mesh-ancestor
93184540|NCT02687386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184541|NCT02687386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184542|NCT02687386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184543|NCT02687386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93184544|NCT02687386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93184545|NCT02687386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184546|NCT02687386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184547|NCT04531813|Butenafine|butenafine|mesh-list
93184548|NCT04531813|Antifungal Agents|antifungal agents|mesh-ancestor
93184549|NCT04531813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184550|NCT01380028|Prednisone|prednisone|mesh-list
93184551|NCT01380028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184552|NCT01380028|Glucocorticoids|glucocorticoids|mesh-ancestor
93184553|NCT01380028|Hormones|hormones|mesh-ancestor
93184554|NCT01380028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184555|NCT01380028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184556|NCT01380028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93184557|NCT01380028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184558|NCT01305460|Azacitidine|azacitidine|mesh-list
93184559|NCT01305460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93184560|NCT01305460|Antimetabolites|antimetabolites|mesh-ancestor
93184561|NCT01305460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184562|NCT01305460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184563|NCT01305460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184564|NCT03754543|Iron|iron|mesh-list
93184565|NCT03754543|Trace Elements|trace elements|mesh-ancestor
93184567|NCT03754543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184568|NCT01199302|Brodalumab|brodalumab|mesh-list
93184569|NCT01199302|Dermatologic Agents|dermatologic agents|mesh-ancestor
93184570|NCT03754387|Ceftazidime|ceftazidime|mesh-list
93184571|NCT03754387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93184572|NCT03754387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184573|NCT03171480|Isosorbide|isosorbide|mesh-list
93184574|NCT03171480|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93184575|NCT03171480|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93184576|NCT03171480|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93184577|NCT03171480|Diuretics|diuretics|mesh-ancestor
93184578|NCT03171480|Natriuretic Agents|natriuretic agents|mesh-ancestor
93184579|NCT03171480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184580|NCT03171480|Vasodilator Agents|vasodilator agents|mesh-ancestor
93184581|NCT03171480|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93184582|NCT03171480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184583|NCT04465357|Erenumab|erenumab|mesh-list
93184584|NCT04465357|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93184585|NCT04465357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184586|NCT04465357|Analgesics|analgesics|mesh-ancestor
93184587|NCT04465357|Sensory System Agents|sensory system agents|mesh-ancestor
93184588|NCT04465357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184589|NCT04465357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184590|NCT05396690|Sevoflurane|sevoflurane|mesh-list
93184591|NCT05396690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93184592|NCT05396690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93184593|NCT05396690|Anesthetics, General|anesthetics, general|mesh-ancestor
93184594|NCT05396690|Anesthetics|anesthetics|mesh-ancestor
93184595|NCT05396690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184596|NCT05396690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184597|NCT01384058|Simvastatin|simvastatin|mesh-list
93184598|NCT01384058|Ezetimibe|ezetimibe|mesh-list
93184599|NCT01384058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93184600|NCT01384058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93184601|NCT01384058|Antimetabolites|antimetabolites|mesh-ancestor
93184602|NCT01384058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184603|NCT01384058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93184604|NCT01384058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93184605|NCT01384058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184606|NCT04401384|Pyridoxine|pyridoxine|mesh-list
93184607|NCT04401384|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
93184608|NCT04401384|Doxylamine|doxylamine|mesh-list
93184609|NCT04401384|Dicyclomine|dicyclomine|mesh-list
93184610|NCT04401384|Antiemetics|antiemetics|mesh-ancestor
93184611|NCT04401384|Autonomic Agents|autonomic agents|mesh-ancestor
93184612|NCT04401384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184613|NCT04401384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184614|NCT04401384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93184615|NCT04401384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93184616|NCT04401384|Histamine Antagonists|histamine antagonists|mesh-ancestor
93184617|NCT04401384|Histamine Agents|histamine agents|mesh-ancestor
93184618|NCT04401384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184619|NCT04401384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184620|NCT04401384|Parasympatholytics|parasympatholytics|mesh-ancestor
93184621|NCT04401384|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93184622|NCT04401384|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93184623|NCT04401384|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184624|NCT04401384|Vitamin B Complex|vitamin b complex|mesh-ancestor
93184625|NCT04401384|Vitamins|vitamins|mesh-ancestor
93184626|NCT04401384|Micronutrients|micronutrients|mesh-ancestor
93184627|NCT03312114|Avelumab|avelumab|mesh-list
93184628|NCT03312114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184629|NCT03312114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184630|NCT04239222|Ibuprofen|ibuprofen|mesh-list
93184631|NCT04239222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93184632|NCT04239222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184633|NCT04239222|Analgesics|analgesics|mesh-ancestor
93184634|NCT04239222|Sensory System Agents|sensory system agents|mesh-ancestor
93184635|NCT04239222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184636|NCT04239222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184637|NCT04239222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184638|NCT04239222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184639|NCT04239222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93184640|NCT04239222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856848|NCT02747316|Iron|iron|mesh-list
93184641|NCT04239222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184642|NCT02566304|Mycophenolic Acid|mycophenolic acid|mesh-list
93184643|NCT02566304|Cyclophosphamide|cyclophosphamide|mesh-list
93184644|NCT02566304|Fludarabine|fludarabine|mesh-list
93184645|NCT02566304|Fludarabine phosphate|fludarabine phosphate|mesh-list
93184647|NCT02566304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93184648|NCT02566304|Immunologic Factors|immunologic factors|mesh-ancestor
93184649|NCT02566304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184650|NCT02566304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184651|NCT02566304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93184652|NCT02566304|Alkylating Agents|alkylating agents|mesh-ancestor
93184653|NCT02566304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184654|NCT02566304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184655|NCT02566304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93184656|NCT02566304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93184657|NCT02566304|Antimetabolites|antimetabolites|mesh-ancestor
93184658|NCT02566304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184659|NCT02566304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93184660|NCT02566304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184661|NCT02566304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93184662|NCT02566304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93184663|NCT02566304|Antitubercular Agents|antitubercular agents|mesh-ancestor
93184664|NCT02566304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93184665|NCT04732260|Letermovir|letermovir|mesh-list
93184666|NCT04732260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93184667|NCT04732260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184668|NCT04732260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184669|NCT04732260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184670|NCT04732260|Antiviral Agents|antiviral agents|mesh-ancestor
93184671|NCT04732260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184672|NCT03084536|Acetaminophen|acetaminophen|mesh-list
93184673|NCT03084536|Celecoxib|celecoxib|mesh-list
93184674|NCT03084536|Fentanyl|fentanyl|mesh-list
93184675|NCT03084536|Midazolam|midazolam|mesh-list
93184676|NCT03084536|Gabapentin|gabapentin|mesh-list
93184677|NCT03084536|Bupivacaine|bupivacaine|mesh-list
93184678|NCT03084536|Anesthetics, Local|anesthetics, local|mesh-ancestor
93184679|NCT03084536|Anesthetics|anesthetics|mesh-ancestor
93184680|NCT03084536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184681|NCT03084536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184682|NCT03084536|Sensory System Agents|sensory system agents|mesh-ancestor
93184683|NCT03084536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184684|NCT03084536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93184685|NCT03084536|Narcotics|narcotics|mesh-ancestor
93184686|NCT03084536|Analgesics|analgesics|mesh-ancestor
93184687|NCT03084536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93184688|NCT03084536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93184689|NCT03084536|Anesthetics, General|anesthetics, general|mesh-ancestor
93184690|NCT03084536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93184691|NCT03084536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93184692|NCT03084536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93184693|NCT03084536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93184694|NCT03084536|GABA Modulators|gaba modulators|mesh-ancestor
93184695|NCT03084536|GABA Agents|gaba agents|mesh-ancestor
93184696|NCT03084536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184697|NCT03084536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184698|NCT03084536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93184699|NCT03084536|Antipyretics|antipyretics|mesh-ancestor
93184700|NCT03084536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93184701|NCT03084536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93184702|NCT03084536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184703|NCT03084536|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93184704|NCT03084536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93184705|NCT03084536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184706|NCT03084536|Anticonvulsants|anticonvulsants|mesh-ancestor
93184707|NCT03084536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93184708|NCT03084536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93184709|NCT03084536|Antimanic Agents|antimanic agents|mesh-ancestor
93184710|NCT03311724|Tirzepatide|tirzepatide|mesh-list
93184711|NCT03311724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93184712|NCT03311724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184713|NCT03311724|Incretins|incretins|mesh-ancestor
93184714|NCT03311724|Hormones|hormones|mesh-ancestor
93184715|NCT03311724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93184716|NCT05213312|Paclitaxel|paclitaxel|mesh-list
92856873|NCT00636246|Serotonin Agents|serotonin agents|mesh-ancestor
93184717|NCT05213312|Fluorouracil|fluorouracil|mesh-list
93184718|NCT05213312|Nivolumab|nivolumab|mesh-list
93184719|NCT05213312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93184720|NCT05213312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184721|NCT05213312|Tubulin Modulators|tubulin modulators|mesh-ancestor
93184722|NCT05213312|Antimitotic Agents|antimitotic agents|mesh-ancestor
93184723|NCT05213312|Mitosis Modulators|mitosis modulators|mesh-ancestor
93184724|NCT05213312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184725|NCT05213312|Antimetabolites|antimetabolites|mesh-ancestor
93184726|NCT05213312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93184727|NCT05213312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93184728|NCT05213312|Immunologic Factors|immunologic factors|mesh-ancestor
93184729|NCT05213312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184730|NCT05213312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184731|NCT05213312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93184732|NCT03311646|Nicotine|nicotine|mesh-list
93184733|NCT03311646|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93184734|NCT03311646|Autonomic Agents|autonomic agents|mesh-ancestor
93184735|NCT03311646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184736|NCT03311646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184737|NCT03311646|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93184738|NCT03311646|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93184739|NCT03311646|Cholinergic Agents|cholinergic agents|mesh-ancestor
93184740|NCT03311646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184741|NCT03311646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184742|NCT03680274|Ascorbic Acid|ascorbic acid|mesh-list
93184743|NCT03680274|Vitamins|vitamins|mesh-ancestor
93184744|NCT03680274|Micronutrients|micronutrients|mesh-ancestor
93184745|NCT03680274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184746|NCT03680274|Antioxidants|antioxidants|mesh-ancestor
93184747|NCT03680274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184748|NCT03680274|Protective Agents|protective agents|mesh-ancestor
93184749|NCT03288987|Leucovorin|leucovorin|mesh-list
93184750|NCT03288987|Bevacizumab|bevacizumab|mesh-list
93184751|NCT03288987|Fluorouracil|fluorouracil|mesh-list
93184752|NCT03288987|Irinotecan|irinotecan|mesh-list
93184753|NCT03288987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184754|NCT03288987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184755|NCT03288987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93184756|NCT03288987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93184757|NCT03288987|Growth Substances|growth substances|mesh-ancestor
93184758|NCT03288987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184759|NCT03288987|Growth Inhibitors|growth inhibitors|mesh-ancestor
93184760|NCT03288987|Antimetabolites|antimetabolites|mesh-ancestor
93184761|NCT03288987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184762|NCT03288987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93184763|NCT03288987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93184764|NCT03288987|Immunologic Factors|immunologic factors|mesh-ancestor
93184765|NCT03288987|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93184766|NCT03288987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93184767|NCT03288987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184768|NCT03288987|Antidotes|antidotes|mesh-ancestor
93184769|NCT03288987|Protective Agents|protective agents|mesh-ancestor
93184770|NCT03288987|Vitamin B Complex|vitamin b complex|mesh-ancestor
93184771|NCT03288987|Vitamins|vitamins|mesh-ancestor
93184772|NCT03288987|Micronutrients|micronutrients|mesh-ancestor
93184773|NCT01379846|Vaccines|vaccines|mesh-list
93184774|NCT01379846|Immunologic Factors|immunologic factors|mesh-ancestor
93184775|NCT01379846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184776|NCT01379300|Rivaroxaban|rivaroxaban|mesh-list
93184777|NCT01379300|Dabigatran|dabigatran|mesh-list
93184778|NCT01379300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93184779|NCT01379300|Antithrombins|antithrombins|mesh-ancestor
93184780|NCT01379300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93184781|NCT01379300|Protease Inhibitors|protease inhibitors|mesh-ancestor
93184782|NCT01379300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184783|NCT01379300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184784|NCT01379300|Anticoagulants|anticoagulants|mesh-ancestor
93184785|NCT03682224|Epinephrine|epinephrine|mesh-list
93184786|NCT03682224|Bupivacaine|bupivacaine|mesh-list
93184787|NCT03682224|Anesthetics, Local|anesthetics, local|mesh-ancestor
93184788|NCT03682224|Anesthetics|anesthetics|mesh-ancestor
93184789|NCT03682224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184790|NCT03682224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856969|NCT02819180|Vaccines|vaccines|mesh-list
93184791|NCT03682224|Sensory System Agents|sensory system agents|mesh-ancestor
93184792|NCT03682224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366322|NCT02058485|Anesthetics|anesthetics|mesh-ancestor
93184793|NCT03682224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93184794|NCT03682224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93184795|NCT03682224|Adrenergic Agents|adrenergic agents|mesh-ancestor
93184796|NCT03682224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184797|NCT03682224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184798|NCT03682224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93184799|NCT03682224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184800|NCT03682224|Autonomic Agents|autonomic agents|mesh-ancestor
93184801|NCT03682224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184802|NCT03682224|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184803|NCT03682224|Mydriatics|mydriatics|mesh-ancestor
93184804|NCT03682224|Sympathomimetics|sympathomimetics|mesh-ancestor
93184805|NCT03682224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93184807|NCT01383044|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93184808|NCT01383044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93184809|NCT01383044|Adrenergic Agents|adrenergic agents|mesh-ancestor
93184810|NCT01383044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184811|NCT01383044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184812|NCT01383044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184813|NCT01383044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93184814|NCT01383044|Antioxidants|antioxidants|mesh-ancestor
93184815|NCT01383044|Protective Agents|protective agents|mesh-ancestor
93184816|NCT01383044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93184817|NCT01383044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184818|NCT01383044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93184819|NCT01383044|Vasodilator Agents|vasodilator agents|mesh-ancestor
93184820|NCT01383044|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93184821|NCT01383044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93184822|NCT01377428|Formoterol Fumarate|formoterol fumarate|mesh-list
93184823|NCT01377428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93184824|NCT01377428|Autonomic Agents|autonomic agents|mesh-ancestor
93184825|NCT01377428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184826|NCT01377428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184827|NCT01377428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93184828|NCT01377428|Respiratory System Agents|respiratory system agents|mesh-ancestor
93184829|NCT01377428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93184830|NCT01377428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93184831|NCT01377428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93184832|NCT01377428|Adrenergic Agents|adrenergic agents|mesh-ancestor
93184833|NCT01377428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184834|NCT01377428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184835|NCT03083990|Bevacizumab|bevacizumab|mesh-list
93184836|NCT03083990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93184837|NCT03083990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184838|NCT03083990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93184839|NCT03083990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93184840|NCT03083990|Growth Substances|growth substances|mesh-ancestor
93184841|NCT03083990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184842|NCT03083990|Growth Inhibitors|growth inhibitors|mesh-ancestor
93184843|NCT03252015|Lasmiditan|lasmiditan|mesh-list
93184844|NCT03252015|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93184845|NCT03252015|Serotonin Agents|serotonin agents|mesh-ancestor
93184846|NCT03252015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184847|NCT03252015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184848|NCT03252015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184849|NCT01314027|Gemcitabine|gemcitabine|mesh-list
93184850|NCT01314027|Oxaliplatin|oxaliplatin|mesh-list
93184851|NCT01314027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93184852|NCT01314027|Antimetabolites|antimetabolites|mesh-ancestor
93184853|NCT01314027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184854|NCT01314027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184855|NCT03708003|Venetoclax|venetoclax|mesh-list
93184856|NCT03708003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184857|NCT03083132|Modafinil|modafinil|mesh-list
93184858|NCT03083132|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93184859|NCT03083132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184860|NCT03083132|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93184861|NCT03083132|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93184862|NCT03083132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93184863|NCT03083132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184864|NCT04121468|Metformin|metformin|mesh-list
93184865|NCT04121468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93184866|NCT04121468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184867|NCT03648489|Paclitaxel|paclitaxel|mesh-list
93184868|NCT03648489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93184869|NCT03648489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184870|NCT03648489|Tubulin Modulators|tubulin modulators|mesh-ancestor
93184871|NCT03648489|Antimitotic Agents|antimitotic agents|mesh-ancestor
93184872|NCT03648489|Mitosis Modulators|mitosis modulators|mesh-ancestor
93184873|NCT03648489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184874|NCT01382888|Heparin|heparin|mesh-list
93184875|NCT01382888|Anticoagulants|anticoagulants|mesh-ancestor
93184876|NCT01382888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93184877|NCT01382888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93184878|NCT01382888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184879|NCT03249909|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93184880|NCT03249909|Laxatives|laxatives|mesh-ancestor
93184881|NCT03249909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93184882|NCT04809116|Pimavanserin|pimavanserin|mesh-list
93184883|NCT04809116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93184884|NCT04809116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93184885|NCT04809116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93184886|NCT04809116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93184887|NCT04809116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184888|NCT04809116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184889|NCT04809116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93184890|NCT04809116|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93184891|NCT04809116|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93184892|NCT04809116|Serotonin Agents|serotonin agents|mesh-ancestor
93184893|NCT04809116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184894|NCT04809116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184895|NCT03077438|Vaccines|vaccines|mesh-list
93184896|NCT03077438|Immunologic Factors|immunologic factors|mesh-ancestor
93184897|NCT03077438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184898|NCT01382732|Oxytocin|oxytocin|mesh-list
93184899|NCT01382732|Carbetocin|carbetocin|mesh-list
93184900|NCT01382732|Oxytocics|oxytocics|mesh-ancestor
93184901|NCT01382732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93184902|NCT01382732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184903|NCT02183870|Crizotinib|crizotinib|mesh-list
93184904|NCT02183870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184905|NCT02183870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93184906|NCT02183870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184907|NCT02183870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184908|NCT03076970|Sumatriptan|sumatriptan|mesh-list
93184909|NCT03076970|Lasmiditan|lasmiditan|mesh-list
93184910|NCT03076970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93184911|NCT03076970|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93184912|NCT03076970|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93184913|NCT03076970|Serotonin Agents|serotonin agents|mesh-ancestor
93184914|NCT03076970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93184915|NCT03076970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184916|NCT03076970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184917|NCT00726596|Hydroxychloroquine|hydroxychloroquine|mesh-list
93184918|NCT00726596|Antimalarials|antimalarials|mesh-ancestor
93184919|NCT00726596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93184920|NCT00726596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93184921|NCT00726596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184922|NCT00726596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184923|NCT00726596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184924|NCT00726596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93184925|NCT04897880|Panobinostat|panobinostat|mesh-list
93184926|NCT04897880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184927|NCT04897880|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93184928|NCT04897880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184929|NCT04897880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184930|NCT02890992|Nicotinic Acids|nicotinic acids|mesh-list
93184931|NCT02890992|Niacin|niacin|mesh-list
93184932|NCT02890992|Niacinamide|niacinamide|mesh-list
93184933|NCT02890992|Ezetimibe|ezetimibe|mesh-list
93184934|NCT02890992|Alirocumab|alirocumab|mesh-list
93184935|NCT02890992|Cholestyramine Resin|cholestyramine resin|mesh-list
93184936|NCT02890992|Fenofibrate|fenofibrate|mesh-list
93184937|NCT02890992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93184938|NCT02890992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93184939|NCT02890992|Antimetabolites|antimetabolites|mesh-ancestor
93184940|NCT02890992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184941|NCT02890992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93184942|NCT02890992|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93184943|NCT02890992|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93184944|NCT02890992|Protease Inhibitors|protease inhibitors|mesh-ancestor
93184945|NCT02890992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184946|NCT02890992|Vitamin B Complex|vitamin b complex|mesh-ancestor
93184947|NCT02890992|Vitamins|vitamins|mesh-ancestor
93184948|NCT02890992|Micronutrients|micronutrients|mesh-ancestor
93184949|NCT02890992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184950|NCT02890992|Vasodilator Agents|vasodilator agents|mesh-ancestor
93184951|NCT03603912|Metformin|metformin|mesh-list
93184952|NCT03603912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93184953|NCT03603912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184954|NCT04357730|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93184955|NCT04357730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93184956|NCT04357730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93184957|NCT04357730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184958|NCT05274984|Lidocaine|lidocaine|mesh-list
93184959|NCT05274984|Anesthetics, Local|anesthetics, local|mesh-ancestor
93184960|NCT05274984|Anesthetics|anesthetics|mesh-ancestor
93184961|NCT05274984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93184962|NCT05274984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184963|NCT05274984|Sensory System Agents|sensory system agents|mesh-ancestor
93184964|NCT05274984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93184965|NCT05274984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93184966|NCT05274984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93184967|NCT05274984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93184968|NCT05274984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93184969|NCT05274984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184970|NCT05274672|Ciprofloxacin|ciprofloxacin|mesh-list
93184971|NCT05274672|Cephalexin|cephalexin|mesh-list
93184972|NCT05274672|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93184973|NCT05274672|Nitrofurantoin|nitrofurantoin|mesh-list
93184974|NCT05274672|Trimethoprim|trimethoprim|mesh-list
93184975|NCT05274672|Sulfamethoxazole|sulfamethoxazole|mesh-list
93184976|NCT05274672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93184977|NCT05274672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93184978|NCT05274672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93184979|NCT05274672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93184980|NCT05274672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93184981|NCT05274672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93184982|NCT05274672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93184983|NCT05274672|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93184984|NCT05274672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93184985|NCT05274672|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93184986|NCT05274672|Antimalarials|antimalarials|mesh-ancestor
93184987|NCT05274672|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93184988|NCT05274672|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93184989|NCT05274672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93184990|NCT05274672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93184991|NCT05274672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93184992|NCT01379144|Latanoprost|latanoprost|mesh-list
93184993|NCT01379144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93184994|NCT01379144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93184995|NCT01376882|Caffeine|caffeine|mesh-list
93184996|NCT01376882|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93184997|NCT01376882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93184998|NCT01376882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93184999|NCT01376882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185000|NCT01376882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185001|NCT01376882|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93185002|NCT01376882|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93185003|NCT01376882|Purinergic Agents|purinergic agents|mesh-ancestor
93185004|NCT01376882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185005|NCT03329196|Darbepoetin alfa|darbepoetin alfa|mesh-list
93185006|NCT03329196|Hematinics|hematinics|mesh-ancestor
93185007|NCT04656002|Vactosertib|vactosertib|mesh-list
93185008|NCT04656002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93185009|NCT04656002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185010|NCT04656002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185011|NCT01382498|Calcium Dobesilate|calcium dobesilate|mesh-list
93185012|NCT01382498|Calcium|calcium|mesh-list
93185013|NCT01382498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93185014|NCT01382498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185015|NCT01382498|Hemostatics|hemostatics|mesh-ancestor
93185016|NCT01382498|Coagulants|coagulants|mesh-ancestor
93185017|NCT03476538|Gabapentin|gabapentin|mesh-list
93185018|NCT03476538|Analgesics|analgesics|mesh-ancestor
93185019|NCT03476538|Sensory System Agents|sensory system agents|mesh-ancestor
93185020|NCT03476538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185021|NCT03476538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185022|NCT03476538|Anticonvulsants|anticonvulsants|mesh-ancestor
93185023|NCT03476538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93185024|NCT03476538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93185025|NCT03476538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185026|NCT03476538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93185027|NCT03476538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93185028|NCT03476538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93185029|NCT03476538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185030|NCT03476538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185031|NCT03476538|Antimanic Agents|antimanic agents|mesh-ancestor
93185032|NCT03326856|Botulinum Toxins|botulinum toxins|mesh-list
93185033|NCT03326856|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93185034|NCT03326856|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93185035|NCT03326856|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93185036|NCT03326856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185037|NCT03326856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185038|NCT03326856|Cholinergic Agents|cholinergic agents|mesh-ancestor
93185039|NCT03326856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185040|NCT03326856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185041|NCT03326856|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93185042|NCT03326856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185043|NCT00000116|Vitamin A|vitamin a|mesh-list
93185044|NCT00000116|Vitamins|vitamins|mesh-ancestor
93185045|NCT00000116|Micronutrients|micronutrients|mesh-ancestor
93185046|NCT00000116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185047|NCT05232396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93185048|NCT05232396|Antibodies|antibodies|mesh-list
93185049|NCT05232396|Immunoglobulins|immunoglobulins|mesh-list
93185050|NCT05232396|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93185051|NCT05232396|Immunologic Factors|immunologic factors|mesh-ancestor
93185052|NCT05232396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185053|NCT05232396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185054|NCT05222724|Ibuprofen|ibuprofen|mesh-list
93185055|NCT05222724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93185056|NCT05222724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185057|NCT05222724|Analgesics|analgesics|mesh-ancestor
93185058|NCT05222724|Sensory System Agents|sensory system agents|mesh-ancestor
93185059|NCT05222724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185060|NCT05222724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185061|NCT05222724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185062|NCT05222724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185063|NCT05222724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93185064|NCT05222724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185065|NCT05222724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185066|NCT01382342|Rasagiline|rasagiline|mesh-list
93185067|NCT01382342|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93185068|NCT01382342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185069|NCT01382342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185070|NCT01382342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93185071|NCT01382342|Protective Agents|protective agents|mesh-ancestor
93185072|NCT01382342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185073|NCT03471728|Linaclotide|linaclotide|mesh-list
93185074|NCT03471728|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93185075|NCT03471728|Enzyme Activators|enzyme activators|mesh-ancestor
93185076|NCT03471728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185077|NCT03471728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185078|NCT03630614|Nicotine|nicotine|mesh-list
93185079|NCT03630614|Varenicline|varenicline|mesh-list
93185080|NCT03630614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93185081|NCT03630614|Autonomic Agents|autonomic agents|mesh-ancestor
93185082|NCT03630614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185083|NCT03630614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185084|NCT03630614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93185085|NCT03630614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93185086|NCT03630614|Cholinergic Agents|cholinergic agents|mesh-ancestor
93185087|NCT03630614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185088|NCT03630614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185089|NCT01378832|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93185090|NCT01378832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185091|NCT01378754|Fospropofol|fospropofol|mesh-list
92857248|NCT04265027|Opicapone|opicapone|mesh-list
93185092|NCT01378754|Propofol|propofol|mesh-list
93185093|NCT01378754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93185094|NCT01378754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185095|NCT01378754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185096|NCT01378754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93185097|NCT01378754|Anesthetics, General|anesthetics, general|mesh-ancestor
93185098|NCT01378754|Anesthetics|anesthetics|mesh-ancestor
93185099|NCT05764304|Sinomenine|sinomenine|mesh-list
93185100|NCT05764304|Glucocorticoids|glucocorticoids|mesh-list
93185101|NCT05764304|Hormones|hormones|mesh-ancestor
93185102|NCT05764304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185103|NCT05764304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185104|NCT05764304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185105|NCT03075410|GSK656|gsk656|mesh-list
93185106|NCT03075410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93185107|NCT03075410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185108|NCT05764226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93185109|NCT02826512|Niraparib|niraparib|mesh-list
93185110|NCT02826512|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93185111|NCT02826512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185112|NCT02826512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185113|NCT02826512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185114|NCT05391230|Permethrin|permethrin|mesh-list
93185115|NCT05391230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185116|NCT05391230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185117|NCT02731352|Apatinib|apatinib|mesh-list
93185118|NCT02731352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185119|NCT02731352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93185120|NCT02731352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185121|NCT02731352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185122|NCT05132660|Levodopa|levodopa|mesh-list
93185123|NCT05132660|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93185124|NCT05132660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93185125|NCT05132660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93185126|NCT05132660|Dopamine Agents|dopamine agents|mesh-ancestor
93185127|NCT05132660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185128|NCT05132660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185129|NCT05132660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185130|NCT05132660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93185131|NCT05132660|Immunologic Factors|immunologic factors|mesh-ancestor
93185132|NCT05132660|Dopamine Agonists|dopamine agonists|mesh-ancestor
93185133|NCT05762744|Exenatide|exenatide|mesh-list
93185134|NCT05762744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93185135|NCT05762744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185136|NCT05762744|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93185137|NCT05762744|Incretins|incretins|mesh-ancestor
93185138|NCT05762744|Hormones|hormones|mesh-ancestor
93185139|NCT05762744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185140|NCT02257424|Hydroxychloroquine|hydroxychloroquine|mesh-list
93185141|NCT02257424|Trametinib|trametinib|mesh-list
93185142|NCT02257424|Dabrafenib|dabrafenib|mesh-list
93185143|NCT02257424|Antimalarials|antimalarials|mesh-ancestor
93185144|NCT02257424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93185145|NCT02257424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93185146|NCT02257424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185147|NCT02257424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185148|NCT02257424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185149|NCT02257424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185150|NCT02257424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185151|NCT02257424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93185152|NCT01858922|Cytarabine|cytarabine|mesh-list
93185153|NCT01858922|Dexamethasone|dexamethasone|mesh-list
93185154|NCT01858922|Prednisone|prednisone|mesh-list
93185155|NCT01858922|Cyclophosphamide|cyclophosphamide|mesh-list
93185156|NCT01858922|Cisplatin|cisplatin|mesh-list
93185157|NCT01858922|Doxorubicin|doxorubicin|mesh-list
93185158|NCT01858922|Etoposide|etoposide|mesh-list
93185159|NCT01858922|Etoposide phosphate|etoposide phosphate|mesh-list
93185160|NCT01858922|Vincristine|vincristine|mesh-list
93185161|NCT01858922|Bleomycin|bleomycin|mesh-list
93185162|NCT01858922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185163|NCT01858922|Immunologic Factors|immunologic factors|mesh-ancestor
93185164|NCT01858922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185165|NCT01858922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185166|NCT01858922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93185167|NCT01858922|Alkylating Agents|alkylating agents|mesh-ancestor
93185168|NCT01858922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185169|NCT01858922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185170|NCT01858922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93185171|NCT01858922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185173|NCT01858922|Autonomic Agents|autonomic agents|mesh-ancestor
93185174|NCT01858922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185175|NCT01858922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185176|NCT01858922|Glucocorticoids|glucocorticoids|mesh-ancestor
93185177|NCT01858922|Hormones|hormones|mesh-ancestor
93185178|NCT01858922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185179|NCT01858922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185180|NCT01858922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185181|NCT01858922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93185182|NCT01858922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93185183|NCT01858922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93185184|NCT01858922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93185185|NCT01858922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93185186|NCT01858922|Antimetabolites|antimetabolites|mesh-ancestor
93185187|NCT01858922|Antiviral Agents|antiviral agents|mesh-ancestor
93185188|NCT01858922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185189|NCT01858922|Tubulin Modulators|tubulin modulators|mesh-ancestor
93185190|NCT01858922|Antimitotic Agents|antimitotic agents|mesh-ancestor
93185191|NCT01858922|Mitosis Modulators|mitosis modulators|mesh-ancestor
93185192|NCT01378286|Artesunate|artesunate|mesh-list
93185193|NCT01378286|Chloroquine|chloroquine|mesh-list
93185194|NCT01378286|Amodiaquine|amodiaquine|mesh-list
93185195|NCT01378286|Antimalarials|antimalarials|mesh-ancestor
93185196|NCT01378286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93185197|NCT01378286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93185198|NCT01378286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185199|NCT01378286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185200|NCT01378286|Antiviral Agents|antiviral agents|mesh-ancestor
93185201|NCT01378286|Schistosomicides|schistosomicides|mesh-ancestor
93185202|NCT01378286|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93185203|NCT01378286|Anthelmintics|anthelmintics|mesh-ancestor
93185204|NCT01378286|Amebicides|amebicides|mesh-ancestor
93185205|NCT01378286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185206|NCT01377974|Miltefosine|miltefosine|mesh-list
93185207|NCT01377974|Meglumine Antimoniate|meglumine antimoniate|mesh-list
93185208|NCT01377974|Antifungal Agents|antifungal agents|mesh-ancestor
93185209|NCT01377974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185210|NCT01377974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185211|NCT01377974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93185212|NCT01377974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93185213|NCT04929080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93185214|NCT04929080|Antibodies|antibodies|mesh-list
93185215|NCT04929080|Immunoglobulins|immunoglobulins|mesh-list
93185216|NCT04929080|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93185217|NCT04929080|Immunoglobulin G|immunoglobulin g|mesh-list
93185218|NCT04929080|Immunologic Factors|immunologic factors|mesh-ancestor
93185219|NCT04929080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185220|NCT04929080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185221|NCT03071276|Cytarabine|cytarabine|mesh-list
93185222|NCT03071276|Hydrocortisone|hydrocortisone|mesh-list
93185223|NCT03071276|Methotrexate|methotrexate|mesh-list
93185224|NCT03071276|Fludarabine phosphate|fludarabine phosphate|mesh-list
93185225|NCT03071276|Fludarabine|fludarabine|mesh-list
93185226|NCT03071276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93185227|NCT03071276|Abortifacient Agents|abortifacient agents|mesh-ancestor
93185228|NCT03071276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93185229|NCT03071276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185230|NCT03071276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93185231|NCT03071276|Antimetabolites|antimetabolites|mesh-ancestor
93185232|NCT03071276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185233|NCT03071276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185234|NCT03071276|Dermatologic Agents|dermatologic agents|mesh-ancestor
93185235|NCT03071276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185236|NCT03071276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93185237|NCT03071276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185238|NCT03071276|Immunologic Factors|immunologic factors|mesh-ancestor
93185239|NCT03071276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185240|NCT03071276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93185241|NCT03071276|Antiviral Agents|antiviral agents|mesh-ancestor
93185242|NCT03071276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185243|NCT03071276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185244|NCT03629600|Indomethacin|indomethacin|mesh-list
93185245|NCT03629600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93185246|NCT03629600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185247|NCT03629600|Analgesics|analgesics|mesh-ancestor
93185248|NCT03629600|Sensory System Agents|sensory system agents|mesh-ancestor
93185249|NCT03629600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185250|NCT03629600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185251|NCT03629600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185252|NCT03629600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185253|NCT03629600|Gout Suppressants|gout suppressants|mesh-ancestor
93185254|NCT03629600|Tocolytic Agents|tocolytic agents|mesh-ancestor
93185255|NCT03629600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93185256|NCT03629600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93185257|NCT03629600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185258|NCT03629600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185260|NCT03074162|Capsaicin|capsaicin|mesh-list
93185261|NCT03074162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93185262|NCT03074162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185263|NCT03074162|Analgesics|analgesics|mesh-ancestor
93185264|NCT03074162|Sensory System Agents|sensory system agents|mesh-ancestor
93185265|NCT03074162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185266|NCT03074162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185267|NCT03074162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185268|NCT03074162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185269|NCT03074162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93185270|NCT03074162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185271|NCT03074162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185272|NCT03074162|Antipruritics|antipruritics|mesh-ancestor
93185273|NCT03074162|Dermatologic Agents|dermatologic agents|mesh-ancestor
93185274|NCT05069012|Morphine|morphine|mesh-list
93185275|NCT05069012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93185276|NCT05069012|Narcotics|narcotics|mesh-ancestor
93185277|NCT05069012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185278|NCT05069012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185279|NCT05069012|Analgesics|analgesics|mesh-ancestor
93185280|NCT05069012|Sensory System Agents|sensory system agents|mesh-ancestor
93185281|NCT05069012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185282|NCT04065074|FX006|fx006|mesh-list
93185283|NCT04065074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185284|NCT04065074|Glucocorticoids|glucocorticoids|mesh-ancestor
93185285|NCT04065074|Hormones|hormones|mesh-ancestor
93185286|NCT04065074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185287|NCT04065074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185288|NCT04065074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185289|NCT04065074|Immunologic Factors|immunologic factors|mesh-ancestor
93185290|NCT03920306|Silver Nitrate|silver nitrate|mesh-list
93185291|NCT03920306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93185292|NCT03920306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185293|NCT02888106|Tenofovir|tenofovir|mesh-list
93185294|NCT02888106|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93185295|NCT02888106|Interferon alpha-2|interferon alpha-2|mesh-list
93185296|NCT02888106|Antiviral Agents|antiviral agents|mesh-ancestor
93185297|NCT02888106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185298|NCT02888106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93185299|NCT02888106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93185300|NCT02888106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185301|NCT02888106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185302|NCT02888106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93185303|NCT02888106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93185304|NCT02888106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185305|NCT03793010|FX006|fx006|mesh-list
93185306|NCT03793010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185307|NCT03793010|Glucocorticoids|glucocorticoids|mesh-ancestor
93185308|NCT03793010|Hormones|hormones|mesh-ancestor
93185309|NCT03793010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185310|NCT03793010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185311|NCT03793010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185312|NCT03793010|Immunologic Factors|immunologic factors|mesh-ancestor
93185313|NCT03055026|Rivaroxaban|rivaroxaban|mesh-list
93185314|NCT03055026|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93185315|NCT03055026|Antithrombins|antithrombins|mesh-ancestor
93185316|NCT03055026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93185317|NCT03055026|Protease Inhibitors|protease inhibitors|mesh-ancestor
93185318|NCT03055026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185319|NCT03055026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185320|NCT03055026|Anticoagulants|anticoagulants|mesh-ancestor
93185321|NCT03304626|Prednisone|prednisone|mesh-list
93185322|NCT03304626|Budesonide|budesonide|mesh-list
93185323|NCT03304626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185324|NCT03304626|Glucocorticoids|glucocorticoids|mesh-ancestor
93185325|NCT03304626|Hormones|hormones|mesh-ancestor
93185326|NCT03304626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185327|NCT03304626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185328|NCT03304626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185329|NCT03304626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185330|NCT03304626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93185331|NCT03304626|Autonomic Agents|autonomic agents|mesh-ancestor
93185332|NCT03304626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185333|NCT03304626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93185334|NCT03304626|Respiratory System Agents|respiratory system agents|mesh-ancestor
93185335|NCT05121714|Fluvoxamine|fluvoxamine|mesh-list
93185336|NCT05121714|Caffeine|caffeine|mesh-list
93185337|NCT05121714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93185338|NCT05121714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185339|NCT05121714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93185340|NCT05121714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185341|NCT05121714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185342|NCT05121714|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93185343|NCT05121714|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93185344|NCT05121714|Purinergic Agents|purinergic agents|mesh-ancestor
93185345|NCT05121714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185346|NCT05121714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93185347|NCT05121714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93185348|NCT05121714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185349|NCT05121714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93185350|NCT05121714|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93185351|NCT05121714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93185352|NCT05121714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185353|NCT05121714|Serotonin Agents|serotonin agents|mesh-ancestor
93185354|NCT05121714|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93185355|NCT05121714|Antidepressive Agents|antidepressive agents|mesh-ancestor
93185356|NCT05121714|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93185357|NCT05121714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93185358|NCT05121714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93185359|NCT02958150|Dexmedetomidine|dexmedetomidine|mesh-list
93185360|NCT02958150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93185361|NCT02958150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185362|NCT02958150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185363|NCT02958150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185364|NCT02958150|Analgesics|analgesics|mesh-ancestor
93185365|NCT02958150|Sensory System Agents|sensory system agents|mesh-ancestor
93185366|NCT02958150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185367|NCT02958150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93185368|NCT02958150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93185369|NCT02958150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93185370|NCT02958150|Adrenergic Agents|adrenergic agents|mesh-ancestor
93185371|NCT02958150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185372|NCT02958150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185373|NCT04250142|Methamphetamine|methamphetamine|mesh-list
93185374|NCT04250142|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93185375|NCT04250142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185376|NCT04250142|Sympathomimetics|sympathomimetics|mesh-ancestor
93185377|NCT04250142|Autonomic Agents|autonomic agents|mesh-ancestor
93185378|NCT04250142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185379|NCT04250142|Dopamine Agents|dopamine agents|mesh-ancestor
93185380|NCT04250142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185381|NCT04250142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185382|NCT04250142|Adrenergic Agents|adrenergic agents|mesh-ancestor
93185383|NCT04250142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93185384|NCT04250142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93185385|NCT04250142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185386|NCT04250142|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93185387|NCT02714322|Adalimumab|adalimumab|mesh-list
93185388|NCT02714322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93185389|NCT02714322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185390|NCT02714322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185391|NCT03267576|Metformin|metformin|mesh-list
93185392|NCT03267576|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93185393|NCT03267576|Canagliflozin|canagliflozin|mesh-list
93185394|NCT03267576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93185395|NCT03267576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185396|NCT03267576|Incretins|incretins|mesh-ancestor
93185397|NCT03267576|Hormones|hormones|mesh-ancestor
93185398|NCT03267576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185399|NCT03267576|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93185400|NCT03267576|Protease Inhibitors|protease inhibitors|mesh-ancestor
93185401|NCT03267576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185402|NCT03267576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185403|NCT03267576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93185404|NCT02472912|Adalimumab|adalimumab|mesh-list
93185405|NCT02472912|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93185406|NCT02472912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185407|NCT02472912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185408|NCT02356458|Bortezomib|bortezomib|mesh-list
93185409|NCT02356458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185410|NCT03243630|Menthol|menthol|mesh-list
93185411|NCT03243630|Nicotine|nicotine|mesh-list
93185412|NCT03243630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93185413|NCT03243630|Autonomic Agents|autonomic agents|mesh-ancestor
93185414|NCT03243630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185415|NCT03243630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185416|NCT03243630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93185417|NCT03243630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93185418|NCT03243630|Cholinergic Agents|cholinergic agents|mesh-ancestor
93185419|NCT03243630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185420|NCT03243630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185421|NCT03243630|Antipruritics|antipruritics|mesh-ancestor
93185422|NCT03243630|Dermatologic Agents|dermatologic agents|mesh-ancestor
93185423|NCT04725331|Pembrolizumab|pembrolizumab|mesh-list
93185424|NCT04725331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93185425|NCT04725331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185426|NCT04725331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93185427|NCT04725331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185428|NCT03753685|Ensartinib|ensartinib|mesh-list
93185429|NCT03753685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185430|NCT03753685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93185431|NCT03753685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185432|NCT03753685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185433|NCT05172050|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93185434|NCT05172050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93185435|NCT05172050|Hormone Antagonists|hormone antagonists|mesh-ancestor
93185436|NCT05172050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185437|NCT05172050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185438|NCT05172050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93185439|NCT05172050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93185440|NCT05172050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93185441|NCT02787044|Vaccines|vaccines|mesh-list
93185442|NCT02787044|Immunologic Factors|immunologic factors|mesh-ancestor
93185443|NCT02787044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185444|NCT01345019|Zoledronic Acid|zoledronic acid|mesh-list
93185445|NCT01345019|Denosumab|denosumab|mesh-list
93185446|NCT01345019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93185447|NCT01345019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185448|NCT03629522|Ondansetron|ondansetron|mesh-list
93185449|NCT03629522|Antiemetics|antiemetics|mesh-ancestor
93185450|NCT03629522|Autonomic Agents|autonomic agents|mesh-ancestor
93185451|NCT03629522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185452|NCT03629522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185453|NCT03629522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185454|NCT03629522|Antipruritics|antipruritics|mesh-ancestor
93185455|NCT03629522|Dermatologic Agents|dermatologic agents|mesh-ancestor
93185456|NCT03629522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93185457|NCT03629522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93185458|NCT03629522|Serotonin Agents|serotonin agents|mesh-ancestor
93185459|NCT03629522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185460|NCT03629522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185461|NCT03751111|Naloxone|naloxone|mesh-list
93185462|NCT03751111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93185463|NCT03751111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185464|NCT03751111|Sensory System Agents|sensory system agents|mesh-ancestor
93185465|NCT03751111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185466|NCT05167370|Amifostine|amifostine|mesh-list
93185467|NCT05167370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93185468|NCT05167370|Protective Agents|protective agents|mesh-ancestor
93185469|NCT05167370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185470|NCT01265537|Tacrolimus|tacrolimus|mesh-list
93185471|NCT01265537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185472|NCT01265537|Immunologic Factors|immunologic factors|mesh-ancestor
93185473|NCT01265537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185474|NCT01265537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93185475|NCT01265537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185476|NCT01265537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185477|NCT05763836|Ibuprofen|ibuprofen|mesh-list
93185478|NCT05763836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93185479|NCT05763836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185480|NCT05763836|Analgesics|analgesics|mesh-ancestor
93185481|NCT05763836|Sensory System Agents|sensory system agents|mesh-ancestor
93185482|NCT05763836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185483|NCT05763836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185484|NCT05763836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185485|NCT05763836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185486|NCT05763836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93185487|NCT05763836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185488|NCT05763836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185489|NCT01237535|Progesterone|progesterone|mesh-list
93185490|NCT01237535|Estrogens|estrogens|mesh-list
93185491|NCT01237535|Progestins|progestins|mesh-ancestor
93185492|NCT01237535|Hormones|hormones|mesh-ancestor
93185493|NCT01237535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185494|NCT01237535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185495|NCT04396639|Factor VIII|factor viii|mesh-list
93185496|NCT04396639|Coagulants|coagulants|mesh-ancestor
93185497|NCT01146431|Anesthetics|anesthetics|mesh-list
93185498|NCT01146431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185499|NCT01146431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185500|NCT01250249|Vaccines|vaccines|mesh-list
93185501|NCT01250249|BCG Vaccine|bcg vaccine|mesh-list
93185502|NCT01250249|Immunologic Factors|immunologic factors|mesh-ancestor
93185503|NCT01250249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185504|NCT01250249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93185505|NCT03747679|Mannitol|mannitol|mesh-list
93185506|NCT03747679|Sorbitol|sorbitol|mesh-list
93185507|NCT03747679|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93185508|NCT03747679|Diuretics|diuretics|mesh-ancestor
93185509|NCT03747679|Natriuretic Agents|natriuretic agents|mesh-ancestor
93185510|NCT03747679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185511|NCT03747679|Cathartics|cathartics|mesh-ancestor
93185512|NCT03747679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185513|NCT01243385|Metformin|metformin|mesh-list
93185514|NCT01243385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93185515|NCT01243385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185516|NCT01147133|Clopidogrel|clopidogrel|mesh-list
93185517|NCT01147133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93185518|NCT01147133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93185519|NCT01147133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93185520|NCT01147133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93185521|NCT01147133|Purinergic Agents|purinergic agents|mesh-ancestor
93185522|NCT01147133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185523|NCT01147133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185524|NCT01147133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185525|NCT02162420|Cyclophosphamide|cyclophosphamide|mesh-list
93185526|NCT02162420|Fludarabine|fludarabine|mesh-list
93185527|NCT02162420|Alemtuzumab|alemtuzumab|mesh-list
93185528|NCT02162420|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93185529|NCT02162420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185530|NCT02162420|Immunologic Factors|immunologic factors|mesh-ancestor
93185531|NCT02162420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185532|NCT02162420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185533|NCT02162420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93185534|NCT02162420|Alkylating Agents|alkylating agents|mesh-ancestor
93185535|NCT02162420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185536|NCT02162420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185537|NCT02162420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93185538|NCT02162420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93185539|NCT04167085|Doxycycline|doxycycline|mesh-list
93185540|NCT04167085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93185541|NCT04167085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185542|NCT04167085|Antimalarials|antimalarials|mesh-ancestor
93185543|NCT04167085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93185544|NCT04167085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93185545|NCT01147289|Meloxicam|meloxicam|mesh-list
93366323|NCT02058485|GABA Modulators|gaba modulators|mesh-ancestor
93185546|NCT01147289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93185547|NCT01147289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185548|NCT01147289|Analgesics|analgesics|mesh-ancestor
93185549|NCT01147289|Sensory System Agents|sensory system agents|mesh-ancestor
93185550|NCT01147289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185551|NCT01147289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185552|NCT01147289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185553|NCT01147289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185554|NCT01147289|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93185555|NCT01147289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93185556|NCT01147289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185557|NCT01147289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185558|NCT01237769|Vitamin D|vitamin d|mesh-list
93185559|NCT01237769|Ergocalciferols|ergocalciferols|mesh-list
93185560|NCT01237769|Cholecalciferol|cholecalciferol|mesh-list
93185561|NCT01237769|Vitamins|vitamins|mesh-list
93185562|NCT01237769|Micronutrients|micronutrients|mesh-ancestor
93185563|NCT01237769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185564|NCT01237769|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93185565|NCT01237769|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93185566|NCT03914963|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93185567|NCT03914963|Hemostatics|hemostatics|mesh-ancestor
93185568|NCT03914963|Coagulants|coagulants|mesh-ancestor
93185569|NCT04162795|Loratadine|loratadine|mesh-list
93185570|NCT04162795|Antipruritics|antipruritics|mesh-ancestor
93185571|NCT04162795|Dermatologic Agents|dermatologic agents|mesh-ancestor
93185572|NCT04162795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93185573|NCT04162795|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93185574|NCT04162795|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93185575|NCT04162795|Histamine Antagonists|histamine antagonists|mesh-ancestor
93185576|NCT04162795|Histamine Agents|histamine agents|mesh-ancestor
93185577|NCT04162795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185578|NCT04162795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185579|NCT04162795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185580|NCT01250951|Deferasirox|deferasirox|mesh-list
93185581|NCT01250951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93185582|NCT01250951|Chelating Agents|chelating agents|mesh-ancestor
93185583|NCT01250951|Sequestering Agents|sequestering agents|mesh-ancestor
93185584|NCT01250951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185585|NCT03069482|Nicotine|nicotine|mesh-list
93185586|NCT03069482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93185587|NCT03069482|Autonomic Agents|autonomic agents|mesh-ancestor
93185588|NCT03069482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185589|NCT03069482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185590|NCT03069482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93185591|NCT03069482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93185592|NCT03069482|Cholinergic Agents|cholinergic agents|mesh-ancestor
93185593|NCT03069482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185594|NCT03069482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185595|NCT01250405|Cinacalcet|cinacalcet|mesh-list
93185596|NCT01250405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93185597|NCT01250405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185598|NCT01250405|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93185599|NCT01250405|Hormone Antagonists|hormone antagonists|mesh-ancestor
93185600|NCT01250405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185601|NCT05083910|Misoprostol|misoprostol|mesh-list
93185602|NCT05083910|Oxytocin|oxytocin|mesh-list
93185603|NCT05083910|Carbetocin|carbetocin|mesh-list
93185604|NCT05083910|Oxytocics|oxytocics|mesh-ancestor
93185605|NCT05083910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93185606|NCT05083910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185607|NCT05083910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93185608|NCT05083910|Abortifacient Agents|abortifacient agents|mesh-ancestor
93185609|NCT05083910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93185610|NCT05083910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185611|NCT01250561|Valacyclovir|valacyclovir|mesh-list
93185612|NCT01250561|Gabapentin|gabapentin|mesh-list
93185613|NCT01250561|Analgesics|analgesics|mesh-ancestor
93185614|NCT01250561|Sensory System Agents|sensory system agents|mesh-ancestor
93185615|NCT01250561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185616|NCT01250561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185617|NCT01250561|Anticonvulsants|anticonvulsants|mesh-ancestor
93185618|NCT01250561|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93185619|NCT01250561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93185620|NCT01250561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185621|NCT01250561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93185622|NCT01250561|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93185623|NCT01250561|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93185624|NCT01250561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185625|NCT01250561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185626|NCT01250561|Antimanic Agents|antimanic agents|mesh-ancestor
93185627|NCT01250561|Antiviral Agents|antiviral agents|mesh-ancestor
93185628|NCT01250561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185629|NCT05055908|Atezolizumab|atezolizumab|mesh-list
93185630|NCT05055908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93185631|NCT05055908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185632|NCT05055908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93185633|NCT05055908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185634|NCT01147523|Vitamin E|vitamin e|mesh-list
93185635|NCT01147523|Spironolactone|spironolactone|mesh-list
93185636|NCT01147523|Vitamins|vitamins|mesh-ancestor
93185637|NCT01147523|Micronutrients|micronutrients|mesh-ancestor
93185638|NCT01147523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185639|NCT01147523|Antioxidants|antioxidants|mesh-ancestor
93185640|NCT01147523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185641|NCT01147523|Protective Agents|protective agents|mesh-ancestor
93185642|NCT01147523|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93185643|NCT01147523|Hormone Antagonists|hormone antagonists|mesh-ancestor
93185644|NCT01147523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185645|NCT01147523|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93185646|NCT01147523|Diuretics|diuretics|mesh-ancestor
93185647|NCT01147523|Natriuretic Agents|natriuretic agents|mesh-ancestor
93185648|NCT01251029|Acetylcysteine|acetylcysteine|mesh-list
93185649|NCT01251029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93185650|NCT01251029|Antiviral Agents|antiviral agents|mesh-ancestor
93185651|NCT01251029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185652|NCT01251029|Expectorants|expectorants|mesh-ancestor
93185653|NCT01251029|Respiratory System Agents|respiratory system agents|mesh-ancestor
93185654|NCT01251029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93185655|NCT01251029|Antioxidants|antioxidants|mesh-ancestor
93185656|NCT01251029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185657|NCT01251029|Protective Agents|protective agents|mesh-ancestor
93185658|NCT01251029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185659|NCT01251029|Antidotes|antidotes|mesh-ancestor
93185660|NCT01251107|Prednisone|prednisone|mesh-list
93185661|NCT01251107|Cyclophosphamide|cyclophosphamide|mesh-list
93185662|NCT01251107|Dacarbazine|dacarbazine|mesh-list
93185663|NCT01251107|Doxorubicin|doxorubicin|mesh-list
93185664|NCT01251107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93185665|NCT01251107|Etoposide|etoposide|mesh-list
93185666|NCT01251107|Etoposide phosphate|etoposide phosphate|mesh-list
93185667|NCT01251107|Vincristine|vincristine|mesh-list
93185668|NCT01251107|Bleomycin|bleomycin|mesh-list
93185669|NCT01251107|Vinblastine|vinblastine|mesh-list
93185670|NCT01251107|Procarbazine|procarbazine|mesh-list
93185671|NCT01251107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185672|NCT01251107|Immunologic Factors|immunologic factors|mesh-ancestor
93185673|NCT01251107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185674|NCT01251107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185675|NCT01251107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93185676|NCT01251107|Alkylating Agents|alkylating agents|mesh-ancestor
93185677|NCT01251107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185678|NCT01251107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185679|NCT01251107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93185680|NCT01251107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93185681|NCT01251107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93185682|NCT01251107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93185683|NCT01251107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185684|NCT01251107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185685|NCT01251107|Glucocorticoids|glucocorticoids|mesh-ancestor
93185686|NCT01251107|Hormones|hormones|mesh-ancestor
93185687|NCT01251107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185688|NCT01251107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185689|NCT01251107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93185690|NCT01251107|Tubulin Modulators|tubulin modulators|mesh-ancestor
93185691|NCT01251107|Antimitotic Agents|antimitotic agents|mesh-ancestor
93185692|NCT01251107|Mitosis Modulators|mitosis modulators|mesh-ancestor
93185693|NCT01125176|Thalidomide|thalidomide|mesh-list
93185694|NCT01125176|Rituximab|rituximab|mesh-list
93185695|NCT01125176|Lenalidomide|lenalidomide|mesh-list
93185696|NCT01125176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93185697|NCT01125176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185698|NCT01125176|Immunologic Factors|immunologic factors|mesh-ancestor
93185699|NCT01125176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185700|NCT01125176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185701|NCT01125176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93185702|NCT01125176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93185703|NCT01125176|Growth Substances|growth substances|mesh-ancestor
93185704|NCT01125176|Growth Inhibitors|growth inhibitors|mesh-ancestor
93185705|NCT01125176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185706|NCT01125176|Leprostatic Agents|leprostatic agents|mesh-ancestor
93185707|NCT01125176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93185708|NCT01125176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185709|NCT00882050|Exenatide|exenatide|mesh-list
93185710|NCT00882050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93185711|NCT00882050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185712|NCT00882050|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93185713|NCT00882050|Incretins|incretins|mesh-ancestor
93185714|NCT00882050|Hormones|hormones|mesh-ancestor
93185715|NCT00882050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185716|NCT03912857|Apatinib|apatinib|mesh-list
93185717|NCT03912857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185718|NCT03912857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93185719|NCT03912857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185720|NCT03912857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185721|NCT04892420|Dexamethasone|dexamethasone|mesh-list
93185722|NCT04892420|Magnesium Sulfate|magnesium sulfate|mesh-list
93185723|NCT04892420|Dexmedetomidine|dexmedetomidine|mesh-list
93185724|NCT04892420|Bupivacaine|bupivacaine|mesh-list
93185725|NCT04892420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185726|NCT04892420|Antiemetics|antiemetics|mesh-ancestor
93185727|NCT04892420|Autonomic Agents|autonomic agents|mesh-ancestor
93185728|NCT04892420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185729|NCT04892420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185730|NCT04892420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185731|NCT04892420|Glucocorticoids|glucocorticoids|mesh-ancestor
93185732|NCT04892420|Hormones|hormones|mesh-ancestor
93185733|NCT04892420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185734|NCT04892420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185735|NCT04892420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185736|NCT04892420|Anesthetics, Local|anesthetics, local|mesh-ancestor
93185737|NCT04892420|Anesthetics|anesthetics|mesh-ancestor
93185738|NCT04892420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185739|NCT04892420|Sensory System Agents|sensory system agents|mesh-ancestor
93185740|NCT04892420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93185741|NCT04892420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185742|NCT04892420|Analgesics|analgesics|mesh-ancestor
93185743|NCT04892420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93185744|NCT04892420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93185745|NCT04892420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93185746|NCT04892420|Adrenergic Agents|adrenergic agents|mesh-ancestor
93185747|NCT04892420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185748|NCT04892420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185749|NCT04892420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93185750|NCT04892420|Anticonvulsants|anticonvulsants|mesh-ancestor
93185751|NCT04892420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93185752|NCT04892420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185753|NCT04892420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93185754|NCT04892420|Tocolytic Agents|tocolytic agents|mesh-ancestor
93185755|NCT04892420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93185756|NCT01251263|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93185757|NCT01251263|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93185758|NCT01251263|Estradiol|estradiol|mesh-list
93185759|NCT01251263|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93185760|NCT01251263|Estrogens|estrogens|mesh-ancestor
93185761|NCT01251263|Hormones|hormones|mesh-ancestor
93185762|NCT01251263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185763|NCT01251263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185764|NCT01251263|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93185765|NCT01251263|Contraceptive Agents|contraceptive agents|mesh-ancestor
93185766|NCT01251263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93185767|NCT01251263|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93185768|NCT04707534|Dexamethasone|dexamethasone|mesh-list
93185769|NCT04707534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185770|NCT04707534|Antiemetics|antiemetics|mesh-ancestor
92857923|NCT05059626|Bazedoxifene|bazedoxifene|mesh-list
93185771|NCT04707534|Autonomic Agents|autonomic agents|mesh-ancestor
93185772|NCT04707534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185773|NCT04707534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185774|NCT04707534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185775|NCT04707534|Glucocorticoids|glucocorticoids|mesh-ancestor
93185776|NCT04707534|Hormones|hormones|mesh-ancestor
93185777|NCT04707534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185778|NCT04707534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185779|NCT04707534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185780|NCT05761730|Dexamethasone|dexamethasone|mesh-list
93185781|NCT05761730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185782|NCT05761730|Antiemetics|antiemetics|mesh-ancestor
93185783|NCT05761730|Autonomic Agents|autonomic agents|mesh-ancestor
93185784|NCT05761730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185785|NCT05761730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185786|NCT05761730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185787|NCT05761730|Glucocorticoids|glucocorticoids|mesh-ancestor
93185788|NCT05761730|Hormones|hormones|mesh-ancestor
93185789|NCT05761730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185790|NCT05761730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185791|NCT05761730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185792|NCT04257500|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93185793|NCT04257500|Etonogestrel|etonogestrel|mesh-list
93185794|NCT04257500|NuvaRing|nuvaring|mesh-list
93185795|NCT04257500|Estradiol|estradiol|mesh-list
93185796|NCT04257500|Estrogens|estrogens|mesh-ancestor
93185797|NCT04257500|Hormones|hormones|mesh-ancestor
93185798|NCT04257500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185799|NCT04257500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185800|NCT04257500|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93185801|NCT04257500|Contraceptive Agents|contraceptive agents|mesh-ancestor
93185802|NCT04257500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93185803|NCT04257500|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93185804|NCT04257500|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93185805|NCT04257500|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93185806|NCT04353817|Ivacaftor|ivacaftor|mesh-list
93185807|NCT04353817|Elexacaftor|elexacaftor|mesh-list
93185808|NCT04353817|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93185809|NCT04353817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185810|NCT04353817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185811|NCT00159588|Angiotensin II|angiotensin ii|mesh-list
93185812|NCT00159588|Gabapentin|gabapentin|mesh-list
93185813|NCT00159588|Valproic Acid|valproic acid|mesh-list
93185814|NCT00159588|Antidepressive Agents|antidepressive agents|mesh-list
93185815|NCT00159588|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
93185816|NCT00159588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93185817|NCT00159588|Analgesics|analgesics|mesh-ancestor
93185818|NCT00159588|Sensory System Agents|sensory system agents|mesh-ancestor
93185819|NCT00159588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185820|NCT00159588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185821|NCT00159588|Anticonvulsants|anticonvulsants|mesh-ancestor
93185822|NCT00159588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93185823|NCT00159588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93185824|NCT00159588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185825|NCT00159588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93185826|NCT00159588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93185827|NCT00159588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93185828|NCT00159588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185829|NCT00159588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185830|NCT00159588|Antimanic Agents|antimanic agents|mesh-ancestor
93185831|NCT00159588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185832|NCT00159588|GABA Agents|gaba agents|mesh-ancestor
93185833|NCT00159588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93185834|NCT00159588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93185835|NCT00159588|Adrenergic Agents|adrenergic agents|mesh-ancestor
93185836|NCT04166942|Belumosudil|belumosudil|mesh-list
93185837|NCT04166942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93185838|NCT04166942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185839|NCT04166942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185840|NCT03903653|Botulinum Toxins|botulinum toxins|mesh-list
93185841|NCT03903653|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93185842|NCT03903653|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93185843|NCT03903653|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93185844|NCT03903653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185845|NCT03903653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185846|NCT03903653|Cholinergic Agents|cholinergic agents|mesh-ancestor
93185847|NCT03903653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185848|NCT03903653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185849|NCT03903653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93185850|NCT03903653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185851|NCT04349917|Methylphenidate|methylphenidate|mesh-list
93185852|NCT04349917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93185853|NCT04349917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185854|NCT04349917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93185855|NCT04349917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93185856|NCT04349917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93185857|NCT04349917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185858|NCT04349917|Dopamine Agents|dopamine agents|mesh-ancestor
93185859|NCT04349917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185860|NCT03903029|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93185861|NCT03903029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93185862|NCT03903029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93185863|NCT03903029|Antimetabolites|antimetabolites|mesh-ancestor
93185864|NCT03903029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185865|NCT03903029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93185866|NCT03903029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93185867|NCT03903029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185868|NCT04691856|Acetaminophen|acetaminophen|mesh-list
93185869|NCT04691856|Ibuprofen|ibuprofen|mesh-list
93185870|NCT04691856|Morphine|morphine|mesh-list
93185871|NCT04691856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93185872|NCT04691856|Narcotics|narcotics|mesh-ancestor
93185873|NCT04691856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185874|NCT04691856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185875|NCT04691856|Analgesics|analgesics|mesh-ancestor
93185876|NCT04691856|Sensory System Agents|sensory system agents|mesh-ancestor
93185877|NCT04691856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185878|NCT04691856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93185879|NCT04691856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93185880|NCT04691856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185881|NCT04691856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185882|NCT04691856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93185883|NCT04691856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185884|NCT04691856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185885|NCT04691856|Antipyretics|antipyretics|mesh-ancestor
93185886|NCT01254929|Frovatriptan|frovatriptan|mesh-list
93185887|NCT01254929|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93185888|NCT01254929|Serotonin Agents|serotonin agents|mesh-ancestor
93185889|NCT01254929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185890|NCT01254929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185891|NCT01254929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185892|NCT03300570|Dolcanatide|dolcanatide|mesh-list
93185893|NCT03300570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93185894|NCT03300570|Enzyme Activators|enzyme activators|mesh-ancestor
93185895|NCT03300570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185896|NCT03300570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185897|NCT03853694|Morphine|morphine|mesh-list
93185898|NCT03853694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93185899|NCT03853694|Narcotics|narcotics|mesh-ancestor
93185900|NCT03853694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93185901|NCT03853694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185902|NCT03853694|Analgesics|analgesics|mesh-ancestor
93185903|NCT03853694|Sensory System Agents|sensory system agents|mesh-ancestor
93185904|NCT03853694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185905|NCT04154293|Isotretinoin|isotretinoin|mesh-list
93185906|NCT04154293|Dermatologic Agents|dermatologic agents|mesh-ancestor
93185907|NCT01148147|Adenosine|adenosine|mesh-list
93185908|NCT01148147|Analgesics|analgesics|mesh-ancestor
93185909|NCT01148147|Sensory System Agents|sensory system agents|mesh-ancestor
93185910|NCT01148147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185911|NCT01148147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185912|NCT01148147|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93185913|NCT01148147|Vasodilator Agents|vasodilator agents|mesh-ancestor
93185914|NCT01148147|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93185915|NCT01148147|Purinergic Agonists|purinergic agonists|mesh-ancestor
93185916|NCT01148147|Purinergic Agents|purinergic agents|mesh-ancestor
93185917|NCT01148147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93185918|NCT01148147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185919|NCT03902249|Dexamethasone|dexamethasone|mesh-list
93185920|NCT03902249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93185921|NCT03902249|Antiemetics|antiemetics|mesh-ancestor
93185922|NCT03902249|Autonomic Agents|autonomic agents|mesh-ancestor
93366324|NCT02058485|GABA Agents|gaba agents|mesh-ancestor
93185923|NCT03902249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93185924|NCT03902249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185925|NCT03902249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93185927|NCT03902249|Hormones|hormones|mesh-ancestor
93185928|NCT03902249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93185929|NCT03902249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93185930|NCT03902249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185931|NCT03908489|Allyl sulfide|allyl sulfide|mesh-list
93185932|NCT03908489|Antioxidants|antioxidants|mesh-ancestor
93185933|NCT03908489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185934|NCT03908489|Protective Agents|protective agents|mesh-ancestor
93185935|NCT03908489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185936|NCT03908489|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93185937|NCT03908489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185938|NCT03908489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93185939|NCT03908489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93185940|NCT04342897|Zansecimab|zansecimab|mesh-list
93185941|NCT04342897|Antiviral Agents|antiviral agents|mesh-ancestor
93185942|NCT04342897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185943|NCT03263767|Cyclophosphamide|cyclophosphamide|mesh-list
93185944|NCT03263767|Fludarabine|fludarabine|mesh-list
93185945|NCT03263767|Clofarabine|clofarabine|mesh-list
93185946|NCT03263767|Thymoglobulin|thymoglobulin|mesh-list
93185947|NCT03263767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93185948|NCT03263767|Immunologic Factors|immunologic factors|mesh-ancestor
93185949|NCT03263767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185950|NCT03263767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185951|NCT03263767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93185952|NCT03263767|Alkylating Agents|alkylating agents|mesh-ancestor
93185953|NCT03263767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185954|NCT03263767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185955|NCT03263767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93185956|NCT03263767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93185957|NCT03263767|Antimetabolites|antimetabolites|mesh-ancestor
93185958|NCT04603742|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93185959|NCT04603742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93185960|NCT03908333|Ascorbic Acid|ascorbic acid|mesh-list
93185961|NCT03908333|Paclitaxel|paclitaxel|mesh-list
93185962|NCT03908333|Gemcitabine|gemcitabine|mesh-list
93185963|NCT03908333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93185964|NCT03908333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93185965|NCT03908333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93185966|NCT03908333|Tubulin Modulators|tubulin modulators|mesh-ancestor
93185967|NCT03908333|Antimitotic Agents|antimitotic agents|mesh-ancestor
93185968|NCT03908333|Mitosis Modulators|mitosis modulators|mesh-ancestor
93185969|NCT03908333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185970|NCT03908333|Vitamins|vitamins|mesh-ancestor
93185971|NCT03908333|Micronutrients|micronutrients|mesh-ancestor
93185972|NCT03908333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185973|NCT03908333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93185974|NCT03908333|Antimetabolites|antimetabolites|mesh-ancestor
93185975|NCT03908333|Antioxidants|antioxidants|mesh-ancestor
93185976|NCT03908333|Protective Agents|protective agents|mesh-ancestor
93185977|NCT04340557|Losartan|losartan|mesh-list
93185978|NCT04340557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93185979|NCT04340557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93185980|NCT04340557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93185981|NCT04340557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93185982|NCT04340557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93185983|NCT04566692|Immunoglobulins|immunoglobulins|mesh-list
93185984|NCT04566692|gamma-Globulins|gamma-globulins|mesh-list
93185985|NCT04566692|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93185986|NCT04566692|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93185987|NCT04566692|Immunologic Factors|immunologic factors|mesh-ancestor
93185988|NCT04566692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185989|NCT04549376|Iodine|iodine|mesh-list
93185990|NCT04549376|Cadexomer iodine|cadexomer iodine|mesh-list
93185991|NCT04549376|Povidone-Iodine|povidone-iodine|mesh-list
93185992|NCT04549376|Povidone|povidone|mesh-list
93185993|NCT04549376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93185994|NCT04549376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93185995|NCT04549376|Trace Elements|trace elements|mesh-ancestor
93185996|NCT04549376|Micronutrients|micronutrients|mesh-ancestor
93185997|NCT04549376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93185998|NCT04549376|Plasma Substitutes|plasma substitutes|mesh-ancestor
93185999|NCT04549376|Blood Substitutes|blood substitutes|mesh-ancestor
93186000|NCT01149395|Dexlansoprazole|dexlansoprazole|mesh-list
93186001|NCT01149395|Lansoprazole|lansoprazole|mesh-list
93186002|NCT01149395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92481817|NCT01903694|Sorafenib|sorafenib|mesh-list
93186003|NCT01149395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186004|NCT01149395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93186005|NCT01149395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186006|NCT01149395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186007|NCT02527733|Ranibizumab|ranibizumab|mesh-list
93186008|NCT02527733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93186009|NCT02527733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93186010|NCT02527733|Growth Substances|growth substances|mesh-ancestor
93186011|NCT02527733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186012|NCT02527733|Growth Inhibitors|growth inhibitors|mesh-ancestor
93186013|NCT02527733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186014|NCT04135495|Ivacaftor|ivacaftor|mesh-list
93186015|NCT04135495|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93186016|NCT04135495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186017|NCT04135495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186018|NCT01148303|Etoricoxib|etoricoxib|mesh-list
93186019|NCT01148303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93186020|NCT01148303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186021|NCT01148303|Analgesics|analgesics|mesh-ancestor
93186022|NCT01148303|Sensory System Agents|sensory system agents|mesh-ancestor
93186023|NCT01148303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186024|NCT01148303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186025|NCT01148303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186026|NCT01148303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186027|NCT01148303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93186028|NCT01148303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93186029|NCT01148303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186030|NCT01148303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186031|NCT03066830|Metformin|metformin|mesh-list
93186032|NCT03066830|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93186033|NCT03066830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186034|NCT03066830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186035|NCT03066830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93186036|NCT03066830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186037|NCT05205200|Paclitaxel|paclitaxel|mesh-list
93186038|NCT05205200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93186039|NCT05205200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186040|NCT05205200|Tubulin Modulators|tubulin modulators|mesh-ancestor
93186041|NCT05205200|Antimitotic Agents|antimitotic agents|mesh-ancestor
93186042|NCT05205200|Mitosis Modulators|mitosis modulators|mesh-ancestor
93186043|NCT05205200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186044|NCT01149629|Droxidopa|droxidopa|mesh-list
93186045|NCT01149629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93186046|NCT01149629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93186047|NCT05205122|Mitomycins|mitomycins|mesh-list
93186048|NCT05205122|Mitomycin|mitomycin|mesh-list
93186049|NCT05205122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93186050|NCT05205122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186051|NCT05205122|Alkylating Agents|alkylating agents|mesh-ancestor
93186052|NCT05205122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186053|NCT05205122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93186054|NCT05205122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186055|NCT03907163|Dronabinol|dronabinol|mesh-list
93186056|NCT03907163|Hallucinogens|hallucinogens|mesh-ancestor
93186057|NCT03907163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186058|NCT03907163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93186059|NCT03907163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186060|NCT03907163|Analgesics|analgesics|mesh-ancestor
93186061|NCT03907163|Sensory System Agents|sensory system agents|mesh-ancestor
93186062|NCT03907163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186063|NCT03907163|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93186064|NCT03907163|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93186065|NCT03907163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186066|NCT03907163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186067|NCT03907163|Hormones|hormones|mesh-ancestor
93186068|NCT03907163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186069|NCT01253681|Paclitaxel|paclitaxel|mesh-list
93186070|NCT01253681|Carboplatin|carboplatin|mesh-list
93186071|NCT01253681|Trebananib|trebananib|mesh-list
93186072|NCT01253681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93186073|NCT01253681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186074|NCT01253681|Tubulin Modulators|tubulin modulators|mesh-ancestor
93186075|NCT01253681|Antimitotic Agents|antimitotic agents|mesh-ancestor
93186076|NCT01253681|Mitosis Modulators|mitosis modulators|mesh-ancestor
93186077|NCT01253681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186078|NCT01253681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93186079|NCT01253681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93186080|NCT01253681|Growth Substances|growth substances|mesh-ancestor
93186081|NCT01253681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186082|NCT01253681|Growth Inhibitors|growth inhibitors|mesh-ancestor
93186083|NCT01149941|Ibuprofen|ibuprofen|mesh-list
93186084|NCT01149941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93186085|NCT01149941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186086|NCT01149941|Analgesics|analgesics|mesh-ancestor
93186087|NCT01149941|Sensory System Agents|sensory system agents|mesh-ancestor
93186088|NCT01149941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186089|NCT01149941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186090|NCT01149941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186091|NCT01149941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186092|NCT01149941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93186093|NCT01149941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186094|NCT01149941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186095|NCT01589549|Methylprednisolone|methylprednisolone|mesh-list
93186096|NCT01589549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186097|NCT01589549|Antiemetics|antiemetics|mesh-ancestor
93186098|NCT01589549|Autonomic Agents|autonomic agents|mesh-ancestor
93186099|NCT01589549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186100|NCT01589549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186101|NCT01589549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186102|NCT01589549|Glucocorticoids|glucocorticoids|mesh-ancestor
93186103|NCT01589549|Hormones|hormones|mesh-ancestor
93186104|NCT01589549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186105|NCT01589549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93186106|NCT01589549|Protective Agents|protective agents|mesh-ancestor
93186107|NCT03899675|Caffeine|caffeine|mesh-list
93186108|NCT03899675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93186109|NCT03899675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186110|NCT03899675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93186111|NCT03899675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186112|NCT03899675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186113|NCT03899675|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93186114|NCT03899675|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93186115|NCT03899675|Purinergic Agents|purinergic agents|mesh-ancestor
93186116|NCT03899675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186117|NCT01562197|Axitinib|axitinib|mesh-list
93186118|NCT01562197|Lomustine|lomustine|mesh-list
93186119|NCT01562197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186120|NCT01562197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93186121|NCT01562197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186122|NCT01562197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186123|NCT01562197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93186124|NCT01562197|Alkylating Agents|alkylating agents|mesh-ancestor
93186125|NCT03905837|Lidocaine|lidocaine|mesh-list
93186126|NCT03905837|Piperidine|piperidine|mesh-list
93186127|NCT03905837|Remifentanil|remifentanil|mesh-list
93186128|NCT03905837|Anesthetics, Local|anesthetics, local|mesh-ancestor
93186129|NCT03905837|Anesthetics|anesthetics|mesh-ancestor
93186130|NCT03905837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186131|NCT03905837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186132|NCT03905837|Sensory System Agents|sensory system agents|mesh-ancestor
93186133|NCT03905837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186134|NCT03905837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93186135|NCT03905837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93186136|NCT03905837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93186137|NCT03905837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186138|NCT03905837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186139|NCT03905837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93186140|NCT03905837|Narcotics|narcotics|mesh-ancestor
93186141|NCT03905837|Analgesics|analgesics|mesh-ancestor
93186142|NCT03905837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93186143|NCT03905837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92858292|NCT04060017|Vitamin B Complex|vitamin b complex|mesh-ancestor
93186144|NCT03063632|Interferons|interferons|mesh-list
93186145|NCT03063632|Interferon-gamma|interferon-gamma|mesh-list
93186146|NCT03063632|Pembrolizumab|pembrolizumab|mesh-list
93186147|NCT03063632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93186148|NCT03063632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186149|NCT03063632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93186150|NCT03063632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186151|NCT03063632|Antiviral Agents|antiviral agents|mesh-ancestor
93186152|NCT03063632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186153|NCT04328467|Hydroxychloroquine|hydroxychloroquine|mesh-list
93186154|NCT04328467|Antimalarials|antimalarials|mesh-ancestor
93186155|NCT04328467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93186156|NCT04328467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93186157|NCT04328467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186158|NCT04328467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186159|NCT04328467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186160|NCT04328467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186161|NCT01148615|Docetaxel|docetaxel|mesh-list
93186162|NCT01148615|Aflibercept|aflibercept|mesh-list
93186163|NCT01148615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186164|NCT01148615|Tubulin Modulators|tubulin modulators|mesh-ancestor
93186165|NCT01148615|Antimitotic Agents|antimitotic agents|mesh-ancestor
93186166|NCT01148615|Mitosis Modulators|mitosis modulators|mesh-ancestor
93186167|NCT01148615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186168|NCT01148615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93186169|NCT01148615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93186170|NCT01148615|Growth Substances|growth substances|mesh-ancestor
93186171|NCT01148615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186172|NCT01148615|Growth Inhibitors|growth inhibitors|mesh-ancestor
93186173|NCT04161248|Dexamethasone|dexamethasone|mesh-list
93186174|NCT04161248|Rituximab|rituximab|mesh-list
93186175|NCT04161248|Gemcitabine|gemcitabine|mesh-list
93186176|NCT04161248|Venetoclax|venetoclax|mesh-list
93186177|NCT04161248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93186178|NCT04161248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186179|NCT04161248|Immunologic Factors|immunologic factors|mesh-ancestor
93186180|NCT04161248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186181|NCT04161248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186182|NCT04161248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186183|NCT04161248|Antiemetics|antiemetics|mesh-ancestor
93186184|NCT04161248|Autonomic Agents|autonomic agents|mesh-ancestor
93186185|NCT04161248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186186|NCT04161248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186187|NCT04161248|Glucocorticoids|glucocorticoids|mesh-ancestor
93186188|NCT04161248|Hormones|hormones|mesh-ancestor
93186189|NCT04161248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186190|NCT04161248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93186191|NCT04161248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93186192|NCT04161248|Antimetabolites|antimetabolites|mesh-ancestor
93186193|NCT04161248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186194|NCT03905759|Colchicine|colchicine|mesh-list
93186195|NCT03905759|Amiodarone|amiodarone|mesh-list
93186196|NCT03905759|Dronedarone|dronedarone|mesh-list
93186197|NCT03905759|Gout Suppressants|gout suppressants|mesh-ancestor
93186198|NCT03905759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186199|NCT03905759|Tubulin Modulators|tubulin modulators|mesh-ancestor
93186200|NCT03905759|Antimitotic Agents|antimitotic agents|mesh-ancestor
93186201|NCT03905759|Mitosis Modulators|mitosis modulators|mesh-ancestor
93186202|NCT03905759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186203|NCT03905759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186204|NCT03905759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93186205|NCT03905759|Vasodilator Agents|vasodilator agents|mesh-ancestor
93186206|NCT03905759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93186207|NCT03905759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186208|NCT03905759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93186209|NCT03905759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93186210|NCT03905759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93186211|NCT03905759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186212|NCT03905759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93186213|NCT03905759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93186214|NCT03905759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93186215|NCT01255475|Amlodipine|amlodipine|mesh-list
93186216|NCT01255475|Hydralazine|hydralazine|mesh-list
93186217|NCT01255475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93186218|NCT01255475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93186219|NCT01255475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366325|NCT02060279|Carotenoids|carotenoids|mesh-list
93186220|NCT01255475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186221|NCT01255475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93186222|NCT01255475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186223|NCT01255475|Vasodilator Agents|vasodilator agents|mesh-ancestor
93186225|NCT05208398|Apixaban|apixaban|mesh-list
93186226|NCT05208398|Anticoagulants|anticoagulants|mesh-ancestor
93186227|NCT05208398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93186228|NCT05208398|Antithrombins|antithrombins|mesh-ancestor
93186229|NCT05208398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93186230|NCT05208398|Protease Inhibitors|protease inhibitors|mesh-ancestor
93186231|NCT05208398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186232|NCT05208398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186233|NCT05593601|Neomycin|neomycin|mesh-list
93186234|NCT05593601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186235|NCT05593601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186236|NCT05593601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93186237|NCT05593601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186238|NCT05593601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186239|NCT03629210|Dexamethasone|dexamethasone|mesh-list
93186240|NCT03629210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186241|NCT03629210|Antiemetics|antiemetics|mesh-ancestor
93186242|NCT03629210|Autonomic Agents|autonomic agents|mesh-ancestor
93186243|NCT03629210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186244|NCT03629210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186245|NCT03629210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186246|NCT03629210|Glucocorticoids|glucocorticoids|mesh-ancestor
93186247|NCT03629210|Hormones|hormones|mesh-ancestor
93186248|NCT03629210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186249|NCT03629210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93186250|NCT03629210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186251|NCT05569811|Letrozole|letrozole|mesh-list
93186252|NCT05569811|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
93186253|NCT05569811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186254|NCT05569811|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93186255|NCT05569811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93186256|NCT05569811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186257|NCT05569811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186258|NCT05569811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93186259|NCT05569811|Hormone Antagonists|hormone antagonists|mesh-ancestor
93186260|NCT05569811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186261|NCT05569811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186262|NCT05569811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93186263|NCT03899285|Citalopram|citalopram|mesh-list
93186264|NCT03899285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93186265|NCT03899285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93186266|NCT03899285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186267|NCT03899285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186268|NCT03899285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186269|NCT03899285|Serotonin Agents|serotonin agents|mesh-ancestor
93186270|NCT03899285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186271|NCT03899285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93186272|NCT03899285|Antidepressive Agents|antidepressive agents|mesh-ancestor
93186273|NCT03899285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93186274|NCT01254071|Tamsulosin|tamsulosin|mesh-list
93186275|NCT01254071|Dutasteride|dutasteride|mesh-list
93186276|NCT01254071|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93186277|NCT01254071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93186278|NCT01254071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93186279|NCT01254071|Adrenergic Agents|adrenergic agents|mesh-ancestor
93186280|NCT01254071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186281|NCT01254071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186282|NCT01254071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186283|NCT01254071|Urological Agents|urological agents|mesh-ancestor
93186284|NCT01254071|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93186285|NCT01254071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93186286|NCT01254071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186287|NCT01254071|Hormone Antagonists|hormone antagonists|mesh-ancestor
93186288|NCT01254071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186289|NCT05761418|Misoprostol|misoprostol|mesh-list
93186290|NCT05761418|Dinoprostone|dinoprostone|mesh-list
93186291|NCT05761418|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93186292|NCT05761418|Abortifacient Agents|abortifacient agents|mesh-ancestor
93186293|NCT05761418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93186294|NCT05761418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186295|NCT05761418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93186296|NCT05761418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186297|NCT05761418|Oxytocics|oxytocics|mesh-ancestor
93186298|NCT05207774|Oxytocin|oxytocin|mesh-list
93186299|NCT05207774|Oxytocics|oxytocics|mesh-ancestor
93186300|NCT05207774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93186301|NCT05207774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186302|NCT02528123|Tobramycin|tobramycin|mesh-list
93186303|NCT02528123|Ofloxacin|ofloxacin|mesh-list
93186304|NCT02528123|Dexamethasone|dexamethasone|mesh-list
93186305|NCT02528123|Benoxinate|benoxinate|mesh-list
93186306|NCT02528123|Proxymetacaine|proxymetacaine|mesh-list
93186307|NCT02528123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186308|NCT02528123|Antiemetics|antiemetics|mesh-ancestor
93186309|NCT02528123|Autonomic Agents|autonomic agents|mesh-ancestor
93186310|NCT02528123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186311|NCT02528123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186312|NCT02528123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186313|NCT02528123|Glucocorticoids|glucocorticoids|mesh-ancestor
93186314|NCT02528123|Hormones|hormones|mesh-ancestor
93186315|NCT02528123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186316|NCT02528123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93186317|NCT02528123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186318|NCT02528123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186319|NCT02528123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186320|NCT02528123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93186321|NCT02528123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93186322|NCT02528123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93186323|NCT02528123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186324|NCT02528123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186325|NCT02528123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93186326|NCT02528123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93186327|NCT02528123|Anesthetics, Local|anesthetics, local|mesh-ancestor
93186328|NCT02528123|Anesthetics|anesthetics|mesh-ancestor
93186329|NCT02528123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186330|NCT02528123|Sensory System Agents|sensory system agents|mesh-ancestor
93186331|NCT02527811|Urinastatin|urinastatin|mesh-list
93186332|NCT02527811|Trypsin Inhibitors|trypsin inhibitors|mesh-list
93186333|NCT02527811|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93186334|NCT02527811|Protease Inhibitors|protease inhibitors|mesh-ancestor
93186335|NCT02527811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186336|NCT02527811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186337|NCT03691831|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93186338|NCT03691831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93186339|NCT03691831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186340|NCT01254383|Sildenafil Citrate|sildenafil citrate|mesh-list
93186341|NCT01254383|Vasodilator Agents|vasodilator agents|mesh-ancestor
93186342|NCT01254383|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93186343|NCT01254383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93186344|NCT01254383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186345|NCT01254383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186346|NCT01254383|Urological Agents|urological agents|mesh-ancestor
93186347|NCT03700970|Bupivacaine|bupivacaine|mesh-list
93186348|NCT03700970|Anesthetics, Local|anesthetics, local|mesh-ancestor
93186349|NCT03700970|Anesthetics|anesthetics|mesh-ancestor
93186350|NCT03700970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186351|NCT03700970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186352|NCT03700970|Sensory System Agents|sensory system agents|mesh-ancestor
93186353|NCT03700970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186354|NCT01256021|Botulinum Toxins|botulinum toxins|mesh-list
93186355|NCT01256021|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93186356|NCT01256021|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93186357|NCT01256021|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93186358|NCT01256021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186359|NCT01256021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186360|NCT01256021|Cholinergic Agents|cholinergic agents|mesh-ancestor
93186361|NCT01256021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186362|NCT01256021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186363|NCT01256021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93186364|NCT01256021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186365|NCT04320745|Testosterone|testosterone|mesh-list
93186366|NCT04320745|Androgens|androgens|mesh-ancestor
93186367|NCT04320745|Hormones|hormones|mesh-ancestor
93186368|NCT04320745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186369|NCT04320745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186370|NCT01254461|Pravastatin|pravastatin|mesh-list
93186371|NCT01254461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93186372|NCT01254461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93186373|NCT01254461|Antimetabolites|antimetabolites|mesh-ancestor
93186374|NCT01254461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186375|NCT01254461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93186376|NCT01254461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93186377|NCT01254461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186378|NCT03747523|Vitamin D|vitamin d|mesh-list
93186379|NCT03747523|Ergocalciferols|ergocalciferols|mesh-list
93186380|NCT03747523|Vitamins|vitamins|mesh-ancestor
93186381|NCT03747523|Micronutrients|micronutrients|mesh-ancestor
93186382|NCT03747523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186383|NCT03747523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93186384|NCT03747523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93186385|NCT05293171|Moxifloxacin|moxifloxacin|mesh-list
93186386|NCT05293171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186387|NCT05293171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186388|NCT05293171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93186389|NCT05293171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93186390|NCT05293171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186391|NCT05293171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186392|NCT05293171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186393|NCT03063086|Fluticasone|fluticasone|mesh-list
93186394|NCT03063086|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93186395|NCT03063086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186396|NCT03063086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93186397|NCT03063086|Autonomic Agents|autonomic agents|mesh-ancestor
93186398|NCT03063086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186399|NCT03063086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186400|NCT03063086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93186401|NCT03063086|Respiratory System Agents|respiratory system agents|mesh-ancestor
93186402|NCT03063086|Dermatologic Agents|dermatologic agents|mesh-ancestor
93186403|NCT03063086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93186404|NCT03063086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93186405|NCT03063086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93186406|NCT03063086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93186407|NCT03063086|Adrenergic Agents|adrenergic agents|mesh-ancestor
93186408|NCT03063086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186409|NCT03063086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186410|NCT03904745|Atosiban|atosiban|mesh-list
93186411|NCT03904745|Hormone Antagonists|hormone antagonists|mesh-ancestor
93186412|NCT03904745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186413|NCT03904745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186414|NCT03904745|Tocolytic Agents|tocolytic agents|mesh-ancestor
93186415|NCT03904745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93186416|NCT05187338|Pembrolizumab|pembrolizumab|mesh-list
93186417|NCT05187338|Ipilimumab|ipilimumab|mesh-list
93186418|NCT05187338|Durvalumab|durvalumab|mesh-list
93186419|NCT05187338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93186420|NCT05187338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186421|NCT05187338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93186422|NCT05187338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186423|NCT03898583|Calcitriol|calcitriol|mesh-list
93186424|NCT03898583|Betamethasone|betamethasone|mesh-list
93186425|NCT03898583|Betamethasone Valerate|betamethasone valerate|mesh-list
93186426|NCT03898583|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93186427|NCT03898583|Betamethasone benzoate|betamethasone benzoate|mesh-list
93186428|NCT03898583|Calcipotriene|calcipotriene|mesh-list
93186429|NCT03898583|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93186430|NCT03898583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186431|NCT03898583|Glucocorticoids|glucocorticoids|mesh-ancestor
93186432|NCT03898583|Hormones|hormones|mesh-ancestor
93186433|NCT03898583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186434|NCT03898583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186435|NCT03898583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93186436|NCT03898583|Respiratory System Agents|respiratory system agents|mesh-ancestor
93186437|NCT03898583|Dermatologic Agents|dermatologic agents|mesh-ancestor
93186438|NCT03898583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93186439|NCT03898583|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93186440|NCT03898583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366326|NCT02060279|Antioxidants|antioxidants|mesh-ancestor
93186441|NCT03898583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186442|NCT03898583|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93186443|NCT03898583|Vitamins|vitamins|mesh-ancestor
93186444|NCT03898583|Micronutrients|micronutrients|mesh-ancestor
93186445|NCT03898583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93186446|NCT03898193|Montelukast|montelukast|mesh-list
93186447|NCT03898193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93186448|NCT03898193|Respiratory System Agents|respiratory system agents|mesh-ancestor
93186449|NCT03898193|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93186450|NCT03898193|Hormone Antagonists|hormone antagonists|mesh-ancestor
93186451|NCT03898193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186452|NCT03898193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186453|NCT03898193|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93186454|NCT03898193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93186455|NCT03898193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186456|NCT03321188|Paclitaxel|paclitaxel|mesh-list
93186457|NCT03321188|Carboplatin|carboplatin|mesh-list
93186458|NCT03321188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93186459|NCT03321188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186460|NCT03321188|Tubulin Modulators|tubulin modulators|mesh-ancestor
93186461|NCT03321188|Antimitotic Agents|antimitotic agents|mesh-ancestor
93186462|NCT03321188|Mitosis Modulators|mitosis modulators|mesh-ancestor
93186463|NCT03321188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186464|NCT03904355|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93186465|NCT03904355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93186466|NCT03904355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186467|NCT01254617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93186468|NCT01254617|Cetuximab|cetuximab|mesh-list
93186469|NCT01254617|Lenalidomide|lenalidomide|mesh-list
93186470|NCT01254617|Antibodies|antibodies|mesh-list
93186471|NCT01254617|Immunoglobulins|immunoglobulins|mesh-list
93186472|NCT01254617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93186473|NCT01254617|Immunologic Factors|immunologic factors|mesh-ancestor
93186474|NCT01254617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186475|NCT01254617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186476|NCT01254617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93186477|NCT01254617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93186478|NCT01254617|Growth Substances|growth substances|mesh-ancestor
93186479|NCT01254617|Growth Inhibitors|growth inhibitors|mesh-ancestor
93186480|NCT01150331|Levetiracetam|levetiracetam|mesh-list
93186481|NCT01150331|Clonazepam|clonazepam|mesh-list
93186482|NCT01150331|Anticonvulsants|anticonvulsants|mesh-list
93186483|NCT01150331|Nootropic Agents|nootropic agents|mesh-ancestor
93186484|NCT01150331|GABA Modulators|gaba modulators|mesh-ancestor
93186485|NCT01150331|GABA Agents|gaba agents|mesh-ancestor
93186486|NCT01150331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186487|NCT01150331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186488|NCT01150331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186489|NCT03191084|Dronabinol|dronabinol|mesh-list
93186490|NCT03191084|Hallucinogens|hallucinogens|mesh-ancestor
93186491|NCT03191084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186492|NCT03191084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93186493|NCT03191084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186494|NCT03191084|Analgesics|analgesics|mesh-ancestor
93186495|NCT03191084|Sensory System Agents|sensory system agents|mesh-ancestor
93186496|NCT03191084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186497|NCT03191084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93186498|NCT03191084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93186499|NCT03191084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186500|NCT03191084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186501|NCT03191084|Hormones|hormones|mesh-ancestor
93186502|NCT03191084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186503|NCT01256489|Infliximab|infliximab|mesh-list
93186504|NCT01256489|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93186505|NCT01256489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186506|NCT01256489|Dermatologic Agents|dermatologic agents|mesh-ancestor
93186507|NCT01256489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186508|NCT01256489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186509|NCT03746119|Nicotine|nicotine|mesh-list
93186510|NCT03746119|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93186511|NCT03746119|Autonomic Agents|autonomic agents|mesh-ancestor
92858667|NCT01856192|Lenalidomide|lenalidomide|mesh-list
93186512|NCT03746119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186513|NCT03746119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186514|NCT03746119|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93186515|NCT03746119|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93186516|NCT03746119|Cholinergic Agents|cholinergic agents|mesh-ancestor
93186517|NCT03746119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186518|NCT03746119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186519|NCT01149005|Insulin|insulin|mesh-list
93186520|NCT01149005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93186521|NCT01149005|Insulin Lispro|insulin lispro|mesh-list
93186522|NCT01149005|Insulin Aspart|insulin aspart|mesh-list
93186523|NCT01149005|Insulin, Short-Acting|insulin, short-acting|mesh-list
93186524|NCT01149005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186525|NCT01149005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186526|NCT03903887|Antibodies|antibodies|mesh-list
93186527|NCT03903887|Immunologic Factors|immunologic factors|mesh-ancestor
93186528|NCT03903887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186529|NCT03903419|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93186530|NCT03903419|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93186531|NCT03903419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186532|NCT05122130|Melatonin|melatonin|mesh-list
93186533|NCT05122130|Antioxidants|antioxidants|mesh-ancestor
93186534|NCT05122130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186535|NCT05122130|Protective Agents|protective agents|mesh-ancestor
93186536|NCT05122130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186537|NCT05122130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186538|NCT02898506|Liraglutide|liraglutide|mesh-list
93186539|NCT02898506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186540|NCT02898506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186541|NCT02898506|Incretins|incretins|mesh-ancestor
93186542|NCT02898506|Hormones|hormones|mesh-ancestor
93186543|NCT02898506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186544|NCT04123405|Acetylcysteine|acetylcysteine|mesh-list
93186545|NCT04123405|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93186546|NCT04123405|Antiviral Agents|antiviral agents|mesh-ancestor
93186547|NCT04123405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186548|NCT04123405|Expectorants|expectorants|mesh-ancestor
93186549|NCT04123405|Respiratory System Agents|respiratory system agents|mesh-ancestor
93186550|NCT04123405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93186551|NCT04123405|Antioxidants|antioxidants|mesh-ancestor
93186552|NCT04123405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186553|NCT04123405|Protective Agents|protective agents|mesh-ancestor
93186554|NCT04123405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186555|NCT04123405|Antidotes|antidotes|mesh-ancestor
93186556|NCT02611232|Liraglutide|liraglutide|mesh-list
93186557|NCT02611232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186558|NCT02611232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186559|NCT02611232|Incretins|incretins|mesh-ancestor
93186560|NCT02611232|Hormones|hormones|mesh-ancestor
93186561|NCT02611232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186562|NCT01150877|Vitamin D|vitamin d|mesh-list
93186563|NCT01150877|Vitamins|vitamins|mesh-ancestor
93186564|NCT01150877|Micronutrients|micronutrients|mesh-ancestor
93186565|NCT01150877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186566|NCT01150877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93186567|NCT03893591|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93186568|NCT03893591|Dalteparin|dalteparin|mesh-list
93186569|NCT03893591|Anticoagulants|anticoagulants|mesh-ancestor
93186570|NCT03893591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93186571|NCT03893591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93186572|NCT03893591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186573|NCT01256801|Interleukin-2|interleukin-2|mesh-list
93186574|NCT01256801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186575|NCT01256801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186576|NCT01256801|Analgesics|analgesics|mesh-ancestor
93186577|NCT01256801|Sensory System Agents|sensory system agents|mesh-ancestor
93186578|NCT01256801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186579|NCT01256801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186580|NCT02519738|Silver Nitrate|silver nitrate|mesh-list
93186581|NCT02519738|Triamcinolone|triamcinolone|mesh-list
93186582|NCT02519738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93186583|NCT02519738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186584|NCT02519738|Glucocorticoids|glucocorticoids|mesh-ancestor
93186585|NCT02519738|Hormones|hormones|mesh-ancestor
93186586|NCT02519738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186587|NCT02519738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186588|NCT02519738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93186589|NCT02519738|Immunologic Factors|immunologic factors|mesh-ancestor
93186590|NCT02519738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93186591|NCT02519738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186592|NCT03893747|Vaccines|vaccines|mesh-list
93186593|NCT03893747|Immunologic Factors|immunologic factors|mesh-ancestor
93186594|NCT03893747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186595|NCT02343224|Interferons|interferons|mesh-list
93186596|NCT02343224|Interferon-alpha|interferon-alpha|mesh-list
93186597|NCT02343224|Interferon alpha-2|interferon alpha-2|mesh-list
93186598|NCT02343224|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93186599|NCT02343224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186600|NCT02343224|Antiviral Agents|antiviral agents|mesh-ancestor
93186601|NCT02343224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186602|NCT02343224|Immunologic Factors|immunologic factors|mesh-ancestor
93186603|NCT02343224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186604|NCT01257035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93186605|NCT01257035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93186606|NCT01257035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186607|NCT04314037|Praziquantel|praziquantel|mesh-list
93186608|NCT04314037|Anthelmintics|anthelmintics|mesh-ancestor
93186609|NCT04314037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93186610|NCT04314037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186611|NCT05737862|Folic Acid|folic acid|mesh-list
93186612|NCT05737862|Hematinics|hematinics|mesh-ancestor
93186613|NCT05737862|Vitamin B Complex|vitamin b complex|mesh-ancestor
93186614|NCT05737862|Vitamins|vitamins|mesh-ancestor
93186615|NCT05737862|Micronutrients|micronutrients|mesh-ancestor
93186616|NCT05737862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186617|NCT02097680|Letrozole|letrozole|mesh-list
93186618|NCT02097680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186619|NCT02097680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93186620|NCT02097680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93186621|NCT02097680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186622|NCT02097680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186623|NCT02097680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93186624|NCT02097680|Hormone Antagonists|hormone antagonists|mesh-ancestor
93186625|NCT02097680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186626|NCT02097680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186627|NCT01150955|Resveratrol|resveratrol|mesh-list
93186628|NCT01150955|Antioxidants|antioxidants|mesh-ancestor
93186629|NCT01150955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186630|NCT01150955|Protective Agents|protective agents|mesh-ancestor
93186631|NCT01150955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186632|NCT01150955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186633|NCT01150955|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93186634|NCT03897413|Antacids|antacids|mesh-list
93186635|NCT03897413|Calcium Carbonate|calcium carbonate|mesh-list
93186636|NCT03897413|Calcium|calcium|mesh-list
93186637|NCT03897413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93186638|NCT03897413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186639|NCT03897413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186640|NCT03897413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186641|NCT01258439|Ritonavir|ritonavir|mesh-list
93186642|NCT01258439|Darunavir|darunavir|mesh-list
93186643|NCT01258439|Tenofovir|tenofovir|mesh-list
93186644|NCT01258439|Emtricitabine|emtricitabine|mesh-list
93186645|NCT01258439|Raltegravir Potassium|raltegravir potassium|mesh-list
93186646|NCT01258439|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93186647|NCT01258439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93186648|NCT01258439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93186649|NCT01258439|Protease Inhibitors|protease inhibitors|mesh-ancestor
93186650|NCT01258439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186651|NCT01258439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186652|NCT01258439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93186653|NCT01258439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93186654|NCT01258439|Antiviral Agents|antiviral agents|mesh-ancestor
93186655|NCT01258439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186656|NCT01258439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93186657|NCT01258439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93186658|NCT01258439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93186659|NCT01258439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93186660|NCT01258439|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93186661|NCT01258439|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93186662|NCT01850888|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93186663|NCT01850888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93186664|NCT01850888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858814|NCT02730624|Piperacillin|piperacillin|mesh-list
93186665|NCT01850888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186666|NCT01850888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186667|NCT01850888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93186668|NCT01560572|Mycophenolic Acid|mycophenolic acid|mesh-list
93186669|NCT01560572|Prednisolone|prednisolone|mesh-list
93186670|NCT01560572|Tacrolimus|tacrolimus|mesh-list
93186671|NCT01560572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93186672|NCT01560572|Immunologic Factors|immunologic factors|mesh-ancestor
93186673|NCT01560572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186674|NCT01560572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93186675|NCT01560572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186676|NCT01560572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186677|NCT01560572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186678|NCT01560572|Glucocorticoids|glucocorticoids|mesh-ancestor
93186679|NCT01560572|Hormones|hormones|mesh-ancestor
93186680|NCT01560572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186681|NCT01560572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93186682|NCT01560572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186683|NCT01560572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93186684|NCT01560572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93186685|NCT01560572|Antitubercular Agents|antitubercular agents|mesh-ancestor
93186686|NCT01560572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186687|NCT01560572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186688|NCT05209256|Pemetrexed|pemetrexed|mesh-list
93186689|NCT05209256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186690|NCT05209256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186691|NCT05209256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186692|NCT05209256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93186693|NCT05209256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93186694|NCT03896321|Anticoagulants|anticoagulants|mesh-list
93186695|NCT03896321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93186696|NCT05211050|Cromakalim|cromakalim|mesh-list
93186697|NCT05211050|Sumatriptan|sumatriptan|mesh-list
93186698|NCT05211050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93186699|NCT05211050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93186700|NCT05211050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93186701|NCT05211050|Serotonin Agents|serotonin agents|mesh-ancestor
93186702|NCT05211050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186703|NCT05211050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186704|NCT05211050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186705|NCT05211050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93186706|NCT05211050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93186707|NCT05211050|Autonomic Agents|autonomic agents|mesh-ancestor
93186708|NCT05211050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186709|NCT05211050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93186710|NCT05211050|Respiratory System Agents|respiratory system agents|mesh-ancestor
93186711|NCT05211050|Parasympatholytics|parasympatholytics|mesh-ancestor
93186712|NCT05211050|Vasodilator Agents|vasodilator agents|mesh-ancestor
93186713|NCT03892499|Itraconazole|itraconazole|mesh-list
93186714|NCT03892499|Antifungal Agents|antifungal agents|mesh-ancestor
93186715|NCT03892499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186716|NCT03892499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93186717|NCT03892499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93186718|NCT03892499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186719|NCT03892499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186720|NCT03892499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93186721|NCT03892499|Hormone Antagonists|hormone antagonists|mesh-ancestor
93186722|NCT03892499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186723|NCT03892499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186724|NCT03892499|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93186725|NCT01152047|Oxytocin|oxytocin|mesh-list
93186726|NCT01152047|Oxytocics|oxytocics|mesh-ancestor
93186727|NCT01152047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93186728|NCT01152047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186729|NCT01151267|Anesthetics|anesthetics|mesh-list
93186730|NCT01151267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186731|NCT01151267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186732|NCT01259141|Azithromycin|azithromycin|mesh-list
93186733|NCT01259141|Moxifloxacin|moxifloxacin|mesh-list
93186734|NCT01259141|Cephalosporins|cephalosporins|mesh-list
93186735|NCT01259141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186736|NCT01259141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186737|NCT01259141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93186738|NCT01259141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93186739|NCT01259141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186740|NCT01259141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186742|NCT05210192|Lidocaine|lidocaine|mesh-list
93186743|NCT05210192|Anesthetics, Local|anesthetics, local|mesh-ancestor
93186744|NCT05210192|Anesthetics|anesthetics|mesh-ancestor
93186745|NCT05210192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186746|NCT05210192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186747|NCT05210192|Sensory System Agents|sensory system agents|mesh-ancestor
93186748|NCT05210192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186749|NCT05210192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93186750|NCT05210192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93186751|NCT05210192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93186752|NCT05210192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186753|NCT05210192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186754|NCT01152203|Bevacizumab|bevacizumab|mesh-list
93186755|NCT01152203|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93186756|NCT01152203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93186757|NCT01152203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186758|NCT01152203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93186759|NCT01152203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93186760|NCT01152203|Growth Substances|growth substances|mesh-ancestor
93186761|NCT01152203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186762|NCT01152203|Growth Inhibitors|growth inhibitors|mesh-ancestor
93186763|NCT01152203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93186764|NCT01152203|Alkylating Agents|alkylating agents|mesh-ancestor
93186765|NCT01152203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186766|NCT01257815|Ranibizumab|ranibizumab|mesh-list
93186767|NCT01257815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93186768|NCT01257815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93186769|NCT01257815|Growth Substances|growth substances|mesh-ancestor
93186770|NCT01257815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186771|NCT01257815|Growth Inhibitors|growth inhibitors|mesh-ancestor
93186772|NCT01257815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186773|NCT03892421|Cytarabine|cytarabine|mesh-list
93186774|NCT03892421|Dexamethasone|dexamethasone|mesh-list
93186775|NCT03892421|Rituximab|rituximab|mesh-list
93186776|NCT03892421|Carboplatin|carboplatin|mesh-list
93186777|NCT03892421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93186778|NCT03892421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186779|NCT03892421|Immunologic Factors|immunologic factors|mesh-ancestor
93186780|NCT03892421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186781|NCT03892421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186782|NCT03892421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186783|NCT03892421|Antiemetics|antiemetics|mesh-ancestor
93186784|NCT03892421|Autonomic Agents|autonomic agents|mesh-ancestor
93186785|NCT03892421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186786|NCT03892421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93186787|NCT03892421|Glucocorticoids|glucocorticoids|mesh-ancestor
93186788|NCT03892421|Hormones|hormones|mesh-ancestor
93186789|NCT03892421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186790|NCT03892421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93186791|NCT03892421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93186792|NCT03892421|Antimetabolites|antimetabolites|mesh-ancestor
93186793|NCT03892421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186794|NCT03892421|Antiviral Agents|antiviral agents|mesh-ancestor
93186795|NCT03892421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186796|NCT03892421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93186797|NCT05546567|Niacinamide|niacinamide|mesh-list
93186798|NCT05546567|Niacin|niacin|mesh-list
93186799|NCT05546567|Nicotinic Acids|nicotinic acids|mesh-list
93186800|NCT05546567|Vitamin B Complex|vitamin b complex|mesh-ancestor
93186801|NCT05546567|Vitamins|vitamins|mesh-ancestor
93186802|NCT05546567|Micronutrients|micronutrients|mesh-ancestor
93186803|NCT05546567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186804|NCT05546567|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93186805|NCT05546567|Antimetabolites|antimetabolites|mesh-ancestor
93186806|NCT05546567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186807|NCT05546567|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93186808|NCT05546567|Vasodilator Agents|vasodilator agents|mesh-ancestor
93186809|NCT03895229|Empagliflozin|empagliflozin|mesh-list
93186810|NCT03895229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93186811|NCT03895229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186812|NCT03895229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186813|NCT03895229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186814|NCT01257893|Aspirin|aspirin|mesh-list
93186815|NCT01257893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93186816|NCT01257893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186818|NCT01257893|Sensory System Agents|sensory system agents|mesh-ancestor
93186819|NCT01257893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186820|NCT01257893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186821|NCT01257893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93186822|NCT01257893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186823|NCT01257893|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93186824|NCT01257893|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93186825|NCT01257893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186826|NCT01257893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93186827|NCT01257893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93186828|NCT01257893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186829|NCT01257893|Antipyretics|antipyretics|mesh-ancestor
93186830|NCT01152593|Mupirocin|mupirocin|mesh-list
93186831|NCT01152593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186832|NCT01152593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186833|NCT01152593|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93186834|NCT01152593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186835|NCT01152593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186836|NCT01259219|Rifabutin|rifabutin|mesh-list
93186837|NCT01259219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93186838|NCT01259219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186839|NCT01259219|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93186840|NCT01259219|Antitubercular Agents|antitubercular agents|mesh-ancestor
93186841|NCT03891095|Oxytocin|oxytocin|mesh-list
93186842|NCT03891095|Oxytocics|oxytocics|mesh-ancestor
93186843|NCT03891095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93186844|NCT03891095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186845|NCT05667077|Amantadine|amantadine|mesh-list
93186846|NCT05667077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93186847|NCT05667077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93186848|NCT05667077|Antiviral Agents|antiviral agents|mesh-ancestor
93186849|NCT05667077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186850|NCT05667077|Dopamine Agents|dopamine agents|mesh-ancestor
93186851|NCT05667077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186852|NCT05667077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186853|NCT05667077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186854|NCT05667077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93186855|NCT05667077|Analgesics|analgesics|mesh-ancestor
93186856|NCT05667077|Sensory System Agents|sensory system agents|mesh-ancestor
93186857|NCT05667077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186858|NCT03894839|Chlorhexidine|chlorhexidine|mesh-list
93186859|NCT03894839|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93186860|NCT03894839|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93186861|NCT03894839|Glutaral|glutaral|mesh-list
93186862|NCT03894839|Eusol|eusol|mesh-list
93186863|NCT03894839|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93186864|NCT03894839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186865|NCT03894839|Disinfectants|disinfectants|mesh-ancestor
93186866|NCT03894839|Dermatologic Agents|dermatologic agents|mesh-ancestor
93186867|NCT01152749|Nicotine|nicotine|mesh-list
93186868|NCT01152749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93186869|NCT01152749|Autonomic Agents|autonomic agents|mesh-ancestor
93186870|NCT01152749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186871|NCT01152749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186872|NCT01152749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93186873|NCT01152749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93186874|NCT01152749|Cholinergic Agents|cholinergic agents|mesh-ancestor
93186875|NCT01152749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186876|NCT01152749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186877|NCT03894683|Melatonin|melatonin|mesh-list
93186878|NCT03894683|Antioxidants|antioxidants|mesh-ancestor
93186879|NCT03894683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186880|NCT03894683|Protective Agents|protective agents|mesh-ancestor
93186881|NCT03894683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186882|NCT03894683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186883|NCT01259531|Silodosin|silodosin|mesh-list
93186884|NCT01259531|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93186885|NCT01259531|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93186886|NCT01259531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93186887|NCT01259531|Adrenergic Agents|adrenergic agents|mesh-ancestor
93186888|NCT01259531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186889|NCT01259531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186890|NCT01259531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186891|NCT01259531|Urological Agents|urological agents|mesh-ancestor
93186892|NCT01151735|Complement C1s|complement c1s|mesh-list
93186893|NCT01151735|Immunologic Factors|immunologic factors|mesh-ancestor
93186894|NCT01151735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186895|NCT03061214|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93186896|NCT03061214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186897|NCT03061214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186898|NCT03061214|Incretins|incretins|mesh-ancestor
93186899|NCT03061214|Hormones|hormones|mesh-ancestor
93186900|NCT03061214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93186901|NCT03061214|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93186902|NCT03061214|Protease Inhibitors|protease inhibitors|mesh-ancestor
93186903|NCT03061214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186904|NCT03061214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186905|NCT01152827|Everolimus|everolimus|mesh-list
93186906|NCT01152827|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93186907|NCT01152827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93186908|NCT01152827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186909|NCT01152827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186910|NCT01152827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93186911|NCT01152827|Immunologic Factors|immunologic factors|mesh-ancestor
93186912|NCT01152827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186913|NCT01152827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186914|NCT01153373|Ethanol|ethanol|mesh-list
93186915|NCT01153373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93186916|NCT01153373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186917|NCT01153373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186918|NCT01153373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186919|NCT03889145|Amlodipine|amlodipine|mesh-list
93186920|NCT03889145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93186921|NCT03889145|Telmisartan|telmisartan|mesh-list
93186922|NCT03889145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93186923|NCT03889145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93186924|NCT03889145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93186925|NCT03889145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186926|NCT03889145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93186927|NCT03889145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186928|NCT03889145|Vasodilator Agents|vasodilator agents|mesh-ancestor
93186929|NCT03889145|Diuretics|diuretics|mesh-ancestor
93186930|NCT03889145|Natriuretic Agents|natriuretic agents|mesh-ancestor
93186931|NCT03889145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93186932|NCT03889145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93186933|NCT03889145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93186934|NCT03888677|Cyclophosphamide|cyclophosphamide|mesh-list
93186935|NCT03888677|Epirubicin|epirubicin|mesh-list
93186936|NCT03888677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93186937|NCT03888677|Immunologic Factors|immunologic factors|mesh-ancestor
93186938|NCT03888677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186939|NCT03888677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93186940|NCT03888677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93186941|NCT03888677|Alkylating Agents|alkylating agents|mesh-ancestor
93186942|NCT03888677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186943|NCT03888677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186944|NCT03888677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93186945|NCT03888677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93186946|NCT03888677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93186947|NCT03888677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93186948|NCT03888677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186949|NCT04655690|Insulin Aspart|insulin aspart|mesh-list
93186950|NCT04655690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93186951|NCT04655690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186952|NCT01260233|Nicotine|nicotine|mesh-list
93186953|NCT01260233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93186954|NCT01260233|Autonomic Agents|autonomic agents|mesh-ancestor
93186955|NCT01260233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186956|NCT01260233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186957|NCT01260233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93186958|NCT01260233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93186959|NCT01260233|Cholinergic Agents|cholinergic agents|mesh-ancestor
93186960|NCT01260233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93186961|NCT01260233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186962|NCT04435964|Immunomodulating Agents|immunomodulating agents|mesh-list
92859113|NCT00927485|Curcumin|curcumin|mesh-list
93186963|NCT04435964|Immunologic Factors|immunologic factors|mesh-ancestor
93186964|NCT04435964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186965|NCT01153919|Interferons|interferons|mesh-list
93186966|NCT01153919|Ribavirin|ribavirin|mesh-list
93186967|NCT01153919|Interferon-alpha|interferon-alpha|mesh-list
93186968|NCT01153919|Interferon alpha-2|interferon alpha-2|mesh-list
93186969|NCT01153919|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93186970|NCT01153919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186971|NCT01153919|Antiviral Agents|antiviral agents|mesh-ancestor
93186972|NCT01153919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93186973|NCT01153919|Antimetabolites|antimetabolites|mesh-ancestor
93186974|NCT01153919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186975|NCT01153919|Immunologic Factors|immunologic factors|mesh-ancestor
93186976|NCT01153919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186977|NCT03912389|Carboplatin|carboplatin|mesh-list
93186978|NCT03912389|Pemetrexed|pemetrexed|mesh-list
93186979|NCT03912389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186980|NCT03912389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93186981|NCT03912389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93186982|NCT03912389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93186983|NCT03912389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93186984|NCT01147757|Remifentanil|remifentanil|mesh-list
93186985|NCT01147757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93186986|NCT01147757|Narcotics|narcotics|mesh-ancestor
93186987|NCT01147757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93186988|NCT01147757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93186989|NCT01147757|Analgesics|analgesics|mesh-ancestor
93186990|NCT01147757|Sensory System Agents|sensory system agents|mesh-ancestor
93186991|NCT01147757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93186992|NCT01251809|Pegaspargase|pegaspargase|mesh-list
93186993|NCT01251809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93186994|NCT01154387|Mycophenolic Acid|mycophenolic acid|mesh-list
93186995|NCT01154387|Tacrolimus|tacrolimus|mesh-list
93186996|NCT01154387|Thymoglobulin|thymoglobulin|mesh-list
93186997|NCT01154387|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93186998|NCT01154387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93186999|NCT01154387|Immunologic Factors|immunologic factors|mesh-ancestor
93187000|NCT01154387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187001|NCT01154387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93187002|NCT01154387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187003|NCT01154387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187004|NCT01154387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93187005|NCT01154387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187006|NCT01154387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93187007|NCT01154387|Antitubercular Agents|antitubercular agents|mesh-ancestor
93187008|NCT01154387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187009|NCT01154387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187010|NCT01154465|Povidone-Iodine|povidone-iodine|mesh-list
93187011|NCT01154465|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93187012|NCT01154465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187013|NCT01260623|Prednisone|prednisone|mesh-list
93187014|NCT01260623|Prednisolone|prednisolone|mesh-list
93187015|NCT01260623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187016|NCT01260623|Glucocorticoids|glucocorticoids|mesh-ancestor
93187017|NCT01260623|Hormones|hormones|mesh-ancestor
93187018|NCT01260623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187019|NCT01260623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187020|NCT01260623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187021|NCT01260623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187022|NCT01252121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93187023|NCT01252121|Lubricant Eye Drops|lubricant eye drops|mesh-list
93187024|NCT01252121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93187025|NCT01260857|Hydroflumethiazide|hydroflumethiazide|mesh-list
93187026|NCT01260857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93187027|NCT01260857|Diuretics|diuretics|mesh-ancestor
93187028|NCT01260857|Natriuretic Agents|natriuretic agents|mesh-ancestor
93187029|NCT01260857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187030|NCT01260857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93187031|NCT01260857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482861|NCT01910766|Ubiquinone|ubiquinone|mesh-list
93187032|NCT01260857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187033|NCT03890003|Insulin Lispro|insulin lispro|mesh-list
93187034|NCT03890003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187035|NCT03890003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187036|NCT01153217|Tenofovir|tenofovir|mesh-list
93187037|NCT01153217|Abacavir|abacavir|mesh-list
93187038|NCT01153217|Antiviral Agents|antiviral agents|mesh-ancestor
93187039|NCT01153217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187040|NCT01153217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93187041|NCT01153217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93187042|NCT01153217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187043|NCT01153217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187044|NCT01153217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93187045|NCT01153217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93187046|NCT01261169|Mycophenolic Acid|mycophenolic acid|mesh-list
93187047|NCT01261169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93187048|NCT01261169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187049|NCT01261169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93187050|NCT01261169|Antitubercular Agents|antitubercular agents|mesh-ancestor
93187051|NCT01261169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187052|NCT01261169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187053|NCT01261169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187054|NCT01261169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187055|NCT03889379|Albuterol|albuterol|mesh-list
93187056|NCT03889379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93187057|NCT03889379|Autonomic Agents|autonomic agents|mesh-ancestor
93187058|NCT03889379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187059|NCT03889379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187060|NCT03889379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93187061|NCT03889379|Respiratory System Agents|respiratory system agents|mesh-ancestor
93187062|NCT03889379|Tocolytic Agents|tocolytic agents|mesh-ancestor
93187063|NCT03889379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93187064|NCT03889379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93187065|NCT03889379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93187066|NCT03889379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93187067|NCT03889379|Adrenergic Agents|adrenergic agents|mesh-ancestor
93187068|NCT03889379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187069|NCT03889379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187070|NCT01586507|Tramadol|tramadol|mesh-list
93187071|NCT01586507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93187072|NCT01586507|Narcotics|narcotics|mesh-ancestor
93187073|NCT01586507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187074|NCT01586507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187075|NCT01586507|Analgesics|analgesics|mesh-ancestor
93187076|NCT01586507|Sensory System Agents|sensory system agents|mesh-ancestor
93187077|NCT01586507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187078|NCT03910361|Pioglitazone|pioglitazone|mesh-list
93187079|NCT03910361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187080|NCT03910361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187081|NCT03700658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93187082|NCT03700658|Medroxyprogesterone|medroxyprogesterone|mesh-list
93187083|NCT03700658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93187084|NCT03700658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93187085|NCT03700658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93187086|NCT03700658|Contraceptive Agents|contraceptive agents|mesh-ancestor
93187087|NCT03700658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93187088|NCT03700658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187089|NCT03700658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93187090|NCT03700658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93187091|NCT03700658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93187092|NCT03700658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187093|NCT03700658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187094|NCT03885947|Fludarabine|fludarabine|mesh-list
93187095|NCT03885947|Cyclophosphamide|cyclophosphamide|mesh-list
93187096|NCT03885947|Thiotepa|thiotepa|mesh-list
93187097|NCT03885947|Valproic Acid|valproic acid|mesh-list
93187098|NCT03885947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187099|NCT03885947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187100|NCT03885947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187101|NCT03885947|Immunologic Factors|immunologic factors|mesh-ancestor
93187102|NCT03885947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187103|NCT03885947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187104|NCT03885947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93187105|NCT03885947|Alkylating Agents|alkylating agents|mesh-ancestor
93187106|NCT03885947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93187107|NCT03885947|Anticonvulsants|anticonvulsants|mesh-ancestor
93187108|NCT03885947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187109|NCT03885947|GABA Agents|gaba agents|mesh-ancestor
93187110|NCT03885947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187111|NCT03885947|Antimanic Agents|antimanic agents|mesh-ancestor
93187112|NCT03885947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93187113|NCT03885947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187114|NCT03885947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93187115|NCT01261481|Tolvaptan|tolvaptan|mesh-list
93187116|NCT01261481|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93187117|NCT01261481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187118|NCT01261481|Natriuretic Agents|natriuretic agents|mesh-ancestor
93187119|NCT01261481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187120|NCT01261637|Ropivacaine|ropivacaine|mesh-list
93187121|NCT01261637|Anesthetics, Local|anesthetics, local|mesh-ancestor
93187122|NCT01261637|Anesthetics|anesthetics|mesh-ancestor
93187123|NCT01261637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187124|NCT01261637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187125|NCT01261637|Sensory System Agents|sensory system agents|mesh-ancestor
93187126|NCT01261637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187127|NCT01262183|Panitumumab|panitumumab|mesh-list
93187128|NCT01262183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187129|NCT01262183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187130|NCT01154933|Exenatide|exenatide|mesh-list
93187131|NCT01154933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187132|NCT01154933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187133|NCT01154933|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93187134|NCT01154933|Incretins|incretins|mesh-ancestor
93187135|NCT01154933|Hormones|hormones|mesh-ancestor
93187136|NCT01154933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187137|NCT01155635|Carvedilol|carvedilol|mesh-list
93187138|NCT01155635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93187139|NCT01155635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93187140|NCT01155635|Adrenergic Agents|adrenergic agents|mesh-ancestor
93187141|NCT01155635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187142|NCT01155635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187143|NCT01155635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187144|NCT01155635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93187145|NCT01155635|Antioxidants|antioxidants|mesh-ancestor
93187146|NCT01155635|Protective Agents|protective agents|mesh-ancestor
93187147|NCT01155635|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93187148|NCT01155635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93187149|NCT01155635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93187150|NCT01155635|Vasodilator Agents|vasodilator agents|mesh-ancestor
93187151|NCT01155635|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93187152|NCT01155635|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93187153|NCT01155089|Anastrozole|anastrozole|mesh-list
93187154|NCT01155089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187155|NCT01155089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187156|NCT01155089|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93187157|NCT01155089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93187158|NCT01155089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187159|NCT01155089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187160|NCT01155089|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93187161|NCT01155089|Hormone Antagonists|hormone antagonists|mesh-ancestor
93187162|NCT01155089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187163|NCT01155089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187164|NCT01155245|Teriparatide|teriparatide|mesh-list
93187165|NCT01155245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93187166|NCT01155245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187167|NCT01155245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93187168|NCT01262417|Hyaluronic Acid|hyaluronic acid|mesh-list
93187169|NCT01262417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93187170|NCT01262417|Immunologic Factors|immunologic factors|mesh-ancestor
93187171|NCT01262417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187172|NCT01262417|Viscosupplements|viscosupplements|mesh-ancestor
93187173|NCT01262417|Protective Agents|protective agents|mesh-ancestor
93187174|NCT01155791|Prednisone|prednisone|mesh-list
93187175|NCT01155791|Docetaxel|docetaxel|mesh-list
93187176|NCT01155791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187177|NCT01155791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92483020|NCT01911598|Paclitaxel|paclitaxel|mesh-list
93187178|NCT01155791|Antimitotic Agents|antimitotic agents|mesh-ancestor
93187179|NCT01155791|Mitosis Modulators|mitosis modulators|mesh-ancestor
93187180|NCT01155791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187181|NCT01155791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187182|NCT01155791|Glucocorticoids|glucocorticoids|mesh-ancestor
93187183|NCT01155791|Hormones|hormones|mesh-ancestor
93187184|NCT01155791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187185|NCT01155791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187186|NCT01155791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187187|NCT01157507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93187188|NCT01157507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93187189|NCT01157507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93187190|NCT01157507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187191|NCT01157507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187192|NCT01157507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93187193|NCT01157507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93187194|NCT01157507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187195|NCT01157507|Cholinergic Agents|cholinergic agents|mesh-ancestor
93187196|NCT01157507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187197|NCT03881423|Bromides|bromides|mesh-list
93187198|NCT03881423|Rocuronium|rocuronium|mesh-list
93187199|NCT03881423|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
93187200|NCT03881423|Anticonvulsants|anticonvulsants|mesh-ancestor
93187201|NCT03881423|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93187202|NCT03881423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93187203|NCT03881423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187204|NCT03881423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187205|NCT03884465|Treprostinil|treprostinil|mesh-list
93187206|NCT03884465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93187207|NCT01155947|Anastrozole|anastrozole|mesh-list
93187208|NCT01155947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187209|NCT01155947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187210|NCT01155947|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93187211|NCT01155947|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93187212|NCT01155947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187213|NCT01155947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187214|NCT01155947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93187215|NCT01155947|Hormone Antagonists|hormone antagonists|mesh-ancestor
93187216|NCT01155947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187217|NCT01155947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187218|NCT01157585|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93187219|NCT01157585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93187220|NCT01157585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93187221|NCT01157585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187222|NCT01157585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187223|NCT01157585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93187224|NCT01157585|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93187225|NCT01157585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93187226|NCT01157585|Serotonin Agents|serotonin agents|mesh-ancestor
93187227|NCT01157585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187228|NCT01157585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187229|NCT01157585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93187230|NCT01157585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93187231|NCT01157585|Dopamine Agents|dopamine agents|mesh-ancestor
93187232|NCT01264133|Adefovir|adefovir|mesh-list
93187233|NCT01264133|Clevudine|clevudine|mesh-list
93187234|NCT01264133|Antiviral Agents|antiviral agents|mesh-ancestor
93187235|NCT01264133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187236|NCT01264133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93187237|NCT01264133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93187238|NCT01264133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187239|NCT01264133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187240|NCT02527577|Ropivacaine|ropivacaine|mesh-list
93187241|NCT02527577|Anesthetics, Local|anesthetics, local|mesh-ancestor
93187242|NCT02527577|Anesthetics|anesthetics|mesh-ancestor
93187243|NCT02527577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187244|NCT02527577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187245|NCT02527577|Sensory System Agents|sensory system agents|mesh-ancestor
93187246|NCT02527577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187247|NCT03883841|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93187248|NCT03883841|Hematinics|hematinics|mesh-ancestor
93187249|NCT03881111|Pembrolizumab|pembrolizumab|mesh-list
93187250|NCT03881111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187251|NCT03881111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187252|NCT03881111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93187253|NCT03881111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187254|NCT01264211|Diacerein|diacerein|mesh-list
93187255|NCT01264211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187256|NCT03880877|Leucovorin|leucovorin|mesh-list
93187257|NCT03880877|Antidotes|antidotes|mesh-ancestor
93187258|NCT03880877|Protective Agents|protective agents|mesh-ancestor
93187259|NCT03880877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187260|NCT03880877|Vitamin B Complex|vitamin b complex|mesh-ancestor
93187262|NCT03880877|Micronutrients|micronutrients|mesh-ancestor
93187263|NCT05666999|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93187264|NCT05666999|Laxatives|laxatives|mesh-ancestor
93187265|NCT05666999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187266|NCT01262729|Xenon|xenon|mesh-list
93187267|NCT01262729|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93187268|NCT01262729|Anesthetics, General|anesthetics, general|mesh-ancestor
93187269|NCT01262729|Anesthetics|anesthetics|mesh-ancestor
93187270|NCT01262729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187271|NCT01262729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187272|NCT01264289|Finasteride|finasteride|mesh-list
93187273|NCT01264289|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93187274|NCT01264289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93187275|NCT01264289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187276|NCT01264289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187277|NCT01264289|Hormone Antagonists|hormone antagonists|mesh-ancestor
93187278|NCT01264289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187279|NCT01264289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187280|NCT01264289|Urological Agents|urological agents|mesh-ancestor
93187281|NCT03880487|Oxycodone|oxycodone|mesh-list
93187282|NCT03880487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93187283|NCT03880487|Narcotics|narcotics|mesh-ancestor
93187284|NCT03880487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187285|NCT03880487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187286|NCT03880487|Analgesics|analgesics|mesh-ancestor
93187287|NCT03880487|Sensory System Agents|sensory system agents|mesh-ancestor
93187288|NCT03880487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187289|NCT03880409|Lidocaine|lidocaine|mesh-list
93187290|NCT03880409|Epinephrine|epinephrine|mesh-list
93187291|NCT03880409|Racepinephrine|racepinephrine|mesh-list
93187292|NCT03880409|Carticaine|carticaine|mesh-list
93187293|NCT03880409|Epinephryl borate|epinephryl borate|mesh-list
93187294|NCT03880409|Anesthetics, Local|anesthetics, local|mesh-ancestor
93187295|NCT03880409|Anesthetics|anesthetics|mesh-ancestor
93187296|NCT03880409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187297|NCT03880409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187298|NCT03880409|Sensory System Agents|sensory system agents|mesh-ancestor
93187299|NCT03880409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187300|NCT03880409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93187301|NCT03880409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93187302|NCT03880409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93187303|NCT03880409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93187304|NCT03880409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187305|NCT03880409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93187306|NCT03880409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93187307|NCT03880409|Adrenergic Agents|adrenergic agents|mesh-ancestor
93187308|NCT03880409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187309|NCT03880409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93187310|NCT03880409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93187311|NCT03880409|Autonomic Agents|autonomic agents|mesh-ancestor
93187312|NCT03880409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93187313|NCT03880409|Respiratory System Agents|respiratory system agents|mesh-ancestor
93187314|NCT03880409|Mydriatics|mydriatics|mesh-ancestor
93187315|NCT03880409|Sympathomimetics|sympathomimetics|mesh-ancestor
93187316|NCT03880409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93187317|NCT01157819|Ciprofloxacin|ciprofloxacin|mesh-list
93187318|NCT01157819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187319|NCT01157819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187320|NCT01157819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93187321|NCT01157819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93187322|NCT01157819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187323|NCT01157819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187324|NCT01157819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483161|NCT01912573|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93187325|NCT01157819|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93187326|NCT01157819|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93187327|NCT01264367|Interferons|interferons|mesh-list
93187328|NCT01264367|Clevudine|clevudine|mesh-list
93187329|NCT01264367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187330|NCT01264367|Antiviral Agents|antiviral agents|mesh-ancestor
93187331|NCT01264367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187332|NCT05097716|Tolbutamide|tolbutamide|mesh-list
93187333|NCT05097716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187334|NCT05097716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187335|NCT01262963|Dabrafenib|dabrafenib|mesh-list
93187336|NCT01262963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187337|NCT01262963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93187338|NCT01262963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187339|NCT01262963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187340|NCT01264445|Vaccines|vaccines|mesh-list
93187341|NCT01264445|Immunologic Factors|immunologic factors|mesh-ancestor
93187342|NCT01264445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187343|NCT01157975|Pioglitazone|pioglitazone|mesh-list
93187344|NCT01157975|Prednisone|prednisone|mesh-list
93187345|NCT01157975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187346|NCT01157975|Glucocorticoids|glucocorticoids|mesh-ancestor
93187347|NCT01157975|Hormones|hormones|mesh-ancestor
93187348|NCT01157975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187349|NCT01157975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187350|NCT01157975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187351|NCT01157975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187352|NCT01157975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187353|NCT03060512|Naloxegol|naloxegol|mesh-list
93187354|NCT03060512|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93187355|NCT03060512|Laxatives|laxatives|mesh-ancestor
93187356|NCT03060512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187357|NCT03060512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93187358|NCT03060512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187359|NCT03060512|Sensory System Agents|sensory system agents|mesh-ancestor
93187360|NCT03060512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187361|NCT01263353|Everolimus|everolimus|mesh-list
93187362|NCT01263353|Pasireotide|pasireotide|mesh-list
93187363|NCT01263353|Somatostatin|somatostatin|mesh-list
93187364|NCT01263353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93187365|NCT01263353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93187366|NCT01263353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187367|NCT01263353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187368|NCT01263353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187369|NCT01263353|Immunologic Factors|immunologic factors|mesh-ancestor
93187370|NCT01263353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187371|NCT01263353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187372|NCT01263353|Hormones|hormones|mesh-ancestor
93187373|NCT01263353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187374|NCT01158287|Sorafenib|sorafenib|mesh-list
93187375|NCT01158287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187376|NCT01158287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93187377|NCT01158287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187378|NCT01158287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187379|NCT01158365|Glycerol|glycerol|mesh-list
93187380|NCT01158365|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93187381|NCT01158365|Protective Agents|protective agents|mesh-ancestor
93187382|NCT01158365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187383|NCT01156649|Acetaminophen|acetaminophen|mesh-list
93187384|NCT01156649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93187385|NCT01156649|Analgesics|analgesics|mesh-ancestor
93187386|NCT01156649|Sensory System Agents|sensory system agents|mesh-ancestor
93187387|NCT01156649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187388|NCT01156649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187389|NCT01156649|Antipyretics|antipyretics|mesh-ancestor
93187390|NCT01158755|Moxifloxacin|moxifloxacin|mesh-list
93187391|NCT01158755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187392|NCT01158755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187393|NCT01158755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93187394|NCT01158755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93187395|NCT01158755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187396|NCT01158755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187397|NCT01158755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187398|NCT03879707|Melatonin|melatonin|mesh-list
93187399|NCT03879707|Antioxidants|antioxidants|mesh-ancestor
93187400|NCT03879707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187401|NCT03879707|Protective Agents|protective agents|mesh-ancestor
93187402|NCT03879707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187403|NCT03879707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187404|NCT01265147|Nedaplatin|nedaplatin|mesh-list
93187405|NCT01265147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187406|NCT01159145|Omeprazole|omeprazole|mesh-list
93187407|NCT01159145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93187408|NCT01159145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187409|NCT01159145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93187410|NCT01159145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187411|NCT01159145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187412|NCT01156883|Cytarabine|cytarabine|mesh-list
93187413|NCT01156883|Dexamethasone|dexamethasone|mesh-list
93187414|NCT01156883|Prednisone|prednisone|mesh-list
93187415|NCT01156883|Methylprednisolone|methylprednisolone|mesh-list
93187416|NCT01156883|Cyclophosphamide|cyclophosphamide|mesh-list
93187417|NCT01156883|Ifosfamide|ifosfamide|mesh-list
93187418|NCT01156883|Doxorubicin|doxorubicin|mesh-list
93187419|NCT01156883|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93187420|NCT01156883|Methotrexate|methotrexate|mesh-list
93187421|NCT01156883|Vincristine|vincristine|mesh-list
93187422|NCT01156883|Daunorubicin|daunorubicin|mesh-list
93187423|NCT01156883|Asparaginase|asparaginase|mesh-list
93187424|NCT01156883|Mercaptopurine|mercaptopurine|mesh-list
93187425|NCT01156883|Thioguanine|thioguanine|mesh-list
93187426|NCT01156883|Vindesine|vindesine|mesh-list
93187427|NCT01156883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187428|NCT01156883|Immunologic Factors|immunologic factors|mesh-ancestor
93187429|NCT01156883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187430|NCT01156883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187431|NCT01156883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93187432|NCT01156883|Alkylating Agents|alkylating agents|mesh-ancestor
93187433|NCT01156883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187434|NCT01156883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187435|NCT01156883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93187436|NCT01156883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187437|NCT01156883|Antiemetics|antiemetics|mesh-ancestor
93187438|NCT01156883|Autonomic Agents|autonomic agents|mesh-ancestor
93187439|NCT01156883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187440|NCT01156883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187441|NCT01156883|Glucocorticoids|glucocorticoids|mesh-ancestor
93187442|NCT01156883|Hormones|hormones|mesh-ancestor
93187443|NCT01156883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187444|NCT01156883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187445|NCT01156883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93187446|NCT01156883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93187447|NCT01156883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93187448|NCT01156883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187449|NCT01156883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93187450|NCT01156883|Abortifacient Agents|abortifacient agents|mesh-ancestor
93187451|NCT01156883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93187452|NCT01156883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93187453|NCT01156883|Antimetabolites|antimetabolites|mesh-ancestor
93187454|NCT01156883|Dermatologic Agents|dermatologic agents|mesh-ancestor
93187455|NCT01156883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93187456|NCT01156883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93187457|NCT01156883|Antiviral Agents|antiviral agents|mesh-ancestor
93187458|NCT01156883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187459|NCT01156883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93187460|NCT01156883|Tubulin Modulators|tubulin modulators|mesh-ancestor
93187461|NCT01156883|Antimitotic Agents|antimitotic agents|mesh-ancestor
93187462|NCT01156883|Mitosis Modulators|mitosis modulators|mesh-ancestor
93187463|NCT01156883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93187464|NCT01156883|Protective Agents|protective agents|mesh-ancestor
93187465|NCT01156961|Paclitaxel|paclitaxel|mesh-list
93187466|NCT01156961|Bevacizumab|bevacizumab|mesh-list
93187467|NCT01156961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93187468|NCT01156961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187469|NCT01156961|Tubulin Modulators|tubulin modulators|mesh-ancestor
93187470|NCT01156961|Antimitotic Agents|antimitotic agents|mesh-ancestor
93187471|NCT01156961|Mitosis Modulators|mitosis modulators|mesh-ancestor
93187472|NCT01156961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187473|NCT01156961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187474|NCT01156961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93187475|NCT01156961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93187476|NCT01156961|Growth Substances|growth substances|mesh-ancestor
93187477|NCT01156961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187478|NCT01156961|Growth Inhibitors|growth inhibitors|mesh-ancestor
93187479|NCT01159301|Sorafenib|sorafenib|mesh-list
93187480|NCT01159301|Entinostat|entinostat|mesh-list
93187481|NCT01159301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93187482|NCT01159301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187483|NCT01159301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93187484|NCT01159301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187485|NCT01159301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187486|NCT01159379|Ertapenem|ertapenem|mesh-list
93187487|NCT01159379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187488|NCT01159379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187489|NCT01159847|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92859696|NCT05843565|Cobalt|cobalt|mesh-list
93187491|NCT01159847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187492|NCT01159847|Incretins|incretins|mesh-ancestor
93187493|NCT01159847|Hormones|hormones|mesh-ancestor
93187494|NCT01159847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187495|NCT01159847|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93187496|NCT01159847|Protease Inhibitors|protease inhibitors|mesh-ancestor
93187497|NCT01159847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187498|NCT01159847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187499|NCT02539160|Ticagrelor|ticagrelor|mesh-list
93187500|NCT02539160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93187501|NCT02539160|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93187502|NCT02539160|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93187503|NCT02539160|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93187504|NCT02539160|Purinergic Agents|purinergic agents|mesh-ancestor
93187505|NCT02539160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187506|NCT02539160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187507|NCT02539160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187508|NCT01265927|Trastuzumab|trastuzumab|mesh-list
93187509|NCT01265927|Imetelstat|imetelstat|mesh-list
93187510|NCT01265927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187511|NCT01265927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187512|NCT01265927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187513|NCT01265927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187514|NCT01266005|Entecavir|entecavir|mesh-list
93187515|NCT01266005|Clevudine|clevudine|mesh-list
93187516|NCT01266005|Antiviral Agents|antiviral agents|mesh-ancestor
93187517|NCT01266005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187518|NCT04292899|Remdesivir|remdesivir|mesh-list
93187519|NCT04292899|Antimetabolites|antimetabolites|mesh-ancestor
93187520|NCT04292899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187521|NCT04292899|Antiviral Agents|antiviral agents|mesh-ancestor
93187522|NCT04292899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187523|NCT03876899|Evening primrose oil|evening primrose oil|mesh-list
93187524|NCT03876899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93187525|NCT03876899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93187526|NCT03876899|Analgesics|analgesics|mesh-ancestor
93187527|NCT03876899|Sensory System Agents|sensory system agents|mesh-ancestor
93187528|NCT03876899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187529|NCT03876899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187530|NCT03876899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187531|NCT03876899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187532|NCT03876899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93187533|NCT03876899|Antimetabolites|antimetabolites|mesh-ancestor
93187534|NCT03876899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187535|NCT03876899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93187536|NCT03876899|Dermatologic Agents|dermatologic agents|mesh-ancestor
93187537|NCT03241173|Nivolumab|nivolumab|mesh-list
93187538|NCT03241173|Ipilimumab|ipilimumab|mesh-list
93187539|NCT03241173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187540|NCT03241173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187541|NCT03241173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93187542|NCT03241173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187543|NCT03264066|Atezolizumab|atezolizumab|mesh-list
93187544|NCT03264066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93187545|NCT03264066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93187546|NCT03264066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187547|NCT03264066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187548|NCT03264066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187549|NCT03264066|Immunologic Factors|immunologic factors|mesh-ancestor
93187550|NCT03264066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187551|NCT03759041|Vancomycin|vancomycin|mesh-list
93187552|NCT03759041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187553|NCT03759041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187554|NCT04110145|Linaclotide|linaclotide|mesh-list
93187555|NCT04110145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93187556|NCT04110145|Enzyme Activators|enzyme activators|mesh-ancestor
93187557|NCT04110145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187558|NCT04110145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187559|NCT02477618|Brexanolone|brexanolone|mesh-list
93187560|NCT02477618|Neurosteroids|neurosteroids|mesh-ancestor
93187561|NCT02477618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187562|NCT02477618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187563|NCT02477618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187564|NCT02477618|GABA Modulators|gaba modulators|mesh-ancestor
93187565|NCT02477618|GABA Agents|gaba agents|mesh-ancestor
93187566|NCT01268033|Rituximab|rituximab|mesh-list
93187567|NCT01268033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187568|NCT01268033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187569|NCT01268033|Immunologic Factors|immunologic factors|mesh-ancestor
93187570|NCT01268033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187571|NCT01268033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187572|NCT01162031|Bortezomib|bortezomib|mesh-list
93187573|NCT01162031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187574|NCT02879162|Durvalumab|durvalumab|mesh-list
93187575|NCT02879162|Tremelimumab|tremelimumab|mesh-list
93187576|NCT02879162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187577|NCT02879162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187578|NCT03285477|Tirbanibulin|tirbanibulin|mesh-list
93187579|NCT03285477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187580|NCT03285477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187581|NCT02285504|Brexanolone|brexanolone|mesh-list
93187582|NCT02285504|Neurosteroids|neurosteroids|mesh-ancestor
93187583|NCT02285504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187584|NCT02285504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187585|NCT02285504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187586|NCT02285504|GABA Modulators|gaba modulators|mesh-ancestor
93187587|NCT02285504|GABA Agents|gaba agents|mesh-ancestor
93187588|NCT05009927|Imatinib Mesylate|imatinib mesylate|mesh-list
93187589|NCT05009927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187590|NCT05009927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93187591|NCT05009927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187592|NCT05009927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187593|NCT02227394|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93187594|NCT02227394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93187595|NCT02227394|Respiratory System Agents|respiratory system agents|mesh-ancestor
93187596|NCT05158491|Irinotecan|irinotecan|mesh-list
93187597|NCT05158491|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93187598|NCT05158491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93187599|NCT05158491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187600|NCT05158491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187601|NCT05158491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187602|NCT04276207|Insulin Lispro|insulin lispro|mesh-list
93187603|NCT04276207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187604|NCT04276207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187605|NCT03876587|Docetaxel|docetaxel|mesh-list
93187606|NCT03876587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187607|NCT03876587|Tubulin Modulators|tubulin modulators|mesh-ancestor
93187608|NCT03876587|Antimitotic Agents|antimitotic agents|mesh-ancestor
93187609|NCT03876587|Mitosis Modulators|mitosis modulators|mesh-ancestor
93187610|NCT03876587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187611|NCT01162889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93187612|NCT01162889|Immunologic Factors|immunologic factors|mesh-ancestor
93187613|NCT01162889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187614|NCT04635423|Vaccines|vaccines|mesh-list
93187615|NCT04635423|Immunologic Factors|immunologic factors|mesh-ancestor
93187616|NCT04635423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187617|NCT03282357|Hyaluronic Acid|hyaluronic acid|mesh-list
93187618|NCT03282357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187619|NCT03282357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93187620|NCT03282357|Immunologic Factors|immunologic factors|mesh-ancestor
93187621|NCT03282357|Viscosupplements|viscosupplements|mesh-ancestor
93187622|NCT03282357|Protective Agents|protective agents|mesh-ancestor
93187623|NCT01162967|Posaconazole|posaconazole|mesh-list
93187624|NCT01162967|Benzonidazole|benzonidazole|mesh-list
92483460|NCT01914627|Analgesics|analgesics|mesh-ancestor
93187625|NCT01162967|Antifungal Agents|antifungal agents|mesh-ancestor
93187626|NCT01162967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187627|NCT01162967|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93187628|NCT01162967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93187629|NCT01162967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93187630|NCT01162967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93187631|NCT01162967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93187632|NCT01162967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187633|NCT01162967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187634|NCT01162967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93187635|NCT01162967|Hormone Antagonists|hormone antagonists|mesh-ancestor
93187636|NCT01162967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187637|NCT01162967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187638|NCT01162967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187639|NCT01162967|Immunologic Factors|immunologic factors|mesh-ancestor
93187640|NCT01268735|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93187641|NCT01268735|Lubricant Eye Drops|lubricant eye drops|mesh-list
93187642|NCT01268735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93187643|NCT04272775|Dexamethasone|dexamethasone|mesh-list
93187644|NCT04272775|Lenalidomide|lenalidomide|mesh-list
93187645|NCT04272775|Ixazomib|ixazomib|mesh-list
93187646|NCT04272775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187647|NCT04272775|Antiemetics|antiemetics|mesh-ancestor
93187648|NCT04272775|Autonomic Agents|autonomic agents|mesh-ancestor
93187649|NCT04272775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187650|NCT04272775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187651|NCT04272775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187652|NCT04272775|Glucocorticoids|glucocorticoids|mesh-ancestor
93187653|NCT04272775|Hormones|hormones|mesh-ancestor
93187654|NCT04272775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187655|NCT04272775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187656|NCT04272775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187657|NCT04272775|Immunologic Factors|immunologic factors|mesh-ancestor
93187658|NCT04272775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93187659|NCT04272775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93187660|NCT04272775|Growth Substances|growth substances|mesh-ancestor
93187661|NCT04272775|Growth Inhibitors|growth inhibitors|mesh-ancestor
93187662|NCT04272775|Protease Inhibitors|protease inhibitors|mesh-ancestor
93187663|NCT04272775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187664|NCT04272775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187665|NCT03232983|Insulin Lispro|insulin lispro|mesh-list
93187666|NCT03232983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187667|NCT03232983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187668|NCT01163201|Cyclophosphamide|cyclophosphamide|mesh-list
93187669|NCT01163201|Fludarabine|fludarabine|mesh-list
93187670|NCT01163201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187671|NCT01163201|Immunologic Factors|immunologic factors|mesh-ancestor
93187672|NCT01163201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187673|NCT01163201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187674|NCT01163201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93187675|NCT01163201|Alkylating Agents|alkylating agents|mesh-ancestor
93187676|NCT01163201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187677|NCT01163201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187678|NCT01163201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93187679|NCT03876041|Dexamethasone|dexamethasone|mesh-list
93187680|NCT03876041|Dexamethasone acetate|dexamethasone acetate|mesh-list
93187681|NCT03876041|Methylprednisolone|methylprednisolone|mesh-list
93187682|NCT03876041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93187683|NCT03876041|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93187684|NCT03876041|BB 1101|bb 1101|mesh-list
93187685|NCT03876041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187686|NCT03876041|Antiemetics|antiemetics|mesh-ancestor
93187687|NCT03876041|Autonomic Agents|autonomic agents|mesh-ancestor
93187688|NCT03876041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187689|NCT03876041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187690|NCT03876041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187691|NCT03876041|Glucocorticoids|glucocorticoids|mesh-ancestor
93187692|NCT03876041|Hormones|hormones|mesh-ancestor
93187693|NCT03876041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187694|NCT03876041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187695|NCT03876041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187696|NCT03876041|Protease Inhibitors|protease inhibitors|mesh-ancestor
93187697|NCT03876041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928474|NCT02403687|Cyclobenzaprine|cyclobenzaprine|mesh-list
93187698|NCT03876041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187699|NCT03876041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93187700|NCT03876041|Protective Agents|protective agents|mesh-ancestor
93187701|NCT04102345|Zolpidem|zolpidem|mesh-list
93187702|NCT04102345|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93187703|NCT04102345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93187704|NCT04102345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187705|NCT04102345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187706|NCT04102345|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93187707|NCT04102345|GABA Agonists|gaba agonists|mesh-ancestor
93187708|NCT04102345|GABA Agents|gaba agents|mesh-ancestor
93187709|NCT04102345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187710|NCT04102345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187711|NCT01163435|Clarithromycin|clarithromycin|mesh-list
93187712|NCT01163435|Levofloxacin|levofloxacin|mesh-list
93187713|NCT01163435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187714|NCT01163435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187715|NCT01163435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93187716|NCT01163435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187717|NCT01163435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187718|NCT01163435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93187719|NCT01163435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93187720|NCT01163435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93187721|NCT01163435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93187722|NCT01163435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93187723|NCT01163435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187724|NCT01163435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93187725|NCT03299244|Cinacalcet|cinacalcet|mesh-list
93187726|NCT03299244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93187727|NCT03299244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187728|NCT03299244|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93187729|NCT03299244|Hormone Antagonists|hormone antagonists|mesh-ancestor
93187730|NCT03299244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187731|NCT03875963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93187732|NCT03875963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187733|NCT03757715|Dexamethasone|dexamethasone|mesh-list
93187734|NCT03757715|Bupivacaine|bupivacaine|mesh-list
93187735|NCT03757715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187736|NCT03757715|Antiemetics|antiemetics|mesh-ancestor
93187737|NCT03757715|Autonomic Agents|autonomic agents|mesh-ancestor
93187738|NCT03757715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187739|NCT03757715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187740|NCT03757715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187741|NCT03757715|Glucocorticoids|glucocorticoids|mesh-ancestor
93187742|NCT03757715|Hormones|hormones|mesh-ancestor
93187743|NCT03757715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187744|NCT03757715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187745|NCT03757715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187746|NCT03757715|Anesthetics, Local|anesthetics, local|mesh-ancestor
93187747|NCT03757715|Anesthetics|anesthetics|mesh-ancestor
93187748|NCT03757715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187749|NCT03757715|Sensory System Agents|sensory system agents|mesh-ancestor
93187750|NCT01163825|Mitogens|mitogens|mesh-list
93187751|NCT01163825|Mitosis Modulators|mitosis modulators|mesh-ancestor
93187752|NCT01163825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187753|NCT01163903|Doxorubicin|doxorubicin|mesh-list
93187754|NCT01163903|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93187755|NCT01163903|Pantoprazole|pantoprazole|mesh-list
93187756|NCT01163903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93187757|NCT01163903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187758|NCT01163903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93187759|NCT01163903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93187760|NCT01163903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187761|NCT01163903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187762|NCT01163903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93187763|NCT01163903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187764|NCT01163903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93187765|NCT03759587|Niraparib|niraparib|mesh-list
93187766|NCT03759587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93187767|NCT03759587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187768|NCT03759587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187769|NCT03759587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187770|NCT03745807|Nivolumab|nivolumab|mesh-list
93187771|NCT03745807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187772|NCT03745807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187773|NCT03745807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93187774|NCT03745807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187775|NCT01164059|Haloperidol|haloperidol|mesh-list
93187776|NCT01164059|Olanzapine|olanzapine|mesh-list
93187777|NCT01164059|Aripiprazole|aripiprazole|mesh-list
93187778|NCT01164059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93187779|NCT01164059|Haloperidol decanoate|haloperidol decanoate|mesh-list
93187780|NCT01164059|Flupenthixol|flupenthixol|mesh-list
93187781|NCT01164059|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
93187782|NCT01164059|Antiemetics|antiemetics|mesh-ancestor
93187783|NCT01164059|Autonomic Agents|autonomic agents|mesh-ancestor
93187784|NCT01164059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187785|NCT01164059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187786|NCT01164059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187787|NCT01164059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93187788|NCT01164059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93187789|NCT01164059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187790|NCT01164059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93187791|NCT01164059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93187792|NCT01164059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93187793|NCT01164059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93187794|NCT01164059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187795|NCT01164059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187796|NCT01164059|Serotonin Agents|serotonin agents|mesh-ancestor
93187797|NCT01164059|Antidepressive Agents|antidepressive agents|mesh-ancestor
93187798|NCT01164059|Dopamine Agonists|dopamine agonists|mesh-ancestor
93187799|NCT01164059|Dopamine Agents|dopamine agents|mesh-ancestor
93187800|NCT01164059|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93187801|NCT01164059|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93187802|NCT01164059|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93187803|NCT01164059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93187804|NCT01164059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93187805|NCT01164059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93187806|NCT01164059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93187807|NCT03879005|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
93187808|NCT03879005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93187809|NCT03879005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187810|NCT03878771|Clobetasol|clobetasol|mesh-list
93187811|NCT03878771|Benzocaine|benzocaine|mesh-list
93187812|NCT03878771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187813|NCT03878771|Glucocorticoids|glucocorticoids|mesh-ancestor
93187814|NCT03878771|Hormones|hormones|mesh-ancestor
93187815|NCT03878771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187816|NCT03878771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187817|NCT03878771|Anesthetics, Local|anesthetics, local|mesh-ancestor
93187818|NCT03878771|Anesthetics|anesthetics|mesh-ancestor
93187819|NCT03878771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93187820|NCT03878771|Sensory System Agents|sensory system agents|mesh-ancestor
93187821|NCT03878771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187822|NCT02959918|Sirolimus|sirolimus|mesh-list
93187823|NCT02959918|Temsirolimus|temsirolimus|mesh-list
93187824|NCT02959918|MTOR Inhibitors|mtor inhibitors|mesh-list
93187825|NCT02959918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93187826|NCT02959918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187827|NCT02959918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93187828|NCT02959918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187829|NCT02959918|Antifungal Agents|antifungal agents|mesh-ancestor
93187830|NCT02959918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187831|NCT02959918|Immunologic Factors|immunologic factors|mesh-ancestor
93187832|NCT02959918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187833|NCT02959918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93187834|NCT02959918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187835|NCT02959918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187836|NCT01266707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93187837|NCT01266707|Vaccines|vaccines|mesh-list
93187838|NCT01266707|Immunologic Factors|immunologic factors|mesh-ancestor
93187839|NCT01266707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187840|NCT01266707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93187841|NCT01266707|Growth Substances|growth substances|mesh-ancestor
93187842|NCT01266707|Growth Inhibitors|growth inhibitors|mesh-ancestor
93187843|NCT01266707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187844|NCT03263442|Thiamine|thiamine|mesh-list
93187845|NCT03263442|Vitamin B Complex|vitamin b complex|mesh-ancestor
93187846|NCT03263442|Vitamins|vitamins|mesh-ancestor
93187847|NCT03263442|Micronutrients|micronutrients|mesh-ancestor
93187848|NCT03263442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187849|NCT01164215|Leucovorin|leucovorin|mesh-list
93187850|NCT01164215|Fluorouracil|fluorouracil|mesh-list
93187851|NCT01164215|Oxaliplatin|oxaliplatin|mesh-list
93187852|NCT01164215|Levoleucovorin|levoleucovorin|mesh-list
93187853|NCT01164215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187854|NCT01164215|Antimetabolites|antimetabolites|mesh-ancestor
93187855|NCT01164215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187856|NCT01164215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93187857|NCT01164215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187858|NCT01164215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187859|NCT01164215|Immunologic Factors|immunologic factors|mesh-ancestor
93187860|NCT01164215|Antidotes|antidotes|mesh-ancestor
93187861|NCT01164215|Protective Agents|protective agents|mesh-ancestor
93187862|NCT01164215|Vitamin B Complex|vitamin b complex|mesh-ancestor
93187863|NCT01164215|Vitamins|vitamins|mesh-ancestor
93187864|NCT01164215|Micronutrients|micronutrients|mesh-ancestor
93187865|NCT04245709|Clenbuterol|clenbuterol|mesh-list
93187866|NCT04245709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93187867|NCT04245709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93187868|NCT04245709|Adrenergic Agents|adrenergic agents|mesh-ancestor
93187869|NCT04245709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187870|NCT04245709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187871|NCT04245709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187872|NCT04245709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93187873|NCT04245709|Autonomic Agents|autonomic agents|mesh-ancestor
93187874|NCT04245709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187875|NCT04245709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93187876|NCT04245709|Respiratory System Agents|respiratory system agents|mesh-ancestor
93187877|NCT04245709|Sympathomimetics|sympathomimetics|mesh-ancestor
93187878|NCT03878693|Fomepizole|fomepizole|mesh-list
93187879|NCT03878693|Antidotes|antidotes|mesh-ancestor
93187880|NCT03878693|Protective Agents|protective agents|mesh-ancestor
93187881|NCT03878693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187882|NCT03878693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187883|NCT03878693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187884|NCT05305495|Empagliflozin|empagliflozin|mesh-list
93187885|NCT05305495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93187886|NCT05305495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187887|NCT05305495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93187888|NCT05305495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187889|NCT03748537|Hydrocortisone|hydrocortisone|mesh-list
93187890|NCT03748537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187891|NCT02527109|Nifedipine|nifedipine|mesh-list
93187892|NCT02527109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93187893|NCT02527109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93187894|NCT02527109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187895|NCT02527109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93187896|NCT02527109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187897|NCT02527109|Vasodilator Agents|vasodilator agents|mesh-ancestor
93187898|NCT02527109|Tocolytic Agents|tocolytic agents|mesh-ancestor
93187899|NCT02527109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93187900|NCT02940522|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93187901|NCT02940522|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93187902|NCT02940522|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93187903|NCT02940522|Hormone Antagonists|hormone antagonists|mesh-ancestor
93187904|NCT02940522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93187905|NCT02940522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187906|NCT02940522|Progestins|progestins|mesh-ancestor
93187907|NCT02940522|Hormones|hormones|mesh-ancestor
93187908|NCT01266785|Infliximab|infliximab|mesh-list
93187909|NCT01266785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93187910|NCT01266785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93187911|NCT01266785|Dermatologic Agents|dermatologic agents|mesh-ancestor
93187912|NCT01266785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187913|NCT01266785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187914|NCT03262038|Ondansetron|ondansetron|mesh-list
93187915|NCT03262038|Antiemetics|antiemetics|mesh-ancestor
93187916|NCT03262038|Autonomic Agents|autonomic agents|mesh-ancestor
93187917|NCT03262038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93187918|NCT03262038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187919|NCT03262038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93187920|NCT03262038|Antipruritics|antipruritics|mesh-ancestor
93187921|NCT03262038|Dermatologic Agents|dermatologic agents|mesh-ancestor
93187922|NCT03262038|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93187923|NCT03262038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93187924|NCT03262038|Serotonin Agents|serotonin agents|mesh-ancestor
93187925|NCT03262038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187926|NCT03262038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187927|NCT03746821|Biotin|biotin|mesh-list
93187928|NCT03746821|Vitamin B Complex|vitamin b complex|mesh-ancestor
93187929|NCT03746821|Vitamins|vitamins|mesh-ancestor
93187930|NCT03746821|Micronutrients|micronutrients|mesh-ancestor
93187931|NCT03746821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187932|NCT02472964|Paclitaxel|paclitaxel|mesh-list
93187933|NCT02472964|Docetaxel|docetaxel|mesh-list
93187934|NCT02472964|Trastuzumab|trastuzumab|mesh-list
93187935|NCT02472964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93187936|NCT02472964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187937|NCT02472964|Tubulin Modulators|tubulin modulators|mesh-ancestor
93187938|NCT02472964|Antimitotic Agents|antimitotic agents|mesh-ancestor
93187940|NCT02472964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187941|NCT02472964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187942|NCT01160315|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93187943|NCT01160315|Norethindrone|norethindrone|mesh-list
93187944|NCT01160315|Norethindrone Acetate|norethindrone acetate|mesh-list
93187945|NCT01160315|Luteolytic Agents|luteolytic agents|mesh-ancestor
93187946|NCT01160315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93187947|NCT01160315|Contraceptive Agents|contraceptive agents|mesh-ancestor
93187948|NCT01160315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93187949|NCT01160315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187950|NCT01160315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93187951|NCT01160315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93187952|NCT01160315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187953|NCT01160315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93187954|NCT01160315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93187955|NCT01160315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93187956|NCT03385174|Carbon Monoxide|carbon monoxide|mesh-list
93187957|NCT03385174|Antimetabolites|antimetabolites|mesh-ancestor
93187958|NCT03385174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187959|NCT03385174|Gasotransmitters|gasotransmitters|mesh-ancestor
93187960|NCT03385174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187961|NCT03385174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187962|NCT01164605|Raltegravir Potassium|raltegravir potassium|mesh-list
93187963|NCT01164605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93187964|NCT01164605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93187965|NCT01164605|Antiviral Agents|antiviral agents|mesh-ancestor
93187966|NCT01164605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93187967|NCT01164605|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93187968|NCT01164605|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93187969|NCT01164605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187970|NCT01164605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187971|NCT03380728|Ibogaine|ibogaine|mesh-list
93187972|NCT03380728|Hallucinogens|hallucinogens|mesh-ancestor
93187973|NCT03380728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187974|NCT03380728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93187975|NCT03380728|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93187976|NCT03380728|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93187977|NCT03380728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93187978|NCT03380728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187979|NCT01104922|Cetuximab|cetuximab|mesh-list
93187980|NCT01104922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93187981|NCT01104922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93187982|NCT01164761|Ramipril|ramipril|mesh-list
93187983|NCT01164761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93187984|NCT01164761|Protease Inhibitors|protease inhibitors|mesh-ancestor
93187985|NCT01164761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93187986|NCT01164761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187987|NCT01164761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93187988|NCT03385096|Cyclophosphamide|cyclophosphamide|mesh-list
93187989|NCT03385096|Melphalan|melphalan|mesh-list
93187990|NCT03385096|Busulfan|busulfan|mesh-list
93187991|NCT03385096|Etoposide|etoposide|mesh-list
93187992|NCT03385096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93187993|NCT03385096|Immunologic Factors|immunologic factors|mesh-ancestor
93187994|NCT03385096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93187995|NCT03385096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93187996|NCT03385096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93187997|NCT03385096|Alkylating Agents|alkylating agents|mesh-ancestor
93187998|NCT03385096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93187999|NCT03385096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188000|NCT03385096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93188001|NCT03385096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93188002|NCT03385096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93188003|NCT03385096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93188004|NCT03385096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188005|NCT02526875|Amlodipine|amlodipine|mesh-list
93188006|NCT02526875|Telmisartan|telmisartan|mesh-list
93188007|NCT02526875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93188008|NCT02526875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93188009|NCT02526875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188010|NCT02526875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188011|NCT02526875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188012|NCT02526875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188013|NCT02526875|Vasodilator Agents|vasodilator agents|mesh-ancestor
93188014|NCT02526875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93188015|NCT02526875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93188016|NCT04222699|Chlorhexidine|chlorhexidine|mesh-list
93188017|NCT04222699|Mupirocin|mupirocin|mesh-list
93188018|NCT04222699|Calcium|calcium|mesh-list
93188019|NCT04222699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188020|NCT04222699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188021|NCT04222699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93188022|NCT04222699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188023|NCT04222699|Disinfectants|disinfectants|mesh-ancestor
93188024|NCT04222699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93188025|NCT04222699|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93188026|NCT04222699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188027|NCT04222699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188028|NCT01269203|Curcumin|curcumin|mesh-list
93188029|NCT01269203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93188030|NCT01269203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93188031|NCT01269203|Analgesics|analgesics|mesh-ancestor
93188032|NCT01269203|Sensory System Agents|sensory system agents|mesh-ancestor
93188033|NCT01269203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188034|NCT01269203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188035|NCT01269203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188036|NCT01269203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93188037|NCT01269203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188038|NCT01269203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188039|NCT01269203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188040|NCT01160627|Acetylcysteine|acetylcysteine|mesh-list
93188041|NCT01160627|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93188042|NCT01160627|Antiviral Agents|antiviral agents|mesh-ancestor
93188043|NCT01160627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188044|NCT01160627|Expectorants|expectorants|mesh-ancestor
93188045|NCT01160627|Respiratory System Agents|respiratory system agents|mesh-ancestor
93188046|NCT01160627|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93188047|NCT01160627|Antioxidants|antioxidants|mesh-ancestor
93188048|NCT01160627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188049|NCT01160627|Protective Agents|protective agents|mesh-ancestor
93188050|NCT01160627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188051|NCT01160627|Antidotes|antidotes|mesh-ancestor
93188052|NCT04075513|Insulin|insulin|mesh-list
93188053|NCT04075513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93188054|NCT04075513|Insulin Glargine|insulin glargine|mesh-list
93188055|NCT04075513|Insulin, Short-Acting|insulin, short-acting|mesh-list
93188056|NCT04075513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93188057|NCT04075513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188058|NCT03877679|Triamcinolone|triamcinolone|mesh-list
93188059|NCT03877679|Curcumin|curcumin|mesh-list
93188060|NCT03877679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188061|NCT03877679|Glucocorticoids|glucocorticoids|mesh-ancestor
93188062|NCT03877679|Hormones|hormones|mesh-ancestor
93188063|NCT03877679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188064|NCT03877679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188065|NCT03877679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188066|NCT03877679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188067|NCT03877679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93188068|NCT03877679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93188069|NCT03877679|Analgesics|analgesics|mesh-ancestor
93188070|NCT03877679|Sensory System Agents|sensory system agents|mesh-ancestor
93188071|NCT03877679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188072|NCT03877679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93188073|NCT03877679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188074|NCT03330249|Cisplatin|cisplatin|mesh-list
93188075|NCT03330249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188076|NCT04652206|Paclitaxel|paclitaxel|mesh-list
93188077|NCT04652206|Gemcitabine|gemcitabine|mesh-list
93188078|NCT04652206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93188079|NCT04652206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188080|NCT04652206|Tubulin Modulators|tubulin modulators|mesh-ancestor
93188081|NCT04652206|Antimitotic Agents|antimitotic agents|mesh-ancestor
93188082|NCT04652206|Mitosis Modulators|mitosis modulators|mesh-ancestor
93188083|NCT04652206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188084|NCT04652206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93188085|NCT04652206|Antimetabolites|antimetabolites|mesh-ancestor
93188086|NCT01269281|Sumatriptan|sumatriptan|mesh-list
93188087|NCT01269281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93188089|NCT01269281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93188090|NCT01269281|Serotonin Agents|serotonin agents|mesh-ancestor
93188091|NCT01269281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188092|NCT01269281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188093|NCT01269281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188094|NCT02778204|Maraviroc|maraviroc|mesh-list
93188095|NCT02778204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93188096|NCT02778204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93188097|NCT02778204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188098|NCT02778204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93188099|NCT02778204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93188100|NCT02778204|Antiviral Agents|antiviral agents|mesh-ancestor
93188101|NCT02778204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188102|NCT02778204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93188103|NCT01160705|Docetaxel|docetaxel|mesh-list
93188104|NCT01160705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188105|NCT01160705|Tubulin Modulators|tubulin modulators|mesh-ancestor
93188106|NCT01160705|Antimitotic Agents|antimitotic agents|mesh-ancestor
93188107|NCT01160705|Mitosis Modulators|mitosis modulators|mesh-ancestor
93188108|NCT01160705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188109|NCT03232281|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93188110|NCT03232281|Luteolytic Agents|luteolytic agents|mesh-ancestor
93188111|NCT03232281|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93188112|NCT03232281|Contraceptive Agents|contraceptive agents|mesh-ancestor
93188113|NCT03232281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93188114|NCT03232281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188115|NCT03232281|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93188116|NCT03232281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93188117|NCT03232281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188118|NCT03261336|Vitamin D|vitamin d|mesh-list
93188119|NCT03261336|Calcitriol|calcitriol|mesh-list
93188120|NCT03261336|Ketoconazole|ketoconazole|mesh-list
93188121|NCT03261336|Hydrocortisone|hydrocortisone|mesh-list
93188122|NCT03261336|Vitamins|vitamins|mesh-ancestor
93188123|NCT03261336|Micronutrients|micronutrients|mesh-ancestor
93188124|NCT03261336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188125|NCT03261336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93188126|NCT03261336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188127|NCT03261336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188128|NCT03261336|Antifungal Agents|antifungal agents|mesh-ancestor
93188129|NCT03261336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188130|NCT03261336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93188131|NCT03261336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93188132|NCT03261336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188133|NCT03261336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188134|NCT03261336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93188135|NCT03261336|Hormone Antagonists|hormone antagonists|mesh-ancestor
93188136|NCT03261336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188137|NCT03261336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93188138|NCT03261336|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93188139|NCT03261336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188140|NCT03261336|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93188141|NCT03384862|Folic Acid|folic acid|mesh-list
93188142|NCT03384862|Vitamin B 12|vitamin b 12|mesh-list
93188143|NCT03384862|Hydroxocobalamin|hydroxocobalamin|mesh-list
93188144|NCT03384862|Vitamins|vitamins|mesh-ancestor
93188145|NCT03384862|Micronutrients|micronutrients|mesh-ancestor
93188146|NCT03384862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188147|NCT03384862|Hematinics|hematinics|mesh-ancestor
93188148|NCT03384862|Vitamin B Complex|vitamin b complex|mesh-ancestor
93188149|NCT01269437|Budesonide|budesonide|mesh-list
93188150|NCT01269437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188151|NCT01269437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93188152|NCT01269437|Autonomic Agents|autonomic agents|mesh-ancestor
93188153|NCT01269437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188154|NCT01269437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188155|NCT01269437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93188156|NCT01269437|Respiratory System Agents|respiratory system agents|mesh-ancestor
93188157|NCT01269437|Glucocorticoids|glucocorticoids|mesh-ancestor
93188158|NCT01269437|Hormones|hormones|mesh-ancestor
93188159|NCT01269437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188160|NCT03909269|Carbon Monoxide|carbon monoxide|mesh-list
93188161|NCT03909269|Antimetabolites|antimetabolites|mesh-ancestor
93188162|NCT03909269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188163|NCT03909269|Gasotransmitters|gasotransmitters|mesh-ancestor
93188164|NCT03909269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188165|NCT03909269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188166|NCT00462748|Atorvastatin|atorvastatin|mesh-list
93188167|NCT00462748|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93188168|NCT00462748|Simvastatin|simvastatin|mesh-list
93188169|NCT00462748|Ezetimibe|ezetimibe|mesh-list
93188170|NCT00462748|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93188171|NCT00462748|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93188172|NCT00462748|Antimetabolites|antimetabolites|mesh-ancestor
93188173|NCT00462748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188174|NCT00462748|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188175|NCT00462748|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93188176|NCT00462748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188177|NCT01161017|Topiramate|topiramate|mesh-list
93188178|NCT01161017|Amitriptyline|amitriptyline|mesh-list
93188179|NCT01161017|Anticonvulsants|anticonvulsants|mesh-ancestor
93188180|NCT01161017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93188181|NCT01161017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188182|NCT01161017|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93188183|NCT01161017|Antidepressive Agents|antidepressive agents|mesh-ancestor
93188184|NCT01161017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188185|NCT01161017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93188186|NCT01161017|Analgesics|analgesics|mesh-ancestor
93188187|NCT01161017|Sensory System Agents|sensory system agents|mesh-ancestor
93188188|NCT01161017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188189|NCT01161017|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93188190|NCT01161017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93188191|NCT01161017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188192|NCT01161017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188193|NCT01161017|Adrenergic Agents|adrenergic agents|mesh-ancestor
93188194|NCT01161017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188195|NCT03935685|Mirtazapine|mirtazapine|mesh-list
93188196|NCT03935685|Antidepressive Agents|antidepressive agents|mesh-ancestor
93188197|NCT03935685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188198|NCT03935685|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93188199|NCT03935685|Histamine Antagonists|histamine antagonists|mesh-ancestor
93188200|NCT03935685|Histamine Agents|histamine agents|mesh-ancestor
93188201|NCT03935685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188202|NCT03935685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188203|NCT03935685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188204|NCT03935685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93188205|NCT03935685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93188206|NCT03935685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188207|NCT03935685|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93188208|NCT03935685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93188209|NCT03935685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93188210|NCT03935685|Adrenergic Agents|adrenergic agents|mesh-ancestor
93188211|NCT03935685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93188212|NCT03935685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93188213|NCT03935685|Serotonin Agents|serotonin agents|mesh-ancestor
93188214|NCT03935685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93188215|NCT01164917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93188216|NCT01164917|Immunologic Factors|immunologic factors|mesh-ancestor
93188217|NCT01164917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188218|NCT03238911|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93188219|NCT03238911|Hematinics|hematinics|mesh-ancestor
93188220|NCT01269515|Etoricoxib|etoricoxib|mesh-list
93188221|NCT01269515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93188222|NCT01269515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93188223|NCT01269515|Analgesics|analgesics|mesh-ancestor
93188224|NCT01269515|Sensory System Agents|sensory system agents|mesh-ancestor
93188225|NCT01269515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188226|NCT01269515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188227|NCT01269515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188228|NCT01269515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93188229|NCT01269515|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93188230|NCT01269515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93188231|NCT01269515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188232|NCT01269515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188233|NCT00418834|Atorvastatin|atorvastatin|mesh-list
93188234|NCT00418834|Ezetimibe|ezetimibe|mesh-list
93188235|NCT00418834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93188236|NCT00418834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93188237|NCT00418834|Antimetabolites|antimetabolites|mesh-ancestor
93188238|NCT00418834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188239|NCT00418834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188240|NCT00418834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93188241|NCT00418834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188242|NCT01269671|Peppermint oil|peppermint oil|mesh-list
93188243|NCT01269671|Melatonin|melatonin|mesh-list
93188244|NCT01269671|Simethicone|simethicone|mesh-list
93188245|NCT01269671|Antioxidants|antioxidants|mesh-ancestor
93188246|NCT01269671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188247|NCT01269671|Protective Agents|protective agents|mesh-ancestor
93188248|NCT01269671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188249|NCT01269671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188250|NCT01269671|Antifoaming Agents|antifoaming agents|mesh-ancestor
93188251|NCT01269671|Emollients|emollients|mesh-ancestor
93188252|NCT01269671|Dermatologic Agents|dermatologic agents|mesh-ancestor
93188253|NCT01269671|Antiemetics|antiemetics|mesh-ancestor
93188254|NCT01269671|Autonomic Agents|autonomic agents|mesh-ancestor
93188255|NCT01269671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188256|NCT01269671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93188257|NCT01269671|Parasympatholytics|parasympatholytics|mesh-ancestor
93188258|NCT04407286|Vitamin D|vitamin d|mesh-list
93188259|NCT04407286|Cholecalciferol|cholecalciferol|mesh-list
93188260|NCT04407286|Vitamins|vitamins|mesh-ancestor
93188261|NCT04407286|Micronutrients|micronutrients|mesh-ancestor
93188262|NCT04407286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188263|NCT04407286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93188264|NCT04407286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188265|NCT03276975|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93188266|NCT03276975|Hemostatics|hemostatics|mesh-ancestor
93188267|NCT03276975|Coagulants|coagulants|mesh-ancestor
93188268|NCT03125746|Exemestane|exemestane|mesh-list
93188269|NCT03125746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188270|NCT03125746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93188271|NCT03125746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93188272|NCT03125746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188273|NCT03125746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188274|NCT03125746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93188275|NCT03125746|Hormone Antagonists|hormone antagonists|mesh-ancestor
93188276|NCT03125746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188277|NCT03125746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188278|NCT03877601|Bevacizumab|bevacizumab|mesh-list
93188279|NCT03877601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188280|NCT03877601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188281|NCT03877601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188282|NCT03877601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188283|NCT03877601|Growth Substances|growth substances|mesh-ancestor
93188284|NCT03877601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188285|NCT03877601|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188286|NCT03297216|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93188287|NCT03297216|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93188288|NCT03297216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93188289|NCT03297216|Hormone Antagonists|hormone antagonists|mesh-ancestor
93188290|NCT03297216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188291|NCT03297216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188292|NCT03297216|Progestins|progestins|mesh-ancestor
93188293|NCT03297216|Hormones|hormones|mesh-ancestor
93188294|NCT03260868|Insulin|insulin|mesh-list
93188295|NCT03260868|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93188296|NCT03260868|Insulin Glargine|insulin glargine|mesh-list
93188297|NCT03260868|Insulin Lispro|insulin lispro|mesh-list
93188298|NCT03260868|Insulin Aspart|insulin aspart|mesh-list
93188299|NCT03260868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93188300|NCT03260868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188301|NCT01165385|Cisplatin|cisplatin|mesh-list
93188302|NCT01165385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188303|NCT01267487|Heparin|heparin|mesh-list
93188304|NCT01267487|Calcium heparin|calcium heparin|mesh-list
93188305|NCT01267487|Protamines|protamines|mesh-list
93188306|NCT01267487|Anticoagulants|anticoagulants|mesh-ancestor
93188307|NCT01267487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93188308|NCT01267487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93188309|NCT01267487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188310|NCT01267487|Heparin Antagonists|heparin antagonists|mesh-ancestor
93188311|NCT01267487|Coagulants|coagulants|mesh-ancestor
93188312|NCT01267643|Alefacept|alefacept|mesh-list
93188313|NCT01267643|Dermatologic Agents|dermatologic agents|mesh-ancestor
93188315|NCT01267643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188316|NCT01269827|Pentoxifylline|pentoxifylline|mesh-list
93188317|NCT01269827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93188318|NCT01269827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188319|NCT01269827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188320|NCT01269827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93188321|NCT01269827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93188322|NCT01269827|Protective Agents|protective agents|mesh-ancestor
93188323|NCT01269827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188324|NCT01269827|Vasodilator Agents|vasodilator agents|mesh-ancestor
93188325|NCT01269827|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93188326|NCT01269827|Antioxidants|antioxidants|mesh-ancestor
93188327|NCT03388372|Temozolomide|temozolomide|mesh-list
93188328|NCT03388372|Nimotuzumab|nimotuzumab|mesh-list
93188329|NCT03388372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93188330|NCT03388372|Alkylating Agents|alkylating agents|mesh-ancestor
93188331|NCT03388372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188332|NCT03388372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188333|NCT03388372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188334|NCT05173246|Paclitaxel|paclitaxel|mesh-list
93188335|NCT05173246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93188336|NCT05173246|Cisplatin|cisplatin|mesh-list
93188337|NCT05173246|Carboplatin|carboplatin|mesh-list
93188338|NCT05173246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93188339|NCT05173246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188340|NCT05173246|Tubulin Modulators|tubulin modulators|mesh-ancestor
93188341|NCT05173246|Antimitotic Agents|antimitotic agents|mesh-ancestor
93188342|NCT05173246|Mitosis Modulators|mitosis modulators|mesh-ancestor
93188343|NCT05173246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188344|NCT01167101|Pantoprazole|pantoprazole|mesh-list
93188345|NCT01167101|Rebamipide|rebamipide|mesh-list
93188346|NCT01167101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93188347|NCT01167101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93188348|NCT01167101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93188349|NCT01167101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188350|NCT01167101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188351|NCT01167101|Antioxidants|antioxidants|mesh-ancestor
93188352|NCT01167101|Protective Agents|protective agents|mesh-ancestor
93188353|NCT01167101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188354|NCT05173090|Ropivacaine|ropivacaine|mesh-list
93188355|NCT05173090|Anesthetics, Local|anesthetics, local|mesh-ancestor
93188356|NCT05173090|Anesthetics|anesthetics|mesh-ancestor
93188357|NCT05173090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188358|NCT05173090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188359|NCT05173090|Sensory System Agents|sensory system agents|mesh-ancestor
93188360|NCT05173090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188361|NCT02526953|Paclitaxel|paclitaxel|mesh-list
93188362|NCT02526953|Capecitabine|capecitabine|mesh-list
93188363|NCT02526953|Mitomycins|mitomycins|mesh-list
93188364|NCT02526953|Mitomycin|mitomycin|mesh-list
93188365|NCT02526953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93188366|NCT02526953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188367|NCT02526953|Tubulin Modulators|tubulin modulators|mesh-ancestor
93188368|NCT02526953|Antimitotic Agents|antimitotic agents|mesh-ancestor
93188369|NCT02526953|Mitosis Modulators|mitosis modulators|mesh-ancestor
93188370|NCT02526953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188371|NCT02526953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93188372|NCT02526953|Antimetabolites|antimetabolites|mesh-ancestor
93188373|NCT02526953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93188374|NCT02526953|Alkylating Agents|alkylating agents|mesh-ancestor
93188375|NCT02526953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93188376|NCT02526953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188377|NCT03258762|Leucovorin|leucovorin|mesh-list
93188378|NCT03258762|Pyrimethamine|pyrimethamine|mesh-list
93188379|NCT03258762|Calcium|calcium|mesh-list
93188380|NCT03258762|Levoleucovorin|levoleucovorin|mesh-list
93188381|NCT03258762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188382|NCT03258762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188383|NCT03258762|Antidotes|antidotes|mesh-ancestor
93188384|NCT03258762|Protective Agents|protective agents|mesh-ancestor
93188385|NCT03258762|Vitamin B Complex|vitamin b complex|mesh-ancestor
93188386|NCT03258762|Vitamins|vitamins|mesh-ancestor
93188387|NCT03258762|Micronutrients|micronutrients|mesh-ancestor
93188388|NCT03258762|Antimalarials|antimalarials|mesh-ancestor
93188389|NCT03258762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93188390|NCT03258762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93188391|NCT03258762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188392|NCT03258762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93188393|NCT03258762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188394|NCT03258762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188395|NCT05427669|Leucovorin|leucovorin|mesh-list
93188396|NCT05427669|Fluorouracil|fluorouracil|mesh-list
93188397|NCT05427669|Oxaliplatin|oxaliplatin|mesh-list
93188398|NCT05427669|Irinotecan|irinotecan|mesh-list
93188399|NCT05427669|Levoleucovorin|levoleucovorin|mesh-list
93188400|NCT05427669|Antimetabolites|antimetabolites|mesh-ancestor
93188401|NCT05427669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188402|NCT05427669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93188403|NCT05427669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188404|NCT05427669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188405|NCT05427669|Immunologic Factors|immunologic factors|mesh-ancestor
93188406|NCT05427669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188407|NCT05427669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93188408|NCT05427669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93188409|NCT05427669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188410|NCT05427669|Antidotes|antidotes|mesh-ancestor
93188411|NCT05427669|Protective Agents|protective agents|mesh-ancestor
93188412|NCT05427669|Vitamin B Complex|vitamin b complex|mesh-ancestor
93188413|NCT05427669|Vitamins|vitamins|mesh-ancestor
93188414|NCT05427669|Micronutrients|micronutrients|mesh-ancestor
93188415|NCT01270373|Docetaxel|docetaxel|mesh-list
93188416|NCT01270373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188417|NCT01270373|Tubulin Modulators|tubulin modulators|mesh-ancestor
93188418|NCT01270373|Antimitotic Agents|antimitotic agents|mesh-ancestor
93188419|NCT01270373|Mitosis Modulators|mitosis modulators|mesh-ancestor
93188420|NCT01270373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188421|NCT03713086|Vaccines|vaccines|mesh-list
93188422|NCT03713086|Immunologic Factors|immunologic factors|mesh-ancestor
93188423|NCT03713086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188424|NCT01271231|Azithromycin|azithromycin|mesh-list
93188425|NCT01271231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93188426|NCT01271231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188427|NCT03697876|Hyaluronic Acid|hyaluronic acid|mesh-list
93188428|NCT03697876|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93188429|NCT03697876|Immunologic Factors|immunologic factors|mesh-ancestor
93188430|NCT03697876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188431|NCT03697876|Viscosupplements|viscosupplements|mesh-ancestor
93188432|NCT03697876|Protective Agents|protective agents|mesh-ancestor
93188433|NCT04526691|Carboplatin|carboplatin|mesh-list
93188434|NCT04526691|Pembrolizumab|pembrolizumab|mesh-list
93188435|NCT04526691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188436|NCT04526691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188437|NCT04526691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93188438|NCT04526691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188439|NCT01280669|Sirolimus|sirolimus|mesh-list
93188440|NCT01280669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93188441|NCT01280669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188442|NCT01280669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93188443|NCT01280669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188444|NCT01280669|Antifungal Agents|antifungal agents|mesh-ancestor
93188445|NCT01280669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188446|NCT01280669|Immunologic Factors|immunologic factors|mesh-ancestor
93188447|NCT01280669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188448|NCT03379558|Alirocumab|alirocumab|mesh-list
93188449|NCT03379558|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93188450|NCT03379558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93188451|NCT03379558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93188452|NCT03379558|Antimetabolites|antimetabolites|mesh-ancestor
93188453|NCT03379558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188454|NCT03379558|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93188455|NCT03379558|Protease Inhibitors|protease inhibitors|mesh-ancestor
93188456|NCT03379558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188457|NCT03379558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188458|NCT01169909|Ranibizumab|ranibizumab|mesh-list
93188459|NCT01169909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188460|NCT01169909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188461|NCT01169909|Growth Substances|growth substances|mesh-ancestor
93188462|NCT01169909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188463|NCT01169909|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188464|NCT01169909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188465|NCT04502589|Disulfiram|disulfiram|mesh-list
93188466|NCT04502589|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93188467|NCT04502589|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93188468|NCT04502589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188469|NCT04502589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188470|NCT03387904|Irinotecan|irinotecan|mesh-list
93188471|NCT03387904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93188472|NCT03387904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93188473|NCT03387904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188474|NCT03387904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188475|NCT03387904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188476|NCT03291288|Tolbutamide|tolbutamide|mesh-list
93188477|NCT03291288|Midazolam|midazolam|mesh-list
93188478|NCT03291288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93188479|NCT03291288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93188480|NCT03291288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188481|NCT03291288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188482|NCT03291288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93188483|NCT03291288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93188484|NCT03291288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188485|NCT03291288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93188486|NCT03291288|Anesthetics, General|anesthetics, general|mesh-ancestor
93188487|NCT03291288|Anesthetics|anesthetics|mesh-ancestor
93188488|NCT03291288|GABA Modulators|gaba modulators|mesh-ancestor
93188489|NCT03291288|GABA Agents|gaba agents|mesh-ancestor
93188490|NCT03291288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188491|NCT03291288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188492|NCT03291288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93188493|NCT05172310|FAPI-46|fapi-46|mesh-list
93188494|NCT05172310|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93188495|NCT05172310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188496|NCT03636711|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93188497|NCT03636711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188498|NCT04084626|Lenalidomide|lenalidomide|mesh-list
93188499|NCT04084626|Antibodies|antibodies|mesh-list
93188500|NCT04084626|Immunologic Factors|immunologic factors|mesh-ancestor
93188501|NCT04084626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188502|NCT04084626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188503|NCT04084626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188504|NCT04084626|Growth Substances|growth substances|mesh-ancestor
93188505|NCT04084626|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188506|NCT04084626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188507|NCT03387826|Ticagrelor|ticagrelor|mesh-list
93188508|NCT03387826|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93188509|NCT03387826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92977235|NCT00246337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188510|NCT03387826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93188511|NCT03387826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93188512|NCT03387826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93188513|NCT03387826|Purinergic Agents|purinergic agents|mesh-ancestor
93188514|NCT03387826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188515|NCT03387826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188516|NCT03387826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188517|NCT03871517|Aspirin|aspirin|mesh-list
93188518|NCT03871517|Indobufen|indobufen|mesh-list
93188519|NCT03871517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93188520|NCT03871517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93188521|NCT03871517|Analgesics|analgesics|mesh-ancestor
93188522|NCT03871517|Sensory System Agents|sensory system agents|mesh-ancestor
93188523|NCT03871517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188524|NCT03871517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188525|NCT03871517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188526|NCT03871517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93188527|NCT03871517|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93188528|NCT03871517|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93188529|NCT03871517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188530|NCT03871517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93188531|NCT03871517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93188532|NCT03871517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188533|NCT03871517|Antipyretics|antipyretics|mesh-ancestor
93188534|NCT03387592|Leucovorin|leucovorin|mesh-list
93188535|NCT03387592|Fluorouracil|fluorouracil|mesh-list
93188536|NCT03387592|Capecitabine|capecitabine|mesh-list
93188537|NCT03387592|Temozolomide|temozolomide|mesh-list
93188538|NCT03387592|Levoleucovorin|levoleucovorin|mesh-list
93188539|NCT03387592|Antimetabolites|antimetabolites|mesh-ancestor
93188540|NCT03387592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188541|NCT03387592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93188542|NCT03387592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188543|NCT03387592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188544|NCT03387592|Immunologic Factors|immunologic factors|mesh-ancestor
93188545|NCT03387592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188546|NCT03387592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93188547|NCT03387592|Alkylating Agents|alkylating agents|mesh-ancestor
93188548|NCT03387592|Antidotes|antidotes|mesh-ancestor
93188549|NCT03387592|Protective Agents|protective agents|mesh-ancestor
93188550|NCT03387592|Vitamin B Complex|vitamin b complex|mesh-ancestor
93188551|NCT03387592|Vitamins|vitamins|mesh-ancestor
93188552|NCT03387592|Micronutrients|micronutrients|mesh-ancestor
93188553|NCT04445506|Dexamethasone|dexamethasone|mesh-list
93188554|NCT04445506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188555|NCT04445506|Antiemetics|antiemetics|mesh-ancestor
93188556|NCT04445506|Autonomic Agents|autonomic agents|mesh-ancestor
93188557|NCT04445506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188558|NCT04445506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188559|NCT04445506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93188560|NCT04445506|Glucocorticoids|glucocorticoids|mesh-ancestor
93188561|NCT04445506|Hormones|hormones|mesh-ancestor
93188562|NCT04445506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188563|NCT04445506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93188564|NCT04445506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188565|NCT03379012|Sunitinib|sunitinib|mesh-list
93188566|NCT03379012|Methyltestosterone|methyltestosterone|mesh-list
93188567|NCT03379012|Testosterone|testosterone|mesh-list
93188568|NCT03379012|Testosterone undecanoate|testosterone undecanoate|mesh-list
93188569|NCT03379012|Testosterone enanthate|testosterone enanthate|mesh-list
93188570|NCT03379012|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93188571|NCT03379012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188572|NCT03379012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188573|NCT03379012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188574|NCT03379012|Growth Substances|growth substances|mesh-ancestor
93188575|NCT03379012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188576|NCT03379012|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188577|NCT03379012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93188578|NCT03379012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188579|NCT03379012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188580|NCT03379012|Androgens|androgens|mesh-ancestor
93188581|NCT03379012|Hormones|hormones|mesh-ancestor
93188582|NCT03379012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188583|NCT03379012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93188584|NCT03379012|Anabolic Agents|anabolic agents|mesh-ancestor
93188585|NCT03383302|Nivolumab|nivolumab|mesh-list
93188586|NCT03383302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188587|NCT03383302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188588|NCT03383302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93188589|NCT03383302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188590|NCT03493126|Estradiol|estradiol|mesh-list
93188591|NCT03493126|Estrogens|estrogens|mesh-ancestor
93188592|NCT03493126|Hormones|hormones|mesh-ancestor
93188593|NCT03493126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188594|NCT03493126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188595|NCT03257358|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93188596|NCT03257358|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93188597|NCT03257358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188598|NCT03257358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188599|NCT03257358|Immunologic Factors|immunologic factors|mesh-ancestor
93188600|NCT03257358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188601|NCT03386656|Tranexamic Acid|tranexamic acid|mesh-list
93188602|NCT03386656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93188603|NCT03386656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93188604|NCT03386656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188605|NCT03386656|Hemostatics|hemostatics|mesh-ancestor
93188606|NCT03386656|Coagulants|coagulants|mesh-ancestor
93188607|NCT01281527|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93188608|NCT01281527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93188609|NCT01281527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93188610|NCT01281527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188611|NCT01281527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188612|NCT01281527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188613|NCT01281527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93188614|NCT01281527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93188615|NCT01281527|Serotonin Agents|serotonin agents|mesh-ancestor
93188616|NCT01281527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188617|NCT01281527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860766|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188618|NCT01281527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93188620|NCT01281527|Dopamine Agents|dopamine agents|mesh-ancestor
93188621|NCT01281605|Insulin|insulin|mesh-list
93188622|NCT01281605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93188623|NCT01281605|Insulin Detemir|insulin detemir|mesh-list
93188624|NCT01281605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93188625|NCT01281605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188626|NCT01170143|Trastuzumab|trastuzumab|mesh-list
93188627|NCT01170143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188628|NCT01170143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188629|NCT05171530|Lenvatinib|lenvatinib|mesh-list
93188630|NCT05171530|Taxane|taxane|mesh-list
93188631|NCT05171530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188632|NCT05171530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93188633|NCT05171530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188634|NCT05171530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188635|NCT02936037|Biotin|biotin|mesh-list
93188636|NCT02936037|Vitamin B Complex|vitamin b complex|mesh-ancestor
93188637|NCT02936037|Vitamins|vitamins|mesh-ancestor
93188638|NCT02936037|Micronutrients|micronutrients|mesh-ancestor
93188639|NCT02936037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188640|NCT04068181|Pembrolizumab|pembrolizumab|mesh-list
93188641|NCT04068181|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93188642|NCT04068181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188643|NCT04068181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188644|NCT04068181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93188645|NCT04068181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188646|NCT01283789|Everolimus|everolimus|mesh-list
93188647|NCT01283789|Lapatinib|lapatinib|mesh-list
93188648|NCT01283789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93188649|NCT01283789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93188650|NCT01283789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188651|NCT01283789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188652|NCT01283789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188653|NCT01283789|Immunologic Factors|immunologic factors|mesh-ancestor
93188654|NCT01283789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188655|NCT01283789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188656|NCT03383068|Metformin|metformin|mesh-list
93188657|NCT03383068|Exenatide|exenatide|mesh-list
93188658|NCT03383068|Acarbose|acarbose|mesh-list
93188659|NCT03383068|Orlistat|orlistat|mesh-list
93188660|NCT03383068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93188661|NCT03383068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188662|NCT03383068|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93188663|NCT03383068|Incretins|incretins|mesh-ancestor
93188664|NCT03383068|Hormones|hormones|mesh-ancestor
93188665|NCT03383068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188666|NCT03383068|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93188667|NCT03383068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188668|NCT03383068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188669|NCT03383068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188670|NCT03378310|Linrodostat|linrodostat|mesh-list
93188671|NCT03378310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188672|NCT03378310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188673|NCT01283867|Mycophenolic Acid|mycophenolic acid|mesh-list
93188674|NCT01283867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93188675|NCT01283867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188676|NCT01283867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93188677|NCT01283867|Antitubercular Agents|antitubercular agents|mesh-ancestor
93188678|NCT01283867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93188679|NCT01283867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188680|NCT01283867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188681|NCT01283867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188682|NCT04094298|FX006|fx006|mesh-list
93188683|NCT04094298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188684|NCT04094298|Glucocorticoids|glucocorticoids|mesh-ancestor
93188685|NCT04094298|Hormones|hormones|mesh-ancestor
93188686|NCT04094298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188687|NCT04094298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188688|NCT04094298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188689|NCT04094298|Immunologic Factors|immunologic factors|mesh-ancestor
93188690|NCT04194151|Propofol|propofol|mesh-list
93188691|NCT04194151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93188692|NCT04194151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188693|NCT04194151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188694|NCT04194151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93188695|NCT04194151|Anesthetics, General|anesthetics, general|mesh-ancestor
93188696|NCT04194151|Anesthetics|anesthetics|mesh-ancestor
93188697|NCT01281761|Irinotecan|irinotecan|mesh-list
93188698|NCT01281761|Cetuximab|cetuximab|mesh-list
93188699|NCT01281761|Simvastatin|simvastatin|mesh-list
93188700|NCT01281761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93188701|NCT01281761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93188702|NCT01281761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188703|NCT01281761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188704|NCT01281761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188705|NCT01281761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188706|NCT01281761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93188707|NCT01281761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93188708|NCT01281761|Antimetabolites|antimetabolites|mesh-ancestor
93188709|NCT01281761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188710|NCT01281761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93188711|NCT04280328|Daratumumab|daratumumab|mesh-list
93188712|NCT04280328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188713|NCT03748147|Misoprostol|misoprostol|mesh-list
93188714|NCT03748147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93188715|NCT03748147|Abortifacient Agents|abortifacient agents|mesh-ancestor
93188716|NCT03748147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93188717|NCT03748147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188718|NCT03748147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93188719|NCT03748147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93188720|NCT03748147|Oxytocics|oxytocics|mesh-ancestor
93188721|NCT01580813|Acipimox|acipimox|mesh-list
93188722|NCT01580813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93188723|NCT01580813|Antimetabolites|antimetabolites|mesh-ancestor
93188724|NCT01580813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188725|NCT01580813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188726|NCT04446364|Disinfectants|disinfectants|mesh-list
93188727|NCT04446364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188728|NCT01588535|Benzocaine|benzocaine|mesh-list
93188729|NCT01588535|Anesthetics, Local|anesthetics, local|mesh-ancestor
93188730|NCT01588535|Anesthetics|anesthetics|mesh-ancestor
93188731|NCT01588535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188732|NCT01588535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188733|NCT01588535|Sensory System Agents|sensory system agents|mesh-ancestor
93188734|NCT01588535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188735|NCT01165931|Riociguat|riociguat|mesh-list
93188736|NCT01165931|Enzyme Activators|enzyme activators|mesh-ancestor
93188737|NCT01165931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188738|NCT03441282|Fentanyl|fentanyl|mesh-list
93188739|NCT03441282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93188740|NCT03441282|Narcotics|narcotics|mesh-ancestor
93188741|NCT03441282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188742|NCT03441282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188743|NCT03441282|Analgesics|analgesics|mesh-ancestor
93188744|NCT03441282|Sensory System Agents|sensory system agents|mesh-ancestor
93188745|NCT03441282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188746|NCT03441282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93188747|NCT03441282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93188748|NCT03441282|Anesthetics, General|anesthetics, general|mesh-ancestor
93188749|NCT03441282|Anesthetics|anesthetics|mesh-ancestor
93188750|NCT01274273|Interferons|interferons|mesh-list
93188751|NCT01274273|Interferon-alpha|interferon-alpha|mesh-list
93188752|NCT01274273|Interferon alpha-2|interferon alpha-2|mesh-list
93188753|NCT01274273|Aldesleukin|aldesleukin|mesh-list
93188754|NCT01274273|Bevacizumab|bevacizumab|mesh-list
93188755|NCT01274273|Interleukin-2|interleukin-2|mesh-list
93188756|NCT01274273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188757|NCT01274273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188758|NCT01274273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188759|NCT01274273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188760|NCT01274273|Growth Substances|growth substances|mesh-ancestor
93188761|NCT01274273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188762|NCT01274273|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188763|NCT01274273|Antiviral Agents|antiviral agents|mesh-ancestor
93188764|NCT01274273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93188765|NCT01274273|Immunologic Factors|immunologic factors|mesh-ancestor
93188766|NCT01274273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93188767|NCT01274273|Analgesics|analgesics|mesh-ancestor
93188768|NCT01274273|Sensory System Agents|sensory system agents|mesh-ancestor
93188769|NCT01274273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188770|NCT01274273|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93188771|NCT01274273|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93188773|NCT04058353|Elexacaftor|elexacaftor|mesh-list
93188774|NCT04058353|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93188775|NCT04058353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188776|NCT04058353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188777|NCT01167725|Leucovorin|leucovorin|mesh-list
93188778|NCT01167725|Bevacizumab|bevacizumab|mesh-list
93188779|NCT01167725|Cetuximab|cetuximab|mesh-list
93188780|NCT01167725|Fluorouracil|fluorouracil|mesh-list
93188781|NCT01167725|Capecitabine|capecitabine|mesh-list
93188782|NCT01167725|Oxaliplatin|oxaliplatin|mesh-list
93188783|NCT01167725|Irinotecan|irinotecan|mesh-list
93188784|NCT01167725|Mitomycins|mitomycins|mesh-list
93188785|NCT01167725|Mitomycin|mitomycin|mesh-list
93188786|NCT01167725|Levoleucovorin|levoleucovorin|mesh-list
93188787|NCT01167725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188788|NCT01167725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188789|NCT01167725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188790|NCT01167725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188791|NCT01167725|Growth Substances|growth substances|mesh-ancestor
93188792|NCT01167725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188793|NCT01167725|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188794|NCT01167725|Antimetabolites|antimetabolites|mesh-ancestor
93188795|NCT01167725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188796|NCT01167725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93188797|NCT01167725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93188798|NCT01167725|Immunologic Factors|immunologic factors|mesh-ancestor
93188799|NCT01167725|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92977236|NCT05012943|Vaccines|vaccines|mesh-list
93188800|NCT01167725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93188801|NCT01167725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188802|NCT01167725|Antidotes|antidotes|mesh-ancestor
93188803|NCT01167725|Protective Agents|protective agents|mesh-ancestor
93188804|NCT01167725|Vitamin B Complex|vitamin b complex|mesh-ancestor
93188805|NCT01167725|Vitamins|vitamins|mesh-ancestor
93188806|NCT01167725|Micronutrients|micronutrients|mesh-ancestor
93188807|NCT01167725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93188808|NCT01167725|Alkylating Agents|alkylating agents|mesh-ancestor
93188809|NCT01167725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93188810|NCT04446130|Decitabine|decitabine|mesh-list
93188811|NCT04446130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93188812|NCT04446130|Antimetabolites|antimetabolites|mesh-ancestor
93188813|NCT04446130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188814|NCT04446130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188815|NCT04446130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188816|NCT03226275|Amlodipine|amlodipine|mesh-list
93188817|NCT03226275|Bisoprolol|bisoprolol|mesh-list
93188818|NCT03226275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93188819|NCT03226275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93188820|NCT03226275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188821|NCT03226275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188822|NCT03226275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188823|NCT03226275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188824|NCT03226275|Vasodilator Agents|vasodilator agents|mesh-ancestor
93188825|NCT03226275|Sympatholytics|sympatholytics|mesh-ancestor
93188826|NCT03226275|Autonomic Agents|autonomic agents|mesh-ancestor
93188827|NCT03226275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188828|NCT03226275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93188829|NCT03226275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93188830|NCT03226275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93188831|NCT03226275|Adrenergic Agents|adrenergic agents|mesh-ancestor
93188832|NCT03226275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188833|NCT03382756|Choline|choline|mesh-list
93188834|NCT03382756|Atorvastatin|atorvastatin|mesh-list
93188835|NCT03382756|Fenofibrate|fenofibrate|mesh-list
93188836|NCT03382756|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93188837|NCT03382756|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93188838|NCT03382756|Antimetabolites|antimetabolites|mesh-ancestor
93188839|NCT03382756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188840|NCT03382756|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93188841|NCT03382756|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93188842|NCT03382756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188843|NCT03382756|Lipotropic Agents|lipotropic agents|mesh-ancestor
93188844|NCT03382756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93188845|NCT03382756|Nootropic Agents|nootropic agents|mesh-ancestor
93188846|NCT01166087|Fluoxetine|fluoxetine|mesh-list
93188847|NCT01166087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92860986|NCT02119468|Dexamethasone|dexamethasone|mesh-list
93188848|NCT01166087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93188849|NCT01166087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188850|NCT01166087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188851|NCT01166087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188852|NCT01166087|Serotonin Agents|serotonin agents|mesh-ancestor
93188853|NCT01166087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188854|NCT01166087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93188855|NCT01166087|Antidepressive Agents|antidepressive agents|mesh-ancestor
93188856|NCT01166087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188857|NCT01166087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93188858|NCT01166087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93188859|NCT01166087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188860|NCT01170767|Bevacizumab|bevacizumab|mesh-list
93188861|NCT01170767|Ranibizumab|ranibizumab|mesh-list
93188862|NCT01170767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188863|NCT01170767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188864|NCT01170767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93188865|NCT01170767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93188866|NCT01170767|Growth Substances|growth substances|mesh-ancestor
93188867|NCT01170767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188868|NCT01170767|Growth Inhibitors|growth inhibitors|mesh-ancestor
93188869|NCT01170845|Sivelestat|sivelestat|mesh-list
93188870|NCT01170845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93188871|NCT01170845|Protease Inhibitors|protease inhibitors|mesh-ancestor
93188872|NCT01170845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93188873|NCT01170845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188874|NCT01150890|Brodalumab|brodalumab|mesh-list
93188875|NCT01150890|Dermatologic Agents|dermatologic agents|mesh-ancestor
93188876|NCT01167803|Desflurane|desflurane|mesh-list
93188877|NCT01167803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93188878|NCT01167803|Anesthetics, General|anesthetics, general|mesh-ancestor
93188879|NCT01167803|Anesthetics|anesthetics|mesh-ancestor
93188880|NCT01167803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188881|NCT01167803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188882|NCT01275521|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93188883|NCT01275521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93188884|NCT01275521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188885|NCT01275521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188886|NCT01275521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93188887|NCT01275521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188888|NCT01275521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188889|NCT01275521|Cholinergic Agents|cholinergic agents|mesh-ancestor
93188890|NCT01275521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188891|NCT01275911|Remifentanil|remifentanil|mesh-list
93188892|NCT01275911|Esmolol|esmolol|mesh-list
93188893|NCT01275911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93188894|NCT01275911|Narcotics|narcotics|mesh-ancestor
93188895|NCT01275911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188896|NCT01275911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188897|NCT01275911|Analgesics|analgesics|mesh-ancestor
93188898|NCT01275911|Sensory System Agents|sensory system agents|mesh-ancestor
93188899|NCT01275911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188900|NCT01275911|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93188901|NCT01275911|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93188902|NCT01275911|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93188903|NCT01275911|Adrenergic Agents|adrenergic agents|mesh-ancestor
93188904|NCT01275911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188905|NCT01275911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188906|NCT01166165|Cholecalciferol|cholecalciferol|mesh-list
93188907|NCT01166165|Vitamin D|vitamin d|mesh-list
93188908|NCT01166165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93188909|NCT01166165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188910|NCT01166165|Vitamins|vitamins|mesh-ancestor
93188911|NCT01166165|Micronutrients|micronutrients|mesh-ancestor
93188912|NCT01166165|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93188913|NCT03286218|Alprazolam|alprazolam|mesh-list
93188914|NCT03286218|Lasmiditan|lasmiditan|mesh-list
93188915|NCT03286218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93188916|NCT03286218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188917|NCT03286218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188918|NCT03286218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93188919|NCT03286218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93188920|NCT03286218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188921|NCT03286218|GABA Modulators|gaba modulators|mesh-ancestor
93188922|NCT03286218|GABA Agents|gaba agents|mesh-ancestor
93188923|NCT03286218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188924|NCT03286218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188925|NCT03286218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93188926|NCT03286218|Serotonin Agents|serotonin agents|mesh-ancestor
93188927|NCT03745261|Fluticasone|fluticasone|mesh-list
93188928|NCT03745261|Xhance|xhance|mesh-list
93188929|NCT03745261|Bromides|bromides|mesh-list
93188930|NCT03745261|Albuterol|albuterol|mesh-list
93188931|NCT03745261|Tiotropium Bromide|tiotropium bromide|mesh-list
93188932|NCT03745261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93188933|NCT03745261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93188934|NCT03745261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93188935|NCT03745261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93188936|NCT03745261|Autonomic Agents|autonomic agents|mesh-ancestor
93188937|NCT03745261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188938|NCT03745261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188939|NCT03745261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93188940|NCT03745261|Respiratory System Agents|respiratory system agents|mesh-ancestor
93188941|NCT03745261|Dermatologic Agents|dermatologic agents|mesh-ancestor
93188942|NCT03745261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93188943|NCT03745261|Parasympatholytics|parasympatholytics|mesh-ancestor
93188944|NCT03745261|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93188945|NCT03745261|Cholinergic Agents|cholinergic agents|mesh-ancestor
93188946|NCT03745261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188947|NCT03745261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188948|NCT03745261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93188949|NCT03745261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93188950|NCT03745261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93188951|NCT03745261|Adrenergic Agents|adrenergic agents|mesh-ancestor
93188952|NCT03745261|Anticonvulsants|anticonvulsants|mesh-ancestor
93188953|NCT03745261|Tocolytic Agents|tocolytic agents|mesh-ancestor
93188954|NCT03745261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93188955|NCT03745261|Glucocorticoids|glucocorticoids|mesh-ancestor
93188956|NCT03745261|Hormones|hormones|mesh-ancestor
93188957|NCT03745261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93188958|NCT03745261|Sympathomimetics|sympathomimetics|mesh-ancestor
93188959|NCT03744949|Remifentanil|remifentanil|mesh-list
93188960|NCT03744949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93188961|NCT03744949|Narcotics|narcotics|mesh-ancestor
93188962|NCT03744949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93188963|NCT03744949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188964|NCT03744949|Analgesics|analgesics|mesh-ancestor
93188965|NCT03744949|Sensory System Agents|sensory system agents|mesh-ancestor
93188966|NCT03744949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93188967|NCT03870581|Warfarin|warfarin|mesh-list
93188968|NCT03870581|Anticoagulants|anticoagulants|mesh-ancestor
93188969|NCT01277315|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93188970|NCT01277315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93188971|NCT04016779|Viloxazine|viloxazine|mesh-list
93188972|NCT04016779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93188973|NCT04016779|Antidepressive Agents|antidepressive agents|mesh-ancestor
93188974|NCT04016779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93188975|NCT04016779|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93188976|NCT04016779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93188977|NCT04016779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93188978|NCT04016779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188979|NCT04016779|Adrenergic Agents|adrenergic agents|mesh-ancestor
93188980|NCT04016779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93188981|NCT04016779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188982|NCT03870503|Misoprostol|misoprostol|mesh-list
93188983|NCT03870503|Oxytocin|oxytocin|mesh-list
93188984|NCT03870503|Carbetocin|carbetocin|mesh-list
93188985|NCT03870503|Oxytocics|oxytocics|mesh-ancestor
93188986|NCT03870503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93188987|NCT03870503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93188988|NCT03870503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93188989|NCT03870503|Abortifacient Agents|abortifacient agents|mesh-ancestor
93188990|NCT03870503|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93188991|NCT03870503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93188992|NCT02857426|Nivolumab|nivolumab|mesh-list
93188993|NCT02857426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93188994|NCT02857426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93188995|NCT02857426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93188996|NCT02857426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93188997|NCT05181033|Letrozole|letrozole|mesh-list
93188999|NCT05181033|Fulvestrant|fulvestrant|mesh-list
93189000|NCT05181033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189001|NCT05181033|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93189002|NCT05181033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93189003|NCT05181033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189004|NCT05181033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189005|NCT05181033|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93189006|NCT05181033|Hormone Antagonists|hormone antagonists|mesh-ancestor
93189007|NCT05181033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189008|NCT05181033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189009|NCT05181033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93189010|NCT05181033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93189011|NCT05181033|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93189012|NCT05666765|Isotretinoin|isotretinoin|mesh-list
93189013|NCT05666765|Silymarin|silymarin|mesh-list
93189014|NCT05666765|Dermatologic Agents|dermatologic agents|mesh-ancestor
93189015|NCT05666765|Antioxidants|antioxidants|mesh-ancestor
93189016|NCT05666765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189017|NCT05666765|Protective Agents|protective agents|mesh-ancestor
93189018|NCT05666765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189019|NCT01127256|Carbamazepine|carbamazepine|mesh-list
93189020|NCT01127256|Zonisamide|zonisamide|mesh-list
93189021|NCT01127256|Anticonvulsants|anticonvulsants|mesh-ancestor
93189022|NCT01127256|Antimanic Agents|antimanic agents|mesh-ancestor
93189023|NCT01127256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93189024|NCT01127256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189025|NCT01127256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189026|NCT01127256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93189027|NCT01127256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189028|NCT01127256|Analgesics|analgesics|mesh-ancestor
93189029|NCT01127256|Sensory System Agents|sensory system agents|mesh-ancestor
93189030|NCT01127256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189031|NCT01127256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93189032|NCT01127256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189033|NCT01127256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189034|NCT01127256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93189035|NCT01127256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93189036|NCT01127256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93189037|NCT01127256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93189038|NCT03377842|Leucovorin|leucovorin|mesh-list
93189039|NCT03377842|Apatinib|apatinib|mesh-list
93189040|NCT03377842|Fluorouracil|fluorouracil|mesh-list
93189041|NCT03377842|Oxaliplatin|oxaliplatin|mesh-list
93189042|NCT03377842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189043|NCT03377842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93189044|NCT03377842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189045|NCT03377842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189046|NCT03377842|Antimetabolites|antimetabolites|mesh-ancestor
93189047|NCT03377842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189048|NCT03377842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189049|NCT03377842|Immunologic Factors|immunologic factors|mesh-ancestor
93189050|NCT03377842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189051|NCT03377842|Antidotes|antidotes|mesh-ancestor
93189052|NCT03377842|Protective Agents|protective agents|mesh-ancestor
93189053|NCT03377842|Vitamin B Complex|vitamin b complex|mesh-ancestor
93189054|NCT03377842|Vitamins|vitamins|mesh-ancestor
93189055|NCT03377842|Micronutrients|micronutrients|mesh-ancestor
93189056|NCT03668613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93189057|NCT03668613|Immunologic Factors|immunologic factors|mesh-ancestor
93189058|NCT03668613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189059|NCT01277705|Vaccines|vaccines|mesh-list
93189060|NCT01277705|Immunologic Factors|immunologic factors|mesh-ancestor
93189061|NCT01277705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189062|NCT04757337|Cyclophosphamide|cyclophosphamide|mesh-list
93189063|NCT04757337|Doxorubicin|doxorubicin|mesh-list
93189064|NCT04757337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189065|NCT04757337|Immunologic Factors|immunologic factors|mesh-ancestor
93189066|NCT04757337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189067|NCT04757337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189068|NCT04757337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93189069|NCT04757337|Alkylating Agents|alkylating agents|mesh-ancestor
93189070|NCT04757337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189071|NCT04757337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189072|NCT04757337|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93189073|NCT04757337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189074|NCT04757337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93189075|NCT04757337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93189076|NCT04757337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189077|NCT03946527|Lanreotide|lanreotide|mesh-list
93189078|NCT03946527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189079|NCT03377608|Tenofovir|tenofovir|mesh-list
93189080|NCT03377608|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93189081|NCT03377608|Medroxyprogesterone|medroxyprogesterone|mesh-list
93189082|NCT03377608|Antiviral Agents|antiviral agents|mesh-ancestor
93189083|NCT03377608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189084|NCT03377608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92484910|NCT01932203|Analgesics|analgesics|mesh-ancestor
93189085|NCT03377608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93189086|NCT03377608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189087|NCT03377608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189088|NCT03377608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93189089|NCT03377608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93189090|NCT03377608|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93189091|NCT03377608|Contraceptive Agents|contraceptive agents|mesh-ancestor
93189092|NCT03377608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93189093|NCT03377608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189094|NCT03377608|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93189095|NCT03377608|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93189096|NCT03377608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93189097|NCT03377608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189098|NCT03377608|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93189099|NCT03377608|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93189100|NCT03377608|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93189101|NCT01282073|Cyclosporine|cyclosporine|mesh-list
93189102|NCT01282073|Mycophenolic Acid|mycophenolic acid|mesh-list
93189103|NCT01282073|Cyclosporins|cyclosporins|mesh-list
93189104|NCT01282073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189105|NCT01282073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189106|NCT01282073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189107|NCT01282073|Immunologic Factors|immunologic factors|mesh-ancestor
93189108|NCT01282073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189109|NCT01282073|Antifungal Agents|antifungal agents|mesh-ancestor
93189110|NCT01282073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189111|NCT01282073|Dermatologic Agents|dermatologic agents|mesh-ancestor
93189112|NCT01282073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189113|NCT01282073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93189114|NCT01282073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189115|NCT01282073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189116|NCT01282073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93189117|NCT01282073|Antitubercular Agents|antitubercular agents|mesh-ancestor
93189118|NCT01282073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189119|NCT01166477|Ritonavir|ritonavir|mesh-list
93189120|NCT01166477|Lopinavir|lopinavir|mesh-list
93189121|NCT01166477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93189122|NCT01166477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93189123|NCT01166477|Protease Inhibitors|protease inhibitors|mesh-ancestor
93189124|NCT01166477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189125|NCT01166477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189126|NCT01166477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93189127|NCT01166477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93189128|NCT01166477|Antiviral Agents|antiviral agents|mesh-ancestor
93189129|NCT01166477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189130|NCT01166477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93189131|NCT01166477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93189132|NCT01282151|Cisplatin|cisplatin|mesh-list
93189133|NCT01282151|Pemetrexed|pemetrexed|mesh-list
93189134|NCT01282151|Docetaxel|docetaxel|mesh-list
93189135|NCT01282151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189136|NCT01282151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189137|NCT01282151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189138|NCT01282151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93189139|NCT01282151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93189140|NCT01282151|Tubulin Modulators|tubulin modulators|mesh-ancestor
93189141|NCT01282151|Antimitotic Agents|antimitotic agents|mesh-ancestor
93189142|NCT01282151|Mitosis Modulators|mitosis modulators|mesh-ancestor
93189143|NCT03377218|Iodine|iodine|mesh-list
93189144|NCT03377218|Selenium|selenium|mesh-list
93189145|NCT03377218|Cadexomer iodine|cadexomer iodine|mesh-list
93189146|NCT03377218|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93189147|NCT03377218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189148|NCT03377218|Trace Elements|trace elements|mesh-ancestor
93189150|NCT03377218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189151|NCT03377218|Antioxidants|antioxidants|mesh-ancestor
93189152|NCT03377218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189153|NCT03377218|Protective Agents|protective agents|mesh-ancestor
93189154|NCT01168505|Teferrol|teferrol|mesh-list
93189155|NCT01168505|Hematinics|hematinics|mesh-ancestor
93189156|NCT03382600|Pembrolizumab|pembrolizumab|mesh-list
93189157|NCT03382600|Oxaliplatin|oxaliplatin|mesh-list
93189158|NCT03382600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189159|NCT03382600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189160|NCT03382600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93189161|NCT03382600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189162|NCT04013191|Padsevonil|padsevonil|mesh-list
93189163|NCT04013191|Anticonvulsants|anticonvulsants|mesh-ancestor
93189164|NCT03867929|Vitamin D|vitamin d|mesh-list
93189165|NCT03867929|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93189166|NCT03867929|Calcifediol|calcifediol|mesh-list
93189167|NCT03867929|Vitamins|vitamins|mesh-ancestor
93189168|NCT03867929|Micronutrients|micronutrients|mesh-ancestor
93189169|NCT03867929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189170|NCT03867929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93189171|NCT03285594|Insulin Glargine|insulin glargine|mesh-list
93189172|NCT03285594|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93189173|NCT03285594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93189174|NCT03285594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189175|NCT03285594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93189176|NCT03285594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189177|NCT01171469|Imiquimod|imiquimod|mesh-list
93189178|NCT01171469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93189179|NCT01171469|Immunologic Factors|immunologic factors|mesh-ancestor
93189180|NCT01171469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189181|NCT01171469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189182|NCT01171469|Interferon Inducers|interferon inducers|mesh-ancestor
93189183|NCT02695992|Metoprolol|metoprolol|mesh-list
93189184|NCT02695992|Diltiazem|diltiazem|mesh-list
93189185|NCT02695992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93189186|NCT02695992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93189187|NCT02695992|Sympatholytics|sympatholytics|mesh-ancestor
93189188|NCT02695992|Autonomic Agents|autonomic agents|mesh-ancestor
93189189|NCT02695992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189190|NCT02695992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189191|NCT02695992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93189192|NCT02695992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93189193|NCT02695992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93189194|NCT02695992|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189195|NCT02695992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189196|NCT02695992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189197|NCT02695992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93189198|NCT02695992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189199|NCT02695992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93189200|NCT02695992|Vasodilator Agents|vasodilator agents|mesh-ancestor
93189201|NCT04050865|Dexamethasone|dexamethasone|mesh-list
93189202|NCT04050865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189203|NCT04050865|Antiemetics|antiemetics|mesh-ancestor
93189204|NCT04050865|Autonomic Agents|autonomic agents|mesh-ancestor
93189205|NCT04050865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189206|NCT04050865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189207|NCT04050865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189208|NCT04050865|Glucocorticoids|glucocorticoids|mesh-ancestor
93189209|NCT04050865|Hormones|hormones|mesh-ancestor
93189210|NCT04050865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189211|NCT04050865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93189212|NCT04050865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189213|NCT03283566|Hydroxychloroquine|hydroxychloroquine|mesh-list
93189214|NCT03283566|Antimalarials|antimalarials|mesh-ancestor
93189215|NCT03283566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93189216|NCT03283566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93189217|NCT03283566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189218|NCT03283566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189219|NCT03283566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189220|NCT03283566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189221|NCT01171547|Daptomycin|daptomycin|mesh-list
93189222|NCT01171547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189223|NCT01171547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189224|NCT04048681|Cocaine|cocaine|mesh-list
93189225|NCT04048681|Anesthetics, Local|anesthetics, local|mesh-ancestor
93189226|NCT04048681|Anesthetics|anesthetics|mesh-ancestor
93189227|NCT04048681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189228|NCT04048681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189229|NCT04048681|Sensory System Agents|sensory system agents|mesh-ancestor
93189230|NCT04048681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189231|NCT04048681|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93189232|NCT04048681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93189233|NCT04048681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93189234|NCT04048681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189235|NCT04048681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189236|NCT04048681|Dopamine Agents|dopamine agents|mesh-ancestor
93189237|NCT04048681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189238|NCT01282385|Simvastatin|simvastatin|mesh-list
93189239|NCT01282385|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93189240|NCT01282385|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93189241|NCT01282385|Antimetabolites|antimetabolites|mesh-ancestor
93189242|NCT01282385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189243|NCT01282385|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93189244|NCT01282385|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93189245|NCT01282385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189246|NCT01166711|Chromium|chromium|mesh-list
93189247|NCT01166711|Paclitaxel|paclitaxel|mesh-list
93189248|NCT01166711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93189249|NCT01166711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93189250|NCT01166711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189251|NCT01166711|Tubulin Modulators|tubulin modulators|mesh-ancestor
93189252|NCT01166711|Antimitotic Agents|antimitotic agents|mesh-ancestor
93189253|NCT01166711|Mitosis Modulators|mitosis modulators|mesh-ancestor
93189254|NCT01166711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189255|NCT01166711|Trace Elements|trace elements|mesh-ancestor
93189256|NCT01166711|Micronutrients|micronutrients|mesh-ancestor
93189257|NCT01166711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189258|NCT01168739|Quercetin|quercetin|mesh-list
93189259|NCT01168739|Antioxidants|antioxidants|mesh-ancestor
93189260|NCT01168739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189261|NCT01168739|Protective Agents|protective agents|mesh-ancestor
93189262|NCT01168739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189263|NCT01171781|Cisplatin|cisplatin|mesh-list
93189264|NCT01171781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189265|NCT04006171|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
93189266|NCT04006171|Natriuretic Agents|natriuretic agents|mesh-ancestor
93189267|NCT04006171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189268|NCT01171859|Doxycycline|doxycycline|mesh-list
93189269|NCT01171859|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
93189270|NCT01171859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189271|NCT01171859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189272|NCT01171859|Antimalarials|antimalarials|mesh-ancestor
93189273|NCT01171859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93189274|NCT01171859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93189275|NCT01171859|Antiviral Agents|antiviral agents|mesh-ancestor
93189276|NCT01171859|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93189277|NCT01171859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189278|NCT02652468|Mycophenolic Acid|mycophenolic acid|mesh-list
93189279|NCT02652468|Cyclophosphamide|cyclophosphamide|mesh-list
93189280|NCT02652468|Rituximab|rituximab|mesh-list
93189281|NCT02652468|Fludarabine|fludarabine|mesh-list
93189282|NCT02652468|Fludarabine phosphate|fludarabine phosphate|mesh-list
93189283|NCT02652468|Tacrolimus|tacrolimus|mesh-list
93189284|NCT02652468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189285|NCT02652468|Immunologic Factors|immunologic factors|mesh-ancestor
93189286|NCT02652468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189287|NCT02652468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189288|NCT02652468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93189289|NCT02652468|Alkylating Agents|alkylating agents|mesh-ancestor
93189290|NCT02652468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189291|NCT02652468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189292|NCT02652468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93189293|NCT02652468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189294|NCT02652468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189295|NCT02652468|Antimetabolites|antimetabolites|mesh-ancestor
93189296|NCT02652468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93189297|NCT02652468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861444|NCT00003519|Cyclophosphamide|cyclophosphamide|mesh-list
93189298|NCT02652468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189299|NCT02652468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93189300|NCT02652468|Antitubercular Agents|antitubercular agents|mesh-ancestor
93189301|NCT02652468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189302|NCT02652468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189303|NCT04673877|Vancomycin|vancomycin|mesh-list
93189304|NCT04673877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189305|NCT04673877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189306|NCT01166789|Lubiprostone|lubiprostone|mesh-list
93189307|NCT01166789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93189308|NCT01166789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189309|NCT01166789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189310|NCT01314339|Desloratadine|desloratadine|mesh-list
93189311|NCT01314339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93189312|NCT01314339|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189313|NCT01314339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189314|NCT01314339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189315|NCT01314339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189316|NCT01314339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93189317|NCT01314339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93189318|NCT01314339|Histamine Antagonists|histamine antagonists|mesh-ancestor
93189319|NCT01314339|Histamine Agents|histamine agents|mesh-ancestor
93189320|NCT01168817|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93189321|NCT01168817|Vasodilator Agents|vasodilator agents|mesh-ancestor
93189322|NCT01168817|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93189323|NCT01168817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93189324|NCT01168817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189325|NCT01168817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189326|NCT01168817|Urological Agents|urological agents|mesh-ancestor
93189327|NCT01279811|Dopamine|dopamine|mesh-list
93189328|NCT01279811|Norepinephrine|norepinephrine|mesh-list
93189329|NCT01279811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93189330|NCT01279811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93189331|NCT01279811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93189332|NCT01279811|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189333|NCT01279811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189334|NCT01279811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189335|NCT01279811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189336|NCT01279811|Sympathomimetics|sympathomimetics|mesh-ancestor
93189337|NCT01279811|Autonomic Agents|autonomic agents|mesh-ancestor
93189338|NCT01279811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189339|NCT01279811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93189340|NCT01279811|Dopamine Agents|dopamine agents|mesh-ancestor
93189341|NCT01279811|Protective Agents|protective agents|mesh-ancestor
93189342|NCT01168895|Ciprofloxacin|ciprofloxacin|mesh-list
93189343|NCT01168895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189344|NCT01168895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189345|NCT01168895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93189346|NCT01168895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93189347|NCT01168895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189348|NCT01168895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189349|NCT01168895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189350|NCT01168895|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93189351|NCT01168895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93189352|NCT03745105|Dexamethasone|dexamethasone|mesh-list
93189353|NCT03745105|Dexamethasone acetate|dexamethasone acetate|mesh-list
93189354|NCT03745105|Piroxicam|piroxicam|mesh-list
93189355|NCT03745105|Mepivacaine|mepivacaine|mesh-list
93189356|NCT03745105|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93189357|NCT03745105|BB 1101|bb 1101|mesh-list
93189358|NCT03745105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189359|NCT03745105|Antiemetics|antiemetics|mesh-ancestor
93189360|NCT03745105|Autonomic Agents|autonomic agents|mesh-ancestor
93189361|NCT03745105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189362|NCT03745105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189363|NCT03745105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189364|NCT03745105|Glucocorticoids|glucocorticoids|mesh-ancestor
93189365|NCT03745105|Hormones|hormones|mesh-ancestor
93189366|NCT03745105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189367|NCT03745105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93189368|NCT03745105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189369|NCT03745105|Anesthetics, Local|anesthetics, local|mesh-ancestor
93189370|NCT03745105|Anesthetics|anesthetics|mesh-ancestor
93189371|NCT03745105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189372|NCT03745105|Sensory System Agents|sensory system agents|mesh-ancestor
93189373|NCT03745105|Protease Inhibitors|protease inhibitors|mesh-ancestor
93189374|NCT03745105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189375|NCT03745105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189376|NCT03745105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93189377|NCT03745105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189378|NCT03745105|Analgesics|analgesics|mesh-ancestor
93189379|NCT03745105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189380|NCT03745105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93189381|NCT01282541|Botulinum Toxins|botulinum toxins|mesh-list
93189382|NCT01282541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93189383|NCT01282541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93189384|NCT01282541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93189385|NCT01282541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189386|NCT01282541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189387|NCT01282541|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189388|NCT01282541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189389|NCT01282541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189390|NCT01282541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93189391|NCT01282541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189392|NCT03744247|Lenvatinib|lenvatinib|mesh-list
93189393|NCT03744247|Antibodies|antibodies|mesh-list
93189394|NCT03744247|Immunoglobulins|immunoglobulins|mesh-list
93189395|NCT03744247|Immunologic Factors|immunologic factors|mesh-ancestor
93189396|NCT03744247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189397|NCT03744247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189398|NCT03744247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93189399|NCT03744247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189400|NCT03744247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189401|NCT01282619|Huperzine A|huperzine a|mesh-list
93189402|NCT01282619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93189403|NCT01282619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189404|NCT01282619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189405|NCT01282619|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189406|NCT01282619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189407|NCT01282619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189408|NCT01282619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93189409|NCT01282619|Protective Agents|protective agents|mesh-ancestor
93189410|NCT01282697|Sirolimus|sirolimus|mesh-list
93189411|NCT01282697|Irinotecan|irinotecan|mesh-list
93189412|NCT01282697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93189413|NCT01282697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93189414|NCT01282697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189415|NCT01282697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189416|NCT01282697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189417|NCT01282697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189418|NCT01282697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189419|NCT01282697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189420|NCT01282697|Antifungal Agents|antifungal agents|mesh-ancestor
93189421|NCT01282697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189422|NCT01282697|Immunologic Factors|immunologic factors|mesh-ancestor
93189423|NCT01282697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189424|NCT01169597|Prednisone|prednisone|mesh-list
93189425|NCT01169597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189426|NCT01169597|Glucocorticoids|glucocorticoids|mesh-ancestor
93189427|NCT01169597|Hormones|hormones|mesh-ancestor
93189428|NCT01169597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189429|NCT01169597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189430|NCT01169597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93189431|NCT01169597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189432|NCT02527798|Furosemide|furosemide|mesh-list
93189433|NCT02527798|Diuretics|diuretics|mesh-ancestor
93189434|NCT02527798|Natriuretic Agents|natriuretic agents|mesh-ancestor
93189435|NCT02527798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189436|NCT02527798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93189437|NCT02527798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189438|NCT02527798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189439|NCT05331911|Propofol|propofol|mesh-list
93189440|NCT05331911|Sevoflurane|sevoflurane|mesh-list
93189441|NCT05331911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93189442|NCT05331911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189443|NCT05331911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189444|NCT05331911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93189445|NCT05331911|Anesthetics, General|anesthetics, general|mesh-ancestor
92861603|NCT00930865|Bumetanide|bumetanide|mesh-list
93189446|NCT05331911|Anesthetics|anesthetics|mesh-ancestor
93189447|NCT05331911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93189448|NCT05331911|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93189449|NCT03857542|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93189450|NCT03857542|Pilocarpine|pilocarpine|mesh-list
93189451|NCT03857542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93189452|NCT03857542|Miotics|miotics|mesh-ancestor
93189453|NCT03857542|Autonomic Agents|autonomic agents|mesh-ancestor
93189454|NCT03857542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189455|NCT03857542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189456|NCT03857542|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93189457|NCT03857542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93189458|NCT03857542|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189459|NCT03857542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189460|NCT03857542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189461|NCT01172717|Panitumumab|panitumumab|mesh-list
93189462|NCT01172717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189463|NCT01172717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189464|NCT03209973|Tislelizumab|tislelizumab|mesh-list
93189465|NCT03209973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189466|NCT03209973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189467|NCT03751631|Phenylephrine|phenylephrine|mesh-list
93189468|NCT03751631|Oxymetazoline|oxymetazoline|mesh-list
93189469|NCT03751631|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93189470|NCT03751631|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93189471|NCT03751631|Tropicamide|tropicamide|mesh-list
93189472|NCT03751631|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93189473|NCT03751631|Mydriatics|mydriatics|mesh-ancestor
93189474|NCT03751631|Autonomic Agents|autonomic agents|mesh-ancestor
93189475|NCT03751631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189476|NCT03751631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189477|NCT03751631|Sympathomimetics|sympathomimetics|mesh-ancestor
93189478|NCT03751631|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93189479|NCT03751631|Nasal Decongestants|nasal decongestants|mesh-ancestor
93189480|NCT03751631|Respiratory System Agents|respiratory system agents|mesh-ancestor
93189481|NCT03751631|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93189482|NCT03751631|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93189483|NCT03751631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93189484|NCT03751631|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189485|NCT03751631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189486|NCT03751631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189487|NCT03751631|Protective Agents|protective agents|mesh-ancestor
93189488|NCT03751631|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93189489|NCT03751631|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93189490|NCT03751631|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189491|NCT03866681|Sirolimus|sirolimus|mesh-list
93189492|NCT03866681|Warfarin|warfarin|mesh-list
93189493|NCT03866681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189494|NCT03866681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189495|NCT03866681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189496|NCT03866681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189497|NCT03866681|Antifungal Agents|antifungal agents|mesh-ancestor
93189498|NCT03866681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189499|NCT03866681|Immunologic Factors|immunologic factors|mesh-ancestor
93189500|NCT03866681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189501|NCT03866681|Anticoagulants|anticoagulants|mesh-ancestor
93189502|NCT03736369|Esomeprazole|esomeprazole|mesh-list
93189503|NCT03736369|Fexuprazan|fexuprazan|mesh-list
93189504|NCT03736369|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93189505|NCT03736369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189506|NCT03736369|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93189507|NCT03736369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189508|NCT03736369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189509|NCT03867695|Ropivacaine|ropivacaine|mesh-list
93189510|NCT03867695|Anesthetics, Local|anesthetics, local|mesh-ancestor
93189511|NCT03867695|Anesthetics|anesthetics|mesh-ancestor
93189512|NCT03867695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189513|NCT03867695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189514|NCT03867695|Sensory System Agents|sensory system agents|mesh-ancestor
93189515|NCT03867695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189516|NCT01172171|Melatonin|melatonin|mesh-list
93189517|NCT01172171|Antioxidants|antioxidants|mesh-ancestor
93189518|NCT01172171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189519|NCT01172171|Protective Agents|protective agents|mesh-ancestor
93189520|NCT01172171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189521|NCT01172171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189522|NCT03655717|Ethanol|ethanol|mesh-list
93189523|NCT03655717|Dronabinol|dronabinol|mesh-list
93189524|NCT03655717|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93189525|NCT03655717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189526|NCT03655717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189527|NCT03655717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189528|NCT03655717|Hallucinogens|hallucinogens|mesh-ancestor
93189529|NCT03655717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93189530|NCT03655717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189531|NCT03655717|Analgesics|analgesics|mesh-ancestor
93189532|NCT03655717|Sensory System Agents|sensory system agents|mesh-ancestor
93189533|NCT03655717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189534|NCT03655717|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93189535|NCT03655717|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93189536|NCT03655717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189537|NCT03655717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189538|NCT03655717|Hormones|hormones|mesh-ancestor
93189539|NCT03655717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189540|NCT03222531|Sofosbuvir|sofosbuvir|mesh-list
93189541|NCT03222531|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93189542|NCT03222531|Velpatasvir|velpatasvir|mesh-list
93189543|NCT03222531|Antiviral Agents|antiviral agents|mesh-ancestor
93189544|NCT03222531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189545|NCT03867071|Epoetin Alfa|epoetin alfa|mesh-list
93189546|NCT03867071|Hematinics|hematinics|mesh-ancestor
93189547|NCT01284413|Cisplatin|cisplatin|mesh-list
93189548|NCT01284413|Gemcitabine|gemcitabine|mesh-list
93189549|NCT01284413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189550|NCT01284413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189551|NCT01284413|Antimetabolites|antimetabolites|mesh-ancestor
93189552|NCT01284413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189553|NCT05152017|Vaccines|vaccines|mesh-list
93189554|NCT05152017|Immunologic Factors|immunologic factors|mesh-ancestor
93189555|NCT05152017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189556|NCT03866993|Paclitaxel|paclitaxel|mesh-list
93189557|NCT03866993|Carboplatin|carboplatin|mesh-list
93189558|NCT03866993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93189559|NCT03866993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189560|NCT03866993|Tubulin Modulators|tubulin modulators|mesh-ancestor
93189561|NCT03866993|Antimitotic Agents|antimitotic agents|mesh-ancestor
93189562|NCT03866993|Mitosis Modulators|mitosis modulators|mesh-ancestor
93189563|NCT03866993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189564|NCT05142735|Acetylcysteine|acetylcysteine|mesh-list
93189565|NCT05142735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93189566|NCT05142735|Antiviral Agents|antiviral agents|mesh-ancestor
93189567|NCT05142735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189568|NCT05142735|Expectorants|expectorants|mesh-ancestor
93189569|NCT05142735|Respiratory System Agents|respiratory system agents|mesh-ancestor
93189570|NCT05142735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93189571|NCT05142735|Antioxidants|antioxidants|mesh-ancestor
93189572|NCT05142735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189573|NCT05142735|Protective Agents|protective agents|mesh-ancestor
93189574|NCT05142735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189575|NCT05142735|Antidotes|antidotes|mesh-ancestor
93189576|NCT01172405|Ibuprofen|ibuprofen|mesh-list
93189577|NCT01172405|Caffeine|caffeine|mesh-list
93189578|NCT01172405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93189579|NCT01172405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189580|NCT01172405|Analgesics|analgesics|mesh-ancestor
93189581|NCT01172405|Sensory System Agents|sensory system agents|mesh-ancestor
93189582|NCT01172405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189583|NCT01172405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189584|NCT01172405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189585|NCT01172405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189586|NCT01172405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93189587|NCT01172405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189588|NCT01172405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189589|NCT01172405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93189590|NCT01172405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93189591|NCT01172405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93189592|NCT01172405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93189593|NCT01172405|Purinergic Agents|purinergic agents|mesh-ancestor
93189594|NCT01172405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189595|NCT04000165|Mitapivat|mitapivat|mesh-list
93189596|NCT04000165|Enzyme Activators|enzyme activators|mesh-ancestor
92861752|NCT04004078|Miconazole|miconazole|mesh-list
93189597|NCT04000165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189598|NCT03375424|Vedolizumab|vedolizumab|mesh-list
93189599|NCT03375424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189600|NCT03187197|Dabigatran|dabigatran|mesh-list
93189601|NCT03187197|Antithrombins|antithrombins|mesh-ancestor
93189602|NCT03187197|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93189603|NCT03187197|Protease Inhibitors|protease inhibitors|mesh-ancestor
93189604|NCT03187197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189605|NCT03187197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189606|NCT03187197|Anticoagulants|anticoagulants|mesh-ancestor
93189607|NCT01284647|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
93189608|NCT01284647|Sucralfate|sucralfate|mesh-list
93189609|NCT01284647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93189610|NCT01284647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189611|NCT01284647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189612|NCT04000009|Pimavanserin|pimavanserin|mesh-list
93189613|NCT04000009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93189614|NCT04000009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93189615|NCT04000009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93189616|NCT04000009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93189617|NCT04000009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189618|NCT04000009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189619|NCT04000009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93189620|NCT04000009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93189621|NCT04000009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93189622|NCT04000009|Serotonin Agents|serotonin agents|mesh-ancestor
93189623|NCT04000009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189624|NCT04000009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189625|NCT03282240|Vaccines|vaccines|mesh-list
93189626|NCT03282240|Immunologic Factors|immunologic factors|mesh-ancestor
93189627|NCT03282240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189628|NCT01284725|Mycophenolic Acid|mycophenolic acid|mesh-list
93189629|NCT01284725|Azathioprine|azathioprine|mesh-list
93189630|NCT01284725|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93189631|NCT01284725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189632|NCT01284725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189633|NCT01284725|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93189634|NCT01284725|Antitubercular Agents|antitubercular agents|mesh-ancestor
93189635|NCT01284725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189636|NCT01284725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189637|NCT01284725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189638|NCT01284725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189639|NCT01284725|Antimetabolites|antimetabolites|mesh-ancestor
93189640|NCT01284725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189641|NCT01284725|Immunologic Factors|immunologic factors|mesh-ancestor
93189642|NCT01284725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189643|NCT01284725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189644|NCT03510598|Deoxycholic Acid|deoxycholic acid|mesh-list
93189645|NCT03510598|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93189646|NCT03510598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93189647|NCT01173107|Colchicine|colchicine|mesh-list
93189648|NCT01173107|Gout Suppressants|gout suppressants|mesh-ancestor
93189649|NCT01173107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189650|NCT01173107|Tubulin Modulators|tubulin modulators|mesh-ancestor
93189651|NCT01173107|Antimitotic Agents|antimitotic agents|mesh-ancestor
93189652|NCT01173107|Mitosis Modulators|mitosis modulators|mesh-ancestor
93189653|NCT01173107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189654|NCT01173107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189655|NCT03744091|Dronabinol|dronabinol|mesh-list
93189656|NCT03744091|Hallucinogens|hallucinogens|mesh-ancestor
93189657|NCT03744091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189658|NCT03744091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93189659|NCT03744091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189660|NCT03744091|Analgesics|analgesics|mesh-ancestor
93189661|NCT03744091|Sensory System Agents|sensory system agents|mesh-ancestor
93189662|NCT03744091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189663|NCT03744091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93189664|NCT03744091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93189665|NCT03744091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189666|NCT03744091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189667|NCT03744091|Hormones|hormones|mesh-ancestor
93189668|NCT03744091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189669|NCT03376594|Loratadine|loratadine|mesh-list
93189670|NCT03376594|Antipruritics|antipruritics|mesh-ancestor
93189671|NCT03376594|Dermatologic Agents|dermatologic agents|mesh-ancestor
93189672|NCT03376594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93189673|NCT03376594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92855476|NCT02824094|Crizotinib|crizotinib|mesh-list
93189674|NCT03376594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93189675|NCT03376594|Histamine Antagonists|histamine antagonists|mesh-ancestor
93189676|NCT03376594|Histamine Agents|histamine agents|mesh-ancestor
93189677|NCT03376594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189678|NCT03376594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189679|NCT03376594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189680|NCT03381664|Quinidine|quinidine|mesh-list
93189681|NCT03381664|Dextromethorphan|dextromethorphan|mesh-list
93189682|NCT03381664|Antitussive Agents|antitussive agents|mesh-ancestor
93189683|NCT03381664|Respiratory System Agents|respiratory system agents|mesh-ancestor
93189684|NCT03381664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93189685|NCT03381664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93189686|NCT03381664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189687|NCT03381664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189688|NCT03381664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189689|NCT03381664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93189690|NCT03381664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93189691|NCT03381664|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189692|NCT03381664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93189693|NCT03381664|Antimalarials|antimalarials|mesh-ancestor
93189694|NCT03381664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93189695|NCT03381664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93189696|NCT03381664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189697|NCT03381664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189698|NCT03381664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93189699|NCT03381664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93189700|NCT03381664|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189701|NCT03381664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93189702|NCT03381664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93189703|NCT03381664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93189704|NCT03381664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93189705|NCT03381664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93189706|NCT04060758|Latanoprost|latanoprost|mesh-list
93189707|NCT04060758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93189708|NCT04060758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93189709|NCT03376438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93189710|NCT03863405|Metformin|metformin|mesh-list
93189711|NCT03863405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93189712|NCT03863405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189713|NCT03866369|Moxifloxacin|moxifloxacin|mesh-list
93189714|NCT03866369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189715|NCT03866369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189716|NCT03866369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93189717|NCT03866369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93189718|NCT03866369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189719|NCT03866369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189720|NCT03866369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189721|NCT04024891|Phentolamine|phentolamine|mesh-list
93189722|NCT04024891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93189723|NCT04024891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93189724|NCT04024891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93189725|NCT04024891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93189726|NCT04024891|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189727|NCT04024891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189728|NCT04024891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189729|NCT04024891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189730|NCT04024891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93189731|NCT01178021|Chloroquine|chloroquine|mesh-list
93189732|NCT01178021|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93189733|NCT01178021|Primaquine|primaquine|mesh-list
93189734|NCT01178021|Amebicides|amebicides|mesh-ancestor
93189735|NCT01178021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93189736|NCT01178021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93189737|NCT01178021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189738|NCT01178021|Antimalarials|antimalarials|mesh-ancestor
93189739|NCT01178021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189740|NCT01178021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93189741|NCT01178021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189742|NCT01178021|Analgesics|analgesics|mesh-ancestor
93189743|NCT01178021|Sensory System Agents|sensory system agents|mesh-ancestor
93189744|NCT01178021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189745|NCT01178021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189746|NCT01178021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189747|NCT01178021|Filaricides|filaricides|mesh-ancestor
93189748|NCT01178021|Antinematodal Agents|antinematodal agents|mesh-ancestor
93189749|NCT01178021|Anthelmintics|anthelmintics|mesh-ancestor
93189750|NCT03250182|Budesonide|budesonide|mesh-list
93189751|NCT03250182|Glycopyrrolate|glycopyrrolate|mesh-list
93189752|NCT03250182|Formoterol Fumarate|formoterol fumarate|mesh-list
93189753|NCT03250182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189754|NCT03250182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93189755|NCT03250182|Autonomic Agents|autonomic agents|mesh-ancestor
93189756|NCT03250182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189757|NCT03250182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189758|NCT03250182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93189759|NCT03250182|Respiratory System Agents|respiratory system agents|mesh-ancestor
93189760|NCT03250182|Glucocorticoids|glucocorticoids|mesh-ancestor
93189761|NCT03250182|Hormones|hormones|mesh-ancestor
93189762|NCT03250182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93189763|NCT03250182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93189764|NCT03250182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93189765|NCT03250182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93189766|NCT03250182|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189767|NCT03250182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189768|NCT03250182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189769|NCT03250182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93189770|NCT03250182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93189771|NCT03250182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93189772|NCT03250182|Cholinergic Agents|cholinergic agents|mesh-ancestor
93189773|NCT01173263|Propofol|propofol|mesh-list
93189774|NCT01173263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93189775|NCT01173263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189776|NCT01173263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189777|NCT01173263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93189778|NCT01173263|Anesthetics, General|anesthetics, general|mesh-ancestor
93189779|NCT01173263|Anesthetics|anesthetics|mesh-ancestor
93189780|NCT03381430|Gefitinib|gefitinib|mesh-list
93189781|NCT03381430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189782|NCT03381430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93189783|NCT03381430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189784|NCT03381430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189785|NCT01288157|Golimumab|golimumab|mesh-list
93189786|NCT01288157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93189787|NCT01288157|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93189788|NCT01288157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189789|NCT01288157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189790|NCT01288157|Immunologic Factors|immunologic factors|mesh-ancestor
93189791|NCT01288157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189792|NCT03993379|Ipilimumab|ipilimumab|mesh-list
93189793|NCT03993379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189794|NCT03993379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189795|NCT03993379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93189796|NCT03993379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189797|NCT03866447|Vitamin D|vitamin d|mesh-list
93189798|NCT03866447|Adapalene|adapalene|mesh-list
93189799|NCT03866447|Vitamins|vitamins|mesh-ancestor
93189800|NCT03866447|Micronutrients|micronutrients|mesh-ancestor
93189801|NCT03866447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189802|NCT03866447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93189803|NCT03866447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93189804|NCT03866447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189805|NCT03866447|Analgesics|analgesics|mesh-ancestor
93189806|NCT03866447|Sensory System Agents|sensory system agents|mesh-ancestor
93189807|NCT03866447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189808|NCT03866447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189809|NCT03866447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93189810|NCT03866447|Dermatologic Agents|dermatologic agents|mesh-ancestor
93189811|NCT03370120|Padsevonil|padsevonil|mesh-list
93189812|NCT03370120|Anticonvulsants|anticonvulsants|mesh-ancestor
93189813|NCT01175291|Leucovorin|leucovorin|mesh-list
93189814|NCT01175291|Bevacizumab|bevacizumab|mesh-list
93189815|NCT01175291|Fluorouracil|fluorouracil|mesh-list
93189816|NCT01175291|Oxaliplatin|oxaliplatin|mesh-list
93189817|NCT01175291|Levoleucovorin|levoleucovorin|mesh-list
93189818|NCT01175291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189819|NCT01175291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189820|NCT01175291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93189821|NCT01175291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93189822|NCT01175291|Growth Substances|growth substances|mesh-ancestor
93189823|NCT01175291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189824|NCT01175291|Growth Inhibitors|growth inhibitors|mesh-ancestor
93189825|NCT01175291|Antimetabolites|antimetabolites|mesh-ancestor
93189826|NCT01175291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189827|NCT01175291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189828|NCT01175291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189829|NCT01175291|Immunologic Factors|immunologic factors|mesh-ancestor
93189831|NCT01175291|Protective Agents|protective agents|mesh-ancestor
93189832|NCT01175291|Vitamin B Complex|vitamin b complex|mesh-ancestor
93189833|NCT01175291|Vitamins|vitamins|mesh-ancestor
93189834|NCT01175291|Micronutrients|micronutrients|mesh-ancestor
93189835|NCT03230266|Insulin|insulin|mesh-list
93189836|NCT03230266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93189837|NCT03230266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189838|NCT03732469|Acetaminophen|acetaminophen|mesh-list
93189839|NCT03732469|Fentanyl|fentanyl|mesh-list
93189840|NCT03732469|Propofol|propofol|mesh-list
93189841|NCT03732469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93189842|NCT03732469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189843|NCT03732469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189844|NCT03732469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93189845|NCT03732469|Anesthetics, General|anesthetics, general|mesh-ancestor
93189846|NCT03732469|Anesthetics|anesthetics|mesh-ancestor
93189847|NCT03732469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93189848|NCT03732469|Narcotics|narcotics|mesh-ancestor
93189849|NCT03732469|Analgesics|analgesics|mesh-ancestor
93189850|NCT03732469|Sensory System Agents|sensory system agents|mesh-ancestor
93189851|NCT03732469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189852|NCT03732469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93189853|NCT03732469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93189854|NCT03732469|Antipyretics|antipyretics|mesh-ancestor
93189855|NCT03381352|Capecitabine|capecitabine|mesh-list
93189856|NCT03381352|Mitomycins|mitomycins|mesh-list
93189857|NCT03381352|Mitomycin|mitomycin|mesh-list
93189858|NCT03381352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189859|NCT03381352|Antimetabolites|antimetabolites|mesh-ancestor
93189860|NCT03381352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189861|NCT03381352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189862|NCT03381352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189863|NCT03381352|Alkylating Agents|alkylating agents|mesh-ancestor
93189864|NCT03381352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93189865|NCT03381352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189866|NCT01175525|Cromolyn Sodium|cromolyn sodium|mesh-list
93189867|NCT01175525|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
93189868|NCT01175525|Immunologic Factors|immunologic factors|mesh-ancestor
93189869|NCT01175525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189870|NCT01175525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93189871|NCT01175525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189872|NCT01175525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93189873|NCT01175525|Respiratory System Agents|respiratory system agents|mesh-ancestor
93189874|NCT03863249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93189875|NCT03863249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189876|NCT03381118|Cytarabine|cytarabine|mesh-list
93189877|NCT03381118|Nivolumab|nivolumab|mesh-list
93189878|NCT03381118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189879|NCT03381118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189880|NCT03381118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93189881|NCT03381118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189882|NCT03381118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189883|NCT03381118|Antimetabolites|antimetabolites|mesh-ancestor
93189884|NCT03381118|Antiviral Agents|antiviral agents|mesh-ancestor
93189885|NCT03381118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189886|NCT03381118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93189887|NCT03381118|Immunologic Factors|immunologic factors|mesh-ancestor
93189888|NCT03381118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189889|NCT03375112|Bupivacaine|bupivacaine|mesh-list
93189890|NCT03375112|Anesthetics, Local|anesthetics, local|mesh-ancestor
93189891|NCT03375112|Anesthetics|anesthetics|mesh-ancestor
93189892|NCT03375112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189893|NCT03375112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189894|NCT03375112|Sensory System Agents|sensory system agents|mesh-ancestor
93189895|NCT03375112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189896|NCT02954575|Factor VIII|factor viii|mesh-list
93189897|NCT02954575|Coagulants|coagulants|mesh-ancestor
93189898|NCT02997358|Doxorubicin|doxorubicin|mesh-list
93189899|NCT02997358|Trabectedin|trabectedin|mesh-list
93189900|NCT02997358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189901|NCT02997358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862049|NCT05504876|Midazolam|midazolam|mesh-list
93189902|NCT02997358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93189903|NCT02997358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93189904|NCT02997358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189905|NCT02997358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189906|NCT02997358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93189907|NCT02997358|Alkylating Agents|alkylating agents|mesh-ancestor
93189908|NCT03375034|Clonazepam|clonazepam|mesh-list
93189909|NCT03375034|Anticonvulsants|anticonvulsants|mesh-ancestor
93189910|NCT03375034|GABA Modulators|gaba modulators|mesh-ancestor
93189911|NCT03375034|GABA Agents|gaba agents|mesh-ancestor
93189912|NCT03375034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189913|NCT03375034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189914|NCT03375034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189915|NCT03381040|Hyaluronic Acid|hyaluronic acid|mesh-list
93189916|NCT03381040|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93189917|NCT03381040|Immunologic Factors|immunologic factors|mesh-ancestor
93189918|NCT03381040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189919|NCT03381040|Viscosupplements|viscosupplements|mesh-ancestor
93189920|NCT03381040|Protective Agents|protective agents|mesh-ancestor
93189921|NCT03376048|Ropivacaine|ropivacaine|mesh-list
93189922|NCT03376048|Anesthetics, Local|anesthetics, local|mesh-ancestor
93189923|NCT03376048|Anesthetics|anesthetics|mesh-ancestor
93189924|NCT03376048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189925|NCT03376048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189926|NCT03376048|Sensory System Agents|sensory system agents|mesh-ancestor
93189927|NCT03376048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189928|NCT03374878|Contraceptive Agents|contraceptive agents|mesh-list
93189929|NCT03374878|Contraceptives, Oral|contraceptives, oral|mesh-list
93189930|NCT03374878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93189931|NCT03374878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189932|NCT03374878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93189933|NCT01285037|Gemcitabine|gemcitabine|mesh-list
93189934|NCT01285037|Cetuximab|cetuximab|mesh-list
93189935|NCT01285037|Ramucirumab|ramucirumab|mesh-list
93189936|NCT01285037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189937|NCT01285037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93189938|NCT01285037|Antimetabolites|antimetabolites|mesh-ancestor
93189939|NCT01285037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189940|NCT01285037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189941|NCT03732391|Carboplatin|carboplatin|mesh-list
93189942|NCT03732391|Pembrolizumab|pembrolizumab|mesh-list
93189943|NCT03732391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93189944|NCT03732391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93189945|NCT03732391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93189946|NCT03732391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189947|NCT03374722|Analgesics, Opioid|analgesics, opioid|mesh-list
93189948|NCT03374722|Narcotics|narcotics|mesh-ancestor
93189949|NCT03374722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189950|NCT03374722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189951|NCT03374722|Analgesics|analgesics|mesh-ancestor
93189952|NCT03374722|Sensory System Agents|sensory system agents|mesh-ancestor
93189953|NCT03374722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189954|NCT03207243|Fluticasone|fluticasone|mesh-list
93189955|NCT03207243|Xhance|xhance|mesh-list
93189956|NCT03207243|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93189957|NCT03207243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93189958|NCT03207243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93189959|NCT03207243|Autonomic Agents|autonomic agents|mesh-ancestor
93189960|NCT03207243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93189961|NCT03207243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189962|NCT03207243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93189963|NCT03207243|Respiratory System Agents|respiratory system agents|mesh-ancestor
93189964|NCT03207243|Dermatologic Agents|dermatologic agents|mesh-ancestor
93189965|NCT03207243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93189966|NCT03207243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93189967|NCT03207243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93189968|NCT03207243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93189969|NCT03207243|Adrenergic Agents|adrenergic agents|mesh-ancestor
93189970|NCT03207243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93189971|NCT03207243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189972|NCT01285271|Sevoflurane|sevoflurane|mesh-list
93189973|NCT01285271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93189974|NCT01285271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93189975|NCT01285271|Anesthetics, General|anesthetics, general|mesh-ancestor
93189976|NCT01285271|Anesthetics|anesthetics|mesh-ancestor
93189977|NCT01285271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93189978|NCT01285271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189980|NCT03982069|Immunologic Factors|immunologic factors|mesh-ancestor
93189981|NCT03982069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189982|NCT03219723|Amoxicillin|amoxicillin|mesh-list
93189983|NCT03219723|Metronidazole|metronidazole|mesh-list
93189984|NCT03219723|Clarithromycin|clarithromycin|mesh-list
93189985|NCT03219723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93189986|NCT03219723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93189987|NCT03219723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93189988|NCT03219723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93189989|NCT03219723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93189990|NCT03219723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93189991|NCT03219723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93189992|NCT03219723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93189993|NCT03219723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93189994|NCT03628417|Bleomycin|bleomycin|mesh-list
93189995|NCT03628417|Calcium|calcium|mesh-list
93189996|NCT03628417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93189997|NCT03628417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93189998|NCT03628417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93189999|NCT03628417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190000|NCT03369964|Atezolizumab|atezolizumab|mesh-list
93190001|NCT03369964|Obinutuzumab|obinutuzumab|mesh-list
93190002|NCT03369964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190003|NCT03369964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190004|NCT03369964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190005|NCT03369964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190006|NCT03245736|Tisotumab vedotin|tisotumab vedotin|mesh-list
93190007|NCT03245736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190008|NCT03245736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190009|NCT01173809|Amiodarone|amiodarone|mesh-list
93190010|NCT01173809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93190011|NCT01173809|Vasodilator Agents|vasodilator agents|mesh-ancestor
93190012|NCT01173809|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93190013|NCT01173809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190014|NCT01173809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190015|NCT01173809|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93190016|NCT01173809|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93190017|NCT01173809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93190018|NCT01173809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190019|NCT01173809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93190020|NCT01173809|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93190021|NCT01173809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93190022|NCT03375580|Metformin|metformin|mesh-list
93190023|NCT03375580|Simvastatin|simvastatin|mesh-list
93190024|NCT03375580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93190025|NCT03375580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190026|NCT03375580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93190027|NCT03375580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93190028|NCT03375580|Antimetabolites|antimetabolites|mesh-ancestor
93190029|NCT03375580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190030|NCT03375580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93190031|NCT03375580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93190032|NCT03375580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190033|NCT03340896|Docetaxel|docetaxel|mesh-list
93190034|NCT03340896|Fluorouracil|fluorouracil|mesh-list
93190035|NCT03340896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190036|NCT03340896|Tubulin Modulators|tubulin modulators|mesh-ancestor
93190037|NCT03340896|Antimitotic Agents|antimitotic agents|mesh-ancestor
93190038|NCT03340896|Mitosis Modulators|mitosis modulators|mesh-ancestor
93190039|NCT03340896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190040|NCT03340896|Antimetabolites|antimetabolites|mesh-ancestor
93190041|NCT03340896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93190042|NCT03340896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190043|NCT03340896|Immunologic Factors|immunologic factors|mesh-ancestor
93190044|NCT03340896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190045|NCT03282981|Timolol|timolol|mesh-list
93190046|NCT03282981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93190047|NCT03282981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93190048|NCT03282981|Adrenergic Agents|adrenergic agents|mesh-ancestor
93190049|NCT03282981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190050|NCT03282981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190051|NCT03282981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190052|NCT03282981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93190053|NCT03282981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93190054|NCT01286909|Lycopene|lycopene|mesh-list
93190055|NCT01286909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190056|NCT01286909|Antioxidants|antioxidants|mesh-ancestor
93190057|NCT01286909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190058|NCT01286909|Protective Agents|protective agents|mesh-ancestor
93190059|NCT01286909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190060|NCT01286909|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93190061|NCT01286909|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93190062|NCT01286909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190063|NCT02954887|Cannabidiol|cannabidiol|mesh-list
93190064|NCT02954887|Anticonvulsants|anticonvulsants|mesh-ancestor
93190065|NCT03860129|Sevoflurane|sevoflurane|mesh-list
93190066|NCT03860129|Desflurane|desflurane|mesh-list
93190067|NCT03860129|Isoflurane|isoflurane|mesh-list
93190068|NCT03860129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93190069|NCT03860129|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93190070|NCT03860129|Anesthetics, General|anesthetics, general|mesh-ancestor
93190071|NCT03860129|Anesthetics|anesthetics|mesh-ancestor
93190072|NCT03860129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190073|NCT03860129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190074|NCT03369808|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93190075|NCT03369808|Vaccines|vaccines|mesh-list
93190076|NCT03369808|Immunologic Factors|immunologic factors|mesh-ancestor
93190077|NCT03369808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190078|NCT03369808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93190079|NCT03369808|Antacids|antacids|mesh-ancestor
93190080|NCT03369808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190081|NCT03369808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190082|NCT02525237|Apatinib|apatinib|mesh-list
93190083|NCT02525237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190084|NCT02525237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190085|NCT02525237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190086|NCT02525237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190087|NCT01173887|Mogamulizumab|mogamulizumab|mesh-list
93190088|NCT01173887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190089|NCT03369574|Reslizumab|reslizumab|mesh-list
93190090|NCT03369574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93190091|NCT03369574|Respiratory System Agents|respiratory system agents|mesh-ancestor
93190092|NCT03278028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93190093|NCT02651740|Rifaximin|rifaximin|mesh-list
93190094|NCT02651740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93190095|NCT02651740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190096|NCT02651740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190097|NCT03862391|Analgesics|analgesics|mesh-list
93190098|NCT03862391|Antiemetics|antiemetics|mesh-list
93190099|NCT03862391|Sensory System Agents|sensory system agents|mesh-ancestor
93190100|NCT03862391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190101|NCT03862391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190102|NCT03862391|Autonomic Agents|autonomic agents|mesh-ancestor
93190103|NCT03862391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190104|NCT03859583|Capsaicin|capsaicin|mesh-list
93190105|NCT03859583|Antipruritics|antipruritics|mesh-ancestor
93190106|NCT03859583|Dermatologic Agents|dermatologic agents|mesh-ancestor
93190107|NCT03859583|Sensory System Agents|sensory system agents|mesh-ancestor
93190108|NCT03859583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928475|NCT02403687|Baclofen|baclofen|mesh-list
93190109|NCT03859583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190110|NCT03369262|Atosiban|atosiban|mesh-list
93190111|NCT03369262|Hormone Antagonists|hormone antagonists|mesh-ancestor
93190112|NCT03369262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190113|NCT03369262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190114|NCT03369262|Tocolytic Agents|tocolytic agents|mesh-ancestor
93190115|NCT03369262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93190116|NCT03276078|Bromides|bromides|mesh-list
93190117|NCT03276078|Formoterol Fumarate|formoterol fumarate|mesh-list
93190118|NCT03276078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93190119|NCT03276078|Autonomic Agents|autonomic agents|mesh-ancestor
93190120|NCT03276078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190121|NCT03276078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190122|NCT03276078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93190123|NCT03276078|Respiratory System Agents|respiratory system agents|mesh-ancestor
93190124|NCT03276078|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93190125|NCT03276078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93190126|NCT03276078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862266|NCT02719392|Antidotes|antidotes|mesh-ancestor
93190127|NCT03276078|Adrenergic Agents|adrenergic agents|mesh-ancestor
93190128|NCT03276078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190129|NCT03276078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190130|NCT03276078|Anticonvulsants|anticonvulsants|mesh-ancestor
93190131|NCT01288547|Theobromine|theobromine|mesh-list
93190132|NCT01288547|Caffeine|caffeine|mesh-list
93190133|NCT01288547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93190134|NCT01288547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190135|NCT01288547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93190136|NCT01288547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190137|NCT01288547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190138|NCT01288547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93190139|NCT01288547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93190140|NCT01288547|Purinergic Agents|purinergic agents|mesh-ancestor
93190141|NCT01288547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190142|NCT01288547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93190143|NCT01288547|Autonomic Agents|autonomic agents|mesh-ancestor
93190144|NCT01288547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190145|NCT01288547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93190146|NCT01288547|Respiratory System Agents|respiratory system agents|mesh-ancestor
93190147|NCT01288547|Vasodilator Agents|vasodilator agents|mesh-ancestor
93190148|NCT03373864|Anesthetics|anesthetics|mesh-list
93190149|NCT03373864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190150|NCT03373864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190151|NCT04597320|Fentanyl|fentanyl|mesh-list
93190152|NCT04597320|Midazolam|midazolam|mesh-list
93190153|NCT04597320|Esketamine|esketamine|mesh-list
93190154|NCT04597320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93190155|NCT04597320|Narcotics|narcotics|mesh-ancestor
93190156|NCT04597320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190157|NCT04597320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190158|NCT04597320|Analgesics|analgesics|mesh-ancestor
93190159|NCT04597320|Sensory System Agents|sensory system agents|mesh-ancestor
93190160|NCT04597320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190161|NCT04597320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93190162|NCT04597320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93190163|NCT04597320|Anesthetics, General|anesthetics, general|mesh-ancestor
93190164|NCT04597320|Anesthetics|anesthetics|mesh-ancestor
93190165|NCT04597320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93190166|NCT04597320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93190167|NCT04597320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93190168|NCT04597320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190169|NCT04597320|GABA Modulators|gaba modulators|mesh-ancestor
93190170|NCT04597320|GABA Agents|gaba agents|mesh-ancestor
93190171|NCT04597320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190172|NCT04597320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190173|NCT04597320|Antidepressive Agents|antidepressive agents|mesh-ancestor
93190174|NCT03373708|Tamoxifen|tamoxifen|mesh-list
93190175|NCT03373708|Cyclophosphamide|cyclophosphamide|mesh-list
93190176|NCT03373708|Docetaxel|docetaxel|mesh-list
93190177|NCT03373708|Letrozole|letrozole|mesh-list
93190178|NCT03373708|Epirubicin|epirubicin|mesh-list
93190179|NCT03373708|Goserelin|goserelin|mesh-list
93190180|NCT03373708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190181|NCT03373708|Immunologic Factors|immunologic factors|mesh-ancestor
93190182|NCT03373708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190183|NCT03373708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486013|NCT01938729|Hormones|hormones|mesh-ancestor
93190184|NCT03373708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93190185|NCT03373708|Alkylating Agents|alkylating agents|mesh-ancestor
93190186|NCT03373708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190187|NCT03373708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190188|NCT03373708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93190189|NCT03373708|Tubulin Modulators|tubulin modulators|mesh-ancestor
93190190|NCT03373708|Antimitotic Agents|antimitotic agents|mesh-ancestor
93190191|NCT03373708|Mitosis Modulators|mitosis modulators|mesh-ancestor
93190192|NCT03373708|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93190193|NCT03373708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93190194|NCT03373708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190195|NCT03373708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93190196|NCT03373708|Hormone Antagonists|hormone antagonists|mesh-ancestor
93190197|NCT03373708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190198|NCT03373708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93190199|NCT03373708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93190200|NCT03373708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93190201|NCT03373708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93190202|NCT03373708|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93190203|NCT03373708|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93190204|NCT03373708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93190205|NCT03123952|ABT-414|abt-414|mesh-list
93190206|NCT03123952|Immunoconjugates|immunoconjugates|mesh-ancestor
93190207|NCT03123952|Immunologic Factors|immunologic factors|mesh-ancestor
93190208|NCT03123952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190209|NCT02519608|Aspirin|aspirin|mesh-list
93190210|NCT02519608|Clopidogrel|clopidogrel|mesh-list
93190211|NCT02519608|Ticagrelor|ticagrelor|mesh-list
93190212|NCT02519608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93190213|NCT02519608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190214|NCT02519608|Analgesics|analgesics|mesh-ancestor
93190215|NCT02519608|Sensory System Agents|sensory system agents|mesh-ancestor
93190216|NCT02519608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190217|NCT02519608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190218|NCT02519608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190219|NCT02519608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190220|NCT02519608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93190221|NCT02519608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93190222|NCT02519608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190223|NCT02519608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93190224|NCT02519608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93190225|NCT02519608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190226|NCT02519608|Antipyretics|antipyretics|mesh-ancestor
93190227|NCT02519608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93190228|NCT02519608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93190229|NCT02519608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93190230|NCT02519608|Purinergic Agents|purinergic agents|mesh-ancestor
93190231|NCT02519608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190232|NCT05181852|Pregabalin|pregabalin|mesh-list
93190233|NCT05181852|Analgesics|analgesics|mesh-ancestor
93190234|NCT05181852|Sensory System Agents|sensory system agents|mesh-ancestor
93190235|NCT05181852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190236|NCT05181852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190237|NCT05181852|Anticonvulsants|anticonvulsants|mesh-ancestor
93190238|NCT05181852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93190239|NCT05181852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190240|NCT05181852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190241|NCT05181852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93190242|NCT05181852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93190243|NCT05181852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93190244|NCT05181852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190245|NCT05181852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190246|NCT04584684|Ethanol|ethanol|mesh-list
93190247|NCT04584684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93190248|NCT04584684|Cetylpyridinium|cetylpyridinium|mesh-list
93190249|NCT04584684|Povidone|povidone|mesh-list
93190250|NCT04584684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93190251|NCT04584684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190252|NCT04584684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190253|NCT04584684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190254|NCT04584684|Plasma Substitutes|plasma substitutes|mesh-ancestor
93190255|NCT04584684|Blood Substitutes|blood substitutes|mesh-ancestor
93190256|NCT03748823|Ravulizumab|ravulizumab|mesh-list
93190257|NCT03748823|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93190258|NCT03748823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190259|NCT03748823|Immunologic Factors|immunologic factors|mesh-ancestor
93190260|NCT03748823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190261|NCT03373318|Plasma-lyte 148|plasma-lyte 148|mesh-list
93190262|NCT03373318|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93190263|NCT03373318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93190264|NCT03124420|Amoxicillin|amoxicillin|mesh-list
93190265|NCT03124420|Clarithromycin|clarithromycin|mesh-list
93190266|NCT03124420|Lansoprazole|lansoprazole|mesh-list
93190267|NCT03124420|Dexlansoprazole|dexlansoprazole|mesh-list
93190268|NCT03124420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93190269|NCT03124420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190270|NCT03124420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93190271|NCT03124420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190272|NCT03124420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190273|NCT03124420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93190274|NCT03124420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93190275|NCT03124420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93190276|NCT03124420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190277|NCT03124420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93190278|NCT03231228|Cefazolin|cefazolin|mesh-list
93190279|NCT03231228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93190280|NCT03231228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190281|NCT03510468|Pyridoxine|pyridoxine|mesh-list
93190282|NCT03510468|Isoniazid|isoniazid|mesh-list
93190283|NCT03510468|Rifapentine|rifapentine|mesh-list
93190284|NCT03510468|Antitubercular Agents|antitubercular agents|mesh-ancestor
93190285|NCT03510468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93190286|NCT03510468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190287|NCT03510468|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93190288|NCT03510468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93190289|NCT03510468|Antimetabolites|antimetabolites|mesh-ancestor
93190290|NCT03510468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190291|NCT03510468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93190292|NCT03510468|Vitamin B Complex|vitamin b complex|mesh-ancestor
93190293|NCT03510468|Vitamins|vitamins|mesh-ancestor
93190294|NCT03510468|Micronutrients|micronutrients|mesh-ancestor
93190295|NCT03510468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190296|NCT03510468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93190297|NCT03510468|Leprostatic Agents|leprostatic agents|mesh-ancestor
93190298|NCT01178645|Cytarabine|cytarabine|mesh-list
93190299|NCT01178645|Etoposide|etoposide|mesh-list
93190300|NCT01178645|Melphalan|melphalan|mesh-list
93190301|NCT01178645|Busulfan|busulfan|mesh-list
93190302|NCT01178645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93190303|NCT01178645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190304|NCT01178645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93190305|NCT01178645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93190306|NCT01178645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190307|NCT01178645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190308|NCT01178645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93190309|NCT01178645|Antimetabolites|antimetabolites|mesh-ancestor
93190310|NCT01178645|Antiviral Agents|antiviral agents|mesh-ancestor
93190311|NCT01178645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190312|NCT01178645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190313|NCT01178645|Immunologic Factors|immunologic factors|mesh-ancestor
93190314|NCT01178645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190315|NCT01178645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93190316|NCT01178645|Alkylating Agents|alkylating agents|mesh-ancestor
93190317|NCT01178645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93190318|NCT01285505|Alprazolam|alprazolam|mesh-list
93190319|NCT01285505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93190320|NCT01285505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190321|NCT01285505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190322|NCT01285505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93190323|NCT01285505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93190324|NCT01285505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190325|NCT01285505|GABA Modulators|gaba modulators|mesh-ancestor
93190326|NCT01285505|GABA Agents|gaba agents|mesh-ancestor
93190327|NCT01285505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190328|NCT01285505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190329|NCT03372850|Esomeprazole|esomeprazole|mesh-list
93190330|NCT03372850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93190331|NCT03372850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190332|NCT03372850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93190333|NCT03372850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190334|NCT03372850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190335|NCT04525066|Hyaluronic Acid|hyaluronic acid|mesh-list
93190336|NCT04525066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93190337|NCT04525066|Immunologic Factors|immunologic factors|mesh-ancestor
93190338|NCT04525066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190339|NCT04525066|Viscosupplements|viscosupplements|mesh-ancestor
93190340|NCT04525066|Protective Agents|protective agents|mesh-ancestor
93190341|NCT03362788|Vitamin K|vitamin k|mesh-list
93190342|NCT03362788|Anticoagulants|anticoagulants|mesh-list
93190343|NCT03362788|Vitamins|vitamins|mesh-ancestor
93190344|NCT03362788|Micronutrients|micronutrients|mesh-ancestor
93190345|NCT03362788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190346|NCT03362788|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93190347|NCT03362788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93190348|NCT03362788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190349|NCT03362788|Hemostatics|hemostatics|mesh-ancestor
93190350|NCT03362788|Coagulants|coagulants|mesh-ancestor
93190351|NCT03368794|Analgesics, Opioid|analgesics, opioid|mesh-list
93190352|NCT03368794|Narcotics|narcotics|mesh-ancestor
92862489|NCT00939835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190353|NCT03368794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190354|NCT03368794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190355|NCT03368794|Analgesics|analgesics|mesh-ancestor
93190357|NCT03368794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190358|NCT03862079|Tazobactam|tazobactam|mesh-list
93190359|NCT03862079|Piperacillin|piperacillin|mesh-list
93190360|NCT03862079|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93190361|NCT03862079|Nystatin|nystatin|mesh-list
93190362|NCT03862079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93190363|NCT03862079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190364|NCT03862079|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93190365|NCT03862079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190366|NCT03862079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190367|NCT03862079|Antifungal Agents|antifungal agents|mesh-ancestor
93190368|NCT03862079|Ionophores|ionophores|mesh-ancestor
93190369|NCT03862079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190370|NCT03362632|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93190371|NCT03362632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190372|NCT01179269|Paclitaxel|paclitaxel|mesh-list
93190373|NCT01179269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93190374|NCT01179269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190375|NCT01179269|Tubulin Modulators|tubulin modulators|mesh-ancestor
93190376|NCT01179269|Antimitotic Agents|antimitotic agents|mesh-ancestor
93190377|NCT01179269|Mitosis Modulators|mitosis modulators|mesh-ancestor
93190378|NCT01179269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190379|NCT00165724|Donepezil|donepezil|mesh-list
93190380|NCT00165724|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93190381|NCT00165724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190382|NCT00165724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190383|NCT00165724|Cholinergic Agents|cholinergic agents|mesh-ancestor
93190384|NCT00165724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190385|NCT00165724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190386|NCT00165724|Nootropic Agents|nootropic agents|mesh-ancestor
93190387|NCT01287455|Vitamin D|vitamin d|mesh-list
93190388|NCT01287455|Cholecalciferol|cholecalciferol|mesh-list
93190389|NCT01287455|Vitamins|vitamins|mesh-ancestor
93190390|NCT01287455|Micronutrients|micronutrients|mesh-ancestor
93190391|NCT01287455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190392|NCT01287455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93190393|NCT01287455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93190394|NCT03865511|Osimertinib|osimertinib|mesh-list
93190395|NCT03865511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190396|NCT03865511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190397|NCT03865511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190398|NCT03865511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190399|NCT03498612|Pembrolizumab|pembrolizumab|mesh-list
93190400|NCT03498612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190401|NCT03498612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190402|NCT03498612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190403|NCT03498612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190404|NCT01287533|Ibandronic Acid|ibandronic acid|mesh-list
93190405|NCT01287533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93190406|NCT01287533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190407|NCT03368404|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93190408|NCT03368404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93190409|NCT01287689|Immunoglobulins|immunoglobulins|mesh-list
93190410|NCT01287689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93190411|NCT01287689|Antibodies|antibodies|mesh-list
93190412|NCT01287689|Immunoglobulin G|immunoglobulin g|mesh-list
93190413|NCT01287689|Immunologic Factors|immunologic factors|mesh-ancestor
93190414|NCT01287689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190415|NCT01179503|Calcium, Dietary|calcium, dietary|mesh-list
93190416|NCT01179503|Vitamin D|vitamin d|mesh-list
93190417|NCT01179503|Calcium|calcium|mesh-list
93190418|NCT01179503|Vitamins|vitamins|mesh-ancestor
93190419|NCT01179503|Micronutrients|micronutrients|mesh-ancestor
93190420|NCT01179503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190421|NCT01179503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93190422|NCT01179503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93190423|NCT03117049|Paclitaxel|paclitaxel|mesh-list
93190424|NCT03117049|Bevacizumab|bevacizumab|mesh-list
93190425|NCT03117049|Carboplatin|carboplatin|mesh-list
93190426|NCT03117049|Nivolumab|nivolumab|mesh-list
93190427|NCT03117049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93190428|NCT03117049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190429|NCT03117049|Tubulin Modulators|tubulin modulators|mesh-ancestor
93190430|NCT03117049|Antimitotic Agents|antimitotic agents|mesh-ancestor
93190431|NCT03117049|Mitosis Modulators|mitosis modulators|mesh-ancestor
93190432|NCT03117049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190433|NCT03117049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190434|NCT03117049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93190435|NCT03117049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93190436|NCT03117049|Growth Substances|growth substances|mesh-ancestor
93190437|NCT03117049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190438|NCT03117049|Growth Inhibitors|growth inhibitors|mesh-ancestor
93190439|NCT03117049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190440|NCT03372304|Ropivacaine|ropivacaine|mesh-list
93190441|NCT03372304|Anesthetics, Local|anesthetics, local|mesh-ancestor
93190442|NCT03372304|Anesthetics|anesthetics|mesh-ancestor
93190443|NCT03372304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190444|NCT03372304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190445|NCT03372304|Sensory System Agents|sensory system agents|mesh-ancestor
93190446|NCT03372304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190447|NCT02525081|Ramipril|ramipril|mesh-list
93190448|NCT02525081|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93190449|NCT02525081|Protease Inhibitors|protease inhibitors|mesh-ancestor
93190450|NCT02525081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190451|NCT02525081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190452|NCT02525081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93190453|NCT05566548|Bilirubin|bilirubin|mesh-list
93190454|NCT05566548|Antioxidants|antioxidants|mesh-ancestor
93190455|NCT05566548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190456|NCT05566548|Protective Agents|protective agents|mesh-ancestor
93190457|NCT05566548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190458|NCT02525003|Vitamin D|vitamin d|mesh-list
93190459|NCT02525003|Ergocalciferols|ergocalciferols|mesh-list
93190460|NCT02525003|Cholecalciferol|cholecalciferol|mesh-list
93190461|NCT02525003|Vitamins|vitamins|mesh-list
93190462|NCT02525003|Micronutrients|micronutrients|mesh-ancestor
93190463|NCT02525003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190464|NCT02525003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93190465|NCT02525003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93190466|NCT03464448|Teriflunomide|teriflunomide|mesh-list
93190467|NCT03464448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93190468|NCT03464448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190469|NCT03464448|Analgesics|analgesics|mesh-ancestor
93190470|NCT03464448|Sensory System Agents|sensory system agents|mesh-ancestor
93190471|NCT03464448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190472|NCT03464448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190473|NCT03464448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190474|NCT03464448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190475|NCT03464448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190476|NCT03464448|Immunologic Factors|immunologic factors|mesh-ancestor
93190477|NCT03362008|Varenicline|varenicline|mesh-list
93190478|NCT03362008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93190479|NCT03362008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93190480|NCT03362008|Cholinergic Agents|cholinergic agents|mesh-ancestor
93190481|NCT03362008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190482|NCT03362008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190483|NCT03362008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190484|NCT03123406|Cinacalcet|cinacalcet|mesh-list
93190485|NCT03123406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93190486|NCT03123406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190487|NCT03123406|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93190488|NCT03123406|Hormone Antagonists|hormone antagonists|mesh-ancestor
93190489|NCT03123406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190490|NCT01179659|Pantoprazole|pantoprazole|mesh-list
93190491|NCT01179659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93190492|NCT01179659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190493|NCT01179659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93190494|NCT01179659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190495|NCT01179659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190496|NCT04523818|Fluorouracil|fluorouracil|mesh-list
93190497|NCT04523818|Capecitabine|capecitabine|mesh-list
93190498|NCT04523818|Antimetabolites|antimetabolites|mesh-ancestor
93190499|NCT04523818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190500|NCT04523818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93190501|NCT04523818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190502|NCT04523818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190503|NCT04523818|Immunologic Factors|immunologic factors|mesh-ancestor
93190504|NCT04523818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190505|NCT03361774|Fluorides|fluorides|mesh-list
93190506|NCT03361774|Cariostatic Agents|cariostatic agents|mesh-ancestor
93190507|NCT03361774|Protective Agents|protective agents|mesh-ancestor
93190508|NCT03361774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190509|NCT04523740|Acetaminophen|acetaminophen|mesh-list
93190510|NCT04523740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190511|NCT04523740|Analgesics|analgesics|mesh-ancestor
93190512|NCT04523740|Sensory System Agents|sensory system agents|mesh-ancestor
93190513|NCT04523740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190514|NCT04523740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190515|NCT04523740|Antipyretics|antipyretics|mesh-ancestor
93190516|NCT03410706|Rivaroxaban|rivaroxaban|mesh-list
93190517|NCT03410706|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93190518|NCT03410706|Antithrombins|antithrombins|mesh-ancestor
93190519|NCT03410706|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93190520|NCT03410706|Protease Inhibitors|protease inhibitors|mesh-ancestor
93190521|NCT03410706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190522|NCT03410706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190523|NCT03410706|Anticoagulants|anticoagulants|mesh-ancestor
93190524|NCT04523662|Apatinib|apatinib|mesh-list
93190525|NCT04523662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190526|NCT04523662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190527|NCT04523662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190528|NCT04523662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190529|NCT03371992|Pembrolizumab|pembrolizumab|mesh-list
93190530|NCT03371992|Nivolumab|nivolumab|mesh-list
93190531|NCT03371992|Atezolizumab|atezolizumab|mesh-list
93190532|NCT03371992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190533|NCT03371992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190534|NCT03371992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190535|NCT03371992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190536|NCT03682705|Upadacitinib|upadacitinib|mesh-list
93190537|NCT03682705|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93190538|NCT03682705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190539|NCT03682705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190540|NCT03682705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190541|NCT03682705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190542|NCT03361618|Zinc Sulfate|zinc sulfate|mesh-list
93190543|NCT03361618|Astringents|astringents|mesh-ancestor
93190544|NCT03361618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190545|NCT03361618|Dermatologic Agents|dermatologic agents|mesh-ancestor
93190546|NCT01314495|Abatacept|abatacept|mesh-list
93190547|NCT01314495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190548|NCT01314495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190549|NCT01314495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190550|NCT01314495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190551|NCT01314495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190552|NCT01314495|Immunologic Factors|immunologic factors|mesh-ancestor
93190553|NCT01314495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190554|NCT01314495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190555|NCT03123484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93190556|NCT03123484|Gefitinib|gefitinib|mesh-list
93190557|NCT03123484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190558|NCT03123484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190559|NCT03123484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190560|NCT03123484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190561|NCT03179787|Aripiprazole|aripiprazole|mesh-list
93190562|NCT03179787|Antidepressive Agents|antidepressive agents|mesh-ancestor
93190563|NCT03179787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190564|NCT03179787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93190565|NCT03179787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93190566|NCT03179787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190567|NCT03179787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190568|NCT03179787|Dopamine Agonists|dopamine agonists|mesh-ancestor
93190569|NCT03179787|Dopamine Agents|dopamine agents|mesh-ancestor
93190570|NCT03179787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190571|NCT03179787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190572|NCT03179787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93190573|NCT03179787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93190574|NCT03179787|Serotonin Agents|serotonin agents|mesh-ancestor
93190575|NCT03179787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93190576|NCT03179787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93190577|NCT03179787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93190578|NCT03179787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93190579|NCT02956057|Ascorbic Acid|ascorbic acid|mesh-list
93190580|NCT02956057|Magnesium citrate|magnesium citrate|mesh-list
93190581|NCT02956057|Picosulfate sodium|picosulfate sodium|mesh-list
93190582|NCT02956057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190583|NCT02956057|Antioxidants|antioxidants|mesh-ancestor
93190584|NCT02956057|Protective Agents|protective agents|mesh-ancestor
93190585|NCT02956057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190586|NCT02956057|Vitamins|vitamins|mesh-ancestor
93190587|NCT02956057|Micronutrients|micronutrients|mesh-ancestor
93190588|NCT02956057|Cathartics|cathartics|mesh-ancestor
93190589|NCT02956057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190590|NCT04526470|Paclitaxel|paclitaxel|mesh-list
93190591|NCT04526470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93190592|NCT04526470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190593|NCT04526470|Tubulin Modulators|tubulin modulators|mesh-ancestor
93190594|NCT04526470|Antimitotic Agents|antimitotic agents|mesh-ancestor
93190595|NCT04526470|Mitosis Modulators|mitosis modulators|mesh-ancestor
93190596|NCT04526470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190597|NCT03367390|Insulin Lispro|insulin lispro|mesh-list
93190598|NCT03367390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93190599|NCT03367390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190600|NCT01176851|Glycopyrrolate|glycopyrrolate|mesh-list
93190601|NCT01176851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93190602|NCT01176851|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93190603|NCT01176851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93190604|NCT01176851|Cholinergic Agents|cholinergic agents|mesh-ancestor
93190605|NCT01176851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190606|NCT01176851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190607|NCT01176851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190608|NCT04526236|Methadone|methadone|mesh-list
93190609|NCT04526236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93190610|NCT04526236|Narcotics|narcotics|mesh-ancestor
93190611|NCT04526236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190612|NCT04526236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190613|NCT04526236|Analgesics|analgesics|mesh-ancestor
93190614|NCT04526236|Sensory System Agents|sensory system agents|mesh-ancestor
93190615|NCT04526236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190616|NCT04526236|Antitussive Agents|antitussive agents|mesh-ancestor
93190617|NCT04526236|Respiratory System Agents|respiratory system agents|mesh-ancestor
93190618|NCT01179971|Evening primrose oil|evening primrose oil|mesh-list
93190619|NCT01179971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93190620|NCT01179971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190621|NCT01179971|Analgesics|analgesics|mesh-ancestor
93190622|NCT01179971|Sensory System Agents|sensory system agents|mesh-ancestor
93190623|NCT01179971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190624|NCT01179971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190625|NCT01179971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190626|NCT01179971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190627|NCT01179971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93190628|NCT01179971|Antimetabolites|antimetabolites|mesh-ancestor
93190629|NCT01179971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190630|NCT01179971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93190631|NCT01179971|Dermatologic Agents|dermatologic agents|mesh-ancestor
93190632|NCT04237584|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93190633|NCT04237584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190634|NCT03681691|Estradiol|estradiol|mesh-list
93190635|NCT03681691|Estrogens|estrogens|mesh-ancestor
93190636|NCT03681691|Hormones|hormones|mesh-ancestor
93190637|NCT03681691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190638|NCT03681691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190639|NCT01289171|Glycolic acid|glycolic acid|mesh-list
93190640|NCT01289171|Keratolytic Agents|keratolytic agents|mesh-ancestor
93190641|NCT01289171|Dermatologic Agents|dermatologic agents|mesh-ancestor
93190642|NCT03360760|Doxorubicin|doxorubicin|mesh-list
93190643|NCT03360760|Methotrexate|methotrexate|mesh-list
93190644|NCT03360760|Ifosfamide|ifosfamide|mesh-list
93190645|NCT03360760|Isophosphamide mustard|isophosphamide mustard|mesh-list
93190646|NCT03360760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190647|NCT03360760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93190648|NCT03360760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93190649|NCT03360760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93190650|NCT03360760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190651|NCT03360760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190652|NCT03360760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93190653|NCT03360760|Abortifacient Agents|abortifacient agents|mesh-ancestor
93190654|NCT03360760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93190655|NCT03360760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862787|NCT04042116|Nivolumab|nivolumab|mesh-list
93190656|NCT03360760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93190657|NCT03360760|Antimetabolites|antimetabolites|mesh-ancestor
93190658|NCT03360760|Dermatologic Agents|dermatologic agents|mesh-ancestor
93190659|NCT03360760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93190660|NCT03360760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93190661|NCT03360760|Immunologic Factors|immunologic factors|mesh-ancestor
93190662|NCT03360760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190663|NCT03360760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93190664|NCT03360760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93190665|NCT03360760|Alkylating Agents|alkylating agents|mesh-ancestor
93190667|NCT01285661|Warfarin|warfarin|mesh-list
93190668|NCT01285661|Anticoagulants|anticoagulants|mesh-list
93190669|NCT01285661|Vitamins|vitamins|mesh-ancestor
93190670|NCT01285661|Micronutrients|micronutrients|mesh-ancestor
93190671|NCT01285661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190672|NCT01285661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93190673|NCT01285661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93190674|NCT01285661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190675|NCT01285661|Hemostatics|hemostatics|mesh-ancestor
93190676|NCT01285661|Coagulants|coagulants|mesh-ancestor
93190677|NCT03360682|Tenofovir|tenofovir|mesh-list
93190678|NCT03360682|Lamivudine|lamivudine|mesh-list
93190679|NCT03360682|Emtricitabine|emtricitabine|mesh-list
93190680|NCT03360682|Dolutegravir|dolutegravir|mesh-list
93190681|NCT03360682|Abacavir|abacavir|mesh-list
93190682|NCT03360682|Antiviral Agents|antiviral agents|mesh-ancestor
93190683|NCT03360682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190684|NCT03360682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93190685|NCT03360682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93190686|NCT03360682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190687|NCT03360682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190688|NCT03360682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93190689|NCT03360682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93190690|NCT03360682|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93190691|NCT03360682|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93190692|NCT01180205|Amlodipine|amlodipine|mesh-list
93190693|NCT01180205|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93190694|NCT01180205|Telmisartan|telmisartan|mesh-list
93190695|NCT01180205|Olmesartan|olmesartan|mesh-list
93190696|NCT01180205|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93190697|NCT01180205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93190698|NCT01180205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93190699|NCT01180205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190700|NCT01180205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190701|NCT01180205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93190702|NCT01180205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190703|NCT01180205|Vasodilator Agents|vasodilator agents|mesh-ancestor
93190704|NCT01180205|Diuretics|diuretics|mesh-ancestor
93190705|NCT01180205|Natriuretic Agents|natriuretic agents|mesh-ancestor
93190706|NCT01180205|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93190707|NCT01180205|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93190708|NCT01180205|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93190709|NCT04523506|Botulinum Toxins|botulinum toxins|mesh-list
93190710|NCT04523506|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93190711|NCT04523506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190712|NCT04523506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190713|NCT04523506|Cholinergic Agents|cholinergic agents|mesh-ancestor
93190714|NCT04523506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190715|NCT04523506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190716|NCT03867084|Pembrolizumab|pembrolizumab|mesh-list
93190717|NCT03867084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190718|NCT03867084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190719|NCT03867084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190720|NCT03867084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190721|NCT03860831|Midazolam|midazolam|mesh-list
93190722|NCT03860831|Ketamine|ketamine|mesh-list
93190723|NCT03860831|Analgesics|analgesics|mesh-ancestor
93190724|NCT03860831|Sensory System Agents|sensory system agents|mesh-ancestor
93190725|NCT03860831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190726|NCT03860831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190727|NCT03860831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93190728|NCT03860831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93190729|NCT03860831|Anesthetics, General|anesthetics, general|mesh-ancestor
92862864|NCT00637988|Sensory System Agents|sensory system agents|mesh-ancestor
93190730|NCT03860831|Anesthetics|anesthetics|mesh-ancestor
93190731|NCT03860831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190732|NCT03860831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93190733|NCT03860831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93190734|NCT03860831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190735|NCT03860831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190736|NCT03860831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93190737|NCT03860831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93190739|NCT03860831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93190740|NCT03860831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190741|NCT03860831|GABA Modulators|gaba modulators|mesh-ancestor
93190742|NCT03860831|GABA Agents|gaba agents|mesh-ancestor
93190743|NCT01064479|Cisplatin|cisplatin|mesh-list
93190744|NCT01064479|Carboplatin|carboplatin|mesh-list
93190745|NCT01064479|Docetaxel|docetaxel|mesh-list
93190746|NCT01064479|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93190747|NCT01064479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190748|NCT01064479|Tubulin Modulators|tubulin modulators|mesh-ancestor
93190749|NCT01064479|Antimitotic Agents|antimitotic agents|mesh-ancestor
93190750|NCT01064479|Mitosis Modulators|mitosis modulators|mesh-ancestor
93190751|NCT01064479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190752|NCT01064479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190753|NCT01064479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190754|NCT04218708|Nicotine|nicotine|mesh-list
93190755|NCT04218708|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93190756|NCT04218708|Autonomic Agents|autonomic agents|mesh-ancestor
93190757|NCT04218708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190758|NCT04218708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190759|NCT04218708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93190760|NCT04218708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93190761|NCT04218708|Cholinergic Agents|cholinergic agents|mesh-ancestor
93190762|NCT04218708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190763|NCT04218708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190764|NCT03667326|Aspirin|aspirin|mesh-list
93190765|NCT03667326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93190766|NCT03667326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190767|NCT03667326|Analgesics|analgesics|mesh-ancestor
93190768|NCT03667326|Sensory System Agents|sensory system agents|mesh-ancestor
93190769|NCT03667326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190770|NCT03667326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190771|NCT03667326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190772|NCT03667326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93190773|NCT03667326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93190774|NCT03667326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93190775|NCT03667326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190776|NCT03667326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93190777|NCT03667326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93190778|NCT03667326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190779|NCT03667326|Antipyretics|antipyretics|mesh-ancestor
93190780|NCT04525300|Liraglutide|liraglutide|mesh-list
93190781|NCT04525300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93190782|NCT04525300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190783|NCT04525300|Incretins|incretins|mesh-ancestor
93190784|NCT04525300|Hormones|hormones|mesh-ancestor
93190785|NCT04525300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190786|NCT03865121|Nicotine|nicotine|mesh-list
93190787|NCT03865121|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93190788|NCT03865121|Autonomic Agents|autonomic agents|mesh-ancestor
93190789|NCT03865121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190790|NCT03865121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190791|NCT03865121|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93190792|NCT03865121|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93190793|NCT03865121|Cholinergic Agents|cholinergic agents|mesh-ancestor
93190794|NCT03865121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190795|NCT03865121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190796|NCT03680911|Acetylcysteine|acetylcysteine|mesh-list
93190797|NCT03680911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93190798|NCT03680911|Antiviral Agents|antiviral agents|mesh-ancestor
93190799|NCT03680911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190800|NCT03680911|Expectorants|expectorants|mesh-ancestor
93190801|NCT03680911|Respiratory System Agents|respiratory system agents|mesh-ancestor
93190802|NCT03680911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93190803|NCT03680911|Antioxidants|antioxidants|mesh-ancestor
93190804|NCT03680911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190805|NCT03680911|Protective Agents|protective agents|mesh-ancestor
93190806|NCT03680911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190807|NCT03680911|Antidotes|antidotes|mesh-ancestor
93190808|NCT03370588|Dexmedetomidine|dexmedetomidine|mesh-list
93190809|NCT03370588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93190810|NCT03370588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190811|NCT03370588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190812|NCT03370588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190813|NCT03370588|Analgesics|analgesics|mesh-ancestor
93190814|NCT03370588|Sensory System Agents|sensory system agents|mesh-ancestor
93190815|NCT03370588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190816|NCT03370588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93190817|NCT03370588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93190818|NCT03370588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93190819|NCT03370588|Adrenergic Agents|adrenergic agents|mesh-ancestor
93190820|NCT03370588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190821|NCT03370588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190822|NCT05156814|Dydrogesterone|dydrogesterone|mesh-list
93190823|NCT05156814|Progestins|progestins|mesh-ancestor
93190824|NCT05156814|Hormones|hormones|mesh-ancestor
93190825|NCT05156814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190826|NCT05156814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190827|NCT01289483|Fospropofol|fospropofol|mesh-list
93190828|NCT01289483|Propofol|propofol|mesh-list
93190829|NCT01289483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93190830|NCT01289483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190831|NCT01289483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190832|NCT01289483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93190833|NCT01289483|Anesthetics, General|anesthetics, general|mesh-ancestor
93190834|NCT01289483|Anesthetics|anesthetics|mesh-ancestor
93190835|NCT03680521|Nivolumab|nivolumab|mesh-list
93190836|NCT03680521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93190837|NCT03680521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190838|NCT03680521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93190839|NCT03680521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190840|NCT01289327|Midazolam|midazolam|mesh-list
93190841|NCT01289327|Alfentanil|alfentanil|mesh-list
93190842|NCT01289327|Propofol|propofol|mesh-list
93190843|NCT01289327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93190844|NCT01289327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190845|NCT01289327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190846|NCT01289327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93190847|NCT01289327|Anesthetics, General|anesthetics, general|mesh-ancestor
93190848|NCT01289327|Anesthetics|anesthetics|mesh-ancestor
93190849|NCT01289327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93190850|NCT01289327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93190851|NCT01289327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93190852|NCT01289327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190853|NCT01289327|GABA Modulators|gaba modulators|mesh-ancestor
93190854|NCT01289327|GABA Agents|gaba agents|mesh-ancestor
93190855|NCT01289327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190856|NCT01289327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190857|NCT01289327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93190858|NCT01289327|Narcotics|narcotics|mesh-ancestor
93190859|NCT01289327|Analgesics|analgesics|mesh-ancestor
93190860|NCT01289327|Sensory System Agents|sensory system agents|mesh-ancestor
93190861|NCT01289327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190862|NCT01181063|Budesonide|budesonide|mesh-list
93190863|NCT01181063|Formoterol Fumarate|formoterol fumarate|mesh-list
93190864|NCT01181063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190865|NCT01181063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93190866|NCT01181063|Autonomic Agents|autonomic agents|mesh-ancestor
93190867|NCT01181063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190868|NCT01181063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190869|NCT01181063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93190870|NCT01181063|Respiratory System Agents|respiratory system agents|mesh-ancestor
93190871|NCT01181063|Glucocorticoids|glucocorticoids|mesh-ancestor
93190872|NCT01181063|Hormones|hormones|mesh-ancestor
93190873|NCT01181063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190874|NCT01181063|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93190875|NCT01181063|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93190876|NCT01181063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93190877|NCT01181063|Adrenergic Agents|adrenergic agents|mesh-ancestor
93190878|NCT01181063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190879|NCT01181063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190880|NCT02596997|Brincidofovir|brincidofovir|mesh-list
93190881|NCT02596997|Antiviral Agents|antiviral agents|mesh-ancestor
93190882|NCT02596997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190883|NCT03649477|Carbetocin|carbetocin|mesh-list
93190884|NCT03649477|Oxytocin|oxytocin|mesh-list
93190885|NCT03649477|Oxytocics|oxytocics|mesh-ancestor
93190886|NCT03649477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93190887|NCT03649477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190888|NCT03359746|Grazoprevir|grazoprevir|mesh-list
93190889|NCT03359746|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93190890|NCT03359746|Antiviral Agents|antiviral agents|mesh-ancestor
93190891|NCT03359746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190892|NCT01310101|Dexamethasone|dexamethasone|mesh-list
93190893|NCT01310101|Ofatumumab|ofatumumab|mesh-list
93190894|NCT01310101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93190895|NCT01310101|Antiemetics|antiemetics|mesh-ancestor
93190896|NCT01310101|Autonomic Agents|autonomic agents|mesh-ancestor
93190897|NCT01310101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190898|NCT01310101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190899|NCT01310101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93190900|NCT01310101|Glucocorticoids|glucocorticoids|mesh-ancestor
93190901|NCT01310101|Hormones|hormones|mesh-ancestor
93190902|NCT01310101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190903|NCT01310101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93190904|NCT01310101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190905|NCT03639727|Mannitol|mannitol|mesh-list
93190906|NCT03639727|Citric Acid|citric acid|mesh-list
93190907|NCT03639727|Sodium Citrate|sodium citrate|mesh-list
93190908|NCT03639727|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93190909|NCT03639727|Diuretics|diuretics|mesh-ancestor
93190910|NCT03639727|Natriuretic Agents|natriuretic agents|mesh-ancestor
93190911|NCT03639727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190912|NCT03639727|Anticoagulants|anticoagulants|mesh-ancestor
93190913|NCT03639727|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93190914|NCT03639727|Chelating Agents|chelating agents|mesh-ancestor
93190915|NCT03639727|Sequestering Agents|sequestering agents|mesh-ancestor
93190916|NCT03639727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190917|NCT01180751|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93190918|NCT01180751|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93190919|NCT01180751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190920|NCT04523272|Sunitinib|sunitinib|mesh-list
93190921|NCT04523272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190922|NCT04523272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93190923|NCT04523272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93190924|NCT04523272|Growth Substances|growth substances|mesh-ancestor
93190925|NCT04523272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190926|NCT04523272|Growth Inhibitors|growth inhibitors|mesh-ancestor
93190927|NCT04523272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93190928|NCT04523272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190929|NCT04523272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190930|NCT01289561|Ethanol|ethanol|mesh-list
93190931|NCT01289561|Quinine|quinine|mesh-list
93190932|NCT01289561|Caffeine|caffeine|mesh-list
93190933|NCT01289561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93190934|NCT01289561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190935|NCT01289561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93190936|NCT01289561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190937|NCT01289561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93190938|NCT01289561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93190939|NCT01289561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190940|NCT01289561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190941|NCT01289561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93190942|NCT01289561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93190943|NCT01289561|Purinergic Agents|purinergic agents|mesh-ancestor
93190944|NCT01289561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190945|NCT01289561|Antimalarials|antimalarials|mesh-ancestor
93190946|NCT01289561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93190947|NCT01289561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93190948|NCT01289561|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93190949|NCT01289561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93190950|NCT01289561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93190951|NCT01289561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93190952|NCT01289561|Analgesics|analgesics|mesh-ancestor
93190953|NCT01289561|Sensory System Agents|sensory system agents|mesh-ancestor
93190954|NCT03855527|Chlorhexidine|chlorhexidine|mesh-list
93190955|NCT03855527|Fluorides|fluorides|mesh-list
92863090|NCT00945997|Abortifacient Agents|abortifacient agents|mesh-ancestor
93190956|NCT03855527|Cariostatic Agents|cariostatic agents|mesh-ancestor
93190957|NCT03855527|Protective Agents|protective agents|mesh-ancestor
93190958|NCT03855527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190959|NCT03855527|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93190960|NCT03855527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93190962|NCT03366064|Pemetrexed|pemetrexed|mesh-list
93190963|NCT03366064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93190964|NCT03366064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93190965|NCT03366064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190966|NCT03366064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93190967|NCT03366064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93190968|NCT03677401|Serlopitant|serlopitant|mesh-list
93190969|NCT03677401|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93190970|NCT03677401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190971|NCT03677401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190972|NCT03677401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190973|NCT03357874|Clopidogrel|clopidogrel|mesh-list
93190974|NCT03357874|Ticagrelor|ticagrelor|mesh-list
93190975|NCT03357874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93190976|NCT03357874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93190977|NCT03357874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93190978|NCT03357874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93190979|NCT03357874|Purinergic Agents|purinergic agents|mesh-ancestor
93190980|NCT03357874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190981|NCT03357874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190982|NCT03357874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190983|NCT01286051|Ganirelix|ganirelix|mesh-list
93190984|NCT01286051|Hormone Antagonists|hormone antagonists|mesh-ancestor
93190985|NCT01286051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93190986|NCT01286051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190987|NCT03357796|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93190988|NCT03357796|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93190989|NCT03357796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93190990|NCT03357796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93190991|NCT03357796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93190992|NCT03357796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93190993|NCT03357796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93190994|NCT03357796|Antidepressive Agents|antidepressive agents|mesh-ancestor
93190995|NCT03357796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93190996|NCT02359513|Fluoxetine|fluoxetine|mesh-list
93190997|NCT02359513|Antidepressive Agents|antidepressive agents|mesh-list
93190998|NCT02359513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93190999|NCT02359513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93191000|NCT02359513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191001|NCT02359513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191002|NCT02359513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191003|NCT02359513|Serotonin Agents|serotonin agents|mesh-ancestor
93191004|NCT02359513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191005|NCT02359513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93191006|NCT02359513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191007|NCT02359513|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93191008|NCT02359513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93191009|NCT02359513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191010|NCT01184495|Epoetin Alfa|epoetin alfa|mesh-list
93191011|NCT01184495|Hematinics|hematinics|mesh-ancestor
93191012|NCT03864575|Celecoxib|celecoxib|mesh-list
93191013|NCT03864575|Nivolumab|nivolumab|mesh-list
93191014|NCT03864575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191015|NCT03864575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191016|NCT03864575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93191017|NCT03864575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191018|NCT03864575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93191019|NCT03864575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93191020|NCT03864575|Analgesics|analgesics|mesh-ancestor
93191021|NCT03864575|Sensory System Agents|sensory system agents|mesh-ancestor
93191022|NCT03864575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191023|NCT03864575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191024|NCT03864575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191025|NCT03864575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191026|NCT03864575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93191027|NCT03864575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93191028|NCT03864575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191029|NCT03357718|Midazolam|midazolam|mesh-list
93191030|NCT03357718|Dexmedetomidine|dexmedetomidine|mesh-list
93191031|NCT03357718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93191032|NCT03357718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191033|NCT03357718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191034|NCT03357718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93191035|NCT03357718|Analgesics|analgesics|mesh-ancestor
93191036|NCT03357718|Sensory System Agents|sensory system agents|mesh-ancestor
93191037|NCT03357718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191038|NCT03357718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93191039|NCT03357718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93191040|NCT03357718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93191041|NCT03357718|Adrenergic Agents|adrenergic agents|mesh-ancestor
93191042|NCT03357718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191043|NCT03357718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191044|NCT03357718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93191045|NCT03357718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93191046|NCT03357718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93191047|NCT03357718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191048|NCT03357718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93191049|NCT03357718|Anesthetics, General|anesthetics, general|mesh-ancestor
93191050|NCT03357718|Anesthetics|anesthetics|mesh-ancestor
93191051|NCT03357718|GABA Modulators|gaba modulators|mesh-ancestor
93191052|NCT03357718|GABA Agents|gaba agents|mesh-ancestor
93191053|NCT04521400|Interferons|interferons|mesh-list
93191054|NCT04521400|Ritonavir|ritonavir|mesh-list
93191055|NCT04521400|Lopinavir|lopinavir|mesh-list
93191056|NCT04521400|Interferon-beta|interferon-beta|mesh-list
93191057|NCT04521400|Interferon beta-1a|interferon beta-1a|mesh-list
93191058|NCT04521400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191059|NCT04521400|Antiviral Agents|antiviral agents|mesh-ancestor
93191060|NCT04521400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191061|NCT04521400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93191062|NCT04521400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93191063|NCT04521400|Protease Inhibitors|protease inhibitors|mesh-ancestor
93191064|NCT04521400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191065|NCT04521400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191066|NCT04521400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93191067|NCT04521400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93191068|NCT04521400|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93191069|NCT04521400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93191070|NCT04521400|Immunologic Factors|immunologic factors|mesh-ancestor
93191071|NCT04521400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191072|NCT04521400|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93191073|NCT03864185|Rituximab|rituximab|mesh-list
93191074|NCT03864185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191075|NCT03864185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191076|NCT03864185|Immunologic Factors|immunologic factors|mesh-ancestor
93191077|NCT03864185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191078|NCT03864185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191079|NCT01185119|Glucagon|glucagon|mesh-list
93191080|NCT01185119|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93191081|NCT01185119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93191082|NCT01185119|Hormones|hormones|mesh-ancestor
93191083|NCT01185119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191084|NCT01185119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191085|NCT01185119|Incretins|incretins|mesh-ancestor
93191086|NCT03357640|Contraceptive Agents|contraceptive agents|mesh-list
93191087|NCT03357640|Contraceptives, Oral|contraceptives, oral|mesh-list
93191088|NCT03357640|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93191089|NCT03357640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93191090|NCT03357640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191091|NCT03357640|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93191092|NCT01185197|Mycophenolic Acid|mycophenolic acid|mesh-list
93191093|NCT01185197|Prednisolone|prednisolone|mesh-list
93191094|NCT01185197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93191095|NCT01185197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191096|NCT01185197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93191097|NCT01185197|Antitubercular Agents|antitubercular agents|mesh-ancestor
93191098|NCT01185197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93191099|NCT01185197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191100|NCT01185197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191101|NCT01185197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191102|NCT01185197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191103|NCT01185197|Glucocorticoids|glucocorticoids|mesh-ancestor
93191104|NCT01185197|Hormones|hormones|mesh-ancestor
93191105|NCT01185197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191106|NCT01185197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191107|NCT01185197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93191108|NCT03733873|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93191109|NCT03733873|Hemostatics|hemostatics|mesh-ancestor
93191110|NCT03733873|Coagulants|coagulants|mesh-ancestor
93191111|NCT03733873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93191112|NCT03733873|Natriuretic Agents|natriuretic agents|mesh-ancestor
93191113|NCT03733873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191114|NCT03733639|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93191115|NCT03733639|Hemostatics|hemostatics|mesh-ancestor
93191116|NCT03733639|Coagulants|coagulants|mesh-ancestor
93191117|NCT03733561|Rotigotine|rotigotine|mesh-list
93191118|NCT03733561|Dopamine Agonists|dopamine agonists|mesh-ancestor
93191119|NCT03733561|Dopamine Agents|dopamine agents|mesh-ancestor
93191120|NCT03733561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191121|NCT03733561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191122|NCT03733561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191123|NCT03358888|Analgesics, Opioid|analgesics, opioid|mesh-list
93191124|NCT03358888|Narcotics|narcotics|mesh-ancestor
93191125|NCT03358888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191126|NCT03358888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191127|NCT03358888|Analgesics|analgesics|mesh-ancestor
93191128|NCT03358888|Sensory System Agents|sensory system agents|mesh-ancestor
93191129|NCT03358888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191130|NCT01291121|Ranibizumab|ranibizumab|mesh-list
93191131|NCT01291121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93191132|NCT01291121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93191133|NCT01291121|Growth Substances|growth substances|mesh-ancestor
93191134|NCT01291121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191135|NCT01291121|Growth Inhibitors|growth inhibitors|mesh-ancestor
93191136|NCT01291121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191137|NCT01187849|Metformin|metformin|mesh-list
93191138|NCT01187849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93191139|NCT01187849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191140|NCT04522882|Insulin|insulin|mesh-list
93191141|NCT04522882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93191142|NCT04522882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191143|NCT03123718|Methotrexate|methotrexate|mesh-list
93191144|NCT03123718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93191145|NCT03123718|Abortifacient Agents|abortifacient agents|mesh-ancestor
93191146|NCT03123718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93191147|NCT03123718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191148|NCT03123718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93191149|NCT03123718|Antimetabolites|antimetabolites|mesh-ancestor
93191150|NCT03123718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191151|NCT03123718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191152|NCT03123718|Dermatologic Agents|dermatologic agents|mesh-ancestor
93191153|NCT03123718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191154|NCT03123718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93191155|NCT03123718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191156|NCT03123718|Immunologic Factors|immunologic factors|mesh-ancestor
93191157|NCT03123718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191158|NCT03123718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93191159|NCT01185743|Olanzapine|olanzapine|mesh-list
93191160|NCT01185743|Ziprasidone|ziprasidone|mesh-list
93191161|NCT01185743|Antiemetics|antiemetics|mesh-ancestor
93191162|NCT01185743|Autonomic Agents|autonomic agents|mesh-ancestor
93191163|NCT01185743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191164|NCT01185743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191165|NCT01185743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93191166|NCT01185743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93191167|NCT01185743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93191168|NCT01185743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191169|NCT01185743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191170|NCT01185743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93191171|NCT01185743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93191172|NCT01185743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191173|NCT01185743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191174|NCT01185743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191175|NCT01185743|Serotonin Agents|serotonin agents|mesh-ancestor
93191176|NCT01185743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93191177|NCT01185743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93191178|NCT01185743|Dopamine Agents|dopamine agents|mesh-ancestor
93191179|NCT01188005|Vitamins|vitamins|mesh-list
93191181|NCT01188005|Vitamin A|vitamin a|mesh-list
93191182|NCT01188005|Acetylcysteine|acetylcysteine|mesh-list
93191183|NCT01188005|Allopurinol|allopurinol|mesh-list
93191184|NCT01188005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93191185|NCT01188005|Micronutrients|micronutrients|mesh-ancestor
93191186|NCT01188005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191187|NCT01188005|Antioxidants|antioxidants|mesh-ancestor
93191188|NCT01188005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191189|NCT01188005|Protective Agents|protective agents|mesh-ancestor
93191190|NCT01188005|Antiviral Agents|antiviral agents|mesh-ancestor
93191191|NCT01188005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191192|NCT01188005|Expectorants|expectorants|mesh-ancestor
93191193|NCT01188005|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191194|NCT01188005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93191195|NCT01188005|Antidotes|antidotes|mesh-ancestor
93191196|NCT01188005|Antimetabolites|antimetabolites|mesh-ancestor
93191197|NCT01188005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191198|NCT01188005|Gout Suppressants|gout suppressants|mesh-ancestor
93191199|NCT01188005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191200|NCT04445194|Vaccines|vaccines|mesh-list
93191201|NCT04445194|Immunologic Factors|immunologic factors|mesh-ancestor
93191202|NCT04445194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191203|NCT01291199|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93191204|NCT01291199|Vasodilator Agents|vasodilator agents|mesh-ancestor
93191205|NCT01291199|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93191206|NCT01291199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93191207|NCT01291199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191208|NCT01291199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191209|NCT01291199|Urological Agents|urological agents|mesh-ancestor
93191210|NCT04444726|Betamethasone|betamethasone|mesh-list
93191211|NCT04444726|Betamethasone Valerate|betamethasone valerate|mesh-list
93191212|NCT04444726|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93191213|NCT04444726|Betamethasone benzoate|betamethasone benzoate|mesh-list
93191214|NCT04444726|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93191215|NCT04444726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191216|NCT04444726|Glucocorticoids|glucocorticoids|mesh-ancestor
93191217|NCT04444726|Hormones|hormones|mesh-ancestor
93191218|NCT04444726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191219|NCT04444726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191220|NCT04444726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93191221|NCT04444726|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191222|NCT03733327|Cyclophosphamide|cyclophosphamide|mesh-list
93191223|NCT03733327|Busulfan|busulfan|mesh-list
93191224|NCT03733327|Etoposide|etoposide|mesh-list
93191225|NCT03733327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191226|NCT03733327|Immunologic Factors|immunologic factors|mesh-ancestor
93191227|NCT03733327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191228|NCT03733327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191229|NCT03733327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93191230|NCT03733327|Alkylating Agents|alkylating agents|mesh-ancestor
93191231|NCT03733327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191232|NCT03733327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191233|NCT03733327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93191234|NCT03733327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93191235|NCT03733327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93191236|NCT03733327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93191237|NCT03733327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191238|NCT03733171|Epinephrine|epinephrine|mesh-list
93191239|NCT03733171|Hemostatics|hemostatics|mesh-list
93191240|NCT03733171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93191241|NCT03733171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93191242|NCT03733171|Adrenergic Agents|adrenergic agents|mesh-ancestor
93191243|NCT03733171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191244|NCT03733171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191245|NCT03733171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191246|NCT03733171|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93191247|NCT03733171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93191248|NCT03733171|Autonomic Agents|autonomic agents|mesh-ancestor
93191249|NCT03733171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191250|NCT03733171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93191251|NCT03733171|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191252|NCT03733171|Mydriatics|mydriatics|mesh-ancestor
93191253|NCT03733171|Sympathomimetics|sympathomimetics|mesh-ancestor
93191254|NCT03733171|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93191255|NCT03733171|Coagulants|coagulants|mesh-ancestor
93191256|NCT03207750|Vaccines|vaccines|mesh-list
93191257|NCT03207750|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93191258|NCT03207750|Immunologic Factors|immunologic factors|mesh-ancestor
93191259|NCT03207750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191260|NCT01185977|Fluoxetine|fluoxetine|mesh-list
93191261|NCT01185977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93191262|NCT01185977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93191263|NCT01185977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191264|NCT01185977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191265|NCT01185977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191266|NCT01185977|Serotonin Agents|serotonin agents|mesh-ancestor
93191267|NCT01185977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191268|NCT01185977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93191269|NCT01185977|Antidepressive Agents|antidepressive agents|mesh-ancestor
93191270|NCT01185977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191271|NCT01185977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93191272|NCT01185977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93191273|NCT01185977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191274|NCT03857399|Caspofungin|caspofungin|mesh-list
93191275|NCT03857399|Antifungal Agents|antifungal agents|mesh-ancestor
93191276|NCT03857399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191277|NCT03857399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191278|NCT03857399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191279|NCT04520620|Enoxaparin|enoxaparin|mesh-list
93191280|NCT04520620|Anticoagulants|anticoagulants|mesh-ancestor
93191281|NCT04520620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93191282|NCT04520620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93191283|NCT04520620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191284|NCT03857711|Amiodarone|amiodarone|mesh-list
93191285|NCT03857711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93191286|NCT03857711|Vasodilator Agents|vasodilator agents|mesh-ancestor
93191287|NCT03857711|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93191288|NCT03857711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191289|NCT03857711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191290|NCT03857711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93191291|NCT03857711|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93191292|NCT03857711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93191293|NCT03857711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191294|NCT03857711|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93191295|NCT03857711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93191296|NCT03857711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93191297|NCT03672097|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93191298|NCT03672097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93191299|NCT03847896|Budesonide|budesonide|mesh-list
93191300|NCT03847896|Albuterol|albuterol|mesh-list
93191301|NCT03847896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191302|NCT03847896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93191303|NCT03847896|Autonomic Agents|autonomic agents|mesh-ancestor
93191304|NCT03847896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191305|NCT03847896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191306|NCT03847896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93191307|NCT03847896|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191308|NCT03847896|Glucocorticoids|glucocorticoids|mesh-ancestor
93191309|NCT03847896|Hormones|hormones|mesh-ancestor
93191310|NCT03847896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191311|NCT03847896|Tocolytic Agents|tocolytic agents|mesh-ancestor
93191312|NCT03847896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93191313|NCT03847896|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93191314|NCT03847896|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93191315|NCT03847896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93191316|NCT03847896|Adrenergic Agents|adrenergic agents|mesh-ancestor
93191317|NCT03847896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191318|NCT03847896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191319|NCT01186289|Atorvastatin|atorvastatin|mesh-list
93191320|NCT01186289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93191321|NCT01186289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93191322|NCT01186289|Antimetabolites|antimetabolites|mesh-ancestor
93191323|NCT01186289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191324|NCT01186289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93191325|NCT01186289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93191326|NCT01186289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191327|NCT01291823|Gefitinib|gefitinib|mesh-list
92863465|NCT03110822|Antiemetics|antiemetics|mesh-ancestor
93191328|NCT01291823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191329|NCT01291823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93191330|NCT01291823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191331|NCT01291823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191332|NCT01181765|Infliximab|infliximab|mesh-list
93191333|NCT01181765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93191334|NCT01181765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191335|NCT01181765|Dermatologic Agents|dermatologic agents|mesh-ancestor
93191336|NCT01181765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93191337|NCT01181765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191338|NCT01186445|Morphine|morphine|mesh-list
93191339|NCT01186445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93191340|NCT01186445|Narcotics|narcotics|mesh-ancestor
93191341|NCT01186445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191342|NCT01186445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191343|NCT01186445|Analgesics|analgesics|mesh-ancestor
93191344|NCT01186445|Sensory System Agents|sensory system agents|mesh-ancestor
93191345|NCT01186445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191346|NCT03739333|Carbon-11 methionine|carbon-11 methionine|mesh-list
93191347|NCT03739333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93191348|NCT03739333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191349|NCT04520230|Budesonide|budesonide|mesh-list
93191350|NCT04520230|Formoterol Fumarate|formoterol fumarate|mesh-list
93191351|NCT04520230|Tiotropium Bromide|tiotropium bromide|mesh-list
93191352|NCT04520230|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93191353|NCT04520230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191354|NCT04520230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93191355|NCT04520230|Autonomic Agents|autonomic agents|mesh-ancestor
93191356|NCT04520230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191357|NCT04520230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191358|NCT04520230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93191359|NCT04520230|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191360|NCT04520230|Glucocorticoids|glucocorticoids|mesh-ancestor
93191361|NCT04520230|Hormones|hormones|mesh-ancestor
93191362|NCT04520230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191363|NCT04520230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93191364|NCT04520230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93191365|NCT04520230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93191366|NCT04520230|Adrenergic Agents|adrenergic agents|mesh-ancestor
93191367|NCT04520230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191368|NCT04520230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191369|NCT04520230|Parasympatholytics|parasympatholytics|mesh-ancestor
93191370|NCT04520230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93191371|NCT04520230|Cholinergic Agents|cholinergic agents|mesh-ancestor
93191372|NCT03619837|Sofosbuvir|sofosbuvir|mesh-list
93191373|NCT03619837|Velpatasvir|velpatasvir|mesh-list
93191374|NCT03619837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93191375|NCT03619837|Antiviral Agents|antiviral agents|mesh-ancestor
93191376|NCT03619837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191377|NCT03852563|Petrolatum|petrolatum|mesh-list
93191378|NCT03852563|Emollients|emollients|mesh-ancestor
92855570|NCT00005112|Hormones|hormones|mesh-list
93191379|NCT03852563|Dermatologic Agents|dermatologic agents|mesh-ancestor
93191380|NCT01188317|Ibuprofen|ibuprofen|mesh-list
93191381|NCT01188317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93191382|NCT01188317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93191383|NCT01188317|Analgesics|analgesics|mesh-ancestor
93191384|NCT01188317|Sensory System Agents|sensory system agents|mesh-ancestor
93191385|NCT01188317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191386|NCT01188317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191387|NCT01188317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191388|NCT01188317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191389|NCT01188317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93191390|NCT01188317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191391|NCT01188317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191392|NCT03206970|Zanubrutinib|zanubrutinib|mesh-list
93191393|NCT03206970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191394|NCT03206970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93191395|NCT03206970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191396|NCT03206970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191397|NCT03739021|Ropivacaine|ropivacaine|mesh-list
93191398|NCT03739021|Anesthetics, Local|anesthetics, local|mesh-ancestor
93191399|NCT03739021|Anesthetics|anesthetics|mesh-ancestor
93191400|NCT03739021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191401|NCT03739021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191402|NCT03739021|Sensory System Agents|sensory system agents|mesh-ancestor
93191403|NCT03739021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191404|NCT03738943|Pyridoxine|pyridoxine|mesh-list
93191405|NCT03738943|Pyridoxal|pyridoxal|mesh-list
93191406|NCT03738943|Vitamin B 6|vitamin b 6|mesh-list
93191407|NCT03738943|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
93191408|NCT03738943|Adenosine|adenosine|mesh-list
93191409|NCT03738943|Nitroprusside|nitroprusside|mesh-list
93191410|NCT03738943|Acetylcholine|acetylcholine|mesh-list
93191411|NCT03738943|Vitamins|vitamins|mesh-ancestor
93191412|NCT03738943|Micronutrients|micronutrients|mesh-ancestor
93191413|NCT03738943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191414|NCT03738943|Vitamin B Complex|vitamin b complex|mesh-ancestor
93191415|NCT03738943|Analgesics|analgesics|mesh-ancestor
93191416|NCT03738943|Sensory System Agents|sensory system agents|mesh-ancestor
93191417|NCT03738943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191418|NCT03738943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93191419|NCT03738943|Vasodilator Agents|vasodilator agents|mesh-ancestor
93191420|NCT03738943|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93191421|NCT03738943|Purinergic Agonists|purinergic agonists|mesh-ancestor
93191422|NCT03738943|Purinergic Agents|purinergic agents|mesh-ancestor
93191423|NCT03738943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191424|NCT03738943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191425|NCT03738943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93191426|NCT03738943|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93191427|NCT03738943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93191428|NCT03738943|Cholinergic Agents|cholinergic agents|mesh-ancestor
93191429|NCT03178851|Atezolizumab|atezolizumab|mesh-list
93191430|NCT03178851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93191431|NCT03178851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93191432|NCT03178851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191433|NCT03178851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191434|NCT03178851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191435|NCT03178851|Immunologic Factors|immunologic factors|mesh-ancestor
93191436|NCT03178851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191437|NCT01291979|Lidocaine|lidocaine|mesh-list
93191438|NCT01291979|Anesthetics, Local|anesthetics, local|mesh-ancestor
93191439|NCT01291979|Anesthetics|anesthetics|mesh-ancestor
93191440|NCT01291979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191441|NCT01291979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191442|NCT01291979|Sensory System Agents|sensory system agents|mesh-ancestor
93191443|NCT01291979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191444|NCT01291979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93191445|NCT01291979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93191446|NCT01291979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93191447|NCT01291979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191448|NCT01291979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191449|NCT04443634|Bupivacaine|bupivacaine|mesh-list
93191450|NCT04443634|Anesthetics, Local|anesthetics, local|mesh-ancestor
93191451|NCT04443634|Anesthetics|anesthetics|mesh-ancestor
93191452|NCT04443634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191453|NCT04443634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191454|NCT04443634|Sensory System Agents|sensory system agents|mesh-ancestor
93191455|NCT04443634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191456|NCT03643159|Aripiprazole|aripiprazole|mesh-list
93191457|NCT03643159|Antipsychotic Agents|antipsychotic agents|mesh-list
93191458|NCT03643159|Antidepressive Agents|antidepressive agents|mesh-ancestor
93191459|NCT03643159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191460|NCT03643159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93191461|NCT03643159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191462|NCT03643159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191463|NCT03643159|Dopamine Agonists|dopamine agonists|mesh-ancestor
93191464|NCT03643159|Dopamine Agents|dopamine agents|mesh-ancestor
93191465|NCT03643159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191466|NCT03643159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191467|NCT03643159|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93191468|NCT03643159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93191469|NCT03643159|Serotonin Agents|serotonin agents|mesh-ancestor
93191470|NCT03643159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93191471|NCT03643159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93191472|NCT03643159|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93191473|NCT03643159|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93191474|NCT03205566|Lamivudine|lamivudine|mesh-list
93191475|NCT03205566|Raltegravir Potassium|raltegravir potassium|mesh-list
93191476|NCT03205566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93191477|NCT03205566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93191478|NCT03205566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191479|NCT03205566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191480|NCT03205566|Antiviral Agents|antiviral agents|mesh-ancestor
93191481|NCT03205566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191482|NCT03205566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93191483|NCT03205566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93191484|NCT03205566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93191485|NCT03205566|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93191486|NCT01181999|Rituximab|rituximab|mesh-list
93191487|NCT01181999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191488|NCT01181999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191489|NCT01181999|Immunologic Factors|immunologic factors|mesh-ancestor
93191490|NCT01181999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191491|NCT01181999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191492|NCT04509232|Fluorides|fluorides|mesh-list
93191493|NCT04509232|Cariostatic Agents|cariostatic agents|mesh-ancestor
93191494|NCT04509232|Protective Agents|protective agents|mesh-ancestor
93191495|NCT04509232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191496|NCT03732235|Bevacizumab|bevacizumab|mesh-list
93191497|NCT03732235|Chlorotrianisene|chlorotrianisene|mesh-list
93191498|NCT03732235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191499|NCT03732235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191500|NCT03732235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93191501|NCT03732235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93191502|NCT03732235|Growth Substances|growth substances|mesh-ancestor
93191503|NCT03732235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191504|NCT03732235|Growth Inhibitors|growth inhibitors|mesh-ancestor
93191505|NCT03732235|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93191506|NCT03732235|Estrogens|estrogens|mesh-ancestor
93191507|NCT03732235|Hormones|hormones|mesh-ancestor
93191508|NCT03732235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191509|NCT03732235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93191510|NCT01289951|Raltegravir Potassium|raltegravir potassium|mesh-list
93191511|NCT01289951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93191512|NCT01289951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93191513|NCT01289951|Antiviral Agents|antiviral agents|mesh-ancestor
93191514|NCT01289951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191515|NCT01289951|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93191516|NCT01289951|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93191517|NCT01289951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191518|NCT01289951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191519|NCT01182077|Midazolam|midazolam|mesh-list
93191520|NCT01182077|Peficitinib|peficitinib|mesh-list
93191521|NCT01182077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93191522|NCT01182077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93191523|NCT01182077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191524|NCT01182077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191525|NCT01182077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93191526|NCT01182077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93191527|NCT01182077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191528|NCT01182077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93191529|NCT01182077|Anesthetics, General|anesthetics, general|mesh-ancestor
93191530|NCT01182077|Anesthetics|anesthetics|mesh-ancestor
93191531|NCT01182077|GABA Modulators|gaba modulators|mesh-ancestor
93191532|NCT01182077|GABA Agents|gaba agents|mesh-ancestor
93191533|NCT01182077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191534|NCT01182077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191535|NCT01182077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191536|NCT01182077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191537|NCT01182077|Immunologic Factors|immunologic factors|mesh-ancestor
93191538|NCT03618823|Acetaminophen|acetaminophen|mesh-list
93191539|NCT03618823|Ibuprofen|ibuprofen|mesh-list
93191540|NCT03618823|Oxycodone|oxycodone|mesh-list
93191541|NCT03618823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93191542|NCT03618823|Analgesics|analgesics|mesh-ancestor
93191543|NCT03618823|Sensory System Agents|sensory system agents|mesh-ancestor
93191544|NCT03618823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191545|NCT03618823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191546|NCT03618823|Antipyretics|antipyretics|mesh-ancestor
93191547|NCT03618823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93191548|NCT03618823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191549|NCT03618823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191550|NCT03618823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93191551|NCT03618823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191552|NCT03618823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191553|NCT03618823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93191554|NCT03618823|Narcotics|narcotics|mesh-ancestor
93191555|NCT03618823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191556|NCT01188707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93191557|NCT01188707|Belinostat|belinostat|mesh-list
93191558|NCT01188707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191559|NCT01188707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93191560|NCT01188707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191561|NCT01188707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191562|NCT01188707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93191563|NCT03356158|Cetuximab|cetuximab|mesh-list
93191564|NCT03356158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191565|NCT03356158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191566|NCT03356080|Cytarabine|cytarabine|mesh-list
93191567|NCT03356080|Decitabine|decitabine|mesh-list
93191568|NCT03356080|Tretinoin|tretinoin|mesh-list
93191569|NCT03356080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93191570|NCT03356080|Antimetabolites|antimetabolites|mesh-ancestor
93191571|NCT03356080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191572|NCT03356080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191573|NCT03356080|Antiviral Agents|antiviral agents|mesh-ancestor
93191574|NCT03356080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191575|NCT03356080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191576|NCT03356080|Immunologic Factors|immunologic factors|mesh-ancestor
93191577|NCT03356080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191578|NCT03356080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191579|NCT03356080|Keratolytic Agents|keratolytic agents|mesh-ancestor
93191580|NCT03356080|Dermatologic Agents|dermatologic agents|mesh-ancestor
93191581|NCT03640507|Chlorhexidine|chlorhexidine|mesh-list
93191582|NCT03640507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93191583|NCT03640507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191584|NCT03640507|Disinfectants|disinfectants|mesh-ancestor
93191585|NCT02937636|Fluorides|fluorides|mesh-list
93191586|NCT02937636|Tin Fluorides|tin fluorides|mesh-list
93191587|NCT02937636|Fluorophosphate|fluorophosphate|mesh-list
93191588|NCT02937636|Cariostatic Agents|cariostatic agents|mesh-ancestor
93191589|NCT02937636|Protective Agents|protective agents|mesh-ancestor
93191590|NCT02937636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191591|NCT03638635|Bupivacaine|bupivacaine|mesh-list
93191592|NCT03638635|Anesthetics, Local|anesthetics, local|mesh-ancestor
93191593|NCT03638635|Anesthetics|anesthetics|mesh-ancestor
93191594|NCT03638635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191595|NCT03638635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191596|NCT03638635|Sensory System Agents|sensory system agents|mesh-ancestor
93191597|NCT03638635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191598|NCT02518516|Atorvastatin|atorvastatin|mesh-list
93191599|NCT02518516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93191600|NCT02518516|Simvastatin|simvastatin|mesh-list
93191601|NCT02518516|Pravastatin|pravastatin|mesh-list
93191602|NCT02518516|Lovastatin|lovastatin|mesh-list
93191603|NCT02518516|L 647318|l 647318|mesh-list
93191604|NCT02518516|Dihydromevinolin|dihydromevinolin|mesh-list
93191605|NCT02518516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93191606|NCT02518516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93191607|NCT02518516|Antimetabolites|antimetabolites|mesh-ancestor
93191608|NCT02518516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191609|NCT02518516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93191610|NCT02518516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93191611|NCT02518516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191612|NCT04508686|Capecitabine|capecitabine|mesh-list
93191613|NCT04508686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93191614|NCT04508686|Antimetabolites|antimetabolites|mesh-ancestor
93191615|NCT04508686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191616|NCT04508686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191617|NCT02518438|Tramadol|tramadol|mesh-list
93191618|NCT02518438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93191619|NCT02518438|Narcotics|narcotics|mesh-ancestor
93191620|NCT02518438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191621|NCT02518438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191622|NCT02518438|Analgesics|analgesics|mesh-ancestor
93191623|NCT02518438|Sensory System Agents|sensory system agents|mesh-ancestor
93191624|NCT02518438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191625|NCT04521556|Morphine|morphine|mesh-list
93191626|NCT04521556|Tramadol|tramadol|mesh-list
93191627|NCT04521556|Anesthetics|anesthetics|mesh-list
93191628|NCT04521556|Ropivacaine|ropivacaine|mesh-list
93191629|NCT04521556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191630|NCT04521556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191631|NCT04521556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93191632|NCT04521556|Narcotics|narcotics|mesh-ancestor
93191633|NCT04521556|Analgesics|analgesics|mesh-ancestor
93191634|NCT04521556|Sensory System Agents|sensory system agents|mesh-ancestor
93191635|NCT04521556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191637|NCT03204279|Palonosetron|palonosetron|mesh-list
93191638|NCT03204279|Antiemetics|antiemetics|mesh-ancestor
93191639|NCT03204279|Autonomic Agents|autonomic agents|mesh-ancestor
93191640|NCT03204279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191641|NCT03204279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191642|NCT03204279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93191643|NCT03204279|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93191644|NCT03204279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93191645|NCT03204279|Serotonin Agents|serotonin agents|mesh-ancestor
93191646|NCT03204279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191647|NCT03204279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191648|NCT02524301|Diprenorphine|diprenorphine|mesh-list
93191649|NCT02524301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93191650|NCT02524301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191651|NCT02524301|Sensory System Agents|sensory system agents|mesh-ancestor
93191652|NCT02524301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191653|NCT03122782|Tranexamic Acid|tranexamic acid|mesh-list
93191654|NCT03122782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93191655|NCT03122782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93191656|NCT03122782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191657|NCT03122782|Hemostatics|hemostatics|mesh-ancestor
93191658|NCT03122782|Coagulants|coagulants|mesh-ancestor
93191659|NCT01291433|Clodronic Acid|clodronic acid|mesh-list
93191660|NCT01291433|Tocopherols|tocopherols|mesh-list
93191661|NCT01291433|Vitamin E|vitamin e|mesh-list
93191662|NCT01291433|Tocotrienols|tocotrienols|mesh-list
93191663|NCT01291433|alpha-Tocopherol|alpha-tocopherol|mesh-list
93191664|NCT01291433|Pentoxifylline|pentoxifylline|mesh-list
93191665|NCT01291433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93191666|NCT01291433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191667|NCT01291433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191668|NCT01291433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93191669|NCT01291433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93191670|NCT01291433|Protective Agents|protective agents|mesh-ancestor
93191671|NCT01291433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191672|NCT01291433|Vasodilator Agents|vasodilator agents|mesh-ancestor
93191673|NCT01291433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93191674|NCT01291433|Antioxidants|antioxidants|mesh-ancestor
93191675|NCT01291433|Vitamins|vitamins|mesh-ancestor
93191676|NCT01291433|Micronutrients|micronutrients|mesh-ancestor
93191677|NCT01291433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93191678|NCT01314144|Bupivacaine|bupivacaine|mesh-list
93191679|NCT01314144|Anesthetics, Local|anesthetics, local|mesh-ancestor
93191680|NCT01314144|Anesthetics|anesthetics|mesh-ancestor
93191681|NCT01314144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191682|NCT01314144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191683|NCT01314144|Sensory System Agents|sensory system agents|mesh-ancestor
93191684|NCT01314144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191685|NCT02954653|Cytarabine|cytarabine|mesh-list
93191686|NCT02954653|Azacitidine|azacitidine|mesh-list
93191687|NCT02954653|Decitabine|decitabine|mesh-list
93191688|NCT02954653|Daunorubicin|daunorubicin|mesh-list
93191689|NCT02954653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93191690|NCT02954653|Antimetabolites|antimetabolites|mesh-ancestor
93191691|NCT02954653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191692|NCT02954653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191693|NCT02954653|Antiviral Agents|antiviral agents|mesh-ancestor
93191694|NCT02954653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191695|NCT02954653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191696|NCT02954653|Immunologic Factors|immunologic factors|mesh-ancestor
93191697|NCT02954653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191698|NCT02954653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191699|NCT02954653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93191700|NCT02954653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93191701|NCT02954653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93191702|NCT04508452|Bevacizumab|bevacizumab|mesh-list
93191703|NCT04508452|Capecitabine|capecitabine|mesh-list
93191704|NCT04508452|Oxaliplatin|oxaliplatin|mesh-list
93191705|NCT04508452|Irinotecan|irinotecan|mesh-list
93191706|NCT04508452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191707|NCT04508452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191708|NCT04508452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93191709|NCT04508452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93191710|NCT04508452|Growth Substances|growth substances|mesh-ancestor
93191711|NCT04508452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191712|NCT04508452|Growth Inhibitors|growth inhibitors|mesh-ancestor
93191713|NCT04508452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93191714|NCT04508452|Antimetabolites|antimetabolites|mesh-ancestor
93191715|NCT04508452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191716|NCT04508452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93191717|NCT04508452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93191718|NCT04508452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191719|NCT03856853|Pirfenidone|pirfenidone|mesh-list
93191720|NCT03856853|Analgesics|analgesics|mesh-ancestor
93191721|NCT03856853|Sensory System Agents|sensory system agents|mesh-ancestor
93191722|NCT03856853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191723|NCT03856853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191724|NCT03856853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93191725|NCT03856853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93191726|NCT03856853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191727|NCT03856853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191728|NCT03856853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191729|NCT03732703|Thalidomide|thalidomide|mesh-list
93191730|NCT03732703|Dexamethasone|dexamethasone|mesh-list
93191731|NCT03732703|Dexamethasone acetate|dexamethasone acetate|mesh-list
93191732|NCT03732703|Venetoclax|venetoclax|mesh-list
93191733|NCT03732703|Daratumumab|daratumumab|mesh-list
93191734|NCT03732703|Pomalidomide|pomalidomide|mesh-list
93191735|NCT03732703|Ixazomib|ixazomib|mesh-list
93191736|NCT03732703|BB 1101|bb 1101|mesh-list
93191737|NCT03732703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93191738|NCT03732703|Glycine|glycine|mesh-list
93191739|NCT03732703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191740|NCT03732703|Antiemetics|antiemetics|mesh-ancestor
93191741|NCT03732703|Autonomic Agents|autonomic agents|mesh-ancestor
93191742|NCT03732703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191743|NCT03732703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191744|NCT03732703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93191745|NCT03732703|Glucocorticoids|glucocorticoids|mesh-ancestor
93191746|NCT03732703|Hormones|hormones|mesh-ancestor
93191747|NCT03732703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191748|NCT03732703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93191749|NCT03732703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191750|NCT03732703|Protease Inhibitors|protease inhibitors|mesh-ancestor
93191751|NCT03732703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191752|NCT03732703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191753|NCT03732703|Immunologic Factors|immunologic factors|mesh-ancestor
93191754|NCT03732703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93191755|NCT03732703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93191756|NCT03732703|Growth Substances|growth substances|mesh-ancestor
93191757|NCT03732703|Growth Inhibitors|growth inhibitors|mesh-ancestor
93191758|NCT03732703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191759|NCT03732703|Leprostatic Agents|leprostatic agents|mesh-ancestor
93191760|NCT03732703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93191761|NCT03732703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191762|NCT03732703|Glycine Agents|glycine agents|mesh-ancestor
93191763|NCT03732703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191764|NCT03636555|Oxytocin|oxytocin|mesh-list
93191765|NCT03636555|Oxytocics|oxytocics|mesh-ancestor
93191766|NCT03636555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93191767|NCT03636555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191768|NCT03123016|Apremilast|apremilast|mesh-list
93191769|NCT03123016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93191770|NCT03123016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93191771|NCT03123016|Analgesics|analgesics|mesh-ancestor
93191772|NCT03123016|Sensory System Agents|sensory system agents|mesh-ancestor
93191773|NCT03123016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191774|NCT03123016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191775|NCT03123016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191776|NCT03123016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191777|NCT03123016|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93191778|NCT03123016|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93191779|NCT03123016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191780|NCT03123016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191781|NCT03636477|Nivolumab|nivolumab|mesh-list
93191782|NCT03636477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191783|NCT03636477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191784|NCT03636477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93191785|NCT03636477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191786|NCT03732001|Docetaxel|docetaxel|mesh-list
93191787|NCT03732001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191788|NCT03732001|Tubulin Modulators|tubulin modulators|mesh-ancestor
93191789|NCT03732001|Antimitotic Agents|antimitotic agents|mesh-ancestor
93191790|NCT03732001|Mitosis Modulators|mitosis modulators|mesh-ancestor
93191791|NCT03732001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191792|NCT01186835|Botulinum Toxins|botulinum toxins|mesh-list
93191793|NCT01186835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93191794|NCT01186835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93191795|NCT01186835|Hyaluronic Acid|hyaluronic acid|mesh-list
92500764|NCT02013986|Midazolam|midazolam|mesh-list
93191796|NCT01186835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93191797|NCT01186835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191798|NCT01186835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191799|NCT01186835|Cholinergic Agents|cholinergic agents|mesh-ancestor
93191800|NCT01186835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191801|NCT01186835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191802|NCT01186835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93191803|NCT01186835|Immunologic Factors|immunologic factors|mesh-ancestor
93191804|NCT01186835|Viscosupplements|viscosupplements|mesh-ancestor
93191805|NCT01186835|Protective Agents|protective agents|mesh-ancestor
93191806|NCT01186835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93191807|NCT01186835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191808|NCT03649464|Antineoplastic Agents|antineoplastic agents|mesh-list
93191809|NCT04812951|Cyclosporine|cyclosporine|mesh-list
93191810|NCT04812951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93191811|NCT04812951|Cyclosporins|cyclosporins|mesh-list
93191812|NCT04812951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191813|NCT04812951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191814|NCT04812951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191815|NCT04812951|Immunologic Factors|immunologic factors|mesh-ancestor
93191816|NCT04812951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191817|NCT04812951|Antifungal Agents|antifungal agents|mesh-ancestor
93191818|NCT04812951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191819|NCT04812951|Dermatologic Agents|dermatologic agents|mesh-ancestor
93191820|NCT04812951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93191821|NCT04812951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93191822|NCT04812951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93191823|NCT05666089|Acetylcysteine|acetylcysteine|mesh-list
93191824|NCT05666089|Calcium|calcium|mesh-list
93191825|NCT05666089|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93191826|NCT05666089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93191827|NCT05666089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191828|NCT05666089|Antiviral Agents|antiviral agents|mesh-ancestor
93191829|NCT05666089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191830|NCT05666089|Expectorants|expectorants|mesh-ancestor
93191831|NCT05666089|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191832|NCT05666089|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93191833|NCT05666089|Antioxidants|antioxidants|mesh-ancestor
93191834|NCT05666089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191835|NCT05666089|Protective Agents|protective agents|mesh-ancestor
93191836|NCT05666089|Antidotes|antidotes|mesh-ancestor
93191837|NCT03732625|Raltegravir Potassium|raltegravir potassium|mesh-list
93191838|NCT03732625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93191839|NCT03732625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93191840|NCT03732625|Antiviral Agents|antiviral agents|mesh-ancestor
93191841|NCT03732625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191842|NCT03732625|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93191843|NCT03732625|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93191844|NCT03732625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191845|NCT03732625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191846|NCT04597476|Fucoidan|fucoidan|mesh-list
93191847|NCT04597476|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93191848|NCT04597476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93191849|NCT04597476|Anticoagulants|anticoagulants|mesh-ancestor
93191850|NCT04597476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191851|NCT01188863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93191852|NCT01188863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93191853|NCT01188863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191854|NCT01188863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93191855|NCT01188863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191856|NCT02730208|Ivacaftor|ivacaftor|mesh-list
93191857|NCT02730208|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93191858|NCT02730208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191859|NCT02730208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863990|NCT04256057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93191860|NCT01291511|Iloperidone|iloperidone|mesh-list
93191861|NCT01291511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93191862|NCT01291511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93191863|NCT01291511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191864|NCT01291511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191865|NCT01291511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93191866|NCT01292213|Dimercaprol|dimercaprol|mesh-list
93191867|NCT01292213|Chelating Agents|chelating agents|mesh-ancestor
93191868|NCT01292213|Sequestering Agents|sequestering agents|mesh-ancestor
93191869|NCT01292213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191870|NCT03122938|Lactoferrin|lactoferrin|mesh-list
93191871|NCT03122938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191872|NCT04971005|Alemtuzumab|alemtuzumab|mesh-list
93191873|NCT04971005|Ocrelizumab|ocrelizumab|mesh-list
93191874|NCT04971005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93191875|NCT04971005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191876|NCT04971005|Immunologic Factors|immunologic factors|mesh-ancestor
93191877|NCT04971005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191878|NCT03782532|Prednisone|prednisone|mesh-list
93191879|NCT03782532|Prednisolone|prednisolone|mesh-list
93191880|NCT03782532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191881|NCT03782532|Glucocorticoids|glucocorticoids|mesh-ancestor
93191882|NCT03782532|Hormones|hormones|mesh-ancestor
93191883|NCT03782532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191884|NCT03782532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191885|NCT03782532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93191886|NCT03782532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191887|NCT03355768|Romidepsin|romidepsin|mesh-list
93191888|NCT03355768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93191889|NCT03355768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191890|NCT03355768|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93191891|NCT03355768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191892|NCT03355768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191893|NCT03349840|Insulin|insulin|mesh-list
93191894|NCT03349840|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93191895|NCT03349840|Insulin Glargine|insulin glargine|mesh-list
93191896|NCT03349840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93191897|NCT03349840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191898|NCT03170271|Benralizumab|benralizumab|mesh-list
93191899|NCT03170271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93191900|NCT03170271|Respiratory System Agents|respiratory system agents|mesh-ancestor
93191901|NCT03355612|Capecitabine|capecitabine|mesh-list
93191902|NCT03355612|Oxaliplatin|oxaliplatin|mesh-list
93191903|NCT03355612|Apatinib|apatinib|mesh-list
93191904|NCT03355612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93191905|NCT03355612|Antimetabolites|antimetabolites|mesh-ancestor
93191906|NCT03355612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191907|NCT03355612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191908|NCT03355612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93191909|NCT03355612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191910|NCT03732547|Poly I-C|poly i-c|mesh-list
93191911|NCT03732547|Antiviral Agents|antiviral agents|mesh-ancestor
93191912|NCT03732547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191913|NCT03732547|Interferon Inducers|interferon inducers|mesh-ancestor
93191914|NCT03732547|Immunologic Factors|immunologic factors|mesh-ancestor
93191915|NCT03732547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191916|NCT04503850|Mirabegron|mirabegron|mesh-list
93191917|NCT04503850|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
93191918|NCT04503850|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93191919|NCT04503850|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93191920|NCT04503850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93191921|NCT04503850|Adrenergic Agents|adrenergic agents|mesh-ancestor
93191922|NCT04503850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191923|NCT04503850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191924|NCT04503850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191925|NCT04503850|Urological Agents|urological agents|mesh-ancestor
93191926|NCT04503850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93191927|NCT03349684|Metformin|metformin|mesh-list
93191928|NCT03349684|Acarbose|acarbose|mesh-list
93191929|NCT03349684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93191930|NCT03349684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191931|NCT03349684|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93191932|NCT03349684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191933|NCT03349684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864071|NCT04908605|Histamine Agents|histamine agents|mesh-ancestor
93191934|NCT03856697|Gefitinib|gefitinib|mesh-list
93191935|NCT03856697|Maleic acid|maleic acid|mesh-list
93191937|NCT03856697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191938|NCT03856697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191939|NCT03856697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191940|NCT03856697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93191941|NCT03349606|Amphetamine|amphetamine|mesh-list
93191942|NCT03349606|Dextroamphetamine|dextroamphetamine|mesh-list
93191943|NCT03349606|FLB 457|flb 457|mesh-list
93191944|NCT03349606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93191945|NCT03349606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191946|NCT03349606|Sympathomimetics|sympathomimetics|mesh-ancestor
93191947|NCT03349606|Autonomic Agents|autonomic agents|mesh-ancestor
93191948|NCT03349606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93191949|NCT03349606|Dopamine Agents|dopamine agents|mesh-ancestor
93191950|NCT03349606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93191951|NCT03349606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191952|NCT03349606|Adrenergic Agents|adrenergic agents|mesh-ancestor
93191953|NCT03349606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93191954|NCT03349606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93191955|NCT03349606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93191956|NCT03349606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93191957|NCT03349606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93191958|NCT02843451|Silymarin|silymarin|mesh-list
93191959|NCT02843451|Antioxidants|antioxidants|mesh-ancestor
93191960|NCT02843451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191961|NCT02843451|Protective Agents|protective agents|mesh-ancestor
93191962|NCT02843451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191963|NCT01292525|Tacrolimus|tacrolimus|mesh-list
93191964|NCT01292525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191965|NCT01292525|Immunologic Factors|immunologic factors|mesh-ancestor
93191966|NCT01292525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191967|NCT01292525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93191968|NCT01292525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191969|NCT01292525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191970|NCT01189019|Ranibizumab|ranibizumab|mesh-list
93191971|NCT01189019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93191972|NCT01189019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93191973|NCT01189019|Growth Substances|growth substances|mesh-ancestor
93191974|NCT01189019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191975|NCT01189019|Growth Inhibitors|growth inhibitors|mesh-ancestor
93191976|NCT01189019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191977|NCT01183247|Sirolimus|sirolimus|mesh-list
93191978|NCT01183247|Prednisone|prednisone|mesh-list
93191979|NCT01183247|Everolimus|everolimus|mesh-list
93191980|NCT01183247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93191981|NCT01183247|Glucocorticoids|glucocorticoids|mesh-ancestor
93191982|NCT01183247|Hormones|hormones|mesh-ancestor
93191983|NCT01183247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93191984|NCT01183247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93191985|NCT01183247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93191986|NCT01183247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93191987|NCT01183247|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93191988|NCT01183247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93191989|NCT01183247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93191990|NCT01183247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93191991|NCT01183247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93191992|NCT01183247|Immunologic Factors|immunologic factors|mesh-ancestor
93191993|NCT01183247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93191994|NCT01183247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93191995|NCT01183247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93191996|NCT01183247|Antifungal Agents|antifungal agents|mesh-ancestor
93191997|NCT03349216|Anesthetics|anesthetics|mesh-list
93191998|NCT03349216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93191999|NCT03349216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192000|NCT04507750|Apatinib|apatinib|mesh-list
93192001|NCT04507750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192002|NCT04507750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93192003|NCT04507750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192004|NCT04507750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192005|NCT03633331|Letrozole|letrozole|mesh-list
93192006|NCT03633331|Fulvestrant|fulvestrant|mesh-list
93192007|NCT03633331|Palbociclib|palbociclib|mesh-list
93192008|NCT03633331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192009|NCT03633331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93192010|NCT03633331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93192011|NCT03633331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192012|NCT03633331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192013|NCT03633331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93192014|NCT03633331|Hormone Antagonists|hormone antagonists|mesh-ancestor
93192015|NCT03633331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192016|NCT03633331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192017|NCT03633331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93192018|NCT03633331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93192019|NCT03633331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93192020|NCT01189097|Dextromethorphan|dextromethorphan|mesh-list
93192021|NCT01189097|Antitussive Agents|antitussive agents|mesh-ancestor
93192022|NCT01189097|Respiratory System Agents|respiratory system agents|mesh-ancestor
93192023|NCT01189097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93192024|NCT01189097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93192025|NCT01189097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192026|NCT01189097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192027|NCT01189097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192028|NCT01187303|Ofatumumab|ofatumumab|mesh-list
93192029|NCT01187303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192030|NCT01187459|Vitamin D|vitamin d|mesh-list
93192031|NCT01187459|Ergocalciferols|ergocalciferols|mesh-list
93192032|NCT01187459|Cholecalciferol|cholecalciferol|mesh-list
93192033|NCT01187459|Vitamins|vitamins|mesh-list
93192034|NCT01187459|Micronutrients|micronutrients|mesh-ancestor
93192035|NCT01187459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192036|NCT01187459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93192037|NCT01187459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93192038|NCT01187537|Bupivacaine|bupivacaine|mesh-list
93192039|NCT01187537|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192040|NCT01187537|Anesthetics|anesthetics|mesh-ancestor
93192041|NCT01187537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192042|NCT01187537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192043|NCT01187537|Sensory System Agents|sensory system agents|mesh-ancestor
93192044|NCT01187537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192045|NCT03348826|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93192046|NCT03348826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93192047|NCT03348826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93192048|NCT03348826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93192049|NCT03348826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192050|NCT01290419|Vaccines|vaccines|mesh-list
93192051|NCT01290419|Immunologic Factors|immunologic factors|mesh-ancestor
93192052|NCT01290419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192053|NCT03737773|Methamphetamine|methamphetamine|mesh-list
93192054|NCT03737773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93192055|NCT03737773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192056|NCT03737773|Sympathomimetics|sympathomimetics|mesh-ancestor
93192057|NCT03737773|Autonomic Agents|autonomic agents|mesh-ancestor
93192058|NCT03737773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192059|NCT03737773|Dopamine Agents|dopamine agents|mesh-ancestor
93192060|NCT03737773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192061|NCT03737773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192062|NCT03737773|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192063|NCT03737773|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93192064|NCT03737773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93192065|NCT03737773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192066|NCT03737773|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93192067|NCT01060579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93192068|NCT01060579|Latanoprost|latanoprost|mesh-list
93192069|NCT01060579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93192070|NCT04443946|Sufentanil|sufentanil|mesh-list
93192071|NCT04443946|Propofol|propofol|mesh-list
93192072|NCT04443946|Sevoflurane|sevoflurane|mesh-list
93192073|NCT04443946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93192074|NCT04443946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192075|NCT04443946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192076|NCT04443946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192077|NCT04443946|Anesthetics, General|anesthetics, general|mesh-ancestor
93192078|NCT04443946|Anesthetics|anesthetics|mesh-ancestor
93192079|NCT04443946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93192080|NCT04443946|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93192081|NCT04443946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93192082|NCT04443946|Narcotics|narcotics|mesh-ancestor
93192083|NCT04443946|Analgesics|analgesics|mesh-ancestor
93192084|NCT04443946|Sensory System Agents|sensory system agents|mesh-ancestor
93192085|NCT04443946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192086|NCT04443946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93192087|NCT03729973|Lidocaine|lidocaine|mesh-list
93192088|NCT03729973|Magnesium Sulfate|magnesium sulfate|mesh-list
93192089|NCT03729973|Ketamine|ketamine|mesh-list
93192090|NCT03729973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93192091|NCT03729973|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192092|NCT03729973|Anesthetics|anesthetics|mesh-ancestor
93192093|NCT03729973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192094|NCT03729973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192095|NCT03729973|Sensory System Agents|sensory system agents|mesh-ancestor
93192096|NCT03729973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192097|NCT03729973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93192098|NCT03729973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93192099|NCT03729973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93192100|NCT03729973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192101|NCT03729973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192102|NCT03729973|Analgesics|analgesics|mesh-ancestor
93192103|NCT03729973|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93192104|NCT03729973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192105|NCT03729973|Anesthetics, General|anesthetics, general|mesh-ancestor
93192106|NCT03729973|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93192107|NCT03729973|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93192108|NCT03729973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192109|NCT03729973|Anticonvulsants|anticonvulsants|mesh-ancestor
93192110|NCT03729973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93192111|NCT03729973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93192112|NCT03729973|Tocolytic Agents|tocolytic agents|mesh-ancestor
93192113|NCT03729973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93192114|NCT01189253|Doxorubicin|doxorubicin|mesh-list
93192115|NCT01189253|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93192116|NCT01189253|Trabectedin|trabectedin|mesh-list
93192117|NCT01189253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93192118|NCT01189253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192119|NCT01189253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93192120|NCT01189253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93192121|NCT01189253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192122|NCT01189253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192123|NCT01189253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93192124|NCT01189253|Alkylating Agents|alkylating agents|mesh-ancestor
93192125|NCT04443868|Nitric Oxide|nitric oxide|mesh-list
93192126|NCT04443868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93192127|NCT04443868|Autonomic Agents|autonomic agents|mesh-ancestor
93192128|NCT04443868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192129|NCT04443868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192130|NCT04443868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93192131|NCT04443868|Respiratory System Agents|respiratory system agents|mesh-ancestor
93192132|NCT04443868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93192133|NCT04443868|Antioxidants|antioxidants|mesh-ancestor
93192134|NCT04443868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192135|NCT04443868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192136|NCT04443868|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93192137|NCT04443868|Vasodilator Agents|vasodilator agents|mesh-ancestor
93192138|NCT04443868|Gasotransmitters|gasotransmitters|mesh-ancestor
93192139|NCT04443868|Protective Agents|protective agents|mesh-ancestor
93192140|NCT03851393|Citric Acid|citric acid|mesh-list
93192141|NCT03851393|Sodium Citrate|sodium citrate|mesh-list
93192142|NCT03851393|Anticoagulants|anticoagulants|mesh-ancestor
93192143|NCT03851393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93192144|NCT03851393|Chelating Agents|chelating agents|mesh-ancestor
93192145|NCT03851393|Sequestering Agents|sequestering agents|mesh-ancestor
93192146|NCT03851393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192147|NCT04443556|Tramadol|tramadol|mesh-list
93192148|NCT04443556|Anesthetics|anesthetics|mesh-list
93192149|NCT04443556|Anesthetics, Local|anesthetics, local|mesh-list
93192150|NCT04443556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192151|NCT04443556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192152|NCT04443556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93192153|NCT04443556|Narcotics|narcotics|mesh-ancestor
93192154|NCT04443556|Analgesics|analgesics|mesh-ancestor
93192155|NCT04443556|Sensory System Agents|sensory system agents|mesh-ancestor
93192156|NCT04443556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192157|NCT01187615|Cisplatin|cisplatin|mesh-list
93192158|NCT01187615|Pemetrexed|pemetrexed|mesh-list
93192159|NCT01187615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192160|NCT01187615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192161|NCT01187615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192162|NCT01187615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93192163|NCT01187615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93192164|NCT05375097|Erenumab|erenumab|mesh-list
93192165|NCT05375097|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93192166|NCT05375097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192167|NCT05375097|Analgesics|analgesics|mesh-ancestor
93192168|NCT05375097|Sensory System Agents|sensory system agents|mesh-ancestor
93192169|NCT05375097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192170|NCT05375097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192171|NCT02752191|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93192172|NCT02752191|Hematinics|hematinics|mesh-ancestor
93192173|NCT02752191|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93192174|NCT02752191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93192175|NCT01290497|Hyaluronic Acid|hyaluronic acid|mesh-list
93192176|NCT01290497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93192177|NCT01290497|Immunologic Factors|immunologic factors|mesh-ancestor
93192178|NCT01290497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192179|NCT01290497|Viscosupplements|viscosupplements|mesh-ancestor
93192180|NCT01290497|Protective Agents|protective agents|mesh-ancestor
93192181|NCT04509466|Mitoxantrone|mitoxantrone|mesh-list
93192182|NCT04509466|Pegaspargase|pegaspargase|mesh-list
93192183|NCT04509466|Asparaginase|asparaginase|mesh-list
93192184|NCT04509466|Analgesics|analgesics|mesh-ancestor
93192185|NCT04509466|Sensory System Agents|sensory system agents|mesh-ancestor
93192186|NCT04509466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192187|NCT04509466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192188|NCT04509466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192189|NCT04509466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93192190|NCT04509466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93192191|NCT04509466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192192|NCT04509466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192193|NCT03738215|Cariprazine|cariprazine|mesh-list
93192194|NCT03738215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93192195|NCT03738215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93192196|NCT03738215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192197|NCT03738215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192198|NCT03738215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93192199|NCT05352321|Gemcitabine|gemcitabine|mesh-list
93192200|NCT05352321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192201|NCT05352321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93192202|NCT05352321|Antimetabolites|antimetabolites|mesh-ancestor
93192203|NCT05352321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192204|NCT03199911|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93192205|NCT03199911|Erythromycin|erythromycin|mesh-list
93192206|NCT03199911|Bacitracin|bacitracin|mesh-list
93192207|NCT03199911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192208|NCT03199911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192209|NCT03199911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93192210|NCT03199911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192211|NCT03199911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192212|NCT03199911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93192213|NCT02517814|Vitamin D|vitamin d|mesh-list
93192214|NCT02517814|Vitamins|vitamins|mesh-ancestor
93192215|NCT02517814|Micronutrients|micronutrients|mesh-ancestor
93192216|NCT02517814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192217|NCT02517814|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93192218|NCT05349201|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93192219|NCT05349201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192220|NCT05349201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192221|NCT05303727|Cyclosporine|cyclosporine|mesh-list
93192222|NCT05303727|Mycophenolic Acid|mycophenolic acid|mesh-list
93192223|NCT05303727|Cyclophosphamide|cyclophosphamide|mesh-list
93192224|NCT05303727|Melphalan|melphalan|mesh-list
93192225|NCT05303727|Busulfan|busulfan|mesh-list
93192226|NCT05303727|Thiotepa|thiotepa|mesh-list
93192227|NCT05303727|Methotrexate|methotrexate|mesh-list
93192228|NCT05303727|Fludarabine|fludarabine|mesh-list
93192229|NCT05303727|Topotecan|topotecan|mesh-list
93192230|NCT05303727|Tacrolimus|tacrolimus|mesh-list
93192231|NCT05303727|Cyclosporins|cyclosporins|mesh-list
93192232|NCT05303727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93192233|NCT05303727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192234|NCT05303727|Immunologic Factors|immunologic factors|mesh-ancestor
93192235|NCT05303727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192236|NCT05303727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93192237|NCT05303727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93192238|NCT05303727|Alkylating Agents|alkylating agents|mesh-ancestor
93192239|NCT05303727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192240|NCT05303727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192241|NCT05303727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93192242|NCT05303727|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93192243|NCT05303727|Abortifacient Agents|abortifacient agents|mesh-ancestor
93192244|NCT05303727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93192245|NCT05303727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93192246|NCT05303727|Antimetabolites|antimetabolites|mesh-ancestor
93192247|NCT05303727|Dermatologic Agents|dermatologic agents|mesh-ancestor
93192248|NCT05303727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192249|NCT05303727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93192250|NCT05303727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93192251|NCT05303727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93192252|NCT05303727|Antifungal Agents|antifungal agents|mesh-ancestor
93192253|NCT05303727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192254|NCT05303727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93192255|NCT05303727|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93192256|NCT05303727|Antitubercular Agents|antitubercular agents|mesh-ancestor
93192257|NCT05303727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93192258|NCT05303727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93192259|NCT05303727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93192260|NCT04502368|Dimercaprol|dimercaprol|mesh-list
93192261|NCT04502368|Chelating Agents|chelating agents|mesh-ancestor
93192262|NCT04502368|Sequestering Agents|sequestering agents|mesh-ancestor
93192263|NCT04502368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192264|NCT04984083|Vitamin K|vitamin k|mesh-list
93192265|NCT04984083|Vitamins|vitamins|mesh-ancestor
93192266|NCT04984083|Micronutrients|micronutrients|mesh-ancestor
93192267|NCT04984083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192268|NCT04984083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93192269|NCT04984083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93192270|NCT04984083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192271|NCT04984083|Hemostatics|hemostatics|mesh-ancestor
93192272|NCT04984083|Coagulants|coagulants|mesh-ancestor
93192273|NCT03736967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93192274|NCT03736967|Immunologic Factors|immunologic factors|mesh-ancestor
93192275|NCT03736967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192276|NCT01581203|Interferons|interferons|mesh-list
93192277|NCT01581203|Ribavirin|ribavirin|mesh-list
93192278|NCT01581203|Interferon-alpha|interferon-alpha|mesh-list
93192279|NCT01581203|Interferon alpha-2|interferon alpha-2|mesh-list
93192280|NCT01581203|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93192281|NCT01581203|Asunaprevir|asunaprevir|mesh-list
93192282|NCT01581203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192283|NCT01581203|Antiviral Agents|antiviral agents|mesh-ancestor
93192284|NCT01581203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192285|NCT01581203|Antimetabolites|antimetabolites|mesh-ancestor
93192286|NCT01581203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192287|NCT01581203|Immunologic Factors|immunologic factors|mesh-ancestor
93192288|NCT01581203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192289|NCT01581203|Protease Inhibitors|protease inhibitors|mesh-ancestor
93192290|NCT01581203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192291|NCT03168555|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
93192292|NCT03168555|Cathartics|cathartics|mesh-ancestor
93192293|NCT03168555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192294|NCT03235050|Liraglutide|liraglutide|mesh-list
93192295|NCT03235050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192296|NCT03235050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192297|NCT03235050|Incretins|incretins|mesh-ancestor
93192298|NCT03235050|Hormones|hormones|mesh-ancestor
93192299|NCT03235050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192300|NCT04933149|Ketamine|ketamine|mesh-list
93192301|NCT04933149|Analgesics|analgesics|mesh-ancestor
93192302|NCT04933149|Sensory System Agents|sensory system agents|mesh-ancestor
93192303|NCT04933149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192304|NCT04933149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192305|NCT04933149|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93192306|NCT04933149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192307|NCT04933149|Anesthetics, General|anesthetics, general|mesh-ancestor
93192308|NCT04933149|Anesthetics|anesthetics|mesh-ancestor
92855628|NCT00779259|Purinergic Agents|purinergic agents|mesh-ancestor
93192309|NCT04933149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192310|NCT04933149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93192311|NCT04933149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93192312|NCT04933149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192313|NCT04933149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192314|NCT01189721|Propofol|propofol|mesh-list
93192315|NCT01189721|Sevoflurane|sevoflurane|mesh-list
93192316|NCT01189721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93192317|NCT01189721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192318|NCT01189721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192319|NCT01189721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192320|NCT01189721|Anesthetics, General|anesthetics, general|mesh-ancestor
93192321|NCT01189721|Anesthetics|anesthetics|mesh-ancestor
93192322|NCT01189721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93192323|NCT01189721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93192324|NCT03167619|Durvalumab|durvalumab|mesh-list
93192325|NCT03167619|Olaparib|olaparib|mesh-list
93192326|NCT03167619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192327|NCT03167619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192328|NCT03167619|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93192329|NCT03167619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192330|NCT03167619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192331|NCT03198507|Amoxicillin|amoxicillin|mesh-list
93192332|NCT03198507|Rifabutin|rifabutin|mesh-list
93192333|NCT03198507|Omeprazole|omeprazole|mesh-list
93192334|NCT03198507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93192335|NCT03198507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192336|NCT03198507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93192337|NCT03198507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192338|NCT03198507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93192339|NCT03198507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192340|NCT03198507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192341|NCT03198507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93192342|NCT03198507|Antitubercular Agents|antitubercular agents|mesh-ancestor
93192343|NCT03850769|Paclitaxel|paclitaxel|mesh-list
93192344|NCT03850769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93192345|NCT03850769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192346|NCT03850769|Tubulin Modulators|tubulin modulators|mesh-ancestor
93192347|NCT03850769|Antimitotic Agents|antimitotic agents|mesh-ancestor
93192348|NCT03850769|Mitosis Modulators|mitosis modulators|mesh-ancestor
93192349|NCT03850769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192350|NCT04663464|Abaloparatide|abaloparatide|mesh-list
93192351|NCT04663464|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
93192352|NCT04663464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93192353|NCT04663464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192354|NCT04663464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93192355|NCT01292993|Metformin|metformin|mesh-list
93192356|NCT01292993|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93192357|NCT01292993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192358|NCT01292993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192359|NCT01292993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93192360|NCT01292993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192361|NCT03849833|Vitamin D|vitamin d|mesh-list
93192362|NCT03849833|Cholecalciferol|cholecalciferol|mesh-list
93192363|NCT03849833|Vitamins|vitamins|mesh-ancestor
93192364|NCT03849833|Micronutrients|micronutrients|mesh-ancestor
93192365|NCT03849833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192366|NCT03849833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93192367|NCT03849833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93192368|NCT03167151|Pembrolizumab|pembrolizumab|mesh-list
93192369|NCT03167151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192370|NCT03167151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192371|NCT03167151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93192372|NCT03167151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192373|NCT01191203|Copper|copper|mesh-list
93192374|NCT01191203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93192375|NCT01191203|Medroxyprogesterone|medroxyprogesterone|mesh-list
93192376|NCT01191203|Trace Elements|trace elements|mesh-ancestor
93192377|NCT01191203|Micronutrients|micronutrients|mesh-ancestor
93192378|NCT01191203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192379|NCT01191203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93192380|NCT01191203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93192381|NCT01191203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93192382|NCT01191203|Contraceptive Agents|contraceptive agents|mesh-ancestor
93192383|NCT01191203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93192384|NCT01191203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93192385|NCT01191203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93192386|NCT01191203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93192387|NCT01191203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93192388|NCT01191203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192389|NCT03197883|Sunscreening Agents|sunscreening agents|mesh-list
93192390|NCT03197883|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93192391|NCT03197883|Protective Agents|protective agents|mesh-ancestor
93192392|NCT03197883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192393|NCT03197883|Dermatologic Agents|dermatologic agents|mesh-ancestor
93192394|NCT03729505|Lidocaine|lidocaine|mesh-list
93192395|NCT03729505|Magnesium Sulfate|magnesium sulfate|mesh-list
93192396|NCT03729505|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192397|NCT03729505|Anesthetics|anesthetics|mesh-ancestor
93192398|NCT03729505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192399|NCT03729505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192400|NCT03729505|Sensory System Agents|sensory system agents|mesh-ancestor
93192401|NCT03729505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192402|NCT03729505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93192403|NCT03729505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93192404|NCT03729505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93192405|NCT03729505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192406|NCT03729505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192407|NCT03729505|Analgesics|analgesics|mesh-ancestor
93192408|NCT03729505|Anticonvulsants|anticonvulsants|mesh-ancestor
93192409|NCT03729505|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93192410|NCT03729505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93192411|NCT03729505|Tocolytic Agents|tocolytic agents|mesh-ancestor
93192412|NCT03729505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93192413|NCT03234036|Ritonavir|ritonavir|mesh-list
93192414|NCT03234036|GSK-2838232|gsk-2838232|mesh-list
93192415|NCT03234036|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93192416|NCT03234036|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93192417|NCT03234036|Protease Inhibitors|protease inhibitors|mesh-ancestor
93192418|NCT03234036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192419|NCT03234036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192420|NCT03234036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93192421|NCT03234036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93192422|NCT03234036|Antiviral Agents|antiviral agents|mesh-ancestor
93192423|NCT03234036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192424|NCT03234036|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93192425|NCT03234036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93192426|NCT03606109|Tranexamic Acid|tranexamic acid|mesh-list
93192427|NCT03606109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93192428|NCT03606109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93192429|NCT03606109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192430|NCT03606109|Hemostatics|hemostatics|mesh-ancestor
93192431|NCT03606109|Coagulants|coagulants|mesh-ancestor
93192432|NCT01191359|Immunomodulating Agents|immunomodulating agents|mesh-list
93192433|NCT01191359|Immunologic Factors|immunologic factors|mesh-ancestor
93192434|NCT01191359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192435|NCT01293071|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93192436|NCT01293071|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93192437|NCT01293071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192438|NCT01293071|Antitubercular Agents|antitubercular agents|mesh-ancestor
93192439|NCT01193855|Dutasteride|dutasteride|mesh-list
93192440|NCT01193855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93192441|NCT01193855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93192442|NCT01193855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192443|NCT01193855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192444|NCT01193855|Hormone Antagonists|hormone antagonists|mesh-ancestor
93192445|NCT01193855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192446|NCT01193855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192447|NCT01190345|Bevacizumab|bevacizumab|mesh-list
93192448|NCT01190345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192449|NCT01190345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192450|NCT01190345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93192451|NCT01190345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93192452|NCT01190345|Growth Substances|growth substances|mesh-ancestor
93192453|NCT01190345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192454|NCT01190345|Growth Inhibitors|growth inhibitors|mesh-ancestor
93192455|NCT02729896|Rituximab|rituximab|mesh-list
93192456|NCT02729896|Atezolizumab|atezolizumab|mesh-list
93192457|NCT02729896|Obinutuzumab|obinutuzumab|mesh-list
93192458|NCT02729896|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93192459|NCT02729896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192460|NCT02729896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192461|NCT02729896|Immunologic Factors|immunologic factors|mesh-ancestor
93192462|NCT02729896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192463|NCT02729896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93192464|NCT02729896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93192465|NCT02729896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192466|NCT02729896|Immunoconjugates|immunoconjugates|mesh-ancestor
93192467|NCT04540380|Cyclophosphamide|cyclophosphamide|mesh-list
93192468|NCT04540380|Rituximab|rituximab|mesh-list
93192469|NCT04540380|Fludarabine|fludarabine|mesh-list
93192470|NCT04540380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192471|NCT04540380|Immunologic Factors|immunologic factors|mesh-ancestor
93192472|NCT04540380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192473|NCT04540380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93192474|NCT04540380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93192475|NCT04540380|Alkylating Agents|alkylating agents|mesh-ancestor
93192476|NCT04540380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192477|NCT04540380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192478|NCT04540380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93192479|NCT04540380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192480|NCT04506034|Lidocaine|lidocaine|mesh-list
93192481|NCT04506034|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192482|NCT04506034|Anesthetics|anesthetics|mesh-ancestor
93192483|NCT04506034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192484|NCT04506034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192485|NCT04506034|Sensory System Agents|sensory system agents|mesh-ancestor
93192486|NCT04506034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192487|NCT04506034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93192488|NCT04506034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93192489|NCT04506034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93192490|NCT04506034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192491|NCT04506034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192492|NCT01294631|Canagliflozin|canagliflozin|mesh-list
93192493|NCT01294631|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93192494|NCT01294631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192495|NCT01294631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192496|NCT01294631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192497|NCT03849209|Pancrelipase|pancrelipase|mesh-list
93192498|NCT03849209|Pancreatin|pancreatin|mesh-list
93192499|NCT03849209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192500|NCT05342662|Methamphetamine|methamphetamine|mesh-list
93192501|NCT05342662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93192502|NCT05342662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192503|NCT05342662|Sympathomimetics|sympathomimetics|mesh-ancestor
93192504|NCT05342662|Autonomic Agents|autonomic agents|mesh-ancestor
93192505|NCT05342662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192506|NCT05342662|Dopamine Agents|dopamine agents|mesh-ancestor
93192507|NCT05342662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192508|NCT05342662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192509|NCT05342662|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192510|NCT05342662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93192511|NCT05342662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93192512|NCT05342662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192513|NCT05342662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93192514|NCT03847571|Acetazolamide|acetazolamide|mesh-list
93192515|NCT03847571|Anticonvulsants|anticonvulsants|mesh-ancestor
93192516|NCT03847571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93192517|NCT03847571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192518|NCT03847571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192519|NCT03847571|Diuretics|diuretics|mesh-ancestor
93192520|NCT03847571|Natriuretic Agents|natriuretic agents|mesh-ancestor
93192521|NCT03847571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192522|NCT01293149|Clonidine|clonidine|mesh-list
93192523|NCT01293149|Ropivacaine|ropivacaine|mesh-list
93192524|NCT01293149|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192525|NCT01293149|Anesthetics|anesthetics|mesh-ancestor
93192526|NCT01293149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192527|NCT01293149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192528|NCT01293149|Sensory System Agents|sensory system agents|mesh-ancestor
93192529|NCT01293149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192530|NCT01293149|Analgesics|analgesics|mesh-ancestor
93192531|NCT01293149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93192532|NCT01293149|Sympatholytics|sympatholytics|mesh-ancestor
93192533|NCT01293149|Autonomic Agents|autonomic agents|mesh-ancestor
93192534|NCT01293149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93192535|NCT01293149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93192536|NCT01293149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93192537|NCT01293149|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192538|NCT01293149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192539|NCT01293149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192540|NCT03575065|Pamiparib|pamiparib|mesh-list
93192541|NCT03575065|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93192542|NCT03575065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192543|NCT03575065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192544|NCT03575065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192545|NCT04454424|Midazolam|midazolam|mesh-list
93192546|NCT04454424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93192547|NCT04454424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93192548|NCT04454424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192549|NCT04454424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192550|NCT04454424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93192551|NCT04454424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93192552|NCT04454424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93192553|NCT04454424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192554|NCT04454424|Anesthetics, General|anesthetics, general|mesh-ancestor
93192555|NCT04454424|Anesthetics|anesthetics|mesh-ancestor
93192556|NCT04454424|GABA Modulators|gaba modulators|mesh-ancestor
93192557|NCT04454424|GABA Agents|gaba agents|mesh-ancestor
93192558|NCT04454424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192559|NCT04454424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192560|NCT03348046|Infliximab|infliximab|mesh-list
93192561|NCT03348046|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93192562|NCT03348046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192563|NCT03348046|Dermatologic Agents|dermatologic agents|mesh-ancestor
93192564|NCT03348046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192565|NCT03348046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93192566|NCT05653492|Sulforaphane|sulforaphane|mesh-list
93192567|NCT05653492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93192568|NCT05653492|Protective Agents|protective agents|mesh-ancestor
93192569|NCT05653492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192570|NCT05653492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192571|NCT04505644|Lidocaine|lidocaine|mesh-list
93192572|NCT04505644|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192573|NCT04505644|Anesthetics|anesthetics|mesh-ancestor
93192574|NCT04505644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192575|NCT04505644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192576|NCT04505644|Sensory System Agents|sensory system agents|mesh-ancestor
93192577|NCT04505644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192578|NCT04505644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93192579|NCT04505644|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93192580|NCT04505644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93192581|NCT04505644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192582|NCT04505644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192583|NCT04505800|Tryptophan|tryptophan|mesh-list
93192584|NCT04505800|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93192585|NCT04505800|Antidepressive Agents|antidepressive agents|mesh-ancestor
93192586|NCT04505800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93192587|NCT05200156|Choline|choline|mesh-list
93192588|NCT05200156|Lipotropic Agents|lipotropic agents|mesh-ancestor
93192589|NCT05200156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93192590|NCT05200156|Antimetabolites|antimetabolites|mesh-ancestor
93192591|NCT05200156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192592|NCT05200156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192593|NCT05200156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93192594|NCT05200156|Nootropic Agents|nootropic agents|mesh-ancestor
93192595|NCT03347968|Warfarin|warfarin|mesh-list
93192596|NCT03347968|Esmolol|esmolol|mesh-list
93192597|NCT03347968|Anticoagulants|anticoagulants|mesh-ancestor
93192598|NCT03347968|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93192599|NCT03347968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93192600|NCT03347968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93192601|NCT03347968|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192602|NCT03347968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192603|NCT03347968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192604|NCT03347968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192605|NCT01191593|Ropivacaine|ropivacaine|mesh-list
93192606|NCT01191593|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192607|NCT01191593|Anesthetics|anesthetics|mesh-ancestor
93192608|NCT01191593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192609|NCT01191593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192610|NCT01191593|Sensory System Agents|sensory system agents|mesh-ancestor
93192611|NCT01191593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192612|NCT03347890|Liraglutide|liraglutide|mesh-list
93192613|NCT03347890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192614|NCT03347890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192615|NCT03347890|Incretins|incretins|mesh-ancestor
93192616|NCT03347890|Hormones|hormones|mesh-ancestor
93192617|NCT03347890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192618|NCT01296503|Thalidomide|thalidomide|mesh-list
93192619|NCT01296503|Dexamethasone|dexamethasone|mesh-list
93192620|NCT01296503|Dexamethasone acetate|dexamethasone acetate|mesh-list
93192621|NCT01296503|BB 1101|bb 1101|mesh-list
93192622|NCT01296503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192623|NCT01296503|Antiemetics|antiemetics|mesh-ancestor
93192624|NCT01296503|Autonomic Agents|autonomic agents|mesh-ancestor
93192625|NCT01296503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192626|NCT01296503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192627|NCT01296503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192628|NCT01296503|Glucocorticoids|glucocorticoids|mesh-ancestor
93192629|NCT01296503|Hormones|hormones|mesh-ancestor
93192630|NCT01296503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192631|NCT01296503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93192632|NCT01296503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192633|NCT01296503|Protease Inhibitors|protease inhibitors|mesh-ancestor
93192634|NCT01296503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192635|NCT01296503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192636|NCT01296503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192637|NCT01296503|Immunologic Factors|immunologic factors|mesh-ancestor
93192638|NCT01296503|Leprostatic Agents|leprostatic agents|mesh-ancestor
93192639|NCT01296503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93192640|NCT01296503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192641|NCT01296503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93192642|NCT01296503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93192643|NCT01296503|Growth Substances|growth substances|mesh-ancestor
93192644|NCT01296503|Growth Inhibitors|growth inhibitors|mesh-ancestor
93192645|NCT01295099|Triamcinolone|triamcinolone|mesh-list
93192646|NCT01295099|Fluorouracil|fluorouracil|mesh-list
93192647|NCT01295099|Antimetabolites|antimetabolites|mesh-ancestor
93192648|NCT01295099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192649|NCT01295099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93192650|NCT01295099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192651|NCT01295099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192652|NCT01295099|Immunologic Factors|immunologic factors|mesh-ancestor
93192653|NCT01295099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192654|NCT01295099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192655|NCT01295099|Glucocorticoids|glucocorticoids|mesh-ancestor
93192656|NCT01295099|Hormones|hormones|mesh-ancestor
93192657|NCT01295099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192658|NCT01426529|Norepinephrine|norepinephrine|mesh-list
93192659|NCT01426529|Angiotensin II|angiotensin ii|mesh-list
93192660|NCT01426529|Giapreza|giapreza|mesh-list
93192661|NCT01426529|Angiotensinogen|angiotensinogen|mesh-list
93192662|NCT01426529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93192663|NCT01426529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93192664|NCT01426529|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192665|NCT01426529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192666|NCT01426529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192667|NCT01426529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192668|NCT01426529|Sympathomimetics|sympathomimetics|mesh-ancestor
93192669|NCT01426529|Autonomic Agents|autonomic agents|mesh-ancestor
93192670|NCT01426529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192671|NCT01426529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93192672|NCT01426529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93192673|NCT01426529|Protease Inhibitors|protease inhibitors|mesh-ancestor
93192674|NCT01426529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192675|NCT03122158|Escitalopram|escitalopram|mesh-list
93192676|NCT03122158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93192677|NCT03122158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93192678|NCT03122158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192679|NCT03122158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192680|NCT03122158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192681|NCT03122158|Serotonin Agents|serotonin agents|mesh-ancestor
93192682|NCT03122158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192683|NCT02668653|Cytarabine|cytarabine|mesh-list
93192684|NCT02668653|Daunorubicin|daunorubicin|mesh-list
93192685|NCT02668653|Idarubicin|idarubicin|mesh-list
93192686|NCT02668653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93192687|NCT02668653|Antimetabolites|antimetabolites|mesh-ancestor
93192688|NCT02668653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192689|NCT02668653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192690|NCT02668653|Antiviral Agents|antiviral agents|mesh-ancestor
93192691|NCT02668653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192692|NCT02668653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192693|NCT02668653|Immunologic Factors|immunologic factors|mesh-ancestor
93192694|NCT02668653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192695|NCT02668653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93192696|NCT02668653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93192697|NCT02668653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93192698|NCT02668653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192699|NCT03555565|Metformin|metformin|mesh-list
93192700|NCT03555565|Alogliptin|alogliptin|mesh-list
93192701|NCT03555565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192702|NCT03555565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192703|NCT03555565|Incretins|incretins|mesh-ancestor
93192704|NCT03555565|Hormones|hormones|mesh-ancestor
93192705|NCT03555565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192706|NCT03555565|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93192707|NCT03555565|Protease Inhibitors|protease inhibitors|mesh-ancestor
93192708|NCT03555565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192709|NCT03555565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192710|NCT01190735|Caffeine|caffeine|mesh-list
93192711|NCT01190735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93192712|NCT01190735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192713|NCT01190735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93192714|NCT01190735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192715|NCT01190735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192716|NCT01190735|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93192717|NCT01190735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93192718|NCT01190735|Purinergic Agents|purinergic agents|mesh-ancestor
93192719|NCT01190735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192720|NCT05097118|Ketamine|ketamine|mesh-list
93192721|NCT05097118|Bupivacaine|bupivacaine|mesh-list
93192722|NCT05097118|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192723|NCT05097118|Anesthetics|anesthetics|mesh-ancestor
93192724|NCT05097118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192725|NCT05097118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192726|NCT05097118|Sensory System Agents|sensory system agents|mesh-ancestor
93192727|NCT05097118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192728|NCT05097118|Analgesics|analgesics|mesh-ancestor
93192729|NCT05097118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93192730|NCT05097118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192731|NCT05097118|Anesthetics, General|anesthetics, general|mesh-ancestor
93192732|NCT05097118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93192733|NCT05097118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93192734|NCT05097118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192735|NCT05097118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192736|NCT01194791|Dexamethasone|dexamethasone|mesh-list
93192737|NCT01194791|Cyclophosphamide|cyclophosphamide|mesh-list
93192738|NCT01194791|Lenalidomide|lenalidomide|mesh-list
93192739|NCT01194791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192740|NCT01194791|Immunologic Factors|immunologic factors|mesh-ancestor
93192741|NCT01194791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192742|NCT01194791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93192743|NCT01194791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93192744|NCT01194791|Alkylating Agents|alkylating agents|mesh-ancestor
93192745|NCT01194791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192746|NCT01194791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192747|NCT01194791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93192748|NCT01194791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192749|NCT01194791|Antiemetics|antiemetics|mesh-ancestor
93192750|NCT01194791|Autonomic Agents|autonomic agents|mesh-ancestor
93192751|NCT01194791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192752|NCT01194791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192753|NCT01194791|Glucocorticoids|glucocorticoids|mesh-ancestor
93192754|NCT01194791|Hormones|hormones|mesh-ancestor
93192755|NCT01194791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192756|NCT01194791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93192757|NCT01194791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93192758|NCT01194791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93192759|NCT01194791|Growth Substances|growth substances|mesh-ancestor
93192760|NCT01194791|Growth Inhibitors|growth inhibitors|mesh-ancestor
93192761|NCT03351322|Minoxidil|minoxidil|mesh-list
93192762|NCT03351322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93192763|NCT03351322|Vasodilator Agents|vasodilator agents|mesh-ancestor
93192764|NCT01296971|Ribavirin|ribavirin|mesh-list
93192765|NCT01296971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93192766|NCT01296971|Antimetabolites|antimetabolites|mesh-ancestor
93192767|NCT01296971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192768|NCT01296971|Antiviral Agents|antiviral agents|mesh-ancestor
93192769|NCT01296971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192770|NCT01195181|Ribavirin|ribavirin|mesh-list
93192771|NCT01195181|Antimetabolites|antimetabolites|mesh-ancestor
93192772|NCT01195181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192773|NCT01195181|Antiviral Agents|antiviral agents|mesh-ancestor
93192774|NCT01195181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192775|NCT01197053|Immunomodulating Agents|immunomodulating agents|mesh-list
93192776|NCT01197053|Immunologic Factors|immunologic factors|mesh-ancestor
93192777|NCT01197053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192778|NCT03845699|Fentanyl|fentanyl|mesh-list
93192779|NCT03845699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93192780|NCT03845699|Narcotics|narcotics|mesh-ancestor
93192781|NCT03845699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192782|NCT03845699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192783|NCT03845699|Analgesics|analgesics|mesh-ancestor
93192784|NCT03845699|Sensory System Agents|sensory system agents|mesh-ancestor
93192785|NCT03845699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192786|NCT03845699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93192787|NCT03845699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192788|NCT03845699|Anesthetics, General|anesthetics, general|mesh-ancestor
93192789|NCT03845699|Anesthetics|anesthetics|mesh-ancestor
93192790|NCT03845777|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93192791|NCT03845777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192792|NCT00709618|Vinorelbine|vinorelbine|mesh-list
93192793|NCT00709618|Lapatinib|lapatinib|mesh-list
93192794|NCT00709618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93192795|NCT00709618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192796|NCT00709618|Tubulin Modulators|tubulin modulators|mesh-ancestor
93192797|NCT00709618|Antimitotic Agents|antimitotic agents|mesh-ancestor
93192798|NCT00709618|Mitosis Modulators|mitosis modulators|mesh-ancestor
93192799|NCT00709618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192800|NCT00709618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93192801|NCT00709618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192802|NCT01195259|Metformin|metformin|mesh-list
93192803|NCT01195259|Rosiglitazone|rosiglitazone|mesh-list
93192804|NCT01195259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192805|NCT01195259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192806|NCT05584228|Infliximab|infliximab|mesh-list
93192807|NCT05584228|Azathioprine|azathioprine|mesh-list
93192808|NCT05584228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93192809|NCT05584228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192810|NCT05584228|Dermatologic Agents|dermatologic agents|mesh-ancestor
93192811|NCT05584228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192812|NCT05584228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93192813|NCT05584228|Antimetabolites|antimetabolites|mesh-ancestor
93192814|NCT05584228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192815|NCT05584228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93192816|NCT05584228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192817|NCT05584228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93192818|NCT05584228|Immunologic Factors|immunologic factors|mesh-ancestor
93192819|NCT05584228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192820|NCT03193047|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93192821|NCT03193047|Evolocumab|evolocumab|mesh-list
93192822|NCT03193047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93192823|NCT03193047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93192824|NCT03193047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93192825|NCT03193047|Antimetabolites|antimetabolites|mesh-ancestor
93192826|NCT03193047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192827|NCT03193047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93192828|NCT03193047|Protease Inhibitors|protease inhibitors|mesh-ancestor
93192829|NCT03193047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192830|NCT03193047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93192831|NCT03193047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192832|NCT03193047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192833|NCT04504552|Avelumab|avelumab|mesh-list
93192834|NCT04504552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93192835|NCT04504552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192836|NCT03845387|Pramipexole|pramipexole|mesh-list
93192837|NCT03845387|Antioxidants|antioxidants|mesh-ancestor
93192838|NCT03845387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192839|NCT03845387|Protective Agents|protective agents|mesh-ancestor
93192840|NCT03845387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192841|NCT03845387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93192842|NCT03845387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93192843|NCT03845387|Dopamine Agonists|dopamine agonists|mesh-ancestor
93192844|NCT03845387|Dopamine Agents|dopamine agents|mesh-ancestor
93192845|NCT03845387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192847|NCT01295177|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93192848|NCT01295177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93192849|NCT01295177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192850|NCT02918019|Astegolimab|astegolimab|mesh-list
93192851|NCT02918019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93192852|NCT02918019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192853|NCT02918019|Antiviral Agents|antiviral agents|mesh-ancestor
93192854|NCT02918019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93192855|NCT04848454|Vinorelbine|vinorelbine|mesh-list
93192856|NCT04848454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192857|NCT04848454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93192858|NCT04848454|Tubulin Modulators|tubulin modulators|mesh-ancestor
93192859|NCT04848454|Antimitotic Agents|antimitotic agents|mesh-ancestor
93192860|NCT04848454|Mitosis Modulators|mitosis modulators|mesh-ancestor
93192861|NCT04848454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192862|NCT04842292|Heparin|heparin|mesh-list
93192863|NCT04842292|Anticoagulants|anticoagulants|mesh-ancestor
93192864|NCT04842292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93192865|NCT04842292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93192866|NCT04842292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192867|NCT01191983|Epoetin Alfa|epoetin alfa|mesh-list
93192868|NCT01191983|Hematinics|hematinics|mesh-ancestor
93192869|NCT03055988|Fluticasone|fluticasone|mesh-list
93192870|NCT03055988|Xhance|xhance|mesh-list
93192871|NCT03055988|Tiotropium Bromide|tiotropium bromide|mesh-list
93192872|NCT03055988|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93192873|NCT03055988|Olodaterol|olodaterol|mesh-list
93192874|NCT03055988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192875|NCT03055988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93192876|NCT03055988|Autonomic Agents|autonomic agents|mesh-ancestor
93192877|NCT03055988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192878|NCT03055988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192879|NCT03055988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93192880|NCT03055988|Respiratory System Agents|respiratory system agents|mesh-ancestor
93192881|NCT03055988|Dermatologic Agents|dermatologic agents|mesh-ancestor
93192882|NCT03055988|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93192883|NCT03055988|Parasympatholytics|parasympatholytics|mesh-ancestor
93192884|NCT03055988|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93192885|NCT03055988|Cholinergic Agents|cholinergic agents|mesh-ancestor
93192886|NCT03055988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192887|NCT03055988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192888|NCT03055988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93192889|NCT03055988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93192890|NCT03055988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93192891|NCT03055988|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192892|NCT03346642|Decitabine|decitabine|mesh-list
93192893|NCT03346642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93192894|NCT03346642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93192895|NCT03346642|Antimetabolites|antimetabolites|mesh-ancestor
93192896|NCT03346642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192897|NCT03346642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192898|NCT03346642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192899|NCT03346642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488755|NCT01947465|Vaccines|vaccines|mesh-list
93192900|NCT02912949|Immunoglobulin G|immunoglobulin g|mesh-list
93192901|NCT02912949|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93192902|NCT02912949|Immunologic Factors|immunologic factors|mesh-ancestor
93192903|NCT02912949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192904|NCT01250912|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93192905|NCT01250912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192906|NCT01250912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93192907|NCT01250912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192908|NCT01250912|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93192909|NCT04789304|Midazolam|midazolam|mesh-list
93192910|NCT04789304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93192911|NCT04789304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93192912|NCT04789304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192913|NCT04789304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192914|NCT04789304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93192915|NCT04789304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93192916|NCT04789304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93192917|NCT04789304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93192918|NCT04789304|Anesthetics, General|anesthetics, general|mesh-ancestor
93192919|NCT04789304|Anesthetics|anesthetics|mesh-ancestor
93192920|NCT04789304|GABA Modulators|gaba modulators|mesh-ancestor
93192921|NCT04789304|GABA Agents|gaba agents|mesh-ancestor
93192922|NCT04789304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192923|NCT04789304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192924|NCT04780724|Nitrox|nitrox|mesh-list
93192925|NCT04780724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93192926|NCT04780724|Protective Agents|protective agents|mesh-ancestor
93192927|NCT04780724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192928|NCT03128866|Tranexamic Acid|tranexamic acid|mesh-list
93192929|NCT03128866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93192930|NCT03128866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93192931|NCT03128866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192932|NCT03128866|Hemostatics|hemostatics|mesh-ancestor
93192933|NCT03128866|Coagulants|coagulants|mesh-ancestor
93192934|NCT05583214|Dexamethasone|dexamethasone|mesh-list
93192935|NCT05583214|Ondansetron|ondansetron|mesh-list
93192936|NCT05583214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93192937|NCT05583214|Antiemetics|antiemetics|mesh-ancestor
93192938|NCT05583214|Autonomic Agents|autonomic agents|mesh-ancestor
93192939|NCT05583214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192940|NCT05583214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192941|NCT05583214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93192942|NCT05583214|Glucocorticoids|glucocorticoids|mesh-ancestor
93192943|NCT05583214|Hormones|hormones|mesh-ancestor
93192944|NCT05583214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93192945|NCT05583214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93192946|NCT05583214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192947|NCT05583214|Antipruritics|antipruritics|mesh-ancestor
93192948|NCT05583214|Dermatologic Agents|dermatologic agents|mesh-ancestor
93192949|NCT05583214|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93192950|NCT05583214|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93192951|NCT05583214|Serotonin Agents|serotonin agents|mesh-ancestor
93192952|NCT05583214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192953|NCT05583214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192954|NCT02871297|Vortioxetine|vortioxetine|mesh-list
93192955|NCT02871297|Antidepressive Agents|antidepressive agents|mesh-ancestor
93192956|NCT02871297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93192957|NCT02871297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93192958|NCT02871297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93192959|NCT02871297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192960|NCT02871297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192961|NCT02871297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93192962|NCT02871297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93192963|NCT02871297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192964|NCT02871297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192965|NCT02871297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192966|NCT02871297|Serotonin Agents|serotonin agents|mesh-ancestor
93192967|NCT02871297|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93192968|NCT02871297|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93192969|NCT02871297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93192970|NCT02871297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93192971|NCT03628430|Lidocaine|lidocaine|mesh-list
93192972|NCT03628430|Epinephrine|epinephrine|mesh-list
93192973|NCT03628430|Anesthetics, Local|anesthetics, local|mesh-ancestor
93192974|NCT03628430|Anesthetics|anesthetics|mesh-ancestor
93192975|NCT03628430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93192976|NCT03628430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93192977|NCT03628430|Sensory System Agents|sensory system agents|mesh-ancestor
93192978|NCT03628430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93192979|NCT03628430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93192980|NCT03628430|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93192981|NCT03628430|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93192982|NCT03628430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93192983|NCT03628430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93192984|NCT03628430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93192985|NCT03628430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92865115|NCT05207358|Mycophenolic Acid|mycophenolic acid|mesh-list
93192986|NCT03628430|Adrenergic Agents|adrenergic agents|mesh-ancestor
93192987|NCT03628430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93192988|NCT03628430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93192989|NCT03628430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93192990|NCT03628430|Autonomic Agents|autonomic agents|mesh-ancestor
93192991|NCT03628430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93192992|NCT03628430|Respiratory System Agents|respiratory system agents|mesh-ancestor
93192993|NCT03628430|Mydriatics|mydriatics|mesh-ancestor
93192994|NCT03628430|Sympathomimetics|sympathomimetics|mesh-ancestor
93192995|NCT03628430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93192996|NCT03121846|Apatinib|apatinib|mesh-list
93192997|NCT03121846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93192998|NCT03121846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93192999|NCT03121846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193000|NCT03121846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193001|NCT03122314|Acetaminophen|acetaminophen|mesh-list
93193002|NCT03122314|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93193003|NCT03122314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193004|NCT03122314|Analgesics|analgesics|mesh-ancestor
93193005|NCT03122314|Sensory System Agents|sensory system agents|mesh-ancestor
93193006|NCT03122314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193007|NCT03122314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193008|NCT03122314|Antipyretics|antipyretics|mesh-ancestor
93193009|NCT03122314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93193010|NCT03122314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193011|NCT03122314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193012|NCT03554005|Acetaminophen|acetaminophen|mesh-list
93193013|NCT03554005|Interferons|interferons|mesh-list
93193014|NCT03554005|Interferon-alpha|interferon-alpha|mesh-list
93193015|NCT03554005|Interferon alpha-2|interferon alpha-2|mesh-list
93193016|NCT03554005|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93193017|NCT03554005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193018|NCT03554005|Antiviral Agents|antiviral agents|mesh-ancestor
93193019|NCT03554005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193020|NCT03554005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193021|NCT03554005|Analgesics|analgesics|mesh-ancestor
93193022|NCT03554005|Sensory System Agents|sensory system agents|mesh-ancestor
93193023|NCT03554005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193024|NCT03554005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193025|NCT03554005|Antipyretics|antipyretics|mesh-ancestor
93193026|NCT03554005|Immunologic Factors|immunologic factors|mesh-ancestor
93193027|NCT00709228|Ribavirin|ribavirin|mesh-list
93193028|NCT00709228|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93193029|NCT00709228|Antimetabolites|antimetabolites|mesh-ancestor
93193030|NCT00709228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193031|NCT00709228|Antiviral Agents|antiviral agents|mesh-ancestor
93193032|NCT00709228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193033|NCT01584557|Tolvaptan|tolvaptan|mesh-list
93193034|NCT01584557|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93193035|NCT01584557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193036|NCT01584557|Natriuretic Agents|natriuretic agents|mesh-ancestor
93193037|NCT01584557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193038|NCT05214872|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93193039|NCT05214872|Calcium|calcium|mesh-list
93193040|NCT05214872|Mitogens|mitogens|mesh-list
93193041|NCT05214872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93193042|NCT05214872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193043|NCT05214872|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193044|NCT05214872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193045|NCT05214872|Natriuretic Agents|natriuretic agents|mesh-ancestor
93193046|NCT01195571|Vaccines|vaccines|mesh-list
93193047|NCT01195571|Immunologic Factors|immunologic factors|mesh-ancestor
93193048|NCT01195571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193049|NCT03219372|Pravastatin|pravastatin|mesh-list
93193050|NCT03219372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93193051|NCT03219372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93193052|NCT03219372|Antimetabolites|antimetabolites|mesh-ancestor
93193053|NCT03219372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193054|NCT03219372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93193055|NCT03219372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93193056|NCT03219372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193057|NCT03304080|Trastuzumab|trastuzumab|mesh-list
93193058|NCT03304080|Pertuzumab|pertuzumab|mesh-list
93193059|NCT03304080|Palbociclib|palbociclib|mesh-list
93193060|NCT03304080|Anastrozole|anastrozole|mesh-list
93193061|NCT03304080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193062|NCT03304080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193063|NCT03304080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93193064|NCT03304080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193065|NCT03304080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193066|NCT03304080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93193067|NCT03304080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93193068|NCT03304080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93193069|NCT03304080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93193070|NCT03304080|Hormone Antagonists|hormone antagonists|mesh-ancestor
93193071|NCT03304080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193072|NCT03304080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193073|NCT02422641|Methotrexate|methotrexate|mesh-list
93193074|NCT02422641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93193075|NCT02422641|Abortifacient Agents|abortifacient agents|mesh-ancestor
93193076|NCT02422641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193077|NCT02422641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193078|NCT02422641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93193079|NCT02422641|Antimetabolites|antimetabolites|mesh-ancestor
93193080|NCT02422641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193081|NCT02422641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193082|NCT02422641|Dermatologic Agents|dermatologic agents|mesh-ancestor
93193083|NCT02422641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193084|NCT02422641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93193085|NCT02422641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193086|NCT02422641|Immunologic Factors|immunologic factors|mesh-ancestor
93193087|NCT02422641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193088|NCT02422641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93193089|NCT03628040|Ropivacaine|ropivacaine|mesh-list
93193090|NCT03628040|Anesthetics, Local|anesthetics, local|mesh-ancestor
93193091|NCT03628040|Anesthetics|anesthetics|mesh-ancestor
93193092|NCT03628040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193093|NCT03628040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193094|NCT03628040|Sensory System Agents|sensory system agents|mesh-ancestor
93193095|NCT03628040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193096|NCT04715763|Telmisartan|telmisartan|mesh-list
93193097|NCT04715763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93193098|NCT04715763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93193099|NCT04715763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93193100|NCT04715763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193101|NCT04338828|Nitric Oxide|nitric oxide|mesh-list
93193102|NCT04338828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93193103|NCT04338828|Autonomic Agents|autonomic agents|mesh-ancestor
93193104|NCT04338828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193105|NCT04338828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193106|NCT04338828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93193107|NCT04338828|Respiratory System Agents|respiratory system agents|mesh-ancestor
93193108|NCT04338828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93193109|NCT04338828|Antioxidants|antioxidants|mesh-ancestor
93193110|NCT04338828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193111|NCT04338828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193112|NCT04338828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93193113|NCT04338828|Vasodilator Agents|vasodilator agents|mesh-ancestor
93193114|NCT04338828|Gasotransmitters|gasotransmitters|mesh-ancestor
93193115|NCT04338828|Protective Agents|protective agents|mesh-ancestor
93193116|NCT01295567|Dipyridamole|dipyridamole|mesh-list
93193117|NCT01295567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93193118|NCT01295567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193119|NCT01295567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193120|NCT01295567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93193121|NCT01295567|Vasodilator Agents|vasodilator agents|mesh-ancestor
93193122|NCT01192529|Phentermine|phentermine|mesh-list
93193123|NCT01192529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93193124|NCT01192529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193125|NCT01192529|Appetite Depressants|appetite depressants|mesh-ancestor
93193126|NCT01192529|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93193127|NCT01192529|Sympathomimetics|sympathomimetics|mesh-ancestor
93193128|NCT01192529|Autonomic Agents|autonomic agents|mesh-ancestor
93193129|NCT01192529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193130|NCT01192529|Adrenergic Agents|adrenergic agents|mesh-ancestor
93193131|NCT01192529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193132|NCT01192529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193133|NCT01195649|Sorafenib|sorafenib|mesh-list
93193134|NCT01195649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865284|NCT00924443|Clofarabine|clofarabine|mesh-list
93193135|NCT01195649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93193136|NCT01195649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193137|NCT01195649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193138|NCT01195727|Apixaban|apixaban|mesh-list
93193139|NCT01195727|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93193140|NCT01195727|Antithrombins|antithrombins|mesh-ancestor
93193141|NCT01195727|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93193142|NCT01195727|Protease Inhibitors|protease inhibitors|mesh-ancestor
93193143|NCT01195727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193144|NCT01195727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193145|NCT01195727|Anticoagulants|anticoagulants|mesh-ancestor
93193146|NCT04958876|Naltrexone|naltrexone|mesh-list
93193147|NCT04958876|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93193148|NCT04958876|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93193149|NCT04958876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193150|NCT04958876|Sensory System Agents|sensory system agents|mesh-ancestor
93193151|NCT04958876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193152|NCT01195805|Amiloride|amiloride|mesh-list
93193153|NCT01195805|Spironolactone|spironolactone|mesh-list
93193154|NCT01195805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93193155|NCT01195805|Hormone Antagonists|hormone antagonists|mesh-ancestor
93193156|NCT01195805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193157|NCT01195805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193158|NCT01195805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93193159|NCT01195805|Diuretics|diuretics|mesh-ancestor
93193160|NCT01195805|Natriuretic Agents|natriuretic agents|mesh-ancestor
93193161|NCT01195805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93193162|NCT01195805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93193163|NCT01195805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193164|NCT01195805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193165|NCT01195805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93193166|NCT04899986|Chlorhexidine|chlorhexidine|mesh-list
93193167|NCT04899986|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93193168|NCT04899986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193169|NCT04899986|Disinfectants|disinfectants|mesh-ancestor
93193170|NCT01791478|Letrozole|letrozole|mesh-list
93193171|NCT01791478|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
93193172|NCT01791478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193173|NCT01791478|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93193174|NCT01791478|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93193175|NCT01791478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193176|NCT01791478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193177|NCT01791478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93193178|NCT01791478|Hormone Antagonists|hormone antagonists|mesh-ancestor
93193179|NCT01791478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193180|NCT01791478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193181|NCT03845153|Metformin|metformin|mesh-list
93193182|NCT03845153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93193183|NCT03845153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193184|NCT00198718|Vitamin A|vitamin a|mesh-list
93193185|NCT00198718|Retinol palmitate|retinol palmitate|mesh-list
93193186|NCT00198718|Vitamins|vitamins|mesh-ancestor
93193187|NCT00198718|Micronutrients|micronutrients|mesh-ancestor
93193188|NCT00198718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193189|NCT00198718|Antioxidants|antioxidants|mesh-ancestor
93193190|NCT00198718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193191|NCT00198718|Protective Agents|protective agents|mesh-ancestor
93193192|NCT00198718|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93193193|NCT00198718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193194|NCT04500808|Macitentan|macitentan|mesh-list
93193195|NCT04500808|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93193196|NCT04500808|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93193197|NCT04500808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193198|NCT04500808|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93193199|NCT01192763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93193200|NCT01192763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93193201|NCT01192763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193202|NCT01192763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193203|NCT04539548|Prednisolone|prednisolone|mesh-list
93193204|NCT04539548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865337|NCT04255121|Adrenergic Agents|adrenergic agents|mesh-ancestor
93193206|NCT04539548|Hormones|hormones|mesh-ancestor
93193207|NCT04539548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193208|NCT04539548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193209|NCT04539548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93193210|NCT04539548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193211|NCT00708916|Apremilast|apremilast|mesh-list
93193212|NCT00708916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93193213|NCT00708916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193214|NCT00708916|Analgesics|analgesics|mesh-ancestor
93193215|NCT00708916|Sensory System Agents|sensory system agents|mesh-ancestor
93193216|NCT00708916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193217|NCT00708916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193218|NCT00708916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193219|NCT00708916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193220|NCT00708916|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93193221|NCT00708916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93193222|NCT00708916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193223|NCT00708916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193224|NCT02352753|Denosumab|denosumab|mesh-list
93193225|NCT02352753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93193226|NCT02352753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193227|NCT04245514|Durvalumab|durvalumab|mesh-list
93193228|NCT04245514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193229|NCT04245514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193230|NCT02517736|Sorafenib|sorafenib|mesh-list
93193231|NCT02517736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193232|NCT02517736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93193233|NCT02517736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193234|NCT02517736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193235|NCT03727971|Omalizumab|omalizumab|mesh-list
93193236|NCT03727971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93193237|NCT03727971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93193238|NCT03727971|Respiratory System Agents|respiratory system agents|mesh-ancestor
93193239|NCT03844841|Dexmedetomidine|dexmedetomidine|mesh-list
93193240|NCT03844841|Propofol|propofol|mesh-list
93193241|NCT03844841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93193242|NCT03844841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193243|NCT03844841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193244|NCT03844841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193245|NCT03844841|Analgesics|analgesics|mesh-ancestor
93193246|NCT03844841|Sensory System Agents|sensory system agents|mesh-ancestor
93193247|NCT03844841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193248|NCT03844841|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93193249|NCT03844841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93193250|NCT03844841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93193251|NCT03844841|Adrenergic Agents|adrenergic agents|mesh-ancestor
93193252|NCT03844841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193253|NCT03844841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193254|NCT03844841|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93193255|NCT03844841|Anesthetics, General|anesthetics, general|mesh-ancestor
93193256|NCT03844841|Anesthetics|anesthetics|mesh-ancestor
93193257|NCT03197766|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
93193258|NCT03197766|Natriuretic Agents|natriuretic agents|mesh-ancestor
93193259|NCT03197766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193260|NCT04501900|Clopidogrel|clopidogrel|mesh-list
93193261|NCT04501900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93193262|NCT04501900|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93193263|NCT04501900|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93193264|NCT04501900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93193265|NCT04501900|Purinergic Agents|purinergic agents|mesh-ancestor
93193266|NCT04501900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193267|NCT04501900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193268|NCT04501900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193269|NCT03637556|Deferasirox|deferasirox|mesh-list
93193270|NCT03637556|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93193271|NCT03637556|Chelating Agents|chelating agents|mesh-ancestor
93193272|NCT03637556|Sequestering Agents|sequestering agents|mesh-ancestor
93193273|NCT03637556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193274|NCT04641351|Triamcinolone|triamcinolone|mesh-list
93193275|NCT04641351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93193276|NCT04641351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93193277|NCT04641351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93193278|NCT04641351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193279|NCT04641351|Glucocorticoids|glucocorticoids|mesh-ancestor
93193280|NCT04641351|Hormones|hormones|mesh-ancestor
93193281|NCT04641351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193282|NCT04641351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193283|NCT04641351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193284|NCT04641351|Immunologic Factors|immunologic factors|mesh-ancestor
93193285|NCT04641351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193286|NCT04641351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193287|NCT01193387|Insulin|insulin|mesh-list
93193288|NCT01193387|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93193289|NCT01193387|Insulin, Long-Acting|insulin, long-acting|mesh-list
93193290|NCT01193387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93193291|NCT01193387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193292|NCT01198223|Nystatin|nystatin|mesh-list
93193293|NCT01198223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193294|NCT01198223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193295|NCT01198223|Antifungal Agents|antifungal agents|mesh-ancestor
93193296|NCT01198223|Ionophores|ionophores|mesh-ancestor
93193297|NCT01198223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193298|NCT01198223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193299|NCT01193465|Anesthetics|anesthetics|mesh-list
93193300|NCT01193465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193301|NCT01193465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193302|NCT03347344|Riluzole|riluzole|mesh-list
93193303|NCT03347344|Anticonvulsants|anticonvulsants|mesh-ancestor
93193304|NCT03347344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93193305|NCT03347344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93193306|NCT03347344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193307|NCT03347344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193308|NCT03347344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193309|NCT03347344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93193310|NCT03347344|Protective Agents|protective agents|mesh-ancestor
93193311|NCT04220866|Pembrolizumab|pembrolizumab|mesh-list
93193312|NCT04220866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193313|NCT04220866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193314|NCT04220866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93193315|NCT04220866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193316|NCT03173456|Acetaminophen|acetaminophen|mesh-list
93193317|NCT03173456|Ibuprofen|ibuprofen|mesh-list
93193318|NCT03173456|Oxycodone|oxycodone|mesh-list
93193319|NCT03173456|Hydrocodone|hydrocodone|mesh-list
93193320|NCT03173456|Codeine|codeine|mesh-list
93193321|NCT03173456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93193322|NCT03173456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193323|NCT03173456|Analgesics|analgesics|mesh-ancestor
93193324|NCT03173456|Sensory System Agents|sensory system agents|mesh-ancestor
93193325|NCT03173456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193326|NCT03173456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193327|NCT03173456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193328|NCT03173456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193329|NCT03173456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93193330|NCT03173456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193331|NCT03173456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193332|NCT03173456|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93193333|NCT03173456|Narcotics|narcotics|mesh-ancestor
93193334|NCT03173456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193335|NCT03173456|Antipyretics|antipyretics|mesh-ancestor
93193336|NCT03173456|Antitussive Agents|antitussive agents|mesh-ancestor
93193337|NCT03173456|Respiratory System Agents|respiratory system agents|mesh-ancestor
93193338|NCT01193621|Haloperidol|haloperidol|mesh-list
93193339|NCT01193621|Haloperidol decanoate|haloperidol decanoate|mesh-list
93193340|NCT01193621|Antiemetics|antiemetics|mesh-ancestor
93193341|NCT01193621|Autonomic Agents|autonomic agents|mesh-ancestor
93193342|NCT01193621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193343|NCT01193621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193344|NCT01193621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193345|NCT01193621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93193346|NCT01193621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93193347|NCT01193621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193348|NCT01193621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93193349|NCT01193621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93193350|NCT01193621|Dopamine Agents|dopamine agents|mesh-ancestor
93193351|NCT01193621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193352|NCT01193621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193353|NCT01193621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93193355|NCT02517424|Hallucinogens|hallucinogens|mesh-ancestor
93193356|NCT02517424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193357|NCT02517424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93193358|NCT02517424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193359|NCT02517424|Analgesics|analgesics|mesh-ancestor
93193360|NCT02517424|Sensory System Agents|sensory system agents|mesh-ancestor
93193361|NCT02517424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193362|NCT02517424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93193363|NCT02517424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93193364|NCT02517424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193365|NCT02517424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193366|NCT02517424|Hormones|hormones|mesh-ancestor
93193367|NCT02517424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193368|NCT01567904|Semuloparin|semuloparin|mesh-list
93193369|NCT01567904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93193370|NCT01567904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93193371|NCT01567904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193372|NCT01196507|Carvedilol|carvedilol|mesh-list
93193373|NCT01196507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93193374|NCT01196507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93193375|NCT01196507|Adrenergic Agents|adrenergic agents|mesh-ancestor
93193376|NCT01196507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193377|NCT01196507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193378|NCT01196507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193379|NCT01196507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93193380|NCT01196507|Antioxidants|antioxidants|mesh-ancestor
93193381|NCT01196507|Protective Agents|protective agents|mesh-ancestor
93193382|NCT01196507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93193383|NCT01196507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193384|NCT01196507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93193385|NCT01196507|Vasodilator Agents|vasodilator agents|mesh-ancestor
93193386|NCT01196507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93193387|NCT01196507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93193388|NCT05670509|Midazolam|midazolam|mesh-list
93193389|NCT05670509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93193390|NCT05670509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93193391|NCT05670509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193392|NCT05670509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193393|NCT05670509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93193394|NCT05670509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93193395|NCT05670509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93193396|NCT05670509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93193397|NCT05670509|Anesthetics, General|anesthetics, general|mesh-ancestor
93193398|NCT05670509|Anesthetics|anesthetics|mesh-ancestor
93193399|NCT05670509|GABA Modulators|gaba modulators|mesh-ancestor
93193400|NCT05670509|GABA Agents|gaba agents|mesh-ancestor
93193401|NCT05670509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193402|NCT05670509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193403|NCT05282771|Nicotinic Acids|nicotinic acids|mesh-list
93193404|NCT05282771|Clobetasol|clobetasol|mesh-list
93193405|NCT05282771|Halobetasol|halobetasol|mesh-list
93193406|NCT05282771|Tazarotene|tazarotene|mesh-list
93193407|NCT05282771|Dermatologic Agents|dermatologic agents|mesh-ancestor
93193408|NCT05282771|Keratolytic Agents|keratolytic agents|mesh-ancestor
93193409|NCT05282771|Vitamin B Complex|vitamin b complex|mesh-ancestor
93193410|NCT05282771|Vitamins|vitamins|mesh-ancestor
93193411|NCT05282771|Micronutrients|micronutrients|mesh-ancestor
93193412|NCT05282771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193413|NCT05282771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93193414|NCT05282771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193415|NCT05282771|Glucocorticoids|glucocorticoids|mesh-ancestor
93193416|NCT05282771|Hormones|hormones|mesh-ancestor
93193417|NCT05282771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193418|NCT05487833|Insulin|insulin|mesh-list
93193419|NCT05487833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93193420|NCT05487833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193421|NCT03600805|Prednisone|prednisone|mesh-list
93193422|NCT03600805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193423|NCT03600805|Glucocorticoids|glucocorticoids|mesh-ancestor
93193424|NCT03600805|Hormones|hormones|mesh-ancestor
93193425|NCT03600805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193426|NCT03600805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193427|NCT03600805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93193429|NCT01198379|Aspirin|aspirin|mesh-list
93193430|NCT01198379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93193431|NCT01198379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193432|NCT01198379|Analgesics|analgesics|mesh-ancestor
93193433|NCT01198379|Sensory System Agents|sensory system agents|mesh-ancestor
93193434|NCT01198379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193435|NCT01198379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193436|NCT01198379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193437|NCT01198379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193438|NCT01198379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93193439|NCT01198379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93193440|NCT01198379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193441|NCT01198379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93193442|NCT01198379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93193443|NCT01198379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193444|NCT01198379|Antipyretics|antipyretics|mesh-ancestor
93193445|NCT03848039|Vaccines|vaccines|mesh-list
93193446|NCT03848039|Immunologic Factors|immunologic factors|mesh-ancestor
93193447|NCT03848039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193448|NCT01296269|Vasopressins|vasopressins|mesh-list
93193449|NCT01296269|Arginine Vasopressin|arginine vasopressin|mesh-list
93193450|NCT01296269|Oxytocin|oxytocin|mesh-list
93193451|NCT01296269|Oxytocics|oxytocics|mesh-ancestor
93193452|NCT01296269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193453|NCT01296269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193454|NCT01296269|Hemostatics|hemostatics|mesh-ancestor
93193455|NCT01296269|Coagulants|coagulants|mesh-ancestor
93193456|NCT01296269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93193457|NCT01296269|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93193458|NCT01296269|Natriuretic Agents|natriuretic agents|mesh-ancestor
93193459|NCT05595772|Mitogens|mitogens|mesh-list
93193460|NCT05595772|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193461|NCT05595772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193462|NCT03844451|Epinephrine|epinephrine|mesh-list
93193463|NCT03844451|Bupivacaine|bupivacaine|mesh-list
93193464|NCT03844451|Anesthetics, Local|anesthetics, local|mesh-ancestor
93193465|NCT03844451|Anesthetics|anesthetics|mesh-ancestor
93193466|NCT03844451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193467|NCT03844451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193468|NCT03844451|Sensory System Agents|sensory system agents|mesh-ancestor
93193469|NCT03844451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193470|NCT03844451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93193471|NCT03844451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93193472|NCT03844451|Adrenergic Agents|adrenergic agents|mesh-ancestor
93193473|NCT03844451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193474|NCT03844451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193475|NCT03844451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93193476|NCT03844451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93193477|NCT03844451|Autonomic Agents|autonomic agents|mesh-ancestor
93193478|NCT03844451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93193479|NCT03844451|Respiratory System Agents|respiratory system agents|mesh-ancestor
93193480|NCT03844451|Mydriatics|mydriatics|mesh-ancestor
93193481|NCT03844451|Sympathomimetics|sympathomimetics|mesh-ancestor
93193482|NCT03844451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93193483|NCT03346096|Thiotepa|thiotepa|mesh-list
93193484|NCT03346096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93193485|NCT03346096|Alkylating Agents|alkylating agents|mesh-ancestor
93193486|NCT03346096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193487|NCT03346096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193488|NCT03346096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93193489|NCT03346096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193490|NCT03346096|Immunologic Factors|immunologic factors|mesh-ancestor
93193491|NCT03346096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193492|NCT01198457|Clodronic Acid|clodronic acid|mesh-list
93193493|NCT01198457|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93193494|NCT01198457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193495|NCT03386214|Pevonedistat|pevonedistat|mesh-list
93193496|NCT03386214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193497|NCT03386214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193498|NCT01198535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93193499|NCT01198535|Cetuximab|cetuximab|mesh-list
93193500|NCT01198535|Antibodies|antibodies|mesh-list
93193501|NCT01198535|Immunoglobulins|immunoglobulins|mesh-list
92865644|NCT00644319|Ibuprofen|ibuprofen|mesh-list
93193502|NCT01198535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93193503|NCT01198535|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93193504|NCT01198535|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93193505|NCT01198535|Immunologic Factors|immunologic factors|mesh-ancestor
93193506|NCT01198535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193507|NCT01198535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193508|NCT01198535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193509|NCT01198535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193510|NCT05081219|Insulin|insulin|mesh-list
93193511|NCT05081219|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93193512|NCT05081219|Empagliflozin|empagliflozin|mesh-list
93193513|NCT05081219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93193514|NCT05081219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193515|NCT05081219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93193516|NCT05081219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193517|NCT03860038|Dexamethasone|dexamethasone|mesh-list
93193518|NCT03860038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193519|NCT03860038|Antiemetics|antiemetics|mesh-ancestor
93193520|NCT03860038|Autonomic Agents|autonomic agents|mesh-ancestor
93193521|NCT03860038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193522|NCT03860038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193523|NCT03860038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193524|NCT03860038|Glucocorticoids|glucocorticoids|mesh-ancestor
93193525|NCT03860038|Hormones|hormones|mesh-ancestor
93193526|NCT03860038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193527|NCT03860038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93193528|NCT03860038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193529|NCT03844763|Cyclophosphamide|cyclophosphamide|mesh-list
93193530|NCT03844763|Avelumab|avelumab|mesh-list
93193531|NCT03844763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193532|NCT03844763|Immunologic Factors|immunologic factors|mesh-ancestor
93193533|NCT03844763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193534|NCT03844763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193535|NCT03844763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93193536|NCT03844763|Alkylating Agents|alkylating agents|mesh-ancestor
93193537|NCT03844763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193538|NCT03844763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193539|NCT03844763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93193540|NCT03844763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193541|NCT01198925|Piperacillin|piperacillin|mesh-list
93193542|NCT01198925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193543|NCT01198925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193544|NCT03844139|Glycerol|glycerol|mesh-list
93193545|NCT03844139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93193546|NCT03844139|Protective Agents|protective agents|mesh-ancestor
93193547|NCT03844139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193548|NCT04500496|Isoniazid|isoniazid|mesh-list
93193549|NCT04500496|Dinoprostone|dinoprostone|mesh-list
93193550|NCT04500496|Oxytocics|oxytocics|mesh-ancestor
93193551|NCT04500496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193552|NCT04500496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193553|NCT04500496|Antitubercular Agents|antitubercular agents|mesh-ancestor
93193554|NCT04500496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193555|NCT04500496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193556|NCT04500496|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93193557|NCT04500496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93193558|NCT04500496|Antimetabolites|antimetabolites|mesh-ancestor
93193559|NCT04500496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193560|NCT04500496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93193561|NCT01199081|Dronedarone|dronedarone|mesh-list
93193562|NCT01199081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93193563|NCT04989335|Fludarabine|fludarabine|mesh-list
93193564|NCT04989335|Clofarabine|clofarabine|mesh-list
93193565|NCT04989335|Bisantrene|bisantrene|mesh-list
93193566|NCT04989335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193567|NCT04989335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93193568|NCT04989335|Antimetabolites|antimetabolites|mesh-ancestor
93193569|NCT04989335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193570|NCT04989335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93193571|NCT03345940|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93193572|NCT03345940|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93193573|NCT03345940|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93193574|NCT03345940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193575|NCT03345940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193576|NCT03345940|Immunologic Factors|immunologic factors|mesh-ancestor
93193577|NCT03345940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193578|NCT03345940|Dermatologic Agents|dermatologic agents|mesh-ancestor
93193579|NCT05670353|Contraceptive Agents|contraceptive agents|mesh-list
93193580|NCT05670353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-list
93193581|NCT05670353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193582|NCT05670353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193583|NCT01199159|Vitamin B 6|vitamin b 6|mesh-list
93193584|NCT01199159|Pyridoxal|pyridoxal|mesh-list
93193585|NCT01199159|Pyridoxine|pyridoxine|mesh-list
93193586|NCT01199159|Misoprostol|misoprostol|mesh-list
93193587|NCT01199159|Vitamins|vitamins|mesh-ancestor
93193588|NCT01199159|Micronutrients|micronutrients|mesh-ancestor
93193589|NCT01199159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193590|NCT01199159|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93193591|NCT01199159|Abortifacient Agents|abortifacient agents|mesh-ancestor
93193592|NCT01199159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193593|NCT01199159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93193594|NCT01199159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193595|NCT01199159|Oxytocics|oxytocics|mesh-ancestor
93193596|NCT01199159|Vitamin B Complex|vitamin b complex|mesh-ancestor
93193597|NCT05669963|Lactoferrin|lactoferrin|mesh-list
93193598|NCT05669963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193599|NCT02507440|Lidocaine|lidocaine|mesh-list
93193600|NCT02507440|Propofol|propofol|mesh-list
93193601|NCT02507440|Anesthetics, Local|anesthetics, local|mesh-ancestor
93193602|NCT02507440|Anesthetics|anesthetics|mesh-ancestor
93193603|NCT02507440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193604|NCT02507440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193605|NCT02507440|Sensory System Agents|sensory system agents|mesh-ancestor
93193606|NCT02507440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193607|NCT02507440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93193608|NCT02507440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93193609|NCT02507440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93193610|NCT02507440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193611|NCT02507440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193612|NCT02507440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93193613|NCT02507440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93193614|NCT02507440|Anesthetics, General|anesthetics, general|mesh-ancestor
93193615|NCT02507362|Riboflavin|riboflavin|mesh-list
93193616|NCT02507362|Dextrans|dextrans|mesh-list
93193617|NCT02507362|Vitamin B Complex|vitamin b complex|mesh-ancestor
93193618|NCT02507362|Vitamins|vitamins|mesh-ancestor
93193619|NCT02507362|Micronutrients|micronutrients|mesh-ancestor
93193620|NCT02507362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193621|NCT02507362|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93193622|NCT02507362|Dermatologic Agents|dermatologic agents|mesh-ancestor
93193623|NCT02507362|Anticoagulants|anticoagulants|mesh-ancestor
93193624|NCT02507362|Plasma Substitutes|plasma substitutes|mesh-ancestor
93193625|NCT02507362|Blood Substitutes|blood substitutes|mesh-ancestor
93193626|NCT05640830|Paclitaxel|paclitaxel|mesh-list
93193627|NCT05640830|Bevacizumab|bevacizumab|mesh-list
93193628|NCT05640830|Trastuzumab|trastuzumab|mesh-list
93193629|NCT05640830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93193630|NCT05640830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193631|NCT05640830|Tubulin Modulators|tubulin modulators|mesh-ancestor
93193632|NCT05640830|Antimitotic Agents|antimitotic agents|mesh-ancestor
93193633|NCT05640830|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193634|NCT05640830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193635|NCT05640830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193636|NCT05640830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92855637|NCT00779259|Analgesics|analgesics|mesh-ancestor
93193637|NCT05640830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93193638|NCT05640830|Growth Substances|growth substances|mesh-ancestor
93193639|NCT05640830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193640|NCT05640830|Growth Inhibitors|growth inhibitors|mesh-ancestor
93193641|NCT03730961|Furosemide|furosemide|mesh-list
93193642|NCT03730961|Diuretics|diuretics|mesh-ancestor
93193643|NCT03730961|Natriuretic Agents|natriuretic agents|mesh-ancestor
93193644|NCT03730961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193645|NCT03730961|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93193646|NCT03730961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193647|NCT03730961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193648|NCT01078454|Dexamethasone|dexamethasone|mesh-list
93193649|NCT01078454|Bortezomib|bortezomib|mesh-list
93193650|NCT01078454|Melphalan|melphalan|mesh-list
93193651|NCT01078454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193652|NCT01078454|Antiemetics|antiemetics|mesh-ancestor
93193653|NCT01078454|Autonomic Agents|autonomic agents|mesh-ancestor
93193654|NCT01078454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193655|NCT01078454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193656|NCT01078454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193657|NCT01078454|Glucocorticoids|glucocorticoids|mesh-ancestor
93193659|NCT01078454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193660|NCT01078454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93193661|NCT01078454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193662|NCT01078454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93193663|NCT01078454|Alkylating Agents|alkylating agents|mesh-ancestor
93193664|NCT01078454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193665|NCT01078454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93193666|NCT01078454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193667|NCT01078454|Immunologic Factors|immunologic factors|mesh-ancestor
93193668|NCT02968602|Minocycline|minocycline|mesh-list
93193669|NCT02968602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193670|NCT02968602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193671|NCT03345004|Vitamin D|vitamin d|mesh-list
93193672|NCT03345004|Ergocalciferols|ergocalciferols|mesh-list
93193673|NCT03345004|Cholecalciferol|cholecalciferol|mesh-list
93193674|NCT03345004|Vitamins|vitamins|mesh-list
93193675|NCT03345004|Micronutrients|micronutrients|mesh-ancestor
93193676|NCT03345004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193677|NCT03345004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93193678|NCT03345004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93193679|NCT03034356|Levetiracetam|levetiracetam|mesh-list
93193680|NCT03034356|Anticonvulsants|anticonvulsants|mesh-ancestor
93193681|NCT03034356|Nootropic Agents|nootropic agents|mesh-ancestor
93193682|NCT03003468|Pembrolizumab|pembrolizumab|mesh-list
93193683|NCT03003468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193684|NCT03003468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193685|NCT03003468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93193686|NCT03003468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193687|NCT03345628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93193688|NCT03345628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193689|NCT03345628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193690|NCT03552523|Pancrelipase|pancrelipase|mesh-list
93193691|NCT03552523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193692|NCT03728101|Dabigatran|dabigatran|mesh-list
93193693|NCT03728101|Simvastatin|simvastatin|mesh-list
93193694|NCT03728101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93193695|NCT03728101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93193696|NCT03728101|Antimetabolites|antimetabolites|mesh-ancestor
93193697|NCT03728101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193698|NCT03728101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93193699|NCT03728101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93193700|NCT03728101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193701|NCT03728101|Antithrombins|antithrombins|mesh-ancestor
93193702|NCT03728101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93193703|NCT03728101|Protease Inhibitors|protease inhibitors|mesh-ancestor
93193704|NCT03728101|Anticoagulants|anticoagulants|mesh-ancestor
93193705|NCT03844217|Tryptophan|tryptophan|mesh-list
93193706|NCT03844217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93193707|NCT03844217|Antidepressive Agents|antidepressive agents|mesh-ancestor
93193708|NCT03844217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93193709|NCT04170972|Insulin|insulin|mesh-list
93193710|NCT04170972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93193711|NCT04170972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193712|NCT02515864|Moxifloxacin|moxifloxacin|mesh-list
93193713|NCT02515864|Dotinurad|dotinurad|mesh-list
93193714|NCT02515864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93193715|NCT02515864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193716|NCT02515864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193717|NCT02515864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93193718|NCT02515864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93193719|NCT02515864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193720|NCT02515864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193721|NCT02515864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193722|NCT02515864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93193723|NCT02515864|Contraceptive Agents|contraceptive agents|mesh-ancestor
93193724|NCT02515864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193725|NCT02515864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193726|NCT02515864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93193727|NCT02515864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93193728|NCT02515864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93193729|NCT02515864|Uricosuric Agents|uricosuric agents|mesh-ancestor
93193730|NCT02515864|Gout Suppressants|gout suppressants|mesh-ancestor
93193731|NCT02515864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193732|NCT02507206|Dihydrexidine|dihydrexidine|mesh-list
93193733|NCT02507206|Dopamine Agonists|dopamine agonists|mesh-ancestor
93193734|NCT02507206|Dopamine Agents|dopamine agents|mesh-ancestor
93193735|NCT02507206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93193736|NCT02507206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193737|NCT02507206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193738|NCT02892409|Amoxicillin|amoxicillin|mesh-list
93193739|NCT02892409|Clarithromycin|clarithromycin|mesh-list
93193740|NCT02892409|Lansoprazole|lansoprazole|mesh-list
93193741|NCT02892409|Dexlansoprazole|dexlansoprazole|mesh-list
93193742|NCT02892409|Bismuth|bismuth|mesh-list
93193743|NCT02892409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193744|NCT02892409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193745|NCT02892409|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93193746|NCT02892409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193747|NCT02892409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193748|NCT02892409|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93193749|NCT02892409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93193750|NCT02892409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93193751|NCT02892409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193752|NCT02892409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93193753|NCT02892409|Antacids|antacids|mesh-ancestor
93193754|NCT02507128|Liraglutide|liraglutide|mesh-list
93193755|NCT02507128|Glucagon|glucagon|mesh-list
93193756|NCT02507128|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93193757|NCT02507128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93193758|NCT02507128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193759|NCT02507128|Incretins|incretins|mesh-ancestor
93193760|NCT02507128|Hormones|hormones|mesh-ancestor
93193761|NCT02507128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193762|NCT02507128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193763|NCT03844529|Lidocaine|lidocaine|mesh-list
93193764|NCT03844529|Anesthetics, Local|anesthetics, local|mesh-ancestor
93193765|NCT03844529|Anesthetics|anesthetics|mesh-ancestor
93193766|NCT03844529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193767|NCT03844529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193768|NCT03844529|Sensory System Agents|sensory system agents|mesh-ancestor
93193769|NCT03844529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193770|NCT03844529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93193771|NCT03844529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93193772|NCT03844529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93193773|NCT03844529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193774|NCT03844529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193775|NCT02292758|Bevacizumab|bevacizumab|mesh-list
93193776|NCT02292758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93193777|NCT02292758|Cetuximab|cetuximab|mesh-list
93193778|NCT02292758|Irinotecan|irinotecan|mesh-list
93193779|NCT02292758|Endothelial Growth Factors|endothelial growth factors|mesh-list
93193780|NCT02292758|Antibodies|antibodies|mesh-list
93193781|NCT02292758|Immunoglobulins|immunoglobulins|mesh-list
93193782|NCT02292758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93193783|NCT02292758|Immunoglobulin G|immunoglobulin g|mesh-list
93193784|NCT02292758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193785|NCT02292758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93193786|NCT02292758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93193787|NCT02292758|Growth Substances|growth substances|mesh-ancestor
93193788|NCT02292758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193789|NCT02292758|Growth Inhibitors|growth inhibitors|mesh-ancestor
93193790|NCT02292758|Immunologic Factors|immunologic factors|mesh-ancestor
93193791|NCT02292758|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93193792|NCT02292758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93193793|NCT02292758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193794|NCT02292758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193795|NCT03727867|Mitogens|mitogens|mesh-list
93193796|NCT03727867|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93193797|NCT03727867|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193798|NCT03727867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193799|NCT03727867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93193800|NCT03727867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193801|NCT02832648|Selenium|selenium|mesh-list
93193802|NCT02832648|Antioxidants|antioxidants|mesh-ancestor
93193803|NCT02832648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193804|NCT02832648|Protective Agents|protective agents|mesh-ancestor
93193805|NCT02832648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193806|NCT02832648|Trace Elements|trace elements|mesh-ancestor
93193807|NCT02832648|Micronutrients|micronutrients|mesh-ancestor
93193808|NCT04497766|Magnesium Sulfate|magnesium sulfate|mesh-list
93193809|NCT04497766|Analgesics|analgesics|mesh-ancestor
93193810|NCT04497766|Sensory System Agents|sensory system agents|mesh-ancestor
93193811|NCT04497766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193812|NCT04497766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193813|NCT04497766|Anesthetics|anesthetics|mesh-ancestor
93193814|NCT04497766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193815|NCT04497766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93193816|NCT04497766|Anticonvulsants|anticonvulsants|mesh-ancestor
93193817|NCT04497766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93193818|NCT04497766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93193819|NCT04497766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193820|NCT04497766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93193821|NCT04497766|Tocolytic Agents|tocolytic agents|mesh-ancestor
93193822|NCT04497766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193823|NCT03841721|Linezolid|linezolid|mesh-list
93193824|NCT03841721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193825|NCT03841721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193826|NCT03841721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93193827|NCT03841721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193828|NCT03841721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193829|NCT03164057|Cytarabine|cytarabine|mesh-list
93193830|NCT03164057|Hydrocortisone|hydrocortisone|mesh-list
93193831|NCT03164057|Methotrexate|methotrexate|mesh-list
93193832|NCT03164057|Azacitidine|azacitidine|mesh-list
93193833|NCT03164057|Decitabine|decitabine|mesh-list
93193834|NCT03164057|Fludarabine|fludarabine|mesh-list
93193835|NCT03164057|Etoposide|etoposide|mesh-list
93193836|NCT03164057|Etoposide phosphate|etoposide phosphate|mesh-list
93193837|NCT03164057|Sorafenib|sorafenib|mesh-list
93193838|NCT03164057|Daunorubicin|daunorubicin|mesh-list
93193839|NCT03164057|Asparaginase|asparaginase|mesh-list
93193840|NCT03164057|Mitoxantrone|mitoxantrone|mesh-list
93193841|NCT03164057|Idarubicin|idarubicin|mesh-list
93193842|NCT03164057|Dexrazoxane|dexrazoxane|mesh-list
93193843|NCT03164057|Razoxane|razoxane|mesh-list
93193844|NCT03164057|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
93193845|NCT03164057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93193846|NCT03164057|Abortifacient Agents|abortifacient agents|mesh-ancestor
93193847|NCT03164057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193848|NCT03164057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193849|NCT03164057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93193850|NCT03164057|Antimetabolites|antimetabolites|mesh-ancestor
93193851|NCT03164057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193852|NCT03164057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193853|NCT03164057|Dermatologic Agents|dermatologic agents|mesh-ancestor
93193854|NCT03164057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193855|NCT03164057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93193856|NCT03164057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193857|NCT03164057|Immunologic Factors|immunologic factors|mesh-ancestor
93193858|NCT03164057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193859|NCT03164057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93193860|NCT03164057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93193861|NCT03164057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93193862|NCT03164057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93193863|NCT03164057|Antiviral Agents|antiviral agents|mesh-ancestor
93193864|NCT03164057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193865|NCT03164057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93193866|NCT03164057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193867|NCT03164057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93193868|NCT03164057|Analgesics|analgesics|mesh-ancestor
93193869|NCT03164057|Sensory System Agents|sensory system agents|mesh-ancestor
93193870|NCT03164057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193871|NCT03164057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93193872|NCT03164057|Protective Agents|protective agents|mesh-ancestor
93193873|NCT03164057|Antimitotic Agents|antimitotic agents|mesh-ancestor
93193874|NCT03164057|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193875|NCT03620526|Iloprost|iloprost|mesh-list
93193876|NCT03620526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93193877|NCT03620526|Vasodilator Agents|vasodilator agents|mesh-ancestor
93193878|NCT04532346|Hydroxychloroquine|hydroxychloroquine|mesh-list
93193879|NCT04532346|Antimalarials|antimalarials|mesh-ancestor
93193880|NCT04532346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93193881|NCT04532346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93193882|NCT04532346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193883|NCT04532346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193884|NCT04532346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193885|NCT04532346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193886|NCT03843749|Trastuzumab|trastuzumab|mesh-list
93193887|NCT03843749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193888|NCT03843749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193889|NCT01199783|Vancomycin|vancomycin|mesh-list
93193890|NCT01199783|Daptomycin|daptomycin|mesh-list
93193891|NCT01199783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93193892|NCT01199783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193893|NCT03192306|Ethanol|ethanol|mesh-list
93193894|NCT03192306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93193895|NCT03192306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193896|NCT03192306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193897|NCT03192306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193898|NCT03216954|Acetylcysteine|acetylcysteine|mesh-list
93193899|NCT03216954|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93193900|NCT03216954|Antiviral Agents|antiviral agents|mesh-ancestor
93193901|NCT03216954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193902|NCT03216954|Expectorants|expectorants|mesh-ancestor
93193903|NCT03216954|Respiratory System Agents|respiratory system agents|mesh-ancestor
93193904|NCT03216954|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93193905|NCT03216954|Antioxidants|antioxidants|mesh-ancestor
93193906|NCT03216954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193907|NCT03216954|Protective Agents|protective agents|mesh-ancestor
93193908|NCT03216954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193909|NCT03216954|Antidotes|antidotes|mesh-ancestor
93193910|NCT05669807|Paclitaxel|paclitaxel|mesh-list
93193911|NCT05669807|Irinotecan|irinotecan|mesh-list
93193912|NCT05669807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93193913|NCT05669807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93193914|NCT05669807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193915|NCT05669807|Tubulin Modulators|tubulin modulators|mesh-ancestor
93193916|NCT05669807|Antimitotic Agents|antimitotic agents|mesh-ancestor
93193917|NCT05669807|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193918|NCT05669807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193919|NCT05669807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93193920|NCT05669807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93193921|NCT05669807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193922|NCT03599089|Acetaminophen|acetaminophen|mesh-list
93193923|NCT03599089|Ketorolac|ketorolac|mesh-list
93193924|NCT03599089|Oxycodone|oxycodone|mesh-list
93193925|NCT03599089|Bupivacaine|bupivacaine|mesh-list
93193926|NCT03599089|Anesthetics, Local|anesthetics, local|mesh-ancestor
93193927|NCT03599089|Anesthetics|anesthetics|mesh-ancestor
93193928|NCT03599089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193929|NCT03599089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193930|NCT03599089|Sensory System Agents|sensory system agents|mesh-ancestor
93193931|NCT03599089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193932|NCT03599089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93193933|NCT03599089|Analgesics|analgesics|mesh-ancestor
93193934|NCT03599089|Antipyretics|antipyretics|mesh-ancestor
93193935|NCT03599089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93193936|NCT03599089|Narcotics|narcotics|mesh-ancestor
93193937|NCT03599089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93193938|NCT03599089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193939|NCT03599089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855639|NCT02746380|Adalimumab|adalimumab|mesh-list
93193940|NCT03599089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93193941|NCT03599089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193942|NCT03599089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193943|NCT03597529|Melatonin|melatonin|mesh-list
93193944|NCT03597529|Antioxidants|antioxidants|mesh-ancestor
93193945|NCT03597529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193946|NCT03597529|Protective Agents|protective agents|mesh-ancestor
93193947|NCT03597529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193948|NCT03597529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93193949|NCT03991091|Oxytocin|oxytocin|mesh-list
93193950|NCT03991091|Oxytocics|oxytocics|mesh-ancestor
93193951|NCT03991091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93193952|NCT03991091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193953|NCT05420454|Paclitaxel|paclitaxel|mesh-list
93193954|NCT05420454|Docetaxel|docetaxel|mesh-list
93193955|NCT05420454|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93193956|NCT05420454|Cyclophosphamide|cyclophosphamide|mesh-list
93193957|NCT05420454|Carboplatin|carboplatin|mesh-list
93193958|NCT05420454|Trastuzumab|trastuzumab|mesh-list
93193959|NCT05420454|Epirubicin|epirubicin|mesh-list
93193960|NCT05420454|Pertuzumab|pertuzumab|mesh-list
93193961|NCT05420454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93193962|NCT05420454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193963|NCT05420454|Tubulin Modulators|tubulin modulators|mesh-ancestor
93193964|NCT05420454|Antimitotic Agents|antimitotic agents|mesh-ancestor
93193965|NCT05420454|Mitosis Modulators|mitosis modulators|mesh-ancestor
93193966|NCT05420454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93193967|NCT05420454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93193968|NCT05420454|Immunologic Factors|immunologic factors|mesh-ancestor
93193969|NCT05420454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193970|NCT05420454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93193971|NCT05420454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93193972|NCT05420454|Alkylating Agents|alkylating agents|mesh-ancestor
93193973|NCT05420454|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93193974|NCT05420454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93193975|NCT05420454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93193976|NCT05420454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93193977|NCT05420454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93193978|NCT05420454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93193979|NCT03180528|Benzoic Acid|benzoic acid|mesh-list
93193980|NCT03180528|Antifungal Agents|antifungal agents|mesh-ancestor
93193981|NCT03180528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93193982|NCT04667507|Dexamethasone|dexamethasone|mesh-list
93193983|NCT04667507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93193984|NCT04667507|Antiemetics|antiemetics|mesh-ancestor
93193985|NCT04667507|Autonomic Agents|autonomic agents|mesh-ancestor
93193986|NCT04667507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93193987|NCT04667507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93193988|NCT04667507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93193989|NCT04667507|Glucocorticoids|glucocorticoids|mesh-ancestor
93193990|NCT04667507|Hormones|hormones|mesh-ancestor
93193991|NCT04667507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93193992|NCT04667507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93193993|NCT04667507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93193994|NCT01200251|Bimatoprost|bimatoprost|mesh-list
93193995|NCT01200251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93193996|NCT03597139|Cyclosporine|cyclosporine|mesh-list
93193997|NCT03597139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93193998|NCT03597139|Cyclosporins|cyclosporins|mesh-list
93193999|NCT03597139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194000|NCT03597139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194001|NCT03597139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194002|NCT03597139|Immunologic Factors|immunologic factors|mesh-ancestor
93194003|NCT03597139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194004|NCT03597139|Antifungal Agents|antifungal agents|mesh-ancestor
93194005|NCT03597139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194006|NCT03597139|Dermatologic Agents|dermatologic agents|mesh-ancestor
93194007|NCT03597139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194008|NCT03597139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93194009|NCT03597139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93194010|NCT01202435|Pregabalin|pregabalin|mesh-list
93194011|NCT01202435|Analgesics|analgesics|mesh-ancestor
93194012|NCT01202435|Sensory System Agents|sensory system agents|mesh-ancestor
93194013|NCT01202435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194014|NCT01202435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194015|NCT01202435|Anticonvulsants|anticonvulsants|mesh-ancestor
93194016|NCT01202435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93194017|NCT01202435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194018|NCT01202435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194019|NCT01202435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194020|NCT01202435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93194021|NCT01202435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93194022|NCT01202435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194023|NCT01202435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93194024|NCT05406102|Propofol|propofol|mesh-list
93194025|NCT05406102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93194026|NCT05406102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194027|NCT05406102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194028|NCT05406102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93194029|NCT05406102|Anesthetics, General|anesthetics, general|mesh-ancestor
93194030|NCT05406102|Anesthetics|anesthetics|mesh-ancestor
93194031|NCT01204307|Cisplatin|cisplatin|mesh-list
93194032|NCT01204307|Docetaxel|docetaxel|mesh-list
93194033|NCT01204307|Pemetrexed|pemetrexed|mesh-list
93194034|NCT01204307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194035|NCT01204307|Tubulin Modulators|tubulin modulators|mesh-ancestor
93194036|NCT01204307|Antimitotic Agents|antimitotic agents|mesh-ancestor
93194037|NCT01204307|Mitosis Modulators|mitosis modulators|mesh-ancestor
93194038|NCT01204307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194039|NCT01204307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194040|NCT01204307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93194041|NCT01204307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93194042|NCT00708214|Letrozole|letrozole|mesh-list
93194043|NCT00708214|Afatinib|afatinib|mesh-list
93194044|NCT00708214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194045|NCT00708214|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93194046|NCT00708214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93194047|NCT00708214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194048|NCT00708214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194049|NCT00708214|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93194050|NCT00708214|Hormone Antagonists|hormone antagonists|mesh-ancestor
93194051|NCT00708214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93194052|NCT00708214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194053|NCT00708214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194054|NCT02506894|Magnesium Sulfate|magnesium sulfate|mesh-list
93194055|NCT02506894|Analgesics|analgesics|mesh-ancestor
93194056|NCT02506894|Sensory System Agents|sensory system agents|mesh-ancestor
93194057|NCT02506894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194058|NCT02506894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194059|NCT02506894|Anesthetics|anesthetics|mesh-ancestor
93194060|NCT02506894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194061|NCT02506894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93194062|NCT02506894|Anticonvulsants|anticonvulsants|mesh-ancestor
93194063|NCT02506894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93194064|NCT02506894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194065|NCT02506894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194066|NCT02506894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194067|NCT02506894|Tocolytic Agents|tocolytic agents|mesh-ancestor
93194068|NCT02506894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93194069|NCT03909737|Azithromycin|azithromycin|mesh-list
93194070|NCT03909737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93194071|NCT03909737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194072|NCT04891250|Ivermectin|ivermectin|mesh-list
93194073|NCT04891250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93194074|NCT04891250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194075|NCT03570697|Evolocumab|evolocumab|mesh-list
93194076|NCT03570697|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93194077|NCT03570697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93194078|NCT03570697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93194079|NCT03570697|Antimetabolites|antimetabolites|mesh-ancestor
93194080|NCT03570697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194081|NCT03570697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93194082|NCT03570697|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194083|NCT03570697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194084|NCT03570697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93194085|NCT02511574|Progesterone|progesterone|mesh-list
93194086|NCT02511574|Progestins|progestins|mesh-ancestor
93194087|NCT02511574|Hormones|hormones|mesh-ancestor
93194088|NCT02511574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93194089|NCT02511574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194090|NCT01200641|Gabapentin|gabapentin|mesh-list
93194091|NCT01200641|Melatonin|melatonin|mesh-list
93194092|NCT01200641|Analgesics|analgesics|mesh-ancestor
93194093|NCT01200641|Sensory System Agents|sensory system agents|mesh-ancestor
93194094|NCT01200641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194095|NCT01200641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194096|NCT01200641|Anticonvulsants|anticonvulsants|mesh-ancestor
93194097|NCT01200641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93194098|NCT01200641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93194099|NCT01200641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194100|NCT01200641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93194101|NCT01200641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93194102|NCT01200641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93194103|NCT01200641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194104|NCT01200641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194105|NCT01200641|Antimanic Agents|antimanic agents|mesh-ancestor
93194106|NCT01200641|Antioxidants|antioxidants|mesh-ancestor
93194107|NCT01200641|Protective Agents|protective agents|mesh-ancestor
93194108|NCT01856270|Amitriptyline|amitriptyline|mesh-list
93194109|NCT01856270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93194110|NCT01856270|Antidepressive Agents|antidepressive agents|mesh-ancestor
93194111|NCT01856270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93194112|NCT01856270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194113|NCT01856270|Analgesics|analgesics|mesh-ancestor
93194114|NCT01856270|Sensory System Agents|sensory system agents|mesh-ancestor
93194115|NCT01856270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194116|NCT01856270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194117|NCT01856270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93194118|NCT01856270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93194119|NCT01856270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194120|NCT01856270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194121|NCT01856270|Adrenergic Agents|adrenergic agents|mesh-ancestor
93194122|NCT01856270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194123|NCT02511340|Flumatinib|flumatinib|mesh-list
93194124|NCT02511340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194125|NCT02511340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194126|NCT02511340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194127|NCT02506348|Diclofenac|diclofenac|mesh-list
93194128|NCT02506348|Nepafenac|nepafenac|mesh-list
93194129|NCT02506348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93194130|NCT02506348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194131|NCT02506348|Analgesics|analgesics|mesh-ancestor
93194132|NCT02506348|Sensory System Agents|sensory system agents|mesh-ancestor
93194133|NCT02506348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194134|NCT02506348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194135|NCT02506348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194136|NCT02506348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194137|NCT02506348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93194138|NCT02506348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194139|NCT02506348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194140|NCT01318070|Pioglitazone|pioglitazone|mesh-list
93194141|NCT01318070|Alogliptin|alogliptin|mesh-list
93194142|NCT01318070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93194143|NCT01318070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194144|NCT01318070|Incretins|incretins|mesh-ancestor
93194145|NCT01318070|Hormones|hormones|mesh-ancestor
93194146|NCT01318070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93194147|NCT01318070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93194148|NCT01318070|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194149|NCT01318070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194150|NCT01318070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194151|NCT01202513|Bimatoprost|bimatoprost|mesh-list
93194152|NCT01202513|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93194153|NCT01202513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93194154|NCT01202513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93194155|NCT03835715|Vortioxetine|vortioxetine|mesh-list
93194156|NCT03835715|Antidepressive Agents|antidepressive agents|mesh-ancestor
93194157|NCT03835715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93194158|NCT03835715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93194159|NCT03835715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93194160|NCT03835715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194161|NCT03835715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194162|NCT03835715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93194163|NCT03835715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93194164|NCT03835715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194165|NCT03835715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194166|NCT03835715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194167|NCT03835715|Serotonin Agents|serotonin agents|mesh-ancestor
93194168|NCT03835715|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93194169|NCT03835715|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93194170|NCT03835715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93194171|NCT03835715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93194172|NCT02505802|Botulinum Toxins|botulinum toxins|mesh-list
93194173|NCT02505802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93194174|NCT02505802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93194175|NCT02505802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194176|NCT02505802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194177|NCT02505802|Cholinergic Agents|cholinergic agents|mesh-ancestor
93194178|NCT02505802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194179|NCT02505802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194180|NCT02505802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93194181|NCT02505802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194182|NCT03627884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92866317|NCT00561925|Nevirapine|nevirapine|mesh-list
93194184|NCT03843281|Morphine|morphine|mesh-list
93194185|NCT03843281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93194186|NCT03843281|Narcotics|narcotics|mesh-ancestor
93194187|NCT03843281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194188|NCT03843281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194189|NCT03843281|Analgesics|analgesics|mesh-ancestor
93194190|NCT03843281|Sensory System Agents|sensory system agents|mesh-ancestor
93194191|NCT03843281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194192|NCT03843281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194193|NCT03843281|Antipyretics|antipyretics|mesh-ancestor
93194194|NCT02515240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93194195|NCT02515240|Immunologic Factors|immunologic factors|mesh-ancestor
93194196|NCT02515240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194197|NCT03843515|Nivolumab|nivolumab|mesh-list
93194198|NCT03843515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194199|NCT03843515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194200|NCT03843515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93194201|NCT03843515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194202|NCT00245960|Etanercept|etanercept|mesh-list
93194203|NCT00245960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93194204|NCT00245960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194205|NCT00245960|Analgesics|analgesics|mesh-ancestor
93194206|NCT00245960|Sensory System Agents|sensory system agents|mesh-ancestor
93194207|NCT00245960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194208|NCT00245960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194209|NCT00245960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194210|NCT00245960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194211|NCT00245960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93194212|NCT00245960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194213|NCT00245960|Immunologic Factors|immunologic factors|mesh-ancestor
93194214|NCT04443322|Durvalumab|durvalumab|mesh-list
93194215|NCT04443322|Lenvatinib|lenvatinib|mesh-list
93194216|NCT04443322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93194217|NCT04443322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194218|NCT04443322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194219|NCT04443322|Immunologic Factors|immunologic factors|mesh-ancestor
93194220|NCT04443322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194221|NCT04443322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194222|NCT04443322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194223|NCT04443322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194224|NCT01202825|Simeprevir|simeprevir|mesh-list
93194225|NCT01202825|Antiviral Agents|antiviral agents|mesh-ancestor
93194226|NCT01202825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194227|NCT01202825|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194228|NCT01202825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194229|NCT01202825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194230|NCT02510872|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93194231|NCT02510872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93194232|NCT02510872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194233|NCT05222204|Paclitaxel|paclitaxel|mesh-list
93194234|NCT05222204|Gemcitabine|gemcitabine|mesh-list
93194235|NCT05222204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93194236|NCT05222204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194237|NCT05222204|Tubulin Modulators|tubulin modulators|mesh-ancestor
93194238|NCT05222204|Antimitotic Agents|antimitotic agents|mesh-ancestor
93194239|NCT05222204|Mitosis Modulators|mitosis modulators|mesh-ancestor
93194240|NCT05222204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194241|NCT05222204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93194242|NCT05222204|Antimetabolites|antimetabolites|mesh-ancestor
93194243|NCT02558465|Rivaroxaban|rivaroxaban|mesh-list
93194244|NCT02558465|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93194245|NCT02558465|Antithrombins|antithrombins|mesh-ancestor
93194246|NCT02558465|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93194247|NCT02558465|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194248|NCT02558465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194249|NCT02558465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194250|NCT02558465|Anticoagulants|anticoagulants|mesh-ancestor
93194251|NCT05218616|Sunitinib|sunitinib|mesh-list
93194252|NCT05218616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194253|NCT05218616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93194254|NCT05218616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93194255|NCT05218616|Growth Substances|growth substances|mesh-ancestor
93194256|NCT05218616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194257|NCT05218616|Growth Inhibitors|growth inhibitors|mesh-ancestor
93194258|NCT05218616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194259|NCT05218616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194260|NCT05218616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194261|NCT02505880|Anesthetics|anesthetics|mesh-list
93194262|NCT02505880|Anesthetics, Local|anesthetics, local|mesh-list
93194263|NCT02505880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194264|NCT02505880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194265|NCT02505880|Sensory System Agents|sensory system agents|mesh-ancestor
93194266|NCT02505880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194267|NCT02510950|Temozolomide|temozolomide|mesh-list
93194269|NCT02510950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93194270|NCT02510950|Alkylating Agents|alkylating agents|mesh-ancestor
93194271|NCT02510950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194272|NCT02510950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194273|NCT02510950|Interferon Inducers|interferon inducers|mesh-ancestor
93194274|NCT02510950|Immunologic Factors|immunologic factors|mesh-ancestor
93194275|NCT02510950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194276|NCT05221736|Ethanol|ethanol|mesh-list
93194277|NCT05221736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93194278|NCT05221736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194279|NCT05221736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194280|NCT05221736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194281|NCT05651594|Leucovorin|leucovorin|mesh-list
93194282|NCT05651594|Pembrolizumab|pembrolizumab|mesh-list
93194283|NCT05651594|Fluorouracil|fluorouracil|mesh-list
93194284|NCT05651594|Oxaliplatin|oxaliplatin|mesh-list
93194285|NCT05651594|Propranolol|propranolol|mesh-list
93194286|NCT05651594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194287|NCT05651594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194288|NCT05651594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93194289|NCT05651594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194290|NCT05651594|Antimetabolites|antimetabolites|mesh-ancestor
93194291|NCT05651594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93194292|NCT05651594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194293|NCT05651594|Immunologic Factors|immunologic factors|mesh-ancestor
93194294|NCT05651594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194295|NCT05651594|Antidotes|antidotes|mesh-ancestor
93194296|NCT05651594|Protective Agents|protective agents|mesh-ancestor
93194297|NCT05651594|Vitamin B Complex|vitamin b complex|mesh-ancestor
93194298|NCT05651594|Vitamins|vitamins|mesh-ancestor
93194299|NCT05651594|Micronutrients|micronutrients|mesh-ancestor
93194300|NCT05651594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93194301|NCT05651594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93194302|NCT05651594|Adrenergic Agents|adrenergic agents|mesh-ancestor
93194303|NCT05651594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194304|NCT05651594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93194305|NCT05651594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93194306|NCT05651594|Vasodilator Agents|vasodilator agents|mesh-ancestor
93194307|NCT02514850|Insulin Lispro|insulin lispro|mesh-list
93194308|NCT02514850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93194309|NCT02514850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194310|NCT04454411|Naltrexone|naltrexone|mesh-list
93194311|NCT04454411|Buprenorphine|buprenorphine|mesh-list
93194312|NCT04454411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93194313|NCT04454411|Narcotics|narcotics|mesh-ancestor
93194314|NCT04454411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194315|NCT04454411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194316|NCT04454411|Analgesics|analgesics|mesh-ancestor
93194317|NCT04454411|Sensory System Agents|sensory system agents|mesh-ancestor
93194318|NCT04454411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194319|NCT04454411|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93194320|NCT04454411|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93194321|NCT02505568|Infliximab|infliximab|mesh-list
93194322|NCT02505568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93194323|NCT02505568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194324|NCT02505568|Dermatologic Agents|dermatologic agents|mesh-ancestor
93194325|NCT02505568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93194326|NCT02505568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194327|NCT05356728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93194328|NCT05356728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93194329|NCT05217836|Hepcidins|hepcidins|mesh-list
93194330|NCT05217836|Chrysarobin|chrysarobin|mesh-list
93194331|NCT05217836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93194332|NCT05217836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194333|NCT05217836|Analgesics|analgesics|mesh-ancestor
93194334|NCT05217836|Sensory System Agents|sensory system agents|mesh-ancestor
93194335|NCT05217836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194336|NCT05217836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194337|NCT05217836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194338|NCT05217836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194339|NCT05217836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194340|NCT02510248|1-2-isopropoxy-2-oxidodihydro-4H,6H-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1H,3H)-dione|1-2-isopropoxy-2-oxidodihydro-4h,6h-spiro(furo(3,2-d)(1,3,2)dioxaphosphinine-7,2'-oxetan)-6-yl)pyrimidine-2,4(1h,3h)-dione|mesh-list
93194341|NCT02510248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194342|NCT02510248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194344|NCT02514538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194345|NCT02514538|Analgesics|analgesics|mesh-ancestor
93194346|NCT02514538|Sensory System Agents|sensory system agents|mesh-ancestor
93194347|NCT02514538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194348|NCT02514538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194349|NCT02514538|Antipyretics|antipyretics|mesh-ancestor
93194350|NCT05669417|Magnesium Sulfate|magnesium sulfate|mesh-list
93194351|NCT05669417|Analgesics|analgesics|mesh-ancestor
93194352|NCT05669417|Sensory System Agents|sensory system agents|mesh-ancestor
93194353|NCT05669417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194354|NCT05669417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194355|NCT05669417|Anesthetics|anesthetics|mesh-ancestor
93194356|NCT05669417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194357|NCT05669417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93194358|NCT05669417|Anticonvulsants|anticonvulsants|mesh-ancestor
93194359|NCT05669417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93194360|NCT05669417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194361|NCT05669417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194362|NCT05669417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194363|NCT05669417|Tocolytic Agents|tocolytic agents|mesh-ancestor
93194364|NCT05669417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93194365|NCT03832673|Pembrolizumab|pembrolizumab|mesh-list
93194366|NCT03832673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194367|NCT03832673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194368|NCT03832673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93194369|NCT03832673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194370|NCT02504944|Propranolol|propranolol|mesh-list
93194371|NCT02504944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93194372|NCT02504944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93194373|NCT02504944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93194374|NCT02504944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93194375|NCT02504944|Adrenergic Agents|adrenergic agents|mesh-ancestor
93194376|NCT02504944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194377|NCT02504944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194378|NCT02504944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194379|NCT02504944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93194380|NCT02504944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93194381|NCT02504944|Vasodilator Agents|vasodilator agents|mesh-ancestor
93194382|NCT01201499|Morphine|morphine|mesh-list
93194383|NCT01201499|Remifentanil|remifentanil|mesh-list
93194384|NCT01201499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93194385|NCT01201499|Narcotics|narcotics|mesh-ancestor
93194386|NCT01201499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194387|NCT01201499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194388|NCT01201499|Analgesics|analgesics|mesh-ancestor
93194389|NCT01201499|Sensory System Agents|sensory system agents|mesh-ancestor
93194390|NCT01201499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194391|NCT03473639|Capecitabine|capecitabine|mesh-list
93194392|NCT03473639|Entinostat|entinostat|mesh-list
93194393|NCT03473639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93194394|NCT03473639|Antimetabolites|antimetabolites|mesh-ancestor
93194395|NCT03473639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194396|NCT03473639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194397|NCT03473639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93194398|NCT03473639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194399|NCT03121690|Prednisone|prednisone|mesh-list
93194400|NCT03121690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194401|NCT03121690|Glucocorticoids|glucocorticoids|mesh-ancestor
93194402|NCT03121690|Hormones|hormones|mesh-ancestor
93194403|NCT03121690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93194404|NCT03121690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194405|NCT03121690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92866532|NCT00637026|Gefitinib|gefitinib|mesh-list
93194406|NCT03121690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194407|NCT03831269|Azithromycin|azithromycin|mesh-list
93194408|NCT03831269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93194409|NCT03831269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194411|NCT02504476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93194412|NCT02504476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93194413|NCT02504476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194414|NCT02504476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194415|NCT02504476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93194416|NCT02504476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93194417|NCT02504476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93194418|NCT02504476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93194419|NCT02504476|Anesthetics, General|anesthetics, general|mesh-ancestor
93194420|NCT02504476|Anesthetics|anesthetics|mesh-ancestor
93194421|NCT02504476|GABA Modulators|gaba modulators|mesh-ancestor
93194422|NCT02504476|GABA Agents|gaba agents|mesh-ancestor
93194423|NCT02504476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194424|NCT02504476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194425|NCT02504398|Methamphetamine|methamphetamine|mesh-list
93194426|NCT02504398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93194427|NCT02504398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194428|NCT02504398|Sympathomimetics|sympathomimetics|mesh-ancestor
93194429|NCT02504398|Autonomic Agents|autonomic agents|mesh-ancestor
93194430|NCT02504398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194431|NCT02504398|Dopamine Agents|dopamine agents|mesh-ancestor
93194432|NCT02504398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194433|NCT02504398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194434|NCT02504398|Adrenergic Agents|adrenergic agents|mesh-ancestor
93194435|NCT02504398|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93194436|NCT02504398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93194437|NCT02504398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194438|NCT02504398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93194439|NCT01205009|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93194440|NCT01205009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93194441|NCT01205009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194442|NCT03830489|Ascorbic Acid|ascorbic acid|mesh-list
93194443|NCT03830489|Antioxidants|antioxidants|mesh-ancestor
93194444|NCT03830489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194445|NCT03830489|Protective Agents|protective agents|mesh-ancestor
93194446|NCT03830489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194447|NCT03830489|Vitamins|vitamins|mesh-ancestor
93194448|NCT03830489|Micronutrients|micronutrients|mesh-ancestor
93194449|NCT02509468|Sirolimus|sirolimus|mesh-list
93194450|NCT02509468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93194451|NCT02509468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194452|NCT02509468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93194453|NCT02509468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194454|NCT02509468|Antifungal Agents|antifungal agents|mesh-ancestor
93194455|NCT02509468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194456|NCT02509468|Immunologic Factors|immunologic factors|mesh-ancestor
93194457|NCT02509468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194458|NCT03344614|Apatinib|apatinib|mesh-list
93194459|NCT03344614|Raltitrexed|raltitrexed|mesh-list
93194460|NCT03344614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194461|NCT03344614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194462|NCT03344614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194463|NCT03344614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194464|NCT03344614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93194465|NCT03344614|Antimetabolites|antimetabolites|mesh-ancestor
93194466|NCT03344614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93194467|NCT01205087|Omeprazole|omeprazole|mesh-list
93194468|NCT01205087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93194469|NCT01205087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93194470|NCT01205087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93194471|NCT01205087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194472|NCT01205087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194473|NCT01205243|Abacavir|abacavir|mesh-list
93194474|NCT01205243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93194475|NCT01205243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92866607|NCT02659917|Methamphetamine|methamphetamine|mesh-list
93194476|NCT01205243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194477|NCT01205243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194478|NCT01205243|Antiviral Agents|antiviral agents|mesh-ancestor
93194479|NCT01205243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194480|NCT01205243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93194481|NCT01205243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93194482|NCT02504164|Midazolam|midazolam|mesh-list
93194483|NCT02504164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93194484|NCT02504164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93194485|NCT02504164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194486|NCT02504164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194487|NCT02504164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93194488|NCT02504164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93194489|NCT02504164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93194490|NCT02504164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93194491|NCT02504164|Anesthetics, General|anesthetics, general|mesh-ancestor
93194492|NCT02504164|Anesthetics|anesthetics|mesh-ancestor
93194493|NCT02504164|GABA Modulators|gaba modulators|mesh-ancestor
93194494|NCT02504164|GABA Agents|gaba agents|mesh-ancestor
93194495|NCT02504164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194496|NCT02504164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194497|NCT02509234|Irinotecan|irinotecan|mesh-list
93194498|NCT02509234|Trabectedin|trabectedin|mesh-list
93194499|NCT02509234|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93194500|NCT02509234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93194501|NCT02509234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194502|NCT02509234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194503|NCT02509234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194504|NCT02509234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93194505|NCT02509234|Alkylating Agents|alkylating agents|mesh-ancestor
93194506|NCT01205321|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
93194507|NCT01205321|Bombesin|bombesin|mesh-list
93194508|NCT01205321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194509|NCT01205321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194510|NCT01205321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194511|NCT01205321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93194512|NCT02504008|Zoledronic Acid|zoledronic acid|mesh-list
93194513|NCT02504008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93194514|NCT02504008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194515|NCT03566485|Atezolizumab|atezolizumab|mesh-list
93194516|NCT03566485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93194517|NCT03566485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194518|NCT03566485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194519|NCT03566485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194520|NCT02513290|Loratadine|loratadine|mesh-list
93194521|NCT02513290|Antipruritics|antipruritics|mesh-ancestor
93194522|NCT02513290|Dermatologic Agents|dermatologic agents|mesh-ancestor
93194523|NCT02513290|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93194524|NCT02513290|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93194525|NCT02513290|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93194526|NCT02513290|Histamine Antagonists|histamine antagonists|mesh-ancestor
93194527|NCT02513290|Histamine Agents|histamine agents|mesh-ancestor
93194528|NCT02513290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855650|NCT00915915|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93194529|NCT02513290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194530|NCT02513290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194531|NCT02501200|Ezetimibe|ezetimibe|mesh-list
93194532|NCT02501200|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93194533|NCT02501200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93194534|NCT02501200|Antimetabolites|antimetabolites|mesh-ancestor
93194535|NCT02501200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194536|NCT02501200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93194537|NCT01205477|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93194538|NCT01205477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194539|NCT02501278|Cisplatin|cisplatin|mesh-list
93194540|NCT02501278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194541|NCT03176238|Everolimus|everolimus|mesh-list
93194542|NCT03176238|Exemestane|exemestane|mesh-list
93194543|NCT03176238|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93194544|NCT03176238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194545|NCT03176238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194546|NCT03176238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194547|NCT03176238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194548|NCT03176238|Immunologic Factors|immunologic factors|mesh-ancestor
93194549|NCT03176238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194550|NCT03176238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194551|NCT03176238|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92866678|NCT03666000|Immunologic Factors|immunologic factors|mesh-ancestor
93194552|NCT03176238|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93194553|NCT03176238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93194554|NCT03176238|Hormone Antagonists|hormone antagonists|mesh-ancestor
93194555|NCT03176238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93194556|NCT01957332|Trastuzumab|trastuzumab|mesh-list
93194557|NCT01957332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194558|NCT01957332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194559|NCT01205711|Leucovorin|leucovorin|mesh-list
93194560|NCT01205711|Fluorouracil|fluorouracil|mesh-list
93194561|NCT01205711|Irinotecan|irinotecan|mesh-list
93194562|NCT01205711|Calcium|calcium|mesh-list
93194563|NCT01205711|Levoleucovorin|levoleucovorin|mesh-list
93194564|NCT01205711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194565|NCT01205711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194566|NCT01205711|Antimetabolites|antimetabolites|mesh-ancestor
93194567|NCT01205711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194568|NCT01205711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93194569|NCT01205711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194570|NCT01205711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194571|NCT01205711|Immunologic Factors|immunologic factors|mesh-ancestor
93194572|NCT01205711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93194573|NCT01205711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93194574|NCT01205711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194575|NCT01205711|Antidotes|antidotes|mesh-ancestor
93194576|NCT01205711|Protective Agents|protective agents|mesh-ancestor
93194577|NCT01205711|Vitamin B Complex|vitamin b complex|mesh-ancestor
93194578|NCT01205711|Vitamins|vitamins|mesh-ancestor
93194579|NCT01205711|Micronutrients|micronutrients|mesh-ancestor
93194580|NCT02508922|Vitamin D|vitamin d|mesh-list
93194581|NCT02508922|Cholecalciferol|cholecalciferol|mesh-list
93194582|NCT02508922|Vitamins|vitamins|mesh-ancestor
93194583|NCT02508922|Micronutrients|micronutrients|mesh-ancestor
93194584|NCT02508922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194585|NCT02508922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93194586|NCT02508922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194587|NCT01860456|Imatinib Mesylate|imatinib mesylate|mesh-list
93194588|NCT01860456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194589|NCT01860456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194590|NCT01860456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194591|NCT01860456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194592|NCT03730675|Sorafenib|sorafenib|mesh-list
93194593|NCT03730675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194594|NCT03730675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194595|NCT03730675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194596|NCT03730675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194597|NCT01765140|Amifampridine|amifampridine|mesh-list
93194598|NCT01765140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93194599|NCT01765140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194600|NCT01765140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194601|NCT01765140|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93194602|NCT01765140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194603|NCT01765140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194604|NCT01345682|Methotrexate|methotrexate|mesh-list
93194605|NCT01345682|Afatinib|afatinib|mesh-list
93194606|NCT01345682|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93194607|NCT01345682|Abortifacient Agents|abortifacient agents|mesh-ancestor
93194608|NCT01345682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93194609|NCT01345682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194610|NCT01345682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93194611|NCT01345682|Antimetabolites|antimetabolites|mesh-ancestor
93194612|NCT01345682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194613|NCT01345682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194614|NCT01345682|Dermatologic Agents|dermatologic agents|mesh-ancestor
93194615|NCT01345682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194616|NCT01345682|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93194617|NCT01345682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194618|NCT01345682|Immunologic Factors|immunologic factors|mesh-ancestor
93194619|NCT01345682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194620|NCT01345682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93194621|NCT01345682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194622|NCT03562117|Gepotidacin|gepotidacin|mesh-list
93194623|NCT03562117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93194624|NCT03562117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194625|NCT03562117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194626|NCT03562117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194627|NCT02503462|Ritonavir|ritonavir|mesh-list
92866752|NCT02462538|Imatinib Mesylate|imatinib mesylate|mesh-list
93194628|NCT02503462|Darunavir|darunavir|mesh-list
93194629|NCT02503462|Cobicistat|cobicistat|mesh-list
93194630|NCT02503462|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93194631|NCT02503462|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93194632|NCT02503462|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194633|NCT02503462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194634|NCT02503462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194635|NCT02503462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93194636|NCT02503462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93194637|NCT02503462|Antiviral Agents|antiviral agents|mesh-ancestor
93194638|NCT02503462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194639|NCT02503462|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93194640|NCT02503462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93194641|NCT03343678|Venetoclax|venetoclax|mesh-list
93194642|NCT03343678|BI 836826|bi 836826|mesh-list
93194643|NCT03343678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194644|NCT03343678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194645|NCT05216822|Racecadotril|racecadotril|mesh-list
93194646|NCT05216822|Antidiarrheals|antidiarrheals|mesh-ancestor
93194647|NCT05216822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93194648|NCT05216822|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194649|NCT05216822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194650|NCT05216822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194651|NCT04498936|Sofosbuvir|sofosbuvir|mesh-list
93194652|NCT04498936|Ledipasvir|ledipasvir|mesh-list
93194653|NCT04498936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93194654|NCT04498936|Nitazoxanide|nitazoxanide|mesh-list
93194655|NCT04498936|Antiviral Agents|antiviral agents|mesh-ancestor
93194656|NCT04498936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194657|NCT04498936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93194658|NCT03627260|Sunscreening Agents|sunscreening agents|mesh-list
93194659|NCT03627260|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93194660|NCT03627260|Protective Agents|protective agents|mesh-ancestor
93194661|NCT03627260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194662|NCT03627260|Dermatologic Agents|dermatologic agents|mesh-ancestor
93194663|NCT05706038|Adalimumab|adalimumab|mesh-list
93194664|NCT05706038|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93194665|NCT05706038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194666|NCT05706038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194667|NCT03546907|Cholinergic Agents|cholinergic agents|mesh-list
93194668|NCT03546907|Muscarinic Agonists|muscarinic agonists|mesh-list
93194669|NCT03546907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194670|NCT03546907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194671|NCT03546907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194672|NCT03546907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93194673|NCT05126264|Ibuprofen|ibuprofen|mesh-list
93194674|NCT05126264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93194675|NCT05126264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194676|NCT05126264|Analgesics|analgesics|mesh-ancestor
93194677|NCT05126264|Sensory System Agents|sensory system agents|mesh-ancestor
93194678|NCT05126264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194679|NCT05126264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194680|NCT05126264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194681|NCT05126264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194682|NCT05126264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93194683|NCT05126264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194684|NCT05126264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194685|NCT03001817|Fenofibrate|fenofibrate|mesh-list
93194686|NCT03001817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93194687|NCT03001817|Antimetabolites|antimetabolites|mesh-ancestor
93194688|NCT03001817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194689|NCT03001817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93194690|NCT02502682|Chlorhexidine|chlorhexidine|mesh-list
93194691|NCT02502682|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93194692|NCT02502682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93194693|NCT02502682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194694|NCT02502682|Disinfectants|disinfectants|mesh-ancestor
93194695|NCT02502682|Dermatologic Agents|dermatologic agents|mesh-ancestor
93194696|NCT03590743|Apixaban|apixaban|mesh-list
93194697|NCT03590743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93194698|NCT03590743|Antithrombins|antithrombins|mesh-ancestor
93194699|NCT03590743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93194700|NCT03590743|Protease Inhibitors|protease inhibitors|mesh-ancestor
93194701|NCT03590743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194702|NCT03590743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194703|NCT03590743|Anticoagulants|anticoagulants|mesh-ancestor
93194704|NCT03343600|Imatinib Mesylate|imatinib mesylate|mesh-list
93194705|NCT03343600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194706|NCT03343600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93194707|NCT03343600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194708|NCT03343600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194709|NCT03589885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93194710|NCT03589885|Immunologic Factors|immunologic factors|mesh-ancestor
93194711|NCT03589885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194712|NCT03121222|Acetylcysteine|acetylcysteine|mesh-list
93194713|NCT03121222|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93194714|NCT03121222|Antiviral Agents|antiviral agents|mesh-ancestor
93194715|NCT03121222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194716|NCT03121222|Expectorants|expectorants|mesh-ancestor
93194717|NCT03121222|Respiratory System Agents|respiratory system agents|mesh-ancestor
93194718|NCT03121222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93194719|NCT03121222|Antioxidants|antioxidants|mesh-ancestor
93194720|NCT03121222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194721|NCT03121222|Protective Agents|protective agents|mesh-ancestor
93194722|NCT03121222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194723|NCT03121222|Antidotes|antidotes|mesh-ancestor
93194724|NCT03639493|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
93194725|NCT03639493|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93194726|NCT03639493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93194727|NCT03639493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93194728|NCT03639493|Antimetabolites|antimetabolites|mesh-ancestor
93194729|NCT03639493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194730|NCT03639493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93194731|NCT03639493|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93194732|NCT03639493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194733|NCT03639493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93194734|NCT03344302|Oxytocin|oxytocin|mesh-list
93194735|NCT03344302|Oxytocics|oxytocics|mesh-ancestor
93194736|NCT03344302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93194737|NCT03344302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194738|NCT03545503|Ketamine|ketamine|mesh-list
93194739|NCT03545503|Etomidate|etomidate|mesh-list
93194740|NCT03545503|Analgesics|analgesics|mesh-ancestor
93194741|NCT03545503|Sensory System Agents|sensory system agents|mesh-ancestor
93194742|NCT03545503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194743|NCT03545503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194744|NCT03545503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93194745|NCT03545503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93194746|NCT03545503|Anesthetics, General|anesthetics, general|mesh-ancestor
93194747|NCT03545503|Anesthetics|anesthetics|mesh-ancestor
93194748|NCT03545503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194749|NCT03545503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93194750|NCT03545503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93194751|NCT03545503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194752|NCT03545503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194753|NCT03545503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93194754|NCT01297829|Ibuprofen|ibuprofen|mesh-list
93194755|NCT01297829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93194756|NCT01297829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194757|NCT01297829|Analgesics|analgesics|mesh-ancestor
93194758|NCT01297829|Sensory System Agents|sensory system agents|mesh-ancestor
93194759|NCT01297829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194760|NCT01297829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194761|NCT01297829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194762|NCT01297829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194763|NCT01297829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93194764|NCT01297829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194765|NCT01297829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194766|NCT03829943|Vitamin D|vitamin d|mesh-list
93194767|NCT03829943|Vitamins|vitamins|mesh-ancestor
93194768|NCT03829943|Micronutrients|micronutrients|mesh-ancestor
93194769|NCT03829943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194770|NCT03829943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93194771|NCT02508142|Scopolamine|scopolamine|mesh-list
93194772|NCT02508142|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93194773|NCT02508142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93194774|NCT02508142|Antiemetics|antiemetics|mesh-ancestor
93194775|NCT02508142|Autonomic Agents|autonomic agents|mesh-ancestor
93194776|NCT02508142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194777|NCT02508142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194778|NCT02508142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93194779|NCT02508142|Mydriatics|mydriatics|mesh-ancestor
93194780|NCT02508142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93194781|NCT02508142|Cholinergic Agents|cholinergic agents|mesh-ancestor
93194782|NCT02508142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194783|NCT02508142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194784|NCT02508142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93194785|NCT02508142|Parasympatholytics|parasympatholytics|mesh-ancestor
93194786|NCT02508220|Oxytocin|oxytocin|mesh-list
93194787|NCT02508220|Oxytocics|oxytocics|mesh-ancestor
93194788|NCT02508220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93194789|NCT02508220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194790|NCT01297907|Methacholine Chloride|methacholine chloride|mesh-list
93194791|NCT01297907|Miotics|miotics|mesh-ancestor
93194792|NCT01297907|Autonomic Agents|autonomic agents|mesh-ancestor
93194793|NCT01297907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194794|NCT01297907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194795|NCT01297907|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93194796|NCT01297907|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93194797|NCT01297907|Respiratory System Agents|respiratory system agents|mesh-ancestor
93194798|NCT01297907|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93194799|NCT01297907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93194800|NCT01297907|Cholinergic Agents|cholinergic agents|mesh-ancestor
93194801|NCT01297907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93194802|NCT01297907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194803|NCT02508064|Fostemsavir|fostemsavir|mesh-list
93194804|NCT02508064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93194805|NCT02508064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93194806|NCT02508064|Antiviral Agents|antiviral agents|mesh-ancestor
93194807|NCT02508064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194808|NCT02508064|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93194809|NCT02508064|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93194810|NCT02508064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194811|NCT05705570|Cyclophosphamide|cyclophosphamide|mesh-list
93194812|NCT05705570|Fludarabine|fludarabine|mesh-list
93194813|NCT05705570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93194814|NCT05705570|Immunologic Factors|immunologic factors|mesh-ancestor
93194815|NCT05705570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194816|NCT05705570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194817|NCT05705570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93194818|NCT05705570|Alkylating Agents|alkylating agents|mesh-ancestor
93194819|NCT05705570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194820|NCT05705570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194821|NCT05705570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93194822|NCT05670236|Lidocaine|lidocaine|mesh-list
93194823|NCT05670236|Anesthetics, Local|anesthetics, local|mesh-ancestor
93194824|NCT05670236|Anesthetics|anesthetics|mesh-ancestor
93194825|NCT05670236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194826|NCT05670236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194827|NCT05670236|Sensory System Agents|sensory system agents|mesh-ancestor
93194828|NCT05670236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194829|NCT05670236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93194830|NCT05670236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93194831|NCT05670236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93194832|NCT05670236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93194833|NCT05670236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194834|NCT03214380|Insulin|insulin|mesh-list
93194835|NCT03214380|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93194836|NCT03214380|Metformin|metformin|mesh-list
93194837|NCT03214380|Insulin Glargine|insulin glargine|mesh-list
93194838|NCT03214380|Insulin Lispro|insulin lispro|mesh-list
93194839|NCT03214380|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93194840|NCT03214380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93194841|NCT03214380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194842|NCT03214380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194843|NCT04498234|Bupivacaine|bupivacaine|mesh-list
93194844|NCT04498234|Anesthetics, Local|anesthetics, local|mesh-ancestor
93194845|NCT04498234|Anesthetics|anesthetics|mesh-ancestor
93194846|NCT04498234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194847|NCT04498234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194848|NCT04498234|Sensory System Agents|sensory system agents|mesh-ancestor
93194849|NCT04498234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194850|NCT03343444|Sofosbuvir|sofosbuvir|mesh-list
93194851|NCT03343444|Ledipasvir|ledipasvir|mesh-list
93194852|NCT03343444|Antiviral Agents|antiviral agents|mesh-ancestor
93194853|NCT03343444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867004|NCT02759198|Celecoxib|celecoxib|mesh-list
93194855|NCT03819101|Atorvastatin|atorvastatin|mesh-list
93194856|NCT03819101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93194857|NCT03819101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93194858|NCT03819101|Antimetabolites|antimetabolites|mesh-ancestor
93194859|NCT03819101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194860|NCT03819101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93194861|NCT03819101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93194862|NCT03819101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194863|NCT03819101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93194864|NCT03819101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93194865|NCT03819101|Analgesics|analgesics|mesh-ancestor
93194866|NCT03819101|Sensory System Agents|sensory system agents|mesh-ancestor
93194867|NCT03819101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194868|NCT03819101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194869|NCT03819101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93194870|NCT03819101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194871|NCT03819101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93194872|NCT03819101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93194873|NCT03819101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93194874|NCT03819101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93194875|NCT03819101|Antipyretics|antipyretics|mesh-ancestor
93194876|NCT05199324|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93194877|NCT05199324|Ciprofloxacin|ciprofloxacin|mesh-list
93194878|NCT05199324|Cefazolin|cefazolin|mesh-list
93194879|NCT05199324|Ceftriaxone|ceftriaxone|mesh-list
93194880|NCT05199324|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93194881|NCT05199324|Fluoroquinolones|fluoroquinolones|mesh-list
93194882|NCT05199324|Trimethoprim|trimethoprim|mesh-list
93194883|NCT05199324|Sulfamethoxazole|sulfamethoxazole|mesh-list
93194884|NCT05199324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194885|NCT05199324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93194886|NCT05199324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93194887|NCT05199324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194888|NCT05199324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194889|NCT05199324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194890|NCT05199324|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93194891|NCT05199324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93194892|NCT05199324|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93194893|NCT05199324|Antimalarials|antimalarials|mesh-ancestor
93194894|NCT05199324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93194895|NCT05199324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93194896|NCT05199324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93194897|NCT05199324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93194898|NCT05199324|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93194899|NCT05199324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93194900|NCT03343366|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93194901|NCT03343366|Metronidazole|metronidazole|mesh-list
93194902|NCT03343366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194903|NCT03343366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93194904|NCT03343366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93194905|NCT01298297|Morphine|morphine|mesh-list
93194906|NCT01298297|Buprenorphine|buprenorphine|mesh-list
93194907|NCT01298297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93194908|NCT01298297|Narcotics|narcotics|mesh-ancestor
93194909|NCT01298297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194910|NCT01298297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194911|NCT01298297|Analgesics|analgesics|mesh-ancestor
93194912|NCT01298297|Sensory System Agents|sensory system agents|mesh-ancestor
93194913|NCT01298297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194914|NCT01298297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93194915|NCT03818945|Listerine|listerine|mesh-list
93194916|NCT03818945|Fluorides|fluorides|mesh-list
93194917|NCT03818945|Sodium Fluoride|sodium fluoride|mesh-list
93194918|NCT03818945|Fluorides, Topical|fluorides, topical|mesh-list
93194919|NCT03818945|Cariostatic Agents|cariostatic agents|mesh-ancestor
93194920|NCT03818945|Protective Agents|protective agents|mesh-ancestor
93194921|NCT03818945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194922|NCT03818945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93194923|NCT03818945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194924|NCT04300751|Analgesics, Opioid|analgesics, opioid|mesh-list
93194925|NCT04300751|Narcotics|narcotics|mesh-ancestor
93194926|NCT04300751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194927|NCT04300751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194928|NCT04300751|Analgesics|analgesics|mesh-ancestor
93194929|NCT04300751|Sensory System Agents|sensory system agents|mesh-ancestor
93194930|NCT04300751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194931|NCT03842423|Anesthetics|anesthetics|mesh-list
93194932|NCT03842423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194933|NCT03842423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194934|NCT03172026|Maraviroc|maraviroc|mesh-list
93194935|NCT03172026|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93194936|NCT03172026|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93194937|NCT03172026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194938|NCT03172026|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93194939|NCT03172026|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93194940|NCT03172026|Antiviral Agents|antiviral agents|mesh-ancestor
93194941|NCT03172026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194942|NCT03172026|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93194943|NCT01201577|Azithromycin|azithromycin|mesh-list
93194944|NCT01201577|Sulfalene|sulfalene|mesh-list
93194945|NCT01201577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93194946|NCT01201577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194947|NCT01201577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93194948|NCT01201577|Antimalarials|antimalarials|mesh-ancestor
93194949|NCT01201577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93194950|NCT01201577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93194951|NCT04496050|Alprostadil|alprostadil|mesh-list
93194952|NCT04496050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93194953|NCT04496050|Vasodilator Agents|vasodilator agents|mesh-ancestor
93194954|NCT04496050|Urological Agents|urological agents|mesh-ancestor
93194955|NCT01300793|Rituximab|rituximab|mesh-list
93194956|NCT01300793|Carboplatin|carboplatin|mesh-list
93194957|NCT01300793|Etoposide|etoposide|mesh-list
93194958|NCT01300793|Bortezomib|bortezomib|mesh-list
93194959|NCT01300793|Ifosfamide|ifosfamide|mesh-list
93194960|NCT01300793|Isophosphamide mustard|isophosphamide mustard|mesh-list
93194961|NCT01300793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93194962|NCT01300793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93194963|NCT01300793|Immunologic Factors|immunologic factors|mesh-ancestor
93194964|NCT01300793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194965|NCT01300793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93194966|NCT01300793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93194967|NCT01300793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93194968|NCT01300793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93194969|NCT01300793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93194970|NCT01300793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93194971|NCT01300793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93194972|NCT01300793|Alkylating Agents|alkylating agents|mesh-ancestor
93194973|NCT03342040|Bupivacaine|bupivacaine|mesh-list
93194974|NCT03342040|Ropivacaine|ropivacaine|mesh-list
93194975|NCT03342040|Anesthetics, Local|anesthetics, local|mesh-ancestor
93194976|NCT03342040|Anesthetics|anesthetics|mesh-ancestor
93194977|NCT03342040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93194978|NCT03342040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194979|NCT03342040|Sensory System Agents|sensory system agents|mesh-ancestor
93194980|NCT03342040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93194981|NCT01298843|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93194982|NCT01298843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93194983|NCT01298843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93194984|NCT03336970|Calcium|calcium|mesh-list
93194985|NCT03336970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194986|NCT03336970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194987|NCT03336814|Terlipressin|terlipressin|mesh-list
93194988|NCT03336814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93194989|NCT03336814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93194990|NCT02495584|Vitamin D|vitamin d|mesh-list
93194991|NCT02495584|Ergocalciferols|ergocalciferols|mesh-list
93194992|NCT02495584|Cholecalciferol|cholecalciferol|mesh-list
93194993|NCT02495584|Vitamins|vitamins|mesh-list
93194994|NCT02495584|Micronutrients|micronutrients|mesh-ancestor
93194995|NCT02495584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93194996|NCT02495584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93194997|NCT02495584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93194998|NCT02495818|Lidocaine|lidocaine|mesh-list
93194999|NCT02495818|Anesthetics, Local|anesthetics, local|mesh-ancestor
93195000|NCT02495818|Anesthetics|anesthetics|mesh-ancestor
93195001|NCT02495818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195002|NCT02495818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195003|NCT02495818|Sensory System Agents|sensory system agents|mesh-ancestor
93195004|NCT02495818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195005|NCT02495818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93195006|NCT02495818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93195007|NCT02495818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93195008|NCT02495818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93195009|NCT02495818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195011|NCT02495662|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93195012|NCT02495662|Methylprednisolone|methylprednisolone|mesh-list
93195013|NCT02495662|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93195014|NCT02495662|Prednisolone acetate|prednisolone acetate|mesh-list
93195015|NCT02495662|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93195016|NCT02495662|Prednisolone phosphate|prednisolone phosphate|mesh-list
93195017|NCT02495662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195018|NCT02495662|Glucocorticoids|glucocorticoids|mesh-ancestor
93195019|NCT02495662|Hormones|hormones|mesh-ancestor
93195020|NCT02495662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195021|NCT02495662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195022|NCT02495662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195023|NCT02495662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195024|NCT02495662|Antiemetics|antiemetics|mesh-ancestor
93195025|NCT02495662|Autonomic Agents|autonomic agents|mesh-ancestor
93195026|NCT02495662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195027|NCT02495662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195028|NCT02495662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93195029|NCT02495662|Protective Agents|protective agents|mesh-ancestor
93195030|NCT02496052|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93195031|NCT02496052|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93195032|NCT02496052|Estradiol|estradiol|mesh-list
93195033|NCT02496052|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93195034|NCT02496052|Dydrogesterone|dydrogesterone|mesh-list
93195035|NCT02496052|Estrogens|estrogens|mesh-ancestor
93195036|NCT02496052|Hormones|hormones|mesh-ancestor
93195037|NCT02496052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195038|NCT02496052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195039|NCT02496052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93195040|NCT02496052|Contraceptive Agents|contraceptive agents|mesh-ancestor
93195041|NCT02496052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195042|NCT02496052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93195043|NCT02496052|Progestins|progestins|mesh-ancestor
93195044|NCT01206569|Tacrolimus|tacrolimus|mesh-list
93195045|NCT01206569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195046|NCT01206569|Immunologic Factors|immunologic factors|mesh-ancestor
93195047|NCT01206569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195048|NCT01206569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93195049|NCT01206569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195050|NCT01206569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195051|NCT01206647|Metformin|metformin|mesh-list
93195052|NCT01206647|Saxagliptin|saxagliptin|mesh-list
93195053|NCT01206647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93195054|NCT01206647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195055|NCT01206647|Incretins|incretins|mesh-ancestor
93195056|NCT01206647|Hormones|hormones|mesh-ancestor
93195057|NCT01206647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195058|NCT01206647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93195059|NCT01206647|Protease Inhibitors|protease inhibitors|mesh-ancestor
93195060|NCT01206647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195061|NCT01206647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195062|NCT03341884|Ipatasertib|ipatasertib|mesh-list
93195063|NCT03341884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195064|NCT03341884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93195065|NCT03341884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195066|NCT03341884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195067|NCT03560245|Bryostatin 1|bryostatin 1|mesh-list
93195068|NCT03560245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93195069|NCT03560245|Immunologic Factors|immunologic factors|mesh-ancestor
93195070|NCT03560245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195071|NCT03560245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195072|NCT02495272|Oxytocin|oxytocin|mesh-list
93195073|NCT02495272|Oxytocics|oxytocics|mesh-ancestor
93195074|NCT02495272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195075|NCT02495272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195076|NCT03336346|Efavirenz|efavirenz|mesh-list
93195077|NCT03336346|Dolutegravir|dolutegravir|mesh-list
93195078|NCT03336346|Etonogestrel|etonogestrel|mesh-list
93195079|NCT03336346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93195080|NCT03336346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93195081|NCT03336346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195082|NCT03336346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195084|NCT03336346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195085|NCT03336346|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93195086|NCT03336346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93195087|NCT03336346|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93195088|NCT03336346|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93195089|NCT03336346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93195090|NCT03336346|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93195091|NCT03336346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93195092|NCT03336346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93195093|NCT03336346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93195094|NCT03336346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93195095|NCT03336346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93195096|NCT03336346|Contraceptive Agents|contraceptive agents|mesh-ancestor
93195097|NCT03336346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195098|NCT03336346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195099|NCT03336346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93195100|NCT03841292|Varenicline|varenicline|mesh-list
93195101|NCT03841292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93195102|NCT03841292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93195103|NCT03841292|Cholinergic Agents|cholinergic agents|mesh-ancestor
93195104|NCT03841292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195105|NCT03841292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195106|NCT03841292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195107|NCT03814577|Antioxidants|antioxidants|mesh-list
93195108|NCT03814577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195109|NCT03814577|Protective Agents|protective agents|mesh-ancestor
93195110|NCT03814577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195111|NCT03730363|Pentamidine|pentamidine|mesh-list
93195112|NCT03730363|Antifungal Agents|antifungal agents|mesh-ancestor
93195113|NCT03730363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195114|NCT03730363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93195115|NCT03730363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93195116|NCT03730363|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93195117|NCT01206803|Ganirelix|ganirelix|mesh-list
93195118|NCT01206803|Hormone Antagonists|hormone antagonists|mesh-ancestor
93195119|NCT01206803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195120|NCT01206803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195121|NCT03335956|Pioglitazone|pioglitazone|mesh-list
93195122|NCT03335956|Prednisone|prednisone|mesh-list
93195123|NCT03335956|Cortisone|cortisone|mesh-list
93195124|NCT03335956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195125|NCT03335956|Glucocorticoids|glucocorticoids|mesh-ancestor
93195126|NCT03335956|Hormones|hormones|mesh-ancestor
93195127|NCT03335956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195128|NCT03335956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195129|NCT03335956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195130|NCT03335956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195131|NCT03335956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93195132|NCT03817931|Solifenacin Succinate|solifenacin succinate|mesh-list
93195133|NCT03817931|Mirabegron|mirabegron|mesh-list
93195134|NCT03817931|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93195135|NCT03817931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
93195136|NCT03817931|Adrenergic Agents|adrenergic agents|mesh-list
93195137|NCT03817931|Adrenergic Agonists|adrenergic agonists|mesh-list
93195138|NCT03817931|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93195139|NCT03817931|Cholinergic Agents|cholinergic agents|mesh-ancestor
93195140|NCT03817931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195141|NCT03817931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195142|NCT03817931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195143|NCT03817931|Urological Agents|urological agents|mesh-ancestor
93195144|NCT03817931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93195145|NCT01206881|Cyclophosphamide|cyclophosphamide|mesh-list
93195146|NCT01206881|Docetaxel|docetaxel|mesh-list
93195147|NCT01206881|Doxorubicin|doxorubicin|mesh-list
93195148|NCT01206881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93195149|NCT01206881|Trastuzumab|trastuzumab|mesh-list
93195150|NCT01206881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195151|NCT01206881|Immunologic Factors|immunologic factors|mesh-ancestor
93195152|NCT01206881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195153|NCT01206881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195154|NCT01206881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93195155|NCT01206881|Alkylating Agents|alkylating agents|mesh-ancestor
93195156|NCT01206881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195158|NCT01206881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93195159|NCT01206881|Tubulin Modulators|tubulin modulators|mesh-ancestor
93195160|NCT01206881|Antimitotic Agents|antimitotic agents|mesh-ancestor
93195161|NCT01206881|Mitosis Modulators|mitosis modulators|mesh-ancestor
93195162|NCT01206881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93195163|NCT01206881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93195164|NCT01206881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93195165|NCT01206881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195166|NCT01206881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195167|NCT02494804|Temozolomide|temozolomide|mesh-list
93195168|NCT02494804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93195169|NCT02494804|Alkylating Agents|alkylating agents|mesh-ancestor
93195170|NCT02494804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195171|NCT02494804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195172|NCT03558997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93195173|NCT03558997|Immunologic Factors|immunologic factors|mesh-ancestor
93195174|NCT03558997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195175|NCT03814343|Amphotericin B|amphotericin b|mesh-list
93195176|NCT03814343|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93195177|NCT03814343|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93195178|NCT03814343|Amebicides|amebicides|mesh-ancestor
93195179|NCT03814343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93195180|NCT03814343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93195181|NCT03814343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195182|NCT03814343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195183|NCT03814343|Antifungal Agents|antifungal agents|mesh-ancestor
93195184|NCT03814343|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93195185|NCT03814343|Protective Agents|protective agents|mesh-ancestor
93195186|NCT03814343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195187|NCT03814343|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93195188|NCT03814343|Antioxidants|antioxidants|mesh-ancestor
93195189|NCT03814343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195190|NCT03817541|Propofol|propofol|mesh-list
93195191|NCT03817541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93195192|NCT03817541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195193|NCT03817541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195194|NCT03817541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93195195|NCT03817541|Anesthetics, General|anesthetics, general|mesh-ancestor
93195196|NCT03817541|Anesthetics|anesthetics|mesh-ancestor
93195197|NCT03341494|Thalidomide|thalidomide|mesh-list
93195198|NCT03341494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195199|NCT03341494|Immunologic Factors|immunologic factors|mesh-ancestor
93195200|NCT03341494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195201|NCT03341494|Leprostatic Agents|leprostatic agents|mesh-ancestor
93195202|NCT03341494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195203|NCT03341494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195204|NCT03341494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93195205|NCT03341494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93195206|NCT03341494|Growth Substances|growth substances|mesh-ancestor
93195207|NCT03341494|Growth Inhibitors|growth inhibitors|mesh-ancestor
93195208|NCT03341494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195209|NCT03586609|Cytarabine|cytarabine|mesh-list
93195210|NCT03586609|Azacitidine|azacitidine|mesh-list
93195211|NCT03586609|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93195212|NCT03586609|Venetoclax|venetoclax|mesh-list
93195213|NCT03586609|Cladribine|cladribine|mesh-list
93195214|NCT03586609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93195215|NCT03586609|Antimetabolites|antimetabolites|mesh-ancestor
93195216|NCT03586609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195217|NCT03586609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195218|NCT03586609|Antiviral Agents|antiviral agents|mesh-ancestor
93195219|NCT03586609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195220|NCT03586609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195221|NCT03586609|Immunologic Factors|immunologic factors|mesh-ancestor
93195222|NCT03586609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195223|NCT03586609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195224|NCT03817619|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93195225|NCT03817619|Antiviral Agents|antiviral agents|mesh-ancestor
93195226|NCT03817619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195227|NCT03725995|Lidocaine|lidocaine|mesh-list
93195228|NCT03725995|Midazolam|midazolam|mesh-list
93195229|NCT03725995|Anesthetics, Local|anesthetics, local|mesh-ancestor
93195230|NCT03725995|Anesthetics|anesthetics|mesh-ancestor
93195231|NCT03725995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195232|NCT03725995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195233|NCT03725995|Sensory System Agents|sensory system agents|mesh-ancestor
93195234|NCT03725995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195235|NCT03725995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93195236|NCT03725995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93195237|NCT03725995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93195238|NCT03725995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93195239|NCT03725995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195240|NCT03725995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93195241|NCT03725995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93195242|NCT03725995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93195243|NCT03725995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93195244|NCT03725995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93195245|NCT03725995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93195246|NCT03725995|Anesthetics, General|anesthetics, general|mesh-ancestor
93195247|NCT03725995|GABA Modulators|gaba modulators|mesh-ancestor
93195248|NCT03725995|GABA Agents|gaba agents|mesh-ancestor
93195249|NCT03725995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195250|NCT03341260|Diclofenac|diclofenac|mesh-list
93195251|NCT03341260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93195252|NCT03341260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195253|NCT03341260|Analgesics|analgesics|mesh-ancestor
93195254|NCT03341260|Sensory System Agents|sensory system agents|mesh-ancestor
93195255|NCT03341260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195256|NCT03341260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195257|NCT03341260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195258|NCT03341260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195259|NCT03341260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93195260|NCT03341260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195261|NCT03341260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195262|NCT03052400|Mifepristone|mifepristone|mesh-list
92491105|NCT00771017|Leuprolide|leuprolide|mesh-list
93195263|NCT03052400|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93195264|NCT03052400|Abortifacient Agents|abortifacient agents|mesh-ancestor
93195265|NCT03052400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195266|NCT03052400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195267|NCT03052400|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93195268|NCT03052400|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93195269|NCT03052400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93195270|NCT03052400|Contraceptive Agents|contraceptive agents|mesh-ancestor
93195271|NCT03052400|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93195272|NCT03052400|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93195273|NCT03052400|Hormone Antagonists|hormone antagonists|mesh-ancestor
93195274|NCT03052400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195275|NCT03052400|Luteolytic Agents|luteolytic agents|mesh-ancestor
93195276|NCT03052400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93195277|NCT03052400|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93195278|NCT03341104|Bupivacaine|bupivacaine|mesh-list
93195279|NCT03341104|Anesthetics, Local|anesthetics, local|mesh-ancestor
93195280|NCT03341104|Anesthetics|anesthetics|mesh-ancestor
93195281|NCT03341104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195282|NCT03341104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195283|NCT03341104|Sensory System Agents|sensory system agents|mesh-ancestor
93195284|NCT03341104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195285|NCT03335098|Thalidomide|thalidomide|mesh-list
93195286|NCT03335098|Dexamethasone|dexamethasone|mesh-list
93195287|NCT03335098|Bortezomib|bortezomib|mesh-list
93195288|NCT03335098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195289|NCT03335098|Antiemetics|antiemetics|mesh-ancestor
93195290|NCT03335098|Autonomic Agents|autonomic agents|mesh-ancestor
93195291|NCT03335098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195292|NCT03335098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195293|NCT03335098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195294|NCT03335098|Glucocorticoids|glucocorticoids|mesh-ancestor
93195295|NCT03335098|Hormones|hormones|mesh-ancestor
93195296|NCT03335098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195297|NCT03335098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195298|NCT03335098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195299|NCT03335098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195300|NCT03335098|Immunologic Factors|immunologic factors|mesh-ancestor
93195301|NCT03335098|Leprostatic Agents|leprostatic agents|mesh-ancestor
93195302|NCT03335098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195303|NCT03335098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195304|NCT03335098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867424|NCT02749994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195305|NCT03335098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93195306|NCT03335098|Growth Substances|growth substances|mesh-ancestor
93195307|NCT03335098|Growth Inhibitors|growth inhibitors|mesh-ancestor
93195308|NCT03639571|Ibuprofen|ibuprofen|mesh-list
93195309|NCT03639571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93195310|NCT03639571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195311|NCT03639571|Analgesics|analgesics|mesh-ancestor
93195312|NCT03639571|Sensory System Agents|sensory system agents|mesh-ancestor
93195313|NCT03639571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195314|NCT03639571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195315|NCT03639571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195316|NCT03639571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195317|NCT03639571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93195318|NCT03639571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195319|NCT03639571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195320|NCT03052322|Adalimumab|adalimumab|mesh-list
93195321|NCT03052322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93195322|NCT03052322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195323|NCT03052322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195324|NCT03722173|Itraconazole|itraconazole|mesh-list
93195325|NCT03722173|Antifungal Agents|antifungal agents|mesh-ancestor
93195326|NCT03722173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195327|NCT03722173|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93195328|NCT03722173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93195329|NCT03722173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195330|NCT03722173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195331|NCT03722173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93195332|NCT03722173|Hormone Antagonists|hormone antagonists|mesh-ancestor
93195333|NCT03722173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491192|NCT01953172|Vitamins|vitamins|mesh-ancestor
93195334|NCT03722173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195335|NCT03722173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93195336|NCT03521791|Bromfenac|bromfenac|mesh-list
93195337|NCT03521791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93195338|NCT03521791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195339|NCT03521791|Analgesics|analgesics|mesh-ancestor
93195340|NCT03521791|Sensory System Agents|sensory system agents|mesh-ancestor
93195341|NCT03521791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195342|NCT03521791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195343|NCT03521791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195344|NCT03521791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195345|NCT03521635|Pramipexole|pramipexole|mesh-list
93195346|NCT03521635|Antioxidants|antioxidants|mesh-ancestor
93195347|NCT03521635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195348|NCT03521635|Protective Agents|protective agents|mesh-ancestor
93195349|NCT03521635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195350|NCT03521635|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93195351|NCT03521635|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93195352|NCT03521635|Dopamine Agonists|dopamine agonists|mesh-ancestor
93195353|NCT03521635|Dopamine Agents|dopamine agents|mesh-ancestor
93195354|NCT03521635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195355|NCT03170544|Insulin Glargine|insulin glargine|mesh-list
93195356|NCT03170544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93195357|NCT03170544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195358|NCT03813641|Capecitabine|capecitabine|mesh-list
93195359|NCT03813641|Raltitrexed|raltitrexed|mesh-list
93195360|NCT03813641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93195361|NCT03813641|Antimetabolites|antimetabolites|mesh-ancestor
93195362|NCT03813641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195363|NCT03813641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195364|NCT03813641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93195365|NCT03813641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195366|NCT02492464|Red yeast rice|red yeast rice|mesh-list
93195367|NCT02492464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93195368|NCT02492464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93195369|NCT02492464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93195370|NCT02492464|Antimetabolites|antimetabolites|mesh-ancestor
93195371|NCT02492464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195372|NCT02492464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195373|NCT02492464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93195374|NCT05255159|Furosemide|furosemide|mesh-list
93195375|NCT05255159|Diuretics|diuretics|mesh-ancestor
93195376|NCT05255159|Natriuretic Agents|natriuretic agents|mesh-ancestor
93195377|NCT05255159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195378|NCT05255159|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93195379|NCT05255159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93195380|NCT05255159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195381|NCT03340558|Atezolizumab|atezolizumab|mesh-list
93195382|NCT03340558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93195383|NCT03340558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195384|NCT03340558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195385|NCT03340558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195386|NCT04905108|Riboflavin|riboflavin|mesh-list
93195387|NCT04905108|Vitamin B Complex|vitamin b complex|mesh-ancestor
93195388|NCT04905108|Vitamins|vitamins|mesh-ancestor
93195389|NCT04905108|Micronutrients|micronutrients|mesh-ancestor
93195390|NCT04905108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195391|NCT04905108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93195392|NCT04905108|Dermatologic Agents|dermatologic agents|mesh-ancestor
93195393|NCT04443166|Hyaluronic Acid|hyaluronic acid|mesh-list
93195394|NCT04443166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93195395|NCT04443166|Immunologic Factors|immunologic factors|mesh-ancestor
93195396|NCT04443166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195397|NCT04443166|Viscosupplements|viscosupplements|mesh-ancestor
93195398|NCT04443166|Protective Agents|protective agents|mesh-ancestor
93195399|NCT01560221|Buprenorphine|buprenorphine|mesh-list
93195400|NCT01560221|Methadone|methadone|mesh-list
93195401|NCT01560221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93195402|NCT01560221|Narcotics|narcotics|mesh-ancestor
93195403|NCT01560221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195404|NCT01560221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195405|NCT01560221|Analgesics|analgesics|mesh-ancestor
93195406|NCT01560221|Sensory System Agents|sensory system agents|mesh-ancestor
93195407|NCT01560221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195408|NCT01560221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93195409|NCT01560221|Antitussive Agents|antitussive agents|mesh-ancestor
93195410|NCT01560221|Respiratory System Agents|respiratory system agents|mesh-ancestor
93195411|NCT03813329|Calcium Carbonate|calcium carbonate|mesh-list
93195412|NCT03813329|Calcium|calcium|mesh-list
93195413|NCT03813329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93195414|NCT03813329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195415|NCT03813329|Antacids|antacids|mesh-ancestor
93195416|NCT03813329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195417|NCT03813329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195418|NCT03639415|Oxycodone|oxycodone|mesh-list
93195419|NCT03639415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93195420|NCT03639415|Narcotics|narcotics|mesh-ancestor
93195421|NCT03639415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195422|NCT03639415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195423|NCT03639415|Analgesics|analgesics|mesh-ancestor
93195424|NCT03639415|Sensory System Agents|sensory system agents|mesh-ancestor
93195425|NCT03639415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195426|NCT02492386|Everolimus|everolimus|mesh-list
93195427|NCT02492386|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93195428|NCT02492386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93195429|NCT02492386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195430|NCT02492386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195431|NCT02492386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195432|NCT02492386|Immunologic Factors|immunologic factors|mesh-ancestor
93195433|NCT02492386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195434|NCT02492386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195435|NCT03340168|Bisphenol A|bisphenol a|mesh-list
93195436|NCT03340168|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93195437|NCT03340168|Estrogens|estrogens|mesh-ancestor
93195438|NCT03340168|Hormones|hormones|mesh-ancestor
93195439|NCT03340168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195440|NCT03340168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195441|NCT03340168|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93195442|NCT03340168|Antioxidants|antioxidants|mesh-ancestor
93195443|NCT03340168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195444|NCT03340168|Protective Agents|protective agents|mesh-ancestor
93195445|NCT01299701|Vadimezan|vadimezan|mesh-list
93195446|NCT01299701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195447|NCT01299779|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93195448|NCT01299779|Laxatives|laxatives|mesh-ancestor
93195449|NCT01299779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195450|NCT03812939|Octreotide|octreotide|mesh-list
93195451|NCT03812939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195452|NCT03812939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195453|NCT03812939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195454|NCT03339700|Cyclophosphamide|cyclophosphamide|mesh-list
93195455|NCT03339700|Busulfan|busulfan|mesh-list
93195456|NCT03339700|Gemcitabine|gemcitabine|mesh-list
93195457|NCT03339700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195458|NCT03339700|Immunologic Factors|immunologic factors|mesh-ancestor
93195459|NCT03339700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195460|NCT03339700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195461|NCT03339700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93195462|NCT03339700|Alkylating Agents|alkylating agents|mesh-ancestor
93195463|NCT03339700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195464|NCT03339700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195465|NCT03339700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93195466|NCT03339700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93195467|NCT03339700|Antimetabolites|antimetabolites|mesh-ancestor
93195468|NCT05661149|Insulin|insulin|mesh-list
93195469|NCT05661149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93195470|NCT05661149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195471|NCT01299857|Rituximab|rituximab|mesh-list
93195472|NCT01299857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195473|NCT01299857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195474|NCT01299857|Immunologic Factors|immunologic factors|mesh-ancestor
93195475|NCT01299857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195476|NCT01299857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195477|NCT03478969|Insulin|insulin|mesh-list
93195478|NCT03478969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93195479|NCT03478969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195480|NCT03812783|Sorafenib|sorafenib|mesh-list
93195481|NCT03812783|Folfirinox|folfirinox|mesh-list
93195482|NCT03812783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195483|NCT03812783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93195484|NCT03812783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117977|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195485|NCT03812783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195486|NCT02500498|Abatacept|abatacept|mesh-list
93195487|NCT02500498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93195488|NCT02500498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195489|NCT02500498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195490|NCT02500498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195491|NCT02500498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195492|NCT02500498|Immunologic Factors|immunologic factors|mesh-ancestor
93195493|NCT02500498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195494|NCT02500498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195495|NCT05644223|Edaravone|edaravone|mesh-list
93195496|NCT05644223|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93195497|NCT05644223|Antioxidants|antioxidants|mesh-ancestor
93195498|NCT05644223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195499|NCT05644223|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93195500|NCT05644223|Protective Agents|protective agents|mesh-ancestor
93195501|NCT05644223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195502|NCT02500108|Domperidone|domperidone|mesh-list
93195503|NCT02500108|Antiemetics|antiemetics|mesh-ancestor
93195504|NCT02500108|Autonomic Agents|autonomic agents|mesh-ancestor
93195505|NCT02500108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195506|NCT02500108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195507|NCT02500108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195508|NCT02500108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93195509|NCT02500108|Dopamine Agents|dopamine agents|mesh-ancestor
93195510|NCT02500108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195511|NCT02500108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195512|NCT02499874|Tenofovir|tenofovir|mesh-list
93195513|NCT02499874|Lamivudine|lamivudine|mesh-list
93195514|NCT02499874|Emtricitabine|emtricitabine|mesh-list
93195515|NCT02499874|Zidovudine|zidovudine|mesh-list
93195516|NCT02499874|Efavirenz|efavirenz|mesh-list
93195517|NCT02499874|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93195518|NCT02499874|Antiviral Agents|antiviral agents|mesh-ancestor
93195519|NCT02499874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195520|NCT02499874|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93195521|NCT02499874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93195522|NCT02499874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195523|NCT02499874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195524|NCT02499874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93195525|NCT02499874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93195526|NCT02499874|Antimetabolites|antimetabolites|mesh-ancestor
93195527|NCT02499874|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93195528|NCT02499874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93195529|NCT02499874|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93195530|NCT02499874|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93195531|NCT02499874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93195532|NCT02499874|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93195534|NCT02492308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195535|NCT02492308|Immunologic Factors|immunologic factors|mesh-ancestor
93195536|NCT02492308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195537|NCT05865470|Dronabinol|dronabinol|mesh-list
93195538|NCT05865470|Hallucinogens|hallucinogens|mesh-ancestor
93195539|NCT05865470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195540|NCT05865470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93195541|NCT05865470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195542|NCT05865470|Analgesics|analgesics|mesh-ancestor
93195543|NCT05865470|Sensory System Agents|sensory system agents|mesh-ancestor
93195544|NCT05865470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195545|NCT05865470|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93195546|NCT05865470|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93195547|NCT05865470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195548|NCT05865470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195549|NCT05865470|Hormones|hormones|mesh-ancestor
93195550|NCT05865470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195551|NCT05865431|Zinc Oxide|zinc oxide|mesh-list
93195552|NCT05865431|Avobenzone|avobenzone|mesh-list
93195553|NCT05865431|Dermatologic Agents|dermatologic agents|mesh-ancestor
93195554|NCT05865431|Sunscreening Agents|sunscreening agents|mesh-ancestor
93195555|NCT05865431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93195556|NCT05865431|Protective Agents|protective agents|mesh-ancestor
93195557|NCT05865431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195558|NCT05865288|Oxytocin|oxytocin|mesh-list
93195559|NCT05865288|Oxytocics|oxytocics|mesh-ancestor
93195560|NCT05865288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195561|NCT05865288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195562|NCT05865132|Palbociclib|palbociclib|mesh-list
93195563|NCT05865132|Afatinib|afatinib|mesh-list
93195564|NCT05865132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195565|NCT05865132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93195566|NCT05865132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195567|NCT05865132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195568|NCT05864885|Minoxidil|minoxidil|mesh-list
93195569|NCT05864885|Latanoprost|latanoprost|mesh-list
93195570|NCT05864885|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93195571|NCT05864885|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93195572|NCT05864885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93195573|NCT05864885|Vasodilator Agents|vasodilator agents|mesh-ancestor
93195574|NCT05864742|Rituximab|rituximab|mesh-list
93195575|NCT05864742|Venetoclax|venetoclax|mesh-list
93195576|NCT05864742|Navitoclax|navitoclax|mesh-list
93195577|NCT05864742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195578|NCT05864742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195579|NCT05864742|Immunologic Factors|immunologic factors|mesh-ancestor
93195580|NCT05864742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195581|NCT05864742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195582|NCT05864677|Cerebrolysin|cerebrolysin|mesh-list
93195583|NCT05864677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93195584|NCT05864677|Protective Agents|protective agents|mesh-ancestor
93195585|NCT05864677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195586|NCT05864677|Nootropic Agents|nootropic agents|mesh-ancestor
93195587|NCT05864664|Anesthetics|anesthetics|mesh-list
93195588|NCT05864664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195589|NCT05864664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195590|NCT05864508|Oxytocin|oxytocin|mesh-list
93195591|NCT05864508|Oxytocics|oxytocics|mesh-ancestor
93195592|NCT05864508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195593|NCT05864508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195594|NCT05864118|Antibodies|antibodies|mesh-list
93195595|NCT05864118|Immunologic Factors|immunologic factors|mesh-ancestor
93195596|NCT05864118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195597|NCT05864053|Ketamine|ketamine|mesh-list
93195598|NCT05864053|Analgesics|analgesics|mesh-ancestor
93195599|NCT05864053|Sensory System Agents|sensory system agents|mesh-ancestor
93195600|NCT05864053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195601|NCT05864053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195602|NCT05864053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93195603|NCT05864053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93195604|NCT05864053|Anesthetics, General|anesthetics, general|mesh-ancestor
93195605|NCT05864053|Anesthetics|anesthetics|mesh-ancestor
93195606|NCT05864053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195607|NCT05864053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93195609|NCT05864053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195610|NCT05864053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195611|NCT05863975|Interferons|interferons|mesh-list
93195612|NCT05863975|Interferon-alpha|interferon-alpha|mesh-list
93195613|NCT05863975|Interferon alpha-2|interferon alpha-2|mesh-list
93195614|NCT05863975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195615|NCT05863975|Antiviral Agents|antiviral agents|mesh-ancestor
93195616|NCT05863975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195617|NCT05863975|Immunologic Factors|immunologic factors|mesh-ancestor
93195618|NCT05863975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195619|NCT05863949|Vitamin D|vitamin d|mesh-list
93195620|NCT05863949|Calcium|calcium|mesh-list
93195621|NCT05863949|Vitamins|vitamins|mesh-ancestor
93195622|NCT05863949|Micronutrients|micronutrients|mesh-ancestor
93195623|NCT05863949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195624|NCT05863949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93195625|NCT05863949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93195626|NCT05863936|Methylprednisolone|methylprednisolone|mesh-list
93195627|NCT05863936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93195628|NCT05863936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93195629|NCT05863936|Prednisolone|prednisolone|mesh-list
93195630|NCT05863936|Prednisolone acetate|prednisolone acetate|mesh-list
93195631|NCT05863936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93195632|NCT05863936|Prednisolone phosphate|prednisolone phosphate|mesh-list
93195633|NCT05863936|Belimumab|belimumab|mesh-list
93195634|NCT05863936|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93195635|NCT05863936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195636|NCT05863936|Antiemetics|antiemetics|mesh-ancestor
93195637|NCT05863936|Autonomic Agents|autonomic agents|mesh-ancestor
93195638|NCT05863936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195639|NCT05863936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195640|NCT05863936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195641|NCT05863936|Glucocorticoids|glucocorticoids|mesh-ancestor
93195642|NCT05863936|Hormones|hormones|mesh-ancestor
93195643|NCT05863936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195644|NCT05863936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93195645|NCT05863936|Protective Agents|protective agents|mesh-ancestor
93195646|NCT05863936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195647|NCT05863936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195648|NCT05863936|Immunologic Factors|immunologic factors|mesh-ancestor
93195649|NCT05863858|Amoxicillin|amoxicillin|mesh-list
93195650|NCT05863858|Moxifloxacin|moxifloxacin|mesh-list
93195651|NCT05863858|Levofloxacin|levofloxacin|mesh-list
93195652|NCT05863858|Ofloxacin|ofloxacin|mesh-list
93195653|NCT05863858|Tinidazole|tinidazole|mesh-list
93195654|NCT05863858|Omeprazole|omeprazole|mesh-list
93195655|NCT05863858|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93195656|NCT05863858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195657|NCT05863858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195658|NCT05863858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93195659|NCT05863858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93195660|NCT05863858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195661|NCT05863858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195662|NCT05863858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195663|NCT05863858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93195664|NCT05863858|Contraceptive Agents|contraceptive agents|mesh-ancestor
93195665|NCT05863858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195666|NCT05863858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195667|NCT05863858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93195668|NCT05863858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93195669|NCT05863858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93195670|NCT05863858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93195671|NCT05863858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195672|NCT05863858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93195673|NCT05863858|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93195674|NCT05863858|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93195675|NCT05863858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93195676|NCT05863858|Alkylating Agents|alkylating agents|mesh-ancestor
93195677|NCT05863858|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93195678|NCT05863858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93195679|NCT05863858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93195680|NCT05863845|Cytarabine|cytarabine|mesh-list
93195681|NCT05863845|Etoposide|etoposide|mesh-list
93195682|NCT05863845|Melphalan|melphalan|mesh-list
93195683|NCT05863845|Venetoclax|venetoclax|mesh-list
93195684|NCT05863845|Carmustine|carmustine|mesh-list
93195685|NCT05863845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93195686|NCT05863845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195687|NCT05863845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93195688|NCT05863845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93195689|NCT05863845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195690|NCT05863845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195691|NCT05863845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93195692|NCT05863845|Antimetabolites|antimetabolites|mesh-ancestor
93195693|NCT05863845|Antiviral Agents|antiviral agents|mesh-ancestor
93195694|NCT05863845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195695|NCT05863845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195696|NCT05863845|Immunologic Factors|immunologic factors|mesh-ancestor
93195697|NCT05863845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195698|NCT05863845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93195699|NCT05863845|Alkylating Agents|alkylating agents|mesh-ancestor
93195700|NCT05863845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93195701|NCT05863832|Metronidazole|metronidazole|mesh-list
93195702|NCT05863832|Ciprofloxacin|ciprofloxacin|mesh-list
93195703|NCT05863832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195704|NCT05863832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195705|NCT05863832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93195706|NCT05863832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93195707|NCT05863832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93195708|NCT05863832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93195709|NCT05863832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195710|NCT05863832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195711|NCT05863832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195712|NCT05863832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93195713|NCT05863832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93195714|NCT05863585|MEDI9197|medi9197|mesh-list
93195715|NCT05863585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93195716|NCT05863585|Immunologic Factors|immunologic factors|mesh-ancestor
93195717|NCT05863585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195718|NCT05863455|Midazolam|midazolam|mesh-list
93195719|NCT05863455|Sufentanil|sufentanil|mesh-list
93195720|NCT05863455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93195721|NCT05863455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93195722|NCT05863455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195723|NCT05863455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195724|NCT05863455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93195725|NCT05863455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93195726|NCT05863455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93195727|NCT05863455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93195728|NCT05863455|Anesthetics, General|anesthetics, general|mesh-ancestor
93195729|NCT05863455|Anesthetics|anesthetics|mesh-ancestor
93195730|NCT05863455|GABA Modulators|gaba modulators|mesh-ancestor
93195731|NCT05863455|GABA Agents|gaba agents|mesh-ancestor
93195732|NCT05863455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195733|NCT05863455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195734|NCT05863455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93195735|NCT05863455|Narcotics|narcotics|mesh-ancestor
93195736|NCT05863455|Analgesics|analgesics|mesh-ancestor
93195737|NCT05863455|Sensory System Agents|sensory system agents|mesh-ancestor
93195738|NCT05863455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195739|NCT05863442|Eculizumab|eculizumab|mesh-list
93195740|NCT05863442|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93195741|NCT05863442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195742|NCT05863442|Immunologic Factors|immunologic factors|mesh-ancestor
93195743|NCT05863442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195744|NCT05863416|Dexmedetomidine|dexmedetomidine|mesh-list
93195745|NCT05863416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93195746|NCT05863416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195747|NCT05863416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195748|NCT05863416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195749|NCT05863416|Analgesics|analgesics|mesh-ancestor
93195750|NCT05863416|Sensory System Agents|sensory system agents|mesh-ancestor
93195751|NCT05863416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195752|NCT05863416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93195753|NCT05863416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93195754|NCT05863416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93195755|NCT05863416|Adrenergic Agents|adrenergic agents|mesh-ancestor
93195756|NCT05863416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195757|NCT05863416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195758|NCT05863364|Rifaximin|rifaximin|mesh-list
93195759|NCT05863364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195760|NCT05863364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195761|NCT05863364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93195762|NCT05863325|Docetaxel|docetaxel|mesh-list
93195763|NCT05863325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195764|NCT05863325|Tubulin Modulators|tubulin modulators|mesh-ancestor
93195765|NCT05863325|Antimitotic Agents|antimitotic agents|mesh-ancestor
93195766|NCT05863325|Mitosis Modulators|mitosis modulators|mesh-ancestor
93195767|NCT05863325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195768|NCT05863312|Temazepam|temazepam|mesh-list
93195769|NCT05863312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93195770|NCT05863312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195771|NCT05863312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195772|NCT05863312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93195773|NCT05863312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93195774|NCT05863312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93195775|NCT05863312|GABA Modulators|gaba modulators|mesh-ancestor
93195776|NCT05863312|GABA Agents|gaba agents|mesh-ancestor
93195777|NCT05863312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195778|NCT05863312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195779|NCT05863273|Apremilast|apremilast|mesh-list
93195780|NCT05863273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93195781|NCT05863273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195782|NCT05863273|Analgesics|analgesics|mesh-ancestor
93195783|NCT05863273|Sensory System Agents|sensory system agents|mesh-ancestor
93195784|NCT05863273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195785|NCT05863273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195786|NCT05863273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195787|NCT05863273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195788|NCT05863273|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93195789|NCT05863273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93195790|NCT05863273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195791|NCT05863273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195792|NCT05862272|Relugolix|relugolix|mesh-list
93195793|NCT05862272|Androgen Antagonists|androgen antagonists|mesh-ancestor
93195794|NCT05862272|Hormone Antagonists|hormone antagonists|mesh-ancestor
93195795|NCT05862272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195796|NCT05862272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195797|NCT05862233|Cyclosporine|cyclosporine|mesh-list
93195798|NCT05862233|Cyclosporins|cyclosporins|mesh-list
93195799|NCT05862233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195800|NCT05862233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195801|NCT05862233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93195802|NCT05862233|Immunologic Factors|immunologic factors|mesh-ancestor
93195803|NCT05862233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195804|NCT05862233|Antifungal Agents|antifungal agents|mesh-ancestor
93195805|NCT05862233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195806|NCT05862233|Dermatologic Agents|dermatologic agents|mesh-ancestor
93195807|NCT05862233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195808|NCT05862233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93195809|NCT05860998|Antibodies|antibodies|mesh-list
93195810|NCT05860998|Immunoglobulin G|immunoglobulin g|mesh-list
93195811|NCT05860998|Immunologic Factors|immunologic factors|mesh-ancestor
93195812|NCT05860998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195813|NCT05860452|Ropivacaine|ropivacaine|mesh-list
93195814|NCT05860452|Anesthetics, Local|anesthetics, local|mesh-ancestor
93195815|NCT05860452|Anesthetics|anesthetics|mesh-ancestor
93195816|NCT05860452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195817|NCT05860452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195818|NCT05860452|Sensory System Agents|sensory system agents|mesh-ancestor
93195819|NCT05860452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195820|NCT05856500|Curcumin|curcumin|mesh-list
93195821|NCT05856500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93195822|NCT05856500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93195823|NCT05856500|Analgesics|analgesics|mesh-ancestor
93195824|NCT05856500|Sensory System Agents|sensory system agents|mesh-ancestor
93195825|NCT05856500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195826|NCT05856500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195827|NCT05856500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195828|NCT05856500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93195829|NCT05856500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195830|NCT05856500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195831|NCT05856500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195832|NCT05850520|Aflibercept|aflibercept|mesh-list
93195833|NCT05850520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93195834|NCT05850520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93195835|NCT05850520|Growth Substances|growth substances|mesh-ancestor
93195836|NCT05850520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195837|NCT05850520|Growth Inhibitors|growth inhibitors|mesh-ancestor
93195838|NCT05850520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195839|NCT05849779|Sevoflurane|sevoflurane|mesh-list
93195840|NCT05849779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93195841|NCT05849779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93195842|NCT05849779|Anesthetics, General|anesthetics, general|mesh-ancestor
93195843|NCT05849779|Anesthetics|anesthetics|mesh-ancestor
93195844|NCT05849779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195845|NCT05849779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195846|NCT05847517|Metoprolol|metoprolol|mesh-list
93195847|NCT05847517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93195848|NCT05847517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93195849|NCT05847517|Sympatholytics|sympatholytics|mesh-ancestor
93195850|NCT05847517|Autonomic Agents|autonomic agents|mesh-ancestor
93195851|NCT05847517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93195852|NCT05847517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195853|NCT05847517|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93195854|NCT05847517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93195855|NCT05847517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93195856|NCT05847517|Adrenergic Agents|adrenergic agents|mesh-ancestor
93195857|NCT05847517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195858|NCT05847517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195859|NCT05837104|Vitamin B 6|vitamin b 6|mesh-list
93195860|NCT05837104|Pyridoxal|pyridoxal|mesh-list
93195861|NCT05837104|Pyridoxine|pyridoxine|mesh-list
93195862|NCT05837104|Vitamins|vitamins|mesh-ancestor
93195863|NCT05837104|Micronutrients|micronutrients|mesh-ancestor
93195864|NCT05837104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195865|NCT05837104|Vitamin B Complex|vitamin b complex|mesh-ancestor
93195866|NCT05828303|Metformin|metformin|mesh-list
93195867|NCT05828303|Digoxin|digoxin|mesh-list
93195868|NCT05828303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93195869|NCT05828303|Calcium|calcium|mesh-list
93195870|NCT05828303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93195871|NCT05828303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195872|NCT05828303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93195873|NCT05828303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93195874|NCT05828303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93195875|NCT05828303|Antimetabolites|antimetabolites|mesh-ancestor
93195876|NCT05828303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195877|NCT05828303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93195878|NCT05828303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93195879|NCT05828303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195880|NCT05828303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93195881|NCT05828303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93195882|NCT05828303|Protective Agents|protective agents|mesh-ancestor
93195883|NCT05801705|Tamoxifen|tamoxifen|mesh-list
93195884|NCT05801705|Toremifene|toremifene|mesh-list
93195885|NCT05801705|Hormones|hormones|mesh-list
93195886|NCT05801705|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93195887|NCT05801705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195888|NCT05801705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195889|NCT05801705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93195890|NCT05801705|Hormone Antagonists|hormone antagonists|mesh-ancestor
93195891|NCT05801705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195892|NCT05801705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195893|NCT05801705|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93195894|NCT05801705|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93195895|NCT05801705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93195896|NCT05801705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93195897|NCT05801705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195898|NCT05801705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195899|NCT05780216|Harmine|harmine|mesh-list
93195900|NCT05780216|Hallucinogens|hallucinogens|mesh-ancestor
93195901|NCT05780216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195902|NCT05780216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93195903|NCT05780216|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93195904|NCT05780216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195905|NCT05780216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195906|NCT05778617|Ambroxol|ambroxol|mesh-list
93195907|NCT05778617|Expectorants|expectorants|mesh-ancestor
93195908|NCT05778617|Respiratory System Agents|respiratory system agents|mesh-ancestor
93195909|NCT05766345|BCG Vaccine|bcg vaccine|mesh-list
93195910|NCT05766345|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93195911|NCT05766345|Immunologic Factors|immunologic factors|mesh-ancestor
93195912|NCT05766345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195914|NCT05756153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195915|NCT05756153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195916|NCT05743777|Pembrolizumab|pembrolizumab|mesh-list
93195917|NCT05743777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195918|NCT05743777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195919|NCT05743777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93195920|NCT05743777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195921|NCT05701007|Docetaxel|docetaxel|mesh-list
93195922|NCT05701007|Goserelin|goserelin|mesh-list
93195923|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93195924|NCT05701007|Leuprolide|leuprolide|mesh-list
93195925|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195926|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
93195927|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
93195928|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
93195929|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195930|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93195931|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
93195932|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93195933|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
93195934|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93195935|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195936|NCT05701007|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93195937|NCT05701007|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93195938|NCT05701007|Fertility Agents|fertility agents|mesh-ancestor
93195939|NCT05676203|Docetaxel|docetaxel|mesh-list
93195940|NCT05676203|Androgens|androgens|mesh-list
92117978|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
93195941|NCT05676203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195942|NCT05676203|Tubulin Modulators|tubulin modulators|mesh-ancestor
93195943|NCT05676203|Antimitotic Agents|antimitotic agents|mesh-ancestor
93195944|NCT05676203|Mitosis Modulators|mitosis modulators|mesh-ancestor
93195945|NCT05676203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195946|NCT05676203|Hormones|hormones|mesh-ancestor
93195947|NCT05676203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93195948|NCT05676203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195949|NCT05673928|Trastuzumab|trastuzumab|mesh-list
93195950|NCT05673928|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93195951|NCT05673928|Maytansine|maytansine|mesh-list
93195952|NCT05673928|Tucatinib|tucatinib|mesh-list
93195953|NCT05673928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93195954|NCT05673928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195955|NCT05673928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93195956|NCT05673928|Tubulin Modulators|tubulin modulators|mesh-ancestor
93195957|NCT05673928|Antimitotic Agents|antimitotic agents|mesh-ancestor
93195958|NCT05673928|Mitosis Modulators|mitosis modulators|mesh-ancestor
93195959|NCT05673928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195960|NCT05673928|Immunotoxins|immunotoxins|mesh-ancestor
93195961|NCT05673928|Immunoconjugates|immunoconjugates|mesh-ancestor
93195962|NCT05673928|Immunologic Factors|immunologic factors|mesh-ancestor
93195963|NCT05673928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195964|NCT05673928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93195965|NCT05673928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195966|NCT05615779|Levan|levan|mesh-list
93195967|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195968|NCT05591092|Iodine|iodine|mesh-list
93195969|NCT05591092|Cadexomer iodine|cadexomer iodine|mesh-list
93195970|NCT05591092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93195971|NCT05591092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195972|NCT05591092|Trace Elements|trace elements|mesh-ancestor
93195973|NCT05591092|Micronutrients|micronutrients|mesh-ancestor
93195974|NCT05591092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195975|NCT05580003|Moxifloxacin|moxifloxacin|mesh-list
93195976|NCT05580003|Midazolam|midazolam|mesh-list
93195977|NCT05580003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93195978|NCT05580003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93195979|NCT05580003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93195980|NCT05580003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93195981|NCT05580003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93195982|NCT05580003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93195983|NCT05580003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93195984|NCT05580003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93195985|NCT05580003|Anesthetics, General|anesthetics, general|mesh-ancestor
93195986|NCT05580003|Anesthetics|anesthetics|mesh-ancestor
93195987|NCT05580003|GABA Modulators|gaba modulators|mesh-ancestor
93195988|NCT05580003|GABA Agents|gaba agents|mesh-ancestor
93195989|NCT05580003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93195990|NCT05580003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93195991|NCT05580003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93195992|NCT05580003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93195993|NCT05580003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93195994|NCT05580003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93195995|NCT05580003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93195996|NCT05580003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93195998|NCT05562466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93195999|NCT05562466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93196000|NCT05562466|Autonomic Agents|autonomic agents|mesh-ancestor
93196001|NCT05562466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196002|NCT05562466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196003|NCT05562466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93196004|NCT05562466|Respiratory System Agents|respiratory system agents|mesh-ancestor
93196005|NCT05562466|Glucocorticoids|glucocorticoids|mesh-ancestor
93196006|NCT05562466|Hormones|hormones|mesh-ancestor
93196007|NCT05562466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196008|NCT05553834|Cemiplimab|cemiplimab|mesh-list
93196009|NCT05553834|Alirocumab|alirocumab|mesh-list
93196010|NCT05553834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196011|NCT05553834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196012|NCT05553834|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93196013|NCT05553834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93196014|NCT05553834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93196015|NCT05553834|Antimetabolites|antimetabolites|mesh-ancestor
93196016|NCT05553834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196017|NCT05553834|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93196018|NCT05553834|Protease Inhibitors|protease inhibitors|mesh-ancestor
93196019|NCT05553834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196020|NCT05553834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93196021|NCT05548283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93196022|NCT05548283|Lactams|lactams|mesh-list
93196023|NCT05548283|beta-Lactams|beta-lactams|mesh-list
93196024|NCT05548283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196025|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
93196026|NCT05513560|Ibudilast|ibudilast|mesh-list
93196027|NCT05513560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93196028|NCT05513560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196029|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196030|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93196031|NCT05513560|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93196032|NCT05513560|Protective Agents|protective agents|mesh-ancestor
93196033|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196034|NCT05513560|Vasodilator Agents|vasodilator agents|mesh-ancestor
93196035|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93196036|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
93196037|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93196038|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
93196039|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196040|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93196041|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
93196042|NCT05489796|Ketorolac|ketorolac|mesh-list
93196043|NCT05489796|Fentanyl|fentanyl|mesh-list
93196044|NCT05489796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93196045|NCT05489796|Narcotics|narcotics|mesh-ancestor
93196046|NCT05489796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196047|NCT05489796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196048|NCT05489796|Analgesics|analgesics|mesh-ancestor
93196049|NCT05489796|Sensory System Agents|sensory system agents|mesh-ancestor
93196050|NCT05489796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196051|NCT05489796|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93196052|NCT05489796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93196053|NCT05489796|Anesthetics, General|anesthetics, general|mesh-ancestor
93196054|NCT05489796|Anesthetics|anesthetics|mesh-ancestor
93196055|NCT05489796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93196056|NCT05489796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93196057|NCT05489796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196058|NCT05489796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196059|NCT05489796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93196060|NCT05489796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196061|NCT05489796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196062|NCT05435547|Dexamethasone|dexamethasone|mesh-list
93196063|NCT05435547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196064|NCT05435547|Antiemetics|antiemetics|mesh-ancestor
93196065|NCT05435547|Autonomic Agents|autonomic agents|mesh-ancestor
93196066|NCT05435547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196067|NCT05435547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196068|NCT05435547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93196069|NCT05435547|Glucocorticoids|glucocorticoids|mesh-ancestor
93196070|NCT05435547|Hormones|hormones|mesh-ancestor
93196071|NCT05435547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196072|NCT05435547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196073|NCT05435547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196074|NCT05422131|Clozapine|clozapine|mesh-list
93196075|NCT05422131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93196076|NCT05422131|Serotonin Agents|serotonin agents|mesh-ancestor
93196077|NCT05422131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93196078|NCT05422131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196079|NCT05422131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196080|NCT05422131|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93196081|NCT05422131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93196082|NCT05422131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196083|NCT05422131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93196084|NCT05422131|GABA Antagonists|gaba antagonists|mesh-ancestor
93196085|NCT05422131|GABA Agents|gaba agents|mesh-ancestor
93196086|NCT05415228|Edetic Acid|edetic acid|mesh-list
93196087|NCT05415228|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93196088|NCT05415228|Chelating Agents|chelating agents|mesh-ancestor
93196089|NCT05415228|Sequestering Agents|sequestering agents|mesh-ancestor
93196090|NCT05415228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196091|NCT05415228|Anticoagulants|anticoagulants|mesh-ancestor
93196092|NCT05415228|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93196093|NCT05415228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93196094|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
93196095|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93196096|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93196097|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196098|NCT05357079|Hemostatics|hemostatics|mesh-ancestor
93196099|NCT05357079|Coagulants|coagulants|mesh-ancestor
93196100|NCT05326997|Tranexamic Acid|tranexamic acid|mesh-list
93196101|NCT05326997|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93196102|NCT05326997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93196103|NCT05326997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196104|NCT05326997|Hemostatics|hemostatics|mesh-ancestor
93196105|NCT05326997|Coagulants|coagulants|mesh-ancestor
93196106|NCT05309629|Carboplatin|carboplatin|mesh-list
93196107|NCT05309629|Etoposide|etoposide|mesh-list
93196108|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196109|NCT05309629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93196110|NCT05309629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93196111|NCT05309629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93196112|NCT05309629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196113|NCT05309629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196114|NCT05297565|Nivolumab|nivolumab|mesh-list
93196115|NCT05297565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196116|NCT05297565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196117|NCT05297565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196118|NCT05297565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196119|NCT05209620|Pemetrexed|pemetrexed|mesh-list
93196120|NCT05209620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196121|NCT05209620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196122|NCT05209620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196123|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93196124|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196125|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
93196126|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93196127|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196128|NCT05184062|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93196129|NCT05184062|Antiviral Agents|antiviral agents|mesh-ancestor
93196130|NCT05184062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196131|NCT05153304|Nivolumab|nivolumab|mesh-list
93196132|NCT05153304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196133|NCT05153304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196134|NCT05153304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196135|NCT05153304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196136|NCT05109728|Temozolomide|temozolomide|mesh-list
93196137|NCT05109728|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93196138|NCT05109728|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93196139|NCT05109728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196140|NCT05109728|Alkylating Agents|alkylating agents|mesh-ancestor
93196141|NCT05109728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196142|NCT05109728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196143|NCT05109728|Chelating Agents|chelating agents|mesh-ancestor
93196144|NCT05109728|Sequestering Agents|sequestering agents|mesh-ancestor
93196145|NCT05109728|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93196146|NCT05103332|Amlodipine|amlodipine|mesh-list
93196147|NCT05103332|Olmesartan|olmesartan|mesh-list
93196148|NCT05103332|Indapamide|indapamide|mesh-list
93196149|NCT05103332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93196150|NCT05103332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93196151|NCT05103332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93196152|NCT05103332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196153|NCT05103332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93196154|NCT05103332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196155|NCT05103332|Vasodilator Agents|vasodilator agents|mesh-ancestor
93196156|NCT05103332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93196157|NCT05103332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93196158|NCT05103332|Diuretics|diuretics|mesh-ancestor
93196159|NCT05103332|Natriuretic Agents|natriuretic agents|mesh-ancestor
93196160|NCT05103332|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93196161|NCT05101070|Pembrolizumab|pembrolizumab|mesh-list
93196162|NCT05101070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196163|NCT05101070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196164|NCT05101070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196165|NCT05101070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196166|NCT05071183|Trametinib|trametinib|mesh-list
93196167|NCT05071183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196168|NCT05071183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196169|NCT05071183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196170|NCT05071183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196171|NCT05068726|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93196172|NCT05068726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196173|NCT05022901|Melphalan|melphalan|mesh-list
93196174|NCT05022901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196175|NCT05022901|Alkylating Agents|alkylating agents|mesh-ancestor
93196176|NCT05022901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196177|NCT05022901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196178|NCT05022901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93196179|NCT05022901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196180|NCT05022901|Immunologic Factors|immunologic factors|mesh-ancestor
93196181|NCT05022901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196182|NCT05009862|Aspirin|aspirin|mesh-list
93196183|NCT05009862|Rivaroxaban|rivaroxaban|mesh-list
93196184|NCT05009862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93196185|NCT05009862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93196186|NCT05009862|Analgesics|analgesics|mesh-ancestor
93196187|NCT05009862|Sensory System Agents|sensory system agents|mesh-ancestor
93196188|NCT05009862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196189|NCT05009862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196190|NCT05009862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196191|NCT05009862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196192|NCT05009862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93196193|NCT05009862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93196194|NCT05009862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196195|NCT05009862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93196196|NCT05009862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93196197|NCT05009862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196198|NCT05009862|Antipyretics|antipyretics|mesh-ancestor
93196199|NCT05009862|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93196200|NCT05009862|Antithrombins|antithrombins|mesh-ancestor
93196201|NCT05009862|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93196202|NCT05009862|Protease Inhibitors|protease inhibitors|mesh-ancestor
93196203|NCT05009862|Anticoagulants|anticoagulants|mesh-ancestor
93196204|NCT04973748|Analgesics, Opioid|analgesics, opioid|mesh-list
93196205|NCT04973748|Narcotics|narcotics|mesh-ancestor
93196206|NCT04973748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196207|NCT04973748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196208|NCT04973748|Analgesics|analgesics|mesh-ancestor
93196209|NCT04973748|Sensory System Agents|sensory system agents|mesh-ancestor
93196210|NCT04973748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196211|NCT04968054|Propofol|propofol|mesh-list
93196212|NCT04968054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93196213|NCT04968054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196214|NCT04968054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196215|NCT04968054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93196216|NCT04968054|Anesthetics, General|anesthetics, general|mesh-ancestor
93196217|NCT04968054|Anesthetics|anesthetics|mesh-ancestor
93196218|NCT04967495|Lenvatinib|lenvatinib|mesh-list
93196219|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
93196220|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196221|NCT04967495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196222|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196223|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196224|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93196225|NCT04967495|Estrogens|estrogens|mesh-ancestor
93196226|NCT04967495|Hormones|hormones|mesh-ancestor
93196227|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196228|NCT04967495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196229|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196230|NCT04965766|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
93196231|NCT04965766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196232|NCT04965766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196233|NCT04933721|Berotralstat|berotralstat|mesh-list
93196234|NCT04933721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93196235|NCT04933721|Protease Inhibitors|protease inhibitors|mesh-ancestor
92855677|NCT00900445|Hydrocortisone|hydrocortisone|mesh-list
93196236|NCT04933721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196237|NCT04933721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196238|NCT04883528|Valsartan|valsartan|mesh-list
93196239|NCT04883528|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93196240|NCT04883528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93196241|NCT04883528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93196242|NCT04883528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93196243|NCT04883528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196244|NCT04828135|Xenon|xenon|mesh-list
93196245|NCT04828135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93196246|NCT04828135|Anesthetics, General|anesthetics, general|mesh-ancestor
93196247|NCT04828135|Anesthetics|anesthetics|mesh-ancestor
93196248|NCT04828135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196249|NCT04828135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196250|NCT04815720|Pembrolizumab|pembrolizumab|mesh-list
93196251|NCT04815720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196252|NCT04815720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196253|NCT04815720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196254|NCT04815720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196255|NCT04777851|Pembrolizumab|pembrolizumab|mesh-list
93196256|NCT04777851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196257|NCT04777851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196258|NCT04777851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196259|NCT04777851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196260|NCT04773353|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93196261|NCT04773353|Hormones|hormones|mesh-ancestor
93196262|NCT04773353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196263|NCT04773353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196264|NCT04765111|Rituximab|rituximab|mesh-list
93196265|NCT04765111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93196266|NCT04765111|Acalabrutinib|acalabrutinib|mesh-list
93196267|NCT04765111|Antibodies|antibodies|mesh-list
93196268|NCT04765111|Immunoglobulins|immunoglobulins|mesh-list
93196269|NCT04765111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93196270|NCT04765111|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93196271|NCT04765111|Immunologic Factors|immunologic factors|mesh-ancestor
93196272|NCT04765111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196273|NCT04765111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196274|NCT04765111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196275|NCT04765111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196276|NCT04765111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196277|NCT04765111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196278|NCT04737889|Rituximab|rituximab|mesh-list
93196279|NCT04737889|Methotrexate|methotrexate|mesh-list
93196280|NCT04737889|Lenalidomide|lenalidomide|mesh-list
93196281|NCT04737889|Temozolomide|temozolomide|mesh-list
93196282|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196283|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196284|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
93196285|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196286|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196287|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93196288|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
93196289|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93196290|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196291|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
93196292|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196293|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
93196294|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196295|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93196296|NCT04737889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196297|NCT04737889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196298|NCT04737889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93196299|NCT04737889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93196300|NCT04737889|Growth Substances|growth substances|mesh-ancestor
93196301|NCT04737889|Growth Inhibitors|growth inhibitors|mesh-ancestor
93196302|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196303|NCT04737889|Alkylating Agents|alkylating agents|mesh-ancestor
93196304|NCT04735354|Valsartan|valsartan|mesh-list
93196305|NCT04735354|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93196306|NCT04735354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93196307|NCT04735354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93196308|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93196309|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196310|NCT04679740|Sirolimus|sirolimus|mesh-list
93196311|NCT04679740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93196312|NCT04679740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196313|NCT04679740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196314|NCT04679740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196315|NCT04679740|Antifungal Agents|antifungal agents|mesh-ancestor
93196316|NCT04679740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196317|NCT04679740|Immunologic Factors|immunologic factors|mesh-ancestor
93196318|NCT04679740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196319|NCT04672291|Poly I-C|poly i-c|mesh-list
93196320|NCT04672291|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93196321|NCT04672291|Poly ICLC|poly iclc|mesh-list
93196322|NCT04672291|Interferon Inducers|interferon inducers|mesh-ancestor
93196323|NCT04672291|Immunologic Factors|immunologic factors|mesh-ancestor
93196324|NCT04672291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196325|NCT04672291|Laxatives|laxatives|mesh-ancestor
93196326|NCT04672291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93196327|NCT04672291|Antiviral Agents|antiviral agents|mesh-ancestor
93196328|NCT04672291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196329|NCT04668365|Prednisone|prednisone|mesh-list
93196330|NCT04668365|Cyclophosphamide|cyclophosphamide|mesh-list
93196331|NCT04668365|Rituximab|rituximab|mesh-list
93196332|NCT04668365|Vincristine|vincristine|mesh-list
93196333|NCT04668365|Epirubicin|epirubicin|mesh-list
93196334|NCT04668365|Zanubrutinib|zanubrutinib|mesh-list
93196335|NCT04668365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196336|NCT04668365|Immunologic Factors|immunologic factors|mesh-ancestor
93196337|NCT04668365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196338|NCT04668365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196339|NCT04668365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196340|NCT04668365|Alkylating Agents|alkylating agents|mesh-ancestor
93196341|NCT04668365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196342|NCT04668365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196343|NCT04668365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93196344|NCT04668365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196345|NCT04668365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196346|NCT04668365|Glucocorticoids|glucocorticoids|mesh-ancestor
93196347|NCT04668365|Hormones|hormones|mesh-ancestor
93196348|NCT04668365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196349|NCT04668365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196350|NCT04668365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93196351|NCT04668365|Tubulin Modulators|tubulin modulators|mesh-ancestor
93196352|NCT04668365|Antimitotic Agents|antimitotic agents|mesh-ancestor
93196353|NCT04668365|Mitosis Modulators|mitosis modulators|mesh-ancestor
93196354|NCT04668365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196355|NCT04668365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93196356|NCT04668365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93196357|NCT04668365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196358|NCT04668365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196359|NCT04646395|Acalabrutinib|acalabrutinib|mesh-list
93196360|NCT04646395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196361|NCT04633239|Olaparib|olaparib|mesh-list
93196362|NCT04633239|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93196363|NCT04633239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196364|NCT04633239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196365|NCT04633239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196366|NCT04626479|Pembrolizumab|pembrolizumab|mesh-list
93196367|NCT04626479|Lenvatinib|lenvatinib|mesh-list
93196368|NCT04626479|Belzutifan|belzutifan|mesh-list
93196369|NCT04626479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196370|NCT04626479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196371|NCT04626479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196372|NCT04626479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196373|NCT04626479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196374|NCT04626479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196375|NCT04616729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93196376|NCT04616729|Luteolytic Agents|luteolytic agents|mesh-ancestor
93196377|NCT04616729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93196378|NCT04616729|Contraceptive Agents|contraceptive agents|mesh-ancestor
93196379|NCT04616729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93196380|NCT04616729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196381|NCT04616729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93196382|NCT04616729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196383|NCT04616729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196384|NCT04590963|Cetuximab|cetuximab|mesh-list
93196385|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196386|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196387|NCT04496401|Tacrolimus|tacrolimus|mesh-list
93196388|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196389|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
93196390|NCT04496401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196391|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93196392|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196393|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196394|NCT04433156|Prednisone|prednisone|mesh-list
93196395|NCT04433156|Cyclophosphamide|cyclophosphamide|mesh-list
93196396|NCT04433156|Rituximab|rituximab|mesh-list
93196397|NCT04433156|Bortezomib|bortezomib|mesh-list
93196398|NCT04433156|Epirubicin|epirubicin|mesh-list
93196399|NCT04433156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196400|NCT04433156|Immunologic Factors|immunologic factors|mesh-ancestor
93196401|NCT04433156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196402|NCT04433156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196403|NCT04433156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196404|NCT04433156|Alkylating Agents|alkylating agents|mesh-ancestor
93196405|NCT04433156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196406|NCT04433156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196407|NCT04433156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93196408|NCT04433156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196409|NCT04433156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196410|NCT04433156|Glucocorticoids|glucocorticoids|mesh-ancestor
93196411|NCT04433156|Hormones|hormones|mesh-ancestor
93196412|NCT04433156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196413|NCT04433156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196414|NCT04433156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196415|NCT04433156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93196416|NCT04433156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93196417|NCT04433156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196418|NCT04388176|Compound 21|compound 21|mesh-list
93196419|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196420|NCT04354129|Immunoglobulins|immunoglobulins|mesh-list
93196421|NCT04354129|Immunologic Factors|immunologic factors|mesh-ancestor
93196422|NCT04354129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196423|NCT04311489|Ularitide|ularitide|mesh-list
93196424|NCT04311489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93196425|NCT04311489|Autonomic Agents|autonomic agents|mesh-ancestor
93196426|NCT04311489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196427|NCT04311489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196428|NCT04311489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93196429|NCT04311489|Respiratory System Agents|respiratory system agents|mesh-ancestor
93196430|NCT04311489|Diuretics|diuretics|mesh-ancestor
93196431|NCT04311489|Natriuretic Agents|natriuretic agents|mesh-ancestor
93196432|NCT04305405|Benralizumab|benralizumab|mesh-list
93196433|NCT04305405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93196434|NCT04305405|Respiratory System Agents|respiratory system agents|mesh-ancestor
93196435|NCT04258488|Vitamin K|vitamin k|mesh-list
93196436|NCT04258488|Warfarin|warfarin|mesh-list
93196437|NCT04258488|Rivaroxaban|rivaroxaban|mesh-list
93196438|NCT04258488|Vitamins|vitamins|mesh-ancestor
93196439|NCT04258488|Micronutrients|micronutrients|mesh-ancestor
93196440|NCT04258488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196441|NCT04258488|Anticoagulants|anticoagulants|mesh-ancestor
93196442|NCT04258488|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93196443|NCT04258488|Antithrombins|antithrombins|mesh-ancestor
93196444|NCT04258488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93196445|NCT04258488|Protease Inhibitors|protease inhibitors|mesh-ancestor
93196446|NCT04258488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196447|NCT04258488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196448|NCT04258488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93196449|NCT04258488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93196450|NCT04258488|Hemostatics|hemostatics|mesh-ancestor
93196451|NCT04258488|Coagulants|coagulants|mesh-ancestor
93196452|NCT04255134|Adalimumab|adalimumab|mesh-list
93196453|NCT04255134|Abatacept|abatacept|mesh-list
93196454|NCT04255134|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93196455|NCT04255134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196456|NCT04255134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196457|NCT04255134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196458|NCT04255134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196459|NCT04255134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196460|NCT04255134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196461|NCT04255134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196462|NCT04255134|Immunologic Factors|immunologic factors|mesh-ancestor
93196463|NCT04255134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196464|NCT04214626|Prednisone|prednisone|mesh-list
93196465|NCT04214626|Cyclophosphamide|cyclophosphamide|mesh-list
93196466|NCT04214626|Rituximab|rituximab|mesh-list
93196467|NCT04214626|Methotrexate|methotrexate|mesh-list
93196468|NCT04214626|Vincristine|vincristine|mesh-list
93196469|NCT04214626|Lenalidomide|lenalidomide|mesh-list
93196470|NCT04214626|Epirubicin|epirubicin|mesh-list
93196471|NCT04214626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196472|NCT04214626|Immunologic Factors|immunologic factors|mesh-ancestor
93196473|NCT04214626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196474|NCT04214626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196475|NCT04214626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196476|NCT04214626|Alkylating Agents|alkylating agents|mesh-ancestor
93196477|NCT04214626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196478|NCT04214626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196479|NCT04214626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93196480|NCT04214626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196481|NCT04214626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196482|NCT04214626|Glucocorticoids|glucocorticoids|mesh-ancestor
93196483|NCT04214626|Hormones|hormones|mesh-ancestor
93196484|NCT04214626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196485|NCT04214626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196486|NCT04214626|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93196487|NCT04214626|Abortifacient Agents|abortifacient agents|mesh-ancestor
93196488|NCT04214626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93196489|NCT04214626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196490|NCT04214626|Antimetabolites|antimetabolites|mesh-ancestor
93196491|NCT04214626|Dermatologic Agents|dermatologic agents|mesh-ancestor
93196492|NCT04214626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196493|NCT04214626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93196494|NCT04214626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196495|NCT04214626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93196496|NCT04214626|Tubulin Modulators|tubulin modulators|mesh-ancestor
93196497|NCT04214626|Antimitotic Agents|antimitotic agents|mesh-ancestor
93196498|NCT04214626|Mitosis Modulators|mitosis modulators|mesh-ancestor
93196499|NCT04214626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93196500|NCT04214626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93196501|NCT04214626|Growth Substances|growth substances|mesh-ancestor
93196502|NCT04214626|Growth Inhibitors|growth inhibitors|mesh-ancestor
93196503|NCT04214626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196504|NCT04214626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93196505|NCT04214626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93196506|NCT04192370|Cannabidiol|cannabidiol|mesh-list
93196507|NCT04192370|Anticonvulsants|anticonvulsants|mesh-ancestor
93196508|NCT04180371|Nivolumab|nivolumab|mesh-list
92868625|NCT02728622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196509|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196510|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196511|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196512|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196513|NCT04165083|Pembrolizumab|pembrolizumab|mesh-list
93196514|NCT04165083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196515|NCT04165083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196516|NCT04165083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196517|NCT04165083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196518|NCT04165070|Paclitaxel|paclitaxel|mesh-list
93196519|NCT04165070|Carboplatin|carboplatin|mesh-list
93196520|NCT04165070|Pembrolizumab|pembrolizumab|mesh-list
93196521|NCT04165070|Pemetrexed|pemetrexed|mesh-list
93196522|NCT04165070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93196523|NCT04165070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196524|NCT04165070|Tubulin Modulators|tubulin modulators|mesh-ancestor
93196525|NCT04165070|Antimitotic Agents|antimitotic agents|mesh-ancestor
93196526|NCT04165070|Mitosis Modulators|mitosis modulators|mesh-ancestor
93196527|NCT04165070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196528|NCT04165070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196529|NCT04165070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196530|NCT04165070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196531|NCT04165070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93196532|NCT04165070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196533|NCT04160910|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
93196534|NCT04160910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93196535|NCT04160910|Antidepressive Agents|antidepressive agents|mesh-ancestor
93196536|NCT04160910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93196537|NCT04152200|Lumasiran|lumasiran|mesh-list
93196538|NCT04152200|Renal Agents|renal agents|mesh-ancestor
93196539|NCT04125472|Lumasiran|lumasiran|mesh-list
93196540|NCT04125472|Renal Agents|renal agents|mesh-ancestor
93196541|NCT04067037|Vincristine|vincristine|mesh-list
93196542|NCT04067037|Epirubicin|epirubicin|mesh-list
93196543|NCT04067037|Dacarbazine|dacarbazine|mesh-list
93196544|NCT04067037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93196545|NCT04067037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196546|NCT04067037|Tubulin Modulators|tubulin modulators|mesh-ancestor
93196547|NCT04067037|Antimitotic Agents|antimitotic agents|mesh-ancestor
93196548|NCT04067037|Mitosis Modulators|mitosis modulators|mesh-ancestor
93196549|NCT04067037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196550|NCT04067037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196551|NCT04067037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93196552|NCT04067037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93196553|NCT04067037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196554|NCT04067037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196555|NCT04067037|Alkylating Agents|alkylating agents|mesh-ancestor
93196556|NCT03905694|Lumasiran|lumasiran|mesh-list
93196557|NCT03905694|Renal Agents|renal agents|mesh-ancestor
93196558|NCT03776487|Fluorouracil|fluorouracil|mesh-list
93196559|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
93196560|NCT03776487|Nivolumab|nivolumab|mesh-list
93196561|NCT03776487|Ipilimumab|ipilimumab|mesh-list
93196562|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
93196563|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196564|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196565|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196566|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196567|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
93196568|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196569|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196570|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196571|NCT03681184|Lumasiran|lumasiran|mesh-list
93196572|NCT03681184|Renal Agents|renal agents|mesh-ancestor
93196573|NCT03668119|Nivolumab|nivolumab|mesh-list
93196574|NCT03668119|Ipilimumab|ipilimumab|mesh-list
93196575|NCT03668119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196576|NCT03668119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196577|NCT03668119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196578|NCT03668119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196579|NCT03632941|Pembrolizumab|pembrolizumab|mesh-list
93196580|NCT03632941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196581|NCT03632941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196582|NCT03632941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196583|NCT03632941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196584|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
93196585|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196586|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196587|NCT03578367|Niacinamide|niacinamide|mesh-list
93196588|NCT03578367|Imatinib Mesylate|imatinib mesylate|mesh-list
93196589|NCT03578367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196590|NCT03578367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196591|NCT03578367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196592|NCT03578367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196593|NCT03578367|Vitamin B Complex|vitamin b complex|mesh-ancestor
93196595|NCT03578367|Micronutrients|micronutrients|mesh-ancestor
93196596|NCT03578367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196597|NCT03568058|Pembrolizumab|pembrolizumab|mesh-list
93196598|NCT03568058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196599|NCT03568058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196600|NCT03568058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196601|NCT03568058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196602|NCT03514017|Pembrolizumab|pembrolizumab|mesh-list
93196603|NCT03514017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196604|NCT03514017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196605|NCT03514017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196606|NCT03514017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196607|NCT03502785|Atezolizumab|atezolizumab|mesh-list
93196608|NCT03502785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196609|NCT03502785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196610|NCT03502785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196611|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196612|NCT03495960|Rituximab|rituximab|mesh-list
93196613|NCT03495960|Methotrexate|methotrexate|mesh-list
93196614|NCT03495960|Lenalidomide|lenalidomide|mesh-list
93196615|NCT03495960|Temozolomide|temozolomide|mesh-list
93196616|NCT03495960|Procarbazine|procarbazine|mesh-list
93196617|NCT03495960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196618|NCT03495960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196619|NCT03495960|Immunologic Factors|immunologic factors|mesh-ancestor
93196620|NCT03495960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196621|NCT03495960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196622|NCT03495960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93196623|NCT03495960|Abortifacient Agents|abortifacient agents|mesh-ancestor
93196624|NCT03495960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93196625|NCT03495960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196626|NCT03495960|Antimetabolites|antimetabolites|mesh-ancestor
93196627|NCT03495960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196628|NCT03495960|Dermatologic Agents|dermatologic agents|mesh-ancestor
93196629|NCT03495960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196630|NCT03495960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93196631|NCT03495960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196632|NCT03495960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196633|NCT03495960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93196634|NCT03495960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93196635|NCT03495960|Growth Substances|growth substances|mesh-ancestor
93196636|NCT03495960|Growth Inhibitors|growth inhibitors|mesh-ancestor
93196637|NCT03495960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196638|NCT03495960|Alkylating Agents|alkylating agents|mesh-ancestor
93196639|NCT03491683|Temozolomide|temozolomide|mesh-list
93196640|NCT03491683|Cemiplimab|cemiplimab|mesh-list
93196641|NCT03491683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196642|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
93196643|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196644|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196645|NCT03491683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196646|NCT03351296|Bevacizumab|bevacizumab|mesh-list
93196647|NCT03351296|Capecitabine|capecitabine|mesh-list
93196648|NCT03351296|Temozolomide|temozolomide|mesh-list
93196649|NCT03351296|Streptozocin|streptozocin|mesh-list
93196650|NCT03351296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196651|NCT03351296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196652|NCT03351296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93196653|NCT03351296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93196654|NCT03351296|Growth Substances|growth substances|mesh-ancestor
93196655|NCT03351296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196656|NCT03351296|Growth Inhibitors|growth inhibitors|mesh-ancestor
93196657|NCT03351296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196658|NCT03351296|Antimetabolites|antimetabolites|mesh-ancestor
93196659|NCT03351296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196660|NCT03351296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196661|NCT03351296|Alkylating Agents|alkylating agents|mesh-ancestor
93196662|NCT03351296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196664|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93196665|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196666|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196667|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196668|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196669|NCT03203850|Deferasirox|deferasirox|mesh-list
93196670|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93196671|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
93196672|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
93196673|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196674|NCT03138161|Nivolumab|nivolumab|mesh-list
93196675|NCT03138161|Ipilimumab|ipilimumab|mesh-list
93196676|NCT03138161|Trabectedin|trabectedin|mesh-list
93196677|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196678|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196679|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92855682|NCT00900445|Vincristine|vincristine|mesh-list
93196680|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196681|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196682|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
93196683|NCT03091075|Oxandrolone|oxandrolone|mesh-list
93196684|NCT03091075|Androgens|androgens|mesh-ancestor
93196685|NCT03091075|Hormones|hormones|mesh-ancestor
93196686|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196687|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196688|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
93196689|NCT03031821|Metformin|metformin|mesh-list
93196690|NCT03031821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93196691|NCT03031821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196692|NCT02907359|Guadecitabine|guadecitabine|mesh-list
93196693|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196694|NCT02714205|Nitroglycerin|nitroglycerin|mesh-list
93196695|NCT02714205|Vasodilator Agents|vasodilator agents|mesh-ancestor
93196696|NCT02669173|Bevacizumab|bevacizumab|mesh-list
93196697|NCT02669173|Capecitabine|capecitabine|mesh-list
93196698|NCT02669173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196699|NCT02669173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196700|NCT02669173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93196701|NCT02669173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93196702|NCT02669173|Growth Substances|growth substances|mesh-ancestor
93196703|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196704|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
93196705|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196706|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
93196707|NCT02669173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196708|NCT02647437|Levetiracetam|levetiracetam|mesh-list
93196709|NCT02647437|Anticonvulsants|anticonvulsants|mesh-ancestor
93196710|NCT02647437|Nootropic Agents|nootropic agents|mesh-ancestor
93196711|NCT02369458|Mitomycins|mitomycins|mesh-list
93196712|NCT02369458|Mitomycin|mitomycin|mesh-list
93196713|NCT02369458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93196714|NCT02369458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196715|NCT02369458|Alkylating Agents|alkylating agents|mesh-ancestor
93196716|NCT02369458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196717|NCT02369458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196718|NCT02369458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196719|NCT02329080|Cytarabine|cytarabine|mesh-list
93196720|NCT02329080|Rituximab|rituximab|mesh-list
93196721|NCT02329080|Methotrexate|methotrexate|mesh-list
93196722|NCT02329080|Etoposide|etoposide|mesh-list
93196723|NCT02329080|Ifosfamide|ifosfamide|mesh-list
93196724|NCT02329080|Thiotepa|thiotepa|mesh-list
93196725|NCT02329080|Carmustine|carmustine|mesh-list
93196726|NCT02329080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196727|NCT02329080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196728|NCT02329080|Immunologic Factors|immunologic factors|mesh-ancestor
93196729|NCT02329080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196730|NCT02329080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196731|NCT02329080|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93196732|NCT02329080|Abortifacient Agents|abortifacient agents|mesh-ancestor
93196733|NCT02329080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93196734|NCT02329080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93196735|NCT02329080|Antimetabolites|antimetabolites|mesh-ancestor
92868847|NCT02720822|Cathartics|cathartics|mesh-list
93196736|NCT02329080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196737|NCT02329080|Dermatologic Agents|dermatologic agents|mesh-ancestor
93196738|NCT02329080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196739|NCT02329080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93196740|NCT02329080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93196741|NCT02329080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93196742|NCT02329080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93196743|NCT02329080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93196744|NCT02329080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93196745|NCT02329080|Antiviral Agents|antiviral agents|mesh-ancestor
93196746|NCT02329080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196747|NCT02329080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196748|NCT02329080|Alkylating Agents|alkylating agents|mesh-ancestor
93196749|NCT02329080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93196750|NCT02227927|Domperidone|domperidone|mesh-list
93196751|NCT02227927|Antiemetics|antiemetics|mesh-ancestor
93196752|NCT02227927|Autonomic Agents|autonomic agents|mesh-ancestor
93196753|NCT02227927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196754|NCT02227927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196755|NCT02227927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93196756|NCT02227927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93196757|NCT02227927|Dopamine Agents|dopamine agents|mesh-ancestor
93196758|NCT02227927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93196759|NCT02227927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196760|NCT02152995|Iodine|iodine|mesh-list
93196761|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
93196762|NCT02152995|Trametinib|trametinib|mesh-list
93196763|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93196764|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196765|NCT02152995|Trace Elements|trace elements|mesh-ancestor
93196766|NCT02152995|Micronutrients|micronutrients|mesh-ancestor
93196767|NCT02152995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196768|NCT02152995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196769|NCT02152995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93196770|NCT02152995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196771|NCT02152995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196772|NCT01820910|Doxycycline|doxycycline|mesh-list
93196773|NCT01820910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93196774|NCT01820910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196775|NCT01820910|Antimalarials|antimalarials|mesh-ancestor
93196776|NCT01820910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93196777|NCT01820910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93196778|NCT01808599|Rituximab|rituximab|mesh-list
93196779|NCT01808599|Chlorambucil|chlorambucil|mesh-list
93196780|NCT01808599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196781|NCT01808599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196782|NCT01808599|Immunologic Factors|immunologic factors|mesh-ancestor
93196783|NCT01808599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196784|NCT01808599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196785|NCT01808599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196786|NCT01808599|Alkylating Agents|alkylating agents|mesh-ancestor
93196787|NCT01808599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196788|NCT01704859|Vitamin D|vitamin d|mesh-list
93196789|NCT01704859|Ergocalciferols|ergocalciferols|mesh-list
93196790|NCT01704859|Cholecalciferol|cholecalciferol|mesh-list
93196791|NCT01704859|Vitamins|vitamins|mesh-list
93196792|NCT01704859|Micronutrients|micronutrients|mesh-ancestor
93196793|NCT01704859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196794|NCT01704859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93196795|NCT01704859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93196796|NCT00071071|Zanolimumab|zanolimumab|mesh-list
93196797|NCT00071071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93196798|NCT00071071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196799|NCT00071071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196800|NCT00071071|Immunologic Factors|immunologic factors|mesh-ancestor
93196801|NCT00071071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196802|NCT05465278|Alirocumab|alirocumab|mesh-list
93196803|NCT05465278|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93196804|NCT05465278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93196805|NCT05465278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93196806|NCT05465278|Antimetabolites|antimetabolites|mesh-ancestor
93196807|NCT05465278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196808|NCT05465278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93196809|NCT05465278|Protease Inhibitors|protease inhibitors|mesh-ancestor
93196810|NCT05465278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196811|NCT05465278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93196812|NCT01302275|Oxcarbazepine|oxcarbazepine|mesh-list
93196813|NCT01302275|Anticonvulsants|anticonvulsants|mesh-ancestor
93196814|NCT01302275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93196815|NCT01302275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93196816|NCT01302275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93196817|NCT01302275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196818|NCT01302275|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93196819|NCT01302275|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93196820|NCT03339544|Celecoxib|celecoxib|mesh-list
93196821|NCT03339544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93196822|NCT03339544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93196823|NCT03339544|Analgesics|analgesics|mesh-ancestor
93196824|NCT03339544|Sensory System Agents|sensory system agents|mesh-ancestor
93196825|NCT03339544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196826|NCT03339544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196827|NCT03339544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196828|NCT03339544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196829|NCT03339544|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93196830|NCT03339544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93196831|NCT03339544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196832|NCT03339544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196833|NCT03332602|Vitamins|vitamins|mesh-list
93196834|NCT03332602|Folic Acid|folic acid|mesh-list
93196835|NCT03332602|Vitamin A|vitamin a|mesh-list
93196836|NCT03332602|Retinol palmitate|retinol palmitate|mesh-list
93196837|NCT03332602|Fesoterodine|fesoterodine|mesh-list
93196838|NCT03332602|Hyaluronic Acid|hyaluronic acid|mesh-list
93196839|NCT03332602|Micronutrients|micronutrients|mesh-ancestor
93196840|NCT03332602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196841|NCT03332602|Hematinics|hematinics|mesh-ancestor
93196842|NCT03332602|Vitamin B Complex|vitamin b complex|mesh-ancestor
93196843|NCT03332602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93196844|NCT03332602|Immunologic Factors|immunologic factors|mesh-ancestor
93196845|NCT03332602|Viscosupplements|viscosupplements|mesh-ancestor
93196846|NCT03332602|Protective Agents|protective agents|mesh-ancestor
93196847|NCT03332602|Antioxidants|antioxidants|mesh-ancestor
93196848|NCT03332602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196849|NCT03332602|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93196850|NCT03332602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196851|NCT03332602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93196852|NCT03332602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93196853|NCT03332602|Cholinergic Agents|cholinergic agents|mesh-ancestor
93196854|NCT03332602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93196855|NCT03332602|Urological Agents|urological agents|mesh-ancestor
93196856|NCT01302353|Isoflurane|isoflurane|mesh-list
93196857|NCT01302353|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93196858|NCT01302353|Anesthetics, General|anesthetics, general|mesh-ancestor
93196859|NCT01302353|Anesthetics|anesthetics|mesh-ancestor
93196860|NCT01302353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196861|NCT01302353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196862|NCT03812315|Propolis|propolis|mesh-list
93196863|NCT03812315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196864|NCT03332524|Chlorpheniramine|chlorpheniramine|mesh-list
93196865|NCT03332524|Ibuprofen|ibuprofen|mesh-list
93196866|NCT03332524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93196867|NCT03332524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93196868|NCT03332524|Analgesics|analgesics|mesh-ancestor
93196869|NCT03332524|Sensory System Agents|sensory system agents|mesh-ancestor
93196870|NCT03332524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196871|NCT03332524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196872|NCT03332524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196873|NCT03332524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93196874|NCT03332524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93196875|NCT03332524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196876|NCT03332524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196877|NCT03332524|Antipruritics|antipruritics|mesh-ancestor
93196878|NCT03332524|Dermatologic Agents|dermatologic agents|mesh-ancestor
93196879|NCT03332524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93196880|NCT03332524|Histamine Antagonists|histamine antagonists|mesh-ancestor
93196881|NCT03332524|Histamine Agents|histamine agents|mesh-ancestor
93196882|NCT03332524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93196883|NCT03332524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93196884|NCT02499484|Nitroglycerin|nitroglycerin|mesh-list
93196885|NCT02499484|Vasodilator Agents|vasodilator agents|mesh-ancestor
93196886|NCT03812003|Remifentanil|remifentanil|mesh-list
93196887|NCT03812003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92868998|NCT02725502|Linagliptin|linagliptin|mesh-list
93196888|NCT03812003|Narcotics|narcotics|mesh-ancestor
93196889|NCT03812003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196890|NCT03812003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196892|NCT03812003|Sensory System Agents|sensory system agents|mesh-ancestor
93196893|NCT03812003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196894|NCT04874610|Methylprednisolone|methylprednisolone|mesh-list
93196895|NCT04874610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93196896|NCT04874610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93196897|NCT04874610|Prednisolone|prednisolone|mesh-list
93196898|NCT04874610|Prednisolone acetate|prednisolone acetate|mesh-list
93196899|NCT04874610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93196900|NCT04874610|Prednisolone phosphate|prednisolone phosphate|mesh-list
93196901|NCT04874610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196902|NCT04874610|Antiemetics|antiemetics|mesh-ancestor
93196903|NCT04874610|Autonomic Agents|autonomic agents|mesh-ancestor
93196904|NCT04874610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196905|NCT04874610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196906|NCT04874610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93196907|NCT04874610|Glucocorticoids|glucocorticoids|mesh-ancestor
93196908|NCT04874610|Hormones|hormones|mesh-ancestor
93196909|NCT04874610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196910|NCT04874610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93196911|NCT04874610|Protective Agents|protective agents|mesh-ancestor
93196912|NCT04874610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196913|NCT04874610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196914|NCT03518125|Vaccines|vaccines|mesh-list
93196915|NCT03518125|Immunologic Factors|immunologic factors|mesh-ancestor
93196916|NCT03518125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196917|NCT02492230|Warfarin|warfarin|mesh-list
93196918|NCT02492230|Anticoagulants|anticoagulants|mesh-ancestor
93196919|NCT03169530|Ethanol|ethanol|mesh-list
93196920|NCT03169530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93196921|NCT03169530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196922|NCT03169530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196923|NCT03169530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196924|NCT03723187|Heparin|heparin|mesh-list
93196925|NCT03723187|Anticoagulants|anticoagulants|mesh-ancestor
93196926|NCT03723187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93196927|NCT03723187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93196928|NCT03723187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196929|NCT02440230|Anastrozole|anastrozole|mesh-list
93196930|NCT02440230|Exemestane|exemestane|mesh-list
93196931|NCT02440230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93196932|NCT02440230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196933|NCT02440230|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93196934|NCT02440230|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93196935|NCT02440230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196936|NCT02440230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196937|NCT02440230|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93196938|NCT02440230|Hormone Antagonists|hormone antagonists|mesh-ancestor
93196939|NCT02440230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196940|NCT02440230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196941|NCT03478891|Ansuvimab|ansuvimab|mesh-list
93196942|NCT03478891|Antiviral Agents|antiviral agents|mesh-ancestor
93196943|NCT03478891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93196944|NCT00706966|Dutasteride|dutasteride|mesh-list
93196945|NCT00706966|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93196946|NCT00706966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93196947|NCT00706966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93196948|NCT00706966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196949|NCT00706966|Hormone Antagonists|hormone antagonists|mesh-ancestor
93196950|NCT00706966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196951|NCT00706966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196952|NCT01330524|Triamcinolone|triamcinolone|mesh-list
93196953|NCT01330524|Bevacizumab|bevacizumab|mesh-list
93196954|NCT01330524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196955|NCT01330524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196956|NCT01330524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93196957|NCT01330524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93196958|NCT01330524|Growth Substances|growth substances|mesh-ancestor
93196959|NCT01330524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196960|NCT01330524|Growth Inhibitors|growth inhibitors|mesh-ancestor
93196961|NCT01330524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93196962|NCT01330524|Glucocorticoids|glucocorticoids|mesh-ancestor
93196963|NCT01330524|Hormones|hormones|mesh-ancestor
92869075|NCT02717780|Fentanyl|fentanyl|mesh-list
93196964|NCT01330524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93196965|NCT01560065|Folic Acid|folic acid|mesh-list
93196966|NCT01560065|Vitamin B Complex|vitamin b complex|mesh-list
93196967|NCT01560065|Inositol|inositol|mesh-list
93196968|NCT01560065|Hematinics|hematinics|mesh-ancestor
93196969|NCT01560065|Vitamins|vitamins|mesh-ancestor
93196970|NCT01560065|Micronutrients|micronutrients|mesh-ancestor
93196971|NCT01560065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196972|NCT01302587|Albuterol|albuterol|mesh-list
93196973|NCT01302587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93196974|NCT01302587|Autonomic Agents|autonomic agents|mesh-ancestor
93196975|NCT01302587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93196976|NCT01302587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196977|NCT01302587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93196978|NCT01302587|Respiratory System Agents|respiratory system agents|mesh-ancestor
93196979|NCT01302587|Tocolytic Agents|tocolytic agents|mesh-ancestor
93196980|NCT01302587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93196981|NCT01302587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93196982|NCT01302587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93196983|NCT01302587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93196984|NCT01302587|Adrenergic Agents|adrenergic agents|mesh-ancestor
93196985|NCT01302587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93196986|NCT01302587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196987|NCT03723109|Anesthetics|anesthetics|mesh-list
93196988|NCT03723109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93196989|NCT03723109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93196990|NCT03018288|Pembrolizumab|pembrolizumab|mesh-list
93196991|NCT03018288|Temozolomide|temozolomide|mesh-list
93196992|NCT03018288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93196993|NCT03018288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93196994|NCT03018288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93196995|NCT03018288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93196996|NCT03018288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93196997|NCT03018288|Alkylating Agents|alkylating agents|mesh-ancestor
93196998|NCT03515941|Leucovorin|leucovorin|mesh-list
93196999|NCT03515941|Fluorouracil|fluorouracil|mesh-list
93197000|NCT03515941|Capecitabine|capecitabine|mesh-list
93197001|NCT03515941|Oxaliplatin|oxaliplatin|mesh-list
93197002|NCT03515941|Antimetabolites|antimetabolites|mesh-ancestor
93197003|NCT03515941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197004|NCT03515941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93197005|NCT03515941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197006|NCT03515941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93197007|NCT03515941|Immunologic Factors|immunologic factors|mesh-ancestor
93197008|NCT03515941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197009|NCT03515941|Antidotes|antidotes|mesh-ancestor
93197010|NCT03515941|Protective Agents|protective agents|mesh-ancestor
93197011|NCT03515941|Vitamin B Complex|vitamin b complex|mesh-ancestor
93197012|NCT03515941|Vitamins|vitamins|mesh-ancestor
93197013|NCT03515941|Micronutrients|micronutrients|mesh-ancestor
93197014|NCT02492074|Dronabinol|dronabinol|mesh-list
93197015|NCT02492074|Cannabidiol|cannabidiol|mesh-list
93197016|NCT02492074|Anticonvulsants|anticonvulsants|mesh-ancestor
93197017|NCT02492074|Hallucinogens|hallucinogens|mesh-ancestor
93197018|NCT02492074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197019|NCT02492074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197020|NCT02492074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197021|NCT02492074|Analgesics|analgesics|mesh-ancestor
93197022|NCT02492074|Sensory System Agents|sensory system agents|mesh-ancestor
93197023|NCT02492074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197024|NCT02492074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93197025|NCT02492074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93197026|NCT02492074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197027|NCT02492074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197028|NCT02492074|Hormones|hormones|mesh-ancestor
93197029|NCT02492074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197030|NCT03819647|Stiripentol|stiripentol|mesh-list
93197031|NCT03819647|Anticonvulsants|anticonvulsants|mesh-ancestor
93197032|NCT02498938|Protease Inhibitors|protease inhibitors|mesh-list
93197033|NCT02498938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197034|NCT02498938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197035|NCT02498860|Pemetrexed|pemetrexed|mesh-list
93197036|NCT02498860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197037|NCT02498860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197038|NCT02498860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869149|NCT02694224|Paclitaxel|paclitaxel|mesh-list
93197039|NCT02498860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93197040|NCT02498860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93197041|NCT03011034|Daratumumab|daratumumab|mesh-list
93197042|NCT03011034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197043|NCT05464966|Insulin|insulin|mesh-list
93197044|NCT05464966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93197045|NCT05464966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197046|NCT03515629|Pembrolizumab|pembrolizumab|mesh-list
93197047|NCT03515629|Cemiplimab|cemiplimab|mesh-list
93197048|NCT03515629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197049|NCT03515629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197050|NCT03515629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93197051|NCT03515629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197052|NCT01302821|Tryptophan|tryptophan|mesh-list
93197053|NCT01302821|Vaccines|vaccines|mesh-list
93197054|NCT01302821|Immunologic Factors|immunologic factors|mesh-ancestor
93197055|NCT01302821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197056|NCT01302821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93197057|NCT01302821|Antidepressive Agents|antidepressive agents|mesh-ancestor
93197058|NCT01302821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197059|NCT03331432|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
93197060|NCT03331432|Antiviral Agents|antiviral agents|mesh-ancestor
93197061|NCT03331432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197062|NCT03331432|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93197063|NCT03331432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197064|NCT03512353|Dexamethasone|dexamethasone|mesh-list
93197065|NCT03512353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197066|NCT03512353|Antiemetics|antiemetics|mesh-ancestor
93197067|NCT03512353|Autonomic Agents|autonomic agents|mesh-ancestor
93197068|NCT03512353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197069|NCT03512353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197070|NCT03512353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197071|NCT03512353|Glucocorticoids|glucocorticoids|mesh-ancestor
93197072|NCT03512353|Hormones|hormones|mesh-ancestor
93197073|NCT03512353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197074|NCT03512353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93197075|NCT03512353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197076|NCT04959006|Antioxidants|antioxidants|mesh-list
93197077|NCT04959006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197078|NCT04959006|Protective Agents|protective agents|mesh-ancestor
93197079|NCT04959006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197080|NCT01300637|Metformin|metformin|mesh-list
93197081|NCT01300637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93197082|NCT01300637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197083|NCT04851522|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93197085|NCT04851522|Petrolatum|petrolatum|mesh-list
93197086|NCT04851522|Disinfectants|disinfectants|mesh-ancestor
93197087|NCT04851522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197088|NCT04851522|Emollients|emollients|mesh-ancestor
93197089|NCT04851522|Dermatologic Agents|dermatologic agents|mesh-ancestor
93197090|NCT03512275|Antibodies|antibodies|mesh-list
93197091|NCT03512275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93197092|NCT03512275|Immunologic Factors|immunologic factors|mesh-ancestor
93197093|NCT03512275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197094|NCT03809897|Nicotine|nicotine|mesh-list
93197095|NCT03809897|Varenicline|varenicline|mesh-list
93197096|NCT03809897|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93197097|NCT03809897|Autonomic Agents|autonomic agents|mesh-ancestor
93197098|NCT03809897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197099|NCT03809897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197100|NCT03809897|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93197101|NCT03809897|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93197102|NCT03809897|Cholinergic Agents|cholinergic agents|mesh-ancestor
93197103|NCT03809897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197104|NCT03809897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197105|NCT03473197|Diacerein|diacerein|mesh-list
93197106|NCT03473197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197107|NCT01560299|Methimazole|methimazole|mesh-list
93197108|NCT01560299|Antithyroid Agents|antithyroid agents|mesh-ancestor
93197109|NCT01560299|Hormone Antagonists|hormone antagonists|mesh-ancestor
93197110|NCT01560299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197111|NCT01560299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197112|NCT03337828|Ethanol|ethanol|mesh-list
93197113|NCT03337828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93197114|NCT03337828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197115|NCT03337828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197116|NCT03337828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197117|NCT03510715|Nicotinic Acids|nicotinic acids|mesh-list
93197118|NCT03510715|Niacin|niacin|mesh-list
93197119|NCT03510715|Niacinamide|niacinamide|mesh-list
93197120|NCT03510715|Atorvastatin|atorvastatin|mesh-list
93197121|NCT03510715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93197122|NCT03510715|Simvastatin|simvastatin|mesh-list
93197123|NCT03510715|Ezetimibe|ezetimibe|mesh-list
93197124|NCT03510715|Pravastatin|pravastatin|mesh-list
93197125|NCT03510715|Alirocumab|alirocumab|mesh-list
93197126|NCT03510715|Lovastatin|lovastatin|mesh-list
93197127|NCT03510715|Cholestyramine Resin|cholestyramine resin|mesh-list
93197128|NCT03510715|Fenofibrate|fenofibrate|mesh-list
93197129|NCT03510715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93197130|NCT03510715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93197131|NCT03510715|Antimetabolites|antimetabolites|mesh-ancestor
93197132|NCT03510715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197133|NCT03510715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93197134|NCT03510715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93197135|NCT03510715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197136|NCT03510715|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93197137|NCT03510715|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93197138|NCT03510715|Protease Inhibitors|protease inhibitors|mesh-ancestor
93197139|NCT03510715|Vitamin B Complex|vitamin b complex|mesh-ancestor
93197140|NCT03510715|Vitamins|vitamins|mesh-ancestor
93197141|NCT03510715|Micronutrients|micronutrients|mesh-ancestor
93197142|NCT03510715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197143|NCT03510715|Vasodilator Agents|vasodilator agents|mesh-ancestor
93197144|NCT03815279|Dexamethasone|dexamethasone|mesh-list
93197145|NCT03815279|Lenalidomide|lenalidomide|mesh-list
93197146|NCT03815279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197147|NCT03815279|Antiemetics|antiemetics|mesh-ancestor
93197148|NCT03815279|Autonomic Agents|autonomic agents|mesh-ancestor
93197149|NCT03815279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197150|NCT03815279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197151|NCT03815279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197152|NCT03815279|Glucocorticoids|glucocorticoids|mesh-ancestor
93197153|NCT03815279|Hormones|hormones|mesh-ancestor
93197154|NCT03815279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197155|NCT03815279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93197156|NCT03815279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197157|NCT03815279|Immunologic Factors|immunologic factors|mesh-ancestor
93197158|NCT03815279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197159|NCT03815279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197160|NCT03815279|Growth Substances|growth substances|mesh-ancestor
93197161|NCT03815279|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197162|NCT03814733|Ketamine|ketamine|mesh-list
93197163|NCT03814733|Alprazolam|alprazolam|mesh-list
93197164|NCT03814733|Analgesics|analgesics|mesh-ancestor
93197165|NCT03814733|Sensory System Agents|sensory system agents|mesh-ancestor
93197166|NCT03814733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197167|NCT03814733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197168|NCT03814733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93197169|NCT03814733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197170|NCT03814733|Anesthetics, General|anesthetics, general|mesh-ancestor
93197171|NCT03814733|Anesthetics|anesthetics|mesh-ancestor
93197172|NCT03814733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197173|NCT03814733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93197174|NCT03814733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93197175|NCT03814733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197176|NCT03814733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197177|NCT03814733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197178|NCT03814733|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93197179|NCT03814733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93197180|NCT03814733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197181|NCT03814733|GABA Modulators|gaba modulators|mesh-ancestor
93197182|NCT03814733|GABA Agents|gaba agents|mesh-ancestor
93197183|NCT03721627|Sofosbuvir|sofosbuvir|mesh-list
93197184|NCT03721627|Ledipasvir|ledipasvir|mesh-list
93197185|NCT03721627|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93197186|NCT03721627|Antiviral Agents|antiviral agents|mesh-ancestor
93197187|NCT03721627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197188|NCT03811223|Evolocumab|evolocumab|mesh-list
93197189|NCT03811223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93197190|NCT03811223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93197191|NCT03811223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93197192|NCT03811223|Antimetabolites|antimetabolites|mesh-ancestor
93197193|NCT03811223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197194|NCT03811223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93197195|NCT03811223|Protease Inhibitors|protease inhibitors|mesh-ancestor
93197196|NCT03811223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197197|NCT03811223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93197198|NCT03723031|Misoprostol|misoprostol|mesh-list
93197199|NCT03723031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93197200|NCT03723031|Abortifacient Agents|abortifacient agents|mesh-ancestor
93197201|NCT03723031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93197202|NCT03723031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197203|NCT03723031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93197204|NCT03723031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197205|NCT03723031|Oxytocics|oxytocics|mesh-ancestor
93197206|NCT03722875|Apatinib|apatinib|mesh-list
93197207|NCT03722875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197208|NCT03722875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93197209|NCT03722875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197210|NCT03722875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197211|NCT04860713|Aspirin|aspirin|mesh-list
93197212|NCT04860713|Ketamine|ketamine|mesh-list
93197213|NCT04860713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93197214|NCT04860713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197215|NCT04860713|Analgesics|analgesics|mesh-ancestor
93197216|NCT04860713|Sensory System Agents|sensory system agents|mesh-ancestor
93197217|NCT04860713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197218|NCT04860713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197219|NCT04860713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197220|NCT04860713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93197221|NCT04860713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93197222|NCT04860713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93197223|NCT04860713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197224|NCT04860713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93197225|NCT04860713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93197226|NCT04860713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197227|NCT04860713|Antipyretics|antipyretics|mesh-ancestor
93197228|NCT04860713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93197229|NCT04860713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197230|NCT04860713|Anesthetics, General|anesthetics, general|mesh-ancestor
93197231|NCT04860713|Anesthetics|anesthetics|mesh-ancestor
93197232|NCT04860713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197233|NCT04860713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93197234|NCT04860713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93197235|NCT04860713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197236|NCT03528577|Albuterol|albuterol|mesh-list
93197237|NCT03528577|Procaterol|procaterol|mesh-list
93197238|NCT03528577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93197239|NCT03528577|Autonomic Agents|autonomic agents|mesh-ancestor
93197240|NCT03528577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197241|NCT03528577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197242|NCT03528577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93197243|NCT03528577|Respiratory System Agents|respiratory system agents|mesh-ancestor
93197244|NCT03528577|Tocolytic Agents|tocolytic agents|mesh-ancestor
93197245|NCT03528577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93197246|NCT03528577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93197247|NCT03528577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93197248|NCT03528577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93197249|NCT03528577|Adrenergic Agents|adrenergic agents|mesh-ancestor
93197250|NCT03528577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197251|NCT03528577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197252|NCT03528577|Sympathomimetics|sympathomimetics|mesh-ancestor
93197253|NCT05432414|Dexamethasone|dexamethasone|mesh-list
93197254|NCT05432414|Bortezomib|bortezomib|mesh-list
93197255|NCT05432414|Pomalidomide|pomalidomide|mesh-list
93197256|NCT05432414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197257|NCT05432414|Antiemetics|antiemetics|mesh-ancestor
93197258|NCT05432414|Autonomic Agents|autonomic agents|mesh-ancestor
93197259|NCT05432414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197260|NCT05432414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197261|NCT05432414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197262|NCT05432414|Glucocorticoids|glucocorticoids|mesh-ancestor
93197263|NCT05432414|Hormones|hormones|mesh-ancestor
93197264|NCT05432414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197265|NCT05432414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93197266|NCT05432414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197267|NCT05432414|Immunologic Factors|immunologic factors|mesh-ancestor
93197268|NCT05432414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92869409|NCT02694146|Hylan|hylan|mesh-list
93197269|NCT05432414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197270|NCT05432414|Growth Substances|growth substances|mesh-ancestor
93197271|NCT05432414|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197272|NCT03796403|Diclofenac|diclofenac|mesh-list
93197273|NCT03796403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93197274|NCT03796403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197275|NCT03796403|Analgesics|analgesics|mesh-ancestor
93197276|NCT03796403|Sensory System Agents|sensory system agents|mesh-ancestor
93197277|NCT03796403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197278|NCT03796403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197279|NCT03796403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197280|NCT03796403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93197281|NCT03796403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93197282|NCT03796403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197283|NCT03796403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197284|NCT00706654|Aripiprazole|aripiprazole|mesh-list
93197285|NCT00706654|Antidepressive Agents|antidepressive agents|mesh-ancestor
93197286|NCT00706654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197287|NCT00706654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93197288|NCT00706654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93197289|NCT00706654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197290|NCT00706654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197291|NCT00706654|Dopamine Agonists|dopamine agonists|mesh-ancestor
93197292|NCT00706654|Dopamine Agents|dopamine agents|mesh-ancestor
93197293|NCT00706654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197294|NCT00706654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197295|NCT00706654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93197296|NCT00706654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93197297|NCT00706654|Serotonin Agents|serotonin agents|mesh-ancestor
93197298|NCT00706654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93197299|NCT00706654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93197300|NCT00706654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93197301|NCT00706654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93197302|NCT03471871|Lemborexant|lemborexant|mesh-list
93197303|NCT03471871|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93197304|NCT03471871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197305|NCT03471871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197306|NCT03471871|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93197307|NCT03471871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197308|NCT03471871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197309|NCT03471871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197310|NCT04313153|Darbepoetin alfa|darbepoetin alfa|mesh-list
93197311|NCT04313153|Hematinics|hematinics|mesh-ancestor
93197312|NCT03337672|Midazolam|midazolam|mesh-list
93197313|NCT03337672|Dexmedetomidine|dexmedetomidine|mesh-list
93197314|NCT03337672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197315|NCT03337672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197316|NCT03337672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197317|NCT03337672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197318|NCT03337672|Analgesics|analgesics|mesh-ancestor
93197319|NCT03337672|Sensory System Agents|sensory system agents|mesh-ancestor
93197320|NCT03337672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197321|NCT03337672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93197322|NCT03337672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93197323|NCT03337672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93197324|NCT03337672|Adrenergic Agents|adrenergic agents|mesh-ancestor
93197325|NCT03337672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197326|NCT03337672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197327|NCT03337672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93197328|NCT03337672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93197329|NCT03337672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93197330|NCT03337672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197331|NCT03337672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197332|NCT03337672|Anesthetics, General|anesthetics, general|mesh-ancestor
93197333|NCT03337672|Anesthetics|anesthetics|mesh-ancestor
93197334|NCT03337672|GABA Modulators|gaba modulators|mesh-ancestor
93197335|NCT03337672|GABA Agents|gaba agents|mesh-ancestor
93197336|NCT03330808|Anesthetics|anesthetics|mesh-list
93197337|NCT03330808|Ropivacaine|ropivacaine|mesh-list
93197338|NCT03330808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197339|NCT03330808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197340|NCT03330808|Anesthetics, Local|anesthetics, local|mesh-ancestor
93197341|NCT03330808|Sensory System Agents|sensory system agents|mesh-ancestor
93197342|NCT03330808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197343|NCT01303055|Metformin|metformin|mesh-list
93197344|NCT01303055|Alogliptin|alogliptin|mesh-list
93197345|NCT01303055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93197346|NCT01303055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197347|NCT01303055|Incretins|incretins|mesh-ancestor
93197348|NCT01303055|Hormones|hormones|mesh-ancestor
92493175|NCT01966575|Hormones|hormones|mesh-ancestor
93197349|NCT01303055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197350|NCT01303055|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93197351|NCT01303055|Protease Inhibitors|protease inhibitors|mesh-ancestor
93197352|NCT01303055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197353|NCT01303055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197354|NCT05474560|Allopurinol|allopurinol|mesh-list
93197355|NCT05474560|Febuxostat|febuxostat|mesh-list
93197356|NCT05474560|Antimetabolites|antimetabolites|mesh-ancestor
93197357|NCT05474560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197358|NCT05474560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197359|NCT05474560|Gout Suppressants|gout suppressants|mesh-ancestor
93197360|NCT05474560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93197361|NCT05474560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93197362|NCT05474560|Antioxidants|antioxidants|mesh-ancestor
93197363|NCT05474560|Protective Agents|protective agents|mesh-ancestor
93197364|NCT05474560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197365|NCT03636048|Bupivacaine|bupivacaine|mesh-list
93197366|NCT03636048|Anesthetics|anesthetics|mesh-list
93197367|NCT03636048|Propofol|propofol|mesh-list
93197368|NCT03636048|Anesthetics, Local|anesthetics, local|mesh-ancestor
93197369|NCT03636048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197370|NCT03636048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197371|NCT03636048|Sensory System Agents|sensory system agents|mesh-ancestor
93197372|NCT03636048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197373|NCT03636048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197374|NCT03636048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197375|NCT03636048|Anesthetics, General|anesthetics, general|mesh-ancestor
93197376|NCT03527173|Vaccines|vaccines|mesh-list
93197377|NCT03527173|Immunologic Factors|immunologic factors|mesh-ancestor
93197378|NCT03527173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197379|NCT04718922|Chlorhexidine|chlorhexidine|mesh-list
93197380|NCT04718922|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93197381|NCT04718922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93197382|NCT04718922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197383|NCT04718922|Disinfectants|disinfectants|mesh-ancestor
93197384|NCT04718922|Dermatologic Agents|dermatologic agents|mesh-ancestor
93197385|NCT01303601|Olanzapine|olanzapine|mesh-list
93197386|NCT01303601|Antiemetics|antiemetics|mesh-ancestor
93197387|NCT01303601|Autonomic Agents|autonomic agents|mesh-ancestor
93197388|NCT01303601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197389|NCT01303601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197390|NCT01303601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197391|NCT01303601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93197392|NCT01303601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93197393|NCT01303601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197394|NCT01303601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197395|NCT01303601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93197396|NCT01303601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93197397|NCT01303601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197398|NCT01303601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197399|NCT01303601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197400|NCT01303601|Serotonin Agents|serotonin agents|mesh-ancestor
93197401|NCT00707980|Vortioxetine|vortioxetine|mesh-list
93197402|NCT00707980|Antidepressive Agents|antidepressive agents|mesh-ancestor
93197403|NCT00707980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197404|NCT00707980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93197405|NCT00707980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93197406|NCT00707980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197407|NCT00707980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197408|NCT00707980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93197409|NCT00707980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93197410|NCT00707980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197411|NCT00707980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197412|NCT00707980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197413|NCT00707980|Serotonin Agents|serotonin agents|mesh-ancestor
93197414|NCT00707980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93197415|NCT00707980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93197416|NCT00707980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93197417|NCT00707980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92869527|NCT04005872|Calcium|calcium|mesh-list
93197418|NCT01304537|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93197419|NCT01304537|Protein C Inhibitor|protein c inhibitor|mesh-list
93197420|NCT01304537|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93197421|NCT01304537|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93197422|NCT01304537|Protease Inhibitors|protease inhibitors|mesh-ancestor
93197423|NCT01304537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197424|NCT01304537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197425|NCT03051620|Alendronate|alendronate|mesh-list
93197426|NCT03051620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93197427|NCT03051620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197428|NCT02861183|Hyaluronic Acid|hyaluronic acid|mesh-list
93197429|NCT02861183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93197430|NCT02861183|Immunologic Factors|immunologic factors|mesh-ancestor
93197431|NCT02861183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197432|NCT02861183|Viscosupplements|viscosupplements|mesh-ancestor
93197433|NCT02861183|Protective Agents|protective agents|mesh-ancestor
93197434|NCT02498002|Lidocaine|lidocaine|mesh-list
93197435|NCT02498002|Anesthetics, Local|anesthetics, local|mesh-ancestor
93197436|NCT02498002|Anesthetics|anesthetics|mesh-ancestor
93197437|NCT02498002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197438|NCT02498002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197439|NCT02498002|Sensory System Agents|sensory system agents|mesh-ancestor
93197440|NCT02498002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197441|NCT02498002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93197442|NCT02498002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93197443|NCT02498002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93197444|NCT02498002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197445|NCT02498002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197446|NCT03810209|Magnesium Sulfate|magnesium sulfate|mesh-list
93197447|NCT03810209|Analgesics|analgesics|mesh-ancestor
93197448|NCT03810209|Sensory System Agents|sensory system agents|mesh-ancestor
93197449|NCT03810209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197450|NCT03810209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197451|NCT03810209|Anesthetics|anesthetics|mesh-ancestor
93197452|NCT03810209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197453|NCT03810209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93197454|NCT03810209|Anticonvulsants|anticonvulsants|mesh-ancestor
93197455|NCT03810209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93197456|NCT03810209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197457|NCT03810209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197458|NCT03810209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93197459|NCT03810209|Tocolytic Agents|tocolytic agents|mesh-ancestor
93197460|NCT03810209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93197461|NCT04186988|9-arabinofuranosylguanine|9-arabinofuranosylguanine|mesh-list
93197462|NCT04186988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197463|NCT01303679|Paclitaxel|paclitaxel|mesh-list
93197464|NCT01303679|Bevacizumab|bevacizumab|mesh-list
93197465|NCT01303679|Exemestane|exemestane|mesh-list
93197466|NCT01303679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93197467|NCT01303679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197468|NCT01303679|Tubulin Modulators|tubulin modulators|mesh-ancestor
93197469|NCT01303679|Antimitotic Agents|antimitotic agents|mesh-ancestor
93197470|NCT01303679|Mitosis Modulators|mitosis modulators|mesh-ancestor
93197471|NCT01303679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197472|NCT01303679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197473|NCT01303679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197474|NCT01303679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197475|NCT01303679|Growth Substances|growth substances|mesh-ancestor
93197476|NCT01303679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197477|NCT01303679|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197478|NCT01303679|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93197479|NCT01303679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93197480|NCT01303679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197481|NCT01303679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93197482|NCT01303679|Hormone Antagonists|hormone antagonists|mesh-ancestor
93197483|NCT01303679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197484|NCT03337282|Anesthetics|anesthetics|mesh-list
93197485|NCT03337282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197486|NCT03337282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197487|NCT03801707|Sofosbuvir|sofosbuvir|mesh-list
93197488|NCT03801707|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93197489|NCT03801707|Velpatasvir|velpatasvir|mesh-list
93197490|NCT03801707|Antiviral Agents|antiviral agents|mesh-ancestor
93197491|NCT03801707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197493|NCT04576871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93197494|NCT04576871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197495|NCT04239872|Calcium, Dietary|calcium, dietary|mesh-list
93197496|NCT04239872|Calcium|calcium|mesh-list
93197497|NCT04239872|Fluorides|fluorides|mesh-list
93197498|NCT04239872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93197499|NCT04239872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197500|NCT04239872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93197501|NCT04239872|Cariostatic Agents|cariostatic agents|mesh-ancestor
93197502|NCT04239872|Protective Agents|protective agents|mesh-ancestor
93197503|NCT03164772|Durvalumab|durvalumab|mesh-list
93197504|NCT03164772|Tremelimumab|tremelimumab|mesh-list
93197505|NCT03164772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197506|NCT03164772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197507|NCT03801317|Micronutrients|micronutrients|mesh-list
93197508|NCT03801317|Trace Elements|trace elements|mesh-list
93197509|NCT03801317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197510|NCT03337126|Metronidazole|metronidazole|mesh-list
93197511|NCT03337126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197512|NCT03337126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93197513|NCT03337126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93197514|NCT03337126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93197515|NCT04710732|Enoxaparin|enoxaparin|mesh-list
93197516|NCT04710732|Enoxaparin sodium|enoxaparin sodium|mesh-list
93197517|NCT04710732|Anticoagulants|anticoagulants|mesh-ancestor
93197518|NCT04710732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93197519|NCT04710732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93197520|NCT04710732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197521|NCT05014334|Amoxicillin|amoxicillin|mesh-list
93197522|NCT05014334|Clarithromycin|clarithromycin|mesh-list
93197523|NCT05014334|Rabeprazole|rabeprazole|mesh-list
93197524|NCT05014334|Bismuth|bismuth|mesh-list
93197525|NCT05014334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93197526|NCT05014334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197527|NCT05014334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93197528|NCT05014334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197529|NCT05014334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197530|NCT05014334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93197531|NCT05014334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93197532|NCT05014334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93197533|NCT05014334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197534|NCT05014334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93197535|NCT05014334|Antacids|antacids|mesh-ancestor
93197536|NCT02497378|Dexamethasone|dexamethasone|mesh-list
93197537|NCT02497378|Bortezomib|bortezomib|mesh-list
93197538|NCT02497378|Daratumumab|daratumumab|mesh-list
93197539|NCT02497378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197540|NCT02497378|Antiemetics|antiemetics|mesh-ancestor
93197541|NCT02497378|Autonomic Agents|autonomic agents|mesh-ancestor
93197542|NCT02497378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197543|NCT02497378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197544|NCT02497378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93197545|NCT02497378|Glucocorticoids|glucocorticoids|mesh-ancestor
93197546|NCT02497378|Hormones|hormones|mesh-ancestor
93197547|NCT02497378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197548|NCT02497378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93197549|NCT02497378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197550|NCT02497222|RNS60|rns60|mesh-list
93197551|NCT02497222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93197552|NCT02497222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197553|NCT02497222|Analgesics|analgesics|mesh-ancestor
93197554|NCT02497222|Sensory System Agents|sensory system agents|mesh-ancestor
93197555|NCT02497222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197556|NCT02497222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197557|NCT02497222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197558|NCT02497222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93197559|NCT02497222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93197560|NCT02491606|Tafenoquine|tafenoquine|mesh-list
93197561|NCT02491606|Antimalarials|antimalarials|mesh-ancestor
93197562|NCT02491606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93197563|NCT02491606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93197564|NCT02491606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197565|NCT03329638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93197566|NCT03329638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93197567|NCT03050450|Lenalidomide|lenalidomide|mesh-list
93197568|NCT03050450|Vorinostat|vorinostat|mesh-list
93197569|NCT03050450|Immunologic Factors|immunologic factors|mesh-ancestor
92855699|NCT00900445|Autonomic Agents|autonomic agents|mesh-ancestor
93197570|NCT03050450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197571|NCT03050450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197572|NCT03050450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197573|NCT03050450|Growth Substances|growth substances|mesh-ancestor
93197574|NCT03050450|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197575|NCT03050450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197576|NCT03050450|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93197577|NCT03050450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197578|NCT03050450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197579|NCT03799679|Antineoplastic Agents|antineoplastic agents|mesh-list
93197580|NCT03505021|Simendan|simendan|mesh-list
93197581|NCT03505021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93197582|NCT03505021|Vasodilator Agents|vasodilator agents|mesh-ancestor
93197583|NCT03505021|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93197584|NCT03505021|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93197585|NCT03505021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197586|NCT03505021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197587|NCT03505021|Protective Agents|protective agents|mesh-ancestor
93197588|NCT03505021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197589|NCT03793283|Insulin|insulin|mesh-list
93197590|NCT03793283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93197591|NCT03793283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93197592|NCT03793283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197593|NCT02496988|Temozolomide|temozolomide|mesh-list
93197594|NCT02496988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93197595|NCT02496988|Alkylating Agents|alkylating agents|mesh-ancestor
93197596|NCT02496988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197597|NCT02496988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197598|NCT03793205|Lenograstim|lenograstim|mesh-list
93197599|NCT03793205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93197600|NCT03793205|Immunologic Factors|immunologic factors|mesh-ancestor
93197601|NCT03793205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197602|NCT03329248|Leucovorin|leucovorin|mesh-list
93197603|NCT03329248|Paclitaxel|paclitaxel|mesh-list
93197604|NCT03329248|Cyclophosphamide|cyclophosphamide|mesh-list
93197605|NCT03329248|Bevacizumab|bevacizumab|mesh-list
93197606|NCT03329248|Fluorouracil|fluorouracil|mesh-list
93197607|NCT03329248|Capecitabine|capecitabine|mesh-list
93197608|NCT03329248|Oxaliplatin|oxaliplatin|mesh-list
93197609|NCT03329248|Avelumab|avelumab|mesh-list
93197610|NCT03329248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93197611|NCT03329248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197612|NCT03329248|Tubulin Modulators|tubulin modulators|mesh-ancestor
93197613|NCT03329248|Antimitotic Agents|antimitotic agents|mesh-ancestor
93197614|NCT03329248|Mitosis Modulators|mitosis modulators|mesh-ancestor
93197615|NCT03329248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197616|NCT03329248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93197617|NCT03329248|Immunologic Factors|immunologic factors|mesh-ancestor
93197618|NCT03329248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197619|NCT03329248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93197620|NCT03329248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93197621|NCT03329248|Alkylating Agents|alkylating agents|mesh-ancestor
93197622|NCT03329248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93197623|NCT03329248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197624|NCT03329248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197625|NCT03329248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197626|NCT03329248|Growth Substances|growth substances|mesh-ancestor
93197627|NCT03329248|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197628|NCT03329248|Antimetabolites|antimetabolites|mesh-ancestor
93197629|NCT03329248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93197630|NCT03329248|Antidotes|antidotes|mesh-ancestor
93197631|NCT03329248|Protective Agents|protective agents|mesh-ancestor
93197632|NCT03329248|Vitamin B Complex|vitamin b complex|mesh-ancestor
93197633|NCT03329248|Vitamins|vitamins|mesh-ancestor
93197634|NCT03329248|Micronutrients|micronutrients|mesh-ancestor
93197635|NCT03795311|Bevacizumab|bevacizumab|mesh-list
93197636|NCT03795311|Folfirinox|folfirinox|mesh-list
93197637|NCT03795311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197638|NCT03795311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197639|NCT03795311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197640|NCT03795311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197641|NCT03795311|Growth Substances|growth substances|mesh-ancestor
93197642|NCT03795311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869747|NCT00655785|Antimetabolites|antimetabolites|mesh-ancestor
93197643|NCT03795311|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197644|NCT03792971|Dextromethorphan|dextromethorphan|mesh-list
93197645|NCT03792971|Avasopasem manganese|avasopasem manganese|mesh-list
93197646|NCT03792971|Antitussive Agents|antitussive agents|mesh-ancestor
93197647|NCT03792971|Respiratory System Agents|respiratory system agents|mesh-ancestor
93197648|NCT03792971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93197649|NCT03792971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93197650|NCT03792971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197651|NCT03792971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197652|NCT03792971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197653|NCT03792971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93197654|NCT03792971|Antioxidants|antioxidants|mesh-ancestor
93197655|NCT03792971|Protective Agents|protective agents|mesh-ancestor
93197656|NCT03328936|Melphalan|melphalan|mesh-list
93197657|NCT03328936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93197658|NCT03328936|Alkylating Agents|alkylating agents|mesh-ancestor
93197659|NCT03328936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197660|NCT03328936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197661|NCT03328936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93197662|NCT03328936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93197663|NCT03328936|Immunologic Factors|immunologic factors|mesh-ancestor
93197664|NCT03328936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197665|NCT02496754|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93197666|NCT02496754|Hormones|hormones|mesh-ancestor
93197667|NCT02496754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197668|NCT02496754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197669|NCT04887194|Nivolumab|nivolumab|mesh-list
93197670|NCT04887194|Digoxin|digoxin|mesh-list
93197671|NCT04887194|Midazolam|midazolam|mesh-list
93197672|NCT04887194|Dextromethorphan|dextromethorphan|mesh-list
93197673|NCT04887194|Warfarin|warfarin|mesh-list
93197674|NCT04887194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93197675|NCT04887194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197676|NCT04887194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197677|NCT04887194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93197678|NCT04887194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197679|NCT04887194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93197680|NCT04887194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197681|NCT04887194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197682|NCT04887194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197683|NCT04887194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93197684|NCT04887194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93197685|NCT04887194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93197686|NCT04887194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197687|NCT04887194|Anesthetics, General|anesthetics, general|mesh-ancestor
93197688|NCT04887194|Anesthetics|anesthetics|mesh-ancestor
93197689|NCT04887194|GABA Modulators|gaba modulators|mesh-ancestor
93197690|NCT04887194|GABA Agents|gaba agents|mesh-ancestor
93197691|NCT04887194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197692|NCT04887194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93197693|NCT04887194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93197694|NCT04887194|Antimetabolites|antimetabolites|mesh-ancestor
93197695|NCT04887194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93197696|NCT04887194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93197697|NCT04887194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197698|NCT04887194|Anticoagulants|anticoagulants|mesh-ancestor
93197699|NCT04887194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93197700|NCT04887194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93197701|NCT04887194|Protective Agents|protective agents|mesh-ancestor
93197702|NCT04887194|Antitussive Agents|antitussive agents|mesh-ancestor
93197703|NCT04887194|Respiratory System Agents|respiratory system agents|mesh-ancestor
93197704|NCT04887194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93197705|NCT04887194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93197706|NCT02496910|Amlodipine|amlodipine|mesh-list
93197707|NCT02496910|Telmisartan|telmisartan|mesh-list
93197708|NCT02496910|Chlorthalidone|chlorthalidone|mesh-list
93197709|NCT02496910|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93197710|NCT02496910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93197711|NCT02496910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93197712|NCT02496910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197713|NCT02496910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197714|NCT02496910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93197715|NCT02496910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197716|NCT02496910|Vasodilator Agents|vasodilator agents|mesh-ancestor
93197717|NCT02496910|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93197718|NCT02496910|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93197719|NCT02496910|Diuretics|diuretics|mesh-ancestor
93197720|NCT02496910|Natriuretic Agents|natriuretic agents|mesh-ancestor
93197721|NCT02496910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93197722|NCT03342352|Carboplatin|carboplatin|mesh-list
93197723|NCT03342352|Fluorouracil|fluorouracil|mesh-list
93197724|NCT03342352|Nivolumab|nivolumab|mesh-list
93197725|NCT03342352|Cetuximab|cetuximab|mesh-list
93197726|NCT03342352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197727|NCT03342352|Antimetabolites|antimetabolites|mesh-ancestor
93197728|NCT03342352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197729|NCT03342352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93197730|NCT03342352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93197731|NCT03342352|Immunologic Factors|immunologic factors|mesh-ancestor
93197732|NCT03342352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197733|NCT03342352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197734|NCT03342352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93197735|NCT03120442|Fentanyl|fentanyl|mesh-list
93197736|NCT03120442|Dexmedetomidine|dexmedetomidine|mesh-list
93197737|NCT03120442|Propofol|propofol|mesh-list
93197738|NCT03120442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197739|NCT03120442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197740|NCT03120442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197741|NCT03120442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197742|NCT03120442|Analgesics|analgesics|mesh-ancestor
93197743|NCT03120442|Sensory System Agents|sensory system agents|mesh-ancestor
93197744|NCT03120442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197745|NCT03120442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93197746|NCT03120442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93197747|NCT03120442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93197748|NCT03120442|Adrenergic Agents|adrenergic agents|mesh-ancestor
93197749|NCT03120442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197750|NCT03120442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197751|NCT03120442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197752|NCT03120442|Anesthetics, General|anesthetics, general|mesh-ancestor
93197753|NCT03120442|Anesthetics|anesthetics|mesh-ancestor
93197754|NCT03120442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93197755|NCT03120442|Narcotics|narcotics|mesh-ancestor
93197756|NCT03120442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93197757|NCT00852696|Solifenacin Succinate|solifenacin succinate|mesh-list
93197758|NCT00852696|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93197759|NCT00852696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93197760|NCT00852696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93197761|NCT00852696|Cholinergic Agents|cholinergic agents|mesh-ancestor
93197762|NCT00852696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197763|NCT00852696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197764|NCT00852696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197765|NCT00852696|Urological Agents|urological agents|mesh-ancestor
93197766|NCT02496832|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93197767|NCT02496832|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93197768|NCT02496832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197769|NCT03324490|Fentanyl|fentanyl|mesh-list
93197770|NCT03324490|Dexmedetomidine|dexmedetomidine|mesh-list
93197771|NCT03324490|Bupivacaine|bupivacaine|mesh-list
93197772|NCT03324490|Anesthetics|anesthetics|mesh-list
93197773|NCT03324490|Anesthetics, Local|anesthetics, local|mesh-ancestor
93197774|NCT03324490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197775|NCT03324490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197776|NCT03324490|Sensory System Agents|sensory system agents|mesh-ancestor
93197777|NCT03324490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197778|NCT03324490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93197779|NCT03324490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93197780|NCT03324490|Analgesics|analgesics|mesh-ancestor
93197781|NCT03324490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93197782|NCT03324490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93197783|NCT03324490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93197784|NCT03324490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93197785|NCT03324490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197786|NCT03324490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197787|NCT03324490|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93197788|NCT03324490|Narcotics|narcotics|mesh-ancestor
93197789|NCT03324490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93197790|NCT03324490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93197791|NCT03324490|Anesthetics, General|anesthetics, general|mesh-ancestor
93197792|NCT03798899|Methoxyflurane|methoxyflurane|mesh-list
93197793|NCT03798899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93197794|NCT03798899|Anesthetics, General|anesthetics, general|mesh-ancestor
93197795|NCT03798899|Anesthetics|anesthetics|mesh-ancestor
93197796|NCT03798899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197797|NCT03798899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197798|NCT03274661|Pembrolizumab|pembrolizumab|mesh-list
93197799|NCT03274661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197800|NCT03274661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197801|NCT03274661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93197802|NCT03274661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197803|NCT03798821|Sulfalene|sulfalene|mesh-list
93197804|NCT03798821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197805|NCT03798821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93197806|NCT03798821|Antimalarials|antimalarials|mesh-ancestor
93197807|NCT03798821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93197808|NCT03798821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93197809|NCT03324334|Antibodies|antibodies|mesh-list
93197810|NCT03324334|Immunologic Factors|immunologic factors|mesh-ancestor
93197811|NCT03324334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197812|NCT03792815|Etoposide|etoposide|mesh-list
93197813|NCT03792815|Melphalan|melphalan|mesh-list
93197814|NCT03792815|Busulfan|busulfan|mesh-list
93197815|NCT03792815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93197816|NCT03792815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197817|NCT03792815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93197818|NCT03792815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93197819|NCT03792815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197820|NCT03792815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197821|NCT03792815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93197822|NCT03792815|Alkylating Agents|alkylating agents|mesh-ancestor
93197823|NCT03792815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93197824|NCT03792815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93197825|NCT03792815|Immunologic Factors|immunologic factors|mesh-ancestor
93197826|NCT03792815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197827|NCT04381364|Ciclesonide|ciclesonide|mesh-list
93197828|NCT04381364|Glucocorticoids|glucocorticoids|mesh-ancestor
93197829|NCT04381364|Hormones|hormones|mesh-ancestor
93197830|NCT04381364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197831|NCT04381364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197832|NCT04381364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93197833|NCT01331382|Resveratrol|resveratrol|mesh-list
93197834|NCT01331382|Antioxidants|antioxidants|mesh-ancestor
93197835|NCT01331382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197836|NCT01331382|Protective Agents|protective agents|mesh-ancestor
93197837|NCT01331382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197838|NCT01331382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197839|NCT01331382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93197840|NCT03794765|Metronidazole|metronidazole|mesh-list
93197841|NCT03794765|Ceftriaxone|ceftriaxone|mesh-list
93197842|NCT03794765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93197843|NCT03794765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93197844|NCT03794765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93197845|NCT03794765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93197846|NCT02496286|Bevacizumab|bevacizumab|mesh-list
93197847|NCT02496286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197848|NCT02496286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197849|NCT02496286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197850|NCT02496286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197851|NCT02496286|Growth Substances|growth substances|mesh-ancestor
93197852|NCT02496286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197853|NCT02496286|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197854|NCT01489176|Regadenoson|regadenoson|mesh-list
93197855|NCT01489176|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93197856|NCT01489176|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93197857|NCT01489176|Purinergic Agonists|purinergic agonists|mesh-ancestor
93197858|NCT01489176|Purinergic Agents|purinergic agents|mesh-ancestor
93197859|NCT01489176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197860|NCT01489176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197861|NCT01489176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197862|NCT03792503|Pemetrexed|pemetrexed|mesh-list
93197863|NCT03792503|Apatinib|apatinib|mesh-list
93197864|NCT03792503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197865|NCT03792503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197866|NCT03792503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197867|NCT03792503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93197868|NCT03792503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93197869|NCT03792503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93197870|NCT03794843|Nimodipine|nimodipine|mesh-list
93197871|NCT03794843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93197872|NCT03794843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93197873|NCT03794843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197874|NCT03794843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197875|NCT03794843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93197876|NCT03794843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197877|NCT03794843|Vasodilator Agents|vasodilator agents|mesh-ancestor
93197878|NCT01333800|Ciclesonide|ciclesonide|mesh-list
93197879|NCT01333800|Beclomethasone|beclomethasone|mesh-list
93197880|NCT01333800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93197881|NCT01333800|Glucocorticoids|glucocorticoids|mesh-ancestor
93197882|NCT01333800|Hormones|hormones|mesh-ancestor
93197883|NCT01333800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93197884|NCT01333800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197885|NCT01333800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93197886|NCT01333800|Respiratory System Agents|respiratory system agents|mesh-ancestor
93197887|NCT01333800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93197888|NCT04494100|Lidocaine|lidocaine|mesh-list
93197889|NCT04494100|Epinephrine|epinephrine|mesh-list
93197890|NCT04494100|Ropivacaine|ropivacaine|mesh-list
93197891|NCT04494100|Anesthetics, Local|anesthetics, local|mesh-ancestor
93197892|NCT04494100|Anesthetics|anesthetics|mesh-ancestor
93197893|NCT04494100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93197894|NCT04494100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197895|NCT04494100|Sensory System Agents|sensory system agents|mesh-ancestor
93197896|NCT04494100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197897|NCT04494100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93197898|NCT04494100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93197899|NCT04494100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93197900|NCT04494100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93197901|NCT04494100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197902|NCT04494100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93197903|NCT04494100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93197904|NCT04494100|Adrenergic Agents|adrenergic agents|mesh-ancestor
93197905|NCT04494100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197906|NCT04494100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93197907|NCT04494100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93197908|NCT04494100|Autonomic Agents|autonomic agents|mesh-ancestor
93197909|NCT04494100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93197910|NCT04494100|Respiratory System Agents|respiratory system agents|mesh-ancestor
93197911|NCT04494100|Mydriatics|mydriatics|mesh-ancestor
93197912|NCT04494100|Sympathomimetics|sympathomimetics|mesh-ancestor
93197913|NCT04494100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93197914|NCT01333878|Abatacept|abatacept|mesh-list
93197915|NCT01333878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93197916|NCT01333878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197917|NCT01333878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197918|NCT01333878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197919|NCT01333878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93197920|NCT01333878|Immunologic Factors|immunologic factors|mesh-ancestor
93197921|NCT01333878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197922|NCT01333878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93197923|NCT03328312|Atropine|atropine|mesh-list
93197924|NCT03328312|Neostigmine|neostigmine|mesh-list
93197925|NCT03328312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93197926|NCT03328312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93197927|NCT03328312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93197928|NCT03328312|Autonomic Agents|autonomic agents|mesh-ancestor
93197929|NCT03328312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93197930|NCT03328312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197931|NCT03328312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93197932|NCT03328312|Respiratory System Agents|respiratory system agents|mesh-ancestor
93197933|NCT03328312|Mydriatics|mydriatics|mesh-ancestor
93197934|NCT03328312|Parasympatholytics|parasympatholytics|mesh-ancestor
93197935|NCT03328312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93197936|NCT03328312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93197937|NCT03328312|Cholinergic Agents|cholinergic agents|mesh-ancestor
93197938|NCT03328312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197939|NCT03328312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197940|NCT03328312|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93197941|NCT03328312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197942|NCT03328312|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93197943|NCT04051580|Plasma-lyte 148|plasma-lyte 148|mesh-list
93197944|NCT04051580|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92870046|NCT03769766|Analgesics|analgesics|mesh-ancestor
93197945|NCT04051580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93197946|NCT03328234|Paclitaxel|paclitaxel|mesh-list
93197947|NCT03328234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93197948|NCT03328234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93197949|NCT03328234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197950|NCT03328234|Tubulin Modulators|tubulin modulators|mesh-ancestor
93197951|NCT03328234|Antimitotic Agents|antimitotic agents|mesh-ancestor
93197952|NCT03328234|Mitosis Modulators|mitosis modulators|mesh-ancestor
93197953|NCT03328234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197954|NCT04781192|Durvalumab|durvalumab|mesh-list
93197955|NCT04781192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93197956|NCT04781192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197957|NCT03323710|Sunitinib|sunitinib|mesh-list
93197958|NCT03323710|Propranolol|propranolol|mesh-list
93197959|NCT03323710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197960|NCT03323710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93197961|NCT03323710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93197962|NCT03323710|Growth Substances|growth substances|mesh-ancestor
93197963|NCT03323710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197964|NCT03323710|Growth Inhibitors|growth inhibitors|mesh-ancestor
93197965|NCT03323710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93197966|NCT03323710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197967|NCT03323710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197968|NCT03323710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93197969|NCT03323710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93197970|NCT03323710|Adrenergic Agents|adrenergic agents|mesh-ancestor
93197971|NCT03323710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93197972|NCT03323710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93197973|NCT03323710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93197974|NCT03323710|Vasodilator Agents|vasodilator agents|mesh-ancestor
93197975|NCT03792269|Capecitabine|capecitabine|mesh-list
93197976|NCT03792269|Oxaliplatin|oxaliplatin|mesh-list
93197977|NCT03792269|Irinotecan|irinotecan|mesh-list
93197978|NCT03792269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93197979|NCT03792269|Antimetabolites|antimetabolites|mesh-ancestor
93197980|NCT03792269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197981|NCT03792269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197982|NCT03792269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93197983|NCT03792269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93197984|NCT03792269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93197985|NCT02488564|Metformin|metformin|mesh-list
93197986|NCT02488564|Docetaxel|docetaxel|mesh-list
93197987|NCT02488564|Doxorubicin|doxorubicin|mesh-list
93197988|NCT02488564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93197989|NCT02488564|Trastuzumab|trastuzumab|mesh-list
93197990|NCT02488564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93197991|NCT02488564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93197992|NCT02488564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93197993|NCT02488564|Tubulin Modulators|tubulin modulators|mesh-ancestor
93197994|NCT02488564|Antimitotic Agents|antimitotic agents|mesh-ancestor
93197995|NCT02488564|Mitosis Modulators|mitosis modulators|mesh-ancestor
93197996|NCT02488564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93197997|NCT02488564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93197998|NCT02488564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93197999|NCT02488564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93198000|NCT02488564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198001|NCT02488564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198002|NCT02966873|Acetylcysteine|acetylcysteine|mesh-list
93198003|NCT02966873|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93198004|NCT02966873|Antiviral Agents|antiviral agents|mesh-ancestor
93198005|NCT02966873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198006|NCT02966873|Expectorants|expectorants|mesh-ancestor
93198007|NCT02966873|Respiratory System Agents|respiratory system agents|mesh-ancestor
93198008|NCT02966873|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93198009|NCT02966873|Antioxidants|antioxidants|mesh-ancestor
93198010|NCT02966873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198011|NCT02966873|Protective Agents|protective agents|mesh-ancestor
93198012|NCT02966873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198013|NCT02966873|Antidotes|antidotes|mesh-ancestor
93198014|NCT03792347|Pembrolizumab|pembrolizumab|mesh-list
93198015|NCT03792347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198016|NCT03792347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198017|NCT03792347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92977240|NCT01581853|Lopinavir|lopinavir|mesh-list
93198018|NCT03792347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198019|NCT04697186|Amoxicillin|amoxicillin|mesh-list
93198020|NCT04697186|Clarithromycin|clarithromycin|mesh-list
93198021|NCT04697186|Rabeprazole|rabeprazole|mesh-list
93198022|NCT04697186|Bismuth|bismuth|mesh-list
93198023|NCT04697186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93198024|NCT04697186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198025|NCT04697186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93198026|NCT04697186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198027|NCT04697186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198028|NCT04697186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93198029|NCT04697186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93198030|NCT04697186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93198031|NCT04697186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198032|NCT04697186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93198033|NCT04697186|Antacids|antacids|mesh-ancestor
93198034|NCT02488642|Isosorbide|isosorbide|mesh-list
93198035|NCT02488642|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93198036|NCT02488642|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93198037|NCT02488642|Misoprostol|misoprostol|mesh-list
93198038|NCT02488642|Oxytocin|oxytocin|mesh-list
93198039|NCT02488642|Oxytocics|oxytocics|mesh-ancestor
93198040|NCT02488642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93198041|NCT02488642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198042|NCT02488642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93198043|NCT02488642|Abortifacient Agents|abortifacient agents|mesh-ancestor
93198044|NCT02488642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93198045|NCT02488642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198046|NCT02488642|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93198047|NCT02488642|Diuretics|diuretics|mesh-ancestor
93198048|NCT02488642|Natriuretic Agents|natriuretic agents|mesh-ancestor
93198049|NCT02488642|Vasodilator Agents|vasodilator agents|mesh-ancestor
93198050|NCT02488642|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93198051|NCT02488642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198052|NCT02488486|Remifentanil|remifentanil|mesh-list
93198053|NCT02488486|Propofol|propofol|mesh-list
93198054|NCT02488486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93198055|NCT02488486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198056|NCT02488486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198057|NCT02488486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93198058|NCT02488486|Anesthetics, General|anesthetics, general|mesh-ancestor
93198059|NCT02488486|Anesthetics|anesthetics|mesh-ancestor
93198060|NCT02488486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93198061|NCT02488486|Narcotics|narcotics|mesh-ancestor
93198062|NCT02488486|Analgesics|analgesics|mesh-ancestor
93198063|NCT02488486|Sensory System Agents|sensory system agents|mesh-ancestor
93198064|NCT02488486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198065|NCT04144517|Pembrolizumab|pembrolizumab|mesh-list
93198066|NCT04144517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198067|NCT04144517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198068|NCT04144517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93198069|NCT04144517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198070|NCT01389024|Hydroxyurea|hydroxyurea|mesh-list
93198071|NCT01389024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198072|NCT01389024|Antisickling Agents|antisickling agents|mesh-ancestor
93198073|NCT01389024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198074|NCT01389024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198075|NCT01389024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93198076|NCT03327766|Calcifediol|calcifediol|mesh-list
93198077|NCT03327766|Vitamins|vitamins|mesh-ancestor
93198078|NCT03327766|Micronutrients|micronutrients|mesh-ancestor
93198079|NCT03327766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198080|NCT03327766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93198081|NCT03798119|Tenofovir|tenofovir|mesh-list
93198082|NCT03798119|Antiviral Agents|antiviral agents|mesh-ancestor
93198083|NCT03798119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198084|NCT03798119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93198085|NCT03798119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93198086|NCT03798119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198087|NCT03798119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198088|NCT03798119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93198089|NCT03798119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93198090|NCT03794219|Naproxen|naproxen|mesh-list
93198091|NCT03794219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198092|NCT03794219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198093|NCT03794219|Analgesics|analgesics|mesh-ancestor
93198094|NCT03794219|Sensory System Agents|sensory system agents|mesh-ancestor
93198095|NCT03794219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198096|NCT03794219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198097|NCT03794219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198098|NCT03794219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198099|NCT03794219|Gout Suppressants|gout suppressants|mesh-ancestor
93198100|NCT03794219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93198101|NCT03794219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198102|NCT03794219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198103|NCT01297764|Dexamethasone|dexamethasone|mesh-list
93198104|NCT01297764|Dexamethasone acetate|dexamethasone acetate|mesh-list
93198105|NCT01297764|Lenalidomide|lenalidomide|mesh-list
93198106|NCT01297764|Vorinostat|vorinostat|mesh-list
93198107|NCT01297764|BB 1101|bb 1101|mesh-list
93198108|NCT01297764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198109|NCT01297764|Antiemetics|antiemetics|mesh-ancestor
93198110|NCT01297764|Autonomic Agents|autonomic agents|mesh-ancestor
93198111|NCT01297764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198112|NCT01297764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198113|NCT01297764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198114|NCT01297764|Glucocorticoids|glucocorticoids|mesh-ancestor
93198115|NCT01297764|Hormones|hormones|mesh-ancestor
93198116|NCT01297764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93198117|NCT01297764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93198118|NCT01297764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198119|NCT01297764|Protease Inhibitors|protease inhibitors|mesh-ancestor
93198120|NCT01297764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198121|NCT01297764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198122|NCT01297764|Immunologic Factors|immunologic factors|mesh-ancestor
93198123|NCT01297764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93198124|NCT01297764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93198125|NCT01297764|Growth Substances|growth substances|mesh-ancestor
93198126|NCT01297764|Growth Inhibitors|growth inhibitors|mesh-ancestor
93198127|NCT01297764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93198128|NCT01334034|Insulin Glargine|insulin glargine|mesh-list
93198129|NCT01334034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198130|NCT01334034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198131|NCT03050060|Nelfinavir|nelfinavir|mesh-list
93198132|NCT03050060|Pembrolizumab|pembrolizumab|mesh-list
93198133|NCT03050060|Nivolumab|nivolumab|mesh-list
93198134|NCT03050060|Atezolizumab|atezolizumab|mesh-list
93198135|NCT03050060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93198136|NCT03050060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198137|NCT03050060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198138|NCT03050060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93198139|NCT03050060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198140|NCT03050060|Immunologic Factors|immunologic factors|mesh-ancestor
93198141|NCT03050060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198142|NCT03050060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93198143|NCT03050060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93198144|NCT03050060|Protease Inhibitors|protease inhibitors|mesh-ancestor
93198145|NCT03050060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198146|NCT03050060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93198147|NCT03050060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93198148|NCT03050060|Antiviral Agents|antiviral agents|mesh-ancestor
93198149|NCT03050060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198150|NCT01334112|Axitinib|axitinib|mesh-list
93198151|NCT01334112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198152|NCT01334112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93198153|NCT01334112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198154|NCT01334112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198155|NCT03791957|Chrysarobin|chrysarobin|mesh-list
93198156|NCT03791957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198157|NCT03791957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198158|NCT03791957|Analgesics|analgesics|mesh-ancestor
93198159|NCT03791957|Sensory System Agents|sensory system agents|mesh-ancestor
93198160|NCT03791957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198161|NCT03791957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198162|NCT03791957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198163|NCT03791957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198164|NCT02491450|Sofosbuvir|sofosbuvir|mesh-list
93198165|NCT02491450|Antiviral Agents|antiviral agents|mesh-ancestor
93198166|NCT02491450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198167|NCT03792113|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93198168|NCT03792113|Hemostatics|hemostatics|mesh-ancestor
93198169|NCT03792113|Coagulants|coagulants|mesh-ancestor
93198170|NCT02491528|Insulin|insulin|mesh-list
93198171|NCT02491528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93198172|NCT02491528|Insulin Aspart|insulin aspart|mesh-list
93198173|NCT02491528|Insulin, Long-Acting|insulin, long-acting|mesh-list
93198174|NCT02491528|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93198176|NCT02491528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198177|NCT01304927|Vitamin D|vitamin d|mesh-list
93198178|NCT01304927|Cholecalciferol|cholecalciferol|mesh-list
93198179|NCT01304927|Calcium|calcium|mesh-list
93198180|NCT01304927|Vitamins|vitamins|mesh-ancestor
93198181|NCT01304927|Micronutrients|micronutrients|mesh-ancestor
93198182|NCT01304927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198183|NCT01304927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93198184|NCT01304927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93198185|NCT05464940|Caffeine|caffeine|mesh-list
93198186|NCT05464940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93198187|NCT05464940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198188|NCT05464940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93198189|NCT05464940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198190|NCT05464940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198191|NCT05464940|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93198192|NCT05464940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93198193|NCT05464940|Purinergic Agents|purinergic agents|mesh-ancestor
93198194|NCT05464940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198195|NCT01305551|Metformin|metformin|mesh-list
93198196|NCT01305551|Saxagliptin|saxagliptin|mesh-list
93198197|NCT01305551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198198|NCT01305551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198199|NCT01305551|Incretins|incretins|mesh-ancestor
93198200|NCT01305551|Hormones|hormones|mesh-ancestor
93198201|NCT01305551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93198202|NCT01305551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93198203|NCT01305551|Protease Inhibitors|protease inhibitors|mesh-ancestor
93198204|NCT01305551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198205|NCT01305551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198206|NCT03799757|Bupivacaine|bupivacaine|mesh-list
93198207|NCT03799757|Anesthetics, Local|anesthetics, local|mesh-ancestor
93198208|NCT03799757|Anesthetics|anesthetics|mesh-ancestor
93198209|NCT03799757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198210|NCT03799757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198211|NCT03799757|Sensory System Agents|sensory system agents|mesh-ancestor
93198212|NCT03799757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198213|NCT03327454|Etanercept|etanercept|mesh-list
93198214|NCT03327454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198215|NCT03327454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198216|NCT03327454|Analgesics|analgesics|mesh-ancestor
93198217|NCT03327454|Sensory System Agents|sensory system agents|mesh-ancestor
93198218|NCT03327454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198219|NCT03327454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198220|NCT03327454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198221|NCT03327454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198222|NCT03327454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198223|NCT03327454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93198224|NCT03327454|Immunologic Factors|immunologic factors|mesh-ancestor
93198225|NCT03799913|Cyclophosphamide|cyclophosphamide|mesh-list
93198226|NCT03799913|Fludarabine|fludarabine|mesh-list
93198227|NCT03799913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93198228|NCT03799913|Immunologic Factors|immunologic factors|mesh-ancestor
93198229|NCT03799913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198230|NCT03799913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198231|NCT03799913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93198232|NCT03799913|Alkylating Agents|alkylating agents|mesh-ancestor
93198233|NCT03799913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198234|NCT03799913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198235|NCT03799913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93198236|NCT01304069|Etoricoxib|etoricoxib|mesh-list
93198237|NCT01304069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198238|NCT01304069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198239|NCT01304069|Analgesics|analgesics|mesh-ancestor
93198240|NCT01304069|Sensory System Agents|sensory system agents|mesh-ancestor
93198241|NCT01304069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198242|NCT01304069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198243|NCT01304069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198244|NCT01304069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198245|NCT01304069|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93198246|NCT01304069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93198247|NCT01304069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870344|NCT05342792|Capecitabine|capecitabine|mesh-list
93198248|NCT01304069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198250|NCT05459402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93198251|NCT05459402|Narcotics|narcotics|mesh-ancestor
93198252|NCT05459402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198253|NCT05459402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198254|NCT05459402|Analgesics|analgesics|mesh-ancestor
93198255|NCT05459402|Sensory System Agents|sensory system agents|mesh-ancestor
93198256|NCT05459402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198257|NCT05459402|Antitussive Agents|antitussive agents|mesh-ancestor
93198258|NCT05459402|Respiratory System Agents|respiratory system agents|mesh-ancestor
93198259|NCT03799601|Carboplatin|carboplatin|mesh-list
93198260|NCT03799601|Docetaxel|docetaxel|mesh-list
93198261|NCT03799601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198262|NCT03799601|Tubulin Modulators|tubulin modulators|mesh-ancestor
93198263|NCT03799601|Antimitotic Agents|antimitotic agents|mesh-ancestor
93198264|NCT03799601|Mitosis Modulators|mitosis modulators|mesh-ancestor
93198265|NCT03799601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198266|NCT03791801|Glycopyrrolate|glycopyrrolate|mesh-list
93198267|NCT03791801|Rocuronium|rocuronium|mesh-list
93198268|NCT03791801|Neostigmine|neostigmine|mesh-list
93198269|NCT03791801|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93198270|NCT03791801|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93198271|NCT03791801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93198272|NCT03791801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198273|NCT03791801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198274|NCT03791801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93198275|NCT03791801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198276|NCT03791801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198277|NCT03791801|Cholinergic Agents|cholinergic agents|mesh-ancestor
93198278|NCT03791801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198279|NCT03791801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93198280|NCT03791801|Autonomic Agents|autonomic agents|mesh-ancestor
93198281|NCT03791801|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93198282|NCT03791801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93198283|NCT03791801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93198284|NCT01305083|Udenafil|udenafil|mesh-list
93198285|NCT01305083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93198286|NCT01305083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93198287|NCT01305083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198288|NCT01305083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198289|NCT03791723|Valsartan|valsartan|mesh-list
93198290|NCT03791723|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93198291|NCT03791723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93198292|NCT03791723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93198293|NCT03791723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93198294|NCT03791723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198295|NCT05452070|Lidocaine|lidocaine|mesh-list
93198296|NCT05452070|Anesthetics, Local|anesthetics, local|mesh-ancestor
93198297|NCT05452070|Anesthetics|anesthetics|mesh-ancestor
93198298|NCT05452070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198299|NCT05452070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198300|NCT05452070|Sensory System Agents|sensory system agents|mesh-ancestor
93198301|NCT05452070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198302|NCT05452070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93198303|NCT05452070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93198304|NCT05452070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93198305|NCT05452070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198306|NCT05452070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198307|NCT03920657|Deferasirox|deferasirox|mesh-list
93198308|NCT03920657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93198309|NCT03920657|Chelating Agents|chelating agents|mesh-ancestor
93198310|NCT03920657|Sequestering Agents|sequestering agents|mesh-ancestor
93198311|NCT03920657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198312|NCT03420950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93198313|NCT03420950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198314|NCT03420950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198315|NCT03501277|Pioglitazone|pioglitazone|mesh-list
93198316|NCT03501277|Alogliptin|alogliptin|mesh-list
93198317|NCT03501277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198318|NCT03501277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198319|NCT03501277|Incretins|incretins|mesh-ancestor
93198320|NCT03501277|Hormones|hormones|mesh-ancestor
93198321|NCT03501277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93198322|NCT03501277|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93198323|NCT03501277|Protease Inhibitors|protease inhibitors|mesh-ancestor
93198324|NCT03501277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198325|NCT03501277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198327|NCT03797729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93198328|NCT03797729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93198329|NCT03797729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198330|NCT03797729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93198331|NCT02487940|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93198332|NCT02487940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93198333|NCT02487940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93198334|NCT02487940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93198335|NCT02487706|Dolutegravir|dolutegravir|mesh-list
93198336|NCT02487706|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93198337|NCT02487706|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93198338|NCT02487706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198339|NCT02487706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198340|NCT02487706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93198341|NCT02487706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93198342|NCT02487706|Antiviral Agents|antiviral agents|mesh-ancestor
93198343|NCT02487706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198344|NCT04551950|Paclitaxel|paclitaxel|mesh-list
93198345|NCT04551950|Bevacizumab|bevacizumab|mesh-list
93198346|NCT04551950|Carboplatin|carboplatin|mesh-list
93198347|NCT04551950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93198348|NCT04551950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198349|NCT04551950|Tubulin Modulators|tubulin modulators|mesh-ancestor
93198350|NCT04551950|Antimitotic Agents|antimitotic agents|mesh-ancestor
93198351|NCT04551950|Mitosis Modulators|mitosis modulators|mesh-ancestor
93198352|NCT04551950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198353|NCT04551950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198354|NCT04551950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93198355|NCT04551950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93198356|NCT04551950|Growth Substances|growth substances|mesh-ancestor
93198357|NCT04551950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198358|NCT04551950|Growth Inhibitors|growth inhibitors|mesh-ancestor
93198359|NCT03326752|Nivolumab|nivolumab|mesh-list
93198360|NCT03326752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93198361|NCT03326752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198362|NCT03326752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198363|NCT03326752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198364|NCT03326674|Capecitabine|capecitabine|mesh-list
93198365|NCT03326674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93198366|NCT03326674|Antimetabolites|antimetabolites|mesh-ancestor
93198367|NCT03326674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198368|NCT03326674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198369|NCT01316900|Bromides|bromides|mesh-list
93198370|NCT01316900|Tiotropium Bromide|tiotropium bromide|mesh-list
93198371|NCT01316900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93198372|NCT01316900|Autonomic Agents|autonomic agents|mesh-ancestor
93198373|NCT01316900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198374|NCT01316900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198375|NCT01316900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93198376|NCT01316900|Respiratory System Agents|respiratory system agents|mesh-ancestor
93198377|NCT01316900|Parasympatholytics|parasympatholytics|mesh-ancestor
93198378|NCT01316900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93198379|NCT01316900|Cholinergic Agents|cholinergic agents|mesh-ancestor
93198380|NCT01316900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198381|NCT01316900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198382|NCT01316900|Anticonvulsants|anticonvulsants|mesh-ancestor
93198383|NCT03714815|Macitentan|macitentan|mesh-list
93198384|NCT03714815|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93198385|NCT03714815|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93198386|NCT03714815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198387|NCT03714815|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93198388|NCT02490982|Teriflunomide|teriflunomide|mesh-list
93198389|NCT02490982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198390|NCT02490982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198391|NCT02490982|Analgesics|analgesics|mesh-ancestor
93198392|NCT02490982|Sensory System Agents|sensory system agents|mesh-ancestor
93198393|NCT02490982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198394|NCT02490982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198395|NCT02490982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198396|NCT02490982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198397|NCT02490982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93198398|NCT02490982|Immunologic Factors|immunologic factors|mesh-ancestor
93198399|NCT03322150|Atropine|atropine|mesh-list
93198400|NCT03322150|Glycopyrrolate|glycopyrrolate|mesh-list
93198401|NCT03322150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93198402|NCT03322150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93198403|NCT03322150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93198404|NCT03322150|Autonomic Agents|autonomic agents|mesh-ancestor
93198405|NCT03322150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198406|NCT03322150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198407|NCT03322150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93198408|NCT03322150|Respiratory System Agents|respiratory system agents|mesh-ancestor
93198409|NCT03322150|Mydriatics|mydriatics|mesh-ancestor
93198410|NCT03322150|Parasympatholytics|parasympatholytics|mesh-ancestor
93198411|NCT03322150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93198412|NCT03322150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93198413|NCT03322150|Cholinergic Agents|cholinergic agents|mesh-ancestor
93198414|NCT03322150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198415|NCT03322150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198416|NCT00936390|Leuprolide|leuprolide|mesh-list
93198417|NCT00936390|Goserelin|goserelin|mesh-list
93198418|NCT00936390|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93198419|NCT00936390|Flutamide|flutamide|mesh-list
93198420|NCT00936390|Bicalutamide|bicalutamide|mesh-list
93198421|NCT00936390|Buserelin|buserelin|mesh-list
93198422|NCT00936390|Androgens|androgens|mesh-list
93198423|NCT00936390|Androgen Antagonists|androgen antagonists|mesh-list
93198424|NCT00936390|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93198425|NCT00936390|Fertility Agents|fertility agents|mesh-ancestor
93198426|NCT00936390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93198427|NCT00936390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198428|NCT00936390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93198429|NCT00936390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198430|NCT00936390|Hormones|hormones|mesh-ancestor
93198431|NCT00936390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93198432|NCT00936390|Hormone Antagonists|hormone antagonists|mesh-ancestor
93198433|NCT00936390|Luteolytic Agents|luteolytic agents|mesh-ancestor
93198434|NCT00936390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93198435|NCT00936390|Contraceptive Agents|contraceptive agents|mesh-ancestor
93198436|NCT00936390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93198437|NCT03326596|Tranexamic Acid|tranexamic acid|mesh-list
93198438|NCT03326596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93198439|NCT03326596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93198440|NCT03326596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198441|NCT03326596|Hemostatics|hemostatics|mesh-ancestor
93198442|NCT03326596|Coagulants|coagulants|mesh-ancestor
93198443|NCT03499873|Nepafenac|nepafenac|mesh-list
93198444|NCT03499873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198445|NCT03499873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198446|NCT03499873|Analgesics|analgesics|mesh-ancestor
93198447|NCT03499873|Sensory System Agents|sensory system agents|mesh-ancestor
93198448|NCT03499873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198449|NCT03499873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198450|NCT03499873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198451|NCT03499873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198452|NCT01305707|Diazepam|diazepam|mesh-list
93198453|NCT01305707|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93198454|NCT01305707|Lorazepam|lorazepam|mesh-list
93198455|NCT01305707|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
93198456|NCT01305707|Dexetimide|dexetimide|mesh-list
93198457|NCT01305707|Olanzapine|olanzapine|mesh-list
93198458|NCT01305707|Risperidone|risperidone|mesh-list
93198459|NCT01305707|Aripiprazole|aripiprazole|mesh-list
93198460|NCT01305707|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93198461|NCT01305707|Antipsychotic Agents|antipsychotic agents|mesh-list
93198462|NCT01305707|Lithium Carbonate|lithium carbonate|mesh-list
93198463|NCT01305707|Mirtazapine|mirtazapine|mesh-list
93198464|NCT01305707|Citalopram|citalopram|mesh-list
93198465|NCT01305707|Sertraline|sertraline|mesh-list
93198466|NCT01305707|Fluoxetine|fluoxetine|mesh-list
93198467|NCT01305707|Paroxetine|paroxetine|mesh-list
93198468|NCT01305707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93198469|NCT01305707|Nortriptyline|nortriptyline|mesh-list
93198470|NCT01305707|Imipramine|imipramine|mesh-list
93198471|NCT01305707|Clomipramine|clomipramine|mesh-list
93198472|NCT01305707|Mianserin|mianserin|mesh-list
93198473|NCT01305707|Antidepressive Agents|antidepressive agents|mesh-list
93198475|NCT01305707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93198476|NCT01305707|Serotonin Agents|serotonin agents|mesh-ancestor
93198477|NCT01305707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198478|NCT01305707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198479|NCT01305707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198480|NCT01305707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93198481|NCT01305707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198482|NCT01305707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93198483|NCT01305707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93198484|NCT01305707|Dopamine Agents|dopamine agents|mesh-ancestor
93198485|NCT01305707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93198486|NCT01305707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93198487|NCT01305707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198488|NCT01305707|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93198489|NCT01305707|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93198490|NCT01305707|Parasympatholytics|parasympatholytics|mesh-ancestor
93198491|NCT01305707|Autonomic Agents|autonomic agents|mesh-ancestor
93198492|NCT01305707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198493|NCT01305707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93198494|NCT01305707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93198495|NCT01305707|Cholinergic Agents|cholinergic agents|mesh-ancestor
93198496|NCT01305707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93198497|NCT01305707|Antiemetics|antiemetics|mesh-ancestor
93198498|NCT01305707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198499|NCT01305707|Dopamine Agonists|dopamine agonists|mesh-ancestor
93198500|NCT01305707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93198501|NCT01305707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93198502|NCT01305707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93198503|NCT01305707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93198504|NCT01305707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93198505|NCT01305707|Analgesics|analgesics|mesh-ancestor
93198506|NCT01305707|Sensory System Agents|sensory system agents|mesh-ancestor
93198507|NCT01305707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93198508|NCT01305707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93198509|NCT01305707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198510|NCT01305707|Antimanic Agents|antimanic agents|mesh-ancestor
93198511|NCT01305707|Anticonvulsants|anticonvulsants|mesh-ancestor
93198512|NCT01305707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93198513|NCT01305707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93198514|NCT01305707|GABA Modulators|gaba modulators|mesh-ancestor
93198515|NCT01305707|GABA Agents|gaba agents|mesh-ancestor
93198516|NCT01305707|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93198517|NCT01305707|Histamine Antagonists|histamine antagonists|mesh-ancestor
93198518|NCT01305707|Histamine Agents|histamine agents|mesh-ancestor
93198519|NCT01305707|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93198520|NCT01305707|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93198521|NCT01305707|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93198522|NCT01305707|Adrenergic Agents|adrenergic agents|mesh-ancestor
93198523|NCT01305707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93198524|NCT01305707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93198525|NCT01305707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93198526|NCT01305707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93198527|NCT01305707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93198528|NCT01305707|Anesthetics, General|anesthetics, general|mesh-ancestor
93198529|NCT01305707|Anesthetics|anesthetics|mesh-ancestor
93198530|NCT01305707|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93198531|NCT01305707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93198532|NCT04051970|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93198533|NCT04051970|Antiviral Agents|antiviral agents|mesh-ancestor
93198534|NCT04051970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198535|NCT03722329|Eculizumab|eculizumab|mesh-list
93198536|NCT03722329|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93198537|NCT03722329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93198538|NCT03722329|Immunologic Factors|immunologic factors|mesh-ancestor
93198539|NCT03722329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198540|NCT03467971|Metformin|metformin|mesh-list
93198541|NCT03467971|Gliclazide|gliclazide|mesh-list
93198542|NCT03467971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198543|NCT03467971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198544|NCT03319498|Peppermint oil|peppermint oil|mesh-list
93198545|NCT03319498|Mineral Oil|mineral oil|mesh-list
93198546|NCT03319498|Antiemetics|antiemetics|mesh-ancestor
93198547|NCT03319498|Autonomic Agents|autonomic agents|mesh-ancestor
93198548|NCT03319498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198549|NCT03319498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198550|NCT03319498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198551|NCT03319498|Parasympatholytics|parasympatholytics|mesh-ancestor
93198552|NCT03319498|Emollients|emollients|mesh-ancestor
93198553|NCT03319498|Dermatologic Agents|dermatologic agents|mesh-ancestor
93198554|NCT03791099|Metronidazole|metronidazole|mesh-list
93198555|NCT03791099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198556|NCT03791099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93198557|NCT03791099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93198558|NCT03791099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93198559|NCT03185000|Immunomodulating Agents|immunomodulating agents|mesh-list
93198560|NCT03185000|Immunologic Factors|immunologic factors|mesh-ancestor
93198561|NCT03185000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198562|NCT03791255|Calcium, Dietary|calcium, dietary|mesh-list
93198563|NCT03791255|Calcium|calcium|mesh-list
93198564|NCT03791255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93198565|NCT03791255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198566|NCT03791255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93198567|NCT03742349|Spartalizumab|spartalizumab|mesh-list
93198568|NCT03742349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93198569|NCT03742349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198570|NCT03742349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198571|NCT03742349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198572|NCT03319420|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93198573|NCT03319420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93198574|NCT03794297|Trametinib|trametinib|mesh-list
93198575|NCT03794297|Dabrafenib|dabrafenib|mesh-list
93198576|NCT03794297|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93198577|NCT03794297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198578|NCT03794297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93198579|NCT03794297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198580|NCT03794297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198581|NCT03794297|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93198582|NCT03794297|Protective Agents|protective agents|mesh-ancestor
93198583|NCT03794297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198584|NCT03794297|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93198585|NCT03794297|Antioxidants|antioxidants|mesh-ancestor
93198586|NCT03048500|Metformin|metformin|mesh-list
93198587|NCT03048500|Nivolumab|nivolumab|mesh-list
93198588|NCT03048500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198589|NCT03048500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198590|NCT03048500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198591|NCT03048500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198592|NCT03048500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93198593|NCT03048500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198594|NCT03790787|Empagliflozin|empagliflozin|mesh-list
93198595|NCT03790787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93198596|NCT03790787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198597|NCT03790787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198598|NCT03790787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198599|NCT01334268|Paclitaxel|paclitaxel|mesh-list
93198600|NCT01334268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93198601|NCT01334268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198602|NCT01334268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93198603|NCT01334268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93198604|NCT01334268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93198605|NCT01334268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198606|NCT04493398|Erythritol|erythritol|mesh-list
93198607|NCT04493398|Vasodilator Agents|vasodilator agents|mesh-ancestor
93198608|NCT00908076|Lubiprostone|lubiprostone|mesh-list
93198609|NCT00908076|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93198610|NCT00908076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198611|NCT00908076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198612|NCT01305317|Atorvastatin|atorvastatin|mesh-list
93198613|NCT01305317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93198614|NCT01305317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93198615|NCT01305317|Antimetabolites|antimetabolites|mesh-ancestor
93198616|NCT01305317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198617|NCT01305317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93198618|NCT01305317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93198619|NCT01305317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198620|NCT02613416|Denosumab|denosumab|mesh-list
93198621|NCT02613416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93198622|NCT02613416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198623|NCT03326050|Ciprofloxacin|ciprofloxacin|mesh-list
93198624|NCT03326050|Rifampin|rifampin|mesh-list
93198625|NCT03326050|Gemifloxacin|gemifloxacin|mesh-list
93198626|NCT03326050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93198627|NCT03326050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198628|NCT03326050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93198629|NCT03326050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93198630|NCT03326050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198631|NCT03326050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198632|NCT03326050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198633|NCT03326050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93198634|NCT03326050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93198635|NCT03326050|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93198636|NCT03326050|Antitubercular Agents|antitubercular agents|mesh-ancestor
93198637|NCT03326050|Leprostatic Agents|leprostatic agents|mesh-ancestor
93198638|NCT03326050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93198639|NCT03326050|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93198640|NCT03326050|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93198641|NCT03326050|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93198642|NCT03326050|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93198643|NCT03326050|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93198644|NCT03326050|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93198645|NCT01334424|Propofol|propofol|mesh-list
93198646|NCT01334424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93198647|NCT01334424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198648|NCT01334424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198649|NCT01334424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93198650|NCT01334424|Anesthetics, General|anesthetics, general|mesh-ancestor
93198651|NCT01334424|Anesthetics|anesthetics|mesh-ancestor
93198652|NCT05083637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93198653|NCT05664685|Bismuth|bismuth|mesh-list
93198654|NCT05664685|Antacids|antacids|mesh-ancestor
93198655|NCT05664685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198656|NCT05664685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198657|NCT03793517|Decitabine|decitabine|mesh-list
93198658|NCT03793517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93198659|NCT03793517|Antimetabolites|antimetabolites|mesh-ancestor
93198660|NCT03793517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198661|NCT03793517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198662|NCT03793517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198663|NCT02886702|Nicotinic Acids|nicotinic acids|mesh-list
93198664|NCT02886702|Tazarotene|tazarotene|mesh-list
93198665|NCT02886702|Dermatologic Agents|dermatologic agents|mesh-ancestor
93198666|NCT02886702|Keratolytic Agents|keratolytic agents|mesh-ancestor
93198667|NCT02886702|Vitamin B Complex|vitamin b complex|mesh-ancestor
93198668|NCT02886702|Vitamins|vitamins|mesh-ancestor
93198669|NCT02886702|Micronutrients|micronutrients|mesh-ancestor
93198670|NCT02886702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198671|NCT03498313|Estradiol|estradiol|mesh-list
93198672|NCT03498313|Progesterone|progesterone|mesh-list
93198673|NCT03498313|Estrogens|estrogens|mesh-ancestor
93198674|NCT03498313|Hormones|hormones|mesh-ancestor
93198675|NCT03498313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93198676|NCT03498313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198677|NCT03498313|Progestins|progestins|mesh-ancestor
93198678|NCT03721081|Lidocaine|lidocaine|mesh-list
93198679|NCT03721081|Anesthetics, Local|anesthetics, local|mesh-ancestor
93198680|NCT03721081|Anesthetics|anesthetics|mesh-ancestor
93198681|NCT03721081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198682|NCT03721081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198683|NCT03721081|Sensory System Agents|sensory system agents|mesh-ancestor
93198684|NCT03721081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198685|NCT03721081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93198686|NCT03721081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93198687|NCT03721081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93198688|NCT03721081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198689|NCT03721081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198690|NCT04493554|Vasopressins|vasopressins|mesh-list
93198691|NCT04493554|Arginine Vasopressin|arginine vasopressin|mesh-list
93198692|NCT04493554|Hemostatics|hemostatics|mesh-ancestor
93198693|NCT04493554|Coagulants|coagulants|mesh-ancestor
93198694|NCT04493554|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93198695|NCT04493554|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93198696|NCT04493554|Natriuretic Agents|natriuretic agents|mesh-ancestor
93198697|NCT04493554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870794|NCT04717700|Bortezomib|bortezomib|mesh-list
93198698|NCT02601014|Nivolumab|nivolumab|mesh-list
93198699|NCT02601014|Ipilimumab|ipilimumab|mesh-list
93198700|NCT02601014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198701|NCT02601014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198702|NCT02601014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93198703|NCT02601014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198704|NCT01307046|Losartan|losartan|mesh-list
93198705|NCT01307046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93198706|NCT01307046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93198707|NCT01307046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93198708|NCT01307046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93198709|NCT01307046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198710|NCT05419115|Furosemide|furosemide|mesh-list
93198711|NCT05419115|Diuretics|diuretics|mesh-ancestor
93198712|NCT05419115|Natriuretic Agents|natriuretic agents|mesh-ancestor
93198713|NCT05419115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198714|NCT05419115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93198715|NCT05419115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198716|NCT05419115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198717|NCT02490592|Fluorides|fluorides|mesh-list
93198718|NCT02490592|Cariostatic Agents|cariostatic agents|mesh-ancestor
93198719|NCT02490592|Protective Agents|protective agents|mesh-ancestor
93198720|NCT02490592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198721|NCT03075462|Apatinib|apatinib|mesh-list
93198722|NCT03075462|Fluzoparib|fluzoparib|mesh-list
93198723|NCT03075462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198724|NCT03075462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93198725|NCT03075462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198726|NCT03075462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198727|NCT03075462|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93198728|NCT01305395|Sirolimus|sirolimus|mesh-list
93198729|NCT01305395|Temsirolimus|temsirolimus|mesh-list
93198730|NCT01305395|MTOR Inhibitors|mtor inhibitors|mesh-list
93198731|NCT01305395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93198732|NCT01305395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198733|NCT01305395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93198734|NCT01305395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198735|NCT01305395|Antifungal Agents|antifungal agents|mesh-ancestor
93198736|NCT01305395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93198737|NCT01305395|Immunologic Factors|immunologic factors|mesh-ancestor
93198738|NCT01305395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198739|NCT01305395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93198740|NCT01305395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198741|NCT01305395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198742|NCT02886624|Grazoprevir|grazoprevir|mesh-list
93198743|NCT02886624|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93198744|NCT02886624|Antiviral Agents|antiviral agents|mesh-ancestor
93198745|NCT02886624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93198746|NCT02487316|Crizotinib|crizotinib|mesh-list
93198747|NCT02487316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198748|NCT02487316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93198749|NCT02487316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198750|NCT02487316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198751|NCT02490436|Cetuximab|cetuximab|mesh-list
93198752|NCT02490436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198753|NCT02490436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198754|NCT03318718|Rocuronium|rocuronium|mesh-list
93198755|NCT03318718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198756|NCT03318718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93198757|NCT03318718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93198758|NCT03318718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93198759|NCT03318718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198760|NCT03325348|Labetalol|labetalol|mesh-list
93198761|NCT03325348|Nifedipine|nifedipine|mesh-list
93198762|NCT03325348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93198763|NCT03325348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198764|NCT03325348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198765|NCT03325348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93198766|NCT03325348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198767|NCT03325348|Vasodilator Agents|vasodilator agents|mesh-ancestor
93198768|NCT03325348|Tocolytic Agents|tocolytic agents|mesh-ancestor
93198769|NCT03325348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93198770|NCT03325348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92870859|NCT04593680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198771|NCT03325348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93198772|NCT03325348|Adrenergic Agents|adrenergic agents|mesh-ancestor
93198773|NCT03325348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198774|NCT03325348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93198776|NCT03325348|Autonomic Agents|autonomic agents|mesh-ancestor
93198777|NCT03325348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198778|NCT03325348|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93198779|NCT03325348|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93198780|NCT03790163|Levobupivacaine|levobupivacaine|mesh-list
93198781|NCT03790163|Anesthetics, Local|anesthetics, local|mesh-ancestor
93198782|NCT03790163|Anesthetics|anesthetics|mesh-ancestor
93198783|NCT03790163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198784|NCT03790163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198785|NCT03790163|Sensory System Agents|sensory system agents|mesh-ancestor
93198786|NCT03790163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198787|NCT03325270|Ferrous fumarate|ferrous fumarate|mesh-list
93198788|NCT03325270|Trace Elements|trace elements|mesh-ancestor
93198789|NCT03325270|Micronutrients|micronutrients|mesh-ancestor
93198790|NCT03325270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198791|NCT02963766|Dulaglutide|dulaglutide|mesh-list
93198792|NCT02963766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93198793|NCT02963766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198794|NCT01334502|Prednisone|prednisone|mesh-list
93198795|NCT01334502|Cyclophosphamide|cyclophosphamide|mesh-list
93198796|NCT01334502|Rituximab|rituximab|mesh-list
93198797|NCT01334502|Doxorubicin|doxorubicin|mesh-list
93198798|NCT01334502|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93198799|NCT01334502|Vincristine|vincristine|mesh-list
93198800|NCT01334502|Everolimus|everolimus|mesh-list
93198801|NCT01334502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93198802|NCT01334502|Immunologic Factors|immunologic factors|mesh-ancestor
93198803|NCT01334502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198804|NCT01334502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198805|NCT01334502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93198806|NCT01334502|Alkylating Agents|alkylating agents|mesh-ancestor
93198807|NCT01334502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198808|NCT01334502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198809|NCT01334502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93198810|NCT01334502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93198811|NCT01334502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93198812|NCT01334502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93198813|NCT01334502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93198814|NCT01334502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198815|NCT01334502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198816|NCT01334502|Glucocorticoids|glucocorticoids|mesh-ancestor
93198817|NCT01334502|Hormones|hormones|mesh-ancestor
93198818|NCT01334502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93198819|NCT01334502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93198820|NCT01334502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93198821|NCT01334502|Tubulin Modulators|tubulin modulators|mesh-ancestor
93198822|NCT01334502|Antimitotic Agents|antimitotic agents|mesh-ancestor
93198823|NCT01334502|Mitosis Modulators|mitosis modulators|mesh-ancestor
93198824|NCT01334502|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93198825|NCT01334502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93198826|NCT02487082|Melatonin|melatonin|mesh-list
93198827|NCT02487082|Donepezil|donepezil|mesh-list
93198828|NCT02487082|Antioxidants|antioxidants|mesh-ancestor
93198829|NCT02487082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198830|NCT02487082|Protective Agents|protective agents|mesh-ancestor
93198831|NCT02487082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198832|NCT02487082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198833|NCT02487082|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93198834|NCT02487082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198835|NCT02487082|Cholinergic Agents|cholinergic agents|mesh-ancestor
93198836|NCT02487082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198837|NCT02487082|Nootropic Agents|nootropic agents|mesh-ancestor
93198838|NCT03788681|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93198839|NCT03788681|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93198840|NCT03788681|Estradiol|estradiol|mesh-list
93198841|NCT03788681|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93198842|NCT03788681|Estrogens|estrogens|mesh-ancestor
93198843|NCT03788681|Hormones|hormones|mesh-ancestor
93198844|NCT03788681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870937|NCT00680433|Anesthetics|anesthetics|mesh-ancestor
93198845|NCT03788681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198846|NCT03788681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93198847|NCT03788681|Contraceptive Agents|contraceptive agents|mesh-ancestor
93198848|NCT03788681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93198849|NCT03788681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93198850|NCT01308203|Niacin|niacin|mesh-list
93198851|NCT01308203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93198852|NCT01308203|Antimetabolites|antimetabolites|mesh-ancestor
93198853|NCT01308203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198854|NCT01308203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93198855|NCT01308203|Vasodilator Agents|vasodilator agents|mesh-ancestor
93198856|NCT01308203|Vitamin B Complex|vitamin b complex|mesh-ancestor
93198857|NCT01308203|Vitamins|vitamins|mesh-ancestor
93198858|NCT01308203|Micronutrients|micronutrients|mesh-ancestor
93198859|NCT01308203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198860|NCT03790085|Olanzapine|olanzapine|mesh-list
93198861|NCT03790085|Risperidone|risperidone|mesh-list
93198862|NCT03790085|Aripiprazole|aripiprazole|mesh-list
93198863|NCT03790085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93198864|NCT03790085|Serotonin Agents|serotonin agents|mesh-ancestor
93198865|NCT03790085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93198866|NCT03790085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198867|NCT03790085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198868|NCT03790085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93198869|NCT03790085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93198870|NCT03790085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198871|NCT03790085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93198872|NCT03790085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93198873|NCT03790085|Dopamine Agents|dopamine agents|mesh-ancestor
93198874|NCT03790085|Antiemetics|antiemetics|mesh-ancestor
93198875|NCT03790085|Autonomic Agents|autonomic agents|mesh-ancestor
93198876|NCT03790085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198877|NCT03790085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198878|NCT03790085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93198879|NCT03790085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93198880|NCT03790085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198881|NCT03790085|Antidepressive Agents|antidepressive agents|mesh-ancestor
93198882|NCT03790085|Dopamine Agonists|dopamine agonists|mesh-ancestor
93198883|NCT03790085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93198884|NCT03790085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93198885|NCT03790085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93198886|NCT03790085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93198887|NCT01306097|Zinc|zinc|mesh-list
93198888|NCT01306097|Zinc Sulfate|zinc sulfate|mesh-list
93198889|NCT01306097|Trace Elements|trace elements|mesh-ancestor
93198890|NCT01306097|Micronutrients|micronutrients|mesh-ancestor
93198891|NCT01306097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198892|NCT01306097|Astringents|astringents|mesh-ancestor
93198893|NCT01306097|Dermatologic Agents|dermatologic agents|mesh-ancestor
93198894|NCT03790007|Bupivacaine|bupivacaine|mesh-list
93198895|NCT03790007|Anesthetics, Local|anesthetics, local|mesh-ancestor
93198896|NCT03790007|Anesthetics|anesthetics|mesh-ancestor
93198897|NCT03790007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198898|NCT03790007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198899|NCT03790007|Sensory System Agents|sensory system agents|mesh-ancestor
93198900|NCT03790007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198901|NCT03789695|Dabigatran|dabigatran|mesh-list
93198902|NCT03789695|Antithrombins|antithrombins|mesh-ancestor
93198903|NCT03789695|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93198904|NCT03789695|Protease Inhibitors|protease inhibitors|mesh-ancestor
93198905|NCT03789695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198906|NCT03789695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198907|NCT03789695|Anticoagulants|anticoagulants|mesh-ancestor
93198908|NCT00739674|Losartan|losartan|mesh-list
93198909|NCT00739674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93198910|NCT00739674|Calcium Channel Blockers|calcium channel blockers|mesh-list
93198911|NCT00739674|Calcium|calcium|mesh-list
93198912|NCT00739674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93198913|NCT00739674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198914|NCT00739674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93198915|NCT00739674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93198916|NCT00739674|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93198917|NCT00739674|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93198918|NCT00739674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198919|NCT00739674|Diuretics|diuretics|mesh-ancestor
93198920|NCT00739674|Natriuretic Agents|natriuretic agents|mesh-ancestor
92871005|NCT05345132|Tocolytic Agents|tocolytic agents|mesh-ancestor
93198921|NCT00739674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93198922|NCT00739674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198923|NCT01306409|Darbepoetin alfa|darbepoetin alfa|mesh-list
93198924|NCT01306409|Hematinics|hematinics|mesh-ancestor
93198925|NCT01331928|Docetaxel|docetaxel|mesh-list
93198926|NCT01331928|Capecitabine|capecitabine|mesh-list
93198927|NCT01331928|Oxaliplatin|oxaliplatin|mesh-list
93198928|NCT01331928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93198929|NCT01331928|Tubulin Modulators|tubulin modulators|mesh-ancestor
93198930|NCT01331928|Antimitotic Agents|antimitotic agents|mesh-ancestor
93198931|NCT01331928|Mitosis Modulators|mitosis modulators|mesh-ancestor
93198932|NCT01331928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198933|NCT01331928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93198934|NCT01331928|Antimetabolites|antimetabolites|mesh-ancestor
93198935|NCT01334580|Methadone|methadone|mesh-list
93198936|NCT01334580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93198937|NCT01334580|Narcotics|narcotics|mesh-ancestor
93198938|NCT01334580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93198939|NCT01334580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198940|NCT01334580|Analgesics|analgesics|mesh-ancestor
93198941|NCT01334580|Sensory System Agents|sensory system agents|mesh-ancestor
93198942|NCT01334580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198943|NCT01334580|Antitussive Agents|antitussive agents|mesh-ancestor
93198944|NCT01334580|Respiratory System Agents|respiratory system agents|mesh-ancestor
93198945|NCT02694588|Infliximab|infliximab|mesh-list
93198946|NCT02694588|Vedolizumab|vedolizumab|mesh-list
93198947|NCT02694588|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93198948|NCT02694588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198949|NCT02694588|Dermatologic Agents|dermatologic agents|mesh-ancestor
93198950|NCT02694588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93198951|NCT02694588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198952|NCT03789539|Vaccines|vaccines|mesh-list
93198953|NCT03789539|Immunologic Factors|immunologic factors|mesh-ancestor
93198954|NCT03789539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198955|NCT00400218|Losartan|losartan|mesh-list
93198956|NCT00400218|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93198957|NCT00400218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93198958|NCT00400218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93198959|NCT00400218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93198960|NCT00400218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93198961|NCT00400218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198962|NCT00400218|Diuretics|diuretics|mesh-ancestor
93198963|NCT00400218|Natriuretic Agents|natriuretic agents|mesh-ancestor
93198964|NCT00400218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198965|NCT00400218|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93198966|NCT00400218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93198967|NCT02486848|Minoxidil|minoxidil|mesh-list
93198968|NCT02486848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93198969|NCT02486848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93198970|NCT02486848|Vasodilator Agents|vasodilator agents|mesh-ancestor
93198971|NCT01306565|Atorvastatin|atorvastatin|mesh-list
93198972|NCT01306565|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93198973|NCT01306565|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93198974|NCT01306565|Antimetabolites|antimetabolites|mesh-ancestor
93198975|NCT01306565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494792|NCT01978405|Vitamins|vitamins|mesh-ancestor
93198976|NCT01306565|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93198977|NCT01306565|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93198978|NCT01306565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198979|NCT03716791|Dimethyl sulfone|dimethyl sulfone|mesh-list
93198980|NCT03716791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198981|NCT03786029|Acetaminophen|acetaminophen|mesh-list
93198982|NCT03786029|Ibuprofen|ibuprofen|mesh-list
93198983|NCT03786029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93198984|NCT03786029|Analgesics|analgesics|mesh-ancestor
93198985|NCT03786029|Sensory System Agents|sensory system agents|mesh-ancestor
93198986|NCT03786029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93198987|NCT03786029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93198988|NCT03786029|Antipyretics|antipyretics|mesh-ancestor
93198989|NCT03786029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93198990|NCT03786029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93198991|NCT03786029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93198992|NCT03786029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93198993|NCT03786029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198994|NCT03786029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198995|NCT01334892|Cyclosporine|cyclosporine|mesh-list
93198996|NCT01334892|Cyclosporins|cyclosporins|mesh-list
93198997|NCT01334892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93198998|NCT01334892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93198999|NCT01334892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199000|NCT01334892|Immunologic Factors|immunologic factors|mesh-ancestor
93199001|NCT01334892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199002|NCT01334892|Antifungal Agents|antifungal agents|mesh-ancestor
93199003|NCT01334892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199004|NCT01334892|Dermatologic Agents|dermatologic agents|mesh-ancestor
93199005|NCT01334892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199006|NCT01334892|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93199007|NCT04730219|Paclitaxel|paclitaxel|mesh-list
93199008|NCT04730219|Tislelizumab|tislelizumab|mesh-list
93199009|NCT04730219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93199010|NCT04730219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199011|NCT04730219|Tubulin Modulators|tubulin modulators|mesh-ancestor
93199012|NCT04730219|Antimitotic Agents|antimitotic agents|mesh-ancestor
93199013|NCT04730219|Mitosis Modulators|mitosis modulators|mesh-ancestor
93199014|NCT04730219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199015|NCT04730219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199016|NCT04492774|Dexamethasone|dexamethasone|mesh-list
93199017|NCT04492774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199018|NCT04492774|Antiemetics|antiemetics|mesh-ancestor
93199019|NCT04492774|Autonomic Agents|autonomic agents|mesh-ancestor
93199020|NCT04492774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199021|NCT04492774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199022|NCT04492774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93199023|NCT04492774|Glucocorticoids|glucocorticoids|mesh-ancestor
93199024|NCT04492774|Hormones|hormones|mesh-ancestor
93199025|NCT04492774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199026|NCT04492774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93199027|NCT04492774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199028|NCT03321292|Aspirin|aspirin|mesh-list
93199029|NCT03321292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93199030|NCT03321292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199031|NCT03321292|Analgesics|analgesics|mesh-ancestor
93199032|NCT03321292|Sensory System Agents|sensory system agents|mesh-ancestor
93199033|NCT03321292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199034|NCT03321292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199035|NCT03321292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199036|NCT03321292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199037|NCT03321292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93199038|NCT03321292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93199039|NCT03321292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199040|NCT03321292|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93199041|NCT03321292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93199042|NCT03321292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199043|NCT03321292|Antipyretics|antipyretics|mesh-ancestor
93199044|NCT01306721|Fexofenadine|fexofenadine|mesh-list
93199045|NCT01306721|Pseudoephedrine|pseudoephedrine|mesh-list
93199046|NCT01306721|Ephedrine|ephedrine|mesh-list
93199047|NCT01306721|Terfenadine|terfenadine|mesh-list
93199048|NCT01306721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93199049|NCT01306721|Autonomic Agents|autonomic agents|mesh-ancestor
93199050|NCT01306721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199051|NCT01306721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199052|NCT01306721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199053|NCT01306721|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199054|NCT01306721|Nasal Decongestants|nasal decongestants|mesh-ancestor
93199055|NCT01306721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93199056|NCT01306721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93199057|NCT01306721|Sympathomimetics|sympathomimetics|mesh-ancestor
93199058|NCT01306721|Adrenergic Agents|adrenergic agents|mesh-ancestor
93199059|NCT01306721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199060|NCT01306721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199061|NCT01306721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93199062|NCT01306721|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93199063|NCT01306721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93199064|NCT01306721|Histamine Antagonists|histamine antagonists|mesh-ancestor
93199065|NCT01306721|Histamine Agents|histamine agents|mesh-ancestor
93199066|NCT01337466|Fialuridine|fialuridine|mesh-list
93199067|NCT01337466|Antiviral Agents|antiviral agents|mesh-ancestor
93199068|NCT01337466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199069|NCT01337466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93199070|NCT01337466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199071|NCT01337466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199072|NCT02486926|Remifentanil|remifentanil|mesh-list
93199073|NCT02486926|Alfentanil|alfentanil|mesh-list
93199074|NCT02486926|Thiopental|thiopental|mesh-list
93199075|NCT02486926|Sevoflurane|sevoflurane|mesh-list
93199076|NCT02486926|Rocuronium|rocuronium|mesh-list
93199077|NCT02486926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93199078|NCT02486926|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93199079|NCT02486926|Anesthetics, General|anesthetics, general|mesh-ancestor
93199080|NCT02486926|Anesthetics|anesthetics|mesh-ancestor
93199081|NCT02486926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199082|NCT02486926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199083|NCT02486926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93199084|NCT02486926|Narcotics|narcotics|mesh-ancestor
93199085|NCT02486926|Analgesics|analgesics|mesh-ancestor
93199086|NCT02486926|Sensory System Agents|sensory system agents|mesh-ancestor
93199087|NCT02486926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199088|NCT02486926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93199089|NCT02486926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93199090|NCT02486926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93199091|NCT02486926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93199092|NCT02486926|Anticonvulsants|anticonvulsants|mesh-ancestor
93199093|NCT02486926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93199094|NCT02486926|GABA Modulators|gaba modulators|mesh-ancestor
93199095|NCT02486926|GABA Agents|gaba agents|mesh-ancestor
93199096|NCT02486926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199097|NCT02486926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199098|NCT01335048|Clopidogrel|clopidogrel|mesh-list
93199099|NCT01335048|Atorvastatin|atorvastatin|mesh-list
93199100|NCT01335048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93199101|NCT01335048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93199102|NCT01335048|Antimetabolites|antimetabolites|mesh-ancestor
93199103|NCT01335048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199104|NCT01335048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93199105|NCT01335048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93199106|NCT01335048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199107|NCT01335048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93199108|NCT01335048|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93199109|NCT01335048|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93199110|NCT01335048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93199111|NCT01335048|Purinergic Agents|purinergic agents|mesh-ancestor
93199112|NCT01335048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199113|NCT01335048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199114|NCT01335126|Lubricant Eye Drops|lubricant eye drops|mesh-list
93199115|NCT01335126|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93199116|NCT01335126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93199117|NCT01567475|Rituximab|rituximab|mesh-list
93199118|NCT01567475|Everolimus|everolimus|mesh-list
93199119|NCT01567475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199120|NCT01567475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199121|NCT01567475|Immunologic Factors|immunologic factors|mesh-ancestor
93199122|NCT01567475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199123|NCT01567475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199124|NCT01567475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93199125|NCT01567475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93199126|NCT01567475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199127|NCT01567475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199128|NCT01567475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199129|NCT03435055|Nitrous Oxide|nitrous oxide|mesh-list
93199130|NCT03435055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93199131|NCT03435055|Anesthetics, General|anesthetics, general|mesh-ancestor
93199132|NCT03435055|Anesthetics|anesthetics|mesh-ancestor
93199133|NCT03435055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199134|NCT03435055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199135|NCT03435055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199136|NCT03435055|Analgesics|analgesics|mesh-ancestor
93199137|NCT03435055|Sensory System Agents|sensory system agents|mesh-ancestor
93199138|NCT03435055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199139|NCT05693246|Glycopyrrolate|glycopyrrolate|mesh-list
93199140|NCT05693246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93199141|NCT05693246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93199142|NCT05693246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93199143|NCT05693246|Cholinergic Agents|cholinergic agents|mesh-ancestor
93199144|NCT05693246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199145|NCT05693246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199146|NCT05693246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199147|NCT03316066|Ropivacaine|ropivacaine|mesh-list
93199148|NCT03316066|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199149|NCT03316066|Anesthetics|anesthetics|mesh-ancestor
93199150|NCT03316066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199151|NCT03316066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199152|NCT03316066|Sensory System Agents|sensory system agents|mesh-ancestor
93199153|NCT03316066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199154|NCT03318016|Cyclophosphamide|cyclophosphamide|mesh-list
93199155|NCT03318016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199156|NCT03318016|Immunologic Factors|immunologic factors|mesh-ancestor
93199157|NCT03318016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199158|NCT03318016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199159|NCT03318016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199160|NCT03318016|Alkylating Agents|alkylating agents|mesh-ancestor
93199161|NCT03318016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199162|NCT03318016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199163|NCT03318016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93199164|NCT03434977|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93199165|NCT03434977|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93199166|NCT03434977|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93199167|NCT03434977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199168|NCT01335360|Nevirapine|nevirapine|mesh-list
93199169|NCT01335360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93199170|NCT01335360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93199171|NCT01335360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199172|NCT01335360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199173|NCT01335360|Antiviral Agents|antiviral agents|mesh-ancestor
93199174|NCT01335360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199175|NCT01335360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93199176|NCT01335360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93199177|NCT01335360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93199178|NCT01335360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93199179|NCT02489266|Aldesleukin|aldesleukin|mesh-list
93199180|NCT02489266|Cyclophosphamide|cyclophosphamide|mesh-list
93199181|NCT02489266|Fludarabine|fludarabine|mesh-list
93199182|NCT02489266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199183|NCT02489266|Immunologic Factors|immunologic factors|mesh-ancestor
93199184|NCT02489266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199185|NCT02489266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199186|NCT02489266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199187|NCT02489266|Alkylating Agents|alkylating agents|mesh-ancestor
93199188|NCT02489266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199189|NCT02489266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199190|NCT02489266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93199191|NCT02489266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93199192|NCT02489266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93199193|NCT02489266|Antiviral Agents|antiviral agents|mesh-ancestor
93199194|NCT02489266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199195|NCT03434119|Insulin|insulin|mesh-list
93199196|NCT03434119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93199197|NCT03434119|Insulin Glargine|insulin glargine|mesh-list
93199198|NCT03434119|Lixisenatide|lixisenatide|mesh-list
93199199|NCT03434119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199200|NCT03434119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199201|NCT02484352|Oxycodone|oxycodone|mesh-list
93199202|NCT02484352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93199203|NCT02484352|Narcotics|narcotics|mesh-ancestor
93199204|NCT02484352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199205|NCT02484352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199206|NCT02484352|Analgesics|analgesics|mesh-ancestor
93199207|NCT02484352|Sensory System Agents|sensory system agents|mesh-ancestor
93199208|NCT02484352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199209|NCT01308671|Varenicline|varenicline|mesh-list
93199210|NCT01308671|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93199211|NCT01308671|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93199212|NCT01308671|Cholinergic Agents|cholinergic agents|mesh-ancestor
93199213|NCT01308671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199214|NCT01308671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199215|NCT01308671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199216|NCT00378378|Mometasone Furoate|mometasone furoate|mesh-list
93199217|NCT00378378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199218|NCT00378378|Dermatologic Agents|dermatologic agents|mesh-ancestor
93199219|NCT00378378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93199220|NCT03315676|Esomeprazole|esomeprazole|mesh-list
93199221|NCT03315676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93199222|NCT03315676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93199223|NCT03315676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93199224|NCT03315676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199225|NCT03315676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199226|NCT01307189|Tiotropium Bromide|tiotropium bromide|mesh-list
93199227|NCT01307189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93199228|NCT01307189|Autonomic Agents|autonomic agents|mesh-ancestor
93199229|NCT01307189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199230|NCT01307189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199231|NCT01307189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199232|NCT01307189|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199233|NCT01307189|Parasympatholytics|parasympatholytics|mesh-ancestor
93199234|NCT01307189|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93199235|NCT01307189|Cholinergic Agents|cholinergic agents|mesh-ancestor
93199236|NCT01307189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199237|NCT01307189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199238|NCT02486458|Listerine|listerine|mesh-list
93199239|NCT02486458|Fluorides|fluorides|mesh-list
93199240|NCT02486458|Sodium Fluoride|sodium fluoride|mesh-list
93199241|NCT02486458|Fluorides, Topical|fluorides, topical|mesh-list
93199242|NCT02486458|Cariostatic Agents|cariostatic agents|mesh-ancestor
93199243|NCT02486458|Protective Agents|protective agents|mesh-ancestor
93199244|NCT02486458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199245|NCT02486458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93199246|NCT02486458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199247|NCT01335516|Terlipressin|terlipressin|mesh-list
93199248|NCT01335516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93199249|NCT01335516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93199250|NCT05694923|Empagliflozin|empagliflozin|mesh-list
93199251|NCT05694923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93199252|NCT05694923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199253|NCT05694923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199254|NCT05694923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199255|NCT01332396|Lapatinib|lapatinib|mesh-list
93199256|NCT01332396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199257|NCT01332396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93199258|NCT01332396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199259|NCT01332396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199260|NCT03719053|Tenofovir|tenofovir|mesh-list
93199261|NCT03719053|Antiviral Agents|antiviral agents|mesh-ancestor
93199262|NCT03719053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199263|NCT03719053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93199264|NCT03719053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93199265|NCT03719053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199266|NCT03719053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199267|NCT03719053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93199268|NCT03719053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93199269|NCT03526848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93199270|NCT03526848|Antibodies|antibodies|mesh-list
93199271|NCT03526848|Immunoglobulins|immunoglobulins|mesh-list
93199272|NCT03526848|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93199273|NCT03526848|Immunologic Factors|immunologic factors|mesh-ancestor
93199274|NCT03526848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199275|NCT03526848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199276|NCT03321136|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93199277|NCT03321136|Hallucinogens|hallucinogens|mesh-ancestor
93199278|NCT03321136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199279|NCT03321136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93199280|NCT03321136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93199281|NCT03321136|Serotonin Agents|serotonin agents|mesh-ancestor
93199282|NCT03321136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199283|NCT03321136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199284|NCT03321136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93199285|NCT01332552|Ritonavir|ritonavir|mesh-list
93199286|NCT01332552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93199287|NCT01332552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93199288|NCT01332552|Protease Inhibitors|protease inhibitors|mesh-ancestor
93199289|NCT01332552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199290|NCT01332552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199291|NCT01332552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93199292|NCT01332552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93199293|NCT01332552|Antiviral Agents|antiviral agents|mesh-ancestor
93199294|NCT01332552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199295|NCT01332552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93199296|NCT01332552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93199297|NCT03720223|Bupivacaine|bupivacaine|mesh-list
93199298|NCT03720223|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199300|NCT03720223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199301|NCT03720223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199302|NCT03720223|Sensory System Agents|sensory system agents|mesh-ancestor
93199303|NCT03720223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199304|NCT03160716|Lidocaine|lidocaine|mesh-list
93199305|NCT03160716|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199306|NCT03160716|Anesthetics|anesthetics|mesh-ancestor
93199307|NCT03160716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199308|NCT03160716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199309|NCT03160716|Sensory System Agents|sensory system agents|mesh-ancestor
93199310|NCT03160716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199311|NCT03160716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93199312|NCT03160716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93199313|NCT03160716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93199314|NCT03160716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93199315|NCT03160716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199316|NCT00092664|Simvastatin|simvastatin|mesh-list
93199317|NCT00092664|Ezetimibe|ezetimibe|mesh-list
93199318|NCT00092664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93199319|NCT00092664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93199320|NCT00092664|Antimetabolites|antimetabolites|mesh-ancestor
93199321|NCT00092664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199322|NCT00092664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93199323|NCT00092664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93199324|NCT00092664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199325|NCT02483884|Bombesin|bombesin|mesh-list
93199326|NCT02483884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199327|NCT02483884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199328|NCT02483884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199329|NCT03317548|Progesterone|progesterone|mesh-list
93199330|NCT03317548|Progestins|progestins|mesh-ancestor
93199331|NCT03317548|Hormones|hormones|mesh-ancestor
93199332|NCT03317548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199333|NCT03317548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199334|NCT00092586|Ezetimibe|ezetimibe|mesh-list
93199335|NCT00092586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93199336|NCT00092586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93199337|NCT00092586|Antimetabolites|antimetabolites|mesh-ancestor
93199338|NCT00092586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199339|NCT00092586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93199340|NCT03786887|Nalbuphine|nalbuphine|mesh-list
93199341|NCT03786887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93199342|NCT03786887|Narcotics|narcotics|mesh-ancestor
93199343|NCT03786887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199344|NCT03786887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199345|NCT03786887|Analgesics|analgesics|mesh-ancestor
93199346|NCT03786887|Sensory System Agents|sensory system agents|mesh-ancestor
93199347|NCT03786887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199348|NCT03787043|Metformin|metformin|mesh-list
93199349|NCT03787043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199350|NCT03787043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199351|NCT00090168|Atorvastatin|atorvastatin|mesh-list
93199352|NCT00090168|Simvastatin|simvastatin|mesh-list
93199353|NCT00090168|Ezetimibe|ezetimibe|mesh-list
93199354|NCT00090168|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93199355|NCT00090168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93199356|NCT00090168|Antimetabolites|antimetabolites|mesh-ancestor
93199357|NCT00090168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199358|NCT00090168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93199359|NCT00090168|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93199360|NCT00090168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199361|NCT01332786|Tigecycline|tigecycline|mesh-list
93199362|NCT01332786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199363|NCT01332786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199364|NCT01332786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93199365|NCT01332786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199366|NCT01332786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199367|NCT01338090|Bevacizumab|bevacizumab|mesh-list
93199368|NCT01338090|Everolimus|everolimus|mesh-list
93199369|NCT01338090|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
93199370|NCT01338090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199371|NCT01338090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199372|NCT01338090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93199373|NCT01338090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93199374|NCT01338090|Growth Substances|growth substances|mesh-ancestor
93199375|NCT01338090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199376|NCT01338090|Growth Inhibitors|growth inhibitors|mesh-ancestor
93199377|NCT01338090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93199378|NCT01338090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93199379|NCT01338090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199380|NCT01338090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199381|NCT01338090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199382|NCT01338090|Immunologic Factors|immunologic factors|mesh-ancestor
93199383|NCT01338090|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93199384|NCT01307969|Lidocaine|lidocaine|mesh-list
93199385|NCT01307969|Epinephrine|epinephrine|mesh-list
93199386|NCT01307969|Racepinephrine|racepinephrine|mesh-list
93199387|NCT01307969|Ropivacaine|ropivacaine|mesh-list
93199388|NCT01307969|Epinephryl borate|epinephryl borate|mesh-list
93199389|NCT01307969|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199390|NCT01307969|Anesthetics|anesthetics|mesh-ancestor
93199391|NCT01307969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199392|NCT01307969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199393|NCT01307969|Sensory System Agents|sensory system agents|mesh-ancestor
93199394|NCT01307969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199395|NCT01307969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93199396|NCT01307969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93199397|NCT01307969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93199398|NCT01307969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93199399|NCT01307969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199400|NCT01307969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93199401|NCT01307969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93199402|NCT01307969|Adrenergic Agents|adrenergic agents|mesh-ancestor
93199403|NCT01307969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199404|NCT01307969|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93199405|NCT01307969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93199406|NCT01307969|Autonomic Agents|autonomic agents|mesh-ancestor
93199407|NCT01307969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199408|NCT01307969|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199409|NCT01307969|Mydriatics|mydriatics|mesh-ancestor
93199410|NCT01307969|Sympathomimetics|sympathomimetics|mesh-ancestor
93199411|NCT01307969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93199412|NCT03786419|Atezolizumab|atezolizumab|mesh-list
93199413|NCT03786419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93199414|NCT03786419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199415|NCT03786419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199416|NCT03786419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199417|NCT01338324|Simvastatin|simvastatin|mesh-list
93199418|NCT01338324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93199419|NCT01338324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93199420|NCT01338324|Antimetabolites|antimetabolites|mesh-ancestor
93199421|NCT01338324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199422|NCT01338324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93199423|NCT01338324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93199424|NCT01338324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199425|NCT01336062|Paclitaxel|paclitaxel|mesh-list
93199426|NCT01336062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93199427|NCT01336062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93199428|NCT01336062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199429|NCT01336062|Tubulin Modulators|tubulin modulators|mesh-ancestor
93199430|NCT01336062|Antimitotic Agents|antimitotic agents|mesh-ancestor
93199431|NCT01336062|Mitosis Modulators|mitosis modulators|mesh-ancestor
93199432|NCT01336062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199433|NCT05694221|Metformin|metformin|mesh-list
93199434|NCT05694221|Digoxin|digoxin|mesh-list
93199435|NCT05694221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199436|NCT05694221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199437|NCT05694221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93199438|NCT05694221|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93199439|NCT05694221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199440|NCT05694221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199441|NCT05694221|Protective Agents|protective agents|mesh-ancestor
93199442|NCT01308047|Bupivacaine|bupivacaine|mesh-list
93199443|NCT01308047|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199444|NCT01308047|Anesthetics|anesthetics|mesh-ancestor
93199445|NCT01308047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199446|NCT01308047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871537|NCT02698748|Filaricides|filaricides|mesh-ancestor
93199447|NCT01308047|Sensory System Agents|sensory system agents|mesh-ancestor
92855751|NCT00905047|Vitamins|vitamins|mesh-ancestor
93199448|NCT01308047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199450|NCT03777605|Vasodilator Agents|vasodilator agents|mesh-ancestor
93199451|NCT03777761|Moxifloxacin|moxifloxacin|mesh-list
93199452|NCT03777761|Tucatinib|tucatinib|mesh-list
93199453|NCT03777761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199454|NCT03777761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199455|NCT03777761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93199456|NCT03777761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93199457|NCT03777761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199458|NCT03777761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199459|NCT03777761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199460|NCT03777761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93199461|NCT01316861|Acarbose|acarbose|mesh-list
93199462|NCT01316861|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93199463|NCT01316861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199464|NCT01316861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199465|NCT01316861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199466|NCT01316861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199467|NCT01336218|Rifampin|rifampin|mesh-list
93199468|NCT01336218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93199469|NCT01336218|Antitubercular Agents|antitubercular agents|mesh-ancestor
93199470|NCT01336218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199471|NCT01336218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199472|NCT01336218|Leprostatic Agents|leprostatic agents|mesh-ancestor
93199473|NCT01336218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93199474|NCT01336218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199475|NCT01336218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199476|NCT01336218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93199477|NCT01336218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93199478|NCT01336218|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93199479|NCT01336218|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93199480|NCT01336218|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93199481|NCT01336218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93199482|NCT05029115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93199483|NCT05029115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199484|NCT05029115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199485|NCT05029115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199486|NCT03776279|Mitoxantrone|mitoxantrone|mesh-list
93199487|NCT03776279|Analgesics|analgesics|mesh-ancestor
93199488|NCT03776279|Sensory System Agents|sensory system agents|mesh-ancestor
93199489|NCT03776279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199490|NCT03776279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199491|NCT03776279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199492|NCT03776279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93199493|NCT03776279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93199494|NCT03776279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199495|NCT03776279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199496|NCT01561391|Factor VIII|factor viii|mesh-list
93199497|NCT01561391|Coagulants|coagulants|mesh-ancestor
93199498|NCT03775655|Dexmedetomidine|dexmedetomidine|mesh-list
93199499|NCT03775655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93199500|NCT03775655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199501|NCT03775655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199502|NCT03775655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199503|NCT03775655|Analgesics|analgesics|mesh-ancestor
93199504|NCT03775655|Sensory System Agents|sensory system agents|mesh-ancestor
93199505|NCT03775655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199506|NCT03775655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93199507|NCT03775655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93199508|NCT03775655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93199509|NCT03775655|Adrenergic Agents|adrenergic agents|mesh-ancestor
93199510|NCT03775655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199511|NCT03775655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199512|NCT01310465|Zoledronic Acid|zoledronic acid|mesh-list
93199513|NCT01310465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93199514|NCT01310465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199515|NCT03781895|Cholecalciferol|cholecalciferol|mesh-list
93199516|NCT03781895|Vitamin D|vitamin d|mesh-list
93199517|NCT03781895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92871613|NCT02705768|Carbamazepine|carbamazepine|mesh-list
93199518|NCT03781895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199520|NCT03781895|Micronutrients|micronutrients|mesh-ancestor
93199521|NCT03781895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93199522|NCT00706030|Vinorelbine|vinorelbine|mesh-list
93199523|NCT00706030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93199524|NCT00706030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199525|NCT00706030|Tubulin Modulators|tubulin modulators|mesh-ancestor
93199526|NCT00706030|Antimitotic Agents|antimitotic agents|mesh-ancestor
93199527|NCT00706030|Mitosis Modulators|mitosis modulators|mesh-ancestor
93199528|NCT00706030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199529|NCT03781505|Acetaminophen|acetaminophen|mesh-list
93199530|NCT03781505|Ropivacaine|ropivacaine|mesh-list
93199531|NCT03781505|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199532|NCT03781505|Anesthetics|anesthetics|mesh-ancestor
93199533|NCT03781505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199534|NCT03781505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199535|NCT03781505|Sensory System Agents|sensory system agents|mesh-ancestor
93199536|NCT03781505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199537|NCT03781505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199538|NCT03781505|Analgesics|analgesics|mesh-ancestor
93199539|NCT03781505|Antipyretics|antipyretics|mesh-ancestor
93199540|NCT03781115|Olanzapine|olanzapine|mesh-list
93199541|NCT03781115|Ziprasidone|ziprasidone|mesh-list
93199542|NCT03781115|Antiemetics|antiemetics|mesh-ancestor
93199543|NCT03781115|Autonomic Agents|autonomic agents|mesh-ancestor
93199544|NCT03781115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199545|NCT03781115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199546|NCT03781115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93199547|NCT03781115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93199548|NCT03781115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93199549|NCT03781115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199550|NCT03781115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93199551|NCT03781115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93199552|NCT03781115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93199553|NCT03781115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93199554|NCT03781115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199555|NCT03781115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199556|NCT03781115|Serotonin Agents|serotonin agents|mesh-ancestor
93199557|NCT03781115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93199558|NCT03781115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93199559|NCT03781115|Dopamine Agents|dopamine agents|mesh-ancestor
93199560|NCT03317236|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93199561|NCT03317236|Antidepressive Agents|antidepressive agents|mesh-ancestor
93199562|NCT03317236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93199563|NCT03317236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93199564|NCT03317236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93199565|NCT03317236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199566|NCT03317236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199567|NCT01313429|Celecoxib|celecoxib|mesh-list
93199568|NCT01313429|Cyclophosphamide|cyclophosphamide|mesh-list
93199569|NCT01313429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199570|NCT01313429|Immunologic Factors|immunologic factors|mesh-ancestor
93199571|NCT01313429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199572|NCT01313429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199573|NCT01313429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199574|NCT01313429|Alkylating Agents|alkylating agents|mesh-ancestor
93199575|NCT01313429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199576|NCT01313429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199577|NCT01313429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93199578|NCT01313429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93199579|NCT01313429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199580|NCT01313429|Analgesics|analgesics|mesh-ancestor
93199581|NCT01313429|Sensory System Agents|sensory system agents|mesh-ancestor
93199582|NCT01313429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199583|NCT01313429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199584|NCT01313429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93199585|NCT01313429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93199586|NCT01313429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199587|NCT03488251|Gemcitabine|gemcitabine|mesh-list
93199588|NCT03488251|Oxaliplatin|oxaliplatin|mesh-list
93199589|NCT03488251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871689|NCT00906035|Aspirin|aspirin|mesh-list
93199590|NCT03488251|Antimetabolites|antimetabolites|mesh-ancestor
93199591|NCT03488251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199593|NCT02727322|Nitrofurantoin|nitrofurantoin|mesh-list
93199594|NCT02727322|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93199595|NCT02727322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199596|NCT02727322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199597|NCT03315520|Cytarabine|cytarabine|mesh-list
93199598|NCT03315520|Cyclophosphamide|cyclophosphamide|mesh-list
93199599|NCT03315520|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93199600|NCT03315520|Etoposide|etoposide|mesh-list
93199601|NCT03315520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199602|NCT03315520|Immunologic Factors|immunologic factors|mesh-ancestor
93199603|NCT03315520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199604|NCT03315520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199605|NCT03315520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199606|NCT03315520|Alkylating Agents|alkylating agents|mesh-ancestor
93199607|NCT03315520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199608|NCT03315520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199609|NCT03315520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93199610|NCT03315520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93199611|NCT03315520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93199612|NCT03315520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93199613|NCT03315520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199614|NCT03315520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93199615|NCT03315520|Antimetabolites|antimetabolites|mesh-ancestor
93199616|NCT03315520|Antiviral Agents|antiviral agents|mesh-ancestor
93199617|NCT03315520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199618|NCT02483182|Acyclovir|acyclovir|mesh-list
93199619|NCT02483182|Antiviral Agents|antiviral agents|mesh-ancestor
93199620|NCT02483182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199621|NCT01338558|Bevacizumab|bevacizumab|mesh-list
93199622|NCT01338558|Cetuximab|cetuximab|mesh-list
93199623|NCT01338558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199624|NCT01338558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199625|NCT01338558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93199626|NCT01338558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93199627|NCT01338558|Growth Substances|growth substances|mesh-ancestor
93199628|NCT01338558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199629|NCT01338558|Growth Inhibitors|growth inhibitors|mesh-ancestor
93199630|NCT03780569|Temozolomide|temozolomide|mesh-list
93199631|NCT03780569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199632|NCT03780569|Alkylating Agents|alkylating agents|mesh-ancestor
93199633|NCT03780569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199634|NCT03780569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199635|NCT03487549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93199636|NCT03487549|Cantharidin|cantharidin|mesh-list
93199637|NCT03487549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199638|NCT03487549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199639|NCT01313585|Beclomethasone|beclomethasone|mesh-list
93199640|NCT01313585|Albuterol|albuterol|mesh-list
93199641|NCT01313585|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93199642|NCT01313585|Autonomic Agents|autonomic agents|mesh-ancestor
93199643|NCT01313585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199644|NCT01313585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199645|NCT01313585|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199646|NCT01313585|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199647|NCT01313585|Tocolytic Agents|tocolytic agents|mesh-ancestor
93199648|NCT01313585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93199649|NCT01313585|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93199650|NCT01313585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93199651|NCT01313585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93199652|NCT01313585|Adrenergic Agents|adrenergic agents|mesh-ancestor
93199653|NCT01313585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199654|NCT01313585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199655|NCT01313585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199656|NCT01313585|Glucocorticoids|glucocorticoids|mesh-ancestor
93199657|NCT01313585|Hormones|hormones|mesh-ancestor
93199658|NCT01313585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199659|NCT01561235|Hormones|hormones|mesh-list
93199660|NCT01561235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199661|NCT01561235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199662|NCT02485990|Olaparib|olaparib|mesh-list
93199663|NCT02485990|Tremelimumab|tremelimumab|mesh-list
93199664|NCT02485990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93199665|NCT02485990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199666|NCT02485990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199667|NCT02485990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199668|NCT01313819|Amantadine|amantadine|mesh-list
93199669|NCT01313819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93199670|NCT01313819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93199671|NCT01313819|Antiviral Agents|antiviral agents|mesh-ancestor
93199672|NCT01313819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199673|NCT01313819|Dopamine Agents|dopamine agents|mesh-ancestor
93199674|NCT01313819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199675|NCT01313819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199676|NCT01313819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199677|NCT01313819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199678|NCT01313819|Analgesics|analgesics|mesh-ancestor
93199679|NCT01313819|Sensory System Agents|sensory system agents|mesh-ancestor
93199680|NCT01313819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199681|NCT03315442|Caffeine|caffeine|mesh-list
93199682|NCT03315442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93199683|NCT03315442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199684|NCT03315442|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93199685|NCT03315442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199686|NCT03315442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199687|NCT03315442|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93199688|NCT03315442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93199689|NCT03315442|Purinergic Agents|purinergic agents|mesh-ancestor
93199690|NCT03315442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199691|NCT03464383|Escitalopram|escitalopram|mesh-list
93199692|NCT03464383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93199693|NCT03464383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93199694|NCT03464383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93199695|NCT03464383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199696|NCT03464383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199697|NCT03464383|Serotonin Agents|serotonin agents|mesh-ancestor
93199698|NCT03464383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199699|NCT03315364|Paclitaxel|paclitaxel|mesh-list
93199700|NCT03315364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93199701|NCT03315364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93199702|NCT03315364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199703|NCT03315364|Tubulin Modulators|tubulin modulators|mesh-ancestor
93199704|NCT03315364|Antimitotic Agents|antimitotic agents|mesh-ancestor
93199705|NCT03315364|Mitosis Modulators|mitosis modulators|mesh-ancestor
93199706|NCT03315364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199707|NCT03779633|Estradiol|estradiol|mesh-list
93199708|NCT03779633|Estrogens|estrogens|mesh-ancestor
93199709|NCT03779633|Hormones|hormones|mesh-ancestor
93199710|NCT03779633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199711|NCT03779633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199712|NCT03720067|Propranolol|propranolol|mesh-list
93199713|NCT03720067|Carvedilol|carvedilol|mesh-list
93199714|NCT03720067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93199715|NCT03720067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93199716|NCT03720067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93199717|NCT03720067|Antimetabolites|antimetabolites|mesh-ancestor
93199718|NCT03720067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199719|NCT03720067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93199720|NCT03720067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93199721|NCT03720067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199722|NCT03720067|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93199723|NCT03720067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93199724|NCT03720067|Adrenergic Agents|adrenergic agents|mesh-ancestor
93199725|NCT03720067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199726|NCT03720067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199727|NCT03720067|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93199728|NCT03720067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93199729|NCT03720067|Vasodilator Agents|vasodilator agents|mesh-ancestor
93199730|NCT03720067|Antioxidants|antioxidants|mesh-ancestor
93199731|NCT03720067|Protective Agents|protective agents|mesh-ancestor
93199732|NCT03720067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93199733|NCT03720067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93199734|NCT03720067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93199735|NCT03720067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93199736|NCT03720067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93199737|NCT01444092|Budesonide|budesonide|mesh-list
93199738|NCT01444092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199740|NCT01444092|Autonomic Agents|autonomic agents|mesh-ancestor
93199741|NCT01444092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199742|NCT01444092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199743|NCT01444092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199744|NCT01444092|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199745|NCT01444092|Glucocorticoids|glucocorticoids|mesh-ancestor
93199746|NCT01444092|Hormones|hormones|mesh-ancestor
93199747|NCT01444092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199748|NCT03719989|Azacitidine|azacitidine|mesh-list
93199749|NCT03719989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93199750|NCT03719989|Antimetabolites|antimetabolites|mesh-ancestor
93199751|NCT03719989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199752|NCT03719989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199753|NCT03719989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199754|NCT05462470|Liver Extracts|liver extracts|mesh-list
93199755|NCT05462470|Hematinics|hematinics|mesh-ancestor
93199756|NCT03779087|Amoxicillin|amoxicillin|mesh-list
93199757|NCT03779087|Levofloxacin|levofloxacin|mesh-list
93199758|NCT03779087|Ofloxacin|ofloxacin|mesh-list
93199759|NCT03779087|Tetracycline|tetracycline|mesh-list
93199760|NCT03779087|Esomeprazole|esomeprazole|mesh-list
93199761|NCT03779087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199762|NCT03779087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199763|NCT03779087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93199764|NCT03779087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93199765|NCT03779087|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93199766|NCT03779087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199767|NCT03779087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199768|NCT03779087|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93199769|NCT03779087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93199770|NCT03779087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93199771|NCT03779087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199772|NCT03779087|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93199773|NCT03779087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93199774|NCT03779087|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93199775|NCT01265784|Ertapenem|ertapenem|mesh-list
93199776|NCT01265784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199777|NCT01265784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199778|NCT05692271|Propranolol|propranolol|mesh-list
93199779|NCT05692271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93199780|NCT05692271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93199781|NCT05692271|Adrenergic Agents|adrenergic agents|mesh-ancestor
93199782|NCT05692271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199783|NCT05692271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199784|NCT05692271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199785|NCT05692271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93199786|NCT05692271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93199787|NCT05692271|Vasodilator Agents|vasodilator agents|mesh-ancestor
93199788|NCT03774953|Vitamins|vitamins|mesh-list
93199789|NCT03774953|Micronutrients|micronutrients|mesh-ancestor
93199790|NCT03774953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199791|NCT02483026|Vitamin D|vitamin d|mesh-list
93199792|NCT02483026|Vitamins|vitamins|mesh-list
93199793|NCT02483026|Micronutrients|micronutrients|mesh-ancestor
93199794|NCT02483026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199795|NCT02483026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93199796|NCT02483104|Paclitaxel|paclitaxel|mesh-list
93199797|NCT02483104|Carboplatin|carboplatin|mesh-list
93199798|NCT02483104|Veliparib|veliparib|mesh-list
93199799|NCT02483104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93199800|NCT02483104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199801|NCT02483104|Tubulin Modulators|tubulin modulators|mesh-ancestor
93199802|NCT02483104|Antimitotic Agents|antimitotic agents|mesh-ancestor
93199803|NCT02483104|Mitosis Modulators|mitosis modulators|mesh-ancestor
93199804|NCT02483104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199805|NCT02483104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93199806|NCT02483104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199807|NCT00116220|Goserelin|goserelin|mesh-list
93199808|NCT00116220|Flutamide|flutamide|mesh-list
93199809|NCT00116220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871915|NCT03537131|Dapagliflozin|dapagliflozin|mesh-list
93199810|NCT00116220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93199811|NCT00116220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199812|NCT00116220|Androgen Antagonists|androgen antagonists|mesh-ancestor
93199813|NCT00116220|Hormone Antagonists|hormone antagonists|mesh-ancestor
93199814|NCT00116220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199815|NCT03785015|Aspirin|aspirin|mesh-list
93199816|NCT03785015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93199817|NCT03785015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199818|NCT03785015|Analgesics|analgesics|mesh-ancestor
93199819|NCT03785015|Sensory System Agents|sensory system agents|mesh-ancestor
93199820|NCT03785015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199821|NCT03785015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199822|NCT03785015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199823|NCT03785015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199824|NCT03785015|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93199825|NCT03785015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93199826|NCT03785015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199827|NCT03785015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93199828|NCT03785015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93199829|NCT03785015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199830|NCT03785015|Antipyretics|antipyretics|mesh-ancestor
93199831|NCT04867343|Fentanyl|fentanyl|mesh-list
93199832|NCT04867343|Remifentanil|remifentanil|mesh-list
93199833|NCT04867343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93199834|NCT04867343|Narcotics|narcotics|mesh-ancestor
93199835|NCT04867343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199836|NCT04867343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199837|NCT04867343|Analgesics|analgesics|mesh-ancestor
93199838|NCT04867343|Sensory System Agents|sensory system agents|mesh-ancestor
93199839|NCT04867343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199840|NCT04867343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93199841|NCT04867343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93199842|NCT04867343|Anesthetics, General|anesthetics, general|mesh-ancestor
93199843|NCT04867343|Anesthetics|anesthetics|mesh-ancestor
93199844|NCT05185518|Insulin|insulin|mesh-list
93199845|NCT05185518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199846|NCT05185518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199847|NCT03316690|Metformin|metformin|mesh-list
93199848|NCT03316690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93199849|NCT03316690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199850|NCT03315052|Mycophenolic Acid|mycophenolic acid|mesh-list
93199851|NCT03315052|Prednisone|prednisone|mesh-list
93199852|NCT03315052|Budesonide|budesonide|mesh-list
93199853|NCT03315052|Tacrolimus|tacrolimus|mesh-list
93199854|NCT03315052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199855|NCT03315052|Glucocorticoids|glucocorticoids|mesh-ancestor
93199856|NCT03315052|Hormones|hormones|mesh-ancestor
93199857|NCT03315052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199858|NCT03315052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199859|NCT03315052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93199860|NCT03315052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199861|NCT03315052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199862|NCT03315052|Immunologic Factors|immunologic factors|mesh-ancestor
93199863|NCT03315052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93199864|NCT03315052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199865|NCT03315052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199866|NCT03315052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93199867|NCT03315052|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93199868|NCT03315052|Antitubercular Agents|antitubercular agents|mesh-ancestor
93199869|NCT03315052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93199870|NCT03315052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199871|NCT03315052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93199872|NCT03315052|Autonomic Agents|autonomic agents|mesh-ancestor
93199873|NCT03315052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199874|NCT03315052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199875|NCT03315052|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199876|NCT03778619|Cyclophosphamide|cyclophosphamide|mesh-list
93199877|NCT03778619|Rituximab|rituximab|mesh-list
93199878|NCT03778619|Fludarabine|fludarabine|mesh-list
93199879|NCT03778619|Interleukin-2|interleukin-2|mesh-list
93199880|NCT03778619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93199881|NCT03778619|Immunologic Factors|immunologic factors|mesh-ancestor
93199882|NCT03778619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199883|NCT03778619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199884|NCT03778619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199885|NCT03778619|Alkylating Agents|alkylating agents|mesh-ancestor
93199886|NCT03778619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199887|NCT03778619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199888|NCT03778619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92871980|NCT04500665|Colchicine|colchicine|mesh-list
93199889|NCT03778619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199890|NCT03778619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199891|NCT03778619|Analgesics|analgesics|mesh-ancestor
93199892|NCT03778619|Sensory System Agents|sensory system agents|mesh-ancestor
93199893|NCT03778619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199894|NCT05714176|Lactoferrin|lactoferrin|mesh-list
93199895|NCT05714176|Dextrans|dextrans|mesh-list
93199896|NCT05714176|Iron-Dextran Complex|iron-dextran complex|mesh-list
93199897|NCT05714176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93199898|NCT05714176|Anticoagulants|anticoagulants|mesh-ancestor
93199899|NCT05714176|Plasma Substitutes|plasma substitutes|mesh-ancestor
93199900|NCT05714176|Blood Substitutes|blood substitutes|mesh-ancestor
93199901|NCT05714176|Hematinics|hematinics|mesh-ancestor
93199902|NCT03156504|Ketamine|ketamine|mesh-list
93199903|NCT03156504|Analgesics|analgesics|mesh-ancestor
93199904|NCT03156504|Sensory System Agents|sensory system agents|mesh-ancestor
93199905|NCT03156504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199906|NCT03156504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199907|NCT03156504|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93199908|NCT03156504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93199909|NCT03156504|Anesthetics, General|anesthetics, general|mesh-ancestor
93199910|NCT03156504|Anesthetics|anesthetics|mesh-ancestor
93199911|NCT03156504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199912|NCT03156504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93199913|NCT03156504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93199914|NCT03156504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93199915|NCT03156504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199916|NCT01333332|Capecitabine|capecitabine|mesh-list
93199917|NCT01333332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93199918|NCT01333332|Antimetabolites|antimetabolites|mesh-ancestor
93199919|NCT01333332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199920|NCT01333332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199921|NCT03316534|Aspirin|aspirin|mesh-list
93199922|NCT03316534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93199923|NCT03316534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93199924|NCT03316534|Analgesics|analgesics|mesh-ancestor
93199925|NCT03316534|Sensory System Agents|sensory system agents|mesh-ancestor
93199926|NCT03316534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199927|NCT03316534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199928|NCT03316534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199929|NCT03316534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93199930|NCT03316534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93199931|NCT03316534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93199932|NCT03316534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199933|NCT03316534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93199934|NCT03316534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93199935|NCT03316534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199936|NCT03316534|Antipyretics|antipyretics|mesh-ancestor
93199937|NCT04476420|Betamethasone|betamethasone|mesh-list
93199938|NCT04476420|Betamethasone Valerate|betamethasone valerate|mesh-list
93199939|NCT04476420|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93199940|NCT04476420|Betamethasone benzoate|betamethasone benzoate|mesh-list
93199941|NCT04476420|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93199942|NCT04476420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93199943|NCT04476420|Glucocorticoids|glucocorticoids|mesh-ancestor
93199944|NCT04476420|Hormones|hormones|mesh-ancestor
93199945|NCT04476420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93199946|NCT04476420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199947|NCT04476420|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93199948|NCT04476420|Respiratory System Agents|respiratory system agents|mesh-ancestor
93199949|NCT03778541|Temozolomide|temozolomide|mesh-list
93199950|NCT03778541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93199951|NCT03778541|Alkylating Agents|alkylating agents|mesh-ancestor
93199952|NCT03778541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199953|NCT03778541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199954|NCT02479828|Ropivacaine|ropivacaine|mesh-list
93199955|NCT02479828|Anesthetics, Local|anesthetics, local|mesh-ancestor
93199956|NCT02479828|Anesthetics|anesthetics|mesh-ancestor
93199957|NCT02479828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93199958|NCT02479828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199959|NCT02479828|Sensory System Agents|sensory system agents|mesh-ancestor
93199960|NCT02479828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93199961|NCT01320449|Epoetin Alfa|epoetin alfa|mesh-list
93199962|NCT01320449|Hematinics|hematinics|mesh-ancestor
93199963|NCT03430063|Ipilimumab|ipilimumab|mesh-list
93199964|NCT03430063|Cemiplimab|cemiplimab|mesh-list
93199965|NCT03430063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93199966|NCT03430063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199967|NCT03430063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93199968|NCT03430063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199970|NCT03158220|Immunologic Factors|immunologic factors|mesh-ancestor
93199971|NCT03158220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199972|NCT01308983|Amiloride|amiloride|mesh-list
93199973|NCT01308983|Diuretics|diuretics|mesh-ancestor
93199974|NCT01308983|Natriuretic Agents|natriuretic agents|mesh-ancestor
93199975|NCT01308983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199976|NCT01308983|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93199977|NCT01308983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93199978|NCT01308983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93199979|NCT01308983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199980|NCT01308983|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93199981|NCT01308983|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93199982|NCT01336842|Pemetrexed|pemetrexed|mesh-list
93199983|NCT01336842|Panobinostat|panobinostat|mesh-list
93199984|NCT01336842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93199985|NCT01336842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93199986|NCT01336842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93199987|NCT01336842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93199988|NCT01336842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93199989|NCT01336842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93199990|NCT05178407|Micronutrients|micronutrients|mesh-list
93199991|NCT05178407|Trace Elements|trace elements|mesh-list
93199992|NCT05178407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93199993|NCT01339026|Clopidogrel|clopidogrel|mesh-list
93199994|NCT01339026|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93199995|NCT01339026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93199996|NCT01339026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93199997|NCT01339026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93199998|NCT01339026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93199999|NCT01339026|Purinergic Agents|purinergic agents|mesh-ancestor
93200000|NCT01339026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200001|NCT01339026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200002|NCT01339026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200003|NCT03314740|Paclitaxel|paclitaxel|mesh-list
93200004|NCT03314740|Olaparib|olaparib|mesh-list
93200005|NCT03314740|Cediranib|cediranib|mesh-list
93200006|NCT03314740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93200007|NCT03314740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200008|NCT03314740|Tubulin Modulators|tubulin modulators|mesh-ancestor
93200009|NCT03314740|Antimitotic Agents|antimitotic agents|mesh-ancestor
93200010|NCT03314740|Mitosis Modulators|mitosis modulators|mesh-ancestor
93200011|NCT03314740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200012|NCT03314740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93200013|NCT03314740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200014|NCT03314740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200015|NCT02482636|Vaccines|vaccines|mesh-list
93200016|NCT02482636|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93200017|NCT02482636|Immunologic Factors|immunologic factors|mesh-ancestor
93200018|NCT02482636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200019|NCT02482402|Iloprost|iloprost|mesh-list
93200020|NCT02482402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93200021|NCT02482402|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200022|NCT03774095|Pycnogenols|pycnogenols|mesh-list
93200023|NCT03774095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93200024|NCT03774095|Immunologic Factors|immunologic factors|mesh-ancestor
93200025|NCT03774095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200026|NCT03774095|Antioxidants|antioxidants|mesh-ancestor
93200027|NCT03774095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200028|NCT03774095|Protective Agents|protective agents|mesh-ancestor
93200029|NCT03774095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93200030|NCT01333410|Mometasone Furoate|mometasone furoate|mesh-list
93200031|NCT01333410|Tacrolimus|tacrolimus|mesh-list
93200032|NCT01333410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200033|NCT01333410|Immunologic Factors|immunologic factors|mesh-ancestor
93200034|NCT01333410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200035|NCT01333410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93200036|NCT01333410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200037|NCT01333410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200038|NCT01333410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200039|NCT01333410|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200040|NCT01333410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93200041|NCT02482090|Cyclophosphamide|cyclophosphamide|mesh-list
93200042|NCT02482090|Fludarabine|fludarabine|mesh-list
93200043|NCT02482090|Interleukin-2|interleukin-2|mesh-list
93200044|NCT02482090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200045|NCT02482090|Immunologic Factors|immunologic factors|mesh-ancestor
93200046|NCT02482090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200047|NCT02482090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200048|NCT02482090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93200049|NCT02482090|Alkylating Agents|alkylating agents|mesh-ancestor
93200050|NCT02482090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200051|NCT02482090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200052|NCT02482090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93200053|NCT02482090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200054|NCT02482090|Analgesics|analgesics|mesh-ancestor
93200055|NCT02482090|Sensory System Agents|sensory system agents|mesh-ancestor
93200056|NCT02482090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200057|NCT02482324|Ibuprofen|ibuprofen|mesh-list
93200058|NCT02482324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93200059|NCT02482324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200060|NCT02482324|Analgesics|analgesics|mesh-ancestor
93200061|NCT02482324|Sensory System Agents|sensory system agents|mesh-ancestor
93200062|NCT02482324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200063|NCT02482324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200064|NCT02482324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200065|NCT02482324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200066|NCT02482324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93200067|NCT02482324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200068|NCT02482324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200069|NCT05185284|Remdesivir|remdesivir|mesh-list
93200070|NCT05185284|Favipiravir|favipiravir|mesh-list
93200071|NCT05185284|Antimetabolites|antimetabolites|mesh-ancestor
93200072|NCT05185284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200073|NCT05185284|Antiviral Agents|antiviral agents|mesh-ancestor
93200074|NCT05185284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200075|NCT03784703|Atorvastatin|atorvastatin|mesh-list
93200076|NCT03784703|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93200077|NCT03784703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93200078|NCT03784703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93200079|NCT03784703|Antimetabolites|antimetabolites|mesh-ancestor
93200080|NCT03784703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200081|NCT03784703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93200082|NCT03784703|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93200083|NCT03784703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200084|NCT02724592|Fluorides|fluorides|mesh-list
93200085|NCT02724592|Fluorides, Topical|fluorides, topical|mesh-list
93200086|NCT02724592|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
93200087|NCT02724592|Cariostatic Agents|cariostatic agents|mesh-ancestor
93200088|NCT02724592|Protective Agents|protective agents|mesh-ancestor
93200089|NCT02724592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200090|NCT02476864|Macitentan|macitentan|mesh-list
93200091|NCT02476864|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93200092|NCT02476864|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93200093|NCT02476864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200094|NCT02476864|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93200095|NCT05451550|Anesthetics|anesthetics|mesh-list
93200096|NCT05451550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200097|NCT05451550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200098|NCT02476708|Curcumin|curcumin|mesh-list
93200099|NCT02476708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93200100|NCT02476708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200101|NCT02476708|Analgesics|analgesics|mesh-ancestor
93200102|NCT02476708|Sensory System Agents|sensory system agents|mesh-ancestor
93200103|NCT02476708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200104|NCT02476708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200105|NCT02476708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200106|NCT02476708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200107|NCT02476708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200108|NCT02476708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200109|NCT02476708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200110|NCT02479204|Atenolol|atenolol|mesh-list
93200111|NCT02479204|Diltiazem|diltiazem|mesh-list
92872199|NCT03929627|Hydrocortisone|hydrocortisone|mesh-list
93200112|NCT02479204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200113|NCT02479204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93200114|NCT02479204|Sympatholytics|sympatholytics|mesh-ancestor
93200115|NCT02479204|Autonomic Agents|autonomic agents|mesh-ancestor
93200116|NCT02479204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200117|NCT02479204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200118|NCT02479204|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93200119|NCT02479204|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93200120|NCT02479204|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93200121|NCT02479204|Adrenergic Agents|adrenergic agents|mesh-ancestor
93200122|NCT02479204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200123|NCT02479204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200124|NCT02479204|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93200125|NCT02479204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93200126|NCT02479204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93200127|NCT02479204|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200128|NCT03784547|Ocrelizumab|ocrelizumab|mesh-list
93200129|NCT03784547|Immunologic Factors|immunologic factors|mesh-ancestor
93200130|NCT03784547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200131|NCT01339572|Plerixafor|plerixafor|mesh-list
93200132|NCT01339572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93200133|NCT01339572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93200134|NCT01339572|Antiviral Agents|antiviral agents|mesh-ancestor
93200135|NCT01339572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200136|NCT04199117|Nicotine|nicotine|mesh-list
93200137|NCT04199117|Varenicline|varenicline|mesh-list
93200138|NCT04199117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93200139|NCT04199117|Autonomic Agents|autonomic agents|mesh-ancestor
93200140|NCT04199117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200141|NCT04199117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200142|NCT04199117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93200143|NCT04199117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93200144|NCT04199117|Cholinergic Agents|cholinergic agents|mesh-ancestor
93200145|NCT04199117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200146|NCT04199117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200147|NCT01309139|Tiotropium Bromide|tiotropium bromide|mesh-list
93200148|NCT01309139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93200149|NCT01309139|Autonomic Agents|autonomic agents|mesh-ancestor
93200150|NCT01309139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200151|NCT01309139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200152|NCT01309139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93200153|NCT01309139|Respiratory System Agents|respiratory system agents|mesh-ancestor
93200154|NCT01309139|Parasympatholytics|parasympatholytics|mesh-ancestor
93200155|NCT01309139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93200156|NCT01309139|Cholinergic Agents|cholinergic agents|mesh-ancestor
93200157|NCT01309139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200158|NCT01309139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200159|NCT03154476|Sildenafil Citrate|sildenafil citrate|mesh-list
93200160|NCT03154476|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200161|NCT03154476|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92855800|NCT02825342|Citalopram|citalopram|mesh-list
93200162|NCT03154476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93200163|NCT03154476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200164|NCT03154476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200165|NCT03154476|Urological Agents|urological agents|mesh-ancestor
93200166|NCT03784391|Nifurtimox|nifurtimox|mesh-list
93200167|NCT03784391|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93200168|NCT03784391|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93200169|NCT03784391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200170|NCT03784391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200171|NCT02476552|Niraparib|niraparib|mesh-list
93200172|NCT02476552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93200173|NCT02476552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200174|NCT02476552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200175|NCT02476552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200176|NCT01316718|Mesalamine|mesalamine|mesh-list
93200177|NCT01316718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93200178|NCT01316718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200179|NCT01316718|Analgesics|analgesics|mesh-ancestor
93200180|NCT01316718|Sensory System Agents|sensory system agents|mesh-ancestor
93200181|NCT01316718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200182|NCT01316718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200183|NCT01316718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200184|NCT01316718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200185|NCT01316952|Carvedilol|carvedilol|mesh-list
92872288|NCT02846831|Insulin|insulin|mesh-list
93200187|NCT01316952|Adrenergic Agents|adrenergic agents|mesh-list
93200188|NCT01316952|Adrenergic Antagonists|adrenergic antagonists|mesh-list
93200189|NCT01316952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200190|NCT01316952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200191|NCT01316952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200192|NCT01316952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93200193|NCT01316952|Antioxidants|antioxidants|mesh-ancestor
93200194|NCT01316952|Protective Agents|protective agents|mesh-ancestor
93200195|NCT01316952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93200196|NCT01316952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93200197|NCT01316952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93200198|NCT01316952|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200199|NCT01316952|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93200200|NCT01316952|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93200201|NCT03768869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93200202|NCT03768869|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93200203|NCT03768869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200204|NCT03768869|Antitubercular Agents|antitubercular agents|mesh-ancestor
93200205|NCT01320917|Levonorgestrel|levonorgestrel|mesh-list
93200206|NCT01320917|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93200207|NCT01320917|Contraceptive Agents|contraceptive agents|mesh-ancestor
93200208|NCT01320917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200209|NCT01320917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200210|NCT01320917|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93200211|NCT01320917|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93200212|NCT01320917|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93200213|NCT03768713|Suvorexant|suvorexant|mesh-list
93200214|NCT03768713|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93200215|NCT03768713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93200216|NCT03768713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200217|NCT03768713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200218|NCT03768713|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93200219|NCT03768713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200220|NCT03768713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200221|NCT02481076|Monensin|monensin|mesh-list
93200222|NCT02481076|Antifungal Agents|antifungal agents|mesh-ancestor
93200223|NCT02481076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200224|NCT02481076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93200225|NCT02481076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200226|NCT02481076|Coccidiostats|coccidiostats|mesh-ancestor
93200227|NCT02481076|Proton Ionophores|proton ionophores|mesh-ancestor
93200228|NCT02481076|Uncoupling Agents|uncoupling agents|mesh-ancestor
93200229|NCT02481076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200230|NCT02481076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200231|NCT02481076|Ionophores|ionophores|mesh-ancestor
93200232|NCT02481076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93200233|NCT02481076|Sodium Ionophores|sodium ionophores|mesh-ancestor
93200234|NCT05713396|Losartan|losartan|mesh-list
93200235|NCT05713396|Quinapril|quinapril|mesh-list
93200236|NCT05713396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200237|NCT05713396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93200238|NCT05713396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93200239|NCT05713396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93200240|NCT05713396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200241|NCT05713396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93200242|NCT05713396|Protease Inhibitors|protease inhibitors|mesh-ancestor
93200243|NCT05713396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200244|NCT02480608|Imatinib Mesylate|imatinib mesylate|mesh-list
93200245|NCT02480608|Hydroxyurea|hydroxyurea|mesh-list
93200246|NCT02480608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200247|NCT02480608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200248|NCT02480608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200249|NCT02480608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200250|NCT02480608|Antisickling Agents|antisickling agents|mesh-ancestor
93200251|NCT02480608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93200252|NCT02480686|Sofosbuvir|sofosbuvir|mesh-list
93200253|NCT02480686|Antiviral Agents|antiviral agents|mesh-ancestor
93200254|NCT02480686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200255|NCT02475382|Nivolumab|nivolumab|mesh-list
93200256|NCT02475382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93200257|NCT02475382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200258|NCT02475382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93200259|NCT02475382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200260|NCT02475304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93200261|NCT02475304|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200262|NCT02475304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200263|NCT02475304|Immunologic Factors|immunologic factors|mesh-ancestor
93200264|NCT02475304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200265|NCT05371288|Thioctic Acid|thioctic acid|mesh-list
93200266|NCT05371288|Acetylcysteine|acetylcysteine|mesh-list
93200267|NCT05371288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93200268|NCT05371288|Antioxidants|antioxidants|mesh-ancestor
93200269|NCT05371288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200270|NCT05371288|Protective Agents|protective agents|mesh-ancestor
93200271|NCT05371288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200272|NCT05371288|Vitamin B Complex|vitamin b complex|mesh-ancestor
93200273|NCT05371288|Vitamins|vitamins|mesh-ancestor
93200274|NCT05371288|Micronutrients|micronutrients|mesh-ancestor
93200275|NCT05371288|Antiviral Agents|antiviral agents|mesh-ancestor
93200276|NCT05371288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200277|NCT05371288|Expectorants|expectorants|mesh-ancestor
93200278|NCT05371288|Respiratory System Agents|respiratory system agents|mesh-ancestor
93200279|NCT05371288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93200280|NCT05371288|Antidotes|antidotes|mesh-ancestor
93200281|NCT02478424|Cyclosporine|cyclosporine|mesh-list
93200282|NCT02478424|Methotrexate|methotrexate|mesh-list
93200283|NCT02478424|Cannabidiol|cannabidiol|mesh-list
93200284|NCT02478424|Cyclosporins|cyclosporins|mesh-list
93200285|NCT02478424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93200286|NCT02478424|Abortifacient Agents|abortifacient agents|mesh-ancestor
93200287|NCT02478424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200288|NCT02478424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200289|NCT02478424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93200290|NCT02478424|Antimetabolites|antimetabolites|mesh-ancestor
93200291|NCT02478424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200292|NCT02478424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200293|NCT02478424|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200294|NCT02478424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200295|NCT02478424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93200296|NCT02478424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200297|NCT02478424|Immunologic Factors|immunologic factors|mesh-ancestor
93200298|NCT02478424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200299|NCT02478424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93200300|NCT02478424|Antifungal Agents|antifungal agents|mesh-ancestor
93200301|NCT02478424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200302|NCT02478424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93200303|NCT02478424|Anticonvulsants|anticonvulsants|mesh-ancestor
93200304|NCT03712787|Tilavonemab|tilavonemab|mesh-list
93200305|NCT03712787|Nootropic Agents|nootropic agents|mesh-ancestor
93200306|NCT02478268|Xenon|xenon|mesh-list
93200307|NCT02478268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93200308|NCT02478268|Anesthetics, General|anesthetics, general|mesh-ancestor
93200309|NCT02478268|Anesthetics|anesthetics|mesh-ancestor
93200310|NCT02478268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200311|NCT02478268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200312|NCT04053881|Certolizumab Pegol|certolizumab pegol|mesh-list
93200313|NCT04053881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93200314|NCT04053881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200315|NCT04053881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200316|NCT04053881|Immunologic Factors|immunologic factors|mesh-ancestor
93200317|NCT04053881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200318|NCT04053881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200319|NCT03768557|Minocycline|minocycline|mesh-list
93200320|NCT03768557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93200321|NCT03768557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200322|NCT03783845|Amoxicillin|amoxicillin|mesh-list
93200323|NCT03783845|Metronidazole|metronidazole|mesh-list
93200324|NCT03783845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93200325|NCT03783845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200326|NCT03783845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93200327|NCT03783845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200328|NCT01560689|Budesonide|budesonide|mesh-list
93200329|NCT01560689|Formoterol Fumarate|formoterol fumarate|mesh-list
93200330|NCT01560689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200331|NCT01560689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93200332|NCT01560689|Autonomic Agents|autonomic agents|mesh-ancestor
93200333|NCT01560689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200334|NCT01560689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200335|NCT01560689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93200336|NCT01560689|Respiratory System Agents|respiratory system agents|mesh-ancestor
93200338|NCT01560689|Hormones|hormones|mesh-ancestor
93200339|NCT01560689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200340|NCT01560689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93200341|NCT01560689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93200342|NCT01560689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93200343|NCT01560689|Adrenergic Agents|adrenergic agents|mesh-ancestor
93200344|NCT01560689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200345|NCT01560689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200346|NCT02474914|Octreotide|octreotide|mesh-list
93200347|NCT02474914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93200348|NCT02474914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93200349|NCT02474914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200350|NCT03769103|Osimertinib|osimertinib|mesh-list
93200351|NCT03769103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200352|NCT03769103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200353|NCT03769103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200354|NCT03769103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200355|NCT04998214|Thrombin|thrombin|mesh-list
93200356|NCT04998214|Hemostatics|hemostatics|mesh-ancestor
93200357|NCT04998214|Coagulants|coagulants|mesh-ancestor
93200358|NCT01309607|Paclitaxel|paclitaxel|mesh-list
93200359|NCT01309607|Carboplatin|carboplatin|mesh-list
93200360|NCT01309607|Lapatinib|lapatinib|mesh-list
93200361|NCT01309607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93200362|NCT01309607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200363|NCT01309607|Tubulin Modulators|tubulin modulators|mesh-ancestor
93200364|NCT01309607|Antimitotic Agents|antimitotic agents|mesh-ancestor
93200365|NCT01309607|Mitosis Modulators|mitosis modulators|mesh-ancestor
93200366|NCT01309607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200367|NCT01309607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200368|NCT01309607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200369|NCT03783455|Hyaluronic Acid|hyaluronic acid|mesh-list
93200370|NCT03783455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93200371|NCT03783455|Immunologic Factors|immunologic factors|mesh-ancestor
93200372|NCT03783455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200373|NCT03783455|Viscosupplements|viscosupplements|mesh-ancestor
93200374|NCT03783455|Protective Agents|protective agents|mesh-ancestor
93200375|NCT05305066|Adalimumab|adalimumab|mesh-list
93200376|NCT05305066|Golimumab|golimumab|mesh-list
93200377|NCT05305066|Etanercept|etanercept|mesh-list
93200378|NCT05305066|Upadacitinib|upadacitinib|mesh-list
93200379|NCT05305066|Tofacitinib|tofacitinib|mesh-list
93200380|NCT05305066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93200381|NCT05305066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200382|NCT05305066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200383|NCT05305066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93200384|NCT05305066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200385|NCT05305066|Analgesics|analgesics|mesh-ancestor
93200386|NCT05305066|Sensory System Agents|sensory system agents|mesh-ancestor
93200387|NCT05305066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855806|NCT02825342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200388|NCT05305066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200389|NCT05305066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93200390|NCT05305066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200391|NCT05305066|Immunologic Factors|immunologic factors|mesh-ancestor
93200392|NCT05305066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93200393|NCT05305066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200394|NCT05305066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200395|NCT05305066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200396|NCT05251714|Fulvestrant|fulvestrant|mesh-list
93200397|NCT05251714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93200398|NCT05251714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200399|NCT05251714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93200400|NCT05251714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93200401|NCT05251714|Hormone Antagonists|hormone antagonists|mesh-ancestor
93200402|NCT05251714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200403|NCT05251714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200404|NCT02478034|Fludrocortisone|fludrocortisone|mesh-list
93200405|NCT02478034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200406|NCT02477956|Vitamin D|vitamin d|mesh-list
93200407|NCT02477956|Ergocalciferols|ergocalciferols|mesh-list
93200408|NCT02477956|Cholecalciferol|cholecalciferol|mesh-list
93200409|NCT02477956|Vitamins|vitamins|mesh-list
93200410|NCT02477956|Micronutrients|micronutrients|mesh-ancestor
93200411|NCT02477956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200412|NCT02477956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93200413|NCT02477956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93200414|NCT02472574|Plasminogen|plasminogen|mesh-list
93200415|NCT02472574|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93200416|NCT02472574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93200417|NCT02472574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93200418|NCT02472574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200419|NCT05708248|Pentoxifylline|pentoxifylline|mesh-list
93200420|NCT05708248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93200421|NCT05708248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200422|NCT05708248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200423|NCT05708248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93200424|NCT05708248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93200425|NCT05708248|Protective Agents|protective agents|mesh-ancestor
93200426|NCT05708248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200427|NCT05708248|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200428|NCT05708248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93200429|NCT05708248|Antioxidants|antioxidants|mesh-ancestor
93200430|NCT05685394|Dapagliflozin|dapagliflozin|mesh-list
93200431|NCT05685394|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93200432|NCT05685394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200433|NCT05685394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93200434|NCT05685394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200435|NCT03772223|Budesonide|budesonide|mesh-list
93200436|NCT03772223|Albuterol|albuterol|mesh-list
93200437|NCT03772223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200438|NCT03772223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93200439|NCT03772223|Autonomic Agents|autonomic agents|mesh-ancestor
93200440|NCT03772223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200441|NCT03772223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200442|NCT03772223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93200443|NCT03772223|Respiratory System Agents|respiratory system agents|mesh-ancestor
93200444|NCT03772223|Glucocorticoids|glucocorticoids|mesh-ancestor
93200445|NCT03772223|Hormones|hormones|mesh-ancestor
93200446|NCT03772223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200447|NCT03772223|Tocolytic Agents|tocolytic agents|mesh-ancestor
93200448|NCT03772223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200449|NCT03772223|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93200450|NCT03772223|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93200451|NCT03772223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93200452|NCT03772223|Adrenergic Agents|adrenergic agents|mesh-ancestor
93200453|NCT03772223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200454|NCT03772223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200455|NCT03783299|Lumefantrine|lumefantrine|mesh-list
93200456|NCT03783299|Artemether|artemether|mesh-list
93200457|NCT03783299|Primaquine|primaquine|mesh-list
93200458|NCT03783299|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93200459|NCT03783299|Antimalarials|antimalarials|mesh-ancestor
93200460|NCT03783299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93200461|NCT03783299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200462|NCT03783299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200463|NCT03771755|Acetaminophen|acetaminophen|mesh-list
93200464|NCT03771755|Ibuprofen|ibuprofen|mesh-list
93200465|NCT03771755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200466|NCT03771755|Analgesics|analgesics|mesh-ancestor
93200467|NCT03771755|Sensory System Agents|sensory system agents|mesh-ancestor
93200468|NCT03771755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200469|NCT03771755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200470|NCT03771755|Antipyretics|antipyretics|mesh-ancestor
93200471|NCT03771755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93200472|NCT03771755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200473|NCT03771755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200474|NCT03771755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93200475|NCT03771755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200476|NCT03771755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200477|NCT02477566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93200478|NCT02477566|Luteolytic Agents|luteolytic agents|mesh-ancestor
93200479|NCT02477566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93200480|NCT02477566|Contraceptive Agents|contraceptive agents|mesh-ancestor
93200481|NCT02477566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200482|NCT02477566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200483|NCT02477566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93200484|NCT02477566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93200485|NCT02477566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200486|NCT05432531|Cyclophosphamide|cyclophosphamide|mesh-list
93200488|NCT05432531|Immunologic Factors|immunologic factors|mesh-ancestor
93200489|NCT05432531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200490|NCT05432531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200491|NCT05432531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93200492|NCT05432531|Alkylating Agents|alkylating agents|mesh-ancestor
93200493|NCT05432531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200494|NCT05432531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200495|NCT05432531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93200496|NCT01309685|Varenicline|varenicline|mesh-list
93200497|NCT01309685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93200498|NCT01309685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93200499|NCT01309685|Cholinergic Agents|cholinergic agents|mesh-ancestor
93200500|NCT01309685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200501|NCT01309685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200502|NCT01309685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200503|NCT03772067|Insulin|insulin|mesh-list
93200504|NCT03772067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93200505|NCT03772067|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93200506|NCT03772067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93200507|NCT03772067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200508|NCT03772067|Incretins|incretins|mesh-ancestor
93200509|NCT03772067|Hormones|hormones|mesh-ancestor
93200510|NCT03772067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200511|NCT03783065|Propranolol|propranolol|mesh-list
93200512|NCT03783065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93200513|NCT03783065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93200514|NCT03783065|Adrenergic Agents|adrenergic agents|mesh-ancestor
93200515|NCT03783065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200516|NCT03783065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200517|NCT03783065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200518|NCT03783065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200519|NCT03783065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93200520|NCT03783065|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200521|NCT03766997|Hydrocortisone|hydrocortisone|mesh-list
93200522|NCT03766997|Betamethasone|betamethasone|mesh-list
93200523|NCT03766997|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
93200524|NCT03766997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200525|NCT03766997|Glucocorticoids|glucocorticoids|mesh-ancestor
93200526|NCT03766997|Hormones|hormones|mesh-ancestor
93200527|NCT03766997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200528|NCT03766997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200529|NCT03766997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93200530|NCT03766997|Respiratory System Agents|respiratory system agents|mesh-ancestor
93200531|NCT03766997|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200532|NCT03782831|Antibodies|antibodies|mesh-list
93200533|NCT03782831|Immunologic Factors|immunologic factors|mesh-ancestor
92977241|NCT01581853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93200534|NCT03782831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200535|NCT05539391|Rocuronium|rocuronium|mesh-list
93200536|NCT05539391|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93200537|NCT05539391|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93200538|NCT05539391|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93200539|NCT05539391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200540|NCT05539391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200541|NCT03766607|Paclitaxel|paclitaxel|mesh-list
93200542|NCT03766607|Trastuzumab|trastuzumab|mesh-list
93200543|NCT03766607|Ramucirumab|ramucirumab|mesh-list
93200544|NCT03766607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93200545|NCT03766607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200546|NCT03766607|Tubulin Modulators|tubulin modulators|mesh-ancestor
93200547|NCT03766607|Antimitotic Agents|antimitotic agents|mesh-ancestor
93200548|NCT03766607|Mitosis Modulators|mitosis modulators|mesh-ancestor
93200549|NCT03766607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200550|NCT03766607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93200551|NCT01567709|Vorinostat|vorinostat|mesh-list
93200552|NCT01567709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200553|NCT01567709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93200554|NCT01567709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200555|NCT01567709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200556|NCT03765827|Vitamins|vitamins|mesh-list
93200557|NCT03765827|Vitamin E|vitamin e|mesh-list
93200558|NCT03765827|Tocopherols|tocopherols|mesh-list
93200559|NCT03765827|Tocotrienols|tocotrienols|mesh-list
93200560|NCT03765827|alpha-Tocopherol|alpha-tocopherol|mesh-list
93200561|NCT03765827|Micronutrients|micronutrients|mesh-ancestor
93200562|NCT03765827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200563|NCT03765827|Antioxidants|antioxidants|mesh-ancestor
93200564|NCT03765827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200565|NCT03765827|Protective Agents|protective agents|mesh-ancestor
93200566|NCT03771053|Simvastatin|simvastatin|mesh-list
93200567|NCT03771053|Ezetimibe|ezetimibe|mesh-list
93200568|NCT03771053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93200569|NCT03771053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93200570|NCT03771053|Antimetabolites|antimetabolites|mesh-ancestor
93200571|NCT03771053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200572|NCT03771053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93200573|NCT03771053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93200574|NCT03771053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200575|NCT03770663|Cyclophosphamide|cyclophosphamide|mesh-list
93200576|NCT03770663|Azathioprine|azathioprine|mesh-list
93200577|NCT03770663|Tacrolimus|tacrolimus|mesh-list
93200578|NCT03770663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200579|NCT03770663|Immunologic Factors|immunologic factors|mesh-ancestor
93200580|NCT03770663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200581|NCT03770663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200582|NCT03770663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93200583|NCT03770663|Alkylating Agents|alkylating agents|mesh-ancestor
93200584|NCT03770663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200585|NCT03770663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200586|NCT03770663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93200587|NCT03770663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93200588|NCT03770663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200589|NCT03770663|Antimetabolites|antimetabolites|mesh-ancestor
93200590|NCT03770663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93200591|NCT03048422|Tenofovir|tenofovir|mesh-list
93200592|NCT03048422|Emtricitabine|emtricitabine|mesh-list
93200593|NCT03048422|Efavirenz|efavirenz|mesh-list
93200594|NCT03048422|Dolutegravir|dolutegravir|mesh-list
93200595|NCT03048422|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93200596|NCT03048422|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93200597|NCT03048422|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93200598|NCT03048422|Antiviral Agents|antiviral agents|mesh-ancestor
93200599|NCT03048422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200600|NCT03048422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93200601|NCT03048422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93200602|NCT03048422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200603|NCT03048422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200604|NCT03048422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93200605|NCT03048422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93200606|NCT03048422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93200607|NCT03048422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93200608|NCT03048422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93200609|NCT03048422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93200610|NCT03048422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93200611|NCT03048422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93200612|NCT03048422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93200613|NCT03048422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93200614|NCT01561781|Digoxin|digoxin|mesh-list
93200615|NCT01561781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200616|NCT01561781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93200617|NCT01561781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200618|NCT01561781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200619|NCT01561781|Protective Agents|protective agents|mesh-ancestor
93200620|NCT01561781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200621|NCT04259255|Edaravone|edaravone|mesh-list
93200622|NCT04259255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93200623|NCT04259255|Antioxidants|antioxidants|mesh-ancestor
93200624|NCT04259255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200625|NCT04259255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93200626|NCT04259255|Protective Agents|protective agents|mesh-ancestor
93200627|NCT04259255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200628|NCT03770039|PF-06700841|pf-06700841|mesh-list
93200629|NCT03770039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200630|NCT03770039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200631|NCT03770039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200632|NCT01321775|Paclitaxel|paclitaxel|mesh-list
93200633|NCT01321775|Cyclophosphamide|cyclophosphamide|mesh-list
93200634|NCT01321775|Bevacizumab|bevacizumab|mesh-list
93200636|NCT01321775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93200637|NCT01321775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200638|NCT01321775|Tubulin Modulators|tubulin modulators|mesh-ancestor
93200639|NCT01321775|Antimitotic Agents|antimitotic agents|mesh-ancestor
93200640|NCT01321775|Mitosis Modulators|mitosis modulators|mesh-ancestor
93200641|NCT01321775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200642|NCT01321775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200643|NCT01321775|Immunologic Factors|immunologic factors|mesh-ancestor
93200644|NCT01321775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200645|NCT01321775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200646|NCT01321775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93200647|NCT01321775|Alkylating Agents|alkylating agents|mesh-ancestor
93200648|NCT01321775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93200649|NCT01321775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93200650|NCT01321775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93200651|NCT01321775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93200652|NCT01321775|Growth Substances|growth substances|mesh-ancestor
93200653|NCT01321775|Growth Inhibitors|growth inhibitors|mesh-ancestor
93200654|NCT05514509|Cabotegravir|cabotegravir|mesh-list
93200655|NCT05514509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93200656|NCT05514509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93200657|NCT05514509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200658|NCT05514509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200659|NCT05514509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93200660|NCT05514509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93200661|NCT05514509|Antiviral Agents|antiviral agents|mesh-ancestor
93200662|NCT05514509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200663|NCT03764267|Lidocaine|lidocaine|mesh-list
93200664|NCT03764267|Remifentanil|remifentanil|mesh-list
93200665|NCT03764267|Anesthetics|anesthetics|mesh-list
93200666|NCT03764267|Anesthetics, General|anesthetics, general|mesh-list
93200667|NCT03764267|Anesthetics, Local|anesthetics, local|mesh-ancestor
93200668|NCT03764267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200669|NCT03764267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200670|NCT03764267|Sensory System Agents|sensory system agents|mesh-ancestor
93200671|NCT03764267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200672|NCT03764267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200673|NCT03764267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93200674|NCT03764267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93200675|NCT03764267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93200676|NCT03764267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200677|NCT03764267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93200678|NCT03764267|Narcotics|narcotics|mesh-ancestor
93200679|NCT03764267|Analgesics|analgesics|mesh-ancestor
93200680|NCT01321931|Nicotine|nicotine|mesh-list
93200681|NCT01321931|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93200682|NCT01321931|Autonomic Agents|autonomic agents|mesh-ancestor
93200683|NCT01321931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200684|NCT01321931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200685|NCT01321931|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93200686|NCT01321931|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93200687|NCT01321931|Cholinergic Agents|cholinergic agents|mesh-ancestor
93200688|NCT01321931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200689|NCT01321931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200690|NCT03763409|Losartan|losartan|mesh-list
93200691|NCT03763409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200692|NCT03763409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93200693|NCT03763409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93200694|NCT03763409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93200695|NCT03763409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200696|NCT01322477|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93200697|NCT01322477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93200698|NCT01322477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200699|NCT03762785|Dexmedetomidine|dexmedetomidine|mesh-list
93200700|NCT03762785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93200701|NCT03762785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200702|NCT03762785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200703|NCT03762785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200704|NCT03762785|Analgesics|analgesics|mesh-ancestor
93200705|NCT03762785|Sensory System Agents|sensory system agents|mesh-ancestor
93200706|NCT03762785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200707|NCT03762785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93200708|NCT03762785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93200709|NCT03762785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93200710|NCT03762785|Adrenergic Agents|adrenergic agents|mesh-ancestor
93200711|NCT03762785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200712|NCT03762785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200713|NCT03758729|Nivolumab|nivolumab|mesh-list
93200714|NCT03758729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93200715|NCT03758729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200716|NCT03758729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93200717|NCT03758729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200718|NCT03756623|Metformin|metformin|mesh-list
93200719|NCT03756623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93200720|NCT03756623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200721|NCT03756233|Remifentanil|remifentanil|mesh-list
93200722|NCT03756233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93200723|NCT03756233|Narcotics|narcotics|mesh-ancestor
93200724|NCT03756233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200725|NCT03756233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200726|NCT03756233|Analgesics|analgesics|mesh-ancestor
93200727|NCT03756233|Sensory System Agents|sensory system agents|mesh-ancestor
93200728|NCT03756233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200729|NCT03758339|Tucatinib|tucatinib|mesh-list
93200730|NCT03758339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200731|NCT03758339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200732|NCT03758339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200733|NCT03758339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200734|NCT03565913|Calcium, Dietary|calcium, dietary|mesh-list
93200735|NCT03565913|Magnesium citrate|magnesium citrate|mesh-list
93200736|NCT03565913|Calcium|calcium|mesh-list
93200737|NCT03565913|Calcium acetate|calcium acetate|mesh-list
93200738|NCT03565913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93200739|NCT03565913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200740|NCT03565913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93200741|NCT03565913|Chelating Agents|chelating agents|mesh-ancestor
93200742|NCT03565913|Sequestering Agents|sequestering agents|mesh-ancestor
93200743|NCT03565913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200744|NCT03565913|Cathartics|cathartics|mesh-ancestor
93200745|NCT03565913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93200746|NCT05085665|Ivermectin|ivermectin|mesh-list
93200747|NCT05085665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200748|NCT05085665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200749|NCT05004077|Amiodarone|amiodarone|mesh-list
93200750|NCT05004077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93200751|NCT05004077|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200752|NCT05004077|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93200753|NCT05004077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93200754|NCT05004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200755|NCT05004077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93200756|NCT05004077|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93200757|NCT05004077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93200758|NCT05004077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200759|NCT05004077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93200760|NCT05004077|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93200761|NCT05004077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93200762|NCT03755609|Fentanyl|fentanyl|mesh-list
93200763|NCT03755609|Oxycodone|oxycodone|mesh-list
93200764|NCT03755609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93200765|NCT03755609|Narcotics|narcotics|mesh-ancestor
93200766|NCT03755609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200767|NCT03755609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200768|NCT03755609|Analgesics|analgesics|mesh-ancestor
93200769|NCT03755609|Sensory System Agents|sensory system agents|mesh-ancestor
93200770|NCT03755609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200771|NCT03755609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93200772|NCT03755609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93200773|NCT03755609|Anesthetics, General|anesthetics, general|mesh-ancestor
93200774|NCT03755609|Anesthetics|anesthetics|mesh-ancestor
93200775|NCT03760445|Cytarabine|cytarabine|mesh-list
93200776|NCT03760445|Posaconazole|posaconazole|mesh-list
93200777|NCT03760445|Daunorubicin|daunorubicin|mesh-list
93200778|NCT03760445|Idarubicin|idarubicin|mesh-list
93200779|NCT03760445|Midostaurin|midostaurin|mesh-list
93200780|NCT03760445|Midazolam|midazolam|mesh-list
93200781|NCT03760445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93200782|NCT03760445|Antimetabolites|antimetabolites|mesh-ancestor
93200783|NCT03760445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200784|NCT03760445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200785|NCT03760445|Antiviral Agents|antiviral agents|mesh-ancestor
93200786|NCT03760445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200787|NCT03760445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200788|NCT03760445|Immunologic Factors|immunologic factors|mesh-ancestor
93200789|NCT03760445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200790|NCT03760445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93200791|NCT03760445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93200792|NCT03760445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200793|NCT03760445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93200794|NCT03760445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93200795|NCT03760445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93200796|NCT03760445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93200797|NCT03760445|Anesthetics, General|anesthetics, general|mesh-ancestor
93200798|NCT03760445|Anesthetics|anesthetics|mesh-ancestor
93200799|NCT03760445|GABA Modulators|gaba modulators|mesh-ancestor
93200800|NCT03760445|GABA Agents|gaba agents|mesh-ancestor
93200801|NCT03760445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200802|NCT03760445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93200803|NCT03760445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93200804|NCT03760445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93200805|NCT03760445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200806|NCT03760445|Antifungal Agents|antifungal agents|mesh-ancestor
93200807|NCT03760445|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93200808|NCT03760445|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93200809|NCT03760445|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200810|NCT03760445|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93200811|NCT03760445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93200812|NCT03760445|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93200813|NCT03760445|Hormone Antagonists|hormone antagonists|mesh-ancestor
93200814|NCT03760445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200815|NCT03760445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200816|NCT05460377|Vaccines|vaccines|mesh-list
93200817|NCT05460377|Immunologic Factors|immunologic factors|mesh-ancestor
93200818|NCT05460377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200819|NCT04956575|Vaccines|vaccines|mesh-list
93200820|NCT04956575|Immunologic Factors|immunologic factors|mesh-ancestor
93200821|NCT04956575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200822|NCT05692856|Clenbuterol|clenbuterol|mesh-list
93200823|NCT05692856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93200824|NCT05692856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93200825|NCT05692856|Adrenergic Agents|adrenergic agents|mesh-ancestor
93200826|NCT05692856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93200827|NCT05692856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200828|NCT05692856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200829|NCT05692856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93200830|NCT05692856|Autonomic Agents|autonomic agents|mesh-ancestor
93200831|NCT05692856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200832|NCT05692856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93200833|NCT05692856|Respiratory System Agents|respiratory system agents|mesh-ancestor
93200834|NCT05692856|Sympathomimetics|sympathomimetics|mesh-ancestor
93200835|NCT03755531|Oxytocin|oxytocin|mesh-list
93200836|NCT03755531|Carbetocin|carbetocin|mesh-list
93200837|NCT03755531|Oxytocics|oxytocics|mesh-ancestor
93200838|NCT03755531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200839|NCT03755531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200840|NCT04854707|Menotropins|menotropins|mesh-list
93200841|NCT04854707|Hormones|hormones|mesh-list
93200842|NCT04854707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93200843|NCT04854707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200844|NCT04854707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200845|NCT04854707|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93200846|NCT04854707|Fertility Agents|fertility agents|mesh-ancestor
93200847|NCT04854707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200848|NCT03215069|Empagliflozin|empagliflozin|mesh-list
93200849|NCT03215069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93200850|NCT03215069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200851|NCT03215069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93200852|NCT03215069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200853|NCT03759353|Lactoferrin|lactoferrin|mesh-list
93200854|NCT03759353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200855|NCT03757559|Hydromorphone|hydromorphone|mesh-list
93200856|NCT03757559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93200857|NCT03757559|Narcotics|narcotics|mesh-ancestor
93200858|NCT03757559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93200859|NCT03757559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200861|NCT03757559|Sensory System Agents|sensory system agents|mesh-ancestor
93200862|NCT03757559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200863|NCT05668949|Pembrolizumab|pembrolizumab|mesh-list
93200864|NCT05668949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93200865|NCT05668949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200866|NCT05668949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93200867|NCT05668949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200868|NCT05415917|Gemcitabine|gemcitabine|mesh-list
93200869|NCT05415917|Capecitabine|capecitabine|mesh-list
93200870|NCT05415917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93200871|NCT05415917|Antimetabolites|antimetabolites|mesh-ancestor
93200872|NCT05415917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200873|NCT05415917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200874|NCT02658929|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93200875|NCT02658929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93200876|NCT02658929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200877|NCT04784897|Brilacidin|brilacidin|mesh-list
93200878|NCT04784897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200879|NCT02780804|Entinostat|entinostat|mesh-list
93200880|NCT02780804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200881|NCT02780804|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93200882|NCT02780804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200883|NCT02780804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200884|NCT01322711|Atorvastatin|atorvastatin|mesh-list
93200885|NCT01322711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93200886|NCT01322711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93200887|NCT01322711|Antimetabolites|antimetabolites|mesh-ancestor
93200888|NCT01322711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200889|NCT01322711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93200890|NCT01322711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93200891|NCT01322711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200892|NCT04532099|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93200893|NCT04532099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93200894|NCT04532099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200895|NCT03041792|Liraglutide|liraglutide|mesh-list
93200896|NCT03041792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93200897|NCT03041792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200898|NCT03041792|Incretins|incretins|mesh-ancestor
93200899|NCT03041792|Hormones|hormones|mesh-ancestor
93200900|NCT03041792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93200901|NCT03753581|Cytarabine|cytarabine|mesh-list
93200902|NCT03753581|Methotrexate|methotrexate|mesh-list
93200903|NCT03753581|Etoposide|etoposide|mesh-list
93200904|NCT03753581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93200905|NCT03753581|Antimetabolites|antimetabolites|mesh-ancestor
93200906|NCT03753581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200907|NCT03753581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200908|NCT03753581|Antiviral Agents|antiviral agents|mesh-ancestor
93200909|NCT03753581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200910|NCT03753581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200911|NCT03753581|Immunologic Factors|immunologic factors|mesh-ancestor
93200912|NCT03753581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200913|NCT03753581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93200914|NCT03753581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93200915|NCT03753581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93200916|NCT03753581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200917|NCT03753581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93200918|NCT03753581|Abortifacient Agents|abortifacient agents|mesh-ancestor
93200919|NCT03753581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93200920|NCT03753581|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200921|NCT03753581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93200922|NCT03753581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200923|NCT03753581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93200924|NCT04507763|Etanercept|etanercept|mesh-list
93200925|NCT04507763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93200926|NCT04507763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93200927|NCT04507763|Analgesics|analgesics|mesh-ancestor
93200928|NCT04507763|Sensory System Agents|sensory system agents|mesh-ancestor
93200929|NCT04507763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93200930|NCT04507763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200931|NCT04507763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200932|NCT04507763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200933|NCT04507763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93200935|NCT04507763|Immunologic Factors|immunologic factors|mesh-ancestor
93200936|NCT00705484|Infliximab|infliximab|mesh-list
93200937|NCT00705484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93200938|NCT00705484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93200939|NCT00705484|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200940|NCT00705484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93200941|NCT00705484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200942|NCT05459597|Anticonvulsants|anticonvulsants|mesh-list
93200943|NCT05358626|Antibodies|antibodies|mesh-list
93200944|NCT05358626|Immunoglobulin G|immunoglobulin g|mesh-list
93200945|NCT05358626|Immunologic Factors|immunologic factors|mesh-ancestor
93200946|NCT05358626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200947|NCT03753269|Fasudil|fasudil|mesh-list
93200948|NCT03753269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93200949|NCT03753269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93200950|NCT03753269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200951|NCT03753269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93200952|NCT03753269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200953|NCT03753269|Vasodilator Agents|vasodilator agents|mesh-ancestor
93200954|NCT03753269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200955|NCT03753269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200956|NCT05459441|Pemetrexed|pemetrexed|mesh-list
93200957|NCT05459441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200958|NCT05459441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200959|NCT05459441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200960|NCT05459441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93200961|NCT05459441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93200962|NCT04523831|Doxycycline|doxycycline|mesh-list
93200963|NCT04523831|Ivermectin|ivermectin|mesh-list
93200964|NCT04523831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93200965|NCT04523831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200966|NCT04523831|Antimalarials|antimalarials|mesh-ancestor
93200967|NCT04523831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93200968|NCT04523831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93200969|NCT05691764|Cyclosporine|cyclosporine|mesh-list
93200970|NCT05691764|Cyclosporins|cyclosporins|mesh-list
93200971|NCT05691764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200972|NCT05691764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200973|NCT05691764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93200974|NCT05691764|Immunologic Factors|immunologic factors|mesh-ancestor
93200975|NCT05691764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200976|NCT05691764|Antifungal Agents|antifungal agents|mesh-ancestor
93200977|NCT05691764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200978|NCT05691764|Dermatologic Agents|dermatologic agents|mesh-ancestor
93200979|NCT05691764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93200980|NCT05691764|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93200981|NCT04707664|Sargramostim|sargramostim|mesh-list
93200982|NCT04707664|Immunologic Factors|immunologic factors|mesh-ancestor
93200983|NCT04707664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93200984|NCT01316276|Amikacin|amikacin|mesh-list
93200985|NCT01316276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93200986|NCT01316276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93200987|NCT02474290|Sorafenib|sorafenib|mesh-list
93200988|NCT02474290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93200989|NCT02474290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93200990|NCT02474290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93200991|NCT02474290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200992|NCT02474212|Enoxaparin|enoxaparin|mesh-list
93200993|NCT02474212|Anticoagulants|anticoagulants|mesh-ancestor
93200994|NCT02474212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93200995|NCT02474212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93200996|NCT02474212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93200997|NCT05200286|Olorofim|olorofim|mesh-list
93200998|NCT05200286|Antifungal Agents|antifungal agents|mesh-ancestor
93200999|NCT05200286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201000|NCT02474446|Vitamin D|vitamin d|mesh-list
93201001|NCT02474446|Vitamins|vitamins|mesh-ancestor
93201002|NCT02474446|Micronutrients|micronutrients|mesh-ancestor
93201003|NCT02474446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201004|NCT02474446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93201005|NCT05199818|Palonosetron|palonosetron|mesh-list
93201006|NCT05199818|Antiemetics|antiemetics|mesh-ancestor
93201007|NCT05199818|Autonomic Agents|autonomic agents|mesh-ancestor
93201008|NCT05199818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201009|NCT05199818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201010|NCT05199818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93201011|NCT05199818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93201012|NCT05199818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93201013|NCT05199818|Serotonin Agents|serotonin agents|mesh-ancestor
93201014|NCT05199818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201015|NCT05199818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201016|NCT02474134|Interferons|interferons|mesh-list
93201017|NCT02474134|Interferon-beta|interferon-beta|mesh-list
93201018|NCT02474134|Interferon beta-1b|interferon beta-1b|mesh-list
93201019|NCT02474134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201020|NCT02474134|Antiviral Agents|antiviral agents|mesh-ancestor
93201021|NCT02474134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201022|NCT02474134|Immunologic Factors|immunologic factors|mesh-ancestor
93201023|NCT02474134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201024|NCT02474134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93201025|NCT02473900|Oseltamivir|oseltamivir|mesh-list
93201026|NCT02473900|Antiviral Agents|antiviral agents|mesh-ancestor
93201027|NCT02473900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201028|NCT02473900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201029|NCT02473900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201030|NCT02471950|Isoflurane|isoflurane|mesh-list
93201031|NCT02471950|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93201032|NCT02471950|Anesthetics, General|anesthetics, general|mesh-ancestor
93201033|NCT02471950|Anesthetics|anesthetics|mesh-ancestor
93201034|NCT02471950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201035|NCT02471950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201036|NCT01322867|Alprazolam|alprazolam|mesh-list
93201037|NCT01322867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93201038|NCT01322867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201039|NCT01322867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201040|NCT01322867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93201041|NCT01322867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93201042|NCT01322867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93201043|NCT01322867|GABA Modulators|gaba modulators|mesh-ancestor
93201044|NCT01322867|GABA Agents|gaba agents|mesh-ancestor
93201045|NCT01322867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201046|NCT01322867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201047|NCT04624828|Androgens|androgens|mesh-list
93201048|NCT04624828|Hormones|hormones|mesh-ancestor
93201049|NCT04624828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201050|NCT04624828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201051|NCT02471560|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93201052|NCT02471560|Dermatologic Agents|dermatologic agents|mesh-ancestor
93201053|NCT02471560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201054|NCT02471560|Immunologic Factors|immunologic factors|mesh-ancestor
93201055|NCT02471560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201056|NCT02477488|Allopurinol|allopurinol|mesh-list
93201057|NCT02477488|Antimetabolites|antimetabolites|mesh-ancestor
93201058|NCT02477488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201059|NCT02477488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201060|NCT02477488|Gout Suppressants|gout suppressants|mesh-ancestor
93201061|NCT02477488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201062|NCT02477488|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93201063|NCT02477488|Antioxidants|antioxidants|mesh-ancestor
93201064|NCT02477488|Protective Agents|protective agents|mesh-ancestor
93201065|NCT02477488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201066|NCT05163106|Letrozole|letrozole|mesh-list
93201067|NCT05163106|Goserelin|goserelin|mesh-list
93201068|NCT05163106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201069|NCT05163106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93201070|NCT05163106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93201071|NCT05163106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201072|NCT05163106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201073|NCT05163106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93201074|NCT05163106|Hormone Antagonists|hormone antagonists|mesh-ancestor
93201075|NCT05163106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201076|NCT05163106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201077|NCT05163106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93201078|NCT02477098|Ropivacaine|ropivacaine|mesh-list
93201079|NCT02477098|Anesthetics, Local|anesthetics, local|mesh-ancestor
93201080|NCT02477098|Anesthetics|anesthetics|mesh-ancestor
93201081|NCT02477098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201082|NCT02477098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201083|NCT02477098|Sensory System Agents|sensory system agents|mesh-ancestor
93201084|NCT02477098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201085|NCT04518046|Nivolumab|nivolumab|mesh-list
93201086|NCT04518046|Ipilimumab|ipilimumab|mesh-list
93201087|NCT04518046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201088|NCT04518046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201089|NCT04518046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93201090|NCT04518046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201091|NCT05571670|Sirolimus|sirolimus|mesh-list
93201092|NCT05571670|MTOR Inhibitors|mtor inhibitors|mesh-list
93201093|NCT05571670|Temsirolimus|temsirolimus|mesh-list
93201094|NCT05571670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201095|NCT05571670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93201096|NCT05571670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201097|NCT05571670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201098|NCT05571670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201099|NCT05571670|Immunologic Factors|immunologic factors|mesh-ancestor
93201100|NCT05571670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201101|NCT05571670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201102|NCT05571670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201103|NCT05571670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93201104|NCT05571670|Antifungal Agents|antifungal agents|mesh-ancestor
93201105|NCT02473354|Remifentanil|remifentanil|mesh-list
93201106|NCT02473354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201107|NCT02473354|Narcotics|narcotics|mesh-ancestor
93201108|NCT02473354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201109|NCT02473354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201110|NCT02473354|Analgesics|analgesics|mesh-ancestor
93201111|NCT02473354|Sensory System Agents|sensory system agents|mesh-ancestor
93201112|NCT02473354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201113|NCT02470858|Sofosbuvir|sofosbuvir|mesh-list
93201114|NCT02470858|Asunaprevir|asunaprevir|mesh-list
93201115|NCT02470858|Antiviral Agents|antiviral agents|mesh-ancestor
93201116|NCT02470858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201117|NCT02470858|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201118|NCT02470858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201119|NCT02470858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201120|NCT02473198|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93201121|NCT02473198|Morphine|morphine|mesh-list
93201122|NCT02473198|Bupivacaine|bupivacaine|mesh-list
93201123|NCT02473198|Anesthetics, Local|anesthetics, local|mesh-ancestor
93201124|NCT02473198|Anesthetics|anesthetics|mesh-ancestor
93201125|NCT02473198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201126|NCT02473198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201127|NCT02473198|Sensory System Agents|sensory system agents|mesh-ancestor
93201128|NCT02473198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201129|NCT02473198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201130|NCT02473198|Narcotics|narcotics|mesh-ancestor
93201131|NCT02473198|Analgesics|analgesics|mesh-ancestor
93201132|NCT02473198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93201133|NCT02473198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93201134|NCT02473198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201135|NCT02473198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201136|NCT02473198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93201137|NCT02473198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201138|NCT02473198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201139|NCT03614728|Azacitidine|azacitidine|mesh-list
93201140|NCT03614728|GSK-3326595|gsk-3326595|mesh-list
93201141|NCT03614728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93201142|NCT03614728|Antimetabolites|antimetabolites|mesh-ancestor
93201143|NCT03614728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201144|NCT03614728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201145|NCT03614728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201146|NCT05069974|Linezolid|linezolid|mesh-list
93201147|NCT05069974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201148|NCT05069974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201149|NCT05069974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93201150|NCT05069974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201151|NCT05069974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201152|NCT05336266|Ketorolac|ketorolac|mesh-list
93201153|NCT05336266|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93201154|NCT05336266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93201155|NCT05336266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93201156|NCT05336266|Analgesics|analgesics|mesh-ancestor
93201157|NCT05336266|Sensory System Agents|sensory system agents|mesh-ancestor
93201158|NCT05336266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201159|NCT05336266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201160|NCT05336266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201161|NCT05336266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873253|NCT02685306|Paclitaxel|paclitaxel|mesh-list
93201162|NCT05336266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93201163|NCT05336266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201164|NCT05336266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201165|NCT02470780|Rifaximin|rifaximin|mesh-list
93201166|NCT02470780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201167|NCT02470780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201168|NCT02470780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93201169|NCT05180292|Carvedilol|carvedilol|mesh-list
93201170|NCT05180292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93201171|NCT05180292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93201172|NCT05180292|Adrenergic Agents|adrenergic agents|mesh-ancestor
93201173|NCT05180292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201174|NCT05180292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201175|NCT05180292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201176|NCT05180292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93201177|NCT05180292|Antioxidants|antioxidants|mesh-ancestor
93201178|NCT05180292|Protective Agents|protective agents|mesh-ancestor
93201179|NCT05180292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93201180|NCT05180292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93201181|NCT05180292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93201182|NCT05180292|Vasodilator Agents|vasodilator agents|mesh-ancestor
93201183|NCT05180292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93201184|NCT05180292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93201185|NCT01315938|Abatacept|abatacept|mesh-list
93201186|NCT01315938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93201187|NCT01315938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201188|NCT01315938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201189|NCT01315938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201190|NCT01315938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201191|NCT01315938|Immunologic Factors|immunologic factors|mesh-ancestor
93201192|NCT01315938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201193|NCT01315938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201194|NCT01339884|Resveratrol|resveratrol|mesh-list
93201195|NCT01339884|Antioxidants|antioxidants|mesh-ancestor
93201196|NCT01339884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201197|NCT01339884|Protective Agents|protective agents|mesh-ancestor
93201198|NCT01339884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201199|NCT01339884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201200|NCT01339884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93201201|NCT04736394|Epirubicin|epirubicin|mesh-list
93201202|NCT04736394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93201203|NCT04736394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117979|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201204|NCT04736394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93201205|NCT04736394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93201206|NCT04736394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201207|NCT04736394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201208|NCT01341834|Everolimus|everolimus|mesh-list
93201209|NCT01341834|Panobinostat|panobinostat|mesh-list
93201210|NCT01341834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93201211|NCT01341834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93201212|NCT01341834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201213|NCT01341834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201214|NCT01341834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201215|NCT01341834|Immunologic Factors|immunologic factors|mesh-ancestor
93201216|NCT01341834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201217|NCT01341834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201218|NCT01341834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93201219|NCT01340118|Budesonide|budesonide|mesh-list
93201220|NCT01340118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201221|NCT01340118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93201222|NCT01340118|Autonomic Agents|autonomic agents|mesh-ancestor
93201223|NCT01340118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201224|NCT01340118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201225|NCT01340118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93201226|NCT01340118|Respiratory System Agents|respiratory system agents|mesh-ancestor
93201227|NCT01340118|Glucocorticoids|glucocorticoids|mesh-ancestor
93201228|NCT01340118|Hormones|hormones|mesh-ancestor
93201229|NCT01340118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201230|NCT03401398|Hydrocortisone|hydrocortisone|mesh-list
93201231|NCT03401398|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93201232|NCT03401398|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93201233|NCT03401398|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93201234|NCT03401398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201235|NCT02470702|Oritavancin|oritavancin|mesh-list
93201236|NCT02470702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201237|NCT02470702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201238|NCT01375582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93201239|NCT01375582|Lubricant Eye Drops|lubricant eye drops|mesh-list
93201240|NCT01375582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93201241|NCT04409964|Lidocaine|lidocaine|mesh-list
93201242|NCT04409964|Dexmedetomidine|dexmedetomidine|mesh-list
93201243|NCT04409964|Remifentanil|remifentanil|mesh-list
93201244|NCT04409964|Anesthetics, Local|anesthetics, local|mesh-ancestor
93201245|NCT04409964|Anesthetics|anesthetics|mesh-ancestor
93201246|NCT04409964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201247|NCT04409964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201248|NCT04409964|Sensory System Agents|sensory system agents|mesh-ancestor
93201249|NCT04409964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201250|NCT04409964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93201251|NCT04409964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93201252|NCT04409964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93201253|NCT04409964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93201254|NCT04409964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201255|NCT04409964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93201256|NCT04409964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93201257|NCT04409964|Analgesics|analgesics|mesh-ancestor
93201258|NCT04409964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93201259|NCT04409964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93201260|NCT04409964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93201261|NCT04409964|Adrenergic Agents|adrenergic agents|mesh-ancestor
93201262|NCT04409964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201263|NCT04409964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201264|NCT04409964|Narcotics|narcotics|mesh-ancestor
93201265|NCT01342146|Hormones|hormones|mesh-list
93201266|NCT01342146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201267|NCT01342146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201268|NCT03212716|Oseltamivir|oseltamivir|mesh-list
93201269|NCT03212716|Diltiazem|diltiazem|mesh-list
93201270|NCT03212716|Antiviral Agents|antiviral agents|mesh-ancestor
93201271|NCT03212716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201272|NCT03212716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201273|NCT03212716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201274|NCT03212716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93201275|NCT03212716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93201276|NCT03212716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855811|NCT02825342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93201277|NCT03212716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93201278|NCT03212716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201279|NCT03212716|Vasodilator Agents|vasodilator agents|mesh-ancestor
93201280|NCT04762836|Cycloserine|cycloserine|mesh-list
93201281|NCT04762836|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93201282|NCT04762836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201283|NCT04762836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93201284|NCT04762836|Antitubercular Agents|antitubercular agents|mesh-ancestor
93201285|NCT04762836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201286|NCT04762836|Antimetabolites|antimetabolites|mesh-ancestor
93201287|NCT04762836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201288|NCT00705406|Peramivir|peramivir|mesh-list
93201289|NCT00705406|Antiviral Agents|antiviral agents|mesh-ancestor
93201290|NCT00705406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201291|NCT00705406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201292|NCT00705406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201293|NCT01342224|Gemcitabine|gemcitabine|mesh-list
93201294|NCT01342224|Tadalafil|tadalafil|mesh-list
93201295|NCT01342224|Sargramostim|sargramostim|mesh-list
93201296|NCT01342224|Immunologic Factors|immunologic factors|mesh-ancestor
93201297|NCT01342224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201298|NCT01342224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93201299|NCT01342224|Antimetabolites|antimetabolites|mesh-ancestor
93201300|NCT01342224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201301|NCT01342224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201302|NCT01342224|Vasodilator Agents|vasodilator agents|mesh-ancestor
93201303|NCT01342224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93201304|NCT01342224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93201305|NCT01342224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201306|NCT01342224|Urological Agents|urological agents|mesh-ancestor
93201307|NCT03155178|Ethanol|ethanol|mesh-list
93201308|NCT03155178|Chlorhexidine|chlorhexidine|mesh-list
93201309|NCT03155178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93201310|NCT03155178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93201311|NCT03155178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201312|NCT03155178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201313|NCT03155178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201314|NCT03155178|Disinfectants|disinfectants|mesh-ancestor
93201315|NCT03155178|Dermatologic Agents|dermatologic agents|mesh-ancestor
93201316|NCT02470546|Metformin|metformin|mesh-list
93201317|NCT02470546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93201318|NCT02470546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201319|NCT03310762|Silicon|silicon|mesh-list
93201320|NCT03310762|Trace Elements|trace elements|mesh-ancestor
93201321|NCT03310762|Micronutrients|micronutrients|mesh-ancestor
93201322|NCT03310762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201323|NCT03310606|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93201324|NCT03310606|Lactams|lactams|mesh-list
93201325|NCT03310606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201326|NCT01315704|Vitamin D|vitamin d|mesh-list
93201327|NCT01315704|Vitamins|vitamins|mesh-ancestor
93201328|NCT01315704|Micronutrients|micronutrients|mesh-ancestor
93201329|NCT01315704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201330|NCT01315704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93201331|NCT03107884|Metformin|metformin|mesh-list
93201332|NCT03107884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93201333|NCT03107884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201334|NCT05158608|Cyclophosphamide|cyclophosphamide|mesh-list
93201335|NCT05158608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201336|NCT05158608|Immunologic Factors|immunologic factors|mesh-ancestor
93201337|NCT05158608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201338|NCT05158608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201339|NCT05158608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93201340|NCT05158608|Alkylating Agents|alkylating agents|mesh-ancestor
93201341|NCT05158608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201342|NCT05158608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201343|NCT05158608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93201344|NCT04702776|Hyaluronic Acid|hyaluronic acid|mesh-list
93201345|NCT04702776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93201346|NCT04702776|Immunologic Factors|immunologic factors|mesh-ancestor
93201347|NCT04702776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201348|NCT04702776|Viscosupplements|viscosupplements|mesh-ancestor
93201349|NCT04702776|Protective Agents|protective agents|mesh-ancestor
93201350|NCT03310372|Temozolomide|temozolomide|mesh-list
93201351|NCT03310372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93201352|NCT03310372|Alkylating Agents|alkylating agents|mesh-ancestor
93201353|NCT03310372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201354|NCT03310372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201355|NCT02980276|Metformin|metformin|mesh-list
93201356|NCT02980276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93201357|NCT02980276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201358|NCT03108664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93201359|NCT03108664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93201360|NCT01342614|Metformin|metformin|mesh-list
93201361|NCT01342614|Fosinopril|fosinopril|mesh-list
93201362|NCT01342614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93201363|NCT01342614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201364|NCT01342614|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93201365|NCT01342614|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201366|NCT01342614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201367|NCT01342614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201368|NCT01342614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93201369|NCT01342692|Lenalidomide|lenalidomide|mesh-list
93201370|NCT01342692|Azacitidine|azacitidine|mesh-list
93201371|NCT01342692|Idarubicin|idarubicin|mesh-list
93201372|NCT01342692|Valproic Acid|valproic acid|mesh-list
93201373|NCT01342692|Immunologic Factors|immunologic factors|mesh-ancestor
93201374|NCT01342692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201375|NCT01342692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93201376|NCT01342692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93201377|NCT01342692|Growth Substances|growth substances|mesh-ancestor
93201378|NCT01342692|Growth Inhibitors|growth inhibitors|mesh-ancestor
93201379|NCT01342692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201380|NCT01342692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93201381|NCT01342692|Antimetabolites|antimetabolites|mesh-ancestor
93201382|NCT01342692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201383|NCT01342692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201384|NCT01342692|Anticonvulsants|anticonvulsants|mesh-ancestor
93201385|NCT01342692|GABA Agents|gaba agents|mesh-ancestor
93201386|NCT01342692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201387|NCT01342692|Antimanic Agents|antimanic agents|mesh-ancestor
93201388|NCT01342692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93201389|NCT01342692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201390|NCT01342692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93201391|NCT01342692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93201392|NCT01342692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93201393|NCT01342692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93201394|NCT05153772|Octreotide|octreotide|mesh-list
93201395|NCT05153772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93201396|NCT05153772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93201397|NCT05153772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201398|NCT03310060|Tranexamic Acid|tranexamic acid|mesh-list
93201399|NCT03310060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93201400|NCT03310060|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93201401|NCT03310060|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93201402|NCT03310060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201403|NCT03310060|Hemostatics|hemostatics|mesh-ancestor
93201404|NCT03310060|Coagulants|coagulants|mesh-ancestor
93201405|NCT02520778|Osimertinib|osimertinib|mesh-list
93201406|NCT02520778|Navitoclax|navitoclax|mesh-list
93201407|NCT02520778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201408|NCT02520778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93201409|NCT02520778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201410|NCT02520778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201411|NCT03740958|Argatroban|argatroban|mesh-list
93201412|NCT03740958|Antithrombins|antithrombins|mesh-ancestor
93201413|NCT03740958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93201414|NCT03740958|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201415|NCT03740958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201416|NCT03740958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201417|NCT03740958|Anticoagulants|anticoagulants|mesh-ancestor
93201418|NCT03740958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93201419|NCT01340820|BCG Vaccine|bcg vaccine|mesh-list
93201420|NCT01340820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93201421|NCT01340820|Immunologic Factors|immunologic factors|mesh-ancestor
93201422|NCT01340820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201423|NCT03685188|Sufentanil|sufentanil|mesh-list
93201424|NCT03685188|Oxycodone|oxycodone|mesh-list
93201425|NCT03685188|Dsuvia|dsuvia|mesh-list
93201426|NCT03685188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201427|NCT03685188|Narcotics|narcotics|mesh-ancestor
93201428|NCT03685188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201429|NCT03685188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201430|NCT03685188|Analgesics|analgesics|mesh-ancestor
93201431|NCT03685188|Sensory System Agents|sensory system agents|mesh-ancestor
93201432|NCT03685188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201433|NCT03685188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93201434|NCT03685188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93201435|NCT03685188|Anesthetics, General|anesthetics, general|mesh-ancestor
93201436|NCT03685188|Anesthetics|anesthetics|mesh-ancestor
93201437|NCT02305654|Paclitaxel|paclitaxel|mesh-list
93201438|NCT02305654|Ifosfamide|ifosfamide|mesh-list
93201439|NCT02305654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93201440|NCT02305654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201441|NCT02305654|Tubulin Modulators|tubulin modulators|mesh-ancestor
93201442|NCT02305654|Antimitotic Agents|antimitotic agents|mesh-ancestor
93201443|NCT02305654|Mitosis Modulators|mitosis modulators|mesh-ancestor
93201444|NCT02305654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201445|NCT02305654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93201446|NCT02305654|Alkylating Agents|alkylating agents|mesh-ancestor
93201447|NCT05251584|Gentamicins|gentamicins|mesh-list
93201448|NCT05251584|Mupirocin|mupirocin|mesh-list
93201449|NCT05251584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201450|NCT05251584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201451|NCT05251584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93201452|NCT05251584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201453|NCT05251584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201454|NCT03309748|Anti-Infective Agents|anti-infective agents|mesh-list
93201455|NCT03309748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93201456|NCT02108860|Abatacept|abatacept|mesh-list
93201457|NCT02108860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93201458|NCT02108860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201459|NCT02108860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201460|NCT02108860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201461|NCT02108860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201462|NCT02108860|Immunologic Factors|immunologic factors|mesh-ancestor
93201463|NCT02108860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201464|NCT02108860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201465|NCT00705250|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93201466|NCT00705250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93201467|NCT00705250|Alkylating Agents|alkylating agents|mesh-ancestor
93201468|NCT00705250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201469|NCT00705250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201470|NCT03309592|Ambrisentan|ambrisentan|mesh-list
93201471|NCT03309592|Tadalafil|tadalafil|mesh-list
93201472|NCT03309592|Vasodilator Agents|vasodilator agents|mesh-ancestor
93201473|NCT03309592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93201474|NCT03309592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93201475|NCT03309592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201476|NCT03309592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201477|NCT03309592|Urological Agents|urological agents|mesh-ancestor
93201478|NCT03309592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93201479|NCT04641312|Dulaglutide|dulaglutide|mesh-list
93201480|NCT04641312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93201481|NCT04641312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201482|NCT03078192|Xenon|xenon|mesh-list
93201483|NCT03078192|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93201484|NCT03078192|Anesthetics, General|anesthetics, general|mesh-ancestor
93201485|NCT03078192|Anesthetics|anesthetics|mesh-ancestor
93201486|NCT03078192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201487|NCT03078192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201488|NCT00703846|Ketoconazole|ketoconazole|mesh-list
93201489|NCT00703846|Antifungal Agents|antifungal agents|mesh-ancestor
93201490|NCT00703846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201491|NCT00703846|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93201492|NCT00703846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93201493|NCT00703846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201494|NCT00703846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855813|NCT02749890|Insulin Glargine|insulin glargine|mesh-list
93201495|NCT00703846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93201496|NCT00703846|Hormone Antagonists|hormone antagonists|mesh-ancestor
93201497|NCT00703846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201498|NCT00703846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201499|NCT00703846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93201500|NCT03309436|Clomiphene|clomiphene|mesh-list
93201501|NCT03309436|Enclomiphene|enclomiphene|mesh-list
93201502|NCT03309436|Zuclomiphene|zuclomiphene|mesh-list
93201503|NCT03309436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93201504|NCT03309436|Hormone Antagonists|hormone antagonists|mesh-ancestor
93201505|NCT03309436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201506|NCT03309436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201507|NCT03309436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93201508|NCT03309436|Fertility Agents|fertility agents|mesh-ancestor
93201509|NCT03309436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93201510|NCT03309436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93201511|NCT03309436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93201512|NCT05183334|Sildenafil Citrate|sildenafil citrate|mesh-list
93201513|NCT05183334|Tramadol|tramadol|mesh-list
93201514|NCT05183334|Vasodilator Agents|vasodilator agents|mesh-ancestor
93201515|NCT05183334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93201516|NCT05183334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93201517|NCT05183334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201518|NCT05183334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201519|NCT05183334|Urological Agents|urological agents|mesh-ancestor
93201520|NCT05183334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201521|NCT05183334|Narcotics|narcotics|mesh-ancestor
93201522|NCT05183334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201523|NCT05183334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201524|NCT05183334|Analgesics|analgesics|mesh-ancestor
93201525|NCT05183334|Sensory System Agents|sensory system agents|mesh-ancestor
93201526|NCT05183334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201527|NCT03304444|Bupivacaine|bupivacaine|mesh-list
93201528|NCT03304444|Anesthetics, Local|anesthetics, local|mesh-ancestor
93201529|NCT03304444|Anesthetics|anesthetics|mesh-ancestor
93201530|NCT03304444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201531|NCT03304444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201532|NCT03304444|Sensory System Agents|sensory system agents|mesh-ancestor
93201533|NCT03304444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201534|NCT03304288|Rituximab|rituximab|mesh-list
93201535|NCT03304288|Tretinoin|tretinoin|mesh-list
93201536|NCT03304288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201537|NCT03304288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201538|NCT03304288|Immunologic Factors|immunologic factors|mesh-ancestor
93201539|NCT03304288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201540|NCT03304288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201541|NCT03304288|Keratolytic Agents|keratolytic agents|mesh-ancestor
93201542|NCT03304288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93201543|NCT03304210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93201544|NCT03304210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201545|NCT03313960|Insulin|insulin|mesh-list
93201546|NCT03313960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93201547|NCT03313960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201548|NCT03308890|Entecavir|entecavir|mesh-list
93201549|NCT03308890|Antiviral Agents|antiviral agents|mesh-ancestor
93201550|NCT03308890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201551|NCT03313726|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93201552|NCT03313726|Hormones|hormones|mesh-ancestor
93201553|NCT03313726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201554|NCT03313726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201555|NCT03303976|Vaccines|vaccines|mesh-list
93201556|NCT03303976|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93201557|NCT03303976|Immunologic Factors|immunologic factors|mesh-ancestor
93201558|NCT03303976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201559|NCT03313414|Sofosbuvir|sofosbuvir|mesh-list
93201560|NCT03313414|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93201561|NCT03313414|Velpatasvir|velpatasvir|mesh-list
93201562|NCT03313414|Antiviral Agents|antiviral agents|mesh-ancestor
93201563|NCT03313414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201564|NCT02468518|Vitamin E|vitamin e|mesh-list
93201565|NCT02468518|Vitamins|vitamins|mesh-ancestor
93201566|NCT02468518|Micronutrients|micronutrients|mesh-ancestor
93201567|NCT02468518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201568|NCT02468518|Antioxidants|antioxidants|mesh-ancestor
92497400|NCT01997164|Growth Inhibitors|growth inhibitors|mesh-ancestor
93201569|NCT02468518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201570|NCT02468518|Protective Agents|protective agents|mesh-ancestor
93201571|NCT03313336|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93201572|NCT03313336|Anesthetics, Local|anesthetics, local|mesh-ancestor
93201573|NCT03313336|Anesthetics|anesthetics|mesh-ancestor
93201574|NCT03313336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201575|NCT03313336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201576|NCT03313336|Sensory System Agents|sensory system agents|mesh-ancestor
93201577|NCT03313336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201578|NCT03313336|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93201579|NCT05262322|Rivaroxaban|rivaroxaban|mesh-list
93201580|NCT05262322|Apixaban|apixaban|mesh-list
93201581|NCT05262322|Edoxaban|edoxaban|mesh-list
93201582|NCT05262322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93201583|NCT05262322|Antithrombins|antithrombins|mesh-ancestor
93201584|NCT05262322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93201585|NCT05262322|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201586|NCT05262322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201587|NCT05262322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201588|NCT05262322|Anticoagulants|anticoagulants|mesh-ancestor
93201589|NCT04490980|Butorphanol|butorphanol|mesh-list
93201590|NCT04490980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201591|NCT04490980|Narcotics|narcotics|mesh-ancestor
93201592|NCT04490980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201593|NCT04490980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201594|NCT04490980|Analgesics|analgesics|mesh-ancestor
93201595|NCT04490980|Sensory System Agents|sensory system agents|mesh-ancestor
93201596|NCT04490980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201597|NCT04490980|Antitussive Agents|antitussive agents|mesh-ancestor
93201598|NCT04490980|Respiratory System Agents|respiratory system agents|mesh-ancestor
93201599|NCT04490980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93201600|NCT03307720|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93201601|NCT03307720|Hormones|hormones|mesh-list
93201602|NCT03307720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201603|NCT03307720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201604|NCT03307720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93201605|NCT04608786|Capecitabine|capecitabine|mesh-list
93201606|NCT04608786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93201607|NCT04608786|Antimetabolites|antimetabolites|mesh-ancestor
93201608|NCT04608786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201609|NCT04608786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201610|NCT01314872|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93201611|NCT01314872|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93201612|NCT01314872|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93201613|NCT01314872|Cholinergic Agents|cholinergic agents|mesh-ancestor
93201614|NCT01314872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201615|NCT01314872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201616|NCT01314872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201617|NCT01314872|Urological Agents|urological agents|mesh-ancestor
93201618|NCT01343628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93201619|NCT01343628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93201620|NCT01343628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93201621|NCT01343628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93201622|NCT01343628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201623|NCT01343628|Adrenergic Agents|adrenergic agents|mesh-ancestor
93201624|NCT01343628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201625|NCT01343628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201626|NCT00703924|Paromomycin|paromomycin|mesh-list
93201627|NCT00703924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201628|NCT00703924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201629|NCT00703924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93201630|NCT00703924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93201631|NCT03302650|Norepinephrine|norepinephrine|mesh-list
93201632|NCT03302650|Angiotensin II|angiotensin ii|mesh-list
93201633|NCT03302650|Giapreza|giapreza|mesh-list
93201634|NCT03302650|Angiotensinogen|angiotensinogen|mesh-list
93201635|NCT03302650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93201636|NCT03302650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93201637|NCT03302650|Adrenergic Agents|adrenergic agents|mesh-ancestor
93201638|NCT03302650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201639|NCT03302650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201640|NCT03302650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201641|NCT03302650|Sympathomimetics|sympathomimetics|mesh-ancestor
93201642|NCT03302650|Autonomic Agents|autonomic agents|mesh-ancestor
91928476|NCT02403687|Capsaicin|capsaicin|mesh-list
93201643|NCT03302650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201644|NCT03302650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93201645|NCT03302650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93201646|NCT03302650|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201647|NCT03302650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201648|NCT01343706|BI 409306|bi 409306|mesh-list
93201649|NCT01343706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93201650|NCT01343706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201651|NCT01343706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201652|NCT03312478|Antibodies|antibodies|mesh-list
93201653|NCT03312478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201654|NCT03312478|Immunologic Factors|immunologic factors|mesh-ancestor
93201655|NCT03312244|Bromides|bromides|mesh-list
93201656|NCT03312244|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93201657|NCT03312244|Anticonvulsants|anticonvulsants|mesh-ancestor
93201658|NCT03312244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93201659|NCT03312244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201660|NCT03312244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201661|NCT03312244|Cholinergic Agents|cholinergic agents|mesh-ancestor
93201662|NCT03312244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201663|NCT03312244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201664|NCT03306940|Botulinum Toxins|botulinum toxins|mesh-list
93201665|NCT03306940|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93201666|NCT03306940|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93201667|NCT03306940|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93201668|NCT03306940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93201669|NCT03306940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201670|NCT03306940|Cholinergic Agents|cholinergic agents|mesh-ancestor
93201671|NCT03306940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201672|NCT03306940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201673|NCT03306940|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93201674|NCT03306940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201675|NCT00739050|Simvastatin|simvastatin|mesh-list
93201676|NCT00739050|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93201677|NCT00739050|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93201678|NCT00739050|Antimetabolites|antimetabolites|mesh-ancestor
93201679|NCT00739050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201680|NCT00739050|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93201681|NCT00739050|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93201682|NCT00739050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201683|NCT03302182|Ritonavir|ritonavir|mesh-list
93201684|NCT03302182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93201685|NCT03302182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93201686|NCT03302182|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201687|NCT03302182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201688|NCT03302182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873776|NCT02677584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201689|NCT03302182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93201690|NCT03302182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93201691|NCT03302182|Antiviral Agents|antiviral agents|mesh-ancestor
93201692|NCT03302182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201693|NCT03302182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93201694|NCT03302182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93201695|NCT01343862|Cycloserine|cycloserine|mesh-list
93201696|NCT01343862|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93201697|NCT01343862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201698|NCT01343862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93201699|NCT01343862|Antitubercular Agents|antitubercular agents|mesh-ancestor
93201700|NCT01343862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93201701|NCT01343862|Antimetabolites|antimetabolites|mesh-ancestor
93201702|NCT01343862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201703|NCT03311932|Hydrocortisone|hydrocortisone|mesh-list
93201704|NCT03311932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201705|NCT00604812|Rizatriptan|rizatriptan|mesh-list
93201706|NCT00604812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93201707|NCT00604812|Serotonin Agents|serotonin agents|mesh-ancestor
93201708|NCT00604812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201709|NCT00604812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201710|NCT00604812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201711|NCT04347408|Antibodies|antibodies|mesh-list
93201712|NCT04347408|Immunologic Factors|immunologic factors|mesh-ancestor
93201713|NCT04347408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201714|NCT03306550|Aspirin|aspirin|mesh-list
92497551|NCT01998165|Analgesics|analgesics|mesh-ancestor
93201715|NCT03306550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93201716|NCT03306550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93201717|NCT03306550|Analgesics|analgesics|mesh-ancestor
93201718|NCT03306550|Sensory System Agents|sensory system agents|mesh-ancestor
93201719|NCT03306550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201720|NCT03306550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201721|NCT03306550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201722|NCT03306550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201723|NCT03306550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93201724|NCT03306550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93201725|NCT03306550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201726|NCT03306550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93201727|NCT03306550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93201728|NCT03306550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201729|NCT03306550|Antipyretics|antipyretics|mesh-ancestor
93201730|NCT03306472|Letrozole|letrozole|mesh-list
93201731|NCT03306472|Megestrol|megestrol|mesh-list
93201732|NCT03306472|Megestrol Acetate|megestrol acetate|mesh-list
93201733|NCT03306472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201734|NCT03306472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93201735|NCT03306472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93201736|NCT03306472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201737|NCT03306472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201738|NCT03306472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93201739|NCT03306472|Hormone Antagonists|hormone antagonists|mesh-ancestor
93201740|NCT03306472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201741|NCT03306472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201742|NCT03306472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93201743|NCT03306472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93201744|NCT03306472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93201745|NCT03306472|Contraceptive Agents|contraceptive agents|mesh-ancestor
93201746|NCT03306472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93201747|NCT03306472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93201748|NCT03306472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93201749|NCT03306472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93201750|NCT03306472|Appetite Stimulants|appetite stimulants|mesh-ancestor
93201751|NCT03306472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93201752|NCT03311542|Pembrolizumab|pembrolizumab|mesh-list
93201753|NCT03311542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201754|NCT03311542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201755|NCT03311542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93201756|NCT03311542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201757|NCT03311464|Adalimumab|adalimumab|mesh-list
93201758|NCT03311464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93201759|NCT03311464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201760|NCT03311464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201761|NCT05214066|Thymoglobulin|thymoglobulin|mesh-list
93201762|NCT05214066|Immunologic Factors|immunologic factors|mesh-ancestor
93201763|NCT05214066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201764|NCT05214066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201766|NCT02468206|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93201767|NCT02468206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93201768|NCT03233854|Cyclophosphamide|cyclophosphamide|mesh-list
93201769|NCT03233854|Fludarabine|fludarabine|mesh-list
93201770|NCT03233854|Fludarabine phosphate|fludarabine phosphate|mesh-list
93201771|NCT03233854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201772|NCT03233854|Immunologic Factors|immunologic factors|mesh-ancestor
93201773|NCT03233854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201774|NCT03233854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201775|NCT03233854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93201776|NCT03233854|Alkylating Agents|alkylating agents|mesh-ancestor
93201777|NCT03233854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201778|NCT03233854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201779|NCT03233854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93201780|NCT03233854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93201781|NCT03233854|Antimetabolites|antimetabolites|mesh-ancestor
93201782|NCT01344174|Lamivudine|lamivudine|mesh-list
93201783|NCT01344174|Dexamethasone|dexamethasone|mesh-list
93201784|NCT01344174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201785|NCT01344174|Antiemetics|antiemetics|mesh-ancestor
93201786|NCT01344174|Autonomic Agents|autonomic agents|mesh-ancestor
93201787|NCT01344174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201788|NCT01344174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201789|NCT01344174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93201790|NCT01344174|Glucocorticoids|glucocorticoids|mesh-ancestor
93201791|NCT01344174|Hormones|hormones|mesh-ancestor
93201792|NCT01344174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201793|NCT01344174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93201794|NCT01344174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201795|NCT01344174|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93201796|NCT01344174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93201797|NCT01344174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201798|NCT01344174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201799|NCT01344174|Antiviral Agents|antiviral agents|mesh-ancestor
93201800|NCT01344174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93201801|NCT01344174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93201802|NCT01344174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93201803|NCT05162274|Lazertinib|lazertinib|mesh-list
93201804|NCT05162274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93201805|NCT05162274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201806|NCT05162274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201807|NCT03023566|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
93201808|NCT03023566|Chelating Agents|chelating agents|mesh-ancestor
93201809|NCT03023566|Sequestering Agents|sequestering agents|mesh-ancestor
93201810|NCT03023566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201811|NCT03311386|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93201812|NCT03311386|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93201813|NCT03311386|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93201814|NCT03311386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201815|NCT02468908|Molgramostim|molgramostim|mesh-list
93201816|NCT02468908|Sargramostim|sargramostim|mesh-list
93201817|NCT02468908|Immunologic Factors|immunologic factors|mesh-ancestor
93201818|NCT02468908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201819|NCT02468908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201820|NCT02468128|Nalbuphine|nalbuphine|mesh-list
93201821|NCT02468128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201822|NCT02468128|Narcotics|narcotics|mesh-ancestor
93201823|NCT02468128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201824|NCT02468128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201825|NCT02468128|Analgesics|analgesics|mesh-ancestor
93201826|NCT02468128|Sensory System Agents|sensory system agents|mesh-ancestor
93201827|NCT02468128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201828|NCT03305536|Vitamin D|vitamin d|mesh-list
93201829|NCT03305536|Vitamins|vitamins|mesh-list
93201830|NCT03305536|Vitamin K|vitamin k|mesh-list
93201831|NCT03305536|Vitamin K 2|vitamin k 2|mesh-list
93201832|NCT03305536|Menaquinone 7|menaquinone 7|mesh-list
93201833|NCT03305536|Micronutrients|micronutrients|mesh-ancestor
93201834|NCT03305536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201835|NCT03305536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93201836|NCT03305536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92873923|NCT04181346|Anticonvulsants|anticonvulsants|mesh-ancestor
93201837|NCT03305536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93201838|NCT03305536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201839|NCT03305536|Hemostatics|hemostatics|mesh-ancestor
93201840|NCT03305536|Coagulants|coagulants|mesh-ancestor
93201841|NCT03210688|Alfacalcidol|alfacalcidol|mesh-list
93201842|NCT03210688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93201843|NCT03210688|Prednisone|prednisone|mesh-list
93201844|NCT03210688|Prednisolone|prednisolone|mesh-list
93201845|NCT03210688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201846|NCT03210688|Glucocorticoids|glucocorticoids|mesh-ancestor
93201847|NCT03210688|Hormones|hormones|mesh-ancestor
93201848|NCT03210688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93201849|NCT03210688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201850|NCT03210688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93201851|NCT03210688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201852|NCT03210688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93201853|NCT03210688|Vitamins|vitamins|mesh-ancestor
93201854|NCT03210688|Micronutrients|micronutrients|mesh-ancestor
93201855|NCT02467426|Mitoxantrone|mitoxantrone|mesh-list
93201856|NCT02467426|Analgesics|analgesics|mesh-ancestor
93201857|NCT02467426|Sensory System Agents|sensory system agents|mesh-ancestor
93201858|NCT02467426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201859|NCT02467426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201860|NCT02467426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201861|NCT02467426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93201862|NCT02467426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93201863|NCT02467426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201864|NCT02467426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201865|NCT04296942|Trastuzumab|trastuzumab|mesh-list
93201866|NCT04296942|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93201867|NCT04296942|Maytansine|maytansine|mesh-list
93201868|NCT04296942|Entinostat|entinostat|mesh-list
93201869|NCT04296942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201870|NCT04296942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201871|NCT04296942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93201872|NCT04296942|Tubulin Modulators|tubulin modulators|mesh-ancestor
93201873|NCT04296942|Antimitotic Agents|antimitotic agents|mesh-ancestor
93201874|NCT04296942|Mitosis Modulators|mitosis modulators|mesh-ancestor
93201875|NCT04296942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201876|NCT04296942|Immunotoxins|immunotoxins|mesh-ancestor
93201877|NCT04296942|Immunoconjugates|immunoconjugates|mesh-ancestor
93201878|NCT04296942|Immunologic Factors|immunologic factors|mesh-ancestor
93201879|NCT04296942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201880|NCT04296942|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93201881|NCT04296942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201882|NCT01344564|Leuprolide|leuprolide|mesh-list
93201883|NCT01344564|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93201884|NCT01344564|Fertility Agents|fertility agents|mesh-ancestor
93201885|NCT01344564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93201886|NCT01344564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201887|NCT01344564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93201888|NCT01344564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201889|NCT01344720|Etoricoxib|etoricoxib|mesh-list
93201890|NCT01344720|Oxycodone|oxycodone|mesh-list
93201891|NCT01344720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93201892|NCT01344720|Narcotics|narcotics|mesh-ancestor
93201893|NCT01344720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201894|NCT01344720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201895|NCT01344720|Analgesics|analgesics|mesh-ancestor
93201896|NCT01344720|Sensory System Agents|sensory system agents|mesh-ancestor
93201897|NCT01344720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201898|NCT01344720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93201899|NCT01344720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93201900|NCT01344720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201901|NCT01344720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201902|NCT01344720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93201903|NCT01344720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93201904|NCT01344720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201905|NCT01344720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201906|NCT03220854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93201907|NCT03220854|Antibodies|antibodies|mesh-list
93201908|NCT03220854|Immunoglobulins|immunoglobulins|mesh-list
93201909|NCT03220854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93201910|NCT03220854|Immunologic Factors|immunologic factors|mesh-ancestor
93201911|NCT03220854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201912|NCT03220854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201914|NCT03305068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93201915|NCT03305068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93201916|NCT03305068|Analgesics|analgesics|mesh-ancestor
93201917|NCT03305068|Sensory System Agents|sensory system agents|mesh-ancestor
93201918|NCT03305068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93201919|NCT03305068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201920|NCT03305068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93201921|NCT03305068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201922|NCT03305068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93201923|NCT03305068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93201924|NCT03305068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201925|NCT03305068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201926|NCT04490590|Etoposide|etoposide|mesh-list
93201927|NCT04490590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93201928|NCT04490590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201929|NCT04490590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93201930|NCT04490590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93201931|NCT04490590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201932|NCT04490590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201933|NCT03299998|Anesthetics|anesthetics|mesh-list
93201934|NCT03299998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93201935|NCT03299998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201936|NCT03735420|Xanthohumol|xanthohumol|mesh-list
93201937|NCT03735420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201938|NCT03735420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93201939|NCT03735420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93201940|NCT03735420|Growth Substances|growth substances|mesh-ancestor
93201941|NCT03735420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201942|NCT03735420|Growth Inhibitors|growth inhibitors|mesh-ancestor
93201943|NCT03299842|Fenfluramine|fenfluramine|mesh-list
93201944|NCT03299842|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93201945|NCT03299842|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93201946|NCT03299842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93201947|NCT03299842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201948|NCT03299842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201949|NCT03299842|Serotonin Agents|serotonin agents|mesh-ancestor
93201950|NCT03299842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201951|NCT02720536|Deferasirox|deferasirox|mesh-list
93201952|NCT02720536|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93201953|NCT02720536|Chelating Agents|chelating agents|mesh-ancestor
93201954|NCT02720536|Sequestering Agents|sequestering agents|mesh-ancestor
93201955|NCT02720536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201956|NCT03168438|Cyclophosphamide|cyclophosphamide|mesh-list
93201957|NCT03168438|Pembrolizumab|pembrolizumab|mesh-list
93201958|NCT03168438|Fludarabine|fludarabine|mesh-list
93201959|NCT03168438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93201960|NCT03168438|Immunologic Factors|immunologic factors|mesh-ancestor
93201961|NCT03168438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201962|NCT03168438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93201963|NCT03168438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93201964|NCT03168438|Alkylating Agents|alkylating agents|mesh-ancestor
93201965|NCT03168438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201966|NCT03168438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93201967|NCT03168438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93201968|NCT03168438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93201969|NCT03168438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93201970|NCT03299296|Enoxaparin|enoxaparin|mesh-list
93201971|NCT03299296|Rivaroxaban|rivaroxaban|mesh-list
93201972|NCT03299296|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93201973|NCT03299296|Antithrombins|antithrombins|mesh-ancestor
93201974|NCT03299296|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93201975|NCT03299296|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201976|NCT03299296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201977|NCT03299296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201978|NCT03299296|Anticoagulants|anticoagulants|mesh-ancestor
93201979|NCT03299296|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93201980|NCT03299296|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93201981|NCT03137784|Glycopyrrolate|glycopyrrolate|mesh-list
93201982|NCT03137784|Bromides|bromides|mesh-list
93201983|NCT03137784|Anticonvulsants|anticonvulsants|mesh-ancestor
93201984|NCT03137784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93201985|NCT03137784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93201986|NCT03137784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93201987|NCT03137784|Cholinergic Agents|cholinergic agents|mesh-ancestor
93201988|NCT03137784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93201989|NCT03137784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201990|NCT03137784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93201991|NCT01344954|Rivaroxaban|rivaroxaban|mesh-list
93201992|NCT01344954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93201993|NCT01344954|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93201994|NCT01344954|Antithrombins|antithrombins|mesh-ancestor
93201995|NCT01344954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93201996|NCT01344954|Protease Inhibitors|protease inhibitors|mesh-ancestor
93201997|NCT01344954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93201998|NCT01344954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93201999|NCT01344954|Anticoagulants|anticoagulants|mesh-ancestor
93202000|NCT01344954|Immunologic Factors|immunologic factors|mesh-ancestor
93202001|NCT01344954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202002|NCT01347996|Interleukin-2|interleukin-2|mesh-list
93202003|NCT01347996|Histamine|histamine|mesh-list
93202004|NCT01347996|Histamine phosphate|histamine phosphate|mesh-list
93202005|NCT01347996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202006|NCT01347996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202007|NCT01347996|Analgesics|analgesics|mesh-ancestor
93202008|NCT01347996|Sensory System Agents|sensory system agents|mesh-ancestor
93202009|NCT01347996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202010|NCT01347996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202011|NCT01347996|Histamine Agonists|histamine agonists|mesh-ancestor
93202012|NCT01347996|Histamine Agents|histamine agents|mesh-ancestor
93202013|NCT01347996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202014|NCT01347996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202015|NCT01352988|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93202016|NCT01352988|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202017|NCT01352988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202018|NCT01352988|Immunologic Factors|immunologic factors|mesh-ancestor
93202019|NCT01352988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202020|NCT02466802|Sildenafil Citrate|sildenafil citrate|mesh-list
93202021|NCT02466802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202022|NCT02466802|Vasodilator Agents|vasodilator agents|mesh-ancestor
93202023|NCT02466802|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93202024|NCT02466802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93202025|NCT02466802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202026|NCT02466802|Urological Agents|urological agents|mesh-ancestor
93202027|NCT01348308|Maraviroc|maraviroc|mesh-list
93202028|NCT01348308|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93202029|NCT01348308|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93202030|NCT01348308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202031|NCT01348308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93202032|NCT01348308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93202033|NCT01348308|Antiviral Agents|antiviral agents|mesh-ancestor
93202034|NCT01348308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202035|NCT01348308|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93202036|NCT04074174|Acetaminophen|acetaminophen|mesh-list
93202037|NCT04074174|Contraceptive Agents|contraceptive agents|mesh-list
93202038|NCT04074174|Contraceptives, Oral|contraceptives, oral|mesh-list
93202039|NCT04074174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202040|NCT04074174|Analgesics|analgesics|mesh-ancestor
93202041|NCT04074174|Sensory System Agents|sensory system agents|mesh-ancestor
93202042|NCT04074174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202043|NCT04074174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202044|NCT04074174|Antipyretics|antipyretics|mesh-ancestor
93202045|NCT04074174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93202046|NCT04074174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93202047|NCT04752826|Pembrolizumab|pembrolizumab|mesh-list
93202048|NCT04752826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202049|NCT04752826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202050|NCT04752826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93202051|NCT04752826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202052|NCT03620292|Bevacizumab|bevacizumab|mesh-list
93202053|NCT03620292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202054|NCT03620292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202055|NCT03620292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93202056|NCT03620292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93202057|NCT03620292|Growth Substances|growth substances|mesh-ancestor
93202058|NCT03620292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202059|NCT03620292|Growth Inhibitors|growth inhibitors|mesh-ancestor
93202060|NCT01353378|Dexmedetomidine|dexmedetomidine|mesh-list
93202061|NCT01353378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202062|NCT01353378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202063|NCT01353378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202064|NCT01353378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202065|NCT01353378|Analgesics|analgesics|mesh-ancestor
93202066|NCT01353378|Sensory System Agents|sensory system agents|mesh-ancestor
93202067|NCT01353378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202068|NCT01353378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93202069|NCT01353378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93202070|NCT01353378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93202071|NCT01353378|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202072|NCT01353378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202073|NCT01353378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202075|NCT05245006|Immunoglobulins|immunoglobulins|mesh-list
93202076|NCT05245006|Immunologic Factors|immunologic factors|mesh-ancestor
93202077|NCT05245006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202078|NCT01465334|Methylprednisolone|methylprednisolone|mesh-list
93202079|NCT01465334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93202080|NCT01465334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93202081|NCT01465334|Prednisolone|prednisolone|mesh-list
93202082|NCT01465334|Prednisolone acetate|prednisolone acetate|mesh-list
93202083|NCT01465334|Alemtuzumab|alemtuzumab|mesh-list
93202084|NCT01465334|Ofatumumab|ofatumumab|mesh-list
93202085|NCT01465334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93202086|NCT01465334|Prednisolone phosphate|prednisolone phosphate|mesh-list
93202087|NCT01465334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202088|NCT01465334|Antiemetics|antiemetics|mesh-ancestor
93202089|NCT01465334|Autonomic Agents|autonomic agents|mesh-ancestor
93202090|NCT01465334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202091|NCT01465334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202092|NCT01465334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202093|NCT01465334|Glucocorticoids|glucocorticoids|mesh-ancestor
93202094|NCT01465334|Hormones|hormones|mesh-ancestor
93202095|NCT01465334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202096|NCT01465334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93202097|NCT01465334|Protective Agents|protective agents|mesh-ancestor
93202098|NCT01465334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202099|NCT01465334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202100|NCT01465334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202101|NCT04019262|Temozolomide|temozolomide|mesh-list
93202102|NCT04019262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93202103|NCT04019262|Alkylating Agents|alkylating agents|mesh-ancestor
93202104|NCT04019262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202105|NCT04019262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202106|NCT05549726|Cabotegravir|cabotegravir|mesh-list
93202107|NCT05549726|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93202108|NCT05549726|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93202109|NCT05549726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202110|NCT05549726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202111|NCT05549726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93202112|NCT05549726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93202113|NCT05549726|Antiviral Agents|antiviral agents|mesh-ancestor
93202114|NCT05549726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202115|NCT01353456|Dexmedetomidine|dexmedetomidine|mesh-list
93202116|NCT01353456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202117|NCT01353456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202118|NCT01353456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202119|NCT01353456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202120|NCT01353456|Analgesics|analgesics|mesh-ancestor
93202121|NCT01353456|Sensory System Agents|sensory system agents|mesh-ancestor
93202122|NCT01353456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202123|NCT01353456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93202124|NCT01353456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93202125|NCT01353456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93202126|NCT01353456|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202127|NCT01353456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202128|NCT01353456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202129|NCT04289142|Dexmedetomidine|dexmedetomidine|mesh-list
93202130|NCT04289142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202131|NCT04289142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202132|NCT04289142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202133|NCT04289142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202134|NCT04289142|Analgesics|analgesics|mesh-ancestor
93202135|NCT04289142|Sensory System Agents|sensory system agents|mesh-ancestor
93202136|NCT04289142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202137|NCT04289142|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93202138|NCT04289142|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93202139|NCT04289142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93202140|NCT04289142|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202141|NCT04289142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202142|NCT04289142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202143|NCT04953962|Nivolumab|nivolumab|mesh-list
93202144|NCT04953962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202145|NCT04953962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202146|NCT04953962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93202147|NCT04953962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202148|NCT04948814|Vancomycin|vancomycin|mesh-list
93202149|NCT04948814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202150|NCT04948814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202151|NCT02718898|Ixekizumab|ixekizumab|mesh-list
93202152|NCT02718898|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202153|NCT05726734|Amoxicillin|amoxicillin|mesh-list
93202154|NCT05726734|Metronidazole|metronidazole|mesh-list
93202155|NCT05726734|Potassium Citrate|potassium citrate|mesh-list
93202156|NCT05726734|Esomeprazole|esomeprazole|mesh-list
93202157|NCT05726734|Bismuth|bismuth|mesh-list
93202158|NCT05726734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202159|NCT05726734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202160|NCT05726734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202161|NCT05726734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93202162|NCT05726734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93202163|NCT05726734|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93202164|NCT05726734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202165|NCT05726734|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93202166|NCT05726734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202167|NCT05726734|Antacids|antacids|mesh-ancestor
93202168|NCT05726734|Diuretics|diuretics|mesh-ancestor
93202169|NCT05726734|Natriuretic Agents|natriuretic agents|mesh-ancestor
93202170|NCT05726734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202171|NCT05726734|Expectorants|expectorants|mesh-ancestor
93202172|NCT05726734|Respiratory System Agents|respiratory system agents|mesh-ancestor
93202173|NCT01317966|Oprelvekin|oprelvekin|mesh-list
93202174|NCT01317966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202175|NCT01345734|Liraglutide|liraglutide|mesh-list
93202176|NCT01345734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93202177|NCT01345734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202178|NCT01345734|Incretins|incretins|mesh-ancestor
93202179|NCT01345734|Hormones|hormones|mesh-ancestor
93202180|NCT01345734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202181|NCT04674670|Naltrexone|naltrexone|mesh-list
93202182|NCT04674670|Bromocriptine|bromocriptine|mesh-list
93202183|NCT04674670|Amisulpride|amisulpride|mesh-list
93202184|NCT04674670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93202185|NCT04674670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93202186|NCT04674670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202187|NCT04674670|Sensory System Agents|sensory system agents|mesh-ancestor
93202188|NCT04674670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202189|NCT04674670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93202190|NCT04674670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202191|NCT04674670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202192|NCT04674670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202193|NCT04674670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93202194|NCT04674670|Dopamine Agents|dopamine agents|mesh-ancestor
93202195|NCT04674670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202196|NCT04674670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202197|NCT04674670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93202198|NCT04674670|Antidepressive Agents|antidepressive agents|mesh-ancestor
93202199|NCT04674670|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93202200|NCT04674670|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93202201|NCT04674670|Hormone Antagonists|hormone antagonists|mesh-ancestor
93202202|NCT04674670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202203|NCT04674670|Dopamine Agonists|dopamine agonists|mesh-ancestor
93202204|NCT01318044|Thiopental|thiopental|mesh-list
93202205|NCT01318044|Propofol|propofol|mesh-list
93202206|NCT01318044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202207|NCT01318044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202208|NCT01318044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202209|NCT01318044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93202210|NCT01318044|Anesthetics, General|anesthetics, general|mesh-ancestor
93202211|NCT01318044|Anesthetics|anesthetics|mesh-ancestor
93202212|NCT01318044|Anticonvulsants|anticonvulsants|mesh-ancestor
93202214|NCT01318044|GABA Agents|gaba agents|mesh-ancestor
93202215|NCT01318044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202216|NCT01318044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202217|NCT01353846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93202218|NCT01353846|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93202219|NCT01353846|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93202220|NCT01353846|Estradiol|estradiol|mesh-list
93202221|NCT01353846|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93202222|NCT01353846|Progesterone|progesterone|mesh-list
93202223|NCT01353846|Estrogens|estrogens|mesh-ancestor
93202224|NCT01353846|Hormones|hormones|mesh-ancestor
93202225|NCT01353846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202226|NCT01353846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202227|NCT01353846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93202228|NCT01353846|Contraceptive Agents|contraceptive agents|mesh-ancestor
93202229|NCT01353846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93202230|NCT01353846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93202231|NCT01353846|Progestins|progestins|mesh-ancestor
93202232|NCT01353846|Luteolytic Agents|luteolytic agents|mesh-ancestor
93202233|NCT01353846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202234|NCT01353846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202235|NCT01349010|Probucol|probucol|mesh-list
93202236|NCT01349010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93202237|NCT01349010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93202238|NCT01349010|Antimetabolites|antimetabolites|mesh-ancestor
93202239|NCT01349010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202240|NCT01349010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93202241|NCT01349010|Antioxidants|antioxidants|mesh-ancestor
93202242|NCT01349010|Protective Agents|protective agents|mesh-ancestor
93202243|NCT01349010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202244|NCT05232370|Losartan|losartan|mesh-list
93202245|NCT05232370|Enalapril|enalapril|mesh-list
93202246|NCT05232370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93202247|NCT05232370|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93202248|NCT05232370|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93202249|NCT05232370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93202250|NCT05232370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93202251|NCT05232370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93202252|NCT05232370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202253|NCT05232370|Protease Inhibitors|protease inhibitors|mesh-ancestor
93202254|NCT01349088|Niacinamide|niacinamide|mesh-list
93202255|NCT01349088|Capecitabine|capecitabine|mesh-list
93202256|NCT01349088|Motesanib diphosphate|motesanib diphosphate|mesh-list
93202257|NCT01349088|Imetelstat|imetelstat|mesh-list
93202258|NCT01349088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93202259|NCT01349088|Antimetabolites|antimetabolites|mesh-ancestor
93202260|NCT01349088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202261|NCT01349088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202262|NCT01349088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93202263|NCT01349088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202264|NCT01349088|Vitamin B Complex|vitamin b complex|mesh-ancestor
93202265|NCT01349088|Vitamins|vitamins|mesh-ancestor
93202266|NCT01349088|Micronutrients|micronutrients|mesh-ancestor
93202267|NCT01349088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202268|NCT04490434|Celecoxib|celecoxib|mesh-list
93202269|NCT04490434|Naproxen|naproxen|mesh-list
93202270|NCT04490434|Meloxicam|meloxicam|mesh-list
93202271|NCT04490434|Fexuprazan|fexuprazan|mesh-list
93202272|NCT04490434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93202273|NCT04490434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202274|NCT04490434|Analgesics|analgesics|mesh-ancestor
93202275|NCT04490434|Sensory System Agents|sensory system agents|mesh-ancestor
93202276|NCT04490434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202277|NCT04490434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202278|NCT04490434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202279|NCT04490434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93202280|NCT04490434|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93202281|NCT04490434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93202282|NCT04490434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202283|NCT04490434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202284|NCT04490434|Gout Suppressants|gout suppressants|mesh-ancestor
93202285|NCT04490434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202286|NCT01353924|Aluminum sulfate|aluminum sulfate|mesh-list
93202287|NCT01353924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93202288|NCT01353924|Immunologic Factors|immunologic factors|mesh-ancestor
93202289|NCT01353924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202291|NCT03143166|Dabigatran|dabigatran|mesh-list
93202292|NCT03143166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93202293|NCT03143166|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93202294|NCT03143166|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93202295|NCT03143166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202296|NCT03143166|Antithrombins|antithrombins|mesh-ancestor
93202297|NCT03143166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93202298|NCT03143166|Protease Inhibitors|protease inhibitors|mesh-ancestor
93202299|NCT03143166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202300|NCT03143166|Anticoagulants|anticoagulants|mesh-ancestor
93202301|NCT02466568|Nivolumab|nivolumab|mesh-list
93202302|NCT02466568|Vaccines|vaccines|mesh-list
93202303|NCT02466568|Immunologic Factors|immunologic factors|mesh-ancestor
93202304|NCT02466568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202305|NCT02466568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202306|NCT02466568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202307|NCT02466568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93202308|NCT02466568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202309|NCT02879994|Pembrolizumab|pembrolizumab|mesh-list
93202310|NCT02879994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202311|NCT02879994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202312|NCT02879994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93202313|NCT02879994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202314|NCT02466022|Fentanyl|fentanyl|mesh-list
93202315|NCT02466022|Midazolam|midazolam|mesh-list
93202316|NCT02466022|Dexmedetomidine|dexmedetomidine|mesh-list
93202317|NCT02466022|Bupivacaine|bupivacaine|mesh-list
93202318|NCT02466022|Anesthetics, Local|anesthetics, local|mesh-ancestor
93202319|NCT02466022|Anesthetics|anesthetics|mesh-ancestor
93202320|NCT02466022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202321|NCT02466022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202322|NCT02466022|Sensory System Agents|sensory system agents|mesh-ancestor
93202323|NCT02466022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202324|NCT02466022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202325|NCT02466022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202326|NCT02466022|Analgesics|analgesics|mesh-ancestor
93202327|NCT02466022|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93202328|NCT02466022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93202329|NCT02466022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93202330|NCT02466022|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202331|NCT02466022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202332|NCT02466022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202333|NCT02466022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93202334|NCT02466022|Narcotics|narcotics|mesh-ancestor
93202335|NCT02466022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93202336|NCT02466022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93202337|NCT02466022|Anesthetics, General|anesthetics, general|mesh-ancestor
93202338|NCT02466022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93202339|NCT02466022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202340|NCT02466022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202341|NCT02466022|GABA Modulators|gaba modulators|mesh-ancestor
93202342|NCT02466022|GABA Agents|gaba agents|mesh-ancestor
93202343|NCT03937596|Cycloserine|cycloserine|mesh-list
93202344|NCT03937596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93202345|NCT03937596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202346|NCT03937596|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93202347|NCT03937596|Antitubercular Agents|antitubercular agents|mesh-ancestor
93202348|NCT03937596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202349|NCT03937596|Antimetabolites|antimetabolites|mesh-ancestor
93202350|NCT03937596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202351|NCT04606264|Dexamethasone|dexamethasone|mesh-list
93202352|NCT04606264|Morphine|morphine|mesh-list
93202353|NCT04606264|Hydromorphone|hydromorphone|mesh-list
93202354|NCT04606264|Ondansetron|ondansetron|mesh-list
93202355|NCT04606264|Aprepitant|aprepitant|mesh-list
93202356|NCT04606264|Dimenhydrinate|dimenhydrinate|mesh-list
93202357|NCT04606264|Perphenazine|perphenazine|mesh-list
93202358|NCT04606264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202359|NCT04606264|Antiemetics|antiemetics|mesh-ancestor
93202360|NCT04606264|Autonomic Agents|autonomic agents|mesh-ancestor
93202361|NCT04606264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202362|NCT04606264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202363|NCT04606264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202364|NCT04606264|Glucocorticoids|glucocorticoids|mesh-ancestor
93202365|NCT04606264|Hormones|hormones|mesh-ancestor
93202366|NCT04606264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202367|NCT04606264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202368|NCT04606264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202369|NCT04606264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93202370|NCT04606264|Narcotics|narcotics|mesh-ancestor
93202371|NCT04606264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202372|NCT04606264|Analgesics|analgesics|mesh-ancestor
93202373|NCT04606264|Sensory System Agents|sensory system agents|mesh-ancestor
93202374|NCT04606264|Antipruritics|antipruritics|mesh-ancestor
93202375|NCT04606264|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202376|NCT04606264|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93202377|NCT04606264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93202378|NCT04606264|Serotonin Agents|serotonin agents|mesh-ancestor
93202379|NCT04606264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202380|NCT04606264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202381|NCT04606264|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93202382|NCT04606264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93202383|NCT04606264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202384|NCT04606264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202385|NCT04606264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93202386|NCT04606264|Dopamine Agents|dopamine agents|mesh-ancestor
93202387|NCT04606264|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93202388|NCT04606264|Histamine Antagonists|histamine antagonists|mesh-ancestor
93202389|NCT04606264|Histamine Agents|histamine agents|mesh-ancestor
93202390|NCT03578172|Menotropins|menotropins|mesh-list
93202392|NCT03578172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202393|NCT03578172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202394|NCT03578172|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93202395|NCT03578172|Fertility Agents|fertility agents|mesh-ancestor
93202396|NCT03578172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93202397|NCT03928158|Valsartan|valsartan|mesh-list
93202398|NCT03928158|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93202399|NCT03928158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93202400|NCT03928158|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93202401|NCT03928158|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93202402|NCT03928158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202403|NCT05174884|Etonogestrel|etonogestrel|mesh-list
93202404|NCT05174884|Desogestrel|desogestrel|mesh-list
93202405|NCT05174884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93202406|NCT05174884|Contraceptive Agents|contraceptive agents|mesh-ancestor
93202407|NCT05174884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93202408|NCT05174884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202409|NCT05174884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93202410|NCT05174884|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93202411|NCT05174884|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93202412|NCT05174884|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93202413|NCT05174884|Progestins|progestins|mesh-ancestor
93202414|NCT05174884|Hormones|hormones|mesh-ancestor
93202415|NCT05174884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202416|NCT01354158|Droxidopa|droxidopa|mesh-list
93202417|NCT01354158|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93202418|NCT01354158|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93202419|NCT02466490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93202420|NCT02466490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93202421|NCT02466490|Diuretics|diuretics|mesh-ancestor
93202422|NCT02466490|Natriuretic Agents|natriuretic agents|mesh-ancestor
93202423|NCT02466490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202424|NCT02466490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93202425|NCT02466490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202426|NCT02466490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202427|NCT04547842|Dexamethasone|dexamethasone|mesh-list
93202428|NCT04547842|Mirtazapine|mirtazapine|mesh-list
93202429|NCT04547842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202430|NCT04547842|Antiemetics|antiemetics|mesh-ancestor
93202431|NCT04547842|Autonomic Agents|autonomic agents|mesh-ancestor
93202432|NCT04547842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202433|NCT04547842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202434|NCT04547842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202435|NCT04547842|Glucocorticoids|glucocorticoids|mesh-ancestor
93202436|NCT04547842|Hormones|hormones|mesh-ancestor
93202437|NCT04547842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202438|NCT04547842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202439|NCT04547842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202440|NCT04547842|Antidepressive Agents|antidepressive agents|mesh-ancestor
93202441|NCT04547842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202442|NCT04547842|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93202443|NCT04547842|Histamine Antagonists|histamine antagonists|mesh-ancestor
93202444|NCT04547842|Histamine Agents|histamine agents|mesh-ancestor
93202445|NCT04547842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202446|NCT04547842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202447|NCT04547842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93202448|NCT04547842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202449|NCT04547842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202450|NCT04547842|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93202451|NCT04547842|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93202452|NCT04547842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93202453|NCT04547842|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202454|NCT04547842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93202455|NCT04547842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93202456|NCT04547842|Serotonin Agents|serotonin agents|mesh-ancestor
93202457|NCT04547842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93202458|NCT03142932|Carbon Monoxide|carbon monoxide|mesh-list
93202459|NCT03142932|Antimetabolites|antimetabolites|mesh-ancestor
93202460|NCT03142932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202461|NCT03142932|Gasotransmitters|gasotransmitters|mesh-ancestor
93202462|NCT03142932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202463|NCT03142932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202464|NCT00702052|Everolimus|everolimus|mesh-list
93202465|NCT00702052|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93202466|NCT00702052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93202467|NCT00702052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202468|NCT00702052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202469|NCT00702052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202470|NCT00702052|Immunologic Factors|immunologic factors|mesh-ancestor
93202471|NCT00702052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202472|NCT00702052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202473|NCT01354470|Modafinil|modafinil|mesh-list
93202474|NCT01354470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93202475|NCT01354470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202476|NCT01354470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93202477|NCT01354470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93202478|NCT01354470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93202479|NCT01354470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202480|NCT01349556|Tretinoin|tretinoin|mesh-list
93202481|NCT01349556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202482|NCT01349556|Keratolytic Agents|keratolytic agents|mesh-ancestor
93202483|NCT01349556|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202484|NCT01354704|Enoxaparin|enoxaparin|mesh-list
93202485|NCT01354704|Anticoagulants|anticoagulants|mesh-ancestor
93202486|NCT01354704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93202487|NCT01354704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93202488|NCT01354704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202489|NCT01346670|Lovastatin|lovastatin|mesh-list
93202490|NCT01346670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93202491|NCT01346670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93202492|NCT01346670|Antimetabolites|antimetabolites|mesh-ancestor
93202493|NCT01346670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202494|NCT01346670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93202495|NCT01346670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93202496|NCT01346670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202497|NCT03136068|Digoxin|digoxin|mesh-list
93202498|NCT03136068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93202499|NCT03136068|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93202500|NCT03136068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202501|NCT03136068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202502|NCT03136068|Protective Agents|protective agents|mesh-ancestor
93202503|NCT03136068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202504|NCT01350024|Lidocaine|lidocaine|mesh-list
93202505|NCT01350024|Epinephrine|epinephrine|mesh-list
93202506|NCT01350024|Racepinephrine|racepinephrine|mesh-list
93202507|NCT01350024|Epinephryl borate|epinephryl borate|mesh-list
93202508|NCT01350024|Anesthetics, Local|anesthetics, local|mesh-ancestor
93202509|NCT01350024|Anesthetics|anesthetics|mesh-ancestor
93202510|NCT01350024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202511|NCT01350024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202512|NCT01350024|Sensory System Agents|sensory system agents|mesh-ancestor
93202513|NCT01350024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202514|NCT01350024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93202515|NCT01350024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93202516|NCT01350024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93202517|NCT01350024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202518|NCT01350024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202519|NCT01350024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93202520|NCT01350024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93202521|NCT01350024|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202522|NCT01350024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202523|NCT01350024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93202524|NCT01350024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93202525|NCT01350024|Autonomic Agents|autonomic agents|mesh-ancestor
93202526|NCT01350024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93202527|NCT01350024|Respiratory System Agents|respiratory system agents|mesh-ancestor
93202528|NCT01350024|Mydriatics|mydriatics|mesh-ancestor
93202529|NCT01350024|Sympathomimetics|sympathomimetics|mesh-ancestor
93202530|NCT01350024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93202531|NCT01318590|Triamcinolone|triamcinolone|mesh-list
93202532|NCT01318590|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93202533|NCT01318590|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93202534|NCT01318590|Bupivacaine|bupivacaine|mesh-list
93202535|NCT01318590|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93202536|NCT01318590|Anesthetics, Local|anesthetics, local|mesh-ancestor
93202537|NCT01318590|Anesthetics|anesthetics|mesh-ancestor
93202538|NCT01318590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202539|NCT01318590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202540|NCT01318590|Sensory System Agents|sensory system agents|mesh-ancestor
93202541|NCT01318590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202542|NCT01318590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202543|NCT01318590|Glucocorticoids|glucocorticoids|mesh-ancestor
93202544|NCT01318590|Hormones|hormones|mesh-ancestor
93202545|NCT01318590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202546|NCT01318590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202547|NCT01318590|Immunologic Factors|immunologic factors|mesh-ancestor
93202548|NCT01318590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202549|NCT01318590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202550|NCT01346826|Infliximab|infliximab|mesh-list
93202551|NCT01346826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93202552|NCT01346826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202553|NCT01346826|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202554|NCT01346826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202555|NCT01346826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93202556|NCT01354860|Lobeline|lobeline|mesh-list
93202557|NCT01354860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93202558|NCT01354860|Autonomic Agents|autonomic agents|mesh-ancestor
93202559|NCT01354860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202560|NCT01354860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202561|NCT01354860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93202562|NCT01354860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93202563|NCT01354860|Cholinergic Agents|cholinergic agents|mesh-ancestor
93202564|NCT01354860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202565|NCT01354860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202566|NCT01354860|Respiratory System Agents|respiratory system agents|mesh-ancestor
93202567|NCT02556606|Midazolam|midazolam|mesh-list
93202568|NCT02556606|Ketamine|ketamine|mesh-list
93202569|NCT02556606|Analgesics|analgesics|mesh-ancestor
93202570|NCT02556606|Sensory System Agents|sensory system agents|mesh-ancestor
93202571|NCT02556606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202572|NCT02556606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202573|NCT02556606|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93202574|NCT02556606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93202575|NCT02556606|Anesthetics, General|anesthetics, general|mesh-ancestor
93202576|NCT02556606|Anesthetics|anesthetics|mesh-ancestor
93202577|NCT02556606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202578|NCT02556606|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93202579|NCT02556606|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93202580|NCT02556606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202581|NCT02556606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202582|NCT02556606|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93202583|NCT02556606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202584|NCT02556606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93202585|NCT02556606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202586|NCT02556606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874681|NCT00648726|Cefuroxime|cefuroxime|mesh-list
93202588|NCT02556606|GABA Agents|gaba agents|mesh-ancestor
93202589|NCT01355562|Interleukin-2|interleukin-2|mesh-list
93202590|NCT01355562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202591|NCT01355562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93202592|NCT01355562|Analgesics|analgesics|mesh-ancestor
93202593|NCT01355562|Sensory System Agents|sensory system agents|mesh-ancestor
93202594|NCT01355562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202595|NCT01355562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202596|NCT01350570|Loperamide|loperamide|mesh-list
93202597|NCT01350570|Antidiarrheals|antidiarrheals|mesh-list
93202598|NCT01350570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202599|NCT01355718|Repaglinide|repaglinide|mesh-list
93202600|NCT01355718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93202601|NCT01355718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202602|NCT03377790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93202603|NCT03377790|Cantharidin|cantharidin|mesh-list
93202604|NCT03377790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202605|NCT03377790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202606|NCT01347294|Bleomycin|bleomycin|mesh-list
93202607|NCT01347294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93202608|NCT01347294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202609|NCT02422368|Methylprednisolone|methylprednisolone|mesh-list
93202610|NCT02422368|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93202611|NCT02422368|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93202612|NCT02422368|Prednisolone|prednisolone|mesh-list
93202613|NCT02422368|Prednisolone acetate|prednisolone acetate|mesh-list
93202614|NCT02422368|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93202615|NCT02422368|Prednisolone phosphate|prednisolone phosphate|mesh-list
93202616|NCT02422368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202617|NCT02422368|Antiemetics|antiemetics|mesh-ancestor
93202618|NCT02422368|Autonomic Agents|autonomic agents|mesh-ancestor
93202619|NCT02422368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202620|NCT02422368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202621|NCT02422368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202622|NCT02422368|Glucocorticoids|glucocorticoids|mesh-ancestor
93202623|NCT02422368|Hormones|hormones|mesh-ancestor
93202624|NCT02422368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202625|NCT02422368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93202626|NCT02422368|Protective Agents|protective agents|mesh-ancestor
93202627|NCT02422368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202628|NCT02422368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202629|NCT01355952|Thioctic Acid|thioctic acid|mesh-list
93202630|NCT01355952|Antioxidants|antioxidants|mesh-ancestor
93202631|NCT01355952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202632|NCT01355952|Protective Agents|protective agents|mesh-ancestor
93202633|NCT01355952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202634|NCT01355952|Vitamin B Complex|vitamin b complex|mesh-ancestor
93202635|NCT01355952|Vitamins|vitamins|mesh-ancestor
93202636|NCT01355952|Micronutrients|micronutrients|mesh-ancestor
93202637|NCT05720572|Antazoline|antazoline|mesh-list
93202638|NCT05720572|Propafenone|propafenone|mesh-list
93202639|NCT05720572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93202640|NCT05720572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93202641|NCT05720572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93202642|NCT05720572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202643|NCT05720572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202644|NCT05720572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93202645|NCT05720572|Histamine Antagonists|histamine antagonists|mesh-ancestor
93202646|NCT05720572|Histamine Agents|histamine agents|mesh-ancestor
93202647|NCT05720572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202648|NCT05720572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202649|NCT05720572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93202650|NCT05111002|Doxycycline|doxycycline|mesh-list
93202651|NCT05111002|Lefamulin|lefamulin|mesh-list
93202652|NCT05111002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202653|NCT05111002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202654|NCT05111002|Antimalarials|antimalarials|mesh-ancestor
93202655|NCT05111002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93202656|NCT05111002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93202657|NCT01347684|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
93202658|NCT01347684|Antidepressive Agents|antidepressive agents|mesh-ancestor
93202659|NCT01347684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874761|NCT02838719|BB 1101|bb 1101|mesh-list
93202660|NCT05716750|Vitamin D|vitamin d|mesh-list
93202661|NCT05716750|Vitamins|vitamins|mesh-ancestor
93202662|NCT05716750|Micronutrients|micronutrients|mesh-ancestor
93202663|NCT05716750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202664|NCT05716750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93202665|NCT01350882|Rituximab|rituximab|mesh-list
93202666|NCT01350882|Citric Acid|citric acid|mesh-list
93202667|NCT01350882|Sodium Citrate|sodium citrate|mesh-list
93202668|NCT01350882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202669|NCT01350882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202670|NCT01350882|Immunologic Factors|immunologic factors|mesh-ancestor
93202671|NCT01350882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202672|NCT01350882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93202673|NCT01350882|Anticoagulants|anticoagulants|mesh-ancestor
93202674|NCT01350882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93202675|NCT01350882|Chelating Agents|chelating agents|mesh-ancestor
93202676|NCT01350882|Sequestering Agents|sequestering agents|mesh-ancestor
93202677|NCT01350882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202678|NCT01844856|Ertapenem|ertapenem|mesh-list
93202679|NCT01844856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202680|NCT01844856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202681|NCT00618098|Thrombin|thrombin|mesh-list
93202682|NCT00618098|Hemostatics|hemostatics|mesh-ancestor
93202683|NCT00618098|Coagulants|coagulants|mesh-ancestor
93202684|NCT02464228|Tipifarnib|tipifarnib|mesh-list
93202685|NCT02464228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202686|NCT01351038|Capecitabine|capecitabine|mesh-list
93202687|NCT01351038|Oxaliplatin|oxaliplatin|mesh-list
93202688|NCT01351038|Panitumumab|panitumumab|mesh-list
93202689|NCT01351038|Epirubicin|epirubicin|mesh-list
93202690|NCT01351038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93202691|NCT01351038|Antimetabolites|antimetabolites|mesh-ancestor
93202692|NCT01351038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202693|NCT01351038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202694|NCT01351038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202695|NCT01351038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93202696|NCT01351038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93202697|NCT01351038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93202698|NCT01351038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202699|NCT02464462|Vitamin D|vitamin d|mesh-list
93202700|NCT02464462|Cholecalciferol|cholecalciferol|mesh-list
93202701|NCT02464462|Calcium|calcium|mesh-list
93202702|NCT02464462|Vitamins|vitamins|mesh-ancestor
93202703|NCT02464462|Micronutrients|micronutrients|mesh-ancestor
93202704|NCT02464462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202705|NCT02464462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93202706|NCT02464462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93202707|NCT04270864|Nivolumab|nivolumab|mesh-list
93202708|NCT04270864|Ipilimumab|ipilimumab|mesh-list
93202709|NCT04270864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202710|NCT04270864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202711|NCT04270864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93202712|NCT04270864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202713|NCT01318668|Vaccines|vaccines|mesh-list
93202714|NCT01318668|Immunologic Factors|immunologic factors|mesh-ancestor
93202715|NCT01318668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202716|NCT01351272|Methylphenidate|methylphenidate|mesh-list
93202717|NCT01351272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93202718|NCT01351272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202719|NCT01351272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93202720|NCT01351272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93202721|NCT01351272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202722|NCT01351272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202723|NCT01351272|Dopamine Agents|dopamine agents|mesh-ancestor
93202724|NCT01351272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202725|NCT01351428|Nifedipine|nifedipine|mesh-list
93202726|NCT01351428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93202727|NCT01351428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202728|NCT01351428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202729|NCT01351428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93202730|NCT01351428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202731|NCT01351428|Vasodilator Agents|vasodilator agents|mesh-ancestor
93202732|NCT01351428|Tocolytic Agents|tocolytic agents|mesh-ancestor
93202733|NCT01351428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93202734|NCT05006326|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93202735|NCT05006326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93202736|NCT05006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202737|NCT00701662|Immunoglobulins|immunoglobulins|mesh-list
93202738|NCT00701662|Immunologic Factors|immunologic factors|mesh-ancestor
93202739|NCT00701662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202740|NCT02464306|Fidaxomicin|fidaxomicin|mesh-list
93202741|NCT02464306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202742|NCT02464306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202743|NCT01351818|Hormones|hormones|mesh-list
93202744|NCT01351818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202745|NCT01351818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202746|NCT02463994|Atezolizumab|atezolizumab|mesh-list
93202747|NCT02463994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93202748|NCT02463994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202749|NCT02463994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93202750|NCT02463994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202751|NCT04235686|Amphetamine|amphetamine|mesh-list
93202752|NCT04235686|Dextroamphetamine|dextroamphetamine|mesh-list
93202753|NCT04235686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93202754|NCT04235686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202755|NCT04235686|Sympathomimetics|sympathomimetics|mesh-ancestor
93202756|NCT04235686|Autonomic Agents|autonomic agents|mesh-ancestor
93202757|NCT04235686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202758|NCT04235686|Dopamine Agents|dopamine agents|mesh-ancestor
93202759|NCT04235686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202760|NCT04235686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202761|NCT04235686|Adrenergic Agents|adrenergic agents|mesh-ancestor
93202762|NCT04235686|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93202763|NCT04235686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93202764|NCT04235686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202765|NCT04235686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93202766|NCT02079948|Folic Acid|folic acid|mesh-list
93202767|NCT02079948|Vitamin B Complex|vitamin b complex|mesh-list
93202768|NCT02079948|Methotrexate|methotrexate|mesh-list
93202769|NCT02079948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93202770|NCT02079948|Abortifacient Agents|abortifacient agents|mesh-ancestor
93202771|NCT02079948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93202772|NCT02079948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202773|NCT02079948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93202774|NCT02079948|Antimetabolites|antimetabolites|mesh-ancestor
93202775|NCT02079948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202776|NCT02079948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202777|NCT02079948|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202778|NCT02079948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202779|NCT02079948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93202780|NCT02079948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202781|NCT02079948|Immunologic Factors|immunologic factors|mesh-ancestor
93202782|NCT02079948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93202783|NCT02079948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93202784|NCT02079948|Hematinics|hematinics|mesh-ancestor
93202785|NCT02079948|Vitamins|vitamins|mesh-ancestor
93202786|NCT02079948|Micronutrients|micronutrients|mesh-ancestor
93202787|NCT01357902|Lamotrigine|lamotrigine|mesh-list
93202788|NCT01357902|Anticonvulsants|anticonvulsants|mesh-ancestor
93202789|NCT01357902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93202790|NCT01357902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202791|NCT01357902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202792|NCT01357902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93202793|NCT01357902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202794|NCT01357902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93202795|NCT01357902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202796|NCT01357902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202797|NCT01357902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202798|NCT01357902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93202799|NCT04634409|Bamlanivimab|bamlanivimab|mesh-list
93202800|NCT04634409|Sotrovimab|sotrovimab|mesh-list
93202801|NCT04634409|Antiviral Agents|antiviral agents|mesh-ancestor
93202802|NCT04634409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202803|NCT01352130|Ondansetron|ondansetron|mesh-list
93202804|NCT01352130|Granisetron|granisetron|mesh-list
93202805|NCT01352130|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
93202806|NCT01352130|Antiemetics|antiemetics|mesh-ancestor
93202807|NCT01352130|Autonomic Agents|autonomic agents|mesh-ancestor
93202808|NCT01352130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202809|NCT01352130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202810|NCT01352130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93202811|NCT01352130|Antipruritics|antipruritics|mesh-ancestor
93202812|NCT01352130|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202813|NCT01352130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93202814|NCT01352130|Serotonin Agents|serotonin agents|mesh-ancestor
93202815|NCT01352130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202816|NCT01352130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202817|NCT05605834|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93202818|NCT05605834|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93202819|NCT05605834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202821|NCT00005780|Cyclophosphamide|cyclophosphamide|mesh-list
93202822|NCT00005780|Doxorubicin|doxorubicin|mesh-list
93202823|NCT00005780|Etoposide|etoposide|mesh-list
93202824|NCT00005780|Vincristine|vincristine|mesh-list
93202825|NCT00005780|Sargramostim|sargramostim|mesh-list
93202826|NCT00005780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202827|NCT00005780|Immunologic Factors|immunologic factors|mesh-ancestor
93202828|NCT00005780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202829|NCT00005780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93202830|NCT00005780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93202831|NCT00005780|Alkylating Agents|alkylating agents|mesh-ancestor
93202832|NCT00005780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202833|NCT00005780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202834|NCT00005780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93202835|NCT00005780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93202836|NCT00005780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93202837|NCT00005780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93202838|NCT00005780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202839|NCT00005780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93202840|NCT00005780|Glucocorticoids|glucocorticoids|mesh-ancestor
93202841|NCT00005780|Hormones|hormones|mesh-ancestor
93202842|NCT00005780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202843|NCT00005780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202844|NCT00005780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93202845|NCT00005780|Tubulin Modulators|tubulin modulators|mesh-ancestor
93202846|NCT00005780|Antimitotic Agents|antimitotic agents|mesh-ancestor
93202847|NCT00005780|Mitosis Modulators|mitosis modulators|mesh-ancestor
93202848|NCT01356732|Sufentanil|sufentanil|mesh-list
93202849|NCT01356732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93202850|NCT01356732|Narcotics|narcotics|mesh-ancestor
93202851|NCT01356732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202852|NCT01356732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202853|NCT01356732|Analgesics|analgesics|mesh-ancestor
93202854|NCT01356732|Sensory System Agents|sensory system agents|mesh-ancestor
93202855|NCT01356732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202856|NCT01356732|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93202857|NCT01356732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93202858|NCT01356732|Anesthetics, General|anesthetics, general|mesh-ancestor
93202859|NCT01356732|Anesthetics|anesthetics|mesh-ancestor
93202860|NCT02463682|Insulin|insulin|mesh-list
93202861|NCT02463682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93202862|NCT02463682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202863|NCT05315648|Anesthetics|anesthetics|mesh-list
93202864|NCT05315648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202865|NCT05315648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202866|NCT01978938|Levofloxacin|levofloxacin|mesh-list
93202867|NCT01978938|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93202868|NCT01978938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202869|NCT01978938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93202870|NCT01978938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93202871|NCT01978938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93202872|NCT01978938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202873|NCT01978938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202874|NCT01978938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202875|NCT01978938|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93202876|NCT01978938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93202877|NCT02465320|Lidocaine|lidocaine|mesh-list
93202878|NCT02465320|Anesthetics, Local|anesthetics, local|mesh-ancestor
93202879|NCT02465320|Anesthetics|anesthetics|mesh-ancestor
93202880|NCT02465320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202881|NCT02465320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202882|NCT02465320|Sensory System Agents|sensory system agents|mesh-ancestor
93202883|NCT02465320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202884|NCT02465320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93202885|NCT02465320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93202886|NCT02465320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93202887|NCT02465320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93202888|NCT02465320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202889|NCT02465008|Levobupivacaine|levobupivacaine|mesh-list
93202890|NCT02465008|Anesthetics, Local|anesthetics, local|mesh-ancestor
93202891|NCT02465008|Anesthetics|anesthetics|mesh-ancestor
93202892|NCT02465008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855848|NCT02745912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202893|NCT02465008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202894|NCT02465008|Sensory System Agents|sensory system agents|mesh-ancestor
93202895|NCT02465008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93202897|NCT03228186|Pevonedistat|pevonedistat|mesh-list
93202898|NCT03228186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202899|NCT03228186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93202900|NCT03228186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93202901|NCT03228186|Mitosis Modulators|mitosis modulators|mesh-ancestor
93202902|NCT03228186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202903|NCT03228186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202904|NCT04105114|Buspirone|buspirone|mesh-list
93202905|NCT04105114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93202906|NCT04105114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202907|NCT04105114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202908|NCT04105114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202909|NCT04105114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202910|NCT04105114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93202911|NCT04105114|Serotonin Agents|serotonin agents|mesh-ancestor
93202912|NCT04105114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202913|NCT04105114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202914|NCT05573230|Cyclosporine|cyclosporine|mesh-list
93202915|NCT05573230|Midazolam|midazolam|mesh-list
93202916|NCT05573230|Cyclosporins|cyclosporins|mesh-list
93202917|NCT05573230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93202918|NCT05573230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93202919|NCT05573230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93202920|NCT05573230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202921|NCT05573230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93202922|NCT05573230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93202923|NCT05573230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93202924|NCT05573230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93202925|NCT05573230|Anesthetics, General|anesthetics, general|mesh-ancestor
93202926|NCT05573230|Anesthetics|anesthetics|mesh-ancestor
93202927|NCT05573230|GABA Modulators|gaba modulators|mesh-ancestor
93202928|NCT05573230|GABA Agents|gaba agents|mesh-ancestor
93202929|NCT05573230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93202930|NCT05573230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202931|NCT05573230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202932|NCT05573230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202933|NCT05573230|Immunologic Factors|immunologic factors|mesh-ancestor
93202934|NCT05573230|Antifungal Agents|antifungal agents|mesh-ancestor
93202935|NCT05573230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202936|NCT05573230|Dermatologic Agents|dermatologic agents|mesh-ancestor
93202937|NCT05573230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93202938|NCT05573230|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93202939|NCT05550142|Vaccines|vaccines|mesh-list
93202940|NCT05550142|Immunologic Factors|immunologic factors|mesh-ancestor
93202941|NCT05550142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202942|NCT00116142|Ascorbic Acid|ascorbic acid|mesh-list
93202943|NCT00116142|Docetaxel|docetaxel|mesh-list
93202944|NCT00116142|Methyltestosterone|methyltestosterone|mesh-list
93202945|NCT00116142|Androgens|androgens|mesh-list
93202946|NCT00116142|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93202947|NCT00116142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202948|NCT00116142|Tubulin Modulators|tubulin modulators|mesh-ancestor
93202949|NCT00116142|Antimitotic Agents|antimitotic agents|mesh-ancestor
93202950|NCT00116142|Mitosis Modulators|mitosis modulators|mesh-ancestor
93202951|NCT00116142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202952|NCT00116142|Hormones|hormones|mesh-ancestor
93202953|NCT00116142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202954|NCT00116142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202955|NCT00116142|Antioxidants|antioxidants|mesh-ancestor
93202956|NCT00116142|Protective Agents|protective agents|mesh-ancestor
93202957|NCT00116142|Vitamins|vitamins|mesh-ancestor
93202958|NCT00116142|Micronutrients|micronutrients|mesh-ancestor
93202959|NCT00116142|Estrogens|estrogens|mesh-ancestor
93202960|NCT00116142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93202961|NCT00116142|Anabolic Agents|anabolic agents|mesh-ancestor
93202962|NCT05547256|Vaccines|vaccines|mesh-list
93202963|NCT05547256|Immunologic Factors|immunologic factors|mesh-ancestor
93202964|NCT05547256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202965|NCT01757782|Sildenafil Citrate|sildenafil citrate|mesh-list
93202966|NCT01757782|Vasodilator Agents|vasodilator agents|mesh-ancestor
93202967|NCT01757782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93202968|NCT01757782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93202969|NCT01757782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855849|NCT02825186|Dexamethasone|dexamethasone|mesh-list
93202970|NCT01757782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202971|NCT01757782|Urological Agents|urological agents|mesh-ancestor
93202972|NCT02023905|Everolimus|everolimus|mesh-list
93202973|NCT02023905|Temozolomide|temozolomide|mesh-list
93202974|NCT02023905|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93202975|NCT02023905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93202976|NCT02023905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202977|NCT02023905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202978|NCT02023905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93202979|NCT02023905|Immunologic Factors|immunologic factors|mesh-ancestor
93202980|NCT02023905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202981|NCT02023905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202982|NCT02023905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93202983|NCT02023905|Alkylating Agents|alkylating agents|mesh-ancestor
93202984|NCT01330563|Ketoconazole|ketoconazole|mesh-list
93202985|NCT01330563|Antifungal Agents|antifungal agents|mesh-ancestor
93202986|NCT01330563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93202987|NCT01330563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93202988|NCT01330563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93202989|NCT01330563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93202990|NCT01330563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93202991|NCT01330563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93202992|NCT01330563|Hormone Antagonists|hormone antagonists|mesh-ancestor
93202993|NCT01330563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93202994|NCT01330563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93202995|NCT01330563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93202996|NCT01991379|Imatinib Mesylate|imatinib mesylate|mesh-list
93202997|NCT01991379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93202998|NCT01991379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93202999|NCT01991379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203000|NCT01991379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203001|NCT02875080|Brexpiprazole|brexpiprazole|mesh-list
93203002|NCT02875080|Serotonin Agents|serotonin agents|mesh-ancestor
93203003|NCT02875080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203004|NCT02875080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203005|NCT02875080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203006|NCT02875080|Dopamine Agonists|dopamine agonists|mesh-ancestor
93203007|NCT02875080|Dopamine Agents|dopamine agents|mesh-ancestor
93203008|NCT04897503|Riboflavin|riboflavin|mesh-list
93203009|NCT04897503|Vitamin B Complex|vitamin b complex|mesh-ancestor
93203010|NCT04897503|Vitamins|vitamins|mesh-ancestor
93203011|NCT04897503|Micronutrients|micronutrients|mesh-ancestor
93203012|NCT04897503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203013|NCT04897503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93203014|NCT04897503|Dermatologic Agents|dermatologic agents|mesh-ancestor
93203015|NCT01333917|Curcumin|curcumin|mesh-list
93203016|NCT01333917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93203017|NCT01333917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93203018|NCT01333917|Analgesics|analgesics|mesh-ancestor
93203019|NCT01333917|Sensory System Agents|sensory system agents|mesh-ancestor
93203020|NCT01333917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203021|NCT01333917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203022|NCT01333917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203023|NCT01333917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93203024|NCT01333917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203025|NCT01333917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203026|NCT01333917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203027|NCT03129360|Levetiracetam|levetiracetam|mesh-list
93203028|NCT03129360|Anticonvulsants|anticonvulsants|mesh-ancestor
93203029|NCT03129360|Nootropic Agents|nootropic agents|mesh-ancestor
93203030|NCT01315275|Ranibizumab|ranibizumab|mesh-list
93203031|NCT01315275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93203032|NCT01315275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93203033|NCT01315275|Growth Substances|growth substances|mesh-ancestor
93203034|NCT01315275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203035|NCT01315275|Growth Inhibitors|growth inhibitors|mesh-ancestor
93203036|NCT01315275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203037|NCT01319448|Artesunate|artesunate|mesh-list
93203038|NCT01319448|Pyrimethamine|pyrimethamine|mesh-list
93203039|NCT01319448|Sulfadoxine|sulfadoxine|mesh-list
93203040|NCT01319448|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93203041|NCT01319448|Amodiaquine|amodiaquine|mesh-list
93203042|NCT01319448|Mefloquine|mefloquine|mesh-list
93203043|NCT01319448|Proguanil|proguanil|mesh-list
93203044|NCT01319448|Antimalarials|antimalarials|mesh-ancestor
93203045|NCT01319448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93203046|NCT01319448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93203047|NCT01319448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203048|NCT01319448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203049|NCT01319448|Antiviral Agents|antiviral agents|mesh-ancestor
93203050|NCT01319448|Schistosomicides|schistosomicides|mesh-ancestor
93203051|NCT01319448|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93203052|NCT01319448|Anthelmintics|anthelmintics|mesh-ancestor
93203053|NCT01319448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93203054|NCT01319448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203055|NCT01319448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203056|NCT01319448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93203057|NCT01319448|Antimetabolites|antimetabolites|mesh-ancestor
93203058|NCT04360551|Telmisartan|telmisartan|mesh-list
93203059|NCT04360551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93203060|NCT04360551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93203061|NCT04360551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93203062|NCT04360551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203063|NCT01334073|Everolimus|everolimus|mesh-list
93203064|NCT01334073|Axitinib|axitinib|mesh-list
93203065|NCT01334073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93203066|NCT01334073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93203067|NCT01334073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203068|NCT01334073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203069|NCT01334073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203070|NCT01334073|Immunologic Factors|immunologic factors|mesh-ancestor
93203071|NCT01334073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203072|NCT01334073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203073|NCT01928199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93203074|NCT01928199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93203075|NCT01928199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203076|NCT01928199|Incretins|incretins|mesh-ancestor
93203077|NCT01928199|Hormones|hormones|mesh-ancestor
93203078|NCT01928199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203079|NCT01928199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93203080|NCT01928199|Protease Inhibitors|protease inhibitors|mesh-ancestor
93203081|NCT01928199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203082|NCT01928199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203083|NCT01845441|Fentanyl|fentanyl|mesh-list
93203084|NCT01845441|Midazolam|midazolam|mesh-list
93203085|NCT01845441|Dexmedetomidine|dexmedetomidine|mesh-list
93203086|NCT01845441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93203087|NCT01845441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203088|NCT01845441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203089|NCT01845441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93203090|NCT01845441|Analgesics|analgesics|mesh-ancestor
93203091|NCT01845441|Sensory System Agents|sensory system agents|mesh-ancestor
93203092|NCT01845441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203093|NCT01845441|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93203094|NCT01845441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93203095|NCT01845441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93203096|NCT01845441|Adrenergic Agents|adrenergic agents|mesh-ancestor
93203097|NCT01845441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203098|NCT01845441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203099|NCT01845441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93203100|NCT01845441|Narcotics|narcotics|mesh-ancestor
93203101|NCT01845441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93203102|NCT01845441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93203103|NCT01845441|Anesthetics, General|anesthetics, general|mesh-ancestor
93203104|NCT01845441|Anesthetics|anesthetics|mesh-ancestor
93203105|NCT01845441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93203106|NCT01845441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93203107|NCT01845441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93203108|NCT01845441|GABA Modulators|gaba modulators|mesh-ancestor
93203109|NCT01845441|GABA Agents|gaba agents|mesh-ancestor
93203110|NCT03296488|Fentanyl|fentanyl|mesh-list
93203111|NCT03296488|Nalbuphine|nalbuphine|mesh-list
93203112|NCT03296488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93203113|NCT03296488|Narcotics|narcotics|mesh-ancestor
93203114|NCT03296488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203115|NCT03296488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203116|NCT03296488|Analgesics|analgesics|mesh-ancestor
93203117|NCT03296488|Sensory System Agents|sensory system agents|mesh-ancestor
92875209|NCT02657148|Hormones|hormones|mesh-ancestor
93203118|NCT03296488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498962|NCT02008006|Cytarabine|cytarabine|mesh-list
93203119|NCT03296488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93203120|NCT03296488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93203121|NCT03296488|Anesthetics, General|anesthetics, general|mesh-ancestor
93203122|NCT03296488|Anesthetics|anesthetics|mesh-ancestor
93203123|NCT01365936|Menotropins|menotropins|mesh-list
93203124|NCT01365936|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93203125|NCT01365936|Fertility Agents|fertility agents|mesh-ancestor
93203126|NCT01365936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203127|NCT01365936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203128|NCT01334151|Insulin|insulin|mesh-list
93203129|NCT01334151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93203130|NCT01334151|Insulin Lispro|insulin lispro|mesh-list
93203131|NCT01334151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93203132|NCT01334151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203133|NCT04216017|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93203134|NCT04216017|Lidocaine|lidocaine|mesh-list
93203135|NCT04216017|Anesthetics, Local|anesthetics, local|mesh-ancestor
93203136|NCT04216017|Anesthetics|anesthetics|mesh-ancestor
93203137|NCT04216017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203138|NCT04216017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203139|NCT04216017|Sensory System Agents|sensory system agents|mesh-ancestor
93203140|NCT04216017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203141|NCT04216017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93203142|NCT04216017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93203143|NCT04216017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93203144|NCT04216017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93203145|NCT04216017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203146|NCT04216017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203147|NCT04216017|Glucocorticoids|glucocorticoids|mesh-ancestor
93203148|NCT04216017|Hormones|hormones|mesh-ancestor
93203149|NCT04216017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203150|NCT04216017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203151|NCT04216017|Immunologic Factors|immunologic factors|mesh-ancestor
93203152|NCT03296410|Vaccines|vaccines|mesh-list
93203153|NCT03296410|Immunologic Factors|immunologic factors|mesh-ancestor
93203154|NCT03296410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203155|NCT05189184|Paclitaxel|paclitaxel|mesh-list
93203156|NCT05189184|Apatinib|apatinib|mesh-list
93203157|NCT05189184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93203158|NCT05189184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93203159|NCT05189184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203160|NCT05189184|Tubulin Modulators|tubulin modulators|mesh-ancestor
93203161|NCT05189184|Antimitotic Agents|antimitotic agents|mesh-ancestor
93203162|NCT05189184|Mitosis Modulators|mitosis modulators|mesh-ancestor
93203163|NCT05189184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203164|NCT05189184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93203165|NCT05189184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203166|NCT01362036|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93203167|NCT01362036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93203168|NCT01362036|Vasodilator Agents|vasodilator agents|mesh-ancestor
93203169|NCT04623099|Escitalopram|escitalopram|mesh-list
93203170|NCT04623099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93203171|NCT04623099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93203172|NCT04623099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93203173|NCT04623099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203174|NCT04623099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203175|NCT04623099|Serotonin Agents|serotonin agents|mesh-ancestor
93203176|NCT04623099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203177|NCT01358916|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93203178|NCT01358916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203179|NCT03735290|Pembrolizumab|pembrolizumab|mesh-list
93203180|NCT03735290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203181|NCT03735290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203182|NCT03735290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93203183|NCT03735290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203184|NCT03619538|Nefopam|nefopam|mesh-list
93203185|NCT03619538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93203186|NCT03619538|Analgesics|analgesics|mesh-ancestor
93203187|NCT03619538|Sensory System Agents|sensory system agents|mesh-ancestor
93203188|NCT03619538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203189|NCT03619538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203190|NCT03296098|Ulipristal acetate|ulipristal acetate|mesh-list
93203191|NCT03296098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93203192|NCT03296098|Contraceptive Agents|contraceptive agents|mesh-ancestor
93203194|NCT03296098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203195|NCT03296098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93203196|NCT01366326|Bromides|bromides|mesh-list
93203197|NCT01366326|Methylnaltrexone|methylnaltrexone|mesh-list
93203198|NCT01366326|Anticonvulsants|anticonvulsants|mesh-ancestor
93203199|NCT01366326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93203200|NCT01366326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203201|NCT01366326|Sensory System Agents|sensory system agents|mesh-ancestor
93203202|NCT01366326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203203|NCT01822275|Temozolomide|temozolomide|mesh-list
93203204|NCT01822275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93203205|NCT01822275|Alkylating Agents|alkylating agents|mesh-ancestor
93203206|NCT01822275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203207|NCT01822275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203208|NCT01331421|Exemestane|exemestane|mesh-list
93203209|NCT01331421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203210|NCT01331421|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93203211|NCT01331421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93203212|NCT01331421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203213|NCT01331421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203214|NCT01331421|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93203215|NCT01331421|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203216|NCT01331421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203217|NCT01331421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203218|NCT01656434|Ferrous fumarate|ferrous fumarate|mesh-list
93203219|NCT01656434|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93203220|NCT01656434|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93203221|NCT01656434|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93203222|NCT01656434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93203223|NCT01656434|Contraceptive Agents|contraceptive agents|mesh-ancestor
93203224|NCT01656434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203225|NCT01656434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203226|NCT01656434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93203227|NCT01656434|Estrogens|estrogens|mesh-ancestor
93203228|NCT01656434|Hormones|hormones|mesh-ancestor
93203229|NCT01656434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203230|NCT01656434|Trace Elements|trace elements|mesh-ancestor
93203231|NCT01656434|Micronutrients|micronutrients|mesh-ancestor
93203232|NCT01319214|Propranolol|propranolol|mesh-list
93203233|NCT01319214|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93203234|NCT01319214|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93203235|NCT01319214|Adrenergic Agents|adrenergic agents|mesh-ancestor
93203236|NCT01319214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203237|NCT01319214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203238|NCT01319214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203239|NCT01319214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93203240|NCT01319214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93203241|NCT01319214|Vasodilator Agents|vasodilator agents|mesh-ancestor
93203242|NCT01359228|Rifaximin|rifaximin|mesh-list
93203243|NCT01359228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93203244|NCT01359228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203245|NCT01359228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93203246|NCT02461030|Listerine|listerine|mesh-list
93203247|NCT02461030|Sodium Fluoride|sodium fluoride|mesh-list
93203248|NCT02461030|Cariostatic Agents|cariostatic agents|mesh-ancestor
93203249|NCT02461030|Protective Agents|protective agents|mesh-ancestor
93203250|NCT02461030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203251|NCT02461030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93203252|NCT02461030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203253|NCT05168618|Atezolizumab|atezolizumab|mesh-list
93203254|NCT05168618|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93203255|NCT05168618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93203256|NCT05168618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203257|NCT05168618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203258|NCT05168618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203259|NCT05168618|Immunologic Factors|immunologic factors|mesh-ancestor
93203260|NCT05168618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203261|NCT01599494|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93203262|NCT01599494|Progesterone|progesterone|mesh-list
93203263|NCT01599494|Ganirelix|ganirelix|mesh-list
93203264|NCT01599494|Progestins|progestins|mesh-ancestor
93203265|NCT01599494|Hormones|hormones|mesh-ancestor
93203266|NCT01599494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203267|NCT01599494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203268|NCT01599494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203269|NCT01599494|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203271|NCT03295786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93203272|NCT03295786|Sympathomimetics|sympathomimetics|mesh-ancestor
93203273|NCT03295786|Autonomic Agents|autonomic agents|mesh-ancestor
93203274|NCT03295786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203275|NCT03295786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203276|NCT03295786|Dopamine Agents|dopamine agents|mesh-ancestor
93203277|NCT03295786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203278|NCT03295786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203279|NCT03295786|Protective Agents|protective agents|mesh-ancestor
93203280|NCT03194932|Cytarabine|cytarabine|mesh-list
93203281|NCT03194932|Hydrocortisone|hydrocortisone|mesh-list
93203282|NCT03194932|Methotrexate|methotrexate|mesh-list
93203283|NCT03194932|Azacitidine|azacitidine|mesh-list
93203284|NCT03194932|Venetoclax|venetoclax|mesh-list
93203285|NCT03194932|Idarubicin|idarubicin|mesh-list
93203286|NCT03194932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93203287|NCT03194932|Abortifacient Agents|abortifacient agents|mesh-ancestor
93203288|NCT03194932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203289|NCT03194932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203290|NCT03194932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93203291|NCT03194932|Antimetabolites|antimetabolites|mesh-ancestor
93203292|NCT03194932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203293|NCT03194932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203294|NCT03194932|Dermatologic Agents|dermatologic agents|mesh-ancestor
93203295|NCT03194932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203296|NCT03194932|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93203297|NCT03194932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203298|NCT03194932|Immunologic Factors|immunologic factors|mesh-ancestor
93203299|NCT03194932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93203300|NCT03194932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93203301|NCT03194932|Antiviral Agents|antiviral agents|mesh-ancestor
93203302|NCT03194932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203303|NCT03194932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203304|NCT03194932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93203305|NCT03194932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93203306|NCT03194932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93203307|NCT03037580|Treprostinil|treprostinil|mesh-list
93203308|NCT03037580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93203309|NCT05154734|Belimumab|belimumab|mesh-list
93203310|NCT05154734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203311|NCT05154734|Immunologic Factors|immunologic factors|mesh-ancestor
93203312|NCT05154734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203313|NCT02978404|Nivolumab|nivolumab|mesh-list
93203314|NCT02978404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203315|NCT02978404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203316|NCT02978404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93203317|NCT02978404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203318|NCT04441918|Antibodies|antibodies|mesh-list
93203319|NCT04441918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93203320|NCT04441918|Immunologic Factors|immunologic factors|mesh-ancestor
93203321|NCT04441918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203322|NCT01331655|Tetrahydrofolates|tetrahydrofolates|mesh-list
93203323|NCT01331655|Drospirenone|drospirenone|mesh-list
93203324|NCT01331655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93203325|NCT01331655|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203326|NCT01331655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203327|NCT01331655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203328|NCT01331655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93203329|NCT01331655|Diuretics|diuretics|mesh-ancestor
93203330|NCT01331655|Natriuretic Agents|natriuretic agents|mesh-ancestor
93203331|NCT01331655|Vitamin B Complex|vitamin b complex|mesh-ancestor
93203332|NCT01331655|Vitamins|vitamins|mesh-ancestor
93203333|NCT01331655|Micronutrients|micronutrients|mesh-ancestor
93203334|NCT03289390|Acetaminophen|acetaminophen|mesh-list
93203335|NCT03289390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93203336|NCT03289390|Analgesics|analgesics|mesh-ancestor
93203337|NCT03289390|Sensory System Agents|sensory system agents|mesh-ancestor
93203338|NCT03289390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203339|NCT03289390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203340|NCT03289390|Antipyretics|antipyretics|mesh-ancestor
93203341|NCT00897104|Sumatriptan|sumatriptan|mesh-list
93203342|NCT00897104|Rizatriptan|rizatriptan|mesh-list
93203343|NCT00897104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93203344|NCT00897104|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92855852|NCT02825186|Autonomic Agents|autonomic agents|mesh-ancestor
93203345|NCT00897104|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93203346|NCT00897104|Serotonin Agents|serotonin agents|mesh-ancestor
93203347|NCT00897104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203348|NCT00897104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203349|NCT00897104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203350|NCT00792506|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
93203351|NCT00792506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93203352|NCT00792506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203353|NCT00792506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203354|NCT03295162|Melatonin|melatonin|mesh-list
93203355|NCT03295162|Antioxidants|antioxidants|mesh-ancestor
93203356|NCT03295162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203357|NCT03295162|Protective Agents|protective agents|mesh-ancestor
93203358|NCT03295162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203359|NCT03295162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203360|NCT05237492|Tramadol|tramadol|mesh-list
93203361|NCT05237492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93203362|NCT05237492|Narcotics|narcotics|mesh-ancestor
93203363|NCT05237492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203364|NCT05237492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203365|NCT05237492|Analgesics|analgesics|mesh-ancestor
93203366|NCT05237492|Sensory System Agents|sensory system agents|mesh-ancestor
93203367|NCT05237492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203368|NCT03295084|Capecitabine|capecitabine|mesh-list
93203369|NCT03295084|Irinotecan|irinotecan|mesh-list
93203370|NCT03295084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93203371|NCT03295084|Antimetabolites|antimetabolites|mesh-ancestor
93203372|NCT03295084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203373|NCT03295084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203374|NCT03295084|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93203375|NCT03295084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93203376|NCT03295084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203377|NCT04710134|Reslizumab|reslizumab|mesh-list
93203378|NCT04710134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93203379|NCT04710134|Respiratory System Agents|respiratory system agents|mesh-ancestor
93203380|NCT01339689|Ganaxolone|ganaxolone|mesh-list
93203381|NCT01339689|Neurosteroids|neurosteroids|mesh-ancestor
93203382|NCT01339689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203383|NCT01339689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203384|NCT01339689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203385|NCT01339689|GABA Modulators|gaba modulators|mesh-ancestor
93203386|NCT01339689|GABA Agents|gaba agents|mesh-ancestor
93203387|NCT00702806|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93203388|NCT00702806|Ganirelix|ganirelix|mesh-list
93203389|NCT00702806|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203390|NCT00702806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203391|NCT00702806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203392|NCT00702806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203393|NCT01336803|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93203394|NCT01336803|Hematinics|hematinics|mesh-ancestor
93203395|NCT01336803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93203396|NCT01336803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93203397|NCT03635931|Mitogens|mitogens|mesh-list
93203398|NCT03635931|Mitosis Modulators|mitosis modulators|mesh-ancestor
93203399|NCT03635931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203400|NCT01331967|Pioglitazone|pioglitazone|mesh-list
93203401|NCT01331967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93203402|NCT01331967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203403|NCT00696878|Progesterone|progesterone|mesh-list
93203404|NCT00696878|Progestins|progestins|mesh-ancestor
93203405|NCT00696878|Hormones|hormones|mesh-ancestor
93203406|NCT00696878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203407|NCT00696878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203408|NCT04493151|Imipenem|imipenem|mesh-list
93203409|NCT04493151|Relebactam|relebactam|mesh-list
93203410|NCT04493151|Cilastatin|cilastatin|mesh-list
93203411|NCT04493151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93203412|NCT04493151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203413|NCT04493151|Protease Inhibitors|protease inhibitors|mesh-ancestor
93203414|NCT04493151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203415|NCT04493151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203416|NCT04493151|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93203417|NCT00731757|Adalimumab|adalimumab|mesh-list
93203418|NCT00731757|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93203419|NCT00731757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203420|NCT00731757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93203422|NCT03108274|Mycophenolic Acid|mycophenolic acid|mesh-list
93203423|NCT03108274|Midazolam|midazolam|mesh-list
93203424|NCT03108274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93203425|NCT03108274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93203426|NCT03108274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203427|NCT03108274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203428|NCT03108274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93203429|NCT03108274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93203430|NCT03108274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93203431|NCT03108274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93203432|NCT03108274|Anesthetics, General|anesthetics, general|mesh-ancestor
93203433|NCT03108274|Anesthetics|anesthetics|mesh-ancestor
93203434|NCT03108274|GABA Modulators|gaba modulators|mesh-ancestor
93203435|NCT03108274|GABA Agents|gaba agents|mesh-ancestor
93203436|NCT03108274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203437|NCT03108274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203438|NCT03108274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93203439|NCT03108274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203440|NCT03108274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93203441|NCT03108274|Antitubercular Agents|antitubercular agents|mesh-ancestor
93203442|NCT03108274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93203443|NCT03108274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203444|NCT03108274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203445|NCT03108274|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93203446|NCT03108274|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93203447|NCT03108274|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93203448|NCT03108274|Histamine Antagonists|histamine antagonists|mesh-ancestor
93203449|NCT03108274|Histamine Agents|histamine agents|mesh-ancestor
93203450|NCT02278588|Rasagiline|rasagiline|mesh-list
93203451|NCT02278588|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93203452|NCT02278588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203453|NCT02278588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203454|NCT02278588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93203455|NCT02278588|Protective Agents|protective agents|mesh-ancestor
93203456|NCT02278588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203457|NCT03288610|Vasopressins|vasopressins|mesh-list
93203458|NCT03288610|Hemostatics|hemostatics|mesh-ancestor
93203459|NCT03288610|Coagulants|coagulants|mesh-ancestor
93203460|NCT03288610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93203461|NCT03288610|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93203462|NCT03288610|Natriuretic Agents|natriuretic agents|mesh-ancestor
93203463|NCT03288610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203464|NCT00696800|Progesterone|progesterone|mesh-list
93203465|NCT00696800|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93203466|NCT00696800|Ganirelix|ganirelix|mesh-list
93203467|NCT00696800|Progestins|progestins|mesh-ancestor
93203468|NCT00696800|Hormones|hormones|mesh-ancestor
93203469|NCT00696800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203470|NCT00696800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203471|NCT00696800|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203472|NCT03294772|Hand Sanitizers|hand sanitizers|mesh-list
93203473|NCT03294772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93203474|NCT03294772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203475|NCT03294772|Disinfectants|disinfectants|mesh-ancestor
93203476|NCT03288532|Durvalumab|durvalumab|mesh-list
93203477|NCT03288532|Tremelimumab|tremelimumab|mesh-list
93203478|NCT03288532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203479|NCT03288532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203480|NCT00598208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93203481|NCT00598208|Hormones|hormones|mesh-ancestor
93203482|NCT00598208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203483|NCT00598208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203484|NCT00480662|Alendronate|alendronate|mesh-list
93203485|NCT00480662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93203486|NCT00480662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203487|NCT00398606|Alendronate|alendronate|mesh-list
93203488|NCT00398606|Calcium Carbonate|calcium carbonate|mesh-list
93203489|NCT00398606|Calcium|calcium|mesh-list
93203490|NCT00398606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93203491|NCT00398606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203492|NCT00398606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203493|NCT00398606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93203494|NCT00398606|Antacids|antacids|mesh-ancestor
93203495|NCT00398606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93203496|NCT00395408|Beclomethasone|beclomethasone|mesh-list
93203497|NCT00395408|Montelukast|montelukast|mesh-list
93203498|NCT00395408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203499|NCT00395408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203500|NCT00395408|Respiratory System Agents|respiratory system agents|mesh-ancestor
93203501|NCT00395408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93203502|NCT00395408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93203503|NCT00395408|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203504|NCT00395408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203505|NCT00395408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93203506|NCT00395408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93203507|NCT00395408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203508|NCT00395408|Glucocorticoids|glucocorticoids|mesh-ancestor
93203509|NCT00395408|Hormones|hormones|mesh-ancestor
93203510|NCT02462044|Iodine|iodine|mesh-list
93203511|NCT02462044|Cadexomer iodine|cadexomer iodine|mesh-list
93203512|NCT02462044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93203513|NCT02462044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203514|NCT02462044|Trace Elements|trace elements|mesh-ancestor
93203515|NCT02462044|Micronutrients|micronutrients|mesh-ancestor
93203516|NCT02462044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203517|NCT00289874|Montelukast|montelukast|mesh-list
93203518|NCT00289874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93203519|NCT00289874|Respiratory System Agents|respiratory system agents|mesh-ancestor
93203520|NCT00289874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93203521|NCT00289874|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203522|NCT00289874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203523|NCT00289874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203524|NCT00289874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93203525|NCT00289874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93203526|NCT00289874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203527|NCT00245570|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93203528|NCT00245570|Montelukast|montelukast|mesh-list
93203529|NCT00245570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93203530|NCT00245570|Autonomic Agents|autonomic agents|mesh-ancestor
93203531|NCT00245570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203532|NCT00245570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203533|NCT00245570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93203534|NCT00245570|Respiratory System Agents|respiratory system agents|mesh-ancestor
93203535|NCT00245570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93203536|NCT00245570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93203537|NCT00245570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93203538|NCT00245570|Adrenergic Agents|adrenergic agents|mesh-ancestor
93203539|NCT00245570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203540|NCT00245570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203541|NCT00245570|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93203542|NCT00245570|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203543|NCT00245570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203544|NCT00245570|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93203545|NCT00245570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93203546|NCT02461888|Dexamethasone|dexamethasone|mesh-list
93203547|NCT02461888|Cyclophosphamide|cyclophosphamide|mesh-list
93203548|NCT02461888|Ixazomib|ixazomib|mesh-list
93203549|NCT02461888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203550|NCT02461888|Immunologic Factors|immunologic factors|mesh-ancestor
93203551|NCT02461888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203552|NCT02461888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93203553|NCT02461888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93203554|NCT02461888|Alkylating Agents|alkylating agents|mesh-ancestor
93203555|NCT02461888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203556|NCT02461888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203557|NCT02461888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93203558|NCT02461888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203559|NCT02461888|Antiemetics|antiemetics|mesh-ancestor
93203560|NCT02461888|Autonomic Agents|autonomic agents|mesh-ancestor
93203561|NCT02461888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203562|NCT02461888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93203563|NCT02461888|Glucocorticoids|glucocorticoids|mesh-ancestor
93203564|NCT02461888|Hormones|hormones|mesh-ancestor
93203565|NCT02461888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203566|NCT02461888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92875647|NCT04324229|Liraglutide|liraglutide|mesh-list
93203567|NCT02461888|Protease Inhibitors|protease inhibitors|mesh-ancestor
93203568|NCT02461888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203569|NCT00229970|Montelukast|montelukast|mesh-list
93203570|NCT00229970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93203571|NCT00229970|Respiratory System Agents|respiratory system agents|mesh-ancestor
93203572|NCT00229970|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93203573|NCT00229970|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203574|NCT00229970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203575|NCT00229970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203576|NCT00229970|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93203577|NCT00229970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93203578|NCT00229970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203579|NCT00111722|Rizatriptan|rizatriptan|mesh-list
93203580|NCT00111722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203581|NCT00111722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203582|NCT00111722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203583|NCT00111722|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93203584|NCT00111722|Serotonin Agents|serotonin agents|mesh-ancestor
93203585|NCT04626596|Etonogestrel|etonogestrel|mesh-list
93203586|NCT04626596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93203587|NCT04626596|Contraceptive Agents|contraceptive agents|mesh-ancestor
93203588|NCT04626596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203589|NCT04626596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203590|NCT04626596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93203591|NCT05235100|Apatinib|apatinib|mesh-list
93203592|NCT05235100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203593|NCT05235100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93203594|NCT05235100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203595|NCT05235100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203596|NCT03294382|Botulinum Toxins|botulinum toxins|mesh-list
93203597|NCT03294382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93203598|NCT03294382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93203599|NCT03294382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93203600|NCT03294382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93203601|NCT03294382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203602|NCT03294382|Cholinergic Agents|cholinergic agents|mesh-ancestor
93203603|NCT03294382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203604|NCT03294382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203605|NCT03294382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93203606|NCT03294382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203607|NCT00092066|Cholecalciferol|cholecalciferol|mesh-list
93203608|NCT00092066|Vitamin D|vitamin d|mesh-list
93203609|NCT00092066|Alendronate|alendronate|mesh-list
93203610|NCT00092066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93203611|NCT00092066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203612|NCT00092066|Vitamins|vitamins|mesh-ancestor
93203613|NCT00092066|Micronutrients|micronutrients|mesh-ancestor
93203614|NCT00092066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93203615|NCT04091750|Nivolumab|nivolumab|mesh-list
93203616|NCT04091750|Ipilimumab|ipilimumab|mesh-list
93203617|NCT04091750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203618|NCT04091750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203619|NCT04091750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93203620|NCT04091750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203621|NCT01334619|Ropivacaine|ropivacaine|mesh-list
93203622|NCT01334619|Anesthetics, Local|anesthetics, local|mesh-ancestor
93203623|NCT01334619|Anesthetics|anesthetics|mesh-ancestor
93203624|NCT01334619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203625|NCT01334619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203626|NCT01334619|Sensory System Agents|sensory system agents|mesh-ancestor
93203627|NCT01334619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203628|NCT03287128|Gemtuzumab|gemtuzumab|mesh-list
93203629|NCT03287128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203630|NCT03287128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203631|NCT03287128|Immunotoxins|immunotoxins|mesh-ancestor
93203632|NCT03287128|Immunoconjugates|immunoconjugates|mesh-ancestor
93203633|NCT03287128|Immunologic Factors|immunologic factors|mesh-ancestor
93203634|NCT03287128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203635|NCT00457275|Ezetimibe|ezetimibe|mesh-list
93203636|NCT00457275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93203637|NCT00457275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93203638|NCT00457275|Antimetabolites|antimetabolites|mesh-ancestor
93203639|NCT00457275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203640|NCT00457275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93203641|NCT03294070|Amlodipine|amlodipine|mesh-list
93203642|NCT03294070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93203643|NCT03294070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93203644|NCT03294070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93203645|NCT03294070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203646|NCT03294070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93203647|NCT03294070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203648|NCT03294070|Vasodilator Agents|vasodilator agents|mesh-ancestor
93203649|NCT04479566|Lithium Carbonate|lithium carbonate|mesh-list
93203650|NCT04479566|Calcium Carbonate|calcium carbonate|mesh-list
93203651|NCT04479566|Calcium|calcium|mesh-list
93203652|NCT04479566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93203653|NCT04479566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203654|NCT04479566|Antidepressive Agents|antidepressive agents|mesh-ancestor
93203655|NCT04479566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93203656|NCT04479566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203657|NCT04479566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203658|NCT04479566|Antimanic Agents|antimanic agents|mesh-ancestor
93203659|NCT04479566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93203660|NCT04479566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203661|NCT04479566|Antacids|antacids|mesh-ancestor
93203662|NCT04479566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93203663|NCT03293992|Latanoprost|latanoprost|mesh-list
93203664|NCT03293992|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93203665|NCT03293992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93203666|NCT01332201|Tacrolimus|tacrolimus|mesh-list
93203667|NCT01332201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203668|NCT01332201|Immunologic Factors|immunologic factors|mesh-ancestor
93203669|NCT01332201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203670|NCT01332201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93203671|NCT01332201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203672|NCT01332201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203673|NCT01332279|Everolimus|everolimus|mesh-list
93203674|NCT01332279|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93203675|NCT01332279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93203676|NCT01332279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93203677|NCT01332279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203678|NCT01332279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203679|NCT01332279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203680|NCT01332279|Immunologic Factors|immunologic factors|mesh-ancestor
93203681|NCT01332279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203682|NCT01332279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203683|NCT03298906|Ticlopidine|ticlopidine|mesh-list
93203684|NCT03298906|Esketamine|esketamine|mesh-list
93203685|NCT03298906|Antidepressive Agents|antidepressive agents|mesh-ancestor
93203686|NCT03298906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93203687|NCT03298906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93203688|NCT03298906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93203689|NCT03298906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203690|NCT03298906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93203691|NCT03298906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93203692|NCT03298906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93203693|NCT03298906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93203694|NCT03298906|Purinergic Agents|purinergic agents|mesh-ancestor
93203695|NCT03298906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203696|NCT03298906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203697|NCT03298906|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93203698|NCT03298906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93203699|NCT03298906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203700|NCT03697629|Daratumumab|daratumumab|mesh-list
93203701|NCT03697629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203702|NCT00398541|Losartan|losartan|mesh-list
93203703|NCT00398541|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93203704|NCT00398541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93203705|NCT00398541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93203706|NCT00398541|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93203707|NCT00398541|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93203708|NCT00398541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203709|NCT00398541|Diuretics|diuretics|mesh-ancestor
93203710|NCT00398541|Natriuretic Agents|natriuretic agents|mesh-ancestor
93203711|NCT00398541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203712|NCT00398541|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93203713|NCT00398541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93203714|NCT03286582|Clobetasol|clobetasol|mesh-list
93203715|NCT03286582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203716|NCT03286582|Glucocorticoids|glucocorticoids|mesh-ancestor
93203717|NCT03286582|Hormones|hormones|mesh-ancestor
93203718|NCT03286582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203719|NCT03286582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203720|NCT05202002|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93203721|NCT05202002|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93203722|NCT05202002|beta-Endorphin|beta-endorphin|mesh-list
93203723|NCT05202002|Hormones|hormones|mesh-ancestor
93203724|NCT05202002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203725|NCT05202002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203726|NCT05202002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203727|NCT05202002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203728|NCT02460640|Morphine|morphine|mesh-list
93203729|NCT02460640|Ropivacaine|ropivacaine|mesh-list
93203730|NCT02460640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93203731|NCT02460640|Narcotics|narcotics|mesh-ancestor
93203732|NCT02460640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203733|NCT02460640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203734|NCT02460640|Analgesics|analgesics|mesh-ancestor
93203735|NCT02460640|Sensory System Agents|sensory system agents|mesh-ancestor
93203736|NCT02460640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203737|NCT02460640|Anesthetics, Local|anesthetics, local|mesh-ancestor
93203738|NCT02460640|Anesthetics|anesthetics|mesh-ancestor
93203739|NCT03298516|Azacitidine|azacitidine|mesh-list
93203740|NCT03298516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93203741|NCT03298516|Antimetabolites|antimetabolites|mesh-ancestor
93203742|NCT03298516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203743|NCT03298516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203744|NCT03298516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203745|NCT05120960|Osimertinib|osimertinib|mesh-list
93203746|NCT05120960|Tepotinib|tepotinib|mesh-list
93203747|NCT05120960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203748|NCT05120960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93203749|NCT05120960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203750|NCT05120960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203751|NCT05169866|Amiodarone|amiodarone|mesh-list
93203752|NCT05169866|Nifekalant|nifekalant|mesh-list
93203753|NCT05169866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93203754|NCT05169866|Vasodilator Agents|vasodilator agents|mesh-ancestor
93203755|NCT05169866|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93203756|NCT05169866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93203757|NCT05169866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203758|NCT05169866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93203759|NCT05169866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93203760|NCT05169866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93203761|NCT05169866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203762|NCT05169866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93203763|NCT05169866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93203764|NCT05169866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93203765|NCT03843008|Melatonin|melatonin|mesh-list
93203766|NCT03843008|Antioxidants|antioxidants|mesh-ancestor
93203767|NCT03843008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203768|NCT03843008|Protective Agents|protective agents|mesh-ancestor
93203769|NCT03843008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203770|NCT03843008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203771|NCT03285802|Everolimus|everolimus|mesh-list
93203772|NCT03285802|Letrozole|letrozole|mesh-list
93203773|NCT03285802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93203774|NCT03285802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93203775|NCT03285802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203776|NCT03285802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203777|NCT03285802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203778|NCT03285802|Immunologic Factors|immunologic factors|mesh-ancestor
93203779|NCT03285802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203780|NCT03285802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203781|NCT03285802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93203782|NCT03285802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93203783|NCT03285802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93203784|NCT03285802|Hormone Antagonists|hormone antagonists|mesh-ancestor
93203785|NCT03285802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203786|NCT05130086|Islatravir|islatravir|mesh-list
93203787|NCT05130086|Antiviral Agents|antiviral agents|mesh-ancestor
93203788|NCT05130086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203789|NCT05130086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203790|NCT05130086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203791|NCT05130086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93203792|NCT05130086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93203793|NCT05130086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93203794|NCT02461186|Piperaquine|piperaquine|mesh-list
93203796|NCT02461186|Antimalarials|antimalarials|mesh-ancestor
93203797|NCT02461186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93203798|NCT02461186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93203799|NCT02461186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203800|NCT04921670|Infliximab|infliximab|mesh-list
93203801|NCT04921670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93203802|NCT04921670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203803|NCT04921670|Dermatologic Agents|dermatologic agents|mesh-ancestor
93203804|NCT04921670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93203805|NCT04921670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93203806|NCT03512210|Sofosbuvir|sofosbuvir|mesh-list
93203807|NCT03512210|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93203808|NCT03512210|Velpatasvir|velpatasvir|mesh-list
93203809|NCT03512210|Antiviral Agents|antiviral agents|mesh-ancestor
93203810|NCT03512210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203811|NCT00383721|Mometasone Furoate|mometasone furoate|mesh-list
93203812|NCT00383721|Formoterol Fumarate|formoterol fumarate|mesh-list
93203813|NCT00383721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93203814|NCT00383721|Autonomic Agents|autonomic agents|mesh-ancestor
93203815|NCT00383721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203816|NCT00383721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203817|NCT00383721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93203818|NCT00383721|Respiratory System Agents|respiratory system agents|mesh-ancestor
93203819|NCT00383721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93203820|NCT00383721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93203821|NCT00383721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93203822|NCT00383721|Adrenergic Agents|adrenergic agents|mesh-ancestor
93203823|NCT00383721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203824|NCT00383721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203825|NCT00383721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203826|NCT00383721|Dermatologic Agents|dermatologic agents|mesh-ancestor
93203827|NCT00383721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93203828|NCT03292822|Paclitaxel|paclitaxel|mesh-list
93203829|NCT03292822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93203830|NCT03292822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203831|NCT03292822|Tubulin Modulators|tubulin modulators|mesh-ancestor
93203832|NCT03292822|Antimitotic Agents|antimitotic agents|mesh-ancestor
93203833|NCT03292822|Mitosis Modulators|mitosis modulators|mesh-ancestor
93203834|NCT03292822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203835|NCT03297502|Pimecrolimus|pimecrolimus|mesh-list
93203836|NCT03297502|Tacrolimus|tacrolimus|mesh-list
93203837|NCT03297502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93203838|NCT03297502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93203839|NCT03297502|Analgesics|analgesics|mesh-ancestor
93203840|NCT03297502|Sensory System Agents|sensory system agents|mesh-ancestor
93203841|NCT03297502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203842|NCT03297502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203843|NCT03297502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203844|NCT03297502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93203845|NCT03297502|Dermatologic Agents|dermatologic agents|mesh-ancestor
93203846|NCT03297502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93203847|NCT03297502|Immunologic Factors|immunologic factors|mesh-ancestor
93203848|NCT03297502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93203849|NCT03297502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203850|NCT03297502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203851|NCT03292744|Cholecalciferol|cholecalciferol|mesh-list
93203852|NCT03292744|Alfacalcidol|alfacalcidol|mesh-list
93203853|NCT03292744|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93203854|NCT03292744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93203855|NCT03292744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203856|NCT03292744|Vitamins|vitamins|mesh-ancestor
93203857|NCT03292744|Micronutrients|micronutrients|mesh-ancestor
93203858|NCT03292744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93203859|NCT03035942|Dexamethasone|dexamethasone|mesh-list
93203860|NCT03035942|Ondansetron|ondansetron|mesh-list
93203861|NCT03035942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203862|NCT03035942|Antiemetics|antiemetics|mesh-ancestor
93203863|NCT03035942|Autonomic Agents|autonomic agents|mesh-ancestor
93203864|NCT03035942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203865|NCT03035942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203866|NCT03035942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93203867|NCT03035942|Glucocorticoids|glucocorticoids|mesh-ancestor
93203868|NCT03035942|Hormones|hormones|mesh-ancestor
93203869|NCT03035942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203870|NCT03035942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93203871|NCT03035942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203872|NCT03035942|Antipruritics|antipruritics|mesh-ancestor
93203873|NCT03035942|Dermatologic Agents|dermatologic agents|mesh-ancestor
93203874|NCT03035942|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93203875|NCT03035942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93203876|NCT03035942|Serotonin Agents|serotonin agents|mesh-ancestor
93203877|NCT03035942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203878|NCT03035942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203879|NCT02820519|Loxapine|loxapine|mesh-list
93203880|NCT02820519|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93203881|NCT02820519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93203882|NCT02820519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93203883|NCT02820519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203884|NCT02820519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93203885|NCT02820519|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93203886|NCT02820519|Dopamine Agents|dopamine agents|mesh-ancestor
93203887|NCT02820519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203888|NCT02820519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203889|NCT02616146|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93203890|NCT02616146|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93203891|NCT02616146|Levonorgestrel|levonorgestrel|mesh-list
93203892|NCT02616146|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93203893|NCT02616146|Etonogestrel|etonogestrel|mesh-list
93203894|NCT02616146|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93203895|NCT02616146|Estradiol|estradiol|mesh-list
93203896|NCT02616146|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93203897|NCT02616146|Estrogens|estrogens|mesh-ancestor
93203898|NCT02616146|Hormones|hormones|mesh-ancestor
93203899|NCT02616146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203900|NCT02616146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203901|NCT02616146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93203902|NCT02616146|Contraceptive Agents|contraceptive agents|mesh-ancestor
93203903|NCT02616146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93203904|NCT02616146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93203905|NCT02616146|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93203906|NCT02616146|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93203907|NCT02616146|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93203908|NCT02616146|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93203909|NCT01332747|Atorvastatin|atorvastatin|mesh-list
93203910|NCT01332747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93203911|NCT01332747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93203912|NCT01332747|Antimetabolites|antimetabolites|mesh-ancestor
93203913|NCT01332747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203914|NCT01332747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93203915|NCT01332747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93203916|NCT01332747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203917|NCT03442413|Nicotine|nicotine|mesh-list
93203918|NCT03442413|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93203919|NCT03442413|Autonomic Agents|autonomic agents|mesh-ancestor
93203920|NCT03442413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93203921|NCT03442413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203922|NCT03442413|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93203923|NCT03442413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93203924|NCT03442413|Cholinergic Agents|cholinergic agents|mesh-ancestor
93203925|NCT03442413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93203926|NCT03442413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203927|NCT01337427|Interferons|interferons|mesh-list
93203928|NCT01337427|Interferon-beta|interferon-beta|mesh-list
93203929|NCT01337427|Interferon beta-1a|interferon beta-1a|mesh-list
93203930|NCT01337427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203931|NCT01337427|Antiviral Agents|antiviral agents|mesh-ancestor
93203932|NCT01337427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203933|NCT01337427|Immunologic Factors|immunologic factors|mesh-ancestor
93203934|NCT01337427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203935|NCT01337427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93203936|NCT02459938|Glucagon|glucagon|mesh-list
93203937|NCT02459938|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93203938|NCT02459938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876025|NCT03703856|Memantine|memantine|mesh-list
93203940|NCT02459938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203941|NCT02459938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203942|NCT02459938|Incretins|incretins|mesh-ancestor
93203943|NCT03284164|Tenofovir|tenofovir|mesh-list
93203944|NCT03284164|Antiviral Agents|antiviral agents|mesh-ancestor
93203945|NCT03284164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203946|NCT03284164|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93203947|NCT03284164|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93203948|NCT03284164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93203949|NCT03284164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203950|NCT03284164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93203951|NCT03284164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93203952|NCT01337583|Dapivirine|dapivirine|mesh-list
93203953|NCT01337583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93203954|NCT01337583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93203955|NCT01337583|Antiviral Agents|antiviral agents|mesh-ancestor
93203956|NCT01337583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93203957|NCT03107962|Pembrolizumab|pembrolizumab|mesh-list
93203958|NCT03107962|Antibodies|antibodies|mesh-list
93203959|NCT03107962|Antibodies, Blocking|antibodies, blocking|mesh-list
93203960|NCT03107962|Immunologic Factors|immunologic factors|mesh-ancestor
93203961|NCT03107962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203962|NCT03107962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203963|NCT03107962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203964|NCT03107962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93203965|NCT03107962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203966|NCT04891172|Immunoglobulins|immunoglobulins|mesh-list
93203967|NCT04891172|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93203968|NCT04891172|Antibodies|antibodies|mesh-list
93203969|NCT04891172|gamma-Globulins|gamma-globulins|mesh-list
93203970|NCT04891172|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93203971|NCT04891172|Immunologic Factors|immunologic factors|mesh-ancestor
93203972|NCT04891172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203973|NCT03135249|Alemtuzumab|alemtuzumab|mesh-list
93203974|NCT03135249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93203975|NCT03135249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203976|NCT01335321|Triamcinolone|triamcinolone|mesh-list
93203977|NCT01335321|Hyaluronic Acid|hyaluronic acid|mesh-list
93203978|NCT01335321|Hylan|hylan|mesh-list
93203979|NCT01335321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93203980|NCT01335321|Glucocorticoids|glucocorticoids|mesh-ancestor
93203981|NCT01335321|Hormones|hormones|mesh-ancestor
93203982|NCT01335321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93203983|NCT01335321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93203984|NCT01335321|Immunologic Factors|immunologic factors|mesh-ancestor
93203985|NCT01335321|Viscosupplements|viscosupplements|mesh-ancestor
93203986|NCT01335321|Protective Agents|protective agents|mesh-ancestor
93203987|NCT01335321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93203988|NCT01333137|Carboplatin|carboplatin|mesh-list
93203989|NCT01333137|Gemcitabine|gemcitabine|mesh-list
93203990|NCT01333137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93203991|NCT01333137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93203992|NCT01333137|Antimetabolites|antimetabolites|mesh-ancestor
93203993|NCT01333137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93203994|NCT03282838|Celecoxib|celecoxib|mesh-list
93203995|NCT03282838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93203996|NCT03282838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93203997|NCT03282838|Analgesics|analgesics|mesh-ancestor
93203998|NCT03282838|Sensory System Agents|sensory system agents|mesh-ancestor
93203999|NCT03282838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204000|NCT03282838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204001|NCT03282838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204002|NCT03282838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204003|NCT03282838|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93204004|NCT03282838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93204005|NCT03282838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204006|NCT03282838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204007|NCT04431466|Ivermectin|ivermectin|mesh-list
93204008|NCT04431466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93204009|NCT04431466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204010|NCT03291418|Naproxen|naproxen|mesh-list
93204011|NCT03291418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93204012|NCT03291418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204013|NCT03291418|Analgesics|analgesics|mesh-ancestor
93204014|NCT03291418|Sensory System Agents|sensory system agents|mesh-ancestor
93204015|NCT03291418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204016|NCT03291418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204017|NCT03291418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204018|NCT03291418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204019|NCT03291418|Gout Suppressants|gout suppressants|mesh-ancestor
93204020|NCT03291418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93204021|NCT03291418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204022|NCT03291418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204023|NCT02885181|Methotrexate|methotrexate|mesh-list
93204024|NCT02885181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93204025|NCT02885181|Abortifacient Agents|abortifacient agents|mesh-ancestor
93204026|NCT02885181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93204027|NCT02885181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204028|NCT02885181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204029|NCT02885181|Antimetabolites|antimetabolites|mesh-ancestor
93204030|NCT02885181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204031|NCT02885181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204032|NCT02885181|Dermatologic Agents|dermatologic agents|mesh-ancestor
93204033|NCT02885181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204034|NCT02885181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93204035|NCT02885181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204036|NCT02885181|Immunologic Factors|immunologic factors|mesh-ancestor
93204037|NCT02885181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204038|NCT02885181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93204039|NCT02459782|Anesthetics|anesthetics|mesh-list
93204040|NCT02459782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204041|NCT02459782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204042|NCT02884089|Metformin|metformin|mesh-list
93204043|NCT02884089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204044|NCT02884089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204045|NCT01315431|Capecitabine|capecitabine|mesh-list
93204046|NCT01315431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204047|NCT01315431|Antimetabolites|antimetabolites|mesh-ancestor
93204048|NCT01315431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204049|NCT01315431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204050|NCT00092625|Ezetimibe|ezetimibe|mesh-list
93204051|NCT00092625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93204052|NCT00092625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93204053|NCT00092625|Antimetabolites|antimetabolites|mesh-ancestor
93204054|NCT00092625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204055|NCT00092625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93204056|NCT01333449|Decitabine|decitabine|mesh-list
93204057|NCT01333449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204058|NCT01333449|Antimetabolites|antimetabolites|mesh-ancestor
93204059|NCT01333449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204060|NCT01333449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204061|NCT01333449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204062|NCT01341717|Metformin|metformin|mesh-list
93204063|NCT01341717|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93204064|NCT01341717|Glimepiride|glimepiride|mesh-list
93204065|NCT01341717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204066|NCT01341717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204067|NCT01341717|Incretins|incretins|mesh-ancestor
93204068|NCT01341717|Hormones|hormones|mesh-ancestor
93204069|NCT01341717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204070|NCT01341717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93204071|NCT01341717|Protease Inhibitors|protease inhibitors|mesh-ancestor
93204072|NCT01341717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204073|NCT01341717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204074|NCT01341717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93204075|NCT01341717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204076|NCT01341717|Immunologic Factors|immunologic factors|mesh-ancestor
93204077|NCT03157089|Pembrolizumab|pembrolizumab|mesh-list
93204078|NCT03157089|Afatinib|afatinib|mesh-list
93204079|NCT03157089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204080|NCT03157089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204081|NCT03157089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93204082|NCT03157089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204083|NCT03157089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93204084|NCT03157089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204085|NCT01338129|Ascorbic Acid|ascorbic acid|mesh-list
93204086|NCT01338129|Vitamins|vitamins|mesh-ancestor
93204087|NCT01338129|Micronutrients|micronutrients|mesh-ancestor
93204088|NCT01338129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204089|NCT01338129|Antioxidants|antioxidants|mesh-ancestor
93204090|NCT01338129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204091|NCT01338129|Protective Agents|protective agents|mesh-ancestor
93204092|NCT05181969|Dextrans|dextrans|mesh-list
93204093|NCT05181969|Anticoagulants|anticoagulants|mesh-ancestor
93204094|NCT05181969|Plasma Substitutes|plasma substitutes|mesh-ancestor
93204095|NCT05181969|Blood Substitutes|blood substitutes|mesh-ancestor
93204096|NCT00092157|Simvastatin|simvastatin|mesh-list
93204097|NCT00092157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93204098|NCT00092157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93204099|NCT00092157|Antimetabolites|antimetabolites|mesh-ancestor
93204100|NCT00092157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204101|NCT00092157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93204102|NCT00092157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93204103|NCT00092157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204104|NCT00089895|Eptifibatide|eptifibatide|mesh-list
93204105|NCT00089895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93204106|NCT05166291|Anesthetics|anesthetics|mesh-list
93204107|NCT05166291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204108|NCT05166291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204109|NCT01338441|Erythromycin|erythromycin|mesh-list
93204110|NCT01338441|Erythromycin Estolate|erythromycin estolate|mesh-list
93204111|NCT01338441|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93204112|NCT01338441|Erythromycin stearate|erythromycin stearate|mesh-list
93204113|NCT01338441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93204114|NCT01338441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204115|NCT01338441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93204116|NCT01338441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93204117|NCT01338441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204118|NCT01338441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204119|NCT01341951|Lenograstim|lenograstim|mesh-list
93204120|NCT01341951|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93204121|NCT01341951|Immunologic Factors|immunologic factors|mesh-ancestor
93204122|NCT01341951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204123|NCT01342185|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
93204124|NCT01342185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204125|NCT02714218|Nivolumab|nivolumab|mesh-list
93204126|NCT02714218|Ipilimumab|ipilimumab|mesh-list
93204127|NCT02714218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204128|NCT02714218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204129|NCT02714218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93204130|NCT02714218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204131|NCT05185869|Paclitaxel|paclitaxel|mesh-list
93204132|NCT05185869|Gemcitabine|gemcitabine|mesh-list
93204133|NCT05185869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93204134|NCT05185869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204135|NCT05185869|Tubulin Modulators|tubulin modulators|mesh-ancestor
93204136|NCT05185869|Antimitotic Agents|antimitotic agents|mesh-ancestor
93204137|NCT05185869|Mitosis Modulators|mitosis modulators|mesh-ancestor
93204138|NCT05185869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204139|NCT05185869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204140|NCT05185869|Antimetabolites|antimetabolites|mesh-ancestor
93204141|NCT01338675|Busulfan|busulfan|mesh-list
93204142|NCT01338675|Alkylating Agents|alkylating agents|mesh-ancestor
93204143|NCT01338675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204144|NCT01338675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204145|NCT01338675|Immunologic Factors|immunologic factors|mesh-ancestor
93204146|NCT01338675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204147|NCT01338675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93204148|NCT01338675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204149|NCT01338675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93204150|NCT01338753|Bevacizumab|bevacizumab|mesh-list
93204151|NCT01338753|Docetaxel|docetaxel|mesh-list
93204152|NCT01338753|Doxorubicin|doxorubicin|mesh-list
93204153|NCT01338753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204154|NCT01338753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204155|NCT01338753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93204156|NCT01338753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93204157|NCT01338753|Growth Substances|growth substances|mesh-ancestor
93204158|NCT01338753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204159|NCT01338753|Growth Inhibitors|growth inhibitors|mesh-ancestor
93204160|NCT01338753|Tubulin Modulators|tubulin modulators|mesh-ancestor
93204161|NCT01338753|Antimitotic Agents|antimitotic agents|mesh-ancestor
93204162|NCT01338753|Mitosis Modulators|mitosis modulators|mesh-ancestor
92500002|NCT02038452|Protective Agents|protective agents|mesh-ancestor
93204163|NCT01338753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204164|NCT01338753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93204165|NCT01338753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93204166|NCT01338753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93204167|NCT01338753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204169|NCT02457286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204170|NCT02457286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204171|NCT01338909|Clopidogrel|clopidogrel|mesh-list
93204172|NCT01338909|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93204173|NCT01338909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93204174|NCT01338909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93204175|NCT01338909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93204176|NCT01338909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93204177|NCT01338909|Purinergic Agents|purinergic agents|mesh-ancestor
93204178|NCT01338909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204179|NCT01338909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204180|NCT01338909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204181|NCT03282136|Incretins|incretins|mesh-list
93204182|NCT03282136|Hormones|hormones|mesh-ancestor
93204183|NCT03282136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204184|NCT03282136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204185|NCT03156621|Alirocumab|alirocumab|mesh-list
93204186|NCT03156621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93204187|NCT03156621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93204188|NCT03156621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93204189|NCT03156621|Antimetabolites|antimetabolites|mesh-ancestor
93204190|NCT03156621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204191|NCT03156621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93204192|NCT03156621|Protease Inhibitors|protease inhibitors|mesh-ancestor
93204193|NCT03156621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204194|NCT03156621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93204195|NCT03264586|Lidocaine|lidocaine|mesh-list
93204196|NCT03264586|Prilocaine|prilocaine|mesh-list
93204197|NCT03264586|Mepivacaine|mepivacaine|mesh-list
93204198|NCT03264586|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93204199|NCT03264586|Anesthetics, Local|anesthetics, local|mesh-ancestor
93204200|NCT03264586|Anesthetics|anesthetics|mesh-ancestor
93204201|NCT03264586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204202|NCT03264586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204203|NCT03264586|Sensory System Agents|sensory system agents|mesh-ancestor
93204204|NCT03264586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204205|NCT03264586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93204206|NCT03264586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93204207|NCT03264586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93204208|NCT03264586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204209|NCT03264586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204210|NCT03264586|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93204211|NCT01342731|Tigecycline|tigecycline|mesh-list
93204212|NCT01342731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93204213|NCT01342731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204214|NCT01342731|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93204215|NCT01342731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204216|NCT01342731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204217|NCT01339065|Ketamine|ketamine|mesh-list
93204218|NCT01339065|Analgesics|analgesics|mesh-ancestor
93204219|NCT01339065|Sensory System Agents|sensory system agents|mesh-ancestor
93204220|NCT01339065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204221|NCT01339065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204222|NCT01339065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93204223|NCT01339065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93204224|NCT01339065|Anesthetics, General|anesthetics, general|mesh-ancestor
93204225|NCT01339065|Anesthetics|anesthetics|mesh-ancestor
93204226|NCT01339065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204227|NCT01339065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93204228|NCT01339065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93204229|NCT01339065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204230|NCT01339065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204231|NCT02460016|Ziresovir|ziresovir|mesh-list
93204232|NCT02460016|Antiviral Agents|antiviral agents|mesh-ancestor
93204233|NCT02460016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204234|NCT05187507|Theobromine|theobromine|mesh-list
93204235|NCT05187507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93204236|NCT05187507|Autonomic Agents|autonomic agents|mesh-ancestor
92876312|NCT00910806|Nevirapine|nevirapine|mesh-list
93204237|NCT05187507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204238|NCT05187507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204239|NCT05187507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93204240|NCT05187507|Respiratory System Agents|respiratory system agents|mesh-ancestor
93204241|NCT05187507|Vasodilator Agents|vasodilator agents|mesh-ancestor
93204242|NCT01339143|Pioglitazone|pioglitazone|mesh-list
93204243|NCT01339143|Vildagliptin|vildagliptin|mesh-list
93204244|NCT01339143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204245|NCT01339143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204246|NCT01339143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93204247|NCT01339143|Protease Inhibitors|protease inhibitors|mesh-ancestor
93204248|NCT01339143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204249|NCT01339143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204250|NCT03264430|Ketamine|ketamine|mesh-list
93204251|NCT03264430|Bupivacaine|bupivacaine|mesh-list
93204252|NCT03264430|Anesthetics, Local|anesthetics, local|mesh-ancestor
93204253|NCT03264430|Anesthetics|anesthetics|mesh-ancestor
93204254|NCT03264430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204255|NCT03264430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204256|NCT03264430|Sensory System Agents|sensory system agents|mesh-ancestor
93204257|NCT03264430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204258|NCT03264430|Analgesics|analgesics|mesh-ancestor
93204259|NCT03264430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93204260|NCT03264430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93204261|NCT03264430|Anesthetics, General|anesthetics, general|mesh-ancestor
93204262|NCT03264430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93204263|NCT03264430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93204264|NCT03264430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204265|NCT03264430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204266|NCT05250843|Lenvatinib|lenvatinib|mesh-list
93204267|NCT05250843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204268|NCT05250843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93204269|NCT05250843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204270|NCT05250843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204271|NCT03264274|Aflibercept|aflibercept|mesh-list
93204272|NCT03264274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93204273|NCT03264274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93204274|NCT03264274|Growth Substances|growth substances|mesh-ancestor
93204275|NCT03264274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204276|NCT03264274|Growth Inhibitors|growth inhibitors|mesh-ancestor
93204277|NCT03264274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204278|NCT02457208|Rifampin|rifampin|mesh-list
93204279|NCT02457208|Isoniazid|isoniazid|mesh-list
93204280|NCT02457208|Pyrazinamide|pyrazinamide|mesh-list
93204281|NCT02457208|Ethambutol|ethambutol|mesh-list
93204282|NCT02457208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93204283|NCT02457208|Antitubercular Agents|antitubercular agents|mesh-ancestor
93204284|NCT02457208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93204285|NCT02457208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204286|NCT02457208|Leprostatic Agents|leprostatic agents|mesh-ancestor
93204287|NCT02457208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93204288|NCT02457208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204289|NCT02457208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204290|NCT02457208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93204291|NCT02457208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93204292|NCT02457208|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93204293|NCT02457208|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93204294|NCT02457208|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93204295|NCT02457208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93204296|NCT02457208|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93204297|NCT02457208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93204298|NCT02457208|Antimetabolites|antimetabolites|mesh-ancestor
93204299|NCT02457208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93204300|NCT02457130|Clopidogrel|clopidogrel|mesh-list
93204301|NCT02457130|Ticagrelor|ticagrelor|mesh-list
93204302|NCT02457130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93204303|NCT02457130|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93204304|NCT02457130|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93204305|NCT02457130|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93204306|NCT02457130|Purinergic Agents|purinergic agents|mesh-ancestor
93204307|NCT02457130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500184|NCT02009592|Rifaximin|rifaximin|mesh-list
93204308|NCT02457130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204309|NCT02457130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204310|NCT01340235|Erythromycin|erythromycin|mesh-list
93204311|NCT01340235|Erythromycin Estolate|erythromycin estolate|mesh-list
93204312|NCT01340235|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93204313|NCT01340235|Erythromycin stearate|erythromycin stearate|mesh-list
93204314|NCT01340235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93204315|NCT01340235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204316|NCT01340235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93204317|NCT01340235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93204318|NCT01340235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204319|NCT01340235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204320|NCT03263962|Canrenone|canrenone|mesh-list
93204321|NCT03263962|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93204322|NCT03263962|Hormone Antagonists|hormone antagonists|mesh-ancestor
93204323|NCT03263962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204324|NCT03263962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204325|NCT03263962|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93204326|NCT03263962|Diuretics|diuretics|mesh-ancestor
93204327|NCT03263962|Natriuretic Agents|natriuretic agents|mesh-ancestor
93204328|NCT05186649|Warfarin|warfarin|mesh-list
93204329|NCT05186649|Anticoagulants|anticoagulants|mesh-ancestor
93204330|NCT05184465|Anesthetics|anesthetics|mesh-list
93204331|NCT05184465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204332|NCT05184465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204333|NCT03152019|Tacrolimus|tacrolimus|mesh-list
93204334|NCT03152019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204335|NCT03152019|Immunologic Factors|immunologic factors|mesh-ancestor
93204336|NCT03152019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204337|NCT03152019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93204338|NCT03152019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204339|NCT03152019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204340|NCT04813107|Tislelizumab|tislelizumab|mesh-list
93204341|NCT04813107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204342|NCT04813107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204343|NCT02714062|Topiramate|topiramate|mesh-list
93204344|NCT02714062|Phentermine|phentermine|mesh-list
93204345|NCT02714062|Anticonvulsants|anticonvulsants|mesh-ancestor
93204346|NCT02714062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204347|NCT02714062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204348|NCT02714062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93204349|NCT02714062|Appetite Depressants|appetite depressants|mesh-ancestor
93204350|NCT02714062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93204351|NCT02714062|Sympathomimetics|sympathomimetics|mesh-ancestor
93204352|NCT02714062|Autonomic Agents|autonomic agents|mesh-ancestor
93204353|NCT02714062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204354|NCT02714062|Adrenergic Agents|adrenergic agents|mesh-ancestor
93204355|NCT02714062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204356|NCT02714062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204357|NCT03280342|Topiramate|topiramate|mesh-list
93204358|NCT03280342|Anticonvulsants|anticonvulsants|mesh-ancestor
93204359|NCT03280342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204360|NCT03280342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204361|NCT04965519|Trastuzumab|trastuzumab|mesh-list
93204362|NCT04965519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204363|NCT04965519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204364|NCT03279796|Betamethasone|betamethasone|mesh-list
93204365|NCT03279796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204366|NCT03279796|Glucocorticoids|glucocorticoids|mesh-ancestor
93204367|NCT03279796|Hormones|hormones|mesh-ancestor
93204368|NCT03279796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204369|NCT03279796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204370|NCT03279796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93204371|NCT03279796|Respiratory System Agents|respiratory system agents|mesh-ancestor
93204372|NCT02713828|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
93204373|NCT02713828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93204374|NCT02713828|Immunoconjugates|immunoconjugates|mesh-ancestor
93204375|NCT02713828|Immunologic Factors|immunologic factors|mesh-ancestor
93204376|NCT02713828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204377|NCT02713828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204378|NCT02713828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204379|NCT05183997|Verapamil|verapamil|mesh-list
93204380|NCT05183997|Thrombin|thrombin|mesh-list
93204381|NCT05183997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93204382|NCT05183997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93204383|NCT05183997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204384|NCT05183997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204385|NCT05183997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93204386|NCT05183997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204387|NCT05183997|Vasodilator Agents|vasodilator agents|mesh-ancestor
93204389|NCT05183997|Coagulants|coagulants|mesh-ancestor
93204390|NCT05119101|Magnesium Sulfate|magnesium sulfate|mesh-list
93204391|NCT05119101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204392|NCT05119101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204393|NCT05119101|Analgesics|analgesics|mesh-ancestor
93204394|NCT05119101|Sensory System Agents|sensory system agents|mesh-ancestor
93204395|NCT05119101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204396|NCT05119101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204397|NCT05119101|Anesthetics|anesthetics|mesh-ancestor
93204398|NCT05119101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93204399|NCT05119101|Anticonvulsants|anticonvulsants|mesh-ancestor
93204400|NCT05119101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93204401|NCT05119101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204402|NCT05119101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93204403|NCT05119101|Tocolytic Agents|tocolytic agents|mesh-ancestor
93204404|NCT05119101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93204405|NCT01340547|Isophosphamide mustard|isophosphamide mustard|mesh-list
93204406|NCT01340547|Ifosfamide|ifosfamide|mesh-list
93204407|NCT01340547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93204408|NCT01340547|Alkylating Agents|alkylating agents|mesh-ancestor
93204409|NCT01340547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204410|NCT01340547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204411|NCT05183841|Fenoterol|fenoterol|mesh-list
93204412|NCT05183841|Ipratropium|ipratropium|mesh-list
93204413|NCT05183841|Bronchodilator Agents|bronchodilator agents|mesh-list
93204414|NCT05183841|Autonomic Agents|autonomic agents|mesh-ancestor
93204415|NCT05183841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204416|NCT05183841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204417|NCT05183841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93204418|NCT05183841|Respiratory System Agents|respiratory system agents|mesh-ancestor
93204419|NCT05183841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93204420|NCT05183841|Cholinergic Agents|cholinergic agents|mesh-ancestor
93204421|NCT05183841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204422|NCT05183841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204423|NCT05183841|Sympathomimetics|sympathomimetics|mesh-ancestor
93204424|NCT05183841|Tocolytic Agents|tocolytic agents|mesh-ancestor
93204425|NCT05183841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93204426|NCT05183841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93204427|NCT05183841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93204428|NCT05183841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93204429|NCT05183841|Adrenergic Agents|adrenergic agents|mesh-ancestor
93204430|NCT03277222|Insulin|insulin|mesh-list
93204431|NCT03277222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93204432|NCT03277222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204433|NCT04931667|Lorecivivint|lorecivivint|mesh-list
93204434|NCT04931667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204435|NCT03262948|Paclitaxel|paclitaxel|mesh-list
93204436|NCT03262948|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93204437|NCT03262948|Carboplatin|carboplatin|mesh-list
93204438|NCT03262948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93204439|NCT03262948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204440|NCT03262948|Tubulin Modulators|tubulin modulators|mesh-ancestor
93204441|NCT03262948|Antimitotic Agents|antimitotic agents|mesh-ancestor
93204442|NCT03262948|Mitosis Modulators|mitosis modulators|mesh-ancestor
93204443|NCT03262948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204444|NCT02876328|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93204445|NCT02876328|Antiviral Agents|antiviral agents|mesh-ancestor
93204446|NCT02876328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204447|NCT03276598|Losartan|losartan|mesh-list
93204448|NCT03276598|Amlodipine|amlodipine|mesh-list
93204449|NCT03276598|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93204450|NCT03276598|Bisoprolol|bisoprolol|mesh-list
93204451|NCT03276598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93204452|NCT03276598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93204453|NCT03276598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204454|NCT03276598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204455|NCT03276598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500307|NCT02010970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204456|NCT03276598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204457|NCT03276598|Vasodilator Agents|vasodilator agents|mesh-ancestor
93204458|NCT03276598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93204459|NCT03276598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93204460|NCT03276598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93204461|NCT03276598|Diuretics|diuretics|mesh-ancestor
93204462|NCT03276598|Natriuretic Agents|natriuretic agents|mesh-ancestor
93204463|NCT03276598|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93204464|NCT03276598|Sympatholytics|sympatholytics|mesh-ancestor
93204465|NCT03276598|Autonomic Agents|autonomic agents|mesh-ancestor
93204466|NCT03276598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204467|NCT03276598|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93204468|NCT03276598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93204469|NCT03276598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93204470|NCT03276598|Adrenergic Agents|adrenergic agents|mesh-ancestor
93204471|NCT03276598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204472|NCT03262792|Andrographolide|andrographolide|mesh-list
93204473|NCT03262792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204474|NCT03262792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93204475|NCT03262792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204476|NCT03262792|Analgesics|analgesics|mesh-ancestor
93204477|NCT03262792|Sensory System Agents|sensory system agents|mesh-ancestor
93204478|NCT03262792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204479|NCT03262792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204480|NCT03262792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204481|NCT03262792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93204482|NCT03262792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93204483|NCT03262792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204484|NCT03262792|Antiviral Agents|antiviral agents|mesh-ancestor
93204485|NCT03262792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93204486|NCT01359462|Tolvaptan|tolvaptan|mesh-list
93204487|NCT01359462|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93204488|NCT01359462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204489|NCT01359462|Natriuretic Agents|natriuretic agents|mesh-ancestor
93204490|NCT01359462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204491|NCT02875392|Fucoidan|fucoidan|mesh-list
93204492|NCT02875392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93204493|NCT02875392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93204494|NCT02875392|Anticoagulants|anticoagulants|mesh-ancestor
93204495|NCT02875392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204496|NCT01359618|Moxifloxacin|moxifloxacin|mesh-list
93204497|NCT01359618|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93204498|NCT01359618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93204499|NCT01359618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204500|NCT01359618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93204501|NCT01359618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93204502|NCT01359618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204503|NCT01359618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204504|NCT01359618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204505|NCT01359618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93204506|NCT01359618|Contraceptive Agents|contraceptive agents|mesh-ancestor
93204507|NCT01359618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93204508|NCT01359618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204509|NCT01359618|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93204510|NCT01359618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93204511|NCT01359618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93204512|NCT03267628|Morphine|morphine|mesh-list
93204513|NCT03267628|Anesthetics|anesthetics|mesh-list
93204514|NCT03267628|Anesthetics, Local|anesthetics, local|mesh-list
93204515|NCT03267628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93204516|NCT03267628|Narcotics|narcotics|mesh-ancestor
93204517|NCT03267628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204518|NCT03267628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204519|NCT03267628|Analgesics|analgesics|mesh-ancestor
93204520|NCT03267628|Sensory System Agents|sensory system agents|mesh-ancestor
93204521|NCT03267628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204522|NCT01359696|Gemcitabine|gemcitabine|mesh-list
93204523|NCT01359696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204524|NCT01359696|Antimetabolites|antimetabolites|mesh-ancestor
93204525|NCT01359696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204526|NCT01359696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204527|NCT03268018|Calcium|calcium|mesh-list
93204528|NCT03268018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93204529|NCT03268018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204530|NCT01362426|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93204531|NCT01362426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93204532|NCT01362426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93204533|NCT01362426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204534|NCT01362426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204535|NCT01362426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93204536|NCT01362426|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93204537|NCT01362426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93204538|NCT01362426|Serotonin Agents|serotonin agents|mesh-ancestor
93204539|NCT01362426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204540|NCT01362426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204541|NCT01362426|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93204542|NCT01362426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93204543|NCT01362426|Dopamine Agents|dopamine agents|mesh-ancestor
93204544|NCT01367028|Bevacizumab|bevacizumab|mesh-list
93204545|NCT01367028|Trastuzumab|trastuzumab|mesh-list
93204546|NCT01367028|Docetaxel|docetaxel|mesh-list
93204547|NCT01367028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204548|NCT01367028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204549|NCT01367028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93204550|NCT01367028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93204551|NCT01367028|Growth Substances|growth substances|mesh-ancestor
93204552|NCT01367028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204553|NCT01367028|Growth Inhibitors|growth inhibitors|mesh-ancestor
93204554|NCT01367028|Tubulin Modulators|tubulin modulators|mesh-ancestor
93204555|NCT01367028|Antimitotic Agents|antimitotic agents|mesh-ancestor
93204556|NCT01367028|Mitosis Modulators|mitosis modulators|mesh-ancestor
93204557|NCT01367028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204558|NCT03965962|Vaccines|vaccines|mesh-list
93204559|NCT03965962|Immunoglobulins|immunoglobulins|mesh-list
93204560|NCT03965962|Antibodies|antibodies|mesh-list
93204561|NCT03965962|gamma-Globulins|gamma-globulins|mesh-list
93204562|NCT03965962|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93204563|NCT03965962|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93204564|NCT03965962|Immunologic Factors|immunologic factors|mesh-ancestor
93204565|NCT03965962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204566|NCT03273088|Etanercept|etanercept|mesh-list
93204567|NCT03273088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93204568|NCT03273088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204569|NCT03273088|Analgesics|analgesics|mesh-ancestor
93204570|NCT03273088|Sensory System Agents|sensory system agents|mesh-ancestor
93204571|NCT03273088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204572|NCT03273088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204573|NCT03273088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204574|NCT03273088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204575|NCT03273088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93204576|NCT03273088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204577|NCT03273088|Immunologic Factors|immunologic factors|mesh-ancestor
93204578|NCT04235634|Alprostadil|alprostadil|mesh-list
93204579|NCT04235634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93204580|NCT04235634|Vasodilator Agents|vasodilator agents|mesh-ancestor
93204581|NCT04235634|Urological Agents|urological agents|mesh-ancestor
93204582|NCT03262090|Dexmedetomidine|dexmedetomidine|mesh-list
93204583|NCT03262090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93204584|NCT03262090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204585|NCT03262090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204586|NCT03262090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204587|NCT03262090|Analgesics|analgesics|mesh-ancestor
93204588|NCT03262090|Sensory System Agents|sensory system agents|mesh-ancestor
93204589|NCT03262090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204590|NCT03262090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93204591|NCT03262090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93204592|NCT03262090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93204593|NCT03262090|Adrenergic Agents|adrenergic agents|mesh-ancestor
93204594|NCT03262090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204595|NCT03262090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204596|NCT03151551|Adalimumab|adalimumab|mesh-list
93204597|NCT03151551|Ixekizumab|ixekizumab|mesh-list
93204598|NCT03151551|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93204599|NCT03151551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204600|NCT03151551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204601|NCT03151551|Dermatologic Agents|dermatologic agents|mesh-ancestor
93204602|NCT03267316|Paclitaxel|paclitaxel|mesh-list
93204603|NCT03267316|Gemcitabine|gemcitabine|mesh-list
93204604|NCT03267316|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93204605|NCT03267316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204606|NCT03267316|Tubulin Modulators|tubulin modulators|mesh-ancestor
93204607|NCT03267316|Antimitotic Agents|antimitotic agents|mesh-ancestor
93204608|NCT03267316|Mitosis Modulators|mitosis modulators|mesh-ancestor
93204609|NCT03267316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204610|NCT03267316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204611|NCT03267316|Antimetabolites|antimetabolites|mesh-ancestor
93204612|NCT01359930|Naltrexone|naltrexone|mesh-list
93204613|NCT01359930|Bupropion|bupropion|mesh-list
93204614|NCT01359930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93204615|NCT01359930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93204616|NCT01359930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204617|NCT01359930|Sensory System Agents|sensory system agents|mesh-ancestor
93204618|NCT01359930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204619|NCT01359930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93204620|NCT01359930|Antidepressive Agents|antidepressive agents|mesh-ancestor
93204621|NCT01359930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93204622|NCT01359930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93204623|NCT01359930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93204624|NCT01359930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204625|NCT01359930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204626|NCT01359930|Dopamine Agents|dopamine agents|mesh-ancestor
93204627|NCT01359930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204628|NCT01359930|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93204629|NCT01359930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93204630|NCT01359930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204631|NCT05075512|Fulvestrant|fulvestrant|mesh-list
93204632|NCT05075512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93204633|NCT05075512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204634|NCT05075512|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93204635|NCT05075512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93204636|NCT05075512|Hormone Antagonists|hormone antagonists|mesh-ancestor
93204637|NCT05075512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204638|NCT05075512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204639|NCT01316757|Paclitaxel|paclitaxel|mesh-list
93204640|NCT01316757|Carboplatin|carboplatin|mesh-list
93204641|NCT01316757|Cetuximab|cetuximab|mesh-list
93204642|NCT01316757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93204643|NCT01316757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93204644|NCT01316757|Antibodies|antibodies|mesh-list
93204645|NCT01316757|Immunoglobulins|immunoglobulins|mesh-list
93204646|NCT01316757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93204647|NCT01316757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93204648|NCT01316757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204649|NCT01316757|Tubulin Modulators|tubulin modulators|mesh-ancestor
93204650|NCT01316757|Antimitotic Agents|antimitotic agents|mesh-ancestor
93204651|NCT01316757|Mitosis Modulators|mitosis modulators|mesh-ancestor
93204652|NCT01316757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204653|NCT01316757|Immunologic Factors|immunologic factors|mesh-ancestor
93204654|NCT01316757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204655|NCT01316757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93204656|NCT01316757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204657|NCT05074966|Cetuximab|cetuximab|mesh-list
93204658|NCT05074966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204659|NCT05074966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204660|NCT03266926|Bupivacaine|bupivacaine|mesh-list
93204661|NCT03266926|Estrogens|estrogens|mesh-list
93204662|NCT03266926|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93204663|NCT03266926|Anesthetics, Local|anesthetics, local|mesh-ancestor
93204664|NCT03266926|Anesthetics|anesthetics|mesh-ancestor
93204665|NCT03266926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204666|NCT03266926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204667|NCT03266926|Sensory System Agents|sensory system agents|mesh-ancestor
93204668|NCT03266926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204669|NCT03266926|Hormones|hormones|mesh-ancestor
93204670|NCT03266926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204671|NCT01343745|Formoterol Fumarate|formoterol fumarate|mesh-list
93204672|NCT01343745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93204673|NCT01343745|Autonomic Agents|autonomic agents|mesh-ancestor
93204674|NCT01343745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204675|NCT01343745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204676|NCT01343745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855857|NCT02825186|Hormones|hormones|mesh-ancestor
93204677|NCT01343745|Respiratory System Agents|respiratory system agents|mesh-ancestor
93204678|NCT01343745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93204679|NCT01343745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93204680|NCT01343745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93204681|NCT01343745|Adrenergic Agents|adrenergic agents|mesh-ancestor
93204682|NCT01343745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204683|NCT01343745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204685|NCT01367418|Morphine|morphine|mesh-list
93204686|NCT01367418|Bupivacaine|bupivacaine|mesh-list
93204687|NCT01367418|Ropivacaine|ropivacaine|mesh-list
93204688|NCT01367418|Anesthetics, Local|anesthetics, local|mesh-ancestor
93204689|NCT01367418|Anesthetics|anesthetics|mesh-ancestor
93204690|NCT01367418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204691|NCT01367418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204692|NCT01367418|Sensory System Agents|sensory system agents|mesh-ancestor
93204693|NCT01367418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204694|NCT01367418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93204695|NCT01367418|Narcotics|narcotics|mesh-ancestor
93204696|NCT01367418|Analgesics|analgesics|mesh-ancestor
93204697|NCT01367418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93204698|NCT01367418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93204699|NCT01367418|Anesthetics, General|anesthetics, general|mesh-ancestor
93204700|NCT01360086|Leucovorin|leucovorin|mesh-list
93204701|NCT01360086|Fluorouracil|fluorouracil|mesh-list
93204702|NCT01360086|Cetuximab|cetuximab|mesh-list
93204703|NCT01360086|Calcium|calcium|mesh-list
93204704|NCT01360086|Levoleucovorin|levoleucovorin|mesh-list
93204705|NCT01360086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204706|NCT01360086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93204707|NCT01360086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204708|NCT01360086|Antimetabolites|antimetabolites|mesh-ancestor
93204709|NCT01360086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204710|NCT01360086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204711|NCT01360086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204712|NCT01360086|Immunologic Factors|immunologic factors|mesh-ancestor
93204713|NCT01360086|Antidotes|antidotes|mesh-ancestor
93204714|NCT01360086|Protective Agents|protective agents|mesh-ancestor
93204715|NCT01360086|Vitamin B Complex|vitamin b complex|mesh-ancestor
93204716|NCT01360086|Vitamins|vitamins|mesh-ancestor
93204717|NCT01360086|Micronutrients|micronutrients|mesh-ancestor
93204718|NCT01360086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204720|NCT02458924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93204721|NCT02458924|Antimetabolites|antimetabolites|mesh-ancestor
93204722|NCT02458924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204723|NCT02458924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93204724|NCT02458924|Vasodilator Agents|vasodilator agents|mesh-ancestor
93204725|NCT02458924|Vitamin B Complex|vitamin b complex|mesh-ancestor
93204726|NCT02458924|Vitamins|vitamins|mesh-ancestor
93204727|NCT02458924|Micronutrients|micronutrients|mesh-ancestor
93204728|NCT02458924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204729|NCT01367496|Naltrexone|naltrexone|mesh-list
93204730|NCT01367496|Methylnaltrexone|methylnaltrexone|mesh-list
93204731|NCT01367496|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93204732|NCT01367496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204733|NCT01367496|Sensory System Agents|sensory system agents|mesh-ancestor
93204734|NCT01367496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204735|NCT01367496|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93204736|NCT02459158|Arbekacin|arbekacin|mesh-list
93204737|NCT02459158|Dibekacin|dibekacin|mesh-list
93204738|NCT02459158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93204739|NCT02459158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93204740|NCT02459158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204741|NCT01367574|Methylnaltrexone|methylnaltrexone|mesh-list
93204742|NCT01367574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93204743|NCT01367574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204744|NCT01367574|Sensory System Agents|sensory system agents|mesh-ancestor
93204745|NCT01367574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204746|NCT04693689|Vaccines|vaccines|mesh-list
93204747|NCT04693689|Immunologic Factors|immunologic factors|mesh-ancestor
93204748|NCT04693689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204749|NCT03126786|Triamcinolone|triamcinolone|mesh-list
93204750|NCT03126786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93204751|NCT03126786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93204752|NCT03126786|Aflibercept|aflibercept|mesh-list
93204753|NCT03126786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93204754|NCT03126786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204755|NCT03126786|Glucocorticoids|glucocorticoids|mesh-ancestor
93204756|NCT03126786|Hormones|hormones|mesh-ancestor
93204757|NCT03126786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876848|NCT02642484|Antacids|antacids|mesh-ancestor
93204758|NCT03126786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204759|NCT03126786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204760|NCT03126786|Immunologic Factors|immunologic factors|mesh-ancestor
93204761|NCT03126786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204762|NCT03126786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204764|NCT03126786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93204765|NCT03126786|Growth Substances|growth substances|mesh-ancestor
93204766|NCT03126786|Growth Inhibitors|growth inhibitors|mesh-ancestor
93204767|NCT03126786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204768|NCT01367652|Letrozole|letrozole|mesh-list
93204769|NCT01367652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204770|NCT01367652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93204771|NCT01367652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93204772|NCT01367652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204773|NCT01367652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204774|NCT01367652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93204775|NCT01367652|Hormone Antagonists|hormone antagonists|mesh-ancestor
93204776|NCT01367652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204777|NCT01367652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204778|NCT02456584|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93204779|NCT02456584|Medroxyprogesterone|medroxyprogesterone|mesh-list
93204780|NCT02456584|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93204781|NCT02456584|Contraceptive Agents|contraceptive agents|mesh-ancestor
93204782|NCT02456584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93204783|NCT02456584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204784|NCT02456584|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93204785|NCT02456584|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93204786|NCT02456584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93204787|NCT02456584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204788|NCT02456584|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93204789|NCT02456584|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93204790|NCT02456584|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93204791|NCT03146403|Vaccines|vaccines|mesh-list
93204792|NCT03146403|Immunologic Factors|immunologic factors|mesh-ancestor
93204793|NCT03146403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204794|NCT01360476|Vitamin D|vitamin d|mesh-list
93204795|NCT01360476|Cholecalciferol|cholecalciferol|mesh-list
93204796|NCT01360476|Vitamins|vitamins|mesh-ancestor
93204797|NCT01360476|Micronutrients|micronutrients|mesh-ancestor
93204798|NCT01360476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204799|NCT01360476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93204800|NCT01360476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93204801|NCT01317069|Fluorouracil|fluorouracil|mesh-list
93204802|NCT01317069|Antimetabolites|antimetabolites|mesh-ancestor
93204803|NCT01317069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204804|NCT01317069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93204805|NCT01317069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204806|NCT01317069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93204807|NCT01317069|Immunologic Factors|immunologic factors|mesh-ancestor
93204808|NCT01317069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204809|NCT01317225|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93204810|NCT01317225|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93204811|NCT01317225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93204812|NCT01317225|Hormone Antagonists|hormone antagonists|mesh-ancestor
93204813|NCT01317225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204814|NCT01317225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204815|NCT01317225|Progestins|progestins|mesh-ancestor
93204816|NCT01317225|Hormones|hormones|mesh-ancestor
93204817|NCT01363206|Ipilimumab|ipilimumab|mesh-list
93204818|NCT01363206|Molgramostim|molgramostim|mesh-list
93204819|NCT01363206|Sargramostim|sargramostim|mesh-list
93204820|NCT01363206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93204821|NCT01363206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204822|NCT01363206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93204823|NCT01363206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204824|NCT01363206|Immunologic Factors|immunologic factors|mesh-ancestor
93204825|NCT01363206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204826|NCT01344213|Celecoxib|celecoxib|mesh-list
93204827|NCT01344213|Pregabalin|pregabalin|mesh-list
93204828|NCT01344213|Analgesics|analgesics|mesh-ancestor
93204829|NCT01344213|Sensory System Agents|sensory system agents|mesh-ancestor
93204830|NCT01344213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204831|NCT01344213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204832|NCT01344213|Anticonvulsants|anticonvulsants|mesh-ancestor
93204833|NCT01344213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93204834|NCT01344213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204835|NCT01344213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204836|NCT01344213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93204837|NCT01344213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93204838|NCT01344213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93204839|NCT01344213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204840|NCT01344213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93204841|NCT01344213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93204842|NCT01344213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204843|NCT01344213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204844|NCT01344213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204845|NCT01344213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93204846|NCT01344213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93204847|NCT01344213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204848|NCT04416048|Rivaroxaban|rivaroxaban|mesh-list
93204849|NCT04416048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93204850|NCT04416048|Antithrombins|antithrombins|mesh-ancestor
93204851|NCT04416048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93204852|NCT04416048|Protease Inhibitors|protease inhibitors|mesh-ancestor
93204853|NCT04416048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204854|NCT04416048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204855|NCT04416048|Anticoagulants|anticoagulants|mesh-ancestor
93204856|NCT01363284|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93204857|NCT01363284|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93204858|NCT01363284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93204859|NCT01363284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93204860|NCT01363284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204861|NCT01363284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204862|NCT01363284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204863|NCT01363284|Analgesics|analgesics|mesh-ancestor
93204864|NCT01363284|Sensory System Agents|sensory system agents|mesh-ancestor
93204865|NCT01363284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204866|NCT01363284|Antidepressive Agents|antidepressive agents|mesh-ancestor
93204867|NCT01363284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93204868|NCT01363284|Dopamine Agents|dopamine agents|mesh-ancestor
93204869|NCT03265834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93204870|NCT03265834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93204871|NCT03265834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93204872|NCT03265834|Antitubercular Agents|antitubercular agents|mesh-ancestor
93204873|NCT01344291|Curcumin|curcumin|mesh-list
93204874|NCT01344291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93204875|NCT01344291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204876|NCT01344291|Analgesics|analgesics|mesh-ancestor
93204877|NCT01344291|Sensory System Agents|sensory system agents|mesh-ancestor
93204878|NCT01344291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204879|NCT01344291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204880|NCT01344291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204881|NCT01344291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204882|NCT01344291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204883|NCT01344291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204884|NCT01344291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204885|NCT01367964|Hormones|hormones|mesh-list
93204886|NCT01367964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93204887|NCT01367964|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93204888|NCT01367964|beta-Endorphin|beta-endorphin|mesh-list
93204889|NCT01367964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204890|NCT01367964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204891|NCT01367964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204892|NCT01367964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204893|NCT04326933|Imatinib Mesylate|imatinib mesylate|mesh-list
93204894|NCT04326933|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93204895|NCT04326933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93204896|NCT04326933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93204897|NCT04326933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204898|NCT04326933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204899|NCT04733560|Bupivacaine|bupivacaine|mesh-list
93204900|NCT04733560|Anesthetics, Local|anesthetics, local|mesh-ancestor
93204901|NCT04733560|Anesthetics|anesthetics|mesh-ancestor
93204902|NCT04733560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204903|NCT04733560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204904|NCT04733560|Sensory System Agents|sensory system agents|mesh-ancestor
93204905|NCT04733560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876981|NCT03513770|Ketorolac|ketorolac|mesh-list
93204907|NCT01347957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93204908|NCT01347957|Autonomic Agents|autonomic agents|mesh-ancestor
93204909|NCT01347957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204910|NCT01347957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204911|NCT01347957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93204912|NCT01347957|Respiratory System Agents|respiratory system agents|mesh-ancestor
93204913|NCT01347957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93204914|NCT01347957|Antioxidants|antioxidants|mesh-ancestor
93204915|NCT01347957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204916|NCT01347957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204917|NCT01347957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93204918|NCT01347957|Vasodilator Agents|vasodilator agents|mesh-ancestor
93204919|NCT01347957|Gasotransmitters|gasotransmitters|mesh-ancestor
93204920|NCT01347957|Protective Agents|protective agents|mesh-ancestor
93204921|NCT04735965|Meperidine|meperidine|mesh-list
93204922|NCT04735965|Dexmedetomidine|dexmedetomidine|mesh-list
93204923|NCT04735965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93204924|NCT04735965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204925|NCT04735965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204926|NCT04735965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204927|NCT04735965|Analgesics|analgesics|mesh-ancestor
93204928|NCT04735965|Sensory System Agents|sensory system agents|mesh-ancestor
93204929|NCT04735965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204930|NCT04735965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93204931|NCT04735965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93204932|NCT04735965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93204933|NCT04735965|Adrenergic Agents|adrenergic agents|mesh-ancestor
93204934|NCT04735965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93204935|NCT04735965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204936|NCT04735965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93204937|NCT04735965|Narcotics|narcotics|mesh-ancestor
93204938|NCT04735965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93204939|NCT04291599|Ketorolac|ketorolac|mesh-list
93204940|NCT04291599|Morphine|morphine|mesh-list
93204941|NCT04291599|Hydromorphone|hydromorphone|mesh-list
93204942|NCT04291599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93204943|NCT04291599|Narcotics|narcotics|mesh-ancestor
93204944|NCT04291599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93204945|NCT04291599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204946|NCT04291599|Analgesics|analgesics|mesh-ancestor
93204947|NCT04291599|Sensory System Agents|sensory system agents|mesh-ancestor
93204948|NCT04291599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93204949|NCT04291599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93204950|NCT04291599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93204951|NCT04291599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93204952|NCT04291599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93204953|NCT04291599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93204954|NCT04291599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204955|NCT04291599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204956|NCT02456428|Insulin|insulin|mesh-list
93204957|NCT02456428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93204958|NCT02456428|Metformin|metformin|mesh-list
93204959|NCT02456428|Pioglitazone|pioglitazone|mesh-list
93204960|NCT02456428|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93204961|NCT02456428|Liraglutide|liraglutide|mesh-list
93204962|NCT02456428|Exenatide|exenatide|mesh-list
93204963|NCT02456428|Glimepiride|glimepiride|mesh-list
93204964|NCT02456428|Rosiglitazone|rosiglitazone|mesh-list
93204965|NCT02456428|Vildagliptin|vildagliptin|mesh-list
93204966|NCT02456428|Saxagliptin|saxagliptin|mesh-list
93204967|NCT02456428|Acarbose|acarbose|mesh-list
93204968|NCT02456428|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93204969|NCT02456428|Repaglinide|repaglinide|mesh-list
93204970|NCT02456428|Gliclazide|gliclazide|mesh-list
93204971|NCT02456428|Glipizide|glipizide|mesh-list
93204972|NCT02456428|Biguanides|biguanides|mesh-list
93204973|NCT02456428|Tolbutamide|tolbutamide|mesh-list
93204974|NCT02456428|Voglibose|voglibose|mesh-list
93204975|NCT02456428|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93204976|NCT02456428|Nateglinide|nateglinide|mesh-list
93204977|NCT02456428|Miglitol|miglitol|mesh-list
93204978|NCT02456428|Meglitinide|meglitinide|mesh-list
93204979|NCT02456428|Troglitazone|troglitazone|mesh-list
93204980|NCT02456428|Acetohexamide|acetohexamide|mesh-list
93204981|NCT02456428|Phenformin|phenformin|mesh-list
93204982|NCT02456428|Chlorpropamide|chlorpropamide|mesh-list
93204983|NCT02456428|Buformin|buformin|mesh-list
93204984|NCT02456428|Glibornuride|glibornuride|mesh-list
93204985|NCT02456428|Tolazamide|tolazamide|mesh-list
93204986|NCT02456428|Carbutamide|carbutamide|mesh-list
93204987|NCT02456428|Gliquidone|gliquidone|mesh-list
93204988|NCT02456428|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93204989|NCT02456428|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
93204991|NCT02456428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93204992|NCT02456428|Hormones|hormones|mesh-ancestor
93204993|NCT02456428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93204994|NCT02456428|Protease Inhibitors|protease inhibitors|mesh-ancestor
93204995|NCT02456428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93204996|NCT02456428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93204997|NCT02456428|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93204998|NCT02456428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93204999|NCT02456428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205000|NCT02456428|Immunologic Factors|immunologic factors|mesh-ancestor
93205001|NCT03259516|Cytarabine|cytarabine|mesh-list
93205002|NCT03259516|Cyclophosphamide|cyclophosphamide|mesh-list
93205003|NCT03259516|Melphalan|melphalan|mesh-list
93205004|NCT03259516|Nivolumab|nivolumab|mesh-list
93205005|NCT03259516|Fludarabine|fludarabine|mesh-list
93205006|NCT03259516|Azacitidine|azacitidine|mesh-list
93205007|NCT03259516|Tretinoin|tretinoin|mesh-list
93205008|NCT03259516|Sildenafil Citrate|sildenafil citrate|mesh-list
93205009|NCT03259516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205010|NCT03259516|Immunologic Factors|immunologic factors|mesh-ancestor
93205011|NCT03259516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205012|NCT03259516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205013|NCT03259516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93205014|NCT03259516|Alkylating Agents|alkylating agents|mesh-ancestor
93205015|NCT03259516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205016|NCT03259516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205017|NCT03259516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93205018|NCT03259516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93205019|NCT03259516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93205020|NCT03259516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93205021|NCT03259516|Antimetabolites|antimetabolites|mesh-ancestor
93205022|NCT03259516|Antiviral Agents|antiviral agents|mesh-ancestor
93205023|NCT03259516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205024|NCT03259516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205025|NCT03259516|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205026|NCT03259516|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93205027|NCT03259516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93205028|NCT03259516|Urological Agents|urological agents|mesh-ancestor
93205029|NCT03259516|Keratolytic Agents|keratolytic agents|mesh-ancestor
93205030|NCT03259516|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205031|NCT01344681|Itraconazole|itraconazole|mesh-list
93205032|NCT01344681|Micafungin|micafungin|mesh-list
93205033|NCT01344681|Antifungal Agents|antifungal agents|mesh-ancestor
93205034|NCT01344681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205035|NCT01344681|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93205036|NCT01344681|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93205037|NCT01344681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205038|NCT01344681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205039|NCT01344681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93205040|NCT01344681|Hormone Antagonists|hormone antagonists|mesh-ancestor
93205041|NCT01344681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205042|NCT01344681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205043|NCT01344681|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93205044|NCT01348269|Zoledronic Acid|zoledronic acid|mesh-list
93205045|NCT01348269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93205046|NCT01348269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205047|NCT03259672|Sevoflurane|sevoflurane|mesh-list
93205048|NCT03259672|Desflurane|desflurane|mesh-list
93205049|NCT03259672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93205050|NCT03259672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93205051|NCT03259672|Anesthetics, General|anesthetics, general|mesh-ancestor
93205052|NCT03259672|Anesthetics|anesthetics|mesh-ancestor
93205053|NCT03259672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205054|NCT03259672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205055|NCT03537742|Alirocumab|alirocumab|mesh-list
93205056|NCT03537742|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93205057|NCT03537742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93205058|NCT03537742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93205059|NCT03537742|Antimetabolites|antimetabolites|mesh-ancestor
93205060|NCT03537742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205061|NCT03537742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93205062|NCT03537742|Protease Inhibitors|protease inhibitors|mesh-ancestor
93205063|NCT03537742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205064|NCT03537742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93205065|NCT03259282|gamma-Globulins|gamma-globulins|mesh-list
93205066|NCT03259282|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93205067|NCT03259282|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93205068|NCT03259282|Immunologic Factors|immunologic factors|mesh-ancestor
93205069|NCT03259282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205070|NCT02456194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93205071|NCT02456194|Calcium|calcium|mesh-list
93205072|NCT02456194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93205073|NCT02456194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205074|NCT02456194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205075|NCT03265288|Fenretinide|fenretinide|mesh-list
93205076|NCT03265288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205077|NCT03265288|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93205078|NCT03265288|Protective Agents|protective agents|mesh-ancestor
93205079|NCT03265288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205080|NCT03261310|Acetaminophen|acetaminophen|mesh-list
93205081|NCT03261310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205082|NCT03261310|Analgesics|analgesics|mesh-ancestor
93205083|NCT03261310|Sensory System Agents|sensory system agents|mesh-ancestor
93205084|NCT03261310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205085|NCT03261310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205086|NCT03261310|Antipyretics|antipyretics|mesh-ancestor
93205087|NCT02456350|Cyclophosphamide|cyclophosphamide|mesh-list
93205088|NCT02456350|Fludarabine|fludarabine|mesh-list
93205089|NCT02456350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205090|NCT02456350|Immunologic Factors|immunologic factors|mesh-ancestor
93205091|NCT02456350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205092|NCT02456350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205093|NCT02456350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93205094|NCT02456350|Alkylating Agents|alkylating agents|mesh-ancestor
93205095|NCT02456350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205096|NCT02456350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205097|NCT02456350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93205098|NCT01319370|Minoxidil|minoxidil|mesh-list
93205099|NCT01319370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93205100|NCT01319370|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205101|NCT01363752|Mycophenolic Acid|mycophenolic acid|mesh-list
93205102|NCT01363752|Sirolimus|sirolimus|mesh-list
93205103|NCT01363752|Tacrolimus|tacrolimus|mesh-list
93205104|NCT01363752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205105|NCT01363752|Immunologic Factors|immunologic factors|mesh-ancestor
93205106|NCT01363752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205107|NCT01363752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93205108|NCT01363752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205109|NCT01363752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205110|NCT01363752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93205111|NCT01363752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205112|NCT01363752|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93205113|NCT01363752|Antitubercular Agents|antitubercular agents|mesh-ancestor
93205114|NCT01363752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93205115|NCT01363752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205116|NCT01363752|Antifungal Agents|antifungal agents|mesh-ancestor
93205117|NCT01368198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93205118|NCT01368198|Lubricant Eye Drops|lubricant eye drops|mesh-list
93205119|NCT01368198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93205120|NCT01360710|Irbesartan|irbesartan|mesh-list
93205121|NCT01360710|Moxonidine|moxonidine|mesh-list
93205122|NCT01360710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93205123|NCT01360710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93205124|NCT01360710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93205125|NCT01360710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205126|NCT01360788|Albuterol|albuterol|mesh-list
93205127|NCT01360788|Ipratropium|ipratropium|mesh-list
93205128|NCT01360788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93205129|NCT01360788|Autonomic Agents|autonomic agents|mesh-ancestor
93205130|NCT01360788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205131|NCT01360788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205132|NCT01360788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93205133|NCT01360788|Respiratory System Agents|respiratory system agents|mesh-ancestor
93205134|NCT01360788|Tocolytic Agents|tocolytic agents|mesh-ancestor
93205135|NCT01360788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93205136|NCT01360788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93205137|NCT01360788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93205138|NCT01360788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93205139|NCT01360788|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205140|NCT01360788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205141|NCT01360788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205142|NCT01360788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93205143|NCT01360788|Cholinergic Agents|cholinergic agents|mesh-ancestor
93205145|NCT01361022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93205146|NCT01361022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205147|NCT01361022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205148|NCT01364220|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93205149|NCT01364220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93205150|NCT01364220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93205151|NCT01364220|Antimetabolites|antimetabolites|mesh-ancestor
93205152|NCT01364220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205153|NCT01364220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93205154|NCT01364220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93205155|NCT01364220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205156|NCT02713204|Aflibercept|aflibercept|mesh-list
93205157|NCT02713204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93205158|NCT02713204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93205159|NCT02713204|Growth Substances|growth substances|mesh-ancestor
93205160|NCT02713204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205161|NCT02713204|Growth Inhibitors|growth inhibitors|mesh-ancestor
93205162|NCT02713204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205163|NCT03695172|Ropivacaine|ropivacaine|mesh-list
93205164|NCT03695172|Anesthetics, Local|anesthetics, local|mesh-ancestor
93205165|NCT03695172|Anesthetics|anesthetics|mesh-ancestor
93205166|NCT03695172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205167|NCT03695172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205168|NCT03695172|Sensory System Agents|sensory system agents|mesh-ancestor
93205169|NCT03695172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205170|NCT01364376|Leucovorin|leucovorin|mesh-list
93205171|NCT01364376|Oxaliplatin|oxaliplatin|mesh-list
93205172|NCT01364376|Calcium|calcium|mesh-list
93205173|NCT01364376|Levoleucovorin|levoleucovorin|mesh-list
93205174|NCT01364376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93205175|NCT01364376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205176|NCT01364376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205177|NCT01364376|Antidotes|antidotes|mesh-ancestor
93205178|NCT01364376|Protective Agents|protective agents|mesh-ancestor
93205179|NCT01364376|Vitamin B Complex|vitamin b complex|mesh-ancestor
93205180|NCT01364376|Vitamins|vitamins|mesh-ancestor
93205181|NCT01364376|Micronutrients|micronutrients|mesh-ancestor
93205182|NCT01348503|Lenalidomide|lenalidomide|mesh-list
93205183|NCT01348503|Sorafenib|sorafenib|mesh-list
93205184|NCT01348503|Immunologic Factors|immunologic factors|mesh-ancestor
93205185|NCT01348503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205186|NCT01348503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93205187|NCT01348503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93205188|NCT01348503|Growth Substances|growth substances|mesh-ancestor
93205189|NCT01348503|Growth Inhibitors|growth inhibitors|mesh-ancestor
93205190|NCT01348503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205191|NCT01348503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205192|NCT01348503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205193|NCT01348503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205194|NCT01369290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93205195|NCT01369290|Bupropion|bupropion|mesh-list
93205196|NCT01369290|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93205197|NCT01369290|Escitalopram|escitalopram|mesh-list
93205198|NCT01369290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93205199|NCT01369290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93205200|NCT01369290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93205201|NCT01369290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205202|NCT01369290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205203|NCT01369290|Serotonin Agents|serotonin agents|mesh-ancestor
93205204|NCT01369290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205205|NCT01369290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205206|NCT01369290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93205207|NCT01369290|Antidepressive Agents|antidepressive agents|mesh-ancestor
93205208|NCT01369290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205209|NCT01369290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93205210|NCT01369290|Dopamine Agents|dopamine agents|mesh-ancestor
93205211|NCT01369290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93205212|NCT01369290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93205213|NCT01369290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205214|NCT01369290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93205215|NCT01369290|Analgesics|analgesics|mesh-ancestor
93205216|NCT01369290|Sensory System Agents|sensory system agents|mesh-ancestor
93205217|NCT03533452|Ropivacaine|ropivacaine|mesh-list
93205218|NCT03533452|Anesthetics, Local|anesthetics, local|mesh-ancestor
93205219|NCT03533452|Anesthetics|anesthetics|mesh-ancestor
93205220|NCT03533452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205221|NCT03533452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205222|NCT03533452|Sensory System Agents|sensory system agents|mesh-ancestor
93205223|NCT03533452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205224|NCT04359147|Hydrocortisone|hydrocortisone|mesh-list
93205225|NCT04359147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93205226|NCT04359147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93205227|NCT04359147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93205228|NCT04359147|Yohimbine|yohimbine|mesh-list
93205229|NCT04359147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205230|NCT04359147|Mydriatics|mydriatics|mesh-ancestor
93205231|NCT04359147|Autonomic Agents|autonomic agents|mesh-ancestor
93205232|NCT04359147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205233|NCT04359147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205234|NCT04359147|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93205235|NCT04359147|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93205236|NCT04359147|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93205237|NCT04359147|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205238|NCT04359147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205239|NCT04359147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205240|NCT04359147|Urological Agents|urological agents|mesh-ancestor
93205241|NCT01369368|Azacitidine|azacitidine|mesh-list
93205242|NCT01369368|Valproic Acid|valproic acid|mesh-list
93205243|NCT01369368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93205244|NCT01369368|Antimetabolites|antimetabolites|mesh-ancestor
93205245|NCT01369368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205246|NCT01369368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205247|NCT01369368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205248|NCT01369368|Anticonvulsants|anticonvulsants|mesh-ancestor
93205249|NCT01369368|GABA Agents|gaba agents|mesh-ancestor
93205250|NCT01369368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205251|NCT01369368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205252|NCT01369368|Antimanic Agents|antimanic agents|mesh-ancestor
93205253|NCT01369368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93205254|NCT01369368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205255|NCT01369368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205256|NCT04074759|Pembrolizumab|pembrolizumab|mesh-list
93205257|NCT04074759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93205258|NCT04074759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205259|NCT04074759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93205260|NCT04074759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205261|NCT01369602|Nicotinic Acids|nicotinic acids|mesh-list
93205262|NCT01369602|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93205263|NCT01369602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205264|NCT01369602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205265|NCT01369602|Vitamin B Complex|vitamin b complex|mesh-ancestor
93205266|NCT01369602|Vitamins|vitamins|mesh-ancestor
93205267|NCT01369602|Micronutrients|micronutrients|mesh-ancestor
93205268|NCT01369602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205269|NCT03252496|Ephedrine|ephedrine|mesh-list
93205270|NCT03252496|Fentanyl|fentanyl|mesh-list
93205271|NCT03252496|Bupivacaine|bupivacaine|mesh-list
93205272|NCT03252496|Oxytocin|oxytocin|mesh-list
93205273|NCT03252496|Anesthetics, Local|anesthetics, local|mesh-ancestor
93205274|NCT03252496|Anesthetics|anesthetics|mesh-ancestor
93205275|NCT03252496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205276|NCT03252496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205277|NCT03252496|Sensory System Agents|sensory system agents|mesh-ancestor
93205278|NCT03252496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205279|NCT03252496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93205280|NCT03252496|Narcotics|narcotics|mesh-ancestor
93205281|NCT03252496|Analgesics|analgesics|mesh-ancestor
93205282|NCT03252496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93205283|NCT03252496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93205284|NCT03252496|Anesthetics, General|anesthetics, general|mesh-ancestor
93205285|NCT03252496|Oxytocics|oxytocics|mesh-ancestor
93205286|NCT03252496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93205287|NCT03252496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93205288|NCT03252496|Sympathomimetics|sympathomimetics|mesh-ancestor
93205289|NCT03252496|Autonomic Agents|autonomic agents|mesh-ancestor
93205290|NCT03252496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93205291|NCT03252496|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205292|NCT03252496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205293|NCT03252496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205294|NCT03252418|Ascorbic Acid|ascorbic acid|mesh-list
93205295|NCT03252418|Antioxidants|antioxidants|mesh-ancestor
93205296|NCT03252418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205297|NCT03252418|Protective Agents|protective agents|mesh-ancestor
93205298|NCT03252418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205299|NCT03252418|Vitamins|vitamins|mesh-ancestor
93205300|NCT03252418|Micronutrients|micronutrients|mesh-ancestor
93205301|NCT01364688|Alfacalcidol|alfacalcidol|mesh-list
93205302|NCT01364688|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93205303|NCT01364688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93205304|NCT01364688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205305|NCT01364688|Vitamins|vitamins|mesh-ancestor
93205306|NCT01364688|Micronutrients|micronutrients|mesh-ancestor
93205307|NCT01370148|Conivaptan|conivaptan|mesh-list
93205308|NCT01370148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93205309|NCT01370148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205310|NCT01370148|Natriuretic Agents|natriuretic agents|mesh-ancestor
93205311|NCT01370148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205312|NCT04684953|Hormones|hormones|mesh-list
93205313|NCT04684953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205314|NCT04684953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205315|NCT01349127|Calcium, Dietary|calcium, dietary|mesh-list
93205316|NCT01349127|Vitamin D|vitamin d|mesh-list
93205317|NCT01349127|Ergocalciferols|ergocalciferols|mesh-list
93205318|NCT01349127|Cholecalciferol|cholecalciferol|mesh-list
93205319|NCT01349127|Vitamins|vitamins|mesh-list
93205320|NCT01349127|Calcium|calcium|mesh-list
93205321|NCT01349127|Micronutrients|micronutrients|mesh-ancestor
93205322|NCT01349127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205323|NCT01349127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93205324|NCT01349127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93205325|NCT03486964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93205326|NCT03486964|Protease Inhibitors|protease inhibitors|mesh-ancestor
93205327|NCT03486964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205328|NCT03486964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205329|NCT03486964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93205330|NCT03486964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205331|NCT01349205|Sodium Benzoate|sodium benzoate|mesh-list
93205332|NCT01349205|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
93205333|NCT01349205|Caffeine|caffeine|mesh-list
93205334|NCT01349205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93205335|NCT01349205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205336|NCT01349205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93205337|NCT01349205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205338|NCT01349205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205339|NCT01349205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93205340|NCT01349205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93205341|NCT01349205|Purinergic Agents|purinergic agents|mesh-ancestor
93205342|NCT01349205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205343|NCT01349205|Antifungal Agents|antifungal agents|mesh-ancestor
93205344|NCT01349205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205345|NCT01349205|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93205346|NCT01349205|Protective Agents|protective agents|mesh-ancestor
93205347|NCT01349205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205348|NCT01349205|Analgesics|analgesics|mesh-ancestor
93205349|NCT01349205|Sensory System Agents|sensory system agents|mesh-ancestor
93205350|NCT01349205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205351|NCT01370304|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93205352|NCT01370304|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93205353|NCT01370304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93205354|NCT01370304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118138|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205355|NCT01370304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205356|NCT01370304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205357|NCT01370304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205358|NCT01370304|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93205359|NCT01370304|Antidepressive Agents|antidepressive agents|mesh-ancestor
92877429|NCT00602420|Naproxen|naproxen|mesh-list
93205360|NCT01370304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205361|NCT03982485|Paclitaxel|paclitaxel|mesh-list
93205362|NCT03982485|Apatinib|apatinib|mesh-list
93205363|NCT03982485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93205364|NCT03982485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205365|NCT03982485|Tubulin Modulators|tubulin modulators|mesh-ancestor
93205366|NCT03982485|Antimitotic Agents|antimitotic agents|mesh-ancestor
93205367|NCT03982485|Mitosis Modulators|mitosis modulators|mesh-ancestor
93205368|NCT03982485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205369|NCT03982485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205370|NCT03982485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205371|NCT03966339|Hormones|hormones|mesh-list
93205372|NCT03966339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205373|NCT03966339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205374|NCT03251872|Olaparib|olaparib|mesh-list
93205375|NCT03251872|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93205376|NCT03251872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205377|NCT03251872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205378|NCT03251872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205379|NCT03160521|Risperidone|risperidone|mesh-list
93205380|NCT03160521|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93205381|NCT03160521|Serotonin Agents|serotonin agents|mesh-ancestor
93205382|NCT03160521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205383|NCT03160521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205384|NCT03160521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205385|NCT03160521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93205386|NCT03160521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93205387|NCT03160521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205388|NCT03160521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205389|NCT03160521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93205390|NCT03160521|Dopamine Agents|dopamine agents|mesh-ancestor
93205391|NCT01365000|Naloxegol|naloxegol|mesh-list
93205392|NCT01365000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93205393|NCT01365000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205394|NCT01365000|Sensory System Agents|sensory system agents|mesh-ancestor
93205395|NCT01365000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205396|NCT03147040|Carboplatin|carboplatin|mesh-list
93205397|NCT03147040|Atezolizumab|atezolizumab|mesh-list
93205398|NCT03147040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205399|NCT03147040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93205400|NCT03147040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205401|NCT03147040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93205402|NCT03251170|Fentanyl|fentanyl|mesh-list
93205403|NCT03251170|Midazolam|midazolam|mesh-list
93205404|NCT03251170|Ketamine|ketamine|mesh-list
93205405|NCT03251170|Analgesics|analgesics|mesh-ancestor
93205406|NCT03251170|Sensory System Agents|sensory system agents|mesh-ancestor
93205407|NCT03251170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205408|NCT03251170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205409|NCT03251170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93205410|NCT03251170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93205411|NCT03251170|Anesthetics, General|anesthetics, general|mesh-ancestor
93205412|NCT03251170|Anesthetics|anesthetics|mesh-ancestor
93205413|NCT03251170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205414|NCT03251170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93205415|NCT03251170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93205416|NCT03251170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205417|NCT03251170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205418|NCT03251170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93205419|NCT03251170|Narcotics|narcotics|mesh-ancestor
93205420|NCT03251170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93205421|NCT03251170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93205422|NCT03251170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93205423|NCT03251170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93205424|NCT03251170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205425|NCT03251170|GABA Modulators|gaba modulators|mesh-ancestor
93205426|NCT03251170|GABA Agents|gaba agents|mesh-ancestor
93205427|NCT03539601|Hydrocortisone|hydrocortisone|mesh-list
93205428|NCT03539601|Pimecrolimus|pimecrolimus|mesh-list
93205429|NCT03539601|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
93205430|NCT03539601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205431|NCT03539601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93205432|NCT03539601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205433|NCT03539601|Analgesics|analgesics|mesh-ancestor
93205434|NCT03539601|Sensory System Agents|sensory system agents|mesh-ancestor
93205435|NCT03539601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205436|NCT03539601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205437|NCT03539601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205438|NCT03539601|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205439|NCT03539601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205440|NCT03539601|Immunologic Factors|immunologic factors|mesh-ancestor
93205441|NCT03539601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93205442|NCT03539601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205443|NCT03539601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205444|NCT02455180|Ascorbic Acid|ascorbic acid|mesh-list
93205445|NCT02455180|Vitamins|vitamins|mesh-ancestor
93205446|NCT02455180|Micronutrients|micronutrients|mesh-ancestor
93205447|NCT02455180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205448|NCT02455180|Antioxidants|antioxidants|mesh-ancestor
93205449|NCT02455180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205450|NCT02455180|Protective Agents|protective agents|mesh-ancestor
93205451|NCT03514719|Avelumab|avelumab|mesh-list
93205452|NCT03514719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93205453|NCT03514719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93205454|NCT03514719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205455|NCT03514719|Immunologic Factors|immunologic factors|mesh-ancestor
93205456|NCT03514719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205457|NCT01349439|Propranolol|propranolol|mesh-list
93205458|NCT01349439|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93205459|NCT01349439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93205460|NCT01349439|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205461|NCT01349439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205462|NCT01349439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205463|NCT01349439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205464|NCT01349439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93205465|NCT01349439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93205466|NCT01349439|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205467|NCT03245554|Propranolol|propranolol|mesh-list
93205468|NCT03245554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93205469|NCT03245554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93205470|NCT03245554|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205471|NCT03245554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205472|NCT03245554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205473|NCT03245554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205474|NCT03245554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93205475|NCT03245554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93205476|NCT03245554|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205477|NCT01346007|Vaccines|vaccines|mesh-list
93205478|NCT01346007|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93205479|NCT01346007|Immunologic Factors|immunologic factors|mesh-ancestor
93205480|NCT01346007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205481|NCT01349751|Levobupivacaine|levobupivacaine|mesh-list
93205482|NCT01349751|Anesthetics, Local|anesthetics, local|mesh-ancestor
93205483|NCT01349751|Anesthetics|anesthetics|mesh-ancestor
93205484|NCT01349751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205485|NCT01349751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205486|NCT01349751|Sensory System Agents|sensory system agents|mesh-ancestor
93205487|NCT01349751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205488|NCT03004131|Fluticasone|fluticasone|mesh-list
93205489|NCT03004131|Xhance|xhance|mesh-list
93205490|NCT03004131|Loratadine|loratadine|mesh-list
93205491|NCT03004131|Azelastine|azelastine|mesh-list
93205492|NCT03004131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205493|NCT03004131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93205494|NCT03004131|Autonomic Agents|autonomic agents|mesh-ancestor
93205495|NCT03004131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205496|NCT03004131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205497|NCT03004131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93205498|NCT03004131|Respiratory System Agents|respiratory system agents|mesh-ancestor
93205499|NCT03004131|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205500|NCT03004131|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92501358|NCT02018055|Aspirin|aspirin|mesh-list
93205501|NCT03004131|Antipruritics|antipruritics|mesh-ancestor
93205502|NCT03004131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93205503|NCT03004131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93205504|NCT03004131|Histamine Antagonists|histamine antagonists|mesh-ancestor
93205505|NCT03004131|Histamine Agents|histamine agents|mesh-ancestor
93205506|NCT03004131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205507|NCT03004131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205508|NCT03004131|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93205509|NCT03004131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205510|NCT01350063|Troclosene|troclosene|mesh-list
92877588|NCT02684786|Lidocaine|lidocaine|mesh-list
93205511|NCT01350063|Antifungal Agents|antifungal agents|mesh-ancestor
93205512|NCT01350063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205513|NCT01350063|Antiviral Agents|antiviral agents|mesh-ancestor
93205514|NCT01350063|Disinfectants|disinfectants|mesh-ancestor
93205515|NCT03421041|Dexamethasone|dexamethasone|mesh-list
93205516|NCT03421041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205517|NCT03421041|Antiemetics|antiemetics|mesh-ancestor
93205518|NCT03421041|Autonomic Agents|autonomic agents|mesh-ancestor
93205519|NCT03421041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205520|NCT03421041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205521|NCT03421041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93205522|NCT03421041|Glucocorticoids|glucocorticoids|mesh-ancestor
93205524|NCT03421041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205525|NCT03421041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93205526|NCT03421041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205527|NCT03244774|Paclitaxel|paclitaxel|mesh-list
93205528|NCT03244774|Fluorouracil|fluorouracil|mesh-list
93205529|NCT03244774|Oxaliplatin|oxaliplatin|mesh-list
93205530|NCT03244774|Apatinib|apatinib|mesh-list
93205531|NCT03244774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93205532|NCT03244774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205533|NCT03244774|Tubulin Modulators|tubulin modulators|mesh-ancestor
93205534|NCT03244774|Antimitotic Agents|antimitotic agents|mesh-ancestor
93205535|NCT03244774|Mitosis Modulators|mitosis modulators|mesh-ancestor
93205536|NCT03244774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205537|NCT03244774|Antimetabolites|antimetabolites|mesh-ancestor
93205538|NCT03244774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93205539|NCT03244774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205540|NCT03244774|Immunologic Factors|immunologic factors|mesh-ancestor
93205541|NCT03244774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205542|NCT03244774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205543|NCT03244774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205544|NCT02903823|Baclofen|baclofen|mesh-list
93205545|NCT02903823|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93205546|NCT02903823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205547|NCT02903823|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93205548|NCT02903823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205549|NCT02903823|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93205550|NCT02903823|GABA Agonists|gaba agonists|mesh-ancestor
93205551|NCT02903823|GABA Agents|gaba agents|mesh-ancestor
93205552|NCT02903823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205553|NCT02903823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205554|NCT03244930|Plerixafor|plerixafor|mesh-list
93205555|NCT03244930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93205556|NCT03244930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93205557|NCT03244930|Antiviral Agents|antiviral agents|mesh-ancestor
93205558|NCT03244930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205559|NCT02855697|Olaparib|olaparib|mesh-list
93205560|NCT02855697|Cediranib|cediranib|mesh-list
93205561|NCT02855697|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93205562|NCT02855697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205563|NCT02855697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205564|NCT02855697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205565|NCT02855697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205566|NCT03894501|Methadone|methadone|mesh-list
93205567|NCT03894501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93205568|NCT03894501|Narcotics|narcotics|mesh-ancestor
93205569|NCT03894501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205570|NCT03894501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205571|NCT03894501|Analgesics|analgesics|mesh-ancestor
93205572|NCT03894501|Sensory System Agents|sensory system agents|mesh-ancestor
93205573|NCT03894501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205574|NCT03894501|Antitussive Agents|antitussive agents|mesh-ancestor
93205575|NCT03894501|Respiratory System Agents|respiratory system agents|mesh-ancestor
93205576|NCT01346865|Cilostazol|cilostazol|mesh-list
93205577|NCT01346865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93205578|NCT01346865|Autonomic Agents|autonomic agents|mesh-ancestor
93205579|NCT01346865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205580|NCT01346865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205581|NCT01346865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93205582|NCT01346865|Respiratory System Agents|respiratory system agents|mesh-ancestor
93205583|NCT01346865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93205584|NCT01346865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93205585|NCT01346865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205586|NCT01346865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93205588|NCT01346865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93205589|NCT01346865|Protective Agents|protective agents|mesh-ancestor
93205590|NCT01346865|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93205591|NCT01346865|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93205592|NCT01346865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205593|NCT03244462|Methotrexate|methotrexate|mesh-list
93205594|NCT03244462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93205595|NCT03244462|Abortifacient Agents|abortifacient agents|mesh-ancestor
93205596|NCT03244462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93205597|NCT03244462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205598|NCT03244462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93205599|NCT03244462|Antimetabolites|antimetabolites|mesh-ancestor
93205600|NCT03244462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205601|NCT03244462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205602|NCT03244462|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205603|NCT03244462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205604|NCT03244462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93205605|NCT03244462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205606|NCT03244462|Immunologic Factors|immunologic factors|mesh-ancestor
93205607|NCT03244462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205608|NCT03244462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93205609|NCT03244540|Acetaminophen|acetaminophen|mesh-list
93205610|NCT03244540|Dipyrone|dipyrone|mesh-list
93205611|NCT03244540|Ketoprofen|ketoprofen|mesh-list
93205612|NCT03244540|Bupivacaine|bupivacaine|mesh-list
93205613|NCT03244540|Ropivacaine|ropivacaine|mesh-list
93205614|NCT03244540|Anesthetics, Local|anesthetics, local|mesh-ancestor
93205615|NCT03244540|Anesthetics|anesthetics|mesh-ancestor
93205616|NCT03244540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205617|NCT03244540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205618|NCT03244540|Sensory System Agents|sensory system agents|mesh-ancestor
93205619|NCT03244540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205620|NCT03244540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205621|NCT03244540|Analgesics|analgesics|mesh-ancestor
93205622|NCT03244540|Antipyretics|antipyretics|mesh-ancestor
93205623|NCT03244540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93205624|NCT03244540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205625|NCT03244540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205626|NCT03244540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93205627|NCT03244540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205628|NCT03244540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205629|NCT03249298|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93205630|NCT03249298|Plasma Substitutes|plasma substitutes|mesh-ancestor
93205631|NCT03249298|Blood Substitutes|blood substitutes|mesh-ancestor
93205632|NCT02454868|Remifentanil|remifentanil|mesh-list
93205633|NCT02454868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93205634|NCT02454868|Narcotics|narcotics|mesh-ancestor
93205635|NCT02454868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205636|NCT02454868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205637|NCT02454868|Analgesics|analgesics|mesh-ancestor
93205638|NCT02454868|Sensory System Agents|sensory system agents|mesh-ancestor
93205639|NCT02454868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205640|NCT03753087|Empagliflozin|empagliflozin|mesh-list
93205641|NCT03753087|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93205642|NCT03753087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205643|NCT03753087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93205644|NCT03753087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205645|NCT02454712|Naltrexone|naltrexone|mesh-list
93205646|NCT02454712|Oxycodone|oxycodone|mesh-list
93205647|NCT02454712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93205648|NCT02454712|Narcotics|narcotics|mesh-ancestor
93205649|NCT02454712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205650|NCT02454712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205651|NCT02454712|Analgesics|analgesics|mesh-ancestor
93205652|NCT02454712|Sensory System Agents|sensory system agents|mesh-ancestor
92501501|NCT02018731|Metformin|metformin|mesh-list
93205653|NCT02454712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205654|NCT02454712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93205655|NCT02454712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93205656|NCT00832455|Montelukast|montelukast|mesh-list
93205657|NCT00832455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93205658|NCT00832455|Respiratory System Agents|respiratory system agents|mesh-ancestor
93205659|NCT00832455|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93205660|NCT00832455|Hormone Antagonists|hormone antagonists|mesh-ancestor
93205661|NCT00832455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205662|NCT00832455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205663|NCT00832455|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93205664|NCT00832455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93205665|NCT00832455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205666|NCT00687531|Mometasone Furoate|mometasone furoate|mesh-list
93205667|NCT00687531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205668|NCT00687531|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205669|NCT00687531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93205670|NCT01350921|Ticagrelor|ticagrelor|mesh-list
93205671|NCT01350921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93205672|NCT01350921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93205673|NCT01350921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93205674|NCT01350921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93205675|NCT01350921|Purinergic Agents|purinergic agents|mesh-ancestor
93205676|NCT01350921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205677|NCT01350921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205678|NCT01350921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205679|NCT00423579|Simvastatin|simvastatin|mesh-list
93205680|NCT00423579|Ezetimibe|ezetimibe|mesh-list
93205681|NCT00423579|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
93205682|NCT00423579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93205683|NCT00423579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93205684|NCT00423579|Antimetabolites|antimetabolites|mesh-ancestor
93205685|NCT00423579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205686|NCT00423579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93205687|NCT00423579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93205688|NCT00423579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205689|NCT03243604|Hormones|hormones|mesh-list
93205690|NCT03243604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205691|NCT03243604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205692|NCT02454556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93205693|NCT02454556|Hormones|hormones|mesh-ancestor
93205694|NCT02454556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205695|NCT02454556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205696|NCT01352559|Milnacipran|milnacipran|mesh-list
93205697|NCT01352559|Mirtazapine|mirtazapine|mesh-list
93205698|NCT01352559|Sertraline|sertraline|mesh-list
93205699|NCT01352559|Fluoxetine|fluoxetine|mesh-list
93205700|NCT01352559|Paroxetine|paroxetine|mesh-list
93205701|NCT01352559|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93205702|NCT01352559|Nortriptyline|nortriptyline|mesh-list
93205703|NCT01352559|Antidepressive Agents|antidepressive agents|mesh-ancestor
93205704|NCT01352559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205705|NCT01352559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93205706|NCT01352559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93205707|NCT01352559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93205708|NCT01352559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205709|NCT01352559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205710|NCT01352559|Serotonin Agents|serotonin agents|mesh-ancestor
93205711|NCT01352559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205712|NCT01352559|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93205713|NCT01352559|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93205714|NCT01352559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93205715|NCT01352559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205716|NCT01352559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93205717|NCT01352559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93205718|NCT01352559|Histamine Antagonists|histamine antagonists|mesh-ancestor
93205719|NCT01352559|Histamine Agents|histamine agents|mesh-ancestor
93205720|NCT01352559|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93205721|NCT01352559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93205722|NCT01352559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977247|NCT01581853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93205723|NCT01352559|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93205724|NCT01352559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93205725|NCT01352559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93205726|NCT01352559|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205727|NCT01352559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93205728|NCT01352559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93205729|NCT01352559|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93205730|NCT01352559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205731|NCT01352559|Analgesics|analgesics|mesh-ancestor
93205732|NCT01352559|Sensory System Agents|sensory system agents|mesh-ancestor
92877804|NCT02810483|Topiramate|topiramate|mesh-list
93205733|NCT01352559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205734|NCT01352559|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93205735|NCT01352559|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93205737|NCT03247972|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93205738|NCT03247972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93205739|NCT03247972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93205740|NCT03247972|Antimetabolites|antimetabolites|mesh-ancestor
93205741|NCT03247972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205742|NCT03247972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93205743|NCT03247972|Protease Inhibitors|protease inhibitors|mesh-ancestor
93205744|NCT03247972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205745|NCT03247972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93205746|NCT01350609|Candesartan|candesartan|mesh-list
93205747|NCT01350609|Candesartan cilexetil|candesartan cilexetil|mesh-list
93205748|NCT01350609|Nifedipine|nifedipine|mesh-list
93205749|NCT01350609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93205750|NCT01350609|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93205751|NCT01350609|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93205752|NCT01350609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205753|NCT01350609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93205754|NCT01350609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93205755|NCT01350609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93205756|NCT01350609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205757|NCT01350609|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205758|NCT01350609|Tocolytic Agents|tocolytic agents|mesh-ancestor
93205759|NCT01350609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93205760|NCT03269409|Coal Tar|coal tar|mesh-list
93205761|NCT03269409|Keratolytic Agents|keratolytic agents|mesh-ancestor
93205762|NCT03269409|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205763|NCT03778372|Methadone|methadone|mesh-list
93205764|NCT03778372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93205765|NCT03778372|Narcotics|narcotics|mesh-ancestor
93205766|NCT03778372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205767|NCT03778372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205768|NCT03778372|Analgesics|analgesics|mesh-ancestor
93205769|NCT03778372|Sensory System Agents|sensory system agents|mesh-ancestor
93205770|NCT03778372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205771|NCT03778372|Antitussive Agents|antitussive agents|mesh-ancestor
93205772|NCT03778372|Respiratory System Agents|respiratory system agents|mesh-ancestor
93205773|NCT03246880|Tadalafil|tadalafil|mesh-list
93205774|NCT03246880|Tamsulosin|tamsulosin|mesh-list
93205775|NCT03246880|Vasodilator Agents|vasodilator agents|mesh-ancestor
93205776|NCT03246880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93205777|NCT03246880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93205778|NCT03246880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205779|NCT03246880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205780|NCT03246880|Urological Agents|urological agents|mesh-ancestor
93205781|NCT03246880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93205782|NCT03246880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93205783|NCT03246880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93205784|NCT03246880|Adrenergic Agents|adrenergic agents|mesh-ancestor
93205785|NCT03246880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205786|NCT03246880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205787|NCT03257722|Pembrolizumab|pembrolizumab|mesh-list
93205788|NCT03257722|Idelalisib|idelalisib|mesh-list
93205789|NCT03257722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93205790|NCT03257722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205791|NCT03257722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93205792|NCT03257722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205793|NCT03257722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205794|NCT03268005|Insulin|insulin|mesh-list
93205795|NCT03268005|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93205796|NCT03268005|Metformin|metformin|mesh-list
93205797|NCT03268005|Insulin Aspart|insulin aspart|mesh-list
93205798|NCT03268005|Insulin, Long-Acting|insulin, long-acting|mesh-list
93205799|NCT03268005|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93205800|NCT03268005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93205801|NCT03268005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205802|NCT03239314|Dexamethasone|dexamethasone|mesh-list
93205803|NCT03239314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93205804|NCT03239314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205805|NCT03239314|Antiemetics|antiemetics|mesh-ancestor
93205806|NCT03239314|Autonomic Agents|autonomic agents|mesh-ancestor
93205807|NCT03239314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205808|NCT03239314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205809|NCT03239314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93205810|NCT03239314|Glucocorticoids|glucocorticoids|mesh-ancestor
93205811|NCT03239314|Hormones|hormones|mesh-ancestor
93205812|NCT03239314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205813|NCT03239314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93205814|NCT03239314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205815|NCT03241888|Megestrol|megestrol|mesh-list
93205816|NCT03241888|Megestrol Acetate|megestrol acetate|mesh-list
93205817|NCT03241888|Levonorgestrel|levonorgestrel|mesh-list
93205818|NCT03241888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93205819|NCT03241888|Contraceptive Agents|contraceptive agents|mesh-ancestor
93205820|NCT03241888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93205821|NCT03241888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205822|NCT03241888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93205823|NCT03241888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93205824|NCT03241888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93205825|NCT03241888|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93205826|NCT03241888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93205827|NCT03241888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205828|NCT03241888|Appetite Stimulants|appetite stimulants|mesh-ancestor
93205829|NCT03241888|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93205830|NCT02454088|Calcium, Dietary|calcium, dietary|mesh-list
93205831|NCT02454088|Triamcinolone|triamcinolone|mesh-list
93205832|NCT02454088|Calcium|calcium|mesh-list
93205833|NCT02454088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93205834|NCT02454088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205835|NCT02454088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93205836|NCT02454088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205837|NCT02454088|Glucocorticoids|glucocorticoids|mesh-ancestor
93205838|NCT02454088|Hormones|hormones|mesh-ancestor
93205839|NCT02454088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93205840|NCT02456116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93205841|NCT02456116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205842|NCT02456116|Analgesics|analgesics|mesh-ancestor
93205843|NCT02456116|Sensory System Agents|sensory system agents|mesh-ancestor
93205844|NCT02456116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205845|NCT02456116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205846|NCT02456116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205847|NCT02456116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205848|NCT03239236|Anesthetics|anesthetics|mesh-list
93205849|NCT03239236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205850|NCT03239236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205851|NCT03257800|Ketamine|ketamine|mesh-list
93205852|NCT03257800|Nitrous Oxide|nitrous oxide|mesh-list
93205853|NCT03257800|Sevoflurane|sevoflurane|mesh-list
93205854|NCT03257800|Analgesics|analgesics|mesh-ancestor
93205855|NCT03257800|Sensory System Agents|sensory system agents|mesh-ancestor
93205856|NCT03257800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205857|NCT03257800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205858|NCT03257800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93205859|NCT03257800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93205860|NCT03257800|Anesthetics, General|anesthetics, general|mesh-ancestor
93205861|NCT03257800|Anesthetics|anesthetics|mesh-ancestor
93205862|NCT03257800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205863|NCT03257800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93205864|NCT03257800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93205865|NCT03257800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205866|NCT03257800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205867|NCT03257800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93205868|NCT03257800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93205869|NCT03257800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93205870|NCT01353339|Levofloxacin|levofloxacin|mesh-list
93205871|NCT01353339|Ofloxacin|ofloxacin|mesh-list
93205872|NCT01353339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93205873|NCT01353339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205874|NCT01353339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93205875|NCT01353339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93205876|NCT01353339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93205877|NCT01353339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205878|NCT01353339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205879|NCT01353339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205880|NCT01353339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92877960|NCT02812355|Heparin|heparin|mesh-list
93205881|NCT01353339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93205882|NCT03239080|Denosumab|denosumab|mesh-list
93205883|NCT03239080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93205884|NCT03239080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205885|NCT03149055|Isavuconazole|isavuconazole|mesh-list
93205886|NCT03149055|Antifungal Agents|antifungal agents|mesh-ancestor
93205887|NCT03149055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205888|NCT01352091|Goserelin|goserelin|mesh-list
93205889|NCT01352091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93205890|NCT01352091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205891|NCT02954523|Dasatinib|dasatinib|mesh-list
93205892|NCT02954523|Osimertinib|osimertinib|mesh-list
93205893|NCT02954523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205894|NCT02954523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205895|NCT02954523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205896|NCT02954523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205897|NCT04486612|Anesthetics|anesthetics|mesh-list
93205898|NCT04486612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205899|NCT04486612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205900|NCT01353729|Moxifloxacin|moxifloxacin|mesh-list
93205901|NCT01353729|Zanamivir|zanamivir|mesh-list
93205902|NCT01353729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93205903|NCT01353729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93205904|NCT01353729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205905|NCT01353729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93205906|NCT01353729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93205907|NCT01353729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205908|NCT01353729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205909|NCT01353729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205910|NCT01353729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93205911|NCT01353729|Contraceptive Agents|contraceptive agents|mesh-ancestor
93205912|NCT01353729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93205913|NCT01353729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205914|NCT01353729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93205915|NCT01353729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93205916|NCT01353729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93205917|NCT01353729|Antiviral Agents|antiviral agents|mesh-ancestor
93205918|NCT01357317|Calcium, Dietary|calcium, dietary|mesh-list
93205919|NCT01357317|Calcium|calcium|mesh-list
93205920|NCT01357317|Calcium acetate|calcium acetate|mesh-list
93205921|NCT01357317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93205922|NCT01357317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205923|NCT01357317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93205924|NCT01357317|Chelating Agents|chelating agents|mesh-ancestor
93205925|NCT01357317|Sequestering Agents|sequestering agents|mesh-ancestor
93205926|NCT01357317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205927|NCT03238612|Clarithromycin|clarithromycin|mesh-list
93205928|NCT03238612|Oseltamivir|oseltamivir|mesh-list
93205929|NCT03238612|Antiviral Agents|antiviral agents|mesh-list
93205930|NCT03238612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93205931|NCT03238612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93205932|NCT03238612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93205933|NCT03238612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205934|NCT03238612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205935|NCT03238612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93205936|NCT03238612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93205937|NCT03137121|Olanzapine|olanzapine|mesh-list
93205938|NCT03137121|Antiemetics|antiemetics|mesh-ancestor
93205939|NCT03137121|Autonomic Agents|autonomic agents|mesh-ancestor
93205940|NCT03137121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93205941|NCT03137121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205942|NCT03137121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93205943|NCT03137121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93205944|NCT03137121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93205945|NCT03137121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93205946|NCT03137121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93205947|NCT03137121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93205948|NCT03137121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93205949|NCT03137121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93205950|NCT03137121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205951|NCT03137121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93205952|NCT03137121|Serotonin Agents|serotonin agents|mesh-ancestor
92878032|NCT02807909|Itraconazole|itraconazole|mesh-list
93205953|NCT02453776|Infliximab|infliximab|mesh-list
93205954|NCT02453776|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93205955|NCT02453776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93205956|NCT02453776|Dermatologic Agents|dermatologic agents|mesh-ancestor
93205957|NCT02453776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93205958|NCT02453776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93205960|NCT03256864|Tacrolimus|tacrolimus|mesh-list
93205961|NCT03256864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93205962|NCT03256864|Immunologic Factors|immunologic factors|mesh-ancestor
93205963|NCT03256864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205964|NCT03256864|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93205965|NCT03256864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205966|NCT03256864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205967|NCT03256864|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93205968|NCT03256864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205969|NCT03256864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205970|NCT01317849|Vitamins|vitamins|mesh-list
93205971|NCT01317849|Folic Acid|folic acid|mesh-list
93205972|NCT01317849|Vitamin B 12|vitamin b 12|mesh-list
93205973|NCT01317849|Pyridoxine|pyridoxine|mesh-list
93205974|NCT01317849|Pyridoxal|pyridoxal|mesh-list
93205975|NCT01317849|Vitamin B 6|vitamin b 6|mesh-list
93205976|NCT01317849|Vitamin B Complex|vitamin b complex|mesh-list
93205977|NCT01317849|Micronutrients|micronutrients|mesh-ancestor
93205978|NCT01317849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205979|NCT01317849|Hematinics|hematinics|mesh-ancestor
93205980|NCT01317927|Belinostat|belinostat|mesh-list
93205981|NCT01317927|Warfarin|warfarin|mesh-list
93205982|NCT01317927|Anticoagulants|anticoagulants|mesh-ancestor
93205983|NCT01317927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205984|NCT01317927|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93205985|NCT01317927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93205986|NCT01317927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93205987|NCT04418427|Aflibercept|aflibercept|mesh-list
93205988|NCT04418427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93205989|NCT04418427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93205990|NCT04418427|Growth Substances|growth substances|mesh-ancestor
93205991|NCT04418427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93205992|NCT04418427|Growth Inhibitors|growth inhibitors|mesh-ancestor
93205993|NCT04418427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205994|NCT02901483|Cisplatin|cisplatin|mesh-list
93205995|NCT02901483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205996|NCT02874651|Apatinib|apatinib|mesh-list
93205997|NCT02874651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93205998|NCT02874651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93205999|NCT02874651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206000|NCT02874651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206001|NCT02453932|Donepezil|donepezil|mesh-list
93206002|NCT02453932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93206003|NCT02453932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206004|NCT02453932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206005|NCT02453932|Cholinergic Agents|cholinergic agents|mesh-ancestor
93206006|NCT02453932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206007|NCT02453932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206008|NCT02453932|Nootropic Agents|nootropic agents|mesh-ancestor
93206009|NCT04385433|Pravastatin|pravastatin|mesh-list
93206010|NCT04385433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93206011|NCT04385433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93206012|NCT04385433|Antimetabolites|antimetabolites|mesh-ancestor
93206013|NCT04385433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206014|NCT04385433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93206015|NCT04385433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93206016|NCT04385433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206017|NCT00700570|Bevacizumab|bevacizumab|mesh-list
93206018|NCT00700570|Capecitabine|capecitabine|mesh-list
93206019|NCT00700570|Oxaliplatin|oxaliplatin|mesh-list
93206020|NCT00700570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206021|NCT00700570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206022|NCT00700570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93206023|NCT00700570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93206024|NCT00700570|Growth Substances|growth substances|mesh-ancestor
93206025|NCT00700570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206026|NCT00700570|Growth Inhibitors|growth inhibitors|mesh-ancestor
93206027|NCT00700570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93206028|NCT00700570|Antimetabolites|antimetabolites|mesh-ancestor
93206029|NCT00700570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206030|NCT02453698|Methylphenidate|methylphenidate|mesh-list
93206031|NCT02453698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93206032|NCT02453698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206033|NCT02453698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93206034|NCT02453698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93206035|NCT02453698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93206036|NCT02453698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206037|NCT02453698|Dopamine Agents|dopamine agents|mesh-ancestor
93206038|NCT02453698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206039|NCT01354275|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93206040|NCT01354275|Hormones|hormones|mesh-ancestor
93206041|NCT01354275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206042|NCT01354275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206043|NCT01318161|Morphine|morphine|mesh-list
93206044|NCT01318161|Ropivacaine|ropivacaine|mesh-list
93206045|NCT01318161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93206046|NCT01318161|Narcotics|narcotics|mesh-ancestor
93206047|NCT01318161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206048|NCT01318161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206049|NCT01318161|Analgesics|analgesics|mesh-ancestor
93206050|NCT01318161|Sensory System Agents|sensory system agents|mesh-ancestor
93206051|NCT01318161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206052|NCT01318161|Anesthetics, Local|anesthetics, local|mesh-ancestor
93206053|NCT01318161|Anesthetics|anesthetics|mesh-ancestor
93206054|NCT03255226|Tolvaptan|tolvaptan|mesh-list
93206055|NCT03255226|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93206056|NCT03255226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206057|NCT03255226|Natriuretic Agents|natriuretic agents|mesh-ancestor
93206058|NCT03255226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206059|NCT02455726|Pregabalin|pregabalin|mesh-list
93206060|NCT02455726|Oxycodone|oxycodone|mesh-list
93206061|NCT02455726|Magnesium Oxide|magnesium oxide|mesh-list
93206062|NCT02455726|Analgesics|analgesics|mesh-ancestor
93206063|NCT02455726|Sensory System Agents|sensory system agents|mesh-ancestor
93206064|NCT02455726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206065|NCT02455726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206066|NCT02455726|Anticonvulsants|anticonvulsants|mesh-ancestor
93206067|NCT02455726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93206068|NCT02455726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93206069|NCT02455726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206070|NCT02455726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206071|NCT02455726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93206072|NCT02455726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93206073|NCT02455726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206074|NCT02455726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93206075|NCT02455726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93206076|NCT02455726|Narcotics|narcotics|mesh-ancestor
93206077|NCT02455726|Antacids|antacids|mesh-ancestor
93206078|NCT02455726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206079|NCT04488172|Vitamins|vitamins|mesh-list
93206080|NCT04488172|Micronutrients|micronutrients|mesh-ancestor
93206081|NCT04488172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206082|NCT03239860|Antibodies|antibodies|mesh-list
93206083|NCT03239860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93206084|NCT03239860|Immunologic Factors|immunologic factors|mesh-ancestor
93206085|NCT03239860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206086|NCT04486690|Ketamine|ketamine|mesh-list
93206087|NCT04486690|Propofol|propofol|mesh-list
93206088|NCT04486690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93206089|NCT04486690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206090|NCT04486690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206091|NCT04486690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93206092|NCT04486690|Anesthetics, General|anesthetics, general|mesh-ancestor
93206093|NCT04486690|Anesthetics|anesthetics|mesh-ancestor
93206094|NCT04486690|Analgesics|analgesics|mesh-ancestor
93206095|NCT04486690|Sensory System Agents|sensory system agents|mesh-ancestor
93206096|NCT04486690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206097|NCT04486690|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93206098|NCT04486690|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93206099|NCT04486690|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93206100|NCT04486690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206101|NCT04486690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206102|NCT03255148|Oxytocin|oxytocin|mesh-list
93206103|NCT03255148|Oxytocics|oxytocics|mesh-ancestor
93206104|NCT03255148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206105|NCT03255148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206106|NCT03236818|Bosentan|bosentan|mesh-list
93206107|NCT03236818|Sildenafil Citrate|sildenafil citrate|mesh-list
93206108|NCT03236818|Tadalafil|tadalafil|mesh-list
93206109|NCT03236818|Macitentan|macitentan|mesh-list
93206110|NCT03236818|Vasodilator Agents|vasodilator agents|mesh-ancestor
93206111|NCT03236818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93206112|NCT03236818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93206113|NCT03236818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206114|NCT03236818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206115|NCT03236818|Urological Agents|urological agents|mesh-ancestor
93206116|NCT03236818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93206117|NCT03236818|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93206118|NCT03236818|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93206119|NCT03236818|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93206120|NCT03236974|Fulvestrant|fulvestrant|mesh-list
93206121|NCT03236974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93206122|NCT03236974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206123|NCT03236974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93206124|NCT03236974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93206125|NCT03236974|Hormone Antagonists|hormone antagonists|mesh-ancestor
93206126|NCT03236974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206127|NCT03236974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206128|NCT03748043|Lactoferrin|lactoferrin|mesh-list
93206129|NCT03748043|Teferrol|teferrol|mesh-list
93206130|NCT03748043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206131|NCT03748043|Hematinics|hematinics|mesh-ancestor
93206132|NCT03750773|Gabapentin|gabapentin|mesh-list
93206133|NCT03750773|Analgesics|analgesics|mesh-ancestor
93206134|NCT03750773|Sensory System Agents|sensory system agents|mesh-ancestor
93206135|NCT03750773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206136|NCT03750773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206137|NCT03750773|Anticonvulsants|anticonvulsants|mesh-ancestor
93206138|NCT03750773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93206139|NCT03750773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93206140|NCT03750773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206141|NCT03750773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93206142|NCT03750773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93206143|NCT03750773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93206144|NCT03750773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206145|NCT03750773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206146|NCT03750773|Antimanic Agents|antimanic agents|mesh-ancestor
93206147|NCT02874924|Sirolimus|sirolimus|mesh-list
93206148|NCT02874924|Temsirolimus|temsirolimus|mesh-list
93206149|NCT02874924|MTOR Inhibitors|mtor inhibitors|mesh-list
93206150|NCT02874924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93206151|NCT02874924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206152|NCT02874924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93206153|NCT02874924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206154|NCT02874924|Antifungal Agents|antifungal agents|mesh-ancestor
93206155|NCT02874924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206156|NCT02874924|Immunologic Factors|immunologic factors|mesh-ancestor
93206157|NCT02874924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206158|NCT02874924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93206159|NCT02874924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206160|NCT02874924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206161|NCT04425863|Aspirin|aspirin|mesh-list
93206162|NCT04425863|Ivermectin|ivermectin|mesh-list
93206163|NCT04425863|Dexamethasone|dexamethasone|mesh-list
93206164|NCT04425863|Dexamethasone acetate|dexamethasone acetate|mesh-list
93206165|NCT04425863|Enoxaparin|enoxaparin|mesh-list
93206166|NCT04425863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93206167|NCT04425863|BB 1101|bb 1101|mesh-list
92118139|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
93206168|NCT04425863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206169|NCT04425863|Antiemetics|antiemetics|mesh-ancestor
93206170|NCT04425863|Autonomic Agents|autonomic agents|mesh-ancestor
93206171|NCT04425863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206172|NCT04425863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206173|NCT04425863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206174|NCT04425863|Glucocorticoids|glucocorticoids|mesh-ancestor
93206175|NCT04425863|Hormones|hormones|mesh-ancestor
93206176|NCT04425863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206177|NCT04425863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93206178|NCT04425863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206179|NCT04425863|Protease Inhibitors|protease inhibitors|mesh-ancestor
93206180|NCT04425863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206181|NCT04425863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206182|NCT04425863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206183|NCT04425863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206185|NCT04425863|Sensory System Agents|sensory system agents|mesh-ancestor
93206186|NCT04425863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206187|NCT04425863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206188|NCT04425863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206189|NCT04425863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93206190|NCT04425863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93206191|NCT04425863|Antipyretics|antipyretics|mesh-ancestor
93206192|NCT04425863|Anticoagulants|anticoagulants|mesh-ancestor
93206193|NCT04425863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93206194|NCT04425863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206195|NCT01370772|Cyclophosphamide|cyclophosphamide|mesh-list
93206196|NCT01370772|Rituximab|rituximab|mesh-list
93206197|NCT01370772|Fludarabine|fludarabine|mesh-list
93206198|NCT01370772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206199|NCT01370772|Immunologic Factors|immunologic factors|mesh-ancestor
93206200|NCT01370772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206201|NCT01370772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206202|NCT01370772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93206203|NCT01370772|Alkylating Agents|alkylating agents|mesh-ancestor
93206204|NCT01370772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206205|NCT01370772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206206|NCT01370772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93206207|NCT01370772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206208|NCT01842282|Amlexanox|amlexanox|mesh-list
93206209|NCT01842282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93206210|NCT03234244|Cholecalciferol|cholecalciferol|mesh-list
93206211|NCT03234244|Vitamin D|vitamin d|mesh-list
93206212|NCT03234244|Bazedoxifene|bazedoxifene|mesh-list
93206213|NCT03234244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206214|NCT03234244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206215|NCT03234244|Vitamins|vitamins|mesh-ancestor
93206216|NCT03234244|Micronutrients|micronutrients|mesh-ancestor
93206217|NCT03234244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93206218|NCT03234244|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93206219|NCT03234244|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93206220|NCT03234244|Hormone Antagonists|hormone antagonists|mesh-ancestor
93206221|NCT03234244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206222|NCT03234400|Dapivirine|dapivirine|mesh-list
93206223|NCT03234400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93206224|NCT03234400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93206225|NCT03234400|Antiviral Agents|antiviral agents|mesh-ancestor
93206226|NCT03234400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206227|NCT03254368|ZGN-1061|zgn-1061|mesh-list
93206228|NCT03254368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206229|NCT03254368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206230|NCT03254368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93206231|NCT03236740|Metformin|metformin|mesh-list
93206232|NCT03236740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93206233|NCT03236740|Estradiol|estradiol|mesh-list
93206234|NCT03236740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93206235|NCT03236740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206236|NCT03236740|Estrogens|estrogens|mesh-ancestor
93206237|NCT03236740|Hormones|hormones|mesh-ancestor
93206238|NCT03236740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206239|NCT03236740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93206240|NCT03236740|Contraceptive Agents|contraceptive agents|mesh-ancestor
93206241|NCT03236740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206242|NCT03236740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93206243|NCT03236740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93206244|NCT03236740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93206245|NCT02453464|Leucovorin|leucovorin|mesh-list
93206246|NCT02453464|Irinotecan|irinotecan|mesh-list
93206247|NCT02453464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93206248|NCT02453464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93206249|NCT02453464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206250|NCT02453464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206251|NCT02453464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206252|NCT02453464|Antidotes|antidotes|mesh-ancestor
93206253|NCT02453464|Protective Agents|protective agents|mesh-ancestor
93206254|NCT02453464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206255|NCT02453464|Vitamin B Complex|vitamin b complex|mesh-ancestor
93206256|NCT02453464|Vitamins|vitamins|mesh-ancestor
93206257|NCT02453464|Micronutrients|micronutrients|mesh-ancestor
93206258|NCT03233932|Leuprolide|leuprolide|mesh-list
93206259|NCT03233932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93206260|NCT03233932|Fertility Agents|fertility agents|mesh-ancestor
93206261|NCT03233932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206262|NCT03233932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206263|NCT03233932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93206264|NCT03233932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206266|NCT03236584|Lamivudine|lamivudine|mesh-list
93206267|NCT03236584|Adefovir|adefovir|mesh-list
93206268|NCT03236584|Antiviral Agents|antiviral agents|mesh-ancestor
93206269|NCT03236584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206270|NCT03236584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93206271|NCT03236584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93206272|NCT03236584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206273|NCT03236584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206274|NCT03236584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93206275|NCT03236584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93206276|NCT03233776|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93206277|NCT03233776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206278|NCT04614168|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93206279|NCT04614168|Glycerol|glycerol|mesh-list
93206280|NCT04614168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206281|NCT04614168|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93206282|NCT04614168|Protective Agents|protective agents|mesh-ancestor
93206283|NCT01365312|Ethanol|ethanol|mesh-list
93206284|NCT01365312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93206285|NCT01365312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206286|NCT01365312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206287|NCT01365312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206288|NCT04495283|Acetaminophen|acetaminophen|mesh-list
93206289|NCT04495283|Pregabalin|pregabalin|mesh-list
93206290|NCT04495283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206291|NCT04495283|Analgesics|analgesics|mesh-ancestor
93206292|NCT04495283|Sensory System Agents|sensory system agents|mesh-ancestor
93206293|NCT04495283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206294|NCT04495283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206295|NCT04495283|Antipyretics|antipyretics|mesh-ancestor
93206296|NCT04495283|Anticonvulsants|anticonvulsants|mesh-ancestor
93206297|NCT04495283|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93206298|NCT04495283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93206299|NCT04495283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206300|NCT04495283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206301|NCT04495283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93206302|NCT04495283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93206303|NCT04495283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206304|NCT04495283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93206305|NCT03634020|Sirolimus|sirolimus|mesh-list
93206306|NCT03634020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93206307|NCT03634020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206308|NCT03634020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93206309|NCT03634020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206310|NCT03634020|Antifungal Agents|antifungal agents|mesh-ancestor
93206311|NCT03634020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206312|NCT03634020|Immunologic Factors|immunologic factors|mesh-ancestor
93206313|NCT03634020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206314|NCT03253276|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
93206315|NCT03253276|Cathartics|cathartics|mesh-ancestor
93206316|NCT03253276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206317|NCT01372644|Pasireotide|pasireotide|mesh-list
93206318|NCT01372644|Hormones|hormones|mesh-ancestor
93206319|NCT01372644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206320|NCT01372644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206321|NCT03253198|Bupivacaine|bupivacaine|mesh-list
93206322|NCT03253198|Anesthetics, Local|anesthetics, local|mesh-ancestor
93206323|NCT03253198|Anesthetics|anesthetics|mesh-ancestor
93206324|NCT03253198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206325|NCT03253198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206326|NCT03253198|Sensory System Agents|sensory system agents|mesh-ancestor
93206327|NCT03253198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206328|NCT04285086|Anagrelide|anagrelide|mesh-list
93206329|NCT04285086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206330|NCT04285086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206331|NCT04285086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206332|NCT04285086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93206333|NCT04485988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93206334|NCT04485988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93206335|NCT04485988|Adrenergic Agents|adrenergic agents|mesh-ancestor
93206336|NCT04485988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206337|NCT04485988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206338|NCT04485988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206339|NCT04234464|Budesonide|budesonide|mesh-list
93206340|NCT04234464|Albuterol|albuterol|mesh-list
93206341|NCT04234464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206342|NCT04234464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93206343|NCT04234464|Autonomic Agents|autonomic agents|mesh-ancestor
93206344|NCT04234464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206345|NCT04234464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206346|NCT04234464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93206347|NCT04234464|Respiratory System Agents|respiratory system agents|mesh-ancestor
93206348|NCT04234464|Glucocorticoids|glucocorticoids|mesh-ancestor
93206349|NCT04234464|Hormones|hormones|mesh-ancestor
93206350|NCT04234464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206351|NCT04234464|Tocolytic Agents|tocolytic agents|mesh-ancestor
93206352|NCT04234464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206353|NCT04234464|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93206354|NCT04234464|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93206355|NCT04234464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93206356|NCT04234464|Adrenergic Agents|adrenergic agents|mesh-ancestor
93206357|NCT04234464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206358|NCT04234464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206359|NCT03233152|Nivolumab|nivolumab|mesh-list
93206360|NCT03233152|Ipilimumab|ipilimumab|mesh-list
93206361|NCT03233152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93206362|NCT03233152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206363|NCT03233152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206364|NCT03233152|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93206365|NCT03233152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206366|NCT03229096|Apatinib|apatinib|mesh-list
93206367|NCT03229096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206368|NCT03229096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93206369|NCT03229096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206370|NCT03229096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206371|NCT03123588|Anagrelide|anagrelide|mesh-list
93206372|NCT03123588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206373|NCT03123588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206374|NCT03123588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206375|NCT03123588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93206376|NCT02452918|Oritavancin|oritavancin|mesh-list
93206377|NCT02452918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93206378|NCT02452918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206379|NCT02821026|Mycophenolic Acid|mycophenolic acid|mesh-list
93206380|NCT02821026|Sirolimus|sirolimus|mesh-list
93206381|NCT02821026|Etanercept|etanercept|mesh-list
93206382|NCT02821026|Tacrolimus|tacrolimus|mesh-list
93206383|NCT02821026|Thymoglobulin|thymoglobulin|mesh-list
93206384|NCT02821026|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93206385|NCT02821026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206386|NCT02821026|Immunologic Factors|immunologic factors|mesh-ancestor
93206387|NCT02821026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206388|NCT02821026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93206389|NCT02821026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206390|NCT02821026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206391|NCT02821026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93206392|NCT02821026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206393|NCT02821026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93206394|NCT02821026|Antitubercular Agents|antitubercular agents|mesh-ancestor
93206395|NCT02821026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93206396|NCT02821026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206397|NCT02821026|Antifungal Agents|antifungal agents|mesh-ancestor
93206398|NCT02821026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206399|NCT02821026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206400|NCT02821026|Analgesics|analgesics|mesh-ancestor
93206401|NCT02821026|Sensory System Agents|sensory system agents|mesh-ancestor
93206402|NCT02821026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206403|NCT02821026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206404|NCT02821026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206405|NCT02821026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206406|NCT03228628|Nitrous Oxide|nitrous oxide|mesh-list
93206407|NCT03228628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93206408|NCT03228628|Anesthetics, General|anesthetics, general|mesh-ancestor
93206409|NCT03228628|Anesthetics|anesthetics|mesh-ancestor
93206410|NCT03228628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206411|NCT03228628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206412|NCT03228628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206413|NCT03228628|Analgesics|analgesics|mesh-ancestor
93206414|NCT03228628|Sensory System Agents|sensory system agents|mesh-ancestor
93206415|NCT03228628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206416|NCT03232450|Aspirin|aspirin|mesh-list
93206417|NCT03232450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206418|NCT03232450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206419|NCT03232450|Analgesics|analgesics|mesh-ancestor
93206420|NCT03232450|Sensory System Agents|sensory system agents|mesh-ancestor
93206421|NCT03232450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206422|NCT03232450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206423|NCT03232450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206424|NCT03232450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206425|NCT03232450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206426|NCT03232450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206427|NCT03232450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206428|NCT03232450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93206429|NCT03232450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93206430|NCT03232450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206431|NCT03232450|Antipyretics|antipyretics|mesh-ancestor
93206432|NCT04411667|gamma-Globulins|gamma-globulins|mesh-list
93206433|NCT04411667|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93206434|NCT04411667|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93206435|NCT04411667|Immunologic Factors|immunologic factors|mesh-ancestor
93206436|NCT04411667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206437|NCT04948697|Tislelizumab|tislelizumab|mesh-list
93206438|NCT04948697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206439|NCT04948697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206440|NCT04358549|Favipiravir|favipiravir|mesh-list
93206441|NCT04358549|Antiviral Agents|antiviral agents|mesh-ancestor
93206442|NCT04358549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206443|NCT01562483|Dronabinol|dronabinol|mesh-list
93206444|NCT01562483|Hallucinogens|hallucinogens|mesh-ancestor
93206445|NCT01562483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206446|NCT01562483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93206447|NCT01562483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206448|NCT01562483|Analgesics|analgesics|mesh-ancestor
93206449|NCT01562483|Sensory System Agents|sensory system agents|mesh-ancestor
93206450|NCT01562483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206451|NCT01562483|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93206452|NCT01562483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93206453|NCT01562483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206454|NCT01562483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206455|NCT01562483|Hormones|hormones|mesh-ancestor
93206456|NCT01562483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206457|NCT00700180|Bevacizumab|bevacizumab|mesh-list
93206458|NCT00700180|Carboplatin|carboplatin|mesh-list
93206459|NCT00700180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206460|NCT00700180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206461|NCT00700180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93206462|NCT00700180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93206463|NCT00700180|Growth Substances|growth substances|mesh-ancestor
93206464|NCT00700180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206465|NCT00700180|Growth Inhibitors|growth inhibitors|mesh-ancestor
93206466|NCT03222544|Methylene Blue|methylene blue|mesh-list
93206467|NCT03222544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206468|NCT03222544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206469|NCT03228862|Ergocalciferols|ergocalciferols|mesh-list
93206470|NCT03228862|Vitamin D|vitamin d|mesh-list
93206471|NCT03228862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206472|NCT03228862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206473|NCT03228862|Vitamins|vitamins|mesh-ancestor
93206474|NCT03228862|Micronutrients|micronutrients|mesh-ancestor
93206475|NCT03228862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93206476|NCT03228238|Vitamins|vitamins|mesh-list
93206477|NCT03228238|Ascorbic Acid|ascorbic acid|mesh-list
93206478|NCT03228238|Vitamin E|vitamin e|mesh-list
93206479|NCT03228238|Tocopherols|tocopherols|mesh-list
93206480|NCT03228238|Calcium Channel Blockers|calcium channel blockers|mesh-list
93206481|NCT03228238|Atorvastatin|atorvastatin|mesh-list
93206482|NCT03228238|Micronutrients|micronutrients|mesh-ancestor
93206483|NCT03228238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206484|NCT03228238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206486|NCT03228238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93206487|NCT03228238|Antimetabolites|antimetabolites|mesh-ancestor
93206488|NCT03228238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206489|NCT03228238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93206490|NCT03228238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93206491|NCT03228238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206492|NCT03228238|Antioxidants|antioxidants|mesh-ancestor
93206493|NCT03228238|Protective Agents|protective agents|mesh-ancestor
93206494|NCT03228238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93206495|NCT03232216|Vitamin D|vitamin d|mesh-list
93206496|NCT03232216|Cholecalciferol|cholecalciferol|mesh-list
93206497|NCT03232216|Vitamins|vitamins|mesh-ancestor
93206498|NCT03232216|Micronutrients|micronutrients|mesh-ancestor
93206499|NCT03232216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206500|NCT03232216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93206501|NCT03232216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206502|NCT03231982|Amlodipine|amlodipine|mesh-list
93206503|NCT03231982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93206504|NCT03231982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93206505|NCT03231982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93206506|NCT03231982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206507|NCT03231982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206508|NCT03231982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206509|NCT03231982|Vasodilator Agents|vasodilator agents|mesh-ancestor
93206510|NCT03222310|Itraconazole|itraconazole|mesh-list
93206511|NCT03222310|Ipatasertib|ipatasertib|mesh-list
93206512|NCT03222310|Antifungal Agents|antifungal agents|mesh-ancestor
93206513|NCT03222310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206514|NCT03222310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93206515|NCT03222310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93206516|NCT03222310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206517|NCT03222310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206518|NCT03222310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93206519|NCT03222310|Hormone Antagonists|hormone antagonists|mesh-ancestor
93206520|NCT03222310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206521|NCT03222310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206522|NCT03222310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93206523|NCT03222310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206524|NCT03222310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93206525|NCT04485520|Chlorhexidine|chlorhexidine|mesh-list
93206526|NCT04485520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93206527|NCT04485520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206528|NCT04485520|Disinfectants|disinfectants|mesh-ancestor
93206529|NCT03231436|Bupivacaine|bupivacaine|mesh-list
93206530|NCT03231436|Anesthetics, Local|anesthetics, local|mesh-ancestor
93206531|NCT03231436|Anesthetics|anesthetics|mesh-ancestor
93206532|NCT03231436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206533|NCT03231436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206534|NCT03231436|Sensory System Agents|sensory system agents|mesh-ancestor
93206535|NCT03231436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206536|NCT02452450|Acetaminophen|acetaminophen|mesh-list
93206537|NCT02452450|Ibuprofen|ibuprofen|mesh-list
93206538|NCT02452450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206539|NCT02452450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206540|NCT02452450|Analgesics|analgesics|mesh-ancestor
93206541|NCT02452450|Sensory System Agents|sensory system agents|mesh-ancestor
91928477|NCT02403687|Menthol|menthol|mesh-list
93206542|NCT02452450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206543|NCT02452450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206544|NCT02452450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206545|NCT02452450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206546|NCT02452450|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93206547|NCT02452450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206548|NCT02452450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206549|NCT02452450|Antipyretics|antipyretics|mesh-ancestor
93206550|NCT01204684|Poly ICLC|poly iclc|mesh-list
93206551|NCT01204684|Interferon Inducers|interferon inducers|mesh-ancestor
93206552|NCT01204684|Immunologic Factors|immunologic factors|mesh-ancestor
93206553|NCT01204684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206554|NCT00594334|Risedronic Acid|risedronic acid|mesh-list
93206555|NCT00594334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93206556|NCT00594334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878626|NCT00642512|Hallucinogens|hallucinogens|mesh-ancestor
93206557|NCT00594334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206558|NCT00594334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93206559|NCT00594334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206560|NCT00594334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93206561|NCT00238420|Paclitaxel|paclitaxel|mesh-list
93206562|NCT00238420|Trastuzumab|trastuzumab|mesh-list
93206563|NCT00238420|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93206564|NCT00238420|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93206565|NCT00238420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93206566|NCT00238420|Antibodies|antibodies|mesh-list
93206567|NCT00238420|Immunoglobulins|immunoglobulins|mesh-list
93206568|NCT00238420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93206569|NCT00238420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93206570|NCT00238420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206571|NCT00238420|Tubulin Modulators|tubulin modulators|mesh-ancestor
93206572|NCT00238420|Antimitotic Agents|antimitotic agents|mesh-ancestor
93206573|NCT00238420|Mitosis Modulators|mitosis modulators|mesh-ancestor
93206574|NCT00238420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206575|NCT00238420|Immunologic Factors|immunologic factors|mesh-ancestor
93206576|NCT00238420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206577|NCT03221998|Acetaminophen|acetaminophen|mesh-list
93206578|NCT03221998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206579|NCT03221998|Analgesics|analgesics|mesh-ancestor
93206580|NCT03221998|Sensory System Agents|sensory system agents|mesh-ancestor
93206581|NCT03221998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206582|NCT03221998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206583|NCT03221998|Antipyretics|antipyretics|mesh-ancestor
93206584|NCT04492475|Interferons|interferons|mesh-list
93206585|NCT04492475|Interferon-beta|interferon-beta|mesh-list
93206586|NCT04492475|Interferon beta-1a|interferon beta-1a|mesh-list
93206587|NCT04492475|Remdesivir|remdesivir|mesh-list
93206588|NCT04492475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206589|NCT04492475|Antiviral Agents|antiviral agents|mesh-ancestor
93206590|NCT04492475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206591|NCT04492475|Immunologic Factors|immunologic factors|mesh-ancestor
93206592|NCT04492475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206593|NCT04492475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93206594|NCT04492475|Antimetabolites|antimetabolites|mesh-ancestor
93206595|NCT04492475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206596|NCT04936763|Hyaluronic Acid|hyaluronic acid|mesh-list
93206597|NCT04936763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93206598|NCT04936763|Immunologic Factors|immunologic factors|mesh-ancestor
93206599|NCT04936763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206600|NCT04936763|Viscosupplements|viscosupplements|mesh-ancestor
93206601|NCT04936763|Protective Agents|protective agents|mesh-ancestor
93206602|NCT03226522|Bupropion|bupropion|mesh-list
93206603|NCT03226522|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93206604|NCT03226522|Antidepressive Agents|antidepressive agents|mesh-ancestor
93206605|NCT03226522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93206606|NCT03226522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93206607|NCT03226522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93206608|NCT03226522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93206609|NCT03226522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206610|NCT03226522|Dopamine Agents|dopamine agents|mesh-ancestor
93206611|NCT03226522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206612|NCT03226522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206613|NCT03226522|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93206614|NCT03226522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93206615|NCT03226522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206616|NCT03752333|Pembrolizumab|pembrolizumab|mesh-list
93206617|NCT03752333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206618|NCT03752333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206619|NCT03752333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93206620|NCT03752333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206621|NCT03750383|Cyclosporine|cyclosporine|mesh-list
93206622|NCT03750383|Prednisone|prednisone|mesh-list
93206623|NCT03750383|Cyclosporins|cyclosporins|mesh-list
93206624|NCT03750383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206625|NCT03750383|Glucocorticoids|glucocorticoids|mesh-ancestor
93206626|NCT03750383|Hormones|hormones|mesh-ancestor
93206627|NCT03750383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206628|NCT03750383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206629|NCT03750383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93206630|NCT03750383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206631|NCT03750383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206632|NCT03750383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206633|NCT03750383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206634|NCT03750383|Immunologic Factors|immunologic factors|mesh-ancestor
93206635|NCT03750383|Antifungal Agents|antifungal agents|mesh-ancestor
93206636|NCT03750383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206637|NCT03750383|Dermatologic Agents|dermatologic agents|mesh-ancestor
93206638|NCT03750383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206639|NCT03750383|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93206640|NCT03226210|Insulin|insulin|mesh-list
93206641|NCT03226210|Insulin Aspart|insulin aspart|mesh-list
93206642|NCT03226210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93206643|NCT03226210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206644|NCT03229954|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93206645|NCT03229954|Hematinics|hematinics|mesh-ancestor
93206646|NCT03220126|Mirikizumab|mirikizumab|mesh-list
93206647|NCT03220126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206648|NCT03220126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206649|NCT03220126|Analgesics|analgesics|mesh-ancestor
93206650|NCT03220126|Sensory System Agents|sensory system agents|mesh-ancestor
93206651|NCT03220126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206652|NCT03220126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206653|NCT03220126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206654|NCT03220126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206655|NCT03220126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93206656|NCT03220126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206657|NCT02452684|Eszopiclone|eszopiclone|mesh-list
93206658|NCT02452684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93206659|NCT02452684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206660|NCT02452684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206661|NCT03119428|Nivolumab|nivolumab|mesh-list
93206662|NCT03119428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93206663|NCT03119428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206664|NCT03119428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93206665|NCT03119428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206666|NCT04345367|Abrocitinib|abrocitinib|mesh-list
93206667|NCT04345367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93206668|NCT04345367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206669|NCT04345367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206670|NCT02452606|Levodopa|levodopa|mesh-list
93206671|NCT02452606|Carbidopa|carbidopa|mesh-list
93206672|NCT02452606|Entacapone|entacapone|mesh-list
93206673|NCT02452606|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93206674|NCT02452606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93206675|NCT02452606|Dopamine Agents|dopamine agents|mesh-ancestor
93206676|NCT02452606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206677|NCT02452606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206678|NCT02452606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206679|NCT02452606|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93206680|NCT02452606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206681|NCT02452606|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93206682|NCT03225352|Aspirin|aspirin|mesh-list
93206683|NCT03225352|Ibuprofen|ibuprofen|mesh-list
93206684|NCT03225352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206685|NCT03225352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206686|NCT03225352|Analgesics|analgesics|mesh-ancestor
93206687|NCT03225352|Sensory System Agents|sensory system agents|mesh-ancestor
93206688|NCT03225352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206689|NCT03225352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206690|NCT03225352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206691|NCT03225352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206692|NCT03225352|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206693|NCT03225352|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206694|NCT03225352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206695|NCT03225352|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93206696|NCT03225352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93206697|NCT03225352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206698|NCT03225352|Antipyretics|antipyretics|mesh-ancestor
93206699|NCT03208270|Antithrombins|antithrombins|mesh-list
93206700|NCT03208270|Antithrombin III|antithrombin iii|mesh-list
93206701|NCT03208270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93206702|NCT03208270|Protease Inhibitors|protease inhibitors|mesh-ancestor
93206703|NCT03208270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206704|NCT03208270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206705|NCT03208270|Anticoagulants|anticoagulants|mesh-ancestor
93206707|NCT03208426|Metronidazole|metronidazole|mesh-list
93206708|NCT03208426|Clarithromycin|clarithromycin|mesh-list
93206709|NCT03208426|Tetracycline|tetracycline|mesh-list
93206710|NCT03208426|Esomeprazole|esomeprazole|mesh-list
93206711|NCT03208426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93206712|NCT03208426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206713|NCT03208426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93206714|NCT03208426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93206715|NCT03208426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93206716|NCT03208426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206717|NCT03208426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93206718|NCT03208426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206719|NCT03208426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206720|NCT03208426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93206721|NCT03208426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93206722|NCT03208426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93206723|NCT03216070|Dasatinib|dasatinib|mesh-list
93206724|NCT03216070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206725|NCT03216070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93206726|NCT03216070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206727|NCT03216070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206728|NCT03215602|Pyrantel|pyrantel|mesh-list
93206729|NCT03215602|Pyrantel Pamoate|pyrantel pamoate|mesh-list
93206730|NCT03215602|Antinematodal Agents|antinematodal agents|mesh-ancestor
93206731|NCT03215602|Anthelmintics|anthelmintics|mesh-ancestor
93206732|NCT03215602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93206733|NCT03215602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206734|NCT03215602|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93206735|NCT03215602|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93206736|NCT03215602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93206737|NCT03215602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206738|NCT03215602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206739|NCT02450968|Dexamethasone|dexamethasone|mesh-list
93206740|NCT02450968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206741|NCT02450968|Antiemetics|antiemetics|mesh-ancestor
93206742|NCT02450968|Autonomic Agents|autonomic agents|mesh-ancestor
93206743|NCT02450968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206744|NCT02450968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206745|NCT02450968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206746|NCT02450968|Glucocorticoids|glucocorticoids|mesh-ancestor
93206747|NCT02450968|Hormones|hormones|mesh-ancestor
93206748|NCT02450968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206749|NCT02450968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93206750|NCT02450968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206751|NCT03749915|Tetracaine|tetracaine|mesh-list
93206752|NCT03749915|Anesthetics, Local|anesthetics, local|mesh-ancestor
93206753|NCT03749915|Anesthetics|anesthetics|mesh-ancestor
93206754|NCT03749915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206755|NCT03749915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206756|NCT03749915|Sensory System Agents|sensory system agents|mesh-ancestor
93206757|NCT03749915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206758|NCT03119116|Rivaroxaban|rivaroxaban|mesh-list
93206759|NCT03119116|Apixaban|apixaban|mesh-list
93206760|NCT03119116|Dabigatran|dabigatran|mesh-list
93206761|NCT03119116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93206762|NCT03119116|Antithrombins|antithrombins|mesh-ancestor
93206763|NCT03119116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93206764|NCT03119116|Protease Inhibitors|protease inhibitors|mesh-ancestor
93206765|NCT03119116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206766|NCT03119116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206767|NCT03119116|Anticoagulants|anticoagulants|mesh-ancestor
93206768|NCT04329923|Hydroxychloroquine|hydroxychloroquine|mesh-list
93206769|NCT04329923|Antimalarials|antimalarials|mesh-ancestor
93206770|NCT04329923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93206771|NCT04329923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93206772|NCT04329923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206773|NCT04329923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206774|NCT04329923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206775|NCT04329923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206776|NCT04403399|Varenicline|varenicline|mesh-list
93206777|NCT04403399|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93206778|NCT04403399|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93206779|NCT04403399|Cholinergic Agents|cholinergic agents|mesh-ancestor
93206780|NCT04403399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93206781|NCT04403399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206782|NCT04403399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206783|NCT03224572|Ascorbic Acid|ascorbic acid|mesh-list
93206784|NCT03224572|Vitamins|vitamins|mesh-ancestor
93206785|NCT03224572|Micronutrients|micronutrients|mesh-ancestor
93206786|NCT03224572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206787|NCT03224572|Antioxidants|antioxidants|mesh-ancestor
93206788|NCT03224572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206789|NCT03224572|Protective Agents|protective agents|mesh-ancestor
93206790|NCT02452216|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93206791|NCT02452216|Hematinics|hematinics|mesh-ancestor
93206792|NCT02452216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93206793|NCT02452216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93206794|NCT03207334|Cytarabine|cytarabine|mesh-list
93206795|NCT03207334|Midostaurin|midostaurin|mesh-list
93206796|NCT03207334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93206797|NCT03207334|Antimetabolites|antimetabolites|mesh-ancestor
93206798|NCT03207334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206799|NCT03207334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206800|NCT03207334|Antiviral Agents|antiviral agents|mesh-ancestor
93206801|NCT03207334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206802|NCT03207334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206803|NCT03207334|Immunologic Factors|immunologic factors|mesh-ancestor
93206804|NCT03207334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206805|NCT03207334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93206806|NCT03207334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206807|NCT03212950|Insulin|insulin|mesh-list
93206808|NCT03212950|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93206809|NCT03212950|Insulin Aspart|insulin aspart|mesh-list
93206810|NCT03212950|Insulin, Long-Acting|insulin, long-acting|mesh-list
93206811|NCT03212950|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93206812|NCT03212950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93206813|NCT03212950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206814|NCT03207100|Antihypertensive Agents|antihypertensive agents|mesh-list
93206815|NCT01561937|Warfarin|warfarin|mesh-list
93206816|NCT01561937|Anticoagulants|anticoagulants|mesh-ancestor
93206817|NCT03210766|Nabilone|nabilone|mesh-list
93206818|NCT03210766|Antiemetics|antiemetics|mesh-ancestor
93206819|NCT03210766|Autonomic Agents|autonomic agents|mesh-ancestor
93206820|NCT03210766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206821|NCT03210766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206822|NCT03210766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206823|NCT03210766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93206824|NCT03210766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93206825|NCT03210766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206826|NCT03210766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93206827|NCT03747341|Fentanyl|fentanyl|mesh-list
93206828|NCT03747341|Oxycodone|oxycodone|mesh-list
93206829|NCT03747341|Buprenorphine|buprenorphine|mesh-list
93206830|NCT03747341|Ondansetron|ondansetron|mesh-list
93206831|NCT03747341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93206832|NCT03747341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93206833|NCT03747341|Narcotics|narcotics|mesh-ancestor
93206834|NCT03747341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206835|NCT03747341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206836|NCT03747341|Analgesics|analgesics|mesh-ancestor
93206837|NCT03747341|Sensory System Agents|sensory system agents|mesh-ancestor
93206838|NCT03747341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206839|NCT03747341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93206840|NCT03747341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93206841|NCT03747341|Anesthetics, General|anesthetics, general|mesh-ancestor
93206842|NCT03747341|Anesthetics|anesthetics|mesh-ancestor
93206843|NCT03747341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93206844|NCT03747341|Antiemetics|antiemetics|mesh-ancestor
93206845|NCT03747341|Autonomic Agents|autonomic agents|mesh-ancestor
93206846|NCT03747341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93206847|NCT03747341|Antipruritics|antipruritics|mesh-ancestor
93206848|NCT03747341|Dermatologic Agents|dermatologic agents|mesh-ancestor
93206849|NCT03747341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93206850|NCT03747341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93206851|NCT03747341|Serotonin Agents|serotonin agents|mesh-ancestor
93206852|NCT03747341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878928|NCT02681198|Paroxetine|paroxetine|mesh-list
93206853|NCT03747341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206854|NCT04401293|Heparin|heparin|mesh-list
93206855|NCT04401293|Enoxaparin|enoxaparin|mesh-list
93206856|NCT04401293|Calcium heparin|calcium heparin|mesh-list
93206857|NCT04401293|Dalteparin|dalteparin|mesh-list
93206858|NCT04401293|Enoxaparin sodium|enoxaparin sodium|mesh-list
93206859|NCT04401293|Anticoagulants|anticoagulants|mesh-ancestor
93206860|NCT04401293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206861|NCT04401293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206862|NCT04401293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206864|NCT03209908|Antiviral Agents|antiviral agents|mesh-ancestor
93206865|NCT03209908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206866|NCT03209908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93206867|NCT03209908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93206868|NCT03209908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206869|NCT03209908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206870|NCT03209908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93206871|NCT03209908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93206872|NCT04484740|Gepotidacin|gepotidacin|mesh-list
93206873|NCT04484740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93206874|NCT04484740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206875|NCT04484740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206876|NCT04484740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206877|NCT04319159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93206878|NCT04319159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93206879|NCT04319159|Dermatologic Agents|dermatologic agents|mesh-ancestor
93206880|NCT03224338|Dolutegravir|dolutegravir|mesh-list
93206881|NCT03224338|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93206882|NCT03224338|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93206883|NCT03224338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206884|NCT03224338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206885|NCT03224338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93206886|NCT03224338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93206887|NCT03224338|Antiviral Agents|antiviral agents|mesh-ancestor
93206888|NCT03224338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206889|NCT04318535|Griseofulvin|griseofulvin|mesh-list
93206890|NCT04318535|Antifungal Agents|antifungal agents|mesh-ancestor
93206891|NCT04318535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206892|NCT02451826|Ulipristal acetate|ulipristal acetate|mesh-list
93206893|NCT02451826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93206894|NCT02451826|Contraceptive Agents|contraceptive agents|mesh-ancestor
93206895|NCT02451826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206896|NCT02451826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206897|NCT02451826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93206898|NCT03224416|Ethanol|ethanol|mesh-list
93206899|NCT03224416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93206900|NCT03224416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206901|NCT03224416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206902|NCT03224416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206903|NCT01562561|Repaglinide|repaglinide|mesh-list
93206904|NCT01562561|Isophane Insulin, Human|isophane insulin, human|mesh-list
93206905|NCT01562561|Insulin, Isophane|insulin, isophane|mesh-list
93206906|NCT01562561|Isophane insulin, beef|isophane insulin, beef|mesh-list
93206907|NCT01562561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93206908|NCT01562561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206909|NCT03206944|Aspirin|aspirin|mesh-list
93206910|NCT03206944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206911|NCT03206944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93206912|NCT03206944|Analgesics|analgesics|mesh-ancestor
93206913|NCT03206944|Sensory System Agents|sensory system agents|mesh-ancestor
93206914|NCT03206944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206915|NCT03206944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206916|NCT03206944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206917|NCT03206944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206918|NCT03206944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93206919|NCT03206944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93206920|NCT03206944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206921|NCT03206944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93206922|NCT03206944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93206923|NCT03206944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206924|NCT03206944|Antipyretics|antipyretics|mesh-ancestor
93206925|NCT04454567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93206926|NCT04454567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93206927|NCT04454567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206928|NCT04454567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206929|NCT04454567|Antiviral Agents|antiviral agents|mesh-ancestor
93206930|NCT04454567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206931|NCT03206554|Ropivacaine|ropivacaine|mesh-list
93206932|NCT03206554|Anesthetics, Local|anesthetics, local|mesh-ancestor
93206933|NCT03206554|Anesthetics|anesthetics|mesh-ancestor
93206934|NCT03206554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93206935|NCT03206554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206936|NCT03206554|Sensory System Agents|sensory system agents|mesh-ancestor
93206937|NCT03206554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93206938|NCT03209206|Docetaxel|docetaxel|mesh-list
93206939|NCT03209206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206940|NCT03209206|Tubulin Modulators|tubulin modulators|mesh-ancestor
93206941|NCT03209206|Antimitotic Agents|antimitotic agents|mesh-ancestor
93206942|NCT03209206|Mitosis Modulators|mitosis modulators|mesh-ancestor
93206943|NCT03209206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206944|NCT03223402|Lamivudine|lamivudine|mesh-list
93206945|NCT03223402|Nevirapine|nevirapine|mesh-list
93206946|NCT03223402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93206947|NCT03223402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93206948|NCT03223402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206949|NCT03223402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206950|NCT03223402|Antiviral Agents|antiviral agents|mesh-ancestor
93206951|NCT03223402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206952|NCT03223402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93206953|NCT03223402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93206954|NCT03223402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93206955|NCT03223402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93206956|NCT03208972|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93206957|NCT03208972|Menotropins|menotropins|mesh-list
93206958|NCT03208972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206959|NCT03208972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206960|NCT03208972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93206961|NCT03208972|Fertility Agents|fertility agents|mesh-ancestor
93206962|NCT03206866|Antibodies|antibodies|mesh-list
93206963|NCT03206866|Immunologic Factors|immunologic factors|mesh-ancestor
93206964|NCT03206866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206965|NCT02451748|Hydroxychloroquine|hydroxychloroquine|mesh-list
93206966|NCT02451748|Sulfasalazine|sulfasalazine|mesh-list
93206967|NCT02451748|Prednisone|prednisone|mesh-list
93206968|NCT02451748|Triamcinolone|triamcinolone|mesh-list
93206969|NCT02451748|Naproxen|naproxen|mesh-list
93206970|NCT02451748|Certolizumab Pegol|certolizumab pegol|mesh-list
93206971|NCT02451748|Methotrexate|methotrexate|mesh-list
93206972|NCT02451748|Leflunomide|leflunomide|mesh-list
93206973|NCT02451748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93206974|NCT02451748|Glucocorticoids|glucocorticoids|mesh-ancestor
93206975|NCT02451748|Hormones|hormones|mesh-ancestor
93206976|NCT02451748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93206977|NCT02451748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93206978|NCT02451748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93206979|NCT02451748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93206980|NCT02451748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93206981|NCT02451748|Abortifacient Agents|abortifacient agents|mesh-ancestor
93206982|NCT02451748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93206983|NCT02451748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93206984|NCT02451748|Antimetabolites|antimetabolites|mesh-ancestor
93206985|NCT02451748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93206986|NCT02451748|Dermatologic Agents|dermatologic agents|mesh-ancestor
93206987|NCT02451748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93206988|NCT02451748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93206989|NCT02451748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93206990|NCT02451748|Immunologic Factors|immunologic factors|mesh-ancestor
93206991|NCT02451748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93206992|NCT02451748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93206993|NCT02451748|Antimalarials|antimalarials|mesh-ancestor
93206994|NCT02451748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93206995|NCT02451748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93206996|NCT02451748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93206997|NCT02451748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93206998|NCT02451748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93206999|NCT02451748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207000|NCT02451748|Analgesics|analgesics|mesh-ancestor
93207001|NCT02451748|Sensory System Agents|sensory system agents|mesh-ancestor
93207002|NCT02451748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207003|NCT02451748|Gout Suppressants|gout suppressants|mesh-ancestor
93207004|NCT02451748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93207005|NCT02451748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207006|NCT03208894|Furosemide|furosemide|mesh-list
93207007|NCT03208894|Diuretics|diuretics|mesh-ancestor
93207008|NCT03208894|Natriuretic Agents|natriuretic agents|mesh-ancestor
93207009|NCT03208894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207010|NCT03208894|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93207011|NCT03208894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207012|NCT03208894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207013|NCT02450656|Docetaxel|docetaxel|mesh-list
93207014|NCT02450656|Afatinib|afatinib|mesh-list
93207015|NCT02450656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207016|NCT02450656|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207017|NCT02450656|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207018|NCT02450656|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207019|NCT02450656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207020|NCT02450656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93207021|NCT02450656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207022|NCT03206320|Lidocaine|lidocaine|mesh-list
93207023|NCT03206320|Anesthetics, Local|anesthetics, local|mesh-ancestor
93207024|NCT03206320|Anesthetics|anesthetics|mesh-ancestor
93207025|NCT03206320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207026|NCT03206320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207027|NCT03206320|Sensory System Agents|sensory system agents|mesh-ancestor
93207028|NCT03206320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207029|NCT03206320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93207030|NCT03206320|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93207031|NCT03206320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93207032|NCT03206320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207033|NCT03206320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207034|NCT04448561|Morphine|morphine|mesh-list
93207035|NCT04448561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93207036|NCT04448561|Narcotics|narcotics|mesh-ancestor
93207037|NCT04448561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207038|NCT04448561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207039|NCT04448561|Analgesics|analgesics|mesh-ancestor
93207040|NCT04448561|Sensory System Agents|sensory system agents|mesh-ancestor
93207041|NCT04448561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207042|NCT03206008|Magnesium Sulfate|magnesium sulfate|mesh-list
93207043|NCT03206008|Analgesics|analgesics|mesh-ancestor
93207044|NCT03206008|Sensory System Agents|sensory system agents|mesh-ancestor
93207045|NCT03206008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207046|NCT03206008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207047|NCT03206008|Anesthetics|anesthetics|mesh-ancestor
93207048|NCT03206008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207049|NCT03206008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93207050|NCT03206008|Anticonvulsants|anticonvulsants|mesh-ancestor
93207051|NCT03206008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93207052|NCT03206008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207053|NCT03206008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207054|NCT03206008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93207055|NCT03206008|Tocolytic Agents|tocolytic agents|mesh-ancestor
93207056|NCT03206008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93207057|NCT04978259|Remdesivir|remdesivir|mesh-list
93207058|NCT04978259|Antimetabolites|antimetabolites|mesh-ancestor
93207059|NCT04978259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207060|NCT04978259|Antiviral Agents|antiviral agents|mesh-ancestor
93207061|NCT04978259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207062|NCT03208582|Risedronic Acid|risedronic acid|mesh-list
93207063|NCT03208582|Diphosphonates|diphosphonates|mesh-list
93207064|NCT03208582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93207065|NCT03208582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207066|NCT03208582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207067|NCT03208582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93207068|NCT03208582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207069|NCT03208582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93207070|NCT03200938|Zinc|zinc|mesh-list
93207071|NCT03200938|Zinc Oxide|zinc oxide|mesh-list
93207072|NCT03200938|Trace Elements|trace elements|mesh-ancestor
93207073|NCT03200938|Micronutrients|micronutrients|mesh-ancestor
93207074|NCT03200938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207075|NCT03200938|Dermatologic Agents|dermatologic agents|mesh-ancestor
93207076|NCT03200938|Sunscreening Agents|sunscreening agents|mesh-ancestor
93207077|NCT03200938|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93207078|NCT03200938|Protective Agents|protective agents|mesh-ancestor
93207079|NCT04297241|Isosorbide|isosorbide|mesh-list
93207080|NCT04297241|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93207081|NCT04297241|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93207082|NCT04297241|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93207083|NCT04297241|Diuretics|diuretics|mesh-ancestor
93207084|NCT04297241|Natriuretic Agents|natriuretic agents|mesh-ancestor
93207085|NCT04297241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207086|NCT04297241|Vasodilator Agents|vasodilator agents|mesh-ancestor
93207087|NCT04297241|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93207088|NCT04297241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207090|NCT04292171|Analgesics|analgesics|mesh-ancestor
93207091|NCT04292171|Sensory System Agents|sensory system agents|mesh-ancestor
93207092|NCT04292171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207093|NCT04292171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207094|NCT04292171|Anticonvulsants|anticonvulsants|mesh-ancestor
93207095|NCT04292171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93207096|NCT04292171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207097|NCT04292171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207098|NCT04292171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207099|NCT04292171|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93207100|NCT04292171|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93207101|NCT04292171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207102|NCT04292171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207103|NCT04292171|Antimanic Agents|antimanic agents|mesh-ancestor
93207104|NCT03200782|Empagliflozin|empagliflozin|mesh-list
93207105|NCT03200782|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93207106|NCT03200782|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93207107|NCT03200782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207108|NCT03200782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93207109|NCT03200782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207110|NCT03200782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207111|NCT02449954|Ketorolac|ketorolac|mesh-list
93207112|NCT02449954|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93207113|NCT02449954|Morphine|morphine|mesh-list
93207114|NCT02449954|Tramadol|tramadol|mesh-list
93207115|NCT02449954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93207116|NCT02449954|Narcotics|narcotics|mesh-ancestor
93207117|NCT02449954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207118|NCT02449954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207119|NCT02449954|Analgesics|analgesics|mesh-ancestor
93207120|NCT02449954|Sensory System Agents|sensory system agents|mesh-ancestor
93207121|NCT02449954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207122|NCT02449954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93207123|NCT02449954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207124|NCT02449954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207125|NCT02449954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207126|NCT02449954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93207127|NCT02449954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207128|NCT02449954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207129|NCT04393493|Chlorthalidone|chlorthalidone|mesh-list
93207130|NCT04393493|Furosemide|furosemide|mesh-list
93207131|NCT04393493|Spironolactone|spironolactone|mesh-list
93207132|NCT04393493|Diuretics|diuretics|mesh-ancestor
93207133|NCT04393493|Natriuretic Agents|natriuretic agents|mesh-ancestor
93207134|NCT04393493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207135|NCT04393493|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93207136|NCT04393493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207137|NCT04393493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207138|NCT04393493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93207139|NCT04393493|Hormone Antagonists|hormone antagonists|mesh-ancestor
93207140|NCT04393493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207141|NCT04393493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93207142|NCT04393493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93207143|NCT04393493|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93207144|NCT02448082|Ichthammol|ichthammol|mesh-list
93207145|NCT02448082|Dermatologic Agents|dermatologic agents|mesh-ancestor
93207146|NCT03205228|Flupenthixol|flupenthixol|mesh-list
93207147|NCT03205228|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
93207148|NCT03205228|Omeprazole|omeprazole|mesh-list
93207149|NCT03205228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93207150|NCT03205228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207151|NCT03205228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93207152|NCT03205228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207153|NCT03205228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207154|NCT03205228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93207155|NCT03205228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207156|NCT03205228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207157|NCT03205228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207158|NCT03205228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207159|NCT03205228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93207160|NCT03205228|Dopamine Agents|dopamine agents|mesh-ancestor
93207161|NCT03205228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207163|NCT03195946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93207164|NCT03195946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93207165|NCT03195946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207166|NCT03195946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207167|NCT03195946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93207168|NCT03195946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207169|NCT03195946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207170|NCT03195946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93207171|NCT03195946|Anesthetics, General|anesthetics, general|mesh-ancestor
93207172|NCT03195946|Anesthetics|anesthetics|mesh-ancestor
93207173|NCT03195946|GABA Modulators|gaba modulators|mesh-ancestor
93207174|NCT03195946|GABA Agents|gaba agents|mesh-ancestor
93207175|NCT03195946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207176|NCT03195946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207177|NCT03204760|Dexamethasone|dexamethasone|mesh-list
93207178|NCT03204760|Prednisolone|prednisolone|mesh-list
93207179|NCT03204760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207180|NCT03204760|Antiemetics|antiemetics|mesh-ancestor
93207181|NCT03204760|Autonomic Agents|autonomic agents|mesh-ancestor
93207182|NCT03204760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207183|NCT03204760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207184|NCT03204760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207185|NCT03204760|Glucocorticoids|glucocorticoids|mesh-ancestor
93207186|NCT03204760|Hormones|hormones|mesh-ancestor
93207187|NCT03204760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207188|NCT03204760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93207189|NCT03204760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207190|NCT03200392|Chromium|chromium|mesh-list
93207191|NCT03200392|Trace Elements|trace elements|mesh-ancestor
93207192|NCT03200392|Micronutrients|micronutrients|mesh-ancestor
93207193|NCT03200392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207194|NCT03200080|Amphetamine|amphetamine|mesh-list
93207195|NCT03200080|Dextroamphetamine|dextroamphetamine|mesh-list
93207196|NCT03200080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93207197|NCT03200080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207198|NCT03200080|Sympathomimetics|sympathomimetics|mesh-ancestor
93207199|NCT03200080|Autonomic Agents|autonomic agents|mesh-ancestor
93207200|NCT03200080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207201|NCT03200080|Dopamine Agents|dopamine agents|mesh-ancestor
93207202|NCT03200080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207203|NCT03200080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207204|NCT03200080|Adrenergic Agents|adrenergic agents|mesh-ancestor
93207205|NCT03200080|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93207206|NCT03200080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93207207|NCT03200080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207208|NCT03200080|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93207209|NCT03200236|Nicotine|nicotine|mesh-list
93207210|NCT03200236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93207211|NCT03200236|Autonomic Agents|autonomic agents|mesh-ancestor
93207212|NCT03200236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207213|NCT03200236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207214|NCT03200236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93207215|NCT03200236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93207216|NCT03200236|Cholinergic Agents|cholinergic agents|mesh-ancestor
93207217|NCT03200236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207218|NCT03200236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207219|NCT03200002|Mycophenolic Acid|mycophenolic acid|mesh-list
93207220|NCT03200002|Cyclophosphamide|cyclophosphamide|mesh-list
93207221|NCT03200002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93207222|NCT03200002|Immunologic Factors|immunologic factors|mesh-ancestor
93207223|NCT03200002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207224|NCT03200002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207225|NCT03200002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93207226|NCT03200002|Alkylating Agents|alkylating agents|mesh-ancestor
93207227|NCT03200002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207228|NCT03200002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207229|NCT03200002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93207230|NCT03200002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93207231|NCT03200002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93207232|NCT03200002|Antitubercular Agents|antitubercular agents|mesh-ancestor
93207233|NCT03200002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93207234|NCT03200002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207235|NCT03200002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207236|NCT02447380|Docetaxel|docetaxel|mesh-list
93207237|NCT02447380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207238|NCT02447380|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207239|NCT02447380|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207240|NCT02447380|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207241|NCT02447380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207242|NCT02447224|Metronidazole|metronidazole|mesh-list
93207243|NCT02447224|Ertapenem|ertapenem|mesh-list
93207244|NCT02447224|Cefdinir|cefdinir|mesh-list
93207245|NCT02447224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207246|NCT02447224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93207247|NCT02447224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93207248|NCT02447224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93207249|NCT03199690|Rifampin|rifampin|mesh-list
93207250|NCT03199690|Dolutegravir|dolutegravir|mesh-list
93207251|NCT03199690|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93207252|NCT03199690|Antitubercular Agents|antitubercular agents|mesh-ancestor
93207253|NCT03199690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93207254|NCT03199690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207255|NCT03199690|Leprostatic Agents|leprostatic agents|mesh-ancestor
93207256|NCT03199690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93207257|NCT03199690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207258|NCT03199690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207259|NCT03199690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93207260|NCT03199690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93207261|NCT03199690|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93207262|NCT03199690|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93207263|NCT03199690|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93207264|NCT03199690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93207265|NCT03199690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93207266|NCT03199690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93207267|NCT03199690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93207268|NCT03199690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93207269|NCT03199690|Antiviral Agents|antiviral agents|mesh-ancestor
93207270|NCT03204058|Metformin|metformin|mesh-list
93207271|NCT03204058|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93207272|NCT03204058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93207273|NCT03204058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207274|NCT03204058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93207275|NCT03204058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93207276|NCT03204058|Antimetabolites|antimetabolites|mesh-ancestor
93207277|NCT03204058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207278|NCT03204058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93207279|NCT03204058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93207280|NCT03204058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207281|NCT03203746|Lycopene|lycopene|mesh-list
93207282|NCT03203746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207283|NCT03203746|Antioxidants|antioxidants|mesh-ancestor
93207284|NCT03203746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207285|NCT03203746|Protective Agents|protective agents|mesh-ancestor
93207286|NCT03203746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207287|NCT03203746|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93207288|NCT03203746|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93207289|NCT03203746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207290|NCT03203668|Choline|choline|mesh-list
93207291|NCT03203668|Lipotropic Agents|lipotropic agents|mesh-ancestor
93207292|NCT03203668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93207293|NCT03203668|Antimetabolites|antimetabolites|mesh-ancestor
93207294|NCT03203668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207295|NCT03203668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207296|NCT03203668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93207297|NCT03203668|Nootropic Agents|nootropic agents|mesh-ancestor
93207298|NCT03199534|Botulinum Toxins|botulinum toxins|mesh-list
93207299|NCT03199534|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93207300|NCT03199534|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93207301|NCT03199534|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93207302|NCT03199534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207303|NCT03199534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207304|NCT03199534|Cholinergic Agents|cholinergic agents|mesh-ancestor
93207305|NCT03199534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207306|NCT03199534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207307|NCT03199534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93207308|NCT03199534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207309|NCT03203356|Hormones|hormones|mesh-list
93207310|NCT03203356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207311|NCT03203356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207312|NCT04280705|Remdesivir|remdesivir|mesh-list
93207313|NCT04280705|Antimetabolites|antimetabolites|mesh-ancestor
93207314|NCT04280705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207315|NCT04280705|Antiviral Agents|antiviral agents|mesh-ancestor
93207316|NCT04280705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207317|NCT03203590|Carboplatin|carboplatin|mesh-list
93207318|NCT03203590|Vinorelbine|vinorelbine|mesh-list
93207319|NCT03203590|Gefitinib|gefitinib|mesh-list
93207320|NCT03203590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207321|NCT03203590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93207322|NCT03203590|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207323|NCT03203590|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207324|NCT03203590|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207325|NCT03203590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207326|NCT03203590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93207327|NCT03203590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207328|NCT02077166|Rituximab|rituximab|mesh-list
93207329|NCT02077166|Lenalidomide|lenalidomide|mesh-list
93207330|NCT02077166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207331|NCT02077166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207332|NCT02077166|Immunologic Factors|immunologic factors|mesh-ancestor
93207333|NCT02077166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207334|NCT02077166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207335|NCT02077166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93207336|NCT02077166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93207337|NCT02077166|Growth Substances|growth substances|mesh-ancestor
93207338|NCT02077166|Growth Inhibitors|growth inhibitors|mesh-ancestor
93207339|NCT02450188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93207340|NCT02450188|Vasodilator Agents|vasodilator agents|mesh-ancestor
93207341|NCT02450188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93207342|NCT02450188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93207343|NCT02450188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207344|NCT02450188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207345|NCT02450188|Urological Agents|urological agents|mesh-ancestor
93207346|NCT03198676|Poly I-C|poly i-c|mesh-list
93207347|NCT03198676|Antiviral Agents|antiviral agents|mesh-ancestor
93207348|NCT03198676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207349|NCT03198676|Interferon Inducers|interferon inducers|mesh-ancestor
93207350|NCT03198676|Immunologic Factors|immunologic factors|mesh-ancestor
93207351|NCT03198676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207352|NCT04484506|Prednisone|prednisone|mesh-list
93207353|NCT04484506|Cyclophosphamide|cyclophosphamide|mesh-list
93207354|NCT04484506|Etoposide|etoposide|mesh-list
93207355|NCT04484506|Vincristine|vincristine|mesh-list
93207356|NCT04484506|Pegaspargase|pegaspargase|mesh-list
93207357|NCT04484506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93207358|NCT04484506|Immunologic Factors|immunologic factors|mesh-ancestor
93207359|NCT04484506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207360|NCT04484506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207361|NCT04484506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93207362|NCT04484506|Alkylating Agents|alkylating agents|mesh-ancestor
93207363|NCT04484506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207364|NCT04484506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207365|NCT04484506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93207366|NCT04484506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207367|NCT04484506|Glucocorticoids|glucocorticoids|mesh-ancestor
93207368|NCT04484506|Hormones|hormones|mesh-ancestor
93207369|NCT04484506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207370|NCT04484506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93207371|NCT04484506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93207372|NCT04484506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93207373|NCT04484506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93207374|NCT04484506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207375|NCT04484506|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207376|NCT04484506|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207377|NCT04484506|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207378|NCT04332653|Pembrolizumab|pembrolizumab|mesh-list
93207379|NCT04332653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207380|NCT04332653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207381|NCT04332653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93207382|NCT04332653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207383|NCT02449564|Sirolimus|sirolimus|mesh-list
93207384|NCT02449564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93207386|NCT02449564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93207387|NCT02449564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207388|NCT02449564|Antifungal Agents|antifungal agents|mesh-ancestor
93207389|NCT02449564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93207390|NCT02449564|Immunologic Factors|immunologic factors|mesh-ancestor
93207391|NCT02449564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207392|NCT02449720|Ropivacaine|ropivacaine|mesh-list
93207393|NCT02449720|Anesthetics, Local|anesthetics, local|mesh-ancestor
93207394|NCT02449720|Anesthetics|anesthetics|mesh-ancestor
93207395|NCT02449720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207396|NCT02449720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207397|NCT02449720|Sensory System Agents|sensory system agents|mesh-ancestor
93207398|NCT02449720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207399|NCT03194620|Proanthocyanidin|proanthocyanidin|mesh-list
93207400|NCT03194620|Epicatechin gallate|epicatechin gallate|mesh-list
93207401|NCT03194620|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93207402|NCT03194620|Procyanidin|procyanidin|mesh-list
93207403|NCT03194620|Theaflavin|theaflavin|mesh-list
93207404|NCT03194620|Antioxidants|antioxidants|mesh-ancestor
93207405|NCT03194620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207406|NCT03194620|Protective Agents|protective agents|mesh-ancestor
93207407|NCT03194620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207408|NCT03194620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93207409|NCT03194620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93207410|NCT03194620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207411|NCT03194620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93207412|NCT03194620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207413|NCT03194620|Protease Inhibitors|protease inhibitors|mesh-ancestor
93207414|NCT03194620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207415|NCT03194620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93207416|NCT03194620|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93207417|NCT03194620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93207418|NCT03194620|Chelating Agents|chelating agents|mesh-ancestor
93207419|NCT03194620|Sequestering Agents|sequestering agents|mesh-ancestor
93207420|NCT02445976|Seviteronel|seviteronel|mesh-list
93207421|NCT02445976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207422|NCT02445976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93207423|NCT02445976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207424|NCT02445976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207425|NCT03198442|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93207426|NCT03198442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93207427|NCT03198442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207428|NCT03198208|Fentanyl|fentanyl|mesh-list
93207429|NCT03198208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93207430|NCT03198208|Narcotics|narcotics|mesh-ancestor
93207431|NCT03198208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207432|NCT03198208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207433|NCT03198208|Analgesics|analgesics|mesh-ancestor
93207434|NCT03198208|Sensory System Agents|sensory system agents|mesh-ancestor
93207435|NCT03198208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207436|NCT03198208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93207437|NCT03198208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93207438|NCT03198208|Anesthetics, General|anesthetics, general|mesh-ancestor
93207439|NCT03198208|Anesthetics|anesthetics|mesh-ancestor
93207440|NCT01044056|Levonorgestrel|levonorgestrel|mesh-list
93207441|NCT01044056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93207442|NCT01044056|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93207443|NCT01044056|NuvaRing|nuvaring|mesh-list
93207444|NCT01044056|Contraceptive Agents|contraceptive agents|mesh-list
93207445|NCT01044056|Contraceptives, Oral|contraceptives, oral|mesh-list
93207446|NCT01044056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93207447|NCT01044056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93207448|NCT01044056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207449|NCT01044056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93207450|NCT01044056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93207451|NCT01044056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93207452|NCT01044056|Estrogens|estrogens|mesh-ancestor
93207453|NCT01044056|Hormones|hormones|mesh-ancestor
93207454|NCT01044056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207455|NCT01044056|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93207456|NCT01005056|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93207457|NCT01005056|Desogestrel|desogestrel|mesh-list
93207458|NCT01005056|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93207459|NCT01005056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93207460|NCT01005056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93207461|NCT01005056|Contraceptive Agents|contraceptive agents|mesh-ancestor
93207462|NCT01005056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93207463|NCT01005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207464|NCT01005056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93207465|NCT01005056|Estrogens|estrogens|mesh-ancestor
93207466|NCT01005056|Hormones|hormones|mesh-ancestor
93207467|NCT01005056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207468|NCT01005056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93207469|NCT01005056|Progestins|progestins|mesh-ancestor
93207470|NCT04796714|Aspirin|aspirin|mesh-list
93207471|NCT04796714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93207472|NCT04796714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207473|NCT04796714|Analgesics|analgesics|mesh-ancestor
93207474|NCT04796714|Sensory System Agents|sensory system agents|mesh-ancestor
93207475|NCT04796714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207476|NCT04796714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207477|NCT04796714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207478|NCT04796714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207479|NCT04796714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93207480|NCT04796714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93207481|NCT04796714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207482|NCT04796714|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93207483|NCT04796714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93207484|NCT04796714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207485|NCT04796714|Antipyretics|antipyretics|mesh-ancestor
93207486|NCT02445898|Methylprednisolone|methylprednisolone|mesh-list
93207487|NCT02445898|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93207488|NCT02445898|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93207489|NCT02445898|Prednisolone|prednisolone|mesh-list
93207490|NCT02445898|Prednisolone acetate|prednisolone acetate|mesh-list
93207491|NCT02445898|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93207492|NCT02445898|Prednisolone phosphate|prednisolone phosphate|mesh-list
93207493|NCT02445898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207494|NCT02445898|Antiemetics|antiemetics|mesh-ancestor
93207495|NCT02445898|Autonomic Agents|autonomic agents|mesh-ancestor
93207496|NCT02445898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207497|NCT02445898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207498|NCT02445898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207499|NCT02445898|Glucocorticoids|glucocorticoids|mesh-ancestor
93207500|NCT02445898|Hormones|hormones|mesh-ancestor
93207501|NCT02445898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207502|NCT02445898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93207503|NCT02445898|Protective Agents|protective agents|mesh-ancestor
93207504|NCT02445898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93207505|NCT02445898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207506|NCT02445820|Plasma-lyte 148|plasma-lyte 148|mesh-list
93207507|NCT02445820|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93207508|NCT02445820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93207509|NCT03198130|Cemiplimab|cemiplimab|mesh-list
93207510|NCT03198130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207511|NCT03198130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207512|NCT04238780|Fentanyl|fentanyl|mesh-list
93207513|NCT04238780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93207514|NCT04238780|Narcotics|narcotics|mesh-ancestor
93207515|NCT04238780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207516|NCT04238780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207517|NCT04238780|Analgesics|analgesics|mesh-ancestor
93207518|NCT04238780|Sensory System Agents|sensory system agents|mesh-ancestor
93207519|NCT04238780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207520|NCT04238780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93207521|NCT04238780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93207522|NCT04238780|Anesthetics, General|anesthetics, general|mesh-ancestor
93207523|NCT04238780|Anesthetics|anesthetics|mesh-ancestor
93207524|NCT00944216|Emollients|emollients|mesh-list
93207525|NCT00944216|Dermatologic Agents|dermatologic agents|mesh-ancestor
93207526|NCT04238663|Bevacizumab|bevacizumab|mesh-list
93207527|NCT04238663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207528|NCT04238663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207529|NCT04238663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93207530|NCT04238663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93207531|NCT04238663|Growth Substances|growth substances|mesh-ancestor
93207532|NCT04238663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207533|NCT04238663|Growth Inhibitors|growth inhibitors|mesh-ancestor
93207534|NCT00878462|Asenapine|asenapine|mesh-list
93207535|NCT00878462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93207536|NCT00878462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207537|NCT00878462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207538|NCT00878462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207539|NCT00878462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207540|NCT03197818|Budesonide|budesonide|mesh-list
93207541|NCT03197818|Formoterol Fumarate|formoterol fumarate|mesh-list
93207542|NCT03197818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207543|NCT03197818|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93207544|NCT03197818|Autonomic Agents|autonomic agents|mesh-ancestor
93207545|NCT03197818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207546|NCT03197818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207547|NCT03197818|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93207548|NCT03197818|Respiratory System Agents|respiratory system agents|mesh-ancestor
93207549|NCT03197818|Glucocorticoids|glucocorticoids|mesh-ancestor
93207550|NCT03197818|Hormones|hormones|mesh-ancestor
93207551|NCT03197818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207552|NCT03197818|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93207553|NCT03197818|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93207554|NCT03197818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93207555|NCT03197818|Adrenergic Agents|adrenergic agents|mesh-ancestor
93207556|NCT03197818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207557|NCT03197818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207558|NCT03442088|Apremilast|apremilast|mesh-list
93207559|NCT03442088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93207560|NCT03442088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207561|NCT03442088|Analgesics|analgesics|mesh-ancestor
93207562|NCT03442088|Sensory System Agents|sensory system agents|mesh-ancestor
93207563|NCT03442088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207564|NCT03442088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207565|NCT03442088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207566|NCT03442088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207567|NCT03442088|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93207568|NCT03442088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93207569|NCT03442088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207570|NCT03442088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207571|NCT01562405|Dexamethasone|dexamethasone|mesh-list
93207572|NCT01562405|Lenalidomide|lenalidomide|mesh-list
93207573|NCT01562405|Pomalidomide|pomalidomide|mesh-list
93207574|NCT01562405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207575|NCT01562405|Antiemetics|antiemetics|mesh-ancestor
93207576|NCT01562405|Autonomic Agents|autonomic agents|mesh-ancestor
93207577|NCT01562405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207578|NCT01562405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207579|NCT01562405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207580|NCT01562405|Glucocorticoids|glucocorticoids|mesh-ancestor
93207581|NCT01562405|Hormones|hormones|mesh-ancestor
93207582|NCT01562405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207583|NCT01562405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93207584|NCT01562405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207585|NCT01562405|Immunologic Factors|immunologic factors|mesh-ancestor
93207586|NCT01562405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93207587|NCT01562405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93207588|NCT01562405|Growth Substances|growth substances|mesh-ancestor
93207589|NCT01562405|Growth Inhibitors|growth inhibitors|mesh-ancestor
93207590|NCT03119194|Opicapone|opicapone|mesh-list
93207591|NCT03119194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93207592|NCT03119194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207593|NCT03119194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207594|NCT03119194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93207595|NCT03119194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93207596|NCT03107338|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93207597|NCT03107338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93207598|NCT03107338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207599|NCT03107338|Analgesics|analgesics|mesh-ancestor
93207600|NCT03107338|Sensory System Agents|sensory system agents|mesh-ancestor
93207601|NCT03107338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207602|NCT03107338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207603|NCT03107338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207604|NCT03107338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207605|NCT05581940|Bupivacaine|bupivacaine|mesh-list
93207606|NCT05581940|Anesthetics|anesthetics|mesh-list
93207607|NCT05581940|Anesthetics, Local|anesthetics, local|mesh-ancestor
93207608|NCT05581940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207609|NCT05581940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207610|NCT05581940|Sensory System Agents|sensory system agents|mesh-ancestor
93207611|NCT05581940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207612|NCT02445508|Cholecystokinin|cholecystokinin|mesh-list
93207613|NCT02445508|Sevelamer|sevelamer|mesh-list
93207614|NCT02445508|Chelating Agents|chelating agents|mesh-ancestor
93207615|NCT02445508|Sequestering Agents|sequestering agents|mesh-ancestor
93207616|NCT02445508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207617|NCT02445508|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93207618|NCT02445508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207619|NCT03197584|Leucovorin|leucovorin|mesh-list
93207620|NCT03197584|Cyclophosphamide|cyclophosphamide|mesh-list
93207621|NCT03197584|Bevacizumab|bevacizumab|mesh-list
93207622|NCT03197584|Fluorouracil|fluorouracil|mesh-list
93207623|NCT03197584|Capecitabine|capecitabine|mesh-list
93207624|NCT03197584|Oxaliplatin|oxaliplatin|mesh-list
93207625|NCT03197584|Fulvestrant|fulvestrant|mesh-list
93207626|NCT03197584|Avelumab|avelumab|mesh-list
93207627|NCT03197584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207628|NCT03197584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207629|NCT03197584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93207630|NCT03197584|Immunologic Factors|immunologic factors|mesh-ancestor
93207631|NCT03197584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207632|NCT03197584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207633|NCT03197584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93207634|NCT03197584|Alkylating Agents|alkylating agents|mesh-ancestor
93207635|NCT03197584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93207636|NCT03197584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207637|NCT03197584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93207638|NCT03197584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93207639|NCT03197584|Growth Substances|growth substances|mesh-ancestor
93207640|NCT03197584|Growth Inhibitors|growth inhibitors|mesh-ancestor
93207641|NCT03197584|Antimetabolites|antimetabolites|mesh-ancestor
93207642|NCT03197584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93207643|NCT03197584|Antidotes|antidotes|mesh-ancestor
93207644|NCT03197584|Protective Agents|protective agents|mesh-ancestor
93207645|NCT03197584|Vitamin B Complex|vitamin b complex|mesh-ancestor
93207646|NCT03197584|Vitamins|vitamins|mesh-ancestor
93207647|NCT03197584|Micronutrients|micronutrients|mesh-ancestor
93207648|NCT03197584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93207649|NCT03197584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93207650|NCT03197584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93207651|NCT03197584|Hormone Antagonists|hormone antagonists|mesh-ancestor
93207652|NCT03197584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207653|NCT03722576|Calcium|calcium|mesh-list
93207654|NCT03722576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93207655|NCT03722576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207656|NCT03416348|Ethanol|ethanol|mesh-list
93207657|NCT03416348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93207658|NCT03416348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207659|NCT03416348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207660|NCT03416348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207661|NCT03236012|Botulinum Toxins|botulinum toxins|mesh-list
93207662|NCT03236012|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93207663|NCT03236012|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93207664|NCT03236012|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93207665|NCT03236012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207666|NCT03236012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207667|NCT03236012|Cholinergic Agents|cholinergic agents|mesh-ancestor
93207668|NCT03236012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207669|NCT03236012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207670|NCT03236012|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93207671|NCT03236012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207672|NCT02449486|Ropivacaine|ropivacaine|mesh-list
93207673|NCT02449486|Anesthetics, Local|anesthetics, local|mesh-ancestor
93207674|NCT02449486|Anesthetics|anesthetics|mesh-ancestor
93207675|NCT02449486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207676|NCT02449486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207677|NCT02449486|Sensory System Agents|sensory system agents|mesh-ancestor
93207678|NCT02449486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207679|NCT03202186|Progesterone|progesterone|mesh-list
93207680|NCT03202186|Progestins|progestins|mesh-ancestor
93207681|NCT03202186|Hormones|hormones|mesh-ancestor
93207682|NCT03202186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207683|NCT03202186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207684|NCT03625076|Lidocaine|lidocaine|mesh-list
93207685|NCT03625076|Propofol|propofol|mesh-list
93207686|NCT03625076|Etomidate|etomidate|mesh-list
93207687|NCT03625076|Anesthetics, Local|anesthetics, local|mesh-ancestor
93207688|NCT03625076|Anesthetics|anesthetics|mesh-ancestor
93207689|NCT03625076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207690|NCT03625076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207691|NCT03625076|Sensory System Agents|sensory system agents|mesh-ancestor
93207692|NCT03625076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207693|NCT03625076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93207694|NCT03625076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93207695|NCT03625076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93207696|NCT03625076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207697|NCT03625076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207698|NCT03625076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93207699|NCT03625076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93207700|NCT03625076|Anesthetics, General|anesthetics, general|mesh-ancestor
93207701|NCT02445352|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93207702|NCT02445352|Ezetimibe|ezetimibe|mesh-list
93207703|NCT02445352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93207704|NCT02445352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93207705|NCT02445352|Antimetabolites|antimetabolites|mesh-ancestor
93207706|NCT02445352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207707|NCT02445352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93207708|NCT02445352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93207709|NCT02445352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207710|NCT03693989|Fluprednisolone|fluprednisolone|mesh-list
93207711|NCT03693989|Difluprednate|difluprednate|mesh-list
93207712|NCT03693989|Glucocorticoids|glucocorticoids|mesh-ancestor
93207713|NCT03693989|Hormones|hormones|mesh-ancestor
92503567|NCT02040220|Aflibercept|aflibercept|mesh-list
93207714|NCT03693989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207715|NCT03693989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207716|NCT03693989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207717|NCT04944212|Vitamin D|vitamin d|mesh-list
93207718|NCT04944212|Vitamins|vitamins|mesh-ancestor
93207719|NCT04944212|Micronutrients|micronutrients|mesh-ancestor
93207720|NCT04944212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207721|NCT04944212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93207722|NCT03197740|Donepezil|donepezil|mesh-list
93207723|NCT03197740|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93207724|NCT03197740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207725|NCT03197740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207726|NCT03197740|Cholinergic Agents|cholinergic agents|mesh-ancestor
93207727|NCT03197740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207728|NCT03197740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207729|NCT03197740|Nootropic Agents|nootropic agents|mesh-ancestor
93207730|NCT03201796|Levofloxacin|levofloxacin|mesh-list
93207731|NCT03201796|Prulifloxacin|prulifloxacin|mesh-list
93207732|NCT03201796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93207733|NCT03201796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207734|NCT03201796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93207735|NCT03201796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93207736|NCT03201796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93207737|NCT03201796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207738|NCT03201796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207739|NCT03201796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207740|NCT03201796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93207741|NCT03201796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93207742|NCT02727998|Midazolam|midazolam|mesh-list
93207743|NCT02727998|Ketamine|ketamine|mesh-list
93207744|NCT02727998|Analgesics|analgesics|mesh-ancestor
93207745|NCT02727998|Sensory System Agents|sensory system agents|mesh-ancestor
93207746|NCT02727998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207747|NCT02727998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207748|NCT02727998|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93207749|NCT02727998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93207750|NCT02727998|Anesthetics, General|anesthetics, general|mesh-ancestor
93207751|NCT02727998|Anesthetics|anesthetics|mesh-ancestor
93207752|NCT02727998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207753|NCT02727998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93207754|NCT02727998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93207755|NCT02727998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207756|NCT02727998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207757|NCT02727998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93207758|NCT02727998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93207759|NCT02727998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93207760|NCT02727998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207761|NCT02727998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207762|NCT02727998|GABA Modulators|gaba modulators|mesh-ancestor
93207763|NCT02727998|GABA Agents|gaba agents|mesh-ancestor
93207764|NCT02636270|Mecasermin|mecasermin|mesh-list
93207765|NCT02636270|Growth Substances|growth substances|mesh-ancestor
93207766|NCT02636270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207767|NCT02108990|Acetaminophen|acetaminophen|mesh-list
93207768|NCT02108990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207769|NCT02108990|Analgesics|analgesics|mesh-ancestor
93207770|NCT02108990|Sensory System Agents|sensory system agents|mesh-ancestor
93207771|NCT02108990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207772|NCT02108990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207773|NCT02108990|Antipyretics|antipyretics|mesh-ancestor
93207774|NCT03194074|Propofol|propofol|mesh-list
93207775|NCT03194074|Desflurane|desflurane|mesh-list
93207776|NCT03194074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93207777|NCT03194074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207778|NCT03194074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207779|NCT03194074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93207780|NCT03194074|Anesthetics, General|anesthetics, general|mesh-ancestor
93207781|NCT03194074|Anesthetics|anesthetics|mesh-ancestor
93207782|NCT03194074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93207783|NCT03201952|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93207784|NCT03201952|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93207785|NCT03201952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93207786|NCT04179461|Vitamin D|vitamin d|mesh-list
93207787|NCT04179461|Cholecalciferol|cholecalciferol|mesh-list
93207788|NCT04179461|Fluticasone|fluticasone|mesh-list
93207789|NCT04179461|Xhance|xhance|mesh-list
93207790|NCT04179461|Mometasone Furoate|mometasone furoate|mesh-list
93207791|NCT04179461|Cetirizine|cetirizine|mesh-list
93207792|NCT04179461|Loratadine|loratadine|mesh-list
93207793|NCT04179461|Azithromycin|azithromycin|mesh-list
93207794|NCT04179461|Budesonide|budesonide|mesh-list
93207795|NCT04179461|Beclomethasone|beclomethasone|mesh-list
93207796|NCT04179461|Emollients|emollients|mesh-list
93207797|NCT04179461|Formoterol Fumarate|formoterol fumarate|mesh-list
93207798|NCT04179461|Tiotropium Bromide|tiotropium bromide|mesh-list
93207799|NCT04179461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93207800|NCT04179461|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93207801|NCT04179461|Histamine Antagonists|histamine antagonists|mesh-list
93207802|NCT04179461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93207803|NCT04179461|Vitamins|vitamins|mesh-ancestor
93207804|NCT04179461|Micronutrients|micronutrients|mesh-ancestor
93207805|NCT04179461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207806|NCT04179461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93207807|NCT04179461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207808|NCT04179461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93207809|NCT04179461|Autonomic Agents|autonomic agents|mesh-ancestor
93207810|NCT04179461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207811|NCT04179461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93207812|NCT04179461|Respiratory System Agents|respiratory system agents|mesh-ancestor
93207813|NCT04179461|Dermatologic Agents|dermatologic agents|mesh-ancestor
93207814|NCT04179461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93207815|NCT04179461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93207816|NCT04179461|Glucocorticoids|glucocorticoids|mesh-ancestor
93207817|NCT04179461|Hormones|hormones|mesh-ancestor
93207818|NCT04179461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207819|NCT04179461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93207820|NCT04179461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207821|NCT04179461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93207822|NCT04179461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93207823|NCT04179461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93207824|NCT04179461|Adrenergic Agents|adrenergic agents|mesh-ancestor
93207825|NCT04179461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207826|NCT04179461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207827|NCT04179461|Parasympatholytics|parasympatholytics|mesh-ancestor
93207828|NCT04179461|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93207829|NCT04179461|Cholinergic Agents|cholinergic agents|mesh-ancestor
93207830|NCT04179461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93207831|NCT04179461|Histamine Agents|histamine agents|mesh-ancestor
93207832|NCT04179461|Antipruritics|antipruritics|mesh-ancestor
93207833|NCT04179461|Sympathomimetics|sympathomimetics|mesh-ancestor
93207834|NCT04844528|Niacinamide|niacinamide|mesh-list
92879900|NCT00960817|Antipyretics|antipyretics|mesh-ancestor
93207835|NCT04844528|Niacin|niacin|mesh-list
93207836|NCT04844528|Nicotinic Acids|nicotinic acids|mesh-list
93207837|NCT04844528|Vitamin B Complex|vitamin b complex|mesh-ancestor
93207838|NCT04844528|Vitamins|vitamins|mesh-ancestor
93207839|NCT04844528|Micronutrients|micronutrients|mesh-ancestor
93207840|NCT04844528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207841|NCT04844528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93207842|NCT04844528|Antimetabolites|antimetabolites|mesh-ancestor
93207843|NCT04844528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207844|NCT04844528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93207845|NCT04844528|Vasodilator Agents|vasodilator agents|mesh-ancestor
93207846|NCT03196882|Iron|iron|mesh-list
93207847|NCT03196882|Trace Elements|trace elements|mesh-ancestor
93207848|NCT03196882|Micronutrients|micronutrients|mesh-ancestor
93207849|NCT03196882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207850|NCT04172831|Cyclobenzaprine|cyclobenzaprine|mesh-list
93207851|NCT04172831|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93207852|NCT04172831|Antidepressive Agents|antidepressive agents|mesh-ancestor
93207853|NCT04172831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207854|NCT04172831|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93207855|NCT04172831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207856|NCT04172831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93207857|NCT04172831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207858|NCT04172831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207859|NCT04172831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207860|NCT01562717|Ibuprofen|ibuprofen|mesh-list
93207861|NCT01562717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93207862|NCT01562717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207863|NCT01562717|Analgesics|analgesics|mesh-ancestor
93207864|NCT01562717|Sensory System Agents|sensory system agents|mesh-ancestor
93207865|NCT01562717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207866|NCT01562717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207867|NCT01562717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207868|NCT01562717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207869|NCT01562717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93207870|NCT01562717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207871|NCT01562717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207872|NCT03196648|Fluorides|fluorides|mesh-list
93207873|NCT03196648|Antioxidants|antioxidants|mesh-list
93207874|NCT03196648|Cariostatic Agents|cariostatic agents|mesh-ancestor
93207875|NCT03196648|Protective Agents|protective agents|mesh-ancestor
93207876|NCT03196648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207877|NCT03196648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207878|NCT03625310|Listerine|listerine|mesh-list
93207879|NCT03625310|Fluorides|fluorides|mesh-list
93207880|NCT03625310|Sodium Fluoride|sodium fluoride|mesh-list
93207881|NCT03625310|Cariostatic Agents|cariostatic agents|mesh-ancestor
93207882|NCT03625310|Protective Agents|protective agents|mesh-ancestor
93207883|NCT03625310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207884|NCT03625310|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93207885|NCT03625310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93207886|NCT05058404|Prednisone|prednisone|mesh-list
93207887|NCT05058404|Rituximab|rituximab|mesh-list
93207888|NCT05058404|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93207889|NCT05058404|Cyclophosphamide|cyclophosphamide|mesh-list
93207890|NCT05058404|Vincristine|vincristine|mesh-list
93207891|NCT05058404|Doxorubicin|doxorubicin|mesh-list
93207892|NCT05058404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207893|NCT05058404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207894|NCT05058404|Immunologic Factors|immunologic factors|mesh-ancestor
93207895|NCT05058404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207896|NCT05058404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93207897|NCT05058404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93207898|NCT05058404|Alkylating Agents|alkylating agents|mesh-ancestor
93207899|NCT05058404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207900|NCT05058404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93207901|NCT05058404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93207902|NCT05058404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93207903|NCT05058404|Glucocorticoids|glucocorticoids|mesh-ancestor
93207904|NCT05058404|Hormones|hormones|mesh-ancestor
93207905|NCT05058404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93207906|NCT05058404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93207907|NCT05058404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93207908|NCT05058404|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207909|NCT05058404|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207910|NCT05058404|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207911|NCT05058404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93207912|NCT05058404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93207913|NCT05058404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93207914|NCT05058404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207915|NCT03118336|Empagliflozin|empagliflozin|mesh-list
93207916|NCT03118336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93207917|NCT03118336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207918|NCT03118336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93207919|NCT03118336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207920|NCT02444572|Enoxaparin|enoxaparin|mesh-list
93207921|NCT02444572|Anticoagulants|anticoagulants|mesh-ancestor
93207922|NCT02444572|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93207923|NCT02444572|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93207924|NCT02444572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207925|NCT04165031|Docetaxel|docetaxel|mesh-list
93207926|NCT04165031|Cetuximab|cetuximab|mesh-list
93207927|NCT04165031|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93207928|NCT04165031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207929|NCT04165031|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207930|NCT04165031|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207931|NCT04165031|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207932|NCT04165031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207933|NCT04165031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93207934|NCT04165031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93207935|NCT04165031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207936|NCT05480150|Dexetimide|dexetimide|mesh-list
93207937|NCT05480150|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93207938|NCT05480150|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93207939|NCT05480150|Citalopram|citalopram|mesh-list
93207940|NCT05480150|Escitalopram|escitalopram|mesh-list
93207941|NCT05480150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93207942|NCT05480150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93207943|NCT05480150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93207944|NCT05480150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207945|NCT05480150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93207946|NCT05480150|Serotonin Agents|serotonin agents|mesh-ancestor
93207947|NCT05480150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207948|NCT05480150|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93207949|NCT05480150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93207950|NCT05480150|Parasympatholytics|parasympatholytics|mesh-ancestor
93207951|NCT05480150|Autonomic Agents|autonomic agents|mesh-ancestor
93207952|NCT05480150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207953|NCT05480150|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93207954|NCT05480150|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93207955|NCT05480150|Cholinergic Agents|cholinergic agents|mesh-ancestor
93207956|NCT05480150|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93207957|NCT05480150|Antidepressive Agents|antidepressive agents|mesh-ancestor
93207958|NCT05480150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93207959|NCT05480150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93207960|NCT05480150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93207961|NCT05480150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207962|NCT05480150|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93207963|NCT05480150|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93207964|NCT05480150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93207965|NCT05480150|Adrenergic Agents|adrenergic agents|mesh-ancestor
93207966|NCT05480150|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93207967|NCT05480150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93207968|NCT05480150|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93207969|NCT05480150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93207970|NCT05480150|Dopamine Agents|dopamine agents|mesh-ancestor
93207971|NCT05464628|Atorvastatin|atorvastatin|mesh-list
93207972|NCT05464628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93207973|NCT05464628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93207974|NCT05464628|Antimetabolites|antimetabolites|mesh-ancestor
93207975|NCT05464628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207976|NCT05464628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93207977|NCT05464628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93207978|NCT05464628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93207979|NCT03193918|Paclitaxel|paclitaxel|mesh-list
93207980|NCT03193918|Ramucirumab|ramucirumab|mesh-list
93207981|NCT03193918|Crenolanib|crenolanib|mesh-list
93207982|NCT03193918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93207983|NCT03193918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93207984|NCT03193918|Tubulin Modulators|tubulin modulators|mesh-ancestor
93207985|NCT03193918|Antimitotic Agents|antimitotic agents|mesh-ancestor
93207986|NCT03193918|Mitosis Modulators|mitosis modulators|mesh-ancestor
93207987|NCT03193918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93207988|NCT03117790|Dexmedetomidine|dexmedetomidine|mesh-list
92880060|NCT02671058|Hydrocortisone|hydrocortisone|mesh-list
93207989|NCT03117790|Morphine|morphine|mesh-list
93207990|NCT03117790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93207991|NCT03117790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93207992|NCT03117790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93207993|NCT03117790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93207994|NCT03117790|Analgesics|analgesics|mesh-ancestor
93207995|NCT03117790|Sensory System Agents|sensory system agents|mesh-ancestor
93207996|NCT03117790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93207997|NCT03117790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93207998|NCT03117790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93207999|NCT03117790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93208000|NCT03117790|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208001|NCT03117790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208002|NCT03117790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208003|NCT03117790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93208004|NCT03117790|Narcotics|narcotics|mesh-ancestor
93208005|NCT03193372|Azelaic acid|azelaic acid|mesh-list
93208006|NCT03193372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208007|NCT03193372|Dermatologic Agents|dermatologic agents|mesh-ancestor
93208008|NCT03034772|Timolol|timolol|mesh-list
93208009|NCT03034772|Dorzolamide|dorzolamide|mesh-list
93208010|NCT03034772|Lubricant Eye Drops|lubricant eye drops|mesh-list
93208011|NCT03034772|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93208012|NCT03034772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93208013|NCT03034772|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208014|NCT03034772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208015|NCT03034772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208016|NCT03034772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208017|NCT03034772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93208018|NCT03034772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208019|NCT03034772|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93208020|NCT03034772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93208021|NCT03034772|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93208022|NCT03034772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208023|NCT03193606|Fluorides|fluorides|mesh-list
93208024|NCT03193606|Cariostatic Agents|cariostatic agents|mesh-ancestor
93208025|NCT03193606|Protective Agents|protective agents|mesh-ancestor
93208026|NCT03193606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208027|NCT02448784|Donepezil|donepezil|mesh-list
93208028|NCT02448784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93208029|NCT02448784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208030|NCT02448784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208031|NCT02448784|Cholinergic Agents|cholinergic agents|mesh-ancestor
93208032|NCT02448784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208033|NCT02448784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208034|NCT02448784|Nootropic Agents|nootropic agents|mesh-ancestor
93208035|NCT04050488|Zinc Sulfate|zinc sulfate|mesh-list
93208036|NCT04050488|Astringents|astringents|mesh-ancestor
93208037|NCT04050488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208038|NCT04050488|Dermatologic Agents|dermatologic agents|mesh-ancestor
93208039|NCT02449252|Prednisone|prednisone|mesh-list
93208040|NCT02449252|Cyclophosphamide|cyclophosphamide|mesh-list
93208041|NCT02449252|Doxorubicin|doxorubicin|mesh-list
93208042|NCT02449252|Vincristine|vincristine|mesh-list
93208043|NCT02449252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93208044|NCT02449252|Immunologic Factors|immunologic factors|mesh-ancestor
93208045|NCT02449252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208046|NCT02449252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208047|NCT02449252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93208048|NCT02449252|Alkylating Agents|alkylating agents|mesh-ancestor
93208049|NCT02449252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208050|NCT02449252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208051|NCT02449252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93208052|NCT02449252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93208053|NCT02449252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93208054|NCT02449252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93208055|NCT02449252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208056|NCT02449252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208057|NCT02449252|Glucocorticoids|glucocorticoids|mesh-ancestor
93208058|NCT02449252|Hormones|hormones|mesh-ancestor
93208059|NCT02449252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208060|NCT02449252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93208061|NCT02449252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93208062|NCT02449252|Tubulin Modulators|tubulin modulators|mesh-ancestor
93208063|NCT02449252|Antimitotic Agents|antimitotic agents|mesh-ancestor
93208064|NCT02449252|Mitosis Modulators|mitosis modulators|mesh-ancestor
93208066|NCT04779554|Mitomycin|mitomycin|mesh-list
93208067|NCT04779554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93208068|NCT04779554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208069|NCT04779554|Alkylating Agents|alkylating agents|mesh-ancestor
93208070|NCT04779554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208071|NCT04779554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93208072|NCT04779554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208073|NCT02444260|Lidocaine|lidocaine|mesh-list
93208074|NCT02444260|Midazolam|midazolam|mesh-list
93208075|NCT02444260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93208076|NCT02444260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93208077|NCT02444260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208078|NCT02444260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208079|NCT02444260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93208080|NCT02444260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93208081|NCT02444260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93208082|NCT02444260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93208083|NCT02444260|Anesthetics, General|anesthetics, general|mesh-ancestor
93208084|NCT02444260|Anesthetics|anesthetics|mesh-ancestor
93208085|NCT02444260|GABA Modulators|gaba modulators|mesh-ancestor
93208086|NCT02444260|GABA Agents|gaba agents|mesh-ancestor
93208087|NCT02444260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208088|NCT02444260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208089|NCT02444260|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208090|NCT02444260|Sensory System Agents|sensory system agents|mesh-ancestor
93208091|NCT02444260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208092|NCT02444260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93208093|NCT02444260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93208094|NCT02444260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93208095|NCT02444260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208096|NCT03195634|Carvedilol|carvedilol|mesh-list
93208097|NCT03195634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93208098|NCT03195634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93208099|NCT03195634|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208100|NCT03195634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208101|NCT03195634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208102|NCT03195634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208103|NCT03195634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208104|NCT03195634|Antioxidants|antioxidants|mesh-ancestor
93208105|NCT03195634|Protective Agents|protective agents|mesh-ancestor
93208106|NCT03195634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93208107|NCT03195634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208108|NCT03195634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93208109|NCT03195634|Vasodilator Agents|vasodilator agents|mesh-ancestor
93208110|NCT03195634|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93208111|NCT03195634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93208112|NCT02448550|Heparin|heparin|mesh-list
93208113|NCT02448550|Calcium heparin|calcium heparin|mesh-list
93208114|NCT02448550|Bivalirudin|bivalirudin|mesh-list
93208115|NCT02448550|Anticoagulants|anticoagulants|mesh-ancestor
93208116|NCT02448550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93208117|NCT02448550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93208118|NCT02448550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208119|NCT02448550|Antithrombins|antithrombins|mesh-ancestor
93208120|NCT02448550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93208121|NCT02448550|Protease Inhibitors|protease inhibitors|mesh-ancestor
93208122|NCT02448550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208123|NCT03701750|Heparin|heparin|mesh-list
93208124|NCT03701750|Enoxaparin|enoxaparin|mesh-list
93208125|NCT03701750|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93208126|NCT03701750|Tinzaparin|tinzaparin|mesh-list
93208127|NCT03701750|Dalteparin|dalteparin|mesh-list
93208128|NCT03701750|Enoxaparin sodium|enoxaparin sodium|mesh-list
93208129|NCT03701750|Anticoagulants|anticoagulants|mesh-ancestor
93208130|NCT03701750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93208131|NCT03701750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93208132|NCT03701750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208133|NCT03704246|Antibodies|antibodies|mesh-list
93208134|NCT03704246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93208135|NCT03704246|Immunologic Factors|immunologic factors|mesh-ancestor
93208136|NCT03704246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208137|NCT05239910|Tenalisib|tenalisib|mesh-list
93208138|NCT05239910|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93208139|NCT05239910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208140|NCT05239910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208142|NCT03701672|Analgesics|analgesics|mesh-list
93208143|NCT03701672|Narcotics|narcotics|mesh-ancestor
93208144|NCT03701672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208145|NCT03701672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208146|NCT03701672|Sensory System Agents|sensory system agents|mesh-ancestor
93208147|NCT03701672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208148|NCT03624530|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93208149|NCT03624530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93208150|NCT03624530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208151|NCT03624530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208152|NCT03746327|Tedizolid phosphate|tedizolid phosphate|mesh-list
93208153|NCT03746327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93208154|NCT03746327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208155|NCT03746249|Lenvatinib|lenvatinib|mesh-list
93208156|NCT03746249|Antibodies|antibodies|mesh-list
93208157|NCT03746249|Immunoglobulins|immunoglobulins|mesh-list
93208158|NCT03746249|Immunologic Factors|immunologic factors|mesh-ancestor
93208159|NCT03746249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208160|NCT03746249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208161|NCT03746249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93208162|NCT03746249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208163|NCT03746249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208164|NCT03698474|Ascorbic Acid|ascorbic acid|mesh-list
93208165|NCT03698474|Magnesium Sulfate|magnesium sulfate|mesh-list
93208166|NCT03698474|Magnesium citrate|magnesium citrate|mesh-list
93208167|NCT03698474|Picosulfate sodium|picosulfate sodium|mesh-list
93208168|NCT03698474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208169|NCT03698474|Analgesics|analgesics|mesh-ancestor
93208170|NCT03698474|Sensory System Agents|sensory system agents|mesh-ancestor
93208171|NCT03698474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208172|NCT03698474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208173|NCT03698474|Anesthetics|anesthetics|mesh-ancestor
93208174|NCT03698474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208175|NCT03698474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93208176|NCT03698474|Anticonvulsants|anticonvulsants|mesh-ancestor
93208177|NCT03698474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93208178|NCT03698474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208179|NCT03698474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93208180|NCT03698474|Tocolytic Agents|tocolytic agents|mesh-ancestor
93208181|NCT03698474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93208182|NCT03698474|Antioxidants|antioxidants|mesh-ancestor
93208183|NCT03698474|Protective Agents|protective agents|mesh-ancestor
93208184|NCT03698474|Vitamins|vitamins|mesh-ancestor
93208185|NCT03698474|Micronutrients|micronutrients|mesh-ancestor
93208186|NCT03698474|Cathartics|cathartics|mesh-ancestor
93208187|NCT03698474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93208188|NCT04709276|Carboplatin|carboplatin|mesh-list
93208189|NCT04709276|Nivolumab|nivolumab|mesh-list
93208190|NCT04709276|Ipilimumab|ipilimumab|mesh-list
93208191|NCT04709276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208192|NCT04709276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93208193|NCT04709276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93208194|NCT04709276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208195|NCT01194622|Fluticasone|fluticasone|mesh-list
93208196|NCT01194622|Xhance|xhance|mesh-list
93208197|NCT01194622|Azelastine|azelastine|mesh-list
93208198|NCT01194622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208199|NCT01194622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93208200|NCT01194622|Autonomic Agents|autonomic agents|mesh-ancestor
93208201|NCT01194622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208202|NCT01194622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208203|NCT01194622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93208204|NCT01194622|Respiratory System Agents|respiratory system agents|mesh-ancestor
93208205|NCT01194622|Dermatologic Agents|dermatologic agents|mesh-ancestor
93208206|NCT01194622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93208207|NCT01194622|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93208208|NCT01194622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208209|NCT01194622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208210|NCT01194622|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93208211|NCT01194622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93208212|NCT01194622|Histamine Antagonists|histamine antagonists|mesh-ancestor
93208213|NCT01194622|Histamine Agents|histamine agents|mesh-ancestor
93208214|NCT01194622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208215|NCT02448316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93208216|NCT02448316|Methylprednisolone|methylprednisolone|mesh-list
93208217|NCT02448316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93208218|NCT02448316|Prednisolone|prednisolone|mesh-list
93208219|NCT02448316|Prednisolone acetate|prednisolone acetate|mesh-list
93208220|NCT02448316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93208221|NCT02448316|Prednisolone phosphate|prednisolone phosphate|mesh-list
93208222|NCT02448316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208223|NCT02448316|Antiemetics|antiemetics|mesh-ancestor
93208224|NCT02448316|Autonomic Agents|autonomic agents|mesh-ancestor
93208225|NCT02448316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208226|NCT02448316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208227|NCT02448316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93208228|NCT02448316|Glucocorticoids|glucocorticoids|mesh-ancestor
93208229|NCT02448316|Hormones|hormones|mesh-ancestor
93208230|NCT02448316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208231|NCT02448316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93208232|NCT02448316|Protective Agents|protective agents|mesh-ancestor
93208233|NCT02448316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93208234|NCT02448316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208235|NCT04564898|Trifluridine|trifluridine|mesh-list
93208236|NCT04564898|Bevacizumab|bevacizumab|mesh-list
93208237|NCT04564898|Capecitabine|capecitabine|mesh-list
93208238|NCT04564898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93208239|NCT04564898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208240|NCT04564898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93208241|NCT04564898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93208242|NCT04564898|Growth Substances|growth substances|mesh-ancestor
93208243|NCT04564898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208244|NCT04564898|Growth Inhibitors|growth inhibitors|mesh-ancestor
93208245|NCT04564898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93208246|NCT04564898|Antimetabolites|antimetabolites|mesh-ancestor
93208247|NCT04564898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208248|NCT04564898|Antiviral Agents|antiviral agents|mesh-ancestor
93208249|NCT04564898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208250|NCT02443714|Insulin|insulin|mesh-list
93208251|NCT02443714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93208252|NCT02443714|Insulin Lispro|insulin lispro|mesh-list
93208253|NCT02443714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93208254|NCT02443714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208255|NCT03703310|Veratrum Alkaloids|veratrum alkaloids|mesh-list
93208256|NCT03703310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208257|NCT03703154|Tacrolimus|tacrolimus|mesh-list
93208258|NCT03703154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93208259|NCT03703154|Immunologic Factors|immunologic factors|mesh-ancestor
93208260|NCT03703154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208261|NCT03703154|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93208262|NCT03703154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208263|NCT03703154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208264|NCT02434276|Hemagglutinins|hemagglutinins|mesh-list
93208265|NCT02434276|Immunologic Factors|immunologic factors|mesh-ancestor
93208266|NCT02434276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208267|NCT02434276|Agglutinins|agglutinins|mesh-ancestor
93208268|NCT02434276|Coagulants|coagulants|mesh-ancestor
93208269|NCT03190642|Methylprednisolone|methylprednisolone|mesh-list
93208270|NCT03190642|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93208271|NCT03190642|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93208272|NCT03190642|Prednisolone|prednisolone|mesh-list
93208273|NCT03190642|Prednisolone acetate|prednisolone acetate|mesh-list
93208274|NCT03190642|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93208275|NCT03190642|Prednisolone phosphate|prednisolone phosphate|mesh-list
93208276|NCT03190642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208277|NCT03190642|Antiemetics|antiemetics|mesh-ancestor
93208278|NCT03190642|Autonomic Agents|autonomic agents|mesh-ancestor
93208279|NCT03190642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208280|NCT03190642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208281|NCT03190642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93208282|NCT03190642|Glucocorticoids|glucocorticoids|mesh-ancestor
93208283|NCT03190642|Hormones|hormones|mesh-ancestor
93208284|NCT03190642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208285|NCT03190642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93208286|NCT03190642|Protective Agents|protective agents|mesh-ancestor
93208287|NCT03190642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93208288|NCT03190642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208289|NCT03702530|Albendazole|albendazole|mesh-list
93208290|NCT03702530|Anthelmintics|anthelmintics|mesh-ancestor
93208291|NCT03702530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93208292|NCT03702530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208293|NCT03702530|Anticestodal Agents|anticestodal agents|mesh-ancestor
93208294|NCT03702530|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93208295|NCT03702530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93208296|NCT03702530|Tubulin Modulators|tubulin modulators|mesh-ancestor
93208297|NCT03702530|Antimitotic Agents|antimitotic agents|mesh-ancestor
93208298|NCT03702530|Mitosis Modulators|mitosis modulators|mesh-ancestor
93208299|NCT03702530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208300|NCT03702530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208301|NCT02443246|Vitamin D|vitamin d|mesh-list
93208302|NCT02443246|Cholecalciferol|cholecalciferol|mesh-list
93208303|NCT02443246|Vitamins|vitamins|mesh-ancestor
93208304|NCT02443246|Micronutrients|micronutrients|mesh-ancestor
93208305|NCT02443246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208306|NCT02443246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93208307|NCT02443246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93208308|NCT03031496|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93208309|NCT03031496|Amiloride|amiloride|mesh-list
93208310|NCT03031496|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
93208311|NCT03031496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208312|NCT03031496|Diuretics|diuretics|mesh-ancestor
93208313|NCT03031496|Natriuretic Agents|natriuretic agents|mesh-ancestor
93208314|NCT03031496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504167|NCT02044952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208315|NCT03031496|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93208316|NCT03031496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208317|NCT03031496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208318|NCT03031496|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93208319|NCT03031496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93208320|NCT03031496|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93208321|NCT03031496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93208322|NCT03187912|Riboflavin|riboflavin|mesh-list
93208323|NCT03187912|Vitamin B Complex|vitamin b complex|mesh-ancestor
93208324|NCT03187912|Vitamins|vitamins|mesh-ancestor
93208325|NCT03187912|Micronutrients|micronutrients|mesh-ancestor
93208326|NCT03187912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208327|NCT03187912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93208328|NCT03187912|Dermatologic Agents|dermatologic agents|mesh-ancestor
93208329|NCT02443012|Nepafenac|nepafenac|mesh-list
93208330|NCT02443012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208331|NCT02443012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208332|NCT02443012|Analgesics|analgesics|mesh-ancestor
93208333|NCT02443012|Sensory System Agents|sensory system agents|mesh-ancestor
93208334|NCT02443012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208335|NCT02443012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208336|NCT02443012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208337|NCT02443012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208338|NCT04670432|Troxerutin|troxerutin|mesh-list
93208339|NCT04670432|Anticoagulants|anticoagulants|mesh-ancestor
93208340|NCT03701126|Bupivacaine|bupivacaine|mesh-list
93208341|NCT03701126|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208342|NCT03701126|Anesthetics|anesthetics|mesh-ancestor
93208343|NCT03701126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208344|NCT03701126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208345|NCT03701126|Sensory System Agents|sensory system agents|mesh-ancestor
93208346|NCT03701126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208347|NCT03702140|Teriparatide|teriparatide|mesh-list
93208348|NCT03702140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93208349|NCT03702140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208350|NCT03702140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93208351|NCT03700814|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93208352|NCT03700814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93208353|NCT03700814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208354|NCT03700814|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93208355|NCT03700814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208356|NCT03700814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208357|NCT02433808|Neostigmine|neostigmine|mesh-list
93208358|NCT02433808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93208359|NCT02433808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208360|NCT02433808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208361|NCT02433808|Cholinergic Agents|cholinergic agents|mesh-ancestor
93208362|NCT02433808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208363|NCT02433808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208364|NCT02433808|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93208365|NCT02433808|Autonomic Agents|autonomic agents|mesh-ancestor
93208366|NCT02433808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208367|NCT03701984|Lidocaine|lidocaine|mesh-list
93208369|NCT03701984|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208370|NCT03701984|Anesthetics|anesthetics|mesh-ancestor
93208371|NCT03701984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208372|NCT03701984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208373|NCT03701984|Sensory System Agents|sensory system agents|mesh-ancestor
93208374|NCT03701984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208375|NCT03701984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93208376|NCT03701984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93208377|NCT03701984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93208378|NCT03701984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208379|NCT03701984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208380|NCT03701984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93208381|NCT03701984|Narcotics|narcotics|mesh-ancestor
93208382|NCT03701984|Analgesics|analgesics|mesh-ancestor
93208383|NCT04651400|Antithrombins|antithrombins|mesh-list
93208384|NCT04651400|Antithrombin III|antithrombin iii|mesh-list
93208385|NCT04651400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93208386|NCT04651400|Protease Inhibitors|protease inhibitors|mesh-ancestor
93208387|NCT04651400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928478|NCT02403687|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208388|NCT04651400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208389|NCT04651400|Anticoagulants|anticoagulants|mesh-ancestor
93208390|NCT02439190|Aspirin|aspirin|mesh-list
93208391|NCT02439190|Clopidogrel|clopidogrel|mesh-list
93208392|NCT02439190|BMS-986120|bms-986120|mesh-list
93208393|NCT02439190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208394|NCT02439190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208395|NCT02439190|Analgesics|analgesics|mesh-ancestor
93208396|NCT02439190|Sensory System Agents|sensory system agents|mesh-ancestor
93208397|NCT02439190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208398|NCT02439190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208399|NCT02439190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208400|NCT02439190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208401|NCT02439190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93208402|NCT02439190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93208403|NCT02439190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208404|NCT02439190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93208405|NCT02439190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93208406|NCT02439190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208407|NCT02439190|Antipyretics|antipyretics|mesh-ancestor
93208408|NCT02439190|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93208409|NCT02439190|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93208410|NCT02439190|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93208411|NCT02439190|Purinergic Agents|purinergic agents|mesh-ancestor
93208412|NCT02439190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208413|NCT02442466|BQ 788|bq 788|mesh-list
93208414|NCT02442466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208415|NCT02442466|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93208416|NCT02442466|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93208417|NCT02442466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208418|NCT02439034|Acetaminophen|acetaminophen|mesh-list
93208419|NCT02439034|Ketoprofen|ketoprofen|mesh-list
93208420|NCT02439034|Codeine|codeine|mesh-list
93208421|NCT02439034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208422|NCT02439034|Analgesics|analgesics|mesh-ancestor
93208423|NCT02439034|Sensory System Agents|sensory system agents|mesh-ancestor
93208424|NCT02439034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208425|NCT02439034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208426|NCT02439034|Antipyretics|antipyretics|mesh-ancestor
93208427|NCT02439034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208428|NCT02439034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208429|NCT02439034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208430|NCT02439034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93208431|NCT02439034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208432|NCT02439034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208433|NCT02439034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93208434|NCT02439034|Narcotics|narcotics|mesh-ancestor
93208435|NCT02439034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208436|NCT02439034|Antitussive Agents|antitussive agents|mesh-ancestor
93208437|NCT02439034|Respiratory System Agents|respiratory system agents|mesh-ancestor
93208438|NCT04483492|Caffeine|caffeine|mesh-list
93208439|NCT04483492|Caffeine citrate|caffeine citrate|mesh-list
93208440|NCT04483492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208441|NCT04483492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93208442|NCT04483492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208443|NCT04483492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93208444|NCT04483492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208445|NCT04483492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93208446|NCT04483492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93208447|NCT04483492|Purinergic Agents|purinergic agents|mesh-ancestor
93208448|NCT04483492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208449|NCT03186742|Eplerenone|eplerenone|mesh-list
93208450|NCT03186742|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93208451|NCT03186742|Hormone Antagonists|hormone antagonists|mesh-ancestor
93208452|NCT03186742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208453|NCT03186742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208454|NCT03186742|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93208455|NCT03186742|Diuretics|diuretics|mesh-ancestor
93208456|NCT03186742|Natriuretic Agents|natriuretic agents|mesh-ancestor
93208457|NCT03186742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208458|NCT03186664|Nabiximols|nabiximols|mesh-list
93208459|NCT03186664|Analgesics|analgesics|mesh-ancestor
93208460|NCT03186664|Sensory System Agents|sensory system agents|mesh-ancestor
93208461|NCT03186664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208462|NCT03186664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208463|NCT02441842|Atenolol|atenolol|mesh-list
93208464|NCT02441842|Lisinopril|lisinopril|mesh-list
93208465|NCT02441842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93208466|NCT02441842|Protease Inhibitors|protease inhibitors|mesh-ancestor
93208467|NCT02441842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208468|NCT02441842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208469|NCT02441842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208470|NCT02441842|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93208471|NCT02441842|Protective Agents|protective agents|mesh-ancestor
93208472|NCT02441842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208473|NCT02441842|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93208474|NCT02441842|Sympatholytics|sympatholytics|mesh-ancestor
93208475|NCT02441842|Autonomic Agents|autonomic agents|mesh-ancestor
93208476|NCT02441842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208477|NCT02441842|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93208478|NCT02441842|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93208479|NCT02441842|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93208480|NCT02441842|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208481|NCT02441842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208482|NCT02438566|Tranexamic Acid|tranexamic acid|mesh-list
93208483|NCT02438566|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93208484|NCT02438566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93208485|NCT02438566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208486|NCT02438566|Hemostatics|hemostatics|mesh-ancestor
93208487|NCT02438566|Coagulants|coagulants|mesh-ancestor
93208488|NCT02433652|Vaccines|vaccines|mesh-list
93208489|NCT02433652|Immunologic Factors|immunologic factors|mesh-ancestor
93208490|NCT02433652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208491|NCT03186586|Ulipristal acetate|ulipristal acetate|mesh-list
93208492|NCT03186586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93208493|NCT03186586|Contraceptive Agents|contraceptive agents|mesh-ancestor
93208494|NCT03186586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93208495|NCT03186586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208496|NCT03186586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93208497|NCT02433418|Diclofenac|diclofenac|mesh-list
93208498|NCT02433418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208499|NCT02433418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208500|NCT02433418|Analgesics|analgesics|mesh-ancestor
93208501|NCT02433418|Sensory System Agents|sensory system agents|mesh-ancestor
93208502|NCT02433418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208503|NCT02433418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208504|NCT02433418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208505|NCT02433418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208506|NCT02433418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93208507|NCT02433418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208508|NCT02433418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208509|NCT02433730|Testosterone|testosterone|mesh-list
93208510|NCT02433730|Androgens|androgens|mesh-ancestor
93208511|NCT02433730|Hormones|hormones|mesh-ancestor
93208512|NCT02433730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208513|NCT02433730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208514|NCT02438098|Rivaroxaban|rivaroxaban|mesh-list
93208515|NCT02438098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92880572|NCT00660582|Cetuximab|cetuximab|mesh-list
93208516|NCT02438098|Antithrombins|antithrombins|mesh-ancestor
93208517|NCT02438098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93208518|NCT02438098|Protease Inhibitors|protease inhibitors|mesh-ancestor
93208519|NCT02438098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208520|NCT02438098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208521|NCT02438098|Anticoagulants|anticoagulants|mesh-ancestor
93208522|NCT02441530|Vitamin D|vitamin d|mesh-list
93208523|NCT02441530|Vitamins|vitamins|mesh-list
93208524|NCT02441530|Vitamin E|vitamin e|mesh-list
93208525|NCT02441530|Ibuprofen|ibuprofen|mesh-list
93208526|NCT02441530|Micronutrients|micronutrients|mesh-ancestor
93208527|NCT02441530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208528|NCT02441530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93208529|NCT02441530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208530|NCT02441530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208531|NCT02441530|Analgesics|analgesics|mesh-ancestor
93208532|NCT02441530|Sensory System Agents|sensory system agents|mesh-ancestor
93208533|NCT02441530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208534|NCT02441530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208535|NCT02441530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504405|NCT02046460|Aspirin|aspirin|mesh-list
93208536|NCT02441530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93208537|NCT02441530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208538|NCT02441530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208539|NCT02441530|Antioxidants|antioxidants|mesh-ancestor
93208540|NCT02441530|Protective Agents|protective agents|mesh-ancestor
93208541|NCT02433184|Hydroxychloroquine|hydroxychloroquine|mesh-list
93208542|NCT02433184|Sulfasalazine|sulfasalazine|mesh-list
93208543|NCT02433184|Etanercept|etanercept|mesh-list
93208544|NCT02433184|Methotrexate|methotrexate|mesh-list
93208545|NCT02433184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93208546|NCT02433184|Abortifacient Agents|abortifacient agents|mesh-ancestor
93208547|NCT02433184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93208548|NCT02433184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208549|NCT02433184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93208550|NCT02433184|Antimetabolites|antimetabolites|mesh-ancestor
93208551|NCT02433184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208552|NCT02433184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208553|NCT02433184|Dermatologic Agents|dermatologic agents|mesh-ancestor
93208554|NCT02433184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208555|NCT02433184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93208556|NCT02433184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93208557|NCT02433184|Immunologic Factors|immunologic factors|mesh-ancestor
93208558|NCT02433184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208559|NCT02433184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93208560|NCT02433184|Antimalarials|antimalarials|mesh-ancestor
93208561|NCT02433184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93208562|NCT02433184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93208563|NCT02433184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208564|NCT02433184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208565|NCT02433184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208566|NCT02433184|Analgesics|analgesics|mesh-ancestor
93208567|NCT02433184|Sensory System Agents|sensory system agents|mesh-ancestor
93208568|NCT02433184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208569|NCT02433184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208570|NCT02433184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93208571|NCT02438020|Metformin|metformin|mesh-list
93208572|NCT02438020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93208573|NCT02438020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208574|NCT02440750|Dienogest|dienogest|mesh-list
93208575|NCT02440750|Ulipristal acetate|ulipristal acetate|mesh-list
93208576|NCT02440750|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93208577|NCT02440750|Contraceptive Agents|contraceptive agents|mesh-ancestor
93208578|NCT02440750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93208579|NCT02440750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208580|NCT02440750|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93208581|NCT02440750|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93208582|NCT02440750|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93208583|NCT02440750|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93208584|NCT02440750|Hormone Antagonists|hormone antagonists|mesh-ancestor
93208585|NCT02440750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208586|NCT02440750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93208587|NCT02440750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208588|NCT03186352|Anti-Infective Agents|anti-infective agents|mesh-list
93208589|NCT03186352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93208590|NCT02432872|Cytarabine|cytarabine|mesh-list
93208591|NCT02432872|Daunorubicin|daunorubicin|mesh-list
93208592|NCT02432872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93208593|NCT02432872|Antimetabolites|antimetabolites|mesh-ancestor
93208594|NCT02432872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208595|NCT02432872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208596|NCT02432872|Antiviral Agents|antiviral agents|mesh-ancestor
93208597|NCT02432872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208598|NCT02432872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93208599|NCT02432872|Immunologic Factors|immunologic factors|mesh-ancestor
93208600|NCT02432872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208601|NCT02432872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93208602|NCT02432872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93208603|NCT02432872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93208604|NCT02432872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208605|NCT02436928|Vaccines|vaccines|mesh-list
93208606|NCT02436928|Immunologic Factors|immunologic factors|mesh-ancestor
93208607|NCT02436928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208608|NCT02436538|Hormones|hormones|mesh-list
93208609|NCT02436538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208610|NCT02436538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208611|NCT02436694|Dexamethasone|dexamethasone|mesh-list
93208612|NCT02436694|Dexamethasone acetate|dexamethasone acetate|mesh-list
93208613|NCT02436694|Ropivacaine|ropivacaine|mesh-list
93208614|NCT02436694|Anesthetics, Local|anesthetics, local|mesh-list
93208615|NCT02436694|Anesthetics|anesthetics|mesh-list
93208616|NCT02436694|BB 1101|bb 1101|mesh-list
93208617|NCT02436694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208618|NCT02436694|Antiemetics|antiemetics|mesh-ancestor
93208619|NCT02436694|Autonomic Agents|autonomic agents|mesh-ancestor
93208620|NCT02436694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208621|NCT02436694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208622|NCT02436694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93208623|NCT02436694|Glucocorticoids|glucocorticoids|mesh-ancestor
93208624|NCT02436694|Hormones|hormones|mesh-ancestor
93208625|NCT02436694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208626|NCT02436694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93208627|NCT02436694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208628|NCT02436694|Protease Inhibitors|protease inhibitors|mesh-ancestor
93208629|NCT02436694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208630|NCT02436694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208631|NCT02436694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208632|NCT02436694|Sensory System Agents|sensory system agents|mesh-ancestor
93208633|NCT03186040|Lacosamide|lacosamide|mesh-list
93208634|NCT03186040|Anticonvulsants|anticonvulsants|mesh-ancestor
93208635|NCT03186040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93208636|NCT03186040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93208637|NCT03186040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208638|NCT03186040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208639|NCT02659020|Gemcitabine|gemcitabine|mesh-list
93208640|NCT02659020|Docetaxel|docetaxel|mesh-list
93208641|NCT02659020|Olaratumab|olaratumab|mesh-list
93208642|NCT02659020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93208643|NCT02659020|Antimetabolites|antimetabolites|mesh-ancestor
93208644|NCT02659020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208645|NCT02659020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208646|NCT02659020|Tubulin Modulators|tubulin modulators|mesh-ancestor
93208647|NCT02659020|Antimitotic Agents|antimitotic agents|mesh-ancestor
93208648|NCT02659020|Mitosis Modulators|mitosis modulators|mesh-ancestor
93208649|NCT03482011|Mirikizumab|mirikizumab|mesh-list
93208650|NCT03482011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208651|NCT03482011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208652|NCT03482011|Analgesics|analgesics|mesh-ancestor
93208653|NCT03482011|Sensory System Agents|sensory system agents|mesh-ancestor
93208654|NCT03482011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208655|NCT03482011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208656|NCT03482011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208657|NCT03482011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208658|NCT03482011|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93208659|NCT03482011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93208660|NCT02436226|Citric Acid|citric acid|mesh-list
93208661|NCT02436226|Sodium Citrate|sodium citrate|mesh-list
93208662|NCT02436226|Clomiphene|clomiphene|mesh-list
93208663|NCT02436226|Enclomiphene|enclomiphene|mesh-list
93208664|NCT02436226|Zuclomiphene|zuclomiphene|mesh-list
93208665|NCT02436226|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93208666|NCT02436226|Anticoagulants|anticoagulants|mesh-ancestor
92880722|NCT00973609|Vitamins|vitamins|mesh-ancestor
93208667|NCT02436226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93208668|NCT02436226|Chelating Agents|chelating agents|mesh-ancestor
93208669|NCT02436226|Sequestering Agents|sequestering agents|mesh-ancestor
93208670|NCT02436226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208671|NCT02436226|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93208672|NCT02436226|Hormone Antagonists|hormone antagonists|mesh-ancestor
93208673|NCT02436226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208674|NCT02436226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208675|NCT02436226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93208676|NCT02436226|Fertility Agents|fertility agents|mesh-ancestor
93208677|NCT02436226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93208678|NCT02436226|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93208679|NCT02436226|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93208680|NCT01374126|Azithromycin|azithromycin|mesh-list
93208681|NCT01374126|Artesunate|artesunate|mesh-list
93208682|NCT01374126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93208683|NCT01374126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208684|NCT01374126|Antimalarials|antimalarials|mesh-ancestor
93208685|NCT01374126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93208686|NCT01374126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93208687|NCT01374126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208688|NCT01374126|Antiviral Agents|antiviral agents|mesh-ancestor
93208689|NCT01374126|Schistosomicides|schistosomicides|mesh-ancestor
93208690|NCT01374126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93208691|NCT01374126|Anthelmintics|anthelmintics|mesh-ancestor
93208692|NCT02584920|Rituximab|rituximab|mesh-list
93208693|NCT02584920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93208694|NCT02584920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208695|NCT02584920|Immunologic Factors|immunologic factors|mesh-ancestor
93208696|NCT02584920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208697|NCT02584920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208698|NCT02431936|Prazosin|prazosin|mesh-list
93208699|NCT02431936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93208700|NCT02431936|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93208701|NCT02431936|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93208702|NCT02431936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93208703|NCT02431936|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208704|NCT02431936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208705|NCT02431936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208706|NCT02431936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208707|NCT02440828|Tobramycin|tobramycin|mesh-list
93208708|NCT02440828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93208709|NCT02440828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208710|NCT01311037|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93208711|NCT01311037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93208712|NCT01311037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208713|NCT01311037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208714|NCT01311037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93208715|NCT01311037|Hormone Antagonists|hormone antagonists|mesh-ancestor
93208716|NCT01311037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208717|NCT01311037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208718|NCT03789318|Acetaminophen|acetaminophen|mesh-list
93208719|NCT03789318|Fentanyl|fentanyl|mesh-list
93208720|NCT03789318|Oxycodone|oxycodone|mesh-list
93208721|NCT03789318|Hydromorphone|hydromorphone|mesh-list
93208722|NCT03789318|Bupivacaine|bupivacaine|mesh-list
93208723|NCT03789318|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208724|NCT03789318|Anesthetics|anesthetics|mesh-ancestor
93208725|NCT03789318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208726|NCT03789318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208727|NCT03789318|Sensory System Agents|sensory system agents|mesh-ancestor
93208728|NCT03789318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208729|NCT03789318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93208730|NCT03789318|Narcotics|narcotics|mesh-ancestor
93208731|NCT03789318|Analgesics|analgesics|mesh-ancestor
93208732|NCT03789318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93208733|NCT03789318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93208734|NCT03789318|Anesthetics, General|anesthetics, general|mesh-ancestor
93208735|NCT03789318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208736|NCT03789318|Antipyretics|antipyretics|mesh-ancestor
93208737|NCT02435368|Mycophenolic Acid|mycophenolic acid|mesh-list
93208738|NCT02435368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93208739|NCT02435368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208740|NCT02435368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93208741|NCT02435368|Antitubercular Agents|antitubercular agents|mesh-ancestor
93208742|NCT02435368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93208743|NCT02435368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208745|NCT02435368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208746|NCT05160090|Bupropion|bupropion|mesh-list
93208747|NCT05160090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93208748|NCT05160090|Antidepressive Agents|antidepressive agents|mesh-ancestor
93208749|NCT05160090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93208750|NCT05160090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93208751|NCT05160090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93208752|NCT05160090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208753|NCT05160090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208754|NCT05160090|Dopamine Agents|dopamine agents|mesh-ancestor
93208755|NCT05160090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208756|NCT05160090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208757|NCT05160090|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93208758|NCT05160090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93208759|NCT05160090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208760|NCT04516616|Paclitaxel|paclitaxel|mesh-list
93208761|NCT04516616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93208762|NCT04516616|Cisplatin|cisplatin|mesh-list
93208763|NCT04516616|Antibodies|antibodies|mesh-list
93208764|NCT04516616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93208765|NCT04516616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93208766|NCT04516616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208767|NCT04516616|Tubulin Modulators|tubulin modulators|mesh-ancestor
93208768|NCT04516616|Antimitotic Agents|antimitotic agents|mesh-ancestor
93208769|NCT04516616|Mitosis Modulators|mitosis modulators|mesh-ancestor
93208770|NCT04516616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208771|NCT04516616|Immunologic Factors|immunologic factors|mesh-ancestor
93208772|NCT04516616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208773|NCT00511134|Eszopiclone|eszopiclone|mesh-list
93208774|NCT00511134|Bupropion|bupropion|mesh-list
93208775|NCT00511134|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93208776|NCT00511134|Antidepressive Agents|antidepressive agents|mesh-ancestor
93208777|NCT00511134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93208778|NCT00511134|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93208779|NCT00511134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93208780|NCT00511134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208781|NCT00511134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208782|NCT00511134|Dopamine Agents|dopamine agents|mesh-ancestor
93208783|NCT00511134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208784|NCT00511134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208785|NCT00511134|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93208786|NCT00511134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93208787|NCT00511134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208788|NCT00511134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93208789|NCT00511134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208790|NCT05103228|Menotropins|menotropins|mesh-list
93208791|NCT05103228|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93208792|NCT05103228|Hormones|hormones|mesh-ancestor
93208793|NCT05103228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208794|NCT05103228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208795|NCT05103228|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93208796|NCT05103228|Fertility Agents|fertility agents|mesh-ancestor
93208797|NCT05103228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93208798|NCT01372384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93208799|NCT01372384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208800|NCT01372384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93208801|NCT01372384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208802|NCT01372384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208803|NCT03190798|Canagliflozin|canagliflozin|mesh-list
93208804|NCT03190798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93208805|NCT03190798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208806|NCT03190798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93208807|NCT03190798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208808|NCT03696290|Aztreonam|aztreonam|mesh-list
93208809|NCT03696290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93208810|NCT03696290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208811|NCT03696212|Pembrolizumab|pembrolizumab|mesh-list
93208812|NCT03696212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93208813|NCT03696212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208814|NCT03696212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93208815|NCT03696212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208816|NCT03692546|Bupivacaine|bupivacaine|mesh-list
93208817|NCT03692546|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208818|NCT03692546|Anesthetics|anesthetics|mesh-ancestor
93208819|NCT03692546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208820|NCT03692546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208821|NCT03692546|Sensory System Agents|sensory system agents|mesh-ancestor
93208822|NCT03692546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208823|NCT03480763|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93208824|NCT03480763|Immunologic Factors|immunologic factors|mesh-ancestor
93208825|NCT03480763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208826|NCT02434822|Vaccines|vaccines|mesh-list
93208827|NCT02434822|Immunologic Factors|immunologic factors|mesh-ancestor
93208828|NCT02434822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208829|NCT01371474|Paroxetine|paroxetine|mesh-list
93208830|NCT01371474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93208831|NCT01371474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93208832|NCT01371474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93208833|NCT01371474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208834|NCT01371474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208835|NCT01371474|Serotonin Agents|serotonin agents|mesh-ancestor
93208836|NCT01371474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208837|NCT01371474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93208838|NCT01371474|Antidepressive Agents|antidepressive agents|mesh-ancestor
93208839|NCT01371474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93208840|NCT01371474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93208841|NCT01371474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93208842|NCT01371474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208843|NCT03185104|Fluorides|fluorides|mesh-list
93208844|NCT03185104|Cariostatic Agents|cariostatic agents|mesh-ancestor
93208845|NCT03185104|Protective Agents|protective agents|mesh-ancestor
93208846|NCT03185104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208847|NCT01319994|Metformin|metformin|mesh-list
93208848|NCT01319994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93208849|NCT01319994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208850|NCT02430298|Melatonin|melatonin|mesh-list
93208851|NCT02430298|Antioxidants|antioxidants|mesh-ancestor
93208852|NCT02430298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208853|NCT02430298|Protective Agents|protective agents|mesh-ancestor
93208854|NCT02430298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208855|NCT02430298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208856|NCT03626376|Valacyclovir|valacyclovir|mesh-list
93208857|NCT03626376|Acyclovir|acyclovir|mesh-list
93208858|NCT03626376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93208859|NCT03626376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93208860|NCT03626376|Antiviral Agents|antiviral agents|mesh-ancestor
93208861|NCT03626376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93208862|NCT03695822|Mirabegron|mirabegron|mesh-list
93208863|NCT03695822|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93208864|NCT03695822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93208865|NCT03695822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93208866|NCT03695822|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208867|NCT03695822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208868|NCT03695822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208869|NCT03695822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208870|NCT03695822|Urological Agents|urological agents|mesh-ancestor
93208871|NCT03718507|Atropine|atropine|mesh-list
93208872|NCT03718507|Fentanyl|fentanyl|mesh-list
93208873|NCT03718507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93208874|NCT03718507|Narcotics|narcotics|mesh-ancestor
93208875|NCT03718507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208876|NCT03718507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208877|NCT03718507|Analgesics|analgesics|mesh-ancestor
93208878|NCT03718507|Sensory System Agents|sensory system agents|mesh-ancestor
93208879|NCT03718507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208880|NCT03718507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93208881|NCT03718507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93208882|NCT03718507|Anesthetics, General|anesthetics, general|mesh-ancestor
93208883|NCT03718507|Anesthetics|anesthetics|mesh-ancestor
93208884|NCT03718507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93208885|NCT03718507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93208886|NCT03718507|Autonomic Agents|autonomic agents|mesh-ancestor
93208887|NCT03718507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93208888|NCT03718507|Respiratory System Agents|respiratory system agents|mesh-ancestor
93208889|NCT03718507|Mydriatics|mydriatics|mesh-ancestor
93208890|NCT03718507|Parasympatholytics|parasympatholytics|mesh-ancestor
93208891|NCT03718507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93208892|NCT03718507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93208893|NCT03718507|Cholinergic Agents|cholinergic agents|mesh-ancestor
93208894|NCT03718507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208895|NCT03718507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208896|NCT01374282|Penicillamine|penicillamine|mesh-list
93208897|NCT01374282|Antidotes|antidotes|mesh-ancestor
93208898|NCT01374282|Protective Agents|protective agents|mesh-ancestor
93208899|NCT01374282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208900|NCT01374282|Chelating Agents|chelating agents|mesh-ancestor
93208901|NCT01374282|Sequestering Agents|sequestering agents|mesh-ancestor
93208902|NCT01374282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208903|NCT01374282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208904|NCT03691922|Epinephrine|epinephrine|mesh-list
93208905|NCT03691922|Racepinephrine|racepinephrine|mesh-list
93208906|NCT03691922|Bupivacaine|bupivacaine|mesh-list
93208907|NCT03691922|Epinephryl borate|epinephryl borate|mesh-list
93208908|NCT03691922|Anesthetics, Local|anesthetics, local|mesh-ancestor
93208909|NCT03691922|Anesthetics|anesthetics|mesh-ancestor
93208910|NCT03691922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208911|NCT03691922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208912|NCT03691922|Sensory System Agents|sensory system agents|mesh-ancestor
93208913|NCT03691922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208914|NCT03691922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93208915|NCT03691922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93208916|NCT03691922|Adrenergic Agents|adrenergic agents|mesh-ancestor
93208917|NCT03691922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208918|NCT03691922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208919|NCT03691922|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93208920|NCT03691922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93208921|NCT03691922|Autonomic Agents|autonomic agents|mesh-ancestor
93208922|NCT03691922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93208923|NCT03691922|Respiratory System Agents|respiratory system agents|mesh-ancestor
93208924|NCT03691922|Mydriatics|mydriatics|mesh-ancestor
93208925|NCT03691922|Sympathomimetics|sympathomimetics|mesh-ancestor
93208926|NCT03691922|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93208927|NCT03453151|Anesthetics|anesthetics|mesh-list
93208928|NCT03453151|Anesthetics, Local|anesthetics, local|mesh-list
93208929|NCT03453151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93208930|NCT03453151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208931|NCT03453151|Sensory System Agents|sensory system agents|mesh-ancestor
93208932|NCT03453151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208933|NCT03433248|Empagliflozin|empagliflozin|mesh-list
93208934|NCT03433248|Gliclazide|gliclazide|mesh-list
93208935|NCT03433248|Linagliptin|linagliptin|mesh-list
93208936|NCT03433248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93208937|NCT03433248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208938|NCT03433248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93208939|NCT03433248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208940|NCT03433248|Incretins|incretins|mesh-ancestor
93208941|NCT03433248|Hormones|hormones|mesh-ancestor
93208942|NCT03433248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208943|NCT03433248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93208944|NCT03433248|Protease Inhibitors|protease inhibitors|mesh-ancestor
93208945|NCT03433248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208946|NCT03691688|Aspirin|aspirin|mesh-list
93208947|NCT03691688|Clopidogrel|clopidogrel|mesh-list
93208948|NCT03691688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93208949|NCT03691688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93208950|NCT03691688|Analgesics|analgesics|mesh-ancestor
93208951|NCT03691688|Sensory System Agents|sensory system agents|mesh-ancestor
93208952|NCT03691688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93208953|NCT03691688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208954|NCT03691688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93208955|NCT03691688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93208956|NCT03691688|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93208957|NCT03691688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93208958|NCT03691688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208959|NCT03691688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93208960|NCT03691688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93208961|NCT03691688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93208962|NCT03691688|Antipyretics|antipyretics|mesh-ancestor
93208963|NCT03691688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93208964|NCT03691688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93208965|NCT03691688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93208966|NCT03691688|Purinergic Agents|purinergic agents|mesh-ancestor
93208967|NCT03691688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93208968|NCT02887248|Paclitaxel|paclitaxel|mesh-list
93208969|NCT02887248|Gemcitabine|gemcitabine|mesh-list
93208970|NCT02887248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93208971|NCT02887248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208972|NCT02887248|Tubulin Modulators|tubulin modulators|mesh-ancestor
93208973|NCT02887248|Antimitotic Agents|antimitotic agents|mesh-ancestor
93208974|NCT02887248|Mitosis Modulators|mitosis modulators|mesh-ancestor
93208975|NCT02887248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93208976|NCT02887248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93208977|NCT02887248|Antimetabolites|antimetabolites|mesh-ancestor
93208978|NCT02425462|Dienogest|dienogest|mesh-list
93208979|NCT02425462|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93208980|NCT02425462|Contraceptive Agents|contraceptive agents|mesh-ancestor
93208981|NCT02425462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504844|NCT00005898|Cyclosporine|cyclosporine|mesh-list
93208982|NCT02425462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208983|NCT02425462|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93208984|NCT02425462|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93208985|NCT02425462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93208986|NCT02425462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93208987|NCT02425462|Hormone Antagonists|hormone antagonists|mesh-ancestor
93208988|NCT02425462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93208989|NCT02425462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93208990|NCT02425462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208991|NCT03452527|Aflibercept|aflibercept|mesh-list
93208992|NCT03452527|Immunoconjugates|immunoconjugates|mesh-list
93208993|NCT03452527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93208994|NCT03452527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93208995|NCT03452527|Growth Substances|growth substances|mesh-ancestor
93208996|NCT03452527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93208997|NCT03452527|Growth Inhibitors|growth inhibitors|mesh-ancestor
93208998|NCT03452527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93208999|NCT03452527|Immunologic Factors|immunologic factors|mesh-ancestor
93209000|NCT04878510|Dexmedetomidine|dexmedetomidine|mesh-list
93209001|NCT04878510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209002|NCT04878510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209003|NCT04878510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209004|NCT04878510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93209005|NCT04878510|Analgesics|analgesics|mesh-ancestor
93209006|NCT04878510|Sensory System Agents|sensory system agents|mesh-ancestor
93209007|NCT04878510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209008|NCT04878510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93209009|NCT04878510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93209010|NCT04878510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93209011|NCT04878510|Adrenergic Agents|adrenergic agents|mesh-ancestor
93209012|NCT04878510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209013|NCT04878510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209014|NCT03028142|Tiotropium Bromide|tiotropium bromide|mesh-list
93209015|NCT03028142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93209016|NCT03028142|Autonomic Agents|autonomic agents|mesh-ancestor
93209017|NCT03028142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209018|NCT03028142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209019|NCT03028142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93209020|NCT03028142|Respiratory System Agents|respiratory system agents|mesh-ancestor
93209021|NCT03028142|Parasympatholytics|parasympatholytics|mesh-ancestor
93209022|NCT03028142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93209023|NCT03028142|Cholinergic Agents|cholinergic agents|mesh-ancestor
93209024|NCT03028142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209025|NCT03028142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209026|NCT02800824|Budesonide|budesonide|mesh-list
93209027|NCT02800824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209028|NCT02800824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93209029|NCT02800824|Autonomic Agents|autonomic agents|mesh-ancestor
93209030|NCT02800824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209031|NCT02800824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209032|NCT02800824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93209033|NCT02800824|Respiratory System Agents|respiratory system agents|mesh-ancestor
93209034|NCT02800824|Glucocorticoids|glucocorticoids|mesh-ancestor
93209035|NCT02800824|Hormones|hormones|mesh-ancestor
93209036|NCT02800824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209037|NCT03715777|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93209038|NCT03715777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93209039|NCT03715777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209040|NCT03715777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209041|NCT03715777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93209042|NCT03715777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93209043|NCT03715777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209044|NCT03715777|Cholinergic Agents|cholinergic agents|mesh-ancestor
93209045|NCT03715777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209046|NCT03715699|Prednisone|prednisone|mesh-list
93209047|NCT03715699|Leflunomide|leflunomide|mesh-list
93209048|NCT03715699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209049|NCT03715699|Glucocorticoids|glucocorticoids|mesh-ancestor
93209050|NCT03715699|Hormones|hormones|mesh-ancestor
93209051|NCT03715699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209052|NCT03715699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209053|NCT03715699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93209054|NCT03715699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209055|NCT03715699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209056|NCT03715699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209057|NCT03715699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93209058|NCT03715699|Immunologic Factors|immunologic factors|mesh-ancestor
93209059|NCT04776408|Nitric Oxide|nitric oxide|mesh-list
93209060|NCT04776408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93209061|NCT04776408|Autonomic Agents|autonomic agents|mesh-ancestor
93209062|NCT04776408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209063|NCT04776408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209064|NCT04776408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93209065|NCT04776408|Respiratory System Agents|respiratory system agents|mesh-ancestor
93209066|NCT04776408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93209067|NCT04776408|Antioxidants|antioxidants|mesh-ancestor
93209068|NCT04776408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209069|NCT04776408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209070|NCT04776408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93209071|NCT04776408|Vasodilator Agents|vasodilator agents|mesh-ancestor
93209072|NCT04776408|Gasotransmitters|gasotransmitters|mesh-ancestor
93209073|NCT04776408|Protective Agents|protective agents|mesh-ancestor
93209074|NCT02429596|Lamotrigine|lamotrigine|mesh-list
93209075|NCT02429596|Carbamazepine|carbamazepine|mesh-list
93209076|NCT02429596|Anticonvulsants|anticonvulsants|mesh-ancestor
93209077|NCT02429596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93209078|NCT02429596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93209079|NCT02429596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209080|NCT02429596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93209081|NCT02429596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209082|NCT02429596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93209083|NCT02429596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209084|NCT02429596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209085|NCT02429596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209086|NCT02429596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93209087|NCT02429596|Antimanic Agents|antimanic agents|mesh-ancestor
93209088|NCT02429596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93209089|NCT02429596|Analgesics|analgesics|mesh-ancestor
93209090|NCT02429596|Sensory System Agents|sensory system agents|mesh-ancestor
93209091|NCT02429596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209092|NCT02429596|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93209093|NCT02429596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93209094|NCT03418675|Brexpiprazole|brexpiprazole|mesh-list
93209095|NCT03418675|Serotonin Agents|serotonin agents|mesh-ancestor
93209096|NCT03418675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209097|NCT03418675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209098|NCT03418675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209099|NCT03418675|Dopamine Agonists|dopamine agonists|mesh-ancestor
93209100|NCT03418675|Dopamine Agents|dopamine agents|mesh-ancestor
93209101|NCT02653092|Heparin|heparin|mesh-list
93209102|NCT02653092|Anticoagulants|anticoagulants|mesh-list
93209103|NCT02653092|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93209104|NCT02653092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93209105|NCT02653092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93209106|NCT02653092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209107|NCT02653092|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93209108|NCT02653092|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93209109|NCT02653092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93209110|NCT03691454|Docetaxel|docetaxel|mesh-list
92881188|NCT00647816|Propranolol|propranolol|mesh-list
93209111|NCT03691454|Oxaliplatin|oxaliplatin|mesh-list
93209112|NCT03691454|Trastuzumab|trastuzumab|mesh-list
93209113|NCT03691454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209114|NCT03691454|Tubulin Modulators|tubulin modulators|mesh-ancestor
93209115|NCT03691454|Antimitotic Agents|antimitotic agents|mesh-ancestor
93209116|NCT03691454|Mitosis Modulators|mitosis modulators|mesh-ancestor
93209117|NCT03691454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209118|NCT03691454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209119|NCT03718273|Digoxin|digoxin|mesh-list
93209120|NCT03718273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93209121|NCT03718273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93209122|NCT03718273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209123|NCT03718273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209124|NCT03718273|Protective Agents|protective agents|mesh-ancestor
93209125|NCT03718273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209126|NCT02421640|Cisplatin|cisplatin|mesh-list
93209127|NCT02421640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209128|NCT03715387|Bacitracin|bacitracin|mesh-list
93209129|NCT03715387|Polymyxin B|polymyxin b|mesh-list
93209130|NCT03715387|Tacrolimus|tacrolimus|mesh-list
93209131|NCT03715387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93209132|NCT03715387|Immunologic Factors|immunologic factors|mesh-ancestor
93209133|NCT03715387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209134|NCT03715387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93209135|NCT03715387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209136|NCT03715387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209137|NCT03715387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93209138|NCT03715387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209139|NCT03715387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209140|NCT03715309|Lenalidomide|lenalidomide|mesh-list
93209141|NCT03715309|Immunologic Factors|immunologic factors|mesh-ancestor
93209142|NCT03715309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209143|NCT03715309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93209144|NCT03715309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93209145|NCT03715309|Growth Substances|growth substances|mesh-ancestor
93209146|NCT03715309|Growth Inhibitors|growth inhibitors|mesh-ancestor
93209147|NCT03715309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209148|NCT03179254|Metformin|metformin|mesh-list
93209149|NCT03179254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209150|NCT03179254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209151|NCT04147715|Dolutegravir|dolutegravir|mesh-list
93209152|NCT04147715|Midazolam|midazolam|mesh-list
93209153|NCT04147715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93209154|NCT04147715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209155|NCT04147715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209156|NCT04147715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209157|NCT04147715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93209158|NCT04147715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209159|NCT04147715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209160|NCT04147715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209161|NCT04147715|Anesthetics, General|anesthetics, general|mesh-ancestor
93209162|NCT04147715|Anesthetics|anesthetics|mesh-ancestor
93209163|NCT04147715|GABA Modulators|gaba modulators|mesh-ancestor
93209164|NCT04147715|GABA Agents|gaba agents|mesh-ancestor
93209165|NCT04147715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209166|NCT04147715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209167|NCT04147715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93209168|NCT04147715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93209169|NCT04147715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209170|NCT04147715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93209171|NCT04147715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93209172|NCT04147715|Antiviral Agents|antiviral agents|mesh-ancestor
93209173|NCT04147715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209174|NCT02420938|Rituximab|rituximab|mesh-list
93209175|NCT02420938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209176|NCT02420938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209177|NCT02420938|Immunologic Factors|immunologic factors|mesh-ancestor
93209178|NCT02420938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209179|NCT02420938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93209180|NCT02429440|Molgramostim|molgramostim|mesh-list
93209181|NCT02429440|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93209182|NCT02429440|Sargramostim|sargramostim|mesh-list
93209183|NCT02429440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93209184|NCT02429440|Immunologic Factors|immunologic factors|mesh-ancestor
93209185|NCT02429440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209186|NCT02429440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209187|NCT02429518|Miltefosine|miltefosine|mesh-list
93209188|NCT02429518|Antifungal Agents|antifungal agents|mesh-ancestor
93209189|NCT02429518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209190|NCT02429518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209191|NCT02429518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93209192|NCT02429518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93209194|NCT00708526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209195|NCT00708526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209196|NCT03712735|Fentanyl|fentanyl|mesh-list
93209197|NCT03712735|Bupivacaine|bupivacaine|mesh-list
93209198|NCT03712735|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209199|NCT03712735|Anesthetics|anesthetics|mesh-ancestor
93209200|NCT03712735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209201|NCT03712735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209202|NCT03712735|Sensory System Agents|sensory system agents|mesh-ancestor
93209203|NCT03712735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209204|NCT03712735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93209205|NCT03712735|Narcotics|narcotics|mesh-ancestor
93209206|NCT03712735|Analgesics|analgesics|mesh-ancestor
93209207|NCT03712735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93209208|NCT03712735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209209|NCT03712735|Anesthetics, General|anesthetics, general|mesh-ancestor
93209210|NCT03182218|Heparin|heparin|mesh-list
93209211|NCT03182218|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93209212|NCT03182218|Tinzaparin|tinzaparin|mesh-list
93209213|NCT03182218|Dalteparin|dalteparin|mesh-list
93209214|NCT03182218|Anticoagulants|anticoagulants|mesh-list
93209215|NCT03182218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93209216|NCT03182218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93209217|NCT03182218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209218|NCT02452554|Maytansine|maytansine|mesh-list
93209219|NCT02452554|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
93209220|NCT02452554|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93209221|NCT02452554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93209222|NCT02452554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209223|NCT02452554|Tubulin Modulators|tubulin modulators|mesh-ancestor
93209224|NCT02452554|Antimitotic Agents|antimitotic agents|mesh-ancestor
93209225|NCT02452554|Mitosis Modulators|mitosis modulators|mesh-ancestor
93209226|NCT02452554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209227|NCT02452554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209228|NCT02452554|Immunotoxins|immunotoxins|mesh-ancestor
93209229|NCT02452554|Immunoconjugates|immunoconjugates|mesh-ancestor
93209230|NCT02452554|Immunologic Factors|immunologic factors|mesh-ancestor
93209231|NCT02452554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209232|NCT03182296|Exenatide|exenatide|mesh-list
93209233|NCT03182296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209234|NCT03182296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209235|NCT03182296|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93209236|NCT03182296|Incretins|incretins|mesh-ancestor
93209237|NCT03182296|Hormones|hormones|mesh-ancestor
93209238|NCT03182296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209239|NCT03182374|Hylan|hylan|mesh-list
93209240|NCT03182374|Viscosupplements|viscosupplements|mesh-ancestor
93209241|NCT03182374|Protective Agents|protective agents|mesh-ancestor
93209242|NCT03182374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209243|NCT01319682|Lidocaine|lidocaine|mesh-list
93209244|NCT01319682|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209245|NCT01319682|Anesthetics|anesthetics|mesh-ancestor
93209246|NCT01319682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209247|NCT01319682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209248|NCT01319682|Sensory System Agents|sensory system agents|mesh-ancestor
93209249|NCT01319682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209250|NCT01319682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93209251|NCT01319682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93209252|NCT01319682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93209253|NCT01319682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93209254|NCT01319682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209255|NCT04009577|Lemborexant|lemborexant|mesh-list
93209256|NCT04009577|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93209257|NCT04009577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209258|NCT04009577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209259|NCT04009577|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93209260|NCT04009577|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209261|NCT04009577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209262|NCT04009577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209263|NCT02176668|Esomeprazole|esomeprazole|mesh-list
93209264|NCT02176668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92881327|NCT05342597|Edaravone|edaravone|mesh-list
93209265|NCT02176668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209266|NCT02176668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93209267|NCT02176668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209268|NCT02176668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209269|NCT03712423|Docetaxel|docetaxel|mesh-list
93209270|NCT03712423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209271|NCT03712423|Tubulin Modulators|tubulin modulators|mesh-ancestor
93209272|NCT03712423|Antimitotic Agents|antimitotic agents|mesh-ancestor
93209273|NCT03712423|Mitosis Modulators|mitosis modulators|mesh-ancestor
93209274|NCT03712423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209275|NCT04620252|Calcium, Dietary|calcium, dietary|mesh-list
93209276|NCT04620252|Calcium Carbonate|calcium carbonate|mesh-list
93209277|NCT04620252|Citric Acid|citric acid|mesh-list
93209278|NCT04620252|Sodium Citrate|sodium citrate|mesh-list
93209279|NCT04620252|Calcium|calcium|mesh-list
93209280|NCT04620252|Fluorides|fluorides|mesh-list
93209281|NCT04620252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93209282|NCT04620252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209283|NCT04620252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93209284|NCT04620252|Anticoagulants|anticoagulants|mesh-ancestor
93209285|NCT04620252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93209286|NCT04620252|Chelating Agents|chelating agents|mesh-ancestor
93209287|NCT04620252|Sequestering Agents|sequestering agents|mesh-ancestor
93209288|NCT04620252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209289|NCT04620252|Cariostatic Agents|cariostatic agents|mesh-ancestor
93209290|NCT04620252|Protective Agents|protective agents|mesh-ancestor
93209291|NCT04620252|Antacids|antacids|mesh-ancestor
93209292|NCT04620252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209293|NCT03694886|Caffeine|caffeine|mesh-list
93209294|NCT03694886|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93209295|NCT03694886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209296|NCT03694886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93209297|NCT03694886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209298|NCT03694886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209299|NCT03694886|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93209300|NCT03694886|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93209301|NCT03694886|Purinergic Agents|purinergic agents|mesh-ancestor
93209302|NCT03694886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209303|NCT05602675|Repaglinide|repaglinide|mesh-list
93209304|NCT05602675|Methotrexate|methotrexate|mesh-list
93209305|NCT05602675|Midazolam|midazolam|mesh-list
93209306|NCT05602675|Dextromethorphan|dextromethorphan|mesh-list
93209307|NCT05602675|Warfarin|warfarin|mesh-list
93209308|NCT05602675|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93209309|NCT05602675|Abortifacient Agents|abortifacient agents|mesh-ancestor
93209310|NCT05602675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209311|NCT05602675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209312|NCT05602675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93209313|NCT05602675|Antimetabolites|antimetabolites|mesh-ancestor
93209314|NCT05602675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209315|NCT05602675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209316|NCT05602675|Dermatologic Agents|dermatologic agents|mesh-ancestor
93209317|NCT05602675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209318|NCT05602675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93209319|NCT05602675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93209320|NCT05602675|Immunologic Factors|immunologic factors|mesh-ancestor
93209321|NCT05602675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93209322|NCT05602675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93209323|NCT05602675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93209324|NCT05602675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209325|NCT05602675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209326|NCT05602675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93209327|NCT05602675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209328|NCT05602675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209329|NCT05602675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209330|NCT05602675|Anesthetics, General|anesthetics, general|mesh-ancestor
93209331|NCT05602675|Anesthetics|anesthetics|mesh-ancestor
93209332|NCT05602675|GABA Modulators|gaba modulators|mesh-ancestor
93209333|NCT05602675|GABA Agents|gaba agents|mesh-ancestor
93209334|NCT05602675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209335|NCT05602675|Anticoagulants|anticoagulants|mesh-ancestor
93209336|NCT05602675|Antitussive Agents|antitussive agents|mesh-ancestor
93209337|NCT05602675|Respiratory System Agents|respiratory system agents|mesh-ancestor
93209338|NCT05602675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93209339|NCT05602675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93209340|NCT05602675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209341|NCT03714685|Firibastat|firibastat|mesh-list
93209343|NCT02705716|Fluorides|fluorides|mesh-list
93209344|NCT02705716|Tin Fluorides|tin fluorides|mesh-list
93209345|NCT02705716|Fluorophosphate|fluorophosphate|mesh-list
93209346|NCT02705716|Cariostatic Agents|cariostatic agents|mesh-ancestor
93209347|NCT02705716|Protective Agents|protective agents|mesh-ancestor
93209348|NCT02705716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209349|NCT02429050|Morphine|morphine|mesh-list
93209350|NCT02429050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93209351|NCT02429050|Narcotics|narcotics|mesh-ancestor
93209352|NCT02429050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209353|NCT02429050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209354|NCT02429050|Analgesics|analgesics|mesh-ancestor
93209355|NCT02429050|Sensory System Agents|sensory system agents|mesh-ancestor
91928556|NCT03169725|Vaccines|vaccines|mesh-list
93209356|NCT02429050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209357|NCT02417142|Exenatide|exenatide|mesh-list
93209358|NCT02417142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209359|NCT02417142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209360|NCT02417142|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93209361|NCT02417142|Incretins|incretins|mesh-ancestor
93209362|NCT02417142|Hormones|hormones|mesh-ancestor
93209363|NCT02417142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209364|NCT01374750|Cyclosporine|cyclosporine|mesh-list
93209365|NCT01374750|Sirolimus|sirolimus|mesh-list
93209366|NCT01374750|Tacrolimus|tacrolimus|mesh-list
93209367|NCT01374750|Cyclosporins|cyclosporins|mesh-list
93209368|NCT01374750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93209369|NCT01374750|Immunologic Factors|immunologic factors|mesh-ancestor
93209370|NCT01374750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209371|NCT01374750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93209372|NCT01374750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209373|NCT01374750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209374|NCT01374750|Antifungal Agents|antifungal agents|mesh-ancestor
93209375|NCT01374750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209376|NCT01374750|Dermatologic Agents|dermatologic agents|mesh-ancestor
93209377|NCT01374750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93209378|NCT01374750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209379|NCT01374750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93209380|NCT01374750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209381|NCT03182140|Levonorgestrel|levonorgestrel|mesh-list
93209382|NCT03182140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93209383|NCT03182140|Contraceptive Agents|contraceptive agents|mesh-ancestor
93209384|NCT03182140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209385|NCT03182140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209386|NCT03182140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93209387|NCT03182140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93209388|NCT03182140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93209389|NCT01374828|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93209390|NCT01374828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93209391|NCT01374828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93209392|NCT01374828|Analgesics|analgesics|mesh-ancestor
93209393|NCT01374828|Sensory System Agents|sensory system agents|mesh-ancestor
93209394|NCT01374828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209395|NCT01374828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209396|NCT01374828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209397|NCT01374828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93209398|NCT01374828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93209399|NCT01374828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209400|NCT01374828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209401|NCT03634332|Pembrolizumab|pembrolizumab|mesh-list
93209402|NCT03634332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209403|NCT03634332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209404|NCT03634332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93209405|NCT03634332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209406|NCT03744767|Spironolactone|spironolactone|mesh-list
93209407|NCT03744767|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93209408|NCT03744767|Hormone Antagonists|hormone antagonists|mesh-ancestor
93209409|NCT03744767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209410|NCT03744767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209411|NCT03744767|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93209412|NCT03744767|Diuretics|diuretics|mesh-ancestor
93209413|NCT03744767|Natriuretic Agents|natriuretic agents|mesh-ancestor
93209414|NCT02428972|Propofol|propofol|mesh-list
93209415|NCT02428972|Sevoflurane|sevoflurane|mesh-list
93209416|NCT02428972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209417|NCT02428972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209418|NCT02428972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209419|NCT02428972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209420|NCT02428972|Anesthetics, General|anesthetics, general|mesh-ancestor
93209421|NCT02428972|Anesthetics|anesthetics|mesh-ancestor
93209422|NCT02428972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93209423|NCT02428972|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93209424|NCT03699332|Labetuzumab|labetuzumab|mesh-list
93209425|NCT03699332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209426|NCT03699332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209427|NCT03389893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93209428|NCT03389893|Immunologic Factors|immunologic factors|mesh-ancestor
93209429|NCT03389893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209430|NCT03178708|Amantadine|amantadine|mesh-list
93209431|NCT03178708|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93209432|NCT03178708|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93209433|NCT03178708|Antiviral Agents|antiviral agents|mesh-ancestor
93209434|NCT03178708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209435|NCT03178708|Dopamine Agents|dopamine agents|mesh-ancestor
93209436|NCT03178708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209437|NCT03178708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209438|NCT03178708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209439|NCT03178708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93209440|NCT03178708|Analgesics|analgesics|mesh-ancestor
93209441|NCT03178708|Sensory System Agents|sensory system agents|mesh-ancestor
93209442|NCT03178708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209443|NCT00787176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93209444|NCT00787176|Oxytocin|oxytocin|mesh-list
93209445|NCT00787176|Oxytocics|oxytocics|mesh-ancestor
93209446|NCT00787176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209447|NCT00787176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209448|NCT03744689|Bupivacaine|bupivacaine|mesh-list
93209449|NCT03744689|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209450|NCT03744689|Anesthetics|anesthetics|mesh-ancestor
93209451|NCT03744689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209452|NCT03744689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209453|NCT03744689|Sensory System Agents|sensory system agents|mesh-ancestor
93209454|NCT03744689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209455|NCT02424214|Ionophores|ionophores|mesh-list
93209456|NCT02424214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93209457|NCT02424214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209458|NCT03712111|Norepinephrine|norepinephrine|mesh-list
93209459|NCT03712111|Bupivacaine|bupivacaine|mesh-list
93209460|NCT03712111|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209461|NCT03712111|Anesthetics|anesthetics|mesh-ancestor
93209462|NCT03712111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209463|NCT03712111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209464|NCT03712111|Sensory System Agents|sensory system agents|mesh-ancestor
93209465|NCT03712111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209466|NCT03712111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93209467|NCT03712111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93209468|NCT03712111|Adrenergic Agents|adrenergic agents|mesh-ancestor
93209469|NCT03712111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209470|NCT03712111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209471|NCT03712111|Sympathomimetics|sympathomimetics|mesh-ancestor
93209472|NCT03712111|Autonomic Agents|autonomic agents|mesh-ancestor
93209473|NCT03712111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93209474|NCT02925494|Norethindrone|norethindrone|mesh-list
93209475|NCT02925494|Norethindrone Acetate|norethindrone acetate|mesh-list
93209476|NCT02925494|Estradiol|estradiol|mesh-list
93209477|NCT02925494|Estrogens|estrogens|mesh-ancestor
93209478|NCT02925494|Hormones|hormones|mesh-ancestor
93209479|NCT02925494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209480|NCT02925494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209481|NCT02925494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93209482|NCT02925494|Contraceptive Agents|contraceptive agents|mesh-ancestor
93209483|NCT02925494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209484|NCT02925494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93209485|NCT02925494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93209486|NCT02925494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93209487|NCT02925494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93209488|NCT03717415|Carboplatin|carboplatin|mesh-list
93209489|NCT03717415|Rebastinib|rebastinib|mesh-list
93209490|NCT03717415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209491|NCT03717415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93209492|NCT03717415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209493|NCT03717415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209494|NCT03689894|Rituximab|rituximab|mesh-list
93209495|NCT03689894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209496|NCT03689894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209497|NCT03689894|Immunologic Factors|immunologic factors|mesh-ancestor
93209498|NCT03689894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209499|NCT03689894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93209500|NCT04126343|Moxifloxacin|moxifloxacin|mesh-list
93209501|NCT04126343|Padsevonil|padsevonil|mesh-list
93209502|NCT04126343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209503|NCT04126343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209504|NCT04126343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93209505|NCT04126343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93209506|NCT04126343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209507|NCT04126343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209508|NCT04126343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209509|NCT04126343|Anticonvulsants|anticonvulsants|mesh-ancestor
93209510|NCT04207710|Ethyl Chloride|ethyl chloride|mesh-list
93209511|NCT04207710|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209512|NCT04207710|Anesthetics|anesthetics|mesh-ancestor
93209513|NCT04207710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209514|NCT04207710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209515|NCT04207710|Sensory System Agents|sensory system agents|mesh-ancestor
93209516|NCT04207710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209517|NCT03119610|Oxytocin|oxytocin|mesh-list
93209518|NCT03119610|Oxytocics|oxytocics|mesh-ancestor
93209519|NCT03119610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209520|NCT03119610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209521|NCT01373736|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93209522|NCT01373736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209523|NCT01373736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209524|NCT01373736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209525|NCT01373736|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93209526|NCT03401749|Chlorhexidine|chlorhexidine|mesh-list
93209527|NCT03401749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93209528|NCT03401749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93209529|NCT03401749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209530|NCT03401749|Disinfectants|disinfectants|mesh-ancestor
93209531|NCT03401749|Dermatologic Agents|dermatologic agents|mesh-ancestor
93209532|NCT03689114|Topiramate|topiramate|mesh-list
93209533|NCT03689114|Lamotrigine|lamotrigine|mesh-list
93209534|NCT03689114|Zonisamide|zonisamide|mesh-list
93209535|NCT03689114|Carbamazepine|carbamazepine|mesh-list
93209536|NCT03689114|Oxcarbazepine|oxcarbazepine|mesh-list
93209537|NCT03689114|Gabapentin|gabapentin|mesh-list
93209538|NCT03689114|Levetiracetam|levetiracetam|mesh-list
93209539|NCT03689114|Anticonvulsants|anticonvulsants|mesh-list
93209540|NCT03689114|Valproic Acid|valproic acid|mesh-list
93209541|NCT03689114|Analgesics|analgesics|mesh-ancestor
93209542|NCT03689114|Sensory System Agents|sensory system agents|mesh-ancestor
93209543|NCT03689114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209544|NCT03689114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209545|NCT03689114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93209546|NCT03689114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209547|NCT03689114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209548|NCT03689114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209549|NCT03689114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93209550|NCT03689114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93209551|NCT03689114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209552|NCT03689114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209553|NCT03689114|Antimanic Agents|antimanic agents|mesh-ancestor
93209554|NCT03689114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209555|NCT03689114|Nootropic Agents|nootropic agents|mesh-ancestor
93209556|NCT03689114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93209557|NCT03689114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93209558|NCT03689114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93209559|NCT03689114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93209560|NCT03689114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93209561|NCT03689114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209562|NCT03689114|GABA Agents|gaba agents|mesh-ancestor
93209563|NCT03689114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93209564|NCT03689114|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93209565|NCT03689114|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93209566|NCT03689114|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93209567|NCT04040946|Choline|choline|mesh-list
93209568|NCT04040946|Lipotropic Agents|lipotropic agents|mesh-ancestor
93209569|NCT04040946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93209570|NCT04040946|Antimetabolites|antimetabolites|mesh-ancestor
93209571|NCT04040946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209572|NCT04040946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209573|NCT04040946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93209574|NCT04040946|Nootropic Agents|nootropic agents|mesh-ancestor
93209575|NCT02952001|Triamcinolone|triamcinolone|mesh-list
93209576|NCT02952001|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93209577|NCT02952001|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93209578|NCT02952001|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93209579|NCT02952001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209580|NCT02952001|Glucocorticoids|glucocorticoids|mesh-ancestor
93209581|NCT02952001|Hormones|hormones|mesh-ancestor
93209582|NCT02952001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209583|NCT02952001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209584|NCT02952001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93209585|NCT02952001|Immunologic Factors|immunologic factors|mesh-ancestor
93209586|NCT02952001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209587|NCT02952001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209588|NCT04050176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93209589|NCT04050176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209590|NCT04050176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209591|NCT01311739|Vitamin B 12|vitamin b 12|mesh-list
93209592|NCT01311739|Hydroxocobalamin|hydroxocobalamin|mesh-list
93209593|NCT01311739|Vitamin B Complex|vitamin b complex|mesh-ancestor
93209594|NCT01311739|Vitamins|vitamins|mesh-ancestor
93209595|NCT01311739|Micronutrients|micronutrients|mesh-ancestor
93209596|NCT01311739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209597|NCT01311739|Hematinics|hematinics|mesh-ancestor
93209598|NCT05507359|Benzocaine|benzocaine|mesh-list
93209599|NCT05507359|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209600|NCT05507359|Anesthetics|anesthetics|mesh-ancestor
93209601|NCT05507359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209602|NCT05507359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209603|NCT05507359|Sensory System Agents|sensory system agents|mesh-ancestor
93209604|NCT05507359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209605|NCT04123067|Pioglitazone|pioglitazone|mesh-list
93209606|NCT04123067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209607|NCT04123067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209608|NCT03703050|Nivolumab|nivolumab|mesh-list
93209609|NCT03703050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209610|NCT03703050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209611|NCT03703050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93209612|NCT03703050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209613|NCT03688958|Iodine|iodine|mesh-list
93209614|NCT03688958|Cadexomer iodine|cadexomer iodine|mesh-list
93209615|NCT03688958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93209616|NCT03688958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209617|NCT03688958|Trace Elements|trace elements|mesh-ancestor
93209618|NCT03688958|Micronutrients|micronutrients|mesh-ancestor
93209619|NCT03688958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209620|NCT04117607|Rezafungin|rezafungin|mesh-list
93209621|NCT04117607|Antifungal Agents|antifungal agents|mesh-ancestor
93209622|NCT04117607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209623|NCT03688568|Imatinib Mesylate|imatinib mesylate|mesh-list
93209624|NCT03688568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209625|NCT03688568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93209626|NCT03688568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209627|NCT03688568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209628|NCT05192304|Maleic acid|maleic acid|mesh-list
93209629|NCT05192304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209630|NCT05192304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209631|NCT03693872|Dopamine|dopamine|mesh-list
93209632|NCT03693872|Apomorphine|apomorphine|mesh-list
93209633|NCT03693872|Dopamine Agonists|dopamine agonists|mesh-list
93209634|NCT03693872|Emetics|emetics|mesh-ancestor
93209635|NCT03693872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209636|NCT03693872|Autonomic Agents|autonomic agents|mesh-ancestor
93209637|NCT03693872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209638|NCT03693872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209639|NCT03693872|Dopamine Agents|dopamine agents|mesh-ancestor
93209640|NCT03693872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209641|NCT03693872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209642|NCT03693872|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93209643|NCT03693872|Sympathomimetics|sympathomimetics|mesh-ancestor
93209644|NCT03693872|Protective Agents|protective agents|mesh-ancestor
93209645|NCT03693638|Fentanyl|fentanyl|mesh-list
93209646|NCT03693638|Bupivacaine|bupivacaine|mesh-list
93209647|NCT03693638|Anesthetics, Local|anesthetics, local|mesh-ancestor
93209648|NCT03693638|Anesthetics|anesthetics|mesh-ancestor
93209649|NCT03693638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209650|NCT03693638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209651|NCT03693638|Sensory System Agents|sensory system agents|mesh-ancestor
93209652|NCT03693638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209653|NCT03693638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93209654|NCT03693638|Narcotics|narcotics|mesh-ancestor
93209655|NCT03693638|Analgesics|analgesics|mesh-ancestor
93209656|NCT03693638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93209657|NCT03693638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209658|NCT03693638|Anesthetics, General|anesthetics, general|mesh-ancestor
93209659|NCT04112303|Sofosbuvir|sofosbuvir|mesh-list
93209660|NCT04112303|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93209661|NCT04112303|Antiviral Agents|antiviral agents|mesh-ancestor
93209662|NCT04112303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209663|NCT01319838|Isotretinoin|isotretinoin|mesh-list
93209664|NCT01319838|Dermatologic Agents|dermatologic agents|mesh-ancestor
93209665|NCT05191914|Fulvestrant|fulvestrant|mesh-list
93209666|NCT05191914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93209667|NCT05191914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209668|NCT05191914|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93209669|NCT05191914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93209670|NCT05191914|Hormone Antagonists|hormone antagonists|mesh-ancestor
93209671|NCT05191914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209672|NCT05191914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209673|NCT04060394|Prednisone|prednisone|mesh-list
93209674|NCT04060394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209675|NCT04060394|Glucocorticoids|glucocorticoids|mesh-ancestor
93209676|NCT04060394|Hormones|hormones|mesh-ancestor
93209677|NCT04060394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209678|NCT04060394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209679|NCT04060394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93209680|NCT04060394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209681|NCT04099277|Pembrolizumab|pembrolizumab|mesh-list
93209682|NCT04099277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209683|NCT04099277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209684|NCT04099277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93209685|NCT04099277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209686|NCT03743987|Pemetrexed|pemetrexed|mesh-list
93209687|NCT03743987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209688|NCT03743987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209689|NCT03743987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209690|NCT03743987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93209691|NCT03743987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93209692|NCT03693326|Spartalizumab|spartalizumab|mesh-list
93209693|NCT03693326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93209694|NCT03693326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209695|NCT03693326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209696|NCT03693326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209697|NCT03988907|Midazolam|midazolam|mesh-list
93209698|NCT03988907|Risdiplam|risdiplam|mesh-list
93209699|NCT03988907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93209700|NCT03988907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209701|NCT03988907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209702|NCT03988907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209703|NCT03988907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93209704|NCT03988907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209705|NCT03988907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209706|NCT03988907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209707|NCT03988907|Anesthetics, General|anesthetics, general|mesh-ancestor
93209708|NCT03988907|Anesthetics|anesthetics|mesh-ancestor
93209709|NCT03988907|GABA Modulators|gaba modulators|mesh-ancestor
93209710|NCT03988907|GABA Agents|gaba agents|mesh-ancestor
93209711|NCT03988907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209712|NCT03988907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209713|NCT03988907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93209714|NCT03988907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209715|NCT03693248|Paclitaxel|paclitaxel|mesh-list
93209716|NCT03693248|Carboplatin|carboplatin|mesh-list
93209717|NCT03693248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93209718|NCT03693248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209719|NCT03693248|Tubulin Modulators|tubulin modulators|mesh-ancestor
93209720|NCT03693248|Antimitotic Agents|antimitotic agents|mesh-ancestor
93209721|NCT03693248|Mitosis Modulators|mitosis modulators|mesh-ancestor
93209722|NCT03693248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209724|NCT03987191|Insulin Aspart|insulin aspart|mesh-list
93209725|NCT03987191|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93209726|NCT03987191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209727|NCT03987191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209728|NCT01373970|Pantoprazole|pantoprazole|mesh-list
93209729|NCT01373970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93209730|NCT01373970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209731|NCT01373970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93209732|NCT01373970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209733|NCT01373970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209734|NCT04050098|Metformin|metformin|mesh-list
93209735|NCT04050098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209736|NCT04050098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209737|NCT03745625|Propofol|propofol|mesh-list
93209738|NCT03745625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209739|NCT03745625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209740|NCT03745625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209741|NCT03745625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209742|NCT03745625|Anesthetics, General|anesthetics, general|mesh-ancestor
93209743|NCT03745625|Anesthetics|anesthetics|mesh-ancestor
93209744|NCT03698630|Dexamethasone|dexamethasone|mesh-list
93209745|NCT03698630|Prednisolone|prednisolone|mesh-list
93209746|NCT03698630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93209747|NCT03698630|Methylprednisolone|methylprednisolone|mesh-list
93209748|NCT03698630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93209749|NCT03698630|Prednisolone acetate|prednisolone acetate|mesh-list
93209750|NCT03698630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93209751|NCT03698630|Prednisolone phosphate|prednisolone phosphate|mesh-list
93209752|NCT03698630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209753|NCT03698630|Antiemetics|antiemetics|mesh-ancestor
93209754|NCT03698630|Autonomic Agents|autonomic agents|mesh-ancestor
93209755|NCT03698630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209756|NCT03698630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209757|NCT03698630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209758|NCT03698630|Glucocorticoids|glucocorticoids|mesh-ancestor
93209759|NCT03698630|Hormones|hormones|mesh-ancestor
93209760|NCT03698630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209761|NCT03698630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93209762|NCT03698630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209763|NCT03698630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93209764|NCT03698630|Protective Agents|protective agents|mesh-ancestor
93209765|NCT01375452|Letrozole|letrozole|mesh-list
93209766|NCT01375452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209767|NCT01375452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93209768|NCT01375452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93209769|NCT01375452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209770|NCT01375452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209771|NCT01375452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93209772|NCT01375452|Hormone Antagonists|hormone antagonists|mesh-ancestor
93209773|NCT01375452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209774|NCT01375452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209775|NCT03046836|Oxytocin|oxytocin|mesh-list
93209776|NCT03046836|Oxytocics|oxytocics|mesh-ancestor
93209777|NCT03046836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209778|NCT03046836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209779|NCT03400033|Epoetin Alfa|epoetin alfa|mesh-list
93209780|NCT03400033|Hematinics|hematinics|mesh-ancestor
93209781|NCT05123820|Midazolam|midazolam|mesh-list
93209782|NCT05123820|Omeprazole|omeprazole|mesh-list
93209783|NCT05123820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93209784|NCT05123820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93209785|NCT05123820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209786|NCT05123820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209787|NCT05123820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93209788|NCT05123820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209789|NCT05123820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209790|NCT05123820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93209791|NCT05123820|Anesthetics, General|anesthetics, general|mesh-ancestor
93209792|NCT05123820|Anesthetics|anesthetics|mesh-ancestor
93209793|NCT05123820|GABA Modulators|gaba modulators|mesh-ancestor
93209794|NCT05123820|GABA Agents|gaba agents|mesh-ancestor
93209795|NCT05123820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209796|NCT05123820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209797|NCT05123820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93209798|NCT05123820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209799|NCT05123820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93209800|NCT05123820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209801|NCT03118518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93209802|NCT02876835|Darbepoetin alfa|darbepoetin alfa|mesh-list
93209803|NCT02876835|Hematinics|hematinics|mesh-ancestor
93209804|NCT03503318|Risperidone|risperidone|mesh-list
93209805|NCT03503318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93209806|NCT03503318|Serotonin Agents|serotonin agents|mesh-ancestor
93209807|NCT03503318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209808|NCT03503318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209809|NCT03503318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209810|NCT03503318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93209811|NCT03503318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209812|NCT03503318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209813|NCT03503318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209814|NCT03503318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93209815|NCT03503318|Dopamine Agents|dopamine agents|mesh-ancestor
93209817|NCT01375920|Antimetabolites|antimetabolites|mesh-ancestor
93209818|NCT01375920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209819|NCT01375920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209820|NCT03683108|Resveratrol|resveratrol|mesh-list
93209821|NCT03683108|Antioxidants|antioxidants|mesh-ancestor
93209822|NCT03683108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209823|NCT03683108|Protective Agents|protective agents|mesh-ancestor
93209824|NCT03683108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209825|NCT03683108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209826|NCT03683108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93209827|NCT05137860|Bortezomib|bortezomib|mesh-list
93209828|NCT05137860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209829|NCT03682952|Alprostadil|alprostadil|mesh-list
93209830|NCT03682952|Beraprost|beraprost|mesh-list
93209831|NCT03682952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93209832|NCT03682952|Vasodilator Agents|vasodilator agents|mesh-ancestor
93209833|NCT03682952|Urological Agents|urological agents|mesh-ancestor
93209834|NCT03682718|Misoprostol|misoprostol|mesh-list
93209835|NCT03682718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93209836|NCT03682718|Abortifacient Agents|abortifacient agents|mesh-ancestor
93209837|NCT03682718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209838|NCT03682718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209839|NCT03682718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93209840|NCT03682718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93209841|NCT03682718|Oxytocics|oxytocics|mesh-ancestor
93209842|NCT03682640|Insulin|insulin|mesh-list
93209843|NCT03682640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93209844|NCT03682640|Insulin Lispro|insulin lispro|mesh-list
93209845|NCT03682640|Azithromycin|azithromycin|mesh-list
93209846|NCT03682640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93209847|NCT03682640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209848|NCT03682640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209849|NCT03682640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209850|NCT04084769|Vaccines|vaccines|mesh-list
93209851|NCT04084769|Immunologic Factors|immunologic factors|mesh-ancestor
93209852|NCT04084769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209853|NCT01376076|Moxifloxacin|moxifloxacin|mesh-list
93209854|NCT01376076|Risperidone|risperidone|mesh-list
93209855|NCT01376076|Cariprazine|cariprazine|mesh-list
93209856|NCT01376076|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93209857|NCT01376076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209858|NCT01376076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209859|NCT01376076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93209860|NCT01376076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93209861|NCT01376076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209862|NCT01376076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209863|NCT01376076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209864|NCT01376076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93209865|NCT01376076|Contraceptive Agents|contraceptive agents|mesh-ancestor
93209866|NCT01376076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93209867|NCT01376076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209868|NCT01376076|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93209869|NCT01376076|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93209870|NCT01376076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93209871|NCT01376076|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93209872|NCT01376076|Serotonin Agents|serotonin agents|mesh-ancestor
92881922|NCT00976105|GABA Agents|gaba agents|mesh-ancestor
93209873|NCT01376076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209874|NCT01376076|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93209875|NCT01376076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209876|NCT01376076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209877|NCT01376076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209878|NCT01376076|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93209880|NCT03395353|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93209881|NCT03395353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92977254|NCT01070641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93209882|NCT03395353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93209883|NCT03395353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93209884|NCT03395353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209885|NCT03395353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209886|NCT03395353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209887|NCT03395353|Analgesics|analgesics|mesh-ancestor
93209888|NCT03395353|Sensory System Agents|sensory system agents|mesh-ancestor
93209889|NCT03395353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209890|NCT03395353|Antidepressive Agents|antidepressive agents|mesh-ancestor
93209891|NCT03395353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209892|NCT03395353|Dopamine Agents|dopamine agents|mesh-ancestor
93209893|NCT01376154|Lamivudine|lamivudine|mesh-list
93209894|NCT01376154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93209895|NCT01376154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93209896|NCT01376154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209897|NCT01376154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209898|NCT01376154|Antiviral Agents|antiviral agents|mesh-ancestor
93209899|NCT01376154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209900|NCT01376154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93209901|NCT01376154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93209902|NCT01562951|Adalimumab|adalimumab|mesh-list
93209903|NCT01562951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93209904|NCT01562951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93209905|NCT01562951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93209906|NCT01375842|Atezolizumab|atezolizumab|mesh-list
93209907|NCT01375842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93209908|NCT01375842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209909|NCT01375842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209910|NCT01375842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209911|NCT03682367|Gabapentin|gabapentin|mesh-list
93209912|NCT03682367|Analgesics|analgesics|mesh-ancestor
93209913|NCT03682367|Sensory System Agents|sensory system agents|mesh-ancestor
93209914|NCT03682367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93209915|NCT03682367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209916|NCT03682367|Anticonvulsants|anticonvulsants|mesh-ancestor
93209917|NCT03682367|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93209918|NCT03682367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93209919|NCT03682367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93209920|NCT03682367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93209921|NCT03682367|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93209922|NCT03682367|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93209923|NCT03682367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209924|NCT03682367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209925|NCT03682367|Antimanic Agents|antimanic agents|mesh-ancestor
93209926|NCT05170464|Caffeine|caffeine|mesh-list
93209927|NCT05170464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93209928|NCT05170464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209929|NCT05170464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93209930|NCT05170464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209931|NCT05170464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209932|NCT05170464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93209933|NCT05170464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93209934|NCT05170464|Purinergic Agents|purinergic agents|mesh-ancestor
93209935|NCT05170464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209936|NCT03677492|Cytochalasin D|cytochalasin d|mesh-list
93209937|NCT03677492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93209938|NCT03677492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209939|NCT03677492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209940|NCT03394885|Paclitaxel|paclitaxel|mesh-list
93209941|NCT03394885|Bevacizumab|bevacizumab|mesh-list
93209942|NCT03394885|Carboplatin|carboplatin|mesh-list
93209943|NCT03394885|Atezolizumab|atezolizumab|mesh-list
93209944|NCT03394885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93209945|NCT03394885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209946|NCT03394885|Tubulin Modulators|tubulin modulators|mesh-ancestor
93209947|NCT03394885|Antimitotic Agents|antimitotic agents|mesh-ancestor
93209948|NCT03394885|Mitosis Modulators|mitosis modulators|mesh-ancestor
93209949|NCT03394885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209950|NCT03394885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93209951|NCT03394885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93209952|NCT03394885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93209953|NCT03394885|Growth Substances|growth substances|mesh-ancestor
93209954|NCT03394885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209955|NCT03394885|Growth Inhibitors|growth inhibitors|mesh-ancestor
93209956|NCT03394885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93209958|NCT01361373|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93209959|NCT01361373|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93209960|NCT01361373|Dopamine Agents|dopamine agents|mesh-ancestor
93209961|NCT01361373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93209962|NCT01361373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209963|NCT01361373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209964|NCT03677336|Progesterone|progesterone|mesh-list
93209965|NCT03677336|Dydrogesterone|dydrogesterone|mesh-list
93209966|NCT03677336|Progestins|progestins|mesh-ancestor
93209967|NCT03677336|Hormones|hormones|mesh-ancestor
93209968|NCT03677336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93209969|NCT03677336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93209970|NCT02877927|Linezolid|linezolid|mesh-list
93209971|NCT02877927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209972|NCT02877927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209973|NCT02877927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93209974|NCT02877927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209975|NCT02877927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209976|NCT02706886|Lumasiran|lumasiran|mesh-list
93209977|NCT02706886|Renal Agents|renal agents|mesh-ancestor
93209978|NCT02809131|Levofloxacin|levofloxacin|mesh-list
93209979|NCT02809131|Clindamycin|clindamycin|mesh-list
93209980|NCT02809131|Clindamycin palmitate|clindamycin palmitate|mesh-list
93209981|NCT02809131|Clindamycin phosphate|clindamycin phosphate|mesh-list
93209982|NCT02809131|Cephalexin|cephalexin|mesh-list
93209983|NCT02809131|Polymyxins|polymyxins|mesh-list
93209984|NCT02809131|Bacitracin|bacitracin|mesh-list
93209985|NCT02809131|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93209986|NCT02809131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93209987|NCT02809131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93209988|NCT02809131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93209989|NCT02809131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93209990|NCT02809131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93209991|NCT02809131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93209992|NCT02809131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93209993|NCT02809131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93209994|NCT02809131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93209995|NCT02809131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93209996|NCT02809131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93209997|NCT05032950|Ritonavir|ritonavir|mesh-list
93209998|NCT05032950|Nirmatrelvir|nirmatrelvir|mesh-list
93209999|NCT05032950|Midazolam|midazolam|mesh-list
93210000|NCT05032950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93210001|NCT05032950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93210002|NCT05032950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210003|NCT05032950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210004|NCT05032950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93210005|NCT05032950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93210006|NCT05032950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93210007|NCT05032950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93210008|NCT05032950|Anesthetics, General|anesthetics, general|mesh-ancestor
93210009|NCT05032950|Anesthetics|anesthetics|mesh-ancestor
93210010|NCT05032950|GABA Modulators|gaba modulators|mesh-ancestor
93210011|NCT05032950|GABA Agents|gaba agents|mesh-ancestor
93210012|NCT05032950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210013|NCT05032950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210014|NCT05032950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93210015|NCT05032950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93210016|NCT05032950|Protease Inhibitors|protease inhibitors|mesh-ancestor
93210017|NCT05032950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210018|NCT05032950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93210019|NCT05032950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93210020|NCT05032950|Antiviral Agents|antiviral agents|mesh-ancestor
93210021|NCT05032950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210022|NCT05032950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93210023|NCT05032950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93210025|NCT01442649|Folic Acid|folic acid|mesh-list
93210026|NCT01442649|Bevacizumab|bevacizumab|mesh-list
93210027|NCT01442649|Cetuximab|cetuximab|mesh-list
93210028|NCT01442649|Oxaliplatin|oxaliplatin|mesh-list
93210029|NCT01442649|Irinotecan|irinotecan|mesh-list
93210030|NCT01442649|Fluorouracil|fluorouracil|mesh-list
93210031|NCT01442649|Levoleucovorin|levoleucovorin|mesh-list
93210032|NCT01442649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93210033|NCT01442649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210034|NCT01442649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93210035|NCT01442649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93210036|NCT01442649|Growth Substances|growth substances|mesh-ancestor
93210037|NCT01442649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210038|NCT01442649|Growth Inhibitors|growth inhibitors|mesh-ancestor
93210039|NCT01442649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93210040|NCT01442649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93210041|NCT01442649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210042|NCT01442649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210043|NCT01442649|Antidotes|antidotes|mesh-ancestor
93210044|NCT01442649|Protective Agents|protective agents|mesh-ancestor
93210045|NCT01442649|Vitamin B Complex|vitamin b complex|mesh-ancestor
93210046|NCT01442649|Vitamins|vitamins|mesh-ancestor
93210047|NCT01442649|Micronutrients|micronutrients|mesh-ancestor
93210048|NCT01442649|Hematinics|hematinics|mesh-ancestor
93210049|NCT01442649|Antimetabolites|antimetabolites|mesh-ancestor
93210050|NCT01442649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93210051|NCT01442649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93210052|NCT01442649|Immunologic Factors|immunologic factors|mesh-ancestor
93210053|NCT04995120|Paclitaxel|paclitaxel|mesh-list
93210054|NCT04995120|Cisplatin|cisplatin|mesh-list
93210055|NCT04995120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93210056|NCT04995120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210057|NCT04995120|Tubulin Modulators|tubulin modulators|mesh-ancestor
93210058|NCT04995120|Antimitotic Agents|antimitotic agents|mesh-ancestor
93210059|NCT04995120|Mitosis Modulators|mitosis modulators|mesh-ancestor
93210060|NCT04995120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210061|NCT01376232|Gemfibrozil|gemfibrozil|mesh-list
93210062|NCT01376232|Glycine|glycine|mesh-list
93210063|NCT01376232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93210064|NCT01376232|Antimetabolites|antimetabolites|mesh-ancestor
93210065|NCT01376232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210066|NCT01376232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93210067|NCT01376232|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93210068|NCT01376232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93210069|NCT01376232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210070|NCT01376232|Glycine Agents|glycine agents|mesh-ancestor
93210071|NCT01376232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210072|NCT01376232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210073|NCT01354665|Interferons|interferons|mesh-list
93210074|NCT01354665|Interferon-beta|interferon-beta|mesh-list
93210075|NCT01354665|Interferon beta-1b|interferon beta-1b|mesh-list
93210076|NCT01354665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210077|NCT01354665|Antiviral Agents|antiviral agents|mesh-ancestor
93210078|NCT01354665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210079|NCT01354665|Immunologic Factors|immunologic factors|mesh-ancestor
93210080|NCT01354665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210081|NCT01354665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93210082|NCT01354743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93210083|NCT01354743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93210084|NCT01354743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210085|NCT01354743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210086|NCT01354743|Cholinergic Agents|cholinergic agents|mesh-ancestor
93210087|NCT01354743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210088|NCT01354743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210089|NCT05008575|Fludarabine|fludarabine|mesh-list
93210090|NCT05008575|Cyclophosphamide|cyclophosphamide|mesh-list
93210091|NCT05008575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210092|NCT05008575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210093|NCT05008575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93210094|NCT05008575|Immunologic Factors|immunologic factors|mesh-ancestor
93210095|NCT05008575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210096|NCT05008575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210097|NCT05008575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93210098|NCT05008575|Alkylating Agents|alkylating agents|mesh-ancestor
92882146|NCT02779283|Sorafenib|sorafenib|mesh-list
93210099|NCT05008575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93210100|NCT01319487|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93210101|NCT01319487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93210102|NCT03111108|Grazoprevir|grazoprevir|mesh-list
93210103|NCT03111108|Antiviral Agents|antiviral agents|mesh-ancestor
93210104|NCT03111108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210105|NCT00702520|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93210106|NCT00702520|Hormones|hormones|mesh-list
93210107|NCT00702520|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93210108|NCT00702520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210109|NCT00702520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210110|NCT00702520|Luteolytic Agents|luteolytic agents|mesh-ancestor
93210111|NCT00702520|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93210112|NCT00702520|Contraceptive Agents|contraceptive agents|mesh-ancestor
93210113|NCT00702520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210114|NCT00702520|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93210115|NCT00702520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210116|NCT00702520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210117|NCT05198856|Thalidomide|thalidomide|mesh-list
93210118|NCT05198856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93210119|NCT05198856|Immunologic Factors|immunologic factors|mesh-ancestor
93210120|NCT05198856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210121|NCT05198856|Leprostatic Agents|leprostatic agents|mesh-ancestor
93210122|NCT05198856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93210123|NCT05198856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210124|NCT05198856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93210125|NCT05198856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93210126|NCT05198856|Growth Substances|growth substances|mesh-ancestor
93210127|NCT05198856|Growth Inhibitors|growth inhibitors|mesh-ancestor
93210128|NCT05198856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210129|NCT02876601|Defibrotide|defibrotide|mesh-list
93210130|NCT02876601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93210131|NCT02876601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93210132|NCT02876601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210133|NCT02876601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210134|NCT04059536|Aspirin|aspirin|mesh-list
93210135|NCT04059536|Heparin|heparin|mesh-list
93210136|NCT04059536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93210137|NCT04059536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93210138|NCT04059536|Analgesics|analgesics|mesh-ancestor
93210139|NCT04059536|Sensory System Agents|sensory system agents|mesh-ancestor
93210140|NCT04059536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210141|NCT04059536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210142|NCT04059536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210143|NCT04059536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210144|NCT04059536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93210145|NCT04059536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93210146|NCT04059536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210147|NCT04059536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210148|NCT04059536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93210149|NCT04059536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210150|NCT04059536|Antipyretics|antipyretics|mesh-ancestor
93210151|NCT04059536|Anticoagulants|anticoagulants|mesh-ancestor
93210152|NCT05711628|Carboplatin|carboplatin|mesh-list
93210153|NCT05711628|Gemcitabine|gemcitabine|mesh-list
93210154|NCT05711628|Doxorubicin|doxorubicin|mesh-list
93210155|NCT05711628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93210156|NCT05711628|Pembrolizumab|pembrolizumab|mesh-list
93210157|NCT05711628|Etoposide|etoposide|mesh-list
93210158|NCT05711628|Etoposide phosphate|etoposide phosphate|mesh-list
93210159|NCT05711628|Vinorelbine|vinorelbine|mesh-list
93210160|NCT05711628|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93210161|NCT05711628|Ifosfamide|ifosfamide|mesh-list
93210162|NCT05711628|Isophosphamide mustard|isophosphamide mustard|mesh-list
93210163|NCT05711628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93210164|NCT05711628|Podophyllotoxin|podophyllotoxin|mesh-list
93210165|NCT05711628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93210166|NCT05711628|Antibodies|antibodies|mesh-list
93210167|NCT05711628|Immunoglobulins|immunoglobulins|mesh-list
93210168|NCT05711628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93210169|NCT05711628|Immunoconjugates|immunoconjugates|mesh-list
93210170|NCT05711628|Immunologic Factors|immunologic factors|mesh-ancestor
93210171|NCT05711628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210172|NCT05711628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210173|NCT05711628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93210174|NCT05711628|Antimetabolites|antimetabolites|mesh-ancestor
93210175|NCT05711628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210176|NCT05711628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93210177|NCT05711628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93210178|NCT05711628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93210179|NCT05711628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210180|NCT05711628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93210181|NCT05711628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93210182|NCT05711628|Tubulin Modulators|tubulin modulators|mesh-ancestor
93210183|NCT05711628|Antimitotic Agents|antimitotic agents|mesh-ancestor
93210184|NCT05711628|Mitosis Modulators|mitosis modulators|mesh-ancestor
91928557|NCT03169725|Immunologic Factors|immunologic factors|mesh-ancestor
93210185|NCT05711628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93210186|NCT05711628|Alkylating Agents|alkylating agents|mesh-ancestor
93210187|NCT05711628|Immunotoxins|immunotoxins|mesh-ancestor
93210188|NCT05711628|Keratolytic Agents|keratolytic agents|mesh-ancestor
93210189|NCT05711628|Dermatologic Agents|dermatologic agents|mesh-ancestor
93210190|NCT03178396|Melatonin|melatonin|mesh-list
93210191|NCT03178396|Antioxidants|antioxidants|mesh-ancestor
93210192|NCT03178396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210193|NCT03178396|Protective Agents|protective agents|mesh-ancestor
93210194|NCT03178396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210195|NCT03178396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210196|NCT03677258|Hyaluronic Acid|hyaluronic acid|mesh-list
93210197|NCT03677258|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93210198|NCT03677258|Immunologic Factors|immunologic factors|mesh-ancestor
93210199|NCT03677258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210200|NCT03677258|Viscosupplements|viscosupplements|mesh-ancestor
93210201|NCT03677258|Protective Agents|protective agents|mesh-ancestor
93210202|NCT01361763|Dabigatran|dabigatran|mesh-list
93210203|NCT01361763|Antithrombins|antithrombins|mesh-ancestor
93210204|NCT01361763|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93210205|NCT01361763|Protease Inhibitors|protease inhibitors|mesh-ancestor
93210206|NCT01361763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210207|NCT01361763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210208|NCT01361763|Anticoagulants|anticoagulants|mesh-ancestor
93210209|NCT02420782|Itraconazole|itraconazole|mesh-list
93210210|NCT02420782|Midazolam|midazolam|mesh-list
93210211|NCT02420782|Pilocarpine|pilocarpine|mesh-list
93210212|NCT02420782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93210213|NCT02420782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93210214|NCT02420782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210215|NCT02420782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210216|NCT02420782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93210217|NCT02420782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93210218|NCT02420782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93210219|NCT02420782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93210220|NCT02420782|Anesthetics, General|anesthetics, general|mesh-ancestor
93210221|NCT02420782|Anesthetics|anesthetics|mesh-ancestor
93210222|NCT02420782|GABA Modulators|gaba modulators|mesh-ancestor
93210223|NCT02420782|GABA Agents|gaba agents|mesh-ancestor
93210224|NCT02420782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210225|NCT02420782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210226|NCT02420782|Antifungal Agents|antifungal agents|mesh-ancestor
93210227|NCT02420782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210228|NCT02420782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93210229|NCT02420782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93210230|NCT02420782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210231|NCT02420782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93210232|NCT02420782|Hormone Antagonists|hormone antagonists|mesh-ancestor
93210233|NCT02420782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210234|NCT02420782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93210235|NCT02420782|Miotics|miotics|mesh-ancestor
93210236|NCT02420782|Autonomic Agents|autonomic agents|mesh-ancestor
93210237|NCT02420782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210238|NCT02420782|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93210239|NCT02420782|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93210240|NCT02420782|Cholinergic Agents|cholinergic agents|mesh-ancestor
93210241|NCT04054193|Dexamethasone|dexamethasone|mesh-list
93210242|NCT04054193|Fosaprepitant|fosaprepitant|mesh-list
93210243|NCT04054193|Aprepitant|aprepitant|mesh-list
93210244|NCT04054193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
93210245|NCT04054193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210246|NCT04054193|Antiemetics|antiemetics|mesh-ancestor
92882296|NCT00867165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93210247|NCT04054193|Autonomic Agents|autonomic agents|mesh-ancestor
93210248|NCT04054193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210249|NCT04054193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210250|NCT04054193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210251|NCT04054193|Glucocorticoids|glucocorticoids|mesh-ancestor
93210252|NCT04054193|Hormones|hormones|mesh-ancestor
93210253|NCT04054193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210254|NCT04054193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210255|NCT04054193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210256|NCT04054193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93210257|NCT04054193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928783|NCT02179931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93210258|NCT04054193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210259|NCT04054193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93210260|NCT04054193|Serotonin Agents|serotonin agents|mesh-ancestor
93210261|NCT03394027|TIC10 compound|tic10 compound|mesh-list
93210262|NCT03394027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210263|NCT03682172|Glucagon|glucagon|mesh-list
93210264|NCT03682172|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93210265|NCT03682172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210266|NCT03682172|Hormones|hormones|mesh-ancestor
93210267|NCT03682172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210268|NCT03682172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210269|NCT03682172|Incretins|incretins|mesh-ancestor
93210270|NCT03184480|Fluticasone|fluticasone|mesh-list
93210271|NCT03184480|Xhance|xhance|mesh-list
93210272|NCT03184480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210273|NCT03184480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93210274|NCT03184480|Autonomic Agents|autonomic agents|mesh-ancestor
93210275|NCT03184480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210276|NCT03184480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210277|NCT03184480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93210278|NCT03184480|Respiratory System Agents|respiratory system agents|mesh-ancestor
93210279|NCT03184480|Dermatologic Agents|dermatologic agents|mesh-ancestor
93210280|NCT03184480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93210281|NCT03136107|Sunscreening Agents|sunscreening agents|mesh-list
93210282|NCT03136107|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93210283|NCT03136107|Protective Agents|protective agents|mesh-ancestor
93210284|NCT03136107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210285|NCT03136107|Dermatologic Agents|dermatologic agents|mesh-ancestor
93210286|NCT03686774|Memantine|memantine|mesh-list
93210287|NCT03686774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93210288|NCT03686774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93210289|NCT03686774|Dopamine Agents|dopamine agents|mesh-ancestor
93210290|NCT03686774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210291|NCT03686774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210292|NCT03686774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210293|NCT03686774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93210294|NCT03686774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93210295|NCT02420392|Dapagliflozin|dapagliflozin|mesh-list
93210296|NCT02420392|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93210297|NCT02420392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210298|NCT02420392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93210299|NCT02420392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210300|NCT01562795|Fluorometholone|fluorometholone|mesh-list
93210301|NCT01562795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93210302|NCT01562795|Lubricant Eye Drops|lubricant eye drops|mesh-list
93210303|NCT01562795|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93210304|NCT01562795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93210305|NCT01562795|Glucocorticoids|glucocorticoids|mesh-ancestor
93210306|NCT01562795|Hormones|hormones|mesh-ancestor
93210307|NCT01562795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210308|NCT01562795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210309|NCT01562795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93210310|NCT02424136|Nitric Oxide|nitric oxide|mesh-list
93210311|NCT02424136|Immunoglobulins|immunoglobulins|mesh-list
93210312|NCT02424136|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93210313|NCT02424136|Antibodies|antibodies|mesh-list
93210314|NCT02424136|Immunologic Factors|immunologic factors|mesh-ancestor
93210315|NCT02424136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210316|NCT02424136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93210317|NCT02424136|Autonomic Agents|autonomic agents|mesh-ancestor
93210318|NCT02424136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210319|NCT02424136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93210320|NCT02424136|Respiratory System Agents|respiratory system agents|mesh-ancestor
93210321|NCT02424136|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93210322|NCT02424136|Antioxidants|antioxidants|mesh-ancestor
93210323|NCT02424136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210324|NCT02424136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210325|NCT02424136|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93210326|NCT02424136|Vasodilator Agents|vasodilator agents|mesh-ancestor
93210327|NCT02424136|Gasotransmitters|gasotransmitters|mesh-ancestor
93210328|NCT02424136|Protective Agents|protective agents|mesh-ancestor
93210329|NCT03770676|Selenium|selenium|mesh-list
93210330|NCT03770676|Antioxidants|antioxidants|mesh-ancestor
93210331|NCT03770676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855907|NCT02745756|Vaccines|vaccines|mesh-list
93210332|NCT03770676|Protective Agents|protective agents|mesh-ancestor
93210333|NCT03770676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210334|NCT03770676|Trace Elements|trace elements|mesh-ancestor
93210335|NCT03770676|Micronutrients|micronutrients|mesh-ancestor
93210336|NCT01361841|Bimatoprost|bimatoprost|mesh-list
93210337|NCT01361841|Travoprost|travoprost|mesh-list
93210338|NCT01361841|Latanoprost|latanoprost|mesh-list
93210339|NCT01361841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93210340|NCT01361841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93210341|NCT01361841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93210342|NCT02583789|Treprostinil|treprostinil|mesh-list
93210343|NCT02583789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93210344|NCT01355367|Nifedipine|nifedipine|mesh-list
93210345|NCT01355367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93210346|NCT01355367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210347|NCT01355367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210348|NCT01355367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93210349|NCT01355367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210350|NCT01355367|Vasodilator Agents|vasodilator agents|mesh-ancestor
93210351|NCT01355367|Tocolytic Agents|tocolytic agents|mesh-ancestor
93210352|NCT01355367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210353|NCT05759520|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93210354|NCT05759520|Immunologic Factors|immunologic factors|mesh-ancestor
93210355|NCT05759520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210356|NCT02427880|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93210357|NCT02427880|Furosemide|furosemide|mesh-list
93210358|NCT02427880|Acetazolamide|acetazolamide|mesh-list
93210359|NCT02427880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93210360|NCT02427880|Diuretics|diuretics|mesh-ancestor
93210361|NCT02427880|Natriuretic Agents|natriuretic agents|mesh-ancestor
93210362|NCT02427880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210363|NCT02427880|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93210364|NCT02427880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210365|NCT02427880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210366|NCT02427880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93210367|NCT02427880|Anticonvulsants|anticonvulsants|mesh-ancestor
93210368|NCT02427880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93210369|NCT02427880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210370|NCT01355445|Irinotecan|irinotecan|mesh-list
93210371|NCT01355445|Vincristine|vincristine|mesh-list
93210372|NCT01355445|Temozolomide|temozolomide|mesh-list
93210373|NCT01355445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93210374|NCT01355445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93210375|NCT01355445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210376|NCT01355445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210377|NCT01355445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210378|NCT01355445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93210379|NCT01355445|Tubulin Modulators|tubulin modulators|mesh-ancestor
93210380|NCT01355445|Antimitotic Agents|antimitotic agents|mesh-ancestor
93210381|NCT01355445|Mitosis Modulators|mitosis modulators|mesh-ancestor
93210382|NCT01355445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93210383|NCT01355445|Alkylating Agents|alkylating agents|mesh-ancestor
93210384|NCT05759442|Metformin|metformin|mesh-list
93210385|NCT05759442|Acetic Acid|acetic acid|mesh-list
93210386|NCT05759442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93210387|NCT05759442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210388|NCT05759442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93210389|NCT05759442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210390|NCT02420080|Brincidofovir|brincidofovir|mesh-list
93210391|NCT02420080|Antiviral Agents|antiviral agents|mesh-ancestor
93210392|NCT02420080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210393|NCT04483258|Sevoflurane|sevoflurane|mesh-list
93210394|NCT04483258|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210395|NCT04483258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93210396|NCT04483258|Anesthetics, General|anesthetics, general|mesh-ancestor
93210397|NCT04483258|Anesthetics|anesthetics|mesh-ancestor
93210398|NCT04483258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210399|NCT04483258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210400|NCT01355757|Anesthetics|anesthetics|mesh-list
92882444|NCT02393248|Gemcitabine|gemcitabine|mesh-list
93210401|NCT01355757|Anesthetics, Local|anesthetics, local|mesh-list
93210402|NCT01355757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210403|NCT01355757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210404|NCT01355757|Sensory System Agents|sensory system agents|mesh-ancestor
93210405|NCT01355757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210406|NCT02507505|Anesthetics|anesthetics|mesh-list
93210407|NCT02507505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210408|NCT02507505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210409|NCT03181360|Tenecteplase|tenecteplase|mesh-list
93210410|NCT03181360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93210411|NCT03181360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93210412|NCT03181360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210413|NCT04275531|Anesthetics|anesthetics|mesh-list
93210414|NCT04275531|Propofol|propofol|mesh-list
93210415|NCT04275531|Sevoflurane|sevoflurane|mesh-list
93210416|NCT04275531|Isoflurane|isoflurane|mesh-list
93210417|NCT04275531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210418|NCT04275531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210419|NCT04275531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93210420|NCT04275531|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93210421|NCT04275531|Anesthetics, General|anesthetics, general|mesh-ancestor
93210422|NCT04275531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210423|NCT04275531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93210424|NCT03689712|Manganese|manganese|mesh-list
93210425|NCT03689712|Avasopasem manganese|avasopasem manganese|mesh-list
93210426|NCT03689712|Trace Elements|trace elements|mesh-ancestor
93210427|NCT03689712|Micronutrients|micronutrients|mesh-ancestor
93210428|NCT03689712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210429|NCT03689712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93210430|NCT03689712|Antioxidants|antioxidants|mesh-ancestor
93210431|NCT03689712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210432|NCT03689712|Protective Agents|protective agents|mesh-ancestor
93210433|NCT01361997|Ethanol|ethanol|mesh-list
93210434|NCT01361997|Chlorhexidine|chlorhexidine|mesh-list
93210435|NCT01361997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93210436|NCT01361997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210437|NCT01361997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210438|NCT01361997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210439|NCT01361997|Disinfectants|disinfectants|mesh-ancestor
93210440|NCT04750824|Afatinib|afatinib|mesh-list
93210441|NCT04750824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210442|NCT04750824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93210443|NCT04750824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210444|NCT04750824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210445|NCT03180970|Lugol's solution|lugol's solution|mesh-list
93210446|NCT03180970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93210447|NCT03180970|Hemostatics|hemostatics|mesh-ancestor
93210448|NCT03180970|Coagulants|coagulants|mesh-ancestor
93210449|NCT03631446|Picosulfate sodium|picosulfate sodium|mesh-list
93210450|NCT03631446|Magnesium Oxide|magnesium oxide|mesh-list
93210451|NCT03631446|Citric Acid|citric acid|mesh-list
93210452|NCT03631446|Sodium Citrate|sodium citrate|mesh-list
93210453|NCT03631446|Cathartics|cathartics|mesh-ancestor
93210454|NCT03631446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210455|NCT03631446|Anticoagulants|anticoagulants|mesh-ancestor
93210456|NCT03631446|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93210457|NCT03631446|Chelating Agents|chelating agents|mesh-ancestor
93210458|NCT03631446|Sequestering Agents|sequestering agents|mesh-ancestor
93210459|NCT03631446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210460|NCT03631446|Antacids|antacids|mesh-ancestor
93210461|NCT01362153|Golimumab|golimumab|mesh-list
93210462|NCT01362153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93210463|NCT01362153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93210464|NCT01362153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210465|NCT01362153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93210466|NCT01362153|Immunologic Factors|immunologic factors|mesh-ancestor
93210467|NCT01362153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210468|NCT03184324|Esomeprazole|esomeprazole|mesh-list
93210469|NCT03184324|Fexuprazan|fexuprazan|mesh-list
93210470|NCT03184324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93210471|NCT03184324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210472|NCT03184324|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93210473|NCT03184324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210474|NCT03184324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210475|NCT02427334|Dienogest|dienogest|mesh-list
92882540|NCT02777801|Entecavir|entecavir|mesh-list
93210476|NCT02427334|Fluoxetine|fluoxetine|mesh-list
93210477|NCT02427334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93210478|NCT02427334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93210480|NCT02427334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210481|NCT02427334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210482|NCT02427334|Serotonin Agents|serotonin agents|mesh-ancestor
92506346|NCT00006264|Zidovudine|zidovudine|mesh-list
93210483|NCT02427334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210484|NCT02427334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93210485|NCT02427334|Antidepressive Agents|antidepressive agents|mesh-ancestor
93210486|NCT02427334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93210487|NCT02427334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93210488|NCT02427334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93210489|NCT02427334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210490|NCT02427334|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93210491|NCT02427334|Contraceptive Agents|contraceptive agents|mesh-ancestor
93210492|NCT02427334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210493|NCT02427334|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93210494|NCT02427334|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93210495|NCT02427334|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93210496|NCT02427334|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93210497|NCT02427334|Hormone Antagonists|hormone antagonists|mesh-ancestor
93210498|NCT02427334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210499|NCT02427334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210500|NCT02427334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210501|NCT03620253|Modafinil|modafinil|mesh-list
93210502|NCT03620253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93210503|NCT03620253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210504|NCT03620253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93210505|NCT03620253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93210506|NCT03620253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93210507|NCT03620253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210508|NCT01355991|Tiotropium Bromide|tiotropium bromide|mesh-list
93210509|NCT01355991|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93210510|NCT01355991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93210511|NCT01355991|Autonomic Agents|autonomic agents|mesh-ancestor
93210512|NCT01355991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210513|NCT01355991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210514|NCT01355991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93210515|NCT01355991|Respiratory System Agents|respiratory system agents|mesh-ancestor
93210516|NCT01355991|Parasympatholytics|parasympatholytics|mesh-ancestor
93210517|NCT01355991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93210518|NCT01355991|Cholinergic Agents|cholinergic agents|mesh-ancestor
93210519|NCT01355991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210520|NCT01355991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210521|NCT01355991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93210522|NCT01355991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93210523|NCT01355991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93210524|NCT01355991|Adrenergic Agents|adrenergic agents|mesh-ancestor
93210525|NCT01358253|Cytarabine|cytarabine|mesh-list
93210526|NCT01358253|Dexamethasone|dexamethasone|mesh-list
93210527|NCT01358253|Prednisone|prednisone|mesh-list
93210528|NCT01358253|Cyclophosphamide|cyclophosphamide|mesh-list
93210529|NCT01358253|Rituximab|rituximab|mesh-list
93210530|NCT01358253|Doxorubicin|doxorubicin|mesh-list
93210531|NCT01358253|Methotrexate|methotrexate|mesh-list
93210532|NCT01358253|Vincristine|vincristine|mesh-list
93210533|NCT01358253|Asparaginase|asparaginase|mesh-list
93210534|NCT01358253|Mercaptopurine|mercaptopurine|mesh-list
93210535|NCT01358253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93210536|NCT01358253|Immunologic Factors|immunologic factors|mesh-ancestor
93210537|NCT01358253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210538|NCT01358253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210539|NCT01358253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93210540|NCT01358253|Alkylating Agents|alkylating agents|mesh-ancestor
93210541|NCT01358253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210542|NCT01358253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210543|NCT01358253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93210544|NCT01358253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93210545|NCT01358253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210546|NCT01358253|Antiemetics|antiemetics|mesh-ancestor
93210547|NCT01358253|Autonomic Agents|autonomic agents|mesh-ancestor
93210548|NCT01358253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210549|NCT01358253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210550|NCT01358253|Glucocorticoids|glucocorticoids|mesh-ancestor
93210551|NCT01358253|Hormones|hormones|mesh-ancestor
93210552|NCT01358253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210553|NCT01358253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210554|NCT01358253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506408|NCT00006294|Vasodilator Agents|vasodilator agents|mesh-ancestor
93210555|NCT01358253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93210556|NCT01358253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93210557|NCT01358253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210558|NCT01358253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93210559|NCT01358253|Abortifacient Agents|abortifacient agents|mesh-ancestor
93210560|NCT01358253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210561|NCT01358253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93210562|NCT01358253|Antimetabolites|antimetabolites|mesh-ancestor
93210563|NCT01358253|Dermatologic Agents|dermatologic agents|mesh-ancestor
93210564|NCT01358253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93210565|NCT01358253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93210566|NCT01358253|Antiviral Agents|antiviral agents|mesh-ancestor
93210567|NCT01358253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210568|NCT01358253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93210569|NCT01358253|Tubulin Modulators|tubulin modulators|mesh-ancestor
93210570|NCT01358253|Antimitotic Agents|antimitotic agents|mesh-ancestor
93210571|NCT01358253|Mitosis Modulators|mitosis modulators|mesh-ancestor
93210572|NCT03548064|Vaccines|vaccines|mesh-list
93210573|NCT03548064|Immunologic Factors|immunologic factors|mesh-ancestor
93210574|NCT03548064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210575|NCT03180346|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93210576|NCT03180346|Laxatives|laxatives|mesh-ancestor
93210577|NCT03180346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210578|NCT01356225|Ketorolac|ketorolac|mesh-list
93210579|NCT01356225|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93210580|NCT01356225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93210581|NCT01356225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93210582|NCT01356225|Analgesics|analgesics|mesh-ancestor
93210583|NCT01356225|Sensory System Agents|sensory system agents|mesh-ancestor
93210584|NCT01356225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210585|NCT01356225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210586|NCT01356225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210587|NCT01356225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210588|NCT01356225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93210589|NCT01356225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210590|NCT01356225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210591|NCT02427412|Tranexamic Acid|tranexamic acid|mesh-list
93210592|NCT02427412|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93210593|NCT02427412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93210594|NCT02427412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210595|NCT02427412|Hemostatics|hemostatics|mesh-ancestor
93210596|NCT02427412|Coagulants|coagulants|mesh-ancestor
93210597|NCT01356303|Docetaxel|docetaxel|mesh-list
93210598|NCT01356303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210599|NCT01356303|Tubulin Modulators|tubulin modulators|mesh-ancestor
93210600|NCT01356303|Antimitotic Agents|antimitotic agents|mesh-ancestor
93210601|NCT01356303|Mitosis Modulators|mitosis modulators|mesh-ancestor
93210602|NCT01356303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210603|NCT02220309|Pramipexole|pramipexole|mesh-list
93210604|NCT02220309|Antioxidants|antioxidants|mesh-ancestor
93210605|NCT02220309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210606|NCT02220309|Protective Agents|protective agents|mesh-ancestor
93210607|NCT02220309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210608|NCT02220309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93210609|NCT02220309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93210610|NCT02220309|Dopamine Agonists|dopamine agonists|mesh-ancestor
93210611|NCT02220309|Dopamine Agents|dopamine agents|mesh-ancestor
93210612|NCT02220309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210613|NCT02419534|Diltiazem|diltiazem|mesh-list
93210614|NCT02419534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93210615|NCT02419534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93210616|NCT02419534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210617|NCT02419534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210618|NCT02419534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93210619|NCT02419534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210620|NCT02419534|Vasodilator Agents|vasodilator agents|mesh-ancestor
93210621|NCT03527316|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93210622|NCT03527316|Hallucinogens|hallucinogens|mesh-ancestor
93210623|NCT03527316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210624|NCT03527316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882666|NCT02660762|Prednisone|prednisone|mesh-list
93210625|NCT03527316|Serotonin Agents|serotonin agents|mesh-ancestor
93210626|NCT03527316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855909|NCT02745756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210627|NCT03527316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210628|NCT03527316|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93210629|NCT03527316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93210630|NCT03527316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210631|NCT03527316|Adrenergic Agents|adrenergic agents|mesh-ancestor
93210632|NCT01358409|Nebivolol|nebivolol|mesh-list
93210633|NCT01358409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93210634|NCT01358409|Vasodilator Agents|vasodilator agents|mesh-ancestor
93210635|NCT01358409|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93210636|NCT01358409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93210637|NCT01358409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93210638|NCT01358409|Adrenergic Agents|adrenergic agents|mesh-ancestor
93210639|NCT01358409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210640|NCT01358409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210641|NCT01358409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210642|NCT02423590|Carboplatin|carboplatin|mesh-list
93210643|NCT02423590|Gemcitabine|gemcitabine|mesh-list
93210644|NCT02423590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210645|NCT02423590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93210646|NCT02423590|Antimetabolites|antimetabolites|mesh-ancestor
93210647|NCT02423590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210648|NCT01362309|Cycloserine|cycloserine|mesh-list
93210649|NCT01362309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93210650|NCT01362309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210651|NCT01362309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93210652|NCT01362309|Antitubercular Agents|antitubercular agents|mesh-ancestor
93210653|NCT01362309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93210654|NCT01362309|Antimetabolites|antimetabolites|mesh-ancestor
93210655|NCT01362309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210656|NCT03710863|Vorolanib|vorolanib|mesh-list
93210657|NCT03710863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93210658|NCT03710863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210659|NCT03710863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210660|NCT03178084|Lamivudine|lamivudine|mesh-list
93210661|NCT03178084|Zidovudine|zidovudine|mesh-list
93210662|NCT03178084|Efavirenz|efavirenz|mesh-list
93210663|NCT03178084|Maraviroc|maraviroc|mesh-list
93210664|NCT03178084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93210665|NCT03178084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93210666|NCT03178084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210667|NCT03178084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210668|NCT03178084|Antiviral Agents|antiviral agents|mesh-ancestor
93210669|NCT03178084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210670|NCT03178084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93210671|NCT03178084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93210672|NCT03178084|Antimetabolites|antimetabolites|mesh-ancestor
93210673|NCT03178084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93210674|NCT03178084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93210675|NCT03178084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93210676|NCT03178084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93210677|NCT03178084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93210678|NCT03178084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93210679|NCT03178084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93210680|NCT03178084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93210681|NCT03178084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93210682|NCT01356381|Vildagliptin|vildagliptin|mesh-list
93210683|NCT01356381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93210684|NCT01356381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210685|NCT01356381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93210686|NCT01356381|Protease Inhibitors|protease inhibitors|mesh-ancestor
93210687|NCT01356381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210688|NCT01356381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210689|NCT03117166|Lidocaine|lidocaine|mesh-list
93210690|NCT03117166|Anesthetics, Local|anesthetics, local|mesh-ancestor
93210691|NCT03117166|Anesthetics|anesthetics|mesh-ancestor
93210692|NCT03117166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93210693|NCT03117166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210694|NCT03117166|Sensory System Agents|sensory system agents|mesh-ancestor
93210695|NCT03117166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210696|NCT03117166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93210697|NCT03117166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93210698|NCT03117166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93210699|NCT03117166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93210700|NCT03117166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210701|NCT03302286|Mannitol|mannitol|mesh-list
93210702|NCT03302286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93210703|NCT03302286|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93210704|NCT03302286|Diuretics|diuretics|mesh-ancestor
93210705|NCT03302286|Natriuretic Agents|natriuretic agents|mesh-ancestor
93210706|NCT03302286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210707|NCT01356615|Heparin|heparin|mesh-list
93210708|NCT01356615|Calcium heparin|calcium heparin|mesh-list
93210709|NCT01356615|Enoxaparin|enoxaparin|mesh-list
93210710|NCT01356615|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93210711|NCT01356615|Tinzaparin|tinzaparin|mesh-list
93210712|NCT01356615|Dalteparin|dalteparin|mesh-list
93210713|NCT01356615|Enoxaparin sodium|enoxaparin sodium|mesh-list
93210714|NCT01356615|Anticoagulants|anticoagulants|mesh-ancestor
93210715|NCT01356615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93210716|NCT01356615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93210717|NCT01356615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210718|NCT03180190|Hydroxychloroquine|hydroxychloroquine|mesh-list
93210719|NCT03180190|Antimalarials|antimalarials|mesh-ancestor
93210720|NCT03180190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93210721|NCT03180190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93210722|NCT03180190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210723|NCT03180190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210724|NCT03180190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210725|NCT03180190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210726|NCT04583592|Gabexate|gabexate|mesh-list
93210727|NCT04583592|Camostat|camostat|mesh-list
93210728|NCT04583592|Protease Inhibitors|protease inhibitors|mesh-ancestor
93210729|NCT04583592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210730|NCT04583592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210731|NCT04583592|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93210732|NCT04583592|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93210733|NCT04583592|Anticoagulants|anticoagulants|mesh-ancestor
93210734|NCT02418988|Chlorotrianisene|chlorotrianisene|mesh-list
93210735|NCT02418988|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93210736|NCT02418988|Estrogens|estrogens|mesh-ancestor
93210737|NCT02418988|Hormones|hormones|mesh-ancestor
93210738|NCT02418988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210739|NCT02418988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210740|NCT02418988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210741|NCT02418988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210742|NCT01356927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93210743|NCT01356927|Etonogestrel|etonogestrel|mesh-list
93210744|NCT01356927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93210745|NCT01356927|Contraceptive Agents|contraceptive agents|mesh-ancestor
93210746|NCT01356927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210747|NCT01356927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210748|NCT01356927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93210749|NCT01356927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93210750|NCT01356927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210751|NCT01356927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210752|NCT03439670|Prednisone|prednisone|mesh-list
93210753|NCT03439670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210754|NCT03439670|Glucocorticoids|glucocorticoids|mesh-ancestor
93210755|NCT03439670|Hormones|hormones|mesh-ancestor
93210756|NCT03439670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210757|NCT03439670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210758|NCT03439670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210759|NCT03439670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210760|NCT02930343|Folic Acid|folic acid|mesh-list
93210761|NCT02930343|Hydroxychloroquine|hydroxychloroquine|mesh-list
93210762|NCT02930343|Sulfasalazine|sulfasalazine|mesh-list
93210763|NCT02930343|Prednisolone|prednisolone|mesh-list
93210764|NCT02930343|Methotrexate|methotrexate|mesh-list
93210765|NCT02930343|Leflunomide|leflunomide|mesh-list
93210766|NCT02930343|Glucocorticoids|glucocorticoids|mesh-list
93210767|NCT02930343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93210768|NCT02930343|Abortifacient Agents|abortifacient agents|mesh-ancestor
93210769|NCT02930343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210770|NCT02930343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882818|NCT02578108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93210771|NCT02930343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93210772|NCT02930343|Antimetabolites|antimetabolites|mesh-ancestor
93210773|NCT02930343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210775|NCT02930343|Dermatologic Agents|dermatologic agents|mesh-ancestor
93210776|NCT02930343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210777|NCT02930343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93210778|NCT02930343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93210779|NCT02930343|Immunologic Factors|immunologic factors|mesh-ancestor
93210780|NCT02930343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210781|NCT02930343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93210782|NCT02930343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210783|NCT02930343|Hormones|hormones|mesh-ancestor
93210784|NCT02930343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210785|NCT02930343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93210786|NCT02930343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210787|NCT02930343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210788|NCT02930343|Antimalarials|antimalarials|mesh-ancestor
93210789|NCT02930343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93210790|NCT02930343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93210791|NCT02930343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210792|NCT02930343|Hematinics|hematinics|mesh-ancestor
93210793|NCT02930343|Vitamin B Complex|vitamin b complex|mesh-ancestor
93210794|NCT02930343|Vitamins|vitamins|mesh-ancestor
93210795|NCT02930343|Micronutrients|micronutrients|mesh-ancestor
93210796|NCT02930343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93210797|NCT02930343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93210798|NCT02930343|Analgesics|analgesics|mesh-ancestor
93210799|NCT02930343|Sensory System Agents|sensory system agents|mesh-ancestor
93210800|NCT03686618|Secretin|secretin|mesh-list
93210801|NCT03686618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210802|NCT03686618|Hormones|hormones|mesh-ancestor
93210803|NCT03686618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210804|NCT03686618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210805|NCT02426866|Efavirenz|efavirenz|mesh-list
93210806|NCT02426866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93210807|NCT02426866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93210808|NCT02426866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210809|NCT02426866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210810|NCT02426866|Antiviral Agents|antiviral agents|mesh-ancestor
93210811|NCT02426866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93210812|NCT02426866|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93210813|NCT02426866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93210814|NCT02426866|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93210815|NCT02426866|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93210816|NCT02426866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93210817|NCT02426866|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93210818|NCT02423824|Liraglutide|liraglutide|mesh-list
93210819|NCT02423824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93210820|NCT02423824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210821|NCT02423824|Incretins|incretins|mesh-ancestor
93210822|NCT02423824|Hormones|hormones|mesh-ancestor
93210823|NCT02423824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210824|NCT01012167|Galantamine|galantamine|mesh-list
93210825|NCT01012167|Oxytocin|oxytocin|mesh-list
93210826|NCT01012167|Oxytocics|oxytocics|mesh-ancestor
93210827|NCT01012167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93210828|NCT01012167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210829|NCT01012167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93210830|NCT01012167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210831|NCT01012167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210832|NCT01012167|Cholinergic Agents|cholinergic agents|mesh-ancestor
93210833|NCT01012167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210834|NCT01012167|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93210835|NCT01012167|Autonomic Agents|autonomic agents|mesh-ancestor
93210836|NCT01012167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210837|NCT01012167|Nootropic Agents|nootropic agents|mesh-ancestor
93210838|NCT02423278|Oxaliplatin|oxaliplatin|mesh-list
93210839|NCT02423278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210840|NCT05189067|Paclitaxel|paclitaxel|mesh-list
93210841|NCT05189067|Docetaxel|docetaxel|mesh-list
93210842|NCT05189067|Trastuzumab|trastuzumab|mesh-list
93210843|NCT05189067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93210844|NCT05189067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210845|NCT05189067|Tubulin Modulators|tubulin modulators|mesh-ancestor
93210846|NCT05189067|Antimitotic Agents|antimitotic agents|mesh-ancestor
93210847|NCT05189067|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882892|NCT00988039|Lopinavir|lopinavir|mesh-list
93210848|NCT05189067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210849|NCT05189067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93210850|NCT03133767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93210851|NCT02422966|Acetaminophen|acetaminophen|mesh-list
93210852|NCT02422966|Ibuprofen|ibuprofen|mesh-list
93210853|NCT02422966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93210854|NCT02422966|Analgesics|analgesics|mesh-ancestor
93210855|NCT02422966|Sensory System Agents|sensory system agents|mesh-ancestor
93210856|NCT02422966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210857|NCT02422966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210858|NCT02422966|Antipyretics|antipyretics|mesh-ancestor
93210859|NCT02422966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93210860|NCT02422966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210861|NCT02422966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210862|NCT02422966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93210863|NCT02422966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210864|NCT02422966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210865|NCT02422888|Ticagrelor|ticagrelor|mesh-list
93210866|NCT02422888|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93210867|NCT02422888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210868|NCT02422888|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93210869|NCT02422888|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93210870|NCT02422888|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93210871|NCT02422888|Purinergic Agents|purinergic agents|mesh-ancestor
93210872|NCT02422888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210873|NCT02422888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210874|NCT02422888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210875|NCT03633552|Temozolomide|temozolomide|mesh-list
93210876|NCT03633552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93210877|NCT03633552|Alkylating Agents|alkylating agents|mesh-ancestor
93210878|NCT03633552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210879|NCT03633552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210880|NCT05760456|Metformin|metformin|mesh-list
93210881|NCT05760456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93210882|NCT05760456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210883|NCT02418130|Inositol|inositol|mesh-list
93210884|NCT02418130|Thiamine|thiamine|mesh-list
93210885|NCT02418130|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93210886|NCT02418130|Vitamin B Complex|vitamin b complex|mesh-ancestor
93210887|NCT02418130|Vitamins|vitamins|mesh-ancestor
93210888|NCT02418130|Micronutrients|micronutrients|mesh-ancestor
93210889|NCT02418130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210890|NCT02418130|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93210891|NCT02418130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210892|NCT03391765|Tilavonemab|tilavonemab|mesh-list
93210893|NCT03391765|Nootropic Agents|nootropic agents|mesh-ancestor
93210894|NCT02802228|Ifetroban|ifetroban|mesh-list
93210895|NCT02802228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210896|NCT02801448|Sulforaphane|sulforaphane|mesh-list
93210897|NCT02801448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93210898|NCT02801448|Protective Agents|protective agents|mesh-ancestor
93210899|NCT02801448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210900|NCT02801448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210901|NCT03179332|Insulin Lispro|insulin lispro|mesh-list
93210902|NCT03179332|Insulin Aspart|insulin aspart|mesh-list
93210903|NCT03179332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93210904|NCT03179332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210905|NCT03674177|Vaccines|vaccines|mesh-list
93210906|NCT03674177|Immunologic Factors|immunologic factors|mesh-ancestor
93210907|NCT03674177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210908|NCT02675790|Hydroxyurea|hydroxyurea|mesh-list
93210909|NCT02675790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93210910|NCT02675790|Antisickling Agents|antisickling agents|mesh-ancestor
93210911|NCT02675790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210912|NCT02675790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210913|NCT02675790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93210914|NCT02417896|Spironolactone|spironolactone|mesh-list
93210915|NCT02417896|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93210916|NCT02417896|Hormone Antagonists|hormone antagonists|mesh-ancestor
93210917|NCT02417896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210918|NCT02417896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210919|NCT02417896|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93210920|NCT02417896|Diuretics|diuretics|mesh-ancestor
93210921|NCT02417896|Natriuretic Agents|natriuretic agents|mesh-ancestor
93210922|NCT03183544|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93210923|NCT03183544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93210924|NCT03183544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210925|NCT04380090|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
93210926|NCT04380090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93210927|NCT04380090|Antidiarrheals|antidiarrheals|mesh-ancestor
93210928|NCT03116776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93210929|NCT03116776|Hyaluronic Acid|hyaluronic acid|mesh-list
93210930|NCT03116776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93210931|NCT03116776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93210932|NCT03116776|Immunologic Factors|immunologic factors|mesh-ancestor
93210933|NCT03116776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210934|NCT03116776|Viscosupplements|viscosupplements|mesh-ancestor
93210935|NCT03116776|Protective Agents|protective agents|mesh-ancestor
93210936|NCT02505204|Clonidine|clonidine|mesh-list
93210937|NCT02505204|Analgesics|analgesics|mesh-ancestor
93210938|NCT02505204|Sensory System Agents|sensory system agents|mesh-ancestor
93210939|NCT02505204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210940|NCT02505204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210941|NCT02505204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93210942|NCT02505204|Sympatholytics|sympatholytics|mesh-ancestor
93210943|NCT02505204|Autonomic Agents|autonomic agents|mesh-ancestor
93210944|NCT02505204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93210945|NCT02505204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93210946|NCT02505204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93210947|NCT02505204|Adrenergic Agents|adrenergic agents|mesh-ancestor
93210948|NCT02505204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210949|NCT02505204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210950|NCT04351698|Montelukast|montelukast|mesh-list
93210951|NCT04351698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93210952|NCT04351698|Respiratory System Agents|respiratory system agents|mesh-ancestor
93210953|NCT04351698|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93210954|NCT04351698|Hormone Antagonists|hormone antagonists|mesh-ancestor
93210955|NCT04351698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93210956|NCT04351698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210957|NCT04351698|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93210958|NCT04351698|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93210959|NCT04351698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210960|NCT01359423|Cilostazol|cilostazol|mesh-list
93210961|NCT01359423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93210962|NCT01359423|Autonomic Agents|autonomic agents|mesh-ancestor
93210963|NCT01359423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210964|NCT01359423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210965|NCT01359423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93210966|NCT01359423|Respiratory System Agents|respiratory system agents|mesh-ancestor
93210967|NCT01359423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93210968|NCT01359423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93210969|NCT01359423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93210970|NCT01359423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93210971|NCT01359423|Vasodilator Agents|vasodilator agents|mesh-ancestor
93210972|NCT01359423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93210973|NCT01359423|Protective Agents|protective agents|mesh-ancestor
93210974|NCT01359423|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93210975|NCT01359423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93210976|NCT01359423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210977|NCT01363089|Ketorolac|ketorolac|mesh-list
93210978|NCT01363089|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93210979|NCT01363089|Phenylephrine|phenylephrine|mesh-list
93210980|NCT01363089|Oxymetazoline|oxymetazoline|mesh-list
93210981|NCT01363089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93210982|NCT01363089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93210983|NCT01363089|Analgesics|analgesics|mesh-ancestor
93210984|NCT01363089|Sensory System Agents|sensory system agents|mesh-ancestor
93210985|NCT01363089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93210986|NCT01363089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93210987|NCT01363089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93210988|NCT01363089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93210989|NCT01363089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93210990|NCT01363089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93210991|NCT01363089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506873|NCT00005959|Hormones|hormones|mesh-ancestor
93210992|NCT01363089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93210993|NCT01363089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93210994|NCT01363089|Adrenergic Agents|adrenergic agents|mesh-ancestor
93210995|NCT01363089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93210996|NCT01363089|Sympathomimetics|sympathomimetics|mesh-ancestor
93210997|NCT01363089|Autonomic Agents|autonomic agents|mesh-ancestor
93210998|NCT01363089|Nasal Decongestants|nasal decongestants|mesh-ancestor
93210999|NCT01363089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93211000|NCT01363089|Respiratory System Agents|respiratory system agents|mesh-ancestor
93211001|NCT01363089|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93211002|NCT01363089|Mydriatics|mydriatics|mesh-ancestor
93211003|NCT01363089|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93211004|NCT01363089|Protective Agents|protective agents|mesh-ancestor
93211005|NCT01365741|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93211006|NCT01365741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93211007|NCT03361748|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93211008|NCT03361748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211009|NCT03361748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211010|NCT03681548|Doxorubicin|doxorubicin|mesh-list
93211011|NCT03681548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93211012|NCT03681548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93211013|NCT03681548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211014|NCT03681548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93211015|NCT03681548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93211016|NCT03681548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211017|NCT03681548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211018|NCT02417506|Ibuprofen|ibuprofen|mesh-list
93211019|NCT02417506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93211020|NCT02417506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93211021|NCT02417506|Analgesics|analgesics|mesh-ancestor
93211022|NCT02417506|Sensory System Agents|sensory system agents|mesh-ancestor
93211023|NCT02417506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211024|NCT02417506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211025|NCT02417506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211026|NCT02417506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211027|NCT02417506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93211028|NCT02417506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211029|NCT02417506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211030|NCT05188911|Prednisone|prednisone|mesh-list
93211031|NCT05188911|Androgens|androgens|mesh-list
93211032|NCT05188911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211033|NCT05188911|Glucocorticoids|glucocorticoids|mesh-ancestor
93211034|NCT05188911|Hormones|hormones|mesh-ancestor
93211035|NCT05188911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211036|NCT05188911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211037|NCT05188911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93211038|NCT05188911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211039|NCT03676946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93211040|NCT03676946|Antibodies|antibodies|mesh-list
93211041|NCT03676946|Immunoglobulins|immunoglobulins|mesh-list
93211042|NCT03676946|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93211043|NCT03676946|Immunologic Factors|immunologic factors|mesh-ancestor
93211044|NCT03676946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211045|NCT03676946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211046|NCT01363167|Vitamin D|vitamin d|mesh-list
93211047|NCT01363167|Cholecalciferol|cholecalciferol|mesh-list
93211048|NCT01363167|Vitamins|vitamins|mesh-ancestor
93211049|NCT01363167|Micronutrients|micronutrients|mesh-ancestor
93211050|NCT01363167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211051|NCT01363167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93211052|NCT01363167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93211053|NCT01359579|Varespladib methyl|varespladib methyl|mesh-list
93211054|NCT01359579|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93211055|NCT01359579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211056|NCT01359579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211057|NCT02422654|Eliglustat|eliglustat|mesh-list
93211058|NCT02422654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211059|NCT02422654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211060|NCT05188833|Paroxetine|paroxetine|mesh-list
93211061|NCT05188833|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93211062|NCT05188833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93211063|NCT05188833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211064|NCT05188833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211065|NCT05188833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211066|NCT05188833|Serotonin Agents|serotonin agents|mesh-ancestor
93211067|NCT05188833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211068|NCT05188833|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93211069|NCT05188833|Antidepressive Agents|antidepressive agents|mesh-ancestor
93211070|NCT05188833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93211071|NCT05188833|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93211072|NCT05188833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93211073|NCT05188833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211074|NCT02426164|Methylprednisolone|methylprednisolone|mesh-list
93211075|NCT02426164|Epinephrine|epinephrine|mesh-list
93211076|NCT02426164|Morphine|morphine|mesh-list
93211077|NCT02426164|Bupivacaine|bupivacaine|mesh-list
93211078|NCT02426164|Anesthetics, Local|anesthetics, local|mesh-ancestor
93211079|NCT02426164|Anesthetics|anesthetics|mesh-ancestor
93211080|NCT02426164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211081|NCT02426164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211082|NCT02426164|Sensory System Agents|sensory system agents|mesh-ancestor
93211083|NCT02426164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211084|NCT02426164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93211085|NCT02426164|Narcotics|narcotics|mesh-ancestor
93211086|NCT02426164|Analgesics|analgesics|mesh-ancestor
93211087|NCT02426164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211088|NCT02426164|Antiemetics|antiemetics|mesh-ancestor
93211089|NCT02426164|Autonomic Agents|autonomic agents|mesh-ancestor
93211090|NCT02426164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211091|NCT02426164|Glucocorticoids|glucocorticoids|mesh-ancestor
93211092|NCT02426164|Hormones|hormones|mesh-ancestor
93211093|NCT02426164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211094|NCT02426164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93211095|NCT02426164|Protective Agents|protective agents|mesh-ancestor
93211096|NCT02426164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93211097|NCT02426164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93211098|NCT02426164|Adrenergic Agents|adrenergic agents|mesh-ancestor
93211099|NCT02426164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211100|NCT02426164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211101|NCT02426164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93211102|NCT02426164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93211103|NCT02426164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93211104|NCT02426164|Respiratory System Agents|respiratory system agents|mesh-ancestor
93211105|NCT02426164|Mydriatics|mydriatics|mesh-ancestor
93211106|NCT02426164|Sympathomimetics|sympathomimetics|mesh-ancestor
93211107|NCT02426164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93211108|NCT03745157|Insulin|insulin|mesh-list
93211109|NCT03745157|Insulin Aspart|insulin aspart|mesh-list
93211110|NCT03745157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93211111|NCT03745157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211112|NCT02426008|Mitogens|mitogens|mesh-list
93211113|NCT02426008|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211114|NCT02426008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211115|NCT04050371|Tenofovir|tenofovir|mesh-list
93211116|NCT04050371|Emtricitabine|emtricitabine|mesh-list
93211117|NCT04050371|Antiviral Agents|antiviral agents|mesh-ancestor
93211118|NCT04050371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211119|NCT04050371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93211120|NCT04050371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93211121|NCT04050371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211122|NCT04050371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211123|NCT04050371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93211124|NCT04050371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93211125|NCT04447287|Buprenorphine|buprenorphine|mesh-list
93211126|NCT04447287|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93211127|NCT04447287|ASP8062|asp8062|mesh-list
93211128|NCT04447287|Naloxone|naloxone|mesh-list
93211129|NCT04447287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93211130|NCT04447287|Narcotics|narcotics|mesh-ancestor
93211131|NCT04447287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211132|NCT04447287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211133|NCT04447287|Analgesics|analgesics|mesh-ancestor
93211134|NCT04447287|Sensory System Agents|sensory system agents|mesh-ancestor
93211135|NCT04447287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211136|NCT04447287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93211137|NCT04447287|GABA Modulators|gaba modulators|mesh-ancestor
93211138|NCT04447287|GABA Agents|gaba agents|mesh-ancestor
93211139|NCT04447287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211140|NCT04447287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211141|NCT01879319|Evolocumab|evolocumab|mesh-list
93211142|NCT01879319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93211143|NCT01879319|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93211144|NCT01879319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92883202|NCT04006639|Analgesics|analgesics|mesh-list
93211145|NCT01879319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93211146|NCT01879319|Antimetabolites|antimetabolites|mesh-ancestor
93211147|NCT01879319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211148|NCT01879319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93211149|NCT01879319|Protease Inhibitors|protease inhibitors|mesh-ancestor
93211150|NCT01879319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211151|NCT01879319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93211152|NCT01879319|Immunologic Factors|immunologic factors|mesh-ancestor
93211153|NCT01879319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211154|NCT04165122|Valacyclovir|valacyclovir|mesh-list
93211155|NCT04165122|Antiviral Agents|antiviral agents|mesh-ancestor
93211156|NCT04165122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211157|NCT02422030|Atorvastatin|atorvastatin|mesh-list
93211158|NCT02422030|Fenofibric acid|fenofibric acid|mesh-list
93211159|NCT02422030|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93211160|NCT02422030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93211161|NCT02422030|Antimetabolites|antimetabolites|mesh-ancestor
93211162|NCT02422030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211163|NCT02422030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93211164|NCT02422030|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93211165|NCT02422030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211166|NCT02425930|Oxaliplatin|oxaliplatin|mesh-list
93211167|NCT02425930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211169|NCT01365897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93211170|NCT01365897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211171|NCT01365897|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93211172|NCT01365897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93211173|NCT01365897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93211174|NCT01365897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211175|NCT02422108|Denosumab|denosumab|mesh-list
93211176|NCT02422108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93211177|NCT02422108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211178|NCT01359657|Dexamethasone|dexamethasone|mesh-list
93211179|NCT01359657|Dexamethasone acetate|dexamethasone acetate|mesh-list
93211180|NCT01359657|Lenalidomide|lenalidomide|mesh-list
93211181|NCT01359657|Bortezomib|bortezomib|mesh-list
93211182|NCT01359657|BB 1101|bb 1101|mesh-list
93211183|NCT01359657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93211184|NCT01359657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211185|NCT01359657|Antiemetics|antiemetics|mesh-ancestor
93211186|NCT01359657|Autonomic Agents|autonomic agents|mesh-ancestor
93211187|NCT01359657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211188|NCT01359657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211189|NCT01359657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211190|NCT01359657|Glucocorticoids|glucocorticoids|mesh-ancestor
93211191|NCT01359657|Hormones|hormones|mesh-ancestor
93211192|NCT01359657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211193|NCT01359657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93211194|NCT01359657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211195|NCT01359657|Protease Inhibitors|protease inhibitors|mesh-ancestor
93211196|NCT01359657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211197|NCT01359657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211198|NCT01359657|Immunologic Factors|immunologic factors|mesh-ancestor
93211199|NCT01359657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93211200|NCT01359657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93211201|NCT01359657|Growth Substances|growth substances|mesh-ancestor
93211202|NCT01359657|Growth Inhibitors|growth inhibitors|mesh-ancestor
93211203|NCT02417116|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93211204|NCT02417116|Hyaluronic Acid|hyaluronic acid|mesh-list
93211205|NCT02417116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93211206|NCT02417116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93211207|NCT02417116|Immunologic Factors|immunologic factors|mesh-ancestor
93211208|NCT02417116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211209|NCT02417116|Viscosupplements|viscosupplements|mesh-ancestor
93211210|NCT02417116|Protective Agents|protective agents|mesh-ancestor
93211211|NCT03183310|Chlorpromazine|chlorpromazine|mesh-list
93211212|NCT03183310|Antiemetics|antiemetics|mesh-ancestor
93211213|NCT03183310|Autonomic Agents|autonomic agents|mesh-ancestor
93211214|NCT03183310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211215|NCT03183310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211216|NCT03183310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211217|NCT03183310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93211218|NCT03183310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93211219|NCT03183310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211220|NCT03183310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93211221|NCT03183310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93211222|NCT03183310|Dopamine Agents|dopamine agents|mesh-ancestor
93211223|NCT03183310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211224|NCT03183310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211225|NCT03177850|Acetazolamide|acetazolamide|mesh-list
93211226|NCT03177850|Anticonvulsants|anticonvulsants|mesh-ancestor
93211227|NCT03177850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93211228|NCT03177850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211229|NCT03177850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211230|NCT03177850|Diuretics|diuretics|mesh-ancestor
93211231|NCT03177850|Natriuretic Agents|natriuretic agents|mesh-ancestor
93211232|NCT03177850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211233|NCT03102918|Cannabidiol|cannabidiol|mesh-list
93211234|NCT03102918|Anticonvulsants|anticonvulsants|mesh-ancestor
93211235|NCT03102762|Botulinum Toxins|botulinum toxins|mesh-list
93211236|NCT03102762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93211237|NCT03102762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93211238|NCT03102762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93211239|NCT03102762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211240|NCT03102762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211241|NCT03102762|Cholinergic Agents|cholinergic agents|mesh-ancestor
93211242|NCT03102762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211243|NCT03102762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211244|NCT03102762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93211245|NCT03102762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211246|NCT03684824|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93211247|NCT03684824|Luteolytic Agents|luteolytic agents|mesh-ancestor
93211248|NCT03684824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93211249|NCT03684824|Contraceptive Agents|contraceptive agents|mesh-ancestor
93211250|NCT03684824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211251|NCT03684824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211252|NCT03684824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93211253|NCT03684824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93211254|NCT03684824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211255|NCT03177538|Menotropins|menotropins|mesh-list
93211256|NCT03177538|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93211257|NCT03177538|Hormones|hormones|mesh-ancestor
93211258|NCT03177538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211259|NCT03177538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211260|NCT03177538|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93211261|NCT03177538|Fertility Agents|fertility agents|mesh-ancestor
93211262|NCT03177538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211263|NCT01363323|Moxifloxacin|moxifloxacin|mesh-list
93211264|NCT01363323|Naltrexone|naltrexone|mesh-list
93211265|NCT01363323|Methylnaltrexone|methylnaltrexone|mesh-list
93211266|NCT01363323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211267|NCT01363323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211268|NCT01363323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93211269|NCT01363323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93211270|NCT01363323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211271|NCT01363323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211272|NCT01363323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211273|NCT01363323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211274|NCT01363323|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93211275|NCT01363323|Sensory System Agents|sensory system agents|mesh-ancestor
93211276|NCT01363323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211277|NCT01363323|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93211278|NCT03183076|Anticonvulsants|anticonvulsants|mesh-list
93211279|NCT03106948|Ascorbic Acid|ascorbic acid|mesh-list
93211280|NCT03106948|Penicillamine|penicillamine|mesh-list
93211281|NCT03106948|Antioxidants|antioxidants|mesh-ancestor
93211282|NCT03106948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211283|NCT03106948|Protective Agents|protective agents|mesh-ancestor
93211284|NCT03106948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211285|NCT03106948|Vitamins|vitamins|mesh-ancestor
93211286|NCT03106948|Micronutrients|micronutrients|mesh-ancestor
93211287|NCT03106948|Antidotes|antidotes|mesh-ancestor
93211288|NCT03106948|Chelating Agents|chelating agents|mesh-ancestor
93211289|NCT03106948|Sequestering Agents|sequestering agents|mesh-ancestor
93211290|NCT03106948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211291|NCT01366365|Methylnaltrexone|methylnaltrexone|mesh-list
93211292|NCT01366365|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93211293|NCT01366365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211294|NCT01366365|Sensory System Agents|sensory system agents|mesh-ancestor
93211295|NCT01366365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211296|NCT01881048|Celecoxib|celecoxib|mesh-list
93211297|NCT01881048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93211298|NCT01881048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93211299|NCT01881048|Analgesics|analgesics|mesh-ancestor
93211300|NCT01881048|Sensory System Agents|sensory system agents|mesh-ancestor
93211301|NCT01881048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211302|NCT01881048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211303|NCT01881048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211304|NCT01881048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211305|NCT01881048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93211306|NCT01881048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93211307|NCT01881048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211308|NCT01881048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211309|NCT01363557|Gefitinib|gefitinib|mesh-list
93211310|NCT01363557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211311|NCT01363557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93211312|NCT01363557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211313|NCT01363557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211314|NCT01346475|Valacyclovir|valacyclovir|mesh-list
93211315|NCT01346475|Antiviral Agents|antiviral agents|mesh-ancestor
93211316|NCT01346475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211317|NCT01338636|Ambrisentan|ambrisentan|mesh-list
93211318|NCT01338636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93211319|NCT02416258|Betamethasone|betamethasone|mesh-list
93211320|NCT02416258|Betamethasone Valerate|betamethasone valerate|mesh-list
93211321|NCT02416258|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93211322|NCT02416258|Betamethasone benzoate|betamethasone benzoate|mesh-list
93211323|NCT02416258|Calcipotriene|calcipotriene|mesh-list
93211324|NCT02416258|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93211325|NCT02416258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211326|NCT02416258|Glucocorticoids|glucocorticoids|mesh-ancestor
93211327|NCT02416258|Hormones|hormones|mesh-ancestor
93211328|NCT02416258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211329|NCT02416258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211330|NCT02416258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93211331|NCT02416258|Respiratory System Agents|respiratory system agents|mesh-ancestor
93211332|NCT02416258|Dermatologic Agents|dermatologic agents|mesh-ancestor
93211333|NCT02410720|Picosulfate sodium|picosulfate sodium|mesh-list
93211334|NCT02410720|Cathartics|cathartics|mesh-ancestor
93211335|NCT02410720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211336|NCT02416570|Clarithromycin|clarithromycin|mesh-list
93211337|NCT02416570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211338|NCT02416570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211339|NCT02416570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93211340|NCT02416570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211341|NCT02416570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211342|NCT02416570|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93211343|NCT02416570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93211344|NCT05328336|Paclitaxel|paclitaxel|mesh-list
93211345|NCT05328336|Tislelizumab|tislelizumab|mesh-list
93211346|NCT05328336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93211347|NCT05328336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211348|NCT05328336|Tubulin Modulators|tubulin modulators|mesh-ancestor
93211349|NCT05328336|Antimitotic Agents|antimitotic agents|mesh-ancestor
93211350|NCT05328336|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211351|NCT05328336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211352|NCT05328336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211353|NCT02873754|Bupropion|bupropion|mesh-list
93211354|NCT02873754|Nicotine|nicotine|mesh-list
93211355|NCT02873754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93211356|NCT02873754|Autonomic Agents|autonomic agents|mesh-ancestor
93211357|NCT02873754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211358|NCT02873754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211359|NCT02873754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93211360|NCT02873754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93211361|NCT02873754|Cholinergic Agents|cholinergic agents|mesh-ancestor
93211362|NCT02873754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211363|NCT02873754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211364|NCT02873754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93211365|NCT02873754|Antidepressive Agents|antidepressive agents|mesh-ancestor
93211366|NCT02873754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93211367|NCT02873754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93211368|NCT02873754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93211369|NCT02873754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211370|NCT02873754|Dopamine Agents|dopamine agents|mesh-ancestor
93211371|NCT02873754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93211372|NCT02873754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93211374|NCT03669614|Gallium citrate|gallium citrate|mesh-list
93211375|NCT03669614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211376|NCT03669614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93211377|NCT05200260|Niraparib|niraparib|mesh-list
93211378|NCT05200260|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93211379|NCT05200260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211380|NCT05200260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211381|NCT05200260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211382|NCT02416804|Buprenorphine|buprenorphine|mesh-list
93211383|NCT02416804|Tramadol|tramadol|mesh-list
93211384|NCT02416804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93211385|NCT02416804|Narcotics|narcotics|mesh-ancestor
93211386|NCT02416804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211387|NCT02416804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211388|NCT02416804|Analgesics|analgesics|mesh-ancestor
93211389|NCT02416804|Sensory System Agents|sensory system agents|mesh-ancestor
93211390|NCT02416804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211391|NCT02416804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93211392|NCT04792320|Charcoal|charcoal|mesh-list
93211393|NCT04792320|Antidotes|antidotes|mesh-ancestor
93211394|NCT04792320|Protective Agents|protective agents|mesh-ancestor
93211395|NCT04792320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211396|NCT03176758|Anesthetics|anesthetics|mesh-list
93211397|NCT03176758|Anesthetics, General|anesthetics, general|mesh-list
93211398|NCT03176758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211399|NCT03176758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211400|NCT03177070|Methylene Blue|methylene blue|mesh-list
93211401|NCT03177070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211402|NCT03177070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211403|NCT03680612|Cefepime|cefepime|mesh-list
93211404|NCT03680612|Enmetazobactam|enmetazobactam|mesh-list
93211405|NCT03680612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211406|NCT03680612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211407|NCT03680612|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93211408|NCT03680612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211409|NCT03680612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211410|NCT02410096|Methacholine Chloride|methacholine chloride|mesh-list
93211411|NCT02410096|Miotics|miotics|mesh-ancestor
93211412|NCT02410096|Autonomic Agents|autonomic agents|mesh-ancestor
93211413|NCT02410096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211414|NCT02410096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211415|NCT02410096|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93211416|NCT02410096|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93211417|NCT02410096|Respiratory System Agents|respiratory system agents|mesh-ancestor
93211418|NCT02410096|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93211419|NCT02410096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93211420|NCT02410096|Cholinergic Agents|cholinergic agents|mesh-ancestor
93211421|NCT02410096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211422|NCT02410096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211423|NCT04046939|Pramipexole|pramipexole|mesh-list
93211424|NCT04046939|Antioxidants|antioxidants|mesh-ancestor
93211425|NCT04046939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211426|NCT04046939|Protective Agents|protective agents|mesh-ancestor
93211427|NCT04046939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211428|NCT04046939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93211429|NCT04046939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93211430|NCT04046939|Dopamine Agonists|dopamine agonists|mesh-ancestor
93211431|NCT04046939|Dopamine Agents|dopamine agents|mesh-ancestor
93211432|NCT04046939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211433|NCT05188131|Diclofenac|diclofenac|mesh-list
93211434|NCT05188131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93211435|NCT05188131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93211436|NCT05188131|Analgesics|analgesics|mesh-ancestor
93211437|NCT05188131|Sensory System Agents|sensory system agents|mesh-ancestor
93211438|NCT05188131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211439|NCT05188131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211440|NCT05188131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211441|NCT05188131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211442|NCT05188131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93211443|NCT05188131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211444|NCT05188131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211445|NCT01360437|Ticagrelor|ticagrelor|mesh-list
93211446|NCT01360437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93211447|NCT01360437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93211448|NCT01360437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93211449|NCT01360437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93211450|NCT01360437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93211451|NCT01360437|Purinergic Agents|purinergic agents|mesh-ancestor
93211452|NCT01360437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211453|NCT01360437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211454|NCT01360437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211455|NCT02409862|Oxytocin|oxytocin|mesh-list
93211456|NCT02409862|Oxytocics|oxytocics|mesh-ancestor
93211457|NCT02409862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211458|NCT02409862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211459|NCT01360671|Sildenafil Citrate|sildenafil citrate|mesh-list
93211460|NCT01360671|Vasodilator Agents|vasodilator agents|mesh-ancestor
93211461|NCT01360671|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93211462|NCT01360671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93211463|NCT01360671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211464|NCT01360671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211465|NCT01360671|Urological Agents|urological agents|mesh-ancestor
93211466|NCT02955797|Vaccines|vaccines|mesh-list
93211467|NCT02955797|Immunologic Factors|immunologic factors|mesh-ancestor
93211468|NCT02955797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211469|NCT03680378|Cefepime|cefepime|mesh-list
93211470|NCT03680378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211471|NCT03680378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211472|NCT01319331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93211473|NCT01319331|Protein C Inhibitor|protein c inhibitor|mesh-list
93211474|NCT01319331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93211475|NCT01319331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93211476|NCT01319331|Protease Inhibitors|protease inhibitors|mesh-ancestor
93211477|NCT01319331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211478|NCT01319331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211479|NCT05418348|Nimodipine|nimodipine|mesh-list
93211480|NCT05418348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93211481|NCT05418348|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93211482|NCT05418348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211483|NCT05418348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211484|NCT05418348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93211485|NCT05418348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211486|NCT05418348|Vasodilator Agents|vasodilator agents|mesh-ancestor
93211487|NCT03010176|Pembrolizumab|pembrolizumab|mesh-list
93211488|NCT03010176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211489|NCT03010176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211490|NCT03010176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93211491|NCT03010176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211492|NCT03176524|Glucagon|glucagon|mesh-list
93211493|NCT03176524|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93211494|NCT03176524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211495|NCT03176524|Hormones|hormones|mesh-ancestor
93211496|NCT03176524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211497|NCT03176524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211498|NCT03176524|Incretins|incretins|mesh-ancestor
93211499|NCT03676088|Mitogens|mitogens|mesh-list
93211500|NCT03676088|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211501|NCT03676088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211502|NCT02414464|Calcium, Dietary|calcium, dietary|mesh-list
93211503|NCT02414464|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93211504|NCT02414464|Calcium|calcium|mesh-list
93211505|NCT02414464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93211506|NCT02414464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211507|NCT02414464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93211508|NCT02414464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93211509|NCT02414464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211510|NCT03226418|Cytarabine|cytarabine|mesh-list
93211511|NCT03226418|Azacitidine|azacitidine|mesh-list
93211512|NCT03226418|Decitabine|decitabine|mesh-list
93211513|NCT03226418|Daunorubicin|daunorubicin|mesh-list
93211514|NCT03226418|Venetoclax|venetoclax|mesh-list
93211515|NCT03226418|Idarubicin|idarubicin|mesh-list
93211516|NCT03226418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93211517|NCT03226418|Antimetabolites|antimetabolites|mesh-ancestor
93211518|NCT03226418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211519|NCT03226418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211520|NCT03226418|Antiviral Agents|antiviral agents|mesh-ancestor
93211521|NCT03226418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883565|NCT02658422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93211522|NCT03226418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93211523|NCT03226418|Immunologic Factors|immunologic factors|mesh-ancestor
93211524|NCT03226418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211525|NCT03226418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211526|NCT03226418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93211527|NCT03226418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93211528|NCT03226418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93211529|NCT04039503|Tirzepatide|tirzepatide|mesh-list
93211530|NCT04039503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93211531|NCT04039503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211532|NCT04039503|Incretins|incretins|mesh-ancestor
93211533|NCT04039503|Hormones|hormones|mesh-ancestor
93211534|NCT04039503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211535|NCT05418114|Magnesium Sulfate|magnesium sulfate|mesh-list
93211536|NCT05418114|Analgesics|analgesics|mesh-ancestor
93211537|NCT05418114|Sensory System Agents|sensory system agents|mesh-ancestor
93211538|NCT05418114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211539|NCT05418114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211540|NCT05418114|Anesthetics|anesthetics|mesh-ancestor
93211541|NCT05418114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211542|NCT05418114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93211543|NCT05418114|Anticonvulsants|anticonvulsants|mesh-ancestor
93211544|NCT05418114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93211545|NCT05418114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211546|NCT05418114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211547|NCT05418114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93211548|NCT05418114|Tocolytic Agents|tocolytic agents|mesh-ancestor
93211549|NCT05418114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211550|NCT05528952|Bevacizumab|bevacizumab|mesh-list
93211551|NCT05528952|Atezolizumab|atezolizumab|mesh-list
93211552|NCT05528952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211553|NCT05528952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211554|NCT05528952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93211555|NCT05528952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93211556|NCT05528952|Growth Substances|growth substances|mesh-ancestor
93211557|NCT05528952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211558|NCT05528952|Growth Inhibitors|growth inhibitors|mesh-ancestor
93211559|NCT05528952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93211560|NCT05528952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211561|NCT05189769|Levonorgestrel|levonorgestrel|mesh-list
93211562|NCT05189769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93211563|NCT05189769|Contraceptive Agents|contraceptive agents|mesh-ancestor
93211564|NCT05189769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211565|NCT05189769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211566|NCT05189769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93211567|NCT05189769|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93211568|NCT05189769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93211569|NCT03672812|Liraglutide|liraglutide|mesh-list
93211570|NCT03672812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93211571|NCT03672812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211572|NCT03672812|Incretins|incretins|mesh-ancestor
93211573|NCT03672812|Hormones|hormones|mesh-ancestor
93211574|NCT03672812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211575|NCT05417880|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93211576|NCT05417880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211577|NCT05029726|Clonidine|clonidine|mesh-list
93211578|NCT05029726|Epinephrine|epinephrine|mesh-list
93211579|NCT05029726|Bupivacaine|bupivacaine|mesh-list
93211580|NCT05029726|Anesthetics, Local|anesthetics, local|mesh-ancestor
93211581|NCT05029726|Anesthetics|anesthetics|mesh-ancestor
93211582|NCT05029726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211583|NCT05029726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211584|NCT05029726|Sensory System Agents|sensory system agents|mesh-ancestor
93211585|NCT05029726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211586|NCT05029726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93211587|NCT05029726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93211588|NCT05029726|Adrenergic Agents|adrenergic agents|mesh-ancestor
93211589|NCT05029726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211590|NCT05029726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211591|NCT05029726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93211592|NCT05029726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93211593|NCT05029726|Autonomic Agents|autonomic agents|mesh-ancestor
93211594|NCT05029726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93211595|NCT05029726|Respiratory System Agents|respiratory system agents|mesh-ancestor
93211597|NCT05029726|Sympathomimetics|sympathomimetics|mesh-ancestor
93211598|NCT05029726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93211599|NCT05029726|Analgesics|analgesics|mesh-ancestor
93211600|NCT05029726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93211601|NCT05029726|Sympatholytics|sympatholytics|mesh-ancestor
93211602|NCT05029726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93211603|NCT05186883|Parathyroid Hormone|parathyroid hormone|mesh-list
93211604|NCT05186883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93211605|NCT05186883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211606|NCT05007652|Plerixafor|plerixafor|mesh-list
93211607|NCT05007652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93211608|NCT05007652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93211609|NCT05007652|Antiviral Agents|antiviral agents|mesh-ancestor
93211610|NCT05007652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211611|NCT03632772|Solifenacin Succinate|solifenacin succinate|mesh-list
93211612|NCT03632772|Mirabegron|mirabegron|mesh-list
93211613|NCT03632772|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93211614|NCT03632772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93211615|NCT03632772|Cholinergic Agents|cholinergic agents|mesh-ancestor
93211616|NCT03632772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211617|NCT03632772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211618|NCT03632772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211619|NCT03632772|Urological Agents|urological agents|mesh-ancestor
93211620|NCT03632772|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93211621|NCT03632772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93211622|NCT03632772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93211623|NCT03632772|Adrenergic Agents|adrenergic agents|mesh-ancestor
93211624|NCT01360749|Lidocaine|lidocaine|mesh-list
93211625|NCT01360749|Anesthetics, Local|anesthetics, local|mesh-ancestor
93211626|NCT01360749|Anesthetics|anesthetics|mesh-ancestor
93211627|NCT01360749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211628|NCT01360749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211629|NCT01360749|Sensory System Agents|sensory system agents|mesh-ancestor
93211630|NCT01360749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211631|NCT01360749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93211632|NCT01360749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93211633|NCT01360749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93211634|NCT01360749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211635|NCT01360749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211636|NCT01367223|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
93211637|NCT01367223|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93211638|NCT01367223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93211639|NCT01367301|Paclitaxel|paclitaxel|mesh-list
93211640|NCT01367301|Carboplatin|carboplatin|mesh-list
93211641|NCT01367301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93211642|NCT01367301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211643|NCT01367301|Tubulin Modulators|tubulin modulators|mesh-ancestor
93211644|NCT01367301|Antimitotic Agents|antimitotic agents|mesh-ancestor
93211645|NCT01367301|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211646|NCT01367301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211647|NCT03675854|Cefazolin|cefazolin|mesh-list
93211648|NCT03675854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211649|NCT03675854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211650|NCT01360827|Cisplatin|cisplatin|mesh-list
93211651|NCT01360827|Fluorouracil|fluorouracil|mesh-list
93211652|NCT01360827|Cetuximab|cetuximab|mesh-list
93211653|NCT01360827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211654|NCT01360827|Antimetabolites|antimetabolites|mesh-ancestor
93211655|NCT01360827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211656|NCT01360827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93211657|NCT01360827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93211658|NCT01360827|Immunologic Factors|immunologic factors|mesh-ancestor
93211659|NCT01360827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211660|NCT01360827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211661|NCT03171610|Fentanyl|fentanyl|mesh-list
93211662|NCT03171610|Sufentanil|sufentanil|mesh-list
93211663|NCT03171610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93211664|NCT03171610|Narcotics|narcotics|mesh-ancestor
93211665|NCT03171610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211666|NCT03171610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883714|NCT00662220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93211667|NCT03171610|Analgesics|analgesics|mesh-ancestor
93211668|NCT03171610|Sensory System Agents|sensory system agents|mesh-ancestor
93211669|NCT03171610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211671|NCT03171610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93211672|NCT03171610|Anesthetics, General|anesthetics, general|mesh-ancestor
93211673|NCT03171610|Anesthetics|anesthetics|mesh-ancestor
93211674|NCT01364181|Udenafil|udenafil|mesh-list
93211675|NCT01364181|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93211676|NCT01364181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93211677|NCT01364181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211678|NCT01364181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211679|NCT03679442|Acetylcysteine|acetylcysteine|mesh-list
93211680|NCT03679442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93211681|NCT03679442|Antidotes|antidotes|mesh-list
93211682|NCT03679442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211683|NCT03679442|Antiviral Agents|antiviral agents|mesh-ancestor
93211684|NCT03679442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211685|NCT03679442|Expectorants|expectorants|mesh-ancestor
93211686|NCT03679442|Respiratory System Agents|respiratory system agents|mesh-ancestor
93211687|NCT03679442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93211688|NCT03679442|Antioxidants|antioxidants|mesh-ancestor
93211689|NCT03679442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211690|NCT03679442|Protective Agents|protective agents|mesh-ancestor
93211691|NCT01367535|Naltrexone|naltrexone|mesh-list
93211692|NCT01367535|Methylnaltrexone|methylnaltrexone|mesh-list
93211693|NCT01367535|Paroxetine|paroxetine|mesh-list
93211694|NCT01367535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93211695|NCT01367535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93211696|NCT01367535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211697|NCT01367535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211698|NCT01367535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211699|NCT01367535|Serotonin Agents|serotonin agents|mesh-ancestor
93211700|NCT01367535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211701|NCT01367535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93211702|NCT01367535|Antidepressive Agents|antidepressive agents|mesh-ancestor
93211703|NCT01367535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93211704|NCT01367535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93211705|NCT01367535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93211706|NCT01367535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211707|NCT01367535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93211708|NCT01367535|Sensory System Agents|sensory system agents|mesh-ancestor
93211709|NCT01367535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211710|NCT01367535|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93211711|NCT02414776|Hydroxychloroquine|hydroxychloroquine|mesh-list
93211712|NCT02414776|Antimalarials|antimalarials|mesh-ancestor
93211713|NCT02414776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93211714|NCT02414776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93211715|NCT02414776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211716|NCT02414776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211717|NCT02414776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211718|NCT02414776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211719|NCT05187663|Chlorhexidine|chlorhexidine|mesh-list
93211720|NCT05187663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93211721|NCT05187663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211722|NCT05187663|Disinfectants|disinfectants|mesh-ancestor
93211723|NCT04482712|Sirolimus|sirolimus|mesh-list
93211724|NCT04482712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211725|NCT04482712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211726|NCT04482712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93211727|NCT04482712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211728|NCT04482712|Antifungal Agents|antifungal agents|mesh-ancestor
93211729|NCT04482712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93211730|NCT04482712|Immunologic Factors|immunologic factors|mesh-ancestor
93211731|NCT04482712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211732|NCT02409004|Rifampin|rifampin|mesh-list
93211733|NCT02409004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93211734|NCT02409004|Antitubercular Agents|antitubercular agents|mesh-ancestor
93211735|NCT02409004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93211736|NCT02409004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211737|NCT02409004|Leprostatic Agents|leprostatic agents|mesh-ancestor
93211738|NCT02409004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93211739|NCT02409004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211740|NCT02409004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211741|NCT02409004|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93211742|NCT02409004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93211743|NCT02409004|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93211744|NCT02409004|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93211745|NCT02409004|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93211746|NCT02409004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93211747|NCT03131895|Dexlansoprazole|dexlansoprazole|mesh-list
93211748|NCT03131895|Lansoprazole|lansoprazole|mesh-list
93211749|NCT03131895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93211750|NCT03131895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211751|NCT03131895|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93211752|NCT03131895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211753|NCT03131895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211754|NCT04039919|Padsevonil|padsevonil|mesh-list
93211755|NCT04039919|Anticonvulsants|anticonvulsants|mesh-ancestor
93211756|NCT01367613|Methylnaltrexone|methylnaltrexone|mesh-list
93211757|NCT01367613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93211758|NCT01367613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211759|NCT01367613|Sensory System Agents|sensory system agents|mesh-ancestor
93211760|NCT01367613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211761|NCT02405104|Chlorzoxazone|chlorzoxazone|mesh-list
93211762|NCT02405104|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93211763|NCT02405104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211764|NCT02405104|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93211765|NCT02405104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211766|NCT01364415|Pasireotide|pasireotide|mesh-list
93211767|NCT01364415|Hormones|hormones|mesh-ancestor
93211768|NCT01364415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211769|NCT01364415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211770|NCT03176446|Anesthetics|anesthetics|mesh-list
93211771|NCT03176446|Anesthetics, Local|anesthetics, local|mesh-list
93211772|NCT03176446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211773|NCT03176446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211774|NCT03176446|Sensory System Agents|sensory system agents|mesh-ancestor
93211775|NCT03176446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211776|NCT03176212|Milk fat globule|milk fat globule|mesh-list
93211777|NCT03176212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211778|NCT04035473|Paclitaxel|paclitaxel|mesh-list
93211779|NCT04035473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93211780|NCT04035473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211781|NCT04035473|Tubulin Modulators|tubulin modulators|mesh-ancestor
93211782|NCT04035473|Antimitotic Agents|antimitotic agents|mesh-ancestor
93211783|NCT04035473|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211784|NCT04035473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211785|NCT02408926|Vaccines|vaccines|mesh-list
93211786|NCT02408926|Immunologic Factors|immunologic factors|mesh-ancestor
93211787|NCT02408926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211788|NCT00704158|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
93211789|NCT00704158|Immunoconjugates|immunoconjugates|mesh-ancestor
93211790|NCT00704158|Immunologic Factors|immunologic factors|mesh-ancestor
93211791|NCT00704158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211792|NCT00704158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211793|NCT00704158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211794|NCT03738527|Tranexamic Acid|tranexamic acid|mesh-list
93211795|NCT03738527|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93211796|NCT03738527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93211797|NCT03738527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211798|NCT03738527|Hemostatics|hemostatics|mesh-ancestor
93211799|NCT03738527|Coagulants|coagulants|mesh-ancestor
93211800|NCT02915978|Fentanyl|fentanyl|mesh-list
93211801|NCT02915978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93211802|NCT02915978|Narcotics|narcotics|mesh-ancestor
93211803|NCT02915978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211804|NCT02915978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211805|NCT02915978|Analgesics|analgesics|mesh-ancestor
93211806|NCT02915978|Sensory System Agents|sensory system agents|mesh-ancestor
93211807|NCT02915978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211808|NCT02915978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93211809|NCT02915978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93211810|NCT02915978|Anesthetics, General|anesthetics, general|mesh-ancestor
93211811|NCT02915978|Anesthetics|anesthetics|mesh-ancestor
93211812|NCT02412904|Menotropins|menotropins|mesh-list
93211813|NCT02412904|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93211814|NCT02412904|Fertility Agents|fertility agents|mesh-ancestor
93211815|NCT02412904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211816|NCT02412904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211817|NCT02408302|Midazolam|midazolam|mesh-list
93211818|NCT02408302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93211819|NCT02408302|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93211820|NCT02408302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211821|NCT02408302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211822|NCT02408302|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93211823|NCT02408302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93211824|NCT02408302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93211825|NCT02408302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93211826|NCT02408302|Anesthetics, General|anesthetics, general|mesh-ancestor
93211828|NCT02408302|GABA Modulators|gaba modulators|mesh-ancestor
93211829|NCT02408302|GABA Agents|gaba agents|mesh-ancestor
93211830|NCT02408302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211831|NCT02408302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211832|NCT02408146|Celecoxib|celecoxib|mesh-list
93211833|NCT02408146|Parecoxib|parecoxib|mesh-list
93211834|NCT02408146|Fentanyl|fentanyl|mesh-list
93211835|NCT02408146|Ondansetron|ondansetron|mesh-list
93211836|NCT02408146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93211837|NCT02408146|Narcotics|narcotics|mesh-ancestor
93211838|NCT02408146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211839|NCT02408146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211840|NCT02408146|Analgesics|analgesics|mesh-ancestor
93211841|NCT02408146|Sensory System Agents|sensory system agents|mesh-ancestor
93211842|NCT02408146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211843|NCT02408146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93211844|NCT02408146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93211845|NCT02408146|Anesthetics, General|anesthetics, general|mesh-ancestor
93211846|NCT02408146|Anesthetics|anesthetics|mesh-ancestor
93211847|NCT02408146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211848|NCT02408146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93211849|NCT02408146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93211850|NCT02408146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211851|NCT02408146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211852|NCT02408146|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93211853|NCT02408146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93211854|NCT02408146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93211855|NCT02408146|Antiemetics|antiemetics|mesh-ancestor
93211856|NCT02408146|Autonomic Agents|autonomic agents|mesh-ancestor
93211857|NCT02408146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211858|NCT02408146|Antipruritics|antipruritics|mesh-ancestor
93211859|NCT02408146|Dermatologic Agents|dermatologic agents|mesh-ancestor
93211860|NCT02408146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93211861|NCT02408146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93211862|NCT02408146|Serotonin Agents|serotonin agents|mesh-ancestor
93211863|NCT02408146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93211864|NCT03175666|Leucovorin|leucovorin|mesh-list
93211865|NCT03175666|Paclitaxel|paclitaxel|mesh-list
93211866|NCT03175666|Cyclophosphamide|cyclophosphamide|mesh-list
93211867|NCT03175666|Bevacizumab|bevacizumab|mesh-list
93211868|NCT03175666|Fluorouracil|fluorouracil|mesh-list
93211869|NCT03175666|Capecitabine|capecitabine|mesh-list
93211870|NCT03175666|Avelumab|avelumab|mesh-list
93211871|NCT03175666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93211872|NCT03175666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211873|NCT03175666|Tubulin Modulators|tubulin modulators|mesh-ancestor
93211874|NCT03175666|Antimitotic Agents|antimitotic agents|mesh-ancestor
93211875|NCT03175666|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211876|NCT03175666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211877|NCT03175666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93211878|NCT03175666|Immunologic Factors|immunologic factors|mesh-ancestor
93211879|NCT03175666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211880|NCT03175666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211881|NCT03175666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93211882|NCT03175666|Alkylating Agents|alkylating agents|mesh-ancestor
93211883|NCT03175666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93211884|NCT03175666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211885|NCT03175666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93211886|NCT03175666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93211887|NCT03175666|Growth Substances|growth substances|mesh-ancestor
93211888|NCT03175666|Growth Inhibitors|growth inhibitors|mesh-ancestor
93211889|NCT03175666|Antimetabolites|antimetabolites|mesh-ancestor
93211890|NCT03175666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93211891|NCT03175666|Antidotes|antidotes|mesh-ancestor
93211892|NCT03175666|Protective Agents|protective agents|mesh-ancestor
93211893|NCT03175666|Vitamin B Complex|vitamin b complex|mesh-ancestor
93211894|NCT03175666|Vitamins|vitamins|mesh-ancestor
93211895|NCT03175666|Micronutrients|micronutrients|mesh-ancestor
93211896|NCT03101358|Paclitaxel|paclitaxel|mesh-list
93211897|NCT03101358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93211898|NCT03101358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93211899|NCT03101358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211901|NCT03101358|Antimitotic Agents|antimitotic agents|mesh-ancestor
93211902|NCT03101358|Mitosis Modulators|mitosis modulators|mesh-ancestor
93211903|NCT03101358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211904|NCT03171220|Cyclophosphamide|cyclophosphamide|mesh-list
93211905|NCT03171220|Fludarabine|fludarabine|mesh-list
93211906|NCT03171220|Interleukin-2|interleukin-2|mesh-list
93211907|NCT03171220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93211908|NCT03171220|Immunologic Factors|immunologic factors|mesh-ancestor
93211909|NCT03171220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211910|NCT03171220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211911|NCT03171220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93211912|NCT03171220|Alkylating Agents|alkylating agents|mesh-ancestor
93211913|NCT03171220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211914|NCT03171220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211915|NCT03171220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93211916|NCT03171220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93211917|NCT03171220|Analgesics|analgesics|mesh-ancestor
93211918|NCT03171220|Sensory System Agents|sensory system agents|mesh-ancestor
93211919|NCT03171220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211920|NCT04853004|Antibodies|antibodies|mesh-list
93211921|NCT04853004|Immunologic Factors|immunologic factors|mesh-ancestor
93211922|NCT04853004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211923|NCT03116542|Alovudine|alovudine|mesh-list
93211924|NCT03116542|Antiviral Agents|antiviral agents|mesh-ancestor
93211925|NCT03116542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211926|NCT03170596|Tazarotene|tazarotene|mesh-list
93211927|NCT03170596|Dermatologic Agents|dermatologic agents|mesh-ancestor
93211928|NCT03170596|Keratolytic Agents|keratolytic agents|mesh-ancestor
93211929|NCT03173326|Anesthetics|anesthetics|mesh-list
93211930|NCT03173326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211931|NCT03173326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211932|NCT03172858|Oxytocin|oxytocin|mesh-list
93211933|NCT03172858|Oxytocics|oxytocics|mesh-ancestor
93211934|NCT03172858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93211935|NCT03172858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211936|NCT02403856|Methylprednisolone|methylprednisolone|mesh-list
93211937|NCT02403856|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93211938|NCT02403856|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93211939|NCT02403856|Prednisolone|prednisolone|mesh-list
93211940|NCT02403856|Prednisolone acetate|prednisolone acetate|mesh-list
93211941|NCT02403856|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93211942|NCT02403856|Prednisolone phosphate|prednisolone phosphate|mesh-list
93211943|NCT02403856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93211944|NCT02403856|Antiemetics|antiemetics|mesh-ancestor
93211945|NCT02403856|Autonomic Agents|autonomic agents|mesh-ancestor
93211946|NCT02403856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211947|NCT02403856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211948|NCT02403856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93211949|NCT02403856|Glucocorticoids|glucocorticoids|mesh-ancestor
93211950|NCT02403856|Hormones|hormones|mesh-ancestor
93211951|NCT02403856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93211952|NCT02403856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93211953|NCT02403856|Protective Agents|protective agents|mesh-ancestor
93211954|NCT02403856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93211955|NCT02403856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211956|NCT03170284|Bevacizumab|bevacizumab|mesh-list
93211957|NCT03170284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93211958|NCT03170284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211959|NCT03170284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93211960|NCT03170284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93211961|NCT03170284|Growth Substances|growth substances|mesh-ancestor
93211962|NCT03170284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211963|NCT03170284|Growth Inhibitors|growth inhibitors|mesh-ancestor
93211964|NCT02407912|Cisplatin|cisplatin|mesh-list
93211965|NCT02407912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211966|NCT03170050|Lidocaine|lidocaine|mesh-list
93211967|NCT03170050|Anesthetics, Local|anesthetics, local|mesh-ancestor
93211968|NCT03170050|Anesthetics|anesthetics|mesh-ancestor
93211969|NCT03170050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93211970|NCT03170050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211971|NCT03170050|Sensory System Agents|sensory system agents|mesh-ancestor
93211972|NCT03170050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93211973|NCT03170050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93211974|NCT03170050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93211975|NCT03170050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93211976|NCT03170050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93211977|NCT03170050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211978|NCT02407834|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93211979|NCT02407834|Eusol|eusol|mesh-list
93211980|NCT02407834|Disinfectants|disinfectants|mesh-ancestor
93211981|NCT02407834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93211982|NCT03169738|Leucovorin|leucovorin|mesh-list
93211983|NCT03169738|Cyclophosphamide|cyclophosphamide|mesh-list
93211984|NCT03169738|Bevacizumab|bevacizumab|mesh-list
93211985|NCT03169738|Fluorouracil|fluorouracil|mesh-list
93211986|NCT03169738|Capecitabine|capecitabine|mesh-list
93211987|NCT03169738|Oxaliplatin|oxaliplatin|mesh-list
93211988|NCT03169738|Nivolumab|nivolumab|mesh-list
93211989|NCT03169738|Fulvestrant|fulvestrant|mesh-list
93211990|NCT03169738|Avelumab|avelumab|mesh-list
93211991|NCT03169738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93211992|NCT03169738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93211993|NCT03169738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93211994|NCT03169738|Immunologic Factors|immunologic factors|mesh-ancestor
93211995|NCT03169738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93211996|NCT03169738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93211997|NCT03169738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93211998|NCT03169738|Alkylating Agents|alkylating agents|mesh-ancestor
93211999|NCT03169738|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93212000|NCT03169738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212001|NCT03169738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93212002|NCT03169738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93212003|NCT03169738|Growth Substances|growth substances|mesh-ancestor
93212004|NCT03169738|Growth Inhibitors|growth inhibitors|mesh-ancestor
93212005|NCT03169738|Antimetabolites|antimetabolites|mesh-ancestor
93212006|NCT03169738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212007|NCT03169738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212008|NCT03169738|Antidotes|antidotes|mesh-ancestor
93212009|NCT03169738|Protective Agents|protective agents|mesh-ancestor
93212010|NCT03169738|Vitamin B Complex|vitamin b complex|mesh-ancestor
93212011|NCT03169738|Vitamins|vitamins|mesh-ancestor
93212012|NCT03169738|Micronutrients|micronutrients|mesh-ancestor
93212013|NCT03169738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93212014|NCT03169738|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93212015|NCT03169738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93212016|NCT03169738|Hormone Antagonists|hormone antagonists|mesh-ancestor
93212017|NCT03169738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212018|NCT02407600|Aprepitant|aprepitant|mesh-list
93212019|NCT02407600|Fosaprepitant|fosaprepitant|mesh-list
93212020|NCT02407600|Antiemetics|antiemetics|mesh-ancestor
93212021|NCT02407600|Autonomic Agents|autonomic agents|mesh-ancestor
93212022|NCT02407600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212023|NCT02407600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212024|NCT02407600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93212025|NCT02407600|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93212026|NCT02407600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212027|NCT02407600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212028|NCT02403544|Capecitabine|capecitabine|mesh-list
93212029|NCT02403544|Oxaliplatin|oxaliplatin|mesh-list
93212030|NCT02403544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212031|NCT02403544|Antimetabolites|antimetabolites|mesh-ancestor
93212032|NCT02403544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212033|NCT02403544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212034|NCT02411344|Pertuzumab|pertuzumab|mesh-list
93212035|NCT02411344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212036|NCT02411344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212037|NCT03657095|Beraprost|beraprost|mesh-list
93212038|NCT03657095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93212039|NCT03657095|Vasodilator Agents|vasodilator agents|mesh-ancestor
93212040|NCT02407366|Carboplatin|carboplatin|mesh-list
93212041|NCT02407366|Pemetrexed|pemetrexed|mesh-list
93212042|NCT02407366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212043|NCT02407366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212044|NCT02407366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212045|NCT02407366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93212046|NCT02407366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93212047|NCT03738137|Lidocaine|lidocaine|mesh-list
93212048|NCT03738137|Midazolam|midazolam|mesh-list
93212049|NCT03738137|Sufentanil|sufentanil|mesh-list
93212050|NCT03738137|Anesthetics, Local|anesthetics, local|mesh-ancestor
93212051|NCT03738137|Anesthetics|anesthetics|mesh-ancestor
93212052|NCT03738137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212053|NCT03738137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212054|NCT03738137|Sensory System Agents|sensory system agents|mesh-ancestor
93212055|NCT03738137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212056|NCT03738137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93212057|NCT03738137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93212058|NCT03738137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93212059|NCT03738137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212060|NCT03738137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212061|NCT03738137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93212062|NCT03738137|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93212063|NCT03738137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93212064|NCT03738137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93212065|NCT03738137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93212066|NCT03738137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93212067|NCT03738137|Anesthetics, General|anesthetics, general|mesh-ancestor
93212068|NCT03738137|GABA Modulators|gaba modulators|mesh-ancestor
93212069|NCT03738137|GABA Agents|gaba agents|mesh-ancestor
93212070|NCT03738137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212071|NCT03738137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93212072|NCT03738137|Narcotics|narcotics|mesh-ancestor
93212073|NCT03738137|Analgesics|analgesics|mesh-ancestor
93212074|NCT02407210|Olmesartan|olmesartan|mesh-list
93212075|NCT02407210|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93212076|NCT02407210|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93212077|NCT02407210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93212078|NCT02407210|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93212079|NCT02407210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93212080|NCT02407210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212081|NCT03737201|Chlorhexidine|chlorhexidine|mesh-list
93212082|NCT03737201|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93212083|NCT03737201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93212084|NCT03737201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212085|NCT03737201|Disinfectants|disinfectants|mesh-ancestor
93212086|NCT03737201|Dermatologic Agents|dermatologic agents|mesh-ancestor
93212087|NCT03175042|Chrysarobin|chrysarobin|mesh-list
93212088|NCT03175042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93212089|NCT03175042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212090|NCT03175042|Analgesics|analgesics|mesh-ancestor
93212091|NCT03175042|Sensory System Agents|sensory system agents|mesh-ancestor
93212092|NCT03175042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212093|NCT03175042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212094|NCT03175042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212095|NCT03175042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93212096|NCT03738059|Dexmedetomidine|dexmedetomidine|mesh-list
93212097|NCT03738059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93212098|NCT03738059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212099|NCT03738059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212100|NCT03738059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212101|NCT03738059|Analgesics|analgesics|mesh-ancestor
93212102|NCT03738059|Sensory System Agents|sensory system agents|mesh-ancestor
93212103|NCT03738059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212104|NCT03738059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93212105|NCT03738059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93212106|NCT03738059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93212107|NCT03738059|Adrenergic Agents|adrenergic agents|mesh-ancestor
93212108|NCT03738059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212109|NCT03738059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212110|NCT05233462|Bupivacaine|bupivacaine|mesh-list
93212111|NCT05233462|Anesthetics, Local|anesthetics, local|mesh-ancestor
93212112|NCT05233462|Anesthetics|anesthetics|mesh-ancestor
93212113|NCT05233462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212114|NCT05233462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212115|NCT05233462|Sensory System Agents|sensory system agents|mesh-ancestor
92855923|NCT04217148|Tretinoin|tretinoin|mesh-list
93212116|NCT05233462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212117|NCT02700412|Cannabidiol|cannabidiol|mesh-list
93212118|NCT02700412|Anticonvulsants|anticonvulsants|mesh-ancestor
93212119|NCT02351544|Botulinum Toxins|botulinum toxins|mesh-list
93212120|NCT02351544|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93212121|NCT02351544|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93212122|NCT02351544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93212123|NCT02351544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212124|NCT02351544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884163|NCT04223219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212125|NCT02351544|Cholinergic Agents|cholinergic agents|mesh-ancestor
93212126|NCT02351544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212127|NCT02351544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212128|NCT02351544|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93212129|NCT02351544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212130|NCT02288832|Azithromycin|azithromycin|mesh-list
93212131|NCT02288832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93212132|NCT02288832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212133|NCT03116308|Opicapone|opicapone|mesh-list
93212134|NCT03116308|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93212135|NCT03116308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212136|NCT03116308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212137|NCT03116308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93212138|NCT03116308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93212139|NCT03665441|Leucovorin|leucovorin|mesh-list
93212140|NCT03665441|Paclitaxel|paclitaxel|mesh-list
93212141|NCT03665441|Gemcitabine|gemcitabine|mesh-list
93212142|NCT03665441|Irinotecan|irinotecan|mesh-list
93212143|NCT03665441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93212144|NCT03665441|Asparaginase|asparaginase|mesh-list
93212145|NCT03665441|Eryaspase|eryaspase|mesh-list
93212146|NCT03665441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93212147|NCT03665441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212148|NCT03665441|Tubulin Modulators|tubulin modulators|mesh-ancestor
93212149|NCT03665441|Antimitotic Agents|antimitotic agents|mesh-ancestor
93212150|NCT03665441|Mitosis Modulators|mitosis modulators|mesh-ancestor
93212151|NCT03665441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212152|NCT03665441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212153|NCT03665441|Antimetabolites|antimetabolites|mesh-ancestor
93212154|NCT03665441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212155|NCT03665441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93212156|NCT03665441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93212157|NCT03665441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212158|NCT03665441|Antidotes|antidotes|mesh-ancestor
93212159|NCT03665441|Protective Agents|protective agents|mesh-ancestor
93212160|NCT03665441|Vitamin B Complex|vitamin b complex|mesh-ancestor
93212161|NCT03665441|Vitamins|vitamins|mesh-ancestor
93212162|NCT03665441|Micronutrients|micronutrients|mesh-ancestor
93212163|NCT03169660|Aflibercept|aflibercept|mesh-list
93212164|NCT03169660|Mitogens|mitogens|mesh-list
93212165|NCT03169660|Endothelial Growth Factors|endothelial growth factors|mesh-list
93212166|NCT03169660|Mitosis Modulators|mitosis modulators|mesh-ancestor
93212167|NCT03169660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212168|NCT03169660|Growth Substances|growth substances|mesh-ancestor
93212169|NCT03169660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212170|NCT03169660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93212171|NCT03169660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93212172|NCT03169660|Growth Inhibitors|growth inhibitors|mesh-ancestor
93212173|NCT03169660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212174|NCT02401828|Dolutegravir|dolutegravir|mesh-list
93212175|NCT02401828|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93212176|NCT02401828|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93212177|NCT02401828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212178|NCT02401828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212179|NCT02401828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93212180|NCT02401828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93212181|NCT02401828|Antiviral Agents|antiviral agents|mesh-ancestor
93212182|NCT02401828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212183|NCT02401594|Enoxaparin|enoxaparin|mesh-list
93212184|NCT02401594|Rivaroxaban|rivaroxaban|mesh-list
93212185|NCT02401594|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93212186|NCT02401594|Antithrombins|antithrombins|mesh-ancestor
93212187|NCT02401594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93212188|NCT02401594|Protease Inhibitors|protease inhibitors|mesh-ancestor
93212189|NCT02401594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212190|NCT02401594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212191|NCT02401594|Anticoagulants|anticoagulants|mesh-ancestor
93212192|NCT02401594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93212193|NCT02401594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212194|NCT02406508|Sorafenib|sorafenib|mesh-list
93212195|NCT02406508|Melphalan|melphalan|mesh-list
93212196|NCT02406508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212197|NCT02406508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93212198|NCT02406508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884239|NCT02696369|Lidocaine|lidocaine|mesh-list
93212199|NCT02406508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212200|NCT02406508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93212201|NCT02406508|Alkylating Agents|alkylating agents|mesh-ancestor
93212203|NCT02406508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93212204|NCT02406508|Immunologic Factors|immunologic factors|mesh-ancestor
93212205|NCT02406508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212206|NCT03662789|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93212207|NCT03662789|Hematinics|hematinics|mesh-ancestor
93212208|NCT04481932|Trastuzumab|trastuzumab|mesh-list
93212209|NCT04481932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212210|NCT04481932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212211|NCT03169582|Sildenafil Citrate|sildenafil citrate|mesh-list
93212212|NCT03169582|Vasodilator Agents|vasodilator agents|mesh-ancestor
93212213|NCT03169582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93212214|NCT03169582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93212215|NCT03169582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212216|NCT03169582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212217|NCT03169582|Urological Agents|urological agents|mesh-ancestor
93212218|NCT03655691|Botulinum Toxins|botulinum toxins|mesh-list
93212219|NCT03655691|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93212220|NCT03655691|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93212221|NCT03655691|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93212222|NCT03655691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212223|NCT03655691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212224|NCT03655691|Cholinergic Agents|cholinergic agents|mesh-ancestor
93212225|NCT03655691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212226|NCT03655691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212227|NCT03655691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93212228|NCT03655691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212229|NCT03169504|Fluticasone|fluticasone|mesh-list
93212230|NCT03169504|Xhance|xhance|mesh-list
93212231|NCT03169504|Bromides|bromides|mesh-list
93212232|NCT03169504|Tiotropium Bromide|tiotropium bromide|mesh-list
93212233|NCT03169504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212234|NCT03169504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93212235|NCT03169504|Autonomic Agents|autonomic agents|mesh-ancestor
93212236|NCT03169504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212237|NCT03169504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212238|NCT03169504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93212239|NCT03169504|Respiratory System Agents|respiratory system agents|mesh-ancestor
93212240|NCT03169504|Dermatologic Agents|dermatologic agents|mesh-ancestor
93212241|NCT03169504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93212242|NCT03169504|Parasympatholytics|parasympatholytics|mesh-ancestor
93212243|NCT03169504|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93212244|NCT03169504|Cholinergic Agents|cholinergic agents|mesh-ancestor
93212245|NCT03169504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212246|NCT03169504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212247|NCT03169504|Anticonvulsants|anticonvulsants|mesh-ancestor
93212248|NCT03169426|Carvedilol|carvedilol|mesh-list
93212249|NCT03169426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93212250|NCT03169426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93212251|NCT03169426|Adrenergic Agents|adrenergic agents|mesh-ancestor
93212252|NCT03169426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212253|NCT03169426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212254|NCT03169426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212255|NCT03169426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93212256|NCT03169426|Antioxidants|antioxidants|mesh-ancestor
93212257|NCT03169426|Protective Agents|protective agents|mesh-ancestor
93212258|NCT03169426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93212259|NCT03169426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212260|NCT03169426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93212261|NCT03169426|Vasodilator Agents|vasodilator agents|mesh-ancestor
93212262|NCT03169426|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93212263|NCT03169426|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93212264|NCT03580928|Venetoclax|venetoclax|mesh-list
93212265|NCT03580928|Obinutuzumab|obinutuzumab|mesh-list
93212266|NCT03580928|Acalabrutinib|acalabrutinib|mesh-list
93212267|NCT03580928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212268|NCT03580928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212269|NCT03169348|Sofosbuvir|sofosbuvir|mesh-list
93212270|NCT03169348|Ledipasvir|ledipasvir|mesh-list
93212271|NCT03169348|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93212272|NCT03169348|Antiviral Agents|antiviral agents|mesh-ancestor
93212273|NCT03169348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212274|NCT03631355|Tranexamic Acid|tranexamic acid|mesh-list
93212275|NCT03631355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93212276|NCT03631355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212277|NCT03631355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212279|NCT03631355|Coagulants|coagulants|mesh-ancestor
93212280|NCT03571568|Rituximab|rituximab|mesh-list
93212281|NCT03571568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212282|NCT03571568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212283|NCT03571568|Immunologic Factors|immunologic factors|mesh-ancestor
93212284|NCT03571568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212285|NCT03571568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93212286|NCT03169192|Zoledronic Acid|zoledronic acid|mesh-list
93212287|NCT03169192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93212288|NCT03169192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212289|NCT03679052|Clonidine|clonidine|mesh-list
93212290|NCT03679052|Mirtazapine|mirtazapine|mesh-list
93212291|NCT03679052|Analgesics|analgesics|mesh-ancestor
93212292|NCT03679052|Sensory System Agents|sensory system agents|mesh-ancestor
93212293|NCT03679052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212294|NCT03679052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212295|NCT03679052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93212296|NCT03679052|Sympatholytics|sympatholytics|mesh-ancestor
93212297|NCT03679052|Autonomic Agents|autonomic agents|mesh-ancestor
93212298|NCT03679052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93212299|NCT03679052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93212300|NCT03679052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93212301|NCT03679052|Adrenergic Agents|adrenergic agents|mesh-ancestor
93212302|NCT03679052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212303|NCT03679052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212304|NCT03679052|Antidepressive Agents|antidepressive agents|mesh-ancestor
93212305|NCT03679052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93212306|NCT03679052|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93212307|NCT03679052|Histamine Antagonists|histamine antagonists|mesh-ancestor
93212308|NCT03679052|Histamine Agents|histamine agents|mesh-ancestor
93212309|NCT03679052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93212310|NCT03679052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93212311|NCT03679052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212312|NCT03679052|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93212313|NCT03679052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93212314|NCT03679052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93212315|NCT03679052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93212316|NCT03679052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93212317|NCT03679052|Serotonin Agents|serotonin agents|mesh-ancestor
93212318|NCT03679052|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93212319|NCT03540914|Acetazolamide|acetazolamide|mesh-list
93212320|NCT03540914|Anticonvulsants|anticonvulsants|mesh-ancestor
93212321|NCT03540914|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93212322|NCT03540914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212323|NCT03540914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212324|NCT03540914|Diuretics|diuretics|mesh-ancestor
93212325|NCT03540914|Natriuretic Agents|natriuretic agents|mesh-ancestor
93212326|NCT03540914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212327|NCT03629249|Indoleacetic Acids|indoleacetic acids|mesh-list
93212328|NCT03629249|Plant Growth Regulators|plant growth regulators|mesh-ancestor
93212329|NCT03629249|Growth Substances|growth substances|mesh-ancestor
93212330|NCT03629249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212331|NCT03671174|Aspirin|aspirin|mesh-list
93212332|NCT03671174|Hydroxychloroquine|hydroxychloroquine|mesh-list
93212333|NCT03671174|Prednisone|prednisone|mesh-list
93212334|NCT03671174|Heparin|heparin|mesh-list
93212335|NCT03671174|Enoxaparin|enoxaparin|mesh-list
93212336|NCT03671174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93212337|NCT03671174|Tinzaparin|tinzaparin|mesh-list
93212338|NCT03671174|Dalteparin|dalteparin|mesh-list
93212339|NCT03671174|Nadroparin|nadroparin|mesh-list
93212340|NCT03671174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212341|NCT03671174|Glucocorticoids|glucocorticoids|mesh-ancestor
93212342|NCT03671174|Hormones|hormones|mesh-ancestor
93212343|NCT03671174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212344|NCT03671174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212345|NCT03671174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93212346|NCT03671174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212347|NCT03671174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93212348|NCT03671174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212349|NCT03671174|Analgesics|analgesics|mesh-ancestor
93212350|NCT03671174|Sensory System Agents|sensory system agents|mesh-ancestor
93212351|NCT03671174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212352|NCT03671174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93212353|NCT03671174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93212354|NCT03671174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212355|NCT03671174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212356|NCT03671174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93212357|NCT03671174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93212358|NCT03671174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212359|NCT03671174|Antipyretics|antipyretics|mesh-ancestor
93212360|NCT03671174|Anticoagulants|anticoagulants|mesh-ancestor
93212361|NCT03671174|Antimalarials|antimalarials|mesh-ancestor
93212362|NCT03671174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93212363|NCT03671174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93212364|NCT03671174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212365|NCT03172234|Amantadine|amantadine|mesh-list
93212366|NCT03172234|Gabapentin|gabapentin|mesh-list
93212367|NCT03172234|Analgesics|analgesics|mesh-ancestor
93212368|NCT03172234|Sensory System Agents|sensory system agents|mesh-ancestor
93212369|NCT03172234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212370|NCT03172234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212371|NCT03172234|Anticonvulsants|anticonvulsants|mesh-ancestor
93212372|NCT03172234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93212373|NCT03172234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93212374|NCT03172234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212375|NCT03172234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93212376|NCT03172234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93212377|NCT03172234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93212378|NCT03172234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212379|NCT03172234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212380|NCT03172234|Antimanic Agents|antimanic agents|mesh-ancestor
93212381|NCT03172234|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93212382|NCT03172234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93212383|NCT03172234|Antiviral Agents|antiviral agents|mesh-ancestor
93212384|NCT03172234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212385|NCT03172234|Dopamine Agents|dopamine agents|mesh-ancestor
93212386|NCT03172234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212387|NCT03709849|Citric Acid|citric acid|mesh-list
93212388|NCT03709849|Sodium Citrate|sodium citrate|mesh-list
93212389|NCT03709849|Clomiphene|clomiphene|mesh-list
93212390|NCT03709849|Enclomiphene|enclomiphene|mesh-list
93212391|NCT03709849|Zuclomiphene|zuclomiphene|mesh-list
93212392|NCT03709849|Anticoagulants|anticoagulants|mesh-ancestor
93212393|NCT03709849|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93212394|NCT03709849|Chelating Agents|chelating agents|mesh-ancestor
93212395|NCT03709849|Sequestering Agents|sequestering agents|mesh-ancestor
93212396|NCT03709849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212397|NCT03709849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93212398|NCT03709849|Hormone Antagonists|hormone antagonists|mesh-ancestor
93212399|NCT03709849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212400|NCT03709849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212401|NCT03709849|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93212402|NCT03709849|Fertility Agents|fertility agents|mesh-ancestor
93212403|NCT03709849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93212404|NCT03709849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93212405|NCT03709849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93212406|NCT05343325|Paclitaxel|paclitaxel|mesh-list
93212407|NCT05343325|Cisplatin|cisplatin|mesh-list
93212408|NCT05343325|Tislelizumab|tislelizumab|mesh-list
93212409|NCT05343325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93212410|NCT05343325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93212411|NCT05343325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212412|NCT05343325|Tubulin Modulators|tubulin modulators|mesh-ancestor
93212413|NCT05343325|Antimitotic Agents|antimitotic agents|mesh-ancestor
93212414|NCT05343325|Mitosis Modulators|mitosis modulators|mesh-ancestor
93212415|NCT05343325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212416|NCT05343325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212417|NCT03349333|Folic Acid|folic acid|mesh-list
93212418|NCT03349333|Vitamin B 12|vitamin b 12|mesh-list
93212419|NCT03349333|Hydroxocobalamin|hydroxocobalamin|mesh-list
93212420|NCT03349333|Vitamins|vitamins|mesh-ancestor
93212421|NCT03349333|Micronutrients|micronutrients|mesh-ancestor
93212422|NCT03349333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212423|NCT03349333|Hematinics|hematinics|mesh-ancestor
93212424|NCT03349333|Vitamin B Complex|vitamin b complex|mesh-ancestor
93212425|NCT03365791|Spartalizumab|spartalizumab|mesh-list
93212426|NCT03365791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212427|NCT03365791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212428|NCT03365791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212429|NCT03365791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212430|NCT03365011|Nitrous Oxide|nitrous oxide|mesh-list
93212431|NCT03365011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93212432|NCT03365011|Anesthetics, General|anesthetics, general|mesh-ancestor
93212433|NCT03365011|Anesthetics|anesthetics|mesh-ancestor
93212434|NCT03365011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212435|NCT03365011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212436|NCT03365011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212437|NCT03365011|Analgesics|analgesics|mesh-ancestor
93212438|NCT03365011|Sensory System Agents|sensory system agents|mesh-ancestor
93212439|NCT03365011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212440|NCT03627767|Abrocitinib|abrocitinib|mesh-list
93212441|NCT03627767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93212442|NCT03627767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212443|NCT03627767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212444|NCT03732365|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93212445|NCT03732365|Cefazolin|cefazolin|mesh-list
93212446|NCT03732365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212447|NCT03732287|Anesthetics|anesthetics|mesh-list
93212448|NCT03732287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212449|NCT03732287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212450|NCT02142738|Paclitaxel|paclitaxel|mesh-list
93212451|NCT02142738|Carboplatin|carboplatin|mesh-list
93212452|NCT02142738|Gemcitabine|gemcitabine|mesh-list
93212453|NCT02142738|Pembrolizumab|pembrolizumab|mesh-list
93212454|NCT02142738|Pemetrexed|pemetrexed|mesh-list
93212455|NCT02142738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93212456|NCT02142738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212457|NCT02142738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93212458|NCT02142738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93212459|NCT02142738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93212460|NCT02142738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212461|NCT02142738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212462|NCT02142738|Antimetabolites|antimetabolites|mesh-ancestor
93212463|NCT02142738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212464|NCT02142738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212465|NCT02142738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212466|NCT02142738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93212467|NCT02142738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93212468|NCT03617861|Secretin|secretin|mesh-list
93212469|NCT03617861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93212470|NCT03617861|Hormones|hormones|mesh-ancestor
93212471|NCT03617861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212472|NCT03617861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212473|NCT03614975|Vaccines|vaccines|mesh-list
93212474|NCT03614975|Immunologic Factors|immunologic factors|mesh-ancestor
93212475|NCT03614975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212476|NCT03613649|Moxifloxacin|moxifloxacin|mesh-list
93212477|NCT03613649|Zoliflodacin|zoliflodacin|mesh-list
93212478|NCT03613649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93212479|NCT03613649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212480|NCT03613649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93212481|NCT03613649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93212482|NCT03613649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212483|NCT03613649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212484|NCT03613649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212485|NCT03096288|Evolocumab|evolocumab|mesh-list
93212486|NCT03096288|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93212487|NCT03096288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93212488|NCT03096288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93212489|NCT03096288|Antimetabolites|antimetabolites|mesh-ancestor
93212490|NCT03096288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212491|NCT03096288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93212492|NCT03096288|Protease Inhibitors|protease inhibitors|mesh-ancestor
93212493|NCT03096288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212494|NCT03096288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93212495|NCT03731897|Lidocaine|lidocaine|mesh-list
93212496|NCT03731897|Anesthetics, Local|anesthetics, local|mesh-ancestor
93212497|NCT03731897|Anesthetics|anesthetics|mesh-ancestor
93212498|NCT03731897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212499|NCT03731897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212500|NCT03731897|Sensory System Agents|sensory system agents|mesh-ancestor
93212501|NCT03731897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212502|NCT03731897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93212503|NCT03731897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93212504|NCT03731897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93212505|NCT03731897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212506|NCT03731897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212507|NCT02072148|Cisplatin|cisplatin|mesh-list
93212508|NCT02072148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212509|NCT04456608|Aspirin|aspirin|mesh-list
93212510|NCT04456608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93212511|NCT04456608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212512|NCT04456608|Analgesics|analgesics|mesh-ancestor
93212513|NCT04456608|Sensory System Agents|sensory system agents|mesh-ancestor
93212514|NCT04456608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212515|NCT04456608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212516|NCT04456608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212517|NCT04456608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93212518|NCT04456608|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93212519|NCT04456608|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212520|NCT04456608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212521|NCT04456608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93212522|NCT04456608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93212523|NCT04456608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212524|NCT04456608|Antipyretics|antipyretics|mesh-ancestor
93212525|NCT04450212|Vitamin K|vitamin k|mesh-list
93212526|NCT04450212|Vitamins|vitamins|mesh-ancestor
93212527|NCT04450212|Micronutrients|micronutrients|mesh-ancestor
93212528|NCT04450212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212529|NCT04450212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93212530|NCT04450212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212531|NCT04450212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212532|NCT04450212|Hemostatics|hemostatics|mesh-ancestor
93212533|NCT04450212|Coagulants|coagulants|mesh-ancestor
93212534|NCT05074290|Taxane|taxane|mesh-list
93212535|NCT05074290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212536|NCT03095508|Menthol|menthol|mesh-list
93212537|NCT03095508|Antipruritics|antipruritics|mesh-ancestor
93212538|NCT03095508|Dermatologic Agents|dermatologic agents|mesh-ancestor
93212539|NCT03632538|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93212540|NCT03632538|Protein C Inhibitor|protein c inhibitor|mesh-list
93212541|NCT03632538|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93212542|NCT03632538|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93212543|NCT03632538|Protease Inhibitors|protease inhibitors|mesh-ancestor
93212544|NCT03632538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212545|NCT03632538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212546|NCT03731741|Pentoxifylline|pentoxifylline|mesh-list
93212547|NCT03731741|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93212548|NCT03731741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212549|NCT03731741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212550|NCT03731741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93212551|NCT03731741|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93212552|NCT03731741|Protective Agents|protective agents|mesh-ancestor
93212553|NCT03731741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212554|NCT03731741|Vasodilator Agents|vasodilator agents|mesh-ancestor
93212555|NCT03731741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93212556|NCT03731741|Antioxidants|antioxidants|mesh-ancestor
93212557|NCT03736187|Metronidazole|metronidazole|mesh-list
93212558|NCT03736187|Cephalexin|cephalexin|mesh-list
93212559|NCT03736187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212560|NCT03736187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93212561|NCT03736187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93212562|NCT03736187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93212563|NCT03731429|Lidocaine|lidocaine|mesh-list
93212564|NCT03731429|Anesthetics, Local|anesthetics, local|mesh-ancestor
93212565|NCT03731429|Anesthetics|anesthetics|mesh-ancestor
93212566|NCT03731429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212567|NCT03731429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212568|NCT03731429|Sensory System Agents|sensory system agents|mesh-ancestor
93212569|NCT03731429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212570|NCT03731429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93212571|NCT03731429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93212572|NCT03731429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93212573|NCT03731429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212574|NCT03731429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212575|NCT03602339|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
93212576|NCT03602339|Chelating Agents|chelating agents|mesh-ancestor
93212577|NCT03602339|Sequestering Agents|sequestering agents|mesh-ancestor
93212578|NCT03602339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212579|NCT03653429|Tranexamic Acid|tranexamic acid|mesh-list
92884615|NCT04857385|Hemostatics|hemostatics|mesh-list
93212580|NCT03653429|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93212581|NCT03653429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212582|NCT03653429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212583|NCT03653429|Hemostatics|hemostatics|mesh-ancestor
93212584|NCT03653429|Coagulants|coagulants|mesh-ancestor
93212585|NCT03731117|Furosemide|furosemide|mesh-list
93212586|NCT03731117|Diuretics|diuretics|mesh-ancestor
93212587|NCT03731117|Natriuretic Agents|natriuretic agents|mesh-ancestor
93212588|NCT03731117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212589|NCT03731117|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93212590|NCT03731117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212591|NCT03731117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212592|NCT03735251|Metoprolol|metoprolol|mesh-list
93212593|NCT03735251|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93212594|NCT03735251|Diuretics|diuretics|mesh-list
93212595|NCT03735251|Natriuretic Agents|natriuretic agents|mesh-ancestor
93212596|NCT03735251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212597|NCT03735251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93212598|NCT03735251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93212599|NCT03735251|Sympatholytics|sympatholytics|mesh-ancestor
93212600|NCT03735251|Autonomic Agents|autonomic agents|mesh-ancestor
93212601|NCT03735251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212602|NCT03735251|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93212603|NCT03735251|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93212604|NCT03735251|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93212605|NCT03735251|Adrenergic Agents|adrenergic agents|mesh-ancestor
93212606|NCT03735251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212607|NCT03735251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212608|NCT03098550|Nivolumab|nivolumab|mesh-list
93212609|NCT03098550|Daratumumab|daratumumab|mesh-list
93212610|NCT03098550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212611|NCT03098550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212612|NCT03098550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212613|NCT03098550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212614|NCT03095118|Daratumumab|daratumumab|mesh-list
93212615|NCT03095118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212616|NCT04224480|Pembrolizumab|pembrolizumab|mesh-list
93212617|NCT04224480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212618|NCT04224480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212619|NCT04224480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212620|NCT04224480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212621|NCT05386758|Molnupiravir|molnupiravir|mesh-list
93212622|NCT05386758|Antiviral Agents|antiviral agents|mesh-ancestor
93212623|NCT05386758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212624|NCT05013216|Poly ICLC|poly iclc|mesh-list
93212625|NCT05013216|Interferon Inducers|interferon inducers|mesh-ancestor
93212626|NCT05013216|Immunologic Factors|immunologic factors|mesh-ancestor
93212627|NCT05013216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212628|NCT03169114|Amikacin|amikacin|mesh-list
93212629|NCT03169114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93212630|NCT03169114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212631|NCT03115762|Bevacizumab|bevacizumab|mesh-list
93212632|NCT03115762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212633|NCT03115762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212634|NCT03115762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93212635|NCT03115762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93212636|NCT03115762|Growth Substances|growth substances|mesh-ancestor
93212637|NCT03115762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212638|NCT03115762|Growth Inhibitors|growth inhibitors|mesh-ancestor
93212639|NCT03168958|Methadone|methadone|mesh-list
93212640|NCT03168958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93212641|NCT03168958|Narcotics|narcotics|mesh-ancestor
93212642|NCT03168958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212643|NCT03168958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212644|NCT03168958|Analgesics|analgesics|mesh-ancestor
93212645|NCT03168958|Sensory System Agents|sensory system agents|mesh-ancestor
93212646|NCT03168958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212647|NCT03168958|Antitussive Agents|antitussive agents|mesh-ancestor
93212648|NCT03168958|Respiratory System Agents|respiratory system agents|mesh-ancestor
93212649|NCT03632460|Dexmedetomidine|dexmedetomidine|mesh-list
93212650|NCT03632460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93212651|NCT03632460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212652|NCT03632460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212653|NCT03632460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212654|NCT03632460|Analgesics|analgesics|mesh-ancestor
93212655|NCT03632460|Sensory System Agents|sensory system agents|mesh-ancestor
93212656|NCT03632460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212657|NCT03632460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93212658|NCT03632460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93212659|NCT03632460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93212660|NCT03632460|Adrenergic Agents|adrenergic agents|mesh-ancestor
93212661|NCT03632460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212662|NCT03632460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212664|NCT05418660|Nivolumab|nivolumab|mesh-list
93212665|NCT05418660|Atezolizumab|atezolizumab|mesh-list
93212666|NCT05418660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212667|NCT05418660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212668|NCT05418660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212669|NCT05418660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212670|NCT03364309|Ixekizumab|ixekizumab|mesh-list
93212671|NCT03364309|Dermatologic Agents|dermatologic agents|mesh-ancestor
93212672|NCT03168178|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93212673|NCT03168178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93212674|NCT03168178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212675|NCT03168178|Antitubercular Agents|antitubercular agents|mesh-ancestor
93212676|NCT05166096|Aspirin|aspirin|mesh-list
93212677|NCT05166096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93212678|NCT05166096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212679|NCT05166096|Analgesics|analgesics|mesh-ancestor
93212680|NCT05166096|Sensory System Agents|sensory system agents|mesh-ancestor
93212681|NCT05166096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212682|NCT05166096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212683|NCT05166096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212684|NCT05166096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93212685|NCT05166096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93212686|NCT05166096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93212687|NCT05166096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212688|NCT05166096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93212689|NCT05166096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93212690|NCT05166096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212691|NCT05166096|Antipyretics|antipyretics|mesh-ancestor
93212692|NCT03168412|Vaccines|vaccines|mesh-list
93212693|NCT03168412|Immunologic Factors|immunologic factors|mesh-ancestor
93212694|NCT03168412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212695|NCT05110638|Luliconazole|luliconazole|mesh-list
93212696|NCT05110638|Antifungal Agents|antifungal agents|mesh-ancestor
93212697|NCT05110638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212698|NCT03700788|Chlorhexidine|chlorhexidine|mesh-list
93212699|NCT03700788|Calcium|calcium|mesh-list
93212700|NCT03700788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93212701|NCT03700788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212702|NCT03700788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93212703|NCT03700788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212704|NCT03700788|Disinfectants|disinfectants|mesh-ancestor
93212705|NCT03334903|Gabapentin|gabapentin|mesh-list
93212706|NCT03334903|Analgesics|analgesics|mesh-ancestor
93212707|NCT03334903|Sensory System Agents|sensory system agents|mesh-ancestor
93212708|NCT03334903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212709|NCT03334903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212710|NCT03334903|Anticonvulsants|anticonvulsants|mesh-ancestor
93212711|NCT03334903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93212712|NCT03334903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93212713|NCT03334903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212714|NCT03334903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93212715|NCT03334903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93212716|NCT03334903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93212717|NCT03334903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212718|NCT03334903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212719|NCT03334903|Antimanic Agents|antimanic agents|mesh-ancestor
93212720|NCT03168100|Dexamethasone|dexamethasone|mesh-list
93212721|NCT03168100|Lenalidomide|lenalidomide|mesh-list
93212722|NCT03168100|Bortezomib|bortezomib|mesh-list
93212723|NCT03168100|Elotuzumab|elotuzumab|mesh-list
93212724|NCT03168100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212725|NCT03168100|Antiemetics|antiemetics|mesh-ancestor
93212726|NCT03168100|Autonomic Agents|autonomic agents|mesh-ancestor
93212727|NCT03168100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212728|NCT03168100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212729|NCT03168100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92884762|NCT00599924|Leucovorin|leucovorin|mesh-list
93212731|NCT03168100|Hormones|hormones|mesh-ancestor
93212732|NCT03168100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212733|NCT03168100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93212734|NCT03168100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212735|NCT03168100|Immunologic Factors|immunologic factors|mesh-ancestor
93212736|NCT03168100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93212737|NCT03168100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93212738|NCT03168100|Growth Substances|growth substances|mesh-ancestor
93212739|NCT03168100|Growth Inhibitors|growth inhibitors|mesh-ancestor
93212740|NCT03709381|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93212741|NCT03709381|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93212742|NCT03709381|Cosyntropin|cosyntropin|mesh-list
93212743|NCT03709381|beta-Endorphin|beta-endorphin|mesh-list
93212744|NCT03709381|Hormones|hormones|mesh-ancestor
93212745|NCT03709381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212746|NCT03709381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212747|NCT03709381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212748|NCT03709381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212749|NCT01353664|Romidepsin|romidepsin|mesh-list
93212750|NCT01353664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93212751|NCT01353664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212752|NCT01353664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93212753|NCT01353664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212754|NCT01353664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212755|NCT02395744|Paclitaxel|paclitaxel|mesh-list
93212756|NCT02395744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93212757|NCT02395744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212758|NCT02395744|Tubulin Modulators|tubulin modulators|mesh-ancestor
93212759|NCT02395744|Antimitotic Agents|antimitotic agents|mesh-ancestor
93212760|NCT02395744|Mitosis Modulators|mitosis modulators|mesh-ancestor
93212761|NCT02395744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212762|NCT02400268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93212763|NCT02400268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93212764|NCT02400268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212765|NCT02400268|Antitubercular Agents|antitubercular agents|mesh-ancestor
93212766|NCT03168568|Valsartan|valsartan|mesh-list
93212767|NCT03168568|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93212768|NCT03168568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93212769|NCT03168568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93212770|NCT03168568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93212771|NCT03168568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212772|NCT02400112|Vancomycin|vancomycin|mesh-list
93212773|NCT02400112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93212774|NCT02400112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212775|NCT02694328|Olanzapine|olanzapine|mesh-list
93212776|NCT02694328|Antiemetics|antiemetics|mesh-ancestor
93212777|NCT02694328|Autonomic Agents|autonomic agents|mesh-ancestor
93212778|NCT02694328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212779|NCT02694328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212780|NCT02694328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93212781|NCT02694328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93212782|NCT02694328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93212783|NCT02694328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212784|NCT02694328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93212785|NCT02694328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93212786|NCT02694328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93212787|NCT02694328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212788|NCT02694328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212789|NCT02694328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212790|NCT02694328|Serotonin Agents|serotonin agents|mesh-ancestor
93212791|NCT02395510|Vortioxetine|vortioxetine|mesh-list
93212792|NCT02395510|Antidepressive Agents|antidepressive agents|mesh-ancestor
93212793|NCT02395510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93212794|NCT02395510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93212795|NCT02395510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93212796|NCT02395510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212797|NCT02395510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212798|NCT02395510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93212799|NCT02395510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93212800|NCT02395510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212801|NCT02395510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212802|NCT02395510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212803|NCT02395510|Serotonin Agents|serotonin agents|mesh-ancestor
93212804|NCT02395510|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93212805|NCT02395510|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93212806|NCT02395510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93212807|NCT02395510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93212809|NCT02399800|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93212810|NCT02399800|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93212811|NCT02399800|Bupivacaine|bupivacaine|mesh-list
93212812|NCT02399800|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93212813|NCT02399800|Anesthetics, Local|anesthetics, local|mesh-ancestor
93212814|NCT02399800|Anesthetics|anesthetics|mesh-ancestor
93212815|NCT02399800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212816|NCT02399800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212817|NCT02399800|Sensory System Agents|sensory system agents|mesh-ancestor
93212818|NCT02399800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212819|NCT02399800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93212820|NCT02399800|Glucocorticoids|glucocorticoids|mesh-ancestor
93212821|NCT02399800|Hormones|hormones|mesh-ancestor
93212822|NCT02399800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212823|NCT02399800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93212824|NCT02399800|Immunologic Factors|immunologic factors|mesh-ancestor
93212825|NCT02399800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212826|NCT02399800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212827|NCT02399566|Pemetrexed|pemetrexed|mesh-list
93212828|NCT02399566|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93212829|NCT02399566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212830|NCT02399566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212831|NCT02399566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212832|NCT02399566|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93212833|NCT02399566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93212834|NCT02399566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93212835|NCT03167164|Leucovorin|leucovorin|mesh-list
93212836|NCT03167164|Paclitaxel|paclitaxel|mesh-list
93212837|NCT03167164|Cyclophosphamide|cyclophosphamide|mesh-list
93212838|NCT03167164|Bevacizumab|bevacizumab|mesh-list
93212839|NCT03167164|Fluorouracil|fluorouracil|mesh-list
93212840|NCT03167164|Capecitabine|capecitabine|mesh-list
93212841|NCT03167164|Avelumab|avelumab|mesh-list
93212842|NCT03167164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93212843|NCT03167164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212844|NCT03167164|Tubulin Modulators|tubulin modulators|mesh-ancestor
93212845|NCT03167164|Antimitotic Agents|antimitotic agents|mesh-ancestor
93212846|NCT03167164|Mitosis Modulators|mitosis modulators|mesh-ancestor
93212847|NCT03167164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212848|NCT03167164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93212849|NCT03167164|Immunologic Factors|immunologic factors|mesh-ancestor
93212850|NCT03167164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212851|NCT03167164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93212852|NCT03167164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93212853|NCT03167164|Alkylating Agents|alkylating agents|mesh-ancestor
93212854|NCT03167164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93212855|NCT03167164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212856|NCT03167164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93212857|NCT03167164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93212858|NCT03167164|Growth Substances|growth substances|mesh-ancestor
93212859|NCT03167164|Growth Inhibitors|growth inhibitors|mesh-ancestor
93212860|NCT03167164|Antimetabolites|antimetabolites|mesh-ancestor
93212861|NCT03167164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212862|NCT03167164|Antidotes|antidotes|mesh-ancestor
93212863|NCT03167164|Protective Agents|protective agents|mesh-ancestor
93212864|NCT03167164|Vitamin B Complex|vitamin b complex|mesh-ancestor
93212865|NCT03167164|Vitamins|vitamins|mesh-ancestor
93212866|NCT03167164|Micronutrients|micronutrients|mesh-ancestor
93212867|NCT03334747|Lumefantrine|lumefantrine|mesh-list
93212868|NCT03334747|Artemether|artemether|mesh-list
93212869|NCT03334747|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93212870|NCT03334747|Antimalarials|antimalarials|mesh-ancestor
93212871|NCT03334747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93212872|NCT03334747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93212873|NCT03334747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212874|NCT02394652|Metformin|metformin|mesh-list
93212875|NCT02394652|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93212876|NCT02394652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93212877|NCT02394652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212878|NCT02394652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93212879|NCT02394652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212880|NCT02394496|Fulvestrant|fulvestrant|mesh-list
93212881|NCT02394496|Lapatinib|lapatinib|mesh-list
93212882|NCT02394496|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93212883|NCT02394496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93212884|NCT02394496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212885|NCT02394496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93212886|NCT02394496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93212887|NCT02394496|Hormone Antagonists|hormone antagonists|mesh-ancestor
93212888|NCT02394496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212889|NCT02394496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212890|NCT02394496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93212891|NCT02394496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212892|NCT02394496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212893|NCT02394496|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93212894|NCT02394418|Dexmedetomidine|dexmedetomidine|mesh-list
93212895|NCT02394418|Propofol|propofol|mesh-list
93212896|NCT02394418|Sevoflurane|sevoflurane|mesh-list
93212897|NCT02394418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93212898|NCT02394418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93212899|NCT02394418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212900|NCT02394418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93212901|NCT02394418|Analgesics|analgesics|mesh-ancestor
93212902|NCT02394418|Sensory System Agents|sensory system agents|mesh-ancestor
93212903|NCT02394418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93212904|NCT02394418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93212905|NCT02394418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93212906|NCT02394418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93212907|NCT02394418|Adrenergic Agents|adrenergic agents|mesh-ancestor
93212908|NCT02394418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93212909|NCT02394418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212910|NCT02394418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93212911|NCT02394418|Anesthetics, General|anesthetics, general|mesh-ancestor
93212912|NCT02394418|Anesthetics|anesthetics|mesh-ancestor
93212913|NCT02394418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93212914|NCT02394418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93212915|NCT02693002|Norethindrone|norethindrone|mesh-list
93212916|NCT02693002|Norethindrone Acetate|norethindrone acetate|mesh-list
93212917|NCT02693002|Estradiol|estradiol|mesh-list
93212918|NCT02693002|Estrogens|estrogens|mesh-ancestor
93212919|NCT02693002|Hormones|hormones|mesh-ancestor
93212920|NCT02693002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212921|NCT02693002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212922|NCT02693002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93212923|NCT02693002|Contraceptive Agents|contraceptive agents|mesh-ancestor
93212924|NCT02693002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93212925|NCT02693002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93212926|NCT02693002|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93212927|NCT02693002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93212928|NCT02693002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93212929|NCT05408923|Chlorhexidine|chlorhexidine|mesh-list
93212930|NCT05408923|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93212931|NCT05408923|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93212932|NCT05408923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212933|NCT05408923|Disinfectants|disinfectants|mesh-ancestor
93212934|NCT05408923|Dermatologic Agents|dermatologic agents|mesh-ancestor
93212935|NCT03707509|Gemcitabine|gemcitabine|mesh-list
93212936|NCT03707509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212937|NCT03707509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212938|NCT03707509|Antimetabolites|antimetabolites|mesh-ancestor
93212939|NCT03707509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212940|NCT03710395|Nifedipine|nifedipine|mesh-list
93212941|NCT03710395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93212942|NCT03710395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93212943|NCT03710395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212944|NCT03710395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93212945|NCT03710395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212946|NCT03710395|Vasodilator Agents|vasodilator agents|mesh-ancestor
93212947|NCT03710395|Tocolytic Agents|tocolytic agents|mesh-ancestor
93212948|NCT03710395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884983|NCT02629848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93212949|NCT03093870|Capecitabine|capecitabine|mesh-list
93212950|NCT03093870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93212951|NCT03093870|Antimetabolites|antimetabolites|mesh-ancestor
93212952|NCT03093870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212953|NCT03093870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212954|NCT05744908|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
93212955|NCT05744908|Anticoagulants|anticoagulants|mesh-ancestor
93212957|NCT02394106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212958|NCT04793646|Acetylcysteine|acetylcysteine|mesh-list
93212959|NCT04793646|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93212960|NCT04793646|Antiviral Agents|antiviral agents|mesh-ancestor
93212961|NCT04793646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93212962|NCT04793646|Expectorants|expectorants|mesh-ancestor
93212963|NCT04793646|Respiratory System Agents|respiratory system agents|mesh-ancestor
93212964|NCT04793646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93212965|NCT04793646|Antioxidants|antioxidants|mesh-ancestor
93212966|NCT04793646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212967|NCT04793646|Protective Agents|protective agents|mesh-ancestor
93212968|NCT04793646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212969|NCT04793646|Antidotes|antidotes|mesh-ancestor
93212970|NCT03607890|Nivolumab|nivolumab|mesh-list
93212971|NCT03607890|Relatlimab|relatlimab|mesh-list
93212972|NCT03607890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93212973|NCT03607890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212974|NCT03607890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93212975|NCT03607890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212976|NCT02393482|Cholecalciferol|cholecalciferol|mesh-list
93212977|NCT02393482|Vitamin D|vitamin d|mesh-list
93212978|NCT02393482|Leuprolide|leuprolide|mesh-list
93212979|NCT02393482|Tibolone|tibolone|mesh-list
93212980|NCT02393482|Calcium Carbonate|calcium carbonate|mesh-list
93212981|NCT02393482|Hormones|hormones|mesh-list
93212982|NCT02393482|Estradiol|estradiol|mesh-list
93212983|NCT02393482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93212984|NCT02393482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93212985|NCT02393482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93212986|NCT02393482|Estrogens|estrogens|mesh-ancestor
93212987|NCT02393482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93212988|NCT02393482|Antacids|antacids|mesh-ancestor
93212989|NCT02393482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93212990|NCT02393482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93212991|NCT02393482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93212992|NCT02393482|Fertility Agents|fertility agents|mesh-ancestor
93212993|NCT02393482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93212994|NCT02393482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93212995|NCT02393482|Androgen Antagonists|androgen antagonists|mesh-ancestor
93212996|NCT02393482|Hormone Antagonists|hormone antagonists|mesh-ancestor
93212997|NCT02393482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93212998|NCT02393482|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93212999|NCT02393482|Anabolic Agents|anabolic agents|mesh-ancestor
93213000|NCT02393482|Vitamins|vitamins|mesh-ancestor
93213001|NCT02393482|Micronutrients|micronutrients|mesh-ancestor
93213002|NCT02393482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93213003|NCT03346057|Glycopyrrolate|glycopyrrolate|mesh-list
93213004|NCT03346057|Rocuronium|rocuronium|mesh-list
93213005|NCT03346057|Vecuronium Bromide|vecuronium bromide|mesh-list
93213006|NCT03346057|Neostigmine|neostigmine|mesh-list
93213007|NCT03346057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93213008|NCT03346057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93213009|NCT03346057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93213010|NCT03346057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213011|NCT03346057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213012|NCT03346057|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93213013|NCT03346057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213014|NCT03346057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213015|NCT03346057|Cholinergic Agents|cholinergic agents|mesh-ancestor
93213016|NCT03346057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213017|NCT03346057|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93213018|NCT03346057|Autonomic Agents|autonomic agents|mesh-ancestor
93213019|NCT03346057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93213020|NCT03346057|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93213021|NCT03346057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93213022|NCT03346057|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93213023|NCT03166306|Bevacizumab|bevacizumab|mesh-list
93213024|NCT03166306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885063|NCT00665418|Sevoflurane|sevoflurane|mesh-list
93213025|NCT03166306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213026|NCT03166306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93213027|NCT03166306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93213028|NCT03166306|Growth Substances|growth substances|mesh-ancestor
93213029|NCT03166306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213030|NCT03166306|Growth Inhibitors|growth inhibitors|mesh-ancestor
93213031|NCT02398630|Hormones|hormones|mesh-list
93213032|NCT02398630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213033|NCT02398630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213034|NCT02398552|Sunitinib|sunitinib|mesh-list
93213035|NCT02398552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213036|NCT02398552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93213037|NCT02398552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93213038|NCT02398552|Growth Substances|growth substances|mesh-ancestor
93213039|NCT02398552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213040|NCT02398552|Growth Inhibitors|growth inhibitors|mesh-ancestor
93213041|NCT02398552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93213042|NCT02398552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213043|NCT02398552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213044|NCT03345979|Aripiprazole|aripiprazole|mesh-list
93213045|NCT03345979|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93213046|NCT03345979|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
93213047|NCT03345979|Antidepressive Agents|antidepressive agents|mesh-ancestor
93213048|NCT03345979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93213049|NCT03345979|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93213050|NCT03345979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93213051|NCT03345979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213052|NCT03345979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213053|NCT03345979|Dopamine Agonists|dopamine agonists|mesh-ancestor
93213054|NCT03345979|Dopamine Agents|dopamine agents|mesh-ancestor
93213055|NCT03345979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213056|NCT03345979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213057|NCT03345979|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93213058|NCT03345979|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93213059|NCT03345979|Serotonin Agents|serotonin agents|mesh-ancestor
93213060|NCT03345979|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93213061|NCT03345979|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93213062|NCT03345979|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93213063|NCT03345979|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93213064|NCT02696434|Naltrexone|naltrexone|mesh-list
93213065|NCT02696434|Buprenorphine|buprenorphine|mesh-list
93213066|NCT02696434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93213067|NCT02696434|Narcotics|narcotics|mesh-ancestor
93213068|NCT02696434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213069|NCT02696434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213070|NCT02696434|Analgesics|analgesics|mesh-ancestor
93213071|NCT02696434|Sensory System Agents|sensory system agents|mesh-ancestor
93213072|NCT02696434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213073|NCT02696434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93213074|NCT02696434|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93213075|NCT03709147|Metformin|metformin|mesh-list
93213076|NCT03709147|Carboplatin|carboplatin|mesh-list
93213077|NCT03709147|Pembrolizumab|pembrolizumab|mesh-list
93213078|NCT03709147|Pemetrexed|pemetrexed|mesh-list
93213079|NCT03709147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213080|NCT03709147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93213081|NCT03709147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213082|NCT03709147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93213083|NCT03709147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93213084|NCT03709147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213085|NCT03709147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213086|NCT03709147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93213087|NCT03709147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93213088|NCT02398474|Ropivacaine|ropivacaine|mesh-list
93213089|NCT02398474|Anesthetics, Local|anesthetics, local|mesh-ancestor
93213090|NCT02398474|Anesthetics|anesthetics|mesh-ancestor
93213091|NCT02398474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213092|NCT02398474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213093|NCT02398474|Sensory System Agents|sensory system agents|mesh-ancestor
93213094|NCT02398474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213095|NCT03710317|Misoprostol|misoprostol|mesh-list
93213096|NCT03710317|Tranexamic Acid|tranexamic acid|mesh-list
93213097|NCT03710317|Carbetocin|carbetocin|mesh-list
93213098|NCT03710317|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92885136|NCT04071106|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213099|NCT03710317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93213100|NCT03710317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213101|NCT03710317|Hemostatics|hemostatics|mesh-ancestor
93213102|NCT03710317|Coagulants|coagulants|mesh-ancestor
93213103|NCT03710317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93213104|NCT03710317|Abortifacient Agents|abortifacient agents|mesh-ancestor
93213105|NCT03710317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93213106|NCT03710317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213107|NCT03710317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93213108|NCT03710317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213109|NCT03710317|Oxytocics|oxytocics|mesh-ancestor
93213110|NCT02392780|Methylprednisolone|methylprednisolone|mesh-list
93213111|NCT02392780|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93213112|NCT02392780|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93213113|NCT02392780|Prednisolone|prednisolone|mesh-list
93213114|NCT02392780|Prednisolone acetate|prednisolone acetate|mesh-list
93213115|NCT02392780|Cannabidiol|cannabidiol|mesh-list
93213116|NCT02392780|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93213117|NCT02392780|Prednisolone phosphate|prednisolone phosphate|mesh-list
93213118|NCT02392780|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93213119|NCT02392780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213120|NCT02392780|Antiemetics|antiemetics|mesh-ancestor
93213121|NCT02392780|Autonomic Agents|autonomic agents|mesh-ancestor
93213122|NCT02392780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213123|NCT02392780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213124|NCT02392780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213125|NCT02392780|Glucocorticoids|glucocorticoids|mesh-ancestor
93213126|NCT02392780|Hormones|hormones|mesh-ancestor
93213127|NCT02392780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213128|NCT02392780|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93213129|NCT02392780|Protective Agents|protective agents|mesh-ancestor
93213130|NCT02392780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93213131|NCT02392780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213132|NCT02392780|Anticonvulsants|anticonvulsants|mesh-ancestor
93213133|NCT02392780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213134|NCT02392780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213135|NCT04053478|Phenylephrine|phenylephrine|mesh-list
93213136|NCT04053478|Vasopressins|vasopressins|mesh-list
93213137|NCT04053478|Arginine Vasopressin|arginine vasopressin|mesh-list
93213138|NCT04053478|Oxymetazoline|oxymetazoline|mesh-list
93213139|NCT04053478|Norepinephrine|norepinephrine|mesh-list
93213140|NCT04053478|Ephedrine|ephedrine|mesh-list
93213141|NCT04053478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93213142|NCT04053478|Mydriatics|mydriatics|mesh-ancestor
93213143|NCT04053478|Autonomic Agents|autonomic agents|mesh-ancestor
93213144|NCT04053478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213145|NCT04053478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213146|NCT04053478|Sympathomimetics|sympathomimetics|mesh-ancestor
93213147|NCT04053478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93213148|NCT04053478|Nasal Decongestants|nasal decongestants|mesh-ancestor
93213149|NCT04053478|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213150|NCT04053478|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93213151|NCT04053478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93213152|NCT04053478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93213153|NCT04053478|Adrenergic Agents|adrenergic agents|mesh-ancestor
93213154|NCT04053478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213155|NCT04053478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213156|NCT04053478|Protective Agents|protective agents|mesh-ancestor
93213157|NCT04053478|Hemostatics|hemostatics|mesh-ancestor
93213158|NCT04053478|Coagulants|coagulants|mesh-ancestor
93213159|NCT04053478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93213160|NCT04053478|Natriuretic Agents|natriuretic agents|mesh-ancestor
93213161|NCT04053478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93213162|NCT02392390|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93213163|NCT02392390|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93213164|NCT02392390|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213165|NCT03593915|Azacitidine|azacitidine|mesh-list
93213166|NCT03593915|Decitabine|decitabine|mesh-list
93213167|NCT03593915|Alvocidib|alvocidib|mesh-list
93213168|NCT03593915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93213169|NCT03593915|Antimetabolites|antimetabolites|mesh-ancestor
93213170|NCT03593915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213171|NCT03593915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213172|NCT03593915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885213|NCT02648672|BPN14770|bpn14770|mesh-list
93213173|NCT03593915|Growth Inhibitors|growth inhibitors|mesh-ancestor
93213174|NCT03593915|Growth Substances|growth substances|mesh-ancestor
93213175|NCT03593915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213176|NCT03593915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93213177|NCT02392702|Ivacaftor|ivacaftor|mesh-list
93213178|NCT02392702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93213179|NCT02392702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93213180|NCT02392702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213181|NCT02392468|BI 409306|bi 409306|mesh-list
93213182|NCT02392468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93213183|NCT02392468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213184|NCT02392468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213185|NCT02397928|Carboplatin|carboplatin|mesh-list
93213186|NCT02397928|Pemetrexed|pemetrexed|mesh-list
93213187|NCT02397928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213188|NCT02397928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213189|NCT02397928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213190|NCT02397928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93213191|NCT02397928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93213192|NCT03734627|Acetaminophen|acetaminophen|mesh-list
93213193|NCT03734627|Sulfasalazine|sulfasalazine|mesh-list
93213194|NCT03734627|Octreotide|octreotide|mesh-list
93213195|NCT03734627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213196|NCT03734627|Analgesics|analgesics|mesh-ancestor
93213197|NCT03734627|Sensory System Agents|sensory system agents|mesh-ancestor
93213198|NCT03734627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213199|NCT03734627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213200|NCT03734627|Antipyretics|antipyretics|mesh-ancestor
93213201|NCT03734627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213202|NCT03734627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93213203|NCT03734627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213204|NCT03734627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213205|NCT03734627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93213206|NCT03734627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213207|NCT03734627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213208|NCT02397772|Albendazole|albendazole|mesh-list
93213209|NCT02397772|Anthelmintics|anthelmintics|mesh-ancestor
93213210|NCT02397772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93213211|NCT02397772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213212|NCT02397772|Anticestodal Agents|anticestodal agents|mesh-ancestor
93213213|NCT02397772|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93213214|NCT02397772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93213215|NCT02397772|Tubulin Modulators|tubulin modulators|mesh-ancestor
93213216|NCT02397772|Antimitotic Agents|antimitotic agents|mesh-ancestor
93213217|NCT02397772|Mitosis Modulators|mitosis modulators|mesh-ancestor
93213218|NCT02397772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213219|NCT02397772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213220|NCT03592277|Vitamins|vitamins|mesh-list
93213221|NCT03592277|Ascorbic Acid|ascorbic acid|mesh-list
93213222|NCT03592277|Thiamine|thiamine|mesh-list
93213223|NCT03592277|Micronutrients|micronutrients|mesh-ancestor
93213224|NCT03592277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213225|NCT03592277|Antioxidants|antioxidants|mesh-ancestor
93213226|NCT03592277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213227|NCT03592277|Protective Agents|protective agents|mesh-ancestor
93213228|NCT03592277|Vitamin B Complex|vitamin b complex|mesh-ancestor
93213229|NCT03106402|Bromfenac|bromfenac|mesh-list
93213230|NCT03106402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93213231|NCT03106402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213232|NCT03106402|Analgesics|analgesics|mesh-ancestor
93213233|NCT03106402|Sensory System Agents|sensory system agents|mesh-ancestor
93213234|NCT03106402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213235|NCT03106402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213236|NCT03106402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213237|NCT03106402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213238|NCT03734159|Ropivacaine|ropivacaine|mesh-list
93213239|NCT03734159|Anesthetics, Local|anesthetics, local|mesh-ancestor
93213240|NCT03734159|Anesthetics|anesthetics|mesh-ancestor
93213241|NCT03734159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213242|NCT03734159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213243|NCT03734159|Sensory System Agents|sensory system agents|mesh-ancestor
93213244|NCT03734159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213245|NCT02397382|Midazolam|midazolam|mesh-list
93213246|NCT02397382|Dextromethorphan|dextromethorphan|mesh-list
93213247|NCT02397382|Caffeine|caffeine|mesh-list
93213248|NCT02397382|Omeprazole|omeprazole|mesh-list
93213249|NCT02397382|Warfarin|warfarin|mesh-list
93213250|NCT02397382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93213251|NCT02397382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93213252|NCT02397382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213253|NCT02397382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213254|NCT02397382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93213255|NCT02397382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93213256|NCT02397382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93213257|NCT02397382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93213258|NCT02397382|Anesthetics, General|anesthetics, general|mesh-ancestor
93213259|NCT02397382|Anesthetics|anesthetics|mesh-ancestor
93213260|NCT02397382|GABA Modulators|gaba modulators|mesh-ancestor
93213261|NCT02397382|GABA Agents|gaba agents|mesh-ancestor
93213262|NCT02397382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213263|NCT02397382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213264|NCT02397382|Anticoagulants|anticoagulants|mesh-ancestor
93213265|NCT02397382|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93213266|NCT02397382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93213267|NCT02397382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213268|NCT02397382|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93213269|NCT02397382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93213270|NCT02397382|Purinergic Agents|purinergic agents|mesh-ancestor
93213271|NCT02397382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93213272|NCT02397382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213273|NCT02397382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93213274|NCT02397382|Antitussive Agents|antitussive agents|mesh-ancestor
93213275|NCT02397382|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213276|NCT02397382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93213277|NCT02397382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93213278|NCT02697916|Aspirin|aspirin|mesh-list
93213279|NCT02697916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93213280|NCT02697916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213281|NCT02697916|Analgesics|analgesics|mesh-ancestor
93213282|NCT02697916|Sensory System Agents|sensory system agents|mesh-ancestor
93213283|NCT02697916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213284|NCT02697916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213285|NCT02697916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213286|NCT02697916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213287|NCT02697916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93213288|NCT02697916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93213289|NCT02697916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213290|NCT02697916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93213291|NCT02697916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93213292|NCT02697916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213293|NCT02697916|Antipyretics|antipyretics|mesh-ancestor
93213294|NCT04762680|Vaccines|vaccines|mesh-list
93213295|NCT04762680|Immunologic Factors|immunologic factors|mesh-ancestor
93213296|NCT04762680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213297|NCT03650387|Lidocaine|lidocaine|mesh-list
93213298|NCT03650387|Anesthetics, Local|anesthetics, local|mesh-ancestor
93213299|NCT03650387|Anesthetics|anesthetics|mesh-ancestor
93213300|NCT03650387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213301|NCT03650387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213302|NCT03650387|Sensory System Agents|sensory system agents|mesh-ancestor
93213303|NCT03650387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213304|NCT03650387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93213305|NCT03650387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93213306|NCT03650387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93213307|NCT03650387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93213308|NCT03650387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213309|NCT02392156|Factor VIII|factor viii|mesh-list
93213310|NCT02392156|Coagulants|coagulants|mesh-ancestor
93213311|NCT03115060|Plasma-lyte 148|plasma-lyte 148|mesh-list
93213312|NCT03115060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93213313|NCT03115060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93213314|NCT03359473|GSK2881078|gsk2881078|mesh-list
93213315|NCT03359473|Anabolic Agents|anabolic agents|mesh-ancestor
93213316|NCT03359473|Hormones|hormones|mesh-ancestor
93213317|NCT03359473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213318|NCT03359473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213319|NCT03632304|Anesthetics|anesthetics|mesh-list
93213320|NCT03632304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213321|NCT03632304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213322|NCT02397538|Amlodipine|amlodipine|mesh-list
93213323|NCT02397538|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93213324|NCT02397538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93213325|NCT02397538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93213326|NCT02397538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885366|NCT00652652|Furosemide|furosemide|mesh-list
93213327|NCT02397538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213328|NCT02397538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93213329|NCT02397538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213330|NCT02397538|Vasodilator Agents|vasodilator agents|mesh-ancestor
93213331|NCT02397538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93213332|NCT02397538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93213333|NCT02397538|Antimetabolites|antimetabolites|mesh-ancestor
93213334|NCT02397538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93213335|NCT02397538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93213336|NCT02397538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213337|NCT03589469|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93213338|NCT03589469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93213339|NCT03589469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213341|NCT03359395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93213342|NCT03359395|Narcotics|narcotics|mesh-ancestor
93213343|NCT03359395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213344|NCT03359395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213345|NCT03359395|Analgesics|analgesics|mesh-ancestor
93213346|NCT03359395|Sensory System Agents|sensory system agents|mesh-ancestor
93213347|NCT03359395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213348|NCT03359395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93213349|NCT03359395|Anesthetics, General|anesthetics, general|mesh-ancestor
93213350|NCT03359395|Anesthetics|anesthetics|mesh-ancestor
93213351|NCT03733691|Lenalidomide|lenalidomide|mesh-list
93213352|NCT03733691|Ixazomib|ixazomib|mesh-list
93213353|NCT03733691|Immunologic Factors|immunologic factors|mesh-ancestor
93213354|NCT03733691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213355|NCT03733691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93213356|NCT03733691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93213357|NCT03733691|Growth Substances|growth substances|mesh-ancestor
93213358|NCT03733691|Growth Inhibitors|growth inhibitors|mesh-ancestor
93213359|NCT03733691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213360|NCT03733691|Protease Inhibitors|protease inhibitors|mesh-ancestor
93213361|NCT03733691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213362|NCT03733691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213363|NCT03358147|Tiotropium Bromide|tiotropium bromide|mesh-list
93213364|NCT03358147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93213365|NCT03358147|Autonomic Agents|autonomic agents|mesh-ancestor
93213366|NCT03358147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213367|NCT03358147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213368|NCT03358147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93213369|NCT03358147|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213370|NCT03358147|Parasympatholytics|parasympatholytics|mesh-ancestor
93213371|NCT03358147|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93213372|NCT03358147|Cholinergic Agents|cholinergic agents|mesh-ancestor
93213373|NCT03358147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213374|NCT03358147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213375|NCT05741632|Moxifloxacin|moxifloxacin|mesh-list
93213376|NCT05741632|Levofloxacin|levofloxacin|mesh-list
93213377|NCT05741632|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93213378|NCT05741632|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93213379|NCT05741632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93213380|NCT05741632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213381|NCT05741632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93213382|NCT05741632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93213383|NCT05741632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213384|NCT05741632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213385|NCT05741632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213386|NCT05741632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93213387|NCT05741632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93213388|NCT05741632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93213389|NCT03093402|Dronabinol|dronabinol|mesh-list
93213390|NCT03093402|Lenabasum|lenabasum|mesh-list
93213391|NCT03093402|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93213392|NCT03093402|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93213393|NCT03093402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213394|NCT03093402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213395|NCT03093402|Hormones|hormones|mesh-ancestor
93213396|NCT03093402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213397|NCT03093402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213398|NCT03093402|Hallucinogens|hallucinogens|mesh-ancestor
92885434|NCT04150536|Sensory System Agents|sensory system agents|mesh-ancestor
93213399|NCT03093402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93213400|NCT03093402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213401|NCT03093402|Analgesics|analgesics|mesh-ancestor
93213402|NCT03093402|Sensory System Agents|sensory system agents|mesh-ancestor
93213403|NCT03093402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213404|NCT02397070|Salicylic Acid|salicylic acid|mesh-list
93213405|NCT02397070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213406|NCT02397070|Antifungal Agents|antifungal agents|mesh-ancestor
93213407|NCT02397070|Keratolytic Agents|keratolytic agents|mesh-ancestor
93213408|NCT02397070|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213409|NCT03733379|Amoxicillin|amoxicillin|mesh-list
93213410|NCT03733379|Metronidazole|metronidazole|mesh-list
93213411|NCT03733379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93213412|NCT03733379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213413|NCT03733379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93213414|NCT03733379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93213415|NCT05733676|Calcium|calcium|mesh-list
93213416|NCT05733676|Fluorides|fluorides|mesh-list
93213417|NCT05733676|Caseins|caseins|mesh-list
93213418|NCT05733676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93213419|NCT05733676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213420|NCT05733676|Cariostatic Agents|cariostatic agents|mesh-ancestor
93213421|NCT05733676|Protective Agents|protective agents|mesh-ancestor
93213422|NCT05733676|Chelating Agents|chelating agents|mesh-ancestor
93213423|NCT05733676|Sequestering Agents|sequestering agents|mesh-ancestor
93213424|NCT05733676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213425|NCT03343639|Serlopitant|serlopitant|mesh-list
93213426|NCT03343639|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93213427|NCT03343639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213428|NCT03343639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213429|NCT03343639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213430|NCT04479748|Dexamethasone|dexamethasone|mesh-list
93213431|NCT04479748|Prednisolone|prednisolone|mesh-list
93213432|NCT04479748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93213433|NCT04479748|Methylprednisolone|methylprednisolone|mesh-list
93213434|NCT04479748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93213435|NCT04479748|Prednisolone acetate|prednisolone acetate|mesh-list
93213436|NCT04479748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93213437|NCT04479748|Prednisolone phosphate|prednisolone phosphate|mesh-list
93213438|NCT04479748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213439|NCT04479748|Antiemetics|antiemetics|mesh-ancestor
93213440|NCT04479748|Autonomic Agents|autonomic agents|mesh-ancestor
93213441|NCT04479748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213442|NCT04479748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213443|NCT04479748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213444|NCT04479748|Glucocorticoids|glucocorticoids|mesh-ancestor
93213445|NCT04479748|Hormones|hormones|mesh-ancestor
93213446|NCT04479748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213447|NCT04479748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93213448|NCT04479748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213449|NCT04479748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93213450|NCT04479748|Protective Agents|protective agents|mesh-ancestor
93213451|NCT02690974|Valsartan|valsartan|mesh-list
93213452|NCT02690974|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93213453|NCT02690974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93213454|NCT02690974|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93213455|NCT02690974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93213456|NCT02690974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213457|NCT03093324|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93213458|NCT03093324|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213459|NCT03093324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93213460|NCT03093324|Immunologic Factors|immunologic factors|mesh-ancestor
93213461|NCT03093324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213462|NCT03584009|Venetoclax|venetoclax|mesh-list
93213463|NCT03584009|Fulvestrant|fulvestrant|mesh-list
93213464|NCT03584009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213465|NCT03584009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93213466|NCT03584009|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93213467|NCT03584009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93213468|NCT03584009|Hormone Antagonists|hormone antagonists|mesh-ancestor
93213469|NCT03584009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213470|NCT03584009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213471|NCT03709927|Moxifloxacin|moxifloxacin|mesh-list
93213472|NCT03709927|Fosfomycin|fosfomycin|mesh-list
93213473|NCT03709927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885514|NCT04150146|Rebamipide|rebamipide|mesh-list
93213474|NCT03709927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213475|NCT03709927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93213476|NCT03709927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93213477|NCT03709927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213478|NCT03709927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213479|NCT03709927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213480|NCT03730181|Isoniazid|isoniazid|mesh-list
93213481|NCT03730181|Rifapentine|rifapentine|mesh-list
93213482|NCT03730181|Antitubercular Agents|antitubercular agents|mesh-ancestor
93213483|NCT03730181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93213484|NCT03730181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213485|NCT03730181|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93213486|NCT03730181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93213487|NCT03730181|Antimetabolites|antimetabolites|mesh-ancestor
93213488|NCT03730181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213489|NCT03730181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93213490|NCT03730181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93213491|NCT03730181|Leprostatic Agents|leprostatic agents|mesh-ancestor
93213492|NCT04167462|Deucravacitinib|deucravacitinib|mesh-list
93213493|NCT04167462|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213494|NCT04167462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93213495|NCT04167462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213496|NCT04167462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213497|NCT04160520|Morphine|morphine|mesh-list
93213498|NCT04160520|Pramipexole|pramipexole|mesh-list
93213499|NCT04160520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93213500|NCT04160520|Narcotics|narcotics|mesh-ancestor
93213501|NCT04160520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213502|NCT04160520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213503|NCT04160520|Analgesics|analgesics|mesh-ancestor
93213504|NCT04160520|Sensory System Agents|sensory system agents|mesh-ancestor
93213505|NCT04160520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213506|NCT04160520|Antioxidants|antioxidants|mesh-ancestor
93213507|NCT04160520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213508|NCT04160520|Protective Agents|protective agents|mesh-ancestor
93213509|NCT04160520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93213510|NCT04160520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93213511|NCT04160520|Dopamine Agonists|dopamine agonists|mesh-ancestor
93213512|NCT04160520|Dopamine Agents|dopamine agents|mesh-ancestor
93213513|NCT04160520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213514|NCT03583385|Metformin|metformin|mesh-list
93213515|NCT03583385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93213516|NCT03583385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213517|NCT05288335|Methamphetamine|methamphetamine|mesh-list
93213518|NCT05288335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93213519|NCT05288335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213520|NCT05288335|Sympathomimetics|sympathomimetics|mesh-ancestor
93213521|NCT05288335|Autonomic Agents|autonomic agents|mesh-ancestor
93213522|NCT05288335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213523|NCT05288335|Dopamine Agents|dopamine agents|mesh-ancestor
93213524|NCT05288335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213525|NCT05288335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213526|NCT05288335|Adrenergic Agents|adrenergic agents|mesh-ancestor
93213527|NCT05288335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93213528|NCT05288335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93213529|NCT05288335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93213530|NCT05288335|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93213531|NCT04792801|Choline|choline|mesh-list
93213532|NCT04792801|Lipotropic Agents|lipotropic agents|mesh-ancestor
93213533|NCT04792801|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93213534|NCT04792801|Antimetabolites|antimetabolites|mesh-ancestor
93213535|NCT04792801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213536|NCT04792801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213537|NCT04792801|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93213538|NCT04792801|Nootropic Agents|nootropic agents|mesh-ancestor
93213539|NCT05420922|Lenvatinib|lenvatinib|mesh-list
93213540|NCT05420922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93213541|NCT05420922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213542|NCT05420922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93213543|NCT05420922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213544|NCT05420922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213545|NCT05420922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93213546|NCT03582215|Salicylates|salicylates|mesh-list
93213547|NCT03582215|Avobenzone|avobenzone|mesh-list
92885583|NCT05299164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213548|NCT03582215|Oxybenzone|oxybenzone|mesh-list
93213549|NCT03582215|Homosalate|homosalate|mesh-list
93213550|NCT03582215|2-ethylhexyl salicylate|2-ethylhexyl salicylate|mesh-list
93213551|NCT03582215|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
93213552|NCT03582215|Sunscreening Agents|sunscreening agents|mesh-ancestor
93213553|NCT03582215|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93213554|NCT03582215|Protective Agents|protective agents|mesh-ancestor
93213555|NCT03582215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213556|NCT03582215|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213557|NCT03582215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93213558|NCT03582215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213559|NCT03582215|Analgesics|analgesics|mesh-ancestor
93213560|NCT03582215|Sensory System Agents|sensory system agents|mesh-ancestor
93213561|NCT03582215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213562|NCT03582215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213563|NCT03582215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213564|NCT03582215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93213565|NCT03582215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213566|NCT03582215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213567|NCT05175703|Paclitaxel|paclitaxel|mesh-list
93213568|NCT05175703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93213569|NCT05175703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213570|NCT05175703|Tubulin Modulators|tubulin modulators|mesh-ancestor
93213571|NCT05175703|Antimitotic Agents|antimitotic agents|mesh-ancestor
93213572|NCT05175703|Mitosis Modulators|mitosis modulators|mesh-ancestor
93213573|NCT05175703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213574|NCT04102800|Benralizumab|benralizumab|mesh-list
93213575|NCT04102800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93213576|NCT04102800|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213577|NCT03323346|Disulfiram|disulfiram|mesh-list
93213578|NCT03323346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93213579|NCT03323346|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93213580|NCT03323346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213581|NCT03323346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213582|NCT05628571|Fluorides|fluorides|mesh-list
93213583|NCT05628571|Cariostatic Agents|cariostatic agents|mesh-ancestor
93213584|NCT05628571|Protective Agents|protective agents|mesh-ancestor
93213585|NCT05628571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213586|NCT05255016|Riboflavin|riboflavin|mesh-list
93213587|NCT05255016|Lubricant Eye Drops|lubricant eye drops|mesh-list
93213588|NCT05255016|Vitamin B Complex|vitamin b complex|mesh-ancestor
93213589|NCT05255016|Vitamins|vitamins|mesh-ancestor
93213590|NCT05255016|Micronutrients|micronutrients|mesh-ancestor
93213591|NCT05255016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213592|NCT05255016|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93213593|NCT05255016|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213594|NCT05255016|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93213595|NCT05255016|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93213596|NCT05178888|Palbociclib|palbociclib|mesh-list
93213597|NCT05178888|Adagrasib|adagrasib|mesh-list
93213598|NCT05178888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213599|NCT05178888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93213600|NCT05178888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213601|NCT05178888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213602|NCT03342001|Calcitonin|calcitonin|mesh-list
93213603|NCT03342001|Salmon calcitonin|salmon calcitonin|mesh-list
93213604|NCT03342001|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93213605|NCT03342001|Katacalcin|katacalcin|mesh-list
93213606|NCT03342001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93213607|NCT03342001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213608|NCT03342001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93213609|NCT03342001|Vasodilator Agents|vasodilator agents|mesh-ancestor
93213610|NCT03579719|Itraconazole|itraconazole|mesh-list
93213611|NCT03579719|Balovaptan|balovaptan|mesh-list
93213612|NCT03579719|Antifungal Agents|antifungal agents|mesh-ancestor
93213613|NCT03579719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213614|NCT03579719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93213615|NCT03579719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93213616|NCT03579719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213617|NCT03579719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213618|NCT03579719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93213619|NCT03579719|Hormone Antagonists|hormone antagonists|mesh-ancestor
93213620|NCT03579719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213621|NCT03579719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213622|NCT03579719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93213623|NCT03579719|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93213624|NCT03579719|Natriuretic Agents|natriuretic agents|mesh-ancestor
93213625|NCT03631602|Antifungal Agents|antifungal agents|mesh-list
93213626|NCT03631602|Clotrimazole|clotrimazole|mesh-list
93213627|NCT03631602|Miconazole|miconazole|mesh-list
93213628|NCT03631602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213629|NCT03631602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93213630|NCT03631602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93213631|NCT03631602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93213632|NCT03631602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213633|NCT03631602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213634|NCT03631602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93213635|NCT03631602|Hormone Antagonists|hormone antagonists|mesh-ancestor
93213636|NCT03631602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213637|NCT03631602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213638|NCT03631602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93213639|NCT03631602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93213640|NCT02688088|Midazolam|midazolam|mesh-list
93213641|NCT02688088|Dextromethorphan|dextromethorphan|mesh-list
93213642|NCT02688088|Caffeine|caffeine|mesh-list
93213643|NCT02688088|Warfarin|warfarin|mesh-list
93213644|NCT02688088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93213645|NCT02688088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93213646|NCT02688088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213647|NCT02688088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213648|NCT02688088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93213649|NCT02688088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93213650|NCT02688088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93213651|NCT02688088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93213652|NCT02688088|Anesthetics, General|anesthetics, general|mesh-ancestor
93213653|NCT02688088|Anesthetics|anesthetics|mesh-ancestor
93213654|NCT02688088|GABA Modulators|gaba modulators|mesh-ancestor
93213655|NCT02688088|GABA Agents|gaba agents|mesh-ancestor
93213656|NCT02688088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213657|NCT02688088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213658|NCT02688088|Anticoagulants|anticoagulants|mesh-ancestor
93213659|NCT02688088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93213660|NCT02688088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93213661|NCT02688088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213662|NCT02688088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93213663|NCT02688088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93213664|NCT02688088|Purinergic Agents|purinergic agents|mesh-ancestor
93213665|NCT02688088|Antitussive Agents|antitussive agents|mesh-ancestor
93213666|NCT02688088|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213667|NCT02688088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93213668|NCT02688088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93213669|NCT03641651|Frovatriptan|frovatriptan|mesh-list
93213670|NCT03641651|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93213671|NCT03641651|Serotonin Agents|serotonin agents|mesh-ancestor
93213672|NCT03641651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213673|NCT03641651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213674|NCT03641651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213675|NCT03341299|Insulin Lispro|insulin lispro|mesh-list
93213676|NCT03341299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93213677|NCT03341299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213678|NCT05666219|Aminophylline|aminophylline|mesh-list
93213679|NCT05666219|Theophylline|theophylline|mesh-list
93213680|NCT05666219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93213681|NCT05666219|Autonomic Agents|autonomic agents|mesh-ancestor
93213682|NCT05666219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213683|NCT05666219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213684|NCT05666219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93213685|NCT05666219|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213686|NCT05666219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93213687|NCT05666219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213688|NCT05666219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213689|NCT05666219|Vasodilator Agents|vasodilator agents|mesh-ancestor
93213690|NCT05666219|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93213691|NCT05666219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93213692|NCT05666219|Purinergic Agents|purinergic agents|mesh-ancestor
93213693|NCT05666219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213694|NCT05666219|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93213695|NCT05666219|Protective Agents|protective agents|mesh-ancestor
93213696|NCT02949271|Fentanyl|fentanyl|mesh-list
93213697|NCT02949271|Ropivacaine|ropivacaine|mesh-list
93213698|NCT02949271|Anesthetics, Local|anesthetics, local|mesh-ancestor
93213699|NCT02949271|Anesthetics|anesthetics|mesh-ancestor
93213700|NCT02949271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213701|NCT02949271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213702|NCT02949271|Sensory System Agents|sensory system agents|mesh-ancestor
93213703|NCT02949271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213704|NCT02949271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93213705|NCT02949271|Narcotics|narcotics|mesh-ancestor
93213706|NCT02949271|Analgesics|analgesics|mesh-ancestor
93213707|NCT02949271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93213708|NCT02949271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93213709|NCT02949271|Anesthetics, General|anesthetics, general|mesh-ancestor
93213710|NCT03339583|Zopiclone|zopiclone|mesh-list
93213711|NCT03339583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93213712|NCT03339583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213713|NCT03339583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213714|NCT03639779|Sodium thiosulfate|sodium thiosulfate|mesh-list
93213715|NCT03639779|Antidotes|antidotes|mesh-ancestor
93213716|NCT03639779|Protective Agents|protective agents|mesh-ancestor
93213717|NCT03639779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213718|NCT03639779|Antioxidants|antioxidants|mesh-ancestor
93213719|NCT03639779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213720|NCT03639779|Antitubercular Agents|antitubercular agents|mesh-ancestor
93213721|NCT03639779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93213722|NCT03639779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213723|NCT03639779|Chelating Agents|chelating agents|mesh-ancestor
93213724|NCT03639779|Sequestering Agents|sequestering agents|mesh-ancestor
93213725|NCT05682547|Lubricant Eye Drops|lubricant eye drops|mesh-list
93213726|NCT05682547|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93213727|NCT05682547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93213728|NCT05173441|Immunoglobulins|immunoglobulins|mesh-list
93213729|NCT05173441|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93213730|NCT05173441|Antibodies|antibodies|mesh-list
93213731|NCT05173441|Immunologic Factors|immunologic factors|mesh-ancestor
93213732|NCT05173441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213733|NCT03708133|Nifurtimox|nifurtimox|mesh-list
93213734|NCT03708133|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93213735|NCT03708133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93213736|NCT03708133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93213737|NCT03708133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213738|NCT05075161|Pirfenidone|pirfenidone|mesh-list
93213739|NCT05075161|Analgesics|analgesics|mesh-ancestor
93213740|NCT05075161|Sensory System Agents|sensory system agents|mesh-ancestor
93213741|NCT05075161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213742|NCT05075161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213743|NCT05075161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93213744|NCT05075161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213745|NCT05075161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213746|NCT05075161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213747|NCT05075161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213748|NCT05095831|Pancrelipase|pancrelipase|mesh-list
93213749|NCT05095831|Pancreatin|pancreatin|mesh-list
93213750|NCT05095831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213751|NCT03638869|Methadone|methadone|mesh-list
93213752|NCT03638869|D-methadone|d-methadone|mesh-list
93213753|NCT03638869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93213754|NCT03638869|Narcotics|narcotics|mesh-ancestor
93213755|NCT03638869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213756|NCT03638869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213757|NCT03638869|Analgesics|analgesics|mesh-ancestor
93213758|NCT03638869|Sensory System Agents|sensory system agents|mesh-ancestor
93213759|NCT03638869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213760|NCT03638869|Antitussive Agents|antitussive agents|mesh-ancestor
93213761|NCT03638869|Respiratory System Agents|respiratory system agents|mesh-ancestor
93213762|NCT03638869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93213763|NCT03091920|Praliciguat|praliciguat|mesh-list
93213764|NCT03091920|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93213765|NCT03091920|Enzyme Activators|enzyme activators|mesh-ancestor
93213766|NCT03091920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213767|NCT03091920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213768|NCT03338569|Ascorbic Acid|ascorbic acid|mesh-list
93213769|NCT03338569|Vitamins|vitamins|mesh-ancestor
92885811|NCT04330690|Antimalarials|antimalarials|mesh-ancestor
93213770|NCT03338569|Micronutrients|micronutrients|mesh-ancestor
93213771|NCT03338569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213772|NCT03338569|Antioxidants|antioxidants|mesh-ancestor
93213773|NCT03338569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213774|NCT03338569|Protective Agents|protective agents|mesh-ancestor
93213775|NCT03338023|Insulin Lispro|insulin lispro|mesh-list
93213776|NCT03338023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93213777|NCT03338023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213778|NCT05053633|Anesthetics|anesthetics|mesh-list
93213779|NCT05053633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213780|NCT05053633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213781|NCT03337477|Insulin|insulin|mesh-list
93213782|NCT03337477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93213783|NCT03337477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93213784|NCT03337477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213785|NCT03707899|Amlodipine|amlodipine|mesh-list
93213786|NCT03707899|Telmisartan|telmisartan|mesh-list
93213787|NCT03707899|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93213788|NCT03707899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93213789|NCT03707899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93213790|NCT03707899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93213791|NCT03707899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93213792|NCT03707899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213793|NCT03707899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93213794|NCT03707899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213795|NCT03707899|Vasodilator Agents|vasodilator agents|mesh-ancestor
93213796|NCT03707899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93213797|NCT03707899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93213798|NCT03707899|Antimetabolites|antimetabolites|mesh-ancestor
93213799|NCT03707899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93213800|NCT03707899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93213801|NCT03707899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213802|NCT03707899|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93213803|NCT03707899|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93213804|NCT03336619|Nitazoxanide|nitazoxanide|mesh-list
93213805|NCT03336619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93213806|NCT03336619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213807|NCT03114904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93213808|NCT03114904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213809|NCT03114904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213810|NCT03706339|Tranexamic Acid|tranexamic acid|mesh-list
93213811|NCT03706339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93213812|NCT03706339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93213813|NCT03706339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213814|NCT03706339|Hemostatics|hemostatics|mesh-ancestor
93213815|NCT03706339|Coagulants|coagulants|mesh-ancestor
93213816|NCT03739476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93213817|NCT03739476|Antidepressive Agents|antidepressive agents|mesh-ancestor
93213818|NCT03739476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93213819|NCT03739476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93213820|NCT03739476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93213821|NCT03739476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213822|NCT03739476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213823|NCT03639558|Promethazine|promethazine|mesh-list
93213824|NCT03639558|Diphenhydramine|diphenhydramine|mesh-list
93213825|NCT03639558|Haloperidol|haloperidol|mesh-list
93213826|NCT03639558|Chlorpromazine|chlorpromazine|mesh-list
93213827|NCT03639558|Haloperidol decanoate|haloperidol decanoate|mesh-list
93213828|NCT03639558|Antiemetics|antiemetics|mesh-ancestor
93213829|NCT03639558|Autonomic Agents|autonomic agents|mesh-ancestor
93213830|NCT03639558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213831|NCT03639558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213832|NCT03639558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213833|NCT03639558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93213834|NCT03639558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93213835|NCT03639558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93213836|NCT03639558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93213837|NCT03639558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93213838|NCT03639558|Dopamine Agents|dopamine agents|mesh-ancestor
93213839|NCT03639558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213840|NCT03639558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213841|NCT03639558|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93213842|NCT03639558|Antipruritics|antipruritics|mesh-ancestor
93213843|NCT03639558|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213844|NCT03639558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93213845|NCT03639558|Histamine Antagonists|histamine antagonists|mesh-ancestor
93213846|NCT03639558|Histamine Agents|histamine agents|mesh-ancestor
93213847|NCT03639558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93213848|NCT03639558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93213849|NCT03639558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93213850|NCT03639558|Anesthetics, Local|anesthetics, local|mesh-ancestor
93213851|NCT03639558|Anesthetics|anesthetics|mesh-ancestor
93213852|NCT03639558|Sensory System Agents|sensory system agents|mesh-ancestor
93213853|NCT01353508|Valsartan|valsartan|mesh-list
93213854|NCT01353508|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93213855|NCT01353508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93213856|NCT01353508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93213857|NCT01353508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93213858|NCT01353508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213859|NCT01568268|Palonosetron|palonosetron|mesh-list
93213860|NCT01568268|Antiemetics|antiemetics|mesh-ancestor
93213861|NCT01568268|Autonomic Agents|autonomic agents|mesh-ancestor
93213862|NCT01568268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213863|NCT01568268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213864|NCT01568268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213865|NCT01568268|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93213866|NCT01568268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93213867|NCT01568268|Serotonin Agents|serotonin agents|mesh-ancestor
93213868|NCT01568268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213869|NCT01568268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213870|NCT04911361|Dexamethasone|dexamethasone|mesh-list
93213871|NCT04911361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93213872|NCT04911361|Antiemetics|antiemetics|mesh-ancestor
93213873|NCT04911361|Autonomic Agents|autonomic agents|mesh-ancestor
93213874|NCT04911361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213875|NCT04911361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213876|NCT04911361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93213877|NCT04911361|Glucocorticoids|glucocorticoids|mesh-ancestor
93213878|NCT04911361|Hormones|hormones|mesh-ancestor
93213879|NCT04911361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213880|NCT04911361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93213881|NCT04911361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213882|NCT04475731|Ponatinib|ponatinib|mesh-list
93213883|NCT04475731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213884|NCT04475731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93213885|NCT04475731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213886|NCT04475731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213887|NCT03087786|Nicotine|nicotine|mesh-list
93213888|NCT03087786|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93213889|NCT03087786|Autonomic Agents|autonomic agents|mesh-ancestor
91928784|NCT02179931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93213890|NCT03087786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93213891|NCT03087786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213892|NCT03087786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93213893|NCT03087786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93213894|NCT03087786|Cholinergic Agents|cholinergic agents|mesh-ancestor
93213895|NCT03087786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213896|NCT03087786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213897|NCT03635957|Folic Acid|folic acid|mesh-list
93213898|NCT03635957|Methotrexate|methotrexate|mesh-list
93213899|NCT03635957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93213900|NCT03635957|Abortifacient Agents|abortifacient agents|mesh-ancestor
93213901|NCT03635957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93213902|NCT03635957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213903|NCT03635957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93213904|NCT03635957|Antimetabolites|antimetabolites|mesh-ancestor
93213905|NCT03635957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213906|NCT03635957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213907|NCT03635957|Dermatologic Agents|dermatologic agents|mesh-ancestor
93213908|NCT03635957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213909|NCT03635957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93213910|NCT03635957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93213911|NCT03635957|Immunologic Factors|immunologic factors|mesh-ancestor
93213912|NCT03635957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213913|NCT03635957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93213914|NCT03635957|Hematinics|hematinics|mesh-ancestor
93213915|NCT03635957|Vitamin B Complex|vitamin b complex|mesh-ancestor
93213916|NCT03635957|Vitamins|vitamins|mesh-ancestor
93213917|NCT03635957|Micronutrients|micronutrients|mesh-ancestor
93213918|NCT05005507|Tenofovir|tenofovir|mesh-list
93213919|NCT05005507|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93213920|NCT05005507|Antiviral Agents|antiviral agents|mesh-ancestor
93213921|NCT05005507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213922|NCT05005507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93213923|NCT05005507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93213924|NCT05005507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213925|NCT05005507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213926|NCT05005507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93213927|NCT05005507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93213928|NCT04739358|Tepotinib|tepotinib|mesh-list
93213929|NCT04739358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213930|NCT04893343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93213931|NCT04893343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93213932|NCT04893343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213933|NCT04893343|Antitubercular Agents|antitubercular agents|mesh-ancestor
93213934|NCT05399641|Ibrexafungerp|ibrexafungerp|mesh-list
93213935|NCT05399641|Antifungal Agents|antifungal agents|mesh-ancestor
93213936|NCT05399641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213937|NCT05593666|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93213938|NCT05593666|Antifungal Agents|antifungal agents|mesh-ancestor
93213939|NCT05593666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213940|NCT05593666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93213941|NCT05593666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93213942|NCT02684344|Tamsulosin|tamsulosin|mesh-list
93213943|NCT02684344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93213944|NCT02684344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93213945|NCT02684344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93213946|NCT02684344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93213947|NCT02684344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93213948|NCT02684344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213949|NCT02684344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213950|NCT02684344|Urological Agents|urological agents|mesh-ancestor
93213951|NCT03974100|Denosumab|denosumab|mesh-list
93213952|NCT03974100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93213953|NCT03974100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213954|NCT02689804|Levonorgestrel|levonorgestrel|mesh-list
93213955|NCT02689804|Ulipristal acetate|ulipristal acetate|mesh-list
93213956|NCT02689804|Contraceptive Agents|contraceptive agents|mesh-list
93213957|NCT02689804|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
93213958|NCT02689804|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93213959|NCT02689804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93213960|NCT02689804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213961|NCT02689804|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93213962|NCT02689804|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93213963|NCT02689804|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93213964|NCT04353271|Hydroxychloroquine|hydroxychloroquine|mesh-list
93213965|NCT04353271|Antimalarials|antimalarials|mesh-ancestor
93213966|NCT04353271|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93213967|NCT04353271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93213968|NCT04353271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93213969|NCT04353271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213970|NCT04353271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213971|NCT04353271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93213972|NCT03417882|Pembrolizumab|pembrolizumab|mesh-list
93213973|NCT03417882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93213974|NCT03417882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93213975|NCT03417882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93213976|NCT03417882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213977|NCT01374568|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93213978|NCT01374568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93213979|NCT01374568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213980|NCT01374568|Incretins|incretins|mesh-ancestor
93213981|NCT01374568|Hormones|hormones|mesh-ancestor
93213982|NCT01374568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93213983|NCT01374568|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93213984|NCT01374568|Protease Inhibitors|protease inhibitors|mesh-ancestor
93213985|NCT01374568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93213986|NCT01374568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93213987|NCT01312441|Ergocalciferols|ergocalciferols|mesh-list
93213988|NCT01312441|Vitamin D|vitamin d|mesh-list
93213989|NCT01312441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93213990|NCT01312441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213991|NCT01312441|Vitamins|vitamins|mesh-ancestor
93213992|NCT01312441|Micronutrients|micronutrients|mesh-ancestor
93213993|NCT01312441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93213994|NCT02682784|Oxytocin|oxytocin|mesh-list
93213995|NCT02682784|Oxytocics|oxytocics|mesh-ancestor
93213996|NCT02682784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93213997|NCT02682784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93213998|NCT03705949|Lubricant Eye Drops|lubricant eye drops|mesh-list
93213999|NCT03705949|Hyaluronic Acid|hyaluronic acid|mesh-list
93214000|NCT03705949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93214001|NCT03705949|Immunologic Factors|immunologic factors|mesh-ancestor
93214002|NCT03705949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214004|NCT03705949|Protective Agents|protective agents|mesh-ancestor
93214005|NCT03705949|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93214006|NCT03705949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93214007|NCT03162562|Oregovomab|oregovomab|mesh-list
93214008|NCT03162562|Poly ICLC|poly iclc|mesh-list
93214009|NCT03162562|Interferon Inducers|interferon inducers|mesh-ancestor
93214010|NCT03162562|Immunologic Factors|immunologic factors|mesh-ancestor
93214011|NCT03162562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214012|NCT03162562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214013|NCT03162562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214014|NCT03164590|Dexmedetomidine|dexmedetomidine|mesh-list
93214015|NCT03164590|Ketamine|ketamine|mesh-list
93214016|NCT03164590|Bupivacaine|bupivacaine|mesh-list
93214017|NCT03164590|Anesthetics, Local|anesthetics, local|mesh-ancestor
93214018|NCT03164590|Anesthetics|anesthetics|mesh-ancestor
93214019|NCT03164590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214020|NCT03164590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214021|NCT03164590|Sensory System Agents|sensory system agents|mesh-ancestor
93214022|NCT03164590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214023|NCT03164590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93214024|NCT03164590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93214025|NCT03164590|Analgesics|analgesics|mesh-ancestor
93214026|NCT03164590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93214027|NCT03164590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93214028|NCT03164590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93214029|NCT03164590|Adrenergic Agents|adrenergic agents|mesh-ancestor
93214030|NCT03164590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214031|NCT03164590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214032|NCT03164590|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93214033|NCT03164590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93214034|NCT03164590|Anesthetics, General|anesthetics, general|mesh-ancestor
93214035|NCT03164590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93214036|NCT03164590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93214037|NCT05119075|Dopamine|dopamine|mesh-list
93214038|NCT05119075|Dopamine Agonists|dopamine agonists|mesh-list
93214039|NCT05119075|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93214040|NCT05119075|Sympathomimetics|sympathomimetics|mesh-ancestor
93214041|NCT05119075|Autonomic Agents|autonomic agents|mesh-ancestor
93214042|NCT05119075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214043|NCT05119075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214044|NCT05119075|Dopamine Agents|dopamine agents|mesh-ancestor
93214045|NCT05119075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214046|NCT05119075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214047|NCT05119075|Protective Agents|protective agents|mesh-ancestor
93214048|NCT03387852|Fluticasone|fluticasone|mesh-list
93214049|NCT03387852|Xhance|xhance|mesh-list
93214050|NCT03387852|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93214051|NCT03387852|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93214052|NCT03387852|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93214053|NCT03387852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214054|NCT03387852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93214055|NCT03387852|Autonomic Agents|autonomic agents|mesh-ancestor
93214056|NCT03387852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214057|NCT03387852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214058|NCT03387852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93214059|NCT03387852|Respiratory System Agents|respiratory system agents|mesh-ancestor
93214060|NCT03387852|Dermatologic Agents|dermatologic agents|mesh-ancestor
93214061|NCT03387852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93214062|NCT03387852|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93214063|NCT03387852|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93214064|NCT03387852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93214065|NCT03387852|Adrenergic Agents|adrenergic agents|mesh-ancestor
93214066|NCT03387852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214067|NCT03387852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214068|NCT03387852|Immunologic Factors|immunologic factors|mesh-ancestor
93214069|NCT03387852|Glucocorticoids|glucocorticoids|mesh-ancestor
93214070|NCT03387852|Hormones|hormones|mesh-ancestor
93214071|NCT03387852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214072|NCT03387852|Sympathomimetics|sympathomimetics|mesh-ancestor
93214073|NCT02679274|Methyltestosterone|methyltestosterone|mesh-list
93214074|NCT02679274|Testosterone|testosterone|mesh-list
92886123|NCT02647424|Letrozole|letrozole|mesh-list
93214075|NCT02679274|Testosterone undecanoate|testosterone undecanoate|mesh-list
93214076|NCT02679274|Testosterone enanthate|testosterone enanthate|mesh-list
93214077|NCT02679274|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93214078|NCT02679274|Androgens|androgens|mesh-ancestor
93214079|NCT02679274|Hormones|hormones|mesh-ancestor
93214080|NCT02679274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214081|NCT02679274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214082|NCT02679274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214083|NCT02679274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214084|NCT02679274|Anabolic Agents|anabolic agents|mesh-ancestor
93214085|NCT03620929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93214086|NCT03620929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93214087|NCT03620929|Estradiol|estradiol|mesh-list
93214088|NCT03620929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93214089|NCT03620929|Dydrogesterone|dydrogesterone|mesh-list
93214090|NCT03620929|Estrogens|estrogens|mesh-ancestor
93214091|NCT03620929|Hormones|hormones|mesh-ancestor
93214092|NCT03620929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214093|NCT03620929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214094|NCT03620929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93214095|NCT03620929|Contraceptive Agents|contraceptive agents|mesh-ancestor
93214096|NCT03620929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93214097|NCT03620929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93214098|NCT03620929|Progestins|progestins|mesh-ancestor
93214099|NCT04969861|Pembrolizumab|pembrolizumab|mesh-list
93214100|NCT04969861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214101|NCT04969861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214102|NCT04969861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93214103|NCT04969861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214104|NCT05308849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93214105|NCT05308849|beta-Lactams|beta-lactams|mesh-list
93214106|NCT05308849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214107|NCT02678416|Acetaminophen|acetaminophen|mesh-list
93214108|NCT02678416|Morphine|morphine|mesh-list
93214109|NCT02678416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214110|NCT02678416|Narcotics|narcotics|mesh-ancestor
93214111|NCT02678416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214112|NCT02678416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214113|NCT02678416|Analgesics|analgesics|mesh-ancestor
93214114|NCT02678416|Sensory System Agents|sensory system agents|mesh-ancestor
93214115|NCT02678416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214116|NCT02678416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93214117|NCT02678416|Antipyretics|antipyretics|mesh-ancestor
93214118|NCT03164668|Menthol|menthol|mesh-list
93214119|NCT03164668|Antipruritics|antipruritics|mesh-ancestor
93214120|NCT03164668|Dermatologic Agents|dermatologic agents|mesh-ancestor
93214121|NCT03164512|Cannabidiol|cannabidiol|mesh-list
93214122|NCT03164512|Anticonvulsants|anticonvulsants|mesh-ancestor
93214123|NCT02680756|Ferric maltol|ferric maltol|mesh-list
93214124|NCT02680756|Hematinics|hematinics|mesh-ancestor
93214125|NCT03631836|Bevacizumab|bevacizumab|mesh-list
93214126|NCT03631836|Antibodies|antibodies|mesh-list
93214127|NCT03631836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93214128|NCT03631836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214129|NCT03631836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214130|NCT03631836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93214131|NCT03631836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93214132|NCT03631836|Growth Substances|growth substances|mesh-ancestor
93214133|NCT03631836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214134|NCT03631836|Growth Inhibitors|growth inhibitors|mesh-ancestor
93214135|NCT03631836|Immunologic Factors|immunologic factors|mesh-ancestor
93214136|NCT03162094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93214137|NCT03162094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93214138|NCT03086460|Formoterol Fumarate|formoterol fumarate|mesh-list
93214139|NCT03086460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93214140|NCT03086460|Autonomic Agents|autonomic agents|mesh-ancestor
93214141|NCT03086460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214142|NCT03086460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214143|NCT03086460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93214144|NCT03086460|Respiratory System Agents|respiratory system agents|mesh-ancestor
93214145|NCT03086460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93214146|NCT03086460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93214147|NCT03086460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93214148|NCT03086460|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886183|NCT02643602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93214149|NCT03086460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214150|NCT03086460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214151|NCT05422066|Prednisone|prednisone|mesh-list
93214152|NCT05422066|Cyclophosphamide|cyclophosphamide|mesh-list
93214153|NCT05422066|Rituximab|rituximab|mesh-list
93214154|NCT05422066|Doxorubicin|doxorubicin|mesh-list
93214155|NCT05422066|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93214156|NCT05422066|Vincristine|vincristine|mesh-list
93214157|NCT05422066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214158|NCT05422066|Immunologic Factors|immunologic factors|mesh-ancestor
93214159|NCT05422066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214160|NCT05422066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214161|NCT05422066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93214162|NCT05422066|Alkylating Agents|alkylating agents|mesh-ancestor
93214163|NCT05422066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214164|NCT05422066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214165|NCT05422066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93214166|NCT05422066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214167|NCT05422066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93214168|NCT05422066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93214169|NCT05422066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93214170|NCT05422066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214171|NCT05422066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214172|NCT05422066|Glucocorticoids|glucocorticoids|mesh-ancestor
93214173|NCT05422066|Hormones|hormones|mesh-ancestor
93214174|NCT05422066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214175|NCT05422066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214176|NCT05422066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93214177|NCT05422066|Tubulin Modulators|tubulin modulators|mesh-ancestor
93214178|NCT05422066|Antimitotic Agents|antimitotic agents|mesh-ancestor
93214179|NCT05422066|Mitosis Modulators|mitosis modulators|mesh-ancestor
93214180|NCT03670706|Analgesics|analgesics|mesh-list
93214181|NCT03670706|Sensory System Agents|sensory system agents|mesh-ancestor
93214182|NCT03670706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214183|NCT03670706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214184|NCT03114280|Carboplatin|carboplatin|mesh-list
93214185|NCT03114280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214186|NCT01312363|Rivastigmine|rivastigmine|mesh-list
93214187|NCT01312363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93214188|NCT01312363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214189|NCT01312363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214190|NCT01312363|Cholinergic Agents|cholinergic agents|mesh-ancestor
93214191|NCT01312363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214192|NCT01312363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214193|NCT01312363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93214194|NCT01312363|Protective Agents|protective agents|mesh-ancestor
93214195|NCT03161678|Clopidogrel|clopidogrel|mesh-list
93214196|NCT03161678|Ticagrelor|ticagrelor|mesh-list
93214197|NCT03161678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93214198|NCT03161678|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93214199|NCT03161678|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93214200|NCT03161678|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93214201|NCT03161678|Purinergic Agents|purinergic agents|mesh-ancestor
93214202|NCT03161678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214203|NCT03161678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214204|NCT03161678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214205|NCT05597280|Rifampin|rifampin|mesh-list
93214206|NCT05597280|Bedaquiline|bedaquiline|mesh-list
93214207|NCT05597280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93214208|NCT05597280|Antitubercular Agents|antitubercular agents|mesh-ancestor
93214209|NCT05597280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93214210|NCT05597280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214211|NCT05597280|Leprostatic Agents|leprostatic agents|mesh-ancestor
93214212|NCT05597280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93214213|NCT05597280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214214|NCT05597280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214215|NCT05597280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93214216|NCT05597280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93214217|NCT05597280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93214218|NCT05597280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93214219|NCT05597280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93214220|NCT05597280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93214221|NCT03674606|Aspirin|aspirin|mesh-list
93214222|NCT03674606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93214223|NCT03674606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93214224|NCT03674606|Analgesics|analgesics|mesh-ancestor
93214225|NCT03674606|Sensory System Agents|sensory system agents|mesh-ancestor
93214226|NCT03674606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214227|NCT03674606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214228|NCT03674606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214229|NCT03674606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214230|NCT03674606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93214231|NCT03674606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93214232|NCT03674606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214233|NCT03674606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93214234|NCT03674606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93214235|NCT03674606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214236|NCT03674606|Antipyretics|antipyretics|mesh-ancestor
93214237|NCT02677324|Venetoclax|venetoclax|mesh-list
93214238|NCT02677324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214239|NCT03163966|Methotrexate|methotrexate|mesh-list
93214240|NCT03163966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93214241|NCT03163966|Abortifacient Agents|abortifacient agents|mesh-ancestor
93214242|NCT03163966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93214243|NCT03163966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214244|NCT03163966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93214245|NCT03163966|Antimetabolites|antimetabolites|mesh-ancestor
93214246|NCT03163966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214247|NCT03163966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214248|NCT03163966|Dermatologic Agents|dermatologic agents|mesh-ancestor
93214249|NCT03163966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214250|NCT03163966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93214251|NCT03163966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214252|NCT03163966|Immunologic Factors|immunologic factors|mesh-ancestor
93214253|NCT03163966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214254|NCT03163966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93214255|NCT03678116|Caffeine|caffeine|mesh-list
93214256|NCT03678116|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93214257|NCT03678116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214258|NCT03678116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93214259|NCT03678116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214260|NCT03678116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214261|NCT03678116|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93214262|NCT03678116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93214263|NCT03678116|Purinergic Agents|purinergic agents|mesh-ancestor
93214264|NCT03678116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214265|NCT03678038|Triamcinolone|triamcinolone|mesh-list
93214266|NCT03678038|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93214267|NCT03678038|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93214268|NCT03678038|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93214269|NCT03678038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214270|NCT03678038|Glucocorticoids|glucocorticoids|mesh-ancestor
93214271|NCT03678038|Hormones|hormones|mesh-ancestor
93214272|NCT03678038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214273|NCT03678038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214274|NCT03678038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214275|NCT03678038|Immunologic Factors|immunologic factors|mesh-ancestor
93214276|NCT03678038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214277|NCT03678038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214278|NCT03163420|Diclofenac|diclofenac|mesh-list
93214279|NCT03163420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93214280|NCT03163420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93214281|NCT03163420|Analgesics|analgesics|mesh-ancestor
93214282|NCT03163420|Sensory System Agents|sensory system agents|mesh-ancestor
93214283|NCT03163420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214284|NCT03163420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214285|NCT03163420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214286|NCT03163420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214287|NCT03163420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93214288|NCT03163420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214289|NCT03163420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214290|NCT04440436|Cyclophosphamide|cyclophosphamide|mesh-list
93214291|NCT04440436|Fludarabine|fludarabine|mesh-list
93214292|NCT04440436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214293|NCT04440436|Immunologic Factors|immunologic factors|mesh-ancestor
93214294|NCT04440436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214295|NCT04440436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214296|NCT04440436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92886330|NCT02652728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214297|NCT04440436|Alkylating Agents|alkylating agents|mesh-ancestor
93214298|NCT04440436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214299|NCT04440436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214300|NCT04440436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93214301|NCT05405686|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93214302|NCT05405686|Hormones|hormones|mesh-ancestor
93214303|NCT05405686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214304|NCT05405686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214305|NCT04711122|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93214306|NCT04711122|Cephalosporins|cephalosporins|mesh-list
93214307|NCT04711122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214308|NCT05272696|Paclitaxel|paclitaxel|mesh-list
93214309|NCT05272696|Pembrolizumab|pembrolizumab|mesh-list
93214310|NCT05272696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93214311|NCT05272696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214312|NCT05272696|Tubulin Modulators|tubulin modulators|mesh-ancestor
93214313|NCT05272696|Antimitotic Agents|antimitotic agents|mesh-ancestor
93214314|NCT05272696|Mitosis Modulators|mitosis modulators|mesh-ancestor
93214315|NCT05272696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214316|NCT05272696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214317|NCT05272696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93214318|NCT05563116|Calcium|calcium|mesh-list
93214319|NCT05563116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93214320|NCT05563116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214321|NCT03520946|Ramucirumab|ramucirumab|mesh-list
93214322|NCT03520946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214323|NCT03709758|Cytarabine|cytarabine|mesh-list
93214324|NCT03709758|Daunorubicin|daunorubicin|mesh-list
93214325|NCT03709758|Venetoclax|venetoclax|mesh-list
93214326|NCT03709758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93214327|NCT03709758|Antimetabolites|antimetabolites|mesh-ancestor
93214328|NCT03709758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214329|NCT03709758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214330|NCT03709758|Antiviral Agents|antiviral agents|mesh-ancestor
93214331|NCT03709758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214332|NCT03709758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214333|NCT03709758|Immunologic Factors|immunologic factors|mesh-ancestor
93214334|NCT03709758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214335|NCT03709758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93214336|NCT03709758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93214337|NCT03709758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93214338|NCT03709758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214339|NCT03674060|Sorafenib|sorafenib|mesh-list
93214340|NCT03674060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214341|NCT03674060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93214342|NCT03674060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214343|NCT03674060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214344|NCT03163576|Niacin|niacin|mesh-list
93214345|NCT03163576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93214346|NCT03163576|Antimetabolites|antimetabolites|mesh-ancestor
93214347|NCT03163576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214348|NCT03163576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93214349|NCT03163576|Vasodilator Agents|vasodilator agents|mesh-ancestor
93214350|NCT03163576|Vitamin B Complex|vitamin b complex|mesh-ancestor
93214351|NCT03163576|Vitamins|vitamins|mesh-ancestor
93214352|NCT03163576|Micronutrients|micronutrients|mesh-ancestor
93214353|NCT03163576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214354|NCT01374178|Insulin Glargine|insulin glargine|mesh-list
93214355|NCT01374178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214356|NCT01374178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214357|NCT03673280|Morphine|morphine|mesh-list
93214358|NCT03673280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214359|NCT03673280|Narcotics|narcotics|mesh-ancestor
93214360|NCT03673280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214361|NCT03673280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214362|NCT03673280|Analgesics|analgesics|mesh-ancestor
93214363|NCT03673280|Sensory System Agents|sensory system agents|mesh-ancestor
93214364|NCT03673280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214365|NCT05420220|Axitinib|axitinib|mesh-list
93214366|NCT05420220|Antibodies|antibodies|mesh-list
93214367|NCT05420220|Immunologic Factors|immunologic factors|mesh-ancestor
93214368|NCT05420220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214369|NCT05420220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214370|NCT05420220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93214371|NCT05420220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214372|NCT05420220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214373|NCT05383560|Vaccines|vaccines|mesh-list
93214374|NCT05383560|Immunologic Factors|immunologic factors|mesh-ancestor
93214375|NCT05383560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214376|NCT01382004|Azithromycin|azithromycin|mesh-list
93214377|NCT01382004|Penicillins|penicillins|mesh-list
93214378|NCT01382004|Penicillin G|penicillin g|mesh-list
93214379|NCT01382004|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93214380|NCT01382004|Penicillin G Procaine|penicillin g procaine|mesh-list
93214381|NCT01382004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93214382|NCT01382004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214383|NCT03669224|Chlorhexidine|chlorhexidine|mesh-list
93214384|NCT03669224|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93214385|NCT03669224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93214386|NCT03669224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214387|NCT03669224|Disinfectants|disinfectants|mesh-ancestor
93214388|NCT03669224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93214389|NCT01381848|Doripenem|doripenem|mesh-list
93214390|NCT01381848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93214391|NCT01381848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214392|NCT04546620|Prednisolone|prednisolone|mesh-list
93214393|NCT04546620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93214394|NCT04546620|Methylprednisolone|methylprednisolone|mesh-list
93214395|NCT04546620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93214396|NCT04546620|Prednisolone acetate|prednisolone acetate|mesh-list
93214397|NCT04546620|Prednisone|prednisone|mesh-list
93214398|NCT04546620|Cyclophosphamide|cyclophosphamide|mesh-list
93214399|NCT04546620|Rituximab|rituximab|mesh-list
93214400|NCT04546620|Doxorubicin|doxorubicin|mesh-list
93214401|NCT04546620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93214402|NCT04546620|Vincristine|vincristine|mesh-list
93214403|NCT04546620|Acalabrutinib|acalabrutinib|mesh-list
93214404|NCT04546620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93214405|NCT04546620|Prednisolone phosphate|prednisolone phosphate|mesh-list
93214406|NCT04546620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214407|NCT04546620|Immunologic Factors|immunologic factors|mesh-ancestor
93214408|NCT04546620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214409|NCT04546620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214410|NCT04546620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93214411|NCT04546620|Alkylating Agents|alkylating agents|mesh-ancestor
93214412|NCT04546620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214413|NCT04546620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214414|NCT04546620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93214415|NCT04546620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214416|NCT04546620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93214417|NCT04546620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93214418|NCT04546620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93214419|NCT04546620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214420|NCT04546620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93214421|NCT04546620|Tubulin Modulators|tubulin modulators|mesh-ancestor
93214422|NCT04546620|Antimitotic Agents|antimitotic agents|mesh-ancestor
93214423|NCT04546620|Mitosis Modulators|mitosis modulators|mesh-ancestor
93214424|NCT04546620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214425|NCT04546620|Glucocorticoids|glucocorticoids|mesh-ancestor
93214426|NCT04546620|Hormones|hormones|mesh-ancestor
93214427|NCT04546620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214428|NCT04546620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214429|NCT04546620|Antiemetics|antiemetics|mesh-ancestor
93214430|NCT04546620|Autonomic Agents|autonomic agents|mesh-ancestor
93214431|NCT04546620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214432|NCT04546620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93214433|NCT04546620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93214434|NCT04546620|Protective Agents|protective agents|mesh-ancestor
93214435|NCT04058210|Ivacaftor|ivacaftor|mesh-list
93214436|NCT04058210|Elexacaftor|elexacaftor|mesh-list
93214437|NCT04058210|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93214438|NCT04058210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93214439|NCT04058210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214440|NCT02250300|Ixazomib|ixazomib|mesh-list
93214441|NCT02250300|Glycine|glycine|mesh-list
93214442|NCT02250300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214443|NCT02250300|Protease Inhibitors|protease inhibitors|mesh-ancestor
93214444|NCT02250300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214445|NCT02250300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214446|NCT02250300|Glycine Agents|glycine agents|mesh-ancestor
93214447|NCT02250300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214448|NCT02250300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214449|NCT03020966|Acetaminophen|acetaminophen|mesh-list
93214450|NCT03020966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93214452|NCT03020966|Sensory System Agents|sensory system agents|mesh-ancestor
93214453|NCT03020966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214454|NCT03020966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214455|NCT03020966|Antipyretics|antipyretics|mesh-ancestor
93214456|NCT04051268|Vaccines|vaccines|mesh-list
93214457|NCT04051268|Immunologic Factors|immunologic factors|mesh-ancestor
93214458|NCT04051268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214459|NCT04595786|Tranexamic Acid|tranexamic acid|mesh-list
93214460|NCT04595786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93214461|NCT04595786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93214462|NCT04595786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214463|NCT04595786|Hemostatics|hemostatics|mesh-ancestor
93214464|NCT04595786|Coagulants|coagulants|mesh-ancestor
93214465|NCT02108652|Atezolizumab|atezolizumab|mesh-list
93214466|NCT02108652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93214467|NCT02108652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214468|NCT02108652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214469|NCT02108652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214470|NCT01381614|Bevacizumab|bevacizumab|mesh-list
93214471|NCT01381614|Sunitinib|sunitinib|mesh-list
93214472|NCT01381614|Sorafenib|sorafenib|mesh-list
93214473|NCT01381614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214474|NCT01381614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214475|NCT01381614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93214476|NCT01381614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93214477|NCT01381614|Growth Substances|growth substances|mesh-ancestor
93214478|NCT01381614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214479|NCT01381614|Growth Inhibitors|growth inhibitors|mesh-ancestor
93214480|NCT01381614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93214481|NCT01381614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214482|NCT01381614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214483|NCT01381536|Belimumab|belimumab|mesh-list
93214484|NCT01381536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214485|NCT01381536|Immunologic Factors|immunologic factors|mesh-ancestor
93214486|NCT01381536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214487|NCT03162406|Vitamin D|vitamin d|mesh-list
93214488|NCT03162406|Cholecalciferol|cholecalciferol|mesh-list
93214489|NCT03162406|Vitamins|vitamins|mesh-ancestor
93214490|NCT03162406|Micronutrients|micronutrients|mesh-ancestor
93214491|NCT03162406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214492|NCT03162406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93214493|NCT03162406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93214494|NCT02946385|Vaccines|vaccines|mesh-list
93214495|NCT02946385|Immunologic Factors|immunologic factors|mesh-ancestor
93214496|NCT02946385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214497|NCT05676190|Immunomodulating Agents|immunomodulating agents|mesh-list
93214498|NCT05676190|Immunologic Factors|immunologic factors|mesh-ancestor
93214499|NCT05676190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214500|NCT02694718|Capecitabine|capecitabine|mesh-list
93214501|NCT02694718|Oxaliplatin|oxaliplatin|mesh-list
93214502|NCT02694718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93214503|NCT02694718|Antimetabolites|antimetabolites|mesh-ancestor
93214504|NCT02694718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214505|NCT02694718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214506|NCT05681299|Liraglutide|liraglutide|mesh-list
93214507|NCT05681299|Hormones|hormones|mesh-list
93214508|NCT05681299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214509|NCT05681299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214510|NCT05681299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214511|NCT05681299|Incretins|incretins|mesh-ancestor
93214512|NCT03161080|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93214513|NCT03161080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93214514|NCT04908787|Paclitaxel|paclitaxel|mesh-list
93214515|NCT04908787|Doxorubicin|doxorubicin|mesh-list
93214516|NCT04908787|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93214517|NCT04908787|Topotecan|topotecan|mesh-list
93214518|NCT04908787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93214519|NCT04908787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214520|NCT04908787|Tubulin Modulators|tubulin modulators|mesh-ancestor
93214521|NCT04908787|Antimitotic Agents|antimitotic agents|mesh-ancestor
93214522|NCT04908787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92886555|NCT00990691|Desipramine|desipramine|mesh-list
93214523|NCT04908787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214524|NCT04908787|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93214525|NCT04908787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93214526|NCT04908787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93214527|NCT04908787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214528|NCT04908787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93214530|NCT04923139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93214531|NCT04923139|Antithrombins|antithrombins|mesh-ancestor
93214532|NCT04923139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93214533|NCT04923139|Protease Inhibitors|protease inhibitors|mesh-ancestor
93214534|NCT04923139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214535|NCT04923139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214536|NCT04923139|Anticoagulants|anticoagulants|mesh-ancestor
93214537|NCT05681221|Calcium|calcium|mesh-list
93214538|NCT05681221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93214539|NCT05681221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214540|NCT04303507|Hydroxychloroquine|hydroxychloroquine|mesh-list
93214541|NCT04303507|Chloroquine|chloroquine|mesh-list
93214542|NCT04303507|Antimalarials|antimalarials|mesh-ancestor
93214543|NCT04303507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93214544|NCT04303507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93214545|NCT04303507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214546|NCT04303507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214547|NCT04303507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214548|NCT04303507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214549|NCT04303507|Amebicides|amebicides|mesh-ancestor
93214550|NCT03202537|Dexlansoprazole|dexlansoprazole|mesh-list
93214551|NCT03202537|Lansoprazole|lansoprazole|mesh-list
93214552|NCT03202537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93214553|NCT03202537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93214554|NCT03202537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93214555|NCT03202537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214556|NCT03202537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214557|NCT03631134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93214558|NCT03631134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214559|NCT03631134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214560|NCT03631134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214561|NCT04138615|Morphine|morphine|mesh-list
93214562|NCT04138615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214563|NCT04138615|Narcotics|narcotics|mesh-ancestor
93214564|NCT04138615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214565|NCT04138615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214566|NCT04138615|Analgesics|analgesics|mesh-ancestor
93214567|NCT04138615|Sensory System Agents|sensory system agents|mesh-ancestor
93214568|NCT04138615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214569|NCT01383330|Megestrol Acetate|megestrol acetate|mesh-list
93214570|NCT01383330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214571|NCT01383330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214572|NCT01383330|Appetite Stimulants|appetite stimulants|mesh-ancestor
93214573|NCT01383330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93214574|NCT01383330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214575|NCT03018938|Insulin|insulin|mesh-list
93214576|NCT03018938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93214577|NCT03018938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214578|NCT03018938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214579|NCT04776499|Perphenazine|perphenazine|mesh-list
93214580|NCT04776499|Riociguat|riociguat|mesh-list
93214581|NCT04776499|Propylthiouracil|propylthiouracil|mesh-list
93214582|NCT04776499|Enzyme Activators|enzyme activators|mesh-ancestor
93214583|NCT04776499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214584|NCT04776499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93214585|NCT04776499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93214586|NCT04776499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214587|NCT04776499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214588|NCT04776499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93214589|NCT04776499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93214590|NCT04776499|Dopamine Agents|dopamine agents|mesh-ancestor
93214591|NCT04776499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214592|NCT04776499|Antimetabolites|antimetabolites|mesh-ancestor
93214593|NCT04776499|Antithyroid Agents|antithyroid agents|mesh-ancestor
93214594|NCT04776499|Hormone Antagonists|hormone antagonists|mesh-ancestor
93214595|NCT04776499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214596|NCT03668054|Bevacizumab|bevacizumab|mesh-list
93214597|NCT03668054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214598|NCT03668054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214599|NCT03668054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93214600|NCT03668054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93214601|NCT03668054|Growth Substances|growth substances|mesh-ancestor
93214602|NCT03668054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214603|NCT03668054|Growth Inhibitors|growth inhibitors|mesh-ancestor
93214604|NCT04698187|Nivolumab|nivolumab|mesh-list
93214605|NCT04698187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214606|NCT04698187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214607|NCT04698187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93214608|NCT04698187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214609|NCT03623048|Chlorhexidine|chlorhexidine|mesh-list
93214610|NCT03623048|Propolis|propolis|mesh-list
93214611|NCT03623048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93214612|NCT03623048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214613|NCT03623048|Disinfectants|disinfectants|mesh-ancestor
93214614|NCT03016598|Oxytocin|oxytocin|mesh-list
93214615|NCT03016598|Oxytocics|oxytocics|mesh-ancestor
93214616|NCT03016598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93214617|NCT03016598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214618|NCT03017846|Cantharidin|cantharidin|mesh-list
93214619|NCT03017846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214620|NCT03017846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214621|NCT03638401|Morphine|morphine|mesh-list
93214622|NCT03638401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214623|NCT03638401|Narcotics|narcotics|mesh-ancestor
93214624|NCT03638401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214625|NCT03638401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214626|NCT03638401|Analgesics|analgesics|mesh-ancestor
93214627|NCT03638401|Sensory System Agents|sensory system agents|mesh-ancestor
93214628|NCT03638401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214629|NCT03666650|Edoxaban|edoxaban|mesh-list
93214630|NCT03666650|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93214631|NCT03666650|Antithrombins|antithrombins|mesh-ancestor
93214632|NCT03666650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93214633|NCT03666650|Protease Inhibitors|protease inhibitors|mesh-ancestor
93214634|NCT03666650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214635|NCT03666650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214636|NCT03666650|Anticoagulants|anticoagulants|mesh-ancestor
93214637|NCT02942485|Metronidazole|metronidazole|mesh-list
93214638|NCT02942485|Tinidazole|tinidazole|mesh-list
92510534|NCT00000892|Ritonavir|ritonavir|mesh-list
93214639|NCT02942485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214640|NCT02942485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93214641|NCT02942485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93214642|NCT02942485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93214643|NCT02942485|Alkylating Agents|alkylating agents|mesh-ancestor
93214644|NCT02942485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214645|NCT02942485|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93214646|NCT03666494|Fentanyl|fentanyl|mesh-list
93214647|NCT03666494|Ketamine|ketamine|mesh-list
93214648|NCT03666494|Propofol|propofol|mesh-list
93214649|NCT03666494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93214650|NCT03666494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214651|NCT03666494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214652|NCT03666494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93214653|NCT03666494|Anesthetics, General|anesthetics, general|mesh-ancestor
93214654|NCT03666494|Anesthetics|anesthetics|mesh-ancestor
93214655|NCT03666494|Analgesics|analgesics|mesh-ancestor
93214656|NCT03666494|Sensory System Agents|sensory system agents|mesh-ancestor
93214657|NCT03666494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214658|NCT03666494|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93214659|NCT03666494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93214660|NCT03666494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93214661|NCT03666494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214662|NCT03666494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214663|NCT03666494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214664|NCT03666494|Narcotics|narcotics|mesh-ancestor
93214665|NCT03666494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93214666|NCT03666884|Cyclosporine|cyclosporine|mesh-list
93214667|NCT03666884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93214668|NCT03666884|Cyclosporins|cyclosporins|mesh-list
93214669|NCT03666884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93214670|NCT03666884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214671|NCT03666884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214672|NCT03666884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214673|NCT03666884|Immunologic Factors|immunologic factors|mesh-ancestor
93214674|NCT03666884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214675|NCT03666884|Antifungal Agents|antifungal agents|mesh-ancestor
93214676|NCT03666884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214677|NCT03666884|Dermatologic Agents|dermatologic agents|mesh-ancestor
93214678|NCT03666884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214679|NCT03666884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93214680|NCT02942407|Warfarin|warfarin|mesh-list
93214681|NCT02942407|Apixaban|apixaban|mesh-list
93214682|NCT02942407|Anticoagulants|anticoagulants|mesh-ancestor
93214683|NCT02942407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93214684|NCT02942407|Antithrombins|antithrombins|mesh-ancestor
93214685|NCT02942407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93214686|NCT02942407|Protease Inhibitors|protease inhibitors|mesh-ancestor
93214687|NCT02942407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214688|NCT02942407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214689|NCT02921035|Interferons|interferons|mesh-list
93214690|NCT02921035|Interferon-beta|interferon-beta|mesh-list
93214691|NCT02921035|Interferon beta-1a|interferon beta-1a|mesh-list
93214692|NCT02921035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214693|NCT02921035|Antiviral Agents|antiviral agents|mesh-ancestor
93214694|NCT02921035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214695|NCT02921035|Immunologic Factors|immunologic factors|mesh-ancestor
93214696|NCT02921035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214697|NCT02921035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93214698|NCT04621981|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93214699|NCT03667352|Fentanyl|fentanyl|mesh-list
93214700|NCT03667352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214701|NCT03667352|Narcotics|narcotics|mesh-ancestor
93214702|NCT03667352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214703|NCT03667352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214704|NCT03667352|Analgesics|analgesics|mesh-ancestor
93214705|NCT03667352|Sensory System Agents|sensory system agents|mesh-ancestor
93214706|NCT03667352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214707|NCT03667352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93214708|NCT03667352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93214709|NCT03667352|Anesthetics, General|anesthetics, general|mesh-ancestor
93214710|NCT03667352|Anesthetics|anesthetics|mesh-ancestor
93214711|NCT03320941|Licogliflozin|licogliflozin|mesh-list
93214712|NCT03320941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93214713|NCT03320941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214714|NCT03320941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214715|NCT03320941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214716|NCT04730947|Dapagliflozin|dapagliflozin|mesh-list
93214717|NCT04730947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93214718|NCT04730947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214719|NCT04730947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214720|NCT04730947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214721|NCT03559699|Mitapivat|mitapivat|mesh-list
93214722|NCT03559699|Enzyme Activators|enzyme activators|mesh-ancestor
93214723|NCT03559699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214724|NCT03557281|GSK656|gsk656|mesh-list
93214725|NCT03557281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93214726|NCT03557281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214727|NCT02573233|Fluticasone|fluticasone|mesh-list
93214728|NCT02573233|Xhance|xhance|mesh-list
93214729|NCT02573233|Mometasone Furoate|mometasone furoate|mesh-list
93214730|NCT02573233|Budesonide|budesonide|mesh-list
93214731|NCT02573233|Formoterol Fumarate|formoterol fumarate|mesh-list
93214732|NCT02573233|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93214733|NCT02573233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214734|NCT02573233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93214735|NCT02573233|Autonomic Agents|autonomic agents|mesh-ancestor
93214736|NCT02573233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214737|NCT02573233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214738|NCT02573233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93214739|NCT02573233|Respiratory System Agents|respiratory system agents|mesh-ancestor
93214740|NCT02573233|Dermatologic Agents|dermatologic agents|mesh-ancestor
93214741|NCT02573233|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93214742|NCT02573233|Glucocorticoids|glucocorticoids|mesh-ancestor
93214743|NCT02573233|Hormones|hormones|mesh-ancestor
93214744|NCT02573233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214745|NCT02573233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93214746|NCT02573233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93214747|NCT02573233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93214748|NCT02573233|Adrenergic Agents|adrenergic agents|mesh-ancestor
93214749|NCT02573233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214750|NCT02573233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214751|NCT03867487|Empagliflozin|empagliflozin|mesh-list
93214752|NCT03867487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93214753|NCT03867487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214754|NCT03867487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214755|NCT03867487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214756|NCT01569048|Dexmedetomidine|dexmedetomidine|mesh-list
93214757|NCT01569048|Remifentanil|remifentanil|mesh-list
93214758|NCT01569048|Propofol|propofol|mesh-list
93214759|NCT01569048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93214760|NCT01569048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93214761|NCT01569048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214762|NCT01569048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93214763|NCT01569048|Analgesics|analgesics|mesh-ancestor
93214764|NCT01569048|Sensory System Agents|sensory system agents|mesh-ancestor
93214765|NCT01569048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214766|NCT01569048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93214767|NCT01569048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93214768|NCT01569048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93214769|NCT01569048|Adrenergic Agents|adrenergic agents|mesh-ancestor
93214770|NCT01569048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214771|NCT01569048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214772|NCT01569048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93214773|NCT01569048|Anesthetics, General|anesthetics, general|mesh-ancestor
93214774|NCT01569048|Anesthetics|anesthetics|mesh-ancestor
93214775|NCT01569048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93214776|NCT01569048|Narcotics|narcotics|mesh-ancestor
93214777|NCT01380912|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93214778|NCT01380912|Methylprednisolone|methylprednisolone|mesh-list
93214779|NCT01380912|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93214780|NCT01380912|Prednisolone|prednisolone|mesh-list
93214781|NCT01380912|Prednisolone acetate|prednisolone acetate|mesh-list
93214782|NCT01380912|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93214783|NCT01380912|Prednisolone phosphate|prednisolone phosphate|mesh-list
93214784|NCT01380912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214785|NCT01380912|Antiemetics|antiemetics|mesh-ancestor
93214786|NCT01380912|Autonomic Agents|autonomic agents|mesh-ancestor
93214787|NCT01380912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214788|NCT01380912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214789|NCT01380912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93214790|NCT01380912|Glucocorticoids|glucocorticoids|mesh-ancestor
93214791|NCT01380912|Hormones|hormones|mesh-ancestor
93214792|NCT01380912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214793|NCT01380912|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93214794|NCT01380912|Protective Agents|protective agents|mesh-ancestor
93214795|NCT01380912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214796|NCT01380912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214797|NCT03315793|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93214798|NCT03315793|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93214799|NCT03315793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93214800|NCT03315793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93214801|NCT03315793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214802|NCT03315793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214803|NCT03315793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214804|NCT03315793|Analgesics|analgesics|mesh-ancestor
93214805|NCT03315793|Sensory System Agents|sensory system agents|mesh-ancestor
93214806|NCT03315793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214807|NCT03315793|Antidepressive Agents|antidepressive agents|mesh-ancestor
93214808|NCT03315793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93214809|NCT03315793|Dopamine Agents|dopamine agents|mesh-ancestor
93214810|NCT01569204|Dexamethasone|dexamethasone|mesh-list
93214811|NCT01569204|Prednisone|prednisone|mesh-list
93214812|NCT01569204|Cyclophosphamide|cyclophosphamide|mesh-list
93214813|NCT01569204|Dacarbazine|dacarbazine|mesh-list
93214814|NCT01569204|Doxorubicin|doxorubicin|mesh-list
93214815|NCT01569204|Etoposide|etoposide|mesh-list
93214816|NCT01569204|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93214817|NCT01569204|Procarbazine|procarbazine|mesh-list
93214818|NCT01569204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214819|NCT01569204|Immunologic Factors|immunologic factors|mesh-ancestor
93214820|NCT01569204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214821|NCT01569204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93214822|NCT01569204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93214823|NCT01569204|Alkylating Agents|alkylating agents|mesh-ancestor
93214824|NCT01569204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214825|NCT01569204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214826|NCT01569204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93214827|NCT01569204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214828|NCT01569204|Antiemetics|antiemetics|mesh-ancestor
93214829|NCT01569204|Autonomic Agents|autonomic agents|mesh-ancestor
93214830|NCT01569204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214831|NCT01569204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93214832|NCT01569204|Glucocorticoids|glucocorticoids|mesh-ancestor
93214833|NCT01569204|Hormones|hormones|mesh-ancestor
93214834|NCT01569204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214835|NCT01569204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214836|NCT01569204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93214837|NCT01569204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93214838|NCT01569204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93214839|NCT01569204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214840|NCT01569204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93214841|NCT01569204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214842|NCT01569204|Immunotoxins|immunotoxins|mesh-ancestor
93214843|NCT01569204|Immunoconjugates|immunoconjugates|mesh-ancestor
93214844|NCT02676466|Losartan|losartan|mesh-list
93214845|NCT02676466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93214846|NCT02676466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93214847|NCT02676466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93214848|NCT02676466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93214849|NCT02676466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214850|NCT04439890|Carboplatin|carboplatin|mesh-list
93214851|NCT04439890|Pemetrexed|pemetrexed|mesh-list
93214852|NCT04439890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214853|NCT04439890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214854|NCT04439890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214855|NCT04439890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93214856|NCT04439890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93214857|NCT02324725|Naltrexone|naltrexone|mesh-list
93214858|NCT02324725|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93214859|NCT02324725|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93214860|NCT02324725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214861|NCT02324725|Sensory System Agents|sensory system agents|mesh-ancestor
93214862|NCT02324725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214863|NCT01380678|Bevacizumab|bevacizumab|mesh-list
93214864|NCT01380678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93214865|NCT01380678|Histamine Antagonists|histamine antagonists|mesh-list
93214866|NCT01380678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93214867|NCT01380678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214868|NCT01380678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214869|NCT01380678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93214870|NCT01380678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93214871|NCT01380678|Growth Substances|growth substances|mesh-ancestor
93214872|NCT01380678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214873|NCT01380678|Growth Inhibitors|growth inhibitors|mesh-ancestor
93214874|NCT01380678|Histamine Agents|histamine agents|mesh-ancestor
93214875|NCT01380678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214876|NCT01380678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214877|NCT01380600|Molgramostim|molgramostim|mesh-list
93214878|NCT01380600|Sargramostim|sargramostim|mesh-list
93214879|NCT01380600|Immunologic Factors|immunologic factors|mesh-ancestor
93214880|NCT01380600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214881|NCT01380600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214882|NCT03264118|Tolonium Chloride|tolonium chloride|mesh-list
93214883|NCT03264118|Hemostatics|hemostatics|mesh-ancestor
93214884|NCT03264118|Coagulants|coagulants|mesh-ancestor
93214885|NCT03264118|Heparin Antagonists|heparin antagonists|mesh-ancestor
93214886|NCT03264118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214887|NCT02674204|Atorvastatin|atorvastatin|mesh-list
93214888|NCT02674204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93214889|NCT02674204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93214890|NCT02674204|Antimetabolites|antimetabolites|mesh-ancestor
93214891|NCT02674204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214892|NCT02674204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93214893|NCT02674204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93214894|NCT02674204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214895|NCT05675644|Drospirenone|drospirenone|mesh-list
93214896|NCT05675644|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93214897|NCT05675644|Hormone Antagonists|hormone antagonists|mesh-ancestor
93214898|NCT05675644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214899|NCT05675644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214900|NCT05675644|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93214901|NCT05675644|Diuretics|diuretics|mesh-ancestor
93214902|NCT05675644|Natriuretic Agents|natriuretic agents|mesh-ancestor
93214903|NCT05010772|Decitabine|decitabine|mesh-list
93214904|NCT05010772|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93214906|NCT05010772|Ivosidenib|ivosidenib|mesh-list
93214907|NCT05010772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93214908|NCT05010772|Antimetabolites|antimetabolites|mesh-ancestor
93214909|NCT05010772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214910|NCT05010772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214911|NCT05010772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214912|NCT02579044|Everolimus|everolimus|mesh-list
93214913|NCT02579044|Lonafarnib|lonafarnib|mesh-list
93214914|NCT02579044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93214915|NCT02579044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93214916|NCT02579044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214917|NCT02579044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214918|NCT02579044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93214919|NCT02579044|Immunologic Factors|immunologic factors|mesh-ancestor
93214920|NCT02579044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214921|NCT02579044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214922|NCT02464696|Methylprednisolone|methylprednisolone|mesh-list
93214923|NCT02464696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93214924|NCT02464696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93214925|NCT02464696|Prednisolone|prednisolone|mesh-list
93214926|NCT02464696|Prednisolone acetate|prednisolone acetate|mesh-list
93214927|NCT02464696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93214928|NCT02464696|Prednisolone phosphate|prednisolone phosphate|mesh-list
93214929|NCT02464696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93214930|NCT02464696|Antiemetics|antiemetics|mesh-ancestor
93214931|NCT02464696|Autonomic Agents|autonomic agents|mesh-ancestor
93214932|NCT02464696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93214933|NCT02464696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214934|NCT02464696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93214935|NCT02464696|Glucocorticoids|glucocorticoids|mesh-ancestor
93214936|NCT02464696|Hormones|hormones|mesh-ancestor
93214937|NCT02464696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93214938|NCT02464696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93214939|NCT02464696|Protective Agents|protective agents|mesh-ancestor
93214940|NCT02464696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93214941|NCT02464696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214942|NCT04503694|Nivolumab|nivolumab|mesh-list
93214943|NCT04503694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214944|NCT04503694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214945|NCT04503694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93214946|NCT04503694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214947|NCT03525379|Resveratrol|resveratrol|mesh-list
93214948|NCT03525379|Antioxidants|antioxidants|mesh-ancestor
93214949|NCT03525379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214950|NCT03525379|Protective Agents|protective agents|mesh-ancestor
93214951|NCT03525379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214952|NCT03525379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214953|NCT03525379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93214954|NCT03476551|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93214955|NCT03476551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93214956|NCT03476551|Diuretics|diuretics|mesh-ancestor
93214957|NCT03476551|Natriuretic Agents|natriuretic agents|mesh-ancestor
93214958|NCT03476551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214959|NCT03476551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93214960|NCT03476551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93214961|NCT03476551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214962|NCT04702789|Timolol|timolol|mesh-list
93214963|NCT04702789|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93214964|NCT04702789|Dorzolamide|dorzolamide|mesh-list
93214965|NCT04702789|Latanoprost|latanoprost|mesh-list
93214966|NCT04702789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93214967|NCT04702789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93214968|NCT04702789|Adrenergic Agents|adrenergic agents|mesh-ancestor
93214969|NCT04702789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93214970|NCT04702789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214971|NCT04702789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214972|NCT04702789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93214973|NCT04702789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93214974|NCT04702789|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93214975|NCT04702789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93214976|NCT04702789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93214977|NCT04702789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93214979|NCT04702789|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93214980|NCT04702789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93214981|NCT03521934|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93214982|NCT03521934|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93214983|NCT03521934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93214984|NCT03521934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93214985|NCT03521934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93214986|NCT03374137|Obinutuzumab|obinutuzumab|mesh-list
93214987|NCT03374137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93214988|NCT03374137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93214989|NCT01380522|Metronidazole|metronidazole|mesh-list
93214990|NCT01380522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93214991|NCT01380522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93214992|NCT01380522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93214993|NCT01380522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93214994|NCT02913326|Warfarin|warfarin|mesh-list
93214995|NCT02913326|Dabigatran|dabigatran|mesh-list
93214996|NCT02913326|Anticoagulants|anticoagulants|mesh-ancestor
93214997|NCT02913326|Antithrombins|antithrombins|mesh-ancestor
93214998|NCT02913326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93214999|NCT02913326|Protease Inhibitors|protease inhibitors|mesh-ancestor
93215000|NCT02913326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215001|NCT02913326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215002|NCT03725891|Aspirin|aspirin|mesh-list
93215003|NCT03725891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93215004|NCT03725891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215005|NCT03725891|Analgesics|analgesics|mesh-ancestor
93215006|NCT03725891|Sensory System Agents|sensory system agents|mesh-ancestor
93215007|NCT03725891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215008|NCT03725891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215009|NCT03725891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93215010|NCT03725891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215011|NCT03725891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93215012|NCT03725891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91928785|NCT02179931|Dopamine Agents|dopamine agents|mesh-ancestor
93215013|NCT03725891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215014|NCT03725891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93215015|NCT03725891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93215016|NCT03725891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215017|NCT03725891|Antipyretics|antipyretics|mesh-ancestor
93215018|NCT03751163|Sunscreening Agents|sunscreening agents|mesh-list
93215019|NCT03751163|Tranexamic Acid|tranexamic acid|mesh-list
93215020|NCT03751163|Hydroquinone|hydroquinone|mesh-list
93215021|NCT03751163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93215022|NCT03751163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93215023|NCT03751163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215024|NCT03751163|Hemostatics|hemostatics|mesh-ancestor
93215025|NCT03751163|Coagulants|coagulants|mesh-ancestor
93215026|NCT03751163|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93215027|NCT03751163|Protective Agents|protective agents|mesh-ancestor
93215028|NCT03751163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215029|NCT03751163|Dermatologic Agents|dermatologic agents|mesh-ancestor
93215030|NCT03751163|Antioxidants|antioxidants|mesh-ancestor
93215031|NCT03639545|Metformin|metformin|mesh-list
93215032|NCT03639545|Empagliflozin|empagliflozin|mesh-list
93215033|NCT03639545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93215034|NCT03639545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215035|NCT03639545|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93215036|NCT03639545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215037|NCT03181386|Warfarin|warfarin|mesh-list
93215038|NCT03181386|Rivaroxaban|rivaroxaban|mesh-list
93215039|NCT03181386|Dabigatran|dabigatran|mesh-list
93215040|NCT03181386|Apixaban|apixaban|mesh-list
93215041|NCT03181386|Anticoagulants|anticoagulants|mesh-ancestor
93215042|NCT03181386|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93215043|NCT03181386|Antithrombins|antithrombins|mesh-ancestor
93215044|NCT03181386|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93215045|NCT03181386|Protease Inhibitors|protease inhibitors|mesh-ancestor
93215046|NCT03181386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215047|NCT03181386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215048|NCT02912468|Mometasone Furoate|mometasone furoate|mesh-list
93215049|NCT02912468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93215050|NCT02912468|Dermatologic Agents|dermatologic agents|mesh-ancestor
93215051|NCT02912468|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93215052|NCT03639467|Gemcitabine|gemcitabine|mesh-list
93215053|NCT03639467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215054|NCT03639467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93215055|NCT03639467|Antimetabolites|antimetabolites|mesh-ancestor
93215056|NCT03639467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215057|NCT01382706|Docetaxel|docetaxel|mesh-list
93215058|NCT01382706|Lapatinib|lapatinib|mesh-list
93215059|NCT01382706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215060|NCT01382706|Tubulin Modulators|tubulin modulators|mesh-ancestor
93215061|NCT01382706|Antimitotic Agents|antimitotic agents|mesh-ancestor
93215062|NCT01382706|Mitosis Modulators|mitosis modulators|mesh-ancestor
93215063|NCT01382706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215064|NCT01382706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215065|NCT01382706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215066|NCT03665402|Isoniazid|isoniazid|mesh-list
93215067|NCT03665402|Antitubercular Agents|antitubercular agents|mesh-ancestor
93215068|NCT03665402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215069|NCT03665402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215070|NCT03665402|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93215071|NCT03665402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215072|NCT03665402|Antimetabolites|antimetabolites|mesh-ancestor
93215073|NCT03665402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215074|NCT03665402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215075|NCT01380288|Rivastigmine|rivastigmine|mesh-list
93215076|NCT01380288|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93215077|NCT01380288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215078|NCT01380288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215079|NCT01380288|Cholinergic Agents|cholinergic agents|mesh-ancestor
93215080|NCT01380288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215081|NCT01380288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215082|NCT01380288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93215083|NCT01380288|Protective Agents|protective agents|mesh-ancestor
93215084|NCT03110484|Pemetrexed|pemetrexed|mesh-list
93215085|NCT03110484|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93215086|NCT03110484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215087|NCT03110484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215088|NCT03110484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215089|NCT03110484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93215090|NCT03110484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93215091|NCT03110484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215092|NCT03110328|Pembrolizumab|pembrolizumab|mesh-list
93215093|NCT03110328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215094|NCT03110328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215095|NCT03110328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93215096|NCT03110328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215097|NCT00002874|Bicalutamide|bicalutamide|mesh-list
93215098|NCT00002874|Androgen Antagonists|androgen antagonists|mesh-ancestor
93215099|NCT00002874|Hormone Antagonists|hormone antagonists|mesh-ancestor
93215100|NCT00002874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215101|NCT00002874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215102|NCT00002874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215103|NCT03001076|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93215104|NCT03001076|Ezetimibe|ezetimibe|mesh-list
93215105|NCT03001076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93215106|NCT03001076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215107|NCT03001076|Antimetabolites|antimetabolites|mesh-ancestor
93215108|NCT03001076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215109|NCT03001076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215110|NCT03001076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215111|NCT03001076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93215112|NCT03001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215113|NCT03555305|Insulin|insulin|mesh-list
93215114|NCT03555305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93215115|NCT03555305|Insulin Glargine|insulin glargine|mesh-list
93215116|NCT03555305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93215117|NCT03555305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215118|NCT03018834|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93215119|NCT03018834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215120|NCT05422716|Baclofen|baclofen|mesh-list
93215121|NCT05422716|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93215122|NCT05422716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215123|NCT05422716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93215124|NCT05422716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215125|NCT05422716|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92887170|NCT00684216|Tamoxifen|tamoxifen|mesh-list
93215127|NCT05422716|GABA Agents|gaba agents|mesh-ancestor
93215128|NCT05422716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215129|NCT05422716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215130|NCT03728777|Resveratrol|resveratrol|mesh-list
93215131|NCT03728777|Antioxidants|antioxidants|mesh-ancestor
93215132|NCT03728777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215133|NCT03728777|Protective Agents|protective agents|mesh-ancestor
93215134|NCT03728777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215135|NCT03728777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215136|NCT03728777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93215137|NCT05421936|Osimertinib|osimertinib|mesh-list
93215138|NCT05421936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215139|NCT05421936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215140|NCT05421936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215141|NCT05421936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215142|NCT01382472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93215143|NCT01382472|Simvastatin|simvastatin|mesh-list
93215144|NCT01382472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93215145|NCT01382472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215146|NCT01382472|Antimetabolites|antimetabolites|mesh-ancestor
93215147|NCT01382472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215148|NCT01382472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215149|NCT01382472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93215150|NCT01382472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215151|NCT03725423|Apatinib|apatinib|mesh-list
93215152|NCT03725423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215153|NCT03725423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215154|NCT03725423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215155|NCT03725423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215156|NCT03521141|Nicotine|nicotine|mesh-list
93215157|NCT03521141|Varenicline|varenicline|mesh-list
93215158|NCT03521141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93215159|NCT03521141|Autonomic Agents|autonomic agents|mesh-ancestor
93215160|NCT03521141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215161|NCT03521141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215162|NCT03521141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93215163|NCT03521141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93215164|NCT03521141|Cholinergic Agents|cholinergic agents|mesh-ancestor
93215165|NCT03521141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215166|NCT03521141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215167|NCT03725267|Melatonin|melatonin|mesh-list
93215168|NCT03725267|Antioxidants|antioxidants|mesh-ancestor
93215169|NCT03725267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215170|NCT03725267|Protective Agents|protective agents|mesh-ancestor
93215171|NCT03725267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215172|NCT03725267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215173|NCT02997176|Talazoparib|talazoparib|mesh-list
93215174|NCT02997176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93215175|NCT02997176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215176|NCT02997176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215177|NCT02997176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215178|NCT03000452|Durvalumab|durvalumab|mesh-list
93215179|NCT03000452|Daratumumab|daratumumab|mesh-list
93215180|NCT03000452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215181|NCT03000452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215182|NCT03664388|Clopidogrel|clopidogrel|mesh-list
93215183|NCT03664388|Ticagrelor|ticagrelor|mesh-list
93215184|NCT03664388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93215185|NCT03664388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93215186|NCT03664388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93215187|NCT03664388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93215188|NCT03664388|Purinergic Agents|purinergic agents|mesh-ancestor
93215189|NCT03664388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215190|NCT03664388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215191|NCT03664388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215192|NCT01373164|Gemcitabine|gemcitabine|mesh-list
93215193|NCT01373164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93215194|NCT01373164|Antimetabolites|antimetabolites|mesh-ancestor
93215195|NCT01373164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215196|NCT01373164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215197|NCT02999984|Busulfan|busulfan|mesh-list
93215198|NCT02999984|Alkylating Agents|alkylating agents|mesh-ancestor
93215199|NCT02999984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215200|NCT02999984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215201|NCT02999984|Immunologic Factors|immunologic factors|mesh-ancestor
93215202|NCT02999984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215203|NCT02999984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93215204|NCT02999984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215205|NCT02999984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93215206|NCT03550313|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93215207|NCT03550313|Immunologic Factors|immunologic factors|mesh-ancestor
93215208|NCT03550313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215209|NCT03312907|Rituximab|rituximab|mesh-list
93215210|NCT03312907|Belimumab|belimumab|mesh-list
93215211|NCT03312907|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93215212|NCT03312907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215213|NCT03312907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215214|NCT03312907|Immunologic Factors|immunologic factors|mesh-ancestor
93215215|NCT03312907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215216|NCT03312907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215217|NCT02999672|Trastuzumab|trastuzumab|mesh-list
93215218|NCT02999672|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93215219|NCT02999672|Maytansine|maytansine|mesh-list
93215220|NCT02999672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215221|NCT02999672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215222|NCT02999672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93215223|NCT02999672|Tubulin Modulators|tubulin modulators|mesh-ancestor
93215224|NCT02999672|Antimitotic Agents|antimitotic agents|mesh-ancestor
93215225|NCT02999672|Mitosis Modulators|mitosis modulators|mesh-ancestor
92855963|NCT04034173|Levoleucovorin|levoleucovorin|mesh-list
93215226|NCT02999672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215227|NCT02999672|Immunotoxins|immunotoxins|mesh-ancestor
93215228|NCT02999672|Immunoconjugates|immunoconjugates|mesh-ancestor
93215229|NCT02999672|Immunologic Factors|immunologic factors|mesh-ancestor
93215230|NCT02999672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215231|NCT03664622|Ketamine|ketamine|mesh-list
93215232|NCT03664622|Morphine|morphine|mesh-list
93215233|NCT03664622|Analgesics|analgesics|mesh-ancestor
93215234|NCT03664622|Sensory System Agents|sensory system agents|mesh-ancestor
93215235|NCT03664622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215236|NCT03664622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215237|NCT03664622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93215238|NCT03664622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93215239|NCT03664622|Anesthetics, General|anesthetics, general|mesh-ancestor
93215240|NCT03664622|Anesthetics|anesthetics|mesh-ancestor
93215241|NCT03664622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215242|NCT03664622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93215243|NCT03664622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93215244|NCT03664622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215245|NCT03664622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215246|NCT03664622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93215247|NCT03664622|Narcotics|narcotics|mesh-ancestor
93215248|NCT04056182|Lofexidine|lofexidine|mesh-list
93215249|NCT04056182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93215250|NCT04056182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93215251|NCT04056182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215252|NCT04056182|Sensory System Agents|sensory system agents|mesh-ancestor
93215253|NCT04056182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215254|NCT04056182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93215255|NCT04056182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93215256|NCT04056182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93215257|NCT04056182|Adrenergic Agents|adrenergic agents|mesh-ancestor
93215258|NCT04056182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215259|NCT04056182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215260|NCT03573323|Ixekizumab|ixekizumab|mesh-list
93215261|NCT03573323|Dermatologic Agents|dermatologic agents|mesh-ancestor
93215262|NCT04058054|Histamine|histamine|mesh-list
93215263|NCT04058054|Histamine Agonists|histamine agonists|mesh-ancestor
93215264|NCT04058054|Histamine Agents|histamine agents|mesh-ancestor
93215265|NCT04058054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215266|NCT04058054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215267|NCT04058054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215268|NCT04498286|Antibodies|antibodies|mesh-list
93215269|NCT04498286|Immunologic Factors|immunologic factors|mesh-ancestor
93215270|NCT04498286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215271|NCT01069172|Dipivefrin|dipivefrin|mesh-list
93215272|NCT01069172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93215273|NCT01069172|Adrenergic Agents|adrenergic agents|mesh-ancestor
93215274|NCT01069172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215275|NCT01069172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215276|NCT01069172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215277|NCT04245280|Ropivacaine|ropivacaine|mesh-list
93215278|NCT04245280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93215279|NCT04245280|Anesthetics, Local|anesthetics, local|mesh-ancestor
93215280|NCT04245280|Anesthetics|anesthetics|mesh-ancestor
93215281|NCT04245280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215282|NCT04245280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215283|NCT04245280|Sensory System Agents|sensory system agents|mesh-ancestor
93215284|NCT04245280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215285|NCT03724955|Estradiol|estradiol|mesh-list
93215286|NCT03724955|Estrogens|estrogens|mesh-ancestor
93215287|NCT03724955|Hormones|hormones|mesh-ancestor
93215288|NCT03724955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215289|NCT03724955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215290|NCT04220008|Mycophenolic Acid|mycophenolic acid|mesh-list
93215291|NCT04220008|Cyclophosphamide|cyclophosphamide|mesh-list
93215292|NCT04220008|Busulfan|busulfan|mesh-list
93215293|NCT04220008|Rituximab|rituximab|mesh-list
93215294|NCT04220008|Gemcitabine|gemcitabine|mesh-list
93215295|NCT04220008|Vorinostat|vorinostat|mesh-list
93215296|NCT04220008|Clofarabine|clofarabine|mesh-list
93215297|NCT04220008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93215298|NCT04220008|Tacrolimus|tacrolimus|mesh-list
93215299|NCT04220008|Antibodies|antibodies|mesh-list
93215300|NCT04220008|Immunoglobulins|immunoglobulins|mesh-list
93215301|NCT04220008|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93215302|NCT04220008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215303|NCT04220008|Immunologic Factors|immunologic factors|mesh-ancestor
93215304|NCT04220008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215305|NCT04220008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215306|NCT04220008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93215307|NCT04220008|Alkylating Agents|alkylating agents|mesh-ancestor
93215308|NCT04220008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215309|NCT04220008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215310|NCT04220008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93215311|NCT04220008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93215312|NCT04220008|Antimetabolites|antimetabolites|mesh-ancestor
93215313|NCT04220008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93215314|NCT04220008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215315|NCT04220008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93215316|NCT04220008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93215317|NCT04220008|Antitubercular Agents|antitubercular agents|mesh-ancestor
93215318|NCT04220008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215319|NCT04220008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215320|NCT04220008|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93215321|NCT03721991|Butyric Acid|butyric acid|mesh-list
93215322|NCT03721991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215323|NCT03721991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215324|NCT03721991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215325|NCT03721991|Histamine Antagonists|histamine antagonists|mesh-ancestor
93215326|NCT03721991|Histamine Agents|histamine agents|mesh-ancestor
93215327|NCT02911688|Vitamin E|vitamin e|mesh-list
93215328|NCT02911688|Tocopherols|tocopherols|mesh-list
93215329|NCT02911688|Tocotrienols|tocotrienols|mesh-list
93215330|NCT02911688|alpha-Tocopherol|alpha-tocopherol|mesh-list
93215331|NCT02911688|gamma-Tocopherol|gamma-tocopherol|mesh-list
93215332|NCT02911688|Vitamins|vitamins|mesh-ancestor
93215333|NCT02911688|Micronutrients|micronutrients|mesh-ancestor
93215334|NCT02911688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215335|NCT02911688|Antioxidants|antioxidants|mesh-ancestor
93215336|NCT02911688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215337|NCT02911688|Protective Agents|protective agents|mesh-ancestor
93215338|NCT05580250|Metformin|metformin|mesh-list
93215339|NCT05580250|Simvastatin|simvastatin|mesh-list
93215340|NCT05580250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93215341|NCT05580250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215342|NCT05580250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93215343|NCT05580250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215344|NCT05580250|Antimetabolites|antimetabolites|mesh-ancestor
93215345|NCT05580250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215346|NCT05580250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215347|NCT05580250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93215348|NCT05580250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215349|NCT03431948|Nivolumab|nivolumab|mesh-list
93215350|NCT03431948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215351|NCT03431948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215352|NCT03431948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93215353|NCT03431948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215354|NCT03662516|Levonorgestrel|levonorgestrel|mesh-list
93215355|NCT03662516|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93215356|NCT03662516|Contraceptive Agents|contraceptive agents|mesh-list
93215357|NCT03662516|Contraceptives, Oral|contraceptives, oral|mesh-list
93215358|NCT03662516|Estradiol|estradiol|mesh-list
93215359|NCT03662516|Abrocitinib|abrocitinib|mesh-list
93215360|NCT03662516|Estrogens|estrogens|mesh-ancestor
93215361|NCT03662516|Hormones|hormones|mesh-ancestor
93215362|NCT03662516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215363|NCT03662516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215364|NCT03662516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93215365|NCT03662516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93215366|NCT03662516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93215367|NCT03662516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93215368|NCT03662516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93215369|NCT03662516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215370|NCT03662516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215371|NCT03662516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215372|NCT03728465|Nivolumab|nivolumab|mesh-list
93215373|NCT03728465|Ipilimumab|ipilimumab|mesh-list
93215374|NCT03728465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215375|NCT03728465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215376|NCT03728465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93215377|NCT03728465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215378|NCT03662984|Ciprofibrate|ciprofibrate|mesh-list
93215379|NCT03662984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215380|NCT03662984|Antimetabolites|antimetabolites|mesh-ancestor
93215381|NCT03662984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215382|NCT03662984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215383|NCT02994056|Sofosbuvir|sofosbuvir|mesh-list
93215384|NCT02994056|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93215385|NCT02994056|Velpatasvir|velpatasvir|mesh-list
93215386|NCT02994056|Antiviral Agents|antiviral agents|mesh-ancestor
93215387|NCT02994056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215388|NCT03728153|Fluoxetine|fluoxetine|mesh-list
93215389|NCT03728153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93215390|NCT03728153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93215391|NCT03728153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93215392|NCT03728153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215393|NCT03728153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215394|NCT03728153|Serotonin Agents|serotonin agents|mesh-ancestor
93215395|NCT03728153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215396|NCT03728153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93215397|NCT03728153|Antidepressive Agents|antidepressive agents|mesh-ancestor
93215398|NCT03728153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93215399|NCT03728153|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93215400|NCT03728153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93215401|NCT03728153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215402|NCT04056806|Ceftriaxone|ceftriaxone|mesh-list
93215403|NCT04056806|Terlipressin|terlipressin|mesh-list
93215404|NCT04056806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215405|NCT04056806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215406|NCT04056806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93215407|NCT04056806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93215408|NCT03305575|Bupivacaine|bupivacaine|mesh-list
93215409|NCT03305575|Chloroprocaine|chloroprocaine|mesh-list
93215410|NCT03305575|Anesthetics, Local|anesthetics, local|mesh-ancestor
93215411|NCT03305575|Anesthetics|anesthetics|mesh-ancestor
93215412|NCT03305575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215413|NCT03305575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215414|NCT03305575|Sensory System Agents|sensory system agents|mesh-ancestor
93215415|NCT03305575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215416|NCT02993822|Maleic acid|maleic acid|mesh-list
93215417|NCT02993822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215418|NCT02993822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215419|NCT02391844|Oxycodone|oxycodone|mesh-list
93215420|NCT02391844|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93215421|NCT02391844|Narcotics|narcotics|mesh-ancestor
93215422|NCT02391844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215423|NCT02391844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887456|NCT04003207|Hormones|hormones|mesh-list
93215424|NCT02391844|Analgesics|analgesics|mesh-ancestor
93215425|NCT02391844|Sensory System Agents|sensory system agents|mesh-ancestor
93215426|NCT02391844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215427|NCT02391688|Fexofenadine|fexofenadine|mesh-list
93215428|NCT02391688|Flurbiprofen|flurbiprofen|mesh-list
93215429|NCT02391688|Midazolam|midazolam|mesh-list
93215430|NCT02391688|Dextromethorphan|dextromethorphan|mesh-list
93215431|NCT02391688|Caffeine|caffeine|mesh-list
93215432|NCT02391688|Bupropion|bupropion|mesh-list
93215433|NCT02391688|Omeprazole|omeprazole|mesh-list
93215434|NCT02391688|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93215435|NCT02391688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93215436|NCT02391688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215437|NCT02391688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215438|NCT02391688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93215439|NCT02391688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93215440|NCT02391688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93215441|NCT02391688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93215442|NCT02391688|Anesthetics, General|anesthetics, general|mesh-ancestor
93215443|NCT02391688|Anesthetics|anesthetics|mesh-ancestor
93215444|NCT02391688|GABA Modulators|gaba modulators|mesh-ancestor
93215445|NCT02391688|GABA Agents|gaba agents|mesh-ancestor
93215446|NCT02391688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215447|NCT02391688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215448|NCT02391688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93215449|NCT02391688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93215450|NCT02391688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215451|NCT02391688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93215452|NCT02391688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93215453|NCT02391688|Purinergic Agents|purinergic agents|mesh-ancestor
93215454|NCT02391688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93215455|NCT02391688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93215456|NCT02391688|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93215457|NCT02391688|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93215458|NCT02391688|Antidepressive Agents|antidepressive agents|mesh-ancestor
93215459|NCT02391688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93215460|NCT02391688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93215461|NCT02391688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93215462|NCT02391688|Dopamine Agents|dopamine agents|mesh-ancestor
93215463|NCT02391688|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93215464|NCT02391688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93215465|NCT02391688|Antitussive Agents|antitussive agents|mesh-ancestor
93215466|NCT02391688|Respiratory System Agents|respiratory system agents|mesh-ancestor
93215467|NCT02391688|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93215468|NCT02391688|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93215469|NCT02391688|Analgesics|analgesics|mesh-ancestor
93215470|NCT02391688|Sensory System Agents|sensory system agents|mesh-ancestor
93215471|NCT02391688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215472|NCT02391688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93215473|NCT02391688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215474|NCT02391688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93215475|NCT02391688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215476|NCT02391688|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93215477|NCT02391688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93215478|NCT02391688|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93215479|NCT02391688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93215480|NCT02391688|Histamine Antagonists|histamine antagonists|mesh-ancestor
93215481|NCT02391688|Histamine Agents|histamine agents|mesh-ancestor
93215482|NCT01068860|Insulin|insulin|mesh-list
93215483|NCT01068860|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93215484|NCT01068860|Metformin|metformin|mesh-list
93215485|NCT01068860|Glimepiride|glimepiride|mesh-list
93215486|NCT01068860|Insulin Lispro|insulin lispro|mesh-list
93215487|NCT01068860|Insulin, Isophane|insulin, isophane|mesh-list
93215488|NCT01068860|Glyburide|glyburide|mesh-list
93215489|NCT01068860|Glipizide|glipizide|mesh-list
93215490|NCT01068860|Troglitazone|troglitazone|mesh-list
93215491|NCT01068860|Tolbutamide|tolbutamide|mesh-list
93215492|NCT01068860|Acetohexamide|acetohexamide|mesh-list
93215493|NCT01068860|Chlorpropamide|chlorpropamide|mesh-list
93215494|NCT01068860|Tolazamide|tolazamide|mesh-list
93215495|NCT01068860|Insulin, Regular, Pork|insulin, regular, pork|mesh-list
93215496|NCT01068860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93215497|NCT01068860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93215498|NCT01068860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215499|NCT01068860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93215500|NCT01068860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215501|NCT01068860|Immunologic Factors|immunologic factors|mesh-ancestor
93215502|NCT04056650|Caffeine|caffeine|mesh-list
93215503|NCT04056650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93215504|NCT04056650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215505|NCT04056650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93215506|NCT04056650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215507|NCT04056650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215508|NCT04056650|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93215509|NCT04056650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93215510|NCT04056650|Purinergic Agents|purinergic agents|mesh-ancestor
93215511|NCT04056650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215513|NCT04055480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93215514|NCT04055480|Insulin Aspart|insulin aspart|mesh-list
93215515|NCT04055480|Insulin, Short-Acting|insulin, short-acting|mesh-list
93215516|NCT04055480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93215517|NCT04055480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215518|NCT03158090|Lanreotide|lanreotide|mesh-list
93215519|NCT03158090|Octreotide|octreotide|mesh-list
93215520|NCT03158090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215521|NCT03158090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93215522|NCT03158090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93215523|NCT02670538|Cariprazine|cariprazine|mesh-list
93215524|NCT02670538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93215525|NCT02670538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93215526|NCT02670538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215527|NCT02670538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215528|NCT02670538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93215529|NCT03727763|Cetuximab|cetuximab|mesh-list
93215530|NCT03727763|Vemurafenib|vemurafenib|mesh-list
93215531|NCT03727763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215532|NCT03727763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215533|NCT03727763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215534|NCT03727763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215535|NCT03727763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215536|NCT01310621|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93215537|NCT01310621|Respiratory System Agents|respiratory system agents|mesh-ancestor
93215538|NCT02991482|Gemcitabine|gemcitabine|mesh-list
93215539|NCT02991482|Pembrolizumab|pembrolizumab|mesh-list
93215540|NCT02991482|Vinorelbine|vinorelbine|mesh-list
93215541|NCT02991482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93215542|NCT02991482|Antimetabolites|antimetabolites|mesh-ancestor
93215543|NCT02991482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215544|NCT02991482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215545|NCT02991482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215546|NCT02991482|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93215547|NCT02991482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93215548|NCT02991482|Tubulin Modulators|tubulin modulators|mesh-ancestor
93215549|NCT02991482|Antimitotic Agents|antimitotic agents|mesh-ancestor
93215550|NCT02991482|Mitosis Modulators|mitosis modulators|mesh-ancestor
93215551|NCT02391142|Lidocaine|lidocaine|mesh-list
93215552|NCT02391142|Ropivacaine|ropivacaine|mesh-list
93215553|NCT02391142|Anesthetics, Local|anesthetics, local|mesh-ancestor
93215554|NCT02391142|Anesthetics|anesthetics|mesh-ancestor
93215555|NCT02391142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215556|NCT02391142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215557|NCT02391142|Sensory System Agents|sensory system agents|mesh-ancestor
93215558|NCT02391142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215559|NCT02391142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93215560|NCT02391142|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93215561|NCT02391142|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93215562|NCT02391142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93215563|NCT02391142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215564|NCT02987972|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93215565|NCT02987972|Immunologic Factors|immunologic factors|mesh-ancestor
93215566|NCT02987972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215567|NCT04479202|Bentonite|bentonite|mesh-list
93215568|NCT04479202|Antidotes|antidotes|mesh-ancestor
93215569|NCT04479202|Protective Agents|protective agents|mesh-ancestor
93215570|NCT04479202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215571|NCT01372618|Pasireotide|pasireotide|mesh-list
93215572|NCT01372618|Hormones|hormones|mesh-ancestor
93215573|NCT01372618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215574|NCT01372618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215575|NCT03304873|Retapamulin|retapamulin|mesh-list
92887608|NCT00717340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215576|NCT03304873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215577|NCT03304873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215578|NCT04526509|Cyclophosphamide|cyclophosphamide|mesh-list
93215579|NCT04526509|Fludarabine|fludarabine|mesh-list
93215580|NCT04526509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215581|NCT04526509|Immunologic Factors|immunologic factors|mesh-ancestor
93215582|NCT04526509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215583|NCT04526509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215584|NCT04526509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93215585|NCT04526509|Alkylating Agents|alkylating agents|mesh-ancestor
93215586|NCT04526509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215587|NCT04526509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215588|NCT04526509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93215589|NCT03660020|Anesthetics|anesthetics|mesh-list
93215590|NCT03660020|Anesthetics, Local|anesthetics, local|mesh-list
93215591|NCT03660020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215592|NCT03660020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215593|NCT03660020|Sensory System Agents|sensory system agents|mesh-ancestor
93215594|NCT03660020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215595|NCT03661892|Dronabinol|dronabinol|mesh-list
93215596|NCT03661892|Hallucinogens|hallucinogens|mesh-ancestor
93215597|NCT03661892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215598|NCT03661892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93215599|NCT03661892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215600|NCT03661892|Analgesics|analgesics|mesh-ancestor
93215601|NCT03661892|Sensory System Agents|sensory system agents|mesh-ancestor
93215602|NCT03661892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215603|NCT03661892|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93215604|NCT03661892|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93215605|NCT03661892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215606|NCT03661892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215607|NCT03661892|Hormones|hormones|mesh-ancestor
93215608|NCT03661892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215609|NCT03658850|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93215610|NCT03658850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93215611|NCT03658850|Diuretics|diuretics|mesh-ancestor
93215612|NCT03658850|Natriuretic Agents|natriuretic agents|mesh-ancestor
93215613|NCT03658850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215614|NCT03658850|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93215615|NCT03658850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93215616|NCT03658850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215617|NCT03659162|Antifungal Agents|antifungal agents|mesh-list
93215618|NCT03659162|Clotrimazole|clotrimazole|mesh-list
93215619|NCT03659162|Miconazole|miconazole|mesh-list
93215620|NCT03659162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215621|NCT03659162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93215622|NCT03659162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93215623|NCT03659162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93215624|NCT03659162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215625|NCT03659162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215626|NCT03659162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93215627|NCT03659162|Hormone Antagonists|hormone antagonists|mesh-ancestor
93215628|NCT03659162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215629|NCT03659162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215630|NCT03659162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93215631|NCT03659162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93215632|NCT03659084|Deferasirox|deferasirox|mesh-list
93215633|NCT03659084|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93215634|NCT03659084|Chelating Agents|chelating agents|mesh-ancestor
93215635|NCT03659084|Sequestering Agents|sequestering agents|mesh-ancestor
93215636|NCT03659084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215637|NCT01068626|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93215638|NCT01068626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93215639|NCT01068626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215640|NCT01068626|Antimetabolites|antimetabolites|mesh-ancestor
93215641|NCT01068626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215642|NCT01068626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215643|NCT01068626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93215644|NCT01068626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215645|NCT02921750|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93215646|NCT02921750|Laxatives|laxatives|mesh-ancestor
93215647|NCT02921750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93215648|NCT03657836|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93215649|NCT03657836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215650|NCT03622502|Dexmedetomidine|dexmedetomidine|mesh-list
93215651|NCT03622502|Remifentanil|remifentanil|mesh-list
93215652|NCT03622502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93215653|NCT03622502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215654|NCT03622502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215655|NCT03622502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215656|NCT03622502|Analgesics|analgesics|mesh-ancestor
93215657|NCT03622502|Sensory System Agents|sensory system agents|mesh-ancestor
93215658|NCT03622502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215659|NCT03622502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93215660|NCT03622502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93215661|NCT03622502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93215662|NCT03622502|Adrenergic Agents|adrenergic agents|mesh-ancestor
93215663|NCT03622502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215664|NCT03622502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215665|NCT03622502|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93215666|NCT03622502|Narcotics|narcotics|mesh-ancestor
93215667|NCT04397354|Dexamethasone|dexamethasone|mesh-list
93215668|NCT04397354|Dexamethasone acetate|dexamethasone acetate|mesh-list
93215669|NCT04397354|BB 1101|bb 1101|mesh-list
93215670|NCT04397354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93215671|NCT04397354|Antiemetics|antiemetics|mesh-ancestor
93215672|NCT04397354|Autonomic Agents|autonomic agents|mesh-ancestor
93215673|NCT04397354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215674|NCT04397354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215675|NCT04397354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93215676|NCT04397354|Glucocorticoids|glucocorticoids|mesh-ancestor
93215677|NCT04397354|Hormones|hormones|mesh-ancestor
93215678|NCT04397354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215679|NCT04397354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93215680|NCT04397354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215681|NCT04397354|Protease Inhibitors|protease inhibitors|mesh-ancestor
93215682|NCT04397354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215683|NCT04397354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215684|NCT03657758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93215685|NCT03657758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93215686|NCT03657758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93215687|NCT03657758|Antimetabolites|antimetabolites|mesh-ancestor
93215688|NCT03657758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215689|NCT03657758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93215690|NCT03657758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93215691|NCT03657758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215692|NCT01068158|Ivermectin|ivermectin|mesh-list
93215693|NCT01068158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93215694|NCT01068158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215695|NCT03303079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93215696|NCT03303079|Immunologic Factors|immunologic factors|mesh-ancestor
93215697|NCT03303079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215698|NCT01067846|Cycloserine|cycloserine|mesh-list
93215699|NCT01067846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93215700|NCT01067846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215701|NCT01067846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93215702|NCT01067846|Antitubercular Agents|antitubercular agents|mesh-ancestor
93215703|NCT01067846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215704|NCT01067846|Antimetabolites|antimetabolites|mesh-ancestor
93215705|NCT01067846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215706|NCT03874234|GSK3186899|gsk3186899|mesh-list
93215707|NCT03874234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215708|NCT03874234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215709|NCT03874234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215710|NCT03657446|Moxifloxacin|moxifloxacin|mesh-list
93215711|NCT03657446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215712|NCT03657446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215713|NCT03657446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93215714|NCT03657446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93215715|NCT03657446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215716|NCT03657446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215717|NCT03657446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215718|NCT05276323|Hydrocortisone|hydrocortisone|mesh-list
92887756|NCT02572960|Valsartan|valsartan|mesh-list
93215719|NCT05276323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93215720|NCT05275777|Paclitaxel|paclitaxel|mesh-list
93215721|NCT05275777|Cyclophosphamide|cyclophosphamide|mesh-list
93215722|NCT05275777|Doxorubicin|doxorubicin|mesh-list
93215723|NCT05275777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93215724|NCT05275777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215725|NCT05275777|Tubulin Modulators|tubulin modulators|mesh-ancestor
93215726|NCT05275777|Antimitotic Agents|antimitotic agents|mesh-ancestor
93215727|NCT05275777|Mitosis Modulators|mitosis modulators|mesh-ancestor
93215728|NCT05275777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215729|NCT05275777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215730|NCT05275777|Immunologic Factors|immunologic factors|mesh-ancestor
93215731|NCT05275777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215732|NCT05275777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215733|NCT05275777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93215734|NCT05275777|Alkylating Agents|alkylating agents|mesh-ancestor
93215735|NCT05275777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93215736|NCT05275777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93215737|NCT05275777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93215738|NCT05275777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93215739|NCT05275777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215740|NCT05672212|Sufentanil|sufentanil|mesh-list
93215741|NCT05672212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93215742|NCT05672212|Narcotics|narcotics|mesh-ancestor
93215743|NCT05672212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215744|NCT05672212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215745|NCT05672212|Analgesics|analgesics|mesh-ancestor
93215746|NCT05672212|Sensory System Agents|sensory system agents|mesh-ancestor
93215747|NCT05672212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215748|NCT05672212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93215749|NCT05672212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93215750|NCT05672212|Anesthetics, General|anesthetics, general|mesh-ancestor
93215751|NCT05672212|Anesthetics|anesthetics|mesh-ancestor
93215752|NCT02390674|Cyclosporine|cyclosporine|mesh-list
93215753|NCT02390674|Cyclosporins|cyclosporins|mesh-list
93215754|NCT02390674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215755|NCT02390674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215756|NCT02390674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215757|NCT02390674|Immunologic Factors|immunologic factors|mesh-ancestor
93215758|NCT02390674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215759|NCT02390674|Antifungal Agents|antifungal agents|mesh-ancestor
93215760|NCT02390674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215761|NCT02390674|Dermatologic Agents|dermatologic agents|mesh-ancestor
93215762|NCT02390674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215763|NCT02390674|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93215764|NCT02390596|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93215765|NCT02390596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215766|NCT02663674|Fluconazole|fluconazole|mesh-list
93215767|NCT02663674|Antifungal Agents|antifungal agents|mesh-ancestor
93215768|NCT02663674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215769|NCT02663674|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93215770|NCT02663674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93215771|NCT02663674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215772|NCT02663674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215773|NCT02663674|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93215774|NCT02663674|Hormone Antagonists|hormone antagonists|mesh-ancestor
93215775|NCT02663674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215776|NCT02663674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215777|NCT02663674|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93215778|NCT02663674|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93215779|NCT03657212|Zolpidem|zolpidem|mesh-list
93215780|NCT03657212|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93215781|NCT03657212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93215782|NCT03657212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215783|NCT03657212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215784|NCT03657212|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93215785|NCT03657212|GABA Agonists|gaba agonists|mesh-ancestor
93215786|NCT03657212|GABA Agents|gaba agents|mesh-ancestor
93215787|NCT03657212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215788|NCT03657212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215789|NCT03310411|Sumatriptan|sumatriptan|mesh-list
93215790|NCT03310411|Lasmiditan|lasmiditan|mesh-list
93215791|NCT03310411|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93215792|NCT03310411|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93215793|NCT03310411|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93215794|NCT03310411|Serotonin Agents|serotonin agents|mesh-ancestor
93215795|NCT03310411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215796|NCT03310411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215797|NCT03310411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215798|NCT02909504|Lithium Carbonate|lithium carbonate|mesh-list
93215799|NCT02909504|Antidepressive Agents|antidepressive agents|mesh-ancestor
93215800|NCT02909504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93215801|NCT02909504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215802|NCT02909504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215803|NCT02909504|Antimanic Agents|antimanic agents|mesh-ancestor
93215804|NCT02909504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93215805|NCT02909504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215806|NCT02909504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215807|NCT02390440|Bupivacaine|bupivacaine|mesh-list
93215808|NCT02390440|Anesthetics, Local|anesthetics, local|mesh-ancestor
93215809|NCT02390440|Anesthetics|anesthetics|mesh-ancestor
93215810|NCT02390440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215811|NCT02390440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215812|NCT02390440|Sensory System Agents|sensory system agents|mesh-ancestor
93215813|NCT02390440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215814|NCT03677830|Acetaminophen|acetaminophen|mesh-list
93215815|NCT03677830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215816|NCT03677830|Analgesics|analgesics|mesh-ancestor
93215817|NCT03677830|Sensory System Agents|sensory system agents|mesh-ancestor
92511713|NCT00000504|Imipramine|imipramine|mesh-list
93215818|NCT03677830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215819|NCT03677830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215820|NCT03677830|Antipyretics|antipyretics|mesh-ancestor
93215822|NCT02199691|Immunologic Factors|immunologic factors|mesh-ancestor
93215823|NCT02199691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215824|NCT05667454|Atropine|atropine|mesh-list
93215825|NCT05667454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93215826|NCT05667454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93215827|NCT05667454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93215828|NCT05667454|Autonomic Agents|autonomic agents|mesh-ancestor
93215829|NCT05667454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215830|NCT05667454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215831|NCT05667454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93215832|NCT05667454|Respiratory System Agents|respiratory system agents|mesh-ancestor
93215833|NCT05667454|Mydriatics|mydriatics|mesh-ancestor
93215834|NCT05667454|Parasympatholytics|parasympatholytics|mesh-ancestor
93215835|NCT05667454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93215836|NCT05667454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93215837|NCT05667454|Cholinergic Agents|cholinergic agents|mesh-ancestor
93215838|NCT05667454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215839|NCT05667454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215840|NCT02389972|Dasatinib|dasatinib|mesh-list
93215841|NCT02389972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215842|NCT02389972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215843|NCT02389972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215844|NCT02389972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215845|NCT03502330|Nivolumab|nivolumab|mesh-list
93215846|NCT03502330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215847|NCT03502330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215848|NCT03502330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93215849|NCT03502330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215850|NCT03495232|Cimetidine|cimetidine|mesh-list
93215851|NCT03495232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93215852|NCT03495232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93215853|NCT03495232|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93215854|NCT03495232|Histamine Antagonists|histamine antagonists|mesh-ancestor
93215855|NCT03495232|Histamine Agents|histamine agents|mesh-ancestor
93215856|NCT03495232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215857|NCT03495232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215858|NCT03495232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215859|NCT03495232|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93215860|NCT03495232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93215861|NCT03495232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215862|NCT02389582|Enoxaparin|enoxaparin|mesh-list
93215863|NCT02389582|Dabigatran|dabigatran|mesh-list
93215864|NCT02389582|Anticoagulants|anticoagulants|mesh-ancestor
93215865|NCT02389582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93215866|NCT02389582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93215867|NCT02389582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215868|NCT02389582|Antithrombins|antithrombins|mesh-ancestor
93215869|NCT02389582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93215870|NCT02389582|Protease Inhibitors|protease inhibitors|mesh-ancestor
93215871|NCT02389582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215872|NCT02389426|Bosentan|bosentan|mesh-list
93215873|NCT02389426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93215874|NCT02389426|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93215875|NCT02389426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215876|NCT02389348|Artefenomel|artefenomel|mesh-list
93215877|NCT02389348|Antimalarials|antimalarials|mesh-ancestor
93215878|NCT02389348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93215879|NCT02389348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93215880|NCT02389348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215881|NCT02387242|Rifampin|rifampin|mesh-list
93215882|NCT02387242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93215883|NCT02387242|Antitubercular Agents|antitubercular agents|mesh-ancestor
93215884|NCT02387242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215885|NCT02387242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215886|NCT02387242|Leprostatic Agents|leprostatic agents|mesh-ancestor
93215887|NCT02387242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93215888|NCT02387242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215889|NCT02387242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215890|NCT02387242|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93215891|NCT02387242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93215892|NCT02387242|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93215893|NCT02387242|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93215894|NCT02387242|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93215895|NCT02387242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93215896|NCT03656588|Iodine|iodine|mesh-list
93215897|NCT03656588|Chlorhexidine|chlorhexidine|mesh-list
93215898|NCT03656588|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93215899|NCT03656588|Cadexomer iodine|cadexomer iodine|mesh-list
93215900|NCT03656588|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93215901|NCT03656588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93215902|NCT03656588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215903|NCT03656588|Disinfectants|disinfectants|mesh-ancestor
93215904|NCT03656588|Dermatologic Agents|dermatologic agents|mesh-ancestor
93215905|NCT03656588|Trace Elements|trace elements|mesh-ancestor
93215906|NCT03656588|Micronutrients|micronutrients|mesh-ancestor
93215907|NCT03656588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215908|NCT02387086|Aspirin|aspirin|mesh-list
93215909|NCT02387086|Thalidomide|thalidomide|mesh-list
93215910|NCT02387086|Gefitinib|gefitinib|mesh-list
93215911|NCT02387086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93215912|NCT02387086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215913|NCT02387086|Analgesics|analgesics|mesh-ancestor
93215914|NCT02387086|Sensory System Agents|sensory system agents|mesh-ancestor
93215915|NCT02387086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215916|NCT02387086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215917|NCT02387086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93215918|NCT02387086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93215919|NCT02387086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93215920|NCT02387086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93215921|NCT02387086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215922|NCT02387086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93215923|NCT02387086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93215924|NCT02387086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215925|NCT02387086|Antipyretics|antipyretics|mesh-ancestor
93215926|NCT02387086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93215927|NCT02387086|Immunologic Factors|immunologic factors|mesh-ancestor
93215928|NCT02387086|Leprostatic Agents|leprostatic agents|mesh-ancestor
93215929|NCT02387086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93215930|NCT02387086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93215931|NCT02387086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93215932|NCT02387086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93215933|NCT02387086|Growth Substances|growth substances|mesh-ancestor
93215934|NCT02387086|Growth Inhibitors|growth inhibitors|mesh-ancestor
93215935|NCT02387086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215936|NCT02387086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93215937|NCT02383030|Fulvestrant|fulvestrant|mesh-list
93215938|NCT02383030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93215939|NCT02383030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215940|NCT02383030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93215941|NCT02383030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93215942|NCT02383030|Hormone Antagonists|hormone antagonists|mesh-ancestor
93215943|NCT02383030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215944|NCT02383030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215945|NCT02388802|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93215946|NCT02388802|Immunologic Factors|immunologic factors|mesh-ancestor
93215947|NCT02388802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215948|NCT02983604|Fulvestrant|fulvestrant|mesh-list
93215949|NCT02983604|Exemestane|exemestane|mesh-list
93215950|NCT02983604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93215951|NCT02983604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215952|NCT02983604|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93215953|NCT02983604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93215954|NCT02983604|Hormone Antagonists|hormone antagonists|mesh-ancestor
93215955|NCT02983604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93215956|NCT02983604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215957|NCT02983604|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93215958|NCT02983604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93215959|NCT02983604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93215960|NCT02983604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215961|NCT03656432|Fluorides|fluorides|mesh-list
93215962|NCT03656432|Cariostatic Agents|cariostatic agents|mesh-ancestor
93215963|NCT03656432|Protective Agents|protective agents|mesh-ancestor
93215964|NCT03656432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855975|NCT04034173|Hematinics|hematinics|mesh-ancestor
93215965|NCT02386462|Dexmedetomidine|dexmedetomidine|mesh-list
93215966|NCT02386462|Propofol|propofol|mesh-list
93215967|NCT02386462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93215968|NCT02386462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93215969|NCT02386462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215970|NCT02386462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93215971|NCT02386462|Analgesics|analgesics|mesh-ancestor
93215972|NCT02386462|Sensory System Agents|sensory system agents|mesh-ancestor
93215973|NCT02386462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93215974|NCT02386462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93215975|NCT02386462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93215976|NCT02386462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93215977|NCT02386462|Adrenergic Agents|adrenergic agents|mesh-ancestor
93215978|NCT02386462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93215979|NCT02386462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215980|NCT02386462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93215981|NCT02386462|Anesthetics, General|anesthetics, general|mesh-ancestor
93215982|NCT02386462|Anesthetics|anesthetics|mesh-ancestor
93215983|NCT02382328|Thioctic Acid|thioctic acid|mesh-list
93215984|NCT02382328|Antioxidants|antioxidants|mesh-ancestor
93215985|NCT02382328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93215986|NCT02382328|Protective Agents|protective agents|mesh-ancestor
93215987|NCT02382328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215988|NCT02382328|Vitamin B Complex|vitamin b complex|mesh-ancestor
93215989|NCT02382328|Vitamins|vitamins|mesh-ancestor
93215990|NCT02382328|Micronutrients|micronutrients|mesh-ancestor
93215991|NCT02388490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93215992|NCT02388490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93215993|NCT02388490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93215994|NCT02388490|Immunotoxins|immunotoxins|mesh-ancestor
93215995|NCT02388490|Immunoconjugates|immunoconjugates|mesh-ancestor
93215996|NCT02388490|Immunologic Factors|immunologic factors|mesh-ancestor
93215997|NCT02388490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93215998|NCT02382094|Bicalutamide|bicalutamide|mesh-list
93215999|NCT02382094|Androgen Antagonists|androgen antagonists|mesh-ancestor
93216000|NCT02382094|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216001|NCT02382094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216002|NCT02382094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216003|NCT02382094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216004|NCT02386150|Vaccines|vaccines|mesh-list
93216005|NCT02386150|Immunologic Factors|immunologic factors|mesh-ancestor
93216006|NCT02386150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216007|NCT02377180|Anesthetics|anesthetics|mesh-list
93216008|NCT02377180|Anesthetics, Local|anesthetics, local|mesh-list
93216009|NCT02377180|Capsaicin|capsaicin|mesh-list
93216010|NCT02377180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93216011|NCT02377180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216012|NCT02377180|Sensory System Agents|sensory system agents|mesh-ancestor
93216013|NCT02377180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216014|NCT02377180|Antipruritics|antipruritics|mesh-ancestor
93216015|NCT02377180|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216016|NCT03656042|Lenograstim|lenograstim|mesh-list
93216017|NCT03656042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92888056|NCT00653510|Insulin|insulin|mesh-list
93216018|NCT03656042|Immunologic Factors|immunologic factors|mesh-ancestor
93216019|NCT03656042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216021|NCT03655964|Nebivolol|nebivolol|mesh-list
93216022|NCT03655964|Antihypertensive Agents|antihypertensive agents|mesh-list
93216023|NCT03655964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93216024|NCT03655964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93216025|NCT03655964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216026|NCT03655964|Vasodilator Agents|vasodilator agents|mesh-ancestor
93216027|NCT03655964|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93216028|NCT03655964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93216029|NCT03655964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93216030|NCT03655964|Adrenergic Agents|adrenergic agents|mesh-ancestor
93216031|NCT03655964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216032|NCT03655964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216033|NCT02982590|Warfarin|warfarin|mesh-list
93216034|NCT02982590|Apixaban|apixaban|mesh-list
93216035|NCT02982590|Anticoagulants|anticoagulants|mesh-ancestor
93216036|NCT02982590|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93216037|NCT02982590|Antithrombins|antithrombins|mesh-ancestor
93216038|NCT02982590|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93216039|NCT02982590|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216040|NCT02982590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216041|NCT02982590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216042|NCT02381548|Belinostat|belinostat|mesh-list
93216043|NCT02381548|Adavosertib|adavosertib|mesh-list
93216044|NCT02381548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216045|NCT02381548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216046|NCT02381548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216047|NCT02381548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93216048|NCT02381314|Ipilimumab|ipilimumab|mesh-list
93216049|NCT02381314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216050|NCT02381314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216051|NCT02381314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93216052|NCT02381314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216053|NCT04282018|Tislelizumab|tislelizumab|mesh-list
93216054|NCT04282018|Zanubrutinib|zanubrutinib|mesh-list
93216055|NCT04282018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216056|NCT04282018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216057|NCT04282018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93216058|NCT04282018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216059|NCT04282018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216060|NCT02386072|Mirabegron|mirabegron|mesh-list
93216061|NCT02386072|Oxybutynin|oxybutynin|mesh-list
93216062|NCT02386072|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93216063|NCT02386072|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93216064|NCT02386072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93216065|NCT02386072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93216066|NCT02386072|Adrenergic Agents|adrenergic agents|mesh-ancestor
93216067|NCT02386072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216068|NCT02386072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216069|NCT02386072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216070|NCT02386072|Urological Agents|urological agents|mesh-ancestor
93216071|NCT02386072|Parasympatholytics|parasympatholytics|mesh-ancestor
93216072|NCT02386072|Autonomic Agents|autonomic agents|mesh-ancestor
93216073|NCT02386072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216074|NCT02386072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93216075|NCT02386072|Cholinergic Agents|cholinergic agents|mesh-ancestor
93216076|NCT03655730|Psychotropic Drugs|psychotropic drugs|mesh-list
93216077|NCT02381470|Amoxicillin|amoxicillin|mesh-list
93216078|NCT02381470|Rifampin|rifampin|mesh-list
93216079|NCT02381470|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93216080|NCT02381470|Clavulanic Acids|clavulanic acids|mesh-list
93216081|NCT02381470|Clavulanic Acid|clavulanic acid|mesh-list
93216082|NCT02381470|Cefadroxil|cefadroxil|mesh-list
93216083|NCT02381470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216084|NCT02381470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216085|NCT02381470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93216086|NCT02381470|Antitubercular Agents|antitubercular agents|mesh-ancestor
93216087|NCT02381470|Leprostatic Agents|leprostatic agents|mesh-ancestor
93216088|NCT02381470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93216089|NCT02381470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216090|NCT02381470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216091|NCT02381470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93216092|NCT02381470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93216093|NCT02381470|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93216094|NCT02381470|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93216095|NCT02381470|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93216096|NCT02381470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93216097|NCT02381470|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93216099|NCT02381158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216100|NCT02381158|Glucocorticoids|glucocorticoids|mesh-ancestor
93216101|NCT02381158|Hormones|hormones|mesh-ancestor
93216102|NCT02381158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216103|NCT02381158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216104|NCT02381158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93216105|NCT02381158|Respiratory System Agents|respiratory system agents|mesh-ancestor
93216106|NCT02381080|Voriconazole|voriconazole|mesh-list
93216107|NCT02381080|Erythromycin|erythromycin|mesh-list
93216108|NCT02381080|Erythromycin Estolate|erythromycin estolate|mesh-list
93216109|NCT02381080|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93216110|NCT02381080|Erythromycin stearate|erythromycin stearate|mesh-list
93216111|NCT02381080|Antifungal Agents|antifungal agents|mesh-ancestor
93216112|NCT02381080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216113|NCT02381080|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91929007|NCT02390739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93216114|NCT02381080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93216115|NCT02381080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216116|NCT02381080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216117|NCT02381080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93216118|NCT02381080|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216119|NCT02381080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216120|NCT02381080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216121|NCT02381080|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93216122|NCT02381080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216123|NCT02381080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216124|NCT02381080|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93216125|NCT04694248|Aspirin|aspirin|mesh-list
93216126|NCT04694248|Rivaroxaban|rivaroxaban|mesh-list
93216127|NCT04694248|Anticoagulants|anticoagulants|mesh-list
93216128|NCT04694248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216129|NCT04694248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216130|NCT04694248|Analgesics|analgesics|mesh-ancestor
93216131|NCT04694248|Sensory System Agents|sensory system agents|mesh-ancestor
93216132|NCT04694248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216133|NCT04694248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216134|NCT04694248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216135|NCT04694248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216136|NCT04694248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93216137|NCT04694248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93216138|NCT04694248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216139|NCT04694248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216140|NCT04694248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93216141|NCT04694248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216142|NCT04694248|Antipyretics|antipyretics|mesh-ancestor
93216143|NCT04694248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93216144|NCT04694248|Antithrombins|antithrombins|mesh-ancestor
93216145|NCT04694248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93216146|NCT04694248|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216147|NCT02376478|Folic Acid|folic acid|mesh-list
93216148|NCT02376478|Sulfasalazine|sulfasalazine|mesh-list
93216149|NCT02376478|Adalimumab|adalimumab|mesh-list
93216150|NCT02376478|Infliximab|infliximab|mesh-list
93216151|NCT02376478|Etanercept|etanercept|mesh-list
93216152|NCT02376478|Methotrexate|methotrexate|mesh-list
93216153|NCT02376478|Mercaptopurine|mercaptopurine|mesh-list
93216154|NCT02376478|Folic Acid Antagonists|folic acid antagonists|mesh-list
93216155|NCT02376478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93216156|NCT02376478|Abortifacient Agents|abortifacient agents|mesh-ancestor
93216157|NCT02376478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93216158|NCT02376478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216159|NCT02376478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93216160|NCT02376478|Antimetabolites|antimetabolites|mesh-ancestor
93216161|NCT02376478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216162|NCT02376478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216163|NCT02376478|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216164|NCT02376478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216165|NCT02376478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216166|NCT02376478|Immunologic Factors|immunologic factors|mesh-ancestor
93216167|NCT02376478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888207|NCT02641652|Sertraline|sertraline|mesh-list
93216168|NCT02376478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93216169|NCT02376478|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93216170|NCT02376478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216171|NCT02376478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216172|NCT02376478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216173|NCT02376478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216174|NCT02376478|Analgesics|analgesics|mesh-ancestor
93216175|NCT02376478|Sensory System Agents|sensory system agents|mesh-ancestor
93216176|NCT02376478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216177|NCT02376478|Hematinics|hematinics|mesh-ancestor
93216178|NCT02376478|Vitamin B Complex|vitamin b complex|mesh-ancestor
93216179|NCT02376478|Vitamins|vitamins|mesh-ancestor
93216180|NCT02376478|Micronutrients|micronutrients|mesh-ancestor
93216181|NCT02376478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216182|NCT02385448|Dienogest|dienogest|mesh-list
93216183|NCT02385448|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93216184|NCT02385448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93216185|NCT02385448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93216186|NCT02385448|Contraceptive Agents|contraceptive agents|mesh-ancestor
93216187|NCT02385448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93216188|NCT02385448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216189|NCT02385448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93216190|NCT02385448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93216191|NCT02385448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93216192|NCT02385448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93216193|NCT02385448|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216194|NCT02385448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216195|NCT02385448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93216196|NCT02385448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216197|NCT02385448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93216198|NCT02385448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93216199|NCT02385448|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93216200|NCT02385448|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93216201|NCT02385448|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93216202|NCT02376400|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93216203|NCT02376400|Antiviral Agents|antiviral agents|mesh-ancestor
93216204|NCT02376400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216205|NCT02385058|Mebendazole|mebendazole|mesh-list
93216206|NCT02385058|Piperazine|piperazine|mesh-list
93216207|NCT02385058|Piperazine citrate|piperazine citrate|mesh-list
93216208|NCT02385058|DMP 777|dmp 777|mesh-list
93216209|NCT02385058|Antinematodal Agents|antinematodal agents|mesh-ancestor
93216210|NCT02385058|Anthelmintics|anthelmintics|mesh-ancestor
93216211|NCT02385058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93216212|NCT02385058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216213|NCT02385058|Tubulin Modulators|tubulin modulators|mesh-ancestor
93216214|NCT02385058|Antimitotic Agents|antimitotic agents|mesh-ancestor
93216215|NCT02385058|Mitosis Modulators|mitosis modulators|mesh-ancestor
93216216|NCT02385058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216217|NCT02385058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216218|NCT02385058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216219|NCT02376088|Methimazole|methimazole|mesh-list
93216220|NCT02376088|Antithyroid Agents|antithyroid agents|mesh-ancestor
93216221|NCT02376088|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216222|NCT02376088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216223|NCT02376088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216224|NCT03310021|Rivaroxaban|rivaroxaban|mesh-list
93216225|NCT03310021|Apixaban|apixaban|mesh-list
93216226|NCT03310021|Edoxaban|edoxaban|mesh-list
93216227|NCT03310021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93216228|NCT03310021|Antithrombins|antithrombins|mesh-ancestor
93216229|NCT03310021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93216230|NCT03310021|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216231|NCT03310021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216232|NCT03310021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216233|NCT03310021|Anticoagulants|anticoagulants|mesh-ancestor
93216234|NCT03333109|Erenumab|erenumab|mesh-list
93216235|NCT03333109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93216236|NCT03333109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216237|NCT03333109|Analgesics|analgesics|mesh-ancestor
93216238|NCT03333109|Sensory System Agents|sensory system agents|mesh-ancestor
93216239|NCT03333109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888278|NCT03752216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216240|NCT03333109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216241|NCT02940223|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93216242|NCT02940223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216243|NCT02940223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93216244|NCT01312831|Vitamin B 12|vitamin b 12|mesh-list
93216245|NCT01312831|Hydroxocobalamin|hydroxocobalamin|mesh-list
93216246|NCT01312831|Vitamins|vitamins|mesh-ancestor
93216247|NCT01312831|Micronutrients|micronutrients|mesh-ancestor
93216248|NCT01312831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216249|NCT01312831|Vitamin B Complex|vitamin b complex|mesh-ancestor
93216250|NCT01312831|Hematinics|hematinics|mesh-ancestor
93216251|NCT03296527|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93216252|NCT03296527|Hormones|hormones|mesh-ancestor
93216253|NCT03296527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216254|NCT03296527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216255|NCT04431193|Oxytocin|oxytocin|mesh-list
93216256|NCT04431193|Oxytocics|oxytocics|mesh-ancestor
93216257|NCT04431193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93216258|NCT04431193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216259|NCT03293485|Imipenem|imipenem|mesh-list
93216260|NCT03293485|Relebactam|relebactam|mesh-list
93216261|NCT03293485|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
93216262|NCT03293485|Cilastatin|cilastatin|mesh-list
93216263|NCT03293485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216264|NCT03293485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216265|NCT03293485|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216266|NCT03293485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216267|NCT03293485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216268|NCT03293485|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93216269|NCT03309943|Propranolol|propranolol|mesh-list
93216270|NCT03309943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93216271|NCT03309943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93216272|NCT03309943|Adrenergic Agents|adrenergic agents|mesh-ancestor
93216273|NCT03309943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216274|NCT03309943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216275|NCT03309943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216276|NCT03309943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93216277|NCT03309943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93216278|NCT03309943|Vasodilator Agents|vasodilator agents|mesh-ancestor
93216279|NCT01732627|Vaccines|vaccines|mesh-list
93216280|NCT01732627|Immunologic Factors|immunologic factors|mesh-ancestor
93216281|NCT01732627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216282|NCT04296799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93216283|NCT03331315|Celecoxib|celecoxib|mesh-list
93216284|NCT03331315|Ketorolac|ketorolac|mesh-list
93216285|NCT03331315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216286|NCT03331315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216287|NCT03331315|Analgesics|analgesics|mesh-ancestor
93216288|NCT03331315|Sensory System Agents|sensory system agents|mesh-ancestor
93216289|NCT03331315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216290|NCT03331315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216291|NCT03331315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216292|NCT03331315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216293|NCT03331315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93216294|NCT03331315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93216295|NCT03331315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216296|NCT03331315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216297|NCT03287869|Brexpiprazole|brexpiprazole|mesh-list
93216298|NCT03287869|Serotonin Agents|serotonin agents|mesh-ancestor
93216299|NCT03287869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216300|NCT03287869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216301|NCT03287869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216302|NCT03287869|Dopamine Agonists|dopamine agonists|mesh-ancestor
93216303|NCT03287869|Dopamine Agents|dopamine agents|mesh-ancestor
93216304|NCT02661490|Vaccines|vaccines|mesh-list
93216305|NCT02661490|Immunologic Factors|immunologic factors|mesh-ancestor
93216306|NCT02661490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216307|NCT03287791|Azelaic acid|azelaic acid|mesh-list
93216308|NCT03287791|Sunscreening Agents|sunscreening agents|mesh-list
93216309|NCT03287791|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93216310|NCT03287791|Protective Agents|protective agents|mesh-ancestor
93216311|NCT03287791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216312|NCT03287791|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216313|NCT03287791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216314|NCT03287635|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93216315|NCT03287635|Hormones|hormones|mesh-ancestor
93216316|NCT03287635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216317|NCT03287635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216318|NCT03287089|Nitrofurantoin|nitrofurantoin|mesh-list
93216319|NCT03287089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93216320|NCT03287089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216321|NCT03287089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216322|NCT02380768|Chlorhexidine|chlorhexidine|mesh-list
93216323|NCT02380768|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93216324|NCT02380768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216325|NCT02380768|Disinfectants|disinfectants|mesh-ancestor
93216326|NCT02385136|Temozolomide|temozolomide|mesh-list
93216327|NCT02385136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93216328|NCT02385136|Alkylating Agents|alkylating agents|mesh-ancestor
93216329|NCT02385136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216330|NCT02385136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216331|NCT04927780|Leucovorin|leucovorin|mesh-list
93216332|NCT04927780|Fluorouracil|fluorouracil|mesh-list
93216333|NCT04927780|Oxaliplatin|oxaliplatin|mesh-list
93216334|NCT04927780|Irinotecan|irinotecan|mesh-list
93216335|NCT04927780|Calcium|calcium|mesh-list
93216336|NCT04927780|Levoleucovorin|levoleucovorin|mesh-list
93216337|NCT04927780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93216338|NCT04927780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216339|NCT04927780|Antimetabolites|antimetabolites|mesh-ancestor
93216340|NCT04927780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216341|NCT04927780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93216342|NCT04927780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216343|NCT04927780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216344|NCT04927780|Immunologic Factors|immunologic factors|mesh-ancestor
93216345|NCT04927780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93216346|NCT04927780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93216347|NCT04927780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216348|NCT04927780|Antidotes|antidotes|mesh-ancestor
93216349|NCT04927780|Protective Agents|protective agents|mesh-ancestor
93216350|NCT04927780|Vitamin B Complex|vitamin b complex|mesh-ancestor
93216351|NCT04927780|Vitamins|vitamins|mesh-ancestor
93216352|NCT04927780|Micronutrients|micronutrients|mesh-ancestor
93216353|NCT02940691|Grazoprevir|grazoprevir|mesh-list
93216354|NCT02940691|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93216355|NCT02940691|Antiviral Agents|antiviral agents|mesh-ancestor
93216356|NCT02940691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216357|NCT04949269|Deucravacitinib|deucravacitinib|mesh-list
93216358|NCT04949269|Famotidine|famotidine|mesh-list
93216359|NCT04949269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93216360|NCT04949269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216361|NCT04949269|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93216362|NCT04949269|Histamine Antagonists|histamine antagonists|mesh-ancestor
93216363|NCT04949269|Histamine Agents|histamine agents|mesh-ancestor
93216364|NCT04949269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216365|NCT04949269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216366|NCT04949269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216367|NCT04949269|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216368|NCT04949269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93216369|NCT04949269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216370|NCT02379754|Gentamicins|gentamicins|mesh-list
93216371|NCT02379754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216372|NCT02379754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216373|NCT02379754|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93216374|NCT02379754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216375|NCT02379754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216376|NCT04914793|Anti-Infective Agents|anti-infective agents|mesh-list
93216377|NCT04914793|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93216378|NCT01313377|Gemcitabine|gemcitabine|mesh-list
93216379|NCT01313377|Oxaliplatin|oxaliplatin|mesh-list
93216380|NCT01313377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93216381|NCT01313377|Antimetabolites|antimetabolites|mesh-ancestor
93216382|NCT01313377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216383|NCT01313377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216384|NCT02384746|Fulvestrant|fulvestrant|mesh-list
93216385|NCT02384746|Ixazomib|ixazomib|mesh-list
93216386|NCT02384746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93216387|NCT02384746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216388|NCT02384746|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93216389|NCT02384746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93216390|NCT02384746|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216391|NCT02384746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216392|NCT02384746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216393|NCT02384746|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216394|NCT02384746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216395|NCT02384746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216396|NCT02375464|Octreotide|octreotide|mesh-list
93216397|NCT02375464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216398|NCT02375464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93216399|NCT02375464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216400|NCT03113344|Amoxicillin|amoxicillin|mesh-list
93216401|NCT03113344|Azithromycin|azithromycin|mesh-list
93216402|NCT03113344|Meropenem|meropenem|mesh-list
93216403|NCT03113344|Ceftriaxone|ceftriaxone|mesh-list
93216404|NCT03113344|Penicillins|penicillins|mesh-list
93216405|NCT03113344|Imipenem|imipenem|mesh-list
93216406|NCT03113344|Erythromycin|erythromycin|mesh-list
93216407|NCT03113344|Ceftazidime|ceftazidime|mesh-list
93216408|NCT03113344|Ampicillin|ampicillin|mesh-list
93216409|NCT03113344|Cephalosporins|cephalosporins|mesh-list
93216410|NCT03113344|Acyclovir|acyclovir|mesh-list
93216411|NCT03113344|Ganciclovir|ganciclovir|mesh-list
93216412|NCT03113344|Antiviral Agents|antiviral agents|mesh-list
93216413|NCT03113344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216414|NCT03113344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216415|NCT03113344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216416|NCT03113344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216417|NCT03113344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216418|NCT03113344|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93216419|NCT03113266|Antibodies|antibodies|mesh-list
93216420|NCT03113266|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93216421|NCT03113266|Immunologic Factors|immunologic factors|mesh-ancestor
93216422|NCT03113266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216423|NCT02379676|Clopidogrel|clopidogrel|mesh-list
93216424|NCT02379676|Ticagrelor|ticagrelor|mesh-list
93216425|NCT02379676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216426|NCT02379676|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93216427|NCT02379676|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93216428|NCT02379676|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93216429|NCT02379676|Purinergic Agents|purinergic agents|mesh-ancestor
93216430|NCT02379676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216431|NCT02379676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216432|NCT02379676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216433|NCT04715230|Lorazepam|lorazepam|mesh-list
93216434|NCT04715230|Haloperidol|haloperidol|mesh-list
93216435|NCT04715230|Haloperidol decanoate|haloperidol decanoate|mesh-list
93216436|NCT04715230|Antiemetics|antiemetics|mesh-ancestor
93216437|NCT04715230|Autonomic Agents|autonomic agents|mesh-ancestor
93216438|NCT04715230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216439|NCT04715230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216440|NCT04715230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216441|NCT04715230|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93216442|NCT04715230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93216443|NCT04715230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93216444|NCT04715230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93216445|NCT04715230|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93216446|NCT04715230|Dopamine Agents|dopamine agents|mesh-ancestor
93216447|NCT04715230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216448|NCT04715230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216449|NCT04715230|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93216450|NCT04715230|Anticonvulsants|anticonvulsants|mesh-ancestor
93216451|NCT04715230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93216452|NCT04715230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93216453|NCT04715230|GABA Modulators|gaba modulators|mesh-ancestor
93216454|NCT04715230|GABA Agents|gaba agents|mesh-ancestor
93216455|NCT02378740|Ketamine|ketamine|mesh-list
93216456|NCT02378740|Analgesics|analgesics|mesh-ancestor
93216457|NCT02378740|Sensory System Agents|sensory system agents|mesh-ancestor
93216458|NCT02378740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216459|NCT02378740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216460|NCT02378740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93216461|NCT02378740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93216462|NCT02378740|Anesthetics, General|anesthetics, general|mesh-ancestor
93216463|NCT02378740|Anesthetics|anesthetics|mesh-ancestor
93216464|NCT02378740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93216465|NCT02378740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93216466|NCT02378740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93216467|NCT02378740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216468|NCT02378740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216469|NCT01411267|Cytarabine|cytarabine|mesh-list
93216470|NCT01411267|Methotrexate|methotrexate|mesh-list
93216471|NCT01411267|Etoposide|etoposide|mesh-list
93216472|NCT01411267|Etoposide phosphate|etoposide phosphate|mesh-list
93216473|NCT01411267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93216474|NCT01411267|Abortifacient Agents|abortifacient agents|mesh-ancestor
93216475|NCT01411267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93216476|NCT01411267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216477|NCT01411267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93216478|NCT01411267|Antimetabolites|antimetabolites|mesh-ancestor
93216479|NCT01411267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216480|NCT01411267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216481|NCT01411267|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216482|NCT01411267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216483|NCT01411267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93216484|NCT01411267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216485|NCT01411267|Immunologic Factors|immunologic factors|mesh-ancestor
93216486|NCT01411267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216487|NCT01411267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93216488|NCT01411267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93216489|NCT01411267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93216490|NCT01411267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93216491|NCT01411267|Antiviral Agents|antiviral agents|mesh-ancestor
93216492|NCT01411267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216493|NCT03113110|Empagliflozin|empagliflozin|mesh-list
93216494|NCT03113110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93216495|NCT03113110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216496|NCT03113110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93216497|NCT03113110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216498|NCT02378428|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93216499|NCT02378428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216500|NCT02378428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216501|NCT02378428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216502|NCT02378428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93216503|NCT02383888|BI 425809|bi 425809|mesh-list
93216504|NCT02383888|Nootropic Agents|nootropic agents|mesh-ancestor
93216505|NCT02377960|Antihypertensive Agents|antihypertensive agents|mesh-list
93216506|NCT03130959|Nivolumab|nivolumab|mesh-list
93216507|NCT03130959|Ipilimumab|ipilimumab|mesh-list
93216508|NCT03130959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216509|NCT03130959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216510|NCT03130959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93216511|NCT03130959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216512|NCT01370031|Charcoal|charcoal|mesh-list
93216513|NCT01370031|Antidotes|antidotes|mesh-ancestor
93216514|NCT01370031|Protective Agents|protective agents|mesh-ancestor
93216515|NCT01370031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216516|NCT02373514|Acetaminophen|acetaminophen|mesh-list
93216517|NCT02373514|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93216518|NCT02373514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216519|NCT02373514|Analgesics|analgesics|mesh-ancestor
93216520|NCT02373514|Sensory System Agents|sensory system agents|mesh-ancestor
93216521|NCT02373514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216522|NCT02373514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216523|NCT02373514|Antipyretics|antipyretics|mesh-ancestor
93216524|NCT02373514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216525|NCT02373514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216526|NCT02373514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216527|NCT01364493|Capecitabine|capecitabine|mesh-list
93216528|NCT01364493|Oxaliplatin|oxaliplatin|mesh-list
93216529|NCT01364493|Trastuzumab|trastuzumab|mesh-list
93216530|NCT01364493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93216531|NCT01364493|Antimetabolites|antimetabolites|mesh-ancestor
93216532|NCT01364493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216533|NCT01364493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216534|NCT01364493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216535|NCT01370187|Montelukast|montelukast|mesh-list
93216536|NCT01370187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93216537|NCT01370187|Respiratory System Agents|respiratory system agents|mesh-ancestor
93216538|NCT01370187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93216539|NCT01370187|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216540|NCT01370187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216541|NCT01370187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216542|NCT01370187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93216543|NCT01370187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93216544|NCT01370187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216545|NCT04483960|Nafamostat|nafamostat|mesh-list
93216546|NCT04483960|Enoxaparin|enoxaparin|mesh-list
93216547|NCT04483960|Dalteparin|dalteparin|mesh-list
93216548|NCT04483960|Tinzaparin|tinzaparin|mesh-list
93216549|NCT04483960|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93216550|NCT04483960|Anticoagulants|anticoagulants|mesh-ancestor
93216551|NCT04483960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93216552|NCT04483960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93216553|NCT04483960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216554|NCT04483960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216555|NCT04483960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216556|NCT04483960|Analgesics|analgesics|mesh-ancestor
93216557|NCT04483960|Sensory System Agents|sensory system agents|mesh-ancestor
93216558|NCT04483960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216559|NCT04483960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216560|NCT04483960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216561|NCT04483960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216562|NCT04483960|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216563|NCT04483960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216564|NCT04483960|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93216565|NCT04483960|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93216566|NCT04483960|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93216567|NCT04483960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216568|NCT04483960|Immunologic Factors|immunologic factors|mesh-ancestor
93216569|NCT01370343|Nicotinic Acids|nicotinic acids|mesh-list
93216570|NCT01370343|Cyclosporine|cyclosporine|mesh-list
93216571|NCT01370343|Cyclosporins|cyclosporins|mesh-list
93216572|NCT01370343|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93216573|NCT01370343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216574|NCT01370343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216575|NCT01370343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216576|NCT01370343|Immunologic Factors|immunologic factors|mesh-ancestor
93216577|NCT01370343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216578|NCT01370343|Antifungal Agents|antifungal agents|mesh-ancestor
93216579|NCT01370343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216580|NCT01370343|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216581|NCT01370343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216582|NCT01370343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93216583|NCT01370343|Vitamin B Complex|vitamin b complex|mesh-ancestor
93216584|NCT01370343|Vitamins|vitamins|mesh-ancestor
93216585|NCT01370343|Micronutrients|micronutrients|mesh-ancestor
93216586|NCT01368003|Dutasteride|dutasteride|mesh-list
93216587|NCT01368003|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93216588|NCT01368003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93216589|NCT01368003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216590|NCT01368003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216591|NCT01368003|Hormone Antagonists|hormone antagonists|mesh-ancestor
93216592|NCT01368003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216593|NCT01368003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216594|NCT01364571|Vaccines|vaccines|mesh-list
93216595|NCT01364571|Immunologic Factors|immunologic factors|mesh-ancestor
93216596|NCT01364571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216597|NCT04222257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93216598|NCT04222257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93216599|NCT04222257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216600|NCT04222257|Antitubercular Agents|antitubercular agents|mesh-ancestor
93216601|NCT03933904|Sirolimus|sirolimus|mesh-list
93216602|NCT03933904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216603|NCT03933904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216604|NCT03933904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93216605|NCT03933904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216606|NCT03933904|Antifungal Agents|antifungal agents|mesh-ancestor
93216607|NCT03933904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216608|NCT03933904|Immunologic Factors|immunologic factors|mesh-ancestor
93216609|NCT03933904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216610|NCT02377648|Everolimus|everolimus|mesh-list
93216611|NCT02377648|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93216612|NCT02377648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93216613|NCT02377648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216614|NCT02377648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216615|NCT02377648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216616|NCT02377648|Immunologic Factors|immunologic factors|mesh-ancestor
93216617|NCT02377648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216618|NCT02377648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216619|NCT02371408|Ribavirin|ribavirin|mesh-list
93216620|NCT02371408|Sofosbuvir|sofosbuvir|mesh-list
93216621|NCT02371408|Antimetabolites|antimetabolites|mesh-ancestor
93216622|NCT02371408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216623|NCT02371408|Antiviral Agents|antiviral agents|mesh-ancestor
93216624|NCT02371408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216625|NCT01364805|Ascorbic Acid|ascorbic acid|mesh-list
93216626|NCT01364805|Gemcitabine|gemcitabine|mesh-list
93216627|NCT01364805|Vitamins|vitamins|mesh-ancestor
93216628|NCT01364805|Micronutrients|micronutrients|mesh-ancestor
93216629|NCT01364805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216630|NCT01364805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93216631|NCT01364805|Antimetabolites|antimetabolites|mesh-ancestor
93216632|NCT01364805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216633|NCT01364805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216634|NCT01364805|Antioxidants|antioxidants|mesh-ancestor
93216635|NCT01364805|Protective Agents|protective agents|mesh-ancestor
93216636|NCT01370889|Resveratrol|resveratrol|mesh-list
93216637|NCT01370889|Antioxidants|antioxidants|mesh-ancestor
93216638|NCT01370889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216639|NCT01370889|Protective Agents|protective agents|mesh-ancestor
93216640|NCT01370889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216641|NCT01370889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216642|NCT01370889|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216643|NCT02373046|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93216644|NCT02373046|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93216645|NCT02373046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216646|NCT02373046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93216647|NCT02373046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216648|NCT04382404|Sofosbuvir|sofosbuvir|mesh-list
93216649|NCT04382404|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93216650|NCT04382404|Velpatasvir|velpatasvir|mesh-list
93216651|NCT04382404|Antiviral Agents|antiviral agents|mesh-ancestor
93216652|NCT04382404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216653|NCT02371096|Rituximab|rituximab|mesh-list
93216654|NCT02371096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216655|NCT02371096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216656|NCT02371096|Immunologic Factors|immunologic factors|mesh-ancestor
93216657|NCT02371096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216658|NCT02371096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216659|NCT04420455|Enoximone|enoximone|mesh-list
93216660|NCT04420455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93216661|NCT04420455|Vasodilator Agents|vasodilator agents|mesh-ancestor
93216662|NCT04420455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93216663|NCT04420455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93216664|NCT04420455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216665|NCT04420455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216666|NCT04420455|Protective Agents|protective agents|mesh-ancestor
93216667|NCT04420455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216668|NCT04381936|Aspirin|aspirin|mesh-list
93216669|NCT04381936|Empagliflozin|empagliflozin|mesh-list
93216670|NCT04381936|Ritonavir|ritonavir|mesh-list
93216671|NCT04381936|Lopinavir|lopinavir|mesh-list
93216672|NCT04381936|Azithromycin|azithromycin|mesh-list
93216673|NCT04381936|Hydroxychloroquine|hydroxychloroquine|mesh-list
93216674|NCT04381936|Nirmatrelvir|nirmatrelvir|mesh-list
93216675|NCT04381936|Sotrovimab|sotrovimab|mesh-list
93216676|NCT04381936|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
93216677|NCT04381936|Molnupiravir|molnupiravir|mesh-list
93216678|NCT04381936|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
93216679|NCT04381936|Colchicine|colchicine|mesh-list
93216680|NCT04381936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93216681|NCT04381936|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93216682|NCT04381936|Antibodies|antibodies|mesh-list
93216683|NCT04381936|Immunoglobulins|immunoglobulins|mesh-list
93216684|NCT04381936|Immunologic Factors|immunologic factors|mesh-ancestor
93216685|NCT04381936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216686|NCT04381936|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216687|NCT04381936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216688|NCT04381936|Analgesics|analgesics|mesh-ancestor
93216689|NCT04381936|Sensory System Agents|sensory system agents|mesh-ancestor
93216690|NCT04381936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216691|NCT04381936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216692|NCT04381936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888732|NCT02646020|Histamine Agents|histamine agents|mesh-ancestor
93216693|NCT04381936|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93216694|NCT04381936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93216695|NCT04381936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216696|NCT04381936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216697|NCT04381936|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93216699|NCT04381936|Antipyretics|antipyretics|mesh-ancestor
93216700|NCT04381936|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93216701|NCT04381936|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93216702|NCT04381936|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216703|NCT04381936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93216704|NCT04381936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93216705|NCT04381936|Antiviral Agents|antiviral agents|mesh-ancestor
93216706|NCT04381936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216707|NCT04381936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93216708|NCT04381936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93216709|NCT04381936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216710|NCT04381936|Antimalarials|antimalarials|mesh-ancestor
93216711|NCT04381936|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93216712|NCT04381936|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93216713|NCT04381936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93216714|NCT04381936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93216715|NCT04381936|Gout Suppressants|gout suppressants|mesh-ancestor
93216716|NCT04381936|Tubulin Modulators|tubulin modulators|mesh-ancestor
93216717|NCT04381936|Antimitotic Agents|antimitotic agents|mesh-ancestor
93216718|NCT04381936|Mitosis Modulators|mitosis modulators|mesh-ancestor
93216719|NCT04381936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216720|NCT04381936|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216721|NCT04381936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216722|NCT03124407|Capsaicin|capsaicin|mesh-list
93216723|NCT03124407|Antipruritics|antipruritics|mesh-ancestor
93216724|NCT03124407|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216725|NCT03124407|Sensory System Agents|sensory system agents|mesh-ancestor
93216726|NCT03124407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216727|NCT03124407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216728|NCT01364961|Resveratrol|resveratrol|mesh-list
93216729|NCT01364961|Antioxidants|antioxidants|mesh-ancestor
93216730|NCT01364961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216731|NCT01364961|Protective Agents|protective agents|mesh-ancestor
93216732|NCT01364961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216733|NCT01364961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216734|NCT01364961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216735|NCT02370862|Glycopyrrolate|glycopyrrolate|mesh-list
93216736|NCT02370862|Neostigmine|neostigmine|mesh-list
93216737|NCT02370862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93216738|NCT02370862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216739|NCT02370862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216740|NCT02370862|Cholinergic Agents|cholinergic agents|mesh-ancestor
93216741|NCT02370862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216742|NCT02370862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216743|NCT02370862|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93216744|NCT02370862|Autonomic Agents|autonomic agents|mesh-ancestor
93216745|NCT02370862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216746|NCT02370862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93216747|NCT02370862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93216748|NCT02370862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93216749|NCT03620578|Nivolumab|nivolumab|mesh-list
93216750|NCT03620578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216751|NCT03620578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216752|NCT03620578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93216753|NCT03620578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216754|NCT02373280|Amoxicillin|amoxicillin|mesh-list
93216755|NCT02373280|Moxifloxacin|moxifloxacin|mesh-list
93216756|NCT02373280|Metronidazole|metronidazole|mesh-list
93216757|NCT02373280|Clarithromycin|clarithromycin|mesh-list
93216758|NCT02373280|Esomeprazole|esomeprazole|mesh-list
93216759|NCT02373280|Bismuth|bismuth|mesh-list
93216760|NCT02373280|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93216761|NCT02373280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216762|NCT02373280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216763|NCT02373280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93216764|NCT02373280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93216765|NCT02373280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216766|NCT02373280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216767|NCT02373280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888807|NCT03675139|Hormones|hormones|mesh-ancestor
93216768|NCT02373280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93216769|NCT02373280|Contraceptive Agents|contraceptive agents|mesh-ancestor
93216770|NCT02373280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93216771|NCT02373280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216772|NCT02373280|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93216773|NCT02373280|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93216774|NCT02373280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93216775|NCT02373280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93216776|NCT02373280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93216777|NCT02373280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93216778|NCT02373280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216779|NCT02373280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93216780|NCT02373280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93216781|NCT02373280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93216782|NCT02373280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93216783|NCT02373280|Antacids|antacids|mesh-ancestor
93216784|NCT02370550|Cyclosporine|cyclosporine|mesh-list
93216785|NCT02370550|Prednisone|prednisone|mesh-list
93216786|NCT02370550|Calcium Carbonate|calcium carbonate|mesh-list
93216787|NCT02370550|Calcium|calcium|mesh-list
93216788|NCT02370550|Cyclosporins|cyclosporins|mesh-list
93216789|NCT02370550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93216790|NCT02370550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216791|NCT02370550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216792|NCT02370550|Glucocorticoids|glucocorticoids|mesh-ancestor
93216793|NCT02370550|Hormones|hormones|mesh-ancestor
93216794|NCT02370550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216795|NCT02370550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93216796|NCT02370550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216797|NCT02370550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216798|NCT02370550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216799|NCT02370550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216800|NCT02370550|Immunologic Factors|immunologic factors|mesh-ancestor
93216801|NCT02370550|Antifungal Agents|antifungal agents|mesh-ancestor
93216802|NCT02370550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216803|NCT02370550|Dermatologic Agents|dermatologic agents|mesh-ancestor
93216804|NCT02370550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216805|NCT02370550|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93216806|NCT02370550|Antacids|antacids|mesh-ancestor
93216807|NCT02370550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93216808|NCT02365402|Entecavir|entecavir|mesh-list
93216809|NCT02365402|Antiviral Agents|antiviral agents|mesh-ancestor
93216810|NCT02365402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216811|NCT02364934|Propofol|propofol|mesh-list
93216812|NCT02364934|Sevoflurane|sevoflurane|mesh-list
93216813|NCT02364934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93216814|NCT02364934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93216815|NCT02364934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216816|NCT02364934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93216817|NCT02364934|Anesthetics, General|anesthetics, general|mesh-ancestor
93216818|NCT02364934|Anesthetics|anesthetics|mesh-ancestor
93216819|NCT02364934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93216820|NCT02364934|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93216821|NCT02372656|Metformin|metformin|mesh-list
93216822|NCT02372656|Simvastatin|simvastatin|mesh-list
93216823|NCT02372656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93216824|NCT02372656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216825|NCT02372656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93216826|NCT02372656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93216827|NCT02372656|Antimetabolites|antimetabolites|mesh-ancestor
93216828|NCT02372656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216829|NCT02372656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93216830|NCT02372656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93216831|NCT02372656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216832|NCT03123939|Tisagenlecleucel|tisagenlecleucel|mesh-list
93216833|NCT03123939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93216834|NCT03123939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216835|NCT01368627|Sirolimus|sirolimus|mesh-list
93216836|NCT01368627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216837|NCT01368627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216838|NCT01368627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93216839|NCT01368627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216840|NCT01368627|Antifungal Agents|antifungal agents|mesh-ancestor
93216841|NCT01368627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93216842|NCT01368627|Immunologic Factors|immunologic factors|mesh-ancestor
93216843|NCT01368627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216844|NCT02358681|Ketorolac|ketorolac|mesh-list
93216845|NCT02358681|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93216846|NCT02358681|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216847|NCT02358681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216848|NCT02358681|Analgesics|analgesics|mesh-ancestor
93216849|NCT02358681|Sensory System Agents|sensory system agents|mesh-ancestor
93216850|NCT02358681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216851|NCT02358681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216852|NCT02358681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216853|NCT02358681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216854|NCT02358681|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93216855|NCT02358681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216856|NCT02358681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216857|NCT03123861|Gabapentin|gabapentin|mesh-list
93216858|NCT03123861|Analgesics|analgesics|mesh-ancestor
93216859|NCT03123861|Sensory System Agents|sensory system agents|mesh-ancestor
93216860|NCT03123861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216861|NCT03123861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216862|NCT03123861|Anticonvulsants|anticonvulsants|mesh-ancestor
93216863|NCT03123861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93216864|NCT03123861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93216865|NCT03123861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93216866|NCT03123861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93216867|NCT03123861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93216868|NCT03123861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93216869|NCT03123861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216870|NCT03123861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216871|NCT03123861|Antimanic Agents|antimanic agents|mesh-ancestor
93216872|NCT01368783|Ritonavir|ritonavir|mesh-list
93216873|NCT01368783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93216874|NCT01368783|Tenofovir|tenofovir|mesh-list
93216875|NCT01368783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93216876|NCT01368783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93216877|NCT01368783|Protease Inhibitors|protease inhibitors|mesh-ancestor
93216878|NCT01368783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216879|NCT01368783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216880|NCT01368783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93216881|NCT01368783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93216882|NCT01368783|Antiviral Agents|antiviral agents|mesh-ancestor
93216883|NCT01368783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216884|NCT01368783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93216885|NCT01368783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93216886|NCT01368783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93216887|NCT01368783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93216888|NCT01509339|Vancomycin|vancomycin|mesh-list
93216889|NCT01509339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93216890|NCT01509339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216891|NCT03123471|Apremilast|apremilast|mesh-list
93216892|NCT03123471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93216893|NCT03123471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216894|NCT03123471|Analgesics|analgesics|mesh-ancestor
93216895|NCT03123471|Sensory System Agents|sensory system agents|mesh-ancestor
93216896|NCT03123471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216897|NCT03123471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216898|NCT03123471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216899|NCT03123471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216900|NCT03123471|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93216901|NCT03123471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93216902|NCT03123471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216903|NCT03123471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216904|NCT02661178|Emodepside|emodepside|mesh-list
93216905|NCT02661178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93216906|NCT02661178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216907|NCT01365117|Insulin|insulin|mesh-list
93216908|NCT01365117|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93216909|NCT01365117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93216910|NCT01365117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216911|NCT02372812|Dexamethasone|dexamethasone|mesh-list
93216912|NCT02372812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93216913|NCT02372812|Antiemetics|antiemetics|mesh-ancestor
93216914|NCT02372812|Autonomic Agents|autonomic agents|mesh-ancestor
93216915|NCT02372812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216916|NCT02372812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216917|NCT02372812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888951|NCT00713440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93216918|NCT02372812|Glucocorticoids|glucocorticoids|mesh-ancestor
93216919|NCT02372812|Hormones|hormones|mesh-ancestor
93216920|NCT02372812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216921|NCT02372812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93216922|NCT02372812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93216923|NCT02365012|Midodrine|midodrine|mesh-list
93216924|NCT02365012|Sympathomimetics|sympathomimetics|mesh-ancestor
93216925|NCT02365012|Autonomic Agents|autonomic agents|mesh-ancestor
93216926|NCT02365012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93216927|NCT02365012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216928|NCT02365012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93216929|NCT02365012|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93216930|NCT02365012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93216931|NCT02365012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93216932|NCT02365012|Adrenergic Agents|adrenergic agents|mesh-ancestor
93216933|NCT02365012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216934|NCT02365012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216935|NCT01369017|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93216936|NCT01369017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93216937|NCT01365351|Hormones|hormones|mesh-list
93216938|NCT01365351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93216939|NCT01365351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216940|NCT04562896|Carbon Fiber|carbon fiber|mesh-list
93216941|NCT04562896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93216942|NCT04562896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93216943|NCT01372449|Memantine|memantine|mesh-list
93216944|NCT01372449|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93216945|NCT01372449|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93216946|NCT01372449|Dopamine Agents|dopamine agents|mesh-ancestor
93216947|NCT01372449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216948|NCT01372449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216949|NCT01372449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216950|NCT01372449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93216951|NCT01372449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93216952|NCT04666389|Atorvastatin|atorvastatin|mesh-list
93216953|NCT04666389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93216954|NCT04666389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93216955|NCT04666389|Antimetabolites|antimetabolites|mesh-ancestor
93216956|NCT04666389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216957|NCT04666389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93216958|NCT04666389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93216959|NCT04666389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216960|NCT02372110|Caffeine|caffeine|mesh-list
93216961|NCT02372110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93216962|NCT02372110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216963|NCT02372110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93216964|NCT02372110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216965|NCT02372110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216966|NCT02372110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93216967|NCT02372110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93216968|NCT02372110|Purinergic Agents|purinergic agents|mesh-ancestor
93216969|NCT02372110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216970|NCT02372188|Caffeine|caffeine|mesh-list
93216971|NCT02372188|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93216972|NCT02372188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216973|NCT02372188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93216974|NCT02372188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216975|NCT02372188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216976|NCT02372188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93216977|NCT02372188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93216978|NCT02372188|Purinergic Agents|purinergic agents|mesh-ancestor
93216979|NCT02372188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216980|NCT01371435|Paroxetine|paroxetine|mesh-list
93216981|NCT01371435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93216982|NCT01371435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93216983|NCT01371435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93216984|NCT01371435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93216985|NCT01371435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93216986|NCT01371435|Serotonin Agents|serotonin agents|mesh-ancestor
93216987|NCT01371435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93216988|NCT01371435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93216990|NCT01371435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93216991|NCT01371435|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93216992|NCT01371435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93216993|NCT01371435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93216994|NCT01369719|Deferasirox|deferasirox|mesh-list
93216995|NCT01369719|Deferoxamine|deferoxamine|mesh-list
93216996|NCT01369719|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93216997|NCT01369719|Chelating Agents|chelating agents|mesh-ancestor
93216998|NCT01369719|Sequestering Agents|sequestering agents|mesh-ancestor
93216999|NCT01369719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217000|NCT01369719|Siderophores|siderophores|mesh-ancestor
93217001|NCT02369380|Hyaluronic Acid|hyaluronic acid|mesh-list
93217002|NCT02369380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93217003|NCT02369380|Immunologic Factors|immunologic factors|mesh-ancestor
92512909|NCT00000966|Antidotes|antidotes|mesh-ancestor
93217004|NCT02369380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217005|NCT02369380|Viscosupplements|viscosupplements|mesh-ancestor
93217006|NCT02369380|Protective Agents|protective agents|mesh-ancestor
93217007|NCT02038816|Azacitidine|azacitidine|mesh-list
93217008|NCT02038816|Deferasirox|deferasirox|mesh-list
93217009|NCT02038816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217010|NCT02038816|Antimetabolites|antimetabolites|mesh-ancestor
93217011|NCT02038816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217012|NCT02038816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217013|NCT02038816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217014|NCT02038816|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93217015|NCT02038816|Chelating Agents|chelating agents|mesh-ancestor
93217016|NCT02038816|Sequestering Agents|sequestering agents|mesh-ancestor
93217017|NCT04809831|Chlorhexidine|chlorhexidine|mesh-list
93217018|NCT04809831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93217019|NCT04809831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217020|NCT04809831|Disinfectants|disinfectants|mesh-ancestor
93217021|NCT02359162|Prednisone|prednisone|mesh-list
93217022|NCT02359162|Cyclophosphamide|cyclophosphamide|mesh-list
93217023|NCT02359162|Gemcitabine|gemcitabine|mesh-list
93217024|NCT02359162|Doxorubicin|doxorubicin|mesh-list
93217025|NCT02359162|Oxaliplatin|oxaliplatin|mesh-list
93217026|NCT02359162|Etoposide|etoposide|mesh-list
93217027|NCT02359162|Vincristine|vincristine|mesh-list
93217028|NCT02359162|Pegaspargase|pegaspargase|mesh-list
93217029|NCT02359162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217030|NCT02359162|Immunologic Factors|immunologic factors|mesh-ancestor
93217031|NCT02359162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217032|NCT02359162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217033|NCT02359162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93217034|NCT02359162|Alkylating Agents|alkylating agents|mesh-ancestor
93217035|NCT02359162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217036|NCT02359162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217037|NCT02359162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93217038|NCT02359162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217039|NCT02359162|Antimetabolites|antimetabolites|mesh-ancestor
93217040|NCT02359162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93217041|NCT02359162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93217042|NCT02359162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93217043|NCT02359162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217044|NCT02359162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217045|NCT02359162|Glucocorticoids|glucocorticoids|mesh-ancestor
93217046|NCT02359162|Hormones|hormones|mesh-ancestor
93217047|NCT02359162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217048|NCT02359162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93217049|NCT02359162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93217050|NCT02359162|Tubulin Modulators|tubulin modulators|mesh-ancestor
93217051|NCT02359162|Antimitotic Agents|antimitotic agents|mesh-ancestor
93217052|NCT02359162|Mitosis Modulators|mitosis modulators|mesh-ancestor
93217053|NCT03634605|Tetracycline|tetracycline|mesh-list
93217054|NCT03634605|Lidocaine|lidocaine|mesh-list
93217055|NCT03634605|Anesthetics, Local|anesthetics, local|mesh-ancestor
93217056|NCT03634605|Anesthetics|anesthetics|mesh-ancestor
93217057|NCT03634605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217058|NCT03634605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217059|NCT03634605|Sensory System Agents|sensory system agents|mesh-ancestor
93217060|NCT03634605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217061|NCT03634605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93217062|NCT03634605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93217063|NCT03634605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93217064|NCT03634605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93217065|NCT03634605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217066|NCT03634605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217067|NCT03634605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217068|NCT03634605|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93217069|NCT03634605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217070|NCT02363764|Dimercaprol|dimercaprol|mesh-list
93217071|NCT02363764|Chelating Agents|chelating agents|mesh-ancestor
93217072|NCT02363764|Sequestering Agents|sequestering agents|mesh-ancestor
93217073|NCT02363764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217074|NCT03654794|Tacrolimus|tacrolimus|mesh-list
93217075|NCT03654794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217076|NCT03654794|Immunologic Factors|immunologic factors|mesh-ancestor
93217077|NCT03654794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217078|NCT03654794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93217079|NCT03654794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217080|NCT03654794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217081|NCT03654170|BI 425809|bi 425809|mesh-list
93217082|NCT03654170|Nootropic Agents|nootropic agents|mesh-ancestor
93217083|NCT02369146|UB-421|ub-421|mesh-list
93217084|NCT02369146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217085|NCT02369146|Antiviral Agents|antiviral agents|mesh-ancestor
93217086|NCT02369146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217087|NCT02363452|Lamivudine|lamivudine|mesh-list
93217088|NCT02363452|Zidovudine|zidovudine|mesh-list
93217089|NCT02363452|Abacavir|abacavir|mesh-list
93217090|NCT02363452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93217091|NCT02363452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93217092|NCT02363452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217093|NCT02363452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217094|NCT02363452|Antiviral Agents|antiviral agents|mesh-ancestor
93217095|NCT02363452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217096|NCT02363452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217097|NCT02363452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217098|NCT02363452|Antimetabolites|antimetabolites|mesh-ancestor
93217099|NCT03634137|Afamelanotide|afamelanotide|mesh-list
93217100|NCT03634137|alpha-MSH|alpha-msh|mesh-list
93217101|NCT03634137|Dermatologic Agents|dermatologic agents|mesh-ancestor
93217102|NCT03634137|Hormones|hormones|mesh-ancestor
93217103|NCT03634137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217104|NCT03634137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217105|NCT02358694|Immunoglobulins|immunoglobulins|mesh-list
93217106|NCT02358694|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93217107|NCT02358694|Antibodies|antibodies|mesh-list
93217108|NCT02358694|Immunologic Factors|immunologic factors|mesh-ancestor
93217109|NCT02358694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217110|NCT04473807|Sotalol|sotalol|mesh-list
93217111|NCT04473807|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93217112|NCT04473807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93217113|NCT04473807|Adrenergic Agents|adrenergic agents|mesh-ancestor
93217114|NCT04473807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217115|NCT04473807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217116|NCT04473807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217117|NCT04473807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93217118|NCT04473807|Sympatholytics|sympatholytics|mesh-ancestor
93217119|NCT04473807|Autonomic Agents|autonomic agents|mesh-ancestor
93217120|NCT04473807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217121|NCT02323659|Interferons|interferons|mesh-list
93217122|NCT02323659|Interferon-alpha|interferon-alpha|mesh-list
93217123|NCT02323659|Interferon alpha-2|interferon alpha-2|mesh-list
93217124|NCT02323659|Methotrexate|methotrexate|mesh-list
93217125|NCT02323659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93217126|NCT02323659|Abortifacient Agents|abortifacient agents|mesh-ancestor
93217127|NCT02323659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93217128|NCT02323659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217129|NCT02323659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217130|NCT02323659|Antimetabolites|antimetabolites|mesh-ancestor
93217131|NCT02323659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217132|NCT02323659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217133|NCT02323659|Dermatologic Agents|dermatologic agents|mesh-ancestor
93217134|NCT02323659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217135|NCT02323659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93217136|NCT02323659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217137|NCT02323659|Immunologic Factors|immunologic factors|mesh-ancestor
93217138|NCT02323659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217139|NCT02323659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93217140|NCT02323659|Antiviral Agents|antiviral agents|mesh-ancestor
93217141|NCT02323659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217142|NCT03634059|Apatinib|apatinib|mesh-list
93217143|NCT03634059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217144|NCT03634059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93217145|NCT03634059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217146|NCT03634059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217147|NCT02358304|Calcitonin|calcitonin|mesh-list
93217148|NCT02358304|Salmon calcitonin|salmon calcitonin|mesh-list
93217149|NCT02358304|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93217150|NCT02358304|Katacalcin|katacalcin|mesh-list
93217151|NCT02358304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93217152|NCT02358304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217153|NCT02358304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93217154|NCT02358304|Vasodilator Agents|vasodilator agents|mesh-ancestor
93217155|NCT02363530|Ethyl cellulose|ethyl cellulose|mesh-list
93217156|NCT02363530|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93217157|NCT02363530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93217158|NCT01316523|Rituximab|rituximab|mesh-list
93217159|NCT01316523|Lenalidomide|lenalidomide|mesh-list
93217160|NCT01316523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217161|NCT01316523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217162|NCT01316523|Immunologic Factors|immunologic factors|mesh-ancestor
93217163|NCT01316523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217164|NCT01316523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217165|NCT01316523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93217166|NCT01316523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93217167|NCT01316523|Growth Substances|growth substances|mesh-ancestor
93217168|NCT01316523|Growth Inhibitors|growth inhibitors|mesh-ancestor
93217169|NCT02362906|Azithromycin|azithromycin|mesh-list
93217170|NCT02362906|Erythromycin|erythromycin|mesh-list
93217171|NCT02362906|Erythromycin Estolate|erythromycin estolate|mesh-list
93217172|NCT02362906|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93217173|NCT02362906|Erythromycin stearate|erythromycin stearate|mesh-list
93217174|NCT02362906|Cephalosporins|cephalosporins|mesh-list
93217175|NCT02362906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217176|NCT02362906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217177|NCT02362906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93217178|NCT02362906|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93217179|NCT02362906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217180|NCT02362906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217181|NCT04469530|Sirolimus|sirolimus|mesh-list
93217182|NCT04469530|Celecoxib|celecoxib|mesh-list
93217183|NCT04469530|Cyclophosphamide|cyclophosphamide|mesh-list
93217184|NCT04469530|Etoposide|etoposide|mesh-list
93217185|NCT04469530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217186|NCT04469530|Immunologic Factors|immunologic factors|mesh-ancestor
93217187|NCT04469530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217188|NCT04469530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217189|NCT04469530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93217190|NCT04469530|Alkylating Agents|alkylating agents|mesh-ancestor
93217191|NCT04469530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217192|NCT04469530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217193|NCT04469530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93217194|NCT04469530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93217195|NCT04469530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93217196|NCT04469530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93217197|NCT04469530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217198|NCT04469530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217199|NCT04469530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217200|NCT04469530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93217201|NCT04469530|Antifungal Agents|antifungal agents|mesh-ancestor
93217202|NCT04469530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93217203|NCT04469530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93217204|NCT04469530|Analgesics|analgesics|mesh-ancestor
93217205|NCT04469530|Sensory System Agents|sensory system agents|mesh-ancestor
93217206|NCT04469530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217207|NCT04469530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217208|NCT04469530|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93217209|NCT04469530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93217210|NCT03085914|Leucovorin|leucovorin|mesh-list
93217211|NCT03085914|Paclitaxel|paclitaxel|mesh-list
93217212|NCT03085914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93217213|NCT03085914|Cyclophosphamide|cyclophosphamide|mesh-list
93217214|NCT03085914|Carboplatin|carboplatin|mesh-list
93217215|NCT03085914|Gemcitabine|gemcitabine|mesh-list
93217216|NCT03085914|Pembrolizumab|pembrolizumab|mesh-list
93217217|NCT03085914|Fluorouracil|fluorouracil|mesh-list
93217218|NCT03085914|Oxaliplatin|oxaliplatin|mesh-list
93217219|NCT03085914|Pemetrexed|pemetrexed|mesh-list
93217220|NCT03085914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93217221|NCT03085914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217222|NCT03085914|Tubulin Modulators|tubulin modulators|mesh-ancestor
93217223|NCT03085914|Antimitotic Agents|antimitotic agents|mesh-ancestor
93217224|NCT03085914|Mitosis Modulators|mitosis modulators|mesh-ancestor
93217225|NCT03085914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217226|NCT03085914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217227|NCT03085914|Immunologic Factors|immunologic factors|mesh-ancestor
93217228|NCT03085914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217229|NCT03085914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217230|NCT03085914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93217231|NCT03085914|Alkylating Agents|alkylating agents|mesh-ancestor
93217232|NCT03085914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93217233|NCT03085914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217234|NCT03085914|Antimetabolites|antimetabolites|mesh-ancestor
93217235|NCT03085914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217236|NCT03085914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217237|NCT03085914|Antidotes|antidotes|mesh-ancestor
93217238|NCT03085914|Protective Agents|protective agents|mesh-ancestor
93217239|NCT03085914|Vitamin B Complex|vitamin b complex|mesh-ancestor
93217240|NCT03085914|Vitamins|vitamins|mesh-ancestor
93217241|NCT03085914|Micronutrients|micronutrients|mesh-ancestor
93217242|NCT03085914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217243|NCT03085914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93217244|NCT03085914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93217245|NCT02467608|Isoniazid|isoniazid|mesh-list
93217246|NCT02467608|Antitubercular Agents|antitubercular agents|mesh-ancestor
93217247|NCT02467608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217248|NCT02467608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217249|NCT02467608|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93217250|NCT02467608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93217251|NCT02467608|Antimetabolites|antimetabolites|mesh-ancestor
93217252|NCT02467608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217253|NCT02467608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93217254|NCT02368288|Entecavir|entecavir|mesh-list
93217255|NCT02368288|Antiviral Agents|antiviral agents|mesh-ancestor
93217256|NCT02368288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217257|NCT02357524|Oritavancin|oritavancin|mesh-list
93217258|NCT02357524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217259|NCT02357524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217260|NCT02368054|Epinephrine|epinephrine|mesh-list
93217261|NCT02368054|Racepinephrine|racepinephrine|mesh-list
93217262|NCT02368054|Bupivacaine|bupivacaine|mesh-list
93217263|NCT02368054|Epinephryl borate|epinephryl borate|mesh-list
93217264|NCT02368054|Anesthetics, Local|anesthetics, local|mesh-ancestor
93217265|NCT02368054|Anesthetics|anesthetics|mesh-ancestor
93217266|NCT02368054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217267|NCT02368054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217268|NCT02368054|Sensory System Agents|sensory system agents|mesh-ancestor
93217269|NCT02368054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217270|NCT02368054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93217271|NCT02368054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93217272|NCT02368054|Adrenergic Agents|adrenergic agents|mesh-ancestor
93217273|NCT02368054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217274|NCT02368054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217275|NCT02368054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93217276|NCT02368054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93217277|NCT02368054|Autonomic Agents|autonomic agents|mesh-ancestor
93217278|NCT02368054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93217279|NCT02368054|Respiratory System Agents|respiratory system agents|mesh-ancestor
93217280|NCT02368054|Mydriatics|mydriatics|mesh-ancestor
93217281|NCT02368054|Sympathomimetics|sympathomimetics|mesh-ancestor
93217282|NCT02368054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93217283|NCT02357602|Tenofovir|tenofovir|mesh-list
93217284|NCT02357602|Antiviral Agents|antiviral agents|mesh-ancestor
93217285|NCT02357602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217286|NCT02357602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93217287|NCT02357602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93217288|NCT02357602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217289|NCT02357602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217290|NCT02357602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217291|NCT02357602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217292|NCT01379196|Azithromycin|azithromycin|mesh-list
93217293|NCT01379196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92889331|NCT00714064|Antidotes|antidotes|mesh-ancestor
93217294|NCT01379196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217295|NCT01382238|Dolutegravir|dolutegravir|mesh-list
93217296|NCT01382238|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93217297|NCT01382238|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93217298|NCT01382238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217299|NCT01382238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217301|NCT01382238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217302|NCT01382238|Antiviral Agents|antiviral agents|mesh-ancestor
93217303|NCT01382238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217304|NCT03112564|Fentanyl|fentanyl|mesh-list
93217305|NCT03112564|Sevoflurane|sevoflurane|mesh-list
93217306|NCT03112564|Rocuronium|rocuronium|mesh-list
93217307|NCT03112564|Cisatracurium|cisatracurium|mesh-list
93217308|NCT03112564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93217309|NCT03112564|Narcotics|narcotics|mesh-ancestor
93217310|NCT03112564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217311|NCT03112564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217312|NCT03112564|Analgesics|analgesics|mesh-ancestor
93217313|NCT03112564|Sensory System Agents|sensory system agents|mesh-ancestor
93217314|NCT03112564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217315|NCT03112564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93217316|NCT03112564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93217317|NCT03112564|Anesthetics, General|anesthetics, general|mesh-ancestor
93217318|NCT03112564|Anesthetics|anesthetics|mesh-ancestor
93217319|NCT03112564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93217320|NCT03112564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93217321|NCT03112564|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93217322|NCT03112564|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93217323|NCT03112564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93217324|NCT01379976|Acetylcarnitine|acetylcarnitine|mesh-list
93217325|NCT01379976|Vitamin B Complex|vitamin b complex|mesh-ancestor
93217326|NCT01379976|Vitamins|vitamins|mesh-ancestor
93217327|NCT01379976|Micronutrients|micronutrients|mesh-ancestor
93217328|NCT01379976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217329|NCT01379976|Nootropic Agents|nootropic agents|mesh-ancestor
93217330|NCT01379898|Doxazosin|doxazosin|mesh-list
93217331|NCT01379898|Phenoxybenzamine|phenoxybenzamine|mesh-list
93217332|NCT01379898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93217333|NCT01379898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93217334|NCT01379898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93217335|NCT01379898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93217336|NCT01379898|Adrenergic Agents|adrenergic agents|mesh-ancestor
93217337|NCT01379898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217338|NCT01379898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217339|NCT01379898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217340|NCT01379898|Vasodilator Agents|vasodilator agents|mesh-ancestor
93217341|NCT02362516|BI 425809|bi 425809|mesh-list
93217342|NCT02362516|Nootropic Agents|nootropic agents|mesh-ancestor
93217343|NCT02367664|Vaccines|vaccines|mesh-list
93217344|NCT02367664|Immunologic Factors|immunologic factors|mesh-ancestor
93217345|NCT02367664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217346|NCT05421000|Anesthetics|anesthetics|mesh-list
93217347|NCT05421000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217348|NCT05421000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217349|NCT05419362|Avelumab|avelumab|mesh-list
93217350|NCT05419362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217351|NCT05419362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217352|NCT02357212|Adenosine|adenosine|mesh-list
93217353|NCT02357212|Analgesics|analgesics|mesh-ancestor
93217354|NCT02357212|Sensory System Agents|sensory system agents|mesh-ancestor
93217355|NCT02357212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217356|NCT02357212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217357|NCT02357212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93217358|NCT02357212|Vasodilator Agents|vasodilator agents|mesh-ancestor
93217359|NCT02357212|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93217360|NCT02357212|Purinergic Agonists|purinergic agonists|mesh-ancestor
93217361|NCT02357212|Purinergic Agents|purinergic agents|mesh-ancestor
93217362|NCT02357212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217363|NCT02357212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217364|NCT01382160|Adalimumab|adalimumab|mesh-list
93217365|NCT01382160|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93217366|NCT01382160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217367|NCT01382160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217368|NCT00735748|Tramadol|tramadol|mesh-list
93217369|NCT00735748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93217370|NCT00735748|Narcotics|narcotics|mesh-ancestor
93217371|NCT00735748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889403|NCT04137198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93217372|NCT00735748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217373|NCT00735748|Analgesics|analgesics|mesh-ancestor
93217374|NCT00735748|Sensory System Agents|sensory system agents|mesh-ancestor
93217375|NCT00735748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217376|NCT02367196|Rituximab|rituximab|mesh-list
93217377|NCT02367196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217378|NCT02367196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217379|NCT02367196|Immunologic Factors|immunologic factors|mesh-ancestor
93217380|NCT02367196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217381|NCT02367196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217382|NCT05418504|Anesthetics|anesthetics|mesh-list
93217383|NCT05418504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217384|NCT05418504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217385|NCT03408886|Vancomycin|vancomycin|mesh-list
93217386|NCT03408886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217387|NCT03408886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217388|NCT02361892|Ulipristal acetate|ulipristal acetate|mesh-list
93217389|NCT02361892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93217390|NCT02361892|Contraceptive Agents|contraceptive agents|mesh-ancestor
93217391|NCT02361892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93217392|NCT02361892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217393|NCT02361892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93217394|NCT04013334|Nivolumab|nivolumab|mesh-list
93217395|NCT04013334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217396|NCT04013334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217397|NCT04013334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217398|NCT04013334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217399|NCT02366884|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93217400|NCT02366884|Antifungal Agents|antifungal agents|mesh-list
93217401|NCT02366884|Clotrimazole|clotrimazole|mesh-list
93217402|NCT02366884|Miconazole|miconazole|mesh-list
93217403|NCT02366884|Antiprotozoal Agents|antiprotozoal agents|mesh-list
93217404|NCT02366884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217405|NCT02366884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93217406|NCT02366884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93217407|NCT02366884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93217408|NCT02366884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217409|NCT02366884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217410|NCT02366884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93217411|NCT02366884|Hormone Antagonists|hormone antagonists|mesh-ancestor
93217412|NCT02366884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217413|NCT02366884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217414|NCT02366884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93217415|NCT02366884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93217416|NCT02366884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93217417|NCT02361502|Mirabegron|mirabegron|mesh-list
93217418|NCT02361502|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93217419|NCT02361502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93217420|NCT02361502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93217421|NCT02361502|Adrenergic Agents|adrenergic agents|mesh-ancestor
93217422|NCT02361502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217423|NCT02361502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217424|NCT02361502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217425|NCT02361502|Urological Agents|urological agents|mesh-ancestor
93217426|NCT02367118|Prednisone|prednisone|mesh-list
93217427|NCT02367118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217428|NCT02367118|Glucocorticoids|glucocorticoids|mesh-ancestor
93217429|NCT02367118|Hormones|hormones|mesh-ancestor
93217430|NCT02367118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217431|NCT02367118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217432|NCT02367118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93217433|NCT02367118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217434|NCT00979212|Paclitaxel|paclitaxel|mesh-list
93217435|NCT00979212|Carboplatin|carboplatin|mesh-list
93217436|NCT00979212|Panitumumab|panitumumab|mesh-list
93217437|NCT00979212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93217438|NCT00979212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217439|NCT00979212|Tubulin Modulators|tubulin modulators|mesh-ancestor
93217440|NCT00979212|Antimitotic Agents|antimitotic agents|mesh-ancestor
93217441|NCT00979212|Mitosis Modulators|mitosis modulators|mesh-ancestor
93217442|NCT00979212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217443|NCT00979212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217444|NCT02361190|Methyltestosterone|methyltestosterone|mesh-list
93217445|NCT02361190|Testosterone|testosterone|mesh-list
93217446|NCT02361190|Testosterone undecanoate|testosterone undecanoate|mesh-list
93217447|NCT02361190|Testosterone enanthate|testosterone enanthate|mesh-list
93217448|NCT02361190|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93217449|NCT02361190|Androgens|androgens|mesh-ancestor
93217450|NCT02361190|Hormones|hormones|mesh-ancestor
93217451|NCT02361190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217452|NCT02361190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217453|NCT02361190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93217454|NCT02361190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217455|NCT02361190|Anabolic Agents|anabolic agents|mesh-ancestor
93217456|NCT02361112|Capecitabine|capecitabine|mesh-list
93217457|NCT02361112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217458|NCT02361112|Antimetabolites|antimetabolites|mesh-ancestor
93217459|NCT02361112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217460|NCT02361112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217461|NCT02360956|Olmesartan|olmesartan|mesh-list
93217462|NCT02360956|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93217463|NCT02360956|Antihypertensive Agents|antihypertensive agents|mesh-list
93217464|NCT02360956|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93217465|NCT02360956|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93217466|NCT02360956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217467|NCT02360800|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93217468|NCT02360800|Hemostatics|hemostatics|mesh-list
93217469|NCT02360800|Coagulants|coagulants|mesh-ancestor
93217470|NCT03501966|Acetazolamide|acetazolamide|mesh-list
93217471|NCT03501966|Diuretics|diuretics|mesh-list
93217472|NCT03501966|Natriuretic Agents|natriuretic agents|mesh-ancestor
93217473|NCT03501966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217474|NCT03501966|Anticonvulsants|anticonvulsants|mesh-ancestor
93217475|NCT03501966|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93217476|NCT03501966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217477|NCT03501966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217478|NCT02355184|Leronlimab|leronlimab|mesh-list
93217479|NCT02355184|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93217480|NCT02355184|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93217481|NCT02355184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217482|NCT02355184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217483|NCT02355184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217484|NCT02355184|Antiviral Agents|antiviral agents|mesh-ancestor
93217485|NCT02355184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217486|NCT03477630|Hyaluronic Acid|hyaluronic acid|mesh-list
93217487|NCT03477630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93217488|NCT03477630|Immunologic Factors|immunologic factors|mesh-ancestor
93217489|NCT03477630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217490|NCT03477630|Viscosupplements|viscosupplements|mesh-ancestor
93217491|NCT03477630|Protective Agents|protective agents|mesh-ancestor
93217492|NCT02981342|Gemcitabine|gemcitabine|mesh-list
93217493|NCT02981342|Capecitabine|capecitabine|mesh-list
93217494|NCT02981342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217495|NCT02981342|Antimetabolites|antimetabolites|mesh-ancestor
93217496|NCT02981342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217497|NCT02981342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217498|NCT02639026|Durvalumab|durvalumab|mesh-list
93217499|NCT02639026|Tremelimumab|tremelimumab|mesh-list
93217500|NCT02639026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217501|NCT02639026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217502|NCT02360644|Vitamin D|vitamin d|mesh-list
93217503|NCT02360644|Cholecalciferol|cholecalciferol|mesh-list
93217504|NCT02360644|Vitamins|vitamins|mesh-ancestor
93217505|NCT02360644|Micronutrients|micronutrients|mesh-ancestor
93217506|NCT02360644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217507|NCT02360644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93217508|NCT02360644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93217509|NCT02365948|Certolizumab Pegol|certolizumab pegol|mesh-list
93217510|NCT02365948|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93217511|NCT02365948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217512|NCT02365948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217513|NCT02365948|Immunologic Factors|immunologic factors|mesh-ancestor
93217514|NCT02365948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217515|NCT02365948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217516|NCT02354950|Cabotegravir|cabotegravir|mesh-list
93217517|NCT02354950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93217518|NCT02354950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93217519|NCT02354950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889558|NCT00726700|Prednisone|prednisone|mesh-list
93217520|NCT02354950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217521|NCT02354950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217522|NCT02354950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217523|NCT02354950|Antiviral Agents|antiviral agents|mesh-ancestor
93217524|NCT02354950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217525|NCT02980874|Triamcinolone|triamcinolone|mesh-list
93217526|NCT02980874|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93217527|NCT02980874|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93217528|NCT02980874|Aflibercept|aflibercept|mesh-list
93217529|NCT02980874|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93217530|NCT02980874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217531|NCT02980874|Glucocorticoids|glucocorticoids|mesh-ancestor
93217532|NCT02980874|Hormones|hormones|mesh-ancestor
93217533|NCT02980874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217534|NCT02980874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217535|NCT02980874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217536|NCT02980874|Immunologic Factors|immunologic factors|mesh-ancestor
93217537|NCT02980874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217538|NCT02980874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217539|NCT02980874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93217540|NCT02980874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93217541|NCT02980874|Growth Substances|growth substances|mesh-ancestor
93217542|NCT02980874|Growth Inhibitors|growth inhibitors|mesh-ancestor
93217543|NCT02980874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217544|NCT02354872|Nicotine|nicotine|mesh-list
93217545|NCT02354872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93217546|NCT02354872|Autonomic Agents|autonomic agents|mesh-ancestor
93217547|NCT02354872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217548|NCT02354872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217549|NCT02354872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93217550|NCT02354872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93217551|NCT02354872|Cholinergic Agents|cholinergic agents|mesh-ancestor
93217552|NCT02354872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217553|NCT02354872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217554|NCT02354638|Nicotine|nicotine|mesh-list
93217555|NCT02354638|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93217556|NCT02354638|Autonomic Agents|autonomic agents|mesh-ancestor
93217557|NCT02354638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217558|NCT02354638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217559|NCT02354638|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93217560|NCT02354638|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93217561|NCT02354638|Cholinergic Agents|cholinergic agents|mesh-ancestor
93217562|NCT02354638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217563|NCT02354638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217564|NCT02360254|Insulin|insulin|mesh-list
93217565|NCT02360254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93217566|NCT02360254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217567|NCT03112642|Anesthetics|anesthetics|mesh-list
93217568|NCT03112642|Bupivacaine|bupivacaine|mesh-list
93217569|NCT03112642|Anesthetics, Local|anesthetics, local|mesh-list
93217570|NCT03112642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217571|NCT03112642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217572|NCT03112642|Sensory System Agents|sensory system agents|mesh-ancestor
93217573|NCT03112642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217574|NCT01377324|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93217575|NCT01377324|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93217576|NCT01377324|Estradiol|estradiol|mesh-list
93217577|NCT01377324|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93217578|NCT01377324|Estrogens|estrogens|mesh-ancestor
93217579|NCT01377324|Hormones|hormones|mesh-ancestor
93217580|NCT01377324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217581|NCT01377324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217582|NCT01377324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93217583|NCT01377324|Contraceptive Agents|contraceptive agents|mesh-ancestor
93217584|NCT01377324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93217585|NCT01377324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93217586|NCT02359942|Citric Acid|citric acid|mesh-list
93217587|NCT02359942|Sodium Citrate|sodium citrate|mesh-list
93217588|NCT02359942|Anticoagulants|anticoagulants|mesh-ancestor
93217589|NCT02359942|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93217590|NCT02359942|Chelating Agents|chelating agents|mesh-ancestor
93217591|NCT02359942|Sequestering Agents|sequestering agents|mesh-ancestor
93217592|NCT02359942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217593|NCT02354560|Erythromycin|erythromycin|mesh-list
93217594|NCT02354560|Erythromycin Estolate|erythromycin estolate|mesh-list
93217595|NCT02354560|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92889638|NCT00675714|Sympatholytics|sympatholytics|mesh-ancestor
93217596|NCT02354560|Erythromycin stearate|erythromycin stearate|mesh-list
93217597|NCT02354560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93217598|NCT02354560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217599|NCT02354560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93217600|NCT02354560|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93217601|NCT02354560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217602|NCT02354560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217603|NCT01378884|Domperidone|domperidone|mesh-list
93217604|NCT01378884|Antiemetics|antiemetics|mesh-ancestor
93217605|NCT01378884|Autonomic Agents|autonomic agents|mesh-ancestor
93217606|NCT01378884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217607|NCT01378884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217608|NCT01378884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93217609|NCT01378884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93217610|NCT01378884|Dopamine Agents|dopamine agents|mesh-ancestor
93217611|NCT01378884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217612|NCT01378884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217613|NCT02039050|Tiotropium Bromide|tiotropium bromide|mesh-list
93217614|NCT02039050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93217615|NCT02039050|Autonomic Agents|autonomic agents|mesh-ancestor
93217616|NCT02039050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217617|NCT02039050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217618|NCT02039050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93217619|NCT02039050|Respiratory System Agents|respiratory system agents|mesh-ancestor
93217620|NCT02039050|Parasympatholytics|parasympatholytics|mesh-ancestor
93217621|NCT02039050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93217622|NCT02039050|Cholinergic Agents|cholinergic agents|mesh-ancestor
93217623|NCT02039050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217624|NCT02039050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217625|NCT05383482|Paclitaxel|paclitaxel|mesh-list
93217626|NCT05383482|Docetaxel|docetaxel|mesh-list
93217627|NCT05383482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93217628|NCT05383482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217629|NCT05383482|Tubulin Modulators|tubulin modulators|mesh-ancestor
93217630|NCT05383482|Antimitotic Agents|antimitotic agents|mesh-ancestor
93217631|NCT05383482|Mitosis Modulators|mitosis modulators|mesh-ancestor
93217632|NCT05383482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217633|NCT02354170|Mifepristone|mifepristone|mesh-list
93217634|NCT02354170|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93217635|NCT02354170|Abortifacient Agents|abortifacient agents|mesh-ancestor
93217636|NCT02354170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93217637|NCT02354170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217638|NCT02354170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93217639|NCT02354170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93217640|NCT02354170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93217641|NCT02354170|Contraceptive Agents|contraceptive agents|mesh-ancestor
93217642|NCT02354170|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93217643|NCT02354170|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93217644|NCT02354170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93217645|NCT02354170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217646|NCT02354170|Luteolytic Agents|luteolytic agents|mesh-ancestor
93217647|NCT02354170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93217648|NCT02354170|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93217649|NCT01377246|Octreotide|octreotide|mesh-list
93217650|NCT01377246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93217651|NCT01377246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93217652|NCT01377246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217653|NCT02353936|Afatinib|afatinib|mesh-list
93217654|NCT02353936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217655|NCT02353936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93217656|NCT02353936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217657|NCT02353936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217658|NCT02353858|Fluorouracil|fluorouracil|mesh-list
93217659|NCT02353858|Antimetabolites|antimetabolites|mesh-ancestor
93217660|NCT02353858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217661|NCT02353858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93217662|NCT02353858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217663|NCT02353858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93217664|NCT02353858|Immunologic Factors|immunologic factors|mesh-ancestor
93217665|NCT02353858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217666|NCT02353702|Ropivacaine|ropivacaine|mesh-list
93217667|NCT02353702|Anesthetics, Local|anesthetics, local|mesh-ancestor
93217668|NCT02353702|Anesthetics|anesthetics|mesh-ancestor
92889709|NCT02723669|Expectorants|expectorants|mesh-ancestor
93217669|NCT02353702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217670|NCT02353702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217671|NCT02353702|Sensory System Agents|sensory system agents|mesh-ancestor
93217672|NCT02353702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217674|NCT02532660|Citalopram|citalopram|mesh-list
93217675|NCT02532660|Escitalopram|escitalopram|mesh-list
93217676|NCT02532660|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93217677|NCT02532660|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93217678|NCT02532660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93217679|NCT02532660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217680|NCT02532660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217681|NCT02532660|Serotonin Agents|serotonin agents|mesh-ancestor
93217682|NCT02532660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217683|NCT02532660|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93217684|NCT02532660|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93217685|NCT02532660|Parasympatholytics|parasympatholytics|mesh-ancestor
93217686|NCT02532660|Autonomic Agents|autonomic agents|mesh-ancestor
93217687|NCT02532660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217688|NCT02532660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93217689|NCT02532660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93217690|NCT02532660|Cholinergic Agents|cholinergic agents|mesh-ancestor
93217691|NCT02532660|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93217692|NCT02532660|Antidepressive Agents|antidepressive agents|mesh-ancestor
93217693|NCT02532660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93217694|NCT01377168|Naltrexone|naltrexone|mesh-list
93217695|NCT01377168|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93217696|NCT01377168|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93217697|NCT01377168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217698|NCT01377168|Sensory System Agents|sensory system agents|mesh-ancestor
93217699|NCT01377168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217700|NCT02892149|Darbepoetin alfa|darbepoetin alfa|mesh-list
93217701|NCT02892149|Hematinics|hematinics|mesh-ancestor
93217702|NCT02348398|Topotecan|topotecan|mesh-list
93217703|NCT02348398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93217704|NCT02348398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93217705|NCT02348398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217706|NCT02348398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217707|NCT02348398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217708|NCT05278338|Denosumab|denosumab|mesh-list
93217709|NCT05278338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93217710|NCT05278338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217711|NCT03721757|Nivolumab|nivolumab|mesh-list
93217712|NCT03721757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217713|NCT03721757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217714|NCT03721757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217715|NCT03721757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217716|NCT03727607|Propofol|propofol|mesh-list
93217717|NCT03727607|Desflurane|desflurane|mesh-list
93217718|NCT03727607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93217719|NCT03727607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217720|NCT03727607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217721|NCT03727607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93217722|NCT03727607|Anesthetics, General|anesthetics, general|mesh-ancestor
93217723|NCT03727607|Anesthetics|anesthetics|mesh-ancestor
93217724|NCT03727607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93217725|NCT02348242|Lubricant Eye Drops|lubricant eye drops|mesh-list
93217726|NCT02348242|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93217727|NCT02348242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93217728|NCT03157804|Plerixafor|plerixafor|mesh-list
93217729|NCT03157804|Lenograstim|lenograstim|mesh-list
93217730|NCT03157804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93217731|NCT03157804|Immunologic Factors|immunologic factors|mesh-ancestor
93217732|NCT03157804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217733|NCT03157804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217734|NCT03157804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217735|NCT03157804|Antiviral Agents|antiviral agents|mesh-ancestor
93217736|NCT03157804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217737|NCT03157414|Empagliflozin|empagliflozin|mesh-list
93217738|NCT03157414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93217739|NCT03157414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217740|NCT03157414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93217741|NCT03157414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217742|NCT03147196|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93217743|NCT03147196|Bicalutamide|bicalutamide|mesh-list
93217745|NCT03147196|Hormone Antagonists|hormone antagonists|mesh-ancestor
93217746|NCT03147196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217747|NCT03147196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217748|NCT03147196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217749|NCT03147196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93217750|NCT03147196|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93217751|NCT03147196|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93217752|NCT03147196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93217753|NCT03153436|Inositol|inositol|mesh-list
93217754|NCT03153436|Vitamin B Complex|vitamin b complex|mesh-ancestor
93217755|NCT03153436|Vitamins|vitamins|mesh-ancestor
93217756|NCT03153436|Micronutrients|micronutrients|mesh-ancestor
93217757|NCT03153436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217758|NCT03544229|Maleic acid|maleic acid|mesh-list
93217759|NCT03544229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217760|NCT03544229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217761|NCT02351908|Tenofovir|tenofovir|mesh-list
93217762|NCT02351908|Raltegravir Potassium|raltegravir potassium|mesh-list
93217763|NCT02351908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93217764|NCT02351908|Dolutegravir|dolutegravir|mesh-list
93217765|NCT02351908|Cobicistat|cobicistat|mesh-list
93217766|NCT02351908|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93217767|NCT02351908|Elvitegravir|elvitegravir|mesh-list
93217768|NCT02351908|Antiviral Agents|antiviral agents|mesh-ancestor
93217769|NCT02351908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217770|NCT02351908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93217771|NCT02351908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93217772|NCT02351908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217773|NCT02351908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217774|NCT02351908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93217775|NCT02351908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93217776|NCT02351908|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93217777|NCT02351908|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93217778|NCT02351908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93217779|NCT02351908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93217780|NCT01371240|Secretin|secretin|mesh-list
93217781|NCT01371240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93217782|NCT01371240|Hormones|hormones|mesh-ancestor
93217783|NCT01371240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217784|NCT01371240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217785|NCT02352064|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93217786|NCT02352064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93217787|NCT02352064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217788|NCT03723941|Etoposide|etoposide|mesh-list
93217789|NCT03723941|Mitotane|mitotane|mesh-list
93217790|NCT03723941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217791|NCT03723941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93217792|NCT03723941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93217793|NCT03723941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93217794|NCT03723941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217795|NCT03723941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217796|NCT03723941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93217797|NCT03721679|Pembrolizumab|pembrolizumab|mesh-list
93217798|NCT03721679|Nivolumab|nivolumab|mesh-list
93217799|NCT03721679|Atezolizumab|atezolizumab|mesh-list
93217800|NCT03721679|Durvalumab|durvalumab|mesh-list
93217801|NCT03721679|Poly ICLC|poly iclc|mesh-list
93217802|NCT03721679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217803|NCT03721679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217804|NCT03721679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217805|NCT03721679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217806|NCT03721679|Interferon Inducers|interferon inducers|mesh-ancestor
93217807|NCT03721679|Immunologic Factors|immunologic factors|mesh-ancestor
93217808|NCT03721679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217809|NCT03639948|Carboplatin|carboplatin|mesh-list
93217810|NCT03639948|Docetaxel|docetaxel|mesh-list
93217811|NCT03639948|Pembrolizumab|pembrolizumab|mesh-list
93217812|NCT03639948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217813|NCT03639948|Tubulin Modulators|tubulin modulators|mesh-ancestor
93217814|NCT03639948|Antimitotic Agents|antimitotic agents|mesh-ancestor
93217815|NCT03639948|Mitosis Modulators|mitosis modulators|mesh-ancestor
93217816|NCT03639948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217817|NCT03639948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217818|NCT03639948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217820|NCT03968406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93217821|NCT03968406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217822|NCT03968406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217823|NCT03968406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217824|NCT03510455|Infigratinib|infigratinib|mesh-list
93217825|NCT03510455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217826|NCT03509675|Ibuprofen|ibuprofen|mesh-list
93217827|NCT03509675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93217828|NCT03509675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93217829|NCT03509675|Analgesics|analgesics|mesh-ancestor
93217830|NCT03509675|Sensory System Agents|sensory system agents|mesh-ancestor
93217831|NCT03509675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217832|NCT03509675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217833|NCT03509675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217834|NCT03509675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217835|NCT03509675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93217836|NCT03509675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217837|NCT03509675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217838|NCT02351752|Hydroxychloroquine|hydroxychloroquine|mesh-list
93217839|NCT02351752|Antimalarials|antimalarials|mesh-ancestor
93217840|NCT02351752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93217841|NCT02351752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93217842|NCT02351752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217843|NCT02351752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217844|NCT02351752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217845|NCT02351752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217846|NCT02353078|Sucralfate|sucralfate|mesh-list
93217847|NCT02353078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93217848|NCT02353078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93217849|NCT03509207|Vorinostat|vorinostat|mesh-list
93217850|NCT03509207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217851|NCT03509207|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93217852|NCT03509207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217853|NCT03509207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217854|NCT04808778|Hydroxyurea|hydroxyurea|mesh-list
93217855|NCT04808778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217856|NCT04808778|Antisickling Agents|antisickling agents|mesh-ancestor
93217857|NCT04808778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217858|NCT04808778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217859|NCT04808778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93217860|NCT03727295|Idebenone|idebenone|mesh-list
93217861|NCT03727295|Antioxidants|antioxidants|mesh-ancestor
93217862|NCT03727295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217863|NCT03727295|Protective Agents|protective agents|mesh-ancestor
93217864|NCT03727295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217865|NCT01378650|Cilostazol|cilostazol|mesh-list
93217866|NCT01378650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93217867|NCT01378650|Autonomic Agents|autonomic agents|mesh-ancestor
93217868|NCT01378650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217869|NCT01378650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217870|NCT01378650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93217871|NCT01378650|Respiratory System Agents|respiratory system agents|mesh-ancestor
93217872|NCT01378650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93217873|NCT01378650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93217874|NCT01378650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217875|NCT01378650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93217876|NCT01378650|Vasodilator Agents|vasodilator agents|mesh-ancestor
93217877|NCT01378650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93217878|NCT01378650|Protective Agents|protective agents|mesh-ancestor
93217879|NCT01378650|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93217880|NCT01378650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93217881|NCT01378650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217882|NCT04796922|Rituximab|rituximab|mesh-list
93217883|NCT04796922|Obinutuzumab|obinutuzumab|mesh-list
93217884|NCT04796922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217885|NCT04796922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217886|NCT04796922|Immunologic Factors|immunologic factors|mesh-ancestor
93217887|NCT04796922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217888|NCT04796922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217889|NCT03723785|Insulin|insulin|mesh-list
93217890|NCT03723785|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93217891|NCT03723785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93217892|NCT03723785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217893|NCT03543137|Nicotine|nicotine|mesh-list
93217894|NCT03543137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93217895|NCT03543137|Autonomic Agents|autonomic agents|mesh-ancestor
93217896|NCT03543137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217897|NCT03543137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217898|NCT03543137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93217899|NCT03543137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93217900|NCT03543137|Cholinergic Agents|cholinergic agents|mesh-ancestor
93217901|NCT03543137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217902|NCT03543137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217903|NCT03146650|Nivolumab|nivolumab|mesh-list
93217904|NCT03146650|Ipilimumab|ipilimumab|mesh-list
93217905|NCT03146650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217906|NCT03146650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217907|NCT03146650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217908|NCT03146650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217909|NCT02343484|Ethanol|ethanol|mesh-list
93217910|NCT02343484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93217911|NCT02343484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93217912|NCT02343484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217913|NCT02343484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217914|NCT03630042|Rituximab|rituximab|mesh-list
93217915|NCT03630042|Pembrolizumab|pembrolizumab|mesh-list
93217916|NCT03630042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93217917|NCT03630042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217918|NCT03630042|Immunologic Factors|immunologic factors|mesh-ancestor
93217919|NCT03630042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217920|NCT03630042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217921|NCT03630042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93217922|NCT03630042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217923|NCT03073980|Acetaminophen|acetaminophen|mesh-list
93217924|NCT03073980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93217925|NCT03073980|Analgesics|analgesics|mesh-ancestor
93217926|NCT03073980|Sensory System Agents|sensory system agents|mesh-ancestor
93217927|NCT03073980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217928|NCT03073980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217929|NCT03073980|Antipyretics|antipyretics|mesh-ancestor
93217930|NCT04117932|Ustekinumab|ustekinumab|mesh-list
93217931|NCT04117932|Dermatologic Agents|dermatologic agents|mesh-ancestor
93217932|NCT03930186|Apremilast|apremilast|mesh-list
93217933|NCT03930186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93217934|NCT03930186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93217935|NCT03930186|Analgesics|analgesics|mesh-ancestor
93217936|NCT03930186|Sensory System Agents|sensory system agents|mesh-ancestor
93217937|NCT03930186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217938|NCT03930186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217939|NCT03930186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93217940|NCT03930186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93217941|NCT03930186|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93217942|NCT03930186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93217943|NCT03930186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93217944|NCT03930186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217945|NCT02351440|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93217946|NCT02351440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93217947|NCT02351440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93217948|NCT02351440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93217949|NCT02351440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217950|NCT02351440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93217951|NCT02351440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217952|NCT02351440|Analgesics|analgesics|mesh-ancestor
93217953|NCT02351440|Sensory System Agents|sensory system agents|mesh-ancestor
93217954|NCT02351440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217955|NCT02351440|Antidepressive Agents|antidepressive agents|mesh-ancestor
93217956|NCT02351440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93217957|NCT02351440|Dopamine Agents|dopamine agents|mesh-ancestor
93217958|NCT03504917|Balovaptan|balovaptan|mesh-list
93217959|NCT03504917|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93217960|NCT03504917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217961|NCT03504917|Natriuretic Agents|natriuretic agents|mesh-ancestor
93217962|NCT03504917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217963|NCT02351128|Lanreotide|lanreotide|mesh-list
93217964|NCT02351128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93217965|NCT02343250|Valsartan|valsartan|mesh-list
93217966|NCT02343250|Cilnidipine|cilnidipine|mesh-list
93217967|NCT02343250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93217968|NCT02343250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93217969|NCT02343250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93217970|NCT02343250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217971|NCT02343250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93217972|NCT02343250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93217973|NCT02343250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93217974|NCT02343250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217975|NCT03781440|Lidocaine|lidocaine|mesh-list
93217976|NCT03781440|Anesthetics, Local|anesthetics, local|mesh-ancestor
93217977|NCT03781440|Anesthetics|anesthetics|mesh-ancestor
93217978|NCT03781440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93217979|NCT03781440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217980|NCT03781440|Sensory System Agents|sensory system agents|mesh-ancestor
93217981|NCT03781440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93217982|NCT03781440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93217983|NCT03781440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93217984|NCT03781440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93217985|NCT03781440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93217986|NCT03781440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93217987|NCT03565211|Progesterone|progesterone|mesh-list
93217988|NCT03565211|Progestins|progestins|mesh-ancestor
93217989|NCT03565211|Hormones|hormones|mesh-ancestor
93217990|NCT03565211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93217991|NCT03565211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93217992|NCT03723395|Repaglinide|repaglinide|mesh-list
93217993|NCT03723395|Tolbutamide|tolbutamide|mesh-list
93217994|NCT03723395|Itraconazole|itraconazole|mesh-list
93217995|NCT03723395|Rifampin|rifampin|mesh-list
93217996|NCT03723395|Tucatinib|tucatinib|mesh-list
93217997|NCT03723395|Digoxin|digoxin|mesh-list
93217998|NCT03723395|Midazolam|midazolam|mesh-list
93217999|NCT03723395|Gemfibrozil|gemfibrozil|mesh-list
93218000|NCT03723395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93218001|NCT03723395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93218002|NCT03723395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218003|NCT03723395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218004|NCT03723395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93218005|NCT03723395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93218006|NCT03723395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93218007|NCT03723395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93218008|NCT03723395|Anesthetics, General|anesthetics, general|mesh-ancestor
93218009|NCT03723395|Anesthetics|anesthetics|mesh-ancestor
93218010|NCT03723395|GABA Modulators|gaba modulators|mesh-ancestor
93218011|NCT03723395|GABA Agents|gaba agents|mesh-ancestor
93218012|NCT03723395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218013|NCT03723395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218014|NCT03723395|Antifungal Agents|antifungal agents|mesh-ancestor
93218015|NCT03723395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218016|NCT03723395|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93218017|NCT03723395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93218018|NCT03723395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218019|NCT03723395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93218020|NCT03723395|Hormone Antagonists|hormone antagonists|mesh-ancestor
93218021|NCT03723395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218022|NCT03723395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93218023|NCT03723395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93218024|NCT03723395|Antitubercular Agents|antitubercular agents|mesh-ancestor
93218025|NCT03723395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218026|NCT03723395|Leprostatic Agents|leprostatic agents|mesh-ancestor
93218027|NCT03723395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93218028|NCT03723395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93218029|NCT03723395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93218030|NCT03723395|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93218031|NCT03723395|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93218032|NCT03723395|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93218033|NCT03723395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93218034|NCT03723395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93218035|NCT03723395|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93218036|NCT03723395|Protective Agents|protective agents|mesh-ancestor
93218037|NCT03723395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93218038|NCT03723395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218039|NCT03723395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93218040|NCT03723395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93218041|NCT03723395|Antimetabolites|antimetabolites|mesh-ancestor
93218042|NCT03723395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93218043|NCT03723395|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93218044|NCT03531905|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93218045|NCT03531905|Ezetimibe|ezetimibe|mesh-list
93218046|NCT03531905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93218047|NCT03531905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93218048|NCT03531905|Antimetabolites|antimetabolites|mesh-ancestor
93218049|NCT03531905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218050|NCT03531905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93218051|NCT03531905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218052|NCT03531905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93218053|NCT03531905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218054|NCT02350426|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93218055|NCT02350426|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93218056|NCT02350426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218057|NCT02346682|Clonazepam|clonazepam|mesh-list
93218058|NCT02346682|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93218059|NCT02346682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93218060|NCT02346682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93218061|NCT02346682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218062|NCT02346682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218063|NCT02346682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218064|NCT02346682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218065|NCT02346682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93218066|NCT02346682|Antidepressive Agents|antidepressive agents|mesh-ancestor
93218067|NCT02346682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93218068|NCT02346682|Anticonvulsants|anticonvulsants|mesh-ancestor
93218069|NCT02346682|GABA Modulators|gaba modulators|mesh-ancestor
93218070|NCT02346682|GABA Agents|gaba agents|mesh-ancestor
93218071|NCT04300296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93218072|NCT04300296|Immunologic Factors|immunologic factors|mesh-ancestor
93218073|NCT04300296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218074|NCT05764590|Sevelamer|sevelamer|mesh-list
93218075|NCT05764590|Chelating Agents|chelating agents|mesh-ancestor
93218076|NCT05764590|Sequestering Agents|sequestering agents|mesh-ancestor
93218077|NCT05764590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218078|NCT05764512|Endorphins|endorphins|mesh-list
93218079|NCT05764512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218080|NCT05764512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218081|NCT05764512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218082|NCT02342392|Ranibizumab|ranibizumab|mesh-list
93218083|NCT02342392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93218084|NCT02342392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93218085|NCT02342392|Growth Substances|growth substances|mesh-ancestor
93218086|NCT02342392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218087|NCT02342392|Growth Inhibitors|growth inhibitors|mesh-ancestor
93218088|NCT02342392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218089|NCT02342002|Misoprostol|misoprostol|mesh-list
93218090|NCT02342002|Mifepristone|mifepristone|mesh-list
93218091|NCT02342002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93218092|NCT02342002|Abortifacient Agents|abortifacient agents|mesh-ancestor
93218093|NCT02342002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93218094|NCT02342002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218095|NCT02342002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93218096|NCT02342002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218097|NCT02342002|Oxytocics|oxytocics|mesh-ancestor
93218098|NCT02342002|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93218099|NCT02342002|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93218100|NCT02342002|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93218101|NCT02342002|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93218102|NCT02342002|Contraceptive Agents|contraceptive agents|mesh-ancestor
93218103|NCT02342002|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93218104|NCT02342002|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93218105|NCT02342002|Hormone Antagonists|hormone antagonists|mesh-ancestor
93218106|NCT02342002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218107|NCT02342002|Luteolytic Agents|luteolytic agents|mesh-ancestor
93218108|NCT02342002|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93218109|NCT02342002|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93218110|NCT03657264|Moxifloxacin|moxifloxacin|mesh-list
93218111|NCT03657264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218112|NCT03657264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218113|NCT03657264|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93218114|NCT03657264|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218115|NCT03657264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218116|NCT03657264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218117|NCT03657264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218118|NCT02345902|Haloperidol|haloperidol|mesh-list
93218119|NCT02345902|Haloperidol decanoate|haloperidol decanoate|mesh-list
93218120|NCT02345902|Antiemetics|antiemetics|mesh-ancestor
93218121|NCT02345902|Autonomic Agents|autonomic agents|mesh-ancestor
93218122|NCT02345902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218123|NCT02345902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218124|NCT02345902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218125|NCT02345902|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93218126|NCT02345902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93218127|NCT02345902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218128|NCT02345902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93218129|NCT02345902|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93218130|NCT02345902|Dopamine Agents|dopamine agents|mesh-ancestor
93218131|NCT02345902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218132|NCT02345902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218133|NCT02345902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93218134|NCT03601806|Thalidomide|thalidomide|mesh-list
93218135|NCT03601806|Pomalidomide|pomalidomide|mesh-list
93218136|NCT03601806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218137|NCT03601806|Immunologic Factors|immunologic factors|mesh-ancestor
93218138|NCT03601806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218139|NCT03601806|Leprostatic Agents|leprostatic agents|mesh-ancestor
93218140|NCT03601806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218141|NCT03601806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218142|NCT03601806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93218143|NCT03601806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93218144|NCT03601806|Growth Substances|growth substances|mesh-ancestor
93218145|NCT03601806|Growth Inhibitors|growth inhibitors|mesh-ancestor
93218146|NCT03601806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218147|NCT02345980|Sildenafil Citrate|sildenafil citrate|mesh-list
93218148|NCT02345980|Vasodilator Agents|vasodilator agents|mesh-ancestor
93218149|NCT02345980|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93218150|NCT02345980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93218151|NCT02345980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218152|NCT02345980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218153|NCT02345980|Urological Agents|urological agents|mesh-ancestor
93218154|NCT02345746|Leucovorin|leucovorin|mesh-list
93218155|NCT02345746|Folic Acid|folic acid|mesh-list
93218156|NCT02345746|Fluorouracil|fluorouracil|mesh-list
93218157|NCT02345746|Oxaliplatin|oxaliplatin|mesh-list
93218158|NCT02345746|Levoleucovorin|levoleucovorin|mesh-list
93218159|NCT02345746|Antimetabolites|antimetabolites|mesh-ancestor
93218160|NCT02345746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218161|NCT02345746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93218162|NCT02345746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218163|NCT02345746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218164|NCT02345746|Immunologic Factors|immunologic factors|mesh-ancestor
93218165|NCT02345746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218166|NCT02345746|Antidotes|antidotes|mesh-ancestor
93218167|NCT02345746|Protective Agents|protective agents|mesh-ancestor
93218168|NCT02345746|Vitamin B Complex|vitamin b complex|mesh-ancestor
93218169|NCT02345746|Vitamins|vitamins|mesh-ancestor
93218170|NCT02345746|Micronutrients|micronutrients|mesh-ancestor
93218171|NCT02345746|Hematinics|hematinics|mesh-ancestor
93218172|NCT03794778|Paclitaxel|paclitaxel|mesh-list
93218173|NCT03794778|Carboplatin|carboplatin|mesh-list
93218174|NCT03794778|Doxorubicin|doxorubicin|mesh-list
93218175|NCT03794778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93218176|NCT03794778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93218177|NCT03794778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218178|NCT03794778|Tubulin Modulators|tubulin modulators|mesh-ancestor
93218179|NCT03794778|Antimitotic Agents|antimitotic agents|mesh-ancestor
93218180|NCT03794778|Mitosis Modulators|mitosis modulators|mesh-ancestor
93218181|NCT03794778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218182|NCT03794778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93218183|NCT03794778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93218184|NCT03794778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218185|NCT03794778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218186|NCT02341300|Iron|iron|mesh-list
93218187|NCT02341300|Trace Elements|trace elements|mesh-ancestor
92890237|NCT04000789|Viscosupplements|viscosupplements|mesh-ancestor
93218188|NCT02341300|Micronutrients|micronutrients|mesh-ancestor
93218189|NCT02341300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218190|NCT05462496|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93218191|NCT05462496|Metronidazole|metronidazole|mesh-list
93218192|NCT05462496|Ciprofloxacin|ciprofloxacin|mesh-list
93218193|NCT05462496|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93218194|NCT05462496|Pembrolizumab|pembrolizumab|mesh-list
93218195|NCT05462496|Folfirinox|folfirinox|mesh-list
93218196|NCT05462496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218197|NCT05462496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218198|NCT05462496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93218199|NCT05462496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218200|NCT05462496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218201|NCT05462496|Antitubercular Agents|antitubercular agents|mesh-ancestor
93218202|NCT05462496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93218203|NCT05462496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93218204|NCT05462496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93218205|NCT05462496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218206|NCT05462496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218207|NCT05462496|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93218208|NCT05462496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93218209|NCT03785340|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93218210|NCT03785340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93218211|NCT03785340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93218212|NCT03785340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93218213|NCT03785340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93218214|NCT03785340|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218215|NCT03785340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218216|NCT03785340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218217|NCT03785340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218218|NCT02345590|Eplerenone|eplerenone|mesh-list
93218219|NCT02345590|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93218220|NCT02345590|Hormone Antagonists|hormone antagonists|mesh-ancestor
93218221|NCT02345590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218222|NCT02345590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218223|NCT02345590|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93218224|NCT02345590|Diuretics|diuretics|mesh-ancestor
93218225|NCT02345590|Natriuretic Agents|natriuretic agents|mesh-ancestor
93218226|NCT02345590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93218227|NCT03723083|Thalidomide|thalidomide|mesh-list
93218228|NCT03723083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218229|NCT03723083|Immunologic Factors|immunologic factors|mesh-ancestor
93218230|NCT03723083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218231|NCT03723083|Leprostatic Agents|leprostatic agents|mesh-ancestor
93218232|NCT03723083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218233|NCT03723083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218234|NCT03723083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93218235|NCT03723083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93218236|NCT03723083|Growth Substances|growth substances|mesh-ancestor
93218237|NCT03723083|Growth Inhibitors|growth inhibitors|mesh-ancestor
93218238|NCT03723083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218239|NCT03562481|Lidocaine|lidocaine|mesh-list
93218240|NCT03562481|Epinephrine|epinephrine|mesh-list
93218241|NCT03562481|Racepinephrine|racepinephrine|mesh-list
93218242|NCT03562481|Epinephryl borate|epinephryl borate|mesh-list
93218243|NCT03562481|Anesthetics, Local|anesthetics, local|mesh-ancestor
93218244|NCT03562481|Anesthetics|anesthetics|mesh-ancestor
93218245|NCT03562481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218246|NCT03562481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218247|NCT03562481|Sensory System Agents|sensory system agents|mesh-ancestor
93218248|NCT03562481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218249|NCT03562481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93218250|NCT03562481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93218251|NCT03562481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93218252|NCT03562481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218253|NCT03562481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218254|NCT03562481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93218255|NCT03562481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93218256|NCT03562481|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218257|NCT03562481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218258|NCT03562481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93218259|NCT03562481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93218260|NCT03562481|Autonomic Agents|autonomic agents|mesh-ancestor
93218261|NCT03562481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93218262|NCT03562481|Respiratory System Agents|respiratory system agents|mesh-ancestor
93218264|NCT03562481|Sympathomimetics|sympathomimetics|mesh-ancestor
93218265|NCT03562481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93218266|NCT03726593|Artesunate|artesunate|mesh-list
93218267|NCT03726593|Mefloquine|mefloquine|mesh-list
93218268|NCT03726593|Atovaquone|atovaquone|mesh-list
93218269|NCT03726593|Pyronaridine|pyronaridine|mesh-list
93218270|NCT03726593|Proguanil|proguanil|mesh-list
93218271|NCT03726593|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93218272|NCT03726593|Antimalarials|antimalarials|mesh-ancestor
93218273|NCT03726593|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93218274|NCT03726593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93218275|NCT03726593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218276|NCT03726593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218277|NCT03726593|Antiviral Agents|antiviral agents|mesh-ancestor
93218278|NCT03726593|Schistosomicides|schistosomicides|mesh-ancestor
93218279|NCT03726593|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93218280|NCT03726593|Anthelmintics|anthelmintics|mesh-ancestor
93218281|NCT03726593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218282|NCT03726593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218283|NCT03726593|Antimetabolites|antimetabolites|mesh-ancestor
93218284|NCT04007224|Oxytocin|oxytocin|mesh-list
93218285|NCT04007224|Oxytocics|oxytocics|mesh-ancestor
93218286|NCT04007224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93218287|NCT04007224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218288|NCT03197064|Fosaprepitant|fosaprepitant|mesh-list
93218289|NCT03197064|Aprepitant|aprepitant|mesh-list
93218290|NCT03197064|Antiemetics|antiemetics|mesh-ancestor
93218291|NCT03197064|Autonomic Agents|autonomic agents|mesh-ancestor
93218292|NCT03197064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218293|NCT03197064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218294|NCT03197064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218295|NCT03197064|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93218296|NCT03197064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218297|NCT03197064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218298|NCT02345044|Eplerenone|eplerenone|mesh-list
93218299|NCT02345044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93218300|NCT02345044|Hormone Antagonists|hormone antagonists|mesh-ancestor
93218301|NCT02345044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218302|NCT02345044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218303|NCT02345044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93218304|NCT02345044|Diuretics|diuretics|mesh-ancestor
93218305|NCT02345044|Natriuretic Agents|natriuretic agents|mesh-ancestor
93218306|NCT02345044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93218307|NCT02349802|Exenatide|exenatide|mesh-list
93218308|NCT02349802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93218309|NCT02349802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218310|NCT02349802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93218311|NCT02349802|Incretins|incretins|mesh-ancestor
93218312|NCT02349802|Hormones|hormones|mesh-ancestor
93218313|NCT02349802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218314|NCT03145714|Dexmedetomidine|dexmedetomidine|mesh-list
93218315|NCT03145714|Anesthetics|anesthetics|mesh-list
93218316|NCT03145714|Propofol|propofol|mesh-list
93218317|NCT03145714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218318|NCT03145714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218319|NCT03145714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93218320|NCT03145714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93218321|NCT03145714|Analgesics|analgesics|mesh-ancestor
93218322|NCT03145714|Sensory System Agents|sensory system agents|mesh-ancestor
93218323|NCT03145714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218324|NCT03145714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93218325|NCT03145714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93218326|NCT03145714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93218327|NCT03145714|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218328|NCT03145714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218329|NCT03145714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218330|NCT03145714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93218331|NCT03145714|Anesthetics, General|anesthetics, general|mesh-ancestor
93218332|NCT02349958|Doxorubicin|doxorubicin|mesh-list
93218333|NCT02349958|Cisplatin|cisplatin|mesh-list
93218334|NCT02349958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93218335|NCT02349958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218336|NCT02349958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93218337|NCT02349958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218338|NCT02349958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218339|NCT02349958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218341|NCT04872426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93218342|NCT04872426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218343|NCT02344888|Folic Acid|folic acid|mesh-list
93218344|NCT02344888|Vitamin B Complex|vitamin b complex|mesh-list
93218345|NCT02344888|Prednisolone|prednisolone|mesh-list
93218346|NCT02344888|Citric Acid|citric acid|mesh-list
93218347|NCT02344888|Sodium Citrate|sodium citrate|mesh-list
93218348|NCT02344888|Clomiphene|clomiphene|mesh-list
93218349|NCT02344888|Enclomiphene|enclomiphene|mesh-list
93218350|NCT02344888|Zuclomiphene|zuclomiphene|mesh-list
93218351|NCT02344888|Anticoagulants|anticoagulants|mesh-ancestor
93218352|NCT02344888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93218353|NCT02344888|Chelating Agents|chelating agents|mesh-ancestor
93218354|NCT02344888|Sequestering Agents|sequestering agents|mesh-ancestor
93218355|NCT02344888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218356|NCT02344888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218357|NCT02344888|Glucocorticoids|glucocorticoids|mesh-ancestor
93218358|NCT02344888|Hormones|hormones|mesh-ancestor
93218359|NCT02344888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218360|NCT02344888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218361|NCT02344888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93218362|NCT02344888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218363|NCT02344888|Hematinics|hematinics|mesh-ancestor
93218364|NCT02344888|Vitamins|vitamins|mesh-ancestor
93218365|NCT02344888|Micronutrients|micronutrients|mesh-ancestor
93218366|NCT02344888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93218367|NCT02344888|Hormone Antagonists|hormone antagonists|mesh-ancestor
93218368|NCT02344888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93218369|NCT02344888|Fertility Agents|fertility agents|mesh-ancestor
93218370|NCT02344888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93218371|NCT02344888|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93218372|NCT02344888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93218373|NCT03497429|Niraparib|niraparib|mesh-list
93218374|NCT03497429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93218375|NCT03497429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218376|NCT03497429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218377|NCT03497429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218378|NCT03146104|Propofol|propofol|mesh-list
93218379|NCT03146104|Isoflurane|isoflurane|mesh-list
93218380|NCT03146104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93218381|NCT03146104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218382|NCT03146104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218383|NCT03146104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93218384|NCT03146104|Anesthetics, General|anesthetics, general|mesh-ancestor
93218385|NCT03146104|Anesthetics|anesthetics|mesh-ancestor
93218386|NCT03146104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93218387|NCT03497039|Diclofenac|diclofenac|mesh-list
93218388|NCT03497039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93218389|NCT03497039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93218390|NCT03497039|Analgesics|analgesics|mesh-ancestor
93218391|NCT03497039|Sensory System Agents|sensory system agents|mesh-ancestor
93218392|NCT03497039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218393|NCT03497039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218394|NCT03497039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218395|NCT03497039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218396|NCT03497039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93218397|NCT03497039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218398|NCT03497039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218399|NCT02340910|Oxymetazoline|oxymetazoline|mesh-list
93218400|NCT02340910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93218401|NCT02340910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93218402|NCT02340910|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218403|NCT02340910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218404|NCT02340910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218405|NCT02340910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218406|NCT02340910|Sympathomimetics|sympathomimetics|mesh-ancestor
93218407|NCT02340910|Autonomic Agents|autonomic agents|mesh-ancestor
93218408|NCT02340910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218409|NCT02340910|Nasal Decongestants|nasal decongestants|mesh-ancestor
93218410|NCT02340910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93218411|NCT02340910|Respiratory System Agents|respiratory system agents|mesh-ancestor
93218412|NCT02349490|Hemostatics|hemostatics|mesh-list
93218413|NCT02349490|Coagulants|coagulants|mesh-ancestor
93218414|NCT03720899|Nicotine|nicotine|mesh-list
92890463|NCT00999505|Analgesics|analgesics|mesh-ancestor
93218415|NCT03720899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93218416|NCT03720899|Autonomic Agents|autonomic agents|mesh-ancestor
93218417|NCT03720899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218418|NCT03720899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218419|NCT03720899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93218420|NCT03720899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93218421|NCT03720899|Cholinergic Agents|cholinergic agents|mesh-ancestor
93218422|NCT03720899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218423|NCT03720899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218425|NCT02340988|Warfarin|warfarin|mesh-list
93218426|NCT02340988|Anticoagulants|anticoagulants|mesh-ancestor
93218427|NCT02340988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218428|NCT02340988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218429|NCT03145480|Obinutuzumab|obinutuzumab|mesh-list
93218430|NCT03145480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218431|NCT03145480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218432|NCT03726515|Pembrolizumab|pembrolizumab|mesh-list
93218433|NCT03726515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218434|NCT03726515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218435|NCT03726515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93218436|NCT03726515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218437|NCT05665283|Ensartinib|ensartinib|mesh-list
93218438|NCT05665283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218439|NCT05665283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93218440|NCT05665283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218441|NCT05665283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218442|NCT03071094|Nivolumab|nivolumab|mesh-list
93218443|NCT03071094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218444|NCT03071094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218445|NCT03071094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93218446|NCT03071094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218447|NCT03148990|Vaccines|vaccines|mesh-list
93218448|NCT03148990|Immunologic Factors|immunologic factors|mesh-ancestor
93218449|NCT03148990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218450|NCT04477642|Abatacept|abatacept|mesh-list
93218451|NCT04477642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93218452|NCT04477642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218453|NCT04477642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218454|NCT04477642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218455|NCT04477642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218456|NCT04477642|Immunologic Factors|immunologic factors|mesh-ancestor
93218457|NCT04477642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218458|NCT04477642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218459|NCT02344732|Polymyxins|polymyxins|mesh-list
93218460|NCT02344732|Neomycin|neomycin|mesh-list
93218461|NCT02344732|Polymyxin B|polymyxin b|mesh-list
93218462|NCT02344732|Dexamethasone|dexamethasone|mesh-list
93218463|NCT02344732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93218464|NCT02344732|Homatropine|homatropine|mesh-list
93218465|NCT02344732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218466|NCT02344732|Antiemetics|antiemetics|mesh-ancestor
93218467|NCT02344732|Autonomic Agents|autonomic agents|mesh-ancestor
93218468|NCT02344732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218469|NCT02344732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218470|NCT02344732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218471|NCT02344732|Glucocorticoids|glucocorticoids|mesh-ancestor
93218472|NCT02344732|Hormones|hormones|mesh-ancestor
93218473|NCT02344732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218474|NCT02344732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93218475|NCT02344732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218476|NCT02344732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93218477|NCT02344732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218478|NCT02344732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218479|NCT02344732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93218480|NCT02344732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218481|NCT02344732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218482|NCT02344732|Parasympatholytics|parasympatholytics|mesh-ancestor
93218483|NCT03720665|Caffeine|caffeine|mesh-list
93218484|NCT03720665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93218485|NCT03720665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218486|NCT03720665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93218487|NCT03720665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218488|NCT03720665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218489|NCT03720665|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93218490|NCT03720665|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93218491|NCT03720665|Purinergic Agents|purinergic agents|mesh-ancestor
93218492|NCT03720665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218493|NCT03726281|Nivolumab|nivolumab|mesh-list
93218494|NCT03726281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218495|NCT03726281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218496|NCT03726281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93218497|NCT03726281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218498|NCT02344264|Ropivacaine|ropivacaine|mesh-list
93218499|NCT02344264|Anesthetics, Local|anesthetics, local|mesh-ancestor
93218500|NCT02344264|Anesthetics|anesthetics|mesh-ancestor
93218501|NCT02344264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218502|NCT02344264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218503|NCT02344264|Sensory System Agents|sensory system agents|mesh-ancestor
93218504|NCT02344264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218505|NCT02344030|Pyrithione zinc|pyrithione zinc|mesh-list
93218506|NCT02344030|Keratolytic Agents|keratolytic agents|mesh-ancestor
93218507|NCT02344030|Dermatologic Agents|dermatologic agents|mesh-ancestor
93218508|NCT02339662|Gabapentin|gabapentin|mesh-list
93218509|NCT02339662|Amitriptyline|amitriptyline|mesh-list
93218510|NCT02339662|Analgesics|analgesics|mesh-ancestor
93218511|NCT02339662|Sensory System Agents|sensory system agents|mesh-ancestor
93218512|NCT02339662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218513|NCT02339662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218514|NCT02339662|Anticonvulsants|anticonvulsants|mesh-ancestor
93218515|NCT02339662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93218516|NCT02339662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93218517|NCT02339662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218518|NCT02339662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93218519|NCT02339662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93218520|NCT02339662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93218521|NCT02339662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218522|NCT02339662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218523|NCT02339662|Antimanic Agents|antimanic agents|mesh-ancestor
93218524|NCT02339662|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93218525|NCT02339662|Antidepressive Agents|antidepressive agents|mesh-ancestor
93218526|NCT02339662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93218527|NCT02339662|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93218528|NCT02339662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93218529|NCT02339662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218530|NCT02339662|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218531|NCT02343718|Sirolimus|sirolimus|mesh-list
93218532|NCT02343718|Temsirolimus|temsirolimus|mesh-list
93218533|NCT02343718|MTOR Inhibitors|mtor inhibitors|mesh-list
93218534|NCT02343718|Vinblastine|vinblastine|mesh-list
93218535|NCT02343718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93218536|NCT02343718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218537|NCT02343718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218538|NCT02343718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218539|NCT02343718|Immunologic Factors|immunologic factors|mesh-ancestor
93218540|NCT02343718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218541|NCT02343718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218542|NCT02343718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218543|NCT02343718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218544|NCT02343718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93218545|NCT02343718|Antifungal Agents|antifungal agents|mesh-ancestor
93218546|NCT02343718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93218547|NCT02343718|Tubulin Modulators|tubulin modulators|mesh-ancestor
93218548|NCT02343718|Antimitotic Agents|antimitotic agents|mesh-ancestor
93218549|NCT02343718|Mitosis Modulators|mitosis modulators|mesh-ancestor
93218550|NCT03148522|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93218551|NCT03148522|Mirtazapine|mirtazapine|mesh-list
93218552|NCT03148522|Escitalopram|escitalopram|mesh-list
93218553|NCT03148522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93218554|NCT03148522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93218555|NCT03148522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218556|NCT03148522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218557|NCT03148522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218558|NCT03148522|Serotonin Agents|serotonin agents|mesh-ancestor
93218559|NCT03148522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218560|NCT03148522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218561|NCT03148522|Antidepressive Agents|antidepressive agents|mesh-ancestor
92890615|NCT02620800|Vitamins|vitamins|mesh-ancestor
93218562|NCT03148522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93218563|NCT03148522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93218564|NCT03148522|Analgesics|analgesics|mesh-ancestor
93218565|NCT03148522|Sensory System Agents|sensory system agents|mesh-ancestor
93218566|NCT03148522|Dopamine Agents|dopamine agents|mesh-ancestor
93218567|NCT03148522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93218568|NCT03148522|Histamine Antagonists|histamine antagonists|mesh-ancestor
93218569|NCT03148522|Histamine Agents|histamine agents|mesh-ancestor
93218570|NCT03148522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93218571|NCT03148522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93218572|NCT03148522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218573|NCT03148522|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93218574|NCT03148522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93218575|NCT03148522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93218576|NCT03148522|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218577|NCT03148522|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93218578|NCT03148522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93218579|NCT03148522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93218580|NCT03148444|Cephalexin|cephalexin|mesh-list
93218581|NCT03148444|Roxithromycin|roxithromycin|mesh-list
93218582|NCT03148444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218583|NCT03148444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218584|NCT03148132|Bevacizumab|bevacizumab|mesh-list
93218585|NCT03148132|Ranibizumab|ranibizumab|mesh-list
93218586|NCT03148132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218587|NCT03148132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218588|NCT03148132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93218589|NCT03148132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93218590|NCT03148132|Growth Substances|growth substances|mesh-ancestor
93218591|NCT03148132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218592|NCT03148132|Growth Inhibitors|growth inhibitors|mesh-ancestor
93218593|NCT02339350|Methotrexate|methotrexate|mesh-list
93218594|NCT02339350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93218595|NCT02339350|Abortifacient Agents|abortifacient agents|mesh-ancestor
93218596|NCT02339350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93218597|NCT02339350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218598|NCT02339350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93218599|NCT02339350|Antimetabolites|antimetabolites|mesh-ancestor
93218600|NCT02339350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218601|NCT02339350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218602|NCT02339350|Dermatologic Agents|dermatologic agents|mesh-ancestor
93218603|NCT02339350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218604|NCT02339350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93218605|NCT02339350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218606|NCT02339350|Immunologic Factors|immunologic factors|mesh-ancestor
93218607|NCT02339350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218608|NCT02339350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93218609|NCT05166304|Rebamipide|rebamipide|mesh-list
93218610|NCT05166304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93218611|NCT05166304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218612|NCT05166304|Antioxidants|antioxidants|mesh-ancestor
93218613|NCT05166304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218614|NCT05166304|Protective Agents|protective agents|mesh-ancestor
93218615|NCT05166304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218616|NCT05166304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218617|NCT02339428|Diclofenac|diclofenac|mesh-list
93218618|NCT02339428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93218619|NCT02339428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93218620|NCT02339428|Analgesics|analgesics|mesh-ancestor
93218621|NCT02339428|Sensory System Agents|sensory system agents|mesh-ancestor
93218622|NCT02339428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218623|NCT02339428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218624|NCT02339428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218625|NCT02339428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218626|NCT02339428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93218627|NCT02339428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218628|NCT02339428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218629|NCT02337322|Ritonavir|ritonavir|mesh-list
93218630|NCT02337322|Darunavir|darunavir|mesh-list
93218631|NCT02337322|Dolutegravir|dolutegravir|mesh-list
93218632|NCT02337322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93218633|NCT02337322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93218634|NCT02337322|Protease Inhibitors|protease inhibitors|mesh-ancestor
93218635|NCT02337322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218636|NCT02337322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218637|NCT02337322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93218638|NCT02337322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93218639|NCT02337322|Antiviral Agents|antiviral agents|mesh-ancestor
93218640|NCT02337322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218641|NCT02337322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93218642|NCT02337322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93218643|NCT02337322|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93218644|NCT02337322|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93218645|NCT02337166|Hyaluronic Acid|hyaluronic acid|mesh-list
93218646|NCT02337166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93218647|NCT02337166|Immunologic Factors|immunologic factors|mesh-ancestor
93218648|NCT02337166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218649|NCT02337166|Viscosupplements|viscosupplements|mesh-ancestor
93218650|NCT02337166|Protective Agents|protective agents|mesh-ancestor
93218651|NCT03148288|Vitamin D|vitamin d|mesh-list
93218652|NCT03148288|Vitamins|vitamins|mesh-ancestor
93218653|NCT03148288|Micronutrients|micronutrients|mesh-ancestor
93218654|NCT03148288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218655|NCT03148288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93218656|NCT02039362|Tenofovir|tenofovir|mesh-list
93218657|NCT02039362|Antiviral Agents|antiviral agents|mesh-ancestor
93218658|NCT02039362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218659|NCT02039362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93218660|NCT02039362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93218661|NCT02039362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218662|NCT02039362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218663|NCT02039362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93218664|NCT02039362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93218665|NCT02339116|Bevacizumab|bevacizumab|mesh-list
93218666|NCT02339116|Oxaliplatin|oxaliplatin|mesh-list
93218667|NCT02339116|Irinotecan|irinotecan|mesh-list
93218668|NCT02339116|Fluorouracil|fluorouracil|mesh-list
93218669|NCT02339116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218670|NCT02339116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218671|NCT02339116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93218672|NCT02339116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93218673|NCT02339116|Growth Substances|growth substances|mesh-ancestor
93218674|NCT02339116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218675|NCT02339116|Growth Inhibitors|growth inhibitors|mesh-ancestor
93218676|NCT02339116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93218677|NCT02339116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218678|NCT02339116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218679|NCT02339116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218680|NCT02339116|Antimetabolites|antimetabolites|mesh-ancestor
93218681|NCT02339116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93218682|NCT02339116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218683|NCT02339116|Immunologic Factors|immunologic factors|mesh-ancestor
93218684|NCT04824274|Fentanyl|fentanyl|mesh-list
93218685|NCT04824274|Morphine|morphine|mesh-list
93218686|NCT04824274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93218687|NCT04824274|Narcotics|narcotics|mesh-ancestor
93218688|NCT04824274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218689|NCT04824274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218690|NCT04824274|Analgesics|analgesics|mesh-ancestor
93218691|NCT04824274|Sensory System Agents|sensory system agents|mesh-ancestor
93218692|NCT04824274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218693|NCT04824274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93218694|NCT04824274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93218695|NCT04824274|Anesthetics, General|anesthetics, general|mesh-ancestor
93218696|NCT04824274|Anesthetics|anesthetics|mesh-ancestor
93218697|NCT02509494|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93218698|NCT02509494|Antiviral Agents|antiviral agents|mesh-ancestor
93218699|NCT02509494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218700|NCT02348788|Lumefantrine|lumefantrine|mesh-list
93218701|NCT02348788|Chloroquine|chloroquine|mesh-list
93218702|NCT02348788|Artemether|artemether|mesh-list
93218703|NCT02348788|Primaquine|primaquine|mesh-list
93218704|NCT02348788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93218705|NCT02348788|Antimalarials|antimalarials|mesh-ancestor
93218706|NCT02348788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93218707|NCT02348788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93218708|NCT02348788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514629|NCT00016198|Leucovorin|leucovorin|mesh-list
93218709|NCT02348788|Amebicides|amebicides|mesh-ancestor
93218710|NCT02348788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218711|NCT02337010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93218712|NCT02338570|Everolimus|everolimus|mesh-list
93218713|NCT02338570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93218714|NCT02338570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93218715|NCT02338570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218716|NCT02338570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218717|NCT02338570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218718|NCT02338570|Immunologic Factors|immunologic factors|mesh-ancestor
93218719|NCT02338570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218720|NCT02338570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218722|NCT02336854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218723|NCT02336854|Immunologic Factors|immunologic factors|mesh-ancestor
93218724|NCT02336854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218725|NCT02336854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93218726|NCT02336854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218727|NCT02336854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218728|NCT02338024|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93218729|NCT02338024|Antiviral Agents|antiviral agents|mesh-ancestor
93218730|NCT02338024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218731|NCT02332174|Rufinamide|rufinamide|mesh-list
93218732|NCT02332174|Anticonvulsants|anticonvulsants|mesh-ancestor
93218733|NCT02332174|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93218734|NCT02332174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93218735|NCT02332174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218736|NCT02332174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218737|NCT03493451|Tislelizumab|tislelizumab|mesh-list
93218738|NCT03493451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218739|NCT03493451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218740|NCT03726125|Insulin|insulin|mesh-list
93218741|NCT03726125|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93218742|NCT03726125|Insulin, Long-Acting|insulin, long-acting|mesh-list
93218743|NCT03726125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93218744|NCT03726125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218745|NCT02336308|Ketamine|ketamine|mesh-list
93218746|NCT02336308|Analgesics|analgesics|mesh-ancestor
93218747|NCT02336308|Sensory System Agents|sensory system agents|mesh-ancestor
93218748|NCT02336308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218749|NCT02336308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218750|NCT02336308|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93218751|NCT02336308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93218752|NCT02336308|Anesthetics, General|anesthetics, general|mesh-ancestor
93218753|NCT02336308|Anesthetics|anesthetics|mesh-ancestor
93218754|NCT02336308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218755|NCT02336308|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93218756|NCT02336308|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93218757|NCT02336308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218758|NCT02336308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218759|NCT02336386|Dexamethasone|dexamethasone|mesh-list
93218760|NCT02336386|Cyclophosphamide|cyclophosphamide|mesh-list
93218761|NCT02336386|Doxorubicin|doxorubicin|mesh-list
93218762|NCT02336386|Bortezomib|bortezomib|mesh-list
93218763|NCT02336386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218764|NCT02336386|Immunologic Factors|immunologic factors|mesh-ancestor
93218765|NCT02336386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218766|NCT02336386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218767|NCT02336386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93218768|NCT02336386|Alkylating Agents|alkylating agents|mesh-ancestor
93218769|NCT02336386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218770|NCT02336386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218771|NCT02336386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93218772|NCT02336386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218773|NCT02336386|Antiemetics|antiemetics|mesh-ancestor
93218774|NCT02336386|Autonomic Agents|autonomic agents|mesh-ancestor
93218775|NCT02336386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218776|NCT02336386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218777|NCT02336386|Glucocorticoids|glucocorticoids|mesh-ancestor
93218778|NCT02336386|Hormones|hormones|mesh-ancestor
93218779|NCT02336386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218780|NCT02336386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93218781|NCT02336386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218782|NCT02336386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93218783|NCT02336386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93218784|NCT02336386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218785|NCT02337712|Etoposide|etoposide|mesh-list
93218786|NCT02337712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218787|NCT02337712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93218788|NCT02337712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93218789|NCT02337712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93218790|NCT02337712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218791|NCT02337712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218792|NCT03492281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93218793|NCT03492281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93218794|NCT03492281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93218795|NCT03492281|Cholinergic Agents|cholinergic agents|mesh-ancestor
93218796|NCT03492281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218797|NCT03492281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218798|NCT03492281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218799|NCT03492281|Urological Agents|urological agents|mesh-ancestor
93218800|NCT02336152|Anesthetics|anesthetics|mesh-list
93218801|NCT02336152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218802|NCT02336152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218803|NCT02331862|Methylprednisolone|methylprednisolone|mesh-list
93218804|NCT02331862|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93218805|NCT02331862|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93218806|NCT02331862|Prednisolone|prednisolone|mesh-list
93218807|NCT02331862|Prednisolone acetate|prednisolone acetate|mesh-list
93218808|NCT02331862|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93218809|NCT02331862|Prednisolone phosphate|prednisolone phosphate|mesh-list
93218810|NCT02331862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218811|NCT02331862|Antiemetics|antiemetics|mesh-ancestor
93218812|NCT02331862|Autonomic Agents|autonomic agents|mesh-ancestor
93218813|NCT02331862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218814|NCT02331862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218815|NCT02331862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218816|NCT02331862|Glucocorticoids|glucocorticoids|mesh-ancestor
93218818|NCT02331862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218819|NCT02331862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93218820|NCT02331862|Protective Agents|protective agents|mesh-ancestor
93218821|NCT02331862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93218822|NCT02331862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218823|NCT03525119|Vaccines|vaccines|mesh-list
93218824|NCT03525119|Immunologic Factors|immunologic factors|mesh-ancestor
93218825|NCT03525119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218826|NCT05230654|Fosaprepitant|fosaprepitant|mesh-list
93218827|NCT05230654|Aprepitant|aprepitant|mesh-list
93218828|NCT05230654|Antiemetics|antiemetics|mesh-ancestor
93218829|NCT05230654|Autonomic Agents|autonomic agents|mesh-ancestor
93218830|NCT05230654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218831|NCT05230654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218832|NCT05230654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218833|NCT05230654|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93218834|NCT05230654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218835|NCT05230654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218836|NCT02039518|Gemcitabine|gemcitabine|mesh-list
93218837|NCT02039518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93218838|NCT02039518|Antimetabolites|antimetabolites|mesh-ancestor
93218839|NCT02039518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218840|NCT02039518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218841|NCT03722381|Amlodipine|amlodipine|mesh-list
93218842|NCT03722381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93218843|NCT03722381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93218844|NCT03722381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218845|NCT03722381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218846|NCT03722381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93218847|NCT03722381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218848|NCT03722381|Vasodilator Agents|vasodilator agents|mesh-ancestor
93218849|NCT04352608|Vaccines|vaccines|mesh-list
93218850|NCT04352608|Immunologic Factors|immunologic factors|mesh-ancestor
93218851|NCT04352608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218852|NCT03722303|Cortisone|cortisone|mesh-list
93218853|NCT03722303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218854|NCT03558503|Mitomycins|mitomycins|mesh-list
93218855|NCT03558503|Mitomycin|mitomycin|mesh-list
93218856|NCT03558503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93218857|NCT03558503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218858|NCT03558503|Alkylating Agents|alkylating agents|mesh-ancestor
91929079|NCT04471441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218859|NCT03558503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218860|NCT03558503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93218861|NCT03558503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890919|NCT02714699|Anticonvulsants|anticonvulsants|mesh-ancestor
93218863|NCT02331706|Interferon-alpha|interferon-alpha|mesh-list
93218864|NCT02331706|Interferon alpha-2|interferon alpha-2|mesh-list
93218865|NCT02331706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218866|NCT02331706|Antiviral Agents|antiviral agents|mesh-ancestor
93218867|NCT02331706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218868|NCT02331706|Immunologic Factors|immunologic factors|mesh-ancestor
93218869|NCT02331706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218870|NCT04400838|Vaccines|vaccines|mesh-list
93218871|NCT04400838|Immunologic Factors|immunologic factors|mesh-ancestor
93218872|NCT04400838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218873|NCT03489863|Ticagrelor|ticagrelor|mesh-list
93218874|NCT03489863|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93218875|NCT03489863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93218876|NCT03489863|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93218877|NCT03489863|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93218878|NCT03489863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93218879|NCT03489863|Purinergic Agents|purinergic agents|mesh-ancestor
93218880|NCT03489863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218881|NCT03489863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218882|NCT03489863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218883|NCT04344444|Azithromycin|azithromycin|mesh-list
93218884|NCT04344444|Hydroxychloroquine|hydroxychloroquine|mesh-list
93218885|NCT04344444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218886|NCT04344444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218887|NCT04344444|Antimalarials|antimalarials|mesh-ancestor
93218888|NCT04344444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93218889|NCT04344444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93218890|NCT04344444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218891|NCT04344444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218892|NCT04344444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93218893|NCT03489551|Haloperidol|haloperidol|mesh-list
93218894|NCT03489551|Antiemetics|antiemetics|mesh-ancestor
93218895|NCT03489551|Autonomic Agents|autonomic agents|mesh-ancestor
93218896|NCT03489551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218897|NCT03489551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218898|NCT03489551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218899|NCT03489551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93218900|NCT03489551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93218901|NCT03489551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93218902|NCT03489551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93218903|NCT03489551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93218904|NCT03489551|Dopamine Agents|dopamine agents|mesh-ancestor
93218905|NCT03489551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218906|NCT03489551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218907|NCT03489551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93218908|NCT05762952|Dapagliflozin|dapagliflozin|mesh-list
93218909|NCT05762952|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93218910|NCT05762952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218911|NCT05762952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93218912|NCT05762952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218913|NCT02335684|Methamphetamine|methamphetamine|mesh-list
93218914|NCT02335684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93218915|NCT02335684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218916|NCT02335684|Sympathomimetics|sympathomimetics|mesh-ancestor
93218917|NCT02335684|Autonomic Agents|autonomic agents|mesh-ancestor
93218918|NCT02335684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218919|NCT02335684|Dopamine Agents|dopamine agents|mesh-ancestor
93218920|NCT02335684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218921|NCT02335684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218922|NCT02335684|Adrenergic Agents|adrenergic agents|mesh-ancestor
93218923|NCT02335684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93218924|NCT02335684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93218925|NCT02335684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218926|NCT02335684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93218927|NCT05198388|Endorphins|endorphins|mesh-list
93218928|NCT05198388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218929|NCT05198388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218930|NCT05198388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218931|NCT04210180|Varenicline|varenicline|mesh-list
93218932|NCT04210180|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93218933|NCT04210180|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93218934|NCT04210180|Cholinergic Agents|cholinergic agents|mesh-ancestor
93218935|NCT04210180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218936|NCT04210180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218937|NCT04210180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218938|NCT03523715|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
93218939|NCT03523715|Antidiarrheals|antidiarrheals|mesh-ancestor
93218940|NCT03523715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93218941|NCT03523091|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93218942|NCT03523091|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93218943|NCT03523091|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93218944|NCT03523091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93218945|NCT03523091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218946|NCT03523091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93218947|NCT03523091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93218948|NCT03523091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218949|NCT03523091|Cholinergic Agents|cholinergic agents|mesh-ancestor
93218950|NCT03523091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93218951|NCT03105310|Interferons|interferons|mesh-list
93218952|NCT03105310|Interferon-alpha|interferon-alpha|mesh-list
93218953|NCT03105310|Ezetimibe|ezetimibe|mesh-list
93218954|NCT03105310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218955|NCT03105310|Antiviral Agents|antiviral agents|mesh-ancestor
93218956|NCT03105310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218957|NCT03105310|Immunologic Factors|immunologic factors|mesh-ancestor
93218958|NCT03105310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218959|NCT03105310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93218960|NCT03105310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93218961|NCT03105310|Antimetabolites|antimetabolites|mesh-ancestor
93218962|NCT03105310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218963|NCT03105310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93218964|NCT03144466|Pembrolizumab|pembrolizumab|mesh-list
93218965|NCT03144466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93218966|NCT03144466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218967|NCT03144466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93218968|NCT03144466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218969|NCT03105466|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93218970|NCT03105466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93218971|NCT03105466|Tacrolimus|tacrolimus|mesh-list
93218972|NCT03105466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93218973|NCT03105466|Immunologic Factors|immunologic factors|mesh-ancestor
93218974|NCT03105466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218975|NCT03105466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93218976|NCT03105466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93218977|NCT03105466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93218978|NCT03105466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93218979|NCT03105466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93218980|NCT03105466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218981|NCT03105466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218982|NCT03105466|Glucocorticoids|glucocorticoids|mesh-ancestor
93218983|NCT03105466|Hormones|hormones|mesh-ancestor
93218984|NCT03105466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93218985|NCT02335372|Acetic Acid|acetic acid|mesh-list
93218986|NCT02335372|Proflavine|proflavine|mesh-list
93218987|NCT02335372|Retinol acetate|retinol acetate|mesh-list
93218988|NCT02335372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93218989|NCT02335372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93218990|NCT02335372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93218991|NCT02335372|Immunologic Factors|immunologic factors|mesh-ancestor
93218992|NCT02335372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93218993|NCT02335372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93218994|NCT02335372|Protective Agents|protective agents|mesh-ancestor
93218995|NCT02335372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93218996|NCT02335372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93218997|NCT03488225|Calcium, Dietary|calcium, dietary|mesh-list
93218998|NCT03488225|Leucovorin|leucovorin|mesh-list
93218999|NCT03488225|Folic Acid|folic acid|mesh-list
93219000|NCT03488225|Cytarabine|cytarabine|mesh-list
93219001|NCT03488225|Dexamethasone|dexamethasone|mesh-list
93219002|NCT03488225|Prednisone|prednisone|mesh-list
93219003|NCT03488225|Dexamethasone acetate|dexamethasone acetate|mesh-list
93219004|NCT03488225|Cortisone|cortisone|mesh-list
93219005|NCT03488225|Cyclophosphamide|cyclophosphamide|mesh-list
93219006|NCT03488225|Rituximab|rituximab|mesh-list
93219007|NCT03488225|Doxorubicin|doxorubicin|mesh-list
93219008|NCT03488225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93219009|NCT03488225|Methotrexate|methotrexate|mesh-list
93219010|NCT03488225|Vincristine|vincristine|mesh-list
93219011|NCT03488225|Mercaptopurine|mercaptopurine|mesh-list
93219012|NCT03488225|Ofatumumab|ofatumumab|mesh-list
93219013|NCT03488225|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93219014|NCT03488225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93219016|NCT03488225|Immunoglobulins|immunoglobulins|mesh-list
93219017|NCT03488225|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93219018|NCT03488225|BB 1101|bb 1101|mesh-list
93219019|NCT03488225|Calcium|calcium|mesh-list
93219020|NCT03488225|Levoleucovorin|levoleucovorin|mesh-list
93219021|NCT03488225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219022|NCT03488225|Immunologic Factors|immunologic factors|mesh-ancestor
93219023|NCT03488225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219024|NCT03488225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219025|NCT03488225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93219026|NCT03488225|Alkylating Agents|alkylating agents|mesh-ancestor
93219027|NCT03488225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219028|NCT03488225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219029|NCT03488225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93219030|NCT03488225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219031|NCT03488225|Antiemetics|antiemetics|mesh-ancestor
93219032|NCT03488225|Autonomic Agents|autonomic agents|mesh-ancestor
93219033|NCT03488225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219034|NCT03488225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219035|NCT03488225|Glucocorticoids|glucocorticoids|mesh-ancestor
93219036|NCT03488225|Hormones|hormones|mesh-ancestor
93219037|NCT03488225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219038|NCT03488225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93219039|NCT03488225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93219040|NCT03488225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93219041|NCT03488225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93219042|NCT03488225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219043|NCT03488225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93219044|NCT03488225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93219045|NCT03488225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93219046|NCT03488225|Abortifacient Agents|abortifacient agents|mesh-ancestor
93219047|NCT03488225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93219048|NCT03488225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93219049|NCT03488225|Antimetabolites|antimetabolites|mesh-ancestor
93219050|NCT03488225|Dermatologic Agents|dermatologic agents|mesh-ancestor
93219051|NCT03488225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93219052|NCT03488225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93219053|NCT03488225|Antiviral Agents|antiviral agents|mesh-ancestor
93219054|NCT03488225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219055|NCT03488225|Antidotes|antidotes|mesh-ancestor
93219056|NCT03488225|Protective Agents|protective agents|mesh-ancestor
93219057|NCT03488225|Vitamin B Complex|vitamin b complex|mesh-ancestor
93219058|NCT03488225|Vitamins|vitamins|mesh-ancestor
93219059|NCT03488225|Micronutrients|micronutrients|mesh-ancestor
93219060|NCT03488225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93219061|NCT03488225|Tubulin Modulators|tubulin modulators|mesh-ancestor
93219062|NCT03488225|Antimitotic Agents|antimitotic agents|mesh-ancestor
93219063|NCT03488225|Mitosis Modulators|mitosis modulators|mesh-ancestor
93219064|NCT03488225|Hematinics|hematinics|mesh-ancestor
93219065|NCT03488225|Protease Inhibitors|protease inhibitors|mesh-ancestor
93219066|NCT03488225|Immunotoxins|immunotoxins|mesh-ancestor
93219067|NCT03488225|Immunoconjugates|immunoconjugates|mesh-ancestor
93219068|NCT02334904|Risperidone|risperidone|mesh-list
93219069|NCT02334904|Aripiprazole|aripiprazole|mesh-list
93219070|NCT02334904|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93219071|NCT02334904|Serotonin Agents|serotonin agents|mesh-ancestor
93219072|NCT02334904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219073|NCT02334904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219074|NCT02334904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219075|NCT02334904|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93219076|NCT02334904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93219077|NCT02334904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219078|NCT02334904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219079|NCT02334904|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93219080|NCT02334904|Dopamine Agents|dopamine agents|mesh-ancestor
93219081|NCT02334904|Antidepressive Agents|antidepressive agents|mesh-ancestor
93219082|NCT02334904|Dopamine Agonists|dopamine agonists|mesh-ancestor
93219083|NCT02334904|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93219084|NCT02334904|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93219085|NCT02334904|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93219086|NCT02334904|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93219087|NCT02326090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93219088|NCT02326090|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93219089|NCT03437447|Praziquantel|praziquantel|mesh-list
93219090|NCT03437447|Anthelmintics|anthelmintics|mesh-ancestor
93219091|NCT03437447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93219092|NCT03437447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219093|NCT03720041|Dexamethasone|dexamethasone|mesh-list
93219094|NCT03720041|Dexamethasone acetate|dexamethasone acetate|mesh-list
93219095|NCT03720041|Lenalidomide|lenalidomide|mesh-list
93219097|NCT03720041|BB 1101|bb 1101|mesh-list
93219098|NCT03720041|Glycine|glycine|mesh-list
93219099|NCT03720041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219100|NCT03720041|Antiemetics|antiemetics|mesh-ancestor
93219101|NCT03720041|Autonomic Agents|autonomic agents|mesh-ancestor
93219102|NCT03720041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219103|NCT03720041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219104|NCT03720041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219105|NCT03720041|Glucocorticoids|glucocorticoids|mesh-ancestor
93219106|NCT03720041|Hormones|hormones|mesh-ancestor
93219107|NCT03720041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219108|NCT03720041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93219109|NCT03720041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219110|NCT03720041|Protease Inhibitors|protease inhibitors|mesh-ancestor
93219111|NCT03720041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219112|NCT03720041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219113|NCT03720041|Immunologic Factors|immunologic factors|mesh-ancestor
93219114|NCT03720041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93219115|NCT03720041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93219116|NCT03720041|Growth Substances|growth substances|mesh-ancestor
93219117|NCT03720041|Growth Inhibitors|growth inhibitors|mesh-ancestor
93219118|NCT03720041|Glycine Agents|glycine agents|mesh-ancestor
93219119|NCT03720041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219120|NCT02326168|BCG Vaccine|bcg vaccine|mesh-list
93219121|NCT02326168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93219122|NCT02326168|Immunologic Factors|immunologic factors|mesh-ancestor
93219123|NCT02326168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219124|NCT02334670|Fluconazole|fluconazole|mesh-list
93219125|NCT02334670|Antifungal Agents|antifungal agents|mesh-ancestor
93219126|NCT02334670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219127|NCT02334670|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93219128|NCT02334670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93219129|NCT02334670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219130|NCT02334670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219131|NCT02334670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93219132|NCT02334670|Hormone Antagonists|hormone antagonists|mesh-ancestor
93219133|NCT02334670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219134|NCT02334670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219135|NCT02334670|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93219136|NCT02334670|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93219137|NCT02974868|PF-06700841|pf-06700841|mesh-list
93219138|NCT02974868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93219139|NCT02974868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219140|NCT02974868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219141|NCT02330770|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93219142|NCT02330770|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93219143|NCT02330770|Luteolytic Agents|luteolytic agents|mesh-ancestor
93219144|NCT02330770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93219145|NCT02330770|Contraceptive Agents|contraceptive agents|mesh-ancestor
93219146|NCT02330770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93219147|NCT02330770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219148|NCT02330770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93219149|NCT02330770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93219150|NCT02330770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219151|NCT05076526|Hyaluronic Acid|hyaluronic acid|mesh-list
93219152|NCT05076526|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93219153|NCT05076526|Immunologic Factors|immunologic factors|mesh-ancestor
93219154|NCT05076526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219155|NCT05076526|Viscosupplements|viscosupplements|mesh-ancestor
93219156|NCT05076526|Protective Agents|protective agents|mesh-ancestor
93219157|NCT02330614|Carbamide Peroxide|carbamide peroxide|mesh-list
93219158|NCT02330614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93219159|NCT02330614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929158|NCT00411385|Antimetabolites|antimetabolites|mesh-ancestor
93219160|NCT03143998|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93219161|NCT03143998|Grazoprevir|grazoprevir|mesh-list
93219162|NCT03143998|Antiviral Agents|antiviral agents|mesh-ancestor
93219163|NCT03143998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219164|NCT02334046|Remifentanil|remifentanil|mesh-list
93219166|NCT02334046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93219167|NCT02334046|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93219168|NCT02334046|Anesthetics, General|anesthetics, general|mesh-ancestor
93219169|NCT02334046|Anesthetics|anesthetics|mesh-ancestor
93219170|NCT02334046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219171|NCT02334046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219172|NCT02334046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93219173|NCT02334046|Narcotics|narcotics|mesh-ancestor
93219174|NCT02334046|Analgesics|analgesics|mesh-ancestor
93219175|NCT02334046|Sensory System Agents|sensory system agents|mesh-ancestor
93219176|NCT02334046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219177|NCT02330380|Adalimumab|adalimumab|mesh-list
93219178|NCT02330380|Etanercept|etanercept|mesh-list
93219179|NCT02330380|Methotrexate|methotrexate|mesh-list
93219180|NCT02330380|Ustekinumab|ustekinumab|mesh-list
93219181|NCT02330380|Acitretin|acitretin|mesh-list
93219182|NCT02330380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93219183|NCT02330380|Abortifacient Agents|abortifacient agents|mesh-ancestor
93219184|NCT02330380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93219185|NCT02330380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219186|NCT02330380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93219187|NCT02330380|Antimetabolites|antimetabolites|mesh-ancestor
93219188|NCT02330380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219189|NCT02330380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219190|NCT02330380|Dermatologic Agents|dermatologic agents|mesh-ancestor
93219191|NCT02330380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219192|NCT02330380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93219193|NCT02330380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219194|NCT02330380|Immunologic Factors|immunologic factors|mesh-ancestor
93219195|NCT02330380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219196|NCT02330380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93219197|NCT02330380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93219198|NCT02330380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219199|NCT02330380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93219200|NCT02330380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93219201|NCT02330380|Analgesics|analgesics|mesh-ancestor
93219202|NCT02330380|Sensory System Agents|sensory system agents|mesh-ancestor
93219203|NCT02330380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219204|NCT02330380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219205|NCT02330380|Keratolytic Agents|keratolytic agents|mesh-ancestor
93219206|NCT04278404|Metformin|metformin|mesh-list
93219207|NCT04278404|Interferons|interferons|mesh-list
93219208|NCT04278404|Ritonavir|ritonavir|mesh-list
93219209|NCT04278404|Ribavirin|ribavirin|mesh-list
93219210|NCT04278404|Lopinavir|lopinavir|mesh-list
93219211|NCT04278404|Oseltamivir|oseltamivir|mesh-list
93219212|NCT04278404|Remdesivir|remdesivir|mesh-list
93219213|NCT04278404|Azithromycin|azithromycin|mesh-list
93219214|NCT04278404|Clindamycin|clindamycin|mesh-list
93219215|NCT04278404|Meropenem|meropenem|mesh-list
93219216|NCT04278404|Voriconazole|voriconazole|mesh-list
93219217|NCT04278404|Ceftazidime|ceftazidime|mesh-list
93219218|NCT04278404|Fosfomycin|fosfomycin|mesh-list
93219219|NCT04278404|Cefepime|cefepime|mesh-list
93219220|NCT04278404|Cefdinir|cefdinir|mesh-list
93219221|NCT04278404|Dexamethasone|dexamethasone|mesh-list
93219222|NCT04278404|Budesonide|budesonide|mesh-list
93219223|NCT04278404|Hydrocortisone|hydrocortisone|mesh-list
93219224|NCT04278404|Colchicine|colchicine|mesh-list
93219225|NCT04278404|Amiodarone|amiodarone|mesh-list
93219226|NCT04278404|Bosentan|bosentan|mesh-list
93219227|NCT04278404|Guanfacine|guanfacine|mesh-list
93219228|NCT04278404|Labetalol|labetalol|mesh-list
93219229|NCT04278404|Nicardipine|nicardipine|mesh-list
93219230|NCT04278404|Nifedipine|nifedipine|mesh-list
93219231|NCT04278404|Milrinone|milrinone|mesh-list
93219232|NCT04278404|Furosemide|furosemide|mesh-list
93219233|NCT04278404|Spironolactone|spironolactone|mesh-list
93219234|NCT04278404|Dexmedetomidine|dexmedetomidine|mesh-list
93219235|NCT04278404|Oxycodone|oxycodone|mesh-list
93219236|NCT04278404|Gabapentin|gabapentin|mesh-list
93219237|NCT04278404|Nalbuphine|nalbuphine|mesh-list
93219238|NCT04278404|Clobazam|clobazam|mesh-list
92891304|NCT02636348|Vitamin D|vitamin d|mesh-list
93219239|NCT04278404|Zolpidem|zolpidem|mesh-list
93219240|NCT04278404|Risperidone|risperidone|mesh-list
93219241|NCT04278404|Amphetamine|amphetamine|mesh-list
93219242|NCT04278404|Dextroamphetamine|dextroamphetamine|mesh-list
93219243|NCT04278404|Sertraline|sertraline|mesh-list
93219244|NCT04278404|Tranexamic Acid|tranexamic acid|mesh-list
93219245|NCT04278404|Aminocaproic Acid|aminocaproic acid|mesh-list
93219246|NCT04278404|Terbutaline|terbutaline|mesh-list
93219247|NCT04278404|Sevelamer|sevelamer|mesh-list
93219248|NCT04278404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219249|NCT04278404|Antiemetics|antiemetics|mesh-ancestor
93219250|NCT04278404|Autonomic Agents|autonomic agents|mesh-ancestor
93219251|NCT04278404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219252|NCT04278404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219253|NCT04278404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219255|NCT04278404|Hormones|hormones|mesh-ancestor
93219256|NCT04278404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219257|NCT04278404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93219258|NCT04278404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219259|NCT04278404|Protease Inhibitors|protease inhibitors|mesh-ancestor
93219260|NCT04278404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219261|NCT04278404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219262|NCT04278404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93219263|NCT04278404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93219264|NCT04278404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219265|NCT04278404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93219266|NCT04278404|Analgesics|analgesics|mesh-ancestor
93219267|NCT04278404|Sensory System Agents|sensory system agents|mesh-ancestor
93219268|NCT04278404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93219269|NCT04278404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93219270|NCT04278404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93219271|NCT04278404|Adrenergic Agents|adrenergic agents|mesh-ancestor
93219272|NCT04278404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219273|NCT04278404|Antiviral Agents|antiviral agents|mesh-ancestor
93219274|NCT04278404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219275|NCT04278404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219276|NCT04278404|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93219277|NCT04278404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93219278|NCT04278404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93219279|NCT04278404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93219280|NCT04278404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93219281|NCT04278404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93219282|NCT04278404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93219283|NCT04278404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93219284|NCT04278404|Antimetabolites|antimetabolites|mesh-ancestor
93219285|NCT04278404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93219286|NCT04278404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93219287|NCT04278404|Respiratory System Agents|respiratory system agents|mesh-ancestor
93219288|NCT04278404|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93219289|NCT04278404|Hemostatics|hemostatics|mesh-ancestor
93219290|NCT04278404|Coagulants|coagulants|mesh-ancestor
93219291|NCT04278404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93219292|NCT04278404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93219293|NCT04278404|Narcotics|narcotics|mesh-ancestor
93219294|NCT04278404|Anticonvulsants|anticonvulsants|mesh-ancestor
93219295|NCT04278404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93219296|NCT04278404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93219297|NCT04278404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219298|NCT04278404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93219299|NCT04278404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93219300|NCT04278404|Antimanic Agents|antimanic agents|mesh-ancestor
93219301|NCT04278404|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93219302|NCT04278404|Serotonin Agents|serotonin agents|mesh-ancestor
93219303|NCT04278404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93219304|NCT04278404|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93219305|NCT04278404|Dopamine Agents|dopamine agents|mesh-ancestor
93219306|NCT04278404|Antidepressive Agents|antidepressive agents|mesh-ancestor
93219307|NCT04278404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93219308|NCT04278404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93219309|NCT04278404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93219310|NCT04278404|Diuretics|diuretics|mesh-ancestor
93219311|NCT04278404|Natriuretic Agents|natriuretic agents|mesh-ancestor
93219312|NCT04278404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93219313|NCT04278404|Gout Suppressants|gout suppressants|mesh-ancestor
93219314|NCT04278404|Tubulin Modulators|tubulin modulators|mesh-ancestor
93219315|NCT04278404|Antimitotic Agents|antimitotic agents|mesh-ancestor
93219316|NCT04278404|Mitosis Modulators|mitosis modulators|mesh-ancestor
93219317|NCT04278404|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93219318|NCT04278404|Hormone Antagonists|hormone antagonists|mesh-ancestor
93219319|NCT04278404|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93219320|NCT04278404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93219321|NCT04278404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93219322|NCT04278404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93219323|NCT04278404|Vasodilator Agents|vasodilator agents|mesh-ancestor
93219324|NCT04278404|Tocolytic Agents|tocolytic agents|mesh-ancestor
93219325|NCT04278404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93219326|NCT04278404|Antifungal Agents|antifungal agents|mesh-ancestor
93219327|NCT04278404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93219328|NCT04278404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93219329|NCT04278404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93219330|NCT04278404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93219331|NCT04278404|GABA Agonists|gaba agonists|mesh-ancestor
93219332|NCT04278404|GABA Agents|gaba agents|mesh-ancestor
93219333|NCT04278404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93219334|NCT04278404|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93219335|NCT04278404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93219336|NCT04278404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93219337|NCT04278404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93219338|NCT04278404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93219339|NCT04278404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93219340|NCT04278404|Sympathomimetics|sympathomimetics|mesh-ancestor
93219341|NCT04278404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93219342|NCT04278404|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93219343|NCT04278404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93219344|NCT04278404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93219345|NCT04278404|Chelating Agents|chelating agents|mesh-ancestor
93219346|NCT04278404|Sequestering Agents|sequestering agents|mesh-ancestor
93219347|NCT04278404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93219348|NCT04278404|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93219349|NCT04278404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93219350|NCT04278404|Protective Agents|protective agents|mesh-ancestor
93219351|NCT04278404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93219352|NCT04278404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93219353|NCT04278404|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93219354|NCT04278404|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93219355|NCT04278404|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93219356|NCT04278404|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93219357|NCT02333890|Chloroquine|chloroquine|mesh-list
93219358|NCT02333890|Amebicides|amebicides|mesh-ancestor
93219359|NCT02333890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93219360|NCT02333890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93219361|NCT02333890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219362|NCT02333890|Antimalarials|antimalarials|mesh-ancestor
93219363|NCT02333890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219364|NCT02330302|Ropivacaine|ropivacaine|mesh-list
93219365|NCT02330302|Anesthetics, Local|anesthetics, local|mesh-ancestor
93219366|NCT02330302|Anesthetics|anesthetics|mesh-ancestor
93219367|NCT02330302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219368|NCT02330302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219369|NCT02330302|Sensory System Agents|sensory system agents|mesh-ancestor
93219370|NCT02330302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219371|NCT03143530|Ropivacaine|ropivacaine|mesh-list
93219372|NCT03143530|Anesthetics, Local|anesthetics, local|mesh-ancestor
93219373|NCT03143530|Anesthetics|anesthetics|mesh-ancestor
93219374|NCT03143530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219375|NCT03143530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219376|NCT03143530|Sensory System Agents|sensory system agents|mesh-ancestor
93219377|NCT03143530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219378|NCT01065818|Telbivudine|telbivudine|mesh-list
93219379|NCT01065818|Antiviral Agents|antiviral agents|mesh-ancestor
93219380|NCT01065818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219381|NCT01065818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93219382|NCT01065818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219383|NCT01065818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219384|NCT03697408|Everolimus|everolimus|mesh-list
93219385|NCT03697408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93219386|NCT03697408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93219387|NCT03697408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219388|NCT03697408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219389|NCT03697408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219390|NCT03697408|Immunologic Factors|immunologic factors|mesh-ancestor
93219391|NCT03697408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219392|NCT03697408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219393|NCT02318277|Durvalumab|durvalumab|mesh-list
93219394|NCT02318277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219395|NCT02318277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219396|NCT03143452|Lidocaine|lidocaine|mesh-list
93219397|NCT03143452|Tetracaine|tetracaine|mesh-list
93219398|NCT03143452|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93219399|NCT03143452|Anesthetics, Local|anesthetics, local|mesh-ancestor
93219400|NCT03143452|Anesthetics|anesthetics|mesh-ancestor
93219401|NCT03143452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219402|NCT03143452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219403|NCT03143452|Sensory System Agents|sensory system agents|mesh-ancestor
93219404|NCT03143452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219405|NCT03143452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93219406|NCT03143452|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93219407|NCT03143452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93219408|NCT03143452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93219409|NCT03143452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219410|NCT03143452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93219411|NCT01063868|Oxycodone|oxycodone|mesh-list
93219412|NCT01063868|Tapentadol|tapentadol|mesh-list
93219413|NCT01063868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93219414|NCT01063868|Narcotics|narcotics|mesh-ancestor
93219415|NCT01063868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219416|NCT01063868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219417|NCT01063868|Analgesics|analgesics|mesh-ancestor
93219418|NCT01063868|Sensory System Agents|sensory system agents|mesh-ancestor
93219419|NCT01063868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219420|NCT01063868|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93219421|NCT01063868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93219422|NCT01063868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93219423|NCT01063868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219424|NCT01063868|Adrenergic Agents|adrenergic agents|mesh-ancestor
93219425|NCT01063868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219426|NCT04993924|Cetrorelix|cetrorelix|mesh-list
93219427|NCT04993924|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93219428|NCT04993924|Fertility Agents|fertility agents|mesh-ancestor
93219429|NCT04993924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93219430|NCT04993924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219431|NCT04993924|Hormone Antagonists|hormone antagonists|mesh-ancestor
93219432|NCT04993924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219433|NCT02330068|Citalopram|citalopram|mesh-list
93219434|NCT02330068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93219435|NCT02330068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93219436|NCT02330068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93219437|NCT02330068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219438|NCT02330068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219439|NCT02330068|Serotonin Agents|serotonin agents|mesh-ancestor
93219440|NCT02330068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219441|NCT02330068|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93219442|NCT02330068|Antidepressive Agents|antidepressive agents|mesh-ancestor
93219443|NCT02330068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219444|NCT02333344|Zoledronic Acid|zoledronic acid|mesh-list
93219445|NCT02333344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93219446|NCT02333344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219447|NCT01312857|Panitumumab|panitumumab|mesh-list
93219448|NCT01312857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219449|NCT01312857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219450|NCT02974010|Cycloserine|cycloserine|mesh-list
93219451|NCT02974010|Ketamine|ketamine|mesh-list
93219452|NCT02974010|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93219453|NCT02974010|Analgesics|analgesics|mesh-ancestor
93219454|NCT02974010|Sensory System Agents|sensory system agents|mesh-ancestor
93219455|NCT02974010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219456|NCT02974010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219457|NCT02974010|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93219458|NCT02974010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93219459|NCT02974010|Anesthetics, General|anesthetics, general|mesh-ancestor
93219460|NCT02974010|Anesthetics|anesthetics|mesh-ancestor
93219461|NCT02974010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219462|NCT02974010|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93219463|NCT02974010|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93219464|NCT02974010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219465|NCT02974010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219466|NCT02974010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93219467|NCT02974010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219468|NCT02974010|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93219469|NCT02974010|Antitubercular Agents|antitubercular agents|mesh-ancestor
93219470|NCT02974010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93219471|NCT02974010|Antimetabolites|antimetabolites|mesh-ancestor
93219472|NCT02974010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93219473|NCT02974010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93219474|NCT02974010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219475|NCT02974010|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93219476|NCT02974010|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93219477|NCT02974010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93219478|NCT02974010|Adrenergic Agents|adrenergic agents|mesh-ancestor
93219479|NCT02974010|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93219480|NCT02974010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93219481|NCT02974010|Serotonin Agents|serotonin agents|mesh-ancestor
93219482|NCT02974010|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93219483|NCT02974010|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93219484|NCT02974010|Dopamine Agents|dopamine agents|mesh-ancestor
93219485|NCT01061606|Sirolimus|sirolimus|mesh-list
93219486|NCT01061606|Temsirolimus|temsirolimus|mesh-list
93219487|NCT01061606|MTOR Inhibitors|mtor inhibitors|mesh-list
93219488|NCT01061606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93219489|NCT01061606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219490|NCT01061606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219491|NCT01061606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219492|NCT01061606|Immunologic Factors|immunologic factors|mesh-ancestor
93219493|NCT01061606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219494|NCT01061606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219495|NCT01061606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93219496|NCT01061606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219497|NCT01061606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93219498|NCT01061606|Antifungal Agents|antifungal agents|mesh-ancestor
93219499|NCT04696822|Epinephrine|epinephrine|mesh-list
93219500|NCT04696822|Racepinephrine|racepinephrine|mesh-list
93219501|NCT04696822|Epinephryl borate|epinephryl borate|mesh-list
93219502|NCT04696822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93219503|NCT04696822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93219504|NCT04696822|Adrenergic Agents|adrenergic agents|mesh-ancestor
93219505|NCT04696822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219506|NCT04696822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219507|NCT04696822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219508|NCT04696822|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93219509|NCT04696822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93219510|NCT04696822|Autonomic Agents|autonomic agents|mesh-ancestor
93219511|NCT04696822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219512|NCT04696822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93219513|NCT04696822|Respiratory System Agents|respiratory system agents|mesh-ancestor
93219514|NCT04696822|Mydriatics|mydriatics|mesh-ancestor
93219515|NCT04696822|Sympathomimetics|sympathomimetics|mesh-ancestor
93219516|NCT04696822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93219517|NCT02329756|Tranexamic Acid|tranexamic acid|mesh-list
93219518|NCT02329756|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93219519|NCT02329756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93219520|NCT02329756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219521|NCT02329756|Hemostatics|hemostatics|mesh-ancestor
93219522|NCT02329756|Coagulants|coagulants|mesh-ancestor
93219523|NCT02329288|Triamcinolone|triamcinolone|mesh-list
93219524|NCT02329288|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93219525|NCT02329288|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93219526|NCT02329288|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93219527|NCT02329288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219528|NCT02329288|Glucocorticoids|glucocorticoids|mesh-ancestor
93219529|NCT02329288|Hormones|hormones|mesh-ancestor
93219530|NCT02329288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219531|NCT02329288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219532|NCT02329288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219533|NCT02329288|Immunologic Factors|immunologic factors|mesh-ancestor
93219534|NCT02329288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219535|NCT02329288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219536|NCT02329054|Favipiravir|favipiravir|mesh-list
93219537|NCT02329054|Antiviral Agents|antiviral agents|mesh-ancestor
93219538|NCT02329054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219539|NCT03122457|C 1027|c 1027|mesh-list
93219540|NCT03122457|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93219541|NCT03122457|Dermatologic Agents|dermatologic agents|mesh-ancestor
93219542|NCT03122457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93219543|NCT03122457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219544|NCT04407988|Letrozole|letrozole|mesh-list
93219545|NCT04407988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219546|NCT04407988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93219547|NCT04407988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93219548|NCT04407988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219549|NCT04407988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219550|NCT04407988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93219551|NCT04407988|Hormone Antagonists|hormone antagonists|mesh-ancestor
93219552|NCT04407988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219553|NCT04407988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219554|NCT02329132|Ranibizumab|ranibizumab|mesh-list
93219555|NCT02329132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93219556|NCT02329132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93219557|NCT02329132|Growth Substances|growth substances|mesh-ancestor
93219558|NCT02329132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219559|NCT02329132|Growth Inhibitors|growth inhibitors|mesh-ancestor
93219560|NCT02329132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219561|NCT04342078|Vitamin D|vitamin d|mesh-list
93219562|NCT04342078|Vitamins|vitamins|mesh-ancestor
93219563|NCT04342078|Micronutrients|micronutrients|mesh-ancestor
93219564|NCT04342078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219565|NCT04342078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93219566|NCT02332954|Vortioxetine|vortioxetine|mesh-list
93219567|NCT02332954|Antidepressive Agents|antidepressive agents|mesh-ancestor
93219568|NCT02332954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219569|NCT02332954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93219570|NCT02332954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93219571|NCT02332954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219572|NCT02332954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219573|NCT02332954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93219574|NCT02332954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93219575|NCT02332954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93219576|NCT02332954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219577|NCT02332954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219578|NCT02332954|Serotonin Agents|serotonin agents|mesh-ancestor
93219579|NCT02332954|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93219580|NCT02332954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93219581|NCT02332954|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93219582|NCT02332954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93219583|NCT01372761|CKD732|ckd732|mesh-list
93219584|NCT01372761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93219585|NCT01372761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93219586|NCT01372761|Growth Substances|growth substances|mesh-ancestor
93219587|NCT01372761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219588|NCT01372761|Growth Inhibitors|growth inhibitors|mesh-ancestor
93219589|NCT01372761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219590|NCT03873675|Hormones|hormones|mesh-list
93219591|NCT03873675|Parathyroid Hormone|parathyroid hormone|mesh-list
93219592|NCT03873675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219593|NCT03873675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219594|NCT03873675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93219595|NCT05173857|Paclitaxel|paclitaxel|mesh-list
93219596|NCT05173857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93219597|NCT05173857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219598|NCT05173857|Tubulin Modulators|tubulin modulators|mesh-ancestor
93219599|NCT05173857|Antimitotic Agents|antimitotic agents|mesh-ancestor
93219600|NCT05173857|Mitosis Modulators|mitosis modulators|mesh-ancestor
93219601|NCT05173857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219602|NCT03417999|Dexmedetomidine|dexmedetomidine|mesh-list
93219603|NCT03417999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93219604|NCT03417999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856012|NCT02749656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219605|NCT03417999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219606|NCT03417999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93219607|NCT03417999|Analgesics|analgesics|mesh-ancestor
93219608|NCT03417999|Sensory System Agents|sensory system agents|mesh-ancestor
93219609|NCT03417999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219610|NCT03417999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93219611|NCT03417999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93219612|NCT03417999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93219613|NCT03417999|Adrenergic Agents|adrenergic agents|mesh-ancestor
93219614|NCT03417999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219615|NCT03417999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219616|NCT03142516|Leucovorin|leucovorin|mesh-list
93219617|NCT03142516|Folic Acid|folic acid|mesh-list
93219618|NCT03142516|Fluorouracil|fluorouracil|mesh-list
93219619|NCT03142516|Irinotecan|irinotecan|mesh-list
93219620|NCT03142516|Panitumumab|panitumumab|mesh-list
93219621|NCT03142516|Levoleucovorin|levoleucovorin|mesh-list
92891671|NCT02710877|Sufentanil|sufentanil|mesh-list
93219622|NCT03142516|Antimetabolites|antimetabolites|mesh-ancestor
93219623|NCT03142516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219624|NCT03142516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93219625|NCT03142516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219626|NCT03142516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219627|NCT03142516|Immunologic Factors|immunologic factors|mesh-ancestor
93219628|NCT03142516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219629|NCT03142516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93219630|NCT03142516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93219631|NCT03142516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219632|NCT03142516|Antidotes|antidotes|mesh-ancestor
93219633|NCT03142516|Protective Agents|protective agents|mesh-ancestor
93219634|NCT03142516|Vitamin B Complex|vitamin b complex|mesh-ancestor
93219635|NCT03142516|Vitamins|vitamins|mesh-ancestor
93219636|NCT03142516|Micronutrients|micronutrients|mesh-ancestor
93219637|NCT03142516|Hematinics|hematinics|mesh-ancestor
93219638|NCT03142516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219639|NCT03719729|Rifaximin|rifaximin|mesh-list
93219640|NCT03719729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93219641|NCT03719729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219642|NCT03719729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219643|NCT05077462|Cryptophycin 52|cryptophycin 52|mesh-list
93219644|NCT05077462|Antimitotic Agents|antimitotic agents|mesh-ancestor
93219645|NCT05077462|Mitosis Modulators|mitosis modulators|mesh-ancestor
93219646|NCT05077462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219647|NCT05077462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219648|NCT03714113|Antibodies|antibodies|mesh-list
93219649|NCT03714113|Immunologic Factors|immunologic factors|mesh-ancestor
93219650|NCT03714113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219651|NCT03472547|Diacerein|diacerein|mesh-list
93219652|NCT03472547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219653|NCT00799396|Aspirin|aspirin|mesh-list
93219654|NCT00799396|Clopidogrel|clopidogrel|mesh-list
93219655|NCT00799396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93219656|NCT00799396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93219657|NCT00799396|Analgesics|analgesics|mesh-ancestor
93219658|NCT00799396|Sensory System Agents|sensory system agents|mesh-ancestor
93219659|NCT00799396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219660|NCT00799396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219661|NCT00799396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219662|NCT00799396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219663|NCT00799396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93219664|NCT00799396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93219665|NCT00799396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219666|NCT00799396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93219667|NCT00799396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93219668|NCT00799396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219669|NCT00799396|Antipyretics|antipyretics|mesh-ancestor
93219670|NCT00799396|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93219671|NCT00799396|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93219672|NCT00799396|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93219673|NCT00799396|Purinergic Agents|purinergic agents|mesh-ancestor
93219674|NCT00799396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219675|NCT02624128|Cetuximab|cetuximab|mesh-list
93219676|NCT02624128|Valproic Acid|valproic acid|mesh-list
93219677|NCT02624128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219678|NCT02624128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219679|NCT02624128|Anticonvulsants|anticonvulsants|mesh-ancestor
93219680|NCT02624128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219681|NCT02624128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219682|NCT02624128|GABA Agents|gaba agents|mesh-ancestor
93219683|NCT02624128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219684|NCT02624128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219685|NCT02624128|Antimanic Agents|antimanic agents|mesh-ancestor
93219686|NCT02624128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93219687|NCT02624128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219688|NCT02624128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219689|NCT03469349|Actovegin|actovegin|mesh-list
93219690|NCT03469349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93219691|NCT03469349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219692|NCT03469349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93219693|NCT03469349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219694|NCT03469349|Antioxidants|antioxidants|mesh-ancestor
93219695|NCT03469349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219696|NCT03469349|Protective Agents|protective agents|mesh-ancestor
93219697|NCT03469349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93219699|NCT03467945|Gliclazide|gliclazide|mesh-list
93219700|NCT03467945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93219701|NCT03467945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219702|NCT03719261|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93219703|NCT03719261|Eusol|eusol|mesh-list
93219704|NCT03719261|Chitosan|chitosan|mesh-list
93219705|NCT03719261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93219706|NCT03719261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93219707|NCT03719261|Antimetabolites|antimetabolites|mesh-ancestor
93219708|NCT03719261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219709|NCT03719261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93219710|NCT03719261|Chelating Agents|chelating agents|mesh-ancestor
93219711|NCT03719261|Sequestering Agents|sequestering agents|mesh-ancestor
93219712|NCT03719261|Hemostatics|hemostatics|mesh-ancestor
93219713|NCT03719261|Coagulants|coagulants|mesh-ancestor
93219714|NCT03719261|Disinfectants|disinfectants|mesh-ancestor
93219715|NCT03719261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219716|NCT00069238|Prednisone|prednisone|mesh-list
93219717|NCT00069238|Cyclophosphamide|cyclophosphamide|mesh-list
93219718|NCT00069238|Doxorubicin|doxorubicin|mesh-list
93219719|NCT00069238|Etoposide|etoposide|mesh-list
93219720|NCT00069238|Vincristine|vincristine|mesh-list
93219721|NCT00069238|Alemtuzumab|alemtuzumab|mesh-list
93219722|NCT00069238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219723|NCT00069238|Immunologic Factors|immunologic factors|mesh-ancestor
93219724|NCT00069238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219725|NCT00069238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219726|NCT00069238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93219727|NCT00069238|Alkylating Agents|alkylating agents|mesh-ancestor
93219728|NCT00069238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219729|NCT00069238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219730|NCT00069238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93219731|NCT00069238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93219732|NCT00069238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93219733|NCT00069238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93219734|NCT00069238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219735|NCT00069238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219736|NCT00069238|Glucocorticoids|glucocorticoids|mesh-ancestor
93219737|NCT00069238|Hormones|hormones|mesh-ancestor
93219738|NCT00069238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219739|NCT00069238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93219740|NCT00069238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93219741|NCT00069238|Tubulin Modulators|tubulin modulators|mesh-ancestor
93219742|NCT00069238|Antimitotic Agents|antimitotic agents|mesh-ancestor
93219743|NCT00069238|Mitosis Modulators|mitosis modulators|mesh-ancestor
93219744|NCT00069238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219745|NCT03639155|Glycine|glycine|mesh-list
93219746|NCT03639155|Glycine Agents|glycine agents|mesh-ancestor
93219747|NCT03639155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219748|NCT03639155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219749|NCT03639155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219750|NCT05080348|Ropivacaine|ropivacaine|mesh-list
93219751|NCT05080348|Anesthetics, Local|anesthetics, local|mesh-ancestor
93219752|NCT05080348|Anesthetics|anesthetics|mesh-ancestor
93219753|NCT05080348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219754|NCT05080348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219755|NCT05080348|Sensory System Agents|sensory system agents|mesh-ancestor
93219756|NCT05080348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219757|NCT03073200|Etanercept|etanercept|mesh-list
93219758|NCT03073200|Ixekizumab|ixekizumab|mesh-list
93219759|NCT03073200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93219760|NCT03073200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93219761|NCT03073200|Analgesics|analgesics|mesh-ancestor
93219762|NCT03073200|Sensory System Agents|sensory system agents|mesh-ancestor
93219763|NCT03073200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219764|NCT03073200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219765|NCT03073200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219766|NCT03073200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93219767|NCT03073200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93219768|NCT03073200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219769|NCT03073200|Immunologic Factors|immunologic factors|mesh-ancestor
93219770|NCT03073200|Dermatologic Agents|dermatologic agents|mesh-ancestor
93219771|NCT02030860|Gemcitabine|gemcitabine|mesh-list
93219772|NCT02030860|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93219773|NCT02030860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93219774|NCT02030860|Antimetabolites|antimetabolites|mesh-ancestor
93219775|NCT02030860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219776|NCT02030860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219777|NCT01569984|Bevacizumab|bevacizumab|mesh-list
93219778|NCT01569984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219779|NCT01569984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219780|NCT01569984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93219781|NCT01569984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93219782|NCT01569984|Growth Substances|growth substances|mesh-ancestor
93219783|NCT01569984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219784|NCT01569984|Growth Inhibitors|growth inhibitors|mesh-ancestor
93219785|NCT02328118|Triamcinolone|triamcinolone|mesh-list
93219786|NCT02328118|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93219787|NCT02328118|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93219788|NCT02328118|Ranibizumab|ranibizumab|mesh-list
93219789|NCT02328118|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93219790|NCT02328118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93219791|NCT02328118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93219792|NCT02328118|Growth Substances|growth substances|mesh-ancestor
93219793|NCT02328118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219794|NCT02328118|Growth Inhibitors|growth inhibitors|mesh-ancestor
93219795|NCT02328118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219796|NCT02328118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219797|NCT02328118|Glucocorticoids|glucocorticoids|mesh-ancestor
93219798|NCT02328118|Hormones|hormones|mesh-ancestor
93219799|NCT02328118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219800|NCT02328118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93219801|NCT02328118|Immunologic Factors|immunologic factors|mesh-ancestor
93219802|NCT02328118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219803|NCT02328118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219804|NCT02602314|Imatinib Mesylate|imatinib mesylate|mesh-list
93219805|NCT02602314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219806|NCT02602314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93219807|NCT02602314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219808|NCT02602314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219809|NCT05079880|Caffeine|caffeine|mesh-list
93219810|NCT05079880|Caffeine citrate|caffeine citrate|mesh-list
93219811|NCT05079880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219812|NCT05079880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93219813|NCT05079880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219814|NCT05079880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93219815|NCT05079880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219816|NCT05079880|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93219817|NCT05079880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93219818|NCT05079880|Purinergic Agents|purinergic agents|mesh-ancestor
93219819|NCT05079880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219820|NCT03716765|Vitamin D|vitamin d|mesh-list
93219821|NCT03716765|Vitamins|vitamins|mesh-ancestor
93219822|NCT03716765|Micronutrients|micronutrients|mesh-ancestor
93219823|NCT03716765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219824|NCT03716765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93219825|NCT03070002|Denosumab|denosumab|mesh-list
93219826|NCT03070002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93219827|NCT03070002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219828|NCT02327728|Botulinum Toxins|botulinum toxins|mesh-list
93219829|NCT02327728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93219830|NCT02327728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92856014|NCT02749656|Hormones|hormones|mesh-ancestor
93219831|NCT02327728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93219832|NCT02327728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93219833|NCT02327728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219834|NCT02327728|Cholinergic Agents|cholinergic agents|mesh-ancestor
93219835|NCT02327728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219836|NCT02327728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219837|NCT02327728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93219838|NCT02327728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219839|NCT02918318|Esketamine|esketamine|mesh-list
93219840|NCT02918318|Antidepressive Agents|antidepressive agents|mesh-ancestor
93219841|NCT02918318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93219842|NCT04926454|Dexmedetomidine|dexmedetomidine|mesh-list
93219843|NCT04926454|Bupivacaine|bupivacaine|mesh-list
93219844|NCT04926454|Anesthetics, Local|anesthetics, local|mesh-ancestor
93219845|NCT04926454|Anesthetics|anesthetics|mesh-ancestor
93219846|NCT04926454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219847|NCT04926454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219848|NCT04926454|Sensory System Agents|sensory system agents|mesh-ancestor
93219849|NCT04926454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219850|NCT04926454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93219851|NCT04926454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93219853|NCT04926454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93219854|NCT04926454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93219855|NCT04926454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93219856|NCT04926454|Adrenergic Agents|adrenergic agents|mesh-ancestor
93219857|NCT04926454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219858|NCT04926454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219859|NCT03652376|Benralizumab|benralizumab|mesh-list
93219860|NCT03652376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93219861|NCT03652376|Respiratory System Agents|respiratory system agents|mesh-ancestor
93219862|NCT05200143|Nivolumab|nivolumab|mesh-list
93219863|NCT05200143|Ipilimumab|ipilimumab|mesh-list
93219864|NCT05200143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219865|NCT05200143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219866|NCT05200143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93219867|NCT05200143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219868|NCT03142828|Chlorhexidine|chlorhexidine|mesh-list
93219869|NCT03142828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93219870|NCT03142828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219871|NCT03142828|Disinfectants|disinfectants|mesh-ancestor
93219872|NCT01372839|Atorvastatin|atorvastatin|mesh-list
93219873|NCT01372839|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93219874|NCT01372839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93219875|NCT01372839|Antimetabolites|antimetabolites|mesh-ancestor
93219876|NCT01372839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219877|NCT01372839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93219878|NCT01372839|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93219879|NCT01372839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219880|NCT01065350|Ketamine|ketamine|mesh-list
93219881|NCT01065350|Propofol|propofol|mesh-list
93219882|NCT01065350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93219883|NCT01065350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219884|NCT01065350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219885|NCT01065350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93219886|NCT01065350|Anesthetics, General|anesthetics, general|mesh-ancestor
93219887|NCT01065350|Anesthetics|anesthetics|mesh-ancestor
93219888|NCT01065350|Analgesics|analgesics|mesh-ancestor
93219889|NCT01065350|Sensory System Agents|sensory system agents|mesh-ancestor
93219890|NCT01065350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219891|NCT01065350|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93219892|NCT01065350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93219893|NCT01065350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93219894|NCT01065350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219895|NCT01065350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219896|NCT02914977|Daunorubicin|daunorubicin|mesh-list
93219897|NCT02914977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93219898|NCT02914977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219899|NCT02914977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93219900|NCT02914977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93219901|NCT02914977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219902|NCT02914977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219903|NCT03718715|Metformin|metformin|mesh-list
93219904|NCT03718715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93219905|NCT03718715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219906|NCT05079022|Aflutinib|aflutinib|mesh-list
93219907|NCT05079022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93219908|NCT05079022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93219909|NCT05079022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219910|NCT05078788|Triamcinolone|triamcinolone|mesh-list
93219911|NCT05078788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93219912|NCT05078788|Glucocorticoids|glucocorticoids|mesh-ancestor
93219913|NCT05078788|Hormones|hormones|mesh-ancestor
93219914|NCT05078788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219915|NCT05078788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219916|NCT02032654|Floxacillin|floxacillin|mesh-list
93219917|NCT02032654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93219918|NCT02032654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219919|NCT04734886|Vitamin D|vitamin d|mesh-list
93219920|NCT04734886|Ergocalciferols|ergocalciferols|mesh-list
93219921|NCT04734886|Cholecalciferol|cholecalciferol|mesh-list
93219922|NCT04734886|Vitamins|vitamins|mesh-list
93219923|NCT04734886|Micronutrients|micronutrients|mesh-ancestor
93219924|NCT04734886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219925|NCT04734886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93219926|NCT04734886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93219927|NCT03114969|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93219928|NCT03114969|Tiotropium Bromide|tiotropium bromide|mesh-list
93219929|NCT03114969|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93219930|NCT03114969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93219931|NCT03114969|Respiratory System Agents|respiratory system agents|mesh-ancestor
93219932|NCT03114969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93219933|NCT03114969|Autonomic Agents|autonomic agents|mesh-ancestor
93219934|NCT03114969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219935|NCT03114969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219936|NCT03114969|Parasympatholytics|parasympatholytics|mesh-ancestor
93219937|NCT03114969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93219938|NCT03114969|Cholinergic Agents|cholinergic agents|mesh-ancestor
93219939|NCT03114969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93219940|NCT03114969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219941|NCT03114969|Glucocorticoids|glucocorticoids|mesh-ancestor
93219942|NCT03114969|Hormones|hormones|mesh-ancestor
93219943|NCT03114969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93219944|NCT03114969|Sympathomimetics|sympathomimetics|mesh-ancestor
93219945|NCT05078710|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93219946|NCT05078710|Immunologic Factors|immunologic factors|mesh-ancestor
93219947|NCT05078710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219948|NCT03144778|Durvalumab|durvalumab|mesh-list
93219949|NCT03144778|Ipilimumab|ipilimumab|mesh-list
93219950|NCT03144778|Tremelimumab|tremelimumab|mesh-list
93219951|NCT03144778|Immunoglobulins|immunoglobulins|mesh-list
93219952|NCT03144778|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93219953|NCT03144778|Immunoglobulin G|immunoglobulin g|mesh-list
93219954|NCT03144778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219955|NCT03144778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219956|NCT03144778|Immunologic Factors|immunologic factors|mesh-ancestor
93219957|NCT03144778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219958|NCT03144778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93219959|NCT03144778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219960|NCT03142360|Beraprost|beraprost|mesh-list
93219961|NCT03142360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93219962|NCT03142360|Vasodilator Agents|vasodilator agents|mesh-ancestor
93219963|NCT05124678|Isoniazid|isoniazid|mesh-list
93219964|NCT05124678|Antitubercular Agents|antitubercular agents|mesh-ancestor
93219965|NCT05124678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93219966|NCT05124678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93219967|NCT05124678|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93219968|NCT05124678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93219969|NCT05124678|Antimetabolites|antimetabolites|mesh-ancestor
93219970|NCT05124678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219971|NCT05124678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93219972|NCT05761860|Oxycodone|oxycodone|mesh-list
93219973|NCT05761860|Oxytocin|oxytocin|mesh-list
93219974|NCT05761860|Oxytocics|oxytocics|mesh-ancestor
93219975|NCT05761860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93219976|NCT05761860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219977|NCT05761860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93219978|NCT05761860|Narcotics|narcotics|mesh-ancestor
93219979|NCT05761860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93219980|NCT05761860|Analgesics|analgesics|mesh-ancestor
93219981|NCT05761860|Sensory System Agents|sensory system agents|mesh-ancestor
93219982|NCT05761860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219983|NCT03122145|Capsaicin|capsaicin|mesh-list
93219984|NCT03122145|Antipruritics|antipruritics|mesh-ancestor
93219985|NCT03122145|Dermatologic Agents|dermatologic agents|mesh-ancestor
93219986|NCT03122145|Sensory System Agents|sensory system agents|mesh-ancestor
93219987|NCT03122145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93219988|NCT03122145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93219989|NCT05081674|Pembrolizumab|pembrolizumab|mesh-list
93219990|NCT05081674|Nivolumab|nivolumab|mesh-list
93219991|NCT05081674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93219992|NCT05081674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93219993|NCT05081674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93219994|NCT05081674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93219995|NCT05081674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93219996|NCT05081674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93219997|NCT05081674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892042|NCT02709473|Anesthetics, General|anesthetics, general|mesh-ancestor
93219999|NCT05003076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93220000|NCT05003076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220001|NCT05003076|Sympathomimetics|sympathomimetics|mesh-ancestor
93220002|NCT05003076|Autonomic Agents|autonomic agents|mesh-ancestor
93220003|NCT05003076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220004|NCT05003076|Dopamine Agents|dopamine agents|mesh-ancestor
93220005|NCT05003076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220006|NCT05003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220007|NCT05003076|Adrenergic Agents|adrenergic agents|mesh-ancestor
93220008|NCT05003076|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93220009|NCT05003076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93220010|NCT05003076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220011|NCT05003076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93220012|NCT03144856|Apatinib|apatinib|mesh-list
93220013|NCT03144856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220014|NCT03144856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220015|NCT03144856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220016|NCT03144856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220017|NCT03141970|Prednisone|prednisone|mesh-list
93220018|NCT03141970|Prednisolone|prednisolone|mesh-list
93220019|NCT03141970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220020|NCT03141970|Glucocorticoids|glucocorticoids|mesh-ancestor
93220021|NCT03141970|Hormones|hormones|mesh-ancestor
93220022|NCT03141970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93220023|NCT03141970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220024|NCT03141970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93220025|NCT03141970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220026|NCT04949022|Insulin|insulin|mesh-list
93220027|NCT04949022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93220028|NCT04949022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220029|NCT02327338|Ibuprofen|ibuprofen|mesh-list
93220030|NCT02327338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93220031|NCT02327338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220032|NCT02327338|Analgesics|analgesics|mesh-ancestor
93220033|NCT02327338|Sensory System Agents|sensory system agents|mesh-ancestor
93220034|NCT02327338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220035|NCT02327338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220036|NCT02327338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220037|NCT02327338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220038|NCT02327338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93220039|NCT02327338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220040|NCT02327338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220041|NCT02327416|Entecavir|entecavir|mesh-list
93220042|NCT02327416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93220043|NCT02327416|Interferon-alpha|interferon-alpha|mesh-list
93220044|NCT02327416|Adefovir|adefovir|mesh-list
93220045|NCT02327416|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93220046|NCT02327416|Molgramostim|molgramostim|mesh-list
93220047|NCT02327416|Sargramostim|sargramostim|mesh-list
93220048|NCT02327416|Antiviral Agents|antiviral agents|mesh-ancestor
93220049|NCT02327416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220050|NCT02327416|Immunologic Factors|immunologic factors|mesh-ancestor
93220051|NCT02327416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220052|NCT02327416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93220053|NCT02327416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93220054|NCT02327416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220055|NCT02327416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220056|NCT02327416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220057|NCT02926950|Metformin|metformin|mesh-list
93220058|NCT02926950|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93220059|NCT02926950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93220060|NCT02926950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220061|NCT02926950|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93220062|NCT02926950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220063|NCT01064414|Canagliflozin|canagliflozin|mesh-list
93220064|NCT01064414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93220065|NCT01064414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220066|NCT01064414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93220067|NCT01064414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220068|NCT03433703|Lenvatinib|lenvatinib|mesh-list
93220069|NCT03433703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220070|NCT03433703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220071|NCT03433703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220072|NCT03433703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220073|NCT01374633|Sevoflurane|sevoflurane|mesh-list
93220074|NCT01374633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93220075|NCT01374633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93220076|NCT01374633|Anesthetics, General|anesthetics, general|mesh-ancestor
93220077|NCT01374633|Anesthetics|anesthetics|mesh-ancestor
93220078|NCT01374633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220079|NCT01374633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220080|NCT01178814|Lenalidomide|lenalidomide|mesh-list
93220081|NCT01178814|Immunologic Factors|immunologic factors|mesh-ancestor
93220082|NCT01178814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220083|NCT01178814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93220084|NCT01178814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93220085|NCT01178814|Growth Substances|growth substances|mesh-ancestor
93220086|NCT01178814|Growth Inhibitors|growth inhibitors|mesh-ancestor
93220087|NCT01178814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220088|NCT05202288|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
93220089|NCT05202288|Antiviral Agents|antiviral agents|mesh-ancestor
93220090|NCT05202288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220091|NCT05762484|Clindamycin|clindamycin|mesh-list
93220092|NCT05762484|Clindamycin palmitate|clindamycin palmitate|mesh-list
93220093|NCT05762484|Clindamycin phosphate|clindamycin phosphate|mesh-list
93220094|NCT05762484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93220095|NCT05762484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220096|NCT05762484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93220097|NCT05762484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220098|NCT05762484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220099|NCT03462641|Flumazenil|flumazenil|mesh-list
93220100|NCT03462641|Antidotes|antidotes|mesh-ancestor
93220101|NCT03462641|Protective Agents|protective agents|mesh-ancestor
93220102|NCT03462641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220103|NCT03462641|GABA Modulators|gaba modulators|mesh-ancestor
93220104|NCT03462641|GABA Agents|gaba agents|mesh-ancestor
93220105|NCT03462641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220106|NCT03462641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220107|NCT05201352|Trifluridine|trifluridine|mesh-list
93220108|NCT05201352|Antimetabolites|antimetabolites|mesh-ancestor
93220109|NCT05201352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220110|NCT05201352|Antiviral Agents|antiviral agents|mesh-ancestor
93220111|NCT05201352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220112|NCT04128956|Aspirin|aspirin|mesh-list
93220113|NCT04128956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93220114|NCT04128956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220115|NCT04128956|Analgesics|analgesics|mesh-ancestor
93220116|NCT04128956|Sensory System Agents|sensory system agents|mesh-ancestor
93220117|NCT04128956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220118|NCT04128956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220119|NCT04128956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220120|NCT04128956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220121|NCT04128956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93220122|NCT04128956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93220123|NCT04128956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220124|NCT04128956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516039|NCT03151720|Histamine Agents|histamine agents|mesh-ancestor
93220125|NCT04128956|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93220126|NCT04128956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220127|NCT04128956|Antipyretics|antipyretics|mesh-ancestor
93220128|NCT05761704|Anticoagulants|anticoagulants|mesh-list
93220129|NCT03652142|Nivolumab|nivolumab|mesh-list
93220130|NCT03652142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220131|NCT03652142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220132|NCT03652142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93220133|NCT03652142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220134|NCT05762328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93220135|NCT05762328|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93220136|NCT05762328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220137|NCT05762328|Antitubercular Agents|antitubercular agents|mesh-ancestor
93220138|NCT04629378|Amoxicillin|amoxicillin|mesh-list
93220139|NCT04629378|Meropenem|meropenem|mesh-list
93220140|NCT04629378|Clavulanic Acid|clavulanic acid|mesh-list
93220141|NCT04629378|Clavulanic Acids|clavulanic acids|mesh-list
93220142|NCT04629378|Pyrazinamide|pyrazinamide|mesh-list
93220143|NCT04629378|Bedaquiline|bedaquiline|mesh-list
93220144|NCT04629378|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93220145|NCT04629378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93220146|NCT04629378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220147|NCT04629378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93220148|NCT04629378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220149|NCT04629378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220150|NCT04629378|Antitubercular Agents|antitubercular agents|mesh-ancestor
93220151|NCT03651674|Olanzapine|olanzapine|mesh-list
93220152|NCT03651674|Clozapine|clozapine|mesh-list
93220153|NCT03651674|Antiemetics|antiemetics|mesh-ancestor
93220154|NCT03651674|Autonomic Agents|autonomic agents|mesh-ancestor
93220155|NCT03651674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220156|NCT03651674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220157|NCT03651674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93220158|NCT03651674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93220159|NCT03651674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93220160|NCT03651674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220161|NCT03651674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93220162|NCT03651674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93220163|NCT03651674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93220164|NCT03651674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220165|NCT03651674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220166|NCT03651674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220167|NCT03651674|Serotonin Agents|serotonin agents|mesh-ancestor
93220168|NCT03651674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93220169|NCT03651674|GABA Antagonists|gaba antagonists|mesh-ancestor
93220170|NCT03651674|GABA Agents|gaba agents|mesh-ancestor
93220171|NCT01061840|Molgramostim|molgramostim|mesh-list
93220172|NCT01061840|Vaccines|vaccines|mesh-list
93220173|NCT01061840|Sargramostim|sargramostim|mesh-list
93220174|NCT01061840|Immunologic Factors|immunologic factors|mesh-ancestor
93220175|NCT01061840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220176|NCT01061840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220177|NCT02926638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93220178|NCT02926638|Rilotumumab|rilotumumab|mesh-list
93220179|NCT02926638|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93220180|NCT02926638|Antibodies|antibodies|mesh-list
93220181|NCT02926638|Immunoglobulins|immunoglobulins|mesh-list
93220182|NCT02926638|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93220183|NCT02926638|Immunologic Factors|immunologic factors|mesh-ancestor
93220184|NCT02926638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220185|NCT02926638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220186|NCT02926638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220187|NCT02926638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220188|NCT02926638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220189|NCT03650582|Glucagon|glucagon|mesh-list
93220190|NCT03650582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93220191|NCT03650582|Hormones|hormones|mesh-ancestor
93220192|NCT03650582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93220193|NCT03650582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220194|NCT02903030|Silicon|silicon|mesh-list
93220195|NCT02903030|Trace Elements|trace elements|mesh-ancestor
93220196|NCT02903030|Micronutrients|micronutrients|mesh-ancestor
93220197|NCT02903030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220198|NCT02969408|Albuterol|albuterol|mesh-list
93220199|NCT02969408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93220200|NCT02969408|Autonomic Agents|autonomic agents|mesh-ancestor
92516134|NCT03151213|Pregabalin|pregabalin|mesh-list
93220201|NCT02969408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220202|NCT02969408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220203|NCT02969408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93220204|NCT02969408|Respiratory System Agents|respiratory system agents|mesh-ancestor
93220205|NCT02969408|Tocolytic Agents|tocolytic agents|mesh-ancestor
93220206|NCT02969408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93220207|NCT02969408|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93220208|NCT02969408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93220209|NCT02969408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93220210|NCT02969408|Adrenergic Agents|adrenergic agents|mesh-ancestor
93220211|NCT02969408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220212|NCT02969408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220213|NCT05180214|Ketorolac|ketorolac|mesh-list
93220214|NCT05180214|Bupivacaine|bupivacaine|mesh-list
93220215|NCT05180214|Anesthetics, Local|anesthetics, local|mesh-ancestor
93220216|NCT05180214|Anesthetics|anesthetics|mesh-ancestor
93220217|NCT05180214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220218|NCT05180214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220219|NCT05180214|Sensory System Agents|sensory system agents|mesh-ancestor
92892272|NCT00597584|Epoetin Alfa|epoetin alfa|mesh-list
93220220|NCT05180214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220221|NCT05180214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93220222|NCT05180214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220223|NCT05180214|Analgesics|analgesics|mesh-ancestor
93220224|NCT05180214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220225|NCT05180214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220226|NCT05180214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93220227|NCT05180214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220228|NCT05180214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220229|NCT01060124|Fentanyl|fentanyl|mesh-list
93220230|NCT01060124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93220231|NCT01060124|Narcotics|narcotics|mesh-ancestor
93220232|NCT01060124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220233|NCT01060124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220234|NCT01060124|Analgesics|analgesics|mesh-ancestor
93220235|NCT01060124|Sensory System Agents|sensory system agents|mesh-ancestor
93220236|NCT01060124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220237|NCT01060124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93220238|NCT01060124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93220239|NCT01060124|Anesthetics, General|anesthetics, general|mesh-ancestor
93220240|NCT01060124|Anesthetics|anesthetics|mesh-ancestor
93220241|NCT03461003|Losartan|losartan|mesh-list
93220242|NCT03461003|Amlodipine|amlodipine|mesh-list
93220243|NCT03461003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93220244|NCT03461003|Lisinopril|lisinopril|mesh-list
93220245|NCT03461003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93220246|NCT03461003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93220247|NCT03461003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220248|NCT03461003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220249|NCT03461003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93220250|NCT03461003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220251|NCT03461003|Vasodilator Agents|vasodilator agents|mesh-ancestor
93220252|NCT03461003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93220253|NCT03461003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93220254|NCT03461003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93220255|NCT03461003|Diuretics|diuretics|mesh-ancestor
93220256|NCT03461003|Natriuretic Agents|natriuretic agents|mesh-ancestor
93220257|NCT03461003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93220258|NCT03461003|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93220259|NCT03461003|Protease Inhibitors|protease inhibitors|mesh-ancestor
93220260|NCT03461003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220261|NCT03461003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93220262|NCT03461003|Protective Agents|protective agents|mesh-ancestor
93220263|NCT03650348|Atezolizumab|atezolizumab|mesh-list
93220264|NCT03650348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93220265|NCT03650348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220266|NCT03650348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220267|NCT03650348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220268|NCT05761470|Paclitaxel|paclitaxel|mesh-list
93220269|NCT05761470|Fluzoparib|fluzoparib|mesh-list
93220270|NCT05761470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93220271|NCT05761470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220272|NCT05761470|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220273|NCT05761470|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220274|NCT05761470|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220275|NCT05761470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220276|NCT05761470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93220277|NCT05761470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220278|NCT01372293|Contraceptive Agents|contraceptive agents|mesh-list
93220279|NCT01372293|Contraceptives, Oral|contraceptives, oral|mesh-list
93220280|NCT01372293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93220281|NCT01372293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93220282|NCT01372293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220283|NCT01372293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93220284|NCT02904902|Adalimumab|adalimumab|mesh-list
93220285|NCT02904902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93220286|NCT02904902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220287|NCT02904902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220288|NCT03650270|Phenytoin|phenytoin|mesh-list
93220289|NCT03650270|Midazolam|midazolam|mesh-list
93220290|NCT03650270|Phenobarbital|phenobarbital|mesh-list
93220291|NCT03650270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92892343|NCT03860597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93220292|NCT03650270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93220293|NCT03650270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220294|NCT03650270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220295|NCT03650270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93220296|NCT03650270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93220297|NCT03650270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93220298|NCT03650270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93220299|NCT03650270|Anesthetics, General|anesthetics, general|mesh-ancestor
93220300|NCT03650270|Anesthetics|anesthetics|mesh-ancestor
93220301|NCT03650270|GABA Modulators|gaba modulators|mesh-ancestor
93220302|NCT03650270|GABA Agents|gaba agents|mesh-ancestor
93220303|NCT03650270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220304|NCT03650270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220305|NCT03650270|Anticonvulsants|anticonvulsants|mesh-ancestor
93220306|NCT03650270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93220307|NCT03650270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93220308|NCT03650270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220309|NCT03650270|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93220310|NCT03650270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93220311|NCT03650270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93220312|NCT03650270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93220313|NCT03650270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93220314|NCT03650270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93220315|NCT05285228|Fluorides|fluorides|mesh-list
93220316|NCT05285228|Fluorides, Topical|fluorides, topical|mesh-list
93220317|NCT05285228|Cariostatic Agents|cariostatic agents|mesh-ancestor
93220318|NCT05285228|Protective Agents|protective agents|mesh-ancestor
93220319|NCT05285228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220320|NCT04075526|Vancomycin|vancomycin|mesh-list
93220321|NCT04075526|Povidone-Iodine|povidone-iodine|mesh-list
93220322|NCT04075526|Povidone|povidone|mesh-list
93220323|NCT04075526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93220324|NCT04075526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220325|NCT04075526|Plasma Substitutes|plasma substitutes|mesh-ancestor
93220326|NCT04075526|Blood Substitutes|blood substitutes|mesh-ancestor
93220327|NCT04075526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93220328|NCT05204628|Crizotinib|crizotinib|mesh-list
93220329|NCT05204628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220330|NCT05204628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220331|NCT05204628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220332|NCT05204628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220333|NCT03650738|Paclitaxel|paclitaxel|mesh-list
93220334|NCT03650738|Carboplatin|carboplatin|mesh-list
93220335|NCT03650738|Apatinib|apatinib|mesh-list
93220336|NCT03650738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93220337|NCT03650738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220338|NCT03650738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220339|NCT03650738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220340|NCT03650738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220341|NCT03650738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220342|NCT03650738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220343|NCT03650738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220344|NCT02904200|Silicon|silicon|mesh-list
93220345|NCT02904200|Trace Elements|trace elements|mesh-ancestor
93220346|NCT02904200|Micronutrients|micronutrients|mesh-ancestor
93220347|NCT02904200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220348|NCT03432533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93220349|NCT03432533|Immunologic Factors|immunologic factors|mesh-ancestor
93220350|NCT03432533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220351|NCT03621800|Menthol|menthol|mesh-list
93220352|NCT03621800|Antipruritics|antipruritics|mesh-ancestor
93220353|NCT03621800|Dermatologic Agents|dermatologic agents|mesh-ancestor
93220354|NCT03649334|Ketorolac|ketorolac|mesh-list
93220355|NCT03649334|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93220356|NCT03649334|Fentanyl|fentanyl|mesh-list
93220357|NCT03649334|Ketamine|ketamine|mesh-list
93220358|NCT03649334|Analgesics|analgesics|mesh-ancestor
93220359|NCT03649334|Sensory System Agents|sensory system agents|mesh-ancestor
93220360|NCT03649334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220361|NCT03649334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220362|NCT03649334|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93220363|NCT03649334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93220364|NCT03649334|Anesthetics, General|anesthetics, general|mesh-ancestor
93220365|NCT03649334|Anesthetics|anesthetics|mesh-ancestor
93220366|NCT03649334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220367|NCT03649334|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93220368|NCT03649334|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93220369|NCT03649334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220370|NCT03649334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220371|NCT03649334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93220372|NCT03649334|Narcotics|narcotics|mesh-ancestor
93220373|NCT03649334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93220374|NCT03649334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93220375|NCT03649334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220376|NCT03649334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220377|NCT03649334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220378|NCT03649334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93220379|NCT03649334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220380|NCT02901548|Durvalumab|durvalumab|mesh-list
93220381|NCT02901548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220382|NCT02901548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366327|NCT02060279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366328|NCT02060279|Protective Agents|protective agents|mesh-ancestor
93366329|NCT02060279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366330|NCT02058641|Darapladib|darapladib|mesh-list
93366331|NCT02058641|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93366332|NCT02058641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366333|NCT02058641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366334|NCT02059889|Deoxyglucose|deoxyglucose|mesh-list
93366335|NCT02059889|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93366336|NCT02059889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93366337|NCT02059889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366338|NCT02059889|Antimetabolites|antimetabolites|mesh-ancestor
93366339|NCT02059889|Antiviral Agents|antiviral agents|mesh-ancestor
93366340|NCT02059889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366341|NCT02059967|Paclitaxel|paclitaxel|mesh-list
93366342|NCT02059967|Carboplatin|carboplatin|mesh-list
93366343|NCT02059967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93366344|NCT02059967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366345|NCT02059967|Tubulin Modulators|tubulin modulators|mesh-ancestor
93366346|NCT02059967|Antimitotic Agents|antimitotic agents|mesh-ancestor
93366347|NCT02059967|Mitosis Modulators|mitosis modulators|mesh-ancestor
93366348|NCT02059967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366349|NCT02061137|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93366350|NCT02061137|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93366351|NCT02061137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366352|NCT02061137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366353|NCT02061137|Immunologic Factors|immunologic factors|mesh-ancestor
93366354|NCT02061137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366355|NCT02061449|Romidepsin|romidepsin|mesh-list
93366356|NCT02061449|Poly ICLC|poly iclc|mesh-list
93366357|NCT02061449|Interferon Inducers|interferon inducers|mesh-ancestor
93366358|NCT02061449|Immunologic Factors|immunologic factors|mesh-ancestor
93366359|NCT02061449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366360|NCT02061449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93366361|NCT02061449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366362|NCT02061449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93366363|NCT02061449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366364|NCT02061449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366365|NCT02060591|Bupivacaine|bupivacaine|mesh-list
93366366|NCT02060591|Anesthetics, Local|anesthetics, local|mesh-ancestor
93366367|NCT02060591|Anesthetics|anesthetics|mesh-ancestor
93366368|NCT02060591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366369|NCT02060591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366370|NCT02060591|Sensory System Agents|sensory system agents|mesh-ancestor
93366371|NCT02060591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366372|NCT02060669|Capecitabine|capecitabine|mesh-list
93366373|NCT02060669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366374|NCT02060669|Antimetabolites|antimetabolites|mesh-ancestor
93366375|NCT02060669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366376|NCT02060669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366377|NCT04428008|Thymalfasin|thymalfasin|mesh-list
93366378|NCT04428008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93366379|NCT04428008|Immunologic Factors|immunologic factors|mesh-ancestor
93366380|NCT04428008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366381|NCT02046590|Propofol|propofol|mesh-list
93366382|NCT02046590|Anesthetics|anesthetics|mesh-ancestor
93366383|NCT02046590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366384|NCT02046590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366385|NCT02046590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93366386|NCT02046590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93366387|NCT02046590|Anesthetics, General|anesthetics, general|mesh-ancestor
93366388|NCT02796755|Riluzole|riluzole|mesh-list
92892496|NCT02624310|Droxidopa|droxidopa|mesh-list
93220383|NCT03457727|Omeprazole|omeprazole|mesh-list
93220384|NCT03457727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93220385|NCT03457727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93220386|NCT03457727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93220387|NCT03457727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220388|NCT03457727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220389|NCT05285384|Myeloma Proteins|myeloma proteins|mesh-list
93220390|NCT05285384|Paraproteins|paraproteins|mesh-list
93220391|NCT05285384|Immunologic Factors|immunologic factors|mesh-ancestor
93220392|NCT05285384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220393|NCT03648554|Dulaglutide|dulaglutide|mesh-list
93220394|NCT03648554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93220395|NCT03648554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220396|NCT03648320|Immunomodulating Agents|immunomodulating agents|mesh-list
93220397|NCT03648320|Immunologic Factors|immunologic factors|mesh-ancestor
93220398|NCT03648320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220399|NCT05284994|Osimertinib|osimertinib|mesh-list
93220400|NCT05284994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220401|NCT05284994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220402|NCT05284994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220403|NCT05284994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220404|NCT03068754|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93220405|NCT03068754|Hormones|hormones|mesh-ancestor
93220406|NCT03068754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93220407|NCT03068754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220408|NCT02965820|Contact Lens Solutions|contact lens solutions|mesh-list
93220409|NCT02965820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93220410|NCT02965820|Disinfectants|disinfectants|mesh-ancestor
93220411|NCT02965820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220412|NCT03430895|Durvalumab|durvalumab|mesh-list
93220413|NCT03430895|Tremelimumab|tremelimumab|mesh-list
93220414|NCT03430895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220415|NCT03430895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220416|NCT05745480|Analgesics, Opioid|analgesics, opioid|mesh-list
93220417|NCT05745480|Narcotics|narcotics|mesh-ancestor
93220418|NCT05745480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220419|NCT05745480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220420|NCT05745480|Analgesics|analgesics|mesh-ancestor
93220421|NCT05745480|Sensory System Agents|sensory system agents|mesh-ancestor
93220422|NCT05745480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220423|NCT03452189|Vancomycin|vancomycin|mesh-list
93220424|NCT03452189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93220425|NCT03452189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220426|NCT00603954|Fludarabine|fludarabine|mesh-list
93220427|NCT00603954|Fludarabine phosphate|fludarabine phosphate|mesh-list
93220428|NCT00603954|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93220429|NCT00603954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220430|NCT00603954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93220431|NCT00603954|Antimetabolites|antimetabolites|mesh-ancestor
93220432|NCT00603954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220433|NCT00603954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220434|NCT00603954|Immunologic Factors|immunologic factors|mesh-ancestor
93220435|NCT00603954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220436|NCT03427619|Picibanil|picibanil|mesh-list
93220437|NCT03427619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220438|NCT03712475|Pregabalin|pregabalin|mesh-list
93220439|NCT03712475|Analgesics|analgesics|mesh-ancestor
93220440|NCT03712475|Sensory System Agents|sensory system agents|mesh-ancestor
93220441|NCT03712475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220442|NCT03712475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220443|NCT03712475|Anticonvulsants|anticonvulsants|mesh-ancestor
93220444|NCT03712475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93220445|NCT03712475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220446|NCT03712475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220447|NCT03712475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93220448|NCT03712475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93220449|NCT03712475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93220450|NCT03712475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220451|NCT03712475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93220452|NCT02435433|Ramucirumab|ramucirumab|mesh-list
93220453|NCT02435433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220454|NCT01372371|Vancomycin|vancomycin|mesh-list
93220455|NCT01372371|Gentamicins|gentamicins|mesh-list
93220456|NCT01372371|Cefuroxime|cefuroxime|mesh-list
93220457|NCT01372371|Cefuroxime axetil|cefuroxime axetil|mesh-list
93220458|NCT01372371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93366389|NCT02796755|Anticonvulsants|anticonvulsants|mesh-ancestor
93220459|NCT01372371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220460|NCT01372371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93220461|NCT01372371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220462|NCT01372371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220463|NCT03120351|Lidocaine|lidocaine|mesh-list
93220464|NCT03120351|Anesthetics, Local|anesthetics, local|mesh-ancestor
93220465|NCT03120351|Anesthetics|anesthetics|mesh-ancestor
93220466|NCT03120351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220467|NCT03120351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220468|NCT03120351|Sensory System Agents|sensory system agents|mesh-ancestor
93220469|NCT03120351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220470|NCT03120351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93220471|NCT03120351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93220472|NCT03120351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93220473|NCT03120351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220474|NCT03120351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220475|NCT05165355|Aflutinib|aflutinib|mesh-list
93220476|NCT05165355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220477|NCT05165355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220478|NCT05165355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220479|NCT01374789|Panitumumab|panitumumab|mesh-list
93220480|NCT01374789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220481|NCT01374789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220482|NCT02354703|Ondansetron|ondansetron|mesh-list
93220483|NCT02354703|Antiemetics|antiemetics|mesh-ancestor
93220484|NCT02354703|Autonomic Agents|autonomic agents|mesh-ancestor
93220485|NCT02354703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220486|NCT02354703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220487|NCT02354703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93220488|NCT02354703|Antipruritics|antipruritics|mesh-ancestor
93220489|NCT02354703|Dermatologic Agents|dermatologic agents|mesh-ancestor
93220490|NCT02354703|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93220491|NCT02354703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93220492|NCT02354703|Serotonin Agents|serotonin agents|mesh-ancestor
93220493|NCT02354703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220494|NCT02354703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220495|NCT05008887|Fluorouracil|fluorouracil|mesh-list
93220496|NCT05008887|Methotrexate|methotrexate|mesh-list
93220497|NCT05008887|Antimetabolites|antimetabolites|mesh-ancestor
93220498|NCT05008887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220499|NCT05008887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93220500|NCT05008887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220501|NCT05008887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220502|NCT05008887|Immunologic Factors|immunologic factors|mesh-ancestor
93220503|NCT05008887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220504|NCT05008887|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93220505|NCT05008887|Abortifacient Agents|abortifacient agents|mesh-ancestor
93220506|NCT05008887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93220507|NCT05008887|Dermatologic Agents|dermatologic agents|mesh-ancestor
93220508|NCT05008887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220509|NCT05008887|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93220510|NCT05008887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220511|NCT05008887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93220512|NCT01376193|Naratriptan|naratriptan|mesh-list
93220513|NCT01376193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93220514|NCT01376193|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93220515|NCT01376193|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93220516|NCT01376193|Serotonin Agents|serotonin agents|mesh-ancestor
93220517|NCT01376193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220518|NCT01376193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220519|NCT01376193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220520|NCT04944771|Rabeprazole|rabeprazole|mesh-list
93220521|NCT04944771|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93220522|NCT04944771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93220523|NCT04944771|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93220524|NCT04944771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220525|NCT04944771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220526|NCT01375023|Thymoglobulin|thymoglobulin|mesh-list
93220527|NCT01375023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93220528|NCT01375023|Immunologic Factors|immunologic factors|mesh-ancestor
93220529|NCT01375023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220530|NCT01375023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92892641|NCT05215405|Venetoclax|venetoclax|mesh-list
93220531|NCT05197101|Oxytocin|oxytocin|mesh-list
93220532|NCT05197101|Oxytocics|oxytocics|mesh-ancestor
93220533|NCT05197101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93220534|NCT05197101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220535|NCT01375101|Quercetin|quercetin|mesh-list
93220536|NCT01375101|Antioxidants|antioxidants|mesh-ancestor
93220537|NCT01375101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220538|NCT01375101|Protective Agents|protective agents|mesh-ancestor
93220539|NCT01375101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220540|NCT04865289|Paclitaxel|paclitaxel|mesh-list
93220541|NCT04865289|Carboplatin|carboplatin|mesh-list
93220542|NCT04865289|Pembrolizumab|pembrolizumab|mesh-list
93220543|NCT04865289|Lenvatinib|lenvatinib|mesh-list
93220544|NCT04865289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93220545|NCT04865289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220546|NCT04865289|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220547|NCT04865289|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220548|NCT04865289|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220549|NCT04865289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220550|NCT04865289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220551|NCT04865289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93220552|NCT04865289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220553|NCT04865289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220554|NCT03633591|Tolcapone|tolcapone|mesh-list
93220555|NCT03633591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93220556|NCT03633591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93220557|NCT03633591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93220558|NCT03633591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220559|NCT03633591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220560|NCT01376271|Paroxetine|paroxetine|mesh-list
93220561|NCT01376271|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93220562|NCT01376271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93220563|NCT01376271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220564|NCT01376271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220565|NCT01376271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220566|NCT01376271|Serotonin Agents|serotonin agents|mesh-ancestor
93220567|NCT01376271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220568|NCT01376271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93220569|NCT01376271|Antidepressive Agents|antidepressive agents|mesh-ancestor
93220570|NCT01376271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93220571|NCT01376271|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93220572|NCT01376271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93220573|NCT01376271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220574|NCT04885881|Lidocaine|lidocaine|mesh-list
93220575|NCT04885881|Anesthetics, Local|anesthetics, local|mesh-ancestor
93220576|NCT04885881|Anesthetics|anesthetics|mesh-ancestor
93220577|NCT04885881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220578|NCT04885881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220579|NCT04885881|Sensory System Agents|sensory system agents|mesh-ancestor
92856017|NCT00603317|Amoxicillin|amoxicillin|mesh-list
93220580|NCT04885881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220581|NCT04885881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93220582|NCT04885881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93220583|NCT04885881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93220584|NCT04885881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93220585|NCT04885881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220586|NCT04820205|Dexmedetomidine|dexmedetomidine|mesh-list
93220587|NCT04820205|Ketamine|ketamine|mesh-list
93220588|NCT04820205|Chloral Hydrate|chloral hydrate|mesh-list
93220589|NCT04820205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93220590|NCT04820205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220591|NCT04820205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220592|NCT04820205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220593|NCT04820205|Analgesics|analgesics|mesh-ancestor
93220594|NCT04820205|Sensory System Agents|sensory system agents|mesh-ancestor
93220595|NCT04820205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220596|NCT04820205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93220597|NCT04820205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93220598|NCT04820205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93220599|NCT04820205|Adrenergic Agents|adrenergic agents|mesh-ancestor
93220600|NCT04820205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220601|NCT04820205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220602|NCT04820205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93220603|NCT04820205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93220604|NCT04820205|Anesthetics, General|anesthetics, general|mesh-ancestor
93220605|NCT04820205|Anesthetics|anesthetics|mesh-ancestor
93220606|NCT04820205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93220607|NCT04820205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93220608|NCT01375257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93220609|NCT01375257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93220610|NCT01375257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220611|NCT01375257|Antitubercular Agents|antitubercular agents|mesh-ancestor
93220612|NCT01375335|Dobutamine|dobutamine|mesh-list
93220613|NCT01375335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93220614|NCT01375335|Sympathomimetics|sympathomimetics|mesh-ancestor
93220615|NCT01375335|Autonomic Agents|autonomic agents|mesh-ancestor
93220616|NCT01375335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220617|NCT01375335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220618|NCT01375335|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93220619|NCT01375335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93220620|NCT01375335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93220621|NCT01375335|Adrenergic Agents|adrenergic agents|mesh-ancestor
93220622|NCT01375335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220623|NCT01375335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220624|NCT01375335|Protective Agents|protective agents|mesh-ancestor
93220625|NCT01373463|Carboplatin|carboplatin|mesh-list
93220626|NCT01373463|Pemetrexed|pemetrexed|mesh-list
93220627|NCT01373463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220628|NCT01373463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220629|NCT01373463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220630|NCT01373463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93220631|NCT01373463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93220632|NCT04573647|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93220633|NCT04573647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93220634|NCT03113409|Naltrexone|naltrexone|mesh-list
93220635|NCT03113409|Buprenorphine|buprenorphine|mesh-list
93220636|NCT03113409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93220637|NCT03113409|Narcotics|narcotics|mesh-ancestor
93220638|NCT03113409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220639|NCT03113409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220640|NCT03113409|Analgesics|analgesics|mesh-ancestor
93220641|NCT03113409|Sensory System Agents|sensory system agents|mesh-ancestor
93220642|NCT03113409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220643|NCT03113409|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93220644|NCT03113409|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93220645|NCT05193747|Anesthetics|anesthetics|mesh-list
93220646|NCT05193747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220647|NCT05193747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220648|NCT03634293|Alirocumab|alirocumab|mesh-list
93220649|NCT03634293|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93220650|NCT03634293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93220651|NCT03634293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93220652|NCT03634293|Antimetabolites|antimetabolites|mesh-ancestor
93220653|NCT03634293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220654|NCT03634293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93220655|NCT03634293|Protease Inhibitors|protease inhibitors|mesh-ancestor
93220656|NCT03634293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220657|NCT03634293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93220658|NCT01373541|Palmitic Acid|palmitic acid|mesh-list
93220659|NCT01373541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220660|NCT01373541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220661|NCT03633747|Propranolol|propranolol|mesh-list
93220662|NCT03633747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93220663|NCT03633747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93220664|NCT03633747|Adrenergic Agents|adrenergic agents|mesh-ancestor
93220665|NCT03633747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220666|NCT03633747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220667|NCT03633747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220668|NCT03633747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93220669|NCT03633747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93220670|NCT03633747|Vasodilator Agents|vasodilator agents|mesh-ancestor
93220671|NCT01376817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93220672|NCT01376817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93220673|NCT01376817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93220674|NCT01376817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93220675|NCT01373697|Ibuprofen|ibuprofen|mesh-list
93220676|NCT01373697|Ketoprofen|ketoprofen|mesh-list
93220677|NCT01373697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93220678|NCT01373697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220679|NCT01373697|Analgesics|analgesics|mesh-ancestor
93220680|NCT01373697|Sensory System Agents|sensory system agents|mesh-ancestor
93220681|NCT01373697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220682|NCT01373697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220683|NCT01373697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220684|NCT01373697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220685|NCT01373697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93220686|NCT01373697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220687|NCT01373697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220688|NCT01375881|Ritonavir|ritonavir|mesh-list
93220689|NCT01375881|Darunavir|darunavir|mesh-list
93220690|NCT01375881|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93220691|NCT01375881|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93220692|NCT01375881|Protease Inhibitors|protease inhibitors|mesh-ancestor
93220693|NCT01375881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220694|NCT01375881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220695|NCT01375881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93220696|NCT01375881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93220697|NCT01375881|Antiviral Agents|antiviral agents|mesh-ancestor
93220698|NCT01375881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220699|NCT01375881|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93220700|NCT01375881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93220701|NCT04690023|Ropivacaine|ropivacaine|mesh-list
93220702|NCT04690023|Anesthetics, Local|anesthetics, local|mesh-ancestor
93220703|NCT04690023|Anesthetics|anesthetics|mesh-ancestor
93220704|NCT04690023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220705|NCT04690023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220706|NCT04690023|Sensory System Agents|sensory system agents|mesh-ancestor
93220707|NCT04690023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220708|NCT03066804|Valsartan|valsartan|mesh-list
93220709|NCT03066804|Enalapril|enalapril|mesh-list
93220710|NCT03066804|Enalaprilat|enalaprilat|mesh-list
93220711|NCT03066804|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93220712|NCT03066804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93220713|NCT03066804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93220714|NCT03066804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93220715|NCT03066804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220716|NCT03066804|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93220717|NCT03066804|Protease Inhibitors|protease inhibitors|mesh-ancestor
93220718|NCT03066804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220719|NCT03629262|Sufentanil|sufentanil|mesh-list
93220720|NCT03629262|Dexmedetomidine|dexmedetomidine|mesh-list
93220721|NCT03629262|Dsuvia|dsuvia|mesh-list
93220722|NCT03629262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93220723|NCT03629262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220724|NCT03629262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220725|NCT03629262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220726|NCT03629262|Analgesics|analgesics|mesh-ancestor
93220727|NCT03629262|Sensory System Agents|sensory system agents|mesh-ancestor
93220728|NCT03629262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220729|NCT03629262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93220730|NCT03629262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93220731|NCT03629262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93220732|NCT03629262|Adrenergic Agents|adrenergic agents|mesh-ancestor
93220733|NCT03629262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220734|NCT03629262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220735|NCT03629262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93220736|NCT03629262|Narcotics|narcotics|mesh-ancestor
93220737|NCT03629262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93220738|NCT03629262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93220739|NCT03629262|Anesthetics, General|anesthetics, general|mesh-ancestor
93220740|NCT03629262|Anesthetics|anesthetics|mesh-ancestor
93220741|NCT05208294|Sulpiride|sulpiride|mesh-list
93220742|NCT05208294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93220743|NCT05208294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93220744|NCT05208294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220745|NCT05208294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220746|NCT05208294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93220747|NCT05208294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93220748|NCT05208294|Dopamine Agents|dopamine agents|mesh-ancestor
93220749|NCT05208294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220750|NCT05208294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220751|NCT05208294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93220752|NCT05208294|Antidepressive Agents|antidepressive agents|mesh-ancestor
93220753|NCT05213988|Clofibric Acid|clofibric acid|mesh-list
93220754|NCT05213988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93220755|NCT05213988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93220756|NCT05213988|Antimetabolites|antimetabolites|mesh-ancestor
93220757|NCT05213988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220758|NCT05213988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93220759|NCT05207904|Paclitaxel|paclitaxel|mesh-list
93220760|NCT05207904|Carboplatin|carboplatin|mesh-list
93220761|NCT05207904|Tislelizumab|tislelizumab|mesh-list
93220762|NCT05207904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93220763|NCT05207904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220764|NCT05207904|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220765|NCT05207904|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220766|NCT05207904|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220767|NCT05207904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220768|NCT05207904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220769|NCT05207514|Ethanol|ethanol|mesh-list
93220770|NCT05207514|Cyclophosphamide|cyclophosphamide|mesh-list
93220771|NCT05207514|Docetaxel|docetaxel|mesh-list
93220772|NCT05207514|Doxorubicin|doxorubicin|mesh-list
93220773|NCT05207514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220774|NCT05207514|Immunologic Factors|immunologic factors|mesh-ancestor
93220775|NCT05207514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220776|NCT05207514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220777|NCT05207514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93220778|NCT05207514|Alkylating Agents|alkylating agents|mesh-ancestor
93220779|NCT05207514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220780|NCT05207514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220781|NCT05207514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93220782|NCT05207514|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220783|NCT05207514|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220784|NCT05207514|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220785|NCT05207514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93220786|NCT05207514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93220787|NCT05207514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93220788|NCT05207514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220789|NCT05207514|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93220790|NCT05207514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220791|NCT05207514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220792|NCT03118947|Pimavanserin|pimavanserin|mesh-list
93220793|NCT03118947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93220794|NCT03118947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93220795|NCT03118947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93220796|NCT03118947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93220797|NCT03118947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220798|NCT03118947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220799|NCT03118947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93220800|NCT03118947|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93220801|NCT03118947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93220802|NCT03118947|Serotonin Agents|serotonin agents|mesh-ancestor
93220803|NCT03118947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220804|NCT03118947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220805|NCT03998319|Tenecteplase|tenecteplase|mesh-list
93220806|NCT03998319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93220807|NCT03998319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93220808|NCT03998319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220809|NCT03953079|Sunitinib|sunitinib|mesh-list
93220810|NCT03953079|Aflibercept|aflibercept|mesh-list
93220811|NCT03953079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220812|NCT03953079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93220813|NCT03953079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93220814|NCT03953079|Growth Substances|growth substances|mesh-ancestor
93220815|NCT03953079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220816|NCT03953079|Growth Inhibitors|growth inhibitors|mesh-ancestor
93220817|NCT03953079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220818|NCT03953079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220819|NCT03953079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220820|NCT03794427|Anesthetics|anesthetics|mesh-list
93220821|NCT03794427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220822|NCT03794427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220823|NCT03410901|Antibodies|antibodies|mesh-list
93220824|NCT03410901|Immunologic Factors|immunologic factors|mesh-ancestor
93220825|NCT03410901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220826|NCT03357939|Adalimumab|adalimumab|mesh-list
93220827|NCT03357939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93220828|NCT03357939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220829|NCT03357939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220830|NCT03567057|Amantadine|amantadine|mesh-list
93220831|NCT03567057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93220832|NCT03567057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93220833|NCT03567057|Antiviral Agents|antiviral agents|mesh-ancestor
93220834|NCT03567057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220835|NCT03567057|Dopamine Agents|dopamine agents|mesh-ancestor
93220836|NCT03567057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93220837|NCT03567057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220838|NCT03567057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220839|NCT03567057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93220840|NCT03567057|Analgesics|analgesics|mesh-ancestor
93220841|NCT03567057|Sensory System Agents|sensory system agents|mesh-ancestor
93220842|NCT03567057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220843|NCT03057600|Paclitaxel|paclitaxel|mesh-list
93220844|NCT03057600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93220845|NCT03057600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220846|NCT03057600|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220847|NCT03057600|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220848|NCT03057600|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220849|NCT03057600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220850|NCT04382937|Ribavirin|ribavirin|mesh-list
93220851|NCT04382937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93220852|NCT04382937|Antimetabolites|antimetabolites|mesh-ancestor
93220853|NCT04382937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220854|NCT04382937|Antiviral Agents|antiviral agents|mesh-ancestor
93220855|NCT04382937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220856|NCT05206890|Fluzoparib|fluzoparib|mesh-list
93220857|NCT05206890|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93220858|NCT05206890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220859|NCT05206890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220860|NCT05206890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220861|NCT02966301|Arsenic Trioxide|arsenic trioxide|mesh-list
93220862|NCT02966301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220863|NCT03107091|Terlipressin|terlipressin|mesh-list
93220864|NCT03107091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93220865|NCT03107091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93220866|NCT03849768|Gefitinib|gefitinib|mesh-list
93220867|NCT03849768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220868|NCT03849768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93220869|NCT03849768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220870|NCT03849768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220871|NCT03189693|Anesthetics|anesthetics|mesh-list
93220872|NCT03189693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220873|NCT03189693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220874|NCT03065400|Pembrolizumab|pembrolizumab|mesh-list
93220875|NCT03065400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220876|NCT03065400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220877|NCT03065400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93220878|NCT03065400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220879|NCT05734716|Epoetin Alfa|epoetin alfa|mesh-list
93220880|NCT05734716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93220881|NCT05734716|Hematinics|hematinics|mesh-ancestor
93220882|NCT05733000|Thioctic Acid|thioctic acid|mesh-list
93220883|NCT05733000|Hydroxychloroquine|hydroxychloroquine|mesh-list
93220884|NCT05733000|Gemcitabine|gemcitabine|mesh-list
93220885|NCT05733000|Fluorouracil|fluorouracil|mesh-list
93220886|NCT05733000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93220887|NCT05733000|Antimetabolites|antimetabolites|mesh-ancestor
93220888|NCT05733000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220889|NCT05733000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220890|NCT05733000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220891|NCT05733000|Immunologic Factors|immunologic factors|mesh-ancestor
93220892|NCT05733000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220893|NCT05733000|Antimalarials|antimalarials|mesh-ancestor
93220894|NCT05733000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93220895|NCT05733000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93220896|NCT05733000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220897|NCT05733000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220898|NCT05733000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220899|NCT05733000|Antioxidants|antioxidants|mesh-ancestor
93220900|NCT05733000|Protective Agents|protective agents|mesh-ancestor
93220901|NCT05733000|Vitamin B Complex|vitamin b complex|mesh-ancestor
93220902|NCT05733000|Vitamins|vitamins|mesh-ancestor
93220903|NCT05733000|Micronutrients|micronutrients|mesh-ancestor
93220904|NCT03417180|Remifentanil|remifentanil|mesh-list
93220905|NCT03417180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93220907|NCT03417180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220908|NCT03417180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220909|NCT03417180|Analgesics|analgesics|mesh-ancestor
93220910|NCT03417180|Sensory System Agents|sensory system agents|mesh-ancestor
93220911|NCT03417180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220912|NCT03085095|Leuprolide|leuprolide|mesh-list
93220913|NCT03085095|Relugolix|relugolix|mesh-list
93220914|NCT03085095|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93220915|NCT03085095|Fertility Agents|fertility agents|mesh-ancestor
93220916|NCT03085095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93220917|NCT03085095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220918|NCT03085095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93220919|NCT03085095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220920|NCT03085095|Androgen Antagonists|androgen antagonists|mesh-ancestor
93220921|NCT03085095|Hormone Antagonists|hormone antagonists|mesh-ancestor
93220922|NCT03085095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93220923|NCT02891811|Thalidomide|thalidomide|mesh-list
93220924|NCT02891811|Dexamethasone|dexamethasone|mesh-list
93220925|NCT02891811|Lenalidomide|lenalidomide|mesh-list
93220926|NCT02891811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93220927|NCT02891811|Antiemetics|antiemetics|mesh-ancestor
93220928|NCT02891811|Autonomic Agents|autonomic agents|mesh-ancestor
93220929|NCT02891811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220930|NCT02891811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220931|NCT02891811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93220932|NCT02891811|Glucocorticoids|glucocorticoids|mesh-ancestor
93220933|NCT02891811|Hormones|hormones|mesh-ancestor
93220934|NCT02891811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93220935|NCT02891811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93220936|NCT02891811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220937|NCT02891811|Immunologic Factors|immunologic factors|mesh-ancestor
93220938|NCT02891811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93220939|NCT02891811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93220940|NCT02891811|Growth Substances|growth substances|mesh-ancestor
93220941|NCT02891811|Growth Inhibitors|growth inhibitors|mesh-ancestor
93220942|NCT02891811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220943|NCT02891811|Leprostatic Agents|leprostatic agents|mesh-ancestor
93220944|NCT02891811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93220945|NCT02891811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220946|NCT02811783|Naloxone|naloxone|mesh-list
93220947|NCT02811783|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93220948|NCT02811783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220949|NCT02811783|Sensory System Agents|sensory system agents|mesh-ancestor
93220950|NCT02811783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93220951|NCT02649855|Docetaxel|docetaxel|mesh-list
93220952|NCT02649855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220953|NCT02649855|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220954|NCT02649855|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220955|NCT02649855|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220956|NCT02649855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220957|NCT05720715|Cyclosporine|cyclosporine|mesh-list
93220958|NCT05720715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93220959|NCT05720715|Cyclosporins|cyclosporins|mesh-list
93220960|NCT05720715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93220961|NCT05720715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220962|NCT05720715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220963|NCT05720715|Immunologic Factors|immunologic factors|mesh-ancestor
93220964|NCT05720715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220965|NCT05720715|Antifungal Agents|antifungal agents|mesh-ancestor
93220966|NCT05720715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93220967|NCT05720715|Dermatologic Agents|dermatologic agents|mesh-ancestor
93220968|NCT05720715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220969|NCT05720715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93220970|NCT05720715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93220971|NCT02310867|Abatacept|abatacept|mesh-list
93220972|NCT02310867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93220973|NCT02310867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220974|NCT02310867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220975|NCT02310867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220976|NCT02310867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93220977|NCT02310867|Immunologic Factors|immunologic factors|mesh-ancestor
93220978|NCT02310867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220979|NCT02310867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93220980|NCT05757219|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93220981|NCT05757219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93220982|NCT05757219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220983|NCT03106077|Maytansine|maytansine|mesh-list
93220984|NCT03106077|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
93220985|NCT03106077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93220986|NCT03106077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93220987|NCT03106077|Tubulin Modulators|tubulin modulators|mesh-ancestor
93220988|NCT03106077|Antimitotic Agents|antimitotic agents|mesh-ancestor
93220989|NCT03106077|Mitosis Modulators|mitosis modulators|mesh-ancestor
93220990|NCT03106077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93220991|NCT03106077|Immunoconjugates|immunoconjugates|mesh-ancestor
93220992|NCT03106077|Immunologic Factors|immunologic factors|mesh-ancestor
93220993|NCT03106077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93220994|NCT03648008|Morphine|morphine|mesh-list
93220995|NCT03648008|Hydromorphone|hydromorphone|mesh-list
93220996|NCT03648008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93220997|NCT03648008|Narcotics|narcotics|mesh-ancestor
93220998|NCT03648008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93220999|NCT03648008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221000|NCT03648008|Analgesics|analgesics|mesh-ancestor
93221001|NCT03648008|Sensory System Agents|sensory system agents|mesh-ancestor
93221002|NCT03648008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221003|NCT05702541|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93221004|NCT05702541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93221005|NCT05702541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221006|NCT05253495|Cytarabine|cytarabine|mesh-list
93221007|NCT05253495|Etoposide|etoposide|mesh-list
93221008|NCT05253495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93221009|NCT05253495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221010|NCT05253495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93221011|NCT05253495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93221012|NCT05253495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221013|NCT05253495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221014|NCT05253495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93221015|NCT05253495|Antimetabolites|antimetabolites|mesh-ancestor
93221016|NCT05253495|Antiviral Agents|antiviral agents|mesh-ancestor
93221017|NCT05253495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221018|NCT05253495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221019|NCT05253495|Immunologic Factors|immunologic factors|mesh-ancestor
93221020|NCT05253495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221021|NCT05054751|Fulvestrant|fulvestrant|mesh-list
93221022|NCT05054751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221023|NCT05054751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221024|NCT05054751|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93221025|NCT05054751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93221026|NCT05054751|Hormone Antagonists|hormone antagonists|mesh-ancestor
93221027|NCT05054751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221028|NCT05054751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221029|NCT00604617|Interferons|interferons|mesh-list
93221030|NCT00604617|Interferon-gamma|interferon-gamma|mesh-list
93221031|NCT00604617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221032|NCT00604617|Antiviral Agents|antiviral agents|mesh-ancestor
93221033|NCT00604617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221034|NCT03426995|Cantharidin|cantharidin|mesh-list
93221035|NCT03426995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221036|NCT03426995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221037|NCT05200299|Leucovorin|leucovorin|mesh-list
93221038|NCT05200299|Fluorouracil|fluorouracil|mesh-list
93221039|NCT05200299|Capecitabine|capecitabine|mesh-list
93221040|NCT05200299|Oxaliplatin|oxaliplatin|mesh-list
93221041|NCT05200299|Irinotecan|irinotecan|mesh-list
93221042|NCT05200299|Levoleucovorin|levoleucovorin|mesh-list
93221043|NCT05200299|Antimetabolites|antimetabolites|mesh-ancestor
93221044|NCT05200299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221045|NCT05200299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93221046|NCT05200299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221047|NCT05200299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221048|NCT05200299|Immunologic Factors|immunologic factors|mesh-ancestor
93221049|NCT05200299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221050|NCT05200299|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93221051|NCT05200299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93221052|NCT05200299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221053|NCT05200299|Antidotes|antidotes|mesh-ancestor
93221054|NCT05200299|Protective Agents|protective agents|mesh-ancestor
93221055|NCT05200299|Vitamin B Complex|vitamin b complex|mesh-ancestor
93221056|NCT05200299|Vitamins|vitamins|mesh-ancestor
93221057|NCT05200299|Micronutrients|micronutrients|mesh-ancestor
93221058|NCT03322566|Pembrolizumab|pembrolizumab|mesh-list
93221059|NCT03322566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221060|NCT03322566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221061|NCT03322566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221062|NCT03322566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221063|NCT03822975|Heparin|heparin|mesh-list
93221064|NCT03822975|Calcium heparin|calcium heparin|mesh-list
93221065|NCT03822975|Bivalirudin|bivalirudin|mesh-list
93221066|NCT03822975|Anticoagulants|anticoagulants|mesh-ancestor
93221067|NCT03822975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93221068|NCT03822975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93221069|NCT03822975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221070|NCT03822975|Antithrombins|antithrombins|mesh-ancestor
93221071|NCT03822975|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93221072|NCT03822975|Protease Inhibitors|protease inhibitors|mesh-ancestor
93221073|NCT03822975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221074|NCT05732532|Dexamethasone|dexamethasone|mesh-list
93221075|NCT05732532|Lidocaine|lidocaine|mesh-list
93221076|NCT05732532|Bupivacaine|bupivacaine|mesh-list
93221077|NCT05732532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221078|NCT05732532|Antiemetics|antiemetics|mesh-ancestor
93221079|NCT05732532|Autonomic Agents|autonomic agents|mesh-ancestor
93221080|NCT05732532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221081|NCT05732532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221082|NCT05732532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221083|NCT05732532|Glucocorticoids|glucocorticoids|mesh-ancestor
93221084|NCT05732532|Hormones|hormones|mesh-ancestor
93221085|NCT05732532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221086|NCT05732532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221087|NCT05732532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221088|NCT05732532|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221089|NCT05732532|Anesthetics|anesthetics|mesh-ancestor
93221090|NCT05732532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221091|NCT05732532|Sensory System Agents|sensory system agents|mesh-ancestor
93221092|NCT05732532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93221093|NCT05732532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93221094|NCT05732532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93221095|NCT05732532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93221096|NCT05732532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221097|NCT05178225|Ubiquinone|ubiquinone|mesh-list
93221098|NCT05178225|Coenzyme Q10|coenzyme q10|mesh-list
93221099|NCT05178225|Anticoagulants|anticoagulants|mesh-list
93221100|NCT05178225|Micronutrients|micronutrients|mesh-ancestor
93221101|NCT05178225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221102|NCT05178225|Vitamins|vitamins|mesh-ancestor
93221103|NCT02969018|PF-06700841|pf-06700841|mesh-list
93221104|NCT02969018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221105|NCT02969018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221106|NCT02969018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221107|NCT03255096|Rituximab|rituximab|mesh-list
93221108|NCT03255096|Venetoclax|venetoclax|mesh-list
93221109|NCT03255096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221110|NCT03255096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221111|NCT03255096|Immunologic Factors|immunologic factors|mesh-ancestor
93221112|NCT03255096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221113|NCT03255096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221114|NCT01319721|Mitomycins|mitomycins|mesh-list
93221115|NCT01319721|Mitomycin|mitomycin|mesh-list
93221116|NCT01319721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93221117|NCT01319721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221118|NCT01319721|Alkylating Agents|alkylating agents|mesh-ancestor
93221119|NCT01319721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221120|NCT01319721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93221121|NCT01319721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221122|NCT03792867|Doxorubicin|doxorubicin|mesh-list
93221123|NCT03792867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93221124|NCT03792867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221125|NCT03792867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93221126|NCT03792867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93221127|NCT03792867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221128|NCT03792867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221129|NCT03015324|Hydroxychloroquine|hydroxychloroquine|mesh-list
93221130|NCT03015324|Antimalarials|antimalarials|mesh-ancestor
92893244|NCT04116411|Valganciclovir|valganciclovir|mesh-list
93221131|NCT03015324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93221132|NCT03015324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93221133|NCT03015324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221134|NCT03015324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221135|NCT03015324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221136|NCT03015324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221137|NCT05139849|Methylprednisolone|methylprednisolone|mesh-list
93221138|NCT05139849|Hydrocortisone|hydrocortisone|mesh-list
93221139|NCT05139849|Vasopressins|vasopressins|mesh-list
93221140|NCT05139849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221141|NCT05139849|Antiemetics|antiemetics|mesh-ancestor
93221142|NCT05139849|Autonomic Agents|autonomic agents|mesh-ancestor
93221143|NCT05139849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221144|NCT05139849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221145|NCT05139849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221146|NCT05139849|Glucocorticoids|glucocorticoids|mesh-ancestor
93221147|NCT05139849|Hormones|hormones|mesh-ancestor
93221148|NCT05139849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221149|NCT05139849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93221150|NCT05139849|Protective Agents|protective agents|mesh-ancestor
93221151|NCT05139849|Hemostatics|hemostatics|mesh-ancestor
93221152|NCT05139849|Coagulants|coagulants|mesh-ancestor
93221153|NCT05139849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93221154|NCT05139849|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93221155|NCT05139849|Natriuretic Agents|natriuretic agents|mesh-ancestor
93221156|NCT03315741|Pirfenidone|pirfenidone|mesh-list
93221157|NCT03315741|Analgesics|analgesics|mesh-ancestor
93221158|NCT03315741|Sensory System Agents|sensory system agents|mesh-ancestor
93221159|NCT03315741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221160|NCT03315741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221161|NCT03315741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93221162|NCT03315741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93221163|NCT03315741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221164|NCT03315741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221165|NCT03315741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221166|NCT05077449|Fulvestrant|fulvestrant|mesh-list
93221167|NCT05077449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221168|NCT05077449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221169|NCT05077449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93221170|NCT05077449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93221171|NCT05077449|Hormone Antagonists|hormone antagonists|mesh-ancestor
93221172|NCT05077449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221173|NCT05077449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221174|NCT03632733|Tetracycline|tetracycline|mesh-list
93221175|NCT03632733|Clotrimazole|clotrimazole|mesh-list
93221176|NCT03632733|Miconazole|miconazole|mesh-list
93221177|NCT03632733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221178|NCT03632733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221179|NCT03632733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93221180|NCT03632733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517159|NCT00276796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93221181|NCT03632733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221182|NCT03632733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93221183|NCT03632733|Antifungal Agents|antifungal agents|mesh-ancestor
93221184|NCT03632733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93221185|NCT03632733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93221186|NCT03632733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93221187|NCT03632733|Hormone Antagonists|hormone antagonists|mesh-ancestor
93221188|NCT03632733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221189|NCT03632733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221190|NCT03632733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93221191|NCT03632733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93221192|NCT05074485|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93221193|NCT05074485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221194|NCT05305287|Pioglitazone|pioglitazone|mesh-list
93221195|NCT05305287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93221196|NCT05305287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221197|NCT03259425|Nivolumab|nivolumab|mesh-list
93221198|NCT03259425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221199|NCT03259425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221200|NCT03259425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221201|NCT03259425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221202|NCT03061188|Nivolumab|nivolumab|mesh-list
93221203|NCT03061188|Veliparib|veliparib|mesh-list
93221204|NCT03061188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221205|NCT03061188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221206|NCT03061188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93366390|NCT02796755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93221207|NCT03061188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221208|NCT03061188|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93221209|NCT03061188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221211|NCT05588453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93221212|NCT05588453|Alkylating Agents|alkylating agents|mesh-ancestor
93221213|NCT05588453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221214|NCT05588453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221215|NCT05186454|Dexamethasone|dexamethasone|mesh-list
93221216|NCT05186454|Midazolam|midazolam|mesh-list
93221217|NCT05186454|Morphine|morphine|mesh-list
93221218|NCT05186454|Bupivacaine|bupivacaine|mesh-list
93221219|NCT05186454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221220|NCT05186454|Antiemetics|antiemetics|mesh-ancestor
93221221|NCT05186454|Autonomic Agents|autonomic agents|mesh-ancestor
93221222|NCT05186454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221223|NCT05186454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221224|NCT05186454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221225|NCT05186454|Glucocorticoids|glucocorticoids|mesh-ancestor
93221226|NCT05186454|Hormones|hormones|mesh-ancestor
93221227|NCT05186454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221228|NCT05186454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221229|NCT05186454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221230|NCT05186454|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221231|NCT05186454|Anesthetics|anesthetics|mesh-ancestor
93221232|NCT05186454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221233|NCT05186454|Sensory System Agents|sensory system agents|mesh-ancestor
93221234|NCT05186454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93221235|NCT05186454|Narcotics|narcotics|mesh-ancestor
93221236|NCT05186454|Analgesics|analgesics|mesh-ancestor
93221237|NCT05186454|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93221238|NCT05186454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93221239|NCT05186454|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93221240|NCT05186454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93221241|NCT05186454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93221242|NCT05186454|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93221243|NCT05186454|Anesthetics, General|anesthetics, general|mesh-ancestor
93221244|NCT05186454|GABA Modulators|gaba modulators|mesh-ancestor
93221245|NCT05186454|GABA Agents|gaba agents|mesh-ancestor
93221246|NCT05186454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221247|NCT05186454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221248|NCT02113878|Cisplatin|cisplatin|mesh-list
93221249|NCT02113878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221250|NCT05162898|Lenvatinib|lenvatinib|mesh-list
93221251|NCT05162898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221252|NCT05162898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221253|NCT05162898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221254|NCT05162898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221255|NCT05113290|Sorafenib|sorafenib|mesh-list
93221256|NCT05113290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221257|NCT05113290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221258|NCT05113290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221259|NCT05113290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221260|NCT03477162|Metformin|metformin|mesh-list
93221261|NCT03477162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93221262|NCT03477162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221263|NCT03461952|Nivolumab|nivolumab|mesh-list
93221264|NCT03461952|Ipilimumab|ipilimumab|mesh-list
93221265|NCT03461952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221266|NCT03461952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221267|NCT03461952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221268|NCT03461952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221269|NCT03619824|Gemcitabine|gemcitabine|mesh-list
93221270|NCT03619824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221271|NCT03619824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93221272|NCT03619824|Antimetabolites|antimetabolites|mesh-ancestor
93221273|NCT03619824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221274|NCT01759836|Atorvastatin|atorvastatin|mesh-list
93221275|NCT01759836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93221276|NCT01759836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93221277|NCT01759836|Antimetabolites|antimetabolites|mesh-ancestor
93221278|NCT01759836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221279|NCT01759836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93221280|NCT01759836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92893386|NCT02638376|Riboflavin|riboflavin|mesh-list
93221281|NCT01759836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221283|NCT03447821|Rifamycin SV|rifamycin sv|mesh-list
93221284|NCT03447821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221285|NCT03447821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221286|NCT03447821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221287|NCT05630339|Vitamin D|vitamin d|mesh-list
93221288|NCT05630339|Cholecalciferol|cholecalciferol|mesh-list
93221289|NCT05630339|Vitamins|vitamins|mesh-ancestor
93221290|NCT05630339|Micronutrients|micronutrients|mesh-ancestor
93221291|NCT05630339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221292|NCT05630339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93221293|NCT05630339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93221294|NCT03447353|Acetaminophen|acetaminophen|mesh-list
93221295|NCT03447353|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93221296|NCT03447353|Hydrocodone|hydrocodone|mesh-list
93221297|NCT03447353|Alprazolam|alprazolam|mesh-list
93221298|NCT03447353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93221299|NCT03447353|Analgesics|analgesics|mesh-ancestor
93221300|NCT03447353|Sensory System Agents|sensory system agents|mesh-ancestor
93221301|NCT03447353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221302|NCT03447353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221303|NCT03447353|Antipyretics|antipyretics|mesh-ancestor
93221304|NCT03447353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93221305|NCT03447353|Narcotics|narcotics|mesh-ancestor
93221306|NCT03447353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221307|NCT03447353|Antitussive Agents|antitussive agents|mesh-ancestor
93221308|NCT03447353|Respiratory System Agents|respiratory system agents|mesh-ancestor
93221309|NCT03447353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93221310|NCT03447353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93221311|NCT03447353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93221312|NCT03447353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93221313|NCT03447353|GABA Modulators|gaba modulators|mesh-ancestor
93221314|NCT03447353|GABA Agents|gaba agents|mesh-ancestor
93221315|NCT03447353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221316|NCT03447353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221317|NCT03447353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93221318|NCT03447353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221319|NCT03447353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221320|NCT03446885|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93221321|NCT03446885|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93221322|NCT03446885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221323|NCT03446885|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93221324|NCT03446885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93221325|NCT03446885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93221326|NCT03446885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221327|NCT03446885|Dopamine Agents|dopamine agents|mesh-ancestor
93221328|NCT03446885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221329|NCT00710970|Tamoxifen|tamoxifen|mesh-list
93221330|NCT00710970|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93221331|NCT00710970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93221332|NCT00710970|Hormone Antagonists|hormone antagonists|mesh-ancestor
93221333|NCT00710970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221334|NCT00710970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221335|NCT00710970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221336|NCT00710970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221337|NCT00710970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93221338|NCT00710970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93221339|NCT00710970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93221340|NCT03421379|Glucagon|glucagon|mesh-list
93221341|NCT03421379|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93221342|NCT03421379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221343|NCT03421379|Hormones|hormones|mesh-ancestor
93221344|NCT03421379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221345|NCT03421379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221346|NCT03421379|Incretins|incretins|mesh-ancestor
93221347|NCT03712241|Indomethacin|indomethacin|mesh-list
93221348|NCT03712241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93221349|NCT03712241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93221350|NCT03712241|Analgesics|analgesics|mesh-ancestor
93221351|NCT03712241|Sensory System Agents|sensory system agents|mesh-ancestor
93221352|NCT03712241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221353|NCT03712241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221354|NCT03712241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221355|NCT03712241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221356|NCT03712241|Gout Suppressants|gout suppressants|mesh-ancestor
93221357|NCT03712241|Tocolytic Agents|tocolytic agents|mesh-ancestor
93221358|NCT03712241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93221359|NCT03712241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93221360|NCT03712241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221361|NCT03712241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221362|NCT02675946|Pembrolizumab|pembrolizumab|mesh-list
93221363|NCT02675946|Cetuximab|cetuximab|mesh-list
93221364|NCT02675946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221365|NCT02675946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221366|NCT02675946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221367|NCT02675946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221368|NCT02900378|Valsartan|valsartan|mesh-list
93221369|NCT02900378|Enalapril|enalapril|mesh-list
93221370|NCT02900378|Enalaprilat|enalaprilat|mesh-list
93221371|NCT02900378|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93221372|NCT02900378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93221373|NCT02900378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93221374|NCT02900378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93221375|NCT02900378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221376|NCT02900378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93221377|NCT02900378|Protease Inhibitors|protease inhibitors|mesh-ancestor
93221378|NCT02900378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221379|NCT03058692|Vaccines|vaccines|mesh-list
93221380|NCT03058692|Immunologic Factors|immunologic factors|mesh-ancestor
93221381|NCT03058692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221382|NCT03647150|Amoxicillin|amoxicillin|mesh-list
93221383|NCT03647150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221384|NCT03647150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221385|NCT03056352|Diphenhydramine|diphenhydramine|mesh-list
93221386|NCT03056352|Promethazine|promethazine|mesh-list
93221387|NCT03056352|Metoclopramide|metoclopramide|mesh-list
93221388|NCT03056352|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93221389|NCT03056352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93221390|NCT03056352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221391|NCT03056352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221392|NCT03056352|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221393|NCT03056352|Anesthetics|anesthetics|mesh-ancestor
93221394|NCT03056352|Sensory System Agents|sensory system agents|mesh-ancestor
93221395|NCT03056352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221396|NCT03056352|Antiemetics|antiemetics|mesh-ancestor
93221397|NCT03056352|Autonomic Agents|autonomic agents|mesh-ancestor
93221398|NCT03056352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221399|NCT03056352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93221400|NCT03056352|Histamine Antagonists|histamine antagonists|mesh-ancestor
93221401|NCT03056352|Histamine Agents|histamine agents|mesh-ancestor
93221402|NCT03056352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221403|NCT03056352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221404|NCT03056352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93221405|NCT03056352|Antipruritics|antipruritics|mesh-ancestor
93221406|NCT03056352|Dermatologic Agents|dermatologic agents|mesh-ancestor
93221407|NCT03056352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93221408|NCT03056352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93221409|NCT03056352|Dopamine Agents|dopamine agents|mesh-ancestor
93221410|NCT04360980|Colchicine|colchicine|mesh-list
93221411|NCT04360980|Gout Suppressants|gout suppressants|mesh-ancestor
93221412|NCT04360980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221413|NCT04360980|Tubulin Modulators|tubulin modulators|mesh-ancestor
93221414|NCT04360980|Antimitotic Agents|antimitotic agents|mesh-ancestor
93221415|NCT04360980|Mitosis Modulators|mitosis modulators|mesh-ancestor
93221416|NCT04360980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221417|NCT04360980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221418|NCT03647072|Famotidine|famotidine|mesh-list
93221419|NCT03647072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93221420|NCT03647072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221421|NCT03647072|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93221422|NCT03647072|Histamine Antagonists|histamine antagonists|mesh-ancestor
93221423|NCT03647072|Histamine Agents|histamine agents|mesh-ancestor
93221424|NCT03647072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221425|NCT03647072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221426|NCT03647072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221427|NCT05284136|Prednisolone|prednisolone|mesh-list
93221428|NCT05284136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221429|NCT05284136|Glucocorticoids|glucocorticoids|mesh-ancestor
93221430|NCT05284136|Hormones|hormones|mesh-ancestor
93221431|NCT05284136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221432|NCT05284136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221433|NCT05284136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221434|NCT05284136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221435|NCT03646916|Dexamethasone|dexamethasone|mesh-list
93221436|NCT03646916|Dexamethasone acetate|dexamethasone acetate|mesh-list
93221437|NCT03646916|BB 1101|bb 1101|mesh-list
93221438|NCT03646916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221439|NCT03646916|Antiemetics|antiemetics|mesh-ancestor
93221440|NCT03646916|Autonomic Agents|autonomic agents|mesh-ancestor
93221441|NCT03646916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221442|NCT03646916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221443|NCT03646916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221444|NCT03646916|Glucocorticoids|glucocorticoids|mesh-ancestor
93221445|NCT03646916|Hormones|hormones|mesh-ancestor
93221446|NCT03646916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221447|NCT03646916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221448|NCT03646916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221449|NCT03646916|Protease Inhibitors|protease inhibitors|mesh-ancestor
93221450|NCT03646916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221451|NCT03646916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221452|NCT04305756|Enoxaparin|enoxaparin|mesh-list
93221453|NCT04305756|Anticoagulants|anticoagulants|mesh-ancestor
93221454|NCT04305756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93221455|NCT04305756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93221456|NCT04305756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221457|NCT05283980|Bupivacaine|bupivacaine|mesh-list
93221458|NCT05283980|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221459|NCT05283980|Anesthetics|anesthetics|mesh-ancestor
93221460|NCT05283980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221461|NCT05283980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221462|NCT05283980|Sensory System Agents|sensory system agents|mesh-ancestor
93221463|NCT05283980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221464|NCT03645980|Sorafenib|sorafenib|mesh-list
93221465|NCT03645980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221466|NCT03645980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221467|NCT03645980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221468|NCT03645980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221469|NCT04315038|Anesthetics|anesthetics|mesh-list
93221470|NCT04315038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221471|NCT04315038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221472|NCT03645200|Apatinib|apatinib|mesh-list
93221473|NCT03645200|Fluzoparib|fluzoparib|mesh-list
93221474|NCT03645200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221475|NCT03645200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221476|NCT03645200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221477|NCT03645200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221478|NCT03645200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93221479|NCT03055338|Risperidone|risperidone|mesh-list
93221480|NCT03055338|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93221481|NCT03055338|Serotonin Agents|serotonin agents|mesh-ancestor
93221482|NCT03055338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221483|NCT03055338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221484|NCT03055338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221485|NCT03055338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93221486|NCT03055338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93221487|NCT03055338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221488|NCT03055338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93221489|NCT03055338|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93221490|NCT03055338|Dopamine Agents|dopamine agents|mesh-ancestor
93221491|NCT03645668|Meropenem|meropenem|mesh-list
93221492|NCT03645668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221493|NCT03645668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221494|NCT04186494|Liraglutide|liraglutide|mesh-list
93221495|NCT04186494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93221496|NCT04186494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221497|NCT04186494|Incretins|incretins|mesh-ancestor
93221498|NCT04186494|Hormones|hormones|mesh-ancestor
93221499|NCT04186494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221500|NCT03712163|Ketotifen|ketotifen|mesh-list
93221501|NCT03712163|Antipruritics|antipruritics|mesh-ancestor
93221502|NCT03712163|Dermatologic Agents|dermatologic agents|mesh-ancestor
93221503|NCT03712163|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93221504|NCT03712163|Histamine Antagonists|histamine antagonists|mesh-ancestor
93221505|NCT03712163|Histamine Agents|histamine agents|mesh-ancestor
93221506|NCT03712163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221507|NCT03712163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221508|NCT03712163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221509|NCT03712163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93221510|NCT01311167|Dexamethasone|dexamethasone|mesh-list
93221511|NCT01311167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221512|NCT01311167|Antiemetics|antiemetics|mesh-ancestor
93221513|NCT01311167|Autonomic Agents|autonomic agents|mesh-ancestor
93221514|NCT01311167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221515|NCT01311167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221516|NCT01311167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221517|NCT01311167|Glucocorticoids|glucocorticoids|mesh-ancestor
93221518|NCT01311167|Hormones|hormones|mesh-ancestor
93221519|NCT01311167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221520|NCT01311167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221521|NCT01311167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221522|NCT04233840|Nivolumab|nivolumab|mesh-list
93221523|NCT04233840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221524|NCT04233840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221525|NCT04233840|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221526|NCT04233840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221527|NCT02896400|Nicotine|nicotine|mesh-list
93221528|NCT02896400|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93221529|NCT02896400|Autonomic Agents|autonomic agents|mesh-ancestor
93221530|NCT02896400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221531|NCT02896400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221532|NCT02896400|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93221533|NCT02896400|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93221534|NCT02896400|Cholinergic Agents|cholinergic agents|mesh-ancestor
93221535|NCT02896400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221536|NCT02896400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221537|NCT03404843|Fasudil|fasudil|mesh-list
93221538|NCT03404843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93221539|NCT03404843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93221540|NCT03404843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221541|NCT03404843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93221542|NCT03404843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221543|NCT03404843|Vasodilator Agents|vasodilator agents|mesh-ancestor
93221544|NCT03404843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221545|NCT03404843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221546|NCT05284448|Pentoxifylline|pentoxifylline|mesh-list
93221547|NCT05284448|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93221548|NCT05284448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517535|NCT04556617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93221549|NCT05284448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221550|NCT05284448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93221551|NCT05284448|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93221552|NCT05284448|Protective Agents|protective agents|mesh-ancestor
93221553|NCT05284448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221554|NCT05284448|Vasodilator Agents|vasodilator agents|mesh-ancestor
93221555|NCT05284448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93221556|NCT05284448|Antioxidants|antioxidants|mesh-ancestor
93221557|NCT03032250|Hydrocortisone|hydrocortisone|mesh-list
93221558|NCT03032250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221559|NCT03444155|Folic Acid|folic acid|mesh-list
93221560|NCT03444155|Vitamin B Complex|vitamin b complex|mesh-list
93221561|NCT03444155|Vitamins|vitamins|mesh-ancestor
93221562|NCT03444155|Micronutrients|micronutrients|mesh-ancestor
93221563|NCT03444155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221564|NCT03444155|Hematinics|hematinics|mesh-ancestor
93221565|NCT02898116|Durvalumab|durvalumab|mesh-list
93221566|NCT02898116|Ensartinib|ensartinib|mesh-list
93221567|NCT02898116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221568|NCT02898116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221569|NCT02898116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221570|NCT02898116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221571|NCT02898116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221572|NCT03717701|Metformin|metformin|mesh-list
93221573|NCT03717701|Esomeprazole|esomeprazole|mesh-list
93221574|NCT03717701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93221575|NCT03717701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221576|NCT03717701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93221577|NCT03717701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221578|NCT03717701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93221579|NCT03717701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366391|NCT02796755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93221580|NCT03717701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221581|NCT03658304|Mitomycins|mitomycins|mesh-list
93221582|NCT03658304|Mitomycin|mitomycin|mesh-list
93221583|NCT03658304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93221584|NCT03658304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221585|NCT03658304|Alkylating Agents|alkylating agents|mesh-ancestor
93221586|NCT03658304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221587|NCT03658304|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93221588|NCT03658304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221589|NCT03422159|Ascorbic Acid|ascorbic acid|mesh-list
93221590|NCT03422159|Thiamine|thiamine|mesh-list
93221591|NCT03422159|Hydrocortisone|hydrocortisone|mesh-list
93221592|NCT03422159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93221593|NCT03422159|Vitamins|vitamins|mesh-ancestor
93221594|NCT03422159|Micronutrients|micronutrients|mesh-ancestor
93221595|NCT03422159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221596|NCT03422159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221597|NCT03422159|Antioxidants|antioxidants|mesh-ancestor
93221598|NCT03422159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221599|NCT03422159|Protective Agents|protective agents|mesh-ancestor
93221600|NCT03422159|Vitamin B Complex|vitamin b complex|mesh-ancestor
93221601|NCT04538040|Tenofovir|tenofovir|mesh-list
93221602|NCT04538040|Emtricitabine|emtricitabine|mesh-list
93221603|NCT04538040|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93221604|NCT04538040|Antiviral Agents|antiviral agents|mesh-ancestor
93221605|NCT04538040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221606|NCT04538040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93221607|NCT04538040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93221608|NCT04538040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221609|NCT04538040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221610|NCT04538040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93221611|NCT04538040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93221612|NCT02297412|Minocycline|minocycline|mesh-list
93221613|NCT02297412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221614|NCT02297412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221615|NCT03644576|Pseudoephedrine|pseudoephedrine|mesh-list
93221616|NCT03644576|Ephedrine|ephedrine|mesh-list
93221617|NCT03644576|Ozanimod|ozanimod|mesh-list
93221618|NCT03644576|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93221619|NCT03644576|Autonomic Agents|autonomic agents|mesh-ancestor
93221620|NCT03644576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221621|NCT03644576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221622|NCT03644576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93221623|NCT03644576|Respiratory System Agents|respiratory system agents|mesh-ancestor
93221624|NCT03644576|Nasal Decongestants|nasal decongestants|mesh-ancestor
93221625|NCT03644576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93221626|NCT03644576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93221627|NCT03644576|Sympathomimetics|sympathomimetics|mesh-ancestor
93221628|NCT03644576|Adrenergic Agents|adrenergic agents|mesh-ancestor
93221629|NCT03644576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221630|NCT03644576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221631|NCT03644576|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93221632|NCT03644576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221633|NCT03644576|Immunologic Factors|immunologic factors|mesh-ancestor
93221634|NCT03418727|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93221635|NCT03418727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93221636|NCT03418727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93221637|NCT03418727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93221638|NCT03418727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93221639|NCT03418727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93221640|NCT03418727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93221641|NCT03418727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93221642|NCT03418727|Adrenergic Agents|adrenergic agents|mesh-ancestor
93221643|NCT03418727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221644|NCT03418727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221645|NCT03418727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221646|NCT03418727|Laxatives|laxatives|mesh-ancestor
93221647|NCT03418727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221648|NCT01180374|Dronabinol|dronabinol|mesh-list
93221649|NCT01180374|Cannabidiol|cannabidiol|mesh-list
93221650|NCT01180374|Anticonvulsants|anticonvulsants|mesh-ancestor
93221651|NCT01180374|Hallucinogens|hallucinogens|mesh-ancestor
93221652|NCT01180374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221653|NCT01180374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93221654|NCT01180374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93221655|NCT01180374|Analgesics|analgesics|mesh-ancestor
93221656|NCT01180374|Sensory System Agents|sensory system agents|mesh-ancestor
93221657|NCT01180374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221658|NCT01180374|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93221659|NCT01180374|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93221660|NCT01180374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221661|NCT01180374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221662|NCT01180374|Hormones|hormones|mesh-ancestor
93221663|NCT01180374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221664|NCT03418571|Gontivimab|gontivimab|mesh-list
93221665|NCT03418571|Antiviral Agents|antiviral agents|mesh-ancestor
93221666|NCT03418571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221667|NCT03715517|Morphine|morphine|mesh-list
93221668|NCT03715517|Hydromorphone|hydromorphone|mesh-list
93221669|NCT03715517|Bupivacaine|bupivacaine|mesh-list
93221670|NCT03715517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93221671|NCT03715517|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221672|NCT03715517|Anesthetics|anesthetics|mesh-ancestor
93221673|NCT03715517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221674|NCT03715517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221675|NCT03715517|Sensory System Agents|sensory system agents|mesh-ancestor
93221676|NCT03715517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221677|NCT03715517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93221678|NCT03715517|Narcotics|narcotics|mesh-ancestor
93221679|NCT03715517|Analgesics|analgesics|mesh-ancestor
93221680|NCT03717467|Magnesium Sulfate|magnesium sulfate|mesh-list
93221681|NCT03717467|Analgesics|analgesics|mesh-ancestor
93221682|NCT03717467|Sensory System Agents|sensory system agents|mesh-ancestor
93221683|NCT03717467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221684|NCT03717467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221685|NCT03717467|Anesthetics|anesthetics|mesh-ancestor
93221686|NCT03717467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221687|NCT03717467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93221688|NCT03717467|Anticonvulsants|anticonvulsants|mesh-ancestor
93221689|NCT03717467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93221690|NCT03717467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93221691|NCT03717467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221692|NCT03717467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93221693|NCT03717467|Tocolytic Agents|tocolytic agents|mesh-ancestor
93221694|NCT03717467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93221695|NCT01318122|Pioglitazone|pioglitazone|mesh-list
93221696|NCT01318122|Alogliptin|alogliptin|mesh-list
93221697|NCT01318122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93221698|NCT01318122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221699|NCT01318122|Incretins|incretins|mesh-ancestor
93221700|NCT01318122|Hormones|hormones|mesh-ancestor
93221701|NCT01318122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221702|NCT01318122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93221703|NCT01318122|Protease Inhibitors|protease inhibitors|mesh-ancestor
93221704|NCT01318122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221705|NCT01318122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221706|NCT02954159|Vedolizumab|vedolizumab|mesh-list
93221707|NCT02954159|Tacrolimus|tacrolimus|mesh-list
93221708|NCT02954159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221709|NCT02954159|Immunologic Factors|immunologic factors|mesh-ancestor
93221710|NCT02954159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221711|NCT02954159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93221712|NCT02954159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221713|NCT02954159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221714|NCT02954159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221715|NCT03763422|Temozolomide|temozolomide|mesh-list
93221716|NCT03763422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93221717|NCT03763422|Alkylating Agents|alkylating agents|mesh-ancestor
93221718|NCT03763422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221719|NCT03763422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221720|NCT03667716|Nivolumab|nivolumab|mesh-list
93221721|NCT03667716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221722|NCT03667716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221723|NCT03667716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221724|NCT03667716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221725|NCT03740334|Dexamethasone|dexamethasone|mesh-list
93221726|NCT03740334|Everolimus|everolimus|mesh-list
93221727|NCT03740334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221728|NCT03740334|Antiemetics|antiemetics|mesh-ancestor
93221729|NCT03740334|Autonomic Agents|autonomic agents|mesh-ancestor
93221730|NCT03740334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221731|NCT03740334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221732|NCT03740334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221733|NCT03740334|Glucocorticoids|glucocorticoids|mesh-ancestor
93221734|NCT03740334|Hormones|hormones|mesh-ancestor
93221735|NCT03740334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221736|NCT03740334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221737|NCT03740334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221738|NCT03740334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93221739|NCT03740334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93221740|NCT03740334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221741|NCT03740334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221742|NCT03740334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221743|NCT03740334|Immunologic Factors|immunologic factors|mesh-ancestor
93221744|NCT03440411|Dexamethasone|dexamethasone|mesh-list
93221745|NCT03440411|Cyclophosphamide|cyclophosphamide|mesh-list
93221746|NCT03440411|Pomalidomide|pomalidomide|mesh-list
93221747|NCT03440411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221748|NCT03440411|Immunologic Factors|immunologic factors|mesh-ancestor
93221749|NCT03440411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221750|NCT03440411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221751|NCT03440411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93221752|NCT03440411|Alkylating Agents|alkylating agents|mesh-ancestor
93221753|NCT03440411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221754|NCT03440411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221755|NCT03440411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93221756|NCT03440411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221757|NCT03440411|Antiemetics|antiemetics|mesh-ancestor
93221758|NCT03440411|Autonomic Agents|autonomic agents|mesh-ancestor
93221759|NCT03440411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221760|NCT03440411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221761|NCT03440411|Glucocorticoids|glucocorticoids|mesh-ancestor
93221762|NCT03440411|Hormones|hormones|mesh-ancestor
93221763|NCT03440411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221764|NCT03440411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221765|NCT03440411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93221766|NCT03440411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93221767|NCT03440411|Growth Substances|growth substances|mesh-ancestor
93221768|NCT03440411|Growth Inhibitors|growth inhibitors|mesh-ancestor
93221769|NCT03714737|Vaccines|vaccines|mesh-list
93221770|NCT03714737|Immunologic Factors|immunologic factors|mesh-ancestor
93221771|NCT03714737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221772|NCT03389555|Vitamins|vitamins|mesh-list
93221773|NCT03389555|Ascorbic Acid|ascorbic acid|mesh-list
93221774|NCT03389555|Thiamine|thiamine|mesh-list
93221775|NCT03389555|Hydrocortisone|hydrocortisone|mesh-list
93221776|NCT03389555|Micronutrients|micronutrients|mesh-ancestor
93221777|NCT03389555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221778|NCT03389555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221779|NCT03389555|Antioxidants|antioxidants|mesh-ancestor
93221780|NCT03389555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221781|NCT03389555|Protective Agents|protective agents|mesh-ancestor
93221782|NCT03389555|Vitamin B Complex|vitamin b complex|mesh-ancestor
93221783|NCT03395639|Heparin|heparin|mesh-list
93221784|NCT03395639|Enoxaparin|enoxaparin|mesh-list
93221785|NCT03395639|Warfarin|warfarin|mesh-list
93221786|NCT03395639|Edoxaban|edoxaban|mesh-list
93221787|NCT03395639|Anticoagulants|anticoagulants|mesh-ancestor
93221788|NCT03395639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93221789|NCT03395639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93221790|NCT03395639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221791|NCT03395639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93221792|NCT03395639|Antithrombins|antithrombins|mesh-ancestor
93221793|NCT03395639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93221794|NCT03395639|Protease Inhibitors|protease inhibitors|mesh-ancestor
93221795|NCT03395639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221796|NCT03353922|Cyclobenzaprine|cyclobenzaprine|mesh-list
93221797|NCT03353922|Tolperisone|tolperisone|mesh-list
93221798|NCT03353922|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93221799|NCT03353922|Antidepressive Agents|antidepressive agents|mesh-ancestor
93221800|NCT03353922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93221801|NCT03353922|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93221802|NCT03353922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221803|NCT03353922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93221804|NCT03353922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221805|NCT03353922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93221806|NCT03353922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893908|NCT02633618|Analgesics|analgesics|mesh-ancestor
93221807|NCT03395405|Nitazoxanide|nitazoxanide|mesh-list
93221808|NCT03395405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93221809|NCT03395405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221810|NCT03387683|Dapagliflozin|dapagliflozin|mesh-list
93221811|NCT03387683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93221812|NCT03387683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221813|NCT03387683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93221814|NCT03387683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221815|NCT05467553|Tenofovir|tenofovir|mesh-list
93221816|NCT05467553|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93221817|NCT05467553|Antiviral Agents|antiviral agents|mesh-ancestor
93221818|NCT05467553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221819|NCT05467553|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93221820|NCT05467553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93221821|NCT05467553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221822|NCT05467553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221823|NCT05467553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93221824|NCT05467553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93221825|NCT05467553|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93221826|NCT05467553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221827|NCT02942004|Pregnanolone|pregnanolone|mesh-list
93221828|NCT02942004|Brexanolone|brexanolone|mesh-list
93221829|NCT02942004|Neurosteroids|neurosteroids|mesh-ancestor
93221830|NCT02942004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221831|NCT02942004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221832|NCT02942004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221833|NCT02942004|GABA Modulators|gaba modulators|mesh-ancestor
93221834|NCT02942004|GABA Agents|gaba agents|mesh-ancestor
93221835|NCT02942004|Anesthetics|anesthetics|mesh-ancestor
93221836|NCT02942004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221837|NCT03414983|Leucovorin|leucovorin|mesh-list
93221838|NCT03414983|Bevacizumab|bevacizumab|mesh-list
93221839|NCT03414983|Nivolumab|nivolumab|mesh-list
93221840|NCT03414983|Fluorouracil|fluorouracil|mesh-list
93221841|NCT03414983|Oxaliplatin|oxaliplatin|mesh-list
93221842|NCT03414983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93221843|NCT03414983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221844|NCT03414983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93221845|NCT03414983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93221846|NCT03414983|Growth Substances|growth substances|mesh-ancestor
93221847|NCT03414983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221848|NCT03414983|Growth Inhibitors|growth inhibitors|mesh-ancestor
93221849|NCT03414983|Antimetabolites|antimetabolites|mesh-ancestor
92118140|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221850|NCT03414983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221851|NCT03414983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93221852|NCT03414983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221853|NCT03414983|Immunologic Factors|immunologic factors|mesh-ancestor
93221854|NCT03414983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93221855|NCT03414983|Antidotes|antidotes|mesh-ancestor
93221856|NCT03414983|Protective Agents|protective agents|mesh-ancestor
93221857|NCT03414983|Vitamin B Complex|vitamin b complex|mesh-ancestor
93221858|NCT03414983|Vitamins|vitamins|mesh-ancestor
93221859|NCT03414983|Micronutrients|micronutrients|mesh-ancestor
93221860|NCT03414359|Lidocaine|lidocaine|mesh-list
93221861|NCT03414359|Chloroprocaine|chloroprocaine|mesh-list
93221862|NCT03414359|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221863|NCT03414359|Anesthetics|anesthetics|mesh-ancestor
93221864|NCT03414359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221865|NCT03414359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221866|NCT03414359|Sensory System Agents|sensory system agents|mesh-ancestor
93221867|NCT03414359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221868|NCT03414359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93221869|NCT03414359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93221870|NCT03414359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93221871|NCT03414359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93221872|NCT03414359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221873|NCT03285295|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
93221874|NCT03285295|Immunologic Factors|immunologic factors|mesh-ancestor
93221875|NCT03285295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221876|NCT02583048|Dolutegravir|dolutegravir|mesh-list
93221877|NCT02583048|Bedaquiline|bedaquiline|mesh-list
93221878|NCT02583048|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93221879|NCT02583048|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93221880|NCT02583048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221881|NCT02583048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221882|NCT02583048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93221883|NCT02583048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93221884|NCT02583048|Antiviral Agents|antiviral agents|mesh-ancestor
93221885|NCT02583048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221886|NCT02583048|Antitubercular Agents|antitubercular agents|mesh-ancestor
93221887|NCT02583048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221888|NCT04661137|Dexamethasone|dexamethasone|mesh-list
93221889|NCT04661137|Daratumumab|daratumumab|mesh-list
93221890|NCT04661137|Pomalidomide|pomalidomide|mesh-list
93221891|NCT04661137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221892|NCT04661137|Antiemetics|antiemetics|mesh-ancestor
93221893|NCT04661137|Autonomic Agents|autonomic agents|mesh-ancestor
93221894|NCT04661137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221895|NCT04661137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221896|NCT04661137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93221897|NCT04661137|Glucocorticoids|glucocorticoids|mesh-ancestor
93221898|NCT04661137|Hormones|hormones|mesh-ancestor
93221899|NCT04661137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221900|NCT04661137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93221901|NCT04661137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221902|NCT04661137|Immunologic Factors|immunologic factors|mesh-ancestor
93221903|NCT04661137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93221904|NCT04661137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93221905|NCT04661137|Growth Substances|growth substances|mesh-ancestor
93221906|NCT04661137|Growth Inhibitors|growth inhibitors|mesh-ancestor
93221907|NCT03274687|Androgens|androgens|mesh-list
93221908|NCT03274687|Hormones|hormones|mesh-ancestor
93221909|NCT03274687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221910|NCT03274687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221911|NCT02542956|Bupivacaine|bupivacaine|mesh-list
93221912|NCT02542956|Anesthetics, Local|anesthetics, local|mesh-ancestor
93221913|NCT02542956|Anesthetics|anesthetics|mesh-ancestor
93221914|NCT02542956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221915|NCT02542956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221916|NCT02542956|Sensory System Agents|sensory system agents|mesh-ancestor
93221917|NCT02542956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221918|NCT03274453|Ketamine|ketamine|mesh-list
93221919|NCT03274453|Analgesics|analgesics|mesh-ancestor
93221920|NCT03274453|Sensory System Agents|sensory system agents|mesh-ancestor
93221921|NCT03274453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221922|NCT03274453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221923|NCT03274453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93221924|NCT03274453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93221925|NCT03274453|Anesthetics, General|anesthetics, general|mesh-ancestor
93221926|NCT03274453|Anesthetics|anesthetics|mesh-ancestor
93221927|NCT03274453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93221928|NCT03274453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93221929|NCT03274453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93221930|NCT03274453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221931|NCT03274453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221932|NCT02313870|Clobetasol|clobetasol|mesh-list
93221933|NCT02313870|Methotrexate|methotrexate|mesh-list
93221934|NCT02313870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93221935|NCT02313870|Abortifacient Agents|abortifacient agents|mesh-ancestor
93221936|NCT02313870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93221937|NCT02313870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221938|NCT02313870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93221939|NCT02313870|Antimetabolites|antimetabolites|mesh-ancestor
93221940|NCT02313870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221941|NCT02313870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221942|NCT02313870|Dermatologic Agents|dermatologic agents|mesh-ancestor
93221943|NCT02313870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221944|NCT02313870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93221945|NCT02313870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93221946|NCT02313870|Immunologic Factors|immunologic factors|mesh-ancestor
93221947|NCT02313870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221948|NCT02313870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93221949|NCT02313870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221950|NCT02313870|Glucocorticoids|glucocorticoids|mesh-ancestor
93221951|NCT02313870|Hormones|hormones|mesh-ancestor
93221952|NCT02313870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93221953|NCT01942122|Mefenamic Acid|mefenamic acid|mesh-list
93221954|NCT01942122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93221955|NCT01942122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93221956|NCT01942122|Analgesics|analgesics|mesh-ancestor
93221957|NCT01942122|Sensory System Agents|sensory system agents|mesh-ancestor
93221958|NCT01942122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221959|NCT01942122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221960|NCT01942122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93221961|NCT01942122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93221962|NCT01942122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93221963|NCT01942122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221964|NCT01942122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221965|NCT04327999|Lubricant Eye Drops|lubricant eye drops|mesh-list
93221966|NCT04327999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93221967|NCT04327999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93221969|NCT02236806|Bisoprolol|bisoprolol|mesh-list
93221970|NCT02236806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93221971|NCT02236806|Protease Inhibitors|protease inhibitors|mesh-ancestor
93221972|NCT02236806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93221973|NCT02236806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93221974|NCT02236806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93221975|NCT02236806|Sympatholytics|sympatholytics|mesh-ancestor
93221976|NCT02236806|Autonomic Agents|autonomic agents|mesh-ancestor
93221977|NCT02236806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93221978|NCT02236806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221979|NCT02236806|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93221980|NCT02236806|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93221981|NCT02236806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93221982|NCT02236806|Adrenergic Agents|adrenergic agents|mesh-ancestor
93221983|NCT02236806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93221984|NCT01578954|Lenalidomide|lenalidomide|mesh-list
93221985|NCT01578954|Immunologic Factors|immunologic factors|mesh-ancestor
93221986|NCT01578954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93221987|NCT01578954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93221988|NCT01578954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93221989|NCT01578954|Growth Substances|growth substances|mesh-ancestor
93221990|NCT01578954|Growth Inhibitors|growth inhibitors|mesh-ancestor
93221991|NCT01578954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93221992|NCT00659646|Levofloxacin|levofloxacin|mesh-list
93221993|NCT00659646|Ofloxacin|ofloxacin|mesh-list
93221994|NCT00659646|Gentamicins|gentamicins|mesh-list
93221995|NCT00659646|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93221996|NCT00659646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93221997|NCT00659646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93221998|NCT00659646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93221999|NCT00659646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93222000|NCT00659646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222001|NCT00659646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222002|NCT00659646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222003|NCT00659646|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93222004|NCT00659646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93222005|NCT00659646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93222006|NCT02236572|Everolimus|everolimus|mesh-list
93222007|NCT02236572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93222008|NCT02236572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222009|NCT02236572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222010|NCT02236572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222011|NCT02236572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222012|NCT02236572|Immunologic Factors|immunologic factors|mesh-ancestor
93222013|NCT02236572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222014|NCT02236572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222015|NCT03054870|Xenon|xenon|mesh-list
93222016|NCT03054870|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93222017|NCT03054870|Anesthetics, General|anesthetics, general|mesh-ancestor
93222018|NCT03054870|Anesthetics|anesthetics|mesh-ancestor
93222019|NCT03054870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222020|NCT03054870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222021|NCT03414047|Prexasertib|prexasertib|mesh-list
93222022|NCT03414047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222023|NCT03414047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222024|NCT03414047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222025|NCT05448677|Bevacizumab|bevacizumab|mesh-list
93222026|NCT05448677|Atezolizumab|atezolizumab|mesh-list
93222027|NCT05448677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222028|NCT05448677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222029|NCT05448677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93222030|NCT05448677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93222031|NCT05448677|Growth Substances|growth substances|mesh-ancestor
93222032|NCT05448677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222034|NCT05448677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93222035|NCT05448677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222036|NCT05222646|Metoclopramide|metoclopramide|mesh-list
93222037|NCT05222646|Antiemetics|antiemetics|mesh-ancestor
93222038|NCT05222646|Autonomic Agents|autonomic agents|mesh-ancestor
93222039|NCT05222646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222040|NCT05222646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222041|NCT05222646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222042|NCT05222646|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93222043|NCT05222646|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93222044|NCT05222646|Dopamine Agents|dopamine agents|mesh-ancestor
93222045|NCT05222646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222046|NCT05222646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222047|NCT05222334|Bupivacaine|bupivacaine|mesh-list
93222048|NCT05222334|Anesthetics, Local|anesthetics, local|mesh-ancestor
93222049|NCT05222334|Anesthetics|anesthetics|mesh-ancestor
93222050|NCT05222334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222051|NCT05222334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222052|NCT05222334|Sensory System Agents|sensory system agents|mesh-ancestor
93222053|NCT05222334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222054|NCT04465266|Tolperisone|tolperisone|mesh-list
93222055|NCT04465266|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93222056|NCT04465266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222057|NCT04465266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93222058|NCT04465266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222059|NCT04434300|Daptomycin|daptomycin|mesh-list
93222060|NCT04434300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93222061|NCT04434300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222062|NCT04315896|Hydroxychloroquine|hydroxychloroquine|mesh-list
93222063|NCT04315896|Antimalarials|antimalarials|mesh-ancestor
93222064|NCT04315896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93222065|NCT04315896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93222066|NCT04315896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222067|NCT04315896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222068|NCT04315896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222069|NCT04315896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222070|NCT05178654|Nirmatrelvir|nirmatrelvir|mesh-list
93222071|NCT05178654|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93222072|NCT05178654|Protease Inhibitors|protease inhibitors|mesh-ancestor
93222073|NCT05178654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222074|NCT05178654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222075|NCT05178654|Antiviral Agents|antiviral agents|mesh-ancestor
93222076|NCT05178654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222077|NCT04108962|Benralizumab|benralizumab|mesh-list
93222078|NCT04108962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222079|NCT04108962|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222080|NCT04865796|Lactoferrin|lactoferrin|mesh-list
93222081|NCT04865796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222082|NCT04811118|Docetaxel|docetaxel|mesh-list
93222083|NCT04811118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222084|NCT04811118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93222085|NCT04811118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93222086|NCT04811118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93222087|NCT04811118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222088|NCT05221164|Aspirin|aspirin|mesh-list
93222089|NCT05221164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222090|NCT05221164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222091|NCT05221164|Analgesics|analgesics|mesh-ancestor
93222092|NCT05221164|Sensory System Agents|sensory system agents|mesh-ancestor
93222093|NCT05221164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222094|NCT05221164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222095|NCT05221164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222096|NCT05221164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222097|NCT05221164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93222098|NCT05221164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93222099|NCT05221164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222100|NCT05221164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93222101|NCT05221164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93222102|NCT05221164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222103|NCT05221164|Antipyretics|antipyretics|mesh-ancestor
93222104|NCT04647084|Lidocaine|lidocaine|mesh-list
93222105|NCT04647084|Anesthetics, Local|anesthetics, local|mesh-ancestor
93222106|NCT04647084|Anesthetics|anesthetics|mesh-ancestor
93222107|NCT04647084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222108|NCT04647084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222109|NCT04647084|Sensory System Agents|sensory system agents|mesh-ancestor
93222110|NCT04647084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222111|NCT04647084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93222112|NCT04647084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93222113|NCT04647084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93222114|NCT04647084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222115|NCT04647084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222116|NCT03627546|Sofosbuvir|sofosbuvir|mesh-list
93222117|NCT03627546|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93222118|NCT03627546|Velpatasvir|velpatasvir|mesh-list
93222119|NCT03627546|Antiviral Agents|antiviral agents|mesh-ancestor
93222120|NCT03627546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222121|NCT04620798|Antibodies|antibodies|mesh-list
93222122|NCT04620798|Immunologic Factors|immunologic factors|mesh-ancestor
93222123|NCT04620798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222124|NCT05220228|Prucalopride|prucalopride|mesh-list
93222125|NCT05220228|Laxatives|laxatives|mesh-ancestor
93222126|NCT05220228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222127|NCT05220228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93222128|NCT05220228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93222129|NCT05220228|Serotonin Agents|serotonin agents|mesh-ancestor
93222130|NCT05220228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222131|NCT05220228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222132|NCT05220228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222133|NCT03822780|Hydroxychloroquine|hydroxychloroquine|mesh-list
93222134|NCT03822780|Antimalarials|antimalarials|mesh-ancestor
93222135|NCT03822780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93222136|NCT03822780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93222137|NCT03822780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222138|NCT03822780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222139|NCT03822780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222140|NCT03822780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222141|NCT04765644|Celecoxib|celecoxib|mesh-list
93222142|NCT04765644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222143|NCT04765644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222144|NCT04765644|Analgesics|analgesics|mesh-ancestor
93222145|NCT04765644|Sensory System Agents|sensory system agents|mesh-ancestor
93222146|NCT04765644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222147|NCT04765644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222148|NCT04765644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222149|NCT04765644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222150|NCT04765644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93222151|NCT04765644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93222152|NCT04765644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222153|NCT04765644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222154|NCT03052764|Botulinum Toxins|botulinum toxins|mesh-list
93222155|NCT03052764|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93222156|NCT03052764|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93222157|NCT03052764|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93222158|NCT03052764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222159|NCT03052764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222160|NCT03052764|Cholinergic Agents|cholinergic agents|mesh-ancestor
93222161|NCT03052764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222162|NCT03052764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222163|NCT03052764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93222164|NCT03052764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222165|NCT05197374|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93222166|NCT05197374|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93222167|NCT05197374|Estradiol|estradiol|mesh-list
93222168|NCT05197374|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93222169|NCT05197374|Estrogens|estrogens|mesh-ancestor
93222170|NCT05197374|Hormones|hormones|mesh-ancestor
93222171|NCT05197374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222172|NCT05197374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222173|NCT05197374|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93222174|NCT05197374|Contraceptive Agents|contraceptive agents|mesh-ancestor
93222175|NCT05197374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93222176|NCT05197374|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93222177|NCT02951819|Dexamethasone|dexamethasone|mesh-list
93222178|NCT02951819|Cyclophosphamide|cyclophosphamide|mesh-list
93222179|NCT02951819|Bortezomib|bortezomib|mesh-list
93222180|NCT02951819|Daratumumab|daratumumab|mesh-list
93222181|NCT02951819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222182|NCT02951819|Immunologic Factors|immunologic factors|mesh-ancestor
93222183|NCT02951819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222184|NCT02951819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222185|NCT02951819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93222186|NCT02951819|Alkylating Agents|alkylating agents|mesh-ancestor
93222187|NCT02951819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222188|NCT02951819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222189|NCT02951819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93222190|NCT02951819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222191|NCT02951819|Antiemetics|antiemetics|mesh-ancestor
93222192|NCT02951819|Autonomic Agents|autonomic agents|mesh-ancestor
93222193|NCT02951819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222194|NCT02951819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222195|NCT02951819|Glucocorticoids|glucocorticoids|mesh-ancestor
93222196|NCT02951819|Hormones|hormones|mesh-ancestor
93222197|NCT02951819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222198|NCT02951819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93222199|NCT05191290|Heparin|heparin|mesh-list
93222200|NCT05191290|Calcium heparin|calcium heparin|mesh-list
93222201|NCT05191290|Citric Acid|citric acid|mesh-list
93222202|NCT05191290|Sodium Citrate|sodium citrate|mesh-list
93222203|NCT05191290|Anticoagulants|anticoagulants|mesh-ancestor
93222204|NCT05191290|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93222205|NCT05191290|Chelating Agents|chelating agents|mesh-ancestor
93222206|NCT05191290|Sequestering Agents|sequestering agents|mesh-ancestor
93222207|NCT05191290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222208|NCT05191290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93222209|NCT05191290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93222210|NCT05627544|Anesthetics|anesthetics|mesh-list
93222211|NCT05627544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222212|NCT05627544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222213|NCT05189028|Gemcitabine|gemcitabine|mesh-list
93222214|NCT05189028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222215|NCT05189028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93222216|NCT05189028|Antimetabolites|antimetabolites|mesh-ancestor
93222217|NCT05189028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222218|NCT05706870|Clobetasol|clobetasol|mesh-list
93222219|NCT05706870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222220|NCT05706870|Glucocorticoids|glucocorticoids|mesh-ancestor
93222221|NCT05706870|Hormones|hormones|mesh-ancestor
93222222|NCT05706870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222223|NCT05706870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222224|NCT03383783|Listerine|listerine|mesh-list
93222225|NCT03383783|Fluorides|fluorides|mesh-list
93222226|NCT03383783|Sodium Fluoride|sodium fluoride|mesh-list
93222227|NCT03383783|Cariostatic Agents|cariostatic agents|mesh-ancestor
93222228|NCT03383783|Protective Agents|protective agents|mesh-ancestor
93222229|NCT03383783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222230|NCT03383783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93222231|NCT03383783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222232|NCT03627390|Molybdenum|molybdenum|mesh-list
93222233|NCT03627390|Trace Elements|trace elements|mesh-ancestor
93222234|NCT03627390|Micronutrients|micronutrients|mesh-ancestor
93222235|NCT03627390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222236|NCT03709745|Ranibizumab|ranibizumab|mesh-list
93222237|NCT03709745|Aflibercept|aflibercept|mesh-list
93222238|NCT03709745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93222239|NCT03709745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93222240|NCT03709745|Growth Substances|growth substances|mesh-ancestor
93222241|NCT03709745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222242|NCT03709745|Growth Inhibitors|growth inhibitors|mesh-ancestor
93222243|NCT03709745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222244|NCT05570526|Melatonin|melatonin|mesh-list
93222245|NCT05570526|Antioxidants|antioxidants|mesh-ancestor
93222246|NCT05570526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222247|NCT05570526|Protective Agents|protective agents|mesh-ancestor
93222248|NCT05570526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222249|NCT05570526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222250|NCT03707639|Apatinib|apatinib|mesh-list
93222251|NCT03707639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222252|NCT03707639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222253|NCT03707639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222254|NCT03707639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222255|NCT03334721|Gabapentin|gabapentin|mesh-list
93222256|NCT03334721|Analgesics|analgesics|mesh-ancestor
93222257|NCT03334721|Sensory System Agents|sensory system agents|mesh-ancestor
93222258|NCT03334721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222259|NCT03334721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222260|NCT03334721|Anticonvulsants|anticonvulsants|mesh-ancestor
93222261|NCT03334721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93222262|NCT03334721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93222263|NCT03334721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222264|NCT03334721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93222265|NCT03334721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93222266|NCT03334721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93222267|NCT03334721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222268|NCT03334721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222269|NCT03334721|Antimanic Agents|antimanic agents|mesh-ancestor
93222270|NCT05706402|Acetylcysteine|acetylcysteine|mesh-list
93222271|NCT05706402|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93222272|NCT05706402|Antiviral Agents|antiviral agents|mesh-ancestor
93222273|NCT05706402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222274|NCT05706402|Expectorants|expectorants|mesh-ancestor
93222275|NCT05706402|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222276|NCT05706402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93222277|NCT05706402|Antioxidants|antioxidants|mesh-ancestor
93222278|NCT05706402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222279|NCT05706402|Protective Agents|protective agents|mesh-ancestor
93222280|NCT05706402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222281|NCT05706402|Antidotes|antidotes|mesh-ancestor
93222282|NCT05706090|Fentanyl|fentanyl|mesh-list
93222283|NCT05706090|Anesthetics|anesthetics|mesh-ancestor
93222284|NCT05706090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222285|NCT05706090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222286|NCT05706090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93222287|NCT05706090|Narcotics|narcotics|mesh-ancestor
93222288|NCT05706090|Analgesics|analgesics|mesh-ancestor
93222289|NCT05706090|Sensory System Agents|sensory system agents|mesh-ancestor
93222290|NCT05706090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222291|NCT05706090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93222292|NCT05706090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93222293|NCT05706090|Anesthetics, General|anesthetics, general|mesh-ancestor
93222294|NCT03380429|Albuterol|albuterol|mesh-list
93222295|NCT03380429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93222296|NCT03380429|Autonomic Agents|autonomic agents|mesh-ancestor
93222297|NCT03380429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222298|NCT03380429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222299|NCT03380429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222300|NCT03380429|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222301|NCT03380429|Tocolytic Agents|tocolytic agents|mesh-ancestor
93222302|NCT03380429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93222303|NCT03380429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93222304|NCT03380429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93222305|NCT03380429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222306|NCT03380429|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222307|NCT03380429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222308|NCT03380429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222309|NCT05096442|Paclitaxel|paclitaxel|mesh-list
93222310|NCT05096442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93222311|NCT05096442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93222312|NCT05096442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222313|NCT05096442|Tubulin Modulators|tubulin modulators|mesh-ancestor
93222314|NCT05096442|Antimitotic Agents|antimitotic agents|mesh-ancestor
93222315|NCT05096442|Mitosis Modulators|mitosis modulators|mesh-ancestor
93222316|NCT05096442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222317|NCT01313143|Esmolol|esmolol|mesh-list
93222318|NCT01313143|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93222319|NCT01313143|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93222320|NCT01313143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93222321|NCT01313143|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222322|NCT01313143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222323|NCT01313143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222324|NCT01313143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222325|NCT05071794|Propofol|propofol|mesh-list
93222326|NCT05071794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93222327|NCT05071794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222328|NCT05071794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222329|NCT05071794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93222330|NCT05071794|Anesthetics, General|anesthetics, general|mesh-ancestor
93222331|NCT05071794|Anesthetics|anesthetics|mesh-ancestor
93222332|NCT03280537|Omalizumab|omalizumab|mesh-list
93222333|NCT03280537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93222334|NCT03280537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222335|NCT03280537|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222336|NCT05618730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93222337|NCT05618730|Lubricant Eye Drops|lubricant eye drops|mesh-list
93222338|NCT05618730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93222339|NCT05029050|Clonidine|clonidine|mesh-list
93222340|NCT05029050|Dexmedetomidine|dexmedetomidine|mesh-list
93222341|NCT05029050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93222342|NCT05029050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222343|NCT05029050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222344|NCT05029050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222345|NCT05029050|Analgesics|analgesics|mesh-ancestor
93222346|NCT05029050|Sensory System Agents|sensory system agents|mesh-ancestor
93222347|NCT05029050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222348|NCT05029050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93222349|NCT05029050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93222350|NCT05029050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222351|NCT05029050|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222352|NCT05029050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222353|NCT05029050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222354|NCT05029050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93222355|NCT05029050|Sympatholytics|sympatholytics|mesh-ancestor
93222356|NCT05029050|Autonomic Agents|autonomic agents|mesh-ancestor
93222357|NCT04690231|Etoposide|etoposide|mesh-list
93222358|NCT04690231|Etoposide phosphate|etoposide phosphate|mesh-list
93222359|NCT04690231|Apatinib|apatinib|mesh-list
93222360|NCT04690231|Ifosfamide|ifosfamide|mesh-list
93222361|NCT04690231|Isophosphamide mustard|isophosphamide mustard|mesh-list
93222362|NCT04690231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93222363|NCT04690231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222364|NCT04690231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93222365|NCT04690231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93222366|NCT04690231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222367|NCT04690231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222368|NCT04690231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222369|NCT04690231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93222370|NCT04690231|Alkylating Agents|alkylating agents|mesh-ancestor
93222371|NCT03270085|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93222372|NCT03270085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93222373|NCT03270085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93222374|NCT03270085|Antimetabolites|antimetabolites|mesh-ancestor
93222375|NCT03270085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222376|NCT03270085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93222377|NCT04998006|Ethanol|ethanol|mesh-list
93222378|NCT04998006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93222379|NCT04998006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222380|NCT04998006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222381|NCT04998006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222382|NCT04234945|Doxycycline|doxycycline|mesh-list
93222383|NCT04234945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93222384|NCT04234945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222385|NCT04234945|Antimalarials|antimalarials|mesh-ancestor
93222386|NCT04234945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93222387|NCT04234945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93222388|NCT03316807|Vaccines|vaccines|mesh-list
93222389|NCT03316807|Immunologic Factors|immunologic factors|mesh-ancestor
93222390|NCT03316807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222391|NCT03379259|Tislelizumab|tislelizumab|mesh-list
93222392|NCT03379259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222393|NCT03379259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222394|NCT03328897|Omalizumab|omalizumab|mesh-list
93222395|NCT03328897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93222396|NCT03328897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222397|NCT03328897|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222398|NCT04918758|Sucralfate|sucralfate|mesh-list
93222399|NCT04918758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93222400|NCT04918758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222401|NCT03378635|Glucagon|glucagon|mesh-list
93222402|NCT03378635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222403|NCT03378635|Hormones|hormones|mesh-ancestor
93222404|NCT03378635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222405|NCT03378635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222406|NCT01182727|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92894502|NCT00661856|Estrogens|estrogens|mesh-ancestor
93222407|NCT01182727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222408|NCT01182727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222409|NCT01182727|Analgesics|analgesics|mesh-ancestor
93222410|NCT01182727|Sensory System Agents|sensory system agents|mesh-ancestor
93222411|NCT01182727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222412|NCT01182727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222413|NCT01182727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222414|NCT01182727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222415|NCT03334409|Vitamins|vitamins|mesh-list
93222416|NCT03334409|Ascorbic Acid|ascorbic acid|mesh-list
93222417|NCT03334409|Micronutrients|micronutrients|mesh-ancestor
93222418|NCT03334409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222419|NCT03334409|Antioxidants|antioxidants|mesh-ancestor
93222420|NCT03334409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222421|NCT03334409|Protective Agents|protective agents|mesh-ancestor
93222422|NCT02891915|Amoxicillin|amoxicillin|mesh-list
93222423|NCT02891915|Clavulanic Acid|clavulanic acid|mesh-list
93222424|NCT02891915|Clavulanic Acids|clavulanic acids|mesh-list
93222425|NCT02891915|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93222426|NCT02891915|Cefdinir|cefdinir|mesh-list
93222427|NCT02891915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93222428|NCT02891915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222429|NCT02891915|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93222430|NCT02891915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222431|NCT02891915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222432|NCT05230368|Decitabine|decitabine|mesh-list
93222433|NCT05230368|Romidepsin|romidepsin|mesh-list
93222434|NCT05230368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93222435|NCT05230368|Antimetabolites|antimetabolites|mesh-ancestor
93222436|NCT05230368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222437|NCT05230368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222438|NCT05230368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222439|NCT05230368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93222440|NCT05230368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93222441|NCT03046446|FX006|fx006|mesh-list
93222442|NCT03046446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222443|NCT03046446|Glucocorticoids|glucocorticoids|mesh-ancestor
93222444|NCT03046446|Hormones|hormones|mesh-ancestor
93222445|NCT03046446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222446|NCT03046446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222447|NCT03046446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222448|NCT03046446|Immunologic Factors|immunologic factors|mesh-ancestor
93222449|NCT03051217|Certolizumab Pegol|certolizumab pegol|mesh-list
92118141|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222450|NCT03051217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93222451|NCT03051217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222452|NCT03051217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222453|NCT03051217|Immunologic Factors|immunologic factors|mesh-ancestor
93222454|NCT03051217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222455|NCT03051217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222456|NCT05035303|Epinephrine|epinephrine|mesh-list
93222457|NCT05035303|Norepinephrine|norepinephrine|mesh-list
93222458|NCT05035303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93222459|NCT05035303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222460|NCT05035303|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222461|NCT05035303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222462|NCT05035303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222463|NCT05035303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222464|NCT05035303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93222465|NCT05035303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93222466|NCT05035303|Autonomic Agents|autonomic agents|mesh-ancestor
93222467|NCT05035303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222468|NCT05035303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222469|NCT05035303|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222470|NCT05035303|Mydriatics|mydriatics|mesh-ancestor
93222471|NCT05035303|Sympathomimetics|sympathomimetics|mesh-ancestor
93222472|NCT05035303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93222473|NCT03347279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93222474|NCT03347279|Immunologic Factors|immunologic factors|mesh-ancestor
93222475|NCT03347279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222476|NCT03262441|Mycophenolic Acid|mycophenolic acid|mesh-list
93222477|NCT03262441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93222478|NCT03262441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222479|NCT03262441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93222480|NCT03262441|Antitubercular Agents|antitubercular agents|mesh-ancestor
93222481|NCT03262441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93222482|NCT03262441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222483|NCT03262441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222484|NCT03262441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222485|NCT04580394|Oxybutynin|oxybutynin|mesh-list
93222486|NCT04580394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93222487|NCT04580394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93222488|NCT04580394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93222489|NCT04580394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222490|NCT04580394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222491|NCT04580394|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222492|NCT04580394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222493|NCT04580394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222494|NCT04580394|Parasympatholytics|parasympatholytics|mesh-ancestor
93222495|NCT04580394|Autonomic Agents|autonomic agents|mesh-ancestor
93222496|NCT04580394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222497|NCT04580394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93222498|NCT04580394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93222499|NCT04580394|Cholinergic Agents|cholinergic agents|mesh-ancestor
93222500|NCT04580394|Urological Agents|urological agents|mesh-ancestor
93222501|NCT01343082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93222502|NCT01343082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93222503|NCT04385173|Temozolomide|temozolomide|mesh-list
93222504|NCT04385173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93222505|NCT04385173|Alkylating Agents|alkylating agents|mesh-ancestor
93222506|NCT04385173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222507|NCT04385173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222508|NCT03707249|Ferric Compounds|ferric compounds|mesh-list
93222509|NCT03707249|Hematinics|hematinics|mesh-ancestor
93222510|NCT05682911|Simvastatin|simvastatin|mesh-list
93222511|NCT05682911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93222512|NCT05682911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93222513|NCT05682911|Antimetabolites|antimetabolites|mesh-ancestor
93222514|NCT05682911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222515|NCT05682911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93222516|NCT05682911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93222517|NCT05682911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222518|NCT04625088|Atropine|atropine|mesh-list
93222519|NCT04625088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93222520|NCT04625088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93222521|NCT04625088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93222522|NCT04625088|Autonomic Agents|autonomic agents|mesh-ancestor
93222523|NCT04625088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222524|NCT04625088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222525|NCT04625088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222526|NCT04625088|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222527|NCT04625088|Mydriatics|mydriatics|mesh-ancestor
93222528|NCT04625088|Parasympatholytics|parasympatholytics|mesh-ancestor
93222529|NCT04625088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93222530|NCT04625088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93222531|NCT04625088|Cholinergic Agents|cholinergic agents|mesh-ancestor
93222532|NCT04625088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222533|NCT04625088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222534|NCT03568422|Paclitaxel|paclitaxel|mesh-list
93222535|NCT03568422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93222536|NCT03568422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222537|NCT03568422|Tubulin Modulators|tubulin modulators|mesh-ancestor
93222538|NCT03568422|Antimitotic Agents|antimitotic agents|mesh-ancestor
93222539|NCT03568422|Mitosis Modulators|mitosis modulators|mesh-ancestor
93222540|NCT03568422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222541|NCT03535350|Temozolomide|temozolomide|mesh-list
93222542|NCT03535350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93222543|NCT03535350|Alkylating Agents|alkylating agents|mesh-ancestor
93222544|NCT03535350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222545|NCT03535350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222546|NCT02547493|Abatacept|abatacept|mesh-list
93222547|NCT02547493|Vaccines|vaccines|mesh-list
93222548|NCT02547493|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93222549|NCT02547493|Immunologic Factors|immunologic factors|mesh-ancestor
93222550|NCT02547493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222551|NCT02547493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93222552|NCT02547493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222553|NCT02547493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222554|NCT02547493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222555|NCT02547493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222556|NCT02547493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222557|NCT03259789|Bexagliflozin|bexagliflozin|mesh-list
93222558|NCT03259789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93222559|NCT03259789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222560|NCT03259555|Brexpiprazole|brexpiprazole|mesh-list
93222561|NCT03259555|Serotonin Agents|serotonin agents|mesh-ancestor
93222562|NCT03259555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222563|NCT03259555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222564|NCT03259555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222565|NCT03259555|Dopamine Agonists|dopamine agonists|mesh-ancestor
93222566|NCT03259555|Dopamine Agents|dopamine agents|mesh-ancestor
93222567|NCT03257995|Maleic acid|maleic acid|mesh-list
93222568|NCT03257995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222569|NCT03257995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222570|NCT03049488|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93222571|NCT03049488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93222572|NCT03049488|Immunologic Factors|immunologic factors|mesh-ancestor
93222573|NCT03049488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222574|NCT03049488|Antacids|antacids|mesh-ancestor
93222575|NCT03049488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222576|NCT03049488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222577|NCT04484922|Dexmedetomidine|dexmedetomidine|mesh-list
93222578|NCT04484922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93222579|NCT04484922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222580|NCT04484922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222581|NCT04484922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222582|NCT04484922|Analgesics|analgesics|mesh-ancestor
93222583|NCT04484922|Sensory System Agents|sensory system agents|mesh-ancestor
93222584|NCT04484922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222585|NCT04484922|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93222586|NCT04484922|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93222587|NCT04484922|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222588|NCT04484922|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222589|NCT04484922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222590|NCT04484922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222591|NCT04446390|Listerine|listerine|mesh-list
93222592|NCT04446390|Sodium Fluoride|sodium fluoride|mesh-list
93222593|NCT04446390|Cariostatic Agents|cariostatic agents|mesh-ancestor
93222594|NCT04446390|Protective Agents|protective agents|mesh-ancestor
93222595|NCT04446390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222596|NCT04446390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93222597|NCT04446390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222598|NCT02338921|Metformin|metformin|mesh-list
93222599|NCT02338921|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93222600|NCT02338921|Dapagliflozin|dapagliflozin|mesh-list
93222601|NCT02338921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93222602|NCT02338921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222603|NCT02338921|Incretins|incretins|mesh-ancestor
93222604|NCT02338921|Hormones|hormones|mesh-ancestor
93222605|NCT02338921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222606|NCT02338921|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93222607|NCT02338921|Protease Inhibitors|protease inhibitors|mesh-ancestor
93222608|NCT02338921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222609|NCT02338921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222610|NCT02338921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93222611|NCT01313845|Amantadine|amantadine|mesh-list
93222612|NCT01313845|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93222613|NCT01313845|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93222614|NCT01313845|Antiviral Agents|antiviral agents|mesh-ancestor
93222615|NCT01313845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222616|NCT01313845|Dopamine Agents|dopamine agents|mesh-ancestor
93222617|NCT01313845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222618|NCT01313845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222619|NCT01313845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222620|NCT01313845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222621|NCT01313845|Analgesics|analgesics|mesh-ancestor
93222622|NCT01313845|Sensory System Agents|sensory system agents|mesh-ancestor
93222623|NCT01313845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222624|NCT04400058|gamma-Globulins|gamma-globulins|mesh-list
93222625|NCT04400058|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93222626|NCT04400058|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93222627|NCT04400058|Immunologic Factors|immunologic factors|mesh-ancestor
93222628|NCT04400058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222629|NCT04745845|Norepinephrine|norepinephrine|mesh-list
93222630|NCT04745845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93222631|NCT04745845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222632|NCT04745845|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222633|NCT04745845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222634|NCT04745845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222635|NCT04745845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222636|NCT04745845|Sympathomimetics|sympathomimetics|mesh-ancestor
93222637|NCT04745845|Autonomic Agents|autonomic agents|mesh-ancestor
93222638|NCT04745845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222639|NCT04745845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93222640|NCT04173247|Mineral Oil|mineral oil|mesh-list
93222641|NCT04173247|Emollients|emollients|mesh-ancestor
93222642|NCT04173247|Dermatologic Agents|dermatologic agents|mesh-ancestor
93222643|NCT03196986|Bevacizumab|bevacizumab|mesh-list
93222644|NCT03196986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222645|NCT03196986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222646|NCT03196986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93222647|NCT03196986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93222648|NCT03196986|Growth Substances|growth substances|mesh-ancestor
93222649|NCT03196986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222650|NCT03196986|Growth Inhibitors|growth inhibitors|mesh-ancestor
93222652|NCT04051632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93222653|NCT04051632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222654|NCT04423237|Deferasirox|deferasirox|mesh-list
93222655|NCT04423237|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93222656|NCT04423237|Chelating Agents|chelating agents|mesh-ancestor
93222657|NCT04423237|Sequestering Agents|sequestering agents|mesh-ancestor
93222658|NCT04423237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222659|NCT03043560|Ezogabine|ezogabine|mesh-list
93222660|NCT03043560|Anticonvulsants|anticonvulsants|mesh-ancestor
93222661|NCT03043560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222662|NCT03043560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222663|NCT02145403|Tacrolimus|tacrolimus|mesh-list
93222664|NCT02145403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222665|NCT02145403|Immunologic Factors|immunologic factors|mesh-ancestor
93222666|NCT02145403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222667|NCT02145403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93222668|NCT02145403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222669|NCT02145403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222670|NCT02899988|Mirikizumab|mirikizumab|mesh-list
93222671|NCT02899988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222672|NCT02899988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222673|NCT02899988|Analgesics|analgesics|mesh-ancestor
93222674|NCT02899988|Sensory System Agents|sensory system agents|mesh-ancestor
93222675|NCT02899988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222676|NCT02899988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222677|NCT02899988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222678|NCT02899988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222679|NCT02899988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93222680|NCT02899988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93222681|NCT03646526|Amitriptyline|amitriptyline|mesh-list
93222682|NCT03646526|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93222683|NCT03646526|Antidepressive Agents|antidepressive agents|mesh-ancestor
93222684|NCT03646526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93222685|NCT03646526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222686|NCT03646526|Analgesics|analgesics|mesh-ancestor
93222687|NCT03646526|Sensory System Agents|sensory system agents|mesh-ancestor
93222688|NCT03646526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222689|NCT03646526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222690|NCT03646526|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93222691|NCT03646526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93222692|NCT03646526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222693|NCT03646526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222694|NCT03646526|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222695|NCT03646526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222696|NCT03646370|Tenofovir|tenofovir|mesh-list
93222697|NCT03646370|Antiviral Agents|antiviral agents|mesh-ancestor
93222698|NCT03646370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222699|NCT03646370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93222700|NCT03646370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93222701|NCT03646370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222702|NCT03646370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222703|NCT03646370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93222704|NCT03646370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93222705|NCT03646292|Pioglitazone|pioglitazone|mesh-list
93222706|NCT03646292|Empagliflozin|empagliflozin|mesh-list
93222707|NCT03646292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93222708|NCT03646292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222709|NCT03646292|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93222710|NCT03646292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222711|NCT03345407|Albuterol|albuterol|mesh-list
93222712|NCT03345407|Nemiralisib|nemiralisib|mesh-list
93222713|NCT03345407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93222714|NCT03345407|Autonomic Agents|autonomic agents|mesh-ancestor
93222715|NCT03345407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222716|NCT03345407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222717|NCT03345407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222718|NCT03345407|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222719|NCT03345407|Tocolytic Agents|tocolytic agents|mesh-ancestor
93222720|NCT03345407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93222721|NCT03345407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93222722|NCT03345407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93222723|NCT03345407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222724|NCT03345407|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222725|NCT03345407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222726|NCT03345407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222727|NCT03345407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222728|NCT03345407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222729|NCT02537418|Durvalumab|durvalumab|mesh-list
93222730|NCT02537418|Tremelimumab|tremelimumab|mesh-list
93222731|NCT02537418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222732|NCT02537418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222733|NCT03626298|Niacinamide|niacinamide|mesh-list
93222734|NCT03626298|Niacin|niacin|mesh-list
93222735|NCT03626298|Nicotinic Acids|nicotinic acids|mesh-list
93222736|NCT03626298|Adapalene|adapalene|mesh-list
93222737|NCT03626298|Vitamin B Complex|vitamin b complex|mesh-ancestor
93222738|NCT03626298|Vitamins|vitamins|mesh-ancestor
93222739|NCT03626298|Micronutrients|micronutrients|mesh-ancestor
93222740|NCT03626298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222741|NCT03626298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93222742|NCT03626298|Antimetabolites|antimetabolites|mesh-ancestor
93222743|NCT03626298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222744|NCT03626298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93222745|NCT03626298|Vasodilator Agents|vasodilator agents|mesh-ancestor
93222746|NCT03626298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222747|NCT03626298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222748|NCT03626298|Analgesics|analgesics|mesh-ancestor
93222749|NCT03626298|Sensory System Agents|sensory system agents|mesh-ancestor
93222750|NCT03626298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222751|NCT03626298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222752|NCT03626298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222753|NCT03626298|Dermatologic Agents|dermatologic agents|mesh-ancestor
93222754|NCT03644264|Sevelamer|sevelamer|mesh-list
93222755|NCT03644264|Chelating Agents|chelating agents|mesh-ancestor
93222756|NCT03644264|Sequestering Agents|sequestering agents|mesh-ancestor
93222757|NCT03644264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222758|NCT02298348|Cyclophosphamide|cyclophosphamide|mesh-list
93222759|NCT02298348|Sorafenib|sorafenib|mesh-list
93222760|NCT02298348|Topotecan|topotecan|mesh-list
93222761|NCT02298348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222762|NCT02298348|Immunologic Factors|immunologic factors|mesh-ancestor
93222763|NCT02298348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222764|NCT02298348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222765|NCT02298348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93222766|NCT02298348|Alkylating Agents|alkylating agents|mesh-ancestor
93222767|NCT02298348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222768|NCT02298348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222769|NCT02298348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93222770|NCT02298348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222771|NCT02298348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222772|NCT02298348|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93222773|NCT02298348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93222774|NCT03240133|Berotralstat|berotralstat|mesh-list
93222775|NCT03240133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93222776|NCT03240133|Protease Inhibitors|protease inhibitors|mesh-ancestor
93222777|NCT03240133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222778|NCT03240133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222779|NCT03814356|Methylphenidate|methylphenidate|mesh-list
93222780|NCT03814356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93222781|NCT03814356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222783|NCT03814356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93222784|NCT03814356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222785|NCT03814356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222786|NCT03814356|Dopamine Agents|dopamine agents|mesh-ancestor
93222787|NCT03814356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222788|NCT03707171|Liraglutide|liraglutide|mesh-list
93222789|NCT03707171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93222790|NCT03707171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222791|NCT03707171|Incretins|incretins|mesh-ancestor
93222792|NCT03707171|Hormones|hormones|mesh-ancestor
93222793|NCT03707171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222794|NCT02030964|Eflornithine|eflornithine|mesh-list
93222795|NCT02030964|Celecoxib|celecoxib|mesh-list
93222796|NCT02030964|Cyclophosphamide|cyclophosphamide|mesh-list
93222797|NCT02030964|Topotecan|topotecan|mesh-list
93222798|NCT02030964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222799|NCT02030964|Immunologic Factors|immunologic factors|mesh-ancestor
93222800|NCT02030964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222801|NCT02030964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222802|NCT02030964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93222803|NCT02030964|Alkylating Agents|alkylating agents|mesh-ancestor
93222804|NCT02030964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222805|NCT02030964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222806|NCT02030964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93222807|NCT02030964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222808|NCT02030964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222809|NCT02030964|Analgesics|analgesics|mesh-ancestor
93222810|NCT02030964|Sensory System Agents|sensory system agents|mesh-ancestor
93222811|NCT02030964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222812|NCT02030964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222813|NCT02030964|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93222814|NCT02030964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93222815|NCT02030964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222816|NCT02030964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93222817|NCT02030964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93222818|NCT02030964|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93222819|NCT02030964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93222820|NCT02030964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93222821|NCT02030964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222822|NCT02030964|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93222823|NCT03372083|Deferasirox|deferasirox|mesh-list
93222824|NCT03372083|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93222825|NCT03372083|Chelating Agents|chelating agents|mesh-ancestor
93222826|NCT03372083|Sequestering Agents|sequestering agents|mesh-ancestor
93222827|NCT03372083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222828|NCT03044886|Vitamin D|vitamin d|mesh-list
93222829|NCT03044886|Vitamins|vitamins|mesh-ancestor
93222830|NCT03044886|Micronutrients|micronutrients|mesh-ancestor
93222831|NCT03044886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222832|NCT03044886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93222833|NCT02961764|Dalbavancin|dalbavancin|mesh-list
93222834|NCT02961764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93222835|NCT02961764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222836|NCT03371459|Albuterol|albuterol|mesh-list
93222837|NCT03371459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93222838|NCT03371459|Autonomic Agents|autonomic agents|mesh-ancestor
93222839|NCT03371459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222840|NCT03371459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222841|NCT03371459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93222842|NCT03371459|Respiratory System Agents|respiratory system agents|mesh-ancestor
93222843|NCT03371459|Tocolytic Agents|tocolytic agents|mesh-ancestor
93222844|NCT03371459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93222845|NCT03371459|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93222846|NCT03371459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93222847|NCT03371459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93222848|NCT03371459|Adrenergic Agents|adrenergic agents|mesh-ancestor
93222849|NCT03371459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93222850|NCT03371459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222851|NCT03371381|Nivolumab|nivolumab|mesh-list
93222852|NCT03371381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222853|NCT03371381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222854|NCT03371381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93222855|NCT03371381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222856|NCT03044730|Pembrolizumab|pembrolizumab|mesh-list
93222857|NCT03044730|Capecitabine|capecitabine|mesh-list
93222858|NCT03044730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93222859|NCT03044730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222860|NCT03044730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93222861|NCT03044730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222862|NCT03044730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93222863|NCT03044730|Antimetabolites|antimetabolites|mesh-ancestor
93222864|NCT03738852|Insulin|insulin|mesh-list
93222865|NCT03738852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93222866|NCT03738852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222867|NCT02961374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93222868|NCT02961374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222869|NCT02961374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222870|NCT02961374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222871|NCT02961374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222872|NCT04783233|Chitosan|chitosan|mesh-list
93222873|NCT04783233|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
93222874|NCT04783233|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93222875|NCT04783233|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93222876|NCT04783233|Antimetabolites|antimetabolites|mesh-ancestor
93222877|NCT04783233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222878|NCT04783233|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93222879|NCT04783233|Chelating Agents|chelating agents|mesh-ancestor
93222880|NCT04783233|Sequestering Agents|sequestering agents|mesh-ancestor
93222881|NCT04783233|Hemostatics|hemostatics|mesh-ancestor
93222882|NCT04783233|Coagulants|coagulants|mesh-ancestor
93222883|NCT04777539|Natalizumab|natalizumab|mesh-list
93222884|NCT04777539|Immunologic Factors|immunologic factors|mesh-ancestor
93222885|NCT04777539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222886|NCT04664829|Capecitabine|capecitabine|mesh-list
93222887|NCT04664829|Bexarotene|bexarotene|mesh-list
93222888|NCT04664829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93222889|NCT04664829|Antimetabolites|antimetabolites|mesh-ancestor
93222890|NCT04664829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222891|NCT04664829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222892|NCT02951429|Pirfenidone|pirfenidone|mesh-list
93222893|NCT02951429|Sildenafil Citrate|sildenafil citrate|mesh-list
93222894|NCT02951429|Vasodilator Agents|vasodilator agents|mesh-ancestor
93222895|NCT02951429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93222896|NCT02951429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93222897|NCT02951429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222898|NCT02951429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222899|NCT02951429|Urological Agents|urological agents|mesh-ancestor
93222900|NCT02951429|Analgesics|analgesics|mesh-ancestor
93222901|NCT02951429|Sensory System Agents|sensory system agents|mesh-ancestor
93222902|NCT02951429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222903|NCT02951429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222904|NCT02951429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93222905|NCT02951429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93222906|NCT02951429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222907|NCT02951429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93222908|NCT02951429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222909|NCT04622709|Furosemide|furosemide|mesh-list
93222910|NCT04622709|Diuretics|diuretics|mesh-list
93222911|NCT04622709|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
93222912|NCT04622709|Natriuretic Agents|natriuretic agents|mesh-ancestor
93222913|NCT04622709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222914|NCT04622709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222915|NCT04622709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222916|NCT05423379|Everolimus|everolimus|mesh-list
93222917|NCT05423379|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93222918|NCT05423379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93222919|NCT05423379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222920|NCT05423379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222921|NCT05423379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93222922|NCT05423379|Immunologic Factors|immunologic factors|mesh-ancestor
93222923|NCT05423379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222924|NCT05423379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222925|NCT05214807|Chitosan|chitosan|mesh-list
93222927|NCT05214807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93222928|NCT05214807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93222929|NCT05214807|Antimetabolites|antimetabolites|mesh-ancestor
93222930|NCT05214807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222931|NCT05214807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93222932|NCT05214807|Chelating Agents|chelating agents|mesh-ancestor
93222933|NCT05214807|Sequestering Agents|sequestering agents|mesh-ancestor
93222934|NCT05214807|Hemostatics|hemostatics|mesh-ancestor
93222935|NCT05214807|Coagulants|coagulants|mesh-ancestor
93222936|NCT05214807|Viscosupplements|viscosupplements|mesh-ancestor
93222937|NCT05214807|Protective Agents|protective agents|mesh-ancestor
93222938|NCT05214807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222939|NCT02454855|Melatonin|melatonin|mesh-list
93222940|NCT02454855|Antioxidants|antioxidants|mesh-ancestor
93222941|NCT02454855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222942|NCT02454855|Protective Agents|protective agents|mesh-ancestor
93222943|NCT02454855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222944|NCT02454855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222945|NCT03343067|Norethindrone|norethindrone|mesh-list
93222946|NCT03343067|Norethindrone Acetate|norethindrone acetate|mesh-list
93222947|NCT03343067|Estradiol|estradiol|mesh-list
93222948|NCT03343067|Estrogens|estrogens|mesh-ancestor
93222949|NCT03343067|Hormones|hormones|mesh-ancestor
93222950|NCT03343067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93222951|NCT03343067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222952|NCT03343067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93222953|NCT03343067|Contraceptive Agents|contraceptive agents|mesh-ancestor
93222954|NCT03343067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93222955|NCT03343067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93222956|NCT03343067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93222957|NCT03343067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93222958|NCT03343067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93222959|NCT05205525|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93222960|NCT05205525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93222961|NCT05205525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222962|NCT05205525|Antitubercular Agents|antitubercular agents|mesh-ancestor
93222963|NCT04707183|Lidocaine|lidocaine|mesh-list
93222964|NCT04707183|Anesthetics, Local|anesthetics, local|mesh-ancestor
93222965|NCT04707183|Anesthetics|anesthetics|mesh-ancestor
93222966|NCT04707183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93222967|NCT04707183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222968|NCT04707183|Sensory System Agents|sensory system agents|mesh-ancestor
91929381|NCT01645930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222969|NCT04707183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93222970|NCT04707183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93222971|NCT04707183|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93222972|NCT04707183|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93222973|NCT04707183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93222974|NCT04707183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222975|NCT04703205|Ivermectin|ivermectin|mesh-list
93222976|NCT04703205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93222977|NCT04703205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222978|NCT03706781|Cetylpyridinium|cetylpyridinium|mesh-list
93222979|NCT03706781|Benzydamine|benzydamine|mesh-list
93222980|NCT03706781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93222981|NCT03706781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93222982|NCT03706781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93222983|NCT03706703|Carboplatin|carboplatin|mesh-list
93222984|NCT03706703|Docetaxel|docetaxel|mesh-list
93222985|NCT03706703|Pemetrexed|pemetrexed|mesh-list
93222986|NCT03706703|Endostar protein|endostar protein|mesh-list
93222987|NCT03706703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93222988|NCT03706703|Tubulin Modulators|tubulin modulators|mesh-ancestor
93222989|NCT03706703|Antimitotic Agents|antimitotic agents|mesh-ancestor
93222990|NCT03706703|Mitosis Modulators|mitosis modulators|mesh-ancestor
93222991|NCT03706703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93222992|NCT03706703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93222993|NCT03706703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93222994|NCT03706703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93222995|NCT03706703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93222996|NCT03706703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93222997|NCT03706703|Growth Substances|growth substances|mesh-ancestor
93222998|NCT03706703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93222999|NCT03706703|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223000|NCT05642403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93223001|NCT03706547|Cyclophosphamide|cyclophosphamide|mesh-list
93223002|NCT03706547|Fludarabine|fludarabine|mesh-list
93223003|NCT03706547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223004|NCT03706547|Immunologic Factors|immunologic factors|mesh-ancestor
93223005|NCT03706547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223006|NCT03706547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223007|NCT03706547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93223008|NCT03706547|Alkylating Agents|alkylating agents|mesh-ancestor
93223009|NCT03706547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223010|NCT03706547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223011|NCT03706547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93223012|NCT05682209|Octreotide|octreotide|mesh-list
93223013|NCT05682209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93223014|NCT05682209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93223015|NCT05682209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223016|NCT03708497|Misoprostol|misoprostol|mesh-list
93223017|NCT03708497|Tranexamic Acid|tranexamic acid|mesh-list
93223018|NCT03708497|Carbetocin|carbetocin|mesh-list
93223019|NCT03708497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93223020|NCT03708497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93223021|NCT03708497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223022|NCT03708497|Hemostatics|hemostatics|mesh-ancestor
93223023|NCT03708497|Coagulants|coagulants|mesh-ancestor
93223024|NCT03708497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93223025|NCT03708497|Abortifacient Agents|abortifacient agents|mesh-ancestor
93223026|NCT03708497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93223027|NCT03708497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223028|NCT03708497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93223029|NCT03708497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93223030|NCT03708497|Oxytocics|oxytocics|mesh-ancestor
93223031|NCT04608903|Sulforaphane|sulforaphane|mesh-list
93223032|NCT04608903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93223033|NCT04608903|Protective Agents|protective agents|mesh-ancestor
93223034|NCT04608903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223035|NCT04608903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223036|NCT05681975|Antibodies|antibodies|mesh-list
93223037|NCT05681975|Immunoglobulins|immunoglobulins|mesh-list
93223038|NCT05681975|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93223039|NCT05681975|Immunoglobulin G|immunoglobulin g|mesh-list
93223040|NCT05681975|Immunologic Factors|immunologic factors|mesh-ancestor
93223041|NCT05681975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223042|NCT05216744|Doxycycline|doxycycline|mesh-list
93223043|NCT05216744|Ceftriaxone|ceftriaxone|mesh-list
93223044|NCT05216744|Cefixime|cefixime|mesh-list
92519044|NCT00091624|Lenalidomide|lenalidomide|mesh-list
93223045|NCT05216744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93223046|NCT05216744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223047|NCT05216744|Antimalarials|antimalarials|mesh-ancestor
93223048|NCT05216744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93223049|NCT05216744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93223050|NCT05681897|Minoxidil|minoxidil|mesh-list
93223051|NCT05681897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93223052|NCT05681897|Vasodilator Agents|vasodilator agents|mesh-ancestor
93223053|NCT01345058|Lacosamide|lacosamide|mesh-list
93223054|NCT01345058|Levetiracetam|levetiracetam|mesh-list
93223055|NCT01345058|Anticonvulsants|anticonvulsants|mesh-ancestor
93223056|NCT01345058|Nootropic Agents|nootropic agents|mesh-ancestor
93223057|NCT01345058|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93223058|NCT01345058|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93223059|NCT01345058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223060|NCT01345058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223061|NCT01345292|Listerine|listerine|mesh-list
93223062|NCT01345292|Fluorides|fluorides|mesh-list
93223063|NCT01345292|Sodium Fluoride|sodium fluoride|mesh-list
93223064|NCT01345292|Cariostatic Agents|cariostatic agents|mesh-ancestor
93223065|NCT01345292|Protective Agents|protective agents|mesh-ancestor
93223066|NCT01345292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223067|NCT01345292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93223068|NCT01345292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223069|NCT03340961|Doxycycline|doxycycline|mesh-list
93223070|NCT03340961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93223071|NCT03340961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223072|NCT03340961|Antimalarials|antimalarials|mesh-ancestor
93223073|NCT03340961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93223074|NCT03340961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93223075|NCT03708341|Melatonin|melatonin|mesh-list
93223076|NCT03708341|Antioxidants|antioxidants|mesh-ancestor
93223077|NCT03708341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223078|NCT03708341|Protective Agents|protective agents|mesh-ancestor
93223079|NCT03708341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223080|NCT03708341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223081|NCT03643874|Albuterol|albuterol|mesh-list
93223082|NCT03643874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93223083|NCT03643874|Autonomic Agents|autonomic agents|mesh-ancestor
93223084|NCT03643874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223085|NCT03643874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223086|NCT03643874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93223087|NCT03643874|Respiratory System Agents|respiratory system agents|mesh-ancestor
93223088|NCT03643874|Tocolytic Agents|tocolytic agents|mesh-ancestor
93223089|NCT03643874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93223090|NCT03643874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93223091|NCT03643874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93223092|NCT03643874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93223093|NCT03643874|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223094|NCT03643874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223095|NCT03643874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223096|NCT03254485|Praliciguat|praliciguat|mesh-list
93223097|NCT03254485|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93223098|NCT03254485|Enzyme Activators|enzyme activators|mesh-ancestor
93223099|NCT03254485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223100|NCT03254485|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93223101|NCT00769327|Imatinib Mesylate|imatinib mesylate|mesh-list
93223102|NCT00769327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223103|NCT00769327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223104|NCT00769327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223105|NCT00769327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223107|NCT01068704|Lapatinib|lapatinib|mesh-list
93223108|NCT01068704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223109|NCT01068704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93223110|NCT01068704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93223111|NCT01068704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223112|NCT01068704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223113|NCT01068704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93223114|NCT01068704|Hormone Antagonists|hormone antagonists|mesh-ancestor
93223115|NCT01068704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223116|NCT01068704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223117|NCT01068704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223118|NCT03339401|Brincidofovir|brincidofovir|mesh-list
93223119|NCT03339401|Antiviral Agents|antiviral agents|mesh-ancestor
93223120|NCT03339401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223121|NCT05179525|Risperidone|risperidone|mesh-list
93223122|NCT05179525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93223123|NCT05179525|Serotonin Agents|serotonin agents|mesh-ancestor
93223124|NCT05179525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223125|NCT05179525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223126|NCT05179525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223127|NCT05179525|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93223128|NCT05179525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93223129|NCT05179525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223130|NCT05179525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223131|NCT05179525|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93223132|NCT05179525|Dopamine Agents|dopamine agents|mesh-ancestor
93223133|NCT03370289|Vaccines|vaccines|mesh-list
93223134|NCT03370289|Immunologic Factors|immunologic factors|mesh-ancestor
93223135|NCT03370289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223136|NCT01344824|Bevacizumab|bevacizumab|mesh-list
93223137|NCT01344824|Carboplatin|carboplatin|mesh-list
93223138|NCT01344824|Pemetrexed|pemetrexed|mesh-list
93223139|NCT01344824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93223140|NCT01344824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223141|NCT01344824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223142|NCT01344824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93223143|NCT01344824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93223144|NCT01344824|Growth Substances|growth substances|mesh-ancestor
93223145|NCT01344824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223146|NCT01344824|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223147|NCT01344824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223148|NCT01344824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223149|NCT01344824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93223150|NCT01344824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93223151|NCT01344824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223152|NCT01311947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93223153|NCT01311947|Antiviral Agents|antiviral agents|mesh-ancestor
93223154|NCT01311947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223155|NCT05137496|Methylprednisolone|methylprednisolone|mesh-list
93223156|NCT05137496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93223157|NCT05137496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93223158|NCT05137496|Prednisolone|prednisolone|mesh-list
93223159|NCT05137496|Prednisolone acetate|prednisolone acetate|mesh-list
93223160|NCT05137496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93223161|NCT05137496|Prednisolone phosphate|prednisolone phosphate|mesh-list
93223162|NCT05137496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223164|NCT05137496|Autonomic Agents|autonomic agents|mesh-ancestor
93223165|NCT05137496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223166|NCT05137496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223167|NCT05137496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93223168|NCT05137496|Glucocorticoids|glucocorticoids|mesh-ancestor
93223169|NCT05137496|Hormones|hormones|mesh-ancestor
93223170|NCT05137496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223171|NCT05137496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93223172|NCT05137496|Protective Agents|protective agents|mesh-ancestor
93223173|NCT05137496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93223174|NCT05137496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223175|NCT03339245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93223176|NCT02959892|Amphetamine|amphetamine|mesh-list
93223177|NCT02959892|Naxagolide|naxagolide|mesh-list
93223178|NCT02959892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93223179|NCT02959892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223180|NCT02959892|Sympathomimetics|sympathomimetics|mesh-ancestor
93223181|NCT02959892|Autonomic Agents|autonomic agents|mesh-ancestor
93223182|NCT02959892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223183|NCT02959892|Dopamine Agents|dopamine agents|mesh-ancestor
93223184|NCT02959892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223185|NCT02959892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223186|NCT02959892|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223187|NCT02959892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93223188|NCT02959892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93223189|NCT02959892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223190|NCT02959892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93223191|NCT02959892|Dopamine Agonists|dopamine agonists|mesh-ancestor
93223192|NCT01661400|Thalidomide|thalidomide|mesh-list
93223193|NCT01661400|Cyclophosphamide|cyclophosphamide|mesh-list
93223194|NCT01661400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223195|NCT01661400|Immunologic Factors|immunologic factors|mesh-ancestor
93223196|NCT01661400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223197|NCT01661400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223198|NCT01661400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93223199|NCT01661400|Alkylating Agents|alkylating agents|mesh-ancestor
93223200|NCT01661400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223201|NCT01661400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223202|NCT01661400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93223203|NCT01661400|Leprostatic Agents|leprostatic agents|mesh-ancestor
93223204|NCT01661400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93223205|NCT01661400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223206|NCT01661400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93223207|NCT01661400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93223208|NCT01661400|Growth Substances|growth substances|mesh-ancestor
93223209|NCT01661400|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223210|NCT05158166|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93223211|NCT05158166|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93223212|NCT05158166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93223213|NCT05158166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223214|NCT05158166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223215|NCT05158166|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93223216|NCT05158166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223217|NCT05158166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223218|NCT05158166|Cholinergic Agents|cholinergic agents|mesh-ancestor
93223219|NCT05158166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223220|NCT03368807|Insulin Lispro|insulin lispro|mesh-list
93223221|NCT03368807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93223222|NCT03368807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223223|NCT05179213|Azacitidine|azacitidine|mesh-list
93223224|NCT05179213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93223225|NCT05179213|Antimetabolites|antimetabolites|mesh-ancestor
93223226|NCT05179213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223227|NCT05179213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223228|NCT05179213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223229|NCT03338855|Dapagliflozin|dapagliflozin|mesh-list
93223230|NCT03338855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93223231|NCT03338855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223232|NCT03338855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93223233|NCT03338855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223234|NCT03367793|Metronidazole|metronidazole|mesh-list
93223235|NCT03367793|Methamphetamine|methamphetamine|mesh-list
93223236|NCT03367793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93223237|NCT03367793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223238|NCT03367793|Sympathomimetics|sympathomimetics|mesh-ancestor
93223239|NCT03367793|Autonomic Agents|autonomic agents|mesh-ancestor
93223240|NCT03367793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223241|NCT03367793|Dopamine Agents|dopamine agents|mesh-ancestor
93223242|NCT03367793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223243|NCT03367793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223244|NCT03367793|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223245|NCT03367793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93223246|NCT03367793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93223247|NCT03367793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223248|NCT03367793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93223249|NCT03367793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223250|NCT03367793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93223251|NCT03367793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93223252|NCT03367793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93223253|NCT05178745|Fluorouracil|fluorouracil|mesh-list
93223255|NCT05178745|Aflibercept|aflibercept|mesh-list
93223256|NCT05178745|Antimetabolites|antimetabolites|mesh-ancestor
93223257|NCT05178745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223258|NCT05178745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93223259|NCT05178745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223260|NCT05178745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223261|NCT05178745|Immunologic Factors|immunologic factors|mesh-ancestor
93223262|NCT05178745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223263|NCT05178745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93223264|NCT05178745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93223265|NCT05178745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223266|NCT05178745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93223267|NCT05178745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93223268|NCT05178745|Growth Substances|growth substances|mesh-ancestor
93223269|NCT05178745|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223270|NCT05178511|Ensartinib|ensartinib|mesh-list
93223271|NCT05178511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223272|NCT05178511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223273|NCT05178511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223274|NCT05178511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223275|NCT05571163|Sotorasib|sotorasib|mesh-list
93223276|NCT05571163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93223277|NCT05571163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223278|NCT05571163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223279|NCT05571163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223280|NCT03995641|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93223281|NCT03995641|Bupivacaine|bupivacaine|mesh-list
93223282|NCT03995641|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223283|NCT03995641|Anesthetics|anesthetics|mesh-ancestor
93223284|NCT03995641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223285|NCT03995641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223286|NCT03995641|Sensory System Agents|sensory system agents|mesh-ancestor
93223287|NCT03995641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223288|NCT03995641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223289|NCT03995641|Glucocorticoids|glucocorticoids|mesh-ancestor
93223290|NCT03995641|Hormones|hormones|mesh-ancestor
93223291|NCT03995641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223292|NCT03995641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223293|NCT03995641|Immunologic Factors|immunologic factors|mesh-ancestor
93223294|NCT04105231|Cannabidiol|cannabidiol|mesh-list
93223295|NCT04105231|Risperidone|risperidone|mesh-list
93223296|NCT04105231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93223297|NCT04105231|Serotonin Agents|serotonin agents|mesh-ancestor
93223298|NCT04105231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223299|NCT04105231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223300|NCT04105231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223301|NCT04105231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93223302|NCT04105231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93223303|NCT04105231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223304|NCT04105231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223305|NCT04105231|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93223307|NCT04105231|Anticonvulsants|anticonvulsants|mesh-ancestor
93223308|NCT03557749|Dimercaprol|dimercaprol|mesh-list
93223309|NCT03557749|Chelating Agents|chelating agents|mesh-ancestor
93223310|NCT03557749|Sequestering Agents|sequestering agents|mesh-ancestor
93223311|NCT03557749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223312|NCT03532555|Zinc|zinc|mesh-list
93223313|NCT03532555|Trace Elements|trace elements|mesh-ancestor
93223314|NCT03532555|Micronutrients|micronutrients|mesh-ancestor
93223315|NCT03532555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223316|NCT03993457|Bupropion|bupropion|mesh-list
93223317|NCT03993457|Escitalopram|escitalopram|mesh-list
93223318|NCT03993457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93223319|NCT03993457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93223320|NCT03993457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223321|NCT03993457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223322|NCT03993457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223323|NCT03993457|Serotonin Agents|serotonin agents|mesh-ancestor
93223324|NCT03993457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223325|NCT03993457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93223326|NCT03993457|Antidepressive Agents|antidepressive agents|mesh-ancestor
93223327|NCT03993457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223328|NCT03993457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93223329|NCT03993457|Dopamine Agents|dopamine agents|mesh-ancestor
93223330|NCT03993457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93223331|NCT03993457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93223332|NCT03993457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223333|NCT04677439|Flumatinib|flumatinib|mesh-list
93223334|NCT04677439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223335|NCT04677439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223336|NCT04677439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223337|NCT05689710|Inositol|inositol|mesh-list
93223338|NCT05689710|Vitamin B Complex|vitamin b complex|mesh-ancestor
93223339|NCT05689710|Vitamins|vitamins|mesh-ancestor
93223340|NCT05689710|Micronutrients|micronutrients|mesh-ancestor
93223341|NCT05689710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223342|NCT02777424|Thrombin|thrombin|mesh-list
93223343|NCT02777424|Hemostatics|hemostatics|mesh-ancestor
93223344|NCT02777424|Coagulants|coagulants|mesh-ancestor
93223345|NCT01347073|Glycerol|glycerol|mesh-list
93223346|NCT01347073|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93223347|NCT01347073|Protective Agents|protective agents|mesh-ancestor
93223348|NCT01347073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223349|NCT01315236|Amikacin|amikacin|mesh-list
93223350|NCT01315236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93223351|NCT01315236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223352|NCT03730051|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
93223353|NCT03730051|Chelating Agents|chelating agents|mesh-ancestor
93223354|NCT03730051|Sequestering Agents|sequestering agents|mesh-ancestor
93223355|NCT03730051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223356|NCT05627466|Magrolimab|magrolimab|mesh-list
93223357|NCT05627466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223358|NCT05627466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223359|NCT03364049|Pembrolizumab|pembrolizumab|mesh-list
93223360|NCT03364049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223361|NCT03364049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223362|NCT03364049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93223363|NCT03364049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223364|NCT05343078|Dapagliflozin|dapagliflozin|mesh-list
93223365|NCT05343078|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93223366|NCT05343078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223367|NCT05343078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93223368|NCT05343078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223369|NCT03710369|Sildenafil Citrate|sildenafil citrate|mesh-list
93223370|NCT03710369|Vasodilator Agents|vasodilator agents|mesh-ancestor
93223371|NCT03710369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93223372|NCT03710369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93223373|NCT03710369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223374|NCT03710369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223375|NCT03710369|Urological Agents|urological agents|mesh-ancestor
93223376|NCT03706157|Doxorubicin|doxorubicin|mesh-list
93223377|NCT03706157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93223378|NCT03706157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93223379|NCT03706157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223380|NCT03706157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93223381|NCT03706157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93223382|NCT03706157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223383|NCT03706157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223384|NCT03707795|Betamethasone|betamethasone|mesh-list
93223385|NCT03707795|Betamethasone Valerate|betamethasone valerate|mesh-list
93223386|NCT03707795|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93223387|NCT03707795|Betamethasone benzoate|betamethasone benzoate|mesh-list
93223388|NCT03707795|Betamethasone acetate|betamethasone acetate|mesh-list
93223389|NCT03707795|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
93223390|NCT03707795|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93223391|NCT03707795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223392|NCT03707795|Glucocorticoids|glucocorticoids|mesh-ancestor
93223393|NCT03707795|Hormones|hormones|mesh-ancestor
93223394|NCT03707795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223395|NCT03707795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223396|NCT03707795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93223397|NCT03707795|Respiratory System Agents|respiratory system agents|mesh-ancestor
93223398|NCT03707795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93223399|NCT03707795|Autonomic Agents|autonomic agents|mesh-ancestor
93223400|NCT03707795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223401|NCT03042312|177Lu-PSMA-617|177lu-psma-617|mesh-list
93223402|NCT03042312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93223403|NCT03042312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223404|NCT05171231|Hemostatics|hemostatics|mesh-list
93223405|NCT05171231|Coagulants|coagulants|mesh-ancestor
93223406|NCT05692986|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93223407|NCT05692986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223408|NCT03360071|Immunomodulating Agents|immunomodulating agents|mesh-list
93223409|NCT03360071|Immunologic Factors|immunologic factors|mesh-list
93223410|NCT03360071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223411|NCT05058924|Aspirin|aspirin|mesh-list
93223412|NCT05058924|Heparin|heparin|mesh-list
93223413|NCT05058924|Calcium heparin|calcium heparin|mesh-list
93223414|NCT05058924|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93223415|NCT05058924|Tinzaparin|tinzaparin|mesh-list
93223416|NCT05058924|Dalteparin|dalteparin|mesh-list
93223417|NCT05058924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93223418|NCT05058924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93223419|NCT05058924|Analgesics|analgesics|mesh-ancestor
93223420|NCT05058924|Sensory System Agents|sensory system agents|mesh-ancestor
93223421|NCT05058924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223422|NCT05058924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223423|NCT05058924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223424|NCT05058924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223425|NCT05058924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93223426|NCT05058924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93223427|NCT05058924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223428|NCT05058924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93223429|NCT05058924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93223430|NCT05058924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223431|NCT05058924|Antipyretics|antipyretics|mesh-ancestor
93223432|NCT05058924|Anticoagulants|anticoagulants|mesh-ancestor
93223433|NCT05681429|Acetaminophen|acetaminophen|mesh-list
93223434|NCT05681429|Parecoxib|parecoxib|mesh-list
93223435|NCT05681429|Lidocaine|lidocaine|mesh-list
93223436|NCT05681429|Dexmedetomidine|dexmedetomidine|mesh-list
93223437|NCT05681429|Sevoflurane|sevoflurane|mesh-list
93223438|NCT05681429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93223439|NCT05681429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223440|NCT05681429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223441|NCT05681429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93223442|NCT05681429|Analgesics|analgesics|mesh-ancestor
93223443|NCT05681429|Sensory System Agents|sensory system agents|mesh-ancestor
93223444|NCT05681429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223445|NCT05681429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93223446|NCT05681429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93223447|NCT05681429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93223448|NCT05681429|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223449|NCT05681429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223450|NCT05681429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223451|NCT05681429|Antipyretics|antipyretics|mesh-ancestor
93223452|NCT05681429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92895558|NCT02699879|Pirfenidone|pirfenidone|mesh-list
93223453|NCT05681429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93223454|NCT05681429|Anesthetics, General|anesthetics, general|mesh-ancestor
93223455|NCT05681429|Anesthetics|anesthetics|mesh-ancestor
93223456|NCT05681429|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223457|NCT05681429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93223458|NCT05681429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93223459|NCT05681429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93223460|NCT05681429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223461|NCT05681429|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93223462|NCT05681429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93223463|NCT05681429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223464|NCT05681429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93223465|NCT05681429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223466|NCT05681429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223467|NCT05024760|Chlorhexidine|chlorhexidine|mesh-list
93223468|NCT05024760|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93223469|NCT05024760|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93223470|NCT05024760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223471|NCT05024760|Disinfectants|disinfectants|mesh-ancestor
93223472|NCT04999020|Ravulizumab|ravulizumab|mesh-list
93223473|NCT04999020|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93223474|NCT04999020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223475|NCT04999020|Immunologic Factors|immunologic factors|mesh-ancestor
93223476|NCT04999020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223477|NCT02949011|Oseltamivir|oseltamivir|mesh-list
93223478|NCT02949011|Baloxavir|baloxavir|mesh-list
93223479|NCT02949011|Antiviral Agents|antiviral agents|mesh-ancestor
93223480|NCT02949011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223481|NCT02949011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223482|NCT02949011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223483|NCT03705533|Telmisartan|telmisartan|mesh-list
93223484|NCT03705533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93223485|NCT03705533|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93223486|NCT03705533|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93223487|NCT03705533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223488|NCT03357731|Nitroglycerin|nitroglycerin|mesh-list
93223489|NCT03357731|Vasodilator Agents|vasodilator agents|mesh-ancestor
93223490|NCT03357341|Albuterol|albuterol|mesh-list
93223491|NCT03357341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93223492|NCT03357341|Autonomic Agents|autonomic agents|mesh-ancestor
93223493|NCT03357341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223494|NCT03357341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223495|NCT03357341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93223496|NCT03357341|Respiratory System Agents|respiratory system agents|mesh-ancestor
93223497|NCT03357341|Tocolytic Agents|tocolytic agents|mesh-ancestor
93223498|NCT03357341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93223499|NCT03357341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93223500|NCT03357341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93223501|NCT03357341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93223502|NCT03357341|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223503|NCT03357341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223504|NCT03357341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223505|NCT05177237|Endostar protein|endostar protein|mesh-list
93223506|NCT05177237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93223507|NCT05177237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93223508|NCT05177237|Growth Substances|growth substances|mesh-ancestor
93223509|NCT05177237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223510|NCT05177237|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223511|NCT05177237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223512|NCT05176925|Tislelizumab|tislelizumab|mesh-list
93223513|NCT05176925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223514|NCT05176925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223515|NCT05175131|Mebeverine|mebeverine|mesh-list
93223516|NCT05175131|Simethicone|simethicone|mesh-list
93223517|NCT05175131|Alverine|alverine|mesh-list
93223518|NCT05175131|Antifoaming Agents|antifoaming agents|mesh-ancestor
93223519|NCT05175131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223520|NCT05175131|Emollients|emollients|mesh-ancestor
93223521|NCT05175131|Dermatologic Agents|dermatologic agents|mesh-ancestor
93223522|NCT05175131|Anticonvulsants|anticonvulsants|mesh-ancestor
93223523|NCT05175131|Parasympatholytics|parasympatholytics|mesh-ancestor
93223524|NCT05175131|Autonomic Agents|autonomic agents|mesh-ancestor
93223525|NCT05175131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223526|NCT05175131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223527|NCT04507373|Simvastatin|simvastatin|mesh-list
93223528|NCT04507373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93223529|NCT04507373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93223530|NCT04507373|Antimetabolites|antimetabolites|mesh-ancestor
93223531|NCT04507373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223533|NCT04507373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93223534|NCT04507373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223535|NCT01312337|Gefitinib|gefitinib|mesh-list
93223536|NCT01312337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223537|NCT01312337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223538|NCT01312337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223539|NCT01312337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223540|NCT05229653|Ketamine|ketamine|mesh-list
93223541|NCT05229653|Analgesics|analgesics|mesh-ancestor
93223542|NCT05229653|Sensory System Agents|sensory system agents|mesh-ancestor
93223543|NCT05229653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223544|NCT05229653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223545|NCT05229653|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93223546|NCT05229653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93223547|NCT05229653|Anesthetics, General|anesthetics, general|mesh-ancestor
93223548|NCT05229653|Anesthetics|anesthetics|mesh-ancestor
93223549|NCT05229653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223550|NCT05229653|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93223551|NCT05229653|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93223552|NCT05229653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223553|NCT05229653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223554|NCT05551949|Estradiol|estradiol|mesh-list
93223555|NCT05551949|Estrogens|estrogens|mesh-ancestor
93223556|NCT05551949|Hormones|hormones|mesh-ancestor
93223557|NCT05551949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223558|NCT05551949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223559|NCT05541497|Varenicline|varenicline|mesh-list
93223560|NCT05541497|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93223561|NCT05541497|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93223562|NCT05541497|Cholinergic Agents|cholinergic agents|mesh-ancestor
93223563|NCT05541497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223564|NCT05541497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223565|NCT05541497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223566|NCT05283954|Ivermectin|ivermectin|mesh-list
93223567|NCT05283954|Albendazole|albendazole|mesh-list
93223568|NCT05283954|Prednisolone|prednisolone|mesh-list
93223569|NCT05283954|Fluoxetine|fluoxetine|mesh-list
93223570|NCT05283954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223571|NCT05283954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223572|NCT05283954|Glucocorticoids|glucocorticoids|mesh-ancestor
93223573|NCT05283954|Hormones|hormones|mesh-ancestor
93223574|NCT05283954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223575|NCT05283954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93223576|NCT05283954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223577|NCT05283954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223578|NCT05283954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93223579|NCT05283954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93223580|NCT05283954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223581|NCT05283954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223582|NCT05283954|Serotonin Agents|serotonin agents|mesh-ancestor
93223583|NCT05283954|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93223584|NCT05283954|Antidepressive Agents|antidepressive agents|mesh-ancestor
93223585|NCT05283954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223586|NCT05283954|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93223587|NCT05283954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93223588|NCT05283954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223589|NCT05283954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93223590|NCT05283954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223591|NCT05283954|Anthelmintics|anthelmintics|mesh-ancestor
93223592|NCT05283954|Anticestodal Agents|anticestodal agents|mesh-ancestor
93223593|NCT05283954|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93223594|NCT05283954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93223595|NCT05283954|Tubulin Modulators|tubulin modulators|mesh-ancestor
93223596|NCT05283954|Antimitotic Agents|antimitotic agents|mesh-ancestor
93223597|NCT05283954|Mitosis Modulators|mitosis modulators|mesh-ancestor
93223598|NCT01312415|Morphine|morphine|mesh-list
93223599|NCT01312415|Levobupivacaine|levobupivacaine|mesh-list
93223600|NCT01312415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93223601|NCT01312415|Narcotics|narcotics|mesh-ancestor
93223602|NCT01312415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895705|NCT00617045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223603|NCT01312415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223605|NCT01312415|Sensory System Agents|sensory system agents|mesh-ancestor
93223606|NCT01312415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223607|NCT01312415|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223608|NCT01312415|Anesthetics|anesthetics|mesh-ancestor
93223609|NCT03036852|Sofosbuvir|sofosbuvir|mesh-list
93223610|NCT03036852|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93223611|NCT03036852|Velpatasvir|velpatasvir|mesh-list
93223612|NCT03036852|Antiviral Agents|antiviral agents|mesh-ancestor
93223613|NCT03036852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223614|NCT01312493|Panitumumab|panitumumab|mesh-list
93223615|NCT01312493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223616|NCT01312493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223617|NCT04313244|Vaccines|vaccines|mesh-list
93223618|NCT04313244|Immunologic Factors|immunologic factors|mesh-ancestor
93223619|NCT04313244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223620|NCT05279898|Dexmedetomidine|dexmedetomidine|mesh-list
93223621|NCT05279898|Ketamine|ketamine|mesh-list
93223622|NCT05279898|Remifentanil|remifentanil|mesh-list
93223623|NCT05279898|Propofol|propofol|mesh-list
93223624|NCT05279898|Ropivacaine|ropivacaine|mesh-list
93223625|NCT05279898|Rocuronium|rocuronium|mesh-list
93223626|NCT05279898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93223627|NCT05279898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223628|NCT05279898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223629|NCT05279898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93223630|NCT05279898|Analgesics|analgesics|mesh-ancestor
93223631|NCT05279898|Sensory System Agents|sensory system agents|mesh-ancestor
93223632|NCT05279898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223633|NCT05279898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93223634|NCT05279898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93223635|NCT05279898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93223636|NCT05279898|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223637|NCT05279898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223638|NCT05279898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223639|NCT05279898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93223640|NCT05279898|Anesthetics, General|anesthetics, general|mesh-ancestor
93223641|NCT05279898|Anesthetics|anesthetics|mesh-ancestor
93223642|NCT05279898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93223643|NCT05279898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93223644|NCT05279898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93223645|NCT05279898|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223646|NCT05279898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93223647|NCT05279898|Narcotics|narcotics|mesh-ancestor
93223648|NCT05279898|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93223649|NCT05279898|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93223650|NCT05279898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93223651|NCT05309694|Copper|copper|mesh-list
93223652|NCT05309694|Contraceptive Agents|contraceptive agents|mesh-list
93223653|NCT05309694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93223654|NCT05309694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223655|NCT05309694|Trace Elements|trace elements|mesh-ancestor
93223656|NCT05309694|Micronutrients|micronutrients|mesh-ancestor
93223657|NCT05268510|Pembrolizumab|pembrolizumab|mesh-list
93223658|NCT05268510|Olaparib|olaparib|mesh-list
93223659|NCT05268510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223660|NCT05268510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223661|NCT05268510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93223662|NCT05268510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223663|NCT05268510|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93223664|NCT05268510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223665|NCT05438303|Celecoxib|celecoxib|mesh-list
93223666|NCT05438303|Midazolam|midazolam|mesh-list
93223667|NCT05438303|Omeprazole|omeprazole|mesh-list
93223668|NCT05438303|Dabigatran|dabigatran|mesh-list
93223669|NCT05438303|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93223670|NCT05438303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93223671|NCT05438303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223672|NCT05438303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223673|NCT05438303|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93223674|NCT05438303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93223675|NCT05438303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223676|NCT05438303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93223677|NCT05438303|Anesthetics, General|anesthetics, general|mesh-ancestor
93223678|NCT05438303|Anesthetics|anesthetics|mesh-ancestor
93223679|NCT05438303|GABA Modulators|gaba modulators|mesh-ancestor
93223680|NCT05438303|GABA Agents|gaba agents|mesh-ancestor
93223681|NCT05438303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223682|NCT05438303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223683|NCT05438303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93223684|NCT05438303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93223686|NCT05438303|Sensory System Agents|sensory system agents|mesh-ancestor
93223687|NCT05438303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223688|NCT05438303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223689|NCT05438303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223690|NCT05438303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93223691|NCT05438303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93223692|NCT05438303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223693|NCT05438303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93223694|NCT05438303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93223695|NCT05438303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93223696|NCT05438303|Antithrombins|antithrombins|mesh-ancestor
93223697|NCT05438303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93223698|NCT05438303|Protease Inhibitors|protease inhibitors|mesh-ancestor
93223699|NCT05438303|Anticoagulants|anticoagulants|mesh-ancestor
93223700|NCT05432141|Vaccines|vaccines|mesh-list
93223701|NCT05432141|Immunologic Factors|immunologic factors|mesh-ancestor
93223702|NCT05432141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223703|NCT04956809|Dapagliflozin|dapagliflozin|mesh-list
93223704|NCT04956809|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93223705|NCT04956809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223706|NCT04956809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93223707|NCT04956809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223708|NCT04735913|Abiraterone Acetate|abiraterone acetate|mesh-list
93223709|NCT04735913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223710|NCT04735913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93223711|NCT04735913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223712|NCT04735913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223713|NCT04735913|Hormone Antagonists|hormone antagonists|mesh-ancestor
93223714|NCT04735913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223715|NCT04735913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223716|NCT04735913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93223717|NCT04906889|Lidocaine|lidocaine|mesh-list
93223718|NCT04906889|Dexmedetomidine|dexmedetomidine|mesh-list
93223719|NCT04906889|Remifentanil|remifentanil|mesh-list
93223720|NCT04906889|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223721|NCT04906889|Anesthetics|anesthetics|mesh-ancestor
93223722|NCT04906889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223723|NCT04906889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223724|NCT04906889|Sensory System Agents|sensory system agents|mesh-ancestor
93223725|NCT04906889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223726|NCT04906889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93223727|NCT04906889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93223728|NCT04906889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93223729|NCT04906889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223730|NCT04906889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223731|NCT04906889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93223732|NCT04906889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93223733|NCT04906889|Analgesics|analgesics|mesh-ancestor
93223734|NCT04906889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93223735|NCT04906889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93223736|NCT04906889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93223737|NCT04906889|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223738|NCT04906889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223739|NCT04906889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93223740|NCT04906889|Narcotics|narcotics|mesh-ancestor
93223741|NCT02948777|Evolocumab|evolocumab|mesh-list
93223742|NCT02948777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93223743|NCT02948777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93223744|NCT02948777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93223745|NCT02948777|Antimetabolites|antimetabolites|mesh-ancestor
93223746|NCT02948777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223747|NCT02948777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93223748|NCT02948777|Protease Inhibitors|protease inhibitors|mesh-ancestor
93223749|NCT02948777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223750|NCT02948777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93223751|NCT04868747|Lidocaine|lidocaine|mesh-list
93223752|NCT04868747|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223753|NCT04868747|Anesthetics|anesthetics|mesh-ancestor
92895881|NCT00920998|Z 338|z 338|mesh-list
93223754|NCT04868747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223755|NCT04868747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223756|NCT04868747|Sensory System Agents|sensory system agents|mesh-ancestor
93223757|NCT04868747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223758|NCT04868747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93223759|NCT04868747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93223760|NCT04868747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93223761|NCT04868747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223762|NCT04868747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223763|NCT05330273|Efavirenz|efavirenz|mesh-list
93223764|NCT05330273|Lumefantrine|lumefantrine|mesh-list
93223765|NCT05330273|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93223766|NCT05330273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93223767|NCT05330273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223768|NCT05330273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223769|NCT05330273|Antiviral Agents|antiviral agents|mesh-ancestor
93223770|NCT05330273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223771|NCT05330273|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93223772|NCT05330273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93223773|NCT05330273|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93223774|NCT05330273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93223775|NCT05330273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93223776|NCT05330273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93223777|NCT05330273|Antimalarials|antimalarials|mesh-ancestor
93223778|NCT05330273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93223779|NCT05330273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93223780|NCT05329259|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93223781|NCT05329259|Immunologic Factors|immunologic factors|mesh-ancestor
93223782|NCT05329259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223783|NCT04533737|Brodalumab|brodalumab|mesh-list
93223784|NCT04533737|Dermatologic Agents|dermatologic agents|mesh-ancestor
93223785|NCT05254847|Capecitabine|capecitabine|mesh-list
93223786|NCT05254847|Lenvatinib|lenvatinib|mesh-list
93223787|NCT05254847|Tislelizumab|tislelizumab|mesh-list
93223788|NCT05254847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93223789|NCT05254847|Antimetabolites|antimetabolites|mesh-ancestor
93223790|NCT05254847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223791|NCT05254847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223792|NCT05254847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93223793|NCT05254847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223794|NCT05254847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223795|NCT05249699|Isoniazid|isoniazid|mesh-list
93223796|NCT05249699|Antitubercular Agents|antitubercular agents|mesh-list
93223797|NCT05249699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93223798|NCT05249699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223799|NCT05249699|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93223800|NCT05249699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93223801|NCT05249699|Antimetabolites|antimetabolites|mesh-ancestor
93223802|NCT05249699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223803|NCT05249699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93223804|NCT04751669|Trace Elements|trace elements|mesh-list
93223805|NCT04751669|Micronutrients|micronutrients|mesh-list
93223806|NCT04751669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223807|NCT04731233|Triamcinolone|triamcinolone|mesh-list
93223808|NCT04731233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93223809|NCT04731233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93223810|NCT04731233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93223811|NCT04731233|Mitogens|mitogens|mesh-list
93223812|NCT04731233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223813|NCT04731233|Glucocorticoids|glucocorticoids|mesh-ancestor
93223814|NCT04731233|Hormones|hormones|mesh-ancestor
93223815|NCT04731233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223816|NCT04731233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223817|NCT04731233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223818|NCT04731233|Immunologic Factors|immunologic factors|mesh-ancestor
93223819|NCT04731233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223820|NCT04731233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223821|NCT04731233|Mitosis Modulators|mitosis modulators|mesh-ancestor
93223822|NCT04417517|Azacitidine|azacitidine|mesh-list
93223823|NCT04417517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93223824|NCT04417517|Antimetabolites|antimetabolites|mesh-ancestor
93223825|NCT04417517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895929|NCT00676286|Choline|choline|mesh-list
93223826|NCT04417517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223827|NCT04417517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223828|NCT04695977|Nivolumab|nivolumab|mesh-list
93223829|NCT04695977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223830|NCT04695977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223831|NCT04695977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93223832|NCT04695977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223833|NCT03093155|Bevacizumab|bevacizumab|mesh-list
93223834|NCT03093155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223835|NCT03093155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223836|NCT03093155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93223837|NCT03093155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93223838|NCT03093155|Growth Substances|growth substances|mesh-ancestor
93223839|NCT03093155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223840|NCT03093155|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223841|NCT03324581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93223842|NCT03324581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93223843|NCT03324581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93223844|NCT03324581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93223845|NCT03324581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223846|NCT03324581|Adrenergic Agents|adrenergic agents|mesh-ancestor
93223847|NCT03324581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223848|NCT03324581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223849|NCT03629873|Cytarabine|cytarabine|mesh-list
93223850|NCT03629873|Cyclophosphamide|cyclophosphamide|mesh-list
93223851|NCT03629873|Carmustine|carmustine|mesh-list
93223852|NCT03629873|Etoposide|etoposide|mesh-list
93223853|NCT03629873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223854|NCT03629873|Immunologic Factors|immunologic factors|mesh-ancestor
93223855|NCT03629873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223856|NCT03629873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223857|NCT03629873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93223858|NCT03629873|Alkylating Agents|alkylating agents|mesh-ancestor
93223859|NCT03629873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223860|NCT03629873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223861|NCT03629873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93223862|NCT03629873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93223863|NCT03629873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93223864|NCT03629873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93223865|NCT03629873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223866|NCT03629873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93223867|NCT03629873|Antimetabolites|antimetabolites|mesh-ancestor
93223868|NCT03629873|Antiviral Agents|antiviral agents|mesh-ancestor
93223869|NCT03629873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223870|NCT04294043|Gallium nitrate|gallium nitrate|mesh-list
93223871|NCT04294043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93223872|NCT04294043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223873|NCT04294043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223874|NCT02899793|Pembrolizumab|pembrolizumab|mesh-list
93223875|NCT02899793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223876|NCT02899793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223877|NCT02899793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93223878|NCT02899793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223879|NCT04981145|Hydroxychloroquine|hydroxychloroquine|mesh-list
93223880|NCT04981145|Antimalarials|antimalarials|mesh-ancestor
93223881|NCT04981145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93223882|NCT04981145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93223883|NCT04981145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223884|NCT04981145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223885|NCT04981145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223886|NCT04981145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93223887|NCT02864147|Imiquimod|imiquimod|mesh-list
93223888|NCT02864147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93223889|NCT02864147|Immunologic Factors|immunologic factors|mesh-ancestor
93223890|NCT02864147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223891|NCT02864147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223892|NCT02864147|Interferon Inducers|interferon inducers|mesh-ancestor
93223893|NCT04258631|Hydromorphone|hydromorphone|mesh-list
93223894|NCT04258631|Bupivacaine|bupivacaine|mesh-list
93223895|NCT04258631|Anesthetics, Local|anesthetics, local|mesh-ancestor
93223896|NCT04258631|Anesthetics|anesthetics|mesh-ancestor
93223897|NCT04258631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223898|NCT04258631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223899|NCT04258631|Sensory System Agents|sensory system agents|mesh-ancestor
93223900|NCT04258631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223901|NCT04258631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93223902|NCT04258631|Narcotics|narcotics|mesh-ancestor
93223903|NCT04258631|Analgesics|analgesics|mesh-ancestor
93223905|NCT02931695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223906|NCT02931695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223907|NCT03638063|Adenosine|adenosine|mesh-list
93223908|NCT03638063|Capsaicin|capsaicin|mesh-list
93223909|NCT03638063|Antipruritics|antipruritics|mesh-ancestor
93223910|NCT03638063|Dermatologic Agents|dermatologic agents|mesh-ancestor
93223911|NCT03638063|Sensory System Agents|sensory system agents|mesh-ancestor
93223912|NCT03638063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223913|NCT03638063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223914|NCT03638063|Analgesics|analgesics|mesh-ancestor
93223915|NCT03638063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93223916|NCT03638063|Vasodilator Agents|vasodilator agents|mesh-ancestor
93223917|NCT03638063|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93223918|NCT03638063|Purinergic Agonists|purinergic agonists|mesh-ancestor
93223919|NCT03638063|Purinergic Agents|purinergic agents|mesh-ancestor
93223920|NCT03638063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223921|NCT03638063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223922|NCT04869371|Prednisone|prednisone|mesh-list
93223923|NCT04869371|Docetaxel|docetaxel|mesh-list
93223924|NCT04869371|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93223925|NCT04869371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223926|NCT04869371|Tubulin Modulators|tubulin modulators|mesh-ancestor
93223927|NCT04869371|Antimitotic Agents|antimitotic agents|mesh-ancestor
93223928|NCT04869371|Mitosis Modulators|mitosis modulators|mesh-ancestor
93223929|NCT04869371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223930|NCT04869371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93223931|NCT04869371|Glucocorticoids|glucocorticoids|mesh-ancestor
93223932|NCT04869371|Hormones|hormones|mesh-ancestor
93223933|NCT04869371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223934|NCT04869371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223935|NCT04869371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93223936|NCT04869371|Luteolytic Agents|luteolytic agents|mesh-ancestor
93223937|NCT04869371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93223938|NCT04869371|Contraceptive Agents|contraceptive agents|mesh-ancestor
93223939|NCT04869371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92856031|NCT02824718|Alfacalcidol|alfacalcidol|mesh-list
93223940|NCT04869371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93223941|NCT02710331|Ethanol|ethanol|mesh-list
93223942|NCT02710331|Dronabinol|dronabinol|mesh-list
93223943|NCT02710331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93223944|NCT02710331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93223945|NCT02710331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93223946|NCT02710331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223947|NCT02710331|Hallucinogens|hallucinogens|mesh-ancestor
93223948|NCT02710331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93223949|NCT02710331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93223950|NCT02710331|Analgesics|analgesics|mesh-ancestor
93223951|NCT02710331|Sensory System Agents|sensory system agents|mesh-ancestor
93223952|NCT02710331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93223953|NCT02710331|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93223954|NCT02710331|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93223955|NCT02710331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93223956|NCT02710331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223957|NCT02710331|Hormones|hormones|mesh-ancestor
93223958|NCT02710331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93223959|NCT02885753|Leucovorin|leucovorin|mesh-list
93223960|NCT02885753|Folic Acid|folic acid|mesh-list
93223961|NCT02885753|Bevacizumab|bevacizumab|mesh-list
93223962|NCT02885753|Panitumumab|panitumumab|mesh-list
93223963|NCT02885753|Oxaliplatin|oxaliplatin|mesh-list
93223964|NCT02885753|Irinotecan|irinotecan|mesh-list
93223965|NCT02885753|Fluorouracil|fluorouracil|mesh-list
93223966|NCT02885753|Levoleucovorin|levoleucovorin|mesh-list
93223967|NCT02885753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93223968|NCT02885753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93223969|NCT02885753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93223970|NCT02885753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93223971|NCT02885753|Growth Substances|growth substances|mesh-ancestor
93223972|NCT02885753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223973|NCT02885753|Growth Inhibitors|growth inhibitors|mesh-ancestor
93223974|NCT02885753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93223975|NCT02885753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93223976|NCT02885753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93223977|NCT02885753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93223978|NCT02885753|Antimetabolites|antimetabolites|mesh-ancestor
93223979|NCT02885753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93223980|NCT02885753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93223981|NCT02885753|Immunologic Factors|immunologic factors|mesh-ancestor
93223982|NCT02885753|Antidotes|antidotes|mesh-ancestor
93223983|NCT02885753|Protective Agents|protective agents|mesh-ancestor
93223984|NCT02885753|Vitamin B Complex|vitamin b complex|mesh-ancestor
93223985|NCT02885753|Vitamins|vitamins|mesh-ancestor
93223986|NCT02885753|Micronutrients|micronutrients|mesh-ancestor
93223987|NCT02885753|Hematinics|hematinics|mesh-ancestor
93223988|NCT03320057|Mifepristone|mifepristone|mesh-list
93223989|NCT03320057|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93223990|NCT03320057|Abortifacient Agents|abortifacient agents|mesh-ancestor
93223991|NCT03320057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93223992|NCT03320057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93223993|NCT03320057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93223994|NCT03320057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93223995|NCT03320057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93223996|NCT03320057|Contraceptive Agents|contraceptive agents|mesh-ancestor
93223997|NCT03320057|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93223998|NCT03320057|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93223999|NCT03320057|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224000|NCT03320057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224001|NCT03320057|Luteolytic Agents|luteolytic agents|mesh-ancestor
93224002|NCT03320057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93224003|NCT03320057|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93224004|NCT04741139|Acetaminophen|acetaminophen|mesh-list
93224005|NCT04741139|Diphenhydramine|diphenhydramine|mesh-list
93224006|NCT04741139|Promethazine|promethazine|mesh-list
93224007|NCT04741139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93224008|NCT04741139|Analgesics|analgesics|mesh-ancestor
93224009|NCT04741139|Sensory System Agents|sensory system agents|mesh-ancestor
93224010|NCT04741139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224011|NCT04741139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224012|NCT04741139|Antipyretics|antipyretics|mesh-ancestor
93224013|NCT04741139|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92856034|NCT02824718|Diuretics|diuretics|mesh-list
93224014|NCT04741139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93224015|NCT04741139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224016|NCT04741139|Anesthetics, Local|anesthetics, local|mesh-ancestor
93224017|NCT04741139|Anesthetics|anesthetics|mesh-ancestor
93224018|NCT04741139|Antiemetics|antiemetics|mesh-ancestor
93224019|NCT04741139|Autonomic Agents|autonomic agents|mesh-ancestor
93224020|NCT04741139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224021|NCT04741139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93224022|NCT04741139|Histamine Antagonists|histamine antagonists|mesh-ancestor
93224023|NCT04741139|Histamine Agents|histamine agents|mesh-ancestor
93224024|NCT04741139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224025|NCT04741139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224026|NCT04741139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93224027|NCT04741139|Antipruritics|antipruritics|mesh-ancestor
93224028|NCT04741139|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224029|NCT02227199|Carboplatin|carboplatin|mesh-list
93224030|NCT02227199|Etoposide|etoposide|mesh-list
93224031|NCT02227199|Etoposide phosphate|etoposide phosphate|mesh-list
93224032|NCT02227199|Ifosfamide|ifosfamide|mesh-list
93224033|NCT02227199|Isophosphamide mustard|isophosphamide mustard|mesh-list
93224034|NCT02227199|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93224035|NCT02227199|Podophyllotoxin|podophyllotoxin|mesh-list
93224036|NCT02227199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93224037|NCT02227199|Antibodies|antibodies|mesh-list
93224038|NCT02227199|Immunoglobulins|immunoglobulins|mesh-list
93224039|NCT02227199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93224040|NCT02227199|Immunoconjugates|immunoconjugates|mesh-list
93224041|NCT02227199|Immunologic Factors|immunologic factors|mesh-ancestor
93224042|NCT02227199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224043|NCT02227199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224044|NCT02227199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93224045|NCT02227199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93224046|NCT02227199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93224047|NCT02227199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224048|NCT02227199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224049|NCT02227199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93224050|NCT02227199|Alkylating Agents|alkylating agents|mesh-ancestor
93224051|NCT02227199|Immunotoxins|immunotoxins|mesh-ancestor
93224052|NCT02227199|Keratolytic Agents|keratolytic agents|mesh-ancestor
93224053|NCT02227199|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224054|NCT02227199|Tubulin Modulators|tubulin modulators|mesh-ancestor
93224055|NCT02227199|Antimitotic Agents|antimitotic agents|mesh-ancestor
93224056|NCT02227199|Mitosis Modulators|mitosis modulators|mesh-ancestor
93224057|NCT04853147|Dexamethasone|dexamethasone|mesh-list
93224058|NCT04853147|Dexamethasone acetate|dexamethasone acetate|mesh-list
93224059|NCT04853147|Palonosetron|palonosetron|mesh-list
93224060|NCT04853147|Fosaprepitant|fosaprepitant|mesh-list
93224062|NCT04853147|BB 1101|bb 1101|mesh-list
93224063|NCT04853147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224064|NCT04853147|Antiemetics|antiemetics|mesh-ancestor
93224065|NCT04853147|Autonomic Agents|autonomic agents|mesh-ancestor
93224066|NCT04853147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224067|NCT04853147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224068|NCT04853147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224069|NCT04853147|Glucocorticoids|glucocorticoids|mesh-ancestor
93224070|NCT04853147|Hormones|hormones|mesh-ancestor
93224071|NCT04853147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224072|NCT04853147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93224073|NCT04853147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224074|NCT04853147|Protease Inhibitors|protease inhibitors|mesh-ancestor
93224075|NCT04853147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224076|NCT04853147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224077|NCT04853147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93224078|NCT04853147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93224079|NCT04853147|Serotonin Agents|serotonin agents|mesh-ancestor
93224080|NCT04853147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224081|NCT04853147|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93224082|NCT03473561|Racecadotril|racecadotril|mesh-list
93224083|NCT03473561|Antidiarrheals|antidiarrheals|mesh-ancestor
93224084|NCT03473561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224085|NCT03473561|Protease Inhibitors|protease inhibitors|mesh-ancestor
93224086|NCT03473561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224087|NCT03473561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224088|NCT04689347|Leucovorin|leucovorin|mesh-list
93224089|NCT04689347|Bevacizumab|bevacizumab|mesh-list
93224090|NCT04689347|Fluorouracil|fluorouracil|mesh-list
93224091|NCT04689347|Irinotecan|irinotecan|mesh-list
93224092|NCT04689347|Temozolomide|temozolomide|mesh-list
93224093|NCT04689347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224094|NCT04689347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224095|NCT04689347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93224096|NCT04689347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93224097|NCT04689347|Growth Substances|growth substances|mesh-ancestor
93224098|NCT04689347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224099|NCT04689347|Growth Inhibitors|growth inhibitors|mesh-ancestor
93224100|NCT04689347|Antimetabolites|antimetabolites|mesh-ancestor
93224101|NCT04689347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224102|NCT04689347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93224103|NCT04689347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93224104|NCT04689347|Immunologic Factors|immunologic factors|mesh-ancestor
93224105|NCT04689347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93224106|NCT04689347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93224107|NCT04689347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224108|NCT04689347|Antidotes|antidotes|mesh-ancestor
93224109|NCT04689347|Protective Agents|protective agents|mesh-ancestor
93224110|NCT04689347|Vitamin B Complex|vitamin b complex|mesh-ancestor
93224111|NCT04689347|Vitamins|vitamins|mesh-ancestor
93224112|NCT04689347|Micronutrients|micronutrients|mesh-ancestor
93224113|NCT04689347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93224114|NCT04689347|Alkylating Agents|alkylating agents|mesh-ancestor
93224115|NCT03313037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93224116|NCT03313037|Immunologic Factors|immunologic factors|mesh-ancestor
93224117|NCT03313037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224118|NCT01268579|Ribavirin|ribavirin|mesh-list
93224119|NCT01268579|Antimetabolites|antimetabolites|mesh-ancestor
93224120|NCT01268579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224121|NCT01268579|Antiviral Agents|antiviral agents|mesh-ancestor
93224122|NCT01268579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224123|NCT02420795|TIC10 compound|tic10 compound|mesh-list
93224124|NCT02420795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224125|NCT02384759|Aflibercept|aflibercept|mesh-list
93224126|NCT02384759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93224127|NCT02384759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93224128|NCT02384759|Growth Substances|growth substances|mesh-ancestor
93224129|NCT02384759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224130|NCT02384759|Growth Inhibitors|growth inhibitors|mesh-ancestor
93224131|NCT02384759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224132|NCT05276687|Vancomycin|vancomycin|mesh-list
93224133|NCT05276687|Povidone-Iodine|povidone-iodine|mesh-list
93224134|NCT05276687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93224135|NCT05276687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224136|NCT05276687|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93224137|NCT03036150|Dapagliflozin|dapagliflozin|mesh-list
93224138|NCT03036150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93224139|NCT03036150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224140|NCT03036150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93224141|NCT03036150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224142|NCT03332771|Metformin|metformin|mesh-list
93224143|NCT03332771|Glimepiride|glimepiride|mesh-list
93224144|NCT03332771|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93224145|NCT03332771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93224146|NCT03332771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224147|NCT03332771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93224148|NCT03332771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93224149|NCT03332771|Immunologic Factors|immunologic factors|mesh-ancestor
93224150|NCT03332771|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93224151|NCT03332771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224152|NCT03625830|Paclitaxel|paclitaxel|mesh-list
93224153|NCT03625830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93224154|NCT03625830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224155|NCT03625830|Tubulin Modulators|tubulin modulators|mesh-ancestor
93224156|NCT03625830|Antimitotic Agents|antimitotic agents|mesh-ancestor
93224157|NCT03625830|Mitosis Modulators|mitosis modulators|mesh-ancestor
93224158|NCT03625830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224159|NCT04108104|Cyproheptadine|cyproheptadine|mesh-list
93224160|NCT04108104|Prazosin|prazosin|mesh-list
93224161|NCT04108104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93224162|NCT04108104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93224163|NCT04108104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93224164|NCT04108104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93224165|NCT04108104|Adrenergic Agents|adrenergic agents|mesh-ancestor
93224166|NCT04108104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224167|NCT04108104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224168|NCT04108104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224169|NCT04108104|Antipruritics|antipruritics|mesh-ancestor
93224170|NCT04108104|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224171|NCT04108104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224172|NCT04108104|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93224173|NCT04108104|Histamine Antagonists|histamine antagonists|mesh-ancestor
93224174|NCT04108104|Histamine Agents|histamine agents|mesh-ancestor
93224175|NCT04108104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93224176|NCT04108104|Serotonin Agents|serotonin agents|mesh-ancestor
93224177|NCT04108104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93224178|NCT05304468|Cisplatin|cisplatin|mesh-list
93224179|NCT05304468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224180|NCT04731480|Propofol|propofol|mesh-list
93224181|NCT04731480|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93224182|NCT04731480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224183|NCT04731480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224184|NCT04731480|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93224185|NCT04731480|Anesthetics, General|anesthetics, general|mesh-ancestor
93224186|NCT04731480|Anesthetics|anesthetics|mesh-ancestor
93224187|NCT03039192|Esketamine|esketamine|mesh-list
93224188|NCT03039192|Antidepressive Agents|antidepressive agents|mesh-ancestor
93224189|NCT03039192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224190|NCT03698279|Vaccines|vaccines|mesh-list
93224191|NCT03698279|Immunologic Factors|immunologic factors|mesh-ancestor
93224192|NCT03698279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224193|NCT03038880|Ranibizumab|ranibizumab|mesh-list
93224194|NCT03038880|Faricimab|faricimab|mesh-list
93224195|NCT03038880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93224196|NCT03038880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93224197|NCT03038880|Growth Substances|growth substances|mesh-ancestor
93224198|NCT03038880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224199|NCT03038880|Growth Inhibitors|growth inhibitors|mesh-ancestor
93224200|NCT03038880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224201|NCT03035916|Anesthetics|anesthetics|mesh-list
93224202|NCT03035916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224203|NCT03035916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896313|NCT00665522|Fentanyl|fentanyl|mesh-list
93224205|NCT01702571|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93224206|NCT01702571|Maytansine|maytansine|mesh-list
93224207|NCT01702571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224208|NCT01702571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224209|NCT01702571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93224210|NCT01702571|Tubulin Modulators|tubulin modulators|mesh-ancestor
93224211|NCT01702571|Antimitotic Agents|antimitotic agents|mesh-ancestor
93224212|NCT01702571|Mitosis Modulators|mitosis modulators|mesh-ancestor
93224213|NCT01702571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224214|NCT01702571|Immunotoxins|immunotoxins|mesh-ancestor
93224215|NCT01702571|Immunoconjugates|immunoconjugates|mesh-ancestor
93224216|NCT01702571|Immunologic Factors|immunologic factors|mesh-ancestor
93224217|NCT01702571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224218|NCT01578239|Octreotide|octreotide|mesh-list
93224219|NCT01578239|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93224220|NCT01578239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224221|NCT01578239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93224222|NCT01578239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224223|NCT01578239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93224224|NCT01578239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224225|NCT05274893|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93224226|NCT05274893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224227|NCT03231709|Alogliptin|alogliptin|mesh-list
93224228|NCT03231709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93224229|NCT03231709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224230|NCT03231709|Incretins|incretins|mesh-ancestor
93224231|NCT03231709|Hormones|hormones|mesh-ancestor
93224232|NCT03231709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224233|NCT03231709|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93224234|NCT03231709|Protease Inhibitors|protease inhibitors|mesh-ancestor
93224235|NCT03231709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224236|NCT03231709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224237|NCT01220531|Cyclosporine|cyclosporine|mesh-list
93224238|NCT01220531|Mycophenolic Acid|mycophenolic acid|mesh-list
93224239|NCT01220531|Methylprednisolone|methylprednisolone|mesh-list
93224240|NCT01220531|Prednisolone|prednisolone|mesh-list
93224241|NCT01220531|Tacrolimus|tacrolimus|mesh-list
93224242|NCT01220531|Cyclosporins|cyclosporins|mesh-list
93224243|NCT01220531|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93224244|NCT01220531|Thymoglobulin|thymoglobulin|mesh-list
93224245|NCT01220531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93224246|NCT01220531|Immunologic Factors|immunologic factors|mesh-ancestor
93224247|NCT01220531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224248|NCT01220531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93224249|NCT01220531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224250|NCT01220531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224251|NCT01220531|Antifungal Agents|antifungal agents|mesh-ancestor
93224252|NCT01220531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224253|NCT01220531|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224254|NCT01220531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93224255|NCT01220531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93224256|NCT01220531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224257|NCT01220531|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93224258|NCT01220531|Antitubercular Agents|antitubercular agents|mesh-ancestor
93224259|NCT01220531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93224260|NCT01220531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224261|NCT01220531|Antiemetics|antiemetics|mesh-ancestor
93224262|NCT01220531|Autonomic Agents|autonomic agents|mesh-ancestor
93224263|NCT01220531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224264|NCT01220531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224265|NCT01220531|Glucocorticoids|glucocorticoids|mesh-ancestor
93224266|NCT01220531|Hormones|hormones|mesh-ancestor
93224267|NCT01220531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224268|NCT01220531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93224269|NCT01220531|Protective Agents|protective agents|mesh-ancestor
93224270|NCT01220531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93224271|NCT05255471|Olaparib|olaparib|mesh-list
93224272|NCT05255471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93224273|NCT05255471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224274|NCT05255471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224275|NCT05255471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224276|NCT03241927|Pembrolizumab|pembrolizumab|mesh-list
93224277|NCT03241927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224278|NCT03241927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224279|NCT03241927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93224280|NCT03241927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224281|NCT02941523|Carboplatin|carboplatin|mesh-list
93224282|NCT02941523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224283|NCT03666143|Tislelizumab|tislelizumab|mesh-list
93224284|NCT03666143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224285|NCT03666143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224286|NCT00360425|Moxifloxacin|moxifloxacin|mesh-list
93224287|NCT00360425|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93224288|NCT00360425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93224289|NCT00360425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224290|NCT00360425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93224291|NCT00360425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93224292|NCT00360425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224293|NCT00360425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224294|NCT00360425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224295|NCT00360425|Hematinics|hematinics|mesh-ancestor
93224296|NCT00360425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93224297|NCT00360425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93224298|NCT02938585|Factor VIII|factor viii|mesh-list
93224299|NCT02938585|Coagulants|coagulants|mesh-ancestor
93224300|NCT00233597|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93224301|NCT00233597|Hematinics|hematinics|mesh-ancestor
93224302|NCT00233597|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93224303|NCT00233597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93224304|NCT04282811|Venetoclax|venetoclax|mesh-list
93224305|NCT04282811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224306|NCT03229759|Octenidine|octenidine|mesh-list
93224307|NCT03229759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224308|NCT03229759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93224309|NCT03476681|Pembrolizumab|pembrolizumab|mesh-list
93224310|NCT03476681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224311|NCT03476681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224312|NCT03476681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92856039|NCT02824718|Natriuretic Agents|natriuretic agents|mesh-ancestor
93224313|NCT03476681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224314|NCT03620825|Indomethacin|indomethacin|mesh-list
93224315|NCT03620825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93224316|NCT03620825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93224317|NCT03620825|Analgesics|analgesics|mesh-ancestor
93224318|NCT03620825|Sensory System Agents|sensory system agents|mesh-ancestor
93224319|NCT03620825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224320|NCT03620825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224321|NCT03620825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224322|NCT03620825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93224323|NCT03620825|Gout Suppressants|gout suppressants|mesh-ancestor
93224324|NCT03620825|Tocolytic Agents|tocolytic agents|mesh-ancestor
93224325|NCT03620825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93224326|NCT03620825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93224327|NCT03620825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224328|NCT03620825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224329|NCT03527537|Insulin|insulin|mesh-list
93224330|NCT03527537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93224331|NCT03527537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224332|NCT01496118|Panobinostat|panobinostat|mesh-list
93224333|NCT01496118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224334|NCT01496118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93224335|NCT01496118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224336|NCT01496118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224337|NCT04544280|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93224338|NCT04544280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93224339|NCT04544280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224340|NCT04544280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224341|NCT04544280|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93224342|NCT04544280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224343|NCT04544280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224344|NCT04544280|Cholinergic Agents|cholinergic agents|mesh-ancestor
93224345|NCT04544280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224346|NCT05014776|Pembrolizumab|pembrolizumab|mesh-list
93224347|NCT05014776|Ipilimumab|ipilimumab|mesh-list
93224348|NCT05014776|Tadalafil|tadalafil|mesh-list
93224349|NCT05014776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224350|NCT05014776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224351|NCT05014776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93224352|NCT05014776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224353|NCT05014776|Vasodilator Agents|vasodilator agents|mesh-ancestor
93224354|NCT05014776|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93224355|NCT05014776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93224356|NCT05014776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224357|NCT05014776|Urological Agents|urological agents|mesh-ancestor
93224358|NCT03329573|Paroxetine|paroxetine|mesh-list
93224359|NCT03329573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93224360|NCT03329573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93224361|NCT03329573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224362|NCT03329573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224363|NCT03329573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224364|NCT03329573|Serotonin Agents|serotonin agents|mesh-ancestor
93224365|NCT03329573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224366|NCT03329573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93224367|NCT03329573|Antidepressive Agents|antidepressive agents|mesh-ancestor
93224368|NCT03329573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224369|NCT03329573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93224370|NCT03329573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93224371|NCT03329573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224372|NCT00492349|Varenicline|varenicline|mesh-list
93224373|NCT00492349|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93224374|NCT00492349|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93224375|NCT00492349|Cholinergic Agents|cholinergic agents|mesh-ancestor
93224376|NCT00492349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224377|NCT00492349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224378|NCT00492349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224379|NCT03924193|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93224380|NCT03924193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93224381|NCT03924193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224382|NCT03924193|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92520387|NCT00101062|Analgesics|analgesics|mesh-ancestor
93224383|NCT03924193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93224384|NCT03924193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224385|NCT03924193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224386|NCT03924193|Dopamine Agents|dopamine agents|mesh-ancestor
93224387|NCT03924193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224388|NCT03308825|Vaccines|vaccines|mesh-list
93224389|NCT03308825|Immunologic Factors|immunologic factors|mesh-ancestor
93224390|NCT03308825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224391|NCT04235855|Liver Extracts|liver extracts|mesh-list
93224392|NCT04235855|Hematinics|hematinics|mesh-ancestor
93224393|NCT03328325|Vaccines|vaccines|mesh-list
93224394|NCT03328325|Immunologic Factors|immunologic factors|mesh-ancestor
93224395|NCT03328325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224396|NCT03476603|Irbesartan|irbesartan|mesh-list
93224397|NCT03476603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93224398|NCT03476603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93224399|NCT03476603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93224400|NCT03476603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224401|NCT03476525|Fluoxetine|fluoxetine|mesh-list
93224402|NCT03476525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93224403|NCT03476525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93224404|NCT03476525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224405|NCT03476525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224406|NCT03476525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224407|NCT03476525|Serotonin Agents|serotonin agents|mesh-ancestor
93224408|NCT03476525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224409|NCT03476525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93224410|NCT03476525|Antidepressive Agents|antidepressive agents|mesh-ancestor
93224411|NCT03476525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224412|NCT03476525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93224413|NCT03476525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93224414|NCT03476525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224415|NCT05039489|Antipsychotic Agents|antipsychotic agents|mesh-list
93224416|NCT05039489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93224417|NCT05039489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224418|NCT05039489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224419|NCT05039489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224420|NCT03665545|Poly I-C|poly i-c|mesh-list
93224421|NCT03665545|Pembrolizumab|pembrolizumab|mesh-list
93224422|NCT03665545|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93224423|NCT03665545|Poly ICLC|poly iclc|mesh-list
92896539|NCT00684866|Albuterol|albuterol|mesh-list
93224424|NCT03665545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224425|NCT03665545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224426|NCT03665545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93224427|NCT03665545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224428|NCT03665545|Interferon Inducers|interferon inducers|mesh-ancestor
93224429|NCT03665545|Immunologic Factors|immunologic factors|mesh-ancestor
93224430|NCT03665545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224431|NCT03665545|Laxatives|laxatives|mesh-ancestor
93224432|NCT03665545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224433|NCT03665545|Antiviral Agents|antiviral agents|mesh-ancestor
93224434|NCT03665545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224436|NCT03305081|Levonorgestrel|levonorgestrel|mesh-list
93224437|NCT03305081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93224438|NCT03305081|Contraceptive Agents|contraceptive agents|mesh-ancestor
93224439|NCT03305081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93224440|NCT03305081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224441|NCT03305081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93224442|NCT03305081|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93224443|NCT03305081|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93224444|NCT03305081|Trace Elements|trace elements|mesh-ancestor
93224445|NCT03305081|Micronutrients|micronutrients|mesh-ancestor
93224446|NCT04079881|Insulin|insulin|mesh-list
93224447|NCT04079881|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93224448|NCT04079881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93224449|NCT04079881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224450|NCT03223909|Hyaluronic Acid|hyaluronic acid|mesh-list
93224451|NCT03223909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93224452|NCT03223909|Immunologic Factors|immunologic factors|mesh-ancestor
93224453|NCT03223909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224454|NCT03223909|Viscosupplements|viscosupplements|mesh-ancestor
93224455|NCT03223909|Protective Agents|protective agents|mesh-ancestor
93224456|NCT03733925|Golimumab|golimumab|mesh-list
93224457|NCT03733925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93224458|NCT03733925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224459|NCT03733925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93224460|NCT03733925|Immunologic Factors|immunologic factors|mesh-ancestor
93224461|NCT03733925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224462|NCT03649711|Aspirin|aspirin|mesh-list
93224463|NCT03649711|Clopidogrel|clopidogrel|mesh-list
93224464|NCT03649711|Ticagrelor|ticagrelor|mesh-list
93224465|NCT03649711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93224466|NCT03649711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93224467|NCT03649711|Analgesics|analgesics|mesh-ancestor
93224468|NCT03649711|Sensory System Agents|sensory system agents|mesh-ancestor
93224469|NCT03649711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224470|NCT03649711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224471|NCT03649711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224472|NCT03649711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93224473|NCT03649711|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93224474|NCT03649711|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93224475|NCT03649711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224476|NCT03649711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93224477|NCT03649711|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93224478|NCT03649711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224479|NCT03649711|Antipyretics|antipyretics|mesh-ancestor
93224480|NCT03649711|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93224481|NCT03649711|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93224482|NCT03649711|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93224483|NCT03649711|Purinergic Agents|purinergic agents|mesh-ancestor
93224484|NCT03649711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224485|NCT03897673|Iron|iron|mesh-list
93224486|NCT03897673|Trace Elements|trace elements|mesh-ancestor
93224487|NCT03897673|Micronutrients|micronutrients|mesh-ancestor
93224488|NCT03897673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224489|NCT03273257|Riociguat|riociguat|mesh-list
93224490|NCT03273257|Enzyme Activators|enzyme activators|mesh-ancestor
93224491|NCT03273257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224492|NCT02553473|Doxycycline|doxycycline|mesh-list
93224493|NCT02553473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93224494|NCT02553473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224495|NCT02553473|Antimalarials|antimalarials|mesh-ancestor
93224496|NCT02553473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93224497|NCT02553473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93224498|NCT04270877|Naltrexone|naltrexone|mesh-list
93224499|NCT04270877|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93224500|NCT04270877|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93224501|NCT04270877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224502|NCT04270877|Sensory System Agents|sensory system agents|mesh-ancestor
93224503|NCT04270877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224504|NCT03271151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93224505|NCT03271151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93224506|NCT03271151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93224507|NCT03271151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224508|NCT03271151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224509|NCT03271151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224510|NCT03271151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224511|NCT03271151|Analgesics|analgesics|mesh-ancestor
93224512|NCT03271151|Sensory System Agents|sensory system agents|mesh-ancestor
93224513|NCT03271151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224514|NCT03271151|Antidepressive Agents|antidepressive agents|mesh-ancestor
93224515|NCT03271151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224516|NCT03271151|Dopamine Agents|dopamine agents|mesh-ancestor
93224517|NCT03301649|Ivermectin|ivermectin|mesh-list
93224518|NCT03301649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93224519|NCT03301649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224520|NCT01144416|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93224521|NCT01144416|Hormones|hormones|mesh-ancestor
93224522|NCT01144416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224523|NCT01144416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224524|NCT00335777|Dihydroergotamine|dihydroergotamine|mesh-list
93224525|NCT00335777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93224526|NCT00335777|Dopamine Agonists|dopamine agonists|mesh-ancestor
93224527|NCT00335777|Dopamine Agents|dopamine agents|mesh-ancestor
93224528|NCT00335777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224529|NCT00335777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224530|NCT00335777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224531|NCT00335777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93224532|NCT00335777|Analgesics|analgesics|mesh-ancestor
93224533|NCT00335777|Sensory System Agents|sensory system agents|mesh-ancestor
93224534|NCT00335777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224535|NCT03764137|Panitumumab|panitumumab|mesh-list
93224536|NCT03764137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224537|NCT03764137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224538|NCT02889809|Fluticasone|fluticasone|mesh-list
93224539|NCT02889809|Xhance|xhance|mesh-list
93224540|NCT02889809|Montelukast|montelukast|mesh-list
93224541|NCT02889809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224542|NCT02889809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93224543|NCT02889809|Autonomic Agents|autonomic agents|mesh-ancestor
93224544|NCT02889809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224545|NCT02889809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224546|NCT02889809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93224547|NCT02889809|Respiratory System Agents|respiratory system agents|mesh-ancestor
93224548|NCT02889809|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224549|NCT02889809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93224550|NCT02889809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93224551|NCT02889809|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224552|NCT02889809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224553|NCT02889809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93224554|NCT02889809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93224555|NCT02889809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224556|NCT03625518|Oxytocin|oxytocin|mesh-list
93224557|NCT03625518|Dinoprostone|dinoprostone|mesh-list
93224558|NCT03625518|Oxytocics|oxytocics|mesh-ancestor
93224559|NCT03625518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93224560|NCT03625518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224561|NCT00972738|Loratadine|loratadine|mesh-list
93224562|NCT00972738|Montelukast|montelukast|mesh-list
93224563|NCT00972738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93224564|NCT00972738|Respiratory System Agents|respiratory system agents|mesh-ancestor
93224565|NCT00972738|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93224566|NCT00972738|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224567|NCT00972738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224568|NCT00972738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224569|NCT00972738|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93224570|NCT00972738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93224571|NCT00972738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224572|NCT00972738|Antipruritics|antipruritics|mesh-ancestor
93224573|NCT00972738|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224574|NCT00972738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93224575|NCT00972738|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93224576|NCT00972738|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93224577|NCT00972738|Histamine Antagonists|histamine antagonists|mesh-ancestor
93224578|NCT00972738|Histamine Agents|histamine agents|mesh-ancestor
93224579|NCT00972738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224580|NCT03452839|Meropenem|meropenem|mesh-list
93224581|NCT03452839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93224582|NCT03452839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224583|NCT04701281|Capecitabine|capecitabine|mesh-list
93224584|NCT04701281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93224585|NCT04701281|Antimetabolites|antimetabolites|mesh-ancestor
93224586|NCT04701281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224587|NCT04701281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224588|NCT03882918|Gaboxadol|gaboxadol|mesh-list
93224589|NCT03882918|Analgesics|analgesics|mesh-ancestor
93224590|NCT03882918|Sensory System Agents|sensory system agents|mesh-ancestor
93224591|NCT03882918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224592|NCT03882918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224593|NCT03882918|Anticonvulsants|anticonvulsants|mesh-ancestor
93224594|NCT03882918|GABA Agonists|gaba agonists|mesh-ancestor
93224595|NCT03882918|GABA Agents|gaba agents|mesh-ancestor
93224596|NCT03882918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224597|NCT03882918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224598|NCT04180397|Furosemide|furosemide|mesh-list
93224599|NCT04180397|Diuretics|diuretics|mesh-ancestor
93224600|NCT04180397|Natriuretic Agents|natriuretic agents|mesh-ancestor
93224601|NCT04180397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224602|NCT04180397|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93224603|NCT04180397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224604|NCT04180397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224605|NCT04174859|Rivaroxaban|rivaroxaban|mesh-list
93224606|NCT04174859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93224607|NCT04174859|Antithrombins|antithrombins|mesh-ancestor
93224608|NCT04174859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93224609|NCT04174859|Protease Inhibitors|protease inhibitors|mesh-ancestor
93224610|NCT04174859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224611|NCT04174859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224612|NCT04174859|Anticoagulants|anticoagulants|mesh-ancestor
93224613|NCT03295721|Bupivacaine|bupivacaine|mesh-list
93224614|NCT03295721|Anesthetics, Local|anesthetics, local|mesh-ancestor
93224615|NCT03295721|Anesthetics|anesthetics|mesh-ancestor
93224616|NCT03295721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224617|NCT03295721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224618|NCT03295721|Sensory System Agents|sensory system agents|mesh-ancestor
93224619|NCT03295721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224620|NCT00803790|Vitamin D|vitamin d|mesh-list
93224621|NCT00803790|Ergocalciferols|ergocalciferols|mesh-list
93224622|NCT00803790|Cholecalciferol|cholecalciferol|mesh-list
93224623|NCT00803790|Alendronate|alendronate|mesh-list
93224624|NCT00803790|Vitamins|vitamins|mesh-list
93224625|NCT00803790|Micronutrients|micronutrients|mesh-ancestor
93224626|NCT00803790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224627|NCT00803790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93224628|NCT00803790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93224629|NCT00442338|Aminophylline|aminophylline|mesh-list
93224630|NCT00442338|Theophylline|theophylline|mesh-list
93224631|NCT00442338|Montelukast|montelukast|mesh-list
93224632|NCT00442338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93224633|NCT00442338|Respiratory System Agents|respiratory system agents|mesh-ancestor
93224634|NCT00442338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93224635|NCT00442338|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224636|NCT00442338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224637|NCT00442338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224638|NCT00442338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93224639|NCT00442338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93224640|NCT00442338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224641|NCT00442338|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93224642|NCT00442338|Autonomic Agents|autonomic agents|mesh-ancestor
93224643|NCT00442338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224644|NCT00442338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93224645|NCT00442338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93224646|NCT00442338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224647|NCT00442338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92896759|NCT04150172|Antioxidants|antioxidants|mesh-ancestor
93224648|NCT00442338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93224649|NCT00442338|Purinergic Agents|purinergic agents|mesh-ancestor
93224650|NCT00442338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224651|NCT00442338|Protective Agents|protective agents|mesh-ancestor
93224652|NCT00442338|Vasodilator Agents|vasodilator agents|mesh-ancestor
93224653|NCT03506412|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93224654|NCT03506412|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93224655|NCT03506412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224656|NCT02316834|Talazoparib|talazoparib|mesh-list
93224657|NCT02316834|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93224658|NCT02316834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224659|NCT02316834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224660|NCT02316834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224661|NCT02975934|Docetaxel|docetaxel|mesh-list
93224662|NCT02975934|Abiraterone Acetate|abiraterone acetate|mesh-list
93224663|NCT02975934|Rucaparib|rucaparib|mesh-list
93224664|NCT02975934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224665|NCT02975934|Tubulin Modulators|tubulin modulators|mesh-ancestor
93224666|NCT02975934|Antimitotic Agents|antimitotic agents|mesh-ancestor
93224667|NCT02975934|Mitosis Modulators|mitosis modulators|mesh-ancestor
93224668|NCT02975934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224669|NCT02975934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93224670|NCT02975934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224671|NCT02975934|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224672|NCT02975934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224673|NCT02975934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224674|NCT02975934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92520674|NCT00006443|Nelfinavir|nelfinavir|mesh-list
93224675|NCT02975934|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93224676|NCT02879136|Methylphenidate|methylphenidate|mesh-list
93224677|NCT02879136|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93224678|NCT02879136|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93224679|NCT02879136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224680|NCT02879136|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93224681|NCT02879136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93224682|NCT02879136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224683|NCT02879136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224684|NCT02879136|Dopamine Agents|dopamine agents|mesh-ancestor
93224685|NCT02879136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224686|NCT02879136|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93224687|NCT02879136|Adrenergic Agents|adrenergic agents|mesh-ancestor
93224688|NCT00250458|Rizatriptan|rizatriptan|mesh-list
93224689|NCT00250458|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93224690|NCT00250458|Serotonin Agents|serotonin agents|mesh-ancestor
93224691|NCT00250458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224692|NCT00250458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224693|NCT00250458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224694|NCT01965132|Adalimumab|adalimumab|mesh-list
93224695|NCT01965132|Infliximab|infliximab|mesh-list
93224696|NCT01965132|Golimumab|golimumab|mesh-list
93224697|NCT01965132|Etanercept|etanercept|mesh-list
93224698|NCT01965132|Abatacept|abatacept|mesh-list
93224699|NCT01965132|Upadacitinib|upadacitinib|mesh-list
93224700|NCT01965132|Ustekinumab|ustekinumab|mesh-list
93224701|NCT01965132|Ixekizumab|ixekizumab|mesh-list
93224702|NCT01965132|Tofacitinib|tofacitinib|mesh-list
93224703|NCT01965132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224704|NCT01965132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224705|NCT01965132|Immunologic Factors|immunologic factors|mesh-ancestor
93224706|NCT01965132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224707|NCT01965132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93224708|NCT01965132|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93224709|NCT01965132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224710|NCT01965132|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224711|NCT01965132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224712|NCT01965132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93224713|NCT01965132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93224714|NCT01965132|Analgesics|analgesics|mesh-ancestor
93224715|NCT01965132|Sensory System Agents|sensory system agents|mesh-ancestor
93224716|NCT01965132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224717|NCT01965132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93224718|NCT01965132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93224719|NCT01965132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224720|NCT01965132|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93224721|NCT01965132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93224722|NCT01965132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224723|NCT01667133|Ponatinib|ponatinib|mesh-list
93224724|NCT01667133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224725|NCT01667133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93224726|NCT01667133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224727|NCT01667133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224728|NCT01498770|Olanzapine|olanzapine|mesh-list
93224729|NCT01498770|Risperidone|risperidone|mesh-list
93224730|NCT01498770|Aripiprazole|aripiprazole|mesh-list
93224731|NCT01498770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93224732|NCT01498770|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93224733|NCT01498770|Ziprasidone|ziprasidone|mesh-list
93224734|NCT01498770|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93224735|NCT01498770|Clozapine|clozapine|mesh-list
93224736|NCT01498770|Asenapine|asenapine|mesh-list
93224737|NCT01498770|Amisulpride|amisulpride|mesh-list
93224738|NCT01498770|Iloperidone|iloperidone|mesh-list
93224739|NCT01498770|Sertindole|sertindole|mesh-list
93224740|NCT01498770|Zotepine|zotepine|mesh-list
93224741|NCT01498770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93224742|NCT01498770|Serotonin Agents|serotonin agents|mesh-ancestor
93224743|NCT01498770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224744|NCT01498770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224745|NCT01498770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224746|NCT01498770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93224747|NCT01498770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93224748|NCT01498770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224749|NCT01498770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224750|NCT01498770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93224751|NCT01498770|Dopamine Agents|dopamine agents|mesh-ancestor
93224752|NCT01498770|Antiemetics|antiemetics|mesh-ancestor
93224753|NCT01498770|Autonomic Agents|autonomic agents|mesh-ancestor
93224754|NCT01498770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224755|NCT01498770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224756|NCT01498770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93224757|NCT01498770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93224758|NCT01498770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224759|NCT01498770|Antidepressive Agents|antidepressive agents|mesh-ancestor
93224760|NCT01498770|Dopamine Agonists|dopamine agonists|mesh-ancestor
93224761|NCT01498770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93224762|NCT01498770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93224763|NCT01498770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93224764|NCT01498770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93224765|NCT01498770|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93224766|NCT01498770|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93224767|NCT01498770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93224768|NCT01498770|Adrenergic Agents|adrenergic agents|mesh-ancestor
93224769|NCT01498770|GABA Antagonists|gaba antagonists|mesh-ancestor
93224770|NCT01498770|GABA Agents|gaba agents|mesh-ancestor
93224771|NCT01498770|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93224772|NCT00140946|Montelukast|montelukast|mesh-list
93224773|NCT00140946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224774|NCT00140946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224775|NCT00140946|Respiratory System Agents|respiratory system agents|mesh-ancestor
93224776|NCT00140946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93224777|NCT00140946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93224778|NCT00140946|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224779|NCT00140946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224780|NCT00140946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93224781|NCT00140946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93224782|NCT00095004|Rizatriptan|rizatriptan|mesh-list
93224783|NCT00095004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224784|NCT00095004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224785|NCT00095004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224786|NCT00095004|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93224787|NCT00095004|Serotonin Agents|serotonin agents|mesh-ancestor
93224788|NCT00967746|Etonogestrel|etonogestrel|mesh-list
93224789|NCT00967746|Desogestrel|desogestrel|mesh-list
93224790|NCT00967746|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93224791|NCT00967746|Contraceptive Agents|contraceptive agents|mesh-ancestor
93224792|NCT00967746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93224793|NCT00967746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224794|NCT00967746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93224795|NCT00967746|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93224796|NCT00967746|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93224797|NCT00967746|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93224798|NCT00967746|Progestins|progestins|mesh-ancestor
93224799|NCT00967746|Hormones|hormones|mesh-ancestor
93224800|NCT00967746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224801|NCT00092118|Montelukast|montelukast|mesh-list
93224802|NCT00092118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93224803|NCT00092118|Respiratory System Agents|respiratory system agents|mesh-ancestor
93224804|NCT00092118|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93224805|NCT00092118|Hormone Antagonists|hormone antagonists|mesh-ancestor
93224806|NCT00092118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224807|NCT00092118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224808|NCT00092118|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93224809|NCT00092118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93224810|NCT00092118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224811|NCT00920634|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93224812|NCT00920634|Hormones|hormones|mesh-ancestor
93224813|NCT00920634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224814|NCT00920634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224815|NCT00092040|Alendronate|alendronate|mesh-list
93224816|NCT00092040|Risedronic Acid|risedronic acid|mesh-list
93224817|NCT00092040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224818|NCT00092040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224819|NCT00092040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93224820|NCT00092040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93224821|NCT00092040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224822|NCT00092040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93224823|NCT05224128|Imatinib Mesylate|imatinib mesylate|mesh-list
93224824|NCT05224128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224825|NCT05224128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93224826|NCT05224128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224827|NCT05224128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224828|NCT05416827|Dexamethasone|dexamethasone|mesh-list
93224829|NCT05416827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224830|NCT05416827|Antiemetics|antiemetics|mesh-ancestor
93224831|NCT05416827|Autonomic Agents|autonomic agents|mesh-ancestor
93224832|NCT05416827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224833|NCT05416827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224834|NCT05416827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224835|NCT05416827|Glucocorticoids|glucocorticoids|mesh-ancestor
93224836|NCT05416827|Hormones|hormones|mesh-ancestor
93224837|NCT05416827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224838|NCT05416827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93224839|NCT05416827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224840|NCT04961619|Trametinib|trametinib|mesh-list
93224841|NCT04961619|Dabrafenib|dabrafenib|mesh-list
93224842|NCT04961619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224843|NCT04961619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93224844|NCT04961619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224845|NCT04961619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224846|NCT05076513|Niraparib|niraparib|mesh-list
93224847|NCT05076513|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93224848|NCT05076513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224849|NCT05076513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224850|NCT05076513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224851|NCT04979910|Ixekizumab|ixekizumab|mesh-list
93224852|NCT04979910|Dermatologic Agents|dermatologic agents|mesh-ancestor
93224853|NCT05418465|Dapagliflozin|dapagliflozin|mesh-list
93224854|NCT05418465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93224855|NCT05418465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224856|NCT05418465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93224857|NCT05418465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224858|NCT03261167|Botulinum Toxins|botulinum toxins|mesh-list
93224859|NCT03261167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93224860|NCT03261167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93224861|NCT03261167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93224862|NCT03261167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224863|NCT03261167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224864|NCT03261167|Cholinergic Agents|cholinergic agents|mesh-ancestor
93224865|NCT03261167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224866|NCT03261167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224867|NCT03261167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93224868|NCT03261167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224869|NCT05391126|Irinotecan|irinotecan|mesh-list
93224870|NCT05391126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93224871|NCT05391126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93224872|NCT05391126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224873|NCT05391126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224874|NCT05391126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224875|NCT05418309|Paclitaxel|paclitaxel|mesh-list
93224876|NCT05418309|Tislelizumab|tislelizumab|mesh-list
93224877|NCT05418309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93224878|NCT05418309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224879|NCT05418309|Tubulin Modulators|tubulin modulators|mesh-ancestor
93224880|NCT05418309|Antimitotic Agents|antimitotic agents|mesh-ancestor
93224881|NCT05418309|Mitosis Modulators|mitosis modulators|mesh-ancestor
93224882|NCT05418309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224883|NCT05418309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224884|NCT05137548|Tenofovir|tenofovir|mesh-list
93224885|NCT05137548|Antiviral Agents|antiviral agents|mesh-ancestor
93224886|NCT05137548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224887|NCT05137548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93224888|NCT05137548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93224889|NCT05137548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224890|NCT05137548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224891|NCT05137548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93224892|NCT05137548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93224893|NCT05044611|Amiloride|amiloride|mesh-list
93224894|NCT05044611|Diuretics|diuretics|mesh-ancestor
93224895|NCT05044611|Natriuretic Agents|natriuretic agents|mesh-ancestor
93224896|NCT05044611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224897|NCT05044611|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93224898|NCT05044611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93224899|NCT05044611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93224900|NCT05044611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224901|NCT05044611|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93224902|NCT05044611|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93224903|NCT05091294|Anesthetics|anesthetics|mesh-list
93224904|NCT05091294|Anesthetics, Local|anesthetics, local|mesh-list
93224905|NCT05091294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224906|NCT05091294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224907|NCT05091294|Sensory System Agents|sensory system agents|mesh-ancestor
93224908|NCT05091294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224909|NCT04520178|Carbidopa|carbidopa|mesh-list
93224910|NCT04520178|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
93224911|NCT04520178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93224912|NCT04520178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93224913|NCT04520178|Dopamine Agents|dopamine agents|mesh-ancestor
93224914|NCT04520178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224915|NCT04520178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224916|NCT04520178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224917|NCT04520178|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93224918|NCT04520178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224919|NCT04520178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93224920|NCT04520178|Antidepressive Agents|antidepressive agents|mesh-ancestor
93224921|NCT04520178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93224922|NCT04872543|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93224923|NCT04872543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93224924|NCT04872543|Antimetabolites|antimetabolites|mesh-ancestor
93224925|NCT04872543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224926|NCT04872543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224927|NCT05320926|Aspirin|aspirin|mesh-list
93224928|NCT05320926|Clopidogrel|clopidogrel|mesh-list
93224929|NCT05320926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93224930|NCT05320926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93224931|NCT05320926|Analgesics|analgesics|mesh-ancestor
93224932|NCT05320926|Sensory System Agents|sensory system agents|mesh-ancestor
93224933|NCT05320926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224934|NCT05320926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224935|NCT05320926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224936|NCT05320926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93224937|NCT05320926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93224938|NCT05320926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92897091|NCT00685568|Celecoxib|celecoxib|mesh-list
93224939|NCT05320926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224940|NCT05320926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93224941|NCT05320926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93224942|NCT05320926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224944|NCT05320926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93224945|NCT05320926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93224946|NCT05320926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93224947|NCT05320926|Purinergic Agents|purinergic agents|mesh-ancestor
93224948|NCT05320926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93224949|NCT05296512|Pembrolizumab|pembrolizumab|mesh-list
93224950|NCT05296512|Lenvatinib|lenvatinib|mesh-list
93224951|NCT05296512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93224952|NCT05296512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224953|NCT05296512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93224954|NCT05296512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224955|NCT05296512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93224956|NCT05296512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224957|NCT05417997|Clarithromycin|clarithromycin|mesh-list
93224958|NCT05417997|Ceftriaxone|ceftriaxone|mesh-list
93224959|NCT05417997|Favipiravir|favipiravir|mesh-list
93224960|NCT05417997|Methylprednisolone|methylprednisolone|mesh-list
93224961|NCT05417997|Enoxaparin|enoxaparin|mesh-list
93224962|NCT05417997|Lansoprazole|lansoprazole|mesh-list
93224963|NCT05417997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93224964|NCT05417997|Antiemetics|antiemetics|mesh-ancestor
93224965|NCT05417997|Autonomic Agents|autonomic agents|mesh-ancestor
93224966|NCT05417997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224967|NCT05417997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224968|NCT05417997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93224969|NCT05417997|Glucocorticoids|glucocorticoids|mesh-ancestor
93224970|NCT05417997|Hormones|hormones|mesh-ancestor
93224971|NCT05417997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93224972|NCT05417997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93224973|NCT05417997|Protective Agents|protective agents|mesh-ancestor
93224974|NCT05417997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93224975|NCT05417997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93224976|NCT05417997|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93224977|NCT05417997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224978|NCT05417997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93224979|NCT05417997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93224980|NCT05417997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93224981|NCT05417997|Anticoagulants|anticoagulants|mesh-ancestor
93224982|NCT05417997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93224983|NCT05417997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93224984|NCT05417997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93224985|NCT05417997|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93224986|NCT05417997|Antiviral Agents|antiviral agents|mesh-ancestor
93224987|NCT03856788|Bupivacaine|bupivacaine|mesh-list
93224988|NCT03856788|Anesthetics, Local|anesthetics, local|mesh-ancestor
93224989|NCT03856788|Anesthetics|anesthetics|mesh-ancestor
93224990|NCT03856788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93224991|NCT03856788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93224992|NCT03856788|Sensory System Agents|sensory system agents|mesh-ancestor
93224993|NCT03856788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93224994|NCT03242759|Pirfenidone|pirfenidone|mesh-list
93224995|NCT03242759|Nintedanib|nintedanib|mesh-list
93224996|NCT03242759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93224997|NCT03242759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93224998|NCT03242759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93224999|NCT03242759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225000|NCT03242759|Analgesics|analgesics|mesh-ancestor
93225001|NCT03242759|Sensory System Agents|sensory system agents|mesh-ancestor
93225002|NCT03242759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225003|NCT03242759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225004|NCT03242759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225005|NCT03242759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225006|NCT03242759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225007|NCT03242759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225008|NCT03625050|Celecoxib|celecoxib|mesh-list
93225009|NCT03625050|Esomeprazole|esomeprazole|mesh-list
93225010|NCT03625050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225011|NCT03625050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225012|NCT03625050|Analgesics|analgesics|mesh-ancestor
93225013|NCT03625050|Sensory System Agents|sensory system agents|mesh-ancestor
93225014|NCT03625050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225015|NCT03625050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225016|NCT03625050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225017|NCT03625050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225018|NCT03625050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93225019|NCT03625050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93225020|NCT03625050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225021|NCT03625050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225022|NCT03625050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93225023|NCT03625050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225024|NCT03625050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93225026|NCT03257813|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93225027|NCT03257813|Dorzolamide|dorzolamide|mesh-list
93225028|NCT03257813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93225029|NCT03257813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93225030|NCT03257813|Adrenergic Agents|adrenergic agents|mesh-ancestor
93225031|NCT03257813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225032|NCT03257813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225033|NCT03257813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225034|NCT03257813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93225035|NCT03257813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93225036|NCT03257813|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93225037|NCT03257813|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93225038|NCT03257813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93225039|NCT03257813|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93225040|NCT03257813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225041|NCT03210259|Adalimumab|adalimumab|mesh-list
93225042|NCT03210259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93225043|NCT03210259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225044|NCT03210259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225045|NCT04319757|Cyclophosphamide|cyclophosphamide|mesh-list
93225046|NCT04319757|Fludarabine|fludarabine|mesh-list
93225047|NCT04319757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93225048|NCT04319757|Immunologic Factors|immunologic factors|mesh-ancestor
93225049|NCT04319757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225050|NCT04319757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225051|NCT04319757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225052|NCT04319757|Alkylating Agents|alkylating agents|mesh-ancestor
93225053|NCT04319757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225054|NCT04319757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225055|NCT04319757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93225056|NCT05180461|Ivermectin|ivermectin|mesh-list
93225057|NCT05180461|Emodepside|emodepside|mesh-list
93225058|NCT05180461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93225059|NCT05180461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225060|NCT02496611|Exenatide|exenatide|mesh-list
93225061|NCT02496611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225062|NCT02496611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225063|NCT02496611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93225064|NCT02496611|Incretins|incretins|mesh-ancestor
93225065|NCT02496611|Hormones|hormones|mesh-ancestor
93225066|NCT02496611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225067|NCT03636295|Warfarin|warfarin|mesh-list
93225068|NCT03636295|Anticoagulants|anticoagulants|mesh-ancestor
93225069|NCT03237481|Bupivacaine|bupivacaine|mesh-list
93225070|NCT03237481|Anesthetics, Local|anesthetics, local|mesh-ancestor
93225071|NCT03237481|Anesthetics|anesthetics|mesh-ancestor
93225072|NCT03237481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225073|NCT03237481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225074|NCT03237481|Sensory System Agents|sensory system agents|mesh-ancestor
93225075|NCT03237481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225076|NCT03704220|Warfarin|warfarin|mesh-list
93225077|NCT03704220|Anticoagulants|anticoagulants|mesh-ancestor
93225078|NCT03222349|Diazepam|diazepam|mesh-list
93225079|NCT03222349|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93225080|NCT03222349|Anticonvulsants|anticonvulsants|mesh-ancestor
93225081|NCT03222349|Antiemetics|antiemetics|mesh-ancestor
93225082|NCT03222349|Autonomic Agents|autonomic agents|mesh-ancestor
93225083|NCT03222349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225084|NCT03222349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225085|NCT03222349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225086|NCT03222349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93225087|NCT03222349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225088|NCT03222349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93225089|NCT03222349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93225090|NCT03222349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93225091|NCT03222349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93225092|NCT03222349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93225093|NCT03222349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93225094|NCT03222349|Anesthetics, General|anesthetics, general|mesh-ancestor
93225095|NCT03222349|Anesthetics|anesthetics|mesh-ancestor
93225096|NCT03222349|GABA Modulators|gaba modulators|mesh-ancestor
93225097|NCT03222349|GABA Agents|gaba agents|mesh-ancestor
93225098|NCT03222349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225099|NCT03222349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225100|NCT02927925|Daratumumab|daratumumab|mesh-list
93225101|NCT02927925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225102|NCT03208933|Pirfenidone|pirfenidone|mesh-list
93225103|NCT03208933|Analgesics|analgesics|mesh-ancestor
93225104|NCT03208933|Sensory System Agents|sensory system agents|mesh-ancestor
93225105|NCT03208933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225106|NCT03208933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225107|NCT03208933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225108|NCT03208933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225109|NCT03208933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225110|NCT03208933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225111|NCT03208933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225112|NCT02499120|Cetuximab|cetuximab|mesh-list
93225113|NCT02499120|Palbociclib|palbociclib|mesh-list
93225114|NCT02499120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225115|NCT02499120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225116|NCT02499120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93225117|NCT02499120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225118|NCT02499120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225119|NCT01568307|Antidepressive Agents|antidepressive agents|mesh-list
93225120|NCT01568307|Serotonin|serotonin|mesh-list
93225121|NCT01568307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93225122|NCT01568307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93225123|NCT01568307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93225124|NCT01568307|Serotonin Agents|serotonin agents|mesh-ancestor
93225125|NCT01568307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225126|NCT01568307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225127|NCT01568307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225128|NCT01568307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93225129|NCT01568307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93225130|NCT02415036|Melphalan|melphalan|mesh-list
93225131|NCT02415036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225132|NCT02415036|Alkylating Agents|alkylating agents|mesh-ancestor
93225133|NCT02415036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225134|NCT02415036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225135|NCT02415036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93225136|NCT02415036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93225137|NCT02415036|Immunologic Factors|immunologic factors|mesh-ancestor
93225138|NCT02415036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225139|NCT04752267|Clevudine|clevudine|mesh-list
93225140|NCT04752267|Antiviral Agents|antiviral agents|mesh-ancestor
93225141|NCT04752267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225142|NCT02117700|Acetylcysteine|acetylcysteine|mesh-list
93225143|NCT02117700|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93225144|NCT02117700|Antiviral Agents|antiviral agents|mesh-ancestor
93225145|NCT02117700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225146|NCT02117700|Expectorants|expectorants|mesh-ancestor
93225147|NCT02117700|Respiratory System Agents|respiratory system agents|mesh-ancestor
93225148|NCT02117700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93225149|NCT02117700|Antioxidants|antioxidants|mesh-ancestor
93225150|NCT02117700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225151|NCT02117700|Protective Agents|protective agents|mesh-ancestor
93225152|NCT02117700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225153|NCT02117700|Antidotes|antidotes|mesh-ancestor
93225154|NCT02932579|Acetaminophen|acetaminophen|mesh-list
93225155|NCT02932579|Ibuprofen|ibuprofen|mesh-list
93225156|NCT02932579|Oxycodone|oxycodone|mesh-list
93225157|NCT02932579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225158|NCT02932579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225159|NCT02932579|Analgesics|analgesics|mesh-ancestor
93225160|NCT02932579|Sensory System Agents|sensory system agents|mesh-ancestor
93225161|NCT02932579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225162|NCT02932579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225163|NCT02932579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225164|NCT02932579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897293|NCT00698724|Bromfenac|bromfenac|mesh-list
93225165|NCT02932579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93225166|NCT02932579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225167|NCT02932579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225168|NCT02932579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93225169|NCT02932579|Narcotics|narcotics|mesh-ancestor
93225170|NCT02932579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225171|NCT02932579|Antipyretics|antipyretics|mesh-ancestor
93225172|NCT04748757|Annexin A5|annexin a5|mesh-list
93225173|NCT04748757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225174|NCT04748757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225175|NCT03207451|Aspirin|aspirin|mesh-list
93225176|NCT03207451|Clopidogrel|clopidogrel|mesh-list
93225177|NCT03207451|Vorapaxar|vorapaxar|mesh-list
93225178|NCT03207451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225179|NCT03207451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225180|NCT03207451|Analgesics|analgesics|mesh-ancestor
93225181|NCT03207451|Sensory System Agents|sensory system agents|mesh-ancestor
93225182|NCT03207451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225183|NCT03207451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225184|NCT03207451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225185|NCT03207451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225186|NCT03207451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93225187|NCT03207451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93225188|NCT03207451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225189|NCT03207451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93225190|NCT03207451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93225191|NCT03207451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225192|NCT03207451|Antipyretics|antipyretics|mesh-ancestor
93225193|NCT03207451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93225194|NCT03207451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93225195|NCT03207451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93225196|NCT03207451|Purinergic Agents|purinergic agents|mesh-ancestor
93225197|NCT03207451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225198|NCT05089123|Vaccines|vaccines|mesh-list
93225199|NCT05089123|Immunologic Factors|immunologic factors|mesh-ancestor
93225200|NCT05089123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225201|NCT02361125|Methylphenidate|methylphenidate|mesh-list
93225202|NCT02361125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93225203|NCT02361125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225204|NCT02361125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93225205|NCT02361125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93225206|NCT02361125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93225207|NCT02361125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225208|NCT02361125|Dopamine Agents|dopamine agents|mesh-ancestor
93225209|NCT02361125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225210|NCT03701256|Atracurium|atracurium|mesh-list
93225211|NCT03701256|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93225212|NCT03701256|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93225213|NCT03701256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93225214|NCT03701256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225215|NCT03701256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225216|NCT03701256|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93225217|NCT03701256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93225218|NCT03701256|Cholinergic Agents|cholinergic agents|mesh-ancestor
93225219|NCT03701256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225220|NCT03701256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225221|NCT04780581|Dexamethasone|dexamethasone|mesh-list
93225222|NCT04780581|Methylprednisolone|methylprednisolone|mesh-list
93225223|NCT04780581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93225224|NCT04780581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93225225|NCT04780581|Prednisolone|prednisolone|mesh-list
93225226|NCT04780581|Prednisolone acetate|prednisolone acetate|mesh-list
93225227|NCT04780581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93225228|NCT04780581|Prednisolone phosphate|prednisolone phosphate|mesh-list
93225229|NCT04780581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225230|NCT04780581|Antiemetics|antiemetics|mesh-ancestor
93225231|NCT04780581|Autonomic Agents|autonomic agents|mesh-ancestor
93225232|NCT04780581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225233|NCT04780581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225234|NCT04780581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225235|NCT04780581|Glucocorticoids|glucocorticoids|mesh-ancestor
93225236|NCT04780581|Hormones|hormones|mesh-ancestor
93225237|NCT04780581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225238|NCT04780581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93225239|NCT04780581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225240|NCT04780581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93225241|NCT04780581|Protective Agents|protective agents|mesh-ancestor
93225242|NCT01526135|Gemcitabine|gemcitabine|mesh-list
93225243|NCT01526135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93225244|NCT01526135|Antimetabolites|antimetabolites|mesh-ancestor
93225245|NCT01526135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225246|NCT01526135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225247|NCT05417139|Immunomodulating Agents|immunomodulating agents|mesh-list
93225248|NCT05417139|Immunologic Factors|immunologic factors|mesh-ancestor
93225249|NCT05417139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225250|NCT03701022|Apatinib|apatinib|mesh-list
93225251|NCT03701022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225252|NCT03701022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93225253|NCT03701022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225254|NCT03701022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225255|NCT04221165|Analgesics, Opioid|analgesics, opioid|mesh-list
93225256|NCT04221165|Narcotics|narcotics|mesh-ancestor
93225257|NCT04221165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225258|NCT04221165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225259|NCT04221165|Analgesics|analgesics|mesh-ancestor
93225260|NCT04221165|Sensory System Agents|sensory system agents|mesh-ancestor
93225261|NCT04221165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225262|NCT03255629|Glucagon|glucagon|mesh-list
93225263|NCT03255629|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93225264|NCT03255629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225265|NCT03255629|Hormones|hormones|mesh-ancestor
93225266|NCT03255629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225267|NCT03255629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225268|NCT03255629|Incretins|incretins|mesh-ancestor
93225269|NCT01143779|Telbivudine|telbivudine|mesh-list
93225270|NCT01143779|Antiviral Agents|antiviral agents|mesh-ancestor
93225271|NCT01143779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225272|NCT01143779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93225273|NCT01143779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225274|NCT01143779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225275|NCT03703596|Docetaxel|docetaxel|mesh-list
93225276|NCT03703596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225277|NCT03703596|Tubulin Modulators|tubulin modulators|mesh-ancestor
93225278|NCT03703596|Antimitotic Agents|antimitotic agents|mesh-ancestor
93225279|NCT03703596|Mitosis Modulators|mitosis modulators|mesh-ancestor
93225280|NCT03703596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225281|NCT01137773|Insulin|insulin|mesh-list
93225282|NCT01137773|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93225283|NCT01137773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225284|NCT01137773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225285|NCT03698292|Metoclopramide|metoclopramide|mesh-list
93225286|NCT03698292|Antiemetics|antiemetics|mesh-ancestor
93225287|NCT03698292|Autonomic Agents|autonomic agents|mesh-ancestor
93225288|NCT03698292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225289|NCT03698292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225290|NCT03698292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225291|NCT03698292|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93225292|NCT03698292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93225293|NCT03698292|Dopamine Agents|dopamine agents|mesh-ancestor
93225294|NCT03698292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225295|NCT03698292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225296|NCT04614909|Temozolomide|temozolomide|mesh-list
93225297|NCT04614909|Olaparib|olaparib|mesh-list
93225298|NCT04614909|Pamiparib|pamiparib|mesh-list
93225299|NCT04614909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225300|NCT04614909|Alkylating Agents|alkylating agents|mesh-ancestor
93225301|NCT04614909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225302|NCT04614909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225303|NCT04614909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93225304|NCT04614909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225305|NCT04613271|Azithromycin|azithromycin|mesh-list
93225306|NCT04613271|Favipiravir|favipiravir|mesh-list
93225307|NCT04613271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93225308|NCT04613271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225309|NCT04613271|Antiviral Agents|antiviral agents|mesh-ancestor
93225310|NCT03094611|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93225311|NCT03094611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225312|NCT03094611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225313|NCT03094611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93225314|NCT03094611|Immunotoxins|immunotoxins|mesh-ancestor
93225315|NCT03094611|Immunoconjugates|immunoconjugates|mesh-ancestor
93225316|NCT03094611|Immunologic Factors|immunologic factors|mesh-ancestor
93225317|NCT03094611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225318|NCT03631953|Trametinib|trametinib|mesh-list
93225319|NCT03631953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225320|NCT03631953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93225321|NCT03631953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225322|NCT03631953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225323|NCT01030575|Inositol|inositol|mesh-list
93225324|NCT01030575|Vitamin B Complex|vitamin b complex|mesh-ancestor
93225325|NCT01030575|Vitamins|vitamins|mesh-ancestor
93225326|NCT01030575|Micronutrients|micronutrients|mesh-ancestor
93225327|NCT01030575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225328|NCT04215471|Antibodies|antibodies|mesh-list
93225329|NCT04215471|Immunoglobulins|immunoglobulins|mesh-list
93225330|NCT04215471|Immunologic Factors|immunologic factors|mesh-ancestor
93225331|NCT04215471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225332|NCT04066023|Zolmitriptan|zolmitriptan|mesh-list
93225333|NCT04066023|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93225334|NCT04066023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93225335|NCT04066023|Serotonin Agents|serotonin agents|mesh-ancestor
93225336|NCT04066023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225337|NCT04066023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929457|NCT02299336|Growth Inhibitors|growth inhibitors|mesh-ancestor
93225338|NCT04066023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225339|NCT03106987|Olaparib|olaparib|mesh-list
93225340|NCT03106987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93225341|NCT03106987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225342|NCT03106987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225343|NCT03106987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225344|NCT02932267|Adapalene|adapalene|mesh-list
93225345|NCT02932267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225346|NCT02932267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225347|NCT02932267|Analgesics|analgesics|mesh-ancestor
93225348|NCT02932267|Sensory System Agents|sensory system agents|mesh-ancestor
93225349|NCT02932267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225350|NCT02932267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225351|NCT02932267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225352|NCT02932267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225353|NCT02932267|Dermatologic Agents|dermatologic agents|mesh-ancestor
93225354|NCT03217591|Praliciguat|praliciguat|mesh-list
93225355|NCT03217591|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93225356|NCT03217591|Enzyme Activators|enzyme activators|mesh-ancestor
93225357|NCT03217591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225358|NCT03217591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225359|NCT03697824|Cyclophosphamide|cyclophosphamide|mesh-list
93225360|NCT03697824|Pembrolizumab|pembrolizumab|mesh-list
93225361|NCT03697824|Fludarabine|fludarabine|mesh-list
93225362|NCT03697824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93225363|NCT03697824|Immunologic Factors|immunologic factors|mesh-ancestor
93225364|NCT03697824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225365|NCT03697824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225366|NCT03697824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225367|NCT03697824|Alkylating Agents|alkylating agents|mesh-ancestor
93225368|NCT03697824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225369|NCT03697824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225370|NCT03697824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93225371|NCT03697824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225372|NCT03697824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93225373|NCT03702894|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93225374|NCT03702894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93225375|NCT03702894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225376|NCT03702894|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93225377|NCT03702894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225378|NCT03702894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225379|NCT03697746|Acetaminophen|acetaminophen|mesh-list
93225380|NCT03697746|Ibuprofen|ibuprofen|mesh-list
93225381|NCT03697746|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93225382|NCT03697746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225383|NCT03697746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225384|NCT03697746|Analgesics|analgesics|mesh-ancestor
93225385|NCT03697746|Sensory System Agents|sensory system agents|mesh-ancestor
93225386|NCT03697746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225387|NCT03697746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225388|NCT03697746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225389|NCT03697746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225390|NCT03697746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93225391|NCT03697746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225392|NCT03697746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225393|NCT03697746|Antipyretics|antipyretics|mesh-ancestor
93225394|NCT03697668|Piperaquine|piperaquine|mesh-list
93225396|NCT03697668|Imatinib Mesylate|imatinib mesylate|mesh-list
93225397|NCT03697668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225398|NCT03697668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93225399|NCT03697668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225400|NCT03697668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225401|NCT03697668|Antimalarials|antimalarials|mesh-ancestor
93225402|NCT03697668|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93225403|NCT03697668|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93225404|NCT03697668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225405|NCT03702738|Acetylcysteine|acetylcysteine|mesh-list
93225406|NCT03702738|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93225407|NCT03702738|Antiviral Agents|antiviral agents|mesh-ancestor
93225408|NCT03702738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225409|NCT03702738|Expectorants|expectorants|mesh-ancestor
93225410|NCT03702738|Respiratory System Agents|respiratory system agents|mesh-ancestor
93225411|NCT03702738|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93225412|NCT03702738|Antioxidants|antioxidants|mesh-ancestor
93225413|NCT03702738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225414|NCT03702738|Protective Agents|protective agents|mesh-ancestor
93225415|NCT03702738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225416|NCT03702738|Antidotes|antidotes|mesh-ancestor
93225417|NCT03702582|Warfarin|warfarin|mesh-list
93225418|NCT03702582|Rivaroxaban|rivaroxaban|mesh-list
93225419|NCT03702582|Anticoagulants|anticoagulants|mesh-ancestor
93225420|NCT03702582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93225421|NCT03702582|Antithrombins|antithrombins|mesh-ancestor
93225422|NCT03702582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93225423|NCT03702582|Protease Inhibitors|protease inhibitors|mesh-ancestor
93225424|NCT03702582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225425|NCT03702582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225426|NCT03697044|Irinotecan|irinotecan|mesh-list
93225427|NCT03697044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93225428|NCT03697044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93225429|NCT03697044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225430|NCT03697044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225431|NCT03697044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225432|NCT03699774|Firuglipel|firuglipel|mesh-list
93225433|NCT03699774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93225434|NCT03699774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93225435|NCT03699774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93225436|NCT03699774|Antimetabolites|antimetabolites|mesh-ancestor
93225437|NCT03699774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225438|NCT03699774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93225439|NCT03699774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93225440|NCT03699774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225441|NCT03699774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225442|NCT03699774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225443|NCT03699696|Propofol|propofol|mesh-list
93225444|NCT03699696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93225445|NCT03699696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225446|NCT03699696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225447|NCT03699696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93225448|NCT03699696|Anesthetics, General|anesthetics, general|mesh-ancestor
93225449|NCT03699696|Anesthetics|anesthetics|mesh-ancestor
93225450|NCT03702426|Norfloxacin|norfloxacin|mesh-list
93225451|NCT03702426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93225452|NCT03702426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225453|NCT03702426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93225454|NCT03702426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93225455|NCT03702426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225456|NCT03702426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225457|NCT03702426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225458|NCT03702426|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93225459|NCT03702426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93225460|NCT00265941|Cetuximab|cetuximab|mesh-list
93225461|NCT00265941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225462|NCT00265941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225463|NCT03699384|Azacitidine|azacitidine|mesh-list
93225464|NCT03699384|Avelumab|avelumab|mesh-list
93225465|NCT03699384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93225467|NCT03699384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225468|NCT03699384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225469|NCT03699384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225470|NCT03699384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225471|NCT05378763|Docetaxel|docetaxel|mesh-list
93225472|NCT05378763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225473|NCT05378763|Tubulin Modulators|tubulin modulators|mesh-ancestor
93225474|NCT05378763|Antimitotic Agents|antimitotic agents|mesh-ancestor
93225475|NCT05378763|Mitosis Modulators|mitosis modulators|mesh-ancestor
93225476|NCT05378763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225477|NCT02937571|Dexamethasone|dexamethasone|mesh-list
93225478|NCT02937571|Lenalidomide|lenalidomide|mesh-list
93225479|NCT02937571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225480|NCT02937571|Antiemetics|antiemetics|mesh-ancestor
93225481|NCT02937571|Autonomic Agents|autonomic agents|mesh-ancestor
93225482|NCT02937571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225483|NCT02937571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225484|NCT02937571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225485|NCT02937571|Glucocorticoids|glucocorticoids|mesh-ancestor
93225486|NCT02937571|Hormones|hormones|mesh-ancestor
93225487|NCT02937571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225488|NCT02937571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93225489|NCT02937571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225490|NCT02937571|Immunologic Factors|immunologic factors|mesh-ancestor
93225491|NCT02937571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93225492|NCT02937571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93225493|NCT02937571|Growth Substances|growth substances|mesh-ancestor
93225494|NCT02937571|Growth Inhibitors|growth inhibitors|mesh-ancestor
93225495|NCT03201211|Vaccines|vaccines|mesh-list
93225496|NCT03201211|Immunologic Factors|immunologic factors|mesh-ancestor
93225497|NCT03201211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225498|NCT04472949|Carboplatin|carboplatin|mesh-list
93225499|NCT04472949|Etoposide|etoposide|mesh-list
93225500|NCT04472949|Durvalumab|durvalumab|mesh-list
93225501|NCT04472949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225502|NCT04472949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93225503|NCT04472949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93225504|NCT04472949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93225505|NCT04472949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225506|NCT04472949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225507|NCT04472949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225508|NCT03696186|Phenobarbital|phenobarbital|mesh-list
93225509|NCT03696186|Anticonvulsants|anticonvulsants|mesh-ancestor
93225510|NCT03696186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93225511|NCT03696186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225512|NCT03696186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225513|NCT03696186|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93225514|NCT03696186|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93225515|NCT03696186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225516|NCT03696186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225517|NCT03696186|GABA Modulators|gaba modulators|mesh-ancestor
93225518|NCT03696186|GABA Agents|gaba agents|mesh-ancestor
93225519|NCT03696186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93225520|NCT03696186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93225521|NCT03696186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93225522|NCT03698916|Celecoxib|celecoxib|mesh-list
93225523|NCT03698916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225524|NCT03698916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225525|NCT03698916|Analgesics|analgesics|mesh-ancestor
93225526|NCT03698916|Sensory System Agents|sensory system agents|mesh-ancestor
93225527|NCT03698916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225528|NCT03698916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225529|NCT03698916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225530|NCT03698916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225531|NCT03698916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93225532|NCT03698916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93225533|NCT03698916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225534|NCT03698916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225535|NCT03336333|Rituximab|rituximab|mesh-list
93225536|NCT03336333|Venetoclax|venetoclax|mesh-list
93225537|NCT03336333|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93225538|NCT03336333|Zanubrutinib|zanubrutinib|mesh-list
93225539|NCT03336333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225540|NCT03336333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225541|NCT03336333|Immunologic Factors|immunologic factors|mesh-ancestor
93225542|NCT03336333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225543|NCT03336333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225544|NCT03336333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225545|NCT03336333|Alkylating Agents|alkylating agents|mesh-ancestor
93225546|NCT03336333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225547|NCT03336333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93225548|NCT03336333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225549|NCT03695952|Pembrolizumab|pembrolizumab|mesh-list
93225550|NCT03695952|Nivolumab|nivolumab|mesh-list
93225551|NCT03695952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93225552|NCT03695952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225553|NCT03695952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225554|NCT03695952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225555|NCT03695640|Magnesium Sulfate|magnesium sulfate|mesh-list
93225556|NCT03695640|Analgesics|analgesics|mesh-ancestor
93225557|NCT03695640|Sensory System Agents|sensory system agents|mesh-ancestor
93225558|NCT03695640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225559|NCT03695640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225560|NCT03695640|Anesthetics|anesthetics|mesh-ancestor
93225561|NCT03695640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225562|NCT03695640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93225563|NCT03695640|Anticonvulsants|anticonvulsants|mesh-ancestor
93225564|NCT03695640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93225565|NCT03695640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93225566|NCT03695640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225567|NCT03695640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93225568|NCT03695640|Tocolytic Agents|tocolytic agents|mesh-ancestor
93225569|NCT03695640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93225570|NCT03698682|Levofloxacin|levofloxacin|mesh-list
93225571|NCT03698682|Ofloxacin|ofloxacin|mesh-list
93225572|NCT03698682|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93225573|NCT03698682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225574|NCT03698682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93225575|NCT03698682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93225576|NCT03698682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93225577|NCT03698682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225578|NCT03698682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225579|NCT03698682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225580|NCT03698682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93225581|NCT03698682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93225582|NCT03029832|Atezolizumab|atezolizumab|mesh-list
93225583|NCT03029832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93225584|NCT03029832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225585|NCT03029832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225586|NCT03029832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225587|NCT05598567|Anesthetics|anesthetics|mesh-list
93225588|NCT05598567|Sevoflurane|sevoflurane|mesh-list
93225589|NCT05598567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225590|NCT05598567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225591|NCT05598567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93225592|NCT05598567|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93225593|NCT05598567|Anesthetics, General|anesthetics, general|mesh-ancestor
93225594|NCT03701880|Bisoprolol|bisoprolol|mesh-list
93225595|NCT03701880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93225596|NCT03701880|Sympatholytics|sympatholytics|mesh-ancestor
93225597|NCT03701880|Autonomic Agents|autonomic agents|mesh-ancestor
93225598|NCT03701880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225599|NCT03701880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225600|NCT03701880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93225601|NCT03701880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93225602|NCT03701880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93225603|NCT03701880|Adrenergic Agents|adrenergic agents|mesh-ancestor
93225604|NCT03701880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225605|NCT03701880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225606|NCT03692754|Calcium, Dietary|calcium, dietary|mesh-list
93225607|NCT03692754|Dexamethasone|dexamethasone|mesh-list
93225608|NCT03692754|Atorvastatin|atorvastatin|mesh-list
93225609|NCT03692754|Calcium|calcium|mesh-list
93225610|NCT03692754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225611|NCT03692754|Antiemetics|antiemetics|mesh-ancestor
93225612|NCT03692754|Autonomic Agents|autonomic agents|mesh-ancestor
93225613|NCT03692754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225614|NCT03692754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225615|NCT03692754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225616|NCT03692754|Glucocorticoids|glucocorticoids|mesh-ancestor
93225617|NCT03692754|Hormones|hormones|mesh-ancestor
93225618|NCT03692754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225619|NCT03692754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93225620|NCT03692754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225621|NCT03692754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93225622|NCT03692754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93225623|NCT03692754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93225624|NCT03692754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93225625|NCT03692754|Antimetabolites|antimetabolites|mesh-ancestor
93225626|NCT03692754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225627|NCT03692754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93225628|NCT03692754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93225629|NCT03692754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225630|NCT04224558|Acetaminophen|acetaminophen|mesh-list
93225631|NCT04224558|Diphenhydramine|diphenhydramine|mesh-list
93225632|NCT04224558|Promethazine|promethazine|mesh-list
93225633|NCT04224558|Methylprednisolone|methylprednisolone|mesh-list
93225634|NCT04224558|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93225635|NCT04224558|Cyclophosphamide|cyclophosphamide|mesh-list
93225636|NCT04224558|Fludarabine|fludarabine|mesh-list
93225637|NCT04224558|Thymoglobulin|thymoglobulin|mesh-list
93225638|NCT04224558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93225639|NCT04224558|Immunoglobulins|immunoglobulins|mesh-list
93225640|NCT04224558|Antibodies|antibodies|mesh-list
93225641|NCT04224558|gamma-Globulins|gamma-globulins|mesh-list
93225642|NCT04224558|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93225643|NCT04224558|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93225644|NCT04224558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93225645|NCT04224558|Immunologic Factors|immunologic factors|mesh-ancestor
93225646|NCT04224558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225647|NCT04224558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225648|NCT04224558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225649|NCT04224558|Alkylating Agents|alkylating agents|mesh-ancestor
93225650|NCT04224558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225651|NCT04224558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225652|NCT04224558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93225653|NCT04224558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225654|NCT04224558|Analgesics|analgesics|mesh-ancestor
93225655|NCT04224558|Sensory System Agents|sensory system agents|mesh-ancestor
93225656|NCT04224558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225657|NCT04224558|Antipyretics|antipyretics|mesh-ancestor
93225658|NCT04224558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225659|NCT04224558|Antiemetics|antiemetics|mesh-ancestor
93225660|NCT04224558|Autonomic Agents|autonomic agents|mesh-ancestor
93225661|NCT04224558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225662|NCT04224558|Glucocorticoids|glucocorticoids|mesh-ancestor
93225663|NCT04224558|Hormones|hormones|mesh-ancestor
93225664|NCT04224558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225665|NCT04224558|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93225666|NCT04224558|Protective Agents|protective agents|mesh-ancestor
93225667|NCT04224558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93225668|NCT04224558|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93225669|NCT04224558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93225670|NCT04224558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225671|NCT04224558|Anesthetics, Local|anesthetics, local|mesh-ancestor
93225672|NCT04224558|Anesthetics|anesthetics|mesh-ancestor
93225673|NCT04224558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93225674|NCT04224558|Histamine Antagonists|histamine antagonists|mesh-ancestor
93225675|NCT04224558|Histamine Agents|histamine agents|mesh-ancestor
93225676|NCT04224558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225677|NCT04224558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93225678|NCT04224558|Antipruritics|antipruritics|mesh-ancestor
93225679|NCT04224558|Dermatologic Agents|dermatologic agents|mesh-ancestor
93225680|NCT05598411|Methylprednisolone|methylprednisolone|mesh-list
93225681|NCT05598411|Glucocorticoids|glucocorticoids|mesh-list
93225682|NCT05598411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225683|NCT05598411|Antiemetics|antiemetics|mesh-ancestor
93225684|NCT05598411|Autonomic Agents|autonomic agents|mesh-ancestor
93225685|NCT05598411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225686|NCT05598411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225687|NCT05598411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225688|NCT05598411|Hormones|hormones|mesh-ancestor
93225689|NCT05598411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225690|NCT05598411|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93225691|NCT05598411|Protective Agents|protective agents|mesh-ancestor
93225692|NCT03688230|Cetuximab|cetuximab|mesh-list
93225693|NCT03688230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225694|NCT03688230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225695|NCT03694236|Durvalumab|durvalumab|mesh-list
93225696|NCT03694236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225697|NCT03694236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225698|NCT03692286|Calcium, Dietary|calcium, dietary|mesh-list
93225699|NCT03692286|Calcium|calcium|mesh-list
93225700|NCT03692286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93225701|NCT03692286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225702|NCT03692286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93225703|NCT03694080|Calcium|calcium|mesh-list
93225704|NCT03694080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93225705|NCT03694080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225706|NCT04203498|Nabiximols|nabiximols|mesh-list
93225707|NCT04203498|Analgesics|analgesics|mesh-ancestor
93225708|NCT04203498|Sensory System Agents|sensory system agents|mesh-ancestor
93225709|NCT04203498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225710|NCT04203498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225711|NCT03691896|Cholecalciferol|cholecalciferol|mesh-list
93225712|NCT03691896|Vitamin D|vitamin d|mesh-list
93225713|NCT03691896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93225714|NCT03691896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225715|NCT03691896|Vitamins|vitamins|mesh-ancestor
93225716|NCT03691896|Micronutrients|micronutrients|mesh-ancestor
93225717|NCT03691896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93225718|NCT03691818|Ibuprofen|ibuprofen|mesh-list
93225719|NCT03691818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93225720|NCT03691818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225721|NCT03691818|Analgesics|analgesics|mesh-ancestor
93225722|NCT03691818|Sensory System Agents|sensory system agents|mesh-ancestor
93225723|NCT03691818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225724|NCT03691818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225725|NCT03691818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225726|NCT03691818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225727|NCT03691818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93225728|NCT03691818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225729|NCT03691818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225730|NCT03687606|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93225731|NCT03687606|Menotropins|menotropins|mesh-list
93225732|NCT03687606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93225733|NCT03687606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225734|NCT03687606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93225735|NCT03687606|Fertility Agents|fertility agents|mesh-ancestor
93225736|NCT03691662|Timolol|timolol|mesh-list
93225737|NCT03691662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93225738|NCT03691662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93225739|NCT03691662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225740|NCT03691662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93225741|NCT03691662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93225742|NCT03691662|Adrenergic Agents|adrenergic agents|mesh-ancestor
93225743|NCT03691662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225744|NCT03691662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225745|NCT03691662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93225746|NCT03691662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93225747|NCT04059978|Remifentanil|remifentanil|mesh-list
93225748|NCT04059978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93225749|NCT04059978|Narcotics|narcotics|mesh-ancestor
93225750|NCT04059978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225751|NCT04059978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225752|NCT04059978|Analgesics|analgesics|mesh-ancestor
93225753|NCT04059978|Sensory System Agents|sensory system agents|mesh-ancestor
93225754|NCT04059978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225755|NCT03199963|Tamoxifen|tamoxifen|mesh-list
93225756|NCT03199963|Afimoxifene|afimoxifene|mesh-list
93225757|NCT03199963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93225758|NCT03199963|Hormone Antagonists|hormone antagonists|mesh-ancestor
93225759|NCT03199963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225760|NCT03199963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225761|NCT03199963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92897899|NCT00692510|Antioxidants|antioxidants|mesh-ancestor
93225762|NCT03199963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225763|NCT03199963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93225764|NCT03199963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93225765|NCT03199963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93225766|NCT03636685|Paclitaxel|paclitaxel|mesh-list
93225767|NCT03636685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93225768|NCT03636685|Carboplatin|carboplatin|mesh-list
93225769|NCT03636685|Pemetrexed|pemetrexed|mesh-list
93225770|NCT03636685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93225771|NCT03636685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225772|NCT03636685|Tubulin Modulators|tubulin modulators|mesh-ancestor
93225773|NCT03636685|Antimitotic Agents|antimitotic agents|mesh-ancestor
93225774|NCT03636685|Mitosis Modulators|mitosis modulators|mesh-ancestor
93225775|NCT03636685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225776|NCT03636685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225777|NCT03636685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93225778|NCT03636685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93225779|NCT03257631|Thalidomide|thalidomide|mesh-list
93225780|NCT03257631|Pomalidomide|pomalidomide|mesh-list
92521793|NCT00111163|Artesunate|artesunate|mesh-list
93225781|NCT03257631|Immunologic Factors|immunologic factors|mesh-ancestor
93225782|NCT03257631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225783|NCT03257631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93225784|NCT03257631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93225785|NCT03257631|Growth Substances|growth substances|mesh-ancestor
93225786|NCT03257631|Growth Inhibitors|growth inhibitors|mesh-ancestor
93225787|NCT03257631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225788|NCT03257631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93225789|NCT03257631|Leprostatic Agents|leprostatic agents|mesh-ancestor
93225790|NCT03257631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93225791|NCT03257631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225792|NCT03883581|Quinidine|quinidine|mesh-list
93225793|NCT03883581|Quinidine gluconate|quinidine gluconate|mesh-list
93225794|NCT03883581|Dextromethorphan|dextromethorphan|mesh-list
93225795|NCT03883581|Antitussive Agents|antitussive agents|mesh-ancestor
93225796|NCT03883581|Respiratory System Agents|respiratory system agents|mesh-ancestor
93225797|NCT03883581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93225798|NCT03883581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93225799|NCT03883581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225800|NCT03883581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225801|NCT03883581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225802|NCT03883581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93225803|NCT03883581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93225804|NCT03883581|Adrenergic Agents|adrenergic agents|mesh-ancestor
93225805|NCT03883581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93225806|NCT03883581|Antimalarials|antimalarials|mesh-ancestor
93225807|NCT03883581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93225808|NCT03883581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93225809|NCT03883581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225810|NCT03883581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225811|NCT03883581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93225812|NCT03883581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93225813|NCT03883581|Cholinergic Agents|cholinergic agents|mesh-ancestor
93225814|NCT03883581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93225815|NCT03883581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93225816|NCT03883581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93225817|NCT03883581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93225818|NCT03883581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93225819|NCT03824535|Deoxyglucose|deoxyglucose|mesh-list
93225820|NCT03824535|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93225821|NCT03824535|Fluorides|fluorides|mesh-list
93225822|NCT03824535|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93225823|NCT03824535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225824|NCT03824535|Cariostatic Agents|cariostatic agents|mesh-ancestor
93225825|NCT03824535|Protective Agents|protective agents|mesh-ancestor
93225826|NCT03824535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225827|NCT03824535|Antimetabolites|antimetabolites|mesh-ancestor
93225828|NCT03824535|Antiviral Agents|antiviral agents|mesh-ancestor
93225829|NCT03824535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225830|NCT03113643|Azacitidine|azacitidine|mesh-list
93225831|NCT03113643|Venetoclax|venetoclax|mesh-list
93225832|NCT03113643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92897971|NCT01986101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93225833|NCT03113643|Antimetabolites|antimetabolites|mesh-ancestor
93225834|NCT03113643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225835|NCT03113643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225836|NCT03113643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225838|NCT03091491|Ipilimumab|ipilimumab|mesh-list
93225839|NCT03091491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225840|NCT03091491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225841|NCT03091491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93225842|NCT03091491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225843|NCT05598255|Dexamethasone|dexamethasone|mesh-list
93225844|NCT05598255|Levobupivacaine|levobupivacaine|mesh-list
93225845|NCT05598255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93225846|NCT05598255|Antiemetics|antiemetics|mesh-ancestor
93225847|NCT05598255|Autonomic Agents|autonomic agents|mesh-ancestor
93225848|NCT05598255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225849|NCT05598255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225850|NCT05598255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93225851|NCT05598255|Glucocorticoids|glucocorticoids|mesh-ancestor
93225852|NCT05598255|Hormones|hormones|mesh-ancestor
93225853|NCT05598255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225854|NCT05598255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93225855|NCT05598255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225856|NCT05598255|Anesthetics, Local|anesthetics, local|mesh-ancestor
93225857|NCT05598255|Anesthetics|anesthetics|mesh-ancestor
93225858|NCT05598255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225859|NCT05598255|Sensory System Agents|sensory system agents|mesh-ancestor
93225860|NCT04733235|Progesterone|progesterone|mesh-list
93225861|NCT04733235|Hormones|hormones|mesh-ancestor
93225862|NCT04733235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225863|NCT04733235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225864|NCT04733235|Progestins|progestins|mesh-ancestor
93225865|NCT05598177|Dexmedetomidine|dexmedetomidine|mesh-list
93225866|NCT05598177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93225867|NCT05598177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225868|NCT05598177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225869|NCT05598177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93225870|NCT05598177|Analgesics|analgesics|mesh-ancestor
93225871|NCT05598177|Sensory System Agents|sensory system agents|mesh-ancestor
93225872|NCT05598177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225873|NCT05598177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93225874|NCT05598177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93225875|NCT05598177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93225876|NCT05598177|Adrenergic Agents|adrenergic agents|mesh-ancestor
93225877|NCT05598177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93225878|NCT05598177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225879|NCT03740529|Rituximab|rituximab|mesh-list
93225880|NCT03740529|Venetoclax|venetoclax|mesh-list
93225881|NCT03740529|Pirtobrutinib|pirtobrutinib|mesh-list
93225882|NCT03740529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225883|NCT03740529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225884|NCT03740529|Immunologic Factors|immunologic factors|mesh-ancestor
93225885|NCT03740529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225886|NCT03740529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225887|NCT03740529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93225888|NCT03740529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225889|NCT03740529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225890|NCT03029208|Darbepoetin alfa|darbepoetin alfa|mesh-list
93225891|NCT03029208|Hematinics|hematinics|mesh-ancestor
93225892|NCT05212623|Vaccines|vaccines|mesh-list
93225893|NCT05212623|Immunologic Factors|immunologic factors|mesh-ancestor
93225894|NCT05212623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225895|NCT03693222|Morphine|morphine|mesh-list
93225896|NCT03693222|Tramadol|tramadol|mesh-list
93225897|NCT03693222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93225898|NCT03693222|Narcotics|narcotics|mesh-ancestor
93225899|NCT03693222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225900|NCT03693222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225901|NCT03693222|Analgesics|analgesics|mesh-ancestor
93225902|NCT03693222|Sensory System Agents|sensory system agents|mesh-ancestor
93225903|NCT03693222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225904|NCT03693066|Chlorhexidine|chlorhexidine|mesh-list
93225905|NCT03693066|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93225906|NCT03693066|Disinfectants|disinfectants|mesh-list
93225907|NCT03693066|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93225908|NCT03693066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93225909|NCT03693066|Dermatologic Agents|dermatologic agents|mesh-ancestor
93225910|NCT03631641|Nivolumab|nivolumab|mesh-list
93225911|NCT03631641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225912|NCT03631641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225913|NCT03631641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93225914|NCT03631641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225915|NCT03631875|Ketamine|ketamine|mesh-list
93225916|NCT03631875|Propofol|propofol|mesh-list
93225917|NCT03631875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93225918|NCT03631875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225919|NCT03631875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225920|NCT03631875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93225921|NCT03631875|Anesthetics, General|anesthetics, general|mesh-ancestor
93225922|NCT03631875|Anesthetics|anesthetics|mesh-ancestor
93225923|NCT03631875|Analgesics|analgesics|mesh-ancestor
93225924|NCT03631875|Sensory System Agents|sensory system agents|mesh-ancestor
93225925|NCT03631875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225926|NCT03631875|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93225927|NCT03631875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93225928|NCT03631875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93225929|NCT03631875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521941|NCT00007358|Hormones|hormones|mesh-ancestor
93225930|NCT03631875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225931|NCT03631563|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93225932|NCT03631563|Immunologic Factors|immunologic factors|mesh-ancestor
93225933|NCT03631563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225934|NCT03158805|Liraglutide|liraglutide|mesh-list
93225935|NCT03158805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225936|NCT03158805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225937|NCT03158805|Incretins|incretins|mesh-ancestor
93225938|NCT03158805|Hormones|hormones|mesh-ancestor
93225939|NCT03158805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93225940|NCT03197935|Paclitaxel|paclitaxel|mesh-list
93225941|NCT03197935|Cyclophosphamide|cyclophosphamide|mesh-list
93225942|NCT03197935|Doxorubicin|doxorubicin|mesh-list
93225943|NCT03197935|Atezolizumab|atezolizumab|mesh-list
93225944|NCT03197935|Antibodies|antibodies|mesh-list
93225945|NCT03197935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93225946|NCT03197935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93225947|NCT03197935|Tubulin Modulators|tubulin modulators|mesh-ancestor
93225948|NCT03197935|Antimitotic Agents|antimitotic agents|mesh-ancestor
93225949|NCT03197935|Mitosis Modulators|mitosis modulators|mesh-ancestor
93225950|NCT03197935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225951|NCT03197935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93225952|NCT03197935|Immunologic Factors|immunologic factors|mesh-ancestor
93225953|NCT03197935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225954|NCT03197935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93225955|NCT03197935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93225956|NCT03197935|Alkylating Agents|alkylating agents|mesh-ancestor
93225957|NCT03197935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93225958|NCT03197935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93225959|NCT03197935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93225960|NCT03197935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93225961|NCT03197935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93225962|NCT03197935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93225963|NCT03197935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93225964|NCT04941261|Vaccines|vaccines|mesh-list
93225965|NCT04941261|Immunologic Factors|immunologic factors|mesh-ancestor
93225966|NCT04941261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225967|NCT05597709|Insulin|insulin|mesh-list
93225968|NCT05597709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225969|NCT05597709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225970|NCT02917629|Pioglitazone|pioglitazone|mesh-list
93225971|NCT02917629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225972|NCT02917629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225973|NCT05417841|Insulin|insulin|mesh-list
93225974|NCT05417841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93225975|NCT05417841|Insulin Aspart|insulin aspart|mesh-list
93225976|NCT05417841|Insulin, Long-Acting|insulin, long-acting|mesh-list
93225977|NCT05417841|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93225978|NCT05417841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93225979|NCT05417841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225980|NCT03691038|Pregabalin|pregabalin|mesh-list
93225981|NCT03691038|Analgesics|analgesics|mesh-ancestor
93225982|NCT03691038|Sensory System Agents|sensory system agents|mesh-ancestor
93225983|NCT03691038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225984|NCT03691038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898148|NCT00499681|Letrozole|letrozole|mesh-list
93225985|NCT03691038|Anticonvulsants|anticonvulsants|mesh-ancestor
93225986|NCT03691038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93225987|NCT03691038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93225988|NCT03691038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93225989|NCT03691038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93225990|NCT03691038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93225991|NCT03691038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93225992|NCT03691038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93225993|NCT03691038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93225994|NCT02927847|Nicotine|nicotine|mesh-list
93225995|NCT02927847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93225996|NCT02927847|Autonomic Agents|autonomic agents|mesh-ancestor
93225997|NCT02927847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93225998|NCT02927847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93225999|NCT02927847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93226000|NCT02927847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93226001|NCT02927847|Cholinergic Agents|cholinergic agents|mesh-ancestor
93226002|NCT02927847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522016|NCT00112567|Fludarabine phosphate|fludarabine phosphate|mesh-list
93226003|NCT02927847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226004|NCT03682692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93226005|NCT03682692|Protease Inhibitors|protease inhibitors|mesh-ancestor
93226006|NCT03682692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226007|NCT03682692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226008|NCT02886585|Pembrolizumab|pembrolizumab|mesh-list
93226009|NCT02886585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226010|NCT02886585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226011|NCT02886585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93226012|NCT02886585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226013|NCT01568853|Norepinephrine|norepinephrine|mesh-list
93226014|NCT01568853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93226015|NCT01568853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226016|NCT01568853|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226017|NCT01568853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226018|NCT01568853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226019|NCT01568853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226020|NCT01568853|Sympathomimetics|sympathomimetics|mesh-ancestor
93226021|NCT01568853|Autonomic Agents|autonomic agents|mesh-ancestor
93226022|NCT01568853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226023|NCT01568853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93226024|NCT02960438|Quetmolimab|quetmolimab|mesh-list
93226025|NCT02960438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226026|NCT03926052|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93226027|NCT03926052|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93226028|NCT03926052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226029|NCT03926052|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93226030|NCT03926052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93226031|NCT03926052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93226032|NCT03926052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226033|NCT03926052|Dopamine Agents|dopamine agents|mesh-ancestor
93226034|NCT03926052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226035|NCT05411991|Chlorthalidone|chlorthalidone|mesh-list
93226036|NCT05411991|Acetazolamide|acetazolamide|mesh-list
93226037|NCT05411991|Bumetanide|bumetanide|mesh-list
93226038|NCT05411991|Diuretics|diuretics|mesh-list
93226039|NCT05411991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
93226040|NCT05411991|Natriuretic Agents|natriuretic agents|mesh-ancestor
93226041|NCT05411991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226042|NCT05411991|Anticonvulsants|anticonvulsants|mesh-ancestor
93226043|NCT05411991|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93226044|NCT05411991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226045|NCT05411991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226046|NCT05411991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93226047|NCT05411991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93226048|NCT05411991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93226049|NCT03690414|Atropine|atropine|mesh-list
93226050|NCT03690414|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93226051|NCT03690414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93226052|NCT03690414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93226053|NCT03690414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93226054|NCT03690414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93226055|NCT03690414|Autonomic Agents|autonomic agents|mesh-ancestor
93226056|NCT03690414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226057|NCT03690414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226058|NCT03690414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93226059|NCT03690414|Respiratory System Agents|respiratory system agents|mesh-ancestor
93226060|NCT03690414|Mydriatics|mydriatics|mesh-ancestor
93226061|NCT03690414|Parasympatholytics|parasympatholytics|mesh-ancestor
93226062|NCT03690414|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93226063|NCT03690414|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93226064|NCT03690414|Cholinergic Agents|cholinergic agents|mesh-ancestor
93226065|NCT03690414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226066|NCT03690414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226067|NCT02959970|Dapsone|dapsone|mesh-list
93226068|NCT02959970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226069|NCT02959970|Antimalarials|antimalarials|mesh-ancestor
93226070|NCT02959970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93226071|NCT02959970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93226072|NCT02959970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93226073|NCT02959970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226074|NCT02959970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226075|NCT02959970|Leprostatic Agents|leprostatic agents|mesh-ancestor
93226076|NCT02959970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93226077|NCT03681990|Ethanol|ethanol|mesh-list
93226078|NCT03681990|Chlorhexidine|chlorhexidine|mesh-list
93226079|NCT03681990|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93226080|NCT03681990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93226081|NCT03681990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226082|NCT03681990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226083|NCT03681990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226084|NCT03681990|Disinfectants|disinfectants|mesh-ancestor
93226085|NCT03681990|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226086|NCT02740335|Protein C|protein c|mesh-list
93226087|NCT02740335|Protein S|protein s|mesh-list
93226088|NCT02740335|Thrombin|thrombin|mesh-list
93226089|NCT02740335|Hemostatics|hemostatics|mesh-ancestor
93226090|NCT02740335|Coagulants|coagulants|mesh-ancestor
93226091|NCT02740335|Anticoagulants|anticoagulants|mesh-ancestor
93226092|NCT02740335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93226093|NCT02740335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93226094|NCT02740335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226095|NCT05351151|Lidocaine|lidocaine|mesh-list
93226096|NCT05351151|Anesthetics, Local|anesthetics, local|mesh-ancestor
93226097|NCT05351151|Anesthetics|anesthetics|mesh-ancestor
93226098|NCT05351151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226099|NCT05351151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226100|NCT05351151|Sensory System Agents|sensory system agents|mesh-ancestor
93226101|NCT05351151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226102|NCT05351151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93226103|NCT05351151|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93226104|NCT05351151|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93226105|NCT05351151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93226106|NCT05351151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226107|NCT01568931|Coal Tar|coal tar|mesh-list
93226108|NCT01568931|Keratolytic Agents|keratolytic agents|mesh-ancestor
93226109|NCT01568931|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226110|NCT04800367|Denosumab|denosumab|mesh-list
93226111|NCT04800367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93226112|NCT04800367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226113|NCT03713658|Risperidone|risperidone|mesh-list
93226114|NCT03713658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93226115|NCT03713658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93226116|NCT03713658|Serotonin Agents|serotonin agents|mesh-ancestor
93226117|NCT03713658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226118|NCT03713658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226119|NCT03713658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226120|NCT03713658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93226121|NCT03713658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93226122|NCT03713658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226123|NCT03713658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93226124|NCT03713658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93226125|NCT03713658|Dopamine Agents|dopamine agents|mesh-ancestor
93226126|NCT03713658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93226127|NCT03713658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93226128|NCT05475717|Alprostadil|alprostadil|mesh-list
93226129|NCT05475717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93226130|NCT05475717|Vasodilator Agents|vasodilator agents|mesh-ancestor
93226131|NCT05475717|Urological Agents|urological agents|mesh-ancestor
93226132|NCT05133687|Bupivacaine|bupivacaine|mesh-list
93226133|NCT05133687|Anesthetics, Local|anesthetics, local|mesh-ancestor
93226134|NCT05133687|Anesthetics|anesthetics|mesh-ancestor
93226135|NCT05133687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226136|NCT05133687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226137|NCT05133687|Sensory System Agents|sensory system agents|mesh-ancestor
93226138|NCT05133687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226139|NCT03685032|Dexamethasone|dexamethasone|mesh-list
93226140|NCT03685032|Ondansetron|ondansetron|mesh-list
93226141|NCT03685032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226142|NCT03685032|Antiemetics|antiemetics|mesh-ancestor
93226143|NCT03685032|Autonomic Agents|autonomic agents|mesh-ancestor
93226144|NCT03685032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226145|NCT03685032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226146|NCT03685032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226147|NCT03685032|Glucocorticoids|glucocorticoids|mesh-ancestor
93226148|NCT03685032|Hormones|hormones|mesh-ancestor
93226149|NCT03685032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226150|NCT03685032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226151|NCT03685032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226152|NCT03685032|Antipruritics|antipruritics|mesh-ancestor
93226153|NCT03685032|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226154|NCT03685032|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93226155|NCT03685032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93226156|NCT03685032|Serotonin Agents|serotonin agents|mesh-ancestor
93226157|NCT03685032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226158|NCT03685032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226159|NCT02451111|Rituximab|rituximab|mesh-list
93226160|NCT02451111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226161|NCT02451111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226162|NCT02451111|Immunologic Factors|immunologic factors|mesh-ancestor
93226163|NCT02451111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226164|NCT02451111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226165|NCT03689010|Azelaic acid|azelaic acid|mesh-list
93226166|NCT03689010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226167|NCT03689010|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226168|NCT05451771|Dexamethasone|dexamethasone|mesh-list
93226169|NCT05451771|Dexamethasone acetate|dexamethasone acetate|mesh-list
93226170|NCT05451771|Venetoclax|venetoclax|mesh-list
93226171|NCT05451771|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93226172|NCT05451771|Daratumumab|daratumumab|mesh-list
93226173|NCT05451771|Pomalidomide|pomalidomide|mesh-list
93226174|NCT05451771|Ixazomib|ixazomib|mesh-list
93226175|NCT05451771|BB 1101|bb 1101|mesh-list
93226176|NCT05451771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226177|NCT05451771|Antiemetics|antiemetics|mesh-ancestor
93226178|NCT05451771|Autonomic Agents|autonomic agents|mesh-ancestor
93226179|NCT05451771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226180|NCT05451771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226181|NCT05451771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226182|NCT05451771|Glucocorticoids|glucocorticoids|mesh-ancestor
93226183|NCT05451771|Hormones|hormones|mesh-ancestor
93226184|NCT05451771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226185|NCT05451771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226186|NCT05451771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226187|NCT05451771|Protease Inhibitors|protease inhibitors|mesh-ancestor
93226188|NCT05451771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226189|NCT05451771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226190|NCT05451771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226191|NCT05451771|Alkylating Agents|alkylating agents|mesh-ancestor
93226192|NCT05451771|Immunologic Factors|immunologic factors|mesh-ancestor
93226193|NCT05451771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93226194|NCT05451771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93226195|NCT05451771|Growth Substances|growth substances|mesh-ancestor
93226196|NCT05451771|Growth Inhibitors|growth inhibitors|mesh-ancestor
93226197|NCT03680976|CXA-10|cxa-10|mesh-list
93226198|NCT03680976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226199|NCT05387343|Vaccines|vaccines|mesh-list
93226200|NCT05387343|Immunologic Factors|immunologic factors|mesh-ancestor
93226201|NCT05387343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226202|NCT04220775|Atezolizumab|atezolizumab|mesh-list
93226203|NCT04220775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93226204|NCT04220775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226205|NCT04220775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226206|NCT04220775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226207|NCT01381887|Canagliflozin|canagliflozin|mesh-list
93226208|NCT01381887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93226209|NCT01381887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226210|NCT01381887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93226211|NCT01381887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226212|NCT04877379|Ceftibuten|ceftibuten|mesh-list
93226213|NCT04877379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93226214|NCT04877379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226215|NCT01382745|Nimotuzumab|nimotuzumab|mesh-list
93226216|NCT01382745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226217|NCT01382745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226218|NCT03684330|Vitamin D|vitamin d|mesh-list
93226219|NCT03684330|Vitamins|vitamins|mesh-ancestor
93226220|NCT03684330|Micronutrients|micronutrients|mesh-ancestor
93226221|NCT03684330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226222|NCT03684330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93226223|NCT03688464|Diphenhydramine|diphenhydramine|mesh-list
93226224|NCT03688464|Promethazine|promethazine|mesh-list
93226225|NCT03688464|Melatonin|melatonin|mesh-list
93226226|NCT03688464|Antioxidants|antioxidants|mesh-ancestor
93226227|NCT03688464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226228|NCT03688464|Protective Agents|protective agents|mesh-ancestor
93226229|NCT03688464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226230|NCT03688464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226231|NCT03688464|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93226232|NCT03688464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93226233|NCT03688464|Anesthetics, Local|anesthetics, local|mesh-ancestor
93226234|NCT03688464|Anesthetics|anesthetics|mesh-ancestor
93226235|NCT03688464|Sensory System Agents|sensory system agents|mesh-ancestor
93226236|NCT03688464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226237|NCT03688464|Antiemetics|antiemetics|mesh-ancestor
93226238|NCT03688464|Autonomic Agents|autonomic agents|mesh-ancestor
93226239|NCT03688464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226240|NCT03688464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93226241|NCT03688464|Histamine Antagonists|histamine antagonists|mesh-ancestor
93226242|NCT03688464|Histamine Agents|histamine agents|mesh-ancestor
93226243|NCT03688464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226244|NCT03688464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93226245|NCT03688464|Antipruritics|antipruritics|mesh-ancestor
93226246|NCT03688464|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226247|NCT03503370|Chlorhexidine|chlorhexidine|mesh-list
93226248|NCT03503370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93226249|NCT03503370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226250|NCT03503370|Disinfectants|disinfectants|mesh-ancestor
93226251|NCT01381809|Epoetin Alfa|epoetin alfa|mesh-list
93226252|NCT01381809|Hematinics|hematinics|mesh-ancestor
93226253|NCT03677466|Tenecteplase|tenecteplase|mesh-list
93226254|NCT03677466|Streptokinase|streptokinase|mesh-list
93226255|NCT03677466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93226256|NCT03677466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93226257|NCT03677466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226258|NCT03447132|Fulvestrant|fulvestrant|mesh-list
93226259|NCT03447132|Goserelin|goserelin|mesh-list
93226260|NCT03447132|Palbociclib|palbociclib|mesh-list
93226261|NCT03447132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226262|NCT03447132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226263|NCT03447132|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93226264|NCT03447132|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93226265|NCT03447132|Hormone Antagonists|hormone antagonists|mesh-ancestor
93226266|NCT03447132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226267|NCT03447132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226268|NCT03447132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93226269|NCT03447132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226270|NCT03447132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226271|NCT04133623|Ibuprofen|ibuprofen|mesh-list
93226272|NCT04133623|Ketorolac|ketorolac|mesh-list
93226273|NCT04133623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93226274|NCT04133623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93226275|NCT04133623|Analgesics|analgesics|mesh-ancestor
93226276|NCT04133623|Sensory System Agents|sensory system agents|mesh-ancestor
93226277|NCT04133623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226278|NCT04133623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226279|NCT04133623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226280|NCT04133623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226281|NCT04133623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93226282|NCT04133623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226283|NCT04133623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226284|NCT03425838|Letrozole|letrozole|mesh-list
93226285|NCT03425838|Fulvestrant|fulvestrant|mesh-list
93226286|NCT03425838|Palbociclib|palbociclib|mesh-list
93226287|NCT03425838|Anastrozole|anastrozole|mesh-list
93226288|NCT03425838|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93226289|NCT03425838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226290|NCT03425838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93226291|NCT03425838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226292|NCT03425838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226293|NCT03425838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93226294|NCT03425838|Hormone Antagonists|hormone antagonists|mesh-ancestor
93226295|NCT03425838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226296|NCT03425838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226297|NCT03425838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226298|NCT03425838|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93226299|NCT03425838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93226300|NCT03188185|Naltrexone|naltrexone|mesh-list
93226301|NCT03188185|Buprenorphine|buprenorphine|mesh-list
93226302|NCT03188185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93226303|NCT03188185|Narcotics|narcotics|mesh-ancestor
93226304|NCT03188185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226305|NCT03188185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226306|NCT03188185|Analgesics|analgesics|mesh-ancestor
93226307|NCT03188185|Sensory System Agents|sensory system agents|mesh-ancestor
93226308|NCT03188185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226309|NCT03188185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93226310|NCT03188185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93226311|NCT03679182|Olanzapine|olanzapine|mesh-list
93226312|NCT03679182|Antiemetics|antiemetics|mesh-ancestor
93226313|NCT03679182|Autonomic Agents|autonomic agents|mesh-ancestor
93226314|NCT03679182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226315|NCT03679182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226316|NCT03679182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226317|NCT03679182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93226318|NCT03679182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93226319|NCT03679182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226320|NCT03679182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93226321|NCT03679182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93226322|NCT03679182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93226323|NCT03679182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93226324|NCT03679182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226325|NCT03679182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226326|NCT03679182|Serotonin Agents|serotonin agents|mesh-ancestor
93226327|NCT03184987|Albuterol|albuterol|mesh-list
93226328|NCT03184987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93226329|NCT03184987|Autonomic Agents|autonomic agents|mesh-ancestor
93226330|NCT03184987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226331|NCT03184987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226332|NCT03184987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93226333|NCT03184987|Respiratory System Agents|respiratory system agents|mesh-ancestor
93226334|NCT03184987|Tocolytic Agents|tocolytic agents|mesh-ancestor
93226335|NCT03184987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93226336|NCT03184987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93226337|NCT03184987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93226338|NCT03184987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226339|NCT03184987|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226340|NCT03184987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226341|NCT03184987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226342|NCT03193333|Timolol|timolol|mesh-list
93226343|NCT03193333|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93226344|NCT03193333|Dorzolamide|dorzolamide|mesh-list
93226345|NCT03193333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93226346|NCT03193333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93226347|NCT03193333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93226348|NCT03193333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93226349|NCT03193333|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226350|NCT03193333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226351|NCT03193333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226352|NCT03193333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226353|NCT03193333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93226354|NCT03193333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93226355|NCT03193333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93226356|NCT03193333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93226357|NCT03193333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226358|NCT03193333|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93226359|NCT03193333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226360|NCT03026166|Nivolumab|nivolumab|mesh-list
93226361|NCT03026166|Ipilimumab|ipilimumab|mesh-list
93226362|NCT03026166|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
93226363|NCT03026166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226364|NCT03026166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226365|NCT03026166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93226366|NCT03026166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226368|NCT03026166|Immunologic Factors|immunologic factors|mesh-ancestor
93226369|NCT03026166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226370|NCT03345576|Methyltestosterone|methyltestosterone|mesh-list
93226371|NCT03345576|Testosterone|testosterone|mesh-list
93226372|NCT03345576|Testosterone undecanoate|testosterone undecanoate|mesh-list
93226373|NCT03345576|Testosterone enanthate|testosterone enanthate|mesh-list
93226374|NCT03345576|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93226375|NCT03345576|Androgens|androgens|mesh-ancestor
93226376|NCT03345576|Hormones|hormones|mesh-ancestor
93226377|NCT03345576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226378|NCT03345576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226379|NCT03345576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226380|NCT03345576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226381|NCT03345576|Anabolic Agents|anabolic agents|mesh-ancestor
93226382|NCT03573648|Palbociclib|palbociclib|mesh-list
93226383|NCT03573648|Avelumab|avelumab|mesh-list
93226384|NCT03573648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226385|NCT03573648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93226386|NCT03573648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226387|NCT03573648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226388|NCT03573648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226389|NCT03026088|Bisoprolol|bisoprolol|mesh-list
93226390|NCT03026088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93226391|NCT03026088|Sympatholytics|sympatholytics|mesh-ancestor
93226392|NCT03026088|Autonomic Agents|autonomic agents|mesh-ancestor
93226393|NCT03026088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226394|NCT03026088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226395|NCT03026088|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93226396|NCT03026088|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93226397|NCT03026088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93226398|NCT03026088|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226399|NCT03026088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226400|NCT03026088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226401|NCT03328884|Irinotecan|irinotecan|mesh-list
93226402|NCT03328884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93226403|NCT03328884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93226404|NCT03328884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226405|NCT03328884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226406|NCT03328884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226407|NCT03678792|Morphine|morphine|mesh-list
93226408|NCT03678792|Buprenorphine|buprenorphine|mesh-list
93226409|NCT03678792|Tramadol|tramadol|mesh-list
93226410|NCT03678792|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93226411|NCT03678792|Naloxone|naloxone|mesh-list
93226412|NCT03678792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93226413|NCT03678792|Narcotics|narcotics|mesh-ancestor
93226414|NCT03678792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226415|NCT03678792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226416|NCT03678792|Analgesics|analgesics|mesh-ancestor
93226417|NCT03678792|Sensory System Agents|sensory system agents|mesh-ancestor
93226418|NCT03678792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226419|NCT03678792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93226420|NCT03678480|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93226421|NCT03678480|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93226422|NCT03678480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226423|NCT03181789|Interleukin-12|interleukin-12|mesh-list
93226424|NCT03181789|Vaccines|vaccines|mesh-list
93226425|NCT03181789|Immunologic Factors|immunologic factors|mesh-ancestor
93226426|NCT03181789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226427|NCT03181789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93226428|NCT03181789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93226429|NCT03181789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93226430|NCT03181789|Growth Substances|growth substances|mesh-ancestor
93226431|NCT03181789|Growth Inhibitors|growth inhibitors|mesh-ancestor
93226432|NCT03181789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226433|NCT03678090|Plasminogen|plasminogen|mesh-list
93226434|NCT03678090|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93226435|NCT03678090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93226436|NCT03678090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93226437|NCT03678090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226438|NCT03678012|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93226439|NCT03678012|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93226440|NCT03678012|Hematinics|hematinics|mesh-ancestor
93226441|NCT03678012|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93226442|NCT03678012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93226443|NCT03678012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93226444|NCT03678012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226445|NCT03259074|Adalimumab|adalimumab|mesh-list
93226446|NCT03259074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93226447|NCT03259074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226448|NCT03259074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226449|NCT03676296|Puerarin|puerarin|mesh-list
93226450|NCT03676296|Vasodilator Agents|vasodilator agents|mesh-ancestor
93226451|NCT03676140|Azithromycin|azithromycin|mesh-list
93226452|NCT03676140|Ivermectin|ivermectin|mesh-list
93226453|NCT03676140|Albendazole|albendazole|mesh-list
93226454|NCT03676140|Diethylcarbamazine|diethylcarbamazine|mesh-list
93226455|NCT03676140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93226456|NCT03676140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226457|NCT03676140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93226458|NCT03676140|Anthelmintics|anthelmintics|mesh-ancestor
93226459|NCT03676140|Anticestodal Agents|anticestodal agents|mesh-ancestor
93226460|NCT03676140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93226461|NCT03676140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93226462|NCT03676140|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226463|NCT03676140|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226464|NCT03676140|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226465|NCT03676140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226466|NCT03676140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226467|NCT03676140|Filaricides|filaricides|mesh-ancestor
93226468|NCT03676140|Antinematodal Agents|antinematodal agents|mesh-ancestor
93226469|NCT03676140|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93226470|NCT03676140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226471|NCT03504774|Immunomodulating Agents|immunomodulating agents|mesh-list
93226472|NCT03504774|Immunologic Factors|immunologic factors|mesh-ancestor
93226473|NCT03504774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226474|NCT04059198|Tenofovir|tenofovir|mesh-list
93226475|NCT04059198|Antiviral Agents|antiviral agents|mesh-ancestor
93226476|NCT04059198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226477|NCT04059198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93226478|NCT04059198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93226479|NCT04059198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226480|NCT04059198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226481|NCT04059198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93226482|NCT04059198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93226483|NCT04058964|Pembrolizumab|pembrolizumab|mesh-list
93226484|NCT04058964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226485|NCT04058964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226486|NCT04058964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93226487|NCT04058964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226488|NCT03246906|Cyclosporine|cyclosporine|mesh-list
93226489|NCT03246906|Sirolimus|sirolimus|mesh-list
93226490|NCT03246906|Mycophenolic Acid|mycophenolic acid|mesh-list
93226491|NCT03246906|Cyclophosphamide|cyclophosphamide|mesh-list
93226492|NCT03246906|Cyclosporins|cyclosporins|mesh-list
93226493|NCT03246906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226494|NCT03246906|Immunologic Factors|immunologic factors|mesh-ancestor
93226495|NCT03246906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226496|NCT03246906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226497|NCT03246906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226498|NCT03246906|Alkylating Agents|alkylating agents|mesh-ancestor
93226499|NCT03246906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226500|NCT03246906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226501|NCT03246906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93226502|NCT03246906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226503|NCT03246906|Antifungal Agents|antifungal agents|mesh-ancestor
93226504|NCT03246906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226505|NCT03246906|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226506|NCT03246906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93226507|NCT03246906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93226508|NCT03246906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93226509|NCT03246906|Antitubercular Agents|antitubercular agents|mesh-ancestor
93226510|NCT03246906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93226511|NCT03675594|Cobalt|cobalt|mesh-list
93226512|NCT03675594|Chromium|chromium|mesh-list
93226513|NCT03675594|Trace Elements|trace elements|mesh-ancestor
93226514|NCT03675594|Micronutrients|micronutrients|mesh-ancestor
93226515|NCT03675594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226516|NCT03671538|Pemetrexed|pemetrexed|mesh-list
93226517|NCT03671538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226518|NCT03671538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226519|NCT03671538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226520|NCT03671538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93226521|NCT03671538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93226522|NCT05420467|Paclitaxel|paclitaxel|mesh-list
93226523|NCT05420467|Docetaxel|docetaxel|mesh-list
93226524|NCT05420467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93226525|NCT05420467|Cyclophosphamide|cyclophosphamide|mesh-list
93226526|NCT05420467|Carboplatin|carboplatin|mesh-list
93226527|NCT05420467|Trastuzumab|trastuzumab|mesh-list
93226528|NCT05420467|Epirubicin|epirubicin|mesh-list
93226529|NCT05420467|Pertuzumab|pertuzumab|mesh-list
93226530|NCT05420467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93226531|NCT05420467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226532|NCT05420467|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226533|NCT05420467|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226534|NCT05420467|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226535|NCT05420467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226536|NCT05420467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226537|NCT05420467|Immunologic Factors|immunologic factors|mesh-ancestor
93226538|NCT05420467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226539|NCT05420467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226540|NCT05420467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226541|NCT05420467|Alkylating Agents|alkylating agents|mesh-ancestor
93226542|NCT05420467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93226543|NCT05420467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226544|NCT05420467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93226545|NCT05420467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93226546|NCT05420467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93226547|NCT05420467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226548|NCT03022578|Lomustine|lomustine|mesh-list
93226549|NCT03022578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226550|NCT03022578|Alkylating Agents|alkylating agents|mesh-ancestor
93226551|NCT03022578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226552|NCT03022578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226553|NCT03671070|Epinephrine|epinephrine|mesh-list
93226554|NCT03671070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93226555|NCT03671070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226556|NCT03671070|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226557|NCT03671070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226558|NCT03671070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226559|NCT03671070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226560|NCT03671070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93226561|NCT03671070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93226562|NCT03671070|Autonomic Agents|autonomic agents|mesh-ancestor
93226563|NCT03671070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226564|NCT03671070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93226565|NCT03671070|Respiratory System Agents|respiratory system agents|mesh-ancestor
93226566|NCT03671070|Mydriatics|mydriatics|mesh-ancestor
93226567|NCT03671070|Sympathomimetics|sympathomimetics|mesh-ancestor
93226568|NCT03671070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93226569|NCT03670758|Protein S|protein s|mesh-list
93226570|NCT03670758|Anticoagulants|anticoagulants|mesh-ancestor
93226571|NCT03674658|Propafenone|propafenone|mesh-list
93226572|NCT03674658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93226573|NCT03674658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93226574|NCT03674658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93226575|NCT03674658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93226576|NCT03674658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226577|NCT03623256|Fentanyl|fentanyl|mesh-list
93226578|NCT03623256|Bupivacaine|bupivacaine|mesh-list
93226579|NCT03623256|Anesthetics, Local|anesthetics, local|mesh-ancestor
93226580|NCT03623256|Anesthetics|anesthetics|mesh-ancestor
93226581|NCT03623256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226582|NCT03623256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226583|NCT03623256|Sensory System Agents|sensory system agents|mesh-ancestor
93226584|NCT03623256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226585|NCT03623256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93226586|NCT03623256|Narcotics|narcotics|mesh-ancestor
93226587|NCT03623256|Analgesics|analgesics|mesh-ancestor
93226588|NCT03623256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93226589|NCT03623256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93226590|NCT03623256|Anesthetics, General|anesthetics, general|mesh-ancestor
93226591|NCT03082014|Losartan|losartan|mesh-list
93226592|NCT03082014|Atenolol|atenolol|mesh-list
92898716|NCT02623478|Insulin Lispro|insulin lispro|mesh-list
93226593|NCT03082014|Amlodipine|amlodipine|mesh-list
93226594|NCT03082014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93226595|NCT03082014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93226596|NCT03082014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93226597|NCT03082014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226598|NCT03082014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91930375|NCT02288923|Ibuprofen|ibuprofen|mesh-list
93226599|NCT03082014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226600|NCT03082014|Vasodilator Agents|vasodilator agents|mesh-ancestor
93226601|NCT03082014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93226602|NCT03082014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93226603|NCT03082014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93226604|NCT03082014|Sympatholytics|sympatholytics|mesh-ancestor
93226605|NCT03082014|Autonomic Agents|autonomic agents|mesh-ancestor
93226606|NCT03082014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226607|NCT03082014|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93226608|NCT03082014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93226609|NCT03082014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93226610|NCT03082014|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226611|NCT03082014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226612|NCT03670212|Hydrocortisone|hydrocortisone|mesh-list
93226613|NCT03670212|Yohimbine|yohimbine|mesh-list
93226614|NCT03670212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226615|NCT03670212|Mydriatics|mydriatics|mesh-ancestor
93226616|NCT03670212|Autonomic Agents|autonomic agents|mesh-ancestor
93226617|NCT03670212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226618|NCT03670212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226619|NCT03670212|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93226620|NCT03670212|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93226621|NCT03670212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93226622|NCT03670212|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226623|NCT03670212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226624|NCT03670212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226625|NCT03670212|Urological Agents|urological agents|mesh-ancestor
93226626|NCT03165955|Paclitaxel|paclitaxel|mesh-list
93226627|NCT03165955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93226628|NCT03165955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226629|NCT03165955|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226630|NCT03165955|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226631|NCT03165955|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226632|NCT03165955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226633|NCT05263921|Ritonavir|ritonavir|mesh-list
93226634|NCT05263921|Nirmatrelvir|nirmatrelvir|mesh-list
93226635|NCT05263921|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93226636|NCT05263921|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93226637|NCT05263921|Protease Inhibitors|protease inhibitors|mesh-ancestor
93226638|NCT05263921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226639|NCT05263921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226640|NCT05263921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93226641|NCT05263921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93226642|NCT05263921|Antiviral Agents|antiviral agents|mesh-ancestor
93226643|NCT05263921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226644|NCT05263921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93226645|NCT05263921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93226646|NCT03673332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93226647|NCT03673332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226648|NCT03673332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226649|NCT03673332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226650|NCT03048084|Levetiracetam|levetiracetam|mesh-list
93226651|NCT03048084|Valproic Acid|valproic acid|mesh-list
93226652|NCT03048084|Anticonvulsants|anticonvulsants|mesh-ancestor
93226653|NCT03048084|Nootropic Agents|nootropic agents|mesh-ancestor
93226654|NCT03048084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226655|NCT03048084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226656|NCT03048084|GABA Agents|gaba agents|mesh-ancestor
93226657|NCT03048084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226658|NCT03048084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226659|NCT03048084|Antimanic Agents|antimanic agents|mesh-ancestor
93226660|NCT03048084|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93226661|NCT03048084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226662|NCT03048084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93226663|NCT02329860|Apatinib|apatinib|mesh-list
93226664|NCT02329860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226665|NCT02329860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93226666|NCT02329860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226667|NCT02329860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226668|NCT02251548|Cyclophosphamide|cyclophosphamide|mesh-list
93226669|NCT02251548|Rituximab|rituximab|mesh-list
93226670|NCT02251548|Fludarabine|fludarabine|mesh-list
93226671|NCT02251548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226672|NCT02251548|Immunologic Factors|immunologic factors|mesh-ancestor
91930376|NCT02288923|Morphine|morphine|mesh-list
93226673|NCT02251548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226674|NCT02251548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226675|NCT02251548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226676|NCT02251548|Alkylating Agents|alkylating agents|mesh-ancestor
93226677|NCT02251548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226678|NCT02251548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226679|NCT02251548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93226680|NCT02251548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226681|NCT03165721|Guadecitabine|guadecitabine|mesh-list
93226682|NCT03165721|Azacitidine|azacitidine|mesh-list
93226683|NCT03165721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226684|NCT03165721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93226685|NCT03165721|Antimetabolites|antimetabolites|mesh-ancestor
93226686|NCT03165721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226687|NCT03165721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226688|NCT02224872|Mycophenolic Acid|mycophenolic acid|mesh-list
93226689|NCT02224872|Cyclophosphamide|cyclophosphamide|mesh-list
93226690|NCT02224872|Fludarabine|fludarabine|mesh-list
93226691|NCT02224872|Tacrolimus|tacrolimus|mesh-list
93226692|NCT02224872|Thymoglobulin|thymoglobulin|mesh-list
93226693|NCT02224872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226694|NCT02224872|Immunologic Factors|immunologic factors|mesh-ancestor
93226695|NCT02224872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226696|NCT02224872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226697|NCT02224872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226698|NCT02224872|Alkylating Agents|alkylating agents|mesh-ancestor
93226699|NCT02224872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226700|NCT02224872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226701|NCT02224872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93226702|NCT02224872|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93226703|NCT02224872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226704|NCT02224872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93226705|NCT02224872|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93226706|NCT02224872|Antitubercular Agents|antitubercular agents|mesh-ancestor
93226707|NCT02224872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93226708|NCT02224872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226709|NCT02187198|Buprenorphine|buprenorphine|mesh-list
93226710|NCT02187198|Naloxone|naloxone|mesh-list
93226711|NCT02187198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93226712|NCT02187198|Narcotics|narcotics|mesh-ancestor
93226713|NCT02187198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226714|NCT02187198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226715|NCT02187198|Analgesics|analgesics|mesh-ancestor
93226716|NCT02187198|Sensory System Agents|sensory system agents|mesh-ancestor
93226717|NCT02187198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226718|NCT02187198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93226719|NCT04969705|Dexmedetomidine|dexmedetomidine|mesh-list
93226720|NCT04969705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93226721|NCT04969705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226722|NCT04969705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226723|NCT04969705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93226724|NCT04969705|Analgesics|analgesics|mesh-ancestor
93226725|NCT04969705|Sensory System Agents|sensory system agents|mesh-ancestor
93226726|NCT04969705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226727|NCT04969705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93226728|NCT04969705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93226729|NCT04969705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226730|NCT04969705|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226731|NCT04969705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226732|NCT04969705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226733|NCT03676374|Prucalopride|prucalopride|mesh-list
93226734|NCT03676374|Laxatives|laxatives|mesh-ancestor
93226735|NCT03676374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226736|NCT03676374|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93226737|NCT03676374|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93226738|NCT03676374|Serotonin Agents|serotonin agents|mesh-ancestor
93226739|NCT03676374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226740|NCT03676374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226741|NCT03676374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226742|NCT01829958|Prednisone|prednisone|mesh-list
93226743|NCT01829958|Rituximab|rituximab|mesh-list
93226744|NCT01829958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226745|NCT01829958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226746|NCT01829958|Immunologic Factors|immunologic factors|mesh-ancestor
93226747|NCT01829958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226748|NCT01829958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226749|NCT01829958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226750|NCT01829958|Glucocorticoids|glucocorticoids|mesh-ancestor
93226751|NCT01829958|Hormones|hormones|mesh-ancestor
93226752|NCT01829958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226753|NCT01829958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226754|NCT03021642|Tepotinib|tepotinib|mesh-list
93226755|NCT03021642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226756|NCT01374984|Immunoglobulins|immunoglobulins|mesh-list
93226757|NCT01374984|gamma-Globulins|gamma-globulins|mesh-list
93226758|NCT01374984|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93226759|NCT01374984|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93226760|NCT01374984|Immunologic Factors|immunologic factors|mesh-ancestor
93226761|NCT01374984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226762|NCT00867048|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93226763|NCT00867048|Antiviral Agents|antiviral agents|mesh-ancestor
93226764|NCT00867048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226765|NCT03023046|Prednisone|prednisone|mesh-list
93226766|NCT03023046|Cortisone|cortisone|mesh-list
93226767|NCT03023046|Cyclophosphamide|cyclophosphamide|mesh-list
93226768|NCT03023046|Rituximab|rituximab|mesh-list
93226769|NCT03023046|Doxorubicin|doxorubicin|mesh-list
93226770|NCT03023046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93226771|NCT03023046|Etoposide|etoposide|mesh-list
93226772|NCT03023046|Vincristine|vincristine|mesh-list
93226773|NCT03023046|Etoposide phosphate|etoposide phosphate|mesh-list
93226774|NCT03023046|Imatinib Mesylate|imatinib mesylate|mesh-list
93226775|NCT03023046|Daunorubicin|daunorubicin|mesh-list
93226776|NCT03023046|Dasatinib|dasatinib|mesh-list
93226777|NCT03023046|Podophyllotoxin|podophyllotoxin|mesh-list
93226778|NCT03023046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93226779|NCT03023046|Antibodies|antibodies|mesh-list
93226780|NCT03023046|Immunoglobulins|immunoglobulins|mesh-list
93226781|NCT03023046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93226782|NCT03023046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226783|NCT03023046|Immunologic Factors|immunologic factors|mesh-ancestor
93226784|NCT03023046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226785|NCT03023046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226786|NCT03023046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93226787|NCT03023046|Alkylating Agents|alkylating agents|mesh-ancestor
93226788|NCT03023046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226789|NCT03023046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226790|NCT03023046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93226791|NCT03023046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93226792|NCT03023046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93226793|NCT03023046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93226794|NCT03023046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226795|NCT03023046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226796|NCT03023046|Glucocorticoids|glucocorticoids|mesh-ancestor
93226797|NCT03023046|Hormones|hormones|mesh-ancestor
93226798|NCT03023046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226799|NCT03023046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93226800|NCT03023046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93226801|NCT03023046|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226802|NCT03023046|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226803|NCT03023046|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226804|NCT03023046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93226805|NCT03023046|Keratolytic Agents|keratolytic agents|mesh-ancestor
93226806|NCT03023046|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226807|NCT03668262|Atracurium|atracurium|mesh-list
93226808|NCT03668262|Cisatracurium|cisatracurium|mesh-list
93226809|NCT03668262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93226810|NCT03668262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93226811|NCT03668262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93226812|NCT03668262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226813|NCT03668262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226814|NCT03668262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93226815|NCT03668262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93226816|NCT03668262|Cholinergic Agents|cholinergic agents|mesh-ancestor
93226817|NCT03668262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226818|NCT03668262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226819|NCT03668964|Vitamin D|vitamin d|mesh-list
93226821|NCT03668964|Vitamins|vitamins|mesh-list
93226822|NCT03668964|Vitamin E|vitamin e|mesh-list
93226823|NCT03668964|Tocopherols|tocopherols|mesh-list
93226824|NCT03668964|alpha-Tocopherol|alpha-tocopherol|mesh-list
93226825|NCT03668964|Vitamin A|vitamin a|mesh-list
93226826|NCT03668964|Riboflavin|riboflavin|mesh-list
93226827|NCT03668964|Vitamin B Complex|vitamin b complex|mesh-list
93226828|NCT03668964|Micronutrients|micronutrients|mesh-ancestor
93226829|NCT03668964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226830|NCT03668964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93226831|NCT03668964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93226832|NCT03668964|Antioxidants|antioxidants|mesh-ancestor
93226833|NCT03668964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226834|NCT03668964|Protective Agents|protective agents|mesh-ancestor
93226835|NCT03668964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93226836|NCT03668964|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226837|NCT03668730|Paclitaxel|paclitaxel|mesh-list
93226838|NCT03668730|Fluorouracil|fluorouracil|mesh-list
93226839|NCT03668730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93226840|NCT03668730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226841|NCT03668730|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226842|NCT03668730|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226843|NCT03668730|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226844|NCT03668730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226845|NCT03668730|Antimetabolites|antimetabolites|mesh-ancestor
93226846|NCT03668730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93226847|NCT03668730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226848|NCT03668730|Immunologic Factors|immunologic factors|mesh-ancestor
93226849|NCT03668730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226850|NCT03021018|Lorazepam|lorazepam|mesh-list
93226851|NCT03021018|Brivaracetam|brivaracetam|mesh-list
93226852|NCT03021018|Anticonvulsants|anticonvulsants|mesh-ancestor
93226853|NCT03021018|Antiemetics|antiemetics|mesh-ancestor
93226854|NCT03021018|Autonomic Agents|autonomic agents|mesh-ancestor
93226855|NCT03021018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226856|NCT03021018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226857|NCT03021018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226858|NCT03021018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93226859|NCT03021018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93226860|NCT03021018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93226861|NCT03021018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93226862|NCT03021018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93226863|NCT03021018|GABA Modulators|gaba modulators|mesh-ancestor
93226864|NCT03021018|GABA Agents|gaba agents|mesh-ancestor
93226865|NCT03021018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226866|NCT03021018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226867|NCT02509507|Pembrolizumab|pembrolizumab|mesh-list
93226868|NCT02509507|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93226869|NCT02509507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93226870|NCT02509507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226871|NCT02509507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93226872|NCT02509507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226873|NCT03175549|Apremilast|apremilast|mesh-list
93226874|NCT03175549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93226875|NCT03175549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93226876|NCT03175549|Analgesics|analgesics|mesh-ancestor
93226877|NCT03175549|Sensory System Agents|sensory system agents|mesh-ancestor
93226878|NCT03175549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226879|NCT03175549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226880|NCT03175549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226881|NCT03175549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93226882|NCT03175549|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93226883|NCT03175549|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93226884|NCT03175549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226885|NCT03175549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226886|NCT01314937|Mebendazole|mebendazole|mesh-list
93226887|NCT01314937|Piperazine|piperazine|mesh-list
93226888|NCT01314937|Piperazine citrate|piperazine citrate|mesh-list
93226889|NCT01314937|DMP 777|dmp 777|mesh-list
93226890|NCT01314937|Antinematodal Agents|antinematodal agents|mesh-ancestor
93226891|NCT01314937|Anthelmintics|anthelmintics|mesh-ancestor
93226892|NCT01314937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93226893|NCT01314937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226894|NCT01314937|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226895|NCT01314937|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226896|NCT01314937|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226897|NCT01314937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226898|NCT01314937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226899|NCT01314937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226900|NCT04718155|Atorvastatin|atorvastatin|mesh-list
93226901|NCT04718155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93226902|NCT04718155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93226903|NCT04718155|Antimetabolites|antimetabolites|mesh-ancestor
93226904|NCT04718155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226905|NCT04718155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93226906|NCT04718155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93226907|NCT04718155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226908|NCT04668859|Midodrine|midodrine|mesh-list
93226909|NCT04668859|Sympathomimetics|sympathomimetics|mesh-ancestor
93226910|NCT04668859|Autonomic Agents|autonomic agents|mesh-ancestor
93226911|NCT04668859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226912|NCT04668859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226913|NCT04668859|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93226914|NCT04668859|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93226915|NCT04668859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93226916|NCT04668859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226917|NCT04668859|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226918|NCT04668859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226919|NCT04668859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226920|NCT02924688|Fluticasone|fluticasone|mesh-list
93226921|NCT02924688|Albuterol|albuterol|mesh-list
93226922|NCT02924688|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93226923|NCT02924688|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93226924|NCT02924688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226925|NCT02924688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93226926|NCT02924688|Autonomic Agents|autonomic agents|mesh-ancestor
93226927|NCT02924688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226928|NCT02924688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226929|NCT02924688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93226930|NCT02924688|Respiratory System Agents|respiratory system agents|mesh-ancestor
93226931|NCT02924688|Dermatologic Agents|dermatologic agents|mesh-ancestor
93226932|NCT02924688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93226933|NCT02924688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93226934|NCT02924688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93226935|NCT02924688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93226936|NCT02924688|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226937|NCT02924688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226938|NCT02924688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226939|NCT02924688|Tocolytic Agents|tocolytic agents|mesh-ancestor
93226940|NCT02924688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93226941|NCT02924688|Glucocorticoids|glucocorticoids|mesh-ancestor
93226942|NCT02924688|Hormones|hormones|mesh-ancestor
93226943|NCT02924688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226944|NCT02924688|Sympathomimetics|sympathomimetics|mesh-ancestor
93226945|NCT03668418|Camptothecin|camptothecin|mesh-list
93226946|NCT03668418|Docetaxel|docetaxel|mesh-list
93226947|NCT03668418|Gemcitabine|gemcitabine|mesh-list
93226948|NCT03668418|Fluorouracil|fluorouracil|mesh-list
93226949|NCT03668418|Oxaliplatin|oxaliplatin|mesh-list
93226950|NCT03668418|Irinotecan|irinotecan|mesh-list
93226951|NCT03668418|Epirubicin|epirubicin|mesh-list
93226952|NCT03668418|Taxane|taxane|mesh-list
93226953|NCT03668418|Antimetabolites|antimetabolites|mesh-list
93226954|NCT03668418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93226955|NCT03668418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226956|NCT03668418|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226957|NCT03668418|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226958|NCT03668418|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226959|NCT03668418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226960|NCT03668418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93226961|NCT03668418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93226962|NCT03668418|Immunologic Factors|immunologic factors|mesh-ancestor
93226963|NCT03668418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226964|NCT03668418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93226965|NCT03668418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93226966|NCT03668418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93226967|NCT03668418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93226968|NCT03668418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93226969|NCT03011892|Triamcinolone|triamcinolone|mesh-list
93226970|NCT03011892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93226971|NCT03011892|Glucocorticoids|glucocorticoids|mesh-ancestor
93226972|NCT03011892|Hormones|hormones|mesh-ancestor
93226973|NCT03011892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93226974|NCT03011892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226975|NCT02125513|Paclitaxel|paclitaxel|mesh-list
93226976|NCT02125513|Carboplatin|carboplatin|mesh-list
93226977|NCT02125513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93226978|NCT02125513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93226979|NCT02125513|Tubulin Modulators|tubulin modulators|mesh-ancestor
93226980|NCT02125513|Antimitotic Agents|antimitotic agents|mesh-ancestor
93226981|NCT02125513|Mitosis Modulators|mitosis modulators|mesh-ancestor
93226982|NCT02125513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226983|NCT04575948|Chlorhexidine|chlorhexidine|mesh-list
93226984|NCT04575948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93226985|NCT04575948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93226986|NCT04575948|Disinfectants|disinfectants|mesh-ancestor
93226987|NCT03666546|Methamphetamine|methamphetamine|mesh-list
93226988|NCT03666546|Lactulose|lactulose|mesh-list
93226989|NCT03666546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93226990|NCT03666546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93226991|NCT03666546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93226992|NCT03666546|Sympathomimetics|sympathomimetics|mesh-ancestor
93226993|NCT03666546|Autonomic Agents|autonomic agents|mesh-ancestor
93226994|NCT03666546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93226995|NCT03666546|Dopamine Agents|dopamine agents|mesh-ancestor
93226996|NCT03666546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93226997|NCT03666546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93226998|NCT03666546|Adrenergic Agents|adrenergic agents|mesh-ancestor
93226999|NCT03666546|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93227000|NCT03666546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93227001|NCT03666546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227002|NCT03666546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93227003|NCT03012828|Moxidectin|moxidectin|mesh-list
93227004|NCT03012828|Anthelmintics|anthelmintics|mesh-ancestor
93227005|NCT03012828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93227006|NCT03012828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227007|NCT03012828|Antinematodal Agents|antinematodal agents|mesh-ancestor
93227008|NCT03666390|Midazolam|midazolam|mesh-list
93227009|NCT03666390|Ketamine|ketamine|mesh-list
93227010|NCT03666390|Analgesics|analgesics|mesh-ancestor
93227011|NCT03666390|Sensory System Agents|sensory system agents|mesh-ancestor
93227012|NCT03666390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227013|NCT03666390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227014|NCT03666390|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93227015|NCT03666390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93227016|NCT03666390|Anesthetics, General|anesthetics, general|mesh-ancestor
93227017|NCT03666390|Anesthetics|anesthetics|mesh-ancestor
93227018|NCT03666390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227019|NCT03666390|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93227020|NCT03666390|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93227021|NCT03666390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227022|NCT03666390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227023|NCT03666390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93227024|NCT03666390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93227025|NCT03666390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93227026|NCT03666390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93227027|NCT03666390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93227028|NCT03666390|GABA Modulators|gaba modulators|mesh-ancestor
93227029|NCT03666390|GABA Agents|gaba agents|mesh-ancestor
93227030|NCT03003390|Enoxaparin|enoxaparin|mesh-list
93227031|NCT03003390|Anticoagulants|anticoagulants|mesh-ancestor
93227032|NCT03003390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93227033|NCT03003390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93227034|NCT03003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227035|NCT03003000|Ibuprofen|ibuprofen|mesh-list
93227036|NCT03003000|Caffeine|caffeine|mesh-list
93227037|NCT03003000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227038|NCT03003000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227039|NCT03003000|Analgesics|analgesics|mesh-ancestor
93227040|NCT03003000|Sensory System Agents|sensory system agents|mesh-ancestor
93227041|NCT03003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227042|NCT03003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227043|NCT03003000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227044|NCT03003000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227045|NCT03003000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93227046|NCT03003000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227047|NCT03003000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227048|NCT03003000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93227049|NCT03003000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93227050|NCT03003000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93227052|NCT03003000|Purinergic Agents|purinergic agents|mesh-ancestor
93227053|NCT03003000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227054|NCT03665766|Cycloserine|cycloserine|mesh-list
93227055|NCT03665766|Tacrolimus|tacrolimus|mesh-list
93227056|NCT03665766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227057|NCT03665766|Immunologic Factors|immunologic factors|mesh-ancestor
93227058|NCT03665766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227059|NCT03665766|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93227060|NCT03665766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227061|NCT03665766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227062|NCT03665766|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93227063|NCT03665766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227064|NCT03665766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93227065|NCT03665766|Antitubercular Agents|antitubercular agents|mesh-ancestor
93227066|NCT03665766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93227067|NCT03665766|Antimetabolites|antimetabolites|mesh-ancestor
93227068|NCT03546894|Ceritinib|ceritinib|mesh-list
93227069|NCT03546894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227070|NCT03546894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227071|NCT03546894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227072|NCT03546894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227073|NCT03637361|Methadone|methadone|mesh-list
93227074|NCT03637361|D-methadone|d-methadone|mesh-list
93227075|NCT03637361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93227076|NCT03637361|Narcotics|narcotics|mesh-ancestor
93227077|NCT03637361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227078|NCT03637361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227079|NCT03637361|Analgesics|analgesics|mesh-ancestor
93227080|NCT03637361|Sensory System Agents|sensory system agents|mesh-ancestor
93227081|NCT03637361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227082|NCT03637361|Antitussive Agents|antitussive agents|mesh-ancestor
93227083|NCT03637361|Respiratory System Agents|respiratory system agents|mesh-ancestor
93227084|NCT03637361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227085|NCT00038675|Imatinib Mesylate|imatinib mesylate|mesh-list
93227086|NCT00038675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227087|NCT00038675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227088|NCT00038675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227089|NCT00038675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227090|NCT03254459|Morphine|morphine|mesh-list
93227091|NCT03254459|Oxycodone|oxycodone|mesh-list
93227092|NCT03254459|Buprenorphine|buprenorphine|mesh-list
93227093|NCT03254459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93227094|NCT03254459|Narcotics|narcotics|mesh-ancestor
93227095|NCT03254459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227096|NCT03254459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227097|NCT03254459|Analgesics|analgesics|mesh-ancestor
93227098|NCT03254459|Sensory System Agents|sensory system agents|mesh-ancestor
93227099|NCT03254459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227100|NCT03254459|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93227101|NCT03620591|Lidocaine|lidocaine|mesh-list
93227102|NCT03620591|Anesthetics, Local|anesthetics, local|mesh-ancestor
93227103|NCT03620591|Anesthetics|anesthetics|mesh-ancestor
93227104|NCT03620591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227105|NCT03620591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227106|NCT03620591|Sensory System Agents|sensory system agents|mesh-ancestor
93227107|NCT03620591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227108|NCT03620591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93227109|NCT03620591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93227110|NCT03620591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93227111|NCT03620591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227112|NCT03620591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227113|NCT05178953|Zinc|zinc|mesh-list
93227114|NCT05178953|Pentoxifylline|pentoxifylline|mesh-list
93227115|NCT05178953|Zinc Sulfate|zinc sulfate|mesh-list
93227116|NCT05178953|Trace Elements|trace elements|mesh-ancestor
93227117|NCT05178953|Micronutrients|micronutrients|mesh-ancestor
93227118|NCT05178953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227119|NCT05178953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93227120|NCT05178953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227121|NCT05178953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899242|NCT00603239|Exenatide|exenatide|mesh-list
93227122|NCT05178953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93227123|NCT05178953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93227124|NCT05178953|Protective Agents|protective agents|mesh-ancestor
93227125|NCT05178953|Vasodilator Agents|vasodilator agents|mesh-ancestor
93227126|NCT05178953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93227128|NCT05178953|Astringents|astringents|mesh-ancestor
93227129|NCT05178953|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227130|NCT02736617|Obinutuzumab|obinutuzumab|mesh-list
93227131|NCT02736617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227132|NCT02736617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227133|NCT03251963|Enoxaparin|enoxaparin|mesh-list
93227134|NCT03251963|Enoxaparin sodium|enoxaparin sodium|mesh-list
93227135|NCT03251963|Anticoagulants|anticoagulants|mesh-ancestor
93227136|NCT03251963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93227137|NCT03251963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93227138|NCT03251963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227139|NCT03287219|Methylene Blue|methylene blue|mesh-list
93227140|NCT03287219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227141|NCT03287219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227142|NCT03286751|Insulin Lispro|insulin lispro|mesh-list
93227143|NCT03286751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93227144|NCT03286751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227145|NCT05572229|Lenalidomide|lenalidomide|mesh-list
93227146|NCT05572229|Daratumumab|daratumumab|mesh-list
93227147|NCT05572229|Immunologic Factors|immunologic factors|mesh-ancestor
93227148|NCT05572229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227149|NCT05572229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93227150|NCT05572229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93227151|NCT05572229|Growth Substances|growth substances|mesh-ancestor
93227152|NCT05572229|Growth Inhibitors|growth inhibitors|mesh-ancestor
93227153|NCT05572229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227154|NCT03249935|Azithromycin|azithromycin|mesh-list
93227155|NCT03249935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93227156|NCT03249935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227157|NCT03622073|Misoprostol|misoprostol|mesh-list
93227158|NCT03622073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93227159|NCT03622073|Abortifacient Agents|abortifacient agents|mesh-ancestor
93227160|NCT03622073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93227161|NCT03622073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227162|NCT03622073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93227163|NCT03622073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227164|NCT03622073|Oxytocics|oxytocics|mesh-ancestor
93227165|NCT03000348|Cysteamine|cysteamine|mesh-list
93227166|NCT03000348|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
93227167|NCT03000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227168|NCT03664986|Bupivacaine|bupivacaine|mesh-list
93227169|NCT03664986|Anesthetics, Local|anesthetics, local|mesh-ancestor
93227170|NCT03664986|Anesthetics|anesthetics|mesh-ancestor
93227171|NCT03664986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227172|NCT03664986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227173|NCT03664986|Sensory System Agents|sensory system agents|mesh-ancestor
93227174|NCT03664986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227175|NCT03492918|Pembrolizumab|pembrolizumab|mesh-list
93227176|NCT03492918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227177|NCT03492918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227178|NCT03492918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93227179|NCT03492918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227180|NCT03247673|Bevacizumab|bevacizumab|mesh-list
93227181|NCT03247673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227182|NCT03247673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227183|NCT03247673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93227184|NCT03247673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93227185|NCT03247673|Growth Substances|growth substances|mesh-ancestor
93227186|NCT03247673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227187|NCT03247673|Growth Inhibitors|growth inhibitors|mesh-ancestor
93227188|NCT03665610|Ozanimod|ozanimod|mesh-list
93227189|NCT03665610|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93227190|NCT03665610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227191|NCT03665610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227192|NCT03665610|Immunologic Factors|immunologic factors|mesh-ancestor
93227193|NCT03665610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227194|NCT03664908|Antibodies|antibodies|mesh-list
93227195|NCT03664908|Immunologic Factors|immunologic factors|mesh-ancestor
93227196|NCT03664908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227197|NCT03665454|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93227198|NCT03665454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93227199|NCT03665454|Immunologic Factors|immunologic factors|mesh-ancestor
93227200|NCT03665454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227201|NCT03665454|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93227202|NCT03665454|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93227203|NCT03665454|Dopamine Agonists|dopamine agonists|mesh-ancestor
93227204|NCT03665454|Dopamine Agents|dopamine agents|mesh-ancestor
93227205|NCT03665454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227206|NCT03665454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227207|NCT03664440|Nevirapine|nevirapine|mesh-list
93227208|NCT03664440|Rilpivirine|rilpivirine|mesh-list
93227209|NCT03664440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93227210|NCT03664440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93227211|NCT03664440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227212|NCT03664440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227213|NCT03664440|Antiviral Agents|antiviral agents|mesh-ancestor
93227214|NCT03664440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227215|NCT03664440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93227216|NCT03664440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93227217|NCT03664440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93227218|NCT03664440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93227219|NCT03664596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93227220|NCT03664596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93227221|NCT03664596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227222|NCT03282227|Oxazolidinones|oxazolidinones|mesh-list
93227223|NCT03282227|Zolmitriptan|zolmitriptan|mesh-list
93227224|NCT03282227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93227225|NCT03282227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93227226|NCT03282227|Serotonin Agents|serotonin agents|mesh-ancestor
93227227|NCT03282227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227228|NCT03282227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227229|NCT03282227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227230|NCT03282227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227231|NCT03282227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93227232|NCT03282227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227233|NCT03240575|Fluticasone|fluticasone|mesh-list
93227234|NCT03240575|Xhance|xhance|mesh-list
93227235|NCT03240575|Tiotropium Bromide|tiotropium bromide|mesh-list
93227236|NCT03240575|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93227237|NCT03240575|Olodaterol|olodaterol|mesh-list
93227238|NCT03240575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227239|NCT03240575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93227240|NCT03240575|Autonomic Agents|autonomic agents|mesh-ancestor
93227241|NCT03240575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227242|NCT03240575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227243|NCT03240575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93227244|NCT03240575|Respiratory System Agents|respiratory system agents|mesh-ancestor
93227245|NCT03240575|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227246|NCT03240575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93227247|NCT03240575|Parasympatholytics|parasympatholytics|mesh-ancestor
93227248|NCT03240575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93227249|NCT03240575|Cholinergic Agents|cholinergic agents|mesh-ancestor
93227250|NCT03240575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227251|NCT03240575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227252|NCT03240575|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93227253|NCT03240575|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93227254|NCT03240575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93227255|NCT03240575|Adrenergic Agents|adrenergic agents|mesh-ancestor
93227256|NCT04034225|Pembrolizumab|pembrolizumab|mesh-list
93227257|NCT04034225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227258|NCT04034225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227259|NCT04034225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93227260|NCT04034225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227261|NCT03690947|Ranibizumab|ranibizumab|mesh-list
93227262|NCT03690947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93227263|NCT03690947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93227264|NCT03690947|Growth Substances|growth substances|mesh-ancestor
93227265|NCT03690947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227266|NCT03690947|Growth Inhibitors|growth inhibitors|mesh-ancestor
93227267|NCT03690947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899404|NCT04115904|Ibuprofen|ibuprofen|mesh-list
93227268|NCT02999178|Nintedanib|nintedanib|mesh-list
93227269|NCT02999178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227270|NCT02999178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227271|NCT02999178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227272|NCT02999178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227273|NCT02999100|Oxytocin|oxytocin|mesh-list
93227274|NCT02999100|Oxytocics|oxytocics|mesh-ancestor
93227275|NCT02999100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93227276|NCT02999100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227277|NCT02749370|Etanercept|etanercept|mesh-list
93227278|NCT02749370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227279|NCT02749370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227280|NCT02749370|Analgesics|analgesics|mesh-ancestor
93227281|NCT02749370|Sensory System Agents|sensory system agents|mesh-ancestor
93227282|NCT02749370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227283|NCT02749370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227284|NCT02749370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227285|NCT02749370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227286|NCT02749370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227287|NCT02749370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227288|NCT02749370|Immunologic Factors|immunologic factors|mesh-ancestor
93227289|NCT03618758|Paclitaxel|paclitaxel|mesh-list
93227290|NCT03618758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93227291|NCT03618758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227292|NCT03618758|Tubulin Modulators|tubulin modulators|mesh-ancestor
93227293|NCT03618758|Antimitotic Agents|antimitotic agents|mesh-ancestor
93227294|NCT03618758|Mitosis Modulators|mitosis modulators|mesh-ancestor
93227295|NCT03618758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227296|NCT03617900|Acetaminophen|acetaminophen|mesh-list
93227297|NCT03617900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227298|NCT03617900|Analgesics|analgesics|mesh-ancestor
93227299|NCT03617900|Sensory System Agents|sensory system agents|mesh-ancestor
93227300|NCT03617900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227301|NCT03617900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227302|NCT03617900|Antipyretics|antipyretics|mesh-ancestor
93227303|NCT05384366|Paclitaxel|paclitaxel|mesh-list
93227304|NCT05384366|Carboplatin|carboplatin|mesh-list
93227305|NCT05384366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93227306|NCT05384366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227307|NCT05384366|Tubulin Modulators|tubulin modulators|mesh-ancestor
93227308|NCT05384366|Antimitotic Agents|antimitotic agents|mesh-ancestor
93227309|NCT05384366|Mitosis Modulators|mitosis modulators|mesh-ancestor
93227310|NCT05384366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227311|NCT03616808|Hemostatics|hemostatics|mesh-list
93227312|NCT03616808|Coagulants|coagulants|mesh-ancestor
93227313|NCT03617510|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
93227314|NCT03617510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227315|NCT03617510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227316|NCT03617510|Analgesics|analgesics|mesh-ancestor
93227317|NCT03617510|Sensory System Agents|sensory system agents|mesh-ancestor
93227318|NCT03617510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227319|NCT03617510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227320|NCT03617510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227321|NCT03617510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227322|NCT03617432|Prednisone|prednisone|mesh-list
93227323|NCT03617432|Cyclophosphamide|cyclophosphamide|mesh-list
93227324|NCT03617432|Doxorubicin|doxorubicin|mesh-list
93227325|NCT03617432|Etoposide|etoposide|mesh-list
93227326|NCT03617432|Vincristine|vincristine|mesh-list
93227327|NCT03617432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227328|NCT03617432|Immunologic Factors|immunologic factors|mesh-ancestor
93227329|NCT03617432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227330|NCT03617432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227331|NCT03617432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93227332|NCT03617432|Alkylating Agents|alkylating agents|mesh-ancestor
93227333|NCT03617432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227334|NCT03617432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227335|NCT03617432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93227336|NCT03617432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93227337|NCT03617432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93227338|NCT03617432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93227339|NCT03617432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227340|NCT03617432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227341|NCT03617432|Glucocorticoids|glucocorticoids|mesh-ancestor
93227342|NCT03617432|Hormones|hormones|mesh-ancestor
93227343|NCT03617432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93227344|NCT03617432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93227345|NCT03617432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93227346|NCT03617432|Tubulin Modulators|tubulin modulators|mesh-ancestor
93227347|NCT03617432|Antimitotic Agents|antimitotic agents|mesh-ancestor
93227348|NCT03617432|Mitosis Modulators|mitosis modulators|mesh-ancestor
93227350|NCT02996682|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93227351|NCT02996682|Antimetabolites|antimetabolites|mesh-ancestor
93227352|NCT02996682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227353|NCT02996682|Antiviral Agents|antiviral agents|mesh-ancestor
93227354|NCT02996682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227355|NCT02873702|Lansoprazole|lansoprazole|mesh-list
93227356|NCT02873702|Dexlansoprazole|dexlansoprazole|mesh-list
93227357|NCT02873702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93227358|NCT02873702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227359|NCT02873702|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93227360|NCT02873702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227361|NCT02873702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227362|NCT03616262|Lidocaine|lidocaine|mesh-list
93227363|NCT03616262|Anesthetics, Local|anesthetics, local|mesh-ancestor
93227364|NCT03616262|Anesthetics|anesthetics|mesh-ancestor
93227365|NCT03616262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227366|NCT03616262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227367|NCT03616262|Sensory System Agents|sensory system agents|mesh-ancestor
93227368|NCT03616262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227369|NCT03616262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93227370|NCT03616262|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93227371|NCT03616262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93227372|NCT03616262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227373|NCT03616262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227374|NCT03615950|Vitamin D|vitamin d|mesh-list
93227375|NCT03615950|Vitamins|vitamins|mesh-ancestor
93227376|NCT03615950|Micronutrients|micronutrients|mesh-ancestor
93227377|NCT03615950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227378|NCT03615950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93227379|NCT02911116|Ustekinumab|ustekinumab|mesh-list
93227380|NCT02911116|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227381|NCT03664050|Letrozole|letrozole|mesh-list
93227382|NCT03664050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227383|NCT03664050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93227384|NCT03664050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93227385|NCT03664050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227386|NCT03664050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227387|NCT03664050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93227388|NCT03664050|Hormone Antagonists|hormone antagonists|mesh-ancestor
93227389|NCT03664050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93227390|NCT03664050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227391|NCT04055844|Decitabine|decitabine|mesh-list
93227392|NCT04055844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93227393|NCT04055844|Antimetabolites|antimetabolites|mesh-ancestor
93227394|NCT04055844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227395|NCT04055844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227396|NCT04055844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227397|NCT04055688|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93227398|NCT04055688|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93227399|NCT04055688|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227400|NCT04054284|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93227401|NCT04054284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227402|NCT04494438|Rituximab|rituximab|mesh-list
93227403|NCT04494438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227404|NCT04494438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227405|NCT04494438|Immunologic Factors|immunologic factors|mesh-ancestor
93227406|NCT04494438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227407|NCT04494438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227408|NCT04057482|Dequalinium|dequalinium|mesh-list
93227409|NCT04057482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93227410|NCT04057482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227411|NCT03662412|Sirolimus|sirolimus|mesh-list
93227412|NCT03662412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93227413|NCT03662412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227414|NCT03662412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93227415|NCT03662412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227416|NCT03662412|Antifungal Agents|antifungal agents|mesh-ancestor
93227417|NCT03662412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227418|NCT03662412|Immunologic Factors|immunologic factors|mesh-ancestor
93227419|NCT03662412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227420|NCT02870972|Berotralstat|berotralstat|mesh-list
92899540|NCT04127084|Empagliflozin|empagliflozin|mesh-list
93227421|NCT02870972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93227422|NCT02870972|Protease Inhibitors|protease inhibitors|mesh-ancestor
93227423|NCT02870972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227424|NCT02870972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227426|NCT03214367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93227427|NCT03214367|Insulin Glargine|insulin glargine|mesh-list
93227428|NCT03214367|Insulin Lispro|insulin lispro|mesh-list
93227429|NCT03214367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93227430|NCT03214367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227431|NCT03662958|Leuprolide|leuprolide|mesh-list
93227432|NCT03662958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93227433|NCT03662958|Fertility Agents|fertility agents|mesh-ancestor
93227434|NCT03662958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93227435|NCT03662958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227436|NCT03662958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93227437|NCT03662958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227438|NCT03231371|Adenosine|adenosine|mesh-list
93227439|NCT03231371|Analgesics|analgesics|mesh-ancestor
93227440|NCT03231371|Sensory System Agents|sensory system agents|mesh-ancestor
93227441|NCT03231371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227442|NCT03231371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227443|NCT03231371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93227444|NCT03231371|Vasodilator Agents|vasodilator agents|mesh-ancestor
93227445|NCT03231371|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93227446|NCT03231371|Purinergic Agonists|purinergic agonists|mesh-ancestor
93227447|NCT03231371|Purinergic Agents|purinergic agents|mesh-ancestor
93227448|NCT03231371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227449|NCT03231371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227450|NCT03663114|Lenvatinib|lenvatinib|mesh-list
93227451|NCT03663114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227452|NCT03663114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227453|NCT03663114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227454|NCT03663114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227455|NCT03526679|Lenvatinib|lenvatinib|mesh-list
93227456|NCT03526679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227457|NCT03526679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227458|NCT03526679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227459|NCT03526679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227460|NCT04057326|Pancreatin|pancreatin|mesh-list
93227461|NCT04057326|Pancrelipase|pancrelipase|mesh-list
93227462|NCT04057326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227463|NCT02870348|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93227464|NCT02870348|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93227465|NCT02870348|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93227466|NCT02870348|Protease Inhibitors|protease inhibitors|mesh-ancestor
93227467|NCT02870348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227468|NCT02870348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227469|NCT05384210|Gabapentin|gabapentin|mesh-list
93227470|NCT05384210|Milnacipran|milnacipran|mesh-list
93227471|NCT05384210|Levomilnacipran|levomilnacipran|mesh-list
93227472|NCT05384210|Analgesics|analgesics|mesh-ancestor
93227473|NCT05384210|Sensory System Agents|sensory system agents|mesh-ancestor
93227474|NCT05384210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227475|NCT05384210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227476|NCT05384210|Anticonvulsants|anticonvulsants|mesh-ancestor
93227477|NCT05384210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93227478|NCT05384210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93227479|NCT05384210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227480|NCT05384210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93227481|NCT05384210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93227482|NCT05384210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93227483|NCT05384210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227484|NCT05384210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227485|NCT05384210|Antimanic Agents|antimanic agents|mesh-ancestor
93227486|NCT05384210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93227487|NCT05384210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93227488|NCT05384210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227489|NCT05384210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227490|NCT05384210|Antidepressive Agents|antidepressive agents|mesh-ancestor
93227491|NCT02032394|Chlorhexidine|chlorhexidine|mesh-list
93227492|NCT02032394|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93227493|NCT02032394|Povidone-Iodine|povidone-iodine|mesh-list
93227494|NCT02032394|Povidone|povidone|mesh-list
93227495|NCT02032394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93227497|NCT02032394|Disinfectants|disinfectants|mesh-ancestor
93227498|NCT02032394|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227499|NCT02032394|Plasma Substitutes|plasma substitutes|mesh-ancestor
93227500|NCT02032394|Blood Substitutes|blood substitutes|mesh-ancestor
93227501|NCT03239483|Dapivirine|dapivirine|mesh-list
93227502|NCT03239483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93227503|NCT03239483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93227504|NCT03239483|Antiviral Agents|antiviral agents|mesh-ancestor
93227505|NCT03239483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227506|NCT01068912|Favipiravir|favipiravir|mesh-list
93227507|NCT01068912|Antiviral Agents|antiviral agents|mesh-ancestor
93227508|NCT01068912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227509|NCT04056702|Ivacaftor|ivacaftor|mesh-list
93227510|NCT04056702|Elexacaftor|elexacaftor|mesh-list
93227511|NCT04056702|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93227512|NCT04056702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227513|NCT04056702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227514|NCT03662100|Mirikizumab|mirikizumab|mesh-list
93227515|NCT03662100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227516|NCT03662100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227517|NCT03662100|Analgesics|analgesics|mesh-ancestor
93227518|NCT03662100|Sensory System Agents|sensory system agents|mesh-ancestor
93227519|NCT03662100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227520|NCT03662100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227521|NCT03662100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227522|NCT03662100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227523|NCT03662100|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93227524|NCT03662100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227525|NCT03612440|Dexmedetomidine|dexmedetomidine|mesh-list
93227526|NCT03612440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93227527|NCT03612440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227528|NCT03612440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227529|NCT03612440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227530|NCT03612440|Analgesics|analgesics|mesh-ancestor
93227531|NCT03612440|Sensory System Agents|sensory system agents|mesh-ancestor
93227532|NCT03612440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227533|NCT03612440|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93227534|NCT03612440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93227535|NCT03612440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93227536|NCT03612440|Adrenergic Agents|adrenergic agents|mesh-ancestor
93227537|NCT03612440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227538|NCT03612440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227539|NCT03662724|Venetoclax|venetoclax|mesh-list
93227540|NCT03662724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227541|NCT03662568|Ritonavir|ritonavir|mesh-list
93227542|NCT03662568|Tenofovir|tenofovir|mesh-list
93227543|NCT03662568|Entecavir|entecavir|mesh-list
93227544|NCT03662568|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93227545|NCT03662568|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93227546|NCT03662568|Protease Inhibitors|protease inhibitors|mesh-ancestor
93227547|NCT03662568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227548|NCT03662568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227549|NCT03662568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93227550|NCT03662568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93227551|NCT03662568|Antiviral Agents|antiviral agents|mesh-ancestor
93227552|NCT03662568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227553|NCT03662568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93227554|NCT03662568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93227555|NCT03662568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93227556|NCT03662568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93227557|NCT02993250|Simeprevir|simeprevir|mesh-list
93227558|NCT02993250|Odalasvir|odalasvir|mesh-list
93227559|NCT02993250|Antiviral Agents|antiviral agents|mesh-ancestor
93227560|NCT02993250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227561|NCT02993250|Protease Inhibitors|protease inhibitors|mesh-ancestor
93227562|NCT02993250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227563|NCT02993250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227564|NCT03661788|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93227565|NCT03661788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93227566|NCT03661788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93227567|NCT03661788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227568|NCT03661788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227569|NCT03661788|Adrenergic Agents|adrenergic agents|mesh-ancestor
93227570|NCT03661788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227571|NCT03661788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227572|NCT05383820|Ketorolac|ketorolac|mesh-list
93227573|NCT05383820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227574|NCT05383820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227575|NCT05383820|Analgesics|analgesics|mesh-ancestor
93227576|NCT05383820|Sensory System Agents|sensory system agents|mesh-ancestor
93227577|NCT05383820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227578|NCT05383820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227579|NCT05383820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227580|NCT05383820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227581|NCT05383820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93227582|NCT05383820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227583|NCT05383820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227584|NCT03611504|Hemostatics|hemostatics|mesh-list
93227585|NCT03611504|Coagulants|coagulants|mesh-ancestor
93227586|NCT02954510|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93227587|NCT02954510|Hematinics|hematinics|mesh-ancestor
93227588|NCT02954510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93227589|NCT02954510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93227590|NCT02032784|Octreotide|octreotide|mesh-list
93227591|NCT02032784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227592|NCT02032784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93227593|NCT02032784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227594|NCT03611426|Thrombin|thrombin|mesh-list
93227595|NCT03611426|Hemostatics|hemostatics|mesh-ancestor
93227596|NCT03611426|Coagulants|coagulants|mesh-ancestor
93227597|NCT03658746|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93227598|NCT03658746|Amoxicillin|amoxicillin|mesh-list
93227599|NCT03658746|Metronidazole|metronidazole|mesh-list
93227600|NCT03658746|Clarithromycin|clarithromycin|mesh-list
93227601|NCT03658746|Levofloxacin|levofloxacin|mesh-list
93227602|NCT03658746|Ofloxacin|ofloxacin|mesh-list
93227603|NCT03658746|Tetracycline|tetracycline|mesh-list
93227604|NCT03658746|Tinidazole|tinidazole|mesh-list
93227605|NCT03658746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93227606|NCT03658746|Furazolidone|furazolidone|mesh-list
93227607|NCT03658746|Bismuth|bismuth|mesh-list
93227608|NCT03658746|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93227609|NCT03658746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227610|NCT03658746|Antitubercular Agents|antitubercular agents|mesh-ancestor
93227611|NCT03658746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93227612|NCT03658746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93227613|NCT03658746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93227614|NCT03658746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227615|NCT03658746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227616|NCT03658746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93227617|NCT03658746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93227618|NCT03658746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93227619|NCT03658746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93227620|NCT03658746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93227621|NCT03658746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227622|NCT03658746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93227623|NCT03658746|Antacids|antacids|mesh-ancestor
93227624|NCT03658746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227625|NCT03658746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93227626|NCT03658746|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93227627|NCT03658746|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93227628|NCT03658746|Alkylating Agents|alkylating agents|mesh-ancestor
93227629|NCT02990910|Analgesics, Opioid|analgesics, opioid|mesh-list
93227630|NCT02990910|Narcotics|narcotics|mesh-ancestor
93227631|NCT02990910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227632|NCT02990910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227633|NCT02990910|Analgesics|analgesics|mesh-ancestor
93227634|NCT02990910|Sensory System Agents|sensory system agents|mesh-ancestor
93227635|NCT02990910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227636|NCT04056000|Caffeine|caffeine|mesh-list
93227637|NCT04056000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93227638|NCT04056000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227639|NCT04056000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93227640|NCT04056000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227641|NCT04056000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227642|NCT04056000|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93227643|NCT04056000|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93227644|NCT04056000|Purinergic Agents|purinergic agents|mesh-ancestor
93227645|NCT04056000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227646|NCT03611348|Latanoprost|latanoprost|mesh-list
93227647|NCT03611348|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93227648|NCT03611348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93227649|NCT02033018|Aflibercept|aflibercept|mesh-list
93227650|NCT02033018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93227651|NCT02033018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93227652|NCT02033018|Growth Substances|growth substances|mesh-ancestor
93227653|NCT02033018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227654|NCT02033018|Growth Inhibitors|growth inhibitors|mesh-ancestor
93227655|NCT02033018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227656|NCT03155100|Dexamethasone|dexamethasone|mesh-list
93227657|NCT03155100|Elotuzumab|elotuzumab|mesh-list
93227658|NCT03155100|Proteasome Inhibitors|proteasome inhibitors|mesh-list
93227659|NCT03155100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227660|NCT03155100|Antiemetics|antiemetics|mesh-ancestor
93227661|NCT03155100|Autonomic Agents|autonomic agents|mesh-ancestor
93227662|NCT03155100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227663|NCT03155100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227664|NCT03155100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227665|NCT03155100|Glucocorticoids|glucocorticoids|mesh-ancestor
93227666|NCT03155100|Hormones|hormones|mesh-ancestor
93227667|NCT03155100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93227668|NCT03155100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93227669|NCT03155100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227670|NCT03155100|Protease Inhibitors|protease inhibitors|mesh-ancestor
93227671|NCT03155100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227672|NCT03155100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227673|NCT02033096|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
93227674|NCT02033096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227675|NCT02033096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227676|NCT03658590|Dexamethasone|dexamethasone|mesh-list
93227677|NCT03658590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227678|NCT03658590|Antiemetics|antiemetics|mesh-ancestor
93227679|NCT03658590|Autonomic Agents|autonomic agents|mesh-ancestor
93227680|NCT03658590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227681|NCT03658590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227682|NCT03658590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227683|NCT03658590|Glucocorticoids|glucocorticoids|mesh-ancestor
93227684|NCT03658590|Hormones|hormones|mesh-ancestor
93227685|NCT03658590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93227686|NCT03658590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93227687|NCT03658590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227688|NCT03428945|Hydroxychloroquine|hydroxychloroquine|mesh-list
93227689|NCT03428945|Antimalarials|antimalarials|mesh-ancestor
93227690|NCT03428945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93227691|NCT03428945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93227692|NCT03428945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227693|NCT03428945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227694|NCT03428945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227695|NCT03428945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227696|NCT03208127|Antiviral Agents|antiviral agents|mesh-list
93227697|NCT03208127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227698|NCT03941093|Leucovorin|leucovorin|mesh-list
93227699|NCT03941093|Paclitaxel|paclitaxel|mesh-list
93227700|NCT03941093|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93227701|NCT03941093|Gemcitabine|gemcitabine|mesh-list
93227702|NCT03941093|Irinotecan|irinotecan|mesh-list
93227703|NCT03941093|Fluorouracil|fluorouracil|mesh-list
93227704|NCT03941093|Folfirinox|folfirinox|mesh-list
93227705|NCT03941093|Levoleucovorin|levoleucovorin|mesh-list
93227706|NCT03941093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93227707|NCT03941093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227708|NCT03941093|Tubulin Modulators|tubulin modulators|mesh-ancestor
93227709|NCT03941093|Antimitotic Agents|antimitotic agents|mesh-ancestor
93227710|NCT03941093|Mitosis Modulators|mitosis modulators|mesh-ancestor
93227711|NCT03941093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227712|NCT03941093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93227713|NCT03941093|Antimetabolites|antimetabolites|mesh-ancestor
93227714|NCT03941093|Antidotes|antidotes|mesh-ancestor
93227715|NCT03941093|Protective Agents|protective agents|mesh-ancestor
93227716|NCT03941093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227717|NCT03941093|Vitamin B Complex|vitamin b complex|mesh-ancestor
93227718|NCT03941093|Vitamins|vitamins|mesh-ancestor
93227719|NCT03941093|Micronutrients|micronutrients|mesh-ancestor
93227720|NCT03941093|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93227721|NCT03941093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93227722|NCT03941093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227723|NCT03941093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227724|NCT03941093|Immunologic Factors|immunologic factors|mesh-ancestor
93227725|NCT02033408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93227727|NCT02033408|Metronidazole|metronidazole|mesh-list
93227728|NCT02033408|Vancomycin|vancomycin|mesh-list
93227729|NCT02033408|Doxycycline|doxycycline|mesh-list
93227730|NCT02033408|Ciprofloxacin|ciprofloxacin|mesh-list
93227731|NCT02033408|Gentamicins|gentamicins|mesh-list
93227732|NCT02033408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227733|NCT02033408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93227734|NCT02033408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93227735|NCT02033408|Antimalarials|antimalarials|mesh-ancestor
93227736|NCT02033408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93227737|NCT02033408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93227738|NCT02033408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227739|NCT02033408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227740|NCT02033408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227741|NCT02033408|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93227742|NCT02033408|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93227743|NCT02033408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93227744|NCT03610880|Yimitasvir|yimitasvir|mesh-list
93227745|NCT03610880|Antiviral Agents|antiviral agents|mesh-ancestor
93227746|NCT03610880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227747|NCT02097121|Botulinum Toxins|botulinum toxins|mesh-list
93227748|NCT02097121|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93227749|NCT02097121|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93227750|NCT02097121|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93227751|NCT02097121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227752|NCT02097121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227753|NCT02097121|Cholinergic Agents|cholinergic agents|mesh-ancestor
93227754|NCT02097121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227755|NCT02097121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227756|NCT02097121|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93227757|NCT02097121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227758|NCT02075671|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93227759|NCT02075671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93227760|NCT02075671|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227761|NCT02560298|Paclitaxel|paclitaxel|mesh-list
93227762|NCT02560298|Cisplatin|cisplatin|mesh-list
93227763|NCT02560298|Carboplatin|carboplatin|mesh-list
93227764|NCT02560298|Fluorouracil|fluorouracil|mesh-list
93227765|NCT02560298|Capecitabine|capecitabine|mesh-list
93227766|NCT02560298|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93227767|NCT02560298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93227768|NCT02560298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227769|NCT02560298|Tubulin Modulators|tubulin modulators|mesh-ancestor
93227770|NCT02560298|Antimitotic Agents|antimitotic agents|mesh-ancestor
93227771|NCT02560298|Mitosis Modulators|mitosis modulators|mesh-ancestor
93227772|NCT02560298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227773|NCT02560298|Antimetabolites|antimetabolites|mesh-ancestor
93227774|NCT02560298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93227775|NCT02560298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227776|NCT02560298|Immunologic Factors|immunologic factors|mesh-ancestor
93227777|NCT02560298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227778|NCT01330615|Lidocaine|lidocaine|mesh-list
93227779|NCT01330615|Prilocaine|prilocaine|mesh-list
93227780|NCT01330615|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93227781|NCT01330615|Anesthetics, Local|anesthetics, local|mesh-ancestor
93227782|NCT01330615|Anesthetics|anesthetics|mesh-ancestor
93227783|NCT01330615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227784|NCT01330615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227785|NCT01330615|Sensory System Agents|sensory system agents|mesh-ancestor
93227786|NCT01330615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227787|NCT01330615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93227788|NCT01330615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93227789|NCT01330615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93227790|NCT01330615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227791|NCT01330615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227792|NCT01330615|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93227793|NCT05034029|Metformin|metformin|mesh-list
93227794|NCT05034029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93227795|NCT05034029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227796|NCT03237065|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93227797|NCT03237065|Hematinics|hematinics|mesh-ancestor
93227798|NCT03620461|Gemcitabine|gemcitabine|mesh-list
93227799|NCT03620461|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93227800|NCT03620461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93227801|NCT03620461|Antimetabolites|antimetabolites|mesh-ancestor
93227802|NCT03620461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227803|NCT03620461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227804|NCT01314781|Solifenacin Succinate|solifenacin succinate|mesh-list
93227805|NCT01314781|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93227806|NCT01314781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93227807|NCT01314781|Cholinergic Agents|cholinergic agents|mesh-ancestor
93227808|NCT01314781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227809|NCT01314781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227810|NCT01314781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227811|NCT01314781|Urological Agents|urological agents|mesh-ancestor
93227812|NCT01330693|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93227813|NCT01330693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93227814|NCT01330693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93227815|NCT01330693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93227816|NCT01330693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227817|NCT01330693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93227818|NCT01330693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227819|NCT01330693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227820|NCT04377451|Metformin|metformin|mesh-list
93227821|NCT04377451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93227822|NCT04377451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227823|NCT02863328|Empagliflozin|empagliflozin|mesh-list
93227824|NCT02863328|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93227825|NCT02863328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227826|NCT02863328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93227827|NCT02863328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227828|NCT03040141|Oseltamivir|oseltamivir|mesh-list
93227829|NCT03040141|Antiviral Agents|antiviral agents|mesh-ancestor
93227830|NCT03040141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227831|NCT03040141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227832|NCT03040141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227833|NCT02937701|Infliximab|infliximab|mesh-list
93227834|NCT02937701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93227835|NCT02937701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227836|NCT02937701|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227837|NCT02937701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227838|NCT02937701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227839|NCT05186623|Ustekinumab|ustekinumab|mesh-list
93227840|NCT05186623|Vedolizumab|vedolizumab|mesh-list
93227841|NCT05186623|Tofacitinib|tofacitinib|mesh-list
93227842|NCT05186623|Dermatologic Agents|dermatologic agents|mesh-ancestor
93227843|NCT05186623|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93227844|NCT05186623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227845|NCT05186623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227846|NCT05186623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227847|NCT05186623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227848|NCT04602845|Flurbiprofen|flurbiprofen|mesh-list
93227849|NCT04602845|Fentanyl|fentanyl|mesh-list
93227850|NCT04602845|Midazolam|midazolam|mesh-list
93227851|NCT04602845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93227852|NCT04602845|Narcotics|narcotics|mesh-ancestor
93227853|NCT04602845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227854|NCT04602845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227855|NCT04602845|Analgesics|analgesics|mesh-ancestor
93227856|NCT04602845|Sensory System Agents|sensory system agents|mesh-ancestor
93227857|NCT04602845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227858|NCT04602845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93227859|NCT04602845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93227860|NCT04602845|Anesthetics, General|anesthetics, general|mesh-ancestor
93227861|NCT04602845|Anesthetics|anesthetics|mesh-ancestor
93227862|NCT04602845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93227863|NCT04602845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93227864|NCT04602845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93227865|NCT04602845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93227866|NCT04602845|GABA Modulators|gaba modulators|mesh-ancestor
93227867|NCT04602845|GABA Agents|gaba agents|mesh-ancestor
93227868|NCT04602845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227869|NCT04602845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227870|NCT04602845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227871|NCT04602845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227872|NCT04602845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227873|NCT04602845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227874|NCT04602845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93227875|NCT04602845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227876|NCT04966325|Moxifloxacin|moxifloxacin|mesh-list
93227877|NCT04966325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93227878|NCT04966325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227879|NCT04966325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93227880|NCT04966325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93227881|NCT04966325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227882|NCT04966325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227883|NCT04966325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227884|NCT03168919|Temozolomide|temozolomide|mesh-list
93227885|NCT03168919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93227886|NCT03168919|Alkylating Agents|alkylating agents|mesh-ancestor
93227887|NCT03168919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227888|NCT03168919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227889|NCT03205163|Factor VIII|factor viii|mesh-list
93227890|NCT03205163|Coagulants|coagulants|mesh-ancestor
93227891|NCT03638947|Povidone-Iodine|povidone-iodine|mesh-list
93227892|NCT03638947|Povidone|povidone|mesh-list
93227893|NCT03638947|Plasma Substitutes|plasma substitutes|mesh-ancestor
93227894|NCT03638947|Blood Substitutes|blood substitutes|mesh-ancestor
93227895|NCT03638947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93227896|NCT03638947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227897|NCT03502681|Avelumab|avelumab|mesh-list
93227898|NCT03502681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227899|NCT03502681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227900|NCT04938817|Pembrolizumab|pembrolizumab|mesh-list
93227901|NCT04938817|Lenvatinib|lenvatinib|mesh-list
93227902|NCT04938817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93227903|NCT04938817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93227904|NCT04938817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93227905|NCT04938817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227906|NCT04938817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227907|NCT04938817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227908|NCT00788671|Levonorgestrel|levonorgestrel|mesh-list
93227909|NCT00788671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93227910|NCT00788671|Contraceptive Agents|contraceptive agents|mesh-ancestor
93227911|NCT00788671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93227912|NCT00788671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227913|NCT00788671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93227914|NCT00788671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93227915|NCT00788671|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93227916|NCT03636373|Triamcinolone|triamcinolone|mesh-list
93227917|NCT03636373|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93227918|NCT03636373|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93227919|NCT03636373|Etanercept|etanercept|mesh-list
93227920|NCT03636373|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93227921|NCT03636373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227922|NCT03636373|Glucocorticoids|glucocorticoids|mesh-ancestor
93227923|NCT03636373|Hormones|hormones|mesh-ancestor
93227924|NCT03636373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93227925|NCT03636373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227926|NCT03636373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227927|NCT03636373|Immunologic Factors|immunologic factors|mesh-ancestor
93227928|NCT03636373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227929|NCT03636373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227930|NCT03636373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227931|NCT03636373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227932|NCT03636373|Analgesics|analgesics|mesh-ancestor
93227933|NCT03636373|Sensory System Agents|sensory system agents|mesh-ancestor
93227934|NCT03636373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227935|NCT03636373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227936|NCT03636373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227937|NCT04485325|Etanercept|etanercept|mesh-list
93227938|NCT04485325|Tofacitinib|tofacitinib|mesh-list
93227939|NCT04485325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93227940|NCT04485325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93227941|NCT04485325|Analgesics|analgesics|mesh-ancestor
93227942|NCT04485325|Sensory System Agents|sensory system agents|mesh-ancestor
93227943|NCT04485325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227944|NCT04485325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227945|NCT04485325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93227946|NCT04485325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93227947|NCT04485325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227948|NCT04485325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93227949|NCT04485325|Immunologic Factors|immunologic factors|mesh-ancestor
93227950|NCT04485325|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93227951|NCT04485325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93227952|NCT04485325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227953|NCT04485325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227954|NCT03610178|Insulin|insulin|mesh-list
93227955|NCT03610178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93227956|NCT03610178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93227957|NCT03610178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227958|NCT02033798|Tamsulosin|tamsulosin|mesh-list
93227959|NCT02033798|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93227960|NCT02033798|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93227961|NCT02033798|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93227962|NCT02033798|Adrenergic Agents|adrenergic agents|mesh-ancestor
93227963|NCT02033798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93227964|NCT02033798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227965|NCT02033798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227966|NCT02033798|Urological Agents|urological agents|mesh-ancestor
93227967|NCT02887183|Valsartan|valsartan|mesh-list
93227968|NCT02887183|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93227969|NCT02887183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93227970|NCT02887183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93227971|NCT02887183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93227972|NCT02887183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227973|NCT03660306|Analgesics, Opioid|analgesics, opioid|mesh-list
93227974|NCT03660306|Anesthetics|anesthetics|mesh-list
93227975|NCT03660306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93227976|NCT03660306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227977|NCT03660306|Narcotics|narcotics|mesh-ancestor
93227978|NCT03660306|Analgesics|analgesics|mesh-ancestor
93227979|NCT03660306|Sensory System Agents|sensory system agents|mesh-ancestor
93227980|NCT03660306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93227981|NCT01067352|Hormones|hormones|mesh-list
93227982|NCT01067352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93227983|NCT01067352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93227984|NCT02920242|Rifaximin|rifaximin|mesh-list
93227985|NCT02920242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93227986|NCT02920242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227987|NCT02920242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93227988|NCT02985996|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93227989|NCT02985996|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93227990|NCT02985996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93227991|NCT02985996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93227992|NCT02985996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93227993|NCT02985996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93227994|NCT02985996|Antiviral Agents|antiviral agents|mesh-ancestor
93227995|NCT02985996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93227996|NCT02985996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93227997|NCT02985996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93227998|NCT03203447|Triamcinolone|triamcinolone|mesh-list
93227999|NCT03203447|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93228000|NCT03203447|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93228001|NCT03203447|Bevacizumab|bevacizumab|mesh-list
93228002|NCT03203447|Ranibizumab|ranibizumab|mesh-list
93228003|NCT03203447|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93228004|NCT03203447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228005|NCT03203447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228006|NCT03203447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93228007|NCT03203447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93228008|NCT03203447|Growth Substances|growth substances|mesh-ancestor
93228009|NCT03203447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228010|NCT03203447|Growth Inhibitors|growth inhibitors|mesh-ancestor
93228011|NCT03203447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228012|NCT03203447|Glucocorticoids|glucocorticoids|mesh-ancestor
93228013|NCT03203447|Hormones|hormones|mesh-ancestor
93228014|NCT03203447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93228015|NCT03203447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228016|NCT03203447|Immunologic Factors|immunologic factors|mesh-ancestor
93228017|NCT03203447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228018|NCT03203447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228019|NCT01068678|Insulin|insulin|mesh-list
93228020|NCT01068678|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93228021|NCT01068678|Insulin Glargine|insulin glargine|mesh-list
93228022|NCT01068678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93228023|NCT01068678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228024|NCT03202511|Tenofovir|tenofovir|mesh-list
93228025|NCT03202511|Emtricitabine|emtricitabine|mesh-list
93228026|NCT03202511|Probenecid|probenecid|mesh-list
93228027|NCT03202511|Antiviral Agents|antiviral agents|mesh-ancestor
93228028|NCT03202511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228029|NCT03202511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93228030|NCT03202511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93228031|NCT03202511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228032|NCT03202511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228033|NCT03202511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93228034|NCT03202511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93228035|NCT03202511|Uricosuric Agents|uricosuric agents|mesh-ancestor
93228036|NCT03202511|Gout Suppressants|gout suppressants|mesh-ancestor
93228037|NCT03202511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228038|NCT03637049|Midazolam|midazolam|mesh-list
93228039|NCT03637049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93228040|NCT03637049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93228041|NCT03637049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228042|NCT03637049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228043|NCT03637049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93228044|NCT03637049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93228045|NCT03637049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93228046|NCT03637049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93228047|NCT03637049|Anesthetics, General|anesthetics, general|mesh-ancestor
93228048|NCT03637049|Anesthetics|anesthetics|mesh-ancestor
93228049|NCT03637049|GABA Modulators|gaba modulators|mesh-ancestor
93228050|NCT03637049|GABA Agents|gaba agents|mesh-ancestor
93228051|NCT03637049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228052|NCT03637049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228053|NCT03636971|Mannitol|mannitol|mesh-list
93228054|NCT03636971|Sorbitol|sorbitol|mesh-list
93228055|NCT03636971|Hyaluronic Acid|hyaluronic acid|mesh-list
93228056|NCT03636971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93228057|NCT03636971|Immunologic Factors|immunologic factors|mesh-ancestor
93228058|NCT03636971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228059|NCT03636971|Viscosupplements|viscosupplements|mesh-ancestor
93228060|NCT03636971|Protective Agents|protective agents|mesh-ancestor
93228061|NCT03636971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93228062|NCT03636971|Diuretics|diuretics|mesh-ancestor
93228063|NCT03636971|Natriuretic Agents|natriuretic agents|mesh-ancestor
93228064|NCT03636971|Cathartics|cathartics|mesh-ancestor
93228065|NCT03636971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228066|NCT03610100|Gemcitabine|gemcitabine|mesh-list
93228067|NCT03610100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93228068|NCT03610100|Antimetabolites|antimetabolites|mesh-ancestor
93228069|NCT03610100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228070|NCT03610100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228071|NCT03657966|Paclitaxel|paclitaxel|mesh-list
93228072|NCT03657966|Carboplatin|carboplatin|mesh-list
93228073|NCT03657966|Gemcitabine|gemcitabine|mesh-list
93228074|NCT03657966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93228075|NCT03657966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228076|NCT03657966|Tubulin Modulators|tubulin modulators|mesh-ancestor
93228077|NCT03657966|Antimitotic Agents|antimitotic agents|mesh-ancestor
93228078|NCT03657966|Mitosis Modulators|mitosis modulators|mesh-ancestor
93228079|NCT03657966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228080|NCT03657966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93228081|NCT03657966|Antimetabolites|antimetabolites|mesh-ancestor
93228082|NCT03659292|Anesthetics|anesthetics|mesh-list
93228083|NCT03659292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228084|NCT03659292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228085|NCT03659058|Colchicine|colchicine|mesh-list
93228086|NCT03659058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93228087|NCT03659058|Antioxidants|antioxidants|mesh-list
93228088|NCT03659058|Silymarin|silymarin|mesh-list
93228089|NCT03659058|Gout Suppressants|gout suppressants|mesh-ancestor
93228090|NCT03659058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228091|NCT03659058|Tubulin Modulators|tubulin modulators|mesh-ancestor
93228092|NCT03659058|Antimitotic Agents|antimitotic agents|mesh-ancestor
93228093|NCT03659058|Mitosis Modulators|mitosis modulators|mesh-ancestor
93228094|NCT03659058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228095|NCT03659058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228096|NCT03659058|Protective Agents|protective agents|mesh-ancestor
93228097|NCT03659058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545690|NCT03957057|Iron|iron|mesh-list
93228098|NCT03659058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93228099|NCT03659058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228100|NCT03635905|Gabapentin|gabapentin|mesh-list
93228101|NCT03635905|Analgesics|analgesics|mesh-ancestor
93228102|NCT03635905|Sensory System Agents|sensory system agents|mesh-ancestor
93228103|NCT03635905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228104|NCT03635905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228105|NCT03635905|Anticonvulsants|anticonvulsants|mesh-ancestor
93228106|NCT03635905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93228107|NCT03635905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91930377|NCT02288923|Antiemetics|antiemetics|mesh-list
93228108|NCT03635905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228109|NCT03635905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93228110|NCT03635905|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93228111|NCT03635905|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93228112|NCT03635905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228113|NCT03635905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228114|NCT03635905|Antimanic Agents|antimanic agents|mesh-ancestor
93228115|NCT02960113|Scopolamine|scopolamine|mesh-list
93228116|NCT02960113|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93228117|NCT02960113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93228118|NCT02960113|Antiemetics|antiemetics|mesh-ancestor
93228119|NCT02960113|Autonomic Agents|autonomic agents|mesh-ancestor
93228120|NCT02960113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228121|NCT02960113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228122|NCT02960113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228123|NCT02960113|Mydriatics|mydriatics|mesh-ancestor
93228124|NCT02960113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93228125|NCT02960113|Cholinergic Agents|cholinergic agents|mesh-ancestor
93228126|NCT02960113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228127|NCT02960113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228128|NCT02960113|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93228129|NCT02960113|Parasympatholytics|parasympatholytics|mesh-ancestor
93228130|NCT04458324|Buspirone|buspirone|mesh-list
93228131|NCT04458324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93228132|NCT04458324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93228133|NCT04458324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228134|NCT04458324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228135|NCT04458324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93228136|NCT04458324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93228137|NCT04458324|Serotonin Agents|serotonin agents|mesh-ancestor
93228138|NCT04458324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228139|NCT04458324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228140|NCT03657420|Dexamethasone|dexamethasone|mesh-list
93228141|NCT03657420|Pomalidomide|pomalidomide|mesh-list
93228142|NCT03657420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228143|NCT03657420|Antiemetics|antiemetics|mesh-ancestor
93228144|NCT03657420|Autonomic Agents|autonomic agents|mesh-ancestor
93228145|NCT03657420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228146|NCT03657420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228147|NCT03657420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228148|NCT03657420|Glucocorticoids|glucocorticoids|mesh-ancestor
93228149|NCT03657420|Hormones|hormones|mesh-ancestor
93228150|NCT03657420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93228151|NCT03657420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93228152|NCT03657420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228153|NCT03657420|Immunologic Factors|immunologic factors|mesh-ancestor
93228154|NCT03657420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93228155|NCT03657420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93228156|NCT03657420|Growth Substances|growth substances|mesh-ancestor
93228157|NCT03657420|Growth Inhibitors|growth inhibitors|mesh-ancestor
93228158|NCT02984982|Anticoagulants|anticoagulants|mesh-list
93228159|NCT02984982|Atorvastatin|atorvastatin|mesh-list
93228160|NCT02984982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93228161|NCT02984982|Ezetimibe|ezetimibe|mesh-list
93228162|NCT02984982|Alirocumab|alirocumab|mesh-list
93228163|NCT02984982|Fenofibrate|fenofibrate|mesh-list
93228164|NCT02984982|Bezafibrate|bezafibrate|mesh-list
93228165|NCT02984982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93228166|NCT02984982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93228167|NCT02984982|Antimetabolites|antimetabolites|mesh-ancestor
93228168|NCT02984982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228169|NCT02984982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93228170|NCT02984982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93228171|NCT02984982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228172|NCT02984982|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93228173|NCT02984982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93228174|NCT02984982|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228175|NCT03656484|Metronidazole|metronidazole|mesh-list
93228176|NCT03656484|Tetracycline|tetracycline|mesh-list
93228177|NCT03656484|Melatonin|melatonin|mesh-list
93228178|NCT03656484|Hyaluronic Acid|hyaluronic acid|mesh-list
93228179|NCT03656484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228180|NCT03656484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93228181|NCT03656484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93228182|NCT03656484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93228183|NCT03656484|Antioxidants|antioxidants|mesh-ancestor
93228184|NCT03656484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228185|NCT03656484|Protective Agents|protective agents|mesh-ancestor
93228186|NCT03656484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228187|NCT03656484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228188|NCT03656484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93228189|NCT03656484|Immunologic Factors|immunologic factors|mesh-ancestor
93228190|NCT03656484|Viscosupplements|viscosupplements|mesh-ancestor
93228191|NCT03656484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93228192|NCT03656484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228193|NCT04309578|Capecitabine|capecitabine|mesh-list
93228194|NCT04309578|Trastuzumab|trastuzumab|mesh-list
93228195|NCT04309578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228196|NCT04309578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93228197|NCT04309578|Antimetabolites|antimetabolites|mesh-ancestor
93228198|NCT04309578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228199|NCT04309578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228200|NCT03656952|Moxifloxacin|moxifloxacin|mesh-list
93228201|NCT03656952|PF-06700841|pf-06700841|mesh-list
93228202|NCT03656952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93228203|NCT03656952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228204|NCT03656952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93228205|NCT03656952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93228206|NCT03656952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228207|NCT03656952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228208|NCT03656952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228209|NCT03656952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93228210|NCT02981472|Vitamin K|vitamin k|mesh-list
93228211|NCT02981472|Heparin|heparin|mesh-list
93228212|NCT02981472|Enoxaparin|enoxaparin|mesh-list
93228213|NCT02981472|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93228214|NCT02981472|Tinzaparin|tinzaparin|mesh-list
93228215|NCT02981472|Dalteparin|dalteparin|mesh-list
93228216|NCT02981472|Warfarin|warfarin|mesh-list
93228217|NCT02981472|Apixaban|apixaban|mesh-list
93228218|NCT02981472|Vitamins|vitamins|mesh-ancestor
93228219|NCT02981472|Micronutrients|micronutrients|mesh-ancestor
93228220|NCT02981472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228221|NCT02981472|Anticoagulants|anticoagulants|mesh-ancestor
93228222|NCT02981472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93228223|NCT02981472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93228224|NCT02981472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228225|NCT02981472|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93228226|NCT02981472|Antithrombins|antithrombins|mesh-ancestor
93228227|NCT02981472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93228228|NCT02981472|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228229|NCT02981472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228230|NCT02981472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93228231|NCT02981472|Hemostatics|hemostatics|mesh-ancestor
93228232|NCT02981472|Coagulants|coagulants|mesh-ancestor
93228233|NCT03656172|Chrysarobin|chrysarobin|mesh-list
93228234|NCT03656172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93228235|NCT03656172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93228236|NCT03656172|Analgesics|analgesics|mesh-ancestor
93228237|NCT03656172|Sensory System Agents|sensory system agents|mesh-ancestor
93228238|NCT03656172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228239|NCT03656172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228240|NCT03656172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228241|NCT03656172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228242|NCT03656094|Docetaxel|docetaxel|mesh-list
93228243|NCT03656094|Pembrolizumab|pembrolizumab|mesh-list
93228244|NCT03656094|Pemetrexed|pemetrexed|mesh-list
93228245|NCT03656094|Vinorelbine|vinorelbine|mesh-list
93228246|NCT03656094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228247|NCT03656094|Tubulin Modulators|tubulin modulators|mesh-ancestor
93228248|NCT03656094|Antimitotic Agents|antimitotic agents|mesh-ancestor
93228249|NCT03656094|Mitosis Modulators|mitosis modulators|mesh-ancestor
93228250|NCT03656094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228251|NCT03656094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228252|NCT03656094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93228253|NCT03656094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228254|NCT03656094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93228255|NCT03656094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93228256|NCT03656094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93228257|NCT04298034|Labetalol|labetalol|mesh-list
93228258|NCT04298034|Nifedipine|nifedipine|mesh-list
93228259|NCT04298034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93228260|NCT04298034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93228261|NCT04298034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228262|NCT04298034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93228263|NCT04298034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228264|NCT04298034|Vasodilator Agents|vasodilator agents|mesh-ancestor
93228265|NCT04298034|Tocolytic Agents|tocolytic agents|mesh-ancestor
93228266|NCT04298034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93228267|NCT04298034|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93228268|NCT04298034|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93228269|NCT04298034|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228270|NCT04298034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228271|NCT04298034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93228272|NCT04298034|Sympathomimetics|sympathomimetics|mesh-ancestor
93228273|NCT04298034|Autonomic Agents|autonomic agents|mesh-ancestor
93228274|NCT04298034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228275|NCT04298034|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93228276|NCT04298034|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93228277|NCT02982720|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93228278|NCT02982720|Pembrolizumab|pembrolizumab|mesh-list
93228279|NCT02982720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228280|NCT02982720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228281|NCT02982720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93228282|NCT02982720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228283|NCT02982720|Antiviral Agents|antiviral agents|mesh-ancestor
93228284|NCT02982720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228285|NCT00849667|Carboplatin|carboplatin|mesh-list
93228286|NCT00849667|Taxane|taxane|mesh-list
93228287|NCT00849667|Farletuzumab|farletuzumab|mesh-list
93228288|NCT00849667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228289|NCT03201419|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93228290|NCT03201419|Hemostatics|hemostatics|mesh-ancestor
93228291|NCT03201419|Coagulants|coagulants|mesh-ancestor
93228292|NCT03201419|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93228293|NCT03201419|Natriuretic Agents|natriuretic agents|mesh-ancestor
93228294|NCT03201419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228295|NCT01764633|Evolocumab|evolocumab|mesh-list
93228296|NCT01764633|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93228297|NCT01764633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93228298|NCT01764633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93228299|NCT01764633|Antimetabolites|antimetabolites|mesh-ancestor
93228300|NCT01764633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228301|NCT01764633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93228302|NCT01764633|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228303|NCT01764633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228304|NCT01764633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93228305|NCT02924389|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93228306|NCT02924389|Dolutegravir|dolutegravir|mesh-list
93228307|NCT02924389|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
93228308|NCT02924389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93228309|NCT02924389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93228310|NCT02924389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228311|NCT02924389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228312|NCT02924389|Antiviral Agents|antiviral agents|mesh-ancestor
93228313|NCT02924389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228314|NCT02924389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93228315|NCT02924389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93228316|NCT02924389|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93228317|NCT02924389|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93228318|NCT01315093|Heparin|heparin|mesh-list
93228319|NCT01315093|Calcium heparin|calcium heparin|mesh-list
93228320|NCT01315093|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93228321|NCT01315093|Tinzaparin|tinzaparin|mesh-list
93228322|NCT01315093|Dalteparin|dalteparin|mesh-list
93228323|NCT01315093|Anticoagulants|anticoagulants|mesh-ancestor
93228324|NCT01315093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93228325|NCT01315093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93228326|NCT01315093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228327|NCT01331707|Everolimus|everolimus|mesh-list
93228328|NCT01331707|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93228329|NCT01331707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93228330|NCT01331707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366392|NCT02796755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900438|NCT00641693|Budesonide|budesonide|mesh-list
93228331|NCT01331707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228332|NCT01331707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228333|NCT01331707|Immunologic Factors|immunologic factors|mesh-ancestor
93228334|NCT01331707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228335|NCT01331707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228336|NCT03953807|Dexamethasone|dexamethasone|mesh-list
93228337|NCT03953807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228338|NCT03953807|Antiemetics|antiemetics|mesh-ancestor
93228339|NCT03953807|Autonomic Agents|autonomic agents|mesh-ancestor
93228340|NCT03953807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228341|NCT03953807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228342|NCT03953807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228343|NCT03953807|Glucocorticoids|glucocorticoids|mesh-ancestor
93228344|NCT03953807|Hormones|hormones|mesh-ancestor
93228345|NCT03953807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93228346|NCT03953807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93228347|NCT03953807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228348|NCT03662711|Bronchodilator Agents|bronchodilator agents|mesh-list
93228349|NCT03662711|Olodaterol|olodaterol|mesh-list
93228350|NCT03662711|Autonomic Agents|autonomic agents|mesh-ancestor
93228351|NCT03662711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228352|NCT03662711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228353|NCT03662711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93228354|NCT03662711|Respiratory System Agents|respiratory system agents|mesh-ancestor
93228355|NCT02923531|Nivolumab|nivolumab|mesh-list
93228356|NCT02923531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228357|NCT02923531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228358|NCT02923531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93228359|NCT02923531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228360|NCT02934503|Carboplatin|carboplatin|mesh-list
93228361|NCT02934503|Pembrolizumab|pembrolizumab|mesh-list
93228362|NCT02934503|Etoposide|etoposide|mesh-list
93228363|NCT02934503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228364|NCT02934503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228365|NCT02934503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93228366|NCT02934503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228367|NCT02934503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93228368|NCT02934503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93228369|NCT02934503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93228370|NCT02934503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228371|NCT04563247|Antibodies|antibodies|mesh-list
93228372|NCT04563247|Immunologic Factors|immunologic factors|mesh-ancestor
93228373|NCT04563247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228374|NCT01314209|Dexmedetomidine|dexmedetomidine|mesh-list
93228375|NCT01314209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93228376|NCT01314209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228377|NCT01314209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228378|NCT01314209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93228379|NCT01314209|Analgesics|analgesics|mesh-ancestor
93228380|NCT01314209|Sensory System Agents|sensory system agents|mesh-ancestor
93228381|NCT01314209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228382|NCT01314209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93228383|NCT01314209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93228384|NCT01314209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93228385|NCT01314209|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228386|NCT01314209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228387|NCT01314209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228388|NCT05431075|Amoxicillin|amoxicillin|mesh-list
93228389|NCT05431075|Tetracycline|tetracycline|mesh-list
93228390|NCT05431075|Potassium Citrate|potassium citrate|mesh-list
93228391|NCT05431075|Esomeprazole|esomeprazole|mesh-list
93228392|NCT05431075|Bismuth|bismuth|mesh-list
93228393|NCT05431075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228394|NCT05431075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93228395|NCT05431075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228396|NCT05431075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93228397|NCT05431075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228398|NCT05431075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93228399|NCT05431075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228400|NCT05431075|Antacids|antacids|mesh-ancestor
93228401|NCT05431075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93228402|NCT05431075|Diuretics|diuretics|mesh-ancestor
93228403|NCT05431075|Natriuretic Agents|natriuretic agents|mesh-ancestor
93228404|NCT05431075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228405|NCT05431075|Expectorants|expectorants|mesh-ancestor
93228406|NCT05431075|Respiratory System Agents|respiratory system agents|mesh-ancestor
93228408|NCT03636659|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93228409|NCT03636659|Amebicides|amebicides|mesh-ancestor
93228410|NCT03636659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93228411|NCT03636659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93228412|NCT03636659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228413|NCT03636659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93228414|NCT03636659|Antifungal Agents|antifungal agents|mesh-ancestor
93228415|NCT04892173|Cetuximab|cetuximab|mesh-list
93228416|NCT04892173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228417|NCT04892173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228418|NCT03198767|Licogliflozin|licogliflozin|mesh-list
93228419|NCT03198767|Calcium Carbonate|calcium carbonate|mesh-list
93228420|NCT03198767|Psyllium|psyllium|mesh-list
93228421|NCT03198767|Calcium|calcium|mesh-list
93228422|NCT03198767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93228423|NCT03198767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228424|NCT03198767|Antacids|antacids|mesh-ancestor
93228425|NCT03198767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228426|NCT03198767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228427|NCT03198767|Cathartics|cathartics|mesh-ancestor
93228428|NCT03198767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93228429|NCT03198767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93228430|NCT03162055|Glycopyrrolate|glycopyrrolate|mesh-list
93228431|NCT03162055|Formoterol Fumarate|formoterol fumarate|mesh-list
93228432|NCT03162055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93228433|NCT03162055|Autonomic Agents|autonomic agents|mesh-ancestor
93228434|NCT03162055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228435|NCT03162055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228436|NCT03162055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93228437|NCT03162055|Respiratory System Agents|respiratory system agents|mesh-ancestor
93228438|NCT03162055|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93228439|NCT03162055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93228440|NCT03162055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93228441|NCT03162055|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228442|NCT03162055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228443|NCT03162055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228444|NCT03162055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93228445|NCT03162055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93228446|NCT03162055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93228447|NCT03162055|Cholinergic Agents|cholinergic agents|mesh-ancestor
93228448|NCT01331785|Midodrine|midodrine|mesh-list
93228449|NCT01331785|Sympathomimetics|sympathomimetics|mesh-ancestor
93228450|NCT01331785|Autonomic Agents|autonomic agents|mesh-ancestor
93228451|NCT01331785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228452|NCT01331785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228453|NCT01331785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93228454|NCT01331785|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93228455|NCT01331785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93228456|NCT01331785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93228457|NCT01331785|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228458|NCT01331785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228459|NCT01331785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228460|NCT01382589|Afamelanotide|afamelanotide|mesh-list
93228461|NCT01382589|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228462|NCT03671759|Caffeine|caffeine|mesh-list
93228463|NCT03671759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93228464|NCT03671759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228465|NCT03671759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93228466|NCT03671759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228467|NCT03671759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228468|NCT03671759|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93228469|NCT03671759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93228470|NCT03671759|Purinergic Agents|purinergic agents|mesh-ancestor
93228471|NCT03671759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228472|NCT01384227|Proflavine|proflavine|mesh-list
93228473|NCT01384227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93228474|NCT01384227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228475|NCT01382511|Simvastatin|simvastatin|mesh-list
93228476|NCT01382511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93228477|NCT01382511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93228478|NCT01382511|Antimetabolites|antimetabolites|mesh-ancestor
93228479|NCT01382511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228480|NCT01382511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93228481|NCT01382511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93228482|NCT01382511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228483|NCT03684447|Propofol|propofol|mesh-list
93228484|NCT03684447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93228485|NCT03684447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228486|NCT03684447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228487|NCT03684447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93228488|NCT03684447|Anesthetics, General|anesthetics, general|mesh-ancestor
93228489|NCT03684447|Anesthetics|anesthetics|mesh-ancestor
93228490|NCT04505059|Anesthetics|anesthetics|mesh-list
93228491|NCT04505059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228492|NCT04505059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228493|NCT01314599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93228494|NCT04217135|Hydralazine|hydralazine|mesh-list
93228495|NCT04217135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93228496|NCT04217135|Vasodilator Agents|vasodilator agents|mesh-ancestor
93228497|NCT01337401|Cediranib|cediranib|mesh-list
93228498|NCT01337401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228499|NCT01337401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93228500|NCT01337401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228501|NCT01337401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228502|NCT04178603|Insulin|insulin|mesh-list
93228503|NCT04178603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93228504|NCT04178603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228505|NCT01333891|Nitroprusside|nitroprusside|mesh-list
93228506|NCT01333891|Phenylephrine|phenylephrine|mesh-list
93228507|NCT01333891|Oxymetazoline|oxymetazoline|mesh-list
93228508|NCT01333891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93228509|NCT01333891|Mydriatics|mydriatics|mesh-ancestor
93228510|NCT01333891|Autonomic Agents|autonomic agents|mesh-ancestor
93228511|NCT01333891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228512|NCT01333891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228513|NCT01333891|Sympathomimetics|sympathomimetics|mesh-ancestor
93228514|NCT01333891|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93228515|NCT01333891|Nasal Decongestants|nasal decongestants|mesh-ancestor
93228516|NCT01333891|Respiratory System Agents|respiratory system agents|mesh-ancestor
93228517|NCT01333891|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93228518|NCT01333891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93228519|NCT01333891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93228520|NCT01333891|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228521|NCT01333891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228522|NCT01333891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228523|NCT01333891|Protective Agents|protective agents|mesh-ancestor
93228524|NCT01333891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93228525|NCT01333891|Vasodilator Agents|vasodilator agents|mesh-ancestor
93228526|NCT01333891|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93228527|NCT04853875|Amoxicillin|amoxicillin|mesh-list
93228528|NCT04853875|Metronidazole|metronidazole|mesh-list
93228529|NCT04853875|Clarithromycin|clarithromycin|mesh-list
93228530|NCT04853875|Tetracycline|tetracycline|mesh-list
93228531|NCT04853875|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
93228532|NCT04853875|Bismuth|bismuth|mesh-list
93228533|NCT04853875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93228534|NCT04853875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228535|NCT04853875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93228536|NCT04853875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93228537|NCT04853875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93228538|NCT04853875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228539|NCT04853875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228540|NCT04853875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93228541|NCT04853875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93228542|NCT04853875|Antacids|antacids|mesh-ancestor
93228543|NCT04853875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228544|NCT04853875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93228545|NCT03196973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93228546|NCT03196973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93228547|NCT03196973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228548|NCT03196973|Antitubercular Agents|antitubercular agents|mesh-ancestor
93228549|NCT03196505|Bupivacaine|bupivacaine|mesh-list
93228550|NCT03196505|Anesthetics, Local|anesthetics, local|mesh-ancestor
93228551|NCT03196505|Anesthetics|anesthetics|mesh-ancestor
93228552|NCT03196505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228553|NCT03196505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228554|NCT03196505|Sensory System Agents|sensory system agents|mesh-ancestor
93228555|NCT03196505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228556|NCT01334047|Vaccines|vaccines|mesh-list
93228557|NCT01334047|Immunologic Factors|immunologic factors|mesh-ancestor
93228558|NCT01334047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228559|NCT01337557|Bepotastine besilate|bepotastine besilate|mesh-list
93228560|NCT01337557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93228561|NCT03196349|Warfarin|warfarin|mesh-list
93228562|NCT03196349|Rivaroxaban|rivaroxaban|mesh-list
93228563|NCT03196349|Apixaban|apixaban|mesh-list
93228564|NCT03196349|Anticoagulants|anticoagulants|mesh-ancestor
93228565|NCT03196349|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93228566|NCT03196349|Antithrombins|antithrombins|mesh-ancestor
93228567|NCT03196349|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93228568|NCT03196349|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228569|NCT03196349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228570|NCT03196349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228571|NCT01331941|Paclitaxel|paclitaxel|mesh-list
93228572|NCT01331941|Trebananib|trebananib|mesh-list
93228573|NCT01331941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93228574|NCT01331941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228575|NCT01331941|Tubulin Modulators|tubulin modulators|mesh-ancestor
93228576|NCT01331941|Antimitotic Agents|antimitotic agents|mesh-ancestor
93228577|NCT01331941|Mitosis Modulators|mitosis modulators|mesh-ancestor
93228578|NCT01331941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228579|NCT01331941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93228580|NCT01331941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93228581|NCT01331941|Growth Substances|growth substances|mesh-ancestor
93228582|NCT01331941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228583|NCT01331941|Growth Inhibitors|growth inhibitors|mesh-ancestor
93228584|NCT02886715|Nicotinic Acids|nicotinic acids|mesh-list
93228585|NCT02886715|Tazarotene|tazarotene|mesh-list
93228586|NCT02886715|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228587|NCT02886715|Keratolytic Agents|keratolytic agents|mesh-ancestor
93228588|NCT02886715|Vitamin B Complex|vitamin b complex|mesh-ancestor
93228589|NCT02886715|Vitamins|vitamins|mesh-ancestor
93228590|NCT02886715|Micronutrients|micronutrients|mesh-ancestor
93228591|NCT02886715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228592|NCT01337791|Telbivudine|telbivudine|mesh-list
93228593|NCT01337791|Antiviral Agents|antiviral agents|mesh-ancestor
93228594|NCT01337791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228595|NCT01337791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93228596|NCT01337791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228597|NCT01337791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228598|NCT01334203|Ranolazine|ranolazine|mesh-list
93228599|NCT01334203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93228600|NCT01334203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93228601|NCT01334203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228602|NCT03085797|Mometasone Furoate|mometasone furoate|mesh-list
93228603|NCT03085797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228604|NCT03085797|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228605|NCT03085797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93228606|NCT01569165|Fluorides|fluorides|mesh-list
93228607|NCT01569165|Fluorides, Topical|fluorides, topical|mesh-list
93228608|NCT01569165|Cariostatic Agents|cariostatic agents|mesh-ancestor
93228609|NCT01569165|Protective Agents|protective agents|mesh-ancestor
93228610|NCT01569165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228611|NCT04259749|Menthol|menthol|mesh-list
93228612|NCT04259749|Antipruritics|antipruritics|mesh-ancestor
93228613|NCT04259749|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228614|NCT02535091|Cenobamate|cenobamate|mesh-list
93228615|NCT02535091|Anticonvulsants|anticonvulsants|mesh-ancestor
93228616|NCT01382277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93228617|NCT01382277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93228618|NCT01382277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93228619|NCT01382277|Antimetabolites|antimetabolites|mesh-ancestor
93228620|NCT01382277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228621|NCT01382277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93228622|NCT01382277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93228623|NCT01382277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228624|NCT01382199|Lactoferrin|lactoferrin|mesh-list
93228625|NCT01382199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228626|NCT01381497|Naproxen|naproxen|mesh-list
93228627|NCT01381497|Sumatriptan|sumatriptan|mesh-list
93228628|NCT01381497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93228629|NCT01381497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93228630|NCT01381497|Analgesics|analgesics|mesh-ancestor
93228631|NCT01381497|Sensory System Agents|sensory system agents|mesh-ancestor
93228632|NCT01381497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228633|NCT01381497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228634|NCT01381497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228635|NCT01381497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228636|NCT01381497|Gout Suppressants|gout suppressants|mesh-ancestor
93228637|NCT01381497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93228638|NCT01381497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228639|NCT01381497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228640|NCT01381497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93228641|NCT01381497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93228642|NCT01381497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93228643|NCT01381497|Serotonin Agents|serotonin agents|mesh-ancestor
93228644|NCT01381497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228646|NCT04221997|Antidepressive Agents|antidepressive agents|mesh-ancestor
93228647|NCT04221997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93228648|NCT04221997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93228649|NCT04221997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93228650|NCT04221997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93228651|NCT04221997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228652|NCT04221997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228653|NCT04221997|Serotonin Agents|serotonin agents|mesh-ancestor
93228654|NCT04221997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228655|NCT03635827|Xenon|xenon|mesh-list
93228656|NCT03635827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93228657|NCT03635827|Anesthetics, General|anesthetics, general|mesh-ancestor
93228658|NCT03635827|Anesthetics|anesthetics|mesh-ancestor
93228659|NCT03635827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228660|NCT03635827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228661|NCT01338103|Rituximab|rituximab|mesh-list
93228662|NCT01338103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228663|NCT01338103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228664|NCT01338103|Immunologic Factors|immunologic factors|mesh-ancestor
93228665|NCT01338103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228666|NCT01338103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228667|NCT03369665|Cladribine|cladribine|mesh-list
93228668|NCT03369665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228669|NCT03369665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228670|NCT03369665|Immunologic Factors|immunologic factors|mesh-ancestor
93228671|NCT03369665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228672|NCT03621761|Modafinil|modafinil|mesh-list
93228673|NCT03621761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93228674|NCT03621761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228675|NCT03621761|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93228676|NCT03621761|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93228677|NCT03621761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93228678|NCT03621761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228679|NCT03318861|Cyclophosphamide|cyclophosphamide|mesh-list
93228680|NCT03318861|Fludarabine|fludarabine|mesh-list
93228681|NCT03318861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228682|NCT03318861|Immunologic Factors|immunologic factors|mesh-ancestor
93228683|NCT03318861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228684|NCT03318861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228685|NCT03318861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93228686|NCT03318861|Alkylating Agents|alkylating agents|mesh-ancestor
93228687|NCT03318861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228688|NCT03318861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228689|NCT03318861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93228690|NCT03084315|Nicotine|nicotine|mesh-list
93228691|NCT03084315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93228692|NCT03084315|Autonomic Agents|autonomic agents|mesh-ancestor
93228693|NCT03084315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228694|NCT03084315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228695|NCT03084315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93228696|NCT03084315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93228697|NCT03084315|Cholinergic Agents|cholinergic agents|mesh-ancestor
93228698|NCT03084315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228699|NCT03084315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228700|NCT03187301|Moxifloxacin|moxifloxacin|mesh-list
93228701|NCT03187301|Apomorphine|apomorphine|mesh-list
93228702|NCT03187301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93228703|NCT03187301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228704|NCT03187301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93228705|NCT03187301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93228706|NCT03187301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228707|NCT03187301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228708|NCT03187301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228709|NCT03187301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228710|NCT03187301|Emetics|emetics|mesh-ancestor
93228711|NCT03187301|Autonomic Agents|autonomic agents|mesh-ancestor
93228712|NCT03187301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228713|NCT03187301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228714|NCT03187301|Dopamine Agonists|dopamine agonists|mesh-ancestor
93228715|NCT03187301|Dopamine Agents|dopamine agents|mesh-ancestor
93228716|NCT03187301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228717|NCT01381185|Aspirin|aspirin|mesh-list
93228718|NCT01381185|Clopidogrel|clopidogrel|mesh-list
93228719|NCT01381185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93228720|NCT01381185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93228721|NCT01381185|Analgesics|analgesics|mesh-ancestor
93228722|NCT01381185|Sensory System Agents|sensory system agents|mesh-ancestor
93228723|NCT01381185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228724|NCT01381185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228725|NCT01381185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228726|NCT01381185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228727|NCT01381185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93228728|NCT01381185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93228729|NCT01381185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228730|NCT01381185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93228731|NCT01381185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93228732|NCT01381185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228733|NCT01381185|Antipyretics|antipyretics|mesh-ancestor
93228734|NCT01381185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93228735|NCT01381185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93228736|NCT01381185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93228737|NCT01381185|Purinergic Agents|purinergic agents|mesh-ancestor
93228738|NCT01381185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228739|NCT02946047|Ixazomib|ixazomib|mesh-list
93228740|NCT02946047|Glycine|glycine|mesh-list
93228741|NCT02946047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228742|NCT02946047|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228743|NCT02946047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228744|NCT02946047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228745|NCT02946047|Glycine Agents|glycine agents|mesh-ancestor
93228746|NCT02946047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228747|NCT02946047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228748|NCT05421897|Cyclophosphamide|cyclophosphamide|mesh-list
93228749|NCT05421897|Temozolomide|temozolomide|mesh-list
93228750|NCT05421897|Irinotecan|irinotecan|mesh-list
93228751|NCT05421897|Topotecan|topotecan|mesh-list
93228752|NCT05421897|Dinutuximab|dinutuximab|mesh-list
93228753|NCT05421897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228754|NCT05421897|Immunologic Factors|immunologic factors|mesh-ancestor
93228755|NCT05421897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228756|NCT05421897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228757|NCT05421897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93228758|NCT05421897|Alkylating Agents|alkylating agents|mesh-ancestor
93228759|NCT05421897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228760|NCT05421897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228761|NCT05421897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93228762|NCT05421897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93228763|NCT05421897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93228764|NCT05421897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228765|NCT03077919|Ropivacaine|ropivacaine|mesh-list
93228766|NCT03077919|Anesthetics, Local|anesthetics, local|mesh-ancestor
93228767|NCT03077919|Anesthetics|anesthetics|mesh-ancestor
93228768|NCT03077919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228769|NCT03077919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228770|NCT03077919|Sensory System Agents|sensory system agents|mesh-ancestor
93228771|NCT03077919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228772|NCT01380951|Telbivudine|telbivudine|mesh-list
93228773|NCT01380951|Antiviral Agents|antiviral agents|mesh-ancestor
93228774|NCT01380951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228775|NCT01380951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93228776|NCT01380951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228777|NCT01380951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228778|NCT01377597|Ranibizumab|ranibizumab|mesh-list
93228779|NCT01377597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93228780|NCT01377597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93228781|NCT01377597|Growth Substances|growth substances|mesh-ancestor
93228782|NCT01377597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228783|NCT01377597|Growth Inhibitors|growth inhibitors|mesh-ancestor
93228784|NCT01377597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228785|NCT03287375|Cisplatin|cisplatin|mesh-list
93228786|NCT03287375|Doxorubicin|doxorubicin|mesh-list
93228787|NCT03287375|Oxaliplatin|oxaliplatin|mesh-list
93228788|NCT03287375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228789|NCT03287375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93228790|NCT03287375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93228791|NCT03287375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93228792|NCT03287375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856064|NCT00777153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93228793|NCT03287375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228794|NCT03881059|Ustekinumab|ustekinumab|mesh-list
92856283|NCT00908869|Interferon alpha-2|interferon alpha-2|mesh-list
93228795|NCT03881059|Deucravacitinib|deucravacitinib|mesh-list
93228796|NCT03881059|Dermatologic Agents|dermatologic agents|mesh-ancestor
92856438|NCT05658692|GABA Agents|gaba agents|mesh-ancestor
93228797|NCT03881059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93228798|NCT03881059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228799|NCT03881059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228800|NCT01338337|Azacitidine|azacitidine|mesh-list
92856654|NCT00603785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92856750|NCT02819648|Hormones|hormones|mesh-ancestor
92856880|NCT02819570|Roxithromycin|roxithromycin|mesh-list
93228801|NCT01338337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93228802|NCT01338337|Antimetabolites|antimetabolites|mesh-ancestor
93228803|NCT01338337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857101|NCT02735928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93228804|NCT01338337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228805|NCT01338337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228806|NCT03083847|Chloroquine|chloroquine|mesh-list
93228807|NCT03083847|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93228808|NCT03083847|Pyrimethamine|pyrimethamine|mesh-list
93228809|NCT03083847|Amebicides|amebicides|mesh-ancestor
93228810|NCT03083847|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93228811|NCT03083847|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93228812|NCT03083847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857542|NCT05784688|Pembrolizumab|pembrolizumab|mesh-list
93228813|NCT03083847|Antimalarials|antimalarials|mesh-ancestor
93228814|NCT03083847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857687|NCT05617963|Durvalumab|durvalumab|mesh-list
92857690|NCT05587036|Rifaximin|rifaximin|mesh-list
92857762|NCT05452512|Vitamin D|vitamin d|mesh-list
93228815|NCT03083847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92502976|NCT02027532|Vancomycin|vancomycin|mesh-list
93228816|NCT03083847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93228817|NCT03083847|Analgesics|analgesics|mesh-ancestor
93228818|NCT03083847|Sensory System Agents|sensory system agents|mesh-ancestor
92857980|NCT04930744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92858051|NCT04759664|LUT014|lut014|mesh-list
93228819|NCT03083847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228820|NCT03083847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228821|NCT03083847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228822|NCT03083847|Filaricides|filaricides|mesh-ancestor
92858210|NCT04318080|Tislelizumab|tislelizumab|mesh-list
93228823|NCT03083847|Antinematodal Agents|antinematodal agents|mesh-ancestor
92858270|NCT04074967|Ipilimumab|ipilimumab|mesh-list
93228824|NCT03083847|Anthelmintics|anthelmintics|mesh-ancestor
93228825|NCT03083847|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93228826|NCT03083847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228827|NCT03083847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228828|NCT03082677|Ixazomib|ixazomib|mesh-list
93228829|NCT03082677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228830|NCT03082677|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228831|NCT03082677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228832|NCT03082677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228833|NCT03136055|Paclitaxel|paclitaxel|mesh-list
93228834|NCT03136055|Pembrolizumab|pembrolizumab|mesh-list
93228835|NCT03136055|Irinotecan|irinotecan|mesh-list
93228836|NCT03136055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93228837|NCT03136055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228838|NCT03136055|Tubulin Modulators|tubulin modulators|mesh-ancestor
93228839|NCT03136055|Antimitotic Agents|antimitotic agents|mesh-ancestor
93228840|NCT03136055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858414|NCT03638141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228841|NCT03136055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228842|NCT03136055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228843|NCT03136055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93228844|NCT03136055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93228845|NCT03136055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93228846|NCT03136055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228847|NCT03221309|Analgesics, Opioid|analgesics, opioid|mesh-list
93228848|NCT03221309|Narcotics|narcotics|mesh-ancestor
93228849|NCT03221309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228850|NCT03221309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228851|NCT03221309|Analgesics|analgesics|mesh-ancestor
93228852|NCT03221309|Sensory System Agents|sensory system agents|mesh-ancestor
93228853|NCT03221309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228854|NCT05353829|Methotrexate|methotrexate|mesh-list
93228855|NCT05353829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93228856|NCT05353829|Abortifacient Agents|abortifacient agents|mesh-ancestor
93228857|NCT05353829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93228858|NCT05353829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228859|NCT05353829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900970|NCT02678585|Narcotics|narcotics|mesh-ancestor
93228861|NCT05353829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228862|NCT05353829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228863|NCT05353829|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228864|NCT05353829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858479|NCT03070886|Fertility Agents|fertility agents|mesh-ancestor
93228865|NCT05353829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93228866|NCT05353829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228867|NCT05353829|Immunologic Factors|immunologic factors|mesh-ancestor
92858528|NCT02772003|Interleukin-12|interleukin-12|mesh-list
93228868|NCT05353829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858604|NCT02340169|Desoximetasone|desoximetasone|mesh-list
93228869|NCT05353829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93228870|NCT03426657|Durvalumab|durvalumab|mesh-list
92858687|NCT01856192|Hormones|hormones|mesh-ancestor
93228871|NCT03426657|Tremelimumab|tremelimumab|mesh-list
92858821|NCT02807870|Methylphenidate|methylphenidate|mesh-list
93228872|NCT03426657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93228873|NCT03426657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228874|NCT02858180|Sofosbuvir|sofosbuvir|mesh-list
93228875|NCT02858180|Ledipasvir|ledipasvir|mesh-list
93228876|NCT02858180|Antiviral Agents|antiviral agents|mesh-ancestor
93228877|NCT02858180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228878|NCT03609086|Melatonin|melatonin|mesh-list
93228879|NCT03609086|Antioxidants|antioxidants|mesh-ancestor
93228880|NCT03609086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228881|NCT03609086|Protective Agents|protective agents|mesh-ancestor
93228882|NCT03609086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859109|NCT02739204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93228883|NCT03609086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228884|NCT00730717|Adalimumab|adalimumab|mesh-list
92859324|NCT00933985|Protective Agents|protective agents|mesh-ancestor
93228885|NCT00730717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93228886|NCT00730717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228887|NCT00730717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93228888|NCT01332409|Fluticasone|fluticasone|mesh-list
93228889|NCT01332409|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93228890|NCT01332409|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93228891|NCT01332409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93228892|NCT01332409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93228893|NCT01332409|Autonomic Agents|autonomic agents|mesh-ancestor
93228894|NCT01332409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859620|NCT05905055|Cefepime|cefepime|mesh-list
93228895|NCT01332409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228896|NCT01332409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93228897|NCT01332409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92859774|NCT05727176|Futibatinib|futibatinib|mesh-list
93228898|NCT01332409|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228899|NCT01332409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93228900|NCT01332409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93228901|NCT01332409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93228902|NCT01332409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93228903|NCT01332409|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228904|NCT01332409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228905|NCT01332409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228906|NCT01332409|Glucocorticoids|glucocorticoids|mesh-ancestor
93228907|NCT01332409|Hormones|hormones|mesh-ancestor
93228908|NCT01332409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93228909|NCT01332409|Sympathomimetics|sympathomimetics|mesh-ancestor
92859984|NCT05418556|Antipyretics|antipyretics|mesh-ancestor
93228910|NCT03181451|Ferric maltol|ferric maltol|mesh-list
92860219|NCT04548999|Hormones|hormones|mesh-ancestor
93228911|NCT03181451|Hematinics|hematinics|mesh-ancestor
93228912|NCT03495973|Ustekinumab|ustekinumab|mesh-list
93228913|NCT03495973|Dermatologic Agents|dermatologic agents|mesh-ancestor
93228914|NCT00480805|Losartan|losartan|mesh-list
92860350|NCT04352205|Thalidomide|thalidomide|mesh-list
93228915|NCT00480805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93228916|NCT00480805|Ramipril|ramipril|mesh-list
93228917|NCT00480805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92860421|NCT04246047|Dexamethasone|dexamethasone|mesh-list
93228918|NCT00480805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93228919|NCT00480805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93228920|NCT00480805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93228921|NCT00480805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228922|NCT00480805|Diuretics|diuretics|mesh-ancestor
93228923|NCT00480805|Natriuretic Agents|natriuretic agents|mesh-ancestor
93228924|NCT00480805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228925|NCT00480805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93228926|NCT00480805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93228927|NCT00480805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93228928|NCT00480805|Protease Inhibitors|protease inhibitors|mesh-ancestor
93228929|NCT00480805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228930|NCT00406783|Desloratadine|desloratadine|mesh-list
93228931|NCT00406783|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93228932|NCT00406783|Cholinergic Agents|cholinergic agents|mesh-ancestor
93228933|NCT00406783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860777|NCT03267836|Avelumab|avelumab|mesh-list
93228934|NCT00406783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228935|NCT00406783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228936|NCT00406783|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93228937|NCT00406783|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93228938|NCT00406783|Histamine Antagonists|histamine antagonists|mesh-ancestor
93228939|NCT00406783|Histamine Agents|histamine agents|mesh-ancestor
93228940|NCT03179891|Diazepam|diazepam|mesh-list
93228941|NCT03179891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93228942|NCT03179891|Anticonvulsants|anticonvulsants|mesh-ancestor
93228943|NCT03179891|Antiemetics|antiemetics|mesh-ancestor
93228944|NCT03179891|Autonomic Agents|autonomic agents|mesh-ancestor
93228945|NCT03179891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93228946|NCT03179891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228947|NCT03179891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93228948|NCT03179891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93228949|NCT03179891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93228950|NCT03179891|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92860914|NCT02554851|Mitogens|mitogens|mesh-list
93228951|NCT03179891|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93228952|NCT03179891|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93228953|NCT03179891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93228954|NCT03179891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93228955|NCT03179891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93228956|NCT03179891|Anesthetics, General|anesthetics, general|mesh-ancestor
93228957|NCT03179891|Anesthetics|anesthetics|mesh-ancestor
93228958|NCT03179891|GABA Modulators|gaba modulators|mesh-ancestor
93228959|NCT03179891|GABA Agents|gaba agents|mesh-ancestor
93228960|NCT03179891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860982|NCT02133196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93228961|NCT03179891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228962|NCT01334671|Atorvastatin|atorvastatin|mesh-list
93228963|NCT01334671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93228964|NCT01334671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93228965|NCT01334671|Antimetabolites|antimetabolites|mesh-ancestor
93228966|NCT01334671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228967|NCT01334671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93228968|NCT01334671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93228969|NCT01334671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228970|NCT01332565|Dolutegravir|dolutegravir|mesh-list
93228971|NCT01332565|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93228972|NCT01332565|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93228973|NCT01332565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228974|NCT01332565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228975|NCT01332565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92861197|NCT00082797|Leucovorin|leucovorin|mesh-list
93228976|NCT01332565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93228977|NCT01332565|Antiviral Agents|antiviral agents|mesh-ancestor
92861338|NCT00026286|Estrogens|estrogens|mesh-list
93228978|NCT01332565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93228979|NCT01314677|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93228980|NCT01314677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93228981|NCT01314677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228982|NCT02736227|Everolimus|everolimus|mesh-list
93228983|NCT02736227|Tacrolimus|tacrolimus|mesh-list
93228984|NCT02736227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93228985|NCT02736227|Immunologic Factors|immunologic factors|mesh-ancestor
93228986|NCT02736227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93228987|NCT02736227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93228988|NCT02736227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93228989|NCT02736227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93228990|NCT02736227|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93228991|NCT02736227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93228992|NCT02736227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93228993|NCT01334905|Mirabegron|mirabegron|mesh-list
93228994|NCT01334905|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93228995|NCT01334905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93228996|NCT01334905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93228997|NCT01334905|Adrenergic Agents|adrenergic agents|mesh-ancestor
93228998|NCT01334905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93228999|NCT01334905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229000|NCT01334905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229001|NCT01334905|Urological Agents|urological agents|mesh-ancestor
93229002|NCT01335139|Immunomodulating Agents|immunomodulating agents|mesh-list
93229003|NCT01335139|Immunologic Factors|immunologic factors|mesh-list
93229004|NCT01335139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229005|NCT05030129|Vitamin B 6|vitamin b 6|mesh-list
93229006|NCT05030129|Pyridoxal|pyridoxal|mesh-list
93229007|NCT05030129|Pyridoxine|pyridoxine|mesh-list
93229008|NCT05030129|Ergoloid Mesylates|ergoloid mesylates|mesh-list
93229009|NCT05030129|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
93229010|NCT05030129|Dihydroergotoxine|dihydroergotoxine|mesh-list
93229011|NCT05030129|Vitamins|vitamins|mesh-ancestor
93229012|NCT05030129|Micronutrients|micronutrients|mesh-ancestor
93229013|NCT05030129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861984|NCT02800772|Acetic Acid|acetic acid|mesh-list
93229014|NCT05030129|Vitamin B Complex|vitamin b complex|mesh-ancestor
92862051|NCT05504876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93229015|NCT05030129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92862209|NCT02724618|Curcumin|curcumin|mesh-list
93229016|NCT05030129|Antidepressive Agents|antidepressive agents|mesh-ancestor
92862277|NCT00938821|Morphine|morphine|mesh-list
93229017|NCT05030129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92862346|NCT00563797|Cholinergic Agents|cholinergic agents|mesh-ancestor
93229018|NCT05030129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93229019|NCT05030129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93229020|NCT05030129|Adrenergic Agents|adrenergic agents|mesh-ancestor
93229021|NCT05030129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229022|NCT05030129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229023|NCT05030129|Vasodilator Agents|vasodilator agents|mesh-ancestor
93229024|NCT05030129|Nootropic Agents|nootropic agents|mesh-ancestor
93229025|NCT05030129|Dopamine Agonists|dopamine agonists|mesh-ancestor
93229026|NCT05030129|Dopamine Agents|dopamine agents|mesh-ancestor
93229027|NCT03260023|Avelumab|avelumab|mesh-list
93229028|NCT03260023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93229029|NCT03260023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229030|NCT01339039|Plerixafor|plerixafor|mesh-list
93229031|NCT01339039|Bevacizumab|bevacizumab|mesh-list
93229032|NCT01339039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93229033|NCT01339039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229034|NCT01339039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93229035|NCT01339039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93229036|NCT01339039|Growth Substances|growth substances|mesh-ancestor
93229037|NCT01339039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229038|NCT01339039|Growth Inhibitors|growth inhibitors|mesh-ancestor
93229039|NCT01339039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93229040|NCT01339039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93229041|NCT01339039|Antiviral Agents|antiviral agents|mesh-ancestor
93229042|NCT01339039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229043|NCT03176459|Bupivacaine|bupivacaine|mesh-list
93229044|NCT03176459|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229045|NCT03176459|Anesthetics|anesthetics|mesh-ancestor
93229046|NCT03176459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229047|NCT03176459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229048|NCT03176459|Sensory System Agents|sensory system agents|mesh-ancestor
92863066|NCT02601651|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229049|NCT03176459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229050|NCT01332955|Ribavirin|ribavirin|mesh-list
93229051|NCT01332955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93229052|NCT01332955|Antimetabolites|antimetabolites|mesh-ancestor
93229053|NCT01332955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229054|NCT01332955|Antiviral Agents|antiviral agents|mesh-ancestor
93229055|NCT01332955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229056|NCT05224895|Anesthetics|anesthetics|mesh-list
93229057|NCT05224895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229058|NCT05224895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229059|NCT01335373|Metronidazole|metronidazole|mesh-list
93229060|NCT01335373|Miconazole|miconazole|mesh-list
93229061|NCT01335373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229062|NCT01335373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93229063|NCT01335373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93229064|NCT01335373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92863220|NCT00946621|Ramipril|ramipril|mesh-list
93229065|NCT01335373|Antifungal Agents|antifungal agents|mesh-ancestor
93229066|NCT01335373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93229067|NCT01335373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92863347|NCT00754065|Dienogest|dienogest|mesh-list
93229068|NCT01335373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229069|NCT01335373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229070|NCT01335373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93229071|NCT01335373|Hormone Antagonists|hormone antagonists|mesh-ancestor
92863575|NCT02783924|Cholecalciferol|cholecalciferol|mesh-list
92863637|NCT02689856|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93229072|NCT01335373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863785|NCT02546934|Gemcitabine|gemcitabine|mesh-list
93229073|NCT01335373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229074|NCT01335373|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92863935|NCT04231370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229075|NCT01335373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93229076|NCT01333267|Hormones|hormones|mesh-list
93229077|NCT01333267|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
93229078|NCT01333267|Testosterone Congeners|testosterone congeners|mesh-list
93229079|NCT01333267|Parathyroid Hormone|parathyroid hormone|mesh-list
93229080|NCT01333267|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
93229081|NCT01333267|Anabolic Agents|anabolic agents|mesh-list
92864301|NCT00555217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93229082|NCT01333267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864388|NCT00940693|Analgesics|analgesics|mesh-ancestor
92864448|NCT00951223|Antiviral Agents|antiviral agents|mesh-ancestor
93229083|NCT01333267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229084|NCT01333267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93229085|NCT01333267|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
93229086|NCT01335529|Interferons|interferons|mesh-list
93229087|NCT01335529|Ribavirin|ribavirin|mesh-list
93229088|NCT01335529|Interferon-alpha|interferon-alpha|mesh-list
93229089|NCT01335529|Interferon alpha-2|interferon alpha-2|mesh-list
93229090|NCT01335529|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93229091|NCT01335529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229092|NCT01335529|Antiviral Agents|antiviral agents|mesh-ancestor
93229093|NCT01335529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229094|NCT01335529|Antimetabolites|antimetabolites|mesh-ancestor
93229095|NCT01335529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229096|NCT01335529|Immunologic Factors|immunologic factors|mesh-ancestor
93229097|NCT01335529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229098|NCT00308347|Losartan|losartan|mesh-list
93229099|NCT00308347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93229100|NCT00308347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93229101|NCT00308347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93229102|NCT00308347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93229103|NCT00308347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229104|NCT02186834|Dexamethasone|dexamethasone|mesh-list
93229105|NCT02186834|Doxorubicin|doxorubicin|mesh-list
93229106|NCT02186834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93229107|NCT02186834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229108|NCT02186834|Antiemetics|antiemetics|mesh-ancestor
93229109|NCT02186834|Autonomic Agents|autonomic agents|mesh-ancestor
92865192|NCT02774876|Insulin|insulin|mesh-list
93229110|NCT02186834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865324|NCT04255121|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229111|NCT02186834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229112|NCT02186834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865474|NCT02676609|Insulin|insulin|mesh-list
93229113|NCT02186834|Glucocorticoids|glucocorticoids|mesh-ancestor
93229114|NCT02186834|Hormones|hormones|mesh-ancestor
92865622|NCT02762942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93229115|NCT02186834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229116|NCT02186834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93229117|NCT02186834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865777|NCT02766140|Docetaxel|docetaxel|mesh-list
93229118|NCT02186834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93229119|NCT02186834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93229120|NCT02186834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93229121|NCT02186834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229122|NCT02186834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229123|NCT04335890|Vaccines|vaccines|mesh-list
93229124|NCT04335890|Immunologic Factors|immunologic factors|mesh-ancestor
93229125|NCT04335890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229126|NCT01379157|Imipenem|imipenem|mesh-list
93229127|NCT01379157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866281|NCT00647127|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93229128|NCT01379157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229129|NCT01538966|Octreotide|octreotide|mesh-list
93229130|NCT01538966|Lanreotide|lanreotide|mesh-list
93229131|NCT01538966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229132|NCT01538966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92866577|NCT05343702|Rocuronium|rocuronium|mesh-list
92866661|NCT00954811|Progesterone|progesterone|mesh-list
92866800|NCT00649311|Diuretics|diuretics|mesh-ancestor
93229133|NCT01538966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229134|NCT01377285|Pentoxifylline|pentoxifylline|mesh-list
92866945|NCT02759510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93229135|NCT01377285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92867163|NCT04219124|Dapagliflozin|dapagliflozin|mesh-list
92867236|NCT02704962|Antiemetics|antiemetics|mesh-ancestor
93229136|NCT01377285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93229137|NCT01377285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229138|NCT01377285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867459|NCT02700906|Lidocaine|lidocaine|mesh-list
92867533|NCT05428670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229139|NCT01377285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93229140|NCT01377285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93229141|NCT01377285|Protective Agents|protective agents|mesh-ancestor
92867758|NCT00615810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229142|NCT01377285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229143|NCT01377285|Vasodilator Agents|vasodilator agents|mesh-ancestor
92867976|NCT01442792|Anticoagulants|anticoagulants|mesh-ancestor
93229144|NCT01377285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92868202|NCT02741024|Artesunate|artesunate|mesh-list
93229145|NCT01377285|Antioxidants|antioxidants|mesh-ancestor
93229146|NCT02905266|Nivolumab|nivolumab|mesh-list
93229147|NCT02905266|Ipilimumab|ipilimumab|mesh-list
93229148|NCT02905266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93229149|NCT02905266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229150|NCT02905266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93229151|NCT02905266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229152|NCT01380717|Calcium Channel Blockers|calcium channel blockers|mesh-list
93229153|NCT01380717|Calcium|calcium|mesh-list
92868640|NCT02728466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93229154|NCT01380717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93229155|NCT01380717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92868790|NCT02737124|Acetaminophen|acetaminophen|mesh-list
92868864|NCT02746796|Capecitabine|capecitabine|mesh-list
92868939|NCT02129348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869012|NCT01959464|Progesterone|progesterone|mesh-list
92869014|NCT01959464|Hormones|hormones|mesh-ancestor
93229156|NCT01380717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93229157|NCT01380717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229158|NCT01380717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93229159|NCT01380717|Adrenergic Agents|adrenergic agents|mesh-ancestor
92869307|NCT00650637|Protease Inhibitors|protease inhibitors|mesh-ancestor
93229160|NCT01380717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229161|NCT01380717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229162|NCT01380717|Protease Inhibitors|protease inhibitors|mesh-ancestor
93229163|NCT01380717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229164|NCT01380717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93229165|NCT03080493|Acetaminophen|acetaminophen|mesh-list
93229166|NCT03080493|Ibuprofen|ibuprofen|mesh-list
93229167|NCT03080493|Gabapentin|gabapentin|mesh-list
93229168|NCT03080493|Codeine|codeine|mesh-list
93229169|NCT03080493|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93229170|NCT03080493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93229171|NCT03080493|Analgesics|analgesics|mesh-ancestor
92869825|NCT02709590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229172|NCT03080493|Sensory System Agents|sensory system agents|mesh-ancestor
93229173|NCT03080493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869974|NCT03781544|Antipyretics|antipyretics|mesh-ancestor
93229174|NCT03080493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229175|NCT03080493|Antipyretics|antipyretics|mesh-ancestor
92870045|NCT03769766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92870118|NCT00884325|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92870190|NCT02693444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229176|NCT03080493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92870266|NCT03712202|Alkylating Agents|alkylating agents|mesh-ancestor
92870337|NCT05342870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93229177|NCT03080493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870480|NCT00659997|Levamisole|levamisole|mesh-list
93229178|NCT03080493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229179|NCT03080493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92870558|NCT00660933|Hematinics|hematinics|mesh-ancestor
93229180|NCT03080493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229181|NCT03080493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229182|NCT03080493|Anticonvulsants|anticonvulsants|mesh-ancestor
93229183|NCT03080493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92870851|NCT03555968|Hormones|hormones|mesh-ancestor
93229184|NCT03080493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870918|NCT00670683|Insulin Detemir|insulin detemir|mesh-list
93229185|NCT03080493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229186|NCT03080493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870993|NCT05345132|Analgesics|analgesics|mesh-ancestor
93229187|NCT03080493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93229188|NCT03080493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93229189|NCT03080493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229190|NCT03080493|Antimanic Agents|antimanic agents|mesh-ancestor
93229191|NCT03080493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93229192|NCT03080493|Narcotics|narcotics|mesh-ancestor
92871305|NCT02703194|Prednisone|prednisone|mesh-list
93229193|NCT03080493|Antitussive Agents|antitussive agents|mesh-ancestor
93229194|NCT03080493|Respiratory System Agents|respiratory system agents|mesh-ancestor
93229195|NCT03080493|Laxatives|laxatives|mesh-ancestor
93229196|NCT03080493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229197|NCT02906007|Bedaquiline|bedaquiline|mesh-list
93229198|NCT02906007|Antitubercular Agents|antitubercular agents|mesh-ancestor
92871519|NCT00615602|Antimetabolites|antimetabolites|mesh-ancestor
93229199|NCT02906007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92871587|NCT02701478|Anesthetics|anesthetics|mesh-ancestor
92871660|NCT03141203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229200|NCT02906007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229201|NCT01339910|Vidarabine|vidarabine|mesh-list
93229202|NCT01339910|Cyclophosphamide|cyclophosphamide|mesh-list
93229203|NCT01339910|Melphalan|melphalan|mesh-list
93229204|NCT01339910|Busulfan|busulfan|mesh-list
92871876|NCT05300594|Vitamins|vitamins|mesh-list
92871962|NCT02849873|Tazarotene|tazarotene|mesh-list
93229205|NCT01339910|Fludarabine|fludarabine|mesh-list
93229206|NCT01339910|Fludarabine phosphate|fludarabine phosphate|mesh-list
93229207|NCT01339910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229208|NCT01339910|Immunologic Factors|immunologic factors|mesh-ancestor
92872169|NCT02848157|Dexmedetomidine|dexmedetomidine|mesh-list
93229209|NCT01339910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229210|NCT01339910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229211|NCT01339910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93229212|NCT01339910|Alkylating Agents|alkylating agents|mesh-ancestor
92872391|NCT05000658|Glucocorticoids|glucocorticoids|mesh-ancestor
92872464|NCT00825630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872537|NCT02771249|Darunavir|darunavir|mesh-list
93229213|NCT01339910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229214|NCT01339910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229215|NCT01339910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93229216|NCT01339910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93229217|NCT01339910|Antimetabolites|antimetabolites|mesh-ancestor
93229218|NCT01339910|Antiviral Agents|antiviral agents|mesh-ancestor
92872977|NCT02574728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873046|NCT03512418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229219|NCT01339910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229220|NCT02647827|Metformin|metformin|mesh-list
92873122|NCT00622674|Cetuximab|cetuximab|mesh-list
93229221|NCT02647827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93229222|NCT02647827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229223|NCT03655392|Nitric Oxide|nitric oxide|mesh-list
93229224|NCT03655392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92873294|NCT00616538|Xhance|xhance|mesh-list
93229225|NCT03655392|Autonomic Agents|autonomic agents|mesh-ancestor
92873424|NCT04183608|Adalimumab|adalimumab|mesh-list
92873493|NCT00618254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229226|NCT03655392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873566|NCT04628663|Analgesics|analgesics|mesh-ancestor
93229227|NCT03655392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229228|NCT03655392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93229229|NCT03655392|Respiratory System Agents|respiratory system agents|mesh-ancestor
92873645|NCT02511132|Gemcitabine|gemcitabine|mesh-list
93229230|NCT03655392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93229231|NCT03655392|Antioxidants|antioxidants|mesh-ancestor
92873784|NCT05662956|Antimetabolites|antimetabolites|mesh-ancestor
92873857|NCT05501886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92874009|NCT02675868|Protective Agents|protective agents|mesh-ancestor
93229232|NCT03655392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874107|NCT00644982|Sertraline|sertraline|mesh-list
92874153|NCT00644670|Antimetabolites|antimetabolites|mesh-ancestor
92874229|NCT00895661|Rituximab|rituximab|mesh-list
92874303|NCT00646854|Alemtuzumab|alemtuzumab|mesh-list
93229233|NCT03655392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874376|NCT04174872|Dexmedetomidine|dexmedetomidine|mesh-list
93229234|NCT03655392|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93229235|NCT03655392|Vasodilator Agents|vasodilator agents|mesh-ancestor
93229236|NCT03655392|Gasotransmitters|gasotransmitters|mesh-ancestor
92874601|NCT00648570|Dexetimide|dexetimide|mesh-list
93229237|NCT03655392|Protective Agents|protective agents|mesh-ancestor
93229238|NCT01430390|Cyclophosphamide|cyclophosphamide|mesh-list
93229239|NCT01430390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229240|NCT01430390|Immunologic Factors|immunologic factors|mesh-ancestor
93229241|NCT01430390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229242|NCT01430390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229243|NCT01430390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93229244|NCT01430390|Alkylating Agents|alkylating agents|mesh-ancestor
93229245|NCT01430390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229246|NCT01430390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229247|NCT01430390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93229248|NCT03608618|Cyclophosphamide|cyclophosphamide|mesh-list
93229249|NCT03608618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229250|NCT03608618|Immunologic Factors|immunologic factors|mesh-ancestor
93229251|NCT03608618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229252|NCT03608618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229253|NCT03608618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92874901|NCT04437329|Cisplatin|cisplatin|mesh-list
93229254|NCT03608618|Alkylating Agents|alkylating agents|mesh-ancestor
93229255|NCT03608618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229256|NCT03608618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229257|NCT03608618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93229258|NCT04203290|Bupivacaine|bupivacaine|mesh-list
93229259|NCT04203290|Sevoflurane|sevoflurane|mesh-list
93229260|NCT04203290|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229261|NCT04203290|Anesthetics|anesthetics|mesh-ancestor
93229262|NCT04203290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229263|NCT04203290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229264|NCT04203290|Sensory System Agents|sensory system agents|mesh-ancestor
93229265|NCT04203290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229266|NCT04203290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93229267|NCT04203290|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92520563|NCT00102310|Z 338|z 338|mesh-list
93229268|NCT04203290|Anesthetics, General|anesthetics, general|mesh-ancestor
92875346|NCT02833025|Thrombin|thrombin|mesh-list
93229269|NCT02981082|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93229270|NCT02981082|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229271|NCT02981082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229272|NCT02981082|Immunologic Factors|immunologic factors|mesh-ancestor
93229273|NCT02981082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875611|NCT00620204|Antimetabolites|antimetabolites|mesh-ancestor
93229274|NCT03654612|Apatinib|apatinib|mesh-list
92875689|NCT02829281|Glucocorticoids|glucocorticoids|mesh-ancestor
93229275|NCT03654612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229276|NCT03654612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93229277|NCT03654612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229278|NCT03654612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229279|NCT01066104|Omalizumab|omalizumab|mesh-list
93229280|NCT01066104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93229281|NCT01066104|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93229282|NCT01066104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93229283|NCT01066104|Respiratory System Agents|respiratory system agents|mesh-ancestor
93229284|NCT01066104|Immunologic Factors|immunologic factors|mesh-ancestor
92876422|NCT02536014|Dexmedetomidine|dexmedetomidine|mesh-list
93229285|NCT01066104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229286|NCT02736968|Auranofin|auranofin|mesh-list
93229287|NCT02736968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229288|NCT03608306|Methamphetamine|methamphetamine|mesh-list
93229289|NCT03608306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93229290|NCT03608306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229291|NCT03608306|Sympathomimetics|sympathomimetics|mesh-ancestor
93229292|NCT03608306|Autonomic Agents|autonomic agents|mesh-ancestor
93229293|NCT03608306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229294|NCT03608306|Dopamine Agents|dopamine agents|mesh-ancestor
93229295|NCT03608306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876926|NCT02638896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229296|NCT03608306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229297|NCT03608306|Adrenergic Agents|adrenergic agents|mesh-ancestor
93229298|NCT03608306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93229299|NCT03608306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93229300|NCT03608306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93229301|NCT03608306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93229302|NCT03654144|Dienogest|dienogest|mesh-list
93229303|NCT03654144|Contraceptive Agents|contraceptive agents|mesh-list
92877142|NCT02638506|Fentanyl|fentanyl|mesh-list
93229304|NCT03654144|Contraceptives, Oral|contraceptives, oral|mesh-list
92877215|NCT02823743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93229305|NCT03654144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93229306|NCT03654144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93229307|NCT03654144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229308|NCT03654144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93229309|NCT03654144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93229310|NCT03654144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92877503|NCT02815787|Glyburide|glyburide|mesh-list
92877576|NCT02687984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93229311|NCT03654144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93229312|NCT03654144|Hormone Antagonists|hormone antagonists|mesh-ancestor
93229313|NCT03654144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229314|NCT03654144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93229315|NCT03654144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229316|NCT02591615|Paclitaxel|paclitaxel|mesh-list
92523302|NCT00120484|Vitamins|vitamins|mesh-ancestor
93229317|NCT02591615|Carboplatin|carboplatin|mesh-list
93229318|NCT02591615|Pembrolizumab|pembrolizumab|mesh-list
93229319|NCT02591615|Pemetrexed|pemetrexed|mesh-list
92878238|NCT04004819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878330|NCT05300347|Adenosine|adenosine|mesh-list
93229320|NCT02591615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229321|NCT02591615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229322|NCT02591615|Tubulin Modulators|tubulin modulators|mesh-ancestor
93229323|NCT02591615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92878766|NCT02817191|Tobramycin|tobramycin|mesh-list
93229324|NCT02591615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92878840|NCT00962299|Beclomethasone|beclomethasone|mesh-list
92878910|NCT02801201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92878985|NCT00963001|Treprostinil|treprostinil|mesh-list
93229325|NCT02591615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229326|NCT02591615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92879145|NCT04009525|Busulfan|busulfan|mesh-list
92879205|NCT00684099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93229327|NCT02591615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92879430|NCT02789813|Anticonvulsants|anticonvulsants|mesh-ancestor
93229328|NCT02591615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229329|NCT02591615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92879512|NCT05252546|Loperamide|loperamide|mesh-list
92879582|NCT00880620|Dopamine Agents|dopamine agents|mesh-ancestor
92879650|NCT04234607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229330|NCT02591615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93229331|NCT03077607|Itraconazole|itraconazole|mesh-list
93229332|NCT03077607|Rifampin|rifampin|mesh-list
93229333|NCT03077607|Talazoparib|talazoparib|mesh-list
93229334|NCT03077607|Antifungal Agents|antifungal agents|mesh-ancestor
93229335|NCT03077607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229336|NCT03077607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92879945|NCT02537210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229337|NCT03077607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93229338|NCT03077607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229339|NCT03077607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229340|NCT03077607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92880245|NCT03102047|Durvalumab|durvalumab|mesh-list
93229341|NCT03077607|Hormone Antagonists|hormone antagonists|mesh-ancestor
92880309|NCT03938857|Anesthetics, General|anesthetics, general|mesh-ancestor
93229342|NCT03077607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229343|NCT03077607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229344|NCT03077607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92880462|NCT02668094|Lidocaine|lidocaine|mesh-list
93229345|NCT03077607|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93229346|NCT03077607|Antitubercular Agents|antitubercular agents|mesh-ancestor
93229347|NCT03077607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93229348|NCT03077607|Leprostatic Agents|leprostatic agents|mesh-ancestor
93229349|NCT03077607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93229350|NCT03077607|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92880757|NCT02785601|Trazodone|trazodone|mesh-list
93229351|NCT03077607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92880827|NCT04157478|Alkylating Agents|alkylating agents|mesh-ancestor
93229352|NCT03077607|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93229353|NCT03077607|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93229354|NCT03077607|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93229355|NCT03077607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93229356|NCT03077607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93229357|NCT03077607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229358|NCT04215588|Hemostatics|hemostatics|mesh-list
93229359|NCT04215588|Coagulants|coagulants|mesh-ancestor
93229360|NCT01377051|Maleic acid|maleic acid|mesh-list
93229361|NCT01377051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881343|NCT02784821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229362|NCT01377051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229363|NCT03217175|Glucagon|glucagon|mesh-list
93229364|NCT03217175|Pancrelipase|pancrelipase|mesh-list
93229365|NCT03217175|Pancreatin|pancreatin|mesh-list
93229366|NCT03217175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229367|NCT03217175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229368|NCT03217175|Hormones|hormones|mesh-ancestor
93229369|NCT03217175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229370|NCT01379079|Aspirin|aspirin|mesh-list
93229371|NCT01379079|Calcium, Dietary|calcium, dietary|mesh-list
93229372|NCT01379079|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
93229373|NCT01379079|Carbaspirin calcium|carbaspirin calcium|mesh-list
93229374|NCT01379079|Calcium|calcium|mesh-list
93229375|NCT01379079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93229376|NCT01379079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229377|NCT01379079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92881701|NCT02665832|Vasodilator Agents|vasodilator agents|mesh-ancestor
93229378|NCT01379079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93229379|NCT01379079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881776|NCT02784743|Ivermectin|ivermectin|mesh-list
93229380|NCT01379079|Analgesics|analgesics|mesh-ancestor
93229381|NCT01379079|Sensory System Agents|sensory system agents|mesh-ancestor
93229382|NCT01379079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229383|NCT01379079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229384|NCT01379079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229385|NCT01379079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93229386|NCT01379079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92882210|NCT02779283|Hematinics|hematinics|mesh-ancestor
93229387|NCT01379079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882358|NCT04132479|Alkylating Agents|alkylating agents|mesh-ancestor
93229388|NCT01379079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93229389|NCT01379079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93229390|NCT01379079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229391|NCT01379079|Antipyretics|antipyretics|mesh-ancestor
93229392|NCT02034968|Nimotuzumab|nimotuzumab|mesh-list
92882581|NCT02656082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229393|NCT02034968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93229394|NCT02034968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229395|NCT01379001|Scopolamine|scopolamine|mesh-list
93229396|NCT01379001|Donepezil|donepezil|mesh-list
93229397|NCT01379001|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93229398|NCT01379001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93229399|NCT01379001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229400|NCT01379001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229401|NCT01379001|Cholinergic Agents|cholinergic agents|mesh-ancestor
93229402|NCT01379001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883030|NCT04226105|Insulin|insulin|mesh-list
93229403|NCT01379001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229404|NCT01379001|Nootropic Agents|nootropic agents|mesh-ancestor
92883109|NCT03061474|Niacin|niacin|mesh-list
93229405|NCT01379001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93229406|NCT01379001|Antiemetics|antiemetics|mesh-ancestor
93229407|NCT01379001|Autonomic Agents|autonomic agents|mesh-ancestor
93229408|NCT01379001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883540|NCT02655614|GABA Agents|gaba agents|mesh-ancestor
93229409|NCT01379001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229410|NCT01379001|Mydriatics|mydriatics|mesh-ancestor
93229411|NCT01379001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93229412|NCT01379001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93229413|NCT01379001|Parasympatholytics|parasympatholytics|mesh-ancestor
93229414|NCT03172325|Folic Acid|folic acid|mesh-list
93229415|NCT03172325|Prednisolone|prednisolone|mesh-list
93229416|NCT03172325|Adalimumab|adalimumab|mesh-list
93229417|NCT03172325|Methotrexate|methotrexate|mesh-list
92883911|NCT02655146|Progesterone|progesterone|mesh-list
93229418|NCT03172325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93229419|NCT03172325|Abortifacient Agents|abortifacient agents|mesh-ancestor
93229420|NCT03172325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93229421|NCT03172325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884281|NCT02630160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92884350|NCT00668616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229422|NCT03172325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93229423|NCT03172325|Antimetabolites|antimetabolites|mesh-ancestor
93229424|NCT03172325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229425|NCT03172325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229426|NCT03172325|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229427|NCT03172325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229428|NCT03172325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93229429|NCT03172325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229430|NCT03172325|Immunologic Factors|immunologic factors|mesh-ancestor
92884736|NCT03909295|Valsartan|valsartan|mesh-list
93229431|NCT03172325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229432|NCT03172325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92884865|NCT02575534|Procainamide|procainamide|mesh-list
93229433|NCT03172325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884945|NCT02756663|Hormones|hormones|mesh-ancestor
93229434|NCT03172325|Glucocorticoids|glucocorticoids|mesh-ancestor
93229435|NCT03172325|Hormones|hormones|mesh-ancestor
92885086|NCT02649140|Acetic Acid|acetic acid|mesh-list
92885164|NCT02760095|Vitamin A|vitamin a|mesh-list
93229436|NCT03172325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229437|NCT03172325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93229438|NCT03172325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93229439|NCT03172325|Hematinics|hematinics|mesh-ancestor
93229440|NCT03172325|Vitamin B Complex|vitamin b complex|mesh-ancestor
93229441|NCT03172325|Vitamins|vitamins|mesh-ancestor
93229442|NCT03172325|Micronutrients|micronutrients|mesh-ancestor
93229443|NCT03653520|Diazepam|diazepam|mesh-list
93229444|NCT03653520|Tramadol|tramadol|mesh-list
93229445|NCT03653520|Ondansetron|ondansetron|mesh-list
93229446|NCT03653520|Antiemetics|antiemetics|mesh-ancestor
93229447|NCT03653520|Autonomic Agents|autonomic agents|mesh-ancestor
93229448|NCT03653520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885684|NCT02758691|Insulin|insulin|mesh-list
93229449|NCT03653520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229450|NCT03653520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229451|NCT03653520|Antipruritics|antipruritics|mesh-ancestor
93229452|NCT03653520|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229453|NCT03653520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93229454|NCT03653520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93229455|NCT03653520|Serotonin Agents|serotonin agents|mesh-ancestor
93229456|NCT03653520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885976|NCT04166006|Sensory System Agents|sensory system agents|mesh-ancestor
92886046|NCT00715780|Biphasic Insulins|biphasic insulins|mesh-list
92886124|NCT02647424|Clomiphene|clomiphene|mesh-list
92886195|NCT00710320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229457|NCT03653520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229458|NCT03653520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93229459|NCT03653520|Narcotics|narcotics|mesh-ancestor
93229460|NCT03653520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229461|NCT03653520|Analgesics|analgesics|mesh-ancestor
93229462|NCT03653520|Sensory System Agents|sensory system agents|mesh-ancestor
93229463|NCT03653520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92886567|NCT00678522|Atorvastatin|atorvastatin|mesh-list
93229464|NCT03653520|Anticonvulsants|anticonvulsants|mesh-ancestor
93229465|NCT03653520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93229466|NCT03653520|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93229467|NCT03653520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93229468|NCT03653520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93229469|NCT03653520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93229470|NCT03653520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93229471|NCT03653520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93229472|NCT03653520|Anesthetics, General|anesthetics, general|mesh-ancestor
93229473|NCT03653520|Anesthetics|anesthetics|mesh-ancestor
93229474|NCT03653520|GABA Modulators|gaba modulators|mesh-ancestor
93229475|NCT03653520|GABA Agents|gaba agents|mesh-ancestor
93229476|NCT01208090|Ponesimod|ponesimod|mesh-list
93229477|NCT01208090|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93229478|NCT01208090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229479|NCT01208090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886775|NCT00682578|Amebicides|amebicides|mesh-ancestor
93229480|NCT01208090|Immunologic Factors|immunologic factors|mesh-ancestor
92886856|NCT02747381|Vitamins|vitamins|mesh-ancestor
93229481|NCT01208090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229482|NCT01380483|Doxycycline|doxycycline|mesh-list
92886923|NCT00537979|Vitamins|vitamins|mesh-ancestor
92886994|NCT02744495|Betamethasone|betamethasone|mesh-list
93229483|NCT01380483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93229484|NCT01380483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229485|NCT01380483|Antimalarials|antimalarials|mesh-ancestor
93229486|NCT01380483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93229487|NCT01380483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93229488|NCT02745392|Zolmitriptan|zolmitriptan|mesh-list
93229489|NCT02745392|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93229490|NCT02745392|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93229491|NCT02745392|Serotonin Agents|serotonin agents|mesh-ancestor
93229492|NCT02745392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887436|NCT02735603|Dopamine Agents|dopamine agents|mesh-ancestor
92887510|NCT00686010|Antimetabolites|antimetabolites|mesh-ancestor
92887586|NCT03785158|Protective Agents|protective agents|mesh-ancestor
92887662|NCT05407597|Icatibant|icatibant|mesh-list
92887736|NCT02737943|Sensory System Agents|sensory system agents|mesh-ancestor
93229493|NCT02745392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229494|NCT02745392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229495|NCT01378845|Bosentan|bosentan|mesh-list
93229496|NCT01378845|Alprostadil|alprostadil|mesh-list
93229497|NCT01378845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93229498|NCT01378845|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93229499|NCT01378845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229500|NCT01378845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93229501|NCT01378845|Vasodilator Agents|vasodilator agents|mesh-ancestor
93229502|NCT01378845|Urological Agents|urological agents|mesh-ancestor
93229503|NCT04884399|Ranibizumab|ranibizumab|mesh-list
93229504|NCT04884399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93229505|NCT04884399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93229506|NCT04884399|Growth Substances|growth substances|mesh-ancestor
93229507|NCT04884399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229508|NCT04884399|Growth Inhibitors|growth inhibitors|mesh-ancestor
93229509|NCT04884399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229510|NCT04904549|Vaccines|vaccines|mesh-list
93229511|NCT04904549|Immunologic Factors|immunologic factors|mesh-ancestor
93229512|NCT04904549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229513|NCT03607916|Morphine|morphine|mesh-list
93229514|NCT03607916|Prilocaine|prilocaine|mesh-list
93229515|NCT03607916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93229516|NCT03607916|Narcotics|narcotics|mesh-ancestor
93229517|NCT03607916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229518|NCT03607916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229519|NCT03607916|Analgesics|analgesics|mesh-ancestor
93229520|NCT03607916|Sensory System Agents|sensory system agents|mesh-ancestor
93229521|NCT03607916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229522|NCT03607916|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229523|NCT03607916|Anesthetics|anesthetics|mesh-ancestor
93229524|NCT01141712|Cytarabine|cytarabine|mesh-list
93229525|NCT01141712|Etoposide|etoposide|mesh-list
93229526|NCT01141712|Melphalan|melphalan|mesh-list
93229527|NCT01141712|Carmustine|carmustine|mesh-list
93229528|NCT01141712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229529|NCT01141712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229530|NCT01141712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93229531|NCT01141712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93229532|NCT01141712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229533|NCT01141712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229534|NCT01141712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92901650|NCT00646529|Hormones|hormones|mesh-ancestor
93229535|NCT01141712|Antimetabolites|antimetabolites|mesh-ancestor
92888293|NCT00686556|Cyclosporine|cyclosporine|mesh-list
93229536|NCT01141712|Antiviral Agents|antiviral agents|mesh-ancestor
93229537|NCT01141712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229538|NCT01141712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888453|NCT03562195|Albuterol|albuterol|mesh-list
93229539|NCT01141712|Immunologic Factors|immunologic factors|mesh-ancestor
93229540|NCT01141712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229541|NCT01141712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93229542|NCT01141712|Alkylating Agents|alkylating agents|mesh-ancestor
93229543|NCT01141712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93229544|NCT02034890|Hyaluronic Acid|hyaluronic acid|mesh-list
93229545|NCT02034890|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93229546|NCT02034890|Immunologic Factors|immunologic factors|mesh-ancestor
92888734|NCT02646020|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229547|NCT02034890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229548|NCT02034890|Viscosupplements|viscosupplements|mesh-ancestor
92888815|NCT00692328|Levodopa|levodopa|mesh-list
93229549|NCT02034890|Protective Agents|protective agents|mesh-ancestor
92888892|NCT02732795|Morphine|morphine|mesh-list
93229550|NCT02015351|Bevacizumab|bevacizumab|mesh-list
93229551|NCT02015351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888955|NCT00993109|Valsartan|valsartan|mesh-list
93229552|NCT02015351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229553|NCT02015351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93229554|NCT02015351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93229555|NCT02015351|Growth Substances|growth substances|mesh-ancestor
93229556|NCT02015351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889100|NCT00993343|Cyclosporine|cyclosporine|mesh-list
93229557|NCT02015351|Growth Inhibitors|growth inhibitors|mesh-ancestor
93229558|NCT03604796|Acetaminophen|acetaminophen|mesh-list
93229559|NCT03604796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93229560|NCT03604796|Analgesics|analgesics|mesh-ancestor
93229561|NCT03604796|Sensory System Agents|sensory system agents|mesh-ancestor
93229562|NCT03604796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229563|NCT03604796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229564|NCT03604796|Antipyretics|antipyretics|mesh-ancestor
93229565|NCT02237534|Calcium Carbonate|calcium carbonate|mesh-list
93229566|NCT02237534|Calcium|calcium|mesh-list
93229567|NCT02237534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93229568|NCT02237534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229569|NCT02237534|Antacids|antacids|mesh-ancestor
93229570|NCT02237534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229571|NCT02237534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229572|NCT03606902|Fentanyl|fentanyl|mesh-list
93229573|NCT03606902|Bupivacaine|bupivacaine|mesh-list
93229574|NCT03606902|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229575|NCT03606902|Anesthetics|anesthetics|mesh-ancestor
92889839|NCT00872898|Dopamine Agents|dopamine agents|mesh-ancestor
93229576|NCT03606902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889921|NCT02718521|Isosorbide|isosorbide|mesh-list
92889985|NCT02722733|Cytarabine|cytarabine|mesh-list
93229577|NCT03606902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229578|NCT03606902|Sensory System Agents|sensory system agents|mesh-ancestor
93229579|NCT03606902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229580|NCT03606902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93229581|NCT03606902|Narcotics|narcotics|mesh-ancestor
93229582|NCT03606902|Analgesics|analgesics|mesh-ancestor
93229583|NCT03606902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93229584|NCT03606902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93229585|NCT03606902|Anesthetics, General|anesthetics, general|mesh-ancestor
93229586|NCT03602378|Hydrocortisone|hydrocortisone|mesh-list
93229587|NCT03602378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890365|NCT00999427|Povidone|povidone|mesh-list
92890430|NCT00996229|Resveratrol|resveratrol|mesh-list
93229588|NCT03606824|Pitavastatin|pitavastatin|mesh-list
93229589|NCT03606824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93229590|NCT03606824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93229591|NCT03606824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93229592|NCT03606824|Antimetabolites|antimetabolites|mesh-ancestor
92890651|NCT00996697|Respiratory System Agents|respiratory system agents|mesh-ancestor
93229593|NCT03606824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229594|NCT03606824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229595|NCT03606824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93229596|NCT03604016|Tenofovir|tenofovir|mesh-list
92890800|NCT01000597|Xhance|xhance|mesh-list
93229597|NCT03604016|Antiviral Agents|antiviral agents|mesh-ancestor
92890947|NCT02712203|Immunologic Factors|immunologic factors|mesh-ancestor
92891023|NCT05167513|Protease Inhibitors|protease inhibitors|mesh-ancestor
93229598|NCT03604016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229599|NCT03604016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93229600|NCT03604016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92891190|NCT01004575|Cobalt|cobalt|mesh-list
93229601|NCT03604016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891319|NCT01002703|Lenalidomide|lenalidomide|mesh-list
92891391|NCT02711579|Analgesics|analgesics|mesh-ancestor
93229602|NCT03604016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229603|NCT03604016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93229604|NCT03604016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93229605|NCT01064622|Hydrocortisone|hydrocortisone|mesh-list
93229606|NCT01064622|Gemcitabine|gemcitabine|mesh-list
92891608|NCT04459871|Thrombin|thrombin|mesh-list
93229607|NCT01064622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92891759|NCT02706509|Narcotics|narcotics|mesh-ancestor
93229608|NCT01064622|Antimetabolites|antimetabolites|mesh-ancestor
93229609|NCT01064622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901714|NCT02663999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93229610|NCT01064622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229611|NCT01064622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229612|NCT01063764|Levetiracetam|levetiracetam|mesh-list
93229613|NCT01063764|Anticonvulsants|anticonvulsants|mesh-ancestor
93229614|NCT01063764|Nootropic Agents|nootropic agents|mesh-ancestor
93229615|NCT04053972|Lenvatinib|lenvatinib|mesh-list
93229616|NCT04053972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229617|NCT04053972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93229618|NCT04053972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229619|NCT04053972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229620|NCT01380249|Bromides|bromides|mesh-list
93229621|NCT01380249|Anticonvulsants|anticonvulsants|mesh-ancestor
93229622|NCT04054518|Durvalumab|durvalumab|mesh-list
93229623|NCT04054518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93229624|NCT04054518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229625|NCT03652896|Liver Extracts|liver extracts|mesh-list
93229626|NCT03652896|Hematinics|hematinics|mesh-ancestor
92892696|NCT00852969|Niacin|niacin|mesh-list
93229627|NCT04565847|Albuterol|albuterol|mesh-list
93229628|NCT04565847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92892793|NCT00851877|Cetuximab|cetuximab|mesh-list
93229629|NCT04565847|Autonomic Agents|autonomic agents|mesh-ancestor
92892865|NCT00520975|Bevacizumab|bevacizumab|mesh-list
93229630|NCT04565847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229631|NCT04565847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893159|NCT00736294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93229632|NCT04565847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93229633|NCT04565847|Respiratory System Agents|respiratory system agents|mesh-ancestor
93229634|NCT04565847|Tocolytic Agents|tocolytic agents|mesh-ancestor
93229635|NCT04565847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92893380|NCT00881894|Rotigotine|rotigotine|mesh-list
92893452|NCT00827775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92893527|NCT03916601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93229636|NCT04565847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93229637|NCT04565847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93229638|NCT04565847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93229639|NCT04565847|Adrenergic Agents|adrenergic agents|mesh-ancestor
93229640|NCT04565847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229641|NCT04565847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229642|NCT03075891|Doxycycline|doxycycline|mesh-list
93229643|NCT03075891|Ivermectin|ivermectin|mesh-list
93229644|NCT03075891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93229645|NCT03075891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229646|NCT03075891|Antimalarials|antimalarials|mesh-ancestor
93229647|NCT03075891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92894190|NCT03393611|Cytarabine|cytarabine|mesh-list
93229648|NCT03075891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92894341|NCT00657254|Sorafenib|sorafenib|mesh-list
93229649|NCT02013167|Blinatumomab|blinatumomab|mesh-list
93229650|NCT02013167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229651|NCT01378533|Paclitaxel|paclitaxel|mesh-list
93229652|NCT01378533|Cyclophosphamide|cyclophosphamide|mesh-list
93229653|NCT01378533|Carboplatin|carboplatin|mesh-list
93229654|NCT01378533|Epirubicin|epirubicin|mesh-list
93229655|NCT01378533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229656|NCT01378533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229657|NCT01378533|Tubulin Modulators|tubulin modulators|mesh-ancestor
93229658|NCT01378533|Antimitotic Agents|antimitotic agents|mesh-ancestor
92894635|NCT03362099|Bupropion|bupropion|mesh-list
93229659|NCT01378533|Mitosis Modulators|mitosis modulators|mesh-ancestor
93229660|NCT01378533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229661|NCT01378533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229662|NCT01378533|Immunologic Factors|immunologic factors|mesh-ancestor
93229663|NCT01378533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229664|NCT01378533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229665|NCT01378533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93229666|NCT01378533|Alkylating Agents|alkylating agents|mesh-ancestor
93229667|NCT01378533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93229668|NCT01378533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93229669|NCT01378533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93229670|NCT01378533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93229671|NCT01378533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229672|NCT02630199|Paclitaxel|paclitaxel|mesh-list
93229673|NCT02630199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229674|NCT02630199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229675|NCT02630199|Tubulin Modulators|tubulin modulators|mesh-ancestor
93229676|NCT02630199|Antimitotic Agents|antimitotic agents|mesh-ancestor
93229677|NCT02630199|Mitosis Modulators|mitosis modulators|mesh-ancestor
93229678|NCT02630199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229679|NCT02588781|Pemetrexed|pemetrexed|mesh-list
92895136|NCT02701517|Cyclosporine|cyclosporine|mesh-list
93229680|NCT02588781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229681|NCT02588781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895275|NCT00505687|Dopamine Agents|dopamine agents|mesh-ancestor
92895350|NCT01009567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895425|NCT02697851|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93229682|NCT02588781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229683|NCT02588781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92895497|NCT02700347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229684|NCT02588781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93229685|NCT01063062|Methotrexate|methotrexate|mesh-list
93229686|NCT01063062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93229687|NCT01063062|Abortifacient Agents|abortifacient agents|mesh-ancestor
93229688|NCT01063062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93229689|NCT01063062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229690|NCT01063062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93229691|NCT01063062|Antimetabolites|antimetabolites|mesh-ancestor
93229692|NCT01063062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229693|NCT01063062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229694|NCT01063062|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229695|NCT01063062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229696|NCT01063062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92895863|NCT00856206|Rilonacept|rilonacept|mesh-list
93229697|NCT01063062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229698|NCT01063062|Immunologic Factors|immunologic factors|mesh-ancestor
93229699|NCT01063062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896007|NCT00674102|Vadimezan|vadimezan|mesh-list
93229700|NCT01063062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93229701|NCT01314989|Cyproheptadine|cyproheptadine|mesh-list
93229702|NCT01314989|Antipruritics|antipruritics|mesh-ancestor
93229703|NCT01314989|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229704|NCT01314989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896229|NCT00855738|GABA Agents|gaba agents|mesh-ancestor
92896301|NCT02566720|Analgesics|analgesics|mesh-ancestor
93229705|NCT01314989|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93229706|NCT01314989|Histamine Antagonists|histamine antagonists|mesh-ancestor
93229707|NCT01314989|Histamine Agents|histamine agents|mesh-ancestor
93229708|NCT01314989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896520|NCT00855582|Urological Agents|urological agents|mesh-ancestor
92896603|NCT02566252|Albuterol|albuterol|mesh-list
93229709|NCT01314989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896671|NCT04595266|Antidotes|antidotes|mesh-ancestor
92896823|NCT00577096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229710|NCT01314989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229711|NCT01314989|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93229712|NCT01314989|Serotonin Agents|serotonin agents|mesh-ancestor
93229713|NCT01314989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93229715|NCT04483115|Vasodilator Agents|vasodilator agents|mesh-ancestor
93229716|NCT04483115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93229717|NCT04483115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93229718|NCT04483115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229719|NCT04483115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229720|NCT04483115|Urological Agents|urological agents|mesh-ancestor
93229721|NCT04054362|Paclitaxel|paclitaxel|mesh-list
93229722|NCT04054362|Gemcitabine|gemcitabine|mesh-list
92897493|NCT04115982|Vitamins|vitamins|mesh-ancestor
93229723|NCT04054362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92897568|NCT00490555|Anabolic Agents|anabolic agents|mesh-ancestor
93229724|NCT04054362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229725|NCT04054362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229726|NCT04054362|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897644|NCT02626754|Sunitinib|sunitinib|mesh-list
92897714|NCT05662163|Anesthetics|anesthetics|mesh-list
93229727|NCT04054362|Antimitotic Agents|antimitotic agents|mesh-ancestor
93229728|NCT04054362|Mitosis Modulators|mitosis modulators|mesh-ancestor
93229729|NCT04054362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229730|NCT04054362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93229731|NCT04054362|Antimetabolites|antimetabolites|mesh-ancestor
93229732|NCT04467281|Daratumumab|daratumumab|mesh-list
93229733|NCT04467281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229734|NCT01378143|Pentamidine|pentamidine|mesh-list
93229735|NCT01378143|Antifungal Agents|antifungal agents|mesh-ancestor
93229736|NCT01378143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898231|NCT00693524|Mycophenolic Acid|mycophenolic acid|mesh-list
93229737|NCT01378143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93229738|NCT01378143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93229739|NCT01378143|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93229740|NCT02973048|Bupivacaine|bupivacaine|mesh-list
93229741|NCT02973048|Prilocaine|prilocaine|mesh-list
93229742|NCT02973048|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229743|NCT02973048|Anesthetics|anesthetics|mesh-ancestor
93229744|NCT02973048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898589|NCT00689858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93229745|NCT02973048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898669|NCT00690170|Ketamine|ketamine|mesh-list
93229746|NCT02973048|Sensory System Agents|sensory system agents|mesh-ancestor
93229747|NCT02973048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229748|NCT03342027|Bupropion|bupropion|mesh-list
93229749|NCT03342027|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93229750|NCT03342027|Antidepressive Agents|antidepressive agents|mesh-ancestor
93229751|NCT03342027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93229752|NCT03342027|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92899029|NCT02686619|Cyclosporine|cyclosporine|mesh-list
93229753|NCT03342027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92899113|NCT04185077|Heparin|heparin|mesh-list
93229754|NCT03342027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93229755|NCT03342027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229756|NCT03342027|Dopamine Agents|dopamine agents|mesh-ancestor
93229757|NCT03342027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899407|NCT04115904|Analgesics|analgesics|mesh-ancestor
93229758|NCT03342027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229759|NCT03342027|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92899487|NCT00593606|Rotigotine|rotigotine|mesh-list
93229760|NCT03342027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93229761|NCT03342027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901860|NCT02663141|Bevacizumab|bevacizumab|mesh-list
93229762|NCT04054206|Ibudilast|ibudilast|mesh-list
93229763|NCT04054206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93229765|NCT04054206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899692|NCT02619266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899764|NCT00867308|Growth Substances|growth substances|mesh-ancestor
93229766|NCT04054206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229767|NCT04054206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93229768|NCT04054206|Respiratory System Agents|respiratory system agents|mesh-ancestor
93229769|NCT04054206|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93229770|NCT04054206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899918|NCT00602537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900071|NCT00859898|Metformin|metformin|mesh-list
93229771|NCT04054206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229772|NCT04054206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92545494|NCT00276770|Fluorides|fluorides|mesh-list
93229773|NCT04054206|Vasodilator Agents|vasodilator agents|mesh-ancestor
93229774|NCT03603938|Losartan|losartan|mesh-list
93229775|NCT03603938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93229776|NCT03603938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93229777|NCT03603938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93229778|NCT03603938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93229779|NCT03603938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229780|NCT03652116|Meperidine|meperidine|mesh-list
93229781|NCT03652116|Bupivacaine|bupivacaine|mesh-list
93229782|NCT03652116|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229783|NCT03652116|Anesthetics|anesthetics|mesh-ancestor
93229784|NCT03652116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229785|NCT03652116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229786|NCT03652116|Sensory System Agents|sensory system agents|mesh-ancestor
93229787|NCT03652116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229788|NCT03652116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93229789|NCT03652116|Narcotics|narcotics|mesh-ancestor
93229790|NCT03652116|Analgesics|analgesics|mesh-ancestor
93229791|NCT03652116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93229792|NCT02232087|Fluticasone|fluticasone|mesh-list
93229793|NCT02232087|Xhance|xhance|mesh-list
93229794|NCT02232087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92900263|NCT00697502|Antimetabolites|antimetabolites|mesh-ancestor
92900337|NCT00856856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900410|NCT04182191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92900488|NCT00921700|Acetaminophen|acetaminophen|mesh-list
93229795|NCT02232087|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92900591|NCT02151604|Xenon|xenon|mesh-list
93229796|NCT02232087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229797|NCT02232087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93229798|NCT02232087|Autonomic Agents|autonomic agents|mesh-ancestor
93229799|NCT02232087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229800|NCT02232087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229801|NCT02232087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92900637|NCT01759459|Lidocaine|lidocaine|mesh-list
93229802|NCT02232087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900702|NCT02677571|Morphine|morphine|mesh-list
93229803|NCT02232087|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229804|NCT02232087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93229805|NCT02232087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93229806|NCT02232087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93229807|NCT02232087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93229808|NCT02232087|Adrenergic Agents|adrenergic agents|mesh-ancestor
93229809|NCT02232087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900995|NCT02675153|Sirolimus|sirolimus|mesh-list
93229810|NCT02232087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229811|NCT02232087|Glucocorticoids|glucocorticoids|mesh-ancestor
93229812|NCT02232087|Hormones|hormones|mesh-ancestor
93229813|NCT02232087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229814|NCT02232087|Sympathomimetics|sympathomimetics|mesh-ancestor
93229815|NCT01380015|Rosmarinic acid|rosmarinic acid|mesh-list
93229816|NCT01380015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93229817|NCT01380015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93229818|NCT01380015|Analgesics|analgesics|mesh-ancestor
93229819|NCT01380015|Sensory System Agents|sensory system agents|mesh-ancestor
93229820|NCT01380015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229821|NCT01380015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901312|NCT00645125|Cefdinir|cefdinir|mesh-list
93229822|NCT01380015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229823|NCT01380015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229824|NCT01380015|Antioxidants|antioxidants|mesh-ancestor
92901436|NCT02667197|Analgesics|analgesics|mesh-ancestor
92901506|NCT00910637|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93229825|NCT01380015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229826|NCT01380015|Protective Agents|protective agents|mesh-ancestor
92901649|NCT00646529|Glucocorticoids|glucocorticoids|mesh-ancestor
93229827|NCT01380015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93229828|NCT01380015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93229829|NCT01380015|Protease Inhibitors|protease inhibitors|mesh-ancestor
92901800|NCT00649181|Metolazone|metolazone|mesh-list
93229830|NCT01380015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229831|NCT03603626|Pregabalin|pregabalin|mesh-list
93229832|NCT03603626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229833|NCT03603626|Analgesics|analgesics|mesh-ancestor
93229834|NCT03603626|Sensory System Agents|sensory system agents|mesh-ancestor
93229835|NCT03603626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229836|NCT03603626|Anticonvulsants|anticonvulsants|mesh-ancestor
93229837|NCT03603626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92902086|NCT00848354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93229838|NCT03603626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93229839|NCT03603626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229840|NCT03603626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93229841|NCT03603626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93229842|NCT03603626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92902359|NCT00691210|Niacin|niacin|mesh-list
93229843|NCT03603626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93229844|NCT03603626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902533|NCT02648711|Vitamins|vitamins|mesh-ancestor
93229846|NCT01765218|Anticonvulsants|anticonvulsants|mesh-ancestor
93229847|NCT01765218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93229848|NCT01765218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229849|NCT02972502|Diphenhydramine|diphenhydramine|mesh-list
93229850|NCT02972502|Promethazine|promethazine|mesh-list
93229851|NCT02972502|Haloperidol|haloperidol|mesh-list
93229852|NCT02972502|Metoclopramide|metoclopramide|mesh-list
93229853|NCT02972502|Haloperidol decanoate|haloperidol decanoate|mesh-list
92902979|NCT02645903|Morphine|morphine|mesh-list
93229854|NCT02972502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92903124|NCT02645279|Anesthetics, General|anesthetics, general|mesh-ancestor
92903200|NCT00686998|Olanzapine|olanzapine|mesh-list
92903273|NCT00837876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229855|NCT02972502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93229856|NCT02972502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903421|NCT00655655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229857|NCT02972502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903500|NCT02118467|Synephrine|synephrine|mesh-list
92903573|NCT02637167|Rifaximin|rifaximin|mesh-list
93229858|NCT02972502|Anesthetics, Local|anesthetics, local|mesh-ancestor
93229859|NCT02972502|Anesthetics|anesthetics|mesh-ancestor
93229860|NCT02972502|Sensory System Agents|sensory system agents|mesh-ancestor
92903648|NCT00656123|Molgramostim|molgramostim|mesh-list
93229861|NCT02972502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229862|NCT02972502|Antiemetics|antiemetics|mesh-ancestor
93229863|NCT02972502|Autonomic Agents|autonomic agents|mesh-ancestor
93229864|NCT02972502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229865|NCT02972502|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93229866|NCT02972502|Histamine Antagonists|histamine antagonists|mesh-ancestor
93229867|NCT02972502|Histamine Agents|histamine agents|mesh-ancestor
93229868|NCT02972502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903873|NCT04158947|Afatinib|afatinib|mesh-list
93229869|NCT02972502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229870|NCT02972502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93229871|NCT02972502|Antipruritics|antipruritics|mesh-ancestor
93229872|NCT02972502|Dermatologic Agents|dermatologic agents|mesh-ancestor
92904081|NCT05863195|Leucovorin|leucovorin|mesh-list
93229873|NCT02972502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93229874|NCT02972502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93229875|NCT02972502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93229876|NCT02972502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92904231|NCT05861791|Ketorolac|ketorolac|mesh-list
93229877|NCT02972502|Dopamine Agents|dopamine agents|mesh-ancestor
93229878|NCT02972502|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93229879|NCT02972502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93229880|NCT03606590|Sorafenib|sorafenib|mesh-list
92904449|NCT05329766|Leucovorin|leucovorin|mesh-list
92904528|NCT05221892|Hematinics|hematinics|mesh-ancestor
93229881|NCT03606590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229882|NCT03606590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93229883|NCT03606590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229884|NCT03606590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229885|NCT03163667|Everolimus|everolimus|mesh-list
93229886|NCT03163667|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93229887|NCT03163667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904977|NCT03711604|Tenalisib|tenalisib|mesh-list
93229888|NCT03163667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905053|NCT03414034|Prednisone|prednisone|mesh-list
93229889|NCT03163667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229890|NCT03163667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229891|NCT03163667|Immunologic Factors|immunologic factors|mesh-ancestor
93229892|NCT03163667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229893|NCT03163667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229894|NCT03603548|Tacrolimus|tacrolimus|mesh-list
93229895|NCT03603548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229896|NCT03603548|Immunologic Factors|immunologic factors|mesh-ancestor
93229897|NCT03603548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229898|NCT03603548|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93229899|NCT03603548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229900|NCT03603548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229901|NCT03954782|Nintedanib|nintedanib|mesh-list
93229902|NCT03954782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229903|NCT03954782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93229904|NCT03954782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229905|NCT03954782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229906|NCT03651726|Palmidrol|palmidrol|mesh-list
93229907|NCT03651726|Dronabinol|dronabinol|mesh-list
93229908|NCT03651726|Hallucinogens|hallucinogens|mesh-ancestor
93229909|NCT03651726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229910|NCT03651726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93229911|NCT03651726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93229912|NCT03651726|Analgesics|analgesics|mesh-ancestor
93229913|NCT03651726|Sensory System Agents|sensory system agents|mesh-ancestor
93229914|NCT03651726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229915|NCT03651726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93229916|NCT03651726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93229917|NCT03651726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229918|NCT03651726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229919|NCT03651726|Hormones|hormones|mesh-ancestor
93229920|NCT03651726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229921|NCT03651726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93229922|NCT03651726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229923|NCT03651726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229924|NCT03651726|Antiviral Agents|antiviral agents|mesh-ancestor
93229925|NCT03651726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229926|NCT00107250|Paclitaxel|paclitaxel|mesh-list
93229927|NCT00107250|Carboplatin|carboplatin|mesh-list
93229928|NCT00107250|Capecitabine|capecitabine|mesh-list
93229929|NCT00107250|Cediranib|cediranib|mesh-list
93229930|NCT00107250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229931|NCT00107250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229932|NCT00107250|Tubulin Modulators|tubulin modulators|mesh-ancestor
92905608|NCT00825162|Vaccines|vaccines|mesh-list
93229933|NCT00107250|Antimitotic Agents|antimitotic agents|mesh-ancestor
93229934|NCT00107250|Mitosis Modulators|mitosis modulators|mesh-ancestor
93229935|NCT00107250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229936|NCT00107250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93229937|NCT00107250|Antimetabolites|antimetabolites|mesh-ancestor
93229938|NCT00107250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229939|NCT00107250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93229940|NCT03167411|Exenatide|exenatide|mesh-list
93229941|NCT03167411|Bexagliflozin|bexagliflozin|mesh-list
93229942|NCT03167411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93229943|NCT03167411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229944|NCT03167411|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93229945|NCT03167411|Incretins|incretins|mesh-ancestor
93229946|NCT03167411|Hormones|hormones|mesh-ancestor
93229947|NCT03167411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229948|NCT02237768|Dirithromycin|dirithromycin|mesh-list
93229949|NCT02237768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93229950|NCT02237768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93229951|NCT05461833|Octylonium|octylonium|mesh-list
93229952|NCT05461833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93229953|NCT05461833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93229954|NCT05461833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229955|NCT05461833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93229956|NCT05461833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229957|NCT05461833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229958|NCT05461833|Parasympatholytics|parasympatholytics|mesh-ancestor
93229959|NCT05461833|Autonomic Agents|autonomic agents|mesh-ancestor
92905870|NCT04155515|Antiviral Agents|antiviral agents|mesh-ancestor
92905951|NCT02629835|BB 1101|bb 1101|mesh-list
93229960|NCT05461833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229961|NCT05461833|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93229962|NCT05461833|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93229963|NCT05461833|Cholinergic Agents|cholinergic agents|mesh-ancestor
93229964|NCT05461833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93229965|NCT01560585|Isotretinoin|isotretinoin|mesh-list
93229966|NCT01560585|Dermatologic Agents|dermatologic agents|mesh-ancestor
93229967|NCT01376427|Dexamethasone|dexamethasone|mesh-list
93229968|NCT01376427|Methotrexate|methotrexate|mesh-list
93229969|NCT01376427|Vincristine|vincristine|mesh-list
93229970|NCT01376427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93229971|NCT01376427|Antiemetics|antiemetics|mesh-ancestor
93229972|NCT01376427|Autonomic Agents|autonomic agents|mesh-ancestor
93229973|NCT01376427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93229974|NCT01376427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93229975|NCT01376427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93229976|NCT01376427|Glucocorticoids|glucocorticoids|mesh-ancestor
93229977|NCT01376427|Hormones|hormones|mesh-ancestor
93229978|NCT01376427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93229979|NCT01376427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93229980|NCT01376427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93229981|NCT01376427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93229982|NCT01376427|Abortifacient Agents|abortifacient agents|mesh-ancestor
93229983|NCT01376427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93229984|NCT01376427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93229985|NCT01376427|Antimetabolites|antimetabolites|mesh-ancestor
93229986|NCT01376427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93229987|NCT01376427|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902087|NCT00848354|Analgesics|analgesics|mesh-ancestor
93229988|NCT01376427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93229989|NCT01376427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93229990|NCT01376427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93229991|NCT01376427|Immunologic Factors|immunologic factors|mesh-ancestor
93229992|NCT01376427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93229993|NCT01376427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93229994|NCT01376427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93229995|NCT01376427|Tubulin Modulators|tubulin modulators|mesh-ancestor
93229996|NCT01376427|Antimitotic Agents|antimitotic agents|mesh-ancestor
93229997|NCT01376427|Mitosis Modulators|mitosis modulators|mesh-ancestor
93229998|NCT03075501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93229999|NCT03075501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230000|NCT03075501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230001|NCT05462535|Losartan|losartan|mesh-list
93230002|NCT05462535|Amlodipine|amlodipine|mesh-list
93230003|NCT05462535|Chlorthalidone|chlorthalidone|mesh-list
93230004|NCT05462535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93230005|NCT05462535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93230006|NCT05462535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230007|NCT05462535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907253|NCT05840211|Antimetabolites|antimetabolites|mesh-ancestor
93230008|NCT05462535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93230009|NCT05462535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230010|NCT05462535|Vasodilator Agents|vasodilator agents|mesh-ancestor
92907396|NCT05705349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230011|NCT05462535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93230012|NCT05462535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93230013|NCT05462535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93230014|NCT05462535|Diuretics|diuretics|mesh-ancestor
93230015|NCT05462535|Natriuretic Agents|natriuretic agents|mesh-ancestor
92907668|NCT05413018|Cc-486|cc-486|mesh-list
93230016|NCT05462535|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93230017|NCT05764317|Amlodipine|amlodipine|mesh-list
93230018|NCT05764317|Perindopril|perindopril|mesh-list
93230019|NCT05764317|Atorvastatin|atorvastatin|mesh-list
93230020|NCT05764317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93230021|NCT05764317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93230022|NCT05764317|Antimetabolites|antimetabolites|mesh-ancestor
92908051|NCT04776252|Islatravir|islatravir|mesh-list
92908204|NCT04525014|Alkylating Agents|alkylating agents|mesh-ancestor
93230023|NCT05764317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230024|NCT05764317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93230025|NCT05764317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93230026|NCT05764317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230027|NCT05764317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92908425|NCT04247542|Vancomycin|vancomycin|mesh-list
93230028|NCT05764317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92908499|NCT04164082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230029|NCT05764317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92908572|NCT04016805|Acalabrutinib|acalabrutinib|mesh-list
93230030|NCT05764317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93230031|NCT05764317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230032|NCT05764317|Vasodilator Agents|vasodilator agents|mesh-ancestor
93230033|NCT05764317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93230034|NCT05764317|Protease Inhibitors|protease inhibitors|mesh-ancestor
93230035|NCT05461365|Insulin|insulin|mesh-list
93230036|NCT05461365|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92908946|NCT03331289|Exenatide|exenatide|mesh-list
93230037|NCT05461365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93230038|NCT05461365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230039|NCT03602846|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92909099|NCT02893917|Olaparib|olaparib|mesh-list
93230040|NCT03602846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230041|NCT02317991|Paclitaxel|paclitaxel|mesh-list
93230042|NCT02317991|Ramucirumab|ramucirumab|mesh-list
93230043|NCT02317991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93230044|NCT02317991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230045|NCT02317991|Tubulin Modulators|tubulin modulators|mesh-ancestor
93230046|NCT02317991|Antimitotic Agents|antimitotic agents|mesh-ancestor
93230047|NCT02317991|Mitosis Modulators|mitosis modulators|mesh-ancestor
93230048|NCT02317991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230049|NCT03602690|Ritonavir|ritonavir|mesh-list
93230050|NCT03602690|Darunavir|darunavir|mesh-list
93230051|NCT03602690|Dolutegravir|dolutegravir|mesh-list
93230052|NCT03602690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93230053|NCT03602690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93230054|NCT03602690|Protease Inhibitors|protease inhibitors|mesh-ancestor
93230055|NCT03602690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230056|NCT03602690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230057|NCT03602690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93230058|NCT03602690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93230059|NCT03602690|Antiviral Agents|antiviral agents|mesh-ancestor
92902159|NCT02657447|Chelating Agents|chelating agents|mesh-ancestor
93230060|NCT03602690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230061|NCT03602690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93230062|NCT03602690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93230064|NCT03602690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93230065|NCT01379547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93230066|NCT01379547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230067|NCT02978495|Paclitaxel|paclitaxel|mesh-list
93230068|NCT02978495|Cyclophosphamide|cyclophosphamide|mesh-list
93230069|NCT02978495|Carboplatin|carboplatin|mesh-list
93230070|NCT02978495|Doxorubicin|doxorubicin|mesh-list
93230071|NCT02978495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93230072|NCT02978495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230073|NCT02978495|Tubulin Modulators|tubulin modulators|mesh-ancestor
93230074|NCT02978495|Antimitotic Agents|antimitotic agents|mesh-ancestor
93230075|NCT02978495|Mitosis Modulators|mitosis modulators|mesh-ancestor
93230076|NCT02978495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230077|NCT02978495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230078|NCT02978495|Immunologic Factors|immunologic factors|mesh-ancestor
93230079|NCT02978495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230080|NCT02978495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230081|NCT02978495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93230082|NCT02978495|Alkylating Agents|alkylating agents|mesh-ancestor
93230083|NCT02978495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92910172|NCT00672958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93230084|NCT02978495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92910247|NCT00770302|Saxagliptin|saxagliptin|mesh-list
93230085|NCT02978495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93230086|NCT02978495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92910402|NCT00670228|Insulin|insulin|mesh-list
93230087|NCT02978495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230088|NCT02237690|Doxorubicin|doxorubicin|mesh-list
92910467|NCT00772174|Metformin|metformin|mesh-list
93230089|NCT02237690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93230090|NCT02237690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92910537|NCT04047940|Metformin|metformin|mesh-list
93230091|NCT02237690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230092|NCT02237690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93230093|NCT02237690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93230094|NCT02237690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910753|NCT02627417|Leprostatic Agents|leprostatic agents|mesh-ancestor
93230095|NCT02237690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230096|NCT04788017|Ziresovir|ziresovir|mesh-list
93230097|NCT04788017|Antiviral Agents|antiviral agents|mesh-ancestor
93230098|NCT04788017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230099|NCT03600974|Domperidone|domperidone|mesh-list
93230100|NCT03600974|Citalopram|citalopram|mesh-list
93230101|NCT03600974|Esomeprazole|esomeprazole|mesh-list
93230102|NCT03600974|Omeprazole|omeprazole|mesh-list
93230103|NCT03600974|Rabeprazole|rabeprazole|mesh-list
93230104|NCT03600974|Pantoprazole|pantoprazole|mesh-list
93230105|NCT03600974|Lansoprazole|lansoprazole|mesh-list
93230106|NCT03600974|Mosapride|mosapride|mesh-list
93230107|NCT03600974|Neurotransmitter Agents|neurotransmitter agents|mesh-list
93230108|NCT03600974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92911119|NCT02633657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230109|NCT03600974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230110|NCT03600974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93230111|NCT03600974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911194|NCT00657059|Prednisone|prednisone|mesh-list
93230112|NCT03600974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230113|NCT03600974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93230114|NCT03600974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93230115|NCT03600974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911461|NCT00682955|Zinc|zinc|mesh-list
92911483|NCT00683111|Famotidine|famotidine|mesh-list
93230116|NCT03600974|Serotonin Agents|serotonin agents|mesh-ancestor
92911554|NCT00683267|Capsaicin|capsaicin|mesh-list
93230117|NCT03600974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230118|NCT03600974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92911703|NCT00781300|Antiemetics|antiemetics|mesh-ancestor
93230119|NCT03600974|Antidepressive Agents|antidepressive agents|mesh-ancestor
92911773|NCT00781846|Sirolimus|sirolimus|mesh-list
93230120|NCT03600974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93230121|NCT03600974|Autonomic Agents|autonomic agents|mesh-ancestor
93230122|NCT03600974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912004|NCT00694967|Hormones|hormones|mesh-ancestor
93230123|NCT03600974|Antiemetics|antiemetics|mesh-ancestor
93230124|NCT03600974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93230125|NCT03600974|Dopamine Agents|dopamine agents|mesh-ancestor
93230126|NCT03600974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93230127|NCT03075267|Budesonide|budesonide|mesh-list
93230128|NCT03075267|Glycopyrrolate|glycopyrrolate|mesh-list
93230129|NCT03075267|Formoterol Fumarate|formoterol fumarate|mesh-list
93230130|NCT03075267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230131|NCT03075267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93230132|NCT03075267|Autonomic Agents|autonomic agents|mesh-ancestor
92912364|NCT00459979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230133|NCT03075267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912440|NCT00661726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230134|NCT03075267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230135|NCT03075267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230136|NCT03075267|Respiratory System Agents|respiratory system agents|mesh-ancestor
93230137|NCT03075267|Glucocorticoids|glucocorticoids|mesh-ancestor
93230138|NCT03075267|Hormones|hormones|mesh-ancestor
92912740|NCT04015908|Celecoxib|celecoxib|mesh-list
93230139|NCT03075267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230140|NCT03075267|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93230141|NCT03075267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93230142|NCT03075267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92912959|NCT00570310|Anticonvulsants|anticonvulsants|mesh-ancestor
93230143|NCT03075267|Adrenergic Agents|adrenergic agents|mesh-ancestor
93230144|NCT03075267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913105|NCT02555488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230145|NCT03075267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913254|NCT00851084|Vitamins|vitamins|mesh-ancestor
93230146|NCT03075267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93230147|NCT03075267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93230148|NCT03075267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93230149|NCT03075267|Cholinergic Agents|cholinergic agents|mesh-ancestor
93230150|NCT03600506|Dexmedetomidine|dexmedetomidine|mesh-list
93230151|NCT03600506|Sympatholytics|sympatholytics|mesh-list
93230152|NCT03600506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93230153|NCT03600506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913693|NCT04137029|Formoterol Fumarate|formoterol fumarate|mesh-list
93230154|NCT03600506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230155|NCT03600506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93230156|NCT03600506|Analgesics|analgesics|mesh-ancestor
93230157|NCT03600506|Sensory System Agents|sensory system agents|mesh-ancestor
93230158|NCT03600506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230159|NCT03600506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92914060|NCT00706862|Talactoferrin alfa|talactoferrin alfa|mesh-list
93230160|NCT03600506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93230161|NCT03600506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93230162|NCT03600506|Adrenergic Agents|adrenergic agents|mesh-ancestor
93230163|NCT03600506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914284|NCT00591006|Phenytoin|phenytoin|mesh-list
92914355|NCT00826514|Tanezumab|tanezumab|mesh-list
92914430|NCT00702728|Furosemide|furosemide|mesh-list
92914505|NCT00789646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92914577|NCT02606994|Histamine Agents|histamine agents|mesh-ancestor
93230164|NCT03600506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230165|NCT03600506|Autonomic Agents|autonomic agents|mesh-ancestor
93230166|NCT03074331|Sofosbuvir|sofosbuvir|mesh-list
92914730|NCT00803218|Fluticasone|fluticasone|mesh-list
92914805|NCT00856583|Risperidone|risperidone|mesh-list
93230167|NCT03074331|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93230168|NCT03074331|Velpatasvir|velpatasvir|mesh-list
93230169|NCT03074331|Antiviral Agents|antiviral agents|mesh-ancestor
93230170|NCT03074331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230171|NCT02237924|Endostar protein|endostar protein|mesh-list
93230172|NCT02237924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93230173|NCT02237924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93230174|NCT02237924|Growth Substances|growth substances|mesh-ancestor
93230175|NCT02237924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915181|NCT00704990|Vitamins|vitamins|mesh-list
93230176|NCT02237924|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915246|NCT00803634|Diltiazem|diltiazem|mesh-list
93230177|NCT02237924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230178|NCT03825302|Mannitol|mannitol|mesh-list
93230179|NCT03825302|Methacholine Chloride|methacholine chloride|mesh-list
93230180|NCT03825302|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93230181|NCT03825302|Diuretics|diuretics|mesh-ancestor
93230182|NCT03825302|Natriuretic Agents|natriuretic agents|mesh-ancestor
93230183|NCT03825302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230184|NCT03825302|Miotics|miotics|mesh-ancestor
93230185|NCT03825302|Autonomic Agents|autonomic agents|mesh-ancestor
93230186|NCT03825302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230187|NCT03825302|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93230188|NCT03825302|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93230189|NCT03825302|Respiratory System Agents|respiratory system agents|mesh-ancestor
93230190|NCT03825302|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93230191|NCT03825302|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93230192|NCT03825302|Cholinergic Agents|cholinergic agents|mesh-ancestor
93230193|NCT03825302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230194|NCT03825302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230195|NCT02238392|Adenosine|adenosine|mesh-list
93230196|NCT02238392|Analgesics|analgesics|mesh-ancestor
93230197|NCT02238392|Sensory System Agents|sensory system agents|mesh-ancestor
93230198|NCT02238392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230199|NCT02238392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230200|NCT02238392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93230201|NCT02238392|Vasodilator Agents|vasodilator agents|mesh-ancestor
92916435|NCT00810862|Lactitol|lactitol|mesh-list
92916498|NCT00447265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230202|NCT02238392|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93230203|NCT02238392|Purinergic Agonists|purinergic agonists|mesh-ancestor
93230204|NCT02238392|Purinergic Agents|purinergic agents|mesh-ancestor
92916796|NCT00446641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93230205|NCT02238392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230206|NCT02238392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230207|NCT02260193|Glycine|glycine|mesh-list
93230208|NCT02260193|Glycine Agents|glycine agents|mesh-ancestor
93230209|NCT02260193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917013|NCT00812344|Hormone Antagonists|hormone antagonists|mesh-ancestor
93230210|NCT02260193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917083|NCT04045522|Zoledronic Acid|zoledronic acid|mesh-list
93230211|NCT02260193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230212|NCT02849678|Lidocaine|lidocaine|mesh-list
92917159|NCT00791778|Sorafenib|sorafenib|mesh-list
93230213|NCT02849678|Ropivacaine|ropivacaine|mesh-list
92917311|NCT02551042|Factor VIII|factor viii|mesh-list
93230214|NCT02849678|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230215|NCT02849678|Anesthetics|anesthetics|mesh-ancestor
92917457|NCT03995563|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230216|NCT02849678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917603|NCT00816712|Testosterone|testosterone|mesh-list
93230217|NCT02849678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230218|NCT02849678|Sensory System Agents|sensory system agents|mesh-ancestor
93230219|NCT02849678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230220|NCT02849678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93230221|NCT02849678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92917895|NCT00847613|Tofacitinib|tofacitinib|mesh-list
93230222|NCT02849678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92918041|NCT05573724|Itraconazole|itraconazole|mesh-list
93230223|NCT02849678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230224|NCT02849678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230225|NCT04295577|Niraparib|niraparib|mesh-list
92918262|NCT00790842|Dexamethasone|dexamethasone|mesh-list
92918417|NCT00821080|Sirolimus|sirolimus|mesh-list
92918484|NCT00828958|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93230226|NCT04295577|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93230227|NCT04295577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918560|NCT00829114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93230228|NCT04295577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230229|NCT04295577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230230|NCT02238158|Ipratropium|ipratropium|mesh-list
93230231|NCT02238158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93230232|NCT02238158|Autonomic Agents|autonomic agents|mesh-ancestor
92918939|NCT02602938|Aspirin|aspirin|mesh-list
92919001|NCT00838240|Antimetabolites|antimetabolites|mesh-ancestor
93230233|NCT02238158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230234|NCT02238158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230235|NCT02238158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230236|NCT02238158|Respiratory System Agents|respiratory system agents|mesh-ancestor
93230237|NCT02238158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93230238|NCT02238158|Cholinergic Agents|cholinergic agents|mesh-ancestor
93230239|NCT02238158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230240|NCT02238158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230241|NCT02238314|Ritonavir|ritonavir|mesh-list
93230242|NCT02238314|Tipranavir|tipranavir|mesh-list
93230243|NCT02238314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93230244|NCT02238314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93230245|NCT02238314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93230246|NCT02238314|Protease Inhibitors|protease inhibitors|mesh-ancestor
93230247|NCT02238314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919360|NCT04120337|Anesthetics|anesthetics|mesh-ancestor
93230248|NCT02238314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230249|NCT02238314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93230250|NCT02238314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93230251|NCT02238314|Antiviral Agents|antiviral agents|mesh-ancestor
93230252|NCT02238314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919659|NCT00844649|Paclitaxel|paclitaxel|mesh-list
93230253|NCT02238314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93230254|NCT02238314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93230255|NCT02238314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93230256|NCT02238470|Warfarin|warfarin|mesh-list
93230257|NCT02238470|Rivaroxaban|rivaroxaban|mesh-list
93230258|NCT02238470|Dabigatran|dabigatran|mesh-list
93230259|NCT02238470|Apixaban|apixaban|mesh-list
93230260|NCT02238470|Anticoagulants|anticoagulants|mesh-list
93230261|NCT02238470|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93230262|NCT02238470|Antithrombins|antithrombins|mesh-ancestor
93230263|NCT02238470|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93230264|NCT02238470|Protease Inhibitors|protease inhibitors|mesh-ancestor
93230265|NCT02238470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920244|NCT00765102|Bortezomib|bortezomib|mesh-list
93230266|NCT02238470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230267|NCT03586934|Acetaminophen|acetaminophen|mesh-list
93230268|NCT03586934|Celecoxib|celecoxib|mesh-list
93230269|NCT03586934|Ketorolac|ketorolac|mesh-list
93230270|NCT03586934|Meloxicam|meloxicam|mesh-list
93230271|NCT03586934|Morphine|morphine|mesh-list
93230272|NCT03586934|Oxycodone|oxycodone|mesh-list
93230273|NCT03586934|Tramadol|tramadol|mesh-list
93230274|NCT03586934|Hydrocodone|hydrocodone|mesh-list
93230275|NCT03586934|Ropivacaine|ropivacaine|mesh-list
93230276|NCT03586934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93230277|NCT03586934|Narcotics|narcotics|mesh-ancestor
92920825|NCT02926898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230278|NCT03586934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230279|NCT03586934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230280|NCT03586934|Analgesics|analgesics|mesh-ancestor
93230281|NCT03586934|Sensory System Agents|sensory system agents|mesh-ancestor
93230282|NCT03586934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920977|NCT02852486|Pioglitazone|pioglitazone|mesh-list
93230283|NCT03586934|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230284|NCT03586934|Anesthetics|anesthetics|mesh-ancestor
93230285|NCT03586934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93230286|NCT03586934|Antipyretics|antipyretics|mesh-ancestor
92921258|NCT02599077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230287|NCT03586934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921408|NCT00743340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93230288|NCT03586934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230289|NCT03586934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230290|NCT03586934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93230291|NCT03586934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92921479|NCT02596776|Protective Agents|protective agents|mesh-ancestor
93230293|NCT03586934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230294|NCT03586934|Antitussive Agents|antitussive agents|mesh-ancestor
93230295|NCT03586934|Respiratory System Agents|respiratory system agents|mesh-ancestor
93230296|NCT03586154|Ketamine|ketamine|mesh-list
93230297|NCT03586154|Bupivacaine|bupivacaine|mesh-list
92921704|NCT02593383|Adapalene|adapalene|mesh-list
93230298|NCT03586154|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230299|NCT03586154|Anesthetics|anesthetics|mesh-ancestor
92921845|NCT02592915|Analgesics|analgesics|mesh-ancestor
92921995|NCT00589628|Infliximab|infliximab|mesh-list
93230300|NCT03586154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230301|NCT03586154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230302|NCT03586154|Sensory System Agents|sensory system agents|mesh-ancestor
93230303|NCT03586154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230304|NCT03586154|Analgesics|analgesics|mesh-ancestor
93230305|NCT03586154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93230306|NCT03586154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93230307|NCT03586154|Anesthetics, General|anesthetics, general|mesh-ancestor
93230308|NCT03586154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93230309|NCT03586154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93230310|NCT03586154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922661|NCT00789698|Adrenergic Agents|adrenergic agents|mesh-ancestor
93230311|NCT03586154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230312|NCT03629847|Everolimus|everolimus|mesh-list
93230313|NCT03629847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92922807|NCT05366595|Zinc Sulfate|zinc sulfate|mesh-list
92922887|NCT00797966|Serotonin Agents|serotonin agents|mesh-ancestor
92922957|NCT00808067|Anticoagulants|anticoagulants|mesh-ancestor
93230314|NCT03629847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93230315|NCT03629847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230316|NCT03629847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230317|NCT03629847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230318|NCT03629847|Immunologic Factors|immunologic factors|mesh-ancestor
93230319|NCT03629847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230320|NCT03629847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230321|NCT01314833|Paclitaxel|paclitaxel|mesh-list
93230322|NCT01314833|Docetaxel|docetaxel|mesh-list
92923334|NCT02603198|Mydriatics|mydriatics|mesh-ancestor
93230323|NCT01314833|Cyclophosphamide|cyclophosphamide|mesh-list
93230324|NCT01314833|Fluorouracil|fluorouracil|mesh-list
93230325|NCT01314833|Epirubicin|epirubicin|mesh-list
92923399|NCT04085913|Bupivacaine|bupivacaine|mesh-list
93230326|NCT01314833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93230327|NCT01314833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230328|NCT01314833|Tubulin Modulators|tubulin modulators|mesh-ancestor
93230329|NCT01314833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92923626|NCT02602652|Vaccines|vaccines|mesh-list
93230330|NCT01314833|Mitosis Modulators|mitosis modulators|mesh-ancestor
93230331|NCT01314833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230332|NCT01314833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230333|NCT01314833|Immunologic Factors|immunologic factors|mesh-ancestor
93230334|NCT01314833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230335|NCT01314833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230336|NCT01314833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93230337|NCT01314833|Alkylating Agents|alkylating agents|mesh-ancestor
93230338|NCT01314833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93230339|NCT01314833|Antimetabolites|antimetabolites|mesh-ancestor
93230340|NCT01314833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93230341|NCT01314833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92924144|NCT00767000|Metformin|metformin|mesh-list
93230342|NCT01314833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93230343|NCT01314833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93230344|NCT01314833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230345|NCT03579836|Gemcitabine|gemcitabine|mesh-list
92569827|NCT00061256|Vitamin D|vitamin d|mesh-list
92924435|NCT04082559|Ciprofloxacin|ciprofloxacin|mesh-list
93230346|NCT03579836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93230347|NCT03579836|Antimetabolites|antimetabolites|mesh-ancestor
92924513|NCT04101812|Doxorubicin|doxorubicin|mesh-list
92924585|NCT00914771|Immunologic Factors|immunologic factors|mesh-ancestor
93230348|NCT03579836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230349|NCT03579836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230350|NCT02737826|Buprenorphine|buprenorphine|mesh-list
93230351|NCT02737826|Gabapentin|gabapentin|mesh-list
93230352|NCT02737826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93230353|NCT02737826|Narcotics|narcotics|mesh-ancestor
93230354|NCT02737826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925035|NCT04454229|Penicillins|penicillins|mesh-list
93230355|NCT02737826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230356|NCT02737826|Analgesics|analgesics|mesh-ancestor
92925105|NCT04078425|Diuretics|diuretics|mesh-ancestor
93230357|NCT02737826|Sensory System Agents|sensory system agents|mesh-ancestor
92925174|NCT00772148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230358|NCT02737826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230359|NCT02737826|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93230360|NCT02737826|Anticonvulsants|anticonvulsants|mesh-ancestor
93230361|NCT02737826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93230362|NCT02737826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93230363|NCT02737826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92925555|NCT00802529|Hormones|hormones|mesh-ancestor
92925624|NCT05277285|Sodium thiosulfate|sodium thiosulfate|mesh-list
93230364|NCT02737826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92925705|NCT04097444|Leucovorin|leucovorin|mesh-list
92925783|NCT00756938|Losartan|losartan|mesh-list
92925855|NCT00792935|Metformin|metformin|mesh-list
93230365|NCT02737826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92925995|NCT04019574|Moxifloxacin|moxifloxacin|mesh-list
93230366|NCT02737826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230367|NCT02737826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230368|NCT02737826|Antimanic Agents|antimanic agents|mesh-ancestor
93230369|NCT03367715|Nivolumab|nivolumab|mesh-list
93230370|NCT03367715|Ipilimumab|ipilimumab|mesh-list
93230371|NCT03367715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230372|NCT03367715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926691|NCT04100330|Cytarabine|cytarabine|mesh-list
93230373|NCT03367715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92926740|NCT00769184|Hormones|hormones|mesh-ancestor
92271761|NCT02071394|Xenon|xenon|mesh-list
92926887|NCT00723450|Anticonvulsants|anticonvulsants|mesh-ancestor
92926961|NCT00720096|Topotecan|topotecan|mesh-list
93230374|NCT03367715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230375|NCT04064931|Niacin|niacin|mesh-list
93230376|NCT04064931|Vitamins|vitamins|mesh-ancestor
93230377|NCT04064931|Micronutrients|micronutrients|mesh-ancestor
93230378|NCT04064931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230379|NCT04064931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92927337|NCT02596334|Lamivudine|lamivudine|mesh-list
93230380|NCT04064931|Antimetabolites|antimetabolites|mesh-ancestor
92927485|NCT00741338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927560|NCT00746252|Risperidone|risperidone|mesh-list
93230381|NCT04064931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230382|NCT04064931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93230383|NCT04064931|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927721|NCT03949153|Nivolumab|nivolumab|mesh-list
93230384|NCT04064931|Vitamin B Complex|vitamin b complex|mesh-ancestor
93230385|NCT03577652|Ticagrelor|ticagrelor|mesh-list
92927794|NCT02591004|Nifedipine|nifedipine|mesh-list
93230386|NCT03577652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93230387|NCT03577652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92928012|NCT00719199|Cetuximab|cetuximab|mesh-list
93230388|NCT03577652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92928156|NCT00720135|Immunoglobulins|immunoglobulins|mesh-list
93230389|NCT03577652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93230390|NCT03577652|Purinergic Agents|purinergic agents|mesh-ancestor
93230391|NCT03577652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928313|NCT00578565|Rituximab|rituximab|mesh-list
92928381|NCT02587260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93230392|NCT03577652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230393|NCT03577652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230394|NCT03620513|Lidocaine|lidocaine|mesh-list
93230395|NCT03620513|Phenylephrine|phenylephrine|mesh-list
93230396|NCT03620513|Oxymetazoline|oxymetazoline|mesh-list
92928682|NCT00787787|Sunitinib|sunitinib|mesh-list
93230397|NCT03620513|Nasal Decongestants|nasal decongestants|mesh-list
93230398|NCT03620513|Pseudoephedrine|pseudoephedrine|mesh-list
92928836|NCT00723411|Aluminum sulfate|aluminum sulfate|mesh-list
93230399|NCT03620513|Ephedrine|ephedrine|mesh-list
93230400|NCT03620513|Anesthetics|anesthetics|mesh-list
93230401|NCT03620513|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230402|NCT03620513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230403|NCT03620513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230404|NCT03620513|Sensory System Agents|sensory system agents|mesh-ancestor
93230405|NCT03620513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230406|NCT03620513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93230407|NCT03620513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93230408|NCT03620513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93230409|NCT03620513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230410|NCT03620513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230411|NCT03620513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93230412|NCT03620513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93230413|NCT03620513|Adrenergic Agents|adrenergic agents|mesh-ancestor
93230414|NCT03620513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230415|NCT03620513|Sympathomimetics|sympathomimetics|mesh-ancestor
93230416|NCT03620513|Autonomic Agents|autonomic agents|mesh-ancestor
92928962|NCT00435409|Capecitabine|capecitabine|mesh-list
93230417|NCT03620513|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93230418|NCT03620513|Respiratory System Agents|respiratory system agents|mesh-ancestor
93230419|NCT03620513|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93230420|NCT03620513|Mydriatics|mydriatics|mesh-ancestor
93230421|NCT03620513|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92929410|NCT04066257|Bismuth|bismuth|mesh-list
93230422|NCT03620513|Protective Agents|protective agents|mesh-ancestor
93230423|NCT03620513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92929557|NCT00735501|Insulin Detemir|insulin detemir|mesh-list
93230424|NCT03620513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93230425|NCT03620513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230426|NCT03585062|Paclitaxel|paclitaxel|mesh-list
93230427|NCT03585062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93230428|NCT03585062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230429|NCT03585062|Tubulin Modulators|tubulin modulators|mesh-ancestor
93230430|NCT03585062|Antimitotic Agents|antimitotic agents|mesh-ancestor
93230431|NCT03585062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92929891|NCT00712335|Xhance|xhance|mesh-list
93230432|NCT03585062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230433|NCT03584360|Calcitriol|calcitriol|mesh-list
93230434|NCT03584360|Betamethasone|betamethasone|mesh-list
93230435|NCT03584360|Betamethasone Valerate|betamethasone valerate|mesh-list
93230436|NCT03584360|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92930006|NCT00733317|Budesonide|budesonide|mesh-list
93230437|NCT03584360|Betamethasone benzoate|betamethasone benzoate|mesh-list
93230438|NCT03584360|Calcipotriene|calcipotriene|mesh-list
93230439|NCT03584360|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93230440|NCT03584360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230441|NCT03584360|Glucocorticoids|glucocorticoids|mesh-ancestor
92930290|NCT00740259|Flunarizine|flunarizine|mesh-list
93230442|NCT03584360|Hormones|hormones|mesh-ancestor
93230443|NCT03584360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230444|NCT03584360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230445|NCT03584360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230446|NCT03584360|Respiratory System Agents|respiratory system agents|mesh-ancestor
92930520|NCT04366518|Scopolamine|scopolamine|mesh-list
93230447|NCT03584360|Dermatologic Agents|dermatologic agents|mesh-ancestor
93230448|NCT03584360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93230449|NCT03584360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93230450|NCT03584360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230451|NCT03584360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230452|NCT03584360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93230453|NCT03584360|Vitamins|vitamins|mesh-ancestor
93230454|NCT03584360|Micronutrients|micronutrients|mesh-ancestor
93230455|NCT03584360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93230456|NCT05763771|Nicotine|nicotine|mesh-list
93230457|NCT05763771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93230458|NCT05763771|Autonomic Agents|autonomic agents|mesh-ancestor
92930803|NCT04062357|Anesthetics|anesthetics|mesh-ancestor
93230459|NCT05763771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230460|NCT05763771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230461|NCT05763771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93230462|NCT05763771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93230463|NCT05763771|Cholinergic Agents|cholinergic agents|mesh-ancestor
92931173|NCT02593370|Lidocaine|lidocaine|mesh-list
92931246|NCT00729326|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93230464|NCT05763771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230465|NCT05763771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230466|NCT03579758|Gemcitabine|gemcitabine|mesh-list
93230467|NCT03579758|Capecitabine|capecitabine|mesh-list
93230468|NCT03579758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230469|NCT03579758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93230470|NCT03579758|Antimetabolites|antimetabolites|mesh-ancestor
92931694|NCT01090089|Immunologic Factors|immunologic factors|mesh-ancestor
93230471|NCT03579758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230472|NCT03577574|Anesthetics|anesthetics|mesh-list
93230473|NCT03577574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230474|NCT03577574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230475|NCT01130519|Bevacizumab|bevacizumab|mesh-list
93230476|NCT01130519|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93230477|NCT01130519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230478|NCT01130519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230479|NCT01130519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93230480|NCT01130519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93230481|NCT01130519|Growth Substances|growth substances|mesh-ancestor
93230482|NCT01130519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230483|NCT01130519|Growth Inhibitors|growth inhibitors|mesh-ancestor
93230484|NCT01130519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93230485|NCT01130519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230486|NCT01130519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230487|NCT01330901|Ustekinumab|ustekinumab|mesh-list
92932010|NCT00751959|Poractant alfa|poractant alfa|mesh-list
93230488|NCT01330901|Dermatologic Agents|dermatologic agents|mesh-ancestor
93230489|NCT02428647|Zinc|zinc|mesh-list
93230490|NCT02428647|Trace Elements|trace elements|mesh-ancestor
93230491|NCT02428647|Micronutrients|micronutrients|mesh-ancestor
93230492|NCT02428647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230493|NCT01071395|Amantadine|amantadine|mesh-list
92932203|NCT00576381|Dexmedetomidine|dexmedetomidine|mesh-list
93230494|NCT01071395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93230495|NCT01071395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93230496|NCT01071395|Antiviral Agents|antiviral agents|mesh-ancestor
93230497|NCT01071395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230498|NCT01071395|Dopamine Agents|dopamine agents|mesh-ancestor
93230499|NCT01071395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230500|NCT01071395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230501|NCT01071395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932427|NCT00718718|Methotrexate|methotrexate|mesh-list
93230502|NCT01071395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93230503|NCT01071395|Analgesics|analgesics|mesh-ancestor
93230504|NCT01071395|Sensory System Agents|sensory system agents|mesh-ancestor
93230505|NCT01071395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230506|NCT00335816|Leucovorin|leucovorin|mesh-list
93230507|NCT00335816|Fluorouracil|fluorouracil|mesh-list
93230508|NCT00335816|Oxaliplatin|oxaliplatin|mesh-list
93230509|NCT00335816|Calcium|calcium|mesh-list
93230510|NCT00335816|Levoleucovorin|levoleucovorin|mesh-list
93230511|NCT00335816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93230512|NCT00335816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230513|NCT00335816|Antimetabolites|antimetabolites|mesh-ancestor
92902541|NCT00854360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230514|NCT00335816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230515|NCT00335816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93230516|NCT00335816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932702|NCT00683475|Analgesics|analgesics|mesh-ancestor
93230517|NCT00335816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230518|NCT00335816|Immunologic Factors|immunologic factors|mesh-ancestor
93230519|NCT00335816|Antidotes|antidotes|mesh-ancestor
93230520|NCT00335816|Protective Agents|protective agents|mesh-ancestor
93230521|NCT00335816|Vitamin B Complex|vitamin b complex|mesh-ancestor
93230522|NCT00335816|Vitamins|vitamins|mesh-ancestor
93230523|NCT00335816|Micronutrients|micronutrients|mesh-ancestor
93230524|NCT03577496|Peppermint oil|peppermint oil|mesh-list
92933167|NCT04082858|Midazolam|midazolam|mesh-list
93230525|NCT03577496|Antiemetics|antiemetics|mesh-ancestor
93230526|NCT03577496|Autonomic Agents|autonomic agents|mesh-ancestor
93230527|NCT03577496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933227|NCT05004350|Fluorouracil|fluorouracil|mesh-list
92933297|NCT02561013|Monensin|monensin|mesh-list
93230528|NCT03577496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230529|NCT03577496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230530|NCT03577496|Parasympatholytics|parasympatholytics|mesh-ancestor
93230531|NCT03582878|Mycophenolic Acid|mycophenolic acid|mesh-list
93230532|NCT03582878|Sirolimus|sirolimus|mesh-list
93230533|NCT03582878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93230534|NCT03582878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933677|NCT00764907|Antiemetics|antiemetics|mesh-ancestor
93230535|NCT03582878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93230536|NCT03582878|Antitubercular Agents|antitubercular agents|mesh-ancestor
93230537|NCT03582878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93230538|NCT03582878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230539|NCT03582878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230540|NCT03582878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230541|NCT03582878|Antifungal Agents|antifungal agents|mesh-ancestor
93230542|NCT03582878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230543|NCT03582878|Immunologic Factors|immunologic factors|mesh-ancestor
93230544|NCT03582878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230545|NCT05763693|Azithromycin|azithromycin|mesh-list
93230546|NCT05763693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93230547|NCT05763693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230548|NCT02238704|Calcium, Dietary|calcium, dietary|mesh-list
93230549|NCT02238704|Iron|iron|mesh-list
93230550|NCT02238704|Folic Acid|folic acid|mesh-list
93230551|NCT02238704|Vitamin B Complex|vitamin b complex|mesh-list
93230552|NCT02238704|Calcium|calcium|mesh-list
93230553|NCT02238704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93230554|NCT02238704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934027|NCT00767871|Serotonin Agents|serotonin agents|mesh-ancestor
93230555|NCT02238704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93230556|NCT02238704|Trace Elements|trace elements|mesh-ancestor
92934107|NCT02558595|Niacin|niacin|mesh-list
93230557|NCT02238704|Micronutrients|micronutrients|mesh-ancestor
93230558|NCT02238704|Hematinics|hematinics|mesh-ancestor
93230559|NCT02238704|Vitamins|vitamins|mesh-ancestor
93230560|NCT01331135|Sirolimus|sirolimus|mesh-list
93230561|NCT01331135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93230562|NCT01331135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230563|NCT01331135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93230564|NCT01331135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230565|NCT01331135|Antifungal Agents|antifungal agents|mesh-ancestor
93230566|NCT01331135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230567|NCT01331135|Immunologic Factors|immunologic factors|mesh-ancestor
93230568|NCT01331135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230569|NCT03577184|Metformin|metformin|mesh-list
93230570|NCT03577184|Vildagliptin|vildagliptin|mesh-list
93230571|NCT03577184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934380|NCT02557269|Mometasone Furoate|mometasone furoate|mesh-list
93230572|NCT03577184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230573|NCT03577184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93230574|NCT03577184|Protease Inhibitors|protease inhibitors|mesh-ancestor
93230575|NCT03577184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934595|NCT00780039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92934670|NCT00669669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230576|NCT03577184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230577|NCT02849171|Choline|choline|mesh-list
93230578|NCT02849171|Lipotropic Agents|lipotropic agents|mesh-ancestor
93230579|NCT02849171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93230580|NCT02849171|Antimetabolites|antimetabolites|mesh-ancestor
93230581|NCT02849171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230582|NCT02849171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230583|NCT02849171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93230584|NCT02849171|Nootropic Agents|nootropic agents|mesh-ancestor
93230585|NCT02238860|Tenofovir|tenofovir|mesh-list
93230586|NCT02238860|Antiviral Agents|antiviral agents|mesh-ancestor
93230587|NCT02238860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935497|NCT02400242|Hormones|hormones|mesh-ancestor
92935563|NCT00427999|Etoricoxib|etoricoxib|mesh-list
93230588|NCT02238860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93230589|NCT02238860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93230590|NCT02238860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935856|NCT00426127|Antimitotic Agents|antimitotic agents|mesh-ancestor
92935929|NCT00430573|Cycloserine|cycloserine|mesh-list
93230591|NCT02238860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230592|NCT02238860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93230593|NCT02238860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93230594|NCT01333709|Folfirinox|folfirinox|mesh-list
92936157|NCT00661089|Botulinum Toxins|botulinum toxins|mesh-list
93230595|NCT01333709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936392|NCT00711854|Antimalarials|antimalarials|mesh-ancestor
93230596|NCT04869137|Pembrolizumab|pembrolizumab|mesh-list
93230597|NCT04869137|Lenvatinib|lenvatinib|mesh-list
93230598|NCT04869137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230599|NCT04869137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936604|NCT00713336|Moxifloxacin|moxifloxacin|mesh-list
92936673|NCT00793845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230600|NCT04869137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93230601|NCT04869137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936821|NCT02573714|Anesthetics, General|anesthetics, general|mesh-ancestor
92936893|NCT00801255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92937044|NCT02575508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92937120|NCT00841126|Iron|iron|mesh-list
93230602|NCT04869137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93230603|NCT04869137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230604|NCT00364637|Anesthetics|anesthetics|mesh-list
93230605|NCT00364637|Sevoflurane|sevoflurane|mesh-list
93230606|NCT00364637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230607|NCT00364637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230608|NCT00364637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93230609|NCT00364637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92937568|NCT04045821|Plerixafor|plerixafor|mesh-list
93230610|NCT00364637|Anesthetics, General|anesthetics, general|mesh-ancestor
93230611|NCT00493961|Hormones|hormones|mesh-list
92937633|NCT00803829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93232193|NCT05708534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230612|NCT00493961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937779|NCT00798213|Immunoconjugates|immunoconjugates|mesh-ancestor
93230613|NCT00493961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230614|NCT02903238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93230615|NCT02903238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93230616|NCT02903238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93230617|NCT02903238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937852|NCT00424489|Autonomic Agents|autonomic agents|mesh-ancestor
93230618|NCT02903238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230619|NCT02903238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230620|NCT02903238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230621|NCT02903238|Analgesics|analgesics|mesh-ancestor
93230622|NCT02903238|Sensory System Agents|sensory system agents|mesh-ancestor
92938067|NCT01037491|Antipyretics|antipyretics|mesh-ancestor
93230623|NCT02903238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230624|NCT02903238|Antidepressive Agents|antidepressive agents|mesh-ancestor
93230625|NCT02903238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93230626|NCT02903238|Dopamine Agents|dopamine agents|mesh-ancestor
93230627|NCT01329809|Molgramostim|molgramostim|mesh-list
93230628|NCT01329809|Sargramostim|sargramostim|mesh-list
92938368|NCT05809518|Propofol|propofol|mesh-list
92583859|NCT00294580|Maloprim|maloprim|mesh-list
93230629|NCT01329809|Immunologic Factors|immunologic factors|mesh-ancestor
92938588|NCT05556200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938665|NCT05366764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230630|NCT01329809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938814|NCT05049707|Tocolytic Agents|tocolytic agents|mesh-ancestor
93230631|NCT01329809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230632|NCT02847260|Treprostinil|treprostinil|mesh-list
93230633|NCT02847260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93230634|NCT01331447|Exemestane|exemestane|mesh-list
93230635|NCT01331447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230636|NCT01331447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93230637|NCT01331447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93230638|NCT01331447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230639|NCT01331447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230640|NCT01331447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93230641|NCT01331447|Hormone Antagonists|hormone antagonists|mesh-ancestor
92939257|NCT04216524|Antiviral Agents|antiviral agents|mesh-ancestor
92939338|NCT04008706|Acalabrutinib|acalabrutinib|mesh-list
93232194|NCT05708534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230642|NCT01331447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939558|NCT03465540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230643|NCT01331447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230644|NCT02968563|Obinutuzumab|obinutuzumab|mesh-list
93230645|NCT02968563|Idelalisib|idelalisib|mesh-list
92939632|NCT02951351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230646|NCT02968563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230647|NCT02968563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230648|NCT02968563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230649|NCT02968563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230650|NCT01329887|Ketanserin|ketanserin|mesh-list
93230651|NCT01329887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93230652|NCT01329887|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92940080|NCT00718536|Antiviral Agents|antiviral agents|mesh-ancestor
93230653|NCT01329887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93230654|NCT01329887|Serotonin Agents|serotonin agents|mesh-ancestor
93230655|NCT01329887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232195|NCT05708534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230656|NCT01329887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230657|NCT01329887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230658|NCT01334099|Tremelimumab|tremelimumab|mesh-list
93230659|NCT01334099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230660|NCT01331525|Ipilimumab|ipilimumab|mesh-list
92940617|NCT00720408|Tacrolimus|tacrolimus|mesh-list
93230661|NCT01331525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230662|NCT01331525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230663|NCT01331525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92940755|NCT00578448|Abatacept|abatacept|mesh-list
93230664|NCT01331525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230665|NCT01334177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92940891|NCT04961528|Hemostatics|hemostatics|mesh-ancestor
93230666|NCT01334177|Cetuximab|cetuximab|mesh-list
93230667|NCT01334177|Antibodies|antibodies|mesh-list
93230668|NCT01334177|Immunoglobulins|immunoglobulins|mesh-list
93230669|NCT01334177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93230670|NCT01334177|Immunologic Factors|immunologic factors|mesh-ancestor
93230671|NCT01334177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230672|NCT01334177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230673|NCT04098393|Fludarabine|fludarabine|mesh-list
93230674|NCT04098393|Melphalan|melphalan|mesh-list
93230675|NCT04098393|Busulfan|busulfan|mesh-list
93230676|NCT04098393|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93230677|NCT04098393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230678|NCT04098393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230679|NCT04098393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230680|NCT04098393|Immunologic Factors|immunologic factors|mesh-ancestor
93230681|NCT04098393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230682|NCT04098393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93230683|NCT04098393|Alkylating Agents|alkylating agents|mesh-ancestor
93230684|NCT04098393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93230685|NCT03649230|Palonosetron|palonosetron|mesh-list
93230686|NCT03649230|Antiemetics|antiemetics|mesh-ancestor
93230687|NCT03649230|Autonomic Agents|autonomic agents|mesh-ancestor
92941415|NCT00865618|Eplerenone|eplerenone|mesh-list
92941473|NCT00724074|Sensory System Agents|sensory system agents|mesh-ancestor
93230688|NCT03649230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941549|NCT00724620|Ribavirin|ribavirin|mesh-list
92941624|NCT04067856|Bevacizumab|bevacizumab|mesh-list
92941703|NCT00804531|Antiemetics|antiemetics|mesh-ancestor
92941776|NCT00577824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92941850|NCT00805233|Growth Inhibitors|growth inhibitors|mesh-ancestor
93230689|NCT03649230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230690|NCT03649230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942000|NCT00862420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93230691|NCT03649230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92942220|NCT00805311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230692|NCT03649230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93230693|NCT03649230|Serotonin Agents|serotonin agents|mesh-ancestor
92942319|NCT00732836|Paclitaxel|paclitaxel|mesh-list
93230694|NCT03649230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230695|NCT03649230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230696|NCT05762523|Vaccines|vaccines|mesh-list
93230697|NCT05762523|Immunologic Factors|immunologic factors|mesh-ancestor
93230698|NCT05762523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942525|NCT00733616|Docetaxel|docetaxel|mesh-list
93230699|NCT02796261|Eflornithine|eflornithine|mesh-list
92942660|NCT00799539|Bortezomib|bortezomib|mesh-list
93230700|NCT02796261|Lomustine|lomustine|mesh-list
93230701|NCT02796261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93230702|NCT02796261|Alkylating Agents|alkylating agents|mesh-ancestor
92942814|NCT00739388|Azacitidine|azacitidine|mesh-list
93230703|NCT02796261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230704|NCT02796261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230705|NCT02796261|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93230706|NCT02796261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93230707|NCT02796261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92943149|NCT04039828|Zinc|zinc|mesh-list
93230708|NCT02796261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230709|NCT02796261|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92943331|NCT00617734|Cetuximab|cetuximab|mesh-list
93230710|NCT02796261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230711|NCT02904096|Lidocaine|lidocaine|mesh-list
92943560|NCT00710762|Nintedanib|nintedanib|mesh-list
93230712|NCT02904096|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230713|NCT02904096|Anesthetics|anesthetics|mesh-ancestor
93230714|NCT02904096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230715|NCT02904096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230716|NCT02904096|Sensory System Agents|sensory system agents|mesh-ancestor
93230717|NCT02904096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230718|NCT02904096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93230719|NCT02904096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93230720|NCT02904096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93230721|NCT02904096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230722|NCT02904096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230723|NCT04079712|Nivolumab|nivolumab|mesh-list
93230724|NCT04079712|Ipilimumab|ipilimumab|mesh-list
93230725|NCT04079712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230726|NCT04079712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230727|NCT04079712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93230728|NCT04079712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230729|NCT02586675|Tamoxifen|tamoxifen|mesh-list
93230730|NCT02586675|Goserelin|goserelin|mesh-list
93230731|NCT02586675|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93230732|NCT02586675|Hormone Antagonists|hormone antagonists|mesh-ancestor
93230733|NCT02586675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230734|NCT02586675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230735|NCT02586675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93230736|NCT02586675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230737|NCT02586675|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93230738|NCT02586675|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93230739|NCT02586675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93230740|NCT03648528|Cholecalciferol|cholecalciferol|mesh-list
93230741|NCT03648528|Vitamin D|vitamin d|mesh-list
92902776|NCT02643719|Topiramate|topiramate|mesh-list
93230742|NCT03648528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93230743|NCT03648528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230744|NCT03648528|Vitamins|vitamins|mesh-ancestor
92943816|NCT00740142|Lactulose|lactulose|mesh-list
93230745|NCT03648528|Micronutrients|micronutrients|mesh-ancestor
93230746|NCT03648528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93230747|NCT03161405|Itraconazole|itraconazole|mesh-list
93230748|NCT03161405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232196|NCT05708534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232197|NCT05708534|Immunologic Factors|immunologic factors|mesh-ancestor
93230749|NCT03161405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230750|NCT03161405|Antifungal Agents|antifungal agents|mesh-ancestor
92944182|NCT00882856|Bisoprolol|bisoprolol|mesh-list
93230751|NCT03161405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93230752|NCT03161405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93230753|NCT03161405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93230754|NCT03161405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93230755|NCT03161405|Hormone Antagonists|hormone antagonists|mesh-ancestor
92944326|NCT04721626|Dermatologic Agents|dermatologic agents|mesh-ancestor
93230756|NCT03161405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230757|NCT03161405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230758|NCT03161405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93230759|NCT01813929|Metformin|metformin|mesh-list
93230760|NCT01813929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92944479|NCT05500170|Niacin|niacin|mesh-list
93230761|NCT01813929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230762|NCT01502085|Dexamethasone|dexamethasone|mesh-list
93230763|NCT01502085|Vorinostat|vorinostat|mesh-list
93230764|NCT01502085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230765|NCT01502085|Antiemetics|antiemetics|mesh-ancestor
93230766|NCT01502085|Autonomic Agents|autonomic agents|mesh-ancestor
93230767|NCT01502085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230768|NCT01502085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230769|NCT01502085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230770|NCT01502085|Glucocorticoids|glucocorticoids|mesh-ancestor
92944559|NCT02543710|Taxane|taxane|mesh-list
93230771|NCT01502085|Hormones|hormones|mesh-ancestor
93230772|NCT01502085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230773|NCT01502085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93230774|NCT01502085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230775|NCT01502085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93230776|NCT01502085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230777|NCT01502085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230778|NCT03648684|Caffeine|caffeine|mesh-list
92944624|NCT00885586|Gabapentin|gabapentin|mesh-list
93230779|NCT03648684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93230780|NCT03648684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230781|NCT03648684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93230782|NCT03648684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230783|NCT03648684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230784|NCT03648684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93230785|NCT03648684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93230786|NCT03648684|Purinergic Agents|purinergic agents|mesh-ancestor
93230787|NCT03648684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230788|NCT03647982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93230789|NCT03647982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93230790|NCT03647982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230791|NCT03647982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230792|NCT03647982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93230793|NCT03647982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230794|NCT03647982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230795|NCT03647982|Cholinergic Agents|cholinergic agents|mesh-ancestor
93230796|NCT03647982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230797|NCT02901054|Ondansetron|ondansetron|mesh-list
93230798|NCT02901054|Antiemetics|antiemetics|mesh-ancestor
93230799|NCT02901054|Autonomic Agents|autonomic agents|mesh-ancestor
93230800|NCT02901054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230801|NCT02901054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230802|NCT02901054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230803|NCT02901054|Antipruritics|antipruritics|mesh-ancestor
93230804|NCT02901054|Dermatologic Agents|dermatologic agents|mesh-ancestor
93230805|NCT02901054|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93230806|NCT02901054|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93230807|NCT02901054|Serotonin Agents|serotonin agents|mesh-ancestor
93230808|NCT02901054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230809|NCT02901054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230810|NCT03647670|Midazolam|midazolam|mesh-list
93230811|NCT03647670|Abrocitinib|abrocitinib|mesh-list
93230812|NCT03647670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93230813|NCT03647670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92902848|NCT03245489|Antipyretics|antipyretics|mesh-ancestor
93230814|NCT03647670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230815|NCT03647670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230816|NCT03647670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93230817|NCT03647670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93230818|NCT03647670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93230819|NCT03647670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93230820|NCT03647670|Anesthetics, General|anesthetics, general|mesh-ancestor
93230821|NCT03647670|Anesthetics|anesthetics|mesh-ancestor
93230822|NCT03647670|GABA Modulators|gaba modulators|mesh-ancestor
93230823|NCT03647670|GABA Agents|gaba agents|mesh-ancestor
93230824|NCT03647670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230825|NCT03647670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230826|NCT03647670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93230827|NCT03647670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230828|NCT02966340|Prazosin|prazosin|mesh-list
93230829|NCT02966340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93230830|NCT02966340|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93230831|NCT02966340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93230832|NCT02966340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93230833|NCT02966340|Adrenergic Agents|adrenergic agents|mesh-ancestor
93230834|NCT02966340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230835|NCT02966340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230836|NCT02966340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230837|NCT05284734|Anesthetics|anesthetics|mesh-list
93230838|NCT05284734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230839|NCT05284734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230840|NCT03629379|Ustekinumab|ustekinumab|mesh-list
93230841|NCT03629379|Vedolizumab|vedolizumab|mesh-list
93230842|NCT03629379|Dermatologic Agents|dermatologic agents|mesh-ancestor
93230843|NCT03629379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230844|NCT05055999|Atezolizumab|atezolizumab|mesh-list
93230845|NCT05055999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92944795|NCT00813735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93230846|NCT05055999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230847|NCT05055999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230848|NCT05055999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230849|NCT05205837|Letrozole|letrozole|mesh-list
93230850|NCT05205837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944845|NCT00611026|Fesoterodine|fesoterodine|mesh-list
93230851|NCT05205837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93230852|NCT05205837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93230853|NCT05205837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230854|NCT05205837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230855|NCT05205837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93230856|NCT05205837|Hormone Antagonists|hormone antagonists|mesh-ancestor
93230857|NCT05205837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230858|NCT05205837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230859|NCT05205603|Infliximab|infliximab|mesh-list
93230860|NCT05205603|Mesalamine|mesalamine|mesh-list
93230861|NCT05205603|Vedolizumab|vedolizumab|mesh-list
93230862|NCT05205603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93230863|NCT05205603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230864|NCT05205603|Dermatologic Agents|dermatologic agents|mesh-ancestor
93230865|NCT05205603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93230866|NCT05205603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230867|NCT05205603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93230868|NCT05205603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93230869|NCT05205603|Analgesics|analgesics|mesh-ancestor
93230870|NCT05205603|Sensory System Agents|sensory system agents|mesh-ancestor
93230871|NCT05205603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230872|NCT05205603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230873|NCT03578900|Citric Acid|citric acid|mesh-list
93230874|NCT03578900|Sodium Citrate|sodium citrate|mesh-list
93230875|NCT03578900|Anticoagulants|anticoagulants|mesh-ancestor
93230876|NCT03578900|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93230877|NCT03578900|Chelating Agents|chelating agents|mesh-ancestor
93230878|NCT03578900|Sequestering Agents|sequestering agents|mesh-ancestor
93230879|NCT03578900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230880|NCT02550002|Aflibercept|aflibercept|mesh-list
93230881|NCT02550002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93230882|NCT02550002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93230883|NCT02550002|Growth Substances|growth substances|mesh-ancestor
93230884|NCT02550002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230885|NCT02550002|Growth Inhibitors|growth inhibitors|mesh-ancestor
93230886|NCT02550002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230887|NCT03574376|Bupivacaine|bupivacaine|mesh-list
93230888|NCT03574376|Anesthetics, Local|anesthetics, local|mesh-ancestor
93230889|NCT03574376|Anesthetics|anesthetics|mesh-ancestor
93230890|NCT03574376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93230891|NCT03574376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230892|NCT03574376|Sensory System Agents|sensory system agents|mesh-ancestor
93230893|NCT03574376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230894|NCT03576794|Prednisolone|prednisolone|mesh-list
93230895|NCT03576794|Leflunomide|leflunomide|mesh-list
93230896|NCT03576794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230897|NCT03576794|Glucocorticoids|glucocorticoids|mesh-ancestor
93230898|NCT03576794|Hormones|hormones|mesh-ancestor
93230899|NCT03576794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230900|NCT03576794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230901|NCT03576794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93230902|NCT03576794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230903|NCT03576794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230904|NCT03576794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230905|NCT03576794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93230906|NCT03576794|Immunologic Factors|immunologic factors|mesh-ancestor
93230907|NCT03578822|Aspirin|aspirin|mesh-list
93230908|NCT03578822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93230909|NCT03578822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93230910|NCT03578822|Analgesics|analgesics|mesh-ancestor
93230911|NCT03578822|Sensory System Agents|sensory system agents|mesh-ancestor
93230912|NCT03578822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230913|NCT03578822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230914|NCT03578822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230915|NCT03578822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93230916|NCT03578822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93230917|NCT03578822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93230918|NCT03578822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230919|NCT03578822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93230920|NCT03578822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93230921|NCT03578822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230922|NCT03578822|Antipyretics|antipyretics|mesh-ancestor
93230923|NCT03576638|Levodopa|levodopa|mesh-list
93230924|NCT03576638|Carbidopa|carbidopa|mesh-list
93230925|NCT03576638|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93230926|NCT03576638|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93230927|NCT03576638|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93230928|NCT03576638|Dopamine Agents|dopamine agents|mesh-ancestor
93230929|NCT03576638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230930|NCT03576638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230931|NCT03576638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230932|NCT03576638|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92944994|NCT00884884|Topiramate|topiramate|mesh-list
93230933|NCT03576638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230934|NCT03576638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93230935|NCT03576638|Immunologic Factors|immunologic factors|mesh-ancestor
93230936|NCT03576638|Dopamine Agonists|dopamine agonists|mesh-ancestor
93230937|NCT04284657|Citric Acid|citric acid|mesh-list
93230938|NCT04284657|Sodium Citrate|sodium citrate|mesh-list
93230939|NCT04284657|Pravastatin|pravastatin|mesh-list
93230940|NCT04284657|Anticoagulants|anticoagulants|mesh-ancestor
93230941|NCT04284657|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93230942|NCT04284657|Chelating Agents|chelating agents|mesh-ancestor
93230943|NCT04284657|Sequestering Agents|sequestering agents|mesh-ancestor
93230944|NCT04284657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230945|NCT04284657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93230946|NCT04284657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93230947|NCT04284657|Antimetabolites|antimetabolites|mesh-ancestor
93230948|NCT04284657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93230949|NCT04284657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93230950|NCT04284657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93230951|NCT01569945|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93230952|NCT01569945|Clomiphene|clomiphene|mesh-list
93230953|NCT01569945|Menotropins|menotropins|mesh-list
93230954|NCT01569945|Estradiol|estradiol|mesh-list
93230955|NCT01569945|Estrogens|estrogens|mesh-ancestor
93230956|NCT01569945|Hormones|hormones|mesh-ancestor
93230957|NCT01569945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230958|NCT01569945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230959|NCT01569945|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93230960|NCT01569945|Contraceptive Agents|contraceptive agents|mesh-ancestor
93230961|NCT01569945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93230962|NCT01569945|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93230963|NCT01569945|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92945112|NCT01041313|Memantine|memantine|mesh-list
93230964|NCT01569945|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93230965|NCT01569945|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93230966|NCT01569945|Hormone Antagonists|hormone antagonists|mesh-ancestor
93230967|NCT01569945|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93230968|NCT01569945|Fertility Agents|fertility agents|mesh-ancestor
93230969|NCT01569945|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93230970|NCT01569945|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93230972|NCT03574220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93230973|NCT03574220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93230974|NCT03574220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93230975|NCT03574220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230976|NCT04876677|Beclomethasone|beclomethasone|mesh-list
93230977|NCT04876677|Glycopyrrolate|glycopyrrolate|mesh-list
93230978|NCT04876677|Formoterol Fumarate|formoterol fumarate|mesh-list
93230979|NCT04876677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93230980|NCT04876677|Autonomic Agents|autonomic agents|mesh-ancestor
93230981|NCT04876677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93230982|NCT04876677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93230983|NCT04876677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93230984|NCT04876677|Respiratory System Agents|respiratory system agents|mesh-ancestor
93230985|NCT04876677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93230986|NCT04876677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93230987|NCT04876677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93230988|NCT04876677|Adrenergic Agents|adrenergic agents|mesh-ancestor
93230989|NCT04876677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93230990|NCT04876677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93230991|NCT04876677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93230992|NCT04876677|Glucocorticoids|glucocorticoids|mesh-ancestor
93230993|NCT04876677|Hormones|hormones|mesh-ancestor
93230994|NCT04876677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93230995|NCT04876677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93230996|NCT04876677|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93230997|NCT04876677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93230998|NCT04876677|Cholinergic Agents|cholinergic agents|mesh-ancestor
93230999|NCT03578432|Everolimus|everolimus|mesh-list
93231000|NCT03578432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93231001|NCT03578432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231002|NCT03578432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231003|NCT03578432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231004|NCT03578432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231005|NCT03578432|Immunologic Factors|immunologic factors|mesh-ancestor
93231006|NCT03578432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231007|NCT03578432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231008|NCT03578354|Atenolol|atenolol|mesh-list
93231009|NCT03578354|4-Aminopyridine|4-aminopyridine|mesh-list
93231010|NCT03578354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93231011|NCT03578354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93231012|NCT03578354|Sympatholytics|sympatholytics|mesh-ancestor
93231013|NCT03578354|Autonomic Agents|autonomic agents|mesh-ancestor
93231014|NCT03578354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231015|NCT03578354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231016|NCT03578354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93231017|NCT03578354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93231018|NCT03578354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93231019|NCT03578354|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231020|NCT03578354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231021|NCT03578354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231022|NCT03578354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93231023|NCT03578354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93231024|NCT05204979|Misoprostol|misoprostol|mesh-list
93231025|NCT05204979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93231026|NCT05204979|Abortifacient Agents|abortifacient agents|mesh-ancestor
93231027|NCT05204979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93231028|NCT05204979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231029|NCT05204979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93231030|NCT05204979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93231031|NCT05204979|Oxytocics|oxytocics|mesh-ancestor
93231032|NCT03647514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93231033|NCT03647514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231034|NCT02239952|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93231035|NCT02239952|Sunitinib|sunitinib|mesh-list
93231036|NCT02239952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903078|NCT02639819|Hemostatics|hemostatics|mesh-ancestor
93231037|NCT02239952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231039|NCT02239952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231040|NCT02239952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93231041|NCT02239952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93231042|NCT02239952|Growth Substances|growth substances|mesh-ancestor
93231043|NCT02239952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231044|NCT02239952|Growth Inhibitors|growth inhibitors|mesh-ancestor
93231045|NCT03647280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93231046|NCT03647280|Epirubicin|epirubicin|mesh-list
93231047|NCT03647280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231048|NCT03647280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231049|NCT03647280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93231050|NCT03647280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93231051|NCT03647280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93231052|NCT03647280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231053|NCT03578042|Losartan|losartan|mesh-list
93231054|NCT03578042|Amlodipine|amlodipine|mesh-list
93231055|NCT03578042|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93231056|NCT03578042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93231057|NCT03578042|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93231058|NCT03578042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93231059|NCT03578042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231060|NCT03578042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93231061|NCT03578042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231062|NCT03578042|Vasodilator Agents|vasodilator agents|mesh-ancestor
93231063|NCT03578042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93231064|NCT03578042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93231065|NCT03578042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93231066|NCT03578042|Diuretics|diuretics|mesh-ancestor
93231067|NCT03578042|Natriuretic Agents|natriuretic agents|mesh-ancestor
93231068|NCT03578042|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93231069|NCT03646500|Remifentanil|remifentanil|mesh-list
93231070|NCT03646500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93231071|NCT03646500|Narcotics|narcotics|mesh-ancestor
93231072|NCT03646500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231073|NCT03646500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231074|NCT03646500|Analgesics|analgesics|mesh-ancestor
93231075|NCT03646500|Sensory System Agents|sensory system agents|mesh-ancestor
93231076|NCT03646500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231077|NCT03574064|Glucagon|glucagon|mesh-list
93231078|NCT03574064|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
93231079|NCT03574064|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93231080|NCT03574064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93231081|NCT03574064|Hormones|hormones|mesh-ancestor
93231082|NCT03574064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93231083|NCT03574064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231084|NCT03574064|Incretins|incretins|mesh-ancestor
93231085|NCT03573986|Bevacizumab|bevacizumab|mesh-list
93231086|NCT03573986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93231087|NCT03573986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231088|NCT03573986|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93231089|NCT03573986|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945526|NCT00402103|Diuretics|diuretics|mesh-ancestor
93231090|NCT03573986|Growth Substances|growth substances|mesh-ancestor
93231091|NCT03573986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231092|NCT03573986|Growth Inhibitors|growth inhibitors|mesh-ancestor
93231093|NCT03959592|Carotenoids|carotenoids|mesh-list
93231094|NCT03959592|Antioxidants|antioxidants|mesh-ancestor
93231095|NCT03959592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231096|NCT03959592|Protective Agents|protective agents|mesh-ancestor
93231097|NCT03959592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231098|NCT04087395|Lidocaine|lidocaine|mesh-list
93231099|NCT04087395|Anesthetics|anesthetics|mesh-list
93231100|NCT04087395|Anesthetics, Local|anesthetics, local|mesh-ancestor
93231101|NCT04087395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231102|NCT04087395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231103|NCT04087395|Sensory System Agents|sensory system agents|mesh-ancestor
93231104|NCT04087395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231105|NCT04087395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945559|NCT00641667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93231106|NCT04087395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92945622|NCT00815841|Dopamine Agents|dopamine agents|mesh-ancestor
93231107|NCT04087395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93231108|NCT04087395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903142|NCT02562664|Metformin|metformin|mesh-list
93231109|NCT04087395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231110|NCT03573596|Dasatinib|dasatinib|mesh-list
93231111|NCT03573596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231112|NCT03573596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231113|NCT03573596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231114|NCT03573596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231115|NCT03621618|Dobutamine|dobutamine|mesh-list
93231116|NCT03621618|Norepinephrine|norepinephrine|mesh-list
93231117|NCT03621618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93231118|NCT03621618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231119|NCT03621618|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231120|NCT03621618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231121|NCT03621618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231122|NCT03621618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231123|NCT03621618|Sympathomimetics|sympathomimetics|mesh-ancestor
93231124|NCT03621618|Autonomic Agents|autonomic agents|mesh-ancestor
93231125|NCT03621618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945845|NCT00821535|Maraviroc|maraviroc|mesh-list
93231126|NCT03621618|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93231127|NCT03621618|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93231128|NCT03621618|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93231129|NCT03621618|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93231130|NCT03621618|Protective Agents|protective agents|mesh-ancestor
93231131|NCT03944304|Paclitaxel|paclitaxel|mesh-list
93231132|NCT03944304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93231133|NCT03944304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231134|NCT03944304|Tubulin Modulators|tubulin modulators|mesh-ancestor
93231135|NCT03944304|Antimitotic Agents|antimitotic agents|mesh-ancestor
93231136|NCT03944304|Mitosis Modulators|mitosis modulators|mesh-ancestor
93231137|NCT03944304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231138|NCT05204121|Elsulfavirine|elsulfavirine|mesh-list
93231139|NCT05204121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93231140|NCT05204121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93231141|NCT05204121|Antiviral Agents|antiviral agents|mesh-ancestor
93231142|NCT05204121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93231143|NCT04671615|Palbociclib|palbociclib|mesh-list
93231144|NCT04671615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231145|NCT04671615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231146|NCT04671615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231147|NCT04671615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231148|NCT03645876|Capecitabine|capecitabine|mesh-list
93231149|NCT03645876|Oxaliplatin|oxaliplatin|mesh-list
93231150|NCT03645876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93231151|NCT03645876|Antimetabolites|antimetabolites|mesh-ancestor
93231152|NCT03645876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231153|NCT03645876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231154|NCT02899728|Cisplatin|cisplatin|mesh-list
93231155|NCT02899728|Carboplatin|carboplatin|mesh-list
93231156|NCT02899728|Etoposide|etoposide|mesh-list
93231157|NCT02899728|Etoposide phosphate|etoposide phosphate|mesh-list
93231158|NCT02899728|Olaparib|olaparib|mesh-list
93231159|NCT02899728|Podophyllotoxin|podophyllotoxin|mesh-list
93231160|NCT02899728|Cediranib|cediranib|mesh-list
93231161|NCT02899728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93231162|NCT02899728|Maleic acid|maleic acid|mesh-list
93231163|NCT02899728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231164|NCT02899728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93231165|NCT02899728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93231166|NCT02899728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93231167|NCT02899728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946026|NCT00822315|Efavirenz|efavirenz|mesh-list
93231168|NCT02899728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231169|NCT02899728|Keratolytic Agents|keratolytic agents|mesh-ancestor
93231170|NCT02899728|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231171|NCT02899728|Tubulin Modulators|tubulin modulators|mesh-ancestor
93231172|NCT02899728|Antimitotic Agents|antimitotic agents|mesh-ancestor
93231173|NCT02899728|Mitosis Modulators|mitosis modulators|mesh-ancestor
93231174|NCT02899728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231175|NCT03646266|Bromides|bromides|mesh-list
93231176|NCT03646266|Rocuronium|rocuronium|mesh-list
93231177|NCT03646266|Anticonvulsants|anticonvulsants|mesh-ancestor
93231178|NCT03646266|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93231179|NCT03646266|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93231180|NCT03646266|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93231181|NCT03646266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231182|NCT03646266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231183|NCT04052178|Capsaicin|capsaicin|mesh-list
93231184|NCT04052178|Antipruritics|antipruritics|mesh-ancestor
93231185|NCT04052178|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231186|NCT04052178|Sensory System Agents|sensory system agents|mesh-ancestor
93231187|NCT04052178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231188|NCT04052178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231189|NCT03645642|Midodrine|midodrine|mesh-list
93231190|NCT03645642|Diuretics|diuretics|mesh-list
93231191|NCT03645642|Natriuretic Agents|natriuretic agents|mesh-ancestor
93231192|NCT03645642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231193|NCT03645642|Sympathomimetics|sympathomimetics|mesh-ancestor
93231194|NCT03645642|Autonomic Agents|autonomic agents|mesh-ancestor
93231195|NCT03645642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231196|NCT03645642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93231197|NCT03645642|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93231198|NCT03645642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93231199|NCT03645642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231200|NCT03645642|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231201|NCT03645642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231202|NCT03645642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231203|NCT03066609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93231204|NCT03066609|Immunologic Factors|immunologic factors|mesh-ancestor
92946147|NCT00921180|Entecavir|entecavir|mesh-list
93231205|NCT03066609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231206|NCT03768492|Caffeine|caffeine|mesh-list
93231207|NCT03768492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93231208|NCT03768492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231209|NCT03768492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93231210|NCT03768492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231211|NCT03768492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231212|NCT03768492|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93231213|NCT03768492|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92946268|NCT01034917|Etravirine|etravirine|mesh-list
93231214|NCT03768492|Purinergic Agents|purinergic agents|mesh-ancestor
93231215|NCT03768492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231216|NCT01345188|Ranolazine|ranolazine|mesh-list
93231217|NCT01345188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93231218|NCT01345188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93231219|NCT01345188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231220|NCT03852459|Ibuprofen|ibuprofen|mesh-list
93231221|NCT03852459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93231222|NCT03852459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231223|NCT03852459|Analgesics|analgesics|mesh-ancestor
93231224|NCT03852459|Sensory System Agents|sensory system agents|mesh-ancestor
92946333|NCT00816855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231225|NCT03852459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231226|NCT03852459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231227|NCT03852459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231228|NCT03852459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93231229|NCT03852459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93231230|NCT03852459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231231|NCT03852459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231232|NCT03580902|Buprenorphine|buprenorphine|mesh-list
93231233|NCT03580902|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93231234|NCT03580902|Naloxone|naloxone|mesh-list
93231235|NCT03580902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93231236|NCT03580902|Narcotics|narcotics|mesh-ancestor
93231237|NCT03580902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231238|NCT03580902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231239|NCT03580902|Analgesics|analgesics|mesh-ancestor
93231240|NCT03580902|Sensory System Agents|sensory system agents|mesh-ancestor
93231241|NCT03580902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231242|NCT03580902|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93231243|NCT02896296|Buprenorphine|buprenorphine|mesh-list
93231244|NCT02896296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93231245|NCT02896296|Narcotics|narcotics|mesh-ancestor
93231246|NCT02896296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946474|NCT00631917|Ramipril|ramipril|mesh-list
93231247|NCT02896296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231248|NCT02896296|Analgesics|analgesics|mesh-ancestor
93231249|NCT02896296|Sensory System Agents|sensory system agents|mesh-ancestor
93231250|NCT02896296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231251|NCT02896296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93231252|NCT03644706|Potassium Citrate|potassium citrate|mesh-list
93231253|NCT03644706|Diuretics|diuretics|mesh-ancestor
93231254|NCT03644706|Natriuretic Agents|natriuretic agents|mesh-ancestor
93231255|NCT03644706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231256|NCT03644706|Expectorants|expectorants|mesh-ancestor
93231257|NCT03644706|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231258|NCT03740919|Insulin|insulin|mesh-list
93231259|NCT03740919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93231260|NCT03740919|Insulin Glargine|insulin glargine|mesh-list
93231261|NCT03740919|Insulin Lispro|insulin lispro|mesh-list
93231262|NCT03740919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93231263|NCT03740919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231264|NCT01335685|Prednisone|prednisone|mesh-list
93231265|NCT01335685|Melphalan|melphalan|mesh-list
93231266|NCT01335685|Ixazomib|ixazomib|mesh-list
93231267|NCT01335685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231268|NCT01335685|Glucocorticoids|glucocorticoids|mesh-ancestor
93231269|NCT01335685|Hormones|hormones|mesh-ancestor
92946523|NCT04060914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231270|NCT01335685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93231271|NCT01335685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231272|NCT01335685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93231273|NCT01335685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231274|NCT01335685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93231275|NCT01335685|Alkylating Agents|alkylating agents|mesh-ancestor
93231276|NCT01335685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231277|NCT01335685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93231278|NCT01335685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231279|NCT01335685|Immunologic Factors|immunologic factors|mesh-ancestor
93231280|NCT01335685|Protease Inhibitors|protease inhibitors|mesh-ancestor
93231281|NCT01335685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231282|NCT01335763|Insulin Glargine|insulin glargine|mesh-list
93231283|NCT01335763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93231284|NCT01335763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231285|NCT04462965|Temozolomide|temozolomide|mesh-list
93231286|NCT04462965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93231287|NCT04462965|Alkylating Agents|alkylating agents|mesh-ancestor
93232198|NCT05708534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231288|NCT04462965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231289|NCT04462965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231290|NCT01339663|Aldesleukin|aldesleukin|mesh-list
93231291|NCT01339663|Cyclophosphamide|cyclophosphamide|mesh-list
93231292|NCT01339663|Interleukin-2|interleukin-2|mesh-list
93231293|NCT01339663|Vaccines|vaccines|mesh-list
93231294|NCT01339663|Immunologic Factors|immunologic factors|mesh-ancestor
93231295|NCT01339663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231296|NCT01339663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231297|NCT01339663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232199|NCT05708534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93231298|NCT01339663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93231299|NCT01339663|Alkylating Agents|alkylating agents|mesh-ancestor
92946843|NCT00409747|Minocycline|minocycline|mesh-list
93231300|NCT01339663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231301|NCT01339663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231302|NCT01339663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93231303|NCT01339663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231304|NCT01339663|Analgesics|analgesics|mesh-ancestor
93231305|NCT01339663|Sensory System Agents|sensory system agents|mesh-ancestor
93232200|NCT03000374|Leucovorin|leucovorin|mesh-list
93231306|NCT01339663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947064|NCT01035853|Colistin|colistin|mesh-list
93231307|NCT01339663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93231308|NCT01339663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93231309|NCT01339663|Antiviral Agents|antiviral agents|mesh-ancestor
93231310|NCT01339663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93231311|NCT00092599|Ezetimibe|ezetimibe|mesh-list
93231312|NCT00092599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93231313|NCT00092599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93231314|NCT00092599|Antimetabolites|antimetabolites|mesh-ancestor
93231315|NCT00092599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231316|NCT00092599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93231317|NCT03737565|Tryptophan|tryptophan|mesh-list
93231318|NCT03737565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93231319|NCT03737565|Antidepressive Agents|antidepressive agents|mesh-ancestor
93231320|NCT03737565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93231321|NCT02889133|Iron|iron|mesh-list
93231322|NCT02889133|Dextrans|dextrans|mesh-list
93231323|NCT02889133|Iron-Dextran Complex|iron-dextran complex|mesh-list
93231324|NCT02889133|Trace Elements|trace elements|mesh-ancestor
93231325|NCT02889133|Micronutrients|micronutrients|mesh-ancestor
93231326|NCT02889133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231327|NCT02889133|Anticoagulants|anticoagulants|mesh-ancestor
93231328|NCT02889133|Plasma Substitutes|plasma substitutes|mesh-ancestor
93231329|NCT02889133|Blood Substitutes|blood substitutes|mesh-ancestor
93231330|NCT02889133|Hematinics|hematinics|mesh-ancestor
93231331|NCT01333423|Roscovitine|roscovitine|mesh-list
93231332|NCT01333423|Doxorubicin|doxorubicin|mesh-list
93231333|NCT01333423|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93231334|NCT01333423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93231335|NCT01333423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231336|NCT01333423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93231337|NCT01333423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93231338|NCT01333423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231339|NCT01333423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231340|NCT01333423|Antiviral Agents|antiviral agents|mesh-ancestor
93231341|NCT01333423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93231342|NCT01333423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231344|NCT00092209|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93231345|NCT00092209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93231346|NCT00092209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93231347|NCT00092209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93231348|NCT00092209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93231349|NCT00092209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231350|NCT00092209|Diuretics|diuretics|mesh-ancestor
93231351|NCT00092209|Natriuretic Agents|natriuretic agents|mesh-ancestor
93231352|NCT00092209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231353|NCT00092209|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93231354|NCT00092209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93231355|NCT01339741|Vitamin D|vitamin d|mesh-list
93231356|NCT01339741|Cholecalciferol|cholecalciferol|mesh-list
93231357|NCT01339741|Vitamins|vitamins|mesh-ancestor
93231358|NCT01339741|Micronutrients|micronutrients|mesh-ancestor
93231359|NCT01339741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231360|NCT01339741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93231361|NCT01339741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93231362|NCT00003777|Fluorouracil|fluorouracil|mesh-list
93231363|NCT00003777|Amifostine|amifostine|mesh-list
93231364|NCT00003777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231365|NCT00003777|Antimetabolites|antimetabolites|mesh-ancestor
93232201|NCT03000374|Fluorouracil|fluorouracil|mesh-list
93231366|NCT00003777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948200|NCT00932542|Lidocaine|lidocaine|mesh-list
93231367|NCT00003777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93231368|NCT00003777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231369|NCT00003777|Immunologic Factors|immunologic factors|mesh-ancestor
93231370|NCT00003777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231371|NCT00003777|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93231372|NCT00003777|Protective Agents|protective agents|mesh-ancestor
93231373|NCT01339819|Dabigatran|dabigatran|mesh-list
92948640|NCT00621543|Copper|copper|mesh-list
93231374|NCT01339819|Phenprocoumon|phenprocoumon|mesh-list
93231375|NCT01339819|Antithrombins|antithrombins|mesh-ancestor
93231376|NCT01339819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93231377|NCT01339819|Protease Inhibitors|protease inhibitors|mesh-ancestor
93231378|NCT01339819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232202|NCT03000374|Oxaliplatin|oxaliplatin|mesh-list
93231379|NCT01339819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949011|NCT00935194|Oseltamivir|oseltamivir|mesh-list
92949080|NCT00833157|Ibuprofen|ibuprofen|mesh-list
93231380|NCT01339819|Anticoagulants|anticoagulants|mesh-ancestor
93231381|NCT02963922|Liraglutide|liraglutide|mesh-list
92949154|NCT00840489|Antiviral Agents|antiviral agents|mesh-ancestor
93231382|NCT02963922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93231383|NCT02963922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231384|NCT02963922|Incretins|incretins|mesh-ancestor
93231385|NCT02963922|Hormones|hormones|mesh-ancestor
93231386|NCT02963922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93231387|NCT00090181|Diclofenac|diclofenac|mesh-list
93231388|NCT00090181|Etoricoxib|etoricoxib|mesh-list
93232203|NCT03000374|Panitumumab|panitumumab|mesh-list
93232204|NCT03000374|Antimetabolites|antimetabolites|mesh-ancestor
92949586|NCT00844233|Irinotecan|irinotecan|mesh-list
93231389|NCT00090181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93231390|NCT00090181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231391|NCT00090181|Analgesics|analgesics|mesh-ancestor
93231392|NCT00090181|Sensory System Agents|sensory system agents|mesh-ancestor
93231393|NCT00090181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950031|NCT00390013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93231394|NCT00090181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231395|NCT00090181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231396|NCT00090181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93231397|NCT00090181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93231398|NCT00090181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231399|NCT00090181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231400|NCT00090181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93231401|NCT03619785|Acetaminophen|acetaminophen|mesh-list
93231402|NCT03619785|Ibuprofen|ibuprofen|mesh-list
93231403|NCT03619785|Ketorolac|ketorolac|mesh-list
93231404|NCT03619785|Fentanyl|fentanyl|mesh-list
93231405|NCT03619785|Ketamine|ketamine|mesh-list
93231406|NCT03619785|Morphine|morphine|mesh-list
93231407|NCT03619785|Gabapentin|gabapentin|mesh-list
93231408|NCT03619785|Hydromorphone|hydromorphone|mesh-list
93231409|NCT03619785|Hydrocodone|hydrocodone|mesh-list
93231410|NCT03619785|Bupivacaine|bupivacaine|mesh-list
93231411|NCT03619785|Anesthetics, Local|anesthetics, local|mesh-ancestor
93231412|NCT03619785|Anesthetics|anesthetics|mesh-ancestor
93231413|NCT03619785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950326|NCT02562690|Thrombin|thrombin|mesh-list
93231414|NCT03619785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950384|NCT00749814|Melatonin|melatonin|mesh-list
93231415|NCT03619785|Sensory System Agents|sensory system agents|mesh-ancestor
93231417|NCT03619785|Analgesics|analgesics|mesh-ancestor
93231418|NCT03619785|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93231419|NCT03619785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93231420|NCT03619785|Anesthetics, General|anesthetics, general|mesh-ancestor
92950765|NCT00619983|Antidepressive Agents|antidepressive agents|mesh-ancestor
93231421|NCT03619785|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93231422|NCT03619785|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93231423|NCT03619785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950909|NCT00943462|Alkylating Agents|alkylating agents|mesh-ancestor
93231424|NCT03619785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231425|NCT03619785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93231426|NCT03619785|Narcotics|narcotics|mesh-ancestor
93231427|NCT03619785|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93231428|NCT03619785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231429|NCT03619785|Antipyretics|antipyretics|mesh-ancestor
93231430|NCT03619785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93231431|NCT03619785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231432|NCT03619785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92951429|NCT00957190|Timolol|timolol|mesh-list
92951508|NCT04030052|Factor VIII|factor viii|mesh-list
93231433|NCT03619785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93231434|NCT03619785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231435|NCT03619785|Anticonvulsants|anticonvulsants|mesh-ancestor
93231436|NCT03619785|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93231437|NCT03619785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93231438|NCT03619785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93231439|NCT03619785|Antimanic Agents|antimanic agents|mesh-ancestor
93231440|NCT03619785|Antitussive Agents|antitussive agents|mesh-ancestor
93231441|NCT03619785|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231442|NCT02881567|Daclizumab|daclizumab|mesh-list
93231443|NCT02881567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231444|NCT02881567|Immunologic Factors|immunologic factors|mesh-ancestor
93231445|NCT02881567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231446|NCT05184517|Cyclosporine|cyclosporine|mesh-list
93231447|NCT05184517|Cyclosporins|cyclosporins|mesh-list
93231448|NCT05184517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231449|NCT05184517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231450|NCT05184517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231451|NCT05184517|Immunologic Factors|immunologic factors|mesh-ancestor
93231452|NCT05184517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231453|NCT05184517|Antifungal Agents|antifungal agents|mesh-ancestor
93231454|NCT05184517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93231455|NCT05184517|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231456|NCT05184517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93231457|NCT05184517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93231458|NCT02962284|Methylprednisolone|methylprednisolone|mesh-list
93231459|NCT02962284|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93231460|NCT02962284|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93231461|NCT02962284|Prednisolone|prednisolone|mesh-list
93231462|NCT02962284|Prednisolone acetate|prednisolone acetate|mesh-list
93231463|NCT02962284|Abiraterone Acetate|abiraterone acetate|mesh-list
93231464|NCT02962284|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93231465|NCT02962284|Prednisolone phosphate|prednisolone phosphate|mesh-list
92951696|NCT00695786|Rituximab|rituximab|mesh-list
93231466|NCT02962284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231467|NCT02962284|Antiemetics|antiemetics|mesh-ancestor
93231468|NCT02962284|Autonomic Agents|autonomic agents|mesh-ancestor
93231469|NCT02962284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231470|NCT02962284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951987|NCT00862875|Insulin Detemir|insulin detemir|mesh-list
92952065|NCT04019379|Calcium, Dietary|calcium, dietary|mesh-list
93231471|NCT02962284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93231472|NCT02962284|Glucocorticoids|glucocorticoids|mesh-ancestor
93231473|NCT02962284|Hormones|hormones|mesh-ancestor
93232205|NCT03000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232206|NCT03000374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93231474|NCT02962284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92952358|NCT00755352|Antimetabolites|antimetabolites|mesh-ancestor
92952433|NCT00868569|Leucovorin|leucovorin|mesh-list
93231475|NCT02962284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93231476|NCT02962284|Protective Agents|protective agents|mesh-ancestor
93231477|NCT02962284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93231478|NCT02962284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231479|NCT02962284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93231480|NCT02962284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952799|NCT00871065|Sildenafil Citrate|sildenafil citrate|mesh-list
93231481|NCT02962284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231482|NCT02962284|Hormone Antagonists|hormone antagonists|mesh-ancestor
93231483|NCT02962284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93231484|NCT03642600|Folic Acid|folic acid|mesh-list
93231485|NCT03642600|Inositol|inositol|mesh-list
93231486|NCT03642600|Liraglutide|liraglutide|mesh-list
93231487|NCT03642600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93231488|NCT03642600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231489|NCT03642600|Incretins|incretins|mesh-ancestor
93231490|NCT03642600|Hormones|hormones|mesh-ancestor
92903524|NCT00702156|Bisoprolol|bisoprolol|mesh-list
93232207|NCT03000374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953313|NCT03083808|Pembrolizumab|pembrolizumab|mesh-list
93231491|NCT03642600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93231492|NCT03642600|Hematinics|hematinics|mesh-ancestor
93231493|NCT03642600|Vitamin B Complex|vitamin b complex|mesh-ancestor
93231494|NCT03642600|Vitamins|vitamins|mesh-ancestor
93231495|NCT03642600|Micronutrients|micronutrients|mesh-ancestor
93231496|NCT01069692|Ferric Compounds|ferric compounds|mesh-list
93231497|NCT01069692|Hematinics|hematinics|mesh-ancestor
93231498|NCT05183178|Ticagrelor|ticagrelor|mesh-list
93231499|NCT05183178|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93231500|NCT05183178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93231501|NCT05183178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93231502|NCT05183178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93231503|NCT05183178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93231504|NCT05183178|Purinergic Agents|purinergic agents|mesh-ancestor
93231505|NCT05183178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231506|NCT05183178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231507|NCT05183178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231508|NCT03161093|Naproxen|naproxen|mesh-list
93231509|NCT03161093|Fasinumab|fasinumab|mesh-list
93231510|NCT03161093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92953817|NCT00611247|Alkylating Agents|alkylating agents|mesh-ancestor
93231511|NCT03161093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231512|NCT03161093|Analgesics|analgesics|mesh-ancestor
92953966|NCT02543229|Growth Substances|growth substances|mesh-ancestor
93231513|NCT03161093|Sensory System Agents|sensory system agents|mesh-ancestor
93231514|NCT03161093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954048|NCT05954897|Lenvatinib|lenvatinib|mesh-list
93231515|NCT03161093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231516|NCT03161093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231517|NCT03161093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93231518|NCT03161093|Gout Suppressants|gout suppressants|mesh-ancestor
93231519|NCT03161093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93231520|NCT03161093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231521|NCT03161093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231522|NCT03573284|Nitric Oxide|nitric oxide|mesh-list
93231523|NCT03573284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93231524|NCT03573284|Autonomic Agents|autonomic agents|mesh-ancestor
93231525|NCT03573284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954518|NCT05776927|Xhance|xhance|mesh-list
92954554|NCT05761041|Listerine|listerine|mesh-list
92954629|NCT05706753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93231526|NCT03573284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231527|NCT03573284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93231528|NCT03573284|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231529|NCT03573284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93231530|NCT03573284|Antioxidants|antioxidants|mesh-ancestor
93231531|NCT03573284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954771|NCT05575063|Viscosupplements|viscosupplements|mesh-ancestor
93231532|NCT03573284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231533|NCT03573284|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93231534|NCT03573284|Vasodilator Agents|vasodilator agents|mesh-ancestor
93231535|NCT03573284|Gasotransmitters|gasotransmitters|mesh-ancestor
93231536|NCT03573284|Protective Agents|protective agents|mesh-ancestor
93231537|NCT03575780|Tirbanibulin|tirbanibulin|mesh-list
93231538|NCT03575780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231539|NCT03575780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231540|NCT01334333|Tacrolimus|tacrolimus|mesh-list
93231541|NCT01334333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231542|NCT01334333|Immunologic Factors|immunologic factors|mesh-ancestor
93231543|NCT01334333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231544|NCT01334333|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93231545|NCT01334333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231546|NCT01334333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231547|NCT03573050|Rivastigmine|rivastigmine|mesh-list
92954987|NCT05421065|Ketamine|ketamine|mesh-list
93231548|NCT03573050|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93231549|NCT03573050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955205|NCT05257590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232208|NCT03000374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231550|NCT03573050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231551|NCT03573050|Cholinergic Agents|cholinergic agents|mesh-ancestor
93231552|NCT03573050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231553|NCT03573050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955514|NCT04947527|Fluorides|fluorides|mesh-list
93231554|NCT03573050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92955574|NCT04895358|Antimetabolites|antimetabolites|mesh-ancestor
93231555|NCT03573050|Protective Agents|protective agents|mesh-ancestor
93231556|NCT03575312|Enrofloxacin|enrofloxacin|mesh-list
93231557|NCT03575312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93231558|NCT03575312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93231559|NCT02847494|Dexamethasone|dexamethasone|mesh-list
93231560|NCT02847494|Methylprednisolone|methylprednisolone|mesh-list
93231561|NCT02847494|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92955880|NCT04539249|Pentazocine|pentazocine|mesh-list
93231562|NCT02847494|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93231563|NCT02847494|Prednisolone|prednisolone|mesh-list
93231564|NCT02847494|Prednisolone acetate|prednisolone acetate|mesh-list
93231565|NCT02847494|Metoclopramide|metoclopramide|mesh-list
92956094|NCT04160494|Atezolizumab|atezolizumab|mesh-list
93231566|NCT02847494|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92956187|NCT04083235|Leucovorin|leucovorin|mesh-list
93231567|NCT02847494|Prednisolone phosphate|prednisolone phosphate|mesh-list
93232209|NCT03000374|Immunologic Factors|immunologic factors|mesh-ancestor
93231568|NCT02847494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231570|NCT02847494|Autonomic Agents|autonomic agents|mesh-ancestor
92956311|NCT03939104|Artemether|artemether|mesh-list
92956389|NCT03809533|Velpatasvir|velpatasvir|mesh-list
92956462|NCT03597568|Antioxidants|antioxidants|mesh-ancestor
93231571|NCT02847494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231572|NCT02847494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231573|NCT02847494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93231574|NCT02847494|Glucocorticoids|glucocorticoids|mesh-ancestor
93231575|NCT02847494|Hormones|hormones|mesh-ancestor
93231576|NCT02847494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956833|NCT02828358|Cyclophosphamide|cyclophosphamide|mesh-list
92956915|NCT02797470|Antimetabolites|antimetabolites|mesh-ancestor
93231577|NCT02847494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93231578|NCT02847494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957137|NCT01998971|Acetaminophen|acetaminophen|mesh-list
93231579|NCT02847494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92957212|NCT01792687|Hormones|hormones|mesh-ancestor
93231580|NCT02847494|Protective Agents|protective agents|mesh-ancestor
92957285|NCT01319565|Alkylating Agents|alkylating agents|mesh-ancestor
93231581|NCT02847494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93231582|NCT02847494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93231583|NCT02847494|Dopamine Agents|dopamine agents|mesh-ancestor
93231584|NCT02847494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957654|NCT00609765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231585|NCT02847494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231586|NCT02554253|Ketamine|ketamine|mesh-list
93231587|NCT02554253|Propofol|propofol|mesh-list
93231588|NCT02554253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93231589|NCT02554253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958023|NCT00966706|Gemcitabine|gemcitabine|mesh-list
92958101|NCT00967096|Rifaximin|rifaximin|mesh-list
93231590|NCT02554253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231591|NCT02554253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93231592|NCT02554253|Anesthetics, General|anesthetics, general|mesh-ancestor
93231593|NCT02554253|Anesthetics|anesthetics|mesh-ancestor
93231594|NCT02554253|Analgesics|analgesics|mesh-ancestor
93231595|NCT02554253|Sensory System Agents|sensory system agents|mesh-ancestor
93231596|NCT02554253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231597|NCT02554253|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93231598|NCT02554253|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93231599|NCT02554253|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93231600|NCT02554253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231601|NCT02554253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231602|NCT02239484|Tadalafil|tadalafil|mesh-list
93231603|NCT02239484|Tamsulosin|tamsulosin|mesh-list
93231604|NCT02239484|Vasodilator Agents|vasodilator agents|mesh-ancestor
93231605|NCT02239484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93231606|NCT02239484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93231607|NCT02239484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958697|NCT00608985|Zolpidem|zolpidem|mesh-list
93232210|NCT03000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231608|NCT02239484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958900|NCT00970996|Analgesics|analgesics|mesh-ancestor
93231609|NCT02239484|Urological Agents|urological agents|mesh-ancestor
93232211|NCT03000374|Antidotes|antidotes|mesh-ancestor
93231610|NCT02239484|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93231611|NCT02239484|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93231612|NCT02239484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93231613|NCT02239484|Adrenergic Agents|adrenergic agents|mesh-ancestor
93232212|NCT03000374|Protective Agents|protective agents|mesh-ancestor
93231614|NCT02239484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231615|NCT02239484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231616|NCT03575234|Cyclophosphamide|cyclophosphamide|mesh-list
93231617|NCT03575234|Nivolumab|nivolumab|mesh-list
93231618|NCT03575234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231619|NCT03575234|Immunologic Factors|immunologic factors|mesh-ancestor
93231620|NCT03575234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231621|NCT03575234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232213|NCT03000374|Vitamin B Complex|vitamin b complex|mesh-ancestor
93232214|NCT03000374|Vitamins|vitamins|mesh-ancestor
93231622|NCT03575234|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93231623|NCT03575234|Alkylating Agents|alkylating agents|mesh-ancestor
92604971|NCT00492388|Ketamine|ketamine|mesh-list
93232215|NCT03000374|Micronutrients|micronutrients|mesh-ancestor
93231624|NCT03575234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231625|NCT03575234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231626|NCT03575234|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93231627|NCT03575234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93231628|NCT03575234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93231629|NCT04508855|Heparin|heparin|mesh-list
93231630|NCT04508855|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93231631|NCT04508855|Tinzaparin|tinzaparin|mesh-list
93231632|NCT04508855|Dalteparin|dalteparin|mesh-list
93231633|NCT04508855|Anticoagulants|anticoagulants|mesh-ancestor
93231634|NCT04508855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93231635|NCT04508855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93231636|NCT04508855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231637|NCT03575078|Olaparib|olaparib|mesh-list
93232216|NCT03000374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93232217|NCT03566576|Docetaxel|docetaxel|mesh-list
93232218|NCT03566576|Pemetrexed|pemetrexed|mesh-list
93231638|NCT03575078|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92959912|NCT00336583|Antiemetics|antiemetics|mesh-ancestor
92960011|NCT01060423|Cetuximab|cetuximab|mesh-list
93231639|NCT03575078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231640|NCT03575078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960210|NCT00986050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93231641|NCT03575078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231642|NCT03157583|Sunscreening Agents|sunscreening agents|mesh-list
93231643|NCT03157583|Glycerol|glycerol|mesh-list
93231644|NCT03157583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93231645|NCT03157583|Protective Agents|protective agents|mesh-ancestor
92960587|NCT00983944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93231646|NCT03157583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231647|NCT03157583|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231648|NCT03157583|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93231649|NCT03570710|Tranexamic Acid|tranexamic acid|mesh-list
92960803|NCT01053871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92960886|NCT01054105|Iloprost|iloprost|mesh-list
93231650|NCT03570710|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93231651|NCT03570710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93231652|NCT03570710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231653|NCT03570710|Hemostatics|hemostatics|mesh-ancestor
92961056|NCT00540046|Copper|copper|mesh-list
93231654|NCT03570710|Coagulants|coagulants|mesh-ancestor
93231655|NCT01337765|Dactolisib|dactolisib|mesh-list
93231656|NCT01337765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231657|NCT01307033|Losartan|losartan|mesh-list
93231658|NCT01307033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93231659|NCT01307033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93231660|NCT01307033|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93231661|NCT01307033|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92961336|NCT00329719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93231662|NCT01307033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231663|NCT04475705|Propofol|propofol|mesh-list
93231664|NCT04475705|Sevoflurane|sevoflurane|mesh-list
92961492|NCT00779376|Zidovudine|zidovudine|mesh-list
93231665|NCT04475705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93231666|NCT04475705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231667|NCT04475705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231668|NCT04475705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93231669|NCT04475705|Anesthetics, General|anesthetics, general|mesh-ancestor
93231670|NCT04475705|Anesthetics|anesthetics|mesh-ancestor
92961619|NCT00780780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231671|NCT04475705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92961713|NCT00400946|Leucovorin|leucovorin|mesh-list
92961769|NCT00400946|Vitamin B Complex|vitamin b complex|mesh-ancestor
93231672|NCT04475705|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93231673|NCT03158311|Fluticasone|fluticasone|mesh-list
93231674|NCT03158311|Tiotropium Bromide|tiotropium bromide|mesh-list
93231675|NCT03158311|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93231676|NCT03158311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231677|NCT03158311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92961993|NCT00929799|Hormones|hormones|mesh-list
93231678|NCT03158311|Autonomic Agents|autonomic agents|mesh-ancestor
93231679|NCT03158311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962063|NCT00742040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93231680|NCT03158311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231681|NCT03158311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93231682|NCT03158311|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231683|NCT03158311|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231684|NCT03158311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93231685|NCT03158311|Parasympatholytics|parasympatholytics|mesh-ancestor
93231686|NCT03158311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93231687|NCT03158311|Cholinergic Agents|cholinergic agents|mesh-ancestor
93231688|NCT03158311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232219|NCT03566576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232220|NCT03566576|Tubulin Modulators|tubulin modulators|mesh-ancestor
93231689|NCT03158311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231690|NCT03158311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93232221|NCT03566576|Antimitotic Agents|antimitotic agents|mesh-ancestor
93231691|NCT03158311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93231692|NCT03158311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231693|NCT03158311|Adrenergic Agents|adrenergic agents|mesh-ancestor
92962582|NCT00566631|Serotonin Agents|serotonin agents|mesh-ancestor
93232222|NCT03566576|Mitosis Modulators|mitosis modulators|mesh-ancestor
93231694|NCT02244866|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93231695|NCT02244866|Hormones|hormones|mesh-ancestor
92962727|NCT00931203|Celecoxib|celecoxib|mesh-list
92962797|NCT00933231|Immunologic Factors|immunologic factors|mesh-ancestor
92962872|NCT00663858|Hormone Antagonists|hormone antagonists|mesh-ancestor
93232223|NCT03566576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231696|NCT02244866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93231697|NCT02244866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231698|NCT01334567|Tenofovir|tenofovir|mesh-list
93231699|NCT01334567|Antiviral Agents|antiviral agents|mesh-ancestor
92963261|NCT00326911|Cetuximab|cetuximab|mesh-list
93231700|NCT01334567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93231701|NCT01334567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93231702|NCT01334567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93231703|NCT01334567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231704|NCT01334567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231705|NCT01334567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93231706|NCT01334567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93231707|NCT04398329|Bupivacaine|bupivacaine|mesh-list
93231708|NCT04398329|Anesthetics, Local|anesthetics, local|mesh-ancestor
93231709|NCT04398329|Anesthetics|anesthetics|mesh-ancestor
93231710|NCT04398329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231711|NCT04398329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231712|NCT04398329|Sensory System Agents|sensory system agents|mesh-ancestor
93231713|NCT04398329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231714|NCT00449111|Losartan|losartan|mesh-list
93231715|NCT00449111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93231716|NCT00449111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93231717|NCT00449111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93231718|NCT00449111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93231719|NCT00449111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231721|NCT03568916|Apixaban|apixaban|mesh-list
93231722|NCT03568916|Dabigatran|dabigatran|mesh-list
92963455|NCT00754910|Trioxsalen|trioxsalen|mesh-list
93231723|NCT03568916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93231724|NCT03568916|Antithrombins|antithrombins|mesh-ancestor
92963612|NCT00681590|Vitamin D|vitamin d|mesh-list
93232224|NCT03566576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963753|NCT03827473|Antioxidants|antioxidants|mesh-ancestor
93231725|NCT03568916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93231726|NCT03568916|Protease Inhibitors|protease inhibitors|mesh-ancestor
93231727|NCT03568916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231728|NCT03568916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231729|NCT03568916|Anticoagulants|anticoagulants|mesh-ancestor
92963964|NCT00757016|Hormones|hormones|mesh-ancestor
93231730|NCT01334645|Arginine Vasopressin|arginine vasopressin|mesh-list
93231731|NCT01334645|Hemostatics|hemostatics|mesh-ancestor
93231732|NCT01334645|Coagulants|coagulants|mesh-ancestor
93231733|NCT01334645|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92964192|NCT00801528|Analgesics|analgesics|mesh-ancestor
93231734|NCT01334645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93231735|NCT01334645|Natriuretic Agents|natriuretic agents|mesh-ancestor
93231736|NCT01334645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231737|NCT03571490|Ropivacaine|ropivacaine|mesh-list
93231738|NCT03571490|Anesthetics, Local|anesthetics, local|mesh-ancestor
93231739|NCT03571490|Anesthetics|anesthetics|mesh-ancestor
93231740|NCT03571490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964489|NCT05407870|Propofol|propofol|mesh-list
93231741|NCT03571490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231742|NCT03571490|Sensory System Agents|sensory system agents|mesh-ancestor
93231743|NCT03571490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231744|NCT01331993|Naproxen|naproxen|mesh-list
93231745|NCT01331993|Esomeprazole|esomeprazole|mesh-list
93231746|NCT01331993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93231747|NCT01331993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231748|NCT01331993|Analgesics|analgesics|mesh-ancestor
93231749|NCT01331993|Sensory System Agents|sensory system agents|mesh-ancestor
92964925|NCT00944541|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93231750|NCT01331993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965078|NCT05427266|Bupivacaine|bupivacaine|mesh-list
93231751|NCT01331993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965148|NCT02533141|Simvastatin|simvastatin|mesh-list
93231752|NCT01331993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231753|NCT01331993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93231754|NCT01331993|Gout Suppressants|gout suppressants|mesh-ancestor
93231755|NCT01331993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93231756|NCT01331993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231757|NCT01331993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231758|NCT01331993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92965514|NCT00940953|Azelastine|azelastine|mesh-list
93231759|NCT01331993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93231760|NCT01331993|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93231761|NCT01338077|Omeprazole|omeprazole|mesh-list
93231762|NCT01338077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93231763|NCT01338077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93231764|NCT01338077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93231765|NCT01338077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231766|NCT01338077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231767|NCT03570320|Analgesics, Opioid|analgesics, opioid|mesh-list
93231768|NCT03570320|Narcotics|narcotics|mesh-ancestor
93231769|NCT03570320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231770|NCT03570320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231771|NCT03570320|Analgesics|analgesics|mesh-ancestor
93231772|NCT03570320|Sensory System Agents|sensory system agents|mesh-ancestor
93231773|NCT03570320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231774|NCT04266665|Dexmedetomidine|dexmedetomidine|mesh-list
93231775|NCT04266665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93231776|NCT04266665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231777|NCT04266665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231778|NCT04266665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93231779|NCT04266665|Analgesics|analgesics|mesh-ancestor
93231780|NCT04266665|Sensory System Agents|sensory system agents|mesh-ancestor
93231781|NCT04266665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231782|NCT04266665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93231783|NCT04266665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93231784|NCT04266665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231785|NCT04266665|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231786|NCT04266665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231787|NCT04266665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231788|NCT03571100|Chlorhexidine|chlorhexidine|mesh-list
92903816|NCT00884273|Goserelin|goserelin|mesh-list
93231789|NCT03571100|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93231790|NCT03571100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93231791|NCT03571100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965860|NCT00946335|Temozolomide|temozolomide|mesh-list
93231792|NCT03571100|Disinfectants|disinfectants|mesh-ancestor
93231793|NCT03571100|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231794|NCT01338311|Albuterol|albuterol|mesh-list
93231795|NCT01338311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93231796|NCT01338311|Autonomic Agents|autonomic agents|mesh-ancestor
92966002|NCT00805116|Cod Liver Oil|cod liver oil|mesh-list
93231797|NCT01338311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231798|NCT01338311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231799|NCT01338311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92966368|NCT00775034|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93231800|NCT01338311|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231801|NCT01338311|Tocolytic Agents|tocolytic agents|mesh-ancestor
93231802|NCT01338311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92966589|NCT00775736|Biphasic Insulins|biphasic insulins|mesh-list
92966662|NCT05355610|Gentamicins|gentamicins|mesh-list
93231803|NCT01338311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93231804|NCT01338311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92966813|NCT00952029|Irinotecan|irinotecan|mesh-list
93231805|NCT01338311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231806|NCT01338311|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231807|NCT01338311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231808|NCT01338311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231809|NCT01334879|Ranibizumab|ranibizumab|mesh-list
93231810|NCT01334879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967117|NCT05297123|Tretinoin|tretinoin|mesh-list
93231811|NCT01334879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967253|NCT03979105|Ketamine|ketamine|mesh-list
93231812|NCT01334879|Growth Substances|growth substances|mesh-ancestor
93231813|NCT01334879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231814|NCT01334879|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967480|NCT00778544|Amoxicillin|amoxicillin|mesh-list
93231815|NCT01334879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231816|NCT01315795|Lanreotide|lanreotide|mesh-list
92967634|NCT00812760|Levodopa|levodopa|mesh-list
93231817|NCT01315795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231818|NCT03570164|Sevoflurane|sevoflurane|mesh-list
93231819|NCT03570164|Desflurane|desflurane|mesh-list
93231820|NCT03570164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92967777|NCT04047680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967853|NCT00647556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967927|NCT00815568|Immunologic Factors|immunologic factors|mesh-ancestor
93231821|NCT03570164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93231822|NCT03570164|Anesthetics, General|anesthetics, general|mesh-ancestor
93231823|NCT03570164|Anesthetics|anesthetics|mesh-ancestor
92968224|NCT00995332|GABA Agents|gaba agents|mesh-ancestor
93231824|NCT03570164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93231825|NCT03570164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968362|NCT00995800|Xhance|xhance|mesh-list
93231826|NCT01315951|Petrolatum|petrolatum|mesh-list
93231827|NCT01315951|Emollients|emollients|mesh-ancestor
93231828|NCT01315951|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231829|NCT05184049|Vitamin B 12|vitamin b 12|mesh-list
93231830|NCT05184049|Epalrestat|epalrestat|mesh-list
93231831|NCT05184049|Vitamin B Complex|vitamin b complex|mesh-ancestor
93231832|NCT05184049|Vitamins|vitamins|mesh-ancestor
93231833|NCT05184049|Micronutrients|micronutrients|mesh-ancestor
93231834|NCT05184049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231835|NCT05184049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968583|NCT00318643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968656|NCT01003054|Cyclophosphamide|cyclophosphamide|mesh-list
92968731|NCT01005160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93231836|NCT05184049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231837|NCT01336543|Cisplatin|cisplatin|mesh-list
92968896|NCT01007500|Hormones|hormones|mesh-ancestor
93231838|NCT01336543|Gemcitabine|gemcitabine|mesh-list
93231839|NCT01336543|Etoposide|etoposide|mesh-list
93231840|NCT01336543|Pemetrexed|pemetrexed|mesh-list
93231841|NCT01336543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231842|NCT01336543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93231843|NCT01336543|Antimetabolites|antimetabolites|mesh-ancestor
93231844|NCT01336543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231845|NCT01336543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969173|NCT00315445|Analgesics|analgesics|mesh-ancestor
93231846|NCT01336543|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93231847|NCT01336543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93231848|NCT01336543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231849|NCT01336543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93231850|NCT01336543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93231851|NCT03568136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93231852|NCT03568136|Immunologic Factors|immunologic factors|mesh-ancestor
93231853|NCT03568136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231854|NCT01336621|Ezogabine|ezogabine|mesh-list
93231855|NCT01336621|Anticonvulsants|anticonvulsants|mesh-ancestor
93231856|NCT01336621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93231857|NCT01336621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969756|NCT04802590|Venetoclax|venetoclax|mesh-list
93231858|NCT00383435|Mometasone Furoate|mometasone furoate|mesh-list
93231859|NCT00383435|Formoterol Fumarate|formoterol fumarate|mesh-list
93231860|NCT00383435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93231861|NCT00383435|Autonomic Agents|autonomic agents|mesh-ancestor
93231862|NCT00383435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231863|NCT00383435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231864|NCT00383435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93231865|NCT00383435|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231866|NCT00383435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93231867|NCT00383435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93231868|NCT00383435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231869|NCT00383435|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231870|NCT00383435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231871|NCT00383435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231872|NCT00383435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231873|NCT00383435|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231874|NCT00383435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93231876|NCT01340521|Enclomiphene|enclomiphene|mesh-list
93231877|NCT01340521|Zuclomiphene|zuclomiphene|mesh-list
93231878|NCT01340521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92969972|NCT03957590|Paclitaxel|paclitaxel|mesh-list
93231879|NCT01340521|Hormone Antagonists|hormone antagonists|mesh-ancestor
92970031|NCT03656081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231880|NCT01340521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93231881|NCT01340521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231882|NCT01340521|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93231883|NCT01340521|Fertility Agents|fertility agents|mesh-ancestor
92970176|NCT03434730|Immunologic Factors|immunologic factors|mesh-ancestor
93231884|NCT01340521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93231885|NCT01340521|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93231886|NCT01340521|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93231887|NCT01340599|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93231888|NCT01340599|Antioxidants|antioxidants|mesh-ancestor
93231889|NCT01340599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231890|NCT01340599|Protective Agents|protective agents|mesh-ancestor
93231891|NCT01340599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231892|NCT01340599|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93231893|NCT01340599|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93231894|NCT01340599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231895|NCT01340599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93231896|NCT01335035|Deferasirox|deferasirox|mesh-list
93231897|NCT01335035|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93231898|NCT01335035|Chelating Agents|chelating agents|mesh-ancestor
93231899|NCT01335035|Sequestering Agents|sequestering agents|mesh-ancestor
93232225|NCT03566576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93231900|NCT01335035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231901|NCT01340677|Canagliflozin|canagliflozin|mesh-list
92970988|NCT04096157|Isavuconazole|isavuconazole|mesh-list
92971062|NCT00527332|Sensory System Agents|sensory system agents|mesh-ancestor
93231902|NCT01340677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93231903|NCT01340677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231904|NCT01340677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93231905|NCT01340677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971209|NCT00626028|Antioxidants|antioxidants|mesh-ancestor
93231906|NCT05163535|Elsulfavirine|elsulfavirine|mesh-list
93231907|NCT05163535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93231908|NCT05163535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93231909|NCT05163535|Antiviral Agents|antiviral agents|mesh-ancestor
93231910|NCT05163535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971356|NCT00830856|Antifungal Agents|antifungal agents|mesh-ancestor
93231911|NCT01338389|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93231912|NCT01338389|Nootropic Agents|nootropic agents|mesh-ancestor
93231913|NCT01340833|Dabrafenib|dabrafenib|mesh-list
93231914|NCT01340833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231915|NCT01340833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93231916|NCT01340833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231917|NCT01340833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231918|NCT01332383|Naratriptan|naratriptan|mesh-list
93231919|NCT01332383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93231920|NCT01332383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93231921|NCT01332383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93231922|NCT01332383|Serotonin Agents|serotonin agents|mesh-ancestor
93231923|NCT01332383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93231924|NCT01332383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971423|NCT00292981|Complement C1s|complement c1s|mesh-list
93231925|NCT01332383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231926|NCT01342237|Carboplatin|carboplatin|mesh-list
93231927|NCT01342237|Etoposide|etoposide|mesh-list
93231928|NCT01342237|Melphalan|melphalan|mesh-list
93231929|NCT01342237|Topotecan|topotecan|mesh-list
93231930|NCT01342237|Thiotepa|thiotepa|mesh-list
93231931|NCT01342237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231932|NCT01342237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93231933|NCT01342237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93231934|NCT01342237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93231935|NCT01342237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93231936|NCT01342237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231937|NCT01342237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93231938|NCT01342237|Alkylating Agents|alkylating agents|mesh-ancestor
92971767|NCT04234360|Hormones|hormones|mesh-ancestor
93231939|NCT01342237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93231940|NCT01342237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93231941|NCT01342237|Immunologic Factors|immunologic factors|mesh-ancestor
93231942|NCT01342237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231943|NCT01342237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93231944|NCT01337323|Fluticasone|fluticasone|mesh-list
93231945|NCT01337323|Xhance|xhance|mesh-list
93231946|NCT01337323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231947|NCT01337323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93231948|NCT01337323|Autonomic Agents|autonomic agents|mesh-ancestor
93231949|NCT01337323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231950|NCT01337323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231951|NCT01337323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93231952|NCT01337323|Respiratory System Agents|respiratory system agents|mesh-ancestor
93231953|NCT01337323|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231954|NCT01337323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93231955|NCT03157037|Immunoglobulins|immunoglobulins|mesh-list
93231956|NCT03157037|Immunoglobulin G|immunoglobulin g|mesh-list
93231957|NCT03157037|Immunologic Factors|immunologic factors|mesh-ancestor
93231958|NCT03157037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231959|NCT04830943|Cerebrolysin|cerebrolysin|mesh-list
93231960|NCT04830943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93231961|NCT04830943|Protective Agents|protective agents|mesh-ancestor
93231962|NCT04830943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93231963|NCT04830943|Nootropic Agents|nootropic agents|mesh-ancestor
93231964|NCT04429321|Nivolumab|nivolumab|mesh-list
93231965|NCT04429321|Ipilimumab|ipilimumab|mesh-list
93231966|NCT04429321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93231967|NCT04429321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231968|NCT04429321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93231969|NCT04429321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231970|NCT03067610|Paclitaxel|paclitaxel|mesh-list
93231971|NCT03067610|Cisplatin|cisplatin|mesh-list
93231972|NCT03067610|Carboplatin|carboplatin|mesh-list
93231973|NCT03067610|Cetuximab|cetuximab|mesh-list
92972125|NCT00291577|Docetaxel|docetaxel|mesh-list
93231974|NCT03067610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93231975|NCT03067610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93231976|NCT03067610|Tubulin Modulators|tubulin modulators|mesh-ancestor
93231977|NCT03067610|Antimitotic Agents|antimitotic agents|mesh-ancestor
93231978|NCT03067610|Mitosis Modulators|mitosis modulators|mesh-ancestor
93232226|NCT03566576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93231979|NCT03067610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93231980|NCT03067610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93231981|NCT00381485|Mometasone Furoate|mometasone furoate|mesh-list
93231982|NCT00381485|Formoterol Fumarate|formoterol fumarate|mesh-list
93231983|NCT00381485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93231984|NCT00381485|Autonomic Agents|autonomic agents|mesh-ancestor
93231985|NCT00381485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93231986|NCT00381485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972550|NCT04011033|Analgesics|analgesics|mesh-ancestor
93231987|NCT00381485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93231988|NCT00381485|Respiratory System Agents|respiratory system agents|mesh-ancestor
93232227|NCT04377997|Heparin|heparin|mesh-list
93232228|NCT04377997|Calcium heparin|calcium heparin|mesh-list
93231989|NCT00381485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92972922|NCT00956319|Estazolam|estazolam|mesh-list
93232229|NCT04377997|Enoxaparin|enoxaparin|mesh-list
92973068|NCT00839358|Midodrine|midodrine|mesh-list
93231990|NCT00381485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92973140|NCT00839826|Antithrombins|antithrombins|mesh-ancestor
93231991|NCT00381485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93231992|NCT00381485|Adrenergic Agents|adrenergic agents|mesh-ancestor
93231993|NCT00381485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973285|NCT00574080|Cytarabine|cytarabine|mesh-list
93231994|NCT00381485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973365|NCT00267865|Antidotes|antidotes|mesh-ancestor
93231995|NCT00381485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93231996|NCT00381485|Dermatologic Agents|dermatologic agents|mesh-ancestor
93231997|NCT00381485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93231998|NCT05182957|Lenalidomide|lenalidomide|mesh-list
93231999|NCT05182957|Azacitidine|azacitidine|mesh-list
93232000|NCT05182957|Antibodies|antibodies|mesh-list
93232001|NCT05182957|Immunoglobulins|immunoglobulins|mesh-list
93232002|NCT05182957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93232003|NCT05182957|Immunologic Factors|immunologic factors|mesh-list
93232004|NCT05182957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232005|NCT05182957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93232006|NCT05182957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93232007|NCT05182957|Growth Substances|growth substances|mesh-ancestor
93232008|NCT05182957|Growth Inhibitors|growth inhibitors|mesh-ancestor
93232009|NCT05182957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973799|NCT00266227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232010|NCT05182957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93232011|NCT05182957|Antimetabolites|antimetabolites|mesh-ancestor
93232012|NCT05182957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232013|NCT05182957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232014|NCT00092651|Simvastatin|simvastatin|mesh-list
93232015|NCT00092651|Ezetimibe|ezetimibe|mesh-list
92974395|NCT00791024|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232230|NCT04377997|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93232016|NCT00092651|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
93232018|NCT00092651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93232019|NCT00092651|Antimetabolites|antimetabolites|mesh-ancestor
93232231|NCT04377997|Tinzaparin|tinzaparin|mesh-list
93232232|NCT04377997|Dalteparin|dalteparin|mesh-list
93232233|NCT04377997|Anticoagulants|anticoagulants|mesh-ancestor
93232020|NCT00092651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232021|NCT00092651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93232234|NCT04377997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93232022|NCT00092651|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93232023|NCT00092651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975024|NCT00859872|Haloperidol|haloperidol|mesh-list
93232024|NCT04889599|Docetaxel|docetaxel|mesh-list
93232025|NCT04889599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975241|NCT00787436|Thalidomide|thalidomide|mesh-list
93232026|NCT04889599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92975328|NCT00784316|Metoprolol|metoprolol|mesh-list
93232027|NCT04889599|Antimitotic Agents|antimitotic agents|mesh-ancestor
93232028|NCT04889599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92975464|NCT00788060|Everolimus|everolimus|mesh-list
93232029|NCT04889599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232030|NCT01342627|Sorafenib|sorafenib|mesh-list
93232031|NCT01342627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232032|NCT01342627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93232033|NCT01342627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232034|NCT01342627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232035|NCT03160703|Fluorides|fluorides|mesh-list
93232036|NCT03160703|Tin Fluorides|tin fluorides|mesh-list
93232037|NCT03160703|Fluorophosphate|fluorophosphate|mesh-list
93232038|NCT03160703|Cariostatic Agents|cariostatic agents|mesh-ancestor
93232039|NCT03160703|Protective Agents|protective agents|mesh-ancestor
93232040|NCT03160703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232041|NCT01332617|Zoledronic Acid|zoledronic acid|mesh-list
93232042|NCT01332617|Methylprednisolone|methylprednisolone|mesh-list
93232043|NCT01332617|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93232044|NCT01332617|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93232045|NCT01332617|Prednisolone|prednisolone|mesh-list
93232046|NCT01332617|Prednisolone acetate|prednisolone acetate|mesh-list
93232047|NCT01332617|Diclofenac|diclofenac|mesh-list
93232048|NCT01332617|Bortezomib|bortezomib|mesh-list
93232049|NCT01332617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93232050|NCT01332617|Simvastatin|simvastatin|mesh-list
93232051|NCT01332617|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93232052|NCT01332617|Prednisolone phosphate|prednisolone phosphate|mesh-list
93232053|NCT01332617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232054|NCT01332617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232055|NCT01332617|Antiemetics|antiemetics|mesh-ancestor
92975614|NCT00283387|Betaine|betaine|mesh-list
93232056|NCT01332617|Autonomic Agents|autonomic agents|mesh-ancestor
93232057|NCT01332617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975885|NCT04088903|Daratumumab|daratumumab|mesh-list
93232058|NCT01332617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232059|NCT01332617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93232060|NCT01332617|Glucocorticoids|glucocorticoids|mesh-ancestor
93232061|NCT01332617|Hormones|hormones|mesh-ancestor
93232062|NCT01332617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93232063|NCT01332617|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93232064|NCT01332617|Protective Agents|protective agents|mesh-ancestor
92976183|NCT00802568|Busulfan|busulfan|mesh-list
93232065|NCT01332617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92976248|NCT00789308|Cyclosporine|cyclosporine|mesh-list
93232066|NCT01332617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93232067|NCT01332617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93232068|NCT01332617|Antimetabolites|antimetabolites|mesh-ancestor
93232069|NCT01332617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232070|NCT01332617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93232071|NCT01332617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93232072|NCT01332617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976685|NCT00797420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232073|NCT01332617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232074|NCT01332617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93232075|NCT01332617|Analgesics|analgesics|mesh-ancestor
92976830|NCT00978315|Cholecalciferol|cholecalciferol|mesh-list
93232076|NCT01332617|Sensory System Agents|sensory system agents|mesh-ancestor
93232077|NCT01332617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232078|NCT01332617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232079|NCT01332617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93232080|NCT01332617|Alkylating Agents|alkylating agents|mesh-ancestor
93232244|NCT04758949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232246|NCT03566030|Antiviral Agents|antiviral agents|mesh-ancestor
93232247|NCT03566030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232248|NCT03566030|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93232249|NCT03566030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93232250|NCT03566030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242991|NCT01364675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93232251|NCT03566030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232252|NCT03566030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93232253|NCT03566030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93232254|NCT01333085|Paclitaxel|paclitaxel|mesh-list
93232255|NCT01333085|Carboplatin|carboplatin|mesh-list
93232256|NCT01333085|Everolimus|everolimus|mesh-list
93232257|NCT01333085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93232258|NCT01333085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232259|NCT01333085|Tubulin Modulators|tubulin modulators|mesh-ancestor
93232260|NCT01333085|Antimitotic Agents|antimitotic agents|mesh-ancestor
93232261|NCT01333085|Mitosis Modulators|mitosis modulators|mesh-ancestor
93232262|NCT01333085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232263|NCT01333085|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93232264|NCT01333085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93232265|NCT01333085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977865|NCT02592083|Tamoxifen|tamoxifen|mesh-list
93232266|NCT01333085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232267|NCT01333085|Immunologic Factors|immunologic factors|mesh-ancestor
92914965|NCT04118777|Ropivacaine|ropivacaine|mesh-list
92978081|NCT00236197|Rabeprazole|rabeprazole|mesh-list
93232268|NCT01333085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232269|NCT01344655|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92978305|NCT02541552|Ropivacaine|ropivacaine|mesh-list
93232270|NCT01344655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93232271|NCT01344655|Autonomic Agents|autonomic agents|mesh-ancestor
92978382|NCT00278161|Rituximab|rituximab|mesh-list
93232272|NCT01344655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978451|NCT00891072|Acetic Acid|acetic acid|mesh-list
93232273|NCT01344655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232274|NCT01344655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93232275|NCT01344655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92978674|NCT00647270|Adalimumab|adalimumab|mesh-list
92978825|NCT00818090|Mitosis Modulators|mitosis modulators|mesh-ancestor
93232276|NCT01344655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93232277|NCT01344655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92978976|NCT00815204|Dexamethasone|dexamethasone|mesh-list
93232278|NCT01344655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93232279|NCT01344655|Adrenergic Agents|adrenergic agents|mesh-ancestor
93232280|NCT01344655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232281|NCT01344655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232282|NCT04734535|Thrombin|thrombin|mesh-list
92979266|NCT04397406|Narcotics|narcotics|mesh-ancestor
93232283|NCT04734535|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
93232284|NCT04734535|Hemostatics|hemostatics|mesh-ancestor
93232285|NCT04734535|Coagulants|coagulants|mesh-ancestor
93232286|NCT03565406|Nivolumab|nivolumab|mesh-list
93232287|NCT03565406|Ipilimumab|ipilimumab|mesh-list
93232288|NCT03565406|Mocetinostat|mocetinostat|mesh-list
92979486|NCT04035330|Eusol|eusol|mesh-list
93232289|NCT03565406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93232290|NCT03565406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232291|NCT03565406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93232292|NCT03565406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979711|NCT04017624|Nicotine|nicotine|mesh-list
93232293|NCT03565406|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93232294|NCT03565406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232295|NCT04734379|Fasudil|fasudil|mesh-list
93232296|NCT04734379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93232297|NCT04734379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232298|NCT04734379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232299|NCT04734379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93232300|NCT04734379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232301|NCT04734379|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979851|NCT00989079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93232302|NCT04734379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93232303|NCT04734379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232304|NCT01339871|Vorinostat|vorinostat|mesh-list
93232305|NCT01339871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232306|NCT01339871|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93232307|NCT01339871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980224|NCT00906126|Misoprostol|misoprostol|mesh-list
93232308|NCT01339871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232309|NCT04693429|Bepotastine besilate|bepotastine besilate|mesh-list
93232310|NCT04693429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93232311|NCT03564704|Cytarabine|cytarabine|mesh-list
93232312|NCT03564704|Dexamethasone|dexamethasone|mesh-list
93232313|NCT03564704|Cyclophosphamide|cyclophosphamide|mesh-list
93232314|NCT03564704|Methotrexate|methotrexate|mesh-list
93232315|NCT03564704|Etoposide|etoposide|mesh-list
93232317|NCT03564704|Doxorubicin|doxorubicin|mesh-list
93232318|NCT03564704|Mercaptopurine|mercaptopurine|mesh-list
93232319|NCT03564704|Idarubicin|idarubicin|mesh-list
93232320|NCT03564704|Pegaspargase|pegaspargase|mesh-list
93232321|NCT03564704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232322|NCT03564704|Immunologic Factors|immunologic factors|mesh-ancestor
93232323|NCT03564704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232324|NCT03564704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232325|NCT03564704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93232326|NCT03564704|Alkylating Agents|alkylating agents|mesh-ancestor
93232327|NCT03564704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232328|NCT03564704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232329|NCT03564704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93232330|NCT03564704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232331|NCT03564704|Antiemetics|antiemetics|mesh-ancestor
93232332|NCT03564704|Autonomic Agents|autonomic agents|mesh-ancestor
93232333|NCT03564704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232334|NCT03564704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93232335|NCT03564704|Glucocorticoids|glucocorticoids|mesh-ancestor
93232336|NCT03564704|Hormones|hormones|mesh-ancestor
93232337|NCT03564704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93232338|NCT03564704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93232339|NCT03564704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93232340|NCT03564704|Abortifacient Agents|abortifacient agents|mesh-ancestor
93232341|NCT03564704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981008|NCT00826358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232342|NCT03564704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93232343|NCT03564704|Antimetabolites|antimetabolites|mesh-ancestor
93232344|NCT03564704|Dermatologic Agents|dermatologic agents|mesh-ancestor
93232345|NCT03564704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232346|NCT03564704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93232347|NCT03564704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93232348|NCT03564704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93232349|NCT03564704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93232350|NCT03564704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93232351|NCT03564704|Antiviral Agents|antiviral agents|mesh-ancestor
93232352|NCT03564704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232353|NCT03564704|Tubulin Modulators|tubulin modulators|mesh-ancestor
93232354|NCT03564704|Antimitotic Agents|antimitotic agents|mesh-ancestor
93232355|NCT03564704|Mitosis Modulators|mitosis modulators|mesh-ancestor
93232356|NCT03564704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93232357|NCT03564548|Morphine|morphine|mesh-list
92981148|NCT00826826|Amiodarone|amiodarone|mesh-list
93232358|NCT03564548|Oxycodone|oxycodone|mesh-list
93232359|NCT03564548|Hydromorphone|hydromorphone|mesh-list
93232360|NCT03564548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93232361|NCT03564548|Narcotics|narcotics|mesh-ancestor
93232362|NCT03564548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232363|NCT03564548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232364|NCT03564548|Analgesics|analgesics|mesh-ancestor
93232365|NCT03564548|Sensory System Agents|sensory system agents|mesh-ancestor
92981590|NCT03977454|Sensory System Agents|sensory system agents|mesh-ancestor
93232366|NCT03564548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232367|NCT05353010|Tacrolimus|tacrolimus|mesh-list
93232368|NCT05353010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232369|NCT05353010|Immunologic Factors|immunologic factors|mesh-ancestor
92981804|NCT04043858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93232370|NCT05353010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232371|NCT05353010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93232372|NCT05353010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232373|NCT05353010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232374|NCT05352854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93232375|NCT05352854|Pilocarpine|pilocarpine|mesh-list
93232376|NCT05352854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93232377|NCT05352854|Miotics|miotics|mesh-ancestor
93232378|NCT05352854|Autonomic Agents|autonomic agents|mesh-ancestor
92982243|NCT01156389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92982389|NCT05407155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232379|NCT05352854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982538|NCT01010308|Nadolol|nadolol|mesh-list
92982609|NCT00989703|Methotrexate|methotrexate|mesh-list
93232380|NCT05352854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232381|NCT05352854|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93232382|NCT05352854|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93232383|NCT05352854|Cholinergic Agents|cholinergic agents|mesh-ancestor
93232384|NCT05352854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982902|NCT04688788|Glucocorticoids|glucocorticoids|mesh-ancestor
93232385|NCT05352854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232386|NCT01841177|Milrinone|milrinone|mesh-list
93232387|NCT01841177|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93232388|NCT01841177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93232389|NCT01841177|Vasodilator Agents|vasodilator agents|mesh-ancestor
93232390|NCT01841177|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93232391|NCT01841177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92983275|NCT00992199|Fluorouracil|fluorouracil|mesh-list
93232392|NCT01841177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983349|NCT00618956|Milnacipran|milnacipran|mesh-list
93232393|NCT01841177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232394|NCT01841177|Protective Agents|protective agents|mesh-ancestor
92983495|NCT00853502|Testosterone|testosterone|mesh-list
93232395|NCT01841177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232396|NCT02838134|Rocuronium|rocuronium|mesh-list
92983568|NCT04042688|Hemostatics|hemostatics|mesh-ancestor
93232397|NCT02838134|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93232398|NCT02838134|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93232399|NCT02838134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93232400|NCT02838134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232401|NCT02838134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232402|NCT03150589|Ranibizumab|ranibizumab|mesh-list
93232403|NCT03150589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93232404|NCT03150589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93232405|NCT03150589|Growth Substances|growth substances|mesh-ancestor
93232406|NCT03150589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232407|NCT03150589|Growth Inhibitors|growth inhibitors|mesh-ancestor
93232408|NCT03150589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232409|NCT05708300|Vaccines|vaccines|mesh-list
92984013|NCT00864890|Dexetimide|dexetimide|mesh-list
93232410|NCT05708300|Immunologic Factors|immunologic factors|mesh-ancestor
92984081|NCT00871052|Calcipotriene|calcipotriene|mesh-list
92984156|NCT00513682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93232411|NCT05708300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232412|NCT05340452|Clarithromycin|clarithromycin|mesh-list
93232413|NCT05340452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232414|NCT05340452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232415|NCT05340452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93232416|NCT05340452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984608|NCT00994305|Protective Agents|protective agents|mesh-ancestor
92984686|NCT00994539|Analgesics|analgesics|mesh-ancestor
92984756|NCT05059223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93232417|NCT05340452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232418|NCT05340452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92984970|NCT00615290|Antiviral Agents|antiviral agents|mesh-ancestor
93232419|NCT05340452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93232420|NCT03145207|Lidocaine|lidocaine|mesh-list
92985121|NCT02585531|Dexamethasone|dexamethasone|mesh-list
93232421|NCT03145207|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232422|NCT03145207|Anesthetics|anesthetics|mesh-ancestor
92985196|NCT04080713|Autonomic Agents|autonomic agents|mesh-ancestor
93232423|NCT03145207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985293|NCT00994773|Tenofovir|tenofovir|mesh-list
93232424|NCT03145207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985340|NCT00996021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93232425|NCT03145207|Sensory System Agents|sensory system agents|mesh-ancestor
93232426|NCT03145207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232427|NCT03145207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232428|NCT03145207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93232429|NCT03145207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93232430|NCT03145207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232431|NCT03145207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232432|NCT02836652|Aspirin|aspirin|mesh-list
93232433|NCT02836652|Warfarin|warfarin|mesh-list
92985792|NCT04075955|Serotonin Agents|serotonin agents|mesh-ancestor
93232434|NCT02836652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232435|NCT02836652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93232436|NCT02836652|Analgesics|analgesics|mesh-ancestor
93232437|NCT02836652|Sensory System Agents|sensory system agents|mesh-ancestor
93232438|NCT02836652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232439|NCT02836652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232440|NCT02836652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232441|NCT02836652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232442|NCT02836652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92986228|NCT01005303|Micronutrients|micronutrients|mesh-ancestor
93232443|NCT02836652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93232444|NCT02836652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986450|NCT05226728|Pembrolizumab|pembrolizumab|mesh-list
93232445|NCT02836652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93232446|NCT02836652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232447|NCT02836652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232448|NCT02836652|Antipyretics|antipyretics|mesh-ancestor
92986603|NCT00142909|Lofexidine|lofexidine|mesh-list
92986669|NCT03498521|Gemcitabine|gemcitabine|mesh-list
93232449|NCT02836652|Anticoagulants|anticoagulants|mesh-ancestor
93232450|NCT02836496|Prednisone|prednisone|mesh-list
93232451|NCT02836496|Prednisolone|prednisolone|mesh-list
93232452|NCT02836496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232453|NCT02836496|Glucocorticoids|glucocorticoids|mesh-ancestor
93232454|NCT02836496|Hormones|hormones|mesh-ancestor
93232455|NCT02836496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987114|NCT03713294|Antiemetics|antiemetics|mesh-ancestor
93232456|NCT02836496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987190|NCT03798314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93232457|NCT02836496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93232458|NCT02836496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232459|NCT01344967|Zoledronic Acid|zoledronic acid|mesh-list
93232460|NCT01344967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92987408|NCT00613574|Parasympatholytics|parasympatholytics|mesh-ancestor
93232461|NCT01344967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232462|NCT05250661|Propolis|propolis|mesh-list
92987487|NCT00141037|Tacrolimus|tacrolimus|mesh-list
93232463|NCT05250661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987631|NCT00936156|Thiotepa|thiotepa|mesh-list
93232464|NCT04044781|BPN14770|bpn14770|mesh-list
93232465|NCT04044781|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93232466|NCT04044781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92987866|NCT03253679|Adavosertib|adavosertib|mesh-list
93232467|NCT04044781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232468|NCT04044781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232469|NCT01345279|Paclitaxel|paclitaxel|mesh-list
93232470|NCT01345279|Topotecan|topotecan|mesh-list
93232471|NCT01345279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93232472|NCT01345279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232473|NCT01345279|Tubulin Modulators|tubulin modulators|mesh-ancestor
93232474|NCT01345279|Antimitotic Agents|antimitotic agents|mesh-ancestor
93232475|NCT01345279|Mitosis Modulators|mitosis modulators|mesh-ancestor
92988228|NCT00887276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232476|NCT01345279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232477|NCT01345279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92988451|NCT00892892|Nitrendipine|nitrendipine|mesh-list
93232478|NCT01345279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93232479|NCT01345279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232480|NCT02833844|Evolocumab|evolocumab|mesh-list
93232481|NCT02833844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93232482|NCT02833844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93232483|NCT02833844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93232484|NCT02833844|Antimetabolites|antimetabolites|mesh-ancestor
92988741|NCT00945438|Immunologic Factors|immunologic factors|mesh-ancestor
93232485|NCT02833844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988831|NCT00944502|Hormones|hormones|mesh-ancestor
93232486|NCT02833844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93232487|NCT02833844|Protease Inhibitors|protease inhibitors|mesh-ancestor
93232488|NCT02833844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232489|NCT02833844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92988967|NCT00582491|Modafinil|modafinil|mesh-list
93232490|NCT01345357|Gemcitabine|gemcitabine|mesh-list
92989053|NCT04073537|Carboplatin|carboplatin|mesh-list
93232491|NCT01345357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989116|NCT00127855|Vaccines|vaccines|mesh-list
93232492|NCT01345357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989211|NCT00132691|Hormones|hormones|mesh-ancestor
93232493|NCT01345357|Antimetabolites|antimetabolites|mesh-ancestor
92989258|NCT03868059|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93232494|NCT01345357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232495|NCT01333631|Valproic Acid|valproic acid|mesh-list
93232496|NCT01333631|Anticonvulsants|anticonvulsants|mesh-ancestor
93232497|NCT01333631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232498|NCT01333631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232499|NCT01333631|GABA Agents|gaba agents|mesh-ancestor
93232500|NCT01333631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232501|NCT01333631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232502|NCT01333631|Antimanic Agents|antimanic agents|mesh-ancestor
93232503|NCT01333631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93232504|NCT01333631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232505|NCT01333631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93232506|NCT04611763|Flurbiprofen|flurbiprofen|mesh-list
93232507|NCT04611763|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
93232508|NCT04611763|Analgesics|analgesics|mesh-ancestor
93232509|NCT04611763|Sensory System Agents|sensory system agents|mesh-ancestor
93232510|NCT04611763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989330|NCT00184093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989387|NCT02576327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989462|NCT02576015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93232511|NCT04611763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989547|NCT00487162|Insulin|insulin|mesh-list
93232512|NCT04611763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232513|NCT04611763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93232514|NCT04611763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232515|NCT04611763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232516|NCT04611763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232517|NCT04611763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232518|NCT04611763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232519|NCT01341782|Ergocalciferols|ergocalciferols|mesh-list
93232520|NCT01341782|Calcitriol|calcitriol|mesh-list
93232521|NCT01341782|Maxacalcitol|maxacalcitol|mesh-list
92989981|NCT00709475|Insulin Detemir|insulin detemir|mesh-list
92990128|NCT00946686|Immunologic Factors|immunologic factors|mesh-ancestor
93232522|NCT01341782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93232523|NCT01341782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232524|NCT01341782|Vitamins|vitamins|mesh-ancestor
93232525|NCT01341782|Micronutrients|micronutrients|mesh-ancestor
93232526|NCT01341782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93232527|NCT01341782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232528|NCT01341782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92990573|NCT00715091|Analgesics|analgesics|mesh-ancestor
93232529|NCT01341782|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93232530|NCT01341782|Protective Agents|protective agents|mesh-ancestor
92990647|NCT00506415|Rivastigmine|rivastigmine|mesh-list
92990716|NCT01022164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93232531|NCT01341782|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93232532|NCT01341782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232533|NCT01341782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232534|NCT01341782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93232535|NCT02250157|Irinotecan|irinotecan|mesh-list
93232536|NCT02250157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93232537|NCT02250157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93232538|NCT02250157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991089|NCT00721331|Adrenergic Agents|adrenergic agents|mesh-ancestor
93232539|NCT02250157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232540|NCT02250157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232541|NCT05063149|Broncho-Vaxom|broncho-vaxom|mesh-list
93232542|NCT05063149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93232543|NCT05063149|Immunologic Factors|immunologic factors|mesh-ancestor
93232544|NCT05063149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232545|NCT03564158|Moxifloxacin|moxifloxacin|mesh-list
92991381|NCT00905918|Vitamin E|vitamin e|mesh-list
93232547|NCT03564158|Vaborbactam|vaborbactam|mesh-list
93232548|NCT03564158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232549|NCT03564158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991459|NCT00894920|Biotin|biotin|mesh-list
92991531|NCT00717821|Epoetin Alfa|epoetin alfa|mesh-list
93232550|NCT03564158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93232551|NCT03564158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92991681|NCT01012869|Everolimus|everolimus|mesh-list
93232552|NCT03564158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232553|NCT03564158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991755|NCT00509925|Insulin|insulin|mesh-list
93232554|NCT03564158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232555|NCT03564158|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93232556|NCT02677298|Botulinum Toxins|botulinum toxins|mesh-list
93232557|NCT02677298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93232558|NCT02677298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93232559|NCT02677298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93232560|NCT02677298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992041|NCT00603980|GABA Agents|gaba agents|mesh-ancestor
93232561|NCT02677298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232562|NCT02677298|Cholinergic Agents|cholinergic agents|mesh-ancestor
93232563|NCT02677298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232564|NCT02677298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992189|NCT02538302|Oxybutynin|oxybutynin|mesh-list
93232565|NCT02677298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93232566|NCT02677298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232567|NCT01345981|Lidocaine|lidocaine|mesh-list
93232568|NCT01345981|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232569|NCT01345981|Anesthetics|anesthetics|mesh-ancestor
93232570|NCT01345981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992480|NCT00731003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93232571|NCT01345981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232572|NCT01345981|Sensory System Agents|sensory system agents|mesh-ancestor
93232573|NCT01345981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232574|NCT01345981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232575|NCT01345981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93232576|NCT01345981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93232577|NCT01345981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232578|NCT01345981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232579|NCT00871351|Atorvastatin|atorvastatin|mesh-list
92992992|NCT00733811|Deferiprone|deferiprone|mesh-list
93232580|NCT00871351|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93232581|NCT00871351|Ezetimibe|ezetimibe|mesh-list
93232582|NCT00871351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93232583|NCT00871351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93232584|NCT00871351|Antimetabolites|antimetabolites|mesh-ancestor
92993137|NCT00515073|Histamine Agents|histamine agents|mesh-ancestor
93232585|NCT00871351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993218|NCT00504075|Antibodies|antibodies|mesh-list
92993285|NCT01079065|Famotidine|famotidine|mesh-list
93232586|NCT00871351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93232587|NCT00871351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92993360|NCT00925106|Celecoxib|celecoxib|mesh-list
93232588|NCT00871351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232589|NCT04920331|Erenumab|erenumab|mesh-list
92993433|NCT00905762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993508|NCT00920933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232590|NCT04920331|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93232591|NCT04920331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232592|NCT04920331|Analgesics|analgesics|mesh-ancestor
92993727|NCT00926900|Antimetabolites|antimetabolites|mesh-ancestor
92993800|NCT00938522|Protective Agents|protective agents|mesh-ancestor
93232593|NCT04920331|Sensory System Agents|sensory system agents|mesh-ancestor
93232594|NCT04920331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232595|NCT04920331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232596|NCT02745080|Adalimumab|adalimumab|mesh-list
93232597|NCT02745080|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93232598|NCT02745080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232599|NCT02745080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232600|NCT01346137|Meloxicam|meloxicam|mesh-list
93232601|NCT01346137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232602|NCT01346137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93232603|NCT01346137|Analgesics|analgesics|mesh-ancestor
92994242|NCT04013438|Hormones|hormones|mesh-ancestor
93232604|NCT01346137|Sensory System Agents|sensory system agents|mesh-ancestor
93232605|NCT01346137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994394|NCT00940550|Melatonin|melatonin|mesh-list
93232606|NCT01346137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232607|NCT01346137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232608|NCT01346137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994547|NCT04061447|Clarithromycin|clarithromycin|mesh-list
93232609|NCT01346137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93232610|NCT01346137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232611|NCT01346137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232612|NCT01346137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232613|NCT00521599|Mometasone Furoate|mometasone furoate|mesh-list
93232614|NCT00521599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232615|NCT00521599|Dermatologic Agents|dermatologic agents|mesh-ancestor
93232616|NCT00521599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93232618|NCT00442897|Simvastatin|simvastatin|mesh-list
93232619|NCT00442897|Ezetimibe|ezetimibe|mesh-list
93232620|NCT00442897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92994681|NCT04060979|Gasotransmitters|gasotransmitters|mesh-ancestor
93232621|NCT00442897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93232622|NCT00442897|Antimetabolites|antimetabolites|mesh-ancestor
92994755|NCT03034642|Chelating Agents|chelating agents|mesh-ancestor
92994828|NCT00562094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93232623|NCT00442897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232624|NCT00442897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93232625|NCT00442897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93232626|NCT00442897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232627|NCT01346215|Heparin|heparin|mesh-list
92995200|NCT00942344|Losartan|losartan|mesh-list
93232628|NCT01346215|Calcium heparin|calcium heparin|mesh-list
93232629|NCT01346215|Anticoagulants|anticoagulants|mesh-ancestor
93232630|NCT01346215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93232631|NCT01346215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93232632|NCT01346215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995426|NCT00949494|Hylan|hylan|mesh-list
93232633|NCT02834390|Cytarabine|cytarabine|mesh-list
93232634|NCT02834390|Daunorubicin|daunorubicin|mesh-list
93232635|NCT02834390|Idarubicin|idarubicin|mesh-list
92995643|NCT00549848|Doxorubicin|doxorubicin|mesh-list
93232636|NCT02834390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93232637|NCT02834390|Antimetabolites|antimetabolites|mesh-ancestor
92995870|NCT00095173|Immunologic Factors|immunologic factors|mesh-ancestor
92995938|NCT03954444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93232638|NCT02834390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232639|NCT02834390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232640|NCT02834390|Antiviral Agents|antiviral agents|mesh-ancestor
93232641|NCT02834390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232642|NCT02834390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232643|NCT02834390|Immunologic Factors|immunologic factors|mesh-ancestor
92996084|NCT00555620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93232644|NCT02834390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232645|NCT02834390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92996157|NCT00956462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93232646|NCT02834390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93232647|NCT02834390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93232648|NCT02834390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996333|NCT00653159|Copper|copper|mesh-list
93232649|NCT01317433|Doxycycline|doxycycline|mesh-list
93232650|NCT01317433|Cetuximab|cetuximab|mesh-list
92996450|NCT00742157|Hormones|hormones|mesh-list
92996525|NCT00948740|Vitamin D|vitamin d|mesh-list
92996675|NCT01079767|Sirolimus|sirolimus|mesh-list
92996749|NCT00958854|Growth Inhibitors|growth inhibitors|mesh-ancestor
92996824|NCT02563847|Tryptophan|tryptophan|mesh-list
93232651|NCT01317433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93232652|NCT01317433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996988|NCT00744887|Darunavir|darunavir|mesh-list
92997119|NCT00964704|Docetaxel|docetaxel|mesh-list
93232653|NCT01317433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232654|NCT01317433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232655|NCT01317433|Antimalarials|antimalarials|mesh-ancestor
93232656|NCT01317433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93232657|NCT01317433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93232658|NCT01317511|Caseins|caseins|mesh-list
93232659|NCT01317511|Chelating Agents|chelating agents|mesh-ancestor
93232660|NCT01317511|Sequestering Agents|sequestering agents|mesh-ancestor
93232661|NCT01317511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232662|NCT01356602|Triamcinolone|triamcinolone|mesh-list
93232663|NCT01356602|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93232664|NCT01356602|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93232665|NCT01356602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92997260|NCT00745433|Metformin|metformin|mesh-list
93232666|NCT01356602|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92997409|NCT00750113|Nifedipine|nifedipine|mesh-list
92997564|NCT00104299|Hormones|hormones|mesh-ancestor
93232667|NCT01356602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232668|NCT01356602|Glucocorticoids|glucocorticoids|mesh-ancestor
93232669|NCT01356602|Hormones|hormones|mesh-ancestor
93242992|NCT01364675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93242993|NCT01364675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232670|NCT01356602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93232671|NCT01356602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998073|NCT00974532|Calcium|calcium|mesh-list
93232672|NCT01356602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998148|NCT00967512|Cytarabine|cytarabine|mesh-list
93232673|NCT01356602|Immunologic Factors|immunologic factors|mesh-ancestor
93232674|NCT01356602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232675|NCT01356602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232676|NCT01347853|Ketorolac|ketorolac|mesh-list
93232677|NCT01347853|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93232678|NCT01347853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232679|NCT01347853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92998750|NCT00429364|Losartan|losartan|mesh-list
93232680|NCT01347853|Analgesics|analgesics|mesh-ancestor
93232681|NCT01347853|Sensory System Agents|sensory system agents|mesh-ancestor
93232682|NCT01347853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232683|NCT01347853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232684|NCT01347853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232685|NCT01347853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999035|NCT00988026|Lymecycline|lymecycline|mesh-list
93232686|NCT01347853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232687|NCT01347853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232688|NCT01347853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232689|NCT01346917|Lidocaine|lidocaine|mesh-list
93232691|NCT01346917|Anesthetics|anesthetics|mesh-ancestor
93232692|NCT01346917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232693|NCT01346917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232694|NCT01346917|Sensory System Agents|sensory system agents|mesh-ancestor
93232695|NCT01346917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232696|NCT01346917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232697|NCT01346917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93232698|NCT01346917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92999170|NCT05919615|Hemostatics|hemostatics|mesh-ancestor
93232699|NCT01346917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92999319|NCT05918302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93232700|NCT01346917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232701|NCT01348009|Cisplatin|cisplatin|mesh-list
93232702|NCT01348009|Capecitabine|capecitabine|mesh-list
93232703|NCT01348009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232704|NCT01348009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93232705|NCT01348009|Antimetabolites|antimetabolites|mesh-ancestor
92999920|NCT04777006|Serotonin Agents|serotonin agents|mesh-ancestor
93232706|NCT01348009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232707|NCT01343173|Imatinib Mesylate|imatinib mesylate|mesh-list
93000064|NCT04497584|Hormones|hormones|mesh-ancestor
93232708|NCT01343173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232709|NCT01343173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93232710|NCT01343173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232711|NCT01343173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232712|NCT01348243|Clodronic Acid|clodronic acid|mesh-list
93232713|NCT01348243|Lidocaine|lidocaine|mesh-list
93232714|NCT01348243|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232715|NCT01348243|Anesthetics|anesthetics|mesh-ancestor
93000358|NCT03533946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000429|NCT03395314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93232716|NCT01348243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232717|NCT01348243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232718|NCT01348243|Sensory System Agents|sensory system agents|mesh-ancestor
93232719|NCT01348243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232720|NCT01348243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232721|NCT01348243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93232722|NCT01348243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93232723|NCT01348243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232724|NCT01348243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232725|NCT01348243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93232726|NCT01348321|Levamisole|levamisole|mesh-list
93000798|NCT00098839|Etoposide|etoposide|mesh-list
93232727|NCT01348321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93232728|NCT01348321|Immunologic Factors|immunologic factors|mesh-ancestor
93232729|NCT01348321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232730|NCT01348321|Antinematodal Agents|antinematodal agents|mesh-ancestor
93001036|NCT01019109|Cobalt|cobalt|mesh-list
93232731|NCT01348321|Anthelmintics|anthelmintics|mesh-ancestor
93232732|NCT01348321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93232733|NCT01348321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232734|NCT01348321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232735|NCT03772951|Clozapine|clozapine|mesh-list
93232736|NCT03772951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93001247|NCT00751205|Prednisone|prednisone|mesh-list
93232737|NCT03772951|Serotonin Agents|serotonin agents|mesh-ancestor
93232738|NCT03772951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232739|NCT03772951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232740|NCT03772951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232741|NCT03772951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93232742|NCT03772951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93232743|NCT03772951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232744|NCT03772951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93232745|NCT03772951|GABA Antagonists|gaba antagonists|mesh-ancestor
93001836|NCT04050059|Lidocaine|lidocaine|mesh-list
93232746|NCT03772951|GABA Agents|gaba agents|mesh-ancestor
93232747|NCT01343329|Propranolol|propranolol|mesh-list
93232748|NCT01343329|Esmolol|esmolol|mesh-list
93232749|NCT01343329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93232750|NCT01343329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93232751|NCT01343329|Adrenergic Agents|adrenergic agents|mesh-ancestor
93001979|NCT00494871|Warfarin|warfarin|mesh-list
93002041|NCT00419926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232752|NCT01343329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002113|NCT01082263|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93002189|NCT04198428|Narcotics|narcotics|mesh-ancestor
93002264|NCT00681629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93232753|NCT01343329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002414|NCT00539838|Prednisone|prednisone|mesh-list
93232754|NCT01343329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232755|NCT01343329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232756|NCT01343329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93232757|NCT01343329|Vasodilator Agents|vasodilator agents|mesh-ancestor
93002643|NCT00972140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93232758|NCT01343329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93232759|NCT01317589|Fentanyl|fentanyl|mesh-list
93232760|NCT01317589|Methadone|methadone|mesh-list
93232761|NCT01317589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93232762|NCT01317589|Narcotics|narcotics|mesh-ancestor
92904801|NCT04424966|Infigratinib|infigratinib|mesh-list
93232763|NCT01317589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232765|NCT01317589|Analgesics|analgesics|mesh-ancestor
93232766|NCT01317589|Sensory System Agents|sensory system agents|mesh-ancestor
93232767|NCT01317589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232768|NCT01317589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93003154|NCT00077857|Docetaxel|docetaxel|mesh-list
93232769|NCT01317589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93232770|NCT01317589|Anesthetics, General|anesthetics, general|mesh-ancestor
93232771|NCT01317589|Anesthetics|anesthetics|mesh-ancestor
93232772|NCT01317589|Antitussive Agents|antitussive agents|mesh-ancestor
93003448|NCT00983450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003520|NCT05537402|Atezolizumab|atezolizumab|mesh-list
93232773|NCT01317589|Respiratory System Agents|respiratory system agents|mesh-ancestor
93232774|NCT02825420|Trabectedin|trabectedin|mesh-list
93003594|NCT00540644|Glucocorticoids|glucocorticoids|mesh-ancestor
93232775|NCT02825420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003670|NCT00543062|Antiemetics|antiemetics|mesh-ancestor
93232776|NCT02825420|Alkylating Agents|alkylating agents|mesh-ancestor
93232777|NCT02825420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232778|NCT02825420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232779|NCT02829944|Ketorolac|ketorolac|mesh-list
93232780|NCT02829944|Ropivacaine|ropivacaine|mesh-list
93232781|NCT02829944|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232782|NCT02829944|Anesthetics|anesthetics|mesh-ancestor
93232783|NCT02829944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004113|NCT04430426|Glycolic acid|glycolic acid|mesh-list
93004194|NCT04334174|Immunotoxins|immunotoxins|mesh-ancestor
93232784|NCT02829944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232785|NCT02829944|Sensory System Agents|sensory system agents|mesh-ancestor
93004346|NCT01034956|Calcium|calcium|mesh-list
93232786|NCT02829944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004410|NCT04003844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93232787|NCT02829944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93232788|NCT02829944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93232789|NCT02829944|Analgesics|analgesics|mesh-ancestor
93232790|NCT02829944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93232791|NCT02829944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232792|NCT02829944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232793|NCT02829944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004704|NCT00762671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93232794|NCT02829944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232795|NCT04014530|Pembrolizumab|pembrolizumab|mesh-list
93004779|NCT00762983|Antipruritics|antipruritics|mesh-ancestor
93232796|NCT04014530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93232797|NCT04014530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005001|NCT00763685|Etoricoxib|etoricoxib|mesh-list
93232798|NCT04014530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93005074|NCT01037140|Vitamins|vitamins|mesh-ancestor
93232799|NCT04014530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232800|NCT03563534|Fluorides|fluorides|mesh-list
93005230|NCT01415882|Antiemetics|antiemetics|mesh-ancestor
93232801|NCT03563534|Cariostatic Agents|cariostatic agents|mesh-ancestor
93005405|NCT00771641|Cobalt|cobalt|mesh-list
93232802|NCT03563534|Protective Agents|protective agents|mesh-ancestor
93005448|NCT00669071|Protective Agents|protective agents|mesh-ancestor
93232803|NCT03563534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232804|NCT03563144|Leucovorin|leucovorin|mesh-list
93232805|NCT03563144|Paclitaxel|paclitaxel|mesh-list
93232806|NCT03563144|Cyclophosphamide|cyclophosphamide|mesh-list
93232807|NCT03563144|Bevacizumab|bevacizumab|mesh-list
93232808|NCT03563144|Gemcitabine|gemcitabine|mesh-list
93232809|NCT03563144|Fluorouracil|fluorouracil|mesh-list
93232810|NCT03563144|Capecitabine|capecitabine|mesh-list
93232811|NCT03563144|Oxaliplatin|oxaliplatin|mesh-list
93232812|NCT03563144|Avelumab|avelumab|mesh-list
93232813|NCT03563144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93232814|NCT03563144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232815|NCT03563144|Tubulin Modulators|tubulin modulators|mesh-ancestor
93232816|NCT03563144|Antimitotic Agents|antimitotic agents|mesh-ancestor
93232817|NCT03563144|Mitosis Modulators|mitosis modulators|mesh-ancestor
93005959|NCT00057811|Leucovorin|leucovorin|mesh-list
93006043|NCT01091077|Naringenin|naringenin|mesh-list
93232818|NCT03563144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232819|NCT03563144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232820|NCT03563144|Immunologic Factors|immunologic factors|mesh-ancestor
93232821|NCT03563144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232822|NCT03563144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232823|NCT03563144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93232824|NCT03563144|Alkylating Agents|alkylating agents|mesh-ancestor
93232825|NCT03563144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93232826|NCT03563144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006499|NCT00784511|Vitamin D|vitamin d|mesh-list
93006553|NCT05346224|Pertuzumab|pertuzumab|mesh-list
93006704|NCT00786149|Varenicline|varenicline|mesh-list
93232827|NCT03563144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93232828|NCT03563144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93232829|NCT03563144|Growth Substances|growth substances|mesh-ancestor
93232830|NCT03563144|Growth Inhibitors|growth inhibitors|mesh-ancestor
93232831|NCT03563144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93232832|NCT03563144|Antimetabolites|antimetabolites|mesh-ancestor
93232833|NCT03563144|Antidotes|antidotes|mesh-ancestor
93007298|NCT00066703|Tamoxifen|tamoxifen|mesh-list
93232834|NCT03563144|Protective Agents|protective agents|mesh-ancestor
93232835|NCT03563144|Vitamin B Complex|vitamin b complex|mesh-ancestor
93232836|NCT03563144|Vitamins|vitamins|mesh-ancestor
93232837|NCT03563144|Micronutrients|micronutrients|mesh-ancestor
93232838|NCT01338818|Methylphenidate|methylphenidate|mesh-list
93007520|NCT01045876|Dexamethasone|dexamethasone|mesh-list
93232839|NCT01338818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93007662|NCT00791531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232840|NCT01338818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232841|NCT01338818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93232842|NCT01338818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93007807|NCT00792857|Vitamins|vitamins|mesh-ancestor
93232843|NCT01338818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232844|NCT01338818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232846|NCT01338818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232847|NCT05310110|Lidocaine|lidocaine|mesh-list
93232848|NCT05310110|Propofol|propofol|mesh-list
93232849|NCT05310110|Cisatracurium|cisatracurium|mesh-list
93232850|NCT05310110|Atracurium|atracurium|mesh-list
93232851|NCT05310110|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232852|NCT05310110|Anesthetics|anesthetics|mesh-ancestor
93232853|NCT05310110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232854|NCT05310110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232855|NCT05310110|Sensory System Agents|sensory system agents|mesh-ancestor
93232856|NCT05310110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232857|NCT05310110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93232858|NCT05310110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93232859|NCT05310110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93232860|NCT05310110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93008257|NCT00804791|Lubricant Eye Drops|lubricant eye drops|mesh-list
93232861|NCT05310110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232862|NCT05310110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93232863|NCT05310110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93232864|NCT05310110|Anesthetics, General|anesthetics, general|mesh-ancestor
93232865|NCT05310110|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93232866|NCT05310110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93232867|NCT05310110|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93232868|NCT05310110|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93232869|NCT05310110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93232870|NCT05310110|Cholinergic Agents|cholinergic agents|mesh-ancestor
93232871|NCT05310110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232872|NCT02823470|Ivacaftor|ivacaftor|mesh-list
93232873|NCT02823470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93232874|NCT02823470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232875|NCT02823470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232876|NCT03562754|Heparin|heparin|mesh-list
93232877|NCT03562754|Anticoagulants|anticoagulants|mesh-ancestor
93232878|NCT03562754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232879|NCT03562754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93232880|NCT03562754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93232881|NCT02259920|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
93232882|NCT02259920|Mydriatics|mydriatics|mesh-ancestor
93008331|NCT00805649|Hormones|hormones|mesh-ancestor
93232883|NCT02259920|Autonomic Agents|autonomic agents|mesh-ancestor
93232884|NCT02259920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232885|NCT02259920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232886|NCT02259920|Sympathomimetics|sympathomimetics|mesh-ancestor
93232887|NCT01371656|Levofloxacin|levofloxacin|mesh-list
93232888|NCT01371656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93232889|NCT01371656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232890|NCT01371656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232891|NCT01371656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93232892|NCT01371656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93232893|NCT01371656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232894|NCT01371656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232895|NCT01371656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232896|NCT01371656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93232897|NCT01371656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93232898|NCT04541888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93232899|NCT04541888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93232900|NCT01354964|Vitamin D|vitamin d|mesh-list
93232901|NCT01354964|Ergocalciferols|ergocalciferols|mesh-list
93232902|NCT01354964|Cholecalciferol|cholecalciferol|mesh-list
93232903|NCT01354964|Vitamins|vitamins|mesh-list
93008519|NCT00808145|Cisplatin|cisplatin|mesh-list
93232904|NCT01354964|Micronutrients|micronutrients|mesh-ancestor
93232905|NCT01354964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008733|NCT02551523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232906|NCT01354964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93008808|NCT00061945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93008886|NCT01046032|Metformin|metformin|mesh-list
93008957|NCT01098019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93232907|NCT01354964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93232908|NCT02259998|Dipyridamole|dipyridamole|mesh-list
93232909|NCT02259998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93232910|NCT02259998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232911|NCT02259998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232912|NCT02259998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93232913|NCT02259998|Vasodilator Agents|vasodilator agents|mesh-ancestor
93232915|NCT02035904|Levobupivacaine|levobupivacaine|mesh-list
93232916|NCT02035904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93232917|NCT02035904|Narcotics|narcotics|mesh-ancestor
93232918|NCT02035904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009102|NCT01093807|Enalapril|enalapril|mesh-list
93009176|NCT01020357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232919|NCT02035904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232920|NCT02035904|Analgesics|analgesics|mesh-ancestor
93009319|NCT00474045|Insulin|insulin|mesh-list
93232921|NCT02035904|Sensory System Agents|sensory system agents|mesh-ancestor
93232922|NCT02035904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232923|NCT02035904|Anesthetics, Local|anesthetics, local|mesh-ancestor
93232924|NCT02035904|Anesthetics|anesthetics|mesh-ancestor
93232925|NCT04110080|Anesthetics|anesthetics|mesh-list
93232926|NCT04110080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93232927|NCT04110080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232928|NCT02035982|Rivastigmine|rivastigmine|mesh-list
93232929|NCT02035982|Donepezil|donepezil|mesh-list
93232930|NCT02035982|Galantamine|galantamine|mesh-list
93009614|NCT00452439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93232931|NCT02035982|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
93232932|NCT02035982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009769|NCT01023243|Antipyretics|antipyretics|mesh-ancestor
93232933|NCT02035982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232934|NCT02035982|Cholinergic Agents|cholinergic agents|mesh-ancestor
93232935|NCT02035982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93232936|NCT02035982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232937|NCT02035982|Nootropic Agents|nootropic agents|mesh-ancestor
93009989|NCT02550665|Donepezil|donepezil|mesh-list
93232938|NCT02035982|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93232939|NCT02035982|Autonomic Agents|autonomic agents|mesh-ancestor
93232940|NCT02035982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93232941|NCT02035982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93232942|NCT02035982|Protective Agents|protective agents|mesh-ancestor
93232943|NCT05707832|Amphotericin B|amphotericin b|mesh-list
93232944|NCT05707832|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93232945|NCT05707832|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
93232946|NCT05707832|Amebicides|amebicides|mesh-ancestor
93010215|NCT02551367|Letrozole|letrozole|mesh-list
93232947|NCT05707832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93232948|NCT05707832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93232949|NCT05707832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010359|NCT00447603|Losartan|losartan|mesh-list
93232950|NCT05707832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232951|NCT05707832|Antifungal Agents|antifungal agents|mesh-ancestor
93232952|NCT05707832|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93232953|NCT05707832|Protease Inhibitors|protease inhibitors|mesh-ancestor
93010570|NCT00443703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93232954|NCT05707832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010719|NCT00536484|Fesoterodine|fesoterodine|mesh-list
93232955|NCT05707832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010799|NCT00363298|Caffeine|caffeine|mesh-list
93010867|NCT05246982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232956|NCT05707832|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93232957|NCT05707832|Protective Agents|protective agents|mesh-ancestor
93232958|NCT05707832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232959|NCT05707832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232960|NCT02822222|Magnesium citrate|magnesium citrate|mesh-list
93232961|NCT02822222|Cathartics|cathartics|mesh-ancestor
93232962|NCT02822222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93232963|NCT02821910|Metformin|metformin|mesh-list
93232964|NCT02821910|Empagliflozin|empagliflozin|mesh-list
93232965|NCT02821910|Linagliptin|linagliptin|mesh-list
93011465|NCT00424749|Prednisone|prednisone|mesh-list
93232966|NCT02821910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93232967|NCT02821910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232968|NCT02821910|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93011604|NCT00368992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93232969|NCT02821910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232970|NCT02821910|Incretins|incretins|mesh-ancestor
93232971|NCT02821910|Hormones|hormones|mesh-ancestor
93011751|NCT03990922|Narcotics|narcotics|mesh-ancestor
93011825|NCT00817271|Hormones|hormones|mesh-ancestor
93011828|NCT01052896|Gabapentin|gabapentin|mesh-list
93232972|NCT02821910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93232973|NCT02821910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93232974|NCT02821910|Protease Inhibitors|protease inhibitors|mesh-ancestor
93232975|NCT02821910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232976|NCT03819452|Vitamin D|vitamin d|mesh-list
93232977|NCT03819452|Vitamins|vitamins|mesh-ancestor
93232978|NCT03819452|Micronutrients|micronutrients|mesh-ancestor
93012043|NCT00626795|Mupirocin|mupirocin|mesh-list
93232979|NCT03819452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93232980|NCT03819452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93232981|NCT03138655|Vedolizumab|vedolizumab|mesh-list
93232982|NCT03138655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93232983|NCT05707520|Mycophenolic Acid|mycophenolic acid|mesh-list
93012266|NCT05889338|Methotrexate|methotrexate|mesh-list
92905025|NCT03516656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93012343|NCT05888493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93232984|NCT05707520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93232985|NCT05707520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93232986|NCT05707520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93232987|NCT05707520|Antitubercular Agents|antitubercular agents|mesh-ancestor
93232988|NCT05707520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93232989|NCT05707520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93232990|NCT05707520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232991|NCT05707520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93232992|NCT04412785|Cyclosporine|cyclosporine|mesh-list
93232993|NCT04412785|Cyclosporins|cyclosporins|mesh-list
93232994|NCT04412785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93232995|NCT04412785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012634|NCT05631236|Methamphetamine|methamphetamine|mesh-list
93232996|NCT04412785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93232997|NCT04412785|Immunologic Factors|immunologic factors|mesh-ancestor
93232998|NCT04412785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012716|NCT05327777|Oxycodone|oxycodone|mesh-list
93232999|NCT04412785|Antifungal Agents|antifungal agents|mesh-ancestor
93233000|NCT04412785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233001|NCT04412785|Dermatologic Agents|dermatologic agents|mesh-ancestor
93012849|NCT04899349|Metformin|metformin|mesh-list
93233002|NCT04412785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233003|NCT04412785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93233005|NCT01352611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93012998|NCT04606446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233006|NCT01352611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233007|NCT01352611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93013145|NCT04245865|Levoleucovorin|levoleucovorin|mesh-list
93233008|NCT01352611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233009|NCT01352611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93233010|NCT01352611|GABA Agonists|gaba agonists|mesh-ancestor
93013291|NCT03922048|Bupivacaine|bupivacaine|mesh-list
93233011|NCT01352611|GABA Agents|gaba agents|mesh-ancestor
93233012|NCT01352611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233013|NCT01352611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233014|NCT02819804|Nivolumab|nivolumab|mesh-list
93233015|NCT02819804|Dasatinib|dasatinib|mesh-list
93013824|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93233016|NCT02819804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013901|NCT01082679|Buprenorphine|buprenorphine|mesh-list
93233017|NCT02819804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014051|NCT02550119|Serotonin Agents|serotonin agents|mesh-ancestor
93233018|NCT02819804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93014130|NCT00824057|Midazolam|midazolam|mesh-list
93233019|NCT02819804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233020|NCT02819804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93233021|NCT02819804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233022|NCT02819726|Rituximab|rituximab|mesh-list
93233023|NCT02819726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93233024|NCT02819726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233025|NCT02819726|Immunologic Factors|immunologic factors|mesh-ancestor
93233026|NCT02819726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014560|NCT00356590|Etanercept|etanercept|mesh-list
93233027|NCT02819726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233028|NCT02816138|Nicotine|nicotine|mesh-list
93233029|NCT02816138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93014711|NCT00828815|Etravirine|etravirine|mesh-list
93233030|NCT02816138|Autonomic Agents|autonomic agents|mesh-ancestor
93233031|NCT02816138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233032|NCT02816138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233033|NCT02816138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93233034|NCT02816138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93233035|NCT02816138|Cholinergic Agents|cholinergic agents|mesh-ancestor
93014996|NCT00621257|Micronutrients|micronutrients|mesh-ancestor
93015070|NCT00851513|Sensory System Agents|sensory system agents|mesh-ancestor
93233036|NCT02816138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233037|NCT02816138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233038|NCT02036060|Prednisone|prednisone|mesh-list
93233039|NCT02036060|Docetaxel|docetaxel|mesh-list
93015220|NCT00621023|Decitabine|decitabine|mesh-list
93233040|NCT02036060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015303|NCT00527904|Naproxen|naproxen|mesh-list
93233041|NCT02036060|Tubulin Modulators|tubulin modulators|mesh-ancestor
93233042|NCT02036060|Antimitotic Agents|antimitotic agents|mesh-ancestor
93015446|NCT00855881|Tegafur|tegafur|mesh-list
93233043|NCT02036060|Mitosis Modulators|mitosis modulators|mesh-ancestor
93015515|NCT00856271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93233044|NCT02036060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015663|NCT00857597|Omeprazole|omeprazole|mesh-list
93233045|NCT02036060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233046|NCT02036060|Glucocorticoids|glucocorticoids|mesh-ancestor
93233047|NCT02036060|Hormones|hormones|mesh-ancestor
93015753|NCT00858299|Valsartan|valsartan|mesh-list
93015809|NCT02544737|Apatinib|apatinib|mesh-list
93233048|NCT02036060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015888|NCT02544425|Alkylating Agents|alkylating agents|mesh-ancestor
93233049|NCT02036060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233050|NCT02036060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93233051|NCT02036528|Doxycycline|doxycycline|mesh-list
93233052|NCT02036528|Ciprofloxacin|ciprofloxacin|mesh-list
93233053|NCT02036528|Gentamicins|gentamicins|mesh-list
93233054|NCT02036528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93233055|NCT02036528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233056|NCT02036528|Antimalarials|antimalarials|mesh-ancestor
93233057|NCT02036528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93233058|NCT02036528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93233059|NCT02036528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93233060|NCT02036528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93233061|NCT02036528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233062|NCT02036528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233063|NCT02036528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233064|NCT02036528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93233065|NCT02036528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93015956|NCT00524316|Sunitinib|sunitinib|mesh-list
93233066|NCT02036528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93233067|NCT02880865|Vaccines|vaccines|mesh-list
93233068|NCT02880865|Immunologic Factors|immunologic factors|mesh-ancestor
93233069|NCT02880865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233070|NCT03635125|Metoprolol|metoprolol|mesh-list
93233071|NCT03635125|Nebivolol|nebivolol|mesh-list
93233072|NCT03635125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93233073|NCT03635125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93233074|NCT03635125|Sympatholytics|sympatholytics|mesh-ancestor
93233075|NCT03635125|Autonomic Agents|autonomic agents|mesh-ancestor
93233076|NCT03635125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233077|NCT03635125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233078|NCT03635125|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93233079|NCT03635125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93233080|NCT03635125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93016450|NCT00516048|Exenatide|exenatide|mesh-list
93233081|NCT03635125|Adrenergic Agents|adrenergic agents|mesh-ancestor
93233082|NCT03635125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233083|NCT03635125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016609|NCT00573443|Quinidine|quinidine|mesh-list
93233084|NCT03635125|Vasodilator Agents|vasodilator agents|mesh-ancestor
93233085|NCT03635125|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93016664|NCT05225753|Chrysarobin|chrysarobin|mesh-list
93016736|NCT00420849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93233086|NCT03635125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93233087|NCT03635125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93233088|NCT01854385|Sumatriptan|sumatriptan|mesh-list
93233089|NCT01854385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93016955|NCT00868829|Sirolimus|sirolimus|mesh-list
93233090|NCT01854385|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93017030|NCT00531206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93233091|NCT01854385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93233092|NCT01854385|Serotonin Agents|serotonin agents|mesh-ancestor
93017184|NCT04040309|Lidocaine|lidocaine|mesh-list
93017249|NCT05883358|Narcotics|narcotics|mesh-ancestor
93233093|NCT01854385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233094|NCT01854385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233095|NCT01854385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233096|NCT02047838|Hormones|hormones|mesh-list
93233097|NCT02047838|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93233098|NCT02047838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017547|NCT05880017|Morphine|morphine|mesh-list
93233099|NCT02047838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233100|NCT01318681|Fluticasone|fluticasone|mesh-list
93233101|NCT01318681|Xhance|xhance|mesh-list
93233102|NCT01318681|Cetirizine|cetirizine|mesh-list
93233103|NCT01318681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233104|NCT01318681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93233105|NCT01318681|Autonomic Agents|autonomic agents|mesh-ancestor
93233106|NCT01318681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233107|NCT01318681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233108|NCT01318681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93233109|NCT01318681|Respiratory System Agents|respiratory system agents|mesh-ancestor
93233110|NCT01318681|Dermatologic Agents|dermatologic agents|mesh-ancestor
93233111|NCT01318681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93233112|NCT01318681|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93233113|NCT01318681|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93233114|NCT01318681|Histamine Antagonists|histamine antagonists|mesh-ancestor
93233115|NCT01318681|Histamine Agents|histamine agents|mesh-ancestor
93233116|NCT01318681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233117|NCT01318681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233118|NCT03604159|Buprenorphine|buprenorphine|mesh-list
93233119|NCT03604159|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93233120|NCT03604159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93233121|NCT03604159|Narcotics|narcotics|mesh-ancestor
93017970|NCT05746546|Nicotine|nicotine|mesh-list
93233122|NCT03604159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018051|NCT05667324|Dexamethasone|dexamethasone|mesh-list
93018125|NCT05628623|Cytarabine|cytarabine|mesh-list
93233123|NCT03604159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233124|NCT03604159|Analgesics|analgesics|mesh-ancestor
93233125|NCT03604159|Sensory System Agents|sensory system agents|mesh-ancestor
93233126|NCT03604159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233127|NCT03604159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93233128|NCT03686930|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93233129|NCT01353235|Prednisolone|prednisolone|mesh-list
93233130|NCT01353235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233131|NCT01353235|Glucocorticoids|glucocorticoids|mesh-ancestor
93233132|NCT01353235|Hormones|hormones|mesh-ancestor
93233133|NCT01353235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018261|NCT05498792|Nivolumab|nivolumab|mesh-list
93233134|NCT01353235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233135|NCT01353235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018333|NCT05403450|Antimetabolites|antimetabolites|mesh-ancestor
93233136|NCT01353235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233137|NCT02048228|Clopidogrel|clopidogrel|mesh-list
93233138|NCT02048228|Ticagrelor|ticagrelor|mesh-list
93233139|NCT02048228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93018552|NCT05090280|Analgesics|analgesics|mesh-ancestor
93233140|NCT02048228|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93233141|NCT02048228|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93018773|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233142|NCT02048228|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93233143|NCT02048228|Purinergic Agents|purinergic agents|mesh-ancestor
93233144|NCT02048228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233145|NCT02048228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233146|NCT02048228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233147|NCT03046927|Vitamin D|vitamin d|mesh-list
93233148|NCT03046927|Ergocalciferols|ergocalciferols|mesh-list
93233149|NCT03046927|Vitamins|vitamins|mesh-ancestor
93233150|NCT03046927|Micronutrients|micronutrients|mesh-ancestor
93019064|NCT04429555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93233151|NCT03046927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233152|NCT03046927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93233153|NCT03046927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93233154|NCT01349257|Formoterol Fumarate|formoterol fumarate|mesh-list
93233155|NCT01349257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93233156|NCT01349257|Autonomic Agents|autonomic agents|mesh-ancestor
93019428|NCT03659136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233157|NCT01349257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233158|NCT01349257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233159|NCT01349257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93233160|NCT01349257|Respiratory System Agents|respiratory system agents|mesh-ancestor
93019728|NCT02998268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93233161|NCT01349257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93233162|NCT01349257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93233163|NCT01349257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93233164|NCT01349257|Adrenergic Agents|adrenergic agents|mesh-ancestor
93233165|NCT01349257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233166|NCT01349257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233167|NCT03589105|Ocrelizumab|ocrelizumab|mesh-list
93233168|NCT03589105|Immunologic Factors|immunologic factors|mesh-ancestor
93233169|NCT03589105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233170|NCT02048384|Metformin|metformin|mesh-list
93233171|NCT02048384|Sirolimus|sirolimus|mesh-list
93020208|NCT00224393|Etanercept|etanercept|mesh-list
93233172|NCT02048384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93020256|NCT00531050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93020339|NCT01008566|Sorafenib|sorafenib|mesh-list
93233173|NCT02048384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233174|NCT02048384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93233175|NCT02048384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233176|NCT02048384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93233177|NCT02048384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233178|NCT02048384|Antifungal Agents|antifungal agents|mesh-ancestor
93020622|NCT00881543|Incretins|incretins|mesh-ancestor
93020697|NCT02543099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93233179|NCT02048384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93233180|NCT02048384|Immunologic Factors|immunologic factors|mesh-ancestor
93233181|NCT01353391|Metformin|metformin|mesh-list
93233182|NCT01353391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93233183|NCT01353391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233184|NCT01349335|Tolvaptan|tolvaptan|mesh-list
93020994|NCT00892541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93021067|NCT04036487|Desflurane|desflurane|mesh-list
93233185|NCT01349335|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93021143|NCT00520130|Fludarabine|fludarabine|mesh-list
93021217|NCT00430989|Anesthetics, General|anesthetics, general|mesh-ancestor
93233186|NCT01349335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233187|NCT01349335|Natriuretic Agents|natriuretic agents|mesh-ancestor
93233188|NCT01349335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233189|NCT03009487|Amlodipine|amlodipine|mesh-list
93233190|NCT03009487|Olmesartan|olmesartan|mesh-list
93233191|NCT03009487|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93021513|NCT01051804|Lubricant Eye Drops|lubricant eye drops|mesh-list
93233192|NCT03009487|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
93233193|NCT03009487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93233194|NCT03009487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93233195|NCT03009487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93021814|NCT00524030|Sensory System Agents|sensory system agents|mesh-ancestor
93233196|NCT03009487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021886|NCT00345046|Prednisolone|prednisolone|mesh-list
93233197|NCT03009487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233198|NCT03009487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93021966|NCT00514904|Vaccines|vaccines|mesh-list
93022036|NCT00514514|Cyclosporine|cyclosporine|mesh-list
93233199|NCT03009487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022188|NCT00509028|Hormones|hormones|mesh-ancestor
93233200|NCT03009487|Vasodilator Agents|vasodilator agents|mesh-ancestor
93022263|NCT03249012|Calcitriol|calcitriol|mesh-list
93233201|NCT03009487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93233202|NCT03009487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93233203|NCT03009487|Antimetabolites|antimetabolites|mesh-ancestor
93233204|NCT03009487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93022415|NCT00606281|Dopamine Agents|dopamine agents|mesh-ancestor
93233205|NCT03009487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93022485|NCT00896285|Analgesics|analgesics|mesh-list
93233206|NCT03009487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233207|NCT03009487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93233208|NCT03009487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93233209|NCT02048540|Bevacizumab|bevacizumab|mesh-list
92368428|NCT00997620|Xhance|xhance|mesh-list
93233210|NCT02048540|Docetaxel|docetaxel|mesh-list
93233212|NCT02048540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93233213|NCT02048540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233214|NCT02048540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93233215|NCT02048540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93233216|NCT02048540|Growth Substances|growth substances|mesh-ancestor
93233217|NCT02048540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233218|NCT02048540|Growth Inhibitors|growth inhibitors|mesh-ancestor
93233219|NCT02048540|Tubulin Modulators|tubulin modulators|mesh-ancestor
93233220|NCT02048540|Antimitotic Agents|antimitotic agents|mesh-ancestor
93233221|NCT02048540|Mitosis Modulators|mitosis modulators|mesh-ancestor
93233222|NCT02048540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233223|NCT01353469|Insulin|insulin|mesh-list
93233224|NCT01353469|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93233225|NCT01353469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93233226|NCT01353469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233227|NCT03562130|Teduglutide|teduglutide|mesh-list
93233228|NCT03562130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93233229|NCT03562130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93022925|NCT00902603|Iloprost|iloprost|mesh-list
93233230|NCT03562130|Protective Agents|protective agents|mesh-ancestor
93233231|NCT03562130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233232|NCT02050178|Paclitaxel|paclitaxel|mesh-list
93233233|NCT02050178|Gemcitabine|gemcitabine|mesh-list
93023061|NCT00903851|Anesthetics|anesthetics|mesh-ancestor
93233234|NCT02050178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93233235|NCT02050178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233236|NCT02050178|Tubulin Modulators|tubulin modulators|mesh-ancestor
93233237|NCT02050178|Antimitotic Agents|antimitotic agents|mesh-ancestor
93233238|NCT02050178|Mitosis Modulators|mitosis modulators|mesh-ancestor
93233239|NCT02050178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023351|NCT01325194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023431|NCT00927875|Carboplatin|carboplatin|mesh-list
93233240|NCT02050178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93233241|NCT02050178|Antimetabolites|antimetabolites|mesh-ancestor
93233242|NCT02048852|Menthol|menthol|mesh-list
93233243|NCT02048852|Nicotine|nicotine|mesh-list
93233244|NCT02048852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93233245|NCT02048852|Autonomic Agents|autonomic agents|mesh-ancestor
93233246|NCT02048852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023642|NCT00925457|Antiemetics|antiemetics|mesh-ancestor
93233247|NCT02048852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233248|NCT02048852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93233249|NCT02048852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93233250|NCT02048852|Cholinergic Agents|cholinergic agents|mesh-ancestor
93233251|NCT02048852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023856|NCT01013454|Varenicline|varenicline|mesh-list
93023930|NCT03760679|Disinfectants|disinfectants|mesh-ancestor
93233252|NCT02048852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233253|NCT02048852|Antipruritics|antipruritics|mesh-ancestor
93233254|NCT02048852|Dermatologic Agents|dermatologic agents|mesh-ancestor
93233255|NCT02048930|Budesonide|budesonide|mesh-list
93024085|NCT00930839|Vitamins|vitamins|mesh-ancestor
93233256|NCT02048930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233257|NCT02048930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93233258|NCT02048930|Autonomic Agents|autonomic agents|mesh-ancestor
93233259|NCT02048930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233260|NCT02048930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233261|NCT02048930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93024370|NCT00502242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233262|NCT02048930|Respiratory System Agents|respiratory system agents|mesh-ancestor
93233263|NCT02048930|Glucocorticoids|glucocorticoids|mesh-ancestor
93233264|NCT02048930|Hormones|hormones|mesh-ancestor
93024605|NCT00522392|Bortezomib|bortezomib|mesh-list
93233265|NCT02048930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233266|NCT02049320|Remifentanil|remifentanil|mesh-list
93233267|NCT02049320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93233268|NCT02049320|Narcotics|narcotics|mesh-ancestor
93024742|NCT01059604|Serotonin Agents|serotonin agents|mesh-ancestor
93233269|NCT02049320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93233270|NCT02049320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233271|NCT02049320|Analgesics|analgesics|mesh-ancestor
93233272|NCT02049320|Sensory System Agents|sensory system agents|mesh-ancestor
93233273|NCT02049320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025112|NCT01009970|Alkylating Agents|alkylating agents|mesh-ancestor
93025187|NCT01010048|Vasodilator Agents|vasodilator agents|mesh-ancestor
93233274|NCT02050724|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
93025269|NCT00503984|Prednisone|prednisone|mesh-list
93233275|NCT02050724|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93233276|NCT02050724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233277|NCT02050802|Moxifloxacin|moxifloxacin|mesh-list
93233278|NCT02050802|Macitentan|macitentan|mesh-list
93025478|NCT01010516|Niacin|niacin|mesh-list
93233279|NCT02050802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93233280|NCT02050802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233281|NCT02050802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93025563|NCT00480636|Dalteparin|dalteparin|mesh-list
93025632|NCT01040559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233282|NCT02050802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93233283|NCT02050802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025861|NCT00319696|Bosentan|bosentan|mesh-list
93233284|NCT02050802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233285|NCT02050802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233286|NCT02050802|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93233287|NCT02050802|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93025930|NCT00318370|Farletuzumab|farletuzumab|mesh-list
93233288|NCT02050802|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93233289|NCT02051738|Mebendazole|mebendazole|mesh-list
93233290|NCT02051738|Piperazine|piperazine|mesh-list
93233291|NCT02051738|Piperazine citrate|piperazine citrate|mesh-list
93233292|NCT02051738|DMP 777|dmp 777|mesh-list
93233293|NCT02051738|Antinematodal Agents|antinematodal agents|mesh-ancestor
93233294|NCT02051738|Anthelmintics|anthelmintics|mesh-ancestor
93233295|NCT02051738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93233296|NCT02051738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233297|NCT02051738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93233298|NCT02051738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93233299|NCT02051738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93233300|NCT02051738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233301|NCT02051738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026522|NCT00400569|Sunitinib|sunitinib|mesh-list
93233302|NCT02051738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233303|NCT02050958|Ibuprofen|ibuprofen|mesh-list
93233304|NCT02050958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93233305|NCT02050958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93026878|NCT00508274|Antimetabolites|antimetabolites|mesh-ancestor
93233306|NCT02050958|Analgesics|analgesics|mesh-ancestor
93233307|NCT02050958|Sensory System Agents|sensory system agents|mesh-ancestor
93233308|NCT02050958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233309|NCT02050958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027097|NCT00456261|Growth Substances|growth substances|mesh-ancestor
93233310|NCT02050958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233311|NCT02050958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233312|NCT02050958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93233313|NCT02050958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233314|NCT02050958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233315|NCT02037464|Capsaicin|capsaicin|mesh-list
93027414|NCT00395967|Plerixafor|plerixafor|mesh-list
93233316|NCT02037464|Antipruritics|antipruritics|mesh-ancestor
93233317|NCT02037464|Dermatologic Agents|dermatologic agents|mesh-ancestor
93233318|NCT02037464|Sensory System Agents|sensory system agents|mesh-ancestor
93027532|NCT00493454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027607|NCT01040091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93233319|NCT02037464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027754|NCT00947453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93233320|NCT02037464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233321|NCT01357603|Insulin Glargine|insulin glargine|mesh-list
93233322|NCT01357603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93233323|NCT01357603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233324|NCT02051894|Dobutamine|dobutamine|mesh-list
93233325|NCT02051894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93233326|NCT02051894|Sympathomimetics|sympathomimetics|mesh-ancestor
93233327|NCT02051894|Autonomic Agents|autonomic agents|mesh-ancestor
93233328|NCT02051894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233329|NCT02051894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233330|NCT02051894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93233331|NCT02051894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93233332|NCT02051894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93233333|NCT02051894|Adrenergic Agents|adrenergic agents|mesh-ancestor
93233334|NCT02051894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233335|NCT02051894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028418|NCT01027494|Glucocorticoids|glucocorticoids|mesh-ancestor
93233336|NCT02051894|Protective Agents|protective agents|mesh-ancestor
93233337|NCT01357681|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93233338|NCT01357681|Antioxidants|antioxidants|mesh-ancestor
93233339|NCT01357681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233340|NCT01357681|Protective Agents|protective agents|mesh-ancestor
93233341|NCT01357681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233342|NCT01357681|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93233343|NCT01357681|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93233344|NCT01357681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233345|NCT01357681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93233346|NCT01543633|Propofol|propofol|mesh-list
93233347|NCT01543633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93028490|NCT00443430|Prednisolone acetate|prednisolone acetate|mesh-list
93233348|NCT01543633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028553|NCT01025934|Growth Substances|growth substances|mesh-ancestor
93233349|NCT01543633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233350|NCT01543633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93233351|NCT01543633|Anesthetics, General|anesthetics, general|mesh-ancestor
93233352|NCT01543633|Anesthetics|anesthetics|mesh-ancestor
93233353|NCT03561740|Capecitabine|capecitabine|mesh-list
93233354|NCT03561740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93233355|NCT03561740|Antimetabolites|antimetabolites|mesh-ancestor
93233356|NCT03561740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233357|NCT03561740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233358|NCT01357759|Gimsilumab|gimsilumab|mesh-list
93233359|NCT01357759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905404|NCT02611596|Ranolazine|ranolazine|mesh-list
93233360|NCT01357759|Antiviral Agents|antiviral agents|mesh-ancestor
93233361|NCT01357759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233362|NCT02052128|Onapristone|onapristone|mesh-list
93029064|NCT01062958|Vitamins|vitamins|mesh-list
93233363|NCT02052128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233364|NCT02052128|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93233365|NCT02052128|Fertility Agents|fertility agents|mesh-ancestor
93233366|NCT02052128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93029279|NCT00959231|Cyclosporins|cyclosporins|mesh-list
93233367|NCT02052128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233368|NCT02052128|Hormone Antagonists|hormone antagonists|mesh-ancestor
93233369|NCT02052128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029569|NCT00546377|Analgesics|analgesics|mesh-ancestor
93233370|NCT01349413|Esomeprazole|esomeprazole|mesh-list
93233371|NCT01349413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93233372|NCT01349413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93233373|NCT01349413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93233374|NCT01349413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233375|NCT01349413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233376|NCT01349647|Vaccines|vaccines|mesh-list
93233377|NCT01349647|Immunologic Factors|immunologic factors|mesh-ancestor
93233378|NCT01349647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233379|NCT02806232|Praziquantel|praziquantel|mesh-list
93233380|NCT02806232|Anthelmintics|anthelmintics|mesh-ancestor
93233381|NCT02806232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93233382|NCT02806232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233383|NCT02908087|Liraglutide|liraglutide|mesh-list
93233384|NCT02908087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93233385|NCT02908087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233386|NCT02908087|Incretins|incretins|mesh-ancestor
93233387|NCT02908087|Hormones|hormones|mesh-ancestor
93233388|NCT02908087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233389|NCT02053766|Dexmedetomidine|dexmedetomidine|mesh-list
93233390|NCT02053766|Propofol|propofol|mesh-list
93233391|NCT02053766|Sevoflurane|sevoflurane|mesh-list
93233392|NCT02053766|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93233393|NCT02053766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93233394|NCT02053766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233395|NCT02053766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93233396|NCT02053766|Analgesics|analgesics|mesh-ancestor
93030069|NCT00975065|Metformin|metformin|mesh-list
93233397|NCT02053766|Sensory System Agents|sensory system agents|mesh-ancestor
93233398|NCT02053766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030212|NCT00979589|Antipyretics|antipyretics|mesh-ancestor
93030286|NCT00977093|Chelating Agents|chelating agents|mesh-ancestor
93233399|NCT02053766|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93030435|NCT00978107|Antimetabolites|antimetabolites|mesh-ancestor
93030522|NCT00981929|Narcotics|narcotics|mesh-ancestor
93233400|NCT02053766|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93233401|NCT02053766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93233402|NCT02053766|Adrenergic Agents|adrenergic agents|mesh-ancestor
93233403|NCT02053766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233404|NCT02053766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233405|NCT02053766|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93233406|NCT02053766|Anesthetics, General|anesthetics, general|mesh-ancestor
93233407|NCT02053766|Anesthetics|anesthetics|mesh-ancestor
93233408|NCT02053766|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93233409|NCT02053766|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93233410|NCT02053922|Misoprostol|misoprostol|mesh-list
93233411|NCT02053922|Oxytocin|oxytocin|mesh-list
93233412|NCT02053922|Carbetocin|carbetocin|mesh-list
93031096|NCT01067638|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93233413|NCT02053922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93233414|NCT02053922|Abortifacient Agents|abortifacient agents|mesh-ancestor
93233415|NCT02053922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93233416|NCT02053922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233417|NCT02053922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93031318|NCT00377403|Sensory System Agents|sensory system agents|mesh-ancestor
93233418|NCT02053922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93233419|NCT02053922|Oxytocics|oxytocics|mesh-ancestor
93233420|NCT02054000|Tirofiban|tirofiban|mesh-list
93233421|NCT02054000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93233422|NCT02054000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93233423|NCT02054000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031691|NCT00282256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93233424|NCT02054000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93233425|NCT02054078|Bevacizumab|bevacizumab|mesh-list
93233426|NCT02054078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93233427|NCT02054078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233428|NCT02054078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031918|NCT01017770|Artesunate|artesunate|mesh-list
93233429|NCT02054078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93233430|NCT02054078|Growth Substances|growth substances|mesh-ancestor
93233431|NCT02054078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233432|NCT02054078|Growth Inhibitors|growth inhibitors|mesh-ancestor
93233433|NCT00392327|Vitamin A|vitamin a|mesh-list
93233434|NCT00392327|Cyclophosphamide|cyclophosphamide|mesh-list
93233435|NCT00392327|Cisplatin|cisplatin|mesh-list
93233436|NCT00392327|Carboplatin|carboplatin|mesh-list
93233437|NCT00392327|Vincristine|vincristine|mesh-list
93233438|NCT00392327|Tretinoin|tretinoin|mesh-list
93233439|NCT00392327|Isotretinoin|isotretinoin|mesh-list
93233440|NCT00392327|Lenograstim|lenograstim|mesh-list
93233441|NCT00392327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93233442|NCT00392327|Immunologic Factors|immunologic factors|mesh-ancestor
93233443|NCT00392327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032511|NCT00280150|Paclitaxel|paclitaxel|mesh-list
93233444|NCT00392327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233445|NCT00392327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93032658|NCT04204343|Bupivacaine|bupivacaine|mesh-list
93032743|NCT00444678|Cetuximab|cetuximab|mesh-list
93233446|NCT00392327|Alkylating Agents|alkylating agents|mesh-ancestor
93032817|NCT01048983|Analgesics|analgesics|mesh-ancestor
93233447|NCT00392327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032882|NCT05360537|Hormones|hormones|mesh-ancestor
93032955|NCT00989729|Glucocorticoids|glucocorticoids|mesh-ancestor
93233448|NCT00392327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233449|NCT00392327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93233450|NCT00392327|Vitamins|vitamins|mesh-ancestor
93233451|NCT00392327|Micronutrients|micronutrients|mesh-ancestor
93233452|NCT00392327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93233453|NCT00392327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93233454|NCT00392327|Tubulin Modulators|tubulin modulators|mesh-ancestor
93233455|NCT00392327|Antimitotic Agents|antimitotic agents|mesh-ancestor
93233456|NCT00392327|Mitosis Modulators|mitosis modulators|mesh-ancestor
93233457|NCT00392327|Keratolytic Agents|keratolytic agents|mesh-ancestor
93233458|NCT00392327|Dermatologic Agents|dermatologic agents|mesh-ancestor
93233459|NCT01336439|Botulinum Toxins|botulinum toxins|mesh-list
93233460|NCT01336439|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93233461|NCT01336439|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93233462|NCT01336439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93233463|NCT01336439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033323|NCT04941443|Antitussive Agents|antitussive agents|mesh-ancestor
93033393|NCT01051947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93233464|NCT01336439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233465|NCT01336439|Cholinergic Agents|cholinergic agents|mesh-ancestor
93033613|NCT01053585|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93233466|NCT01336439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233467|NCT01336439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233468|NCT01336439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93033909|NCT00992069|Antiviral Agents|antiviral agents|mesh-ancestor
93033984|NCT04001465|Methacholine Chloride|methacholine chloride|mesh-list
93034057|NCT03892889|Serotonin Agents|serotonin agents|mesh-ancestor
93233469|NCT01336439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233470|NCT01336595|Cobalt|cobalt|mesh-list
93233471|NCT01336595|Triamcinolone|triamcinolone|mesh-list
93233472|NCT01336595|Trace Elements|trace elements|mesh-ancestor
93233473|NCT01336595|Micronutrients|micronutrients|mesh-ancestor
93233474|NCT01336595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233475|NCT01336595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233476|NCT01336595|Glucocorticoids|glucocorticoids|mesh-ancestor
93233477|NCT01336595|Hormones|hormones|mesh-ancestor
93034352|NCT00436644|Topotecan|topotecan|mesh-list
93034430|NCT01055301|Melphalan|melphalan|mesh-list
93034501|NCT03987867|Mitosis Modulators|mitosis modulators|mesh-ancestor
93233478|NCT01336595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233479|NCT01336751|Insulin|insulin|mesh-list
93034572|NCT00322881|Paclitaxel|paclitaxel|mesh-list
93034643|NCT00531947|Selegiline|selegiline|mesh-list
93034757|NCT03882047|Xhance|xhance|mesh-list
93233480|NCT01336751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93233481|NCT01336751|Insulin Glargine|insulin glargine|mesh-list
93233482|NCT01336751|Insulin Lispro|insulin lispro|mesh-list
93233483|NCT01336751|Protamines|protamines|mesh-list
93233484|NCT01336751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035016|NCT00529763|Dasatinib|dasatinib|mesh-list
93233485|NCT01336751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233486|NCT01336751|Heparin Antagonists|heparin antagonists|mesh-ancestor
93035162|NCT00463346|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93035234|NCT03836664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233487|NCT01336751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233488|NCT01336751|Coagulants|coagulants|mesh-ancestor
93233489|NCT01336829|Rilpivirine|rilpivirine|mesh-list
93233490|NCT01336829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93233491|NCT01336829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93233492|NCT01336829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035525|NCT00452348|Xhance|xhance|mesh-list
93233493|NCT01336829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233494|NCT01336829|Antiviral Agents|antiviral agents|mesh-ancestor
93233495|NCT01336829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233496|NCT01336829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93035819|NCT01027520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233497|NCT01336829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93233498|NCT02960490|Quetmolimab|quetmolimab|mesh-list
93233499|NCT02960490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233500|NCT05184179|Olmesartan|olmesartan|mesh-list
93035967|NCT00431964|Azithromycin|azithromycin|mesh-list
93233501|NCT05184179|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93233502|NCT05184179|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93233503|NCT05184179|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93233504|NCT05184179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93233505|NCT05184179|Antimetabolites|antimetabolites|mesh-ancestor
93036187|NCT00449930|Protease Inhibitors|protease inhibitors|mesh-ancestor
93233506|NCT05184179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233507|NCT05184179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93036414|NCT01039740|Mirtazapine|mirtazapine|mesh-list
93233508|NCT05184179|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93233509|NCT05184179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233510|NCT05184179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93036634|NCT00446030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036711|NCT00439556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93233511|NCT05184179|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93036789|NCT01031030|Fluorouracil|fluorouracil|mesh-list
93233512|NCT05184179|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93233513|NCT05163834|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93233514|NCT05163834|Immunologic Factors|immunologic factors|mesh-ancestor
93233515|NCT05163834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233517|NCT01065012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93037012|NCT00436436|Temozolomide|temozolomide|mesh-list
93233518|NCT01065012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93233519|NCT01065012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037299|NCT00426764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233520|NCT01065012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233521|NCT01315691|Amikacin|amikacin|mesh-list
93233522|NCT01315691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93233523|NCT01315691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233524|NCT05654090|Sulbactam|sulbactam|mesh-list
93233525|NCT05654090|Cefoperazone|cefoperazone|mesh-list
93233526|NCT05654090|Sulperazone|sulperazone|mesh-list
93233527|NCT05654090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93233528|NCT05654090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037740|NCT01071694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93233529|NCT05654090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93233530|NCT05654090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037963|NCT00306189|Denosumab|denosumab|mesh-list
93038037|NCT01063023|Asunaprevir|asunaprevir|mesh-list
93038111|NCT01064271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93233531|NCT05654090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233532|NCT05654090|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93233533|NCT02054468|Remifentanil|remifentanil|mesh-list
93233534|NCT02054468|Propofol|propofol|mesh-list
93233535|NCT02054468|Rocuronium|rocuronium|mesh-list
93233536|NCT02054468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93233537|NCT02054468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038506|NCT01068327|Leucovorin|leucovorin|mesh-list
93233538|NCT02054468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233539|NCT02054468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93038559|NCT01046058|Simeprevir|simeprevir|mesh-list
93233540|NCT02054468|Anesthetics, General|anesthetics, general|mesh-ancestor
93233541|NCT02054468|Anesthetics|anesthetics|mesh-ancestor
93038627|NCT00413660|Tofacitinib|tofacitinib|mesh-list
93233542|NCT02054468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93233543|NCT02054468|Narcotics|narcotics|mesh-ancestor
93233544|NCT02054468|Analgesics|analgesics|mesh-ancestor
93233545|NCT02054468|Sensory System Agents|sensory system agents|mesh-ancestor
93233546|NCT02054468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233547|NCT02054468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93233548|NCT02054468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93233549|NCT02054468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93233550|NCT03640650|Triamcinolone|triamcinolone|mesh-list
93233551|NCT03640650|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93039067|NCT00397488|Sunitinib|sunitinib|mesh-list
93039133|NCT00424190|Vancomycin|vancomycin|mesh-list
93233552|NCT03640650|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93233553|NCT03640650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93233554|NCT03640650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93233555|NCT03640650|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93233556|NCT03640650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93233557|NCT03640650|Glucocorticoids|glucocorticoids|mesh-ancestor
93233558|NCT03640650|Hormones|hormones|mesh-ancestor
93039427|NCT01040702|Methylphenidate|methylphenidate|mesh-list
93039499|NCT01042704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93039572|NCT01041170|Hormones|hormones|mesh-ancestor
93233559|NCT03640650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039719|NCT00381888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039792|NCT00403130|Antimetabolites|antimetabolites|mesh-ancestor
93233560|NCT03640650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233561|NCT03640650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93233562|NCT03640650|Immunologic Factors|immunologic factors|mesh-ancestor
93233563|NCT03640650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040085|NCT00377676|Hormone Antagonists|hormone antagonists|mesh-ancestor
93233564|NCT03640650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233565|NCT05183555|Edotreotide|edotreotide|mesh-list
93233566|NCT05183555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93233567|NCT05183555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233568|NCT02052908|Naproxen|naproxen|mesh-list
93040228|NCT00398216|Edoxaban|edoxaban|mesh-list
93233569|NCT02052908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93233570|NCT02052908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93040389|NCT00406640|Serotonin Agents|serotonin agents|mesh-ancestor
93233571|NCT02052908|Analgesics|analgesics|mesh-ancestor
93233572|NCT02052908|Sensory System Agents|sensory system agents|mesh-ancestor
93233573|NCT02052908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040523|NCT00200356|Protective Agents|protective agents|mesh-ancestor
93233574|NCT02052908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233575|NCT02052908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685908|NCT00591994|Piribedil|piribedil|mesh-list
93233576|NCT02052908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233577|NCT02052908|Gout Suppressants|gout suppressants|mesh-ancestor
93233578|NCT02052908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93233579|NCT02052908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233580|NCT02052908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233581|NCT01336985|Irinotecan|irinotecan|mesh-list
93040974|NCT00221104|Pravastatin|pravastatin|mesh-list
93041048|NCT00219544|Pregabalin|pregabalin|mesh-list
93233582|NCT01336985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93041125|NCT00186628|Rituximab|rituximab|mesh-list
93041192|NCT01050036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233583|NCT01336985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041285|NCT01075438|Vaccines|vaccines|mesh-list
93233584|NCT01336985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041342|NCT00356148|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93041413|NCT00185380|Levonorgestrel|levonorgestrel|mesh-list
93041487|NCT00373880|Dopamine Agonists|dopamine agonists|mesh-ancestor
93041560|NCT00184054|Vitamins|vitamins|mesh-ancestor
93041567|NCT02533908|Fentanyl|fentanyl|mesh-list
93233585|NCT01336985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041634|NCT01055652|Dapagliflozin|dapagliflozin|mesh-list
93233586|NCT01336985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041727|NCT01071291|Niacin|niacin|mesh-list
93233587|NCT01337375|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93233588|NCT01337375|Interferon-alpha|interferon-alpha|mesh-list
93233590|NCT01337375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233591|NCT01337375|Immunologic Factors|immunologic factors|mesh-ancestor
93233592|NCT01337375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233593|NCT03635411|Niacinamide|niacinamide|mesh-list
93233594|NCT03635411|Niacin|niacin|mesh-list
93233595|NCT03635411|Nicotinic Acids|nicotinic acids|mesh-list
93233596|NCT03635411|Vitamin B Complex|vitamin b complex|mesh-ancestor
93233597|NCT03635411|Vitamins|vitamins|mesh-ancestor
93233598|NCT03635411|Micronutrients|micronutrients|mesh-ancestor
92687445|NCT00623077|Mesna|mesna|mesh-list
93042222|NCT00391274|Docetaxel|docetaxel|mesh-list
93042296|NCT00264537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93233599|NCT03635411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233600|NCT03635411|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93233601|NCT03635411|Antimetabolites|antimetabolites|mesh-ancestor
93042518|NCT01047722|Antipyretics|antipyretics|mesh-ancestor
93233602|NCT03635411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233603|NCT03635411|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93233604|NCT03635411|Vasodilator Agents|vasodilator agents|mesh-ancestor
93233605|NCT02748512|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93233606|NCT02748512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233607|NCT02748512|Glucocorticoids|glucocorticoids|mesh-ancestor
93233608|NCT02748512|Hormones|hormones|mesh-ancestor
93233609|NCT02748512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233610|NCT02748512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233611|NCT01341041|Chlorine dioxide|chlorine dioxide|mesh-list
93233612|NCT01341041|Dental Disinfectants|dental disinfectants|mesh-ancestor
93233613|NCT01341041|Disinfectants|disinfectants|mesh-ancestor
93233614|NCT01341041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233615|NCT02053142|Acyclovir|acyclovir|mesh-list
93233616|NCT02053142|Antiviral Agents|antiviral agents|mesh-ancestor
93233617|NCT02053142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233618|NCT01316549|Fludarabine|fludarabine|mesh-list
93233619|NCT01316549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233620|NCT03439657|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93233621|NCT03439657|Immunologic Factors|immunologic factors|mesh-ancestor
93233622|NCT03439657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233623|NCT01341743|Entecavir|entecavir|mesh-list
93233624|NCT01341743|Adefovir|adefovir|mesh-list
93233625|NCT01341743|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93233626|NCT01341743|Antiviral Agents|antiviral agents|mesh-ancestor
93233627|NCT01341743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233628|NCT01341743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93233629|NCT01341743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93233630|NCT01341743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233631|NCT01341743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233632|NCT01341275|Vaccines|vaccines|mesh-list
93233633|NCT01341275|Immunologic Factors|immunologic factors|mesh-ancestor
93233634|NCT01341275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233635|NCT01353937|Plerixafor|plerixafor|mesh-list
93233636|NCT01353937|Becaplermin|becaplermin|mesh-list
93233637|NCT01353937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93233638|NCT01353937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93233639|NCT01353937|Antiviral Agents|antiviral agents|mesh-ancestor
93233640|NCT01353937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233641|NCT01353937|Anticoagulants|anticoagulants|mesh-ancestor
93233642|NCT01353937|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93233643|NCT01353937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93233644|NCT01353937|Growth Substances|growth substances|mesh-ancestor
93233645|NCT01353937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233646|NCT04705883|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93233647|NCT04705883|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93233648|NCT04705883|Immunologic Factors|immunologic factors|mesh-ancestor
93233649|NCT04705883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233650|NCT02053298|Timolol|timolol|mesh-list
93233651|NCT02053298|Dorzolamide|dorzolamide|mesh-list
93233652|NCT02053298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93043674|NCT01049048|Vitamin D|vitamin d|mesh-list
93233653|NCT02053298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93233654|NCT02053298|Adrenergic Agents|adrenergic agents|mesh-ancestor
93043754|NCT00525161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043826|NCT00524303|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043899|NCT00523991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233655|NCT02053298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043971|NCT03755765|Clavulanic Acid|clavulanic acid|mesh-list
93233656|NCT02053298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233657|NCT02053298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233658|NCT02053298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93044120|NCT00186537|Rosiglitazone|rosiglitazone|mesh-list
93233659|NCT02053298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93044192|NCT00516893|Natalizumab|natalizumab|mesh-list
93233660|NCT02053298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93233661|NCT02053298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233662|NCT02054936|Warfarin|warfarin|mesh-list
93233663|NCT02054936|Rivaroxaban|rivaroxaban|mesh-list
93044344|NCT00340704|Tamsulosin|tamsulosin|mesh-list
93233664|NCT02054936|Anticoagulants|anticoagulants|mesh-ancestor
93233665|NCT02054936|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93233666|NCT02054936|Antithrombins|antithrombins|mesh-ancestor
93233667|NCT02054936|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93044787|NCT00105196|Dopamine Agents|dopamine agents|mesh-ancestor
93233668|NCT02054936|Protease Inhibitors|protease inhibitors|mesh-ancestor
93233669|NCT02054936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045080|NCT00513305|Antimetabolites|antimetabolites|mesh-ancestor
93045153|NCT01009541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93233670|NCT02054936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233671|NCT04782791|Nivolumab|nivolumab|mesh-list
93233672|NCT04782791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045308|NCT00362180|Mipomersen|mipomersen|mesh-list
93045373|NCT00361634|Analgesics|analgesics|mesh-ancestor
93233673|NCT04782791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233674|NCT04782791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93233675|NCT04782791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233676|NCT01341353|Amiodarone|amiodarone|mesh-list
93045531|NCT00381680|Antimetabolites|antimetabolites|mesh-ancestor
93045596|NCT01050374|Antimitotic Agents|antimitotic agents|mesh-ancestor
93233677|NCT01341353|Calcium Channel Blockers|calcium channel blockers|mesh-list
93233678|NCT01341353|Calcium|calcium|mesh-list
93233679|NCT01341353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93045749|NCT00493025|Paclitaxel|paclitaxel|mesh-list
93233680|NCT01341353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233681|NCT01341353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93233682|NCT01341353|Vasodilator Agents|vasodilator agents|mesh-ancestor
93045895|NCT01015235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93233683|NCT01341353|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93233684|NCT01341353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93045967|NCT00491387|Metoprolol|metoprolol|mesh-list
93045990|NCT01015547|Infliximab|infliximab|mesh-list
93233685|NCT01341353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046041|NCT04275713|Metformin|metformin|mesh-list
93233686|NCT01341353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93233687|NCT01341353|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93233688|NCT01341353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93233689|NCT01341353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233690|NCT01341353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93233691|NCT01341353|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93233692|NCT01341353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93233693|NCT02056106|Antidepressive Agents|antidepressive agents|mesh-list
93233694|NCT02056106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93233695|NCT02056184|Adalimumab|adalimumab|mesh-list
93046553|NCT00375674|Growth Inhibitors|growth inhibitors|mesh-ancestor
93233696|NCT02056184|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93233697|NCT02056184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046636|NCT03989024|Hormones|hormones|mesh-ancestor
93233698|NCT02056184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233699|NCT02800928|Aticaprant|aticaprant|mesh-list
93233700|NCT02800928|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93233701|NCT02800928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233702|NCT02800928|Sensory System Agents|sensory system agents|mesh-ancestor
93233703|NCT02800928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233704|NCT02056418|Prednisone|prednisone|mesh-list
93233705|NCT02056418|Hydrocortisone|hydrocortisone|mesh-list
93233706|NCT02056418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233707|NCT02056418|Glucocorticoids|glucocorticoids|mesh-ancestor
93233708|NCT02056418|Hormones|hormones|mesh-ancestor
93233709|NCT02056418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233710|NCT02056418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233711|NCT02056418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93047393|NCT00314574|Omalizumab|omalizumab|mesh-list
93233712|NCT02056418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233713|NCT02055014|Liraglutide|liraglutide|mesh-list
93233714|NCT02055014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93233715|NCT02055014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233716|NCT02055014|Incretins|incretins|mesh-ancestor
93233717|NCT02055014|Hormones|hormones|mesh-ancestor
93233718|NCT02055014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233719|NCT02055170|Finasteride|finasteride|mesh-list
93233720|NCT02055170|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93047682|NCT00150969|Hemostatics|hemostatics|mesh-ancestor
93233721|NCT02055170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93233722|NCT02055170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233723|NCT02055170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233724|NCT02055170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93047899|NCT00329108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047973|NCT00295932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93233725|NCT02055170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93233726|NCT02055170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233727|NCT02055170|Urological Agents|urological agents|mesh-ancestor
93233728|NCT04490993|Epirubicin|epirubicin|mesh-list
93233729|NCT04490993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93233730|NCT04490993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233731|NCT04490993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93233732|NCT04490993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93233733|NCT04490993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233734|NCT04490993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233735|NCT02055482|Darbepoetin alfa|darbepoetin alfa|mesh-list
93233736|NCT02055482|Hematinics|hematinics|mesh-ancestor
93233737|NCT02059460|Terlipressin|terlipressin|mesh-list
93233738|NCT02059460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93233739|NCT02059460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93233740|NCT02055716|Sulforaphane|sulforaphane|mesh-list
93233741|NCT02055716|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93233742|NCT02055716|Protective Agents|protective agents|mesh-ancestor
93233743|NCT02055716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233744|NCT02055716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233745|NCT04739735|Anesthetics|anesthetics|mesh-list
93233746|NCT04739735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93233747|NCT04739735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233748|NCT02059616|Amlodipine|amlodipine|mesh-list
93233749|NCT02059616|Candesartan|candesartan|mesh-list
93233750|NCT02059616|Candesartan cilexetil|candesartan cilexetil|mesh-list
93048551|NCT01066494|Cytarabine|cytarabine|mesh-list
93233751|NCT02059616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048622|NCT01066728|Vasodilator Agents|vasodilator agents|mesh-ancestor
93048697|NCT01066962|Raltegravir Potassium|raltegravir potassium|mesh-list
93233752|NCT02059616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93048781|NCT03978884|Diuretics|diuretics|mesh-ancestor
93233753|NCT02059616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048843|NCT00303602|Serotonin Agents|serotonin agents|mesh-ancestor
93233754|NCT02059616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048922|NCT00286494|Pioglitazone|pioglitazone|mesh-list
93233755|NCT02059616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93233756|NCT02059616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233757|NCT02059616|Vasodilator Agents|vasodilator agents|mesh-ancestor
93233758|NCT02059616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93233759|NCT02059616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93233760|NCT04356209|Pravastatin|pravastatin|mesh-list
93233761|NCT04356209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93049141|NCT00283062|Docetaxel|docetaxel|mesh-list
93233762|NCT04356209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93233763|NCT04356209|Antimetabolites|antimetabolites|mesh-ancestor
93233764|NCT04356209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233765|NCT04356209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93049355|NCT00291642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93233766|NCT04356209|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93233767|NCT04356209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233768|NCT02059694|Lidocaine|lidocaine|mesh-list
93233769|NCT02059694|Epinephrine|epinephrine|mesh-list
93233770|NCT02059694|Racepinephrine|racepinephrine|mesh-list
93233771|NCT02059694|Epinephryl borate|epinephryl borate|mesh-list
93233772|NCT02059694|Anesthetics, Local|anesthetics, local|mesh-ancestor
93233773|NCT02059694|Anesthetics|anesthetics|mesh-ancestor
93049736|NCT00276744|Sirolimus|sirolimus|mesh-list
93233774|NCT02059694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93233775|NCT02059694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233776|NCT02059694|Sensory System Agents|sensory system agents|mesh-ancestor
93233777|NCT02059694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233778|NCT02059694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93049948|NCT01066988|Emollients|emollients|mesh-list
93233779|NCT02059694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93233780|NCT02059694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93050166|NCT01021787|Dermatologic Agents|dermatologic agents|mesh-ancestor
93233781|NCT02059694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93233782|NCT02059694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233783|NCT02059694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93233784|NCT02059694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93233785|NCT02059694|Adrenergic Agents|adrenergic agents|mesh-ancestor
93050383|NCT00467363|Aspirin|aspirin|mesh-list
93233786|NCT02059694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050600|NCT00464087|PENTA|penta|mesh-list
93050612|NCT00452699|Fluticasone|fluticasone|mesh-list
93050684|NCT00463385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050759|NCT03741660|Cathartics|cathartics|mesh-ancestor
93233787|NCT02059694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93233788|NCT02059694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93233789|NCT02059694|Autonomic Agents|autonomic agents|mesh-ancestor
93233790|NCT02059694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93233791|NCT02059694|Respiratory System Agents|respiratory system agents|mesh-ancestor
93050987|NCT01069796|Antimetabolites|antimetabolites|mesh-ancestor
93233792|NCT02059694|Mydriatics|mydriatics|mesh-ancestor
93233793|NCT02059694|Sympathomimetics|sympathomimetics|mesh-ancestor
93233794|NCT02059694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93233795|NCT03146741|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93233796|NCT03146741|Antiviral Agents|antiviral agents|mesh-ancestor
93233797|NCT03146741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233798|NCT02056730|Calcium|calcium|mesh-list
93051427|NCT03956134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93233799|NCT02056730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93233800|NCT02056730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233801|NCT05162573|177Lu-PSMA-617|177lu-psma-617|mesh-list
93233802|NCT05162573|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93233803|NCT05162573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233804|NCT01337219|Tobramycin|tobramycin|mesh-list
93233805|NCT01337219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93233806|NCT01337219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233807|NCT03560804|Olmesartan|olmesartan|mesh-list
93233808|NCT03560804|Chlorthalidone|chlorthalidone|mesh-list
93233809|NCT03560804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93233810|NCT03560804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93233811|NCT03560804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93051938|NCT00456521|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93052009|NCT00235716|Antioxidants|antioxidants|mesh-ancestor
93233812|NCT03560804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905840|NCT00669773|Tubulin Modulators|tubulin modulators|mesh-ancestor
93233813|NCT03560804|Diuretics|diuretics|mesh-ancestor
93233814|NCT03560804|Natriuretic Agents|natriuretic agents|mesh-ancestor
93233815|NCT03560804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052303|NCT00059332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93233816|NCT03560804|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93052463|NCT00267488|Topotecan|topotecan|mesh-list
93233817|NCT03560804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93233818|NCT03150719|Ivacaftor|ivacaftor|mesh-list
93052522|NCT01096498|Levonorgestrel|levonorgestrel|mesh-list
93233819|NCT03150719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93052673|NCT00266708|Etidronic Acid|etidronic acid|mesh-list
93233820|NCT03150719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93233821|NCT03150719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233822|NCT02059772|Ranibizumab|ranibizumab|mesh-list
93233823|NCT02059772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93233824|NCT02059772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93233825|NCT02059772|Growth Substances|growth substances|mesh-ancestor
93233826|NCT02059772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233827|NCT02059772|Growth Inhibitors|growth inhibitors|mesh-ancestor
93233828|NCT02059772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233829|NCT01344083|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93233830|NCT01344083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93233831|NCT01344083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93233832|NCT01344083|Analgesics|analgesics|mesh-ancestor
93233833|NCT01344083|Sensory System Agents|sensory system agents|mesh-ancestor
93233834|NCT01344083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233835|NCT01344083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233836|NCT01344083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233837|NCT01344083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233838|NCT01344083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93233839|NCT01344083|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93233840|NCT01344083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93053340|NCT01028339|Mannitol|mannitol|mesh-list
93233841|NCT01344083|Histamine Antagonists|histamine antagonists|mesh-ancestor
93053410|NCT00437489|Insulin|insulin|mesh-list
93233842|NCT01344083|Histamine Agents|histamine agents|mesh-ancestor
93233843|NCT01344083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233844|NCT01344083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233845|NCT02059850|Cyclophosphamide|cyclophosphamide|mesh-list
93233846|NCT02059850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93233847|NCT02059850|Immunologic Factors|immunologic factors|mesh-ancestor
93233848|NCT02059850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233849|NCT02059850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233850|NCT02059850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053631|NCT01029743|PENTA|penta|mesh-list
93233851|NCT02059850|Alkylating Agents|alkylating agents|mesh-ancestor
93233852|NCT02059850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233853|NCT02059850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233854|NCT02059850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93233855|NCT00982111|Pemetrexed|pemetrexed|mesh-list
93233856|NCT00982111|Necitumumab|necitumumab|mesh-list
93233857|NCT00982111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053993|NCT00127803|Vaccines|vaccines|mesh-list
93233858|NCT00982111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054076|NCT00127101|Vorinostat|vorinostat|mesh-list
93233859|NCT00982111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233860|NCT00982111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93233861|NCT00982111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93233862|NCT00982111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93233863|NCT02957682|Alirocumab|alirocumab|mesh-list
93233864|NCT02957682|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93054369|NCT01327222|Bevacizumab|bevacizumab|mesh-list
93054442|NCT01584778|Immunologic Factors|immunologic factors|mesh-ancestor
93233865|NCT02957682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93054519|NCT00124449|Abatacept|abatacept|mesh-list
93233866|NCT02957682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93233867|NCT02957682|Antimetabolites|antimetabolites|mesh-ancestor
93054661|NCT00183248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233868|NCT02957682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233869|NCT02957682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93233870|NCT02957682|Protease Inhibitors|protease inhibitors|mesh-ancestor
93233871|NCT02957682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233872|NCT02957682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93233873|NCT03057951|Empagliflozin|empagliflozin|mesh-list
93233874|NCT03057951|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93233875|NCT03057951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233876|NCT03057951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93233877|NCT03057951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233878|NCT02060318|Infliximab|infliximab|mesh-list
93055174|NCT00165776|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93233879|NCT02060318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93233880|NCT02060318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055254|NCT03892642|Avelumab|avelumab|mesh-list
93233881|NCT02060318|Dermatologic Agents|dermatologic agents|mesh-ancestor
93060720|NCT03971604|Protective Agents|protective agents|mesh-ancestor
93233882|NCT02060318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93233883|NCT02060318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233884|NCT01318837|Solifenacin Succinate|solifenacin succinate|mesh-list
93233885|NCT01318837|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93233886|NCT01318837|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93233887|NCT01318837|Cholinergic Agents|cholinergic agents|mesh-ancestor
93055666|NCT01328236|Bortezomib|bortezomib|mesh-list
93233888|NCT01318837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93233889|NCT01318837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233890|NCT01318837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233891|NCT01318837|Urological Agents|urological agents|mesh-ancestor
93233892|NCT01350037|Remifentanil|remifentanil|mesh-list
93233894|NCT01350037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93233895|NCT01350037|Narcotics|narcotics|mesh-ancestor
93233896|NCT01350037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93233897|NCT01350037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233898|NCT01350037|Analgesics|analgesics|mesh-ancestor
93233899|NCT01350037|Sensory System Agents|sensory system agents|mesh-ancestor
93056031|NCT01219036|Hormones|hormones|mesh-ancestor
93233900|NCT01350037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233901|NCT01350037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93056109|NCT01124656|Pioglitazone|pioglitazone|mesh-list
93233902|NCT01350037|Anesthetics, General|anesthetics, general|mesh-ancestor
93233903|NCT01350037|Anesthetics|anesthetics|mesh-ancestor
93233904|NCT02060006|Meloxicam|meloxicam|mesh-list
93233905|NCT02060006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
93233906|NCT02060006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93056408|NCT01127464|Poly ICLC|poly iclc|mesh-list
93233907|NCT02060006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93233908|NCT02060006|Analgesics|analgesics|mesh-ancestor
93233909|NCT02060006|Sensory System Agents|sensory system agents|mesh-ancestor
93233910|NCT02060006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233911|NCT02060006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056693|NCT01126138|Vinorelbine|vinorelbine|mesh-list
93056768|NCT00257660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93233912|NCT02060006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93233913|NCT02060006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233914|NCT02060006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93233915|NCT02060006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056989|NCT01127386|Lenalidomide|lenalidomide|mesh-list
93233916|NCT02060006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233917|NCT03620435|Atezolizumab|atezolizumab|mesh-list
93233918|NCT03620435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93233919|NCT03620435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233920|NCT03620435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057209|NCT01228630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057293|NCT01133470|Fexofenadine|fexofenadine|mesh-list
93233921|NCT03620435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233922|NCT01317017|Interferon-gamma|interferon-gamma|mesh-list
93233923|NCT01317017|Antiviral Agents|antiviral agents|mesh-ancestor
93233924|NCT01317017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93233925|NCT04686773|Vaccines|vaccines|mesh-list
93233926|NCT04686773|Immunologic Factors|immunologic factors|mesh-ancestor
93233927|NCT04686773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233928|NCT02956278|Allopurinol|allopurinol|mesh-list
93233929|NCT02956278|Antimetabolites|antimetabolites|mesh-ancestor
93057656|NCT05195944|Protease Inhibitors|protease inhibitors|mesh-ancestor
93233930|NCT02956278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233931|NCT02956278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233932|NCT02956278|Gout Suppressants|gout suppressants|mesh-ancestor
93057802|NCT02334124|Ceftriaxone|ceftriaxone|mesh-list
93233933|NCT02956278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233934|NCT02956278|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93233935|NCT02956278|Antioxidants|antioxidants|mesh-ancestor
93233936|NCT02956278|Protective Agents|protective agents|mesh-ancestor
93233937|NCT02956278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233938|NCT02060396|Aspirin|aspirin|mesh-list
93058021|NCT00113373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233939|NCT02060396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93233940|NCT02060396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93233941|NCT02060396|Analgesics|analgesics|mesh-ancestor
93058166|NCT01141894|Mydriatics|mydriatics|mesh-ancestor
93233942|NCT02060396|Sensory System Agents|sensory system agents|mesh-ancestor
93058240|NCT01145404|Capecitabine|capecitabine|mesh-list
93233943|NCT02060396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93233944|NCT02060396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233945|NCT02060396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93058541|NCT03530800|Analgesics|analgesics|mesh-ancestor
93233946|NCT02060396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93233947|NCT02060396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93233948|NCT02060396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93058833|NCT00420641|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93058904|NCT01148446|Doxorubicin|doxorubicin|mesh-list
93058980|NCT01251874|Alovudine|alovudine|mesh-list
93233949|NCT02060396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233950|NCT02060396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93059200|NCT03972462|Sirolimus|sirolimus|mesh-list
93233951|NCT02060396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93233952|NCT02060396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233953|NCT02060396|Antipyretics|antipyretics|mesh-ancestor
93233954|NCT01358071|Doxorubicin|doxorubicin|mesh-list
93233955|NCT01358071|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93233956|NCT01358071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93233957|NCT01358071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059497|NCT03893032|Sympathomimetics|sympathomimetics|mesh-ancestor
93233958|NCT01358071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93233959|NCT01358071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93059578|NCT01260376|Acipimox|acipimox|mesh-list
93233960|NCT01358071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233961|NCT01358071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233962|NCT02058212|Vitamin E|vitamin e|mesh-list
93233963|NCT02058212|Selenium|selenium|mesh-list
93233964|NCT02058212|Vitamins|vitamins|mesh-ancestor
93059733|NCT01155700|Omalizumab|omalizumab|mesh-list
93233965|NCT02058212|Micronutrients|micronutrients|mesh-ancestor
93233966|NCT02058212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233967|NCT02058212|Antioxidants|antioxidants|mesh-ancestor
93059863|NCT03884530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93059937|NCT01261234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93233968|NCT02058212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233969|NCT02058212|Protective Agents|protective agents|mesh-ancestor
93233970|NCT02058212|Trace Elements|trace elements|mesh-ancestor
93060232|NCT00224016|Oxybutynin|oxybutynin|mesh-list
93233971|NCT02058446|Amlodipine|amlodipine|mesh-list
93233972|NCT02058446|Valsartan|valsartan|mesh-list
93233973|NCT02058446|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
93233974|NCT02058446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93233975|NCT02058446|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93233976|NCT02058446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93060404|NCT01267084|Hormones|hormones|mesh-ancestor
93233977|NCT02058446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060525|NCT03877120|Anticonvulsants|anticonvulsants|mesh-ancestor
93233978|NCT02058446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93233979|NCT02058446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93233980|NCT02058446|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060674|NCT03874156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233981|NCT02058446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93233982|NCT02058446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93233983|NCT01354405|Lanreotide|lanreotide|mesh-list
93233984|NCT01354405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93233985|NCT03363035|Enoxaparin|enoxaparin|mesh-list
93233986|NCT03363035|Rivaroxaban|rivaroxaban|mesh-list
93233987|NCT03363035|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92756166|NCT00996658|Hormones|hormones|mesh-ancestor
93233988|NCT03363035|Antithrombins|antithrombins|mesh-ancestor
93233989|NCT03363035|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93233990|NCT03363035|Protease Inhibitors|protease inhibitors|mesh-ancestor
93233991|NCT03363035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93233992|NCT03363035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93233993|NCT03363035|Anticoagulants|anticoagulants|mesh-ancestor
93233994|NCT03363035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92756379|NCT01121913|Trazodone|trazodone|mesh-list
93233995|NCT03363035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93233996|NCT02582775|Mycophenolic Acid|mycophenolic acid|mesh-list
93233997|NCT02582775|Cyclophosphamide|cyclophosphamide|mesh-list
93233998|NCT02582775|Busulfan|busulfan|mesh-list
92756531|NCT01119105|Vancomycin|vancomycin|mesh-list
93233999|NCT02582775|Fludarabine|fludarabine|mesh-list
93234000|NCT02582775|Fludarabine phosphate|fludarabine phosphate|mesh-list
93234001|NCT02582775|Tacrolimus|tacrolimus|mesh-list
93234002|NCT02582775|Thymoglobulin|thymoglobulin|mesh-list
93234003|NCT02582775|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93234004|NCT02582775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234005|NCT02582775|Immunologic Factors|immunologic factors|mesh-ancestor
93234006|NCT02582775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234007|NCT02582775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756975|NCT04319978|Hormones|hormones|mesh-ancestor
92757037|NCT04128748|Antimetabolites|antimetabolites|mesh-ancestor
93234008|NCT02582775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93234009|NCT02582775|Alkylating Agents|alkylating agents|mesh-ancestor
92757114|NCT02865460|Vitamins|vitamins|mesh-ancestor
93234010|NCT02582775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234011|NCT02582775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234012|NCT02582775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92757259|NCT01256060|Oxytocin|oxytocin|mesh-list
92757344|NCT01111539|Aripiprazole|aripiprazole|mesh-list
93234013|NCT02582775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93234014|NCT02582775|Antimetabolites|antimetabolites|mesh-ancestor
93234015|NCT02582775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757627|NCT02879097|Paclitaxel|paclitaxel|mesh-list
93234016|NCT02582775|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92757697|NCT01097421|Dopamine Agents|dopamine agents|mesh-ancestor
93234017|NCT02582775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757771|NCT01096017|Tocolytic Agents|tocolytic agents|mesh-ancestor
93234018|NCT02582775|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93234019|NCT02582775|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93234020|NCT02582775|Antitubercular Agents|antitubercular agents|mesh-ancestor
93234021|NCT02582775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234022|NCT02060552|Diacerein|diacerein|mesh-list
93234023|NCT02060552|Colchicine|colchicine|mesh-list
93234024|NCT02060552|Febuxostat|febuxostat|mesh-list
93234025|NCT02060552|Gout Suppressants|gout suppressants|mesh-ancestor
93234026|NCT02060552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758015|NCT01090011|Cetuximab|cetuximab|mesh-list
93234027|NCT02060552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234028|NCT02060552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234029|NCT02060552|Mitosis Modulators|mitosis modulators|mesh-ancestor
92758131|NCT02888327|Anesthetics|anesthetics|mesh-ancestor
93234030|NCT02060552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758208|NCT01246583|Tofacitinib|tofacitinib|mesh-list
92758278|NCT00977080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92758446|NCT00907153|Vitamin D|vitamin d|mesh-list
92758511|NCT04319705|Azithromycin|azithromycin|mesh-list
93234031|NCT02060552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234032|NCT02060552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758641|NCT04319549|Eusol|eusol|mesh-list
93234033|NCT05384574|Cholecalciferol|cholecalciferol|mesh-list
93234034|NCT05384574|Vitamin D|vitamin d|mesh-list
93234035|NCT05384574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93234036|NCT05384574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234037|NCT05384574|Vitamins|vitamins|mesh-ancestor
93234038|NCT05384574|Micronutrients|micronutrients|mesh-ancestor
92758873|NCT04937413|Protease Inhibitors|protease inhibitors|mesh-ancestor
93234039|NCT05384574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93234040|NCT04355585|Colchicine|colchicine|mesh-list
93234041|NCT04355585|Gout Suppressants|gout suppressants|mesh-ancestor
93234042|NCT04355585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234043|NCT04355585|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234044|NCT04355585|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234045|NCT04355585|Mitosis Modulators|mitosis modulators|mesh-ancestor
93234046|NCT04355585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234047|NCT04355585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234048|NCT02031744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93234049|NCT02031744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234050|NCT02031744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93234051|NCT02031744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234052|NCT02031744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234053|NCT04653389|Immunomodulating Agents|immunomodulating agents|mesh-list
92759617|NCT00973102|Estrogens|estrogens|mesh-list
93234054|NCT04653389|Immunologic Factors|immunologic factors|mesh-ancestor
92759682|NCT02842567|Disinfectants|disinfectants|mesh-ancestor
93234055|NCT04653389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234056|NCT01344395|Ketorolac|ketorolac|mesh-list
92759754|NCT00140959|Autonomic Agents|autonomic agents|mesh-ancestor
93234057|NCT01344395|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93234058|NCT01344395|Ropivacaine|ropivacaine|mesh-list
93234059|NCT01344395|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234060|NCT01344395|Anesthetics|anesthetics|mesh-ancestor
93234061|NCT01344395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234062|NCT01344395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760068|NCT00892957|Thrombin|thrombin|mesh-list
93234063|NCT01344395|Sensory System Agents|sensory system agents|mesh-ancestor
92760134|NCT00967798|Incretins|incretins|mesh-ancestor
93234064|NCT01344395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234065|NCT01344395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93234066|NCT01344395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234067|NCT01344395|Analgesics|analgesics|mesh-ancestor
93234068|NCT01344395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234069|NCT01344395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234070|NCT01344395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93234071|NCT01344395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760263|NCT05170672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760339|NCT04285528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93234072|NCT01344395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234073|NCT02291445|Peppermint oil|peppermint oil|mesh-list
93234074|NCT02291445|Antiemetics|antiemetics|mesh-ancestor
93234075|NCT02291445|Autonomic Agents|autonomic agents|mesh-ancestor
92760491|NCT01227395|Azithromycin|azithromycin|mesh-list
93234076|NCT02291445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234077|NCT02291445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234078|NCT02291445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234079|NCT02291445|Parasympatholytics|parasympatholytics|mesh-ancestor
93234080|NCT02062112|Laxatives|laxatives|mesh-list
93234081|NCT02062112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234082|NCT01342289|Mycophenolic Acid|mycophenolic acid|mesh-list
93234083|NCT01342289|Cyclophosphamide|cyclophosphamide|mesh-list
93234084|NCT01342289|Fludarabine|fludarabine|mesh-list
93234085|NCT01342289|Tacrolimus|tacrolimus|mesh-list
93234086|NCT01342289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234087|NCT01342289|Immunologic Factors|immunologic factors|mesh-ancestor
92761078|NCT04241653|Anesthetics, General|anesthetics, general|mesh-ancestor
93234088|NCT01342289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761153|NCT02825095|Lidocaine|lidocaine|mesh-list
93234089|NCT01342289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234090|NCT01342289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93234091|NCT01342289|Alkylating Agents|alkylating agents|mesh-ancestor
93234092|NCT01342289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234093|NCT01342289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234094|NCT01342289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93234095|NCT01342289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93234096|NCT01342289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234097|NCT01342289|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93234098|NCT01342289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93234099|NCT01342289|Antitubercular Agents|antitubercular agents|mesh-ancestor
93234100|NCT01342289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234101|NCT01342289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234102|NCT02062190|Resveratrol|resveratrol|mesh-list
93234103|NCT02062190|Antioxidants|antioxidants|mesh-ancestor
93234104|NCT02062190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234105|NCT02062190|Protective Agents|protective agents|mesh-ancestor
93234106|NCT02062190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234107|NCT02062190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234108|NCT02062190|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93234109|NCT01354483|Methylprednisolone|methylprednisolone|mesh-list
92762181|NCT00946192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762253|NCT04081831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234110|NCT01354483|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93234111|NCT01354483|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93234112|NCT01354483|Prednisolone|prednisolone|mesh-list
93234113|NCT01354483|Prednisolone acetate|prednisolone acetate|mesh-list
92906146|NCT00705042|Etanercept|etanercept|mesh-list
93234114|NCT01354483|Lithium Carbonate|lithium carbonate|mesh-list
92762551|NCT02795299|Methotrexate|methotrexate|mesh-list
92762628|NCT04233463|Glucocorticoids|glucocorticoids|mesh-ancestor
93234115|NCT01354483|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93234116|NCT01354483|Prednisolone phosphate|prednisolone phosphate|mesh-list
93234117|NCT01354483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234118|NCT01354483|Antiemetics|antiemetics|mesh-ancestor
93234119|NCT01354483|Autonomic Agents|autonomic agents|mesh-ancestor
93234120|NCT01354483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762855|NCT03116425|Vitamins|vitamins|mesh-ancestor
93234121|NCT01354483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234122|NCT01354483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234123|NCT01354483|Glucocorticoids|glucocorticoids|mesh-ancestor
93234124|NCT01354483|Hormones|hormones|mesh-ancestor
92763212|NCT04229407|Vitamins|vitamins|mesh-list
93234125|NCT01354483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763361|NCT05338489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234126|NCT01354483|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93234127|NCT01354483|Protective Agents|protective agents|mesh-ancestor
92763435|NCT02775877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234128|NCT01354483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234129|NCT01354483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234130|NCT01354483|Antidepressive Agents|antidepressive agents|mesh-ancestor
93234131|NCT01354483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234132|NCT01354483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234133|NCT01354483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234134|NCT01354483|Antimanic Agents|antimanic agents|mesh-ancestor
93234135|NCT01354483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93234136|NCT01354483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234137|NCT03618264|Dexamethasone|dexamethasone|mesh-list
93234138|NCT03618264|Ropivacaine|ropivacaine|mesh-list
93234139|NCT03618264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764026|NCT02762617|Tenofovir|tenofovir|mesh-list
93234140|NCT03618264|Antiemetics|antiemetics|mesh-ancestor
93234141|NCT03618264|Autonomic Agents|autonomic agents|mesh-ancestor
93234142|NCT03618264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234143|NCT03618264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764171|NCT02757469|Diuretics|diuretics|mesh-ancestor
93234144|NCT03618264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234145|NCT03618264|Glucocorticoids|glucocorticoids|mesh-ancestor
93234146|NCT03618264|Hormones|hormones|mesh-ancestor
93234147|NCT03618264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234148|NCT03618264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234149|NCT03618264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234150|NCT03618264|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234151|NCT03618264|Anesthetics|anesthetics|mesh-ancestor
93234152|NCT03618264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234153|NCT03618264|Sensory System Agents|sensory system agents|mesh-ancestor
93234154|NCT03617016|Domperidone|domperidone|mesh-list
93234155|NCT03617016|Antiemetics|antiemetics|mesh-ancestor
93234156|NCT03617016|Autonomic Agents|autonomic agents|mesh-ancestor
93234157|NCT03617016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764309|NCT02199184|Glucocorticoids|glucocorticoids|mesh-ancestor
93234158|NCT03617016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234159|NCT03617016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764382|NCT04268524|Miltefosine|miltefosine|mesh-list
93234160|NCT03617016|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93234161|NCT03617016|Dopamine Agents|dopamine agents|mesh-ancestor
93234162|NCT03617016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764530|NCT01185366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92764606|NCT02855788|Leucovorin|leucovorin|mesh-list
93234163|NCT03617016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234164|NCT02060786|Clopidogrel|clopidogrel|mesh-list
93234165|NCT02060786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93234166|NCT02060786|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93234167|NCT02060786|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93234168|NCT02060786|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92764825|NCT05380960|Hemostatics|hemostatics|mesh-ancestor
93234169|NCT02060786|Purinergic Agents|purinergic agents|mesh-ancestor
93234170|NCT02060786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234171|NCT02060786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234172|NCT02060786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764967|NCT01162122|Vaccines|vaccines|mesh-list
92765043|NCT01160484|Lenalidomide|lenalidomide|mesh-list
93234173|NCT03153137|Macitentan|macitentan|mesh-list
93234174|NCT03153137|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93234175|NCT03153137|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93234176|NCT03153137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234177|NCT03153137|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93234178|NCT03617484|Bortezomib|bortezomib|mesh-list
93234179|NCT03617484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234180|NCT01344473|Caseins|caseins|mesh-list
93234181|NCT01344473|Chelating Agents|chelating agents|mesh-ancestor
93234182|NCT01344473|Sequestering Agents|sequestering agents|mesh-ancestor
92765482|NCT02750059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93234183|NCT01344473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234184|NCT03618108|Azithromycin|azithromycin|mesh-list
93234185|NCT03618108|Doxycycline|doxycycline|mesh-list
93234186|NCT03618108|Rifabutin|rifabutin|mesh-list
93234187|NCT03618108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906219|NCT04152161|BCG Vaccine|bcg vaccine|mesh-list
93234189|NCT03618108|Antimalarials|antimalarials|mesh-ancestor
92765850|NCT02741947|Dopamine Agents|dopamine agents|mesh-ancestor
93234190|NCT03618108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93234191|NCT03618108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93234192|NCT03618108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93234193|NCT03618108|Antitubercular Agents|antitubercular agents|mesh-ancestor
93234194|NCT01342601|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93234195|NCT01342601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93234196|NCT02236728|Pramipexole|pramipexole|mesh-list
93234197|NCT02236728|Antioxidants|antioxidants|mesh-ancestor
93234198|NCT02236728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234199|NCT02236728|Protective Agents|protective agents|mesh-ancestor
93234200|NCT02236728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234201|NCT02236728|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93234202|NCT02236728|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93234203|NCT02236728|Dopamine Agonists|dopamine agonists|mesh-ancestor
93234204|NCT02236728|Dopamine Agents|dopamine agents|mesh-ancestor
93234205|NCT02236728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234206|NCT03136861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93234207|NCT03136861|Immunologic Factors|immunologic factors|mesh-ancestor
93234208|NCT03136861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234209|NCT01342679|Dasatinib|dasatinib|mesh-list
93234210|NCT01342679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234211|NCT01342679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93234212|NCT01342679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234213|NCT01342679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234214|NCT01342835|Propofol|propofol|mesh-list
93234215|NCT01342835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93234216|NCT01342835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234217|NCT01342835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766221|NCT02721433|Denosumab|denosumab|mesh-list
93234218|NCT01342835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93234219|NCT01342835|Anesthetics, General|anesthetics, general|mesh-ancestor
93234220|NCT01342835|Anesthetics|anesthetics|mesh-ancestor
93234221|NCT01344863|Trastuzumab|trastuzumab|mesh-list
93234222|NCT01344863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234223|NCT01344863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234224|NCT03139279|Dexmedetomidine|dexmedetomidine|mesh-list
93234225|NCT03139279|Propofol|propofol|mesh-list
93234226|NCT03139279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93234227|NCT03139279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234228|NCT03139279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234229|NCT03139279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234230|NCT03139279|Analgesics|analgesics|mesh-ancestor
93234231|NCT03139279|Sensory System Agents|sensory system agents|mesh-ancestor
93234232|NCT03139279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234233|NCT03139279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93234234|NCT03139279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93234235|NCT03139279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93234236|NCT03139279|Adrenergic Agents|adrenergic agents|mesh-ancestor
93234237|NCT03139279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234238|NCT03139279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234239|NCT03139279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93234240|NCT03139279|Anesthetics, General|anesthetics, general|mesh-ancestor
93234241|NCT03139279|Anesthetics|anesthetics|mesh-ancestor
93234242|NCT02562599|Raltitrexed|raltitrexed|mesh-list
93234243|NCT02562599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234244|NCT02562599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93234245|NCT02562599|Antimetabolites|antimetabolites|mesh-ancestor
93234246|NCT02562599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234247|NCT02562599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93234248|NCT02562599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234249|NCT03311958|Nivolumab|nivolumab|mesh-list
93234250|NCT03311958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766466|NCT02724163|Cytarabine|cytarabine|mesh-list
93234251|NCT03311958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234252|NCT03311958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93234253|NCT03311958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234254|NCT02225405|Cisplatin|cisplatin|mesh-list
93234255|NCT02225405|Docetaxel|docetaxel|mesh-list
93234256|NCT02225405|Nintedanib|nintedanib|mesh-list
93234257|NCT02225405|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93234258|NCT02225405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234259|NCT02225405|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234260|NCT02225405|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234261|NCT02225405|Mitosis Modulators|mitosis modulators|mesh-ancestor
93234262|NCT02225405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234263|NCT02225405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93234264|NCT02225405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234265|NCT01370642|Ribavirin|ribavirin|mesh-list
93234266|NCT01370642|Antimetabolites|antimetabolites|mesh-ancestor
93234267|NCT01370642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234268|NCT01370642|Antiviral Agents|antiviral agents|mesh-ancestor
93234269|NCT01370642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234270|NCT03138967|Glycopyrrolate|glycopyrrolate|mesh-list
93234271|NCT03138967|Bromides|bromides|mesh-list
93234272|NCT03138967|Rocuronium|rocuronium|mesh-list
93234273|NCT03138967|Neostigmine|neostigmine|mesh-list
93234274|NCT03138967|Anticonvulsants|anticonvulsants|mesh-ancestor
93234275|NCT03138967|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93234276|NCT03138967|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93234277|NCT03138967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93234278|NCT03138967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234279|NCT03138967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234280|NCT03138967|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93234281|NCT03138967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234282|NCT03138967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234283|NCT03138967|Cholinergic Agents|cholinergic agents|mesh-ancestor
93234284|NCT03138967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234285|NCT03138967|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93234286|NCT03138967|Autonomic Agents|autonomic agents|mesh-ancestor
93234287|NCT03138967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93234288|NCT03138967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93234289|NCT03138967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92767048|NCT00603772|Tretinoin|tretinoin|mesh-list
93234290|NCT01547117|Carbon Monoxide|carbon monoxide|mesh-list
93234291|NCT01547117|Antimetabolites|antimetabolites|mesh-ancestor
93234292|NCT01547117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234293|NCT01547117|Gasotransmitters|gasotransmitters|mesh-ancestor
92767332|NCT00935818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92767409|NCT05244031|Analgesics, Opioid|analgesics, opioid|mesh-list
93234294|NCT01547117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767558|NCT05198791|Diuretics|diuretics|mesh-ancestor
93234295|NCT01547117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234296|NCT01358383|Naproxen|naproxen|mesh-list
93234297|NCT01358383|Esomeprazole|esomeprazole|mesh-list
93234298|NCT01358383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93234299|NCT01358383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767856|NCT04074187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767937|NCT02118727|Memantine|memantine|mesh-list
93234300|NCT01358383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93234301|NCT01358383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234302|NCT01358383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234303|NCT01358383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768148|NCT00405613|Aspirin|aspirin|mesh-list
93234304|NCT01358383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234305|NCT01358383|Analgesics|analgesics|mesh-ancestor
92768295|NCT02691949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768369|NCT02494141|Sensory System Agents|sensory system agents|mesh-ancestor
93234306|NCT01358383|Sensory System Agents|sensory system agents|mesh-ancestor
93234307|NCT01358383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234308|NCT01358383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234309|NCT01358383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234310|NCT01358383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234311|NCT01358383|Gout Suppressants|gout suppressants|mesh-ancestor
93234312|NCT01358383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93234313|NCT03560336|Liraglutide|liraglutide|mesh-list
93234314|NCT03560336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93234315|NCT03560336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234316|NCT03560336|Incretins|incretins|mesh-ancestor
93234317|NCT03560336|Hormones|hormones|mesh-ancestor
92768657|NCT05323201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93234318|NCT03560336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234319|NCT03136159|Anti-Infective Agents|anti-infective agents|mesh-list
93234320|NCT03136159|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93234321|NCT03615768|Clindamycin|clindamycin|mesh-list
93234322|NCT03615768|Clindamycin palmitate|clindamycin palmitate|mesh-list
93234323|NCT03615768|Clindamycin phosphate|clindamycin phosphate|mesh-list
93234324|NCT03615768|Adapalene|adapalene|mesh-list
93234325|NCT03615768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234326|NCT03615768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234327|NCT03615768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93234328|NCT03615768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234329|NCT03615768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234330|NCT03615768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93234331|NCT03615768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234332|NCT03615768|Analgesics|analgesics|mesh-ancestor
93234333|NCT03615768|Sensory System Agents|sensory system agents|mesh-ancestor
93234334|NCT03615768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234335|NCT03615768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769233|NCT04210765|Clomiphene|clomiphene|mesh-list
93234336|NCT03615768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234337|NCT03615768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234338|NCT03615768|Dermatologic Agents|dermatologic agents|mesh-ancestor
93234339|NCT02061644|Anesthetics|anesthetics|mesh-list
92769529|NCT02697331|Progesterone|progesterone|mesh-list
93234340|NCT02061644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234341|NCT02061644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234342|NCT03793400|Bevacizumab|bevacizumab|mesh-list
93234343|NCT03793400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234344|NCT03793400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234345|NCT03793400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93234346|NCT03793400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93234347|NCT03793400|Growth Substances|growth substances|mesh-ancestor
93234348|NCT03793400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234349|NCT03793400|Growth Inhibitors|growth inhibitors|mesh-ancestor
93234350|NCT01318369|Diazepam|diazepam|mesh-list
93234351|NCT01318369|Dronabinol|dronabinol|mesh-list
93234352|NCT01318369|Hallucinogens|hallucinogens|mesh-ancestor
93234353|NCT01318369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234354|NCT01318369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234355|NCT01318369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234356|NCT01318369|Analgesics|analgesics|mesh-ancestor
93234357|NCT01318369|Sensory System Agents|sensory system agents|mesh-ancestor
93234358|NCT01318369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234359|NCT01318369|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93234360|NCT01318369|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93234361|NCT01318369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234362|NCT01318369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234363|NCT01318369|Hormones|hormones|mesh-ancestor
93234364|NCT01318369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234365|NCT01318369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93234366|NCT01318369|Anticonvulsants|anticonvulsants|mesh-ancestor
93234367|NCT01318369|Antiemetics|antiemetics|mesh-ancestor
93234368|NCT01318369|Autonomic Agents|autonomic agents|mesh-ancestor
93234369|NCT01318369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234370|NCT01318369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93234371|NCT01318369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234372|NCT01318369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93234373|NCT01318369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93234374|NCT01318369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93234375|NCT01318369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93234376|NCT01318369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93234377|NCT01318369|Anesthetics, General|anesthetics, general|mesh-ancestor
93234378|NCT01318369|Anesthetics|anesthetics|mesh-ancestor
93234379|NCT01318369|GABA Modulators|gaba modulators|mesh-ancestor
93234380|NCT01318369|GABA Agents|gaba agents|mesh-ancestor
93234381|NCT03479684|Warfarin|warfarin|mesh-list
93234382|NCT03479684|Anticoagulants|anticoagulants|mesh-ancestor
93234383|NCT03614052|Tamsulosin|tamsulosin|mesh-list
93234384|NCT03614052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93234385|NCT03614052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93234386|NCT03614052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93234387|NCT03614052|Adrenergic Agents|adrenergic agents|mesh-ancestor
93234388|NCT03614052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234389|NCT03614052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234390|NCT03614052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234391|NCT03614052|Urological Agents|urological agents|mesh-ancestor
93234392|NCT02062892|Sirolimus|sirolimus|mesh-list
93234393|NCT02062892|Everolimus|everolimus|mesh-list
93234394|NCT02062892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93234395|NCT02062892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93234396|NCT02062892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234397|NCT02062892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234398|NCT02062892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234399|NCT02062892|Immunologic Factors|immunologic factors|mesh-ancestor
93234400|NCT02062892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234401|NCT02062892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234402|NCT02062892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234403|NCT02062892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234404|NCT02062892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93234405|NCT02062892|Antifungal Agents|antifungal agents|mesh-ancestor
93234406|NCT02063360|Ritonavir|ritonavir|mesh-list
93234407|NCT02063360|Darunavir|darunavir|mesh-list
93234408|NCT02063360|Fostemsavir|fostemsavir|mesh-list
93234409|NCT02063360|Etravirine|etravirine|mesh-list
92770365|NCT00629187|Alkylating Agents|alkylating agents|mesh-ancestor
92770436|NCT01196429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234410|NCT02063360|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92770512|NCT04124562|Sensory System Agents|sensory system agents|mesh-ancestor
93234411|NCT02063360|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93234412|NCT02063360|Protease Inhibitors|protease inhibitors|mesh-ancestor
93234413|NCT02063360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906434|NCT00678431|Resveratrol|resveratrol|mesh-list
93234414|NCT02063360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234415|NCT02063360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93234416|NCT02063360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93234417|NCT02063360|Antiviral Agents|antiviral agents|mesh-ancestor
93234418|NCT02063360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234419|NCT02063360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93234420|NCT02063360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93234421|NCT02063360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93234422|NCT02063360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93234423|NCT02063360|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93234424|NCT02063360|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93234425|NCT03614832|Clopidogrel|clopidogrel|mesh-list
93234426|NCT03614832|Ticagrelor|ticagrelor|mesh-list
93234427|NCT03614832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93234428|NCT03614832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93234429|NCT03614832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93234430|NCT03614832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93234431|NCT03614832|Purinergic Agents|purinergic agents|mesh-ancestor
93234432|NCT03614832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234433|NCT03614832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234434|NCT03614832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234435|NCT05210595|Clopidogrel|clopidogrel|mesh-list
93234436|NCT05210595|Ticagrelor|ticagrelor|mesh-list
93234437|NCT05210595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93234438|NCT05210595|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93234439|NCT05210595|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93234440|NCT05210595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93234441|NCT05210595|Purinergic Agents|purinergic agents|mesh-ancestor
93234442|NCT05210595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770865|NCT01152996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770931|NCT01173120|Abatacept|abatacept|mesh-list
93234443|NCT05210595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234444|NCT05210595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234445|NCT02061800|Methylprednisolone|methylprednisolone|mesh-list
92771152|NCT01147068|Hemagglutinins|hemagglutinins|mesh-list
92771225|NCT00640705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771301|NCT00931918|Alkylating Agents|alkylating agents|mesh-ancestor
93234446|NCT02061800|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93234447|NCT02061800|Cyclophosphamide|cyclophosphamide|mesh-list
93234448|NCT02061800|Melphalan|melphalan|mesh-list
93234449|NCT02061800|Busulfan|busulfan|mesh-list
92771500|NCT00975195|Xhance|xhance|mesh-list
93234450|NCT02061800|Thiotepa|thiotepa|mesh-list
93234451|NCT02061800|Fludarabine|fludarabine|mesh-list
93234452|NCT02061800|Alemtuzumab|alemtuzumab|mesh-list
93234453|NCT02061800|Tacrolimus|tacrolimus|mesh-list
93234454|NCT02061800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234455|NCT02061800|Immunologic Factors|immunologic factors|mesh-ancestor
93234456|NCT02061800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234457|NCT02061800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771820|NCT02672527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234458|NCT02061800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93234459|NCT02061800|Alkylating Agents|alkylating agents|mesh-ancestor
93234460|NCT02061800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234461|NCT02061800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772142|NCT05826964|Elafin|elafin|mesh-list
93234462|NCT02061800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93234463|NCT02061800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92772197|NCT05746442|Nicotine|nicotine|mesh-list
93234464|NCT02061800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234465|NCT02061800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234466|NCT02061800|Antiemetics|antiemetics|mesh-ancestor
93234467|NCT02061800|Autonomic Agents|autonomic agents|mesh-ancestor
93234468|NCT02061800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234469|NCT02061800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92772588|NCT05020860|Paclitaxel|paclitaxel|mesh-list
93234470|NCT02061800|Glucocorticoids|glucocorticoids|mesh-ancestor
93234471|NCT02061800|Hormones|hormones|mesh-ancestor
93234472|NCT02061800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234473|NCT02061800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93234474|NCT02061800|Protective Agents|protective agents|mesh-ancestor
93234475|NCT02061800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234476|NCT02061800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234477|NCT01350817|Docetaxel|docetaxel|mesh-list
93234478|NCT01350817|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93234479|NCT01350817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234480|NCT01350817|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234481|NCT01350817|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234482|NCT01350817|Mitosis Modulators|mitosis modulators|mesh-ancestor
93234483|NCT01350817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234484|NCT01350817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93234485|NCT01350817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234486|NCT01986075|Amphetamine|amphetamine|mesh-list
93234487|NCT01986075|Adderall|adderall|mesh-list
93234488|NCT01986075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92773526|NCT00077129|Paclitaxel|paclitaxel|mesh-list
93234489|NCT01986075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234490|NCT01986075|Sympathomimetics|sympathomimetics|mesh-ancestor
93234491|NCT01986075|Autonomic Agents|autonomic agents|mesh-ancestor
93234492|NCT01986075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234493|NCT01986075|Dopamine Agents|dopamine agents|mesh-ancestor
93234494|NCT01986075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234495|NCT01986075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773898|NCT04287387|Incretins|incretins|mesh-ancestor
93234496|NCT01986075|Adrenergic Agents|adrenergic agents|mesh-ancestor
93234497|NCT01986075|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92774045|NCT02670655|Anesthetics|anesthetics|mesh-ancestor
93234498|NCT01986075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92774193|NCT02668159|Micronutrients|micronutrients|mesh-ancestor
93234499|NCT01986075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92774340|NCT02667535|Diuretics|diuretics|mesh-ancestor
93234500|NCT01986075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93234501|NCT02061878|Bexarotene|bexarotene|mesh-list
92774489|NCT00646009|Glucocorticoids|glucocorticoids|mesh-ancestor
93234502|NCT02061878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234503|NCT00394355|Fluticasone|fluticasone|mesh-list
93234504|NCT00394355|Xhance|xhance|mesh-list
93234505|NCT00394355|Mometasone Furoate|mometasone furoate|mesh-list
93234506|NCT00394355|Montelukast|montelukast|mesh-list
93234507|NCT00394355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234508|NCT00394355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93234509|NCT00394355|Autonomic Agents|autonomic agents|mesh-ancestor
93234510|NCT00394355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774938|NCT04895761|Letrozole|letrozole|mesh-list
93234511|NCT00394355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234512|NCT00394355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93234513|NCT00394355|Respiratory System Agents|respiratory system agents|mesh-ancestor
93234514|NCT00394355|Dermatologic Agents|dermatologic agents|mesh-ancestor
93234515|NCT00394355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92775080|NCT00625248|Anticoagulants|anticoagulants|mesh-list
93234516|NCT00394355|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93234517|NCT00394355|Hormone Antagonists|hormone antagonists|mesh-ancestor
93234518|NCT00394355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775301|NCT00648505|Metformin|metformin|mesh-list
93234519|NCT00394355|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93234520|NCT00394355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93234521|NCT00394355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234522|NCT02797808|Sertraline|sertraline|mesh-list
93234523|NCT02797808|Antidepressive Agents|antidepressive agents|mesh-ancestor
93234524|NCT02797808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234525|NCT02797808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93234526|NCT02797808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775665|NCT02662309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234527|NCT02797808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775741|NCT00649051|Metolazone|metolazone|mesh-list
93234528|NCT02797808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234529|NCT02797808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234530|NCT02797808|Serotonin Agents|serotonin agents|mesh-ancestor
93234531|NCT02797808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234532|NCT02796560|Travoprost|travoprost|mesh-list
93234533|NCT02796560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93234534|NCT01316081|Vitamins|vitamins|mesh-list
93234535|NCT01316081|Ascorbic Acid|ascorbic acid|mesh-list
93234536|NCT01316081|Vitamin E|vitamin e|mesh-list
93234537|NCT01316081|Tocopherols|tocopherols|mesh-list
93234538|NCT01316081|Tocotrienols|tocotrienols|mesh-list
93234539|NCT01316081|alpha-Tocopherol|alpha-tocopherol|mesh-list
93234540|NCT01316081|Micronutrients|micronutrients|mesh-ancestor
92776174|NCT02651311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93234541|NCT01316081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234542|NCT01316081|Antioxidants|antioxidants|mesh-ancestor
93234543|NCT01316081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234544|NCT01316081|Protective Agents|protective agents|mesh-ancestor
93234545|NCT00958737|Leucovorin|leucovorin|mesh-list
93234546|NCT00958737|Fluorouracil|fluorouracil|mesh-list
93234547|NCT00958737|Capecitabine|capecitabine|mesh-list
93234548|NCT00958737|Oxaliplatin|oxaliplatin|mesh-list
93234549|NCT00958737|Calcium|calcium|mesh-list
93234550|NCT00958737|Levoleucovorin|levoleucovorin|mesh-list
93234551|NCT00958737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93234552|NCT00958737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776910|NCT04329442|Tenofovir|tenofovir|mesh-list
93234553|NCT00958737|Antimetabolites|antimetabolites|mesh-ancestor
92776986|NCT00957801|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93234554|NCT00958737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234555|NCT00958737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777358|NCT01165307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777432|NCT04282941|Analgesics|analgesics|mesh-ancestor
93234556|NCT00958737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234557|NCT00958737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234558|NCT00958737|Immunologic Factors|immunologic factors|mesh-ancestor
93234559|NCT00958737|Antidotes|antidotes|mesh-ancestor
93234560|NCT00958737|Protective Agents|protective agents|mesh-ancestor
93234561|NCT00958737|Vitamin B Complex|vitamin b complex|mesh-ancestor
93234562|NCT00958737|Vitamins|vitamins|mesh-ancestor
93234563|NCT00958737|Micronutrients|micronutrients|mesh-ancestor
93234564|NCT02062034|Vitamins|vitamins|mesh-list
93234565|NCT02062034|Vitamin E|vitamin e|mesh-list
93234566|NCT02062034|Coenzyme Q10|coenzyme q10|mesh-list
93234567|NCT02062034|Ubiquinone|ubiquinone|mesh-list
92777948|NCT01605253|Eszopiclone|eszopiclone|mesh-list
93234569|NCT02062034|Micronutrients|micronutrients|mesh-ancestor
93234570|NCT02062034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778023|NCT00883129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778098|NCT04202536|Tenofovir|tenofovir|mesh-list
93234571|NCT02062034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234572|NCT02062034|Protective Agents|protective agents|mesh-ancestor
93234573|NCT00344487|Ritonavir|ritonavir|mesh-list
93234574|NCT00344487|Lopinavir|lopinavir|mesh-list
93234575|NCT00344487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92778322|NCT02848612|Heparin|heparin|mesh-list
93234576|NCT00344487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93234577|NCT00344487|Protease Inhibitors|protease inhibitors|mesh-ancestor
93234578|NCT00344487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234579|NCT00344487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234580|NCT00344487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93234581|NCT00344487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93234582|NCT00344487|Antiviral Agents|antiviral agents|mesh-ancestor
92778615|NCT00952341|Glucocorticoids|glucocorticoids|mesh-ancestor
93234583|NCT00344487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778687|NCT02852577|Anticonvulsants|anticonvulsants|mesh-ancestor
93234584|NCT00344487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92778758|NCT03936790|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234585|NCT00344487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93234586|NCT03789968|Tenofovir|tenofovir|mesh-list
93234587|NCT03789968|Emtricitabine|emtricitabine|mesh-list
92778833|NCT02642419|Purinergic Agents|purinergic agents|mesh-ancestor
93234588|NCT03789968|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93234589|NCT03789968|Antiviral Agents|antiviral agents|mesh-ancestor
93234590|NCT03789968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234591|NCT03789968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93234592|NCT03789968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92778902|NCT00656773|Analgesics|analgesics|mesh-ancestor
93234593|NCT03789968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234594|NCT03789968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234595|NCT03789968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92779050|NCT00884221|Menotropins|menotropins|mesh-list
92779136|NCT00157924|Ezetimibe|ezetimibe|mesh-list
92779196|NCT02841982|Narcotics|narcotics|mesh-ancestor
93234596|NCT03789968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93234597|NCT05089643|Capecitabine|capecitabine|mesh-list
92779271|NCT01212770|Analgesics|analgesics|mesh-ancestor
92779352|NCT02633683|Antimanic Agents|antimanic agents|mesh-ancestor
93234598|NCT05089643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93234599|NCT05089643|Antimetabolites|antimetabolites|mesh-ancestor
93234600|NCT05089643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779500|NCT02636101|Betamethasone|betamethasone|mesh-list
93234601|NCT05089643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234602|NCT02871492|Acyclovir|acyclovir|mesh-list
93234603|NCT02871492|Pritelivir|pritelivir|mesh-list
93234604|NCT02871492|Antiviral Agents|antiviral agents|mesh-ancestor
93234605|NCT02871492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234606|NCT02871492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779931|NCT00666601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234607|NCT02871492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234608|NCT03613974|Lidocaine|lidocaine|mesh-list
93234609|NCT03613974|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234610|NCT03613974|Anesthetics|anesthetics|mesh-ancestor
93234611|NCT03613974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234612|NCT03613974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234613|NCT03613974|Sensory System Agents|sensory system agents|mesh-ancestor
93234614|NCT03613974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234615|NCT03613974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93234616|NCT03613974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93234617|NCT03613974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93234618|NCT03613974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93234619|NCT03613974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234620|NCT01343225|Ritonavir|ritonavir|mesh-list
93234621|NCT01343225|Darunavir|darunavir|mesh-list
93234622|NCT01343225|Raltegravir Potassium|raltegravir potassium|mesh-list
93234623|NCT01343225|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93234624|NCT01343225|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93234625|NCT01343225|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93234626|NCT01343225|Protease Inhibitors|protease inhibitors|mesh-ancestor
93234627|NCT01343225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234628|NCT01343225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234629|NCT01343225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93234630|NCT01343225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93234631|NCT01343225|Antiviral Agents|antiviral agents|mesh-ancestor
93234632|NCT01343225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234633|NCT01343225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93234634|NCT01343225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93234635|NCT01343225|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93234636|NCT01343225|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93234637|NCT01343225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93234638|NCT01343225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93234639|NCT05208879|Carotenoids|carotenoids|mesh-list
93234640|NCT05208879|Antioxidants|antioxidants|mesh-ancestor
93234641|NCT05208879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234643|NCT05208879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234644|NCT04739865|Psilocybin|psilocybin|mesh-list
93234645|NCT04739865|Hallucinogens|hallucinogens|mesh-ancestor
93234646|NCT04739865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234647|NCT04739865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234648|NCT01370408|Dexamethasone|dexamethasone|mesh-list
93234649|NCT01370408|Ondansetron|ondansetron|mesh-list
93234650|NCT01370408|Palonosetron|palonosetron|mesh-list
93234651|NCT01370408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234652|NCT01370408|Antiemetics|antiemetics|mesh-ancestor
93234653|NCT01370408|Autonomic Agents|autonomic agents|mesh-ancestor
93234654|NCT01370408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234655|NCT01370408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234656|NCT01370408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234657|NCT01370408|Glucocorticoids|glucocorticoids|mesh-ancestor
93234658|NCT01370408|Hormones|hormones|mesh-ancestor
93234659|NCT01370408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234660|NCT01370408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234661|NCT01370408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234662|NCT01370408|Antipruritics|antipruritics|mesh-ancestor
93234663|NCT01370408|Dermatologic Agents|dermatologic agents|mesh-ancestor
93234664|NCT01370408|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93234665|NCT01370408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93234666|NCT01370408|Serotonin Agents|serotonin agents|mesh-ancestor
93234667|NCT01370408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234668|NCT01370408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234669|NCT04769388|Carboplatin|carboplatin|mesh-list
93234670|NCT04769388|Pemetrexed|pemetrexed|mesh-list
93234671|NCT04769388|Osimertinib|osimertinib|mesh-list
93234672|NCT04769388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234673|NCT04769388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234674|NCT04769388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234675|NCT04769388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93234676|NCT04769388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93234677|NCT04769388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93234678|NCT03294109|Bupivacaine|bupivacaine|mesh-list
93234679|NCT03294109|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234680|NCT03294109|Anesthetics|anesthetics|mesh-ancestor
93234681|NCT03294109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234682|NCT03294109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234683|NCT03294109|Sensory System Agents|sensory system agents|mesh-ancestor
93234684|NCT03294109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234685|NCT01345643|Chrysarobin|chrysarobin|mesh-list
93234686|NCT01345643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93234687|NCT01345643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234688|NCT01345643|Analgesics|analgesics|mesh-ancestor
93234689|NCT01345643|Sensory System Agents|sensory system agents|mesh-ancestor
93234690|NCT01345643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780235|NCT00670345|Hemostatics|hemostatics|mesh-ancestor
93234691|NCT01345643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234692|NCT01345643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234693|NCT01345643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234694|NCT02065466|Paclitaxel|paclitaxel|mesh-list
93234695|NCT02065466|Bevacizumab|bevacizumab|mesh-list
93234696|NCT02065466|Temozolomide|temozolomide|mesh-list
93234697|NCT02065466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93234698|NCT02065466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234699|NCT02065466|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234700|NCT02065466|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234701|NCT02065466|Mitosis Modulators|mitosis modulators|mesh-ancestor
93234702|NCT02065466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234703|NCT02065466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234704|NCT02065466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93234705|NCT02065466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93234706|NCT02065466|Growth Substances|growth substances|mesh-ancestor
93234707|NCT02065466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425446|NCT01532856|Prednisone|prednisone|mesh-list
93234708|NCT02065466|Growth Inhibitors|growth inhibitors|mesh-ancestor
92780438|NCT01185821|Siponimod|siponimod|mesh-list
93234709|NCT02065466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93234710|NCT02065466|Alkylating Agents|alkylating agents|mesh-ancestor
93234711|NCT03446040|Nivolumab|nivolumab|mesh-list
93234712|NCT03446040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234713|NCT03446040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234714|NCT03446040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93234715|NCT03446040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234716|NCT05208801|Morphine|morphine|mesh-list
93234717|NCT05208801|Bupivacaine|bupivacaine|mesh-list
93234718|NCT05208801|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234719|NCT05208801|Anesthetics|anesthetics|mesh-ancestor
93234720|NCT05208801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780510|NCT00633490|Apatinib|apatinib|mesh-list
93234721|NCT05208801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234722|NCT05208801|Sensory System Agents|sensory system agents|mesh-ancestor
93234723|NCT05208801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234724|NCT05208801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93234725|NCT05208801|Narcotics|narcotics|mesh-ancestor
93234726|NCT05208801|Analgesics|analgesics|mesh-ancestor
93234727|NCT02064140|Rocuronium|rocuronium|mesh-list
93234728|NCT02064140|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93234729|NCT02064140|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93234730|NCT02064140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93234731|NCT02064140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234732|NCT02064140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234733|NCT05190627|Loratadine|loratadine|mesh-list
93234734|NCT05190627|Sirolimus|sirolimus|mesh-list
93234735|NCT05190627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234736|NCT05190627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234737|NCT05190627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93234738|NCT05190627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234739|NCT05190627|Antifungal Agents|antifungal agents|mesh-ancestor
93234740|NCT05190627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93234741|NCT05190627|Immunologic Factors|immunologic factors|mesh-ancestor
93234742|NCT05190627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234743|NCT05190627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234744|NCT05190627|Antipruritics|antipruritics|mesh-ancestor
93234745|NCT05190627|Dermatologic Agents|dermatologic agents|mesh-ancestor
93234746|NCT05190627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93234747|NCT05190627|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93234748|NCT05190627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93234749|NCT05190627|Histamine Antagonists|histamine antagonists|mesh-ancestor
93234750|NCT05190627|Histamine Agents|histamine agents|mesh-ancestor
93234751|NCT05190627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234752|NCT02064218|Antihypertensive Agents|antihypertensive agents|mesh-list
93234753|NCT01343303|Naproxen|naproxen|mesh-list
93234754|NCT01343303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93234755|NCT01343303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234756|NCT01343303|Analgesics|analgesics|mesh-ancestor
93234757|NCT01343303|Sensory System Agents|sensory system agents|mesh-ancestor
93234758|NCT01343303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234759|NCT01343303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234760|NCT01343303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234761|NCT01343303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234762|NCT01343303|Gout Suppressants|gout suppressants|mesh-ancestor
93234763|NCT01343303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93234764|NCT01343303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234765|NCT01343303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234766|NCT01343381|Heparin|heparin|mesh-list
93234767|NCT01343381|Calcium heparin|calcium heparin|mesh-list
93234768|NCT01343381|Anticoagulants|anticoagulants|mesh-ancestor
93234769|NCT01343381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93234770|NCT01343381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93234771|NCT01343381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234772|NCT03620149|Denosumab|denosumab|mesh-list
93234773|NCT03620149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93234774|NCT03620149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234775|NCT02064374|Metformin|metformin|mesh-list
93234776|NCT02064374|Dolutegravir|dolutegravir|mesh-list
93234777|NCT02064374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93234778|NCT02064374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234779|NCT02064374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93234780|NCT02064374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93234781|NCT02064374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780880|NCT00888940|Ecallantide|ecallantide|mesh-list
93234782|NCT02064374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234783|NCT02064374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93234784|NCT02064374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93234785|NCT02064374|Antiviral Agents|antiviral agents|mesh-ancestor
93234786|NCT02064374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234787|NCT01355263|Vitamin A|vitamin a|mesh-list
92906814|NCT04060264|Eculizumab|eculizumab|mesh-list
93234788|NCT01355263|Vitamins|vitamins|mesh-ancestor
93234789|NCT01355263|Micronutrients|micronutrients|mesh-ancestor
93234790|NCT01355263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234791|NCT03613428|Prednisone|prednisone|mesh-list
93234792|NCT03613428|Vincristine|vincristine|mesh-list
93234793|NCT03613428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234794|NCT03613428|Glucocorticoids|glucocorticoids|mesh-ancestor
93234795|NCT03613428|Hormones|hormones|mesh-ancestor
93234796|NCT03613428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234797|NCT03613428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234798|NCT03613428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234799|NCT03613428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234800|NCT03613428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93234801|NCT03613428|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234802|NCT03613428|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234803|NCT03613428|Mitosis Modulators|mitosis modulators|mesh-ancestor
93234804|NCT03613428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234805|NCT02064530|Dexmedetomidine|dexmedetomidine|mesh-list
93234806|NCT02064530|Bupivacaine|bupivacaine|mesh-list
93234807|NCT02064530|Anesthetics, Local|anesthetics, local|mesh-ancestor
93234808|NCT02064530|Anesthetics|anesthetics|mesh-ancestor
93234809|NCT02064530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234810|NCT02064530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234811|NCT02064530|Sensory System Agents|sensory system agents|mesh-ancestor
93234812|NCT02064530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781079|NCT04157491|Antibodies|antibodies|mesh-list
93234813|NCT02064530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93234814|NCT02064530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93234815|NCT02064530|Analgesics|analgesics|mesh-ancestor
93234816|NCT02064530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93234817|NCT02064530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93234818|NCT02064530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93234819|NCT02064530|Adrenergic Agents|adrenergic agents|mesh-ancestor
93234820|NCT02064530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234821|NCT02064530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234822|NCT04519437|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
93234823|NCT04519437|Antiviral Agents|antiviral agents|mesh-ancestor
93234824|NCT04519437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234825|NCT01359085|Pregabalin|pregabalin|mesh-list
92781367|NCT01104246|Testosterone|testosterone|mesh-list
93234826|NCT01359085|Analgesics|analgesics|mesh-ancestor
93234827|NCT01359085|Sensory System Agents|sensory system agents|mesh-ancestor
93234828|NCT01359085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234829|NCT01359085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234830|NCT01359085|Anticonvulsants|anticonvulsants|mesh-ancestor
93234831|NCT01359085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92781504|NCT01108068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234832|NCT01359085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93234833|NCT01359085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234834|NCT01359085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93234835|NCT01359085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93234836|NCT01359085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93234837|NCT01359085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234838|NCT01359085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234839|NCT04322357|Prednisone|prednisone|mesh-list
93234840|NCT04322357|Glucocorticoids|glucocorticoids|mesh-list
93234841|NCT04322357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234842|NCT04322357|Hormones|hormones|mesh-ancestor
93234843|NCT04322357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234844|NCT04322357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234845|NCT04322357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93234846|NCT04322357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234847|NCT01351285|Remifentanil|remifentanil|mesh-list
93234848|NCT01351285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93234849|NCT01351285|Narcotics|narcotics|mesh-ancestor
93234850|NCT01351285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234851|NCT01351285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234852|NCT01351285|Analgesics|analgesics|mesh-ancestor
93234853|NCT01351285|Sensory System Agents|sensory system agents|mesh-ancestor
93234854|NCT01351285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234855|NCT02032290|Clopidogrel|clopidogrel|mesh-list
93234856|NCT02032290|Ticagrelor|ticagrelor|mesh-list
93234857|NCT02032290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93234858|NCT02032290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93234859|NCT02032290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93234860|NCT02032290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93234861|NCT02032290|Purinergic Agents|purinergic agents|mesh-ancestor
93234862|NCT02032290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234863|NCT02032290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906884|NCT05958342|Vasopressins|vasopressins|mesh-list
93234865|NCT03379428|Trastuzumab|trastuzumab|mesh-list
93234866|NCT03379428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234867|NCT03379428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234868|NCT03628131|Carboplatin|carboplatin|mesh-list
93234869|NCT03628131|Etoposide|etoposide|mesh-list
93234870|NCT03628131|Ifosfamide|ifosfamide|mesh-list
93234871|NCT03628131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234872|NCT03628131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93234873|NCT03628131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93234874|NCT03628131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93234875|NCT03628131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234876|NCT03628131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234877|NCT03628131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93234878|NCT03628131|Alkylating Agents|alkylating agents|mesh-ancestor
93234879|NCT03560024|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
93234880|NCT03560024|Growth Substances|growth substances|mesh-ancestor
93234881|NCT03560024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234882|NCT03560024|Vasodilator Agents|vasodilator agents|mesh-ancestor
93234883|NCT03560024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234884|NCT03560024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234885|NCT05095857|Ketamine|ketamine|mesh-list
93234886|NCT05095857|Esketamine|esketamine|mesh-list
93234887|NCT05095857|Analgesics|analgesics|mesh-ancestor
93234888|NCT05095857|Sensory System Agents|sensory system agents|mesh-ancestor
93234889|NCT05095857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234890|NCT05095857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234891|NCT05095857|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93234892|NCT05095857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93234893|NCT05095857|Anesthetics, General|anesthetics, general|mesh-ancestor
93234894|NCT05095857|Anesthetics|anesthetics|mesh-ancestor
93234895|NCT05095857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234896|NCT05095857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93234897|NCT05095857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93234898|NCT05095857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234899|NCT05095857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234900|NCT05095857|Antidepressive Agents|antidepressive agents|mesh-ancestor
93234901|NCT05095857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93234902|NCT01351519|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93234903|NCT01351519|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92781913|NCT02690506|Pregabalin|pregabalin|mesh-list
93234904|NCT01351519|Dermatologic Agents|dermatologic agents|mesh-ancestor
93234905|NCT03612492|Lidocaine|lidocaine|mesh-list
93234906|NCT03612492|Anesthetics, Local|anesthetics, local|mesh-list
93234907|NCT03612492|Anesthetics|anesthetics|mesh-list
93234908|NCT03612492|Esmolol|esmolol|mesh-list
93234909|NCT03612492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93234910|NCT03612492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234911|NCT03612492|Sensory System Agents|sensory system agents|mesh-ancestor
93234912|NCT03612492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234913|NCT03612492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93234914|NCT03612492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93234915|NCT03612492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92782021|NCT02821312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234916|NCT03612492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427156|NCT01542138|Niacin|niacin|mesh-list
92782168|NCT05658640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93234917|NCT03612492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234918|NCT03612492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93234919|NCT03612492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93234920|NCT03612492|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782313|NCT00684853|Bevacizumab|bevacizumab|mesh-list
93234921|NCT03612492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234922|NCT03612492|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93234923|NCT01359163|Ethynodiol Diacetate|ethynodiol diacetate|mesh-list
93234924|NCT01359163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93234925|NCT01359163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93234926|NCT01359163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93234927|NCT01359163|Contraceptive Agents|contraceptive agents|mesh-ancestor
93234928|NCT01359163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782468|NCT04425538|Infliximab|infliximab|mesh-list
93234929|NCT01359163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234930|NCT01359163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92782673|NCT02810782|Chlorpromazine|chlorpromazine|mesh-list
92782748|NCT04237090|Cetirizine|cetirizine|mesh-list
93234931|NCT01359163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93234932|NCT03730337|Nivolumab|nivolumab|mesh-list
93234933|NCT03730337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234934|NCT03730337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234935|NCT03730337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92782825|NCT01185353|Methotrexate|methotrexate|mesh-list
93234936|NCT03730337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234937|NCT01351597|Docetaxel|docetaxel|mesh-list
93234938|NCT01351597|Oxaliplatin|oxaliplatin|mesh-list
93234939|NCT01351597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234940|NCT01351597|Tubulin Modulators|tubulin modulators|mesh-ancestor
93234941|NCT01351597|Antimitotic Agents|antimitotic agents|mesh-ancestor
93234942|NCT01351597|Mitosis Modulators|mitosis modulators|mesh-ancestor
93234943|NCT01351597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234944|NCT02793128|Mitomycins|mitomycins|mesh-list
93234945|NCT02793128|Mitomycin|mitomycin|mesh-list
93234946|NCT02793128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93234947|NCT02793128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234948|NCT02793128|Alkylating Agents|alkylating agents|mesh-ancestor
93234949|NCT02793128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234950|NCT02793128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93234951|NCT02793128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93234952|NCT03612180|Metoprolol|metoprolol|mesh-list
93234953|NCT03612180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93234954|NCT03612180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93234955|NCT03612180|Sympatholytics|sympatholytics|mesh-ancestor
93234956|NCT03612180|Autonomic Agents|autonomic agents|mesh-ancestor
93234957|NCT03612180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93234958|NCT03612180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234959|NCT03612180|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93234960|NCT03612180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93234961|NCT03612180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93234962|NCT03612180|Adrenergic Agents|adrenergic agents|mesh-ancestor
93234963|NCT03612180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93234964|NCT03612180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234965|NCT04400799|Enoxaparin|enoxaparin|mesh-list
93234966|NCT04400799|Anticoagulants|anticoagulants|mesh-ancestor
93234967|NCT04400799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93234968|NCT04400799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93234969|NCT04400799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234970|NCT01359241|Insulin|insulin|mesh-list
93234971|NCT01359241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93234972|NCT01359241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234973|NCT02068196|Ipilimumab|ipilimumab|mesh-list
93234974|NCT02068196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93234975|NCT02068196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234976|NCT02068196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93234977|NCT02068196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93234978|NCT03142451|Minocycline|minocycline|mesh-list
93234979|NCT03142451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93234980|NCT03142451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93234981|NCT04065789|Dexamethasone|dexamethasone|mesh-list
93234982|NCT04065789|Lenalidomide|lenalidomide|mesh-list
93234983|NCT04065789|Daratumumab|daratumumab|mesh-list
93234984|NCT04065789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93234985|NCT04065789|Antiemetics|antiemetics|mesh-ancestor
93234986|NCT04065789|Autonomic Agents|autonomic agents|mesh-ancestor
92783138|NCT00689845|Antimetabolites|antimetabolites|mesh-ancestor
93234987|NCT04065789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783216|NCT01154153|Antipruritics|antipruritics|mesh-ancestor
93234988|NCT04065789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93234989|NCT04065789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93234990|NCT04065789|Glucocorticoids|glucocorticoids|mesh-ancestor
93234991|NCT04065789|Hormones|hormones|mesh-ancestor
93234992|NCT04065789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93234993|NCT04065789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92783364|NCT00691951|Hormones|hormones|mesh-ancestor
93234994|NCT04065789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93234995|NCT04065789|Immunologic Factors|immunologic factors|mesh-ancestor
93234996|NCT04065789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93234997|NCT04065789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93234998|NCT04065789|Growth Substances|growth substances|mesh-ancestor
93234999|NCT04065789|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235000|NCT02066558|Carbon Monoxide|carbon monoxide|mesh-list
93235001|NCT02066558|Antimetabolites|antimetabolites|mesh-ancestor
93235002|NCT02066558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235003|NCT02066558|Gasotransmitters|gasotransmitters|mesh-ancestor
93235004|NCT02066558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235005|NCT02066558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235006|NCT02064842|Ritonavir|ritonavir|mesh-list
93235007|NCT02064842|Simeprevir|simeprevir|mesh-list
93235008|NCT02064842|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93235009|NCT02064842|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93235010|NCT02064842|Protease Inhibitors|protease inhibitors|mesh-ancestor
93235011|NCT02064842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235012|NCT02064842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235013|NCT02064842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93235014|NCT02064842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93235015|NCT02064842|Antiviral Agents|antiviral agents|mesh-ancestor
93235016|NCT02064842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235017|NCT02064842|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93235018|NCT02064842|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93235019|NCT04192266|Estradiol|estradiol|mesh-list
93235020|NCT04192266|Estrogens|estrogens|mesh-ancestor
93235021|NCT04192266|Hormones|hormones|mesh-ancestor
93235022|NCT04192266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235023|NCT04192266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235024|NCT01370018|Protease Inhibitors|protease inhibitors|mesh-list
93235025|NCT01370018|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93235026|NCT01370018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235027|NCT01370018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235028|NCT01370018|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93235029|NCT01370018|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92784085|NCT02789332|Paclitaxel|paclitaxel|mesh-list
93235030|NCT01359397|Bevacizumab|bevacizumab|mesh-list
93235031|NCT01359397|Trastuzumab|trastuzumab|mesh-list
93235032|NCT01359397|Docetaxel|docetaxel|mesh-list
93235033|NCT01359397|Oxaliplatin|oxaliplatin|mesh-list
93235034|NCT01359397|Capecitabine|capecitabine|mesh-list
92784215|NCT04232800|Micronutrients|micronutrients|mesh-ancestor
93235035|NCT01359397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235036|NCT01359397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235037|NCT01359397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93235038|NCT01359397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93235039|NCT01359397|Growth Substances|growth substances|mesh-ancestor
93235040|NCT01359397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235041|NCT01359397|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235042|NCT01359397|Tubulin Modulators|tubulin modulators|mesh-ancestor
93235043|NCT01359397|Antimitotic Agents|antimitotic agents|mesh-ancestor
93235044|NCT01359397|Mitosis Modulators|mitosis modulators|mesh-ancestor
93235045|NCT01359397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235046|NCT01359397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93235047|NCT01359397|Antimetabolites|antimetabolites|mesh-ancestor
93061284|NCT01164046|Vitamin K|vitamin k|mesh-list
93235048|NCT05250245|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93235049|NCT05250245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93235050|NCT05250245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93235051|NCT05250245|Cholinergic Agents|cholinergic agents|mesh-ancestor
93235052|NCT05250245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235053|NCT05250245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718566|NCT04650555|Hormones|hormones|mesh-ancestor
93061549|NCT01175044|Povidone-Iodine|povidone-iodine|mesh-list
93235054|NCT05250245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235055|NCT05250245|Urological Agents|urological agents|mesh-ancestor
93235056|NCT01347983|Methotrexate|methotrexate|mesh-list
93235057|NCT01347983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93235058|NCT01347983|Abortifacient Agents|abortifacient agents|mesh-ancestor
93235059|NCT01347983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93235060|NCT01347983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235061|NCT01347983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93235062|NCT01347983|Antimetabolites|antimetabolites|mesh-ancestor
93235063|NCT01347983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235064|NCT01347983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235065|NCT01347983|Dermatologic Agents|dermatologic agents|mesh-ancestor
93235066|NCT01347983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235067|NCT01347983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93235068|NCT01347983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93235069|NCT01347983|Immunologic Factors|immunologic factors|mesh-ancestor
93235070|NCT01347983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93235071|NCT01347983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93235072|NCT05249933|Benzocaine|benzocaine|mesh-list
93235073|NCT05249933|Anesthetics, Local|anesthetics, local|mesh-ancestor
93235074|NCT05249933|Anesthetics|anesthetics|mesh-ancestor
93235075|NCT05249933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235076|NCT05249933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235077|NCT05249933|Sensory System Agents|sensory system agents|mesh-ancestor
93235078|NCT05249933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235079|NCT02032836|Iloprost|iloprost|mesh-list
93235080|NCT02032836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93235081|NCT02032836|Vasodilator Agents|vasodilator agents|mesh-ancestor
93235082|NCT02065076|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
93235083|NCT02065076|Chelating Agents|chelating agents|mesh-ancestor
93235084|NCT02065076|Sequestering Agents|sequestering agents|mesh-ancestor
93235085|NCT02065076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235087|NCT02465593|Capecitabine|capecitabine|mesh-list
93235088|NCT02465593|Antimetabolites|antimetabolites|mesh-ancestor
93061891|NCT03862456|Metronidazole|metronidazole|mesh-list
93235089|NCT02465593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235090|NCT02465593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93235091|NCT02465593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235092|NCT02465593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93235093|NCT02465593|Immunologic Factors|immunologic factors|mesh-ancestor
93235094|NCT02465593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235095|NCT02424019|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93235096|NCT02424019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235097|NCT02424019|Glucocorticoids|glucocorticoids|mesh-ancestor
93235098|NCT02424019|Hormones|hormones|mesh-ancestor
93235099|NCT02424019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062334|NCT01184716|Vitamins|vitamins|mesh-ancestor
93062408|NCT00113490|Palivizumab|palivizumab|mesh-list
93062488|NCT01291186|Autonomic Agents|autonomic agents|mesh-ancestor
93235100|NCT02424019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235101|NCT02066870|Arsenic Trioxide|arsenic trioxide|mesh-list
93235102|NCT02066870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235103|NCT03611244|Benzocaine|benzocaine|mesh-list
93235104|NCT03611244|Anesthetics, Local|anesthetics, local|mesh-ancestor
93235105|NCT03611244|Anesthetics|anesthetics|mesh-ancestor
93235106|NCT03611244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235107|NCT03611244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235108|NCT03611244|Sensory System Agents|sensory system agents|mesh-ancestor
93235109|NCT03611244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235110|NCT01359709|Nicotine|nicotine|mesh-list
93235111|NCT01359709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93235112|NCT01359709|Autonomic Agents|autonomic agents|mesh-ancestor
93235113|NCT01359709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235114|NCT01359709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235115|NCT01359709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93062707|NCT01294072|Curcumin|curcumin|mesh-list
93235116|NCT01359709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93235117|NCT01359709|Cholinergic Agents|cholinergic agents|mesh-ancestor
93062841|NCT03847792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93235118|NCT01359709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235119|NCT01359709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235120|NCT02826486|Leucovorin|leucovorin|mesh-list
93235121|NCT02826486|Pembrolizumab|pembrolizumab|mesh-list
93235122|NCT02826486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235123|NCT02826486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235124|NCT02826486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93063060|NCT01196260|Oxaliplatin|oxaliplatin|mesh-list
93063134|NCT03844594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93235125|NCT02826486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235126|NCT02826486|Antidotes|antidotes|mesh-ancestor
93235127|NCT02826486|Protective Agents|protective agents|mesh-ancestor
93235128|NCT02826486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235129|NCT02826486|Vitamin B Complex|vitamin b complex|mesh-ancestor
93235130|NCT02826486|Vitamins|vitamins|mesh-ancestor
93235131|NCT02826486|Micronutrients|micronutrients|mesh-ancestor
93235132|NCT02825940|Gemcitabine|gemcitabine|mesh-list
93235133|NCT02825940|Atezolizumab|atezolizumab|mesh-list
93235134|NCT02825940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235135|NCT02825940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063595|NCT01202890|Bevacizumab|bevacizumab|mesh-list
93235136|NCT02825940|Antimetabolites|antimetabolites|mesh-ancestor
93063646|NCT01204372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235137|NCT02825940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235138|NCT02825940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92720799|NCT04601142|Prednisolone|prednisolone|mesh-list
93063803|NCT01205074|Ethanol|ethanol|mesh-list
93235139|NCT02825940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235140|NCT02304991|Glycerol|glycerol|mesh-list
93235141|NCT02304991|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93235142|NCT02304991|Protective Agents|protective agents|mesh-ancestor
93235143|NCT02304991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235144|NCT02069132|Warfarin|warfarin|mesh-list
93235145|NCT02069132|Anticoagulants|anticoagulants|mesh-ancestor
93235146|NCT01352065|Bosentan|bosentan|mesh-list
93235147|NCT01352065|Ambrisentan|ambrisentan|mesh-list
93235148|NCT01352065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93235149|NCT01352065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93235150|NCT01352065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235151|NCT01356043|Niacin|niacin|mesh-list
93235152|NCT01356043|Amlodipine|amlodipine|mesh-list
93235153|NCT01356043|Telmisartan|telmisartan|mesh-list
93235154|NCT01356043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93235155|NCT01356043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93235156|NCT01356043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93235157|NCT01356043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235158|NCT01356043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93064373|NCT01299922|Immunologic Factors|immunologic factors|mesh-ancestor
93235159|NCT01356043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235160|NCT01356043|Vasodilator Agents|vasodilator agents|mesh-ancestor
93235161|NCT01356043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93235162|NCT01356043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93235163|NCT01356043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93235165|NCT01356043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93235166|NCT01356043|Vitamin B Complex|vitamin b complex|mesh-ancestor
93235167|NCT01356043|Vitamins|vitamins|mesh-ancestor
93235168|NCT01356043|Micronutrients|micronutrients|mesh-ancestor
93235169|NCT02065388|Warfarin|warfarin|mesh-list
93235170|NCT02065388|Anticoagulants|anticoagulants|mesh-ancestor
93235171|NCT01317563|Vitamin A|vitamin a|mesh-list
93235172|NCT01317563|Selenium|selenium|mesh-list
93235173|NCT01317563|Vitamins|vitamins|mesh-ancestor
93235174|NCT01317563|Micronutrients|micronutrients|mesh-ancestor
93064657|NCT01560052|Prednisolone|prednisolone|mesh-list
93235175|NCT01317563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235176|NCT01317563|Antioxidants|antioxidants|mesh-ancestor
93064730|NCT04246762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93235177|NCT01317563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235178|NCT01317563|Protective Agents|protective agents|mesh-ancestor
93235179|NCT01317563|Trace Elements|trace elements|mesh-ancestor
93235180|NCT02067338|Morphine|morphine|mesh-list
93235181|NCT02067338|Cellulose, Oxidized|cellulose, oxidized|mesh-list
93235182|NCT02067338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93235183|NCT02067338|Narcotics|narcotics|mesh-ancestor
93235184|NCT02067338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235185|NCT02067338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235186|NCT02067338|Analgesics|analgesics|mesh-ancestor
93235187|NCT02067338|Sensory System Agents|sensory system agents|mesh-ancestor
93235188|NCT02067338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235189|NCT02067338|Hemostatics|hemostatics|mesh-ancestor
93235190|NCT02067338|Coagulants|coagulants|mesh-ancestor
93235191|NCT01352143|Thrombin|thrombin|mesh-list
93235192|NCT01352143|Hemostatics|hemostatics|mesh-ancestor
93235193|NCT01352143|Coagulants|coagulants|mesh-ancestor
93065016|NCT01078428|Petrolatum|petrolatum|mesh-list
93235194|NCT01352299|Pyrithione zinc|pyrithione zinc|mesh-list
93235195|NCT01352299|Keratolytic Agents|keratolytic agents|mesh-ancestor
93235196|NCT01352299|Dermatologic Agents|dermatologic agents|mesh-ancestor
93235197|NCT05188495|Trastuzumab|trastuzumab|mesh-list
93235198|NCT05188495|Pertuzumab|pertuzumab|mesh-list
93065231|NCT03794596|Lansoprazole|lansoprazole|mesh-list
93235199|NCT05188495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065462|NCT03787030|Vitamin E|vitamin e|mesh-list
93065534|NCT00419159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065615|NCT00419003|Anesthetics, General|anesthetics, general|mesh-ancestor
93235200|NCT05188495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235201|NCT02069288|Fludrocortisone|fludrocortisone|mesh-list
93235202|NCT02069288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235203|NCT01356121|Midazolam|midazolam|mesh-list
93235204|NCT01356121|Propofol|propofol|mesh-list
93235205|NCT01356121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93235206|NCT01356121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065832|NCT01035593|Immunologic Factors|immunologic factors|mesh-ancestor
93235207|NCT01356121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235208|NCT01356121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93235209|NCT01356121|Anesthetics, General|anesthetics, general|mesh-ancestor
93235210|NCT01356121|Anesthetics|anesthetics|mesh-ancestor
93235211|NCT01356121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93235212|NCT01356121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93235213|NCT01356121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93066129|NCT03774706|Oxytocics|oxytocics|mesh-ancestor
93235214|NCT01356121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93235215|NCT01356121|GABA Modulators|gaba modulators|mesh-ancestor
93235216|NCT01356121|GABA Agents|gaba agents|mesh-ancestor
93235217|NCT01356121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066277|NCT01039181|Micronutrients|micronutrients|mesh-ancestor
93066349|NCT00122460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93235218|NCT01356121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235219|NCT01336608|Fluticasone|fluticasone|mesh-list
93235220|NCT01336608|Xhance|xhance|mesh-list
93066571|NCT03767296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235221|NCT01336608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235222|NCT01336608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93235223|NCT01336608|Autonomic Agents|autonomic agents|mesh-ancestor
93235224|NCT01336608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235225|NCT01336608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066790|NCT00106704|Hormones|hormones|mesh-ancestor
93066863|NCT01076478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93235226|NCT01336608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93235227|NCT01336608|Respiratory System Agents|respiratory system agents|mesh-ancestor
93067025|NCT01081704|Ustekinumab|ustekinumab|mesh-list
93235228|NCT01336608|Dermatologic Agents|dermatologic agents|mesh-ancestor
93235229|NCT01336608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93235230|NCT03628521|Carboplatin|carboplatin|mesh-list
93235231|NCT03628521|Gemcitabine|gemcitabine|mesh-list
93235232|NCT03628521|Pemetrexed|pemetrexed|mesh-list
93235233|NCT03628521|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93067395|NCT00130728|Bevacizumab|bevacizumab|mesh-list
93235234|NCT03628521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235235|NCT03628521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93235236|NCT03628521|Antimetabolites|antimetabolites|mesh-ancestor
93067531|NCT01077752|Morphine|morphine|mesh-list
93235237|NCT03628521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067613|NCT00133952|Ruboxistaurin|ruboxistaurin|mesh-list
93235238|NCT03628521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235239|NCT03628521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93235240|NCT03628521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067825|NCT03697252|Trospium chloride|trospium chloride|mesh-list
93067900|NCT03750760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93067977|NCT03822416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235241|NCT03628521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93235242|NCT05697003|Fluticasone|fluticasone|mesh-list
93235243|NCT05697003|Xhance|xhance|mesh-list
93235244|NCT05697003|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93068127|NCT03963024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93235245|NCT05697003|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93068274|NCT00127166|Fluticasone|fluticasone|mesh-list
93235246|NCT05697003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235247|NCT05697003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93068355|NCT03747094|Fentanyl|fentanyl|mesh-list
93235248|NCT05697003|Autonomic Agents|autonomic agents|mesh-ancestor
93068436|NCT04060654|Buprenorphine|buprenorphine|mesh-list
93068494|NCT01326650|Vitamins|vitamins|mesh-list
93235249|NCT05697003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235250|NCT05697003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068644|NCT04195828|Apatinib|apatinib|mesh-list
93235251|NCT05697003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93235252|NCT05697003|Respiratory System Agents|respiratory system agents|mesh-ancestor
93235253|NCT05697003|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068720|NCT03656692|Hormones|hormones|mesh-ancestor
93235254|NCT05697003|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93235255|NCT05697003|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93235256|NCT05697003|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93235257|NCT05697003|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93235258|NCT05697003|Adrenergic Agents|adrenergic agents|mesh-ancestor
93235259|NCT05697003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235260|NCT05697003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235261|NCT05697003|Glucocorticoids|glucocorticoids|mesh-ancestor
93235262|NCT05697003|Hormones|hormones|mesh-ancestor
93235263|NCT05697003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069100|NCT00094094|Axitinib|axitinib|mesh-list
93235264|NCT05697003|Sympathomimetics|sympathomimetics|mesh-ancestor
93235265|NCT02069522|Carotenoids|carotenoids|mesh-list
93235266|NCT02069522|Antioxidants|antioxidants|mesh-ancestor
93069156|NCT00094458|Antimetabolites|antimetabolites|mesh-ancestor
93235267|NCT02069522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235268|NCT02069522|Protective Agents|protective agents|mesh-ancestor
93235269|NCT02069522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235270|NCT01361425|Methyldopa|methyldopa|mesh-list
93235271|NCT01361425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93235272|NCT01361425|Sympatholytics|sympatholytics|mesh-ancestor
93235273|NCT01361425|Autonomic Agents|autonomic agents|mesh-ancestor
93235274|NCT01361425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069450|NCT00091442|Docetaxel|docetaxel|mesh-list
93069522|NCT00119678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235275|NCT01361425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069595|NCT00118430|Antidepressive Agents|antidepressive agents|mesh-list
93235276|NCT01361425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93235277|NCT01361425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93069680|NCT00089648|Sunitinib|sunitinib|mesh-list
93235278|NCT01361425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93235279|NCT01361425|Adrenergic Agents|adrenergic agents|mesh-ancestor
93235280|NCT01361425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235281|NCT01361425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235282|NCT01356355|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93235283|NCT01356355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93235284|NCT01356355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93235285|NCT01356355|Cholinergic Agents|cholinergic agents|mesh-ancestor
93235286|NCT01356355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235287|NCT01356355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235288|NCT01356355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235289|NCT01356355|Urological Agents|urological agents|mesh-ancestor
93235290|NCT01356433|Vitamins|vitamins|mesh-list
93069879|NCT01045889|Hormones|hormones|mesh-ancestor
93235291|NCT01356433|Ascorbic Acid|ascorbic acid|mesh-list
93235292|NCT01356433|Micronutrients|micronutrients|mesh-ancestor
93069956|NCT00372905|Rituximab|rituximab|mesh-list
93235293|NCT01356433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235294|NCT01356433|Antioxidants|antioxidants|mesh-ancestor
93235295|NCT01356433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070177|NCT01086956|Narcotics|narcotics|mesh-ancestor
93235296|NCT01356433|Protective Agents|protective agents|mesh-ancestor
93235297|NCT03691727|Tirofiban|tirofiban|mesh-list
93235298|NCT03691727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93070251|NCT01087190|Isoniazid|isoniazid|mesh-list
93235299|NCT03691727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93235300|NCT03691727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235301|NCT03691727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93235302|NCT01346371|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93235303|NCT01346371|Lubricant Eye Drops|lubricant eye drops|mesh-list
93235304|NCT01346371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93235305|NCT01356511|Dexamethasone|dexamethasone|mesh-list
93235306|NCT01356511|Prednisone|prednisone|mesh-list
93235307|NCT01356511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235308|NCT01356511|Antiemetics|antiemetics|mesh-ancestor
93235309|NCT01356511|Autonomic Agents|autonomic agents|mesh-ancestor
93235310|NCT01356511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070474|NCT00119379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235311|NCT01356511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235312|NCT01356511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235313|NCT01356511|Glucocorticoids|glucocorticoids|mesh-ancestor
93235314|NCT01356511|Hormones|hormones|mesh-ancestor
93070613|NCT03664024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93070697|NCT03734614|Aspirin|aspirin|mesh-list
93235315|NCT01356511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235316|NCT01356511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070758|NCT01088282|Dipivefrin|dipivefrin|mesh-list
93235317|NCT01356511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235318|NCT02069990|Cholecalciferol|cholecalciferol|mesh-list
93235319|NCT02069990|Vitamin D|vitamin d|mesh-list
93070908|NCT03605212|Febuxostat|febuxostat|mesh-list
93235320|NCT02069990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93235321|NCT02069990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071054|NCT03639532|Tacrine|tacrine|mesh-list
93235322|NCT02069990|Vitamins|vitamins|mesh-ancestor
93235323|NCT02069990|Micronutrients|micronutrients|mesh-ancestor
93235324|NCT02069990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93235325|NCT05076409|Fluconazole|fluconazole|mesh-list
93235326|NCT05076409|BI 425809|bi 425809|mesh-list
93235327|NCT05076409|Antifungal Agents|antifungal agents|mesh-ancestor
93071358|NCT00078338|(T,G)-A-L|(t,g)-a-l|mesh-list
93235328|NCT05076409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235329|NCT05076409|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93235330|NCT05076409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93235331|NCT05076409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071494|NCT03567616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235332|NCT05076409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071639|NCT01084473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235333|NCT05076409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93235334|NCT05076409|Hormone Antagonists|hormone antagonists|mesh-ancestor
93071790|NCT03586726|Antitubercular Agents|antitubercular agents|mesh-ancestor
93235335|NCT05076409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235336|NCT05076409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071933|NCT05781633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93235337|NCT05076409|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93072013|NCT05868967|Fexuprazan|fexuprazan|mesh-list
93235338|NCT05076409|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93235339|NCT05076409|Nootropic Agents|nootropic agents|mesh-ancestor
93235340|NCT02076386|Dolutegravir|dolutegravir|mesh-list
93235341|NCT02076386|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93235342|NCT02076386|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93235343|NCT02076386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235344|NCT02076386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235345|NCT02076386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93235346|NCT02076386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93235347|NCT02076386|Antiviral Agents|antiviral agents|mesh-ancestor
93235348|NCT02076386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235349|NCT01347593|Ceftizoxime|ceftizoxime|mesh-list
93072594|NCT03900884|Letrozole|letrozole|mesh-list
93235350|NCT01347593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93235351|NCT01347593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235352|NCT02072330|Amlodipine|amlodipine|mesh-list
93235353|NCT02072330|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93235354|NCT02072330|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93235355|NCT02072330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93235356|NCT02072330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93235357|NCT02072330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073120|NCT05639686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93235358|NCT02072330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073273|NCT05394740|Vitamins|vitamins|mesh-ancestor
93073344|NCT05169112|Fertility Agents|fertility agents|mesh-ancestor
93235359|NCT02072330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93073422|NCT04991974|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93235360|NCT02072330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235361|NCT02072330|Vasodilator Agents|vasodilator agents|mesh-ancestor
93235362|NCT02072330|Diuretics|diuretics|mesh-ancestor
93235363|NCT02072330|Natriuretic Agents|natriuretic agents|mesh-ancestor
93073643|NCT04377204|Anesthetics|anesthetics|mesh-ancestor
93235364|NCT02072330|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93235365|NCT02072330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93235366|NCT02072330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93235367|NCT02072408|Aflibercept|aflibercept|mesh-list
93235368|NCT02072408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92429528|NCT05839522|Antibodies|antibodies|mesh-list
93235369|NCT02072408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93235370|NCT02072408|Growth Substances|growth substances|mesh-ancestor
93235371|NCT02072408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235372|NCT02072408|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235373|NCT02072408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235374|NCT02070458|Cytarabine|cytarabine|mesh-list
93235375|NCT02070458|Etoposide|etoposide|mesh-list
93235376|NCT02070458|Mitoxantrone|mitoxantrone|mesh-list
93235377|NCT02070458|Etoposide phosphate|etoposide phosphate|mesh-list
93235378|NCT02070458|Ixazomib|ixazomib|mesh-list
93235379|NCT02070458|Glycine|glycine|mesh-list
93235380|NCT02070458|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92430043|NCT04835129|Elotuzumab|elotuzumab|mesh-list
93235381|NCT02070458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430117|NCT04591431|Trastuzumab|trastuzumab|mesh-list
93235382|NCT02070458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235383|NCT02070458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93235384|NCT02070458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92430271|NCT04249063|Lidocaine|lidocaine|mesh-list
93235385|NCT02070458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430414|NCT04023071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430489|NCT03909152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235386|NCT02070458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235387|NCT02070458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93235388|NCT02070458|Antimetabolites|antimetabolites|mesh-ancestor
93235389|NCT02070458|Antiviral Agents|antiviral agents|mesh-ancestor
93235390|NCT02070458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235391|NCT02070458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93235392|NCT02070458|Immunologic Factors|immunologic factors|mesh-ancestor
93235393|NCT02070458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235394|NCT02070458|Analgesics|analgesics|mesh-ancestor
93235395|NCT02070458|Sensory System Agents|sensory system agents|mesh-ancestor
92430858|NCT03297593|Nivolumab|nivolumab|mesh-list
93235396|NCT02070458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235397|NCT02070458|Protease Inhibitors|protease inhibitors|mesh-ancestor
93235398|NCT02070458|Glycine Agents|glycine agents|mesh-ancestor
93235399|NCT02070458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235400|NCT03131479|Licogliflozin|licogliflozin|mesh-list
93235401|NCT03131479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93235402|NCT03131479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235403|NCT03131479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92431010|NCT03020030|Hormones|hormones|mesh-ancestor
93235404|NCT03131479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235405|NCT04984369|Cetuximab|cetuximab|mesh-list
92431153|NCT02192021|Doxorubicin|doxorubicin|mesh-list
92431225|NCT01468896|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235406|NCT04984369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235407|NCT04984369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235408|NCT02077010|Milrinone|milrinone|mesh-list
93235409|NCT02077010|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93235410|NCT02077010|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93235411|NCT02077010|Vasodilator Agents|vasodilator agents|mesh-ancestor
93235412|NCT02077010|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93235413|NCT02077010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93235414|NCT02077010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235415|NCT02077010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235416|NCT02077010|Protective Agents|protective agents|mesh-ancestor
93235417|NCT02077010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235418|NCT01319461|Hyaluronic Acid|hyaluronic acid|mesh-list
93235419|NCT01319461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93235420|NCT01319461|Immunologic Factors|immunologic factors|mesh-ancestor
93235421|NCT01319461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431511|NCT01557634|Insulin|insulin|mesh-list
93235422|NCT01319461|Viscosupplements|viscosupplements|mesh-ancestor
93235423|NCT01319461|Protective Agents|protective agents|mesh-ancestor
93235424|NCT02072720|Bevacizumab|bevacizumab|mesh-list
93235425|NCT02072720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235426|NCT02072720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235427|NCT02072720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93235428|NCT02072720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93235429|NCT02072720|Growth Substances|growth substances|mesh-ancestor
93235430|NCT02072720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235431|NCT02072720|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235432|NCT01356745|Nitrous Oxide|nitrous oxide|mesh-list
93235433|NCT01356745|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93235434|NCT01356745|Anesthetics, General|anesthetics, general|mesh-ancestor
93235435|NCT01356745|Anesthetics|anesthetics|mesh-ancestor
93235436|NCT01356745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235437|NCT01356745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235438|NCT01356745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235439|NCT01356745|Analgesics|analgesics|mesh-ancestor
93235440|NCT01356745|Sensory System Agents|sensory system agents|mesh-ancestor
93235441|NCT01356745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235442|NCT02072798|Cefuroxime|cefuroxime|mesh-list
93235443|NCT02072798|Cefuroxime axetil|cefuroxime axetil|mesh-list
92431723|NCT01559025|Protease Inhibitors|protease inhibitors|mesh-ancestor
93235444|NCT02072798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93235445|NCT02072798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235446|NCT04943549|Bupivacaine|bupivacaine|mesh-list
93235447|NCT04943549|Anesthetics, Local|anesthetics, local|mesh-ancestor
93235448|NCT04943549|Anesthetics|anesthetics|mesh-ancestor
93235449|NCT04943549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235450|NCT04943549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235451|NCT04943549|Sensory System Agents|sensory system agents|mesh-ancestor
93235452|NCT04943549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235453|NCT04252105|Antioxidants|antioxidants|mesh-list
93235454|NCT04252105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235455|NCT04252105|Protective Agents|protective agents|mesh-ancestor
93235456|NCT04252105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235457|NCT02077322|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
93235458|NCT02077322|Hemostatics|hemostatics|mesh-ancestor
93235459|NCT02077322|Coagulants|coagulants|mesh-ancestor
93235460|NCT02077400|Cefazolin|cefazolin|mesh-list
93235461|NCT02077400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93235462|NCT02077400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235463|NCT02077478|Remifentanil|remifentanil|mesh-list
93235464|NCT02077478|Propofol|propofol|mesh-list
93235465|NCT02077478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93235466|NCT02077478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235467|NCT02077478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235468|NCT02077478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93235469|NCT02077478|Anesthetics, General|anesthetics, general|mesh-ancestor
93235471|NCT02077478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93235472|NCT02077478|Narcotics|narcotics|mesh-ancestor
93235473|NCT02077478|Analgesics|analgesics|mesh-ancestor
93235474|NCT02077478|Sensory System Agents|sensory system agents|mesh-ancestor
93235475|NCT02077478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235476|NCT02077556|Mycophenolic Acid|mycophenolic acid|mesh-list
93235477|NCT02077556|Methylprednisolone|methylprednisolone|mesh-list
93235478|NCT02077556|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93235479|NCT02077556|Prednisolone|prednisolone|mesh-list
93235480|NCT02077556|Everolimus|everolimus|mesh-list
93235481|NCT02077556|Tacrolimus|tacrolimus|mesh-list
93235482|NCT02077556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93235483|NCT02077556|Immunologic Factors|immunologic factors|mesh-ancestor
93235484|NCT02077556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432266|NCT03471507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235485|NCT02077556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92432347|NCT02909686|Antioxidants|antioxidants|mesh-ancestor
93235486|NCT02077556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235487|NCT02077556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235488|NCT02077556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93235489|NCT02077556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93235490|NCT02077556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235491|NCT02077556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93235492|NCT02077556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93235493|NCT02077556|Antitubercular Agents|antitubercular agents|mesh-ancestor
93235494|NCT02077556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93235495|NCT02077556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235496|NCT02077556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235497|NCT02077556|Antiemetics|antiemetics|mesh-ancestor
93235498|NCT02077556|Autonomic Agents|autonomic agents|mesh-ancestor
92432474|NCT01564095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93235499|NCT02077556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235500|NCT02077556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235501|NCT02077556|Glucocorticoids|glucocorticoids|mesh-ancestor
93235502|NCT02077556|Hormones|hormones|mesh-ancestor
92432773|NCT01571037|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92432848|NCT01571570|Antiviral Agents|antiviral agents|mesh-ancestor
93235503|NCT02077556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235504|NCT02077556|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93235505|NCT02077556|Protective Agents|protective agents|mesh-ancestor
93235506|NCT02077556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93235507|NCT02930941|Tranexamic Acid|tranexamic acid|mesh-list
93235508|NCT02930941|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93235509|NCT02930941|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93235510|NCT02930941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235511|NCT02930941|Hemostatics|hemostatics|mesh-ancestor
93235512|NCT02930941|Coagulants|coagulants|mesh-ancestor
93235513|NCT02077634|Prednisone|prednisone|mesh-list
93235514|NCT02077634|Abiraterone Acetate|abiraterone acetate|mesh-list
92432988|NCT01572116|Sympathomimetics|sympathomimetics|mesh-ancestor
93235515|NCT02077634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235516|NCT02077634|Glucocorticoids|glucocorticoids|mesh-ancestor
93235517|NCT02077634|Hormones|hormones|mesh-ancestor
93235518|NCT02077634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235519|NCT02077634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235520|NCT02077634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93235521|NCT02077634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235522|NCT02077634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93235523|NCT02077634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235524|NCT02077634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163195|NCT05249309|Anesthetics|anesthetics|mesh-ancestor
93235525|NCT02077634|Hormone Antagonists|hormone antagonists|mesh-ancestor
93235526|NCT02077634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93235527|NCT01365403|Carbamazepine|carbamazepine|mesh-list
93235528|NCT01365403|Anticonvulsants|anticonvulsants|mesh-ancestor
93235529|NCT01365403|Antimanic Agents|antimanic agents|mesh-ancestor
92433223|NCT01573377|Cyproterone|cyproterone|mesh-list
93235530|NCT01365403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93235531|NCT01365403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235532|NCT01365403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235533|NCT01365403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93235534|NCT01365403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235535|NCT01365403|Analgesics|analgesics|mesh-ancestor
93235536|NCT01365403|Sensory System Agents|sensory system agents|mesh-ancestor
93235537|NCT01365403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235538|NCT01365403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92907561|NCT05554380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92433629|NCT01577017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433707|NCT01577589|Cephalosporins|cephalosporins|mesh-list
93235539|NCT01365403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93235540|NCT01365403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235541|NCT01365403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93235542|NCT01365403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93235543|NCT01352663|Insulin|insulin|mesh-list
93235544|NCT01352663|Insulin Glargine|insulin glargine|mesh-list
93235545|NCT01352663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433842|NCT01578265|Ondansetron|ondansetron|mesh-list
92433916|NCT01578447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235546|NCT01352663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235547|NCT01362361|Nintedanib|nintedanib|mesh-list
93235548|NCT01362361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235549|NCT01362361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92434062|NCT01579201|Carbetocin|carbetocin|mesh-list
93235550|NCT01362361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235551|NCT01362361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235552|NCT02077712|Dexmedetomidine|dexmedetomidine|mesh-list
93235553|NCT02077712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92434278|NCT01583426|Paclitaxel|paclitaxel|mesh-list
93235554|NCT02077712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235555|NCT02077712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434352|NCT01587625|Oxytocin|oxytocin|mesh-list
93235556|NCT02077712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434466|NCT01590537|Copper|copper|mesh-list
93235557|NCT02077712|Analgesics|analgesics|mesh-ancestor
93235558|NCT02077712|Sensory System Agents|sensory system agents|mesh-ancestor
93235559|NCT02077712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434572|NCT01591083|Esomeprazole|esomeprazole|mesh-list
93235560|NCT02077712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93235561|NCT02077712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93235562|NCT02077712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93235563|NCT02077712|Adrenergic Agents|adrenergic agents|mesh-ancestor
93235564|NCT02077712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235565|NCT02077712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235566|NCT02073734|Dexamethasone|dexamethasone|mesh-list
92434867|NCT01593033|Micronutrients|micronutrients|mesh-list
93235567|NCT02073734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235568|NCT02073734|Antiemetics|antiemetics|mesh-ancestor
93235569|NCT02073734|Autonomic Agents|autonomic agents|mesh-ancestor
93235570|NCT02073734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235571|NCT02073734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235572|NCT02073734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235573|NCT02073734|Glucocorticoids|glucocorticoids|mesh-ancestor
93235574|NCT02073734|Hormones|hormones|mesh-ancestor
92435083|NCT01594047|Ketamine|ketamine|mesh-list
93242994|NCT01364675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92435204|NCT01594619|Diltiazem|diltiazem|mesh-list
93235575|NCT02073734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235576|NCT02073734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93235577|NCT02073734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235578|NCT02071004|Aspirin|aspirin|mesh-list
93235579|NCT02071004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93235580|NCT02071004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235581|NCT02071004|Analgesics|analgesics|mesh-ancestor
93235582|NCT02071004|Sensory System Agents|sensory system agents|mesh-ancestor
93235583|NCT02071004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235584|NCT02071004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235585|NCT02071004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235586|NCT02071004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93235587|NCT02071004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93235588|NCT02071004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92435636|NCT01596673|Hydrocodone|hydrocodone|mesh-list
93235589|NCT02071004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242995|NCT01364675|Protease Inhibitors|protease inhibitors|mesh-ancestor
93235590|NCT02071004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93235591|NCT02071004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93235592|NCT02071004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235593|NCT02071004|Antipyretics|antipyretics|mesh-ancestor
93235594|NCT02071160|Melatonin|melatonin|mesh-list
93235595|NCT02071160|Antioxidants|antioxidants|mesh-ancestor
93235596|NCT02071160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235597|NCT02071160|Protective Agents|protective agents|mesh-ancestor
93235598|NCT02071160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436090|NCT01598623|Oxytocin|oxytocin|mesh-list
93235599|NCT02071160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235600|NCT03131713|Acetaminophen|acetaminophen|mesh-list
93235601|NCT03131713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235602|NCT03131713|Analgesics|analgesics|mesh-ancestor
92436316|NCT05689242|Narcotics|narcotics|mesh-ancestor
93235603|NCT03131713|Sensory System Agents|sensory system agents|mesh-ancestor
93235604|NCT03131713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235605|NCT03131713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235606|NCT03131713|Antipyretics|antipyretics|mesh-ancestor
93235607|NCT03514121|Pembrolizumab|pembrolizumab|mesh-list
92436458|NCT05189483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235608|NCT03514121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235609|NCT03514121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235610|NCT03514121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93235611|NCT03514121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235612|NCT02930005|Meclofenamic Acid|meclofenamic acid|mesh-list
93235613|NCT02930005|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
93235614|NCT02930005|Anticoagulants|anticoagulants|mesh-ancestor
93235615|NCT02930005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93235616|NCT02930005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235617|NCT02930005|Analgesics|analgesics|mesh-ancestor
92436752|NCT03935646|Adderall|adderall|mesh-list
93235618|NCT02930005|Sensory System Agents|sensory system agents|mesh-ancestor
92436824|NCT03340766|Pembrolizumab|pembrolizumab|mesh-list
93235619|NCT02930005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235620|NCT02930005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235621|NCT02930005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235622|NCT02930005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436961|NCT05703373|Trace Elements|trace elements|mesh-list
92437033|NCT05476939|Immunologic Factors|immunologic factors|mesh-ancestor
93235623|NCT02930005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93235624|NCT02930005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235625|NCT02930005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235626|NCT01349387|Metformin|metformin|mesh-list
93235627|NCT01349387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93235628|NCT01349387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235629|NCT04905173|Amyl Nitrite|amyl nitrite|mesh-list
93235630|NCT04905173|Vasodilator Agents|vasodilator agents|mesh-ancestor
93235631|NCT01361269|Clindamycin|clindamycin|mesh-list
92437481|NCT02229084|Docetaxel|docetaxel|mesh-list
93235632|NCT01361269|Clindamycin palmitate|clindamycin palmitate|mesh-list
93235633|NCT01361269|Clindamycin phosphate|clindamycin phosphate|mesh-list
93235634|NCT01361269|Fosmidomycin|fosmidomycin|mesh-list
92437704|NCT02829931|Bevacizumab|bevacizumab|mesh-list
92437791|NCT02652455|Analgesics|analgesics|mesh-ancestor
92437853|NCT01953926|Trastuzumab|trastuzumab|mesh-list
93235635|NCT01361269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93235636|NCT01361269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438079|NCT01606722|Darunavir|darunavir|mesh-list
93235637|NCT01361269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92438156|NCT01610141|Warfarin|warfarin|mesh-list
93235638|NCT01361269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235639|NCT01361269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235640|NCT01353209|Letrozole|letrozole|mesh-list
93235641|NCT01353209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235642|NCT01353209|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92438339|NCT01611909|Terpin|terpin|mesh-list
93235643|NCT01353209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93235644|NCT01353209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242996|NCT01364675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93235645|NCT01353209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235646|NCT01353209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93235647|NCT01353209|Hormone Antagonists|hormone antagonists|mesh-ancestor
93235648|NCT01353209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235649|NCT01353209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235650|NCT03637491|Avelumab|avelumab|mesh-list
93235651|NCT03637491|Talazoparib|talazoparib|mesh-list
93242997|NCT02253758|Propofol|propofol|mesh-list
93235652|NCT03637491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235653|NCT03637491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438893|NCT01615055|Serotonin Agents|serotonin agents|mesh-ancestor
93235654|NCT03637491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93235655|NCT03637491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438958|NCT01615393|Antimetabolites|antimetabolites|mesh-ancestor
93235656|NCT03637491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235657|NCT01363063|Ketorolac|ketorolac|mesh-list
92439094|NCT01616355|Eusol|eusol|mesh-list
93235658|NCT01363063|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93235659|NCT01363063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93235660|NCT01363063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439253|NCT01617226|Vorinostat|vorinostat|mesh-list
92439328|NCT01617707|Midazolam|midazolam|mesh-list
92439411|NCT01618253|Sorafenib|sorafenib|mesh-list
93235661|NCT01363063|Analgesics|analgesics|mesh-ancestor
93235662|NCT01363063|Sensory System Agents|sensory system agents|mesh-ancestor
93235663|NCT01363063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235664|NCT01363063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439619|NCT01619176|Antimetabolites|antimetabolites|mesh-ancestor
93235665|NCT01363063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235666|NCT01363063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93235667|NCT01363063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93235668|NCT01363063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439847|NCT01620463|Hormones|hormones|mesh-ancestor
93235669|NCT01363063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439965|NCT01621256|Ancrod|ancrod|mesh-list
93235670|NCT04550455|Cladribine|cladribine|mesh-list
92439997|NCT01621373|Propofol|propofol|mesh-list
93235671|NCT04550455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235672|NCT04550455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93235673|NCT04550455|Immunologic Factors|immunologic factors|mesh-ancestor
93235674|NCT04550455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440208|NCT01622556|Immunologic Factors|immunologic factors|mesh-ancestor
93235675|NCT01349699|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93235676|NCT01349699|Deferasirox|deferasirox|mesh-list
93235677|NCT01349699|Hematinics|hematinics|mesh-ancestor
93235678|NCT01349699|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92440365|NCT01623817|Vancomycin|vancomycin|mesh-list
93235679|NCT01349699|Chelating Agents|chelating agents|mesh-ancestor
93235680|NCT01349699|Sequestering Agents|sequestering agents|mesh-ancestor
92165229|NCT05269628|Analgesics|analgesics|mesh-ancestor
93235681|NCT01349699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235682|NCT01370161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93235683|NCT01370161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93235684|NCT01370161|Adrenergic Agents|adrenergic agents|mesh-ancestor
93235685|NCT01370161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235686|NCT01370161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235687|NCT01370161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235688|NCT03628443|Mitogens|mitogens|mesh-list
93235689|NCT03628443|Mitosis Modulators|mitosis modulators|mesh-ancestor
93235690|NCT03628443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235691|NCT01365871|Anesthetics|anesthetics|mesh-list
93235692|NCT01365871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235693|NCT01365871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235694|NCT01349777|Clopidogrel|clopidogrel|mesh-list
92440861|NCT01627353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235695|NCT01349777|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93235696|NCT01349777|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93235697|NCT01349777|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93235698|NCT01349777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93235699|NCT01349777|Purinergic Agents|purinergic agents|mesh-ancestor
92441002|NCT01627938|Antimitotic Agents|antimitotic agents|mesh-ancestor
93235700|NCT01349777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235701|NCT01349777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235702|NCT01349777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235703|NCT03446157|Cetuximab|cetuximab|mesh-list
93235704|NCT03446157|Palbociclib|palbociclib|mesh-list
93235705|NCT03446157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235706|NCT03446157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235707|NCT03446157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93235708|NCT03446157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235709|NCT03446157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235710|NCT04700007|Diphenhydramine|diphenhydramine|mesh-list
92441474|NCT01631409|Aspirin|aspirin|mesh-list
93235711|NCT04700007|Promethazine|promethazine|mesh-list
93235712|NCT04700007|Morphine|morphine|mesh-list
93235713|NCT04700007|Capsaicin|capsaicin|mesh-list
93235714|NCT04700007|Histamine|histamine|mesh-list
92441597|NCT01632007|Alogliptin|alogliptin|mesh-list
93235715|NCT04700007|Histamine Antagonists|histamine antagonists|mesh-list
93235716|NCT04700007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93235717|NCT04700007|Narcotics|narcotics|mesh-ancestor
93235718|NCT04700007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441816|NCT01634061|Dactolisib|dactolisib|mesh-list
93235719|NCT04700007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235720|NCT04700007|Analgesics|analgesics|mesh-ancestor
93235721|NCT04700007|Sensory System Agents|sensory system agents|mesh-ancestor
93235722|NCT04700007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235723|NCT04700007|Antipruritics|antipruritics|mesh-ancestor
92441966|NCT01634893|Sorafenib|sorafenib|mesh-list
93235724|NCT04700007|Dermatologic Agents|dermatologic agents|mesh-ancestor
93235725|NCT04700007|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92442109|NCT01635829|Carbamazepine|carbamazepine|mesh-list
93235726|NCT04700007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92442182|NCT01636128|Analgesics|analgesics|mesh-ancestor
93235727|NCT04700007|Anesthetics, Local|anesthetics, local|mesh-ancestor
93235728|NCT04700007|Anesthetics|anesthetics|mesh-ancestor
93235729|NCT04700007|Antiemetics|antiemetics|mesh-ancestor
93235730|NCT04700007|Autonomic Agents|autonomic agents|mesh-ancestor
93235731|NCT04700007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235732|NCT04700007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93235733|NCT04700007|Histamine Agents|histamine agents|mesh-ancestor
93235734|NCT04700007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235735|NCT04700007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442486|NCT01637376|Temoporfin|temoporfin|mesh-list
93235736|NCT04700007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93235737|NCT04700007|Histamine Agonists|histamine agonists|mesh-ancestor
93235738|NCT01349855|Insulin Glargine|insulin glargine|mesh-list
93235739|NCT01349855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93235740|NCT01349855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235741|NCT01318655|Naloxegol|naloxegol|mesh-list
93235742|NCT01318655|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92442770|NCT01638663|Tolvaptan|tolvaptan|mesh-list
93235743|NCT01318655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235744|NCT01318655|Sensory System Agents|sensory system agents|mesh-ancestor
93235745|NCT01318655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235746|NCT01353599|Mometasone Furoate|mometasone furoate|mesh-list
93235747|NCT01353599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93235748|NCT01353599|Dermatologic Agents|dermatologic agents|mesh-ancestor
93235749|NCT01353599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93235750|NCT02961881|Blinatumomab|blinatumomab|mesh-list
92704584|NCT04397692|Antioxidants|antioxidants|mesh-ancestor
92443137|NCT01645839|Cytarabine|cytarabine|mesh-list
92443211|NCT01648777|Bupivacaine|bupivacaine|mesh-list
93235751|NCT02961881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235752|NCT03334539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92443378|NCT01650740|Analgesics|analgesics|mesh-ancestor
93235753|NCT03334539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93235754|NCT01350089|Ethanol|ethanol|mesh-list
93235755|NCT01350089|Caffeine|caffeine|mesh-list
93235756|NCT01350089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93235757|NCT01350089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443800|NCT01652638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93235758|NCT01350089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235759|NCT01350089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235760|NCT01350089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93235761|NCT01350089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93235762|NCT01350089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242998|NCT02253758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92444084|NCT01654575|Abortifacient Agents|abortifacient agents|mesh-ancestor
93242999|NCT02253758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93235763|NCT01350089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444230|NCT01655303|Propranolol|propranolol|mesh-list
93235764|NCT01350089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93235766|NCT01350089|Purinergic Agents|purinergic agents|mesh-ancestor
93235767|NCT01350089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235768|NCT03137303|Albuterol|albuterol|mesh-list
93235769|NCT03137303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93235770|NCT03137303|Autonomic Agents|autonomic agents|mesh-ancestor
92444672|NCT01657409|Cholinergic Agents|cholinergic agents|mesh-ancestor
93235771|NCT03137303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235772|NCT03137303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235773|NCT03137303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93235774|NCT03137303|Respiratory System Agents|respiratory system agents|mesh-ancestor
93235775|NCT03137303|Tocolytic Agents|tocolytic agents|mesh-ancestor
92444951|NCT01658774|Albendazole|albendazole|mesh-list
93235776|NCT03137303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93235777|NCT03137303|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92445030|NCT01659099|Hormones|hormones|mesh-ancestor
93235778|NCT03137303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93235779|NCT03137303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93235780|NCT03137303|Adrenergic Agents|adrenergic agents|mesh-ancestor
93235781|NCT03137303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235782|NCT03137303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235783|NCT03296553|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92445243|NCT01660295|Certoparin|certoparin|mesh-list
93235784|NCT03296553|Valganciclovir|valganciclovir|mesh-list
93235785|NCT03296553|Antiviral Agents|antiviral agents|mesh-ancestor
92445298|NCT01660477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93235786|NCT03296553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235787|NCT01363375|Carbon Fiber|carbon fiber|mesh-list
93235788|NCT01363375|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93235789|NCT01363375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235790|NCT01370707|Metformin|metformin|mesh-list
93235791|NCT01370707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93235792|NCT01370707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235793|NCT01363531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93235794|NCT01363531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235795|NCT01363609|Insulin Glargine|insulin glargine|mesh-list
93235796|NCT01363609|Liraglutide|liraglutide|mesh-list
93235797|NCT01363609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92445809|NCT01664650|Genistein|genistein|mesh-list
93235798|NCT01363609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235799|NCT01363609|Incretins|incretins|mesh-ancestor
93235800|NCT01363609|Hormones|hormones|mesh-ancestor
93243000|NCT02253758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446030|NCT01665638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93243001|NCT02253758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93235801|NCT01363609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235802|NCT03060447|Vesatolimod|vesatolimod|mesh-list
93235803|NCT03060447|Antiviral Agents|antiviral agents|mesh-ancestor
92446250|NCT01667315|Anesthetics|anesthetics|mesh-ancestor
93235804|NCT03060447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235805|NCT04623567|Metformin|metformin|mesh-list
93235806|NCT04623567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93235807|NCT04623567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235808|NCT01712789|Dexamethasone|dexamethasone|mesh-list
93235809|NCT01712789|Pomalidomide|pomalidomide|mesh-list
93235810|NCT01712789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446490|NCT01668927|Antacids|antacids|mesh-ancestor
93235811|NCT01712789|Antiemetics|antiemetics|mesh-ancestor
93235812|NCT01712789|Autonomic Agents|autonomic agents|mesh-ancestor
93235813|NCT01712789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243002|NCT02253758|Anesthetics, General|anesthetics, general|mesh-ancestor
93235814|NCT01712789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235815|NCT01712789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235816|NCT01712789|Glucocorticoids|glucocorticoids|mesh-ancestor
93235817|NCT01712789|Hormones|hormones|mesh-ancestor
93243003|NCT02253758|Anesthetics|anesthetics|mesh-ancestor
93243004|NCT03547232|Indomethacin|indomethacin|mesh-list
93243005|NCT03547232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446886|NCT01679093|Dexamethasone|dexamethasone|mesh-list
93235818|NCT01712789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446961|NCT05596669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93235819|NCT01712789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93235820|NCT01712789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235821|NCT01712789|Immunologic Factors|immunologic factors|mesh-ancestor
93235822|NCT01712789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93235823|NCT01712789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93235824|NCT01712789|Growth Substances|growth substances|mesh-ancestor
93235825|NCT01712789|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235826|NCT01350323|Bevacizumab|bevacizumab|mesh-list
93235827|NCT01350323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235828|NCT01350323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235829|NCT01350323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93235830|NCT01350323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93235831|NCT01350323|Growth Substances|growth substances|mesh-ancestor
93235832|NCT01350323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235833|NCT01350323|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235834|NCT03074318|Avelumab|avelumab|mesh-list
93235835|NCT03074318|Trabectedin|trabectedin|mesh-list
93235836|NCT03074318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92447475|NCT03722927|Anesthetics|anesthetics|mesh-ancestor
93235837|NCT03074318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235838|NCT03074318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235839|NCT03074318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93235840|NCT03074318|Alkylating Agents|alkylating agents|mesh-ancestor
93235841|NCT03074318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235842|NCT03074318|Immunologic Factors|immunologic factors|mesh-ancestor
92447872|NCT05837286|Cortisone|cortisone|mesh-list
93235843|NCT03074318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235844|NCT02071316|Esomeprazole|esomeprazole|mesh-list
92447935|NCT05834049|GABA Agents|gaba agents|mesh-ancestor
93235845|NCT02071316|Tranexamic Acid|tranexamic acid|mesh-list
92448001|NCT05769868|Adrenergic Agents|adrenergic agents|mesh-ancestor
92172977|NCT01332357|Hormones|hormones|mesh-ancestor
93235846|NCT02071316|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93235847|NCT02071316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93235848|NCT02071316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235849|NCT02071316|Hemostatics|hemostatics|mesh-ancestor
93235850|NCT02071316|Coagulants|coagulants|mesh-ancestor
93235851|NCT02071316|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93235852|NCT02071316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235853|NCT02071316|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93235854|NCT02071316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235855|NCT02074202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93235856|NCT02074202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93235857|NCT02074202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235858|NCT02074280|Rifaximin|rifaximin|mesh-list
93235859|NCT02074280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93235860|NCT02074280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235861|NCT02074280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235862|NCT02077946|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93235863|NCT02077946|Liraglutide|liraglutide|mesh-list
93235864|NCT02077946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93235865|NCT02077946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235866|NCT02077946|Incretins|incretins|mesh-ancestor
93235867|NCT02077946|Hormones|hormones|mesh-ancestor
93243006|NCT03547232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93235868|NCT02077946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93235869|NCT02077946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92448889|NCT01690533|Moxifloxacin|moxifloxacin|mesh-list
93235870|NCT02077946|Protease Inhibitors|protease inhibitors|mesh-ancestor
93235871|NCT02077946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235872|NCT02077946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235873|NCT03559790|Tenofovir|tenofovir|mesh-list
93235874|NCT03559790|Antiviral Agents|antiviral agents|mesh-ancestor
93235875|NCT03559790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449027|NCT01691001|Analgesics|analgesics|mesh-ancestor
93235876|NCT03559790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93235877|NCT03559790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93235878|NCT03559790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243007|NCT03547232|Analgesics|analgesics|mesh-ancestor
93243008|NCT03547232|Sensory System Agents|sensory system agents|mesh-ancestor
93235879|NCT03559790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235880|NCT03559790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92449396|NCT05288738|Analgesics|analgesics|mesh-ancestor
93235881|NCT03559790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93235882|NCT02079974|Pravastatin|pravastatin|mesh-list
93235883|NCT02079974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93235884|NCT02079974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93235885|NCT02079974|Antimetabolites|antimetabolites|mesh-ancestor
93235886|NCT02079974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235887|NCT02079974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93235888|NCT02079974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93235889|NCT02079974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235890|NCT01353755|Immunomodulating Agents|immunomodulating agents|mesh-list
93235891|NCT01353755|Immunologic Factors|immunologic factors|mesh-ancestor
93235892|NCT01353755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235893|NCT01317953|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93235894|NCT01317953|Antioxidants|antioxidants|mesh-ancestor
92449682|NCT05294666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235895|NCT01317953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235896|NCT01317953|Protective Agents|protective agents|mesh-ancestor
93235897|NCT01317953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235898|NCT01317953|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93235899|NCT01317953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93235900|NCT01317953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235901|NCT01317953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93235902|NCT02078336|Atropine|atropine|mesh-list
93235903|NCT02078336|Midazolam|midazolam|mesh-list
93235904|NCT02078336|Droperidol|droperidol|mesh-list
93235905|NCT02078336|Lorazepam|lorazepam|mesh-list
93235906|NCT02078336|Biperiden|biperiden|mesh-list
93235907|NCT02078336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93235908|NCT02078336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93235909|NCT02078336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450051|NCT05220826|Ethylene|ethylene|mesh-list
93235910|NCT02078336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235911|NCT02078336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93235912|NCT02078336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93235913|NCT02078336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92450201|NCT05008926|Naloxegol|naloxegol|mesh-list
93235914|NCT02078336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93235915|NCT02078336|Anesthetics, General|anesthetics, general|mesh-ancestor
93235916|NCT02078336|Anesthetics|anesthetics|mesh-ancestor
93235917|NCT02078336|GABA Modulators|gaba modulators|mesh-ancestor
93235918|NCT02078336|GABA Agents|gaba agents|mesh-ancestor
93235919|NCT02078336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235920|NCT02078336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450421|NCT04602078|Gemcitabine|gemcitabine|mesh-list
92450496|NCT04490707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235921|NCT02078336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93235922|NCT02078336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93235923|NCT02078336|Autonomic Agents|autonomic agents|mesh-ancestor
93235924|NCT02078336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93235925|NCT02078336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93235926|NCT02078336|Respiratory System Agents|respiratory system agents|mesh-ancestor
92450798|NCT03993249|Nivolumab|nivolumab|mesh-list
93235927|NCT02078336|Mydriatics|mydriatics|mesh-ancestor
93235928|NCT02078336|Parasympatholytics|parasympatholytics|mesh-ancestor
93235929|NCT02078336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93235930|NCT02078336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93235931|NCT02078336|Cholinergic Agents|cholinergic agents|mesh-ancestor
93235932|NCT02078336|Anticonvulsants|anticonvulsants|mesh-ancestor
93235933|NCT02078336|Antiemetics|antiemetics|mesh-ancestor
93235934|NCT02078336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93235935|NCT02078336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93235936|NCT02078336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93235937|NCT02078336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92451095|NCT05798663|Atezolizumab|atezolizumab|mesh-list
93235938|NCT02078336|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93235939|NCT02078336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93235940|NCT02078336|Dopamine Agents|dopamine agents|mesh-ancestor
93235941|NCT01353833|Aldesleukin|aldesleukin|mesh-list
93235942|NCT01353833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235943|NCT01353833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93235944|NCT01353833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93235945|NCT01353833|Antiviral Agents|antiviral agents|mesh-ancestor
93235946|NCT01353833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235947|NCT03353675|Nivolumab|nivolumab|mesh-list
93235948|NCT03353675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451445|NCT04991480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93235949|NCT03353675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235950|NCT03353675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451520|NCT04824092|Glucocorticoids|glucocorticoids|mesh-ancestor
93235951|NCT03353675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235952|NCT01350713|Povidone-Iodine|povidone-iodine|mesh-list
93235953|NCT01350713|Povidone|povidone|mesh-list
93235954|NCT01350713|Plasma Substitutes|plasma substitutes|mesh-ancestor
92451670|NCT04112498|Nivolumab|nivolumab|mesh-list
93235955|NCT01350713|Blood Substitutes|blood substitutes|mesh-ancestor
93235956|NCT01350713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93235957|NCT01350713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235958|NCT02075294|Entecavir|entecavir|mesh-list
93235959|NCT02075294|Adefovir|adefovir|mesh-list
93235960|NCT02075294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93235961|NCT02075294|Antiviral Agents|antiviral agents|mesh-ancestor
93235962|NCT02075294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93235963|NCT02075294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93235964|NCT02075294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93235965|NCT02075294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243009|NCT03547232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452179|NCT03770299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93235966|NCT02075294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93235967|NCT01357967|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93235968|NCT01357967|Antidepressive Agents|antidepressive agents|mesh-ancestor
93235969|NCT01357967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93235970|NCT01357967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93235971|NCT01357967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92452480|NCT03242772|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93235972|NCT01357967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452553|NCT05437471|Progestins|progestins|mesh-ancestor
93235973|NCT01357967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235974|NCT02075528|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93235975|NCT02075528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92452701|NCT03230097|BI 409306|bi 409306|mesh-list
93235976|NCT02075528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93235977|NCT02075528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452850|NCT03126812|Paclitaxel|paclitaxel|mesh-list
93235978|NCT02075528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235979|NCT02075528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93235980|NCT02075528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93235981|NCT02075528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93235982|NCT02075528|Serotonin Agents|serotonin agents|mesh-ancestor
92453079|NCT02497131|Immunotoxins|immunotoxins|mesh-ancestor
93235983|NCT02075528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93235984|NCT02075528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453162|NCT02363998|Analgesics|analgesics|mesh-ancestor
92453224|NCT02162563|Irinotecan|irinotecan|mesh-list
92453299|NCT02040857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92453372|NCT01863186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93235985|NCT02075528|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93235986|NCT02075528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93235987|NCT02075528|Dopamine Agents|dopamine agents|mesh-ancestor
93235988|NCT02078648|Poly I-C|poly i-c|mesh-list
93235989|NCT02078648|Bevacizumab|bevacizumab|mesh-list
93235990|NCT02078648|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93235991|NCT02078648|Poly ICLC|poly iclc|mesh-list
93235992|NCT02078648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93235993|NCT02078648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453898|NCT01696422|Vaccines|vaccines|mesh-list
93235995|NCT02078648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93235996|NCT02078648|Growth Substances|growth substances|mesh-ancestor
93235997|NCT02078648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93235998|NCT02078648|Growth Inhibitors|growth inhibitors|mesh-ancestor
93235999|NCT02078648|Interferon Inducers|interferon inducers|mesh-ancestor
93236000|NCT02078648|Immunologic Factors|immunologic factors|mesh-ancestor
93236001|NCT02078648|Antiviral Agents|antiviral agents|mesh-ancestor
93236002|NCT02078648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236003|NCT02078648|Laxatives|laxatives|mesh-ancestor
92454280|NCT01698723|Ribavirin|ribavirin|mesh-list
93236004|NCT02078648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236005|NCT01358045|Calcitriol|calcitriol|mesh-list
93236006|NCT01358045|Diclofenac|diclofenac|mesh-list
93236007|NCT01358045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93236008|NCT01358045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236009|NCT01358045|Analgesics|analgesics|mesh-ancestor
93236010|NCT01358045|Sensory System Agents|sensory system agents|mesh-ancestor
93236011|NCT01358045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236012|NCT01358045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236013|NCT01358045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236014|NCT01358045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236015|NCT01358045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236016|NCT01358045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236017|NCT01358045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236018|NCT01358045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93236019|NCT01358045|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93236020|NCT01358045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93236021|NCT01358045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93236022|NCT01358045|Vitamins|vitamins|mesh-ancestor
93236023|NCT01358045|Micronutrients|micronutrients|mesh-ancestor
93236024|NCT01358045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93236025|NCT02076230|Phosphoramide Mustards|phosphoramide mustards|mesh-list
93236026|NCT02076230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93236027|NCT02076230|Alkylating Agents|alkylating agents|mesh-ancestor
93236028|NCT02076230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236029|NCT02076230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236030|NCT01357811|Digoxin|digoxin|mesh-list
93236031|NCT01357811|Eliglustat|eliglustat|mesh-list
93236032|NCT01357811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93236033|NCT01357811|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93236034|NCT01357811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243010|NCT03547232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455162|NCT01704339|Capsaicin|capsaicin|mesh-list
93236035|NCT01357811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236036|NCT01357811|Protective Agents|protective agents|mesh-ancestor
93236037|NCT01357811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236038|NCT04300985|Magnesium Sulfate|magnesium sulfate|mesh-list
93236039|NCT04300985|Dexmedetomidine|dexmedetomidine|mesh-list
93236040|NCT04300985|Anesthetics|anesthetics|mesh-list
93236041|NCT04300985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236042|NCT04300985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236043|NCT04300985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92455308|NCT01704898|Antiviral Agents|antiviral agents|mesh-ancestor
93236044|NCT04300985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236045|NCT04300985|Analgesics|analgesics|mesh-ancestor
92455373|NCT01705392|Propranolol|propranolol|mesh-list
93236046|NCT04300985|Sensory System Agents|sensory system agents|mesh-ancestor
93236047|NCT04300985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236048|NCT04300985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92455594|NCT01707160|Insulin Aspart|insulin aspart|mesh-list
93236049|NCT04300985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93236050|NCT04300985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92455751|NCT01707953|Midodrine|midodrine|mesh-list
93236051|NCT04300985|Adrenergic Agents|adrenergic agents|mesh-ancestor
93236052|NCT04300985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236053|NCT04300985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236054|NCT04300985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93236055|NCT04300985|Anticonvulsants|anticonvulsants|mesh-ancestor
92456103|NCT01710228|Antiemetics|antiemetics|mesh-ancestor
93236056|NCT04300985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92456183|NCT01710670|Ethanol|ethanol|mesh-list
93236057|NCT04300985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93236058|NCT04300985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93236059|NCT04300985|Tocolytic Agents|tocolytic agents|mesh-ancestor
93236060|NCT04300985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93236061|NCT02079194|Aspirin|aspirin|mesh-list
93236062|NCT02079194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93236063|NCT02079194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236064|NCT02079194|Analgesics|analgesics|mesh-ancestor
93236065|NCT02079194|Sensory System Agents|sensory system agents|mesh-ancestor
92456480|NCT01712113|Irbesartan|irbesartan|mesh-list
93236066|NCT02079194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908085|NCT04721977|Tucatinib|tucatinib|mesh-list
93236067|NCT02079194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456697|NCT01713166|Plasma-lyte 148|plasma-lyte 148|mesh-list
93236068|NCT02079194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236069|NCT02079194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236070|NCT02079194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93236071|NCT02079194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93236072|NCT02079194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457071|NCT01715142|Paclitaxel|paclitaxel|mesh-list
93236073|NCT02079194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93236074|NCT02079194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236075|NCT02079194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236076|NCT02079194|Antipyretics|antipyretics|mesh-ancestor
93236077|NCT01351493|Nitric Oxide|nitric oxide|mesh-list
93236078|NCT01351493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93236079|NCT01351493|Autonomic Agents|autonomic agents|mesh-ancestor
92457301|NCT01716637|Etanercept|etanercept|mesh-list
93236080|NCT01351493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236081|NCT01351493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236082|NCT01351493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93236083|NCT01351493|Respiratory System Agents|respiratory system agents|mesh-ancestor
93236084|NCT01351493|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93236085|NCT01351493|Antioxidants|antioxidants|mesh-ancestor
93243011|NCT03547232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236086|NCT01351493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236087|NCT01351493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236088|NCT01351493|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92457737|NCT01719042|Ondansetron|ondansetron|mesh-list
93236089|NCT01351493|Vasodilator Agents|vasodilator agents|mesh-ancestor
93236090|NCT01351493|Gasotransmitters|gasotransmitters|mesh-ancestor
93236091|NCT01351493|Protective Agents|protective agents|mesh-ancestor
93236092|NCT01318187|Acetaminophen|acetaminophen|mesh-list
93236093|NCT01318187|Morphine|morphine|mesh-list
93236094|NCT01318187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93236095|NCT01318187|Narcotics|narcotics|mesh-ancestor
93236096|NCT01318187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236097|NCT01318187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236098|NCT01318187|Analgesics|analgesics|mesh-ancestor
93236099|NCT01318187|Sensory System Agents|sensory system agents|mesh-ancestor
92458338|NCT01731457|Analgesics|analgesics|mesh-ancestor
93236100|NCT01318187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236101|NCT01318187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236102|NCT01318187|Antipyretics|antipyretics|mesh-ancestor
93236103|NCT01358435|Insulin|insulin|mesh-list
93236104|NCT01358435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92458488|NCT01732367|Tenofovir|tenofovir|mesh-list
93236105|NCT01358435|Insulin, Isophane|insulin, isophane|mesh-list
93236106|NCT01358435|Isophane Insulin, Human|isophane insulin, human|mesh-list
93236107|NCT01358435|Isophane insulin, beef|isophane insulin, beef|mesh-list
93236108|NCT01358435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92458631|NCT01733589|Etoposide|etoposide|mesh-list
93236109|NCT01358435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236110|NCT01318265|Ketoconazole|ketoconazole|mesh-list
93236111|NCT01318265|Antifungal Agents|antifungal agents|mesh-ancestor
93243012|NCT03547232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236112|NCT01318265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243013|NCT03547232|Gout Suppressants|gout suppressants|mesh-ancestor
93236113|NCT01318265|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93236114|NCT01318265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93236115|NCT01318265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236116|NCT01318265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458927|NCT01735669|Anesthetics|anesthetics|mesh-ancestor
93236117|NCT01318265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93236118|NCT01318265|Hormone Antagonists|hormone antagonists|mesh-ancestor
93236119|NCT01318265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236120|NCT01318265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236121|NCT01318265|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93236122|NCT01354457|Epratuzumab|epratuzumab|mesh-list
93236123|NCT01354457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236124|NCT01354457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236125|NCT02079350|Polygeline|polygeline|mesh-list
92459448|NCT01739218|Paclitaxel|paclitaxel|mesh-list
93236126|NCT02079350|Plasma Substitutes|plasma substitutes|mesh-ancestor
93236127|NCT02079350|Blood Substitutes|blood substitutes|mesh-ancestor
93236128|NCT03062540|Cyclobenzaprine|cyclobenzaprine|mesh-list
93236129|NCT03062540|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92459588|NCT01740271|Epirubicin|epirubicin|mesh-list
93236130|NCT03062540|Antidepressive Agents|antidepressive agents|mesh-ancestor
93236131|NCT03062540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93236132|NCT03062540|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93236133|NCT03062540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236134|NCT03062540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93236135|NCT03062540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236136|NCT03062540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92459734|NCT01741519|Esmolol|esmolol|mesh-list
93236137|NCT03062540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236138|NCT03060980|Empagliflozin|empagliflozin|mesh-list
93236139|NCT03060980|Glimepiride|glimepiride|mesh-list
93236140|NCT03060980|Exenatide|exenatide|mesh-list
93236141|NCT03060980|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93236142|NCT03060980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236143|NCT03060980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236144|NCT03060980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236145|NCT03060980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93236146|NCT03060980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93236147|NCT03060980|Immunologic Factors|immunologic factors|mesh-ancestor
93236148|NCT03060980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93236150|NCT03060980|Hormones|hormones|mesh-ancestor
93236151|NCT03060980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236152|NCT01358591|Calcium Carbonate|calcium carbonate|mesh-list
93236153|NCT01358591|Calcium|calcium|mesh-list
93243014|NCT03547232|Tocolytic Agents|tocolytic agents|mesh-ancestor
92460394|NCT01744964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236154|NCT01358591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460468|NCT01745601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92460542|NCT01745809|Chelating Agents|chelating agents|mesh-ancestor
93236155|NCT01358591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236156|NCT01358591|Antacids|antacids|mesh-ancestor
93236157|NCT01358591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236158|NCT01358591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236159|NCT02081144|Nicotine|nicotine|mesh-list
93236160|NCT02081144|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93236161|NCT02081144|Autonomic Agents|autonomic agents|mesh-ancestor
92460917|NCT01748279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93236162|NCT02081144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236163|NCT02081144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236164|NCT02081144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93236165|NCT02081144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93236166|NCT02081144|Cholinergic Agents|cholinergic agents|mesh-ancestor
93236167|NCT02081144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461214|NCT01749397|Floxuridine|floxuridine|mesh-list
93236168|NCT02081144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236169|NCT02083328|Mannitol|mannitol|mesh-list
93236170|NCT02083328|Caffeine|caffeine|mesh-list
93236171|NCT02083328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93236172|NCT02083328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461589|NCT01752205|Mitosis Modulators|mitosis modulators|mesh-ancestor
92461662|NCT01752959|Esmolol|esmolol|mesh-list
93236173|NCT02083328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93236174|NCT02083328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236175|NCT02083328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236176|NCT02083328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93236177|NCT02083328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93236178|NCT02083328|Purinergic Agents|purinergic agents|mesh-ancestor
93236179|NCT02083328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236180|NCT02083328|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93236181|NCT02083328|Diuretics|diuretics|mesh-ancestor
93236182|NCT02083328|Natriuretic Agents|natriuretic agents|mesh-ancestor
93236183|NCT02079506|Candesartan|candesartan|mesh-list
93236184|NCT02079506|Candesartan cilexetil|candesartan cilexetil|mesh-list
93236185|NCT02079506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93236186|NCT02079506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93236187|NCT02079506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93236188|NCT02079506|Antimetabolites|antimetabolites|mesh-ancestor
93236189|NCT02079506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462396|NCT01757587|Insulin|insulin|mesh-list
93236190|NCT02079506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93236191|NCT02079506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92462474|NCT01758029|Hormones|hormones|mesh-ancestor
93236192|NCT02079506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236193|NCT02079506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93243015|NCT03547232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462761|NCT01759706|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93236194|NCT02079506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93236195|NCT02079506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93236196|NCT02940548|Amlodipine|amlodipine|mesh-list
93236197|NCT02940548|Nifedipine|nifedipine|mesh-list
93236198|NCT02940548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92462897|NCT01760226|Rituximab|rituximab|mesh-list
93236199|NCT02940548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93236200|NCT02940548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463043|NCT01760694|Oxaliplatin|oxaliplatin|mesh-list
93236201|NCT02940548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236202|NCT02940548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93236203|NCT02940548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236204|NCT02940548|Vasodilator Agents|vasodilator agents|mesh-ancestor
93236205|NCT02940548|Tocolytic Agents|tocolytic agents|mesh-ancestor
93236206|NCT02940548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93236207|NCT01366183|Paclitaxel|paclitaxel|mesh-list
93236208|NCT01366183|Carboplatin|carboplatin|mesh-list
93236209|NCT01366183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93236210|NCT01366183|Lenograstim|lenograstim|mesh-list
93236211|NCT01366183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93236212|NCT01366183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236213|NCT01366183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908241|NCT04512235|Antiemetics|antiemetics|mesh-ancestor
93236214|NCT01366183|Antimitotic Agents|antimitotic agents|mesh-ancestor
93236215|NCT01366183|Mitosis Modulators|mitosis modulators|mesh-ancestor
93243016|NCT03547232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236216|NCT01366183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236217|NCT01366183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93236218|NCT01366183|Immunologic Factors|immunologic factors|mesh-ancestor
93236219|NCT01366183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236220|NCT03134183|Misoprostol|misoprostol|mesh-list
93236221|NCT03134183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93236222|NCT03134183|Abortifacient Agents|abortifacient agents|mesh-ancestor
93236223|NCT03134183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93236224|NCT03134183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236225|NCT03134183|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93236226|NCT03134183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464128|NCT01766609|Hormones|hormones|mesh-ancestor
93236227|NCT03134183|Oxytocics|oxytocics|mesh-ancestor
93236228|NCT02083484|Pembrolizumab|pembrolizumab|mesh-list
93236229|NCT02083484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236230|NCT02083484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236231|NCT02083484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243017|NCT03547232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236232|NCT02083484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236233|NCT01354613|Amlodipine|amlodipine|mesh-list
93236234|NCT01354613|Dobutamine|dobutamine|mesh-list
92464433|NCT01768377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93236235|NCT01354613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93236236|NCT01354613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93236237|NCT01354613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464506|NCT01768663|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93236238|NCT01354613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464655|NCT01769651|Analgesics|analgesics|mesh-ancestor
93236239|NCT01354613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93236240|NCT01354613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236241|NCT01354613|Vasodilator Agents|vasodilator agents|mesh-ancestor
93236242|NCT01354613|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93236243|NCT01354613|Sympathomimetics|sympathomimetics|mesh-ancestor
93236244|NCT01354613|Autonomic Agents|autonomic agents|mesh-ancestor
93236245|NCT01354613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464951|NCT01771081|Growth Substances|growth substances|mesh-ancestor
93236246|NCT01354613|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93236247|NCT01354613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93236248|NCT01354613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93236249|NCT01354613|Adrenergic Agents|adrenergic agents|mesh-ancestor
93236250|NCT01354613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236251|NCT01354613|Protective Agents|protective agents|mesh-ancestor
93236252|NCT02083640|Palbociclib|palbociclib|mesh-list
93236253|NCT02083640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465238|NCT01773096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93236254|NCT02083640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93236255|NCT02083640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236256|NCT02083640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465388|NCT01774474|BB 1101|bb 1101|mesh-list
93236257|NCT01352039|Heparin|heparin|mesh-list
93236258|NCT01352039|Calcium heparin|calcium heparin|mesh-list
93236259|NCT01352039|Anticoagulants|anticoagulants|mesh-ancestor
93236260|NCT01352039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93236261|NCT01352039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93236262|NCT01352039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236263|NCT04419337|Metformin|metformin|mesh-list
93236264|NCT04419337|Pioglitazone|pioglitazone|mesh-list
93236265|NCT04419337|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93236266|NCT04419337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236267|NCT04419337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465758|NCT01778192|Chelating Agents|chelating agents|mesh-ancestor
92465829|NCT01778803|Paclitaxel|paclitaxel|mesh-list
93236268|NCT04419337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236269|NCT01359059|Pregabalin|pregabalin|mesh-list
93236270|NCT01359059|Analgesics|analgesics|mesh-ancestor
93236271|NCT01359059|Sensory System Agents|sensory system agents|mesh-ancestor
93236272|NCT01359059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236273|NCT01359059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236274|NCT01359059|Anticonvulsants|anticonvulsants|mesh-ancestor
93236275|NCT01359059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93236276|NCT01359059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92466281|NCT01781988|Gemcitabine|gemcitabine|mesh-list
92466357|NCT01782651|Antimetabolites|antimetabolites|mesh-ancestor
93236277|NCT01359059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466508|NCT01783756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236278|NCT01359059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93236279|NCT01359059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93236280|NCT01359059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92466733|NCT01785108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236281|NCT01359059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236282|NCT01359059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93236283|NCT05189093|Antibodies|antibodies|mesh-list
93236284|NCT05189093|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93236285|NCT05189093|Immunologic Factors|immunologic factors|mesh-ancestor
93236286|NCT05189093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236287|NCT01371331|Tacrolimus|tacrolimus|mesh-list
93236288|NCT01371331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93236289|NCT01371331|Immunologic Factors|immunologic factors|mesh-ancestor
92466959|NCT01786382|Midazolam|midazolam|mesh-list
93236290|NCT01371331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236291|NCT01371331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93236292|NCT01371331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236293|NCT01371331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236294|NCT01366339|Methylnaltrexone|methylnaltrexone|mesh-list
93236295|NCT01366339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93236296|NCT01366339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467184|NCT01788332|Olaparib|olaparib|mesh-list
93236297|NCT01366339|Sensory System Agents|sensory system agents|mesh-ancestor
93236298|NCT01366339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236299|NCT03133793|Coenzyme Q10|coenzyme q10|mesh-list
93236300|NCT03133793|Vitamins|vitamins|mesh-ancestor
93236301|NCT03133793|Micronutrients|micronutrients|mesh-ancestor
93236302|NCT03133793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236303|NCT03133481|Ropivacaine|ropivacaine|mesh-list
93236304|NCT03133481|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236305|NCT03133481|Anesthetics|anesthetics|mesh-ancestor
93236306|NCT03133481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236307|NCT03133481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236308|NCT03133481|Sensory System Agents|sensory system agents|mesh-ancestor
93236309|NCT03133481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236310|NCT01366651|Doripenem|doripenem|mesh-list
93236311|NCT01366651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93236312|NCT01366651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236313|NCT05124509|Vaccines|vaccines|mesh-list
93236314|NCT05124509|Immunologic Factors|immunologic factors|mesh-ancestor
93236315|NCT05124509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236316|NCT02864316|Nivolumab|nivolumab|mesh-list
93236317|NCT02864316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236318|NCT02864316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468126|NCT01802918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93236319|NCT02864316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93236320|NCT02864316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236321|NCT03941509|Anti-Infective Agents|anti-infective agents|mesh-list
93236322|NCT03941509|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93236323|NCT01361399|Aspirin|aspirin|mesh-list
93236324|NCT01361399|Lidocaine|lidocaine|mesh-list
93236325|NCT01361399|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236326|NCT01361399|Anesthetics|anesthetics|mesh-ancestor
92468494|NCT01808495|Alkylating Agents|alkylating agents|mesh-ancestor
93236327|NCT01361399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468568|NCT01809158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468647|NCT01809743|Vasodilator Agents|vasodilator agents|mesh-ancestor
92468724|NCT01810458|Sensory System Agents|sensory system agents|mesh-ancestor
93236328|NCT01361399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236329|NCT01361399|Sensory System Agents|sensory system agents|mesh-ancestor
93236330|NCT01361399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236331|NCT01361399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468946|NCT01812018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236332|NCT01361399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93236333|NCT01361399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93236334|NCT01361399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93236335|NCT01361399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469169|NCT01813448|Fidaxomicin|fidaxomicin|mesh-list
93236336|NCT01361399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93236337|NCT01361399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236338|NCT01361399|Analgesics|analgesics|mesh-ancestor
93236339|NCT01361399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236340|NCT01361399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194373|NCT04149938|Lidocaine|lidocaine|mesh-list
93236341|NCT01361399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93236342|NCT01361399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93236343|NCT01361399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93236344|NCT01361399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236345|NCT01361399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236346|NCT01361399|Antipyretics|antipyretics|mesh-ancestor
93236347|NCT02862600|Perhexiline|perhexiline|mesh-list
92469758|NCT01816646|Probenecid|probenecid|mesh-list
93236348|NCT02862600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92469833|NCT01817322|Methylprednisolone|methylprednisolone|mesh-list
93236349|NCT02862600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93236350|NCT02862600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469975|NCT01818232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236351|NCT02862600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93236352|NCT02862600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236353|NCT02862600|Vasodilator Agents|vasodilator agents|mesh-ancestor
93236354|NCT01354925|Insulin|insulin|mesh-list
93236355|NCT01354925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236356|NCT01354925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236357|NCT03556345|Trastuzumab|trastuzumab|mesh-list
93236358|NCT03556345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236359|NCT03556345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236360|NCT03610230|Iron|iron|mesh-list
93236361|NCT03610230|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92470484|NCT01821612|Antidotes|antidotes|mesh-ancestor
93236362|NCT03610230|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93236363|NCT03610230|Ferric Compounds|ferric compounds|mesh-list
92470562|NCT01822405|Antioxidants|antioxidants|mesh-ancestor
93236364|NCT03610230|Trace Elements|trace elements|mesh-ancestor
93236365|NCT03610230|Micronutrients|micronutrients|mesh-ancestor
92470708|NCT01823159|Ezogabine|ezogabine|mesh-list
93236366|NCT03610230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236367|NCT03610230|Hematinics|hematinics|mesh-ancestor
93236368|NCT01359605|Varespladib methyl|varespladib methyl|mesh-list
93236369|NCT01359605|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93236370|NCT01359605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471020|NCT01825603|Cisplatin|cisplatin|mesh-list
93236371|NCT01359605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236372|NCT05188859|Pemetrexed|pemetrexed|mesh-list
93236373|NCT05188859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236374|NCT05188859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471223|NCT01827293|GABA Modulators|gaba modulators|mesh-ancestor
93236375|NCT05188859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236376|NCT05188859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93236377|NCT05188859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93236378|NCT02033538|Paclitaxel|paclitaxel|mesh-list
93236379|NCT02033538|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93236380|NCT02033538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92471526|NCT01829802|Ritonavir|ritonavir|mesh-list
93236381|NCT02033538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236382|NCT02033538|Tubulin Modulators|tubulin modulators|mesh-ancestor
93236383|NCT02033538|Antimitotic Agents|antimitotic agents|mesh-ancestor
93236384|NCT02033538|Mitosis Modulators|mitosis modulators|mesh-ancestor
93236385|NCT02033538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236386|NCT02792192|Atezolizumab|atezolizumab|mesh-list
93236387|NCT02792192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93236388|NCT02792192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471881|NCT01840774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92471956|NCT01841294|Sensory System Agents|sensory system agents|mesh-ancestor
93236389|NCT02792192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236390|NCT02792192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472116|NCT01842256|Amlodipine|amlodipine|mesh-list
93236391|NCT03609996|Ranibizumab|ranibizumab|mesh-list
93236392|NCT03609996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92472177|NCT01842529|Cholinergic Agents|cholinergic agents|mesh-ancestor
93236393|NCT03609996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93236394|NCT03609996|Growth Substances|growth substances|mesh-ancestor
93236395|NCT03609996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236396|NCT03609996|Growth Inhibitors|growth inhibitors|mesh-ancestor
93236397|NCT03609996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236398|NCT02088008|Valsartan|valsartan|mesh-list
93236399|NCT02088008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93236400|NCT02088008|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93236401|NCT02088008|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93236402|NCT02088008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236403|NCT01361789|Dexamethasone|dexamethasone|mesh-list
93236404|NCT01361789|Dexamethasone acetate|dexamethasone acetate|mesh-list
93236405|NCT01361789|Etoricoxib|etoricoxib|mesh-list
93236406|NCT01361789|Parecoxib|parecoxib|mesh-list
93236407|NCT01361789|Valdecoxib|valdecoxib|mesh-list
93236408|NCT01361789|BB 1101|bb 1101|mesh-list
92472841|NCT01846650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236409|NCT01361789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236410|NCT01361789|Antiemetics|antiemetics|mesh-ancestor
93236411|NCT01361789|Autonomic Agents|autonomic agents|mesh-ancestor
92472993|NCT01847872|Vaccines|vaccines|mesh-list
93236412|NCT01361789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473149|NCT01848769|Hormones|hormones|mesh-ancestor
93236413|NCT01361789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236414|NCT01361789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236415|NCT01361789|Glucocorticoids|glucocorticoids|mesh-ancestor
93236416|NCT01361789|Hormones|hormones|mesh-ancestor
93236417|NCT01361789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236418|NCT01361789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92473287|NCT01850147|Sunitinib|sunitinib|mesh-list
93236419|NCT01361789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236420|NCT01361789|Protease Inhibitors|protease inhibitors|mesh-ancestor
92473437|NCT01851265|Olaparib|olaparib|mesh-list
93236421|NCT01361789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236422|NCT01361789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473607|NCT01852266|Vaccines|vaccines|mesh-list
93236423|NCT01361789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92473655|NCT01852539|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473729|NCT01853111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93236424|NCT01361789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473808|NCT01853956|Alprazolam|alprazolam|mesh-list
93236425|NCT01361789|Analgesics|analgesics|mesh-ancestor
93236426|NCT01361789|Sensory System Agents|sensory system agents|mesh-ancestor
93236427|NCT01361789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236428|NCT01361789|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93236429|NCT01361789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236430|NCT02964507|Fulvestrant|fulvestrant|mesh-list
93236431|NCT02964507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93236432|NCT02964507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236433|NCT02964507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93236434|NCT02964507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93236435|NCT02964507|Hormone Antagonists|hormone antagonists|mesh-ancestor
93236436|NCT02964507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236437|NCT02964507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236438|NCT02083874|Cannabidiol|cannabidiol|mesh-list
93236439|NCT02083874|Anticonvulsants|anticonvulsants|mesh-ancestor
93236440|NCT05188781|Pembrolizumab|pembrolizumab|mesh-list
93236441|NCT05188781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236442|NCT05188781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236443|NCT05188781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93236444|NCT05188781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236445|NCT03634735|Thiamine|thiamine|mesh-list
93236446|NCT03634735|Vitamins|vitamins|mesh-ancestor
93236447|NCT03634735|Micronutrients|micronutrients|mesh-ancestor
93236448|NCT03634735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236449|NCT03634735|Vitamin B Complex|vitamin b complex|mesh-ancestor
93236450|NCT02084342|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93236451|NCT02084342|Tranexamic Acid|tranexamic acid|mesh-list
93236452|NCT02084342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93236453|NCT02084342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92474621|NCT01858090|Levobupivacaine|levobupivacaine|mesh-list
93236454|NCT02084342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236455|NCT02084342|Hemostatics|hemostatics|mesh-ancestor
93236456|NCT02084342|Coagulants|coagulants|mesh-ancestor
92474772|NCT01858623|Diuretics|diuretics|mesh-ancestor
93236457|NCT02084342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93236458|NCT02084342|Natriuretic Agents|natriuretic agents|mesh-ancestor
93236459|NCT02084342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236460|NCT01371487|Trametinib|trametinib|mesh-list
92474986|NCT01860144|Growth Inhibitors|growth inhibitors|mesh-ancestor
93236461|NCT01371487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236462|NCT01371487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93236463|NCT01371487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236464|NCT01371487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236465|NCT02084420|Pantoprazole|pantoprazole|mesh-list
93236466|NCT02084420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93236467|NCT02084420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236468|NCT02084420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93236469|NCT02084420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236470|NCT02084420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236471|NCT01367431|Xanthohumol|xanthohumol|mesh-list
93236472|NCT01367431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475575|NCT01863888|Immunologic Factors|immunologic factors|mesh-ancestor
93236473|NCT01367431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93236474|NCT01367431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93236475|NCT01367431|Growth Substances|growth substances|mesh-ancestor
92475722|NCT01865201|Mannitol|mannitol|mesh-list
92475800|NCT01865760|Octreotide|octreotide|mesh-list
93236476|NCT01367431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236477|NCT01367431|Growth Inhibitors|growth inhibitors|mesh-ancestor
93236478|NCT01367509|Methylnaltrexone|methylnaltrexone|mesh-list
93236479|NCT01367509|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93236480|NCT01367509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475951|NCT01867281|Aspirin|aspirin|mesh-list
93236481|NCT01367509|Sensory System Agents|sensory system agents|mesh-ancestor
92476109|NCT01868464|BCG Vaccine|bcg vaccine|mesh-list
93236482|NCT01367509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236483|NCT01364701|Sildenafil Citrate|sildenafil citrate|mesh-list
93236484|NCT01364701|Tadalafil|tadalafil|mesh-list
93236485|NCT01364701|Vasodilator Agents|vasodilator agents|mesh-ancestor
92476247|NCT01869569|Pregabalin|pregabalin|mesh-list
92476320|NCT01870011|Propofol|propofol|mesh-list
93236486|NCT01364701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92476472|NCT01870466|Cilostazol|cilostazol|mesh-list
93236487|NCT01364701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93236488|NCT01364701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476615|NCT01871649|Methotrexate|methotrexate|mesh-list
93236489|NCT01364701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236490|NCT01364701|Urological Agents|urological agents|mesh-ancestor
93236491|NCT02440464|Fludarabine|fludarabine|mesh-list
93236492|NCT02440464|Bortezomib|bortezomib|mesh-list
93236493|NCT02440464|Melphalan|melphalan|mesh-list
93236494|NCT02440464|Ixazomib|ixazomib|mesh-list
93236495|NCT02440464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236496|NCT02440464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236497|NCT02440464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93236498|NCT02440464|Immunologic Factors|immunologic factors|mesh-ancestor
93236499|NCT02440464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477064|NCT05855629|Sensory System Agents|sensory system agents|mesh-ancestor
93236500|NCT02440464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93236501|NCT02440464|Alkylating Agents|alkylating agents|mesh-ancestor
93236502|NCT02440464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93236503|NCT02440464|Protease Inhibitors|protease inhibitors|mesh-ancestor
93236504|NCT02440464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236505|NCT01367587|Methylnaltrexone|methylnaltrexone|mesh-list
93236506|NCT01367587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93236507|NCT01367587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477501|NCT05416580|Metformin|metformin|mesh-list
93236508|NCT01367587|Sensory System Agents|sensory system agents|mesh-ancestor
93236509|NCT01367587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236510|NCT02088398|Ricolinostat|ricolinostat|mesh-list
93236511|NCT02088398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236512|NCT02088398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92477728|NCT04957615|Nivolumab|nivolumab|mesh-list
93236513|NCT02088398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477794|NCT04788667|Sensory System Agents|sensory system agents|mesh-ancestor
93236514|NCT02088398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236515|NCT02084576|Ketorolac|ketorolac|mesh-list
93236516|NCT02084576|Nepafenac|nepafenac|mesh-list
93236517|NCT02084576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93236518|NCT02084576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236519|NCT02084576|Analgesics|analgesics|mesh-ancestor
93236520|NCT02084576|Sensory System Agents|sensory system agents|mesh-ancestor
92478018|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93236521|NCT02084576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236522|NCT02084576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236523|NCT02084576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236524|NCT02084576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236525|NCT02084576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236526|NCT02084576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236527|NCT02084576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236528|NCT03131453|Umibecestat|umibecestat|mesh-list
93236529|NCT03131453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236530|NCT03131453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236531|NCT01364857|GTPase-Activating Proteins|gtpase-activating proteins|mesh-list
92478308|NCT03202316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236532|NCT01364857|GTP Phosphohydrolase Activators|gtp phosphohydrolase activators|mesh-ancestor
93236533|NCT01364857|Enzyme Activators|enzyme activators|mesh-ancestor
92478387|NCT02397226|Anesthetics|anesthetics|mesh-list
93236534|NCT01364857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236535|NCT02084654|Exenatide|exenatide|mesh-list
93236536|NCT02084654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236537|NCT02084654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236538|NCT02084654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93236539|NCT02084654|Incretins|incretins|mesh-ancestor
93236540|NCT02084654|Hormones|hormones|mesh-ancestor
93243018|NCT03547232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236541|NCT02084654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236542|NCT01367743|Epinephrine|epinephrine|mesh-list
93236543|NCT01367743|Norepinephrine|norepinephrine|mesh-list
93236544|NCT01367743|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93236545|NCT01367743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93236546|NCT01367743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93236547|NCT01367743|Adrenergic Agents|adrenergic agents|mesh-ancestor
93236548|NCT01367743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243019|NCT02250534|Nicotine|nicotine|mesh-list
93236549|NCT01367743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236550|NCT01367743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236551|NCT01367743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93236552|NCT01367743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93236553|NCT01367743|Autonomic Agents|autonomic agents|mesh-ancestor
93236554|NCT01367743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236555|NCT01367743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93236556|NCT01367743|Respiratory System Agents|respiratory system agents|mesh-ancestor
93236557|NCT01367743|Mydriatics|mydriatics|mesh-ancestor
93236558|NCT01367743|Sympathomimetics|sympathomimetics|mesh-ancestor
93236559|NCT02084732|Sorafenib|sorafenib|mesh-list
93236560|NCT02084732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236561|NCT02084732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93236562|NCT02084732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236563|NCT02084732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236564|NCT02780401|Vaccines|vaccines|mesh-list
93236565|NCT02780401|Sargramostim|sargramostim|mesh-list
93236566|NCT02780401|Immunologic Factors|immunologic factors|mesh-ancestor
93236567|NCT02780401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236568|NCT02533232|Minocycline|minocycline|mesh-list
93236569|NCT02533232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93236570|NCT02533232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236571|NCT02673151|Edetic Acid|edetic acid|mesh-list
93236572|NCT02673151|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93236573|NCT02673151|Chelating Agents|chelating agents|mesh-ancestor
93236574|NCT02673151|Sequestering Agents|sequestering agents|mesh-ancestor
93236575|NCT02673151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236576|NCT02673151|Anticoagulants|anticoagulants|mesh-ancestor
93236577|NCT02673151|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93236578|NCT02673151|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93236579|NCT02942277|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93236580|NCT02942277|Antimalarials|antimalarials|mesh-ancestor
93236581|NCT02942277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93236582|NCT02942277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93236583|NCT02942277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236584|NCT05042947|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93236585|NCT05042947|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93236586|NCT05042947|beta-Endorphin|beta-endorphin|mesh-list
93236587|NCT05042947|Hormones|hormones|mesh-ancestor
93236588|NCT05042947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236589|NCT05042947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236590|NCT05042947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236591|NCT05042947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236593|NCT02082236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93236594|NCT02082236|Narcotics|narcotics|mesh-ancestor
93236595|NCT02082236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236596|NCT02082236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236597|NCT02082236|Analgesics|analgesics|mesh-ancestor
93236598|NCT02082236|Sensory System Agents|sensory system agents|mesh-ancestor
93236599|NCT02082236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236600|NCT02082236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92479535|NCT01880385|Growth Substances|growth substances|mesh-ancestor
93236601|NCT02082236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93236602|NCT02082236|Anesthetics, General|anesthetics, general|mesh-ancestor
93236603|NCT02082236|Anesthetics|anesthetics|mesh-ancestor
93236604|NCT03557996|Listerine|listerine|mesh-list
93236605|NCT03557996|Fluorides|fluorides|mesh-list
93236606|NCT03557996|Sodium Fluoride|sodium fluoride|mesh-list
93236607|NCT03557996|Fluorides, Topical|fluorides, topical|mesh-list
93236608|NCT03557996|Cariostatic Agents|cariostatic agents|mesh-ancestor
93236609|NCT03557996|Protective Agents|protective agents|mesh-ancestor
92479828|NCT01883505|Levodopa|levodopa|mesh-list
92479914|NCT01884298|Lidocaine|lidocaine|mesh-list
92479982|NCT01884506|Ascorbic Acid|ascorbic acid|mesh-list
93236610|NCT03557996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480136|NCT01885481|BB 1101|bb 1101|mesh-list
93236611|NCT03557996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93236612|NCT03557996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236613|NCT02296801|Letrozole|letrozole|mesh-list
93236614|NCT02296801|Palbociclib|palbociclib|mesh-list
93236615|NCT02296801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236616|NCT02296801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93236617|NCT02296801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93236618|NCT02296801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243020|NCT02250534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93236619|NCT02296801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236620|NCT02296801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93236621|NCT02296801|Hormone Antagonists|hormone antagonists|mesh-ancestor
93243021|NCT02250534|Autonomic Agents|autonomic agents|mesh-ancestor
93243022|NCT02250534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236622|NCT02296801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236623|NCT02296801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236624|NCT02296801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93236625|NCT02859324|Nivolumab|nivolumab|mesh-list
93236626|NCT02859324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236627|NCT02859324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236628|NCT02859324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92481093|NCT01895049|Mycophenolic Acid|mycophenolic acid|mesh-list
93236629|NCT02859324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236630|NCT02085590|Vaccines|vaccines|mesh-list
93236631|NCT02085590|BCG Vaccine|bcg vaccine|mesh-list
93236632|NCT02085590|Immunologic Factors|immunologic factors|mesh-ancestor
93236633|NCT02085590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236634|NCT02085590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93236635|NCT02143063|Cocaine|cocaine|mesh-list
93236636|NCT02143063|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236637|NCT02143063|Anesthetics|anesthetics|mesh-ancestor
92481460|NCT01901276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236638|NCT02143063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236639|NCT02143063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236640|NCT02143063|Sensory System Agents|sensory system agents|mesh-ancestor
92481602|NCT01901861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481678|NCT01902550|Metoprolol|metoprolol|mesh-list
93236641|NCT02143063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236642|NCT02143063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93236643|NCT02143063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93236644|NCT02143063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93236645|NCT02143063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481828|NCT01903785|Albuterol|albuterol|mesh-list
92481898|NCT01904214|Siponimod|siponimod|mesh-list
93236646|NCT02143063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236647|NCT02143063|Dopamine Agents|dopamine agents|mesh-ancestor
93236648|NCT02143063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236649|NCT02088866|Lidocaine|lidocaine|mesh-list
93236650|NCT02088866|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236651|NCT02088866|Anesthetics|anesthetics|mesh-ancestor
92482124|NCT01905696|Acetylcysteine|acetylcysteine|mesh-list
93236652|NCT02088866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236653|NCT02088866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236654|NCT02088866|Sensory System Agents|sensory system agents|mesh-ancestor
92482273|NCT01907048|Anticoagulants|anticoagulants|mesh-ancestor
93236655|NCT02088866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236656|NCT02088866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93236657|NCT02088866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93236658|NCT02088866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93236659|NCT02088866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482422|NCT01907867|Finafloxacin|finafloxacin|mesh-list
93236660|NCT02088866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236661|NCT02859246|Guaifenesin|guaifenesin|mesh-list
93236662|NCT02859246|Expectorants|expectorants|mesh-ancestor
93236663|NCT02859246|Respiratory System Agents|respiratory system agents|mesh-ancestor
93236664|NCT02088944|Infliximab|infliximab|mesh-list
93236665|NCT02088944|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93236666|NCT02088944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236667|NCT02088944|Dermatologic Agents|dermatologic agents|mesh-ancestor
92482799|NCT01910415|Moxifloxacin|moxifloxacin|mesh-list
93236668|NCT02088944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236669|NCT02088944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236670|NCT02073097|Acyclovir|acyclovir|mesh-list
93236671|NCT02073097|Prednisone|prednisone|mesh-list
93236672|NCT02073097|Cyclophosphamide|cyclophosphamide|mesh-list
93236673|NCT02073097|Rituximab|rituximab|mesh-list
93236674|NCT02073097|Doxorubicin|doxorubicin|mesh-list
93236675|NCT02073097|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93236676|NCT02073097|Vincristine|vincristine|mesh-list
93236677|NCT02073097|Lenograstim|lenograstim|mesh-list
92483088|NCT01911975|Lacosamide|lacosamide|mesh-list
93236678|NCT02073097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93236679|NCT02073097|Immunologic Factors|immunologic factors|mesh-ancestor
93236680|NCT02073097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236681|NCT02073097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236682|NCT02073097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93236683|NCT02073097|Alkylating Agents|alkylating agents|mesh-ancestor
92483381|NCT01914042|Analgesics|analgesics|mesh-ancestor
93236684|NCT02073097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236685|NCT02073097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483526|NCT01914965|Dopamine Agents|dopamine agents|mesh-ancestor
93236686|NCT02073097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93236687|NCT02073097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93236688|NCT02073097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93236689|NCT02073097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93236690|NCT02073097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92483750|NCT01916447|Bevacizumab|bevacizumab|mesh-list
93236691|NCT02073097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483863|NCT01917045|Dsuvia|dsuvia|mesh-list
92483894|NCT01917097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93236692|NCT02073097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236693|NCT02073097|Glucocorticoids|glucocorticoids|mesh-ancestor
93236694|NCT02073097|Hormones|hormones|mesh-ancestor
92484193|NCT01918852|Capecitabine|capecitabine|mesh-list
93243023|NCT02250534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243024|NCT02250534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92484349|NCT01919905|Vitamin D|vitamin d|mesh-list
93243025|NCT02250534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92484496|NCT01924676|Oxycodone|oxycodone|mesh-list
93243026|NCT02250534|Cholinergic Agents|cholinergic agents|mesh-ancestor
93243027|NCT02250534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236695|NCT02073097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236696|NCT02073097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92484719|NCT01930864|Irinotecan|irinotecan|mesh-list
93236697|NCT02073097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93236698|NCT02073097|Tubulin Modulators|tubulin modulators|mesh-ancestor
93236699|NCT02073097|Antimitotic Agents|antimitotic agents|mesh-ancestor
93236700|NCT02073097|Mitosis Modulators|mitosis modulators|mesh-ancestor
93236701|NCT02073097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93236702|NCT02073097|Antiviral Agents|antiviral agents|mesh-ancestor
93236703|NCT02073097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236704|NCT02921997|Vaccines|vaccines|mesh-list
92485024|NCT01932554|Ibuprofen|ibuprofen|mesh-list
93236705|NCT02921997|Immunologic Factors|immunologic factors|mesh-ancestor
93236706|NCT02921997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236707|NCT02791490|Metformin|metformin|mesh-list
93236708|NCT02791490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93236709|NCT02791490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236710|NCT02791490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236711|NCT02791490|Incretins|incretins|mesh-ancestor
93236712|NCT02791490|Hormones|hormones|mesh-ancestor
93236713|NCT02791490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236714|NCT02791490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93236715|NCT02791490|Protease Inhibitors|protease inhibitors|mesh-ancestor
93236716|NCT02791490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236717|NCT02791490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236718|NCT04635631|Talazoparib|talazoparib|mesh-list
93236719|NCT04635631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93236720|NCT04635631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236721|NCT04635631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485679|NCT01936532|Dexamethasone|dexamethasone|mesh-list
92485749|NCT01937104|Desflurane|desflurane|mesh-list
93236722|NCT04635631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236723|NCT02085824|Enoxaparin|enoxaparin|mesh-list
93236724|NCT02085824|Rivaroxaban|rivaroxaban|mesh-list
93236725|NCT02085824|Dabigatran|dabigatran|mesh-list
93236726|NCT02085824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93236727|NCT02085824|Antithrombins|antithrombins|mesh-ancestor
92486043|NCT01938872|Tubulin Modulators|tubulin modulators|mesh-ancestor
93236728|NCT02085824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93236729|NCT02085824|Protease Inhibitors|protease inhibitors|mesh-ancestor
93236730|NCT02085824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236731|NCT02085824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236732|NCT02085824|Anticoagulants|anticoagulants|mesh-ancestor
93236733|NCT02085824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93236734|NCT02085824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93236735|NCT01368445|Azelastine|azelastine|mesh-list
93236736|NCT01368445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93236737|NCT01368445|Autonomic Agents|autonomic agents|mesh-ancestor
93236738|NCT01368445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486489|NCT01941173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92486567|NCT01941888|Anesthetics|anesthetics|mesh-ancestor
93236739|NCT01368445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236740|NCT01368445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93236741|NCT01368445|Respiratory System Agents|respiratory system agents|mesh-ancestor
93236742|NCT01368445|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93236743|NCT01368445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236744|NCT01368445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486863|NCT01943617|Entecavir|entecavir|mesh-list
93236745|NCT01368445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93236746|NCT01368445|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93236747|NCT01368445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93236748|NCT01368445|Histamine Antagonists|histamine antagonists|mesh-ancestor
93236749|NCT01368445|Histamine Agents|histamine agents|mesh-ancestor
93236750|NCT01368445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236752|NCT02085902|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236753|NCT02085902|Anesthetics|anesthetics|mesh-ancestor
93236754|NCT02085902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236755|NCT02085902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236756|NCT02085902|Sensory System Agents|sensory system agents|mesh-ancestor
93236757|NCT02085902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236758|NCT01368757|Lenalidomide|lenalidomide|mesh-list
93236759|NCT01368757|Immunologic Factors|immunologic factors|mesh-ancestor
92487295|NCT04773392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93236760|NCT01368757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487395|NCT04030429|Crizotinib|crizotinib|mesh-list
93236761|NCT01368757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93236762|NCT01368757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93236763|NCT01368757|Growth Substances|growth substances|mesh-ancestor
93236764|NCT01368757|Growth Inhibitors|growth inhibitors|mesh-ancestor
93236765|NCT01368757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236766|NCT02086292|Lidocaine|lidocaine|mesh-list
92487664|NCT04917055|Ropivacaine|ropivacaine|mesh-list
93236767|NCT02086292|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236768|NCT02086292|Anesthetics|anesthetics|mesh-ancestor
93236769|NCT02086292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236770|NCT02086292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236771|NCT02086292|Sensory System Agents|sensory system agents|mesh-ancestor
93236772|NCT02086292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487896|NCT02864368|Temozolomide|temozolomide|mesh-list
93236773|NCT02086292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93236774|NCT02086292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92487961|NCT02257346|Lidocaine|lidocaine|mesh-list
93236775|NCT02086292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92488040|NCT05414149|Ranibizumab|ranibizumab|mesh-list
93236776|NCT02086292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93236777|NCT02086292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236778|NCT02425644|Teriflunomide|teriflunomide|mesh-list
93236779|NCT02425644|Ponesimod|ponesimod|mesh-list
93236780|NCT02425644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93236781|NCT02425644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236782|NCT02425644|Analgesics|analgesics|mesh-ancestor
92488335|NCT03578276|Bromfenac|bromfenac|mesh-list
93236783|NCT02425644|Sensory System Agents|sensory system agents|mesh-ancestor
93236784|NCT02425644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488480|NCT01503632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236785|NCT02425644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236786|NCT02425644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488645|NCT01946607|Citalopram|citalopram|mesh-list
93236787|NCT02425644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488703|NCT01947062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236788|NCT02425644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93236789|NCT02425644|Immunologic Factors|immunologic factors|mesh-ancestor
92488851|NCT01948011|Thiorphan|thiorphan|mesh-list
93236790|NCT02425644|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92488926|NCT01948583|Viscosupplements|viscosupplements|mesh-ancestor
93236791|NCT02425644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236792|NCT02184741|Immunoglobulins|immunoglobulins|mesh-list
93236793|NCT02184741|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93236794|NCT02184741|gamma-Globulins|gamma-globulins|mesh-list
93236795|NCT02184741|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93236796|NCT02184741|Immunologic Factors|immunologic factors|mesh-ancestor
93236797|NCT02184741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236798|NCT02086526|Metformin|metformin|mesh-list
92489293|NCT01950884|Antimetabolites|antimetabolites|mesh-ancestor
93236799|NCT02086526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236800|NCT02086526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236801|NCT04180995|Axitinib|axitinib|mesh-list
92489366|NCT01951430|Posaconazole|posaconazole|mesh-list
93236802|NCT04180995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489438|NCT01951729|Atropine|atropine|mesh-list
93236803|NCT04180995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93236804|NCT04180995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236805|NCT04180995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236806|NCT02089178|Remifentanil|remifentanil|mesh-list
93236807|NCT02089178|Anesthetics|anesthetics|mesh-list
93236808|NCT02089178|Propofol|propofol|mesh-list
93236809|NCT02089178|Sevoflurane|sevoflurane|mesh-list
93236810|NCT02089178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236811|NCT02089178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489878|NCT05872789|Anesthetics, General|anesthetics, general|mesh-ancestor
93236812|NCT02089178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92908851|NCT03399539|Venetoclax|venetoclax|mesh-list
93236813|NCT02089178|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92490027|NCT05698407|Dsuvia|dsuvia|mesh-list
93236814|NCT02089178|Anesthetics, General|anesthetics, general|mesh-ancestor
93236815|NCT02089178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92490170|NCT05312645|Analgesics|analgesics|mesh-ancestor
92490245|NCT05044962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236816|NCT02089178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93236817|NCT02089178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93236818|NCT02089178|Narcotics|narcotics|mesh-ancestor
93236819|NCT02089178|Analgesics|analgesics|mesh-ancestor
93236820|NCT02089178|Sensory System Agents|sensory system agents|mesh-ancestor
92490394|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236821|NCT02089178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236822|NCT02089256|Liraglutide|liraglutide|mesh-list
93236823|NCT02089256|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92490539|NCT04198805|Vitamins|vitamins|mesh-list
93236824|NCT02089256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236825|NCT02089256|Incretins|incretins|mesh-ancestor
93236826|NCT02089256|Hormones|hormones|mesh-ancestor
93236827|NCT02089256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236828|NCT02861664|Fluorides|fluorides|mesh-list
93236829|NCT02861664|Tin Fluorides|tin fluorides|mesh-list
93236830|NCT02861664|Fluorophosphate|fluorophosphate|mesh-list
93236831|NCT02861664|Cariostatic Agents|cariostatic agents|mesh-ancestor
93236832|NCT02861664|Protective Agents|protective agents|mesh-ancestor
93236833|NCT02861664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236834|NCT02086838|Dextrans|dextrans|mesh-list
93236835|NCT02086838|Iron-Dextran Complex|iron-dextran complex|mesh-list
93236836|NCT02086838|Hematinics|hematinics|mesh-list
93236837|NCT02086838|Anticoagulants|anticoagulants|mesh-ancestor
93236838|NCT02086838|Plasma Substitutes|plasma substitutes|mesh-ancestor
93236839|NCT02086838|Blood Substitutes|blood substitutes|mesh-ancestor
93236840|NCT02236962|Pioglitazone|pioglitazone|mesh-list
93236841|NCT02236962|Ephedrine|ephedrine|mesh-list
93236842|NCT02236962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93236843|NCT02236962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236844|NCT02236962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93236845|NCT02236962|Sympathomimetics|sympathomimetics|mesh-ancestor
93236846|NCT02236962|Autonomic Agents|autonomic agents|mesh-ancestor
93236847|NCT02236962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236848|NCT02236962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93236849|NCT02236962|Adrenergic Agents|adrenergic agents|mesh-ancestor
93236850|NCT02236962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236851|NCT02236962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236852|NCT04431375|Tenofovir|tenofovir|mesh-list
93236853|NCT04431375|Antiviral Agents|antiviral agents|mesh-ancestor
93236854|NCT04431375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236855|NCT04431375|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93236856|NCT04431375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93236857|NCT04431375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491199|NCT01953406|Mitomycin|mitomycin|mesh-list
92491273|NCT01953744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491345|NCT01953848|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92491419|NCT01954043|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92491510|NCT01954914|Plerixafor|plerixafor|mesh-list
93236858|NCT04431375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236859|NCT04431375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93236860|NCT04431375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93236861|NCT02086994|Misoprostol|misoprostol|mesh-list
93236862|NCT02086994|Carbetocin|carbetocin|mesh-list
93236863|NCT02086994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93236864|NCT02086994|Abortifacient Agents|abortifacient agents|mesh-ancestor
93236865|NCT02086994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93236866|NCT02086994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236867|NCT02086994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93236868|NCT02086994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236869|NCT02086994|Oxytocics|oxytocics|mesh-ancestor
93236870|NCT05664711|Bupivacaine|bupivacaine|mesh-list
93236871|NCT05664711|Anesthetics, Local|anesthetics, local|mesh-ancestor
93236872|NCT05664711|Anesthetics|anesthetics|mesh-ancestor
93236873|NCT05664711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93236874|NCT05664711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236875|NCT05664711|Sensory System Agents|sensory system agents|mesh-ancestor
93236876|NCT05664711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236877|NCT02089568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93236878|NCT02089568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93236879|NCT02089568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236880|NCT02089568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93236881|NCT02089568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236882|NCT02089568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236883|NCT03284853|Latanoprost|latanoprost|mesh-list
93236884|NCT03284853|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93236885|NCT03284853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93236886|NCT02087384|Vaccines|vaccines|mesh-list
93236887|NCT02087384|Immunologic Factors|immunologic factors|mesh-ancestor
92491614|NCT01955200|Autonomic Agents|autonomic agents|mesh-ancestor
93236888|NCT02087384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236889|NCT02087462|Vitamins|vitamins|mesh-list
93236890|NCT02087462|Thiamine|thiamine|mesh-list
93236891|NCT02087462|Vitamin B Complex|vitamin b complex|mesh-list
93236893|NCT02087462|Micronutrients|micronutrients|mesh-ancestor
93236894|NCT02087462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236895|NCT02087462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93236896|NCT02087462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236897|NCT02087462|Analgesics|analgesics|mesh-ancestor
93236898|NCT02087462|Sensory System Agents|sensory system agents|mesh-ancestor
93236899|NCT02087462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236900|NCT02087462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236901|NCT02087462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236902|NCT02087462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93236903|NCT02087462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236904|NCT02087462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236905|NCT02087540|Telmisartan|telmisartan|mesh-list
93236906|NCT02087540|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93236907|NCT02087540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93236908|NCT02087540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93236909|NCT02087540|Antimetabolites|antimetabolites|mesh-ancestor
93236910|NCT02087540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236911|NCT02087540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93236912|NCT02087540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93236913|NCT02087540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236914|NCT02087540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93236915|NCT02087540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93236916|NCT02087540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93236917|NCT03055221|Treprostinil|treprostinil|mesh-list
93236918|NCT03055221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93236919|NCT03206463|Dronabinol|dronabinol|mesh-list
93236920|NCT03206463|Hallucinogens|hallucinogens|mesh-ancestor
93236921|NCT03206463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236922|NCT03206463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93236923|NCT03206463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236924|NCT03206463|Analgesics|analgesics|mesh-ancestor
93236925|NCT03206463|Sensory System Agents|sensory system agents|mesh-ancestor
93236926|NCT03206463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236927|NCT03206463|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93236928|NCT03206463|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93236929|NCT03206463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236930|NCT03206463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236931|NCT03206463|Hormones|hormones|mesh-ancestor
93236932|NCT03206463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236933|NCT02091674|Hyaluronic Acid|hyaluronic acid|mesh-list
93236934|NCT02091674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93236935|NCT02091674|Immunologic Factors|immunologic factors|mesh-ancestor
93236936|NCT02091674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236937|NCT02091674|Viscosupplements|viscosupplements|mesh-ancestor
93236938|NCT02091674|Protective Agents|protective agents|mesh-ancestor
93236939|NCT01218555|Lenalidomide|lenalidomide|mesh-list
93236940|NCT01218555|Everolimus|everolimus|mesh-list
93236941|NCT01218555|Immunologic Factors|immunologic factors|mesh-ancestor
93236942|NCT01218555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236943|NCT01218555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93236944|NCT01218555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93236945|NCT01218555|Growth Substances|growth substances|mesh-ancestor
93236946|NCT01218555|Growth Inhibitors|growth inhibitors|mesh-ancestor
93236947|NCT01218555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236948|NCT01218555|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93236949|NCT01218555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93236950|NCT01218555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236951|NCT01218555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236952|NCT01218555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93236953|NCT02091830|Acetaminophen|acetaminophen|mesh-list
93236954|NCT02091830|Cortisone|cortisone|mesh-list
93236955|NCT02091830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93236956|NCT02091830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93236957|NCT02091830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93236958|NCT02091830|Analgesics|analgesics|mesh-ancestor
93236959|NCT02091830|Sensory System Agents|sensory system agents|mesh-ancestor
93236960|NCT02091830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236961|NCT02091830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236962|NCT02091830|Antipyretics|antipyretics|mesh-ancestor
93236963|NCT02091830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93236964|NCT01111305|Diethylcarbamazine|diethylcarbamazine|mesh-list
93236965|NCT01111305|Reslizumab|reslizumab|mesh-list
93236966|NCT01111305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93236967|NCT01111305|Respiratory System Agents|respiratory system agents|mesh-ancestor
93236968|NCT01111305|Filaricides|filaricides|mesh-ancestor
93236969|NCT01111305|Antinematodal Agents|antinematodal agents|mesh-ancestor
93236970|NCT01111305|Anthelmintics|anthelmintics|mesh-ancestor
93236971|NCT01111305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93236972|NCT01111305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93236973|NCT01111305|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93236974|NCT01111305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93236975|NCT01111305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236976|NCT03752307|Prednisone|prednisone|mesh-list
93236977|NCT03752307|Methylprednisolone|methylprednisolone|mesh-list
93236978|NCT03752307|Isoxsuprine|isoxsuprine|mesh-list
93236979|NCT03752307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93236980|NCT03752307|Glucocorticoids|glucocorticoids|mesh-ancestor
93236981|NCT03752307|Hormones|hormones|mesh-ancestor
93236982|NCT03752307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93236983|NCT03752307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93236984|NCT03752307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93236985|NCT03752307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93236986|NCT03752307|Antiemetics|antiemetics|mesh-ancestor
93236987|NCT03752307|Autonomic Agents|autonomic agents|mesh-ancestor
93236988|NCT03752307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93236989|NCT03752307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93236990|NCT03752307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93236991|NCT03752307|Protective Agents|protective agents|mesh-ancestor
93236992|NCT03752307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93236993|NCT03752307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93236994|NCT03752307|Adrenergic Agents|adrenergic agents|mesh-ancestor
93236995|NCT03752307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93236996|NCT03752307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93236997|NCT03752307|Sympathomimetics|sympathomimetics|mesh-ancestor
93236998|NCT03752307|Vasodilator Agents|vasodilator agents|mesh-ancestor
93236999|NCT03752307|Tocolytic Agents|tocolytic agents|mesh-ancestor
93237000|NCT03752307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93237001|NCT00792831|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
93237002|NCT00792831|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93237003|NCT00792831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237004|NCT00792831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237005|NCT00496431|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
93237006|NCT00496431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93237007|NCT00496431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237008|NCT00496431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237009|NCT02091908|Lactitol|lactitol|mesh-list
93237010|NCT02091908|Vaccines|vaccines|mesh-list
93237011|NCT02091908|Immunologic Factors|immunologic factors|mesh-ancestor
93237012|NCT02091908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237013|NCT02091908|Cathartics|cathartics|mesh-ancestor
93237014|NCT02091908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237015|NCT03627897|Bupivacaine|bupivacaine|mesh-list
93237016|NCT03627897|Anesthetics, Local|anesthetics, local|mesh-ancestor
93237017|NCT03627897|Anesthetics|anesthetics|mesh-ancestor
93237018|NCT03627897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237019|NCT03627897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237020|NCT03627897|Sensory System Agents|sensory system agents|mesh-ancestor
93237021|NCT03627897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237022|NCT01372111|Cisplatin|cisplatin|mesh-list
93237023|NCT01372111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237024|NCT03125941|Dexamethasone|dexamethasone|mesh-list
93237025|NCT03125941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237026|NCT03125941|Antiemetics|antiemetics|mesh-ancestor
93237027|NCT03125941|Autonomic Agents|autonomic agents|mesh-ancestor
93237028|NCT03125941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237029|NCT03125941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237030|NCT03125941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237031|NCT03125941|Glucocorticoids|glucocorticoids|mesh-ancestor
93237032|NCT03125941|Hormones|hormones|mesh-ancestor
93237033|NCT03125941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237034|NCT03125941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93237035|NCT03125941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237036|NCT02092142|Vaccines|vaccines|mesh-list
93237037|NCT02092142|Immunologic Factors|immunologic factors|mesh-ancestor
93237038|NCT02092142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237039|NCT02095886|BMS-955176|bms-955176|mesh-list
93237040|NCT02095886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93237041|NCT02095886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93237042|NCT02095886|Antiviral Agents|antiviral agents|mesh-ancestor
93237043|NCT02095886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237045|NCT01372579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237046|NCT02090036|Lumefantrine|lumefantrine|mesh-list
93237047|NCT02090036|Artemether|artemether|mesh-list
93237048|NCT02090036|Primaquine|primaquine|mesh-list
93237049|NCT02090036|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93237050|NCT02090036|Antimalarials|antimalarials|mesh-ancestor
93237051|NCT02090036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93237052|NCT02090036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93237053|NCT02090036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237054|NCT03125629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93237055|NCT03125629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93237056|NCT03125629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237057|NCT02092376|Cholecalciferol|cholecalciferol|mesh-list
93237058|NCT02092376|Vitamin D|vitamin d|mesh-list
93237059|NCT02092376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93237060|NCT02092376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237061|NCT02092376|Vitamins|vitamins|mesh-ancestor
93237062|NCT02092376|Micronutrients|micronutrients|mesh-ancestor
93237063|NCT02092376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93237064|NCT05452928|Valacyclovir|valacyclovir|mesh-list
93237065|NCT05452928|Acyclovir|acyclovir|mesh-list
93237066|NCT05452928|Antiviral Agents|antiviral agents|mesh-ancestor
93237067|NCT05452928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237068|NCT03125395|Ivacaftor|ivacaftor|mesh-list
93237069|NCT03125395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93237070|NCT03125395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93237071|NCT03125395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237072|NCT01369303|Tenofovir|tenofovir|mesh-list
93237073|NCT01369303|Antiviral Agents|antiviral agents|mesh-ancestor
93237074|NCT01369303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237075|NCT01369303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93237076|NCT01369303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93237077|NCT01369303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237078|NCT01369303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237079|NCT01369303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93237080|NCT01369303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93237081|NCT02092532|Aflibercept|aflibercept|mesh-list
93237082|NCT02092532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93237083|NCT02092532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93237084|NCT02092532|Growth Substances|growth substances|mesh-ancestor
93237085|NCT02092532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237086|NCT02092532|Growth Inhibitors|growth inhibitors|mesh-ancestor
93237087|NCT02092532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237088|NCT02092766|Artesunate|artesunate|mesh-list
93237089|NCT02092766|Quinine|quinine|mesh-list
93237090|NCT02092766|Antimalarials|antimalarials|mesh-ancestor
93237091|NCT02092766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93237092|NCT02092766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93237093|NCT02092766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237094|NCT02092766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237095|NCT02092766|Antiviral Agents|antiviral agents|mesh-ancestor
93237096|NCT02092766|Schistosomicides|schistosomicides|mesh-ancestor
93237097|NCT02092766|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93237098|NCT02092766|Anthelmintics|anthelmintics|mesh-ancestor
93237099|NCT02092766|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93237100|NCT02092766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237101|NCT02092766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93237102|NCT02092766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237103|NCT02092766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237104|NCT02092766|Analgesics|analgesics|mesh-ancestor
93237105|NCT02092766|Sensory System Agents|sensory system agents|mesh-ancestor
93237106|NCT02090348|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93237107|NCT02090348|Dermatologic Agents|dermatologic agents|mesh-ancestor
93237108|NCT02090348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93237109|NCT02090348|Immunologic Factors|immunologic factors|mesh-ancestor
93237110|NCT02090348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237111|NCT02721069|Diazepam|diazepam|mesh-list
93237112|NCT02721069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93237113|NCT02721069|Anticonvulsants|anticonvulsants|mesh-ancestor
93237114|NCT02721069|Antiemetics|antiemetics|mesh-ancestor
93237115|NCT02721069|Autonomic Agents|autonomic agents|mesh-ancestor
93237116|NCT02721069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909142|NCT02565628|PF-06669571|pf-06669571|mesh-list
93237117|NCT02721069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237118|NCT02721069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237119|NCT02721069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93237120|NCT02721069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237121|NCT02721069|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93237122|NCT02721069|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93237123|NCT02721069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93237124|NCT02721069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93237125|NCT02721069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93237126|NCT02721069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93237127|NCT02721069|Anesthetics, General|anesthetics, general|mesh-ancestor
93237128|NCT02721069|Anesthetics|anesthetics|mesh-ancestor
93237129|NCT02721069|GABA Modulators|gaba modulators|mesh-ancestor
93237130|NCT02721069|GABA Agents|gaba agents|mesh-ancestor
93237131|NCT02721069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237132|NCT02721069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237133|NCT02093000|Bevacizumab|bevacizumab|mesh-list
93237134|NCT02093000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93237135|NCT02093000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237136|NCT02093000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93237137|NCT02093000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93237138|NCT02093000|Growth Substances|growth substances|mesh-ancestor
93237139|NCT02093000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237140|NCT02093000|Growth Inhibitors|growth inhibitors|mesh-ancestor
93237141|NCT00261807|Daptomycin|daptomycin|mesh-list
93237142|NCT00261807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93237143|NCT00261807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237144|NCT02090504|Sodium Oxybate|sodium oxybate|mesh-list
93237145|NCT02090504|Oxazepam|oxazepam|mesh-list
93237146|NCT02090504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93237147|NCT02090504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93237148|NCT02090504|Anesthetics, General|anesthetics, general|mesh-ancestor
93237149|NCT02090504|Anesthetics|anesthetics|mesh-ancestor
93237150|NCT02090504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237151|NCT02090504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237152|NCT02090504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93237153|NCT02090504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93237154|NCT02090504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93237155|NCT02090504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93237156|NCT02090504|GABA Modulators|gaba modulators|mesh-ancestor
93237157|NCT02090504|GABA Agents|gaba agents|mesh-ancestor
93237158|NCT02090504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237159|NCT02090504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237160|NCT01567059|Cytarabine|cytarabine|mesh-list
93237161|NCT01567059|Decitabine|decitabine|mesh-list
93237162|NCT01567059|Azacitidine|azacitidine|mesh-list
93237163|NCT01567059|Tosedostat|tosedostat|mesh-list
93237164|NCT01567059|Glycine|glycine|mesh-list
93237165|NCT01567059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93237166|NCT01567059|Antimetabolites|antimetabolites|mesh-ancestor
93237167|NCT01567059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237168|NCT01567059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237169|NCT01567059|Antiviral Agents|antiviral agents|mesh-ancestor
93237170|NCT01567059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237171|NCT01567059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93237172|NCT01567059|Immunologic Factors|immunologic factors|mesh-ancestor
93237173|NCT01567059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237174|NCT01567059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237175|NCT01567059|Glycine Agents|glycine agents|mesh-ancestor
93237176|NCT01567059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237177|NCT02090738|Amoxicillin|amoxicillin|mesh-list
93237178|NCT02090738|Clarithromycin|clarithromycin|mesh-list
93237179|NCT02090738|Acetazolamide|acetazolamide|mesh-list
93237180|NCT02090738|Esomeprazole|esomeprazole|mesh-list
93237181|NCT02090738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93237182|NCT02090738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237183|NCT02090738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93237184|NCT02090738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237185|NCT02090738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93237186|NCT02090738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237187|NCT02090738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237188|NCT02090738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93237189|NCT02090738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93237190|NCT02090738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93237191|NCT02090738|Anticonvulsants|anticonvulsants|mesh-ancestor
93237192|NCT02090738|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93237193|NCT02090738|Diuretics|diuretics|mesh-ancestor
93237194|NCT02090738|Natriuretic Agents|natriuretic agents|mesh-ancestor
92909219|NCT02307812|Paclitaxel|paclitaxel|mesh-list
93237195|NCT02090738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237196|NCT02096510|Hydrocortisone|hydrocortisone|mesh-list
93237197|NCT02096510|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93237198|NCT02096510|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93237199|NCT02096510|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93237200|NCT02096510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237201|NCT03441555|Venetoclax|venetoclax|mesh-list
93237202|NCT03441555|Alvocidib|alvocidib|mesh-list
93237203|NCT03441555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237204|NCT03441555|Growth Inhibitors|growth inhibitors|mesh-ancestor
93237205|NCT03441555|Growth Substances|growth substances|mesh-ancestor
93237206|NCT03441555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237207|NCT03441555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93237208|NCT03441555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237209|NCT03441555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237210|NCT02093780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93237211|NCT03346239|Escitalopram|escitalopram|mesh-list
93237212|NCT03346239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93237213|NCT03346239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93237214|NCT03346239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93237215|NCT03346239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237216|NCT03346239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237217|NCT03346239|Serotonin Agents|serotonin agents|mesh-ancestor
93237218|NCT03346239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237219|NCT05218161|Dexmedetomidine|dexmedetomidine|mesh-list
93237220|NCT05218161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93237221|NCT05218161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237222|NCT05218161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237223|NCT05218161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237224|NCT05218161|Analgesics|analgesics|mesh-ancestor
93237225|NCT05218161|Sensory System Agents|sensory system agents|mesh-ancestor
93237226|NCT05218161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237227|NCT05218161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93237228|NCT05218161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93237229|NCT05218161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93237230|NCT05218161|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237231|NCT05218161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237232|NCT05218161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237233|NCT02861586|Vaccines|vaccines|mesh-list
93237234|NCT02861586|Immunologic Factors|immunologic factors|mesh-ancestor
92491861|NCT01956981|Tocolytic Agents|tocolytic agents|mesh-ancestor
93237235|NCT02861586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237236|NCT02099240|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93237237|NCT02099240|Amoxicillin|amoxicillin|mesh-list
93237238|NCT02099240|Azithromycin|azithromycin|mesh-list
93237239|NCT02099240|Moxifloxacin|moxifloxacin|mesh-list
93237240|NCT02099240|Vancomycin|vancomycin|mesh-list
93237241|NCT02099240|Clarithromycin|clarithromycin|mesh-list
93237242|NCT02099240|Doxycycline|doxycycline|mesh-list
93237243|NCT02099240|Ciprofloxacin|ciprofloxacin|mesh-list
93237244|NCT02099240|Levofloxacin|levofloxacin|mesh-list
93237245|NCT02099240|Ofloxacin|ofloxacin|mesh-list
93237246|NCT02099240|Minocycline|minocycline|mesh-list
93237247|NCT02099240|Rifampin|rifampin|mesh-list
93237248|NCT02099240|Clindamycin|clindamycin|mesh-list
93237249|NCT02099240|Clindamycin palmitate|clindamycin palmitate|mesh-list
93237250|NCT02099240|Clindamycin phosphate|clindamycin phosphate|mesh-list
93237251|NCT02099240|Gentamicins|gentamicins|mesh-list
93237252|NCT02099240|Isoniazid|isoniazid|mesh-list
93237253|NCT02099240|Meropenem|meropenem|mesh-list
93237254|NCT02099240|Ceftriaxone|ceftriaxone|mesh-list
93237255|NCT02099240|Linezolid|linezolid|mesh-list
93237256|NCT02099240|Tazobactam|tazobactam|mesh-list
93237257|NCT02099240|Cycloserine|cycloserine|mesh-list
93237258|NCT02099240|Piperacillin|piperacillin|mesh-list
93237259|NCT02099240|Metronidazole|metronidazole|mesh-list
93237260|NCT02099240|Penicillins|penicillins|mesh-list
93237261|NCT02099240|Imipenem|imipenem|mesh-list
93237262|NCT02099240|Amikacin|amikacin|mesh-list
93237263|NCT02099240|Pyrazinamide|pyrazinamide|mesh-list
93237264|NCT02099240|Erythromycin|erythromycin|mesh-list
93237265|NCT02099240|Erythromycin Estolate|erythromycin estolate|mesh-list
93237266|NCT02099240|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93237267|NCT02099240|Erythromycin stearate|erythromycin stearate|mesh-list
92909293|NCT01251718|Donepezil|donepezil|mesh-list
93237268|NCT02099240|Colistin|colistin|mesh-list
93237269|NCT02099240|Ceftazidime|ceftazidime|mesh-list
93237270|NCT02099240|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93237271|NCT02099240|Clavulanic Acids|clavulanic acids|mesh-list
93237272|NCT02099240|Clavulanic Acid|clavulanic acid|mesh-list
93237273|NCT02099240|Ampicillin|ampicillin|mesh-list
93237274|NCT02099240|Mupirocin|mupirocin|mesh-list
93237275|NCT02099240|Rifabutin|rifabutin|mesh-list
93237276|NCT02099240|Rifapentine|rifapentine|mesh-list
93237277|NCT02099240|Cefuroxime|cefuroxime|mesh-list
93237278|NCT02099240|Cefuroxime axetil|cefuroxime axetil|mesh-list
93237279|NCT02099240|Fosfomycin|fosfomycin|mesh-list
93237280|NCT02099240|Cefepime|cefepime|mesh-list
93237281|NCT02099240|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93237282|NCT02099240|Paromomycin|paromomycin|mesh-list
93237283|NCT02099240|Aztreonam|aztreonam|mesh-list
93237284|NCT02099240|Nitrofurantoin|nitrofurantoin|mesh-list
93237285|NCT02099240|Polymyxins|polymyxins|mesh-list
93237286|NCT02099240|Neomycin|neomycin|mesh-list
93237287|NCT02099240|Bacitracin|bacitracin|mesh-list
93237288|NCT02099240|Sulbactam|sulbactam|mesh-list
93237289|NCT02099240|Cefotaxime|cefotaxime|mesh-list
93237290|NCT02099240|Cefoxitin|cefoxitin|mesh-list
93237291|NCT02099240|Gatifloxacin|gatifloxacin|mesh-list
93237292|NCT02099240|Sulfadiazine|sulfadiazine|mesh-list
93237293|NCT02099240|Cefixime|cefixime|mesh-list
93237294|NCT02099240|Polymyxin B|polymyxin b|mesh-list
93237295|NCT02099240|Cefdinir|cefdinir|mesh-list
93237296|NCT02099240|Penicillin G|penicillin g|mesh-list
93237297|NCT02099240|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92491970|NCT01957631|Hormones|hormones|mesh-ancestor
93237298|NCT02099240|Penicillin G Procaine|penicillin g procaine|mesh-list
93237299|NCT02099240|Norfloxacin|norfloxacin|mesh-list
93237300|NCT02099240|Cloxacillin|cloxacillin|mesh-list
93237301|NCT02099240|Cefprozil|cefprozil|mesh-list
93237302|NCT02099240|Cephalosporins|cephalosporins|mesh-list
93237303|NCT02099240|Oxacillin|oxacillin|mesh-list
93237304|NCT02099240|Nafcillin|nafcillin|mesh-list
93237305|NCT02099240|Streptomycin|streptomycin|mesh-list
93237306|NCT02099240|Ticarcillin|ticarcillin|mesh-list
93237307|NCT02099240|Methenamine hippurate|methenamine hippurate|mesh-list
93237308|NCT02099240|Methenamine mandelate|methenamine mandelate|mesh-list
93237309|NCT02099240|Sultamicillin|sultamicillin|mesh-list
93237310|NCT02099240|Dicloxacillin|dicloxacillin|mesh-list
93237311|NCT02099240|Cefoperazone|cefoperazone|mesh-list
93237312|NCT02099240|Penicillin V|penicillin v|mesh-list
93237313|NCT02099240|Cefpodoxime|cefpodoxime|mesh-list
93237314|NCT02099240|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
93237315|NCT02099240|Ceftizoxime|ceftizoxime|mesh-list
93237316|NCT02099240|Ethionamide|ethionamide|mesh-list
93237317|NCT02099240|Kanamycin|kanamycin|mesh-list
92492556|NCT01963299|Ropivacaine|ropivacaine|mesh-list
93237318|NCT02099240|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
93237319|NCT02099240|Ceftibuten|ceftibuten|mesh-list
93237320|NCT02099240|Lincomycin|lincomycin|mesh-list
93237321|NCT02099240|Cefotetan|cefotetan|mesh-list
93237322|NCT02099240|Demeclocycline|demeclocycline|mesh-list
93237323|NCT02099240|Dirithromycin|dirithromycin|mesh-list
93237324|NCT02099240|Cefaclor|cefaclor|mesh-list
93237325|NCT02099240|Capreomycin|capreomycin|mesh-list
93237326|NCT02099240|Mafenide|mafenide|mesh-list
93237327|NCT02099240|Tobramycin|tobramycin|mesh-list
93237328|NCT02099240|Oxytetracycline|oxytetracycline|mesh-list
93237329|NCT02099240|Chloramphenicol|chloramphenicol|mesh-list
93237330|NCT02099240|Chloramphenicol succinate|chloramphenicol succinate|mesh-list
93237331|NCT02099240|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
93237332|NCT02099240|Netilmicin|netilmicin|mesh-list
93237333|NCT02099240|Enoxacin|enoxacin|mesh-list
93237334|NCT02099240|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
93237335|NCT02099240|Virginiamycin|virginiamycin|mesh-list
93237336|NCT02099240|Novobiocin|novobiocin|mesh-list
93237337|NCT02099240|Methicillin|methicillin|mesh-list
93237338|NCT02099240|Sulfacetamide|sulfacetamide|mesh-list
93237339|NCT02099240|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93237340|NCT02099240|Spectinomycin|spectinomycin|mesh-list
93237341|NCT02099240|Dalfopristin|dalfopristin|mesh-list
93237342|NCT02099240|Chlortetracycline|chlortetracycline|mesh-list
93237343|NCT02099240|Tetracycline|tetracycline|mesh-list
93237344|NCT02099240|Methacycline|methacycline|mesh-list
93237345|NCT02099240|Sparfloxacin|sparfloxacin|mesh-list
93237346|NCT02099240|Fluoroquinolones|fluoroquinolones|mesh-list
93237347|NCT02099240|Nalidixic Acid|nalidixic acid|mesh-list
93237348|NCT02099240|Lomefloxacin|lomefloxacin|mesh-list
93237349|NCT02099240|Grepafloxacin|grepafloxacin|mesh-list
93237350|NCT02099240|Loracarbef|loracarbef|mesh-list
93237351|NCT02099240|Cefmetazole|cefmetazole|mesh-list
92909372|NCT00755950|Silymarin|silymarin|mesh-list
93237352|NCT02099240|Cefonicid|cefonicid|mesh-list
93237353|NCT02099240|Cefamandole nafate|cefamandole nafate|mesh-list
93237354|NCT02099240|Cefamandole|cefamandole|mesh-list
93237355|NCT02099240|Benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|benzathine benzylpenicillin, procaine benzylpenicillin, drug combination|mesh-list
93237356|NCT02099240|Mezlocillin|mezlocillin|mesh-list
93237357|NCT02099240|Carbenicillin indanyl|carbenicillin indanyl|mesh-list
93237358|NCT02099240|Carbenicillin|carbenicillin|mesh-list
93237359|NCT02099240|Bacampicillin|bacampicillin|mesh-list
93237360|NCT02099240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93237361|NCT02099240|Sulfamethoxazole|sulfamethoxazole|mesh-list
93237362|NCT02099240|Sulfasalazine|sulfasalazine|mesh-list
93237363|NCT02099240|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93237364|NCT02099240|Methenamine|methenamine|mesh-list
93237365|NCT02099240|Sulperazone|sulperazone|mesh-list
93237366|NCT02099240|Sulfisoxazole|sulfisoxazole|mesh-list
93237367|NCT02099240|Cinoxacin|cinoxacin|mesh-list
93237368|NCT02099240|Nitrofurazone|nitrofurazone|mesh-list
93237369|NCT02099240|Trimethoprim|trimethoprim|mesh-list
93237370|NCT02099240|Sulfamethizole|sulfamethizole|mesh-list
93237371|NCT02099240|Procaine|procaine|mesh-list
93237372|NCT02099240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93237373|NCT02099240|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93237374|NCT02099240|Cilastatin|cilastatin|mesh-list
93237375|NCT02099240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237376|NCT02099240|Antitubercular Agents|antitubercular agents|mesh-ancestor
93237377|NCT02099240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93237378|NCT02099240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92493851|NCT01971190|Aflibercept|aflibercept|mesh-list
92493937|NCT01971658|Bortezomib|bortezomib|mesh-list
93237379|NCT02099240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237380|NCT02099240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237381|NCT02099240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494152|NCT01973322|Vaccines|vaccines|mesh-list
93237382|NCT02099240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93237383|NCT02099240|Contraceptive Agents|contraceptive agents|mesh-ancestor
93237384|NCT02099240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93237385|NCT02099240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237386|NCT02099240|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93237387|NCT02099240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93237388|NCT02099240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93237389|NCT02099240|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93237390|NCT02099240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92494367|NCT01974648|Narcotics|narcotics|mesh-ancestor
93237391|NCT02099240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93237392|NCT02099240|Antimalarials|antimalarials|mesh-ancestor
93237393|NCT02099240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92494436|NCT01975363|Curcumin|curcumin|mesh-list
93237394|NCT02099240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92494509|NCT01975727|Protease Inhibitors|protease inhibitors|mesh-ancestor
93237395|NCT02099240|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93237396|NCT02099240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93237397|NCT02099240|Leprostatic Agents|leprostatic agents|mesh-ancestor
93237398|NCT02099240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93237399|NCT02099240|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93237400|NCT02099240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93237401|NCT02099240|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92494735|NCT01977235|Irinotecan|irinotecan|mesh-list
93237402|NCT02099240|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93237403|NCT02099240|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92494810|NCT01978457|Cocaine|cocaine|mesh-list
93237404|NCT02099240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93237405|NCT02099240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93237406|NCT02099240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93237407|NCT02099240|Antimetabolites|antimetabolites|mesh-ancestor
93237408|NCT02099240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93237409|NCT02099240|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92494957|NCT01979653|Anesthetics|anesthetics|mesh-ancestor
93237410|NCT02099240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237411|NCT02099240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93237412|NCT02099240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237413|NCT02099240|Analgesics|analgesics|mesh-ancestor
93237414|NCT02099240|Sensory System Agents|sensory system agents|mesh-ancestor
93237415|NCT02099240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237416|NCT02099240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237417|NCT02099240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93237418|NCT02099240|Protease Inhibitors|protease inhibitors|mesh-ancestor
93237419|NCT02099240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93237420|NCT02099240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93237421|NCT02099240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93237422|NCT02099240|Coccidiostats|coccidiostats|mesh-ancestor
93237423|NCT02099240|Anesthetics, Local|anesthetics, local|mesh-ancestor
93237424|NCT02099240|Anesthetics|anesthetics|mesh-ancestor
93237425|NCT02099240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237426|NCT02099240|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93237427|NCT02099240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93237428|NCT02099240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93237429|NCT02099240|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93237430|NCT02099240|Dermatologic Agents|dermatologic agents|mesh-ancestor
93237431|NCT02245230|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93237432|NCT02245230|Trimethaphan|trimethaphan|mesh-list
93237433|NCT02245230|Phenylephrine|phenylephrine|mesh-list
93237434|NCT02245230|Oxymetazoline|oxymetazoline|mesh-list
93237435|NCT02245230|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
93237436|NCT02245230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93237437|NCT02245230|Mydriatics|mydriatics|mesh-ancestor
93237438|NCT02245230|Autonomic Agents|autonomic agents|mesh-ancestor
93237439|NCT02245230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237440|NCT02245230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495774|NCT01985750|Cycloserine|cycloserine|mesh-list
93237441|NCT02245230|Sympathomimetics|sympathomimetics|mesh-ancestor
93237442|NCT02245230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93237443|NCT02245230|Nasal Decongestants|nasal decongestants|mesh-ancestor
92495984|NCT01986673|Sildenafil Citrate|sildenafil citrate|mesh-list
92909437|NCT00705510|Antifungal Agents|antifungal agents|mesh-ancestor
92496051|NCT01987076|Prednisone|prednisone|mesh-list
93237444|NCT02245230|Respiratory System Agents|respiratory system agents|mesh-ancestor
93237445|NCT02245230|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93237446|NCT02245230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93237447|NCT02245230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92496202|NCT01988649|Oxytocin|oxytocin|mesh-list
93237448|NCT02245230|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237449|NCT02245230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496270|NCT01989312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93237450|NCT02245230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237451|NCT02245230|Protective Agents|protective agents|mesh-ancestor
93237452|NCT02245230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93237453|NCT02245230|Vasodilator Agents|vasodilator agents|mesh-ancestor
93237454|NCT02245230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93237455|NCT02245230|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
93237456|NCT02245230|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93237457|NCT02245230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93237458|NCT02245230|Cholinergic Agents|cholinergic agents|mesh-ancestor
93237459|NCT05215743|Acetylcysteine|acetylcysteine|mesh-list
93237460|NCT05215743|Antioxidants|antioxidants|mesh-list
93237461|NCT05215743|Deferoxamine|deferoxamine|mesh-list
93237462|NCT05215743|Antiviral Agents|antiviral agents|mesh-ancestor
93237463|NCT05215743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237464|NCT05215743|Expectorants|expectorants|mesh-ancestor
93237465|NCT05215743|Respiratory System Agents|respiratory system agents|mesh-ancestor
93237466|NCT05215743|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93237467|NCT05215743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237468|NCT05215743|Protective Agents|protective agents|mesh-ancestor
92496476|NCT01990781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237469|NCT05215743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237470|NCT05215743|Siderophores|siderophores|mesh-ancestor
93237471|NCT05215743|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93237472|NCT05215743|Chelating Agents|chelating agents|mesh-ancestor
93237473|NCT05215743|Sequestering Agents|sequestering agents|mesh-ancestor
93237474|NCT02099396|Gemcitabine|gemcitabine|mesh-list
93237475|NCT02099396|Docetaxel|docetaxel|mesh-list
93237476|NCT02099396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93237477|NCT02099396|Antimetabolites|antimetabolites|mesh-ancestor
93237478|NCT02099396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237479|NCT02099396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237480|NCT02099396|Tubulin Modulators|tubulin modulators|mesh-ancestor
93237481|NCT02099396|Antimitotic Agents|antimitotic agents|mesh-ancestor
92496926|NCT01994460|Linezolid|linezolid|mesh-list
93237482|NCT02099396|Mitosis Modulators|mitosis modulators|mesh-ancestor
93237483|NCT05215665|Lenvatinib|lenvatinib|mesh-list
93237484|NCT05215665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237485|NCT05215665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93237486|NCT05215665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237487|NCT05215665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237488|NCT02099474|Raltegravir Potassium|raltegravir potassium|mesh-list
93237489|NCT02099474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93237490|NCT02099474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93237491|NCT02099474|Antiviral Agents|antiviral agents|mesh-ancestor
93237492|NCT02099474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237493|NCT02099474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92497224|NCT01996306|Antidotes|antidotes|mesh-ancestor
93237494|NCT02099474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93237495|NCT02099474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237496|NCT02099474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237497|NCT05217069|Leucovorin|leucovorin|mesh-list
93237498|NCT05217069|Folic Acid|folic acid|mesh-list
93237499|NCT05217069|Irinotecan|irinotecan|mesh-list
93237500|NCT05217069|Cetuximab|cetuximab|mesh-list
93237501|NCT05217069|Avelumab|avelumab|mesh-list
93237502|NCT05217069|Levoleucovorin|levoleucovorin|mesh-list
93237503|NCT05217069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93237504|NCT05217069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93237505|NCT05217069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237506|NCT05217069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237507|NCT05217069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237508|NCT05217069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93237509|NCT05217069|Antidotes|antidotes|mesh-ancestor
93237510|NCT05217069|Protective Agents|protective agents|mesh-ancestor
93237511|NCT05217069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237512|NCT05217069|Vitamin B Complex|vitamin b complex|mesh-ancestor
93237513|NCT05217069|Vitamins|vitamins|mesh-ancestor
93237514|NCT05217069|Micronutrients|micronutrients|mesh-ancestor
93237515|NCT05217069|Hematinics|hematinics|mesh-ancestor
93237516|NCT02065635|Propofol|propofol|mesh-list
93237517|NCT02065635|Sevoflurane|sevoflurane|mesh-list
92909512|NCT00757978|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93237518|NCT02065635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92497802|NCT02000193|Fulvestrant|fulvestrant|mesh-list
93237519|NCT02065635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497870|NCT02000674|Rocuronium|rocuronium|mesh-list
93237520|NCT02065635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237521|NCT02065635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93237522|NCT02065635|Anesthetics, General|anesthetics, general|mesh-ancestor
93237523|NCT02065635|Anesthetics|anesthetics|mesh-ancestor
93237524|NCT02065635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93237525|NCT02065635|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93237526|NCT03628053|Blinatumomab|blinatumomab|mesh-list
93237527|NCT03628053|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93237528|NCT03628053|Tisagenlecleucel|tisagenlecleucel|mesh-list
93237529|NCT03628053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498089|NCT02001896|Antimetabolites|antimetabolites|mesh-ancestor
93237530|NCT03628053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93237531|NCT03628053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93237532|NCT03628053|Immunotoxins|immunotoxins|mesh-ancestor
93237533|NCT03628053|Immunoconjugates|immunoconjugates|mesh-ancestor
93237534|NCT03628053|Immunologic Factors|immunologic factors|mesh-ancestor
93237535|NCT03628053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237536|NCT02100176|Dopamine|dopamine|mesh-list
93237537|NCT02100176|Rotigotine|rotigotine|mesh-list
93237538|NCT02100176|Dopamine Agonists|dopamine agonists|mesh-list
93237539|NCT02100176|Dopamine Agents|dopamine agents|mesh-ancestor
93237540|NCT02100176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498608|NCT02005523|Sensory System Agents|sensory system agents|mesh-ancestor
93237541|NCT02100176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498682|NCT02005757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93237542|NCT02100176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237543|NCT02100176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93237544|NCT02100176|Sympathomimetics|sympathomimetics|mesh-ancestor
93237545|NCT02100176|Autonomic Agents|autonomic agents|mesh-ancestor
93237546|NCT02100176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237547|NCT02100176|Protective Agents|protective agents|mesh-ancestor
93237548|NCT02250482|Factor VIII|factor viii|mesh-list
93237549|NCT02250482|Coagulants|coagulants|mesh-ancestor
93237550|NCT05189145|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93237551|NCT05189145|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93237552|NCT05189145|Hormones|hormones|mesh-list
93237553|NCT05189145|Estradiol|estradiol|mesh-list
92499119|NCT02008981|Analgesics|analgesics|mesh-ancestor
93237554|NCT05189145|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93237555|NCT05189145|Progesterone|progesterone|mesh-list
93237556|NCT05189145|Dydrogesterone|dydrogesterone|mesh-list
93237557|NCT05189145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237558|NCT05189145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499340|NCT05587894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93237559|NCT05189145|Estrogens|estrogens|mesh-ancestor
93237560|NCT05189145|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93237561|NCT05189145|Contraceptive Agents|contraceptive agents|mesh-ancestor
93237562|NCT05189145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93237563|NCT05189145|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93237564|NCT05189145|Progestins|progestins|mesh-ancestor
93237565|NCT04967079|Trametinib|trametinib|mesh-list
93237566|NCT04967079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237567|NCT04967079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93237568|NCT04967079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499628|NCT04112641|Micronutrients|micronutrients|mesh-ancestor
93237569|NCT04967079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237570|NCT03556592|Metoprolol|metoprolol|mesh-list
93237571|NCT03556592|Midazolam|midazolam|mesh-list
93237572|NCT03556592|Caffeine|caffeine|mesh-list
93237573|NCT03556592|Omeprazole|omeprazole|mesh-list
93237574|NCT03556592|Warfarin|warfarin|mesh-list
93237575|NCT03556592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93237576|NCT03556592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93237577|NCT03556592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499851|NCT03281304|Tofacitinib|tofacitinib|mesh-list
93237578|NCT03556592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237579|NCT03556592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93237580|NCT03556592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93237581|NCT03556592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93237582|NCT03556592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93237583|NCT03556592|Anesthetics, General|anesthetics, general|mesh-ancestor
93237584|NCT03556592|Anesthetics|anesthetics|mesh-ancestor
93237585|NCT03556592|GABA Modulators|gaba modulators|mesh-ancestor
93237586|NCT03556592|GABA Agents|gaba agents|mesh-ancestor
93237587|NCT03556592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237588|NCT03556592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237589|NCT03556592|Anticoagulants|anticoagulants|mesh-ancestor
92500220|NCT02010164|Coenzyme Q10|coenzyme q10|mesh-list
93237590|NCT03556592|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93237591|NCT03556592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93237592|NCT03556592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237593|NCT03556592|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93237594|NCT03556592|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92500514|NCT02012166|Octreotide|octreotide|mesh-list
93237595|NCT03556592|Purinergic Agents|purinergic agents|mesh-ancestor
93237596|NCT03556592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93237597|NCT03556592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500591|NCT02012738|Immunologic Factors|immunologic factors|mesh-ancestor
93237598|NCT03556592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93237599|NCT03556592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93237601|NCT03556592|Sympatholytics|sympatholytics|mesh-ancestor
93237602|NCT03556592|Autonomic Agents|autonomic agents|mesh-ancestor
93237603|NCT03556592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237604|NCT03556592|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93237605|NCT03556592|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93237606|NCT03556592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93237607|NCT03556592|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237608|NCT04964193|Cyproterone Acetate|cyproterone acetate|mesh-list
93237609|NCT04964193|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93237610|NCT04964193|Cyproterone|cyproterone|mesh-list
92501051|NCT02015650|Cetuximab|cetuximab|mesh-list
93237611|NCT04964193|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
93237612|NCT04964193|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93237613|NCT04964193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93237614|NCT04964193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93237615|NCT04964193|Contraceptive Agents|contraceptive agents|mesh-ancestor
93237616|NCT04964193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93237617|NCT04964193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237618|NCT04964193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93237619|NCT04964193|Estrogens|estrogens|mesh-ancestor
93237620|NCT04964193|Hormones|hormones|mesh-ancestor
93237621|NCT04964193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237622|NCT04964193|Androgen Antagonists|androgen antagonists|mesh-ancestor
93237623|NCT04964193|Hormone Antagonists|hormone antagonists|mesh-ancestor
93237624|NCT04964193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237625|NCT04964193|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93237626|NCT02100488|Insulin|insulin|mesh-list
93237627|NCT02100488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93237628|NCT02100488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93237629|NCT02100488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237630|NCT02095418|Mycophenolic Acid|mycophenolic acid|mesh-list
93237631|NCT02095418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93237632|NCT02095418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501392|NCT02018094|Iodine|iodine|mesh-list
93237633|NCT02095418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93237634|NCT02095418|Antitubercular Agents|antitubercular agents|mesh-ancestor
93237635|NCT02095418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93237636|NCT02095418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237637|NCT02095418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237638|NCT02095418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237639|NCT04865497|Vaccines|vaccines|mesh-list
93237640|NCT04865497|Immunologic Factors|immunologic factors|mesh-ancestor
93237641|NCT04865497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237642|NCT05665725|Siltuximab|siltuximab|mesh-list
93237643|NCT05665725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93237644|NCT05665725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237645|NCT05665725|Immunologic Factors|immunologic factors|mesh-ancestor
92501684|NCT02019797|Anesthetics|anesthetics|mesh-ancestor
93237646|NCT05665725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237647|NCT02098148|Xenon|xenon|mesh-list
93237648|NCT02098148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93237649|NCT02098148|Anesthetics, General|anesthetics, general|mesh-ancestor
93237650|NCT02098148|Anesthetics|anesthetics|mesh-ancestor
93237651|NCT02098148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237652|NCT02098148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237653|NCT05168527|Paclitaxel|paclitaxel|mesh-list
93237654|NCT05168527|Gemcitabine|gemcitabine|mesh-list
93237655|NCT05168527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93237656|NCT05168527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501898|NCT02021240|Antiemetics|antiemetics|mesh-ancestor
93237657|NCT05168527|Tubulin Modulators|tubulin modulators|mesh-ancestor
93237658|NCT05168527|Antimitotic Agents|antimitotic agents|mesh-ancestor
93237659|NCT05168527|Mitosis Modulators|mitosis modulators|mesh-ancestor
92502046|NCT02022358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237660|NCT05168527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237661|NCT05168527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93237662|NCT05168527|Antimetabolites|antimetabolites|mesh-ancestor
93237663|NCT02098460|Cilostazol|cilostazol|mesh-list
93237664|NCT02098460|Atorvastatin|atorvastatin|mesh-list
93237665|NCT02098460|Probucol|probucol|mesh-list
93237666|NCT02098460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92502340|NCT02024009|Nelfinavir|nelfinavir|mesh-list
93237667|NCT02098460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93237668|NCT02098460|Antimetabolites|antimetabolites|mesh-ancestor
92502485|NCT02024659|Budesonide|budesonide|mesh-list
93237669|NCT02098460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237670|NCT02098460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502559|NCT02025166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237671|NCT02098460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93237672|NCT02098460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502634|NCT02025491|Amphotericin B|amphotericin b|mesh-list
92502704|NCT02025881|Alkylating Agents|alkylating agents|mesh-ancestor
93237673|NCT02098460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93237674|NCT02098460|Autonomic Agents|autonomic agents|mesh-ancestor
93237675|NCT02098460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237676|NCT02098460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502871|NCT02026973|Hormones|hormones|mesh-ancestor
93237677|NCT02098460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93237678|NCT02098460|Respiratory System Agents|respiratory system agents|mesh-ancestor
92502934|NCT02027337|Estrogens|estrogens|mesh-ancestor
93237679|NCT02098460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93237680|NCT02098460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93237681|NCT02098460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93237682|NCT02098460|Vasodilator Agents|vasodilator agents|mesh-ancestor
93237683|NCT02098460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93237684|NCT02098460|Protective Agents|protective agents|mesh-ancestor
93237685|NCT02098460|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92503146|NCT02028689|Metformin|metformin|mesh-list
93237686|NCT02098460|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93237687|NCT02098460|Antioxidants|antioxidants|mesh-ancestor
93237688|NCT02095574|Venetoclax|venetoclax|mesh-list
92503220|NCT02029118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237689|NCT02095574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237690|NCT04856319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93237691|NCT04856319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237692|NCT02095730|Vitamins|vitamins|mesh-list
93237693|NCT02095730|Riboflavin|riboflavin|mesh-list
93237694|NCT02095730|Vitamin B Complex|vitamin b complex|mesh-list
93237695|NCT02095730|Micronutrients|micronutrients|mesh-ancestor
92503369|NCT02029950|Antimetabolites|antimetabolites|mesh-ancestor
93237696|NCT02095730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237697|NCT02095730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93237698|NCT02095730|Dermatologic Agents|dermatologic agents|mesh-ancestor
93237699|NCT02102438|Paclitaxel|paclitaxel|mesh-list
93237700|NCT02102438|Carboplatin|carboplatin|mesh-list
93237701|NCT02102438|Trastuzumab|trastuzumab|mesh-list
93237702|NCT02102438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93237703|NCT02102438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237704|NCT02102438|Tubulin Modulators|tubulin modulators|mesh-ancestor
93237705|NCT02102438|Antimitotic Agents|antimitotic agents|mesh-ancestor
93237706|NCT02102438|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503660|NCT02040597|Hormones|hormones|mesh-ancestor
93237707|NCT02102438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237708|NCT02102438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93237709|NCT02098616|Asunaprevir|asunaprevir|mesh-list
93237710|NCT02098616|Protease Inhibitors|protease inhibitors|mesh-ancestor
93237711|NCT02098616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503955|NCT02042742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93237712|NCT02098616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237713|NCT02102516|Ketorolac|ketorolac|mesh-list
93237714|NCT02102516|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93237715|NCT02102516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93237716|NCT02102516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237717|NCT02102516|Analgesics|analgesics|mesh-ancestor
93237718|NCT02102516|Sensory System Agents|sensory system agents|mesh-ancestor
93237719|NCT02102516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237720|NCT02102516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237721|NCT02102516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237722|NCT02102516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93237723|NCT02102516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92504128|NCT02044354|Docetaxel|docetaxel|mesh-list
93237724|NCT02102516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237725|NCT02102516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237726|NCT02106182|Silodosin|silodosin|mesh-list
93237727|NCT02106182|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93237728|NCT02106182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93237729|NCT02106182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93237730|NCT02106182|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237731|NCT02106182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237732|NCT02106182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237733|NCT02106182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237734|NCT02106182|Urological Agents|urological agents|mesh-ancestor
93237735|NCT01369693|Lobeline|lobeline|mesh-list
93237736|NCT01369693|Nicotine|nicotine|mesh-list
93237737|NCT01369693|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93237738|NCT01369693|Autonomic Agents|autonomic agents|mesh-ancestor
93237739|NCT01369693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237740|NCT01369693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504315|NCT02045914|Calcium|calcium|mesh-list
93237741|NCT01369693|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93237742|NCT01369693|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92504406|NCT02046460|Vitamin K|vitamin k|mesh-list
93237743|NCT01369693|Cholinergic Agents|cholinergic agents|mesh-ancestor
93237744|NCT01369693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504446|NCT02046538|Leucovorin|leucovorin|mesh-list
93237745|NCT01369693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237746|NCT01369693|Respiratory System Agents|respiratory system agents|mesh-ancestor
93237747|NCT02102594|Bortezomib|bortezomib|mesh-list
93237748|NCT02102594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237749|NCT02102672|Trimetazidine|trimetazidine|mesh-list
93237750|NCT02102672|Vasodilator Agents|vasodilator agents|mesh-ancestor
93237751|NCT02106338|REP 3123|rep 3123|mesh-list
93237752|NCT02106338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93237753|NCT02106338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237754|NCT03121261|Clonidine|clonidine|mesh-list
93237755|NCT03121261|Levobupivacaine|levobupivacaine|mesh-list
93237756|NCT03121261|Analgesics|analgesics|mesh-ancestor
93237757|NCT03121261|Sensory System Agents|sensory system agents|mesh-ancestor
93237758|NCT03121261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237759|NCT03121261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237760|NCT03121261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92504659|NCT00005823|Cytarabine|cytarabine|mesh-list
93237761|NCT03121261|Sympatholytics|sympatholytics|mesh-ancestor
93237762|NCT03121261|Autonomic Agents|autonomic agents|mesh-ancestor
93237763|NCT03121261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93237764|NCT03121261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92504801|NCT00005880|Autonomic Agents|autonomic agents|mesh-ancestor
93237765|NCT03121261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93237766|NCT03121261|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237767|NCT03121261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237768|NCT03121261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237769|NCT03121261|Anesthetics, Local|anesthetics, local|mesh-ancestor
93237770|NCT03121261|Anesthetics|anesthetics|mesh-ancestor
93237771|NCT03121261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237772|NCT04249323|Prednisone|prednisone|mesh-list
93237773|NCT04249323|Cortisone|cortisone|mesh-list
92505013|NCT00005958|Docetaxel|docetaxel|mesh-list
93237774|NCT04249323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237775|NCT04249323|Glucocorticoids|glucocorticoids|mesh-ancestor
93237776|NCT04249323|Hormones|hormones|mesh-ancestor
93237777|NCT04249323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237778|NCT04249323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237779|NCT04249323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93237780|NCT04249323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237781|NCT04227327|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93237782|NCT04227327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93237783|NCT04227327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505462|NCT05679375|Ketamine|ketamine|mesh-list
93237784|NCT04227327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505535|NCT05160597|Edetic Acid|edetic acid|mesh-list
93237785|NCT04227327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93237786|NCT04227327|Hormone Antagonists|hormone antagonists|mesh-ancestor
93237787|NCT04227327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237788|NCT04227327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237789|NCT02102828|Aspirin|aspirin|mesh-list
93237790|NCT02102828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92505687|NCT03869736|Nitrous Oxide|nitrous oxide|mesh-list
93237791|NCT02102828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237792|NCT02102828|Analgesics|analgesics|mesh-ancestor
92505753|NCT00387504|Protective Agents|protective agents|mesh-ancestor
92505824|NCT02373813|Micronutrients|micronutrients|mesh-ancestor
93237793|NCT02102828|Sensory System Agents|sensory system agents|mesh-ancestor
93237794|NCT02102828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237795|NCT02102828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237796|NCT02102828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237797|NCT02102828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93237798|NCT02102828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93237799|NCT02102828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92230920|NCT00002692|Vitamins|vitamins|mesh-ancestor
93237800|NCT02102828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237801|NCT02102828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92506193|NCT00006219|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93237802|NCT02102828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93237803|NCT02102828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237804|NCT02102828|Antipyretics|antipyretics|mesh-ancestor
93237805|NCT01372423|Lubiprostone|lubiprostone|mesh-list
93237806|NCT01372423|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93237807|NCT01372423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93237808|NCT01372423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237809|NCT02106650|Leucovorin|leucovorin|mesh-list
93237810|NCT02106650|Folic Acid|folic acid|mesh-list
93237811|NCT02106650|Vitamin B 12|vitamin b 12|mesh-list
93237812|NCT02106650|Hydroxocobalamin|hydroxocobalamin|mesh-list
93237813|NCT02106650|Vitamins|vitamins|mesh-ancestor
93237814|NCT02106650|Micronutrients|micronutrients|mesh-ancestor
93237815|NCT02106650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237816|NCT02106650|Antidotes|antidotes|mesh-ancestor
93237817|NCT02106650|Protective Agents|protective agents|mesh-ancestor
93237818|NCT02106650|Vitamin B Complex|vitamin b complex|mesh-ancestor
93237819|NCT02106650|Hematinics|hematinics|mesh-ancestor
93237820|NCT05221437|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93237821|NCT05221437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237822|NCT01376011|Quercetin|quercetin|mesh-list
93237823|NCT01376011|Antioxidants|antioxidants|mesh-ancestor
93237824|NCT01376011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237825|NCT01376011|Protective Agents|protective agents|mesh-ancestor
93237826|NCT01376011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237828|NCT04033107|Metformin|metformin|mesh-list
93237829|NCT04033107|Vitamins|vitamins|mesh-ancestor
93237830|NCT04033107|Micronutrients|micronutrients|mesh-ancestor
93237831|NCT04033107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237832|NCT04033107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93237833|NCT04033107|Antioxidants|antioxidants|mesh-ancestor
92506930|NCT00005977|Vincristine|vincristine|mesh-list
92507006|NCT00005998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93237834|NCT04033107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237835|NCT04033107|Protective Agents|protective agents|mesh-ancestor
93237836|NCT02106806|Zinc|zinc|mesh-list
93237837|NCT02106806|Zinc Sulfate|zinc sulfate|mesh-list
93237838|NCT02106806|Trace Elements|trace elements|mesh-ancestor
93237839|NCT02106806|Micronutrients|micronutrients|mesh-ancestor
92507153|NCT00386659|Antimetabolites|antimetabolites|mesh-ancestor
93237840|NCT02106806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237841|NCT02106806|Astringents|astringents|mesh-ancestor
93237842|NCT02106806|Dermatologic Agents|dermatologic agents|mesh-ancestor
93237843|NCT02966119|Aspirin|aspirin|mesh-list
93237844|NCT02966119|Clopidogrel|clopidogrel|mesh-list
92507223|NCT00006363|Alkylating Agents|alkylating agents|mesh-ancestor
93237845|NCT02966119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93237846|NCT02966119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237847|NCT02966119|Analgesics|analgesics|mesh-ancestor
93237848|NCT02966119|Sensory System Agents|sensory system agents|mesh-ancestor
93237849|NCT02966119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237850|NCT02966119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237851|NCT02966119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507517|NCT05247970|Anesthetics|anesthetics|mesh-ancestor
93237852|NCT02966119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93237853|NCT02966119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93237854|NCT02966119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93237855|NCT02966119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237856|NCT02966119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92507663|NCT00006468|Antidotes|antidotes|mesh-ancestor
93237857|NCT02966119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93237858|NCT02966119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237859|NCT02966119|Antipyretics|antipyretics|mesh-ancestor
92507737|NCT03352765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93237860|NCT02966119|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92507807|NCT02425501|Growth Substances|growth substances|mesh-ancestor
93237861|NCT02966119|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93237862|NCT02966119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93237863|NCT02966119|Purinergic Agents|purinergic agents|mesh-ancestor
92507891|NCT00006669|Hormones|hormones|mesh-ancestor
92507957|NCT00006786|Growth Inhibitors|growth inhibitors|mesh-ancestor
93237864|NCT02966119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237865|NCT02101892|Amitriptyline|amitriptyline|mesh-list
93237866|NCT02101892|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93237867|NCT02101892|Antidepressive Agents|antidepressive agents|mesh-ancestor
93237868|NCT02101892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93237869|NCT02101892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93237870|NCT02101892|Analgesics|analgesics|mesh-ancestor
93237871|NCT02101892|Sensory System Agents|sensory system agents|mesh-ancestor
93237872|NCT02101892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237873|NCT02101892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237874|NCT02101892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92508174|NCT00006112|Mitomycins|mitomycins|mesh-list
93237875|NCT02101892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93237876|NCT02101892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93237877|NCT02101892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237878|NCT02101892|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237879|NCT02101892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237880|NCT03634111|Morphine|morphine|mesh-list
93237881|NCT03634111|Ropivacaine|ropivacaine|mesh-list
93237882|NCT03634111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93237883|NCT03634111|Narcotics|narcotics|mesh-ancestor
93237884|NCT03634111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237885|NCT03634111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508490|NCT00006250|Hormones|hormones|mesh-ancestor
93237886|NCT03634111|Analgesics|analgesics|mesh-ancestor
93237887|NCT03634111|Sensory System Agents|sensory system agents|mesh-ancestor
93237888|NCT03634111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237889|NCT03634111|Anesthetics, Local|anesthetics, local|mesh-ancestor
93237890|NCT03634111|Anesthetics|anesthetics|mesh-ancestor
93237891|NCT02102048|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93237892|NCT02102048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92508612|NCT00007683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93237893|NCT02102048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93237894|NCT02102048|Protease Inhibitors|protease inhibitors|mesh-ancestor
93237895|NCT02102048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508757|NCT00007917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237896|NCT02102048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237897|NCT02102048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93237898|NCT02102048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92509060|NCT00006457|Oltipraz|oltipraz|mesh-list
93237899|NCT02102048|Antiviral Agents|antiviral agents|mesh-ancestor
92509135|NCT00006472|Paclitaxel|paclitaxel|mesh-list
93237900|NCT02102048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237901|NCT03118297|Ulipristal acetate|ulipristal acetate|mesh-list
92509279|NCT00388219|Narcotics|narcotics|mesh-ancestor
93237902|NCT03118297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93237903|NCT03118297|Contraceptive Agents|contraceptive agents|mesh-ancestor
93237904|NCT03118297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93237905|NCT03118297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237906|NCT03118297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93237908|NCT02250794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93237909|NCT02250794|Metformin|metformin|mesh-list
93237910|NCT02250794|Insulin Glargine|insulin glargine|mesh-list
93237911|NCT02250794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93237912|NCT02250794|Insulin Lispro|insulin lispro|mesh-list
93237913|NCT02250794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93237914|NCT02250794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237915|NCT02250794|Incretins|incretins|mesh-ancestor
93237916|NCT02250794|Hormones|hormones|mesh-ancestor
93237917|NCT02250794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237918|NCT02250794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93237919|NCT02250794|Protease Inhibitors|protease inhibitors|mesh-ancestor
93237920|NCT02250794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509795|NCT00000256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237921|NCT02250794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237922|NCT02103374|Terbutaline|terbutaline|mesh-list
93237923|NCT02103374|Ipratropium|ipratropium|mesh-list
93237924|NCT02103374|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93237925|NCT02103374|Autonomic Agents|autonomic agents|mesh-ancestor
93237926|NCT02103374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510091|NCT00000556|Sympatholytics|sympatholytics|mesh-ancestor
93237927|NCT02103374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237928|NCT02103374|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93237929|NCT02103374|Respiratory System Agents|respiratory system agents|mesh-ancestor
93237930|NCT02103374|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93237931|NCT02103374|Cholinergic Agents|cholinergic agents|mesh-ancestor
93237932|NCT02103374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237933|NCT02103374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237934|NCT02103374|Sympathomimetics|sympathomimetics|mesh-ancestor
93237935|NCT02103374|Tocolytic Agents|tocolytic agents|mesh-ancestor
93237936|NCT02103374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93237937|NCT02103374|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93237938|NCT02103374|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93237939|NCT02103374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93237940|NCT02103374|Adrenergic Agents|adrenergic agents|mesh-ancestor
93237941|NCT03555188|Ondansetron|ondansetron|mesh-list
93237942|NCT03555188|Antiemetics|antiemetics|mesh-ancestor
92510605|NCT00000919|Ritonavir|ritonavir|mesh-list
93237943|NCT03555188|Autonomic Agents|autonomic agents|mesh-ancestor
93237944|NCT03555188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237945|NCT03555188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237946|NCT03555188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237947|NCT03555188|Antipruritics|antipruritics|mesh-ancestor
93237948|NCT03555188|Dermatologic Agents|dermatologic agents|mesh-ancestor
93237949|NCT03555188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93237950|NCT03555188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93237951|NCT03555188|Serotonin Agents|serotonin agents|mesh-ancestor
93237952|NCT03555188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511062|NCT00001267|Zidovudine|zidovudine|mesh-list
92511131|NCT00388635|Melphalan|melphalan|mesh-list
92511207|NCT00000147|Prednisone|prednisone|mesh-list
92511276|NCT00389428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92511424|NCT05640427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237953|NCT03555188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237954|NCT05707221|Chlorhexidine|chlorhexidine|mesh-list
93237955|NCT05707221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93237956|NCT05707221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93237957|NCT05707221|Disinfectants|disinfectants|mesh-ancestor
93237958|NCT03117361|Dexamethasone|dexamethasone|mesh-list
93237959|NCT03117361|Bortezomib|bortezomib|mesh-list
93237960|NCT03117361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237961|NCT03117361|Antiemetics|antiemetics|mesh-ancestor
93237962|NCT03117361|Autonomic Agents|autonomic agents|mesh-ancestor
93237963|NCT03117361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237964|NCT03117361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237965|NCT03117361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93237966|NCT03117361|Glucocorticoids|glucocorticoids|mesh-ancestor
93237967|NCT03117361|Hormones|hormones|mesh-ancestor
93237968|NCT03117361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93237969|NCT03117361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93237970|NCT03117361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93237971|NCT03053427|Gabapentin|gabapentin|mesh-list
93237972|NCT03053427|Analgesics|analgesics|mesh-ancestor
92512075|NCT00000639|Amebicides|amebicides|mesh-ancestor
93237973|NCT03053427|Sensory System Agents|sensory system agents|mesh-ancestor
93237974|NCT03053427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93237975|NCT03053427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237976|NCT03053427|Anticonvulsants|anticonvulsants|mesh-ancestor
93237977|NCT03053427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93237979|NCT03053427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93237980|NCT03053427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93237981|NCT03053427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93237982|NCT03053427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93237983|NCT03053427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93237984|NCT03053427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93237985|NCT03053427|Antimanic Agents|antimanic agents|mesh-ancestor
93237986|NCT02107118|Complement Factor H|complement factor h|mesh-list
93237987|NCT02107118|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93237988|NCT02107118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92512316|NCT00000711|Zidovudine|zidovudine|mesh-list
93237989|NCT02107118|Immunologic Factors|immunologic factors|mesh-ancestor
93237990|NCT02107118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93237991|NCT05081089|Lumefantrine|lumefantrine|mesh-list
93237992|NCT05081089|Artemether|artemether|mesh-list
93237993|NCT05081089|Pyrimethamine|pyrimethamine|mesh-list
93237994|NCT05081089|Primaquine|primaquine|mesh-list
93237995|NCT05081089|Sulfadoxine|sulfadoxine|mesh-list
93237996|NCT05081089|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92512433|NCT04020172|Autonomic Agents|autonomic agents|mesh-ancestor
92512505|NCT03937609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93237997|NCT05081089|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93237998|NCT05081089|Amodiaquine|amodiaquine|mesh-list
93237999|NCT05081089|Tafenoquine|tafenoquine|mesh-list
93238000|NCT05081089|Antimalarials|antimalarials|mesh-ancestor
93238001|NCT05081089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93238002|NCT05081089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93238003|NCT05081089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238004|NCT05081089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93238005|NCT05081089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512956|NCT00000999|Zidovudine|zidovudine|mesh-list
93238006|NCT05081089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238007|NCT05081089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93238008|NCT03555032|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93238009|NCT03555032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238010|NCT03555032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238011|NCT03554408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93238012|NCT03554408|Antibodies|antibodies|mesh-list
93238013|NCT03554408|Immunoglobulins|immunoglobulins|mesh-list
93238014|NCT03554408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93238015|NCT03554408|Immunologic Factors|immunologic factors|mesh-ancestor
93238016|NCT03554408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238017|NCT03554408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238018|NCT02103686|Pregabalin|pregabalin|mesh-list
93238019|NCT02103686|Analgesics|analgesics|mesh-ancestor
93238020|NCT02103686|Sensory System Agents|sensory system agents|mesh-ancestor
93238021|NCT02103686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238022|NCT02103686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238023|NCT02103686|Anticonvulsants|anticonvulsants|mesh-ancestor
93238024|NCT02103686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93238025|NCT02103686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93238026|NCT02103686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513622|NCT00009919|Semaxinib|semaxinib|mesh-list
93238027|NCT02103686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93238028|NCT02103686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93238029|NCT02103686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93238030|NCT02103686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238031|NCT02103686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93238032|NCT02110082|Cetuximab|cetuximab|mesh-list
93238033|NCT02110082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92513847|NCT00001212|Prednisone|prednisone|mesh-list
93238034|NCT02110082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238035|NCT02103764|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93238036|NCT02103764|Medroxyprogesterone|medroxyprogesterone|mesh-list
93238037|NCT02103764|Desogestrel|desogestrel|mesh-list
93238038|NCT02103764|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93238039|NCT02103764|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93238040|NCT02103764|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93238041|NCT02103764|Contraceptive Agents|contraceptive agents|mesh-ancestor
93238042|NCT02103764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93238043|NCT02103764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238044|NCT02103764|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93238045|NCT02103764|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93238046|NCT02103764|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93238047|NCT02103764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514211|NCT00014209|Antiemetics|antiemetics|mesh-ancestor
93238048|NCT02103764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238049|NCT02103764|Progestins|progestins|mesh-ancestor
92910036|NCT02915224|Chlorambucil|chlorambucil|mesh-list
93238050|NCT02103764|Hormones|hormones|mesh-ancestor
93238051|NCT02103764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514358|NCT00005987|Carmustine|carmustine|mesh-list
93238052|NCT02110316|Voriconazole|voriconazole|mesh-list
93238053|NCT02110316|Antifungal Agents|antifungal agents|mesh-ancestor
93238054|NCT02110316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514443|NCT00015028|Naloxone|naloxone|mesh-list
93238055|NCT02110316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93238056|NCT02110316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93238057|NCT02110316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238058|NCT02110316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514645|NCT00016198|Vitamins|vitamins|mesh-ancestor
93238059|NCT02110316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93238060|NCT02110316|Hormone Antagonists|hormone antagonists|mesh-ancestor
92514792|NCT00386672|Vitamin D|vitamin d|mesh-list
93238061|NCT02110316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238062|NCT02110316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238063|NCT02110316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93238064|NCT05625087|Fulvestrant|fulvestrant|mesh-list
93238065|NCT05625087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238066|NCT05625087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238067|NCT05625087|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93238068|NCT05625087|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93238069|NCT05625087|Hormone Antagonists|hormone antagonists|mesh-ancestor
93238070|NCT05625087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514869|NCT00371059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238071|NCT05625087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238072|NCT02110394|Rituximab|rituximab|mesh-list
93238073|NCT02110394|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92515009|NCT00017368|Thiotepa|thiotepa|mesh-list
92515089|NCT00017680|Melphalan|melphalan|mesh-list
93238074|NCT02110394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238075|NCT02110394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238076|NCT02110394|Immunologic Factors|immunologic factors|mesh-ancestor
93238077|NCT02110394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238078|NCT02110394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515401|NCT05419921|Lidocaine|lidocaine|mesh-list
93238079|NCT02110394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93238080|NCT02110394|Alkylating Agents|alkylating agents|mesh-ancestor
92515523|NCT05156905|Docetaxel|docetaxel|mesh-list
93238081|NCT02110394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238082|NCT02373241|Losartan|losartan|mesh-list
93238083|NCT02373241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93238084|NCT02373241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93238085|NCT02373241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93238086|NCT02373241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93238087|NCT02373241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238088|NCT05656131|Fluzoparib|fluzoparib|mesh-list
93238089|NCT05656131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93238090|NCT05656131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238091|NCT05656131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238092|NCT05656131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238093|NCT02103998|Iodine|iodine|mesh-list
93238094|NCT02103998|Hormones|hormones|mesh-list
93238095|NCT02103998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238096|NCT02103998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238097|NCT02103998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93238098|NCT02103998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238099|NCT02103998|Trace Elements|trace elements|mesh-ancestor
93238100|NCT02103998|Micronutrients|micronutrients|mesh-ancestor
93238101|NCT01941589|Methylprednisolone|methylprednisolone|mesh-list
93238102|NCT01941589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93238103|NCT01941589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93238104|NCT01941589|Prednisolone|prednisolone|mesh-list
93238105|NCT01941589|Prednisolone acetate|prednisolone acetate|mesh-list
93238106|NCT01941589|Hydrocortisone|hydrocortisone|mesh-list
93238107|NCT01941589|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93238108|NCT01941589|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93238109|NCT01941589|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92515795|NCT04733521|Cisplatin|cisplatin|mesh-list
93238110|NCT01941589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93238111|NCT01941589|Prednisolone phosphate|prednisolone phosphate|mesh-list
93238112|NCT01941589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238113|NCT01941589|Antiemetics|antiemetics|mesh-ancestor
93238114|NCT01941589|Autonomic Agents|autonomic agents|mesh-ancestor
93238115|NCT01941589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238116|NCT01941589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238117|NCT01941589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238118|NCT01941589|Glucocorticoids|glucocorticoids|mesh-ancestor
93238119|NCT01941589|Hormones|hormones|mesh-ancestor
93238120|NCT01941589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238121|NCT01941589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92910109|NCT00763906|Norepinephrine|norepinephrine|mesh-list
93238122|NCT01941589|Protective Agents|protective agents|mesh-ancestor
92516236|NCT05597553|Pemetrexed|pemetrexed|mesh-list
93238123|NCT01941589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238124|NCT01941589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238125|NCT01845649|Estradiol|estradiol|mesh-list
93238126|NCT01845649|Estrogens|estrogens|mesh-ancestor
93238127|NCT01845649|Hormones|hormones|mesh-ancestor
92516459|NCT01806259|Ketorolac|ketorolac|mesh-list
93238128|NCT01845649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238129|NCT01845649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238130|NCT01345929|Levofloxacin|levofloxacin|mesh-list
93238131|NCT01345929|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93238132|NCT01345929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516752|NCT00393835|Azithromycin|azithromycin|mesh-list
93238133|NCT01345929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93238134|NCT01345929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93238135|NCT01345929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93238136|NCT01345929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238137|NCT01345929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238138|NCT01345929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238139|NCT01345929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93238140|NCT01345929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93238141|NCT02107742|Lidocaine|lidocaine|mesh-list
93238142|NCT02107742|Anesthetics, Local|anesthetics, local|mesh-ancestor
93238143|NCT02107742|Anesthetics|anesthetics|mesh-ancestor
92516971|NCT00846703|Hormones|hormones|mesh-ancestor
92517041|NCT00846118|Pitavastatin|pitavastatin|mesh-list
93238144|NCT02107742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242054|NCT04623541|Prednisone|prednisone|mesh-list
93238145|NCT02107742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238146|NCT02107742|Sensory System Agents|sensory system agents|mesh-ancestor
92517272|NCT00276289|Spironolactone|spironolactone|mesh-list
93238147|NCT02107742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238148|NCT02107742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92517412|NCT02921555|Prednisolone phosphate|prednisolone phosphate|mesh-list
93238149|NCT02107742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93238150|NCT02107742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93238151|NCT02107742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517488|NCT04732507|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93238152|NCT02107742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238153|NCT02250872|Cisplatin|cisplatin|mesh-list
93238154|NCT02250872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238155|NCT02110784|Piperaquine|piperaquine|mesh-list
93238156|NCT02110784|Artenimol|artenimol|mesh-list
93238157|NCT02110784|Antimalarials|antimalarials|mesh-ancestor
93238158|NCT02110784|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92517713|NCT00006047|Etoposide|etoposide|mesh-list
93238159|NCT02110784|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93238160|NCT02110784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238161|NCT04988425|Methylprednisolone|methylprednisolone|mesh-list
93238162|NCT04988425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93238163|NCT04988425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93238164|NCT04988425|Prednisolone|prednisolone|mesh-list
93238165|NCT04988425|Prednisolone acetate|prednisolone acetate|mesh-list
93238166|NCT04988425|Antibodies|antibodies|mesh-list
93238167|NCT04988425|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93238168|NCT04988425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93238169|NCT04988425|Prednisolone phosphate|prednisolone phosphate|mesh-list
93238170|NCT04988425|Immunologic Factors|immunologic factors|mesh-ancestor
93238171|NCT04988425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238172|NCT04988425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238173|NCT04988425|Antiemetics|antiemetics|mesh-ancestor
93238174|NCT04988425|Autonomic Agents|autonomic agents|mesh-ancestor
93238175|NCT04988425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238176|NCT04988425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238177|NCT04988425|Glucocorticoids|glucocorticoids|mesh-ancestor
93238178|NCT04988425|Hormones|hormones|mesh-ancestor
93238179|NCT04988425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238180|NCT04988425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92518384|NCT00087334|Gefitinib|gefitinib|mesh-list
93238181|NCT04988425|Protective Agents|protective agents|mesh-ancestor
93238182|NCT04988425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238183|NCT04988425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238184|NCT01343901|Bevacizumab|bevacizumab|mesh-list
93238185|NCT01343901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238186|NCT01343901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238187|NCT01343901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93238188|NCT01343901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93238189|NCT01343901|Growth Substances|growth substances|mesh-ancestor
93238190|NCT01343901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238191|NCT01343901|Growth Inhibitors|growth inhibitors|mesh-ancestor
93238192|NCT05617521|Caffeine|caffeine|mesh-list
92518518|NCT00088270|Leucovorin|leucovorin|mesh-list
93238193|NCT05617521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92243589|NCT05143502|Xhance|xhance|mesh-list
93238194|NCT05617521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238195|NCT05617521|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93238196|NCT05617521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238197|NCT05617521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238198|NCT05617521|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93238199|NCT05617521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93238200|NCT05617521|Purinergic Agents|purinergic agents|mesh-ancestor
93238201|NCT05617521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518811|NCT00089401|Melphalan|melphalan|mesh-list
93238202|NCT02108210|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93238203|NCT02108210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238205|NCT02104700|Emtricitabine|emtricitabine|mesh-list
93238206|NCT02104700|Rilpivirine|rilpivirine|mesh-list
93238207|NCT02104700|Antiviral Agents|antiviral agents|mesh-ancestor
93238208|NCT02104700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518921|NCT00090727|AQ4N|aq4n|mesh-list
93238209|NCT02104700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92518948|NCT00091078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238210|NCT02104700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93238211|NCT02104700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238212|NCT02104700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238213|NCT02104700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93238214|NCT02104700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93238215|NCT02104778|Dexamethasone|dexamethasone|mesh-list
93238216|NCT02104778|Epinephrine|epinephrine|mesh-list
93238217|NCT02104778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238218|NCT02104778|Antiemetics|antiemetics|mesh-ancestor
93238219|NCT02104778|Autonomic Agents|autonomic agents|mesh-ancestor
92519239|NCT00093301|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93238220|NCT02104778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238221|NCT02104778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238222|NCT02104778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238223|NCT02104778|Glucocorticoids|glucocorticoids|mesh-ancestor
93238224|NCT02104778|Hormones|hormones|mesh-ancestor
93238225|NCT02104778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238226|NCT02104778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238227|NCT02104778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238228|NCT02104778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93238229|NCT02104778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93238230|NCT02104778|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244513|NCT00486824|Indomethacin|indomethacin|mesh-list
93238231|NCT02104778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238232|NCT02104778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238233|NCT02104778|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93238234|NCT02104778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93238235|NCT02104778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93238236|NCT02104778|Respiratory System Agents|respiratory system agents|mesh-ancestor
93238237|NCT02104778|Mydriatics|mydriatics|mesh-ancestor
93238238|NCT02104778|Sympathomimetics|sympathomimetics|mesh-ancestor
93238239|NCT02104778|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93238240|NCT02108366|Oseltamivir|oseltamivir|mesh-list
93238241|NCT02108366|Celecoxib|celecoxib|mesh-list
92519971|NCT00097942|Memantine|memantine|mesh-list
93238242|NCT02108366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92520059|NCT00387920|Sunitinib|sunitinib|mesh-list
93238243|NCT02108366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93238244|NCT02108366|Analgesics|analgesics|mesh-ancestor
93238245|NCT02108366|Sensory System Agents|sensory system agents|mesh-ancestor
93238246|NCT02108366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520188|NCT00099970|Dacarbazine|dacarbazine|mesh-list
93238247|NCT02108366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520262|NCT00006371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93238248|NCT02108366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238249|NCT02108366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238250|NCT02108366|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93238251|NCT02108366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93238252|NCT02108366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238253|NCT02108366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238254|NCT02108366|Antiviral Agents|antiviral agents|mesh-ancestor
93238255|NCT02108366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238256|NCT05706207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93238257|NCT05706207|Antibodies|antibodies|mesh-list
93238258|NCT05706207|Immunoglobulins|immunoglobulins|mesh-list
93238259|NCT05706207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93238260|NCT05706207|Immunologic Factors|immunologic factors|mesh-ancestor
93238261|NCT05706207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520778|NCT00103948|Donepezil|donepezil|mesh-list
93238262|NCT05706207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521074|NCT00106288|Micafungin|micafungin|mesh-list
93238263|NCT02105090|Anesthetics|anesthetics|mesh-list
93238264|NCT02105090|Anesthetics, Local|anesthetics, local|mesh-list
93238265|NCT02105090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238266|NCT02105090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238267|NCT02105090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238268|NCT02105090|Sensory System Agents|sensory system agents|mesh-ancestor
93238269|NCT03553628|Chlorhexidine|chlorhexidine|mesh-list
93238270|NCT03553628|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93238271|NCT03553628|Propolis|propolis|mesh-list
92521443|NCT00108511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238272|NCT03553628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93238273|NCT03553628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238274|NCT03553628|Disinfectants|disinfectants|mesh-ancestor
93238275|NCT03553628|Dermatologic Agents|dermatologic agents|mesh-ancestor
93238276|NCT02112032|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93238277|NCT02112032|Pembrolizumab|pembrolizumab|mesh-list
93238278|NCT02112032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238279|NCT02112032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521663|NCT00110188|Sirolimus|sirolimus|mesh-list
93238280|NCT02112032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92521733|NCT00110773|Lidocaine|lidocaine|mesh-list
93238281|NCT02112032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238282|NCT02112032|Antiviral Agents|antiviral agents|mesh-ancestor
93238283|NCT02112032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238284|NCT01343823|Ecallantide|ecallantide|mesh-list
92521887|NCT00111904|Paclitaxel|paclitaxel|mesh-list
93238285|NCT01343823|Analgesics|analgesics|mesh-ancestor
93238286|NCT01343823|Sensory System Agents|sensory system agents|mesh-ancestor
93238287|NCT01343823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238288|NCT01343823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238289|NCT01343823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92522112|NCT00112879|Hormones|hormones|mesh-ancestor
93238290|NCT01343823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93238291|NCT01343823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238292|NCT01343823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238294|NCT02251184|Dipyridamole|dipyridamole|mesh-list
93238295|NCT02251184|Lansoprazole|lansoprazole|mesh-list
93238296|NCT02251184|Dexlansoprazole|dexlansoprazole|mesh-list
93238297|NCT02251184|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
93238298|NCT02251184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92522334|NCT00114205|Docetaxel|docetaxel|mesh-list
93238299|NCT02251184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93238300|NCT02251184|Analgesics|analgesics|mesh-ancestor
93238301|NCT02251184|Sensory System Agents|sensory system agents|mesh-ancestor
93238302|NCT02251184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238303|NCT02251184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238304|NCT02251184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238305|NCT02251184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247421|NCT00623714|Xhance|xhance|mesh-list
93238306|NCT02251184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93238307|NCT02251184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93238308|NCT02251184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238309|NCT02251184|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93238310|NCT02251184|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93238311|NCT02251184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238312|NCT02251184|Antipyretics|antipyretics|mesh-ancestor
93238313|NCT02251184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93238314|NCT02251184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238315|NCT02251184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93238316|NCT02251184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93238317|NCT02251184|Vasodilator Agents|vasodilator agents|mesh-ancestor
93238318|NCT02108756|Pantoprazole|pantoprazole|mesh-list
93238319|NCT02108756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93238320|NCT02108756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238321|NCT02108756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93238322|NCT02108756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238323|NCT02108756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238324|NCT05547399|Zanubrutinib|zanubrutinib|mesh-list
93238325|NCT05547399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238326|NCT05547399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93238327|NCT05547399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238328|NCT05547399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238329|NCT01318083|Glimepiride|glimepiride|mesh-list
93238330|NCT01318083|Alogliptin|alogliptin|mesh-list
92522905|NCT00117247|Hematinics|hematinics|mesh-ancestor
93238331|NCT01318083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93238332|NCT01318083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238333|NCT01318083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238334|NCT01318083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93238335|NCT01318083|Immunologic Factors|immunologic factors|mesh-ancestor
93238336|NCT01318083|Incretins|incretins|mesh-ancestor
93238337|NCT01318083|Hormones|hormones|mesh-ancestor
93238338|NCT01318083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523279|NCT04727437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93238339|NCT01318083|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93238340|NCT01318083|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238341|NCT01318083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523356|NCT00120835|Antiviral Agents|antiviral agents|mesh-ancestor
93238342|NCT01318083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238343|NCT05545137|Fosfomycin|fosfomycin|mesh-list
93238344|NCT05545137|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
92523429|NCT00121459|Psyllium|psyllium|mesh-list
93238345|NCT05545137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910337|NCT04049344|Oxaliplatin|oxaliplatin|mesh-list
93238346|NCT05545137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238347|NCT05545137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93238348|NCT02105714|Formaldehyde|formaldehyde|mesh-list
93238349|NCT02105714|Disinfectants|disinfectants|mesh-ancestor
93238350|NCT02105714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238351|NCT02105792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93238352|NCT02105792|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93238353|NCT02105792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238354|NCT02105792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238355|NCT02105792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238356|NCT02105792|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238357|NCT02105792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238358|NCT03817515|Sirolimus|sirolimus|mesh-list
93238359|NCT03817515|Temsirolimus|temsirolimus|mesh-list
93238360|NCT03817515|MTOR Inhibitors|mtor inhibitors|mesh-list
93238361|NCT03817515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93238362|NCT03817515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238363|NCT03817515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93238364|NCT03817515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523634|NCT00129337|Bavituximab|bavituximab|mesh-list
93238365|NCT03817515|Antifungal Agents|antifungal agents|mesh-ancestor
93238366|NCT03817515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93238367|NCT03817515|Immunologic Factors|immunologic factors|mesh-ancestor
93238368|NCT03817515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238369|NCT03817515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93238370|NCT03817515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238371|NCT03817515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238372|NCT02105870|Abciximab|abciximab|mesh-list
93238373|NCT02105870|Anticoagulants|anticoagulants|mesh-ancestor
92523994|NCT00019396|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93238374|NCT02105870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93238375|NCT02112422|Dexamethasone|dexamethasone|mesh-list
92524091|NCT00019786|Melphalan|melphalan|mesh-list
93238376|NCT02112422|Dexamethasone acetate|dexamethasone acetate|mesh-list
93238377|NCT02112422|BB 1101|bb 1101|mesh-list
93238378|NCT02112422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238379|NCT02112422|Antiemetics|antiemetics|mesh-ancestor
93238380|NCT02112422|Autonomic Agents|autonomic agents|mesh-ancestor
93238381|NCT02112422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238382|NCT02112422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238383|NCT02112422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238384|NCT02112422|Glucocorticoids|glucocorticoids|mesh-ancestor
93238385|NCT02112422|Hormones|hormones|mesh-ancestor
93238386|NCT02112422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238387|NCT02112422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238388|NCT02112422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238389|NCT02112422|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238390|NCT02112422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238391|NCT02112422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238392|NCT02109614|Niacin|niacin|mesh-list
93238393|NCT02109614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93238394|NCT02109614|Antimetabolites|antimetabolites|mesh-ancestor
93238395|NCT02109614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238396|NCT02109614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93238397|NCT02109614|Vasodilator Agents|vasodilator agents|mesh-ancestor
93238398|NCT02109614|Vitamin B Complex|vitamin b complex|mesh-ancestor
93238399|NCT02109614|Vitamins|vitamins|mesh-ancestor
93238400|NCT02109614|Micronutrients|micronutrients|mesh-ancestor
93238401|NCT02109614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238402|NCT02106104|Glimepiride|glimepiride|mesh-list
93238403|NCT02106104|Linagliptin|linagliptin|mesh-list
93238404|NCT02106104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93238405|NCT02106104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92524576|NCT00022087|Cholecalciferol|cholecalciferol|mesh-list
92524659|NCT00022165|Selenium|selenium|mesh-list
93238406|NCT02106104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238407|NCT02106104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524729|NCT00000143|Cidofovir|cidofovir|mesh-list
93238408|NCT02106104|Immunologic Factors|immunologic factors|mesh-ancestor
93238409|NCT02106104|Incretins|incretins|mesh-ancestor
93238410|NCT02106104|Hormones|hormones|mesh-ancestor
93238411|NCT02106104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238412|NCT02106104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93238413|NCT02106104|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238414|NCT02106104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525014|NCT00023530|Voriconazole|voriconazole|mesh-list
93238415|NCT02106104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238416|NCT01376323|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93238417|NCT01376323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238418|NCT01376323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238419|NCT01376323|Incretins|incretins|mesh-ancestor
93238420|NCT01376323|Hormones|hormones|mesh-ancestor
93366393|NCT02796755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238421|NCT01376323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525346|NCT00000257|Analgesics|analgesics|mesh-ancestor
93238422|NCT01376323|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93238423|NCT01376323|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238424|NCT01376323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238425|NCT01376323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238426|NCT02113904|Adalimumab|adalimumab|mesh-list
93238427|NCT02113904|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93238428|NCT02113904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238429|NCT02113904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238430|NCT05438979|Calcium|calcium|mesh-list
93238431|NCT05438979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93238432|NCT05438979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238433|NCT05432115|Amoxicillin|amoxicillin|mesh-list
93238434|NCT05432115|Tetracycline|tetracycline|mesh-list
93238435|NCT05432115|Esomeprazole|esomeprazole|mesh-list
93238436|NCT05432115|Bismuth|bismuth|mesh-list
93238437|NCT05432115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93238438|NCT05432115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238439|NCT05432115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92526083|NCT00027742|Interferons|interferons|mesh-list
93238440|NCT05432115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238441|NCT05432115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93238442|NCT05432115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238443|NCT05432115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238444|NCT05432115|Antacids|antacids|mesh-ancestor
93238445|NCT05432115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93238446|NCT02114528|Amiodarone|amiodarone|mesh-list
93238447|NCT02114528|Sotalol|sotalol|mesh-list
93238448|NCT02114528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93238449|NCT02114528|Mexiletine|mexiletine|mesh-list
93238450|NCT02114528|Procainamide|procainamide|mesh-list
93238451|NCT02114528|Vasodilator Agents|vasodilator agents|mesh-ancestor
93238452|NCT02114528|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93238453|NCT02114528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93238454|NCT02114528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238455|NCT02114528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92526471|NCT00028756|Doxorubicin|doxorubicin|mesh-list
93238456|NCT02114528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93238457|NCT02114528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93238458|NCT02114528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238459|NCT02114528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93238460|NCT02114528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92526674|NCT00012519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93238461|NCT02114528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92526814|NCT00000518|Sotalol|sotalol|mesh-list
93238462|NCT02114528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93238463|NCT02114528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93238464|NCT02114528|Adrenergic Agents|adrenergic agents|mesh-ancestor
93238465|NCT02114528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238466|NCT02114528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238467|NCT02114528|Sympatholytics|sympatholytics|mesh-ancestor
93238468|NCT02114528|Autonomic Agents|autonomic agents|mesh-ancestor
93238469|NCT02114528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238470|NCT02114528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93238471|NCT02113202|Bevacizumab|bevacizumab|mesh-list
93238472|NCT02113202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238473|NCT02113202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238474|NCT02113202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93238475|NCT02113202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93238476|NCT02113202|Growth Substances|growth substances|mesh-ancestor
93238477|NCT02113202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238478|NCT02113202|Growth Inhibitors|growth inhibitors|mesh-ancestor
93238479|NCT01376401|Prednisone|prednisone|mesh-list
93238480|NCT01376401|Bortezomib|bortezomib|mesh-list
92291383|NCT02377271|Bosentan|bosentan|mesh-list
93238481|NCT01376401|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93238482|NCT01376401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238483|NCT01376401|Glucocorticoids|glucocorticoids|mesh-ancestor
93238484|NCT01376401|Hormones|hormones|mesh-ancestor
92527246|NCT00032149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238485|NCT01376401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238486|NCT01376401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238487|NCT01376401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238488|NCT01376401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238489|NCT01376401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93238490|NCT01376401|Alkylating Agents|alkylating agents|mesh-ancestor
92527385|NCT00032968|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93238491|NCT01376401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238492|NCT02119520|Atorvastatin|atorvastatin|mesh-list
92302873|NCT04832100|Pregabalin|pregabalin|mesh-list
93238493|NCT02119520|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93238494|NCT02119520|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93238495|NCT02119520|Antimetabolites|antimetabolites|mesh-ancestor
92527640|NCT00033748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92311086|NCT02684942|Fentanyl|fentanyl|mesh-list
93238496|NCT02119520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238497|NCT02119520|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93238498|NCT02119520|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93238499|NCT02119520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238500|NCT03961789|Analgesics, Opioid|analgesics, opioid|mesh-list
93238501|NCT03961789|Narcotics|narcotics|mesh-ancestor
93238502|NCT03961789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238503|NCT03961789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238504|NCT03961789|Analgesics|analgesics|mesh-ancestor
93238505|NCT03961789|Sensory System Agents|sensory system agents|mesh-ancestor
93238506|NCT03961789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238507|NCT04854343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93238508|NCT04854343|Protease Inhibitors|protease inhibitors|mesh-list
93238509|NCT04854343|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
92528077|NCT00000710|Didanosine|didanosine|mesh-list
93238510|NCT04854343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238511|NCT04854343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328069|NCT00003146|Melphalan|melphalan|mesh-list
93238512|NCT04854343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93238513|NCT04854343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93238514|NCT04854343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93238515|NCT04854343|Antiviral Agents|antiviral agents|mesh-ancestor
93238516|NCT04854343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238517|NCT04854343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92343117|NCT00004433|Pergolide|pergolide|mesh-list
92528453|NCT00036088|Olanzapine|olanzapine|mesh-list
93238518|NCT01376713|Dacarbazine|dacarbazine|mesh-list
93238519|NCT01376713|Ofatumumab|ofatumumab|mesh-list
93238520|NCT01376713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93238521|NCT01376713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93238522|NCT01376713|Alkylating Agents|alkylating agents|mesh-ancestor
93238523|NCT01376713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238524|NCT01376713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238525|NCT01376713|Immunologic Factors|immunologic factors|mesh-ancestor
92528714|NCT00000869|Nevirapine|nevirapine|mesh-list
93238526|NCT01376713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238527|NCT03728179|Aspirin|aspirin|mesh-list
93238528|NCT03728179|Celecoxib|celecoxib|mesh-list
93238529|NCT03728179|Cyclophosphamide|cyclophosphamide|mesh-list
93238530|NCT03728179|Nivolumab|nivolumab|mesh-list
93238531|NCT03728179|Ipilimumab|ipilimumab|mesh-list
92528908|NCT00038116|Dopamine Agents|dopamine agents|mesh-ancestor
93238532|NCT03728179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93238533|NCT03728179|Immunologic Factors|immunologic factors|mesh-ancestor
93238534|NCT03728179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238535|NCT03728179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238536|NCT03728179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93238537|NCT03728179|Alkylating Agents|alkylating agents|mesh-ancestor
92378552|NCT02464176|Hormones|hormones|mesh-ancestor
92378695|NCT02500836|Cocaine|cocaine|mesh-list
93238538|NCT03728179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529234|NCT00001004|Interferons|interferons|mesh-list
93238539|NCT03728179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238540|NCT03728179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93238541|NCT03728179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238542|NCT03728179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93238543|NCT03728179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93238544|NCT03728179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93238545|NCT03728179|Analgesics|analgesics|mesh-ancestor
93238546|NCT03728179|Sensory System Agents|sensory system agents|mesh-ancestor
93238547|NCT03728179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238548|NCT03728179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238549|NCT03728179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92102169|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
93238550|NCT03728179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93238551|NCT03728179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93238552|NCT03728179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93238553|NCT03728179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238554|NCT03728179|Antipyretics|antipyretics|mesh-ancestor
93238555|NCT03728179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93238556|NCT01368536|Amlodipine|amlodipine|mesh-list
93238557|NCT01368536|Chlorthalidone|chlorthalidone|mesh-list
93238558|NCT01368536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93238559|NCT01368536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93238560|NCT01368536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93238561|NCT01368536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529942|NCT00038974|Ribavirin|ribavirin|mesh-list
93238562|NCT01368536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92530015|NCT00039286|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93238563|NCT01368536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238564|NCT01368536|Vasodilator Agents|vasodilator agents|mesh-ancestor
93238565|NCT01368536|Diuretics|diuretics|mesh-ancestor
93238566|NCT01368536|Natriuretic Agents|natriuretic agents|mesh-ancestor
93238567|NCT01368536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93238568|NCT05103735|Dexmedetomidine|dexmedetomidine|mesh-list
93238569|NCT05103735|Remifentanil|remifentanil|mesh-list
93238570|NCT05103735|Propofol|propofol|mesh-list
93238571|NCT05103735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93238572|NCT05103735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238573|NCT05103735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238574|NCT05103735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93238575|NCT05103735|Analgesics|analgesics|mesh-ancestor
93238576|NCT05103735|Sensory System Agents|sensory system agents|mesh-ancestor
93238577|NCT05103735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238578|NCT05103735|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93238579|NCT05103735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93238580|NCT05103735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93238581|NCT05103735|Adrenergic Agents|adrenergic agents|mesh-ancestor
93238582|NCT05103735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238583|NCT05103735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238584|NCT05103735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93238585|NCT05103735|Anesthetics, General|anesthetics, general|mesh-ancestor
93238586|NCT05103735|Anesthetics|anesthetics|mesh-ancestor
93238587|NCT05103735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93238588|NCT05103735|Narcotics|narcotics|mesh-ancestor
93238589|NCT01319929|CB2 receptor agonist LY2828360|cb2 receptor agonist ly2828360|mesh-list
93238590|NCT01319929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93238591|NCT01319929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93238592|NCT01319929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238593|NCT01319929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238594|NCT01319929|Hormones|hormones|mesh-ancestor
93238595|NCT01319929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238596|NCT01319929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238597|NCT03633565|Prednisolone|prednisolone|mesh-list
93238598|NCT03633565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93238599|NCT03633565|Methylprednisolone|methylprednisolone|mesh-list
93238600|NCT03633565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93238601|NCT03633565|Prednisolone acetate|prednisolone acetate|mesh-list
93238602|NCT03633565|Sildenafil Citrate|sildenafil citrate|mesh-list
93238603|NCT03633565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93238604|NCT03633565|Prednisolone phosphate|prednisolone phosphate|mesh-list
93238605|NCT03633565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
93238606|NCT03633565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238607|NCT03633565|Glucocorticoids|glucocorticoids|mesh-ancestor
93238608|NCT03633565|Hormones|hormones|mesh-ancestor
93238609|NCT03633565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120237|NCT03212352|Misoprostol|misoprostol|mesh-list
93238610|NCT03633565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238611|NCT03633565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238612|NCT03633565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238613|NCT03633565|Antiemetics|antiemetics|mesh-ancestor
93238614|NCT03633565|Autonomic Agents|autonomic agents|mesh-ancestor
93238615|NCT03633565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238616|NCT03633565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238617|NCT03633565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93238618|NCT03633565|Protective Agents|protective agents|mesh-ancestor
93238619|NCT03633565|Vasodilator Agents|vasodilator agents|mesh-ancestor
93238620|NCT03633565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93238621|NCT03633565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238622|NCT03633565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238623|NCT03633565|Urological Agents|urological agents|mesh-ancestor
93238624|NCT02120066|Plasminogen|plasminogen|mesh-list
93238625|NCT02120066|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93238626|NCT02120066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93238627|NCT02120066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93238628|NCT02120066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238629|NCT01373359|Misoprostol|misoprostol|mesh-list
93238630|NCT01373359|Oxytocin|oxytocin|mesh-list
93238631|NCT01373359|Oxytocics|oxytocics|mesh-ancestor
93238632|NCT01373359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93238633|NCT01373359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238634|NCT01373359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93238635|NCT01373359|Abortifacient Agents|abortifacient agents|mesh-ancestor
93238636|NCT01373359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93238637|NCT01373359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238638|NCT02123264|Zoledronic Acid|zoledronic acid|mesh-list
93238639|NCT02123264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93238640|NCT02123264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238641|NCT02251964|Rituximab|rituximab|mesh-list
93238642|NCT02251964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238643|NCT02251964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238644|NCT02251964|Immunologic Factors|immunologic factors|mesh-ancestor
93238645|NCT02251964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238646|NCT02251964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238647|NCT04739995|Naltrexone|naltrexone|mesh-list
93238648|NCT04739995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93238649|NCT04739995|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93238650|NCT04739995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238651|NCT04739995|Sensory System Agents|sensory system agents|mesh-ancestor
93238652|NCT04739995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238653|NCT02120612|Naloxone|naloxone|mesh-list
93238654|NCT02120612|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93238655|NCT02120612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238656|NCT02120612|Sensory System Agents|sensory system agents|mesh-ancestor
93238657|NCT02120612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238658|NCT02115152|Cyclophosphamide|cyclophosphamide|mesh-list
93238659|NCT02115152|Fluorouracil|fluorouracil|mesh-list
93238660|NCT02115152|Capecitabine|capecitabine|mesh-list
93238661|NCT02115152|Epirubicin|epirubicin|mesh-list
93238662|NCT02115152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93238663|NCT02115152|Immunologic Factors|immunologic factors|mesh-ancestor
93238664|NCT02115152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238665|NCT02115152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238666|NCT02115152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93238667|NCT02115152|Alkylating Agents|alkylating agents|mesh-ancestor
93238668|NCT02115152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238669|NCT02115152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238670|NCT02115152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93238671|NCT02115152|Antimetabolites|antimetabolites|mesh-ancestor
93238672|NCT02115152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93238673|NCT02115152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93238674|NCT02115152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93238675|NCT02115152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93238676|NCT02115152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238677|NCT02115464|Metformin|metformin|mesh-list
93238678|NCT02115464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238679|NCT02115464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238680|NCT02858076|Aflibercept|aflibercept|mesh-list
93238681|NCT02858076|Endothelial Growth Factors|endothelial growth factors|mesh-list
93238682|NCT02858076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93238683|NCT02858076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93238684|NCT02858076|Growth Substances|growth substances|mesh-ancestor
93238685|NCT02858076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238686|NCT02858076|Growth Inhibitors|growth inhibitors|mesh-ancestor
93238687|NCT02858076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238688|NCT01319695|Hormones|hormones|mesh-list
93238689|NCT01319695|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93238690|NCT01319695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238691|NCT01319695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238692|NCT04594759|Isotretinoin|isotretinoin|mesh-list
93238693|NCT04594759|Dermatologic Agents|dermatologic agents|mesh-ancestor
93238694|NCT02123498|Omeprazole|omeprazole|mesh-list
93238695|NCT02123498|Pantoprazole|pantoprazole|mesh-list
93238696|NCT02123498|Ranitidine|ranitidine|mesh-list
93238697|NCT02123498|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92134551|NCT00538863|Fentanyl|fentanyl|mesh-list
93238698|NCT02123498|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93238699|NCT02123498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238700|NCT02123498|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93238701|NCT02123498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238702|NCT02123498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238703|NCT02123498|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93238704|NCT02123498|Histamine Antagonists|histamine antagonists|mesh-ancestor
93238705|NCT02123498|Histamine Agents|histamine agents|mesh-ancestor
93238706|NCT02123498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238707|NCT02123498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147770|NCT04989660|Phenol|phenol|mesh-list
93238708|NCT02115776|Amoxicillin|amoxicillin|mesh-list
93238709|NCT02115776|Clavulanic Acid|clavulanic acid|mesh-list
93238710|NCT02115776|Clavulanic Acids|clavulanic acids|mesh-list
93238711|NCT02115776|Chlorhexidine|chlorhexidine|mesh-list
92151621|NCT05045274|Antipyretics|antipyretics|mesh-ancestor
93238712|NCT02115776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93238713|NCT02115776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238714|NCT02115776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93238715|NCT02115776|Disinfectants|disinfectants|mesh-ancestor
93238716|NCT02115776|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93238717|NCT02115776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238718|NCT02115776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238719|NCT02123654|Asunaprevir|asunaprevir|mesh-list
92531206|NCT00045565|Arsenic Trioxide|arsenic trioxide|mesh-list
93238720|NCT02123654|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238721|NCT02123654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238722|NCT02123654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238723|NCT02116010|Sulfadiazine|sulfadiazine|mesh-list
93238724|NCT02116010|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93238725|NCT02116010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93238726|NCT02116010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238727|NCT02116010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93238728|NCT02116010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93238729|NCT02116010|Coccidiostats|coccidiostats|mesh-ancestor
93238730|NCT02116010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93238731|NCT03609294|Linagliptin|linagliptin|mesh-list
93238732|NCT03609294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238733|NCT03609294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238734|NCT03609294|Incretins|incretins|mesh-ancestor
93238735|NCT03609294|Hormones|hormones|mesh-ancestor
93238736|NCT03609294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238737|NCT03609294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93238738|NCT03609294|Protease Inhibitors|protease inhibitors|mesh-ancestor
93238739|NCT03609294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238740|NCT03609294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238741|NCT01917552|Capecitabine|capecitabine|mesh-list
93238742|NCT01917552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93238743|NCT01917552|Antimetabolites|antimetabolites|mesh-ancestor
93238744|NCT01917552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238745|NCT01917552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238746|NCT01261728|Gemcitabine|gemcitabine|mesh-list
93238747|NCT01261728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238748|NCT01261728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93238749|NCT01261728|Antimetabolites|antimetabolites|mesh-ancestor
93238750|NCT01261728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238751|NCT02116400|Lithium Carbonate|lithium carbonate|mesh-list
93238752|NCT02116400|Antidepressive Agents|antidepressive agents|mesh-ancestor
93238753|NCT02116400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93238754|NCT02116400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238755|NCT02116400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238756|NCT02116400|Antimanic Agents|antimanic agents|mesh-ancestor
93238757|NCT02116400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93238758|NCT02116400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238759|NCT02116400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238760|NCT03119701|Interferons|interferons|mesh-list
93238761|NCT03119701|Interferon-beta|interferon-beta|mesh-list
93238762|NCT03119701|Interferon beta-1a|interferon beta-1a|mesh-list
93238763|NCT03119701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238764|NCT03119701|Antiviral Agents|antiviral agents|mesh-ancestor
93238765|NCT03119701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238766|NCT03119701|Immunologic Factors|immunologic factors|mesh-ancestor
93238767|NCT03119701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238768|NCT03119701|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93238769|NCT03717129|Tenofovir|tenofovir|mesh-list
93238770|NCT03717129|Emtricitabine|emtricitabine|mesh-list
93238771|NCT03717129|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93238772|NCT03717129|Cobicistat|cobicistat|mesh-list
93238773|NCT03717129|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93238774|NCT03717129|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93238775|NCT03717129|Elvitegravir|elvitegravir|mesh-list
93238776|NCT03717129|Antiviral Agents|antiviral agents|mesh-ancestor
93238777|NCT03717129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238778|NCT03717129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93238779|NCT03717129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93238780|NCT03717129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238781|NCT03717129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238782|NCT03717129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93238783|NCT03717129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92531450|NCT00397735|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93238784|NCT03717129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93238785|NCT03717129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93238786|NCT03717129|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93238787|NCT03627039|Metformin|metformin|mesh-list
93238788|NCT03627039|Dapagliflozin|dapagliflozin|mesh-list
93238789|NCT03627039|Empagliflozin|empagliflozin|mesh-list
93238790|NCT03627039|Canagliflozin|canagliflozin|mesh-list
93238791|NCT03627039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238792|NCT03627039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910779|NCT00829296|Metoprolol|metoprolol|mesh-list
93238793|NCT03627039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93238794|NCT03627039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238795|NCT01374373|Epoetin Alfa|epoetin alfa|mesh-list
93238796|NCT01374373|Hematinics|hematinics|mesh-ancestor
93238798|NCT02116556|Prednisone|prednisone|mesh-list
93238799|NCT02116556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238800|NCT02116556|Glucocorticoids|glucocorticoids|mesh-ancestor
93238801|NCT02116556|Hormones|hormones|mesh-ancestor
93238802|NCT02116556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238803|NCT02116556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238804|NCT02116556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238805|NCT02116556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238806|NCT02116556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93238807|NCT02116556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238808|NCT02116556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238809|NCT03634345|Fluconazole|fluconazole|mesh-list
93238810|NCT03634345|Fluvoxamine|fluvoxamine|mesh-list
93238811|NCT03634345|Abrocitinib|abrocitinib|mesh-list
93238812|NCT03634345|Antifungal Agents|antifungal agents|mesh-ancestor
93238813|NCT03634345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238814|NCT03634345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93238815|NCT03634345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93238816|NCT03634345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238817|NCT03634345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238818|NCT03634345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93238819|NCT03634345|Hormone Antagonists|hormone antagonists|mesh-ancestor
92531578|NCT04733781|Anesthetics|anesthetics|mesh-ancestor
93238820|NCT03634345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238821|NCT03634345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238822|NCT03634345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93238823|NCT03634345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93238824|NCT03634345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93238825|NCT03634345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93238826|NCT03634345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238827|NCT03634345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93238828|NCT03634345|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93238829|NCT03634345|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93238830|NCT03634345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93238831|NCT03634345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238832|NCT03634345|Serotonin Agents|serotonin agents|mesh-ancestor
93238833|NCT03634345|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93238834|NCT03634345|Antidepressive Agents|antidepressive agents|mesh-ancestor
93238835|NCT03634345|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93238836|NCT03634345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93238837|NCT03553238|Cytarabine|cytarabine|mesh-list
93238838|NCT03553238|Dexamethasone|dexamethasone|mesh-list
93238839|NCT03553238|Cyclophosphamide|cyclophosphamide|mesh-list
93238840|NCT03553238|Methotrexate|methotrexate|mesh-list
93238841|NCT03553238|Etoposide|etoposide|mesh-list
93238842|NCT03553238|Vincristine|vincristine|mesh-list
93238843|NCT03553238|Doxorubicin|doxorubicin|mesh-list
93238844|NCT03553238|Mercaptopurine|mercaptopurine|mesh-list
93238845|NCT03553238|Idarubicin|idarubicin|mesh-list
93238846|NCT03553238|Pegaspargase|pegaspargase|mesh-list
93238847|NCT03553238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93238848|NCT03553238|Immunologic Factors|immunologic factors|mesh-ancestor
93238849|NCT03553238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238850|NCT03553238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238851|NCT03553238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93238852|NCT03553238|Alkylating Agents|alkylating agents|mesh-ancestor
93238853|NCT03553238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238854|NCT03553238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238855|NCT03553238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92531697|NCT00047710|Antimetabolites|antimetabolites|mesh-ancestor
93238856|NCT03553238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238857|NCT03553238|Antiemetics|antiemetics|mesh-ancestor
93238858|NCT03553238|Autonomic Agents|autonomic agents|mesh-ancestor
93238859|NCT03553238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238860|NCT03553238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93238861|NCT03553238|Glucocorticoids|glucocorticoids|mesh-ancestor
93238862|NCT03553238|Hormones|hormones|mesh-ancestor
93238863|NCT03553238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93238864|NCT03553238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93238865|NCT03553238|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93238866|NCT03553238|Abortifacient Agents|abortifacient agents|mesh-ancestor
93238867|NCT03553238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93238868|NCT03553238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93238870|NCT03553238|Dermatologic Agents|dermatologic agents|mesh-ancestor
93238871|NCT03553238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238872|NCT03553238|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93238873|NCT03553238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93238874|NCT03553238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93238875|NCT03553238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93238876|NCT03553238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93238877|NCT03553238|Antiviral Agents|antiviral agents|mesh-ancestor
93238878|NCT03553238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238879|NCT03553238|Tubulin Modulators|tubulin modulators|mesh-ancestor
93238880|NCT03553238|Antimitotic Agents|antimitotic agents|mesh-ancestor
93238881|NCT03553238|Mitosis Modulators|mitosis modulators|mesh-ancestor
93238882|NCT03553238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93238883|NCT04980027|Insulin Glargine|insulin glargine|mesh-list
93238884|NCT04980027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93238885|NCT04980027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238886|NCT01373593|Lidocaine|lidocaine|mesh-list
93238887|NCT01373593|Anesthetics, Local|anesthetics, local|mesh-ancestor
93238888|NCT01373593|Anesthetics|anesthetics|mesh-ancestor
93238889|NCT01373593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238890|NCT01373593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238891|NCT01373593|Sensory System Agents|sensory system agents|mesh-ancestor
93238892|NCT01373593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238893|NCT01373593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92412456|NCT02715609|Copper|copper|mesh-list
93238894|NCT01373593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93238895|NCT01373593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93238896|NCT01373593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93238897|NCT01373593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238898|NCT02116712|Saracatinib|saracatinib|mesh-list
93238899|NCT02116712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238900|NCT02116712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238901|NCT02116712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238902|NCT02116790|Naproxen|naproxen|mesh-list
93238903|NCT02116790|Levodopa|levodopa|mesh-list
93238904|NCT02116790|Carbidopa|carbidopa|mesh-list
93238905|NCT02116790|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93238906|NCT02116790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93238907|NCT02116790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93238908|NCT02116790|Analgesics|analgesics|mesh-ancestor
93238909|NCT02116790|Sensory System Agents|sensory system agents|mesh-ancestor
93238910|NCT02116790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238911|NCT02116790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238912|NCT02116790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93238913|NCT02116790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93238914|NCT02116790|Gout Suppressants|gout suppressants|mesh-ancestor
93238915|NCT02116790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93238916|NCT02116790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93238917|NCT02116790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238918|NCT02116790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93238919|NCT02116790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93238920|NCT02116790|Dopamine Agents|dopamine agents|mesh-ancestor
93238921|NCT02116790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238922|NCT02116790|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93238923|NCT02116790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93238924|NCT02116790|Immunologic Factors|immunologic factors|mesh-ancestor
92532317|NCT00052390|Bevacizumab|bevacizumab|mesh-list
93238925|NCT02116790|Dopamine Agonists|dopamine agonists|mesh-ancestor
93238926|NCT02859961|Leronlimab|leronlimab|mesh-list
93238927|NCT02859961|HIV Antibodies|hiv antibodies|mesh-list
93238928|NCT02859961|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93238929|NCT02859961|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93238930|NCT02859961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238931|NCT02859961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93238932|NCT02859961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93238933|NCT02859961|Antiviral Agents|antiviral agents|mesh-ancestor
93238934|NCT02859961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93238935|NCT02859961|Immunologic Factors|immunologic factors|mesh-ancestor
93238936|NCT02859961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238937|NCT02124200|Nicotine|nicotine|mesh-list
93238938|NCT02124200|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93238939|NCT02124200|Autonomic Agents|autonomic agents|mesh-ancestor
93238940|NCT02124200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238941|NCT02124200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238942|NCT02124200|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93238943|NCT02124200|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93238944|NCT02124200|Cholinergic Agents|cholinergic agents|mesh-ancestor
93238945|NCT02124200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238946|NCT02124200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238947|NCT02124278|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
93238948|NCT02124278|Respiratory System Agents|respiratory system agents|mesh-ancestor
93238949|NCT04503993|Antibodies|antibodies|mesh-list
93238950|NCT04503993|Immunoglobulins|immunoglobulins|mesh-list
93238951|NCT04503993|Immunologic Factors|immunologic factors|mesh-ancestor
93238952|NCT04503993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238953|NCT02116868|Antihypertensive Agents|antihypertensive agents|mesh-list
93238954|NCT02116868|Nicardipine|nicardipine|mesh-list
93238955|NCT02116868|Urapidil|urapidil|mesh-list
93238956|NCT02116868|Remifentanil|remifentanil|mesh-list
93238957|NCT02116868|Esmolol|esmolol|mesh-list
93238958|NCT02116868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93238959|NCT02116868|Narcotics|narcotics|mesh-ancestor
93238960|NCT02116868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238961|NCT02116868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238962|NCT02116868|Analgesics|analgesics|mesh-ancestor
93238963|NCT02116868|Sensory System Agents|sensory system agents|mesh-ancestor
93238964|NCT02116868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93238965|NCT02116868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93238966|NCT02116868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93238967|NCT02116868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93238968|NCT02116868|Adrenergic Agents|adrenergic agents|mesh-ancestor
93238969|NCT02116868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238970|NCT02116868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238971|NCT02116868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92532822|NCT00055666|Hormones|hormones|mesh-ancestor
93238972|NCT02116868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93238973|NCT02116868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93238974|NCT02116868|Vasodilator Agents|vasodilator agents|mesh-ancestor
93238975|NCT02116868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93238976|NCT02116868|Serotonin Agents|serotonin agents|mesh-ancestor
93238977|NCT02116868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93238978|NCT02116868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93238979|NCT02679781|Midazolam|midazolam|mesh-list
93238980|NCT02679781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93238981|NCT02679781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93238982|NCT02679781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93238983|NCT02679781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93238984|NCT02679781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93238985|NCT02679781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93238986|NCT02679781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93238987|NCT02679781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93238988|NCT02679781|Anesthetics, General|anesthetics, general|mesh-ancestor
93238989|NCT02679781|Anesthetics|anesthetics|mesh-ancestor
93238990|NCT02679781|GABA Modulators|gaba modulators|mesh-ancestor
93238991|NCT02679781|GABA Agents|gaba agents|mesh-ancestor
93238992|NCT02679781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93238993|NCT02679781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238994|NCT04373031|Pembrolizumab|pembrolizumab|mesh-list
93238995|NCT04373031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93238996|NCT04373031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93238997|NCT04373031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93238998|NCT04373031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93238999|NCT02624869|Evolocumab|evolocumab|mesh-list
92532927|NCT00056329|Vitamins|vitamins|mesh-ancestor
93239000|NCT02624869|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93239001|NCT02624869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93239002|NCT02624869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93239003|NCT02624869|Antimetabolites|antimetabolites|mesh-ancestor
93239004|NCT02624869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239005|NCT02624869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93239006|NCT02624869|Protease Inhibitors|protease inhibitors|mesh-ancestor
93239007|NCT02624869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239008|NCT02624869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93239009|NCT02121782|Vaccines|vaccines|mesh-list
93239010|NCT02121782|Immunologic Factors|immunologic factors|mesh-ancestor
93239011|NCT02121782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239012|NCT03553082|Propofol|propofol|mesh-list
93239013|NCT03553082|Sevoflurane|sevoflurane|mesh-list
93239014|NCT03553082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93239015|NCT03553082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239016|NCT03553082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239017|NCT03553082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93239018|NCT03553082|Anesthetics, General|anesthetics, general|mesh-ancestor
93239019|NCT03553082|Anesthetics|anesthetics|mesh-ancestor
93239020|NCT03553082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93239021|NCT03553082|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93239022|NCT03318393|Heparin|heparin|mesh-list
93239023|NCT03318393|Calcium heparin|calcium heparin|mesh-list
93239024|NCT03318393|Bivalirudin|bivalirudin|mesh-list
93239025|NCT03318393|Anticoagulants|anticoagulants|mesh-ancestor
93239026|NCT03318393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93239027|NCT03318393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93239028|NCT03318393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239029|NCT03318393|Antithrombins|antithrombins|mesh-ancestor
93239030|NCT03318393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93239031|NCT03318393|Protease Inhibitors|protease inhibitors|mesh-ancestor
93239032|NCT03318393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239033|NCT03110029|Efinaconazole|efinaconazole|mesh-list
93239034|NCT03110029|Antifungal Agents|antifungal agents|mesh-ancestor
93239035|NCT03110029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239036|NCT03552146|Dexmedetomidine|dexmedetomidine|mesh-list
93239037|NCT03552146|Propofol|propofol|mesh-list
93239038|NCT03552146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93239039|NCT03552146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239040|NCT03552146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239041|NCT03552146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93239042|NCT03552146|Analgesics|analgesics|mesh-ancestor
93239043|NCT03552146|Sensory System Agents|sensory system agents|mesh-ancestor
93239044|NCT03552146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533212|NCT00058435|Abagovomab|abagovomab|mesh-list
93239045|NCT03552146|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93239046|NCT03552146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93239047|NCT03552146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239048|NCT03552146|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239049|NCT03552146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239050|NCT03552146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239051|NCT03552146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93239052|NCT03552146|Anesthetics, General|anesthetics, general|mesh-ancestor
93239053|NCT03552146|Anesthetics|anesthetics|mesh-ancestor
93239054|NCT01374763|Oxycodone|oxycodone|mesh-list
93239055|NCT01374763|Naloxone|naloxone|mesh-list
93239056|NCT01374763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93239057|NCT01374763|Narcotics|narcotics|mesh-ancestor
93239058|NCT01374763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239059|NCT01374763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239060|NCT01374763|Analgesics|analgesics|mesh-ancestor
92533264|NCT00059254|Palmitic Acid|palmitic acid|mesh-list
93239061|NCT01374763|Sensory System Agents|sensory system agents|mesh-ancestor
93239062|NCT01374763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239063|NCT01374763|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93239064|NCT02747004|Tamoxifen|tamoxifen|mesh-list
93239065|NCT02747004|Loperamide|loperamide|mesh-list
93239066|NCT02747004|Antidiarrheals|antidiarrheals|mesh-list
93239067|NCT02747004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93239068|NCT02747004|Hormone Antagonists|hormone antagonists|mesh-ancestor
93239069|NCT02747004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533367|NCT00060112|Oblimersen|oblimersen|mesh-list
93239070|NCT02747004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239071|NCT02747004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93239072|NCT02747004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239073|NCT02747004|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93239074|NCT02747004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93239075|NCT02747004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93239076|NCT02747004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239077|NCT04454515|Dexmedetomidine|dexmedetomidine|mesh-list
93239078|NCT04454515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93239079|NCT04454515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258156|NCT01635101|Acetaminophen|acetaminophen|mesh-list
93239080|NCT04454515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239081|NCT04454515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93239082|NCT04454515|Analgesics|analgesics|mesh-ancestor
93239083|NCT04454515|Sensory System Agents|sensory system agents|mesh-ancestor
93239084|NCT04454515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239085|NCT04454515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93239086|NCT04454515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93239087|NCT04454515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239088|NCT04454515|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239089|NCT04454515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239090|NCT04454515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239091|NCT03608514|Terlipressin|terlipressin|mesh-list
93239092|NCT03608514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93239093|NCT03608514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93239094|NCT02117726|Midazolam|midazolam|mesh-list
93239095|NCT02117726|Dexmedetomidine|dexmedetomidine|mesh-list
93239096|NCT02117726|Propofol|propofol|mesh-list
93239097|NCT02117726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93239098|NCT02117726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239099|NCT02117726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239100|NCT02117726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93239101|NCT02117726|Analgesics|analgesics|mesh-ancestor
93239102|NCT02117726|Sensory System Agents|sensory system agents|mesh-ancestor
93239103|NCT02117726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239104|NCT02117726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93239105|NCT02117726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93239106|NCT02117726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239107|NCT02117726|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239108|NCT02117726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239109|NCT02117726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239110|NCT02117726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93239111|NCT02117726|Anesthetics, General|anesthetics, general|mesh-ancestor
93239112|NCT02117726|Anesthetics|anesthetics|mesh-ancestor
93239113|NCT02117726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93239114|NCT02117726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93239115|NCT02117726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93239116|NCT02117726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93239117|NCT02117726|GABA Modulators|gaba modulators|mesh-ancestor
93239118|NCT02117726|GABA Agents|gaba agents|mesh-ancestor
92533721|NCT00061984|Ifosfamide|ifosfamide|mesh-list
93239119|NCT02733432|Fluconazole|fluconazole|mesh-list
93239120|NCT02733432|Rezafungin|rezafungin|mesh-list
93239121|NCT02733432|Antifungal Agents|antifungal agents|mesh-ancestor
93239122|NCT02733432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239123|NCT02733432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92533793|NCT00062140|Cyclophosphamide|cyclophosphamide|mesh-list
93239124|NCT02733432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93239125|NCT02733432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239126|NCT02733432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239127|NCT02733432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93239128|NCT02733432|Hormone Antagonists|hormone antagonists|mesh-ancestor
93239129|NCT02733432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239130|NCT02733432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239131|NCT02733432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93239132|NCT02733432|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93239133|NCT03634189|Cannabidiol|cannabidiol|mesh-list
93239134|NCT03634189|Anticonvulsants|anticonvulsants|mesh-ancestor
93239135|NCT03608046|Irinotecan|irinotecan|mesh-list
93239136|NCT03608046|Cetuximab|cetuximab|mesh-list
93239137|NCT03608046|Avelumab|avelumab|mesh-list
93239138|NCT03608046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93239139|NCT03608046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93239140|NCT03608046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533927|NCT00064012|Mitosis Modulators|mitosis modulators|mesh-ancestor
93239141|NCT03608046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239142|NCT03608046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239143|NCT03608046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93239144|NCT02122484|Colchicine|colchicine|mesh-list
93239145|NCT02122484|Gout Suppressants|gout suppressants|mesh-ancestor
93239146|NCT02122484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239147|NCT02122484|Tubulin Modulators|tubulin modulators|mesh-ancestor
93239148|NCT02122484|Antimitotic Agents|antimitotic agents|mesh-ancestor
93239149|NCT02122484|Mitosis Modulators|mitosis modulators|mesh-ancestor
93239150|NCT02122484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239151|NCT02122484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239152|NCT03606018|Insulin|insulin|mesh-list
93239153|NCT03606018|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93239154|NCT03606018|Insulin Lispro|insulin lispro|mesh-list
93239155|NCT03606018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92533980|NCT00064129|Immunologic Factors|immunologic factors|mesh-ancestor
93239156|NCT03606018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239157|NCT01373749|Sildenafil Citrate|sildenafil citrate|mesh-list
93239158|NCT01373749|Vasodilator Agents|vasodilator agents|mesh-ancestor
92539226|NCT00010400|Cyclophosphamide|cyclophosphamide|mesh-list
93239159|NCT01373749|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93239160|NCT01373749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93239161|NCT01373749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239162|NCT01373749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239163|NCT01373749|Urological Agents|urological agents|mesh-ancestor
92533995|NCT00064285|Alvocidib|alvocidib|mesh-list
93239164|NCT04045795|Dexamethasone|dexamethasone|mesh-list
93239165|NCT04045795|Pomalidomide|pomalidomide|mesh-list
93239166|NCT04045795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93239167|NCT04045795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93239168|NCT04045795|Antiemetics|antiemetics|mesh-ancestor
93239169|NCT04045795|Autonomic Agents|autonomic agents|mesh-ancestor
92533996|NCT00064285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239170|NCT04045795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239171|NCT04045795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239172|NCT04045795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239173|NCT04045795|Glucocorticoids|glucocorticoids|mesh-ancestor
93239174|NCT04045795|Hormones|hormones|mesh-ancestor
92539782|NCT00013520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239175|NCT04045795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239176|NCT04045795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93239177|NCT04045795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239178|NCT04045795|Immunologic Factors|immunologic factors|mesh-ancestor
93239179|NCT04045795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93239180|NCT04045795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93239181|NCT04045795|Growth Substances|growth substances|mesh-ancestor
93239182|NCT04045795|Growth Inhibitors|growth inhibitors|mesh-ancestor
93239183|NCT03605940|Methoxsalen|methoxsalen|mesh-list
93239184|NCT03605940|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93239185|NCT03605940|Dermatologic Agents|dermatologic agents|mesh-ancestor
93239186|NCT03607734|Amoxicillin|amoxicillin|mesh-list
93239187|NCT03607734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93239188|NCT03607734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239189|NCT02035488|Tobramycin|tobramycin|mesh-list
93239190|NCT02035488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93239191|NCT02035488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239192|NCT03602430|Vitamin D|vitamin d|mesh-list
93239193|NCT03602430|Cholecalciferol|cholecalciferol|mesh-list
93239194|NCT03602430|Vitamins|vitamins|mesh-ancestor
93239195|NCT03602430|Micronutrients|micronutrients|mesh-ancestor
93239196|NCT03602430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239197|NCT03602430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93239198|NCT03602430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93239199|NCT02260544|Doxorubicin|doxorubicin|mesh-list
93239200|NCT02260544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93239201|NCT02260544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93239202|NCT02260544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239203|NCT02260544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93239204|NCT02260544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540677|NCT00016601|Nelfinavir|nelfinavir|mesh-list
93239205|NCT02260544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540767|NCT00129363|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93239206|NCT02260544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239207|NCT05470647|Interleukin-4|interleukin-4|mesh-list
93239208|NCT05470647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93239209|NCT05470647|Immunologic Factors|immunologic factors|mesh-ancestor
93239210|NCT05470647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239211|NCT05470647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239212|NCT05470647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239213|NCT04409665|Ketamine|ketamine|mesh-list
93239214|NCT04409665|Analgesics|analgesics|mesh-ancestor
93239215|NCT04409665|Sensory System Agents|sensory system agents|mesh-ancestor
93239216|NCT04409665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239217|NCT04409665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534031|NCT02967211|Insulin|insulin|mesh-list
93239218|NCT04409665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93239219|NCT04409665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93239220|NCT04409665|Anesthetics, General|anesthetics, general|mesh-ancestor
93239221|NCT04409665|Anesthetics|anesthetics|mesh-ancestor
93239222|NCT04409665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239223|NCT04409665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93239224|NCT04409665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93239225|NCT04409665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239226|NCT04409665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239227|NCT02854800|Varenicline|varenicline|mesh-list
93239228|NCT02854800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93239229|NCT02854800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92534047|NCT00065143|Antimetabolites|antimetabolites|mesh-ancestor
92534057|NCT00398788|Analgesics|analgesics|mesh-ancestor
93239230|NCT02854800|Cholinergic Agents|cholinergic agents|mesh-ancestor
93239231|NCT02854800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239232|NCT02854800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239233|NCT02854800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239234|NCT03552770|Bevacizumab|bevacizumab|mesh-list
93239235|NCT03552770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93239236|NCT03552770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239237|NCT03552770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93239238|NCT03552770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93239239|NCT03552770|Growth Substances|growth substances|mesh-ancestor
93239240|NCT03552770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239241|NCT03552770|Growth Inhibitors|growth inhibitors|mesh-ancestor
93239242|NCT02127164|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93239243|NCT02127164|Eusol|eusol|mesh-list
93239244|NCT02127164|Disinfectants|disinfectants|mesh-ancestor
93239245|NCT02127164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239246|NCT02931539|Valganciclovir|valganciclovir|mesh-list
93239247|NCT02931539|Ganciclovir|ganciclovir|mesh-list
93239248|NCT02931539|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93239249|NCT02931539|Cidofovir|cidofovir|mesh-list
93239250|NCT02931539|Foscarnet|foscarnet|mesh-list
93239251|NCT02931539|Maribavir|maribavir|mesh-list
93239252|NCT02931539|Antiviral Agents|antiviral agents|mesh-ancestor
92534075|NCT00065455|Vitamins|vitamins|mesh-ancestor
93239253|NCT02931539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239254|NCT02931539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93239255|NCT02931539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239256|NCT02931539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534084|NCT04488081|Apremilast|apremilast|mesh-list
93239257|NCT02931539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93239258|NCT03602118|Phenobarbital|phenobarbital|mesh-list
93239259|NCT03602118|Anticonvulsants|anticonvulsants|mesh-ancestor
93239260|NCT03602118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93239261|NCT03602118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239262|NCT03602118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239263|NCT03602118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93239264|NCT03602118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93239265|NCT03602118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239266|NCT03602118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239267|NCT03602118|GABA Modulators|gaba modulators|mesh-ancestor
93239268|NCT03602118|GABA Agents|gaba agents|mesh-ancestor
93239269|NCT03602118|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93239270|NCT03602118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93239271|NCT03602118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93239272|NCT02125682|Atorvastatin|atorvastatin|mesh-list
93239273|NCT02125682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93239274|NCT02125682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93239275|NCT02125682|Antimetabolites|antimetabolites|mesh-ancestor
93239276|NCT02125682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239277|NCT02125682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93239278|NCT02125682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93239279|NCT02125682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239280|NCT02546999|Botulinum Toxins|botulinum toxins|mesh-list
93239281|NCT02546999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93239282|NCT02546999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93239283|NCT02546999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534105|NCT04488081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239284|NCT02546999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239285|NCT02546999|Cholinergic Agents|cholinergic agents|mesh-ancestor
93239286|NCT02546999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239287|NCT02546999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239288|NCT02546999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93239289|NCT02546999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239290|NCT02131220|Tirofiban|tirofiban|mesh-list
93239291|NCT02131220|Saruplase|saruplase|mesh-list
93239292|NCT02131220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93239293|NCT02131220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93239294|NCT02131220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534118|NCT04488081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93239295|NCT02131220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93239296|NCT04042077|Vancomycin|vancomycin|mesh-list
93239297|NCT04042077|Linezolid|linezolid|mesh-list
93239298|NCT04042077|Tazobactam|tazobactam|mesh-list
93239299|NCT04042077|Piperacillin|piperacillin|mesh-list
93239300|NCT04042077|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93239301|NCT04042077|Tigecycline|tigecycline|mesh-list
93239302|NCT04042077|Delafloxacin|delafloxacin|mesh-list
92542506|NCT00025428|Carboplatin|carboplatin|mesh-list
93239303|NCT04042077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93239304|NCT04042077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239305|NCT04042077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93239306|NCT04042077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239307|NCT04042077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542805|NCT00027495|Curcumin|curcumin|mesh-list
93239308|NCT04042077|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93239309|NCT03557359|Nivolumab|nivolumab|mesh-list
93239310|NCT03557359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93239311|NCT03557359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239312|NCT03557359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93239313|NCT03557359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239314|NCT02127320|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93239315|NCT02127320|Ezetimibe|ezetimibe|mesh-list
93239316|NCT02127320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93239317|NCT02127320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93239318|NCT02127320|Antimetabolites|antimetabolites|mesh-ancestor
93239319|NCT02127320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239320|NCT02127320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93239321|NCT02127320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93239322|NCT02127320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239323|NCT03522415|Methotrexate|methotrexate|mesh-list
93239324|NCT03522415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93239325|NCT03522415|Abortifacient Agents|abortifacient agents|mesh-ancestor
93239326|NCT03522415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93239327|NCT03522415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239328|NCT03522415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93239329|NCT03522415|Antimetabolites|antimetabolites|mesh-ancestor
93239330|NCT03522415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239331|NCT03522415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239332|NCT03522415|Dermatologic Agents|dermatologic agents|mesh-ancestor
93239333|NCT03522415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239334|NCT03522415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93239335|NCT03522415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93239336|NCT03522415|Immunologic Factors|immunologic factors|mesh-ancestor
93239337|NCT03522415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239338|NCT03522415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93239339|NCT04226833|Entrectinib|entrectinib|mesh-list
93239340|NCT04226833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93239341|NCT04226833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239342|NCT04226833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239343|NCT02131298|Itraconazole|itraconazole|mesh-list
93239344|NCT02131298|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93239345|NCT02131298|Palbociclib|palbociclib|mesh-list
93239346|NCT02131298|Antifungal Agents|antifungal agents|mesh-ancestor
93239347|NCT02131298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239348|NCT02131298|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93239349|NCT02131298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93239350|NCT02131298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239351|NCT02131298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239352|NCT02131298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93239353|NCT02131298|Hormone Antagonists|hormone antagonists|mesh-ancestor
92534177|NCT00066157|Medroxyprogesterone|medroxyprogesterone|mesh-list
93239354|NCT02131298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239355|NCT02131298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239356|NCT02131298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93239357|NCT02131298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239358|NCT02131298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93239359|NCT01375387|Lacosamide|lacosamide|mesh-list
93239360|NCT01375387|Anticonvulsants|anticonvulsants|mesh-ancestor
93239361|NCT01375387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93239362|NCT01375387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93239363|NCT01375387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534189|NCT00066157|Progestins|progestins|mesh-ancestor
93239364|NCT01375387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239365|NCT02853318|Cyclophosphamide|cyclophosphamide|mesh-list
93239366|NCT02853318|Bevacizumab|bevacizumab|mesh-list
93239367|NCT02853318|Pembrolizumab|pembrolizumab|mesh-list
93239368|NCT02853318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93239369|NCT02853318|Antibodies|antibodies|mesh-list
93239370|NCT02853318|Immunoglobulins|immunoglobulins|mesh-list
93239371|NCT02853318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93239372|NCT02853318|Immunoglobulin G|immunoglobulin g|mesh-list
93239373|NCT02853318|Endothelial Growth Factors|endothelial growth factors|mesh-list
93239374|NCT02853318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93239375|NCT02853318|Immunologic Factors|immunologic factors|mesh-ancestor
93239376|NCT02853318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239377|NCT02853318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239378|NCT02853318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93239379|NCT02853318|Alkylating Agents|alkylating agents|mesh-ancestor
93239380|NCT02853318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239381|NCT02853318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239382|NCT02853318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93239383|NCT02853318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93239384|NCT02853318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93239385|NCT02853318|Growth Substances|growth substances|mesh-ancestor
93239386|NCT02853318|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534203|NCT00066274|Oxaliplatin|oxaliplatin|mesh-list
93239387|NCT02853318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93239388|NCT03626727|Sodium Oxybate|sodium oxybate|mesh-list
93239389|NCT03626727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93239390|NCT03626727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93239391|NCT03626727|Anesthetics, General|anesthetics, general|mesh-ancestor
93239393|NCT03626727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239394|NCT03626727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239395|NCT03604224|Canagliflozin|canagliflozin|mesh-list
93239396|NCT03604224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93239397|NCT03604224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239398|NCT03604224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93239399|NCT03604224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239400|NCT02126384|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93239401|NCT02126384|Immunologic Factors|immunologic factors|mesh-ancestor
93239402|NCT02126384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239403|NCT02035410|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93239404|NCT02035410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93239405|NCT02035410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239406|NCT02404155|Clozapine|clozapine|mesh-list
93239407|NCT02404155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93239408|NCT02404155|Serotonin Agents|serotonin agents|mesh-ancestor
93239409|NCT02404155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239410|NCT02404155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239411|NCT02404155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239412|NCT02404155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93239413|NCT02404155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93239414|NCT02404155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534235|NCT00066391|Irinotecan|irinotecan|mesh-list
93239415|NCT02404155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93239416|NCT02404155|GABA Antagonists|gaba antagonists|mesh-ancestor
93239417|NCT02404155|GABA Agents|gaba agents|mesh-ancestor
93239418|NCT02127788|Micafungin|micafungin|mesh-list
93239419|NCT02127788|Antifungal Agents|antifungal agents|mesh-ancestor
93239420|NCT02127788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239421|NCT02131688|Mitoxantrone|mitoxantrone|mesh-list
93239422|NCT02131688|Analgesics|analgesics|mesh-ancestor
93239423|NCT02131688|Sensory System Agents|sensory system agents|mesh-ancestor
93239424|NCT02131688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239425|NCT02131688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239426|NCT02131688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239427|NCT02131688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93239428|NCT02131688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93239429|NCT02131688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239430|NCT02131688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239431|NCT02126462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93239432|NCT02126462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93239433|NCT02126462|Immunologic Factors|immunologic factors|mesh-ancestor
93239434|NCT02126462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239435|NCT02126462|Antacids|antacids|mesh-ancestor
93239436|NCT02126462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239437|NCT02126462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239438|NCT03113071|Decitabine|decitabine|mesh-list
93239439|NCT03113071|Digoxin|digoxin|mesh-list
92534253|NCT00066508|Bortezomib|bortezomib|mesh-list
93239440|NCT03113071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93239441|NCT03113071|Antimetabolites|antimetabolites|mesh-ancestor
92534260|NCT00066586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239442|NCT03113071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239443|NCT03113071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239444|NCT03113071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239445|NCT03113071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93239446|NCT03113071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93239447|NCT03113071|Protective Agents|protective agents|mesh-ancestor
93239448|NCT03113071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239449|NCT03050307|Lansoprazole|lansoprazole|mesh-list
93239450|NCT03050307|Dexlansoprazole|dexlansoprazole|mesh-list
93239451|NCT03050307|Bismuth|bismuth|mesh-list
93239452|NCT03050307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93239453|NCT03050307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239454|NCT03050307|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93239455|NCT03050307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239456|NCT03050307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239457|NCT03050307|Antacids|antacids|mesh-ancestor
93239458|NCT02127866|Beclomethasone|beclomethasone|mesh-list
93239459|NCT02127866|Glycopyrrolate|glycopyrrolate|mesh-list
93239460|NCT02127866|Formoterol Fumarate|formoterol fumarate|mesh-list
93239461|NCT02127866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93239462|NCT02127866|Autonomic Agents|autonomic agents|mesh-ancestor
93239463|NCT02127866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239464|NCT02127866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239465|NCT02127866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93239466|NCT02127866|Respiratory System Agents|respiratory system agents|mesh-ancestor
93239467|NCT02127866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92534280|NCT00066859|Serotonin Agents|serotonin agents|mesh-ancestor
93239468|NCT02127866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93239469|NCT02127866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239470|NCT02127866|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239471|NCT02127866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239472|NCT02127866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239473|NCT02127866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93239474|NCT02127866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92546824|NCT04654689|Curcumin|curcumin|mesh-list
93239475|NCT02127866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93239476|NCT02127866|Cholinergic Agents|cholinergic agents|mesh-ancestor
93239477|NCT02127866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93239478|NCT02127866|Glucocorticoids|glucocorticoids|mesh-ancestor
93239479|NCT02127866|Hormones|hormones|mesh-ancestor
92534288|NCT00067015|Goserelin|goserelin|mesh-list
93239480|NCT02127866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239481|NCT03550508|Antibodies|antibodies|mesh-list
93239482|NCT03550508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93239483|NCT03550508|Immunologic Factors|immunologic factors|mesh-ancestor
92547093|NCT04182997|Hormones|hormones|mesh-ancestor
93239484|NCT03550508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239485|NCT03607578|Sunscreening Agents|sunscreening agents|mesh-list
92547150|NCT03965195|Vaccines|vaccines|mesh-list
93239486|NCT03607578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93239487|NCT03607578|Protective Agents|protective agents|mesh-ancestor
93239488|NCT03607578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239489|NCT03607578|Dermatologic Agents|dermatologic agents|mesh-ancestor
93239490|NCT05760079|Lactoferrin|lactoferrin|mesh-list
93239491|NCT05760079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239492|NCT03603834|Leucovorin|leucovorin|mesh-list
93239493|NCT03603834|Fluorouracil|fluorouracil|mesh-list
93239494|NCT03603834|Oxaliplatin|oxaliplatin|mesh-list
93239495|NCT03603834|Irinotecan|irinotecan|mesh-list
93239496|NCT03603834|Antimetabolites|antimetabolites|mesh-ancestor
93239497|NCT03603834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239498|NCT03603834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93239499|NCT03603834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239500|NCT03603834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547582|NCT05772871|Levamisole|levamisole|mesh-list
93239501|NCT03603834|Immunologic Factors|immunologic factors|mesh-ancestor
93239502|NCT03603834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239503|NCT03603834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93239504|NCT03603834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92534308|NCT00067093|Hemostatics|hemostatics|mesh-ancestor
93239505|NCT03603834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239506|NCT03603834|Antidotes|antidotes|mesh-ancestor
93239507|NCT03603834|Protective Agents|protective agents|mesh-ancestor
93239508|NCT03603834|Vitamin B Complex|vitamin b complex|mesh-ancestor
93239509|NCT03603834|Vitamins|vitamins|mesh-ancestor
93239510|NCT03603834|Micronutrients|micronutrients|mesh-ancestor
93239511|NCT03601338|Bemiparin|bemiparin|mesh-list
93239512|NCT03601338|Anticoagulants|anticoagulants|mesh-ancestor
93239513|NCT02128022|Glyburide|glyburide|mesh-list
93239514|NCT02128022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93239515|NCT02128022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547971|NCT04892511|Labetalol|labetalol|mesh-list
93239516|NCT03256045|Dexamethasone|dexamethasone|mesh-list
93239517|NCT03256045|Dexamethasone acetate|dexamethasone acetate|mesh-list
93239518|NCT03256045|Panobinostat|panobinostat|mesh-list
93239519|NCT03256045|Ichthammol|ichthammol|mesh-list
93239520|NCT03256045|BB 1101|bb 1101|mesh-list
93239521|NCT03256045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93239522|NCT03256045|Antiemetics|antiemetics|mesh-ancestor
92548181|NCT04616807|Mexiletine|mexiletine|mesh-list
93239523|NCT03256045|Autonomic Agents|autonomic agents|mesh-ancestor
92534329|NCT00067444|Paroxetine|paroxetine|mesh-list
93239524|NCT03256045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239525|NCT03256045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239526|NCT03256045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239527|NCT03256045|Glucocorticoids|glucocorticoids|mesh-ancestor
93239528|NCT03256045|Hormones|hormones|mesh-ancestor
92548459|NCT03671811|Megestrol|megestrol|mesh-list
93239529|NCT03256045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239530|NCT03256045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93239531|NCT03256045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534335|NCT00067444|Serotonin Agents|serotonin agents|mesh-ancestor
93239532|NCT03256045|Protease Inhibitors|protease inhibitors|mesh-ancestor
93239533|NCT03256045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239534|NCT03256045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239535|NCT03256045|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93239536|NCT03256045|Dermatologic Agents|dermatologic agents|mesh-ancestor
93239537|NCT03603756|Paclitaxel|paclitaxel|mesh-list
93239538|NCT03603756|Irinotecan|irinotecan|mesh-list
93239539|NCT03603756|Apatinib|apatinib|mesh-list
93239540|NCT03603756|Nedaplatin|nedaplatin|mesh-list
92911528|NCT02557594|Antiviral Agents|antiviral agents|mesh-ancestor
93239541|NCT03603756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549144|NCT00019760|Calcium|calcium|mesh-list
93239542|NCT03603756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239543|NCT03603756|Tubulin Modulators|tubulin modulators|mesh-ancestor
93239544|NCT03603756|Antimitotic Agents|antimitotic agents|mesh-ancestor
93239545|NCT03603756|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549291|NCT00020189|Growth Substances|growth substances|mesh-ancestor
93239546|NCT03603756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239547|NCT03603756|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93239548|NCT03603756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93239549|NCT03603756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239550|NCT03603756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93239551|NCT02372409|Doxorubicin|doxorubicin|mesh-list
93239552|NCT02372409|Etoposide|etoposide|mesh-list
93239553|NCT02372409|Etoposide phosphate|etoposide phosphate|mesh-list
93239554|NCT02372409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93239555|NCT02372409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239556|NCT02372409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93239557|NCT02372409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93239558|NCT02372409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239559|NCT02372409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239560|NCT02372409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93239561|NCT03626259|Losartan|losartan|mesh-list
93239562|NCT03626259|Amlodipine|amlodipine|mesh-list
92549791|NCT00021827|Hormones|hormones|mesh-list
93239563|NCT03626259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93239564|NCT03626259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93239565|NCT03626259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534358|NCT00065533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239566|NCT03626259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550059|NCT00022724|Antifungal Agents|antifungal agents|mesh-ancestor
93239567|NCT03626259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93239568|NCT03626259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239569|NCT03626259|Vasodilator Agents|vasodilator agents|mesh-ancestor
93239570|NCT03626259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93239571|NCT03626259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93239572|NCT03626259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93239573|NCT03601260|Allopurinol|allopurinol|mesh-list
93239574|NCT03601260|Antimetabolites|antimetabolites|mesh-ancestor
92534367|NCT00067561|Serotonin Agents|serotonin agents|mesh-ancestor
93239575|NCT03601260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239576|NCT03601260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239577|NCT03601260|Gout Suppressants|gout suppressants|mesh-ancestor
93239578|NCT03601260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239579|NCT03601260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93239580|NCT03601260|Antioxidants|antioxidants|mesh-ancestor
93239581|NCT03601260|Protective Agents|protective agents|mesh-ancestor
92534375|NCT05010707|Hormones|hormones|mesh-list
93239582|NCT03601260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239583|NCT05193253|Liver Extracts|liver extracts|mesh-list
93239584|NCT05193253|Hematinics|hematinics|mesh-ancestor
93239585|NCT02131922|Chlorhexidine|chlorhexidine|mesh-list
93239586|NCT02131922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92550744|NCT00024986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92534377|NCT05010707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239587|NCT02131922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239588|NCT02131922|Disinfectants|disinfectants|mesh-ancestor
93239589|NCT03600948|Sirolimus|sirolimus|mesh-list
93239590|NCT03600948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92534381|NCT05010707|Diuretics|diuretics|mesh-ancestor
93239591|NCT03600948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239592|NCT03600948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93239593|NCT03600948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551211|NCT00026273|Calcium|calcium|mesh-list
93239594|NCT03600948|Antifungal Agents|antifungal agents|mesh-ancestor
93239595|NCT03600948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93239596|NCT03600948|Immunologic Factors|immunologic factors|mesh-ancestor
93239597|NCT03600948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239598|NCT02132000|Tamoxifen|tamoxifen|mesh-list
93239599|NCT02132000|Toremifene|toremifene|mesh-list
93239600|NCT02132000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93239601|NCT02132000|Hormone Antagonists|hormone antagonists|mesh-ancestor
93239602|NCT02132000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551504|NCT00027638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93239603|NCT02132000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239604|NCT02132000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93239605|NCT02132000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239606|NCT02132000|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93239607|NCT02132000|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93239608|NCT02132000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93239609|NCT03118765|Bromides|bromides|mesh-list
92551724|NCT00028574|Gabapentin|gabapentin|mesh-list
93239610|NCT03118765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93239611|NCT03118765|Tiotropium Bromide|tiotropium bromide|mesh-list
92551903|NCT00423540|Anticonvulsants|anticonvulsants|mesh-ancestor
93239612|NCT03118765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93239613|NCT03118765|Autonomic Agents|autonomic agents|mesh-ancestor
93239614|NCT03118765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239615|NCT03118765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239616|NCT03118765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93239617|NCT03118765|Respiratory System Agents|respiratory system agents|mesh-ancestor
93239618|NCT03118765|Parasympatholytics|parasympatholytics|mesh-ancestor
93239619|NCT03118765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93239620|NCT03118765|Cholinergic Agents|cholinergic agents|mesh-ancestor
93239621|NCT03118765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239622|NCT03118765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239623|NCT03118765|Anticonvulsants|anticonvulsants|mesh-ancestor
93239624|NCT02128100|Leucovorin|leucovorin|mesh-list
93239625|NCT02128100|Fluorouracil|fluorouracil|mesh-list
93239626|NCT02128100|Oxaliplatin|oxaliplatin|mesh-list
93239627|NCT02128100|Irinotecan|irinotecan|mesh-list
93239628|NCT02128100|Folfirinox|folfirinox|mesh-list
93239629|NCT02128100|Antimetabolites|antimetabolites|mesh-ancestor
93239630|NCT02128100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239631|NCT02128100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93239632|NCT02128100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239633|NCT02128100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93239634|NCT02128100|Immunologic Factors|immunologic factors|mesh-ancestor
93239635|NCT02128100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239636|NCT02128100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93239637|NCT02128100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93239638|NCT02128100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239639|NCT02128100|Antidotes|antidotes|mesh-ancestor
93239640|NCT02128100|Protective Agents|protective agents|mesh-ancestor
93239641|NCT02128100|Vitamin B Complex|vitamin b complex|mesh-ancestor
93239642|NCT02128100|Vitamins|vitamins|mesh-ancestor
93239643|NCT02128100|Micronutrients|micronutrients|mesh-ancestor
93239644|NCT03603366|Aspirin|aspirin|mesh-list
93239645|NCT03603366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93239646|NCT03603366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92552411|NCT00031109|Antacids|antacids|mesh-ancestor
93239647|NCT03603366|Analgesics|analgesics|mesh-ancestor
93239648|NCT03603366|Sensory System Agents|sensory system agents|mesh-ancestor
92552465|NCT00058968|Analgesics|analgesics|mesh-ancestor
93239649|NCT03603366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534429|NCT00068029|Octreotide|octreotide|mesh-list
93239650|NCT03603366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239651|NCT03603366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93239652|NCT03603366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239653|NCT03603366|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93239654|NCT03603366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93239655|NCT03603366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239656|NCT03603366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93239657|NCT03603366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93239658|NCT03603366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239659|NCT03603366|Antipyretics|antipyretics|mesh-ancestor
93239660|NCT02128178|Enoxaparin|enoxaparin|mesh-list
93239661|NCT02128178|Enoxaparin sodium|enoxaparin sodium|mesh-list
92552853|NCT00060645|Sirolimus|sirolimus|mesh-list
93239662|NCT02128178|Anticoagulants|anticoagulants|mesh-ancestor
93239663|NCT02128178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93239664|NCT02128178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93239665|NCT02128178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239666|NCT03600870|Midodrine|midodrine|mesh-list
93239667|NCT03600870|Sympathomimetics|sympathomimetics|mesh-ancestor
93239668|NCT03600870|Autonomic Agents|autonomic agents|mesh-ancestor
93239669|NCT03600870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239670|NCT03600870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239671|NCT03600870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93239672|NCT03600870|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93239673|NCT03600870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93239674|NCT03600870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239675|NCT03600870|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239676|NCT03600870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239677|NCT03600870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239678|NCT02128334|Leuprolide|leuprolide|mesh-list
93239679|NCT02128334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93239680|NCT02128334|Fertility Agents|fertility agents|mesh-ancestor
93239681|NCT02128334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93239682|NCT02128334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239683|NCT02128334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93239684|NCT02128334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239685|NCT01375699|Doxorubicin|doxorubicin|mesh-list
92534451|NCT00068497|Gefitinib|gefitinib|mesh-list
93239686|NCT01375699|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93239687|NCT01375699|Sildenafil Citrate|sildenafil citrate|mesh-list
93239688|NCT01375699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93239689|NCT01375699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239690|NCT01375699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92911678|NCT00778024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93239691|NCT01375699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93239692|NCT01375699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239693|NCT01375699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553474|NCT00062322|Irinotecan|irinotecan|mesh-list
93239694|NCT01375699|Vasodilator Agents|vasodilator agents|mesh-ancestor
93239695|NCT01375699|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93239696|NCT01375699|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93239697|NCT01375699|Urological Agents|urological agents|mesh-ancestor
93239698|NCT01373983|Ziconotide|ziconotide|mesh-list
93239699|NCT01373983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93239700|NCT01373983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93239701|NCT01373983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239702|NCT01373983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92553734|NCT02967276|Metformin|metformin|mesh-list
93239703|NCT01373983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239704|NCT01373983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93239705|NCT01373983|Protective Agents|protective agents|mesh-ancestor
93239706|NCT01373983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93239707|NCT01373983|Analgesics|analgesics|mesh-ancestor
92553950|NCT04730622|Mitogens|mitogens|mesh-list
93239708|NCT01373983|Sensory System Agents|sensory system agents|mesh-ancestor
93239709|NCT01373983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239710|NCT05173597|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93239711|NCT05173597|Hormones|hormones|mesh-ancestor
92534482|NCT00068809|Antiviral Agents|antiviral agents|mesh-ancestor
93239712|NCT05173597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534484|NCT00068848|Contraceptive Agents|contraceptive agents|mesh-list
93239713|NCT05173597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239714|NCT05812612|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93239715|NCT05812612|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92554265|NCT00070122|Leucovorin|leucovorin|mesh-list
93239716|NCT05812612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239717|NCT05812521|Methylene Blue|methylene blue|mesh-list
93239718|NCT05812521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239719|NCT05812521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239720|NCT05812430|Paclitaxel|paclitaxel|mesh-list
93239721|NCT05812430|Cisplatin|cisplatin|mesh-list
92534489|NCT00399061|Cyclosporine|cyclosporine|mesh-list
93239722|NCT05812430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93239723|NCT05812430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239724|NCT05812430|Tubulin Modulators|tubulin modulators|mesh-ancestor
93239725|NCT05812430|Antimitotic Agents|antimitotic agents|mesh-ancestor
93239726|NCT05812430|Mitosis Modulators|mitosis modulators|mesh-ancestor
93239727|NCT05812430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239728|NCT05812404|Fexuprazan|fexuprazan|mesh-list
93239729|NCT05812404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239730|NCT03607110|Fentanyl|fentanyl|mesh-list
93239731|NCT03607110|Ketamine|ketamine|mesh-list
93239732|NCT03607110|Analgesics|analgesics|mesh-ancestor
93239733|NCT03607110|Sensory System Agents|sensory system agents|mesh-ancestor
93239734|NCT03607110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239735|NCT03607110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239736|NCT03607110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93239737|NCT03607110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93239738|NCT03607110|Anesthetics, General|anesthetics, general|mesh-ancestor
93239739|NCT03607110|Anesthetics|anesthetics|mesh-ancestor
92554885|NCT00144703|Sirolimus|sirolimus|mesh-list
93239740|NCT03607110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239741|NCT03607110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93239742|NCT03607110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93239743|NCT03607110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239744|NCT03607110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239745|NCT03607110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93239746|NCT03607110|Narcotics|narcotics|mesh-ancestor
93239747|NCT03607110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93239748|NCT05812300|Hyaluronic Acid|hyaluronic acid|mesh-list
93239749|NCT05812300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93239750|NCT05812300|Immunologic Factors|immunologic factors|mesh-ancestor
93239751|NCT05812300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239752|NCT05812300|Viscosupplements|viscosupplements|mesh-ancestor
93239753|NCT05812300|Protective Agents|protective agents|mesh-ancestor
93239754|NCT05811793|Bevacizumab|bevacizumab|mesh-list
93239755|NCT05811793|Tislelizumab|tislelizumab|mesh-list
93239756|NCT05811793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93239757|NCT05811793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239758|NCT05811793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93239759|NCT05811793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93239760|NCT05811793|Growth Substances|growth substances|mesh-ancestor
93239761|NCT05811793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239762|NCT05811793|Growth Inhibitors|growth inhibitors|mesh-ancestor
93239763|NCT05811507|Testosterone|testosterone|mesh-list
93239764|NCT05811507|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93239765|NCT05811507|Androgens|androgens|mesh-ancestor
93239766|NCT05811507|Hormones|hormones|mesh-ancestor
93239767|NCT05811507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239768|NCT05811507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239769|NCT05811507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93239770|NCT05811507|Immunologic Factors|immunologic factors|mesh-ancestor
93239771|NCT05811377|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93239772|NCT05811377|Hematinics|hematinics|mesh-ancestor
93239773|NCT05811377|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93239774|NCT05811377|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93239775|NCT05811221|Anesthetics|anesthetics|mesh-list
93239776|NCT05811221|Esketamine|esketamine|mesh-list
93239777|NCT05811221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239778|NCT05811221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239779|NCT05811221|Antidepressive Agents|antidepressive agents|mesh-ancestor
93239780|NCT05811221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93239781|NCT05811000|Donepezil|donepezil|mesh-list
93239782|NCT05811000|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93239783|NCT05811000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239784|NCT05811000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239785|NCT05811000|Cholinergic Agents|cholinergic agents|mesh-ancestor
93239786|NCT05811000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239787|NCT05811000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239788|NCT05811000|Nootropic Agents|nootropic agents|mesh-ancestor
93239789|NCT05810909|Calcium Carbonate|calcium carbonate|mesh-list
93239790|NCT05810909|Calcium|calcium|mesh-list
93239791|NCT05810909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93239792|NCT05810909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239793|NCT05810909|Antacids|antacids|mesh-ancestor
93239794|NCT05810909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239795|NCT05810909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239796|NCT05810350|Pemetrexed|pemetrexed|mesh-list
93239797|NCT05810350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239798|NCT05810350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239799|NCT05810350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239800|NCT05810350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93239801|NCT05810350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93239802|NCT05807360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93239803|NCT05807360|Hyaluronic Acid|hyaluronic acid|mesh-list
93239804|NCT05807360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93239805|NCT05807360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93239806|NCT05807360|Immunologic Factors|immunologic factors|mesh-ancestor
93239807|NCT05807360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239808|NCT05807360|Viscosupplements|viscosupplements|mesh-ancestor
93239809|NCT05807360|Protective Agents|protective agents|mesh-ancestor
93239810|NCT05804084|Acetazolamide|acetazolamide|mesh-list
93239811|NCT05804084|Anticonvulsants|anticonvulsants|mesh-ancestor
93239812|NCT05804084|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92556782|NCT00213109|Miglitol|miglitol|mesh-list
93239813|NCT05804084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239814|NCT05804084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239815|NCT05804084|Diuretics|diuretics|mesh-ancestor
93239816|NCT05804084|Natriuretic Agents|natriuretic agents|mesh-ancestor
93239817|NCT05804084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239818|NCT05803655|Oxymetazoline|oxymetazoline|mesh-list
93239819|NCT05803655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92556921|NCT00214630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93239820|NCT05803655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239821|NCT05803655|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239822|NCT05803655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239823|NCT05803655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239824|NCT05803655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239825|NCT05803655|Sympathomimetics|sympathomimetics|mesh-ancestor
93239826|NCT05803655|Autonomic Agents|autonomic agents|mesh-ancestor
93239827|NCT05803655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239828|NCT05803655|Nasal Decongestants|nasal decongestants|mesh-ancestor
93239829|NCT05803655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93239830|NCT05803655|Respiratory System Agents|respiratory system agents|mesh-ancestor
93239831|NCT05801224|Nitric Oxide|nitric oxide|mesh-list
93239832|NCT05801224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93239833|NCT05801224|Autonomic Agents|autonomic agents|mesh-ancestor
93239834|NCT05801224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239835|NCT05801224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239836|NCT05801224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93239837|NCT05801224|Respiratory System Agents|respiratory system agents|mesh-ancestor
93239838|NCT05801224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93239839|NCT05801224|Antioxidants|antioxidants|mesh-ancestor
93239840|NCT05801224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239841|NCT05801224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239842|NCT05801224|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93239843|NCT05801224|Vasodilator Agents|vasodilator agents|mesh-ancestor
92911827|NCT00769288|Deoxyuridine|deoxyuridine|mesh-list
93239844|NCT05801224|Gasotransmitters|gasotransmitters|mesh-ancestor
93239845|NCT05801224|Protective Agents|protective agents|mesh-ancestor
93239846|NCT05793489|Silybin|silybin|mesh-list
93239847|NCT05793489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93239848|NCT05793489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239849|NCT05793489|Protective Agents|protective agents|mesh-ancestor
93239850|NCT05793489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239851|NCT05754853|Paclitaxel|paclitaxel|mesh-list
93239852|NCT05754853|Docetaxel|docetaxel|mesh-list
93239853|NCT05754853|Gemcitabine|gemcitabine|mesh-list
93239854|NCT05754853|Pemetrexed|pemetrexed|mesh-list
93239855|NCT05754853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93239856|NCT05754853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558012|NCT00043004|Calcium|calcium|mesh-list
93239857|NCT05754853|Tubulin Modulators|tubulin modulators|mesh-ancestor
93239858|NCT05754853|Antimitotic Agents|antimitotic agents|mesh-ancestor
93239859|NCT05754853|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534606|NCT00070174|Antiviral Agents|antiviral agents|mesh-ancestor
92558184|NCT00124267|Analgesics|analgesics|mesh-ancestor
92558186|NCT00077844|Enoxaparin|enoxaparin|mesh-list
93239860|NCT05754853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534609|NCT00070174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93239861|NCT05754853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93239862|NCT05754853|Antimetabolites|antimetabolites|mesh-ancestor
93239863|NCT05754853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558422|NCT00078039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93239864|NCT05754853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93239865|NCT05754853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93239866|NCT05747625|Panitumumab|panitumumab|mesh-list
93239867|NCT05747625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93239868|NCT05747625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239869|NCT05742347|Protective Agents|protective agents|mesh-list
93239870|NCT05742347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239871|NCT05729932|Analgesics, Opioid|analgesics, opioid|mesh-list
93239872|NCT05729932|Narcotics|narcotics|mesh-ancestor
93239873|NCT05729932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239874|NCT05729932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239875|NCT05729932|Analgesics|analgesics|mesh-ancestor
93239876|NCT05729932|Sensory System Agents|sensory system agents|mesh-ancestor
93239877|NCT05729932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239878|NCT05708989|Dexmedetomidine|dexmedetomidine|mesh-list
93239879|NCT05708989|Ropivacaine|ropivacaine|mesh-list
93239880|NCT05708989|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93239881|NCT05708989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93239882|NCT05708989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239883|NCT05708989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93239884|NCT05708989|Analgesics|analgesics|mesh-ancestor
93239885|NCT05708989|Sensory System Agents|sensory system agents|mesh-ancestor
93239886|NCT05708989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239887|NCT05708989|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93239888|NCT05708989|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93239889|NCT05708989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93239890|NCT05708989|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239891|NCT05708989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239892|NCT05708989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558912|NCT00127972|Lamivudine|lamivudine|mesh-list
93239893|NCT05708989|Anesthetics, Local|anesthetics, local|mesh-ancestor
93239894|NCT05708989|Anesthetics|anesthetics|mesh-ancestor
93239895|NCT05705427|Tenofovir|tenofovir|mesh-list
93239896|NCT05705427|Vaccines|vaccines|mesh-list
93239897|NCT05705427|Immunologic Factors|immunologic factors|mesh-ancestor
92534645|NCT00070252|Antimetabolites|antimetabolites|mesh-ancestor
93239898|NCT05705427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239899|NCT05705427|Antiviral Agents|antiviral agents|mesh-ancestor
92559053|NCT00044525|Taxane|taxane|mesh-list
93239900|NCT05705427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239901|NCT05705427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93239902|NCT05705427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93239903|NCT05705427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559271|NCT04321408|Sensory System Agents|sensory system agents|mesh-ancestor
93239904|NCT05705427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239905|NCT05705427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93239906|NCT05705427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93239907|NCT05692869|Propranolol|propranolol|mesh-list
93239908|NCT05692869|Pseudoephedrine|pseudoephedrine|mesh-list
93239909|NCT05692869|Ephedrine|ephedrine|mesh-list
93239910|NCT05692869|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93239911|NCT05692869|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93239912|NCT05692869|Adrenergic Agents|adrenergic agents|mesh-ancestor
93239913|NCT05692869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93239914|NCT05692869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239915|NCT05692869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239916|NCT05692869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93239917|NCT05692869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911898|NCT00769522|Cyclophosphamide|cyclophosphamide|mesh-list
93239918|NCT05692869|Vasodilator Agents|vasodilator agents|mesh-ancestor
93239919|NCT05692869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93239920|NCT05692869|Autonomic Agents|autonomic agents|mesh-ancestor
93239921|NCT05692869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239922|NCT05692869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93239923|NCT05692869|Respiratory System Agents|respiratory system agents|mesh-ancestor
93239924|NCT05692869|Nasal Decongestants|nasal decongestants|mesh-ancestor
92534667|NCT00070447|Glucocorticoids|glucocorticoids|mesh-ancestor
93239925|NCT05692869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93239926|NCT05692869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93239927|NCT05692869|Sympathomimetics|sympathomimetics|mesh-ancestor
93239928|NCT05655468|Dronedarone|dronedarone|mesh-list
92560095|NCT00131989|Sorafenib|sorafenib|mesh-list
93239929|NCT05655468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93239930|NCT05644353|Mirikizumab|mirikizumab|mesh-list
93239931|NCT05644353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93239932|NCT05644353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93239933|NCT05644353|Analgesics|analgesics|mesh-ancestor
93239934|NCT05644353|Sensory System Agents|sensory system agents|mesh-ancestor
93239935|NCT05644353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239936|NCT05644353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239937|NCT05644353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93239938|NCT05644353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239939|NCT05644353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93239940|NCT05644353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239941|NCT05563389|Atorvastatin|atorvastatin|mesh-list
93239942|NCT05563389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93239943|NCT05563389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93239944|NCT05563389|Antimetabolites|antimetabolites|mesh-ancestor
92560562|NCT00134212|Epinephrine|epinephrine|mesh-list
93239945|NCT05563389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239946|NCT05563389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93239947|NCT05563389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93239948|NCT05563389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239949|NCT05548660|Analgesics|analgesics|mesh-list
93239950|NCT05548660|Sensory System Agents|sensory system agents|mesh-ancestor
93239951|NCT05548660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239952|NCT05548660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239953|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93239954|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239955|NCT05525273|Trametinib|trametinib|mesh-list
93239956|NCT05525273|Dabrafenib|dabrafenib|mesh-list
93239957|NCT05525273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239958|NCT05525273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93239959|NCT05525273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239960|NCT05525273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239961|NCT05516849|Oxandrolone|oxandrolone|mesh-list
93239962|NCT05516849|Androgens|androgens|mesh-ancestor
93239963|NCT05516849|Hormones|hormones|mesh-ancestor
93239964|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93239965|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239966|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
93239967|NCT05511766|Allopurinol|allopurinol|mesh-list
93239968|NCT05511766|Atorvastatin|atorvastatin|mesh-list
93239969|NCT05511766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93239970|NCT05511766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93239971|NCT05511766|Antimetabolites|antimetabolites|mesh-ancestor
93239972|NCT05511766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534709|NCT00070642|Alkylating Agents|alkylating agents|mesh-ancestor
91912704|NCT02087813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93239973|NCT05511766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93239974|NCT05511766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93239975|NCT05511766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93239976|NCT05511766|Gout Suppressants|gout suppressants|mesh-ancestor
93239977|NCT05511766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93239978|NCT05511766|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93239979|NCT05511766|Antioxidants|antioxidants|mesh-ancestor
93239980|NCT05511766|Protective Agents|protective agents|mesh-ancestor
93239981|NCT05511766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239982|NCT05476796|Trifluridine|trifluridine|mesh-list
93239983|NCT05476796|Oxaliplatin|oxaliplatin|mesh-list
93239984|NCT05476796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93239985|NCT05476796|Antimetabolites|antimetabolites|mesh-ancestor
93239986|NCT05476796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239987|NCT05476796|Antiviral Agents|antiviral agents|mesh-ancestor
93239988|NCT05476796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93239989|NCT05466734|Cilostazol|cilostazol|mesh-list
93239990|NCT05466734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93239991|NCT05466734|Autonomic Agents|autonomic agents|mesh-ancestor
93239992|NCT05466734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93239993|NCT05466734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93239994|NCT05466734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91913670|NCT04856852|Iodine|iodine|mesh-list
92534733|NCT00071227|Glucocorticoids|glucocorticoids|mesh-ancestor
93239995|NCT05466734|Respiratory System Agents|respiratory system agents|mesh-ancestor
93239996|NCT05466734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93239997|NCT05466734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92534734|NCT00071227|Hormones|hormones|mesh-ancestor
93239998|NCT05466734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93239999|NCT05466734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93240000|NCT05466734|Vasodilator Agents|vasodilator agents|mesh-ancestor
93240001|NCT05466734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93240002|NCT05466734|Protective Agents|protective agents|mesh-ancestor
93240003|NCT05466734|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93240004|NCT05466734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93240005|NCT05466734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240006|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93240007|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240008|NCT05450029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240009|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259502|NCT00957242|Warfarin|warfarin|mesh-list
93240011|NCT05420402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93240012|NCT05420402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240013|NCT05420402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240014|NCT05420402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93240015|NCT05420402|Anesthetics, General|anesthetics, general|mesh-ancestor
93240016|NCT05420402|Anesthetics|anesthetics|mesh-ancestor
93240017|NCT05417087|Vortioxetine|vortioxetine|mesh-list
93240018|NCT05417087|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240019|NCT05417087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240020|NCT05417087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93240021|NCT05417087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93240022|NCT05417087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92565079|NCT00168025|Antibodies|antibodies|mesh-list
93240023|NCT05417087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240024|NCT05417087|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93240025|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93240026|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93240027|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240028|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240029|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
93240030|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93240031|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93240032|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93240033|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93240034|NCT05416957|Vortioxetine|vortioxetine|mesh-list
93240035|NCT05416957|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240036|NCT05416957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240037|NCT05416957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93240038|NCT05416957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92534773|NCT02966743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93240039|NCT05416957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240040|NCT05416957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240041|NCT05416957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93240042|NCT05416957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93240043|NCT05416957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534780|NCT02966743|GABA Agents|gaba agents|mesh-ancestor
93240044|NCT05416957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240045|NCT05416957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240046|NCT05416957|Serotonin Agents|serotonin agents|mesh-ancestor
93240047|NCT05416957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93240048|NCT05416957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93240049|NCT05416957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93240050|NCT05416957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93240051|NCT05416762|Vortioxetine|vortioxetine|mesh-list
93240052|NCT05416762|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240053|NCT05416762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240054|NCT05416762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93240055|NCT05416762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93240056|NCT05416762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240057|NCT05416762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240058|NCT05416762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93240059|NCT05416762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92534793|NCT00071695|Analgesics|analgesics|mesh-ancestor
93240060|NCT05416762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534796|NCT00071695|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240061|NCT05416762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240062|NCT05416762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240063|NCT05416762|Serotonin Agents|serotonin agents|mesh-ancestor
92912041|NCT00689585|Ethosuximide|ethosuximide|mesh-list
93240064|NCT05416762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92534800|NCT00071929|Oxaliplatin|oxaliplatin|mesh-list
93240065|NCT05416762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93240066|NCT05416762|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93240067|NCT05416762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93240069|NCT05383742|Isoniazid|isoniazid|mesh-list
93240070|NCT05383742|Linezolid|linezolid|mesh-list
93240071|NCT05383742|Pyrazinamide|pyrazinamide|mesh-list
93240072|NCT05383742|Ethambutol|ethambutol|mesh-list
93240073|NCT05383742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93240074|NCT05383742|Antitubercular Agents|antitubercular agents|mesh-ancestor
93240075|NCT05383742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93240076|NCT05383742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240077|NCT05383742|Leprostatic Agents|leprostatic agents|mesh-ancestor
93240078|NCT05383742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93240079|NCT05383742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240080|NCT05383742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240081|NCT05383742|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91916681|NCT02135627|Mydriatics|mydriatics|mesh-ancestor
93240082|NCT05383742|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93240083|NCT05383742|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93240084|NCT05383742|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93240085|NCT05383742|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92567480|NCT03731832|Ixazomib|ixazomib|mesh-list
93240086|NCT05383742|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93240087|NCT05383742|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93240088|NCT05383742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93240089|NCT05383742|Antimetabolites|antimetabolites|mesh-ancestor
93240090|NCT05383742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92534824|NCT00390065|Antioxidants|antioxidants|mesh-ancestor
93240091|NCT05383742|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93240092|NCT05365802|FAPI-46|fapi-46|mesh-list
93240093|NCT05365802|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93240094|NCT05365802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240095|NCT05358639|Olaparib|olaparib|mesh-list
93240096|NCT05358639|Navitoclax|navitoclax|mesh-list
93240097|NCT05358639|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93240098|NCT05358639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240099|NCT05358639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240100|NCT05358639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240101|NCT05330871|Vaccines|vaccines|mesh-list
93240102|NCT05330871|Immunologic Factors|immunologic factors|mesh-ancestor
93240103|NCT05330871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240104|NCT05327595|Midazolam|midazolam|mesh-list
93240105|NCT05327595|Atorvastatin|atorvastatin|mesh-list
92568186|NCT03238365|Nivolumab|nivolumab|mesh-list
93240106|NCT05327595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93240107|NCT05327595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93240108|NCT05327595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240109|NCT05327595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240110|NCT05327595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92568373|NCT00191347|Pemetrexed|pemetrexed|mesh-list
93240111|NCT05327595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93240112|NCT05327595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240113|NCT05327595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93240114|NCT05327595|Anesthetics, General|anesthetics, general|mesh-ancestor
93240115|NCT05327595|Anesthetics|anesthetics|mesh-ancestor
93240116|NCT05327595|GABA Modulators|gaba modulators|mesh-ancestor
93240117|NCT05327595|GABA Agents|gaba agents|mesh-ancestor
93240118|NCT05327595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240119|NCT05327595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240120|NCT05327595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91917948|NCT05545592|Estrogens|estrogens|mesh-list
93240121|NCT05327595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93240122|NCT05327595|Antimetabolites|antimetabolites|mesh-ancestor
93240123|NCT05327595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93240124|NCT05327595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93240125|NCT05327595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240126|NCT05314153|Brexanolone|brexanolone|mesh-list
93240127|NCT05314153|Neurosteroids|neurosteroids|mesh-ancestor
93240128|NCT05314153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240129|NCT05314153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240130|NCT05314153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240131|NCT05314153|GABA Modulators|gaba modulators|mesh-ancestor
93240132|NCT05314153|GABA Agents|gaba agents|mesh-ancestor
93240133|NCT05283408|Dexmedetomidine|dexmedetomidine|mesh-list
93240134|NCT05283408|Esketamine|esketamine|mesh-list
93240135|NCT05283408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93240136|NCT05283408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240137|NCT05283408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240138|NCT05283408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240139|NCT05283408|Analgesics|analgesics|mesh-ancestor
93240140|NCT05283408|Sensory System Agents|sensory system agents|mesh-ancestor
91918545|NCT02171143|ASP2409|asp2409|mesh-list
93240141|NCT05283408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569354|NCT00084669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240142|NCT05283408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93240143|NCT05283408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93240144|NCT05283408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93240145|NCT05283408|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240146|NCT05283408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240147|NCT05283408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240148|NCT05283408|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240149|NCT05283408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240150|NCT05275400|Insulin|insulin|mesh-list
93240151|NCT05275400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93240152|NCT05275400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93240153|NCT05275400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240154|NCT05240755|Cannabidiol|cannabidiol|mesh-list
93240155|NCT05240755|Anticonvulsants|anticonvulsants|mesh-ancestor
93240156|NCT05229315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93240157|NCT05229315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240158|NCT05229315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240159|NCT05229315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534883|NCT04730596|Analgesics|analgesics|mesh-ancestor
93240160|NCT05213143|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92569930|NCT00410449|Vitamins|vitamins|mesh-ancestor
93240161|NCT05213143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93240162|NCT05213143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93240163|NCT05213143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240164|NCT05213143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240165|NCT05213143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534890|NCT04730596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240166|NCT05213143|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93240167|NCT05213143|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91919351|NCT05691920|Anesthetics|anesthetics|mesh-ancestor
93240168|NCT05213143|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93240169|NCT05213143|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240170|NCT05213143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240171|NCT05213143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240172|NCT05213143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93240173|NCT05213143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93240174|NCT05213143|Serotonin Agents|serotonin agents|mesh-ancestor
93240175|NCT05213143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92534899|NCT00072085|Freund's Adjuvant|freund's adjuvant|mesh-list
93240176|NCT05213143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93240177|NCT05213143|Dopamine Agents|dopamine agents|mesh-ancestor
93240178|NCT05208931|Mitogens|mitogens|mesh-list
93240179|NCT05208931|Endothelial Growth Factors|endothelial growth factors|mesh-list
93240180|NCT05208931|Mitosis Modulators|mitosis modulators|mesh-ancestor
93240181|NCT05208931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240182|NCT05208931|Growth Substances|growth substances|mesh-ancestor
92534907|NCT00072085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240183|NCT05208931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240184|NCT05191862|Cilostazol|cilostazol|mesh-list
93240185|NCT05191862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93240186|NCT05191862|Autonomic Agents|autonomic agents|mesh-ancestor
92534908|NCT04730674|Tetracycline|tetracycline|mesh-list
93240187|NCT05191862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240188|NCT05191862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240189|NCT05191862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93240190|NCT05191862|Respiratory System Agents|respiratory system agents|mesh-ancestor
93240191|NCT05191862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93240192|NCT05191862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93240193|NCT05191862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570980|NCT00095823|Aripiprazole|aripiprazole|mesh-list
92537692|NCT02825979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240194|NCT05191862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93240195|NCT05191862|Vasodilator Agents|vasodilator agents|mesh-ancestor
93240196|NCT05191862|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93240197|NCT05191862|Protective Agents|protective agents|mesh-ancestor
92534921|NCT04730674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93240198|NCT05191862|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93240199|NCT05191862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93240200|NCT05191862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240201|NCT05189704|Analgesics, Opioid|analgesics, opioid|mesh-list
93240202|NCT05189704|Narcotics|narcotics|mesh-ancestor
93240203|NCT05189704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240204|NCT05189704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240205|NCT05189704|Analgesics|analgesics|mesh-ancestor
93240206|NCT05189704|Sensory System Agents|sensory system agents|mesh-ancestor
93240207|NCT05189704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240208|NCT05179421|Oxytocin|oxytocin|mesh-list
92571524|NCT00096720|Levodopa|levodopa|mesh-list
93240209|NCT05179421|Oxytocics|oxytocics|mesh-ancestor
93240210|NCT05179421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92571642|NCT00230503|Pradefovir|pradefovir|mesh-list
92571715|NCT00075738|Vitamins|vitamins|mesh-ancestor
93240211|NCT05179421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912193|NCT05298683|Acetaminophen|acetaminophen|mesh-list
93240212|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93240213|NCT05136703|Antiviral Agents|antiviral agents|mesh-ancestor
93240214|NCT05136703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240216|NCT05100160|Analgesics|analgesics|mesh-ancestor
93240217|NCT05100160|Sensory System Agents|sensory system agents|mesh-ancestor
93240218|NCT05100160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240219|NCT05100160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572076|NCT02958566|Antipyretics|antipyretics|mesh-ancestor
93240220|NCT05100160|Anticonvulsants|anticonvulsants|mesh-ancestor
93240221|NCT05100160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93240222|NCT05100160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93240223|NCT05100160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240224|NCT05100160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240225|NCT05100160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93240226|NCT05100160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93240227|NCT05100160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240228|NCT05100160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240229|NCT05100160|Antimanic Agents|antimanic agents|mesh-ancestor
93240230|NCT05060822|Pirfenidone|pirfenidone|mesh-list
93240231|NCT05060822|Analgesics|analgesics|mesh-ancestor
93240232|NCT05060822|Sensory System Agents|sensory system agents|mesh-ancestor
93240233|NCT05060822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240234|NCT05060822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240235|NCT05060822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93240236|NCT05060822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240237|NCT05060822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240238|NCT05060822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240239|NCT05060822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240240|NCT05052931|Paclitaxel|paclitaxel|mesh-list
93240241|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
92572220|NCT00233584|Budesonide|budesonide|mesh-list
93240242|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93240243|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240244|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
93240245|NCT05052931|Antimitotic Agents|antimitotic agents|mesh-ancestor
93240246|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
93240247|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240248|NCT05052229|Nitric Oxide|nitric oxide|mesh-list
93240249|NCT05052229|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93240250|NCT05052229|Autonomic Agents|autonomic agents|mesh-ancestor
92534969|NCT00072319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240251|NCT05052229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534973|NCT03959397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240252|NCT05052229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240253|NCT05052229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93240254|NCT05052229|Respiratory System Agents|respiratory system agents|mesh-ancestor
93240255|NCT05052229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93240256|NCT05052229|Antioxidants|antioxidants|mesh-ancestor
93240257|NCT05052229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240258|NCT05052229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240259|NCT05052229|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93240260|NCT05052229|Vasodilator Agents|vasodilator agents|mesh-ancestor
93240261|NCT05052229|Gasotransmitters|gasotransmitters|mesh-ancestor
93240262|NCT05052229|Protective Agents|protective agents|mesh-ancestor
93240263|NCT05048212|Nivolumab|nivolumab|mesh-list
93240264|NCT05048212|Ipilimumab|ipilimumab|mesh-list
93240265|NCT05048212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240266|NCT05048212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240267|NCT05048212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240268|NCT05048212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240269|NCT05037500|Decitabine|decitabine|mesh-list
93240270|NCT05037500|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93240271|NCT05037500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93240272|NCT05037500|Antimetabolites|antimetabolites|mesh-ancestor
93240273|NCT05037500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240274|NCT05037500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240275|NCT05037500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240276|NCT05020769|Osimertinib|osimertinib|mesh-list
93240277|NCT05020769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240278|NCT05020769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93240279|NCT05020769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240280|NCT05020769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240281|NCT05002738|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93240282|NCT05002738|Desogestrel|desogestrel|mesh-list
93240283|NCT05002738|Estradiol|estradiol|mesh-list
93240284|NCT05002738|Estrogens|estrogens|mesh-ancestor
93240285|NCT05002738|Hormones|hormones|mesh-ancestor
92912272|NCT00700466|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240286|NCT05002738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93240287|NCT05002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240288|NCT05002738|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93240289|NCT05002738|Contraceptive Agents|contraceptive agents|mesh-ancestor
93240290|NCT05002738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93240291|NCT05002738|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92573786|NCT00242359|Omalizumab|omalizumab|mesh-list
91922632|NCT02231359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93240292|NCT05002738|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93240293|NCT05002738|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93240294|NCT05002738|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93240295|NCT05002738|Progestins|progestins|mesh-ancestor
93240296|NCT04990284|Levodopa|levodopa|mesh-list
92298891|NCT05340465|Iron|iron|mesh-list
93240297|NCT04990284|Opicapone|opicapone|mesh-list
93240298|NCT04990284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93240299|NCT04990284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93240300|NCT04990284|Dopamine Agents|dopamine agents|mesh-ancestor
93240301|NCT04990284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240302|NCT04990284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240303|NCT04990284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240304|NCT04990284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93240305|NCT04990284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574236|NCT00245713|Levetiracetam|levetiracetam|mesh-list
93240306|NCT04955158|Dexmedetomidine|dexmedetomidine|mesh-list
93240307|NCT04955158|Ketamine|ketamine|mesh-list
93240308|NCT04955158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92535027|NCT00072631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240309|NCT04955158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240310|NCT04955158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535029|NCT00072670|Trabectedin|trabectedin|mesh-list
93240311|NCT04955158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240312|NCT04955158|Analgesics|analgesics|mesh-ancestor
93240313|NCT04955158|Sensory System Agents|sensory system agents|mesh-ancestor
93240314|NCT04955158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240315|NCT04955158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93240316|NCT04955158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93240317|NCT04955158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93240318|NCT04955158|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240319|NCT04955158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240320|NCT04955158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240321|NCT04955158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93240322|NCT04955158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93240323|NCT04955158|Anesthetics, General|anesthetics, general|mesh-ancestor
93240324|NCT04955158|Anesthetics|anesthetics|mesh-ancestor
93240325|NCT04955158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92574846|NCT00099957|Vildagliptin|vildagliptin|mesh-list
93240326|NCT04955158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93240327|NCT04928391|Dexmedetomidine|dexmedetomidine|mesh-list
93240328|NCT04928391|Nalbuphine|nalbuphine|mesh-list
92574989|NCT00100074|Lobeline|lobeline|mesh-list
93240329|NCT04928391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93240330|NCT04928391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240331|NCT04928391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240332|NCT04928391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240333|NCT04928391|Analgesics|analgesics|mesh-ancestor
93240334|NCT04928391|Sensory System Agents|sensory system agents|mesh-ancestor
93240335|NCT04928391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240336|NCT04928391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93240337|NCT04928391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93240338|NCT04928391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93240339|NCT04928391|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240340|NCT04928391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240341|NCT04928391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240342|NCT04928391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93240343|NCT04928391|Narcotics|narcotics|mesh-ancestor
93240344|NCT04928352|Bupivacaine|bupivacaine|mesh-list
93240345|NCT04928352|Anesthetics, Local|anesthetics, local|mesh-ancestor
93240346|NCT04928352|Anesthetics|anesthetics|mesh-ancestor
93240347|NCT04928352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240348|NCT04928352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240349|NCT04928352|Sensory System Agents|sensory system agents|mesh-ancestor
93240350|NCT04928352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240351|NCT04928300|Dexmedetomidine|dexmedetomidine|mesh-list
93240352|NCT04928300|Ketamine|ketamine|mesh-list
93240353|NCT04928300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92535067|NCT00072943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93240354|NCT04928300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240355|NCT04928300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240356|NCT04928300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240357|NCT04928300|Analgesics|analgesics|mesh-ancestor
93240358|NCT04928300|Sensory System Agents|sensory system agents|mesh-ancestor
92576116|NCT00100971|Vaccines|vaccines|mesh-list
93240359|NCT04928300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240360|NCT04928300|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93240361|NCT04928300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93240362|NCT04928300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93240363|NCT04928300|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240364|NCT04928300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535076|NCT04834349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240365|NCT04928300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240366|NCT04928300|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93240367|NCT04928300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93240368|NCT04928300|Anesthetics, General|anesthetics, general|mesh-ancestor
93240369|NCT04928300|Anesthetics|anesthetics|mesh-ancestor
92535080|NCT03959124|Memantine|memantine|mesh-list
91925191|NCT01175785|Cyclosporins|cyclosporins|mesh-list
93240370|NCT04928300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93240371|NCT04928300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93240372|NCT04920695|Nitric Oxide|nitric oxide|mesh-list
93240373|NCT04920695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93240374|NCT04920695|Autonomic Agents|autonomic agents|mesh-ancestor
93240375|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240376|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240377|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93240378|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
93240379|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93240380|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
93240381|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240382|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240383|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93240384|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
93240385|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
93240386|NCT04920695|Protective Agents|protective agents|mesh-ancestor
93240387|NCT04910464|Tranexamic Acid|tranexamic acid|mesh-list
93240388|NCT04910464|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93240389|NCT04910464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93240390|NCT04910464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240391|NCT04910464|Hemostatics|hemostatics|mesh-ancestor
93240392|NCT04910464|Coagulants|coagulants|mesh-ancestor
93240393|NCT04905901|Tranexamic Acid|tranexamic acid|mesh-list
93240394|NCT04905901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92535106|NCT04711291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240395|NCT04905901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93240396|NCT04905901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240397|NCT04905901|Hemostatics|hemostatics|mesh-ancestor
93240398|NCT04905901|Coagulants|coagulants|mesh-ancestor
93240399|NCT04901988|Nivolumab|nivolumab|mesh-list
93240400|NCT04901988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240401|NCT04901988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240402|NCT04901988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240403|NCT04901988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240404|NCT04899687|Dextromethorphan|dextromethorphan|mesh-list
93240405|NCT04899687|Fluoxetine|fluoxetine|mesh-list
93240406|NCT04899687|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93240407|NCT04899687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92579135|NCT00110058|Interferons|interferons|mesh-list
93240408|NCT04899687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926518|NCT05454709|Hormones|hormones|mesh-ancestor
93240409|NCT04899687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240410|NCT04899687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579368|NCT00417157|Ganirelix|ganirelix|mesh-list
93240411|NCT04899687|Serotonin Agents|serotonin agents|mesh-ancestor
92579517|NCT00284947|Prednisone|prednisone|mesh-list
93240412|NCT04899687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240413|NCT04899687|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93240414|NCT04899687|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240415|NCT04899687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240416|NCT04899687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93240417|NCT04899687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93240418|NCT04899687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240419|NCT04899687|Antitussive Agents|antitussive agents|mesh-ancestor
92579722|NCT00286273|Tinzaparin|tinzaparin|mesh-list
93240420|NCT04899687|Respiratory System Agents|respiratory system agents|mesh-ancestor
93240421|NCT04899687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93240422|NCT04899687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93240423|NCT04823845|Adapalene|adapalene|mesh-list
93240424|NCT04823845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92579960|NCT00287326|Clonidine|clonidine|mesh-list
93240425|NCT04823845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240426|NCT04823845|Analgesics|analgesics|mesh-ancestor
93240427|NCT04823845|Sensory System Agents|sensory system agents|mesh-ancestor
93240428|NCT04823845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240429|NCT04823845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240430|NCT04823845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535142|NCT02966041|Antiemetics|antiemetics|mesh-ancestor
93240431|NCT04823845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912422|NCT00873119|Paclitaxel|paclitaxel|mesh-list
93240433|NCT04792749|Metformin|metformin|mesh-list
93240434|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93240435|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240436|NCT04792190|Dapagliflozin|dapagliflozin|mesh-list
93240437|NCT04792190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93240438|NCT04792190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535147|NCT02966041|Antipruritics|antipruritics|mesh-ancestor
93240439|NCT04792190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93240440|NCT04792190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240441|NCT04789070|Sirolimus|sirolimus|mesh-list
93240442|NCT04789070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93240443|NCT04789070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580485|NCT00112515|Modafinil|modafinil|mesh-list
93240444|NCT04789070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91927759|NCT02173457|Hormones|hormones|mesh-ancestor
93240445|NCT04789070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240446|NCT04789070|Antifungal Agents|antifungal agents|mesh-ancestor
92580737|NCT00130195|Dermatologic Agents|dermatologic agents|mesh-ancestor
93240447|NCT04789070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93240448|NCT04789070|Immunologic Factors|immunologic factors|mesh-ancestor
93240449|NCT04789070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240450|NCT04756427|Citric Acid|citric acid|mesh-list
93240451|NCT04756427|Sodium Citrate|sodium citrate|mesh-list
93240452|NCT04756427|Anticoagulants|anticoagulants|mesh-list
93240453|NCT04756427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93240454|NCT04756427|Chelating Agents|chelating agents|mesh-ancestor
93240455|NCT04756427|Sequestering Agents|sequestering agents|mesh-ancestor
93240456|NCT04756427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240457|NCT04722601|Azacitidine|azacitidine|mesh-list
93240458|NCT04722601|Venetoclax|venetoclax|mesh-list
93240459|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
93240460|NCT04722601|Cc-486|cc-486|mesh-list
93240461|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93240462|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
93240463|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581230|NCT00300118|Analgesics|analgesics|mesh-ancestor
93240464|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240465|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240466|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240467|NCT04692844|Propranolol|propranolol|mesh-list
93240468|NCT04692844|Primidone|primidone|mesh-list
93240469|NCT04692844|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93240470|NCT04692844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93240471|NCT04692844|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240472|NCT04692844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240473|NCT04692844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240474|NCT04692844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240475|NCT04692844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92581516|NCT00080522|Ritonavir|ritonavir|mesh-list
93240476|NCT04692844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93240477|NCT04692844|Vasodilator Agents|vasodilator agents|mesh-ancestor
93240478|NCT04692844|Anticonvulsants|anticonvulsants|mesh-ancestor
93240479|NCT04692844|GABA Modulators|gaba modulators|mesh-ancestor
93240480|NCT04692844|GABA Agents|gaba agents|mesh-ancestor
93240481|NCT04692077|Tenofovir|tenofovir|mesh-list
93240482|NCT04692077|Emtricitabine|emtricitabine|mesh-list
93240483|NCT04692077|Cabotegravir|cabotegravir|mesh-list
93240484|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
93240485|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240486|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92535189|NCT00074074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240487|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93240488|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240489|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582191|NCT00120432|Mydriatics|mydriatics|mesh-ancestor
93240490|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93240491|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93240492|NCT04692077|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92307135|NCT00004785|Hormones|hormones|mesh-ancestor
93240493|NCT04692077|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93240494|NCT04657003|Tirzepatide|tirzepatide|mesh-list
93240495|NCT04657003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93240496|NCT04657003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240497|NCT04657003|Incretins|incretins|mesh-ancestor
93240498|NCT04657003|Hormones|hormones|mesh-ancestor
93240499|NCT04657003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93240500|NCT04624906|Rituximab|rituximab|mesh-list
93240501|NCT04624906|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93240502|NCT04624906|Acalabrutinib|acalabrutinib|mesh-list
92535208|NCT00074191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93240503|NCT04624906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240504|NCT04624906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240505|NCT04624906|Immunologic Factors|immunologic factors|mesh-ancestor
93240506|NCT04624906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240507|NCT04624906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912495|NCT00784966|Etanercept|etanercept|mesh-list
93240508|NCT04624906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93240509|NCT04624906|Alkylating Agents|alkylating agents|mesh-ancestor
93240510|NCT04624906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240511|NCT04610320|Daratumumab|daratumumab|mesh-list
93240512|NCT04610320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240513|NCT04546399|Calcium, Dietary|calcium, dietary|mesh-list
93240514|NCT04546399|Leucovorin|leucovorin|mesh-list
93240515|NCT04546399|Folic Acid|folic acid|mesh-list
93240516|NCT04546399|Cytarabine|cytarabine|mesh-list
93240517|NCT04546399|Dexamethasone|dexamethasone|mesh-list
93240518|NCT04546399|Dexamethasone acetate|dexamethasone acetate|mesh-list
93240519|NCT04546399|Hydrocortisone|hydrocortisone|mesh-list
93240520|NCT04546399|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93240521|NCT04546399|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93240522|NCT04546399|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93240523|NCT04546399|Cyclophosphamide|cyclophosphamide|mesh-list
93240524|NCT04546399|Nivolumab|nivolumab|mesh-list
93240525|NCT04546399|Methotrexate|methotrexate|mesh-list
93240526|NCT04546399|Etoposide|etoposide|mesh-list
93240527|NCT04546399|Vincristine|vincristine|mesh-list
93240528|NCT04546399|Etoposide phosphate|etoposide phosphate|mesh-list
93240529|NCT04546399|Asparaginase|asparaginase|mesh-list
92583582|NCT00121563|Ibuprofen|ibuprofen|mesh-list
93240530|NCT04546399|Mercaptopurine|mercaptopurine|mesh-list
93240531|NCT04546399|Podophyllotoxin|podophyllotoxin|mesh-list
93240532|NCT04546399|Pegaspargase|pegaspargase|mesh-list
93240533|NCT04546399|Thioguanine|thioguanine|mesh-list
93240534|NCT04546399|Blinatumomab|blinatumomab|mesh-list
93240535|NCT04546399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93240536|NCT04546399|Muromonab-CD3|muromonab-cd3|mesh-list
93240537|NCT04546399|Antibodies|antibodies|mesh-list
93240538|NCT04546399|Immunoglobulins|immunoglobulins|mesh-list
93240539|NCT04546399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93240540|NCT04546399|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93240541|NCT04546399|BB 1101|bb 1101|mesh-list
93240542|NCT04546399|Calcium|calcium|mesh-list
93240543|NCT04546399|2-Aminopurine|2-aminopurine|mesh-list
93240544|NCT04546399|Levoleucovorin|levoleucovorin|mesh-list
93240545|NCT04546399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93240546|NCT04546399|Immunologic Factors|immunologic factors|mesh-ancestor
93240547|NCT04546399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240548|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240549|NCT04546399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93240550|NCT04546399|Alkylating Agents|alkylating agents|mesh-ancestor
93240551|NCT04546399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240552|NCT04546399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240553|NCT04546399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93240554|NCT04546399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240555|NCT04546399|Antiemetics|antiemetics|mesh-ancestor
93240556|NCT04546399|Autonomic Agents|autonomic agents|mesh-ancestor
93240557|NCT04546399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240558|NCT04546399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93240559|NCT04546399|Glucocorticoids|glucocorticoids|mesh-ancestor
93240560|NCT04546399|Hormones|hormones|mesh-ancestor
93240561|NCT04546399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93240562|NCT04546399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93240563|NCT04546399|Protease Inhibitors|protease inhibitors|mesh-ancestor
93240564|NCT04546399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240565|NCT04546399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93240566|NCT04546399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93240567|NCT04546399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240568|NCT04546399|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93240569|NCT04546399|Abortifacient Agents|abortifacient agents|mesh-ancestor
93240570|NCT04546399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93240571|NCT04546399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93240572|NCT04546399|Antimetabolites|antimetabolites|mesh-ancestor
93240573|NCT04546399|Dermatologic Agents|dermatologic agents|mesh-ancestor
93240574|NCT04546399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93240575|NCT04546399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93240576|NCT04546399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93240577|NCT04546399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93240578|NCT04546399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93240579|NCT04546399|Antiviral Agents|antiviral agents|mesh-ancestor
93240580|NCT04546399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240581|NCT04546399|Antidotes|antidotes|mesh-ancestor
93240582|NCT04546399|Protective Agents|protective agents|mesh-ancestor
92912583|NCT00696215|Rasagiline|rasagiline|mesh-list
93240583|NCT04546399|Vitamin B Complex|vitamin b complex|mesh-ancestor
93240584|NCT04546399|Vitamins|vitamins|mesh-ancestor
93240585|NCT04546399|Micronutrients|micronutrients|mesh-ancestor
93240586|NCT04546399|Tubulin Modulators|tubulin modulators|mesh-ancestor
93240587|NCT04546399|Antimitotic Agents|antimitotic agents|mesh-ancestor
93240588|NCT04546399|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535279|NCT00074620|Hirudins|hirudins|mesh-list
91931925|NCT01371630|Antimetabolites|antimetabolites|mesh-ancestor
93240589|NCT04546399|Hematinics|hematinics|mesh-ancestor
93240590|NCT04546399|Keratolytic Agents|keratolytic agents|mesh-ancestor
93240591|NCT04540120|Dapansutrile|dapansutrile|mesh-list
93240592|NCT04540120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240593|NCT04480086|Navitoclax|navitoclax|mesh-list
93240594|NCT04480086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240595|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93240596|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240597|NCT04441138|Durvalumab|durvalumab|mesh-list
92535281|NCT00074620|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93240598|NCT04441138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240599|NCT04441138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240600|NCT04432688|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92585211|NCT00419068|Cholecalciferol|cholecalciferol|mesh-list
93240601|NCT04432688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93240602|NCT04432688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93240603|NCT04432688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240604|NCT04432688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240605|NCT04432688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240606|NCT04432688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93240607|NCT04432688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93240608|NCT04432688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93240609|NCT04432688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92585485|NCT00315367|Donepezil|donepezil|mesh-list
93240610|NCT04432688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240611|NCT04432688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240612|NCT04432688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93240613|NCT04432688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93240614|NCT04432688|Serotonin Agents|serotonin agents|mesh-ancestor
93240615|NCT04432688|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93240616|NCT04432688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93240617|NCT04432688|Dopamine Agents|dopamine agents|mesh-ancestor
93240618|NCT04426825|Bevacizumab|bevacizumab|mesh-list
93240619|NCT04426825|Atezolizumab|atezolizumab|mesh-list
93240620|NCT04426825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240621|NCT04426825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240622|NCT04426825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93240623|NCT04426825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92585991|NCT00123903|Metoprolol|metoprolol|mesh-list
93240624|NCT04426825|Growth Substances|growth substances|mesh-ancestor
93240625|NCT04426825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535314|NCT00074776|Anticonvulsants|anticonvulsants|mesh-ancestor
93240626|NCT04426825|Growth Inhibitors|growth inhibitors|mesh-ancestor
91932957|NCT05092841|Baclofen|baclofen|mesh-list
93240627|NCT04426825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240628|NCT04426825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240629|NCT04418479|Aspirin|aspirin|mesh-list
92535320|NCT00075010|Decitabine|decitabine|mesh-list
93240630|NCT04418479|Clopidogrel|clopidogrel|mesh-list
93240631|NCT04418479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93240632|NCT04418479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240633|NCT04418479|Analgesics|analgesics|mesh-ancestor
92535321|NCT00075010|Valproic Acid|valproic acid|mesh-list
93240634|NCT04418479|Sensory System Agents|sensory system agents|mesh-ancestor
93240635|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240636|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240637|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240638|NCT04418479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240639|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93240640|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93240641|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240642|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93240643|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93240644|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240645|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
93240646|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93240647|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93240648|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93240649|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
93240650|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240651|NCT04417998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93240652|NCT04417998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93240653|NCT04417998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240654|NCT04408508|Amoxicillin|amoxicillin|mesh-list
93240655|NCT04408508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93240656|NCT04408508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240657|NCT04314375|Budesonide|budesonide|mesh-list
93240658|NCT04314375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240659|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93240660|NCT04314375|Autonomic Agents|autonomic agents|mesh-ancestor
93240661|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240662|NCT04314375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240663|NCT04314375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93240664|NCT04314375|Respiratory System Agents|respiratory system agents|mesh-ancestor
93240666|NCT04314375|Hormones|hormones|mesh-ancestor
93240667|NCT04314375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93240668|NCT04262206|Atorvastatin|atorvastatin|mesh-list
93240669|NCT04262206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93240670|NCT04262206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93240671|NCT04262206|Antimetabolites|antimetabolites|mesh-ancestor
93240672|NCT04262206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240673|NCT04262206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93240674|NCT04262206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93240675|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240676|NCT04181515|Hydrocortisone|hydrocortisone|mesh-list
93240677|NCT04181515|Yohimbine|yohimbine|mesh-list
93240678|NCT04181515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240679|NCT04181515|Mydriatics|mydriatics|mesh-ancestor
93240680|NCT04181515|Autonomic Agents|autonomic agents|mesh-ancestor
93240681|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240682|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240683|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93240684|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93240685|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93240686|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240687|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240688|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240689|NCT04181515|Urological Agents|urological agents|mesh-ancestor
93240690|NCT04180969|Hydrocortisone|hydrocortisone|mesh-list
93240691|NCT04180969|Yohimbine|yohimbine|mesh-list
93240692|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240693|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
93240694|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
93240695|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240696|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535381|NCT00075595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93240697|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93240698|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93240699|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93240700|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240701|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535393|NCT00075634|Cyclophosphamide|cyclophosphamide|mesh-list
93240702|NCT04180969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240703|NCT04180969|Urological Agents|urological agents|mesh-ancestor
93240704|NCT04123470|Atezolizumab|atezolizumab|mesh-list
92535398|NCT00075634|Lenograstim|lenograstim|mesh-list
93240705|NCT04123470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240706|NCT04123470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240707|NCT04123470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240708|NCT04123470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240709|NCT04083495|Cyclophosphamide|cyclophosphamide|mesh-list
93240710|NCT04083495|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93240711|NCT04083495|Fludarabine|fludarabine|mesh-list
93240712|NCT04083495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587109|NCT00320827|Antibodies|antibodies|mesh-list
93240713|NCT04083495|Immunologic Factors|immunologic factors|mesh-ancestor
93240714|NCT04083495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240715|NCT04083495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240716|NCT04083495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93240717|NCT04083495|Alkylating Agents|alkylating agents|mesh-ancestor
93240718|NCT04083495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240719|NCT04083495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240720|NCT04083495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93240721|NCT04082442|Evolocumab|evolocumab|mesh-list
93240722|NCT04082442|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93240723|NCT04082442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93240724|NCT04082442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93240725|NCT04082442|Antimetabolites|antimetabolites|mesh-ancestor
91934244|NCT02298595|Cetuximab|cetuximab|mesh-list
93240726|NCT04082442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240727|NCT04082442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93240728|NCT04082442|Protease Inhibitors|protease inhibitors|mesh-ancestor
93240729|NCT04082442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240730|NCT04082442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93240731|NCT04080518|Dapagliflozin|dapagliflozin|mesh-list
93240732|NCT04080518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93240733|NCT04080518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240734|NCT04080518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93240735|NCT04080518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240736|NCT04069052|Nitric Oxide|nitric oxide|mesh-list
93240737|NCT04069052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93240738|NCT04069052|Autonomic Agents|autonomic agents|mesh-ancestor
93240739|NCT04069052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587753|NCT00331084|Hormones|hormones|mesh-ancestor
93240740|NCT04069052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240741|NCT04069052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93240742|NCT04069052|Respiratory System Agents|respiratory system agents|mesh-ancestor
93240743|NCT04069052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93240744|NCT04069052|Antioxidants|antioxidants|mesh-ancestor
93240745|NCT04069052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240746|NCT04069052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240747|NCT04069052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93240748|NCT04069052|Vasodilator Agents|vasodilator agents|mesh-ancestor
93240749|NCT04069052|Gasotransmitters|gasotransmitters|mesh-ancestor
93240750|NCT04069052|Protective Agents|protective agents|mesh-ancestor
93240751|NCT04060108|Methamphetamine|methamphetamine|mesh-list
93240752|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93240753|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240754|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
93240755|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
93240756|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240757|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
93240758|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240759|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240760|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240761|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93240762|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93240763|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93240764|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93240765|NCT04017598|Iron|iron|mesh-list
93240766|NCT04017598|Trace Elements|trace elements|mesh-ancestor
93240767|NCT04017598|Micronutrients|micronutrients|mesh-ancestor
93240768|NCT04017598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240769|NCT04014803|Aspirin|aspirin|mesh-list
93240770|NCT04014803|Clopidogrel|clopidogrel|mesh-list
93240771|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93240772|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93240773|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240774|NCT04014803|Analgesics|analgesics|mesh-ancestor
93240775|NCT04014803|Sensory System Agents|sensory system agents|mesh-ancestor
93240776|NCT04014803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240777|NCT04014803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240778|NCT04014803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240779|NCT04014803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240780|NCT04014803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93240781|NCT04014803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93240782|NCT04014803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240783|NCT04014803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93240784|NCT04014803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93240785|NCT04014803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240786|NCT04014803|Antipyretics|antipyretics|mesh-ancestor
93240787|NCT04014803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93240788|NCT04014803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93240789|NCT04014803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93240790|NCT04014803|Purinergic Agents|purinergic agents|mesh-ancestor
93240791|NCT04014803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240792|NCT03980184|Guanfacine|guanfacine|mesh-list
93240793|NCT03980184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93240794|NCT03980184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93240795|NCT03980184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93240796|NCT03980184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93240797|NCT03980184|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240798|NCT03980184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240799|NCT03980184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240800|NCT03980184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240801|NCT03945903|Golimumab|golimumab|mesh-list
93240802|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93240803|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240804|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93240805|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
93240806|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240807|NCT03944876|Botulinum Toxins|botulinum toxins|mesh-list
93240808|NCT03944876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93240809|NCT03944876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93240810|NCT03944876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93240811|NCT03944876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93240812|NCT03944876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240813|NCT03944876|Cholinergic Agents|cholinergic agents|mesh-ancestor
93240814|NCT03944876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240815|NCT03944876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240816|NCT03944876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93240817|NCT03944876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240818|NCT03943589|Immunoglobulins|immunoglobulins|mesh-list
93240819|NCT03943589|Immunoglobulin G|immunoglobulin g|mesh-list
93240820|NCT03943589|Immunologic Factors|immunologic factors|mesh-ancestor
93240821|NCT03943589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240822|NCT03937219|Nivolumab|nivolumab|mesh-list
93240823|NCT03937219|Ipilimumab|ipilimumab|mesh-list
93240824|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240825|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240826|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240827|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240828|NCT03934684|Dexamethasone|dexamethasone|mesh-list
93240829|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
93240830|NCT03934684|Lenalidomide|lenalidomide|mesh-list
93240831|NCT03934684|BB 1101|bb 1101|mesh-list
93240832|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240833|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
93240834|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
93240835|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240836|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240837|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93240838|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
93240839|NCT03934684|Hormones|hormones|mesh-ancestor
93240840|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535529|NCT00076609|Capecitabine|capecitabine|mesh-list
93240841|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93240842|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240843|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
93240844|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240845|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240846|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
93240847|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93240848|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93240849|NCT03934684|Growth Substances|growth substances|mesh-ancestor
93240850|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
93240851|NCT03875235|Durvalumab|durvalumab|mesh-list
92535538|NCT00076726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93240852|NCT03875235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240853|NCT03875235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240854|NCT03873805|Vidarabine|vidarabine|mesh-list
93240855|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
93240856|NCT03873805|Fludarabine|fludarabine|mesh-list
93240857|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
93240858|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93240859|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
93240860|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240861|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240862|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93240863|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
93240864|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240865|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240866|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93240867|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93240868|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
93240869|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
93240870|NCT03873805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240871|NCT03869268|Aspirin|aspirin|mesh-list
93240872|NCT03869268|Ticagrelor|ticagrelor|mesh-list
93240873|NCT03869268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93240874|NCT03869268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240875|NCT03869268|Analgesics|analgesics|mesh-ancestor
93240876|NCT03869268|Sensory System Agents|sensory system agents|mesh-ancestor
93240877|NCT03869268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240878|NCT03869268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240879|NCT03869268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240880|NCT03869268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93240881|NCT03869268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93240882|NCT03869268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93240883|NCT03869268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240884|NCT03869268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93240885|NCT03869268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93240886|NCT03869268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240887|NCT03869268|Antipyretics|antipyretics|mesh-ancestor
93240888|NCT03869268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93240889|NCT03869268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92535571|NCT00077116|Immunotoxins|immunotoxins|mesh-ancestor
93240890|NCT03869268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93240891|NCT03869268|Purinergic Agents|purinergic agents|mesh-ancestor
93240892|NCT03869268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240893|NCT03843463|Dexetimide|dexetimide|mesh-list
93240894|NCT03843463|Citalopram|citalopram|mesh-list
93240895|NCT03843463|Escitalopram|escitalopram|mesh-list
93240896|NCT03843463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93240897|NCT03843463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93240898|NCT03843463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93240899|NCT03843463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240900|NCT03843463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240901|NCT03843463|Serotonin Agents|serotonin agents|mesh-ancestor
93240902|NCT03843463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240903|NCT03843463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92535596|NCT00077233|Fluorouracil|fluorouracil|mesh-list
93240904|NCT03843463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93240905|NCT03843463|Parasympatholytics|parasympatholytics|mesh-ancestor
93240906|NCT03843463|Autonomic Agents|autonomic agents|mesh-ancestor
93240907|NCT03843463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240908|NCT03843463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93240909|NCT03843463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93240910|NCT03843463|Cholinergic Agents|cholinergic agents|mesh-ancestor
93240911|NCT03843463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93240912|NCT03843463|Antidepressive Agents|antidepressive agents|mesh-ancestor
93240913|NCT03843463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93240914|NCT03660930|Sirolimus|sirolimus|mesh-list
93240915|NCT03660930|Temsirolimus|temsirolimus|mesh-list
93240916|NCT03660930|MTOR Inhibitors|mtor inhibitors|mesh-list
93240917|NCT03660930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93240918|NCT03660930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93240919|NCT03660930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93240920|NCT03660930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240921|NCT03660930|Antifungal Agents|antifungal agents|mesh-ancestor
93240922|NCT03660930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93240923|NCT03660930|Immunologic Factors|immunologic factors|mesh-ancestor
93240924|NCT03660930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240925|NCT03660930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93240926|NCT03660930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93240927|NCT03660930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240928|NCT03643796|Dexmedetomidine|dexmedetomidine|mesh-list
93240929|NCT03643796|Ketamine|ketamine|mesh-list
93240930|NCT03643796|Remifentanil|remifentanil|mesh-list
93240931|NCT03643796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93240932|NCT03643796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535630|NCT00077311|Hematinics|hematinics|mesh-ancestor
93240933|NCT03643796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589304|NCT02649790|Dexamethasone|dexamethasone|mesh-list
93240934|NCT03643796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93240935|NCT03643796|Analgesics|analgesics|mesh-ancestor
93240936|NCT03643796|Sensory System Agents|sensory system agents|mesh-ancestor
93240937|NCT03643796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240938|NCT03643796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93240939|NCT03643796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93240940|NCT03643796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93240941|NCT03643796|Adrenergic Agents|adrenergic agents|mesh-ancestor
93240942|NCT03643796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240943|NCT03643796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589520|NCT02057978|Chlorhexidine|chlorhexidine|mesh-list
93240944|NCT03643796|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93240945|NCT03643796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93240946|NCT03643796|Anesthetics, General|anesthetics, general|mesh-ancestor
93240947|NCT03643796|Anesthetics|anesthetics|mesh-ancestor
93240948|NCT03643796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93240949|NCT03643796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93240950|NCT03643796|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93240951|NCT03643796|Narcotics|narcotics|mesh-ancestor
93240952|NCT03623854|Nivolumab|nivolumab|mesh-list
93240953|NCT03623854|Relatlimab|relatlimab|mesh-list
93240954|NCT03623854|Immunoglobulins|immunoglobulins|mesh-list
93240955|NCT03623854|Immunoglobulin G|immunoglobulin g|mesh-list
92535652|NCT00077428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93240956|NCT03623854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240957|NCT03623854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912949|NCT05758116|Tislelizumab|tislelizumab|mesh-list
93240958|NCT03623854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93240959|NCT03623854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240960|NCT03623854|Immunologic Factors|immunologic factors|mesh-ancestor
93240961|NCT03623854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240962|NCT03584334|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93240963|NCT03584334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93240964|NCT03584334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240965|NCT03530215|Antineoplastic Agents|antineoplastic agents|mesh-list
93240966|NCT03530215|Immunomodulating Agents|immunomodulating agents|mesh-list
93240967|NCT03530215|Immunologic Factors|immunologic factors|mesh-ancestor
92535664|NCT04551482|Oxytocics|oxytocics|mesh-ancestor
93240968|NCT03530215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240969|NCT03475277|Ketamine|ketamine|mesh-list
93240970|NCT03475277|Analgesics|analgesics|mesh-ancestor
93240971|NCT03475277|Sensory System Agents|sensory system agents|mesh-ancestor
93240972|NCT03475277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93240973|NCT03475277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93240974|NCT03475277|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93240975|NCT03475277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93240976|NCT03475277|Anesthetics, General|anesthetics, general|mesh-ancestor
93240977|NCT03475277|Anesthetics|anesthetics|mesh-ancestor
93240978|NCT03475277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93240979|NCT03475277|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92535675|NCT00077779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93240980|NCT03475277|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93240981|NCT03475277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93240982|NCT03475277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240983|NCT03472274|Durvalumab|durvalumab|mesh-list
92535677|NCT00077818|Enoxaparin|enoxaparin|mesh-list
93240984|NCT03472274|Tremelimumab|tremelimumab|mesh-list
93240985|NCT03472274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93240986|NCT03472274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93240987|NCT03436433|Lacosamide|lacosamide|mesh-list
93240988|NCT03436433|Levetiracetam|levetiracetam|mesh-list
93240989|NCT03436433|Anticonvulsants|anticonvulsants|mesh-ancestor
93240990|NCT03436433|Nootropic Agents|nootropic agents|mesh-ancestor
93240991|NCT03436433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92535685|NCT00078130|Naloxone|naloxone|mesh-list
93240992|NCT03436433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93240993|NCT03436433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93240994|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93240995|NCT04227275|Cyclophosphamide|cyclophosphamide|mesh-list
93240996|NCT04227275|Fludarabine|fludarabine|mesh-list
93240997|NCT04227275|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93240998|NCT04227275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93240999|NCT04227275|Immunologic Factors|immunologic factors|mesh-ancestor
92535699|NCT04711213|BB 1101|bb 1101|mesh-list
93241000|NCT04227275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241001|NCT04227275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241002|NCT04227275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93241003|NCT04227275|Alkylating Agents|alkylating agents|mesh-ancestor
93241004|NCT04227275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591046|NCT04696042|Lanreotide|lanreotide|mesh-list
93241005|NCT04227275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241006|NCT04227275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93241007|NCT03415854|Paclitaxel|paclitaxel|mesh-list
93241008|NCT03415854|Cisplatin|cisplatin|mesh-list
93241009|NCT03415854|Gemcitabine|gemcitabine|mesh-list
93241010|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93241011|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241012|NCT03415854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241013|NCT03415854|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241014|NCT03415854|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241015|NCT03415854|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241016|NCT03415854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241017|NCT03415854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241018|NCT03415854|Antimetabolites|antimetabolites|mesh-ancestor
93241019|NCT03405090|Fentanyl|fentanyl|mesh-list
93241020|NCT03405090|Bronchodilator Agents|bronchodilator agents|mesh-list
93241021|NCT03405090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93241022|NCT03405090|Narcotics|narcotics|mesh-ancestor
92535719|NCT00078247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241023|NCT03405090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241024|NCT03405090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241025|NCT03405090|Analgesics|analgesics|mesh-ancestor
93241026|NCT03405090|Sensory System Agents|sensory system agents|mesh-ancestor
93241027|NCT03405090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241028|NCT03405090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93241029|NCT03405090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92913022|NCT00796432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241030|NCT03405090|Anesthetics, General|anesthetics, general|mesh-ancestor
93241031|NCT03405090|Anesthetics|anesthetics|mesh-ancestor
93241032|NCT03405090|Autonomic Agents|autonomic agents|mesh-ancestor
93241033|NCT03405090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93241034|NCT03405090|Respiratory System Agents|respiratory system agents|mesh-ancestor
93241035|NCT03284307|Midazolam|midazolam|mesh-list
93241036|NCT03284307|Dexmedetomidine|dexmedetomidine|mesh-list
93241037|NCT03284307|Ketamine|ketamine|mesh-list
93241038|NCT03284307|Propofol|propofol|mesh-list
93241039|NCT03284307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93241040|NCT03284307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241041|NCT03284307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241042|NCT03284307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241043|NCT03284307|Analgesics|analgesics|mesh-ancestor
93241044|NCT03284307|Sensory System Agents|sensory system agents|mesh-ancestor
93241045|NCT03284307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241046|NCT03284307|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93241047|NCT03284307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93241048|NCT03284307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93241049|NCT03284307|Adrenergic Agents|adrenergic agents|mesh-ancestor
93241050|NCT03284307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535744|NCT00078598|Immunologic Factors|immunologic factors|mesh-ancestor
93241051|NCT03284307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241052|NCT03284307|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93241053|NCT03284307|Anesthetics, General|anesthetics, general|mesh-ancestor
93241054|NCT03284307|Anesthetics|anesthetics|mesh-ancestor
93241055|NCT03284307|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93241056|NCT03284307|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93241057|NCT03284307|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93241058|NCT03284307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93241059|NCT03284307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93241060|NCT03284307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592307|NCT00333424|Vaccines|vaccines|mesh-list
93241061|NCT03284307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93241062|NCT03284307|GABA Modulators|gaba modulators|mesh-ancestor
93241063|NCT03284307|GABA Agents|gaba agents|mesh-ancestor
93241064|NCT03279289|Leucovorin|leucovorin|mesh-list
93241065|NCT03279289|Folic Acid|folic acid|mesh-list
93241066|NCT03279289|Fluorouracil|fluorouracil|mesh-list
93241067|NCT03279289|Irinotecan|irinotecan|mesh-list
93241068|NCT03279289|Aflibercept|aflibercept|mesh-list
93241069|NCT03279289|Levoleucovorin|levoleucovorin|mesh-list
93241070|NCT03279289|Antimetabolites|antimetabolites|mesh-ancestor
93241071|NCT03279289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241072|NCT03279289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592513|NCT00089453|Dexamethasone|dexamethasone|mesh-list
93241073|NCT03279289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241074|NCT03279289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592593|NCT04715152|Dexamethasone|dexamethasone|mesh-list
93241075|NCT03279289|Immunologic Factors|immunologic factors|mesh-ancestor
93241076|NCT03279289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241077|NCT03279289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93241078|NCT03279289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241079|NCT03279289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535770|NCT01350128|Bromides|bromides|mesh-list
93241080|NCT03279289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93241081|NCT03279289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93241082|NCT03279289|Growth Substances|growth substances|mesh-ancestor
93241083|NCT03279289|Growth Inhibitors|growth inhibitors|mesh-ancestor
93241084|NCT03279289|Antidotes|antidotes|mesh-ancestor
93241085|NCT03279289|Protective Agents|protective agents|mesh-ancestor
93241086|NCT03279289|Vitamin B Complex|vitamin b complex|mesh-ancestor
93241087|NCT03279289|Vitamins|vitamins|mesh-ancestor
93241088|NCT03279289|Micronutrients|micronutrients|mesh-ancestor
93241089|NCT03279289|Hematinics|hematinics|mesh-ancestor
93241090|NCT03207867|Spartalizumab|spartalizumab|mesh-list
93241091|NCT03207867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93241092|NCT03207867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241093|NCT03207867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241094|NCT03207867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241095|NCT03186456|Aspirin|aspirin|mesh-list
93241096|NCT03186456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241097|NCT03186456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241098|NCT03186456|Analgesics|analgesics|mesh-ancestor
93241099|NCT03186456|Sensory System Agents|sensory system agents|mesh-ancestor
93241100|NCT03186456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241101|NCT03186456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241102|NCT03186456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241103|NCT03186456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241104|NCT03186456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93241105|NCT03186456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913098|NCT02619773|Mupirocin|mupirocin|mesh-list
93241106|NCT03186456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241107|NCT03186456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93241108|NCT03186456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93241109|NCT03186456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241110|NCT03186456|Antipyretics|antipyretics|mesh-ancestor
93241111|NCT03184935|Decitabine|decitabine|mesh-list
93241112|NCT03184935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241113|NCT03184935|Antimetabolites|antimetabolites|mesh-ancestor
93241114|NCT03184935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241115|NCT03184935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241116|NCT03184935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241117|NCT03176498|Aspirin|aspirin|mesh-list
93241118|NCT03176498|Atorvastatin|atorvastatin|mesh-list
93241119|NCT03176498|Calcium|calcium|mesh-list
93241120|NCT03176498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93241121|NCT03176498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535813|NCT00078988|Alkylating Agents|alkylating agents|mesh-ancestor
93241122|NCT03176498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241123|NCT03176498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241124|NCT03176498|Analgesics|analgesics|mesh-ancestor
93241125|NCT03176498|Sensory System Agents|sensory system agents|mesh-ancestor
93241126|NCT03176498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241127|NCT03176498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241128|NCT03176498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241129|NCT03176498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93241130|NCT03176498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92593590|NCT00347581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241131|NCT03176498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241132|NCT03176498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92535823|NCT00079027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241133|NCT03176498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93241134|NCT03176498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241135|NCT03176498|Antipyretics|antipyretics|mesh-ancestor
93241136|NCT03176498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93241137|NCT03176498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93241138|NCT03176498|Antimetabolites|antimetabolites|mesh-ancestor
93241139|NCT03176498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93241140|NCT03176498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93241141|NCT03126591|Pembrolizumab|pembrolizumab|mesh-list
93241142|NCT03126591|Olaratumab|olaratumab|mesh-list
93241143|NCT03126591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241144|NCT03126591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241145|NCT03126591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93241146|NCT03126591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241147|NCT03122197|Letrozole|letrozole|mesh-list
93241148|NCT03122197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241149|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93241150|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93241151|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241152|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241153|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93241154|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
93241155|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241156|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241157|NCT03085004|Ethanol|ethanol|mesh-list
93241158|NCT03085004|Paclitaxel|paclitaxel|mesh-list
93241159|NCT03085004|Gemcitabine|gemcitabine|mesh-list
93241160|NCT03085004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241161|NCT03085004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241162|NCT03085004|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241163|NCT03085004|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241164|NCT03085004|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241165|NCT03085004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241166|NCT03085004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241167|NCT03085004|Antimetabolites|antimetabolites|mesh-ancestor
93241168|NCT03085004|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93241169|NCT03085004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241170|NCT03085004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241171|NCT03085004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241172|NCT03059862|Tryptophan|tryptophan|mesh-list
93241173|NCT03059862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93241174|NCT03059862|Antidepressive Agents|antidepressive agents|mesh-ancestor
93241175|NCT03059862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93241176|NCT03015844|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93241177|NCT03015844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241178|NCT03015844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241179|NCT03015844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241180|NCT03015844|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93241181|NCT02949284|Prednisone|prednisone|mesh-list
93241182|NCT02949284|Cortisone|cortisone|mesh-list
93241183|NCT02949284|Abiraterone Acetate|abiraterone acetate|mesh-list
93241184|NCT02949284|Hormones|hormones|mesh-list
93241185|NCT02949284|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93241186|NCT02949284|Androgens|androgens|mesh-list
93241187|NCT02949284|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
93241188|NCT02949284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241189|NCT02949284|Glucocorticoids|glucocorticoids|mesh-ancestor
93241190|NCT02949284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241191|NCT02949284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241192|NCT02949284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93241193|NCT02949284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241194|NCT02949284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93241195|NCT02949284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241196|NCT02949284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241197|NCT02949284|Hormone Antagonists|hormone antagonists|mesh-ancestor
93241198|NCT02949284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93241199|NCT02949284|Androgen Antagonists|androgen antagonists|mesh-ancestor
93241200|NCT02916862|Calcium, Dietary|calcium, dietary|mesh-list
93241201|NCT02916862|Calcium|calcium|mesh-list
93241202|NCT02916862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93241203|NCT02916862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241204|NCT02916862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93241205|NCT02891447|Cisplatin|cisplatin|mesh-list
93241206|NCT02891447|Mitomycins|mitomycins|mesh-list
93241207|NCT02891447|Mitomycin|mitomycin|mesh-list
93241208|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241209|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93241210|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
93241211|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241212|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93241213|NCT02891447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241214|NCT02867761|Glycopyrrolate|glycopyrrolate|mesh-list
93241215|NCT02867761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93241216|NCT02867761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93241217|NCT02867761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93241218|NCT02867761|Cholinergic Agents|cholinergic agents|mesh-ancestor
93241219|NCT02867761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93241220|NCT02867761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241221|NCT02867761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241222|NCT02754726|Paclitaxel|paclitaxel|mesh-list
93241223|NCT02754726|Gemcitabine|gemcitabine|mesh-list
93241224|NCT02754726|Nivolumab|nivolumab|mesh-list
93241225|NCT02754726|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92594506|NCT00095654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93241226|NCT02754726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241227|NCT02754726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241228|NCT02754726|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241229|NCT02754726|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241230|NCT02754726|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241231|NCT02754726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241232|NCT02754726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241233|NCT02754726|Antimetabolites|antimetabolites|mesh-ancestor
93241234|NCT02754726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241235|NCT02754726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93241236|NCT02680626|Magnesium Sulfate|magnesium sulfate|mesh-list
93241237|NCT02680626|Ropivacaine|ropivacaine|mesh-list
93241238|NCT02680626|Anesthetics, Local|anesthetics, local|mesh-ancestor
93241239|NCT02680626|Anesthetics|anesthetics|mesh-ancestor
92535924|NCT00079261|Hormones|hormones|mesh-ancestor
93241240|NCT02680626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241241|NCT02680626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241242|NCT02680626|Sensory System Agents|sensory system agents|mesh-ancestor
93241243|NCT02680626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241244|NCT02680626|Analgesics|analgesics|mesh-ancestor
93241245|NCT02680626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93241246|NCT02680626|Anticonvulsants|anticonvulsants|mesh-ancestor
93241247|NCT02680626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93241248|NCT02680626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93241249|NCT02680626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241250|NCT02680626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93241251|NCT02680626|Tocolytic Agents|tocolytic agents|mesh-ancestor
93241252|NCT02680626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93241253|NCT02494583|Pembrolizumab|pembrolizumab|mesh-list
93241254|NCT02494583|Capecitabine|capecitabine|mesh-list
93241255|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241256|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241257|NCT02494583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92535939|NCT00079378|Valproic Acid|valproic acid|mesh-list
93241258|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241259|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241261|NCT02473042|Promethazine|promethazine|mesh-list
93241262|NCT02473042|Dexamethasone|dexamethasone|mesh-list
93241263|NCT02473042|Ondansetron|ondansetron|mesh-list
93241264|NCT02473042|Famotidine|famotidine|mesh-list
93241265|NCT02473042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241266|NCT02473042|Antiemetics|antiemetics|mesh-ancestor
93241267|NCT02473042|Autonomic Agents|autonomic agents|mesh-ancestor
93241268|NCT02473042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241269|NCT02473042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241270|NCT02473042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93241271|NCT02473042|Glucocorticoids|glucocorticoids|mesh-ancestor
93241272|NCT02473042|Hormones|hormones|mesh-ancestor
93241273|NCT02473042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241274|NCT02473042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93241275|NCT02473042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241276|NCT02473042|Antipruritics|antipruritics|mesh-ancestor
93241277|NCT02473042|Dermatologic Agents|dermatologic agents|mesh-ancestor
93241278|NCT02473042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93241279|NCT02473042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92535967|NCT04467086|Propranolol|propranolol|mesh-list
93241280|NCT02473042|Serotonin Agents|serotonin agents|mesh-ancestor
93241281|NCT02473042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93241282|NCT02473042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241283|NCT02473042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93241284|NCT02473042|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93241285|NCT02473042|Histamine Antagonists|histamine antagonists|mesh-ancestor
93241286|NCT02473042|Histamine Agents|histamine agents|mesh-ancestor
93241287|NCT02473042|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93241288|NCT02473042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93241289|NCT02359331|Amoxicillin|amoxicillin|mesh-list
93241290|NCT02359331|Moxifloxacin|moxifloxacin|mesh-list
93241291|NCT02359331|Metronidazole|metronidazole|mesh-list
93241292|NCT02359331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93241293|NCT02359331|Tetracycline|tetracycline|mesh-list
93241294|NCT02359331|Anti-Infective Agents|anti-infective agents|mesh-list
93241295|NCT02359331|Bismuth|bismuth|mesh-list
93241296|NCT02359331|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93241297|NCT02359331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93241298|NCT02359331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241299|NCT02359331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241300|NCT02359331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241301|NCT02359331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241302|NCT02359331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93241303|NCT02359331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93241304|NCT02359331|Antacids|antacids|mesh-ancestor
93241305|NCT02359331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93241306|NCT02359331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93241307|NCT02322814|Paclitaxel|paclitaxel|mesh-list
93241308|NCT02322814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93241309|NCT02322814|Atezolizumab|atezolizumab|mesh-list
93241310|NCT02322814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241311|NCT02322814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241312|NCT02322814|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241313|NCT02322814|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241314|NCT02322814|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241315|NCT02322814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241316|NCT02322814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93241317|NCT02322814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241318|NCT02057133|Tamoxifen|tamoxifen|mesh-list
93241319|NCT02057133|Trastuzumab|trastuzumab|mesh-list
93241320|NCT02057133|Pertuzumab|pertuzumab|mesh-list
93241321|NCT02057133|Everolimus|everolimus|mesh-list
93241322|NCT02057133|Letrozole|letrozole|mesh-list
93241323|NCT02057133|Fulvestrant|fulvestrant|mesh-list
93241324|NCT02057133|Anastrozole|anastrozole|mesh-list
93241325|NCT02057133|Exemestane|exemestane|mesh-list
93241326|NCT02057133|Loperamide|loperamide|mesh-list
93241327|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241328|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241329|NCT02057133|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93241330|NCT02057133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93241331|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241332|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241333|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241334|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
93241335|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241336|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93241337|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93241338|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93241339|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
93241340|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241341|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93241342|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93241343|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93241344|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93241345|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93241346|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
93241347|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93241348|NCT01894308|Testosterone|testosterone|mesh-list
93241349|NCT01894308|Androgens|androgens|mesh-ancestor
93241350|NCT01894308|Hormones|hormones|mesh-ancestor
93241351|NCT01894308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241352|NCT01894308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241353|NCT01837862|Mebendazole|mebendazole|mesh-list
93241354|NCT01837862|Piperazine|piperazine|mesh-list
93241355|NCT01837862|Piperazine citrate|piperazine citrate|mesh-list
93241356|NCT01837862|Bevacizumab|bevacizumab|mesh-list
93241357|NCT01837862|Carboplatin|carboplatin|mesh-list
93241358|NCT01837862|Irinotecan|irinotecan|mesh-list
93241359|NCT01837862|Vincristine|vincristine|mesh-list
93241360|NCT01837862|Temozolomide|temozolomide|mesh-list
93241361|NCT01837862|DMP 777|dmp 777|mesh-list
93241362|NCT01837862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241363|NCT01837862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241364|NCT01837862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93241365|NCT01837862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93241366|NCT01837862|Growth Substances|growth substances|mesh-ancestor
93241367|NCT01837862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241368|NCT01837862|Growth Inhibitors|growth inhibitors|mesh-ancestor
93241369|NCT01837862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93241370|NCT01837862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241371|NCT01837862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241372|NCT01837862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241373|NCT01837862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241374|NCT01837862|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241375|NCT01837862|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241376|NCT01837862|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241377|NCT01837862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93241378|NCT01837862|Alkylating Agents|alkylating agents|mesh-ancestor
93241379|NCT01837862|Antinematodal Agents|antinematodal agents|mesh-ancestor
93241380|NCT01837862|Anthelmintics|anthelmintics|mesh-ancestor
93241381|NCT01837862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93241382|NCT01837862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241383|NCT01675219|Mitomycins|mitomycins|mesh-list
93241384|NCT01675219|Mitomycin|mitomycin|mesh-list
93241385|NCT01675219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93241386|NCT01675219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241387|NCT01675219|Alkylating Agents|alkylating agents|mesh-ancestor
93241388|NCT01675219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241389|NCT01675219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93241390|NCT01675219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241391|NCT01590069|Aldesleukin|aldesleukin|mesh-list
93241392|NCT01590069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241393|NCT01590069|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93241394|NCT01590069|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93241395|NCT01590069|Antiviral Agents|antiviral agents|mesh-ancestor
93241396|NCT01590069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241397|NCT01529593|Metformin|metformin|mesh-list
93241398|NCT01529593|Sirolimus|sirolimus|mesh-list
93241399|NCT01529593|Temsirolimus|temsirolimus|mesh-list
93241400|NCT01529593|MTOR Inhibitors|mtor inhibitors|mesh-list
93241401|NCT01529593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93241402|NCT01529593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241403|NCT01529593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93241404|NCT01529593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241405|NCT01529593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241406|NCT01529593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241407|NCT01529593|Immunologic Factors|immunologic factors|mesh-ancestor
93241408|NCT01529593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241409|NCT01529593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93241410|NCT01529593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241411|NCT01529593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93241412|NCT01529593|Antifungal Agents|antifungal agents|mesh-ancestor
93241413|NCT01446133|Rituximab|rituximab|mesh-list
93241414|NCT01446133|Lenalidomide|lenalidomide|mesh-list
93241415|NCT01446133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241416|NCT01446133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241417|NCT01446133|Immunologic Factors|immunologic factors|mesh-ancestor
93241418|NCT01446133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241419|NCT01446133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241420|NCT01446133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93241421|NCT01446133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93241422|NCT01446133|Growth Substances|growth substances|mesh-ancestor
93241423|NCT01446133|Growth Inhibitors|growth inhibitors|mesh-ancestor
93241424|NCT01424982|Cytarabine|cytarabine|mesh-list
93241425|NCT01424982|Dexamethasone|dexamethasone|mesh-list
93241426|NCT01424982|Prednisone|prednisone|mesh-list
93241427|NCT01424982|Dexamethasone acetate|dexamethasone acetate|mesh-list
93241428|NCT01424982|Cortisone|cortisone|mesh-list
93241429|NCT01424982|Cyclophosphamide|cyclophosphamide|mesh-list
93241430|NCT01424982|Rituximab|rituximab|mesh-list
93241431|NCT01424982|Doxorubicin|doxorubicin|mesh-list
93241432|NCT01424982|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93241433|NCT01424982|Methotrexate|methotrexate|mesh-list
93241434|NCT01424982|Vincristine|vincristine|mesh-list
93241435|NCT01424982|Daunorubicin|daunorubicin|mesh-list
93241436|NCT01424982|Ponatinib|ponatinib|mesh-list
93241437|NCT01424982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93241438|NCT01424982|Antibodies|antibodies|mesh-list
93241439|NCT01424982|Immunoglobulins|immunoglobulins|mesh-list
93241440|NCT01424982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93241441|NCT01424982|BB 1101|bb 1101|mesh-list
93241442|NCT01424982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241443|NCT01424982|Immunologic Factors|immunologic factors|mesh-ancestor
93241444|NCT01424982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241445|NCT01424982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241446|NCT01424982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93241447|NCT01424982|Alkylating Agents|alkylating agents|mesh-ancestor
93241448|NCT01424982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241449|NCT01424982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241450|NCT01424982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93241451|NCT01424982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241452|NCT01424982|Antiemetics|antiemetics|mesh-ancestor
93241453|NCT01424982|Autonomic Agents|autonomic agents|mesh-ancestor
93241454|NCT01424982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241455|NCT01424982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93241456|NCT01424982|Glucocorticoids|glucocorticoids|mesh-ancestor
93241457|NCT01424982|Hormones|hormones|mesh-ancestor
91942020|NCT05627232|Promethazine|promethazine|mesh-list
93241458|NCT01424982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241459|NCT01424982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93241460|NCT01424982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93241461|NCT01424982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93241462|NCT01424982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241463|NCT01424982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241464|NCT01424982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93241465|NCT01424982|Abortifacient Agents|abortifacient agents|mesh-ancestor
93241466|NCT01424982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93241467|NCT01424982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241468|NCT01424982|Antimetabolites|antimetabolites|mesh-ancestor
93241469|NCT01424982|Dermatologic Agents|dermatologic agents|mesh-ancestor
93241470|NCT01424982|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92536140|NCT00080314|Dopamine Agents|dopamine agents|mesh-ancestor
93241471|NCT01424982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93241472|NCT01424982|Antiviral Agents|antiviral agents|mesh-ancestor
93241473|NCT01424982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241474|NCT01424982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241475|NCT01424982|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241476|NCT01424982|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241477|NCT01424982|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241478|NCT01424982|Protease Inhibitors|protease inhibitors|mesh-ancestor
93241479|NCT01424982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93241480|NCT01333033|Leucovorin|leucovorin|mesh-list
93241481|NCT01333033|Paclitaxel|paclitaxel|mesh-list
93241482|NCT01333033|Carboplatin|carboplatin|mesh-list
93241483|NCT01333033|Fluorouracil|fluorouracil|mesh-list
93241484|NCT01333033|Oxaliplatin|oxaliplatin|mesh-list
93241485|NCT01333033|Calcium|calcium|mesh-list
93241486|NCT01333033|Levoleucovorin|levoleucovorin|mesh-list
93241487|NCT01333033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241488|NCT01333033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241489|NCT01333033|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241490|NCT01333033|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241491|NCT01333033|Mitosis Modulators|mitosis modulators|mesh-ancestor
93366394|NCT02796755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241492|NCT01333033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241493|NCT01333033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93241494|NCT01333033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241495|NCT01333033|Antimetabolites|antimetabolites|mesh-ancestor
93241496|NCT01333033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241497|NCT01333033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241498|NCT01333033|Immunologic Factors|immunologic factors|mesh-ancestor
93241499|NCT01333033|Antidotes|antidotes|mesh-ancestor
93241500|NCT01333033|Protective Agents|protective agents|mesh-ancestor
93241501|NCT01333033|Vitamin B Complex|vitamin b complex|mesh-ancestor
93241502|NCT01333033|Vitamins|vitamins|mesh-ancestor
93241503|NCT01333033|Micronutrients|micronutrients|mesh-ancestor
93241504|NCT01187199|Sirolimus|sirolimus|mesh-list
93241505|NCT01187199|Paclitaxel|paclitaxel|mesh-list
93241506|NCT01187199|Bevacizumab|bevacizumab|mesh-list
93241507|NCT01187199|Carboplatin|carboplatin|mesh-list
93241508|NCT01187199|Sorafenib|sorafenib|mesh-list
93241509|NCT01187199|Temsirolimus|temsirolimus|mesh-list
93241510|NCT01187199|MTOR Inhibitors|mtor inhibitors|mesh-list
93241511|NCT01187199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93241512|NCT01187199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241513|NCT01187199|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241514|NCT01187199|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241515|NCT01187199|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241516|NCT01187199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241517|NCT01187199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241518|NCT01187199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93241519|NCT01187199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93241520|NCT01187199|Growth Substances|growth substances|mesh-ancestor
93241521|NCT01187199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241522|NCT01187199|Growth Inhibitors|growth inhibitors|mesh-ancestor
93241523|NCT01187199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93241524|NCT01187199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241525|NCT01187199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241526|NCT01187199|Immunologic Factors|immunologic factors|mesh-ancestor
93241527|NCT01187199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93241528|NCT01187199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241529|NCT01187199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93241530|NCT01187199|Antifungal Agents|antifungal agents|mesh-ancestor
93241531|NCT00778063|Dexmedetomidine|dexmedetomidine|mesh-list
93241532|NCT00778063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93241533|NCT00778063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241534|NCT00778063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241535|NCT00778063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241536|NCT00778063|Analgesics|analgesics|mesh-ancestor
93241537|NCT00778063|Sensory System Agents|sensory system agents|mesh-ancestor
93241538|NCT00778063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241539|NCT00778063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93241540|NCT00778063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93241541|NCT00778063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93241542|NCT00778063|Adrenergic Agents|adrenergic agents|mesh-ancestor
93241543|NCT00778063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93241544|NCT00778063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241545|NCT00547196|Cyclosporine|cyclosporine|mesh-list
93241546|NCT00547196|Mycophenolic Acid|mycophenolic acid|mesh-list
93241547|NCT00547196|Cyclophosphamide|cyclophosphamide|mesh-list
93241548|NCT00547196|Melphalan|melphalan|mesh-list
93241549|NCT00547196|Busulfan|busulfan|mesh-list
93241550|NCT00547196|Fludarabine|fludarabine|mesh-list
93241551|NCT00547196|Fludarabine phosphate|fludarabine phosphate|mesh-list
93241552|NCT00547196|Cyclosporins|cyclosporins|mesh-list
93241553|NCT00547196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241554|NCT00547196|Immunologic Factors|immunologic factors|mesh-ancestor
93241555|NCT00547196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241556|NCT00547196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241557|NCT00547196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92536187|NCT00080665|Docetaxel|docetaxel|mesh-list
93241558|NCT00547196|Alkylating Agents|alkylating agents|mesh-ancestor
93241559|NCT00547196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241560|NCT00547196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241561|NCT00547196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93241562|NCT00547196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241563|NCT00547196|Antimetabolites|antimetabolites|mesh-ancestor
93241564|NCT00547196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241565|NCT00547196|Antifungal Agents|antifungal agents|mesh-ancestor
93241566|NCT00547196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241567|NCT00547196|Dermatologic Agents|dermatologic agents|mesh-ancestor
93241568|NCT00547196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93241570|NCT00547196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93241571|NCT00547196|Antitubercular Agents|antitubercular agents|mesh-ancestor
93241572|NCT00547196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93241573|NCT00330941|Lidocaine|lidocaine|mesh-list
93241574|NCT00330941|Anesthetics, Local|anesthetics, local|mesh-ancestor
93241575|NCT00330941|Anesthetics|anesthetics|mesh-ancestor
93241576|NCT00330941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241577|NCT00330941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241578|NCT00330941|Sensory System Agents|sensory system agents|mesh-ancestor
93241579|NCT00330941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241580|NCT00330941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93241581|NCT00330941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93241582|NCT00330941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93241583|NCT00330941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93241584|NCT00330941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241585|NCT03149107|Acetylcysteine|acetylcysteine|mesh-list
93241586|NCT03149107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92536253|NCT00081055|Busulfan|busulfan|mesh-list
93241587|NCT03149107|Antiviral Agents|antiviral agents|mesh-ancestor
93241588|NCT03149107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241589|NCT03149107|Expectorants|expectorants|mesh-ancestor
93241590|NCT03149107|Respiratory System Agents|respiratory system agents|mesh-ancestor
93241591|NCT03149107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93241592|NCT03149107|Antioxidants|antioxidants|mesh-ancestor
93241593|NCT03149107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241594|NCT03149107|Protective Agents|protective agents|mesh-ancestor
93241595|NCT03149107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241596|NCT03149107|Antidotes|antidotes|mesh-ancestor
93241597|NCT03135301|Metformin|metformin|mesh-list
93241598|NCT03135301|Letrozole|letrozole|mesh-list
93241599|NCT03135301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93241600|NCT03135301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241601|NCT03135301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241602|NCT03135301|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93241603|NCT03135301|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93241604|NCT03135301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241605|NCT03135301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241606|NCT03135301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93241607|NCT03135301|Hormone Antagonists|hormone antagonists|mesh-ancestor
93241608|NCT03135301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241609|NCT03602898|Cyclosporine|cyclosporine|mesh-list
93241610|NCT03602898|Cyclophosphamide|cyclophosphamide|mesh-list
93241611|NCT03602898|Busulfan|busulfan|mesh-list
93241612|NCT03602898|Methotrexate|methotrexate|mesh-list
93241613|NCT03602898|Fludarabine|fludarabine|mesh-list
93241614|NCT03602898|Fludarabine phosphate|fludarabine phosphate|mesh-list
93241615|NCT03602898|Tacrolimus|tacrolimus|mesh-list
93241616|NCT03602898|Cyclosporins|cyclosporins|mesh-list
93241617|NCT03602898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93241618|NCT03602898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241619|NCT03602898|Immunologic Factors|immunologic factors|mesh-ancestor
93241620|NCT03602898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241621|NCT03602898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536280|NCT00081133|Imatinib Mesylate|imatinib mesylate|mesh-list
93241622|NCT03602898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93241623|NCT03602898|Alkylating Agents|alkylating agents|mesh-ancestor
93241624|NCT03602898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241625|NCT03602898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241626|NCT03602898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93241627|NCT03602898|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93241628|NCT03602898|Abortifacient Agents|abortifacient agents|mesh-ancestor
93241629|NCT03602898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93241630|NCT03602898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241631|NCT03602898|Antimetabolites|antimetabolites|mesh-ancestor
93241632|NCT03602898|Dermatologic Agents|dermatologic agents|mesh-ancestor
93241633|NCT03602898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241634|NCT03602898|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93241635|NCT03602898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93241636|NCT03602898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93241637|NCT03602898|Antifungal Agents|antifungal agents|mesh-ancestor
93241638|NCT03602898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241639|NCT02983747|Loxoprofen|loxoprofen|mesh-list
93241640|NCT02983747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241641|NCT02983747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241642|NCT02983747|Analgesics|analgesics|mesh-ancestor
93241643|NCT02983747|Sensory System Agents|sensory system agents|mesh-ancestor
93241644|NCT02983747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241645|NCT02983747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241646|NCT02983747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241648|NCT05759845|Topiramate|topiramate|mesh-list
93241649|NCT05759845|Amitriptyline|amitriptyline|mesh-list
93241650|NCT05759845|Anticonvulsants|anticonvulsants|mesh-ancestor
93241651|NCT05759845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93241652|NCT05759845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241653|NCT05759845|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93241654|NCT05759845|Antidepressive Agents|antidepressive agents|mesh-ancestor
93241655|NCT05759845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93241656|NCT05759845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241657|NCT05759845|Analgesics|analgesics|mesh-ancestor
93241658|NCT05759845|Sensory System Agents|sensory system agents|mesh-ancestor
93241659|NCT05759845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241660|NCT05759845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93241661|NCT05759845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93241662|NCT05759845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93241663|NCT05759845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241664|NCT05759845|Adrenergic Agents|adrenergic agents|mesh-ancestor
93241665|NCT05759845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93241666|NCT03931291|Azacitidine|azacitidine|mesh-list
93241667|NCT03931291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241668|NCT03931291|Antimetabolites|antimetabolites|mesh-ancestor
93241669|NCT03931291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241670|NCT03931291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241671|NCT03931291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241672|NCT00799110|Imiquimod|imiquimod|mesh-list
93241673|NCT00799110|Vaccines|vaccines|mesh-list
93241674|NCT00799110|Immunologic Factors|immunologic factors|mesh-ancestor
93241675|NCT00799110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241676|NCT00799110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93241677|NCT00799110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241678|NCT00799110|Interferon Inducers|interferon inducers|mesh-ancestor
93241679|NCT05199727|Tadalafil|tadalafil|mesh-list
93241680|NCT05199727|Vasodilator Agents|vasodilator agents|mesh-ancestor
93241681|NCT05199727|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93241682|NCT05199727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93241683|NCT05199727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241684|NCT05199727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241685|NCT05199727|Urological Agents|urological agents|mesh-ancestor
93241686|NCT02132234|Adalimumab|adalimumab|mesh-list
93241687|NCT02132234|Infliximab|infliximab|mesh-list
93241688|NCT02132234|Certolizumab Pegol|certolizumab pegol|mesh-list
93241689|NCT02132234|Etanercept|etanercept|mesh-list
93241690|NCT02132234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93241691|NCT02132234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241692|NCT02132234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241693|NCT02132234|Dermatologic Agents|dermatologic agents|mesh-ancestor
93241694|NCT02132234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596016|NCT04728386|Curcumin|curcumin|mesh-list
93241695|NCT02132234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241696|NCT02132234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241697|NCT02132234|Analgesics|analgesics|mesh-ancestor
93241698|NCT02132234|Sensory System Agents|sensory system agents|mesh-ancestor
93241699|NCT02132234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241700|NCT02132234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241701|NCT02132234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241702|NCT02132234|Immunologic Factors|immunologic factors|mesh-ancestor
93241703|NCT02132390|Toremifene|toremifene|mesh-list
93241704|NCT02132390|Goserelin|goserelin|mesh-list
93241705|NCT02132390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93241706|NCT02132390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241707|NCT02132390|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93241708|NCT02132390|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93241709|NCT02132390|Hormone Antagonists|hormone antagonists|mesh-ancestor
93241710|NCT02132390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241711|NCT02132390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241712|NCT02132390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93241713|NCT02128646|Ketorolac|ketorolac|mesh-list
93241714|NCT02128646|Bupivacaine|bupivacaine|mesh-list
93241715|NCT02128646|Anesthetics, Local|anesthetics, local|mesh-ancestor
93241716|NCT02128646|Anesthetics|anesthetics|mesh-ancestor
93241717|NCT02128646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241718|NCT02128646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241719|NCT02128646|Sensory System Agents|sensory system agents|mesh-ancestor
93241720|NCT02128646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241721|NCT02128646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241722|NCT02128646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241723|NCT02128646|Analgesics|analgesics|mesh-ancestor
93241724|NCT02128646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241725|NCT02128646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241726|NCT02128646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93241727|NCT02128646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241728|NCT02128646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241729|NCT05199103|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93241730|NCT05199103|Thymoglobulin|thymoglobulin|mesh-list
93241731|NCT05199103|Immunologic Factors|immunologic factors|mesh-ancestor
93241732|NCT05199103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241733|NCT05199103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241734|NCT02132546|Chlorhexidine|chlorhexidine|mesh-list
93241735|NCT02132546|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93241736|NCT02132546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241737|NCT02132546|Disinfectants|disinfectants|mesh-ancestor
93241738|NCT05198947|Ivermectin|ivermectin|mesh-list
93241739|NCT05198947|Permethrin|permethrin|mesh-list
93241740|NCT05198947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93241741|NCT05198947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241742|NCT05198947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241743|NCT05198947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241744|NCT01367834|Hormones|hormones|mesh-list
93241745|NCT01367834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93241746|NCT01367834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241747|NCT03106753|Bupivacaine|bupivacaine|mesh-list
93241748|NCT03106753|Terbutaline|terbutaline|mesh-list
93241749|NCT03106753|Anesthetics, Local|anesthetics, local|mesh-ancestor
93241750|NCT03106753|Anesthetics|anesthetics|mesh-ancestor
93241751|NCT03106753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241752|NCT03106753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241753|NCT03106753|Sensory System Agents|sensory system agents|mesh-ancestor
93241754|NCT03106753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241755|NCT03106753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93241756|NCT03106753|Autonomic Agents|autonomic agents|mesh-ancestor
93241757|NCT03106753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93241758|NCT03106753|Respiratory System Agents|respiratory system agents|mesh-ancestor
93241759|NCT03106753|Sympathomimetics|sympathomimetics|mesh-ancestor
93241760|NCT03106753|Tocolytic Agents|tocolytic agents|mesh-ancestor
93241761|NCT03106753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93241762|NCT03106753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93241763|NCT03106753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93241764|NCT03106753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93241765|NCT03106753|Adrenergic Agents|adrenergic agents|mesh-ancestor
93241766|NCT03106753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93241767|NCT03106753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241768|NCT02133014|Fluorouracil|fluorouracil|mesh-list
93241769|NCT02133014|Antimetabolites|antimetabolites|mesh-ancestor
93241770|NCT02133014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241771|NCT02133014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241772|NCT02133014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241773|NCT02133014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241774|NCT02133014|Immunologic Factors|immunologic factors|mesh-ancestor
93241775|NCT02133014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241776|NCT05759455|Vitamin D|vitamin d|mesh-list
93241777|NCT05759455|Vitamins|vitamins|mesh-ancestor
93241778|NCT05759455|Micronutrients|micronutrients|mesh-ancestor
93241779|NCT05759455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241780|NCT05759455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93241781|NCT02129114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93241782|NCT02129114|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93241783|NCT02129114|Estradiol|estradiol|mesh-list
93241784|NCT02129114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93241785|NCT02129114|Estrogens|estrogens|mesh-ancestor
93241786|NCT02129114|Hormones|hormones|mesh-ancestor
93241787|NCT02129114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536468|NCT03151863|Analgesics|analgesics|mesh-ancestor
93241788|NCT02129114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241789|NCT02129114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93241790|NCT02129114|Contraceptive Agents|contraceptive agents|mesh-ancestor
93241791|NCT02129114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93241792|NCT02129114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92913773|NCT04031027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241794|NCT02136992|Analgesics|analgesics|mesh-ancestor
93241795|NCT02136992|Sensory System Agents|sensory system agents|mesh-ancestor
93241796|NCT02136992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241797|NCT02136992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241798|NCT02136992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241799|NCT02136992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943650|NCT00561743|Bortezomib|bortezomib|mesh-list
93241800|NCT02136992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241801|NCT02136992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241802|NCT02136992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241803|NCT02252978|Ciprofloxacin|ciprofloxacin|mesh-list
93241804|NCT02252978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93241805|NCT02252978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241806|NCT02252978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93241807|NCT02252978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241808|NCT02252978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241809|NCT02252978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241810|NCT02252978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241811|NCT02252978|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93241812|NCT02252978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93241813|NCT02129270|Lidocaine|lidocaine|mesh-list
92536493|NCT00083278|Ipilimumab|ipilimumab|mesh-list
93241814|NCT02129270|Anesthetics, Local|anesthetics, local|mesh-ancestor
93241815|NCT02129270|Anesthetics|anesthetics|mesh-ancestor
93241816|NCT02129270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241817|NCT02129270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241818|NCT02129270|Sensory System Agents|sensory system agents|mesh-ancestor
93241819|NCT02129270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241820|NCT02129270|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93241821|NCT02129270|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93241822|NCT02129270|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93241823|NCT02129270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93241824|NCT02129270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241825|NCT05370547|Cyclophosphamide|cyclophosphamide|mesh-list
93241826|NCT05370547|Fludarabine|fludarabine|mesh-list
93241827|NCT05370547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241828|NCT05370547|Immunologic Factors|immunologic factors|mesh-ancestor
93241829|NCT05370547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241830|NCT05370547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241831|NCT05370547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93241832|NCT05370547|Alkylating Agents|alkylating agents|mesh-ancestor
93241833|NCT05370547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241834|NCT05370547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241835|NCT05370547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93241836|NCT02133326|Acetaminophen|acetaminophen|mesh-list
93241837|NCT02133326|Ibuprofen|ibuprofen|mesh-list
93241838|NCT02133326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93241839|NCT02133326|Analgesics|analgesics|mesh-ancestor
93241840|NCT02133326|Sensory System Agents|sensory system agents|mesh-ancestor
93241841|NCT02133326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241842|NCT02133326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241843|NCT02133326|Antipyretics|antipyretics|mesh-ancestor
93241844|NCT02133326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93241845|NCT02133326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93241846|NCT02133326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241847|NCT02133326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93241848|NCT02133326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241849|NCT02133326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241850|NCT02137616|Olanzapine|olanzapine|mesh-list
93241851|NCT02137616|Risperidone|risperidone|mesh-list
93241852|NCT02137616|Aripiprazole|aripiprazole|mesh-list
93241853|NCT02137616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93241854|NCT02137616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93241855|NCT02137616|Serotonin Agents|serotonin agents|mesh-ancestor
93241856|NCT02137616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93241857|NCT02137616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241858|NCT02137616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241859|NCT02137616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93241860|NCT02137616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93241861|NCT02137616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241862|NCT02137616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93241863|NCT02137616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93241864|NCT02137616|Dopamine Agents|dopamine agents|mesh-ancestor
93241865|NCT02137616|Antiemetics|antiemetics|mesh-ancestor
93241866|NCT02137616|Autonomic Agents|autonomic agents|mesh-ancestor
93241867|NCT02137616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241869|NCT02137616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93241870|NCT02137616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93241871|NCT02137616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93241872|NCT02137616|Antidepressive Agents|antidepressive agents|mesh-ancestor
93241873|NCT02137616|Dopamine Agonists|dopamine agonists|mesh-ancestor
93241874|NCT02137616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93241875|NCT02137616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93241876|NCT02137616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93241877|NCT02137616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93241878|NCT02133638|Propofol|propofol|mesh-list
93241879|NCT02133638|Sevoflurane|sevoflurane|mesh-list
92597140|NCT00105326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93241880|NCT02133638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92322072|NCT00002030|Pentamidine|pentamidine|mesh-list
93241881|NCT02133638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241882|NCT02133638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241883|NCT02133638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93241884|NCT02133638|Anesthetics, General|anesthetics, general|mesh-ancestor
93241885|NCT02133638|Anesthetics|anesthetics|mesh-ancestor
93241886|NCT02133638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93241887|NCT02133638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93241888|NCT02545283|Cytarabine|cytarabine|mesh-list
93241889|NCT02545283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241890|NCT02545283|Antimetabolites|antimetabolites|mesh-ancestor
93241891|NCT02545283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241892|NCT02545283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241893|NCT02545283|Antiviral Agents|antiviral agents|mesh-ancestor
93241894|NCT02545283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241895|NCT02545283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241896|NCT02545283|Immunologic Factors|immunologic factors|mesh-ancestor
93241897|NCT02545283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241898|NCT02137928|Carboplatin|carboplatin|mesh-list
93241899|NCT02137928|Etoposide|etoposide|mesh-list
93241900|NCT02137928|Etoposide phosphate|etoposide phosphate|mesh-list
93241901|NCT02137928|Vincristine|vincristine|mesh-list
93241902|NCT02137928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241903|NCT02137928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92597486|NCT04702204|Denosumab|denosumab|mesh-list
93241904|NCT02137928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93241905|NCT02137928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241906|NCT02137928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536591|NCT05568082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93241907|NCT02137928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241908|NCT02137928|Tubulin Modulators|tubulin modulators|mesh-ancestor
93241909|NCT02137928|Antimitotic Agents|antimitotic agents|mesh-ancestor
93241910|NCT02137928|Mitosis Modulators|mitosis modulators|mesh-ancestor
93241911|NCT02138084|Ritonavir|ritonavir|mesh-list
93241912|NCT02138084|Fostemsavir|fostemsavir|mesh-list
93241913|NCT02138084|Rifabutin|rifabutin|mesh-list
93241914|NCT02138084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92536599|NCT05567653|Sulfalene|sulfalene|mesh-list
93241915|NCT02138084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93241916|NCT02138084|Protease Inhibitors|protease inhibitors|mesh-ancestor
93241917|NCT02138084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241918|NCT02138084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241919|NCT02138084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93241920|NCT02138084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92536605|NCT04733508|Exenatide|exenatide|mesh-list
93241921|NCT02138084|Antiviral Agents|antiviral agents|mesh-ancestor
93241922|NCT02138084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241923|NCT02138084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93241924|NCT02138084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93241925|NCT02138084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93241926|NCT02138084|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93241927|NCT02138084|Antitubercular Agents|antitubercular agents|mesh-ancestor
93241928|NCT02138084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93241929|NCT02138084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93241930|NCT02129582|Methotrexate|methotrexate|mesh-list
92536613|NCT00135304|Vitamin D|vitamin d|mesh-list
93241931|NCT02129582|Fludarabine phosphate|fludarabine phosphate|mesh-list
93241932|NCT02129582|Fludarabine|fludarabine|mesh-list
93241933|NCT02129582|Busulfan|busulfan|mesh-list
93241934|NCT02129582|Tacrolimus|tacrolimus|mesh-list
93241935|NCT02129582|Thymoglobulin|thymoglobulin|mesh-list
93241936|NCT02129582|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93241937|NCT02129582|Immunoglobulins|immunoglobulins|mesh-list
93241938|NCT02129582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93241939|NCT02129582|Abortifacient Agents|abortifacient agents|mesh-ancestor
93241940|NCT02129582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92536624|NCT00135499|Prednisone|prednisone|mesh-list
93241941|NCT02129582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241942|NCT02129582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93241943|NCT02129582|Antimetabolites|antimetabolites|mesh-ancestor
93241944|NCT02129582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241945|NCT02129582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241946|NCT02129582|Dermatologic Agents|dermatologic agents|mesh-ancestor
93241947|NCT02129582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241948|NCT02129582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93241949|NCT02129582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93241950|NCT02129582|Immunologic Factors|immunologic factors|mesh-ancestor
93241951|NCT02129582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93241952|NCT02129582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93241953|NCT02129582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93241954|NCT02129582|Alkylating Agents|alkylating agents|mesh-ancestor
93241955|NCT02129582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93241956|NCT02129582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93241957|NCT02138396|Fentanyl|fentanyl|mesh-list
93241958|NCT02138396|Naltrexone|naltrexone|mesh-list
93241959|NCT02138396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93241960|NCT02138396|Narcotics|narcotics|mesh-ancestor
93241961|NCT02138396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93241962|NCT02138396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241963|NCT02138396|Analgesics|analgesics|mesh-ancestor
93241964|NCT02138396|Sensory System Agents|sensory system agents|mesh-ancestor
92536644|NCT00135499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93241965|NCT02138396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93241966|NCT02138396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93241967|NCT02138396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93241968|NCT02138396|Anesthetics, General|anesthetics, general|mesh-ancestor
93241969|NCT02138396|Anesthetics|anesthetics|mesh-ancestor
93241970|NCT02138396|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93241971|NCT02138396|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93241972|NCT04560881|Vaccines|vaccines|mesh-list
93241973|NCT04560881|Immunologic Factors|immunologic factors|mesh-ancestor
93241974|NCT04560881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241975|NCT02828761|Calcium, Dietary|calcium, dietary|mesh-list
93241976|NCT02828761|Calcium|calcium|mesh-list
93241977|NCT02828761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93241978|NCT02828761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241979|NCT02828761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93241980|NCT02875613|Avelumab|avelumab|mesh-list
93241981|NCT02875613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93241982|NCT02875613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93241983|NCT02815267|Minocycline|minocycline|mesh-list
93241984|NCT02815267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93241985|NCT02815267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241986|NCT02130440|Resveratrol|resveratrol|mesh-list
93241987|NCT02130440|Antioxidants|antioxidants|mesh-ancestor
93241988|NCT02130440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93241989|NCT02130440|Protective Agents|protective agents|mesh-ancestor
93241990|NCT02130440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93241991|NCT02130440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93241992|NCT02130440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93241993|NCT02138552|Octenidine|octenidine|mesh-list
93241994|NCT02138552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93241995|NCT02138552|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93241996|NCT02930837|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93241997|NCT02930837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93241998|NCT02930837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93241999|NCT02930837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242000|NCT02138708|Adenosine|adenosine|mesh-list
93242001|NCT02138708|Acetylcholine|acetylcholine|mesh-list
93242002|NCT02138708|Analgesics|analgesics|mesh-ancestor
93242003|NCT02138708|Sensory System Agents|sensory system agents|mesh-ancestor
93242004|NCT02138708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242005|NCT02138708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242006|NCT02138708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93242007|NCT02138708|Vasodilator Agents|vasodilator agents|mesh-ancestor
93242008|NCT02138708|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93242009|NCT02138708|Purinergic Agonists|purinergic agonists|mesh-ancestor
93242010|NCT02138708|Purinergic Agents|purinergic agents|mesh-ancestor
93242011|NCT02138708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242012|NCT02138708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242013|NCT02138708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93242014|NCT02138708|Cholinergic Agents|cholinergic agents|mesh-ancestor
92913995|NCT04961190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242015|NCT03633175|Progesterone|progesterone|mesh-list
93242016|NCT03633175|Progestins|progestins|mesh-ancestor
93242017|NCT03633175|Hormones|hormones|mesh-ancestor
93242018|NCT03633175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242019|NCT03633175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242021|NCT02539693|Clonidine|clonidine|mesh-list
93242022|NCT02539693|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242023|NCT02539693|Anesthetics|anesthetics|mesh-ancestor
93242024|NCT02539693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242025|NCT02539693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242026|NCT02539693|Sensory System Agents|sensory system agents|mesh-ancestor
93242027|NCT02539693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242028|NCT02539693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93242029|NCT02539693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93242030|NCT02539693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93242031|NCT02539693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242032|NCT02539693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242033|NCT02539693|Analgesics|analgesics|mesh-ancestor
93242034|NCT02539693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93242035|NCT02539693|Sympatholytics|sympatholytics|mesh-ancestor
93242036|NCT02539693|Autonomic Agents|autonomic agents|mesh-ancestor
93242037|NCT02539693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93242038|NCT02539693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93242039|NCT02539693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93242040|NCT02539693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93242041|NCT02539693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242042|NCT05062135|Progesterone|progesterone|mesh-list
93242043|NCT05062135|Progestins|progestins|mesh-ancestor
93242044|NCT05062135|Hormones|hormones|mesh-ancestor
93242045|NCT05062135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536727|NCT00135967|Antiemetics|antiemetics|mesh-ancestor
93242046|NCT05062135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242047|NCT02130518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93242048|NCT02134106|Polymyxins|polymyxins|mesh-list
93242049|NCT02134106|Doripenem|doripenem|mesh-list
93242050|NCT02134106|Polymyxin B|polymyxin b|mesh-list
93242051|NCT02134106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242052|NCT02134106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242053|NCT01354301|Mycophenolic Acid|mycophenolic acid|mesh-list
93242054|NCT01354301|Everolimus|everolimus|mesh-list
93242055|NCT01354301|Tacrolimus|tacrolimus|mesh-list
93242056|NCT01354301|Thymoglobulin|thymoglobulin|mesh-list
93242057|NCT01354301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93242058|NCT01354301|Immunologic Factors|immunologic factors|mesh-ancestor
93242059|NCT01354301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242060|NCT01354301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93242061|NCT01354301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242062|NCT01354301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242063|NCT01354301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93242064|NCT01354301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242065|NCT01354301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242066|NCT01354301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92536745|NCT03151239|Niacinamide|niacinamide|mesh-list
93242067|NCT01354301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93242068|NCT01354301|Antitubercular Agents|antitubercular agents|mesh-ancestor
93242069|NCT01354301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242070|NCT01354301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242071|NCT02134262|Cyclophosphamide|cyclophosphamide|mesh-list
93242072|NCT02134262|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93242073|NCT02134262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536756|NCT00136474|Amifostine|amifostine|mesh-list
93242074|NCT02134262|Immunologic Factors|immunologic factors|mesh-ancestor
93242075|NCT02134262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242076|NCT02134262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242077|NCT02134262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93242078|NCT02134262|Alkylating Agents|alkylating agents|mesh-ancestor
93242079|NCT02134262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242080|NCT02134262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242081|NCT02134262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93242082|NCT01343277|Dacarbazine|dacarbazine|mesh-list
93242083|NCT01343277|Trabectedin|trabectedin|mesh-list
93242084|NCT01343277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93242085|NCT01343277|Alkylating Agents|alkylating agents|mesh-ancestor
93242086|NCT01343277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242087|NCT01343277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242088|NCT04856293|Crizotinib|crizotinib|mesh-list
93242089|NCT04856293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242090|NCT04856293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242091|NCT04856293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914071|NCT00837434|Adalimumab|adalimumab|mesh-list
93242092|NCT04856293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242094|NCT02253212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242095|NCT01355939|Zinc Oxide|zinc oxide|mesh-list
93242096|NCT01355939|Dermatologic Agents|dermatologic agents|mesh-ancestor
93242097|NCT01355939|Sunscreening Agents|sunscreening agents|mesh-ancestor
92536779|NCT00404053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93242098|NCT01355939|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93242099|NCT01355939|Protective Agents|protective agents|mesh-ancestor
93242100|NCT01355939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242101|NCT01356017|Amlodipine|amlodipine|mesh-list
93242102|NCT01356017|Telmisartan|telmisartan|mesh-list
93242103|NCT01356017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93242104|NCT01356017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93242105|NCT01356017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242106|NCT01356017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242107|NCT01356017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93242108|NCT01356017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242109|NCT01356017|Vasodilator Agents|vasodilator agents|mesh-ancestor
92536790|NCT00136747|Bupropion|bupropion|mesh-list
93242110|NCT01356017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93242111|NCT01356017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93242112|NCT02139098|Amitriptyline|amitriptyline|mesh-list
93242113|NCT02139098|Zolpidem|zolpidem|mesh-list
93242114|NCT02139098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93242115|NCT02139098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93242116|NCT02139098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242117|NCT02139098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242118|NCT02139098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93242119|NCT02139098|GABA Agonists|gaba agonists|mesh-ancestor
93242120|NCT02139098|GABA Agents|gaba agents|mesh-ancestor
93242121|NCT02139098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242122|NCT02139098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242123|NCT02139098|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93242124|NCT02139098|Antidepressive Agents|antidepressive agents|mesh-ancestor
93242125|NCT02139098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93242126|NCT02139098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242127|NCT02139098|Analgesics|analgesics|mesh-ancestor
93242128|NCT02139098|Sensory System Agents|sensory system agents|mesh-ancestor
93242129|NCT02139098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242130|NCT02139098|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93242131|NCT02139098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93242132|NCT02139098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242133|NCT02139098|Adrenergic Agents|adrenergic agents|mesh-ancestor
93242134|NCT04498715|Zoledronic Acid|zoledronic acid|mesh-list
92536811|NCT00136786|Dopamine Agents|dopamine agents|mesh-ancestor
93242135|NCT04498715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93242136|NCT04498715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242137|NCT02487979|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
93242138|NCT02487979|Immunoconjugates|immunoconjugates|mesh-list
93242139|NCT02487979|Immunotoxins|immunotoxins|mesh-list
93242140|NCT02487979|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93242141|NCT02487979|Immunologic Factors|immunologic factors|mesh-ancestor
93242142|NCT02487979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242143|NCT02487979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93242144|NCT02487979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242145|NCT02130830|Lidocaine|lidocaine|mesh-list
93242146|NCT02130830|Prilocaine|prilocaine|mesh-list
93242147|NCT02130830|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242148|NCT02130830|Anesthetics|anesthetics|mesh-ancestor
92536821|NCT00136825|Expectorants|expectorants|mesh-ancestor
93242149|NCT02130830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242150|NCT02130830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242151|NCT02130830|Sensory System Agents|sensory system agents|mesh-ancestor
92536826|NCT00136825|Protective Agents|protective agents|mesh-ancestor
93242152|NCT02130830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242153|NCT02130830|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93242154|NCT02130830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93242155|NCT02130830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93242156|NCT02130830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242157|NCT02130830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242158|NCT04471727|Atezolizumab|atezolizumab|mesh-list
93242159|NCT04471727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93242160|NCT04471727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242161|NCT04471727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93242162|NCT04471727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242163|NCT01360151|Ranibizumab|ranibizumab|mesh-list
93242164|NCT01360151|Verteporfin|verteporfin|mesh-list
93242165|NCT01360151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93242166|NCT01360151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93242167|NCT01360151|Growth Substances|growth substances|mesh-ancestor
93242168|NCT01360151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242169|NCT01360151|Growth Inhibitors|growth inhibitors|mesh-ancestor
93242170|NCT01360151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242171|NCT01360151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93242172|NCT01360151|Dermatologic Agents|dermatologic agents|mesh-ancestor
93242173|NCT01363037|Maraviroc|maraviroc|mesh-list
93242174|NCT01363037|Dapivirine|dapivirine|mesh-list
93242175|NCT01363037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93242176|NCT01363037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93242177|NCT01363037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242178|NCT01363037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93242179|NCT01363037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93242180|NCT01363037|Antiviral Agents|antiviral agents|mesh-ancestor
93242181|NCT01363037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242182|NCT01363037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93242183|NCT01363115|Vitamin D|vitamin d|mesh-list
93242184|NCT01363115|Calcium|calcium|mesh-list
93242185|NCT01363115|Vitamins|vitamins|mesh-ancestor
93242186|NCT01363115|Micronutrients|micronutrients|mesh-ancestor
93242187|NCT01363115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242188|NCT01363115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93242189|NCT01363115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93242190|NCT01356329|Heparin|heparin|mesh-list
93242191|NCT01356329|Enoxaparin|enoxaparin|mesh-list
93242192|NCT01356329|Anticoagulants|anticoagulants|mesh-ancestor
93242193|NCT01356329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93242194|NCT01356329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93242195|NCT01356329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242196|NCT05579522|Hyaluronic Acid|hyaluronic acid|mesh-list
93242197|NCT05579522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93242198|NCT05579522|Immunologic Factors|immunologic factors|mesh-ancestor
93242199|NCT05579522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242200|NCT05579522|Viscosupplements|viscosupplements|mesh-ancestor
92601531|NCT00449410|Atorvastatin|atorvastatin|mesh-list
93242201|NCT05579522|Protective Agents|protective agents|mesh-ancestor
93242202|NCT01356485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93242203|NCT01363193|Heparin|heparin|mesh-list
93242204|NCT01363193|Calcium heparin|calcium heparin|mesh-list
93242205|NCT01363193|Anticoagulants|anticoagulants|mesh-ancestor
93242206|NCT01363193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93242207|NCT01363193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92536874|NCT00137020|Ziprasidone|ziprasidone|mesh-list
93242208|NCT01363193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242209|NCT01319279|Hydrocodone|hydrocodone|mesh-list
93242210|NCT01319279|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93242211|NCT01319279|Narcotics|narcotics|mesh-ancestor
92601754|NCT00458614|Lansoprazole|lansoprazole|mesh-list
93242212|NCT01319279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242213|NCT01319279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242214|NCT01319279|Analgesics|analgesics|mesh-ancestor
93242215|NCT01319279|Sensory System Agents|sensory system agents|mesh-ancestor
93242216|NCT01319279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536885|NCT00137020|Dopamine Agents|dopamine agents|mesh-ancestor
93242217|NCT01319279|Antitussive Agents|antitussive agents|mesh-ancestor
93242218|NCT01319279|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242219|NCT01363271|Vancomycin|vancomycin|mesh-list
93242220|NCT01363271|Linezolid|linezolid|mesh-list
93242221|NCT01363271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242222|NCT01363271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536892|NCT00137059|Antipyretics|antipyretics|mesh-ancestor
93242223|NCT01363271|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93242224|NCT01363271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242225|NCT01363271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242226|NCT02134886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93242227|NCT02134886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242228|NCT02134886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242229|NCT02134886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242230|NCT02134886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242231|NCT01360463|Methadone|methadone|mesh-list
93242232|NCT01360463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93242233|NCT01360463|Narcotics|narcotics|mesh-ancestor
93242234|NCT01360463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242235|NCT01360463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242236|NCT01360463|Analgesics|analgesics|mesh-ancestor
93242237|NCT01360463|Sensory System Agents|sensory system agents|mesh-ancestor
93242238|NCT01360463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914223|NCT05599880|Bortezomib|bortezomib|mesh-list
93242239|NCT01360463|Antitussive Agents|antitussive agents|mesh-ancestor
93242240|NCT01360463|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242241|NCT01356641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93242242|NCT01356641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242243|NCT03103087|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93242244|NCT03103087|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93242245|NCT03103087|Norethindrone|norethindrone|mesh-list
93242246|NCT03103087|Norethindrone Acetate|norethindrone acetate|mesh-list
93242247|NCT03103087|Estradiol|estradiol|mesh-list
93242248|NCT03103087|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93242249|NCT03103087|Relugolix|relugolix|mesh-list
93242250|NCT03103087|Estrogens|estrogens|mesh-ancestor
93242251|NCT03103087|Hormones|hormones|mesh-ancestor
92536921|NCT00137410|Analgesics|analgesics|mesh-ancestor
93242252|NCT03103087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242253|NCT03103087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242254|NCT03103087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92602467|NCT03272425|Allopurinol|allopurinol|mesh-list
93242255|NCT03103087|Contraceptive Agents|contraceptive agents|mesh-ancestor
93242256|NCT03103087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93242257|NCT03103087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93242258|NCT03103087|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93242259|NCT03103087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93242260|NCT03103087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93242261|NCT03103087|Androgen Antagonists|androgen antagonists|mesh-ancestor
93242262|NCT03103087|Hormone Antagonists|hormone antagonists|mesh-ancestor
93242263|NCT05579288|Nitrous Oxide|nitrous oxide|mesh-list
93242264|NCT05579288|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93242265|NCT05579288|Anesthetics, General|anesthetics, general|mesh-ancestor
93242266|NCT05579288|Anesthetics|anesthetics|mesh-ancestor
93242267|NCT05579288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242268|NCT05579288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242269|NCT05579288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242270|NCT05579288|Analgesics|analgesics|mesh-ancestor
93242271|NCT05579288|Sensory System Agents|sensory system agents|mesh-ancestor
93242272|NCT05579288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242273|NCT03132467|Durvalumab|durvalumab|mesh-list
93242274|NCT03132467|Ipilimumab|ipilimumab|mesh-list
93242275|NCT03132467|Tremelimumab|tremelimumab|mesh-list
92536944|NCT00137527|Anesthetics|anesthetics|mesh-list
93242276|NCT03132467|Immunoglobulins|immunoglobulins|mesh-list
93242277|NCT03132467|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92602889|NCT00476359|Lopinavir|lopinavir|mesh-list
93242278|NCT03132467|Immunoglobulin G|immunoglobulin g|mesh-list
93242279|NCT03132467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93242280|NCT03132467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242281|NCT03132467|Immunologic Factors|immunologic factors|mesh-ancestor
93242282|NCT03132467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242283|NCT03132467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93242284|NCT03132467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242285|NCT02134964|Dapansutrile|dapansutrile|mesh-list
93242286|NCT02134964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242287|NCT01363583|Epoprostenol|epoprostenol|mesh-list
93242288|NCT01363583|Tezosentan|tezosentan|mesh-list
93242289|NCT01363583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93242290|NCT01363583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93242291|NCT01363583|Vasodilator Agents|vasodilator agents|mesh-ancestor
93242292|NCT02135120|Morphine|morphine|mesh-list
92536957|NCT00137761|Docetaxel|docetaxel|mesh-list
93242293|NCT02135120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242294|NCT02135120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242295|NCT02135120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93242296|NCT02135120|Narcotics|narcotics|mesh-ancestor
93242297|NCT02135120|Analgesics|analgesics|mesh-ancestor
93242298|NCT02135120|Sensory System Agents|sensory system agents|mesh-ancestor
93242299|NCT02135120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242300|NCT03131999|Imatinib Mesylate|imatinib mesylate|mesh-list
93242301|NCT03131999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242302|NCT03131999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242303|NCT03131999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242304|NCT03131999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536972|NCT02858921|Trametinib|trametinib|mesh-list
93242305|NCT01319357|Saxagliptin|saxagliptin|mesh-list
93242306|NCT01319357|Incretins|incretins|mesh-ancestor
93242307|NCT01319357|Hormones|hormones|mesh-ancestor
92536975|NCT02858921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242308|NCT01319357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242309|NCT01319357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242310|NCT01319357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93242311|NCT01319357|Protease Inhibitors|protease inhibitors|mesh-ancestor
93242312|NCT01319357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242313|NCT01319357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242314|NCT01319357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93242315|NCT02135354|Azithromycin|azithromycin|mesh-list
93242316|NCT02135354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242317|NCT02135354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242318|NCT02055053|Bupivacaine|bupivacaine|mesh-list
93242319|NCT02055053|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242320|NCT02055053|Anesthetics|anesthetics|mesh-ancestor
93242321|NCT02055053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242322|NCT02055053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242323|NCT02055053|Sensory System Agents|sensory system agents|mesh-ancestor
93242324|NCT02055053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242325|NCT02303431|Edoxaban|edoxaban|mesh-list
93242326|NCT02303431|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93242327|NCT02303431|Antithrombins|antithrombins|mesh-ancestor
93242328|NCT02303431|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93242329|NCT02303431|Protease Inhibitors|protease inhibitors|mesh-ancestor
93242330|NCT02303431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242331|NCT02303431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242332|NCT02303431|Anticoagulants|anticoagulants|mesh-ancestor
93242333|NCT02135510|Palonosetron|palonosetron|mesh-list
93242334|NCT02135510|Metoclopramide|metoclopramide|mesh-list
93242335|NCT02135510|Antiemetics|antiemetics|mesh-ancestor
93242336|NCT02135510|Autonomic Agents|autonomic agents|mesh-ancestor
93242337|NCT02135510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242338|NCT02135510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604259|NCT01241773|Antiviral Agents|antiviral agents|mesh-ancestor
93242339|NCT02135510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93242340|NCT02135510|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93242341|NCT02135510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93242342|NCT02135510|Serotonin Agents|serotonin agents|mesh-ancestor
93242343|NCT02135510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242344|NCT02135510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242345|NCT02135510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93242346|NCT02135510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93242347|NCT02135510|Dopamine Agents|dopamine agents|mesh-ancestor
93242348|NCT02004275|Dexamethasone|dexamethasone|mesh-list
92611826|NCT00149292|Olanzapine|olanzapine|mesh-list
93242349|NCT02004275|Pomalidomide|pomalidomide|mesh-list
93242350|NCT02004275|Ixazomib|ixazomib|mesh-list
93242351|NCT02004275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242352|NCT02004275|Antiemetics|antiemetics|mesh-ancestor
93242353|NCT02004275|Autonomic Agents|autonomic agents|mesh-ancestor
93242354|NCT02004275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242355|NCT02004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242356|NCT02004275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92537016|NCT00138112|Vancomycin|vancomycin|mesh-list
93242357|NCT02004275|Glucocorticoids|glucocorticoids|mesh-ancestor
93242358|NCT02004275|Hormones|hormones|mesh-ancestor
93242359|NCT02004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242360|NCT02004275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93242361|NCT02004275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242362|NCT02004275|Immunologic Factors|immunologic factors|mesh-ancestor
93242363|NCT02004275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93242364|NCT02004275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93242365|NCT02004275|Growth Substances|growth substances|mesh-ancestor
93242366|NCT02004275|Growth Inhibitors|growth inhibitors|mesh-ancestor
93242367|NCT02004275|Protease Inhibitors|protease inhibitors|mesh-ancestor
93242368|NCT02004275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242369|NCT02004275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242370|NCT03548714|Ethanol|ethanol|mesh-list
93242371|NCT03548714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93242372|NCT03548714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612183|NCT05262452|Folfirinox|folfirinox|mesh-list
93242373|NCT03548714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242374|NCT03548714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242375|NCT02135588|Plasminogen|plasminogen|mesh-list
93242376|NCT02135588|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93242377|NCT02135588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93242378|NCT02135588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93242379|NCT02135588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242380|NCT05578664|Pembrolizumab|pembrolizumab|mesh-list
93242381|NCT05578664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93242382|NCT05578664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242383|NCT05578664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93242384|NCT05578664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242385|NCT01491763|Imatinib Mesylate|imatinib mesylate|mesh-list
93242386|NCT01491763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242387|NCT01491763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242388|NCT01491763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242389|NCT01491763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242390|NCT01363817|Dexamethasone|dexamethasone|mesh-list
93242391|NCT01363817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242392|NCT01363817|Antiemetics|antiemetics|mesh-ancestor
93242394|NCT01363817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242395|NCT01363817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242396|NCT01363817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93242397|NCT01363817|Glucocorticoids|glucocorticoids|mesh-ancestor
93242398|NCT01363817|Hormones|hormones|mesh-ancestor
93242399|NCT01363817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242400|NCT01363817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93242401|NCT01363817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242402|NCT02140268|Midazolam|midazolam|mesh-list
93242403|NCT02140268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93242404|NCT02140268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93242405|NCT02140268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242406|NCT02140268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242407|NCT02140268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93242408|NCT02140268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93242409|NCT02140268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93242410|NCT02140268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93242411|NCT02140268|Anesthetics, General|anesthetics, general|mesh-ancestor
93242412|NCT02140268|Anesthetics|anesthetics|mesh-ancestor
93242413|NCT02140268|GABA Modulators|gaba modulators|mesh-ancestor
93242414|NCT02140268|GABA Agents|gaba agents|mesh-ancestor
93242415|NCT02140268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242416|NCT02140268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242417|NCT05578352|Insulin|insulin|mesh-list
93242418|NCT05578352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93242419|NCT05578352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242420|NCT03602508|Solifenacin Succinate|solifenacin succinate|mesh-list
93242421|NCT03602508|Mirabegron|mirabegron|mesh-list
93242422|NCT03602508|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93242423|NCT03602508|Fesoterodine|fesoterodine|mesh-list
93242424|NCT03602508|Oxybutynin|oxybutynin|mesh-list
93242425|NCT03602508|Darifenacin|darifenacin|mesh-list
93242426|NCT03602508|Propiverine|propiverine|mesh-list
93242427|NCT03602508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93242428|NCT03602508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93242429|NCT03602508|Cholinergic Agents|cholinergic agents|mesh-ancestor
93242430|NCT03602508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242431|NCT03602508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242432|NCT03602508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242433|NCT03602508|Urological Agents|urological agents|mesh-ancestor
93242434|NCT03602508|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93242435|NCT03602508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93242436|NCT03602508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93242437|NCT03602508|Adrenergic Agents|adrenergic agents|mesh-ancestor
93242438|NCT03602508|Parasympatholytics|parasympatholytics|mesh-ancestor
93242439|NCT03602508|Autonomic Agents|autonomic agents|mesh-ancestor
93242440|NCT03602508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242441|NCT03549728|Lenograstim|lenograstim|mesh-list
93242442|NCT03549728|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93242443|NCT03549728|Immunologic Factors|immunologic factors|mesh-ancestor
93242444|NCT03549728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242445|NCT01356797|Fentanyl|fentanyl|mesh-list
93242446|NCT01356797|Bupivacaine|bupivacaine|mesh-list
93242447|NCT01356797|Levobupivacaine|levobupivacaine|mesh-list
93242448|NCT01356797|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242449|NCT01356797|Anesthetics|anesthetics|mesh-ancestor
93242450|NCT01356797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242451|NCT01356797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242452|NCT01356797|Sensory System Agents|sensory system agents|mesh-ancestor
93242453|NCT01356797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242454|NCT01356797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93242455|NCT01356797|Narcotics|narcotics|mesh-ancestor
93242456|NCT01356797|Analgesics|analgesics|mesh-ancestor
93242457|NCT01356797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93242458|NCT01356797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93242459|NCT01356797|Anesthetics, General|anesthetics, general|mesh-ancestor
93242460|NCT02238132|Ipratropium|ipratropium|mesh-list
93242461|NCT02238132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93242462|NCT02238132|Autonomic Agents|autonomic agents|mesh-ancestor
93242463|NCT02238132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242464|NCT02238132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242465|NCT02238132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93242466|NCT02238132|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242467|NCT02238132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93242468|NCT02238132|Cholinergic Agents|cholinergic agents|mesh-ancestor
93242469|NCT02238132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537128|NCT00138970|Protective Agents|protective agents|mesh-ancestor
93242470|NCT02238132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242471|NCT05200429|Ivacaftor|ivacaftor|mesh-list
93242472|NCT05200429|Elexacaftor|elexacaftor|mesh-list
93242473|NCT05200429|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93242474|NCT05200429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242475|NCT05200429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242476|NCT05578196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93242477|NCT02135822|Paclitaxel|paclitaxel|mesh-list
93242478|NCT02135822|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93242479|NCT02135822|Gemcitabine|gemcitabine|mesh-list
93242480|NCT02135822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93242481|NCT02135822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242482|NCT02135822|Tubulin Modulators|tubulin modulators|mesh-ancestor
93242483|NCT02135822|Antimitotic Agents|antimitotic agents|mesh-ancestor
93242484|NCT02135822|Mitosis Modulators|mitosis modulators|mesh-ancestor
93242485|NCT02135822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242486|NCT02135822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93242487|NCT02135822|Antimetabolites|antimetabolites|mesh-ancestor
93242488|NCT02238210|Ipratropium|ipratropium|mesh-list
93242489|NCT02238210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93242490|NCT02238210|Autonomic Agents|autonomic agents|mesh-ancestor
93242491|NCT02238210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944840|NCT02446418|Budesonide|budesonide|mesh-list
93242492|NCT02238210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242493|NCT02238210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93242494|NCT02238210|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242495|NCT02238210|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93242496|NCT02238210|Cholinergic Agents|cholinergic agents|mesh-ancestor
93242497|NCT02238210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613533|NCT02950441|Niacinamide|niacinamide|mesh-list
93242498|NCT02238210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242499|NCT05739955|Disinfectants|disinfectants|mesh-list
93242500|NCT05739955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242501|NCT02978456|Sirolimus|sirolimus|mesh-list
93242502|NCT02978456|Temsirolimus|temsirolimus|mesh-list
93242503|NCT02978456|MTOR Inhibitors|mtor inhibitors|mesh-list
93242504|NCT02978456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242505|NCT02978456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944852|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
93242506|NCT02978456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93242507|NCT02978456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242508|NCT02978456|Antifungal Agents|antifungal agents|mesh-ancestor
93242509|NCT02978456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93242510|NCT02978456|Immunologic Factors|immunologic factors|mesh-ancestor
93242511|NCT02978456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242512|NCT02978456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242513|NCT02978456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242514|NCT02978456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242515|NCT05736913|Vaccines|vaccines|mesh-list
93242516|NCT05736913|Immunologic Factors|immunologic factors|mesh-ancestor
93242517|NCT05736913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242518|NCT03598452|Ganciclovir|ganciclovir|mesh-list
93242519|NCT03598452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93242520|NCT03598452|Antiviral Agents|antiviral agents|mesh-ancestor
93242521|NCT03598452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242522|NCT03598452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614009|NCT05501665|Pemetrexed|pemetrexed|mesh-list
93242523|NCT03598452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242524|NCT03598452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242525|NCT03549026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92537177|NCT00139165|Glucocorticoids|glucocorticoids|mesh-ancestor
93242526|NCT03549026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93242527|NCT03549026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93242528|NCT03549026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242529|NCT03549026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242530|NCT03549026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242531|NCT03549026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242532|NCT03549026|Analgesics|analgesics|mesh-ancestor
93242533|NCT03549026|Sensory System Agents|sensory system agents|mesh-ancestor
92537185|NCT00139243|Docetaxel|docetaxel|mesh-list
93242534|NCT03549026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242535|NCT03549026|Antidepressive Agents|antidepressive agents|mesh-ancestor
93242536|NCT03549026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93242537|NCT03549026|Dopamine Agents|dopamine agents|mesh-ancestor
93242538|NCT03101371|Iodine|iodine|mesh-list
93242539|NCT03101371|Povidone-Iodine|povidone-iodine|mesh-list
93242540|NCT03101371|Povidone|povidone|mesh-list
93242541|NCT03101371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93242542|NCT03101371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242543|NCT03101371|Trace Elements|trace elements|mesh-ancestor
92537196|NCT00139243|Vitamins|vitamins|mesh-ancestor
93242544|NCT03101371|Micronutrients|micronutrients|mesh-ancestor
93242545|NCT03101371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242546|NCT03101371|Plasma Substitutes|plasma substitutes|mesh-ancestor
92537201|NCT00139282|Squalamine|squalamine|mesh-list
93242547|NCT03101371|Blood Substitutes|blood substitutes|mesh-ancestor
93242548|NCT03588078|Azacitidine|azacitidine|mesh-list
93242549|NCT03588078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93242550|NCT03588078|Antimetabolites|antimetabolites|mesh-ancestor
93242551|NCT03588078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242552|NCT03588078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242553|NCT03588078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242554|NCT02238366|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93242555|NCT02238366|Luteolytic Agents|luteolytic agents|mesh-ancestor
93242556|NCT02238366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93242557|NCT02238366|Contraceptive Agents|contraceptive agents|mesh-ancestor
93242558|NCT02238366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93242559|NCT02238366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242560|NCT02238366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93242561|NCT02238366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93242562|NCT02238366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242563|NCT05494190|Docetaxel|docetaxel|mesh-list
93242564|NCT05494190|Capecitabine|capecitabine|mesh-list
93242565|NCT05494190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242566|NCT05494190|Tubulin Modulators|tubulin modulators|mesh-ancestor
93242567|NCT05494190|Antimitotic Agents|antimitotic agents|mesh-ancestor
93242568|NCT05494190|Mitosis Modulators|mitosis modulators|mesh-ancestor
93242569|NCT05494190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242570|NCT05494190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93242571|NCT05494190|Antimetabolites|antimetabolites|mesh-ancestor
93242572|NCT02850276|Bromides|bromides|mesh-list
93242573|NCT02850276|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93242574|NCT02850276|Anticonvulsants|anticonvulsants|mesh-ancestor
92537222|NCT00139360|Growth Inhibitors|growth inhibitors|mesh-ancestor
93242575|NCT02850276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93242576|NCT02850276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242577|NCT02850276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242578|NCT02850276|Cholinergic Agents|cholinergic agents|mesh-ancestor
93242579|NCT02850276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242580|NCT02850276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242581|NCT04961593|Caspofungin|caspofungin|mesh-list
93242582|NCT04961593|Antifungal Agents|antifungal agents|mesh-ancestor
93242583|NCT04961593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242584|NCT04961593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242585|NCT04961593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242586|NCT03862170|Ciprofloxacin|ciprofloxacin|mesh-list
93242587|NCT03862170|Cefazolin|cefazolin|mesh-list
93242588|NCT03862170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242589|NCT03862170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242590|NCT03862170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92537233|NCT00139555|Amlodipine|amlodipine|mesh-list
93242591|NCT03862170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93242592|NCT03862170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242593|NCT03862170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242594|NCT03862170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242595|NCT03862170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93242596|NCT03862170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92616097|NCT00525928|Varenicline|varenicline|mesh-list
93242597|NCT02140580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93242598|NCT02140580|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242599|NCT05577806|Dydrogesterone|dydrogesterone|mesh-list
93242600|NCT05577806|Progestins|progestins|mesh-ancestor
93242601|NCT05577806|Hormones|hormones|mesh-ancestor
93242602|NCT05577806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242603|NCT05577806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242604|NCT03591276|Antineoplastic Agents|antineoplastic agents|mesh-list
93242605|NCT05465876|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93242606|NCT05465876|Antiviral Agents|antiviral agents|mesh-ancestor
93242607|NCT05465876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242609|NCT03548948|Trace Elements|trace elements|mesh-ancestor
93242610|NCT03548948|Micronutrients|micronutrients|mesh-ancestor
92616403|NCT02947243|Analgesics|analgesics|mesh-ancestor
93242611|NCT03548948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242612|NCT02238444|Aspirin|aspirin|mesh-list
93242613|NCT02238444|Heparin|heparin|mesh-list
93242614|NCT02238444|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93242615|NCT02238444|Tinzaparin|tinzaparin|mesh-list
93242616|NCT02238444|Dalteparin|dalteparin|mesh-list
93242617|NCT02238444|Dipyridamole|dipyridamole|mesh-list
93242618|NCT02238444|Warfarin|warfarin|mesh-list
93242619|NCT02238444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93242620|NCT02238444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242621|NCT02238444|Analgesics|analgesics|mesh-ancestor
93242622|NCT02238444|Sensory System Agents|sensory system agents|mesh-ancestor
93242623|NCT02238444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242624|NCT02238444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242625|NCT02238444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242626|NCT02238444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242627|NCT02238444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93242628|NCT02238444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92537270|NCT00139633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242629|NCT02238444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242630|NCT02238444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93242631|NCT02238444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93242632|NCT02238444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242633|NCT02238444|Antipyretics|antipyretics|mesh-ancestor
91962054|NCT05243355|Endostatins|endostatins|mesh-list
93242634|NCT02238444|Anticoagulants|anticoagulants|mesh-ancestor
93242635|NCT02238444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93242636|NCT02238444|Vasodilator Agents|vasodilator agents|mesh-ancestor
93242637|NCT03131687|Dulaglutide|dulaglutide|mesh-list
93242638|NCT03131687|Tirzepatide|tirzepatide|mesh-list
93242639|NCT03131687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93242640|NCT03131687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242641|NCT03131687|Incretins|incretins|mesh-ancestor
93242642|NCT03131687|Hormones|hormones|mesh-ancestor
93242643|NCT03131687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537285|NCT03837977|Irinotecan|irinotecan|mesh-list
93242644|NCT03579888|Cyclophosphamide|cyclophosphamide|mesh-list
93242645|NCT03579888|Fludarabine|fludarabine|mesh-list
93242646|NCT03579888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93242647|NCT03579888|Immunologic Factors|immunologic factors|mesh-ancestor
93242648|NCT03579888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242649|NCT03579888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242650|NCT03579888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93242651|NCT03579888|Alkylating Agents|alkylating agents|mesh-ancestor
93242652|NCT03579888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242653|NCT03579888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242654|NCT03579888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93242655|NCT05344027|Mitotane|mitotane|mesh-list
93242656|NCT05344027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93242657|NCT05344027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242658|NCT05430698|Antibodies|antibodies|mesh-list
93242659|NCT05430698|Immunologic Factors|immunologic factors|mesh-ancestor
93242660|NCT05430698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242661|NCT03585894|Ketorolac|ketorolac|mesh-list
93242662|NCT03585894|Sumatriptan|sumatriptan|mesh-list
93242663|NCT03585894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93242664|NCT03585894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242665|NCT03585894|Analgesics|analgesics|mesh-ancestor
92537306|NCT00404326|Hydralazine|hydralazine|mesh-list
93242666|NCT03585894|Sensory System Agents|sensory system agents|mesh-ancestor
93242667|NCT03585894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242668|NCT03585894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242669|NCT03585894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537311|NCT00404326|GABA Agents|gaba agents|mesh-ancestor
93242670|NCT03585894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242671|NCT03585894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93242672|NCT03585894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617425|NCT02942758|Tretinoin|tretinoin|mesh-list
93242673|NCT03585894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242674|NCT03585894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93242675|NCT03585894|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93242676|NCT03585894|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93242677|NCT03585894|Serotonin Agents|serotonin agents|mesh-ancestor
93242678|NCT03585894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242679|NCT04912921|Palmidrol|palmidrol|mesh-list
93242680|NCT04912921|Curcumin|curcumin|mesh-list
93242681|NCT04912921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93242682|NCT04912921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242683|NCT04912921|Analgesics|analgesics|mesh-ancestor
93242684|NCT04912921|Sensory System Agents|sensory system agents|mesh-ancestor
93242685|NCT04912921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242686|NCT04912921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242687|NCT04912921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242688|NCT04912921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242689|NCT04912921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242690|NCT04912921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537331|NCT00139867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91963151|NCT03306745|Folic Acid|folic acid|mesh-list
93242691|NCT04912921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242692|NCT04912921|Antiviral Agents|antiviral agents|mesh-ancestor
93242693|NCT04912921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242694|NCT04912921|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93242695|NCT04912921|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93242696|NCT04912921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242697|NCT04912921|Hormones|hormones|mesh-ancestor
92537338|NCT03150459|Simvastatin|simvastatin|mesh-list
93242698|NCT04912921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242699|NCT05420324|Paclitaxel|paclitaxel|mesh-list
93242700|NCT05420324|Pembrolizumab|pembrolizumab|mesh-list
93242701|NCT05420324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92537345|NCT03150459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242702|NCT05420324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242703|NCT05420324|Tubulin Modulators|tubulin modulators|mesh-ancestor
93242704|NCT05420324|Antimitotic Agents|antimitotic agents|mesh-ancestor
93242705|NCT05420324|Mitosis Modulators|mitosis modulators|mesh-ancestor
93242706|NCT05420324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242707|NCT05420324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537349|NCT00140023|Azithromycin|azithromycin|mesh-list
93242708|NCT05420324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93242709|NCT02238288|Acetaminophen|acetaminophen|mesh-list
93242710|NCT02238288|Lidocaine|lidocaine|mesh-list
93242711|NCT02238288|Epinephrine|epinephrine|mesh-list
93242712|NCT02238288|Aminocaproic Acid|aminocaproic acid|mesh-list
93242713|NCT02238288|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242714|NCT02238288|Anesthetics|anesthetics|mesh-ancestor
93242715|NCT02238288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537360|NCT00140101|Mitosis Modulators|mitosis modulators|mesh-ancestor
93242716|NCT02238288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242717|NCT02238288|Sensory System Agents|sensory system agents|mesh-ancestor
93242718|NCT02238288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537362|NCT03150420|Sodium thiosulfate|sodium thiosulfate|mesh-list
93242719|NCT02238288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93242720|NCT02238288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93242721|NCT02238288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93242722|NCT02238288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242723|NCT02238288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242724|NCT02238288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242725|NCT02238288|Analgesics|analgesics|mesh-ancestor
93242726|NCT02238288|Antipyretics|antipyretics|mesh-ancestor
93242727|NCT02238288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93242728|NCT02238288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93242729|NCT02238288|Adrenergic Agents|adrenergic agents|mesh-ancestor
93242730|NCT02238288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242731|NCT02238288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93242732|NCT02238288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93242733|NCT02238288|Autonomic Agents|autonomic agents|mesh-ancestor
93242734|NCT02238288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93242735|NCT02238288|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242736|NCT02238288|Mydriatics|mydriatics|mesh-ancestor
93242737|NCT02238288|Sympathomimetics|sympathomimetics|mesh-ancestor
93242738|NCT02238288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93242739|NCT02238288|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93242740|NCT02238288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93242741|NCT02238288|Hemostatics|hemostatics|mesh-ancestor
93242742|NCT02238288|Coagulants|coagulants|mesh-ancestor
93242743|NCT01561040|Vitamin D|vitamin d|mesh-list
93242744|NCT01561040|Vitamin A|vitamin a|mesh-list
93242745|NCT01561040|Vitamins|vitamins|mesh-ancestor
93242746|NCT01561040|Micronutrients|micronutrients|mesh-ancestor
93242747|NCT01561040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242748|NCT01561040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93242749|NCT03590496|Calcium|calcium|mesh-list
93242750|NCT03590496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93242751|NCT03590496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242752|NCT05577260|Dexmedetomidine|dexmedetomidine|mesh-list
93242753|NCT05577260|Bupivacaine|bupivacaine|mesh-list
93242754|NCT05577260|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242755|NCT05577260|Anesthetics|anesthetics|mesh-ancestor
93242756|NCT05577260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242757|NCT05577260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242758|NCT05577260|Sensory System Agents|sensory system agents|mesh-ancestor
93242759|NCT05577260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242760|NCT05577260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93242761|NCT05577260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242762|NCT05577260|Analgesics|analgesics|mesh-ancestor
93242763|NCT05577260|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93242764|NCT05577260|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93242765|NCT05577260|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93242766|NCT05577260|Adrenergic Agents|adrenergic agents|mesh-ancestor
93242767|NCT05577260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242768|NCT05577260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242769|NCT03760562|Glucocorticoids|glucocorticoids|mesh-list
93242770|NCT03760562|Hormones|hormones|mesh-ancestor
93242771|NCT03760562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93242772|NCT03760562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242773|NCT01357031|Amitriptyline|amitriptyline|mesh-list
93242774|NCT01357031|Melatonin|melatonin|mesh-list
93242775|NCT01357031|Antioxidants|antioxidants|mesh-ancestor
93242776|NCT01357031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242777|NCT01357031|Protective Agents|protective agents|mesh-ancestor
93242778|NCT01357031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242779|NCT01357031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242780|NCT01357031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93242781|NCT01357031|Antidepressive Agents|antidepressive agents|mesh-ancestor
93242782|NCT01357031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93242783|NCT01357031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242784|NCT01357031|Analgesics|analgesics|mesh-ancestor
93242785|NCT01357031|Sensory System Agents|sensory system agents|mesh-ancestor
93242786|NCT01357031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242787|NCT01357031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93242788|NCT01357031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93242789|NCT01357031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242790|NCT01357031|Adrenergic Agents|adrenergic agents|mesh-ancestor
93242791|NCT01357031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242792|NCT01357109|Bosentan|bosentan|mesh-list
93242793|NCT01357109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93242794|NCT01357109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93242795|NCT01357109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242796|NCT04792580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93242797|NCT04792580|Lifitegrast|lifitegrast|mesh-list
93242798|NCT04792580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93242799|NCT02253446|Diclofenac|diclofenac|mesh-list
93242800|NCT02253446|Piroxicam|piroxicam|mesh-list
93242801|NCT02253446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93242802|NCT02253446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93242803|NCT02253446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242804|NCT02253446|Analgesics|analgesics|mesh-ancestor
93242805|NCT02253446|Sensory System Agents|sensory system agents|mesh-ancestor
93242806|NCT02253446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242807|NCT02253446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242808|NCT02253446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242809|NCT02253446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242810|NCT02253446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93242811|NCT02253446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242812|NCT02253446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242813|NCT05417893|Sirolimus|sirolimus|mesh-list
93242814|NCT05417893|Everolimus|everolimus|mesh-list
93242815|NCT05417893|MTOR Inhibitors|mtor inhibitors|mesh-list
93242816|NCT05417893|Temsirolimus|temsirolimus|mesh-list
93242817|NCT05417893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93242818|NCT05417893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242819|NCT05417893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242820|NCT05417893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93242821|NCT05417893|Immunologic Factors|immunologic factors|mesh-ancestor
93242822|NCT05417893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242823|NCT05417893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242824|NCT05417893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93242825|NCT05417893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242826|NCT05417893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93242827|NCT05417893|Antifungal Agents|antifungal agents|mesh-ancestor
93242828|NCT03585348|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
93242829|NCT03585348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93242830|NCT03585348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242831|NCT03585348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242832|NCT05384678|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93242833|NCT05384678|Hallucinogens|hallucinogens|mesh-ancestor
93242834|NCT05384678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242835|NCT05384678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93242836|NCT05384678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93242837|NCT05384678|Serotonin Agents|serotonin agents|mesh-ancestor
93242838|NCT05384678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242839|NCT05384678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242840|NCT05384678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93242841|NCT01563224|Baclofen|baclofen|mesh-list
93242842|NCT01563224|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93242843|NCT01563224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242844|NCT01563224|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92914817|NCT00856583|Dopamine Agents|dopamine agents|mesh-ancestor
93242845|NCT01563224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242846|NCT01563224|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93242847|NCT01563224|GABA Agonists|gaba agonists|mesh-ancestor
93242848|NCT01563224|GABA Agents|gaba agents|mesh-ancestor
93242849|NCT01563224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242850|NCT01563224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242851|NCT01369979|Imidacloprid|imidacloprid|mesh-list
93242852|NCT01369979|Cholinergic Agents|cholinergic agents|mesh-ancestor
93242853|NCT01369979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537487|NCT00140998|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93242854|NCT01369979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242855|NCT01369979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242856|NCT03577860|Bupivacaine|bupivacaine|mesh-list
93242857|NCT03577860|Anesthetics, Local|anesthetics, local|mesh-ancestor
93242858|NCT03577860|Anesthetics|anesthetics|mesh-ancestor
93242859|NCT03577860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537504|NCT00141154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242860|NCT03577860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242861|NCT03577860|Sensory System Agents|sensory system agents|mesh-ancestor
93242862|NCT03577860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242863|NCT03577782|Vedolizumab|vedolizumab|mesh-list
93242864|NCT03577782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93242865|NCT03432065|Buspirone|buspirone|mesh-list
92537510|NCT03709706|Pembrolizumab|pembrolizumab|mesh-list
93242866|NCT03432065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93242867|NCT03432065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93242868|NCT03432065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93242869|NCT03432065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242870|NCT03432065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93242871|NCT03432065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93242872|NCT03432065|Serotonin Agents|serotonin agents|mesh-ancestor
93242873|NCT03432065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93242874|NCT03432065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242875|NCT03577626|Hemay005|hemay005|mesh-list
93242876|NCT03577626|Dermatologic Agents|dermatologic agents|mesh-ancestor
93242877|NCT03577626|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93242878|NCT03577626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93242879|NCT03577626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242880|NCT03577626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242881|NCT03412799|Paclitaxel|paclitaxel|mesh-list
92537518|NCT00141193|Analgesics|analgesics|mesh-ancestor
91945172|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242882|NCT03412799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93242883|NCT03412799|Gemcitabine|gemcitabine|mesh-list
93242884|NCT03412799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93242885|NCT03412799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242886|NCT03412799|Tubulin Modulators|tubulin modulators|mesh-ancestor
93242887|NCT03412799|Antimitotic Agents|antimitotic agents|mesh-ancestor
93242888|NCT03412799|Mitosis Modulators|mitosis modulators|mesh-ancestor
93242889|NCT03412799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242890|NCT03412799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93242891|NCT03412799|Antimetabolites|antimetabolites|mesh-ancestor
93242892|NCT03579732|Aspirin|aspirin|mesh-list
93242893|NCT03579732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93242894|NCT03579732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93242895|NCT03579732|Analgesics|analgesics|mesh-ancestor
93242896|NCT03579732|Sensory System Agents|sensory system agents|mesh-ancestor
93242897|NCT03579732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242898|NCT03579732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242899|NCT03579732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242900|NCT03579732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93242901|NCT03579732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92619434|NCT04880863|Docetaxel|docetaxel|mesh-list
93242902|NCT03579732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93242903|NCT03579732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242904|NCT03579732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93242905|NCT03579732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92537549|NCT00141388|Analgesics|analgesics|mesh-ancestor
93242906|NCT03579732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242907|NCT03579732|Antipyretics|antipyretics|mesh-ancestor
93242908|NCT02259816|Amlodipine|amlodipine|mesh-list
93242909|NCT02259816|Telmisartan|telmisartan|mesh-list
93242910|NCT02259816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93242911|NCT02259816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93242912|NCT02259816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93242913|NCT02259816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242914|NCT02259816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93242915|NCT02259816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242916|NCT02259816|Vasodilator Agents|vasodilator agents|mesh-ancestor
93242917|NCT02259816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93242918|NCT02259816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92914892|NCT00652366|Gemcitabine|gemcitabine|mesh-list
93242920|NCT01567735|Antiviral Agents|antiviral agents|mesh-ancestor
93242921|NCT01567735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242922|NCT01567735|Protease Inhibitors|protease inhibitors|mesh-ancestor
93242923|NCT01567735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242924|NCT01567735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242925|NCT04631471|Ibudilast|ibudilast|mesh-list
93242926|NCT04631471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93242927|NCT04631471|Autonomic Agents|autonomic agents|mesh-ancestor
93242928|NCT04631471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242929|NCT04631471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242930|NCT04631471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93242931|NCT04631471|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242932|NCT04631471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93242933|NCT04631471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242934|NCT04631471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242935|NCT04631471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93242936|NCT04631471|Vasodilator Agents|vasodilator agents|mesh-ancestor
93242937|NCT03577392|Capecitabine|capecitabine|mesh-list
93242938|NCT03577392|Oxaliplatin|oxaliplatin|mesh-list
93242939|NCT03577392|Endostatins|endostatins|mesh-list
93242940|NCT03577392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93242941|NCT03577392|Antimetabolites|antimetabolites|mesh-ancestor
93242942|NCT03577392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242943|NCT03577392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93242944|NCT03577392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93242945|NCT03577392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93242946|NCT03577392|Growth Substances|growth substances|mesh-ancestor
93242947|NCT03577392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242948|NCT03577392|Growth Inhibitors|growth inhibitors|mesh-ancestor
93242949|NCT03579576|Ribavirin|ribavirin|mesh-list
93242950|NCT03579576|Sofosbuvir|sofosbuvir|mesh-list
93242951|NCT03579576|Velpatasvir|velpatasvir|mesh-list
93242952|NCT03579576|Antimetabolites|antimetabolites|mesh-ancestor
93242953|NCT03579576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242954|NCT03579576|Antiviral Agents|antiviral agents|mesh-ancestor
93242955|NCT03579576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242956|NCT01364519|Fluticasone|fluticasone|mesh-list
93242957|NCT01364519|Xhance|xhance|mesh-list
93242958|NCT01364519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93242959|NCT01364519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92537601|NCT00141427|Pregabalin|pregabalin|mesh-list
93242960|NCT01364519|Autonomic Agents|autonomic agents|mesh-ancestor
93242961|NCT01364519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93242962|NCT01364519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242963|NCT01364519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93242964|NCT01364519|Respiratory System Agents|respiratory system agents|mesh-ancestor
93242965|NCT01364519|Dermatologic Agents|dermatologic agents|mesh-ancestor
93242966|NCT01364519|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93242967|NCT03577158|Insulin|insulin|mesh-list
93242968|NCT03577158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93242969|NCT03577158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242970|NCT02253914|Ritonavir|ritonavir|mesh-list
93242971|NCT02253914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93242972|NCT02253914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93242973|NCT02253914|Protease Inhibitors|protease inhibitors|mesh-ancestor
93242974|NCT02253914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93242975|NCT02253914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93242976|NCT02253914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93242977|NCT02253914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93242978|NCT02253914|Antiviral Agents|antiviral agents|mesh-ancestor
93242979|NCT02253914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93242980|NCT02253914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93242981|NCT02253914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93242982|NCT01364675|Metformin|metformin|mesh-list
93242983|NCT01364675|Enalapril|enalapril|mesh-list
93242984|NCT01364675|Simvastatin|simvastatin|mesh-list
93242985|NCT01364675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93242986|NCT01364675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93242987|NCT01364675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92537615|NCT00141544|Methyltestosterone|methyltestosterone|mesh-list
93242988|NCT01364675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93242989|NCT01364675|Antimetabolites|antimetabolites|mesh-ancestor
93242990|NCT01364675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243028|NCT02250534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243029|NCT01370135|Ranibizumab|ranibizumab|mesh-list
93243030|NCT01370135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93243031|NCT01370135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93243032|NCT01370135|Growth Substances|growth substances|mesh-ancestor
93243033|NCT01370135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243034|NCT01370135|Growth Inhibitors|growth inhibitors|mesh-ancestor
93243035|NCT01370135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243036|NCT05266586|Ezetimibe|ezetimibe|mesh-list
93243037|NCT05266586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93243038|NCT05266586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93243039|NCT05266586|Antimetabolites|antimetabolites|mesh-ancestor
93243040|NCT05266586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243041|NCT05266586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93243042|NCT01370291|Risperidone|risperidone|mesh-list
93243043|NCT01370291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93243044|NCT01370291|Serotonin Agents|serotonin agents|mesh-ancestor
93243045|NCT01370291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243046|NCT01370291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243047|NCT01370291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537715|NCT00142324|Donepezil|donepezil|mesh-list
93243048|NCT01370291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93243049|NCT01370291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93243050|NCT01370291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243051|NCT01370291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243052|NCT01370291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93243053|NCT01370291|Dopamine Agents|dopamine agents|mesh-ancestor
93243054|NCT05575544|Morphine|morphine|mesh-list
93243055|NCT05575544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93243056|NCT05575544|Narcotics|narcotics|mesh-ancestor
93243057|NCT05575544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243058|NCT05575544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243059|NCT05575544|Analgesics|analgesics|mesh-ancestor
93243060|NCT05575544|Sensory System Agents|sensory system agents|mesh-ancestor
93243061|NCT05575544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243062|NCT05179772|Olanzapine|olanzapine|mesh-list
93243063|NCT05179772|Antiemetics|antiemetics|mesh-ancestor
93243064|NCT05179772|Autonomic Agents|autonomic agents|mesh-ancestor
93243065|NCT05179772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243066|NCT05179772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243067|NCT05179772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243068|NCT05179772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93243069|NCT05179772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93243070|NCT05179772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243071|NCT05179772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92537737|NCT00142480|Growth Substances|growth substances|mesh-ancestor
93243072|NCT05179772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93243073|NCT05179772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93243074|NCT05179772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93243075|NCT05179772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243076|NCT05179772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243077|NCT05179772|Serotonin Agents|serotonin agents|mesh-ancestor
93243078|NCT01364987|Mycophenolic Acid|mycophenolic acid|mesh-list
93243079|NCT01364987|Peficitinib|peficitinib|mesh-list
93243080|NCT01364987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93243081|NCT01364987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537741|NCT00142480|Antimetabolites|antimetabolites|mesh-ancestor
93243082|NCT01364987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93243083|NCT01364987|Antitubercular Agents|antitubercular agents|mesh-ancestor
91945412|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243084|NCT01364987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93243085|NCT01364987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243086|NCT01364987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092420|NCT05571046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243087|NCT01364987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243088|NCT01364987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620742|NCT00151073|Docetaxel|docetaxel|mesh-list
93243089|NCT01364987|Immunologic Factors|immunologic factors|mesh-ancestor
93243090|NCT01364987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243091|NCT01365923|Dexmedetomidine|dexmedetomidine|mesh-list
93243092|NCT01365923|Remifentanil|remifentanil|mesh-list
93243093|NCT01365923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93243094|NCT01365923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243095|NCT01365923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243096|NCT01365923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93243097|NCT01365923|Analgesics|analgesics|mesh-ancestor
93243098|NCT01365923|Sensory System Agents|sensory system agents|mesh-ancestor
93243099|NCT01365923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243100|NCT01365923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93243101|NCT01365923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93243102|NCT01365923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93243103|NCT01365923|Adrenergic Agents|adrenergic agents|mesh-ancestor
93243104|NCT01365923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243105|NCT01365923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243106|NCT01365923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93243107|NCT01365923|Narcotics|narcotics|mesh-ancestor
93243109|NCT01370915|Pregabalin|pregabalin|mesh-list
93243110|NCT01370915|Micronutrients|micronutrients|mesh-ancestor
93243111|NCT01370915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243112|NCT01370915|Analgesics|analgesics|mesh-ancestor
93243113|NCT01370915|Sensory System Agents|sensory system agents|mesh-ancestor
93243114|NCT01370915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243115|NCT01370915|Anticonvulsants|anticonvulsants|mesh-ancestor
93243116|NCT01370915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93243117|NCT01370915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93243118|NCT01370915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243119|NCT01370915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93243120|NCT01370915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93243121|NCT01370915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537768|NCT00142870|Dopamine Agents|dopamine agents|mesh-ancestor
93243122|NCT01370915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243123|NCT01370915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243124|NCT05574998|Paclitaxel|paclitaxel|mesh-list
93243125|NCT05574998|Cisplatin|cisplatin|mesh-list
93243126|NCT05574998|Carboplatin|carboplatin|mesh-list
93243127|NCT05574998|Pemetrexed|pemetrexed|mesh-list
93243128|NCT05574998|Endostar protein|endostar protein|mesh-list
93243129|NCT05574998|Endostatins|endostatins|mesh-list
93243130|NCT05574998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93243131|NCT05574998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243132|NCT05574998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92621295|NCT00152282|Estrogens|estrogens|mesh-ancestor
93243133|NCT05574998|Antimitotic Agents|antimitotic agents|mesh-ancestor
93243134|NCT05574998|Mitosis Modulators|mitosis modulators|mesh-ancestor
93243135|NCT05574998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243136|NCT05574998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243137|NCT05574998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93092421|NCT03849404|Adalimumab|adalimumab|mesh-list
93243138|NCT05574998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93243139|NCT05574998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93243140|NCT05574998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93243141|NCT05574998|Growth Substances|growth substances|mesh-ancestor
93243142|NCT05574998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243143|NCT05574998|Growth Inhibitors|growth inhibitors|mesh-ancestor
93243144|NCT03547778|Misoprostol|misoprostol|mesh-list
93243145|NCT03547778|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93243146|NCT03547778|Abortifacient Agents|abortifacient agents|mesh-ancestor
93243147|NCT03547778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92621675|NCT02935075|Tenofovir|tenofovir|mesh-list
93243148|NCT03547778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243149|NCT03547778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93243150|NCT03547778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243151|NCT03547778|Oxytocics|oxytocics|mesh-ancestor
93243152|NCT03547700|Ixazomib|ixazomib|mesh-list
93243153|NCT03547700|Romidepsin|romidepsin|mesh-list
92537812|NCT00404599|Simvastatin|simvastatin|mesh-list
93243154|NCT03547700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243155|NCT03547700|Protease Inhibitors|protease inhibitors|mesh-ancestor
93243156|NCT03547700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243157|NCT03547700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243158|NCT03547700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92621906|NCT00165477|Lenalidomide|lenalidomide|mesh-list
93243159|NCT03547700|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93243160|NCT02239458|Saxagliptin|saxagliptin|mesh-list
93243161|NCT02239458|Incretins|incretins|mesh-ancestor
93243162|NCT02239458|Hormones|hormones|mesh-ancestor
92537820|NCT00143065|Rituximab|rituximab|mesh-list
93243163|NCT02239458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92622040|NCT00153998|Irinotecan|irinotecan|mesh-list
93243164|NCT02239458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243165|NCT02239458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93243166|NCT02239458|Protease Inhibitors|protease inhibitors|mesh-ancestor
93243167|NCT02239458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537828|NCT00143104|Insulin|insulin|mesh-list
93243168|NCT02239458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243169|NCT02239458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93243170|NCT03578874|Capecitabine|capecitabine|mesh-list
93243171|NCT03578874|Oxaliplatin|oxaliplatin|mesh-list
93243172|NCT03578874|Sorafenib|sorafenib|mesh-list
93243173|NCT03578874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93243174|NCT03578874|Antimetabolites|antimetabolites|mesh-ancestor
93243175|NCT03578874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243176|NCT03578874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243177|NCT03578874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93243178|NCT03578874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243179|NCT04586504|Midazolam|midazolam|mesh-list
93243180|NCT04586504|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93243181|NCT04586504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92622399|NCT02920489|Sufentanil|sufentanil|mesh-list
93243182|NCT04586504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243183|NCT04586504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243184|NCT04586504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93243185|NCT04586504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93243186|NCT04586504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91968002|NCT05015595|Memantine|memantine|mesh-list
93243187|NCT04586504|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93243188|NCT04586504|Anesthetics, General|anesthetics, general|mesh-ancestor
93243189|NCT04586504|Anesthetics|anesthetics|mesh-ancestor
93243190|NCT04586504|GABA Modulators|gaba modulators|mesh-ancestor
93243191|NCT04586504|GABA Agents|gaba agents|mesh-ancestor
93243192|NCT04586504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243193|NCT04586504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243194|NCT01366001|Buprenorphine|buprenorphine|mesh-list
93243195|NCT01366001|ALKS-33|alks-33|mesh-list
93243196|NCT01366001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93243197|NCT01366001|Narcotics|narcotics|mesh-ancestor
93243198|NCT01366001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243199|NCT01366001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243200|NCT01366001|Analgesics|analgesics|mesh-ancestor
93243201|NCT01366001|Sensory System Agents|sensory system agents|mesh-ancestor
93243202|NCT01366001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243203|NCT01366001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93243204|NCT01365065|Vorinostat|vorinostat|mesh-list
93243205|NCT01365065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622850|NCT04686448|Anesthetics|anesthetics|mesh-ancestor
93243206|NCT01365065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93243207|NCT01365065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243208|NCT01365065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243209|NCT03576456|Alprazolam|alprazolam|mesh-list
93243210|NCT03576456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93243211|NCT03576456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243212|NCT03576456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243213|NCT03576456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93243214|NCT03576456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93243215|NCT03576456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243216|NCT03576456|GABA Modulators|gaba modulators|mesh-ancestor
93243217|NCT03576456|GABA Agents|gaba agents|mesh-ancestor
93243218|NCT03576456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243219|NCT03576456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243221|NCT03576378|Cyclophosphamide|cyclophosphamide|mesh-list
93243222|NCT03576378|Etoposide|etoposide|mesh-list
93243223|NCT03576378|Mitoxantrone|mitoxantrone|mesh-list
93243224|NCT03576378|Procarbazine|procarbazine|mesh-list
93243225|NCT03576378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93243226|NCT03576378|Immunologic Factors|immunologic factors|mesh-ancestor
92537876|NCT00143377|Urological Agents|urological agents|mesh-ancestor
93243227|NCT03576378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243228|NCT03576378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243229|NCT03576378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93243230|NCT03576378|Alkylating Agents|alkylating agents|mesh-ancestor
93243231|NCT03576378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243232|NCT03576378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243233|NCT03576378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93243234|NCT03576378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243235|NCT03576378|Glucocorticoids|glucocorticoids|mesh-ancestor
93243236|NCT03576378|Hormones|hormones|mesh-ancestor
93243237|NCT03576378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243238|NCT03576378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93243239|NCT03576378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93243240|NCT03576378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93243241|NCT03576378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243242|NCT03576378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243243|NCT03576378|Analgesics|analgesics|mesh-ancestor
93243244|NCT03576378|Sensory System Agents|sensory system agents|mesh-ancestor
93243245|NCT03576378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243246|NCT05572190|Hydrocodone|hydrocodone|mesh-list
93243247|NCT05572190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93243248|NCT05572190|Narcotics|narcotics|mesh-ancestor
93243249|NCT05572190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243250|NCT05572190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243251|NCT05572190|Analgesics|analgesics|mesh-ancestor
93243252|NCT05572190|Sensory System Agents|sensory system agents|mesh-ancestor
93243253|NCT05572190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243254|NCT05572190|Antitussive Agents|antitussive agents|mesh-ancestor
93243255|NCT05572190|Respiratory System Agents|respiratory system agents|mesh-ancestor
93243256|NCT01365221|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93243257|NCT01365221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93243258|NCT05567588|Pembrolizumab|pembrolizumab|mesh-list
93243259|NCT05567588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243260|NCT05567588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243261|NCT05567588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243262|NCT05567588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243263|NCT03124199|Rifaximin|rifaximin|mesh-list
93243264|NCT03124199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93243265|NCT03124199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243266|NCT03124199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243267|NCT03578640|Grazoprevir|grazoprevir|mesh-list
93243268|NCT03578640|Antiviral Agents|antiviral agents|mesh-ancestor
93243269|NCT03578640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243270|NCT04465916|Tenofovir|tenofovir|mesh-list
93243271|NCT04465916|Entecavir|entecavir|mesh-list
93243272|NCT04465916|Antiviral Agents|antiviral agents|mesh-ancestor
93243273|NCT04465916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243274|NCT04465916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93243275|NCT04465916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93243276|NCT04465916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243277|NCT04465916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243278|NCT04465916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93243279|NCT04465916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93243280|NCT01366235|Chloroquine|chloroquine|mesh-list
93243281|NCT01366235|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93243282|NCT01366235|Amebicides|amebicides|mesh-ancestor
93243283|NCT01366235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93243284|NCT01366235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93243285|NCT01366235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243286|NCT01366235|Antimalarials|antimalarials|mesh-ancestor
93243287|NCT01366235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537909|NCT00393315|Paclitaxel|paclitaxel|mesh-list
93243288|NCT01366235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93243289|NCT01366235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93243290|NCT01366235|Analgesics|analgesics|mesh-ancestor
93243291|NCT01366235|Sensory System Agents|sensory system agents|mesh-ancestor
93243292|NCT01366235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243293|NCT01366235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243294|NCT01366235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243295|NCT01366235|Filaricides|filaricides|mesh-ancestor
93243296|NCT01366235|Antinematodal Agents|antinematodal agents|mesh-ancestor
93243297|NCT01366235|Anthelmintics|anthelmintics|mesh-ancestor
93243298|NCT04871165|Immunoglobulins|immunoglobulins|mesh-list
93243299|NCT04871165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93243300|NCT04871165|Antibodies|antibodies|mesh-list
93243301|NCT04871165|Immunologic Factors|immunologic factors|mesh-ancestor
93243302|NCT04871165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243303|NCT04465760|Antibodies|antibodies|mesh-list
93243304|NCT04465760|Immunoglobulins|immunoglobulins|mesh-list
93243305|NCT04465760|Immunologic Factors|immunologic factors|mesh-ancestor
93243306|NCT04465760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243307|NCT04249739|Pembrolizumab|pembrolizumab|mesh-list
93243308|NCT04249739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243309|NCT04249739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243310|NCT04249739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243311|NCT04249739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243312|NCT01366313|Acetaminophen|acetaminophen|mesh-list
93243313|NCT01366313|Morphine|morphine|mesh-list
93243314|NCT01366313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93243315|NCT01366313|Narcotics|narcotics|mesh-ancestor
93243316|NCT01366313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537944|NCT00143728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93243317|NCT01366313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243318|NCT01366313|Analgesics|analgesics|mesh-ancestor
93243319|NCT01366313|Sensory System Agents|sensory system agents|mesh-ancestor
93243320|NCT01366313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243321|NCT01366313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93243322|NCT01366313|Antipyretics|antipyretics|mesh-ancestor
93243323|NCT05561738|Niacinamide|niacinamide|mesh-list
93243324|NCT05561738|Niacin|niacin|mesh-list
93243325|NCT05561738|Nicotinic Acids|nicotinic acids|mesh-list
93243326|NCT05561738|Vitamin B Complex|vitamin b complex|mesh-ancestor
93243327|NCT05561738|Vitamins|vitamins|mesh-ancestor
93243328|NCT05561738|Micronutrients|micronutrients|mesh-ancestor
93243329|NCT05561738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243330|NCT05561738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93243331|NCT05561738|Antimetabolites|antimetabolites|mesh-ancestor
93243332|NCT05561738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243333|NCT05561738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93243334|NCT05561738|Vasodilator Agents|vasodilator agents|mesh-ancestor
93243335|NCT02253524|Metoclopramide|metoclopramide|mesh-list
93243336|NCT02253524|Dimenhydrinate|dimenhydrinate|mesh-list
93243337|NCT02253524|Antiemetics|antiemetics|mesh-ancestor
93243338|NCT02253524|Autonomic Agents|autonomic agents|mesh-ancestor
93243339|NCT02253524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243340|NCT02253524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243341|NCT02253524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262727|NCT05857982|Hormones|hormones|mesh-ancestor
93243342|NCT02253524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93243343|NCT02253524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93243344|NCT02253524|Dopamine Agents|dopamine agents|mesh-ancestor
93243345|NCT02253524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243346|NCT02253524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243347|NCT02253524|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93243348|NCT02253524|Histamine Antagonists|histamine antagonists|mesh-ancestor
93243349|NCT02253524|Histamine Agents|histamine agents|mesh-ancestor
93243350|NCT02253602|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93243351|NCT02253602|Hematinics|hematinics|mesh-ancestor
93243352|NCT02253602|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93243353|NCT02253602|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93243354|NCT03575520|Cyclophosphamide|cyclophosphamide|mesh-list
93243355|NCT03575520|Doxorubicin|doxorubicin|mesh-list
93243356|NCT03575520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93243357|NCT03575520|Immunologic Factors|immunologic factors|mesh-ancestor
93243358|NCT03575520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243359|NCT03575520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243360|NCT03575520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93243361|NCT03575520|Alkylating Agents|alkylating agents|mesh-ancestor
93243362|NCT03575520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243363|NCT03575520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243364|NCT03575520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93243365|NCT03575520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93243366|NCT03575520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93243367|NCT03575520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243368|NCT03575520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243369|NCT01366391|Metformin|metformin|mesh-list
93243370|NCT01366391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93243371|NCT01366391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243372|NCT04408586|Topiramate|topiramate|mesh-list
93243373|NCT04408586|Phentermine|phentermine|mesh-list
93243374|NCT04408586|Anticonvulsants|anticonvulsants|mesh-ancestor
93243375|NCT04408586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93243376|NCT04408586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243377|NCT04408586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93243378|NCT04408586|Appetite Depressants|appetite depressants|mesh-ancestor
93243379|NCT04408586|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93243380|NCT04408586|Sympathomimetics|sympathomimetics|mesh-ancestor
93243381|NCT04408586|Autonomic Agents|autonomic agents|mesh-ancestor
93243382|NCT04408586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243383|NCT04408586|Adrenergic Agents|adrenergic agents|mesh-ancestor
93243384|NCT04408586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243385|NCT04408586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243386|NCT02239614|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93243387|NCT02239614|Aluminum sulfate|aluminum sulfate|mesh-list
93243388|NCT02239614|Immunologic Factors|immunologic factors|mesh-ancestor
93243389|NCT02239614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243390|NCT02239614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93243391|NCT02239614|Antacids|antacids|mesh-ancestor
93243392|NCT02239614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243393|NCT02239614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243394|NCT03572400|Gemcitabine|gemcitabine|mesh-list
93243395|NCT03572400|Durvalumab|durvalumab|mesh-list
93243396|NCT03572400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92538035|NCT00404716|Cilostazol|cilostazol|mesh-list
93243397|NCT03572400|Antimetabolites|antimetabolites|mesh-ancestor
93092422|NCT03849404|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93243398|NCT03572400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243399|NCT03572400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243400|NCT03572400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243401|NCT02253836|Ritonavir|ritonavir|mesh-list
93243402|NCT02253836|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93243403|NCT02253836|Tipranavir|tipranavir|mesh-list
93243404|NCT02253836|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93243405|NCT02253836|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92538058|NCT00404794|Tacrolimus|tacrolimus|mesh-list
93243406|NCT02253836|Protease Inhibitors|protease inhibitors|mesh-ancestor
93243407|NCT02253836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243408|NCT02253836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243409|NCT02253836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93243410|NCT02253836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93243411|NCT02253836|Antiviral Agents|antiviral agents|mesh-ancestor
93243412|NCT02253836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243413|NCT02253836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93243414|NCT02253836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93243415|NCT03575130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93243416|NCT03575130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93243417|NCT02241018|Antibodies|antibodies|mesh-list
93243418|NCT02241018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93243419|NCT02241018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93243420|NCT02241018|Immunologic Factors|immunologic factors|mesh-ancestor
93243421|NCT02241018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243422|NCT02241018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092423|NCT03849404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243423|NCT02241018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243424|NCT04039022|Dextromethorphan|dextromethorphan|mesh-list
93243425|NCT04039022|Bupropion|bupropion|mesh-list
93243426|NCT04039022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93243427|NCT04039022|Antidepressive Agents|antidepressive agents|mesh-ancestor
93243428|NCT04039022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243429|NCT04039022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93243430|NCT04039022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93243431|NCT04039022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93243432|NCT04039022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243433|NCT04039022|Dopamine Agents|dopamine agents|mesh-ancestor
93243434|NCT04039022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243435|NCT04039022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243436|NCT04039022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93243437|NCT04039022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93243438|NCT04039022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243439|NCT04039022|Antitussive Agents|antitussive agents|mesh-ancestor
93243440|NCT04039022|Respiratory System Agents|respiratory system agents|mesh-ancestor
93243441|NCT04039022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93243442|NCT04039022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93243443|NCT00109772|Lenalidomide|lenalidomide|mesh-list
93243444|NCT00109772|Immunologic Factors|immunologic factors|mesh-ancestor
93243445|NCT00109772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243446|NCT00109772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93243447|NCT00109772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93243448|NCT00109772|Growth Substances|growth substances|mesh-ancestor
93243449|NCT00109772|Growth Inhibitors|growth inhibitors|mesh-ancestor
93243450|NCT00109772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243451|NCT03572010|Fesoterodine|fesoterodine|mesh-list
93243452|NCT03572010|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93243453|NCT03572010|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93243454|NCT03572010|Cholinergic Agents|cholinergic agents|mesh-ancestor
93243455|NCT03572010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243456|NCT03572010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243457|NCT03572010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243458|NCT03572010|Urological Agents|urological agents|mesh-ancestor
93243459|NCT01560104|Paclitaxel|paclitaxel|mesh-list
93243460|NCT01560104|Carboplatin|carboplatin|mesh-list
93243461|NCT01560104|Veliparib|veliparib|mesh-list
93243462|NCT01560104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93243463|NCT01560104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243464|NCT01560104|Tubulin Modulators|tubulin modulators|mesh-ancestor
93243465|NCT01560104|Antimitotic Agents|antimitotic agents|mesh-ancestor
93243466|NCT01560104|Mitosis Modulators|mitosis modulators|mesh-ancestor
93243467|NCT01560104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243468|NCT01560104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93243469|NCT01560104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243470|NCT00101972|Antibodies|antibodies|mesh-list
93243471|NCT00101972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93243472|NCT00101972|Immunologic Factors|immunologic factors|mesh-ancestor
93243473|NCT00101972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243474|NCT02245932|Resveratrol|resveratrol|mesh-list
93243475|NCT02245932|Antioxidants|antioxidants|mesh-ancestor
93243476|NCT02245932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243477|NCT02245932|Protective Agents|protective agents|mesh-ancestor
93243478|NCT02245932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243479|NCT02245932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243480|NCT02245932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93243481|NCT03573102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93243482|NCT03573102|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92538120|NCT03128021|Milnacipran|milnacipran|mesh-list
93243483|NCT03573102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243484|NCT03573102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243485|NCT03573102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243486|NCT03573102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93243487|NCT03573102|Protease Inhibitors|protease inhibitors|mesh-ancestor
93243488|NCT03865706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93243489|NCT03865706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93243490|NCT03865706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243491|NCT03865706|Antitubercular Agents|antitubercular agents|mesh-ancestor
93243492|NCT04944368|Myeloma Proteins|myeloma proteins|mesh-list
93243493|NCT04944368|Paraproteins|paraproteins|mesh-list
93243494|NCT04944368|Immunologic Factors|immunologic factors|mesh-ancestor
93243495|NCT04944368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243496|NCT04260464|PF-06700841|pf-06700841|mesh-list
93243497|NCT04260464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93243498|NCT04260464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243499|NCT04260464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243500|NCT03651518|Rituximab|rituximab|mesh-list
93243501|NCT03651518|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93243502|NCT03651518|Ustekinumab|ustekinumab|mesh-list
93243503|NCT03651518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243504|NCT03651518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243505|NCT03651518|Immunologic Factors|immunologic factors|mesh-ancestor
93243506|NCT03651518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243507|NCT03651518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243508|NCT03651518|Dermatologic Agents|dermatologic agents|mesh-ancestor
93243509|NCT03546530|Interferons|interferons|mesh-list
93243510|NCT03546530|Resveratrol|resveratrol|mesh-list
93243511|NCT03546530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243512|NCT03546530|Antiviral Agents|antiviral agents|mesh-ancestor
93243513|NCT03546530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243514|NCT03546530|Antioxidants|antioxidants|mesh-ancestor
93243515|NCT03546530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243516|NCT03546530|Protective Agents|protective agents|mesh-ancestor
93243517|NCT03546530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243518|NCT03546530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243519|NCT03546530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93243520|NCT03568994|Cytarabine|cytarabine|mesh-list
93243521|NCT03568994|Atovaquone|atovaquone|mesh-list
93243522|NCT03568994|Etoposide|etoposide|mesh-list
93243523|NCT03568994|Daunorubicin|daunorubicin|mesh-list
93243525|NCT03568994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93243526|NCT03568994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243527|NCT03568994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93243528|NCT03568994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243529|NCT03568994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243530|NCT03568994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243531|NCT03568994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93243532|NCT03568994|Antimetabolites|antimetabolites|mesh-ancestor
93243533|NCT03568994|Antiviral Agents|antiviral agents|mesh-ancestor
93243534|NCT03568994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243535|NCT03568994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93243536|NCT03568994|Immunologic Factors|immunologic factors|mesh-ancestor
93243537|NCT03568994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243538|NCT03568994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93243539|NCT03568994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243540|NCT03568994|Immunotoxins|immunotoxins|mesh-ancestor
93243541|NCT03568994|Immunoconjugates|immunoconjugates|mesh-ancestor
93243542|NCT03568994|Antimalarials|antimalarials|mesh-ancestor
93243543|NCT03568994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93243544|NCT03568994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93243545|NCT04203056|Aripiprazole|aripiprazole|mesh-list
93243546|NCT04203056|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
93243547|NCT04203056|Antidepressive Agents|antidepressive agents|mesh-ancestor
93243548|NCT04203056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243549|NCT04203056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93243550|NCT04203056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93243551|NCT04203056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243552|NCT04203056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243553|NCT04203056|Dopamine Agonists|dopamine agonists|mesh-ancestor
93243554|NCT04203056|Dopamine Agents|dopamine agents|mesh-ancestor
93243555|NCT04203056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243556|NCT04203056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538188|NCT03092453|Cyclophosphamide|cyclophosphamide|mesh-list
93243557|NCT04203056|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93243558|NCT04203056|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93243559|NCT04203056|Serotonin Agents|serotonin agents|mesh-ancestor
93243560|NCT04203056|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93243561|NCT04203056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93243562|NCT04203056|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93243563|NCT04203056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93243564|NCT04894994|Ipilimumab|ipilimumab|mesh-list
93243565|NCT04894994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243566|NCT04894994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243567|NCT04894994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243568|NCT04894994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243569|NCT01366547|Lamivudine|lamivudine|mesh-list
93243570|NCT01366547|Abacavir|abacavir|mesh-list
93243571|NCT01366547|Dideoxynucleosides|dideoxynucleosides|mesh-list
93243572|NCT01366547|Dolutegravir|dolutegravir|mesh-list
93243573|NCT01366547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93243574|NCT01366547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93243575|NCT01366547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243576|NCT01366547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243577|NCT01366547|Antiviral Agents|antiviral agents|mesh-ancestor
93243578|NCT01366547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243579|NCT01366547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93243580|NCT01366547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93243581|NCT01366547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93243582|NCT01366547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93243583|NCT01366547|Antimetabolites|antimetabolites|mesh-ancestor
93243584|NCT05190341|Ibuprofen|ibuprofen|mesh-list
93243585|NCT05190341|Ketorolac|ketorolac|mesh-list
92624001|NCT00158834|Xhance|xhance|mesh-list
93243586|NCT05190341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93243587|NCT05190341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93243588|NCT05190341|Analgesics|analgesics|mesh-ancestor
93243589|NCT05190341|Sensory System Agents|sensory system agents|mesh-ancestor
93243590|NCT05190341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243591|NCT05190341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243592|NCT05190341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243593|NCT05190341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243594|NCT05190341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93243595|NCT05190341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243596|NCT05190341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915580|NCT00790023|Hormones|hormones|mesh-ancestor
93243597|NCT04347239|Leronlimab|leronlimab|mesh-list
93243598|NCT04347239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93243599|NCT04347239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93243600|NCT04347239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243601|NCT04347239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93243602|NCT04347239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93243603|NCT04347239|Antiviral Agents|antiviral agents|mesh-ancestor
93243604|NCT04347239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243605|NCT00109928|Methylprednisolone|methylprednisolone|mesh-list
93243606|NCT00109928|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93243607|NCT00109928|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93243608|NCT00109928|Prednisolone|prednisolone|mesh-list
93243609|NCT00109928|Prednisolone acetate|prednisolone acetate|mesh-list
93243610|NCT00109928|Gemcitabine|gemcitabine|mesh-list
93243611|NCT00109928|Etoposide|etoposide|mesh-list
93243612|NCT00109928|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93243613|NCT00109928|Prednisolone phosphate|prednisolone phosphate|mesh-list
93243614|NCT00109928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243615|NCT00109928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93243616|NCT00109928|Antimetabolites|antimetabolites|mesh-ancestor
93243617|NCT00109928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243618|NCT00109928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93243619|NCT00109928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93243620|NCT00109928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243621|NCT00109928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243622|NCT00109928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243623|NCT00109928|Antiemetics|antiemetics|mesh-ancestor
93243624|NCT00109928|Autonomic Agents|autonomic agents|mesh-ancestor
93243625|NCT00109928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243626|NCT00109928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243627|NCT00109928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243628|NCT00109928|Glucocorticoids|glucocorticoids|mesh-ancestor
93243629|NCT00109928|Hormones|hormones|mesh-ancestor
93243630|NCT00109928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243631|NCT00109928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93243632|NCT00109928|Protective Agents|protective agents|mesh-ancestor
93243633|NCT00109928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93243634|NCT02104310|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
93243635|NCT02104310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243636|NCT02104310|Dopamine Agents|dopamine agents|mesh-ancestor
92538263|NCT03079427|Antimetabolites|antimetabolites|mesh-ancestor
93243637|NCT02104310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243638|NCT02104310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243639|NCT00109850|Irinotecan|irinotecan|mesh-list
93243640|NCT00109850|Cetuximab|cetuximab|mesh-list
93243641|NCT00109850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243642|NCT00109850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93243643|NCT00109850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243644|NCT00109850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243645|NCT00109850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243646|NCT00109850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243647|NCT03318770|Dasatinib|dasatinib|mesh-list
93243648|NCT03318770|Blinatumomab|blinatumomab|mesh-list
93243649|NCT03318770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243650|NCT03318770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93243651|NCT03318770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243652|NCT03318770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243653|NCT01065519|Umirolimus|umirolimus|mesh-list
93243654|NCT01065519|Everolimus|everolimus|mesh-list
93243655|NCT01065519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93243656|NCT01065519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93243657|NCT01065519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243658|NCT01065519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243659|NCT01065519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93243660|NCT01065519|Immunologic Factors|immunologic factors|mesh-ancestor
93243661|NCT01065519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243662|NCT01065519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243663|NCT01065519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243664|NCT05539989|Vaccines|vaccines|mesh-list
93243665|NCT05539989|BCG Vaccine|bcg vaccine|mesh-list
93243666|NCT05539989|Immunologic Factors|immunologic factors|mesh-ancestor
93243667|NCT05539989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243668|NCT05539989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93243669|NCT05493111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93243670|NCT05493111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93243671|NCT01810016|Poly I-C|poly i-c|mesh-list
92915644|NCT03746275|Sensory System Agents|sensory system agents|mesh-ancestor
93243672|NCT01810016|Ipilimumab|ipilimumab|mesh-list
93243673|NCT01810016|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93243674|NCT01810016|Vaccines|vaccines|mesh-list
93243675|NCT01810016|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93243676|NCT01810016|Poly ICLC|poly iclc|mesh-list
93243677|NCT01810016|Immunologic Factors|immunologic factors|mesh-ancestor
93243678|NCT01810016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243679|NCT01810016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243680|NCT01810016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243681|NCT01810016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243682|NCT01810016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243683|NCT01810016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93243684|NCT01810016|Interferon Inducers|interferon inducers|mesh-ancestor
93243685|NCT01810016|Laxatives|laxatives|mesh-ancestor
93243686|NCT01810016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243687|NCT01810016|Antiviral Agents|antiviral agents|mesh-ancestor
93243688|NCT01810016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243689|NCT01722266|Liraglutide|liraglutide|mesh-list
93243690|NCT01722266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93243691|NCT01722266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243692|NCT01722266|Incretins|incretins|mesh-ancestor
93243693|NCT01722266|Hormones|hormones|mesh-ancestor
93243694|NCT01722266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243695|NCT02254148|Metoprolol|metoprolol|mesh-list
93243696|NCT02254148|Digoxin|digoxin|mesh-list
93243697|NCT02254148|Midazolam|midazolam|mesh-list
93243698|NCT02254148|Caffeine|caffeine|mesh-list
93243699|NCT02254148|Omeprazole|omeprazole|mesh-list
93243700|NCT02254148|Warfarin|warfarin|mesh-list
93243701|NCT02254148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93243702|NCT02254148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93243703|NCT02254148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93243704|NCT02254148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243705|NCT02254148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93243706|NCT02254148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93243707|NCT02254148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243708|NCT02254148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93243709|NCT02254148|Anesthetics, General|anesthetics, general|mesh-ancestor
93243710|NCT02254148|Anesthetics|anesthetics|mesh-ancestor
93243711|NCT02254148|GABA Modulators|gaba modulators|mesh-ancestor
93243712|NCT02254148|GABA Agents|gaba agents|mesh-ancestor
93243713|NCT02254148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243714|NCT02254148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243715|NCT02254148|Anticoagulants|anticoagulants|mesh-ancestor
93243716|NCT02254148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93243717|NCT02254148|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93243718|NCT02254148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243719|NCT02254148|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93243720|NCT02254148|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93243721|NCT02254148|Purinergic Agents|purinergic agents|mesh-ancestor
93243722|NCT02254148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93243723|NCT02254148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243724|NCT02254148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93243725|NCT02254148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92538358|NCT01806753|GABA Modulators|gaba modulators|mesh-ancestor
93243726|NCT02254148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93243727|NCT02254148|Sympatholytics|sympatholytics|mesh-ancestor
93243728|NCT02254148|Autonomic Agents|autonomic agents|mesh-ancestor
93243729|NCT02254148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243730|NCT02254148|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93243731|NCT02254148|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93243732|NCT02254148|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93243733|NCT02254148|Adrenergic Agents|adrenergic agents|mesh-ancestor
93243734|NCT02254148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93243735|NCT02254148|Protective Agents|protective agents|mesh-ancestor
93243736|NCT02842866|Vaccines|vaccines|mesh-list
93243737|NCT02842866|Immunologic Factors|immunologic factors|mesh-ancestor
93243738|NCT02842866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243739|NCT01316913|Bromides|bromides|mesh-list
93243740|NCT01316913|Tiotropium Bromide|tiotropium bromide|mesh-list
93243741|NCT01316913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93243742|NCT01316913|Autonomic Agents|autonomic agents|mesh-ancestor
92538387|NCT05175430|Hallucinogens|hallucinogens|mesh-ancestor
93243743|NCT01316913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243744|NCT01316913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243745|NCT01316913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93243746|NCT01316913|Respiratory System Agents|respiratory system agents|mesh-ancestor
93243747|NCT01316913|Parasympatholytics|parasympatholytics|mesh-ancestor
93243748|NCT01316913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93243749|NCT01316913|Cholinergic Agents|cholinergic agents|mesh-ancestor
93243750|NCT01316913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243751|NCT01316913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243752|NCT01316913|Anticonvulsants|anticonvulsants|mesh-ancestor
93243753|NCT02875067|Pembrolizumab|pembrolizumab|mesh-list
93243754|NCT02875067|Lenalidomide|lenalidomide|mesh-list
93243755|NCT02875067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243756|NCT02875067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243757|NCT02875067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243758|NCT02875067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243759|NCT02875067|Immunologic Factors|immunologic factors|mesh-ancestor
93243760|NCT02875067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243761|NCT02875067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93243762|NCT02875067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93243763|NCT02875067|Growth Substances|growth substances|mesh-ancestor
93243764|NCT02875067|Growth Inhibitors|growth inhibitors|mesh-ancestor
93243765|NCT03570294|Atosiban|atosiban|mesh-list
93243766|NCT03570294|Hormone Antagonists|hormone antagonists|mesh-ancestor
93243767|NCT03570294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243768|NCT03570294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243769|NCT03570294|Tocolytic Agents|tocolytic agents|mesh-ancestor
93243770|NCT03570294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93243771|NCT02143622|Cetuximab|cetuximab|mesh-list
93243772|NCT02143622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243773|NCT02143622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243774|NCT02781506|Nivolumab|nivolumab|mesh-list
93243775|NCT02781506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243776|NCT02781506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243777|NCT02781506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243778|NCT02781506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243779|NCT03571230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93243780|NCT03571230|Amoxicillin|amoxicillin|mesh-list
93243781|NCT03571230|Metronidazole|metronidazole|mesh-list
93243782|NCT03571230|Clarithromycin|clarithromycin|mesh-list
93243783|NCT03571230|Levofloxacin|levofloxacin|mesh-list
93243784|NCT03571230|Tetracycline|tetracycline|mesh-list
93243785|NCT03571230|Tinidazole|tinidazole|mesh-list
93243786|NCT03571230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93243787|NCT03571230|Furazolidone|furazolidone|mesh-list
93243788|NCT03571230|Bismuth|bismuth|mesh-list
93243789|NCT03571230|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93243790|NCT03571230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243791|NCT03571230|Antitubercular Agents|antitubercular agents|mesh-ancestor
93243792|NCT03571230|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93243793|NCT03571230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93243794|NCT03571230|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93243795|NCT03571230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243796|NCT03571230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243797|NCT03571230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93243798|NCT03571230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93243799|NCT03571230|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93243800|NCT03571230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93243801|NCT03571230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243802|NCT03571230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243803|NCT03571230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93243804|NCT03571230|Antacids|antacids|mesh-ancestor
93243805|NCT03571230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93243806|NCT03571230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93243807|NCT03571230|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93243808|NCT03571230|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93243809|NCT03571230|Alkylating Agents|alkylating agents|mesh-ancestor
93243810|NCT03368963|Trifluridine|trifluridine|mesh-list
93243811|NCT03368963|Irinotecan|irinotecan|mesh-list
92538453|NCT01806363|Diuretics|diuretics|mesh-ancestor
93243812|NCT03368963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93243813|NCT03368963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243814|NCT03368963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243815|NCT03368963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243816|NCT03368963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243817|NCT03368963|Antimetabolites|antimetabolites|mesh-ancestor
93243818|NCT03368963|Antiviral Agents|antiviral agents|mesh-ancestor
92538464|NCT02964403|Indomethacin|indomethacin|mesh-list
93243819|NCT03368963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243820|NCT05489211|Leucovorin|leucovorin|mesh-list
93243821|NCT05489211|Bevacizumab|bevacizumab|mesh-list
93243822|NCT05489211|Nivolumab|nivolumab|mesh-list
93243823|NCT05489211|Durvalumab|durvalumab|mesh-list
93243824|NCT05489211|Carboplatin|carboplatin|mesh-list
93243825|NCT05489211|Fluorouracil|fluorouracil|mesh-list
93243826|NCT05489211|Capecitabine|capecitabine|mesh-list
93243827|NCT05489211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243828|NCT05489211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243829|NCT05489211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93243830|NCT05489211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93243831|NCT05489211|Growth Substances|growth substances|mesh-ancestor
93243832|NCT05489211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243833|NCT05489211|Growth Inhibitors|growth inhibitors|mesh-ancestor
93243834|NCT05489211|Antimetabolites|antimetabolites|mesh-ancestor
93243835|NCT05489211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243836|NCT05489211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93243837|NCT05489211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93243838|NCT05489211|Immunologic Factors|immunologic factors|mesh-ancestor
93243839|NCT05489211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243840|NCT05489211|Antidotes|antidotes|mesh-ancestor
93243841|NCT05489211|Protective Agents|protective agents|mesh-ancestor
93243842|NCT05489211|Vitamin B Complex|vitamin b complex|mesh-ancestor
93243843|NCT05489211|Vitamins|vitamins|mesh-ancestor
93243844|NCT05489211|Micronutrients|micronutrients|mesh-ancestor
93243845|NCT02254226|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93243846|NCT02254226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93243847|NCT02254226|Autonomic Agents|autonomic agents|mesh-ancestor
93243848|NCT02254226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243849|NCT02254226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243850|NCT02254226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93243851|NCT02254226|Respiratory System Agents|respiratory system agents|mesh-ancestor
93243852|NCT02254226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93243853|NCT02254226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93243854|NCT02254226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93243855|NCT02254226|Adrenergic Agents|adrenergic agents|mesh-ancestor
93243856|NCT02254226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243857|NCT02254226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243858|NCT02143934|Lumefantrine|lumefantrine|mesh-list
93243859|NCT02143934|Chloroquine|chloroquine|mesh-list
93243860|NCT02143934|Artemether|artemether|mesh-list
93243861|NCT02143934|Primaquine|primaquine|mesh-list
93243862|NCT02143934|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93243863|NCT02143934|Antimalarials|antimalarials|mesh-ancestor
93243864|NCT02143934|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93243865|NCT02143934|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93243866|NCT02143934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243867|NCT02143934|Amebicides|amebicides|mesh-ancestor
93243868|NCT02143934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243869|NCT03096847|Letrozole|letrozole|mesh-list
93243870|NCT03096847|Goserelin|goserelin|mesh-list
93243871|NCT03096847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243872|NCT03096847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93243873|NCT03096847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93243874|NCT03096847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243875|NCT03096847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243876|NCT03096847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93243877|NCT03096847|Hormone Antagonists|hormone antagonists|mesh-ancestor
93243878|NCT03096847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243879|NCT03096847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243880|NCT03096847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93243881|NCT03545516|Dexmedetomidine|dexmedetomidine|mesh-list
93243882|NCT03545516|Bupivacaine|bupivacaine|mesh-list
93243883|NCT03545516|Anesthetics, Local|anesthetics, local|mesh-ancestor
93243884|NCT03545516|Anesthetics|anesthetics|mesh-ancestor
93243885|NCT03545516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092424|NCT03849404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243886|NCT03545516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243887|NCT03545516|Sensory System Agents|sensory system agents|mesh-ancestor
93243888|NCT03545516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243889|NCT03545516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93243890|NCT03545516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93243891|NCT03545516|Analgesics|analgesics|mesh-ancestor
93243892|NCT03545516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93243893|NCT03545516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93243894|NCT03545516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93243895|NCT03545516|Adrenergic Agents|adrenergic agents|mesh-ancestor
93243896|NCT03545516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538535|NCT00393471|Etanercept|etanercept|mesh-list
93243897|NCT03545516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243898|NCT04753879|Paclitaxel|paclitaxel|mesh-list
93243899|NCT04753879|Gemcitabine|gemcitabine|mesh-list
93243900|NCT04753879|Pembrolizumab|pembrolizumab|mesh-list
93243901|NCT04753879|Capecitabine|capecitabine|mesh-list
93243902|NCT04753879|Irinotecan|irinotecan|mesh-list
92915869|NCT01026961|Mydriatics|mydriatics|mesh-ancestor
93243903|NCT04753879|Olaparib|olaparib|mesh-list
93243904|NCT04753879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93243905|NCT04753879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243906|NCT04753879|Tubulin Modulators|tubulin modulators|mesh-ancestor
93243907|NCT04753879|Antimitotic Agents|antimitotic agents|mesh-ancestor
93243908|NCT04753879|Mitosis Modulators|mitosis modulators|mesh-ancestor
93243909|NCT04753879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243910|NCT04753879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93243911|NCT04753879|Antimetabolites|antimetabolites|mesh-ancestor
93243912|NCT04753879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243913|NCT04753879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243914|NCT04753879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93243915|NCT04753879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93243916|NCT04753879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243917|NCT04753879|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93243918|NCT02846532|Aspirin|aspirin|mesh-list
93243919|NCT02846532|Rivaroxaban|rivaroxaban|mesh-list
93243920|NCT02846532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93243921|NCT02846532|Antithrombins|antithrombins|mesh-ancestor
93243922|NCT02846532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93243923|NCT02846532|Protease Inhibitors|protease inhibitors|mesh-ancestor
93243924|NCT02846532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243925|NCT02846532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243926|NCT02846532|Anticoagulants|anticoagulants|mesh-ancestor
93243927|NCT02846532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93243928|NCT02846532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93243929|NCT02846532|Analgesics|analgesics|mesh-ancestor
93243930|NCT02846532|Sensory System Agents|sensory system agents|mesh-ancestor
93243931|NCT02846532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93243932|NCT02846532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243933|NCT02846532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93243934|NCT02846532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243935|NCT02846532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93243936|NCT02846532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93243937|NCT02846532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93243938|NCT02846532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93243939|NCT02846532|Antipyretics|antipyretics|mesh-ancestor
93243940|NCT01371461|Paroxetine|paroxetine|mesh-list
93243941|NCT01371461|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93243942|NCT01371461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93243943|NCT01371461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93243944|NCT01371461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243945|NCT01371461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93243946|NCT01371461|Serotonin Agents|serotonin agents|mesh-ancestor
93243947|NCT01371461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243948|NCT01371461|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93243949|NCT01371461|Antidepressive Agents|antidepressive agents|mesh-ancestor
93243950|NCT01371461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93243951|NCT01371461|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93243952|NCT01371461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93243953|NCT01371461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243954|NCT05324423|Colchicine|colchicine|mesh-list
93243955|NCT05324423|Febuxostat|febuxostat|mesh-list
93243956|NCT05324423|Gout Suppressants|gout suppressants|mesh-ancestor
93243957|NCT05324423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93243958|NCT05324423|Tubulin Modulators|tubulin modulators|mesh-ancestor
93243959|NCT05324423|Antimitotic Agents|antimitotic agents|mesh-ancestor
93243960|NCT05324423|Mitosis Modulators|mitosis modulators|mesh-ancestor
93243961|NCT05324423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243962|NCT05324423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243963|NCT04704219|Pembrolizumab|pembrolizumab|mesh-list
93243964|NCT04704219|Lenvatinib|lenvatinib|mesh-list
93243965|NCT04704219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93243966|NCT04704219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243967|NCT04704219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93243968|NCT04704219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93243969|NCT04704219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93243970|NCT04704219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93243971|NCT00842348|Lanreotide|lanreotide|mesh-list
93243972|NCT00842348|Somatostatin|somatostatin|mesh-list
93243973|NCT00842348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93243974|NCT00842348|Hormones|hormones|mesh-ancestor
93243975|NCT00842348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243976|NCT00842348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243977|NCT02144246|Moxifloxacin|moxifloxacin|mesh-list
93243978|NCT02144246|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93243979|NCT02144246|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93243980|NCT02144246|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93243981|NCT02144246|Norgestimate|norgestimate|mesh-list
93243982|NCT02144246|Norgestrel|norgestrel|mesh-list
93243983|NCT02144246|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93243984|NCT02144246|Estradiol|estradiol|mesh-list
93243985|NCT02144246|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93243986|NCT02144246|Estrogens|estrogens|mesh-ancestor
93243987|NCT02144246|Hormones|hormones|mesh-ancestor
93243988|NCT02144246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93243989|NCT02144246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93243990|NCT02144246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93243991|NCT02144246|Contraceptive Agents|contraceptive agents|mesh-ancestor
93243992|NCT02144246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93243993|NCT02144246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93243994|NCT02144246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93243995|NCT02144246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93243996|NCT02144246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93243997|NCT02144246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93243998|NCT02144246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93243999|NCT02144246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93244000|NCT02144246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93244001|NCT02144246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244002|NCT02144246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244003|NCT02144246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244004|NCT02144246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93244005|NCT03095521|Menthol|menthol|mesh-list
93244006|NCT03095521|Antipruritics|antipruritics|mesh-ancestor
93244007|NCT03095521|Dermatologic Agents|dermatologic agents|mesh-ancestor
93244008|NCT01372865|Mometasone Furoate|mometasone furoate|mesh-list
93244009|NCT01372865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244010|NCT01372865|Dermatologic Agents|dermatologic agents|mesh-ancestor
93244011|NCT01372865|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93244012|NCT05242315|Tacrolimus|tacrolimus|mesh-list
93244013|NCT05242315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93244014|NCT05242315|Immunologic Factors|immunologic factors|mesh-ancestor
93244015|NCT05242315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244016|NCT05242315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93244017|NCT05242315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244018|NCT05242315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244019|NCT03569046|Antihypertensive Agents|antihypertensive agents|mesh-list
93244020|NCT03569046|Bupivacaine|bupivacaine|mesh-list
93244021|NCT03569046|Anesthetics, Local|anesthetics, local|mesh-list
93244022|NCT03569046|Anesthetics|anesthetics|mesh-list
93244023|NCT03569046|Anesthetics, General|anesthetics, general|mesh-list
93244024|NCT03569046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244025|NCT03569046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244026|NCT03569046|Sensory System Agents|sensory system agents|mesh-ancestor
93244027|NCT03569046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244028|NCT02935595|Ketamine|ketamine|mesh-list
93244029|NCT02935595|Analgesics|analgesics|mesh-ancestor
93244030|NCT02935595|Sensory System Agents|sensory system agents|mesh-ancestor
93244031|NCT02935595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244032|NCT02935595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244033|NCT02935595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93244034|NCT02935595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93244035|NCT02935595|Anesthetics, General|anesthetics, general|mesh-ancestor
93244036|NCT02935595|Anesthetics|anesthetics|mesh-ancestor
93244037|NCT02935595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244038|NCT02935595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93244039|NCT02935595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93244040|NCT02935595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244041|NCT02935595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244042|NCT02649673|Topotecan|topotecan|mesh-list
93244043|NCT02649673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93244044|NCT02649673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93244045|NCT02649673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244046|NCT02649673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244047|NCT02649673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244048|NCT03568968|Niacinamide|niacinamide|mesh-list
93244049|NCT03568968|Niacin|niacin|mesh-list
93244050|NCT03568968|Nicotinic Acids|nicotinic acids|mesh-list
93244051|NCT03568968|Vitamin B Complex|vitamin b complex|mesh-ancestor
93244052|NCT03568968|Vitamins|vitamins|mesh-ancestor
93244053|NCT03568968|Micronutrients|micronutrients|mesh-ancestor
93244054|NCT03568968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244055|NCT03568968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93244056|NCT03568968|Antimetabolites|antimetabolites|mesh-ancestor
93244057|NCT03568968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244058|NCT03568968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93244059|NCT03568968|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244060|NCT02817347|Tazobactam|tazobactam|mesh-list
93244061|NCT02817347|Piperacillin|piperacillin|mesh-list
93244062|NCT02817347|Dexamethasone|dexamethasone|mesh-list
93244063|NCT02817347|Dexamethasone acetate|dexamethasone acetate|mesh-list
93244064|NCT02817347|BB 1101|bb 1101|mesh-list
93244065|NCT02817347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244066|NCT02817347|Antiemetics|antiemetics|mesh-ancestor
93244067|NCT02817347|Autonomic Agents|autonomic agents|mesh-ancestor
93244068|NCT02817347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244069|NCT02817347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244070|NCT02817347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93244071|NCT02817347|Glucocorticoids|glucocorticoids|mesh-ancestor
93244072|NCT02817347|Hormones|hormones|mesh-ancestor
93244073|NCT02817347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244074|NCT02817347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93244075|NCT02817347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244076|NCT02817347|Protease Inhibitors|protease inhibitors|mesh-ancestor
93244077|NCT02817347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244078|NCT02817347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244079|NCT02817347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244080|NCT02817347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244081|NCT02817347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93244082|NCT01373021|Fentanyl|fentanyl|mesh-list
93244083|NCT01373021|Dexmedetomidine|dexmedetomidine|mesh-list
93244084|NCT01373021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93244085|NCT01373021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244086|NCT01373021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244087|NCT01373021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93244088|NCT01373021|Analgesics|analgesics|mesh-ancestor
93244089|NCT01373021|Sensory System Agents|sensory system agents|mesh-ancestor
93244090|NCT01373021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244091|NCT01373021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93244092|NCT01373021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93244093|NCT01373021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93244094|NCT01373021|Adrenergic Agents|adrenergic agents|mesh-ancestor
93244095|NCT01373021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244096|NCT01373021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244097|NCT01373021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93244098|NCT01373021|Narcotics|narcotics|mesh-ancestor
93244099|NCT01373021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93244100|NCT01373021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93244101|NCT01373021|Anesthetics, General|anesthetics, general|mesh-ancestor
93244102|NCT01373021|Anesthetics|anesthetics|mesh-ancestor
93244103|NCT02690558|Gemcitabine|gemcitabine|mesh-list
93244104|NCT02690558|Pembrolizumab|pembrolizumab|mesh-list
93244105|NCT02690558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092425|NCT00051636|Vitamin D|vitamin d|mesh-list
93244106|NCT02690558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93244107|NCT02690558|Antimetabolites|antimetabolites|mesh-ancestor
93244108|NCT02690558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244109|NCT02690558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244110|NCT02690558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93244111|NCT03568578|Entecavir|entecavir|mesh-list
93244112|NCT03568578|Antiviral Agents|antiviral agents|mesh-ancestor
93244113|NCT03568578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244114|NCT01367483|Methylnaltrexone|methylnaltrexone|mesh-list
93244115|NCT01367483|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93244116|NCT01367483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244117|NCT01367483|Sensory System Agents|sensory system agents|mesh-ancestor
93244118|NCT01367483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244119|NCT02140736|Epoetin Alfa|epoetin alfa|mesh-list
93244120|NCT02140736|Hematinics|hematinics|mesh-ancestor
93244121|NCT05417035|Testosterone undecanoate|testosterone undecanoate|mesh-list
93244122|NCT05417035|Androgens|androgens|mesh-ancestor
93244123|NCT05417035|Hormones|hormones|mesh-ancestor
93244124|NCT05417035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244125|NCT05417035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244126|NCT05708742|Bupivacaine|bupivacaine|mesh-list
93244127|NCT05708742|Anesthetics, Local|anesthetics, local|mesh-list
93244128|NCT05708742|Anesthetics|anesthetics|mesh-list
93244129|NCT05708742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244130|NCT05708742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244131|NCT05708742|Sensory System Agents|sensory system agents|mesh-ancestor
93244132|NCT05708742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244133|NCT03095287|Factor VIII|factor viii|mesh-list
93244134|NCT03095287|Coagulants|coagulants|mesh-ancestor
93244135|NCT01335581|Tretinoin|tretinoin|mesh-list
93244136|NCT01335581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244137|NCT01335581|Keratolytic Agents|keratolytic agents|mesh-ancestor
93244138|NCT01335581|Dermatologic Agents|dermatologic agents|mesh-ancestor
93244139|NCT05204563|Imipenem|imipenem|mesh-list
93244140|NCT05204563|Relebactam|relebactam|mesh-list
93244141|NCT05204563|Cilastatin|cilastatin|mesh-list
93244142|NCT05204563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244143|NCT05204563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244144|NCT05204563|Protease Inhibitors|protease inhibitors|mesh-ancestor
93244145|NCT05204563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244146|NCT05204563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244147|NCT05204563|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93244148|NCT02140814|Niacinamide|niacinamide|mesh-list
93244149|NCT02140814|Niacin|niacin|mesh-list
93244150|NCT02140814|Nicotinic Acids|nicotinic acids|mesh-list
93244151|NCT02140814|Vitamins|vitamins|mesh-ancestor
93244152|NCT02140814|Micronutrients|micronutrients|mesh-ancestor
93244153|NCT02140814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244154|NCT02140814|Vitamin B Complex|vitamin b complex|mesh-ancestor
93244155|NCT02140814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93244156|NCT02140814|Antimetabolites|antimetabolites|mesh-ancestor
93244157|NCT02140814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244158|NCT02140814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93244159|NCT02140814|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244160|NCT03015090|Theophylline|theophylline|mesh-list
93244161|NCT03015090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93244162|NCT03015090|Autonomic Agents|autonomic agents|mesh-ancestor
93244163|NCT03015090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244164|NCT03015090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244165|NCT03015090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93244166|NCT03015090|Respiratory System Agents|respiratory system agents|mesh-ancestor
93244167|NCT03015090|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93244168|NCT03015090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244169|NCT03015090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244170|NCT03015090|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244171|NCT03015090|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93244172|NCT03015090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93244173|NCT03015090|Purinergic Agents|purinergic agents|mesh-ancestor
93244174|NCT03015090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244175|NCT02620748|Tranexamic Acid|tranexamic acid|mesh-list
93244176|NCT02620748|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93244177|NCT02620748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93244178|NCT02620748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244179|NCT02620748|Hemostatics|hemostatics|mesh-ancestor
93244180|NCT02620748|Coagulants|coagulants|mesh-ancestor
93244181|NCT02144792|Verapamil|verapamil|mesh-list
93244182|NCT02144792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93244183|NCT02144792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93244184|NCT02144792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244185|NCT02144792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244186|NCT02144792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93244187|NCT02144792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244188|NCT02144792|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244189|NCT03566394|Gabapentin|gabapentin|mesh-list
93244190|NCT03566394|Analgesics|analgesics|mesh-ancestor
93244191|NCT03566394|Sensory System Agents|sensory system agents|mesh-ancestor
93244192|NCT03566394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538827|NCT02825641|Oxytocin|oxytocin|mesh-list
93244193|NCT03566394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244194|NCT03566394|Anticonvulsants|anticonvulsants|mesh-ancestor
93244195|NCT03566394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93244196|NCT03566394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93244197|NCT03566394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244198|NCT03566394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93244199|NCT03566394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93244200|NCT03566394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93244201|NCT03566394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244202|NCT03566394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244203|NCT03566394|Antimanic Agents|antimanic agents|mesh-ancestor
93244204|NCT00033293|Prednisone|prednisone|mesh-list
93244205|NCT00033293|Cortisone|cortisone|mesh-list
93244206|NCT00033293|Cyclophosphamide|cyclophosphamide|mesh-list
93244207|NCT00033293|Immunoglobulins|immunoglobulins|mesh-list
93244208|NCT00033293|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93244209|NCT00033293|Antibodies|antibodies|mesh-list
93244210|NCT00033293|gamma-Globulins|gamma-globulins|mesh-list
93244211|NCT00033293|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93244212|NCT00033293|Immunoglobulin G|immunoglobulin g|mesh-list
93244213|NCT00033293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93244214|NCT00033293|Immunologic Factors|immunologic factors|mesh-ancestor
93244215|NCT00033293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244216|NCT00033293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244217|NCT00033293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93244218|NCT00033293|Alkylating Agents|alkylating agents|mesh-ancestor
93244219|NCT00033293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244220|NCT00033293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244221|NCT00033293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93244222|NCT00033293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244223|NCT00033293|Glucocorticoids|glucocorticoids|mesh-ancestor
93244224|NCT00033293|Hormones|hormones|mesh-ancestor
93092426|NCT00051636|Zoledronic Acid|zoledronic acid|mesh-list
93244225|NCT00033293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244226|NCT00033293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93244227|NCT03566316|Amlodipine|amlodipine|mesh-list
93244228|NCT03566316|Telmisartan|telmisartan|mesh-list
93244229|NCT03566316|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93244230|NCT03566316|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93244231|NCT03566316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93244232|NCT03566316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93244233|NCT03566316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244234|NCT03566316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244235|NCT03566316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93244236|NCT03566316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244237|NCT03566316|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244238|NCT03566316|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93244239|NCT03566316|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93244240|NCT03566316|Antimetabolites|antimetabolites|mesh-ancestor
93244241|NCT03566316|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93244242|NCT03566316|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93244243|NCT03566316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244244|NCT03566316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93244245|NCT03566316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93244246|NCT02145104|Valsartan|valsartan|mesh-list
93244247|NCT02145104|Cilnidipine|cilnidipine|mesh-list
93244248|NCT02145104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93244249|NCT02145104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93244250|NCT02145104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93244251|NCT02145104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244252|NCT02145104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93244253|NCT02145104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244254|NCT02145104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92625528|NCT00184899|Heparin|heparin|mesh-list
93244255|NCT02145104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244256|NCT02145338|Trimethoprim|trimethoprim|mesh-list
93244257|NCT02145338|Nitrofurantoin|nitrofurantoin|mesh-list
93244258|NCT02145338|Cephalexin|cephalexin|mesh-list
93244259|NCT02145338|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93244260|NCT02145338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244261|NCT02145338|Antimalarials|antimalarials|mesh-ancestor
93244262|NCT02145338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93244263|NCT02145338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93244264|NCT02145338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93244265|NCT02145338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244266|NCT02145338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244267|NCT02145338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92538906|NCT01466361|Nicotine|nicotine|mesh-list
93244268|NCT02145338|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93244269|NCT02145338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93244270|NCT02145338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244271|NCT03565536|Sorafenib|sorafenib|mesh-list
93244272|NCT03565536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244273|NCT03565536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244274|NCT03565536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244275|NCT03565536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244276|NCT03565458|Dapagliflozin|dapagliflozin|mesh-list
93244277|NCT03565458|Empagliflozin|empagliflozin|mesh-list
93244278|NCT03565458|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93244279|NCT03565458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244280|NCT03565458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92538930|NCT00001832|Analgesics|analgesics|mesh-ancestor
93244281|NCT03565458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244282|NCT03565302|Terbutaline|terbutaline|mesh-list
93244283|NCT03565302|Formoterol Fumarate|formoterol fumarate|mesh-list
93244284|NCT03565302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93244285|NCT03565302|Autonomic Agents|autonomic agents|mesh-ancestor
93244286|NCT03565302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244287|NCT03565302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244288|NCT03565302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93244289|NCT03565302|Respiratory System Agents|respiratory system agents|mesh-ancestor
93092427|NCT00051636|Risedronic Acid|risedronic acid|mesh-list
93244290|NCT03565302|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93244291|NCT03565302|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93244292|NCT03565302|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93244293|NCT03565302|Adrenergic Agents|adrenergic agents|mesh-ancestor
93244294|NCT03565302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244295|NCT03565302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244296|NCT03565302|Sympathomimetics|sympathomimetics|mesh-ancestor
93244297|NCT03565302|Tocolytic Agents|tocolytic agents|mesh-ancestor
93244298|NCT03565302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93244299|NCT05193227|Lidocaine|lidocaine|mesh-list
93244300|NCT05193227|Bupivacaine|bupivacaine|mesh-list
93244301|NCT05193227|Anesthetics, Local|anesthetics, local|mesh-ancestor
93244302|NCT05193227|Anesthetics|anesthetics|mesh-ancestor
93244303|NCT05193227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626104|NCT00552799|Penicillins|penicillins|mesh-list
93244304|NCT05193227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244305|NCT05193227|Sensory System Agents|sensory system agents|mesh-ancestor
93244306|NCT05193227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244307|NCT05193227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92538955|NCT00009191|Serotonin Agents|serotonin agents|mesh-ancestor
93244308|NCT05193227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93244309|NCT05193227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93244310|NCT05193227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244311|NCT05193227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244312|NCT01372007|Lanreotide|lanreotide|mesh-list
93244313|NCT01372007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244314|NCT01373411|Ticagrelor|ticagrelor|mesh-list
91973739|NCT02454881|Narcotics|narcotics|mesh-ancestor
93244315|NCT01373411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93244316|NCT01373411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93244317|NCT01373411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93092428|NCT00051636|Etidronic Acid|etidronic acid|mesh-list
93244318|NCT01373411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93244319|NCT01373411|Purinergic Agents|purinergic agents|mesh-ancestor
93092429|NCT00051636|Calcium|calcium|mesh-list
93244320|NCT01373411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244321|NCT01373411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244322|NCT01373411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244323|NCT03567408|Bivalirudin|bivalirudin|mesh-list
93244324|NCT03567408|Antithrombins|antithrombins|mesh-ancestor
93244325|NCT03567408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93244326|NCT03567408|Protease Inhibitors|protease inhibitors|mesh-ancestor
93244327|NCT03567408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244328|NCT03567408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244329|NCT03567408|Anticoagulants|anticoagulants|mesh-ancestor
93244330|NCT05354076|Doxorubicin|doxorubicin|mesh-list
93244331|NCT05354076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93244332|NCT05354076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93244333|NCT05354076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244334|NCT05354076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93244335|NCT05354076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93244336|NCT05354076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244337|NCT05354076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244338|NCT05106335|Docetaxel|docetaxel|mesh-list
93244339|NCT05106335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244340|NCT05106335|Tubulin Modulators|tubulin modulators|mesh-ancestor
93244341|NCT05106335|Antimitotic Agents|antimitotic agents|mesh-ancestor
93244342|NCT05106335|Mitosis Modulators|mitosis modulators|mesh-ancestor
93244343|NCT05106335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244344|NCT05192681|Docetaxel|docetaxel|mesh-list
93244345|NCT05192681|Tislelizumab|tislelizumab|mesh-list
93244346|NCT05192681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244347|NCT05192681|Tubulin Modulators|tubulin modulators|mesh-ancestor
93244348|NCT05192681|Antimitotic Agents|antimitotic agents|mesh-ancestor
93244349|NCT05192681|Mitosis Modulators|mitosis modulators|mesh-ancestor
93244350|NCT05192681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244351|NCT05192681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244352|NCT05192213|Thiamine|thiamine|mesh-list
93244353|NCT05192213|Hydrocortisone|hydrocortisone|mesh-list
93244354|NCT05192213|Vitamins|vitamins|mesh-ancestor
93244355|NCT05192213|Micronutrients|micronutrients|mesh-ancestor
93244356|NCT05192213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244357|NCT05192213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244358|NCT05192213|Vitamin B Complex|vitamin b complex|mesh-ancestor
93244359|NCT02039674|Paclitaxel|paclitaxel|mesh-list
93244360|NCT02039674|Bevacizumab|bevacizumab|mesh-list
93244361|NCT02039674|Carboplatin|carboplatin|mesh-list
93244362|NCT02039674|Pembrolizumab|pembrolizumab|mesh-list
93244363|NCT02039674|Pemetrexed|pemetrexed|mesh-list
93244364|NCT02039674|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93244365|NCT02039674|Ipilimumab|ipilimumab|mesh-list
93244366|NCT02039674|Gefitinib|gefitinib|mesh-list
93244367|NCT02039674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93244368|NCT02039674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244369|NCT02039674|Tubulin Modulators|tubulin modulators|mesh-ancestor
93244370|NCT02039674|Antimitotic Agents|antimitotic agents|mesh-ancestor
93244371|NCT02039674|Mitosis Modulators|mitosis modulators|mesh-ancestor
93244372|NCT02039674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244373|NCT02039674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244374|NCT02039674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93244375|NCT02039674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93244376|NCT02039674|Growth Substances|growth substances|mesh-ancestor
93244377|NCT02039674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244378|NCT02039674|Growth Inhibitors|growth inhibitors|mesh-ancestor
93244379|NCT02039674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93244380|NCT02039674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244381|NCT02039674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93244382|NCT02039674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93244383|NCT02039674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244384|NCT03099187|Pirfenidone|pirfenidone|mesh-list
93244385|NCT03099187|Analgesics|analgesics|mesh-ancestor
93244386|NCT03099187|Sensory System Agents|sensory system agents|mesh-ancestor
93092430|NCT00051636|Vitamins|vitamins|mesh-ancestor
93244387|NCT03099187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244388|NCT03099187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244389|NCT03099187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93244390|NCT03099187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93244391|NCT03099187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244392|NCT03099187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244393|NCT03099187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244394|NCT04162756|Cyclophosphamide|cyclophosphamide|mesh-list
93244395|NCT04162756|Fludarabine|fludarabine|mesh-list
93244396|NCT04162756|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
93244397|NCT04162756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93244398|NCT04162756|Immunologic Factors|immunologic factors|mesh-ancestor
93244399|NCT04162756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244400|NCT04162756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244401|NCT04162756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93244402|NCT04162756|Alkylating Agents|alkylating agents|mesh-ancestor
93244403|NCT04162756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244404|NCT04162756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244405|NCT04162756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93244406|NCT04162756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244407|NCT04544267|Vaccines|vaccines|mesh-list
93244408|NCT04544267|Immunologic Factors|immunologic factors|mesh-ancestor
93244409|NCT04544267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244410|NCT04895488|Vortioxetine|vortioxetine|mesh-list
93244411|NCT04895488|Antipsychotic Agents|antipsychotic agents|mesh-list
93244412|NCT04895488|Antidepressive Agents|antidepressive agents|mesh-ancestor
93244413|NCT04895488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93244414|NCT04895488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93244415|NCT04895488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93244416|NCT04895488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244417|NCT04895488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244418|NCT04895488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93244419|NCT04895488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93244420|NCT04895488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244421|NCT04895488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244422|NCT04895488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244423|NCT04895488|Serotonin Agents|serotonin agents|mesh-ancestor
93244424|NCT04895488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93244425|NCT04895488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93244426|NCT04895488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93244427|NCT04895488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93244428|NCT04342715|Paromomycin|paromomycin|mesh-list
93244429|NCT04342715|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
93244430|NCT04342715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244431|NCT04342715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244432|NCT04342715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93244433|NCT04342715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93244434|NCT04342715|Schistosomicides|schistosomicides|mesh-ancestor
93244435|NCT04342715|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93244436|NCT04342715|Anthelmintics|anthelmintics|mesh-ancestor
93244438|NCT01373333|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93244439|NCT01373333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244440|NCT01373333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539047|NCT00009815|Leucovorin|leucovorin|mesh-list
93244441|NCT01373333|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93244442|NCT01373333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244443|NCT01373333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244444|NCT01368341|Amoxicillin|amoxicillin|mesh-list
93244445|NCT01368341|Doxycycline|doxycycline|mesh-list
93244446|NCT01368341|Penicillin V|penicillin v|mesh-list
93244447|NCT01368341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244448|NCT01368341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244449|NCT01368341|Antimalarials|antimalarials|mesh-ancestor
93244450|NCT01368341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93244451|NCT01368341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93244452|NCT01368419|Endostar protein|endostar protein|mesh-list
93244453|NCT01368419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93244454|NCT01368419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93244455|NCT01368419|Growth Substances|growth substances|mesh-ancestor
93244456|NCT01368419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244457|NCT01368419|Growth Inhibitors|growth inhibitors|mesh-ancestor
93244458|NCT01368419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244459|NCT04639219|Trastuzumab|trastuzumab|mesh-list
93244460|NCT04639219|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93244461|NCT04639219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244462|NCT04639219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244463|NCT04639219|Immunoconjugates|immunoconjugates|mesh-ancestor
93244464|NCT04639219|Immunologic Factors|immunologic factors|mesh-ancestor
93244465|NCT04639219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244466|NCT04455100|Itraconazole|itraconazole|mesh-list
93244467|NCT04455100|Antifungal Agents|antifungal agents|mesh-ancestor
93244468|NCT04455100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244469|NCT04455100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93244470|NCT04455100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93244471|NCT04455100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244472|NCT04455100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244473|NCT04455100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93244474|NCT04455100|Hormone Antagonists|hormone antagonists|mesh-ancestor
93244475|NCT04455100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244476|NCT04455100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244477|NCT04455100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93244478|NCT04439578|Rifampin|rifampin|mesh-list
93244479|NCT04439578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93244480|NCT04439578|Antitubercular Agents|antitubercular agents|mesh-ancestor
93244481|NCT04439578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244482|NCT04439578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244483|NCT04439578|Leprostatic Agents|leprostatic agents|mesh-ancestor
93244484|NCT04439578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93244485|NCT04439578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244486|NCT04439578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244487|NCT04439578|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93244488|NCT04439578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93244489|NCT04439578|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93244490|NCT04439578|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93244491|NCT04439578|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93244492|NCT04439578|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93244493|NCT03110848|Methylprednisolone|methylprednisolone|mesh-list
93244494|NCT03110848|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93244495|NCT03110848|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93244496|NCT03110848|Prednisolone|prednisolone|mesh-list
93244497|NCT03110848|Prednisolone acetate|prednisolone acetate|mesh-list
93244498|NCT03110848|Atorvastatin|atorvastatin|mesh-list
93244499|NCT03110848|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93244500|NCT03110848|Prednisolone phosphate|prednisolone phosphate|mesh-list
93244501|NCT03110848|Glucocorticoids|glucocorticoids|mesh-list
93244502|NCT03110848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92916471|NCT00651118|Xhance|xhance|mesh-list
93244503|NCT03110848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93244504|NCT03110848|Antimetabolites|antimetabolites|mesh-ancestor
93244505|NCT03110848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244506|NCT03110848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93244507|NCT03110848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93244508|NCT03110848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244509|NCT03110848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244510|NCT03110848|Antiemetics|antiemetics|mesh-ancestor
93244511|NCT03110848|Autonomic Agents|autonomic agents|mesh-ancestor
93244512|NCT03110848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244513|NCT03110848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244514|NCT03110848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93244515|NCT03110848|Hormones|hormones|mesh-ancestor
93244516|NCT03110848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244517|NCT03110848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93244518|NCT03110848|Protective Agents|protective agents|mesh-ancestor
93244519|NCT03110848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93244520|NCT03110848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244521|NCT03139474|Hormones|hormones|mesh-list
93244522|NCT03139474|Hormone Antagonists|hormone antagonists|mesh-list
93244523|NCT03139474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244524|NCT03139474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244525|NCT01368887|Niacinamide|niacinamide|mesh-list
93244526|NCT01368887|Niacin|niacin|mesh-list
93244527|NCT01368887|Nicotinic Acids|nicotinic acids|mesh-list
93244528|NCT01368887|Calcipotriene|calcipotriene|mesh-list
93244529|NCT01368887|Vitamin B Complex|vitamin b complex|mesh-ancestor
93244530|NCT01368887|Vitamins|vitamins|mesh-ancestor
93244531|NCT01368887|Micronutrients|micronutrients|mesh-ancestor
93244532|NCT01368887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244533|NCT01368887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93244534|NCT01368887|Antimetabolites|antimetabolites|mesh-ancestor
93244535|NCT01368887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244536|NCT01368887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93244537|NCT01368887|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244538|NCT01368887|Dermatologic Agents|dermatologic agents|mesh-ancestor
93244539|NCT01369043|Vitamins|vitamins|mesh-list
93244540|NCT01369043|Vitamin E|vitamin e|mesh-list
93244541|NCT01369043|Micronutrients|micronutrients|mesh-ancestor
93244542|NCT01369043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244543|NCT01369043|Antioxidants|antioxidants|mesh-ancestor
93244544|NCT01369043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244545|NCT01369043|Protective Agents|protective agents|mesh-ancestor
93244546|NCT04477096|Emtricitabine|emtricitabine|mesh-list
93244547|NCT04477096|Antiviral Agents|antiviral agents|mesh-ancestor
93244548|NCT04477096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244549|NCT04477096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93244550|NCT04477096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93244551|NCT04477096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244552|NCT04477096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244553|NCT04477096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93244554|NCT04477096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93244555|NCT01369121|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
93244556|NCT01369121|Hormones|hormones|mesh-ancestor
93244557|NCT01369121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244558|NCT01369121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244559|NCT03868150|Amiodarone|amiodarone|mesh-list
93244560|NCT03868150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93244561|NCT03868150|Vasodilator Agents|vasodilator agents|mesh-ancestor
93244562|NCT03868150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93244563|NCT03868150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244564|NCT03868150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244565|NCT03868150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93244566|NCT03868150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93244567|NCT03868150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93244568|NCT03868150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244569|NCT03868150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93244570|NCT03868150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93244571|NCT03868150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93244572|NCT03521687|Apremilast|apremilast|mesh-list
93244573|NCT03521687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93244574|NCT03521687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93244575|NCT03521687|Analgesics|analgesics|mesh-ancestor
92916552|NCT05146804|Sulforaphane|sulforaphane|mesh-list
93244576|NCT03521687|Sensory System Agents|sensory system agents|mesh-ancestor
93244577|NCT03521687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244578|NCT03521687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244579|NCT03521687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244580|NCT03521687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244581|NCT03521687|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93244582|NCT03521687|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93244583|NCT03521687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244584|NCT03521687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244585|NCT03141658|Ketamine|ketamine|mesh-list
93244586|NCT03141658|Analgesics|analgesics|mesh-ancestor
93244587|NCT03141658|Sensory System Agents|sensory system agents|mesh-ancestor
93244588|NCT03141658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244589|NCT03141658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244590|NCT03141658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93244591|NCT03141658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93244592|NCT03141658|Anesthetics, General|anesthetics, general|mesh-ancestor
93244593|NCT03141658|Anesthetics|anesthetics|mesh-ancestor
93244594|NCT03141658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244595|NCT03141658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93244596|NCT03141658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93244597|NCT03141658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244598|NCT03141658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244599|NCT03498131|Melatonin|melatonin|mesh-list
93244600|NCT03498131|Antioxidants|antioxidants|mesh-ancestor
93244601|NCT03498131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244602|NCT03498131|Protective Agents|protective agents|mesh-ancestor
93244603|NCT03498131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244604|NCT03498131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244605|NCT01319825|Milnacipran|milnacipran|mesh-list
93244606|NCT01319825|Levomilnacipran|levomilnacipran|mesh-list
93244607|NCT01319825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93244608|NCT01319825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93244609|NCT01319825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244610|NCT01319825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244611|NCT01319825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244612|NCT01319825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244613|NCT01319825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93244614|NCT01319825|Analgesics|analgesics|mesh-ancestor
93244615|NCT01319825|Sensory System Agents|sensory system agents|mesh-ancestor
93244616|NCT01319825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244617|NCT01319825|Antidepressive Agents|antidepressive agents|mesh-ancestor
93244618|NCT01319825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93244619|NCT01369277|Nicotinic Acids|nicotinic acids|mesh-list
93244620|NCT01369277|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93244621|NCT01369277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244622|NCT01369277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244623|NCT01369277|Vitamin B Complex|vitamin b complex|mesh-ancestor
93244624|NCT01369277|Vitamins|vitamins|mesh-ancestor
93244625|NCT01369277|Micronutrients|micronutrients|mesh-ancestor
93244626|NCT01369277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244627|NCT02983006|Nivolumab|nivolumab|mesh-list
93244628|NCT02983006|DS-8273a|ds-8273a|mesh-list
93244629|NCT02983006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244630|NCT02983006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244631|NCT02983006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93244632|NCT02983006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244633|NCT03811756|Coenzyme Q10|coenzyme q10|mesh-list
93244634|NCT03811756|Vitamins|vitamins|mesh-ancestor
93244635|NCT03811756|Micronutrients|micronutrients|mesh-ancestor
93244636|NCT03811756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244637|NCT03141268|Lactulose|lactulose|mesh-list
93244638|NCT03141268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93244639|NCT03316781|Adalimumab|adalimumab|mesh-list
93244640|NCT03316781|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93244641|NCT03316781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244642|NCT03316781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244643|NCT01319903|Antibodies|antibodies|mesh-list
93244644|NCT01319903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93244645|NCT01319903|Immunologic Factors|immunologic factors|mesh-ancestor
93244646|NCT01319903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244647|NCT02839200|Zolpidem|zolpidem|mesh-list
93244648|NCT02839200|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93244649|NCT02839200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93244650|NCT02839200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244651|NCT02839200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244652|NCT02839200|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93244653|NCT02839200|GABA Agonists|gaba agonists|mesh-ancestor
93244654|NCT02839200|GABA Agents|gaba agents|mesh-ancestor
93244655|NCT02839200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244656|NCT02839200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244658|NCT01369667|Cholecalciferol|cholecalciferol|mesh-list
93244659|NCT01369667|Vitamins|vitamins|mesh-ancestor
93244660|NCT01369667|Micronutrients|micronutrients|mesh-ancestor
93244661|NCT01369667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244662|NCT01369667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93244663|NCT01369667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93244664|NCT03564912|Capecitabine|capecitabine|mesh-list
93244665|NCT03564912|Oxaliplatin|oxaliplatin|mesh-list
93244666|NCT03564912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93244667|NCT03564912|Antimetabolites|antimetabolites|mesh-ancestor
93244668|NCT03564912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244669|NCT03564912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244670|NCT03551626|Trametinib|trametinib|mesh-list
93244671|NCT03551626|Dabrafenib|dabrafenib|mesh-list
93244672|NCT03551626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244673|NCT03551626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244674|NCT03551626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244675|NCT03551626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244676|NCT05760053|Cisplatin|cisplatin|mesh-list
93244677|NCT05760053|Carboplatin|carboplatin|mesh-list
93244678|NCT05760053|Etoposide|etoposide|mesh-list
93244679|NCT05760053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244680|NCT05760053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93244681|NCT05760053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93244682|NCT05760053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93244683|NCT05760053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244684|NCT05760053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244685|NCT03118739|Febuxostat|febuxostat|mesh-list
93244686|NCT03118739|Verinurad|verinurad|mesh-list
93244687|NCT03118739|Gout Suppressants|gout suppressants|mesh-ancestor
93244688|NCT03118739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244689|NCT03181126|Venetoclax|venetoclax|mesh-list
93244690|NCT03181126|Navitoclax|navitoclax|mesh-list
93244691|NCT03181126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244692|NCT05139875|Triamcinolone|triamcinolone|mesh-list
93244693|NCT05139875|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93244694|NCT05139875|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93244695|NCT05139875|Betamethasone|betamethasone|mesh-list
93244696|NCT05139875|Betamethasone Valerate|betamethasone valerate|mesh-list
93244697|NCT05139875|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93244698|NCT05139875|Betamethasone benzoate|betamethasone benzoate|mesh-list
93244699|NCT05139875|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
93244700|NCT05139875|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93244701|NCT05139875|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93244702|NCT05139875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244703|NCT05139875|Glucocorticoids|glucocorticoids|mesh-ancestor
93244704|NCT05139875|Hormones|hormones|mesh-ancestor
93244705|NCT05139875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244706|NCT05139875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244707|NCT05139875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93244708|NCT05139875|Immunologic Factors|immunologic factors|mesh-ancestor
93244709|NCT05139875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244710|NCT05139875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244711|NCT05139875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93244712|NCT05139875|Respiratory System Agents|respiratory system agents|mesh-ancestor
93244713|NCT03140410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93244714|NCT03140410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244715|NCT04799548|Tislelizumab|tislelizumab|mesh-list
93244716|NCT04799548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244717|NCT04799548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244718|NCT01375985|Radavirsen|radavirsen|mesh-list
93244719|NCT01375985|Antiviral Agents|antiviral agents|mesh-ancestor
93244720|NCT01375985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244721|NCT05384821|Irinotecan|irinotecan|mesh-list
93244722|NCT05384821|Etoposide|etoposide|mesh-list
93244723|NCT05384821|Vincristine|vincristine|mesh-list
93244724|NCT05384821|Temozolomide|temozolomide|mesh-list
93244725|NCT05384821|Tretinoin|tretinoin|mesh-list
93244727|NCT05384821|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93244728|NCT05384821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93244729|NCT05384821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244730|NCT05384821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244731|NCT05384821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244732|NCT05384821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93244733|NCT05384821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93244734|NCT05384821|Tubulin Modulators|tubulin modulators|mesh-ancestor
93244735|NCT05384821|Antimitotic Agents|antimitotic agents|mesh-ancestor
93244736|NCT05384821|Mitosis Modulators|mitosis modulators|mesh-ancestor
93244737|NCT05384821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93244738|NCT05384821|Alkylating Agents|alkylating agents|mesh-ancestor
93244739|NCT05384821|Keratolytic Agents|keratolytic agents|mesh-ancestor
93244740|NCT05384821|Dermatologic Agents|dermatologic agents|mesh-ancestor
93244741|NCT02654080|Vaccines|vaccines|mesh-list
93244742|NCT02654080|Immunologic Factors|immunologic factors|mesh-ancestor
93244743|NCT02654080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244744|NCT05375305|Morphine|morphine|mesh-list
93244745|NCT05375305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93244746|NCT05375305|Narcotics|narcotics|mesh-ancestor
93244747|NCT05375305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244748|NCT05375305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244749|NCT05375305|Analgesics|analgesics|mesh-ancestor
93244750|NCT05375305|Sensory System Agents|sensory system agents|mesh-ancestor
93244751|NCT05375305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244752|NCT03140332|Sorafenib|sorafenib|mesh-list
93244753|NCT03140332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244754|NCT03140332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244755|NCT03140332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244756|NCT03140332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244757|NCT02835690|Pembrolizumab|pembrolizumab|mesh-list
93244758|NCT02835690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244759|NCT02835690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244760|NCT02835690|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93244761|NCT02835690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244762|NCT02832167|Nivolumab|nivolumab|mesh-list
93244763|NCT02832167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244764|NCT02832167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244765|NCT02832167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93244766|NCT02832167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244767|NCT04941040|Analgesics, Opioid|analgesics, opioid|mesh-list
93244768|NCT04941040|Anesthetics|anesthetics|mesh-list
93244769|NCT04941040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244770|NCT04941040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244771|NCT04941040|Narcotics|narcotics|mesh-ancestor
93244772|NCT04941040|Analgesics|analgesics|mesh-ancestor
93244773|NCT04941040|Sensory System Agents|sensory system agents|mesh-ancestor
93244774|NCT04941040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244775|NCT00913705|Carboplatin|carboplatin|mesh-list
93244776|NCT00913705|Paclitaxel|paclitaxel|mesh-list
93244777|NCT00913705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93244778|NCT00913705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244779|NCT00913705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93244780|NCT00913705|Tubulin Modulators|tubulin modulators|mesh-ancestor
93244781|NCT00913705|Antimitotic Agents|antimitotic agents|mesh-ancestor
93244782|NCT00913705|Mitosis Modulators|mitosis modulators|mesh-ancestor
93244783|NCT00913705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244784|NCT04934410|Midazolam|midazolam|mesh-list
93244785|NCT04934410|Etomidate|etomidate|mesh-list
93244786|NCT04934410|Sevoflurane|sevoflurane|mesh-list
93244787|NCT04934410|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93244788|NCT04934410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93244789|NCT04934410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244790|NCT04934410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244791|NCT04934410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93244792|NCT04934410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93244793|NCT04934410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93244794|NCT04934410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93244795|NCT04934410|Anesthetics, General|anesthetics, general|mesh-ancestor
93244796|NCT04934410|Anesthetics|anesthetics|mesh-ancestor
93244797|NCT04934410|GABA Modulators|gaba modulators|mesh-ancestor
93244798|NCT04934410|GABA Agents|gaba agents|mesh-ancestor
93244799|NCT04934410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244800|NCT04934410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244801|NCT04934410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93244802|NCT04934410|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93244803|NCT02787239|Rituximab|rituximab|mesh-list
93244804|NCT02787239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244805|NCT02787239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244806|NCT02787239|Immunologic Factors|immunologic factors|mesh-ancestor
93244807|NCT02787239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244808|NCT02787239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244809|NCT03140956|Levodopa|levodopa|mesh-list
93244810|NCT03140956|Carbidopa|carbidopa|mesh-list
93244811|NCT03140956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93244812|NCT03140956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93244813|NCT03140956|Dopamine Agents|dopamine agents|mesh-ancestor
93244814|NCT03140956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244815|NCT03140956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244816|NCT03140956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244817|NCT03140956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93244818|NCT03140956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244819|NCT02681237|Olaparib|olaparib|mesh-list
93244820|NCT02681237|Cediranib|cediranib|mesh-list
93244821|NCT02681237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93244822|NCT02681237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244823|NCT02681237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244824|NCT02681237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244825|NCT02681237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244826|NCT00089245|Iodine|iodine|mesh-list
93244827|NCT00089245|Cadexomer iodine|cadexomer iodine|mesh-list
93244828|NCT00089245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93244829|NCT00089245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244830|NCT00089245|Trace Elements|trace elements|mesh-ancestor
93244831|NCT00089245|Micronutrients|micronutrients|mesh-ancestor
93244832|NCT00089245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244833|NCT02674529|Escitalopram|escitalopram|mesh-list
93244834|NCT02674529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93244835|NCT02674529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93244836|NCT02674529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244837|NCT02674529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244838|NCT02674529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244839|NCT02674529|Serotonin Agents|serotonin agents|mesh-ancestor
93244840|NCT02674529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244841|NCT05081986|Cycloserine|cycloserine|mesh-list
93244842|NCT05081986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93244843|NCT05081986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244844|NCT05081986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93244845|NCT05081986|Antitubercular Agents|antitubercular agents|mesh-ancestor
93244846|NCT05081986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244847|NCT05081986|Antimetabolites|antimetabolites|mesh-ancestor
93244848|NCT05081986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244849|NCT05418907|Exenatide|exenatide|mesh-list
93244850|NCT05418907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93244851|NCT05418907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244852|NCT05418907|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93244853|NCT05418907|Incretins|incretins|mesh-ancestor
93244854|NCT05418907|Hormones|hormones|mesh-ancestor
93244855|NCT05418907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244856|NCT02666599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93244857|NCT02666599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93244858|NCT02666599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244859|NCT03632317|Everolimus|everolimus|mesh-list
93244860|NCT03632317|Panobinostat|panobinostat|mesh-list
93244861|NCT03632317|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93244862|NCT03632317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244863|NCT03632317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244864|NCT03632317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244865|NCT03632317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93244866|NCT03632317|Immunologic Factors|immunologic factors|mesh-ancestor
93244867|NCT03632317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244868|NCT03632317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244869|NCT03632317|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93244870|NCT02591784|Nimotuzumab|nimotuzumab|mesh-list
93244871|NCT02591784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244872|NCT02591784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244873|NCT02653963|Triamcinolone|triamcinolone|mesh-list
93244874|NCT02653963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916872|NCT00814216|Xhance|xhance|mesh-list
93244876|NCT02653963|Hormones|hormones|mesh-ancestor
93244877|NCT02653963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244878|NCT02653963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244879|NCT03097861|Lubiprostone|lubiprostone|mesh-list
93244880|NCT03097861|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93244881|NCT03097861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244882|NCT03097861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244883|NCT03910673|Fosfomycin|fosfomycin|mesh-list
93244884|NCT03910673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93244885|NCT03910673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244886|NCT01376141|Sumatriptan|sumatriptan|mesh-list
93244887|NCT01376141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93244888|NCT01376141|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93244889|NCT01376141|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93244890|NCT01376141|Serotonin Agents|serotonin agents|mesh-ancestor
93244891|NCT01376141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244892|NCT01376141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244893|NCT01376141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244894|NCT03642067|Nivolumab|nivolumab|mesh-list
93244895|NCT03642067|Relatlimab|relatlimab|mesh-list
93244896|NCT03642067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93244897|NCT03642067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244898|NCT03642067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93244899|NCT03642067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244900|NCT01816139|Estradiol|estradiol|mesh-list
93244901|NCT01816139|Estrogens|estrogens|mesh-ancestor
93244902|NCT01816139|Hormones|hormones|mesh-ancestor
93244903|NCT01816139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244904|NCT01816139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244905|NCT04052776|Levodopa|levodopa|mesh-list
93244906|NCT04052776|Carbidopa|carbidopa|mesh-list
93244907|NCT04052776|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93244908|NCT04052776|Buspirone|buspirone|mesh-list
93244909|NCT04052776|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93244910|NCT04052776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93244911|NCT04052776|Dopamine Agents|dopamine agents|mesh-ancestor
93244912|NCT04052776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244913|NCT04052776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244914|NCT04052776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244915|NCT04052776|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93244916|NCT04052776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244917|NCT04052776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93244918|NCT04052776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93244919|NCT04052776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244920|NCT04052776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93244921|NCT04052776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93244922|NCT04052776|Serotonin Agents|serotonin agents|mesh-ancestor
93244923|NCT04052776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93244924|NCT04052776|Immunologic Factors|immunologic factors|mesh-ancestor
93244925|NCT04052776|Dopamine Agonists|dopamine agonists|mesh-ancestor
93244926|NCT01374191|Botulinum Toxins|botulinum toxins|mesh-list
93244927|NCT01374191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93244928|NCT01374191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93244929|NCT01374191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93244930|NCT01374191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93244931|NCT01374191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244932|NCT01374191|Cholinergic Agents|cholinergic agents|mesh-ancestor
93244933|NCT01374191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244934|NCT01374191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244935|NCT01374191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93244936|NCT01374191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244937|NCT03764735|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93244938|NCT03764735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93244939|NCT03764735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93244940|NCT05041673|Metformin|metformin|mesh-list
93244941|NCT05041673|Liraglutide|liraglutide|mesh-list
93244942|NCT05041673|Empagliflozin|empagliflozin|mesh-list
93244943|NCT05041673|Vildagliptin|vildagliptin|mesh-list
93244944|NCT05041673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93244945|NCT05041673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244946|NCT05041673|Incretins|incretins|mesh-ancestor
93244947|NCT05041673|Hormones|hormones|mesh-ancestor
93244948|NCT05041673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93244949|NCT05041673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93244950|NCT05041673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244951|NCT05041673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93244952|NCT05041673|Protease Inhibitors|protease inhibitors|mesh-ancestor
93244953|NCT05041673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244954|NCT03907540|Belumosudil|belumosudil|mesh-list
93244955|NCT03907540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244956|NCT03907540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244957|NCT03907540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244958|NCT05759429|Melatonin|melatonin|mesh-list
93244959|NCT05759429|Antioxidants|antioxidants|mesh-ancestor
93244960|NCT05759429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244961|NCT05759429|Protective Agents|protective agents|mesh-ancestor
93244962|NCT05759429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244963|NCT05759429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244964|NCT04005209|Ketamine|ketamine|mesh-list
93244965|NCT04005209|Analgesics|analgesics|mesh-ancestor
93244966|NCT04005209|Sensory System Agents|sensory system agents|mesh-ancestor
93244967|NCT04005209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93244968|NCT04005209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244969|NCT04005209|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93244970|NCT04005209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93244971|NCT04005209|Anesthetics, General|anesthetics, general|mesh-ancestor
93244972|NCT04005209|Anesthetics|anesthetics|mesh-ancestor
93244973|NCT04005209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93244974|NCT04005209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93244975|NCT04005209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93244976|NCT04005209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93244977|NCT04005209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244978|NCT03904108|Ramucirumab|ramucirumab|mesh-list
93244979|NCT03904108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244980|NCT02833350|Folic Acid|folic acid|mesh-list
93244981|NCT02833350|Adalimumab|adalimumab|mesh-list
93244982|NCT02833350|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93244983|NCT02833350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93244984|NCT02833350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93244985|NCT02833350|Hematinics|hematinics|mesh-ancestor
93244986|NCT02833350|Vitamin B Complex|vitamin b complex|mesh-ancestor
93244987|NCT02833350|Vitamins|vitamins|mesh-ancestor
93244988|NCT02833350|Micronutrients|micronutrients|mesh-ancestor
93244989|NCT02833350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93244990|NCT03137134|Crizotinib|crizotinib|mesh-list
93244991|NCT03137134|Esomeprazole|esomeprazole|mesh-list
93244992|NCT03137134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93244993|NCT03137134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93244994|NCT03137134|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93244995|NCT03137134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93244996|NCT03137134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93244997|NCT03137134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93244998|NCT03137134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93244999|NCT03137368|Tamoxifen|tamoxifen|mesh-list
93245000|NCT03137368|Exemestane|exemestane|mesh-list
93245001|NCT03137368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93245002|NCT03137368|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245003|NCT03137368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245004|NCT03137368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245005|NCT03137368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245006|NCT03137368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245007|NCT03137368|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93245008|NCT03137368|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93245009|NCT03137368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93245010|NCT03137368|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93245011|NCT03137368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93245012|NCT03137368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245013|NCT03137368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245014|NCT03138616|Vitamin D|vitamin d|mesh-list
93245015|NCT03138616|Vitamins|vitamins|mesh-ancestor
93245016|NCT03138616|Micronutrients|micronutrients|mesh-ancestor
93245017|NCT03138616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245018|NCT03138616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93245019|NCT03137290|Neostigmine|neostigmine|mesh-list
93245020|NCT03137290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93245021|NCT03137290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245022|NCT03137290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245023|NCT03137290|Cholinergic Agents|cholinergic agents|mesh-ancestor
93245024|NCT03137290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245025|NCT03137290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245026|NCT03137290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93245027|NCT03137290|Autonomic Agents|autonomic agents|mesh-ancestor
93245028|NCT03137290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245029|NCT03782818|Olaparib|olaparib|mesh-list
93245030|NCT03782818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93245031|NCT03782818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245032|NCT03782818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245033|NCT03782818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245034|NCT05391724|Brincidofovir|brincidofovir|mesh-list
93245035|NCT05391724|Antiviral Agents|antiviral agents|mesh-ancestor
93245036|NCT05391724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245037|NCT03355534|Dexmedetomidine|dexmedetomidine|mesh-list
93245038|NCT03355534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93245039|NCT03355534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245040|NCT03355534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245041|NCT03355534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93245042|NCT03355534|Analgesics|analgesics|mesh-ancestor
93245043|NCT03355534|Sensory System Agents|sensory system agents|mesh-ancestor
93245044|NCT03355534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245045|NCT03355534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93245046|NCT03355534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93245047|NCT03355534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93245048|NCT03355534|Adrenergic Agents|adrenergic agents|mesh-ancestor
93245049|NCT03355534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245050|NCT03355534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245051|NCT05385562|Triamcinolone|triamcinolone|mesh-list
93245052|NCT05385562|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93245053|NCT05385562|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93245054|NCT05385562|Hyaluronic Acid|hyaluronic acid|mesh-list
93245055|NCT05385562|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93245056|NCT05385562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245057|NCT05385562|Glucocorticoids|glucocorticoids|mesh-ancestor
93245058|NCT05385562|Hormones|hormones|mesh-ancestor
93245059|NCT05385562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245060|NCT05385562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245061|NCT05385562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245062|NCT05385562|Immunologic Factors|immunologic factors|mesh-ancestor
93245063|NCT05385562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245064|NCT05385562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245065|NCT05385562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93245066|NCT05385562|Viscosupplements|viscosupplements|mesh-ancestor
93245067|NCT05385562|Protective Agents|protective agents|mesh-ancestor
93245068|NCT01343043|Cyclophosphamide|cyclophosphamide|mesh-list
93245069|NCT01343043|Fludarabine|fludarabine|mesh-list
93245070|NCT01343043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245071|NCT01343043|Immunologic Factors|immunologic factors|mesh-ancestor
93245072|NCT01343043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245073|NCT01343043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93245074|NCT01343043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93245075|NCT01343043|Alkylating Agents|alkylating agents|mesh-ancestor
93245076|NCT01343043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245077|NCT01343043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245078|NCT01343043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93245079|NCT03139708|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93245080|NCT03139708|Phenylephrine|phenylephrine|mesh-list
93245081|NCT03139708|Oxymetazoline|oxymetazoline|mesh-list
93245082|NCT03139708|Tropicamide|tropicamide|mesh-list
93245083|NCT03139708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93245084|NCT03139708|Mydriatics|mydriatics|mesh-ancestor
93245085|NCT03139708|Autonomic Agents|autonomic agents|mesh-ancestor
93245086|NCT03139708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245087|NCT03139708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245088|NCT03139708|Sympathomimetics|sympathomimetics|mesh-ancestor
93245089|NCT03139708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93245090|NCT03139708|Nasal Decongestants|nasal decongestants|mesh-ancestor
93245091|NCT03139708|Respiratory System Agents|respiratory system agents|mesh-ancestor
93245092|NCT03139708|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93245093|NCT03139708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93245094|NCT03139708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93245095|NCT03139708|Adrenergic Agents|adrenergic agents|mesh-ancestor
93245096|NCT03139708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245097|NCT03139708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245098|NCT03139708|Protective Agents|protective agents|mesh-ancestor
93245099|NCT03139708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93245100|NCT03139708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93245101|NCT03139708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93245102|NCT03139708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93245103|NCT03139708|Cholinergic Agents|cholinergic agents|mesh-ancestor
93245104|NCT01358760|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93245105|NCT01358760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93245106|NCT01358760|Immunologic Factors|immunologic factors|mesh-ancestor
93245107|NCT01358760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245108|NCT05330364|Cladribine|cladribine|mesh-list
93245109|NCT05330364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245110|NCT05330364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245111|NCT05330364|Immunologic Factors|immunologic factors|mesh-ancestor
93245112|NCT05330364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245113|NCT05087368|Vaccines|vaccines|mesh-list
93245114|NCT05087368|Immunologic Factors|immunologic factors|mesh-ancestor
93245115|NCT05087368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245116|NCT01341990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93245117|NCT05087134|Choline|choline|mesh-list
93245118|NCT05087134|Lipotropic Agents|lipotropic agents|mesh-ancestor
93245119|NCT05087134|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93245120|NCT05087134|Antimetabolites|antimetabolites|mesh-ancestor
93245121|NCT05087134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245122|NCT05087134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245123|NCT05087134|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93245124|NCT05087134|Nootropic Agents|nootropic agents|mesh-ancestor
93245125|NCT03048747|Tolvaptan|tolvaptan|mesh-list
93245126|NCT03048747|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93245127|NCT03048747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245128|NCT03048747|Natriuretic Agents|natriuretic agents|mesh-ancestor
93245129|NCT03048747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245130|NCT05086822|Irinotecan|irinotecan|mesh-list
93245131|NCT05086822|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93245132|NCT05086822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93245133|NCT05086822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245134|NCT05086822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245135|NCT05086822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245136|NCT05354128|Fibrinolytic Agents|fibrinolytic agents|mesh-list
93245137|NCT05354128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93245138|NCT05354128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245139|NCT04051827|Midazolam|midazolam|mesh-list
93245140|NCT04051827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93245141|NCT04051827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93245142|NCT04051827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245143|NCT04051827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539747|NCT00845910|Bevacizumab|bevacizumab|mesh-list
93245144|NCT04051827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93245145|NCT04051827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93245146|NCT04051827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93245147|NCT04051827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93245148|NCT04051827|Anesthetics, General|anesthetics, general|mesh-ancestor
93245149|NCT04051827|Anesthetics|anesthetics|mesh-ancestor
93245150|NCT04051827|GABA Modulators|gaba modulators|mesh-ancestor
93245151|NCT04051827|GABA Agents|gaba agents|mesh-ancestor
93245152|NCT04051827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245153|NCT04051827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245154|NCT05346874|Oxaliplatin|oxaliplatin|mesh-list
93245155|NCT05346874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245156|NCT05325502|Mannitol|mannitol|mesh-list
93245157|NCT05325502|Caffeine|caffeine|mesh-list
93245158|NCT05325502|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93245159|NCT05325502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245160|NCT05325502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93245161|NCT05325502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245162|NCT05325502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245163|NCT05325502|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93245164|NCT05325502|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93245165|NCT05325502|Purinergic Agents|purinergic agents|mesh-ancestor
93245166|NCT05325502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245167|NCT05325502|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93245168|NCT05325502|Diuretics|diuretics|mesh-ancestor
93245169|NCT05325502|Natriuretic Agents|natriuretic agents|mesh-ancestor
93245170|NCT02123823|Everolimus|everolimus|mesh-list
93245171|NCT02123823|Exemestane|exemestane|mesh-list
93245172|NCT02123823|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92917136|NCT00701285|Pitavastatin|pitavastatin|mesh-list
93245173|NCT02123823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245174|NCT02123823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245175|NCT02123823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245176|NCT02123823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245177|NCT02123823|Immunologic Factors|immunologic factors|mesh-ancestor
93245178|NCT02123823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245179|NCT02123823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245180|NCT02123823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93245181|NCT02123823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93245182|NCT02123823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93245183|NCT02123823|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245184|NCT02123823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245185|NCT05085652|Anesthetics|anesthetics|mesh-list
93245186|NCT05085652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245187|NCT05085652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245188|NCT03136510|Apixaban|apixaban|mesh-list
93245189|NCT03136510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93245190|NCT03136510|Antithrombins|antithrombins|mesh-ancestor
93245191|NCT03136510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93245192|NCT03136510|Protease Inhibitors|protease inhibitors|mesh-ancestor
93245193|NCT03136510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245194|NCT03136510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245195|NCT03136510|Anticoagulants|anticoagulants|mesh-ancestor
93245196|NCT05692245|Dexamethasone|dexamethasone|mesh-list
93245197|NCT05692245|Ondansetron|ondansetron|mesh-list
93245198|NCT05692245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245199|NCT05692245|Antiemetics|antiemetics|mesh-ancestor
93245200|NCT05692245|Autonomic Agents|autonomic agents|mesh-ancestor
93245201|NCT05692245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245202|NCT05692245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245203|NCT05692245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245204|NCT05692245|Glucocorticoids|glucocorticoids|mesh-ancestor
93245205|NCT05692245|Hormones|hormones|mesh-ancestor
93245206|NCT05692245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245207|NCT05692245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245208|NCT05692245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245209|NCT05692245|Antipruritics|antipruritics|mesh-ancestor
93245210|NCT05692245|Dermatologic Agents|dermatologic agents|mesh-ancestor
93245211|NCT05692245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93245212|NCT05692245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93245213|NCT05692245|Serotonin Agents|serotonin agents|mesh-ancestor
93245214|NCT05692245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245215|NCT05692245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245216|NCT05085106|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
93245217|NCT05085106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93245218|NCT05085106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93245219|NCT05085106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93245220|NCT05085106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93245221|NCT05085106|Analgesics|analgesics|mesh-ancestor
93245222|NCT05085106|Sensory System Agents|sensory system agents|mesh-ancestor
93245223|NCT05085106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245224|NCT05085106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245225|NCT05085106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245226|NCT05085106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93245227|NCT05692167|Dexmedetomidine|dexmedetomidine|mesh-list
93245228|NCT05692167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93245229|NCT05692167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245230|NCT05692167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245231|NCT05692167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93245232|NCT05692167|Analgesics|analgesics|mesh-ancestor
93245233|NCT05692167|Sensory System Agents|sensory system agents|mesh-ancestor
93245234|NCT05692167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245235|NCT05692167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93245236|NCT05692167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93245237|NCT05692167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93245238|NCT05692167|Adrenergic Agents|adrenergic agents|mesh-ancestor
93245239|NCT05692167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245240|NCT05692167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245241|NCT05084872|Hydroxychloroquine|hydroxychloroquine|mesh-list
93245242|NCT05084872|Antimalarials|antimalarials|mesh-ancestor
93245243|NCT05084872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93245244|NCT05084872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93245245|NCT05084872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245246|NCT05084872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245247|NCT05084872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245248|NCT05084872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93245249|NCT00159796|Olanzapine|olanzapine|mesh-list
93245250|NCT00159796|Asenapine|asenapine|mesh-list
93245251|NCT00159796|Antiemetics|antiemetics|mesh-ancestor
93245252|NCT00159796|Autonomic Agents|autonomic agents|mesh-ancestor
93245253|NCT00159796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245254|NCT00159796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245255|NCT00159796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245256|NCT00159796|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93245257|NCT00159796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93245258|NCT00159796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245259|NCT00159796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93245260|NCT00159796|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93245261|NCT00159796|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93245262|NCT00159796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93245263|NCT00159796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245264|NCT00159796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245265|NCT00159796|Serotonin Agents|serotonin agents|mesh-ancestor
93245266|NCT03626571|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93245267|NCT03626571|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93245268|NCT03626571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245269|NCT03327844|Calcium, Dietary|calcium, dietary|mesh-list
93245270|NCT03327844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93245271|NCT03327844|Metronidazole|metronidazole|mesh-list
93245272|NCT03327844|Ciprofloxacin|ciprofloxacin|mesh-list
93245273|NCT03327844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93245274|NCT03327844|Calcium|calcium|mesh-list
93245275|NCT03327844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93245276|NCT03327844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245277|NCT03327844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93245278|NCT03327844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245279|NCT03327844|Antitubercular Agents|antitubercular agents|mesh-ancestor
93245280|NCT03327844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93245281|NCT03327844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93245282|NCT03327844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93245283|NCT03327844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93245284|NCT03327844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245285|NCT03327844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245286|NCT03327844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245287|NCT03327844|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93245288|NCT03327844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93245289|NCT05008510|Camptothecin|camptothecin|mesh-list
93245290|NCT05008510|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93245291|NCT05008510|Immunoconjugates|immunoconjugates|mesh-list
93245292|NCT05008510|Immunologic Factors|immunologic factors|mesh-ancestor
93245293|NCT05008510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245294|NCT05008510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93245295|NCT05008510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245296|NCT05008510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93245297|NCT05008510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93245298|NCT05008510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245299|NCT05008510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245300|NCT05194995|Cetuximab|cetuximab|mesh-list
93245301|NCT05194995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245302|NCT05194995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245303|NCT05187039|Anesthetics|anesthetics|mesh-list
93245304|NCT05187039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245305|NCT05187039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245306|NCT03136666|Candesartan|candesartan|mesh-list
93245307|NCT03136666|Candesartan cilexetil|candesartan cilexetil|mesh-list
93245308|NCT03136666|Nifedipine|nifedipine|mesh-list
93245309|NCT03136666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93245310|NCT03136666|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93245311|NCT03136666|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93245312|NCT03136666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245313|NCT03136666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93245314|NCT03136666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93245315|NCT03136666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93245316|NCT03136666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245317|NCT03136666|Vasodilator Agents|vasodilator agents|mesh-ancestor
93245318|NCT03136666|Tocolytic Agents|tocolytic agents|mesh-ancestor
93245319|NCT03136666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93245320|NCT03255083|Osimertinib|osimertinib|mesh-list
93245321|NCT03255083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245322|NCT03255083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245323|NCT03255083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245324|NCT03255083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245325|NCT04861558|Fluorouracil|fluorouracil|mesh-list
93245326|NCT04861558|Oxaliplatin|oxaliplatin|mesh-list
93245327|NCT04861558|Irinotecan|irinotecan|mesh-list
93245328|NCT04861558|Antimetabolites|antimetabolites|mesh-ancestor
93245329|NCT04861558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245330|NCT04861558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93245331|NCT04861558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245332|NCT04861558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245333|NCT04861558|Immunologic Factors|immunologic factors|mesh-ancestor
93245334|NCT04861558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245335|NCT04861558|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93245336|NCT04861558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93245337|NCT04861558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245338|NCT03735537|Zoledronic Acid|zoledronic acid|mesh-list
93245339|NCT03735537|Teriparatide|teriparatide|mesh-list
93245340|NCT03735537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93245341|NCT03735537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93245342|NCT03735537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245343|NCT03735537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93245344|NCT04531059|Metronidazole|metronidazole|mesh-list
93245345|NCT04531059|Minocycline|minocycline|mesh-list
93245346|NCT04531059|Tetracycline|tetracycline|mesh-list
93245347|NCT04531059|Potassium Citrate|potassium citrate|mesh-list
93245348|NCT04531059|Esomeprazole|esomeprazole|mesh-list
93245349|NCT04531059|Bismuth|bismuth|mesh-list
93245350|NCT04531059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245351|NCT04531059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245352|NCT04531059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93245353|NCT04531059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93245354|NCT04531059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93245355|NCT04531059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93245356|NCT04531059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245357|NCT04531059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93245358|NCT04531059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245359|NCT04531059|Antacids|antacids|mesh-ancestor
93245360|NCT04531059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93245361|NCT04531059|Diuretics|diuretics|mesh-ancestor
93245362|NCT04531059|Natriuretic Agents|natriuretic agents|mesh-ancestor
93245363|NCT04531059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245364|NCT04531059|Expectorants|expectorants|mesh-ancestor
93245365|NCT04531059|Respiratory System Agents|respiratory system agents|mesh-ancestor
93245366|NCT05090176|Povidone|povidone|mesh-list
93245367|NCT05090176|Plasma Substitutes|plasma substitutes|mesh-ancestor
93245368|NCT05090176|Blood Substitutes|blood substitutes|mesh-ancestor
93245369|NCT04530981|Repaglinide|repaglinide|mesh-list
93245370|NCT04530981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93245371|NCT04530981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245372|NCT01316055|4-Aminopyridine|4-aminopyridine|mesh-list
93245373|NCT01316055|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93245374|NCT01316055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93245375|NCT01316055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245376|NCT05659563|Tamoxifen|tamoxifen|mesh-list
93245377|NCT05659563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93245378|NCT05659563|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245379|NCT05659563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245380|NCT05659563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245381|NCT05659563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245382|NCT05659563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539963|NCT00014456|Docetaxel|docetaxel|mesh-list
93245383|NCT05659563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93245384|NCT05659563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93245385|NCT05659563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93245386|NCT04558294|Ketanserin|ketanserin|mesh-list
93245387|NCT04558294|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93245388|NCT04558294|Hallucinogens|hallucinogens|mesh-ancestor
93245389|NCT04558294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245390|NCT04558294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93245391|NCT04558294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93245392|NCT04558294|Serotonin Agents|serotonin agents|mesh-ancestor
93245393|NCT04558294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245394|NCT04558294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245395|NCT04558294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93245396|NCT04558294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93245397|NCT04558294|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93245398|NCT05626257|Omalizumab|omalizumab|mesh-list
93245399|NCT05626257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93245400|NCT05626257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93245401|NCT05626257|Respiratory System Agents|respiratory system agents|mesh-ancestor
93245402|NCT04396821|Paclitaxel|paclitaxel|mesh-list
93245403|NCT04396821|Gemcitabine|gemcitabine|mesh-list
93245404|NCT04396821|Nivolumab|nivolumab|mesh-list
93245405|NCT04396821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93245406|NCT04396821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93245407|NCT04396821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245408|NCT04396821|Tubulin Modulators|tubulin modulators|mesh-ancestor
93245409|NCT04396821|Antimitotic Agents|antimitotic agents|mesh-ancestor
93245410|NCT04396821|Mitosis Modulators|mitosis modulators|mesh-ancestor
93245411|NCT04396821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245412|NCT04396821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93245413|NCT04396821|Antimetabolites|antimetabolites|mesh-ancestor
93245414|NCT04396821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245415|NCT04396821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93245416|NCT03378466|Heparin|heparin|mesh-list
93245417|NCT03378466|Calcium heparin|calcium heparin|mesh-list
93245418|NCT03378466|Anticoagulants|anticoagulants|mesh-ancestor
93245419|NCT03378466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93245420|NCT03378466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93245421|NCT03378466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245422|NCT05077540|Misoprostol|misoprostol|mesh-list
93245423|NCT05077540|Oxytocin|oxytocin|mesh-list
93245424|NCT05077540|Oxytocics|oxytocics|mesh-ancestor
93245425|NCT05077540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93245426|NCT05077540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245427|NCT05077540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93245428|NCT05077540|Abortifacient Agents|abortifacient agents|mesh-ancestor
93245429|NCT05077540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93245430|NCT05077540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245431|NCT04977375|Pembrolizumab|pembrolizumab|mesh-list
93245432|NCT04977375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245433|NCT04977375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245434|NCT04977375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93245435|NCT04977375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245436|NCT02744898|Paclitaxel|paclitaxel|mesh-list
93245437|NCT02744898|Carboplatin|carboplatin|mesh-list
93245438|NCT02744898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93245439|NCT02744898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93245440|NCT02744898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245441|NCT02744898|Tubulin Modulators|tubulin modulators|mesh-ancestor
93245442|NCT02744898|Antimitotic Agents|antimitotic agents|mesh-ancestor
93245443|NCT02744898|Mitosis Modulators|mitosis modulators|mesh-ancestor
93245444|NCT02744898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245445|NCT03587311|Paclitaxel|paclitaxel|mesh-list
93245446|NCT03587311|Maytansine|maytansine|mesh-list
93245447|NCT03587311|Bevacizumab|bevacizumab|mesh-list
93245448|NCT03587311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93245449|NCT03587311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93245450|NCT03587311|Endothelial Growth Factors|endothelial growth factors|mesh-list
93245451|NCT03587311|Antibodies|antibodies|mesh-list
93245452|NCT03587311|Immunoglobulins|immunoglobulins|mesh-list
93245453|NCT03587311|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93245454|NCT03587311|Immunoglobulin G|immunoglobulin g|mesh-list
93245455|NCT03587311|Anetumab ravtansine|anetumab ravtansine|mesh-list
93245456|NCT03587311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93245457|NCT03587311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245458|NCT03587311|Tubulin Modulators|tubulin modulators|mesh-ancestor
93245459|NCT03587311|Antimitotic Agents|antimitotic agents|mesh-ancestor
93245460|NCT03587311|Mitosis Modulators|mitosis modulators|mesh-ancestor
93245461|NCT03587311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245462|NCT03587311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93245463|NCT03587311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93245464|NCT03587311|Growth Substances|growth substances|mesh-ancestor
93245465|NCT03587311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540095|NCT00015080|Naltrexone|naltrexone|mesh-list
93245466|NCT03587311|Growth Inhibitors|growth inhibitors|mesh-ancestor
93245467|NCT03587311|Immunologic Factors|immunologic factors|mesh-ancestor
93245468|NCT03587311|Immunoconjugates|immunoconjugates|mesh-ancestor
92917441|NCT01027117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245469|NCT03097315|Triamcinolone|triamcinolone|mesh-list
93245470|NCT03097315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93245471|NCT03097315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93245473|NCT03097315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245474|NCT03097315|Glucocorticoids|glucocorticoids|mesh-ancestor
93245475|NCT03097315|Hormones|hormones|mesh-ancestor
93245476|NCT03097315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245477|NCT03097315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245478|NCT03097315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245479|NCT03097315|Immunologic Factors|immunologic factors|mesh-ancestor
93245480|NCT03097315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245481|NCT03097315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245482|NCT05530707|Niacinamide|niacinamide|mesh-list
93245483|NCT05530707|Niacin|niacin|mesh-list
93245484|NCT05530707|Nicotinic Acids|nicotinic acids|mesh-list
93245485|NCT05530707|Vitamin B Complex|vitamin b complex|mesh-ancestor
93245486|NCT05530707|Vitamins|vitamins|mesh-ancestor
93245487|NCT05530707|Micronutrients|micronutrients|mesh-ancestor
93245488|NCT05530707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245489|NCT05530707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93245490|NCT05530707|Antimetabolites|antimetabolites|mesh-ancestor
93245491|NCT05530707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245492|NCT05530707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93245493|NCT05530707|Vasodilator Agents|vasodilator agents|mesh-ancestor
93245494|NCT02833974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93245495|NCT03093415|Grazoprevir|grazoprevir|mesh-list
93245496|NCT03093415|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93245497|NCT03093415|Antiviral Agents|antiviral agents|mesh-ancestor
93245498|NCT03093415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245499|NCT01358526|Oxycodone|oxycodone|mesh-list
93245500|NCT01358526|Naloxone|naloxone|mesh-list
93245501|NCT01358526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93245502|NCT01358526|Narcotics|narcotics|mesh-ancestor
93245503|NCT01358526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245504|NCT01358526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245505|NCT01358526|Analgesics|analgesics|mesh-ancestor
93245506|NCT01358526|Sensory System Agents|sensory system agents|mesh-ancestor
93245507|NCT01358526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245508|NCT01358526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93245509|NCT05434689|Dexamethasone|dexamethasone|mesh-list
93245510|NCT05434689|Daratumumab|daratumumab|mesh-list
93245511|NCT05434689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245512|NCT05434689|Antiemetics|antiemetics|mesh-ancestor
93245513|NCT05434689|Autonomic Agents|autonomic agents|mesh-ancestor
93245514|NCT05434689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245515|NCT05434689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245516|NCT05434689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245517|NCT05434689|Glucocorticoids|glucocorticoids|mesh-ancestor
93245518|NCT05434689|Hormones|hormones|mesh-ancestor
93245519|NCT05434689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245520|NCT05434689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245521|NCT05434689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245522|NCT01310010|Dasatinib|dasatinib|mesh-list
93245523|NCT01310010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245524|NCT01310010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245525|NCT01310010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245526|NCT01310010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245527|NCT02830776|Bimatoprost|bimatoprost|mesh-list
93245528|NCT02830776|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93245529|NCT02830776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93245530|NCT02830776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93245531|NCT03563664|Danazol|danazol|mesh-list
93245532|NCT03563664|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93245533|NCT03563664|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245534|NCT03563664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245535|NCT03563664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245536|NCT01904136|Mycophenolic Acid|mycophenolic acid|mesh-list
93245537|NCT01904136|Cyclophosphamide|cyclophosphamide|mesh-list
93245538|NCT01904136|Melphalan|melphalan|mesh-list
93245539|NCT01904136|Mechlorethamine|mechlorethamine|mesh-list
93245540|NCT01904136|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93245541|NCT01904136|Fludarabine|fludarabine|mesh-list
93245542|NCT01904136|Tacrolimus|tacrolimus|mesh-list
93245543|NCT01904136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245544|NCT01904136|Immunologic Factors|immunologic factors|mesh-ancestor
93245545|NCT01904136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245546|NCT01904136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93245547|NCT01904136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93245548|NCT01904136|Alkylating Agents|alkylating agents|mesh-ancestor
93245549|NCT01904136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245550|NCT01904136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245551|NCT01904136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93245552|NCT01904136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93245553|NCT01904136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245554|NCT01904136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93245555|NCT01904136|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93245556|NCT01904136|Antitubercular Agents|antitubercular agents|mesh-ancestor
93245557|NCT01904136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93245558|NCT01904136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245559|NCT03041181|Gemcitabine|gemcitabine|mesh-list
93245560|NCT03041181|Docetaxel|docetaxel|mesh-list
93245561|NCT03041181|Nivolumab|nivolumab|mesh-list
93245562|NCT03041181|Pemetrexed|pemetrexed|mesh-list
93245563|NCT03041181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93245564|NCT03041181|Antimetabolites|antimetabolites|mesh-ancestor
93245565|NCT03041181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245566|NCT03041181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245567|NCT03041181|Tubulin Modulators|tubulin modulators|mesh-ancestor
93245568|NCT03041181|Antimitotic Agents|antimitotic agents|mesh-ancestor
93245569|NCT03041181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540183|NCT00275535|Mycophenolic Acid|mycophenolic acid|mesh-list
93245570|NCT03041181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245571|NCT03041181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93245572|NCT03041181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245573|NCT03041181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93245574|NCT03041181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93245575|NCT05351229|Morphine|morphine|mesh-list
93245576|NCT05351229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93245577|NCT05351229|Narcotics|narcotics|mesh-ancestor
93245578|NCT05351229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245579|NCT05351229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245580|NCT05351229|Analgesics|analgesics|mesh-ancestor
93245581|NCT05351229|Sensory System Agents|sensory system agents|mesh-ancestor
93245582|NCT05351229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245583|NCT05121909|Listerine|listerine|mesh-list
93245584|NCT05121909|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93245585|NCT05121909|Sodium Fluoride|sodium fluoride|mesh-list
93245586|NCT05121909|Cariostatic Agents|cariostatic agents|mesh-ancestor
93245587|NCT05121909|Protective Agents|protective agents|mesh-ancestor
93245588|NCT05121909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245589|NCT05121909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245590|NCT02828124|Nivolumab|nivolumab|mesh-list
93245591|NCT02828124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245592|NCT02828124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245593|NCT02828124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93245594|NCT02828124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245595|NCT04761393|Xenon|xenon|mesh-list
93245596|NCT04761393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93245597|NCT04761393|Anesthetics, General|anesthetics, general|mesh-ancestor
93245598|NCT04761393|Anesthetics|anesthetics|mesh-ancestor
93245599|NCT04761393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245600|NCT04761393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245601|NCT02829996|Latanoprost|latanoprost|mesh-list
93245602|NCT02829996|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93245603|NCT02829996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93245604|NCT05385549|Imatinib Mesylate|imatinib mesylate|mesh-list
93245605|NCT05385549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245606|NCT05385549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245607|NCT05385549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245608|NCT05385549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245609|NCT03563586|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93245610|NCT03563586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245611|NCT05197062|Aticaprant|aticaprant|mesh-list
93245612|NCT05197062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93245613|NCT05197062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245614|NCT05197062|Sensory System Agents|sensory system agents|mesh-ancestor
93245615|NCT05197062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245616|NCT05000736|Fulvestrant|fulvestrant|mesh-list
93245617|NCT05000736|Palbociclib|palbociclib|mesh-list
93245618|NCT05000736|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93245619|NCT05000736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245620|NCT05000736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245621|NCT05000736|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93245622|NCT05000736|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93245623|NCT05000736|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245624|NCT05000736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245625|NCT05000736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245626|NCT05000736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245627|NCT05000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245628|NCT05000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245629|NCT05000736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93245630|NCT03828162|Anticoagulants|anticoagulants|mesh-list
93245631|NCT03563040|Methoxsalen|methoxsalen|mesh-list
93245632|NCT03563040|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93245633|NCT03563040|Dermatologic Agents|dermatologic agents|mesh-ancestor
93245634|NCT03094416|Esomeprazole|esomeprazole|mesh-list
93245636|NCT03094416|Rabeprazole|rabeprazole|mesh-list
93245637|NCT03094416|Pantoprazole|pantoprazole|mesh-list
93245638|NCT03094416|Lansoprazole|lansoprazole|mesh-list
93245639|NCT03094416|Dexlansoprazole|dexlansoprazole|mesh-list
93245640|NCT03094416|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93245641|NCT03094416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93245642|NCT03094416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245643|NCT03094416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245644|NCT03094416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245645|NCT05109429|Analgesics, Opioid|analgesics, opioid|mesh-list
93245646|NCT05109429|Narcotics|narcotics|mesh-ancestor
93245647|NCT05109429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245648|NCT05109429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245649|NCT05109429|Analgesics|analgesics|mesh-ancestor
93245650|NCT05109429|Sensory System Agents|sensory system agents|mesh-ancestor
93245651|NCT05109429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245652|NCT01338870|Nicotinic Acids|nicotinic acids|mesh-list
93245653|NCT01338870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93245654|NCT01338870|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93245655|NCT01338870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93245656|NCT01338870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245657|NCT01338870|Incretins|incretins|mesh-ancestor
93245658|NCT01338870|Hormones|hormones|mesh-ancestor
93245659|NCT01338870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245660|NCT01338870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93245661|NCT01338870|Protease Inhibitors|protease inhibitors|mesh-ancestor
93245662|NCT01338870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245663|NCT01338870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245664|NCT01338870|Vitamin B Complex|vitamin b complex|mesh-ancestor
93245665|NCT01338870|Vitamins|vitamins|mesh-ancestor
93245666|NCT01338870|Micronutrients|micronutrients|mesh-ancestor
93245667|NCT02824224|Tamoxifen|tamoxifen|mesh-list
93245668|NCT02824224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93245669|NCT02824224|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245670|NCT02824224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245671|NCT02824224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245672|NCT02824224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245673|NCT02824224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245674|NCT02824224|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93245675|NCT02824224|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93245676|NCT02824224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93245677|NCT01338792|Oxaliplatin|oxaliplatin|mesh-list
93245678|NCT01338792|Pemetrexed|pemetrexed|mesh-list
93245679|NCT01338792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245680|NCT01338792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245681|NCT01338792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245682|NCT01338792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93245683|NCT01338792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93245684|NCT01314105|Carboplatin|carboplatin|mesh-list
93245685|NCT01314105|Nintedanib|nintedanib|mesh-list
93245686|NCT01314105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245687|NCT01314105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245688|NCT01314105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245689|NCT01314105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245690|NCT01966471|Maytansine|maytansine|mesh-list
93245691|NCT01966471|Docetaxel|docetaxel|mesh-list
93245692|NCT01966471|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93245693|NCT01966471|Cyclophosphamide|cyclophosphamide|mesh-list
93245694|NCT01966471|Doxorubicin|doxorubicin|mesh-list
93245695|NCT01966471|Fluorouracil|fluorouracil|mesh-list
93245696|NCT01966471|Trastuzumab|trastuzumab|mesh-list
93245697|NCT01966471|Epirubicin|epirubicin|mesh-list
93245698|NCT01966471|Pertuzumab|pertuzumab|mesh-list
92917670|NCT05500586|Glucagon|glucagon|mesh-list
93245699|NCT01966471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93245700|NCT01966471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245701|NCT01966471|Tubulin Modulators|tubulin modulators|mesh-ancestor
93245702|NCT01966471|Antimitotic Agents|antimitotic agents|mesh-ancestor
93245703|NCT01966471|Mitosis Modulators|mitosis modulators|mesh-ancestor
93245704|NCT01966471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245705|NCT01966471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245706|NCT01966471|Immunologic Factors|immunologic factors|mesh-ancestor
93245707|NCT01966471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245708|NCT01966471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93245709|NCT01966471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93245710|NCT01966471|Alkylating Agents|alkylating agents|mesh-ancestor
93245711|NCT01966471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93245712|NCT01966471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93245713|NCT01966471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93245714|NCT01966471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93245715|NCT01966471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245716|NCT01966471|Antimetabolites|antimetabolites|mesh-ancestor
93245717|NCT01966471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93245718|NCT01966471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245719|NCT01966471|Immunotoxins|immunotoxins|mesh-ancestor
93245720|NCT01966471|Immunoconjugates|immunoconjugates|mesh-ancestor
93245721|NCT04188847|Apatinib|apatinib|mesh-list
93245722|NCT04188847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245723|NCT04188847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245724|NCT04188847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245725|NCT04188847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245726|NCT05255107|Riboflavin|riboflavin|mesh-list
93245727|NCT05255107|Lubricant Eye Drops|lubricant eye drops|mesh-list
93245728|NCT05255107|Vitamin B Complex|vitamin b complex|mesh-ancestor
93245729|NCT05255107|Vitamins|vitamins|mesh-ancestor
93245730|NCT05255107|Micronutrients|micronutrients|mesh-ancestor
93245731|NCT05255107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245732|NCT05255107|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93245733|NCT05255107|Dermatologic Agents|dermatologic agents|mesh-ancestor
93245734|NCT05255107|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93245735|NCT05255107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93245736|NCT03227471|Ivacaftor|ivacaftor|mesh-list
93245737|NCT03227471|Elexacaftor|elexacaftor|mesh-list
93245738|NCT03227471|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93245739|NCT03227471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93245740|NCT03227471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245741|NCT01354314|Fluconazole|fluconazole|mesh-list
93245742|NCT01354314|Paroxetine|paroxetine|mesh-list
93245743|NCT01354314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93245744|NCT01354314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93245745|NCT01354314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93245746|NCT01354314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245747|NCT01354314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245748|NCT01354314|Serotonin Agents|serotonin agents|mesh-ancestor
93245749|NCT01354314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245750|NCT01354314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93245751|NCT01354314|Antidepressive Agents|antidepressive agents|mesh-ancestor
93245752|NCT01354314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93245753|NCT01354314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93245754|NCT01354314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93245755|NCT01354314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245756|NCT01354314|Antifungal Agents|antifungal agents|mesh-ancestor
93245757|NCT01354314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245758|NCT01354314|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93245759|NCT01354314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93245760|NCT01354314|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245761|NCT01354314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245762|NCT01354314|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93245763|NCT01354314|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93245764|NCT04509336|Orphenadrine|orphenadrine|mesh-list
93245765|NCT04509336|Baclofen|baclofen|mesh-list
93245766|NCT04509336|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93245767|NCT04509336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245768|NCT04509336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93245769|NCT04509336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245770|NCT04509336|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93245771|NCT04509336|GABA Agonists|gaba agonists|mesh-ancestor
93245772|NCT04509336|GABA Agents|gaba agents|mesh-ancestor
93245773|NCT04509336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245774|NCT04509336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245775|NCT04509336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93245776|NCT04509336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93245777|NCT04509336|Parasympatholytics|parasympatholytics|mesh-ancestor
93245778|NCT04509336|Autonomic Agents|autonomic agents|mesh-ancestor
93245779|NCT04509336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93245780|NCT04509336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93245781|NCT04509336|Cholinergic Agents|cholinergic agents|mesh-ancestor
93245782|NCT04509336|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
93245783|NCT04509336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93245784|NCT04509336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245785|NCT03194321|Tacrolimus|tacrolimus|mesh-list
93245786|NCT03194321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245787|NCT03194321|Immunologic Factors|immunologic factors|mesh-ancestor
93245788|NCT03194321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245789|NCT03194321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93245790|NCT03194321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245791|NCT03194321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245792|NCT05231460|Narcotics|narcotics|mesh-list
93245793|NCT05231460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245794|NCT05231460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245795|NCT05231460|Analgesics|analgesics|mesh-ancestor
93245796|NCT05231460|Sensory System Agents|sensory system agents|mesh-ancestor
93245797|NCT05231460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245798|NCT01374581|Artesunate|artesunate|mesh-list
93245799|NCT01374581|Lumefantrine|lumefantrine|mesh-list
93245800|NCT01374581|Artemether|artemether|mesh-list
93245801|NCT01374581|Amodiaquine|amodiaquine|mesh-list
93245802|NCT01374581|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93245803|NCT01374581|Quinine|quinine|mesh-list
93245804|NCT01374581|Clindamycin|clindamycin|mesh-list
93245805|NCT01374581|Clindamycin palmitate|clindamycin palmitate|mesh-list
93245806|NCT01374581|Clindamycin phosphate|clindamycin phosphate|mesh-list
93245807|NCT01374581|Antimalarials|antimalarials|mesh-ancestor
93245808|NCT01374581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93245809|NCT01374581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93245810|NCT01374581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245811|NCT01374581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245812|NCT01374581|Antiviral Agents|antiviral agents|mesh-ancestor
93245813|NCT01374581|Schistosomicides|schistosomicides|mesh-ancestor
93245814|NCT01374581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93245815|NCT01374581|Anthelmintics|anthelmintics|mesh-ancestor
93245816|NCT01374581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93245817|NCT01374581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93245818|NCT01374581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245819|NCT01374581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245820|NCT01374581|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93245821|NCT01374581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245822|NCT01374581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93245823|NCT01374581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245824|NCT01374581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93245825|NCT01374581|Analgesics|analgesics|mesh-ancestor
93245826|NCT01374581|Sensory System Agents|sensory system agents|mesh-ancestor
93245827|NCT01354938|Clarithromycin|clarithromycin|mesh-list
93245828|NCT01354938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93245829|NCT01354938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93245830|NCT01354938|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93245831|NCT01354938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245832|NCT01354938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245833|NCT01354938|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93245834|NCT01354938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93245835|NCT03065556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93245836|NCT01374737|Dexmedetomidine|dexmedetomidine|mesh-list
93245837|NCT01374737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93245838|NCT01374737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245839|NCT01374737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245840|NCT01374737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93245841|NCT01374737|Analgesics|analgesics|mesh-ancestor
93245842|NCT01374737|Sensory System Agents|sensory system agents|mesh-ancestor
93245843|NCT01374737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245844|NCT01374737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93245845|NCT01374737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93245846|NCT01374737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93245847|NCT01374737|Adrenergic Agents|adrenergic agents|mesh-ancestor
93245848|NCT01374737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245849|NCT01374737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245851|NCT03631615|Immunologic Factors|immunologic factors|mesh-ancestor
93245852|NCT03631615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245853|NCT01376453|Fluorouracil|fluorouracil|mesh-list
93245854|NCT01376453|Sorafenib|sorafenib|mesh-list
93245855|NCT01376453|Antimetabolites|antimetabolites|mesh-ancestor
93245856|NCT01376453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245857|NCT01376453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93245858|NCT01376453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245859|NCT01376453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93245860|NCT01376453|Immunologic Factors|immunologic factors|mesh-ancestor
93245861|NCT01376453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245862|NCT01376453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93245863|NCT01376453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245864|NCT05107219|Linaclotide|linaclotide|mesh-list
93245865|NCT05107219|Plecanatide|plecanatide|mesh-list
93245866|NCT05107219|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93245867|NCT05107219|Enzyme Activators|enzyme activators|mesh-ancestor
93245868|NCT05107219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245869|NCT05107219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245870|NCT01568125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93245871|NCT01568125|Incretins|incretins|mesh-list
93245872|NCT01568125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245873|NCT01568125|Hormones|hormones|mesh-ancestor
93245874|NCT01568125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245875|NCT03360721|Prednisone|prednisone|mesh-list
93245876|NCT03360721|Cortisone|cortisone|mesh-list
93245877|NCT03360721|Abiraterone Acetate|abiraterone acetate|mesh-list
93245878|NCT03360721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245879|NCT03360721|Glucocorticoids|glucocorticoids|mesh-ancestor
93245880|NCT03360721|Hormones|hormones|mesh-ancestor
93245881|NCT03360721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245882|NCT03360721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245883|NCT03360721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245884|NCT03360721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245885|NCT03360721|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93245886|NCT03360721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93245887|NCT03360721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245888|NCT03360721|Hormone Antagonists|hormone antagonists|mesh-ancestor
93245889|NCT03360721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93245890|NCT02288897|Temozolomide|temozolomide|mesh-list
93245891|NCT02288897|Dacarbazine|dacarbazine|mesh-list
93245892|NCT02288897|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93245893|NCT02288897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93245894|NCT02288897|Alkylating Agents|alkylating agents|mesh-ancestor
93245895|NCT02288897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245896|NCT02288897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245897|NCT02288897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93245898|NCT05707572|Methylprednisolone|methylprednisolone|mesh-list
93245899|NCT05707572|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93245900|NCT05707572|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93245901|NCT05707572|Prednisolone|prednisolone|mesh-list
93245902|NCT05707572|Prednisolone acetate|prednisolone acetate|mesh-list
93245903|NCT05707572|Lidocaine|lidocaine|mesh-list
93245904|NCT05707572|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93245905|NCT05707572|Prednisolone phosphate|prednisolone phosphate|mesh-list
93245906|NCT05707572|Anesthetics, Local|anesthetics, local|mesh-ancestor
93245907|NCT05707572|Anesthetics|anesthetics|mesh-ancestor
93245908|NCT05707572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93245909|NCT05707572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245910|NCT05707572|Sensory System Agents|sensory system agents|mesh-ancestor
93245911|NCT05707572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245912|NCT05707572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93245913|NCT05707572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93245914|NCT05707572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93245915|NCT05707572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93245916|NCT05707572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245917|NCT05707572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245918|NCT05707572|Antiemetics|antiemetics|mesh-ancestor
93245919|NCT05707572|Autonomic Agents|autonomic agents|mesh-ancestor
93245920|NCT05707572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245921|NCT05707572|Glucocorticoids|glucocorticoids|mesh-ancestor
93245922|NCT05707572|Hormones|hormones|mesh-ancestor
93245923|NCT05707572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245924|NCT05707572|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93245925|NCT05707572|Protective Agents|protective agents|mesh-ancestor
93245926|NCT05707572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245927|NCT05707572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245928|NCT02035800|Adalimumab|adalimumab|mesh-list
93245929|NCT02035800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93245930|NCT02035800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245931|NCT02035800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93245932|NCT03993912|Dexamethasone|dexamethasone|mesh-list
93245933|NCT03993912|Lenalidomide|lenalidomide|mesh-list
93245934|NCT03993912|Daratumumab|daratumumab|mesh-list
93245935|NCT03993912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93245936|NCT03993912|Antiemetics|antiemetics|mesh-ancestor
93245937|NCT03993912|Autonomic Agents|autonomic agents|mesh-ancestor
93245938|NCT03993912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245939|NCT03993912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245940|NCT03993912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245941|NCT03993912|Glucocorticoids|glucocorticoids|mesh-ancestor
93245942|NCT03993912|Hormones|hormones|mesh-ancestor
93245943|NCT03993912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93245944|NCT03993912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93245945|NCT03993912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93245946|NCT03993912|Immunologic Factors|immunologic factors|mesh-ancestor
93245947|NCT03993912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93245948|NCT03993912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93245949|NCT03993912|Growth Substances|growth substances|mesh-ancestor
93245950|NCT03993912|Growth Inhibitors|growth inhibitors|mesh-ancestor
93245951|NCT01568749|Acetaminophen|acetaminophen|mesh-list
93245952|NCT01568749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93245953|NCT01568749|Analgesics|analgesics|mesh-ancestor
93245954|NCT01568749|Sensory System Agents|sensory system agents|mesh-ancestor
93245955|NCT01568749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245956|NCT01568749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245957|NCT01568749|Antipyretics|antipyretics|mesh-ancestor
93245958|NCT02819310|Laxatives|laxatives|mesh-list
93245959|NCT02819310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245960|NCT03633773|Immunomodulating Agents|immunomodulating agents|mesh-list
93245961|NCT03633773|Immunologic Factors|immunologic factors|mesh-ancestor
93245962|NCT03633773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245963|NCT01375361|Albuterol|albuterol|mesh-list
93245964|NCT01375361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93245965|NCT01375361|Autonomic Agents|autonomic agents|mesh-ancestor
93245966|NCT01375361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245967|NCT01375361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245968|NCT01375361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93245969|NCT01375361|Respiratory System Agents|respiratory system agents|mesh-ancestor
93245970|NCT01375361|Tocolytic Agents|tocolytic agents|mesh-ancestor
93245971|NCT01375361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93245972|NCT01375361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93245973|NCT01375361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93245974|NCT01375361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93245975|NCT01375361|Adrenergic Agents|adrenergic agents|mesh-ancestor
93245976|NCT01375361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245977|NCT01375361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245978|NCT01376765|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93245979|NCT01376765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93245980|NCT01376765|Immunologic Factors|immunologic factors|mesh-ancestor
93245981|NCT01376765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245982|NCT01376765|Antacids|antacids|mesh-ancestor
93245983|NCT01376765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245984|NCT01376765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93245985|NCT03278509|Metoprolol|metoprolol|mesh-list
93245986|NCT03278509|Bisoprolol|bisoprolol|mesh-list
93245987|NCT03278509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93245988|NCT03278509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93245989|NCT03278509|Sympatholytics|sympatholytics|mesh-ancestor
93245990|NCT03278509|Autonomic Agents|autonomic agents|mesh-ancestor
93245991|NCT03278509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93245992|NCT03278509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93245993|NCT03278509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93245994|NCT03278509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93245995|NCT03278509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93245996|NCT03278509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92917961|NCT04109742|Curcumin|curcumin|mesh-list
93245997|NCT03278509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93245998|NCT03278509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93245999|NCT05754593|Hormones|hormones|mesh-list
93246000|NCT05754593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246001|NCT05754593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246002|NCT04788563|Antihypertensive Agents|antihypertensive agents|mesh-list
93246003|NCT05196347|Dapagliflozin|dapagliflozin|mesh-list
93246004|NCT05196347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92540619|NCT00016406|Paclitaxel|paclitaxel|mesh-list
93246005|NCT05196347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246006|NCT05196347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246007|NCT05196347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246008|NCT01358201|Cytarabine|cytarabine|mesh-list
93246009|NCT01358201|Dexamethasone|dexamethasone|mesh-list
93246010|NCT01358201|Methotrexate|methotrexate|mesh-list
93246011|NCT01358201|Vincristine|vincristine|mesh-list
93246012|NCT01358201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246013|NCT01358201|Antiemetics|antiemetics|mesh-ancestor
93246014|NCT01358201|Autonomic Agents|autonomic agents|mesh-ancestor
93246015|NCT01358201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246016|NCT01358201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246017|NCT01358201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93246018|NCT01358201|Glucocorticoids|glucocorticoids|mesh-ancestor
93246019|NCT01358201|Hormones|hormones|mesh-ancestor
93246020|NCT01358201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246021|NCT01358201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93246022|NCT01358201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246023|NCT01358201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93246024|NCT01358201|Abortifacient Agents|abortifacient agents|mesh-ancestor
93246025|NCT01358201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93246026|NCT01358201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246027|NCT01358201|Antimetabolites|antimetabolites|mesh-ancestor
93246028|NCT01358201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246029|NCT01358201|Dermatologic Agents|dermatologic agents|mesh-ancestor
93246030|NCT01358201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246031|NCT01358201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93246032|NCT01358201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93246033|NCT01358201|Immunologic Factors|immunologic factors|mesh-ancestor
93246034|NCT01358201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246035|NCT01358201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93246036|NCT01358201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246037|NCT01358201|Tubulin Modulators|tubulin modulators|mesh-ancestor
93246038|NCT01358201|Antimitotic Agents|antimitotic agents|mesh-ancestor
93246039|NCT01358201|Mitosis Modulators|mitosis modulators|mesh-ancestor
93246040|NCT01358201|Antiviral Agents|antiviral agents|mesh-ancestor
93246041|NCT01358201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246042|NCT02969083|Cisplatin|cisplatin|mesh-list
93246043|NCT02969083|Gemcitabine|gemcitabine|mesh-list
93246044|NCT02969083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246045|NCT02969083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246046|NCT02969083|Antimetabolites|antimetabolites|mesh-ancestor
93246047|NCT02969083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246048|NCT04726475|Cannabidiol|cannabidiol|mesh-list
93246049|NCT04726475|Anticonvulsants|anticonvulsants|mesh-ancestor
93246050|NCT02951767|Atezolizumab|atezolizumab|mesh-list
93246051|NCT02951767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93246052|NCT02951767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246053|NCT02951767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246054|NCT02951767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246055|NCT05170763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93246056|NCT03091777|Metronidazole|metronidazole|mesh-list
93246057|NCT03091777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246058|NCT03091777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93246059|NCT03091777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93246060|NCT03091777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93246061|NCT05603741|Lidocaine|lidocaine|mesh-list
93246062|NCT05603741|Anesthetics, Local|anesthetics, local|mesh-ancestor
93246063|NCT05603741|Anesthetics|anesthetics|mesh-ancestor
93246064|NCT05603741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246065|NCT05603741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246066|NCT05603741|Sensory System Agents|sensory system agents|mesh-ancestor
93246067|NCT05603741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246068|NCT05603741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93246069|NCT05603741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93246070|NCT05603741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93246071|NCT05603741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246072|NCT05603741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246074|NCT05392361|Baclofen|baclofen|mesh-list
93246075|NCT05392361|Analgesics|analgesics|mesh-ancestor
93246076|NCT05392361|Sensory System Agents|sensory system agents|mesh-ancestor
93246077|NCT05392361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246078|NCT05392361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246079|NCT05392361|Anticonvulsants|anticonvulsants|mesh-ancestor
93246080|NCT05392361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93246081|NCT05392361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93246082|NCT05392361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246083|NCT05392361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93246084|NCT05392361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93246085|NCT05392361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93246086|NCT05392361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246087|NCT05392361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246088|NCT05392361|Antimanic Agents|antimanic agents|mesh-ancestor
93246089|NCT05392361|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93246090|NCT05392361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93246091|NCT05392361|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93246092|NCT05392361|GABA Agonists|gaba agonists|mesh-ancestor
93246093|NCT05392361|GABA Agents|gaba agents|mesh-ancestor
93246094|NCT05338541|Etoposide|etoposide|mesh-list
93246095|NCT05338541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246096|NCT05338541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246097|NCT05338541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93246098|NCT05338541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246099|NCT05338541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246100|NCT05338541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246101|NCT05335655|Dexmedetomidine|dexmedetomidine|mesh-list
93246102|NCT05335655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93246103|NCT05335655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246104|NCT05335655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246105|NCT05335655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246106|NCT05335655|Analgesics|analgesics|mesh-ancestor
93246107|NCT05335655|Sensory System Agents|sensory system agents|mesh-ancestor
93246108|NCT05335655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246109|NCT05335655|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93246110|NCT05335655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93246111|NCT05335655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93246112|NCT05335655|Adrenergic Agents|adrenergic agents|mesh-ancestor
93246113|NCT05335655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246114|NCT05335655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246115|NCT04589351|Ezetimibe|ezetimibe|mesh-list
93246116|NCT04589351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93246117|NCT04589351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93246118|NCT04589351|Antimetabolites|antimetabolites|mesh-ancestor
93246119|NCT04589351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246120|NCT04589351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93246121|NCT02818998|Aflibercept|aflibercept|mesh-list
93246122|NCT02818998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93246123|NCT02818998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93246124|NCT02818998|Growth Substances|growth substances|mesh-ancestor
93246125|NCT02818998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246126|NCT02818998|Growth Inhibitors|growth inhibitors|mesh-ancestor
93246127|NCT02818998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246128|NCT05760677|Metformin|metformin|mesh-list
93246129|NCT05760677|Pioglitazone|pioglitazone|mesh-list
93246130|NCT05760677|Orlistat|orlistat|mesh-list
93246131|NCT05760677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246132|NCT05760677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246133|NCT05760677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246134|NCT05760677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246135|NCT05760677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93246136|NCT05760677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93246137|NCT02821416|Benralizumab|benralizumab|mesh-list
93246138|NCT02821416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93246139|NCT02821416|Respiratory System Agents|respiratory system agents|mesh-ancestor
93246140|NCT03108521|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93246141|NCT03108521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246142|NCT03108521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246143|NCT03108521|Incretins|incretins|mesh-ancestor
93246144|NCT03108521|Hormones|hormones|mesh-ancestor
93246145|NCT03108521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246146|NCT03108521|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93246147|NCT03108521|Protease Inhibitors|protease inhibitors|mesh-ancestor
93246148|NCT03108521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246149|NCT03108521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246150|NCT04500509|Diclofenac|diclofenac|mesh-list
93246151|NCT04500509|Dinoprostone|dinoprostone|mesh-list
93246152|NCT04500509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93246153|NCT04500509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246154|NCT04500509|Analgesics|analgesics|mesh-ancestor
93246155|NCT04500509|Sensory System Agents|sensory system agents|mesh-ancestor
93246156|NCT04500509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246157|NCT04500509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246158|NCT04500509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246159|NCT04500509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246160|NCT04500509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93246161|NCT04500509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246162|NCT04500509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246163|NCT04500509|Oxytocics|oxytocics|mesh-ancestor
93246164|NCT04500509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93246165|NCT05760599|Bevacizumab|bevacizumab|mesh-list
93246166|NCT05760599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246167|NCT05760599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246168|NCT05760599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93246169|NCT05760599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93246170|NCT05760599|Growth Substances|growth substances|mesh-ancestor
93246171|NCT05760599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246172|NCT05760599|Growth Inhibitors|growth inhibitors|mesh-ancestor
93246173|NCT04441073|Lidocaine|lidocaine|mesh-list
93246174|NCT04441073|Anesthetics, Local|anesthetics, local|mesh-ancestor
93246175|NCT04441073|Anesthetics|anesthetics|mesh-ancestor
93246176|NCT04441073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246177|NCT04441073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246178|NCT04441073|Sensory System Agents|sensory system agents|mesh-ancestor
93246179|NCT04441073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246180|NCT04441073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93246181|NCT04441073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93246182|NCT04441073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93246183|NCT04441073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246184|NCT04441073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246185|NCT02817828|Drospirenone|drospirenone|mesh-list
93246186|NCT02817828|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93246187|NCT02817828|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246188|NCT02817828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246189|NCT02817828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246190|NCT02817828|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93246191|NCT02817828|Diuretics|diuretics|mesh-ancestor
93246192|NCT02817828|Natriuretic Agents|natriuretic agents|mesh-ancestor
93246193|NCT03632681|Insulin|insulin|mesh-list
93246194|NCT03632681|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93246195|NCT03632681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246196|NCT03632681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246197|NCT05597995|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
93246198|NCT05597995|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93246199|NCT05597995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93246200|NCT05597917|Trabectedin|trabectedin|mesh-list
93246201|NCT05597917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93246202|NCT05597917|Alkylating Agents|alkylating agents|mesh-ancestor
93246203|NCT05597917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246204|NCT05597917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246205|NCT03796650|Vancomycin|vancomycin|mesh-list
93246206|NCT03796650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93246207|NCT03796650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246208|NCT05597527|Apatinib|apatinib|mesh-list
93246209|NCT05597527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246210|NCT05597527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93246211|NCT05597527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246212|NCT05597527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246213|NCT05198141|Letrozole|letrozole|mesh-list
93246214|NCT05198141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246215|NCT05198141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93246216|NCT05198141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93246217|NCT05198141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366395|NCT02796755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92918184|NCT00819754|Bevacizumab|bevacizumab|mesh-list
93246218|NCT05198141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246219|NCT05198141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93246220|NCT05198141|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246221|NCT05198141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246222|NCT05198141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246223|NCT02813694|Moxifloxacin|moxifloxacin|mesh-list
93246224|NCT02813694|Lefamulin|lefamulin|mesh-list
93246225|NCT02813694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93246226|NCT02813694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246227|NCT02813694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93246228|NCT02813694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246229|NCT02813694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246230|NCT02813694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246231|NCT02813694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246232|NCT03632161|Dexmedetomidine|dexmedetomidine|mesh-list
93246233|NCT03632161|Bupivacaine|bupivacaine|mesh-list
93246234|NCT03632161|Anesthetics, Local|anesthetics, local|mesh-ancestor
93246235|NCT03632161|Anesthetics|anesthetics|mesh-ancestor
93246236|NCT03632161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246237|NCT03632161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246238|NCT03632161|Sensory System Agents|sensory system agents|mesh-ancestor
93246239|NCT03632161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246240|NCT03632161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93246241|NCT03632161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246242|NCT03632161|Analgesics|analgesics|mesh-ancestor
93246243|NCT03632161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93246244|NCT03632161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93246245|NCT03632161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93246246|NCT03632161|Adrenergic Agents|adrenergic agents|mesh-ancestor
93246247|NCT03632161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246248|NCT03632161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246249|NCT03103919|Rotigotine|rotigotine|mesh-list
93246250|NCT03103919|Dopamine Agonists|dopamine agonists|mesh-ancestor
93246251|NCT03103919|Dopamine Agents|dopamine agents|mesh-ancestor
93246252|NCT03103919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246253|NCT03103919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246254|NCT03103919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246255|NCT04173325|Nivolumab|nivolumab|mesh-list
93246256|NCT04173325|Irinotecan|irinotecan|mesh-list
93246257|NCT04173325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246258|NCT04173325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246259|NCT04173325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93246260|NCT04173325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246261|NCT04173325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93246262|NCT04173325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246263|NCT04173325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246264|NCT02810964|Sulforaphane|sulforaphane|mesh-list
93246265|NCT02810964|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93246266|NCT02810964|Protective Agents|protective agents|mesh-ancestor
93246267|NCT02810964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246268|NCT02810964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246269|NCT04073147|Venetoclax|venetoclax|mesh-list
93246270|NCT04073147|Obinutuzumab|obinutuzumab|mesh-list
93246271|NCT04073147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246272|NCT04073147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246273|NCT02707159|Paclitaxel|paclitaxel|mesh-list
93246274|NCT02707159|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93246275|NCT02707159|Gemcitabine|gemcitabine|mesh-list
93246276|NCT02707159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246277|NCT02707159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246278|NCT02707159|Tubulin Modulators|tubulin modulators|mesh-ancestor
93246279|NCT02707159|Antimitotic Agents|antimitotic agents|mesh-ancestor
93246280|NCT02707159|Mitosis Modulators|mitosis modulators|mesh-ancestor
93246281|NCT02707159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246282|NCT02707159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246283|NCT02707159|Antimetabolites|antimetabolites|mesh-ancestor
93246284|NCT04113187|Propranolol|propranolol|mesh-list
93246285|NCT04113187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93246286|NCT04113187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93246287|NCT04113187|Adrenergic Agents|adrenergic agents|mesh-ancestor
93246288|NCT04113187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246289|NCT04113187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246290|NCT04113187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246291|NCT04113187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93246292|NCT04113187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93246293|NCT04113187|Vasodilator Agents|vasodilator agents|mesh-ancestor
93246295|NCT03103763|Anticoagulants|anticoagulants|mesh-ancestor
93246296|NCT05197517|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93246297|NCT05197517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93246298|NCT05197517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93246299|NCT05197517|Antimetabolites|antimetabolites|mesh-ancestor
93246300|NCT05197517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246301|NCT05197517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93246302|NCT05197517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93246303|NCT05197517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246304|NCT04011475|Tiotropium Bromide|tiotropium bromide|mesh-list
93246305|NCT04011475|Olodaterol|olodaterol|mesh-list
93246306|NCT04011475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93246307|NCT04011475|Autonomic Agents|autonomic agents|mesh-ancestor
93246308|NCT04011475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246309|NCT04011475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246310|NCT04011475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93246311|NCT04011475|Respiratory System Agents|respiratory system agents|mesh-ancestor
93246312|NCT04011475|Parasympatholytics|parasympatholytics|mesh-ancestor
93246313|NCT04011475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93246314|NCT04011475|Cholinergic Agents|cholinergic agents|mesh-ancestor
93246315|NCT04011475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246316|NCT04011475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246317|NCT05110781|Atezolizumab|atezolizumab|mesh-list
93246318|NCT05110781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93246319|NCT05110781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93246320|NCT05110781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246321|NCT05110781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246322|NCT05110781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246323|NCT05110781|Immunologic Factors|immunologic factors|mesh-ancestor
93246324|NCT05110781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246325|NCT04138277|Miglustat|miglustat|mesh-list
93246326|NCT04138277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246327|NCT04138277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246328|NCT04138277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93246329|NCT04138277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93246330|NCT04138277|Antiviral Agents|antiviral agents|mesh-ancestor
93246331|NCT04138277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246332|NCT04138277|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93246333|NCT04138277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092431|NCT00051636|Micronutrients|micronutrients|mesh-ancestor
93246334|NCT04138277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246335|NCT03663335|Tacrolimus|tacrolimus|mesh-list
93246336|NCT03663335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93246337|NCT03663335|Immunologic Factors|immunologic factors|mesh-ancestor
93246338|NCT03663335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246339|NCT03663335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93246340|NCT03663335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246341|NCT03663335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246342|NCT03632915|Lacosamide|lacosamide|mesh-list
93246343|NCT03632915|Phenytoin|phenytoin|mesh-list
93246344|NCT03632915|Ketamine|ketamine|mesh-list
93246345|NCT03632915|Levetiracetam|levetiracetam|mesh-list
93246346|NCT03632915|Valproic Acid|valproic acid|mesh-list
93246347|NCT03632915|Phenobarbital|phenobarbital|mesh-list
93246348|NCT03632915|Analgesics|analgesics|mesh-ancestor
93246349|NCT03632915|Sensory System Agents|sensory system agents|mesh-ancestor
93246350|NCT03632915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246351|NCT03632915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246352|NCT03632915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93246353|NCT03632915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93246354|NCT03632915|Anesthetics, General|anesthetics, general|mesh-ancestor
93246355|NCT03632915|Anesthetics|anesthetics|mesh-ancestor
93246356|NCT03632915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246357|NCT03632915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93246358|NCT03632915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93246359|NCT03632915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246360|NCT03632915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246361|NCT03632915|Anticonvulsants|anticonvulsants|mesh-ancestor
93246362|NCT03632915|Nootropic Agents|nootropic agents|mesh-ancestor
93246363|NCT03632915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246364|NCT03632915|GABA Agents|gaba agents|mesh-ancestor
93246365|NCT03632915|Antimanic Agents|antimanic agents|mesh-ancestor
92918341|NCT00823030|Lidocaine|lidocaine|mesh-list
93246366|NCT03632915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93246367|NCT03632915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93246368|NCT03632915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93246369|NCT03632915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93246370|NCT03632915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246371|NCT03632915|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93246372|NCT03632915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93246373|NCT03632915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93246374|NCT03632915|GABA Modulators|gaba modulators|mesh-ancestor
93246375|NCT03632915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93246376|NCT03632915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93246377|NCT05649605|Methyltestosterone|methyltestosterone|mesh-list
93246379|NCT05649605|Testosterone undecanoate|testosterone undecanoate|mesh-list
93246380|NCT05649605|Testosterone enanthate|testosterone enanthate|mesh-list
93246381|NCT05649605|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93246382|NCT05649605|Androgens|androgens|mesh-ancestor
93246383|NCT05649605|Hormones|hormones|mesh-ancestor
93246384|NCT05649605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246385|NCT05649605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246386|NCT05649605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93246387|NCT05649605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246388|NCT05649605|Anabolic Agents|anabolic agents|mesh-ancestor
93246389|NCT05640479|Pregabalin|pregabalin|mesh-list
93246390|NCT05640479|Dexmedetomidine|dexmedetomidine|mesh-list
93246391|NCT05640479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93246392|NCT05640479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246393|NCT05640479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246394|NCT05640479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246395|NCT05640479|Analgesics|analgesics|mesh-ancestor
93246396|NCT05640479|Sensory System Agents|sensory system agents|mesh-ancestor
93246397|NCT05640479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246398|NCT05640479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93246399|NCT05640479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93246400|NCT05640479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93246401|NCT05640479|Adrenergic Agents|adrenergic agents|mesh-ancestor
93246402|NCT05640479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246403|NCT05640479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246404|NCT05640479|Anticonvulsants|anticonvulsants|mesh-ancestor
93246405|NCT05640479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93246406|NCT05640479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246407|NCT05640479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93246408|NCT05640479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93246409|NCT05640479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93246410|NCT05640479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93246411|NCT05309525|Tranexamic Acid|tranexamic acid|mesh-list
93246412|NCT05309525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93246413|NCT05309525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93246414|NCT05309525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246415|NCT05309525|Hemostatics|hemostatics|mesh-ancestor
93246416|NCT05309525|Coagulants|coagulants|mesh-ancestor
93246417|NCT04905563|Acetaminophen|acetaminophen|mesh-list
93246418|NCT04905563|Ibuprofen|ibuprofen|mesh-list
93246419|NCT04905563|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93246420|NCT04905563|Hydrocodone|hydrocodone|mesh-list
93246421|NCT04905563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246422|NCT04905563|Analgesics|analgesics|mesh-ancestor
93246423|NCT04905563|Sensory System Agents|sensory system agents|mesh-ancestor
93246424|NCT04905563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246425|NCT04905563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246426|NCT04905563|Antipyretics|antipyretics|mesh-ancestor
93246427|NCT04905563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93246428|NCT04905563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246429|NCT04905563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246430|NCT04905563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93246431|NCT04905563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246432|NCT04905563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246433|NCT04905563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93246434|NCT04905563|Narcotics|narcotics|mesh-ancestor
93246435|NCT04905563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246436|NCT04905563|Antitussive Agents|antitussive agents|mesh-ancestor
93246437|NCT04905563|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918407|NCT00624052|Telmisartan|telmisartan|mesh-list
93246438|NCT05253131|Durvalumab|durvalumab|mesh-list
93246439|NCT05253131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246440|NCT05253131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246441|NCT02810418|Paclitaxel|paclitaxel|mesh-list
93246442|NCT02810418|LMB-100|lmb-100|mesh-list
93246443|NCT02810418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246444|NCT02810418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246445|NCT02810418|Tubulin Modulators|tubulin modulators|mesh-ancestor
93246446|NCT02810418|Antimitotic Agents|antimitotic agents|mesh-ancestor
93246447|NCT02810418|Mitosis Modulators|mitosis modulators|mesh-ancestor
93246448|NCT02810418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246449|NCT02810418|Immunoconjugates|immunoconjugates|mesh-ancestor
93246450|NCT02810418|Immunologic Factors|immunologic factors|mesh-ancestor
93246451|NCT02810418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246452|NCT02959541|Leucovorin|leucovorin|mesh-list
93246453|NCT02959541|Levoleucovorin|levoleucovorin|mesh-list
93246454|NCT02959541|Antidotes|antidotes|mesh-ancestor
93246455|NCT02959541|Protective Agents|protective agents|mesh-ancestor
93246456|NCT02959541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246457|NCT02959541|Vitamin B Complex|vitamin b complex|mesh-ancestor
93246458|NCT02959541|Vitamins|vitamins|mesh-ancestor
93246459|NCT02959541|Micronutrients|micronutrients|mesh-ancestor
93246460|NCT02675465|Miglustat|miglustat|mesh-list
93246461|NCT02675465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246462|NCT02675465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246463|NCT02675465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93246464|NCT02675465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93246465|NCT02675465|Antiviral Agents|antiviral agents|mesh-ancestor
93246466|NCT02675465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246467|NCT02675465|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93246468|NCT02675465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246469|NCT02675465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246470|NCT05705700|Dutasteride|dutasteride|mesh-list
93246471|NCT05705700|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93246472|NCT05705700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93246473|NCT05705700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246474|NCT05705700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246475|NCT05705700|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246476|NCT05705700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246477|NCT05705700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246478|NCT02498951|Obinutuzumab|obinutuzumab|mesh-list
93246479|NCT02498951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246480|NCT02498951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246481|NCT02260050|Epinastine|epinastine|mesh-list
93246482|NCT02260050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93246483|NCT02260050|Histamine Antagonists|histamine antagonists|mesh-ancestor
93246484|NCT02260050|Histamine Agents|histamine agents|mesh-ancestor
93246485|NCT02260050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246486|NCT02260050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246487|NCT02260050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246488|NCT02036736|Propofol|propofol|mesh-list
93246489|NCT02036736|Anesthetics|anesthetics|mesh-list
93246490|NCT02036736|Desflurane|desflurane|mesh-list
93246491|NCT02036736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93246492|NCT02036736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246493|NCT02036736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246494|NCT02036736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93246495|NCT02036736|Anesthetics, General|anesthetics, general|mesh-ancestor
93246496|NCT02036736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93246497|NCT05693688|Atosiban|atosiban|mesh-list
93246498|NCT05693688|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246499|NCT05693688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246500|NCT05693688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246501|NCT05693688|Tocolytic Agents|tocolytic agents|mesh-ancestor
93246502|NCT05693688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93246503|NCT02047422|Metolazone|metolazone|mesh-list
93246504|NCT02047422|Furosemide|furosemide|mesh-list
93246505|NCT02047422|Spironolactone|spironolactone|mesh-list
93246506|NCT02047422|Diuretics|diuretics|mesh-ancestor
93246507|NCT02047422|Natriuretic Agents|natriuretic agents|mesh-ancestor
93246508|NCT02047422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246509|NCT02047422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93246510|NCT02047422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246511|NCT02047422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246512|NCT02047422|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93246513|NCT02047422|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246514|NCT02047422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246515|NCT02047422|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93246516|NCT02047422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93246517|NCT02047422|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93246518|NCT02048358|Methylprednisolone|methylprednisolone|mesh-list
93246519|NCT02048358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93246520|NCT02048358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93246521|NCT02048358|Prednisolone|prednisolone|mesh-list
93246522|NCT02048358|Prednisolone acetate|prednisolone acetate|mesh-list
93246523|NCT02048358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93246524|NCT02048358|Prednisolone phosphate|prednisolone phosphate|mesh-list
93246525|NCT02048358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246526|NCT02048358|Antiemetics|antiemetics|mesh-ancestor
93246527|NCT02048358|Autonomic Agents|autonomic agents|mesh-ancestor
93246528|NCT02048358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246529|NCT02048358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246530|NCT02048358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93246531|NCT02048358|Glucocorticoids|glucocorticoids|mesh-ancestor
93246532|NCT02048358|Hormones|hormones|mesh-ancestor
93246533|NCT02048358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246534|NCT02048358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93246535|NCT02048358|Protective Agents|protective agents|mesh-ancestor
93246536|NCT02048358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93246537|NCT02048358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246538|NCT02928029|Dexamethasone|dexamethasone|mesh-list
93246539|NCT02928029|Bortezomib|bortezomib|mesh-list
93246540|NCT02928029|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93246541|NCT02928029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246542|NCT02928029|Antiemetics|antiemetics|mesh-ancestor
93246543|NCT02928029|Autonomic Agents|autonomic agents|mesh-ancestor
93246544|NCT02928029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246545|NCT02928029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246546|NCT02928029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93246547|NCT02928029|Glucocorticoids|glucocorticoids|mesh-ancestor
93246548|NCT02928029|Hormones|hormones|mesh-ancestor
93246549|NCT02928029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246550|NCT02928029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93246551|NCT02928029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246552|NCT02050074|Metformin|metformin|mesh-list
93246553|NCT02050074|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93246554|NCT02050074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246555|NCT02050074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246556|NCT02050074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93246557|NCT02050074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93246558|NCT02050074|Antimetabolites|antimetabolites|mesh-ancestor
93246559|NCT02050074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246560|NCT02050074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93246561|NCT02050152|Nitrous Oxide|nitrous oxide|mesh-list
93246562|NCT02050152|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93246563|NCT02050152|Anesthetics, General|anesthetics, general|mesh-ancestor
93246564|NCT02050152|Anesthetics|anesthetics|mesh-ancestor
93246565|NCT02050152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246566|NCT02050152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541174|NCT00018200|Autonomic Agents|autonomic agents|mesh-ancestor
93246567|NCT02050152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246568|NCT02050152|Analgesics|analgesics|mesh-ancestor
93246569|NCT02050152|Sensory System Agents|sensory system agents|mesh-ancestor
93246570|NCT02050152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246571|NCT02806986|Immunoglobulins|immunoglobulins|mesh-list
93246572|NCT02806986|gamma-Globulins|gamma-globulins|mesh-list
93246573|NCT02806986|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93246574|NCT02806986|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93246575|NCT02806986|Immunologic Factors|immunologic factors|mesh-ancestor
93246576|NCT02806986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246577|NCT03095651|Insulin Glargine|insulin glargine|mesh-list
93246578|NCT03095651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246579|NCT03095651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246580|NCT04717193|Epinephrine|epinephrine|mesh-list
93246581|NCT04717193|Racepinephrine|racepinephrine|mesh-list
93246582|NCT04717193|Bupivacaine|bupivacaine|mesh-list
93246583|NCT04717193|Anesthetics, Local|anesthetics, local|mesh-list
93246584|NCT04717193|Anesthetics|anesthetics|mesh-list
93246585|NCT04717193|Epinephryl borate|epinephryl borate|mesh-list
93246586|NCT04717193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246587|NCT04717193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246588|NCT04717193|Sensory System Agents|sensory system agents|mesh-ancestor
93246589|NCT04717193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246590|NCT04717193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93246591|NCT04717193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93246592|NCT04717193|Adrenergic Agents|adrenergic agents|mesh-ancestor
93246593|NCT04717193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246594|NCT04717193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246595|NCT04717193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93246596|NCT04717193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93246597|NCT04717193|Autonomic Agents|autonomic agents|mesh-ancestor
93246598|NCT04717193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93246599|NCT04717193|Respiratory System Agents|respiratory system agents|mesh-ancestor
93246600|NCT04717193|Mydriatics|mydriatics|mesh-ancestor
93246601|NCT04717193|Sympathomimetics|sympathomimetics|mesh-ancestor
93246602|NCT04717193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93246603|NCT05212025|Gemcitabine|gemcitabine|mesh-list
93246604|NCT05212025|Adavosertib|adavosertib|mesh-list
93246605|NCT05212025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246606|NCT05212025|Antimetabolites|antimetabolites|mesh-ancestor
93246607|NCT05212025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246608|NCT05212025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246609|NCT05212025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246610|NCT02051868|Paclitaxel|paclitaxel|mesh-list
93246611|NCT02051868|Carboplatin|carboplatin|mesh-list
93246612|NCT02051868|Fluorouracil|fluorouracil|mesh-list
93246613|NCT02051868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246614|NCT02051868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246615|NCT02051868|Tubulin Modulators|tubulin modulators|mesh-ancestor
93246616|NCT02051868|Antimitotic Agents|antimitotic agents|mesh-ancestor
93246617|NCT02051868|Mitosis Modulators|mitosis modulators|mesh-ancestor
93246618|NCT02051868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246619|NCT02051868|Antimetabolites|antimetabolites|mesh-ancestor
93246620|NCT02051868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246621|NCT02051868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93246622|NCT02051868|Immunologic Factors|immunologic factors|mesh-ancestor
93246623|NCT02051868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246624|NCT04696757|Capecitabine|capecitabine|mesh-list
93246625|NCT04696757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246626|NCT04696757|Antimetabolites|antimetabolites|mesh-ancestor
93246627|NCT04696757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246628|NCT04696757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246629|NCT02049294|Omalizumab|omalizumab|mesh-list
93246630|NCT02049294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93246631|NCT02049294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93246632|NCT02049294|Respiratory System Agents|respiratory system agents|mesh-ancestor
93246633|NCT02051946|Ethacrynic Acid|ethacrynic acid|mesh-list
93246634|NCT02051946|Diuretics|diuretics|mesh-ancestor
93246635|NCT02051946|Natriuretic Agents|natriuretic agents|mesh-ancestor
93246636|NCT02051946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246637|NCT02051946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246638|NCT02051946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246639|NCT02049606|Nabumetone|nabumetone|mesh-list
93246640|NCT02049606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93246641|NCT02049606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246642|NCT02049606|Analgesics|analgesics|mesh-ancestor
93246643|NCT02049606|Sensory System Agents|sensory system agents|mesh-ancestor
93246644|NCT02049606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246645|NCT02049606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246646|NCT02049606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246647|NCT02049606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246648|NCT02049606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93246649|NCT02049606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93246650|NCT02049606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246651|NCT02049606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246652|NCT05071703|Carboplatin|carboplatin|mesh-list
93246653|NCT05071703|Etoposide|etoposide|mesh-list
93246654|NCT05071703|Topotecan|topotecan|mesh-list
93246655|NCT05071703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246656|NCT05071703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246657|NCT05071703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93246658|NCT05071703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246659|NCT05071703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246660|NCT05071703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246661|NCT05071703|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93246662|NCT02037516|Neostigmine|neostigmine|mesh-list
93246663|NCT02037516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93246664|NCT02037516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246665|NCT02037516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246666|NCT02037516|Cholinergic Agents|cholinergic agents|mesh-ancestor
93246667|NCT02037516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246668|NCT02037516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246669|NCT02037516|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93246670|NCT02037516|Autonomic Agents|autonomic agents|mesh-ancestor
93246671|NCT02037516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246672|NCT02052024|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
93246673|NCT02052024|Botulinum Toxins|botulinum toxins|mesh-list
93246674|NCT02052024|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93246675|NCT02052024|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93246676|NCT02052024|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93246677|NCT02052024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246678|NCT02052024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246679|NCT02052024|Cholinergic Agents|cholinergic agents|mesh-ancestor
93246680|NCT02052024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246681|NCT02052024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246682|NCT02052024|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93246683|NCT02052024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246684|NCT02052024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93246686|NCT02037672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93246687|NCT02037672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246688|NCT02049762|Aspirin|aspirin|mesh-list
93246689|NCT02049762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93246690|NCT02049762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246691|NCT02049762|Analgesics|analgesics|mesh-ancestor
93246692|NCT02049762|Sensory System Agents|sensory system agents|mesh-ancestor
93246693|NCT02049762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246694|NCT02049762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246695|NCT02049762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246696|NCT02049762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246697|NCT02049762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93246698|NCT02049762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93246699|NCT02049762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246700|NCT02049762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93246701|NCT02049762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93246702|NCT02049762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246703|NCT02049762|Antipyretics|antipyretics|mesh-ancestor
93246704|NCT03561558|Ibuprofen|ibuprofen|mesh-list
93246705|NCT03561558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93246706|NCT03561558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246707|NCT03561558|Analgesics|analgesics|mesh-ancestor
93246708|NCT03561558|Sensory System Agents|sensory system agents|mesh-ancestor
93246709|NCT03561558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246710|NCT03561558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246711|NCT03561558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246712|NCT03561558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246713|NCT03561558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93246714|NCT03561558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246715|NCT03561558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246716|NCT03099161|Pembrolizumab|pembrolizumab|mesh-list
93246717|NCT03099161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246718|NCT03099161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246719|NCT03099161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93246720|NCT03099161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246721|NCT04639115|Ozanimod|ozanimod|mesh-list
93246722|NCT04639115|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93246723|NCT04639115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246724|NCT04639115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93246725|NCT04639115|Immunologic Factors|immunologic factors|mesh-ancestor
93246726|NCT04639115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246727|NCT04260659|Lidocaine|lidocaine|mesh-list
93246728|NCT04260659|Magnesium Sulfate|magnesium sulfate|mesh-list
93246729|NCT04260659|Fentanyl|fentanyl|mesh-list
93246730|NCT04260659|Dexmedetomidine|dexmedetomidine|mesh-list
93246731|NCT04260659|Ketamine|ketamine|mesh-list
93246732|NCT04260659|Remifentanil|remifentanil|mesh-list
93246733|NCT04260659|Anesthetics, Local|anesthetics, local|mesh-ancestor
93246734|NCT04260659|Anesthetics|anesthetics|mesh-ancestor
93246735|NCT04260659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246736|NCT04260659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246737|NCT04260659|Sensory System Agents|sensory system agents|mesh-ancestor
93246738|NCT04260659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246739|NCT04260659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92918706|NCT00830050|Analgesics|analgesics|mesh-ancestor
93246740|NCT04260659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93246741|NCT04260659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93246742|NCT04260659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246743|NCT04260659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246744|NCT04260659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93246745|NCT04260659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246746|NCT04260659|Analgesics|analgesics|mesh-ancestor
93246747|NCT04260659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93246748|NCT04260659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93246749|NCT04260659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93246750|NCT04260659|Adrenergic Agents|adrenergic agents|mesh-ancestor
93246751|NCT04260659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246752|NCT04260659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93246753|NCT04260659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93246754|NCT04260659|Anesthetics, General|anesthetics, general|mesh-ancestor
93246755|NCT04260659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93246756|NCT04260659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93246757|NCT04260659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93246758|NCT04260659|Narcotics|narcotics|mesh-ancestor
93246759|NCT04260659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93246760|NCT04260659|Anticonvulsants|anticonvulsants|mesh-ancestor
93246761|NCT04260659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93246762|NCT04260659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93246763|NCT04260659|Tocolytic Agents|tocolytic agents|mesh-ancestor
93246764|NCT04260659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93246765|NCT05068661|Fentanyl|fentanyl|mesh-list
93246766|NCT05068661|Bupivacaine|bupivacaine|mesh-list
93246767|NCT05068661|Ropivacaine|ropivacaine|mesh-list
93246768|NCT05068661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93246769|NCT05068661|Anesthetics, Local|anesthetics, local|mesh-ancestor
93246770|NCT05068661|Anesthetics|anesthetics|mesh-ancestor
93246771|NCT05068661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246772|NCT05068661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246773|NCT05068661|Sensory System Agents|sensory system agents|mesh-ancestor
93246774|NCT05068661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246775|NCT05068661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93246776|NCT05068661|Narcotics|narcotics|mesh-ancestor
93246777|NCT05068661|Analgesics|analgesics|mesh-ancestor
93246778|NCT05068661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93246779|NCT05068661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93246780|NCT05068661|Anesthetics, General|anesthetics, general|mesh-ancestor
93246781|NCT04455815|Gabexate|gabexate|mesh-list
93246782|NCT04455815|Camostat|camostat|mesh-list
93246783|NCT04455815|Protease Inhibitors|protease inhibitors|mesh-ancestor
93246784|NCT04455815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246785|NCT04455815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246786|NCT04455815|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93246787|NCT04455815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93246788|NCT04455815|Anticoagulants|anticoagulants|mesh-ancestor
93246789|NCT04197713|Olaparib|olaparib|mesh-list
93246790|NCT04197713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93246791|NCT04197713|Adavosertib|adavosertib|mesh-list
93246792|NCT04197713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246793|NCT04197713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246794|NCT04197713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246795|NCT04303403|Trametinib|trametinib|mesh-list
93246796|NCT04303403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246797|NCT04303403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93246798|NCT04303403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541397|NCT00019968|Melphalan|melphalan|mesh-list
93246799|NCT04303403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246800|NCT04148495|Acetaminophen|acetaminophen|mesh-list
93246801|NCT04148495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93246802|NCT04148495|Analgesics|analgesics|mesh-ancestor
93246803|NCT04148495|Sensory System Agents|sensory system agents|mesh-ancestor
93246804|NCT04148495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246805|NCT04148495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246806|NCT04148495|Antipyretics|antipyretics|mesh-ancestor
93246807|NCT05060003|Atezolizumab|atezolizumab|mesh-list
93246808|NCT05060003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93246809|NCT05060003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246810|NCT05060003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246811|NCT05060003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246812|NCT04203641|Doxorubicin|doxorubicin|mesh-list
93246813|NCT04203641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93246814|NCT04203641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246815|NCT04203641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93246816|NCT04203641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246817|NCT04203641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246818|NCT04203641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246819|NCT05051189|Fentanyl|fentanyl|mesh-list
93246820|NCT05051189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93246821|NCT05051189|Narcotics|narcotics|mesh-ancestor
93246822|NCT05051189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246823|NCT05051189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246824|NCT05051189|Analgesics|analgesics|mesh-ancestor
93246825|NCT05051189|Sensory System Agents|sensory system agents|mesh-ancestor
93246826|NCT05051189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246827|NCT05051189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93246828|NCT05051189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93246829|NCT05051189|Anesthetics, General|anesthetics, general|mesh-ancestor
93246830|NCT05051189|Anesthetics|anesthetics|mesh-ancestor
93246831|NCT04521647|Nicotine|nicotine|mesh-list
93246832|NCT04521647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93246833|NCT04521647|Autonomic Agents|autonomic agents|mesh-ancestor
93246834|NCT04521647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246835|NCT04521647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246836|NCT04521647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93246837|NCT04521647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93246838|NCT04521647|Cholinergic Agents|cholinergic agents|mesh-ancestor
93246839|NCT04521647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93246840|NCT04521647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246841|NCT04172597|Loperamide|loperamide|mesh-list
93246842|NCT04172597|Antidiarrheals|antidiarrheals|mesh-list
93246843|NCT04172597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93246844|NCT00446225|Carboplatin|carboplatin|mesh-list
93246845|NCT00446225|Docetaxel|docetaxel|mesh-list
93246846|NCT00446225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93246847|NCT00446225|Gemcitabine|gemcitabine|mesh-list
93246848|NCT00446225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246849|NCT00446225|Tubulin Modulators|tubulin modulators|mesh-ancestor
93246850|NCT00446225|Antimitotic Agents|antimitotic agents|mesh-ancestor
93246851|NCT00446225|Mitosis Modulators|mitosis modulators|mesh-ancestor
93246852|NCT00446225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246853|NCT00446225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93246854|NCT00446225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246855|NCT00446225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246856|NCT00446225|Antimetabolites|antimetabolites|mesh-ancestor
93246857|NCT03080935|Evolocumab|evolocumab|mesh-list
93246858|NCT03080935|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93246859|NCT03080935|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93246860|NCT03080935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93246861|NCT03080935|Antimetabolites|antimetabolites|mesh-ancestor
93246862|NCT03080935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246863|NCT03080935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93246864|NCT03080935|Protease Inhibitors|protease inhibitors|mesh-ancestor
93246865|NCT03080935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246866|NCT03080935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93246867|NCT04479449|Otaplimastat|otaplimastat|mesh-list
93246868|NCT04479449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93246869|NCT04479449|Protective Agents|protective agents|mesh-ancestor
93246870|NCT04479449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246871|NCT03674567|Pembrolizumab|pembrolizumab|mesh-list
93246872|NCT03674567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93246873|NCT03674567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246874|NCT03674567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93246875|NCT03674567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246876|NCT04986605|Methoxsalen|methoxsalen|mesh-list
93246877|NCT04986605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93246878|NCT04986605|Dermatologic Agents|dermatologic agents|mesh-ancestor
93246879|NCT04390399|Leucovorin|leucovorin|mesh-list
93246880|NCT04390399|Paclitaxel|paclitaxel|mesh-list
93246881|NCT04390399|Cyclophosphamide|cyclophosphamide|mesh-list
93246882|NCT04390399|Gemcitabine|gemcitabine|mesh-list
93246883|NCT04390399|Fluorouracil|fluorouracil|mesh-list
93246884|NCT04390399|Irinotecan|irinotecan|mesh-list
93246885|NCT04390399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246886|NCT04390399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246887|NCT04390399|Tubulin Modulators|tubulin modulators|mesh-ancestor
93246888|NCT04390399|Antimitotic Agents|antimitotic agents|mesh-ancestor
93246889|NCT04390399|Mitosis Modulators|mitosis modulators|mesh-ancestor
93246890|NCT04390399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246891|NCT04390399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93246892|NCT04390399|Immunologic Factors|immunologic factors|mesh-ancestor
93246893|NCT04390399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246894|NCT04390399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93246895|NCT04390399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93246896|NCT04390399|Alkylating Agents|alkylating agents|mesh-ancestor
93246897|NCT04390399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93246898|NCT04390399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246899|NCT04390399|Antimetabolites|antimetabolites|mesh-ancestor
93246900|NCT04390399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93246901|NCT04390399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246902|NCT04390399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246904|NCT04390399|Protective Agents|protective agents|mesh-ancestor
93246905|NCT04390399|Vitamin B Complex|vitamin b complex|mesh-ancestor
93246906|NCT04390399|Vitamins|vitamins|mesh-ancestor
93246907|NCT04390399|Micronutrients|micronutrients|mesh-ancestor
93246908|NCT01383655|Magnesium Sulfate|magnesium sulfate|mesh-list
93246909|NCT01383655|Analgesics|analgesics|mesh-ancestor
93246910|NCT01383655|Sensory System Agents|sensory system agents|mesh-ancestor
93246911|NCT01383655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93246912|NCT01383655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246913|NCT01383655|Anesthetics|anesthetics|mesh-ancestor
92541512|NCT00020709|Docetaxel|docetaxel|mesh-list
93246914|NCT01383655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93246915|NCT01383655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93246916|NCT01383655|Anticonvulsants|anticonvulsants|mesh-ancestor
93246917|NCT01383655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93246918|NCT01383655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93246919|NCT01383655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246920|NCT01383655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93246921|NCT01383655|Tocolytic Agents|tocolytic agents|mesh-ancestor
93246922|NCT01383655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93246923|NCT01568281|Anastrozole|anastrozole|mesh-list
93246924|NCT01568281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93246925|NCT01568281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246926|NCT01568281|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93246927|NCT01568281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93246928|NCT01568281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246929|NCT01568281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246930|NCT01568281|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93246931|NCT01568281|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246932|NCT01568281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246933|NCT01568281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246934|NCT02921789|Mycophenolic Acid|mycophenolic acid|mesh-list
93246935|NCT02921789|Prednisone|prednisone|mesh-list
93246936|NCT02921789|Tacrolimus|tacrolimus|mesh-list
93246937|NCT02921789|Basiliximab|basiliximab|mesh-list
93246938|NCT02921789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246939|NCT02921789|Glucocorticoids|glucocorticoids|mesh-ancestor
93246940|NCT02921789|Hormones|hormones|mesh-ancestor
93246941|NCT02921789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246942|NCT02921789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246943|NCT02921789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93246944|NCT02921789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246945|NCT02921789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93246946|NCT02921789|Immunologic Factors|immunologic factors|mesh-ancestor
93246947|NCT02921789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93246948|NCT02921789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246949|NCT02921789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246950|NCT02921789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93246951|NCT02921789|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93246952|NCT02921789|Antitubercular Agents|antitubercular agents|mesh-ancestor
93246953|NCT02921789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93246954|NCT02921789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246955|NCT02564900|Camptothecin|camptothecin|mesh-list
93246956|NCT02564900|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93246957|NCT02564900|Immunoconjugates|immunoconjugates|mesh-list
93246958|NCT02564900|Immunologic Factors|immunologic factors|mesh-ancestor
93246959|NCT02564900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246960|NCT02564900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93246961|NCT02564900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246962|NCT02564900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93246963|NCT02564900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93246964|NCT02564900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246965|NCT02564900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246966|NCT01568333|Decitabine|decitabine|mesh-list
93246967|NCT01568333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93246968|NCT01568333|Antimetabolites|antimetabolites|mesh-ancestor
93246969|NCT01568333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246970|NCT01568333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246971|NCT01568333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246972|NCT03437005|Ketoconazole|ketoconazole|mesh-list
93246973|NCT03437005|Desonide|desonide|mesh-list
93246974|NCT03437005|Antifungal Agents|antifungal agents|mesh-ancestor
93246975|NCT03437005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93246976|NCT03437005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93246977|NCT03437005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93246978|NCT03437005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246979|NCT03437005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246980|NCT03437005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93246981|NCT03437005|Hormone Antagonists|hormone antagonists|mesh-ancestor
93246982|NCT03437005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246983|NCT03437005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246984|NCT03437005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93246985|NCT03437005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93246986|NCT03943823|Estrogens|estrogens|mesh-list
93246987|NCT03943823|Hormones|hormones|mesh-ancestor
93246988|NCT03943823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93246989|NCT03943823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93246990|NCT02535338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93246991|NCT02535338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93246992|NCT02535338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93246993|NCT02535338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93246994|NCT02535338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93246995|NCT02484248|Ketotifen|ketotifen|mesh-list
93246996|NCT02484248|Antipruritics|antipruritics|mesh-ancestor
93246997|NCT02484248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93246998|NCT02484248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93246999|NCT02484248|Histamine Antagonists|histamine antagonists|mesh-ancestor
93247000|NCT02484248|Histamine Agents|histamine agents|mesh-ancestor
93247001|NCT02484248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247002|NCT02484248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247003|NCT02484248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247004|NCT02484248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93247005|NCT02419742|Paclitaxel|paclitaxel|mesh-list
93247006|NCT02419742|Docetaxel|docetaxel|mesh-list
93247007|NCT02419742|Cyclophosphamide|cyclophosphamide|mesh-list
93247008|NCT02419742|Carboplatin|carboplatin|mesh-list
93247009|NCT02419742|Doxorubicin|doxorubicin|mesh-list
93247010|NCT02419742|Trastuzumab|trastuzumab|mesh-list
93247011|NCT02419742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247012|NCT02419742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247013|NCT02419742|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247014|NCT02419742|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247015|NCT02419742|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247016|NCT02419742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247017|NCT02419742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247018|NCT02419742|Immunologic Factors|immunologic factors|mesh-ancestor
93247019|NCT02419742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247020|NCT02419742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247021|NCT02419742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93247022|NCT02419742|Alkylating Agents|alkylating agents|mesh-ancestor
93247023|NCT02419742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93247024|NCT02419742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93247025|NCT02419742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93247026|NCT02419742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247027|NCT02419742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247028|NCT02419742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247029|NCT02409290|Moxifloxacin|moxifloxacin|mesh-list
93247030|NCT02409290|Levofloxacin|levofloxacin|mesh-list
93247031|NCT02409290|Isoniazid|isoniazid|mesh-list
93247032|NCT02409290|Pyrazinamide|pyrazinamide|mesh-list
93247033|NCT02409290|Ethambutol|ethambutol|mesh-list
93247034|NCT02409290|Bedaquiline|bedaquiline|mesh-list
93247035|NCT02409290|Clofazimine|clofazimine|mesh-list
93247036|NCT02409290|Kanamycin|kanamycin|mesh-list
93247037|NCT02409290|Prothionamide|prothionamide|mesh-list
93247038|NCT02409290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247039|NCT02409290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247040|NCT02409290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93247041|NCT02409290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247042|NCT02409290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919006|NCT00838240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247043|NCT02409290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247044|NCT02409290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247045|NCT02409290|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93247046|NCT02409290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93247047|NCT02409290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93247048|NCT02409290|Antitubercular Agents|antitubercular agents|mesh-ancestor
93247049|NCT02409290|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93247050|NCT02409290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93247051|NCT02409290|Antimetabolites|antimetabolites|mesh-ancestor
93247052|NCT02409290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93247053|NCT02409290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247054|NCT02409290|Leprostatic Agents|leprostatic agents|mesh-ancestor
93247055|NCT02409290|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93247056|NCT02898077|Paclitaxel|paclitaxel|mesh-list
93247057|NCT02898077|Ramucirumab|ramucirumab|mesh-list
93247058|NCT02898077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247059|NCT02898077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247060|NCT02898077|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247061|NCT02898077|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247062|NCT02898077|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247063|NCT02898077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247064|NCT02145884|Timolol|timolol|mesh-list
93247065|NCT02145884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247066|NCT02145884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93247067|NCT02145884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93247068|NCT02145884|Adrenergic Agents|adrenergic agents|mesh-ancestor
93247069|NCT02145884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247070|NCT02145884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247071|NCT02145884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93247072|NCT02145884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93247073|NCT03544814|Cisplatin|cisplatin|mesh-list
93247074|NCT03544814|Pemetrexed|pemetrexed|mesh-list
93247075|NCT03544814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247076|NCT03544814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247077|NCT03544814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247078|NCT03544814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93247079|NCT03544814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93247080|NCT03097133|Esketamine|esketamine|mesh-list
93247081|NCT03097133|Antidepressive Agents|antidepressive agents|mesh-ancestor
93247082|NCT03097133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247083|NCT02148380|Carboplatin|carboplatin|mesh-list
93247084|NCT02148380|Pemetrexed|pemetrexed|mesh-list
93247085|NCT02148380|Gefitinib|gefitinib|mesh-list
93247086|NCT02148380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247087|NCT02148380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247088|NCT02148380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247089|NCT02148380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93247090|NCT02148380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93247091|NCT02148380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247092|NCT02146118|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93247093|NCT02146118|Silybin|silybin|mesh-list
93247094|NCT02146118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247095|NCT02146118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247096|NCT02146118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247097|NCT02146118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247098|NCT02146118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247099|NCT02146118|Protective Agents|protective agents|mesh-ancestor
93247100|NCT02146118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247101|NCT02142140|Methylphenidate|methylphenidate|mesh-list
93247102|NCT02142140|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93247103|NCT02142140|Adderall|adderall|mesh-list
93247104|NCT02142140|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
93247105|NCT02142140|Dextroamphetamine|dextroamphetamine|mesh-list
93247106|NCT02142140|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93247107|NCT02142140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247108|NCT02142140|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93247109|NCT02142140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93247110|NCT02142140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93247111|NCT02142140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247112|NCT02142140|Dopamine Agents|dopamine agents|mesh-ancestor
93247113|NCT02142140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247114|NCT02142140|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93247115|NCT02142140|Adrenergic Agents|adrenergic agents|mesh-ancestor
92919085|NCT00853385|Adalimumab|adalimumab|mesh-list
93247116|NCT02142218|Nivolumab|nivolumab|mesh-list
93247117|NCT02142218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247118|NCT02142218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247119|NCT02142218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93247120|NCT02142218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247121|NCT02142296|Aflibercept|aflibercept|mesh-list
93247122|NCT02142296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93247123|NCT02142296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93247124|NCT02142296|Growth Substances|growth substances|mesh-ancestor
93247125|NCT02142296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247126|NCT02142296|Growth Inhibitors|growth inhibitors|mesh-ancestor
93247127|NCT02142296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247128|NCT02142530|Belinostat|belinostat|mesh-list
93247129|NCT02142530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541728|NCT00018161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93247130|NCT02142530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93247131|NCT02142530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247132|NCT02142530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247133|NCT01383343|Calcium, Dietary|calcium, dietary|mesh-list
93247134|NCT01383343|Leucovorin|leucovorin|mesh-list
93247135|NCT01383343|Folic Acid|folic acid|mesh-list
93247136|NCT01383343|Bevacizumab|bevacizumab|mesh-list
93247137|NCT01383343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93247138|NCT01383343|Fluorouracil|fluorouracil|mesh-list
93247139|NCT01383343|Irinotecan|irinotecan|mesh-list
93247140|NCT01383343|Sorafenib|sorafenib|mesh-list
93247141|NCT01383343|Camptothecin|camptothecin|mesh-list
93247142|NCT01383343|Endothelial Growth Factors|endothelial growth factors|mesh-list
93247143|NCT01383343|Antibodies|antibodies|mesh-list
93247144|NCT01383343|Immunoglobulins|immunoglobulins|mesh-list
93247145|NCT01383343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93247146|NCT01383343|Immunoglobulin G|immunoglobulin g|mesh-list
93247147|NCT01383343|Calcium|calcium|mesh-list
93247148|NCT01383343|Levoleucovorin|levoleucovorin|mesh-list
93247149|NCT01383343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247150|NCT01383343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93247151|NCT01383343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93247152|NCT01383343|Growth Substances|growth substances|mesh-ancestor
93247153|NCT01383343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247154|NCT01383343|Growth Inhibitors|growth inhibitors|mesh-ancestor
93247155|NCT01383343|Immunologic Factors|immunologic factors|mesh-ancestor
93247156|NCT01383343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93247157|NCT01383343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93247158|NCT01383343|Antimetabolites|antimetabolites|mesh-ancestor
93247159|NCT01383343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247160|NCT01383343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247161|NCT01383343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247162|NCT01383343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93247163|NCT01383343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247164|NCT01383343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247165|NCT01383343|Antidotes|antidotes|mesh-ancestor
93247166|NCT01383343|Protective Agents|protective agents|mesh-ancestor
93247167|NCT01383343|Vitamin B Complex|vitamin b complex|mesh-ancestor
93247168|NCT01383343|Vitamins|vitamins|mesh-ancestor
93247169|NCT01383343|Micronutrients|micronutrients|mesh-ancestor
93247170|NCT01383343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247171|NCT01383343|Hematinics|hematinics|mesh-ancestor
93247172|NCT01383343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247173|NCT03631147|Rifaximin|rifaximin|mesh-list
93247174|NCT03631147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247175|NCT03631147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247176|NCT03631147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93247177|NCT02148848|Risedronic Acid|risedronic acid|mesh-list
93247178|NCT02148848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93247179|NCT02148848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93247180|NCT02148848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247181|NCT02148848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93247182|NCT02148848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247183|NCT02148848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93247184|NCT03265145|Cholinergic Agents|cholinergic agents|mesh-list
93247185|NCT03265145|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93247186|NCT03265145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247187|NCT03265145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247188|NCT03265145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247189|NCT03265145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93247190|NCT05344495|Midazolam|midazolam|mesh-list
93247191|NCT05344495|Bupivacaine|bupivacaine|mesh-list
93247192|NCT05344495|Anesthetics, Local|anesthetics, local|mesh-ancestor
93247193|NCT05344495|Anesthetics|anesthetics|mesh-ancestor
93247194|NCT05344495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247195|NCT05344495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247196|NCT05344495|Sensory System Agents|sensory system agents|mesh-ancestor
93247197|NCT05344495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247198|NCT05344495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93247199|NCT05344495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93247200|NCT05344495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93247201|NCT05344495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93247202|NCT05344495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247203|NCT05344495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93247204|NCT05344495|Anesthetics, General|anesthetics, general|mesh-ancestor
93247205|NCT05344495|GABA Modulators|gaba modulators|mesh-ancestor
93247206|NCT05344495|GABA Agents|gaba agents|mesh-ancestor
93247207|NCT05344495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247208|NCT05344495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247209|NCT01593241|Carboplatin|carboplatin|mesh-list
93247210|NCT01593241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247211|NCT05960565|Glucagon|glucagon|mesh-list
93247212|NCT05960565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93247213|NCT05960565|Hormones|hormones|mesh-ancestor
93247214|NCT05960565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247215|NCT05960565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247216|NCT05960227|Dextrans|dextrans|mesh-list
93247217|NCT05960227|Iron-Dextran Complex|iron-dextran complex|mesh-list
93247218|NCT05960227|Anticoagulants|anticoagulants|mesh-ancestor
93247219|NCT05960227|Plasma Substitutes|plasma substitutes|mesh-ancestor
93247220|NCT05960227|Blood Substitutes|blood substitutes|mesh-ancestor
93247221|NCT05960227|Hematinics|hematinics|mesh-ancestor
93247222|NCT05960110|Fluorides|fluorides|mesh-list
93247223|NCT05960110|Fluorides, Topical|fluorides, topical|mesh-list
93247224|NCT05960110|Cariostatic Agents|cariostatic agents|mesh-ancestor
93247225|NCT05960110|Protective Agents|protective agents|mesh-ancestor
93247226|NCT05960110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247227|NCT05959941|Macitentan|macitentan|mesh-list
93247228|NCT05959941|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93247229|NCT05959941|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93247230|NCT05959941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247231|NCT05959941|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93247232|NCT05959889|Montelukast|montelukast|mesh-list
93247233|NCT05959889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93247234|NCT05959889|Respiratory System Agents|respiratory system agents|mesh-ancestor
93247235|NCT05959889|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93247236|NCT05959889|Hormone Antagonists|hormone antagonists|mesh-ancestor
93247237|NCT05959889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247238|NCT05959889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247239|NCT05959889|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93247240|NCT05959889|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93247241|NCT05959889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247242|NCT05959863|Captopril|captopril|mesh-list
93247243|NCT05959863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93247244|NCT05959863|Protease Inhibitors|protease inhibitors|mesh-ancestor
93247245|NCT05959863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247246|NCT05959863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247247|NCT05959863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93247248|NCT05959850|Ambroxol|ambroxol|mesh-list
93247249|NCT05959850|Expectorants|expectorants|mesh-ancestor
93247250|NCT05959850|Respiratory System Agents|respiratory system agents|mesh-ancestor
93247251|NCT05959759|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93247252|NCT05959759|Dermatologic Agents|dermatologic agents|mesh-ancestor
93247253|NCT05959759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247254|NCT05959759|Immunologic Factors|immunologic factors|mesh-ancestor
93247255|NCT05959759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247256|NCT05959629|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93247258|NCT05959629|Disinfectants|disinfectants|mesh-ancestor
93247259|NCT05959629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247260|NCT05959616|Ciprofloxacin|ciprofloxacin|mesh-list
93247261|NCT05959616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247262|NCT05959616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247263|NCT05959616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93247264|NCT05959616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247265|NCT05959616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247266|NCT05959616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247267|NCT05959616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247268|NCT05959616|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93247269|NCT05959616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93247270|NCT05959603|Vancomycin|vancomycin|mesh-list
93247271|NCT05959603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247272|NCT05959603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247273|NCT05959447|Dabigatran|dabigatran|mesh-list
93247274|NCT05959447|Gemfibrozil|gemfibrozil|mesh-list
93247275|NCT05959447|Antithrombins|antithrombins|mesh-ancestor
93247276|NCT05959447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93247277|NCT05959447|Protease Inhibitors|protease inhibitors|mesh-ancestor
93247278|NCT05959447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247279|NCT05959447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247280|NCT05959447|Anticoagulants|anticoagulants|mesh-ancestor
93247281|NCT05959447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93247282|NCT05959447|Antimetabolites|antimetabolites|mesh-ancestor
93247283|NCT05959447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93247284|NCT05959447|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93247285|NCT05959447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93247286|NCT05959356|Leucovorin|leucovorin|mesh-list
93247287|NCT05959356|Oxaliplatin|oxaliplatin|mesh-list
93247288|NCT05959356|Irinotecan|irinotecan|mesh-list
93247289|NCT05959356|Cetuximab|cetuximab|mesh-list
93247290|NCT05959356|Levoleucovorin|levoleucovorin|mesh-list
93247291|NCT05959356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247292|NCT05959356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93247293|NCT05959356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247294|NCT05959356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247295|NCT05959356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247296|NCT05959356|Antidotes|antidotes|mesh-ancestor
93247297|NCT05959356|Protective Agents|protective agents|mesh-ancestor
93247298|NCT05959356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247299|NCT05959356|Vitamin B Complex|vitamin b complex|mesh-ancestor
93247300|NCT05959356|Vitamins|vitamins|mesh-ancestor
93247301|NCT05959356|Micronutrients|micronutrients|mesh-ancestor
93247302|NCT05959356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247303|NCT05959252|Heparin|heparin|mesh-list
93247304|NCT05959252|Calcium heparin|calcium heparin|mesh-list
93247305|NCT05959252|Bivalirudin|bivalirudin|mesh-list
93247306|NCT05959252|Anticoagulants|anticoagulants|mesh-ancestor
93247307|NCT05959252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93247308|NCT05959252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93247309|NCT05959252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247310|NCT05959252|Antithrombins|antithrombins|mesh-ancestor
93247311|NCT05959252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93247312|NCT05959252|Protease Inhibitors|protease inhibitors|mesh-ancestor
93247313|NCT05959252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247314|NCT05959044|Folic Acid|folic acid|mesh-list
93247315|NCT05959044|Vitamins|vitamins|mesh-ancestor
93247316|NCT05959044|Micronutrients|micronutrients|mesh-ancestor
93247317|NCT05959044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247318|NCT05959044|Hematinics|hematinics|mesh-ancestor
93247319|NCT05959044|Vitamin B Complex|vitamin b complex|mesh-ancestor
93247320|NCT05958914|Calcitonin|calcitonin|mesh-list
93247321|NCT05958914|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93247322|NCT05958914|Katacalcin|katacalcin|mesh-list
93247323|NCT05958914|Enkephalins|enkephalins|mesh-list
93247324|NCT05958914|Vasodilator Agents|vasodilator agents|mesh-ancestor
93247325|NCT05958914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93247326|NCT05958914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247327|NCT05958914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93247328|NCT05958914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247329|NCT05958914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247330|NCT05958875|Antipsychotic Agents|antipsychotic agents|mesh-list
93247331|NCT05958875|Clozapine|clozapine|mesh-list
93247332|NCT05958875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93247333|NCT05958875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247334|NCT05958875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247335|NCT05958875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247336|NCT05958875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93247337|NCT05958875|Serotonin Agents|serotonin agents|mesh-ancestor
93247338|NCT05958875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247339|NCT05958875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247340|NCT05958875|GABA Antagonists|gaba antagonists|mesh-ancestor
93247341|NCT05958875|GABA Agents|gaba agents|mesh-ancestor
93247342|NCT05958810|Lumefantrine|lumefantrine|mesh-list
93247343|NCT05958810|Artemether|artemether|mesh-list
93247344|NCT05958810|Primaquine|primaquine|mesh-list
93247345|NCT05958810|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93247346|NCT05958810|Antimalarials|antimalarials|mesh-ancestor
93247347|NCT05958810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93247348|NCT05958810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93247349|NCT05958810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247350|NCT05958797|Chloroquine|chloroquine|mesh-list
93247352|NCT05958797|Amebicides|amebicides|mesh-ancestor
93247353|NCT05958797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93247354|NCT05958797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93247355|NCT05958797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247356|NCT05958797|Antimalarials|antimalarials|mesh-ancestor
93247357|NCT05958797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247358|NCT05958758|Psilocybin|psilocybin|mesh-list
93247359|NCT05958758|Hallucinogens|hallucinogens|mesh-ancestor
93247360|NCT05958758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247361|NCT05958758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247362|NCT05958719|Azacitidine|azacitidine|mesh-list
93247363|NCT05958719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247364|NCT05958719|Antimetabolites|antimetabolites|mesh-ancestor
93247365|NCT05958719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247366|NCT05958719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247367|NCT05958719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247368|NCT05958290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93247369|NCT05958290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247370|NCT05955885|Flurbiprofen|flurbiprofen|mesh-list
93247371|NCT05955885|Benzydamine|benzydamine|mesh-list
93247372|NCT05955885|Analgesics|analgesics|mesh-ancestor
93247373|NCT05955885|Sensory System Agents|sensory system agents|mesh-ancestor
93247374|NCT05955885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247375|NCT05955885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247376|NCT05955885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93247377|NCT05955885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93247378|NCT05955885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247379|NCT05955885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247380|NCT05955885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93247381|NCT05955885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247382|NCT05955885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247383|NCT05952804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93247384|NCT05952804|Immunoglobulins|immunoglobulins|mesh-list
93247385|NCT05952804|Antibodies|antibodies|mesh-list
93247386|NCT05952804|gamma-Globulins|gamma-globulins|mesh-list
93247387|NCT05952804|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93247388|NCT05952804|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93247389|NCT05952804|Immunologic Factors|immunologic factors|mesh-ancestor
93247390|NCT05952804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247391|NCT05952752|Dexamethasone|dexamethasone|mesh-list
93247392|NCT05952752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247393|NCT05952752|Antiemetics|antiemetics|mesh-ancestor
93247394|NCT05952752|Autonomic Agents|autonomic agents|mesh-ancestor
93247395|NCT05952752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247396|NCT05952752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247397|NCT05952752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93247398|NCT05952752|Glucocorticoids|glucocorticoids|mesh-ancestor
93247399|NCT05952752|Hormones|hormones|mesh-ancestor
93247400|NCT05952752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247401|NCT05952752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93247402|NCT05952752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247403|NCT05949125|Cyclophosphamide|cyclophosphamide|mesh-list
93247404|NCT05949125|Fludarabine|fludarabine|mesh-list
93247405|NCT05949125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247406|NCT05949125|Immunologic Factors|immunologic factors|mesh-ancestor
93247407|NCT05949125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247408|NCT05949125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542013|NCT00022932|Antibodies|antibodies|mesh-list
93247409|NCT05949125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93247410|NCT05949125|Alkylating Agents|alkylating agents|mesh-ancestor
93247411|NCT05949125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247412|NCT05949125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247413|NCT05949125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93247414|NCT05939414|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93247415|NCT05939414|Chelating Agents|chelating agents|mesh-ancestor
93247416|NCT05939414|Sequestering Agents|sequestering agents|mesh-ancestor
93247417|NCT05939414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247418|NCT05923060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93247419|NCT05923060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93247420|NCT05923060|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919377|NCT00592319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247421|NCT05914857|Dapagliflozin|dapagliflozin|mesh-list
93247422|NCT05914857|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93247423|NCT05914857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247424|NCT05914857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93247425|NCT05914857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247426|NCT05911061|Vaccines|vaccines|mesh-list
93247427|NCT05911061|Immunologic Factors|immunologic factors|mesh-ancestor
93247428|NCT05911061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247429|NCT05911048|Vaccines|vaccines|mesh-list
93247430|NCT05911048|Immunologic Factors|immunologic factors|mesh-ancestor
93247431|NCT05911048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247432|NCT05909696|Rocuronium|rocuronium|mesh-list
93247433|NCT05909696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93247434|NCT05909696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93247435|NCT05909696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93247436|NCT05909696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247437|NCT05909696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247438|NCT05907811|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
93247439|NCT05907811|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93247440|NCT05907811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247441|NCT05907811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247442|NCT05903352|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93247443|NCT05903352|Anti-Infective Agents|anti-infective agents|mesh-list
93247444|NCT05902780|Dexmedetomidine|dexmedetomidine|mesh-list
93247445|NCT05902780|Bupivacaine|bupivacaine|mesh-list
93247446|NCT05902780|Anesthetics, Local|anesthetics, local|mesh-ancestor
93247447|NCT05902780|Anesthetics|anesthetics|mesh-ancestor
93247448|NCT05902780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247449|NCT05902780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247450|NCT05902780|Sensory System Agents|sensory system agents|mesh-ancestor
93247451|NCT05902780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247452|NCT05902780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93247453|NCT05902780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93247454|NCT05902780|Analgesics|analgesics|mesh-ancestor
93247455|NCT05902780|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93247456|NCT05902780|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93247457|NCT05902780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93247458|NCT05902780|Adrenergic Agents|adrenergic agents|mesh-ancestor
93247459|NCT05902780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247460|NCT05902780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247461|NCT05901350|Levodopa|levodopa|mesh-list
93247462|NCT05901350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93247463|NCT05901350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93247464|NCT05901350|Dopamine Agents|dopamine agents|mesh-ancestor
93247465|NCT05901350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247466|NCT05901350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247467|NCT05901350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247468|NCT05899933|Erythritol|erythritol|mesh-list
93247469|NCT05899933|Vasodilator Agents|vasodilator agents|mesh-ancestor
93247470|NCT05894018|Fluzoparib|fluzoparib|mesh-list
93247471|NCT05894018|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93247472|NCT05894018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247473|NCT05894018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247474|NCT05894018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247475|NCT05892276|Cannabidiol|cannabidiol|mesh-list
93247476|NCT05892276|Anticonvulsants|anticonvulsants|mesh-ancestor
93247477|NCT05891548|Aflibercept|aflibercept|mesh-list
93247478|NCT05891548|Axitinib|axitinib|mesh-list
93247479|NCT05891548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93247480|NCT05891548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93247481|NCT05891548|Growth Substances|growth substances|mesh-ancestor
93247482|NCT05891548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247483|NCT05891548|Growth Inhibitors|growth inhibitors|mesh-ancestor
93247484|NCT05891548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247485|NCT05891548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247486|NCT05891548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247487|NCT05891548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247488|NCT05891262|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93247489|NCT05891262|Norethindrone|norethindrone|mesh-list
93247490|NCT05891262|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
93247491|NCT05891262|Estradiol|estradiol|mesh-list
93247492|NCT05891262|Estrogens|estrogens|mesh-ancestor
93247493|NCT05891262|Hormones|hormones|mesh-ancestor
93247494|NCT05891262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247495|NCT05891262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247496|NCT05891262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93247497|NCT05891262|Contraceptive Agents|contraceptive agents|mesh-ancestor
93247498|NCT05891262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93247499|NCT05891262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93247500|NCT05891262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93247501|NCT05891262|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93247502|NCT05891262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93247503|NCT05891262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93247504|NCT05891262|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
93247505|NCT05890352|Lenalidomide|lenalidomide|mesh-list
93247506|NCT05890352|Zanubrutinib|zanubrutinib|mesh-list
93247507|NCT05890352|Immunoglobulins|immunoglobulins|mesh-list
93247508|NCT05890352|Immunologic Factors|immunologic factors|mesh-ancestor
93247509|NCT05890352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247510|NCT05890352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93247511|NCT05890352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93247512|NCT05890352|Growth Substances|growth substances|mesh-ancestor
93247513|NCT05890352|Growth Inhibitors|growth inhibitors|mesh-ancestor
93247514|NCT05890352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247515|NCT05890352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247516|NCT05890352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247517|NCT05890352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247518|NCT05856227|Ceftobiprole|ceftobiprole|mesh-list
93247519|NCT05856227|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93247520|NCT05856227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247521|NCT05856227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247522|NCT05852262|Cephalexin|cephalexin|mesh-list
93247523|NCT05852262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247524|NCT05852262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247525|NCT05838768|Irinotecan|irinotecan|mesh-list
93247526|NCT05838768|Tislelizumab|tislelizumab|mesh-list
93247527|NCT05838768|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93247528|NCT05838768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247529|NCT05838768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247530|NCT05838768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247531|NCT05838768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247532|NCT05838768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247533|NCT05824559|Bevacizumab|bevacizumab|mesh-list
93247534|NCT05824559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247535|NCT05824559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247536|NCT05824559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93247537|NCT05824559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93247538|NCT05824559|Growth Substances|growth substances|mesh-ancestor
93247539|NCT05824559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247540|NCT05824559|Growth Inhibitors|growth inhibitors|mesh-ancestor
93247541|NCT05822583|Abatacept|abatacept|mesh-list
93247542|NCT05822583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93247543|NCT05822583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247544|NCT05822583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247545|NCT05822583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247546|NCT05822583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247547|NCT05822583|Immunologic Factors|immunologic factors|mesh-ancestor
93247548|NCT05822583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247549|NCT05822583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247550|NCT05822440|Itraconazole|itraconazole|mesh-list
93247551|NCT05822440|Antifungal Agents|antifungal agents|mesh-ancestor
93247552|NCT05822440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247553|NCT05822440|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93247554|NCT05822440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93247555|NCT05822440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247556|NCT05822440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247557|NCT05822440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93247558|NCT05822440|Hormone Antagonists|hormone antagonists|mesh-ancestor
93247559|NCT05822440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247560|NCT05822440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247561|NCT05822440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93247562|NCT05805839|Corticosterone|corticosterone|mesh-list
93247563|NCT05805839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247564|NCT05800860|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93247565|NCT05800860|Hallucinogens|hallucinogens|mesh-ancestor
93247566|NCT05800860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247567|NCT05800860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92919526|NCT00861341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93247568|NCT05800860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93247569|NCT05800860|Serotonin Agents|serotonin agents|mesh-ancestor
93247570|NCT05800860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247571|NCT05800860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247572|NCT05800860|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93247573|NCT05790252|Buprenorphine|buprenorphine|mesh-list
93247574|NCT05790252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93247575|NCT05790252|Narcotics|narcotics|mesh-ancestor
93247576|NCT05790252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247577|NCT05790252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247578|NCT05790252|Analgesics|analgesics|mesh-ancestor
93247579|NCT05790252|Sensory System Agents|sensory system agents|mesh-ancestor
93247580|NCT05790252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247581|NCT05790252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93247582|NCT05789173|Efavirenz|efavirenz|mesh-list
93247583|NCT05789173|Clonidine|clonidine|mesh-list
93247584|NCT05789173|Methadone|methadone|mesh-list
93247585|NCT05789173|Tizanidine|tizanidine|mesh-list
93247586|NCT05789173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93247587|NCT05789173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93247588|NCT05789173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247589|NCT05789173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247590|NCT05789173|Antiviral Agents|antiviral agents|mesh-ancestor
93247591|NCT05789173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247592|NCT05789173|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93247593|NCT05789173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93247594|NCT05789173|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93247595|NCT05789173|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93247596|NCT05789173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93247597|NCT05789173|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93247598|NCT05789173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93247599|NCT05789173|Narcotics|narcotics|mesh-ancestor
93247600|NCT05789173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247601|NCT05789173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247602|NCT05789173|Analgesics|analgesics|mesh-ancestor
93247603|NCT05789173|Sensory System Agents|sensory system agents|mesh-ancestor
93247604|NCT05789173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247605|NCT05789173|Antitussive Agents|antitussive agents|mesh-ancestor
93247606|NCT05789173|Respiratory System Agents|respiratory system agents|mesh-ancestor
93247607|NCT05789173|Anticonvulsants|anticonvulsants|mesh-ancestor
93247608|NCT05789173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93247609|NCT05789173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93247610|NCT05789173|Parasympatholytics|parasympatholytics|mesh-ancestor
93247611|NCT05789173|Autonomic Agents|autonomic agents|mesh-ancestor
93247612|NCT05789173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93247613|NCT05789173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93247614|NCT05789173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93247615|NCT05789173|Adrenergic Agents|adrenergic agents|mesh-ancestor
93247616|NCT05789173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247617|NCT05789173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93247618|NCT05789173|Sympatholytics|sympatholytics|mesh-ancestor
93247619|NCT05778760|Vitamin A|vitamin a|mesh-list
93247620|NCT05778760|Vitamins|vitamins|mesh-ancestor
93247621|NCT05778760|Micronutrients|micronutrients|mesh-ancestor
93247622|NCT05778760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247623|NCT05773274|Everolimus|everolimus|mesh-list
93247624|NCT05773274|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93247625|NCT05773274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93247626|NCT05773274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247627|NCT05773274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247628|NCT05773274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247629|NCT05773274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247630|NCT05773274|Immunologic Factors|immunologic factors|mesh-ancestor
93247631|NCT05773274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247632|NCT05773274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247633|NCT05773274|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93247634|NCT05757999|Magnesium Sulfate|magnesium sulfate|mesh-list
93247635|NCT05757999|Analgesics|analgesics|mesh-ancestor
93247636|NCT05757999|Sensory System Agents|sensory system agents|mesh-ancestor
93247637|NCT05757999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247638|NCT05757999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247639|NCT05757999|Anesthetics|anesthetics|mesh-ancestor
93247640|NCT05757999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247641|NCT05757999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93247642|NCT05757999|Anticonvulsants|anticonvulsants|mesh-ancestor
92919604|NCT00764517|Antimetabolites|antimetabolites|mesh-ancestor
93247643|NCT05757999|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93247644|NCT05757999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93247645|NCT05757999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247646|NCT05757999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93247647|NCT05757999|Tocolytic Agents|tocolytic agents|mesh-ancestor
93247648|NCT05757999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93247649|NCT05750264|Ibuprofen|ibuprofen|mesh-list
93247650|NCT05750264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93247651|NCT05750264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93247652|NCT05750264|Analgesics|analgesics|mesh-ancestor
93247653|NCT05750264|Sensory System Agents|sensory system agents|mesh-ancestor
93247654|NCT05750264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247655|NCT05750264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247656|NCT05750264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247657|NCT05750264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247658|NCT05750264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93247659|NCT05750264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247660|NCT05750264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247661|NCT05744375|Trastuzumab|trastuzumab|mesh-list
93247662|NCT05744375|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93247663|NCT05744375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247664|NCT05744375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247665|NCT05744375|Immunoconjugates|immunoconjugates|mesh-ancestor
93247666|NCT05744375|Immunologic Factors|immunologic factors|mesh-ancestor
93247667|NCT05744375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247668|NCT05743244|Abrocitinib|abrocitinib|mesh-list
93247669|NCT05743244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247670|NCT05743244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247671|NCT05743244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247672|NCT05741164|Pembrolizumab|pembrolizumab|mesh-list
93247673|NCT05741164|Propranolol|propranolol|mesh-list
93247674|NCT05741164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247675|NCT05741164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247676|NCT05741164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93247677|NCT05741164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247678|NCT05741164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93247679|NCT05741164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93247680|NCT05741164|Adrenergic Agents|adrenergic agents|mesh-ancestor
93247681|NCT05741164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247682|NCT05741164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247683|NCT05741164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93247684|NCT05741164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93247685|NCT05741164|Vasodilator Agents|vasodilator agents|mesh-ancestor
93247686|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
93247687|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247688|NCT05691465|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93247689|NCT05691465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247690|NCT05691465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93247691|NCT05689359|Hydroxychloroquine|hydroxychloroquine|mesh-list
93247692|NCT05689359|Antimalarials|antimalarials|mesh-ancestor
93247693|NCT05689359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93247694|NCT05689359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93247695|NCT05689359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247696|NCT05689359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247697|NCT05689359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247698|NCT05689359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247699|NCT05675410|Deoxyglucose|deoxyglucose|mesh-list
93247700|NCT05675410|Prednisone|prednisone|mesh-list
93247701|NCT05675410|Prednisolone|prednisolone|mesh-list
93247702|NCT05675410|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93247703|NCT05675410|Methylprednisolone|methylprednisolone|mesh-list
93247704|NCT05675410|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93247705|NCT05675410|Prednisolone acetate|prednisolone acetate|mesh-list
93247706|NCT05675410|Hydrocortisone|hydrocortisone|mesh-list
93247707|NCT05675410|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93247708|NCT05675410|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93247709|NCT05675410|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93247710|NCT05675410|Cortisone|cortisone|mesh-list
93247711|NCT05675410|Cyclophosphamide|cyclophosphamide|mesh-list
93247712|NCT05675410|Dacarbazine|dacarbazine|mesh-list
93247713|NCT05675410|Doxorubicin|doxorubicin|mesh-list
93247714|NCT05675410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93247715|NCT05675410|Nivolumab|nivolumab|mesh-list
93247716|NCT05675410|Etoposide|etoposide|mesh-list
93247717|NCT05675410|Etoposide phosphate|etoposide phosphate|mesh-list
93247718|NCT05675410|Vincristine|vincristine|mesh-list
93247719|NCT05675410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93247720|NCT05675410|Bleomycin|bleomycin|mesh-list
93247721|NCT05675410|Vinblastine|vinblastine|mesh-list
93247722|NCT05675410|Podophyllotoxin|podophyllotoxin|mesh-list
93247723|NCT05675410|Procarbazine|procarbazine|mesh-list
93247724|NCT05675410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93247725|NCT05675410|Antibodies|antibodies|mesh-list
93247726|NCT05675410|Immunoglobulins|immunoglobulins|mesh-list
93247727|NCT05675410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93247728|NCT05675410|Imidazole|imidazole|mesh-list
93247729|NCT05675410|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93247730|NCT05675410|Prednisolone phosphate|prednisolone phosphate|mesh-list
93247731|NCT05675410|Immunoconjugates|immunoconjugates|mesh-list
93247732|NCT05675410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93247733|NCT05675410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247734|NCT05675410|Immunologic Factors|immunologic factors|mesh-ancestor
93247735|NCT05675410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247736|NCT05675410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93247737|NCT05675410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93247738|NCT05675410|Alkylating Agents|alkylating agents|mesh-ancestor
93247739|NCT05675410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247740|NCT05675410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247741|NCT05675410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93247742|NCT05675410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93247743|NCT05675410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93247744|NCT05675410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247745|NCT05675410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247746|NCT05675410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93247747|NCT05675410|Glucocorticoids|glucocorticoids|mesh-ancestor
93247748|NCT05675410|Hormones|hormones|mesh-ancestor
93247749|NCT05675410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247750|NCT05675410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93247751|NCT05675410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93247752|NCT05675410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247753|NCT05675410|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247754|NCT05675410|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247755|NCT05675410|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247756|NCT05675410|Antiemetics|antiemetics|mesh-ancestor
93247757|NCT05675410|Autonomic Agents|autonomic agents|mesh-ancestor
93247758|NCT05675410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247759|NCT05675410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93247760|NCT05675410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93247761|NCT05675410|Protective Agents|protective agents|mesh-ancestor
93247762|NCT05675410|Immunotoxins|immunotoxins|mesh-ancestor
93247763|NCT05675410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93247764|NCT05675410|Keratolytic Agents|keratolytic agents|mesh-ancestor
93247765|NCT05675410|Dermatologic Agents|dermatologic agents|mesh-ancestor
93247766|NCT05675410|Antimetabolites|antimetabolites|mesh-ancestor
93247767|NCT05675410|Antiviral Agents|antiviral agents|mesh-ancestor
93247768|NCT05675410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247769|NCT05673200|Paclitaxel|paclitaxel|mesh-list
93247770|NCT05673200|Pembrolizumab|pembrolizumab|mesh-list
93247771|NCT05673200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93247772|NCT05673200|Decitabine|decitabine|mesh-list
93247773|NCT05673200|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93247774|NCT05673200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247775|NCT05673200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247776|NCT05673200|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247777|NCT05673200|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247778|NCT05673200|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247779|NCT05673200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247780|NCT05673200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247781|NCT05673200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93247782|NCT05673200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247783|NCT05673200|Antimetabolites|antimetabolites|mesh-ancestor
93247784|NCT05673200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247785|NCT05670106|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93247786|NCT05670106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93247787|NCT05670106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247788|NCT05664217|Antithrombin III|antithrombin iii|mesh-list
93247789|NCT05664217|Antithrombins|antithrombins|mesh-list
93247790|NCT05664217|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92919749|NCT00841763|Vaccines|vaccines|mesh-list
93247791|NCT05664217|Protease Inhibitors|protease inhibitors|mesh-ancestor
93247792|NCT05664217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247793|NCT05664217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247794|NCT05664217|Anticoagulants|anticoagulants|mesh-ancestor
93247795|NCT05660395|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93247796|NCT05660395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93247797|NCT05660395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247798|NCT05656664|Folic Acid|folic acid|mesh-list
93247799|NCT05656664|Hematinics|hematinics|mesh-ancestor
93247800|NCT05656664|Vitamin B Complex|vitamin b complex|mesh-ancestor
93247801|NCT05656664|Vitamins|vitamins|mesh-ancestor
93247802|NCT05656664|Micronutrients|micronutrients|mesh-ancestor
93247803|NCT05656664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247804|NCT05646862|Fulvestrant|fulvestrant|mesh-list
93247805|NCT05646862|Inavolisib|inavolisib|mesh-list
93247806|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93247807|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247808|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93247809|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93247810|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
93247811|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247812|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247813|NCT05646862|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93247814|NCT05646862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247815|NCT05646862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247816|NCT05566795|Antineoplastic Agents|antineoplastic agents|mesh-list
93247817|NCT05564377|Leucovorin|leucovorin|mesh-list
93247818|NCT05564377|Paclitaxel|paclitaxel|mesh-list
93247819|NCT05564377|Fluorouracil|fluorouracil|mesh-list
93247820|NCT05564377|Oxaliplatin|oxaliplatin|mesh-list
93247821|NCT05564377|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93247822|NCT05564377|Fulvestrant|fulvestrant|mesh-list
93247823|NCT05564377|Olaparib|olaparib|mesh-list
93247824|NCT05564377|Palbociclib|palbociclib|mesh-list
93247825|NCT05564377|Panitumumab|panitumumab|mesh-list
93247826|NCT05564377|Ipatasertib|ipatasertib|mesh-list
93247827|NCT05564377|Sotorasib|sotorasib|mesh-list
93247828|NCT05564377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93247829|NCT05564377|Antibodies|antibodies|mesh-list
93247830|NCT05564377|Immunoglobulins|immunoglobulins|mesh-list
93247831|NCT05564377|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93247832|NCT05564377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247833|NCT05564377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247834|NCT05564377|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247835|NCT05564377|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247836|NCT05564377|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247837|NCT05564377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247838|NCT05564377|Immunologic Factors|immunologic factors|mesh-ancestor
93247839|NCT05564377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247840|NCT05564377|Antimetabolites|antimetabolites|mesh-ancestor
93247841|NCT05564377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247842|NCT05564377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247843|NCT05564377|Antidotes|antidotes|mesh-ancestor
93247844|NCT05564377|Protective Agents|protective agents|mesh-ancestor
93247845|NCT05564377|Vitamin B Complex|vitamin b complex|mesh-ancestor
93247846|NCT05564377|Vitamins|vitamins|mesh-ancestor
93247847|NCT05564377|Micronutrients|micronutrients|mesh-ancestor
93247848|NCT05564377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93247849|NCT05564377|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93247850|NCT05564377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93247851|NCT05564377|Hormone Antagonists|hormone antagonists|mesh-ancestor
93247852|NCT05564377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93247853|NCT05564377|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93247854|NCT05564377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247855|NCT05564377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93247856|NCT05564377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93247857|NCT05557136|Ether|ether|mesh-list
93247858|NCT05557136|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93247859|NCT05557136|Anesthetics, General|anesthetics, general|mesh-ancestor
93247860|NCT05557136|Anesthetics|anesthetics|mesh-ancestor
93247861|NCT05557136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247862|NCT05557136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247863|NCT05556798|Pomalidomide|pomalidomide|mesh-list
93247864|NCT05556798|Nirogacestat|nirogacestat|mesh-list
93247865|NCT05556798|Immunologic Factors|immunologic factors|mesh-ancestor
92919822|NCT02612207|Bilirubin|bilirubin|mesh-list
92542477|NCT00025311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247866|NCT05556798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247867|NCT05556798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93247868|NCT05556798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93247869|NCT05556798|Growth Substances|growth substances|mesh-ancestor
93247870|NCT05556798|Growth Inhibitors|growth inhibitors|mesh-ancestor
93247871|NCT05556798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247872|NCT05556798|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93247873|NCT05556798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247874|NCT05556798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247876|NCT05554341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93247877|NCT05554341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247878|NCT05554341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247879|NCT05554341|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247880|NCT05554341|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247881|NCT05554341|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247882|NCT05554341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247883|NCT05536154|Cytarabine|cytarabine|mesh-list
93247884|NCT05536154|Etoposide|etoposide|mesh-list
93247885|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247886|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247887|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93247888|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247889|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247890|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247891|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247892|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
93247893|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
93247894|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247895|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247896|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
93247897|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247898|NCT05534984|Tecovirimat|tecovirimat|mesh-list
93247899|NCT05534984|Antiviral Agents|antiviral agents|mesh-ancestor
93247900|NCT05534984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247901|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
93247902|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93247903|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247904|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247905|NCT05510089|Cytarabine|cytarabine|mesh-list
93247906|NCT05510089|Etoposide|etoposide|mesh-list
93247907|NCT05510089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247908|NCT05510089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247909|NCT05510089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93247910|NCT05510089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93247911|NCT05510089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247912|NCT05510089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247913|NCT05510089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247914|NCT05510089|Antimetabolites|antimetabolites|mesh-ancestor
93247915|NCT05510089|Antiviral Agents|antiviral agents|mesh-ancestor
93247916|NCT05510089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247917|NCT05510089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93247918|NCT05510089|Immunologic Factors|immunologic factors|mesh-ancestor
93247919|NCT05510089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247920|NCT05506943|Paclitaxel|paclitaxel|mesh-list
92542533|NCT00025467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93247921|NCT05506943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93247922|NCT05506943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247923|NCT05506943|Tubulin Modulators|tubulin modulators|mesh-ancestor
93247924|NCT05506943|Antimitotic Agents|antimitotic agents|mesh-ancestor
93247925|NCT05506943|Mitosis Modulators|mitosis modulators|mesh-ancestor
93247926|NCT05506943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247927|NCT05502081|Remdesivir|remdesivir|mesh-list
93247928|NCT05502081|Favipiravir|favipiravir|mesh-list
93247929|NCT05502081|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
93247930|NCT05502081|Antimetabolites|antimetabolites|mesh-ancestor
93247931|NCT05502081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247932|NCT05502081|Antiviral Agents|antiviral agents|mesh-ancestor
93247933|NCT05502081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247934|NCT05494385|Gabapentin|gabapentin|mesh-list
93247935|NCT05494385|Analgesics|analgesics|mesh-ancestor
93247936|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
93247937|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247938|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247939|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
93247940|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93247941|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93247942|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247943|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247944|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93247945|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93247946|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247947|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247948|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
93247949|NCT05470491|Maraviroc|maraviroc|mesh-list
93247950|NCT05470491|Plerixafor|plerixafor|mesh-list
93247951|NCT05470491|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93247952|NCT05470491|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93247953|NCT05470491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247954|NCT05470491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93247955|NCT05470491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93247956|NCT05470491|Antiviral Agents|antiviral agents|mesh-ancestor
93247957|NCT05470491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93247958|NCT05470491|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93247959|NCT05455294|Decitabine|decitabine|mesh-list
93247960|NCT05455294|Venetoclax|venetoclax|mesh-list
93247961|NCT05455294|Navitoclax|navitoclax|mesh-list
93247962|NCT05455294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247963|NCT05455294|Antimetabolites|antimetabolites|mesh-ancestor
93247964|NCT05455294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247965|NCT05455294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247966|NCT05455294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247967|NCT05437796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93247968|NCT05437796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247969|NCT05437796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247970|NCT05405114|Decitabine|decitabine|mesh-list
93247971|NCT05405114|Hydroxyurea|hydroxyurea|mesh-list
93247972|NCT05405114|Tetrahydrouridine|tetrahydrouridine|mesh-list
93247973|NCT05405114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93247974|NCT05405114|Antimetabolites|antimetabolites|mesh-ancestor
93247975|NCT05405114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247976|NCT05405114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93247977|NCT05405114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93247978|NCT05405114|Antisickling Agents|antisickling agents|mesh-ancestor
93247979|NCT05405114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93247980|NCT05396014|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93247981|NCT05396014|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93247982|NCT05396014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93247983|NCT05396014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93247984|NCT05396014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93247985|NCT05396014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93247986|NCT05396014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247987|NCT05396014|Analgesics|analgesics|mesh-ancestor
93247988|NCT05396014|Sensory System Agents|sensory system agents|mesh-ancestor
93247989|NCT05396014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93247990|NCT05396014|Antidepressive Agents|antidepressive agents|mesh-ancestor
93247991|NCT05396014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247992|NCT05396014|Dopamine Agents|dopamine agents|mesh-ancestor
93247993|NCT05368558|Cariprazine|cariprazine|mesh-list
93247994|NCT05368558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93247995|NCT05368558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93247996|NCT05368558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93247997|NCT05368558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93247998|NCT05368558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93247999|NCT05357989|Phenserine|phenserine|mesh-list
93248000|NCT05357989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93248001|NCT05357989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248002|NCT05357989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248003|NCT05357989|Cholinergic Agents|cholinergic agents|mesh-ancestor
93248004|NCT05357989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248005|NCT05357989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248006|NCT05348577|Docetaxel|docetaxel|mesh-list
93248007|NCT05348577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248008|NCT05348577|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248009|NCT05348577|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248010|NCT05348577|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248011|NCT05348577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248012|NCT05321940|Interferons|interferons|mesh-list
93248013|NCT05321940|Vaccines|vaccines|mesh-list
93248014|NCT05321940|Immunologic Factors|immunologic factors|mesh-ancestor
93248015|NCT05321940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248016|NCT05321940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248017|NCT05321940|Antiviral Agents|antiviral agents|mesh-ancestor
93248018|NCT05321940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248019|NCT05304455|Heparin|heparin|mesh-list
93248020|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93248021|NCT05304455|Tinzaparin|tinzaparin|mesh-list
93248022|NCT05304455|Dalteparin|dalteparin|mesh-list
93248023|NCT05304455|Dipyridamole|dipyridamole|mesh-list
93248024|NCT05304455|Apixaban|apixaban|mesh-list
93248025|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
93248026|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93248027|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93248028|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248029|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93248030|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
93248031|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93248032|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
93248033|NCT05304455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248034|NCT05304455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93248035|NCT05304455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93248036|NCT05304455|Vasodilator Agents|vasodilator agents|mesh-ancestor
93248037|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93248038|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93248039|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
93248040|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248041|NCT05256225|Paclitaxel|paclitaxel|mesh-list
93248042|NCT05256225|Carboplatin|carboplatin|mesh-list
93248043|NCT05256225|Trastuzumab|trastuzumab|mesh-list
93248044|NCT05256225|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93248045|NCT05256225|Pertuzumab|pertuzumab|mesh-list
93248046|NCT05256225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248047|NCT05256225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248048|NCT05256225|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248049|NCT05256225|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248050|NCT05256225|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248051|NCT05256225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248052|NCT05256225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248053|NCT05253651|Leucovorin|leucovorin|mesh-list
93248054|NCT05253651|Bevacizumab|bevacizumab|mesh-list
93248055|NCT05253651|Trastuzumab|trastuzumab|mesh-list
93248056|NCT05253651|Cetuximab|cetuximab|mesh-list
93248057|NCT05253651|Fluorouracil|fluorouracil|mesh-list
93248058|NCT05253651|Oxaliplatin|oxaliplatin|mesh-list
93248059|NCT05253651|Tucatinib|tucatinib|mesh-list
93248060|NCT05253651|Levoleucovorin|levoleucovorin|mesh-list
93248061|NCT05253651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248062|NCT05253651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248063|NCT05253651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248064|NCT05253651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248065|NCT05253651|Growth Substances|growth substances|mesh-ancestor
93248066|NCT05253651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248067|NCT05253651|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248068|NCT05253651|Antimetabolites|antimetabolites|mesh-ancestor
93248069|NCT05253651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248070|NCT05253651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93248071|NCT05253651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248072|NCT05253651|Immunologic Factors|immunologic factors|mesh-ancestor
93248073|NCT05253651|Antidotes|antidotes|mesh-ancestor
93248074|NCT05253651|Protective Agents|protective agents|mesh-ancestor
93248075|NCT05253651|Vitamin B Complex|vitamin b complex|mesh-ancestor
93248076|NCT05253651|Vitamins|vitamins|mesh-ancestor
93248077|NCT05253651|Micronutrients|micronutrients|mesh-ancestor
93248078|NCT05253651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248079|NCT05253651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248080|NCT05236842|Sulthiame|sulthiame|mesh-list
93248081|NCT05236842|Anticonvulsants|anticonvulsants|mesh-ancestor
93248082|NCT05233098|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
93248083|NCT05233098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93248084|NCT05233098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248085|NCT05232825|Diphenhydramine|diphenhydramine|mesh-list
93248086|NCT05232825|Promethazine|promethazine|mesh-list
93248087|NCT05232825|Dexamethasone|dexamethasone|mesh-list
93248088|NCT05232825|Methylprednisolone|methylprednisolone|mesh-list
93248089|NCT05232825|Desloratadine|desloratadine|mesh-list
93248090|NCT05232825|Ocrelizumab|ocrelizumab|mesh-list
93248091|NCT05232825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248092|NCT05232825|Antiemetics|antiemetics|mesh-ancestor
93248093|NCT05232825|Autonomic Agents|autonomic agents|mesh-ancestor
93248094|NCT05232825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248095|NCT05232825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248096|NCT05232825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248097|NCT05232825|Glucocorticoids|glucocorticoids|mesh-ancestor
93248098|NCT05232825|Hormones|hormones|mesh-ancestor
93248099|NCT05232825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366396|NCT02796755|Protective Agents|protective agents|mesh-ancestor
93248100|NCT05232825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248101|NCT05232825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248102|NCT05232825|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93248103|NCT05232825|Protective Agents|protective agents|mesh-ancestor
93248104|NCT05232825|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93248105|NCT05232825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93248106|NCT05232825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248107|NCT05232825|Anesthetics, Local|anesthetics, local|mesh-ancestor
93248108|NCT05232825|Anesthetics|anesthetics|mesh-ancestor
93248109|NCT05232825|Sensory System Agents|sensory system agents|mesh-ancestor
93248110|NCT05232825|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93248111|NCT05232825|Histamine Antagonists|histamine antagonists|mesh-ancestor
93248112|NCT05232825|Histamine Agents|histamine agents|mesh-ancestor
93248113|NCT05232825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248114|NCT05232825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248115|NCT05232825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93248116|NCT05232825|Antipruritics|antipruritics|mesh-ancestor
93248117|NCT05232825|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248118|NCT05232825|Immunologic Factors|immunologic factors|mesh-ancestor
93248119|NCT05232825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93248120|NCT05232825|Cholinergic Agents|cholinergic agents|mesh-ancestor
93248121|NCT05232825|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93248122|NCT05231122|Bevacizumab|bevacizumab|mesh-list
93248123|NCT05231122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93248124|NCT05231122|Pembrolizumab|pembrolizumab|mesh-list
93248125|NCT05231122|Endothelial Growth Factors|endothelial growth factors|mesh-list
93248126|NCT05231122|Antibodies|antibodies|mesh-list
93248127|NCT05231122|Immunoglobulins|immunoglobulins|mesh-list
93248128|NCT05231122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248129|NCT05231122|Immunoglobulin G|immunoglobulin g|mesh-list
93248130|NCT05231122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248131|NCT05231122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248132|NCT05231122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248133|NCT05231122|Growth Substances|growth substances|mesh-ancestor
93248134|NCT05231122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248135|NCT05231122|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248136|NCT05231122|Immunologic Factors|immunologic factors|mesh-ancestor
93248137|NCT05231122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248138|NCT05231122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248139|NCT05219110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93248140|NCT05201300|Propofol|propofol|mesh-list
93248141|NCT05201300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93248142|NCT05201300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248143|NCT05201300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248144|NCT05201300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93248145|NCT05201300|Anesthetics, General|anesthetics, general|mesh-ancestor
93248146|NCT05201300|Anesthetics|anesthetics|mesh-ancestor
93248147|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93248148|NCT05200208|Nootropic Agents|nootropic agents|mesh-ancestor
93248149|NCT05198050|Letrozole|letrozole|mesh-list
93248150|NCT05198050|Alprostadil|alprostadil|mesh-list
93248151|NCT05198050|Misoprostol|misoprostol|mesh-list
93248152|NCT05198050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248153|NCT05198050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93248154|NCT05198050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93248155|NCT05198050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248156|NCT05198050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248157|NCT05198050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93248158|NCT05198050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92542764|NCT04473950|Naloxone|naloxone|mesh-list
93248159|NCT05198050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248160|NCT05198050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248161|NCT05198050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93248162|NCT05198050|Abortifacient Agents|abortifacient agents|mesh-ancestor
93248163|NCT05198050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93248164|NCT05198050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93248165|NCT05198050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248166|NCT05198050|Oxytocics|oxytocics|mesh-ancestor
93248167|NCT05198050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93248168|NCT05198050|Vasodilator Agents|vasodilator agents|mesh-ancestor
93248169|NCT05198050|Urological Agents|urological agents|mesh-ancestor
93248170|NCT05182840|Empagliflozin|empagliflozin|mesh-list
93248171|NCT05182840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93248172|NCT05182840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248173|NCT05182840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93248174|NCT05182840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248175|NCT05142696|Carboplatin|carboplatin|mesh-list
93248176|NCT05142696|Etoposide|etoposide|mesh-list
93248177|NCT05142696|Tislelizumab|tislelizumab|mesh-list
93248178|NCT05142696|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93248179|NCT05142696|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93248180|NCT05142696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248181|NCT05142696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248182|NCT05142696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93248183|NCT05142696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93248184|NCT05142696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248185|NCT05142696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248186|NCT05142696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248187|NCT05142696|Chelating Agents|chelating agents|mesh-ancestor
93248188|NCT05142696|Sequestering Agents|sequestering agents|mesh-ancestor
93248189|NCT05142696|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93248190|NCT05136196|Nivolumab|nivolumab|mesh-list
93248191|NCT05136196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248192|NCT05136196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248193|NCT05136196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248194|NCT05136196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248195|NCT05132582|Trastuzumab|trastuzumab|mesh-list
93248196|NCT05132582|Pertuzumab|pertuzumab|mesh-list
93248197|NCT05132582|Tucatinib|tucatinib|mesh-list
93248198|NCT05132582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248199|NCT05132582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248200|NCT05132582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248201|NCT05132582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248202|NCT05132582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248203|NCT05119439|Misoprostol|misoprostol|mesh-list
93248204|NCT05119439|Mifepristone|mifepristone|mesh-list
93248205|NCT05119439|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93248206|NCT05119439|Abortifacient Agents|abortifacient agents|mesh-ancestor
93248207|NCT05119439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93248208|NCT05119439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248209|NCT05119439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93248210|NCT05119439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248211|NCT05119439|Oxytocics|oxytocics|mesh-ancestor
93248212|NCT05119439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93248213|NCT05119439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93248214|NCT05119439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93248215|NCT05119439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93248216|NCT05119439|Contraceptive Agents|contraceptive agents|mesh-ancestor
93248217|NCT05119439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93248218|NCT05119439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93248219|NCT05119439|Hormone Antagonists|hormone antagonists|mesh-ancestor
93248220|NCT05119439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248221|NCT05119439|Luteolytic Agents|luteolytic agents|mesh-ancestor
93248222|NCT05119439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93248223|NCT05119439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93248224|NCT05111574|Nivolumab|nivolumab|mesh-list
93248225|NCT05111574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248226|NCT05111574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248227|NCT05111574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248228|NCT05111574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248229|NCT05092958|Avelumab|avelumab|mesh-list
93248230|NCT05092958|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248231|NCT05092958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248232|NCT05092958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248233|NCT05092958|Immunologic Factors|immunologic factors|mesh-ancestor
93248234|NCT05092958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248235|NCT05065021|Paclitaxel|paclitaxel|mesh-list
93248236|NCT05065021|Bevacizumab|bevacizumab|mesh-list
93248237|NCT05065021|Niraparib|niraparib|mesh-list
93248238|NCT05065021|Dostarlimab|dostarlimab|mesh-list
93248239|NCT05065021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248240|NCT05065021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248241|NCT05065021|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248242|NCT05065021|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248243|NCT05065021|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248244|NCT05065021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248245|NCT05065021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248246|NCT05065021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93366397|NCT02061917|Lobeline|lobeline|mesh-list
92920196|NCT00818753|Antithrombins|antithrombins|mesh-ancestor
93248247|NCT05065021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248248|NCT05065021|Growth Substances|growth substances|mesh-ancestor
93248249|NCT05065021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248250|NCT05065021|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248251|NCT05065021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93248252|NCT05065021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248253|NCT05063552|Bevacizumab|bevacizumab|mesh-list
93248254|NCT05063552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93248255|NCT05063552|Cetuximab|cetuximab|mesh-list
93248256|NCT05063552|Atezolizumab|atezolizumab|mesh-list
93248257|NCT05063552|Cisplatin|cisplatin|mesh-list
93248258|NCT05063552|Carboplatin|carboplatin|mesh-list
93248259|NCT05063552|Docetaxel|docetaxel|mesh-list
93248260|NCT05063552|Endothelial Growth Factors|endothelial growth factors|mesh-list
93248261|NCT05063552|Antibodies|antibodies|mesh-list
93248262|NCT05063552|Immunoglobulins|immunoglobulins|mesh-list
93248263|NCT05063552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248264|NCT05063552|Immunoglobulin G|immunoglobulin g|mesh-list
93248265|NCT05063552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248266|NCT05063552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248267|NCT05063552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248268|NCT05063552|Growth Substances|growth substances|mesh-ancestor
93248269|NCT05063552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248270|NCT05063552|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248271|NCT05063552|Immunologic Factors|immunologic factors|mesh-ancestor
93248272|NCT05063552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248273|NCT05063552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248274|NCT05063552|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248275|NCT05063552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248276|NCT05063552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248277|NCT05058651|Cisplatin|cisplatin|mesh-list
93248278|NCT05058651|Carboplatin|carboplatin|mesh-list
93248279|NCT05058651|Etoposide|etoposide|mesh-list
93248280|NCT05058651|Etoposide phosphate|etoposide phosphate|mesh-list
93248281|NCT05058651|Atezolizumab|atezolizumab|mesh-list
93248282|NCT05058651|Podophyllotoxin|podophyllotoxin|mesh-list
93248283|NCT05058651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248284|NCT05058651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248285|NCT05058651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248286|NCT05058651|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542892|NCT00027885|Alkylating Agents|alkylating agents|mesh-ancestor
93248287|NCT05058651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93248288|NCT05058651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248289|NCT05058651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248290|NCT05058651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248291|NCT05058651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248292|NCT05058651|Immunologic Factors|immunologic factors|mesh-ancestor
93248293|NCT05058651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248294|NCT05058651|Keratolytic Agents|keratolytic agents|mesh-ancestor
93248295|NCT05058651|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248296|NCT05058651|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248297|NCT05058651|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248298|NCT05058651|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248299|NCT05039619|Acetaminophen|acetaminophen|mesh-list
93248300|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
93248301|NCT05039619|Promethazine|promethazine|mesh-list
93248302|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
93248303|NCT05039619|Prednisone|prednisone|mesh-list
93248304|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
93248305|NCT05039619|Obinutuzumab|obinutuzumab|mesh-list
93248306|NCT05039619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248307|NCT05039619|Glucocorticoids|glucocorticoids|mesh-ancestor
93248308|NCT05039619|Hormones|hormones|mesh-ancestor
93248309|NCT05039619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248310|NCT05039619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248311|NCT05039619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248312|NCT05039619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248313|NCT05039619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93248314|NCT05039619|Analgesics|analgesics|mesh-ancestor
93248315|NCT05039619|Sensory System Agents|sensory system agents|mesh-ancestor
93248316|NCT05039619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248317|NCT05039619|Antipyretics|antipyretics|mesh-ancestor
93248318|NCT05039619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93248319|NCT05039619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93248320|NCT05039619|Antitubercular Agents|antitubercular agents|mesh-ancestor
93248321|NCT05039619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93248322|NCT05039619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248323|NCT05039619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248324|NCT05039619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248325|NCT05039619|Antiemetics|antiemetics|mesh-ancestor
93248326|NCT05039619|Autonomic Agents|autonomic agents|mesh-ancestor
93248327|NCT05039619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248328|NCT05039619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93248329|NCT05039619|Protective Agents|protective agents|mesh-ancestor
93248330|NCT05039619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248331|NCT05039619|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93248332|NCT05039619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93248333|NCT05039619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248334|NCT05039619|Anesthetics, Local|anesthetics, local|mesh-ancestor
93248335|NCT05039619|Anesthetics|anesthetics|mesh-ancestor
93248336|NCT05039619|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93248337|NCT05039619|Histamine Antagonists|histamine antagonists|mesh-ancestor
93248338|NCT05039619|Histamine Agents|histamine agents|mesh-ancestor
93248339|NCT05039619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248340|NCT05039619|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93248341|NCT05039619|Antipruritics|antipruritics|mesh-ancestor
93248342|NCT05039619|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248343|NCT05020392|Vidarabine|vidarabine|mesh-list
93248344|NCT05020392|Fludarabine|fludarabine|mesh-list
93248345|NCT05020392|Fludarabine phosphate|fludarabine phosphate|mesh-list
93248346|NCT05020392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248347|NCT05020392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93248348|NCT05020392|Antimetabolites|antimetabolites|mesh-ancestor
93248349|NCT05020392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248350|NCT05020392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248351|NCT05020392|Immunologic Factors|immunologic factors|mesh-ancestor
93248352|NCT05020392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248353|NCT05020392|Antiviral Agents|antiviral agents|mesh-ancestor
93248354|NCT05020392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248355|NCT05003895|Cyclophosphamide|cyclophosphamide|mesh-list
93248356|NCT05003895|Fludarabine|fludarabine|mesh-list
93248357|NCT05003895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248358|NCT05003895|Immunologic Factors|immunologic factors|mesh-ancestor
93248359|NCT05003895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248360|NCT05003895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248361|NCT05003895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93248362|NCT05003895|Alkylating Agents|alkylating agents|mesh-ancestor
93248363|NCT05003895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248364|NCT05003895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248365|NCT05003895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93248366|NCT05001880|Bevacizumab|bevacizumab|mesh-list
93248367|NCT05001880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93248368|NCT05001880|Atezolizumab|atezolizumab|mesh-list
93248369|NCT05001880|Carboplatin|carboplatin|mesh-list
93248370|NCT05001880|Pemetrexed|pemetrexed|mesh-list
93248371|NCT05001880|Endothelial Growth Factors|endothelial growth factors|mesh-list
93248372|NCT05001880|Antibodies|antibodies|mesh-list
93248373|NCT05001880|Immunoglobulins|immunoglobulins|mesh-list
93248374|NCT05001880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248375|NCT05001880|Immunoglobulin G|immunoglobulin g|mesh-list
93248376|NCT05001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248377|NCT05001880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248378|NCT05001880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248379|NCT05001880|Growth Substances|growth substances|mesh-ancestor
93248380|NCT05001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248381|NCT05001880|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248382|NCT05001880|Immunologic Factors|immunologic factors|mesh-ancestor
93248383|NCT05001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248384|NCT05001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248385|NCT05001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93248386|NCT05001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93248387|NCT05001880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248388|NCT04998812|Ocrelizumab|ocrelizumab|mesh-list
93248389|NCT04998812|Immunologic Factors|immunologic factors|mesh-ancestor
93248390|NCT04998812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248391|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93248392|NCT04992468|Hormones|hormones|mesh-ancestor
93248393|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248394|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248395|NCT04978493|Ustekinumab|ustekinumab|mesh-list
92543010|NCT00028275|Interferon-gamma|interferon-gamma|mesh-list
93248396|NCT04978493|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248397|NCT04975100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93248398|NCT04975100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920340|NCT03908060|Analgesics|analgesics|mesh-ancestor
93248399|NCT04975100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93248400|NCT04975100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248401|NCT04975100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248402|NCT04975100|Serotonin Agents|serotonin agents|mesh-ancestor
93248403|NCT04975100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248405|NCT04974528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93248406|NCT04974528|Insulin Glargine|insulin glargine|mesh-list
93248407|NCT04974528|Insulin Aspart|insulin aspart|mesh-list
93248408|NCT04974528|Insulin Lispro|insulin lispro|mesh-list
93248409|NCT04974528|Insulin Detemir|insulin detemir|mesh-list
93248410|NCT04974528|Insulin glulisine|insulin glulisine|mesh-list
93248411|NCT04974528|Insulin, Short-Acting|insulin, short-acting|mesh-list
93248412|NCT04974528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93248413|NCT04974528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248414|NCT04970342|Alprazolam|alprazolam|mesh-list
93248415|NCT04970342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248416|NCT04970342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93248417|NCT04970342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248418|NCT04970342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248419|NCT04970342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93248420|NCT04970342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248421|NCT04970342|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93248422|NCT04970342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93248423|NCT04970342|GABA Modulators|gaba modulators|mesh-ancestor
93248424|NCT04970342|GABA Agents|gaba agents|mesh-ancestor
93248425|NCT04959981|Osimertinib|osimertinib|mesh-list
93248426|NCT04959981|Sotorasib|sotorasib|mesh-list
93248427|NCT04959981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248428|NCT04959981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248429|NCT04959981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248430|NCT04959981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248431|NCT04959981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248432|NCT04959981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248433|NCT04923893|Dexamethasone|dexamethasone|mesh-list
93248434|NCT04923893|Cyclophosphamide|cyclophosphamide|mesh-list
93248435|NCT04923893|Fludarabine|fludarabine|mesh-list
93248436|NCT04923893|Lenalidomide|lenalidomide|mesh-list
93248437|NCT04923893|Bortezomib|bortezomib|mesh-list
93248438|NCT04923893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248439|NCT04923893|Immunologic Factors|immunologic factors|mesh-ancestor
93248440|NCT04923893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248441|NCT04923893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248442|NCT04923893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93248443|NCT04923893|Alkylating Agents|alkylating agents|mesh-ancestor
93248444|NCT04923893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248445|NCT04923893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248446|NCT04923893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93248447|NCT04923893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248448|NCT04923893|Antiemetics|antiemetics|mesh-ancestor
93248449|NCT04923893|Autonomic Agents|autonomic agents|mesh-ancestor
93248450|NCT04923893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248451|NCT04923893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248452|NCT04923893|Glucocorticoids|glucocorticoids|mesh-ancestor
93248453|NCT04923893|Hormones|hormones|mesh-ancestor
93248454|NCT04923893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248455|NCT04923893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248456|NCT04923893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248457|NCT04923893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248458|NCT04923893|Growth Substances|growth substances|mesh-ancestor
93248459|NCT04923893|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248460|NCT04901377|Dienogest|dienogest|mesh-list
93248461|NCT04901377|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93248462|NCT04901377|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93248463|NCT04901377|Estradiol|estradiol|mesh-list
93248464|NCT04901377|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93248465|NCT04901377|Estrogens|estrogens|mesh-ancestor
93248466|NCT04901377|Hormones|hormones|mesh-ancestor
93248467|NCT04901377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248468|NCT04901377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248469|NCT04901377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93248470|NCT04901377|Contraceptive Agents|contraceptive agents|mesh-ancestor
93248471|NCT04901377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93248472|NCT04901377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93248473|NCT04901377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93248474|NCT04901377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93248475|NCT04901377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93248476|NCT04901377|Hormone Antagonists|hormone antagonists|mesh-ancestor
93248477|NCT04901377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248478|NCT04901377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248479|NCT04881240|Cyclophosphamide|cyclophosphamide|mesh-list
93248480|NCT04881240|Fludarabine|fludarabine|mesh-list
93248481|NCT04881240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248482|NCT04881240|Immunologic Factors|immunologic factors|mesh-ancestor
93248483|NCT04881240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248484|NCT04881240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248485|NCT04881240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93248486|NCT04881240|Alkylating Agents|alkylating agents|mesh-ancestor
93248487|NCT04881240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248488|NCT04881240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248489|NCT04881240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93248490|NCT04879329|Pembrolizumab|pembrolizumab|mesh-list
93248491|NCT04879329|Disitamab vedotin|disitamab vedotin|mesh-list
93248492|NCT04879329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248493|NCT04879329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248494|NCT04879329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248495|NCT04879329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248496|NCT04879329|Immunoconjugates|immunoconjugates|mesh-ancestor
93248497|NCT04879329|Immunologic Factors|immunologic factors|mesh-ancestor
93248498|NCT04879329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248499|NCT04876248|Lenalidomide|lenalidomide|mesh-list
93248500|NCT04876248|Immunologic Factors|immunologic factors|mesh-ancestor
93248501|NCT04876248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248502|NCT04876248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248503|NCT04876248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248504|NCT04876248|Growth Substances|growth substances|mesh-ancestor
93248505|NCT04876248|Growth Inhibitors|growth inhibitors|mesh-ancestor
93248506|NCT04876248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248507|NCT04873362|Trastuzumab|trastuzumab|mesh-list
93248508|NCT04873362|Atezolizumab|atezolizumab|mesh-list
93248509|NCT04873362|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93248510|NCT04873362|Maytansine|maytansine|mesh-list
93248511|NCT04873362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248512|NCT04873362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248513|NCT04873362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248514|NCT04873362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543119|NCT03959540|Levodopa|levodopa|mesh-list
93248515|NCT04873362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248516|NCT04873362|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248517|NCT04873362|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248518|NCT04873362|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248519|NCT04873362|Immunotoxins|immunotoxins|mesh-ancestor
93248520|NCT04873362|Immunoconjugates|immunoconjugates|mesh-ancestor
93248521|NCT04873362|Immunologic Factors|immunologic factors|mesh-ancestor
93248522|NCT04873362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248523|NCT04858334|Olaparib|olaparib|mesh-list
93248524|NCT04858334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93248525|NCT04858334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248526|NCT04858334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248527|NCT04858334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248528|NCT04847557|Tirzepatide|tirzepatide|mesh-list
93248529|NCT04847557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93248530|NCT04847557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248531|NCT04847557|Incretins|incretins|mesh-ancestor
93248532|NCT04847557|Hormones|hormones|mesh-ancestor
93248533|NCT04847557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248534|NCT04838613|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93248535|NCT04838613|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93248536|NCT04838613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248537|NCT04826341|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93248538|NCT04826341|Immunoconjugates|immunoconjugates|mesh-ancestor
93248539|NCT04826341|Immunologic Factors|immunologic factors|mesh-ancestor
93248540|NCT04826341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248541|NCT04795245|Afatinib|afatinib|mesh-list
93248542|NCT04795245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248543|NCT04795245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248544|NCT04795245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248545|NCT04795245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248546|NCT04778397|Cytarabine|cytarabine|mesh-list
93248547|NCT04778397|Azacitidine|azacitidine|mesh-list
93248548|NCT04778397|Daunorubicin|daunorubicin|mesh-list
93248549|NCT04778397|Venetoclax|venetoclax|mesh-list
93248550|NCT04778397|Idarubicin|idarubicin|mesh-list
93248551|NCT04778397|Magrolimab|magrolimab|mesh-list
93248552|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93248553|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93248554|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
93248555|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248556|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248557|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
93248558|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248559|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248560|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
93248561|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248562|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248563|NCT04778397|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93248564|NCT04778397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93248565|NCT04778397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93248566|NCT04778397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93248567|NCT04778397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248568|NCT04742101|Azacitidine|azacitidine|mesh-list
93248569|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93248570|NCT04742101|Antimetabolites|antimetabolites|mesh-ancestor
93248571|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248572|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248573|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248574|NCT04738422|Glycine|glycine|mesh-list
93248575|NCT04738422|Glycine Agents|glycine agents|mesh-ancestor
93248576|NCT04738422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248577|NCT04738422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248578|NCT04738422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248579|NCT04729959|Atezolizumab|atezolizumab|mesh-list
93248580|NCT04729959|Immunoglobulins|immunoglobulins|mesh-list
93248581|NCT04729959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248582|NCT04729959|Immunoglobulin G|immunoglobulin g|mesh-list
93248583|NCT04729959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248584|NCT04729959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248585|NCT04729959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248586|NCT04729959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248587|NCT04729959|Immunologic Factors|immunologic factors|mesh-ancestor
93248588|NCT04729959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248589|NCT04729114|Dexamethasone|dexamethasone|mesh-list
93248590|NCT04729114|Prednisone|prednisone|mesh-list
93248591|NCT04729114|Docetaxel|docetaxel|mesh-list
93248592|NCT04729114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248593|NCT04729114|Antiemetics|antiemetics|mesh-ancestor
93248594|NCT04729114|Autonomic Agents|autonomic agents|mesh-ancestor
93248595|NCT04729114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248596|NCT04729114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248597|NCT04729114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248598|NCT04729114|Glucocorticoids|glucocorticoids|mesh-ancestor
93248599|NCT04729114|Hormones|hormones|mesh-ancestor
93248600|NCT04729114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248601|NCT04729114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248602|NCT04729114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248603|NCT04729114|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248604|NCT04729114|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248605|NCT04729114|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248606|NCT04729114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248607|NCT04708418|Pembrolizumab|pembrolizumab|mesh-list
93248608|NCT04708418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248609|NCT04708418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248610|NCT04708418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248611|NCT04708418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248612|NCT04704999|Lumefantrine|lumefantrine|mesh-list
93248613|NCT04704999|Chloroquine|chloroquine|mesh-list
93248614|NCT04704999|Artemether|artemether|mesh-list
93248615|NCT04704999|Tafenoquine|tafenoquine|mesh-list
93248616|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
93248617|NCT04704999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93248618|NCT04704999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93248619|NCT04704999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248620|NCT04704999|Amebicides|amebicides|mesh-ancestor
93248621|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248622|NCT04689828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93248623|NCT04689828|177Lu-PSMA-617|177lu-psma-617|mesh-list
93248624|NCT04689828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93248625|NCT04689828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248626|NCT04686305|Carboplatin|carboplatin|mesh-list
93248627|NCT04686305|Trastuzumab|trastuzumab|mesh-list
93248629|NCT04686305|Durvalumab|durvalumab|mesh-list
93248630|NCT04686305|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93248631|NCT04686305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248632|NCT04686305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248633|NCT04686305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248634|NCT04686305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248635|NCT04686305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93248636|NCT04686305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93248637|NCT04686305|Immunoconjugates|immunoconjugates|mesh-ancestor
93248638|NCT04686305|Immunologic Factors|immunologic factors|mesh-ancestor
93248639|NCT04686305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248640|NCT04679402|Carbon Monoxide|carbon monoxide|mesh-list
93248641|NCT04679402|Antimetabolites|antimetabolites|mesh-ancestor
93248642|NCT04679402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248643|NCT04679402|Gasotransmitters|gasotransmitters|mesh-ancestor
93248644|NCT04679402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248645|NCT04679402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248646|NCT04671667|Cisplatin|cisplatin|mesh-list
93248647|NCT04671667|Carboplatin|carboplatin|mesh-list
93248648|NCT04671667|Pembrolizumab|pembrolizumab|mesh-list
93248649|NCT04671667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248650|NCT04671667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248651|NCT04671667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248652|NCT04671667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248653|NCT04665739|Everolimus|everolimus|mesh-list
93248654|NCT04665739|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93248655|NCT04665739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93248656|NCT04665739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248657|NCT04665739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248658|NCT04665739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248659|NCT04665739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248660|NCT04665739|Immunologic Factors|immunologic factors|mesh-ancestor
93248661|NCT04665739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248662|NCT04665739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248663|NCT04665739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93248664|NCT04654507|Dexamethasone|dexamethasone|mesh-list
93248665|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248666|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
93248667|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
93248668|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248669|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248670|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248671|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
93248672|NCT04654507|Hormones|hormones|mesh-ancestor
93248673|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248674|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248675|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248676|NCT04646655|Enoxaparin|enoxaparin|mesh-list
93248677|NCT04646655|Anticoagulants|anticoagulants|mesh-ancestor
93248678|NCT04646655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93248679|NCT04646655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93248680|NCT04646655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248681|NCT04645550|Aspirin|aspirin|mesh-list
93248682|NCT04645550|Heparin|heparin|mesh-list
93248683|NCT04645550|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93248684|NCT04645550|Tinzaparin|tinzaparin|mesh-list
93248685|NCT04645550|Dalteparin|dalteparin|mesh-list
93248686|NCT04645550|Dipyridamole|dipyridamole|mesh-list
93248687|NCT04645550|Warfarin|warfarin|mesh-list
93248688|NCT04645550|Apixaban|apixaban|mesh-list
93248689|NCT04645550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93248690|NCT04645550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93248691|NCT04645550|Analgesics|analgesics|mesh-ancestor
93248692|NCT04645550|Sensory System Agents|sensory system agents|mesh-ancestor
93248693|NCT04645550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248694|NCT04645550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248695|NCT04645550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248696|NCT04645550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248697|NCT04645550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93248698|NCT04645550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93248699|NCT04645550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248700|NCT04645550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93248701|NCT04645550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93248702|NCT04645550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248703|NCT04645550|Antipyretics|antipyretics|mesh-ancestor
93248705|NCT04645550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93248706|NCT04645550|Antithrombins|antithrombins|mesh-ancestor
93248707|NCT04645550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93248708|NCT04645550|Protease Inhibitors|protease inhibitors|mesh-ancestor
93248709|NCT04645550|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93248710|NCT04645550|Vasodilator Agents|vasodilator agents|mesh-ancestor
93248711|NCT04629443|Azacitidine|azacitidine|mesh-list
93248712|NCT04629443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93248713|NCT04629443|Antimetabolites|antimetabolites|mesh-ancestor
93248714|NCT04629443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248715|NCT04629443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248716|NCT04629443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248717|NCT04629248|Acetaminophen|acetaminophen|mesh-list
93248718|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
93248719|NCT04629248|Promethazine|promethazine|mesh-list
93248720|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
93248721|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
93248722|NCT04629248|Tacrolimus|tacrolimus|mesh-list
93248723|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248724|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
93248725|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248726|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93248727|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248728|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248729|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93248730|NCT04629248|Analgesics|analgesics|mesh-ancestor
93248731|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
93248732|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248733|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
93248734|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248735|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
93248736|NCT04629248|Autonomic Agents|autonomic agents|mesh-ancestor
93248737|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248738|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
93248739|NCT04629248|Hormones|hormones|mesh-ancestor
93248740|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248741|NCT04629248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93248742|NCT04629248|Protective Agents|protective agents|mesh-ancestor
93248743|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248744|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248745|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93248746|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93248747|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248748|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
93248749|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
93248750|NCT04629248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93248751|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
93248752|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
93248753|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248754|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93248755|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
93248756|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248757|NCT04627922|Acetylcysteine|acetylcysteine|mesh-list
93248758|NCT04627922|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93248759|NCT04627922|Antiviral Agents|antiviral agents|mesh-ancestor
93248760|NCT04627922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248761|NCT04627922|Expectorants|expectorants|mesh-ancestor
93248762|NCT04627922|Respiratory System Agents|respiratory system agents|mesh-ancestor
93248763|NCT04627922|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93248764|NCT04627922|Antioxidants|antioxidants|mesh-ancestor
93248765|NCT04627922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248766|NCT04627922|Protective Agents|protective agents|mesh-ancestor
93248767|NCT04627922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248768|NCT04627922|Antidotes|antidotes|mesh-ancestor
93248769|NCT04616560|Trastuzumab|trastuzumab|mesh-list
93248770|NCT04616560|Camptothecin|camptothecin|mesh-list
93248771|NCT04616560|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93248772|NCT04616560|Immunoconjugates|immunoconjugates|mesh-list
93248773|NCT04616560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248774|NCT04616560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248775|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
93248776|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248777|NCT04616560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248778|NCT04616560|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93248779|NCT04616560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93248780|NCT04616560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248781|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248782|NCT04603807|Crizotinib|crizotinib|mesh-list
93248783|NCT04603807|Entrectinib|entrectinib|mesh-list
93248784|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248785|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248786|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248787|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248788|NCT04599634|Venetoclax|venetoclax|mesh-list
93248789|NCT04599634|Obinutuzumab|obinutuzumab|mesh-list
93248790|NCT04599634|Magrolimab|magrolimab|mesh-list
93248791|NCT04599634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248792|NCT04599634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248793|NCT04596657|Vitamin D|vitamin d|mesh-list
93248794|NCT04596657|Vitamins|vitamins|mesh-ancestor
93248795|NCT04596657|Micronutrients|micronutrients|mesh-ancestor
93248796|NCT04596657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248797|NCT04596657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93248798|NCT04586023|Teriflunomide|teriflunomide|mesh-list
93248799|NCT04586023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93248800|NCT04586023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93248801|NCT04586023|Analgesics|analgesics|mesh-ancestor
93248802|NCT04586023|Sensory System Agents|sensory system agents|mesh-ancestor
93248803|NCT04586023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248804|NCT04586023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248805|NCT04586023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248806|NCT04586023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248807|NCT04586023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248808|NCT04586023|Immunologic Factors|immunologic factors|mesh-ancestor
93248809|NCT04580121|Acetaminophen|acetaminophen|mesh-list
93248810|NCT04580121|Diphenhydramine|diphenhydramine|mesh-list
93248811|NCT04580121|Promethazine|promethazine|mesh-list
93248812|NCT04580121|Dexamethasone|dexamethasone|mesh-list
93248813|NCT04580121|Dasatinib|dasatinib|mesh-list
93248814|NCT04580121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248815|NCT04580121|Antiemetics|antiemetics|mesh-ancestor
93248816|NCT04580121|Autonomic Agents|autonomic agents|mesh-ancestor
93248817|NCT04580121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248818|NCT04580121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248819|NCT04580121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248820|NCT04580121|Glucocorticoids|glucocorticoids|mesh-ancestor
93248821|NCT04580121|Hormones|hormones|mesh-ancestor
93248822|NCT04580121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248823|NCT04580121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248824|NCT04580121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248825|NCT04580121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93248826|NCT04580121|Analgesics|analgesics|mesh-ancestor
93248827|NCT04580121|Sensory System Agents|sensory system agents|mesh-ancestor
93248828|NCT04580121|Antipyretics|antipyretics|mesh-ancestor
93248829|NCT04580121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248830|NCT04580121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248831|NCT04580121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248832|NCT04580121|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93248833|NCT04580121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93248834|NCT04580121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248835|NCT04580121|Anesthetics, Local|anesthetics, local|mesh-ancestor
93248836|NCT04580121|Anesthetics|anesthetics|mesh-ancestor
93248837|NCT04580121|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93248838|NCT04580121|Histamine Antagonists|histamine antagonists|mesh-ancestor
93248839|NCT04580121|Histamine Agents|histamine agents|mesh-ancestor
93248840|NCT04580121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93248841|NCT04580121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93248842|NCT04580121|Antipruritics|antipruritics|mesh-ancestor
93248843|NCT04580121|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248844|NCT04577716|Listerine|listerine|mesh-list
93248845|NCT04577716|Fluorides|fluorides|mesh-list
93248846|NCT04577716|Sodium Fluoride|sodium fluoride|mesh-list
93248847|NCT04577716|Cariostatic Agents|cariostatic agents|mesh-ancestor
93248848|NCT04577716|Protective Agents|protective agents|mesh-ancestor
93248849|NCT04577716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248850|NCT04577716|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93248851|NCT04577716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93248852|NCT04576117|Vinblastine|vinblastine|mesh-list
93248853|NCT04576117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248854|NCT04576117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248855|NCT04576117|Tubulin Modulators|tubulin modulators|mesh-ancestor
93248856|NCT04576117|Antimitotic Agents|antimitotic agents|mesh-ancestor
93248857|NCT04576117|Mitosis Modulators|mitosis modulators|mesh-ancestor
93248858|NCT04576117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248859|NCT04569032|Prednisone|prednisone|mesh-list
93248860|NCT04569032|Cyclophosphamide|cyclophosphamide|mesh-list
93248861|NCT04569032|Doxorubicin|doxorubicin|mesh-list
93248862|NCT04569032|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93248863|NCT04569032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248864|NCT04569032|Immunologic Factors|immunologic factors|mesh-ancestor
93248865|NCT04569032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248866|NCT04569032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248867|NCT04569032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93248868|NCT04569032|Alkylating Agents|alkylating agents|mesh-ancestor
93248869|NCT04569032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248870|NCT04569032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248871|NCT04569032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93248872|NCT04569032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93248873|NCT04569032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93248874|NCT04569032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93248875|NCT04569032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248876|NCT04569032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248877|NCT04569032|Glucocorticoids|glucocorticoids|mesh-ancestor
93248878|NCT04569032|Hormones|hormones|mesh-ancestor
93248879|NCT04569032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248880|NCT04569032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248881|NCT04569032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248882|NCT04569032|Immunotoxins|immunotoxins|mesh-ancestor
93248883|NCT04569032|Immunoconjugates|immunoconjugates|mesh-ancestor
93248884|NCT04557956|Trametinib|trametinib|mesh-list
93248885|NCT04557956|Dabrafenib|dabrafenib|mesh-list
93248886|NCT04557956|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93248887|NCT04557956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248888|NCT04557956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248889|NCT04557956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248890|NCT04557956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248891|NCT04557956|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93248892|NCT04557956|Protective Agents|protective agents|mesh-ancestor
93248893|NCT04557956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248894|NCT04557956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93248895|NCT04557956|Antioxidants|antioxidants|mesh-ancestor
93248896|NCT04551131|Dexamethasone|dexamethasone|mesh-list
93248897|NCT04551131|Etoposide|etoposide|mesh-list
93248898|NCT04551131|Etoposide phosphate|etoposide phosphate|mesh-list
93248899|NCT04551131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93248900|NCT04551131|Antiemetics|antiemetics|mesh-ancestor
93248901|NCT04551131|Autonomic Agents|autonomic agents|mesh-ancestor
93248902|NCT04551131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248903|NCT04551131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248904|NCT04551131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248905|NCT04551131|Glucocorticoids|glucocorticoids|mesh-ancestor
93248906|NCT04551131|Hormones|hormones|mesh-ancestor
93248907|NCT04551131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93248908|NCT04551131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93248909|NCT04551131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248910|NCT04551131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93248911|NCT04551131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93248912|NCT04551131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93248913|NCT04551131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248914|NCT04551131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248915|NCT04548752|Pembrolizumab|pembrolizumab|mesh-list
93248916|NCT04548752|Olaparib|olaparib|mesh-list
93248917|NCT04548752|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93248918|NCT04548752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248919|NCT04548752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248920|NCT04548752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248921|NCT04548752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248922|NCT04548752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248923|NCT04541589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93248924|NCT04541589|Immunologic Factors|immunologic factors|mesh-ancestor
93248925|NCT04541589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248926|NCT04540705|Nivolumab|nivolumab|mesh-list
93248927|NCT04540705|Axitinib|axitinib|mesh-list
93248928|NCT04540705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248929|NCT04540705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248930|NCT04540705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248931|NCT04540705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248932|NCT04540705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248933|NCT04540705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248934|NCT04539938|Trastuzumab|trastuzumab|mesh-list
93248935|NCT04539938|Tucatinib|tucatinib|mesh-list
93248936|NCT04539938|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93248937|NCT04539938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248938|NCT04539938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248939|NCT04539938|Immunoconjugates|immunoconjugates|mesh-ancestor
93248940|NCT04539938|Immunologic Factors|immunologic factors|mesh-ancestor
93248941|NCT04539938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248942|NCT04539938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248943|NCT04539938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248944|NCT04539938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248945|NCT04522323|Lenvatinib|lenvatinib|mesh-list
93248946|NCT04522323|Axitinib|axitinib|mesh-list
93248947|NCT04522323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248948|NCT04522323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93248949|NCT04522323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248950|NCT04522323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248951|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
93248952|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248953|NCT04521413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248954|NCT04521413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93248955|NCT04521413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248956|NCT04516057|Nabilone|nabilone|mesh-list
93248957|NCT04516057|Antiemetics|antiemetics|mesh-ancestor
93248958|NCT04516057|Autonomic Agents|autonomic agents|mesh-ancestor
93248959|NCT04516057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93248960|NCT04516057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248961|NCT04516057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93248962|NCT04516057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93248963|NCT04516057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93248964|NCT04516057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93248965|NCT04516057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93248966|NCT04511702|Methotrexate|methotrexate|mesh-list
93248967|NCT04511702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93248968|NCT04511702|Abortifacient Agents|abortifacient agents|mesh-ancestor
93248969|NCT04511702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93248970|NCT04511702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248971|NCT04511702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93248972|NCT04511702|Antimetabolites|antimetabolites|mesh-ancestor
93248973|NCT04511702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248974|NCT04511702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248975|NCT04511702|Dermatologic Agents|dermatologic agents|mesh-ancestor
93248976|NCT04511702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93248977|NCT04511702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93248978|NCT04511702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93248979|NCT04511702|Immunologic Factors|immunologic factors|mesh-ancestor
93248980|NCT04511702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93248981|NCT04511702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93248982|NCT04475276|Thioctic Acid|thioctic acid|mesh-list
93248983|NCT04475276|Antioxidants|antioxidants|mesh-ancestor
93248984|NCT04475276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93248985|NCT04475276|Protective Agents|protective agents|mesh-ancestor
93248986|NCT04475276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93248987|NCT04475276|Vitamin B Complex|vitamin b complex|mesh-ancestor
93248988|NCT04475276|Vitamins|vitamins|mesh-ancestor
93248989|NCT04475276|Micronutrients|micronutrients|mesh-ancestor
93248990|NCT04449874|Bevacizumab|bevacizumab|mesh-list
93248991|NCT04449874|Cetuximab|cetuximab|mesh-list
93248992|NCT04449874|Atezolizumab|atezolizumab|mesh-list
93248993|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93248994|NCT04449874|Inavolisib|inavolisib|mesh-list
93248995|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93248996|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93248997|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93248998|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93248999|NCT04449874|Growth Substances|growth substances|mesh-ancestor
93249000|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249001|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
93249002|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249003|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249004|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249005|NCT04449874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249006|NCT04449874|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93249007|NCT04444921|Paclitaxel|paclitaxel|mesh-list
93249008|NCT04444921|Carboplatin|carboplatin|mesh-list
93249009|NCT04444921|Nivolumab|nivolumab|mesh-list
93249010|NCT04444921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93249011|NCT04444921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249012|NCT04444921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249013|NCT04444921|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249014|NCT04444921|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249015|NCT04444921|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249016|NCT04444921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249017|NCT04444921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249018|NCT04444921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249019|NCT04424641|Antibodies|antibodies|mesh-list
93249020|NCT04424641|Immunoglobulins|immunoglobulins|mesh-list
93249021|NCT04424641|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93249022|NCT04424641|Immunoglobulin G|immunoglobulin g|mesh-list
93249023|NCT04424641|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93249024|NCT04424641|Immunologic Factors|immunologic factors|mesh-ancestor
93249025|NCT04424641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249026|NCT04404283|Rituximab|rituximab|mesh-list
93249027|NCT04404283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93249028|NCT04404283|Lenalidomide|lenalidomide|mesh-list
93249029|NCT04404283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249030|NCT04404283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249031|NCT04404283|Immunologic Factors|immunologic factors|mesh-ancestor
93249032|NCT04404283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249033|NCT04404283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249034|NCT04404283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93249035|NCT04404283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93249036|NCT04404283|Growth Substances|growth substances|mesh-ancestor
93249037|NCT04404283|Growth Inhibitors|growth inhibitors|mesh-ancestor
93249038|NCT04404283|Immunotoxins|immunotoxins|mesh-ancestor
93249039|NCT04404283|Immunoconjugates|immunoconjugates|mesh-ancestor
93249040|NCT04402788|Atezolizumab|atezolizumab|mesh-list
93249041|NCT04402788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249042|NCT04402788|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249043|NCT04402788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249044|NCT04402788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249045|NCT04402788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249046|NCT04402788|Immunologic Factors|immunologic factors|mesh-ancestor
93249047|NCT04402788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249048|NCT04394546|Anticoagulants|anticoagulants|mesh-list
93249049|NCT04393103|Atropine|atropine|mesh-list
93249050|NCT04393103|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93249051|NCT04393103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93249052|NCT04393103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93249053|NCT04393103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93249054|NCT04393103|Autonomic Agents|autonomic agents|mesh-ancestor
93249055|NCT04393103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249056|NCT04393103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249057|NCT04393103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93249058|NCT04393103|Respiratory System Agents|respiratory system agents|mesh-ancestor
93249059|NCT04393103|Mydriatics|mydriatics|mesh-ancestor
93249060|NCT04393103|Parasympatholytics|parasympatholytics|mesh-ancestor
93249061|NCT04393103|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93249062|NCT04393103|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93249063|NCT04393103|Cholinergic Agents|cholinergic agents|mesh-ancestor
93249064|NCT04393103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249065|NCT04393103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249066|NCT04393103|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93249067|NCT04393103|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93249068|NCT04393103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93249069|NCT04334629|Ibuprofen|ibuprofen|mesh-list
93249070|NCT04334629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93249071|NCT04334629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93249072|NCT04334629|Analgesics|analgesics|mesh-ancestor
93249073|NCT04334629|Sensory System Agents|sensory system agents|mesh-ancestor
93249074|NCT04334629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249075|NCT04334629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249076|NCT04334629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249077|NCT04334629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249078|NCT04334629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93249079|NCT04334629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249080|NCT04334629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249081|NCT04329975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93249082|NCT04329975|Hemostatics|hemostatics|mesh-ancestor
93249083|NCT04329975|Coagulants|coagulants|mesh-ancestor
93249084|NCT04329975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93249085|NCT04329975|Natriuretic Agents|natriuretic agents|mesh-ancestor
93249086|NCT04329975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249087|NCT04310020|Atezolizumab|atezolizumab|mesh-list
93249088|NCT04310020|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249089|NCT04310020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249090|NCT04310020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249091|NCT04310020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249092|NCT04310020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249093|NCT04310020|Immunologic Factors|immunologic factors|mesh-ancestor
93249094|NCT04310020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249095|NCT04300647|Atezolizumab|atezolizumab|mesh-list
93249096|NCT04300647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249097|NCT04300647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249098|NCT04300647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249099|NCT04300647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249100|NCT04296890|Maytansine|maytansine|mesh-list
93249101|NCT04296890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
93249102|NCT04296890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249103|NCT04296890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249104|NCT04296890|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249105|NCT04296890|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249106|NCT04296890|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249107|NCT04296890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249108|NCT04296890|Immunoconjugates|immunoconjugates|mesh-ancestor
93249109|NCT04296890|Immunologic Factors|immunologic factors|mesh-ancestor
93249110|NCT04296890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249111|NCT04284774|Tipifarnib|tipifarnib|mesh-list
93249112|NCT04284774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249113|NCT04276090|Dexamethasone|dexamethasone|mesh-list
93249114|NCT04276090|Floxuridine|floxuridine|mesh-list
93249115|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249116|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
93249117|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
93249118|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249119|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249120|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93249121|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
93249122|NCT04276090|Hormones|hormones|mesh-ancestor
93249123|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249124|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249125|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249126|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249127|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
93249128|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249129|NCT04273139|Venetoclax|venetoclax|mesh-list
93249130|NCT04273139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249131|NCT04267848|Paclitaxel|paclitaxel|mesh-list
93249132|NCT04267848|Cisplatin|cisplatin|mesh-list
93249133|NCT04267848|Carboplatin|carboplatin|mesh-list
93249134|NCT04267848|Gemcitabine|gemcitabine|mesh-list
93249135|NCT04267848|Pembrolizumab|pembrolizumab|mesh-list
93249136|NCT04267848|Pemetrexed|pemetrexed|mesh-list
93249137|NCT04267848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93249138|NCT04267848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249139|NCT04267848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249140|NCT04267848|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249141|NCT04267848|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249142|NCT04267848|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249143|NCT04267848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249144|NCT04267848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249145|NCT04267848|Antimetabolites|antimetabolites|mesh-ancestor
93249146|NCT04267848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249147|NCT04267848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249148|NCT04267848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249149|NCT04267848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93249150|NCT04267848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93249151|NCT04254107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93249152|NCT04254107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249153|NCT04254107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249154|NCT04254107|Immunotoxins|immunotoxins|mesh-ancestor
93249155|NCT04254107|Immunoconjugates|immunoconjugates|mesh-ancestor
93249156|NCT04254107|Immunologic Factors|immunologic factors|mesh-ancestor
93249157|NCT04254107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249158|NCT04216329|Temozolomide|temozolomide|mesh-list
93249159|NCT04216329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249160|NCT04216329|Alkylating Agents|alkylating agents|mesh-ancestor
93249161|NCT04216329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249162|NCT04216329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249163|NCT04214262|Atezolizumab|atezolizumab|mesh-list
93249164|NCT04214262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249165|NCT04214262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249166|NCT04214262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249167|NCT04214262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249168|NCT04214262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249169|NCT04214262|Immunologic Factors|immunologic factors|mesh-ancestor
93249170|NCT04214262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249171|NCT04195555|Ivosidenib|ivosidenib|mesh-list
93249172|NCT04195555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249173|NCT04195555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249174|NCT04195555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249175|NCT04166409|Carboplatin|carboplatin|mesh-list
93249176|NCT04166409|Vincristine|vincristine|mesh-list
93249177|NCT04166409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249178|NCT04166409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249179|NCT04166409|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249180|NCT04166409|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249181|NCT04166409|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249182|NCT04166409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249183|NCT04145115|Nivolumab|nivolumab|mesh-list
93249184|NCT04145115|Ipilimumab|ipilimumab|mesh-list
93249185|NCT04145115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249186|NCT04145115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249187|NCT04145115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249188|NCT04145115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249189|NCT04081688|Atezolizumab|atezolizumab|mesh-list
93249190|NCT04081688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249191|NCT04081688|Immunoglobulins|immunoglobulins|mesh-list
93249192|NCT04081688|Immunoglobulin G|immunoglobulin g|mesh-list
93249193|NCT04081688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249194|NCT04081688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249195|NCT04081688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249196|NCT04081688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249197|NCT04081688|Immunologic Factors|immunologic factors|mesh-ancestor
93249198|NCT04081688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249199|NCT04064814|Thioctic Acid|thioctic acid|mesh-list
93249200|NCT04064814|Flunarizine|flunarizine|mesh-list
93249201|NCT04064814|Antioxidants|antioxidants|mesh-ancestor
93249202|NCT04064814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249203|NCT04064814|Protective Agents|protective agents|mesh-ancestor
93249204|NCT04064814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249205|NCT04064814|Vitamin B Complex|vitamin b complex|mesh-ancestor
93249206|NCT04064814|Vitamins|vitamins|mesh-ancestor
93249207|NCT04064814|Micronutrients|micronutrients|mesh-ancestor
93249208|NCT04064814|Anticonvulsants|anticonvulsants|mesh-ancestor
93249209|NCT04064814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93249210|NCT04064814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93249211|NCT04064814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93249212|NCT04064814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93249213|NCT04064814|Histamine Antagonists|histamine antagonists|mesh-ancestor
93249214|NCT04064814|Histamine Agents|histamine agents|mesh-ancestor
93249215|NCT04064814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249216|NCT04064814|Vasodilator Agents|vasodilator agents|mesh-ancestor
93249217|NCT04035005|Ocrelizumab|ocrelizumab|mesh-list
93249218|NCT04035005|Immunologic Factors|immunologic factors|mesh-ancestor
93249219|NCT04035005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249220|NCT03992404|Botulinum Toxins|botulinum toxins|mesh-list
93249221|NCT03992404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93249222|NCT03992404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93249223|NCT03992404|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93249224|NCT03992404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93249225|NCT03992404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93249226|NCT03992404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249227|NCT03992404|Cholinergic Agents|cholinergic agents|mesh-ancestor
93249228|NCT03992404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249229|NCT03992404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249230|NCT03992404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93249231|NCT03992404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249232|NCT03984448|Prednisone|prednisone|mesh-list
93249233|NCT03984448|Cortisone|cortisone|mesh-list
93249234|NCT03984448|Cyclophosphamide|cyclophosphamide|mesh-list
93249235|NCT03984448|Rituximab|rituximab|mesh-list
93249236|NCT03984448|Doxorubicin|doxorubicin|mesh-list
93249237|NCT03984448|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93249238|NCT03984448|Etoposide|etoposide|mesh-list
93249239|NCT03984448|Vincristine|vincristine|mesh-list
93249240|NCT03984448|Etoposide phosphate|etoposide phosphate|mesh-list
93249241|NCT03984448|Venetoclax|venetoclax|mesh-list
93249242|NCT03984448|Podophyllotoxin|podophyllotoxin|mesh-list
93249243|NCT03984448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93249244|NCT03984448|Antibodies|antibodies|mesh-list
93249245|NCT03984448|Immunoglobulins|immunoglobulins|mesh-list
93249246|NCT03984448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249247|NCT03984448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249248|NCT03984448|Immunologic Factors|immunologic factors|mesh-ancestor
93249249|NCT03984448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249250|NCT03984448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249251|NCT03984448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249252|NCT03984448|Alkylating Agents|alkylating agents|mesh-ancestor
93249253|NCT03984448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249254|NCT03984448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249255|NCT03984448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93249256|NCT03984448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93249257|NCT03984448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93249258|NCT03984448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93249259|NCT03984448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249260|NCT03984448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249261|NCT03984448|Glucocorticoids|glucocorticoids|mesh-ancestor
93249262|NCT03984448|Hormones|hormones|mesh-ancestor
93249263|NCT03984448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249264|NCT03984448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249265|NCT03984448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249266|NCT03984448|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249267|NCT03984448|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249268|NCT03984448|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249269|NCT03984448|Keratolytic Agents|keratolytic agents|mesh-ancestor
93249270|NCT03984448|Dermatologic Agents|dermatologic agents|mesh-ancestor
93249271|NCT03972306|Ocrelizumab|ocrelizumab|mesh-list
93249272|NCT03972306|Immunologic Factors|immunologic factors|mesh-ancestor
93249273|NCT03972306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249274|NCT03970447|Temozolomide|temozolomide|mesh-list
93249275|NCT03970447|Lomustine|lomustine|mesh-list
93249276|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
93249277|NCT03970447|GDC-0084|gdc-0084|mesh-list
93249278|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249279|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
93249280|NCT03970447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249281|NCT03970447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249282|NCT03970447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249283|NCT03952585|Deoxyglucose|deoxyglucose|mesh-list
93249284|NCT03952585|Cisplatin|cisplatin|mesh-list
93249285|NCT03952585|Nivolumab|nivolumab|mesh-list
93249286|NCT03952585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93249287|NCT03952585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249288|NCT03952585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249289|NCT03952585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249290|NCT03952585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249291|NCT03952585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93249292|NCT03952585|Antimetabolites|antimetabolites|mesh-ancestor
93249293|NCT03952585|Antiviral Agents|antiviral agents|mesh-ancestor
93249294|NCT03952585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249295|NCT03930953|Rituximab|rituximab|mesh-list
93249296|NCT03930953|Obinutuzumab|obinutuzumab|mesh-list
93249297|NCT03930953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249298|NCT03930953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249299|NCT03930953|Immunologic Factors|immunologic factors|mesh-ancestor
93249300|NCT03930953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249301|NCT03930953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249302|NCT03924414|Zoledronic Acid|zoledronic acid|mesh-list
93249303|NCT03924414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93249304|NCT03924414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249305|NCT03919071|Trametinib|trametinib|mesh-list
93249306|NCT03919071|Dabrafenib|dabrafenib|mesh-list
93249307|NCT03919071|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93249308|NCT03919071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249309|NCT03919071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249310|NCT03919071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249311|NCT03919071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249312|NCT03919071|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93249313|NCT03919071|Protective Agents|protective agents|mesh-ancestor
93249314|NCT03919071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249315|NCT03919071|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93249316|NCT03919071|Antioxidants|antioxidants|mesh-ancestor
93249317|NCT03910452|Sirolimus|sirolimus|mesh-list
93249318|NCT03910452|Cyclophosphamide|cyclophosphamide|mesh-list
93249319|NCT03910452|Busulfan|busulfan|mesh-list
93249320|NCT03910452|Alemtuzumab|alemtuzumab|mesh-list
93249321|NCT03910452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249322|NCT03910452|Immunologic Factors|immunologic factors|mesh-ancestor
93249323|NCT03910452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249324|NCT03910452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249325|NCT03910452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249326|NCT03910452|Alkylating Agents|alkylating agents|mesh-ancestor
93249327|NCT03910452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249328|NCT03910452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249329|NCT03910452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93249330|NCT03910452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93249331|NCT03910452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249332|NCT03910452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93249333|NCT03910452|Antifungal Agents|antifungal agents|mesh-ancestor
93249334|NCT03910452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249335|NCT03889418|Analgesics, Opioid|analgesics, opioid|mesh-list
93249336|NCT03889418|Narcotics|narcotics|mesh-ancestor
93249337|NCT03889418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93249338|NCT03889418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249339|NCT03889418|Analgesics|analgesics|mesh-ancestor
93249340|NCT03889418|Sensory System Agents|sensory system agents|mesh-ancestor
93249341|NCT03889418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249342|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
93249343|NCT03873818|Ipilimumab|ipilimumab|mesh-list
93249344|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249345|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249346|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249347|NCT03873818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249348|NCT03871257|Carboplatin|carboplatin|mesh-list
93249349|NCT03871257|Vincristine|vincristine|mesh-list
93249350|NCT03871257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249351|NCT03871257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249352|NCT03871257|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249353|NCT03871257|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249354|NCT03871257|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249355|NCT03871257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249356|NCT03846388|Hormones|hormones|mesh-list
93249357|NCT03846388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93249358|NCT03846388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249359|NCT03846388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249360|NCT03845166|Atezolizumab|atezolizumab|mesh-list
93249361|NCT03845166|Avelumab|avelumab|mesh-list
93249362|NCT03845166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249363|NCT03845166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249364|NCT03845166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249365|NCT03845166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249366|NCT03816345|Nivolumab|nivolumab|mesh-list
93249367|NCT03816345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249368|NCT03816345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249369|NCT03816345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249370|NCT03816345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249371|NCT03793179|Carboplatin|carboplatin|mesh-list
93249372|NCT03793179|Pembrolizumab|pembrolizumab|mesh-list
93249373|NCT03793179|Pemetrexed|pemetrexed|mesh-list
93249374|NCT03793179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249375|NCT03793179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249376|NCT03793179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249377|NCT03793179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249378|NCT03793179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249379|NCT03793179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93249380|NCT03793179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93249381|NCT03793166|Nivolumab|nivolumab|mesh-list
93249382|NCT03793166|Ipilimumab|ipilimumab|mesh-list
93249383|NCT03793166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249384|NCT03793166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249385|NCT03793166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249386|NCT03793166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249388|NCT03789240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249389|NCT03789240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249390|NCT03789240|Immunologic Factors|immunologic factors|mesh-ancestor
93249391|NCT03789240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249392|NCT03789240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249393|NCT03773107|Dexamethasone|dexamethasone|mesh-list
93249394|NCT03773107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249395|NCT03773107|Antiemetics|antiemetics|mesh-ancestor
93249396|NCT03773107|Autonomic Agents|autonomic agents|mesh-ancestor
93249397|NCT03773107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249398|NCT03773107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249399|NCT03773107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93249400|NCT03773107|Glucocorticoids|glucocorticoids|mesh-ancestor
93249401|NCT03773107|Hormones|hormones|mesh-ancestor
93249402|NCT03773107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249403|NCT03773107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249404|NCT03773107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249405|NCT03714828|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93249406|NCT03714828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249407|NCT03714828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249408|NCT03712605|Pembrolizumab|pembrolizumab|mesh-list
93249409|NCT03712605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249410|NCT03712605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249411|NCT03712605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249412|NCT03712605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249413|NCT03701308|Cytarabine|cytarabine|mesh-list
93249414|NCT03701308|Daunorubicin|daunorubicin|mesh-list
93249415|NCT03701308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249416|NCT03701308|Antimetabolites|antimetabolites|mesh-ancestor
93249417|NCT03701308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249418|NCT03701308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249419|NCT03701308|Antiviral Agents|antiviral agents|mesh-ancestor
93249420|NCT03701308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249421|NCT03701308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249422|NCT03701308|Immunologic Factors|immunologic factors|mesh-ancestor
93249423|NCT03701308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249424|NCT03701308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93249425|NCT03701308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93249426|NCT03701308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93249427|NCT03701308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249428|NCT03675815|Ritonavir|ritonavir|mesh-list
93249429|NCT03675815|Darunavir|darunavir|mesh-list
93249430|NCT03675815|Tenofovir|tenofovir|mesh-list
93249431|NCT03675815|Lamivudine|lamivudine|mesh-list
93249432|NCT03675815|Emtricitabine|emtricitabine|mesh-list
93249433|NCT03675815|Dolutegravir|dolutegravir|mesh-list
93249434|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93249435|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93249436|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93249437|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
93249438|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249439|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249440|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93249441|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93249442|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
93249443|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249444|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93249445|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93249446|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93249447|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93249448|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93249449|NCT03672695|Venetoclax|venetoclax|mesh-list
93249450|NCT03672695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249451|NCT03669133|Vitamin E|vitamin e|mesh-list
93249452|NCT03669133|Vitamins|vitamins|mesh-ancestor
93249453|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
93249454|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249455|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
93249456|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249457|NCT03669133|Protective Agents|protective agents|mesh-ancestor
93249458|NCT03647969|Nivolumab|nivolumab|mesh-list
93249459|NCT03647969|Ipilimumab|ipilimumab|mesh-list
93249460|NCT03647969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249461|NCT03647969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249462|NCT03647969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249463|NCT03647969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249464|NCT03644186|Paclitaxel|paclitaxel|mesh-list
93249465|NCT03644186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93249466|NCT03644186|Trastuzumab|trastuzumab|mesh-list
93249467|NCT03644186|Letrozole|letrozole|mesh-list
93249468|NCT03644186|Palbociclib|palbociclib|mesh-list
93249469|NCT03644186|Pertuzumab|pertuzumab|mesh-list
93249470|NCT03644186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249471|NCT03644186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249472|NCT03644186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249473|NCT03644186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249474|NCT03644186|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249475|NCT03644186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249476|NCT03644186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249477|NCT03644186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93249478|NCT03644186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93249479|NCT03644186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249480|NCT03644186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93249481|NCT03644186|Hormone Antagonists|hormone antagonists|mesh-ancestor
93249482|NCT03644186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249483|NCT03644186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249484|NCT03644186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249485|NCT03593759|Prednisone|prednisone|mesh-list
93249486|NCT03593759|Prednisolone|prednisolone|mesh-list
93249487|NCT03593759|Methotrexate|methotrexate|mesh-list
93249488|NCT03593759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249489|NCT03593759|Glucocorticoids|glucocorticoids|mesh-ancestor
93249490|NCT03593759|Hormones|hormones|mesh-ancestor
93249491|NCT03593759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249492|NCT03593759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249493|NCT03593759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249494|NCT03593759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249495|NCT03593759|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93249496|NCT03593759|Abortifacient Agents|abortifacient agents|mesh-ancestor
93249497|NCT03593759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93249498|NCT03593759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249499|NCT03593759|Antimetabolites|antimetabolites|mesh-ancestor
93249500|NCT03593759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249501|NCT03593759|Dermatologic Agents|dermatologic agents|mesh-ancestor
93249502|NCT03593759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249503|NCT03593759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93249504|NCT03593759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249505|NCT03593759|Immunologic Factors|immunologic factors|mesh-ancestor
93249506|NCT03593759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249507|NCT03593759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93249508|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93249509|NCT03548155|Antipsychotic Agents|antipsychotic agents|mesh-list
93249510|NCT03548155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93249511|NCT03548155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93249512|NCT03548155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249513|NCT03548155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93249514|NCT03457701|Iron|iron|mesh-list
93249515|NCT03457701|Trace Elements|trace elements|mesh-ancestor
93249516|NCT03457701|Micronutrients|micronutrients|mesh-ancestor
93249517|NCT03457701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249518|NCT03457142|Dexamethasone|dexamethasone|mesh-list
93249519|NCT03457142|Dexamethasone acetate|dexamethasone acetate|mesh-list
93249520|NCT03457142|Abatacept|abatacept|mesh-list
93249521|NCT03457142|Ixazomib|ixazomib|mesh-list
93249522|NCT03457142|Ichthammol|ichthammol|mesh-list
93249523|NCT03457142|BB 1101|bb 1101|mesh-list
93249524|NCT03457142|Glycine|glycine|mesh-list
93249525|NCT03457142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249526|NCT03457142|Antiemetics|antiemetics|mesh-ancestor
93249527|NCT03457142|Autonomic Agents|autonomic agents|mesh-ancestor
93249528|NCT03457142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249529|NCT03457142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249530|NCT03457142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93249531|NCT03457142|Glucocorticoids|glucocorticoids|mesh-ancestor
93249532|NCT03457142|Hormones|hormones|mesh-ancestor
93249533|NCT03457142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249534|NCT03457142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249535|NCT03457142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249536|NCT03457142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249537|NCT03457142|Protease Inhibitors|protease inhibitors|mesh-ancestor
93249538|NCT03457142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249539|NCT03457142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249540|NCT03457142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249541|NCT03457142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544134|NCT02984384|Tinzaparin|tinzaparin|mesh-list
93249542|NCT03457142|Immunologic Factors|immunologic factors|mesh-ancestor
93249543|NCT03457142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249544|NCT03457142|Dermatologic Agents|dermatologic agents|mesh-ancestor
93249546|NCT03457142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249547|NCT03370406|Fluorouracil|fluorouracil|mesh-list
93249548|NCT03370406|Imiquimod|imiquimod|mesh-list
93249549|NCT03370406|Antimetabolites|antimetabolites|mesh-ancestor
93249550|NCT03370406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249551|NCT03370406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249552|NCT03370406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249553|NCT03370406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249554|NCT03370406|Immunologic Factors|immunologic factors|mesh-ancestor
93249555|NCT03370406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249556|NCT03370406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93249557|NCT03370406|Interferon Inducers|interferon inducers|mesh-ancestor
93249558|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
93249559|NCT03347292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249560|NCT03347292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249561|NCT03347292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249562|NCT03347292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249563|NCT03317405|Tamoxifen|tamoxifen|mesh-list
93249564|NCT03317405|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93249565|NCT03317405|Hormone Antagonists|hormone antagonists|mesh-ancestor
93249566|NCT03317405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249567|NCT03317405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249568|NCT03317405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249569|NCT03317405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249570|NCT03317405|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93249571|NCT03317405|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93249572|NCT03317405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93249573|NCT03213652|Ensartinib|ensartinib|mesh-list
93249574|NCT03213652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249575|NCT03213652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249576|NCT03213652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249577|NCT03213652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249578|NCT03198650|Obinutuzumab|obinutuzumab|mesh-list
93249579|NCT03198650|Acalabrutinib|acalabrutinib|mesh-list
93249580|NCT03198650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249581|NCT03198650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249582|NCT03182426|Liraglutide|liraglutide|mesh-list
93249583|NCT03182426|Plerixafor|plerixafor|mesh-list
93249584|NCT03182426|Etanercept|etanercept|mesh-list
93249585|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
93249586|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93249587|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93249588|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249589|NCT03182426|Incretins|incretins|mesh-ancestor
93249590|NCT03182426|Hormones|hormones|mesh-ancestor
93249591|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249592|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93249593|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93249594|NCT03182426|Analgesics|analgesics|mesh-ancestor
93249595|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
93249596|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249597|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249598|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249599|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93249600|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249601|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
93249602|NCT03182426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249603|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249604|NCT03182426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93249605|NCT03182426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93249606|NCT03182426|Antiviral Agents|antiviral agents|mesh-ancestor
93249607|NCT03182426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249608|NCT03161379|Cyclophosphamide|cyclophosphamide|mesh-list
93249609|NCT03161379|Nivolumab|nivolumab|mesh-list
93249610|NCT03161379|Pancrelipase|pancrelipase|mesh-list
93249611|NCT03161379|Vaccines|vaccines|mesh-list
93249612|NCT03161379|Immunologic Factors|immunologic factors|mesh-ancestor
93249613|NCT03161379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249614|NCT03161379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249615|NCT03161379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249616|NCT03161379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249617|NCT03161379|Alkylating Agents|alkylating agents|mesh-ancestor
93249618|NCT03161379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249619|NCT03161379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249620|NCT03161379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93249621|NCT03161379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249622|NCT03161379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249623|NCT03161379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93249625|NCT03155620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93249626|NCT03155620|Palbociclib|palbociclib|mesh-list
93249627|NCT03155620|Vemurafenib|vemurafenib|mesh-list
93249628|NCT03155620|Tipifarnib|tipifarnib|mesh-list
93249629|NCT03155620|Ensartinib|ensartinib|mesh-list
93249630|NCT03155620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249631|NCT03155620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249632|NCT03155620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249633|NCT03155620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249634|NCT03141359|Paclitaxel|paclitaxel|mesh-list
93249635|NCT03141359|Etoposide|etoposide|mesh-list
93249636|NCT03141359|Carboplatin|carboplatin|mesh-list
93249637|NCT03141359|Durvalumab|durvalumab|mesh-list
93249638|NCT03141359|Cisplatin|cisplatin|mesh-list
93249639|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249640|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249641|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249642|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249643|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249644|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249645|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93249646|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93249647|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249648|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249649|NCT03131037|Valacyclovir|valacyclovir|mesh-list
93249650|NCT03131037|Antiviral Agents|antiviral agents|mesh-ancestor
93249651|NCT03131037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249652|NCT03109288|Pioglitazone|pioglitazone|mesh-list
93249653|NCT03109288|Clemastine|clemastine|mesh-list
93249654|NCT03109288|Pirfenidone|pirfenidone|mesh-list
93249655|NCT03109288|Dantrolene|dantrolene|mesh-list
93249656|NCT03109288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93249657|NCT03109288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249658|NCT03109288|Analgesics|analgesics|mesh-ancestor
93249659|NCT03109288|Sensory System Agents|sensory system agents|mesh-ancestor
93249660|NCT03109288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249661|NCT03109288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93249662|NCT03109288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93249663|NCT03109288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249664|NCT03109288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249665|NCT03109288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249666|NCT03109288|Antipruritics|antipruritics|mesh-ancestor
93249667|NCT03109288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93249668|NCT03109288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93249669|NCT03109288|Histamine Antagonists|histamine antagonists|mesh-ancestor
93249670|NCT03109288|Histamine Agents|histamine agents|mesh-ancestor
93249671|NCT03109288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249672|NCT03109288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249673|NCT03109288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93249674|NCT03109288|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93249675|NCT03109288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93249676|NCT03078946|Midazolam|midazolam|mesh-list
93249677|NCT03078946|Dexmedetomidine|dexmedetomidine|mesh-list
93249678|NCT03078946|Morphine|morphine|mesh-list
93249679|NCT03078946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93249680|NCT03078946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93249681|NCT03078946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249682|NCT03078946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93249683|NCT03078946|Analgesics|analgesics|mesh-ancestor
93249684|NCT03078946|Sensory System Agents|sensory system agents|mesh-ancestor
93249685|NCT03078946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249686|NCT03078946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93249687|NCT03078946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93249688|NCT03078946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93249689|NCT03078946|Adrenergic Agents|adrenergic agents|mesh-ancestor
93249690|NCT03078946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249691|NCT03078946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249692|NCT03078946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93249693|NCT03078946|Narcotics|narcotics|mesh-ancestor
93249694|NCT03078946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93249695|NCT03078946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93249696|NCT03078946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93249697|NCT03078946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93249698|NCT03078946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93249699|NCT03078946|Anesthetics, General|anesthetics, general|mesh-ancestor
93249700|NCT03078946|Anesthetics|anesthetics|mesh-ancestor
93249701|NCT03078946|GABA Modulators|gaba modulators|mesh-ancestor
93249702|NCT03078946|GABA Agents|gaba agents|mesh-ancestor
93249703|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
93249704|NCT03071861|Hematinics|hematinics|mesh-ancestor
93249706|NCT02997228|Bevacizumab|bevacizumab|mesh-list
93249707|NCT02997228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93249708|NCT02997228|Atezolizumab|atezolizumab|mesh-list
93249709|NCT02997228|Fluorouracil|fluorouracil|mesh-list
93249710|NCT02997228|Oxaliplatin|oxaliplatin|mesh-list
93249711|NCT02997228|Endothelial Growth Factors|endothelial growth factors|mesh-list
93249712|NCT02997228|Antibodies|antibodies|mesh-list
93249713|NCT02997228|Immunoglobulins|immunoglobulins|mesh-list
93249714|NCT02997228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249715|NCT02997228|Immunoglobulin G|immunoglobulin g|mesh-list
93249716|NCT02997228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249717|NCT02997228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93249718|NCT02997228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93249719|NCT02997228|Growth Substances|growth substances|mesh-ancestor
93249720|NCT02997228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249721|NCT02997228|Growth Inhibitors|growth inhibitors|mesh-ancestor
93249722|NCT02997228|Immunologic Factors|immunologic factors|mesh-ancestor
93249723|NCT02997228|Antimetabolites|antimetabolites|mesh-ancestor
93249724|NCT02997228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249725|NCT02997228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249726|NCT02997228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249727|NCT02997228|Antidotes|antidotes|mesh-ancestor
93249728|NCT02997228|Protective Agents|protective agents|mesh-ancestor
93249729|NCT02997228|Vitamin B Complex|vitamin b complex|mesh-ancestor
93249730|NCT02997228|Vitamins|vitamins|mesh-ancestor
93249731|NCT02997228|Micronutrients|micronutrients|mesh-ancestor
93249732|NCT02997228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249733|NCT02974621|Bevacizumab|bevacizumab|mesh-list
93249734|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93249735|NCT02974621|Olaparib|olaparib|mesh-list
93249736|NCT02974621|Cediranib|cediranib|mesh-list
93249737|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
93249738|NCT02974621|Antibodies|antibodies|mesh-list
93249739|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
93249740|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249741|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
93249742|NCT02974621|Maleic acid|maleic acid|mesh-list
93249743|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249744|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93249745|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93249746|NCT02974621|Growth Substances|growth substances|mesh-ancestor
93249747|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249748|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
93249749|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
93249750|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249751|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93249752|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249753|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249754|NCT02970448|Temozolomide|temozolomide|mesh-list
93249755|NCT02970448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249756|NCT02970448|Alkylating Agents|alkylating agents|mesh-ancestor
93249757|NCT02970448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249758|NCT02970448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249759|NCT02875223|Itraconazole|itraconazole|mesh-list
93249760|NCT02875223|Rifampin|rifampin|mesh-list
93249761|NCT02875223|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
93249762|NCT02875223|Antifungal Agents|antifungal agents|mesh-ancestor
93249763|NCT02875223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249764|NCT02875223|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93249765|NCT02875223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93249766|NCT02875223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249767|NCT02875223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249768|NCT02875223|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93249769|NCT02875223|Hormone Antagonists|hormone antagonists|mesh-ancestor
93249770|NCT02875223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249771|NCT02875223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249772|NCT02875223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93249773|NCT02875223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93249774|NCT02875223|Antitubercular Agents|antitubercular agents|mesh-ancestor
93249775|NCT02875223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93249776|NCT02875223|Leprostatic Agents|leprostatic agents|mesh-ancestor
93249777|NCT02875223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93249778|NCT02875223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93249779|NCT02875223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93249780|NCT02875223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93249781|NCT02875223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93249782|NCT02875223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93249783|NCT02875223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93249784|NCT02875223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249785|NCT02759835|Osimertinib|osimertinib|mesh-list
93249786|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249787|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249788|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249789|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249790|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93249791|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93249792|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249793|NCT02694978|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93249794|NCT02694978|Hematinics|hematinics|mesh-ancestor
93249795|NCT02694978|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93249796|NCT02694978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93249797|NCT02693535|Pembrolizumab|pembrolizumab|mesh-list
93249798|NCT02693535|Nivolumab|nivolumab|mesh-list
93249799|NCT02693535|Trastuzumab|trastuzumab|mesh-list
93249800|NCT02693535|Ipilimumab|ipilimumab|mesh-list
93249801|NCT02693535|Atezolizumab|atezolizumab|mesh-list
93249802|NCT02693535|Pertuzumab|pertuzumab|mesh-list
93249803|NCT02693535|Sunitinib|sunitinib|mesh-list
93249804|NCT02693535|Olaparib|olaparib|mesh-list
93249805|NCT02693535|Palbociclib|palbociclib|mesh-list
93249806|NCT02693535|Temsirolimus|temsirolimus|mesh-list
93249807|NCT02693535|Vemurafenib|vemurafenib|mesh-list
93249808|NCT02693535|Talazoparib|talazoparib|mesh-list
93249809|NCT02693535|Tucatinib|tucatinib|mesh-list
93249810|NCT02693535|Futibatinib|futibatinib|mesh-list
93249811|NCT02693535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93249812|NCT02693535|Entrectinib|entrectinib|mesh-list
93249813|NCT02693535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249814|NCT02693535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249815|NCT02693535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93092432|NCT00051636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249816|NCT02693535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249817|NCT02693535|Immunologic Factors|immunologic factors|mesh-ancestor
93249818|NCT02693535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249819|NCT02693535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93249820|NCT02693535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93249821|NCT02693535|Growth Substances|growth substances|mesh-ancestor
93249822|NCT02693535|Growth Inhibitors|growth inhibitors|mesh-ancestor
93249823|NCT02693535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249824|NCT02693535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249825|NCT02693535|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93249826|NCT02693535|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93249827|NCT02693535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249828|NCT02663518|Rituximab|rituximab|mesh-list
93249829|NCT02663518|Nivolumab|nivolumab|mesh-list
93249830|NCT02663518|Immunoglobulin G|immunoglobulin g|mesh-list
93249831|NCT02663518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249832|NCT02663518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249833|NCT02663518|Immunologic Factors|immunologic factors|mesh-ancestor
93249834|NCT02663518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249835|NCT02663518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249836|NCT02663518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249837|NCT02663518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249838|NCT02639273|Nalmefene|nalmefene|mesh-list
93249839|NCT02639273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93249840|NCT02639273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249841|NCT02639273|Sensory System Agents|sensory system agents|mesh-ancestor
93249842|NCT02639273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249843|NCT02563002|Bevacizumab|bevacizumab|mesh-list
92921754|NCT00729651|Calcium|calcium|mesh-list
93249844|NCT02563002|Pembrolizumab|pembrolizumab|mesh-list
93249846|NCT02563002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249847|NCT02563002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249848|NCT02563002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93249849|NCT02563002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93249850|NCT02563002|Growth Substances|growth substances|mesh-ancestor
93249851|NCT02563002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249852|NCT02563002|Growth Inhibitors|growth inhibitors|mesh-ancestor
93249853|NCT02563002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249854|NCT02563002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249855|NCT02531126|Ozanimod|ozanimod|mesh-list
93249856|NCT02531126|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93249857|NCT02531126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249858|NCT02531126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249859|NCT02531126|Immunologic Factors|immunologic factors|mesh-ancestor
93249860|NCT02531126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249861|NCT02511028|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93249862|NCT02511028|Hematinics|hematinics|mesh-ancestor
93249863|NCT02511028|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93249864|NCT02511028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93249865|NCT02454933|Durvalumab|durvalumab|mesh-list
93249866|NCT02454933|Osimertinib|osimertinib|mesh-list
93249867|NCT02454933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249868|NCT02454933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249869|NCT02454933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249870|NCT02454933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249871|NCT02454933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249872|NCT02430480|Goserelin|goserelin|mesh-list
93249873|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249874|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249875|NCT02359565|Pembrolizumab|pembrolizumab|mesh-list
93249876|NCT02359565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249877|NCT02359565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249878|NCT02359565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249879|NCT02359565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249880|NCT02211755|Bortezomib|bortezomib|mesh-list
93249881|NCT02211755|Clofarabine|clofarabine|mesh-list
93249882|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249883|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249884|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
93249885|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249886|NCT02207439|Nelfinavir|nelfinavir|mesh-list
93249887|NCT02207439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93249888|NCT02207439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93249889|NCT02207439|Protease Inhibitors|protease inhibitors|mesh-ancestor
93249890|NCT02207439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249891|NCT02207439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249892|NCT02207439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93249893|NCT02207439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93249894|NCT02207439|Antiviral Agents|antiviral agents|mesh-ancestor
93249895|NCT02207439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249896|NCT02194738|Paclitaxel|paclitaxel|mesh-list
93249897|NCT02194738|Cisplatin|cisplatin|mesh-list
93249898|NCT02194738|Carboplatin|carboplatin|mesh-list
93249899|NCT02194738|Gemcitabine|gemcitabine|mesh-list
93249900|NCT02194738|Pembrolizumab|pembrolizumab|mesh-list
93249901|NCT02194738|Nivolumab|nivolumab|mesh-list
93249902|NCT02194738|Pemetrexed|pemetrexed|mesh-list
93249903|NCT02194738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93249904|NCT02194738|Crizotinib|crizotinib|mesh-list
93249905|NCT02194738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93249906|NCT02194738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249907|NCT02194738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249908|NCT02194738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249909|NCT02194738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249910|NCT02194738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249911|NCT02194738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249912|NCT02194738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93249913|NCT02194738|Antimetabolites|antimetabolites|mesh-ancestor
93249914|NCT02194738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249915|NCT02194738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93249916|NCT02194738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249917|NCT02194738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93249918|NCT02194738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93249919|NCT02194738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93249920|NCT02015013|Plerixafor|plerixafor|mesh-list
93249921|NCT02015013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93249922|NCT02015013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93249923|NCT02015013|Antiviral Agents|antiviral agents|mesh-ancestor
93249924|NCT02015013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93249925|NCT01983241|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93249926|NCT01983241|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93249927|NCT01983241|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93249928|NCT01983241|Protease Inhibitors|protease inhibitors|mesh-ancestor
93249929|NCT01983241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249930|NCT01983241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249931|NCT01906814|Carboplatin|carboplatin|mesh-list
93249932|NCT01906814|Etoposide|etoposide|mesh-list
93249933|NCT01906814|Etoposide phosphate|etoposide phosphate|mesh-list
93249934|NCT01906814|Vincristine|vincristine|mesh-list
93249935|NCT01906814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249936|NCT01906814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249937|NCT01906814|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93249938|NCT01906814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93249939|NCT01906814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249940|NCT01906814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249941|NCT01906814|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249942|NCT01906814|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249943|NCT01906814|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249944|NCT01864018|Dexamethasone|dexamethasone|mesh-list
93249945|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
93249946|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
93249947|NCT01864018|Ixazomib|ixazomib|mesh-list
93249948|NCT01864018|Ichthammol|ichthammol|mesh-list
93249949|NCT01864018|BB 1101|bb 1101|mesh-list
93249950|NCT01864018|Glycine|glycine|mesh-list
93249951|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249952|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
93249953|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249954|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249955|NCT01864018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249956|NCT01864018|Alkylating Agents|alkylating agents|mesh-ancestor
93249957|NCT01864018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249958|NCT01864018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249959|NCT01864018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93249960|NCT01864018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93249961|NCT01864018|Antiemetics|antiemetics|mesh-ancestor
93249962|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
93249963|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93249964|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93249965|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
93249966|NCT01864018|Hormones|hormones|mesh-ancestor
93249967|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93249968|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93249969|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
92544566|NCT00035295|Antiemetics|antiemetics|mesh-ancestor
93249970|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93249971|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
93249972|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
93249973|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93249974|NCT01842386|Rituximab|rituximab|mesh-list
93249975|NCT01842386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93249976|NCT01842386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249977|NCT01842386|Immunologic Factors|immunologic factors|mesh-ancestor
93249978|NCT01842386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249979|NCT01842386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249980|NCT01796197|Paclitaxel|paclitaxel|mesh-list
93249981|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
93249982|NCT01796197|Doxorubicin|doxorubicin|mesh-list
93249983|NCT01796197|Trastuzumab|trastuzumab|mesh-list
93249984|NCT01796197|Pertuzumab|pertuzumab|mesh-list
93249985|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93249986|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93249987|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
93249988|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
93249989|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
93249990|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93249991|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93249992|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
93249993|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93249994|NCT01796197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93249995|NCT01796197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93249996|NCT01796197|Alkylating Agents|alkylating agents|mesh-ancestor
93249997|NCT01796197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93249998|NCT01796197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93249999|NCT01796197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93250000|NCT01796197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93250001|NCT01796197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250002|NCT01796197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250003|NCT01712620|Spironolactone|spironolactone|mesh-list
93250004|NCT01712620|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93250005|NCT01712620|Hormone Antagonists|hormone antagonists|mesh-ancestor
93250006|NCT01712620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250007|NCT01712620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250008|NCT01712620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93250009|NCT01712620|Diuretics|diuretics|mesh-ancestor
93250010|NCT01712620|Natriuretic Agents|natriuretic agents|mesh-ancestor
93250011|NCT01689766|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
93250012|NCT01689766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93250013|NCT01689766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250014|NCT01631617|Doxycycline|doxycycline|mesh-list
93250015|NCT01631617|Cephalexin|cephalexin|mesh-list
93250016|NCT01631617|Trimethoprim|trimethoprim|mesh-list
93250017|NCT01631617|Sulfamethoxazole|sulfamethoxazole|mesh-list
93250018|NCT01631617|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93250020|NCT01631617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93250021|NCT01631617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250022|NCT01631617|Antimalarials|antimalarials|mesh-ancestor
93250023|NCT01631617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93250024|NCT01631617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93250025|NCT01631617|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93250026|NCT01631617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93250027|NCT01631617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250028|NCT01631617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250029|NCT01631617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93250030|NCT01631617|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93250031|NCT01631617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93250032|NCT01631617|Disinfectants|disinfectants|mesh-ancestor
93250033|NCT01572506|Biotin|biotin|mesh-list
93250034|NCT01572506|Vitamin B Complex|vitamin b complex|mesh-ancestor
93250035|NCT01572506|Vitamins|vitamins|mesh-ancestor
93250036|NCT01572506|Micronutrients|micronutrients|mesh-ancestor
93250037|NCT01572506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250038|NCT01553214|Dexamethasone|dexamethasone|mesh-list
93250039|NCT01553214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250040|NCT01553214|Antiemetics|antiemetics|mesh-ancestor
93250041|NCT01553214|Autonomic Agents|autonomic agents|mesh-ancestor
93250042|NCT01553214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250043|NCT01553214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250044|NCT01553214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250045|NCT01553214|Glucocorticoids|glucocorticoids|mesh-ancestor
93250046|NCT01553214|Hormones|hormones|mesh-ancestor
93250047|NCT01553214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250048|NCT01553214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93250049|NCT01553214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250050|NCT01445509|Bevacizumab|bevacizumab|mesh-list
93250051|NCT01445509|Dasatinib|dasatinib|mesh-list
93250052|NCT01445509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250053|NCT01445509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250054|NCT01445509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250055|NCT01445509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250056|NCT01445509|Growth Substances|growth substances|mesh-ancestor
93250057|NCT01445509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250058|NCT01445509|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250059|NCT01445509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93250060|NCT01445509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250061|NCT01445509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250062|NCT01352962|Carboplatin|carboplatin|mesh-list
93250063|NCT01352962|Gemcitabine|gemcitabine|mesh-list
93250064|NCT01352962|Lenalidomide|lenalidomide|mesh-list
93250065|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250066|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93250067|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
93250068|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250069|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
93250070|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250071|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250072|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250073|NCT01352962|Growth Substances|growth substances|mesh-ancestor
93250074|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250075|NCT01205048|Lidocaine|lidocaine|mesh-list
93250076|NCT01205048|Anesthetics, Local|anesthetics, local|mesh-ancestor
93250077|NCT01205048|Anesthetics|anesthetics|mesh-ancestor
93250078|NCT01205048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250079|NCT01205048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250080|NCT01205048|Sensory System Agents|sensory system agents|mesh-ancestor
93250081|NCT01205048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250082|NCT01205048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93250083|NCT01205048|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93250084|NCT01205048|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93250085|NCT01205048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93250086|NCT01205048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250087|NCT01052779|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93250088|NCT01052779|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93250089|NCT01052779|Hematinics|hematinics|mesh-ancestor
93250090|NCT01052779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93250091|NCT01052779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93250092|NCT00862433|Vitamins|vitamins|mesh-list
93250093|NCT00862433|Vitamin E|vitamin e|mesh-list
93250094|NCT00862433|Tocopherols|tocopherols|mesh-list
93250095|NCT00862433|Tocotrienols|tocotrienols|mesh-list
93250096|NCT00862433|alpha-Tocopherol|alpha-tocopherol|mesh-list
93250097|NCT00862433|Micronutrients|micronutrients|mesh-ancestor
93250098|NCT00862433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250099|NCT00862433|Antioxidants|antioxidants|mesh-ancestor
93250100|NCT00862433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250101|NCT00862433|Protective Agents|protective agents|mesh-ancestor
93250102|NCT00785525|Lenograstim|lenograstim|mesh-list
93250103|NCT00785525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93250104|NCT00785525|Immunologic Factors|immunologic factors|mesh-ancestor
93250105|NCT00785525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250106|NCT00781612|Paclitaxel|paclitaxel|mesh-list
93250107|NCT00781612|Maytansine|maytansine|mesh-list
93250108|NCT00781612|Docetaxel|docetaxel|mesh-list
93250109|NCT00781612|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93250110|NCT00781612|Trastuzumab|trastuzumab|mesh-list
93250111|NCT00781612|Atezolizumab|atezolizumab|mesh-list
93250112|NCT00781612|Pertuzumab|pertuzumab|mesh-list
93250113|NCT00781612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93250114|NCT00781612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250115|NCT00781612|Tubulin Modulators|tubulin modulators|mesh-ancestor
93250116|NCT00781612|Antimitotic Agents|antimitotic agents|mesh-ancestor
93250117|NCT00781612|Mitosis Modulators|mitosis modulators|mesh-ancestor
93250118|NCT00781612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250119|NCT00781612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250120|NCT00781612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93250121|NCT00781612|Immunotoxins|immunotoxins|mesh-ancestor
93250122|NCT00781612|Immunoconjugates|immunoconjugates|mesh-ancestor
93250123|NCT00781612|Immunologic Factors|immunologic factors|mesh-ancestor
93250124|NCT00781612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250125|NCT00720785|Bortezomib|bortezomib|mesh-list
93250126|NCT00720785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250127|NCT00591370|Temozolomide|temozolomide|mesh-list
93250128|NCT00591370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93250129|NCT00591370|Alkylating Agents|alkylating agents|mesh-ancestor
93250130|NCT00591370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250131|NCT00591370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250132|NCT00389610|Pancrelipase|pancrelipase|mesh-list
93250133|NCT00389610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250134|NCT00097474|Hydrocortisone|hydrocortisone|mesh-list
93250135|NCT00097474|Melatonin|melatonin|mesh-list
93250136|NCT00097474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250137|NCT00097474|Antioxidants|antioxidants|mesh-ancestor
93250138|NCT00097474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250139|NCT00097474|Protective Agents|protective agents|mesh-ancestor
93250140|NCT00097474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250141|NCT00097474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250142|NCT00092222|Interferons|interferons|mesh-list
93250143|NCT00092222|Interferon-alpha|interferon-alpha|mesh-list
93250144|NCT00092222|Zidovudine|zidovudine|mesh-list
93250145|NCT00092222|Valganciclovir|valganciclovir|mesh-list
93250146|NCT00092222|Sirolimus|sirolimus|mesh-list
93250147|NCT00092222|Prednisone|prednisone|mesh-list
92922059|NCT02605460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93250148|NCT00092222|Cyclophosphamide|cyclophosphamide|mesh-list
93250149|NCT00092222|Rituximab|rituximab|mesh-list
93250150|NCT00092222|Doxorubicin|doxorubicin|mesh-list
93250151|NCT00092222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93250152|NCT00092222|Etoposide|etoposide|mesh-list
93250153|NCT00092222|Vincristine|vincristine|mesh-list
93250154|NCT00092222|Bortezomib|bortezomib|mesh-list
93250155|NCT00092222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250156|NCT00092222|Immunologic Factors|immunologic factors|mesh-ancestor
93250157|NCT00092222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250158|NCT00092222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250159|NCT00092222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93250160|NCT00092222|Alkylating Agents|alkylating agents|mesh-ancestor
93250161|NCT00092222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250162|NCT00092222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250163|NCT00092222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93250164|NCT00092222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250165|NCT00092222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93250166|NCT00092222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93250167|NCT00092222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93250168|NCT00092222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250169|NCT00092222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250170|NCT00092222|Glucocorticoids|glucocorticoids|mesh-ancestor
93250171|NCT00092222|Hormones|hormones|mesh-ancestor
93250172|NCT00092222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250173|NCT00092222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93250174|NCT00092222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93250175|NCT00092222|Antiviral Agents|antiviral agents|mesh-ancestor
93250176|NCT00092222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250177|NCT00092222|Tubulin Modulators|tubulin modulators|mesh-ancestor
93250178|NCT00092222|Antimitotic Agents|antimitotic agents|mesh-ancestor
93250179|NCT00092222|Mitosis Modulators|mitosis modulators|mesh-ancestor
93250180|NCT00092222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93250181|NCT00092222|Antifungal Agents|antifungal agents|mesh-ancestor
93250182|NCT00092222|Antimetabolites|antimetabolites|mesh-ancestor
93250183|NCT00092222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93250184|NCT00092222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93250185|NCT00092222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93250186|NCT00092222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93250187|NCT00065676|Quercetin|quercetin|mesh-list
93250188|NCT00065676|Antioxidants|antioxidants|mesh-ancestor
93250189|NCT00065676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250190|NCT00065676|Protective Agents|protective agents|mesh-ancestor
93250191|NCT00065676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250192|NCT00025935|Lithium Carbonate|lithium carbonate|mesh-list
93250193|NCT00025935|Antidepressive Agents|antidepressive agents|mesh-ancestor
93250194|NCT00025935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93250195|NCT00025935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250196|NCT00025935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250197|NCT00025935|Antimanic Agents|antimanic agents|mesh-ancestor
93250198|NCT00025935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93250199|NCT00025935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250200|NCT00025935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250201|NCT00024622|Levodopa|levodopa|mesh-list
93250202|NCT00024622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93250203|NCT00024622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93250204|NCT00024622|Dopamine Agents|dopamine agents|mesh-ancestor
93250205|NCT00024622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250206|NCT00024622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250207|NCT00024622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250208|NCT00006421|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93250209|NCT00006421|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93250210|NCT00006421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250211|NCT00001481|Estradiol|estradiol|mesh-list
93250212|NCT00001481|Progesterone|progesterone|mesh-list
93250213|NCT00001481|Estrogens|estrogens|mesh-ancestor
93250214|NCT00001481|Hormones|hormones|mesh-ancestor
93250215|NCT00001481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250216|NCT00001481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250217|NCT00001481|Progestins|progestins|mesh-ancestor
93250218|NCT00001379|Interferons|interferons|mesh-list
93250219|NCT00001379|Rituximab|rituximab|mesh-list
93250220|NCT00001379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250221|NCT00001379|Antiviral Agents|antiviral agents|mesh-ancestor
93250222|NCT00001379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922133|NCT04025840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250223|NCT00001379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250224|NCT00001379|Immunologic Factors|immunologic factors|mesh-ancestor
93250225|NCT00001379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250226|NCT00001379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250228|NCT00001230|Filaricides|filaricides|mesh-ancestor
93250229|NCT00001230|Antinematodal Agents|antinematodal agents|mesh-ancestor
93250230|NCT00001230|Anthelmintics|anthelmintics|mesh-ancestor
93250231|NCT00001230|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93250232|NCT00001230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250233|NCT00001230|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93250234|NCT00001230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250235|NCT00001230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250236|NCT03064763|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93250237|NCT03064763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250238|NCT03064763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250239|NCT02782676|Hyaluronic Acid|hyaluronic acid|mesh-list
93250240|NCT02782676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93250241|NCT02782676|Immunologic Factors|immunologic factors|mesh-ancestor
93250242|NCT02782676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250243|NCT02782676|Viscosupplements|viscosupplements|mesh-ancestor
93250244|NCT02782676|Protective Agents|protective agents|mesh-ancestor
93250245|NCT03033095|Etanercept|etanercept|mesh-list
93250246|NCT03033095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93250247|NCT03033095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93250248|NCT03033095|Analgesics|analgesics|mesh-ancestor
93250249|NCT03033095|Sensory System Agents|sensory system agents|mesh-ancestor
93250250|NCT03033095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250251|NCT03033095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250252|NCT03033095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250253|NCT03033095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250254|NCT03033095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250255|NCT03033095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250256|NCT03033095|Immunologic Factors|immunologic factors|mesh-ancestor
93250257|NCT02142920|Gedatolisib|gedatolisib|mesh-list
93250258|NCT02142920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93250259|NCT02142920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250260|NCT02142920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250261|NCT01383785|Abciximab|abciximab|mesh-list
93250262|NCT01383785|Anticoagulants|anticoagulants|mesh-ancestor
93250263|NCT01383785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93250264|NCT02923739|Paclitaxel|paclitaxel|mesh-list
93250265|NCT02923739|Bevacizumab|bevacizumab|mesh-list
93250266|NCT02923739|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93250267|NCT02923739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93250268|NCT02923739|Endothelial Growth Factors|endothelial growth factors|mesh-list
93250269|NCT02923739|Antibodies|antibodies|mesh-list
93250270|NCT02923739|Immunoglobulins|immunoglobulins|mesh-list
93250271|NCT02923739|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93250272|NCT02923739|Immunoglobulin G|immunoglobulin g|mesh-list
93250273|NCT02923739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93250274|NCT02923739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250275|NCT02923739|Tubulin Modulators|tubulin modulators|mesh-ancestor
93250276|NCT02923739|Antimitotic Agents|antimitotic agents|mesh-ancestor
93250277|NCT02923739|Mitosis Modulators|mitosis modulators|mesh-ancestor
93250278|NCT02923739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250279|NCT02923739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250280|NCT02923739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250281|NCT02923739|Growth Substances|growth substances|mesh-ancestor
93250282|NCT02923739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250283|NCT02923739|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250284|NCT02923739|Immunologic Factors|immunologic factors|mesh-ancestor
93250285|NCT02146976|Propofol|propofol|mesh-list
93250286|NCT02146976|Sevoflurane|sevoflurane|mesh-list
93250287|NCT02146976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93250288|NCT02146976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250289|NCT02146976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250290|NCT02146976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250291|NCT02146976|Anesthetics, General|anesthetics, general|mesh-ancestor
93250292|NCT02146976|Anesthetics|anesthetics|mesh-ancestor
93250293|NCT02146976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93250294|NCT02146976|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93250295|NCT02147054|Rocuronium|rocuronium|mesh-list
93250296|NCT02147054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93250297|NCT02147054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93250298|NCT02147054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92922208|NCT00739596|Diuretics|diuretics|mesh-ancestor
93250299|NCT02147054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250300|NCT02147054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250301|NCT00107978|Vancomycin|vancomycin|mesh-list
93250302|NCT00107978|Telavancin|telavancin|mesh-list
93250303|NCT00107978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93250304|NCT00107978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250305|NCT02781818|Triamcinolone|triamcinolone|mesh-list
93250306|NCT02781818|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93250307|NCT02781818|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93250308|NCT02781818|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93250309|NCT02781818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250310|NCT02781818|Glucocorticoids|glucocorticoids|mesh-ancestor
93250311|NCT02781818|Hormones|hormones|mesh-ancestor
93250312|NCT02781818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250313|NCT02781818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250314|NCT02781818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250315|NCT02781818|Immunologic Factors|immunologic factors|mesh-ancestor
93250316|NCT02781818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250317|NCT02781818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250318|NCT02149628|Propofol|propofol|mesh-list
93250319|NCT02149628|Desflurane|desflurane|mesh-list
93250320|NCT02149628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93250321|NCT02149628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250322|NCT02149628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250323|NCT02149628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250324|NCT02149628|Anesthetics, General|anesthetics, general|mesh-ancestor
93250325|NCT02149628|Anesthetics|anesthetics|mesh-ancestor
93250326|NCT02149628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93250327|NCT02927873|Vaccines|vaccines|mesh-list
93250328|NCT02927873|Immunologic Factors|immunologic factors|mesh-ancestor
93250329|NCT02927873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250330|NCT02460419|Capecitabine|capecitabine|mesh-list
93250331|NCT02460419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93250332|NCT02460419|Antimetabolites|antimetabolites|mesh-ancestor
93250333|NCT02460419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250334|NCT02460419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250335|NCT01568411|Itraconazole|itraconazole|mesh-list
93250336|NCT01568411|Antifungal Agents|antifungal agents|mesh-ancestor
93250337|NCT01568411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250338|NCT01568411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93250339|NCT01568411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93250340|NCT01568411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250341|NCT01568411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250342|NCT01568411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93250343|NCT01568411|Hormone Antagonists|hormone antagonists|mesh-ancestor
93250344|NCT01568411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250345|NCT01568411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250346|NCT01568411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93250347|NCT00142415|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93250348|NCT00142415|Chelating Agents|chelating agents|mesh-ancestor
93250349|NCT00142415|Sequestering Agents|sequestering agents|mesh-ancestor
93250350|NCT00142415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250351|NCT03631901|Diazepam|diazepam|mesh-list
93250352|NCT03631901|Melatonin|melatonin|mesh-list
93250353|NCT03631901|Antioxidants|antioxidants|mesh-ancestor
93250354|NCT03631901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250355|NCT03631901|Protective Agents|protective agents|mesh-ancestor
93250356|NCT03631901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250357|NCT03631901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250358|NCT03631901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93250359|NCT03631901|Anticonvulsants|anticonvulsants|mesh-ancestor
93250360|NCT03631901|Antiemetics|antiemetics|mesh-ancestor
93250361|NCT03631901|Autonomic Agents|autonomic agents|mesh-ancestor
93250362|NCT03631901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250363|NCT03631901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250364|NCT03631901|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93250365|NCT03631901|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93250366|NCT03631901|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93250367|NCT03631901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93250368|NCT03631901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93250369|NCT03631901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93250370|NCT03631901|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250371|NCT03631901|Anesthetics, General|anesthetics, general|mesh-ancestor
93250372|NCT03631901|Anesthetics|anesthetics|mesh-ancestor
93250373|NCT03631901|GABA Modulators|gaba modulators|mesh-ancestor
92922278|NCT00796562|Alkylating Agents|alkylating agents|mesh-ancestor
93250374|NCT03631901|GABA Agents|gaba agents|mesh-ancestor
93250375|NCT03631901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250376|NCT01383395|Cilostazol|cilostazol|mesh-list
93250377|NCT01383395|Simvastatin|simvastatin|mesh-list
93250378|NCT01383395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93250379|NCT01383395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93250380|NCT01383395|Antimetabolites|antimetabolites|mesh-ancestor
93250381|NCT01383395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250382|NCT01383395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93250383|NCT01383395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93250384|NCT01383395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250385|NCT01383395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93250386|NCT01383395|Autonomic Agents|autonomic agents|mesh-ancestor
93250387|NCT01383395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250388|NCT01383395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250389|NCT01383395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93250390|NCT01383395|Respiratory System Agents|respiratory system agents|mesh-ancestor
93250391|NCT01383395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93250392|NCT01383395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93250393|NCT01383395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93250394|NCT01383395|Vasodilator Agents|vasodilator agents|mesh-ancestor
93250395|NCT01383395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93250396|NCT01383395|Protective Agents|protective agents|mesh-ancestor
93250397|NCT01383395|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93250398|NCT01383395|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93250399|NCT05084651|Itraconazole|itraconazole|mesh-list
93250400|NCT05084651|Lumefantrine|lumefantrine|mesh-list
93250401|NCT05084651|Antifungal Agents|antifungal agents|mesh-ancestor
93250402|NCT05084651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250403|NCT05084651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93250404|NCT05084651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93250405|NCT05084651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250406|NCT05084651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250407|NCT05084651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93250408|NCT05084651|Hormone Antagonists|hormone antagonists|mesh-ancestor
93250409|NCT05084651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250410|NCT05084651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250411|NCT05084651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93250412|NCT05084651|Antimalarials|antimalarials|mesh-ancestor
93250413|NCT05084651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93250414|NCT05084651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93250415|NCT02781584|Firsocostat|firsocostat|mesh-list
93250416|NCT02781584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250417|NCT02781584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250418|NCT02149706|Freund's Adjuvant|freund's adjuvant|mesh-list
93250419|NCT02149706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93250420|NCT02149706|Immunologic Factors|immunologic factors|mesh-ancestor
93250421|NCT02149706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250422|NCT02147678|Remifentanil|remifentanil|mesh-list
93250423|NCT02147678|Propofol|propofol|mesh-list
93250424|NCT02147678|Etomidate|etomidate|mesh-list
93250425|NCT02147678|Anesthetics|anesthetics|mesh-ancestor
93250426|NCT02147678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250427|NCT02147678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250428|NCT02147678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93250429|NCT02147678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250430|NCT02147678|Anesthetics, General|anesthetics, general|mesh-ancestor
93250431|NCT02147678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93250432|NCT02147678|Narcotics|narcotics|mesh-ancestor
93250433|NCT02147678|Analgesics|analgesics|mesh-ancestor
93250434|NCT02147678|Sensory System Agents|sensory system agents|mesh-ancestor
93250435|NCT02147678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250436|NCT02151344|Vaccines|vaccines|mesh-list
93250437|NCT02151344|Immunologic Factors|immunologic factors|mesh-ancestor
93250438|NCT02151344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250439|NCT02155634|Lenalidomide|lenalidomide|mesh-list
93250440|NCT02155634|Immunologic Factors|immunologic factors|mesh-ancestor
93250441|NCT02155634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250442|NCT02155634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250443|NCT02155634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250444|NCT02155634|Growth Substances|growth substances|mesh-ancestor
93250445|NCT02155634|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250446|NCT02155634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250447|NCT02151812|Paclitaxel|paclitaxel|mesh-list
93250448|NCT02151812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93250449|NCT02151812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93250450|NCT02151812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250452|NCT02151812|Antimitotic Agents|antimitotic agents|mesh-ancestor
93250453|NCT02151812|Mitosis Modulators|mitosis modulators|mesh-ancestor
93250454|NCT02151812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250455|NCT02151968|Anesthetics|anesthetics|mesh-list
93250456|NCT02151968|Anesthetics, Local|anesthetics, local|mesh-list
93250457|NCT02151968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250458|NCT02151968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250459|NCT02151968|Sensory System Agents|sensory system agents|mesh-ancestor
93250460|NCT02151968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250461|NCT02776670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93250462|NCT02776670|Lubricant Eye Drops|lubricant eye drops|mesh-list
93250463|NCT02776670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93250464|NCT02255084|Menthol|menthol|mesh-list
93250465|NCT02255084|Antipruritics|antipruritics|mesh-ancestor
93250466|NCT02255084|Dermatologic Agents|dermatologic agents|mesh-ancestor
93250467|NCT02150330|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93250468|NCT02150330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93250469|NCT02150330|Immunologic Factors|immunologic factors|mesh-ancestor
93250470|NCT02150330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250471|NCT02255162|Cytarabine|cytarabine|mesh-list
93250472|NCT02255162|Lenalidomide|lenalidomide|mesh-list
93250473|NCT02255162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93250474|NCT02255162|Antimetabolites|antimetabolites|mesh-ancestor
93250475|NCT02255162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250476|NCT02255162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250477|NCT02255162|Antiviral Agents|antiviral agents|mesh-ancestor
93250478|NCT02255162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250479|NCT02255162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250480|NCT02255162|Immunologic Factors|immunologic factors|mesh-ancestor
93250481|NCT02255162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250482|NCT02255162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250483|NCT02255162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250484|NCT02255162|Growth Substances|growth substances|mesh-ancestor
93250485|NCT02255162|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250486|NCT02152514|Sufentanil|sufentanil|mesh-list
93250487|NCT02152514|Morphine|morphine|mesh-list
93250488|NCT02152514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93250489|NCT02152514|Narcotics|narcotics|mesh-ancestor
93250490|NCT02152514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250491|NCT02152514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250492|NCT02152514|Analgesics|analgesics|mesh-ancestor
93250493|NCT02152514|Sensory System Agents|sensory system agents|mesh-ancestor
93250494|NCT02152514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250495|NCT02152514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93250496|NCT02152514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250497|NCT02152514|Anesthetics, General|anesthetics, general|mesh-ancestor
93250498|NCT02152514|Anesthetics|anesthetics|mesh-ancestor
93250499|NCT02261090|Pramipexole|pramipexole|mesh-list
93250500|NCT02261090|Antioxidants|antioxidants|mesh-ancestor
93250501|NCT02261090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250502|NCT02261090|Protective Agents|protective agents|mesh-ancestor
93250503|NCT02261090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250504|NCT02261090|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93250505|NCT02261090|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93250506|NCT02261090|Dopamine Agonists|dopamine agonists|mesh-ancestor
93250507|NCT02261090|Dopamine Agents|dopamine agents|mesh-ancestor
93250508|NCT02261090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250509|NCT01307423|Thalidomide|thalidomide|mesh-list
93250510|NCT01307423|Apremilast|apremilast|mesh-list
93250511|NCT01307423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93250512|NCT01307423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93250513|NCT01307423|Analgesics|analgesics|mesh-ancestor
93250514|NCT01307423|Sensory System Agents|sensory system agents|mesh-ancestor
93250515|NCT01307423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250516|NCT01307423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250517|NCT01307423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250518|NCT01307423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250519|NCT01307423|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93250520|NCT01307423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93250521|NCT01307423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250522|NCT01307423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250523|NCT01307423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250524|NCT01307423|Immunologic Factors|immunologic factors|mesh-ancestor
93250525|NCT01307423|Leprostatic Agents|leprostatic agents|mesh-ancestor
93250526|NCT01307423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93250527|NCT01307423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250528|NCT01307423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250529|NCT01307423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250530|NCT01307423|Growth Substances|growth substances|mesh-ancestor
93250531|NCT01307423|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250532|NCT01307423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250533|NCT03543254|Botulinum Toxins|botulinum toxins|mesh-list
93250534|NCT03543254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93250535|NCT03543254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93250536|NCT03543254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93250537|NCT03543254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93250538|NCT03543254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250539|NCT03543254|Cholinergic Agents|cholinergic agents|mesh-ancestor
93250540|NCT03543254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250541|NCT03543254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250542|NCT03543254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93250543|NCT03543254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250544|NCT02156336|Ranolazine|ranolazine|mesh-list
93250545|NCT02156336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93250546|NCT02156336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93250547|NCT02156336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250548|NCT03542240|Curcumin|curcumin|mesh-list
93250549|NCT03542240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93250550|NCT03542240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93250551|NCT03542240|Analgesics|analgesics|mesh-ancestor
93250552|NCT03542240|Sensory System Agents|sensory system agents|mesh-ancestor
93250553|NCT03542240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250554|NCT03542240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250555|NCT03542240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250556|NCT03542240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250557|NCT03542240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250558|NCT03542240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250559|NCT03542240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250560|NCT00911183|Prednisone|prednisone|mesh-list
93250561|NCT00911183|Cyclophosphamide|cyclophosphamide|mesh-list
93250562|NCT00911183|Rituximab|rituximab|mesh-list
93250563|NCT00911183|Doxorubicin|doxorubicin|mesh-list
93250564|NCT00911183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93250565|NCT00911183|Vincristine|vincristine|mesh-list
93250566|NCT00911183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250567|NCT00911183|Immunologic Factors|immunologic factors|mesh-ancestor
92545137|NCT00038259|Aldesleukin|aldesleukin|mesh-list
93250568|NCT00911183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250569|NCT00911183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250570|NCT00911183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93250571|NCT00911183|Alkylating Agents|alkylating agents|mesh-ancestor
93250572|NCT00911183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250573|NCT00911183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250574|NCT00911183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93250575|NCT00911183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250576|NCT00911183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93250577|NCT00911183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93250578|NCT00911183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93250579|NCT00911183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250580|NCT00911183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250581|NCT00911183|Glucocorticoids|glucocorticoids|mesh-ancestor
93250582|NCT00911183|Hormones|hormones|mesh-ancestor
93250583|NCT00911183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250584|NCT00911183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93250585|NCT00911183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93250586|NCT00911183|Tubulin Modulators|tubulin modulators|mesh-ancestor
93250587|NCT00911183|Antimitotic Agents|antimitotic agents|mesh-ancestor
93250588|NCT00911183|Mitosis Modulators|mitosis modulators|mesh-ancestor
93250589|NCT03631121|Insulin Glargine|insulin glargine|mesh-list
93250590|NCT03631121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93250591|NCT03631121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250592|NCT02768792|Pembrolizumab|pembrolizumab|mesh-list
93250593|NCT02768792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250594|NCT02768792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250595|NCT02768792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93250596|NCT02768792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250597|NCT05420441|Chitosan|chitosan|mesh-list
93250598|NCT05420441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93250599|NCT05420441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93250600|NCT05420441|Antimetabolites|antimetabolites|mesh-ancestor
93250601|NCT05420441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250602|NCT05420441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93250603|NCT05420441|Chelating Agents|chelating agents|mesh-ancestor
93250604|NCT05420441|Sequestering Agents|sequestering agents|mesh-ancestor
93250605|NCT05420441|Hemostatics|hemostatics|mesh-ancestor
93250606|NCT05420441|Coagulants|coagulants|mesh-ancestor
93250607|NCT05598593|Cytarabine|cytarabine|mesh-list
93250608|NCT05598593|Fludarabine|fludarabine|mesh-list
93250609|NCT05598593|Busulfan|busulfan|mesh-list
93250610|NCT05598593|Thiotepa|thiotepa|mesh-list
93250611|NCT05598593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250612|NCT05598593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93250613|NCT05598593|Antimetabolites|antimetabolites|mesh-ancestor
93250614|NCT05598593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250615|NCT05598593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250616|NCT05598593|Immunologic Factors|immunologic factors|mesh-ancestor
93250617|NCT05598593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250618|NCT05598593|Antiviral Agents|antiviral agents|mesh-ancestor
93250619|NCT05598593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250620|NCT05598593|Alkylating Agents|alkylating agents|mesh-ancestor
93250621|NCT05598593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93250622|NCT05598593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93250623|NCT05337449|Fluorides|fluorides|mesh-list
93250624|NCT05337449|Cariostatic Agents|cariostatic agents|mesh-ancestor
93250625|NCT05337449|Protective Agents|protective agents|mesh-ancestor
93250626|NCT05337449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250627|NCT02150720|Tranexamic Acid|tranexamic acid|mesh-list
93250628|NCT02150720|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93250629|NCT02150720|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93250630|NCT02150720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93250631|NCT02150720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250632|NCT02150720|Hemostatics|hemostatics|mesh-ancestor
93250633|NCT02150720|Coagulants|coagulants|mesh-ancestor
93250634|NCT02153060|Dexamethasone|dexamethasone|mesh-list
93250635|NCT02153060|Dexamethasone acetate|dexamethasone acetate|mesh-list
93250636|NCT02153060|BB 1101|bb 1101|mesh-list
93250637|NCT02153060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250638|NCT02153060|Antiemetics|antiemetics|mesh-ancestor
93250639|NCT02153060|Autonomic Agents|autonomic agents|mesh-ancestor
93250640|NCT02153060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250641|NCT02153060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250642|NCT02153060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250643|NCT02153060|Glucocorticoids|glucocorticoids|mesh-ancestor
93250644|NCT02153060|Hormones|hormones|mesh-ancestor
93250645|NCT02153060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250646|NCT02153060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93250647|NCT02153060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250648|NCT02153060|Protease Inhibitors|protease inhibitors|mesh-ancestor
93250649|NCT02153060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250650|NCT02153060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250651|NCT02156570|Ribavirin|ribavirin|mesh-list
93250652|NCT02156570|Sofosbuvir|sofosbuvir|mesh-list
93250653|NCT02156570|Antimetabolites|antimetabolites|mesh-ancestor
93250654|NCT02156570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250655|NCT02156570|Antiviral Agents|antiviral agents|mesh-ancestor
93250656|NCT02156570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250657|NCT03087851|Zoledronic Acid|zoledronic acid|mesh-list
93250658|NCT03087851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93250659|NCT03087851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250660|NCT02156726|Cyclophosphamide|cyclophosphamide|mesh-list
93250661|NCT02156726|Fludarabine|fludarabine|mesh-list
93250662|NCT02156726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93250663|NCT02156726|Immunologic Factors|immunologic factors|mesh-ancestor
93250664|NCT02156726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250665|NCT02156726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250666|NCT02156726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93250667|NCT02156726|Alkylating Agents|alkylating agents|mesh-ancestor
93250668|NCT02156726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250669|NCT02156726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250670|NCT02156726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93250671|NCT02153450|Metformin|metformin|mesh-list
93250672|NCT02153450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93250673|NCT02153450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250674|NCT05598281|Sotorasib|sotorasib|mesh-list
93250675|NCT05598281|Digoxin|digoxin|mesh-list
93250676|NCT05598281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93250677|NCT05598281|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93250678|NCT05598281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250679|NCT05598281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250680|NCT05598281|Protective Agents|protective agents|mesh-ancestor
93250681|NCT05598281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250682|NCT05598281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93250683|NCT05598281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250684|NCT05598281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250685|NCT03092375|Ribavirin|ribavirin|mesh-list
93250686|NCT03092375|Antimetabolites|antimetabolites|mesh-ancestor
93250687|NCT03092375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250688|NCT03092375|Antiviral Agents|antiviral agents|mesh-ancestor
93250689|NCT03092375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250690|NCT01995513|Prednisone|prednisone|mesh-list
93250691|NCT01995513|Prednisolone|prednisolone|mesh-list
93250692|NCT01995513|Abiraterone Acetate|abiraterone acetate|mesh-list
93250693|NCT01995513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250694|NCT01995513|Glucocorticoids|glucocorticoids|mesh-ancestor
93250695|NCT01995513|Hormones|hormones|mesh-ancestor
93250696|NCT01995513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250697|NCT01995513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250698|NCT01995513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93250699|NCT01995513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250700|NCT01995513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93250701|NCT01995513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250702|NCT01995513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250703|NCT01995513|Hormone Antagonists|hormone antagonists|mesh-ancestor
93250704|NCT01995513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93250705|NCT03180359|Vaccines|vaccines|mesh-list
93250706|NCT03180359|Immunologic Factors|immunologic factors|mesh-ancestor
93250707|NCT03180359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250708|NCT05199285|Nivolumab|nivolumab|mesh-list
93250709|NCT05199285|Ipilimumab|ipilimumab|mesh-list
93250710|NCT05199285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250711|NCT05199285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250712|NCT05199285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93250713|NCT05199285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250714|NCT01304511|Ganirelix|ganirelix|mesh-list
93250715|NCT01304511|Hormone Antagonists|hormone antagonists|mesh-ancestor
93250716|NCT01304511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250717|NCT01304511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250718|NCT04808973|Lamivudine|lamivudine|mesh-list
93250719|NCT04808973|Dolutegravir|dolutegravir|mesh-list
93250720|NCT04808973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93250721|NCT04808973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93250722|NCT04808973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250723|NCT04808973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250724|NCT04808973|Antiviral Agents|antiviral agents|mesh-ancestor
93250725|NCT04808973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250726|NCT04808973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93250727|NCT04808973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93250728|NCT04808973|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93250729|NCT04808973|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93250730|NCT00103610|Plerixafor|plerixafor|mesh-list
93250731|NCT00103610|Lenograstim|lenograstim|mesh-list
93250732|NCT00103610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93250733|NCT00103610|Immunologic Factors|immunologic factors|mesh-ancestor
93250734|NCT00103610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250735|NCT00103610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93250736|NCT00103610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93250737|NCT00103610|Antiviral Agents|antiviral agents|mesh-ancestor
93250738|NCT00103610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250739|NCT04871321|Paclitaxel|paclitaxel|mesh-list
93250740|NCT04871321|Gemcitabine|gemcitabine|mesh-list
93250741|NCT04871321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93250742|NCT04871321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250743|NCT04871321|Tubulin Modulators|tubulin modulators|mesh-ancestor
93250744|NCT04871321|Antimitotic Agents|antimitotic agents|mesh-ancestor
93250745|NCT04871321|Mitosis Modulators|mitosis modulators|mesh-ancestor
92545317|NCT05428683|Hormones|hormones|mesh-ancestor
93250746|NCT04871321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250747|NCT04871321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93250748|NCT04871321|Antimetabolites|antimetabolites|mesh-ancestor
93250749|NCT02156960|Denosumab|denosumab|mesh-list
93250750|NCT02156960|Teriparatide|teriparatide|mesh-list
93250751|NCT02156960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92922660|NCT00789698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93250752|NCT02156960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250753|NCT02156960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93250755|NCT02153606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93250756|NCT02153606|Protective Agents|protective agents|mesh-ancestor
93250757|NCT02153606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250758|NCT02153762|Hydrocortisone|hydrocortisone|mesh-list
93250759|NCT02153762|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93250760|NCT02153762|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93250761|NCT02153762|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93250762|NCT02153762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250763|NCT04687631|Bevacizumab|bevacizumab|mesh-list
93250764|NCT04687631|Cetuximab|cetuximab|mesh-list
93250765|NCT04687631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250766|NCT04687631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250767|NCT04687631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250768|NCT04687631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250769|NCT04687631|Growth Substances|growth substances|mesh-ancestor
93250770|NCT04687631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250771|NCT04687631|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250772|NCT04833023|Olanzapine|olanzapine|mesh-list
93250773|NCT04833023|Antiemetics|antiemetics|mesh-ancestor
93250774|NCT04833023|Autonomic Agents|autonomic agents|mesh-ancestor
93250775|NCT04833023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250776|NCT04833023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250777|NCT04833023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250778|NCT04833023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93250779|NCT04833023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93250780|NCT04833023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250781|NCT04833023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93250782|NCT04833023|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93250783|NCT04833023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93250784|NCT04833023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93250785|NCT04833023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250786|NCT04833023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250787|NCT04833023|Serotonin Agents|serotonin agents|mesh-ancestor
93250788|NCT03091439|Dalbavancin|dalbavancin|mesh-list
93250789|NCT03091439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93250790|NCT03091439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250791|NCT03631823|Temozolomide|temozolomide|mesh-list
93250792|NCT03631823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93250793|NCT03631823|Alkylating Agents|alkylating agents|mesh-ancestor
93250794|NCT03631823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250795|NCT03631823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250796|NCT02157272|Rivaroxaban|rivaroxaban|mesh-list
93250797|NCT02157272|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93250798|NCT02157272|Antithrombins|antithrombins|mesh-ancestor
93250799|NCT02157272|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93250800|NCT02157272|Protease Inhibitors|protease inhibitors|mesh-ancestor
93250801|NCT02157272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250802|NCT02157272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250803|NCT02157272|Anticoagulants|anticoagulants|mesh-ancestor
93250804|NCT02154074|Dexmedetomidine|dexmedetomidine|mesh-list
93250805|NCT02154074|Isoflurane|isoflurane|mesh-list
93250806|NCT02154074|Anesthetics|anesthetics|mesh-ancestor
93250807|NCT02154074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250808|NCT02154074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250809|NCT02154074|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93250810|NCT02154074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93250811|NCT02154074|Analgesics|analgesics|mesh-ancestor
93250812|NCT02154074|Sensory System Agents|sensory system agents|mesh-ancestor
93250813|NCT02154074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250814|NCT02154074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93250815|NCT02154074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93250816|NCT02154074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93250817|NCT02154074|Adrenergic Agents|adrenergic agents|mesh-ancestor
93250818|NCT02154074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250819|NCT02154074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250820|NCT02154074|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93250821|NCT02154074|Anesthetics, General|anesthetics, general|mesh-ancestor
93250822|NCT05460455|Antibodies|antibodies|mesh-list
93250823|NCT05460455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92922732|NCT01020331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250824|NCT05460455|Immunologic Factors|immunologic factors|mesh-ancestor
93250825|NCT05460455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250826|NCT03104413|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93250827|NCT03104413|Immunologic Factors|immunologic factors|mesh-ancestor
93250828|NCT03104413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250829|NCT01382147|Daunorubicin|daunorubicin|mesh-list
93250830|NCT01382147|Mitoxantrone|mitoxantrone|mesh-list
93250831|NCT01382147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93250832|NCT01382147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250833|NCT01382147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93250834|NCT01382147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93250835|NCT01382147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250836|NCT01382147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250837|NCT01382147|Analgesics|analgesics|mesh-ancestor
93250838|NCT01382147|Sensory System Agents|sensory system agents|mesh-ancestor
93250839|NCT01382147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250840|NCT01382147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250842|NCT01381835|Antiviral Agents|antiviral agents|mesh-ancestor
93250843|NCT01381835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250844|NCT01381835|Protease Inhibitors|protease inhibitors|mesh-ancestor
93250845|NCT01381835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250846|NCT01381835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250847|NCT04429685|Ketamine|ketamine|mesh-list
93250848|NCT04429685|Analgesics|analgesics|mesh-ancestor
93250849|NCT04429685|Sensory System Agents|sensory system agents|mesh-ancestor
93250850|NCT04429685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250851|NCT04429685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250852|NCT04429685|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93250853|NCT04429685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250854|NCT04429685|Anesthetics, General|anesthetics, general|mesh-ancestor
93250855|NCT04429685|Anesthetics|anesthetics|mesh-ancestor
93250856|NCT04429685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250857|NCT04429685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93250858|NCT04429685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93250859|NCT04429685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250860|NCT04429685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250861|NCT01384279|Metformin|metformin|mesh-list
93250862|NCT01384279|Topiramate|topiramate|mesh-list
93250863|NCT01384279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93250864|NCT01384279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250865|NCT01384279|Anticonvulsants|anticonvulsants|mesh-ancestor
93250866|NCT01381601|Bevacizumab|bevacizumab|mesh-list
93250867|NCT01381601|Sunitinib|sunitinib|mesh-list
93250868|NCT01381601|Sorafenib|sorafenib|mesh-list
93250869|NCT01381601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93250870|NCT01381601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250871|NCT01381601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93250872|NCT01381601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93250873|NCT01381601|Growth Substances|growth substances|mesh-ancestor
93250874|NCT01381601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250875|NCT01381601|Growth Inhibitors|growth inhibitors|mesh-ancestor
93250876|NCT01381601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93250877|NCT01381601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250878|NCT01381601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250879|NCT02823353|Fenofibrate|fenofibrate|mesh-list
93250880|NCT02823353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93250881|NCT02823353|Antimetabolites|antimetabolites|mesh-ancestor
93250882|NCT02823353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250883|NCT02823353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93250884|NCT04509193|Warfarin|warfarin|mesh-list
93250885|NCT04509193|Rivaroxaban|rivaroxaban|mesh-list
93250886|NCT04509193|Anticoagulants|anticoagulants|mesh-ancestor
93250887|NCT04509193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93250888|NCT04509193|Antithrombins|antithrombins|mesh-ancestor
93250889|NCT04509193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93250890|NCT04509193|Protease Inhibitors|protease inhibitors|mesh-ancestor
93250891|NCT04509193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250892|NCT04509193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250893|NCT02697383|Dexamethasone|dexamethasone|mesh-list
93250894|NCT02697383|Ixazomib|ixazomib|mesh-list
93250895|NCT02697383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250896|NCT02697383|Antiemetics|antiemetics|mesh-ancestor
93250897|NCT02697383|Autonomic Agents|autonomic agents|mesh-ancestor
93250898|NCT02697383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250899|NCT02697383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250900|NCT02697383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250902|NCT02697383|Hormones|hormones|mesh-ancestor
93250903|NCT02697383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250904|NCT02697383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93250905|NCT02697383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93250906|NCT02697383|Protease Inhibitors|protease inhibitors|mesh-ancestor
93250907|NCT02697383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250908|NCT02697383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250909|NCT04173949|Ramipril|ramipril|mesh-list
93250910|NCT04173949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93250911|NCT04173949|Protease Inhibitors|protease inhibitors|mesh-ancestor
93250912|NCT04173949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250913|NCT04173949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250914|NCT04173949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93250915|NCT05422001|Ketamine|ketamine|mesh-list
93250916|NCT05422001|Analgesics|analgesics|mesh-ancestor
93250917|NCT05422001|Sensory System Agents|sensory system agents|mesh-ancestor
93250918|NCT05422001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250919|NCT05422001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250920|NCT05422001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93250921|NCT05422001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93250922|NCT05422001|Anesthetics, General|anesthetics, general|mesh-ancestor
93250923|NCT05422001|Anesthetics|anesthetics|mesh-ancestor
93250924|NCT05422001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250925|NCT05422001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93250926|NCT05422001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93250927|NCT05422001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250928|NCT05422001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250929|NCT01382017|Lacosamide|lacosamide|mesh-list
93250930|NCT01382017|Carbamazepine|carbamazepine|mesh-list
93250931|NCT01382017|Anticonvulsants|anticonvulsants|mesh-ancestor
93250932|NCT01382017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93250933|NCT01382017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93250934|NCT01382017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93250935|NCT01382017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250936|NCT01382017|Antimanic Agents|antimanic agents|mesh-ancestor
93250937|NCT01382017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93250938|NCT01382017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93250939|NCT01382017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250940|NCT01382017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93250941|NCT01382017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93250942|NCT01382017|Analgesics|analgesics|mesh-ancestor
93250943|NCT01382017|Sensory System Agents|sensory system agents|mesh-ancestor
93250944|NCT01382017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250945|NCT01382017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93250946|NCT01382017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93250947|NCT01381523|Naproxen|naproxen|mesh-list
93250948|NCT01381523|Sumatriptan|sumatriptan|mesh-list
93250949|NCT01381523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93250950|NCT01381523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93250951|NCT01381523|Analgesics|analgesics|mesh-ancestor
93250952|NCT01381523|Sensory System Agents|sensory system agents|mesh-ancestor
93250953|NCT01381523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93250954|NCT01381523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250955|NCT01381523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250956|NCT01381523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93250957|NCT01381523|Gout Suppressants|gout suppressants|mesh-ancestor
93250958|NCT01381523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93250959|NCT01381523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250960|NCT01381523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250961|NCT01381523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93250962|NCT01381523|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93250963|NCT01381523|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93250964|NCT01381523|Serotonin Agents|serotonin agents|mesh-ancestor
93250965|NCT01381523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93250966|NCT04233047|Fostemsavir|fostemsavir|mesh-list
93250967|NCT04233047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93250968|NCT04233047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93250969|NCT04233047|Antiviral Agents|antiviral agents|mesh-ancestor
93250970|NCT04233047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250971|NCT04233047|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93250972|NCT04233047|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92922880|NCT00797966|Escitalopram|escitalopram|mesh-list
93250973|NCT04233047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250974|NCT01381445|Clobetasol|clobetasol|mesh-list
93250975|NCT01381445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93250976|NCT01381445|Glucocorticoids|glucocorticoids|mesh-ancestor
93250977|NCT01381445|Hormones|hormones|mesh-ancestor
93250978|NCT01381445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93250979|NCT01381445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93250980|NCT03083639|Esomeprazole|esomeprazole|mesh-list
93250981|NCT03083639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93250982|NCT03083639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93250983|NCT03083639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93250984|NCT03083639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250985|NCT03083639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250986|NCT02927431|Oseltamivir|oseltamivir|mesh-list
93250987|NCT02927431|Antiviral Agents|antiviral agents|mesh-ancestor
93250988|NCT02927431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250989|NCT02927431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250990|NCT02927431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250991|NCT05027893|Moxifloxacin|moxifloxacin|mesh-list
93250992|NCT05027893|Cefixime|cefixime|mesh-list
93250993|NCT05027893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93250994|NCT05027893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93250995|NCT05027893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93250996|NCT05027893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93250997|NCT05027893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93250998|NCT05027893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93250999|NCT05027893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251000|NCT04113083|Dehydrocholesterols|dehydrocholesterols|mesh-list
93251001|NCT04113083|Provitamins|provitamins|mesh-ancestor
93251002|NCT04113083|Vitamins|vitamins|mesh-ancestor
93251003|NCT04113083|Micronutrients|micronutrients|mesh-ancestor
93251004|NCT04113083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251005|NCT01381367|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93251006|NCT01381367|Immunologic Factors|immunologic factors|mesh-ancestor
93251007|NCT01381367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251008|NCT04989361|Hyaluronic Acid|hyaluronic acid|mesh-list
93251009|NCT04989361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93251010|NCT04989361|Immunologic Factors|immunologic factors|mesh-ancestor
93251011|NCT04989361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251012|NCT04989361|Viscosupplements|viscosupplements|mesh-ancestor
93251013|NCT04989361|Protective Agents|protective agents|mesh-ancestor
93251014|NCT01381289|Ivacaftor|ivacaftor|mesh-list
93251015|NCT01381289|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93251016|NCT01381289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93251017|NCT01381289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251018|NCT04899193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93251019|NCT04899193|Hormones|hormones|mesh-ancestor
93251020|NCT04899193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251021|NCT04899193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251022|NCT01381705|Rituximab|rituximab|mesh-list
93251023|NCT01381705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251024|NCT01381705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251025|NCT01381705|Immunologic Factors|immunologic factors|mesh-ancestor
93251026|NCT01381705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251027|NCT01381705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251028|NCT04401709|Gemcitabine|gemcitabine|mesh-list
93251029|NCT04401709|Capecitabine|capecitabine|mesh-list
93251030|NCT04401709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251031|NCT04401709|Antimetabolites|antimetabolites|mesh-ancestor
93251032|NCT04401709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251033|NCT04401709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251034|NCT04497987|Bamlanivimab|bamlanivimab|mesh-list
93251035|NCT04497987|Antiviral Agents|antiviral agents|mesh-ancestor
93251036|NCT04497987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251037|NCT01381627|Dexmedetomidine|dexmedetomidine|mesh-list
93251038|NCT01381627|Remifentanil|remifentanil|mesh-list
93251039|NCT01381627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93251040|NCT01381627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251041|NCT01381627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251042|NCT01381627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251043|NCT01381627|Analgesics|analgesics|mesh-ancestor
93251044|NCT01381627|Sensory System Agents|sensory system agents|mesh-ancestor
93251045|NCT01381627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251046|NCT01381627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93251047|NCT01381627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93251048|NCT01381627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93251049|NCT01381627|Adrenergic Agents|adrenergic agents|mesh-ancestor
93251050|NCT01381627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251051|NCT01381627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251052|NCT01381627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93251053|NCT01381627|Narcotics|narcotics|mesh-ancestor
93251054|NCT00974571|Cetirizine|cetirizine|mesh-list
93251055|NCT00974571|Montelukast|montelukast|mesh-list
93251056|NCT00974571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251057|NCT00974571|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251058|NCT00974571|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93251059|NCT00974571|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251060|NCT00974571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251061|NCT00974571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251062|NCT00974571|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93251063|NCT00974571|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93251064|NCT00974571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251065|NCT00974571|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93251066|NCT00974571|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93251067|NCT00974571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93251068|NCT00974571|Histamine Antagonists|histamine antagonists|mesh-ancestor
93251069|NCT00974571|Histamine Agents|histamine agents|mesh-ancestor
93251070|NCT00974571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251071|NCT02766608|Budesonide|budesonide|mesh-list
93251072|NCT02766608|Formoterol Fumarate|formoterol fumarate|mesh-list
93251073|NCT02766608|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93251074|NCT02766608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251075|NCT02766608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93251076|NCT02766608|Autonomic Agents|autonomic agents|mesh-ancestor
93251077|NCT02766608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251078|NCT02766608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251079|NCT02766608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251080|NCT02766608|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251081|NCT02766608|Glucocorticoids|glucocorticoids|mesh-ancestor
93251082|NCT02766608|Hormones|hormones|mesh-ancestor
93251083|NCT02766608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251084|NCT02766608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93251085|NCT02766608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93251086|NCT02766608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93251087|NCT02766608|Adrenergic Agents|adrenergic agents|mesh-ancestor
93251088|NCT02766608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251089|NCT02766608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251090|NCT01382407|Cetuximab|cetuximab|mesh-list
93251091|NCT01382407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251092|NCT01382407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251093|NCT02235857|Dextrans|dextrans|mesh-list
93251094|NCT02235857|Anticoagulants|anticoagulants|mesh-ancestor
93251095|NCT02235857|Plasma Substitutes|plasma substitutes|mesh-ancestor
93251096|NCT02235857|Blood Substitutes|blood substitutes|mesh-ancestor
93251097|NCT05082285|Vaccines|vaccines|mesh-list
93251098|NCT05082285|Immunologic Factors|immunologic factors|mesh-ancestor
93251099|NCT05082285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251100|NCT03317119|Trifluridine|trifluridine|mesh-list
93251101|NCT03317119|Trametinib|trametinib|mesh-list
93251102|NCT03317119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251103|NCT03317119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93251104|NCT03317119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251105|NCT03317119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251106|NCT03317119|Antimetabolites|antimetabolites|mesh-ancestor
93251107|NCT03317119|Antiviral Agents|antiviral agents|mesh-ancestor
93251108|NCT03317119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251109|NCT04356495|Ciclesonide|ciclesonide|mesh-list
93251110|NCT04356495|Interferons|interferons|mesh-list
93251111|NCT04356495|Interferon-beta|interferon-beta|mesh-list
93251112|NCT04356495|Telmisartan|telmisartan|mesh-list
93251113|NCT04356495|Interferon beta-1b|interferon beta-1b|mesh-list
93251114|NCT04356495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251115|NCT04356495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251116|NCT04356495|Antiviral Agents|antiviral agents|mesh-ancestor
93251117|NCT04356495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251118|NCT04356495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93251119|NCT04356495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93251120|NCT04356495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93251121|NCT04356495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923029|NCT00807599|Immunologic Factors|immunologic factors|mesh-ancestor
93251122|NCT04356495|Glucocorticoids|glucocorticoids|mesh-ancestor
93251123|NCT04356495|Hormones|hormones|mesh-ancestor
93251124|NCT04356495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251125|NCT04356495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93251126|NCT04356495|Immunologic Factors|immunologic factors|mesh-ancestor
93251127|NCT04356495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93251128|NCT05345249|Ropivacaine|ropivacaine|mesh-list
93251129|NCT05345249|Anesthetics, Local|anesthetics, local|mesh-ancestor
93251130|NCT05345249|Anesthetics|anesthetics|mesh-ancestor
93251131|NCT05345249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251132|NCT05345249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251133|NCT05345249|Sensory System Agents|sensory system agents|mesh-ancestor
93251134|NCT05345249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251135|NCT02154230|Calcium|calcium|mesh-list
93251136|NCT02154230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93251137|NCT02154230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251138|NCT04200963|Nivolumab|nivolumab|mesh-list
93251139|NCT04200963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251140|NCT04200963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251141|NCT04200963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251142|NCT04200963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251143|NCT02157428|Flumazenil|flumazenil|mesh-list
93251144|NCT02157428|Antidotes|antidotes|mesh-ancestor
93251145|NCT02157428|Protective Agents|protective agents|mesh-ancestor
93251146|NCT02157428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251147|NCT02157428|GABA Modulators|gaba modulators|mesh-ancestor
93251148|NCT02157428|GABA Agents|gaba agents|mesh-ancestor
93251149|NCT02157428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251150|NCT02157428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251151|NCT00960141|Loratadine|loratadine|mesh-list
93251152|NCT00960141|Montelukast|montelukast|mesh-list
93251153|NCT00960141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251154|NCT00960141|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251155|NCT00960141|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93251156|NCT00960141|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251157|NCT00960141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251158|NCT00960141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251159|NCT00960141|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93251160|NCT00960141|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93251161|NCT00960141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251162|NCT00960141|Antipruritics|antipruritics|mesh-ancestor
93251163|NCT00960141|Dermatologic Agents|dermatologic agents|mesh-ancestor
93251164|NCT00960141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93251165|NCT00960141|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93251166|NCT00960141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93251167|NCT00960141|Histamine Antagonists|histamine antagonists|mesh-ancestor
93251168|NCT00960141|Histamine Agents|histamine agents|mesh-ancestor
93251169|NCT00960141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251170|NCT00759655|Factor VIII|factor viii|mesh-list
93251171|NCT00759655|Coagulants|coagulants|mesh-ancestor
93251172|NCT03918915|Atropine|atropine|mesh-list
93251173|NCT03918915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93251174|NCT03918915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93251175|NCT03918915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93251176|NCT03918915|Autonomic Agents|autonomic agents|mesh-ancestor
93251177|NCT03918915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251178|NCT03918915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545748|NCT00041574|Autonomic Agents|autonomic agents|mesh-ancestor
93251179|NCT03918915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251180|NCT03918915|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251181|NCT03918915|Mydriatics|mydriatics|mesh-ancestor
93251182|NCT03918915|Parasympatholytics|parasympatholytics|mesh-ancestor
93251183|NCT03918915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93251184|NCT03918915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93251185|NCT03918915|Cholinergic Agents|cholinergic agents|mesh-ancestor
93251186|NCT03918915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251187|NCT03918915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251188|NCT02255006|Glyburide|glyburide|mesh-list
93251189|NCT02255006|Celecoxib|celecoxib|mesh-list
93251190|NCT02255006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251191|NCT02255006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251192|NCT02255006|Analgesics|analgesics|mesh-ancestor
93251193|NCT02255006|Sensory System Agents|sensory system agents|mesh-ancestor
93251194|NCT02255006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923103|NCT00719901|Bortezomib|bortezomib|mesh-list
93251195|NCT02255006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251196|NCT02255006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251197|NCT02255006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251198|NCT02255006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93251199|NCT02255006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93251200|NCT02255006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251201|NCT02255006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251202|NCT02255006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93251203|NCT03396471|Pembrolizumab|pembrolizumab|mesh-list
93251204|NCT03396471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251205|NCT03396471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251206|NCT03396471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251207|NCT03396471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251208|NCT00103142|Sargramostim|sargramostim|mesh-list
93251209|NCT00103142|Immunologic Factors|immunologic factors|mesh-ancestor
93251210|NCT00103142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251211|NCT00943683|Montelukast|montelukast|mesh-list
93251212|NCT00943683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251213|NCT00943683|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251214|NCT00943683|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93251215|NCT00943683|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251216|NCT00943683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251217|NCT00943683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251218|NCT00943683|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93251219|NCT00943683|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93251220|NCT00943683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251221|NCT03542006|Brinzolamide|brinzolamide|mesh-list
93251222|NCT03542006|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93251223|NCT03542006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251224|NCT03542006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251225|NCT02154464|Acetaminophen|acetaminophen|mesh-list
93251226|NCT02154464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251227|NCT02154464|Analgesics|analgesics|mesh-ancestor
93251228|NCT02154464|Sensory System Agents|sensory system agents|mesh-ancestor
93251229|NCT02154464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251230|NCT02154464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251231|NCT02154464|Antipyretics|antipyretics|mesh-ancestor
93251232|NCT00911547|Beclomethasone|beclomethasone|mesh-list
93251233|NCT00911547|Montelukast|montelukast|mesh-list
93251234|NCT00911547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251235|NCT00911547|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251236|NCT00911547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93251237|NCT00911547|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251238|NCT00911547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251239|NCT00911547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251240|NCT00911547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93251241|NCT00911547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93251242|NCT00911547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251243|NCT00911547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251244|NCT00911547|Glucocorticoids|glucocorticoids|mesh-ancestor
93251245|NCT00911547|Hormones|hormones|mesh-ancestor
93251246|NCT02159690|Prednisone|prednisone|mesh-list
93251247|NCT02159690|Abiraterone Acetate|abiraterone acetate|mesh-list
93251248|NCT02159690|Dutasteride|dutasteride|mesh-list
93251249|NCT02159690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251250|NCT02159690|Glucocorticoids|glucocorticoids|mesh-ancestor
93251251|NCT02159690|Hormones|hormones|mesh-ancestor
93251252|NCT02159690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251253|NCT02159690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251254|NCT02159690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251255|NCT02159690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251256|NCT02159690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93251257|NCT02159690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251258|NCT02159690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251259|NCT02159690|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251260|NCT02159690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93251261|NCT02159690|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93251262|NCT02157818|Midazolam|midazolam|mesh-list
93251263|NCT02157818|Dexmedetomidine|dexmedetomidine|mesh-list
93251264|NCT02157818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93251265|NCT02157818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251266|NCT02157818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923175|NCT00727272|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93251267|NCT02157818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251268|NCT02157818|Analgesics|analgesics|mesh-ancestor
93251269|NCT02157818|Sensory System Agents|sensory system agents|mesh-ancestor
93251270|NCT02157818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251271|NCT02157818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93251272|NCT02157818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93251273|NCT02157818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93251274|NCT02157818|Adrenergic Agents|adrenergic agents|mesh-ancestor
93251275|NCT02157818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251276|NCT02157818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251277|NCT02157818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93251278|NCT02157818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93251279|NCT02157818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93251280|NCT02157818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93251281|NCT02157818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93251282|NCT02157818|Anesthetics, General|anesthetics, general|mesh-ancestor
93251283|NCT02157818|Anesthetics|anesthetics|mesh-ancestor
93251284|NCT02157818|GABA Modulators|gaba modulators|mesh-ancestor
93251285|NCT02157818|GABA Agents|gaba agents|mesh-ancestor
93251286|NCT00899379|Rizatriptan|rizatriptan|mesh-list
93251287|NCT00899379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93251288|NCT00899379|Serotonin Agents|serotonin agents|mesh-ancestor
93251289|NCT00899379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251290|NCT00899379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251291|NCT00899379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251292|NCT04326439|Cytarabine|cytarabine|mesh-list
93251293|NCT04326439|Etoposide|etoposide|mesh-list
93251294|NCT04326439|Daunorubicin|daunorubicin|mesh-list
93251295|NCT04326439|Sorafenib|sorafenib|mesh-list
93251296|NCT04326439|Asparaginase|asparaginase|mesh-list
93251297|NCT04326439|Gemtuzumab|gemtuzumab|mesh-list
93251298|NCT04326439|Calicheamicins|calicheamicins|mesh-list
93251299|NCT04326439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93251300|NCT04326439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251301|NCT04326439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93251302|NCT04326439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93251303|NCT04326439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251304|NCT04326439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251305|NCT04326439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251306|NCT04326439|Antimetabolites|antimetabolites|mesh-ancestor
93251307|NCT04326439|Antiviral Agents|antiviral agents|mesh-ancestor
93251308|NCT04326439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251309|NCT04326439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93251310|NCT04326439|Immunologic Factors|immunologic factors|mesh-ancestor
93251311|NCT04326439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251312|NCT04326439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93251313|NCT04326439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93251314|NCT04326439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251315|NCT04326439|Immunotoxins|immunotoxins|mesh-ancestor
93251316|NCT04326439|Immunoconjugates|immunoconjugates|mesh-ancestor
93251317|NCT03541928|Valacyclovir|valacyclovir|mesh-list
93251318|NCT03541928|Leuprolide|leuprolide|mesh-list
93251319|NCT03541928|Bicalutamide|bicalutamide|mesh-list
93251320|NCT03541928|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93251321|NCT03541928|Fertility Agents|fertility agents|mesh-ancestor
93251322|NCT03541928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251323|NCT03541928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251324|NCT03541928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251325|NCT03541928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251326|NCT03541928|Androgen Antagonists|androgen antagonists|mesh-ancestor
93251327|NCT03541928|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251328|NCT03541928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251329|NCT03541928|Antiviral Agents|antiviral agents|mesh-ancestor
93251330|NCT03541928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251331|NCT00145795|Ritonavir|ritonavir|mesh-list
93251332|NCT00145795|Lopinavir|lopinavir|mesh-list
93251333|NCT00145795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93251334|NCT00145795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93251335|NCT00145795|Protease Inhibitors|protease inhibitors|mesh-ancestor
93251336|NCT00145795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251337|NCT00145795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251338|NCT00145795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93251339|NCT00145795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93251340|NCT00145795|Antiviral Agents|antiviral agents|mesh-ancestor
93251341|NCT00145795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251342|NCT00145795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93251343|NCT00145795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93251344|NCT02771210|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93251345|NCT02771210|Immunologic Factors|immunologic factors|mesh-ancestor
93251346|NCT02771210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251347|NCT00898677|Sumatriptan|sumatriptan|mesh-list
93251348|NCT00898677|Rizatriptan|rizatriptan|mesh-list
93251349|NCT00898677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93251350|NCT00898677|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93251351|NCT00898677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93251352|NCT00898677|Serotonin Agents|serotonin agents|mesh-ancestor
93251353|NCT00898677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251354|NCT00898677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251355|NCT00898677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251356|NCT01381393|Ibandronic Acid|ibandronic acid|mesh-list
93251357|NCT01381393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93251358|NCT01381393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251359|NCT02154776|Letrozole|letrozole|mesh-list
93251360|NCT02154776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251361|NCT02154776|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93251362|NCT02154776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93251363|NCT02154776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251364|NCT02154776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251365|NCT02154776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93251366|NCT02154776|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251367|NCT02154776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251368|NCT02154776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251369|NCT04967157|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93251370|NCT04967157|Nootropic Agents|nootropic agents|mesh-ancestor
93251371|NCT03388749|Annamycin|annamycin|mesh-list
93251372|NCT03388749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93251373|NCT03388749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251374|NCT02770820|Aldesleukin|aldesleukin|mesh-list
93251375|NCT02770820|Interleukin-2|interleukin-2|mesh-list
93251376|NCT02770820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251377|NCT02770820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251378|NCT02770820|Analgesics|analgesics|mesh-ancestor
93251379|NCT02770820|Sensory System Agents|sensory system agents|mesh-ancestor
93251380|NCT02770820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251381|NCT02770820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251382|NCT02770820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93251383|NCT02770820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93251384|NCT02770820|Antiviral Agents|antiviral agents|mesh-ancestor
93251385|NCT02770820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251386|NCT02154854|Tacrolimus|tacrolimus|mesh-list
93251387|NCT02154854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93251388|NCT02154854|Immunologic Factors|immunologic factors|mesh-ancestor
93251389|NCT02154854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251390|NCT02154854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93251391|NCT02154854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251392|NCT02154854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251393|NCT02160080|Interferons|interferons|mesh-list
93251394|NCT02160080|Ribavirin|ribavirin|mesh-list
93251395|NCT02160080|Interferon-alpha|interferon-alpha|mesh-list
93251396|NCT02160080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251397|NCT02160080|Antiviral Agents|antiviral agents|mesh-ancestor
93251398|NCT02160080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251399|NCT02160080|Antimetabolites|antimetabolites|mesh-ancestor
93251400|NCT02160080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251401|NCT02160080|Immunologic Factors|immunologic factors|mesh-ancestor
93251402|NCT02160080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251403|NCT05422183|Lenvatinib|lenvatinib|mesh-list
93251404|NCT05422183|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93251405|NCT05422183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251406|NCT05422183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93251407|NCT05422183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251408|NCT05422183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251409|NCT02160158|Fesoterodine|fesoterodine|mesh-list
93251410|NCT02160158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93251411|NCT02160158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93251412|NCT02160158|Cholinergic Agents|cholinergic agents|mesh-ancestor
93251413|NCT02160158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251414|NCT02160158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251415|NCT02160158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251416|NCT02160158|Urological Agents|urological agents|mesh-ancestor
92545990|NCT00129506|Oxytocics|oxytocics|mesh-ancestor
93251417|NCT02160236|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93251418|NCT02160236|Tenoxicam|tenoxicam|mesh-list
93251419|NCT02160236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251420|NCT02160236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251421|NCT02160236|Analgesics|analgesics|mesh-ancestor
93251422|NCT02160236|Sensory System Agents|sensory system agents|mesh-ancestor
93251423|NCT02160236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251424|NCT02160236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251425|NCT02160236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251426|NCT02160236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251427|NCT02160236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93251428|NCT02160236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251429|NCT02160236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251430|NCT02154932|Misoprostol|misoprostol|mesh-list
93251431|NCT02154932|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93251432|NCT02154932|Abortifacient Agents|abortifacient agents|mesh-ancestor
93251433|NCT02154932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251434|NCT02154932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251435|NCT02154932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93251436|NCT02154932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93251437|NCT02154932|Oxytocics|oxytocics|mesh-ancestor
93251438|NCT02158286|Acetaminophen|acetaminophen|mesh-list
93251439|NCT02158286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251440|NCT02158286|Analgesics|analgesics|mesh-ancestor
93251441|NCT02158286|Sensory System Agents|sensory system agents|mesh-ancestor
93251442|NCT02158286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251443|NCT02158286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251444|NCT02158286|Antipyretics|antipyretics|mesh-ancestor
93251445|NCT01377415|Bupivacaine|bupivacaine|mesh-list
93251446|NCT01377415|Anesthetics, Local|anesthetics, local|mesh-ancestor
93251447|NCT01377415|Anesthetics|anesthetics|mesh-ancestor
93251448|NCT01377415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251449|NCT01377415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251450|NCT01377415|Sensory System Agents|sensory system agents|mesh-ancestor
93251451|NCT01377415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251452|NCT02155088|Paclitaxel|paclitaxel|mesh-list
93251453|NCT02155088|Gemcitabine|gemcitabine|mesh-list
93251454|NCT02155088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93251455|NCT02155088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251456|NCT02155088|Tubulin Modulators|tubulin modulators|mesh-ancestor
93251457|NCT02155088|Antimitotic Agents|antimitotic agents|mesh-ancestor
93251458|NCT02155088|Mitosis Modulators|mitosis modulators|mesh-ancestor
93251459|NCT02155088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251460|NCT02155088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251461|NCT02155088|Antimetabolites|antimetabolites|mesh-ancestor
93251462|NCT02160548|Atropine|atropine|mesh-list
93251463|NCT02160548|Albuterol|albuterol|mesh-list
93251464|NCT02160548|Pralidoxime|pralidoxime|mesh-list
93251465|NCT02160548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93251466|NCT02160548|Autonomic Agents|autonomic agents|mesh-ancestor
93251467|NCT02160548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251468|NCT02160548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251469|NCT02160548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93251470|NCT02160548|Respiratory System Agents|respiratory system agents|mesh-ancestor
93251471|NCT02160548|Tocolytic Agents|tocolytic agents|mesh-ancestor
93251472|NCT02160548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251473|NCT02160548|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93251474|NCT02160548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93251475|NCT02160548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93251476|NCT02160548|Adrenergic Agents|adrenergic agents|mesh-ancestor
93251477|NCT02160548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546059|NCT00470223|Etoposide|etoposide|mesh-list
93251478|NCT02160548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251479|NCT02160548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93251480|NCT02160548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93251481|NCT02160548|Mydriatics|mydriatics|mesh-ancestor
93251482|NCT02160548|Parasympatholytics|parasympatholytics|mesh-ancestor
93251483|NCT02160548|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93251484|NCT02160548|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93251485|NCT02160548|Cholinergic Agents|cholinergic agents|mesh-ancestor
93251486|NCT02160548|Antidotes|antidotes|mesh-ancestor
93251487|NCT02160548|Protective Agents|protective agents|mesh-ancestor
93251488|NCT02160548|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
93251489|NCT02160548|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
93251490|NCT02158598|Vitamin D|vitamin d|mesh-list
93251491|NCT02158598|Ergocalciferols|ergocalciferols|mesh-list
92923403|NCT04085913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251492|NCT02158598|Cholecalciferol|cholecalciferol|mesh-list
93251493|NCT02158598|Vitamins|vitamins|mesh-list
93251494|NCT02158598|Micronutrients|micronutrients|mesh-ancestor
93251495|NCT02158598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251496|NCT02158598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93251497|NCT02158598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93251498|NCT03082729|Apremilast|apremilast|mesh-list
93251499|NCT03082729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251500|NCT03082729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251501|NCT03082729|Analgesics|analgesics|mesh-ancestor
93251502|NCT03082729|Sensory System Agents|sensory system agents|mesh-ancestor
93251503|NCT03082729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251504|NCT03082729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251505|NCT03082729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251506|NCT03082729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251507|NCT03082729|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93251508|NCT03082729|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93251509|NCT03082729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251510|NCT03082729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251511|NCT02160704|Enclomiphene|enclomiphene|mesh-list
93251512|NCT02160704|Clomiphene|clomiphene|mesh-list
93251513|NCT02160704|Zuclomiphene|zuclomiphene|mesh-list
93251514|NCT02160704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93251515|NCT02160704|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251516|NCT02160704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251517|NCT02160704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251518|NCT02160704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93251519|NCT02160704|Fertility Agents|fertility agents|mesh-ancestor
93251520|NCT02160704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251521|NCT02160704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93251522|NCT02160704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93251523|NCT03542552|Magnesium Sulfate|magnesium sulfate|mesh-list
93251524|NCT03542552|Nifedipine|nifedipine|mesh-list
93251525|NCT03542552|Analgesics|analgesics|mesh-ancestor
93251526|NCT03542552|Sensory System Agents|sensory system agents|mesh-ancestor
93251527|NCT03542552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251528|NCT03542552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251529|NCT03542552|Anesthetics|anesthetics|mesh-ancestor
93251530|NCT03542552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251531|NCT03542552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93251532|NCT03542552|Anticonvulsants|anticonvulsants|mesh-ancestor
93251533|NCT03542552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93251534|NCT03542552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93251535|NCT03542552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251536|NCT03542552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93251537|NCT03542552|Tocolytic Agents|tocolytic agents|mesh-ancestor
93251538|NCT03542552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251539|NCT03542552|Vasodilator Agents|vasodilator agents|mesh-ancestor
93251540|NCT02155166|Ibuprofen|ibuprofen|mesh-list
93251541|NCT02155166|Lidocaine|lidocaine|mesh-list
93251542|NCT02155166|Anesthetics, Local|anesthetics, local|mesh-ancestor
93251543|NCT02155166|Anesthetics|anesthetics|mesh-ancestor
93251544|NCT02155166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251545|NCT02155166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251546|NCT02155166|Sensory System Agents|sensory system agents|mesh-ancestor
93251547|NCT02155166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251548|NCT02155166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93251549|NCT02155166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93251550|NCT02155166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93251551|NCT02155166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93251552|NCT02155166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251553|NCT02155166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251554|NCT02155166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251555|NCT02155166|Analgesics|analgesics|mesh-ancestor
93251556|NCT02155166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251557|NCT02155166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251558|NCT02155166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93251559|NCT02155166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251560|NCT00398931|Alendronate|alendronate|mesh-list
93251561|NCT00398931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251562|NCT00398931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93251563|NCT00920361|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93251564|NCT00920361|Hormones|hormones|mesh-ancestor
93251565|NCT00920361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251566|NCT00920361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251567|NCT00651807|Etonogestrel|etonogestrel|mesh-list
93251568|NCT00651807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93251569|NCT00651807|Contraceptive Agents|contraceptive agents|mesh-ancestor
93251570|NCT00651807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251571|NCT00651807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251572|NCT00651807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93251573|NCT03246529|Lenograstim|lenograstim|mesh-list
93251574|NCT03246529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93251575|NCT03246529|Immunologic Factors|immunologic factors|mesh-ancestor
93251576|NCT03246529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251577|NCT02158910|Donepezil|donepezil|mesh-list
93251578|NCT02158910|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93251579|NCT02158910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251580|NCT02158910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251581|NCT02158910|Cholinergic Agents|cholinergic agents|mesh-ancestor
93251582|NCT02158910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251583|NCT02158910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251584|NCT02158910|Nootropic Agents|nootropic agents|mesh-ancestor
93251585|NCT03077659|Paclitaxel|paclitaxel|mesh-list
93251586|NCT03077659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93251587|NCT03077659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251588|NCT03077659|Tubulin Modulators|tubulin modulators|mesh-ancestor
93251589|NCT03077659|Antimitotic Agents|antimitotic agents|mesh-ancestor
93251590|NCT03077659|Mitosis Modulators|mitosis modulators|mesh-ancestor
93251591|NCT03077659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251592|NCT05052723|Pembrolizumab|pembrolizumab|mesh-list
93251593|NCT05052723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251594|NCT05052723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251595|NCT05052723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251596|NCT05052723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251597|NCT02807883|Blinatumomab|blinatumomab|mesh-list
93251598|NCT02807883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251599|NCT05563155|Dexamethasone|dexamethasone|mesh-list
93251600|NCT05563155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251601|NCT05563155|Antiemetics|antiemetics|mesh-ancestor
93251602|NCT05563155|Autonomic Agents|autonomic agents|mesh-ancestor
93251603|NCT05563155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251604|NCT05563155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251605|NCT05563155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93251606|NCT05563155|Glucocorticoids|glucocorticoids|mesh-ancestor
93251607|NCT05563155|Hormones|hormones|mesh-ancestor
93251608|NCT05563155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251609|NCT05563155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251610|NCT05563155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251611|NCT04051047|Gemcitabine|gemcitabine|mesh-list
93251612|NCT04051047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251613|NCT04051047|Antimetabolites|antimetabolites|mesh-ancestor
93251614|NCT04051047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251615|NCT04051047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251616|NCT00102440|Allopurinol|allopurinol|mesh-list
93251617|NCT00102440|Febuxostat|febuxostat|mesh-list
93251618|NCT00102440|Antimetabolites|antimetabolites|mesh-ancestor
93251619|NCT00102440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251620|NCT00102440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251621|NCT00102440|Gout Suppressants|gout suppressants|mesh-ancestor
93251622|NCT00102440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251623|NCT00102440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93251624|NCT00102440|Antioxidants|antioxidants|mesh-ancestor
93251625|NCT00102440|Protective Agents|protective agents|mesh-ancestor
93251626|NCT00102440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251627|NCT05224167|Melatonin|melatonin|mesh-list
93251628|NCT05224167|Hydroxyzine|hydroxyzine|mesh-list
93251629|NCT05224167|Antioxidants|antioxidants|mesh-ancestor
93251630|NCT05224167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251631|NCT05224167|Protective Agents|protective agents|mesh-ancestor
93251632|NCT05224167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251633|NCT05224167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251634|NCT05224167|Antipruritics|antipruritics|mesh-ancestor
93251635|NCT05224167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93251636|NCT05224167|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93251637|NCT05224167|Histamine Antagonists|histamine antagonists|mesh-ancestor
93251638|NCT05224167|Histamine Agents|histamine agents|mesh-ancestor
93251639|NCT05224167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251640|NCT01377259|Anesthetics|anesthetics|mesh-list
93251641|NCT01377259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251642|NCT01377259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251643|NCT04994535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93251644|NCT04994535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93251645|NCT04994535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93251646|NCT04994535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251647|NCT04994535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251648|NCT04994535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93251649|NCT04994535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93251650|NCT04994535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251651|NCT04994535|Cholinergic Agents|cholinergic agents|mesh-ancestor
93251652|NCT04994535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251653|NCT03909607|Ketamine|ketamine|mesh-list
93251654|NCT03909607|Analgesics|analgesics|mesh-ancestor
93251655|NCT03909607|Sensory System Agents|sensory system agents|mesh-ancestor
93251656|NCT03909607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251657|NCT03909607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251658|NCT03909607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93251659|NCT03909607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93251660|NCT03909607|Anesthetics, General|anesthetics, general|mesh-ancestor
93251661|NCT03909607|Anesthetics|anesthetics|mesh-ancestor
93251662|NCT03909607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251663|NCT03909607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93251664|NCT03909607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93251665|NCT03909607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251666|NCT03909607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251667|NCT03902509|Pirfenidone|pirfenidone|mesh-list
93251668|NCT03902509|Analgesics|analgesics|mesh-ancestor
93251669|NCT03902509|Sensory System Agents|sensory system agents|mesh-ancestor
93251670|NCT03902509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251671|NCT03902509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251672|NCT03902509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251673|NCT03902509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251674|NCT03902509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251675|NCT03902509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251676|NCT03902509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251677|NCT02166632|Bupivacaine|bupivacaine|mesh-list
93251678|NCT02166632|Anesthetics, Local|anesthetics, local|mesh-ancestor
93251679|NCT02166632|Anesthetics|anesthetics|mesh-ancestor
93251680|NCT02166632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251681|NCT02166632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251682|NCT02166632|Sensory System Agents|sensory system agents|mesh-ancestor
93251683|NCT02166632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251684|NCT02161952|Pirfenidone|pirfenidone|mesh-list
93251685|NCT02161952|Analgesics|analgesics|mesh-ancestor
93251686|NCT02161952|Sensory System Agents|sensory system agents|mesh-ancestor
93251687|NCT02161952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251688|NCT02161952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251689|NCT02161952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251690|NCT02161952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251691|NCT02161952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251692|NCT02161952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251693|NCT02161952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251694|NCT04993677|Carboplatin|carboplatin|mesh-list
93251695|NCT04993677|Pembrolizumab|pembrolizumab|mesh-list
93251696|NCT04993677|Pemetrexed|pemetrexed|mesh-list
93251697|NCT04993677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251698|NCT04993677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251699|NCT04993677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251700|NCT04993677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251701|NCT04993677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251702|NCT04993677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93251703|NCT04993677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93251704|NCT05047731|Antihypertensive Agents|antihypertensive agents|mesh-list
93251705|NCT04795869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93251706|NCT04795869|Pembrolizumab|pembrolizumab|mesh-list
93251707|NCT04795869|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93251708|NCT04795869|Antibodies|antibodies|mesh-list
93251709|NCT04795869|Immunoglobulins|immunoglobulins|mesh-list
93251710|NCT04795869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93251711|NCT04795869|Immunoconjugates|immunoconjugates|mesh-list
93251712|NCT04795869|Immunologic Factors|immunologic factors|mesh-ancestor
93251713|NCT04795869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251714|NCT04795869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251715|NCT04795869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251716|NCT04795869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251717|NCT04795869|Immunotoxins|immunotoxins|mesh-ancestor
93251718|NCT04050735|Ethanol|ethanol|mesh-list
93251719|NCT04050735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93251720|NCT04050735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251721|NCT04050735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251722|NCT04050735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251723|NCT04784559|Remdesivir|remdesivir|mesh-list
93251724|NCT04784559|Favipiravir|favipiravir|mesh-list
93251725|NCT04784559|Dexamethasone|dexamethasone|mesh-list
93251726|NCT04784559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251727|NCT04784559|Antiemetics|antiemetics|mesh-ancestor
93251728|NCT04784559|Autonomic Agents|autonomic agents|mesh-ancestor
93251729|NCT04784559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251730|NCT04784559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251731|NCT04784559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93251732|NCT04784559|Glucocorticoids|glucocorticoids|mesh-ancestor
93251733|NCT04784559|Hormones|hormones|mesh-ancestor
93251734|NCT04784559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251735|NCT04784559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251736|NCT04784559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251737|NCT04784559|Antimetabolites|antimetabolites|mesh-ancestor
93251738|NCT04784559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251739|NCT04784559|Antiviral Agents|antiviral agents|mesh-ancestor
93251740|NCT04784559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251741|NCT03704181|Colchicine|colchicine|mesh-list
93251742|NCT03704181|Gout Suppressants|gout suppressants|mesh-ancestor
93251743|NCT03704181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251744|NCT03704181|Tubulin Modulators|tubulin modulators|mesh-ancestor
93251745|NCT03704181|Antimitotic Agents|antimitotic agents|mesh-ancestor
93251746|NCT03704181|Mitosis Modulators|mitosis modulators|mesh-ancestor
93251747|NCT03704181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251748|NCT03704181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251749|NCT03625011|Gabapentin|gabapentin|mesh-list
93251750|NCT03625011|Analgesics|analgesics|mesh-ancestor
93251751|NCT03625011|Sensory System Agents|sensory system agents|mesh-ancestor
93251752|NCT03625011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251753|NCT03625011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251754|NCT03625011|Anticonvulsants|anticonvulsants|mesh-ancestor
93251755|NCT03625011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93251756|NCT03625011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93251757|NCT03625011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251758|NCT03625011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93251759|NCT03625011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93251760|NCT03625011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93251761|NCT03625011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251762|NCT03625011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251763|NCT03625011|Antimanic Agents|antimanic agents|mesh-ancestor
93251764|NCT03625167|Petrolatum|petrolatum|mesh-list
93251765|NCT03625167|Emollients|emollients|mesh-ancestor
93251766|NCT03625167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93251767|NCT04718727|Olanzapine|olanzapine|mesh-list
93251768|NCT04718727|Antiemetics|antiemetics|mesh-ancestor
93251769|NCT04718727|Autonomic Agents|autonomic agents|mesh-ancestor
93251770|NCT04718727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546352|NCT05663580|Rilpivirine|rilpivirine|mesh-list
93251771|NCT04718727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251772|NCT04718727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93251773|NCT04718727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93251774|NCT04718727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93251775|NCT04718727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251776|NCT04718727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93251777|NCT04718727|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93251778|NCT04718727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93251779|NCT04718727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93251780|NCT04718727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251781|NCT04718727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251782|NCT04718727|Serotonin Agents|serotonin agents|mesh-ancestor
93251783|NCT03701529|Anesthetics|anesthetics|mesh-list
93251784|NCT03701529|Propofol|propofol|mesh-list
93251785|NCT03701529|Sevoflurane|sevoflurane|mesh-list
93251786|NCT03701529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251787|NCT03701529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251788|NCT03701529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93251789|NCT03701529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93251790|NCT03701529|Anesthetics, General|anesthetics, general|mesh-ancestor
93251791|NCT03701529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92923701|NCT00915746|Ketoconazole|ketoconazole|mesh-list
93251792|NCT03701529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93251793|NCT04535271|Gemcitabine|gemcitabine|mesh-list
93251794|NCT04535271|Dacarbazine|dacarbazine|mesh-list
93251795|NCT04535271|Trabectedin|trabectedin|mesh-list
93251796|NCT04535271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251797|NCT04535271|Antimetabolites|antimetabolites|mesh-ancestor
93251798|NCT04535271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251799|NCT04535271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251800|NCT04535271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93251801|NCT04535271|Alkylating Agents|alkylating agents|mesh-ancestor
93251802|NCT04553133|Letrozole|letrozole|mesh-list
93251803|NCT04553133|Fulvestrant|fulvestrant|mesh-list
93251804|NCT04553133|Palbociclib|palbociclib|mesh-list
93251805|NCT04553133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251806|NCT04553133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93251807|NCT04553133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93251808|NCT04553133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251809|NCT04553133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251810|NCT04553133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93251811|NCT04553133|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251812|NCT04553133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251813|NCT04553133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251814|NCT04553133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251815|NCT04553133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93251816|NCT04553133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93251817|NCT03701451|Decitabine|decitabine|mesh-list
93251818|NCT03701451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251819|NCT03701451|Antimetabolites|antimetabolites|mesh-ancestor
93251820|NCT03701451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251821|NCT03701451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251822|NCT03701451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251823|NCT03703089|Paclitaxel|paclitaxel|mesh-list
93251824|NCT03703089|Gemcitabine|gemcitabine|mesh-list
93251825|NCT03703089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93251826|NCT03703089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251827|NCT03703089|Tubulin Modulators|tubulin modulators|mesh-ancestor
93251828|NCT03703089|Antimitotic Agents|antimitotic agents|mesh-ancestor
93251829|NCT03703089|Mitosis Modulators|mitosis modulators|mesh-ancestor
93251830|NCT03703089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251831|NCT03703089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251832|NCT03703089|Antimetabolites|antimetabolites|mesh-ancestor
93251833|NCT02807844|Spartalizumab|spartalizumab|mesh-list
93251834|NCT02807844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251835|NCT02807844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251836|NCT02807844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251837|NCT02807844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251838|NCT02763566|Letrozole|letrozole|mesh-list
93251839|NCT02763566|Fulvestrant|fulvestrant|mesh-list
93251840|NCT02763566|Anastrozole|anastrozole|mesh-list
93251841|NCT02763566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251842|NCT02763566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93251843|NCT02763566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93251844|NCT02763566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251845|NCT02763566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251846|NCT02763566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93251847|NCT02763566|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251848|NCT02763566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251849|NCT02763566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251850|NCT02763566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251851|NCT02763566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93251852|NCT03702855|Tetrabenazine|tetrabenazine|mesh-list
93251853|NCT03702855|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93251854|NCT03702855|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93251855|NCT03702855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93251856|NCT03702855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251857|NCT03702855|Adrenergic Agents|adrenergic agents|mesh-ancestor
93251858|NCT03702855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251859|NCT03702855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251860|NCT02052180|Bupivacaine|bupivacaine|mesh-list
93251861|NCT02052180|Anesthetics, Local|anesthetics, local|mesh-ancestor
93251862|NCT02052180|Anesthetics|anesthetics|mesh-ancestor
93251863|NCT02052180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251864|NCT02052180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251865|NCT02052180|Sensory System Agents|sensory system agents|mesh-ancestor
93251866|NCT02052180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251868|NCT03561402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251869|NCT03561402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251870|NCT03561402|Analgesics|analgesics|mesh-ancestor
93251871|NCT03561402|Sensory System Agents|sensory system agents|mesh-ancestor
93251872|NCT03561402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251873|NCT03561402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251874|NCT03561402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251875|NCT03561402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251876|NCT03561402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93251877|NCT03561402|Immunologic Factors|immunologic factors|mesh-ancestor
93251878|NCT04542135|Sulindac|sulindac|mesh-list
93251879|NCT04542135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93251880|NCT04542135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93251881|NCT04542135|Analgesics|analgesics|mesh-ancestor
93251882|NCT04542135|Sensory System Agents|sensory system agents|mesh-ancestor
93251883|NCT04542135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251884|NCT04542135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251885|NCT04542135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251886|NCT04542135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93251887|NCT04542135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251888|NCT04542135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93251889|NCT04542135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251890|NCT04542135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251891|NCT04694781|Pembrolizumab|pembrolizumab|mesh-list
93251892|NCT04694781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251893|NCT04694781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251894|NCT04694781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251895|NCT04694781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251896|NCT02805972|Naloxone|naloxone|mesh-list
93251897|NCT02805972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93251898|NCT02805972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251899|NCT02805972|Sensory System Agents|sensory system agents|mesh-ancestor
93251900|NCT02805972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251901|NCT02052258|Oxytocin|oxytocin|mesh-list
93251902|NCT02052258|Oxytocics|oxytocics|mesh-ancestor
93251903|NCT02052258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93251904|NCT02052258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251905|NCT02053818|Sufentanil|sufentanil|mesh-list
93251906|NCT02053818|Remifentanil|remifentanil|mesh-list
93251907|NCT02053818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93251908|NCT02053818|Narcotics|narcotics|mesh-ancestor
93251909|NCT02053818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251910|NCT02053818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251911|NCT02053818|Analgesics|analgesics|mesh-ancestor
93251912|NCT02053818|Sensory System Agents|sensory system agents|mesh-ancestor
93251913|NCT02053818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93251914|NCT02053818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93251915|NCT02053818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93251916|NCT02053818|Anesthetics, General|anesthetics, general|mesh-ancestor
93251917|NCT02053818|Anesthetics|anesthetics|mesh-ancestor
93251918|NCT03702387|Anesthetics|anesthetics|mesh-list
93251919|NCT03702387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93251920|NCT03702387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251921|NCT03031899|Tolonium Chloride|tolonium chloride|mesh-list
93251922|NCT03031899|Hemostatics|hemostatics|mesh-ancestor
93251923|NCT03031899|Coagulants|coagulants|mesh-ancestor
93251924|NCT03031899|Heparin Antagonists|heparin antagonists|mesh-ancestor
93251925|NCT03031899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251926|NCT03700905|Nivolumab|nivolumab|mesh-list
93251927|NCT03700905|Ipilimumab|ipilimumab|mesh-list
93251928|NCT03700905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93251929|NCT03700905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251930|NCT03700905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93251931|NCT03700905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251932|NCT03700749|Iodine|iodine|mesh-list
93251933|NCT03700749|Chlorhexidine|chlorhexidine|mesh-list
93251934|NCT03700749|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93251935|NCT03700749|Cadexomer iodine|cadexomer iodine|mesh-list
93251936|NCT03700749|Povidone-Iodine|povidone-iodine|mesh-list
93251937|NCT03700749|Povidone|povidone|mesh-list
93251938|NCT03700749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93251939|NCT03700749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93251940|NCT03700749|Disinfectants|disinfectants|mesh-ancestor
93251941|NCT03700749|Dermatologic Agents|dermatologic agents|mesh-ancestor
93251942|NCT03700749|Trace Elements|trace elements|mesh-ancestor
93251943|NCT03700749|Micronutrients|micronutrients|mesh-ancestor
93251944|NCT03700749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251945|NCT03700749|Plasma Substitutes|plasma substitutes|mesh-ancestor
93251946|NCT03700749|Blood Substitutes|blood substitutes|mesh-ancestor
93251947|NCT03086369|Paclitaxel|paclitaxel|mesh-list
93251948|NCT03086369|Gemcitabine|gemcitabine|mesh-list
93251949|NCT03086369|Olaratumab|olaratumab|mesh-list
93251950|NCT03086369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93251951|NCT03086369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251952|NCT03086369|Tubulin Modulators|tubulin modulators|mesh-ancestor
93251953|NCT03086369|Antimitotic Agents|antimitotic agents|mesh-ancestor
93251954|NCT03086369|Mitosis Modulators|mitosis modulators|mesh-ancestor
93251955|NCT03086369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251956|NCT03086369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93251957|NCT03086369|Antimetabolites|antimetabolites|mesh-ancestor
93251958|NCT00101582|Cisplatin|cisplatin|mesh-list
93251959|NCT00101582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251960|NCT05326373|Fluorides|fluorides|mesh-list
93251961|NCT05326373|Tin Fluorides|tin fluorides|mesh-list
93251962|NCT05326373|Cariostatic Agents|cariostatic agents|mesh-ancestor
93251963|NCT05326373|Protective Agents|protective agents|mesh-ancestor
93251964|NCT05326373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251965|NCT02166944|Tamoxifen|tamoxifen|mesh-list
93251966|NCT02166944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93251967|NCT02166944|Hormone Antagonists|hormone antagonists|mesh-ancestor
93251968|NCT02166944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93251969|NCT02166944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251970|NCT02166944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93251971|NCT02166944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251972|NCT02166944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93251973|NCT02166944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93251974|NCT02166944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93251975|NCT03540836|Cortisone|cortisone|mesh-list
93251976|NCT03540836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93251977|NCT04211675|Irinotecan|irinotecan|mesh-list
93251978|NCT04211675|Temozolomide|temozolomide|mesh-list
93251979|NCT04211675|Dinutuximab|dinutuximab|mesh-list
93251980|NCT04211675|Sargramostim|sargramostim|mesh-list
93251981|NCT04211675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93251982|NCT04211675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93251983|NCT04211675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251984|NCT04211675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251985|NCT04211675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93251986|NCT04211675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93251987|NCT04211675|Alkylating Agents|alkylating agents|mesh-ancestor
93251988|NCT04211675|Immunologic Factors|immunologic factors|mesh-ancestor
93251989|NCT04211675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251990|NCT02162264|Donepezil|donepezil|mesh-list
93251991|NCT02162264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93251992|NCT02162264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93251993|NCT02162264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93251994|NCT02162264|Cholinergic Agents|cholinergic agents|mesh-ancestor
93251995|NCT02162264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93251996|NCT02162264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93251997|NCT02162264|Nootropic Agents|nootropic agents|mesh-ancestor
93251998|NCT03700515|Epoetin Alfa|epoetin alfa|mesh-list
93251999|NCT03700515|Hematinics|hematinics|mesh-ancestor
93252000|NCT04740008|Nicotine|nicotine|mesh-list
93252001|NCT04740008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93252002|NCT04740008|Autonomic Agents|autonomic agents|mesh-ancestor
93252003|NCT04740008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252004|NCT04740008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252005|NCT04740008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93252006|NCT04740008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93252007|NCT04740008|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252008|NCT04740008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252009|NCT04740008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252010|NCT03700359|Etoposide|etoposide|mesh-list
93252011|NCT03700359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93252012|NCT03700359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252013|NCT03700359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93252014|NCT03700359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92923929|NCT00784550|Fluticasone|fluticasone|mesh-list
93252015|NCT03700359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366398|NCT02061917|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93252016|NCT03700359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252018|NCT02167178|Plasma Substitutes|plasma substitutes|mesh-ancestor
93252019|NCT02167178|Blood Substitutes|blood substitutes|mesh-ancestor
93252020|NCT03625089|Atorvastatin|atorvastatin|mesh-list
93252021|NCT03625089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93252022|NCT03625089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93252023|NCT03625089|Antimetabolites|antimetabolites|mesh-ancestor
93252024|NCT03625089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252025|NCT03625089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93252026|NCT03625089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93252027|NCT03625089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252028|NCT01378949|Morphine|morphine|mesh-list
93252029|NCT01378949|Bupivacaine|bupivacaine|mesh-list
93252030|NCT01378949|Anesthetics, Local|anesthetics, local|mesh-ancestor
93252031|NCT01378949|Anesthetics|anesthetics|mesh-ancestor
93252032|NCT01378949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252033|NCT01378949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252034|NCT01378949|Sensory System Agents|sensory system agents|mesh-ancestor
93252035|NCT01378949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252036|NCT01378949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93252037|NCT01378949|Narcotics|narcotics|mesh-ancestor
93252038|NCT01378949|Analgesics|analgesics|mesh-ancestor
93252039|NCT01381055|Pentoxifylline|pentoxifylline|mesh-list
93252040|NCT01381055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93252041|NCT01381055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252042|NCT01381055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252043|NCT01381055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93252044|NCT01381055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93252045|NCT01381055|Protective Agents|protective agents|mesh-ancestor
93252046|NCT01381055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252047|NCT01381055|Vasodilator Agents|vasodilator agents|mesh-ancestor
93252048|NCT01381055|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93252049|NCT01381055|Antioxidants|antioxidants|mesh-ancestor
93252050|NCT04649229|Aprepitant|aprepitant|mesh-list
93252051|NCT04649229|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93252052|NCT04649229|Antiemetics|antiemetics|mesh-ancestor
93252053|NCT04649229|Autonomic Agents|autonomic agents|mesh-ancestor
93252054|NCT04649229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252055|NCT04649229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252056|NCT04649229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93252057|NCT04649229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93252058|NCT04649229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252059|NCT04649229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252060|NCT04649229|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93252061|NCT03122613|Curcumin|curcumin|mesh-list
93252062|NCT03122613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93252063|NCT03122613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252064|NCT03122613|Analgesics|analgesics|mesh-ancestor
93252065|NCT03122613|Sensory System Agents|sensory system agents|mesh-ancestor
93252066|NCT03122613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252067|NCT03122613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252068|NCT03122613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93252069|NCT03122613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252070|NCT03122613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252071|NCT03122613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252072|NCT03122613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252073|NCT03540368|Tranexamic Acid|tranexamic acid|mesh-list
93252074|NCT03540368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93252075|NCT03540368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93252076|NCT03540368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252077|NCT03540368|Hemostatics|hemostatics|mesh-ancestor
93252078|NCT03540368|Coagulants|coagulants|mesh-ancestor
93252079|NCT02255396|Estradiol|estradiol|mesh-list
93252080|NCT02255396|Estrogens|estrogens|mesh-ancestor
93252081|NCT02255396|Hormones|hormones|mesh-ancestor
93252082|NCT02255396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252083|NCT02255396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252084|NCT02163980|Dexmedetomidine|dexmedetomidine|mesh-list
93252085|NCT02163980|Ropivacaine|ropivacaine|mesh-list
93252086|NCT02163980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93252087|NCT02163980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252088|NCT02163980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924004|NCT05684913|Hemostatics|hemostatics|mesh-list
93252089|NCT02163980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252090|NCT02163980|Analgesics|analgesics|mesh-ancestor
93252091|NCT02163980|Sensory System Agents|sensory system agents|mesh-ancestor
93252092|NCT02163980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252093|NCT02163980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93252094|NCT02163980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93252095|NCT02163980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93252096|NCT02163980|Adrenergic Agents|adrenergic agents|mesh-ancestor
93252097|NCT02163980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252098|NCT02163980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252099|NCT02163980|Anesthetics, Local|anesthetics, local|mesh-ancestor
93252100|NCT02163980|Anesthetics|anesthetics|mesh-ancestor
93252101|NCT02162888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93252102|NCT02162888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252103|NCT02162888|Alkylating Agents|alkylating agents|mesh-ancestor
93252104|NCT02162888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252105|NCT02162888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252106|NCT01569035|Warfarin|warfarin|mesh-list
93252107|NCT01569035|Anticoagulants|anticoagulants|mesh-ancestor
93252108|NCT03841565|Dexamethasone|dexamethasone|mesh-list
93252109|NCT03841565|Dexamethasone acetate|dexamethasone acetate|mesh-list
93252110|NCT03841565|Daratumumab|daratumumab|mesh-list
93252111|NCT03841565|Pomalidomide|pomalidomide|mesh-list
93252112|NCT03841565|Ichthammol|ichthammol|mesh-list
93252113|NCT03841565|BB 1101|bb 1101|mesh-list
93252114|NCT03841565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93252115|NCT03841565|Antiemetics|antiemetics|mesh-ancestor
93252116|NCT03841565|Autonomic Agents|autonomic agents|mesh-ancestor
93252117|NCT03841565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252118|NCT03841565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252119|NCT03841565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93252120|NCT03841565|Glucocorticoids|glucocorticoids|mesh-ancestor
93252121|NCT03841565|Hormones|hormones|mesh-ancestor
93252122|NCT03841565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252123|NCT03841565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93252124|NCT03841565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252125|NCT03841565|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252126|NCT03841565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252127|NCT03841565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252128|NCT03841565|Immunologic Factors|immunologic factors|mesh-ancestor
93252129|NCT03841565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93252130|NCT03841565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93252131|NCT03841565|Growth Substances|growth substances|mesh-ancestor
93252132|NCT03841565|Growth Inhibitors|growth inhibitors|mesh-ancestor
93252133|NCT03841565|Dermatologic Agents|dermatologic agents|mesh-ancestor
93252134|NCT02162966|Colistin|colistin|mesh-list
93252135|NCT02162966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93252136|NCT02162966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252137|NCT01595321|Leucovorin|leucovorin|mesh-list
93252138|NCT01595321|Cyclophosphamide|cyclophosphamide|mesh-list
93252139|NCT01595321|Fluorouracil|fluorouracil|mesh-list
93252140|NCT01595321|Oxaliplatin|oxaliplatin|mesh-list
93252141|NCT01595321|Irinotecan|irinotecan|mesh-list
93252142|NCT01595321|Folfirinox|folfirinox|mesh-list
93252143|NCT01595321|Vaccines|vaccines|mesh-list
93252144|NCT01595321|Immunologic Factors|immunologic factors|mesh-ancestor
93252145|NCT01595321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252146|NCT01595321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252147|NCT01595321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252148|NCT01595321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252149|NCT01595321|Alkylating Agents|alkylating agents|mesh-ancestor
93252150|NCT01595321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252151|NCT01595321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252152|NCT01595321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93252153|NCT01595321|Antimetabolites|antimetabolites|mesh-ancestor
93252154|NCT01595321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93252155|NCT01595321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93252156|NCT01595321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93252157|NCT01595321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252158|NCT01595321|Antidotes|antidotes|mesh-ancestor
93252159|NCT01595321|Protective Agents|protective agents|mesh-ancestor
93252160|NCT01595321|Vitamin B Complex|vitamin b complex|mesh-ancestor
93252161|NCT01595321|Vitamins|vitamins|mesh-ancestor
93252162|NCT01595321|Micronutrients|micronutrients|mesh-ancestor
93252163|NCT02164214|Etanercept|etanercept|mesh-list
93252164|NCT02164214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92924076|NCT00775190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252165|NCT02164214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252166|NCT02164214|Analgesics|analgesics|mesh-ancestor
93252167|NCT02164214|Sensory System Agents|sensory system agents|mesh-ancestor
93252168|NCT02164214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252169|NCT02164214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252170|NCT02164214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93252171|NCT02164214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252172|NCT02164214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93252173|NCT02164214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252174|NCT02164214|Immunologic Factors|immunologic factors|mesh-ancestor
93252175|NCT03722849|Adenosine|adenosine|mesh-list
93252176|NCT03722849|Capsaicin|capsaicin|mesh-list
93252177|NCT03722849|Antipruritics|antipruritics|mesh-ancestor
93252178|NCT03722849|Dermatologic Agents|dermatologic agents|mesh-ancestor
93252179|NCT03722849|Sensory System Agents|sensory system agents|mesh-ancestor
93252180|NCT03722849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252181|NCT03722849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252182|NCT03722849|Analgesics|analgesics|mesh-ancestor
93252183|NCT03722849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252184|NCT03722849|Vasodilator Agents|vasodilator agents|mesh-ancestor
93252185|NCT03722849|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93252186|NCT03722849|Purinergic Agonists|purinergic agonists|mesh-ancestor
93252187|NCT03722849|Purinergic Agents|purinergic agents|mesh-ancestor
93252188|NCT03722849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252189|NCT03722849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252190|NCT02170844|Dabigatran|dabigatran|mesh-list
93252191|NCT02170844|Antithrombins|antithrombins|mesh-ancestor
93252192|NCT02170844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252193|NCT02170844|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252194|NCT02170844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252195|NCT02170844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252196|NCT02170844|Anticoagulants|anticoagulants|mesh-ancestor
93252197|NCT02170922|Dabigatran|dabigatran|mesh-list
93252198|NCT02170922|Antithrombins|antithrombins|mesh-ancestor
93252199|NCT02170922|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252200|NCT02170922|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252201|NCT02170922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252202|NCT02170922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252203|NCT02170922|Anticoagulants|anticoagulants|mesh-ancestor
93252204|NCT02167958|Cyclophosphamide|cyclophosphamide|mesh-list
93252205|NCT02167958|Fludarabine|fludarabine|mesh-list
93252206|NCT02167958|Tacrolimus|tacrolimus|mesh-list
93252207|NCT02167958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252208|NCT02167958|Immunologic Factors|immunologic factors|mesh-ancestor
93252209|NCT02167958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252210|NCT02167958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252211|NCT02167958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252212|NCT02167958|Alkylating Agents|alkylating agents|mesh-ancestor
93252213|NCT02167958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252214|NCT02167958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252215|NCT02167958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93252216|NCT02167958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93252217|NCT02167958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252218|NCT01384331|NuvaRing|nuvaring|mesh-list
93252219|NCT01384331|Desogestrel|desogestrel|mesh-list
93252220|NCT01384331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93252221|NCT01384331|Contraceptive Agents|contraceptive agents|mesh-ancestor
93252222|NCT01384331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93252223|NCT01384331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252224|NCT01384331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93252225|NCT01384331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93252226|NCT01384331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93252227|NCT01384331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93252228|NCT01384331|Progestins|progestins|mesh-ancestor
93252229|NCT01384331|Hormones|hormones|mesh-ancestor
93252230|NCT01384331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252231|NCT03699423|Atropine|atropine|mesh-list
93252232|NCT03699423|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93252233|NCT03699423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93252234|NCT03699423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93252235|NCT03699423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252236|NCT03699423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252237|NCT03699423|Autonomic Agents|autonomic agents|mesh-ancestor
93252238|NCT03699423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252239|NCT03699423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252240|NCT03699423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93366399|NCT02061917|Autonomic Agents|autonomic agents|mesh-ancestor
92924151|NCT00724932|Atropine|atropine|mesh-list
93252241|NCT03699423|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252242|NCT03699423|Mydriatics|mydriatics|mesh-ancestor
93252243|NCT03699423|Parasympatholytics|parasympatholytics|mesh-ancestor
93252244|NCT03699423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93252245|NCT03699423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252246|NCT03699423|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252247|NCT03699423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252248|NCT03699423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252249|NCT02164448|Dexmedetomidine|dexmedetomidine|mesh-list
93252250|NCT02164448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93252251|NCT02164448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252252|NCT02164448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252253|NCT02164448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252254|NCT02164448|Analgesics|analgesics|mesh-ancestor
93252255|NCT02164448|Sensory System Agents|sensory system agents|mesh-ancestor
93252256|NCT02164448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252257|NCT02164448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93252258|NCT02164448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93252259|NCT02164448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93252260|NCT02164448|Adrenergic Agents|adrenergic agents|mesh-ancestor
93252261|NCT02164448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252262|NCT02164448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252263|NCT03612713|Oxycodone|oxycodone|mesh-list
93252264|NCT03612713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93252265|NCT03612713|Narcotics|narcotics|mesh-ancestor
93252266|NCT03612713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252267|NCT03612713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252268|NCT03612713|Analgesics|analgesics|mesh-ancestor
93252269|NCT03612713|Sensory System Agents|sensory system agents|mesh-ancestor
93252270|NCT03612713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252271|NCT01380509|Metronidazole|metronidazole|mesh-list
93252272|NCT01380509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252273|NCT01380509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93252274|NCT01380509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93252275|NCT01380509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93252276|NCT01378715|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93252277|NCT01378715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93252278|NCT01378715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93252279|NCT01378715|Antimetabolites|antimetabolites|mesh-ancestor
92546850|NCT04629534|Vitamins|vitamins|mesh-ancestor
93252280|NCT01378715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252281|NCT01378715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93252282|NCT01378715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93252283|NCT01378715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252284|NCT04853043|Cetuximab|cetuximab|mesh-list
93252285|NCT04853043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252286|NCT04853043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252287|NCT00976131|Ubiquinone|ubiquinone|mesh-list
93252288|NCT00976131|Coenzyme Q10|coenzyme q10|mesh-list
93252289|NCT00976131|Cyclophosphamide|cyclophosphamide|mesh-list
93252290|NCT00976131|Doxorubicin|doxorubicin|mesh-list
93252291|NCT00976131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252292|NCT00976131|Immunologic Factors|immunologic factors|mesh-ancestor
93252293|NCT00976131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252294|NCT00976131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252295|NCT00976131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252296|NCT00976131|Alkylating Agents|alkylating agents|mesh-ancestor
93252297|NCT00976131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252298|NCT00976131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252299|NCT00976131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93252300|NCT00976131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93252301|NCT00976131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93252302|NCT00976131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93252303|NCT00976131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252304|NCT00976131|Micronutrients|micronutrients|mesh-ancestor
93252305|NCT00976131|Vitamins|vitamins|mesh-ancestor
93252306|NCT01384253|Trastuzumab|trastuzumab|mesh-list
93252307|NCT01384253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252308|NCT01384253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252309|NCT03631277|Calcium|calcium|mesh-list
93252310|NCT03631277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93252311|NCT03631277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252312|NCT02171000|Dabigatran|dabigatran|mesh-list
93252313|NCT02171000|Antithrombins|antithrombins|mesh-ancestor
93252314|NCT02171000|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252315|NCT02171000|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252316|NCT02171000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252317|NCT02171000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252318|NCT02171000|Anticoagulants|anticoagulants|mesh-ancestor
93252319|NCT04841265|Vitamin D|vitamin d|mesh-list
93252320|NCT04841265|Cholecalciferol|cholecalciferol|mesh-list
93252321|NCT04841265|Vitamins|vitamins|mesh-ancestor
93252322|NCT04841265|Micronutrients|micronutrients|mesh-ancestor
93252323|NCT04841265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252324|NCT04841265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93252325|NCT04841265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93252326|NCT02164604|Ranibizumab|ranibizumab|mesh-list
93252327|NCT02164604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93252328|NCT02164604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93252329|NCT02164604|Growth Substances|growth substances|mesh-ancestor
93252330|NCT02164604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252331|NCT02164604|Growth Inhibitors|growth inhibitors|mesh-ancestor
93252332|NCT02164604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252333|NCT04380831|Cyclophosphamide|cyclophosphamide|mesh-list
93252334|NCT04380831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252335|NCT04380831|Immunologic Factors|immunologic factors|mesh-ancestor
93252336|NCT04380831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252337|NCT04380831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252338|NCT04380831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252339|NCT04380831|Alkylating Agents|alkylating agents|mesh-ancestor
93252340|NCT04380831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252341|NCT04380831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252342|NCT04380831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93252343|NCT04571645|Heparin|heparin|mesh-list
93252344|NCT04571645|Anticoagulants|anticoagulants|mesh-ancestor
93252345|NCT04571645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93252346|NCT04571645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93252347|NCT04571645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252348|NCT04050267|Nitrous Oxide|nitrous oxide|mesh-list
93252349|NCT04050267|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93252350|NCT04050267|Anesthetics, General|anesthetics, general|mesh-ancestor
93252351|NCT04050267|Anesthetics|anesthetics|mesh-ancestor
93252352|NCT04050267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252353|NCT04050267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252354|NCT04050267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252355|NCT04050267|Analgesics|analgesics|mesh-ancestor
93252356|NCT04050267|Sensory System Agents|sensory system agents|mesh-ancestor
93252357|NCT04050267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252358|NCT02759120|Doxycycline|doxycycline|mesh-list
93252359|NCT02759120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93252360|NCT02759120|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93252361|NCT02759120|Anti-Infective Agents|anti-infective agents|mesh-list
93252362|NCT02759120|Antimalarials|antimalarials|mesh-ancestor
93252363|NCT02759120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93252364|NCT02759120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93252365|NCT02759120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93252366|NCT01569113|Levonorgestrel|levonorgestrel|mesh-list
93252367|NCT01569113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93252368|NCT01569113|Ulipristal acetate|ulipristal acetate|mesh-list
93252369|NCT01569113|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93252370|NCT01569113|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93252371|NCT01569113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93252372|NCT01569113|Contraceptive Agents|contraceptive agents|mesh-ancestor
93252373|NCT01569113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93252374|NCT01569113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252375|NCT01569113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93252376|NCT01569113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93252377|NCT01569113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93252378|NCT01569113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93252379|NCT01569113|Estrogens|estrogens|mesh-ancestor
93252380|NCT01569113|Hormones|hormones|mesh-ancestor
93252381|NCT01569113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252382|NCT01569113|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93252383|NCT01569113|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93252384|NCT01569113|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93252385|NCT01569113|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93252386|NCT03699033|Paclitaxel|paclitaxel|mesh-list
93252387|NCT03699033|Carboplatin|carboplatin|mesh-list
93252388|NCT03699033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93252389|NCT03699033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924325|NCT03002389|Xhance|xhance|mesh-list
93252390|NCT03699033|Tubulin Modulators|tubulin modulators|mesh-ancestor
93252391|NCT03699033|Antimitotic Agents|antimitotic agents|mesh-ancestor
93252392|NCT03699033|Mitosis Modulators|mitosis modulators|mesh-ancestor
93252393|NCT03699033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252394|NCT03697239|Ascorbic Acid|ascorbic acid|mesh-list
93252395|NCT03697239|Paclitaxel|paclitaxel|mesh-list
93252396|NCT03697239|Gemcitabine|gemcitabine|mesh-list
93252397|NCT03697239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93252398|NCT03697239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93252399|NCT03697239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252400|NCT03697239|Tubulin Modulators|tubulin modulators|mesh-ancestor
93252401|NCT03697239|Antimitotic Agents|antimitotic agents|mesh-ancestor
93252402|NCT03697239|Mitosis Modulators|mitosis modulators|mesh-ancestor
93252403|NCT03697239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252404|NCT03697239|Vitamins|vitamins|mesh-ancestor
93252405|NCT03697239|Micronutrients|micronutrients|mesh-ancestor
93252406|NCT03697239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252407|NCT03697239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93252408|NCT03697239|Antimetabolites|antimetabolites|mesh-ancestor
93252409|NCT03697239|Antioxidants|antioxidants|mesh-ancestor
93252410|NCT03697239|Protective Agents|protective agents|mesh-ancestor
93252411|NCT01380431|Lisinopril|lisinopril|mesh-list
93252412|NCT01380431|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93252413|NCT01380431|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252414|NCT01380431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252415|NCT01380431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252416|NCT01380431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93252417|NCT01380431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93252418|NCT01380431|Protective Agents|protective agents|mesh-ancestor
93252419|NCT01380431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252420|NCT03697161|Gaboxadol|gaboxadol|mesh-list
93252421|NCT03697161|Analgesics|analgesics|mesh-ancestor
93252422|NCT03697161|Sensory System Agents|sensory system agents|mesh-ancestor
93252423|NCT03697161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252424|NCT03697161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252425|NCT03697161|Anticonvulsants|anticonvulsants|mesh-ancestor
93252426|NCT03697161|GABA Agonists|gaba agonists|mesh-ancestor
93252427|NCT03697161|GABA Agents|gaba agents|mesh-ancestor
93252428|NCT03697161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252429|NCT03697161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252430|NCT03164993|Cyclophosphamide|cyclophosphamide|mesh-list
93252431|NCT03164993|Doxorubicin|doxorubicin|mesh-list
93252432|NCT03164993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93252433|NCT03164993|Atezolizumab|atezolizumab|mesh-list
93252434|NCT03164993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252435|NCT03164993|Immunologic Factors|immunologic factors|mesh-ancestor
93252436|NCT03164993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252437|NCT03164993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252438|NCT03164993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252439|NCT03164993|Alkylating Agents|alkylating agents|mesh-ancestor
93252440|NCT03164993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252441|NCT03164993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252442|NCT03164993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93252443|NCT03164993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93252444|NCT03164993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93252445|NCT03164993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93252446|NCT03164993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252447|NCT03164993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93252448|NCT03164993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252449|NCT02171156|Nintedanib|nintedanib|mesh-list
93252450|NCT02171156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252451|NCT02171156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93252452|NCT02171156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252453|NCT02171156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252454|NCT01380353|Diclofenac|diclofenac|mesh-list
93252455|NCT01380353|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
93252456|NCT01380353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93252457|NCT01380353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252458|NCT01380353|Analgesics|analgesics|mesh-ancestor
93252459|NCT01380353|Sensory System Agents|sensory system agents|mesh-ancestor
93252460|NCT01380353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252461|NCT01380353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252462|NCT01380353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93252463|NCT01380353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252464|NCT01380353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93252465|NCT01380353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252466|NCT01380353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252467|NCT02168426|Hyaluronic Acid|hyaluronic acid|mesh-list
93252468|NCT02168426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93252469|NCT02168426|Immunologic Factors|immunologic factors|mesh-ancestor
93252470|NCT02168426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252471|NCT02168426|Viscosupplements|viscosupplements|mesh-ancestor
93252472|NCT02168426|Protective Agents|protective agents|mesh-ancestor
93252473|NCT01380275|Docetaxel|docetaxel|mesh-list
93252474|NCT01380275|Irinotecan|irinotecan|mesh-list
93252475|NCT01380275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252476|NCT01380275|Tubulin Modulators|tubulin modulators|mesh-ancestor
93252477|NCT01380275|Antimitotic Agents|antimitotic agents|mesh-ancestor
93252478|NCT01380275|Mitosis Modulators|mitosis modulators|mesh-ancestor
93252479|NCT01380275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252480|NCT01380275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93252481|NCT01380275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93252482|NCT01380275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252483|NCT02171390|Methyltestosterone|methyltestosterone|mesh-list
93252484|NCT02171390|Testosterone|testosterone|mesh-list
93252485|NCT02171390|Testosterone undecanoate|testosterone undecanoate|mesh-list
93252486|NCT02171390|Testosterone enanthate|testosterone enanthate|mesh-list
93252487|NCT02171390|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93252488|NCT02171390|Androgens|androgens|mesh-ancestor
93252489|NCT02171390|Hormones|hormones|mesh-ancestor
93252490|NCT02171390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252491|NCT02171390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252492|NCT02171390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93252493|NCT02171390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252494|NCT02171390|Anabolic Agents|anabolic agents|mesh-ancestor
93252495|NCT01378481|Vorinostat|vorinostat|mesh-list
93252496|NCT01378481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252497|NCT01378481|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93252498|NCT01378481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252499|NCT01378481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252500|NCT02171468|Dabigatran|dabigatran|mesh-list
93252501|NCT02171468|Antithrombins|antithrombins|mesh-ancestor
93252502|NCT02171468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252503|NCT02171468|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252504|NCT02171468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252505|NCT02171468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252506|NCT02171468|Anticoagulants|anticoagulants|mesh-ancestor
93252507|NCT03502031|Losartan|losartan|mesh-list
93252508|NCT03502031|Valsartan|valsartan|mesh-list
93252509|NCT03502031|Enalapril|enalapril|mesh-list
93252510|NCT03502031|Enalaprilat|enalaprilat|mesh-list
93252511|NCT03502031|Lisinopril|lisinopril|mesh-list
93252512|NCT03502031|Perindopril|perindopril|mesh-list
93252513|NCT03502031|Spironolactone|spironolactone|mesh-list
93252514|NCT03502031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93252515|NCT03502031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93252516|NCT03502031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93252517|NCT03502031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252518|NCT03502031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252519|NCT03502031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93252520|NCT03502031|Hormone Antagonists|hormone antagonists|mesh-ancestor
93252521|NCT03502031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252522|NCT03502031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252523|NCT03502031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93252524|NCT03502031|Diuretics|diuretics|mesh-ancestor
93252525|NCT03502031|Natriuretic Agents|natriuretic agents|mesh-ancestor
93252526|NCT03502031|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93252527|NCT03502031|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252528|NCT03502031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252529|NCT03502031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93252530|NCT03502031|Protective Agents|protective agents|mesh-ancestor
93252531|NCT02171546|Fexofenadine|fexofenadine|mesh-list
93252532|NCT02171546|Quinidine|quinidine|mesh-list
93252533|NCT02171546|Quinidine gluconate|quinidine gluconate|mesh-list
93252534|NCT02171546|Dabigatran|dabigatran|mesh-list
93252535|NCT02171546|Antithrombins|antithrombins|mesh-ancestor
93252536|NCT02171546|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252537|NCT02171546|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252538|NCT02171546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924454|NCT02587845|Tranexamic Acid|tranexamic acid|mesh-list
93252539|NCT02171546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252540|NCT02171546|Anticoagulants|anticoagulants|mesh-ancestor
93252541|NCT02171546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93252542|NCT02171546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93252543|NCT02171546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93252544|NCT02171546|Histamine Antagonists|histamine antagonists|mesh-ancestor
93252545|NCT02171546|Histamine Agents|histamine agents|mesh-ancestor
93252546|NCT02171546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252547|NCT02171546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252548|NCT02171546|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93252549|NCT02171546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93252550|NCT02171546|Adrenergic Agents|adrenergic agents|mesh-ancestor
93252551|NCT02171546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252552|NCT02171546|Antimalarials|antimalarials|mesh-ancestor
93252553|NCT02171546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93252554|NCT02171546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93252555|NCT02171546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252556|NCT02171546|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93252557|NCT02171546|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252558|NCT02171546|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252559|NCT02171546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93252560|NCT02171546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93252561|NCT02171546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93252562|NCT02171546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93252563|NCT02171546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93252564|NCT02171624|Quinidine|quinidine|mesh-list
93252565|NCT02171624|Dabigatran|dabigatran|mesh-list
93252566|NCT02171624|Antithrombins|antithrombins|mesh-ancestor
93252567|NCT02171624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252568|NCT02171624|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252569|NCT02171624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252570|NCT02171624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252571|NCT02171624|Anticoagulants|anticoagulants|mesh-ancestor
93252572|NCT02171624|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93252573|NCT02171624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93252574|NCT02171624|Adrenergic Agents|adrenergic agents|mesh-ancestor
93252575|NCT02171624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252576|NCT02171624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252577|NCT02171624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252578|NCT02171624|Antimalarials|antimalarials|mesh-ancestor
93252579|NCT02171624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93252580|NCT02171624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93252581|NCT02171624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252582|NCT02171624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93252583|NCT02171624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252584|NCT02171624|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252585|NCT02171624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93252586|NCT02171624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93252587|NCT02171624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93252588|NCT02171624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93252589|NCT02171624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93252590|NCT03705351|Temozolomide|temozolomide|mesh-list
92547184|NCT03848689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252591|NCT03705351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93252592|NCT03705351|Alkylating Agents|alkylating agents|mesh-ancestor
93252593|NCT03705351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252594|NCT03705351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252595|NCT03705195|Gliclazide|gliclazide|mesh-list
93252596|NCT03705195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93252597|NCT03705195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252598|NCT00101192|Cetuximab|cetuximab|mesh-list
93252599|NCT00101192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252600|NCT00101192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252601|NCT03688269|Dexamethasone|dexamethasone|mesh-list
93252602|NCT03688269|Ropivacaine|ropivacaine|mesh-list
93252603|NCT03688269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93252604|NCT03688269|Antiemetics|antiemetics|mesh-ancestor
93252605|NCT03688269|Autonomic Agents|autonomic agents|mesh-ancestor
93252606|NCT03688269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252607|NCT03688269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252608|NCT03688269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93252609|NCT03688269|Glucocorticoids|glucocorticoids|mesh-ancestor
93252610|NCT03688269|Hormones|hormones|mesh-ancestor
93252611|NCT03688269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252612|NCT03688269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93252613|NCT03688269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252614|NCT03688269|Anesthetics, Local|anesthetics, local|mesh-ancestor
92924533|NCT02587533|Dopamine|dopamine|mesh-list
93252616|NCT03688269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252617|NCT03688269|Sensory System Agents|sensory system agents|mesh-ancestor
93252618|NCT03688191|Sirolimus|sirolimus|mesh-list
93252619|NCT03688191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93252620|NCT03688191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252621|NCT03688191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93252622|NCT03688191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252623|NCT03688191|Antifungal Agents|antifungal agents|mesh-ancestor
93252624|NCT03688191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252625|NCT03688191|Immunologic Factors|immunologic factors|mesh-ancestor
93252626|NCT03688191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252627|NCT02164838|Axitinib|axitinib|mesh-list
93252628|NCT02164838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252629|NCT02164838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93252630|NCT02164838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252631|NCT02164838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252632|NCT02171702|Afatinib|afatinib|mesh-list
93252633|NCT02171702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252634|NCT02171702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93252635|NCT02171702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252636|NCT02171702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252637|NCT02171780|Olodaterol|olodaterol|mesh-list
93252638|NCT02171780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252639|NCT02171780|Autonomic Agents|autonomic agents|mesh-ancestor
93252640|NCT02171780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252641|NCT02171780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252642|NCT02171780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93252643|NCT02171780|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252644|NCT02172014|Fentanyl|fentanyl|mesh-list
93252645|NCT02172014|Midazolam|midazolam|mesh-list
93252646|NCT02172014|Citric Acid|citric acid|mesh-list
93252647|NCT02172014|Sodium Citrate|sodium citrate|mesh-list
93252648|NCT02172014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93252649|NCT02172014|Narcotics|narcotics|mesh-ancestor
93252650|NCT02172014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252651|NCT02172014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252652|NCT02172014|Analgesics|analgesics|mesh-ancestor
93252653|NCT02172014|Sensory System Agents|sensory system agents|mesh-ancestor
93252654|NCT02172014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252655|NCT02172014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93252656|NCT02172014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93252657|NCT02172014|Anesthetics, General|anesthetics, general|mesh-ancestor
93252658|NCT02172014|Anesthetics|anesthetics|mesh-ancestor
93252659|NCT02172014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93252660|NCT02172014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93252661|NCT02172014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93252662|NCT02172014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93252663|NCT02172014|GABA Modulators|gaba modulators|mesh-ancestor
93252664|NCT02172014|GABA Agents|gaba agents|mesh-ancestor
93252665|NCT02172014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252666|NCT02172014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252667|NCT02172014|Anticoagulants|anticoagulants|mesh-ancestor
93252668|NCT02172014|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93252669|NCT02172014|Chelating Agents|chelating agents|mesh-ancestor
93252670|NCT02172014|Sequestering Agents|sequestering agents|mesh-ancestor
93252671|NCT02172170|Empagliflozin|empagliflozin|mesh-list
93252672|NCT02172170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93252673|NCT02172170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252674|NCT02172170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93252675|NCT02172170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252676|NCT02255942|Zinc|zinc|mesh-list
93252677|NCT02255942|Iron|iron|mesh-list
93252678|NCT02255942|Zinc Sulfate|zinc sulfate|mesh-list
93252679|NCT02255942|Zinc Oxide|zinc oxide|mesh-list
93252680|NCT02255942|Trace Elements|trace elements|mesh-ancestor
93252681|NCT02255942|Micronutrients|micronutrients|mesh-ancestor
93252682|NCT02255942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252683|NCT02255942|Astringents|astringents|mesh-ancestor
93252684|NCT02255942|Dermatologic Agents|dermatologic agents|mesh-ancestor
93252685|NCT02255942|Sunscreening Agents|sunscreening agents|mesh-ancestor
93252686|NCT02255942|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93252687|NCT02255942|Protective Agents|protective agents|mesh-ancestor
93252688|NCT03029247|Epoetin Alfa|epoetin alfa|mesh-list
93252689|NCT03029247|Hematinics|hematinics|mesh-ancestor
93252690|NCT03696459|Moxifloxacin|moxifloxacin|mesh-list
93252691|NCT03696459|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93252692|NCT03696459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93252693|NCT03696459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252694|NCT03696459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93252695|NCT03696459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93252696|NCT03696459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252697|NCT03696459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252698|NCT03696459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252699|NCT03696459|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93252700|NCT03696459|Contraceptive Agents|contraceptive agents|mesh-ancestor
93252701|NCT03696459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93252702|NCT03696459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252703|NCT03696459|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93252704|NCT03696459|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93252705|NCT03696459|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93252706|NCT03624309|Docetaxel|docetaxel|mesh-list
93252707|NCT03624309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252708|NCT03624309|Tubulin Modulators|tubulin modulators|mesh-ancestor
93252709|NCT03624309|Antimitotic Agents|antimitotic agents|mesh-ancestor
93252710|NCT03624309|Mitosis Modulators|mitosis modulators|mesh-ancestor
93252711|NCT03624309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252712|NCT04327791|Baloxavir|baloxavir|mesh-list
93252713|NCT04327791|Antiviral Agents|antiviral agents|mesh-ancestor
93252714|NCT04327791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252715|NCT04327791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252716|NCT04327791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252717|NCT03624231|Durvalumab|durvalumab|mesh-list
93252718|NCT03624231|Tremelimumab|tremelimumab|mesh-list
93252719|NCT03624231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252720|NCT03624231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252721|NCT03692013|Losartan|losartan|mesh-list
93252722|NCT03692013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252723|NCT03692013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93252724|NCT03692013|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93252725|NCT03692013|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93252726|NCT03692013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252727|NCT03695835|Immunomodulating Agents|immunomodulating agents|mesh-list
93252728|NCT03695835|Immunologic Factors|immunologic factors|mesh-ancestor
93252729|NCT03695835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252730|NCT03687255|Tazobactam|tazobactam|mesh-list
93252731|NCT03687255|Piperacillin|piperacillin|mesh-list
93252732|NCT03687255|Cefepime|cefepime|mesh-list
93252733|NCT03687255|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93252734|NCT03687255|Enmetazobactam|enmetazobactam|mesh-list
93252735|NCT03687255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93252736|NCT03687255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252737|NCT03687255|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93252738|NCT03687255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252739|NCT03687255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252740|NCT03691467|Hyaluronic Acid|hyaluronic acid|mesh-list
93252741|NCT03691467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93252742|NCT03691467|Immunologic Factors|immunologic factors|mesh-ancestor
93252743|NCT03691467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252744|NCT03691467|Viscosupplements|viscosupplements|mesh-ancestor
93252745|NCT03691467|Protective Agents|protective agents|mesh-ancestor
93252746|NCT02165774|Neurotransmitter Agents|neurotransmitter agents|mesh-list
93252747|NCT02165774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252748|NCT02165774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252749|NCT02165930|Naltrexone|naltrexone|mesh-list
93252750|NCT02165930|Oxycodone|oxycodone|mesh-list
93252751|NCT02165930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93252752|NCT02165930|Narcotics|narcotics|mesh-ancestor
93252753|NCT02165930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252754|NCT02165930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252755|NCT02165930|Analgesics|analgesics|mesh-ancestor
93252756|NCT02165930|Sensory System Agents|sensory system agents|mesh-ancestor
93252757|NCT02165930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252758|NCT02165930|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93252759|NCT02165930|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93252760|NCT03694977|Spartalizumab|spartalizumab|mesh-list
93252761|NCT03694977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93252762|NCT03694977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252763|NCT03694977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252764|NCT03694977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252765|NCT02172248|Metformin|metformin|mesh-list
93252766|NCT02172248|Empagliflozin|empagliflozin|mesh-list
92924686|NCT04081077|Moxifloxacin|moxifloxacin|mesh-list
93252767|NCT02172248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93252768|NCT02172248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252769|NCT02172248|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93252770|NCT02172248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252771|NCT02172326|Tiotropium Bromide|tiotropium bromide|mesh-list
93252772|NCT02172326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252773|NCT02172326|Autonomic Agents|autonomic agents|mesh-ancestor
93252774|NCT02172326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252775|NCT02172326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252776|NCT02172326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93252777|NCT02172326|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252778|NCT02172326|Parasympatholytics|parasympatholytics|mesh-ancestor
93252779|NCT02172326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252780|NCT02172326|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252781|NCT02172326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252782|NCT02172326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252783|NCT02169596|Ticagrelor|ticagrelor|mesh-list
93252784|NCT02169596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93252785|NCT02169596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93252786|NCT02169596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93252787|NCT02169596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93252788|NCT02169596|Purinergic Agents|purinergic agents|mesh-ancestor
93252789|NCT02169596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252790|NCT02169596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252791|NCT02169596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252792|NCT02169752|Ambrisentan|ambrisentan|mesh-list
93252793|NCT02169752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93252794|NCT02172404|Ipratropium|ipratropium|mesh-list
93252795|NCT02172404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252796|NCT02172404|Autonomic Agents|autonomic agents|mesh-ancestor
93252797|NCT02172404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252798|NCT02172404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252799|NCT02172404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93252800|NCT02172404|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252801|NCT02172404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252802|NCT02172404|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252803|NCT02172404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252804|NCT02172404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252805|NCT00109538|Lonafarnib|lonafarnib|mesh-list
93252806|NCT00109538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252807|NCT00109538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252808|NCT02172482|Bromides|bromides|mesh-list
93252809|NCT02172482|Tiotropium Bromide|tiotropium bromide|mesh-list
93252810|NCT02172482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252811|NCT02172482|Autonomic Agents|autonomic agents|mesh-ancestor
93252812|NCT02172482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252813|NCT02172482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252814|NCT02172482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93252815|NCT02172482|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252816|NCT02172482|Parasympatholytics|parasympatholytics|mesh-ancestor
93252817|NCT02172482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252818|NCT02172482|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252819|NCT02172482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252820|NCT02172482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252821|NCT02172482|Anticonvulsants|anticonvulsants|mesh-ancestor
93252822|NCT02172560|Tiotropium Bromide|tiotropium bromide|mesh-list
93252823|NCT02172560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252824|NCT02172560|Autonomic Agents|autonomic agents|mesh-ancestor
93252825|NCT02172560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252826|NCT02172560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252827|NCT02172560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93252828|NCT02172560|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252829|NCT02172560|Parasympatholytics|parasympatholytics|mesh-ancestor
93252830|NCT02172560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252831|NCT02172560|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252832|NCT02172560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252833|NCT02172560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252834|NCT00106808|Pioglitazone|pioglitazone|mesh-list
93252835|NCT00106808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93252836|NCT00106808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252837|NCT02166554|Hyaluronic Acid|hyaluronic acid|mesh-list
93252838|NCT02166554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92924760|NCT04101578|Hormones|hormones|mesh-ancestor
93252839|NCT02166554|Immunologic Factors|immunologic factors|mesh-ancestor
93252840|NCT02166554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252841|NCT02166554|Viscosupplements|viscosupplements|mesh-ancestor
93252842|NCT02166554|Protective Agents|protective agents|mesh-ancestor
93252843|NCT02174666|Vitamin D|vitamin d|mesh-list
93252844|NCT02174666|Ergocalciferols|ergocalciferols|mesh-list
93252845|NCT02174666|Cholecalciferol|cholecalciferol|mesh-list
93252846|NCT02174666|Vitamins|vitamins|mesh-list
93252847|NCT02174666|Genistein|genistein|mesh-list
93252848|NCT02174666|Biochanin A|biochanin a|mesh-list
93252849|NCT02174666|Daidzein|daidzein|mesh-list
93252850|NCT02174666|Formononetin|formononetin|mesh-list
93252851|NCT02174666|Micronutrients|micronutrients|mesh-ancestor
93252852|NCT02174666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252853|NCT02174666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93252854|NCT02174666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93252855|NCT02174666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93252856|NCT02174666|Protective Agents|protective agents|mesh-ancestor
93252857|NCT02174666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252858|NCT02174666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93252859|NCT02174666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252860|NCT02174666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252861|NCT02174666|Phytoestrogens|phytoestrogens|mesh-ancestor
93252862|NCT02174666|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93252863|NCT02174666|Estrogens|estrogens|mesh-ancestor
93252864|NCT02174666|Hormones|hormones|mesh-ancestor
93252865|NCT02174666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252866|NCT03687021|Progesterone|progesterone|mesh-list
93252867|NCT03687021|Progestins|progestins|mesh-ancestor
93252868|NCT03687021|Hormones|hormones|mesh-ancestor
93252869|NCT03687021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93252870|NCT03687021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252871|NCT03691077|Ocrelizumab|ocrelizumab|mesh-list
93252872|NCT03691077|Immunologic Factors|immunologic factors|mesh-ancestor
93252873|NCT03691077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252874|NCT02172794|Tiotropium Bromide|tiotropium bromide|mesh-list
93252875|NCT02172794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93252876|NCT02172794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93252877|NCT02172794|Autonomic Agents|autonomic agents|mesh-ancestor
93252878|NCT02172794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252879|NCT02172794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252880|NCT02172794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93252881|NCT02172794|Respiratory System Agents|respiratory system agents|mesh-ancestor
93252882|NCT02172794|Parasympatholytics|parasympatholytics|mesh-ancestor
93252883|NCT02172794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93252884|NCT02172794|Cholinergic Agents|cholinergic agents|mesh-ancestor
93252885|NCT02172794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93252886|NCT02172794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252887|NCT02172794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93252888|NCT02172794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93252889|NCT02172794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93252890|NCT02172794|Adrenergic Agents|adrenergic agents|mesh-ancestor
93252891|NCT02174900|Lumefantrine|lumefantrine|mesh-list
93252892|NCT02174900|Artemether|artemether|mesh-list
93252893|NCT02174900|Primaquine|primaquine|mesh-list
93252894|NCT02174900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93252895|NCT02174900|Antimalarials|antimalarials|mesh-ancestor
93252896|NCT02174900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93252897|NCT02174900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93252898|NCT02174900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252899|NCT02170610|Pantoprazole|pantoprazole|mesh-list
93252900|NCT02170610|Dabigatran|dabigatran|mesh-list
93252901|NCT02170610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93252902|NCT02170610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93252903|NCT02170610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93252904|NCT02170610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252905|NCT02170610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252906|NCT02170610|Antithrombins|antithrombins|mesh-ancestor
93252907|NCT02170610|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252908|NCT02170610|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252909|NCT02170610|Anticoagulants|anticoagulants|mesh-ancestor
93252910|NCT02173106|Cyclosporine|cyclosporine|mesh-list
93252911|NCT02173106|Cyclosporins|cyclosporins|mesh-list
93252912|NCT02173106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252913|NCT02173106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252914|NCT02173106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252915|NCT02173106|Immunologic Factors|immunologic factors|mesh-ancestor
93252916|NCT02173106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252917|NCT02173106|Antifungal Agents|antifungal agents|mesh-ancestor
93252918|NCT02173106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93252919|NCT02173106|Dermatologic Agents|dermatologic agents|mesh-ancestor
93252920|NCT02173106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252921|NCT02173106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93252922|NCT03932721|Evolocumab|evolocumab|mesh-list
93252923|NCT03932721|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93252924|NCT03932721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93252925|NCT03932721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93252926|NCT03932721|Antimetabolites|antimetabolites|mesh-ancestor
93252927|NCT03932721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252928|NCT03932721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252929|NCT03932721|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252930|NCT03932721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252931|NCT03932721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93252932|NCT00106340|Metformin|metformin|mesh-list
93252933|NCT00106340|Glimepiride|glimepiride|mesh-list
93252934|NCT00106340|Vildagliptin|vildagliptin|mesh-list
93252935|NCT00106340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93252936|NCT00106340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252937|NCT00106340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93252938|NCT00106340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252939|NCT00106340|Immunologic Factors|immunologic factors|mesh-ancestor
93252940|NCT00106340|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93252941|NCT00106340|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252942|NCT00106340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252943|NCT00106340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252944|NCT03538496|Bupivacaine|bupivacaine|mesh-list
93252945|NCT03538496|Anesthetics, Local|anesthetics, local|mesh-ancestor
93252946|NCT03538496|Anesthetics|anesthetics|mesh-ancestor
93252947|NCT03538496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93252948|NCT03538496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252949|NCT03538496|Sensory System Agents|sensory system agents|mesh-ancestor
93252950|NCT03538496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252951|NCT03686787|Tranexamic Acid|tranexamic acid|mesh-list
93252952|NCT03686787|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93252953|NCT03686787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93252954|NCT03686787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252955|NCT03686787|Hemostatics|hemostatics|mesh-ancestor
93252956|NCT03686787|Coagulants|coagulants|mesh-ancestor
93252957|NCT03694587|Ibuprofen|ibuprofen|mesh-list
93252958|NCT03694587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93252959|NCT03694587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93252960|NCT03694587|Analgesics|analgesics|mesh-ancestor
93252961|NCT03694587|Sensory System Agents|sensory system agents|mesh-ancestor
93252962|NCT03694587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93252963|NCT03694587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252964|NCT03694587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93252965|NCT03694587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252966|NCT03694587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93252967|NCT03694587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252968|NCT03694587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252969|NCT02175056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93252970|NCT02175056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93252971|NCT02170766|Pantoprazole|pantoprazole|mesh-list
93252972|NCT02170766|Dabigatran|dabigatran|mesh-list
93252973|NCT02170766|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93252974|NCT02170766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93252975|NCT02170766|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93252976|NCT02170766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252977|NCT02170766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252978|NCT02170766|Antithrombins|antithrombins|mesh-ancestor
93252979|NCT02170766|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93252980|NCT02170766|Protease Inhibitors|protease inhibitors|mesh-ancestor
93252981|NCT02170766|Anticoagulants|anticoagulants|mesh-ancestor
93252982|NCT04156659|Tisagenlecleucel|tisagenlecleucel|mesh-list
93252983|NCT04156659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93252984|NCT04156659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93252985|NCT03694119|Phenelzine|phenelzine|mesh-list
93252986|NCT03694119|Ozanimod|ozanimod|mesh-list
93252987|NCT03694119|Tyramine|tyramine|mesh-list
93252988|NCT03694119|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93252989|NCT03694119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93252990|NCT03694119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93252991|NCT03694119|Immunologic Factors|immunologic factors|mesh-ancestor
93252992|NCT03694119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93252993|NCT03694119|Antidepressive Agents|antidepressive agents|mesh-ancestor
93252995|NCT03694119|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93252996|NCT03694119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93252997|NCT03694119|Sympathomimetics|sympathomimetics|mesh-ancestor
93252998|NCT03694119|Autonomic Agents|autonomic agents|mesh-ancestor
93252999|NCT03694119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253000|NCT03694119|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93253001|NCT03694119|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93253002|NCT03694119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253003|NCT03694119|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253004|NCT03694119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253005|NCT02178254|Fosfomycin|fosfomycin|mesh-list
93253006|NCT02178254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253007|NCT02178254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253008|NCT02173262|Ciprofloxacin|ciprofloxacin|mesh-list
93253009|NCT02173262|Lenograstim|lenograstim|mesh-list
93253010|NCT02173262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253011|NCT02173262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253012|NCT02173262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93253013|NCT02173262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93253014|NCT02173262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253015|NCT02173262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253016|NCT02173262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253017|NCT02173262|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93253018|NCT02173262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93253019|NCT02173262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93253020|NCT02173262|Immunologic Factors|immunologic factors|mesh-ancestor
93253021|NCT02173262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253022|NCT02173418|Ropivacaine|ropivacaine|mesh-list
93253023|NCT02173418|Anesthetics, Local|anesthetics, local|mesh-ancestor
93253024|NCT02173418|Anesthetics|anesthetics|mesh-ancestor
93253025|NCT02173418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253026|NCT02173418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253027|NCT02173418|Sensory System Agents|sensory system agents|mesh-ancestor
93253028|NCT02173418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253029|NCT03932331|Acalabrutinib|acalabrutinib|mesh-list
93253030|NCT03932331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253031|NCT02178488|Cholecalciferol|cholecalciferol|mesh-list
93253032|NCT02178488|Vitamin D|vitamin d|mesh-list
93253033|NCT02178488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93253034|NCT02178488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253035|NCT02178488|Vitamins|vitamins|mesh-ancestor
93253036|NCT02178488|Micronutrients|micronutrients|mesh-ancestor
93253037|NCT02178488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93253038|NCT02173652|Linagliptin|linagliptin|mesh-list
93253039|NCT02173652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93253040|NCT02173652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253041|NCT02173652|Incretins|incretins|mesh-ancestor
93253042|NCT02173652|Hormones|hormones|mesh-ancestor
93253043|NCT02173652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547628|NCT05772676|Aprepitant|aprepitant|mesh-list
93253044|NCT02173652|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93253045|NCT02173652|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253046|NCT02173652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253047|NCT02173652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253048|NCT02173730|Pantoprazole|pantoprazole|mesh-list
93253049|NCT02173730|Dabigatran|dabigatran|mesh-list
93253050|NCT02173730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93253051|NCT02173730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93253052|NCT02173730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93253053|NCT02173730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253054|NCT02173730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253055|NCT02173730|Antithrombins|antithrombins|mesh-ancestor
93253056|NCT02173730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93253057|NCT02173730|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253058|NCT02173730|Anticoagulants|anticoagulants|mesh-ancestor
93253059|NCT02175446|Bevacizumab|bevacizumab|mesh-list
93253060|NCT02175446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93253061|NCT02175446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253062|NCT02175446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93253063|NCT02175446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93253064|NCT02175446|Growth Substances|growth substances|mesh-ancestor
93253065|NCT02175446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253066|NCT02175446|Growth Inhibitors|growth inhibitors|mesh-ancestor
93253067|NCT02178644|Capecitabine|capecitabine|mesh-list
93253068|NCT02178644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253069|NCT02178644|Antimetabolites|antimetabolites|mesh-ancestor
93253070|NCT02178644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253071|NCT02178644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253072|NCT03686163|Mitogens|mitogens|mesh-list
93253073|NCT03686163|Mitosis Modulators|mitosis modulators|mesh-ancestor
93253074|NCT03686163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253075|NCT02173808|Levonorgestrel|levonorgestrel|mesh-list
93253076|NCT02173808|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
93253077|NCT02173808|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93253078|NCT02173808|Contraceptive Agents|contraceptive agents|mesh-ancestor
93253079|NCT02173808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253080|NCT02173808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253081|NCT02173808|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93253082|NCT02173808|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93253083|NCT02173808|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93253084|NCT02173808|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93253085|NCT02173886|Bupropion|bupropion|mesh-list
93253086|NCT02173886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93253087|NCT02173886|Antidepressive Agents|antidepressive agents|mesh-ancestor
93253088|NCT02173886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253089|NCT02173886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93253090|NCT02173886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93253091|NCT02173886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253092|NCT02173886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253093|NCT02173886|Dopamine Agents|dopamine agents|mesh-ancestor
93253094|NCT02173886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253095|NCT02173886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547689|NCT05771012|Cyclosporine|cyclosporine|mesh-list
93253096|NCT02173886|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93253097|NCT02173886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93253098|NCT02173886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253099|NCT02173964|Pinaverium|pinaverium|mesh-list
93253100|NCT02173964|Bromides|bromides|mesh-list
93253101|NCT02173964|Anticonvulsants|anticonvulsants|mesh-ancestor
93253102|NCT02173964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93253103|NCT02173964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253104|NCT02173964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253105|NCT02173964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93253106|NCT02173964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253107|NCT02173964|Parasympatholytics|parasympatholytics|mesh-ancestor
93253108|NCT02173964|Autonomic Agents|autonomic agents|mesh-ancestor
93253109|NCT02173964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253110|NCT02175602|Sertraline|sertraline|mesh-list
93253111|NCT02175602|Escitalopram|escitalopram|mesh-list
93253112|NCT02175602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93253113|NCT02175602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93253114|NCT02175602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253115|NCT02175602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253116|NCT02175602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253117|NCT02175602|Serotonin Agents|serotonin agents|mesh-ancestor
93253118|NCT02175602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253119|NCT02175602|Antidepressive Agents|antidepressive agents|mesh-ancestor
93253120|NCT02175602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253121|NCT03686085|Dinoprostone|dinoprostone|mesh-list
93253122|NCT03686085|Oxytocics|oxytocics|mesh-ancestor
93253123|NCT03686085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253124|NCT03686085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253125|NCT03693885|Oxytocin|oxytocin|mesh-list
93253126|NCT03693885|Oxytocics|oxytocics|mesh-ancestor
93253127|NCT03693885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253128|NCT03693885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253129|NCT02174120|Propofol|propofol|mesh-list
93253130|NCT02174120|Etomidate|etomidate|mesh-list
93253131|NCT02174120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253132|NCT02174120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253133|NCT02174120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253134|NCT02174120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93253135|NCT02174120|Anesthetics, General|anesthetics, general|mesh-ancestor
93253136|NCT02174120|Anesthetics|anesthetics|mesh-ancestor
93253137|NCT02175914|Erythromycin|erythromycin|mesh-list
93253138|NCT02175914|Erythromycin Estolate|erythromycin estolate|mesh-list
93253139|NCT02175914|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93253140|NCT02175914|Erythromycin stearate|erythromycin stearate|mesh-list
93253141|NCT02175914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253142|NCT02175914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253143|NCT02175914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93253144|NCT02175914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93253145|NCT02175914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253146|NCT02175914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253147|NCT02753816|Tranexamic Acid|tranexamic acid|mesh-list
93253148|NCT02753816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93253149|NCT02753816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93253150|NCT02753816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253151|NCT02753816|Hemostatics|hemostatics|mesh-ancestor
93253152|NCT02753816|Coagulants|coagulants|mesh-ancestor
93253153|NCT02179034|Menthol|menthol|mesh-list
93253154|NCT02179034|Nicotine|nicotine|mesh-list
93253155|NCT02179034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93253156|NCT02179034|Autonomic Agents|autonomic agents|mesh-ancestor
93253157|NCT02179034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253158|NCT02179034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253159|NCT02179034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93253160|NCT02179034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93253161|NCT02179034|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253162|NCT02179034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253163|NCT02179034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253164|NCT02179034|Antipruritics|antipruritics|mesh-ancestor
93253165|NCT02179034|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253166|NCT02174588|Midazolam|midazolam|mesh-list
93253167|NCT02174588|Propofol|propofol|mesh-list
93253168|NCT02174588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253169|NCT02174588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253170|NCT02174588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253171|NCT02174588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93253172|NCT02174588|Anesthetics, General|anesthetics, general|mesh-ancestor
93253173|NCT02174588|Anesthetics|anesthetics|mesh-ancestor
93253174|NCT02174588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93253175|NCT02174588|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93253176|NCT02174588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93253177|NCT02174588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253178|NCT02174588|GABA Modulators|gaba modulators|mesh-ancestor
93253179|NCT02174588|GABA Agents|gaba agents|mesh-ancestor
93253180|NCT02174588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253181|NCT02174588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253182|NCT03693573|Bevacizumab|bevacizumab|mesh-list
93253183|NCT03693573|Atezolizumab|atezolizumab|mesh-list
93253184|NCT03693573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93253185|NCT03693573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253186|NCT03693573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93253187|NCT03693573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93253188|NCT03693573|Growth Substances|growth substances|mesh-ancestor
93253189|NCT03693573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253190|NCT03693573|Growth Inhibitors|growth inhibitors|mesh-ancestor
93253191|NCT03693573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93253192|NCT03693573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253193|NCT02176304|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93253194|NCT02176304|Methylprednisolone|methylprednisolone|mesh-list
93253195|NCT02176304|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93253196|NCT02176304|Prednisolone|prednisolone|mesh-list
93253197|NCT02176304|Prednisolone acetate|prednisolone acetate|mesh-list
93253198|NCT02176304|Lidocaine|lidocaine|mesh-list
93253199|NCT02176304|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93253200|NCT02176304|Prednisolone phosphate|prednisolone phosphate|mesh-list
93253201|NCT02176304|Anesthetics, Local|anesthetics, local|mesh-ancestor
93253202|NCT02176304|Anesthetics|anesthetics|mesh-ancestor
93253203|NCT02176304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253204|NCT02176304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253205|NCT02176304|Sensory System Agents|sensory system agents|mesh-ancestor
93253206|NCT02176304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253207|NCT02176304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93253208|NCT02176304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93253209|NCT02176304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93253210|NCT02176304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253211|NCT02176304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253212|NCT02176304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253213|NCT02176304|Antiemetics|antiemetics|mesh-ancestor
93253214|NCT02176304|Autonomic Agents|autonomic agents|mesh-ancestor
93253215|NCT02176304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93253216|NCT02176304|Glucocorticoids|glucocorticoids|mesh-ancestor
93253217|NCT02176304|Hormones|hormones|mesh-ancestor
93253218|NCT02176304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253219|NCT02176304|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93253220|NCT02176304|Protective Agents|protective agents|mesh-ancestor
93253221|NCT02176304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93253222|NCT02176304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253223|NCT02176460|Colchicine|colchicine|mesh-list
93253224|NCT02176460|Gout Suppressants|gout suppressants|mesh-ancestor
93253225|NCT02176460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253226|NCT02176460|Tubulin Modulators|tubulin modulators|mesh-ancestor
93253227|NCT02176460|Antimitotic Agents|antimitotic agents|mesh-ancestor
93253228|NCT02176460|Mitosis Modulators|mitosis modulators|mesh-ancestor
93253229|NCT02176460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253230|NCT02176460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253231|NCT02256254|Simvastatin|simvastatin|mesh-list
93253232|NCT02256254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93253233|NCT02256254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93253234|NCT02256254|Antimetabolites|antimetabolites|mesh-ancestor
93253235|NCT02256254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253236|NCT02256254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93253237|NCT02256254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93253238|NCT02256254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253239|NCT02182076|Nintedanib|nintedanib|mesh-list
93253240|NCT02182076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253241|NCT02182076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93253242|NCT02182076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253243|NCT02182076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253244|NCT02179268|Sertraline|sertraline|mesh-list
93253245|NCT02179268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93253246|NCT02179268|Citalopram|citalopram|mesh-list
93253247|NCT02179268|Reboxetine|reboxetine|mesh-list
93253248|NCT02179268|Antidepressive Agents|antidepressive agents|mesh-ancestor
93253249|NCT02179268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253250|NCT02179268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93253251|NCT02179268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93253252|NCT02179268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253253|NCT02179268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253254|NCT02179268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253255|NCT02179268|Serotonin Agents|serotonin agents|mesh-ancestor
93253256|NCT02179268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253257|NCT02179268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93253258|NCT02179268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93253259|NCT02179268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93253260|NCT02179268|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253261|NCT02182154|Nintedanib|nintedanib|mesh-list
93253262|NCT02182154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253263|NCT02182154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93253264|NCT02182154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253265|NCT02182154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253266|NCT02182232|Paclitaxel|paclitaxel|mesh-list
93253267|NCT02182232|Carboplatin|carboplatin|mesh-list
93253268|NCT02182232|Nintedanib|nintedanib|mesh-list
93253269|NCT02182232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93253270|NCT02182232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253271|NCT02182232|Tubulin Modulators|tubulin modulators|mesh-ancestor
93253272|NCT02182232|Antimitotic Agents|antimitotic agents|mesh-ancestor
93253273|NCT02182232|Mitosis Modulators|mitosis modulators|mesh-ancestor
93253274|NCT02182232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253275|NCT02182232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93253276|NCT02182232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253277|NCT02182310|Moxifloxacin|moxifloxacin|mesh-list
93253278|NCT02182310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253279|NCT02182310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253280|NCT02182310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93253281|NCT02182310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93253282|NCT02182310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253283|NCT02182310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253284|NCT02182310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253285|NCT02176850|Telmisartan|telmisartan|mesh-list
93253286|NCT02176850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93253287|NCT02176850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93253288|NCT02176850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93366400|NCT02061917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925205|NCT04077957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253289|NCT02176850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253291|NCT03537326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253292|NCT03537326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93253293|NCT03537326|Autonomic Agents|autonomic agents|mesh-ancestor
93253294|NCT03537326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253295|NCT03537326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253296|NCT03537326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93253297|NCT03537326|Respiratory System Agents|respiratory system agents|mesh-ancestor
93253298|NCT03537326|Glucocorticoids|glucocorticoids|mesh-ancestor
93253299|NCT03537326|Hormones|hormones|mesh-ancestor
93253300|NCT03537326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253301|NCT02182544|Ketotifen|ketotifen|mesh-list
93253302|NCT02182544|Epinastine|epinastine|mesh-list
93253303|NCT02182544|Antipruritics|antipruritics|mesh-ancestor
93253304|NCT02182544|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253305|NCT02182544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93253306|NCT02182544|Histamine Antagonists|histamine antagonists|mesh-ancestor
93253307|NCT02182544|Histamine Agents|histamine agents|mesh-ancestor
93253308|NCT02182544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253309|NCT02182544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253310|NCT02182544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253311|NCT02182544|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93253312|NCT02179658|Vancomycin|vancomycin|mesh-list
93253313|NCT02179658|Fidaxomicin|fidaxomicin|mesh-list
93253314|NCT02179658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253315|NCT02179658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253316|NCT02177318|Bromides|bromides|mesh-list
93253317|NCT02177318|Tiotropium Bromide|tiotropium bromide|mesh-list
93253318|NCT02177318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93253319|NCT02177318|Autonomic Agents|autonomic agents|mesh-ancestor
93253320|NCT02177318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253321|NCT02177318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253322|NCT02177318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93253323|NCT02177318|Respiratory System Agents|respiratory system agents|mesh-ancestor
93253324|NCT02177318|Parasympatholytics|parasympatholytics|mesh-ancestor
93253325|NCT02177318|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93253326|NCT02177318|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253327|NCT02177318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547910|NCT05408247|Antidotes|antidotes|mesh-ancestor
93253328|NCT02177318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253329|NCT02177318|Anticonvulsants|anticonvulsants|mesh-ancestor
93253330|NCT02177396|Valsartan|valsartan|mesh-list
93253331|NCT02177396|Telmisartan|telmisartan|mesh-list
93253332|NCT02177396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93253333|NCT02177396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93253334|NCT02177396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93253335|NCT02177396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253336|NCT02030054|Atorvastatin|atorvastatin|mesh-list
93253337|NCT02030054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93253338|NCT02030054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93253339|NCT02030054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93253340|NCT02030054|Antimetabolites|antimetabolites|mesh-ancestor
93253341|NCT02030054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253342|NCT02030054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93253343|NCT02030054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93253344|NCT02030054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253345|NCT02182622|Prednisone|prednisone|mesh-list
93253346|NCT02182622|Docetaxel|docetaxel|mesh-list
93253347|NCT02182622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253348|NCT02182622|Tubulin Modulators|tubulin modulators|mesh-ancestor
93253349|NCT02182622|Antimitotic Agents|antimitotic agents|mesh-ancestor
93253350|NCT02182622|Mitosis Modulators|mitosis modulators|mesh-ancestor
93253351|NCT02182622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253352|NCT02182622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253353|NCT02182622|Glucocorticoids|glucocorticoids|mesh-ancestor
93253354|NCT02182622|Hormones|hormones|mesh-ancestor
93253355|NCT02182622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253356|NCT02182622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253357|NCT02182622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93253358|NCT02182700|Bromides|bromides|mesh-list
93253359|NCT02182700|Albuterol|albuterol|mesh-list
93253360|NCT02182700|Ipratropium|ipratropium|mesh-list
93253361|NCT02182700|Anticonvulsants|anticonvulsants|mesh-ancestor
93253362|NCT02182700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93253363|NCT02182700|Autonomic Agents|autonomic agents|mesh-ancestor
92925283|NCT05637515|Adalimumab|adalimumab|mesh-list
93253364|NCT02182700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253365|NCT02182700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253366|NCT02182700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93253367|NCT02182700|Respiratory System Agents|respiratory system agents|mesh-ancestor
93253368|NCT02182700|Tocolytic Agents|tocolytic agents|mesh-ancestor
93253369|NCT02182700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253370|NCT02182700|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93253371|NCT02182700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93253372|NCT02182700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93253373|NCT02182700|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253374|NCT02182700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253375|NCT02182700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253376|NCT02182700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93253377|NCT02182700|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253378|NCT02182778|Cisplatin|cisplatin|mesh-list
93253379|NCT02182778|Gemcitabine|gemcitabine|mesh-list
93253380|NCT02182778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253381|NCT02182778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253382|NCT02182778|Antimetabolites|antimetabolites|mesh-ancestor
93253383|NCT02182778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253384|NCT03688971|Ketoconazole|ketoconazole|mesh-list
93253385|NCT03688971|Antifungal Agents|antifungal agents|mesh-ancestor
93253386|NCT03688971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253387|NCT03688971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93253388|NCT03688971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93253389|NCT03688971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253390|NCT03688971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253391|NCT03688971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93253392|NCT03688971|Hormone Antagonists|hormone antagonists|mesh-ancestor
93253393|NCT03688971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253394|NCT03688971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253395|NCT03688971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93253396|NCT02179814|Diphenhydramine|diphenhydramine|mesh-list
93253397|NCT02179814|Promethazine|promethazine|mesh-list
93253398|NCT02179814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93253399|NCT02179814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253400|NCT02179814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253401|NCT02179814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253402|NCT02179814|Anesthetics, Local|anesthetics, local|mesh-ancestor
93253403|NCT02179814|Anesthetics|anesthetics|mesh-ancestor
93253404|NCT02179814|Sensory System Agents|sensory system agents|mesh-ancestor
93253405|NCT02179814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253406|NCT02179814|Antiemetics|antiemetics|mesh-ancestor
93253407|NCT02179814|Autonomic Agents|autonomic agents|mesh-ancestor
93253408|NCT02179814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93253409|NCT02179814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93253410|NCT02179814|Histamine Antagonists|histamine antagonists|mesh-ancestor
93253411|NCT02179814|Histamine Agents|histamine agents|mesh-ancestor
93253412|NCT02179814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253413|NCT02179814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253414|NCT02179814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93253415|NCT02179814|Antipruritics|antipruritics|mesh-ancestor
93253416|NCT02179814|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253417|NCT02179970|Plerixafor|plerixafor|mesh-list
93253418|NCT02179970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93253419|NCT02179970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93253420|NCT02179970|Antiviral Agents|antiviral agents|mesh-ancestor
93253421|NCT02179970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253422|NCT03537950|Cannabidiol|cannabidiol|mesh-list
93253423|NCT03537950|Anticonvulsants|anticonvulsants|mesh-ancestor
93253424|NCT02182856|Bromides|bromides|mesh-list
93253425|NCT02182856|Albuterol|albuterol|mesh-list
93253426|NCT02182856|Ipratropium|ipratropium|mesh-list
93253427|NCT02182856|Anticonvulsants|anticonvulsants|mesh-ancestor
93253428|NCT02182856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93253429|NCT02182856|Autonomic Agents|autonomic agents|mesh-ancestor
92548037|NCT04752163|Methotrexate|methotrexate|mesh-list
93253430|NCT02182856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253431|NCT02182856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253432|NCT02182856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93253433|NCT02182856|Respiratory System Agents|respiratory system agents|mesh-ancestor
93253434|NCT02182856|Tocolytic Agents|tocolytic agents|mesh-ancestor
93253435|NCT02182856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253436|NCT02182856|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93253437|NCT02182856|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93253438|NCT02182856|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93253439|NCT02182856|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253440|NCT02182856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253441|NCT02182856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253442|NCT02182856|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93253443|NCT02182856|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253444|NCT02183012|Ibuprofen|ibuprofen|mesh-list
93253445|NCT02183012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93253446|NCT02183012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253447|NCT02183012|Analgesics|analgesics|mesh-ancestor
93253448|NCT02183012|Sensory System Agents|sensory system agents|mesh-ancestor
93253449|NCT02183012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253450|NCT02183012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253451|NCT02183012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253452|NCT02183012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253453|NCT02183012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93253454|NCT02183012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253455|NCT02183012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253456|NCT02180048|Caffeine|caffeine|mesh-list
93253457|NCT02180048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93253458|NCT02180048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253459|NCT02180048|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93253460|NCT02180048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253461|NCT02180048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253462|NCT02180048|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93253463|NCT02180048|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93253464|NCT02180048|Purinergic Agents|purinergic agents|mesh-ancestor
93253465|NCT02180048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253466|NCT03688659|Vancomycin|vancomycin|mesh-list
93253467|NCT03688659|Gentamicins|gentamicins|mesh-list
93253468|NCT03688659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253469|NCT03688659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253470|NCT03688659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93253471|NCT03688659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253472|NCT03688659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253473|NCT03683043|Leuprolide|leuprolide|mesh-list
93253474|NCT03683043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93253475|NCT03683043|Fertility Agents|fertility agents|mesh-ancestor
93253476|NCT03683043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253477|NCT03683043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253478|NCT03683043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93253479|NCT03683043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253480|NCT02180204|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93253481|NCT02180204|Tenecteplase|tenecteplase|mesh-list
93253482|NCT02180204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93253483|NCT02180204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93253484|NCT02180204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253485|NCT02183090|Meloxicam|meloxicam|mesh-list
93253486|NCT02183090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93253487|NCT02183090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253488|NCT02183090|Analgesics|analgesics|mesh-ancestor
93253489|NCT02183090|Sensory System Agents|sensory system agents|mesh-ancestor
93253490|NCT02183090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253491|NCT02183090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253492|NCT02183090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253493|NCT02183090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253494|NCT02183090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93253495|NCT02183090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93253496|NCT02183090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253497|NCT02183090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253498|NCT02177552|Carboplatin|carboplatin|mesh-list
93253499|NCT02177552|Docetaxel|docetaxel|mesh-list
93253500|NCT02177552|Capecitabine|capecitabine|mesh-list
93253501|NCT02177552|Oxaliplatin|oxaliplatin|mesh-list
93253502|NCT02177552|Epirubicin|epirubicin|mesh-list
93253503|NCT02177552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253504|NCT02177552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93253505|NCT02177552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93253506|NCT02177552|Mitosis Modulators|mitosis modulators|mesh-ancestor
93253507|NCT02177552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253508|NCT02177552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253509|NCT02177552|Antimetabolites|antimetabolites|mesh-ancestor
93253510|NCT02177552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93253511|NCT02177552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93253512|NCT02177552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93253513|NCT02177552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253514|NCT03682653|Azithromycin|azithromycin|mesh-list
93253515|NCT03682653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253516|NCT03682653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253517|NCT03684993|Chlorhexidine|chlorhexidine|mesh-list
93253518|NCT03684993|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93253519|NCT03684993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93253520|NCT03684993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253521|NCT03684993|Disinfectants|disinfectants|mesh-ancestor
93253522|NCT03684993|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253523|NCT04062279|Autoantibodies|autoantibodies|mesh-list
93253524|NCT04062279|Immunologic Factors|immunologic factors|mesh-ancestor
93253525|NCT04062279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253526|NCT02183168|Indomethacin|indomethacin|mesh-list
93253527|NCT02183168|Meloxicam|meloxicam|mesh-list
93253528|NCT02183168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93253529|NCT02183168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253530|NCT02183168|Analgesics|analgesics|mesh-ancestor
93253531|NCT02183168|Sensory System Agents|sensory system agents|mesh-ancestor
93253532|NCT02183168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253533|NCT02183168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253534|NCT02183168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253535|NCT02183168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253536|NCT02183168|Gout Suppressants|gout suppressants|mesh-ancestor
93253537|NCT02183168|Tocolytic Agents|tocolytic agents|mesh-ancestor
93253538|NCT02183168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253539|NCT02183168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93253540|NCT02183168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253541|NCT02183168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253542|NCT02183168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93253543|NCT02183246|Porfiromycin|porfiromycin|mesh-list
93253544|NCT02183246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92548143|NCT04671966|Cetrorelix|cetrorelix|mesh-list
93253545|NCT02183246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253546|NCT02183324|Linagliptin|linagliptin|mesh-list
93253547|NCT02183324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93253548|NCT02183324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253549|NCT02183324|Incretins|incretins|mesh-ancestor
93253550|NCT02183324|Hormones|hormones|mesh-ancestor
93253551|NCT02183324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253552|NCT02183324|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93253553|NCT02183324|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253554|NCT02183324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253555|NCT02183324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253556|NCT02183402|Linagliptin|linagliptin|mesh-list
93253557|NCT02183402|Digoxin|digoxin|mesh-list
93253558|NCT02183402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93253559|NCT02183402|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93253560|NCT02183402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253561|NCT02183402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253562|NCT02183402|Protective Agents|protective agents|mesh-ancestor
93253563|NCT02183402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253564|NCT02183402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93253565|NCT02183402|Incretins|incretins|mesh-ancestor
93253566|NCT02183402|Hormones|hormones|mesh-ancestor
93253567|NCT02183402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253568|NCT02183402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93253569|NCT02183402|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253570|NCT02183480|Linagliptin|linagliptin|mesh-list
93253571|NCT02183480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93253572|NCT02183480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253573|NCT02183480|Incretins|incretins|mesh-ancestor
93253574|NCT02183480|Hormones|hormones|mesh-ancestor
93253575|NCT02183480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253576|NCT02183480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93253577|NCT02183480|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253578|NCT02183480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253579|NCT02183480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253580|NCT05141864|Lidocaine|lidocaine|mesh-list
93253581|NCT05141864|Anesthetics, Local|anesthetics, local|mesh-ancestor
93253582|NCT05141864|Anesthetics|anesthetics|mesh-ancestor
93253583|NCT05141864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253584|NCT05141864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253585|NCT05141864|Sensory System Agents|sensory system agents|mesh-ancestor
93253586|NCT05141864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253587|NCT05141864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93253588|NCT05141864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93253589|NCT05141864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93253590|NCT05141864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253591|NCT05141864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253593|NCT02180516|Etodolac|etodolac|mesh-list
93253594|NCT02180516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93253595|NCT02180516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93253596|NCT02180516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253597|NCT02180516|Analgesics|analgesics|mesh-ancestor
93253598|NCT02180516|Sensory System Agents|sensory system agents|mesh-ancestor
93253599|NCT02180516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253600|NCT02180516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253601|NCT02180516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253602|NCT02180516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93253603|NCT02180516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93253604|NCT02180516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253605|NCT02180516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253606|NCT02183636|Pioglitazone|pioglitazone|mesh-list
93253607|NCT02183636|Linagliptin|linagliptin|mesh-list
93253608|NCT02183636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93253609|NCT02183636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253610|NCT02183636|Incretins|incretins|mesh-ancestor
93253611|NCT02183636|Hormones|hormones|mesh-ancestor
93253612|NCT02183636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253613|NCT02183636|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93253614|NCT02183636|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253615|NCT02183636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253616|NCT02183636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253617|NCT02183948|Oxytocin|oxytocin|mesh-list
93253618|NCT02183948|Oxytocics|oxytocics|mesh-ancestor
93253619|NCT02183948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253620|NCT02183948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253621|NCT02184104|Caffeine|caffeine|mesh-list
93253622|NCT02184104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93253623|NCT02184104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253624|NCT02184104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93253625|NCT02184104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253626|NCT02184104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253627|NCT02184104|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93253628|NCT02184104|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93253629|NCT02184104|Purinergic Agents|purinergic agents|mesh-ancestor
93253630|NCT02184104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253631|NCT02184260|Dipyrone|dipyrone|mesh-list
93253632|NCT02184260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93253633|NCT02184260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253634|NCT02184260|Analgesics|analgesics|mesh-ancestor
93253635|NCT02184260|Sensory System Agents|sensory system agents|mesh-ancestor
93253636|NCT02184260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253637|NCT02184260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253638|NCT02184260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253639|NCT02184260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253640|NCT02184260|Antipyretics|antipyretics|mesh-ancestor
93253641|NCT03813147|Cytarabine|cytarabine|mesh-list
93253642|NCT03813147|Hydrocortisone|hydrocortisone|mesh-list
93253643|NCT03813147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93253644|NCT03813147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93253645|NCT03813147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93253646|NCT03813147|Methotrexate|methotrexate|mesh-list
93253647|NCT03813147|Fludarabine phosphate|fludarabine phosphate|mesh-list
93253648|NCT03813147|Azacitidine|azacitidine|mesh-list
93253649|NCT03813147|Fludarabine|fludarabine|mesh-list
93253650|NCT03813147|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93253651|NCT03813147|Pevonedistat|pevonedistat|mesh-list
93253652|NCT03813147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93253653|NCT03813147|Abortifacient Agents|abortifacient agents|mesh-ancestor
93253654|NCT03813147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253655|NCT03813147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253656|NCT03813147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253657|NCT03813147|Antimetabolites|antimetabolites|mesh-ancestor
93253658|NCT03813147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253659|NCT03813147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253660|NCT03813147|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253661|NCT03813147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93253662|NCT03813147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93253663|NCT03813147|Immunologic Factors|immunologic factors|mesh-ancestor
93253664|NCT03813147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253665|NCT03813147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93253666|NCT03813147|Antiviral Agents|antiviral agents|mesh-ancestor
93253667|NCT03813147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253668|NCT03813147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253669|NCT03684837|Vitamin D|vitamin d|mesh-list
93253670|NCT03684837|Vitamins|vitamins|mesh-ancestor
93253671|NCT03684837|Micronutrients|micronutrients|mesh-ancestor
93253672|NCT03684837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253673|NCT03684837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93253674|NCT03810417|Digoxin|digoxin|mesh-list
93253675|NCT03810417|Antibodies|antibodies|mesh-list
93253676|NCT03810417|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
93253677|NCT03810417|Immunologic Factors|immunologic factors|mesh-ancestor
93253678|NCT03810417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253679|NCT03810417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93253680|NCT03810417|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93253681|NCT03810417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253682|NCT03810417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253683|NCT03810417|Protective Agents|protective agents|mesh-ancestor
93253684|NCT03808155|Tamsulosin|tamsulosin|mesh-list
93253685|NCT03808155|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93253686|NCT03808155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93253687|NCT03808155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93253688|NCT03808155|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253689|NCT03808155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253690|NCT03808155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253691|NCT03808155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253692|NCT03808155|Urological Agents|urological agents|mesh-ancestor
93253693|NCT02752958|Fluorides|fluorides|mesh-list
93253694|NCT02752958|Tin Fluorides|tin fluorides|mesh-list
93253695|NCT02752958|Cariostatic Agents|cariostatic agents|mesh-ancestor
93253696|NCT02752958|Protective Agents|protective agents|mesh-ancestor
93253697|NCT02752958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253698|NCT02181218|Dexamethasone|dexamethasone|mesh-list
93253699|NCT02181218|Dexamethasone acetate|dexamethasone acetate|mesh-list
93253700|NCT02181218|Gemcitabine|gemcitabine|mesh-list
93253701|NCT02181218|Oxaliplatin|oxaliplatin|mesh-list
93253702|NCT02181218|Romidepsin|romidepsin|mesh-list
93253703|NCT02181218|BB 1101|bb 1101|mesh-list
93253704|NCT02181218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253705|NCT02181218|Antiemetics|antiemetics|mesh-ancestor
93253706|NCT02181218|Autonomic Agents|autonomic agents|mesh-ancestor
93253707|NCT02181218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253708|NCT02181218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253709|NCT02181218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93253710|NCT02181218|Glucocorticoids|glucocorticoids|mesh-ancestor
93253711|NCT02181218|Hormones|hormones|mesh-ancestor
93253712|NCT02181218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253713|NCT02181218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93253714|NCT02181218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253715|NCT02181218|Protease Inhibitors|protease inhibitors|mesh-ancestor
93253716|NCT02181218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253717|NCT02181218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253718|NCT02181218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253719|NCT02181218|Antimetabolites|antimetabolites|mesh-ancestor
93253720|NCT02181218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93253721|NCT02181218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93253722|NCT03536234|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93253723|NCT03536234|Luteolytic Agents|luteolytic agents|mesh-ancestor
93253724|NCT03536234|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93253725|NCT03536234|Contraceptive Agents|contraceptive agents|mesh-ancestor
93253726|NCT03536234|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253727|NCT03536234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253728|NCT03536234|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93253729|NCT03536234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93253730|NCT03536234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253731|NCT03682497|Spironolactone|spironolactone|mesh-list
93253732|NCT03682497|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93253733|NCT03682497|Hormone Antagonists|hormone antagonists|mesh-ancestor
93253734|NCT03682497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253735|NCT03682497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253736|NCT03682497|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93253737|NCT03682497|Diuretics|diuretics|mesh-ancestor
93253738|NCT03682497|Natriuretic Agents|natriuretic agents|mesh-ancestor
93253739|NCT02185898|Menthol|menthol|mesh-list
93253740|NCT02185898|Nicotine|nicotine|mesh-list
93253741|NCT02185898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93253742|NCT02185898|Autonomic Agents|autonomic agents|mesh-ancestor
93253743|NCT02185898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253744|NCT02185898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253745|NCT02185898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93253746|NCT02185898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93253747|NCT02185898|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253748|NCT02185898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253749|NCT02185898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253750|NCT02185898|Antipruritics|antipruritics|mesh-ancestor
93253751|NCT02185898|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253752|NCT02805660|Durvalumab|durvalumab|mesh-list
93253753|NCT02805660|Mocetinostat|mocetinostat|mesh-list
93253754|NCT02805660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93253755|NCT02805660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253756|NCT02805660|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93253757|NCT02805660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253758|NCT02805660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253759|NCT02186132|Atropine|atropine|mesh-list
93253760|NCT02186132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93253761|NCT02186132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93253762|NCT02186132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93253763|NCT02186132|Autonomic Agents|autonomic agents|mesh-ancestor
93253764|NCT02186132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253765|NCT02186132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253766|NCT02186132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93253767|NCT02186132|Respiratory System Agents|respiratory system agents|mesh-ancestor
93253768|NCT02186132|Mydriatics|mydriatics|mesh-ancestor
93253769|NCT02186132|Parasympatholytics|parasympatholytics|mesh-ancestor
93253770|NCT02186132|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93253771|NCT02186132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93253772|NCT02186132|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253773|NCT02186132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253774|NCT02186132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253775|NCT03536780|Gemcitabine|gemcitabine|mesh-list
93253776|NCT03536780|Avelumab|avelumab|mesh-list
93253777|NCT03536780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253778|NCT03536780|Antimetabolites|antimetabolites|mesh-ancestor
92548378|NCT04189107|Dexamethasone|dexamethasone|mesh-list
93253779|NCT03536780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253780|NCT03536780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253781|NCT03536780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93253782|NCT02052336|Clarithromycin|clarithromycin|mesh-list
93253783|NCT02052336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93253784|NCT02052336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93253785|NCT02052336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93253786|NCT02052336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253787|NCT02052336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253788|NCT02052336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93253789|NCT02052336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93253790|NCT02181920|Dipyrone|dipyrone|mesh-list
93253791|NCT02181920|Diclofenac|diclofenac|mesh-list
93253792|NCT02181920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93253793|NCT02181920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253794|NCT02181920|Analgesics|analgesics|mesh-ancestor
93253795|NCT02181920|Sensory System Agents|sensory system agents|mesh-ancestor
93253796|NCT02181920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253797|NCT02181920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253798|NCT02181920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253799|NCT02181920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253800|NCT02181920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93253801|NCT02181920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253802|NCT02181920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253803|NCT02181920|Antipyretics|antipyretics|mesh-ancestor
93253804|NCT02185118|Sevoflurane|sevoflurane|mesh-list
93253805|NCT02185118|Isoflurane|isoflurane|mesh-list
93253806|NCT02185118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93253807|NCT02185118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93253808|NCT02185118|Anesthetics, General|anesthetics, general|mesh-ancestor
93253809|NCT02185118|Anesthetics|anesthetics|mesh-ancestor
93253810|NCT02185118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253811|NCT02185118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925734|NCT04097288|Dexetimide|dexetimide|mesh-list
93253812|NCT02186366|Buspirone|buspirone|mesh-list
93253813|NCT02186366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93253814|NCT02186366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93253815|NCT02186366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253816|NCT02186366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253817|NCT02186366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253818|NCT02186366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93253819|NCT02186366|Serotonin Agents|serotonin agents|mesh-ancestor
93253820|NCT02186366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253821|NCT02186366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253822|NCT02053974|Spironolactone|spironolactone|mesh-list
93253823|NCT02053974|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93253824|NCT02053974|Hormone Antagonists|hormone antagonists|mesh-ancestor
93253825|NCT02053974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93253826|NCT02053974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253827|NCT02053974|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93253828|NCT02053974|Diuretics|diuretics|mesh-ancestor
93253829|NCT02053974|Natriuretic Agents|natriuretic agents|mesh-ancestor
93253830|NCT02185196|Vitamin D|vitamin d|mesh-list
93253831|NCT02185196|Cholecalciferol|cholecalciferol|mesh-list
93253832|NCT02185196|Vitamins|vitamins|mesh-ancestor
93253833|NCT02185196|Micronutrients|micronutrients|mesh-ancestor
93253834|NCT02185196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253835|NCT02185196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93253836|NCT02185196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93253837|NCT02052492|Vitamin D|vitamin d|mesh-list
93253838|NCT02052492|Vitamins|vitamins|mesh-ancestor
93253839|NCT02052492|Micronutrients|micronutrients|mesh-ancestor
93253840|NCT02052492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253841|NCT02052492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93253842|NCT02181998|Heparin|heparin|mesh-list
93253843|NCT02181998|Enoxaparin|enoxaparin|mesh-list
93253844|NCT02181998|Tenecteplase|tenecteplase|mesh-list
93253845|NCT02181998|Anticoagulants|anticoagulants|mesh-ancestor
93253846|NCT02181998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93253847|NCT02181998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93253848|NCT02181998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253849|NCT02054052|Bevacizumab|bevacizumab|mesh-list
93253850|NCT02054052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93253851|NCT02054052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253852|NCT02054052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93253853|NCT02054052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93253854|NCT02054052|Growth Substances|growth substances|mesh-ancestor
93253855|NCT02054052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253856|NCT02054052|Growth Inhibitors|growth inhibitors|mesh-ancestor
93253857|NCT02185352|Cisplatin|cisplatin|mesh-list
93253858|NCT02185352|Etoposide|etoposide|mesh-list
93253859|NCT02185352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253860|NCT02185352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93253861|NCT02185352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93253862|NCT02185352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93253863|NCT02185352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253864|NCT02185352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253865|NCT02186600|Vitamin D|vitamin d|mesh-list
93253866|NCT02186600|Cholecalciferol|cholecalciferol|mesh-list
93253867|NCT02186600|Risedronic Acid|risedronic acid|mesh-list
93253868|NCT02186600|Calcium Carbonate|calcium carbonate|mesh-list
93253869|NCT02186600|Calcium|calcium|mesh-list
93253870|NCT02186600|Vitamins|vitamins|mesh-ancestor
93253871|NCT02186600|Micronutrients|micronutrients|mesh-ancestor
93253872|NCT02186600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253873|NCT02186600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93253874|NCT02186600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93253875|NCT02186600|Antacids|antacids|mesh-ancestor
93253876|NCT02186600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253877|NCT02186600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93253878|NCT02186600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93253879|NCT02186600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253880|NCT02052726|Vaccines|vaccines|mesh-list
93253881|NCT02052726|Immunologic Factors|immunologic factors|mesh-ancestor
93253882|NCT02052726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253883|NCT02185430|Dexmedetomidine|dexmedetomidine|mesh-list
93253884|NCT02185430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253885|NCT02185430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253886|NCT02185430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253887|NCT02185430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253888|NCT02185430|Analgesics|analgesics|mesh-ancestor
93253889|NCT02185430|Sensory System Agents|sensory system agents|mesh-ancestor
93253890|NCT02185430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253891|NCT02185430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93253892|NCT02185430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93253893|NCT02185430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93253894|NCT02185430|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253895|NCT02185430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253896|NCT02185430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253897|NCT03536390|Methylphenidate|methylphenidate|mesh-list
93253898|NCT03536390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93253899|NCT03536390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253900|NCT03536390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93253901|NCT03536390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93253902|NCT03536390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253903|NCT03536390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253904|NCT03536390|Dopamine Agents|dopamine agents|mesh-ancestor
93253905|NCT03536390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253907|NCT03561870|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93253908|NCT03561870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548495|NCT03589729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93253909|NCT03561870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253910|NCT03561870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253911|NCT02186990|Propofol|propofol|mesh-list
93253912|NCT02186990|Etomidate|etomidate|mesh-list
93253913|NCT02186990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253914|NCT02186990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253915|NCT02186990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253916|NCT02186990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93253917|NCT02186990|Anesthetics, General|anesthetics, general|mesh-ancestor
93253918|NCT02186990|Anesthetics|anesthetics|mesh-ancestor
93253919|NCT05657028|Lidocaine|lidocaine|mesh-list
93253920|NCT05657028|Dexmedetomidine|dexmedetomidine|mesh-list
93253921|NCT05657028|Anesthetics, Local|anesthetics, local|mesh-ancestor
93253922|NCT05657028|Anesthetics|anesthetics|mesh-ancestor
93253923|NCT05657028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253924|NCT05657028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253925|NCT05657028|Sensory System Agents|sensory system agents|mesh-ancestor
93253926|NCT05657028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253927|NCT05657028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93253928|NCT05657028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93253929|NCT05657028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93253930|NCT05657028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93253931|NCT05657028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253932|NCT05657028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253933|NCT05657028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253934|NCT05657028|Analgesics|analgesics|mesh-ancestor
93253935|NCT05657028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93253936|NCT05657028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93253937|NCT05657028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93253938|NCT05657028|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253939|NCT05657028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253940|NCT02187068|Dexmedetomidine|dexmedetomidine|mesh-list
93253941|NCT02187068|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93253942|NCT02187068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93253943|NCT02187068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253944|NCT02187068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253945|NCT02187068|Analgesics|analgesics|mesh-ancestor
93253946|NCT02187068|Sensory System Agents|sensory system agents|mesh-ancestor
93253947|NCT02187068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253948|NCT02187068|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93253949|NCT02187068|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93253950|NCT02187068|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93253951|NCT02187068|Adrenergic Agents|adrenergic agents|mesh-ancestor
93253952|NCT02187068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253953|NCT02187068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253954|NCT02054442|Methotrexate|methotrexate|mesh-list
93253955|NCT02054442|Cetuximab|cetuximab|mesh-list
92548562|NCT03390933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253956|NCT02054442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93253957|NCT02054442|Abortifacient Agents|abortifacient agents|mesh-ancestor
93253958|NCT02054442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93253959|NCT02054442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253960|NCT02054442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93253961|NCT02054442|Antimetabolites|antimetabolites|mesh-ancestor
93253962|NCT02054442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253963|NCT02054442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93253964|NCT02054442|Dermatologic Agents|dermatologic agents|mesh-ancestor
93253965|NCT02054442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253966|NCT02054442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93253967|NCT02054442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93253968|NCT02054442|Immunologic Factors|immunologic factors|mesh-ancestor
93253969|NCT02054442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253970|NCT02054442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93253971|NCT02054442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93253973|NCT02054676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93253974|NCT02054676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253975|NCT02054676|Analgesics|analgesics|mesh-ancestor
93253976|NCT02054676|Sensory System Agents|sensory system agents|mesh-ancestor
93253977|NCT02054676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93253978|NCT02054676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253979|NCT02054676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93253980|NCT02054676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93253981|NCT02054676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93253982|NCT02054676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93253983|NCT02054676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253984|NCT02256956|Amitriptyline|amitriptyline|mesh-list
93253985|NCT02256956|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93253986|NCT02256956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93253987|NCT02256956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93253988|NCT02256956|Cholinergic Agents|cholinergic agents|mesh-ancestor
93253989|NCT02256956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93253990|NCT02256956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93253991|NCT02256956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93253992|NCT02256956|Urological Agents|urological agents|mesh-ancestor
93253993|NCT02256956|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93253994|NCT02256956|Antidepressive Agents|antidepressive agents|mesh-ancestor
93253995|NCT02256956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93253996|NCT02256956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93253997|NCT02256956|Analgesics|analgesics|mesh-ancestor
93253998|NCT02256956|Sensory System Agents|sensory system agents|mesh-ancestor
93253999|NCT02256956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254000|NCT02256956|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93254001|NCT02256956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93254002|NCT02256956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254003|NCT02256956|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254004|NCT02187536|Telmisartan|telmisartan|mesh-list
93254005|NCT02187536|Simvastatin|simvastatin|mesh-list
93254006|NCT02187536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93254007|NCT02187536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93254008|NCT02187536|Antimetabolites|antimetabolites|mesh-ancestor
93254009|NCT02187536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254010|NCT02187536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93254011|NCT02187536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93254012|NCT02187536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254013|NCT02187536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93254014|NCT02187536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92548610|NCT03140358|Atropine|atropine|mesh-list
93254015|NCT02187536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93254016|NCT02256722|Propranolol|propranolol|mesh-list
93254017|NCT02256722|Bisoprolol|bisoprolol|mesh-list
93254018|NCT02256722|Acipimox|acipimox|mesh-list
93254019|NCT02256722|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93254020|NCT02256722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93254021|NCT02256722|Autonomic Agents|autonomic agents|mesh-ancestor
93254022|NCT02256722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254023|NCT02256722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254024|NCT02256722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93254025|NCT02256722|Respiratory System Agents|respiratory system agents|mesh-ancestor
93254026|NCT02256722|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93254027|NCT02256722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93254028|NCT02256722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93254029|NCT02256722|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254030|NCT02256722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254031|NCT02256722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254032|NCT02256722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93254033|NCT02256722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93254034|NCT02256722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93254035|NCT02256722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93254036|NCT02256722|Vasodilator Agents|vasodilator agents|mesh-ancestor
93254037|NCT02256722|Sympatholytics|sympatholytics|mesh-ancestor
93254038|NCT02256722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93254039|NCT02256722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93254040|NCT02256722|Antimetabolites|antimetabolites|mesh-ancestor
93254041|NCT02256722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93254042|NCT02193620|Nalbuphine|nalbuphine|mesh-list
93254043|NCT02193620|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93254044|NCT02193620|Narcotics|narcotics|mesh-ancestor
93254045|NCT02193620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254046|NCT02193620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254047|NCT02193620|Analgesics|analgesics|mesh-ancestor
93254048|NCT02193620|Sensory System Agents|sensory system agents|mesh-ancestor
93254049|NCT02193620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254050|NCT02187614|Acetaminophen|acetaminophen|mesh-list
93254051|NCT02187614|Diclofenac|diclofenac|mesh-list
93254052|NCT02187614|Morphine|morphine|mesh-list
93254053|NCT02187614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93254054|NCT02187614|Narcotics|narcotics|mesh-ancestor
93254055|NCT02187614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254056|NCT02187614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254057|NCT02187614|Analgesics|analgesics|mesh-ancestor
93254058|NCT02187614|Sensory System Agents|sensory system agents|mesh-ancestor
93254059|NCT02187614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254060|NCT02187614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93254061|NCT02187614|Antipyretics|antipyretics|mesh-ancestor
93254062|NCT02187614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93254063|NCT02187614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254064|NCT02187614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93254065|NCT02187614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93254066|NCT02187614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254067|NCT02187614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254068|NCT02030678|Irinotecan|irinotecan|mesh-list
93254069|NCT02030678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93254070|NCT02030678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93254071|NCT02030678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254072|NCT02030678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254073|NCT02030678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254074|NCT02054988|Caffeine|caffeine|mesh-list
92548678|NCT02573831|Oxycodone|oxycodone|mesh-list
93254075|NCT02054988|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93254076|NCT02054988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254077|NCT02054988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93254078|NCT02054988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254079|NCT02054988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254080|NCT02054988|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93254081|NCT02054988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93254082|NCT02054988|Purinergic Agents|purinergic agents|mesh-ancestor
93254083|NCT02054988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254084|NCT02191124|Mirtazapine|mirtazapine|mesh-list
93254085|NCT02191124|Paroxetine|paroxetine|mesh-list
93254086|NCT02191124|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93254087|NCT02191124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93254088|NCT02191124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254089|NCT02191124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254090|NCT02191124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254091|NCT02191124|Serotonin Agents|serotonin agents|mesh-ancestor
93254092|NCT02191124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254093|NCT02191124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93254094|NCT02191124|Antidepressive Agents|antidepressive agents|mesh-ancestor
93254095|NCT02191124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93254096|NCT02191124|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93254097|NCT02191124|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93254098|NCT02191124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254099|NCT02191124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93254100|NCT02191124|Histamine Antagonists|histamine antagonists|mesh-ancestor
93254101|NCT02191124|Histamine Agents|histamine agents|mesh-ancestor
93254102|NCT02191124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93254103|NCT02191124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93254104|NCT02191124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254105|NCT02191124|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93254106|NCT02191124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93254107|NCT02191124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93254108|NCT02191124|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254109|NCT02191124|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93254110|NCT02191124|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93254111|NCT02191124|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93254113|NCT02193698|Lenalidomide|lenalidomide|mesh-list
93254114|NCT02193698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254115|NCT02193698|Antiemetics|antiemetics|mesh-ancestor
93254116|NCT02193698|Autonomic Agents|autonomic agents|mesh-ancestor
93254117|NCT02193698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254118|NCT02193698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254119|NCT02193698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93254120|NCT02193698|Glucocorticoids|glucocorticoids|mesh-ancestor
93254121|NCT02193698|Hormones|hormones|mesh-ancestor
93254122|NCT02193698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254123|NCT02193698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254124|NCT02193698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254125|NCT02193698|Immunologic Factors|immunologic factors|mesh-ancestor
93254126|NCT02193698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254127|NCT02193698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254128|NCT02193698|Growth Substances|growth substances|mesh-ancestor
93254129|NCT02193698|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254130|NCT02191202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93254131|NCT02191202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93254132|NCT02191202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254133|NCT02191202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254134|NCT02191202|Antiviral Agents|antiviral agents|mesh-ancestor
93254135|NCT02191202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254136|NCT02055300|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93254137|NCT02055300|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93254138|NCT02055300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93254139|NCT02055300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254140|NCT02055300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254141|NCT02055300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254142|NCT02055300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254143|NCT02055300|Antidepressive Agents|antidepressive agents|mesh-ancestor
93254144|NCT02055300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93254145|NCT02191280|Quercetin|quercetin|mesh-list
93254146|NCT02191280|Antioxidants|antioxidants|mesh-ancestor
93254147|NCT02191280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254148|NCT02191280|Protective Agents|protective agents|mesh-ancestor
93254149|NCT02191280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254150|NCT02055378|Atropine|atropine|mesh-list
93254151|NCT02055378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93254152|NCT02055378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93254153|NCT02055378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93254154|NCT02055378|Autonomic Agents|autonomic agents|mesh-ancestor
93254155|NCT02055378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254156|NCT02055378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254157|NCT02055378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93254158|NCT02055378|Respiratory System Agents|respiratory system agents|mesh-ancestor
93254159|NCT02055378|Mydriatics|mydriatics|mesh-ancestor
93254160|NCT02055378|Parasympatholytics|parasympatholytics|mesh-ancestor
93254161|NCT02055378|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93254162|NCT02055378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93254163|NCT02055378|Cholinergic Agents|cholinergic agents|mesh-ancestor
93254164|NCT02055378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254165|NCT02055378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254166|NCT04558190|Ubiquinone|ubiquinone|mesh-list
93254167|NCT04558190|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93254168|NCT04558190|Albuterol|albuterol|mesh-list
93254169|NCT04558190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93254170|NCT04558190|Autonomic Agents|autonomic agents|mesh-ancestor
93254171|NCT04558190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254172|NCT04558190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254173|NCT04558190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93254174|NCT04558190|Respiratory System Agents|respiratory system agents|mesh-ancestor
93254175|NCT04558190|Tocolytic Agents|tocolytic agents|mesh-ancestor
93254176|NCT04558190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93254177|NCT04558190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93254178|NCT04558190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93254179|NCT04558190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92926118|NCT00717756|Lenalidomide|lenalidomide|mesh-list
93254181|NCT04558190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254182|NCT04558190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254183|NCT04558190|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93254184|NCT04558190|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93254185|NCT04558190|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93254186|NCT04558190|Micronutrients|micronutrients|mesh-ancestor
93254187|NCT02055456|Nandrolone Decanoate|nandrolone decanoate|mesh-list
93254188|NCT02055456|Nandrolone|nandrolone|mesh-list
93254189|NCT02055456|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
93254190|NCT02055456|Androgens|androgens|mesh-ancestor
93254191|NCT02055456|Hormones|hormones|mesh-ancestor
93254192|NCT02055456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254193|NCT02055456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254194|NCT02055456|Anabolic Agents|anabolic agents|mesh-ancestor
93254195|NCT02055456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93254196|NCT03676959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93254197|NCT03676959|Antibodies|antibodies|mesh-list
93254198|NCT03676959|Immunoglobulins|immunoglobulins|mesh-list
93254199|NCT03676959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93254200|NCT03676959|Immunologic Factors|immunologic factors|mesh-ancestor
93254201|NCT03676959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254202|NCT03676959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254203|NCT03755973|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93254204|NCT03755973|Hormones|hormones|mesh-ancestor
93254205|NCT03755973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254206|NCT03755973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254207|NCT02056938|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93254208|NCT02056938|Basiliximab|basiliximab|mesh-list
93254209|NCT02056938|Immunologic Factors|immunologic factors|mesh-ancestor
93254210|NCT02056938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254211|NCT02056938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93254212|NCT02191670|Tenecteplase|tenecteplase|mesh-list
93254213|NCT02191670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93254214|NCT02191670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93254215|NCT02191670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254216|NCT02057094|Caseins|caseins|mesh-list
93254217|NCT02057094|Chelating Agents|chelating agents|mesh-ancestor
93254218|NCT02057094|Sequestering Agents|sequestering agents|mesh-ancestor
93254219|NCT02057094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254220|NCT02917941|Dexamethasone|dexamethasone|mesh-list
93254221|NCT02917941|Lenalidomide|lenalidomide|mesh-list
93254222|NCT02917941|Ixazomib|ixazomib|mesh-list
93254223|NCT02917941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254224|NCT02917941|Antiemetics|antiemetics|mesh-ancestor
93254225|NCT02917941|Autonomic Agents|autonomic agents|mesh-ancestor
93254226|NCT02917941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254227|NCT02917941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254228|NCT02917941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93254229|NCT02917941|Glucocorticoids|glucocorticoids|mesh-ancestor
93254230|NCT02917941|Hormones|hormones|mesh-ancestor
93254231|NCT02917941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254232|NCT02917941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254233|NCT02917941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254234|NCT02917941|Immunologic Factors|immunologic factors|mesh-ancestor
93254235|NCT02917941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254236|NCT02917941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254237|NCT02917941|Growth Substances|growth substances|mesh-ancestor
93254238|NCT02917941|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254239|NCT02917941|Protease Inhibitors|protease inhibitors|mesh-ancestor
93254240|NCT02917941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254241|NCT02917941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254242|NCT02055690|Fosbretabulin|fosbretabulin|mesh-list
93254243|NCT02055690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93254244|NCT02055690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254245|NCT02191748|Triamcinolone|triamcinolone|mesh-list
93254246|NCT02191748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254247|NCT02191748|Glucocorticoids|glucocorticoids|mesh-ancestor
93254248|NCT02191748|Hormones|hormones|mesh-ancestor
93254249|NCT02191748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254250|NCT02191748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254251|NCT02191826|Tolcapone|tolcapone|mesh-list
93254252|NCT02191826|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93254253|NCT02191826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92926194|NCT00791765|Etanercept|etanercept|mesh-list
93254254|NCT02191826|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93254255|NCT02191826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254256|NCT02191826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254257|NCT01333956|Pregabalin|pregabalin|mesh-list
93254258|NCT01333956|Analgesics|analgesics|mesh-ancestor
93254259|NCT01333956|Sensory System Agents|sensory system agents|mesh-ancestor
93254260|NCT01333956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254261|NCT01333956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254262|NCT01333956|Anticonvulsants|anticonvulsants|mesh-ancestor
93254263|NCT01333956|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93254264|NCT01333956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254265|NCT01333956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254266|NCT01333956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93254267|NCT01333956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93254268|NCT01333956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93254269|NCT01333956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254270|NCT01333956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93254271|NCT02057328|Telmisartan|telmisartan|mesh-list
93254272|NCT02057328|Nebivolol|nebivolol|mesh-list
93254273|NCT02057328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93254274|NCT02057328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93254275|NCT02057328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93254276|NCT02057328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254277|NCT02057328|Vasodilator Agents|vasodilator agents|mesh-ancestor
93254278|NCT02057328|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93254279|NCT02057328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93254280|NCT02057328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93254281|NCT02057328|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254282|NCT02057328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254283|NCT02057328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254284|NCT02057484|Tacrolimus|tacrolimus|mesh-list
93254285|NCT02057484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93254286|NCT02057484|Immunologic Factors|immunologic factors|mesh-ancestor
93254287|NCT02057484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254288|NCT02057484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93254289|NCT02057484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254290|NCT02057484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254291|NCT02192060|Triclosan|triclosan|mesh-list
92548902|NCT00018902|Serotonin Agents|serotonin agents|mesh-ancestor
93254292|NCT02192060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93254293|NCT02192060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254294|NCT02192060|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93254295|NCT02192060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93254296|NCT02192060|Antimetabolites|antimetabolites|mesh-ancestor
93254297|NCT02192060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254298|NCT02192060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93254299|NCT02188394|Bupivacaine|bupivacaine|mesh-list
93254300|NCT02188394|Anesthetics|anesthetics|mesh-list
93254301|NCT02188394|Anesthetics, Local|anesthetics, local|mesh-ancestor
93254302|NCT02188394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254303|NCT02188394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254304|NCT02188394|Sensory System Agents|sensory system agents|mesh-ancestor
93254305|NCT02188394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254306|NCT01333722|Acetaminophen|acetaminophen|mesh-list
93254307|NCT01333722|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93254308|NCT01333722|Hydrocodone|hydrocodone|mesh-list
93254309|NCT01333722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93254310|NCT01333722|Analgesics|analgesics|mesh-ancestor
93254311|NCT01333722|Sensory System Agents|sensory system agents|mesh-ancestor
93254312|NCT01333722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254313|NCT01333722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254314|NCT01333722|Antipyretics|antipyretics|mesh-ancestor
93254315|NCT01333722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93254316|NCT01333722|Narcotics|narcotics|mesh-ancestor
93254317|NCT01333722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254318|NCT01333722|Antitussive Agents|antitussive agents|mesh-ancestor
93254319|NCT01333722|Respiratory System Agents|respiratory system agents|mesh-ancestor
93254320|NCT01333722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93254321|NCT01333722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254322|NCT01333722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93254323|NCT02188472|Trimethoprim|trimethoprim|mesh-list
93254324|NCT02188472|Penicillins|penicillins|mesh-list
93254325|NCT02188472|Penicillin V|penicillin v|mesh-list
93254326|NCT02188472|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93254327|NCT02188472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254328|NCT02188472|Antimalarials|antimalarials|mesh-ancestor
93254329|NCT02188472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93254330|NCT02188472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93254331|NCT02188472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93254332|NCT02188472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254333|NCT02188472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254334|NCT02188472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93254335|NCT02188472|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93254336|NCT02188472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93254337|NCT02188472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254338|NCT02188550|Everolimus|everolimus|mesh-list
93254339|NCT02188550|Letrozole|letrozole|mesh-list
93254340|NCT02188550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93254341|NCT02188550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93254342|NCT02188550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254343|NCT02188550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254344|NCT02188550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93254345|NCT02188550|Immunologic Factors|immunologic factors|mesh-ancestor
93254346|NCT02188550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254347|NCT02188550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254348|NCT02188550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93254349|NCT02188550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93254350|NCT02188550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93254351|NCT02188550|Hormone Antagonists|hormone antagonists|mesh-ancestor
93254352|NCT02188550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254353|NCT02059590|Isavuconazole|isavuconazole|mesh-list
93254354|NCT02059590|Antifungal Agents|antifungal agents|mesh-ancestor
93254355|NCT02059590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254356|NCT02057796|Efavirenz|efavirenz|mesh-list
93254357|NCT02057796|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93254358|NCT02057796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93254359|NCT02057796|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93254360|NCT02057796|Rifampin|rifampin|mesh-list
93254361|NCT02057796|Isoniazid|isoniazid|mesh-list
93254362|NCT02057796|Pyrazinamide|pyrazinamide|mesh-list
93254363|NCT02057796|Ethambutol|ethambutol|mesh-list
93254364|NCT02057796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93254365|NCT02057796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93254366|NCT02057796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254367|NCT02057796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254368|NCT02057796|Antiviral Agents|antiviral agents|mesh-ancestor
93254369|NCT02057796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254370|NCT02057796|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93254371|NCT02057796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93254372|NCT02057796|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93254373|NCT02057796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93254374|NCT02057796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93254375|NCT02057796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93254376|NCT02057796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93254377|NCT02057796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93254378|NCT02057796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93254379|NCT02057796|Antitubercular Agents|antitubercular agents|mesh-ancestor
93254380|NCT02057796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254381|NCT02057796|Leprostatic Agents|leprostatic agents|mesh-ancestor
93254382|NCT02057796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93254383|NCT02057796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93254384|NCT02057796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93254385|NCT02057796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93254386|NCT02057796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93254387|NCT02057796|Antimetabolites|antimetabolites|mesh-ancestor
93254388|NCT02057796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93254389|NCT02192450|Insulin|insulin|mesh-list
93254390|NCT02192450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93254391|NCT02192450|Insulin Aspart|insulin aspart|mesh-list
93254392|NCT02192450|Insulin, Long-Acting|insulin, long-acting|mesh-list
93254393|NCT02192450|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93254394|NCT02192450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93254395|NCT02192450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254396|NCT03284385|Adavosertib|adavosertib|mesh-list
93254397|NCT03284385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254398|NCT03284385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254399|NCT03560856|Fulvestrant|fulvestrant|mesh-list
93254400|NCT03560856|Palbociclib|palbociclib|mesh-list
93254401|NCT03560856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254402|NCT03560856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254403|NCT03560856|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93254404|NCT03560856|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93254405|NCT03560856|Hormone Antagonists|hormone antagonists|mesh-ancestor
93254406|NCT03560856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254407|NCT03560856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254408|NCT03560856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93254409|NCT03560856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254410|NCT03560856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254411|NCT03676413|Fluticasone|fluticasone|mesh-list
93254413|NCT03676413|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93254414|NCT03676413|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93254415|NCT03676413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254416|NCT03676413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93254417|NCT03676413|Autonomic Agents|autonomic agents|mesh-ancestor
92549026|NCT00019331|Aldesleukin|aldesleukin|mesh-list
93254418|NCT03676413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254419|NCT03676413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254420|NCT03676413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93254421|NCT03676413|Respiratory System Agents|respiratory system agents|mesh-ancestor
93254422|NCT03676413|Dermatologic Agents|dermatologic agents|mesh-ancestor
93254423|NCT03676413|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93254424|NCT03676413|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93254425|NCT03676413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93254426|NCT03676413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93254427|NCT03676413|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254428|NCT03676413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254429|NCT03676413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254430|NCT03676413|Glucocorticoids|glucocorticoids|mesh-ancestor
93254431|NCT03676413|Hormones|hormones|mesh-ancestor
93254432|NCT03676413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254433|NCT03676413|Sympathomimetics|sympathomimetics|mesh-ancestor
93254434|NCT03676335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93254435|NCT03676335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93254436|NCT01370694|Prednisolone|prednisolone|mesh-list
93254437|NCT01370694|Cyclophosphamide|cyclophosphamide|mesh-list
93254438|NCT01370694|Vincristine|vincristine|mesh-list
93254439|NCT01370694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93254440|NCT01370694|Immunologic Factors|immunologic factors|mesh-ancestor
93254441|NCT01370694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254442|NCT01370694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93254443|NCT01370694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93254444|NCT01370694|Alkylating Agents|alkylating agents|mesh-ancestor
93254445|NCT01370694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254446|NCT01370694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254447|NCT01370694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93254448|NCT01370694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93254449|NCT01370694|Tubulin Modulators|tubulin modulators|mesh-ancestor
93254450|NCT01370694|Antimitotic Agents|antimitotic agents|mesh-ancestor
93254451|NCT01370694|Mitosis Modulators|mitosis modulators|mesh-ancestor
93254452|NCT01370694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254453|NCT01370694|Glucocorticoids|glucocorticoids|mesh-ancestor
93254454|NCT01370694|Hormones|hormones|mesh-ancestor
93254455|NCT01370694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254456|NCT01370694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254457|NCT02256878|Amitriptyline|amitriptyline|mesh-list
93254458|NCT02256878|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93254459|NCT02256878|Antidepressive Agents|antidepressive agents|mesh-ancestor
93254460|NCT02256878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93254461|NCT02256878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93254462|NCT02256878|Analgesics|analgesics|mesh-ancestor
93254463|NCT02256878|Sensory System Agents|sensory system agents|mesh-ancestor
93254464|NCT02256878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254465|NCT02256878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254466|NCT02256878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93254467|NCT02256878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93254468|NCT02256878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254469|NCT02256878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254470|NCT02256878|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254471|NCT02256878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254472|NCT02058186|Vitamin D|vitamin d|mesh-list
93254473|NCT02058186|Vitamins|vitamins|mesh-ancestor
93254474|NCT02058186|Micronutrients|micronutrients|mesh-ancestor
93254475|NCT02058186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254476|NCT02058186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93254477|NCT03676023|Tranexamic Acid|tranexamic acid|mesh-list
93254478|NCT03676023|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93254479|NCT03676023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93254480|NCT03676023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254481|NCT03676023|Hemostatics|hemostatics|mesh-ancestor
93254482|NCT03676023|Coagulants|coagulants|mesh-ancestor
93254483|NCT02260206|Colchicine|colchicine|mesh-list
93254484|NCT02260206|Gout Suppressants|gout suppressants|mesh-ancestor
93254485|NCT02260206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93254486|NCT02260206|Tubulin Modulators|tubulin modulators|mesh-ancestor
93254487|NCT02260206|Antimitotic Agents|antimitotic agents|mesh-ancestor
93254488|NCT02260206|Mitosis Modulators|mitosis modulators|mesh-ancestor
93254489|NCT02260206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254490|NCT02260206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254491|NCT02058576|Tamsulosin|tamsulosin|mesh-list
93254492|NCT02058576|Dutasteride|dutasteride|mesh-list
93254493|NCT02058576|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93254494|NCT02058576|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93254495|NCT02058576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93254496|NCT02058576|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254497|NCT02058576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254498|NCT02058576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254499|NCT02058576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254500|NCT02058576|Urological Agents|urological agents|mesh-ancestor
93254501|NCT02058576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93254502|NCT02058576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93254503|NCT02058576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254504|NCT02058576|Hormone Antagonists|hormone antagonists|mesh-ancestor
93254505|NCT02058576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254506|NCT03535220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93254507|NCT03535220|Protease Inhibitors|protease inhibitors|mesh-list
93254508|NCT03535220|Proteasome Inhibitors|proteasome inhibitors|mesh-list
93254509|NCT03535220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254510|NCT03535220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254511|NCT03535220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93254512|NCT03535220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93254513|NCT03535220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93254514|NCT03535220|Antiviral Agents|antiviral agents|mesh-ancestor
93254515|NCT03535220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254516|NCT02189720|Amifampridine|amifampridine|mesh-list
93254517|NCT02189720|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92549151|NCT00019760|Vitamins|vitamins|mesh-ancestor
93254518|NCT02189720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254519|NCT02189720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254520|NCT02189720|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93254521|NCT02189720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254522|NCT02189720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254523|NCT03675555|Dexamethasone|dexamethasone|mesh-list
93254524|NCT03675555|Mirtazapine|mirtazapine|mesh-list
93254525|NCT03675555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93254526|NCT03675555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254527|NCT03675555|Antiemetics|antiemetics|mesh-ancestor
93254528|NCT03675555|Autonomic Agents|autonomic agents|mesh-ancestor
93254529|NCT03675555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254530|NCT03675555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254531|NCT03675555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93254532|NCT03675555|Glucocorticoids|glucocorticoids|mesh-ancestor
93254533|NCT03675555|Hormones|hormones|mesh-ancestor
93254534|NCT03675555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254535|NCT03675555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254536|NCT03675555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254537|NCT03675555|Antidepressive Agents|antidepressive agents|mesh-ancestor
93254538|NCT03675555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93254539|NCT03675555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93254540|NCT03675555|Histamine Antagonists|histamine antagonists|mesh-ancestor
93254541|NCT03675555|Histamine Agents|histamine agents|mesh-ancestor
93254542|NCT03675555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254543|NCT03675555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254544|NCT03675555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93254545|NCT03675555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93254546|NCT03675555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366401|NCT02061917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254547|NCT03675555|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93254548|NCT03675555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93254549|NCT03675555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93254550|NCT03675555|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254551|NCT03675555|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93254552|NCT03675555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93254553|NCT03675555|Serotonin Agents|serotonin agents|mesh-ancestor
93254554|NCT03675555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93254555|NCT02194166|Paclitaxel|paclitaxel|mesh-list
93254556|NCT02194166|Docetaxel|docetaxel|mesh-list
93254557|NCT02194166|Trastuzumab|trastuzumab|mesh-list
93254558|NCT02194166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93254559|NCT02194166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254560|NCT02194166|Tubulin Modulators|tubulin modulators|mesh-ancestor
93254561|NCT02194166|Antimitotic Agents|antimitotic agents|mesh-ancestor
93254562|NCT02194166|Mitosis Modulators|mitosis modulators|mesh-ancestor
93254563|NCT02194166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254564|NCT02194166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93254565|NCT02194322|Olcegepant|olcegepant|mesh-list
93254566|NCT02194322|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93254567|NCT02194322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254568|NCT02194322|Analgesics|analgesics|mesh-ancestor
93254569|NCT02194322|Sensory System Agents|sensory system agents|mesh-ancestor
93254570|NCT02194322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254571|NCT02194322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254572|NCT02193308|Amlodipine|amlodipine|mesh-list
93254573|NCT02193308|Telmisartan|telmisartan|mesh-list
92549197|NCT00039546|Paclitaxel|paclitaxel|mesh-list
93254574|NCT02193308|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93254575|NCT02193308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93254576|NCT02193308|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93254577|NCT02193308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93254578|NCT02193308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254579|NCT02193308|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93254580|NCT02193308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254581|NCT02193308|Vasodilator Agents|vasodilator agents|mesh-ancestor
93254582|NCT02193308|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93254583|NCT02193308|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93254584|NCT02060604|Ketorolac|ketorolac|mesh-list
93254585|NCT02060604|Ranibizumab|ranibizumab|mesh-list
93254586|NCT02060604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254587|NCT02060604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254588|NCT02060604|Growth Substances|growth substances|mesh-ancestor
93254589|NCT02060604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254590|NCT02060604|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254591|NCT02060604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254592|NCT02060604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93254593|NCT02060604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93254594|NCT02060604|Analgesics|analgesics|mesh-ancestor
93254595|NCT02060604|Sensory System Agents|sensory system agents|mesh-ancestor
93254596|NCT02060604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254597|NCT02060604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254598|NCT02060604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93254599|NCT02060604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93254600|NCT02060604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254601|NCT02060604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254602|NCT03679455|Obinutuzumab|obinutuzumab|mesh-list
93254603|NCT03679455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93254604|NCT03679455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254605|NCT03315143|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93254606|NCT03315143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93254607|NCT03315143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254608|NCT03315143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93254609|NCT03315143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254610|NCT02194556|Gemcitabine|gemcitabine|mesh-list
93254611|NCT02194556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549258|NCT00039858|Argatroban|argatroban|mesh-list
93254612|NCT02194556|Antimetabolites|antimetabolites|mesh-ancestor
93254613|NCT02194556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254614|NCT02194556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254615|NCT02030912|Amoxicillin|amoxicillin|mesh-list
93254616|NCT02030912|Minocycline|minocycline|mesh-list
93254617|NCT02030912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254618|NCT02030912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254620|NCT02060916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93254621|NCT02060916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254622|NCT02797080|Interferons|interferons|mesh-list
93254623|NCT02797080|Interferon-gamma|interferon-gamma|mesh-list
93254624|NCT02797080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254625|NCT02797080|Antiviral Agents|antiviral agents|mesh-ancestor
93254626|NCT02797080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254627|NCT02196194|Tiotropium Bromide|tiotropium bromide|mesh-list
93254628|NCT02196194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93254629|NCT02196194|Autonomic Agents|autonomic agents|mesh-ancestor
93254630|NCT02196194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254631|NCT02196194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254632|NCT02196194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93254633|NCT02196194|Respiratory System Agents|respiratory system agents|mesh-ancestor
93254634|NCT02196194|Parasympatholytics|parasympatholytics|mesh-ancestor
93254635|NCT02196194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93254636|NCT02196194|Cholinergic Agents|cholinergic agents|mesh-ancestor
93254637|NCT02196194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254638|NCT02196194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254639|NCT02915835|Riociguat|riociguat|mesh-list
93254640|NCT02915835|Enzyme Activators|enzyme activators|mesh-ancestor
93254641|NCT02915835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254642|NCT01370616|Amoxicillin|amoxicillin|mesh-list
93254643|NCT01370616|Tazobactam|tazobactam|mesh-list
93254644|NCT01370616|Piperacillin|piperacillin|mesh-list
93254645|NCT01370616|Ertapenem|ertapenem|mesh-list
93254646|NCT01370616|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93254647|NCT01370616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254648|NCT01370616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254649|NCT01370616|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93254650|NCT01370616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254651|NCT01370616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254652|NCT02688881|Sirolimus|sirolimus|mesh-list
93254653|NCT02688881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254654|NCT02688881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254655|NCT02688881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93254656|NCT02688881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254657|NCT02688881|Antifungal Agents|antifungal agents|mesh-ancestor
93254658|NCT02688881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93254659|NCT02688881|Immunologic Factors|immunologic factors|mesh-ancestor
93254660|NCT02688881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254661|NCT03560310|Ticagrelor|ticagrelor|mesh-list
93254662|NCT03560310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93254663|NCT03560310|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93254664|NCT03560310|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93254665|NCT03560310|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93254666|NCT03560310|Purinergic Agents|purinergic agents|mesh-ancestor
93254667|NCT03560310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254668|NCT03560310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254669|NCT03560310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254670|NCT02197286|Vitamin D|vitamin d|mesh-list
93254671|NCT02197286|Ergocalciferols|ergocalciferols|mesh-list
93254672|NCT02197286|Cholecalciferol|cholecalciferol|mesh-list
93254673|NCT02197286|Vitamins|vitamins|mesh-list
93254674|NCT02197286|Micronutrients|micronutrients|mesh-ancestor
93254675|NCT02197286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254676|NCT02197286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93254677|NCT02197286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93254678|NCT02197442|Valsartan|valsartan|mesh-list
93254679|NCT02197442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93254680|NCT02197442|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93254681|NCT02197442|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93254682|NCT02197442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254683|NCT03534674|Vitamin D|vitamin d|mesh-list
93254684|NCT03534674|Cholecalciferol|cholecalciferol|mesh-list
93254685|NCT03534674|Vitamins|vitamins|mesh-ancestor
93254686|NCT03534674|Micronutrients|micronutrients|mesh-ancestor
93254687|NCT03534674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254688|NCT03534674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93254689|NCT03534674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93254690|NCT02063334|Vitamin D|vitamin d|mesh-list
93254691|NCT02063334|Cholecalciferol|cholecalciferol|mesh-list
93254692|NCT02063334|Vitamins|vitamins|mesh-ancestor
93254693|NCT02063334|Micronutrients|micronutrients|mesh-ancestor
93254694|NCT02063334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254695|NCT02063334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93254696|NCT02063334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93254697|NCT02916927|Ketamine|ketamine|mesh-list
93254698|NCT02916927|Analgesics|analgesics|mesh-ancestor
93254699|NCT02916927|Sensory System Agents|sensory system agents|mesh-ancestor
93254700|NCT02916927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254701|NCT02916927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254702|NCT02916927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93254703|NCT02916927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93254704|NCT02916927|Anesthetics, General|anesthetics, general|mesh-ancestor
93254705|NCT02916927|Anesthetics|anesthetics|mesh-ancestor
93254706|NCT02916927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254707|NCT02916927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93254708|NCT02916927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93254709|NCT02916927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254710|NCT02916927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254711|NCT02197598|Nalmefene|nalmefene|mesh-list
93254712|NCT02197598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93254713|NCT02197598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254714|NCT02197598|Sensory System Agents|sensory system agents|mesh-ancestor
93254715|NCT02197598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254716|NCT02196662|Mesalamine|mesalamine|mesh-list
93254717|NCT02196662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93254718|NCT02196662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93254719|NCT02196662|Analgesics|analgesics|mesh-ancestor
93254720|NCT02196662|Sensory System Agents|sensory system agents|mesh-ancestor
93254721|NCT02196662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254722|NCT02196662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254723|NCT02196662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254724|NCT02196662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93254725|NCT02195180|Leucovorin|leucovorin|mesh-list
93254726|NCT02195180|Gemcitabine|gemcitabine|mesh-list
93254727|NCT02195180|Fluorouracil|fluorouracil|mesh-list
93254728|NCT02195180|Oxaliplatin|oxaliplatin|mesh-list
93254729|NCT02195180|Asparaginase|asparaginase|mesh-list
93254730|NCT02195180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93254731|NCT02195180|Antimetabolites|antimetabolites|mesh-ancestor
92549352|NCT00040053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93254732|NCT02195180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254733|NCT02195180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254734|NCT02195180|Antidotes|antidotes|mesh-ancestor
93254735|NCT02195180|Protective Agents|protective agents|mesh-ancestor
93254736|NCT02195180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254737|NCT02195180|Vitamin B Complex|vitamin b complex|mesh-ancestor
93254738|NCT02195180|Vitamins|vitamins|mesh-ancestor
93254739|NCT02195180|Micronutrients|micronutrients|mesh-ancestor
93254740|NCT02195180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93254741|NCT02195180|Immunologic Factors|immunologic factors|mesh-ancestor
93254742|NCT03623529|Angiotensin II|angiotensin ii|mesh-list
93254743|NCT03623529|Giapreza|giapreza|mesh-list
93254744|NCT03623529|Angiotensinogen|angiotensinogen|mesh-list
93254745|NCT03623529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93254746|NCT03623529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93254747|NCT03623529|Protease Inhibitors|protease inhibitors|mesh-ancestor
93254748|NCT03623529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254749|NCT03623529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254750|NCT02197676|Guadecitabine|guadecitabine|mesh-list
93254751|NCT02197676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254752|NCT02916693|Mirabegron|mirabegron|mesh-list
93254753|NCT02916693|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93254754|NCT02916693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93254755|NCT02916693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93254756|NCT02916693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93254757|NCT02916693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254758|NCT02916693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254759|NCT02916693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254760|NCT02916693|Urological Agents|urological agents|mesh-ancestor
93254761|NCT02195336|Paclitaxel|paclitaxel|mesh-list
93254762|NCT02195336|Bevacizumab|bevacizumab|mesh-list
93254763|NCT02195336|Carboplatin|carboplatin|mesh-list
93254764|NCT02195336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93254765|NCT02195336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254766|NCT02195336|Tubulin Modulators|tubulin modulators|mesh-ancestor
93254767|NCT02195336|Antimitotic Agents|antimitotic agents|mesh-ancestor
93254768|NCT02195336|Mitosis Modulators|mitosis modulators|mesh-ancestor
93254769|NCT02195336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254770|NCT02195336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93254771|NCT02195336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254772|NCT02195336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254773|NCT02195336|Growth Substances|growth substances|mesh-ancestor
93254774|NCT02195336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254775|NCT02195336|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254776|NCT03679065|Acetaminophen|acetaminophen|mesh-list
93254777|NCT03679065|Dexamethasone|dexamethasone|mesh-list
93254778|NCT03679065|Dexamethasone acetate|dexamethasone acetate|mesh-list
93254779|NCT03679065|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93254780|NCT03679065|BB 1101|bb 1101|mesh-list
93254781|NCT03679065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254782|NCT03679065|Antiemetics|antiemetics|mesh-ancestor
93254783|NCT03679065|Autonomic Agents|autonomic agents|mesh-ancestor
93254784|NCT03679065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254785|NCT03679065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254786|NCT03679065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93254787|NCT03679065|Glucocorticoids|glucocorticoids|mesh-ancestor
93254788|NCT03679065|Hormones|hormones|mesh-ancestor
93254789|NCT03679065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254790|NCT03679065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254791|NCT03679065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254792|NCT03679065|Protease Inhibitors|protease inhibitors|mesh-ancestor
93254793|NCT03679065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254794|NCT03679065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254795|NCT03679065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93254796|NCT03679065|Analgesics|analgesics|mesh-ancestor
93254797|NCT03679065|Sensory System Agents|sensory system agents|mesh-ancestor
93254798|NCT03679065|Antipyretics|antipyretics|mesh-ancestor
93254799|NCT02196740|Metronidazole|metronidazole|mesh-list
93254800|NCT02196740|Ciprofloxacin|ciprofloxacin|mesh-list
93254801|NCT02196740|Clindamycin|clindamycin|mesh-list
93254802|NCT02196740|Clindamycin palmitate|clindamycin palmitate|mesh-list
93254803|NCT02196740|Clindamycin phosphate|clindamycin phosphate|mesh-list
93254804|NCT02196740|Gatifloxacin|gatifloxacin|mesh-list
93254805|NCT02196740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254806|NCT02196740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254807|NCT02196740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93254808|NCT02196740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93254809|NCT02196740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93254810|NCT02196740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93254811|NCT02196740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254812|NCT02196740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254813|NCT02196740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254814|NCT02196740|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93254815|NCT02196740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93254816|NCT02196740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93254817|NCT02196740|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93254818|NCT02196740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93254819|NCT02195492|Hylan|hylan|mesh-list
93254820|NCT02195492|Viscosupplements|viscosupplements|mesh-ancestor
93254821|NCT02195492|Protective Agents|protective agents|mesh-ancestor
93254822|NCT02195492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254823|NCT03678987|Mycophenolic Acid|mycophenolic acid|mesh-list
93254824|NCT03678987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93254825|NCT03678987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254826|NCT03678987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93254827|NCT03678987|Antitubercular Agents|antitubercular agents|mesh-ancestor
93254828|NCT03678987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254829|NCT03678987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254830|NCT03678987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254831|NCT03678987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254832|NCT02919345|Dapagliflozin|dapagliflozin|mesh-list
93254833|NCT02919345|Glyburide|glyburide|mesh-list
93254834|NCT02919345|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93254835|NCT02919345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254836|NCT02919345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93254837|NCT02919345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254838|NCT02195804|Ranitidine|ranitidine|mesh-list
93254839|NCT02195804|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93254840|NCT02195804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93254841|NCT02195804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93254842|NCT02195804|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93254843|NCT02195804|Histamine Antagonists|histamine antagonists|mesh-ancestor
93254844|NCT02195804|Histamine Agents|histamine agents|mesh-ancestor
93254845|NCT02195804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254846|NCT02195804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254847|NCT02195804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254849|NCT03672435|Anesthetics, Local|anesthetics, local|mesh-ancestor
93254850|NCT03672435|Anesthetics|anesthetics|mesh-ancestor
93254851|NCT03672435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254852|NCT03672435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254853|NCT03672435|Sensory System Agents|sensory system agents|mesh-ancestor
93254854|NCT03672435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254855|NCT03674463|Immunomodulating Agents|immunomodulating agents|mesh-list
93254856|NCT03674463|Immunologic Factors|immunologic factors|mesh-ancestor
93254857|NCT03674463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254858|NCT03674385|Vitamin E|vitamin e|mesh-list
93254859|NCT03674385|Metformin|metformin|mesh-list
93254860|NCT03674385|Clomiphene|clomiphene|mesh-list
93254861|NCT03674385|Enclomiphene|enclomiphene|mesh-list
93254862|NCT03674385|Zuclomiphene|zuclomiphene|mesh-list
93254863|NCT03674385|Vitamins|vitamins|mesh-ancestor
93254864|NCT03674385|Micronutrients|micronutrients|mesh-ancestor
93254865|NCT03674385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254866|NCT03674385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93254867|NCT03674385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254868|NCT03674385|Antioxidants|antioxidants|mesh-ancestor
93254869|NCT03674385|Protective Agents|protective agents|mesh-ancestor
93254870|NCT03674385|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93254871|NCT03674385|Hormone Antagonists|hormone antagonists|mesh-ancestor
93254872|NCT03674385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254873|NCT03674385|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93254874|NCT03674385|Fertility Agents|fertility agents|mesh-ancestor
93254875|NCT03674385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93254876|NCT03674385|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93254877|NCT03674385|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93254878|NCT02574455|Gemcitabine|gemcitabine|mesh-list
93254879|NCT02574455|Capecitabine|capecitabine|mesh-list
93254880|NCT02574455|Vinorelbine|vinorelbine|mesh-list
93254881|NCT02574455|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93254882|NCT02574455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93254883|NCT02574455|Antimetabolites|antimetabolites|mesh-ancestor
93254884|NCT02574455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254885|NCT02574455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254886|NCT02574455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93254887|NCT02574455|Tubulin Modulators|tubulin modulators|mesh-ancestor
93254888|NCT02574455|Antimitotic Agents|antimitotic agents|mesh-ancestor
93254889|NCT02574455|Mitosis Modulators|mitosis modulators|mesh-ancestor
93254890|NCT02574455|Immunoconjugates|immunoconjugates|mesh-ancestor
93254891|NCT02574455|Immunologic Factors|immunologic factors|mesh-ancestor
93254892|NCT02574455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254893|NCT02197988|Fentanyl|fentanyl|mesh-list
93254894|NCT02197988|Bupivacaine|bupivacaine|mesh-list
93254895|NCT02197988|Anesthetics, Local|anesthetics, local|mesh-ancestor
93254896|NCT02197988|Anesthetics|anesthetics|mesh-ancestor
93254897|NCT02197988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254898|NCT02197988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254899|NCT02197988|Sensory System Agents|sensory system agents|mesh-ancestor
93254900|NCT02197988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93254901|NCT02197988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93254902|NCT02197988|Narcotics|narcotics|mesh-ancestor
93254903|NCT02197988|Analgesics|analgesics|mesh-ancestor
93254904|NCT02197988|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93254905|NCT02197988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93254906|NCT02197988|Anesthetics, General|anesthetics, general|mesh-ancestor
93254907|NCT03672357|Liver Extracts|liver extracts|mesh-list
93254908|NCT03672357|Hematinics|hematinics|mesh-ancestor
93254909|NCT02201030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93254910|NCT02201030|Immunologic Factors|immunologic factors|mesh-ancestor
93254911|NCT02201030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254912|NCT03674073|Vaccines|vaccines|mesh-list
93254913|NCT03674073|Immunologic Factors|immunologic factors|mesh-ancestor
93254914|NCT03674073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254915|NCT03673995|Inositol|inositol|mesh-list
93254916|NCT03673995|Vitamin B Complex|vitamin b complex|mesh-ancestor
93254917|NCT03673995|Vitamins|vitamins|mesh-ancestor
93254918|NCT03673995|Micronutrients|micronutrients|mesh-ancestor
93254919|NCT03673995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254920|NCT01378091|Prednisone|prednisone|mesh-list
93254921|NCT01378091|Docetaxel|docetaxel|mesh-list
93254922|NCT01378091|Lenalidomide|lenalidomide|mesh-list
93254923|NCT01378091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254924|NCT01378091|Tubulin Modulators|tubulin modulators|mesh-ancestor
93254925|NCT01378091|Antimitotic Agents|antimitotic agents|mesh-ancestor
93254926|NCT01378091|Mitosis Modulators|mitosis modulators|mesh-ancestor
93254927|NCT01378091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254928|NCT01378091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93254929|NCT01378091|Glucocorticoids|glucocorticoids|mesh-ancestor
93254930|NCT01378091|Hormones|hormones|mesh-ancestor
93254931|NCT01378091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93254932|NCT01378091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254933|NCT01378091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93254934|NCT01378091|Immunologic Factors|immunologic factors|mesh-ancestor
93254935|NCT01378091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254936|NCT01378091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254937|NCT01378091|Growth Substances|growth substances|mesh-ancestor
93254938|NCT01378091|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254939|NCT02794974|Anesthetics|anesthetics|mesh-list
93254940|NCT02794974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93254941|NCT02794974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254942|NCT02063568|Oxytocin|oxytocin|mesh-list
93254943|NCT02063568|Oxytocics|oxytocics|mesh-ancestor
93254944|NCT02063568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93254945|NCT02063568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254946|NCT02257502|Aflibercept|aflibercept|mesh-list
93254947|NCT02257502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254948|NCT02257502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254949|NCT02257502|Growth Substances|growth substances|mesh-ancestor
93254950|NCT02257502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254951|NCT02257502|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254952|NCT02257502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254953|NCT02907099|Pembrolizumab|pembrolizumab|mesh-list
93254954|NCT02907099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93254955|NCT02907099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254956|NCT02907099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93254957|NCT02907099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254958|NCT02450123|Sunitinib|sunitinib|mesh-list
93254959|NCT02450123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93254960|NCT02450123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93254961|NCT02450123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93254962|NCT02450123|Growth Substances|growth substances|mesh-ancestor
93254963|NCT02450123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254964|NCT02450123|Growth Inhibitors|growth inhibitors|mesh-ancestor
93254965|NCT02450123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93254966|NCT02450123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254967|NCT02450123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254968|NCT02063802|Metformin|metformin|mesh-list
93254969|NCT02063802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93254970|NCT02063802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254971|NCT03672045|Carbetocin|carbetocin|mesh-list
93254972|NCT03672045|Oxytocics|oxytocics|mesh-ancestor
93254973|NCT03672045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93254974|NCT03672045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254975|NCT02198300|Clopidogrel|clopidogrel|mesh-list
93254976|NCT02198300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93254977|NCT02198300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93254978|NCT02198300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93254979|NCT02198300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93254980|NCT02198300|Purinergic Agents|purinergic agents|mesh-ancestor
93254981|NCT02198300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93254982|NCT02198300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254983|NCT02198300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93254984|NCT03560232|Clindamycin|clindamycin|mesh-list
93254985|NCT03560232|Gentamicins|gentamicins|mesh-list
93254986|NCT03560232|Cefazolin|cefazolin|mesh-list
93254987|NCT03560232|Ceftriaxone|ceftriaxone|mesh-list
93254988|NCT03560232|Tazobactam|tazobactam|mesh-list
93254989|NCT03560232|Piperacillin|piperacillin|mesh-list
93254990|NCT03560232|Ampicillin|ampicillin|mesh-list
93254991|NCT03560232|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93254992|NCT03560232|Sulbactam|sulbactam|mesh-list
93254993|NCT03560232|Sultamicillin|sultamicillin|mesh-list
93254994|NCT03560232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93254995|NCT03560232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93254996|NCT03560232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93254997|NCT03560232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93254998|NCT03560232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93254999|NCT03560232|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93255000|NCT02201342|Udenafil|udenafil|mesh-list
93255001|NCT02201342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93255002|NCT02201342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93255003|NCT02201342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255004|NCT02201342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255005|NCT02201576|Bortezomib|bortezomib|mesh-list
93255006|NCT02201576|Immunoglobulins|immunoglobulins|mesh-list
93255007|NCT02201576|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93255008|NCT02201576|Antibodies|antibodies|mesh-list
93255009|NCT02201576|gamma-Globulins|gamma-globulins|mesh-list
93255010|NCT02201576|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93255011|NCT02201576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255012|NCT02201576|Immunologic Factors|immunologic factors|mesh-ancestor
93255013|NCT02201576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255014|NCT02198378|Acetaminophen|acetaminophen|mesh-list
93255015|NCT02198378|Morphine|morphine|mesh-list
93255016|NCT02198378|Entonox|entonox|mesh-list
93255017|NCT02198378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93255018|NCT02198378|Narcotics|narcotics|mesh-ancestor
93255019|NCT02198378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255020|NCT02198378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255021|NCT02198378|Analgesics|analgesics|mesh-ancestor
93255022|NCT02198378|Sensory System Agents|sensory system agents|mesh-ancestor
93255023|NCT02198378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255024|NCT02198378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255025|NCT02198378|Antipyretics|antipyretics|mesh-ancestor
93255026|NCT02198378|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93255027|NCT02198378|Anesthetics|anesthetics|mesh-ancestor
93255028|NCT02063100|Losartan|losartan|mesh-list
93255029|NCT02063100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93255030|NCT02063100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255031|NCT02063100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93255032|NCT02063100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93255033|NCT02063100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255034|NCT02198846|Insulin|insulin|mesh-list
93255035|NCT02198846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255036|NCT02198846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255037|NCT02198924|Celecoxib|celecoxib|mesh-list
93255038|NCT02198924|Parecoxib|parecoxib|mesh-list
93255039|NCT02198924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93255040|NCT02198924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255041|NCT02198924|Analgesics|analgesics|mesh-ancestor
93255042|NCT02198924|Sensory System Agents|sensory system agents|mesh-ancestor
93255043|NCT02198924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255044|NCT02198924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255045|NCT02198924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255046|NCT02198924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93255047|NCT02198924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93255048|NCT02198924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93255049|NCT02198924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255050|NCT02198924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255051|NCT05462093|Liver Extracts|liver extracts|mesh-list
93255052|NCT05462093|Hematinics|hematinics|mesh-ancestor
93255053|NCT02064348|Moxifloxacin|moxifloxacin|mesh-list
93255054|NCT02064348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255055|NCT02064348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255056|NCT02064348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93255057|NCT02064348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93255058|NCT02064348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255059|NCT02064348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255060|NCT02064348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255061|NCT02202200|Palbociclib|palbociclib|mesh-list
93255062|NCT02202200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255063|NCT02202200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255064|NCT02202200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255065|NCT02202200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255066|NCT02064504|Fluticasone|fluticasone|mesh-list
93255067|NCT02064504|Xhance|xhance|mesh-list
93255068|NCT02064504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255069|NCT02064504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93255070|NCT02064504|Autonomic Agents|autonomic agents|mesh-ancestor
93255071|NCT02064504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255072|NCT02064504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255073|NCT02064504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93255074|NCT02064504|Respiratory System Agents|respiratory system agents|mesh-ancestor
93255075|NCT02064504|Dermatologic Agents|dermatologic agents|mesh-ancestor
93255076|NCT02064504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93255077|NCT02067936|Remifentanil|remifentanil|mesh-list
93255078|NCT02067936|Propofol|propofol|mesh-list
93255079|NCT02067936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93255080|NCT02067936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255081|NCT02067936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255082|NCT02067936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93255083|NCT02067936|Anesthetics, General|anesthetics, general|mesh-ancestor
93255084|NCT02067936|Anesthetics|anesthetics|mesh-ancestor
93255085|NCT02067936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93255086|NCT02067936|Narcotics|narcotics|mesh-ancestor
93255087|NCT02067936|Analgesics|analgesics|mesh-ancestor
93255088|NCT02067936|Sensory System Agents|sensory system agents|mesh-ancestor
93255089|NCT02067936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255090|NCT01377545|Anesthetics|anesthetics|mesh-list
93255091|NCT01377545|Anesthetics, Local|anesthetics, local|mesh-list
93255092|NCT01377545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255093|NCT01377545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255094|NCT01377545|Sensory System Agents|sensory system agents|mesh-ancestor
93255095|NCT01377545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255096|NCT01379807|Docetaxel|docetaxel|mesh-list
93255097|NCT01379807|Panitumumab|panitumumab|mesh-list
93255098|NCT01379807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255099|NCT01379807|Tubulin Modulators|tubulin modulators|mesh-ancestor
93255100|NCT01379807|Antimitotic Agents|antimitotic agents|mesh-ancestor
93255101|NCT01379807|Mitosis Modulators|mitosis modulators|mesh-ancestor
93255102|NCT01379807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255103|NCT01379807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255104|NCT02202512|Naproxen|naproxen|mesh-list
93255105|NCT02202512|Cimetidine|cimetidine|mesh-list
93255106|NCT02202512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93255107|NCT02202512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255108|NCT02202512|Analgesics|analgesics|mesh-ancestor
93255109|NCT02202512|Sensory System Agents|sensory system agents|mesh-ancestor
93255110|NCT02202512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255111|NCT02202512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255112|NCT02202512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255113|NCT02202512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93255114|NCT02202512|Gout Suppressants|gout suppressants|mesh-ancestor
93255115|NCT02202512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93255116|NCT02202512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255117|NCT02202512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255118|NCT02202512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93255119|NCT02202512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255120|NCT02202512|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93255121|NCT02202512|Histamine Antagonists|histamine antagonists|mesh-ancestor
93255122|NCT02202512|Histamine Agents|histamine agents|mesh-ancestor
93255123|NCT02202512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255124|NCT02202512|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93255125|NCT02202512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93255126|NCT02065752|Metformin|metformin|mesh-list
93255127|NCT02065752|Canagliflozin|canagliflozin|mesh-list
93255128|NCT02065752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255129|NCT02065752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255130|NCT02065752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93255131|NCT02065752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255132|NCT02206490|Naltrexone|naltrexone|mesh-list
93255133|NCT02206490|Dextromethorphan|dextromethorphan|mesh-list
93255134|NCT02206490|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93255135|NCT02206490|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93255136|NCT02206490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255137|NCT02206490|Sensory System Agents|sensory system agents|mesh-ancestor
93255138|NCT02206490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255139|NCT02206490|Antitussive Agents|antitussive agents|mesh-ancestor
93255140|NCT02206490|Respiratory System Agents|respiratory system agents|mesh-ancestor
93255141|NCT02206490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93255142|NCT02206490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93255143|NCT02206490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255144|NCT02206490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255145|NCT02068170|Azithromycin|azithromycin|mesh-list
93255146|NCT02068170|Moxifloxacin|moxifloxacin|mesh-list
93255147|NCT02068170|Clarithromycin|clarithromycin|mesh-list
93255148|NCT02068170|Levofloxacin|levofloxacin|mesh-list
93255149|NCT02068170|Erythromycin|erythromycin|mesh-list
93255150|NCT02068170|Erythromycin Estolate|erythromycin estolate|mesh-list
93255151|NCT02068170|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93255152|NCT02068170|Erythromycin stearate|erythromycin stearate|mesh-list
92549770|NCT00049218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93255153|NCT02068170|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93255154|NCT02068170|Itraconazole|itraconazole|mesh-list
93255155|NCT02068170|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93255156|NCT02068170|Fluconazole|fluconazole|mesh-list
93255157|NCT02068170|Ketoconazole|ketoconazole|mesh-list
93255158|NCT02068170|Voriconazole|voriconazole|mesh-list
93255159|NCT02068170|Sunitinib|sunitinib|mesh-list
93255160|NCT02068170|Methadone|methadone|mesh-list
93255161|NCT02068170|Haloperidol|haloperidol|mesh-list
93255162|NCT02068170|Haloperidol decanoate|haloperidol decanoate|mesh-list
93255163|NCT02068170|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93255164|NCT02068170|Tacrolimus|tacrolimus|mesh-list
93255165|NCT02068170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93255166|NCT02068170|Immunologic Factors|immunologic factors|mesh-ancestor
93255167|NCT02068170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255168|NCT02068170|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93255169|NCT02068170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255170|NCT02068170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255171|NCT02068170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255172|NCT02068170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255173|NCT02068170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93255174|NCT02068170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93255175|NCT02068170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255176|NCT02068170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93255177|NCT02068170|Contraceptive Agents|contraceptive agents|mesh-ancestor
93255178|NCT02068170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93255179|NCT02068170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93255180|NCT02068170|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93255181|NCT02068170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93255182|NCT02068170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93255183|NCT02068170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93255184|NCT02068170|Growth Substances|growth substances|mesh-ancestor
93255185|NCT02068170|Growth Inhibitors|growth inhibitors|mesh-ancestor
93255186|NCT02068170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255187|NCT02068170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93255188|NCT02068170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93255189|NCT02068170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93255190|NCT02068170|Antifungal Agents|antifungal agents|mesh-ancestor
93255191|NCT02068170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93255192|NCT02068170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93255193|NCT02068170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93255194|NCT02068170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255195|NCT02068170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93255196|NCT02068170|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93255197|NCT02068170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93255198|NCT02068170|Narcotics|narcotics|mesh-ancestor
93255199|NCT02068170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255200|NCT02068170|Analgesics|analgesics|mesh-ancestor
93255201|NCT02068170|Sensory System Agents|sensory system agents|mesh-ancestor
93255202|NCT02068170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255203|NCT02068170|Antitussive Agents|antitussive agents|mesh-ancestor
93255204|NCT02068170|Respiratory System Agents|respiratory system agents|mesh-ancestor
93255205|NCT02068170|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93255206|NCT02068170|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93255207|NCT02068170|Antiemetics|antiemetics|mesh-ancestor
93255208|NCT02068170|Autonomic Agents|autonomic agents|mesh-ancestor
93255209|NCT02068170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255210|NCT02068170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93255211|NCT02068170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93255212|NCT02068170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93255213|NCT02068170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93255214|NCT02068170|Dopamine Agents|dopamine agents|mesh-ancestor
93255215|NCT02068170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255216|NCT02068170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93255217|NCT02068170|Antimalarials|antimalarials|mesh-ancestor
93255218|NCT02068170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93255219|NCT02068170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93255220|NCT05545020|Chromium|chromium|mesh-list
93255221|NCT05545020|Trace Elements|trace elements|mesh-ancestor
93255222|NCT05545020|Micronutrients|micronutrients|mesh-ancestor
93255223|NCT05545020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255224|NCT02206568|Insulin Lispro|insulin lispro|mesh-list
93255225|NCT02206568|Insulin, Short-Acting|insulin, short-acting|mesh-list
93255226|NCT02206568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255227|NCT02206568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255228|NCT02206646|Tenecteplase|tenecteplase|mesh-list
93255229|NCT02206646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93255230|NCT02206646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93255231|NCT02206646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255232|NCT02419417|Nivolumab|nivolumab|mesh-list
93255233|NCT02419417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255234|NCT02419417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255235|NCT02419417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93255236|NCT02419417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255237|NCT02068404|Nifedipine|nifedipine|mesh-list
93255238|NCT02068404|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93255239|NCT02068404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93255240|NCT02068404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255241|NCT02068404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93255242|NCT02068404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255243|NCT02068404|Vasodilator Agents|vasodilator agents|mesh-ancestor
93255244|NCT02068404|Tocolytic Agents|tocolytic agents|mesh-ancestor
93255245|NCT02068404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93255246|NCT02068482|Rifaximin|rifaximin|mesh-list
93255247|NCT02068482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255248|NCT02068482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255249|NCT02068482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255250|NCT02206802|Minoxidil|minoxidil|mesh-list
93255251|NCT02206802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255252|NCT02206802|Vasodilator Agents|vasodilator agents|mesh-ancestor
93255253|NCT02065986|Tenofovir|tenofovir|mesh-list
93255254|NCT02065986|Emtricitabine|emtricitabine|mesh-list
93255255|NCT02065986|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93255256|NCT02065986|Antiviral Agents|antiviral agents|mesh-ancestor
93255257|NCT02065986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255258|NCT02065986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93255259|NCT02065986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93255260|NCT02065986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255261|NCT02065986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255262|NCT02065986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93255263|NCT02065986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93255264|NCT02068560|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93255265|NCT02068560|Hemostatics|hemostatics|mesh-ancestor
93255266|NCT02068560|Coagulants|coagulants|mesh-ancestor
93255267|NCT02068560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93255268|NCT02068560|Natriuretic Agents|natriuretic agents|mesh-ancestor
93255269|NCT02068560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255270|NCT01377103|Testosterone|testosterone|mesh-list
93255271|NCT01377103|Androgens|androgens|mesh-ancestor
93255272|NCT01377103|Hormones|hormones|mesh-ancestor
92549897|NCT00049569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255273|NCT01377103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255274|NCT01377103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255275|NCT01377025|Sorafenib|sorafenib|mesh-list
93255276|NCT01377025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255277|NCT01377025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255278|NCT01377025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255279|NCT01377025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255280|NCT02342275|Propranolol|propranolol|mesh-list
93255281|NCT02342275|Atenolol|atenolol|mesh-list
93255282|NCT02342275|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93255283|NCT02342275|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93255284|NCT02342275|Adrenergic Agents|adrenergic agents|mesh-ancestor
93255285|NCT02342275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255286|NCT02342275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255287|NCT02342275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255288|NCT02342275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93255289|NCT02342275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255290|NCT02342275|Vasodilator Agents|vasodilator agents|mesh-ancestor
93255291|NCT02342275|Sympatholytics|sympatholytics|mesh-ancestor
93255292|NCT02342275|Autonomic Agents|autonomic agents|mesh-ancestor
93255293|NCT02342275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255294|NCT02342275|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93255295|NCT01827553|Gemcitabine|gemcitabine|mesh-list
93255296|NCT01827553|Folfirinox|folfirinox|mesh-list
93255297|NCT01827553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255298|NCT01827553|Antimetabolites|antimetabolites|mesh-ancestor
93255299|NCT01827553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927241|NCT01298193|Alizapride|alizapride|mesh-list
93255300|NCT01827553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255301|NCT02207348|Liraglutide|liraglutide|mesh-list
93255302|NCT02207348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255303|NCT02207348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255304|NCT02207348|Incretins|incretins|mesh-ancestor
93255305|NCT02207348|Hormones|hormones|mesh-ancestor
93255306|NCT02207348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255307|NCT02066454|Apixaban|apixaban|mesh-list
93255308|NCT02066454|Anticoagulants|anticoagulants|mesh-list
93255309|NCT02066454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93255310|NCT02066454|Antithrombins|antithrombins|mesh-ancestor
93255311|NCT02066454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93255312|NCT02066454|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255313|NCT02066454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255314|NCT02066454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255315|NCT02207426|Tobramycin|tobramycin|mesh-list
93255316|NCT02207426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255317|NCT02207426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255318|NCT00777491|Cisplatin|cisplatin|mesh-list
93255319|NCT00777491|Gemcitabine|gemcitabine|mesh-list
93255320|NCT00777491|Fluorouracil|fluorouracil|mesh-list
93255321|NCT00777491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255322|NCT00777491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255323|NCT00777491|Antimetabolites|antimetabolites|mesh-ancestor
93255324|NCT00777491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255325|NCT00777491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93255326|NCT00777491|Immunologic Factors|immunologic factors|mesh-ancestor
93255327|NCT00777491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255328|NCT02199392|Lenvatinib|lenvatinib|mesh-list
93255329|NCT02199392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255330|NCT02199392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255331|NCT02199392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255332|NCT02199392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255333|NCT05320627|Edoxaban|edoxaban|mesh-list
93255334|NCT05320627|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93255335|NCT05320627|Antithrombins|antithrombins|mesh-ancestor
93255336|NCT05320627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93255337|NCT05320627|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255338|NCT05320627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255339|NCT05320627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255340|NCT05320627|Anticoagulants|anticoagulants|mesh-ancestor
93255341|NCT03559920|Propofol|propofol|mesh-list
93255342|NCT03559920|Anesthetics|anesthetics|mesh-list
93255343|NCT03559920|Sevoflurane|sevoflurane|mesh-list
93255344|NCT03559920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93255345|NCT03559920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255346|NCT03559920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255347|NCT03559920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93255348|NCT03559920|Anesthetics, General|anesthetics, general|mesh-ancestor
93255349|NCT03559920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93255350|NCT03559920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93255351|NCT02203760|Gemcitabine|gemcitabine|mesh-list
93255352|NCT02203760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255353|NCT02203760|Antimetabolites|antimetabolites|mesh-ancestor
93255354|NCT02203760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255355|NCT02203760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255356|NCT03703271|Methotrexate|methotrexate|mesh-list
93255357|NCT03703271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93255358|NCT03703271|Abortifacient Agents|abortifacient agents|mesh-ancestor
93255359|NCT03703271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93255360|NCT03703271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255361|NCT03703271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255362|NCT03703271|Antimetabolites|antimetabolites|mesh-ancestor
93255363|NCT03703271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255364|NCT03703271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255365|NCT03703271|Dermatologic Agents|dermatologic agents|mesh-ancestor
93255366|NCT03703271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255367|NCT03703271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93255368|NCT03703271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93255369|NCT03703271|Immunologic Factors|immunologic factors|mesh-ancestor
93255370|NCT03703271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93255371|NCT03703271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93255372|NCT03532802|Metoprolol|metoprolol|mesh-list
93255373|NCT03532802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93255374|NCT03532802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255375|NCT03532802|Sympatholytics|sympatholytics|mesh-ancestor
93255376|NCT03532802|Autonomic Agents|autonomic agents|mesh-ancestor
93255377|NCT03532802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255378|NCT03532802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255379|NCT03532802|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93255380|NCT03532802|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93255381|NCT03532802|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93255382|NCT03532802|Adrenergic Agents|adrenergic agents|mesh-ancestor
93255383|NCT03532802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255384|NCT03532802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255385|NCT03430531|Lidocaine|lidocaine|mesh-list
93255386|NCT03430531|Anesthetics, Local|anesthetics, local|mesh-ancestor
93255387|NCT03430531|Anesthetics|anesthetics|mesh-ancestor
92550015|NCT00022607|Bevacizumab|bevacizumab|mesh-list
93255388|NCT03430531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255389|NCT03430531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255390|NCT03430531|Sensory System Agents|sensory system agents|mesh-ancestor
93255391|NCT03430531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255392|NCT03430531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93255393|NCT03430531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93255394|NCT03430531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93255395|NCT03430531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93255396|NCT03430531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255397|NCT02066532|Trastuzumab|trastuzumab|mesh-list
93255398|NCT02066532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255399|NCT02066532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255400|NCT05763329|Lemborexant|lemborexant|mesh-list
93255401|NCT05763329|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93255402|NCT05763329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255403|NCT05763329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255404|NCT05763329|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93255405|NCT05763329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93255406|NCT05763329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255407|NCT05763329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255408|NCT04088513|Aspirin|aspirin|mesh-list
93255409|NCT04088513|Clopidogrel|clopidogrel|mesh-list
93255410|NCT04088513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93255411|NCT04088513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255412|NCT04088513|Analgesics|analgesics|mesh-ancestor
93255413|NCT04088513|Sensory System Agents|sensory system agents|mesh-ancestor
93255414|NCT04088513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255415|NCT04088513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255416|NCT04088513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255417|NCT04088513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93255418|NCT04088513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93255419|NCT04088513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93255420|NCT04088513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255421|NCT04088513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93255422|NCT04088513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93255423|NCT04088513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255424|NCT04088513|Antipyretics|antipyretics|mesh-ancestor
93255425|NCT04088513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93255426|NCT04088513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93255427|NCT04088513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93255428|NCT04088513|Purinergic Agents|purinergic agents|mesh-ancestor
93255429|NCT04088513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255430|NCT02207660|Fluorouracil|fluorouracil|mesh-list
93255431|NCT02207660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255432|NCT02207660|Antimetabolites|antimetabolites|mesh-ancestor
93255433|NCT02207660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255434|NCT02207660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255435|NCT02207660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93255436|NCT02207660|Immunologic Factors|immunologic factors|mesh-ancestor
93255437|NCT02207660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255438|NCT02069340|Zoledronic Acid|zoledronic acid|mesh-list
93255439|NCT02069340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93255440|NCT02069340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255441|NCT02069418|Alovudine|alovudine|mesh-list
93255442|NCT02069418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93255443|NCT02069418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93255444|NCT02069418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255445|NCT02069418|Antiviral Agents|antiviral agents|mesh-ancestor
93255446|NCT02069418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255447|NCT03386357|Pembrolizumab|pembrolizumab|mesh-list
93255448|NCT03386357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255449|NCT03386357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255450|NCT03386357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93255451|NCT03386357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255452|NCT02208128|Bevacizumab|bevacizumab|mesh-list
93255453|NCT02208128|Sunitinib|sunitinib|mesh-list
93255454|NCT02208128|Everolimus|everolimus|mesh-list
93255455|NCT02208128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255456|NCT02208128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255457|NCT02208128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93255458|NCT02208128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93255459|NCT02208128|Growth Substances|growth substances|mesh-ancestor
93255460|NCT02208128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255461|NCT02208128|Growth Inhibitors|growth inhibitors|mesh-ancestor
93255462|NCT02208128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93255463|NCT02208128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255464|NCT02208128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255465|NCT02208128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255466|NCT02208128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93255467|NCT02208128|Immunologic Factors|immunologic factors|mesh-ancestor
93255468|NCT02066610|Selenium|selenium|mesh-list
93255469|NCT02066610|Selenious Acid|selenious acid|mesh-list
93255470|NCT02066610|Sodium Selenite|sodium selenite|mesh-list
93255471|NCT02066610|Selenic Acid|selenic acid|mesh-list
93255472|NCT02066610|Antioxidants|antioxidants|mesh-ancestor
93255473|NCT02066610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255474|NCT02066610|Protective Agents|protective agents|mesh-ancestor
93255475|NCT02066610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255476|NCT02066610|Trace Elements|trace elements|mesh-ancestor
93255477|NCT02066610|Micronutrients|micronutrients|mesh-ancestor
93255478|NCT03077711|Trimethoprim|trimethoprim|mesh-list
93255479|NCT03077711|Methenamine|methenamine|mesh-list
93255480|NCT03077711|Methenamine hippurate|methenamine hippurate|mesh-list
93255481|NCT03077711|Methenamine mandelate|methenamine mandelate|mesh-list
93255482|NCT03077711|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93255483|NCT03077711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255484|NCT03077711|Antimalarials|antimalarials|mesh-ancestor
93255485|NCT03077711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93255486|NCT03077711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93255487|NCT03077711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93255488|NCT03077711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255489|NCT03077711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255490|NCT03077711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93255491|NCT03077711|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93255492|NCT03077711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93255493|NCT03077711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255494|NCT04374019|Artesunate|artesunate|mesh-list
93255495|NCT04374019|Ivermectin|ivermectin|mesh-list
93255496|NCT04374019|Camostat|camostat|mesh-list
93255497|NCT04374019|Antimalarials|antimalarials|mesh-ancestor
93255498|NCT04374019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93255499|NCT04374019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93255500|NCT04374019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255501|NCT04374019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255502|NCT04374019|Antiviral Agents|antiviral agents|mesh-ancestor
93255503|NCT04374019|Schistosomicides|schistosomicides|mesh-ancestor
93255504|NCT04374019|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93255505|NCT04374019|Anthelmintics|anthelmintics|mesh-ancestor
93255506|NCT04374019|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255507|NCT04374019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255508|NCT04374019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255509|NCT04374019|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93255510|NCT04374019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93255511|NCT02069808|Leuprolide|leuprolide|mesh-list
93255512|NCT02069808|Menotropins|menotropins|mesh-list
93255513|NCT02069808|Ganirelix|ganirelix|mesh-list
93255514|NCT02069808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93255515|NCT02069808|Fertility Agents|fertility agents|mesh-ancestor
93255516|NCT02069808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93255517|NCT02069808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255518|NCT02069808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93255519|NCT02069808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255520|NCT02069808|Hormone Antagonists|hormone antagonists|mesh-ancestor
93255521|NCT02069808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255522|NCT03673605|Warfarin|warfarin|mesh-list
93255523|NCT03673605|Rivaroxaban|rivaroxaban|mesh-list
93255524|NCT03673605|Anticoagulants|anticoagulants|mesh-ancestor
93255525|NCT03673605|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92927473|NCT04086186|Bupivacaine|bupivacaine|mesh-list
93255526|NCT03673605|Antithrombins|antithrombins|mesh-ancestor
93255527|NCT03673605|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93255528|NCT03673605|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255529|NCT03673605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255530|NCT03673605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255531|NCT02069886|Deferasirox|deferasirox|mesh-list
93255532|NCT02069886|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93255533|NCT02069886|Chelating Agents|chelating agents|mesh-ancestor
93255534|NCT02069886|Sequestering Agents|sequestering agents|mesh-ancestor
93255535|NCT02069886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255536|NCT04311463|Paroxetine|paroxetine|mesh-list
93255537|NCT04311463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93255538|NCT04311463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93255539|NCT04311463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93255540|NCT04311463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255541|NCT04311463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255542|NCT04311463|Serotonin Agents|serotonin agents|mesh-ancestor
93255543|NCT04311463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255544|NCT04311463|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93255545|NCT04311463|Antidepressive Agents|antidepressive agents|mesh-ancestor
93255546|NCT04311463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93255547|NCT04311463|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93255548|NCT04311463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93255549|NCT04311463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255550|NCT02065128|Capsaicin|capsaicin|mesh-list
93255551|NCT02065128|Antipruritics|antipruritics|mesh-ancestor
93255552|NCT02065128|Dermatologic Agents|dermatologic agents|mesh-ancestor
93255553|NCT02065128|Sensory System Agents|sensory system agents|mesh-ancestor
93255554|NCT02065128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255555|NCT02065128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255556|NCT03677895|Hyaluronic Acid|hyaluronic acid|mesh-list
93255557|NCT03677895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93255558|NCT03677895|Immunologic Factors|immunologic factors|mesh-ancestor
93255559|NCT03677895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255560|NCT03677895|Viscosupplements|viscosupplements|mesh-ancestor
93255561|NCT03677895|Protective Agents|protective agents|mesh-ancestor
93255562|NCT04295005|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93255563|NCT04295005|Empagliflozin|empagliflozin|mesh-list
93255564|NCT04295005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255565|NCT04295005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255566|NCT04295005|Incretins|incretins|mesh-ancestor
93255567|NCT04295005|Hormones|hormones|mesh-ancestor
93255568|NCT04295005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255569|NCT04295005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93255570|NCT04295005|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255571|NCT04295005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255572|NCT04295005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255573|NCT04295005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93255574|NCT03174353|Lanreotide|lanreotide|mesh-list
93255575|NCT03174353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255576|NCT05214235|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93255577|NCT05214235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255578|NCT03054363|Letrozole|letrozole|mesh-list
93255579|NCT03054363|Palbociclib|palbociclib|mesh-list
93255580|NCT03054363|Tucatinib|tucatinib|mesh-list
93255581|NCT03054363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255582|NCT03054363|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93255583|NCT03054363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93255584|NCT03054363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255585|NCT03054363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255586|NCT03054363|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93255587|NCT03054363|Hormone Antagonists|hormone antagonists|mesh-ancestor
93255588|NCT03054363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255589|NCT03054363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255590|NCT03054363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255591|NCT04080947|Montelukast|montelukast|mesh-list
93255592|NCT04080947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93255593|NCT04080947|Respiratory System Agents|respiratory system agents|mesh-ancestor
93255594|NCT04080947|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93255595|NCT04080947|Hormone Antagonists|hormone antagonists|mesh-ancestor
93255596|NCT04080947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255597|NCT04080947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255598|NCT04080947|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93366402|NCT02061917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93255599|NCT04080947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93255600|NCT04080947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255601|NCT02066688|Calcium, Dietary|calcium, dietary|mesh-list
93255602|NCT02066688|Vitamin D|vitamin d|mesh-list
93255603|NCT02066688|Folic Acid|folic acid|mesh-list
93255604|NCT02066688|Vitamin B Complex|vitamin b complex|mesh-list
93255605|NCT02066688|Calcium|calcium|mesh-list
93255606|NCT02066688|Vitamins|vitamins|mesh-ancestor
93255607|NCT02066688|Micronutrients|micronutrients|mesh-ancestor
93255608|NCT02066688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255609|NCT02066688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93255610|NCT02066688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93255611|NCT02066688|Hematinics|hematinics|mesh-ancestor
93255612|NCT03671733|Liraglutide|liraglutide|mesh-list
93255613|NCT03671733|Exenatide|exenatide|mesh-list
93255614|NCT03671733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255615|NCT03671733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255616|NCT03671733|Incretins|incretins|mesh-ancestor
93255617|NCT03671733|Hormones|hormones|mesh-ancestor
93255618|NCT03671733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92550253|NCT00051090|Lamivudine|lamivudine|mesh-list
93255619|NCT03671733|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93255620|NCT03119363|Methamphetamine|methamphetamine|mesh-list
93255621|NCT03119363|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93255622|NCT03119363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255623|NCT03119363|Sympathomimetics|sympathomimetics|mesh-ancestor
93255624|NCT03119363|Autonomic Agents|autonomic agents|mesh-ancestor
93255625|NCT03119363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255626|NCT03119363|Dopamine Agents|dopamine agents|mesh-ancestor
93255627|NCT03119363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255628|NCT03119363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255629|NCT03119363|Adrenergic Agents|adrenergic agents|mesh-ancestor
93255630|NCT03119363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93255631|NCT03119363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93255632|NCT03119363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93255633|NCT03119363|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93255634|NCT04059081|Obinutuzumab|obinutuzumab|mesh-list
93255635|NCT04059081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255636|NCT04059081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255637|NCT03671655|Paclitaxel|paclitaxel|mesh-list
93255638|NCT03671655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93255639|NCT03671655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255640|NCT03671655|Tubulin Modulators|tubulin modulators|mesh-ancestor
93255641|NCT03671655|Antimitotic Agents|antimitotic agents|mesh-ancestor
93255642|NCT03671655|Mitosis Modulators|mitosis modulators|mesh-ancestor
93255643|NCT03671655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255644|NCT02200094|Telmisartan|telmisartan|mesh-list
93255645|NCT02200094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255646|NCT02200094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93255647|NCT02200094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93255648|NCT02200094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255649|NCT01370538|Esomeprazole|esomeprazole|mesh-list
93255650|NCT01370538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93255651|NCT01370538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255652|NCT01370538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93255653|NCT01370538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255654|NCT01370538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255655|NCT03248297|Amoxicillin|amoxicillin|mesh-list
93255656|NCT03248297|Azithromycin|azithromycin|mesh-list
93255657|NCT03248297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255658|NCT03248297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255659|NCT02208596|Pentazocine|pentazocine|mesh-list
93255660|NCT02208596|Propofol|propofol|mesh-list
93255661|NCT02208596|Etomidate|etomidate|mesh-list
93255662|NCT02208596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93255663|NCT02208596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255664|NCT02208596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255665|NCT02208596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93255666|NCT02208596|Anesthetics, General|anesthetics, general|mesh-ancestor
93255667|NCT02208596|Anesthetics|anesthetics|mesh-ancestor
93255668|NCT02208596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93255669|NCT02208596|Narcotics|narcotics|mesh-ancestor
93255670|NCT02208596|Analgesics|analgesics|mesh-ancestor
93255671|NCT02208596|Sensory System Agents|sensory system agents|mesh-ancestor
93255672|NCT02208596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255673|NCT02208596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92927617|NCT04084158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255674|NCT02208596|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93255675|NCT02070120|Mitomycins|mitomycins|mesh-list
93255676|NCT02070120|Mitomycin|mitomycin|mesh-list
93255677|NCT02070120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93255678|NCT02070120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255679|NCT02070120|Alkylating Agents|alkylating agents|mesh-ancestor
93255680|NCT02070120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255681|NCT02070120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93255682|NCT02070120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255683|NCT02200172|Melatonin|melatonin|mesh-list
93255684|NCT02200172|Antioxidants|antioxidants|mesh-ancestor
93255685|NCT02200172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255686|NCT02200172|Protective Agents|protective agents|mesh-ancestor
93255687|NCT02200172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255688|NCT02200172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255689|NCT03673137|Gemcitabine|gemcitabine|mesh-list
93255690|NCT03673137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255691|NCT03673137|Antimetabolites|antimetabolites|mesh-ancestor
93255692|NCT03673137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255693|NCT03673137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255694|NCT02066844|Betamethasone|betamethasone|mesh-list
93255695|NCT02066844|Betamethasone Valerate|betamethasone valerate|mesh-list
93255696|NCT02066844|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93255697|NCT02066844|Betamethasone benzoate|betamethasone benzoate|mesh-list
93255698|NCT02066844|Lidocaine|lidocaine|mesh-list
93255699|NCT02066844|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93255700|NCT02066844|Anesthetics, Local|anesthetics, local|mesh-ancestor
93255701|NCT02066844|Anesthetics|anesthetics|mesh-ancestor
93255702|NCT02066844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255703|NCT02066844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255704|NCT02066844|Sensory System Agents|sensory system agents|mesh-ancestor
93255705|NCT02066844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255706|NCT02066844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93255707|NCT02066844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93255708|NCT02066844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93255709|NCT02066844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93255710|NCT02066844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255711|NCT02066844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255712|NCT02066844|Glucocorticoids|glucocorticoids|mesh-ancestor
93255713|NCT02066844|Hormones|hormones|mesh-ancestor
93255714|NCT02066844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255715|NCT02066844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93255716|NCT02066844|Respiratory System Agents|respiratory system agents|mesh-ancestor
93255717|NCT03669783|Dactinomycin|dactinomycin|mesh-list
93255718|NCT03669783|Carboplatin|carboplatin|mesh-list
93255719|NCT03669783|Doxorubicin|doxorubicin|mesh-list
93255720|NCT03669783|Etoposide|etoposide|mesh-list
93255721|NCT03669783|Vincristine|vincristine|mesh-list
93255722|NCT03669783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255723|NCT03669783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93255724|NCT03669783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93255725|NCT03669783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93255726|NCT03669783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255727|NCT03669783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550363|NCT00398034|Testosterone|testosterone|mesh-list
93255728|NCT03669783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93255729|NCT03669783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255730|NCT03669783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255731|NCT03669783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93255732|NCT03669783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93255733|NCT03669783|Tubulin Modulators|tubulin modulators|mesh-ancestor
93255734|NCT03669783|Antimitotic Agents|antimitotic agents|mesh-ancestor
93255735|NCT03669783|Mitosis Modulators|mitosis modulators|mesh-ancestor
93255736|NCT02067078|Dexamethasone|dexamethasone|mesh-list
93255737|NCT02067078|Dexamethasone acetate|dexamethasone acetate|mesh-list
93255738|NCT02067078|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93255739|NCT02067078|Clonidine|clonidine|mesh-list
93255740|NCT02067078|Epinephrine|epinephrine|mesh-list
93255741|NCT02067078|Racepinephrine|racepinephrine|mesh-list
93255742|NCT02067078|Ropivacaine|ropivacaine|mesh-list
93255743|NCT02067078|Bupivacaine|bupivacaine|mesh-list
93255744|NCT02067078|Epinephryl borate|epinephryl borate|mesh-list
93255745|NCT02067078|BB 1101|bb 1101|mesh-list
93255746|NCT02067078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255747|NCT02067078|Antiemetics|antiemetics|mesh-ancestor
93255748|NCT02067078|Autonomic Agents|autonomic agents|mesh-ancestor
93255749|NCT02067078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366403|NCT02061917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93255750|NCT02067078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255751|NCT02067078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255752|NCT02067078|Glucocorticoids|glucocorticoids|mesh-ancestor
93255753|NCT02067078|Hormones|hormones|mesh-ancestor
93255754|NCT02067078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255755|NCT02067078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93255756|NCT02067078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255757|NCT02067078|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255758|NCT02067078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255759|NCT02067078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255760|NCT02067078|Anesthetics, Local|anesthetics, local|mesh-ancestor
93255761|NCT02067078|Anesthetics|anesthetics|mesh-ancestor
93255762|NCT02067078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255763|NCT02067078|Sensory System Agents|sensory system agents|mesh-ancestor
93255764|NCT02067078|Analgesics|analgesics|mesh-ancestor
93255765|NCT02067078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255766|NCT02067078|Sympatholytics|sympatholytics|mesh-ancestor
93255767|NCT02067078|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93255768|NCT02067078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93255769|NCT02067078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93255770|NCT02067078|Adrenergic Agents|adrenergic agents|mesh-ancestor
93255771|NCT02067078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255772|NCT02067078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93255773|NCT02067078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93255774|NCT02067078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93255775|NCT02067078|Respiratory System Agents|respiratory system agents|mesh-ancestor
93255776|NCT02067078|Mydriatics|mydriatics|mesh-ancestor
93255777|NCT02067078|Sympathomimetics|sympathomimetics|mesh-ancestor
93255778|NCT02067078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93255779|NCT02067078|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93255780|NCT02067078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255781|NCT02067078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93255782|NCT02067078|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93255783|NCT05461235|Pembrolizumab|pembrolizumab|mesh-list
93255784|NCT05461235|Nivolumab|nivolumab|mesh-list
93255785|NCT05461235|Tislelizumab|tislelizumab|mesh-list
93255786|NCT05461235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255787|NCT05461235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255788|NCT05461235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93255789|NCT05461235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255790|NCT02070198|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92550422|NCT00024050|Busulfan|busulfan|mesh-list
93255791|NCT02070198|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93255792|NCT02070198|Hormones|hormones|mesh-ancestor
93255793|NCT02070198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255794|NCT02070198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255795|NCT02070198|Luteolytic Agents|luteolytic agents|mesh-ancestor
93255796|NCT02070198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93255797|NCT02070198|Contraceptive Agents|contraceptive agents|mesh-ancestor
93255798|NCT02070198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93255799|NCT02070198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93255800|NCT02070198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93255801|NCT02070198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255802|NCT02918201|Tranexamic Acid|tranexamic acid|mesh-list
93255803|NCT02918201|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93255804|NCT02918201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93255805|NCT02918201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255806|NCT02918201|Hemostatics|hemostatics|mesh-ancestor
93255807|NCT02918201|Coagulants|coagulants|mesh-ancestor
93255808|NCT02200406|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93255809|NCT02200406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93255810|NCT02200406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93255811|NCT02200406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93255812|NCT02200406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255813|NCT02200406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255814|NCT02200406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255815|NCT02200406|Antidepressive Agents|antidepressive agents|mesh-ancestor
93255816|NCT02200406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93255817|NCT02204852|Iloprost|iloprost|mesh-list
93255818|NCT02204852|Eptifibatide|eptifibatide|mesh-list
93255819|NCT02204852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93255820|NCT02204852|Vasodilator Agents|vasodilator agents|mesh-ancestor
93255821|NCT02070510|Lisinopril|lisinopril|mesh-list
93255822|NCT02070510|Warfarin|warfarin|mesh-list
92927773|NCT00435487|Heparin|heparin|mesh-list
93255823|NCT02070510|Anticoagulants|anticoagulants|mesh-ancestor
93255824|NCT02070510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93255825|NCT02070510|Protease Inhibitors|protease inhibitors|mesh-ancestor
93255826|NCT02070510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255827|NCT02070510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255828|NCT02070510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255829|NCT02070510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93255830|NCT02070510|Protective Agents|protective agents|mesh-ancestor
93255831|NCT02070510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255832|NCT02200562|Ipilimumab|ipilimumab|mesh-list
93255833|NCT02200562|Dabrafenib|dabrafenib|mesh-list
93255834|NCT02200562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255835|NCT02200562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255836|NCT02200562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93255837|NCT02200562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255838|NCT02200562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93255839|NCT02200562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255840|NCT02200640|Losartan|losartan|mesh-list
93255841|NCT02200640|Telmisartan|telmisartan|mesh-list
93255842|NCT02200640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93255843|NCT02200640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93255844|NCT02200640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93255845|NCT02200640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93255846|NCT02200640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255847|NCT02200718|Freund's Adjuvant|freund's adjuvant|mesh-list
93255848|NCT02200718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93255849|NCT02200718|Immunologic Factors|immunologic factors|mesh-ancestor
93255850|NCT02200718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255851|NCT02208986|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93255852|NCT02208986|Luteolytic Agents|luteolytic agents|mesh-ancestor
93255853|NCT02208986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93255854|NCT02208986|Contraceptive Agents|contraceptive agents|mesh-ancestor
93255855|NCT02208986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93255856|NCT02208986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255857|NCT02208986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93255858|NCT02208986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93255859|NCT02208986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255860|NCT02067780|Levofloxacin|levofloxacin|mesh-list
93255861|NCT02067780|Ofloxacin|ofloxacin|mesh-list
93255862|NCT02067780|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93255863|NCT02067780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255864|NCT02067780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255865|NCT02067780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93255866|NCT02067780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93255867|NCT02067780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255868|NCT02067780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255869|NCT02067780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255870|NCT02067780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93255871|NCT02067780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93255872|NCT02205164|Aprepitant|aprepitant|mesh-list
93255873|NCT02205164|Palonosetron|palonosetron|mesh-list
93255874|NCT02205164|Antiemetics|antiemetics|mesh-ancestor
93255875|NCT02205164|Autonomic Agents|autonomic agents|mesh-ancestor
93255876|NCT02205164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255877|NCT02205164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255878|NCT02205164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255879|NCT02205164|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93255880|NCT02205164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255881|NCT02205164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255882|NCT02205164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93255883|NCT02205164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93255884|NCT02205164|Serotonin Agents|serotonin agents|mesh-ancestor
93255885|NCT02071212|Ticagrelor|ticagrelor|mesh-list
93255886|NCT02071212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93255887|NCT02071212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93255888|NCT02071212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93255889|NCT02071212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93255890|NCT02071212|Purinergic Agents|purinergic agents|mesh-ancestor
93255891|NCT02071212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93255892|NCT02071212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255893|NCT02071212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255894|NCT02072382|Metformin|metformin|mesh-list
93255895|NCT02072382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255896|NCT02072382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255897|NCT02205242|Azithromycin|azithromycin|mesh-list
93255898|NCT02205242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93255899|NCT02205242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93255901|NCT02071368|Canagliflozin|canagliflozin|mesh-list
93255902|NCT02071368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93255903|NCT02071368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255904|NCT02071368|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93255905|NCT02071368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255906|NCT03402841|Olaparib|olaparib|mesh-list
93255907|NCT03402841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93255908|NCT03402841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255909|NCT03402841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255910|NCT03402841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255911|NCT02205398|Cetuximab|cetuximab|mesh-list
93255912|NCT02205398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255913|NCT02205398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255914|NCT04130659|Omeprazole|omeprazole|mesh-list
93255915|NCT04130659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93255916|NCT04130659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255917|NCT04130659|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93255918|NCT04130659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255919|NCT04130659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255920|NCT02220608|Bortezomib|bortezomib|mesh-list
93255921|NCT02220608|Lenograstim|lenograstim|mesh-list
93255922|NCT02220608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93255923|NCT02220608|Immunologic Factors|immunologic factors|mesh-ancestor
93255924|NCT02220608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255925|NCT02220608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255926|NCT03630367|Dexamethasone|dexamethasone|mesh-list
93255927|NCT03630367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255928|NCT03630367|Antiemetics|antiemetics|mesh-ancestor
93255929|NCT03630367|Autonomic Agents|autonomic agents|mesh-ancestor
93255930|NCT03630367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255931|NCT03630367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255932|NCT03630367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255933|NCT03630367|Glucocorticoids|glucocorticoids|mesh-ancestor
93255934|NCT03630367|Hormones|hormones|mesh-ancestor
93255935|NCT03630367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93255936|NCT03630367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93255937|NCT03630367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255938|NCT02258282|Etanercept|etanercept|mesh-list
93255939|NCT02258282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93255940|NCT02258282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255941|NCT02258282|Analgesics|analgesics|mesh-ancestor
93255942|NCT02258282|Sensory System Agents|sensory system agents|mesh-ancestor
93255943|NCT02258282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255944|NCT02258282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255945|NCT02258282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93255946|NCT02258282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93255947|NCT02258282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93255948|NCT02258282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93255949|NCT02258282|Immunologic Factors|immunologic factors|mesh-ancestor
93255950|NCT02076594|Docetaxel|docetaxel|mesh-list
93255951|NCT02076594|Capecitabine|capecitabine|mesh-list
93255952|NCT02076594|Oxaliplatin|oxaliplatin|mesh-list
93255953|NCT02076594|Epirubicin|epirubicin|mesh-list
93255954|NCT02076594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255955|NCT02076594|Tubulin Modulators|tubulin modulators|mesh-ancestor
93255956|NCT02076594|Antimitotic Agents|antimitotic agents|mesh-ancestor
93255957|NCT02076594|Mitosis Modulators|mitosis modulators|mesh-ancestor
93255958|NCT02076594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255959|NCT02076594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93255960|NCT02076594|Antimetabolites|antimetabolites|mesh-ancestor
93255961|NCT02076594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93255962|NCT02076594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93255963|NCT02076594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93255964|NCT02076594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255965|NCT04175509|Acetaminophen|acetaminophen|mesh-list
93255966|NCT04175509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93255967|NCT04175509|Analgesics|analgesics|mesh-ancestor
93255968|NCT04175509|Sensory System Agents|sensory system agents|mesh-ancestor
93255969|NCT04175509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255970|NCT04175509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255971|NCT04175509|Antipyretics|antipyretics|mesh-ancestor
93255972|NCT02220842|Atezolizumab|atezolizumab|mesh-list
93255973|NCT02220842|Obinutuzumab|obinutuzumab|mesh-list
93255974|NCT02220842|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93255975|NCT02220842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255976|NCT02220842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93255977|NCT02220842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255978|NCT02205554|Tramadol|tramadol|mesh-list
93255979|NCT02205554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93255980|NCT02205554|Narcotics|narcotics|mesh-ancestor
93255981|NCT02205554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93255982|NCT02205554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255983|NCT02205554|Analgesics|analgesics|mesh-ancestor
93255984|NCT02205554|Sensory System Agents|sensory system agents|mesh-ancestor
93255985|NCT02205554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93255986|NCT02076750|Vitamin D|vitamin d|mesh-list
93255987|NCT02076750|Cholecalciferol|cholecalciferol|mesh-list
93255988|NCT02076750|Vitamins|vitamins|mesh-ancestor
93255989|NCT02076750|Micronutrients|micronutrients|mesh-ancestor
93255990|NCT02076750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93255991|NCT02076750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93255992|NCT02076750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93255993|NCT05262608|Olaparib|olaparib|mesh-list
93255994|NCT05262608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93255995|NCT05262608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93255996|NCT05262608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93255997|NCT05262608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93255998|NCT01380457|Dronabinol|dronabinol|mesh-list
93255999|NCT01380457|Hallucinogens|hallucinogens|mesh-ancestor
93256000|NCT01380457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256001|NCT01380457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93256002|NCT01380457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256003|NCT01380457|Analgesics|analgesics|mesh-ancestor
93256004|NCT01380457|Sensory System Agents|sensory system agents|mesh-ancestor
93256005|NCT01380457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256006|NCT01380457|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93256007|NCT01380457|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93256008|NCT01380457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256009|NCT01380457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256010|NCT01380457|Hormones|hormones|mesh-ancestor
93256011|NCT01380457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256012|NCT02071680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93256013|NCT02071680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256014|NCT02071680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256015|NCT02071680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256016|NCT02071680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93256017|NCT01380301|Miltefosine|miltefosine|mesh-list
93256018|NCT01380301|Antifungal Agents|antifungal agents|mesh-ancestor
93256019|NCT01380301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256020|NCT01380301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256021|NCT01380301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93256022|NCT01380301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93256023|NCT02076828|Zinc|zinc|mesh-list
93256024|NCT02076828|Glycine|glycine|mesh-list
93256025|NCT02076828|Trace Elements|trace elements|mesh-ancestor
93256026|NCT02076828|Micronutrients|micronutrients|mesh-ancestor
93256027|NCT02076828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256028|NCT02076828|Glycine Agents|glycine agents|mesh-ancestor
93256029|NCT02076828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256030|NCT02076828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256031|NCT02221154|Folic Acid|folic acid|mesh-list
93256032|NCT02221154|Hematinics|hematinics|mesh-ancestor
93256033|NCT02221154|Vitamin B Complex|vitamin b complex|mesh-ancestor
93256034|NCT02221154|Vitamins|vitamins|mesh-ancestor
93256035|NCT02221154|Micronutrients|micronutrients|mesh-ancestor
93256036|NCT02221154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256037|NCT02073084|Moxifloxacin|moxifloxacin|mesh-list
93256038|NCT02073084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93256039|NCT02073084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256040|NCT02073084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93256041|NCT02073084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93256042|NCT02073084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256043|NCT02073084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256044|NCT02073084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256045|NCT03787849|Anesthetics|anesthetics|mesh-list
93256046|NCT03787849|Propofol|propofol|mesh-list
93256047|NCT03787849|Sevoflurane|sevoflurane|mesh-list
92927998|NCT00719121|Adapalene|adapalene|mesh-list
93256048|NCT03787849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256049|NCT03787849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256050|NCT03787849|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256051|NCT03787849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256052|NCT03787849|Anesthetics, General|anesthetics, general|mesh-ancestor
93256053|NCT03787849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93256054|NCT03787849|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93256055|NCT03777319|Prednisolone|prednisolone|mesh-list
93256056|NCT03777319|Spironolactone|spironolactone|mesh-list
93256057|NCT03777319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256058|NCT03777319|Glucocorticoids|glucocorticoids|mesh-ancestor
93256059|NCT03777319|Hormones|hormones|mesh-ancestor
93256060|NCT03777319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256061|NCT03777319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256062|NCT03777319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93256063|NCT03777319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256064|NCT03777319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93256065|NCT03777319|Hormone Antagonists|hormone antagonists|mesh-ancestor
93256066|NCT03777319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93256067|NCT03777319|Diuretics|diuretics|mesh-ancestor
93256068|NCT03777319|Natriuretic Agents|natriuretic agents|mesh-ancestor
93256069|NCT03671265|Apatinib|apatinib|mesh-list
93256070|NCT03671265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256071|NCT03671265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256072|NCT03671265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256073|NCT03671265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256074|NCT02881957|Vitamin D|vitamin d|mesh-list
93256075|NCT02881957|Cholecalciferol|cholecalciferol|mesh-list
93256076|NCT02881957|Vitamins|vitamins|mesh-ancestor
93256077|NCT02881957|Micronutrients|micronutrients|mesh-ancestor
93256078|NCT02881957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256079|NCT02881957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93256080|NCT02881957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93256081|NCT02206022|Remifentanil|remifentanil|mesh-list
93256082|NCT02206022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93256083|NCT02206022|Narcotics|narcotics|mesh-ancestor
93256084|NCT02206022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256085|NCT02206022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256086|NCT02206022|Analgesics|analgesics|mesh-ancestor
93256087|NCT02206022|Sensory System Agents|sensory system agents|mesh-ancestor
93256088|NCT02206022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256089|NCT02073552|Ascorbic Acid|ascorbic acid|mesh-list
93256090|NCT02073552|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93256091|NCT02073552|Antioxidants|antioxidants|mesh-ancestor
93256092|NCT02073552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256093|NCT02073552|Protective Agents|protective agents|mesh-ancestor
93256094|NCT02073552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256095|NCT02073552|Vitamins|vitamins|mesh-ancestor
93256096|NCT02073552|Micronutrients|micronutrients|mesh-ancestor
93256097|NCT02073552|Laxatives|laxatives|mesh-ancestor
93256098|NCT02073552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93256099|NCT02210156|Micronutrients|micronutrients|mesh-list
93256100|NCT02210156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256101|NCT02080026|Chloroquine|chloroquine|mesh-list
93256102|NCT02080026|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93256103|NCT02080026|Atovaquone|atovaquone|mesh-list
93256104|NCT02080026|Proguanil|proguanil|mesh-list
93256105|NCT02080026|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93256106|NCT02080026|Amebicides|amebicides|mesh-ancestor
93256107|NCT02080026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93256108|NCT02080026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93256109|NCT02080026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256110|NCT02080026|Antimalarials|antimalarials|mesh-ancestor
93256111|NCT02080026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256112|NCT02080026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93256113|NCT02080026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256114|NCT02080026|Analgesics|analgesics|mesh-ancestor
93256115|NCT02080026|Sensory System Agents|sensory system agents|mesh-ancestor
93256116|NCT02080026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256117|NCT02080026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256118|NCT02080026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256119|NCT02080026|Filaricides|filaricides|mesh-ancestor
93256120|NCT02080026|Antinematodal Agents|antinematodal agents|mesh-ancestor
93256121|NCT02080026|Anthelmintics|anthelmintics|mesh-ancestor
93256122|NCT02080026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256123|NCT02080026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256124|NCT02080026|Antimetabolites|antimetabolites|mesh-ancestor
93256125|NCT02206178|Acetaminophen|acetaminophen|mesh-list
93256126|NCT02206178|Acetylcysteine|acetylcysteine|mesh-list
93256127|NCT02206178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93256128|NCT02206178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256129|NCT02206178|Analgesics|analgesics|mesh-ancestor
93256130|NCT02206178|Sensory System Agents|sensory system agents|mesh-ancestor
93256131|NCT02206178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256132|NCT02206178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256133|NCT02206178|Antipyretics|antipyretics|mesh-ancestor
93256134|NCT02206178|Antiviral Agents|antiviral agents|mesh-ancestor
93256135|NCT02206178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256136|NCT02206178|Expectorants|expectorants|mesh-ancestor
93256137|NCT02206178|Respiratory System Agents|respiratory system agents|mesh-ancestor
93256138|NCT02206178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93256139|NCT02206178|Antioxidants|antioxidants|mesh-ancestor
93256140|NCT02206178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256141|NCT02206178|Protective Agents|protective agents|mesh-ancestor
93256142|NCT02206178|Antidotes|antidotes|mesh-ancestor
93256143|NCT02080104|Oxytocin|oxytocin|mesh-list
93256144|NCT02080104|Oxytocics|oxytocics|mesh-ancestor
93256145|NCT02080104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93256146|NCT02080104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256147|NCT03463057|Atezolizumab|atezolizumab|mesh-list
93256148|NCT03463057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93256149|NCT03463057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256150|NCT03463057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93256151|NCT03463057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256152|NCT02211326|Warfarin|warfarin|mesh-list
93256153|NCT02211326|Anticoagulants|anticoagulants|mesh-ancestor
93256154|NCT02691793|Sunitinib|sunitinib|mesh-list
93256155|NCT02691793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256156|NCT02691793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93256157|NCT02691793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93256158|NCT02691793|Growth Substances|growth substances|mesh-ancestor
93256159|NCT02691793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256160|NCT02691793|Growth Inhibitors|growth inhibitors|mesh-ancestor
93256161|NCT02691793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256162|NCT02691793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256163|NCT02691793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256164|NCT02221622|Pregnanolone|pregnanolone|mesh-list
93256165|NCT02221622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93256166|NCT02221622|Anesthetics|anesthetics|mesh-ancestor
93256167|NCT02221622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256168|NCT02221622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256169|NCT02080182|Acetylcysteine|acetylcysteine|mesh-list
93256170|NCT02080182|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93256171|NCT02080182|Antiviral Agents|antiviral agents|mesh-ancestor
93256172|NCT02080182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256173|NCT02080182|Expectorants|expectorants|mesh-ancestor
93256174|NCT02080182|Respiratory System Agents|respiratory system agents|mesh-ancestor
93256175|NCT02080182|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93256176|NCT02080182|Antioxidants|antioxidants|mesh-ancestor
93256177|NCT02080182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256178|NCT02080182|Protective Agents|protective agents|mesh-ancestor
93256179|NCT02080182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256180|NCT02080182|Antidotes|antidotes|mesh-ancestor
93256181|NCT02750930|rGLP-1 protein|rglp-1 protein|mesh-list
93256182|NCT02750930|Incretins|incretins|mesh-ancestor
93256183|NCT02750930|Hormones|hormones|mesh-ancestor
93256184|NCT02750930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256185|NCT02750930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256186|NCT02080416|Nelfinavir|nelfinavir|mesh-list
93256187|NCT02080416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93256188|NCT02080416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93256189|NCT02080416|Protease Inhibitors|protease inhibitors|mesh-ancestor
93256190|NCT02080416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256191|NCT02080416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256192|NCT02080416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93256193|NCT02080416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93256194|NCT02080416|Antiviral Agents|antiviral agents|mesh-ancestor
93256195|NCT02080416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256196|NCT02080494|Tranexamic Acid|tranexamic acid|mesh-list
93256197|NCT02080494|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93256198|NCT02080494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93256199|NCT02080494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256200|NCT02080494|Hemostatics|hemostatics|mesh-ancestor
93256201|NCT02080494|Coagulants|coagulants|mesh-ancestor
93256203|NCT02213744|Capecitabine|capecitabine|mesh-list
93256204|NCT02213744|Trastuzumab|trastuzumab|mesh-list
93256205|NCT02213744|Vinorelbine|vinorelbine|mesh-list
93256206|NCT02213744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93256207|NCT02213744|Antimetabolites|antimetabolites|mesh-ancestor
93256208|NCT02213744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256209|NCT02213744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256210|NCT02213744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93256211|NCT02213744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93256212|NCT02213744|Tubulin Modulators|tubulin modulators|mesh-ancestor
93256213|NCT02213744|Antimitotic Agents|antimitotic agents|mesh-ancestor
93256214|NCT02213744|Mitosis Modulators|mitosis modulators|mesh-ancestor
93256215|NCT01378741|Dexmedetomidine|dexmedetomidine|mesh-list
93256216|NCT01378741|Propofol|propofol|mesh-list
93256217|NCT01378741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256218|NCT01378741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256219|NCT01378741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256220|NCT01378741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256221|NCT01378741|Analgesics|analgesics|mesh-ancestor
93256222|NCT01378741|Sensory System Agents|sensory system agents|mesh-ancestor
93256223|NCT01378741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256224|NCT01378741|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93256225|NCT01378741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93256226|NCT01378741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93256227|NCT01378741|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256228|NCT01378741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256229|NCT01378741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256230|NCT01378741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256231|NCT01378741|Anesthetics, General|anesthetics, general|mesh-ancestor
93256232|NCT01378741|Anesthetics|anesthetics|mesh-ancestor
93256233|NCT02461849|Imatinib Mesylate|imatinib mesylate|mesh-list
93256234|NCT02461849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256235|NCT02461849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256236|NCT02461849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256237|NCT02461849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256238|NCT02225054|Dexmedetomidine|dexmedetomidine|mesh-list
93256239|NCT02225054|Ropivacaine|ropivacaine|mesh-list
93256240|NCT02225054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256241|NCT02225054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256242|NCT02225054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256243|NCT02225054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256244|NCT02225054|Analgesics|analgesics|mesh-ancestor
93256245|NCT02225054|Sensory System Agents|sensory system agents|mesh-ancestor
93256246|NCT02225054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256247|NCT02225054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93256248|NCT02225054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93256249|NCT02225054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93256250|NCT02225054|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256251|NCT02225054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256252|NCT02225054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256253|NCT02225054|Anesthetics, Local|anesthetics, local|mesh-ancestor
93256254|NCT02225054|Anesthetics|anesthetics|mesh-ancestor
93256255|NCT02080728|Ropivacaine|ropivacaine|mesh-list
93256256|NCT02080728|Anesthetics, Local|anesthetics, local|mesh-ancestor
93256257|NCT02080728|Anesthetics|anesthetics|mesh-ancestor
93256258|NCT02080728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256259|NCT02080728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256260|NCT02080728|Sensory System Agents|sensory system agents|mesh-ancestor
93256261|NCT02080728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256262|NCT03078907|Selexipag|selexipag|mesh-list
93256263|NCT03078907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93256264|NCT02225210|Fentanyl|fentanyl|mesh-list
93256265|NCT02225210|Midazolam|midazolam|mesh-list
93256266|NCT02225210|Dexmedetomidine|dexmedetomidine|mesh-list
93256267|NCT02225210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256268|NCT02225210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256269|NCT02225210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256270|NCT02225210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256271|NCT02225210|Analgesics|analgesics|mesh-ancestor
93256272|NCT02225210|Sensory System Agents|sensory system agents|mesh-ancestor
93256273|NCT02225210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256274|NCT02225210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93256275|NCT02225210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92928244|NCT00578643|Busulfan|busulfan|mesh-list
93256276|NCT02225210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93256277|NCT02225210|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256278|NCT02225210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256279|NCT02225210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256280|NCT02225210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93256281|NCT02225210|Narcotics|narcotics|mesh-ancestor
93256282|NCT02225210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93256283|NCT02225210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256284|NCT02225210|Anesthetics, General|anesthetics, general|mesh-ancestor
93256285|NCT02225210|Anesthetics|anesthetics|mesh-ancestor
93256286|NCT02225210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93256287|NCT02225210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93256288|NCT02225210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93256289|NCT02225210|GABA Modulators|gaba modulators|mesh-ancestor
93256290|NCT02225210|GABA Agents|gaba agents|mesh-ancestor
93256291|NCT02217020|Oxaliplatin|oxaliplatin|mesh-list
93256292|NCT02217020|Irinotecan|irinotecan|mesh-list
93256293|NCT02217020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256294|NCT02217020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93256295|NCT02217020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93256296|NCT02217020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256297|NCT02217020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256298|NCT03249714|Ofatumumab|ofatumumab|mesh-list
93256299|NCT03249714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93256300|NCT03249714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256301|NCT03249714|Immunologic Factors|immunologic factors|mesh-ancestor
93256302|NCT03249714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256303|NCT02222168|BI 409306|bi 409306|mesh-list
93256304|NCT02222168|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93256305|NCT02222168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256306|NCT02222168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256307|NCT02925117|Upadacitinib|upadacitinib|mesh-list
93256308|NCT02925117|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93256309|NCT02925117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256310|NCT02925117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256311|NCT02925117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256312|NCT02925117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256313|NCT02077920|Chlorhexidine|chlorhexidine|mesh-list
93256314|NCT02077920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93256315|NCT02077920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256316|NCT02077920|Disinfectants|disinfectants|mesh-ancestor
93256317|NCT02225756|Cyclosporine|cyclosporine|mesh-list
93256318|NCT02225756|Cyclosporins|cyclosporins|mesh-list
93256319|NCT02225756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256320|NCT02225756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256321|NCT02225756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93256322|NCT02225756|Immunologic Factors|immunologic factors|mesh-ancestor
93256323|NCT02225756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256324|NCT02225756|Antifungal Agents|antifungal agents|mesh-ancestor
93256325|NCT02225756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256326|NCT02225756|Dermatologic Agents|dermatologic agents|mesh-ancestor
93256327|NCT02225756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256328|NCT02225756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93256329|NCT02225834|Atorvastatin|atorvastatin|mesh-list
93256330|NCT02225834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93256331|NCT02225834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93256332|NCT02225834|Antimetabolites|antimetabolites|mesh-ancestor
93256333|NCT02225834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256334|NCT02225834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93256335|NCT02225834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93256336|NCT02225834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256337|NCT02077998|Oxaliplatin|oxaliplatin|mesh-list
93256338|NCT02077998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256339|NCT02222324|Moxifloxacin|moxifloxacin|mesh-list
93256340|NCT02222324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93256341|NCT02222324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550983|NCT00025532|Antibodies|antibodies|mesh-list
93256342|NCT02222324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93256343|NCT02222324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93256344|NCT02222324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256345|NCT02222324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256346|NCT02222324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256347|NCT02074800|Siltuximab|siltuximab|mesh-list
93256348|NCT02074800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93256349|NCT02074800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256350|NCT02074800|Immunologic Factors|immunologic factors|mesh-ancestor
93256351|NCT02074800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256352|NCT04504045|Metformin|metformin|mesh-list
93256354|NCT04504045|Losartan|losartan|mesh-list
93256355|NCT04504045|Metoprolol|metoprolol|mesh-list
93256356|NCT04504045|Midazolam|midazolam|mesh-list
93256357|NCT04504045|Caffeine|caffeine|mesh-list
93256358|NCT04504045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93256359|NCT04504045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256360|NCT04504045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93256361|NCT04504045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256362|NCT04504045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256363|NCT04504045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93256364|NCT04504045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93256365|NCT04504045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93256366|NCT04504045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256367|NCT04504045|Anesthetics, General|anesthetics, general|mesh-ancestor
93256368|NCT04504045|Anesthetics|anesthetics|mesh-ancestor
93256369|NCT04504045|GABA Modulators|gaba modulators|mesh-ancestor
93256370|NCT04504045|GABA Agents|gaba agents|mesh-ancestor
93256371|NCT04504045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256372|NCT04504045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256373|NCT04504045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93256374|NCT04504045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93256375|NCT04504045|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93256376|NCT04504045|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93256377|NCT04504045|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93256378|NCT04504045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93256379|NCT04504045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256380|NCT04504045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93256381|NCT04504045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93256382|NCT04504045|Purinergic Agents|purinergic agents|mesh-ancestor
93256383|NCT04504045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93256384|NCT04504045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93256385|NCT04504045|Antiviral Agents|antiviral agents|mesh-ancestor
93256386|NCT04504045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256387|NCT04504045|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93256388|NCT04504045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93256389|NCT04504045|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93256390|NCT04504045|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93256391|NCT04504045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93256392|NCT04504045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93256393|NCT04504045|Sympatholytics|sympatholytics|mesh-ancestor
93256394|NCT04504045|Autonomic Agents|autonomic agents|mesh-ancestor
93256395|NCT04504045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256396|NCT04504045|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93256397|NCT04504045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93256398|NCT04504045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93256399|NCT04504045|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256400|NCT03283488|Megestrol|megestrol|mesh-list
93256401|NCT03283488|Megestrol Acetate|megestrol acetate|mesh-list
93256402|NCT03283488|Mirtazapine|mirtazapine|mesh-list
93256403|NCT03283488|Antidepressive Agents|antidepressive agents|mesh-ancestor
93256404|NCT03283488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93256405|NCT03283488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93256406|NCT03283488|Histamine Antagonists|histamine antagonists|mesh-ancestor
93256407|NCT03283488|Histamine Agents|histamine agents|mesh-ancestor
93256408|NCT03283488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256409|NCT03283488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256410|NCT03283488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256411|NCT03283488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93256412|NCT03283488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93256413|NCT03283488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256414|NCT03283488|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93256415|NCT03283488|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93256416|NCT03283488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93256417|NCT03283488|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256418|NCT03283488|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93256419|NCT03283488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93256420|NCT03283488|Serotonin Agents|serotonin agents|mesh-ancestor
93256421|NCT03283488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93256422|NCT03283488|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93256423|NCT03283488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93256424|NCT03283488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93256425|NCT03283488|Contraceptive Agents|contraceptive agents|mesh-ancestor
92928441|NCT00740792|Xhance|xhance|mesh-list
93256426|NCT03283488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93256427|NCT03283488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93256428|NCT03283488|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93256429|NCT03283488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93256430|NCT03283488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256431|NCT03283488|Appetite Stimulants|appetite stimulants|mesh-ancestor
93256432|NCT03283488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93256433|NCT02258204|Ketamine|ketamine|mesh-list
93256434|NCT02258204|Analgesics|analgesics|mesh-ancestor
93256435|NCT02258204|Sensory System Agents|sensory system agents|mesh-ancestor
93256436|NCT02258204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256437|NCT02258204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256438|NCT02258204|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93256439|NCT02258204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256440|NCT02258204|Anesthetics, General|anesthetics, general|mesh-ancestor
93256441|NCT02258204|Anesthetics|anesthetics|mesh-ancestor
93256442|NCT02258204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256443|NCT02258204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93256444|NCT02258204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93256445|NCT02258204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256446|NCT02258204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256447|NCT02226068|Cyclosporine|cyclosporine|mesh-list
93256448|NCT02226068|Cyclosporins|cyclosporins|mesh-list
93256449|NCT02226068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256450|NCT02226068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256451|NCT02226068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93256452|NCT02226068|Immunologic Factors|immunologic factors|mesh-ancestor
93256453|NCT02226068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256454|NCT02226068|Antifungal Agents|antifungal agents|mesh-ancestor
93256455|NCT02226068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256456|NCT02226068|Dermatologic Agents|dermatologic agents|mesh-ancestor
93256457|NCT02226068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256458|NCT02226068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93256459|NCT02220218|Metformin|metformin|mesh-list
93256460|NCT02220218|Canagliflozin|canagliflozin|mesh-list
93256461|NCT02220218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93256462|NCT02220218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256463|NCT02220218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93256464|NCT02220218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256465|NCT02222480|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93256466|NCT02222480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93256467|NCT02222480|Diuretics|diuretics|mesh-ancestor
93256468|NCT02222480|Natriuretic Agents|natriuretic agents|mesh-ancestor
93256469|NCT02222480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256470|NCT02222480|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93256471|NCT02222480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93256472|NCT02222480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256473|NCT03670875|Curcumin|curcumin|mesh-list
93256474|NCT03670875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93256475|NCT03670875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256476|NCT03670875|Analgesics|analgesics|mesh-ancestor
93256477|NCT03670875|Sensory System Agents|sensory system agents|mesh-ancestor
93256478|NCT03670875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256479|NCT03670875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256480|NCT03670875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256481|NCT03670875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256482|NCT03670875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256483|NCT03670875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256484|NCT03670875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256485|NCT01379677|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
93256486|NCT01379677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93256487|NCT01379677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256488|NCT02220296|Insulin|insulin|mesh-list
93256489|NCT02220296|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93256490|NCT02220296|Insulin Glargine|insulin glargine|mesh-list
93256491|NCT02220296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93256492|NCT02220296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256493|NCT02074878|Sunitinib|sunitinib|mesh-list
93256494|NCT02074878|Crizotinib|crizotinib|mesh-list
93256495|NCT02074878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256496|NCT02074878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93256497|NCT02074878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93256498|NCT02074878|Growth Substances|growth substances|mesh-ancestor
93366404|NCT02061917|Cholinergic Agents|cholinergic agents|mesh-ancestor
93256499|NCT02074878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256500|NCT02074878|Growth Inhibitors|growth inhibitors|mesh-ancestor
93256501|NCT02074878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256502|NCT02074878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256503|NCT02074878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256504|NCT03075163|Ondansetron|ondansetron|mesh-list
93256505|NCT03075163|Antiemetics|antiemetics|mesh-ancestor
93256506|NCT03075163|Autonomic Agents|autonomic agents|mesh-ancestor
93256507|NCT03075163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256508|NCT03075163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256509|NCT03075163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93256510|NCT03075163|Antipruritics|antipruritics|mesh-ancestor
93256511|NCT03075163|Dermatologic Agents|dermatologic agents|mesh-ancestor
93256512|NCT03075163|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93256513|NCT03075163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93256514|NCT03075163|Serotonin Agents|serotonin agents|mesh-ancestor
93256515|NCT03075163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256516|NCT03075163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256517|NCT02628405|Rituximab|rituximab|mesh-list
93256518|NCT02628405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93256519|NCT02628405|Carboplatin|carboplatin|mesh-list
93256520|NCT02628405|Etoposide|etoposide|mesh-list
93256521|NCT02628405|Lenalidomide|lenalidomide|mesh-list
93256522|NCT02628405|Etoposide phosphate|etoposide phosphate|mesh-list
93256523|NCT02628405|Ifosfamide|ifosfamide|mesh-list
93256524|NCT02628405|Isophosphamide mustard|isophosphamide mustard|mesh-list
93256525|NCT02628405|Podophyllotoxin|podophyllotoxin|mesh-list
93256526|NCT02628405|Antibodies|antibodies|mesh-list
93256527|NCT02628405|Immunoglobulins|immunoglobulins|mesh-list
93256528|NCT02628405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93256529|NCT02628405|Immunologic Factors|immunologic factors|mesh-ancestor
93256530|NCT02628405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256531|NCT02628405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256532|NCT02628405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256533|NCT02628405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93256534|NCT02628405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93256535|NCT02628405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93256536|NCT02628405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256537|NCT02628405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256538|NCT02628405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93256539|NCT02628405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93256540|NCT02628405|Growth Substances|growth substances|mesh-ancestor
93256541|NCT02628405|Growth Inhibitors|growth inhibitors|mesh-ancestor
93256542|NCT02628405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93256543|NCT02628405|Alkylating Agents|alkylating agents|mesh-ancestor
93256544|NCT02628405|Keratolytic Agents|keratolytic agents|mesh-ancestor
93256545|NCT02628405|Dermatologic Agents|dermatologic agents|mesh-ancestor
93256546|NCT02628405|Tubulin Modulators|tubulin modulators|mesh-ancestor
93256547|NCT02628405|Antimitotic Agents|antimitotic agents|mesh-ancestor
93256548|NCT02628405|Mitosis Modulators|mitosis modulators|mesh-ancestor
93256549|NCT02220530|Fentanyl|fentanyl|mesh-list
93256550|NCT02220530|Midazolam|midazolam|mesh-list
93256551|NCT02220530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93256552|NCT02220530|Narcotics|narcotics|mesh-ancestor
93256553|NCT02220530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256554|NCT02220530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256555|NCT02220530|Analgesics|analgesics|mesh-ancestor
93256556|NCT02220530|Sensory System Agents|sensory system agents|mesh-ancestor
93256557|NCT02220530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256558|NCT02220530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93256559|NCT02220530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256560|NCT02220530|Anesthetics, General|anesthetics, general|mesh-ancestor
93256561|NCT02220530|Anesthetics|anesthetics|mesh-ancestor
93256562|NCT02220530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256563|NCT02220530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93256564|NCT02220530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93256565|NCT02220530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93256566|NCT02220530|GABA Modulators|gaba modulators|mesh-ancestor
93256567|NCT02220530|GABA Agents|gaba agents|mesh-ancestor
93256568|NCT02220530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256569|NCT02220530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256570|NCT02078232|Pancrelipase|pancrelipase|mesh-list
93256571|NCT02078232|Pancreatin|pancreatin|mesh-list
93256572|NCT02078232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93256573|NCT02075034|ON 01910|on 01910|mesh-list
93256574|NCT02075034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256575|NCT02075034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256576|NCT02075034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256577|NCT02075034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256578|NCT02567175|Domperidone|domperidone|mesh-list
93256579|NCT02567175|Antiemetics|antiemetics|mesh-ancestor
93256580|NCT02567175|Autonomic Agents|autonomic agents|mesh-ancestor
93256581|NCT02567175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256582|NCT02567175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256583|NCT02567175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93256584|NCT02567175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93256585|NCT02567175|Dopamine Agents|dopamine agents|mesh-ancestor
93256586|NCT02567175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256587|NCT02567175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256588|NCT02078388|Doxorubicin|doxorubicin|mesh-list
93256589|NCT02078388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93256590|NCT02078388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256591|NCT02078388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93256592|NCT02078388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93256593|NCT02078388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256594|NCT02078388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256595|NCT02222636|Fentanyl|fentanyl|mesh-list
93256596|NCT02222636|Dexmedetomidine|dexmedetomidine|mesh-list
93256597|NCT02222636|Anesthetics|anesthetics|mesh-list
93256598|NCT02222636|Sevoflurane|sevoflurane|mesh-list
93256599|NCT02222636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256600|NCT02222636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256601|NCT02222636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93256602|NCT02222636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256603|NCT02222636|Analgesics|analgesics|mesh-ancestor
93256604|NCT02222636|Sensory System Agents|sensory system agents|mesh-ancestor
93256605|NCT02222636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256606|NCT02222636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93256607|NCT02222636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93256608|NCT02222636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93256609|NCT02222636|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256610|NCT02222636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256611|NCT02222636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256612|NCT02222636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93256613|NCT02222636|Narcotics|narcotics|mesh-ancestor
93256614|NCT02222636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93256615|NCT02222636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256616|NCT02222636|Anesthetics, General|anesthetics, general|mesh-ancestor
93256617|NCT02222636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93256618|NCT02222636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93256619|NCT04058145|Plerixafor|plerixafor|mesh-list
93256620|NCT04058145|Pembrolizumab|pembrolizumab|mesh-list
93256621|NCT04058145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93256622|NCT04058145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256623|NCT04058145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93256624|NCT04058145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256625|NCT04058145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93256626|NCT04058145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93256627|NCT04058145|Antiviral Agents|antiviral agents|mesh-ancestor
93256628|NCT04058145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93256629|NCT02230982|Nintedanib|nintedanib|mesh-list
93256630|NCT02230982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256631|NCT02230982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256632|NCT02230982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256633|NCT02230982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256634|NCT02075112|Genistein|genistein|mesh-list
93256635|NCT02075112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256636|NCT02075112|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93256637|NCT02075112|Protective Agents|protective agents|mesh-ancestor
93256638|NCT02075112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256639|NCT02075112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256640|NCT02075112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256641|NCT02075112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256642|NCT02075112|Phytoestrogens|phytoestrogens|mesh-ancestor
93256643|NCT02075112|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93256644|NCT02075112|Estrogens|estrogens|mesh-ancestor
93256645|NCT02075112|Hormones|hormones|mesh-ancestor
93256646|NCT02075112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256647|NCT02223026|Metformin|metformin|mesh-list
93256648|NCT02223026|Linagliptin|linagliptin|mesh-list
93256649|NCT02223026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93256650|NCT02223026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256651|NCT02223026|Incretins|incretins|mesh-ancestor
93256652|NCT02223026|Hormones|hormones|mesh-ancestor
93256653|NCT02223026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256654|NCT02223026|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93256655|NCT02223026|Protease Inhibitors|protease inhibitors|mesh-ancestor
93256656|NCT02223026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256657|NCT02223026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256658|NCT02075268|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93256659|NCT02075268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93256660|NCT02477384|Propranolol|propranolol|mesh-list
93256661|NCT02477384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93256662|NCT02477384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93256663|NCT02477384|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256664|NCT02477384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256665|NCT02477384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256666|NCT02477384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256667|NCT02477384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93256668|NCT02477384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93256669|NCT02477384|Vasodilator Agents|vasodilator agents|mesh-ancestor
93256670|NCT02231294|Pramipexole|pramipexole|mesh-list
93256671|NCT02231294|Antioxidants|antioxidants|mesh-ancestor
93256672|NCT02231294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256673|NCT02231294|Protective Agents|protective agents|mesh-ancestor
93256674|NCT02231294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256675|NCT02231294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93256676|NCT02231294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93256677|NCT02231294|Dopamine Agonists|dopamine agonists|mesh-ancestor
93256678|NCT02231294|Dopamine Agents|dopamine agents|mesh-ancestor
93256679|NCT02231294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256680|NCT02223416|Teriparatide|teriparatide|mesh-list
93256681|NCT02223416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93256682|NCT02223416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256683|NCT02223416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93256684|NCT02082054|Chlorpheniramine|chlorpheniramine|mesh-list
93256685|NCT02082054|Atropine|atropine|mesh-list
93256686|NCT02082054|Pseudoephedrine|pseudoephedrine|mesh-list
93256687|NCT02082054|Ephedrine|ephedrine|mesh-list
93256688|NCT02082054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93256689|NCT02082054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93256690|NCT02082054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93256691|NCT02082054|Autonomic Agents|autonomic agents|mesh-ancestor
93256692|NCT02082054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256693|NCT02082054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256694|NCT02082054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93256695|NCT02082054|Respiratory System Agents|respiratory system agents|mesh-ancestor
93256696|NCT02082054|Mydriatics|mydriatics|mesh-ancestor
93256697|NCT02082054|Parasympatholytics|parasympatholytics|mesh-ancestor
93256698|NCT02082054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93256699|NCT02082054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93256700|NCT02082054|Cholinergic Agents|cholinergic agents|mesh-ancestor
93256701|NCT02082054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256702|NCT02082054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256703|NCT02082054|Nasal Decongestants|nasal decongestants|mesh-ancestor
93256704|NCT02082054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93256705|NCT02082054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93256706|NCT02082054|Sympathomimetics|sympathomimetics|mesh-ancestor
93256707|NCT02082054|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256708|NCT02082054|Antipruritics|antipruritics|mesh-ancestor
93256709|NCT02082054|Dermatologic Agents|dermatologic agents|mesh-ancestor
93256710|NCT02082054|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93256711|NCT02082054|Histamine Antagonists|histamine antagonists|mesh-ancestor
93256712|NCT02082054|Histamine Agents|histamine agents|mesh-ancestor
93256713|NCT02082054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93256714|NCT02231372|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93256715|NCT02231372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93256716|NCT02231372|Autonomic Agents|autonomic agents|mesh-ancestor
93256717|NCT02231372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256718|NCT02231372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256719|NCT02231372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93256720|NCT02231372|Respiratory System Agents|respiratory system agents|mesh-ancestor
93256721|NCT02884544|Dextroamphetamine|dextroamphetamine|mesh-list
93256722|NCT02884544|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93256723|NCT02884544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256724|NCT02884544|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93256725|NCT02884544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93256726|NCT02884544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93256727|NCT02884544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256728|NCT02884544|Dopamine Agents|dopamine agents|mesh-ancestor
93256729|NCT02884544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256730|NCT02226926|Aspirin|aspirin|mesh-list
93256731|NCT02226926|Dipyridamole|dipyridamole|mesh-list
93256732|NCT02226926|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
93256733|NCT02226926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93256734|NCT02226926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256735|NCT02226926|Analgesics|analgesics|mesh-ancestor
93256736|NCT02226926|Sensory System Agents|sensory system agents|mesh-ancestor
93256737|NCT02226926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256738|NCT02226926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256739|NCT02226926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256740|NCT02226926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256741|NCT02226926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93256742|NCT02226926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93256743|NCT02226926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256744|NCT02226926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93256745|NCT02226926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93256746|NCT02226926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256747|NCT02226926|Antipyretics|antipyretics|mesh-ancestor
93256748|NCT02226926|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93256749|NCT02226926|Vasodilator Agents|vasodilator agents|mesh-ancestor
93256750|NCT02924883|Trastuzumab|trastuzumab|mesh-list
93256751|NCT02924883|Atezolizumab|atezolizumab|mesh-list
93256752|NCT02924883|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93256753|NCT02924883|Maytansine|maytansine|mesh-list
93256754|NCT02924883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93256755|NCT02924883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256756|NCT02924883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93256757|NCT02924883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256758|NCT02924883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93256759|NCT02924883|Tubulin Modulators|tubulin modulators|mesh-ancestor
93256760|NCT02924883|Antimitotic Agents|antimitotic agents|mesh-ancestor
93256761|NCT02924883|Mitosis Modulators|mitosis modulators|mesh-ancestor
93256762|NCT02924883|Immunotoxins|immunotoxins|mesh-ancestor
93256763|NCT02924883|Immunoconjugates|immunoconjugates|mesh-ancestor
93256764|NCT02924883|Immunologic Factors|immunologic factors|mesh-ancestor
93256765|NCT02924883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256766|NCT02075970|Epoetin Alfa|epoetin alfa|mesh-list
93256767|NCT02075970|Hematinics|hematinics|mesh-ancestor
93256768|NCT02231450|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
93256769|NCT02231450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93256770|NCT02231450|Serotonin Agents|serotonin agents|mesh-ancestor
93256771|NCT02231450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256772|NCT02231450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256773|NCT02231450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256774|NCT05764057|Dapagliflozin|dapagliflozin|mesh-list
93256775|NCT05764057|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93256776|NCT05764057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256777|NCT05764057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93256778|NCT05764057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256779|NCT02227082|Olaparib|olaparib|mesh-list
93256780|NCT02227082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93256781|NCT02227082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256782|NCT02227082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256783|NCT02227082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256784|NCT01369680|Ketamine|ketamine|mesh-list
93256785|NCT01369680|Analgesics|analgesics|mesh-ancestor
93256786|NCT01369680|Sensory System Agents|sensory system agents|mesh-ancestor
93256787|NCT01369680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256788|NCT01369680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256789|NCT01369680|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93256790|NCT01369680|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93256791|NCT01369680|Anesthetics, General|anesthetics, general|mesh-ancestor
93256792|NCT01369680|Anesthetics|anesthetics|mesh-ancestor
93256793|NCT01369680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256794|NCT01369680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93256795|NCT01369680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93256796|NCT01369680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256797|NCT01369680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256798|NCT04780321|Antibodies|antibodies|mesh-list
93256799|NCT04780321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93256800|NCT04780321|Immunologic Factors|immunologic factors|mesh-ancestor
93256801|NCT04780321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256802|NCT03670095|Memantine|memantine|mesh-list
93256803|NCT03670095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93256804|NCT03670095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93256805|NCT03670095|Dopamine Agents|dopamine agents|mesh-ancestor
93256806|NCT03670095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256807|NCT03670095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256808|NCT03670095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256809|NCT03670095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92551455|NCT00055653|Cyclosporine|cyclosporine|mesh-list
93256810|NCT03670095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93256811|NCT01378039|Budesonide|budesonide|mesh-list
93256812|NCT01378039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256813|NCT01378039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93256814|NCT01378039|Autonomic Agents|autonomic agents|mesh-ancestor
93256815|NCT01378039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256816|NCT01378039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256817|NCT01378039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93256818|NCT01378039|Respiratory System Agents|respiratory system agents|mesh-ancestor
93256819|NCT01378039|Glucocorticoids|glucocorticoids|mesh-ancestor
93256820|NCT01378039|Hormones|hormones|mesh-ancestor
93256821|NCT01378039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256822|NCT01377961|Lycopene|lycopene|mesh-list
93256823|NCT01377961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256824|NCT01377961|Antioxidants|antioxidants|mesh-ancestor
93256825|NCT01377961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256826|NCT01377961|Protective Agents|protective agents|mesh-ancestor
93256827|NCT01377961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256828|NCT01377961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93256829|NCT01377961|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93256830|NCT01377961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256831|NCT03558750|Rituximab|rituximab|mesh-list
93256832|NCT03558750|Nivolumab|nivolumab|mesh-list
93256833|NCT03558750|Lenalidomide|lenalidomide|mesh-list
93256834|NCT03558750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93256835|NCT03558750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256836|NCT03558750|Immunologic Factors|immunologic factors|mesh-ancestor
93256837|NCT03558750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256838|NCT03558750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256839|NCT03558750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93256840|NCT03558750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256841|NCT03558750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93256842|NCT03558750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93256843|NCT03558750|Growth Substances|growth substances|mesh-ancestor
93256844|NCT03558750|Growth Inhibitors|growth inhibitors|mesh-ancestor
93256845|NCT03559140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93256846|NCT02751320|Citric Acid|citric acid|mesh-list
93256847|NCT02751320|Sodium Citrate|sodium citrate|mesh-list
93256848|NCT02751320|Anticoagulants|anticoagulants|mesh-ancestor
93256849|NCT02751320|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93256850|NCT02751320|Chelating Agents|chelating agents|mesh-ancestor
93256851|NCT02751320|Sequestering Agents|sequestering agents|mesh-ancestor
93256852|NCT02751320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256853|NCT04093219|Acetaminophen|acetaminophen|mesh-list
93256854|NCT04093219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93256855|NCT04093219|Analgesics|analgesics|mesh-ancestor
93256856|NCT04093219|Sensory System Agents|sensory system agents|mesh-ancestor
93256857|NCT04093219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256858|NCT04093219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256859|NCT04093219|Antipyretics|antipyretics|mesh-ancestor
93256860|NCT03559764|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93256861|NCT03559764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93256862|NCT03559764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256863|NCT04931641|Ferrous fumarate|ferrous fumarate|mesh-list
93256864|NCT04931641|Trace Elements|trace elements|mesh-ancestor
93256865|NCT04931641|Micronutrients|micronutrients|mesh-ancestor
93256866|NCT04931641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256867|NCT02083536|Docetaxel|docetaxel|mesh-list
93256868|NCT02083536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256869|NCT02083536|Tubulin Modulators|tubulin modulators|mesh-ancestor
93256870|NCT02083536|Antimitotic Agents|antimitotic agents|mesh-ancestor
93256871|NCT02083536|Mitosis Modulators|mitosis modulators|mesh-ancestor
93256872|NCT02083536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256873|NCT02231606|Methamphetamine|methamphetamine|mesh-list
92928829|NCT00739934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256874|NCT02231606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93256875|NCT02231606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256876|NCT02231606|Sympathomimetics|sympathomimetics|mesh-ancestor
93256877|NCT02231606|Autonomic Agents|autonomic agents|mesh-ancestor
93256878|NCT02231606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256879|NCT02231606|Dopamine Agents|dopamine agents|mesh-ancestor
93256880|NCT02231606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256881|NCT02231606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256882|NCT02231606|Adrenergic Agents|adrenergic agents|mesh-ancestor
93256883|NCT02231606|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93256884|NCT02231606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93256885|NCT02231606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93256886|NCT02231606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93256887|NCT02083692|Metformin|metformin|mesh-list
93256888|NCT02083692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93256889|NCT02083692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256890|NCT02227550|Vitamin K|vitamin k|mesh-list
93256891|NCT02227550|Warfarin|warfarin|mesh-list
93256892|NCT02227550|Apixaban|apixaban|mesh-list
93256893|NCT02227550|Phenprocoumon|phenprocoumon|mesh-list
93256894|NCT02227550|Fluindione|fluindione|mesh-list
93256895|NCT02227550|Vitamins|vitamins|mesh-ancestor
93256896|NCT02227550|Micronutrients|micronutrients|mesh-ancestor
93256897|NCT02227550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256898|NCT02227550|Anticoagulants|anticoagulants|mesh-ancestor
93256899|NCT02227550|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93256900|NCT02227550|Antithrombins|antithrombins|mesh-ancestor
93256901|NCT02227550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93256902|NCT02227550|Protease Inhibitors|protease inhibitors|mesh-ancestor
93256903|NCT02227550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256904|NCT02227550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256905|NCT02227550|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93256906|NCT02227550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93256907|NCT02227550|Hemostatics|hemostatics|mesh-ancestor
93256908|NCT02227550|Coagulants|coagulants|mesh-ancestor
93256909|NCT02206035|Methotrexate|methotrexate|mesh-list
93256910|NCT02206035|Tacrolimus|tacrolimus|mesh-list
93256911|NCT02206035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93256912|NCT02206035|Abortifacient Agents|abortifacient agents|mesh-ancestor
93256913|NCT02206035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93256914|NCT02206035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256915|NCT02206035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93256916|NCT02206035|Antimetabolites|antimetabolites|mesh-ancestor
93256917|NCT02206035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256918|NCT02206035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256919|NCT02206035|Dermatologic Agents|dermatologic agents|mesh-ancestor
93256920|NCT02206035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256921|NCT02206035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93256922|NCT02206035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93256923|NCT02206035|Immunologic Factors|immunologic factors|mesh-ancestor
93256924|NCT02206035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93256925|NCT02206035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93256926|NCT02206035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93256927|NCT02258828|Memantine|memantine|mesh-list
93256928|NCT02258828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93256929|NCT02258828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93256930|NCT02258828|Dopamine Agents|dopamine agents|mesh-ancestor
93256931|NCT02258828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93256932|NCT02258828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256933|NCT02258828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256934|NCT02258828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93256935|NCT02258828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93256936|NCT02083068|Vaccines|vaccines|mesh-list
93256937|NCT02083068|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93256938|NCT02083068|Immunologic Factors|immunologic factors|mesh-ancestor
93256939|NCT02083068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256940|NCT02083068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93256941|NCT02228252|Caseins|caseins|mesh-list
93256942|NCT02228252|Chelating Agents|chelating agents|mesh-ancestor
93256943|NCT02228252|Sequestering Agents|sequestering agents|mesh-ancestor
93256944|NCT02228252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256945|NCT02070549|Trametinib|trametinib|mesh-list
93256946|NCT02070549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256947|NCT02070549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93256948|NCT02070549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93256949|NCT02070549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256950|NCT02591953|Methylprednisolone|methylprednisolone|mesh-list
93256951|NCT02591953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93256952|NCT02591953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93256953|NCT02591953|Prednisolone|prednisolone|mesh-list
93256954|NCT02591953|Prednisolone acetate|prednisolone acetate|mesh-list
93256955|NCT02591953|Lidocaine|lidocaine|mesh-list
93256956|NCT02591953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93256957|NCT02591953|Prednisolone phosphate|prednisolone phosphate|mesh-list
93256958|NCT02591953|Anesthetics, Local|anesthetics, local|mesh-ancestor
93256959|NCT02591953|Anesthetics|anesthetics|mesh-ancestor
93256960|NCT02591953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93256961|NCT02591953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256962|NCT02591953|Sensory System Agents|sensory system agents|mesh-ancestor
93256963|NCT02591953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93256964|NCT02591953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93256965|NCT02591953|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93256966|NCT02591953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93256967|NCT02591953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92551629|NCT00056004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93256968|NCT02591953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256969|NCT02591953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93256970|NCT02591953|Antiemetics|antiemetics|mesh-ancestor
93256971|NCT02591953|Autonomic Agents|autonomic agents|mesh-ancestor
93256972|NCT02591953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93256973|NCT02591953|Glucocorticoids|glucocorticoids|mesh-ancestor
93256974|NCT02591953|Hormones|hormones|mesh-ancestor
93256975|NCT02591953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93256976|NCT02591953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93256977|NCT02591953|Protective Agents|protective agents|mesh-ancestor
93256978|NCT02591953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93256979|NCT02591953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256980|NCT02223884|Carboplatin|carboplatin|mesh-list
93256981|NCT02223884|Docetaxel|docetaxel|mesh-list
93256982|NCT02223884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256983|NCT02223884|Tubulin Modulators|tubulin modulators|mesh-ancestor
93256984|NCT02223884|Antimitotic Agents|antimitotic agents|mesh-ancestor
93256985|NCT02223884|Mitosis Modulators|mitosis modulators|mesh-ancestor
93256986|NCT02223884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256987|NCT02079480|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93256988|NCT02079480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93256989|NCT02079480|Immunologic Factors|immunologic factors|mesh-ancestor
93256990|NCT02079480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93256991|NCT02569489|Paclitaxel|paclitaxel|mesh-list
93256992|NCT02569489|Trastuzumab|trastuzumab|mesh-list
93256993|NCT02569489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93256994|NCT02569489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93256995|NCT02569489|Tubulin Modulators|tubulin modulators|mesh-ancestor
93256996|NCT02569489|Antimitotic Agents|antimitotic agents|mesh-ancestor
93256997|NCT02569489|Mitosis Modulators|mitosis modulators|mesh-ancestor
93256998|NCT02569489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93256999|NCT02569489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257000|NCT02079558|Oxytocin|oxytocin|mesh-list
93257001|NCT02079558|Carbetocin|carbetocin|mesh-list
93257002|NCT02079558|Oxytocics|oxytocics|mesh-ancestor
93257003|NCT02079558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93257004|NCT02079558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257005|NCT04057755|Botulinum Toxins|botulinum toxins|mesh-list
93257006|NCT04057755|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93257007|NCT04057755|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93257008|NCT04057755|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93257009|NCT04057755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257010|NCT04057755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257011|NCT04057755|Cholinergic Agents|cholinergic agents|mesh-ancestor
93257012|NCT04057755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257013|NCT04057755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257014|NCT04057755|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93257015|NCT04057755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257016|NCT03669003|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
93257017|NCT03669003|Hemostatics|hemostatics|mesh-ancestor
93257018|NCT03669003|Coagulants|coagulants|mesh-ancestor
93257019|NCT04313959|Dexamethasone|dexamethasone|mesh-list
93257020|NCT04313959|Ropivacaine|ropivacaine|mesh-list
93257021|NCT04313959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257022|NCT04313959|Antiemetics|antiemetics|mesh-ancestor
93257023|NCT04313959|Autonomic Agents|autonomic agents|mesh-ancestor
93257024|NCT04313959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257025|NCT04313959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257026|NCT04313959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93257027|NCT04313959|Glucocorticoids|glucocorticoids|mesh-ancestor
93257028|NCT04313959|Hormones|hormones|mesh-ancestor
93257029|NCT04313959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551679|NCT00028418|Antimetabolites|antimetabolites|mesh-ancestor
93257030|NCT04313959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93257031|NCT04313959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257032|NCT04313959|Anesthetics, Local|anesthetics, local|mesh-ancestor
93257033|NCT04313959|Anesthetics|anesthetics|mesh-ancestor
93257034|NCT04313959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257035|NCT04313959|Sensory System Agents|sensory system agents|mesh-ancestor
93257036|NCT03073213|Ixekizumab|ixekizumab|mesh-list
93257037|NCT03073213|Dermatologic Agents|dermatologic agents|mesh-ancestor
93257038|NCT03070483|Vitamin D|vitamin d|mesh-list
93257039|NCT03070483|Cholecalciferol|cholecalciferol|mesh-list
93257040|NCT03070483|Vitamins|vitamins|mesh-ancestor
93257041|NCT03070483|Micronutrients|micronutrients|mesh-ancestor
93257042|NCT03070483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257043|NCT03070483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93257044|NCT03070483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93257045|NCT05763667|Bupivacaine|bupivacaine|mesh-list
93257046|NCT05763667|Anesthetics, Local|anesthetics, local|mesh-ancestor
93257047|NCT05763667|Anesthetics|anesthetics|mesh-ancestor
93257048|NCT05763667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257049|NCT05763667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257050|NCT05763667|Sensory System Agents|sensory system agents|mesh-ancestor
93257051|NCT05763667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257052|NCT04107727|Cytarabine|cytarabine|mesh-list
93257053|NCT04107727|Idarubicin|idarubicin|mesh-list
93257054|NCT04107727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257055|NCT04107727|Antimetabolites|antimetabolites|mesh-ancestor
93257056|NCT04107727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257057|NCT04107727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257058|NCT04107727|Antiviral Agents|antiviral agents|mesh-ancestor
93257059|NCT04107727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257060|NCT04107727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257061|NCT04107727|Immunologic Factors|immunologic factors|mesh-ancestor
93257062|NCT04107727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257063|NCT04107727|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93257064|NCT04107727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93257065|NCT04107727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93257066|NCT04107727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257067|NCT01074151|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93257068|NCT01074151|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93257069|NCT01074151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93257070|NCT01074151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257071|NCT01074151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257072|NCT01074151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257073|NCT01074151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257074|NCT01074151|Analgesics|analgesics|mesh-ancestor
93257075|NCT01074151|Sensory System Agents|sensory system agents|mesh-ancestor
93257076|NCT01074151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257077|NCT01074151|Antidepressive Agents|antidepressive agents|mesh-ancestor
93257078|NCT01074151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257079|NCT01074151|Dopamine Agents|dopamine agents|mesh-ancestor
93257080|NCT05761405|Ceftriaxone|ceftriaxone|mesh-list
93257081|NCT05761405|Amikacin|amikacin|mesh-list
93257082|NCT05761405|Mannitol|mannitol|mesh-list
93257083|NCT05761405|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93257084|NCT05761405|Diuretics|diuretics|mesh-ancestor
93257085|NCT05761405|Natriuretic Agents|natriuretic agents|mesh-ancestor
93257086|NCT05761405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257087|NCT05761405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93257088|NCT05761405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257089|NCT02786329|Lidocaine|lidocaine|mesh-list
93257090|NCT02786329|Sevoflurane|sevoflurane|mesh-list
93257091|NCT02786329|Anesthetics, Local|anesthetics, local|mesh-ancestor
93257092|NCT02786329|Anesthetics|anesthetics|mesh-ancestor
93257093|NCT02786329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257094|NCT02786329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257095|NCT02786329|Sensory System Agents|sensory system agents|mesh-ancestor
93257096|NCT02786329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257097|NCT02786329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93257098|NCT02786329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93257099|NCT02786329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92929056|NCT02570841|Capsaicin|capsaicin|mesh-list
93257100|NCT02786329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257101|NCT02786329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257102|NCT02786329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93257103|NCT02786329|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93257105|NCT05761951|Pembrolizumab|pembrolizumab|mesh-list
92551781|NCT00028730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93257106|NCT05761951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257107|NCT05761951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257108|NCT05761951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93257109|NCT05761951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257110|NCT05761327|Curcumin|curcumin|mesh-list
93257111|NCT05761327|Resveratrol|resveratrol|mesh-list
93257112|NCT05761327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93257113|NCT05761327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93257114|NCT05761327|Analgesics|analgesics|mesh-ancestor
93257115|NCT05761327|Sensory System Agents|sensory system agents|mesh-ancestor
93257116|NCT05761327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257117|NCT05761327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257118|NCT05761327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257119|NCT05761327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257120|NCT05761327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257121|NCT05761327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257122|NCT05761327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257123|NCT05761327|Antioxidants|antioxidants|mesh-ancestor
93257124|NCT05761327|Protective Agents|protective agents|mesh-ancestor
93257125|NCT05761327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93257126|NCT02231762|Temozolomide|temozolomide|mesh-list
93257127|NCT02231762|Lanreotide|lanreotide|mesh-list
93257128|NCT02231762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93257129|NCT02231762|Alkylating Agents|alkylating agents|mesh-ancestor
93257130|NCT02231762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257131|NCT02231762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257132|NCT01191957|Cyclophosphamide|cyclophosphamide|mesh-list
93257133|NCT01191957|Busulfan|busulfan|mesh-list
93257134|NCT01191957|Fludarabine|fludarabine|mesh-list
93257135|NCT01191957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257136|NCT01191957|Immunologic Factors|immunologic factors|mesh-ancestor
93257137|NCT01191957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257138|NCT01191957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257139|NCT01191957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93257140|NCT01191957|Alkylating Agents|alkylating agents|mesh-ancestor
93257141|NCT01191957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257142|NCT01191957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257143|NCT01191957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93257144|NCT01050855|Busulfan|busulfan|mesh-list
93257145|NCT01050855|Alemtuzumab|alemtuzumab|mesh-list
93257146|NCT01050855|Alkylating Agents|alkylating agents|mesh-ancestor
93257147|NCT01050855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257148|NCT01050855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257149|NCT01050855|Immunologic Factors|immunologic factors|mesh-ancestor
93257150|NCT01050855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257151|NCT01050855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93257152|NCT01050855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257153|NCT01050855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93257154|NCT01050855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257155|NCT04459286|Ritonavir|ritonavir|mesh-list
93257156|NCT04459286|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93257157|NCT04459286|Nitazoxanide|nitazoxanide|mesh-list
93257158|NCT04459286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93257159|NCT04459286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93257160|NCT04459286|Protease Inhibitors|protease inhibitors|mesh-ancestor
93257161|NCT04459286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257162|NCT04459286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257163|NCT04459286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93257164|NCT04459286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93257165|NCT04459286|Antiviral Agents|antiviral agents|mesh-ancestor
93257166|NCT04459286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257167|NCT04459286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93257168|NCT04459286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93257169|NCT04459286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93257170|NCT00744081|Topotecan|topotecan|mesh-list
93257171|NCT00744081|Mitoxantrone|mitoxantrone|mesh-list
93257172|NCT00744081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93257173|NCT00744081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93257174|NCT00744081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257175|NCT00744081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257176|NCT00744081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257178|NCT00744081|Sensory System Agents|sensory system agents|mesh-ancestor
93257179|NCT00744081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257180|NCT00744081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257181|NCT00744081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93257182|NCT02229266|Cytarabine|cytarabine|mesh-list
93257183|NCT02229266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257184|NCT02229266|Antimetabolites|antimetabolites|mesh-ancestor
93257185|NCT02229266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257186|NCT02229266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257187|NCT02229266|Antiviral Agents|antiviral agents|mesh-ancestor
93257188|NCT02229266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257189|NCT02229266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257190|NCT02229266|Immunologic Factors|immunologic factors|mesh-ancestor
93257191|NCT02229266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257192|NCT02224040|Azithromycin|azithromycin|mesh-list
93257193|NCT02224040|Ceftriaxone|ceftriaxone|mesh-list
93257194|NCT02224040|Cefixime|cefixime|mesh-list
93257195|NCT02224040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93257196|NCT02224040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257197|NCT04448834|Vincristine|vincristine|mesh-list
93257198|NCT04448834|Blinatumomab|blinatumomab|mesh-list
93257199|NCT04448834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93257200|NCT04448834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257201|NCT04448834|Tubulin Modulators|tubulin modulators|mesh-ancestor
93257202|NCT04448834|Antimitotic Agents|antimitotic agents|mesh-ancestor
93257203|NCT04448834|Mitosis Modulators|mitosis modulators|mesh-ancestor
93257204|NCT04448834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257205|NCT02229422|Obinutuzumab|obinutuzumab|mesh-list
93257206|NCT02229422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257207|NCT02229422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257208|NCT02232308|Lisinopril|lisinopril|mesh-list
93257209|NCT02232308|Nizatidine|nizatidine|mesh-list
93257210|NCT02232308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93257211|NCT02232308|Protease Inhibitors|protease inhibitors|mesh-ancestor
93257212|NCT02232308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257213|NCT02232308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257214|NCT02232308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93257215|NCT02232308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93257216|NCT02232308|Protective Agents|protective agents|mesh-ancestor
93257217|NCT02232308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257218|NCT02232308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93257219|NCT02232308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93257220|NCT02232308|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93257221|NCT02232308|Histamine Antagonists|histamine antagonists|mesh-ancestor
93257222|NCT02232308|Histamine Agents|histamine agents|mesh-ancestor
93257223|NCT02232308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257224|NCT02232386|Rituximab|rituximab|mesh-list
93257225|NCT02232386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257226|NCT02232386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257227|NCT02232386|Immunologic Factors|immunologic factors|mesh-ancestor
93257228|NCT02232386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257229|NCT02232386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257230|NCT02229734|Androgens|androgens|mesh-list
93257231|NCT02229734|Hormones|hormones|mesh-ancestor
93257232|NCT02229734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257233|NCT02229734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257234|NCT04333160|Hylan|hylan|mesh-list
93257235|NCT04333160|Viscosupplements|viscosupplements|mesh-ancestor
93257236|NCT04333160|Protective Agents|protective agents|mesh-ancestor
93257237|NCT04333160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257238|NCT02258906|Urinastatin|urinastatin|mesh-list
93257239|NCT02258906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93257240|NCT02258906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93257241|NCT02258906|Protease Inhibitors|protease inhibitors|mesh-ancestor
93257242|NCT02258906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257243|NCT02258906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257244|NCT02229812|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93257245|NCT02229812|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93257246|NCT02229812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93257247|NCT02229812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929204|NCT00725829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257248|NCT04222712|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93257249|NCT04222712|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93257250|NCT02229890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93257251|NCT02229890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93257252|NCT02229890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93257253|NCT02229890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257254|NCT02230046|Abiraterone Acetate|abiraterone acetate|mesh-list
93257255|NCT02230046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551928|NCT00423696|Growth Inhibitors|growth inhibitors|mesh-ancestor
93257256|NCT02230046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93257257|NCT02230046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257258|NCT02230046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257259|NCT02230046|Hormone Antagonists|hormone antagonists|mesh-ancestor
93257260|NCT02230046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257261|NCT02230046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257262|NCT02230046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93257263|NCT03068455|Nivolumab|nivolumab|mesh-list
93257264|NCT03068455|Ipilimumab|ipilimumab|mesh-list
93257265|NCT03068455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257266|NCT03068455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257267|NCT03068455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93257268|NCT03068455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257269|NCT03646994|Crizotinib|crizotinib|mesh-list
93257270|NCT03646994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257271|NCT03646994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93257272|NCT03646994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257273|NCT03646994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257274|NCT04209296|Ketamine|ketamine|mesh-list
93257275|NCT04209296|Analgesics|analgesics|mesh-ancestor
93257276|NCT04209296|Sensory System Agents|sensory system agents|mesh-ancestor
93257277|NCT04209296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257278|NCT04209296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257279|NCT04209296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93257280|NCT04209296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93257281|NCT04209296|Anesthetics, General|anesthetics, general|mesh-ancestor
93257282|NCT04209296|Anesthetics|anesthetics|mesh-ancestor
93257283|NCT04209296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257284|NCT04209296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93257285|NCT04209296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93257286|NCT04209296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257287|NCT04209296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257288|NCT04207736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93257289|NCT04207736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93257290|NCT02232932|Capecitabine|capecitabine|mesh-list
93257291|NCT02232932|Liver Extracts|liver extracts|mesh-list
93257292|NCT02232932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257293|NCT02232932|Antimetabolites|antimetabolites|mesh-ancestor
93257294|NCT02232932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257295|NCT02232932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257296|NCT02232932|Hematinics|hematinics|mesh-ancestor
93257297|NCT02230358|Anesthetics|anesthetics|mesh-list
93257298|NCT02230358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257299|NCT02230358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257300|NCT03494504|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93257301|NCT03494504|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93257302|NCT04049864|Lenalidomide|lenalidomide|mesh-list
93257303|NCT04049864|Vaccines|vaccines|mesh-list
93257304|NCT04049864|Immunologic Factors|immunologic factors|mesh-ancestor
93257305|NCT04049864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257306|NCT04049864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93257307|NCT04049864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93257308|NCT04049864|Growth Substances|growth substances|mesh-ancestor
93257309|NCT04049864|Growth Inhibitors|growth inhibitors|mesh-ancestor
93257310|NCT04049864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257311|NCT03475706|Solabegron|solabegron|mesh-list
93257312|NCT03475706|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93257313|NCT03475706|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93257314|NCT03475706|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92551975|NCT02970084|Hemostatics|hemostatics|mesh-ancestor
93257315|NCT03475706|Adrenergic Agents|adrenergic agents|mesh-ancestor
93257316|NCT03475706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257317|NCT03475706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257318|NCT03475706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257319|NCT02234492|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93257320|NCT02234492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93257321|NCT02234492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257322|NCT02234492|Antimetabolites|antimetabolites|mesh-ancestor
93257323|NCT02234492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257324|NCT02234492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257325|NCT02234492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93257326|NCT02234492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257327|NCT03928184|Lorecivivint|lorecivivint|mesh-list
93257328|NCT03928184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257329|NCT02259374|Ropivacaine|ropivacaine|mesh-list
93257330|NCT02259374|Anesthetics, Local|anesthetics, local|mesh-ancestor
93257331|NCT02259374|Anesthetics|anesthetics|mesh-ancestor
93257332|NCT02259374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257333|NCT02259374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257334|NCT02259374|Sensory System Agents|sensory system agents|mesh-ancestor
93257335|NCT02259374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257336|NCT04921982|Propranolol|propranolol|mesh-list
93257337|NCT04921982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93257338|NCT04921982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93257339|NCT04921982|Adrenergic Agents|adrenergic agents|mesh-ancestor
93257340|NCT04921982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257341|NCT04921982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257342|NCT04921982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257343|NCT04921982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93257344|NCT04921982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93257345|NCT04921982|Vasodilator Agents|vasodilator agents|mesh-ancestor
93257346|NCT04874324|Levonadifloxacin|levonadifloxacin|mesh-list
93257347|NCT04874324|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93257348|NCT04874324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257349|NCT04874324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257350|NCT04874324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93257351|NCT04874324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257352|NCT04866056|Azacitidine|azacitidine|mesh-list
93257353|NCT04866056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257354|NCT04866056|Antimetabolites|antimetabolites|mesh-ancestor
93257355|NCT04866056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257356|NCT04866056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257357|NCT04866056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257358|NCT03911102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93257359|NCT03911102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93257360|NCT03911102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93257361|NCT03911102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257362|NCT03911102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257363|NCT03911102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93257364|NCT03911102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257365|NCT03911102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257366|NCT03911102|Cholinergic Agents|cholinergic agents|mesh-ancestor
93257367|NCT03911102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257368|NCT04789148|Oxytocin|oxytocin|mesh-list
93257369|NCT04789148|Oxytocics|oxytocics|mesh-ancestor
93257370|NCT04789148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93257371|NCT04789148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257372|NCT03172910|Rivaroxaban|rivaroxaban|mesh-list
93257373|NCT03172910|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93257374|NCT03172910|Antithrombins|antithrombins|mesh-ancestor
93257375|NCT03172910|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93257376|NCT03172910|Protease Inhibitors|protease inhibitors|mesh-ancestor
93257377|NCT03172910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257378|NCT03172910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257379|NCT03172910|Anticoagulants|anticoagulants|mesh-ancestor
93257380|NCT03881852|Reboxetine|reboxetine|mesh-list
93257381|NCT03881852|Antidepressive Agents|antidepressive agents|mesh-ancestor
93257382|NCT03881852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257383|NCT03881852|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93257384|NCT03881852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93257385|NCT03881852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257386|NCT03881852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257387|NCT03881852|Adrenergic Agents|adrenergic agents|mesh-ancestor
93257388|NCT03881852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257389|NCT03881852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257390|NCT03818828|Iodine|iodine|mesh-list
93257391|NCT03818828|Cadexomer iodine|cadexomer iodine|mesh-list
93257392|NCT03818828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93257393|NCT03818828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929351|NCT00727077|Antiviral Agents|antiviral agents|mesh-ancestor
93257394|NCT03818828|Trace Elements|trace elements|mesh-ancestor
93257395|NCT03818828|Micronutrients|micronutrients|mesh-ancestor
93257396|NCT03818828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257397|NCT02804282|Furosemide|furosemide|mesh-list
93257398|NCT02804282|Diuretics|diuretics|mesh-ancestor
93257399|NCT02804282|Natriuretic Agents|natriuretic agents|mesh-ancestor
93257400|NCT02804282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257401|NCT02804282|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93257402|NCT02804282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257403|NCT02804282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257404|NCT02233244|Midazolam|midazolam|mesh-list
93257405|NCT02233244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93257406|NCT02233244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93257407|NCT02233244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257408|NCT02233244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257409|NCT02233244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93257410|NCT02233244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93257411|NCT02233244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257412|NCT02233244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93257413|NCT02233244|Anesthetics, General|anesthetics, general|mesh-ancestor
93257414|NCT02233244|Anesthetics|anesthetics|mesh-ancestor
93257415|NCT02233244|GABA Modulators|gaba modulators|mesh-ancestor
93257416|NCT02233244|GABA Agents|gaba agents|mesh-ancestor
93257417|NCT02233244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257418|NCT02233244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257419|NCT02259530|Psychotropic Drugs|psychotropic drugs|mesh-list
93257420|NCT02234882|Fostemsavir|fostemsavir|mesh-list
93257421|NCT02234882|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93257422|NCT02234882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93257423|NCT02234882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257424|NCT02234882|Antimetabolites|antimetabolites|mesh-ancestor
93257425|NCT02234882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257426|NCT02234882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257427|NCT02234882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93257428|NCT02234882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257429|NCT02234882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93257430|NCT02234882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93257431|NCT02234882|Antiviral Agents|antiviral agents|mesh-ancestor
93257432|NCT02234882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257433|NCT02234882|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93257434|NCT02234882|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93257435|NCT03729362|Miglustat|miglustat|mesh-list
93257436|NCT03729362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257437|NCT03729362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257438|NCT03729362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93257439|NCT03729362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93257440|NCT03729362|Antiviral Agents|antiviral agents|mesh-ancestor
93257441|NCT03729362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257442|NCT03729362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93257443|NCT03729362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93257444|NCT03729362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257445|NCT03727022|Lorecivivint|lorecivivint|mesh-list
93257446|NCT03727022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257447|NCT02233322|Ferrous gluconate|ferrous gluconate|mesh-list
93257448|NCT02233322|Hematinics|hematinics|mesh-ancestor
93257449|NCT02233400|Acetaminophen|acetaminophen|mesh-list
93257450|NCT02233400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93257451|NCT02233400|Analgesics|analgesics|mesh-ancestor
93257452|NCT02233400|Sensory System Agents|sensory system agents|mesh-ancestor
93257453|NCT02233400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257454|NCT02233400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257455|NCT02233400|Antipyretics|antipyretics|mesh-ancestor
93257456|NCT03067441|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93257457|NCT03067441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257458|NCT03067441|Antimetabolites|antimetabolites|mesh-ancestor
93257459|NCT03067441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257460|NCT03067441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257461|NCT03067441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257462|NCT03067441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93257463|NCT03067441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257464|NCT02235194|Chromium|chromium|mesh-list
93257465|NCT02235194|Picolinic acid|picolinic acid|mesh-list
93257466|NCT02235194|Trace Elements|trace elements|mesh-ancestor
93257467|NCT02235194|Micronutrients|micronutrients|mesh-ancestor
93257468|NCT02235194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257469|NCT02235194|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93257470|NCT02235194|Chelating Agents|chelating agents|mesh-ancestor
93257471|NCT02235194|Sequestering Agents|sequestering agents|mesh-ancestor
93257472|NCT02235194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257474|NCT03684278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93257475|NCT03684278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257476|NCT03684278|Dermatologic Agents|dermatologic agents|mesh-ancestor
93257477|NCT03684278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93257478|NCT03684278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257479|NCT02726659|Celecoxib|celecoxib|mesh-list
93257480|NCT02726659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93257481|NCT02726659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93257482|NCT02726659|Analgesics|analgesics|mesh-ancestor
93257483|NCT02726659|Sensory System Agents|sensory system agents|mesh-ancestor
93257484|NCT02726659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257485|NCT02726659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257486|NCT02726659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257487|NCT02726659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257488|NCT02726659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93257489|NCT02726659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93257490|NCT02726659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257491|NCT02726659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257492|NCT03660878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93257493|NCT03660878|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93257494|NCT04446962|Lenalidomide|lenalidomide|mesh-list
93257495|NCT04446962|Immunologic Factors|immunologic factors|mesh-ancestor
93257496|NCT04446962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257497|NCT04446962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93257498|NCT04446962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93257499|NCT04446962|Growth Substances|growth substances|mesh-ancestor
93257500|NCT04446962|Growth Inhibitors|growth inhibitors|mesh-ancestor
93257501|NCT04446962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257502|NCT03951961|Midostaurin|midostaurin|mesh-list
93257503|NCT03951961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257504|NCT03951961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93257505|NCT03951961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257506|NCT03951961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257507|NCT02232542|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93257508|NCT02232542|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93257509|NCT02232542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93257510|NCT02232542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257511|NCT02232542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257512|NCT02232542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257513|NCT02232542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257514|NCT02232542|Analgesics|analgesics|mesh-ancestor
93257515|NCT02232542|Sensory System Agents|sensory system agents|mesh-ancestor
93257516|NCT02232542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257517|NCT02232542|Antidepressive Agents|antidepressive agents|mesh-ancestor
93257518|NCT02232542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257519|NCT02232542|Dopamine Agents|dopamine agents|mesh-ancestor
93257520|NCT02600923|Letrozole|letrozole|mesh-list
93257521|NCT02600923|Palbociclib|palbociclib|mesh-list
93257522|NCT02600923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257523|NCT02600923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93257524|NCT02600923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93257525|NCT02600923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257526|NCT02600923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257527|NCT02600923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93257528|NCT02600923|Hormone Antagonists|hormone antagonists|mesh-ancestor
93257529|NCT02600923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257530|NCT02600923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257531|NCT02600923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93257532|NCT05761171|Cytarabine|cytarabine|mesh-list
93257533|NCT05761171|Prednisone|prednisone|mesh-list
93257534|NCT05761171|Prednisolone|prednisolone|mesh-list
93257535|NCT05761171|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93257536|NCT05761171|Methylprednisolone|methylprednisolone|mesh-list
93257537|NCT05761171|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93257538|NCT05761171|Prednisolone acetate|prednisolone acetate|mesh-list
93257539|NCT05761171|Hydrocortisone|hydrocortisone|mesh-list
93257540|NCT05761171|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93257541|NCT05761171|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93257542|NCT05761171|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93257543|NCT05761171|Cortisone|cortisone|mesh-list
93257544|NCT05761171|Methotrexate|methotrexate|mesh-list
93257545|NCT05761171|Fludarabine|fludarabine|mesh-list
93257546|NCT05761171|Fludarabine phosphate|fludarabine phosphate|mesh-list
93257547|NCT05761171|Vincristine|vincristine|mesh-list
93257548|NCT05761171|Asparaginase|asparaginase|mesh-list
93257549|NCT05761171|Pegaspargase|pegaspargase|mesh-list
93257550|NCT05761171|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93257551|NCT05761171|Prednisolone phosphate|prednisolone phosphate|mesh-list
93257552|NCT05761171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257553|NCT05761171|Glucocorticoids|glucocorticoids|mesh-ancestor
93257555|NCT05761171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257556|NCT05761171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257557|NCT05761171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93257558|NCT05761171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257559|NCT05761171|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93257560|NCT05761171|Abortifacient Agents|abortifacient agents|mesh-ancestor
93257561|NCT05761171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93257562|NCT05761171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257563|NCT05761171|Antimetabolites|antimetabolites|mesh-ancestor
93257564|NCT05761171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257565|NCT05761171|Dermatologic Agents|dermatologic agents|mesh-ancestor
93257566|NCT05761171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257567|NCT05761171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93257568|NCT05761171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257569|NCT05761171|Immunologic Factors|immunologic factors|mesh-ancestor
93257570|NCT05761171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552223|NCT00030719|Cyclophosphamide|cyclophosphamide|mesh-list
93257571|NCT05761171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93257572|NCT05761171|Antiviral Agents|antiviral agents|mesh-ancestor
93257573|NCT05761171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257574|NCT05761171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93257575|NCT05761171|Tubulin Modulators|tubulin modulators|mesh-ancestor
93257576|NCT05761171|Antimitotic Agents|antimitotic agents|mesh-ancestor
93257577|NCT05761171|Mitosis Modulators|mitosis modulators|mesh-ancestor
93257578|NCT05761171|Antiemetics|antiemetics|mesh-ancestor
93257579|NCT05761171|Autonomic Agents|autonomic agents|mesh-ancestor
93257580|NCT05761171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257581|NCT05761171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93257582|NCT05761171|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93257583|NCT05761171|Protective Agents|protective agents|mesh-ancestor
93257584|NCT02232776|Losartan|losartan|mesh-list
93257585|NCT02232776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93257586|NCT02232776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93257587|NCT02232776|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93257588|NCT02232776|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93257589|NCT02232776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257590|NCT03847519|Pembrolizumab|pembrolizumab|mesh-list
93257591|NCT03847519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257592|NCT03847519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257593|NCT03847519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93257594|NCT03847519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257595|NCT02235428|Bromides|bromides|mesh-list
93257596|NCT02235428|Albuterol|albuterol|mesh-list
93257597|NCT02235428|Ipratropium|ipratropium|mesh-list
93257598|NCT02235428|Anticonvulsants|anticonvulsants|mesh-ancestor
93257599|NCT02235428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93257600|NCT02235428|Autonomic Agents|autonomic agents|mesh-ancestor
93257601|NCT02235428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257602|NCT02235428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257603|NCT02235428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93257604|NCT02235428|Respiratory System Agents|respiratory system agents|mesh-ancestor
93257605|NCT02235428|Tocolytic Agents|tocolytic agents|mesh-ancestor
93257606|NCT02235428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93257607|NCT02235428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93257608|NCT02235428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93257609|NCT02235428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93257610|NCT02235428|Adrenergic Agents|adrenergic agents|mesh-ancestor
93257611|NCT02235428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257612|NCT02235428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257613|NCT02235428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93257614|NCT02235428|Cholinergic Agents|cholinergic agents|mesh-ancestor
93257615|NCT03070171|Dabigatran|dabigatran|mesh-list
93257616|NCT03070171|Antithrombins|antithrombins|mesh-ancestor
92929578|NCT00728013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257617|NCT03070171|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93257618|NCT03070171|Protease Inhibitors|protease inhibitors|mesh-ancestor
93257619|NCT03070171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257620|NCT03070171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257621|NCT03070171|Anticoagulants|anticoagulants|mesh-ancestor
93257622|NCT02262572|Telmisartan|telmisartan|mesh-list
93257623|NCT02262572|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93257624|NCT02262572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93257625|NCT02262572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93257626|NCT02262572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93257627|NCT02262572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257628|NCT02262572|Diuretics|diuretics|mesh-ancestor
93257629|NCT02262572|Natriuretic Agents|natriuretic agents|mesh-ancestor
93257630|NCT02262572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257631|NCT02262572|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93257632|NCT02262572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257633|NCT02235584|Dexamethasone|dexamethasone|mesh-list
93257634|NCT02235584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257635|NCT02235584|Antiemetics|antiemetics|mesh-ancestor
93257636|NCT02235584|Autonomic Agents|autonomic agents|mesh-ancestor
93257637|NCT02235584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257638|NCT02235584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257639|NCT02235584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93257640|NCT02235584|Glucocorticoids|glucocorticoids|mesh-ancestor
93257641|NCT02235584|Hormones|hormones|mesh-ancestor
92552287|NCT00030914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257642|NCT02235584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257643|NCT02235584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93257644|NCT02235584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257645|NCT02235662|Tenofovir|tenofovir|mesh-list
93257646|NCT02235662|Levonorgestrel|levonorgestrel|mesh-list
93257647|NCT02235662|Antiviral Agents|antiviral agents|mesh-ancestor
93257648|NCT02235662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257649|NCT02235662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93257650|NCT02235662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93257651|NCT02235662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257652|NCT02235662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257653|NCT02235662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93257654|NCT02235662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93257655|NCT02235662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93257656|NCT02235662|Contraceptive Agents|contraceptive agents|mesh-ancestor
93257657|NCT02235662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93257658|NCT02235662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257659|NCT02235662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93257660|NCT02235662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93257661|NCT02235662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93257662|NCT02262650|Telmisartan|telmisartan|mesh-list
93257663|NCT02262650|Clopidogrel|clopidogrel|mesh-list
93257664|NCT02262650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93257665|NCT02262650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93257666|NCT02262650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93257667|NCT02262650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93257668|NCT02262650|Purinergic Agents|purinergic agents|mesh-ancestor
93257669|NCT02262650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257670|NCT02262650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257671|NCT02262650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257672|NCT02262650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93257673|NCT02262650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93257674|NCT02262650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93257675|NCT02784002|Fidaxomicin|fidaxomicin|mesh-list
93257676|NCT02784002|Ridinilazole|ridinilazole|mesh-list
93257677|NCT02784002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93257678|NCT02784002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257679|NCT02233556|Memantine|memantine|mesh-list
93257680|NCT02233556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93257681|NCT02233556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93257682|NCT02233556|Dopamine Agents|dopamine agents|mesh-ancestor
93257683|NCT02233556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257684|NCT02233556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257685|NCT02233556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257686|NCT02233556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93257687|NCT02233556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93257688|NCT04240288|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93257689|NCT04240288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93257690|NCT04240288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929652|NCT00731289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93257691|NCT04240288|Antitubercular Agents|antitubercular agents|mesh-ancestor
93257692|NCT02236052|Vaccines|vaccines|mesh-list
93257693|NCT02236052|Immunologic Factors|immunologic factors|mesh-ancestor
93257694|NCT02236052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257695|NCT04122196|Pregabalin|pregabalin|mesh-list
93257696|NCT04122196|Analgesics|analgesics|mesh-ancestor
93257697|NCT04122196|Sensory System Agents|sensory system agents|mesh-ancestor
93257698|NCT04122196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257699|NCT04122196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257700|NCT04122196|Anticonvulsants|anticonvulsants|mesh-ancestor
93257701|NCT04122196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92552359|NCT00058305|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93257702|NCT04122196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257703|NCT04122196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257704|NCT04122196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93257705|NCT04122196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93257706|NCT04122196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93257707|NCT04122196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257708|NCT04122196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257709|NCT04908592|Dexamethasone|dexamethasone|mesh-list
93257710|NCT04908592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257711|NCT04908592|Antiemetics|antiemetics|mesh-ancestor
93257712|NCT04908592|Autonomic Agents|autonomic agents|mesh-ancestor
93257713|NCT04908592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257714|NCT04908592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257715|NCT04908592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93257716|NCT04908592|Glucocorticoids|glucocorticoids|mesh-ancestor
93257717|NCT04908592|Hormones|hormones|mesh-ancestor
93257718|NCT04908592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257719|NCT04908592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93257720|NCT04908592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257721|NCT04759768|Naltrexone|naltrexone|mesh-list
93257722|NCT04759768|Nalmefene|nalmefene|mesh-list
93257723|NCT04759768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93257724|NCT04759768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257725|NCT04759768|Sensory System Agents|sensory system agents|mesh-ancestor
93257726|NCT04759768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257727|NCT04759768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93257728|NCT02564744|Rituximab|rituximab|mesh-list
93257729|NCT02564744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257730|NCT02564744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257731|NCT02564744|Immunologic Factors|immunologic factors|mesh-ancestor
93257732|NCT02564744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257733|NCT02564744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257734|NCT05759767|Tamsulosin|tamsulosin|mesh-list
93257735|NCT05759767|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93257736|NCT05759767|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93257737|NCT05759767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93257738|NCT05759767|Adrenergic Agents|adrenergic agents|mesh-ancestor
93257739|NCT05759767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257740|NCT05759767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257741|NCT05759767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257742|NCT05759767|Urological Agents|urological agents|mesh-ancestor
93257743|NCT02750306|Suvorexant|suvorexant|mesh-list
93257744|NCT02750306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93257745|NCT02750306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93257746|NCT02750306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257747|NCT02750306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257748|NCT02750306|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93257749|NCT02750306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257750|NCT02750306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257751|NCT03845140|Praziquantel|praziquantel|mesh-list
93257752|NCT03845140|Anthelmintics|anthelmintics|mesh-ancestor
93257753|NCT03845140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93257754|NCT03845140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257755|NCT01816165|Acipimox|acipimox|mesh-list
93257756|NCT01816165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257757|NCT01816165|Antimetabolites|antimetabolites|mesh-ancestor
93257758|NCT01816165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257759|NCT01816165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257760|NCT04476680|Vitamin D|vitamin d|mesh-list
93257761|NCT04476680|Vitamins|vitamins|mesh-ancestor
93257762|NCT04476680|Micronutrients|micronutrients|mesh-ancestor
93257763|NCT04476680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257764|NCT04476680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93257765|NCT04952350|Atorvastatin|atorvastatin|mesh-list
92929728|NCT00729339|Mosapride|mosapride|mesh-list
93257766|NCT04952350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93257767|NCT04952350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257768|NCT04952350|Antimetabolites|antimetabolites|mesh-ancestor
93257769|NCT04952350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257770|NCT04952350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257771|NCT04952350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93257772|NCT04952350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257773|NCT05376202|Cetuximab|cetuximab|mesh-list
93257774|NCT05376202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93257775|NCT05376202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257776|NCT04812808|Bazedoxifene|bazedoxifene|mesh-list
93257777|NCT04812808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93257778|NCT04812808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93257779|NCT04812808|Hormone Antagonists|hormone antagonists|mesh-ancestor
93257780|NCT04812808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93257781|NCT04812808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257782|NCT04812808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93257783|NCT04788550|Listerine|listerine|mesh-list
93257784|NCT04788550|Fluorides|fluorides|mesh-list
93257785|NCT04788550|Sodium Fluoride|sodium fluoride|mesh-list
93257786|NCT04788550|Fluorides, Topical|fluorides, topical|mesh-list
93257787|NCT04788550|Cariostatic Agents|cariostatic agents|mesh-ancestor
93257788|NCT04788550|Protective Agents|protective agents|mesh-ancestor
93257789|NCT04788550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257790|NCT04788550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93257791|NCT04788550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257792|NCT01677988|Folfirinox|folfirinox|mesh-list
93257793|NCT01677988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257794|NCT02233790|Clopidogrel|clopidogrel|mesh-list
93257795|NCT02233790|Ticagrelor|ticagrelor|mesh-list
93257796|NCT02233790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93257797|NCT02233790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93257798|NCT02233790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93257799|NCT02233790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93257800|NCT02233790|Purinergic Agents|purinergic agents|mesh-ancestor
93257801|NCT02233790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257802|NCT02233790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257803|NCT02233790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257804|NCT02547818|Ibuprofen|ibuprofen|mesh-list
93257805|NCT02547818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93257806|NCT02547818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93257807|NCT02547818|Analgesics|analgesics|mesh-ancestor
93257808|NCT02547818|Sensory System Agents|sensory system agents|mesh-ancestor
93257809|NCT02547818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257810|NCT02547818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257811|NCT02547818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257812|NCT02547818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93257813|NCT02547818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93257814|NCT02547818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257815|NCT02547818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257816|NCT04539808|Calcium, Dietary|calcium, dietary|mesh-list
93257817|NCT04539808|Leucovorin|leucovorin|mesh-list
93257818|NCT04539808|Folic Acid|folic acid|mesh-list
93257819|NCT04539808|Fluorouracil|fluorouracil|mesh-list
93257820|NCT04539808|Capecitabine|capecitabine|mesh-list
93257821|NCT04539808|Oxaliplatin|oxaliplatin|mesh-list
93257822|NCT04539808|Irinotecan|irinotecan|mesh-list
93257823|NCT04539808|Camptothecin|camptothecin|mesh-list
93257824|NCT04539808|Losartan|losartan|mesh-list
93257825|NCT04539808|Calcium|calcium|mesh-list
93257826|NCT04539808|Levoleucovorin|levoleucovorin|mesh-list
93257827|NCT04539808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93257828|NCT04539808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257829|NCT04539808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93257830|NCT04539808|Antimetabolites|antimetabolites|mesh-ancestor
93257831|NCT04539808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257832|NCT04539808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257833|NCT04539808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257834|NCT04539808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257835|NCT04539808|Immunologic Factors|immunologic factors|mesh-ancestor
93257836|NCT04539808|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93257837|NCT04539808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93257838|NCT04539808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257839|NCT04539808|Antidotes|antidotes|mesh-ancestor
93257840|NCT04539808|Protective Agents|protective agents|mesh-ancestor
93257841|NCT04539808|Vitamin B Complex|vitamin b complex|mesh-ancestor
93257842|NCT04539808|Vitamins|vitamins|mesh-ancestor
93257843|NCT04539808|Micronutrients|micronutrients|mesh-ancestor
93257844|NCT04539808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93257845|NCT04539808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93257846|NCT04539808|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93257847|NCT04539808|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93257848|NCT04539808|Hematinics|hematinics|mesh-ancestor
93257849|NCT04539808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93257850|NCT02520076|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93257851|NCT02520076|Protein C Inhibitor|protein c inhibitor|mesh-list
93257852|NCT02520076|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93257853|NCT02520076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93257854|NCT02520076|Protease Inhibitors|protease inhibitors|mesh-ancestor
93257855|NCT02520076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257856|NCT02520076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257857|NCT03752918|Niacin|niacin|mesh-list
93257858|NCT03752918|Nicotinic Acids|nicotinic acids|mesh-list
93257859|NCT03752918|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93257860|NCT03752918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93257861|NCT03752918|Antimetabolites|antimetabolites|mesh-ancestor
93257862|NCT03752918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257863|NCT03752918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93257864|NCT03752918|Vasodilator Agents|vasodilator agents|mesh-ancestor
93257865|NCT03752918|Vitamin B Complex|vitamin b complex|mesh-ancestor
93257866|NCT03752918|Vitamins|vitamins|mesh-ancestor
93257867|NCT03752918|Micronutrients|micronutrients|mesh-ancestor
93257868|NCT03752918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257869|NCT03752918|Hallucinogens|hallucinogens|mesh-ancestor
93257870|NCT03752918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257871|NCT03752918|Serotonin Agents|serotonin agents|mesh-ancestor
93257872|NCT03752918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257873|NCT03752918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93257874|NCT03752918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93257875|NCT03752918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93257876|NCT03752918|Adrenergic Agents|adrenergic agents|mesh-ancestor
93257877|NCT04259320|Propolis|propolis|mesh-list
93257878|NCT04259320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257879|NCT04058158|Eculizumab|eculizumab|mesh-list
93257880|NCT04058158|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93257881|NCT04058158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93257882|NCT04058158|Immunologic Factors|immunologic factors|mesh-ancestor
93257883|NCT04058158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257884|NCT02263196|Ethanol|ethanol|mesh-list
93257885|NCT02263196|Povidone-Iodine|povidone-iodine|mesh-list
93257886|NCT02263196|Povidone|povidone|mesh-list
93257887|NCT02263196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93257888|NCT02263196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257889|NCT02263196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257890|NCT02263196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257891|NCT02263196|Plasma Substitutes|plasma substitutes|mesh-ancestor
93257892|NCT02263196|Blood Substitutes|blood substitutes|mesh-ancestor
93257893|NCT05160506|Hydrocortisone|hydrocortisone|mesh-list
93257894|NCT05160506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93257895|NCT02926573|Gabapentin|gabapentin|mesh-list
93257896|NCT02926573|Analgesics|analgesics|mesh-ancestor
93257897|NCT02926573|Sensory System Agents|sensory system agents|mesh-ancestor
92552549|NCT00059592|Valacyclovir|valacyclovir|mesh-list
93257898|NCT02926573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257899|NCT02926573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257900|NCT02926573|Anticonvulsants|anticonvulsants|mesh-ancestor
93257901|NCT02926573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93257902|NCT02926573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93257903|NCT02926573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93257904|NCT02926573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93257905|NCT02926573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93257906|NCT02926573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93257907|NCT02926573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257908|NCT02926573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257909|NCT02926573|Antimanic Agents|antimanic agents|mesh-ancestor
93257910|NCT04477018|Iron|iron|mesh-list
93257911|NCT04477018|Chelating Agents|chelating agents|mesh-list
93257912|NCT04477018|Micronutrients|micronutrients|mesh-ancestor
93257913|NCT04477018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257914|NCT04477018|Trace Elements|trace elements|mesh-ancestor
93257915|NCT04477018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257916|NCT04477018|Sequestering Agents|sequestering agents|mesh-ancestor
93257917|NCT00158860|Valacyclovir|valacyclovir|mesh-list
93257918|NCT00158860|Antiviral Agents|antiviral agents|mesh-ancestor
93257919|NCT00158860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257921|NCT02490488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93257922|NCT02490488|Antimetabolites|antimetabolites|mesh-ancestor
93257923|NCT02490488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257924|NCT02490488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257925|NCT02471222|Amantadine|amantadine|mesh-list
93257926|NCT02471222|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93257927|NCT02471222|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93257928|NCT02471222|Antiviral Agents|antiviral agents|mesh-ancestor
93257929|NCT02471222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93257930|NCT02471222|Dopamine Agents|dopamine agents|mesh-ancestor
93257931|NCT02471222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257932|NCT02471222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257933|NCT02471222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257934|NCT02471222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93257935|NCT02471222|Analgesics|analgesics|mesh-ancestor
93257936|NCT02471222|Sensory System Agents|sensory system agents|mesh-ancestor
93257937|NCT02471222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257938|NCT03136120|Bromides|bromides|mesh-list
93257939|NCT03136120|Ipratropium|ipratropium|mesh-list
93257940|NCT03136120|Anticonvulsants|anticonvulsants|mesh-ancestor
93257941|NCT03136120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93257942|NCT03136120|Autonomic Agents|autonomic agents|mesh-ancestor
93257943|NCT03136120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257944|NCT03136120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257945|NCT03136120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93257946|NCT03136120|Respiratory System Agents|respiratory system agents|mesh-ancestor
93257947|NCT03136120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93257948|NCT03136120|Cholinergic Agents|cholinergic agents|mesh-ancestor
93257949|NCT03136120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257950|NCT03136120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257951|NCT01625234|Ensartinib|ensartinib|mesh-list
93257952|NCT01625234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257953|NCT01625234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93257954|NCT01625234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257955|NCT01625234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257956|NCT02264834|Sufentanil|sufentanil|mesh-list
93257957|NCT02264834|Dsuvia|dsuvia|mesh-list
93257958|NCT02264834|Levobupivacaine|levobupivacaine|mesh-list
93257959|NCT02264834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93257960|NCT02264834|Narcotics|narcotics|mesh-ancestor
93257961|NCT02264834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552622|NCT00031928|Mafosfamide|mafosfamide|mesh-list
93257962|NCT02264834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257963|NCT02264834|Analgesics|analgesics|mesh-ancestor
93257964|NCT02264834|Sensory System Agents|sensory system agents|mesh-ancestor
93257965|NCT02264834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93257966|NCT02264834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93257967|NCT02264834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93257968|NCT02264834|Anesthetics, General|anesthetics, general|mesh-ancestor
93257969|NCT02264834|Anesthetics|anesthetics|mesh-ancestor
93257970|NCT02264834|Anesthetics, Local|anesthetics, local|mesh-ancestor
93257971|NCT05762419|Etoposide|etoposide|mesh-list
93257972|NCT05762419|Etoposide phosphate|etoposide phosphate|mesh-list
93257973|NCT05762419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93257974|NCT05762419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93257975|NCT05762419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93257976|NCT05762419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93257977|NCT05762419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93257978|NCT05762419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257979|NCT02264912|Clopidogrel|clopidogrel|mesh-list
93257980|NCT02264912|Ticagrelor|ticagrelor|mesh-list
93257981|NCT02264912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93257982|NCT02264912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93257983|NCT02264912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93257984|NCT02264912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93257985|NCT02264912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93257986|NCT02264912|Purinergic Agents|purinergic agents|mesh-ancestor
93257987|NCT02264912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93257988|NCT02264912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257989|NCT02264912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257990|NCT02263352|Carotenoids|carotenoids|mesh-list
93257991|NCT02263352|Antioxidants|antioxidants|mesh-ancestor
93257992|NCT02263352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257993|NCT02263352|Protective Agents|protective agents|mesh-ancestor
93257994|NCT02263352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93257995|NCT01435226|Ribavirin|ribavirin|mesh-list
93257996|NCT01435226|Ledipasvir|ledipasvir|mesh-list
93257997|NCT01435226|Antimetabolites|antimetabolites|mesh-ancestor
93257998|NCT01435226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93257999|NCT01435226|Antiviral Agents|antiviral agents|mesh-ancestor
93258000|NCT01435226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258001|NCT01679002|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
93258002|NCT01679002|Oxcarbazepine|oxcarbazepine|mesh-list
93258003|NCT01679002|Anticonvulsants|anticonvulsants|mesh-ancestor
93258004|NCT01679002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93258005|NCT01679002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93258006|NCT01679002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258007|NCT01679002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258008|NCT01679002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93258009|NCT01679002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93258010|NCT04409509|Antibodies|antibodies|mesh-list
93258011|NCT04409509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93258012|NCT04409509|Immunologic Factors|immunologic factors|mesh-ancestor
93258013|NCT04409509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258014|NCT04401865|Riboflavin|riboflavin|mesh-list
93258015|NCT04401865|Vitamin B Complex|vitamin b complex|mesh-ancestor
93258016|NCT04401865|Vitamins|vitamins|mesh-ancestor
93258017|NCT04401865|Micronutrients|micronutrients|mesh-ancestor
93258018|NCT04401865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258019|NCT04401865|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93258020|NCT04401865|Dermatologic Agents|dermatologic agents|mesh-ancestor
93258021|NCT02609048|Seladelpar|seladelpar|mesh-list
93258022|NCT02609048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93258023|NCT02609048|Antimetabolites|antimetabolites|mesh-ancestor
93258024|NCT02609048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258025|NCT02609048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93258026|NCT02265068|Ticagrelor|ticagrelor|mesh-list
93258027|NCT02265068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93258028|NCT02265068|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93258029|NCT02265068|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93258030|NCT02265068|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93258031|NCT02265068|Purinergic Agents|purinergic agents|mesh-ancestor
93258032|NCT02265068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258033|NCT02265068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258034|NCT02265068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258035|NCT02262416|Leuprolide|leuprolide|mesh-list
93258036|NCT02262416|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93258037|NCT02262416|Fertility Agents|fertility agents|mesh-ancestor
93258038|NCT02262416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93258039|NCT02262416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258040|NCT02262416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258041|NCT02262416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258042|NCT01577654|Folic Acid|folic acid|mesh-list
93258043|NCT01577654|Docetaxel|docetaxel|mesh-list
93258044|NCT01577654|Vinca Alkaloids|vinca alkaloids|mesh-list
93258045|NCT01577654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258046|NCT01577654|Tubulin Modulators|tubulin modulators|mesh-ancestor
93258047|NCT01577654|Antimitotic Agents|antimitotic agents|mesh-ancestor
93258048|NCT01577654|Mitosis Modulators|mitosis modulators|mesh-ancestor
93258049|NCT01577654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258050|NCT01577654|Hematinics|hematinics|mesh-ancestor
93258051|NCT01577654|Vitamin B Complex|vitamin b complex|mesh-ancestor
93258052|NCT01577654|Vitamins|vitamins|mesh-ancestor
93258053|NCT01577654|Micronutrients|micronutrients|mesh-ancestor
93258054|NCT01577654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258055|NCT01423058|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
93258056|NCT01423058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258057|NCT01423058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258058|NCT01423058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258059|NCT04413292|BIRC5 protein, human|birc5 protein, human|mesh-list
93258060|NCT04413292|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93258061|NCT04413292|Protease Inhibitors|protease inhibitors|mesh-ancestor
93258062|NCT04413292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258063|NCT04413292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258064|NCT01418222|Leucovorin|leucovorin|mesh-list
93258065|NCT01418222|Bevacizumab|bevacizumab|mesh-list
93258066|NCT01418222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258067|NCT01418222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258068|NCT01418222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93258069|NCT01418222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93258070|NCT01418222|Growth Substances|growth substances|mesh-ancestor
93258071|NCT01418222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258072|NCT01418222|Growth Inhibitors|growth inhibitors|mesh-ancestor
93258073|NCT01418222|Antidotes|antidotes|mesh-ancestor
93258074|NCT01418222|Protective Agents|protective agents|mesh-ancestor
93258075|NCT01418222|Vitamin B Complex|vitamin b complex|mesh-ancestor
93258077|NCT01418222|Micronutrients|micronutrients|mesh-ancestor
93258078|NCT05377606|Temazepam|temazepam|mesh-list
93258079|NCT05377606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93258080|NCT05377606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258081|NCT05377606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258082|NCT05377606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93258083|NCT05377606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93258084|NCT05377606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93258085|NCT05377606|GABA Modulators|gaba modulators|mesh-ancestor
93258086|NCT05377606|GABA Agents|gaba agents|mesh-ancestor
93258087|NCT05377606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258088|NCT05377606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258089|NCT01256762|Paclitaxel|paclitaxel|mesh-list
93258090|NCT01256762|Bevacizumab|bevacizumab|mesh-list
93258091|NCT01256762|Imetelstat|imetelstat|mesh-list
93258092|NCT01256762|Motesanib diphosphate|motesanib diphosphate|mesh-list
93258093|NCT01256762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93258094|NCT01256762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258095|NCT01256762|Tubulin Modulators|tubulin modulators|mesh-ancestor
93258096|NCT01256762|Antimitotic Agents|antimitotic agents|mesh-ancestor
93258097|NCT01256762|Mitosis Modulators|mitosis modulators|mesh-ancestor
93258098|NCT01256762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258099|NCT01256762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258100|NCT01256762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93258101|NCT01256762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93258102|NCT01256762|Growth Substances|growth substances|mesh-ancestor
93258103|NCT01256762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258104|NCT01256762|Growth Inhibitors|growth inhibitors|mesh-ancestor
93258105|NCT01256762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258106|NCT01256762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258107|NCT01252628|Cetuximab|cetuximab|mesh-list
93258108|NCT01252628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258109|NCT01252628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552752|NCT00060294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258110|NCT01236638|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
93258111|NCT01236638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258112|NCT01236638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258113|NCT01236638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258114|NCT04349371|Chloroquine|chloroquine|mesh-list
93258115|NCT04349371|Amebicides|amebicides|mesh-ancestor
93258116|NCT04349371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93258117|NCT04349371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93258118|NCT04349371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258119|NCT04349371|Antimalarials|antimalarials|mesh-ancestor
93258120|NCT04349371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93258121|NCT01410188|Latanoprost|latanoprost|mesh-list
93258122|NCT01410188|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93258123|NCT01410188|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93258124|NCT01408082|Azithromycin|azithromycin|mesh-list
93258125|NCT01408082|Dexamethasone|dexamethasone|mesh-list
93258126|NCT01408082|Dexamethasone acetate|dexamethasone acetate|mesh-list
93258127|NCT01408082|BB 1101|bb 1101|mesh-list
93258128|NCT01408082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258129|NCT01408082|Antiemetics|antiemetics|mesh-ancestor
93258130|NCT01408082|Autonomic Agents|autonomic agents|mesh-ancestor
93258131|NCT01408082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258132|NCT01408082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258133|NCT01408082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258134|NCT01408082|Glucocorticoids|glucocorticoids|mesh-ancestor
93258135|NCT01408082|Hormones|hormones|mesh-ancestor
93258136|NCT01408082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258137|NCT01408082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258138|NCT01408082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258139|NCT01408082|Protease Inhibitors|protease inhibitors|mesh-ancestor
93258140|NCT01408082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258141|NCT01408082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258142|NCT01408082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93258143|NCT01408082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258144|NCT03071263|Spironolactone|spironolactone|mesh-list
93258145|NCT03071263|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93258146|NCT03071263|Hormone Antagonists|hormone antagonists|mesh-ancestor
93258147|NCT03071263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258148|NCT03071263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258149|NCT03071263|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93258150|NCT03071263|Diuretics|diuretics|mesh-ancestor
93258151|NCT03071263|Natriuretic Agents|natriuretic agents|mesh-ancestor
93258152|NCT05200663|Tamoxifen|tamoxifen|mesh-list
93258153|NCT05200663|Vitamin E|vitamin e|mesh-list
93258154|NCT05200663|Vitamins|vitamins|mesh-ancestor
93258155|NCT05200663|Micronutrients|micronutrients|mesh-ancestor
93258156|NCT05200663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258157|NCT05200663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93258158|NCT05200663|Hormone Antagonists|hormone antagonists|mesh-ancestor
93258159|NCT05200663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258160|NCT05200663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258161|NCT05200663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258162|NCT05200663|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93258163|NCT05200663|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93258164|NCT05200663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93258165|NCT05200663|Antioxidants|antioxidants|mesh-ancestor
93258166|NCT05200663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258167|NCT05200663|Protective Agents|protective agents|mesh-ancestor
93258168|NCT02268422|Buprenorphine|buprenorphine|mesh-list
93258169|NCT02268422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93258170|NCT02268422|Narcotics|narcotics|mesh-ancestor
93258171|NCT02268422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258172|NCT02268422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258173|NCT02268422|Analgesics|analgesics|mesh-ancestor
93258174|NCT02268422|Sensory System Agents|sensory system agents|mesh-ancestor
93258175|NCT02268422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258176|NCT02268422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93258177|NCT01522196|Varespladib methyl|varespladib methyl|mesh-list
93258178|NCT01522196|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93258179|NCT01522196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258180|NCT01522196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258181|NCT05049343|Ketamine|ketamine|mesh-list
93258182|NCT05049343|Analgesics|analgesics|mesh-ancestor
93258183|NCT05049343|Sensory System Agents|sensory system agents|mesh-ancestor
93258184|NCT05049343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258185|NCT05049343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258186|NCT05049343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93258187|NCT05049343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93258188|NCT05049343|Anesthetics, General|anesthetics, general|mesh-ancestor
93258189|NCT05049343|Anesthetics|anesthetics|mesh-ancestor
93258190|NCT05049343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258191|NCT05049343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93258192|NCT05049343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93258193|NCT05049343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258194|NCT05049343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258195|NCT01569919|Folic Acid|folic acid|mesh-list
93258196|NCT01569919|Vitamin B 12|vitamin b 12|mesh-list
93258197|NCT01569919|Dexamethasone|dexamethasone|mesh-list
93258198|NCT01569919|Pemetrexed|pemetrexed|mesh-list
93258199|NCT01569919|Vitamins|vitamins|mesh-ancestor
93258200|NCT01569919|Micronutrients|micronutrients|mesh-ancestor
93258201|NCT01569919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258202|NCT01569919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258203|NCT01569919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258204|NCT01569919|Antiemetics|antiemetics|mesh-ancestor
93258205|NCT01569919|Autonomic Agents|autonomic agents|mesh-ancestor
93258206|NCT01569919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258207|NCT01569919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258208|NCT01569919|Glucocorticoids|glucocorticoids|mesh-ancestor
93258209|NCT01569919|Hormones|hormones|mesh-ancestor
93258210|NCT01569919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258211|NCT01569919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258212|NCT01569919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258213|NCT01569919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258214|NCT01569919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93258215|NCT01569919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93258216|NCT01569919|Hematinics|hematinics|mesh-ancestor
93258217|NCT01569919|Vitamin B Complex|vitamin b complex|mesh-ancestor
93258218|NCT01399580|Atrasentan|atrasentan|mesh-list
93258219|NCT01399580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258220|NCT01399580|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93258221|NCT01399580|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93258222|NCT01399580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258223|NCT04069585|Lidocaine|lidocaine|mesh-list
93258224|NCT04069585|Anesthetics|anesthetics|mesh-list
93258225|NCT04069585|Anesthetics, Local|anesthetics, local|mesh-ancestor
93258226|NCT04069585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258227|NCT04069585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258228|NCT04069585|Sensory System Agents|sensory system agents|mesh-ancestor
93258229|NCT04069585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258230|NCT04069585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93258231|NCT04069585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93258232|NCT04069585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93258233|NCT04069585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258234|NCT04069585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258235|NCT00157196|Cyclophosphamide|cyclophosphamide|mesh-list
93258236|NCT00157196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258237|NCT00157196|Immunologic Factors|immunologic factors|mesh-ancestor
93258238|NCT00157196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258239|NCT00157196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93258240|NCT00157196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93258241|NCT00157196|Alkylating Agents|alkylating agents|mesh-ancestor
93258242|NCT00157196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258243|NCT00157196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258244|NCT00157196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93258245|NCT02265770|Cyclophosphamide|cyclophosphamide|mesh-list
93258246|NCT02265770|Cisplatin|cisplatin|mesh-list
93258247|NCT02265770|Carboplatin|carboplatin|mesh-list
93258248|NCT02265770|Methotrexate|methotrexate|mesh-list
93258249|NCT02265770|Etoposide|etoposide|mesh-list
93258250|NCT02265770|Etoposide phosphate|etoposide phosphate|mesh-list
93258251|NCT02265770|Vincristine|vincristine|mesh-list
93258252|NCT02265770|Valproic Acid|valproic acid|mesh-list
93258253|NCT02265770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258254|NCT02265770|Immunologic Factors|immunologic factors|mesh-ancestor
93258255|NCT02265770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258256|NCT02265770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93258257|NCT02265770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93258258|NCT02265770|Alkylating Agents|alkylating agents|mesh-ancestor
93258259|NCT02265770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258260|NCT02265770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258261|NCT02265770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93258262|NCT02265770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93258263|NCT02265770|Abortifacient Agents|abortifacient agents|mesh-ancestor
93258264|NCT02265770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93258265|NCT02265770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258266|NCT02265770|Antimetabolites|antimetabolites|mesh-ancestor
93258267|NCT02265770|Dermatologic Agents|dermatologic agents|mesh-ancestor
93258268|NCT02265770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258269|NCT02265770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93258270|NCT02265770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93258271|NCT02265770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93258272|NCT02265770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93258273|NCT02265770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93258274|NCT02265770|Tubulin Modulators|tubulin modulators|mesh-ancestor
93258275|NCT02265770|Antimitotic Agents|antimitotic agents|mesh-ancestor
93258276|NCT02265770|Mitosis Modulators|mitosis modulators|mesh-ancestor
93258277|NCT02265770|Anticonvulsants|anticonvulsants|mesh-ancestor
93258278|NCT02265770|GABA Agents|gaba agents|mesh-ancestor
93258279|NCT02265770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258280|NCT02265770|Antimanic Agents|antimanic agents|mesh-ancestor
93258281|NCT02265770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93258282|NCT02265770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258283|NCT02265770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93258284|NCT03066193|Palmidrol|palmidrol|mesh-list
93258285|NCT03066193|Dronabinol|dronabinol|mesh-list
93258286|NCT03066193|Hallucinogens|hallucinogens|mesh-ancestor
93258287|NCT03066193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258288|NCT03066193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93258289|NCT03066193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93258290|NCT03066193|Analgesics|analgesics|mesh-ancestor
93258291|NCT03066193|Sensory System Agents|sensory system agents|mesh-ancestor
93258292|NCT03066193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258293|NCT03066193|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92930256|NCT04384692|Antimetabolites|antimetabolites|mesh-ancestor
93258294|NCT03066193|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93258295|NCT03066193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258296|NCT03066193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258297|NCT03066193|Hormones|hormones|mesh-ancestor
93258298|NCT03066193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258299|NCT03066193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93258300|NCT03066193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258301|NCT03066193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93258302|NCT03066193|Antiviral Agents|antiviral agents|mesh-ancestor
93258303|NCT03066193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258304|NCT02263976|Bromides|bromides|mesh-list
93258305|NCT02263976|Tiotropium Bromide|tiotropium bromide|mesh-list
93258306|NCT02263976|Methacholine Chloride|methacholine chloride|mesh-list
93258307|NCT02263976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93258308|NCT02263976|Autonomic Agents|autonomic agents|mesh-ancestor
93258309|NCT02263976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258310|NCT02263976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258311|NCT02263976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93258312|NCT02263976|Respiratory System Agents|respiratory system agents|mesh-ancestor
93258313|NCT02263976|Parasympatholytics|parasympatholytics|mesh-ancestor
93258314|NCT02263976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93258315|NCT02263976|Cholinergic Agents|cholinergic agents|mesh-ancestor
93258316|NCT02263976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258317|NCT02263976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258318|NCT02263976|Anticonvulsants|anticonvulsants|mesh-ancestor
93258319|NCT02263976|Miotics|miotics|mesh-ancestor
93258320|NCT02263976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93258321|NCT02263976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93258322|NCT02263976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93258323|NCT02263976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93258324|NCT01382654|Azelastine|azelastine|mesh-list
93258325|NCT01382654|Epinastine|epinastine|mesh-list
93258326|NCT01382654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93258327|NCT01382654|Autonomic Agents|autonomic agents|mesh-ancestor
93258328|NCT01382654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258329|NCT01382654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258330|NCT01382654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93258331|NCT01382654|Respiratory System Agents|respiratory system agents|mesh-ancestor
93258332|NCT01382654|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93258333|NCT01382654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258334|NCT01382654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258335|NCT01382654|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93258336|NCT01382654|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93258337|NCT01382654|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93258338|NCT01382654|Histamine Antagonists|histamine antagonists|mesh-ancestor
93258339|NCT01382654|Histamine Agents|histamine agents|mesh-ancestor
93258340|NCT01382654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258341|NCT01378676|Riluzole|riluzole|mesh-list
93258342|NCT01378676|Anticonvulsants|anticonvulsants|mesh-ancestor
93258343|NCT01378676|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93258344|NCT01378676|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93258345|NCT01378676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258346|NCT01378676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258347|NCT01378676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258348|NCT01378676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93258349|NCT01378676|Protective Agents|protective agents|mesh-ancestor
93258350|NCT01377662|Methylphenidate|methylphenidate|mesh-list
93258351|NCT01377662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93258352|NCT01377662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258353|NCT01377662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93258354|NCT01377662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93258355|NCT01377662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258356|NCT01377662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258357|NCT01377662|Dopamine Agents|dopamine agents|mesh-ancestor
93258358|NCT01377662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258359|NCT01371578|Ribavirin|ribavirin|mesh-list
93258360|NCT01371578|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93258361|NCT01371578|Ledipasvir|ledipasvir|mesh-list
93258362|NCT01371578|Antimetabolites|antimetabolites|mesh-ancestor
93258363|NCT01371578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258364|NCT01371578|Antiviral Agents|antiviral agents|mesh-ancestor
93258365|NCT01371578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258366|NCT01225640|Oxazolidinones|oxazolidinones|mesh-list
93258367|NCT01225640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258368|NCT01225640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93258369|NCT01225640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258370|NCT01225640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258371|NCT01498328|Bevacizumab|bevacizumab|mesh-list
93258372|NCT01498328|Rindopepimut|rindopepimut|mesh-list
93258373|NCT01498328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258374|NCT01498328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258375|NCT01498328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93258376|NCT01498328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92553046|NCT00061152|Capsaicin|capsaicin|mesh-list
93258377|NCT01498328|Growth Substances|growth substances|mesh-ancestor
93258378|NCT01498328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258379|NCT01498328|Growth Inhibitors|growth inhibitors|mesh-ancestor
93258380|NCT01497704|Apatinib|apatinib|mesh-list
93258381|NCT01497704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258382|NCT01497704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258383|NCT01497704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258384|NCT01497704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258385|NCT02266160|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93258386|NCT02266160|Anesthetics, Local|anesthetics, local|mesh-ancestor
93258387|NCT02266160|Anesthetics|anesthetics|mesh-ancestor
93258388|NCT02266160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258389|NCT02266160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258390|NCT02266160|Sensory System Agents|sensory system agents|mesh-ancestor
93258391|NCT02266160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258392|NCT02266160|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93258393|NCT03911713|Ivacaftor|ivacaftor|mesh-list
93258394|NCT03911713|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93258395|NCT03911713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258396|NCT03911713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258397|NCT02264132|Pramipexole|pramipexole|mesh-list
93258398|NCT02264132|Antioxidants|antioxidants|mesh-ancestor
93258399|NCT02264132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258400|NCT02264132|Protective Agents|protective agents|mesh-ancestor
93258401|NCT02264132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258402|NCT02264132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93258403|NCT02264132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93258404|NCT02264132|Dopamine Agonists|dopamine agonists|mesh-ancestor
93258405|NCT02264132|Dopamine Agents|dopamine agents|mesh-ancestor
93258406|NCT02264132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258407|NCT01192880|Antipsychotic Agents|antipsychotic agents|mesh-list
93258408|NCT01192880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93258409|NCT01192880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258410|NCT01192880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258411|NCT01192880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93258412|NCT04540744|Tadalafil|tadalafil|mesh-list
93258413|NCT04540744|Macitentan|macitentan|mesh-list
93258414|NCT04540744|Vasodilator Agents|vasodilator agents|mesh-ancestor
93258415|NCT04540744|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93258416|NCT04540744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93258417|NCT04540744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258418|NCT04540744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258419|NCT04540744|Urological Agents|urological agents|mesh-ancestor
93258420|NCT04540744|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93258421|NCT04540744|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93258422|NCT04540744|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93258423|NCT05375734|Tislelizumab|tislelizumab|mesh-list
93258424|NCT05375734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258425|NCT05375734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258426|NCT01489046|Tenofovir|tenofovir|mesh-list
93258427|NCT01489046|Lamivudine|lamivudine|mesh-list
93258428|NCT01489046|Efavirenz|efavirenz|mesh-list
93258429|NCT01489046|Antiviral Agents|antiviral agents|mesh-ancestor
93258430|NCT01489046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258431|NCT01489046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93258432|NCT01489046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93258433|NCT01489046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258434|NCT01489046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258435|NCT01489046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93258436|NCT01489046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93258437|NCT01489046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93258438|NCT01489046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93258439|NCT01489046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93258440|NCT01489046|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93258441|NCT01489046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93258442|NCT01489046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93258444|NCT01180634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93258445|NCT01180634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258446|NCT01180634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93258447|NCT01180634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93258448|NCT01180634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93258449|NCT01180634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258450|NCT01180634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258451|NCT01180634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258452|NCT01180634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93258453|NCT01180634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93258454|NCT02268890|Bortezomib|bortezomib|mesh-list
93258455|NCT02268890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258456|NCT02268968|Lidocaine|lidocaine|mesh-list
93258457|NCT02268968|Anesthetics, Local|anesthetics, local|mesh-ancestor
93258458|NCT02268968|Anesthetics|anesthetics|mesh-ancestor
93258459|NCT02268968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258460|NCT02268968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258461|NCT02268968|Sensory System Agents|sensory system agents|mesh-ancestor
93258462|NCT02268968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258463|NCT02268968|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93258464|NCT02268968|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93258465|NCT02268968|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93258466|NCT02268968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258467|NCT02268968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258468|NCT01359566|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
93258469|NCT01359566|Baclofen|baclofen|mesh-list
93258470|NCT01359566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93258471|NCT01359566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258472|NCT01359566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93258473|NCT01359566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258474|NCT01359566|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93258475|NCT01359566|GABA Agonists|gaba agonists|mesh-ancestor
93258476|NCT01359566|GABA Agents|gaba agents|mesh-ancestor
93258477|NCT01359566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258478|NCT01359566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258479|NCT04885816|Sirolimus|sirolimus|mesh-list
93258480|NCT04885816|Everolimus|everolimus|mesh-list
93258481|NCT04885816|MTOR Inhibitors|mtor inhibitors|mesh-list
93258482|NCT04885816|Temsirolimus|temsirolimus|mesh-list
93258483|NCT04885816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258484|NCT04885816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258485|NCT04885816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258486|NCT04885816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258487|NCT04885816|Immunologic Factors|immunologic factors|mesh-ancestor
93258488|NCT04885816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258489|NCT04885816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258490|NCT04885816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93258491|NCT04885816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258492|NCT04885816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93258493|NCT04885816|Antifungal Agents|antifungal agents|mesh-ancestor
93258494|NCT04865614|Sevoflurane|sevoflurane|mesh-list
93258495|NCT04865614|Etomidate|etomidate|mesh-list
93258496|NCT04865614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93258497|NCT04865614|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93258498|NCT04865614|Anesthetics, General|anesthetics, general|mesh-ancestor
93258499|NCT04865614|Anesthetics|anesthetics|mesh-ancestor
93258500|NCT04865614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258501|NCT04865614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258502|NCT04865614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93258503|NCT04865614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93258504|NCT02269046|Simvastatin|simvastatin|mesh-list
93258505|NCT02269046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93258506|NCT02269046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93258507|NCT02269046|Antimetabolites|antimetabolites|mesh-ancestor
93258508|NCT02269046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258509|NCT02269046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93258510|NCT02269046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93258511|NCT02269046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258512|NCT01483742|Ritonavir|ritonavir|mesh-list
93258513|NCT01483742|Ribavirin|ribavirin|mesh-list
92930482|NCT05224401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93258514|NCT01483742|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93258515|NCT01483742|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93258516|NCT01483742|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93258517|NCT01483742|Protease Inhibitors|protease inhibitors|mesh-ancestor
93258518|NCT01483742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258519|NCT01483742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258521|NCT01483742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93258522|NCT01483742|Antiviral Agents|antiviral agents|mesh-ancestor
93258523|NCT01483742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258524|NCT01483742|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93258525|NCT01483742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93258526|NCT01483742|Antimetabolites|antimetabolites|mesh-ancestor
93258527|NCT04691128|Anesthetics|anesthetics|mesh-list
93258528|NCT04691128|Propofol|propofol|mesh-list
93258529|NCT04691128|Desflurane|desflurane|mesh-list
93258530|NCT04691128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258531|NCT04691128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258532|NCT04691128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93258533|NCT04691128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93258534|NCT04691128|Anesthetics, General|anesthetics, general|mesh-ancestor
93258535|NCT04691128|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93258536|NCT04207918|Nimotuzumab|nimotuzumab|mesh-list
93258537|NCT04207918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258538|NCT04207918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258539|NCT02269202|Midazolam|midazolam|mesh-list
93258540|NCT02269202|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93258541|NCT02269202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93258542|NCT02269202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258543|NCT02269202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258544|NCT02269202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93258545|NCT02269202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93258546|NCT02269202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93258547|NCT02269202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93258548|NCT02269202|Anesthetics, General|anesthetics, general|mesh-ancestor
93258549|NCT02269202|Anesthetics|anesthetics|mesh-ancestor
93258550|NCT02269202|GABA Modulators|gaba modulators|mesh-ancestor
93258551|NCT02269202|GABA Agents|gaba agents|mesh-ancestor
93258552|NCT02269202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258553|NCT02269202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258554|NCT03614923|Mometasone Furoate|mometasone furoate|mesh-list
93258555|NCT03614923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258556|NCT03614923|Dermatologic Agents|dermatologic agents|mesh-ancestor
93258557|NCT03614923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93258558|NCT01353248|Ribavirin|ribavirin|mesh-list
93258559|NCT01353248|Ledipasvir|ledipasvir|mesh-list
93258560|NCT01353248|Antimetabolites|antimetabolites|mesh-ancestor
93258561|NCT01353248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258562|NCT01353248|Antiviral Agents|antiviral agents|mesh-ancestor
93258563|NCT01353248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258564|NCT05095636|Apatinib|apatinib|mesh-list
93258565|NCT05095636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258566|NCT05095636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258567|NCT05095636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258568|NCT05095636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258569|NCT01343966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93258570|NCT01343966|Immunologic Factors|immunologic factors|mesh-ancestor
93258571|NCT01343966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258572|NCT05095480|Red yeast rice|red yeast rice|mesh-list
92553223|NCT02971397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258573|NCT05095480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93258574|NCT05095480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93258575|NCT05095480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93258576|NCT05095480|Antimetabolites|antimetabolites|mesh-ancestor
93258577|NCT05095480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258578|NCT05095480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258579|NCT05095480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93258580|NCT02915016|Vaccines|vaccines|mesh-list
93258581|NCT02915016|MF59 oil emulsion|mf59 oil emulsion|mesh-list
93258582|NCT02915016|Immunologic Factors|immunologic factors|mesh-ancestor
93258583|NCT02915016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258584|NCT02915016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93258585|NCT02269280|Azacitidine|azacitidine|mesh-list
93258586|NCT02269280|Decitabine|decitabine|mesh-list
93258587|NCT02269280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258588|NCT02269280|Antimetabolites|antimetabolites|mesh-ancestor
93258589|NCT02269280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258591|NCT02269280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258592|NCT01170650|Doxorubicin|doxorubicin|mesh-list
93258593|NCT01170650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93258594|NCT01170650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93258595|NCT01170650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258596|NCT01170650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93258597|NCT01170650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93258598|NCT01170650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258599|NCT01170650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258600|NCT04533646|Insulin|insulin|mesh-list
93258601|NCT04533646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93258602|NCT04533646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258603|NCT01168310|Fluticasone|fluticasone|mesh-list
93258604|NCT01168310|Xhance|xhance|mesh-list
93258605|NCT01168310|Formoterol Fumarate|formoterol fumarate|mesh-list
93258606|NCT01168310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258607|NCT01168310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93258608|NCT01168310|Autonomic Agents|autonomic agents|mesh-ancestor
93258609|NCT01168310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258610|NCT01168310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258611|NCT01168310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93258612|NCT01168310|Respiratory System Agents|respiratory system agents|mesh-ancestor
93258613|NCT01168310|Dermatologic Agents|dermatologic agents|mesh-ancestor
93258614|NCT01168310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93258615|NCT01168310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93258616|NCT01168310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93258617|NCT01168310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93258618|NCT01168310|Adrenergic Agents|adrenergic agents|mesh-ancestor
93258619|NCT01168310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258620|NCT01168310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258621|NCT01472198|Gemcitabine|gemcitabine|mesh-list
93258622|NCT01472198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258623|NCT01472198|Antimetabolites|antimetabolites|mesh-ancestor
93258624|NCT01472198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258625|NCT01472198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258626|NCT02269358|Methotrexate|methotrexate|mesh-list
93258627|NCT02269358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93258628|NCT02269358|Abortifacient Agents|abortifacient agents|mesh-ancestor
93258629|NCT02269358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93258630|NCT02269358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258631|NCT02269358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258632|NCT02269358|Antimetabolites|antimetabolites|mesh-ancestor
93258633|NCT02269358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258634|NCT02269358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258635|NCT02269358|Dermatologic Agents|dermatologic agents|mesh-ancestor
93258636|NCT02269358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258637|NCT02269358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93258638|NCT02269358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258639|NCT02269358|Immunologic Factors|immunologic factors|mesh-ancestor
93258640|NCT02269358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93258641|NCT02269358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93258642|NCT04504240|Famotidine|famotidine|mesh-list
93258643|NCT04504240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93258644|NCT04504240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258645|NCT04504240|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93258646|NCT04504240|Histamine Antagonists|histamine antagonists|mesh-ancestor
93258647|NCT04504240|Histamine Agents|histamine agents|mesh-ancestor
93258648|NCT04504240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258649|NCT04504240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258650|NCT04504240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258651|NCT02088060|Cannabidiol|cannabidiol|mesh-list
93258652|NCT02088060|Olanzapine|olanzapine|mesh-list
93258653|NCT02088060|Antiemetics|antiemetics|mesh-ancestor
93258654|NCT02088060|Autonomic Agents|autonomic agents|mesh-ancestor
93258655|NCT02088060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258656|NCT02088060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258657|NCT02088060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258658|NCT02088060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93258659|NCT02088060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93258660|NCT02088060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258661|NCT02088060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93258662|NCT02088060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93258663|NCT02088060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93258664|NCT02088060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258665|NCT02088060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258666|NCT02088060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258667|NCT02088060|Serotonin Agents|serotonin agents|mesh-ancestor
93258668|NCT02088060|Anticonvulsants|anticonvulsants|mesh-ancestor
93258669|NCT02264522|Dialysis Solutions|dialysis solutions|mesh-list
93258670|NCT02264522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93258672|NCT02269514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93258673|NCT02269514|Autonomic Agents|autonomic agents|mesh-ancestor
93258674|NCT02269514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258675|NCT02269514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258676|NCT02269514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93258677|NCT02269514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93258678|NCT02269514|Cholinergic Agents|cholinergic agents|mesh-ancestor
93258679|NCT02269514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258680|NCT02269514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258681|NCT01332812|Dexamethasone|dexamethasone|mesh-list
93258682|NCT01332812|Dexamethasone acetate|dexamethasone acetate|mesh-list
93258683|NCT01332812|BB 1101|bb 1101|mesh-list
93258684|NCT01332812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258685|NCT01332812|Antiemetics|antiemetics|mesh-ancestor
93258686|NCT01332812|Autonomic Agents|autonomic agents|mesh-ancestor
93258687|NCT01332812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258688|NCT01332812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258689|NCT01332812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258690|NCT01332812|Glucocorticoids|glucocorticoids|mesh-ancestor
93258691|NCT01332812|Hormones|hormones|mesh-ancestor
93258692|NCT01332812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258693|NCT01332812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258694|NCT01332812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258695|NCT01332812|Protease Inhibitors|protease inhibitors|mesh-ancestor
93258696|NCT01332812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258697|NCT01332812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258698|NCT03408652|Zoledronic Acid|zoledronic acid|mesh-list
93258699|NCT03408652|Denosumab|denosumab|mesh-list
93258700|NCT03408652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93258701|NCT03408652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258702|NCT01332656|Paclitaxel|paclitaxel|mesh-list
93258703|NCT01332656|Carboplatin|carboplatin|mesh-list
93258704|NCT01332656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93258705|NCT01332656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258706|NCT01332656|Tubulin Modulators|tubulin modulators|mesh-ancestor
93258707|NCT01332656|Antimitotic Agents|antimitotic agents|mesh-ancestor
93258708|NCT01332656|Mitosis Modulators|mitosis modulators|mesh-ancestor
93258709|NCT01332656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258710|NCT02084472|Petrolatum|petrolatum|mesh-list
93258711|NCT02084472|Glycerol|glycerol|mesh-list
93258712|NCT02084472|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93258713|NCT02084472|Protective Agents|protective agents|mesh-ancestor
93258714|NCT02084472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258715|NCT02084472|Emollients|emollients|mesh-ancestor
93258716|NCT02084472|Dermatologic Agents|dermatologic agents|mesh-ancestor
93258717|NCT02266784|Nicotine|nicotine|mesh-list
93258718|NCT02266784|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93258719|NCT02266784|Autonomic Agents|autonomic agents|mesh-ancestor
93258720|NCT02266784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258721|NCT02266784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258722|NCT02266784|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93258723|NCT02266784|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93258724|NCT02266784|Cholinergic Agents|cholinergic agents|mesh-ancestor
93258725|NCT02266784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258726|NCT02266784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258727|NCT02090790|Dexamethasone|dexamethasone|mesh-list
93258728|NCT02090790|Dexamethasone acetate|dexamethasone acetate|mesh-list
93258729|NCT02090790|BB 1101|bb 1101|mesh-list
93258730|NCT02090790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93258731|NCT02090790|Antiemetics|antiemetics|mesh-ancestor
93258732|NCT02090790|Autonomic Agents|autonomic agents|mesh-ancestor
93258733|NCT02090790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258734|NCT02090790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258735|NCT02090790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258736|NCT02090790|Glucocorticoids|glucocorticoids|mesh-ancestor
93258737|NCT02090790|Hormones|hormones|mesh-ancestor
93258738|NCT02090790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258739|NCT02090790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258740|NCT02090790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258741|NCT02090790|Protease Inhibitors|protease inhibitors|mesh-ancestor
93258742|NCT02090790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258743|NCT02090790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258744|NCT02084550|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
93258745|NCT02084550|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93258746|NCT02084550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93258747|NCT01443728|Vitamin D|vitamin d|mesh-list
93258748|NCT01443728|Ergocalciferols|ergocalciferols|mesh-list
93258749|NCT01443728|Cholecalciferol|cholecalciferol|mesh-list
93258750|NCT01443728|Vitamins|vitamins|mesh-list
93258751|NCT01443728|Micronutrients|micronutrients|mesh-ancestor
93258752|NCT01443728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258753|NCT01443728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93258754|NCT01443728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93258755|NCT01324466|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
93258756|NCT01324466|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
93258757|NCT01324466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258758|NCT01324466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258759|NCT01312454|Travoprost|travoprost|mesh-list
93258760|NCT01312454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93258761|NCT01312454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93258762|NCT02084784|Methylene Blue|methylene blue|mesh-list
93258763|NCT02084784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258764|NCT02084784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258765|NCT03267589|Durvalumab|durvalumab|mesh-list
93258766|NCT03267589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258767|NCT03267589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258768|NCT02091180|Mannitol|mannitol|mesh-list
93258769|NCT02091180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93258770|NCT02091180|Diuretics|diuretics|mesh-ancestor
93258771|NCT02091180|Natriuretic Agents|natriuretic agents|mesh-ancestor
93258772|NCT02091180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258773|NCT02269748|Analgesics|analgesics|mesh-list
93258774|NCT02269748|Sensory System Agents|sensory system agents|mesh-ancestor
93258775|NCT02269748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258776|NCT02269748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258777|NCT03149809|Solifenacin Succinate|solifenacin succinate|mesh-list
93258778|NCT03149809|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93258779|NCT03149809|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93258780|NCT03149809|Cholinergic Agents|cholinergic agents|mesh-ancestor
93258781|NCT03149809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258782|NCT03149809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258783|NCT03149809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258784|NCT03149809|Urological Agents|urological agents|mesh-ancestor
93258785|NCT02269904|Fluorouracil|fluorouracil|mesh-list
93258786|NCT02269904|Antimetabolites|antimetabolites|mesh-ancestor
93258787|NCT02269904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258788|NCT02269904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258789|NCT02269904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258790|NCT02269904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258791|NCT02269904|Immunologic Factors|immunologic factors|mesh-ancestor
93258792|NCT02269904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258793|NCT03557112|Nimotuzumab|nimotuzumab|mesh-list
93258794|NCT03557112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258795|NCT03557112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258796|NCT01300208|CC-11050|cc-11050|mesh-list
93258797|NCT01300208|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93258798|NCT01300208|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93258799|NCT01300208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258800|NCT01300208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258801|NCT02085018|Omeprazole|omeprazole|mesh-list
93258802|NCT02085018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93258803|NCT02085018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258804|NCT02085018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93258805|NCT02085018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258806|NCT02085018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258807|NCT02091336|Metformin|metformin|mesh-list
93258808|NCT02091336|Glyburide|glyburide|mesh-list
93258809|NCT02091336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93258810|NCT02091336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930785|NCT04003506|Anesthetics, Local|anesthetics, local|mesh-ancestor
93258811|NCT01442090|Everolimus|everolimus|mesh-list
93258812|NCT01442090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93258813|NCT01442090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258815|NCT01442090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258816|NCT01442090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258817|NCT01442090|Immunologic Factors|immunologic factors|mesh-ancestor
93258818|NCT01442090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258819|NCT01442090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258820|NCT04475042|Dapagliflozin|dapagliflozin|mesh-list
93258821|NCT04475042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93258822|NCT04475042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258823|NCT04475042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93258824|NCT04475042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258825|NCT02088450|Nitrendipine|nitrendipine|mesh-list
93258826|NCT02088450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93258827|NCT02088450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93258828|NCT02088450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258829|NCT02088450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258830|NCT02088450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93258831|NCT02088450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258832|NCT02088450|Vasodilator Agents|vasodilator agents|mesh-ancestor
93258833|NCT03688828|Amoxicillin|amoxicillin|mesh-list
93258834|NCT03688828|Clarithromycin|clarithromycin|mesh-list
93258835|NCT03688828|Potassium Citrate|potassium citrate|mesh-list
93258836|NCT03688828|Esomeprazole|esomeprazole|mesh-list
93258837|NCT03688828|Bismuth|bismuth|mesh-list
93258838|NCT03688828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258839|NCT03688828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93258840|NCT03688828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258841|NCT03688828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93258842|NCT03688828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258843|NCT03688828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93258844|NCT03688828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258845|NCT03688828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93258846|NCT03688828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93258847|NCT03688828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93258848|NCT03688828|Antacids|antacids|mesh-ancestor
93258849|NCT03688828|Diuretics|diuretics|mesh-ancestor
93258850|NCT03688828|Natriuretic Agents|natriuretic agents|mesh-ancestor
93258851|NCT03688828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258852|NCT03688828|Expectorants|expectorants|mesh-ancestor
93258853|NCT03688828|Respiratory System Agents|respiratory system agents|mesh-ancestor
93258854|NCT02091492|Teriparatide|teriparatide|mesh-list
93258855|NCT02091492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93258856|NCT02091492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258857|NCT02091492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93258858|NCT02266940|DS-1971a|ds-1971a|mesh-list
93258859|NCT02266940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93258860|NCT02266940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93258861|NCT02266940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93258862|NCT02266940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258863|NCT03981952|Vaccines|vaccines|mesh-list
93258864|NCT03981952|Immunologic Factors|immunologic factors|mesh-ancestor
93258865|NCT03981952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258866|NCT04475120|Lactoferrin|lactoferrin|mesh-list
93258867|NCT04475120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258868|NCT02088528|Mitomycins|mitomycins|mesh-list
93258869|NCT02088528|Mitomycin|mitomycin|mesh-list
93258870|NCT02088528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93258871|NCT02088528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258872|NCT02088528|Alkylating Agents|alkylating agents|mesh-ancestor
93258873|NCT02088528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258874|NCT02088528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93258875|NCT02088528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258876|NCT03634150|Doxorubicin|doxorubicin|mesh-list
93258877|NCT03634150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93258878|NCT03634150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258879|NCT03634150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93258880|NCT03634150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93258881|NCT03634150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258882|NCT03634150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258883|NCT02092038|Temozolomide|temozolomide|mesh-list
93258884|NCT02092038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93258885|NCT02092038|Alkylating Agents|alkylating agents|mesh-ancestor
92930901|NCT04137354|Iron|iron|mesh-list
93258886|NCT02092038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258887|NCT02092038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258888|NCT02272166|Propofol|propofol|mesh-list
93258889|NCT02272166|Sevoflurane|sevoflurane|mesh-list
93258890|NCT02272166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93258891|NCT02272166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93258892|NCT02272166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258893|NCT02272166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93258894|NCT02272166|Anesthetics, General|anesthetics, general|mesh-ancestor
93258895|NCT02272166|Anesthetics|anesthetics|mesh-ancestor
93258896|NCT02272166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93258897|NCT02272166|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93258898|NCT02088684|Fulvestrant|fulvestrant|mesh-list
93258899|NCT02088684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93258900|NCT02088684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258901|NCT02088684|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93258902|NCT02088684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93258903|NCT02088684|Hormone Antagonists|hormone antagonists|mesh-ancestor
93258904|NCT02088684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93258905|NCT02088684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258906|NCT01137968|Bevacizumab|bevacizumab|mesh-list
93258907|NCT01137968|Imetelstat|imetelstat|mesh-list
93258908|NCT01137968|Motesanib diphosphate|motesanib diphosphate|mesh-list
93258909|NCT01137968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258910|NCT01137968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258911|NCT01137968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93258912|NCT01137968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93258913|NCT01137968|Growth Substances|growth substances|mesh-ancestor
93258914|NCT01137968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258915|NCT01137968|Growth Inhibitors|growth inhibitors|mesh-ancestor
93258916|NCT01137968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258917|NCT01137968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258918|NCT01137968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93258919|NCT01133990|Leucovorin|leucovorin|mesh-list
93258920|NCT01133990|Bevacizumab|bevacizumab|mesh-list
93258921|NCT01133990|Fluorouracil|fluorouracil|mesh-list
93258922|NCT01133990|Irinotecan|irinotecan|mesh-list
93258923|NCT01133990|Calcium|calcium|mesh-list
93258924|NCT01133990|Levoleucovorin|levoleucovorin|mesh-list
93258925|NCT01133990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258926|NCT01133990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258927|NCT01133990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93258928|NCT01133990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93258929|NCT01133990|Growth Substances|growth substances|mesh-ancestor
93258930|NCT01133990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258931|NCT01133990|Growth Inhibitors|growth inhibitors|mesh-ancestor
93258932|NCT01133990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93258933|NCT01133990|Antimetabolites|antimetabolites|mesh-ancestor
93258934|NCT01133990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258935|NCT01133990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258936|NCT01133990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93258937|NCT01133990|Immunologic Factors|immunologic factors|mesh-ancestor
93258938|NCT01133990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93258939|NCT01133990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93258940|NCT01133990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258941|NCT01133990|Antidotes|antidotes|mesh-ancestor
93258942|NCT01133990|Protective Agents|protective agents|mesh-ancestor
93258943|NCT01133990|Vitamin B Complex|vitamin b complex|mesh-ancestor
93258944|NCT01133990|Vitamins|vitamins|mesh-ancestor
93258945|NCT01133990|Micronutrients|micronutrients|mesh-ancestor
93258946|NCT02249910|Metformin|metformin|mesh-list
93258947|NCT02249910|Digoxin|digoxin|mesh-list
93258948|NCT02249910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93258949|NCT02249910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258950|NCT02249910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93258951|NCT02249910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93258952|NCT02249910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258953|NCT02249910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258954|NCT02249910|Protective Agents|protective agents|mesh-ancestor
93258955|NCT02936596|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93258956|NCT02936596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93258957|NCT02936596|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93258958|NCT02936596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258959|NCT02936596|Immunologic Factors|immunologic factors|mesh-ancestor
93258960|NCT02936596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258961|NCT02398396|Lactitol|lactitol|mesh-list
93258962|NCT02398396|Cathartics|cathartics|mesh-ancestor
93258963|NCT02398396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93258964|NCT05628584|Metformin|metformin|mesh-list
93258965|NCT05628584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93258966|NCT05628584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258967|NCT02088918|Metformin|metformin|mesh-list
93258968|NCT02088918|Nateglinide|nateglinide|mesh-list
93258969|NCT02088918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93258970|NCT02088918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258971|NCT02419378|Alemtuzumab|alemtuzumab|mesh-list
93258972|NCT02419378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93258973|NCT02419378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93258974|NCT02092428|Adenosine|adenosine|mesh-list
93258975|NCT02092428|Regadenoson|regadenoson|mesh-list
93258976|NCT02092428|Analgesics|analgesics|mesh-ancestor
93258977|NCT02092428|Sensory System Agents|sensory system agents|mesh-ancestor
93258978|NCT02092428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93258979|NCT02092428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93258980|NCT02092428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93258981|NCT02092428|Vasodilator Agents|vasodilator agents|mesh-ancestor
93258982|NCT02092428|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93258983|NCT02092428|Purinergic Agonists|purinergic agonists|mesh-ancestor
93258984|NCT02092428|Purinergic Agents|purinergic agents|mesh-ancestor
93258985|NCT02092428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93258986|NCT02092428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258987|NCT02092428|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93258988|NCT02783404|Amoxicillin|amoxicillin|mesh-list
93258989|NCT02783404|Clavulanic Acid|clavulanic acid|mesh-list
93258990|NCT02783404|Clavulanic Acids|clavulanic acids|mesh-list
93258991|NCT02783404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93258992|NCT02783404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93258993|NCT02783404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93258994|NCT02783404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93258995|NCT02783404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93258996|NCT01097018|Capecitabine|capecitabine|mesh-list
93258997|NCT01097018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93258998|NCT01097018|Antimetabolites|antimetabolites|mesh-ancestor
93258999|NCT01097018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259000|NCT01097018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259001|NCT01096862|Peficitinib|peficitinib|mesh-list
93259002|NCT01096862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259003|NCT01096862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259004|NCT01096862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259005|NCT01096862|Immunologic Factors|immunologic factors|mesh-ancestor
93259006|NCT01096862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259007|NCT02092506|Amoxicillin|amoxicillin|mesh-list
93259008|NCT02092506|Metronidazole|metronidazole|mesh-list
93259009|NCT02092506|Clarithromycin|clarithromycin|mesh-list
93259010|NCT02092506|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93259011|NCT02092506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259012|NCT02092506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259013|NCT02092506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93259014|NCT02092506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93259015|NCT02092506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93259016|NCT02092506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259017|NCT02092506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259018|NCT02092506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93259019|NCT02092506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93259020|NCT01092104|Cenicriviroc|cenicriviroc|mesh-list
93259021|NCT01092104|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93259022|NCT01092104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259023|NCT01092104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93259024|NCT01092104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93259025|NCT01092104|Antiviral Agents|antiviral agents|mesh-ancestor
93259026|NCT01092104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259027|NCT01128530|Linezolid|linezolid|mesh-list
93259028|NCT01128530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259029|NCT01128530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259030|NCT01128530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93259031|NCT01128530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259032|NCT01128530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259033|NCT02086032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93259034|NCT02086032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93259035|NCT02086032|Estradiol|estradiol|mesh-list
93259036|NCT02086032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93259037|NCT02086032|Estrogens|estrogens|mesh-list
93259038|NCT02086032|Progesterone|progesterone|mesh-list
93259039|NCT02086032|Dydrogesterone|dydrogesterone|mesh-list
93259040|NCT02086032|Hormones|hormones|mesh-ancestor
93259041|NCT02086032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259042|NCT02086032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259043|NCT02086032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93259044|NCT02086032|Contraceptive Agents|contraceptive agents|mesh-ancestor
93259045|NCT02086032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93259046|NCT02086032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93259047|NCT02086032|Progestins|progestins|mesh-ancestor
93259048|NCT02092818|Riociguat|riociguat|mesh-list
93259049|NCT02092818|Enzyme Activators|enzyme activators|mesh-ancestor
93259050|NCT02092818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259051|NCT02086188|Mirabegron|mirabegron|mesh-list
93259052|NCT02086188|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93259053|NCT02086188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93259054|NCT02086188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93259055|NCT02086188|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259056|NCT02086188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259057|NCT02086188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259058|NCT02086188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259059|NCT02086188|Urological Agents|urological agents|mesh-ancestor
93259060|NCT02267408|Warfarin|warfarin|mesh-list
93259061|NCT02267408|Anticoagulants|anticoagulants|mesh-ancestor
93259062|NCT02092896|Liraglutide|liraglutide|mesh-list
93259063|NCT02092896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93259064|NCT02092896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259065|NCT02092896|Incretins|incretins|mesh-ancestor
93259066|NCT02092896|Hormones|hormones|mesh-ancestor
93259067|NCT02092896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259068|NCT02092974|Citalopram|citalopram|mesh-list
93259069|NCT02092974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93259070|NCT02092974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93259071|NCT02092974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259072|NCT02092974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259073|NCT02092974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259074|NCT02092974|Serotonin Agents|serotonin agents|mesh-ancestor
93259075|NCT02092974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259076|NCT02092974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93259077|NCT02092974|Antidepressive Agents|antidepressive agents|mesh-ancestor
93259078|NCT02092974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93259079|NCT05097508|Bromides|bromides|mesh-list
93259080|NCT05097508|Rocuronium|rocuronium|mesh-list
93259081|NCT05097508|Atracurium|atracurium|mesh-list
93259082|NCT05097508|Anticonvulsants|anticonvulsants|mesh-ancestor
93259083|NCT05097508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93259084|NCT05097508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93259085|NCT05097508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93259086|NCT05097508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259087|NCT05097508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259088|NCT05097508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93259089|NCT05097508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93259090|NCT05097508|Cholinergic Agents|cholinergic agents|mesh-ancestor
93259091|NCT05097508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259092|NCT05097508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259093|NCT02089308|Nicotine|nicotine|mesh-list
93259094|NCT02089308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93259095|NCT02089308|Autonomic Agents|autonomic agents|mesh-ancestor
93259096|NCT02089308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259097|NCT02089308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259098|NCT02089308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93259099|NCT02089308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93259100|NCT02089308|Cholinergic Agents|cholinergic agents|mesh-ancestor
93259101|NCT02089308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259102|NCT02089308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259103|NCT00153920|Bortezomib|bortezomib|mesh-list
93259104|NCT00153920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259105|NCT05095714|Liver Extracts|liver extracts|mesh-list
93259106|NCT05095714|Hematinics|hematinics|mesh-ancestor
93259107|NCT02660242|Glucagon|glucagon|mesh-list
93259108|NCT02660242|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93259109|NCT02660242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259110|NCT02660242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259111|NCT02660242|Hormones|hormones|mesh-ancestor
93259112|NCT02660242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259113|NCT02660242|Incretins|incretins|mesh-ancestor
93259114|NCT02089386|Tamoxifen|tamoxifen|mesh-list
93259115|NCT02089386|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93259116|NCT02089386|Hormone Antagonists|hormone antagonists|mesh-ancestor
93259117|NCT02089386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259118|NCT02089386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259119|NCT02089386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259120|NCT02089386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259121|NCT02089386|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93259122|NCT02089386|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93259123|NCT02089386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93259124|NCT05628038|Capecitabine|capecitabine|mesh-list
93259125|NCT05628038|Oxaliplatin|oxaliplatin|mesh-list
93259126|NCT05628038|Antibodies|antibodies|mesh-list
93259127|NCT05628038|Immunologic Factors|immunologic factors|mesh-ancestor
93259128|NCT05628038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259129|NCT05628038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259130|NCT05628038|Antimetabolites|antimetabolites|mesh-ancestor
93259131|NCT05628038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259132|NCT05628038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259133|NCT03557580|Isosorbide|isosorbide|mesh-list
93259134|NCT03557580|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93259135|NCT03557580|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93259136|NCT03557580|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93259137|NCT03557580|Diuretics|diuretics|mesh-ancestor
93259138|NCT03557580|Natriuretic Agents|natriuretic agents|mesh-ancestor
93259139|NCT03557580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259140|NCT03557580|Vasodilator Agents|vasodilator agents|mesh-ancestor
93259141|NCT03557580|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93259142|NCT03557580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259143|NCT02089542|Methylene Blue|methylene blue|mesh-list
93259144|NCT02089542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259145|NCT02089542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259146|NCT01295060|Octreotide|octreotide|mesh-list
93259147|NCT01295060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259148|NCT01295060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259149|NCT01295060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259150|NCT02086656|Bevacizumab|bevacizumab|mesh-list
93259151|NCT02086656|Capecitabine|capecitabine|mesh-list
93259152|NCT02086656|Oxaliplatin|oxaliplatin|mesh-list
93259153|NCT02086656|Irinotecan|irinotecan|mesh-list
93259154|NCT02086656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93259155|NCT02086656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259156|NCT02086656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93259157|NCT02086656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93259158|NCT02086656|Growth Substances|growth substances|mesh-ancestor
93259159|NCT02086656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259160|NCT02086656|Growth Inhibitors|growth inhibitors|mesh-ancestor
93259161|NCT02086656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259162|NCT02086656|Antimetabolites|antimetabolites|mesh-ancestor
93259163|NCT02086656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259164|NCT02086656|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93259165|NCT02086656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93259166|NCT02086656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259167|NCT01294202|Imatinib Mesylate|imatinib mesylate|mesh-list
93259168|NCT01294202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259169|NCT01294202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93259170|NCT01294202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259171|NCT01294202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259172|NCT01071902|Moxifloxacin|moxifloxacin|mesh-list
93259173|NCT01071902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92553822|NCT00064194|Vitamin E|vitamin e|mesh-list
93259174|NCT01071902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259175|NCT01071902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259176|NCT01071902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93259177|NCT01071902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93259178|NCT01071902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259179|NCT01071902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259180|NCT01071902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259181|NCT01126970|Orlistat|orlistat|mesh-list
93259182|NCT01126970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259183|NCT01126970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259184|NCT01126970|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93259185|NCT01126970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93259186|NCT03557424|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93259187|NCT03557424|Cathartics|cathartics|mesh-ancestor
93259188|NCT03557424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259189|NCT05057572|Carvedilol|carvedilol|mesh-list
93259190|NCT05057572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93259191|NCT05057572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93259192|NCT05057572|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259193|NCT05057572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259194|NCT05057572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259195|NCT05057572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259196|NCT05057572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93259197|NCT05057572|Antioxidants|antioxidants|mesh-ancestor
93259198|NCT05057572|Protective Agents|protective agents|mesh-ancestor
93259199|NCT05057572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93259200|NCT05057572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259201|NCT05057572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93259202|NCT05057572|Vasodilator Agents|vasodilator agents|mesh-ancestor
93259203|NCT05057572|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93259204|NCT05057572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93259205|NCT02093598|Sirolimus|sirolimus|mesh-list
93259206|NCT02093598|Temsirolimus|temsirolimus|mesh-list
93259207|NCT02093598|MTOR Inhibitors|mtor inhibitors|mesh-list
93259208|NCT02093598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93259209|NCT02093598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259210|NCT02093598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259211|NCT02093598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259212|NCT02093598|Immunologic Factors|immunologic factors|mesh-ancestor
93259213|NCT02093598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259214|NCT02093598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259215|NCT02093598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259216|NCT02093598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259217|NCT02093598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93259218|NCT02093598|Antifungal Agents|antifungal agents|mesh-ancestor
93259219|NCT01124552|Botulinum Toxins|botulinum toxins|mesh-list
93259220|NCT01124552|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93259221|NCT01124552|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93259222|NCT01124552|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93259223|NCT01124552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259224|NCT01124552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259225|NCT01124552|Cholinergic Agents|cholinergic agents|mesh-ancestor
93259226|NCT01124552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259227|NCT01124552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259228|NCT01124552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93259229|NCT01124552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259230|NCT02087202|Magnesium Sulfate|magnesium sulfate|mesh-list
93259231|NCT02087202|Ketamine|ketamine|mesh-list
93259232|NCT02087202|Analgesics|analgesics|mesh-ancestor
93259233|NCT02087202|Sensory System Agents|sensory system agents|mesh-ancestor
93259234|NCT02087202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259235|NCT02087202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259236|NCT02087202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93259237|NCT02087202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93259238|NCT02087202|Anesthetics, General|anesthetics, general|mesh-ancestor
93259239|NCT02087202|Anesthetics|anesthetics|mesh-ancestor
93259240|NCT02087202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259241|NCT02087202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93259242|NCT02087202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93259243|NCT02087202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259244|NCT02087202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259245|NCT02087202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93259246|NCT02087202|Anticonvulsants|anticonvulsants|mesh-ancestor
93259247|NCT02087202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93259248|NCT02087202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259249|NCT02087202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93259250|NCT02087202|Tocolytic Agents|tocolytic agents|mesh-ancestor
93259251|NCT02087202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93259252|NCT01283594|Levodopa|levodopa|mesh-list
93259253|NCT01283594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93259254|NCT01283594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93259255|NCT01283594|Dopamine Agents|dopamine agents|mesh-ancestor
93259256|NCT01283594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259257|NCT01283594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259258|NCT01283594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259259|NCT01281254|Trebananib|trebananib|mesh-list
93259260|NCT01281254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931235|NCT00729326|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93259261|NCT01281254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93259262|NCT01281254|Growth Substances|growth substances|mesh-ancestor
93259263|NCT01281254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259264|NCT01281254|Growth Inhibitors|growth inhibitors|mesh-ancestor
93259265|NCT01281254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259266|NCT05104138|Eplerenone|eplerenone|mesh-list
93259267|NCT05104138|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93259268|NCT05104138|Hormone Antagonists|hormone antagonists|mesh-ancestor
93259269|NCT05104138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259270|NCT05104138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259271|NCT05104138|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93259272|NCT05104138|Diuretics|diuretics|mesh-ancestor
93259273|NCT05104138|Natriuretic Agents|natriuretic agents|mesh-ancestor
93259274|NCT05104138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93259275|NCT03072043|Azacitidine|azacitidine|mesh-list
93259276|NCT03072043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259277|NCT03072043|Antimetabolites|antimetabolites|mesh-ancestor
93259278|NCT03072043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259279|NCT03072043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259280|NCT03072043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259281|NCT05626010|Acetaminophen|acetaminophen|mesh-list
93259282|NCT05626010|Ibuprofen|ibuprofen|mesh-list
93259283|NCT05626010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93259284|NCT05626010|Analgesics|analgesics|mesh-ancestor
93259285|NCT05626010|Sensory System Agents|sensory system agents|mesh-ancestor
93259286|NCT05626010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259287|NCT05626010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259288|NCT05626010|Antipyretics|antipyretics|mesh-ancestor
93259289|NCT05626010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93259290|NCT05626010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93259291|NCT05626010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93259292|NCT05626010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93259293|NCT05626010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259294|NCT05626010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259295|NCT02089854|Toremifene|toremifene|mesh-list
93259296|NCT02089854|Anastrozole|anastrozole|mesh-list
93259297|NCT02089854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259298|NCT02089854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259299|NCT02089854|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93259300|NCT02089854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93259301|NCT02089854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259302|NCT02089854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259303|NCT02089854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93259304|NCT02089854|Hormone Antagonists|hormone antagonists|mesh-ancestor
93259305|NCT02089854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259306|NCT02089854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259307|NCT02089854|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93259308|NCT02089854|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93259309|NCT02089854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93259310|NCT05624840|Ritonavir|ritonavir|mesh-list
93259311|NCT05624840|Nirmatrelvir|nirmatrelvir|mesh-list
93259312|NCT05624840|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
93259313|NCT05624840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93259314|NCT05624840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93259315|NCT05624840|Protease Inhibitors|protease inhibitors|mesh-ancestor
93259316|NCT05624840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259317|NCT05624840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259318|NCT05624840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93259319|NCT05624840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93259320|NCT05624840|Antiviral Agents|antiviral agents|mesh-ancestor
93259321|NCT05624840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259322|NCT05624840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93259323|NCT05624840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93259324|NCT02093910|Dexamethasone|dexamethasone|mesh-list
93259325|NCT02093910|Bortezomib|bortezomib|mesh-list
93259326|NCT02093910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93259327|NCT02093910|Antiemetics|antiemetics|mesh-ancestor
93259328|NCT02093910|Autonomic Agents|autonomic agents|mesh-ancestor
93259329|NCT02093910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259330|NCT02093910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259331|NCT02093910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259332|NCT02093910|Glucocorticoids|glucocorticoids|mesh-ancestor
93259333|NCT02093910|Hormones|hormones|mesh-ancestor
93366405|NCT02061917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259334|NCT02093910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259335|NCT02093910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259336|NCT02093910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259337|NCT04437160|Cyclophosphamide|cyclophosphamide|mesh-list
93259338|NCT04437160|Epirubicin|epirubicin|mesh-list
93259339|NCT04437160|Pirarubicin|pirarubicin|mesh-list
93259340|NCT04437160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259341|NCT04437160|Immunologic Factors|immunologic factors|mesh-ancestor
93259342|NCT04437160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259343|NCT04437160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93259344|NCT04437160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93259345|NCT04437160|Alkylating Agents|alkylating agents|mesh-ancestor
93259346|NCT04437160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259347|NCT04437160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259348|NCT04437160|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93259349|NCT04437160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93259350|NCT04437160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93259351|NCT04437160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93259352|NCT04437160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259353|NCT02089932|Dexmedetomidine|dexmedetomidine|mesh-list
93259354|NCT02089932|Bupivacaine|bupivacaine|mesh-list
93259355|NCT02089932|Anesthetics, Local|anesthetics, local|mesh-ancestor
93259356|NCT02089932|Anesthetics|anesthetics|mesh-ancestor
93259357|NCT02089932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259358|NCT02089932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259359|NCT02089932|Sensory System Agents|sensory system agents|mesh-ancestor
93259360|NCT02089932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259361|NCT02089932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93259362|NCT02089932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93259363|NCT02089932|Analgesics|analgesics|mesh-ancestor
93259364|NCT02089932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93259365|NCT02089932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93259366|NCT02089932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93259367|NCT02089932|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259368|NCT02089932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259369|NCT02089932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259370|NCT01037036|Latanoprost|latanoprost|mesh-list
93259371|NCT01037036|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92554044|NCT00038168|Paclitaxel|paclitaxel|mesh-list
93259372|NCT01037036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93259373|NCT05204641|Rifaximin|rifaximin|mesh-list
93259374|NCT05204641|Levodopa|levodopa|mesh-list
93259375|NCT05204641|Benserazide|benserazide|mesh-list
93259376|NCT05204641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93259377|NCT05204641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93259378|NCT05204641|Dopamine Agents|dopamine agents|mesh-ancestor
93259379|NCT05204641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259380|NCT05204641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259381|NCT05204641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259382|NCT05204641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259383|NCT05204641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259384|NCT05204641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259385|NCT05204641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259386|NCT03069313|Vitamin B 12|vitamin b 12|mesh-list
93259387|NCT03069313|Hydroxocobalamin|hydroxocobalamin|mesh-list
93259388|NCT03069313|Vitamins|vitamins|mesh-ancestor
93259389|NCT03069313|Micronutrients|micronutrients|mesh-ancestor
93259390|NCT03069313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259391|NCT03069313|Vitamin B Complex|vitamin b complex|mesh-ancestor
93259392|NCT03069313|Hematinics|hematinics|mesh-ancestor
93259393|NCT02094066|Tranexamic Acid|tranexamic acid|mesh-list
93259394|NCT02094066|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93259395|NCT02094066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93259396|NCT02094066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259397|NCT02094066|Hemostatics|hemostatics|mesh-ancestor
93259398|NCT02094066|Coagulants|coagulants|mesh-ancestor
93259399|NCT01033292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93259400|NCT01033292|Iniparib|iniparib|mesh-list
93259401|NCT01033292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259402|NCT01033292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259403|NCT01033292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259404|NCT03068767|Vitamin D|vitamin d|mesh-list
93259405|NCT03068767|Vitamins|vitamins|mesh-ancestor
93259406|NCT03068767|Micronutrients|micronutrients|mesh-ancestor
93259407|NCT03068767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259408|NCT03068767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93259409|NCT02267720|Salicylic Acid|salicylic acid|mesh-list
92931386|NCT00693225|Omeprazole|omeprazole|mesh-list
93259410|NCT02267720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259411|NCT02267720|Antifungal Agents|antifungal agents|mesh-ancestor
93259412|NCT02267720|Keratolytic Agents|keratolytic agents|mesh-ancestor
93259413|NCT02267720|Dermatologic Agents|dermatologic agents|mesh-ancestor
93259414|NCT05204329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93259415|NCT05204329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93259416|NCT01110902|Agomelatine|agomelatine|mesh-list
93259417|NCT01110902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93259418|NCT01110902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259419|NCT01110902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259420|NCT05204173|Paclitaxel|paclitaxel|mesh-list
93259421|NCT05204173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93259422|NCT05204173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259423|NCT05204173|Tubulin Modulators|tubulin modulators|mesh-ancestor
93259424|NCT05204173|Antimitotic Agents|antimitotic agents|mesh-ancestor
93259425|NCT05204173|Mitosis Modulators|mitosis modulators|mesh-ancestor
93259426|NCT05204173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259427|NCT01025648|Epinephrine|epinephrine|mesh-list
93259428|NCT01025648|Racepinephrine|racepinephrine|mesh-list
93259429|NCT01025648|Epinephryl borate|epinephryl borate|mesh-list
93259430|NCT01025648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93259431|NCT01025648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93259432|NCT01025648|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259433|NCT01025648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259434|NCT01025648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259435|NCT01025648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259436|NCT01025648|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93259437|NCT01025648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93259438|NCT01025648|Autonomic Agents|autonomic agents|mesh-ancestor
93259439|NCT01025648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259440|NCT01025648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93259441|NCT01025648|Respiratory System Agents|respiratory system agents|mesh-ancestor
93259442|NCT01025648|Mydriatics|mydriatics|mesh-ancestor
93259443|NCT01025648|Sympathomimetics|sympathomimetics|mesh-ancestor
93259444|NCT01025648|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93259445|NCT01110746|Insulin|insulin|mesh-list
93259446|NCT01110746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93259447|NCT01110746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93259448|NCT01110746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259449|NCT05622968|Dinoprostone|dinoprostone|mesh-list
93259450|NCT05622968|Oxytocics|oxytocics|mesh-ancestor
93259451|NCT05622968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93259452|NCT05622968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259453|NCT02268032|Androgens|androgens|mesh-list
93259454|NCT02268032|Hormones|hormones|mesh-ancestor
93259455|NCT02268032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259456|NCT02268032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259457|NCT03019965|Meropenem|meropenem|mesh-list
93259458|NCT03019965|Tazobactam|tazobactam|mesh-list
93259459|NCT03019965|Piperacillin|piperacillin|mesh-list
93259460|NCT03019965|Imipenem|imipenem|mesh-list
93259461|NCT03019965|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93259462|NCT03019965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259463|NCT03019965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259464|NCT03019965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93259465|NCT03019965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259466|NCT03019965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259467|NCT01468831|Minocycline|minocycline|mesh-list
93259468|NCT01468831|Bevacizumab|bevacizumab|mesh-list
93259469|NCT01468831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93259470|NCT01468831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259471|NCT01468831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93259472|NCT01468831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93259473|NCT01468831|Growth Substances|growth substances|mesh-ancestor
93259474|NCT01468831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259475|NCT01468831|Growth Inhibitors|growth inhibitors|mesh-ancestor
93259476|NCT01468831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259477|NCT01468831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259478|NCT05627414|Paclitaxel|paclitaxel|mesh-list
93259479|NCT05627414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93259480|NCT05627414|Tegafur|tegafur|mesh-list
93259481|NCT05627414|Disitamab vedotin|disitamab vedotin|mesh-list
93259482|NCT05627414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93259483|NCT05627414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259484|NCT05627414|Tubulin Modulators|tubulin modulators|mesh-ancestor
92931461|NCT00695019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259485|NCT05627414|Antimitotic Agents|antimitotic agents|mesh-ancestor
93259486|NCT05627414|Mitosis Modulators|mitosis modulators|mesh-ancestor
93259487|NCT05627414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259488|NCT05627414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259489|NCT05627414|Antimetabolites|antimetabolites|mesh-ancestor
93259490|NCT05627414|Immunoconjugates|immunoconjugates|mesh-ancestor
93259491|NCT05627414|Immunologic Factors|immunologic factors|mesh-ancestor
93259492|NCT05627414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259493|NCT05617508|Niacinamide|niacinamide|mesh-list
93259495|NCT05617508|Nicotinic Acids|nicotinic acids|mesh-list
93259496|NCT05617508|Vitamin B Complex|vitamin b complex|mesh-ancestor
93259497|NCT05617508|Vitamins|vitamins|mesh-ancestor
93259498|NCT05617508|Micronutrients|micronutrients|mesh-ancestor
93259499|NCT05617508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259500|NCT05617508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93259501|NCT05617508|Antimetabolites|antimetabolites|mesh-ancestor
93259502|NCT05617508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259503|NCT05617508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93259504|NCT05617508|Vasodilator Agents|vasodilator agents|mesh-ancestor
93259505|NCT03018249|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93259506|NCT03018249|Entinostat|entinostat|mesh-list
93259507|NCT03018249|Medroxyprogesterone|medroxyprogesterone|mesh-list
93259508|NCT03018249|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93259509|NCT03018249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93259510|NCT03018249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93259511|NCT03018249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93259512|NCT03018249|Contraceptive Agents|contraceptive agents|mesh-ancestor
93259513|NCT03018249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93259514|NCT03018249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259515|NCT03018249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92554171|NCT00069927|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259516|NCT03018249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93259517|NCT03018249|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93259518|NCT03018249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259519|NCT03018249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259520|NCT03018249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259521|NCT03018249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259522|NCT05380154|Botulinum Toxins|botulinum toxins|mesh-list
93259523|NCT05380154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93259524|NCT05380154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93259525|NCT05380154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93259526|NCT05380154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259527|NCT05380154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259528|NCT05380154|Cholinergic Agents|cholinergic agents|mesh-ancestor
93259529|NCT05380154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259530|NCT05380154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259531|NCT05380154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93259532|NCT05380154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259533|NCT05374252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93259534|NCT05374252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259535|NCT05374252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93259536|NCT05374252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259537|NCT04602975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93259538|NCT04602975|Vaccines|vaccines|mesh-list
93259539|NCT04602975|Immunologic Factors|immunologic factors|mesh-ancestor
93259540|NCT04602975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259541|NCT04602975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93259542|NCT04602975|Antacids|antacids|mesh-ancestor
93259543|NCT04602975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259544|NCT04602975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259545|NCT00905606|Topiramate|topiramate|mesh-list
93259546|NCT00905606|Anticonvulsants|anticonvulsants|mesh-ancestor
93259547|NCT00905606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93259548|NCT00905606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259549|NCT03017235|Picosulfate sodium|picosulfate sodium|mesh-list
93259550|NCT03017235|Magnesium Oxide|magnesium oxide|mesh-list
93259551|NCT03017235|Sodium Citrate|sodium citrate|mesh-list
93259552|NCT03017235|Citric Acid|citric acid|mesh-list
93259553|NCT03017235|Anticoagulants|anticoagulants|mesh-ancestor
93259554|NCT03017235|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93259555|NCT03017235|Chelating Agents|chelating agents|mesh-ancestor
93259556|NCT03017235|Sequestering Agents|sequestering agents|mesh-ancestor
93259557|NCT03017235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259558|NCT03017235|Cathartics|cathartics|mesh-ancestor
92931543|NCT00776009|Dopamine Agents|dopamine agents|mesh-ancestor
93259559|NCT03017235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259560|NCT03017235|Antacids|antacids|mesh-ancestor
93259561|NCT05048134|Trametinib|trametinib|mesh-list
93259562|NCT05048134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259563|NCT05048134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93259564|NCT05048134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259565|NCT05048134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259566|NCT04438928|Micronutrients|micronutrients|mesh-list
93259567|NCT04438928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259568|NCT03667677|Amlodipine|amlodipine|mesh-list
93259569|NCT03667677|Tandospirone|tandospirone|mesh-list
93259570|NCT03667677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93259571|NCT03667677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93259572|NCT03667677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554242|NCT00070083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259573|NCT03667677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259574|NCT03667677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93259575|NCT03667677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259576|NCT03667677|Vasodilator Agents|vasodilator agents|mesh-ancestor
93259577|NCT03667677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93259578|NCT03667677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93259579|NCT03667677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259580|NCT03667677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93259581|NCT03667677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93259582|NCT03667677|Serotonin Agents|serotonin agents|mesh-ancestor
93259583|NCT03667677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259584|NCT04176718|Dexamethasone|dexamethasone|mesh-list
93259585|NCT04176718|Daratumumab|daratumumab|mesh-list
93259586|NCT04176718|Pomalidomide|pomalidomide|mesh-list
93259587|NCT04176718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93259588|NCT04176718|Antiemetics|antiemetics|mesh-ancestor
93259589|NCT04176718|Autonomic Agents|autonomic agents|mesh-ancestor
93259590|NCT04176718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259591|NCT04176718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259592|NCT04176718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259593|NCT04176718|Glucocorticoids|glucocorticoids|mesh-ancestor
93259594|NCT04176718|Hormones|hormones|mesh-ancestor
93259595|NCT04176718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259596|NCT04176718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259597|NCT04176718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259598|NCT04176718|Immunologic Factors|immunologic factors|mesh-ancestor
93259599|NCT04176718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93259600|NCT04176718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93259601|NCT04176718|Growth Substances|growth substances|mesh-ancestor
93259602|NCT04176718|Growth Inhibitors|growth inhibitors|mesh-ancestor
93259603|NCT02880371|Pembrolizumab|pembrolizumab|mesh-list
93259604|NCT02880371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93259605|NCT02880371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259606|NCT02880371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93259607|NCT02880371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259608|NCT00813956|Carboplatin|carboplatin|mesh-list
93259609|NCT00813956|Gemcitabine|gemcitabine|mesh-list
93259610|NCT00813956|Iniparib|iniparib|mesh-list
93259611|NCT00813956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259612|NCT00813956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259613|NCT00813956|Antimetabolites|antimetabolites|mesh-ancestor
93259614|NCT00813956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259615|NCT00813956|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93259616|NCT00813956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259617|NCT01002248|Dexamethasone|dexamethasone|mesh-list
93259618|NCT01002248|Bortezomib|bortezomib|mesh-list
93259619|NCT01002248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93259620|NCT01002248|Antiemetics|antiemetics|mesh-ancestor
93259621|NCT01002248|Autonomic Agents|autonomic agents|mesh-ancestor
93259622|NCT01002248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259623|NCT01002248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259624|NCT01002248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259625|NCT01002248|Glucocorticoids|glucocorticoids|mesh-ancestor
93259626|NCT01002248|Hormones|hormones|mesh-ancestor
93259627|NCT01002248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259628|NCT01002248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259629|NCT01002248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259630|NCT02837029|Nivolumab|nivolumab|mesh-list
93259631|NCT02837029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93259632|NCT02837029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259633|NCT02837029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93259634|NCT02837029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259635|NCT03667131|Enalapril|enalapril|mesh-list
93259636|NCT03667131|Enalaprilat|enalaprilat|mesh-list
93259637|NCT03667131|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93259638|NCT03667131|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93259639|NCT03667131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259640|NCT03667131|Protease Inhibitors|protease inhibitors|mesh-ancestor
93259641|NCT03667131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93259642|NCT04532710|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93259643|NCT04532710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93259644|NCT02642965|Cytarabine|cytarabine|mesh-list
93259645|NCT02642965|Fludarabine|fludarabine|mesh-list
92554303|NCT00070200|Etoposide|etoposide|mesh-list
93259646|NCT02642965|Fludarabine phosphate|fludarabine phosphate|mesh-list
93259647|NCT02642965|Daunorubicin|daunorubicin|mesh-list
93259648|NCT02642965|Lenograstim|lenograstim|mesh-list
93259649|NCT02642965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259650|NCT02642965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259651|NCT02642965|Antimetabolites|antimetabolites|mesh-ancestor
93259652|NCT02642965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259653|NCT02642965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259654|NCT02642965|Immunologic Factors|immunologic factors|mesh-ancestor
93259655|NCT02642965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259656|NCT02642965|Antiviral Agents|antiviral agents|mesh-ancestor
93259657|NCT02642965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259658|NCT02642965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93259659|NCT02642965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93259660|NCT02642965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93259661|NCT02642965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93259662|NCT02642965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259663|NCT01377155|Insulin Detemir|insulin detemir|mesh-list
93259664|NCT01377155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93259665|NCT01377155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259666|NCT04976374|Dexmedetomidine|dexmedetomidine|mesh-list
93259667|NCT04976374|Gabapentin|gabapentin|mesh-list
93259668|NCT04976374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93259669|NCT04976374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259670|NCT04976374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259671|NCT04976374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93259672|NCT04976374|Analgesics|analgesics|mesh-ancestor
93259673|NCT04976374|Sensory System Agents|sensory system agents|mesh-ancestor
93259674|NCT04976374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259675|NCT04976374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93259676|NCT04976374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93259677|NCT04976374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93259678|NCT04976374|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259679|NCT04976374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259680|NCT04976374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259681|NCT04976374|Anticonvulsants|anticonvulsants|mesh-ancestor
93259682|NCT04976374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93259683|NCT04976374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93259684|NCT04976374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93259685|NCT04976374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93259686|NCT04976374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93259687|NCT04976374|Antimanic Agents|antimanic agents|mesh-ancestor
93259688|NCT02764541|Tamoxifen|tamoxifen|mesh-list
93259689|NCT02764541|Letrozole|letrozole|mesh-list
93259690|NCT02764541|Palbociclib|palbociclib|mesh-list
93259691|NCT02764541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259692|NCT02764541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93259693|NCT02764541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93259694|NCT02764541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259695|NCT02764541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259696|NCT02764541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93259697|NCT02764541|Hormone Antagonists|hormone antagonists|mesh-ancestor
93259698|NCT02764541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259699|NCT02764541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259700|NCT02764541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259701|NCT02764541|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93259702|NCT02764541|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93259703|NCT02764541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93259704|NCT02764541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93259705|NCT00894530|Azithromycin|azithromycin|mesh-list
93259706|NCT00894530|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93259707|NCT00894530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93259708|NCT00894530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259709|NCT00894530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259710|NCT01376999|Hormones|hormones|mesh-list
93259711|NCT01376999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259712|NCT01376999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259713|NCT00892970|Azithromycin|azithromycin|mesh-list
93259714|NCT00892970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93259715|NCT00892970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93259716|NCT00892970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259717|NCT00892970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259718|NCT05340257|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93259719|NCT05340257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259720|NCT05340257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259721|NCT05340257|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93259722|NCT05340257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259723|NCT05340257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259724|NCT02201381|Metformin|metformin|mesh-list
93259725|NCT02201381|Doxycycline|doxycycline|mesh-list
93259726|NCT02201381|Mebendazole|mebendazole|mesh-list
93259727|NCT02201381|Atorvastatin|atorvastatin|mesh-list
93259728|NCT02201381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93259729|NCT02201381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259730|NCT02201381|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93259731|NCT02201381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93259732|NCT02201381|Antimetabolites|antimetabolites|mesh-ancestor
93259733|NCT02201381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259734|NCT02201381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93259735|NCT02201381|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93259736|NCT02201381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259737|NCT02201381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93259738|NCT02201381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259739|NCT02201381|Antimalarials|antimalarials|mesh-ancestor
93259740|NCT02201381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93259741|NCT02201381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93259742|NCT02201381|Antinematodal Agents|antinematodal agents|mesh-ancestor
93259743|NCT02201381|Anthelmintics|anthelmintics|mesh-ancestor
93259744|NCT02201381|Tubulin Modulators|tubulin modulators|mesh-ancestor
93259745|NCT02201381|Antimitotic Agents|antimitotic agents|mesh-ancestor
93259746|NCT02201381|Mitosis Modulators|mitosis modulators|mesh-ancestor
93259747|NCT02201381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259748|NCT00803114|Morphine|morphine|mesh-list
93259749|NCT00803114|Narcotics|narcotics|mesh-list
93259750|NCT00803114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93259751|NCT00803114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259752|NCT00803114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259753|NCT00803114|Analgesics|analgesics|mesh-ancestor
93259754|NCT00803114|Sensory System Agents|sensory system agents|mesh-ancestor
93259755|NCT00803114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259756|NCT05519384|Cyclophosphamide|cyclophosphamide|mesh-list
93259757|NCT05519384|Fludarabine|fludarabine|mesh-list
93259758|NCT05519384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259759|NCT05519384|Immunologic Factors|immunologic factors|mesh-ancestor
93259760|NCT05519384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259761|NCT05519384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93259762|NCT05519384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93259763|NCT05519384|Alkylating Agents|alkylating agents|mesh-ancestor
93259764|NCT05519384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259765|NCT05519384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259766|NCT05519384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93259767|NCT05302271|Prednisone|prednisone|mesh-list
93259768|NCT05302271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93259769|NCT05302271|Glucocorticoids|glucocorticoids|mesh-ancestor
93259770|NCT05302271|Hormones|hormones|mesh-ancestor
93259771|NCT05302271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259772|NCT05302271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259773|NCT05302271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93259774|NCT05302271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259775|NCT00799292|Vasopressins|vasopressins|mesh-list
93259776|NCT00799292|Arginine Vasopressin|arginine vasopressin|mesh-list
93259777|NCT00799292|Hemostatics|hemostatics|mesh-ancestor
93259778|NCT00799292|Coagulants|coagulants|mesh-ancestor
93259779|NCT00799292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93259780|NCT00799292|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93259781|NCT00799292|Natriuretic Agents|natriuretic agents|mesh-ancestor
93259782|NCT00799292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259783|NCT02162849|Nicotine|nicotine|mesh-list
93259784|NCT02162849|Varenicline|varenicline|mesh-list
93259785|NCT02162849|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92931764|NCT00688623|Everolimus|everolimus|mesh-list
93259786|NCT02162849|Autonomic Agents|autonomic agents|mesh-ancestor
93259787|NCT02162849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259788|NCT02162849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259789|NCT02162849|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93259790|NCT02162849|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93259791|NCT02162849|Cholinergic Agents|cholinergic agents|mesh-ancestor
93259792|NCT02162849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259793|NCT02162849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259794|NCT02914275|Vaccines|vaccines|mesh-list
93259795|NCT02914275|Immunologic Factors|immunologic factors|mesh-ancestor
93259796|NCT02914275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259797|NCT01941875|Progesterone|progesterone|mesh-list
93259798|NCT01941875|Progestins|progestins|mesh-ancestor
93259799|NCT01941875|Hormones|hormones|mesh-ancestor
93259800|NCT01941875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259801|NCT01941875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259802|NCT05508074|Riluzole|riluzole|mesh-list
93259803|NCT05508074|Anticonvulsants|anticonvulsants|mesh-ancestor
93259804|NCT05508074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93259805|NCT05508074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93259806|NCT05508074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259807|NCT05508074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259808|NCT05508074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259809|NCT05508074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93259810|NCT05508074|Protective Agents|protective agents|mesh-ancestor
93259811|NCT01814657|Lidocaine|lidocaine|mesh-list
93259812|NCT01814657|Anesthetics, Local|anesthetics, local|mesh-ancestor
93259813|NCT01814657|Anesthetics|anesthetics|mesh-ancestor
93259814|NCT01814657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259815|NCT01814657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259816|NCT01814657|Sensory System Agents|sensory system agents|mesh-ancestor
93259817|NCT01814657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259818|NCT01814657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93259819|NCT01814657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93259820|NCT01814657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93259821|NCT01814657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259822|NCT01814657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259823|NCT01773395|Methotrexate|methotrexate|mesh-list
93259824|NCT01773395|Fludarabine|fludarabine|mesh-list
93259825|NCT01773395|Busulfan|busulfan|mesh-list
93259826|NCT01773395|Tacrolimus|tacrolimus|mesh-list
93259827|NCT01773395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93259828|NCT01773395|Abortifacient Agents|abortifacient agents|mesh-ancestor
93259829|NCT01773395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93259830|NCT01773395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259831|NCT01773395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93259832|NCT01773395|Antimetabolites|antimetabolites|mesh-ancestor
93259833|NCT01773395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259834|NCT01773395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259835|NCT01773395|Dermatologic Agents|dermatologic agents|mesh-ancestor
93259836|NCT01773395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259837|NCT01773395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93259838|NCT01773395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93259839|NCT01773395|Immunologic Factors|immunologic factors|mesh-ancestor
93259840|NCT01773395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93259841|NCT01773395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93259842|NCT01773395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93259843|NCT01773395|Alkylating Agents|alkylating agents|mesh-ancestor
93259844|NCT01773395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93259845|NCT01773395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93259846|NCT01000922|Insulin|insulin|mesh-list
93259847|NCT01000922|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93259848|NCT01000922|Insulin Glargine|insulin glargine|mesh-list
93259849|NCT01000922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93259850|NCT01000922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259851|NCT04559217|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93259852|NCT04559217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259853|NCT03666195|Titanium dioxide|titanium dioxide|mesh-list
93259854|NCT03666195|Sunscreening Agents|sunscreening agents|mesh-ancestor
93259855|NCT03666195|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93259856|NCT03666195|Protective Agents|protective agents|mesh-ancestor
93259857|NCT03666195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259858|NCT03666195|Dermatologic Agents|dermatologic agents|mesh-ancestor
93259859|NCT03666195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93259860|NCT00889382|Paclitaxel|paclitaxel|mesh-list
93259861|NCT00889382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93259862|NCT00889382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259863|NCT00889382|Tubulin Modulators|tubulin modulators|mesh-ancestor
93259864|NCT00889382|Antimitotic Agents|antimitotic agents|mesh-ancestor
93259865|NCT00889382|Mitosis Modulators|mitosis modulators|mesh-ancestor
93259866|NCT00889382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259867|NCT04059003|Taxane|taxane|mesh-list
93259868|NCT04059003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259869|NCT05375188|Dexmedetomidine|dexmedetomidine|mesh-list
93259870|NCT05375188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93259871|NCT05375188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259872|NCT05375188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259873|NCT05375188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93259874|NCT05375188|Analgesics|analgesics|mesh-ancestor
93259875|NCT05375188|Sensory System Agents|sensory system agents|mesh-ancestor
93259876|NCT05375188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259877|NCT05375188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93259878|NCT05375188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93259879|NCT05375188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93259880|NCT05375188|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259881|NCT05375188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259882|NCT05375188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259883|NCT00994292|Darexaban|darexaban|mesh-list
93259884|NCT00994292|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93259885|NCT00994292|Antithrombins|antithrombins|mesh-ancestor
93259886|NCT00994292|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93259887|NCT00994292|Protease Inhibitors|protease inhibitors|mesh-ancestor
93259888|NCT00994292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259889|NCT00994292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259890|NCT00994292|Anticoagulants|anticoagulants|mesh-ancestor
93259891|NCT02604433|Luspatercept|luspatercept|mesh-list
93259892|NCT02604433|Hematinics|hematinics|mesh-ancestor
93259893|NCT04437004|Fenfluramine|fenfluramine|mesh-list
93259894|NCT04437004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93259895|NCT04437004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93259896|NCT04437004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259897|NCT04437004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259898|NCT04437004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259899|NCT04437004|Serotonin Agents|serotonin agents|mesh-ancestor
93259900|NCT04437004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259901|NCT00992732|Valganciclovir|valganciclovir|mesh-list
93259902|NCT00992732|Ganciclovir|ganciclovir|mesh-list
93259903|NCT00992732|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93259904|NCT00992732|Arginine butyrate|arginine butyrate|mesh-list
93259905|NCT00992732|Antiviral Agents|antiviral agents|mesh-ancestor
93259906|NCT00992732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259907|NCT00992732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93259908|NCT00992732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259909|NCT00992732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259910|NCT00992732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259911|NCT00884234|Botulinum Toxins|botulinum toxins|mesh-list
93259912|NCT00884234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93259913|NCT00884234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93259914|NCT00884234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93259915|NCT00884234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93259916|NCT00884234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259917|NCT00884234|Cholinergic Agents|cholinergic agents|mesh-ancestor
93259918|NCT00884234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259919|NCT00884234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259920|NCT00884234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93259921|NCT00884234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259922|NCT03006393|Infliximab|infliximab|mesh-list
93259923|NCT03006393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93259924|NCT03006393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93259925|NCT03006393|Dermatologic Agents|dermatologic agents|mesh-ancestor
93259926|NCT03006393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93259927|NCT03006393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93259928|NCT00991172|Fasinumab|fasinumab|mesh-list
93259929|NCT00991172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93259930|NCT00991172|Analgesics|analgesics|mesh-ancestor
93259931|NCT00991172|Sensory System Agents|sensory system agents|mesh-ancestor
93259932|NCT00991172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259933|NCT00991172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931919|NCT00741741|Rilpivirine|rilpivirine|mesh-list
93259934|NCT01383109|Pyronaridine|pyronaridine|mesh-list
93259935|NCT01383109|Antimalarials|antimalarials|mesh-ancestor
93259936|NCT01383109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93259937|NCT01383109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93259938|NCT01383109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259939|NCT00882440|Losartan|losartan|mesh-list
93259940|NCT00882440|Enalapril|enalapril|mesh-list
93259941|NCT00882440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93259942|NCT00882440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93259943|NCT00882440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93259944|NCT00882440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93259945|NCT00882440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259946|NCT00882440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93259947|NCT00882440|Protease Inhibitors|protease inhibitors|mesh-ancestor
93259948|NCT00882440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259949|NCT05214391|Zanubrutinib|zanubrutinib|mesh-list
93259950|NCT05214391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93259951|NCT05214391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93259952|NCT05214391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259953|NCT05214391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259954|NCT00880490|Formoterol Fumarate|formoterol fumarate|mesh-list
93259955|NCT00880490|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93259956|NCT00880490|Autonomic Agents|autonomic agents|mesh-ancestor
93259957|NCT00880490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259958|NCT00880490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259959|NCT00880490|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93259960|NCT00880490|Respiratory System Agents|respiratory system agents|mesh-ancestor
93259961|NCT00880490|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93259962|NCT00880490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93259963|NCT00880490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93259964|NCT00880490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93259965|NCT00880490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93259966|NCT00880490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259967|NCT05214157|Bupivacaine|bupivacaine|mesh-list
93259968|NCT05214157|Anesthetics, Local|anesthetics, local|mesh-ancestor
93259969|NCT05214157|Anesthetics|anesthetics|mesh-ancestor
93259970|NCT05214157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93259971|NCT05214157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259972|NCT05214157|Sensory System Agents|sensory system agents|mesh-ancestor
93259973|NCT05214157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93259974|NCT04549467|Tenofovir|tenofovir|mesh-list
93259975|NCT04549467|Lamivudine|lamivudine|mesh-list
93259976|NCT04549467|Emtricitabine|emtricitabine|mesh-list
93259977|NCT04549467|Dolutegravir|dolutegravir|mesh-list
93259978|NCT04549467|Antiviral Agents|antiviral agents|mesh-ancestor
93259979|NCT04549467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93259980|NCT04549467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93259981|NCT04549467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93259982|NCT04549467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93259983|NCT04549467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93259984|NCT04549467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93259985|NCT04549467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93259986|NCT04549467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93259987|NCT04549467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93259988|NCT03630341|Clomiphene|clomiphene|mesh-list
93259989|NCT03630341|Enclomiphene|enclomiphene|mesh-list
93259990|NCT03630341|Zuclomiphene|zuclomiphene|mesh-list
93259991|NCT03630341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93259992|NCT03630341|Hormone Antagonists|hormone antagonists|mesh-ancestor
93259993|NCT03630341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93259994|NCT03630341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93259995|NCT03630341|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93259996|NCT03630341|Fertility Agents|fertility agents|mesh-ancestor
93259997|NCT03630341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93259998|NCT03630341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93259999|NCT03630341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93260000|NCT02632396|Rituximab|rituximab|mesh-list
93260001|NCT02632396|Ixazomib|ixazomib|mesh-list
93260002|NCT02632396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93260003|NCT02632396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260004|NCT02632396|Immunologic Factors|immunologic factors|mesh-ancestor
93260005|NCT02632396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260006|NCT02632396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93260007|NCT02632396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931991|NCT00719264|Growth Substances|growth substances|mesh-ancestor
93260008|NCT02632396|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260009|NCT02632396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260010|NCT05102422|Propofol|propofol|mesh-list
93260011|NCT05102422|Sevoflurane|sevoflurane|mesh-list
93260012|NCT05102422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93260013|NCT05102422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260014|NCT05102422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260015|NCT05102422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93260016|NCT05102422|Anesthetics, General|anesthetics, general|mesh-ancestor
93260017|NCT05102422|Anesthetics|anesthetics|mesh-ancestor
93260018|NCT05102422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93260019|NCT05102422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93260020|NCT01088789|Cyclophosphamide|cyclophosphamide|mesh-list
93260021|NCT01088789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93260022|NCT01088789|Immunologic Factors|immunologic factors|mesh-ancestor
93260023|NCT01088789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260024|NCT01088789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554710|NCT01349673|Budesonide|budesonide|mesh-list
93260025|NCT01088789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93260026|NCT01088789|Alkylating Agents|alkylating agents|mesh-ancestor
93260027|NCT01088789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260028|NCT01088789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260029|NCT01088789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93260030|NCT03665181|Bismuth|bismuth|mesh-list
93260031|NCT03665181|Antacids|antacids|mesh-ancestor
93260032|NCT03665181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260033|NCT03665181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93260034|NCT05326906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93260035|NCT05326906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260036|NCT05326906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93260037|NCT05326906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260038|NCT05101954|Mitogens|mitogens|mesh-list
93260039|NCT05101954|Mitosis Modulators|mitosis modulators|mesh-ancestor
93260040|NCT05101954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260041|NCT00875108|Insulin|insulin|mesh-list
93260042|NCT00875108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93260043|NCT00875108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260044|NCT00875108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260045|NCT04044209|Nivolumab|nivolumab|mesh-list
93260046|NCT04044209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93260047|NCT04044209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260048|NCT04044209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93260049|NCT04044209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260050|NCT03817463|Empagliflozin|empagliflozin|mesh-list
93260051|NCT03817463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93260052|NCT03817463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93260053|NCT03817463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260054|NCT03817463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260055|NCT03817463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260056|NCT03817463|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260057|NCT03817463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260058|NCT05207683|Antibodies|antibodies|mesh-list
93260059|NCT05207683|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
93260060|NCT05207683|Immunologic Factors|immunologic factors|mesh-ancestor
93260061|NCT05207683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260062|NCT03000075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93260063|NCT03000075|Immunologic Factors|immunologic factors|mesh-ancestor
93260064|NCT03000075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260065|NCT05213065|Bupivacaine|bupivacaine|mesh-list
93260066|NCT05213065|Anesthetics, Local|anesthetics, local|mesh-ancestor
93260067|NCT05213065|Anesthetics|anesthetics|mesh-ancestor
93260068|NCT05213065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260069|NCT05213065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260070|NCT05213065|Sensory System Agents|sensory system agents|mesh-ancestor
93260071|NCT05213065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260072|NCT04578938|Ketamine|ketamine|mesh-list
93260073|NCT04578938|Analgesics|analgesics|mesh-ancestor
93260074|NCT04578938|Sensory System Agents|sensory system agents|mesh-ancestor
93260075|NCT04578938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260076|NCT04578938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260077|NCT04578938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93260078|NCT04578938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92554774|NCT00071331|Tolvaptan|tolvaptan|mesh-list
93260079|NCT04578938|Anesthetics, General|anesthetics, general|mesh-ancestor
93260080|NCT04578938|Anesthetics|anesthetics|mesh-ancestor
93260081|NCT04578938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260082|NCT04578938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93260083|NCT04578938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93260084|NCT04578938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260085|NCT04578938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260086|NCT00969722|Tretinoin|tretinoin|mesh-list
93260087|NCT00969722|Molgramostim|molgramostim|mesh-list
93260088|NCT00969722|Isotretinoin|isotretinoin|mesh-list
93260089|NCT00969722|Sargramostim|sargramostim|mesh-list
93260090|NCT00969722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260091|NCT00969722|Keratolytic Agents|keratolytic agents|mesh-ancestor
93260092|NCT00969722|Dermatologic Agents|dermatologic agents|mesh-ancestor
93260093|NCT00969722|Immunologic Factors|immunologic factors|mesh-ancestor
93260094|NCT00969722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260095|NCT05099614|Naloxone|naloxone|mesh-list
93260096|NCT05099614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93260097|NCT05099614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260098|NCT05099614|Sensory System Agents|sensory system agents|mesh-ancestor
93260099|NCT05099614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260100|NCT00968942|Botulinum Toxins|botulinum toxins|mesh-list
93260101|NCT00968942|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93260102|NCT00968942|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93260103|NCT00968942|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93260104|NCT00968942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260105|NCT00968942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260106|NCT00968942|Cholinergic Agents|cholinergic agents|mesh-ancestor
93260107|NCT00968942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260108|NCT00968942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260109|NCT00968942|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93260110|NCT00968942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260111|NCT05283382|Cannabidiol|cannabidiol|mesh-list
93260112|NCT05283382|Anticonvulsants|anticonvulsants|mesh-ancestor
93260113|NCT00869336|Luliconazole|luliconazole|mesh-list
93260114|NCT00869336|Antifungal Agents|antifungal agents|mesh-ancestor
93260115|NCT00869336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260116|NCT02371889|Topiramate|topiramate|mesh-list
93260117|NCT02371889|Anticonvulsants|anticonvulsants|mesh-ancestor
93260118|NCT02371889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260119|NCT02371889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260120|NCT00860288|Metformin|metformin|mesh-list
93260121|NCT00860288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93260122|NCT00860288|Vildagliptin|vildagliptin|mesh-list
93260123|NCT00860288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260124|NCT00860288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260125|NCT00860288|Incretins|incretins|mesh-ancestor
93260126|NCT00860288|Hormones|hormones|mesh-ancestor
93260127|NCT00860288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260128|NCT00860288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93260129|NCT00860288|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260130|NCT00860288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260131|NCT00860288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260132|NCT03630029|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93260133|NCT03630029|Hematinics|hematinics|mesh-ancestor
93260134|NCT05763953|Etripamil|etripamil|mesh-list
93260135|NCT05763953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93260136|NCT05763953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260137|NCT05763953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260138|NCT05763953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260139|NCT05763953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260140|NCT05212597|Losartan|losartan|mesh-list
93260141|NCT05212597|Amlodipine|amlodipine|mesh-list
93260142|NCT05212597|Valsartan|valsartan|mesh-list
93260143|NCT05212597|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93260144|NCT05212597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93260145|NCT05212597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93260146|NCT05212597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260147|NCT05212597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260148|NCT05212597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260149|NCT05212597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260150|NCT05212597|Vasodilator Agents|vasodilator agents|mesh-ancestor
93260151|NCT05212597|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93260152|NCT05212597|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93260153|NCT05212597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260154|NCT02450812|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93260155|NCT02450812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260156|NCT03629717|Vitamin D|vitamin d|mesh-list
93260157|NCT03629717|Denosumab|denosumab|mesh-list
93260158|NCT03629717|Calcium|calcium|mesh-list
93260159|NCT03629717|Vitamins|vitamins|mesh-ancestor
93260160|NCT03629717|Micronutrients|micronutrients|mesh-ancestor
93260161|NCT03629717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260162|NCT03629717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260163|NCT03629717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93260164|NCT05108350|Metformin|metformin|mesh-list
93260165|NCT05108350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260166|NCT05108350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260167|NCT00859430|Levetiracetam|levetiracetam|mesh-list
93260168|NCT00859430|Anticonvulsants|anticonvulsants|mesh-ancestor
93260169|NCT00859430|Nootropic Agents|nootropic agents|mesh-ancestor
93260170|NCT00855764|Paclitaxel|paclitaxel|mesh-list
93260171|NCT00855764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93260172|NCT00855764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260173|NCT00855764|Tubulin Modulators|tubulin modulators|mesh-ancestor
93260174|NCT00855764|Antimitotic Agents|antimitotic agents|mesh-ancestor
93260175|NCT00855764|Mitosis Modulators|mitosis modulators|mesh-ancestor
93260176|NCT00855764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260177|NCT00959036|Methotrexate|methotrexate|mesh-list
93260178|NCT00959036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93260179|NCT00959036|Abortifacient Agents|abortifacient agents|mesh-ancestor
93260180|NCT00959036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93260181|NCT00959036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260182|NCT00959036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93260183|NCT00959036|Antimetabolites|antimetabolites|mesh-ancestor
93260184|NCT00959036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260185|NCT00959036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260186|NCT00959036|Dermatologic Agents|dermatologic agents|mesh-ancestor
93260187|NCT00959036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260188|NCT00959036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93260189|NCT00959036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93260190|NCT00959036|Immunologic Factors|immunologic factors|mesh-ancestor
93260191|NCT00959036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93260192|NCT00959036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93260193|NCT04129723|Tin Fluorides|tin fluorides|mesh-list
93260194|NCT04129723|Cariostatic Agents|cariostatic agents|mesh-ancestor
93260195|NCT04129723|Protective Agents|protective agents|mesh-ancestor
93260196|NCT04129723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260197|NCT04474262|Midodrine|midodrine|mesh-list
93260198|NCT04474262|Sympathomimetics|sympathomimetics|mesh-ancestor
93260199|NCT04474262|Autonomic Agents|autonomic agents|mesh-ancestor
93260200|NCT04474262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260201|NCT04474262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260202|NCT04474262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93260203|NCT04474262|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93260204|NCT04474262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93260205|NCT04474262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93260206|NCT04474262|Adrenergic Agents|adrenergic agents|mesh-ancestor
93260207|NCT04474262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260208|NCT04474262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260209|NCT05211583|Progesterone|progesterone|mesh-list
93260210|NCT05211583|Progestins|progestins|mesh-ancestor
93260211|NCT05211583|Hormones|hormones|mesh-ancestor
93260212|NCT05211583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260213|NCT05211583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260214|NCT04031599|Hormones|hormones|mesh-list
93260215|NCT04031599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260216|NCT04031599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260217|NCT04724759|Lidocaine|lidocaine|mesh-list
93260218|NCT04724759|Dexmedetomidine|dexmedetomidine|mesh-list
93260219|NCT04724759|Ketamine|ketamine|mesh-list
93260220|NCT04724759|Anesthetics, Local|anesthetics, local|mesh-ancestor
93260221|NCT04724759|Anesthetics|anesthetics|mesh-ancestor
93260222|NCT04724759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260223|NCT04724759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260224|NCT04724759|Sensory System Agents|sensory system agents|mesh-ancestor
93260225|NCT04724759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260226|NCT04724759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260227|NCT04724759|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93260228|NCT04724759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93260229|NCT04724759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260230|NCT04724759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260231|NCT04724759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93260232|NCT04724759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260233|NCT04724759|Analgesics|analgesics|mesh-ancestor
93260234|NCT04724759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93260235|NCT04724759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93260236|NCT04724759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93260237|NCT04724759|Adrenergic Agents|adrenergic agents|mesh-ancestor
93260238|NCT04724759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260239|NCT04724759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93260240|NCT04724759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93260241|NCT04724759|Anesthetics, General|anesthetics, general|mesh-ancestor
93260242|NCT04724759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93260243|NCT04724759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93260244|NCT04019821|Insulin|insulin|mesh-list
93260245|NCT04019821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93260246|NCT04019821|Insulin Aspart|insulin aspart|mesh-list
93260247|NCT04019821|Insulin Lispro|insulin lispro|mesh-list
93260248|NCT04019821|Insulin glulisine|insulin glulisine|mesh-list
93260249|NCT04019821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260250|NCT04019821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260251|NCT05186467|Magnesium Sulfate|magnesium sulfate|mesh-list
93260252|NCT05186467|Analgesics|analgesics|mesh-ancestor
93260253|NCT05186467|Sensory System Agents|sensory system agents|mesh-ancestor
93260254|NCT05186467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260255|NCT05186467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260256|NCT05186467|Anesthetics|anesthetics|mesh-ancestor
93260257|NCT05186467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260258|NCT05186467|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260259|NCT05186467|Anticonvulsants|anticonvulsants|mesh-ancestor
93260260|NCT05186467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93260261|NCT05186467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260262|NCT05186467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260263|NCT05186467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260264|NCT05186467|Tocolytic Agents|tocolytic agents|mesh-ancestor
93260265|NCT05186467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93260266|NCT00771134|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93260267|NCT00771134|Antidepressive Agents|antidepressive agents|mesh-ancestor
93260268|NCT00771134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260269|NCT00771134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93260270|NCT00771134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93260271|NCT00771134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260272|NCT00771134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260273|NCT00768482|Buprenorphine|buprenorphine|mesh-list
93260274|NCT00768482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93260275|NCT00768482|Narcotics|narcotics|mesh-ancestor
93260276|NCT00768482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260277|NCT00768482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260278|NCT00768482|Analgesics|analgesics|mesh-ancestor
93260279|NCT00768482|Sensory System Agents|sensory system agents|mesh-ancestor
93260280|NCT00768482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260281|NCT00768482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93260282|NCT00840866|Cefprozil|cefprozil|mesh-list
93260283|NCT00840866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93260284|NCT00840866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260285|NCT05043116|Vitamin D|vitamin d|mesh-list
93260286|NCT05043116|Cholecalciferol|cholecalciferol|mesh-list
93260287|NCT05043116|Vitamins|vitamins|mesh-ancestor
93260288|NCT05043116|Micronutrients|micronutrients|mesh-ancestor
93260289|NCT05043116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260290|NCT05043116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93260291|NCT05043116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260292|NCT00840632|Trandolapril|trandolapril|mesh-list
93260293|NCT00840632|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93260294|NCT00840632|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260295|NCT00840632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260296|NCT00840632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260297|NCT00840632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93260298|NCT00840476|Meloxicam|meloxicam|mesh-list
93260299|NCT00840476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93260300|NCT00840476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260301|NCT00840476|Analgesics|analgesics|mesh-ancestor
93260302|NCT00840476|Sensory System Agents|sensory system agents|mesh-ancestor
93260303|NCT00840476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260304|NCT00840476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260305|NCT00840476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93260306|NCT00840476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93260307|NCT00840476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93260308|NCT00840476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93260309|NCT00840476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260310|NCT00840476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260311|NCT00765830|Vildagliptin|vildagliptin|mesh-list
93260312|NCT00765830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260313|NCT00765830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260314|NCT00765830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93260315|NCT00765830|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260316|NCT00765830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260317|NCT00765830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260318|NCT03664869|Mitomycins|mitomycins|mesh-list
93260319|NCT03664869|Mitomycin|mitomycin|mesh-list
93260320|NCT03664869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93260321|NCT03664869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260322|NCT03664869|Alkylating Agents|alkylating agents|mesh-ancestor
93260323|NCT03664869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260324|NCT03664869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93260325|NCT03664869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260326|NCT00953420|Dexamethasone|dexamethasone|mesh-list
93260327|NCT00953420|Carboplatin|carboplatin|mesh-list
93260328|NCT00953420|Docetaxel|docetaxel|mesh-list
93260329|NCT00953420|Lenograstim|lenograstim|mesh-list
93260330|NCT00953420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93260331|NCT00953420|Antiemetics|antiemetics|mesh-ancestor
93260332|NCT00953420|Autonomic Agents|autonomic agents|mesh-ancestor
93260333|NCT00953420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260334|NCT00953420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260335|NCT00953420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93260336|NCT00953420|Glucocorticoids|glucocorticoids|mesh-ancestor
93260337|NCT00953420|Hormones|hormones|mesh-ancestor
93260338|NCT00953420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260339|NCT00953420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93260340|NCT00953420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260341|NCT00953420|Tubulin Modulators|tubulin modulators|mesh-ancestor
93260342|NCT00953420|Antimitotic Agents|antimitotic agents|mesh-ancestor
93260343|NCT00953420|Mitosis Modulators|mitosis modulators|mesh-ancestor
93260344|NCT00953420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260345|NCT00953420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93260346|NCT00953420|Immunologic Factors|immunologic factors|mesh-ancestor
93260347|NCT01602562|Valacyclovir|valacyclovir|mesh-list
93260348|NCT01602562|Antiviral Agents|antiviral agents|mesh-ancestor
93260349|NCT01602562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260350|NCT01945775|Talazoparib|talazoparib|mesh-list
93260351|NCT01945775|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93260352|NCT01945775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260353|NCT01945775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260354|NCT01945775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260355|NCT00839930|Cilostazol|cilostazol|mesh-list
93260356|NCT00839930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93260357|NCT00839930|Autonomic Agents|autonomic agents|mesh-ancestor
93260358|NCT00839930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260359|NCT00839930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260360|NCT00839930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93260361|NCT00839930|Respiratory System Agents|respiratory system agents|mesh-ancestor
93260362|NCT00839930|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93260363|NCT00839930|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93260364|NCT00839930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260365|NCT00839930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93260366|NCT00839930|Vasodilator Agents|vasodilator agents|mesh-ancestor
93260367|NCT00839930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93260368|NCT00839930|Protective Agents|protective agents|mesh-ancestor
93260369|NCT00839930|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93260370|NCT00839930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93260371|NCT00839930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260372|NCT00838136|Lamotrigine|lamotrigine|mesh-list
93260373|NCT00838136|Anticonvulsants|anticonvulsants|mesh-ancestor
93260374|NCT00838136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93260375|NCT00838136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260376|NCT00838136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260377|NCT00838136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260378|NCT00838136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260379|NCT00838136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93260380|NCT00838136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93260381|NCT00838136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260382|NCT00838136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260383|NCT00838136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93260384|NCT00944294|Adenosine|adenosine|mesh-list
93260385|NCT00944294|Binodenoson|binodenoson|mesh-list
93260386|NCT00944294|Analgesics|analgesics|mesh-ancestor
93260387|NCT00944294|Sensory System Agents|sensory system agents|mesh-ancestor
93260388|NCT00944294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260389|NCT00944294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260390|NCT00944294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260391|NCT00944294|Vasodilator Agents|vasodilator agents|mesh-ancestor
93260392|NCT00944294|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93260393|NCT00944294|Purinergic Agonists|purinergic agonists|mesh-ancestor
93260394|NCT00944294|Purinergic Agents|purinergic agents|mesh-ancestor
93260395|NCT00944294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260396|NCT00944294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260397|NCT00758966|Naltrexone|naltrexone|mesh-list
93260398|NCT00758966|Fluoxetine|fluoxetine|mesh-list
93260399|NCT00758966|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93260400|NCT00758966|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93260401|NCT00758966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260402|NCT00758966|Sensory System Agents|sensory system agents|mesh-ancestor
93260403|NCT00758966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260404|NCT00758966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93260405|NCT00758966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93260406|NCT00758966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260407|NCT00758966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260408|NCT00758966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260409|NCT00758966|Serotonin Agents|serotonin agents|mesh-ancestor
93260410|NCT00758966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93260411|NCT00758966|Antidepressive Agents|antidepressive agents|mesh-ancestor
93260412|NCT00758966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260413|NCT00758966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93260414|NCT00758966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93260415|NCT00758966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260416|NCT03072719|Fluorides|fluorides|mesh-list
93260417|NCT03072719|Tin Fluorides|tin fluorides|mesh-list
93260418|NCT03072719|Fluorophosphate|fluorophosphate|mesh-list
93260419|NCT03072719|Cariostatic Agents|cariostatic agents|mesh-ancestor
93260420|NCT03072719|Protective Agents|protective agents|mesh-ancestor
93260421|NCT03072719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260422|NCT05106400|Lidocaine|lidocaine|mesh-list
93260423|NCT05106400|Menthol|menthol|mesh-list
93260424|NCT05106400|Anesthetics, Local|anesthetics, local|mesh-ancestor
93260425|NCT05106400|Anesthetics|anesthetics|mesh-ancestor
93260426|NCT05106400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260427|NCT05106400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260428|NCT05106400|Sensory System Agents|sensory system agents|mesh-ancestor
93260429|NCT05106400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260430|NCT05106400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260431|NCT05106400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93260432|NCT05106400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93260433|NCT05106400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260434|NCT05106400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260435|NCT05106400|Antipruritics|antipruritics|mesh-ancestor
93260436|NCT05106400|Dermatologic Agents|dermatologic agents|mesh-ancestor
93260437|NCT00754988|Metformin|metformin|mesh-list
93260438|NCT00754988|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93260439|NCT00754988|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93260440|NCT00754988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260441|NCT00754988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260442|NCT00754988|Incretins|incretins|mesh-ancestor
93260443|NCT00754988|Hormones|hormones|mesh-ancestor
93260444|NCT00754988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260445|NCT00754988|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93260446|NCT00754988|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260447|NCT00754988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260448|NCT00754988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260449|NCT01416935|Amiodarone|amiodarone|mesh-list
93260450|NCT01416935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260451|NCT01416935|Vasodilator Agents|vasodilator agents|mesh-ancestor
93260452|NCT01416935|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93260453|NCT01416935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260454|NCT01416935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555144|NCT00203632|Rosiglitazone|rosiglitazone|mesh-list
93260455|NCT01416935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93260456|NCT01416935|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93260457|NCT01416935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93260458|NCT01416935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260459|NCT01416935|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93260460|NCT01416935|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93260461|NCT01416935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93260462|NCT05012566|Botulinum Toxins|botulinum toxins|mesh-list
93260463|NCT05012566|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93260464|NCT05012566|Hyaluronic Acid|hyaluronic acid|mesh-list
93260465|NCT05012566|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93260466|NCT05012566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260467|NCT05012566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260468|NCT05012566|Cholinergic Agents|cholinergic agents|mesh-ancestor
93260469|NCT05012566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260470|NCT05012566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260471|NCT05012566|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93260472|NCT05012566|Immunologic Factors|immunologic factors|mesh-ancestor
93260473|NCT05012566|Viscosupplements|viscosupplements|mesh-ancestor
93260474|NCT05012566|Protective Agents|protective agents|mesh-ancestor
93260475|NCT05012566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93260476|NCT05012566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260477|NCT05202665|Fluorides|fluorides|mesh-list
93260478|NCT05202665|Fluorides, Topical|fluorides, topical|mesh-list
93260479|NCT05202665|Cariostatic Agents|cariostatic agents|mesh-ancestor
93260480|NCT05202665|Protective Agents|protective agents|mesh-ancestor
93260481|NCT05202665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260482|NCT04438772|Anesthetics|anesthetics|mesh-list
93260483|NCT04438772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260484|NCT04438772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260485|NCT04560634|Norepinephrine|norepinephrine|mesh-list
93260486|NCT04560634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93260487|NCT04560634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93260488|NCT04560634|Adrenergic Agents|adrenergic agents|mesh-ancestor
93260489|NCT04560634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260490|NCT04560634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260491|NCT04560634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260492|NCT04560634|Sympathomimetics|sympathomimetics|mesh-ancestor
93260493|NCT04560634|Autonomic Agents|autonomic agents|mesh-ancestor
93260494|NCT04560634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260495|NCT04560634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93260496|NCT00927914|Ranirestat|ranirestat|mesh-list
93260497|NCT00927914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260498|NCT00927914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260499|NCT05261464|Metoprolol|metoprolol|mesh-list
93260500|NCT05261464|Diltiazem|diltiazem|mesh-list
93260501|NCT05261464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260502|NCT05261464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93260503|NCT05261464|Sympatholytics|sympatholytics|mesh-ancestor
93260504|NCT05261464|Autonomic Agents|autonomic agents|mesh-ancestor
93260505|NCT05261464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260506|NCT05261464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260507|NCT05261464|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93260508|NCT05261464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93260509|NCT05261464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93260510|NCT05261464|Adrenergic Agents|adrenergic agents|mesh-ancestor
93260511|NCT05261464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260512|NCT05261464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260513|NCT05261464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93260514|NCT05261464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260515|NCT05261464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260516|NCT05261464|Vasodilator Agents|vasodilator agents|mesh-ancestor
93260517|NCT05681377|Flumazenil|flumazenil|mesh-list
93260518|NCT05681377|Antidotes|antidotes|mesh-ancestor
93260519|NCT05681377|Protective Agents|protective agents|mesh-ancestor
93260520|NCT05681377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260521|NCT05681377|GABA Modulators|gaba modulators|mesh-ancestor
93260522|NCT05681377|GABA Agents|gaba agents|mesh-ancestor
93260523|NCT05681377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260524|NCT05681377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260525|NCT00835796|Finasteride|finasteride|mesh-list
93260526|NCT00835796|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93260527|NCT00835796|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92932541|NCT00715520|Levodopa|levodopa|mesh-list
93260528|NCT00835796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260529|NCT00835796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260530|NCT00835796|Hormone Antagonists|hormone antagonists|mesh-ancestor
93260531|NCT00835796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260532|NCT00835796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260533|NCT00835796|Urological Agents|urological agents|mesh-ancestor
93260534|NCT05106712|Vitamin D|vitamin d|mesh-list
93260535|NCT05106712|Cholecalciferol|cholecalciferol|mesh-list
93260536|NCT05106712|Letrozole|letrozole|mesh-list
93260537|NCT05106712|Clomiphene|clomiphene|mesh-list
93260538|NCT05106712|Enclomiphene|enclomiphene|mesh-list
93260539|NCT05106712|Zuclomiphene|zuclomiphene|mesh-list
93260540|NCT05106712|Vitamins|vitamins|mesh-ancestor
93260541|NCT05106712|Micronutrients|micronutrients|mesh-ancestor
93260542|NCT05106712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260543|NCT05106712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93260544|NCT05106712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260545|NCT05106712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93260546|NCT05106712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260547|NCT05106712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93260548|NCT05106712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93260549|NCT05106712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260550|NCT05106712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93260551|NCT05106712|Hormone Antagonists|hormone antagonists|mesh-ancestor
93260552|NCT05106712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260553|NCT05106712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93260554|NCT05106712|Fertility Agents|fertility agents|mesh-ancestor
93260555|NCT05106712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93260556|NCT05106712|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93260557|NCT05106712|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93260558|NCT05105698|Dapagliflozin|dapagliflozin|mesh-list
93260559|NCT05105698|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93260560|NCT05105698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93260561|NCT05105698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260562|NCT05105698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260563|NCT05105698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260564|NCT05105698|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260565|NCT05105698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260566|NCT00835640|Fexofenadine|fexofenadine|mesh-list
93260567|NCT00835640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93260568|NCT00835640|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93260569|NCT00835640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93260570|NCT00835640|Histamine Antagonists|histamine antagonists|mesh-ancestor
93260571|NCT00835640|Histamine Agents|histamine agents|mesh-ancestor
93260572|NCT00835640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260573|NCT00835640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260574|NCT00835640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260575|NCT00752570|Trebananib|trebananib|mesh-list
93260576|NCT00752570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93260577|NCT00752570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93260578|NCT00752570|Growth Substances|growth substances|mesh-ancestor
93260579|NCT00752570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260580|NCT00752570|Growth Inhibitors|growth inhibitors|mesh-ancestor
93260581|NCT00752570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260582|NCT05083000|Topotecan|topotecan|mesh-list
93260583|NCT05083000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93260584|NCT05083000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93260585|NCT05083000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260586|NCT05083000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260587|NCT05083000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260588|NCT00752258|Botulinum Toxins|botulinum toxins|mesh-list
93260589|NCT00752258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93260590|NCT00752258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93260591|NCT00752258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93260592|NCT00752258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260593|NCT00752258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260594|NCT00752258|Cholinergic Agents|cholinergic agents|mesh-ancestor
93260595|NCT00752258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260596|NCT00752258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260597|NCT00752258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93260598|NCT00752258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260599|NCT02942017|Brexanolone|brexanolone|mesh-list
93260600|NCT02942017|Neurosteroids|neurosteroids|mesh-ancestor
93260601|NCT02942017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260602|NCT02942017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260603|NCT02942017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260604|NCT02942017|GABA Modulators|gaba modulators|mesh-ancestor
93260605|NCT02942017|GABA Agents|gaba agents|mesh-ancestor
93260606|NCT04447781|Citric Acid|citric acid|mesh-list
93260607|NCT04447781|Sodium Citrate|sodium citrate|mesh-list
93260608|NCT04447781|Anticoagulants|anticoagulants|mesh-ancestor
93260609|NCT04447781|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93260610|NCT04447781|Chelating Agents|chelating agents|mesh-ancestor
93260611|NCT04447781|Sequestering Agents|sequestering agents|mesh-ancestor
93260612|NCT04447781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260613|NCT04364776|Durvalumab|durvalumab|mesh-list
93260614|NCT04364776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93260615|NCT04364776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260616|NCT00835484|Cefdinir|cefdinir|mesh-list
93260617|NCT00835484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93260618|NCT00835484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260619|NCT00835406|Alendronate|alendronate|mesh-list
93260620|NCT00835406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93260621|NCT00835406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260622|NCT05202275|Olanzapine|olanzapine|mesh-list
93260623|NCT05202275|Aprepitant|aprepitant|mesh-list
93260624|NCT05202275|Palonosetron|palonosetron|mesh-list
93260625|NCT05202275|Antiemetics|antiemetics|mesh-ancestor
93260626|NCT05202275|Autonomic Agents|autonomic agents|mesh-ancestor
93260627|NCT05202275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260628|NCT05202275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260629|NCT05202275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93260630|NCT05202275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93260631|NCT05202275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93260632|NCT05202275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260633|NCT05202275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260634|NCT05202275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93260635|NCT05202275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93260636|NCT05202275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260637|NCT05202275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260638|NCT05202275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260639|NCT05202275|Serotonin Agents|serotonin agents|mesh-ancestor
93260640|NCT05202275|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93260641|NCT05202275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93260642|NCT05202275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93260643|NCT04369937|Pembrolizumab|pembrolizumab|mesh-list
93260644|NCT04369937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260645|NCT04369937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93260646|NCT04369937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93260647|NCT04369937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260648|NCT00745316|Adenosine|adenosine|mesh-list
93260649|NCT00745316|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-list
93260650|NCT00745316|Analgesics|analgesics|mesh-ancestor
93260651|NCT00745316|Sensory System Agents|sensory system agents|mesh-ancestor
93260652|NCT00745316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260653|NCT00745316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260654|NCT00745316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260655|NCT00745316|Vasodilator Agents|vasodilator agents|mesh-ancestor
93260656|NCT00745316|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93260657|NCT00745316|Purinergic Agonists|purinergic agonists|mesh-ancestor
93260658|NCT00745316|Purinergic Agents|purinergic agents|mesh-ancestor
93260659|NCT00745316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260660|NCT00745316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260661|NCT00745316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93260662|NCT00745316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93260663|NCT00744926|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93260664|NCT00744926|Incretins|incretins|mesh-ancestor
93260665|NCT00744926|Hormones|hormones|mesh-ancestor
93260666|NCT00744926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260667|NCT00744926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260668|NCT03838744|Olaparib|olaparib|mesh-list
93260669|NCT03838744|Trabectedin|trabectedin|mesh-list
93260670|NCT03838744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93260671|NCT03838744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260672|NCT03838744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260673|NCT03838744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260674|NCT03838744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93260675|NCT03838744|Alkylating Agents|alkylating agents|mesh-ancestor
93260676|NCT05327348|Ascorbic Acid|ascorbic acid|mesh-list
93260677|NCT05327348|Antioxidants|antioxidants|mesh-ancestor
93260678|NCT05327348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260679|NCT05327348|Protective Agents|protective agents|mesh-ancestor
93260680|NCT05327348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260681|NCT05327348|Vitamins|vitamins|mesh-ancestor
93260682|NCT05327348|Micronutrients|micronutrients|mesh-ancestor
93260683|NCT04695106|Aspirin|aspirin|mesh-list
93260684|NCT04695106|Dabigatran|dabigatran|mesh-list
93260685|NCT04695106|Clopidogrel|clopidogrel|mesh-list
93260686|NCT04695106|Ticagrelor|ticagrelor|mesh-list
93260687|NCT04695106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93260688|NCT04695106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260689|NCT04695106|Analgesics|analgesics|mesh-ancestor
93260690|NCT04695106|Sensory System Agents|sensory system agents|mesh-ancestor
93260691|NCT04695106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260692|NCT04695106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260693|NCT04695106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93260694|NCT04695106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93260695|NCT04695106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93260696|NCT04695106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93260697|NCT04695106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260698|NCT04695106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93260699|NCT04695106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93260700|NCT04695106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260701|NCT04695106|Antipyretics|antipyretics|mesh-ancestor
93260702|NCT04695106|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93260703|NCT04695106|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93260704|NCT04695106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93260705|NCT04695106|Purinergic Agents|purinergic agents|mesh-ancestor
93260706|NCT04695106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260707|NCT04695106|Antithrombins|antithrombins|mesh-ancestor
93260708|NCT04695106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93260709|NCT04695106|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260710|NCT04695106|Anticoagulants|anticoagulants|mesh-ancestor
93260711|NCT04032665|Rivaroxaban|rivaroxaban|mesh-list
93260712|NCT04032665|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93260713|NCT04032665|Antithrombins|antithrombins|mesh-ancestor
93260714|NCT04032665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93260715|NCT04032665|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260716|NCT04032665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260717|NCT04032665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260718|NCT04032665|Anticoagulants|anticoagulants|mesh-ancestor
93260719|NCT03629639|Metformin|metformin|mesh-list
93260720|NCT03629639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260721|NCT03629639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260722|NCT00835172|Glimepiride|glimepiride|mesh-list
93260723|NCT00835172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260724|NCT00835172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260725|NCT00835172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260726|NCT00835172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93260727|NCT00835172|Immunologic Factors|immunologic factors|mesh-ancestor
93260728|NCT04941755|Famotidine|famotidine|mesh-list
93260729|NCT04941755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93260730|NCT04941755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93260731|NCT04941755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93260732|NCT04941755|Histamine Antagonists|histamine antagonists|mesh-ancestor
93260733|NCT04941755|Histamine Agents|histamine agents|mesh-ancestor
93260734|NCT04941755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260735|NCT04941755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260736|NCT04941755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260737|NCT04921735|Cisatracurium|cisatracurium|mesh-list
93260738|NCT04921735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93260739|NCT04921735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93260740|NCT04921735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260741|NCT04921735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260742|NCT01676116|Liraglutide|liraglutide|mesh-list
93260743|NCT01676116|Exenatide|exenatide|mesh-list
93260744|NCT01676116|Xultophy|xultophy|mesh-list
93260745|NCT01676116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260746|NCT01676116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260747|NCT01676116|Incretins|incretins|mesh-ancestor
93260748|NCT01676116|Hormones|hormones|mesh-ancestor
93260749|NCT01676116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260750|NCT01676116|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93260751|NCT05200793|Metformin|metformin|mesh-list
93260752|NCT05200793|Empagliflozin|empagliflozin|mesh-list
93260753|NCT05200793|Linagliptin|linagliptin|mesh-list
93260754|NCT05200793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93260755|NCT05200793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260756|NCT05200793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93260757|NCT05200793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260759|NCT05200793|Hormones|hormones|mesh-ancestor
93260760|NCT05200793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555437|NCT00205738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93260761|NCT05200793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93260762|NCT05200793|Protease Inhibitors|protease inhibitors|mesh-ancestor
93260763|NCT05200793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260764|NCT03383224|Nicotine|nicotine|mesh-list
93260765|NCT03383224|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93260766|NCT03383224|Autonomic Agents|autonomic agents|mesh-ancestor
93260767|NCT03383224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260768|NCT03383224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260769|NCT03383224|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93260770|NCT03383224|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93260771|NCT03383224|Cholinergic Agents|cholinergic agents|mesh-ancestor
93260772|NCT03383224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260773|NCT03383224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260774|NCT04699357|Atropine|atropine|mesh-list
93260775|NCT04699357|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93260776|NCT04699357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93260777|NCT04699357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93260778|NCT04699357|Autonomic Agents|autonomic agents|mesh-ancestor
93260779|NCT04699357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260780|NCT04699357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260781|NCT04699357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93260782|NCT04699357|Respiratory System Agents|respiratory system agents|mesh-ancestor
93260783|NCT04699357|Mydriatics|mydriatics|mesh-ancestor
93260784|NCT04699357|Parasympatholytics|parasympatholytics|mesh-ancestor
93260785|NCT04699357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93260786|NCT04699357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93260787|NCT04699357|Cholinergic Agents|cholinergic agents|mesh-ancestor
93260788|NCT04699357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260789|NCT04699357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260790|NCT03030118|Hydroxychloroquine|hydroxychloroquine|mesh-list
93260791|NCT03030118|Antimalarials|antimalarials|mesh-ancestor
93260792|NCT03030118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93260793|NCT03030118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93260794|NCT03030118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260795|NCT03030118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260796|NCT03030118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260797|NCT03030118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93260798|NCT05198531|Gemcitabine|gemcitabine|mesh-list
93260799|NCT05198531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260800|NCT05198531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93260801|NCT05198531|Antimetabolites|antimetabolites|mesh-ancestor
93260802|NCT05198531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260803|NCT04177706|Ketamine|ketamine|mesh-list
93260804|NCT04177706|Analgesics|analgesics|mesh-ancestor
93260805|NCT04177706|Sensory System Agents|sensory system agents|mesh-ancestor
93260806|NCT04177706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260807|NCT04177706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260808|NCT04177706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93260809|NCT04177706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93260810|NCT04177706|Anesthetics, General|anesthetics, general|mesh-ancestor
93260811|NCT04177706|Anesthetics|anesthetics|mesh-ancestor
93260812|NCT04177706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260813|NCT04177706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93260814|NCT04177706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93260815|NCT04177706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260816|NCT04177706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260817|NCT01869829|Antifungal Agents|antifungal agents|mesh-list
93260818|NCT01869829|Clotrimazole|clotrimazole|mesh-list
93260819|NCT01869829|Miconazole|miconazole|mesh-list
93260820|NCT01869829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260821|NCT01869829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93260822|NCT01869829|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93260823|NCT01869829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93260824|NCT01869829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260825|NCT01869829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260826|NCT01869829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93260827|NCT01869829|Hormone Antagonists|hormone antagonists|mesh-ancestor
93260828|NCT01869829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260829|NCT01869829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260830|NCT01869829|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93260831|NCT01869829|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93260833|NCT02683018|Hallucinogens|hallucinogens|mesh-ancestor
93260834|NCT02683018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260835|NCT02683018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260836|NCT02683018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260837|NCT02683018|Analgesics|analgesics|mesh-ancestor
93260838|NCT02683018|Sensory System Agents|sensory system agents|mesh-ancestor
93260839|NCT02683018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260840|NCT02683018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93260841|NCT02683018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93260842|NCT02683018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260843|NCT02683018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260844|NCT02683018|Hormones|hormones|mesh-ancestor
93260845|NCT02683018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260846|NCT03982576|Nicotine|nicotine|mesh-list
93260847|NCT03982576|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93260848|NCT03982576|Autonomic Agents|autonomic agents|mesh-ancestor
93260849|NCT03982576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260850|NCT03982576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260851|NCT03982576|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93260852|NCT03982576|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93260853|NCT03982576|Cholinergic Agents|cholinergic agents|mesh-ancestor
93260854|NCT03982576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260855|NCT03982576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260856|NCT04172246|Zanubrutinib|zanubrutinib|mesh-list
93260857|NCT04172246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260858|NCT04172246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93260859|NCT04172246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93260860|NCT04172246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260861|NCT02675842|Dronabinol|dronabinol|mesh-list
93260862|NCT02675842|Hallucinogens|hallucinogens|mesh-ancestor
93260863|NCT02675842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260864|NCT02675842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260865|NCT02675842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260866|NCT02675842|Analgesics|analgesics|mesh-ancestor
93260867|NCT02675842|Sensory System Agents|sensory system agents|mesh-ancestor
93260868|NCT02675842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260869|NCT02675842|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93260870|NCT02675842|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93260871|NCT02675842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260872|NCT02675842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260873|NCT02675842|Hormones|hormones|mesh-ancestor
93260874|NCT02675842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93260875|NCT04528108|Hemostatics|hemostatics|mesh-list
93260876|NCT04528108|Coagulants|coagulants|mesh-ancestor
93260877|NCT05074121|Acetylcysteine|acetylcysteine|mesh-list
93260878|NCT05074121|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93260879|NCT05074121|Antiviral Agents|antiviral agents|mesh-ancestor
93260880|NCT05074121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260881|NCT05074121|Expectorants|expectorants|mesh-ancestor
93260882|NCT05074121|Respiratory System Agents|respiratory system agents|mesh-ancestor
93260883|NCT05074121|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93260884|NCT05074121|Antioxidants|antioxidants|mesh-ancestor
93260885|NCT05074121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260886|NCT05074121|Protective Agents|protective agents|mesh-ancestor
93260887|NCT05074121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260888|NCT05074121|Antidotes|antidotes|mesh-ancestor
93260889|NCT04251689|Mannitol|mannitol|mesh-list
93260890|NCT04251689|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93260891|NCT04251689|Diuretics|diuretics|mesh-ancestor
93260892|NCT04251689|Natriuretic Agents|natriuretic agents|mesh-ancestor
93260893|NCT04251689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260894|NCT04232423|Olanzapine|olanzapine|mesh-list
93260895|NCT04232423|Antiemetics|antiemetics|mesh-ancestor
93260896|NCT04232423|Autonomic Agents|autonomic agents|mesh-ancestor
93260897|NCT04232423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260898|NCT04232423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260899|NCT04232423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932891|NCT02588534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260901|NCT04232423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93260902|NCT04232423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260903|NCT04232423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555583|NCT00411190|Acetaminophen|acetaminophen|mesh-list
93260904|NCT04232423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93260905|NCT04232423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93260906|NCT04232423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260907|NCT04232423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260908|NCT04232423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260909|NCT04232423|Serotonin Agents|serotonin agents|mesh-ancestor
93260910|NCT04178993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93260911|NCT04178993|Methylphenidate|methylphenidate|mesh-list
93260912|NCT04178993|Methamphetamine|methamphetamine|mesh-list
93260913|NCT04178993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93260914|NCT04178993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260915|NCT04178993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93260916|NCT04178993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93260917|NCT04178993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260918|NCT04178993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260919|NCT04178993|Dopamine Agents|dopamine agents|mesh-ancestor
93260920|NCT04178993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260921|NCT04178993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93260922|NCT04178993|Analgesics|analgesics|mesh-ancestor
93260923|NCT04178993|Sensory System Agents|sensory system agents|mesh-ancestor
93260924|NCT04178993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260925|NCT04178993|Antidepressive Agents|antidepressive agents|mesh-ancestor
93260926|NCT04178993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93260927|NCT04178993|Sympathomimetics|sympathomimetics|mesh-ancestor
93260928|NCT04178993|Autonomic Agents|autonomic agents|mesh-ancestor
93260929|NCT04178993|Adrenergic Agents|adrenergic agents|mesh-ancestor
93260930|NCT04178993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93260931|NCT04436536|Methamphetamine|methamphetamine|mesh-list
93260932|NCT04436536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93260933|NCT04436536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260934|NCT04436536|Sympathomimetics|sympathomimetics|mesh-ancestor
93260935|NCT04436536|Autonomic Agents|autonomic agents|mesh-ancestor
93260936|NCT04436536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260937|NCT04436536|Dopamine Agents|dopamine agents|mesh-ancestor
93260938|NCT04436536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260939|NCT04436536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260940|NCT04436536|Adrenergic Agents|adrenergic agents|mesh-ancestor
93260941|NCT04436536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93260942|NCT04436536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93260943|NCT04436536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93260944|NCT04436536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93260945|NCT05762003|Interferons|interferons|mesh-list
93260946|NCT05762003|Teriflunomide|teriflunomide|mesh-list
93260947|NCT05762003|Rituximab|rituximab|mesh-list
93260948|NCT05762003|Alemtuzumab|alemtuzumab|mesh-list
93260949|NCT05762003|Ofatumumab|ofatumumab|mesh-list
93260950|NCT05762003|Cladribine|cladribine|mesh-list
93260951|NCT05762003|Glatiramer Acetate|glatiramer acetate|mesh-list
93260952|NCT05762003|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93260953|NCT05762003|Ocrelizumab|ocrelizumab|mesh-list
93260954|NCT05762003|Natalizumab|natalizumab|mesh-list
93260955|NCT05762003|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93260956|NCT05762003|(T,G)-A-L|(t,g)-a-l|mesh-list
93260957|NCT05762003|Ponesimod|ponesimod|mesh-list
93260958|NCT05762003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93260959|NCT05762003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93260960|NCT05762003|Immunologic Factors|immunologic factors|mesh-ancestor
93260961|NCT05762003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93260962|NCT05762003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93260963|NCT05762003|Antiviral Agents|antiviral agents|mesh-ancestor
93260964|NCT05762003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260965|NCT05762003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93260966|NCT05762003|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93260967|NCT05762003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260968|NCT05762003|Dermatologic Agents|dermatologic agents|mesh-ancestor
93260969|NCT05762003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93260970|NCT05762003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93260971|NCT05762003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93260972|NCT05762003|Analgesics|analgesics|mesh-ancestor
93260973|NCT05762003|Sensory System Agents|sensory system agents|mesh-ancestor
93260974|NCT05762003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93260975|NCT05762003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93260977|NCT04094012|Rifapentine|rifapentine|mesh-list
93260978|NCT04094012|Antitubercular Agents|antitubercular agents|mesh-ancestor
93260979|NCT04094012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93260980|NCT04094012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93260981|NCT04094012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93260982|NCT04094012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93260983|NCT04094012|Antimetabolites|antimetabolites|mesh-ancestor
93260984|NCT04094012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260985|NCT04094012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93260986|NCT04094012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93260987|NCT04094012|Leprostatic Agents|leprostatic agents|mesh-ancestor
93260988|NCT03679676|Omalizumab|omalizumab|mesh-list
93260989|NCT03679676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93260990|NCT03679676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93260991|NCT03679676|Respiratory System Agents|respiratory system agents|mesh-ancestor
93260992|NCT03001557|Lemborexant|lemborexant|mesh-list
93260993|NCT03001557|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93260994|NCT03001557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93260995|NCT03001557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93260996|NCT03001557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93260997|NCT03001557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93260998|NCT03001557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93260999|NCT03001557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261000|NCT03134612|Lidocaine|lidocaine|mesh-list
93261001|NCT03134612|Ondansetron|ondansetron|mesh-list
93261002|NCT03134612|Anesthetics, Local|anesthetics, local|mesh-ancestor
93261003|NCT03134612|Anesthetics|anesthetics|mesh-ancestor
93261004|NCT03134612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261005|NCT03134612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261006|NCT03134612|Sensory System Agents|sensory system agents|mesh-ancestor
93261007|NCT03134612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261008|NCT03134612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93261009|NCT03134612|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93261010|NCT03134612|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93261011|NCT03134612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261012|NCT03134612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261013|NCT03134612|Antiemetics|antiemetics|mesh-ancestor
93261014|NCT03134612|Autonomic Agents|autonomic agents|mesh-ancestor
93261015|NCT03134612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261016|NCT03134612|Antipruritics|antipruritics|mesh-ancestor
93261017|NCT03134612|Dermatologic Agents|dermatologic agents|mesh-ancestor
93261018|NCT03134612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93261019|NCT03134612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93261020|NCT03134612|Serotonin Agents|serotonin agents|mesh-ancestor
93261021|NCT03134612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261022|NCT00831662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93261023|NCT00831662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93261024|NCT04365985|Naltrexone|naltrexone|mesh-list
93261025|NCT04365985|Ketamine|ketamine|mesh-list
93261026|NCT04365985|Analgesics|analgesics|mesh-ancestor
93261027|NCT04365985|Sensory System Agents|sensory system agents|mesh-ancestor
93261028|NCT04365985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261029|NCT04365985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261030|NCT04365985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93261031|NCT04365985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93261032|NCT04365985|Anesthetics, General|anesthetics, general|mesh-ancestor
93261033|NCT04365985|Anesthetics|anesthetics|mesh-ancestor
93261034|NCT04365985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261035|NCT04365985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93261036|NCT04365985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93261037|NCT04365985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261038|NCT04365985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261039|NCT04365985|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93261040|NCT04365985|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93261041|NCT05111860|Bevacizumab|bevacizumab|mesh-list
91933386|NCT02223377|Hydromorphone|hydromorphone|mesh-list
93261042|NCT05111860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261043|NCT05111860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261044|NCT05111860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93261045|NCT05111860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93261046|NCT05111860|Growth Substances|growth substances|mesh-ancestor
93261047|NCT05111860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261049|NCT00830336|Azithromycin|azithromycin|mesh-list
93261050|NCT00830336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261051|NCT00830336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261052|NCT00830258|Pravastatin|pravastatin|mesh-list
93261053|NCT00830258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93261054|NCT00830258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93261055|NCT00830258|Antimetabolites|antimetabolites|mesh-ancestor
93261056|NCT00830258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261057|NCT00830258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93261058|NCT00830258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93261059|NCT00830258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261060|NCT00830102|Fluticasone|fluticasone|mesh-list
93261061|NCT00830102|Xhance|xhance|mesh-list
93261062|NCT00830102|Formoterol Fumarate|formoterol fumarate|mesh-list
93261063|NCT00830102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261064|NCT00830102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93261065|NCT00830102|Autonomic Agents|autonomic agents|mesh-ancestor
93261066|NCT00830102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261067|NCT00830102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261068|NCT00830102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93261069|NCT00830102|Respiratory System Agents|respiratory system agents|mesh-ancestor
93261070|NCT00830102|Dermatologic Agents|dermatologic agents|mesh-ancestor
93261071|NCT00830102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93261072|NCT00830102|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93261073|NCT00830102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93261074|NCT00830102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261075|NCT00830102|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261076|NCT00830102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261077|NCT00830102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261078|NCT03349775|Metformin|metformin|mesh-list
93261079|NCT03349775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261080|NCT03349775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261081|NCT00830024|Alprazolam|alprazolam|mesh-list
93261082|NCT00830024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93261083|NCT00830024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261084|NCT00830024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261085|NCT00830024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93261086|NCT00830024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93261087|NCT00830024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93261088|NCT00830024|GABA Modulators|gaba modulators|mesh-ancestor
93261089|NCT00830024|GABA Agents|gaba agents|mesh-ancestor
93261090|NCT00830024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261091|NCT00830024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261092|NCT00829868|Zaleplon|zaleplon|mesh-list
93261093|NCT00829868|Anticonvulsants|anticonvulsants|mesh-ancestor
93261094|NCT00829868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93261095|NCT00829868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261096|NCT00829868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261097|NCT00829868|GABA Modulators|gaba modulators|mesh-ancestor
93261098|NCT00829868|GABA Agents|gaba agents|mesh-ancestor
93261099|NCT00829868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261100|NCT00829868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261101|NCT00721760|Enoxaparin|enoxaparin|mesh-list
93261102|NCT00721760|Semuloparin|semuloparin|mesh-list
93261103|NCT00721760|Enoxaparin sodium|enoxaparin sodium|mesh-list
93261104|NCT00721760|Anticoagulants|anticoagulants|mesh-ancestor
93261105|NCT00721760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93261106|NCT00721760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93261107|NCT00721760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261108|NCT04491370|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93261109|NCT04491370|Immunoconjugates|immunoconjugates|mesh-ancestor
93261110|NCT04491370|Immunologic Factors|immunologic factors|mesh-ancestor
92555797|NCT00040391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261111|NCT04491370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261112|NCT00829790|Doxycycline|doxycycline|mesh-list
93261113|NCT00829790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261114|NCT00829790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261115|NCT00829790|Antimalarials|antimalarials|mesh-ancestor
93261116|NCT00829790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93261117|NCT00829790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93261118|NCT03207815|Prednisone|prednisone|mesh-list
93261119|NCT03207815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261120|NCT03207815|Glucocorticoids|glucocorticoids|mesh-ancestor
93261121|NCT03207815|Hormones|hormones|mesh-ancestor
93261122|NCT03207815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261123|NCT03207815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261124|NCT03207815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93261125|NCT03207815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261126|NCT02911935|Azithromycin|azithromycin|mesh-list
93261127|NCT02911935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261128|NCT02911935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261129|NCT05193487|Anesthetics|anesthetics|mesh-list
93261130|NCT05193487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261131|NCT05193487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261132|NCT03479762|Liraglutide|liraglutide|mesh-list
93261133|NCT03479762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261134|NCT03479762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261135|NCT03479762|Incretins|incretins|mesh-ancestor
93261136|NCT03479762|Hormones|hormones|mesh-ancestor
93261137|NCT03479762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261138|NCT00829712|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
93261139|NCT00829712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93261140|NCT00829712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261141|NCT00829712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93261142|NCT00829712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93261143|NCT00829712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261144|NCT00829712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261145|NCT00829712|Dopamine Agents|dopamine agents|mesh-ancestor
93261146|NCT00829712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261147|NCT05079802|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93261148|NCT05079802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93261149|NCT05079802|Chitosan|chitosan|mesh-list
93261150|NCT05079802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261151|NCT05079802|Antitubercular Agents|antitubercular agents|mesh-ancestor
93261152|NCT05079802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93261153|NCT05079802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93261154|NCT05079802|Antimetabolites|antimetabolites|mesh-ancestor
93261155|NCT05079802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261156|NCT05079802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93261157|NCT05079802|Chelating Agents|chelating agents|mesh-ancestor
93261158|NCT05079802|Sequestering Agents|sequestering agents|mesh-ancestor
93261159|NCT05079802|Hemostatics|hemostatics|mesh-ancestor
93261160|NCT05079802|Coagulants|coagulants|mesh-ancestor
93261161|NCT05203055|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93261162|NCT05203055|Interferon-alpha|interferon-alpha|mesh-list
93261163|NCT05203055|Antiviral Agents|antiviral agents|mesh-ancestor
93261164|NCT05203055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261165|NCT05203055|Immunologic Factors|immunologic factors|mesh-ancestor
93261166|NCT05203055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261167|NCT03899636|Folfirinox|folfirinox|mesh-list
93261168|NCT03899636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261169|NCT05761223|Pembrolizumab|pembrolizumab|mesh-list
93261170|NCT05761223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261171|NCT05761223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261172|NCT05761223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93261173|NCT05761223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261174|NCT03386942|Farletuzumab|farletuzumab|mesh-list
93261175|NCT03386942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261176|NCT04910230|Niacinamide|niacinamide|mesh-list
93261177|NCT04910230|Niacin|niacin|mesh-list
93261178|NCT04910230|Nicotinic Acids|nicotinic acids|mesh-list
93261179|NCT04910230|Vitamin B Complex|vitamin b complex|mesh-ancestor
93261180|NCT04910230|Vitamins|vitamins|mesh-ancestor
93261181|NCT04910230|Micronutrients|micronutrients|mesh-ancestor
93261182|NCT04910230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261183|NCT04910230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93261184|NCT04910230|Antimetabolites|antimetabolites|mesh-ancestor
93261185|NCT04910230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261186|NCT04910230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93261187|NCT04910230|Vasodilator Agents|vasodilator agents|mesh-ancestor
93261188|NCT04995094|Pembrolizumab|pembrolizumab|mesh-list
93261189|NCT04995094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261190|NCT04995094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261191|NCT04995094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93261192|NCT04995094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261193|NCT05202821|Fluorides|fluorides|mesh-list
93261194|NCT05202821|Fluorides, Topical|fluorides, topical|mesh-list
93261195|NCT05202821|Cariostatic Agents|cariostatic agents|mesh-ancestor
93261196|NCT05202821|Protective Agents|protective agents|mesh-ancestor
93261197|NCT05202821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933190|NCT00679029|Bevacizumab|bevacizumab|mesh-list
93261198|NCT02560805|Losartan|losartan|mesh-list
93261199|NCT02560805|Atenolol|atenolol|mesh-list
93261200|NCT02560805|Nitroprusside|nitroprusside|mesh-list
93261201|NCT02560805|Phenylephrine|phenylephrine|mesh-list
93261202|NCT02560805|Oxymetazoline|oxymetazoline|mesh-list
93261203|NCT02560805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93261204|NCT02560805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93261205|NCT02560805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93261206|NCT02560805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93261207|NCT02560805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261208|NCT02560805|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93261209|NCT02560805|Mydriatics|mydriatics|mesh-ancestor
93261210|NCT02560805|Autonomic Agents|autonomic agents|mesh-ancestor
93261211|NCT02560805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261212|NCT02560805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261213|NCT02560805|Sympathomimetics|sympathomimetics|mesh-ancestor
93261214|NCT02560805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93261215|NCT02560805|Nasal Decongestants|nasal decongestants|mesh-ancestor
93261216|NCT02560805|Respiratory System Agents|respiratory system agents|mesh-ancestor
93261217|NCT02560805|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93261218|NCT02560805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93261219|NCT02560805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261220|NCT02560805|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261221|NCT02560805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261222|NCT02560805|Protective Agents|protective agents|mesh-ancestor
93261223|NCT02560805|Sympatholytics|sympatholytics|mesh-ancestor
93261224|NCT02560805|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93261225|NCT02560805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93261226|NCT02560805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93261227|NCT02560805|Vasodilator Agents|vasodilator agents|mesh-ancestor
93261228|NCT02560805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93261229|NCT04615936|Methylene Blue|methylene blue|mesh-list
93261230|NCT04615936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261231|NCT04615936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261232|NCT03797222|Vitamin E|vitamin e|mesh-list
93261233|NCT03797222|Tocopherols|tocopherols|mesh-list
93261234|NCT03797222|alpha-Tocopherol|alpha-tocopherol|mesh-list
93261235|NCT03797222|Vitamins|vitamins|mesh-ancestor
93261236|NCT03797222|Micronutrients|micronutrients|mesh-ancestor
93261237|NCT03797222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261238|NCT03797222|Antioxidants|antioxidants|mesh-ancestor
93261239|NCT03797222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261240|NCT03797222|Protective Agents|protective agents|mesh-ancestor
93261241|NCT04471675|Docetaxel|docetaxel|mesh-list
93261242|NCT04471675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261243|NCT04471675|Tubulin Modulators|tubulin modulators|mesh-ancestor
93261244|NCT04471675|Antimitotic Agents|antimitotic agents|mesh-ancestor
93261245|NCT04471675|Mitosis Modulators|mitosis modulators|mesh-ancestor
93261246|NCT04471675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261247|NCT04461028|Dexamethasone|dexamethasone|mesh-list
93261248|NCT04461028|Bupivacaine|bupivacaine|mesh-list
93261249|NCT04461028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261250|NCT04461028|Antiemetics|antiemetics|mesh-ancestor
93261251|NCT04461028|Autonomic Agents|autonomic agents|mesh-ancestor
93261252|NCT04461028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261253|NCT04461028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261254|NCT04461028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261255|NCT04461028|Glucocorticoids|glucocorticoids|mesh-ancestor
93261256|NCT04461028|Hormones|hormones|mesh-ancestor
93261257|NCT04461028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261258|NCT04461028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93261259|NCT04461028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261260|NCT04461028|Anesthetics, Local|anesthetics, local|mesh-ancestor
93261261|NCT04461028|Anesthetics|anesthetics|mesh-ancestor
93261262|NCT04461028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261263|NCT04461028|Sensory System Agents|sensory system agents|mesh-ancestor
93261264|NCT00716534|Paclitaxel|paclitaxel|mesh-list
93261265|NCT00716534|Carboplatin|carboplatin|mesh-list
93261266|NCT00716534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93261267|NCT00716534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261268|NCT00716534|Tubulin Modulators|tubulin modulators|mesh-ancestor
93261269|NCT00716534|Antimitotic Agents|antimitotic agents|mesh-ancestor
93261270|NCT00716534|Mitosis Modulators|mitosis modulators|mesh-ancestor
93261271|NCT00716534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261272|NCT02283476|Gemcitabine|gemcitabine|mesh-list
93261273|NCT02283476|Endostar protein|endostar protein|mesh-list
93261274|NCT02283476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933315|NCT03417687|Xenon|xenon|mesh-list
93261275|NCT02283476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93261277|NCT02283476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261278|NCT02283476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93261279|NCT02283476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93261280|NCT02283476|Growth Substances|growth substances|mesh-ancestor
93261281|NCT02283476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261282|NCT02283476|Growth Inhibitors|growth inhibitors|mesh-ancestor
93261283|NCT05156879|Aspirin|aspirin|mesh-list
93261284|NCT05156879|Drospirenone|drospirenone|mesh-list
93261285|NCT05156879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93261286|NCT05156879|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93261287|NCT05156879|Estradiol|estradiol|mesh-list
93261288|NCT05156879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93261289|NCT05156879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93261290|NCT05156879|Analgesics|analgesics|mesh-ancestor
93261291|NCT05156879|Sensory System Agents|sensory system agents|mesh-ancestor
93261292|NCT05156879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261293|NCT05156879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261294|NCT05156879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261295|NCT05156879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261296|NCT05156879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93261297|NCT05156879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93261298|NCT05156879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261299|NCT05156879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93261300|NCT05156879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93261301|NCT05156879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261302|NCT05156879|Antipyretics|antipyretics|mesh-ancestor
93261303|NCT05156879|Estrogens|estrogens|mesh-ancestor
93261304|NCT05156879|Hormones|hormones|mesh-ancestor
93261305|NCT05156879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261306|NCT05156879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93261307|NCT05156879|Contraceptive Agents|contraceptive agents|mesh-ancestor
93261308|NCT05156879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93261309|NCT05156879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93261310|NCT05156879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93261311|NCT05156879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93261312|NCT05156879|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93261313|NCT05156879|Hormone Antagonists|hormone antagonists|mesh-ancestor
93261314|NCT05156879|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93261315|NCT05156879|Diuretics|diuretics|mesh-ancestor
93261316|NCT05156879|Natriuretic Agents|natriuretic agents|mesh-ancestor
93261317|NCT02283554|Metformin|metformin|mesh-list
93261318|NCT02283554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261319|NCT02283554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261320|NCT00641732|Enoxaparin|enoxaparin|mesh-list
93261321|NCT00641732|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
93261322|NCT00641732|Anticoagulants|anticoagulants|mesh-ancestor
93261323|NCT00641732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93261324|NCT00641732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93261325|NCT00641732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261326|NCT00641732|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93261327|NCT00641732|Antithrombins|antithrombins|mesh-ancestor
93261328|NCT00641732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93261329|NCT00641732|Protease Inhibitors|protease inhibitors|mesh-ancestor
93261330|NCT00641732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261331|NCT00790829|Nicotine|nicotine|mesh-list
93261332|NCT00790829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93261333|NCT00790829|Autonomic Agents|autonomic agents|mesh-ancestor
93261334|NCT00790829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261335|NCT00790829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261336|NCT00790829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93261337|NCT00790829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93261338|NCT00790829|Cholinergic Agents|cholinergic agents|mesh-ancestor
93261339|NCT00790829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261340|NCT00790829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261341|NCT00640484|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93261342|NCT00640484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93261343|NCT00640484|Autonomic Agents|autonomic agents|mesh-ancestor
93261344|NCT00640484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261345|NCT00640484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261346|NCT00640484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93261347|NCT00640484|Respiratory System Agents|respiratory system agents|mesh-ancestor
92933376|NCT02584400|Imidazole|imidazole|mesh-list
93261348|NCT00640484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93261349|NCT00640484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93261350|NCT00640484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261351|NCT00640484|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261352|NCT00640484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261353|NCT00640484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261355|NCT03065933|Analgesics|analgesics|mesh-ancestor
93261356|NCT03065933|Sensory System Agents|sensory system agents|mesh-ancestor
93261357|NCT03065933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261358|NCT03065933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261359|NCT03065933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93261360|NCT03065933|Sympatholytics|sympatholytics|mesh-ancestor
93261361|NCT03065933|Autonomic Agents|autonomic agents|mesh-ancestor
93261362|NCT03065933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93261363|NCT03065933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93261364|NCT03065933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261365|NCT03065933|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261366|NCT03065933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261367|NCT03065933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261368|NCT00630656|Talactoferrin alfa|talactoferrin alfa|mesh-list
93261369|NCT00630656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261370|NCT04256629|Allopurinol|allopurinol|mesh-list
93261371|NCT04256629|Verinurad|verinurad|mesh-list
93261372|NCT04256629|Antimetabolites|antimetabolites|mesh-ancestor
93261373|NCT04256629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261374|NCT04256629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261375|NCT04256629|Gout Suppressants|gout suppressants|mesh-ancestor
93261376|NCT04256629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261377|NCT04256629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93261378|NCT04256629|Antioxidants|antioxidants|mesh-ancestor
93261379|NCT04256629|Protective Agents|protective agents|mesh-ancestor
93261380|NCT04256629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261381|NCT05206721|Chlorhexidine|chlorhexidine|mesh-list
93261382|NCT05206721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93261383|NCT05206721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261384|NCT05206721|Disinfectants|disinfectants|mesh-ancestor
93261385|NCT00696332|alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid|mesh-list
93261386|NCT00696332|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93261387|NCT00696332|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93261388|NCT00696332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261389|NCT00696332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261390|NCT00696332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261391|NCT05125523|Sirolimus|sirolimus|mesh-list
93261392|NCT05125523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261393|NCT05125523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261394|NCT05125523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93261395|NCT05125523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261396|NCT05125523|Antifungal Agents|antifungal agents|mesh-ancestor
93261397|NCT05125523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261398|NCT05125523|Immunologic Factors|immunologic factors|mesh-ancestor
93261399|NCT05125523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261400|NCT00625664|Gemcitabine|gemcitabine|mesh-list
93261401|NCT00625664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261402|NCT00625664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93261403|NCT00625664|Antimetabolites|antimetabolites|mesh-ancestor
93261404|NCT00625664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261405|NCT02947165|Spartalizumab|spartalizumab|mesh-list
93261406|NCT02947165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93261407|NCT02947165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261408|NCT02947165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261409|NCT02947165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261410|NCT03629093|Anesthetics|anesthetics|mesh-list
93261411|NCT03629093|Anesthetics, General|anesthetics, general|mesh-list
93261412|NCT03629093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261413|NCT03629093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261414|NCT02283710|Pentoxifylline|pentoxifylline|mesh-list
93261415|NCT02283710|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93261416|NCT02283710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261417|NCT02283710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261418|NCT02283710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93261419|NCT02283710|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93261420|NCT02283710|Protective Agents|protective agents|mesh-ancestor
93261421|NCT02283710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261422|NCT02283710|Vasodilator Agents|vasodilator agents|mesh-ancestor
93261423|NCT02283710|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93261424|NCT02283710|Antioxidants|antioxidants|mesh-ancestor
93261425|NCT05055947|Atezolizumab|atezolizumab|mesh-list
93261426|NCT05055947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93261427|NCT05055947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261428|NCT05055947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261429|NCT05055947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261430|NCT03943342|Venetoclax|venetoclax|mesh-list
93261431|NCT03943342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261432|NCT00357565|Cyclosporine|cyclosporine|mesh-list
93261433|NCT00357565|Mycophenolic Acid|mycophenolic acid|mesh-list
93261434|NCT00357565|Fludarabine|fludarabine|mesh-list
93261435|NCT00357565|Fludarabine phosphate|fludarabine phosphate|mesh-list
93261436|NCT00357565|Melphalan|melphalan|mesh-list
93261437|NCT00357565|Busulfan|busulfan|mesh-list
93261438|NCT00357565|Cyclosporins|cyclosporins|mesh-list
93261439|NCT00357565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261440|NCT00357565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93261441|NCT00357565|Antimetabolites|antimetabolites|mesh-ancestor
93261442|NCT00357565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261443|NCT00357565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261444|NCT00357565|Immunologic Factors|immunologic factors|mesh-ancestor
93261445|NCT00357565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261446|NCT00357565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261447|NCT00357565|Antifungal Agents|antifungal agents|mesh-ancestor
93261448|NCT00357565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261449|NCT00357565|Dermatologic Agents|dermatologic agents|mesh-ancestor
93261450|NCT00357565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261451|NCT00357565|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93261452|NCT00357565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93261453|NCT00357565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93261454|NCT00357565|Antitubercular Agents|antitubercular agents|mesh-ancestor
93261455|NCT00357565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261456|NCT00357565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93261457|NCT00357565|Alkylating Agents|alkylating agents|mesh-ancestor
93261458|NCT00357565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93261459|NCT00694928|Clindamycin|clindamycin|mesh-list
93261460|NCT00694928|Clindamycin palmitate|clindamycin palmitate|mesh-list
93261461|NCT00694928|Clindamycin phosphate|clindamycin phosphate|mesh-list
93261462|NCT00694928|Butoconazole|butoconazole|mesh-list
93261463|NCT00694928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261464|NCT00694928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261465|NCT00694928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93261466|NCT00694928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261467|NCT00694928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261468|NCT00694928|Antifungal Agents|antifungal agents|mesh-ancestor
93261469|NCT03272464|Trametinib|trametinib|mesh-list
93261470|NCT03272464|Dabrafenib|dabrafenib|mesh-list
93261471|NCT03272464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261472|NCT03272464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93261473|NCT03272464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261474|NCT03272464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261475|NCT00694382|Semuloparin|semuloparin|mesh-list
93261476|NCT00694382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93261477|NCT00694382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93261478|NCT00694382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93261479|NCT00694382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261480|NCT00694382|Anticoagulants|anticoagulants|mesh-ancestor
93261481|NCT05116228|Rituximab|rituximab|mesh-list
93261482|NCT05116228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261483|NCT05116228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261484|NCT05116228|Immunologic Factors|immunologic factors|mesh-ancestor
93261485|NCT05116228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261486|NCT05116228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261487|NCT05116150|Grape Seed Extract|grape seed extract|mesh-list
93261488|NCT05116150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93261489|NCT05116150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261490|NCT05116150|Antioxidants|antioxidants|mesh-ancestor
93261491|NCT05116150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261492|NCT05116150|Protective Agents|protective agents|mesh-ancestor
93261493|NCT05116150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261494|NCT00136903|Cyclosporine|cyclosporine|mesh-list
93261495|NCT00136903|Mycophenolic Acid|mycophenolic acid|mesh-list
93261496|NCT00136903|Remestemcel-l|remestemcel-l|mesh-list
93261497|NCT00136903|Prednisone|prednisone|mesh-list
93261498|NCT00136903|Methylprednisolone|methylprednisolone|mesh-list
93261499|NCT00136903|Tacrolimus|tacrolimus|mesh-list
93261500|NCT00136903|Cyclosporins|cyclosporins|mesh-list
93261501|NCT00136903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261502|NCT00136903|Glucocorticoids|glucocorticoids|mesh-ancestor
93261503|NCT00136903|Hormones|hormones|mesh-ancestor
93261504|NCT00136903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261505|NCT00136903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261506|NCT00136903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93261507|NCT00136903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261508|NCT00136903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261509|NCT00136903|Immunologic Factors|immunologic factors|mesh-ancestor
93261510|NCT00136903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93261511|NCT00136903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261512|NCT00136903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261513|NCT00136903|Antifungal Agents|antifungal agents|mesh-ancestor
93261514|NCT00136903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261515|NCT00136903|Dermatologic Agents|dermatologic agents|mesh-ancestor
93261516|NCT00136903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261517|NCT00136903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93261518|NCT00136903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93261519|NCT00136903|Antitubercular Agents|antitubercular agents|mesh-ancestor
93261520|NCT00136903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261521|NCT00136903|Antiemetics|antiemetics|mesh-ancestor
93261522|NCT00136903|Autonomic Agents|autonomic agents|mesh-ancestor
93261523|NCT00136903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261524|NCT00136903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261525|NCT00136903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93261526|NCT00136903|Protective Agents|protective agents|mesh-ancestor
93261527|NCT00136903|Antiviral Agents|antiviral agents|mesh-ancestor
93261528|NCT04917029|Dexmedetomidine|dexmedetomidine|mesh-list
93261529|NCT04917029|Bupivacaine|bupivacaine|mesh-list
93261530|NCT04917029|Anesthetics, Local|anesthetics, local|mesh-ancestor
93261531|NCT04917029|Anesthetics|anesthetics|mesh-ancestor
93261532|NCT04917029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261533|NCT04917029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261534|NCT04917029|Sensory System Agents|sensory system agents|mesh-ancestor
93261535|NCT04917029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261536|NCT04917029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93261537|NCT04917029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93261538|NCT04917029|Analgesics|analgesics|mesh-ancestor
93261539|NCT04917029|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93261540|NCT04917029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93261541|NCT04917029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261542|NCT04917029|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261543|NCT04917029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261544|NCT04917029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261545|NCT04189510|Pancrelipase|pancrelipase|mesh-list
93261546|NCT04189510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261547|NCT03632759|Liraglutide|liraglutide|mesh-list
93261548|NCT03632759|Golimumab|golimumab|mesh-list
93261549|NCT03632759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261550|NCT03632759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261551|NCT03632759|Incretins|incretins|mesh-ancestor
93261552|NCT03632759|Hormones|hormones|mesh-ancestor
93261553|NCT03632759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261554|NCT03632759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93261555|NCT03632759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261556|NCT03632759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261557|NCT03632759|Immunologic Factors|immunologic factors|mesh-ancestor
93261558|NCT02953093|Acarbose|acarbose|mesh-list
93261559|NCT02953093|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93261560|NCT02953093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261561|NCT02953093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261562|NCT02953093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261563|NCT02953093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261564|NCT04518280|Capecitabine|capecitabine|mesh-list
93261565|NCT04518280|Oxaliplatin|oxaliplatin|mesh-list
93261566|NCT04518280|Antibodies|antibodies|mesh-list
93261567|NCT04518280|Immunologic Factors|immunologic factors|mesh-ancestor
93261568|NCT04518280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261569|NCT04518280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93261570|NCT04518280|Antimetabolites|antimetabolites|mesh-ancestor
93261571|NCT04518280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261572|NCT04518280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261573|NCT00498836|Sorafenib|sorafenib|mesh-list
93261574|NCT00498836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261575|NCT00498836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93261576|NCT00498836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261577|NCT00498836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261578|NCT02283866|Desflurane|desflurane|mesh-list
93261579|NCT02283866|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93261580|NCT02283866|Anesthetics, General|anesthetics, general|mesh-ancestor
93261581|NCT02283866|Anesthetics|anesthetics|mesh-ancestor
93261582|NCT02283866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261583|NCT02283866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261584|NCT04517110|Pregabalin|pregabalin|mesh-list
93261585|NCT04517110|Analgesics|analgesics|mesh-ancestor
93261586|NCT04517110|Sensory System Agents|sensory system agents|mesh-ancestor
93261587|NCT04517110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261588|NCT04517110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261589|NCT04517110|Anticonvulsants|anticonvulsants|mesh-ancestor
93261590|NCT04517110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93261591|NCT04517110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261592|NCT04517110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261593|NCT04517110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93261594|NCT04517110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93261595|NCT04517110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93261596|NCT04517110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261597|NCT04517110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93261598|NCT00498212|1018 oligonucleotide|1018 oligonucleotide|mesh-list
93261599|NCT00498212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93261600|NCT00498212|Immunologic Factors|immunologic factors|mesh-ancestor
93261601|NCT00498212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261602|NCT02281058|Abatacept|abatacept|mesh-list
93261603|NCT02281058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93261604|NCT02281058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261605|NCT02281058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261606|NCT02281058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261607|NCT02281058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261608|NCT02281058|Immunologic Factors|immunologic factors|mesh-ancestor
93261609|NCT02281058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261610|NCT02281058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261611|NCT02784262|Botulinum Toxins|botulinum toxins|mesh-list
93261612|NCT02784262|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93261613|NCT02784262|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93261614|NCT02784262|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93261615|NCT02784262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261616|NCT02784262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261617|NCT02784262|Cholinergic Agents|cholinergic agents|mesh-ancestor
93261618|NCT02784262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261619|NCT02784262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261620|NCT02784262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93261621|NCT02784262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261622|NCT05205317|Metformin|metformin|mesh-list
93261623|NCT05205317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261624|NCT05205317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261625|NCT00691964|Etanercept|etanercept|mesh-list
93261626|NCT00691964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93261627|NCT00691964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93261628|NCT00691964|Analgesics|analgesics|mesh-ancestor
93261629|NCT00691964|Sensory System Agents|sensory system agents|mesh-ancestor
93261630|NCT00691964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261631|NCT00691964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261632|NCT00691964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261633|NCT00691964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261634|NCT00691964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261635|NCT00691964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261636|NCT00691964|Immunologic Factors|immunologic factors|mesh-ancestor
93261637|NCT04470908|Rifabutin|rifabutin|mesh-list
93261638|NCT04470908|Zanubrutinib|zanubrutinib|mesh-list
93261639|NCT04470908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261640|NCT04470908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93261641|NCT04470908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261642|NCT04470908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261643|NCT04470908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261644|NCT04470908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261645|NCT04470908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93261646|NCT04470908|Antitubercular Agents|antitubercular agents|mesh-ancestor
93261647|NCT02281292|Ranibizumab|ranibizumab|mesh-list
93261648|NCT02281292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93261649|NCT02281292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93261650|NCT02281292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93261651|NCT02281292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93261652|NCT02281292|Growth Substances|growth substances|mesh-ancestor
93261653|NCT02281292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261654|NCT02281292|Growth Inhibitors|growth inhibitors|mesh-ancestor
93261655|NCT02281292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261656|NCT03723772|Insulin|insulin|mesh-list
93261657|NCT03723772|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93261658|NCT03723772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261659|NCT03723772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261660|NCT02660827|Insulin|insulin|mesh-list
93261661|NCT02660827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261662|NCT02660827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261663|NCT00491738|Bevacizumab|bevacizumab|mesh-list
93261664|NCT00491738|Sunitinib|sunitinib|mesh-list
93261665|NCT00491738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261666|NCT00491738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261667|NCT00491738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93261668|NCT00491738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93261669|NCT00491738|Growth Substances|growth substances|mesh-ancestor
93261670|NCT00491738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261671|NCT00491738|Growth Inhibitors|growth inhibitors|mesh-ancestor
93261672|NCT00491738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93261673|NCT00491738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261674|NCT00491738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261675|NCT02281370|Cyclosporine|cyclosporine|mesh-list
93261676|NCT02281370|Cyclosporins|cyclosporins|mesh-list
93261677|NCT02281370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261678|NCT02281370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261679|NCT02281370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261680|NCT02281370|Immunologic Factors|immunologic factors|mesh-ancestor
93261681|NCT02281370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261682|NCT02281370|Antifungal Agents|antifungal agents|mesh-ancestor
93261683|NCT02281370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261684|NCT02281370|Dermatologic Agents|dermatologic agents|mesh-ancestor
93261685|NCT02281370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261686|NCT02281370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93261687|NCT00680342|Silymarin|silymarin|mesh-list
93261688|NCT00680342|Antioxidants|antioxidants|mesh-ancestor
92556379|NCT00210028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261689|NCT00680342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261690|NCT00680342|Protective Agents|protective agents|mesh-ancestor
93261691|NCT00680342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261692|NCT04057365|Nivolumab|nivolumab|mesh-list
93261693|NCT04057365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93261694|NCT04057365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261695|NCT04057365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93261696|NCT04057365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261697|NCT00616148|Cenobamate|cenobamate|mesh-list
93261698|NCT00616148|Anticonvulsants|anticonvulsants|mesh-ancestor
93261699|NCT03622827|Endostar protein|endostar protein|mesh-list
93261700|NCT03622827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93261701|NCT03622827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93261702|NCT03622827|Growth Substances|growth substances|mesh-ancestor
93261703|NCT03622827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261704|NCT03622827|Growth Inhibitors|growth inhibitors|mesh-ancestor
93261705|NCT03622827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261706|NCT00486512|Aspirin|aspirin|mesh-list
93261707|NCT00486512|Calcium, Dietary|calcium, dietary|mesh-list
93261708|NCT00486512|Calcitriol|calcitriol|mesh-list
93261709|NCT00486512|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93261710|NCT00486512|Calcium Carbonate|calcium carbonate|mesh-list
93261711|NCT00486512|Calcium|calcium|mesh-list
93261712|NCT00486512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93261713|NCT00486512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261714|NCT00486512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93261715|NCT00486512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93261716|NCT00486512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93261717|NCT00486512|Analgesics|analgesics|mesh-ancestor
93261718|NCT00486512|Sensory System Agents|sensory system agents|mesh-ancestor
93261719|NCT00486512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261720|NCT00486512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261721|NCT00486512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261722|NCT00486512|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93261723|NCT00486512|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93261724|NCT00486512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261725|NCT00486512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93261726|NCT00486512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93261728|NCT00486512|Antipyretics|antipyretics|mesh-ancestor
93261729|NCT00486512|Antacids|antacids|mesh-ancestor
93261730|NCT00486512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261731|NCT00486512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93261732|NCT00486512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261733|NCT00486512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93261734|NCT00486512|Vitamins|vitamins|mesh-ancestor
93261735|NCT00486512|Micronutrients|micronutrients|mesh-ancestor
93261736|NCT04057989|Ketamine|ketamine|mesh-list
93261737|NCT04057989|Analgesics|analgesics|mesh-ancestor
93261738|NCT04057989|Sensory System Agents|sensory system agents|mesh-ancestor
93261739|NCT04057989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261740|NCT04057989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261741|NCT04057989|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93261742|NCT04057989|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93261743|NCT04057989|Anesthetics, General|anesthetics, general|mesh-ancestor
93261744|NCT04057989|Anesthetics|anesthetics|mesh-ancestor
93261745|NCT04057989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261746|NCT04057989|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93261747|NCT04057989|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93261748|NCT04057989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261749|NCT04057989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261750|NCT00486200|Valacyclovir|valacyclovir|mesh-list
93261751|NCT00486200|Antiviral Agents|antiviral agents|mesh-ancestor
93261752|NCT00486200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261753|NCT00479258|Insulin|insulin|mesh-list
93261754|NCT00479258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93261755|NCT00479258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261756|NCT00479258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261757|NCT00612170|Reboxetine|reboxetine|mesh-list
93261758|NCT00612170|Antidepressive Agents|antidepressive agents|mesh-ancestor
93261759|NCT00612170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93261760|NCT00612170|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93261761|NCT00612170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93261762|NCT00612170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261763|NCT00612170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556448|NCT00210340|Rituximab|rituximab|mesh-list
93261764|NCT00612170|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261765|NCT00612170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261766|NCT00612170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261767|NCT05068336|Anesthetics|anesthetics|mesh-list
93261768|NCT05068336|Sevoflurane|sevoflurane|mesh-list
93261769|NCT05068336|Desflurane|desflurane|mesh-list
93261770|NCT05068336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261771|NCT05068336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261772|NCT05068336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93261773|NCT05068336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93261774|NCT05068336|Anesthetics, General|anesthetics, general|mesh-ancestor
93261775|NCT00607256|Reboxetine|reboxetine|mesh-list
93261776|NCT00607256|Antidepressive Agents|antidepressive agents|mesh-ancestor
93261777|NCT00607256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93261778|NCT00607256|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93261779|NCT00607256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93261780|NCT00607256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93261781|NCT00607256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261782|NCT00607256|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261783|NCT00607256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261784|NCT00607256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261785|NCT02774590|Timolol|timolol|mesh-list
93261786|NCT02774590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93261787|NCT02774590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93261788|NCT02774590|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261789|NCT02774590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261790|NCT02774590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261791|NCT02774590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261792|NCT02774590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93261793|NCT02774590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93261794|NCT01069341|Ranibizumab|ranibizumab|mesh-list
93261795|NCT01069341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93261796|NCT01069341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93261797|NCT01069341|Growth Substances|growth substances|mesh-ancestor
93261798|NCT01069341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261799|NCT01069341|Growth Inhibitors|growth inhibitors|mesh-ancestor
93261800|NCT01069341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261801|NCT00676832|Prednisolone|prednisolone|mesh-list
93261802|NCT00676832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93261803|NCT00676832|Methylprednisolone|methylprednisolone|mesh-list
93261804|NCT00676832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93261805|NCT00676832|Prednisolone acetate|prednisolone acetate|mesh-list
93261806|NCT00676832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93261807|NCT00676832|Prednisolone phosphate|prednisolone phosphate|mesh-list
93261808|NCT00676832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261809|NCT00676832|Glucocorticoids|glucocorticoids|mesh-ancestor
93261810|NCT00676832|Hormones|hormones|mesh-ancestor
93261811|NCT00676832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261812|NCT00676832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261813|NCT00676832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93261814|NCT00676832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261815|NCT00676832|Antiemetics|antiemetics|mesh-ancestor
93261816|NCT00676832|Autonomic Agents|autonomic agents|mesh-ancestor
93261817|NCT00676832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261818|NCT00676832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261819|NCT00676832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93261820|NCT00676832|Protective Agents|protective agents|mesh-ancestor
93261821|NCT01909414|Vaccines|vaccines|mesh-list
93261822|NCT01909414|Immunologic Factors|immunologic factors|mesh-ancestor
93261823|NCT01909414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261824|NCT00467402|Agomelatine|agomelatine|mesh-list
93261825|NCT00467402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93261826|NCT00467402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261827|NCT00467402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261828|NCT02996097|Triamcinolone|triamcinolone|mesh-list
93261829|NCT02996097|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93261830|NCT02996097|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93261831|NCT02996097|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93261832|NCT02996097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261833|NCT02996097|Glucocorticoids|glucocorticoids|mesh-ancestor
93261834|NCT02996097|Hormones|hormones|mesh-ancestor
93261835|NCT02996097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261836|NCT02996097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261837|NCT02996097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261838|NCT02996097|Immunologic Factors|immunologic factors|mesh-ancestor
93261839|NCT02996097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261840|NCT02996097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261841|NCT04054713|Acetic Acid|acetic acid|mesh-list
93261842|NCT04054713|Retinol acetate|retinol acetate|mesh-list
93261843|NCT04054713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93261844|NCT04054713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261845|NCT04054713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93261846|NCT04054713|Immunologic Factors|immunologic factors|mesh-ancestor
93261847|NCT04054713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261848|NCT04054713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93261849|NCT04054713|Protective Agents|protective agents|mesh-ancestor
93261850|NCT04054713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261851|NCT02568124|Tranexamic Acid|tranexamic acid|mesh-list
93261852|NCT02568124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93261853|NCT02568124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93261854|NCT02568124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261855|NCT02568124|Hemostatics|hemostatics|mesh-ancestor
93261856|NCT02568124|Coagulants|coagulants|mesh-ancestor
93261857|NCT03314181|Dexamethasone|dexamethasone|mesh-list
93261858|NCT03314181|Bortezomib|bortezomib|mesh-list
93261859|NCT03314181|Venetoclax|venetoclax|mesh-list
93261860|NCT03314181|Daratumumab|daratumumab|mesh-list
93261861|NCT03314181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261862|NCT03314181|Antiemetics|antiemetics|mesh-ancestor
93261863|NCT03314181|Autonomic Agents|autonomic agents|mesh-ancestor
93261864|NCT03314181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261865|NCT03314181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261866|NCT03314181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93261867|NCT03314181|Glucocorticoids|glucocorticoids|mesh-ancestor
93261868|NCT03314181|Hormones|hormones|mesh-ancestor
93261869|NCT03314181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261870|NCT03314181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93261871|NCT03314181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261872|NCT03133832|Praziquantel|praziquantel|mesh-list
93261873|NCT03133832|Anthelmintics|anthelmintics|mesh-ancestor
93261874|NCT03133832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93261875|NCT03133832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93261876|NCT03663465|Antipsychotic Agents|antipsychotic agents|mesh-list
93261877|NCT03663465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93261878|NCT03663465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261879|NCT03663465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261880|NCT03663465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93261881|NCT04161430|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93261882|NCT04161430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261883|NCT04161430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261884|NCT04161430|Incretins|incretins|mesh-ancestor
93261885|NCT04161430|Hormones|hormones|mesh-ancestor
93261886|NCT04161430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93261887|NCT04161430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93261888|NCT04161430|Protease Inhibitors|protease inhibitors|mesh-ancestor
93261889|NCT04161430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261890|NCT04161430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261891|NCT00673478|Tiotropium Bromide|tiotropium bromide|mesh-list
93261892|NCT00673478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93261893|NCT00673478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93261894|NCT00673478|Autonomic Agents|autonomic agents|mesh-ancestor
93261895|NCT00673478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261896|NCT00673478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261897|NCT00673478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93261898|NCT00673478|Respiratory System Agents|respiratory system agents|mesh-ancestor
93261899|NCT00673478|Parasympatholytics|parasympatholytics|mesh-ancestor
93261900|NCT00673478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93261901|NCT00673478|Cholinergic Agents|cholinergic agents|mesh-ancestor
93261902|NCT00673478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261903|NCT00673478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261904|NCT00673478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93261905|NCT00673478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93261906|NCT00673478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261907|NCT00673478|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261908|NCT02203474|Tiotropium Bromide|tiotropium bromide|mesh-list
93261909|NCT02203474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93261910|NCT02203474|Autonomic Agents|autonomic agents|mesh-ancestor
93261911|NCT02203474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261912|NCT02203474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261913|NCT02203474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93261914|NCT02203474|Respiratory System Agents|respiratory system agents|mesh-ancestor
93261915|NCT02203474|Parasympatholytics|parasympatholytics|mesh-ancestor
93261916|NCT02203474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93261917|NCT02203474|Cholinergic Agents|cholinergic agents|mesh-ancestor
93261918|NCT02203474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261919|NCT02203474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261920|NCT04053699|Factor VIII|factor viii|mesh-list
93261921|NCT04053699|Coagulants|coagulants|mesh-ancestor
93261922|NCT04303000|Analgesics, Opioid|analgesics, opioid|mesh-list
93261923|NCT04303000|Naloxone|naloxone|mesh-list
93261924|NCT04303000|Narcotics|narcotics|mesh-ancestor
93261925|NCT04303000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93261926|NCT04303000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261927|NCT04303000|Analgesics|analgesics|mesh-ancestor
93261928|NCT04303000|Sensory System Agents|sensory system agents|mesh-ancestor
93261929|NCT04303000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261930|NCT04303000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93261931|NCT00672386|Metformin|metformin|mesh-list
93261932|NCT00672386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93261933|NCT00672386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261934|NCT04056897|Teriflunomide|teriflunomide|mesh-list
93261935|NCT04056897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93261936|NCT04056897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93261937|NCT04056897|Analgesics|analgesics|mesh-ancestor
93261938|NCT04056897|Sensory System Agents|sensory system agents|mesh-ancestor
93261939|NCT04056897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93261940|NCT04056897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261941|NCT04056897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93261942|NCT04056897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261943|NCT04056897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261944|NCT04056897|Immunologic Factors|immunologic factors|mesh-ancestor
93261945|NCT02281682|Fluorouracil|fluorouracil|mesh-list
93261946|NCT02281682|Imiquimod|imiquimod|mesh-list
93261947|NCT02281682|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93261948|NCT02281682|Antimetabolites|antimetabolites|mesh-ancestor
93261949|NCT02281682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261950|NCT02281682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93261951|NCT02281682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261952|NCT02281682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261953|NCT02281682|Immunologic Factors|immunologic factors|mesh-ancestor
93261954|NCT02281682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261955|NCT02281682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93261956|NCT02281682|Interferon Inducers|interferon inducers|mesh-ancestor
93261957|NCT02281682|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93261958|NCT02281682|Dermatologic Agents|dermatologic agents|mesh-ancestor
93261959|NCT04057053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93261960|NCT04057053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93261961|NCT04056975|Antibodies|antibodies|mesh-list
93261962|NCT04056975|Immunologic Factors|immunologic factors|mesh-ancestor
93261963|NCT04056975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261964|NCT02281916|Immunomodulating Agents|immunomodulating agents|mesh-list
93261965|NCT02281916|Immunologic Factors|immunologic factors|mesh-ancestor
93261966|NCT02281916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261967|NCT03662763|Guanfacine|guanfacine|mesh-list
93261968|NCT03662763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93261969|NCT03662763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93261970|NCT03662763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93261971|NCT03662763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93261972|NCT03662763|Adrenergic Agents|adrenergic agents|mesh-ancestor
93261973|NCT03662763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93261974|NCT03662763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261975|NCT03662763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261976|NCT00458978|Cediranib|cediranib|mesh-list
93261977|NCT00458978|Maleic acid|maleic acid|mesh-list
93261978|NCT00458978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93261979|NCT00458978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261980|NCT00458978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261981|NCT00458978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93261982|NCT00458276|Tezosentan|tezosentan|mesh-list
93261983|NCT00458276|Vasodilator Agents|vasodilator agents|mesh-ancestor
93261984|NCT04520074|Cyclophosphamide|cyclophosphamide|mesh-list
93261985|NCT04520074|Carboplatin|carboplatin|mesh-list
93261986|NCT04520074|Etoposide|etoposide|mesh-list
93261987|NCT04520074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93261988|NCT04520074|Immunologic Factors|immunologic factors|mesh-ancestor
93261989|NCT04520074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93261990|NCT04520074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93261991|NCT04520074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93261992|NCT04520074|Alkylating Agents|alkylating agents|mesh-ancestor
93261993|NCT04520074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93261994|NCT04520074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93261995|NCT04520074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93261996|NCT04520074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93261997|NCT04520074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93261998|NCT04520074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93261999|NCT04520074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262000|NCT00455156|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93262001|NCT00455156|ST 1435|st 1435|mesh-list
93262002|NCT00455156|Estradiol|estradiol|mesh-list
93262003|NCT00455156|Estrogens|estrogens|mesh-ancestor
93262004|NCT00455156|Hormones|hormones|mesh-ancestor
93262005|NCT00455156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262006|NCT00455156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262007|NCT00455156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93262008|NCT00455156|Contraceptive Agents|contraceptive agents|mesh-ancestor
93262009|NCT00455156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93262010|NCT00455156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93262011|NCT00455156|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93262012|NCT00455156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93262013|NCT03661515|Cytarabine|cytarabine|mesh-list
93262014|NCT03661515|Fludarabine|fludarabine|mesh-list
93262015|NCT03661515|Idarubicin|idarubicin|mesh-list
93262016|NCT03661515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262017|NCT03661515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262018|NCT03661515|Antimetabolites|antimetabolites|mesh-ancestor
93262019|NCT03661515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262020|NCT03661515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262021|NCT03661515|Immunologic Factors|immunologic factors|mesh-ancestor
93262022|NCT03661515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262023|NCT03661515|Antiviral Agents|antiviral agents|mesh-ancestor
93262024|NCT03661515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262025|NCT03661515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93262026|NCT03661515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93262027|NCT03661515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93262028|NCT03661515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262029|NCT01624480|Modafinil|modafinil|mesh-list
93262030|NCT01624480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93262031|NCT01624480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262032|NCT01624480|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93262033|NCT01624480|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93262034|NCT01624480|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93262035|NCT01624480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262036|NCT00448058|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93262037|NCT00448058|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93262038|NCT00448058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93262039|NCT00448058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262040|NCT00448058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262041|NCT00448058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262042|NCT00448058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262043|NCT00448058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93262044|NCT00448058|Antidepressive Agents|antidepressive agents|mesh-ancestor
93262045|NCT00448058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93262046|NCT05073172|Sulfadiazine|sulfadiazine|mesh-list
93262047|NCT05073172|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93262048|NCT05073172|Petrolatum|petrolatum|mesh-list
93262049|NCT05073172|Mineral Oil|mineral oil|mesh-list
93262050|NCT05073172|Emollients|emollients|mesh-ancestor
93262051|NCT05073172|Dermatologic Agents|dermatologic agents|mesh-ancestor
93262052|NCT05073172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262053|NCT05073172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262054|NCT05073172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93262055|NCT05073172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93262056|NCT05073172|Coccidiostats|coccidiostats|mesh-ancestor
93262057|NCT05073172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93262058|NCT02284412|Neostigmine|neostigmine|mesh-list
93262059|NCT02284412|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93262060|NCT02284412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262061|NCT02284412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262062|NCT02284412|Cholinergic Agents|cholinergic agents|mesh-ancestor
93262063|NCT02284412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262064|NCT02284412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262065|NCT02284412|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93262066|NCT02284412|Autonomic Agents|autonomic agents|mesh-ancestor
93262067|NCT02284412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262068|NCT02789020|Rasagiline|rasagiline|mesh-list
93262069|NCT02789020|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93262070|NCT02789020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262071|NCT02789020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262072|NCT02789020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93262073|NCT02789020|Protective Agents|protective agents|mesh-ancestor
93262074|NCT02789020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262075|NCT02284490|Pemetrexed|pemetrexed|mesh-list
93262076|NCT02284490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262077|NCT02284490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262078|NCT02284490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262079|NCT02284490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93262080|NCT02284490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93262081|NCT02273570|Vitamin D|vitamin d|mesh-list
93262082|NCT02273570|Calcium|calcium|mesh-list
93262083|NCT02273570|Vitamins|vitamins|mesh-ancestor
93262084|NCT02273570|Micronutrients|micronutrients|mesh-ancestor
93262085|NCT02273570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262086|NCT02273570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93262087|NCT02273570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93262088|NCT02282150|Hydrocortisone|hydrocortisone|mesh-list
93262089|NCT02282150|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93262090|NCT02282150|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93262091|NCT02282150|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93262092|NCT02282150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262093|NCT00579020|Moxifloxacin|moxifloxacin|mesh-list
93262094|NCT00579020|Dexamethasone|dexamethasone|mesh-list
93262095|NCT00579020|Dexamethasone acetate|dexamethasone acetate|mesh-list
93262096|NCT00579020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93262097|NCT00579020|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93262098|NCT00579020|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93262099|NCT00579020|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93262100|NCT00579020|BB 1101|bb 1101|mesh-list
93262101|NCT00579020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262102|NCT00579020|Antiemetics|antiemetics|mesh-ancestor
93262103|NCT00579020|Autonomic Agents|autonomic agents|mesh-ancestor
93262104|NCT00579020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262105|NCT00579020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262106|NCT00579020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262107|NCT00579020|Glucocorticoids|glucocorticoids|mesh-ancestor
93262108|NCT00579020|Hormones|hormones|mesh-ancestor
93262109|NCT00579020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262110|NCT00579020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93262111|NCT00579020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262112|NCT00579020|Protease Inhibitors|protease inhibitors|mesh-ancestor
93262113|NCT00579020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262114|NCT00579020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262115|NCT00579020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262116|NCT00579020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262117|NCT00579020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93262118|NCT00579020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93262119|NCT00579020|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93262120|NCT00579020|Contraceptive Agents|contraceptive agents|mesh-ancestor
93262121|NCT00579020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93262122|NCT00579020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93262123|NCT00579020|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93262124|NCT00579020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93262125|NCT04530604|Defibrotide|defibrotide|mesh-list
93262126|NCT04530604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93262127|NCT04530604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93262128|NCT04530604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262129|NCT04530604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93262130|NCT04169698|Denosumab|denosumab|mesh-list
93262131|NCT04169698|Alendronate|alendronate|mesh-list
93262132|NCT04169698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93262133|NCT04169698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262134|NCT04470752|Capsaicin|capsaicin|mesh-list
93262135|NCT04470752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93262136|NCT04470752|Antipruritics|antipruritics|mesh-ancestor
93262137|NCT04470752|Dermatologic Agents|dermatologic agents|mesh-ancestor
93262138|NCT04470752|Sensory System Agents|sensory system agents|mesh-ancestor
93262139|NCT04470752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262140|NCT04470752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262141|NCT02273804|Topiramate|topiramate|mesh-list
93262142|NCT02273804|Anticonvulsants|anticonvulsants|mesh-ancestor
93262143|NCT02273804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262144|NCT02273804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262145|NCT00578474|Ofloxacin|ofloxacin|mesh-list
93262146|NCT00578474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93262147|NCT00578474|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93262148|NCT00578474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262149|NCT00578474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262150|NCT00578474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93262151|NCT00578474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93262152|NCT00578474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262153|NCT00578474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262154|NCT00578474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262155|NCT00578474|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93262156|NCT00578474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93262157|NCT00577148|Rimonabant|rimonabant|mesh-list
93262158|NCT00577148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93262159|NCT00577148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93262160|NCT00577148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93262161|NCT00577148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262162|NCT00577148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262163|NCT00577148|Hormones|hormones|mesh-ancestor
93262164|NCT00577148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262165|NCT00577148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262166|NCT03673228|Nicotine|nicotine|mesh-list
93262167|NCT03673228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93262168|NCT03673228|Autonomic Agents|autonomic agents|mesh-ancestor
93262169|NCT03673228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262170|NCT03673228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262171|NCT03673228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93262172|NCT03673228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93262173|NCT03673228|Cholinergic Agents|cholinergic agents|mesh-ancestor
93262174|NCT03673228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262175|NCT03673228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262176|NCT05116462|Paclitaxel|paclitaxel|mesh-list
93262177|NCT05116462|Docetaxel|docetaxel|mesh-list
93262178|NCT05116462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93262179|NCT05116462|Carboplatin|carboplatin|mesh-list
93262180|NCT05116462|Gemcitabine|gemcitabine|mesh-list
93262181|NCT05116462|Pemetrexed|pemetrexed|mesh-list
93262182|NCT05116462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93262183|NCT05116462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262184|NCT05116462|Tubulin Modulators|tubulin modulators|mesh-ancestor
93262185|NCT05116462|Antimitotic Agents|antimitotic agents|mesh-ancestor
93262186|NCT05116462|Mitosis Modulators|mitosis modulators|mesh-ancestor
93262187|NCT05116462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262188|NCT05116462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262189|NCT05116462|Antimetabolites|antimetabolites|mesh-ancestor
93262190|NCT05116462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262191|NCT05116462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93262192|NCT05116462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92556904|NCT00069459|Bupropion|bupropion|mesh-list
93262193|NCT05116306|Hyaluronic Acid|hyaluronic acid|mesh-list
93262194|NCT05116306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93262195|NCT05116306|Immunologic Factors|immunologic factors|mesh-ancestor
93262196|NCT05116306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262197|NCT05116306|Viscosupplements|viscosupplements|mesh-ancestor
93262198|NCT05116306|Protective Agents|protective agents|mesh-ancestor
93262199|NCT00570986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93262200|NCT00570986|Immunologic Factors|immunologic factors|mesh-ancestor
93262201|NCT00570986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262202|NCT00570752|Atorvastatin|atorvastatin|mesh-list
93262203|NCT00570752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93262204|NCT00570752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93262205|NCT00570752|Antimetabolites|antimetabolites|mesh-ancestor
93262206|NCT00570752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262207|NCT00570752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93262208|NCT00570752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93262209|NCT00570752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262210|NCT02282384|Oseltamivir|oseltamivir|mesh-list
93262211|NCT02282384|Calcium Carbonate|calcium carbonate|mesh-list
93262212|NCT02282384|Antiviral Agents|antiviral agents|mesh-ancestor
93262213|NCT02282384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262214|NCT02282384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262215|NCT02282384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262216|NCT02282384|Antacids|antacids|mesh-ancestor
93262217|NCT02282384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262218|NCT02989389|Itraconazole|itraconazole|mesh-list
93262219|NCT02989389|Antifungal Agents|antifungal agents|mesh-ancestor
93262220|NCT02989389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262221|NCT02989389|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93262222|NCT02989389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93262223|NCT02989389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262224|NCT02989389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262225|NCT02989389|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93262226|NCT02989389|Hormone Antagonists|hormone antagonists|mesh-ancestor
93262227|NCT02989389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262228|NCT02989389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262229|NCT02989389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93262230|NCT02653300|Insulin|insulin|mesh-list
93262231|NCT02653300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262232|NCT02653300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262233|NCT00436670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93262234|NCT00436670|Immunologic Factors|immunologic factors|mesh-ancestor
93262235|NCT00436670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262236|NCT03187509|Torsemide|torsemide|mesh-list
93262237|NCT03187509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93262238|NCT03187509|Diuretics|diuretics|mesh-ancestor
93262239|NCT03187509|Natriuretic Agents|natriuretic agents|mesh-ancestor
93262240|NCT03187509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262241|NCT03187509|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93262242|NCT03187509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262243|NCT03187509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262244|NCT00430508|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93262245|NCT00430508|Olmesartan|olmesartan|mesh-list
93262246|NCT00430508|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93262247|NCT00430508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93262248|NCT00430508|Diuretics|diuretics|mesh-ancestor
93262249|NCT00430508|Natriuretic Agents|natriuretic agents|mesh-ancestor
93262250|NCT00430508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262251|NCT00430508|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93262252|NCT00430508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262253|NCT00430508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262254|NCT00430508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93262255|NCT00430508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93262256|NCT04221880|Lidocaine|lidocaine|mesh-list
93262257|NCT04221880|Bupivacaine|bupivacaine|mesh-list
93262258|NCT04221880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93262259|NCT04221880|Anesthetics, Local|anesthetics, local|mesh-ancestor
93262260|NCT04221880|Anesthetics|anesthetics|mesh-ancestor
93262261|NCT04221880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262262|NCT04221880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262263|NCT04221880|Sensory System Agents|sensory system agents|mesh-ancestor
93262264|NCT04221880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262265|NCT04221880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93262266|NCT04221880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93262267|NCT04221880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93262268|NCT04221880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262269|NCT04221880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262270|NCT04055415|Bronchodilator Agents|bronchodilator agents|mesh-list
93262271|NCT04055415|Expectorants|expectorants|mesh-list
93262272|NCT04055415|Autonomic Agents|autonomic agents|mesh-ancestor
93262273|NCT04055415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262274|NCT04055415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262275|NCT04055415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93262276|NCT04055415|Respiratory System Agents|respiratory system agents|mesh-ancestor
93262277|NCT00427856|Rituximab|rituximab|mesh-list
93262278|NCT00427856|Obatoclax|obatoclax|mesh-list
93262279|NCT00427856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262280|NCT00427856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262281|NCT00427856|Immunologic Factors|immunologic factors|mesh-ancestor
93262282|NCT00427856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262283|NCT00427856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262284|NCT00427856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262285|NCT00427856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262286|NCT00427154|Insulin|insulin|mesh-list
93262287|NCT00427154|Metformin|metformin|mesh-list
93262288|NCT00427154|Glimepiride|glimepiride|mesh-list
93262289|NCT00427154|Rosiglitazone|rosiglitazone|mesh-list
93262290|NCT00427154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93262291|NCT00427154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262292|NCT00427154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262293|NCT00427154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93262294|NCT00427154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262295|NCT00427154|Immunologic Factors|immunologic factors|mesh-ancestor
93262296|NCT02988219|Epinephrine|epinephrine|mesh-list
93262297|NCT02988219|Fentanyl|fentanyl|mesh-list
93262298|NCT02988219|Bupivacaine|bupivacaine|mesh-list
93262299|NCT02988219|Anesthetics|anesthetics|mesh-list
93262300|NCT02988219|Anesthetics, Local|anesthetics, local|mesh-ancestor
93262301|NCT02988219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262302|NCT02988219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262303|NCT02988219|Sensory System Agents|sensory system agents|mesh-ancestor
93262304|NCT02988219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262305|NCT02988219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93262306|NCT02988219|Narcotics|narcotics|mesh-ancestor
93262307|NCT02988219|Analgesics|analgesics|mesh-ancestor
93262308|NCT02988219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93262309|NCT02988219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93262310|NCT02988219|Anesthetics, General|anesthetics, general|mesh-ancestor
93262311|NCT02988219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93262312|NCT02988219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93262313|NCT02988219|Adrenergic Agents|adrenergic agents|mesh-ancestor
93262314|NCT02988219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262315|NCT02988219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262316|NCT02988219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93262317|NCT02988219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93262318|NCT02988219|Autonomic Agents|autonomic agents|mesh-ancestor
93262319|NCT02988219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93262320|NCT02988219|Respiratory System Agents|respiratory system agents|mesh-ancestor
93262321|NCT02988219|Mydriatics|mydriatics|mesh-ancestor
93262322|NCT02988219|Sympathomimetics|sympathomimetics|mesh-ancestor
93262323|NCT02988219|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92934324|NCT02557503|Fluorouracil|fluorouracil|mesh-list
93262324|NCT01346059|Vancomycin|vancomycin|mesh-list
93262325|NCT01346059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262326|NCT01346059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262327|NCT05204069|Cyclopentolate|cyclopentolate|mesh-list
93262328|NCT05204069|Mydriatics|mydriatics|mesh-ancestor
93262329|NCT05204069|Autonomic Agents|autonomic agents|mesh-ancestor
93262330|NCT05204069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262331|NCT05204069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262332|NCT05204069|Parasympatholytics|parasympatholytics|mesh-ancestor
93262333|NCT05204069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93262334|NCT05204069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93262335|NCT05204069|Cholinergic Agents|cholinergic agents|mesh-ancestor
93262336|NCT05204069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262337|NCT05204069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262338|NCT04548973|Esketamine|esketamine|mesh-list
93262339|NCT04548973|Antidepressive Agents|antidepressive agents|mesh-ancestor
93262340|NCT04548973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93262341|NCT02277938|Amantadine|amantadine|mesh-list
93262342|NCT02277938|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93262343|NCT02277938|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93262344|NCT02277938|Antiviral Agents|antiviral agents|mesh-ancestor
93262345|NCT02277938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262346|NCT02277938|Dopamine Agents|dopamine agents|mesh-ancestor
93262347|NCT02277938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262348|NCT02277938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262349|NCT02277938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262350|NCT02277938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262351|NCT02277938|Analgesics|analgesics|mesh-ancestor
93262352|NCT02277938|Sensory System Agents|sensory system agents|mesh-ancestor
93262353|NCT02277938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262354|NCT00415142|Escitalopram|escitalopram|mesh-list
93262355|NCT00415142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93262356|NCT00415142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93262357|NCT00415142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262358|NCT00415142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262359|NCT00415142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262360|NCT00415142|Serotonin Agents|serotonin agents|mesh-ancestor
93262361|NCT00415142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262362|NCT04708145|Aflibercept|aflibercept|mesh-list
93262363|NCT04708145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93262364|NCT04708145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93262365|NCT04708145|Growth Substances|growth substances|mesh-ancestor
93262366|NCT04708145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262367|NCT04708145|Growth Inhibitors|growth inhibitors|mesh-ancestor
93262368|NCT04708145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262369|NCT03661125|Saracatinib|saracatinib|mesh-list
93262370|NCT03661125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262371|NCT03661125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262372|NCT03661125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262373|NCT00413114|Obatoclax|obatoclax|mesh-list
93262374|NCT00413114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262375|NCT00413114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262376|NCT03016013|Methotrexate|methotrexate|mesh-list
93262377|NCT03016013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93262378|NCT03016013|Abortifacient Agents|abortifacient agents|mesh-ancestor
93262379|NCT03016013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93262380|NCT03016013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262381|NCT03016013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262382|NCT03016013|Antimetabolites|antimetabolites|mesh-ancestor
93262383|NCT03016013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262384|NCT03016013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262385|NCT03016013|Dermatologic Agents|dermatologic agents|mesh-ancestor
93262386|NCT03016013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262387|NCT03016013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93262388|NCT03016013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262389|NCT03016013|Immunologic Factors|immunologic factors|mesh-ancestor
93262390|NCT03016013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262391|NCT03016013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93262392|NCT01318915|Mycophenolic Acid|mycophenolic acid|mesh-list
93262393|NCT01318915|Sirolimus|sirolimus|mesh-list
93262394|NCT01318915|Rituximab|rituximab|mesh-list
93262395|NCT01318915|Tacrolimus|tacrolimus|mesh-list
93262396|NCT01318915|Thymoglobulin|thymoglobulin|mesh-list
93262397|NCT01318915|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93262398|NCT01318915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262399|NCT01318915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262400|NCT01318915|Immunologic Factors|immunologic factors|mesh-ancestor
93262401|NCT01318915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262402|NCT01318915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262403|NCT01318915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262404|NCT01318915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93262405|NCT01318915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262406|NCT01318915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262407|NCT01318915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93262408|NCT01318915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93262409|NCT01318915|Antitubercular Agents|antitubercular agents|mesh-ancestor
93262410|NCT01318915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262411|NCT01318915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262412|NCT01318915|Antifungal Agents|antifungal agents|mesh-ancestor
93262413|NCT04688177|Nicotine|nicotine|mesh-list
93262414|NCT04688177|Carbon Monoxide|carbon monoxide|mesh-list
93262415|NCT04688177|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93262416|NCT04688177|Autonomic Agents|autonomic agents|mesh-ancestor
93262417|NCT04688177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262418|NCT04688177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262419|NCT04688177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93262420|NCT04688177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93262421|NCT04688177|Cholinergic Agents|cholinergic agents|mesh-ancestor
93262422|NCT04688177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262423|NCT04688177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262424|NCT04688177|Antimetabolites|antimetabolites|mesh-ancestor
93262425|NCT04688177|Gasotransmitters|gasotransmitters|mesh-ancestor
93262426|NCT04675294|Pembrolizumab|pembrolizumab|mesh-list
93262427|NCT04675294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262428|NCT04675294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262429|NCT04675294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93262430|NCT04675294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262431|NCT00411242|Agomelatine|agomelatine|mesh-list
93262432|NCT00411242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93262433|NCT00411242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262434|NCT00411242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262435|NCT05203913|Paclitaxel|paclitaxel|mesh-list
93262436|NCT05203913|Nivolumab|nivolumab|mesh-list
93262437|NCT05203913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93262438|NCT05203913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262439|NCT05203913|Tubulin Modulators|tubulin modulators|mesh-ancestor
93262440|NCT05203913|Antimitotic Agents|antimitotic agents|mesh-ancestor
93262441|NCT05203913|Mitosis Modulators|mitosis modulators|mesh-ancestor
93262442|NCT05203913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262443|NCT05203913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262444|NCT05203913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93262445|NCT00402428|Interferons|interferons|mesh-list
93262446|NCT00402428|Ribavirin|ribavirin|mesh-list
93262447|NCT00402428|Interferon-alpha|interferon-alpha|mesh-list
93262448|NCT00402428|Interferon alpha-2|interferon alpha-2|mesh-list
93262449|NCT00402428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93262450|NCT00402428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262451|NCT00402428|Antiviral Agents|antiviral agents|mesh-ancestor
93262452|NCT00402428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262453|NCT00402428|Antimetabolites|antimetabolites|mesh-ancestor
93262454|NCT00402428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262455|NCT00402428|Immunologic Factors|immunologic factors|mesh-ancestor
93262456|NCT00402428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262457|NCT05120206|Chlorhexidine|chlorhexidine|mesh-list
93262458|NCT05120206|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93262459|NCT05120206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93262460|NCT05120206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262461|NCT05120206|Disinfectants|disinfectants|mesh-ancestor
93262462|NCT05120206|Dermatologic Agents|dermatologic agents|mesh-ancestor
93262463|NCT03660267|Caffeine|caffeine|mesh-list
93262464|NCT03660267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93262465|NCT03660267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262466|NCT03660267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93262467|NCT03660267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262468|NCT03660267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262469|NCT03660267|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93262470|NCT03660267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93262471|NCT03660267|Purinergic Agents|purinergic agents|mesh-ancestor
93262472|NCT03660267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262473|NCT03950245|Glucagon|glucagon|mesh-list
93262474|NCT03950245|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93262475|NCT03950245|Incretins|incretins|mesh-ancestor
93262476|NCT03950245|Hormones|hormones|mesh-ancestor
93262477|NCT03950245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262478|NCT03950245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262479|NCT03950245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262480|NCT00401570|Gemcitabine|gemcitabine|mesh-list
93262481|NCT00401570|Volociximab|volociximab|mesh-list
93262482|NCT00401570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262483|NCT00401570|Antimetabolites|antimetabolites|mesh-ancestor
93262484|NCT00401570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262485|NCT00401570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557167|NCT00216346|Amebicides|amebicides|mesh-ancestor
93262486|NCT00401570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93262487|NCT00401570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93262488|NCT00401570|Growth Substances|growth substances|mesh-ancestor
93262489|NCT00401570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262490|NCT00401570|Growth Inhibitors|growth inhibitors|mesh-ancestor
93262491|NCT04056741|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93262492|NCT04056741|Respiratory System Agents|respiratory system agents|mesh-ancestor
93262493|NCT05193565|Mycophenolic Acid|mycophenolic acid|mesh-list
93262494|NCT05193565|Sirolimus|sirolimus|mesh-list
93262495|NCT05193565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93262496|NCT05193565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262497|NCT05193565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93262498|NCT05193565|Antitubercular Agents|antitubercular agents|mesh-ancestor
93262499|NCT05193565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262500|NCT05193565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262501|NCT05193565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262502|NCT05193565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262503|NCT05193565|Antifungal Agents|antifungal agents|mesh-ancestor
93262504|NCT05193565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262505|NCT05193565|Immunologic Factors|immunologic factors|mesh-ancestor
93262506|NCT05193565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262507|NCT04471922|Rabeprazole|rabeprazole|mesh-list
93262508|NCT04471922|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93262509|NCT04471922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262510|NCT04471922|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93262511|NCT04471922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262512|NCT04471922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262513|NCT04368364|Morphine|morphine|mesh-list
93262514|NCT04368364|Bupivacaine|bupivacaine|mesh-list
93262515|NCT04368364|Ropivacaine|ropivacaine|mesh-list
93262516|NCT04368364|Anesthetics, Local|anesthetics, local|mesh-ancestor
93262517|NCT04368364|Anesthetics|anesthetics|mesh-ancestor
93262518|NCT04368364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262519|NCT04368364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262520|NCT04368364|Sensory System Agents|sensory system agents|mesh-ancestor
93262521|NCT04368364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262522|NCT04368364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93262523|NCT04368364|Narcotics|narcotics|mesh-ancestor
93262524|NCT04368364|Analgesics|analgesics|mesh-ancestor
93262525|NCT02285036|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93262526|NCT02285036|Immunologic Factors|immunologic factors|mesh-ancestor
93262527|NCT02285036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262528|NCT00543374|Remestemcel-l|remestemcel-l|mesh-list
93262529|NCT00543374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262530|NCT00543374|Antiviral Agents|antiviral agents|mesh-ancestor
93262531|NCT00543374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262532|NCT02926937|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93262533|NCT02926937|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93262534|NCT02926937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262535|NCT02926937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262536|NCT02926937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262537|NCT05229796|Empagliflozin|empagliflozin|mesh-list
93262538|NCT05229796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93262539|NCT05229796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262540|NCT05229796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262541|NCT05229796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262542|NCT04189588|Diphenhydramine|diphenhydramine|mesh-list
93262543|NCT04189588|Promethazine|promethazine|mesh-list
93262544|NCT04189588|Cetirizine|cetirizine|mesh-list
93262545|NCT04189588|Paclitaxel|paclitaxel|mesh-list
93262546|NCT04189588|Rituximab|rituximab|mesh-list
93262547|NCT04189588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93262548|NCT04189588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262549|NCT04189588|Tubulin Modulators|tubulin modulators|mesh-ancestor
93262550|NCT04189588|Antimitotic Agents|antimitotic agents|mesh-ancestor
93262551|NCT04189588|Mitosis Modulators|mitosis modulators|mesh-ancestor
93262552|NCT04189588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262553|NCT04189588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262554|NCT04189588|Immunologic Factors|immunologic factors|mesh-ancestor
93262555|NCT04189588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262556|NCT04189588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262557|NCT04189588|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93262558|NCT04189588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93262559|NCT04189588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262560|NCT04189588|Anesthetics, Local|anesthetics, local|mesh-ancestor
93262561|NCT04189588|Anesthetics|anesthetics|mesh-ancestor
93262562|NCT04189588|Sensory System Agents|sensory system agents|mesh-ancestor
93262563|NCT04189588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262564|NCT04189588|Antiemetics|antiemetics|mesh-ancestor
93262565|NCT04189588|Autonomic Agents|autonomic agents|mesh-ancestor
93262566|NCT04189588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262567|NCT04189588|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93262568|NCT04189588|Histamine Antagonists|histamine antagonists|mesh-ancestor
93262569|NCT04189588|Histamine Agents|histamine agents|mesh-ancestor
93262570|NCT04189588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262571|NCT04189588|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93262572|NCT04189588|Antipruritics|antipruritics|mesh-ancestor
93262573|NCT04189588|Dermatologic Agents|dermatologic agents|mesh-ancestor
93262574|NCT04189588|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93262575|NCT00151892|Mesalamine|mesalamine|mesh-list
93262576|NCT00151892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93262577|NCT00151892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262578|NCT00151892|Analgesics|analgesics|mesh-ancestor
93262579|NCT00151892|Sensory System Agents|sensory system agents|mesh-ancestor
93262580|NCT00151892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262581|NCT00151892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262582|NCT00151892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262583|NCT00151892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262584|NCT02740127|Dexamethasone|dexamethasone|mesh-list
93262585|NCT02740127|Clonidine|clonidine|mesh-list
93262586|NCT02740127|Epinephrine|epinephrine|mesh-list
93262587|NCT02740127|Propofol|propofol|mesh-list
93262588|NCT02740127|Ropivacaine|ropivacaine|mesh-list
93262589|NCT02740127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262590|NCT02740127|Antiemetics|antiemetics|mesh-ancestor
93262591|NCT02740127|Autonomic Agents|autonomic agents|mesh-ancestor
93262592|NCT02740127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262593|NCT02740127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262594|NCT02740127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262595|NCT02740127|Glucocorticoids|glucocorticoids|mesh-ancestor
93262596|NCT02740127|Hormones|hormones|mesh-ancestor
93262597|NCT02740127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262598|NCT02740127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93262599|NCT02740127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262600|NCT02740127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262601|NCT02740127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93262602|NCT02740127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262603|NCT02740127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93262604|NCT02740127|Anesthetics, General|anesthetics, general|mesh-ancestor
93262605|NCT02740127|Anesthetics|anesthetics|mesh-ancestor
93262606|NCT02740127|Anesthetics, Local|anesthetics, local|mesh-ancestor
93262607|NCT02740127|Sensory System Agents|sensory system agents|mesh-ancestor
93262608|NCT02740127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93262609|NCT02740127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93262610|NCT02740127|Adrenergic Agents|adrenergic agents|mesh-ancestor
93262611|NCT02740127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262612|NCT02740127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93262613|NCT02740127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93262614|NCT02740127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93262615|NCT02740127|Respiratory System Agents|respiratory system agents|mesh-ancestor
93262616|NCT02740127|Mydriatics|mydriatics|mesh-ancestor
93262617|NCT02740127|Sympathomimetics|sympathomimetics|mesh-ancestor
93262618|NCT02740127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93262619|NCT02740127|Analgesics|analgesics|mesh-ancestor
93262620|NCT02740127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93262621|NCT02740127|Sympatholytics|sympatholytics|mesh-ancestor
92557322|NCT00041678|Dopamine Agents|dopamine agents|mesh-ancestor
93262622|NCT02740127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93262623|NCT05008783|Capecitabine|capecitabine|mesh-list
93262624|NCT05008783|Oxaliplatin|oxaliplatin|mesh-list
93262625|NCT05008783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262626|NCT05008783|Antimetabolites|antimetabolites|mesh-ancestor
93262627|NCT05008783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262628|NCT05008783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262629|NCT04450498|Vaccines|vaccines|mesh-list
93262630|NCT04450498|Immunologic Factors|immunologic factors|mesh-ancestor
93262631|NCT04450498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262632|NCT00654992|Epoetin Alfa|epoetin alfa|mesh-list
93262633|NCT00654992|Hematinics|hematinics|mesh-ancestor
93262634|NCT02921919|Talazoparib|talazoparib|mesh-list
93262635|NCT02921919|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93262636|NCT02921919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262637|NCT02921919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262638|NCT02921919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262639|NCT00393068|Paclitaxel|paclitaxel|mesh-list
93262640|NCT00393068|Bevacizumab|bevacizumab|mesh-list
93262641|NCT00393068|Carboplatin|carboplatin|mesh-list
93262642|NCT00393068|Fluorouracil|fluorouracil|mesh-list
93262643|NCT00393068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93262644|NCT00393068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93262645|NCT00393068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262646|NCT00393068|Tubulin Modulators|tubulin modulators|mesh-ancestor
93262647|NCT00393068|Antimitotic Agents|antimitotic agents|mesh-ancestor
93262648|NCT00393068|Mitosis Modulators|mitosis modulators|mesh-ancestor
93262649|NCT00393068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262650|NCT00393068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262651|NCT00393068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93262652|NCT00393068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93262653|NCT00393068|Growth Substances|growth substances|mesh-ancestor
93262654|NCT00393068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262655|NCT00393068|Growth Inhibitors|growth inhibitors|mesh-ancestor
93262656|NCT00393068|Antimetabolites|antimetabolites|mesh-ancestor
93262657|NCT00393068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262658|NCT00393068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262659|NCT00393068|Immunologic Factors|immunologic factors|mesh-ancestor
93262660|NCT00393068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93262661|NCT00393068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262662|NCT02280278|Immunomodulating Agents|immunomodulating agents|mesh-list
93262663|NCT02280278|Immunologic Factors|immunologic factors|mesh-ancestor
93262664|NCT02280278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262665|NCT04769401|Progesterone|progesterone|mesh-list
93262666|NCT04769401|Progestins|progestins|mesh-ancestor
93262667|NCT04769401|Hormones|hormones|mesh-ancestor
93262668|NCT04769401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262669|NCT04769401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262670|NCT02094222|Glycerol|glycerol|mesh-list
93262671|NCT02094222|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93262672|NCT02094222|Protective Agents|protective agents|mesh-ancestor
93262673|NCT02094222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262674|NCT02280590|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93262675|NCT02280590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93262676|NCT02280590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93262677|NCT02280590|Antimetabolites|antimetabolites|mesh-ancestor
93262678|NCT02280590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262679|NCT02280590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93262680|NCT02280590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93262681|NCT02280590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262682|NCT02090244|Teriparatide|teriparatide|mesh-list
93262683|NCT02090244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93262684|NCT02090244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262685|NCT02090244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93262686|NCT02282774|Lidocaine|lidocaine|mesh-list
93262687|NCT02282774|Bupivacaine|bupivacaine|mesh-list
93262688|NCT02282774|Anesthetics, Local|anesthetics, local|mesh-ancestor
93262689|NCT02282774|Anesthetics|anesthetics|mesh-ancestor
93262690|NCT02282774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262691|NCT02282774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262692|NCT02282774|Sensory System Agents|sensory system agents|mesh-ancestor
93262693|NCT02282774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262694|NCT02282774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93262695|NCT02282774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93262696|NCT02282774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93262697|NCT02282774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262698|NCT02282774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262699|NCT02090322|Bevacizumab|bevacizumab|mesh-list
93262700|NCT02090322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262701|NCT02090322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262702|NCT02090322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93262703|NCT02090322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93262704|NCT02090322|Growth Substances|growth substances|mesh-ancestor
93262705|NCT02090322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262706|NCT02090322|Growth Inhibitors|growth inhibitors|mesh-ancestor
93262707|NCT03658785|Aldesleukin|aldesleukin|mesh-list
93262708|NCT03658785|Cyclophosphamide|cyclophosphamide|mesh-list
93262709|NCT03658785|Fludarabine|fludarabine|mesh-list
93262710|NCT03658785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262711|NCT03658785|Immunologic Factors|immunologic factors|mesh-ancestor
93262712|NCT03658785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262713|NCT03658785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262714|NCT03658785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93262715|NCT03658785|Alkylating Agents|alkylating agents|mesh-ancestor
93262716|NCT03658785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262717|NCT03658785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262718|NCT03658785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93262719|NCT03658785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93262720|NCT03658785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93262721|NCT03658785|Antiviral Agents|antiviral agents|mesh-ancestor
93262722|NCT03658785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262723|NCT02095782|Paclitaxel|paclitaxel|mesh-list
93262724|NCT02095782|Carboplatin|carboplatin|mesh-list
93262725|NCT02095782|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93262726|NCT02095782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93262727|NCT02095782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262728|NCT02095782|Tubulin Modulators|tubulin modulators|mesh-ancestor
93262729|NCT02095782|Antimitotic Agents|antimitotic agents|mesh-ancestor
93262730|NCT02095782|Mitosis Modulators|mitosis modulators|mesh-ancestor
93262731|NCT02095782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262732|NCT02095782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93262733|NCT02095782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262734|NCT02094378|Esketamine|esketamine|mesh-list
93262735|NCT02094378|Antidepressive Agents|antidepressive agents|mesh-ancestor
93262736|NCT02094378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93262737|NCT02285738|Aspirin|aspirin|mesh-list
93262738|NCT02285738|Simvastatin|simvastatin|mesh-list
93262739|NCT02285738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93262740|NCT02285738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262741|NCT02285738|Analgesics|analgesics|mesh-ancestor
93262742|NCT02285738|Sensory System Agents|sensory system agents|mesh-ancestor
93262743|NCT02285738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262744|NCT02285738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262745|NCT02285738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262746|NCT02285738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262747|NCT02285738|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93262748|NCT02285738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93262749|NCT02285738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262750|NCT02285738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93262751|NCT02285738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93262752|NCT02285738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262753|NCT02285738|Antipyretics|antipyretics|mesh-ancestor
93262754|NCT02285738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93262755|NCT02285738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93262756|NCT02285738|Antimetabolites|antimetabolites|mesh-ancestor
93262757|NCT02285738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93262758|NCT02285738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93262759|NCT00650702|Latanoprost|latanoprost|mesh-list
93262760|NCT00650702|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93262761|NCT00650702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93262762|NCT02090400|Bazedoxifene|bazedoxifene|mesh-list
93262763|NCT02090400|Calcium|calcium|mesh-list
93262764|NCT02090400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93262765|NCT02090400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262766|NCT02090400|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93262767|NCT02090400|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93262768|NCT02090400|Hormone Antagonists|hormone antagonists|mesh-ancestor
93262769|NCT02090400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262770|NCT02090400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93262771|NCT03134846|Cetuximab|cetuximab|mesh-list
93262772|NCT03134846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93262773|NCT03134846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262774|NCT01068717|Metformin|metformin|mesh-list
93262775|NCT01068717|Saxagliptin|saxagliptin|mesh-list
93262776|NCT01068717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262777|NCT01068717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262778|NCT01068717|Incretins|incretins|mesh-ancestor
93262779|NCT01068717|Hormones|hormones|mesh-ancestor
93262780|NCT01068717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262781|NCT01068717|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93262782|NCT01068717|Protease Inhibitors|protease inhibitors|mesh-ancestor
93262783|NCT01068717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262784|NCT01068717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262785|NCT02095938|Amisulpride|amisulpride|mesh-list
93262786|NCT02095938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93262787|NCT02095938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93262788|NCT02095938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262789|NCT02095938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262790|NCT02095938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93262791|NCT02095938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93262792|NCT02095938|Dopamine Agents|dopamine agents|mesh-ancestor
93262793|NCT02095938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262794|NCT02095938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262795|NCT02095938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93262796|NCT02095938|Antidepressive Agents|antidepressive agents|mesh-ancestor
93262797|NCT02285972|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93262798|NCT02285972|Tenoxicam|tenoxicam|mesh-list
93262799|NCT02285972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93262800|NCT02285972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262801|NCT02285972|Analgesics|analgesics|mesh-ancestor
93262802|NCT02285972|Sensory System Agents|sensory system agents|mesh-ancestor
93262803|NCT02285972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262804|NCT02285972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262805|NCT02285972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262806|NCT02285972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262807|NCT02285972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93262808|NCT02285972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262809|NCT02285972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262810|NCT02096094|Chlorhexidine|chlorhexidine|mesh-list
93262811|NCT02096094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93262812|NCT02096094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262813|NCT02096094|Disinfectants|disinfectants|mesh-ancestor
93262814|NCT02921763|Dydrogesterone|dydrogesterone|mesh-list
93262815|NCT02921763|Progestins|progestins|mesh-ancestor
93262816|NCT02921763|Hormones|hormones|mesh-ancestor
93262817|NCT02921763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262818|NCT02921763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262819|NCT03658473|Naproxen|naproxen|mesh-list
93262820|NCT03658473|Rabeprazole|rabeprazole|mesh-list
93262821|NCT03658473|Rebamipide|rebamipide|mesh-list
93262822|NCT03658473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93262823|NCT03658473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262824|NCT03658473|Analgesics|analgesics|mesh-ancestor
93262825|NCT03658473|Sensory System Agents|sensory system agents|mesh-ancestor
93262826|NCT03658473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262827|NCT03658473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262828|NCT03658473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262829|NCT03658473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262830|NCT03658473|Gout Suppressants|gout suppressants|mesh-ancestor
93262831|NCT03658473|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93262832|NCT03658473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262833|NCT03658473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262834|NCT03658473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93262835|NCT03658473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93262836|NCT03658473|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93262837|NCT03658473|Antioxidants|antioxidants|mesh-ancestor
93262838|NCT03658473|Protective Agents|protective agents|mesh-ancestor
93262839|NCT02096250|Ferrous fumarate|ferrous fumarate|mesh-list
93262840|NCT02096250|Edetic Acid|edetic acid|mesh-list
93262841|NCT02096250|Ferric Compounds|ferric compounds|mesh-list
93262842|NCT02096250|Fe(III)-EDTA|fe(iii)-edta|mesh-list
93262843|NCT02096250|Trace Elements|trace elements|mesh-ancestor
93262844|NCT02096250|Micronutrients|micronutrients|mesh-ancestor
93262845|NCT02096250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262846|NCT02096250|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93262847|NCT02096250|Chelating Agents|chelating agents|mesh-ancestor
93262848|NCT02096250|Sequestering Agents|sequestering agents|mesh-ancestor
93262849|NCT02096250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934844|NCT03540212|Sofosbuvir|sofosbuvir|mesh-list
93262850|NCT02096250|Anticoagulants|anticoagulants|mesh-ancestor
93262851|NCT02096250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93262852|NCT02096250|Hematinics|hematinics|mesh-ancestor
93262853|NCT02096328|Murepavadin|murepavadin|mesh-list
93262854|NCT02096328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93262855|NCT02096328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93262857|NCT01318135|Glimepiride|glimepiride|mesh-list
93262858|NCT01318135|Alogliptin|alogliptin|mesh-list
93262859|NCT01318135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93262860|NCT01318135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262861|NCT01318135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93262862|NCT01318135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93262863|NCT01318135|Immunologic Factors|immunologic factors|mesh-ancestor
93262864|NCT01318135|Incretins|incretins|mesh-ancestor
93262865|NCT01318135|Hormones|hormones|mesh-ancestor
93262866|NCT01318135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93262867|NCT01318135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93262868|NCT01318135|Protease Inhibitors|protease inhibitors|mesh-ancestor
93262869|NCT01318135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262870|NCT01318135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262871|NCT02094924|Candesartan|candesartan|mesh-list
93262872|NCT02094924|Candesartan cilexetil|candesartan cilexetil|mesh-list
93262873|NCT02094924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93262874|NCT02094924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93262875|NCT02094924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93262876|NCT02094924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262877|NCT02286206|Clozapine|clozapine|mesh-list
93262878|NCT02286206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93262879|NCT02286206|Serotonin Agents|serotonin agents|mesh-ancestor
93262880|NCT02286206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262881|NCT02286206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262882|NCT02286206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262883|NCT02286206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93262884|NCT02286206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93262885|NCT02286206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262886|NCT02286206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93262887|NCT02286206|GABA Antagonists|gaba antagonists|mesh-ancestor
93262888|NCT02286206|GABA Agents|gaba agents|mesh-ancestor
93262889|NCT03104283|Apatinib|apatinib|mesh-list
93262890|NCT03104283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262891|NCT03104283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93262892|NCT03104283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262893|NCT03104283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262894|NCT00529178|Pravastatin|pravastatin|mesh-list
93262895|NCT00529178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93262896|NCT00529178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93262897|NCT00529178|Antimetabolites|antimetabolites|mesh-ancestor
93262898|NCT00529178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262899|NCT00529178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93262900|NCT00529178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93262901|NCT00529178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262902|NCT00382460|Pravastatin|pravastatin|mesh-list
93262903|NCT00382460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93262904|NCT00382460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93262905|NCT00382460|Antimetabolites|antimetabolites|mesh-ancestor
93262906|NCT00382460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262907|NCT00382460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93262908|NCT00382460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93262909|NCT00382460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262910|NCT00523250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93262911|NCT00523250|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93262912|NCT02286596|Heparin|heparin|mesh-list
93262913|NCT02286596|Dextrans|dextrans|mesh-list
93262914|NCT02286596|Anticoagulants|anticoagulants|mesh-ancestor
93262915|NCT02286596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93262916|NCT02286596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93262917|NCT02286596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262918|NCT02286596|Plasma Substitutes|plasma substitutes|mesh-ancestor
93262919|NCT02286596|Blood Substitutes|blood substitutes|mesh-ancestor
93262920|NCT02098824|Methylphenidate|methylphenidate|mesh-list
93262921|NCT02098824|Galantamine|galantamine|mesh-list
93262922|NCT02098824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93262923|NCT02098824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262924|NCT02098824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93262925|NCT02098824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93262926|NCT02098824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93262927|NCT02098824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262928|NCT02098824|Dopamine Agents|dopamine agents|mesh-ancestor
93262929|NCT02098824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262930|NCT02098824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93262931|NCT02098824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262932|NCT02098824|Cholinergic Agents|cholinergic agents|mesh-ancestor
93262933|NCT02098824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93262934|NCT02098824|Autonomic Agents|autonomic agents|mesh-ancestor
93262935|NCT02098824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262936|NCT02098824|Nootropic Agents|nootropic agents|mesh-ancestor
93262937|NCT03658317|Uric Acid|uric acid|mesh-list
93262938|NCT03658317|Antioxidants|antioxidants|mesh-ancestor
93262939|NCT03658317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262940|NCT03658317|Protective Agents|protective agents|mesh-ancestor
93262941|NCT03658317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262942|NCT02286752|Neostigmine|neostigmine|mesh-list
93262943|NCT02286752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93262944|NCT02286752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262945|NCT02286752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262946|NCT02286752|Cholinergic Agents|cholinergic agents|mesh-ancestor
93262947|NCT02286752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262948|NCT02286752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262949|NCT02286752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93262950|NCT02286752|Autonomic Agents|autonomic agents|mesh-ancestor
93262951|NCT02286752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262952|NCT04470050|Dexmedetomidine|dexmedetomidine|mesh-list
93262953|NCT04470050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93262954|NCT04470050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93262955|NCT04470050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262956|NCT04470050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262957|NCT04470050|Analgesics|analgesics|mesh-ancestor
93262958|NCT04470050|Sensory System Agents|sensory system agents|mesh-ancestor
93262959|NCT04470050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262960|NCT04470050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93262961|NCT04470050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93262962|NCT04470050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93262963|NCT04470050|Adrenergic Agents|adrenergic agents|mesh-ancestor
93262964|NCT04470050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93262965|NCT04470050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262966|NCT02095314|Vaccines|vaccines|mesh-list
93262967|NCT02095314|Immunologic Factors|immunologic factors|mesh-ancestor
93262968|NCT02095314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262969|NCT02098980|Vitamin D|vitamin d|mesh-list
93262970|NCT02098980|Vitamins|vitamins|mesh-ancestor
93262971|NCT02098980|Micronutrients|micronutrients|mesh-ancestor
93262972|NCT02098980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262973|NCT02098980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93262974|NCT00372944|Capecitabine|capecitabine|mesh-list
93262975|NCT00372944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93262976|NCT00372944|Antimetabolites|antimetabolites|mesh-ancestor
93262977|NCT00372944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262978|NCT00372944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262979|NCT02099136|Celecoxib|celecoxib|mesh-list
93262980|NCT02099136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93262981|NCT02099136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93262982|NCT02099136|Analgesics|analgesics|mesh-ancestor
93262983|NCT02099136|Sensory System Agents|sensory system agents|mesh-ancestor
93262984|NCT02099136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93262985|NCT02099136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93262986|NCT02099136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93262987|NCT02099136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93262988|NCT02099136|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93262989|NCT02099136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93262990|NCT02099136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262991|NCT02099136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93262992|NCT00117650|Etoposide|etoposide|mesh-list
93262993|NCT00117650|Etoposide phosphate|etoposide phosphate|mesh-list
93262994|NCT00117650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93262995|NCT00117650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93262996|NCT00117650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93262997|NCT00117650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92934994|NCT00667017|Immunologic Factors|immunologic factors|mesh-ancestor
93262998|NCT00117650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93262999|NCT00117650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263000|NCT02095548|Lorecivivint|lorecivivint|mesh-list
93263001|NCT02095548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263003|NCT00113438|Fosbretabulin|fosbretabulin|mesh-list
93263004|NCT00113438|Combretastatin|combretastatin|mesh-list
93263005|NCT00113438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93263006|NCT00113438|Carboplatin|carboplatin|mesh-list
93263007|NCT00113438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93263008|NCT00113438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263009|NCT00113438|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263010|NCT00113438|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263011|NCT00113438|Mitosis Modulators|mitosis modulators|mesh-ancestor
93263012|NCT00113438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263013|NCT04087408|Hormones|hormones|mesh-list
93263014|NCT04087408|Progesterone|progesterone|mesh-list
93263015|NCT04087408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263016|NCT04087408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263017|NCT04087408|Progestins|progestins|mesh-ancestor
93263018|NCT02099292|Rituximab|rituximab|mesh-list
93263019|NCT02099292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263020|NCT02099292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263021|NCT02099292|Immunologic Factors|immunologic factors|mesh-ancestor
93263022|NCT02099292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263023|NCT02099292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263024|NCT02283242|Galantamine|galantamine|mesh-list
93263025|NCT02283242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93263026|NCT02283242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263027|NCT02283242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263028|NCT02283242|Cholinergic Agents|cholinergic agents|mesh-ancestor
93263029|NCT02283242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263030|NCT02283242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263031|NCT02283242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93263032|NCT02283242|Autonomic Agents|autonomic agents|mesh-ancestor
93263033|NCT02283242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263034|NCT02283242|Nootropic Agents|nootropic agents|mesh-ancestor
93263035|NCT02283320|Docetaxel|docetaxel|mesh-list
93263036|NCT02283320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263037|NCT02283320|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263038|NCT02283320|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263039|NCT02283320|Mitosis Modulators|mitosis modulators|mesh-ancestor
93263040|NCT02283320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263041|NCT03556098|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
93263042|NCT03556098|Hormones|hormones|mesh-list
93263043|NCT03556098|Incretins|incretins|mesh-list
93263044|NCT03556098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263045|NCT03556098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263046|NCT03556098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93263047|NCT02286986|Cannabidiol|cannabidiol|mesh-list
93263048|NCT02286986|Anticonvulsants|anticonvulsants|mesh-ancestor
93263049|NCT04995874|Micronutrients|micronutrients|mesh-list
93263050|NCT04995874|Trace Elements|trace elements|mesh-list
93263051|NCT04995874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263052|NCT02287064|Immunoglobulins|immunoglobulins|mesh-list
93263053|NCT02287064|Antibodies|antibodies|mesh-list
93263054|NCT02287064|gamma-Globulins|gamma-globulins|mesh-list
93263055|NCT02287064|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93263056|NCT02287064|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93263057|NCT02287064|Immunologic Factors|immunologic factors|mesh-ancestor
93263058|NCT02287064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263059|NCT02095704|Acetaminophen|acetaminophen|mesh-list
93263060|NCT02095704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263061|NCT02095704|Analgesics|analgesics|mesh-ancestor
93263062|NCT02095704|Sensory System Agents|sensory system agents|mesh-ancestor
93263063|NCT02095704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263064|NCT02095704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263065|NCT02095704|Antipyretics|antipyretics|mesh-ancestor
93263066|NCT02099604|Vitamin D|vitamin d|mesh-list
93263067|NCT02099604|Interferons|interferons|mesh-list
93263068|NCT02099604|Ribavirin|ribavirin|mesh-list
93263069|NCT02099604|Interferon-alpha|interferon-alpha|mesh-list
93263070|NCT02099604|Interferon alpha-2|interferon alpha-2|mesh-list
93263071|NCT02099604|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93263072|NCT02099604|Vitamins|vitamins|mesh-ancestor
93263073|NCT02099604|Micronutrients|micronutrients|mesh-ancestor
93263074|NCT02099604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263075|NCT02099604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93263076|NCT02099604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263077|NCT02099604|Antiviral Agents|antiviral agents|mesh-ancestor
93263078|NCT02099604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263079|NCT02099604|Antimetabolites|antimetabolites|mesh-ancestor
93263080|NCT02099604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263081|NCT02099604|Immunologic Factors|immunologic factors|mesh-ancestor
93263082|NCT02099916|Menotropins|menotropins|mesh-list
93263083|NCT02099916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263084|NCT02099916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93263085|NCT02099916|Fertility Agents|fertility agents|mesh-ancestor
93263086|NCT02099916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263087|NCT02102646|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93263088|NCT02102646|Luteolytic Agents|luteolytic agents|mesh-ancestor
93263089|NCT02102646|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93263090|NCT02102646|Contraceptive Agents|contraceptive agents|mesh-ancestor
93263091|NCT02102646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263092|NCT02102646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263093|NCT02102646|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93263094|NCT02102646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93263095|NCT02102646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263096|NCT00366704|Risperidone|risperidone|mesh-list
93263097|NCT00366704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93263098|NCT00366704|Serotonin Agents|serotonin agents|mesh-ancestor
93263099|NCT00366704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263100|NCT00366704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263101|NCT00366704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263102|NCT00366704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93263103|NCT00366704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93263104|NCT00366704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263105|NCT00366704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93263106|NCT00366704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93263107|NCT00366704|Dopamine Agents|dopamine agents|mesh-ancestor
93263108|NCT02097264|Adalimumab|adalimumab|mesh-list
93263109|NCT02097264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93263110|NCT02097264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263111|NCT02097264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263112|NCT02097342|Linagliptin|linagliptin|mesh-list
93263113|NCT02097342|Voglibose|voglibose|mesh-list
93263114|NCT02097342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93263115|NCT02097342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263116|NCT02097342|Incretins|incretins|mesh-ancestor
93263117|NCT02097342|Hormones|hormones|mesh-ancestor
93263118|NCT02097342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263119|NCT02097342|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93263120|NCT02097342|Protease Inhibitors|protease inhibitors|mesh-ancestor
93263121|NCT02097342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263122|NCT02097342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263123|NCT02097342|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93263124|NCT04294498|Entecavir|entecavir|mesh-list
93263125|NCT04294498|Durvalumab|durvalumab|mesh-list
93263126|NCT04294498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263127|NCT04294498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263128|NCT04294498|Antiviral Agents|antiviral agents|mesh-ancestor
93263129|NCT04294498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263130|NCT04059172|Ibuprofen|ibuprofen|mesh-list
93263131|NCT04059172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263132|NCT04059172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263133|NCT04059172|Analgesics|analgesics|mesh-ancestor
93263134|NCT04059172|Sensory System Agents|sensory system agents|mesh-ancestor
93263135|NCT04059172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263136|NCT04059172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263137|NCT04059172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263138|NCT04059172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263139|NCT04059172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93263140|NCT04059172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263141|NCT04059172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263142|NCT00359450|Taxane|taxane|mesh-list
93263143|NCT00359450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263144|NCT03530462|Methylprednisolone|methylprednisolone|mesh-list
93263145|NCT03530462|Cyclophosphamide|cyclophosphamide|mesh-list
93263146|NCT03530462|Rituximab|rituximab|mesh-list
93263147|NCT03530462|Immunoglobulins|immunoglobulins|mesh-list
93263148|NCT03530462|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92935146|NCT00774813|Serotonin Agents|serotonin agents|mesh-ancestor
93263149|NCT03530462|Antibodies|antibodies|mesh-list
93263150|NCT03530462|gamma-Globulins|gamma-globulins|mesh-list
93263151|NCT03530462|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93263152|NCT03530462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263153|NCT03530462|Immunologic Factors|immunologic factors|mesh-ancestor
93263154|NCT03530462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263155|NCT03530462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263156|NCT03530462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263157|NCT03530462|Alkylating Agents|alkylating agents|mesh-ancestor
93263158|NCT03530462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263159|NCT03530462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263160|NCT03530462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93263161|NCT03530462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263162|NCT03530462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263163|NCT03530462|Antiemetics|antiemetics|mesh-ancestor
93263164|NCT03530462|Autonomic Agents|autonomic agents|mesh-ancestor
93263165|NCT03530462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263166|NCT03530462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93263167|NCT03530462|Glucocorticoids|glucocorticoids|mesh-ancestor
93263168|NCT03530462|Hormones|hormones|mesh-ancestor
93263169|NCT03530462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263170|NCT03530462|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93263171|NCT03530462|Protective Agents|protective agents|mesh-ancestor
93263172|NCT02103192|Antioxidants|antioxidants|mesh-list
93263173|NCT02103192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263174|NCT02103192|Protective Agents|protective agents|mesh-ancestor
93263175|NCT02103192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263176|NCT02097810|Entrectinib|entrectinib|mesh-list
93263177|NCT02097810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93263178|NCT02097810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263179|NCT02097810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263180|NCT02100462|Aspirin|aspirin|mesh-list
93263181|NCT02100462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93263182|NCT02100462|Chlorthalidone|chlorthalidone|mesh-list
93263183|NCT02100462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263184|NCT02100462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263185|NCT02100462|Analgesics|analgesics|mesh-ancestor
93263186|NCT02100462|Sensory System Agents|sensory system agents|mesh-ancestor
93263187|NCT02100462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263188|NCT02100462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263189|NCT02100462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263190|NCT02100462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263191|NCT02100462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93263192|NCT02100462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93263193|NCT02100462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263194|NCT02100462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93263195|NCT02100462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93263196|NCT02100462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263197|NCT02100462|Antipyretics|antipyretics|mesh-ancestor
93263198|NCT02100462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93263199|NCT02100462|Diuretics|diuretics|mesh-ancestor
93263200|NCT02100462|Natriuretic Agents|natriuretic agents|mesh-ancestor
92557903|NCT00122785|Hormones|hormones|mesh-ancestor
93263201|NCT02100462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93263202|NCT02100462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93263203|NCT04507126|BCG Vaccine|bcg vaccine|mesh-list
93263204|NCT04507126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93263205|NCT04507126|Immunologic Factors|immunologic factors|mesh-ancestor
93263206|NCT04507126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263207|NCT00150176|Asenapine|asenapine|mesh-list
93263208|NCT00150176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93263209|NCT00150176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93263210|NCT00150176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263211|NCT00150176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263212|NCT00150176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93263213|NCT00961792|Diphenhydramine|diphenhydramine|mesh-list
93263214|NCT00961792|Promethazine|promethazine|mesh-list
93263215|NCT00961792|Ethanol|ethanol|mesh-list
93263216|NCT00961792|Caffeine|caffeine|mesh-list
93263217|NCT00961792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93263218|NCT00961792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263219|NCT00961792|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93263220|NCT00961792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263221|NCT00961792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263222|NCT00961792|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93263223|NCT00961792|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93263224|NCT00961792|Purinergic Agents|purinergic agents|mesh-ancestor
93263225|NCT00961792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263226|NCT00961792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93263227|NCT00961792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263228|NCT00961792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263229|NCT00961792|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93263230|NCT00961792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93263231|NCT00961792|Anesthetics, Local|anesthetics, local|mesh-ancestor
93263232|NCT00961792|Anesthetics|anesthetics|mesh-ancestor
93263233|NCT00961792|Sensory System Agents|sensory system agents|mesh-ancestor
93263234|NCT00961792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263235|NCT00961792|Antiemetics|antiemetics|mesh-ancestor
93263236|NCT00961792|Autonomic Agents|autonomic agents|mesh-ancestor
93263237|NCT00961792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93263238|NCT00961792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93263239|NCT00961792|Histamine Antagonists|histamine antagonists|mesh-ancestor
93263240|NCT00961792|Histamine Agents|histamine agents|mesh-ancestor
93263241|NCT00961792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93263242|NCT00961792|Antipruritics|antipruritics|mesh-ancestor
93263243|NCT00961792|Dermatologic Agents|dermatologic agents|mesh-ancestor
93263244|NCT04435912|Hydrocortisone|hydrocortisone|mesh-list
93263245|NCT04435912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263246|NCT02100852|Obinutuzumab|obinutuzumab|mesh-list
93263247|NCT02100852|Chlorambucil|chlorambucil|mesh-list
93263248|NCT02100852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263249|NCT02100852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263250|NCT02100852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263251|NCT02100852|Alkylating Agents|alkylating agents|mesh-ancestor
93263252|NCT02100852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263253|NCT00057980|Celecoxib|celecoxib|mesh-list
93263254|NCT00057980|Epirubicin|epirubicin|mesh-list
93263255|NCT00057980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263256|NCT00057980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263257|NCT00057980|Analgesics|analgesics|mesh-ancestor
93263258|NCT00057980|Sensory System Agents|sensory system agents|mesh-ancestor
93263259|NCT00057980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263260|NCT00057980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263261|NCT00057980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263262|NCT00057980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263263|NCT00057980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93263264|NCT00057980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93263265|NCT00057980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263266|NCT00057980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263267|NCT00057980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93263268|NCT00057980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263269|NCT00057980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93263270|NCT00057980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93263271|NCT02985879|Tilavonemab|tilavonemab|mesh-list
93263272|NCT02985879|Nootropic Agents|nootropic agents|mesh-ancestor
93263273|NCT02097966|Ribavirin|ribavirin|mesh-list
93263274|NCT02097966|Sofosbuvir|sofosbuvir|mesh-list
93263275|NCT02097966|Antimetabolites|antimetabolites|mesh-ancestor
93263276|NCT02097966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263277|NCT02097966|Antiviral Agents|antiviral agents|mesh-ancestor
93263278|NCT02097966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263279|NCT00052598|Aldesleukin|aldesleukin|mesh-list
93263280|NCT00052598|Interleukin-2|interleukin-2|mesh-list
93263281|NCT00052598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263282|NCT00052598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263283|NCT00052598|Analgesics|analgesics|mesh-ancestor
93263284|NCT00052598|Sensory System Agents|sensory system agents|mesh-ancestor
93263285|NCT00052598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263286|NCT00052598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263287|NCT00052598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93263288|NCT00052598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93263289|NCT00052598|Antiviral Agents|antiviral agents|mesh-ancestor
93263290|NCT00052598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263291|NCT05037994|Prednisolone|prednisolone|mesh-list
93263292|NCT05037994|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93263293|NCT05037994|Methylprednisolone|methylprednisolone|mesh-list
93263294|NCT05037994|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93263295|NCT05037994|Prednisolone acetate|prednisolone acetate|mesh-list
93263296|NCT05037994|Gabapentin|gabapentin|mesh-list
93263297|NCT05037994|Bupivacaine|bupivacaine|mesh-list
93263298|NCT05037994|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93263299|NCT05037994|Prednisolone phosphate|prednisolone phosphate|mesh-list
93263300|NCT05037994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263301|NCT05037994|Glucocorticoids|glucocorticoids|mesh-ancestor
93263302|NCT05037994|Hormones|hormones|mesh-ancestor
93366406|NCT02061917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263303|NCT05037994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263304|NCT05037994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263305|NCT05037994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93263307|NCT05037994|Antiemetics|antiemetics|mesh-ancestor
93263308|NCT05037994|Autonomic Agents|autonomic agents|mesh-ancestor
93263309|NCT05037994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263310|NCT05037994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93263311|NCT05037994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93263312|NCT05037994|Protective Agents|protective agents|mesh-ancestor
93263313|NCT05037994|Analgesics|analgesics|mesh-ancestor
93263314|NCT05037994|Sensory System Agents|sensory system agents|mesh-ancestor
93263315|NCT05037994|Anticonvulsants|anticonvulsants|mesh-ancestor
93263316|NCT05037994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93263317|NCT05037994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93263318|NCT05037994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263319|NCT05037994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93263320|NCT05037994|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93263321|NCT05037994|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93263322|NCT05037994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263323|NCT05037994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263324|NCT05037994|Antimanic Agents|antimanic agents|mesh-ancestor
93263325|NCT05037994|Anesthetics, Local|anesthetics, local|mesh-ancestor
93263326|NCT05037994|Anesthetics|anesthetics|mesh-ancestor
93263327|NCT00052520|Aldesleukin|aldesleukin|mesh-list
93263328|NCT00052520|Interleukin-2|interleukin-2|mesh-list
93263329|NCT00052520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263330|NCT00052520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263331|NCT00052520|Analgesics|analgesics|mesh-ancestor
93263332|NCT00052520|Sensory System Agents|sensory system agents|mesh-ancestor
93263333|NCT00052520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263334|NCT00052520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263335|NCT00052520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93263336|NCT00052520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93263337|NCT00052520|Antiviral Agents|antiviral agents|mesh-ancestor
93263338|NCT00052520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263339|NCT05036434|Pembrolizumab|pembrolizumab|mesh-list
93263340|NCT05036434|Lenvatinib|lenvatinib|mesh-list
93263341|NCT05036434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263342|NCT05036434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263343|NCT05036434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93263344|NCT05036434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263345|NCT05036434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93263346|NCT05036434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263347|NCT00051038|Entecavir|entecavir|mesh-list
93263348|NCT00051038|Antiviral Agents|antiviral agents|mesh-ancestor
93263349|NCT00051038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263350|NCT05035186|Amoxicillin|amoxicillin|mesh-list
93263351|NCT05035186|Clarithromycin|clarithromycin|mesh-list
93263352|NCT05035186|Levofloxacin|levofloxacin|mesh-list
93263353|NCT05035186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93263354|NCT05035186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263355|NCT05035186|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93263356|NCT05035186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263357|NCT05035186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263358|NCT05035186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93263359|NCT05035186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93263360|NCT05035186|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93263361|NCT05035186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93263362|NCT05035186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93263363|NCT05035186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263364|NCT05035186|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93263365|NCT01067469|Bevacizumab|bevacizumab|mesh-list
93263366|NCT01067469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93263367|NCT01067469|Lomustine|lomustine|mesh-list
93263368|NCT01067469|Antibodies|antibodies|mesh-list
93263369|NCT01067469|Immunoglobulins|immunoglobulins|mesh-list
93263370|NCT01067469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93263371|NCT01067469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263372|NCT01067469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93263373|NCT01067469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93263374|NCT01067469|Growth Substances|growth substances|mesh-ancestor
93263375|NCT01067469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263376|NCT01067469|Growth Inhibitors|growth inhibitors|mesh-ancestor
93263377|NCT01067469|Immunologic Factors|immunologic factors|mesh-ancestor
93263378|NCT01067469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263379|NCT01067469|Alkylating Agents|alkylating agents|mesh-ancestor
93263380|NCT01067469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263381|NCT00050102|Ipilimumab|ipilimumab|mesh-list
93263382|NCT00050102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263383|NCT00050102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263384|NCT00050102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93263385|NCT00050102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263386|NCT02103660|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93263387|NCT02103660|Contraceptive Agents|contraceptive agents|mesh-list
93263388|NCT02103660|Medroxyprogesterone|medroxyprogesterone|mesh-list
93263389|NCT02103660|Progestins|progestins|mesh-list
93263390|NCT02103660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263391|NCT02103660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263392|NCT02103660|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93263393|NCT02103660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93263394|NCT02103660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93263395|NCT02103660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93263396|NCT02103660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93263397|NCT02103660|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93263398|NCT02103660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93263399|NCT02103660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263400|NCT02103660|Hormones|hormones|mesh-ancestor
93263401|NCT02103660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263402|NCT02788773|Durvalumab|durvalumab|mesh-list
93263403|NCT02788773|Tremelimumab|tremelimumab|mesh-list
93263404|NCT02788773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263405|NCT02788773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263406|NCT00358982|Mocetinostat|mocetinostat|mesh-list
93263407|NCT00358982|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93263408|NCT00358982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263409|NCT00358982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263410|NCT02101164|Denosumab|denosumab|mesh-list
93263411|NCT02101164|Pamidronate|pamidronate|mesh-list
93263412|NCT02101164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93263413|NCT02101164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263414|NCT00036608|Entecavir|entecavir|mesh-list
93263415|NCT00036608|Antiviral Agents|antiviral agents|mesh-ancestor
93263416|NCT00036608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263417|NCT02103738|Ranibizumab|ranibizumab|mesh-list
93263418|NCT02103738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93263419|NCT02103738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93263420|NCT02103738|Growth Substances|growth substances|mesh-ancestor
93263421|NCT02103738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263422|NCT02103738|Growth Inhibitors|growth inhibitors|mesh-ancestor
93263423|NCT02103738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263424|NCT02985021|Carboplatin|carboplatin|mesh-list
93263425|NCT02985021|Docetaxel|docetaxel|mesh-list
93263426|NCT02985021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263427|NCT02985021|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263428|NCT02985021|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263429|NCT02985021|Mitosis Modulators|mitosis modulators|mesh-ancestor
93263430|NCT02985021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263431|NCT05714540|Magnesium Sulfate|magnesium sulfate|mesh-list
93263432|NCT05714540|Ketamine|ketamine|mesh-list
93263433|NCT05714540|Analgesics|analgesics|mesh-ancestor
93263434|NCT05714540|Sensory System Agents|sensory system agents|mesh-ancestor
93263435|NCT05714540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263436|NCT05714540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263437|NCT05714540|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93263438|NCT05714540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93263439|NCT05714540|Anesthetics, General|anesthetics, general|mesh-ancestor
93263440|NCT05714540|Anesthetics|anesthetics|mesh-ancestor
93263441|NCT05714540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263442|NCT05714540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93263443|NCT05714540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93263444|NCT05714540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263445|NCT05714540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263446|NCT05714540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93263447|NCT05714540|Anticonvulsants|anticonvulsants|mesh-ancestor
93263448|NCT05714540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93263449|NCT05714540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93263450|NCT05714540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93263451|NCT05714540|Tocolytic Agents|tocolytic agents|mesh-ancestor
93263452|NCT05714540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263454|NCT04385667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93263455|NCT04385667|Contraceptive Agents|contraceptive agents|mesh-ancestor
93263456|NCT04385667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263457|NCT04385667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263458|NCT04385667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93263459|NCT04385667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93263460|NCT04385667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93263461|NCT04441424|Azithromycin|azithromycin|mesh-list
93263462|NCT04441424|Hydroxychloroquine|hydroxychloroquine|mesh-list
93263463|NCT04441424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93263464|NCT04441424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263465|NCT04441424|Antimalarials|antimalarials|mesh-ancestor
93263466|NCT04441424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93263467|NCT04441424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93263468|NCT04441424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263469|NCT04441424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263470|NCT04441424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263471|NCT03530228|Esomeprazole|esomeprazole|mesh-list
93263472|NCT03530228|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93263473|NCT03530228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93263474|NCT03530228|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93263475|NCT03530228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263476|NCT03530228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263477|NCT01066923|Aspirin|aspirin|mesh-list
93263478|NCT01066923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263479|NCT01066923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263480|NCT01066923|Analgesics|analgesics|mesh-ancestor
93263481|NCT01066923|Sensory System Agents|sensory system agents|mesh-ancestor
93263482|NCT01066923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263483|NCT01066923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263484|NCT01066923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263485|NCT01066923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263486|NCT01066923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93263487|NCT01066923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93263488|NCT01066923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263489|NCT01066923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93263490|NCT01066923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93263491|NCT01066923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263492|NCT01066923|Antipyretics|antipyretics|mesh-ancestor
93263493|NCT03530150|Pirfenidone|pirfenidone|mesh-list
93263494|NCT03530150|Analgesics|analgesics|mesh-ancestor
93263495|NCT03530150|Sensory System Agents|sensory system agents|mesh-ancestor
93263496|NCT03530150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263497|NCT03530150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263498|NCT03530150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263499|NCT03530150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263500|NCT03530150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263501|NCT03530150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263502|NCT03530150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263503|NCT02098590|Chloroquine|chloroquine|mesh-list
93263504|NCT02098590|Atovaquone|atovaquone|mesh-list
93263505|NCT02098590|Proguanil|proguanil|mesh-list
93263506|NCT02098590|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93263507|NCT02098590|Amebicides|amebicides|mesh-ancestor
93263508|NCT02098590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93263509|NCT02098590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93263510|NCT02098590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263511|NCT02098590|Antimalarials|antimalarials|mesh-ancestor
93263512|NCT02098590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263513|NCT02098590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263514|NCT02098590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263515|NCT02098590|Antimetabolites|antimetabolites|mesh-ancestor
93263516|NCT03657381|Antibodies|antibodies|mesh-list
93263517|NCT03657381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93263518|NCT03657381|Immunologic Factors|immunologic factors|mesh-ancestor
93263519|NCT03657381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263520|NCT00005918|Lamivudine|lamivudine|mesh-list
93263521|NCT00005918|Efavirenz|efavirenz|mesh-list
93263522|NCT00005918|Stavudine|stavudine|mesh-list
93263523|NCT00005918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93263524|NCT00005918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93263525|NCT00005918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263526|NCT00005918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263527|NCT00005918|Antiviral Agents|antiviral agents|mesh-ancestor
93263528|NCT00005918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263529|NCT00005918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93263530|NCT00005918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93263531|NCT00005918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93263532|NCT00005918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93263533|NCT00005918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93263534|NCT00005918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93263535|NCT00005918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93263536|NCT00005918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93263537|NCT00005918|Antimetabolites|antimetabolites|mesh-ancestor
93263538|NCT02656797|Amphotericin B|amphotericin b|mesh-list
93263539|NCT02656797|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93263540|NCT02656797|Amebicides|amebicides|mesh-ancestor
93263541|NCT02656797|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93263542|NCT02656797|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93263543|NCT02656797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263544|NCT02656797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93263545|NCT02656797|Antifungal Agents|antifungal agents|mesh-ancestor
93263546|NCT04443244|Botulinum Toxins|botulinum toxins|mesh-list
93263547|NCT04443244|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93263548|NCT04443244|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93263549|NCT04443244|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93263550|NCT04443244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93263551|NCT04443244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263552|NCT04443244|Cholinergic Agents|cholinergic agents|mesh-ancestor
93263553|NCT04443244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263554|NCT04443244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263555|NCT04443244|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93263556|NCT04443244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263557|NCT02101476|Acetaminophen|acetaminophen|mesh-list
93263559|NCT02101476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263560|NCT02101476|Analgesics|analgesics|mesh-ancestor
93263561|NCT02101476|Sensory System Agents|sensory system agents|mesh-ancestor
93263562|NCT02101476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263563|NCT02101476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263564|NCT02101476|Antipyretics|antipyretics|mesh-ancestor
93263565|NCT02101476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93263566|NCT02101476|Narcotics|narcotics|mesh-ancestor
93263567|NCT02101476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263568|NCT02104128|Bupropion|bupropion|mesh-list
93263569|NCT02104128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93263570|NCT02104128|Antidepressive Agents|antidepressive agents|mesh-ancestor
93263571|NCT02104128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93263572|NCT02104128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93263573|NCT02104128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93263574|NCT02104128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93263575|NCT02104128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263576|NCT02104128|Dopamine Agents|dopamine agents|mesh-ancestor
93263577|NCT02104128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263578|NCT02104128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263579|NCT02104128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93263580|NCT02104128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93263581|NCT02104128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263582|NCT00004916|Paclitaxel|paclitaxel|mesh-list
93263583|NCT00004916|Ifosfamide|ifosfamide|mesh-list
93263584|NCT00004916|Teniposide|teniposide|mesh-list
93263585|NCT00004916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93263586|NCT00004916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263587|NCT00004916|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263588|NCT00004916|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263589|NCT00004916|Mitosis Modulators|mitosis modulators|mesh-ancestor
93263590|NCT00004916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263591|NCT00004916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263592|NCT00004916|Alkylating Agents|alkylating agents|mesh-ancestor
93263593|NCT00004916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93263594|NCT00004916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93263595|NCT00004916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263596|NCT02101632|Petrolatum|petrolatum|mesh-list
93263597|NCT02101632|Emollients|emollients|mesh-ancestor
93263598|NCT02101632|Dermatologic Agents|dermatologic agents|mesh-ancestor
93263599|NCT02101710|Isosorbide|isosorbide|mesh-list
92935591|NCT00661713|Immunologic Factors|immunologic factors|mesh-ancestor
93263600|NCT02101710|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93263601|NCT02101710|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93263602|NCT02101710|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93263603|NCT02101710|Diuretics|diuretics|mesh-ancestor
93263604|NCT02101710|Natriuretic Agents|natriuretic agents|mesh-ancestor
93263605|NCT02101710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263606|NCT02101710|Vasodilator Agents|vasodilator agents|mesh-ancestor
93263607|NCT02101710|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93263608|NCT02101710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263609|NCT03878368|Sulforaphane|sulforaphane|mesh-list
93263610|NCT03878368|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93263611|NCT03878368|Protective Agents|protective agents|mesh-ancestor
93263612|NCT03878368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263613|NCT03878368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263614|NCT02910063|Blinatumomab|blinatumomab|mesh-list
93263615|NCT02910063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263616|NCT04441762|Ketorolac|ketorolac|mesh-list
93263617|NCT04441762|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93263618|NCT04441762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263619|NCT04441762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263620|NCT04441762|Analgesics|analgesics|mesh-ancestor
93263621|NCT04441762|Sensory System Agents|sensory system agents|mesh-ancestor
93263622|NCT04441762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263623|NCT04441762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263624|NCT04441762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263625|NCT04441762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263626|NCT04441762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93263627|NCT04441762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263628|NCT04441762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263629|NCT02104284|Mannitol|mannitol|mesh-list
93263630|NCT02104284|Methacholine Chloride|methacholine chloride|mesh-list
93263631|NCT02104284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93263632|NCT02104284|Diuretics|diuretics|mesh-ancestor
93263633|NCT02104284|Natriuretic Agents|natriuretic agents|mesh-ancestor
93263634|NCT02104284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263635|NCT02104284|Miotics|miotics|mesh-ancestor
93263636|NCT02104284|Autonomic Agents|autonomic agents|mesh-ancestor
93263637|NCT02104284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263638|NCT02104284|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93263639|NCT02104284|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93263640|NCT02104284|Respiratory System Agents|respiratory system agents|mesh-ancestor
93263641|NCT02104284|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93263642|NCT02104284|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93263643|NCT02104284|Cholinergic Agents|cholinergic agents|mesh-ancestor
93263644|NCT02104284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263645|NCT02104284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263646|NCT00337532|Paclitaxel|paclitaxel|mesh-list
93263647|NCT00337532|Cisplatin|cisplatin|mesh-list
93263648|NCT00337532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93263649|NCT00337532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263650|NCT00337532|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263651|NCT00337532|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263652|NCT00337532|Mitosis Modulators|mitosis modulators|mesh-ancestor
93263653|NCT00337532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263654|NCT02625441|Trastuzumab|trastuzumab|mesh-list
93263655|NCT02625441|Pertuzumab|pertuzumab|mesh-list
93263656|NCT02625441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263657|NCT02625441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263658|NCT04209868|Bupivacaine|bupivacaine|mesh-list
93263659|NCT04209868|Levobupivacaine|levobupivacaine|mesh-list
93263660|NCT04209868|Anesthetics, Local|anesthetics, local|mesh-ancestor
93263661|NCT04209868|Anesthetics|anesthetics|mesh-ancestor
93263662|NCT04209868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263663|NCT04209868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263664|NCT04209868|Sensory System Agents|sensory system agents|mesh-ancestor
93263665|NCT04209868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263666|NCT02361801|Dobutamine|dobutamine|mesh-list
93263667|NCT02361801|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93263668|NCT02361801|Sympathomimetics|sympathomimetics|mesh-ancestor
93263669|NCT02361801|Autonomic Agents|autonomic agents|mesh-ancestor
93263670|NCT02361801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263671|NCT02361801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263672|NCT02361801|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93263673|NCT02361801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93263674|NCT02361801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92935665|NCT00427921|Adalimumab|adalimumab|mesh-list
93263675|NCT02361801|Adrenergic Agents|adrenergic agents|mesh-ancestor
93263676|NCT02361801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366407|NCT02061917|Respiratory System Agents|respiratory system agents|mesh-ancestor
93263677|NCT02361801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263678|NCT02361801|Protective Agents|protective agents|mesh-ancestor
93263679|NCT03965728|Methotrexate|methotrexate|mesh-list
93263680|NCT03965728|Midazolam|midazolam|mesh-list
93263681|NCT03965728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93263682|NCT03965728|Abortifacient Agents|abortifacient agents|mesh-ancestor
93263683|NCT03965728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263684|NCT03965728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263685|NCT03965728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93263686|NCT03965728|Antimetabolites|antimetabolites|mesh-ancestor
93263687|NCT03965728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263688|NCT03965728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263689|NCT03965728|Dermatologic Agents|dermatologic agents|mesh-ancestor
93263690|NCT03965728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263691|NCT03965728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93263692|NCT03965728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263693|NCT03965728|Immunologic Factors|immunologic factors|mesh-ancestor
93263694|NCT03965728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263695|NCT03965728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93263696|NCT03965728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93263697|NCT03965728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93263698|NCT03965728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263699|NCT03965728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93263700|NCT03965728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93263701|NCT03965728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93263702|NCT03965728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93263703|NCT03965728|Anesthetics, General|anesthetics, general|mesh-ancestor
93263704|NCT03965728|Anesthetics|anesthetics|mesh-ancestor
93263705|NCT03965728|GABA Modulators|gaba modulators|mesh-ancestor
93263706|NCT03965728|GABA Agents|gaba agents|mesh-ancestor
93263707|NCT03965728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263708|NCT00337454|Dasatinib|dasatinib|mesh-list
93263709|NCT00337454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263710|NCT00337454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93263711|NCT00337454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263712|NCT00337454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263713|NCT02909907|Botulinum Toxins|botulinum toxins|mesh-list
93263714|NCT02909907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93263715|NCT02909907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93263716|NCT02909907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263717|NCT02909907|Cholinergic Agents|cholinergic agents|mesh-ancestor
93263718|NCT02909907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263719|NCT02909907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263720|NCT00004898|Cyclophosphamide|cyclophosphamide|mesh-list
93263721|NCT00004898|Etoposide|etoposide|mesh-list
93263722|NCT00004898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263723|NCT00004898|Immunologic Factors|immunologic factors|mesh-ancestor
93263724|NCT00004898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263725|NCT00004898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263726|NCT00004898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263727|NCT00004898|Alkylating Agents|alkylating agents|mesh-ancestor
93263728|NCT00004898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263729|NCT00004898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263730|NCT00004898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93263731|NCT00004898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93263732|NCT00004898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93263733|NCT00004898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93263734|NCT00004898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263735|NCT02106468|Prednisone|prednisone|mesh-list
93263736|NCT02106468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263737|NCT02106468|Glucocorticoids|glucocorticoids|mesh-ancestor
93263738|NCT02106468|Hormones|hormones|mesh-ancestor
92558409|NCT00125827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263739|NCT02106468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263740|NCT02106468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263741|NCT02106468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93263742|NCT02106468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263743|NCT03956446|Doxycycline|doxycycline|mesh-list
93263744|NCT03956446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93263745|NCT03956446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263746|NCT03956446|Antimalarials|antimalarials|mesh-ancestor
93263747|NCT03956446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93263748|NCT03956446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93263749|NCT00325364|Insulin|insulin|mesh-list
93263750|NCT00325364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93263751|NCT00325364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93263752|NCT00325364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263753|NCT02104674|Montelukast|montelukast|mesh-list
93263754|NCT02104674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93263755|NCT02104674|Respiratory System Agents|respiratory system agents|mesh-ancestor
93263756|NCT02104674|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93263757|NCT02104674|Hormone Antagonists|hormone antagonists|mesh-ancestor
93263758|NCT02104674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93263759|NCT02104674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263760|NCT02104674|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93263761|NCT02104674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93263762|NCT02104674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263763|NCT01903330|Cyclophosphamide|cyclophosphamide|mesh-list
93263764|NCT01903330|Bevacizumab|bevacizumab|mesh-list
93263765|NCT01903330|Sargramostim|sargramostim|mesh-list
93263766|NCT01903330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263767|NCT01903330|Immunologic Factors|immunologic factors|mesh-ancestor
93263768|NCT01903330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263769|NCT01903330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263770|NCT01903330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263771|NCT01903330|Alkylating Agents|alkylating agents|mesh-ancestor
93263772|NCT01903330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263773|NCT01903330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263774|NCT01903330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93263775|NCT01903330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263776|NCT01903330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93263777|NCT01903330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93263778|NCT01903330|Growth Substances|growth substances|mesh-ancestor
93263779|NCT01903330|Growth Inhibitors|growth inhibitors|mesh-ancestor
93263780|NCT02907177|Ponesimod|ponesimod|mesh-list
93263781|NCT02907177|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93263782|NCT02907177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263783|NCT02907177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263784|NCT02907177|Immunologic Factors|immunologic factors|mesh-ancestor
93263785|NCT02907177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263786|NCT00004172|Cyclophosphamide|cyclophosphamide|mesh-list
93263787|NCT00004172|Ifosfamide|ifosfamide|mesh-list
93263788|NCT00004172|Thiotepa|thiotepa|mesh-list
93263789|NCT00004172|Carboplatin|carboplatin|mesh-list
93263790|NCT00004172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263791|NCT00004172|Immunologic Factors|immunologic factors|mesh-ancestor
93263792|NCT00004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263793|NCT00004172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263794|NCT00004172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263795|NCT00004172|Alkylating Agents|alkylating agents|mesh-ancestor
93263796|NCT00004172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263797|NCT00004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263798|NCT00004172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93263799|NCT04353310|Curcumin|curcumin|mesh-list
93263800|NCT04353310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263801|NCT04353310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263802|NCT04353310|Analgesics|analgesics|mesh-ancestor
93263803|NCT04353310|Sensory System Agents|sensory system agents|mesh-ancestor
93263804|NCT04353310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263805|NCT04353310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263806|NCT04353310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263807|NCT04353310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263808|NCT04353310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263809|NCT04353310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558479|NCT00126022|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93263810|NCT04353310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263811|NCT00004166|Amifostine|amifostine|mesh-list
93263812|NCT00004166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93263813|NCT00004166|Protective Agents|protective agents|mesh-ancestor
93263814|NCT00004166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263815|NCT00004106|Temozolomide|temozolomide|mesh-list
93263816|NCT00004106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93263817|NCT00004106|Alkylating Agents|alkylating agents|mesh-ancestor
93263818|NCT00004106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263819|NCT00004106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263820|NCT00002246|Stavudine|stavudine|mesh-list
93263821|NCT00002246|Antimetabolites|antimetabolites|mesh-ancestor
93263822|NCT00002246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263823|NCT00002246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92935815|NCT02598960|Nivolumab|nivolumab|mesh-list
93263824|NCT00002246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93263825|NCT00002246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263826|NCT00002246|Antiviral Agents|antiviral agents|mesh-ancestor
93263827|NCT00002246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263828|NCT00002246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93263829|NCT00002246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93263830|NCT00002240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93263831|NCT00002240|Nelfinavir|nelfinavir|mesh-list
93263832|NCT00002240|Didanosine|didanosine|mesh-list
93263833|NCT00002240|Stavudine|stavudine|mesh-list
93263834|NCT00002240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93263835|NCT00002240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93263836|NCT00002240|Protease Inhibitors|protease inhibitors|mesh-ancestor
93263837|NCT00002240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263838|NCT00002240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263839|NCT00002240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93263840|NCT00002240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93263841|NCT00002240|Antiviral Agents|antiviral agents|mesh-ancestor
93263842|NCT00002240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263843|NCT00002240|Antimetabolites|antimetabolites|mesh-ancestor
93263844|NCT00002240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93263845|NCT00002240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93263846|NCT02250924|Caffeine|caffeine|mesh-list
93263847|NCT02250924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93263848|NCT02250924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263849|NCT02250924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93263850|NCT02250924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263851|NCT02250924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263852|NCT02250924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93263853|NCT02250924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93263854|NCT02250924|Purinergic Agents|purinergic agents|mesh-ancestor
93263855|NCT02250924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93263856|NCT03645148|Molgramostim|molgramostim|mesh-list
93263857|NCT03645148|Sargramostim|sargramostim|mesh-list
93263858|NCT03645148|Immunologic Factors|immunologic factors|mesh-ancestor
93263859|NCT03645148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263860|NCT03645148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263861|NCT04082728|Dipyrone|dipyrone|mesh-list
93263862|NCT04082728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93263863|NCT04082728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93263864|NCT04082728|Analgesics|analgesics|mesh-ancestor
93263865|NCT04082728|Sensory System Agents|sensory system agents|mesh-ancestor
93263866|NCT04082728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263867|NCT04082728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263868|NCT04082728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93263869|NCT04082728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93263870|NCT04082728|Antipyretics|antipyretics|mesh-ancestor
93263871|NCT02906709|Insulin|insulin|mesh-list
93263872|NCT02906709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93263873|NCT02906709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263874|NCT00321308|Pemetrexed|pemetrexed|mesh-list
93263875|NCT00321308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263876|NCT00321308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263877|NCT00321308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263878|NCT00321308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93263879|NCT00321308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93263880|NCT02110134|Hydroquinone|hydroquinone|mesh-list
93263881|NCT02110134|Antioxidants|antioxidants|mesh-ancestor
93263882|NCT02110134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263883|NCT02110134|Protective Agents|protective agents|mesh-ancestor
93263884|NCT02110134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263885|NCT02110134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93263886|NCT00318656|Metformin|metformin|mesh-list
93263887|NCT00318656|Glimepiride|glimepiride|mesh-list
93263888|NCT00318656|Rosiglitazone|rosiglitazone|mesh-list
93263889|NCT00318656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93263890|NCT00318656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263891|NCT00318656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93263892|NCT00318656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93263893|NCT00318656|Immunologic Factors|immunologic factors|mesh-ancestor
93263894|NCT02110524|Paclitaxel|paclitaxel|mesh-list
93263895|NCT02110524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93263896|NCT02110524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263897|NCT02110524|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263898|NCT02110524|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263899|NCT02110524|Mitosis Modulators|mitosis modulators|mesh-ancestor
93366408|NCT03560375|Empagliflozin|empagliflozin|mesh-list
93263900|NCT02110524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263901|NCT00317486|Bosentan|bosentan|mesh-list
93263902|NCT00317486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93263903|NCT00317486|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93263904|NCT00317486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263905|NCT02107170|Remifentanil|remifentanil|mesh-list
93263906|NCT02107170|Propofol|propofol|mesh-list
93263907|NCT02107170|Sevoflurane|sevoflurane|mesh-list
93263908|NCT02107170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93263909|NCT02107170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263910|NCT02107170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263911|NCT02107170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93263912|NCT02107170|Anesthetics, General|anesthetics, general|mesh-ancestor
93263913|NCT02107170|Anesthetics|anesthetics|mesh-ancestor
93263914|NCT02107170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93263915|NCT02107170|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93263916|NCT02107170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93263917|NCT02107170|Narcotics|narcotics|mesh-ancestor
93263918|NCT02107170|Analgesics|analgesics|mesh-ancestor
93263919|NCT02107170|Sensory System Agents|sensory system agents|mesh-ancestor
93263920|NCT02107170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263921|NCT00313196|Bosentan|bosentan|mesh-list
93263922|NCT00313196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93263923|NCT00313196|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93263924|NCT00313196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263925|NCT03656679|Iodine|iodine|mesh-list
93263926|NCT03656679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93263927|NCT03656679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263928|NCT03656679|Trace Elements|trace elements|mesh-ancestor
93263929|NCT03656679|Micronutrients|micronutrients|mesh-ancestor
93263930|NCT03656679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263931|NCT03663166|Nivolumab|nivolumab|mesh-list
93263932|NCT03663166|Ipilimumab|ipilimumab|mesh-list
93263933|NCT03663166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93263934|NCT03663166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263935|NCT03663166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93263936|NCT03663166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263937|NCT03554304|Moxifloxacin|moxifloxacin|mesh-list
93263938|NCT03554304|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
93263939|NCT03554304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93263940|NCT03554304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93263941|NCT03554304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263942|NCT03554304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93263943|NCT03554304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93263944|NCT03554304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263945|NCT03554304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263946|NCT03554304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263947|NCT03554304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93263948|NCT03554304|Contraceptive Agents|contraceptive agents|mesh-ancestor
93263949|NCT03554304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93263950|NCT03554304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263951|NCT03554304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93263952|NCT03554304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93263953|NCT03554304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93263954|NCT02107716|Lidocaine|lidocaine|mesh-list
93263955|NCT02107716|Anesthetics, Local|anesthetics, local|mesh-ancestor
93263956|NCT02107716|Anesthetics|anesthetics|mesh-ancestor
93263957|NCT02107716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93263958|NCT02107716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263959|NCT02107716|Sensory System Agents|sensory system agents|mesh-ancestor
93263960|NCT02107716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263961|NCT02107716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93263962|NCT02107716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93263963|NCT02107716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93263964|NCT02107716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93263965|NCT02107716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263966|NCT02110992|Docetaxel|docetaxel|mesh-list
93263967|NCT02110992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93263968|NCT02110992|Tubulin Modulators|tubulin modulators|mesh-ancestor
93263969|NCT02110992|Antimitotic Agents|antimitotic agents|mesh-ancestor
93263970|NCT02110992|Mitosis Modulators|mitosis modulators|mesh-ancestor
93263971|NCT02110992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263972|NCT03306394|Trifluridine|trifluridine|mesh-list
93263973|NCT03306394|Antimetabolites|antimetabolites|mesh-ancestor
93263974|NCT03306394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263975|NCT03306394|Antiviral Agents|antiviral agents|mesh-ancestor
93263976|NCT03306394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93263977|NCT03532178|Rocuronium|rocuronium|mesh-list
93263978|NCT03532178|Succinylcholine|succinylcholine|mesh-list
93263979|NCT03532178|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93263980|NCT03532178|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93263981|NCT03532178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93263982|NCT03532178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93263983|NCT03532178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93263984|NCT03532178|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93263985|NCT00311090|Idraparinux|idraparinux|mesh-list
93263986|NCT00311090|Idrabiotaparinux|idrabiotaparinux|mesh-list
93263987|NCT00311090|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93263988|NCT00311090|Antithrombins|antithrombins|mesh-ancestor
93263989|NCT00311090|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93263990|NCT00311090|Protease Inhibitors|protease inhibitors|mesh-ancestor
93263991|NCT00311090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93263992|NCT00311090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93263993|NCT00311090|Anticoagulants|anticoagulants|mesh-ancestor
93263994|NCT02105610|Anesthetics|anesthetics|mesh-list
93263995|NCT02105610|Sevoflurane|sevoflurane|mesh-list
93263996|NCT02105610|Desflurane|desflurane|mesh-list
93263997|NCT02105610|Isoflurane|isoflurane|mesh-list
93263998|NCT02105610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
93263999|NCT02105610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264000|NCT02105610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264001|NCT02105610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264002|NCT02105610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93264003|NCT02105610|Anesthetics, General|anesthetics, general|mesh-ancestor
93264004|NCT00301262|Sildenafil Citrate|sildenafil citrate|mesh-list
93264005|NCT00301262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264006|NCT00301262|Vasodilator Agents|vasodilator agents|mesh-ancestor
93264007|NCT00301262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93264008|NCT00301262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93264009|NCT00301262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264010|NCT00301262|Urological Agents|urological agents|mesh-ancestor
93264011|NCT02254941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93264012|NCT02254941|Antibodies|antibodies|mesh-list
93264013|NCT02254941|Immunoglobulins|immunoglobulins|mesh-list
93264014|NCT02254941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93264015|NCT02254941|Immunologic Factors|immunologic factors|mesh-ancestor
93264016|NCT02254941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264017|NCT02254941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264018|NCT03598270|Paclitaxel|paclitaxel|mesh-list
93264019|NCT03598270|Carboplatin|carboplatin|mesh-list
93264020|NCT03598270|Gemcitabine|gemcitabine|mesh-list
93264021|NCT03598270|Doxorubicin|doxorubicin|mesh-list
93264022|NCT03598270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93264023|NCT03598270|Atezolizumab|atezolizumab|mesh-list
93264024|NCT03598270|Niraparib|niraparib|mesh-list
93264025|NCT03598270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93264026|NCT03598270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93264027|NCT03598270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264028|NCT03598270|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264029|NCT03598270|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264030|NCT03598270|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264031|NCT03598270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264032|NCT03598270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264033|NCT03598270|Antimetabolites|antimetabolites|mesh-ancestor
93264034|NCT03598270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93264035|NCT03598270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93264036|NCT03598270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93264037|NCT03598270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264038|NCT03598270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264039|NCT03598270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264040|NCT03598270|Immunologic Factors|immunologic factors|mesh-ancestor
93264041|NCT03598270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264042|NCT03598270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93264043|NCT03077620|Suvorexant|suvorexant|mesh-list
93264044|NCT03077620|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93264045|NCT03077620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264046|NCT03077620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264047|NCT03077620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264048|NCT03077620|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92936039|NCT01937468|Interleukin-2|interleukin-2|mesh-list
93264049|NCT03077620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264050|NCT03077620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264051|NCT03656445|Tranexamic Acid|tranexamic acid|mesh-list
93264052|NCT03656445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93264053|NCT03656445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93264054|NCT03656445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264055|NCT03656445|Hemostatics|hemostatics|mesh-ancestor
93264056|NCT03656445|Coagulants|coagulants|mesh-ancestor
93264057|NCT01903486|Prednisone|prednisone|mesh-list
93264058|NCT01903486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264059|NCT01903486|Glucocorticoids|glucocorticoids|mesh-ancestor
93264060|NCT01903486|Hormones|hormones|mesh-ancestor
93264061|NCT01903486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264062|NCT01903486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264063|NCT01903486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93264064|NCT01903486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264065|NCT03656289|Etonogestrel|etonogestrel|mesh-list
93264066|NCT03656289|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93264067|NCT03656289|Contraceptive Agents|contraceptive agents|mesh-ancestor
93264068|NCT03656289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93264069|NCT03656289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264070|NCT03656289|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93264071|NCT00599170|Rituximab|rituximab|mesh-list
93264072|NCT00599170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264073|NCT00599170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264074|NCT00599170|Immunologic Factors|immunologic factors|mesh-ancestor
93264075|NCT00599170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264076|NCT00599170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264077|NCT04256434|Nalbuphine|nalbuphine|mesh-list
93264078|NCT04256434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93264079|NCT04256434|Narcotics|narcotics|mesh-ancestor
93264080|NCT04256434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264081|NCT04256434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264082|NCT04256434|Analgesics|analgesics|mesh-ancestor
93264083|NCT04256434|Sensory System Agents|sensory system agents|mesh-ancestor
93264084|NCT04256434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264085|NCT02588326|Mometasone Furoate|mometasone furoate|mesh-list
93264086|NCT02588326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264087|NCT02588326|Dermatologic Agents|dermatologic agents|mesh-ancestor
93264088|NCT02588326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93264089|NCT02107950|Carboplatin|carboplatin|mesh-list
93264090|NCT02107950|Gemcitabine|gemcitabine|mesh-list
93264091|NCT02107950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264092|NCT02107950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264093|NCT02107950|Antimetabolites|antimetabolites|mesh-ancestor
93264094|NCT02107950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264095|NCT02108106|Mitapivat|mitapivat|mesh-list
93264096|NCT02108106|Enzyme Activators|enzyme activators|mesh-ancestor
93264097|NCT02108106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264098|NCT02113800|Everolimus|everolimus|mesh-list
93264099|NCT02113800|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93264100|NCT02113800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93264101|NCT02113800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264102|NCT02113800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264103|NCT02113800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264104|NCT02113800|Immunologic Factors|immunologic factors|mesh-ancestor
93264105|NCT02113800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264106|NCT02113800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264107|NCT01066143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93264108|NCT01066143|Antidepressive Agents|antidepressive agents|mesh-ancestor
93264109|NCT01066143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93264110|NCT01066143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93264111|NCT01066143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93264112|NCT01066143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264113|NCT01066143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264114|NCT02111928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93264115|NCT02111928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93264116|NCT02112006|Bupivacaine|bupivacaine|mesh-list
93264117|NCT02112006|Anesthetics, Local|anesthetics, local|mesh-ancestor
93264118|NCT02112006|Anesthetics|anesthetics|mesh-ancestor
93264119|NCT02112006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264120|NCT02112006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264121|NCT02112006|Sensory System Agents|sensory system agents|mesh-ancestor
93264122|NCT02112006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264123|NCT02251158|Ritonavir|ritonavir|mesh-list
93264124|NCT02251158|Tipranavir|tipranavir|mesh-list
93264125|NCT02251158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93264126|NCT02251158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93264127|NCT02251158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93264128|NCT02251158|Protease Inhibitors|protease inhibitors|mesh-ancestor
93264129|NCT02251158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264130|NCT02251158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264131|NCT02251158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93264132|NCT02251158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93264133|NCT02251158|Antiviral Agents|antiviral agents|mesh-ancestor
93264134|NCT02251158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264135|NCT02251158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93264136|NCT02251158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93264137|NCT02652130|Remestemcel-l|remestemcel-l|mesh-list
93264138|NCT02652130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264139|NCT02652130|Antiviral Agents|antiviral agents|mesh-ancestor
93264140|NCT02652130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264141|NCT05404516|Cytarabine|cytarabine|mesh-list
93264142|NCT05404516|Sorafenib|sorafenib|mesh-list
93264143|NCT05404516|Idarubicin|idarubicin|mesh-list
93264144|NCT05404516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264145|NCT05404516|Antimetabolites|antimetabolites|mesh-ancestor
93264146|NCT05404516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264147|NCT05404516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264148|NCT05404516|Antiviral Agents|antiviral agents|mesh-ancestor
93264149|NCT05404516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264150|NCT05404516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264151|NCT05404516|Immunologic Factors|immunologic factors|mesh-ancestor
93264152|NCT05404516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264153|NCT05404516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93264154|NCT05404516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264155|NCT05404516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93264156|NCT05404516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93264157|NCT05404516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93264158|NCT02114346|Atorvastatin|atorvastatin|mesh-list
93264159|NCT02114346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93264160|NCT02114346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93264161|NCT02114346|Antimetabolites|antimetabolites|mesh-ancestor
93264162|NCT02114346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264163|NCT02114346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93264164|NCT02114346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93264165|NCT02114346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264166|NCT02112162|Deoxyglucose|deoxyglucose|mesh-list
93264167|NCT02112162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93264168|NCT02112162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93264169|NCT02112162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264170|NCT02112162|Antimetabolites|antimetabolites|mesh-ancestor
93264171|NCT02112162|Antiviral Agents|antiviral agents|mesh-ancestor
93264172|NCT02112162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264173|NCT02108808|Clopidogrel|clopidogrel|mesh-list
93264174|NCT02108808|Ticagrelor|ticagrelor|mesh-list
93264175|NCT02108808|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93264176|NCT02108808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264177|NCT02108808|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93264178|NCT02108808|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93264179|NCT02108808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93264180|NCT02108808|Purinergic Agents|purinergic agents|mesh-ancestor
93264181|NCT02108808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264182|NCT02108808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264183|NCT02108808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264184|NCT02108886|Montelukast|montelukast|mesh-list
93264185|NCT02108886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93264186|NCT02108886|Respiratory System Agents|respiratory system agents|mesh-ancestor
93264187|NCT02108886|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93264188|NCT02108886|Hormone Antagonists|hormone antagonists|mesh-ancestor
93264189|NCT02108886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264190|NCT02108886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264191|NCT02108886|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93264192|NCT02108886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93264193|NCT02108886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264194|NCT02114502|Pyridoxine|pyridoxine|mesh-list
93264195|NCT02114502|Dexamethasone|dexamethasone|mesh-list
93264196|NCT02114502|Gemcitabine|gemcitabine|mesh-list
93264197|NCT02114502|Melphalan|melphalan|mesh-list
93264198|NCT02114502|Busulfan|busulfan|mesh-list
93264199|NCT02114502|Vorinostat|vorinostat|mesh-list
93264200|NCT02114502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264201|NCT02114502|Antiemetics|antiemetics|mesh-ancestor
93264202|NCT02114502|Autonomic Agents|autonomic agents|mesh-ancestor
93264203|NCT02114502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264204|NCT02114502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264205|NCT02114502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93264206|NCT02114502|Glucocorticoids|glucocorticoids|mesh-ancestor
93264207|NCT02114502|Hormones|hormones|mesh-ancestor
93264208|NCT02114502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264209|NCT02114502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93264210|NCT02114502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264211|NCT02114502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264212|NCT02114502|Antimetabolites|antimetabolites|mesh-ancestor
93264213|NCT02114502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264214|NCT02114502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93264215|NCT02114502|Alkylating Agents|alkylating agents|mesh-ancestor
93264216|NCT02114502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93264217|NCT02114502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264218|NCT02114502|Immunologic Factors|immunologic factors|mesh-ancestor
93264219|NCT02114502|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93264220|NCT02114502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264221|NCT02114502|Vitamin B Complex|vitamin b complex|mesh-ancestor
93264222|NCT02114502|Vitamins|vitamins|mesh-ancestor
93264223|NCT02114502|Micronutrients|micronutrients|mesh-ancestor
93264224|NCT03654027|Docetaxel|docetaxel|mesh-list
93264225|NCT03654027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264226|NCT03654027|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264227|NCT03654027|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264228|NCT03654027|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264229|NCT03654027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264230|NCT02114658|Sorafenib|sorafenib|mesh-list
93264231|NCT02114658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264232|NCT02114658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93264233|NCT02114658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264234|NCT02114658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264235|NCT05126602|Vitamin D|vitamin d|mesh-list
93264236|NCT05126602|Ergocalciferols|ergocalciferols|mesh-list
93264237|NCT05126602|Cholecalciferol|cholecalciferol|mesh-list
93264238|NCT05126602|Vitamins|vitamins|mesh-list
93264239|NCT05126602|Micronutrients|micronutrients|mesh-ancestor
93264240|NCT05126602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264241|NCT05126602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93264242|NCT05126602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93264243|NCT02114736|Botulinum Toxins|botulinum toxins|mesh-list
93264244|NCT02114736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93264245|NCT02114736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93264246|NCT02114736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93264247|NCT02114736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264248|NCT02114736|Cholinergic Agents|cholinergic agents|mesh-ancestor
93264249|NCT02114736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264250|NCT02114736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264251|NCT02114736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93264252|NCT02114736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264253|NCT02112552|Paclitaxel|paclitaxel|mesh-list
93264254|NCT02112552|Carboplatin|carboplatin|mesh-list
93264255|NCT02112552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93264256|NCT02112552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264257|NCT02112552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264258|NCT02112552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264259|NCT02112552|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264260|NCT02112552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264261|NCT02109354|Vaccines|vaccines|mesh-list
93264262|NCT02109354|Immunologic Factors|immunologic factors|mesh-ancestor
93264263|NCT02109354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264264|NCT03165136|Hydroxychloroquine|hydroxychloroquine|mesh-list
93264265|NCT03165136|Antimalarials|antimalarials|mesh-ancestor
92558898|NCT00402766|Antiemetics|antiemetics|mesh-ancestor
93264266|NCT03165136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93264267|NCT03165136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93264268|NCT03165136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264269|NCT03165136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264270|NCT03165136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264271|NCT03165136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264272|NCT02109510|Lidocaine|lidocaine|mesh-list
93264273|NCT02109510|Dexmedetomidine|dexmedetomidine|mesh-list
93264274|NCT02109510|Ketamine|ketamine|mesh-list
93264275|NCT02109510|Anesthetics|anesthetics|mesh-list
93264276|NCT02109510|Propofol|propofol|mesh-list
93264277|NCT02109510|Sevoflurane|sevoflurane|mesh-list
93264278|NCT02109510|Rocuronium|rocuronium|mesh-list
93264279|NCT02109510|Anesthetics, Local|anesthetics, local|mesh-ancestor
93264280|NCT02109510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264281|NCT02109510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264282|NCT02109510|Sensory System Agents|sensory system agents|mesh-ancestor
93264283|NCT02109510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264284|NCT02109510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93264285|NCT02109510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93264286|NCT02109510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93264287|NCT02109510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93264288|NCT02109510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264289|NCT02109510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264290|NCT02109510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264291|NCT02109510|Analgesics|analgesics|mesh-ancestor
93264292|NCT02109510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93264293|NCT02109510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93264294|NCT02109510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93264295|NCT02109510|Adrenergic Agents|adrenergic agents|mesh-ancestor
93264296|NCT02109510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264297|NCT02109510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264298|NCT02109510|Anesthetics, General|anesthetics, general|mesh-ancestor
93264299|NCT02109510|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93264300|NCT02109510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93264301|NCT02109510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93264302|NCT02109510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264303|NCT02109510|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93264304|NCT02109510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93264305|NCT02109510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93264306|NCT02109510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93264307|NCT02109666|Abatacept|abatacept|mesh-list
93264308|NCT02109666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264309|NCT02109666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264310|NCT02109666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264311|NCT02109666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264312|NCT02109666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264313|NCT02109666|Immunologic Factors|immunologic factors|mesh-ancestor
93264314|NCT02109666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264315|NCT02109666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264316|NCT02865928|Bupivacaine|bupivacaine|mesh-list
93264317|NCT02865928|Anesthetics, Local|anesthetics, local|mesh-ancestor
93264318|NCT02865928|Anesthetics|anesthetics|mesh-ancestor
93264319|NCT02865928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264320|NCT02865928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264321|NCT02865928|Sensory System Agents|sensory system agents|mesh-ancestor
93264322|NCT02865928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264323|NCT02109900|Progesterone|progesterone|mesh-list
93264324|NCT02109900|Progestins|progestins|mesh-ancestor
93264325|NCT02109900|Hormones|hormones|mesh-ancestor
93264326|NCT02109900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264327|NCT02109900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264328|NCT02112630|Interferons|interferons|mesh-list
93264329|NCT02112630|Ribavirin|ribavirin|mesh-list
93264330|NCT02112630|Interferon-alpha|interferon-alpha|mesh-list
93264331|NCT02112630|Interferon alpha-2|interferon alpha-2|mesh-list
93264332|NCT02112630|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93264333|NCT02112630|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93264334|NCT02112630|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93264335|NCT02112630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264336|NCT02112630|Antiviral Agents|antiviral agents|mesh-ancestor
93264337|NCT02112630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264338|NCT02112630|Antimetabolites|antimetabolites|mesh-ancestor
93264339|NCT02112630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264340|NCT02112630|Immunologic Factors|immunologic factors|mesh-ancestor
93264341|NCT02112630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264342|NCT04873375|Cemiplimab|cemiplimab|mesh-list
93264343|NCT04873375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264344|NCT04873375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264345|NCT05125588|Meloxicam|meloxicam|mesh-list
93264346|NCT05125588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93264347|NCT05125588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264348|NCT05125588|Analgesics|analgesics|mesh-ancestor
93264349|NCT05125588|Sensory System Agents|sensory system agents|mesh-ancestor
92936341|NCT03070392|Dacarbazine|dacarbazine|mesh-list
93264350|NCT05125588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264351|NCT05125588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264352|NCT05125588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264353|NCT05125588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264354|NCT05125588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93264355|NCT05125588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93264356|NCT05125588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264357|NCT05125588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264358|NCT02115204|Cyclophosphamide|cyclophosphamide|mesh-list
93264360|NCT02115204|Fluorouracil|fluorouracil|mesh-list
93264361|NCT02115204|Methotrexate|methotrexate|mesh-list
93264362|NCT02115204|Epirubicin|epirubicin|mesh-list
93264363|NCT02115204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264364|NCT02115204|Immunologic Factors|immunologic factors|mesh-ancestor
93264365|NCT02115204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264366|NCT02115204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264367|NCT02115204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93264368|NCT02115204|Alkylating Agents|alkylating agents|mesh-ancestor
93264369|NCT02115204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264370|NCT02115204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264371|NCT02115204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93264372|NCT02115204|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264373|NCT02115204|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264374|NCT02115204|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264375|NCT02115204|Antimetabolites|antimetabolites|mesh-ancestor
93264376|NCT02115204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264377|NCT02115204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93264378|NCT02115204|Abortifacient Agents|abortifacient agents|mesh-ancestor
93264379|NCT02115204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93264380|NCT02115204|Dermatologic Agents|dermatologic agents|mesh-ancestor
93264381|NCT02115204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264382|NCT02115204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93264383|NCT02115204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93264384|NCT02115204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93264385|NCT02115204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93264386|NCT02115204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93264387|NCT02115360|Calcitonin|calcitonin|mesh-list
93264388|NCT02115360|Salmon calcitonin|salmon calcitonin|mesh-list
93264389|NCT02115360|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93264390|NCT02115360|Fentanyl|fentanyl|mesh-list
93264391|NCT02115360|Katacalcin|katacalcin|mesh-list
93264392|NCT02115360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93264393|NCT02115360|Narcotics|narcotics|mesh-ancestor
93264394|NCT02115360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264395|NCT02115360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264396|NCT02115360|Analgesics|analgesics|mesh-ancestor
93264397|NCT02115360|Sensory System Agents|sensory system agents|mesh-ancestor
93264398|NCT02115360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264399|NCT02115360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93264400|NCT02115360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264401|NCT02115360|Anesthetics, General|anesthetics, general|mesh-ancestor
93264402|NCT02115360|Anesthetics|anesthetics|mesh-ancestor
93264403|NCT02115360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93264404|NCT02115360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93264405|NCT02115360|Vasodilator Agents|vasodilator agents|mesh-ancestor
93264406|NCT02432404|NuvaRing|nuvaring|mesh-list
93264407|NCT02432404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93264408|NCT02432404|Contraceptive Agents|contraceptive agents|mesh-ancestor
93264409|NCT02432404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93264410|NCT02432404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264411|NCT02113176|Minocycline|minocycline|mesh-list
93264412|NCT02113176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93264413|NCT02113176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264414|NCT02118870|Aspirin|aspirin|mesh-list
93264415|NCT02118870|Clopidogrel|clopidogrel|mesh-list
93264416|NCT02118870|Ticagrelor|ticagrelor|mesh-list
93264417|NCT02118870|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93264418|NCT02118870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93264419|NCT02118870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264420|NCT02118870|Analgesics|analgesics|mesh-ancestor
93264421|NCT02118870|Sensory System Agents|sensory system agents|mesh-ancestor
93264422|NCT02118870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264423|NCT02118870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264424|NCT02118870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264425|NCT02118870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264426|NCT02118870|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93264427|NCT02118870|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93264428|NCT02118870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264429|NCT02118870|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264430|NCT02118870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93264431|NCT02118870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264432|NCT02118870|Antipyretics|antipyretics|mesh-ancestor
93264433|NCT02118870|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93264434|NCT02118870|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93264435|NCT02118870|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93264436|NCT02118870|Purinergic Agents|purinergic agents|mesh-ancestor
93264437|NCT02118870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264438|NCT03552666|Vitamin D|vitamin d|mesh-list
93264439|NCT03552666|Cholecalciferol|cholecalciferol|mesh-list
93264440|NCT03552666|Vitamins|vitamins|mesh-ancestor
93264441|NCT03552666|Micronutrients|micronutrients|mesh-ancestor
93264442|NCT03552666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264443|NCT03552666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93264444|NCT03552666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93264445|NCT02115594|Fulvestrant|fulvestrant|mesh-list
93264446|NCT02115594|Entinostat|entinostat|mesh-list
93264447|NCT02115594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93264448|NCT02115594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264449|NCT02115594|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93264450|NCT02115594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93264451|NCT02115594|Hormone Antagonists|hormone antagonists|mesh-ancestor
93264452|NCT02115594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264453|NCT02115594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264454|NCT02115594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93264455|NCT02115594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264456|NCT02115594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264457|NCT05125042|Amiodarone|amiodarone|mesh-list
93264458|NCT05125042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93264459|NCT05125042|Vasodilator Agents|vasodilator agents|mesh-ancestor
93264460|NCT05125042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93264461|NCT05125042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93264462|NCT05125042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264463|NCT05125042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93264464|NCT05125042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93264465|NCT05125042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93264466|NCT05125042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264467|NCT05125042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93264468|NCT05125042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93264469|NCT05125042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93264470|NCT02113332|Liraglutide|liraglutide|mesh-list
93264471|NCT02113332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93264472|NCT02113332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264473|NCT02113332|Incretins|incretins|mesh-ancestor
93264474|NCT02113332|Hormones|hormones|mesh-ancestor
93264475|NCT02113332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264476|NCT02119338|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93264477|NCT02119338|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93264478|NCT02119338|Dermatologic Agents|dermatologic agents|mesh-ancestor
93264479|NCT02918877|Propofol|propofol|mesh-list
93264480|NCT02918877|Sevoflurane|sevoflurane|mesh-list
93264481|NCT02918877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264482|NCT02918877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264483|NCT02918877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264484|NCT02918877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264485|NCT02918877|Anesthetics, General|anesthetics, general|mesh-ancestor
93264486|NCT02918877|Anesthetics|anesthetics|mesh-ancestor
93264487|NCT02918877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264488|NCT02918877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93264489|NCT03652857|Apatinib|apatinib|mesh-list
93264490|NCT03652857|Vinorelbine|vinorelbine|mesh-list
93264491|NCT03652857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264492|NCT03652857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93264493|NCT03652857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264494|NCT03652857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264495|NCT03652857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93264496|NCT03652857|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264497|NCT03652857|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264498|NCT03652857|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264499|NCT05129410|Mycophenolic Acid|mycophenolic acid|mesh-list
93264500|NCT05129410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93264501|NCT05129410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264502|NCT05129410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93264503|NCT05129410|Antitubercular Agents|antitubercular agents|mesh-ancestor
93264504|NCT05129410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93264505|NCT05129410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264506|NCT05129410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264507|NCT05129410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264508|NCT04221555|Docetaxel|docetaxel|mesh-list
93264509|NCT04221555|Oxaliplatin|oxaliplatin|mesh-list
93264510|NCT04221555|Durvalumab|durvalumab|mesh-list
93264511|NCT04221555|Tremelimumab|tremelimumab|mesh-list
93264512|NCT04221555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93264513|NCT04221555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264514|NCT04221555|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264515|NCT04221555|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264516|NCT04221555|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264517|NCT04221555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264518|NCT04221555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264519|NCT04221555|Immunologic Factors|immunologic factors|mesh-ancestor
93264520|NCT04221555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264521|NCT02113566|Acetaminophen|acetaminophen|mesh-list
93264522|NCT02113566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264523|NCT02113566|Analgesics|analgesics|mesh-ancestor
93264524|NCT02113566|Sensory System Agents|sensory system agents|mesh-ancestor
93264525|NCT02113566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264526|NCT02113566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264527|NCT02113566|Antipyretics|antipyretics|mesh-ancestor
93264528|NCT05124730|Metformin|metformin|mesh-list
93264529|NCT05124730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93264530|NCT05124730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264531|NCT02251626|Ubiquinone|ubiquinone|mesh-list
93264532|NCT02251626|Coenzyme Q10|coenzyme q10|mesh-list
93264533|NCT02251626|Micronutrients|micronutrients|mesh-ancestor
93264534|NCT02251626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264535|NCT02251626|Vitamins|vitamins|mesh-ancestor
93264536|NCT02123004|Clopidogrel|clopidogrel|mesh-list
93264537|NCT02123004|Ticagrelor|ticagrelor|mesh-list
93264538|NCT02123004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264539|NCT02123004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93264540|NCT02123004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93264541|NCT02123004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93264542|NCT02123004|Purinergic Agents|purinergic agents|mesh-ancestor
93264543|NCT02123004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264544|NCT02123004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264545|NCT02123004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264546|NCT01674712|Simvastatin|simvastatin|mesh-list
93264547|NCT01674712|Fenofibrate|fenofibrate|mesh-list
93264548|NCT01674712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93264549|NCT01674712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93264550|NCT01674712|Antimetabolites|antimetabolites|mesh-ancestor
93264551|NCT01674712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264552|NCT01674712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93264553|NCT01674712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93264554|NCT01674712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264555|NCT01368432|Escitalopram|escitalopram|mesh-list
93264556|NCT01368432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93264557|NCT01368432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93264558|NCT01368432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93264559|NCT01368432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264560|NCT01368432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264561|NCT01368432|Serotonin Agents|serotonin agents|mesh-ancestor
93264562|NCT01368432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264563|NCT05122780|Acetylcholine|acetylcholine|mesh-list
93264564|NCT05122780|Anticoagulants|anticoagulants|mesh-list
93264565|NCT05122780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93264566|NCT05122780|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93264567|NCT05122780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93264568|NCT05122780|Adrenergic Agents|adrenergic agents|mesh-ancestor
93264569|NCT05122780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264570|NCT05122780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264571|NCT05122780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264572|NCT05122780|Vasodilator Agents|vasodilator agents|mesh-ancestor
93264573|NCT05122780|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93264574|NCT05122780|Cholinergic Agents|cholinergic agents|mesh-ancestor
93264575|NCT02119806|Fentanyl|fentanyl|mesh-list
93264576|NCT02119806|Midazolam|midazolam|mesh-list
93264577|NCT02119806|Propofol|propofol|mesh-list
93264578|NCT02119806|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264579|NCT02119806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264580|NCT02119806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264581|NCT02119806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264582|NCT02119806|Anesthetics, General|anesthetics, general|mesh-ancestor
93264583|NCT02119806|Anesthetics|anesthetics|mesh-ancestor
93264584|NCT02119806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93264585|NCT02119806|Narcotics|narcotics|mesh-ancestor
93264586|NCT02119806|Analgesics|analgesics|mesh-ancestor
93264587|NCT02119806|Sensory System Agents|sensory system agents|mesh-ancestor
93264588|NCT02119806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264589|NCT02119806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93264590|NCT02119806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93264591|NCT02119806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93264592|NCT02119806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93264593|NCT02119806|GABA Modulators|gaba modulators|mesh-ancestor
93264594|NCT02119806|GABA Agents|gaba agents|mesh-ancestor
93264595|NCT02119806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264596|NCT02119806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264597|NCT02119884|Octreotide|octreotide|mesh-list
93264598|NCT02119884|Terlipressin|terlipressin|mesh-list
93264599|NCT02119884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93264600|NCT02119884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93264601|NCT02119884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264602|NCT02119884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93264603|NCT02119884|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93264604|NCT05104918|Vortioxetine|vortioxetine|mesh-list
93264605|NCT05104918|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93264606|NCT05104918|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93264607|NCT05104918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93264608|NCT05104918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93264609|NCT05104918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264610|NCT05104918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264611|NCT05104918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264612|NCT05104918|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93264613|NCT05104918|Antidepressive Agents|antidepressive agents|mesh-ancestor
93264614|NCT05104918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93264615|NCT05104918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93264616|NCT05104918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93264617|NCT05104918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264618|NCT05104918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93264619|NCT05104918|Serotonin Agents|serotonin agents|mesh-ancestor
93264620|NCT05104918|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93264621|NCT05104918|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93264622|NCT05104918|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93264623|NCT05104918|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93264624|NCT05089942|Insulin|insulin|mesh-list
93264625|NCT05089942|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93264626|NCT05089942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93264627|NCT05089942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264628|NCT04941508|Dexmedetomidine|dexmedetomidine|mesh-list
93264629|NCT04941508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264630|NCT04941508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264631|NCT04941508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264632|NCT04941508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264633|NCT04941508|Analgesics|analgesics|mesh-ancestor
93264634|NCT04941508|Sensory System Agents|sensory system agents|mesh-ancestor
93264635|NCT04941508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264636|NCT04941508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93264637|NCT04941508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93264638|NCT04941508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93264639|NCT04941508|Adrenergic Agents|adrenergic agents|mesh-ancestor
93264640|NCT04941508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264641|NCT04941508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264642|NCT01062555|Cyclosporine|cyclosporine|mesh-list
93264643|NCT01062555|Sirolimus|sirolimus|mesh-list
93264644|NCT01062555|Mycophenolic Acid|mycophenolic acid|mesh-list
93264645|NCT01062555|Tacrolimus|tacrolimus|mesh-list
93264646|NCT01062555|Cyclosporins|cyclosporins|mesh-list
93264647|NCT01062555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264648|NCT01062555|Immunologic Factors|immunologic factors|mesh-ancestor
92936640|NCT00713726|Anesthetics|anesthetics|mesh-ancestor
93264649|NCT01062555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264650|NCT01062555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93264651|NCT01062555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264652|NCT01062555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264653|NCT01062555|Antifungal Agents|antifungal agents|mesh-ancestor
93264654|NCT01062555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264655|NCT01062555|Dermatologic Agents|dermatologic agents|mesh-ancestor
93264656|NCT01062555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264657|NCT01062555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93264658|NCT01062555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264659|NCT01062555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93264660|NCT01062555|Antitubercular Agents|antitubercular agents|mesh-ancestor
93264661|NCT01062555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93264662|NCT03622047|Sufentanil|sufentanil|mesh-list
93264663|NCT03622047|Dexmedetomidine|dexmedetomidine|mesh-list
93264664|NCT03622047|Ropivacaine|ropivacaine|mesh-list
93264665|NCT03622047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264666|NCT03622047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264667|NCT03622047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264668|NCT03622047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264669|NCT03622047|Analgesics|analgesics|mesh-ancestor
93264670|NCT03622047|Sensory System Agents|sensory system agents|mesh-ancestor
93264671|NCT03622047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264672|NCT03622047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93264673|NCT03622047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93264674|NCT03622047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93264675|NCT03622047|Adrenergic Agents|adrenergic agents|mesh-ancestor
93264676|NCT03622047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264677|NCT03622047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264678|NCT03622047|Anesthetics, Local|anesthetics, local|mesh-ancestor
93264679|NCT03622047|Anesthetics|anesthetics|mesh-ancestor
93264680|NCT03622047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93264681|NCT03622047|Narcotics|narcotics|mesh-ancestor
93264682|NCT03622047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93264683|NCT03622047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264684|NCT03622047|Anesthetics, General|anesthetics, general|mesh-ancestor
93264685|NCT05128630|Durvalumab|durvalumab|mesh-list
93264686|NCT05128630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264687|NCT05128630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264688|NCT05073562|Folic Acid|folic acid|mesh-list
93264689|NCT05073562|Mebendazole|mebendazole|mesh-list
93264690|NCT05073562|Piperazine|piperazine|mesh-list
93264691|NCT05073562|Piperazine citrate|piperazine citrate|mesh-list
93264692|NCT05073562|DMP 777|dmp 777|mesh-list
93264693|NCT05073562|Hematinics|hematinics|mesh-ancestor
93264694|NCT05073562|Vitamin B Complex|vitamin b complex|mesh-ancestor
93264695|NCT05073562|Vitamins|vitamins|mesh-ancestor
93264696|NCT05073562|Micronutrients|micronutrients|mesh-ancestor
93264697|NCT05073562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264698|NCT05073562|Antinematodal Agents|antinematodal agents|mesh-ancestor
93264699|NCT05073562|Anthelmintics|anthelmintics|mesh-ancestor
93264700|NCT05073562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93264701|NCT05073562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264702|NCT05073562|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264703|NCT05073562|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264704|NCT05073562|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264705|NCT05073562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264706|NCT05073562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264707|NCT05073562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264708|NCT01368276|Molgramostim|molgramostim|mesh-list
93264709|NCT01368276|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93264710|NCT01368276|Sargramostim|sargramostim|mesh-list
93264711|NCT01368276|Immunologic Factors|immunologic factors|mesh-ancestor
93264712|NCT01368276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264713|NCT01368276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264714|NCT01368276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264715|NCT02116842|Fentanyl|fentanyl|mesh-list
93264716|NCT02116842|Bupivacaine|bupivacaine|mesh-list
93264717|NCT02116842|Anesthetics, Local|anesthetics, local|mesh-ancestor
93264718|NCT02116842|Anesthetics|anesthetics|mesh-ancestor
93264719|NCT02116842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264720|NCT02116842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264721|NCT02116842|Sensory System Agents|sensory system agents|mesh-ancestor
93264722|NCT02116842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264723|NCT02116842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93264724|NCT02116842|Narcotics|narcotics|mesh-ancestor
93264725|NCT02116842|Analgesics|analgesics|mesh-ancestor
93264726|NCT02116842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93264727|NCT02116842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264728|NCT02116842|Anesthetics, General|anesthetics, general|mesh-ancestor
93264729|NCT02120118|Docetaxel|docetaxel|mesh-list
93264730|NCT02120118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264731|NCT02120118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264732|NCT02120118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264733|NCT02120118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264734|NCT02120118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264735|NCT04054089|Tenofovir|tenofovir|mesh-list
93264736|NCT04054089|Lamivudine|lamivudine|mesh-list
93264737|NCT04054089|Emtricitabine|emtricitabine|mesh-list
93264738|NCT04054089|Dolutegravir|dolutegravir|mesh-list
93264739|NCT04054089|Antiviral Agents|antiviral agents|mesh-ancestor
93264740|NCT04054089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264741|NCT04054089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93264742|NCT04054089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93264743|NCT04054089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264744|NCT04054089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264745|NCT04054089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93264746|NCT04054089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93264747|NCT04054089|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93264748|NCT04054089|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93264749|NCT02120196|Rifaximin|rifaximin|mesh-list
93264750|NCT02120196|Norfloxacin|norfloxacin|mesh-list
93264751|NCT02120196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93264752|NCT02120196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264753|NCT02120196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93264754|NCT02120196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93264755|NCT02120196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93264756|NCT02120196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264757|NCT02120196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264758|NCT02120196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264759|NCT02120196|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93264760|NCT02120196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93264761|NCT05001802|Ropivacaine|ropivacaine|mesh-list
93264762|NCT05001802|Anesthetics, Local|anesthetics, local|mesh-ancestor
93264763|NCT05001802|Anesthetics|anesthetics|mesh-ancestor
93264764|NCT05001802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264765|NCT05001802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264766|NCT05001802|Sensory System Agents|sensory system agents|mesh-ancestor
93264767|NCT05001802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93264768|NCT02120274|Vitamin D|vitamin d|mesh-list
93264769|NCT02120274|Vitamins|vitamins|mesh-list
93264770|NCT02120274|Vitamin B 12|vitamin b 12|mesh-list
93264771|NCT02120274|Hydroxocobalamin|hydroxocobalamin|mesh-list
93264772|NCT02120274|Micronutrients|micronutrients|mesh-ancestor
93264773|NCT02120274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264774|NCT02120274|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93264775|NCT02120274|Vitamin B Complex|vitamin b complex|mesh-ancestor
93264776|NCT02120274|Hematinics|hematinics|mesh-ancestor
93264777|NCT02402842|Docetaxel|docetaxel|mesh-list
93264778|NCT02402842|Fluorouracil|fluorouracil|mesh-list
93264779|NCT02402842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264780|NCT02402842|Tubulin Modulators|tubulin modulators|mesh-ancestor
93264781|NCT02402842|Antimitotic Agents|antimitotic agents|mesh-ancestor
93264782|NCT02402842|Mitosis Modulators|mitosis modulators|mesh-ancestor
93264783|NCT02402842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264784|NCT02402842|Antimetabolites|antimetabolites|mesh-ancestor
93264785|NCT02402842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264786|NCT02402842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264787|NCT02402842|Immunologic Factors|immunologic factors|mesh-ancestor
93264788|NCT02402842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264789|NCT02741570|Cisplatin|cisplatin|mesh-list
93264790|NCT02741570|Carboplatin|carboplatin|mesh-list
93264791|NCT02741570|Fluorouracil|fluorouracil|mesh-list
93264792|NCT02741570|Nivolumab|nivolumab|mesh-list
93264793|NCT02741570|Cetuximab|cetuximab|mesh-list
93264794|NCT02741570|Ipilimumab|ipilimumab|mesh-list
93264795|NCT02741570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264796|NCT02741570|Antimetabolites|antimetabolites|mesh-ancestor
93264797|NCT02741570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264798|NCT02741570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93264799|NCT02741570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264800|NCT02741570|Immunologic Factors|immunologic factors|mesh-ancestor
93264801|NCT02741570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264802|NCT02741570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264803|NCT02741570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264804|NCT01061775|Exenatide|exenatide|mesh-list
93264806|NCT01061775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264807|NCT01061775|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93264808|NCT01061775|Incretins|incretins|mesh-ancestor
93264809|NCT01061775|Hormones|hormones|mesh-ancestor
93264810|NCT01061775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264811|NCT02123628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93264812|NCT02123628|Doxycycline|doxycycline|mesh-list
93264813|NCT02123628|Ciprofloxacin|ciprofloxacin|mesh-list
93264814|NCT02123628|Levofloxacin|levofloxacin|mesh-list
93264815|NCT02123628|Rifampin|rifampin|mesh-list
93264816|NCT02123628|Ceftriaxone|ceftriaxone|mesh-list
93264817|NCT02123628|Linezolid|linezolid|mesh-list
93264818|NCT02123628|Cefepime|cefepime|mesh-list
93264819|NCT02123628|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93264820|NCT02123628|Cefotaxime|cefotaxime|mesh-list
93264821|NCT02123628|Fusidic Acid|fusidic acid|mesh-list
93264822|NCT02123628|Trimethoprim|trimethoprim|mesh-list
93264823|NCT02123628|Sulfamethoxazole|sulfamethoxazole|mesh-list
93264824|NCT02123628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93264825|NCT02123628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93264826|NCT02123628|Antitubercular Agents|antitubercular agents|mesh-ancestor
93264827|NCT02123628|Antimalarials|antimalarials|mesh-ancestor
93264828|NCT02123628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93264829|NCT02123628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93264830|NCT02123628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93264831|NCT02123628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93264832|NCT02123628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264833|NCT02123628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264834|NCT02123628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264835|NCT02123628|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93264836|NCT02123628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93264837|NCT02123628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93264838|NCT02123628|Leprostatic Agents|leprostatic agents|mesh-ancestor
93264839|NCT02123628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93264840|NCT02123628|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93264841|NCT02123628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93264842|NCT02123628|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93264843|NCT02123628|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93264844|NCT02123628|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93264845|NCT02123628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93264846|NCT02123628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93264847|NCT02123628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93264848|NCT02123628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93264849|NCT02123628|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93264850|NCT02651116|Dextromethorphan|dextromethorphan|mesh-list
93264851|NCT02651116|Antitussive Agents|antitussive agents|mesh-ancestor
93264852|NCT02651116|Respiratory System Agents|respiratory system agents|mesh-ancestor
93264853|NCT02651116|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93264854|NCT02651116|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93264855|NCT02651116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264856|NCT02651116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264857|NCT02651116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264858|NCT03652467|Chlorotrianisene|chlorotrianisene|mesh-list
93264859|NCT03652467|Deferoxamine|deferoxamine|mesh-list
93264860|NCT03652467|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93264861|NCT03652467|Estrogens|estrogens|mesh-ancestor
93264862|NCT03652467|Hormones|hormones|mesh-ancestor
93264863|NCT03652467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93264864|NCT03652467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264865|NCT03652467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93264866|NCT03652467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264867|NCT03652467|Siderophores|siderophores|mesh-ancestor
93264868|NCT03652467|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93264869|NCT03652467|Chelating Agents|chelating agents|mesh-ancestor
93264870|NCT03652467|Sequestering Agents|sequestering agents|mesh-ancestor
93264871|NCT03652467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264872|NCT03528824|Diclofenac|diclofenac|mesh-list
93264873|NCT03528824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93264874|NCT03528824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93264875|NCT03528824|Analgesics|analgesics|mesh-ancestor
93264876|NCT03528824|Sensory System Agents|sensory system agents|mesh-ancestor
93264877|NCT03528824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936863|NCT00801177|Necitumumab|necitumumab|mesh-list
93264878|NCT03528824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264879|NCT03528824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93264880|NCT03528824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93264881|NCT03528824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93264882|NCT03528824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264883|NCT03528824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264885|NCT05045638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93264886|NCT05045638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93264887|NCT05045638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93264888|NCT05045638|Antimetabolites|antimetabolites|mesh-ancestor
93264889|NCT05045638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264890|NCT05045638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93264891|NCT05045638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93264892|NCT05045638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264893|NCT05045638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264894|NCT05045638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264895|NCT05045638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264896|NCT00289640|Ipilimumab|ipilimumab|mesh-list
93264897|NCT00289640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264898|NCT00289640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264899|NCT00289640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264900|NCT00289640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264901|NCT05039086|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
93264902|NCT05039086|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
93264903|NCT05039086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93264904|NCT05039086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264905|NCT05039086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264906|NCT03552432|Alirocumab|alirocumab|mesh-list
93264907|NCT03552432|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93264908|NCT03552432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93264909|NCT03552432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93264910|NCT03552432|Antimetabolites|antimetabolites|mesh-ancestor
93264911|NCT03552432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264912|NCT03552432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93264913|NCT03552432|Protease Inhibitors|protease inhibitors|mesh-ancestor
93264914|NCT03552432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264915|NCT03552432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93264916|NCT03765632|Busulfan|busulfan|mesh-list
93264917|NCT03765632|Alkylating Agents|alkylating agents|mesh-ancestor
93264918|NCT03765632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264919|NCT03765632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264920|NCT03765632|Immunologic Factors|immunologic factors|mesh-ancestor
93264921|NCT03765632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264922|NCT03765632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93264923|NCT03765632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264924|NCT03765632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93264925|NCT02973477|Dapagliflozin|dapagliflozin|mesh-list
93264926|NCT02973477|Glimepiride|glimepiride|mesh-list
93264927|NCT02973477|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93264928|NCT02973477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264929|NCT02973477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93264930|NCT02973477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264931|NCT02973477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93264932|NCT02973477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93264933|NCT02973477|Immunologic Factors|immunologic factors|mesh-ancestor
93264934|NCT03552354|Argatroban|argatroban|mesh-list
93264935|NCT03552354|Antithrombins|antithrombins|mesh-ancestor
93264936|NCT03552354|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93264937|NCT03552354|Protease Inhibitors|protease inhibitors|mesh-ancestor
93264938|NCT03552354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264939|NCT03552354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264940|NCT03552354|Anticoagulants|anticoagulants|mesh-ancestor
93264941|NCT03552354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93264942|NCT02288000|Memantine|memantine|mesh-list
93264943|NCT02288000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93264944|NCT02288000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93264945|NCT02288000|Dopamine Agents|dopamine agents|mesh-ancestor
93264946|NCT02288000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264947|NCT02288000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264948|NCT02288000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264949|NCT02288000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93264950|NCT02288000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93264952|NCT02788656|Angiotensin II|angiotensin ii|mesh-list
93264953|NCT02788656|Giapreza|giapreza|mesh-list
93264954|NCT02788656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
93264955|NCT02788656|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93264956|NCT02788656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93264957|NCT02788656|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93264958|NCT02788656|Angiotensinogen|angiotensinogen|mesh-list
93264959|NCT02788656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93264960|NCT02788656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93264961|NCT02788656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264962|NCT02788656|Protease Inhibitors|protease inhibitors|mesh-ancestor
93264963|NCT02788656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93264964|NCT02788656|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93264965|NCT05258110|Midazolam|midazolam|mesh-list
93264966|NCT05258110|BI 425809|bi 425809|mesh-list
93264967|NCT05258110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93264968|NCT05258110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93264969|NCT05258110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93264970|NCT05258110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264971|NCT05258110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93264972|NCT05258110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93264973|NCT05258110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93264974|NCT05258110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93264975|NCT05258110|Anesthetics, General|anesthetics, general|mesh-ancestor
93264976|NCT05258110|Anesthetics|anesthetics|mesh-ancestor
93264977|NCT05258110|GABA Modulators|gaba modulators|mesh-ancestor
93264978|NCT05258110|GABA Agents|gaba agents|mesh-ancestor
93264979|NCT05258110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93264980|NCT05258110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264981|NCT05258110|Nootropic Agents|nootropic agents|mesh-ancestor
93264982|NCT03652233|Nivolumab|nivolumab|mesh-list
93264983|NCT03652233|Afatinib|afatinib|mesh-list
93264984|NCT03652233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264985|NCT03652233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264986|NCT03652233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264987|NCT03652233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93264988|NCT03652233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93264989|NCT03652233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93264990|NCT02117466|Cetuximab|cetuximab|mesh-list
93264991|NCT02117466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93264992|NCT02117466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93264993|NCT02117622|Insulin|insulin|mesh-list
93264994|NCT02117622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93264995|NCT02117622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93264996|NCT04529902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93264997|NCT04529902|Abatacept|abatacept|mesh-list
93264998|NCT04529902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93264999|NCT04529902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265000|NCT04529902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265001|NCT04529902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265002|NCT04529902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265003|NCT04529902|Immunologic Factors|immunologic factors|mesh-ancestor
93265004|NCT04529902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265005|NCT04529902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265006|NCT04529902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265007|NCT04693468|Palbociclib|palbociclib|mesh-list
93265008|NCT04693468|Axitinib|axitinib|mesh-list
93265009|NCT04693468|Crizotinib|crizotinib|mesh-list
93265010|NCT04693468|Talazoparib|talazoparib|mesh-list
93265011|NCT04693468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93265012|NCT04693468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265013|NCT04693468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265014|NCT04693468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265015|NCT04693468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265016|NCT04693468|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93265017|NCT02288078|Dexamethasone|dexamethasone|mesh-list
93265018|NCT02288078|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93265019|NCT02288078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265020|NCT02288078|Antiemetics|antiemetics|mesh-ancestor
93265021|NCT02288078|Autonomic Agents|autonomic agents|mesh-ancestor
93265022|NCT02288078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265023|NCT02288078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265024|NCT02288078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93265026|NCT02288078|Hormones|hormones|mesh-ancestor
93265027|NCT02288078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265028|NCT02288078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93265029|NCT02288078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265030|NCT02288078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265031|NCT02288078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265032|NCT02288234|Telavancin|telavancin|mesh-list
93265033|NCT02288234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265034|NCT02288234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265035|NCT04654312|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93265036|NCT04654312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93265037|NCT04654312|Diuretics|diuretics|mesh-ancestor
93265038|NCT04654312|Natriuretic Agents|natriuretic agents|mesh-ancestor
93265039|NCT04654312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265040|NCT04654312|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93265041|NCT04654312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93265042|NCT04654312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265043|NCT02973087|Factor VIII|factor viii|mesh-list
93265044|NCT02973087|Coagulants|coagulants|mesh-ancestor
93265045|NCT05284656|Folic Acid|folic acid|mesh-list
93265046|NCT05284656|Vitamin B Complex|vitamin b complex|mesh-list
93265047|NCT05284656|Pentoxifylline|pentoxifylline|mesh-list
93265048|NCT05284656|Hematinics|hematinics|mesh-ancestor
93265049|NCT05284656|Vitamins|vitamins|mesh-ancestor
93265050|NCT05284656|Micronutrients|micronutrients|mesh-ancestor
93265051|NCT05284656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265052|NCT05284656|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93265053|NCT05284656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265054|NCT05284656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265055|NCT05284656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93265056|NCT05284656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93265057|NCT05284656|Protective Agents|protective agents|mesh-ancestor
93265058|NCT05284656|Vasodilator Agents|vasodilator agents|mesh-ancestor
93265059|NCT05284656|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93265060|NCT05284656|Antioxidants|antioxidants|mesh-ancestor
93265061|NCT02124174|Azacitidine|azacitidine|mesh-list
93265062|NCT02124174|Valproic Acid|valproic acid|mesh-list
93265063|NCT02124174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93265064|NCT02124174|Antimetabolites|antimetabolites|mesh-ancestor
93265065|NCT02124174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265066|NCT02124174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265067|NCT02124174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265068|NCT02124174|Anticonvulsants|anticonvulsants|mesh-ancestor
93265069|NCT02124174|GABA Agents|gaba agents|mesh-ancestor
93265070|NCT02124174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265071|NCT02124174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265072|NCT02124174|Antimanic Agents|antimanic agents|mesh-ancestor
93265073|NCT02124174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93265074|NCT02124174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265075|NCT02124174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93265076|NCT03956368|Atorvastatin|atorvastatin|mesh-list
93265077|NCT03956368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93265078|NCT03956368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93265079|NCT03956368|Antimetabolites|antimetabolites|mesh-ancestor
93265080|NCT03956368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265081|NCT03956368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93265082|NCT03956368|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93265083|NCT03956368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265084|NCT02124330|Bentonite|bentonite|mesh-list
93265085|NCT02124330|Antidotes|antidotes|mesh-ancestor
93265086|NCT02124330|Protective Agents|protective agents|mesh-ancestor
93265087|NCT02124330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265088|NCT02118090|Chloroquine|chloroquine|mesh-list
93265089|NCT02118090|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93265090|NCT02118090|Amebicides|amebicides|mesh-ancestor
93265091|NCT02118090|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93265092|NCT02118090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93265093|NCT02118090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265094|NCT02118090|Antimalarials|antimalarials|mesh-ancestor
93265095|NCT02118090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265096|NCT02118090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93265097|NCT02118090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93265098|NCT02118090|Analgesics|analgesics|mesh-ancestor
93265099|NCT02118090|Sensory System Agents|sensory system agents|mesh-ancestor
93265100|NCT02118090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265101|NCT02118090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265102|NCT02118090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265103|NCT02118090|Filaricides|filaricides|mesh-ancestor
93265104|NCT02118090|Antinematodal Agents|antinematodal agents|mesh-ancestor
93265105|NCT02118090|Anthelmintics|anthelmintics|mesh-ancestor
93265106|NCT04235114|Nimotuzumab|nimotuzumab|mesh-list
93265107|NCT04235114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265108|NCT04235114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265109|NCT03551808|Ketorolac|ketorolac|mesh-list
93265110|NCT03551808|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93265111|NCT03551808|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93265112|NCT03551808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93265113|NCT03551808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93265114|NCT03551808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93265115|NCT03551808|Analgesics|analgesics|mesh-ancestor
93265116|NCT03551808|Sensory System Agents|sensory system agents|mesh-ancestor
93265117|NCT03551808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265118|NCT03551808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265119|NCT03551808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265120|NCT03551808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265121|NCT03551808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93265122|NCT03551808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265123|NCT03551808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265124|NCT04053543|CXA-10|cxa-10|mesh-list
93265125|NCT04053543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265126|NCT04202458|Tenecteplase|tenecteplase|mesh-list
93265127|NCT04202458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93265128|NCT04202458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93265129|NCT04202458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265130|NCT00273650|Vitamin B 12|vitamin b 12|mesh-list
93265131|NCT00273650|Vitamins|vitamins|mesh-ancestor
93265132|NCT00273650|Micronutrients|micronutrients|mesh-ancestor
93265133|NCT00273650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265134|NCT00273650|Vitamin B Complex|vitamin b complex|mesh-ancestor
93265135|NCT02121288|Clopidogrel|clopidogrel|mesh-list
93265136|NCT02121288|Ticagrelor|ticagrelor|mesh-list
93265137|NCT02121288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93265138|NCT02121288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93265139|NCT02121288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93265140|NCT02121288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93265141|NCT02121288|Purinergic Agents|purinergic agents|mesh-ancestor
93265142|NCT02121288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265143|NCT02121288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265144|NCT02121288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265145|NCT01525329|Fluorouracil|fluorouracil|mesh-list
93265146|NCT01525329|Antimetabolites|antimetabolites|mesh-ancestor
93265147|NCT01525329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265148|NCT01525329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93265149|NCT01525329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265150|NCT01525329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265151|NCT01525329|Immunologic Factors|immunologic factors|mesh-ancestor
93265152|NCT01525329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265153|NCT02121366|Ethanol|ethanol|mesh-list
93265154|NCT02121366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93265155|NCT02121366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265156|NCT02121366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265157|NCT02121366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265158|NCT02121444|Interferons|interferons|mesh-list
93265159|NCT02121444|Interferon-beta|interferon-beta|mesh-list
93265160|NCT02121444|Interferon beta-1b|interferon beta-1b|mesh-list
93265161|NCT02121444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265162|NCT02121444|Antiviral Agents|antiviral agents|mesh-ancestor
93265163|NCT02121444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265164|NCT02121444|Immunologic Factors|immunologic factors|mesh-ancestor
93265165|NCT02121444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265166|NCT02121444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93265167|NCT04413526|Chlorotrianisene|chlorotrianisene|mesh-list
93265168|NCT04413526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93265169|NCT04413526|Estrogens|estrogens|mesh-ancestor
93265170|NCT04413526|Hormones|hormones|mesh-ancestor
93265171|NCT04413526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265172|NCT04413526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265173|NCT04413526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93265174|NCT04413526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265175|NCT03665506|Trifluridine|trifluridine|mesh-list
93265176|NCT03665506|Antimetabolites|antimetabolites|mesh-ancestor
93265177|NCT03665506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265178|NCT03665506|Antiviral Agents|antiviral agents|mesh-ancestor
93265179|NCT03665506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265180|NCT03318874|Hyaluronic Acid|hyaluronic acid|mesh-list
93265181|NCT03318874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93265182|NCT03318874|Immunologic Factors|immunologic factors|mesh-ancestor
93265183|NCT03318874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265184|NCT03318874|Viscosupplements|viscosupplements|mesh-ancestor
93265185|NCT03318874|Protective Agents|protective agents|mesh-ancestor
93265186|NCT03551652|Rocuronium|rocuronium|mesh-list
93265187|NCT03551652|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93265188|NCT03551652|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93265189|NCT03551652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93265190|NCT03551652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265191|NCT03551652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265192|NCT00263042|Rimonabant|rimonabant|mesh-list
93265193|NCT00263042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93265194|NCT00263042|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93265195|NCT00263042|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93265196|NCT00263042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265197|NCT00263042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265198|NCT00263042|Hormones|hormones|mesh-ancestor
93265199|NCT00263042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265200|NCT00263042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265201|NCT05002192|Eucalyptol|eucalyptol|mesh-list
93265202|NCT05002192|Ambroxol|ambroxol|mesh-list
93265203|NCT05002192|Expectorants|expectorants|mesh-list
93265204|NCT05002192|Respiratory System Agents|respiratory system agents|mesh-ancestor
93265205|NCT05002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265206|NCT05002192|Antitussive Agents|antitussive agents|mesh-ancestor
93265207|NCT05002192|Insect Repellents|insect repellents|mesh-ancestor
93265208|NCT05002192|Protective Agents|protective agents|mesh-ancestor
93265209|NCT05002192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265210|NCT04973020|Efavirenz|efavirenz|mesh-list
93265211|NCT04973020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93265212|NCT04973020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93265213|NCT04973020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265214|NCT04973020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265215|NCT04973020|Antiviral Agents|antiviral agents|mesh-ancestor
93265216|NCT04973020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265217|NCT04973020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93265218|NCT04973020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93265219|NCT04973020|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93265220|NCT04973020|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93265221|NCT04973020|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93265222|NCT04973020|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93265223|NCT05724446|Prednisolone|prednisolone|mesh-list
93265224|NCT05724446|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93265225|NCT05724446|Methylprednisolone|methylprednisolone|mesh-list
93265226|NCT05724446|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93265227|NCT05724446|Prednisolone acetate|prednisolone acetate|mesh-list
93265228|NCT05724446|Clobetasol|clobetasol|mesh-list
93265229|NCT05724446|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93265230|NCT05724446|Prednisolone phosphate|prednisolone phosphate|mesh-list
93265231|NCT05724446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265232|NCT05724446|Glucocorticoids|glucocorticoids|mesh-ancestor
93265233|NCT05724446|Hormones|hormones|mesh-ancestor
93265234|NCT05724446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265235|NCT05724446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265236|NCT05724446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93265237|NCT05724446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265238|NCT05724446|Antiemetics|antiemetics|mesh-ancestor
93265239|NCT05724446|Autonomic Agents|autonomic agents|mesh-ancestor
93265240|NCT05724446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265241|NCT05724446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93265242|NCT05724446|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93265243|NCT05724446|Protective Agents|protective agents|mesh-ancestor
93265244|NCT02124642|Folic Acid|folic acid|mesh-list
93265245|NCT02124642|Vitamin B Complex|vitamin b complex|mesh-list
93265246|NCT02124642|Hematinics|hematinics|mesh-ancestor
93265247|NCT02124642|Vitamins|vitamins|mesh-ancestor
93265248|NCT02124642|Micronutrients|micronutrients|mesh-ancestor
92559867|NCT00046319|Ambrisentan|ambrisentan|mesh-list
93265249|NCT02124642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265250|NCT03094234|Propranolol|propranolol|mesh-list
93265251|NCT03094234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93265252|NCT03094234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93265253|NCT03094234|Adrenergic Agents|adrenergic agents|mesh-ancestor
93265254|NCT03094234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265255|NCT03094234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265256|NCT03094234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265257|NCT03094234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93265258|NCT03094234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93265259|NCT03094234|Vasodilator Agents|vasodilator agents|mesh-ancestor
93265260|NCT00260156|Vildagliptin|vildagliptin|mesh-list
93265261|NCT00260156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93265262|NCT00260156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265263|NCT00260156|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93265264|NCT00260156|Protease Inhibitors|protease inhibitors|mesh-ancestor
93265265|NCT00260156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265266|NCT00260156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265267|NCT04367103|Phenylephrine|phenylephrine|mesh-list
93265268|NCT04367103|Oxymetazoline|oxymetazoline|mesh-list
93265269|NCT04367103|Norepinephrine|norepinephrine|mesh-list
93265270|NCT04367103|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93265271|NCT04367103|Mydriatics|mydriatics|mesh-ancestor
93265272|NCT04367103|Autonomic Agents|autonomic agents|mesh-ancestor
93265273|NCT04367103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265274|NCT04367103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265275|NCT04367103|Sympathomimetics|sympathomimetics|mesh-ancestor
93265276|NCT04367103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93265277|NCT04367103|Nasal Decongestants|nasal decongestants|mesh-ancestor
93265278|NCT04367103|Respiratory System Agents|respiratory system agents|mesh-ancestor
93265279|NCT04367103|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93265280|NCT04367103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93265281|NCT04367103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93265282|NCT04367103|Adrenergic Agents|adrenergic agents|mesh-ancestor
93265283|NCT04367103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265284|NCT04367103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265285|NCT04367103|Protective Agents|protective agents|mesh-ancestor
93265286|NCT00260078|Ritonavir|ritonavir|mesh-list
93265287|NCT00260078|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93265288|NCT00260078|Darunavir|darunavir|mesh-list
93265289|NCT00260078|Tenofovir|tenofovir|mesh-list
93265290|NCT00260078|Nevirapine|nevirapine|mesh-list
93265291|NCT00260078|Efavirenz|efavirenz|mesh-list
93265292|NCT00260078|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93265293|NCT00260078|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93265294|NCT00260078|Protease Inhibitors|protease inhibitors|mesh-ancestor
93265295|NCT00260078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265296|NCT00260078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265297|NCT00260078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93265298|NCT00260078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93265299|NCT00260078|Antiviral Agents|antiviral agents|mesh-ancestor
93265300|NCT00260078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265301|NCT00260078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93265302|NCT00260078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93265303|NCT00260078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93265304|NCT00260078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93265305|NCT00260078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93265306|NCT00260078|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93265307|NCT00260078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93265308|NCT00260078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93265309|NCT00260078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93265310|NCT03034564|Droxidopa|droxidopa|mesh-list
93265311|NCT03034564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93265312|NCT03034564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93265313|NCT05342532|Amoxicillin|amoxicillin|mesh-list
93265314|NCT05342532|Clarithromycin|clarithromycin|mesh-list
93265315|NCT05342532|Omeprazole|omeprazole|mesh-list
93265316|NCT05342532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265317|NCT05342532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265318|NCT05342532|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93265319|NCT05342532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93265320|NCT05342532|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93265321|NCT05342532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265322|NCT05342532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265323|NCT05342532|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93265324|NCT05342532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93265325|NCT05342532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93265326|NCT04469114|Tofacitinib|tofacitinib|mesh-list
93265327|NCT04469114|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93265328|NCT04469114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265329|NCT04469114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265330|NCT04469114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265331|NCT02400567|Cyclophosphamide|cyclophosphamide|mesh-list
93265332|NCT02400567|Letrozole|letrozole|mesh-list
93265333|NCT02400567|Epirubicin|epirubicin|mesh-list
93265334|NCT02400567|Palbociclib|palbociclib|mesh-list
93265335|NCT02400567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265336|NCT02400567|Immunologic Factors|immunologic factors|mesh-ancestor
93265337|NCT02400567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265338|NCT02400567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265339|NCT02400567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93265340|NCT02400567|Alkylating Agents|alkylating agents|mesh-ancestor
93265341|NCT02400567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265342|NCT02400567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265343|NCT02400567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93265344|NCT02400567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93265345|NCT02400567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93265346|NCT02400567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265347|NCT02400567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93265348|NCT02400567|Hormone Antagonists|hormone antagonists|mesh-ancestor
93265349|NCT02400567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265350|NCT02400567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93265351|NCT02400567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265352|NCT02400567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265353|NCT02400567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265354|NCT05501054|Nivolumab|nivolumab|mesh-list
93265355|NCT05501054|Ipilimumab|ipilimumab|mesh-list
93265356|NCT05501054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265357|NCT05501054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265358|NCT05501054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93265359|NCT05501054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265360|NCT00228176|Rimonabant|rimonabant|mesh-list
93265361|NCT00228176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93265362|NCT00228176|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93265363|NCT00228176|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93265364|NCT00228176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265365|NCT00228176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265366|NCT00228176|Hormones|hormones|mesh-ancestor
93265367|NCT00228176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265368|NCT00228176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265369|NCT05131984|Ocrelizumab|ocrelizumab|mesh-list
93265370|NCT05131984|Immunologic Factors|immunologic factors|mesh-ancestor
93265371|NCT05131984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265372|NCT01308190|Capecitabine|capecitabine|mesh-list
93265373|NCT01308190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93265374|NCT01308190|Antimetabolites|antimetabolites|mesh-ancestor
93265375|NCT01308190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265376|NCT01308190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265377|NCT01210768|Cyclophosphamide|cyclophosphamide|mesh-list
93265378|NCT01210768|Doxorubicin|doxorubicin|mesh-list
93265379|NCT01210768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93265380|NCT01210768|Epirubicin|epirubicin|mesh-list
93265381|NCT01210768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265382|NCT01210768|Immunologic Factors|immunologic factors|mesh-ancestor
93265383|NCT01210768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265384|NCT01210768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265385|NCT01210768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93265386|NCT01210768|Alkylating Agents|alkylating agents|mesh-ancestor
93265387|NCT01210768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265388|NCT01210768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265389|NCT01210768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93265390|NCT01210768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93265391|NCT01210768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265392|NCT01210768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265393|NCT01210768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265394|NCT02971605|Psilocybin|psilocybin|mesh-list
93265395|NCT02971605|Hallucinogens|hallucinogens|mesh-ancestor
93265396|NCT02971605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265397|NCT02971605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93265398|NCT04410874|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92937389|NCT00802581|Sensory System Agents|sensory system agents|mesh-ancestor
93265399|NCT04410874|Vaccines|vaccines|mesh-list
93265400|NCT04410874|Immunologic Factors|immunologic factors|mesh-ancestor
93265401|NCT04410874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265402|NCT04410874|Antiviral Agents|antiviral agents|mesh-ancestor
93265403|NCT04410874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265404|NCT02124954|Digoxin|digoxin|mesh-list
93265405|NCT02124954|Midazolam|midazolam|mesh-list
93265406|NCT02124954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93265407|NCT02124954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93265408|NCT02124954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265409|NCT02124954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265410|NCT02124954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93265411|NCT02124954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93265412|NCT02124954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93265413|NCT02124954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93265414|NCT02124954|Anesthetics, General|anesthetics, general|mesh-ancestor
93265415|NCT02124954|Anesthetics|anesthetics|mesh-ancestor
93265416|NCT02124954|GABA Modulators|gaba modulators|mesh-ancestor
93265417|NCT02124954|GABA Agents|gaba agents|mesh-ancestor
93265418|NCT02124954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265419|NCT02124954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265420|NCT02124954|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93265421|NCT02124954|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93265422|NCT02124954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265423|NCT02124954|Protective Agents|protective agents|mesh-ancestor
93265424|NCT04441112|Triamcinolone|triamcinolone|mesh-list
93265425|NCT04441112|Ketorolac|ketorolac|mesh-list
93265426|NCT04441112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93265427|NCT04441112|Glucocorticoids|glucocorticoids|mesh-ancestor
93265428|NCT04441112|Hormones|hormones|mesh-ancestor
93265429|NCT04441112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265430|NCT04441112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265431|NCT04441112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265432|NCT04441112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265433|NCT04441112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93265434|NCT04441112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93265435|NCT04441112|Analgesics|analgesics|mesh-ancestor
93265436|NCT04441112|Sensory System Agents|sensory system agents|mesh-ancestor
93265437|NCT04441112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265438|NCT04441112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265439|NCT04441112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93265440|NCT02121990|Paclitaxel|paclitaxel|mesh-list
93265441|NCT02121990|Bevacizumab|bevacizumab|mesh-list
93265442|NCT02121990|Olaparib|olaparib|mesh-list
93265443|NCT02121990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93265444|NCT02121990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265445|NCT02121990|Tubulin Modulators|tubulin modulators|mesh-ancestor
93265446|NCT02121990|Antimitotic Agents|antimitotic agents|mesh-ancestor
93265447|NCT02121990|Mitosis Modulators|mitosis modulators|mesh-ancestor
93265448|NCT02121990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265449|NCT02121990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265450|NCT02121990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93265451|NCT02121990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93265452|NCT02121990|Growth Substances|growth substances|mesh-ancestor
93265453|NCT02121990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265454|NCT02121990|Growth Inhibitors|growth inhibitors|mesh-ancestor
93265455|NCT02121990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93265456|NCT02121990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265457|NCT05724056|Hyaluronic Acid|hyaluronic acid|mesh-list
93265458|NCT05724056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93265459|NCT05724056|Immunologic Factors|immunologic factors|mesh-ancestor
93265460|NCT05724056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265461|NCT05724056|Viscosupplements|viscosupplements|mesh-ancestor
93265462|NCT05724056|Protective Agents|protective agents|mesh-ancestor
93265463|NCT02609737|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93265464|NCT02609737|Chelating Agents|chelating agents|mesh-ancestor
93265465|NCT02609737|Sequestering Agents|sequestering agents|mesh-ancestor
93265466|NCT02609737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265467|NCT01060059|Exenatide|exenatide|mesh-list
93265468|NCT01060059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93265469|NCT01060059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265470|NCT01060059|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93265471|NCT01060059|Incretins|incretins|mesh-ancestor
93265472|NCT01060059|Hormones|hormones|mesh-ancestor
93265473|NCT01060059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265474|NCT04318015|Hydroxychloroquine|hydroxychloroquine|mesh-list
93265475|NCT04318015|Antimalarials|antimalarials|mesh-ancestor
93265476|NCT04318015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93265477|NCT04318015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93265478|NCT04318015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265479|NCT04318015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265480|NCT04318015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265481|NCT04318015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265482|NCT04307797|Exenatide|exenatide|mesh-list
93265483|NCT04307797|Glucagon|glucagon|mesh-list
93265484|NCT04307797|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93265485|NCT04307797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93265486|NCT04307797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265487|NCT04307797|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93265488|NCT04307797|Incretins|incretins|mesh-ancestor
93265489|NCT04307797|Hormones|hormones|mesh-ancestor
93265490|NCT04307797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265491|NCT04307797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93265492|NCT02125188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93265493|NCT02125188|Hemostatics|hemostatics|mesh-ancestor
93265494|NCT02125188|Coagulants|coagulants|mesh-ancestor
93265495|NCT02125188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93265496|NCT02125188|Natriuretic Agents|natriuretic agents|mesh-ancestor
93265497|NCT02125188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265498|NCT02125344|Paclitaxel|paclitaxel|mesh-list
93265499|NCT02125344|Cyclophosphamide|cyclophosphamide|mesh-list
93265500|NCT02125344|Carboplatin|carboplatin|mesh-list
93265501|NCT02125344|Doxorubicin|doxorubicin|mesh-list
93265502|NCT02125344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93265503|NCT02125344|Trastuzumab|trastuzumab|mesh-list
93265504|NCT02125344|Epirubicin|epirubicin|mesh-list
93265505|NCT02125344|Pertuzumab|pertuzumab|mesh-list
93265506|NCT02125344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93265507|NCT02125344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265508|NCT02125344|Tubulin Modulators|tubulin modulators|mesh-ancestor
93265509|NCT02125344|Antimitotic Agents|antimitotic agents|mesh-ancestor
93265510|NCT02125344|Mitosis Modulators|mitosis modulators|mesh-ancestor
93265511|NCT02125344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265512|NCT02125344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265513|NCT02125344|Immunologic Factors|immunologic factors|mesh-ancestor
93265514|NCT02125344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265515|NCT02125344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265516|NCT02125344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93265517|NCT02125344|Alkylating Agents|alkylating agents|mesh-ancestor
93265518|NCT02125344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93265519|NCT02125344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93265520|NCT02125344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265521|NCT02125344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265522|NCT02125344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265523|NCT02125344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265524|NCT05468840|Ketamine|ketamine|mesh-list
93265525|NCT05468840|Analgesics|analgesics|mesh-ancestor
93265526|NCT05468840|Sensory System Agents|sensory system agents|mesh-ancestor
93265527|NCT05468840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265528|NCT05468840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265529|NCT05468840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93265530|NCT05468840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93265531|NCT05468840|Anesthetics, General|anesthetics, general|mesh-ancestor
93265532|NCT05468840|Anesthetics|anesthetics|mesh-ancestor
93265533|NCT05468840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265534|NCT05468840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93265535|NCT05468840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93265536|NCT05468840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265537|NCT05468840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265538|NCT05723900|Castor Oil|castor oil|mesh-list
93265539|NCT05723900|Cathartics|cathartics|mesh-ancestor
93265540|NCT05723900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93265541|NCT02127138|Sirolimus|sirolimus|mesh-list
93265542|NCT02127138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265543|NCT02127138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265544|NCT02127138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93265545|NCT02127138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265546|NCT02127138|Antifungal Agents|antifungal agents|mesh-ancestor
93265547|NCT02127138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265548|NCT02127138|Immunologic Factors|immunologic factors|mesh-ancestor
92937545|NCT00439777|Enoxaparin|enoxaparin|mesh-list
93265549|NCT02127138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265550|NCT03651531|Metformin|metformin|mesh-list
93265551|NCT03651531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93265552|NCT03651531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265553|NCT02903511|Metformin|metformin|mesh-list
93265554|NCT02903511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93265555|NCT02903511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265556|NCT05325528|Oxaliplatin|oxaliplatin|mesh-list
93265557|NCT05325528|Tislelizumab|tislelizumab|mesh-list
93265558|NCT05325528|Tegafur|tegafur|mesh-list
93265559|NCT05325528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265560|NCT05325528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265561|NCT05325528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93265562|NCT05325528|Antimetabolites|antimetabolites|mesh-ancestor
93265563|NCT05325528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265564|NCT02125500|Sofosbuvir|sofosbuvir|mesh-list
93265565|NCT02125500|Ledipasvir|ledipasvir|mesh-list
93265566|NCT02125500|Antiviral Agents|antiviral agents|mesh-ancestor
93265567|NCT02125500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265568|NCT02125578|Interferons|interferons|mesh-list
93265569|NCT02125578|Interferon-beta|interferon-beta|mesh-list
93265570|NCT02125578|Interferon beta-1a|interferon beta-1a|mesh-list
93265571|NCT02125578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265572|NCT02125578|Antiviral Agents|antiviral agents|mesh-ancestor
93265573|NCT02125578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265574|NCT02125578|Immunologic Factors|immunologic factors|mesh-ancestor
93265575|NCT02125578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265576|NCT02125578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93265577|NCT02122536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93265578|NCT02122536|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93265579|NCT02122536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93265580|NCT02122536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93265581|NCT02122536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265582|NCT02122536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265583|NCT02122536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93265584|NCT02122536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93265585|NCT02122536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265586|NCT02122536|Cholinergic Agents|cholinergic agents|mesh-ancestor
93265587|NCT02122536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265588|NCT05606965|Vaccines|vaccines|mesh-list
93265589|NCT05606965|Immunologic Factors|immunologic factors|mesh-ancestor
93265590|NCT05606965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265591|NCT03830359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93265592|NCT03830359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93265593|NCT00141284|Lamivudine|lamivudine|mesh-list
93265594|NCT00141284|Zidovudine|zidovudine|mesh-list
93265595|NCT00141284|Nelfinavir|nelfinavir|mesh-list
93265596|NCT00141284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93265597|NCT00141284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93265598|NCT00141284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265599|NCT00141284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265600|NCT00141284|Antiviral Agents|antiviral agents|mesh-ancestor
93265601|NCT00141284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265602|NCT00141284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93265603|NCT00141284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93265604|NCT00141284|Antimetabolites|antimetabolites|mesh-ancestor
93265605|NCT00141284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93265606|NCT00141284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93265607|NCT00141284|Protease Inhibitors|protease inhibitors|mesh-ancestor
93265608|NCT04328506|Vorolanib|vorolanib|mesh-list
93265609|NCT04328506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265610|NCT04328506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265611|NCT04328506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265612|NCT02125812|Moxifloxacin|moxifloxacin|mesh-list
93265613|NCT02125812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265614|NCT02125812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265615|NCT02125812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265616|NCT02125812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265617|NCT02125812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265618|NCT02125812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265619|NCT02125812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265620|NCT02125890|Tranexamic Acid|tranexamic acid|mesh-list
93265621|NCT02125890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93265622|NCT02125890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93265623|NCT02125890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265624|NCT02125890|Hemostatics|hemostatics|mesh-ancestor
93265625|NCT02125890|Coagulants|coagulants|mesh-ancestor
93265626|NCT05433116|Pembrolizumab|pembrolizumab|mesh-list
93265627|NCT05433116|Lenvatinib|lenvatinib|mesh-list
93265628|NCT05433116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265629|NCT05433116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265630|NCT05433116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93265631|NCT05433116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265632|NCT05433116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265633|NCT05433116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265634|NCT05287984|Cyclophosphamide|cyclophosphamide|mesh-list
93265635|NCT05287984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93265636|NCT05287984|Rituximab|rituximab|mesh-list
93265637|NCT05287984|Fludarabine|fludarabine|mesh-list
93265638|NCT05287984|Zanubrutinib|zanubrutinib|mesh-list
93265639|NCT05287984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265640|NCT05287984|Immunologic Factors|immunologic factors|mesh-ancestor
93265641|NCT05287984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265642|NCT05287984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265643|NCT05287984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93265644|NCT05287984|Alkylating Agents|alkylating agents|mesh-ancestor
93265645|NCT05287984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265646|NCT05287984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265647|NCT05287984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93265648|NCT05287984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265649|NCT05287984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265650|NCT05287984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265651|NCT02125968|Oxymetazoline|oxymetazoline|mesh-list
93265652|NCT02125968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93265653|NCT02125968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93265654|NCT02125968|Adrenergic Agents|adrenergic agents|mesh-ancestor
93265655|NCT02125968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265656|NCT02125968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265657|NCT02125968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265658|NCT02125968|Sympathomimetics|sympathomimetics|mesh-ancestor
93265659|NCT02125968|Autonomic Agents|autonomic agents|mesh-ancestor
93265660|NCT02125968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265661|NCT02125968|Nasal Decongestants|nasal decongestants|mesh-ancestor
93265662|NCT02125968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93265663|NCT02125968|Respiratory System Agents|respiratory system agents|mesh-ancestor
93265664|NCT00134264|Atorvastatin|atorvastatin|mesh-list
93265665|NCT00134264|Torcetrapib|torcetrapib|mesh-list
93265666|NCT00134264|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93265667|NCT00134264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93265668|NCT00134264|Antimetabolites|antimetabolites|mesh-ancestor
93265669|NCT00134264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265670|NCT00134264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93265671|NCT00134264|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93265672|NCT00134264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265673|NCT05285800|Bupivacaine|bupivacaine|mesh-list
93265674|NCT05285800|Anesthetics, Local|anesthetics, local|mesh-ancestor
93265675|NCT05285800|Anesthetics|anesthetics|mesh-ancestor
93265676|NCT05285800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265677|NCT05285800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265678|NCT05285800|Sensory System Agents|sensory system agents|mesh-ancestor
93265679|NCT05285800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265680|NCT02122692|Itraconazole|itraconazole|mesh-list
93265681|NCT02122692|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93265682|NCT02122692|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
93265683|NCT02122692|Antifungal Agents|antifungal agents|mesh-ancestor
93265684|NCT02122692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265685|NCT02122692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93265686|NCT02122692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93265687|NCT02122692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265688|NCT02122692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265689|NCT02122692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93265690|NCT02122692|Hormone Antagonists|hormone antagonists|mesh-ancestor
93265691|NCT02122692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265692|NCT02122692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265693|NCT02122692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93265694|NCT02122692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93265695|NCT02122692|Serotonin Agents|serotonin agents|mesh-ancestor
93265696|NCT02122692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265697|NCT00131924|Estrogens|estrogens|mesh-list
93265698|NCT00131924|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
93265699|NCT00131924|Hormones|hormones|mesh-ancestor
93265700|NCT00131924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265701|NCT00131924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265702|NCT05284474|Mitogens|mitogens|mesh-list
93265703|NCT05284474|Mitosis Modulators|mitosis modulators|mesh-ancestor
93265704|NCT05284474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265705|NCT05609695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93265706|NCT05609695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265707|NCT05609695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265708|NCT05609695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265709|NCT04246060|Cysteamine|cysteamine|mesh-list
93265710|NCT04246060|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
93265711|NCT04246060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265712|NCT05129176|Metronidazole|metronidazole|mesh-list
93265713|NCT05129176|Levofloxacin|levofloxacin|mesh-list
93265714|NCT05129176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265715|NCT05129176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265716|NCT05129176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93265717|NCT05129176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93265718|NCT05129176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93265719|NCT05129176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265720|NCT05129176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265721|NCT05129176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265722|NCT05129176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265723|NCT05129176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265724|NCT05129176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93265725|NCT05129176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93265726|NCT02127684|Ranibizumab|ranibizumab|mesh-list
93265727|NCT02127684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93265728|NCT02127684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93265729|NCT02127684|Growth Substances|growth substances|mesh-ancestor
93265730|NCT02127684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265731|NCT02127684|Growth Inhibitors|growth inhibitors|mesh-ancestor
93265732|NCT02127684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265733|NCT02126358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93265734|NCT02126358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93265735|NCT02126358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93265736|NCT02126358|Antimetabolites|antimetabolites|mesh-ancestor
93265737|NCT02126358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265738|NCT02126358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93265739|NCT02126358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93265740|NCT02126358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265741|NCT02127840|Epinephrine|epinephrine|mesh-list
93265742|NCT02127840|Racepinephrine|racepinephrine|mesh-list
93265743|NCT02127840|Epinephryl borate|epinephryl borate|mesh-list
93265744|NCT02127840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93265745|NCT02127840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93265746|NCT02127840|Adrenergic Agents|adrenergic agents|mesh-ancestor
93265747|NCT02127840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265748|NCT02127840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265749|NCT02127840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265750|NCT02127840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93265751|NCT02127840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93265752|NCT02127840|Autonomic Agents|autonomic agents|mesh-ancestor
93265753|NCT02127840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265754|NCT02127840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93265755|NCT02127840|Respiratory System Agents|respiratory system agents|mesh-ancestor
93265756|NCT02127840|Mydriatics|mydriatics|mesh-ancestor
93265757|NCT02127840|Sympathomimetics|sympathomimetics|mesh-ancestor
93265758|NCT02127840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93265759|NCT05031442|Zinc Oxide|zinc oxide|mesh-list
92560384|NCT00133744|Vitamin B Complex|vitamin b complex|mesh-list
93265760|NCT05031442|Dermatologic Agents|dermatologic agents|mesh-ancestor
93265761|NCT05031442|Sunscreening Agents|sunscreening agents|mesh-ancestor
93265762|NCT05031442|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93265763|NCT05031442|Protective Agents|protective agents|mesh-ancestor
93265764|NCT05031442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265765|NCT02127918|Clobazam|clobazam|mesh-list
93265766|NCT02127918|Anticonvulsants|anticonvulsants|mesh-ancestor
93265767|NCT02127918|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93265768|NCT02127918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93265769|NCT02127918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265770|NCT02127918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265771|NCT02127918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93265772|NCT02127918|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93265773|NCT02127918|GABA Agonists|gaba agonists|mesh-ancestor
93265774|NCT02127918|GABA Agents|gaba agents|mesh-ancestor
92937769|NCT00806871|Hormones|hormones|mesh-ancestor
93265775|NCT02127918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265776|NCT02127918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265777|NCT00127634|Insulin|insulin|mesh-list
93265778|NCT00127634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93265779|NCT00127634|Insulin Glargine|insulin glargine|mesh-list
93265780|NCT00127634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93265781|NCT00127634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265782|NCT02127996|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93265783|NCT02127996|Incretins|incretins|mesh-ancestor
93265784|NCT02127996|Hormones|hormones|mesh-ancestor
93265785|NCT02127996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265786|NCT02127996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265787|NCT02131350|Ranibizumab|ranibizumab|mesh-list
93265788|NCT02131350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93265789|NCT02131350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93265790|NCT02131350|Growth Substances|growth substances|mesh-ancestor
93265791|NCT02131350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265792|NCT02131350|Growth Inhibitors|growth inhibitors|mesh-ancestor
93265793|NCT02131350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265794|NCT02128308|Moxifloxacin|moxifloxacin|mesh-list
93265795|NCT02128308|Levofloxacin|levofloxacin|mesh-list
93265796|NCT02128308|Ofloxacin|ofloxacin|mesh-list
93265797|NCT02128308|Cycloserine|cycloserine|mesh-list
93265798|NCT02128308|Pyrazinamide|pyrazinamide|mesh-list
93265799|NCT02128308|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93265800|NCT02128308|Streptomycin|streptomycin|mesh-list
93265801|NCT02128308|Kanamycin|kanamycin|mesh-list
93265802|NCT02128308|Prothionamide|prothionamide|mesh-list
93265803|NCT02128308|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93265804|NCT02128308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265805|NCT02128308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265806|NCT02128308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265807|NCT02128308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265808|NCT02128308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265809|NCT02128308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265810|NCT02128308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265811|NCT02128308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93265812|NCT02128308|Contraceptive Agents|contraceptive agents|mesh-ancestor
93265813|NCT02128308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93265814|NCT02128308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265815|NCT02128308|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92560449|NCT00133822|Dopamine Agents|dopamine agents|mesh-ancestor
93265816|NCT02128308|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93265817|NCT02128308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93265818|NCT02128308|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93265819|NCT02128308|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93265820|NCT02128308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93265821|NCT02128308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93265822|NCT02128308|Antitubercular Agents|antitubercular agents|mesh-ancestor
93265823|NCT02128308|Antimetabolites|antimetabolites|mesh-ancestor
93265824|NCT02128308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93265825|NCT02131506|Lapatinib|lapatinib|mesh-list
93265826|NCT02131506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93265827|NCT02131506|Doxorubicin|doxorubicin|mesh-list
93265828|NCT02131506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265829|NCT02131506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265830|NCT02131506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265831|NCT02131506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265832|NCT02131506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93265833|NCT02131506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93265834|NCT02131506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93265835|NCT01674010|Inositol|inositol|mesh-list
93265836|NCT01674010|Lamotrigine|lamotrigine|mesh-list
93265837|NCT01674010|Valproic Acid|valproic acid|mesh-list
93265838|NCT01674010|Anticonvulsants|anticonvulsants|mesh-ancestor
93265839|NCT01674010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93265840|NCT01674010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93265841|NCT01674010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265842|NCT01674010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93265843|NCT01674010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265844|NCT01674010|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93265845|NCT01674010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93265846|NCT01674010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265847|NCT01674010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93265848|NCT01674010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93265849|NCT01674010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265850|NCT01674010|GABA Agents|gaba agents|mesh-ancestor
93265851|NCT01674010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265852|NCT01674010|Antimanic Agents|antimanic agents|mesh-ancestor
93265853|NCT01674010|Vitamin B Complex|vitamin b complex|mesh-ancestor
93265854|NCT01674010|Vitamins|vitamins|mesh-ancestor
93265855|NCT01674010|Micronutrients|micronutrients|mesh-ancestor
93265856|NCT02252328|Simvastatin|simvastatin|mesh-list
93265857|NCT02252328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93265858|NCT02252328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93265859|NCT02252328|Antimetabolites|antimetabolites|mesh-ancestor
93265860|NCT02252328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265861|NCT02252328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93265862|NCT02252328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93265863|NCT02252328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265864|NCT04656964|Midazolam|midazolam|mesh-list
93265865|NCT04656964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93265866|NCT04656964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93265867|NCT04656964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265868|NCT04656964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265869|NCT04656964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93265870|NCT04656964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93265871|NCT04656964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93265872|NCT04656964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93265873|NCT04656964|Anesthetics, General|anesthetics, general|mesh-ancestor
93265874|NCT04656964|Anesthetics|anesthetics|mesh-ancestor
93265875|NCT04656964|GABA Modulators|gaba modulators|mesh-ancestor
93265876|NCT04656964|GABA Agents|gaba agents|mesh-ancestor
93265877|NCT04656964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265878|NCT04656964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265879|NCT02136030|Amphotericin B|amphotericin b|mesh-list
93265880|NCT02136030|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93265881|NCT02136030|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
93265882|NCT02136030|Deoxycholic Acid|deoxycholic acid|mesh-list
93265883|NCT02136030|Amebicides|amebicides|mesh-ancestor
93265884|NCT02136030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93265885|NCT02136030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93265886|NCT02136030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265887|NCT02136030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92560501|NCT00080847|Doxorubicin|doxorubicin|mesh-list
93265888|NCT02136030|Antifungal Agents|antifungal agents|mesh-ancestor
93265889|NCT02136030|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93265890|NCT02136030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93265891|NCT02131818|Amoxicillin|amoxicillin|mesh-list
93265892|NCT02131818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265893|NCT02131818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265894|NCT04605796|Bevacizumab|bevacizumab|mesh-list
93265895|NCT04605796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265896|NCT04605796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265897|NCT04605796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93265898|NCT04605796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93265899|NCT04605796|Growth Substances|growth substances|mesh-ancestor
93265900|NCT04605796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265901|NCT04605796|Growth Inhibitors|growth inhibitors|mesh-ancestor
93265902|NCT01345669|Afatinib|afatinib|mesh-list
93265903|NCT01345669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265904|NCT01345669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265905|NCT01345669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265906|NCT01345669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265907|NCT04313608|Gemcitabine|gemcitabine|mesh-list
93265908|NCT04313608|Oxaliplatin|oxaliplatin|mesh-list
93265909|NCT04313608|Obinutuzumab|obinutuzumab|mesh-list
93265910|NCT04313608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93265911|NCT04313608|Antimetabolites|antimetabolites|mesh-ancestor
93265912|NCT04313608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265913|NCT04313608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265914|NCT04313608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265915|NCT04502264|Botulinum Toxins|botulinum toxins|mesh-list
93265916|NCT04502264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93265917|NCT04502264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93265918|NCT04502264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93265919|NCT04502264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93265920|NCT04502264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265921|NCT04502264|Cholinergic Agents|cholinergic agents|mesh-ancestor
93265922|NCT04502264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265923|NCT04502264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937914|NCT00631566|Mupirocin|mupirocin|mesh-list
93265924|NCT04502264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93265925|NCT04502264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93265926|NCT03527732|Ivermectin|ivermectin|mesh-list
93265927|NCT03527732|Albendazole|albendazole|mesh-list
93265928|NCT03527732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93265929|NCT03527732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265930|NCT03527732|Anthelmintics|anthelmintics|mesh-ancestor
93265931|NCT03527732|Anticestodal Agents|anticestodal agents|mesh-ancestor
93265932|NCT03527732|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93265933|NCT03527732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93265934|NCT03527732|Tubulin Modulators|tubulin modulators|mesh-ancestor
93265935|NCT03527732|Antimitotic Agents|antimitotic agents|mesh-ancestor
93265936|NCT03527732|Mitosis Modulators|mitosis modulators|mesh-ancestor
93265937|NCT03527732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265938|NCT03527732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265939|NCT01673854|Ipilimumab|ipilimumab|mesh-list
93265940|NCT01673854|Vemurafenib|vemurafenib|mesh-list
93265941|NCT01673854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93265942|NCT01673854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265943|NCT01673854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93265944|NCT01673854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265945|NCT01673854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93265946|NCT01673854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93265947|NCT03549702|Povidone-Iodine|povidone-iodine|mesh-list
93265948|NCT03549702|Povidone|povidone|mesh-list
93265949|NCT03549702|Plasma Substitutes|plasma substitutes|mesh-ancestor
93265950|NCT03549702|Blood Substitutes|blood substitutes|mesh-ancestor
93265951|NCT03549702|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93265952|NCT03549702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265953|NCT02529904|Vaccines|vaccines|mesh-list
93265954|NCT02529904|Immunologic Factors|immunologic factors|mesh-ancestor
93265955|NCT02529904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265956|NCT03099356|Sirolimus|sirolimus|mesh-list
93265957|NCT03099356|Cyclophosphamide|cyclophosphamide|mesh-list
93265958|NCT03099356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93265959|NCT03099356|Immunologic Factors|immunologic factors|mesh-ancestor
93265960|NCT03099356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265961|NCT03099356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93265962|NCT03099356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93265963|NCT03099356|Alkylating Agents|alkylating agents|mesh-ancestor
93265964|NCT03099356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265965|NCT03099356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93265966|NCT03099356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93265967|NCT03099356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93265968|NCT03099356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93265969|NCT03099356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93265970|NCT03099356|Antifungal Agents|antifungal agents|mesh-ancestor
93265971|NCT01367886|Fesoterodine|fesoterodine|mesh-list
93265972|NCT01367886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93265973|NCT01367886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93265974|NCT01367886|Cholinergic Agents|cholinergic agents|mesh-ancestor
93265975|NCT01367886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93265976|NCT01367886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265977|NCT01367886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265978|NCT01367886|Urological Agents|urological agents|mesh-ancestor
93265979|NCT05222191|Chlorthalidone|chlorthalidone|mesh-list
93265980|NCT05222191|Spironolactone|spironolactone|mesh-list
93265981|NCT05222191|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93265982|NCT05222191|Hormone Antagonists|hormone antagonists|mesh-ancestor
93265983|NCT05222191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93265984|NCT05222191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265985|NCT05222191|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93265986|NCT05222191|Diuretics|diuretics|mesh-ancestor
93265987|NCT05222191|Natriuretic Agents|natriuretic agents|mesh-ancestor
93265988|NCT05222191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93265989|NCT05222191|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93265990|NCT05222191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93265991|NCT05222191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93265992|NCT05706337|Propofol|propofol|mesh-list
93265993|NCT05706337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93265994|NCT05706337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93265995|NCT05706337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93265996|NCT05706337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93265997|NCT05706337|Anesthetics, General|anesthetics, general|mesh-ancestor
93265998|NCT05706337|Anesthetics|anesthetics|mesh-ancestor
93265999|NCT05222113|Remdesivir|remdesivir|mesh-list
93266000|NCT05222113|Favipiravir|favipiravir|mesh-list
93266001|NCT05222113|Antimetabolites|antimetabolites|mesh-ancestor
93266002|NCT05222113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266003|NCT05222113|Antiviral Agents|antiviral agents|mesh-ancestor
93266004|NCT05222113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266005|NCT03854578|Citalopram|citalopram|mesh-list
93266006|NCT03854578|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93266007|NCT03854578|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93266008|NCT03854578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93266009|NCT03854578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266010|NCT03854578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266011|NCT03854578|Serotonin Agents|serotonin agents|mesh-ancestor
93266012|NCT03854578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266013|NCT03854578|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93266014|NCT03854578|Antidepressive Agents|antidepressive agents|mesh-ancestor
93266015|NCT03854578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93266016|NCT03038594|Hormones|hormones|mesh-list
93266017|NCT03038594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266018|NCT03038594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266019|NCT02136888|Moxifloxacin|moxifloxacin|mesh-list
93266020|NCT02136888|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93266021|NCT02136888|Ponesimod|ponesimod|mesh-list
93266022|NCT02136888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266023|NCT02136888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266024|NCT02136888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93266025|NCT02136888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266026|NCT02136888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266027|NCT02136888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266028|NCT02136888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266029|NCT02136888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93266030|NCT02136888|Contraceptive Agents|contraceptive agents|mesh-ancestor
93266031|NCT02136888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93266032|NCT02136888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266033|NCT02136888|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93266034|NCT02136888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93266035|NCT02136888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93266036|NCT02136888|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93266037|NCT02136888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266038|NCT02136888|Immunologic Factors|immunologic factors|mesh-ancestor
93266039|NCT02132286|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93266040|NCT02132286|Antidepressive Agents|antidepressive agents|mesh-ancestor
93266041|NCT02132286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93266042|NCT02132286|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93266043|NCT02132286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93266044|NCT02132286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266045|NCT02132286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266046|NCT05252754|Indomethacin|indomethacin|mesh-list
93266047|NCT05252754|Tacrolimus|tacrolimus|mesh-list
93266048|NCT05252754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266049|NCT05252754|Immunologic Factors|immunologic factors|mesh-ancestor
93266050|NCT05252754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266051|NCT05252754|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93266052|NCT05252754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266053|NCT05252754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266054|NCT05252754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93266055|NCT05252754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266056|NCT05252754|Analgesics|analgesics|mesh-ancestor
93266057|NCT05252754|Sensory System Agents|sensory system agents|mesh-ancestor
93266058|NCT05252754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266059|NCT05252754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266060|NCT05252754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266061|NCT05252754|Gout Suppressants|gout suppressants|mesh-ancestor
93266062|NCT05252754|Tocolytic Agents|tocolytic agents|mesh-ancestor
93266063|NCT05252754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93266064|NCT05252754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93266065|NCT03548246|Hydrocortisone|hydrocortisone|mesh-list
93266066|NCT03548246|Fludrocortisone|fludrocortisone|mesh-list
93266067|NCT03548246|Abiraterone Acetate|abiraterone acetate|mesh-list
93266068|NCT03548246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266069|NCT03548246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266070|NCT03548246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93266071|NCT03548246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266072|NCT03548246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266074|NCT03548246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266075|NCT03548246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266076|NCT03548246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93266077|NCT02132442|Vitamin D|vitamin d|mesh-list
93266078|NCT02132442|Ergocalciferols|ergocalciferols|mesh-list
93266079|NCT02132442|Vitamins|vitamins|mesh-ancestor
93266080|NCT02132442|Micronutrients|micronutrients|mesh-ancestor
93266081|NCT02132442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266082|NCT02132442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93266083|NCT02132442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93266084|NCT05010148|Lidocaine|lidocaine|mesh-list
93266085|NCT05010148|Anesthetics, Local|anesthetics, local|mesh-ancestor
93266086|NCT05010148|Anesthetics|anesthetics|mesh-ancestor
93266087|NCT05010148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266088|NCT05010148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266089|NCT05010148|Sensory System Agents|sensory system agents|mesh-ancestor
93266090|NCT05010148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266091|NCT05010148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93266092|NCT05010148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93266093|NCT05010148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93266094|NCT05010148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560723|NCT00081042|Paclitaxel|paclitaxel|mesh-list
93266095|NCT05010148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266096|NCT05138146|Doxorubicin|doxorubicin|mesh-list
93266097|NCT05138146|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93266098|NCT05138146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93266099|NCT05138146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266100|NCT05138146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93266101|NCT05138146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266102|NCT05138146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266103|NCT05138146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266104|NCT05221879|Enoxaparin|enoxaparin|mesh-list
93266105|NCT05221879|Anticoagulants|anticoagulants|mesh-ancestor
93266106|NCT05221879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93266107|NCT05221879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93266108|NCT05221879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266109|NCT03450772|Pancrelipase|pancrelipase|mesh-list
93266110|NCT03450772|Pancreatin|pancreatin|mesh-list
93266111|NCT03450772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266112|NCT02129088|Esketamine|esketamine|mesh-list
93266113|NCT02129088|Antidepressive Agents|antidepressive agents|mesh-ancestor
93266114|NCT02129088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93266115|NCT05137522|Methylprednisolone|methylprednisolone|mesh-list
93266116|NCT05137522|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93266117|NCT05137522|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93266118|NCT05137522|Prednisolone|prednisolone|mesh-list
93266119|NCT05137522|Prednisolone acetate|prednisolone acetate|mesh-list
93266120|NCT05137522|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93266121|NCT05137522|Prednisolone phosphate|prednisolone phosphate|mesh-list
93266122|NCT05137522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266123|NCT05137522|Antiemetics|antiemetics|mesh-ancestor
93266124|NCT05137522|Autonomic Agents|autonomic agents|mesh-ancestor
93266125|NCT05137522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266126|NCT05137522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266127|NCT05137522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266128|NCT05137522|Glucocorticoids|glucocorticoids|mesh-ancestor
93266129|NCT05137522|Hormones|hormones|mesh-ancestor
93266130|NCT05137522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266131|NCT05137522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93266132|NCT05137522|Protective Agents|protective agents|mesh-ancestor
93266133|NCT05137522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93266134|NCT05137522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266135|NCT02129166|Imatinib Mesylate|imatinib mesylate|mesh-list
93266136|NCT02129166|Dasatinib|dasatinib|mesh-list
93266137|NCT02129166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266138|NCT02129166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93266139|NCT02129166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266140|NCT02129166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266141|NCT02137278|Antihypertensive Agents|antihypertensive agents|mesh-list
93266142|NCT02137278|Levodopa|levodopa|mesh-list
93266143|NCT02137278|Antipsychotic Agents|antipsychotic agents|mesh-list
93266144|NCT02137278|Antidepressive Agents|antidepressive agents|mesh-list
93266145|NCT02137278|Diuretics|diuretics|mesh-list
93266146|NCT02137278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93266147|NCT02137278|Natriuretic Agents|natriuretic agents|mesh-ancestor
93266148|NCT02137278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266149|NCT02137278|Dopamine Agents|dopamine agents|mesh-ancestor
93266150|NCT02137278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266151|NCT02137278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266152|NCT02137278|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93266153|NCT02137278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93266154|NCT02137278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93266155|NCT02137278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266157|NCT05705635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266158|NCT05705635|Tubulin Modulators|tubulin modulators|mesh-ancestor
93266159|NCT05705635|Antimitotic Agents|antimitotic agents|mesh-ancestor
93266160|NCT05705635|Mitosis Modulators|mitosis modulators|mesh-ancestor
93266161|NCT05705635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266162|NCT05204550|Heparin|heparin|mesh-list
93266163|NCT05204550|Calcium heparin|calcium heparin|mesh-list
93266164|NCT05204550|Anticoagulants|anticoagulants|mesh-ancestor
93266165|NCT05204550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93266166|NCT05204550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93266167|NCT05204550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266168|NCT00085774|Albuterol|albuterol|mesh-list
93266169|NCT00085774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93266170|NCT00085774|Autonomic Agents|autonomic agents|mesh-ancestor
93266171|NCT00085774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266172|NCT00085774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266173|NCT00085774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93266174|NCT00085774|Respiratory System Agents|respiratory system agents|mesh-ancestor
93266175|NCT00085774|Tocolytic Agents|tocolytic agents|mesh-ancestor
93266176|NCT00085774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93266177|NCT00085774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93266178|NCT00085774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93266179|NCT00085774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93266180|NCT00085774|Adrenergic Agents|adrenergic agents|mesh-ancestor
93266181|NCT00085774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266182|NCT00085774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266183|NCT04491682|Megestrol|megestrol|mesh-list
93266184|NCT04491682|Megestrol Acetate|megestrol acetate|mesh-list
93266185|NCT04491682|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93266186|NCT04491682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93266187|NCT04491682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93266188|NCT04491682|Antimetabolites|antimetabolites|mesh-ancestor
93266189|NCT04491682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266190|NCT04491682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93266191|NCT04491682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93266192|NCT04491682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266193|NCT04491682|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93266194|NCT04491682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93266195|NCT04491682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93266196|NCT04491682|Contraceptive Agents|contraceptive agents|mesh-ancestor
93266197|NCT04491682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93266198|NCT04491682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266199|NCT04491682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93266200|NCT04491682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93266201|NCT04491682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93266202|NCT04491682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266203|NCT04491682|Appetite Stimulants|appetite stimulants|mesh-ancestor
93266204|NCT04491682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93266205|NCT05193968|Nitroprusside|nitroprusside|mesh-list
93266206|NCT05193968|Norepinephrine|norepinephrine|mesh-list
93266207|NCT05193968|Acetylcholine|acetylcholine|mesh-list
93266208|NCT05193968|Terbutaline|terbutaline|mesh-list
93266209|NCT05193968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93266210|NCT05193968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93266211|NCT05193968|Adrenergic Agents|adrenergic agents|mesh-ancestor
93266212|NCT05193968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266213|NCT05193968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266214|NCT05193968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266215|NCT05193968|Sympathomimetics|sympathomimetics|mesh-ancestor
93266216|NCT05193968|Autonomic Agents|autonomic agents|mesh-ancestor
93266217|NCT05193968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266218|NCT05193968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93266219|NCT05193968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93266220|NCT05193968|Vasodilator Agents|vasodilator agents|mesh-ancestor
93266221|NCT05193968|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93266222|NCT05193968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93266223|NCT05193968|Cholinergic Agents|cholinergic agents|mesh-ancestor
93266224|NCT05193968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93266225|NCT05193968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93266226|NCT05193968|Respiratory System Agents|respiratory system agents|mesh-ancestor
93266227|NCT05193968|Tocolytic Agents|tocolytic agents|mesh-ancestor
93266228|NCT05193968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93266229|NCT05193968|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93266230|NCT05193968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93266231|NCT02137356|Capecitabine|capecitabine|mesh-list
93266232|NCT02137356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93266233|NCT02137356|Antimetabolites|antimetabolites|mesh-ancestor
93266234|NCT02137356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266235|NCT02137356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266236|NCT05137288|Atropine|atropine|mesh-list
93266237|NCT05137288|Ondansetron|ondansetron|mesh-list
93266238|NCT05137288|Bupivacaine|bupivacaine|mesh-list
93266239|NCT05137288|Anesthetics, Local|anesthetics, local|mesh-ancestor
93266240|NCT05137288|Anesthetics|anesthetics|mesh-ancestor
93266241|NCT05137288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266242|NCT05137288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266243|NCT05137288|Sensory System Agents|sensory system agents|mesh-ancestor
93266244|NCT05137288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266245|NCT05137288|Antiemetics|antiemetics|mesh-ancestor
93266246|NCT05137288|Autonomic Agents|autonomic agents|mesh-ancestor
93266247|NCT05137288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266248|NCT05137288|Antipruritics|antipruritics|mesh-ancestor
93266249|NCT05137288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93266250|NCT05137288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93266251|NCT05137288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93266252|NCT05137288|Serotonin Agents|serotonin agents|mesh-ancestor
93266253|NCT05137288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266254|NCT05137288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266255|NCT05137288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93266256|NCT05137288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93266257|NCT05137288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93266258|NCT05137288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93266259|NCT05137288|Respiratory System Agents|respiratory system agents|mesh-ancestor
93266260|NCT05137288|Mydriatics|mydriatics|mesh-ancestor
93266261|NCT05137288|Parasympatholytics|parasympatholytics|mesh-ancestor
93266262|NCT05137288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93266263|NCT05137288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93266264|NCT05137288|Cholinergic Agents|cholinergic agents|mesh-ancestor
93266265|NCT05135182|Metronidazole|metronidazole|mesh-list
93266266|NCT05135182|Furazolidone|furazolidone|mesh-list
93266267|NCT05135182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266268|NCT05135182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266269|NCT05135182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93266270|NCT05135182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93266271|NCT05135182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93266272|NCT05135182|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93266273|NCT05135182|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93266274|NCT05135182|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93266275|NCT05135182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266276|NCT05135182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266277|NCT02137434|Calcium, Dietary|calcium, dietary|mesh-list
93266278|NCT02137434|Calcium|calcium|mesh-list
93266279|NCT02137434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93266280|NCT02137434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266281|NCT02137434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93266282|NCT02137668|Vancomycin|vancomycin|mesh-list
93266283|NCT02137668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266284|NCT02137668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266285|NCT04216472|Paclitaxel|paclitaxel|mesh-list
93266286|NCT04216472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93266287|NCT04216472|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
93266288|NCT04216472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93266289|NCT04216472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266290|NCT04216472|Tubulin Modulators|tubulin modulators|mesh-ancestor
93266291|NCT04216472|Antimitotic Agents|antimitotic agents|mesh-ancestor
93266292|NCT04216472|Mitosis Modulators|mitosis modulators|mesh-ancestor
93266293|NCT04216472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266294|NCT04216472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266295|NCT03522428|Vitamin B 12|vitamin b 12|mesh-list
93266296|NCT03522428|Hydroxocobalamin|hydroxocobalamin|mesh-list
92938286|NCT00620542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266298|NCT03522428|Micronutrients|micronutrients|mesh-ancestor
93266299|NCT03522428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266300|NCT03522428|Vitamin B Complex|vitamin b complex|mesh-ancestor
93266301|NCT03522428|Hematinics|hematinics|mesh-ancestor
93266302|NCT05575999|Ketorolac|ketorolac|mesh-list
93266303|NCT05575999|Ketamine|ketamine|mesh-list
93266304|NCT05575999|Bupivacaine|bupivacaine|mesh-list
93266305|NCT05575999|Anesthetics, Local|anesthetics, local|mesh-ancestor
93266306|NCT05575999|Anesthetics|anesthetics|mesh-ancestor
93266307|NCT05575999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266308|NCT05575999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266309|NCT05575999|Sensory System Agents|sensory system agents|mesh-ancestor
93266310|NCT05575999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266311|NCT05575999|Analgesics|analgesics|mesh-ancestor
93266312|NCT05575999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93266313|NCT05575999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93266314|NCT05575999|Anesthetics, General|anesthetics, general|mesh-ancestor
93266315|NCT05575999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93266316|NCT05575999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93266317|NCT05575999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266318|NCT05575999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266319|NCT05575999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93266320|NCT05575999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266321|NCT05575999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266322|NCT05575999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266323|NCT05575999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93266324|NCT05575999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266325|NCT01062399|Everolimus|everolimus|mesh-list
93266326|NCT01062399|Temozolomide|temozolomide|mesh-list
93266327|NCT01062399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93266328|NCT01062399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93266329|NCT01062399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266330|NCT01062399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266331|NCT01062399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266332|NCT01062399|Immunologic Factors|immunologic factors|mesh-ancestor
93266333|NCT01062399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266334|NCT01062399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266335|NCT01062399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93266336|NCT01062399|Alkylating Agents|alkylating agents|mesh-ancestor
93266337|NCT05136508|Propofol|propofol|mesh-list
93266338|NCT05136508|Sevoflurane|sevoflurane|mesh-list
93266339|NCT05136508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93266340|NCT05136508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266341|NCT05136508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266342|NCT05136508|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93266343|NCT05136508|Anesthetics, General|anesthetics, general|mesh-ancestor
93266344|NCT05136508|Anesthetics|anesthetics|mesh-ancestor
93266345|NCT05136508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93266346|NCT05136508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93266347|NCT02129322|Oxaliplatin|oxaliplatin|mesh-list
93266348|NCT02129322|Sorafenib|sorafenib|mesh-list
93266349|NCT02129322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266350|NCT02129322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93266351|NCT02129322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266352|NCT02129322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266353|NCT05125978|Dipyrone|dipyrone|mesh-list
93266354|NCT05125978|Tramadol|tramadol|mesh-list
93266355|NCT05125978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93266356|NCT05125978|Narcotics|narcotics|mesh-ancestor
93266357|NCT05125978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266358|NCT05125978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266359|NCT05125978|Analgesics|analgesics|mesh-ancestor
93266360|NCT05125978|Sensory System Agents|sensory system agents|mesh-ancestor
93266361|NCT05125978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266362|NCT05125978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93266363|NCT05125978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266364|NCT05125978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266365|NCT05125978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266366|NCT05125978|Antipyretics|antipyretics|mesh-ancestor
93266367|NCT03767712|Antibodies|antibodies|mesh-list
93266368|NCT03767712|Antibodies, Antinuclear|antibodies, antinuclear|mesh-list
93266369|NCT03767712|Immunologic Factors|immunologic factors|mesh-ancestor
93266370|NCT03767712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266371|NCT05221411|Mycophenolic Acid|mycophenolic acid|mesh-list
93266372|NCT05221411|Tacrolimus|tacrolimus|mesh-list
93266373|NCT05221411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266374|NCT05221411|Immunologic Factors|immunologic factors|mesh-ancestor
93266375|NCT05221411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266376|NCT05221411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93266377|NCT05221411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266378|NCT05221411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266379|NCT05221411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93266380|NCT05221411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266381|NCT05221411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93266382|NCT05221411|Antitubercular Agents|antitubercular agents|mesh-ancestor
93266383|NCT05221411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266384|NCT05221411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266385|NCT05306002|Antioxidants|antioxidants|mesh-list
93266386|NCT05306002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266387|NCT05306002|Protective Agents|protective agents|mesh-ancestor
93266388|NCT05306002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266389|NCT04346914|Carboplatin|carboplatin|mesh-list
93266390|NCT04346914|Etoposide|etoposide|mesh-list
93266391|NCT04346914|Antibodies|antibodies|mesh-list
93266392|NCT04346914|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93266393|NCT04346914|Immunologic Factors|immunologic factors|mesh-ancestor
93266394|NCT04346914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266395|NCT04346914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266396|NCT04346914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93266397|NCT04346914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93266398|NCT04346914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266399|NCT04346914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266400|NCT04346914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266401|NCT02129400|Anesthetics|anesthetics|mesh-list
93266402|NCT02129400|Xenon|xenon|mesh-list
93266403|NCT02129400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266404|NCT02129400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266405|NCT02129400|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93266406|NCT02129400|Anesthetics, General|anesthetics, general|mesh-ancestor
93266407|NCT05305768|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93266408|NCT05305768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93266409|NCT05305768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266410|NCT05305768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266411|NCT05305768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93266412|NCT05305768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93266413|NCT05305768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266414|NCT05305768|Cholinergic Agents|cholinergic agents|mesh-ancestor
93266415|NCT05305768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266416|NCT02133378|Hemostatics|hemostatics|mesh-list
93266417|NCT02133378|Coagulants|coagulants|mesh-ancestor
93266418|NCT04171622|Pembrolizumab|pembrolizumab|mesh-list
93266419|NCT04171622|Lenvatinib|lenvatinib|mesh-list
93266420|NCT04171622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93266421|NCT04171622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266422|NCT04171622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93266423|NCT04171622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266424|NCT04171622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93266425|NCT04171622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266426|NCT05234580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93266427|NCT02138058|Topiramate|topiramate|mesh-list
93266428|NCT02138058|Anticonvulsants|anticonvulsants|mesh-ancestor
93266429|NCT02138058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93266430|NCT02138058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266431|NCT02129634|Paclitaxel|paclitaxel|mesh-list
93266432|NCT02129634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93266433|NCT02129634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266434|NCT02129634|Tubulin Modulators|tubulin modulators|mesh-ancestor
93266435|NCT02129634|Antimitotic Agents|antimitotic agents|mesh-ancestor
93266436|NCT02129634|Mitosis Modulators|mitosis modulators|mesh-ancestor
93266437|NCT02129634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266438|NCT05174455|Niraparib|niraparib|mesh-list
93266439|NCT05174455|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93266440|NCT05174455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266441|NCT05174455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266442|NCT05174455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266443|NCT05162053|Clopidogrel|clopidogrel|mesh-list
93266444|NCT05162053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93266445|NCT05162053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93266446|NCT05162053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93266447|NCT05162053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93266449|NCT05162053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266450|NCT05162053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266451|NCT05162053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266452|NCT02138292|Trametinib|trametinib|mesh-list
93266453|NCT02138292|Digoxin|digoxin|mesh-list
93266454|NCT02138292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266455|NCT02138292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93266456|NCT02138292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266457|NCT02138292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266458|NCT02138292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93266459|NCT02138292|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93266460|NCT02138292|Protective Agents|protective agents|mesh-ancestor
93266461|NCT02138292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266462|NCT02133612|Paclitaxel|paclitaxel|mesh-list
93266463|NCT02133612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93266464|NCT02133612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93266465|NCT02133612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266466|NCT02133612|Tubulin Modulators|tubulin modulators|mesh-ancestor
93266467|NCT02133612|Antimitotic Agents|antimitotic agents|mesh-ancestor
93266468|NCT02133612|Mitosis Modulators|mitosis modulators|mesh-ancestor
93266469|NCT02133612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266470|NCT03522194|Propofol|propofol|mesh-list
93266471|NCT03522194|Sevoflurane|sevoflurane|mesh-list
93266472|NCT03522194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93266473|NCT03522194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266474|NCT03522194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266475|NCT03522194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93266476|NCT03522194|Anesthetics, General|anesthetics, general|mesh-ancestor
93266477|NCT03522194|Anesthetics|anesthetics|mesh-ancestor
93266478|NCT03522194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93266479|NCT03522194|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93266480|NCT04820686|Tenofovir|tenofovir|mesh-list
93266481|NCT04820686|Entecavir|entecavir|mesh-list
93266482|NCT04820686|Antiviral Agents|antiviral agents|mesh-ancestor
93266483|NCT04820686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266484|NCT04820686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93266485|NCT04820686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93266486|NCT04820686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266487|NCT04820686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266488|NCT04820686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93266489|NCT04820686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93266490|NCT02260908|Enoxaparin|enoxaparin|mesh-list
93266491|NCT02260908|Anticoagulants|anticoagulants|mesh-ancestor
93266492|NCT02260908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93266493|NCT02260908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93266494|NCT02260908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266495|NCT02969655|Darbepoetin alfa|darbepoetin alfa|mesh-list
93266496|NCT02969655|Glycine|glycine|mesh-list
93266497|NCT02969655|Hematinics|hematinics|mesh-ancestor
93266498|NCT02969655|Glycine Agents|glycine agents|mesh-ancestor
93266499|NCT02969655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266500|NCT02969655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266501|NCT02969655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266502|NCT04488874|Mannitol|mannitol|mesh-list
93266503|NCT04488874|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93266504|NCT04488874|Diuretics|diuretics|mesh-ancestor
93266505|NCT04488874|Natriuretic Agents|natriuretic agents|mesh-ancestor
93266506|NCT04488874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266507|NCT03651219|Irinotecan|irinotecan|mesh-list
93266508|NCT03651219|Apatinib|apatinib|mesh-list
93266509|NCT03651219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93266510|NCT03651219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266511|NCT03651219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266512|NCT03651219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266513|NCT03651219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266514|NCT03651219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93266515|NCT02648698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93266516|NCT02648698|Levofloxacin|levofloxacin|mesh-list
93266517|NCT02648698|Tinidazole|tinidazole|mesh-list
93266518|NCT02648698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266519|NCT02648698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93266520|NCT02648698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93266521|NCT02648698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266522|NCT02648698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938512|NCT05679908|Oxytocin|oxytocin|mesh-list
93266523|NCT02648698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266524|NCT02648698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266525|NCT02648698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93266526|NCT02648698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93266527|NCT02648698|Alkylating Agents|alkylating agents|mesh-ancestor
93266528|NCT02648698|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93266529|NCT02648698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93266530|NCT02648698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93266531|NCT04059458|Calcium, Dietary|calcium, dietary|mesh-list
93266532|NCT04059458|Calcium|calcium|mesh-list
93266533|NCT04059458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93266534|NCT04059458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266535|NCT04059458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93266536|NCT05304598|Dexmedetomidine|dexmedetomidine|mesh-list
93266537|NCT05304598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93266538|NCT05304598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266539|NCT05304598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266540|NCT05304598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266541|NCT05304598|Analgesics|analgesics|mesh-ancestor
93266542|NCT05304598|Sensory System Agents|sensory system agents|mesh-ancestor
93266543|NCT05304598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266544|NCT05304598|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93266545|NCT05304598|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93266546|NCT05304598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93266547|NCT05304598|Adrenergic Agents|adrenergic agents|mesh-ancestor
93266548|NCT05304598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266549|NCT05304598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266550|NCT03524846|Vitamins|vitamins|mesh-list
93266551|NCT03524846|Ascorbic Acid|ascorbic acid|mesh-list
93266552|NCT03524846|Micronutrients|micronutrients|mesh-ancestor
93266553|NCT03524846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266554|NCT03524846|Antioxidants|antioxidants|mesh-ancestor
93266555|NCT03524846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266556|NCT03524846|Protective Agents|protective agents|mesh-ancestor
93266557|NCT05134558|Xenon|xenon|mesh-list
93266558|NCT05134558|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93266559|NCT05134558|Anesthetics, General|anesthetics, general|mesh-ancestor
93266560|NCT05134558|Anesthetics|anesthetics|mesh-ancestor
93266561|NCT05134558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266562|NCT05134558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266563|NCT02970669|Valsartan|valsartan|mesh-list
93266564|NCT02970669|Enalapril|enalapril|mesh-list
93266565|NCT02970669|Enalaprilat|enalaprilat|mesh-list
93266566|NCT02970669|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93266567|NCT02970669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93266568|NCT02970669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93266569|NCT02970669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93266570|NCT02970669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266571|NCT02970669|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93266572|NCT02970669|Protease Inhibitors|protease inhibitors|mesh-ancestor
93266573|NCT02970669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266574|NCT02134002|Disulfiram|disulfiram|mesh-list
93266575|NCT02134002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93266576|NCT02134002|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93266577|NCT02134002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266578|NCT02134002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266579|NCT03650361|Adapalene|adapalene|mesh-list
93266580|NCT03650361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93266581|NCT03650361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266582|NCT03650361|Analgesics|analgesics|mesh-ancestor
93266583|NCT03650361|Sensory System Agents|sensory system agents|mesh-ancestor
93266584|NCT03650361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266585|NCT03650361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266586|NCT03650361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266587|NCT03650361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266588|NCT03650361|Dermatologic Agents|dermatologic agents|mesh-ancestor
93266589|NCT02138994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92561230|NCT04732104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93266590|NCT02138994|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
93266591|NCT02138994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266592|NCT02138994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93266593|NCT05303818|Rivaroxaban|rivaroxaban|mesh-list
93266594|NCT05303818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93266595|NCT05303818|Antithrombins|antithrombins|mesh-ancestor
93266596|NCT05303818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93266597|NCT05303818|Protease Inhibitors|protease inhibitors|mesh-ancestor
93266598|NCT05303818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266599|NCT05303818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266601|NCT02902965|Dexamethasone|dexamethasone|mesh-list
93266602|NCT02902965|Bortezomib|bortezomib|mesh-list
93266603|NCT02902965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266604|NCT02902965|Antiemetics|antiemetics|mesh-ancestor
93266605|NCT02902965|Autonomic Agents|autonomic agents|mesh-ancestor
93266606|NCT02902965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266607|NCT02902965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266608|NCT02902965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266609|NCT02902965|Glucocorticoids|glucocorticoids|mesh-ancestor
93266610|NCT02902965|Hormones|hormones|mesh-ancestor
93266611|NCT02902965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266612|NCT02902965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93266613|NCT02902965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266614|NCT02130414|Cyclosporine|cyclosporine|mesh-list
93266615|NCT02130414|Cyclosporins|cyclosporins|mesh-list
93266616|NCT02130414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266617|NCT02130414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266618|NCT02130414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266619|NCT02130414|Immunologic Factors|immunologic factors|mesh-ancestor
93266620|NCT02130414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266621|NCT02130414|Antifungal Agents|antifungal agents|mesh-ancestor
93266622|NCT02130414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266623|NCT02130414|Dermatologic Agents|dermatologic agents|mesh-ancestor
93266624|NCT02130414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266625|NCT02130414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93266626|NCT02902809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93266627|NCT02902809|Immunologic Factors|immunologic factors|mesh-ancestor
93266628|NCT02902809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266629|NCT02134470|Testosterone|testosterone|mesh-list
93266630|NCT02134470|Androgens|androgens|mesh-ancestor
93266631|NCT02134470|Hormones|hormones|mesh-ancestor
93266632|NCT02134470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266633|NCT02134470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266634|NCT02134626|Simvastatin|simvastatin|mesh-list
93266635|NCT02134626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93266636|NCT02134626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93266637|NCT02134626|Antimetabolites|antimetabolites|mesh-ancestor
93266638|NCT02134626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266639|NCT02134626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93266640|NCT02134626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93266641|NCT02134626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266642|NCT02969187|Bupivacaine|bupivacaine|mesh-list
93266643|NCT02969187|Anesthetics, Local|anesthetics, local|mesh-ancestor
93266644|NCT02969187|Anesthetics|anesthetics|mesh-ancestor
93266645|NCT02969187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266646|NCT02969187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266647|NCT02969187|Sensory System Agents|sensory system agents|mesh-ancestor
93266648|NCT02969187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266649|NCT04893655|Dobutamine|dobutamine|mesh-list
93266650|NCT04893655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93266651|NCT04893655|Sympathomimetics|sympathomimetics|mesh-ancestor
93266652|NCT04893655|Autonomic Agents|autonomic agents|mesh-ancestor
93266653|NCT04893655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266654|NCT04893655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266655|NCT04893655|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93266656|NCT04893655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93266657|NCT04893655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93266658|NCT04893655|Adrenergic Agents|adrenergic agents|mesh-ancestor
93266659|NCT04893655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266660|NCT04893655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266661|NCT04893655|Protective Agents|protective agents|mesh-ancestor
93266662|NCT02139618|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93266663|NCT02139618|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93266664|NCT02139618|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93266665|NCT02139618|Dermatologic Agents|dermatologic agents|mesh-ancestor
93266666|NCT05285085|Atorvastatin|atorvastatin|mesh-list
93266667|NCT05285085|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93266668|NCT05285085|Simvastatin|simvastatin|mesh-list
93266669|NCT05285085|Pravastatin|pravastatin|mesh-list
93266670|NCT05285085|Pitavastatin|pitavastatin|mesh-list
93266671|NCT05285085|Lovastatin|lovastatin|mesh-list
93266672|NCT05285085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93266673|NCT05285085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93266674|NCT05285085|Antimetabolites|antimetabolites|mesh-ancestor
93266675|NCT05285085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266676|NCT05285085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93266677|NCT05285085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93266678|NCT05285085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266679|NCT02139930|Nicotine|nicotine|mesh-list
93266680|NCT02139930|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93266681|NCT02139930|Autonomic Agents|autonomic agents|mesh-ancestor
93266682|NCT02139930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266683|NCT02139930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266684|NCT02139930|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93266685|NCT02139930|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93266686|NCT02139930|Cholinergic Agents|cholinergic agents|mesh-ancestor
93266687|NCT02139930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266688|NCT02139930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266689|NCT04843111|Vaccines|vaccines|mesh-list
93266690|NCT04843111|Immunologic Factors|immunologic factors|mesh-ancestor
93266691|NCT04843111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266692|NCT02130804|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
93266693|NCT02130804|Salicylates|salicylates|mesh-list
93266694|NCT02130804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93266695|NCT02130804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266696|NCT02130804|Analgesics|analgesics|mesh-ancestor
93266697|NCT02130804|Sensory System Agents|sensory system agents|mesh-ancestor
93266698|NCT02130804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266699|NCT02130804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266700|NCT02130804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266701|NCT02130804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266702|NCT02130804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93266703|NCT02130804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266704|NCT02130804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266705|NCT05303272|Mycophenolic Acid|mycophenolic acid|mesh-list
93266706|NCT05303272|Abatacept|abatacept|mesh-list
93266707|NCT05303272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93266708|NCT05303272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266709|NCT05303272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93266710|NCT05303272|Antitubercular Agents|antitubercular agents|mesh-ancestor
93266711|NCT05303272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266712|NCT05303272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266713|NCT05303272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266714|NCT05303272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266715|NCT05303272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93266716|NCT05303272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93266717|NCT05303272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266718|NCT05303272|Immunologic Factors|immunologic factors|mesh-ancestor
93266719|NCT05303272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266720|NCT05303272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266721|NCT03549312|Tenofovir|tenofovir|mesh-list
93266722|NCT03549312|Emtricitabine|emtricitabine|mesh-list
93266723|NCT03549312|Sofosbuvir|sofosbuvir|mesh-list
93266724|NCT03549312|Cobicistat|cobicistat|mesh-list
93266725|NCT03549312|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93266726|NCT03549312|Velpatasvir|velpatasvir|mesh-list
93266727|NCT03549312|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93266728|NCT03549312|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93266729|NCT03549312|Elvitegravir|elvitegravir|mesh-list
93266730|NCT03549312|Antiviral Agents|antiviral agents|mesh-ancestor
93266731|NCT03549312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266732|NCT03549312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93266733|NCT03549312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93266734|NCT03549312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561361|NCT00081744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266735|NCT03549312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266736|NCT03549312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93266737|NCT03549312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93266738|NCT03549312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93266739|NCT03549312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93266740|NCT03549312|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93266741|NCT03649269|Bezafibrate|bezafibrate|mesh-list
93266742|NCT03649269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93266743|NCT03649269|Antimetabolites|antimetabolites|mesh-ancestor
93266744|NCT03649269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266745|NCT03649269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93266746|NCT02134938|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93266747|NCT02134938|Cathartics|cathartics|mesh-ancestor
93266748|NCT02134938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266750|NCT05373446|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93266751|NCT05373446|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93266752|NCT05373446|Protease Inhibitors|protease inhibitors|mesh-ancestor
93266753|NCT05373446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266754|NCT05373446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266755|NCT05373446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93266756|NCT05373446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93266757|NCT05373446|Antiviral Agents|antiviral agents|mesh-ancestor
93266758|NCT05373446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266759|NCT05373446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93266760|NCT05373446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93266761|NCT04734028|Clopidogrel|clopidogrel|mesh-list
93266762|NCT04734028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266763|NCT04734028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266764|NCT04734028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93266765|NCT04734028|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93266766|NCT04734028|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93266767|NCT04734028|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93266768|NCT04734028|Purinergic Agents|purinergic agents|mesh-ancestor
93266769|NCT04734028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266770|NCT05285397|Liraglutide|liraglutide|mesh-list
93266771|NCT05285397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93266772|NCT05285397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266773|NCT05285397|Incretins|incretins|mesh-ancestor
93266774|NCT05285397|Hormones|hormones|mesh-ancestor
93266775|NCT05285397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266776|NCT03050359|Lansoprazole|lansoprazole|mesh-list
93266777|NCT03050359|Dexlansoprazole|dexlansoprazole|mesh-list
93266778|NCT03050359|Bismuth|bismuth|mesh-list
93266779|NCT03050359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93266780|NCT03050359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266781|NCT03050359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93266782|NCT03050359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266783|NCT03050359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266784|NCT03050359|Antacids|antacids|mesh-ancestor
93266785|NCT02140242|Daunorubicin|daunorubicin|mesh-list
93266786|NCT02140242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93266787|NCT02140242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266788|NCT02140242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93266789|NCT02140242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266790|NCT02140242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266791|NCT02140242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266792|NCT05302726|Estrogens|estrogens|mesh-list
93266793|NCT05302726|Hormones|hormones|mesh-ancestor
93266794|NCT05302726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266795|NCT05302726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266796|NCT02253264|Rituximab|rituximab|mesh-list
93266797|NCT02253264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93266798|NCT02253264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266799|NCT02253264|Immunologic Factors|immunologic factors|mesh-ancestor
93266800|NCT02253264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266801|NCT02253264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93266802|NCT03648333|Niacin|niacin|mesh-list
93266803|NCT03648333|Amlodipine|amlodipine|mesh-list
93266804|NCT03648333|Valsartan|valsartan|mesh-list
93266805|NCT03648333|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
93266806|NCT03648333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93266807|NCT03648333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93266808|NCT03648333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93266809|NCT03648333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266810|NCT03648333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93266811|NCT03648333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266812|NCT03648333|Vasodilator Agents|vasodilator agents|mesh-ancestor
93266813|NCT03648333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93266814|NCT03648333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93266815|NCT03648333|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93266816|NCT03648333|Antimetabolites|antimetabolites|mesh-ancestor
93266817|NCT03648333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92938816|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
93266819|NCT03648333|Vitamins|vitamins|mesh-ancestor
93266820|NCT03648333|Micronutrients|micronutrients|mesh-ancestor
93266821|NCT02252796|Paclitaxel|paclitaxel|mesh-list
93266822|NCT02252796|Carboplatin|carboplatin|mesh-list
93266823|NCT02252796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93266824|NCT02252796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266825|NCT02252796|Tubulin Modulators|tubulin modulators|mesh-ancestor
93266826|NCT02252796|Antimitotic Agents|antimitotic agents|mesh-ancestor
93266827|NCT02252796|Mitosis Modulators|mitosis modulators|mesh-ancestor
93266828|NCT02252796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266829|NCT02785770|Moxifloxacin|moxifloxacin|mesh-list
93266830|NCT02785770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266831|NCT02785770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266832|NCT02785770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93266833|NCT02785770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93266834|NCT02785770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266835|NCT02785770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266836|NCT02785770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266837|NCT04166474|Dolutegravir|dolutegravir|mesh-list
93266838|NCT04166474|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93266839|NCT04166474|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93266840|NCT04166474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266841|NCT04166474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266842|NCT04166474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93266843|NCT04166474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93266844|NCT04166474|Antiviral Agents|antiviral agents|mesh-ancestor
93266845|NCT04166474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266846|NCT04660123|Bismuth|bismuth|mesh-list
93266847|NCT04660123|Antacids|antacids|mesh-ancestor
93266848|NCT04660123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266849|NCT04660123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93266850|NCT04530136|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93266851|NCT04530136|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93266852|NCT04530136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266853|NCT04530136|Immunologic Factors|immunologic factors|mesh-ancestor
93266854|NCT04530136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266855|NCT02965833|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93266856|NCT02965833|Contact Lens Solutions|contact lens solutions|mesh-list
93266857|NCT02965833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93266858|NCT02965833|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93266859|NCT02965833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266860|NCT02965833|Disinfectants|disinfectants|mesh-ancestor
93266861|NCT05579418|Evolocumab|evolocumab|mesh-list
93266862|NCT05579418|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93266863|NCT05579418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93266864|NCT05579418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93266865|NCT05579418|Antimetabolites|antimetabolites|mesh-ancestor
93266866|NCT05579418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266867|NCT05579418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93266868|NCT05579418|Protease Inhibitors|protease inhibitors|mesh-ancestor
93266869|NCT05579418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266870|NCT05579418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93266871|NCT02968173|Palivizumab|palivizumab|mesh-list
93266872|NCT02968173|Antiviral Agents|antiviral agents|mesh-ancestor
93266873|NCT02968173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266874|NCT02135640|Denosumab|denosumab|mesh-list
93266875|NCT02135640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93266876|NCT02135640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266877|NCT02784834|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93266878|NCT02784834|Dermatologic Agents|dermatologic agents|mesh-ancestor
93266879|NCT02784834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93266880|NCT02784834|Immunologic Factors|immunologic factors|mesh-ancestor
93266881|NCT02784834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266882|NCT02253342|Levonadifloxacin|levonadifloxacin|mesh-list
93266883|NCT02253342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93266884|NCT02253342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266885|NCT02253342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266886|NCT02253342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93266887|NCT02253342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266888|NCT04038099|Lidocaine|lidocaine|mesh-list
93266889|NCT04038099|Anesthetics, Local|anesthetics, local|mesh-ancestor
93266890|NCT04038099|Anesthetics|anesthetics|mesh-ancestor
93266891|NCT04038099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266892|NCT04038099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266893|NCT04038099|Sensory System Agents|sensory system agents|mesh-ancestor
93266894|NCT04038099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266896|NCT04038099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93266897|NCT04038099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93266898|NCT04038099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93266899|NCT04038099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266900|NCT00495508|Lumefantrine|lumefantrine|mesh-list
93266901|NCT00495508|Artemether|artemether|mesh-list
93266902|NCT00495508|Quinine|quinine|mesh-list
93266903|NCT00495508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93266904|NCT00495508|Antimalarials|antimalarials|mesh-ancestor
93266905|NCT00495508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93266906|NCT00495508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93266907|NCT00495508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266908|NCT00495508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93266909|NCT00495508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266910|NCT00495508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93266911|NCT00495508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266912|NCT00495508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93266913|NCT00495508|Analgesics|analgesics|mesh-ancestor
93266914|NCT00495508|Sensory System Agents|sensory system agents|mesh-ancestor
93266915|NCT01554046|Methylphenidate|methylphenidate|mesh-list
93266916|NCT01554046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93266917|NCT01554046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266918|NCT01554046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93266919|NCT01554046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93266920|NCT01554046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93266921|NCT01554046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266922|NCT01554046|Dopamine Agents|dopamine agents|mesh-ancestor
93266923|NCT01554046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266924|NCT05284851|Vaccines|vaccines|mesh-list
93266925|NCT05284851|Immunologic Factors|immunologic factors|mesh-ancestor
93266926|NCT05284851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266927|NCT03049735|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93266928|NCT03049735|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93266929|NCT03049735|Norethindrone|norethindrone|mesh-list
93266930|NCT03049735|Norethindrone Acetate|norethindrone acetate|mesh-list
93266931|NCT03049735|Estradiol|estradiol|mesh-list
93266932|NCT03049735|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93266933|NCT03049735|Relugolix|relugolix|mesh-list
93266934|NCT03049735|Estrogens|estrogens|mesh-ancestor
93266935|NCT03049735|Hormones|hormones|mesh-ancestor
93266936|NCT03049735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266937|NCT03049735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266938|NCT03049735|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93266939|NCT03049735|Contraceptive Agents|contraceptive agents|mesh-ancestor
93266940|NCT03049735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93266941|NCT03049735|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93266942|NCT03049735|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93266943|NCT03049735|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93266944|NCT03049735|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93266945|NCT03049735|Androgen Antagonists|androgen antagonists|mesh-ancestor
93266946|NCT03049735|Hormone Antagonists|hormone antagonists|mesh-ancestor
93266947|NCT04785638|Bupivacaine|bupivacaine|mesh-list
93266948|NCT04785638|Anesthetics, Local|anesthetics, local|mesh-ancestor
93266949|NCT04785638|Anesthetics|anesthetics|mesh-ancestor
93266950|NCT04785638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93266951|NCT04785638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266952|NCT04785638|Sensory System Agents|sensory system agents|mesh-ancestor
93266953|NCT04785638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266954|NCT04762472|Montelukast|montelukast|mesh-list
93266955|NCT04762472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93266956|NCT04762472|Respiratory System Agents|respiratory system agents|mesh-ancestor
93266957|NCT04762472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93266958|NCT04762472|Hormone Antagonists|hormone antagonists|mesh-ancestor
93266959|NCT04762472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93266960|NCT04762472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266961|NCT04762472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93266962|NCT04762472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93266963|NCT04762472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266964|NCT01295944|Bevacizumab|bevacizumab|mesh-list
93266965|NCT01295944|Carboplatin|carboplatin|mesh-list
92938961|NCT04692623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93266966|NCT01295944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93266967|NCT01295944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93266968|NCT01295944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93266969|NCT01295944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93266970|NCT01295944|Growth Substances|growth substances|mesh-ancestor
93266971|NCT01295944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266972|NCT01295944|Growth Inhibitors|growth inhibitors|mesh-ancestor
93266973|NCT04742348|Levodopa|levodopa|mesh-list
93266974|NCT04742348|Carbidopa|carbidopa|mesh-list
93266975|NCT04742348|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93266976|NCT04742348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93266977|NCT04742348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93266978|NCT04742348|Dopamine Agents|dopamine agents|mesh-ancestor
93266979|NCT04742348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93266980|NCT04742348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93266981|NCT04742348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266982|NCT04742348|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93266983|NCT04742348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93266984|NCT04742348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93266985|NCT04742348|Immunologic Factors|immunologic factors|mesh-ancestor
93266986|NCT04742348|Dopamine Agonists|dopamine agonists|mesh-ancestor
93266987|NCT02140632|Methylprednisolone|methylprednisolone|mesh-list
93266988|NCT02140632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93266989|NCT02140632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93266990|NCT02140632|Prednisolone|prednisolone|mesh-list
93266991|NCT02140632|Prednisolone acetate|prednisolone acetate|mesh-list
93266992|NCT02140632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93266993|NCT02140632|Prednisolone phosphate|prednisolone phosphate|mesh-list
93266994|NCT02140632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93266995|NCT02140632|Antiemetics|antiemetics|mesh-ancestor
93266996|NCT02140632|Autonomic Agents|autonomic agents|mesh-ancestor
93266997|NCT02140632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93266998|NCT02140632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93266999|NCT02140632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267000|NCT02140632|Glucocorticoids|glucocorticoids|mesh-ancestor
93267001|NCT02140632|Hormones|hormones|mesh-ancestor
93267002|NCT02140632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267003|NCT02140632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93267004|NCT02140632|Protective Agents|protective agents|mesh-ancestor
93267005|NCT02140632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93267006|NCT02140632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267007|NCT04712942|Azacitidine|azacitidine|mesh-list
93267008|NCT04712942|Pevonedistat|pevonedistat|mesh-list
93267009|NCT04712942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93267010|NCT04712942|Antimetabolites|antimetabolites|mesh-ancestor
93267011|NCT04712942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267012|NCT04712942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267013|NCT04712942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267014|NCT05578404|Cholecalciferol|cholecalciferol|mesh-list
93267015|NCT05578404|Vitamin D|vitamin d|mesh-list
93267016|NCT05578404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93267017|NCT05578404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267018|NCT05578404|Vitamins|vitamins|mesh-ancestor
93267019|NCT05578404|Micronutrients|micronutrients|mesh-ancestor
93267020|NCT05578404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93267021|NCT04848584|Vaccines|vaccines|mesh-list
93267022|NCT04848584|Immunologic Factors|immunologic factors|mesh-ancestor
93267023|NCT04848584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267024|NCT03521960|Buspirone|buspirone|mesh-list
93267025|NCT03521960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93267026|NCT03521960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93267027|NCT03521960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267028|NCT03521960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267029|NCT03521960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267030|NCT03521960|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93267031|NCT03521960|Serotonin Agents|serotonin agents|mesh-ancestor
93267032|NCT03521960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267033|NCT03521960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267034|NCT05479578|Dexamethasone|dexamethasone|mesh-list
93267035|NCT05479578|Dexamethasone acetate|dexamethasone acetate|mesh-list
93267036|NCT05479578|Cyclophosphamide|cyclophosphamide|mesh-list
93267037|NCT05479578|Ichthammol|ichthammol|mesh-list
93267038|NCT05479578|BB 1101|bb 1101|mesh-list
93267039|NCT05479578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267040|NCT05479578|Immunologic Factors|immunologic factors|mesh-ancestor
93267041|NCT05479578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267042|NCT05479578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267043|NCT05479578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93267044|NCT05479578|Alkylating Agents|alkylating agents|mesh-ancestor
93267045|NCT05479578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267046|NCT05479578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267047|NCT05479578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93267048|NCT05479578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267049|NCT05479578|Antiemetics|antiemetics|mesh-ancestor
93267050|NCT05479578|Autonomic Agents|autonomic agents|mesh-ancestor
93267051|NCT05479578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267052|NCT05479578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267053|NCT05479578|Glucocorticoids|glucocorticoids|mesh-ancestor
93267054|NCT05479578|Hormones|hormones|mesh-ancestor
93267055|NCT05479578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267056|NCT05479578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93267057|NCT05479578|Protease Inhibitors|protease inhibitors|mesh-ancestor
93267058|NCT05479578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267059|NCT05479578|Dermatologic Agents|dermatologic agents|mesh-ancestor
93267060|NCT02899377|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
93267061|NCT02899377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267062|NCT02899377|Chelating Agents|chelating agents|mesh-ancestor
93267063|NCT02899377|Sequestering Agents|sequestering agents|mesh-ancestor
93267064|NCT05363462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93267065|NCT05363462|Vancomycin|vancomycin|mesh-list
93267066|NCT05363462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267067|NCT04853628|Ethanol|ethanol|mesh-list
93267068|NCT04853628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93267069|NCT04853628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267070|NCT04853628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267071|NCT04853628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267072|NCT03521726|Amoxicillin|amoxicillin|mesh-list
93267073|NCT03521726|Rabeprazole|rabeprazole|mesh-list
93267074|NCT03521726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267075|NCT03521726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267076|NCT03521726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93267077|NCT03521726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267078|NCT03521726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93267079|NCT03521726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267080|NCT03521726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267081|NCT03546426|Pembrolizumab|pembrolizumab|mesh-list
93267082|NCT03546426|Interleukin-2|interleukin-2|mesh-list
93267083|NCT03546426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267084|NCT03546426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267085|NCT03546426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267086|NCT03546426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267087|NCT03546426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267088|NCT03546426|Analgesics|analgesics|mesh-ancestor
93267089|NCT03546426|Sensory System Agents|sensory system agents|mesh-ancestor
93267090|NCT03546426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267091|NCT03546426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267092|NCT02897349|Linagliptin|linagliptin|mesh-list
93267093|NCT02897349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93267094|NCT02897349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267095|NCT02897349|Incretins|incretins|mesh-ancestor
93267096|NCT02897349|Hormones|hormones|mesh-ancestor
93267097|NCT02897349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267098|NCT02897349|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93267099|NCT02897349|Protease Inhibitors|protease inhibitors|mesh-ancestor
93267100|NCT02897349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267101|NCT02897349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267102|NCT03134378|Amoxicillin|amoxicillin|mesh-list
93267103|NCT03134378|Clarithromycin|clarithromycin|mesh-list
93267104|NCT03134378|Rabeprazole|rabeprazole|mesh-list
93267105|NCT03134378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267106|NCT03134378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267107|NCT03134378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93267108|NCT03134378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267109|NCT03134378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561752|NCT00049088|Tubulin Modulators|tubulin modulators|mesh-ancestor
93267110|NCT03134378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93267111|NCT03134378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93267112|NCT03134378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93267113|NCT03134378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267114|NCT03134378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93267115|NCT05434104|Metronidazole|metronidazole|mesh-list
93267116|NCT05434104|Fluconazole|fluconazole|mesh-list
93267117|NCT05434104|Lactoferrin|lactoferrin|mesh-list
93267118|NCT05434104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267119|NCT05434104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267120|NCT05434104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93267121|NCT05434104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93267122|NCT05434104|Antifungal Agents|antifungal agents|mesh-ancestor
93267123|NCT05434104|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93267124|NCT05434104|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93267125|NCT05434104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267126|NCT05434104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267127|NCT05434104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93267128|NCT05434104|Hormone Antagonists|hormone antagonists|mesh-ancestor
93092433|NCT00051636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93267129|NCT05434104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267130|NCT05434104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267131|NCT05434104|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93267132|NCT05434104|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93267133|NCT00488072|Mirtazapine|mirtazapine|mesh-list
93267134|NCT00488072|Antidepressive Agents|antidepressive agents|mesh-ancestor
93267135|NCT00488072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267136|NCT00488072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93267137|NCT00488072|Histamine Antagonists|histamine antagonists|mesh-ancestor
93267138|NCT00488072|Histamine Agents|histamine agents|mesh-ancestor
93267139|NCT00488072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267140|NCT00488072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267141|NCT00488072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267142|NCT00488072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93267143|NCT00488072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93267144|NCT00488072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267145|NCT00488072|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93267146|NCT00488072|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93267147|NCT00488072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93267148|NCT00488072|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267149|NCT00488072|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93267150|NCT00488072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93267151|NCT00488072|Serotonin Agents|serotonin agents|mesh-ancestor
93267152|NCT00488072|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93267153|NCT03525704|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93267154|NCT03523832|Celecoxib|celecoxib|mesh-list
93267155|NCT03523832|Pregabalin|pregabalin|mesh-list
93267156|NCT03523832|Analgesics|analgesics|mesh-ancestor
93267157|NCT03523832|Sensory System Agents|sensory system agents|mesh-ancestor
93267158|NCT03523832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267159|NCT03523832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267160|NCT03523832|Anticonvulsants|anticonvulsants|mesh-ancestor
93267161|NCT03523832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93267162|NCT03523832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561855|NCT00049283|Docetaxel|docetaxel|mesh-list
93267163|NCT03523832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267164|NCT03523832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93267165|NCT03523832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92627953|NCT00193401|Topotecan|topotecan|mesh-list
93267166|NCT03523832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93267167|NCT03523832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267168|NCT03523832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267169|NCT03523832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93267170|NCT03523832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267171|NCT03523832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267172|NCT03523832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267173|NCT03523832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93267174|NCT03523832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93267175|NCT03523832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267176|NCT05577624|Rifampin|rifampin|mesh-list
93267177|NCT05577624|Sotorasib|sotorasib|mesh-list
93267178|NCT05577624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93267179|NCT05577624|Antitubercular Agents|antitubercular agents|mesh-ancestor
93267180|NCT05577624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267181|NCT05577624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267182|NCT05577624|Leprostatic Agents|leprostatic agents|mesh-ancestor
93267183|NCT05577624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93267184|NCT05577624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267185|NCT05577624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267186|NCT05577624|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92939192|NCT04218786|Colchicine|colchicine|mesh-list
92628139|NCT00164801|Diltiazem|diltiazem|mesh-list
93267187|NCT05577624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93267188|NCT05577624|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93267189|NCT05577624|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93267190|NCT05577624|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93267191|NCT05577624|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93267193|NCT05577624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267194|NCT05577624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267195|NCT03294694|Fulvestrant|fulvestrant|mesh-list
93267196|NCT03294694|Spartalizumab|spartalizumab|mesh-list
93267197|NCT03294694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93267198|NCT03294694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561893|NCT00049361|Temozolomide|temozolomide|mesh-list
93267199|NCT03294694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93267200|NCT03294694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93267201|NCT03294694|Hormone Antagonists|hormone antagonists|mesh-ancestor
93267202|NCT03294694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267203|NCT03294694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267204|NCT03294694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267205|NCT03294694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267206|NCT03294694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267207|NCT03523754|Isosorbide|isosorbide|mesh-list
93267208|NCT03523754|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93267209|NCT03523754|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93267210|NCT03523754|Misoprostol|misoprostol|mesh-list
92561907|NCT00049361|Growth Inhibitors|growth inhibitors|mesh-ancestor
93267211|NCT03523754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93267212|NCT03523754|Abortifacient Agents|abortifacient agents|mesh-ancestor
93267213|NCT03523754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976217|NCT02503319|Oxytocin|oxytocin|mesh-list
93267214|NCT03523754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267215|NCT03523754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93267216|NCT03523754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267217|NCT03523754|Oxytocics|oxytocics|mesh-ancestor
93267218|NCT03523754|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93267219|NCT03523754|Diuretics|diuretics|mesh-ancestor
93267220|NCT03523754|Natriuretic Agents|natriuretic agents|mesh-ancestor
93267221|NCT03523754|Vasodilator Agents|vasodilator agents|mesh-ancestor
93267222|NCT03523754|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93092434|NCT00051636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92561921|NCT00150436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267223|NCT03523754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267224|NCT04727034|Propofol|propofol|mesh-list
93267225|NCT04727034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93267226|NCT04727034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267227|NCT04727034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267228|NCT04727034|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92561922|NCT00150553|Carbamazepine|carbamazepine|mesh-list
93267229|NCT04727034|Anesthetics, General|anesthetics, general|mesh-ancestor
93267230|NCT04727034|Anesthetics|anesthetics|mesh-ancestor
93267231|NCT03644511|Sorafenib|sorafenib|mesh-list
93267232|NCT03644511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267233|NCT03644511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93267234|NCT03644511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561928|NCT00150553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267235|NCT03644511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267236|NCT03290560|Kallikreins|kallikreins|mesh-list
93267237|NCT03290560|Coagulants|coagulants|mesh-ancestor
93267238|NCT03290560|Fertility Agents, Male|fertility agents, male|mesh-ancestor
93267239|NCT03290560|Fertility Agents|fertility agents|mesh-ancestor
93267240|NCT03290560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93267241|NCT03290560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267242|NCT01316419|Amlodipine|amlodipine|mesh-list
93267243|NCT01316419|Telmisartan|telmisartan|mesh-list
93267244|NCT01316419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93267245|NCT01316419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93267246|NCT01316419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93267247|NCT01316419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267248|NCT01316419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93267249|NCT01316419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267250|NCT01316419|Vasodilator Agents|vasodilator agents|mesh-ancestor
93267251|NCT01316419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93267252|NCT01316419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93267253|NCT03547362|Caseins|caseins|mesh-list
93267254|NCT03547362|Chelating Agents|chelating agents|mesh-ancestor
93267255|NCT03547362|Sequestering Agents|sequestering agents|mesh-ancestor
93267256|NCT03547362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267257|NCT04258150|Nivolumab|nivolumab|mesh-list
93267258|NCT04258150|Ipilimumab|ipilimumab|mesh-list
92939270|NCT04202692|Viscosupplements|viscosupplements|mesh-ancestor
93267259|NCT04258150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267260|NCT04258150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267261|NCT04258150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93092435|NCT00051636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93267262|NCT04258150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267263|NCT02854696|Insulin|insulin|mesh-list
93267264|NCT02854696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93267265|NCT02854696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267266|NCT04664946|Neuroprotective Agents|neuroprotective agents|mesh-list
93267267|NCT04664946|Protective Agents|protective agents|mesh-ancestor
93267268|NCT04664946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267269|NCT02289248|Ketamine|ketamine|mesh-list
93267270|NCT02289248|Analgesics|analgesics|mesh-ancestor
93267271|NCT02289248|Sensory System Agents|sensory system agents|mesh-ancestor
93267272|NCT02289248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629752|NCT02898376|Vitamin E|vitamin e|mesh-list
93267273|NCT02289248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267274|NCT02289248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93267275|NCT02289248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267276|NCT02289248|Anesthetics, General|anesthetics, general|mesh-ancestor
93267277|NCT02289248|Anesthetics|anesthetics|mesh-ancestor
93267278|NCT02289248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267279|NCT02289248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93267280|NCT02289248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93267281|NCT02289248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561980|NCT00150826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93267282|NCT02289248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267283|NCT02782468|Azacitidine|azacitidine|mesh-list
93267284|NCT02782468|Pevonedistat|pevonedistat|mesh-list
93267285|NCT02782468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93267286|NCT02782468|Antimetabolites|antimetabolites|mesh-ancestor
93267287|NCT02782468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267288|NCT02782468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267289|NCT02782468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267290|NCT02253420|Itraconazole|itraconazole|mesh-list
93267291|NCT02253420|Rifampin|rifampin|mesh-list
93267292|NCT02253420|Antifungal Agents|antifungal agents|mesh-ancestor
93267293|NCT02253420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267294|NCT02253420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93267295|NCT02253420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93267296|NCT02253420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561993|NCT00150982|Alefacept|alefacept|mesh-list
93267297|NCT02253420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267298|NCT02253420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93267299|NCT02253420|Hormone Antagonists|hormone antagonists|mesh-ancestor
93267300|NCT02253420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267301|NCT02253420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267302|NCT02253420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93267303|NCT02253420|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93267304|NCT02253420|Antitubercular Agents|antitubercular agents|mesh-ancestor
93267305|NCT02253420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267306|NCT02253420|Leprostatic Agents|leprostatic agents|mesh-ancestor
93267307|NCT02253420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93267308|NCT02253420|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93267309|NCT02253420|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93267310|NCT02253420|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93267311|NCT02253420|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93267312|NCT02253420|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93267313|NCT02253420|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93267314|NCT02028364|Everolimus|everolimus|mesh-list
93267315|NCT02028364|Exemestane|exemestane|mesh-list
93267316|NCT02028364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93267317|NCT02028364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93267318|NCT02028364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267319|NCT02028364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267320|NCT02028364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267321|NCT02028364|Immunologic Factors|immunologic factors|mesh-ancestor
93267322|NCT02028364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267323|NCT02028364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267324|NCT02028364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93267325|NCT02028364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93267326|NCT02028364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93267327|NCT02028364|Hormone Antagonists|hormone antagonists|mesh-ancestor
93267328|NCT02028364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267329|NCT02897115|Adalimumab|adalimumab|mesh-list
93267330|NCT02897115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93267331|NCT02897115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93267332|NCT02897115|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93267333|NCT02897115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267334|NCT02897115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267335|NCT02897115|Analgesics|analgesics|mesh-ancestor
93267336|NCT02897115|Sensory System Agents|sensory system agents|mesh-ancestor
93267337|NCT02897115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267338|NCT02897115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267339|NCT02289482|Ritonavir|ritonavir|mesh-list
93267340|NCT02289482|GSK-2838232|gsk-2838232|mesh-list
93267341|NCT02289482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93267342|NCT02289482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93267343|NCT02289482|Protease Inhibitors|protease inhibitors|mesh-ancestor
93267344|NCT02289482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267345|NCT02289482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267346|NCT02289482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93267347|NCT02289482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93267348|NCT02289482|Antiviral Agents|antiviral agents|mesh-ancestor
93267349|NCT02289482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267350|NCT02289482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93267351|NCT02289482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93267352|NCT05277636|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93267353|NCT05277636|Hallucinogens|hallucinogens|mesh-ancestor
93267354|NCT05277636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267355|NCT05277636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267356|NCT05277636|Serotonin Agents|serotonin agents|mesh-ancestor
93267357|NCT05277636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562057|NCT00082485|Baclofen|baclofen|mesh-list
93267358|NCT05277636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267359|NCT05277636|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92562064|NCT00082485|GABA Agents|gaba agents|mesh-ancestor
93267360|NCT05277636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93267361|NCT05277636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93267362|NCT05277636|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267363|NCT04030195|Cyclophosphamide|cyclophosphamide|mesh-list
93267364|NCT04030195|Fludarabine|fludarabine|mesh-list
93267365|NCT04030195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267366|NCT04030195|Immunologic Factors|immunologic factors|mesh-ancestor
93267367|NCT04030195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267368|NCT04030195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267369|NCT04030195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93267370|NCT04030195|Alkylating Agents|alkylating agents|mesh-ancestor
93267371|NCT04030195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267372|NCT04030195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267373|NCT04030195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93267374|NCT02253966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93267375|NCT02253966|Methylprednisolone|methylprednisolone|mesh-list
93267376|NCT02253966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93267377|NCT02253966|Prednisolone|prednisolone|mesh-list
93267378|NCT02253966|Prednisolone acetate|prednisolone acetate|mesh-list
93267379|NCT02253966|Lidocaine|lidocaine|mesh-list
93267380|NCT02253966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93267381|NCT02253966|Prednisolone phosphate|prednisolone phosphate|mesh-list
93267382|NCT02253966|Anesthetics, Local|anesthetics, local|mesh-ancestor
93267383|NCT02253966|Anesthetics|anesthetics|mesh-ancestor
93267384|NCT02253966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267385|NCT02253966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267386|NCT02253966|Sensory System Agents|sensory system agents|mesh-ancestor
93267387|NCT02253966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267388|NCT02253966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93267389|NCT02253966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93267390|NCT02253966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93267391|NCT02253966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93267392|NCT02253966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267393|NCT02253966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267394|NCT02253966|Antiemetics|antiemetics|mesh-ancestor
92631121|NCT00203112|(T,G)-A-L|(t,g)-a-l|mesh-list
93267395|NCT02253966|Autonomic Agents|autonomic agents|mesh-ancestor
93267396|NCT02253966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267397|NCT02253966|Glucocorticoids|glucocorticoids|mesh-ancestor
93267398|NCT02253966|Hormones|hormones|mesh-ancestor
93267399|NCT02253966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267400|NCT02253966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93267401|NCT02253966|Protective Agents|protective agents|mesh-ancestor
93267402|NCT02253966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93267403|NCT02253966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267404|NCT01673620|Loratadine|loratadine|mesh-list
93267405|NCT01673620|Montelukast|montelukast|mesh-list
93267406|NCT01673620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93267407|NCT01673620|Respiratory System Agents|respiratory system agents|mesh-ancestor
93267408|NCT01673620|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93267409|NCT01673620|Hormone Antagonists|hormone antagonists|mesh-ancestor
93267410|NCT01673620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267411|NCT01673620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267412|NCT01673620|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93267413|NCT01673620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93267414|NCT01673620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562116|NCT00151450|Analgesics|analgesics|mesh-ancestor
93267415|NCT01673620|Antipruritics|antipruritics|mesh-ancestor
93267416|NCT01673620|Dermatologic Agents|dermatologic agents|mesh-ancestor
93267417|NCT01673620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93267418|NCT01673620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93267419|NCT01673620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93267420|NCT01673620|Histamine Antagonists|histamine antagonists|mesh-ancestor
93267421|NCT01673620|Histamine Agents|histamine agents|mesh-ancestor
93267422|NCT01673620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267423|NCT04671355|Fluticasone|fluticasone|mesh-list
93267424|NCT04671355|Xhance|xhance|mesh-list
93267425|NCT04671355|Beclomethasone|beclomethasone|mesh-list
93267426|NCT04671355|Glycopyrrolate|glycopyrrolate|mesh-list
93267427|NCT04671355|Formoterol Fumarate|formoterol fumarate|mesh-list
93267428|NCT04671355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267429|NCT04671355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93267430|NCT04671355|Autonomic Agents|autonomic agents|mesh-ancestor
93267431|NCT04671355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267432|NCT04671355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267433|NCT04671355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93267434|NCT04671355|Respiratory System Agents|respiratory system agents|mesh-ancestor
93267435|NCT04671355|Dermatologic Agents|dermatologic agents|mesh-ancestor
93267436|NCT04671355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93267437|NCT04671355|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93267438|NCT04671355|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93267439|NCT04671355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93267440|NCT04671355|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267441|NCT04671355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267442|NCT04671355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267443|NCT04671355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93267444|NCT04671355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93267445|NCT04671355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93267446|NCT04671355|Cholinergic Agents|cholinergic agents|mesh-ancestor
93267447|NCT04671355|Glucocorticoids|glucocorticoids|mesh-ancestor
93267448|NCT04671355|Hormones|hormones|mesh-ancestor
93092436|NCT00051636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93267449|NCT04671355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267450|NCT03521492|Vitamin D|vitamin d|mesh-list
93267451|NCT03521492|Calcium|calcium|mesh-list
93267452|NCT03521492|Parathyroid Hormone|parathyroid hormone|mesh-list
93267453|NCT03521492|Hormones|hormones|mesh-list
93267454|NCT03521492|Vitamins|vitamins|mesh-ancestor
93267455|NCT03521492|Micronutrients|micronutrients|mesh-ancestor
93267456|NCT03521492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267457|NCT03521492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93267458|NCT03521492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93267459|NCT03521492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267460|NCT03521414|Sevoflurane|sevoflurane|mesh-list
93267461|NCT03521414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93267462|NCT03521414|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93267463|NCT03521414|Anesthetics, General|anesthetics, general|mesh-ancestor
93267464|NCT03521414|Anesthetics|anesthetics|mesh-ancestor
93267465|NCT03521414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267466|NCT03521414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267467|NCT00432094|Paclitaxel|paclitaxel|mesh-list
93267468|NCT00432094|Etoposide|etoposide|mesh-list
93267469|NCT00432094|Carboplatin|carboplatin|mesh-list
93267470|NCT00432094|Ifosfamide|ifosfamide|mesh-list
93267471|NCT00432094|Thiotepa|thiotepa|mesh-list
93267472|NCT00432094|Mesna|mesna|mesh-list
93267473|NCT00432094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93267474|NCT00432094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267475|NCT00432094|Tubulin Modulators|tubulin modulators|mesh-ancestor
93267476|NCT00432094|Antimitotic Agents|antimitotic agents|mesh-ancestor
93267477|NCT00432094|Mitosis Modulators|mitosis modulators|mesh-ancestor
93267478|NCT00432094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267479|NCT00432094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93267480|NCT00432094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93267481|NCT00432094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267482|NCT00432094|Immunologic Factors|immunologic factors|mesh-ancestor
93267483|NCT00432094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632394|NCT03430882|Paclitaxel|paclitaxel|mesh-list
93267484|NCT00432094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93267485|NCT00432094|Alkylating Agents|alkylating agents|mesh-ancestor
93267486|NCT00432094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93267487|NCT00432094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267488|NCT00432094|Protective Agents|protective agents|mesh-ancestor
93267489|NCT05575518|Rifamycins|rifamycins|mesh-list
93267490|NCT05575518|Fluoroquinolones|fluoroquinolones|mesh-list
93267491|NCT05575518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267492|NCT05575518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090443|NCT01903031|Tenofovir|tenofovir|mesh-list
93267493|NCT05575518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93267494|NCT05575518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267495|NCT05575518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267496|NCT04562779|Naltrexone|naltrexone|mesh-list
93267497|NCT04562779|Ketamine|ketamine|mesh-list
93267498|NCT04562779|Analgesics|analgesics|mesh-ancestor
93267499|NCT04562779|Sensory System Agents|sensory system agents|mesh-ancestor
93267500|NCT04562779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562197|NCT00406042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267501|NCT04562779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267502|NCT04562779|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93267503|NCT04562779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267504|NCT04562779|Anesthetics, General|anesthetics, general|mesh-ancestor
93267505|NCT04562779|Anesthetics|anesthetics|mesh-ancestor
93267506|NCT04562779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267507|NCT04562779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93267508|NCT04562779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92632887|NCT00554710|Hormones|hormones|mesh-ancestor
93267509|NCT04562779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267510|NCT04562779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267511|NCT04562779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93267512|NCT04562779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93267513|NCT03751761|Paclitaxel|paclitaxel|mesh-list
93267514|NCT03751761|Durvalumab|durvalumab|mesh-list
93267515|NCT03751761|Tremelimumab|tremelimumab|mesh-list
93267516|NCT03751761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93267517|NCT03751761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267518|NCT03751761|Tubulin Modulators|tubulin modulators|mesh-ancestor
93267519|NCT03751761|Antimitotic Agents|antimitotic agents|mesh-ancestor
93267520|NCT03751761|Mitosis Modulators|mitosis modulators|mesh-ancestor
93267521|NCT03751761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267522|NCT03751761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267523|NCT03644823|Atezolizumab|atezolizumab|mesh-list
93267524|NCT03644823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267525|NCT03644823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267526|NCT03644823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267527|NCT03644823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267528|NCT00072358|Carbamide Peroxide|carbamide peroxide|mesh-list
93267529|NCT00072358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93267530|NCT00072358|Irinotecan|irinotecan|mesh-list
93267531|NCT00072358|Temozolomide|temozolomide|mesh-list
93267532|NCT00072358|Molgramostim|molgramostim|mesh-list
93267533|NCT00072358|Isotretinoin|isotretinoin|mesh-list
93267534|NCT00072358|Antibodies|antibodies|mesh-list
93267535|NCT00072358|Immunoglobulins|immunoglobulins|mesh-list
92633375|NCT00206193|Oxytocics|oxytocics|mesh-ancestor
93267536|NCT00072358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93267537|NCT00072358|Sargramostim|sargramostim|mesh-list
93267538|NCT00072358|Immunoglobulin G|immunoglobulin g|mesh-list
93267539|NCT00072358|Immunologic Factors|immunologic factors|mesh-ancestor
91981602|NCT03180281|Hormones|hormones|mesh-ancestor
93267540|NCT00072358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267541|NCT00072358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267542|NCT00072358|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92562238|NCT00397787|Sunitinib|sunitinib|mesh-list
93267543|NCT00072358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93267544|NCT00072358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633669|NCT00179231|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93267545|NCT00072358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267546|NCT00072358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93267547|NCT00072358|Alkylating Agents|alkylating agents|mesh-ancestor
93267548|NCT00072358|Dermatologic Agents|dermatologic agents|mesh-ancestor
93267549|NCT00072358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93267550|NCT00072358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267551|NCT03104998|Ubiquinone|ubiquinone|mesh-list
93267552|NCT03104998|Coenzyme Q10|coenzyme q10|mesh-list
93267553|NCT03104998|Micronutrients|micronutrients|mesh-ancestor
92562248|NCT00082602|Galantamine|galantamine|mesh-list
93267554|NCT03104998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267555|NCT03104998|Vitamins|vitamins|mesh-ancestor
93267556|NCT03990766|Theophylline|theophylline|mesh-list
93267557|NCT03990766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93267559|NCT03990766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267560|NCT03990766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267561|NCT03990766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93267562|NCT03990766|Respiratory System Agents|respiratory system agents|mesh-ancestor
93267563|NCT03990766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93267564|NCT03990766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267565|NCT03990766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267566|NCT03990766|Vasodilator Agents|vasodilator agents|mesh-ancestor
93267567|NCT03990766|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93267568|NCT03990766|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93267569|NCT03990766|Purinergic Agents|purinergic agents|mesh-ancestor
93267570|NCT03990766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267571|NCT02294162|Ketamine|ketamine|mesh-list
93267572|NCT02294162|Analgesics|analgesics|mesh-ancestor
92634231|NCT00577837|Risedronic Acid|risedronic acid|mesh-list
93267573|NCT02294162|Sensory System Agents|sensory system agents|mesh-ancestor
93267574|NCT02294162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267575|NCT02294162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969768|NCT03195673|Terazosin|terazosin|mesh-list
93267576|NCT02294162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93267577|NCT02294162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267578|NCT02294162|Anesthetics, General|anesthetics, general|mesh-ancestor
93267579|NCT02294162|Anesthetics|anesthetics|mesh-ancestor
93267580|NCT02294162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267581|NCT02294162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93267582|NCT02294162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92562270|NCT00397826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93267583|NCT02294162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267584|NCT02294162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267585|NCT05176158|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93267586|NCT05176158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92562276|NCT00151684|Diazoxide|diazoxide|mesh-list
93267587|NCT05176158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267588|NCT05176158|Analgesics|analgesics|mesh-ancestor
93267589|NCT05176158|Sensory System Agents|sensory system agents|mesh-ancestor
93267590|NCT05176158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267591|NCT05176158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267592|NCT05176158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267593|NCT05176158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267594|NCT02294240|Folic Acid|folic acid|mesh-list
93267595|NCT02294240|Hematinics|hematinics|mesh-ancestor
93267596|NCT02294240|Vitamin B Complex|vitamin b complex|mesh-ancestor
93267597|NCT02294240|Vitamins|vitamins|mesh-ancestor
93267598|NCT02294240|Micronutrients|micronutrients|mesh-ancestor
93267599|NCT02294240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267600|NCT04481724|Evening primrose oil|evening primrose oil|mesh-list
93267601|NCT04481724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92562286|NCT00151801|Interferon-beta|interferon-beta|mesh-list
93267602|NCT04481724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267603|NCT04481724|Analgesics|analgesics|mesh-ancestor
93267604|NCT04481724|Sensory System Agents|sensory system agents|mesh-ancestor
93267605|NCT04481724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267606|NCT04481724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267607|NCT04481724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267608|NCT04481724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267609|NCT04481724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93267610|NCT04481724|Antimetabolites|antimetabolites|mesh-ancestor
93267611|NCT04481724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267612|NCT04481724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93267613|NCT04481724|Dermatologic Agents|dermatologic agents|mesh-ancestor
93267614|NCT02298218|Meloxicam|meloxicam|mesh-list
92635026|NCT00587119|Hormones|hormones|mesh-ancestor
93267615|NCT02298218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93267616|NCT02298218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267617|NCT02298218|Analgesics|analgesics|mesh-ancestor
93267618|NCT02298218|Sensory System Agents|sensory system agents|mesh-ancestor
93267619|NCT02298218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267620|NCT02298218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267621|NCT02298218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267622|NCT02298218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983305|NCT03169127|Ibuprofen|ibuprofen|mesh-list
93267623|NCT02298218|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93267624|NCT02298218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93267625|NCT02298218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267626|NCT02298218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267627|NCT03547830|Plerixafor|plerixafor|mesh-list
93267628|NCT03547830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93267629|NCT03547830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93267630|NCT03547830|Antiviral Agents|antiviral agents|mesh-ancestor
92939649|NCT02891278|Sertraline|sertraline|mesh-list
93267631|NCT03547830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267632|NCT04390945|Capecitabine|capecitabine|mesh-list
93267633|NCT04390945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93267634|NCT04390945|Antimetabolites|antimetabolites|mesh-ancestor
93267635|NCT04390945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267636|NCT04390945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267637|NCT03734809|Pembrolizumab|pembrolizumab|mesh-list
93267638|NCT03734809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267639|NCT03734809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267640|NCT03734809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267641|NCT03734809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267642|NCT02291666|Tolbutamide|tolbutamide|mesh-list
93267643|NCT02291666|Midazolam|midazolam|mesh-list
93267644|NCT02291666|Dextromethorphan|dextromethorphan|mesh-list
93267645|NCT02291666|Caffeine|caffeine|mesh-list
93267646|NCT02291666|Chlorzoxazone|chlorzoxazone|mesh-list
93267647|NCT02291666|Bupropion|bupropion|mesh-list
93267648|NCT02291666|Omeprazole|omeprazole|mesh-list
93267649|NCT02291666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93267650|NCT02291666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93267651|NCT02291666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267652|NCT02291666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267653|NCT02291666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93267654|NCT02291666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93267655|NCT02291666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267656|NCT02291666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267657|NCT02291666|Anesthetics, General|anesthetics, general|mesh-ancestor
93267658|NCT02291666|Anesthetics|anesthetics|mesh-ancestor
93267659|NCT02291666|GABA Modulators|gaba modulators|mesh-ancestor
93267660|NCT02291666|GABA Agents|gaba agents|mesh-ancestor
93267661|NCT02291666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267662|NCT02291666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562346|NCT00152035|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267663|NCT02291666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93267664|NCT02291666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93267665|NCT02291666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267666|NCT02291666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93267667|NCT02291666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93267668|NCT02291666|Purinergic Agents|purinergic agents|mesh-ancestor
93267669|NCT02291666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93267670|NCT02291666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267671|NCT02291666|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93267672|NCT02291666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93267673|NCT02291666|Antidepressive Agents|antidepressive agents|mesh-ancestor
93267674|NCT02291666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93267675|NCT02291666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93267676|NCT02291666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93267677|NCT02291666|Dopamine Agents|dopamine agents|mesh-ancestor
93267678|NCT02291666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92562364|NCT00152191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267679|NCT02291666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93267680|NCT02291666|Antitussive Agents|antitussive agents|mesh-ancestor
93267681|NCT02291666|Respiratory System Agents|respiratory system agents|mesh-ancestor
93267682|NCT02291666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93267683|NCT02291666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93267684|NCT02291666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93267685|NCT02291666|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93267686|NCT02291666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93267687|NCT02291666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267688|NCT03102658|Micafungin|micafungin|mesh-list
93267689|NCT03102658|Antifungal Agents|antifungal agents|mesh-ancestor
93267690|NCT03102658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267691|NCT02646748|Pembrolizumab|pembrolizumab|mesh-list
93267692|NCT02646748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267693|NCT02646748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267694|NCT02646748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267695|NCT02646748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267696|NCT03624985|Lidocaine|lidocaine|mesh-list
93267697|NCT03624985|Anesthetics, Local|anesthetics, local|mesh-ancestor
93267698|NCT03624985|Anesthetics|anesthetics|mesh-ancestor
93267699|NCT03624985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267700|NCT03624985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267701|NCT03624985|Sensory System Agents|sensory system agents|mesh-ancestor
93267702|NCT03624985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267703|NCT03624985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93267704|NCT03624985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93267705|NCT03624985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92562388|NCT00152308|Antifungal Agents|antifungal agents|mesh-ancestor
93267706|NCT03624985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93267707|NCT03624985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267708|NCT03521024|Lithium Carbonate|lithium carbonate|mesh-list
93267709|NCT03521024|Ether|ether|mesh-list
93267710|NCT03521024|Antidepressive Agents|antidepressive agents|mesh-ancestor
93267711|NCT03521024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267712|NCT03521024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267713|NCT03521024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267714|NCT03521024|Antimanic Agents|antimanic agents|mesh-ancestor
93267715|NCT03521024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93267716|NCT03521024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636479|NCT00188006|Heparin|heparin|mesh-list
93267717|NCT03521024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267718|NCT03521024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93267719|NCT03521024|Anesthetics, General|anesthetics, general|mesh-ancestor
93267720|NCT03521024|Anesthetics|anesthetics|mesh-ancestor
93267721|NCT02635672|Pembrolizumab|pembrolizumab|mesh-list
93267722|NCT02635672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267723|NCT02635672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267724|NCT02635672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93267725|NCT02635672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267726|NCT02294552|Mycophenolic Acid|mycophenolic acid|mesh-list
93267727|NCT02294552|Cyclophosphamide|cyclophosphamide|mesh-list
93267728|NCT02294552|Busulfan|busulfan|mesh-list
93267729|NCT02294552|Fludarabine|fludarabine|mesh-list
93267730|NCT02294552|Fludarabine phosphate|fludarabine phosphate|mesh-list
93267731|NCT02294552|Tacrolimus|tacrolimus|mesh-list
93267732|NCT02294552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267733|NCT02294552|Immunologic Factors|immunologic factors|mesh-ancestor
93267734|NCT02294552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267735|NCT02294552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267736|NCT02294552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93267737|NCT02294552|Alkylating Agents|alkylating agents|mesh-ancestor
92562414|NCT00152425|Immunologic Factors|immunologic factors|mesh-ancestor
93267738|NCT02294552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267739|NCT02294552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267740|NCT02294552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93267741|NCT02294552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93267742|NCT02294552|Antimetabolites|antimetabolites|mesh-ancestor
92636946|NCT00213252|Hormones|hormones|mesh-ancestor
93267743|NCT02294552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93267744|NCT02294552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267745|NCT02294552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93267746|NCT02294552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93267747|NCT02294552|Antitubercular Agents|antitubercular agents|mesh-ancestor
93267748|NCT02294552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92636986|NCT00213291|Hematinics|hematinics|mesh-ancestor
93267749|NCT02294552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267750|NCT05574036|Vitamin E|vitamin e|mesh-list
93267751|NCT05574036|Febuxostat|febuxostat|mesh-list
93267752|NCT05574036|Vitamins|vitamins|mesh-ancestor
93267753|NCT05574036|Micronutrients|micronutrients|mesh-ancestor
93267754|NCT05574036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267755|NCT05574036|Antioxidants|antioxidants|mesh-ancestor
93267756|NCT05574036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267757|NCT05574036|Protective Agents|protective agents|mesh-ancestor
93267758|NCT05574036|Gout Suppressants|gout suppressants|mesh-ancestor
93267759|NCT05574036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93267760|NCT03517982|Mycophenolic Acid|mycophenolic acid|mesh-list
93267761|NCT03517982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93267762|NCT03517982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267763|NCT03517982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92637262|NCT00220896|Nootropic Agents|nootropic agents|mesh-ancestor
93267764|NCT03517982|Antitubercular Agents|antitubercular agents|mesh-ancestor
93267765|NCT03517982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93267766|NCT03517982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267767|NCT03517982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267768|NCT03517982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267769|NCT03869944|Lamivudine|lamivudine|mesh-list
93267770|NCT03869944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93267771|NCT03869944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93267772|NCT03869944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267773|NCT03869944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267774|NCT03869944|Antiviral Agents|antiviral agents|mesh-ancestor
93267775|NCT03869944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267776|NCT03869944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93267777|NCT03869944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93267778|NCT03864094|Phenylephrine|phenylephrine|mesh-list
93267779|NCT03864094|Oxymetazoline|oxymetazoline|mesh-list
93267780|NCT03864094|Norepinephrine|norepinephrine|mesh-list
93267781|NCT03864094|Ephedrine|ephedrine|mesh-list
93267782|NCT03864094|Pseudoephedrine|pseudoephedrine|mesh-list
93267783|NCT03864094|Remifentanil|remifentanil|mesh-list
93267784|NCT03864094|Propofol|propofol|mesh-list
93267785|NCT03864094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93267786|NCT03864094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267787|NCT03864094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267788|NCT03864094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267789|NCT03864094|Anesthetics, General|anesthetics, general|mesh-ancestor
93267790|NCT03864094|Anesthetics|anesthetics|mesh-ancestor
93267791|NCT03864094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93267792|NCT03864094|Narcotics|narcotics|mesh-ancestor
93267793|NCT03864094|Analgesics|analgesics|mesh-ancestor
93267794|NCT03864094|Sensory System Agents|sensory system agents|mesh-ancestor
93267795|NCT03864094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267796|NCT03864094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93267797|NCT03864094|Mydriatics|mydriatics|mesh-ancestor
93267798|NCT03864094|Autonomic Agents|autonomic agents|mesh-ancestor
93267799|NCT03864094|Sympathomimetics|sympathomimetics|mesh-ancestor
93267800|NCT03864094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93267801|NCT03864094|Nasal Decongestants|nasal decongestants|mesh-ancestor
93267802|NCT03864094|Respiratory System Agents|respiratory system agents|mesh-ancestor
93267803|NCT03864094|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93267804|NCT03864094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93267805|NCT03864094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93267806|NCT03864094|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267807|NCT03864094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267808|NCT03864094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267809|NCT03864094|Protective Agents|protective agents|mesh-ancestor
93267810|NCT03864094|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93267811|NCT03864094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93267812|NCT03864094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93267813|NCT05573802|Dexamethasone|dexamethasone|mesh-list
93267814|NCT05573802|Lenalidomide|lenalidomide|mesh-list
93267815|NCT05573802|Nirogacestat|nirogacestat|mesh-list
92562485|NCT00050180|Indinavir|indinavir|mesh-list
93267816|NCT05573802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267817|NCT05573802|Antiemetics|antiemetics|mesh-ancestor
93267818|NCT05573802|Autonomic Agents|autonomic agents|mesh-ancestor
93267819|NCT05573802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267820|NCT05573802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267821|NCT05573802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93267822|NCT05573802|Glucocorticoids|glucocorticoids|mesh-ancestor
93267823|NCT05573802|Hormones|hormones|mesh-ancestor
93267824|NCT05573802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93267825|NCT05573802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93267826|NCT05573802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267827|NCT05573802|Immunologic Factors|immunologic factors|mesh-ancestor
93267828|NCT05573802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93267829|NCT05573802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93267830|NCT05573802|Growth Substances|growth substances|mesh-ancestor
93267831|NCT05573802|Growth Inhibitors|growth inhibitors|mesh-ancestor
93267832|NCT05573802|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93267833|NCT05573802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267834|NCT05573802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267835|NCT04435522|Maraviroc|maraviroc|mesh-list
93267836|NCT04435522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93267837|NCT04435522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93267838|NCT04435522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267839|NCT04435522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93267840|NCT04435522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93267841|NCT04435522|Antiviral Agents|antiviral agents|mesh-ancestor
93267842|NCT04435522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267843|NCT04435522|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93267844|NCT03575325|Cytarabine|cytarabine|mesh-list
93267845|NCT03575325|Daunorubicin|daunorubicin|mesh-list
93267846|NCT03575325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93267847|NCT03575325|Antimetabolites|antimetabolites|mesh-ancestor
92562513|NCT00082914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267848|NCT03575325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267849|NCT03575325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267850|NCT03575325|Antiviral Agents|antiviral agents|mesh-ancestor
93267851|NCT03575325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93267852|NCT03575325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267853|NCT03575325|Immunologic Factors|immunologic factors|mesh-ancestor
92638052|NCT00192842|Curcumin|curcumin|mesh-list
93267854|NCT03575325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267855|NCT03575325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93267856|NCT03575325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93267857|NCT03575325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638125|NCT00193115|Docetaxel|docetaxel|mesh-list
93267858|NCT03575325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267860|NCT03843970|Levobupivacaine|levobupivacaine|mesh-list
93267861|NCT03843970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93267862|NCT03843970|Anesthetics, Local|anesthetics, local|mesh-ancestor
93267863|NCT03843970|Anesthetics|anesthetics|mesh-ancestor
93267864|NCT03843970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267865|NCT03843970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267866|NCT03843970|Sensory System Agents|sensory system agents|mesh-ancestor
93267867|NCT03843970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267868|NCT03043651|Treprostinil|treprostinil|mesh-list
93267869|NCT03043651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93267870|NCT04353024|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93267871|NCT04353024|Hallucinogens|hallucinogens|mesh-ancestor
93267872|NCT04353024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267873|NCT04353024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93267874|NCT04353024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93267875|NCT04353024|Serotonin Agents|serotonin agents|mesh-ancestor
93267876|NCT04353024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267877|NCT04353024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267878|NCT04353024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93267879|NCT04465292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93267880|NCT04465292|Immunologic Factors|immunologic factors|mesh-ancestor
93267881|NCT04465292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267882|NCT02298530|Caffeine|caffeine|mesh-list
93267883|NCT02298530|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93267884|NCT02298530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267885|NCT02298530|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92638707|NCT00194402|Niacin|niacin|mesh-list
93267886|NCT02298530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267887|NCT02298530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267888|NCT02298530|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93267889|NCT02298530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93267890|NCT02298530|Purinergic Agents|purinergic agents|mesh-ancestor
93267891|NCT02298530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267892|NCT05051436|Tadalafil|tadalafil|mesh-list
93267893|NCT05051436|Mirabegron|mirabegron|mesh-list
93267894|NCT05051436|Vasodilator Agents|vasodilator agents|mesh-ancestor
93267895|NCT05051436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93267896|NCT05051436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93267897|NCT05051436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93267898|NCT05051436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267899|NCT05051436|Urological Agents|urological agents|mesh-ancestor
93267900|NCT05051436|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93267901|NCT05051436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93267902|NCT05051436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93267903|NCT05051436|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267904|NCT05051436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267905|NCT05051436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267906|NCT03644589|Pembrolizumab|pembrolizumab|mesh-list
93267907|NCT03644589|Immunoglobulins|immunoglobulins|mesh-list
93267908|NCT03644589|Immunoglobulin G|immunoglobulin g|mesh-list
92562583|NCT00050336|Lonafarnib|lonafarnib|mesh-list
93267909|NCT03644589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267910|NCT03644589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93267911|NCT03644589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92562589|NCT00043758|Natriuretic Agents|natriuretic agents|mesh-ancestor
91988679|NCT03139487|Dalteparin|dalteparin|mesh-list
93267912|NCT03644589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267913|NCT03644589|Immunologic Factors|immunologic factors|mesh-ancestor
92562591|NCT00050375|Oregovomab|oregovomab|mesh-list
93267914|NCT03644589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267915|NCT03514550|Propofol|propofol|mesh-list
93267916|NCT03514550|Sevoflurane|sevoflurane|mesh-list
93267917|NCT03514550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93267918|NCT03514550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267919|NCT03514550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267920|NCT03514550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267921|NCT03514550|Anesthetics, General|anesthetics, general|mesh-ancestor
93267922|NCT03514550|Anesthetics|anesthetics|mesh-ancestor
93267923|NCT03514550|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93267924|NCT03514550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93267925|NCT04173988|Cyclophosphamide|cyclophosphamide|mesh-list
93267926|NCT04173988|Fludarabine|fludarabine|mesh-list
93267927|NCT04173988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267928|NCT04173988|Immunologic Factors|immunologic factors|mesh-ancestor
93267929|NCT04173988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267930|NCT04173988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92939959|NCT04097470|Decitabine|decitabine|mesh-list
93267931|NCT04173988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93267932|NCT04173988|Alkylating Agents|alkylating agents|mesh-ancestor
93267933|NCT04173988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267934|NCT04173988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267935|NCT04173988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93267936|NCT01344759|Dexmedetomidine|dexmedetomidine|mesh-list
93267937|NCT01344759|Propofol|propofol|mesh-list
93267938|NCT01344759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93267939|NCT01344759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93267940|NCT01344759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267941|NCT01344759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93267942|NCT01344759|Analgesics|analgesics|mesh-ancestor
93267943|NCT01344759|Sensory System Agents|sensory system agents|mesh-ancestor
93267944|NCT01344759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267945|NCT01344759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93267946|NCT01344759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93267947|NCT01344759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93267948|NCT01344759|Adrenergic Agents|adrenergic agents|mesh-ancestor
93267949|NCT01344759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93267950|NCT01344759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267951|NCT01344759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93267952|NCT01344759|Anesthetics, General|anesthetics, general|mesh-ancestor
93267953|NCT01344759|Anesthetics|anesthetics|mesh-ancestor
93267954|NCT05885386|Temozolomide|temozolomide|mesh-list
93267955|NCT05885386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640141|NCT00197249|Vaccines|vaccines|mesh-list
93267956|NCT05885386|Alkylating Agents|alkylating agents|mesh-ancestor
91989666|NCT03179839|Sertraline|sertraline|mesh-list
93267957|NCT05885386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267958|NCT05885386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93267959|NCT05885360|Istradefylline|istradefylline|mesh-list
93267960|NCT05885360|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93267961|NCT05885360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93267962|NCT05885360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93267963|NCT05885360|Purinergic Agents|purinergic agents|mesh-ancestor
93267964|NCT05885360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989780|NCT02449733|Tenofovir|tenofovir|mesh-list
93267965|NCT05885360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267966|NCT05885360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267967|NCT05885269|Clobetasol|clobetasol|mesh-list
93267968|NCT05885269|Tacrolimus|tacrolimus|mesh-list
93267969|NCT05885269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93267970|NCT05885269|Immunologic Factors|immunologic factors|mesh-ancestor
93267971|NCT05885269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267972|NCT05885269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93267973|NCT05885269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640636|NCT00231387|Rosiglitazone|rosiglitazone|mesh-list
93267974|NCT05885269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267975|NCT05885269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93267976|NCT05885269|Glucocorticoids|glucocorticoids|mesh-ancestor
93267977|NCT05885269|Hormones|hormones|mesh-ancestor
93267978|NCT05885269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640899|NCT00228930|Tamoxifen|tamoxifen|mesh-list
93267979|NCT05885074|Empagliflozin|empagliflozin|mesh-list
92640970|NCT00229125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93267980|NCT05885074|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91990449|NCT04438421|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93267981|NCT05885074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93267982|NCT05885074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93267983|NCT05885074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267984|NCT05885035|Calcium|calcium|mesh-list
93267985|NCT05885035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93267986|NCT05885035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267987|NCT05884983|Vaccines|vaccines|mesh-list
93267988|NCT05884983|Immunologic Factors|immunologic factors|mesh-ancestor
93267989|NCT05884983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267990|NCT05884970|Albuterol|albuterol|mesh-list
93267991|NCT05884970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93267992|NCT05884970|Autonomic Agents|autonomic agents|mesh-ancestor
93267993|NCT05884970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93267994|NCT05884970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93267995|NCT05884970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93267996|NCT05884970|Respiratory System Agents|respiratory system agents|mesh-ancestor
93267997|NCT05884970|Tocolytic Agents|tocolytic agents|mesh-ancestor
93267998|NCT05884970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93267999|NCT05884970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93268000|NCT05884970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93268001|NCT05884970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93268002|NCT05884970|Adrenergic Agents|adrenergic agents|mesh-ancestor
93268003|NCT05884970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268004|NCT05884970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268005|NCT05884957|Nitric Oxide|nitric oxide|mesh-list
93268006|NCT05884957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93268007|NCT05884957|Autonomic Agents|autonomic agents|mesh-ancestor
93268008|NCT05884957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268009|NCT05884957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268010|NCT05884957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93268011|NCT05884957|Respiratory System Agents|respiratory system agents|mesh-ancestor
93268012|NCT05884957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93268013|NCT05884957|Antioxidants|antioxidants|mesh-ancestor
93268014|NCT05884957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268015|NCT05884957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268016|NCT05884957|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93268017|NCT05884957|Vasodilator Agents|vasodilator agents|mesh-ancestor
93268018|NCT05884957|Gasotransmitters|gasotransmitters|mesh-ancestor
93268019|NCT05884957|Protective Agents|protective agents|mesh-ancestor
93268020|NCT05884866|Dapagliflozin|dapagliflozin|mesh-list
93268021|NCT05884866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93268022|NCT05884866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268023|NCT05884866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93268024|NCT05884866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268026|NCT05884671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93268027|NCT05884671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93268028|NCT05884671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970148|NCT04911959|Lenvatinib|lenvatinib|mesh-list
93268029|NCT05884671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268030|NCT05884671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93268031|NCT05884671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93268032|NCT05884671|Dopamine Agents|dopamine agents|mesh-ancestor
93268033|NCT05884671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268034|NCT05884671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268035|NCT05884671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92562702|NCT00153517|Metronidazole|metronidazole|mesh-list
93268036|NCT05884671|Antidepressive Agents|antidepressive agents|mesh-ancestor
93268037|NCT05884502|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93268038|NCT05884502|Ezetimibe|ezetimibe|mesh-list
93268039|NCT05884502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92562710|NCT00083187|Hydroxyurea|hydroxyurea|mesh-list
93268040|NCT05884502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93268041|NCT05884502|Antimetabolites|antimetabolites|mesh-ancestor
93268042|NCT05884502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268043|NCT05884502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93268044|NCT05884502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93268045|NCT05884502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268046|NCT05884463|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93268047|NCT05884463|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268048|NCT05884463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268049|NCT05884320|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93268050|NCT05884320|Immunoconjugates|immunoconjugates|mesh-ancestor
93268051|NCT05884320|Immunologic Factors|immunologic factors|mesh-ancestor
93268052|NCT05884320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268053|NCT05884268|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93268054|NCT05884268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93268055|NCT05884268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562726|NCT00153634|Ticarcillin|ticarcillin|mesh-list
93268056|NCT05884268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93268057|NCT05884268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268058|NCT05884268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268059|NCT05884268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268060|NCT05884268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93268061|NCT05884268|Antidepressive Agents|antidepressive agents|mesh-ancestor
93268062|NCT05884268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93268063|NCT05884255|Octreotide|octreotide|mesh-list
93268064|NCT05884255|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93268065|NCT05884255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268066|NCT05884255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268067|NCT05884255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268068|NCT05884255|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268069|NCT05884255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268070|NCT05884151|Tranexamic Acid|tranexamic acid|mesh-list
93268071|NCT05884151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93268072|NCT05884151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93268073|NCT05884151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268074|NCT05884151|Hemostatics|hemostatics|mesh-ancestor
93268075|NCT05884151|Coagulants|coagulants|mesh-ancestor
93268076|NCT05883956|Azacitidine|azacitidine|mesh-list
93268077|NCT05883956|Decitabine|decitabine|mesh-list
93268078|NCT05883956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268079|NCT05883956|Antimetabolites|antimetabolites|mesh-ancestor
93268080|NCT05883956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268081|NCT05883956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268082|NCT05883956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268083|NCT05883891|Thrombin|thrombin|mesh-list
93268084|NCT05883891|Hemostatics|hemostatics|mesh-ancestor
93268085|NCT05883891|Coagulants|coagulants|mesh-ancestor
93268086|NCT05883865|Fenofibrate|fenofibrate|mesh-list
93268087|NCT05883865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93268088|NCT05883865|Antimetabolites|antimetabolites|mesh-ancestor
93268089|NCT05883865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268090|NCT05883865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93268091|NCT05883709|Lenalidomide|lenalidomide|mesh-list
93268092|NCT05883709|Immunologic Factors|immunologic factors|mesh-ancestor
93268093|NCT05883709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268094|NCT05883709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93268095|NCT05883709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93268096|NCT05883709|Growth Substances|growth substances|mesh-ancestor
93268097|NCT05883709|Growth Inhibitors|growth inhibitors|mesh-ancestor
93268098|NCT05883709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268099|NCT05883540|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93268100|NCT05883540|Hallucinogens|hallucinogens|mesh-ancestor
93268101|NCT05883540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268102|NCT05883540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93268103|NCT05883540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93268104|NCT05883540|Serotonin Agents|serotonin agents|mesh-ancestor
93268105|NCT05883540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268106|NCT05883540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268107|NCT05883540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93268108|NCT05883449|Cyclophosphamide|cyclophosphamide|mesh-list
93268109|NCT05883449|Fludarabine|fludarabine|mesh-list
93268110|NCT05883449|Interleukin-2|interleukin-2|mesh-list
93268111|NCT05883449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268112|NCT05883449|Immunologic Factors|immunologic factors|mesh-ancestor
93268113|NCT05883449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268114|NCT05883449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268115|NCT05883449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562783|NCT00050726|Interleukin-2|interleukin-2|mesh-list
93268116|NCT05883449|Alkylating Agents|alkylating agents|mesh-ancestor
93268117|NCT05883449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268118|NCT05883449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268119|NCT05883449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93268120|NCT05883449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93268121|NCT05883449|Analgesics|analgesics|mesh-ancestor
93268122|NCT05883449|Sensory System Agents|sensory system agents|mesh-ancestor
93268123|NCT05883449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268124|NCT05881720|Valsartan|valsartan|mesh-list
93268125|NCT05881720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92642776|NCT04566718|Metformin|metformin|mesh-list
93268126|NCT05881720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93268127|NCT05881720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93268128|NCT05881720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93268129|NCT05881720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562797|NCT00154024|Irbesartan|irbesartan|mesh-list
93268130|NCT05873725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93268131|NCT05873725|Hormones|hormones|mesh-ancestor
93268132|NCT05873725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268133|NCT05873725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268134|NCT05860530|Olaparib|olaparib|mesh-list
92642979|NCT00211562|Antioxidants|antioxidants|mesh-ancestor
93268135|NCT05860530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93268136|NCT05860530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562803|NCT00154024|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93268137|NCT05860530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268138|NCT05860530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268139|NCT05855798|Magnesium Sulfate|magnesium sulfate|mesh-list
93268140|NCT05855798|Ketamine|ketamine|mesh-list
93268141|NCT05855798|Bupivacaine|bupivacaine|mesh-list
93268142|NCT05855798|Anesthetics, Local|anesthetics, local|mesh-ancestor
93268143|NCT05855798|Anesthetics|anesthetics|mesh-ancestor
93268144|NCT05855798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268145|NCT05855798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268146|NCT05855798|Sensory System Agents|sensory system agents|mesh-ancestor
93268147|NCT05855798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268148|NCT05855798|Analgesics|analgesics|mesh-ancestor
93268149|NCT05855798|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93268150|NCT05855798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93268151|NCT05855798|Anesthetics, General|anesthetics, general|mesh-ancestor
93268152|NCT05855798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93268153|NCT05855798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93268154|NCT05855798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268155|NCT05855798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268156|NCT05855798|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93268157|NCT05855798|Anticonvulsants|anticonvulsants|mesh-ancestor
93268158|NCT05855798|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93268159|NCT05855798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93268160|NCT05855798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93268161|NCT05855798|Tocolytic Agents|tocolytic agents|mesh-ancestor
92562830|NCT00154219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268162|NCT05855798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93268163|NCT05833126|Bevacizumab|bevacizumab|mesh-list
93268164|NCT05833126|Atezolizumab|atezolizumab|mesh-list
93268165|NCT05833126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268166|NCT05833126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268167|NCT05833126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93268168|NCT05833126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93268169|NCT05833126|Growth Substances|growth substances|mesh-ancestor
93268170|NCT05833126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268171|NCT05833126|Growth Inhibitors|growth inhibitors|mesh-ancestor
92643801|NCT00240513|Tretinoin|tretinoin|mesh-list
93268172|NCT05833126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268173|NCT05833126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268174|NCT05830799|Tolbutamide|tolbutamide|mesh-list
93268175|NCT05830799|Nintedanib|nintedanib|mesh-list
93268176|NCT05830799|Midazolam|midazolam|mesh-list
93268177|NCT05830799|Caffeine|caffeine|mesh-list
93268178|NCT05830799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93268179|NCT05830799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92644006|NCT00215579|Dopamine Agents|dopamine agents|mesh-ancestor
93268180|NCT05830799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268181|NCT05830799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268182|NCT05830799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93268183|NCT05830799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93268184|NCT05830799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93268185|NCT05830799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93268186|NCT05830799|Anesthetics, General|anesthetics, general|mesh-ancestor
93268187|NCT05830799|Anesthetics|anesthetics|mesh-ancestor
93268188|NCT05830799|GABA Modulators|gaba modulators|mesh-ancestor
93268189|NCT05830799|GABA Agents|gaba agents|mesh-ancestor
93268190|NCT05830799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268191|NCT05830799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268192|NCT05830799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93268193|NCT05830799|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93268194|NCT05830799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268195|NCT05830799|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92644207|NCT02961816|Hormones|hormones|mesh-ancestor
93268196|NCT05830799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93268197|NCT05830799|Purinergic Agents|purinergic agents|mesh-ancestor
93268198|NCT05830799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268199|NCT05830799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93268200|NCT05830799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93268201|NCT05827523|Cisplatin|cisplatin|mesh-list
93268202|NCT05827523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268203|NCT05798156|Rituximab|rituximab|mesh-list
93268204|NCT05798156|Obinutuzumab|obinutuzumab|mesh-list
93268205|NCT05798156|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93268206|NCT05798156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268207|NCT05798156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268208|NCT05798156|Immunologic Factors|immunologic factors|mesh-ancestor
93268209|NCT05798156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268210|NCT05798156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268211|NCT05798156|Immunoconjugates|immunoconjugates|mesh-ancestor
93268212|NCT05766371|Pembrolizumab|pembrolizumab|mesh-list
93268213|NCT05766371|177Lu-PSMA-617|177lu-psma-617|mesh-list
93268214|NCT05766371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268215|NCT05766371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268216|NCT05766371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268217|NCT05766371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268218|NCT05766371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268219|NCT05731843|Ruzasvir|ruzasvir|mesh-list
93268220|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
93268221|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268222|NCT05721937|Abrocitinib|abrocitinib|mesh-list
92940253|NCT04041856|Povidone-Iodine|povidone-iodine|mesh-list
93268223|NCT05721937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93268224|NCT05721937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268225|NCT05721937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268226|NCT05720949|Dexamethasone|dexamethasone|mesh-list
93268227|NCT05720949|Bupivacaine|bupivacaine|mesh-list
93268228|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268229|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
93268230|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
93268231|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268232|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268233|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268234|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
93268235|NCT05720949|Hormones|hormones|mesh-ancestor
93268236|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268237|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268238|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268239|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
93268240|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
93268241|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268242|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
93268243|NCT05714631|Lidocaine|lidocaine|mesh-list
93268244|NCT05714631|Anesthetics, Local|anesthetics, local|mesh-ancestor
93268245|NCT05714631|Anesthetics|anesthetics|mesh-ancestor
93268246|NCT05714631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268247|NCT05714631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268248|NCT05714631|Sensory System Agents|sensory system agents|mesh-ancestor
93268249|NCT05714631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268250|NCT05714631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93268251|NCT05714631|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93268252|NCT05714631|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93268253|NCT05714631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93268254|NCT05714631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268255|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93268256|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
93268257|NCT05674877|Dexmedetomidine|dexmedetomidine|mesh-list
93268258|NCT05674877|Ketamine|ketamine|mesh-list
93268259|NCT05674877|Analgesics, Opioid|analgesics, opioid|mesh-list
93268260|NCT05674877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93268261|NCT05674877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268262|NCT05674877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268263|NCT05674877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93268264|NCT05674877|Analgesics|analgesics|mesh-ancestor
93268265|NCT05674877|Sensory System Agents|sensory system agents|mesh-ancestor
93268266|NCT05674877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268267|NCT05674877|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93268268|NCT05674877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93268269|NCT05674877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93268270|NCT05674877|Adrenergic Agents|adrenergic agents|mesh-ancestor
93268271|NCT05674877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268272|NCT05674877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268273|NCT05674877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92562920|NCT00083304|Efaproxiral|efaproxiral|mesh-list
93268274|NCT05674877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93268275|NCT05674877|Anesthetics, General|anesthetics, general|mesh-ancestor
93268276|NCT05674877|Anesthetics|anesthetics|mesh-ancestor
93268277|NCT05674877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93268278|NCT05674877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93268279|NCT05674877|Narcotics|narcotics|mesh-ancestor
93268280|NCT05650476|Talazoparib|talazoparib|mesh-list
93268281|NCT05650476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93268282|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562940|NCT00406432|Paroxetine|paroxetine|mesh-list
93268283|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268284|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268285|NCT05633563|Trimetazidine|trimetazidine|mesh-list
93268286|NCT05633563|Vasodilator Agents|vasodilator agents|mesh-ancestor
93268287|NCT05627271|Ofatumumab|ofatumumab|mesh-list
93268288|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
93268289|NCT05627271|Natalizumab|natalizumab|mesh-list
93268290|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268291|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
93268292|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268293|NCT05610735|Doxorubicin|doxorubicin|mesh-list
93268294|NCT05610735|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93268295|NCT05610735|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93268296|NCT05610735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268297|NCT05610735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93268298|NCT05610735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93268299|NCT05610735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268300|NCT05610735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268301|NCT05609370|Bevacizumab|bevacizumab|mesh-list
93268302|NCT05609370|Tislelizumab|tislelizumab|mesh-list
93268303|NCT05609370|Capecitabine|capecitabine|mesh-list
93268304|NCT05609370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268305|NCT05609370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645513|NCT00242775|Budesonide|budesonide|mesh-list
93268306|NCT05609370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93268307|NCT05609370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93268308|NCT05609370|Growth Substances|growth substances|mesh-ancestor
93268309|NCT05609370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268310|NCT05609370|Growth Inhibitors|growth inhibitors|mesh-ancestor
93268311|NCT05609370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268312|NCT05609370|Antimetabolites|antimetabolites|mesh-ancestor
93268313|NCT05609370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268314|NCT05593458|Oxaliplatin|oxaliplatin|mesh-list
93268315|NCT05593458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268316|NCT05571514|Calcium Carbonate|calcium carbonate|mesh-list
93268317|NCT05571514|Calcium|calcium|mesh-list
93268318|NCT05571514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93268319|NCT05571514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268320|NCT05571514|Antacids|antacids|mesh-ancestor
93268321|NCT05571514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268322|NCT05571514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268323|NCT05562713|Denatonium|denatonium|mesh-list
93268324|NCT05562713|Aversive Agents|aversive agents|mesh-ancestor
92562980|NCT00154687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268325|NCT05562713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268326|NCT05562713|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
93268327|NCT05562713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268328|NCT05562713|Sensory System Agents|sensory system agents|mesh-ancestor
93268329|NCT05562713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268330|NCT05556720|Vaccines|vaccines|mesh-list
93268331|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
93268332|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268333|NCT05518032|Pembrolizumab|pembrolizumab|mesh-list
93268334|NCT05518032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92562991|NCT00083460|Glucocorticoids|glucocorticoids|mesh-ancestor
93268335|NCT05518032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268336|NCT05518032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268337|NCT05518032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268338|NCT05513391|Vaccines|vaccines|mesh-list
93268339|NCT05513391|Immunologic Factors|immunologic factors|mesh-ancestor
93268340|NCT05513391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268341|NCT05498766|Capecitabine|capecitabine|mesh-list
93268342|NCT05498766|Tegafur|tegafur|mesh-list
93268343|NCT05498766|Oxaliplatin|oxaliplatin|mesh-list
91970423|NCT02470559|Analgesics|analgesics|mesh-ancestor
93268344|NCT05498766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268345|NCT05498766|Antimetabolites|antimetabolites|mesh-ancestor
93268346|NCT05498766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268347|NCT05498766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268348|NCT05498389|Osimertinib|osimertinib|mesh-list
93268349|NCT05498389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268350|NCT05498389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93268351|NCT05498389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268352|NCT05498389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268353|NCT05466578|Abrocitinib|abrocitinib|mesh-list
93268354|NCT05466578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93268355|NCT05466578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268356|NCT05466578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268357|NCT05361395|Carboplatin|carboplatin|mesh-list
93268358|NCT05361395|Etoposide|etoposide|mesh-list
93268359|NCT05361395|Atezolizumab|atezolizumab|mesh-list
93268360|NCT05361395|Durvalumab|durvalumab|mesh-list
93268361|NCT05361395|AMG 757|amg 757|mesh-list
93268362|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268363|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93268364|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93268365|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93268366|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268367|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268368|NCT05361395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268369|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268370|NCT05351541|Zolpidem|zolpidem|mesh-list
93268371|NCT05351541|Modafinil|modafinil|mesh-list
93268372|NCT05351541|Psilocybin|psilocybin|mesh-list
93268373|NCT05351541|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93268374|NCT05351541|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93268375|NCT05351541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268376|NCT05351541|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93268377|NCT05351541|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93268378|NCT05351541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93268379|NCT05351541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268380|NCT05351541|Hallucinogens|hallucinogens|mesh-ancestor
93268381|NCT05351541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93268382|NCT05351541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93268383|NCT05351541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93268384|NCT05351541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268385|NCT05351541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93268386|NCT05351541|GABA Agonists|gaba agonists|mesh-ancestor
93268387|NCT05351541|GABA Agents|gaba agents|mesh-ancestor
93268388|NCT05351541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268389|NCT05351541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93268390|NCT05351541|Serotonin Agents|serotonin agents|mesh-ancestor
93268391|NCT05351541|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93268392|NCT05334056|Cocaine|cocaine|mesh-list
93268393|NCT05334056|Anesthetics, Local|anesthetics, local|mesh-ancestor
93268394|NCT05334056|Anesthetics|anesthetics|mesh-ancestor
92563049|NCT00154882|Paclitaxel|paclitaxel|mesh-list
93268395|NCT05334056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268396|NCT05334056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268397|NCT05334056|Sensory System Agents|sensory system agents|mesh-ancestor
92563052|NCT00154882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996359|NCT01953328|Evolocumab|evolocumab|mesh-list
93268398|NCT05334056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268399|NCT05334056|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93268400|NCT05334056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93268401|NCT05334056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93268402|NCT05334056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563055|NCT00154882|Mitosis Modulators|mitosis modulators|mesh-ancestor
93268403|NCT05334056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268404|NCT05334056|Dopamine Agents|dopamine agents|mesh-ancestor
93268405|NCT05334056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268406|NCT05328414|Prednisolone|prednisolone|mesh-list
93268407|NCT05328414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268408|NCT05328414|Glucocorticoids|glucocorticoids|mesh-ancestor
93268409|NCT05328414|Hormones|hormones|mesh-ancestor
93268410|NCT05328414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268411|NCT05328414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268412|NCT05328414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268413|NCT05328414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268414|NCT05320393|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93268415|NCT05320393|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93268416|NCT05320393|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93268417|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268418|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268419|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93268420|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563079|NCT00051116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268421|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268422|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
93268423|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268424|NCT05298085|Oxytocin|oxytocin|mesh-list
93268425|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
93268426|NCT05298085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92563082|NCT00051116|Growth Substances|growth substances|mesh-ancestor
93268427|NCT05298085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268428|NCT05291598|Ketorolac|ketorolac|mesh-list
93268429|NCT05291598|Meloxicam|meloxicam|mesh-list
93268430|NCT05291598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93268431|NCT05291598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93268432|NCT05291598|Analgesics|analgesics|mesh-ancestor
93268433|NCT05291598|Sensory System Agents|sensory system agents|mesh-ancestor
93268434|NCT05291598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268435|NCT05291598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268436|NCT05291598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268437|NCT05291598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268438|NCT05291598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93268439|NCT05291598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268440|NCT05291598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268441|NCT05291598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93268442|NCT05288153|Metformin|metformin|mesh-list
93268443|NCT05288153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93268444|NCT05288153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268445|NCT05255003|Enoxaparin|enoxaparin|mesh-list
93268446|NCT05255003|Dalteparin|dalteparin|mesh-list
93268447|NCT05255003|Tinzaparin|tinzaparin|mesh-list
93268448|NCT05255003|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93268449|NCT05255003|Anticoagulants|anticoagulants|mesh-ancestor
93268450|NCT05255003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93268451|NCT05255003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93268452|NCT05255003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268453|NCT05190432|Taxifolin|taxifolin|mesh-list
93268454|NCT05190432|Ergothioneine|ergothioneine|mesh-list
93268455|NCT05190432|Antioxidants|antioxidants|mesh-ancestor
93268456|NCT05190432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268457|NCT05190432|Protective Agents|protective agents|mesh-ancestor
93268458|NCT05190432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268459|NCT05190432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93268460|NCT05190432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93268461|NCT05190432|Analgesics|analgesics|mesh-ancestor
93268462|NCT05190432|Sensory System Agents|sensory system agents|mesh-ancestor
93268463|NCT05190432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268464|NCT05190432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268465|NCT05190432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268466|NCT05171166|Leucovorin|leucovorin|mesh-list
93268467|NCT05171166|Fluorouracil|fluorouracil|mesh-list
93268468|NCT05171166|Oxaliplatin|oxaliplatin|mesh-list
93268469|NCT05171166|Chlorotrianisene|chlorotrianisene|mesh-list
93268470|NCT05171166|Antimetabolites|antimetabolites|mesh-ancestor
93268471|NCT05171166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268472|NCT05171166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92563130|NCT00083538|Antiemetics|antiemetics|mesh-ancestor
93268473|NCT05171166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268474|NCT05171166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268475|NCT05171166|Immunologic Factors|immunologic factors|mesh-ancestor
93268476|NCT05171166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268477|NCT05171166|Antidotes|antidotes|mesh-ancestor
93268478|NCT05171166|Protective Agents|protective agents|mesh-ancestor
93268479|NCT05171166|Vitamin B Complex|vitamin b complex|mesh-ancestor
93268480|NCT05171166|Vitamins|vitamins|mesh-ancestor
93268481|NCT05171166|Micronutrients|micronutrients|mesh-ancestor
93268482|NCT05171166|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93268483|NCT05171166|Estrogens|estrogens|mesh-ancestor
93268484|NCT05171166|Hormones|hormones|mesh-ancestor
92563139|NCT00083538|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93268485|NCT05171166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268486|NCT05171166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268487|NCT05150340|Immunoglobulins|immunoglobulins|mesh-list
93268488|NCT05150340|Immunologic Factors|immunologic factors|mesh-ancestor
93268489|NCT05150340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268490|NCT05123131|Dexamethasone|dexamethasone|mesh-list
93268491|NCT05123131|Lenalidomide|lenalidomide|mesh-list
93268492|NCT05123131|Bortezomib|bortezomib|mesh-list
93268493|NCT05123131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268494|NCT05123131|Antiemetics|antiemetics|mesh-ancestor
93268495|NCT05123131|Autonomic Agents|autonomic agents|mesh-ancestor
93268496|NCT05123131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268497|NCT05123131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268498|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268499|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
93268500|NCT05123131|Hormones|hormones|mesh-ancestor
93268501|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268502|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268503|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268504|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
93268505|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93268506|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93268507|NCT05123131|Growth Substances|growth substances|mesh-ancestor
93268508|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
93268509|NCT05102162|Meropenem|meropenem|mesh-list
93268510|NCT05102162|Tazobactam|tazobactam|mesh-list
93268511|NCT05102162|Piperacillin|piperacillin|mesh-list
93268512|NCT05102162|Cefepime|cefepime|mesh-list
93268513|NCT05102162|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93268514|NCT05102162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93268515|NCT05102162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268516|NCT05102162|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93268517|NCT05102162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268518|NCT05102162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268519|NCT05101187|Amphotericin B|amphotericin b|mesh-list
93268520|NCT05101187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93268521|NCT05101187|Olorofim|olorofim|mesh-list
93268522|NCT05101187|Amebicides|amebicides|mesh-ancestor
93268523|NCT05101187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93268524|NCT05101187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93268525|NCT05101187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268526|NCT05101187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93268527|NCT05101187|Antifungal Agents|antifungal agents|mesh-ancestor
93268528|NCT05065866|Azacitidine|azacitidine|mesh-list
93268529|NCT05065866|Cc-486|cc-486|mesh-list
93268530|NCT05065866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268531|NCT05065866|Antimetabolites|antimetabolites|mesh-ancestor
93268532|NCT05065866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268533|NCT05065866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268534|NCT05065866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268535|NCT05024513|Fluorouracil|fluorouracil|mesh-list
93268536|NCT05024513|Oxaliplatin|oxaliplatin|mesh-list
93268537|NCT05024513|Antimetabolites|antimetabolites|mesh-ancestor
93268538|NCT05024513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268539|NCT05024513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268540|NCT05024513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268541|NCT05024513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268542|NCT05024513|Immunologic Factors|immunologic factors|mesh-ancestor
93268543|NCT05024513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268544|NCT05024045|Pirtobrutinib|pirtobrutinib|mesh-list
93268545|NCT05024045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93268546|NCT05024045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268547|NCT05024045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268548|NCT05000047|Silicon|silicon|mesh-list
93268549|NCT05000047|Trace Elements|trace elements|mesh-ancestor
93268550|NCT05000047|Micronutrients|micronutrients|mesh-ancestor
93268551|NCT05000047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268552|NCT04982848|Talazoparib|talazoparib|mesh-list
93268553|NCT04982848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92563201|NCT00156403|Amlodipine|amlodipine|mesh-list
93268554|NCT04982848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268555|NCT04982848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268556|NCT04982848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268557|NCT04982445|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
93268558|NCT04982445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93268559|NCT04982445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93268560|NCT04982445|Antiviral Agents|antiviral agents|mesh-ancestor
93268561|NCT04982445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268562|NCT04974047|Tislelizumab|tislelizumab|mesh-list
93268563|NCT04974047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268564|NCT04974047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268565|NCT04934800|Cladribine|cladribine|mesh-list
93268566|NCT04934800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268567|NCT04934800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268568|NCT04934800|Immunologic Factors|immunologic factors|mesh-ancestor
93268569|NCT04934800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268570|NCT04920942|Ivermectin|ivermectin|mesh-list
93268571|NCT04920942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93268572|NCT04920942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268573|NCT04918186|Durvalumab|durvalumab|mesh-list
92563213|NCT00051272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93268574|NCT04918186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268575|NCT04918186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268576|NCT04821687|Opicapone|opicapone|mesh-list
93268577|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
93268578|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649230|NCT00574366|Everolimus|everolimus|mesh-list
93268579|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268580|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
93268581|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268582|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563228|NCT00156520|Aminocaproic Acid|aminocaproic acid|mesh-list
93268583|NCT04821687|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93268584|NCT04821687|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93268585|NCT04821687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93268586|NCT04764344|Haloperidol|haloperidol|mesh-list
93268587|NCT04764344|Ondansetron|ondansetron|mesh-list
93268588|NCT04764344|Haloperidol decanoate|haloperidol decanoate|mesh-list
93268589|NCT04764344|Antiemetics|antiemetics|mesh-ancestor
93268590|NCT04764344|Autonomic Agents|autonomic agents|mesh-ancestor
93268591|NCT04764344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563235|NCT00083694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268592|NCT04764344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268593|NCT04764344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268594|NCT04764344|Antipruritics|antipruritics|mesh-ancestor
93268595|NCT04764344|Dermatologic Agents|dermatologic agents|mesh-ancestor
93268596|NCT04764344|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93268597|NCT04764344|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93268598|NCT04764344|Serotonin Agents|serotonin agents|mesh-ancestor
93268599|NCT04764344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268600|NCT04764344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268601|NCT04764344|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92940633|NCT00852670|Ponesimod|ponesimod|mesh-list
93268602|NCT04764344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93268603|NCT04764344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268604|NCT04764344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563252|NCT00156949|Epoetin Alfa|epoetin alfa|mesh-list
93268605|NCT04764344|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93268606|NCT04764344|Dopamine Agents|dopamine agents|mesh-ancestor
93268607|NCT04764344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93268608|NCT04745026|Cannabidiol|cannabidiol|mesh-list
93268609|NCT04745026|Anticonvulsants|anticonvulsants|mesh-ancestor
93268610|NCT04738981|Basiliximab|basiliximab|mesh-list
93268611|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268612|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
93268613|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268614|NCT04709185|Dexamethasone|dexamethasone|mesh-list
93268615|NCT04709185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268616|NCT04709185|Antiemetics|antiemetics|mesh-ancestor
93268617|NCT04709185|Autonomic Agents|autonomic agents|mesh-ancestor
93268618|NCT04709185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268619|NCT04709185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563264|NCT00157066|Vitamin D|vitamin d|mesh-list
93268620|NCT04709185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268621|NCT04709185|Glucocorticoids|glucocorticoids|mesh-ancestor
93268622|NCT04709185|Hormones|hormones|mesh-ancestor
93268623|NCT04709185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268624|NCT04709185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268625|NCT04709185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268626|NCT04693156|Bupivacaine|bupivacaine|mesh-list
93268627|NCT04693156|Prilocaine|prilocaine|mesh-list
93268628|NCT04693156|Anesthetics, Local|anesthetics, local|mesh-ancestor
93268629|NCT04693156|Anesthetics|anesthetics|mesh-ancestor
93268630|NCT04693156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268631|NCT04693156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268632|NCT04693156|Sensory System Agents|sensory system agents|mesh-ancestor
92563279|NCT00157300|Epoetin Alfa|epoetin alfa|mesh-list
93268633|NCT04693156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268634|NCT04685616|Doxorubicin|doxorubicin|mesh-list
93268635|NCT04685616|Bleomycin|bleomycin|mesh-list
93268636|NCT04685616|Dacarbazine|dacarbazine|mesh-list
93268637|NCT04685616|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93268638|NCT04685616|Vinblastine|vinblastine|mesh-list
93268639|NCT04685616|Mitogens|mitogens|mesh-list
93268640|NCT04685616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93268641|NCT04685616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268642|NCT04685616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93268643|NCT04685616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93268644|NCT04685616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268645|NCT04685616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268646|NCT04685616|Mitosis Modulators|mitosis modulators|mesh-ancestor
93268647|NCT04685616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93268648|NCT04685616|Alkylating Agents|alkylating agents|mesh-ancestor
93268649|NCT04685616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268650|NCT04685616|Immunotoxins|immunotoxins|mesh-ancestor
93268651|NCT04685616|Immunoconjugates|immunoconjugates|mesh-ancestor
93268652|NCT04685616|Immunologic Factors|immunologic factors|mesh-ancestor
93268653|NCT04685616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268654|NCT04685616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93268655|NCT04685616|Tubulin Modulators|tubulin modulators|mesh-ancestor
93268656|NCT04685616|Antimitotic Agents|antimitotic agents|mesh-ancestor
93268657|NCT04504331|Tamoxifen|tamoxifen|mesh-list
93268658|NCT04504331|Infigratinib|infigratinib|mesh-list
93268659|NCT04504331|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93268660|NCT04504331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93268661|NCT04504331|Hormone Antagonists|hormone antagonists|mesh-ancestor
93268662|NCT04504331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268663|NCT04504331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268664|NCT04504331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268665|NCT04504331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268666|NCT04504331|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93268667|NCT04504331|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93268668|NCT04504331|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93268669|NCT04504331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563316|NCT00398099|Ertapenem|ertapenem|mesh-list
93268670|NCT04504331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268671|NCT04504331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268672|NCT04481919|Diuretics|diuretics|mesh-list
92940705|NCT00723164|Sensory System Agents|sensory system agents|mesh-ancestor
93268673|NCT04481919|Natriuretic Agents|natriuretic agents|mesh-ancestor
93268674|NCT04481919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563320|NCT00406978|Prednisone|prednisone|mesh-list
93268675|NCT04447911|Empagliflozin|empagliflozin|mesh-list
93268676|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93268677|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268678|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93268679|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268680|NCT04420195|Tacrolimus|tacrolimus|mesh-list
93268681|NCT04420195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268682|NCT04420195|Immunologic Factors|immunologic factors|mesh-ancestor
92651097|NCT00410540|Analgesics|analgesics|mesh-ancestor
93268683|NCT04420195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268684|NCT04420195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93268685|NCT04420195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563331|NCT00406978|Alkylating Agents|alkylating agents|mesh-ancestor
93268686|NCT04420195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268687|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
93268688|NCT04313985|Immunomodulating Agents|immunomodulating agents|mesh-list
93268689|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268690|NCT04283578|Oxytocin|oxytocin|mesh-list
92651246|NCT00202163|Hormones|hormones|mesh-ancestor
93268691|NCT04283578|Oxytocics|oxytocics|mesh-ancestor
93268692|NCT04283578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92651325|NCT00415779|Docetaxel|docetaxel|mesh-list
93268693|NCT04283578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268694|NCT04123873|Acetaminophen|acetaminophen|mesh-list
93268695|NCT04123873|Dexamethasone|dexamethasone|mesh-list
93268696|NCT04123873|Ibuprofen|ibuprofen|mesh-list
93268697|NCT04123873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268698|NCT04123873|Antiemetics|antiemetics|mesh-ancestor
93268699|NCT04123873|Autonomic Agents|autonomic agents|mesh-ancestor
93268700|NCT04123873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268701|NCT04123873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268702|NCT04123873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268703|NCT04123873|Glucocorticoids|glucocorticoids|mesh-ancestor
93268704|NCT04123873|Hormones|hormones|mesh-ancestor
92563346|NCT00157651|Warfarin|warfarin|mesh-list
93268705|NCT04123873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268706|NCT04123873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268707|NCT04123873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563351|NCT00044343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268708|NCT04123873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93268709|NCT04123873|Analgesics|analgesics|mesh-ancestor
93268710|NCT04123873|Sensory System Agents|sensory system agents|mesh-ancestor
93268711|NCT04123873|Antipyretics|antipyretics|mesh-ancestor
92563356|NCT00051506|Carboplatin|carboplatin|mesh-list
93268712|NCT04123873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93268713|NCT04123873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268714|NCT04123873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93268715|NCT04123873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268716|NCT04123873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268717|NCT04116203|Metformin|metformin|mesh-list
93268718|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93268719|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268720|NCT04106362|Cisplatin|cisplatin|mesh-list
93268721|NCT04106362|Cetuximab|cetuximab|mesh-list
93268722|NCT04106362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93268723|NCT04106362|Antibodies|antibodies|mesh-list
93268724|NCT04106362|Immunoglobulins|immunoglobulins|mesh-list
93268725|NCT04106362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93268726|NCT04106362|Immunologic Factors|immunologic factors|mesh-ancestor
93268727|NCT04106362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268728|NCT04106362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268729|NCT04089865|Tranexamic Acid|tranexamic acid|mesh-list
93268730|NCT04089865|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93268731|NCT04089865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93268732|NCT04089865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268733|NCT04089865|Hemostatics|hemostatics|mesh-ancestor
93268734|NCT04089865|Coagulants|coagulants|mesh-ancestor
93268735|NCT04079088|Interferons|interferons|mesh-list
93268736|NCT04079088|Interferon-beta|interferon-beta|mesh-list
93268737|NCT04079088|Glatiramer Acetate|glatiramer acetate|mesh-list
93268738|NCT04079088|(T,G)-A-L|(t,g)-a-l|mesh-list
93268739|NCT04079088|Interferon beta-1b|interferon beta-1b|mesh-list
93268740|NCT04079088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268741|NCT04079088|Antiviral Agents|antiviral agents|mesh-ancestor
93268742|NCT04079088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268743|NCT04079088|Immunologic Factors|immunologic factors|mesh-ancestor
93268744|NCT04079088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563384|NCT00158002|Topiramate|topiramate|mesh-list
93268745|NCT04079088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93268746|NCT04079088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268747|NCT04079088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268748|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
93268749|NCT04060030|Leucovorin|leucovorin|mesh-list
93268750|NCT04060030|Calcium|calcium|mesh-list
93268751|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
92563390|NCT00158041|Protective Agents|protective agents|mesh-ancestor
93268752|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93268753|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268754|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93268756|NCT04060030|Protective Agents|protective agents|mesh-ancestor
93268757|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
93268758|NCT04060030|Vitamins|vitamins|mesh-ancestor
93268759|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
93268760|NCT04008797|Lenvatinib|lenvatinib|mesh-list
93268761|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970755|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
93268762|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93268763|NCT04008797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268764|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268765|NCT04005352|Aflibercept|aflibercept|mesh-list
93268766|NCT04005352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93268767|NCT04005352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93268768|NCT04005352|Growth Substances|growth substances|mesh-ancestor
92563405|NCT00044382|Lenalidomide|lenalidomide|mesh-list
93268769|NCT04005352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268770|NCT04005352|Growth Inhibitors|growth inhibitors|mesh-ancestor
93268771|NCT04005352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268772|NCT03913819|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93268773|NCT03913819|Cholinergic Agents|cholinergic agents|mesh-ancestor
93268774|NCT03913819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268775|NCT03913819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268776|NCT03913819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268777|NCT03819465|Paclitaxel|paclitaxel|mesh-list
93268778|NCT03819465|Carboplatin|carboplatin|mesh-list
93268779|NCT03819465|Gemcitabine|gemcitabine|mesh-list
93268780|NCT03819465|Pemetrexed|pemetrexed|mesh-list
93268781|NCT03819465|Durvalumab|durvalumab|mesh-list
93268782|NCT03819465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93268783|NCT03819465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268784|NCT03819465|Tubulin Modulators|tubulin modulators|mesh-ancestor
93268785|NCT03819465|Antimitotic Agents|antimitotic agents|mesh-ancestor
93268786|NCT03819465|Mitosis Modulators|mitosis modulators|mesh-ancestor
93268787|NCT03819465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268788|NCT03819465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268789|NCT03819465|Antimetabolites|antimetabolites|mesh-ancestor
93268790|NCT03819465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563431|NCT00158236|Naloxone|naloxone|mesh-list
93268791|NCT03819465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93268792|NCT03819465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563436|NCT00158236|Analgesics|analgesics|mesh-ancestor
93268793|NCT03819465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268794|NCT03796273|Ketoconazole|ketoconazole|mesh-list
93268795|NCT03796273|Antifungal Agents|antifungal agents|mesh-ancestor
93268796|NCT03796273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268797|NCT03796273|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93268798|NCT03796273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93268799|NCT03796273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268800|NCT03796273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268801|NCT03796273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93268802|NCT03796273|Hormone Antagonists|hormone antagonists|mesh-ancestor
92563445|NCT00051701|Alemtuzumab|alemtuzumab|mesh-list
92653251|NCT02213653|Iron|iron|mesh-list
93268803|NCT03796273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268804|NCT03796273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268805|NCT03796273|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93268806|NCT03713424|Clavulanic Acids|clavulanic acids|mesh-list
93268807|NCT03713424|Clavulanic Acid|clavulanic acid|mesh-list
93268808|NCT03713424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93268809|NCT03713424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268810|NCT03713424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268811|NCT03713424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268812|NCT03713424|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93268813|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
93268814|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268815|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268816|NCT03637803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92653414|NCT00269217|Niacin|niacin|mesh-list
93268817|NCT03637803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268818|NCT03567720|Paclitaxel|paclitaxel|mesh-list
93268819|NCT03567720|Carboplatin|carboplatin|mesh-list
93268820|NCT03567720|Gemcitabine|gemcitabine|mesh-list
93268821|NCT03567720|Pembrolizumab|pembrolizumab|mesh-list
92563465|NCT00158470|Antimetabolites|antimetabolites|mesh-ancestor
93268822|NCT03567720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93268823|NCT03567720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268824|NCT03567720|Tubulin Modulators|tubulin modulators|mesh-ancestor
93268825|NCT03567720|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940851|NCT02571842|Enalapril|enalapril|mesh-list
93268826|NCT03567720|Mitosis Modulators|mitosis modulators|mesh-ancestor
93268827|NCT03567720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268828|NCT03567720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93268830|NCT03567720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268831|NCT03567720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268832|NCT03519906|Metoprolol|metoprolol|mesh-list
93268833|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93268834|NCT03519906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93268835|NCT03519906|Sympatholytics|sympatholytics|mesh-ancestor
93268836|NCT03519906|Autonomic Agents|autonomic agents|mesh-ancestor
93268837|NCT03519906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563478|NCT00158548|Antiviral Agents|antiviral agents|mesh-ancestor
93268838|NCT03519906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268839|NCT03519906|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93268840|NCT03519906|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93268841|NCT03519906|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93268842|NCT03519906|Adrenergic Agents|adrenergic agents|mesh-ancestor
93268843|NCT03519906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268844|NCT03519906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268845|NCT03519893|Losartan|losartan|mesh-list
93268846|NCT03519893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93268847|NCT03519893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93268848|NCT03519893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92653966|NCT00237614|Expectorants|expectorants|mesh-ancestor
93268849|NCT03519893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93268850|NCT03519893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268851|NCT03519256|Nivolumab|nivolumab|mesh-list
93268852|NCT03519256|Linrodostat|linrodostat|mesh-list
93268853|NCT03519256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268854|NCT03519256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268855|NCT03519256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268856|NCT03519256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268857|NCT03519256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268858|NCT03507608|Flutamide|flutamide|mesh-list
93268859|NCT03507608|Androgen Antagonists|androgen antagonists|mesh-ancestor
93268860|NCT03507608|Hormone Antagonists|hormone antagonists|mesh-ancestor
93268861|NCT03507608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268862|NCT03507608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268863|NCT03507608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268864|NCT03507608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268865|NCT03465579|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93268866|NCT03465579|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268867|NCT03465579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268868|NCT03453528|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93268869|NCT03453528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268870|NCT03453528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268871|NCT03343054|Talazoparib|talazoparib|mesh-list
93268872|NCT03343054|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93268873|NCT03343054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268874|NCT03343054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268875|NCT03343054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268876|NCT03336398|Ketamine|ketamine|mesh-list
93268877|NCT03336398|Analgesics|analgesics|mesh-ancestor
93268878|NCT03336398|Sensory System Agents|sensory system agents|mesh-ancestor
93268879|NCT03336398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268880|NCT03336398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268881|NCT03336398|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93268882|NCT03336398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93268883|NCT03336398|Anesthetics, General|anesthetics, general|mesh-ancestor
93268884|NCT03336398|Anesthetics|anesthetics|mesh-ancestor
93268885|NCT03336398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268886|NCT03336398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93268887|NCT03336398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93268888|NCT03336398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268889|NCT03336398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268890|NCT03330847|Olaparib|olaparib|mesh-list
93268891|NCT03330847|Adavosertib|adavosertib|mesh-list
93268892|NCT03330847|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93268893|NCT03330847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268894|NCT03330847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268895|NCT03330847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268896|NCT03215927|Abatacept|abatacept|mesh-list
93268897|NCT03215927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268898|NCT03215927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268899|NCT03215927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268900|NCT03215927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268901|NCT03215927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93268902|NCT03215927|Immunologic Factors|immunologic factors|mesh-ancestor
93268903|NCT03215927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268904|NCT03215927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268905|NCT03073967|Foscarnet|foscarnet|mesh-list
93268906|NCT03073967|Pritelivir|pritelivir|mesh-list
93268907|NCT03073967|Antiviral Agents|antiviral agents|mesh-ancestor
93268908|NCT03073967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268909|NCT03073967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93268910|NCT03073967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93268911|NCT03073967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268912|NCT03073967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268913|NCT02999230|Listerine|listerine|mesh-list
93268914|NCT02999230|Fluorides|fluorides|mesh-list
93268915|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
93268916|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
93268917|NCT02999230|Protective Agents|protective agents|mesh-ancestor
93268918|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268919|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93268920|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93268921|NCT02941315|Captopril|captopril|mesh-list
93268922|NCT02941315|Spironolactone|spironolactone|mesh-list
93268923|NCT02941315|Furosemide|furosemide|mesh-list
93268924|NCT02941315|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93268925|NCT02941315|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93268926|NCT02941315|Hormone Antagonists|hormone antagonists|mesh-ancestor
93268927|NCT02941315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268928|NCT02941315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268929|NCT02941315|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93268930|NCT02941315|Diuretics|diuretics|mesh-ancestor
93268931|NCT02941315|Natriuretic Agents|natriuretic agents|mesh-ancestor
93268932|NCT02941315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93268933|NCT02941315|Adrenergic Agents|adrenergic agents|mesh-ancestor
93268934|NCT02941315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93268935|NCT02941315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268936|NCT02941315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93268937|NCT02941315|Protease Inhibitors|protease inhibitors|mesh-ancestor
93268938|NCT02941315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93268939|NCT02941315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93268940|NCT02941315|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93268941|NCT02941315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93268942|NCT02920229|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93268943|NCT02920229|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268944|NCT02920229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268945|NCT02918721|Lidocaine|lidocaine|mesh-list
93268946|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
93268947|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
93268948|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
93268949|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93268950|NCT02918721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268951|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
93268952|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268953|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93268954|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93268955|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93268956|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93268957|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268958|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93268959|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
93268960|NCT02918721|Viscosupplements|viscosupplements|mesh-ancestor
93268961|NCT02918721|Protective Agents|protective agents|mesh-ancestor
93268962|NCT02884180|Dexamethasone|dexamethasone|mesh-list
93268963|NCT02884180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268964|NCT02884180|Antiemetics|antiemetics|mesh-ancestor
93268965|NCT02884180|Autonomic Agents|autonomic agents|mesh-ancestor
93268966|NCT02884180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93268967|NCT02884180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268968|NCT02884180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268969|NCT02884180|Glucocorticoids|glucocorticoids|mesh-ancestor
93268970|NCT02884180|Hormones|hormones|mesh-ancestor
93268971|NCT02884180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92940999|NCT00721604|Blood Substitutes|blood substitutes|mesh-ancestor
93268972|NCT02884180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93268973|NCT02884180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268974|NCT02799602|Docetaxel|docetaxel|mesh-list
93268975|NCT02799602|Androgens|androgens|mesh-list
93268976|NCT02799602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268977|NCT02799602|Tubulin Modulators|tubulin modulators|mesh-ancestor
93268978|NCT02799602|Antimitotic Agents|antimitotic agents|mesh-ancestor
93268979|NCT02799602|Mitosis Modulators|mitosis modulators|mesh-ancestor
93268980|NCT02799602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268981|NCT02799602|Hormones|hormones|mesh-ancestor
93268982|NCT02799602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93268983|NCT02799602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93268984|NCT02770040|Infliximab|infliximab|mesh-list
93268985|NCT02770040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93268986|NCT02770040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93268987|NCT02770040|Dermatologic Agents|dermatologic agents|mesh-ancestor
93268988|NCT02770040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93268989|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93268990|NCT02754297|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93268991|NCT02754297|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93268992|NCT02754297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268993|NCT02451423|Atezolizumab|atezolizumab|mesh-list
93268994|NCT02451423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93268995|NCT02451423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93268996|NCT02451423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93268997|NCT02451423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93268998|NCT02291705|Tramadol|tramadol|mesh-list
93268999|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93269000|NCT02291705|Narcotics|narcotics|mesh-ancestor
93269001|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269002|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269003|NCT02291705|Analgesics|analgesics|mesh-ancestor
93269004|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
93269005|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269006|NCT02243709|Mifepristone|mifepristone|mesh-list
93269007|NCT02243709|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93269008|NCT02243709|Abortifacient Agents|abortifacient agents|mesh-ancestor
93269009|NCT02243709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269010|NCT02243709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269011|NCT02243709|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93269012|NCT02243709|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93269013|NCT02243709|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93269014|NCT02243709|Contraceptive Agents|contraceptive agents|mesh-ancestor
93269015|NCT02243709|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93269016|NCT02243709|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93269017|NCT02243709|Hormone Antagonists|hormone antagonists|mesh-ancestor
93269018|NCT02243709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269019|NCT02243709|Luteolytic Agents|luteolytic agents|mesh-ancestor
93269020|NCT02243709|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93269021|NCT02243709|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93269022|NCT02027935|Aldesleukin|aldesleukin|mesh-list
93269023|NCT02027935|Cyclophosphamide|cyclophosphamide|mesh-list
93269024|NCT02027935|Ipilimumab|ipilimumab|mesh-list
93269025|NCT02027935|Interleukin-2|interleukin-2|mesh-list
93269026|NCT02027935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269027|NCT02027935|Immunologic Factors|immunologic factors|mesh-ancestor
93269028|NCT02027935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269029|NCT02027935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269030|NCT02027935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93269031|NCT02027935|Alkylating Agents|alkylating agents|mesh-ancestor
93269032|NCT02027935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269033|NCT02027935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269034|NCT02027935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93269035|NCT02027935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269036|NCT02027935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93269037|NCT02027935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93269038|NCT02027935|Analgesics|analgesics|mesh-ancestor
93269039|NCT02027935|Sensory System Agents|sensory system agents|mesh-ancestor
93269040|NCT02027935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269041|NCT02027935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93269042|NCT02027935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93269043|NCT02027935|Antiviral Agents|antiviral agents|mesh-ancestor
93269044|NCT02027935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269045|NCT01969578|Paclitaxel|paclitaxel|mesh-list
93269046|NCT01969578|Carboplatin|carboplatin|mesh-list
93269047|NCT01969578|Doxorubicin|doxorubicin|mesh-list
93269048|NCT01969578|Bicalutamide|bicalutamide|mesh-list
93269049|NCT01969578|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93269050|NCT01969578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269051|NCT01969578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269052|NCT01969578|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269053|NCT01969578|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269054|NCT01969578|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269055|NCT01969578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269056|NCT01969578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93269057|NCT01969578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93269058|NCT01969578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93269059|NCT01969578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269060|NCT01969578|Androgen Antagonists|androgen antagonists|mesh-ancestor
93269061|NCT01969578|Hormone Antagonists|hormone antagonists|mesh-ancestor
93269062|NCT01969578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269063|NCT01969578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269064|NCT01969578|Luteolytic Agents|luteolytic agents|mesh-ancestor
93269065|NCT01969578|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93269066|NCT01969578|Contraceptive Agents|contraceptive agents|mesh-ancestor
93269067|NCT01969578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269068|NCT01969578|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93269069|NCT01969578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269070|NCT01896011|Teriparatide|teriparatide|mesh-list
93269071|NCT01896011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93269072|NCT01896011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269073|NCT01896011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93269074|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
93269075|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93269076|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
93269077|NCT01891396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269078|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
93269079|NCT01891396|Protective Agents|protective agents|mesh-ancestor
93269080|NCT01746225|Paclitaxel|paclitaxel|mesh-list
93269081|NCT01746225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269082|NCT01746225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269083|NCT01746225|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269084|NCT01746225|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269085|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269086|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269087|NCT01716806|Nivolumab|nivolumab|mesh-list
93269088|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93269089|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93269090|NCT01716806|Dacarbazine|dacarbazine|mesh-list
93269091|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269092|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269093|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93269094|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269095|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93269096|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
93269097|NCT01716806|Immunotoxins|immunotoxins|mesh-ancestor
93269098|NCT01716806|Immunoconjugates|immunoconjugates|mesh-ancestor
93269099|NCT01716806|Immunologic Factors|immunologic factors|mesh-ancestor
93269100|NCT01716806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269101|NCT01650545|Cyclosporine|cyclosporine|mesh-list
93269102|NCT01650545|Sirolimus|sirolimus|mesh-list
93269103|NCT01650545|Tacrolimus|tacrolimus|mesh-list
93269104|NCT01650545|Cyclosporins|cyclosporins|mesh-list
93269105|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269106|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
93269107|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269108|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93269109|NCT01650545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269110|NCT01650545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269111|NCT01650545|Antifungal Agents|antifungal agents|mesh-ancestor
93269112|NCT01650545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269113|NCT01650545|Dermatologic Agents|dermatologic agents|mesh-ancestor
93269114|NCT01650545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269115|NCT01650545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93269116|NCT01650545|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93269117|NCT01650545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269118|NCT01191008|Timolol|timolol|mesh-list
93269119|NCT01191008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93269120|NCT01191008|Latanoprost|latanoprost|mesh-list
93269121|NCT01191008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93269122|NCT01191008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269123|NCT01191008|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93269124|NCT01191008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93269125|NCT01191008|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269126|NCT01191008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269127|NCT01191008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269128|NCT01191008|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269129|NCT01191008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269130|NCT01155232|Teriparatide|teriparatide|mesh-list
93269131|NCT01155232|Parathyroid Hormone|parathyroid hormone|mesh-list
93269132|NCT01155232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269133|NCT01155232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93269134|NCT01155232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93269135|NCT00821587|Cyclosporine|cyclosporine|mesh-list
93269136|NCT00821587|Tacrolimus|tacrolimus|mesh-list
93269137|NCT00821587|Cyclosporins|cyclosporins|mesh-list
93269138|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269139|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
93269140|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269141|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93269142|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269143|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269144|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
93269145|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269146|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
93269147|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269148|NCT00751829|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93269149|NCT00751829|Olmesartan|olmesartan|mesh-list
93269150|NCT00751829|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93269151|NCT00751829|Nitrendipine|nitrendipine|mesh-list
93269152|NCT00751829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269153|NCT00751829|Diuretics|diuretics|mesh-ancestor
93269154|NCT00751829|Natriuretic Agents|natriuretic agents|mesh-ancestor
93269155|NCT00751829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269156|NCT00751829|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93269157|NCT00751829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269158|NCT00751829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269159|NCT00751829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93269160|NCT00751829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93269161|NCT00751829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93269162|NCT00751829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93269163|NCT00751829|Vasodilator Agents|vasodilator agents|mesh-ancestor
93269164|NCT00645801|Lubiprostone|lubiprostone|mesh-list
93269165|NCT00645801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93269166|NCT00645801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269167|NCT00645801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269168|NCT00424099|Methylphenidate|methylphenidate|mesh-list
93269169|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93269170|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269171|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93269172|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93269173|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269174|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269175|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
93269176|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269177|NCT00382213|Olmesartan|olmesartan|mesh-list
93269178|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93269179|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269180|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93269181|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93269182|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269183|NCT00176267|Paclitaxel|paclitaxel|mesh-list
93269184|NCT00176267|Carboplatin|carboplatin|mesh-list
93269185|NCT00176267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269186|NCT00176267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269187|NCT00176267|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269188|NCT00176267|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269189|NCT00176267|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269190|NCT00176267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269191|NCT00146562|Paclitaxel|paclitaxel|mesh-list
93269192|NCT00146562|Cyclophosphamide|cyclophosphamide|mesh-list
93269193|NCT00146562|Doxorubicin|doxorubicin|mesh-list
92941230|NCT00861094|Antidotes|antidotes|mesh-ancestor
93269194|NCT00146562|Darbepoetin alfa|darbepoetin alfa|mesh-list
93269195|NCT00146562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269196|NCT00146562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269197|NCT00146562|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269198|NCT00146562|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269199|NCT00146562|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269200|NCT00146562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269201|NCT00146562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269202|NCT00146562|Immunologic Factors|immunologic factors|mesh-ancestor
93269203|NCT00146562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269204|NCT00146562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269205|NCT00146562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93269206|NCT00146562|Alkylating Agents|alkylating agents|mesh-ancestor
93269207|NCT00146562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93269208|NCT00146562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93269209|NCT00146562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93269210|NCT00146562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93269211|NCT00146562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269212|NCT00146562|Hematinics|hematinics|mesh-ancestor
93269213|NCT04299438|Propranolol|propranolol|mesh-list
93269214|NCT04299438|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93269215|NCT04299438|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93269216|NCT04299438|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269217|NCT04299438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269218|NCT04299438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269219|NCT04299438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269220|NCT04299438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269221|NCT04299438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269222|NCT04299438|Vasodilator Agents|vasodilator agents|mesh-ancestor
93269223|NCT02298764|Psychotropic Drugs|psychotropic drugs|mesh-list
93269224|NCT02298920|Zoliflodacin|zoliflodacin|mesh-list
93269225|NCT02298920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93269226|NCT02298920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93269227|NCT02298920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269228|NCT02298920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269229|NCT02298920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269230|NCT03517748|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93269231|NCT03517748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93269232|NCT03517670|Milrinone|milrinone|mesh-list
93269233|NCT03517670|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93269234|NCT03517670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93269235|NCT03517670|Vasodilator Agents|vasodilator agents|mesh-ancestor
93269236|NCT03517670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93269237|NCT03517670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93269238|NCT03517670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269239|NCT03517670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269240|NCT03517670|Protective Agents|protective agents|mesh-ancestor
93269241|NCT03517670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269242|NCT03316573|Pembrolizumab|pembrolizumab|mesh-list
93269243|NCT03316573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269244|NCT03316573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269245|NCT03316573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93269246|NCT03316573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269247|NCT00109668|Beclomethasone|beclomethasone|mesh-list
93269248|NCT00109668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93269249|NCT00109668|Glucocorticoids|glucocorticoids|mesh-ancestor
93269250|NCT00109668|Hormones|hormones|mesh-ancestor
93269251|NCT00109668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269252|NCT00109668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269253|NCT00109668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93269254|NCT00109668|Respiratory System Agents|respiratory system agents|mesh-ancestor
93269255|NCT03104140|Ketamine|ketamine|mesh-list
93269256|NCT03104140|Thiopental|thiopental|mesh-list
93269257|NCT03104140|Analgesics|analgesics|mesh-ancestor
93269258|NCT03104140|Sensory System Agents|sensory system agents|mesh-ancestor
93269259|NCT03104140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269260|NCT03104140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269261|NCT03104140|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93269262|NCT03104140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93269263|NCT03104140|Anesthetics, General|anesthetics, general|mesh-ancestor
93269264|NCT03104140|Anesthetics|anesthetics|mesh-ancestor
93269265|NCT03104140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269266|NCT03104140|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93269267|NCT03104140|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93269268|NCT03104140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269269|NCT03104140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269270|NCT03104140|Anticonvulsants|anticonvulsants|mesh-ancestor
93269271|NCT03104140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93269272|NCT03104140|GABA Modulators|gaba modulators|mesh-ancestor
93269273|NCT03104140|GABA Agents|gaba agents|mesh-ancestor
93269274|NCT03520478|Bicalutamide|bicalutamide|mesh-list
93269275|NCT03520478|Androgen Antagonists|androgen antagonists|mesh-ancestor
93269276|NCT03520478|Hormone Antagonists|hormone antagonists|mesh-ancestor
93269277|NCT03520478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269278|NCT03520478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269279|NCT03520478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269280|NCT00102648|Temozolomide|temozolomide|mesh-list
93269281|NCT00102648|Lonafarnib|lonafarnib|mesh-list
93269282|NCT00102648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93269283|NCT00102648|Alkylating Agents|alkylating agents|mesh-ancestor
93269284|NCT00102648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269285|NCT00102648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269286|NCT00102648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269287|NCT03290287|Bromides|bromides|mesh-list
93269288|NCT03290287|Anticonvulsants|anticonvulsants|mesh-ancestor
93269289|NCT02253888|Ritonavir|ritonavir|mesh-list
93269290|NCT02253888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93269291|NCT02253888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93269292|NCT02253888|Protease Inhibitors|protease inhibitors|mesh-ancestor
93269293|NCT02253888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269294|NCT02253888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269295|NCT02253888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93269296|NCT02253888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93269297|NCT02253888|Antiviral Agents|antiviral agents|mesh-ancestor
93269298|NCT02253888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269299|NCT02253888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93269300|NCT02253888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93269301|NCT05430802|Pemetrexed|pemetrexed|mesh-list
93269302|NCT05430802|Aflutinib|aflutinib|mesh-list
93269303|NCT05430802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269304|NCT05430802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269305|NCT05430802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269306|NCT05430802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93269307|NCT05430802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93269308|NCT05430802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269309|NCT05524038|Dexamethasone|dexamethasone|mesh-list
93269310|NCT05524038|Dexamethasone acetate|dexamethasone acetate|mesh-list
93269311|NCT05524038|Bupivacaine|bupivacaine|mesh-list
93269312|NCT05524038|BB 1101|bb 1101|mesh-list
93269313|NCT05524038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93269314|NCT05524038|Antiemetics|antiemetics|mesh-ancestor
93269315|NCT05524038|Autonomic Agents|autonomic agents|mesh-ancestor
93269316|NCT05524038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269317|NCT05524038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269318|NCT05524038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269319|NCT05524038|Glucocorticoids|glucocorticoids|mesh-ancestor
93269320|NCT05524038|Hormones|hormones|mesh-ancestor
93269321|NCT05524038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269322|NCT05524038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269323|NCT05524038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269324|NCT05524038|Protease Inhibitors|protease inhibitors|mesh-ancestor
93269325|NCT05524038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269326|NCT05524038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269327|NCT05524038|Anesthetics, Local|anesthetics, local|mesh-ancestor
93269328|NCT05524038|Anesthetics|anesthetics|mesh-ancestor
93269329|NCT05524038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269330|NCT05524038|Sensory System Agents|sensory system agents|mesh-ancestor
93269331|NCT03240835|Docetaxel|docetaxel|mesh-list
93269332|NCT03240835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269333|NCT03240835|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269334|NCT03240835|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269335|NCT03240835|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269336|NCT03240835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269337|NCT04118868|Pembrolizumab|pembrolizumab|mesh-list
93269338|NCT04118868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269339|NCT04118868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269340|NCT04118868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93269341|NCT04118868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941384|NCT00865540|Prednisolone|prednisolone|mesh-list
93269342|NCT04900350|Azacitidine|azacitidine|mesh-list
93269343|NCT04900350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93269344|NCT04900350|Antimetabolites|antimetabolites|mesh-ancestor
93269345|NCT04900350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269346|NCT04900350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269347|NCT04900350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269348|NCT02292290|Pioglitazone|pioglitazone|mesh-list
93269349|NCT02292290|Liraglutide|liraglutide|mesh-list
93269350|NCT02292290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93269351|NCT02292290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269352|NCT02292290|Incretins|incretins|mesh-ancestor
93269353|NCT02292290|Hormones|hormones|mesh-ancestor
93269354|NCT02292290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269355|NCT02299232|Dexmedetomidine|dexmedetomidine|mesh-list
93269356|NCT02299232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93269357|NCT02299232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269358|NCT02299232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269359|NCT02299232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93269360|NCT02299232|Analgesics|analgesics|mesh-ancestor
93269361|NCT02299232|Sensory System Agents|sensory system agents|mesh-ancestor
93269362|NCT02299232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269363|NCT02299232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93269364|NCT02299232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93269365|NCT02299232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93269366|NCT02299232|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269367|NCT02299232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269368|NCT02299232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269369|NCT02963493|Dexamethasone|dexamethasone|mesh-list
93269370|NCT02963493|Melphalan|melphalan|mesh-list
93269371|NCT02963493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93269372|NCT02963493|Antiemetics|antiemetics|mesh-ancestor
93269373|NCT02963493|Autonomic Agents|autonomic agents|mesh-ancestor
93269374|NCT02963493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269375|NCT02963493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269376|NCT02963493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269377|NCT02963493|Glucocorticoids|glucocorticoids|mesh-ancestor
93269378|NCT02963493|Hormones|hormones|mesh-ancestor
93269379|NCT02963493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269380|NCT02963493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269381|NCT02963493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269382|NCT02963493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93269383|NCT02963493|Alkylating Agents|alkylating agents|mesh-ancestor
93269384|NCT02963493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269385|NCT02963493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93269386|NCT02963493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269387|NCT02963493|Immunologic Factors|immunologic factors|mesh-ancestor
93269388|NCT02299310|Valsartan|valsartan|mesh-list
93269389|NCT02299310|Perindopril|perindopril|mesh-list
93269390|NCT02299310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269391|NCT02299310|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92563980|NCT00161668|Immunotoxins|immunotoxins|mesh-ancestor
93269392|NCT02299310|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93269393|NCT02299310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269394|NCT02299310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93269395|NCT02299310|Protease Inhibitors|protease inhibitors|mesh-ancestor
93269396|NCT02299310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269397|NCT03519776|Progesterone|progesterone|mesh-list
93269398|NCT03519776|Progestins|progestins|mesh-ancestor
93269399|NCT03519776|Hormones|hormones|mesh-ancestor
93269400|NCT03519776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269401|NCT03519776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269402|NCT02295566|Nitric Oxide|nitric oxide|mesh-list
93269403|NCT02295566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93269404|NCT02295566|Autonomic Agents|autonomic agents|mesh-ancestor
93269405|NCT02295566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269406|NCT02295566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269407|NCT02295566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93269408|NCT02295566|Respiratory System Agents|respiratory system agents|mesh-ancestor
93269409|NCT02295566|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93269410|NCT02295566|Antioxidants|antioxidants|mesh-ancestor
93269411|NCT02295566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269412|NCT02295566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269413|NCT02295566|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93269414|NCT02295566|Vasodilator Agents|vasodilator agents|mesh-ancestor
93269415|NCT02295566|Gasotransmitters|gasotransmitters|mesh-ancestor
93269416|NCT02295566|Protective Agents|protective agents|mesh-ancestor
93269417|NCT05283681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93269418|NCT05283681|Immunologic Factors|immunologic factors|mesh-ancestor
93269419|NCT05283681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269420|NCT03513458|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93269421|NCT03513458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269422|NCT03738397|Upadacitinib|upadacitinib|mesh-list
93269423|NCT03738397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93269424|NCT03738397|Immunologic Factors|immunologic factors|mesh-ancestor
93269425|NCT03738397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269426|NCT03738397|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93269427|NCT03738397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269428|NCT03738397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269429|NCT03738397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269430|NCT03738397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269432|NCT03643497|Linezolid|linezolid|mesh-list
93269433|NCT03643497|Anti-Infective Agents|anti-infective agents|mesh-list
93269434|NCT03643497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93269435|NCT03643497|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93269436|NCT03643497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269437|NCT03643497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269438|NCT03519542|Sunitinib|sunitinib|mesh-list
93269439|NCT03519542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269440|NCT03519542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93269441|NCT03519542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93269442|NCT03519542|Growth Substances|growth substances|mesh-ancestor
93269443|NCT03519542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269444|NCT03519542|Growth Inhibitors|growth inhibitors|mesh-ancestor
93269445|NCT03519542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269446|NCT03519542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269447|NCT03519542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269448|NCT03516500|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93269449|NCT03516500|Hematinics|hematinics|mesh-ancestor
93269450|NCT02293148|Moxifloxacin|moxifloxacin|mesh-list
93269451|NCT02293148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93269452|NCT02293148|Glycine|glycine|mesh-list
93269453|NCT02293148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93269454|NCT02293148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269455|NCT02293148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93269456|NCT02293148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93269457|NCT02293148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269458|NCT02293148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269459|NCT02293148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269460|NCT02293148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93269461|NCT02293148|Contraceptive Agents|contraceptive agents|mesh-ancestor
93269462|NCT02293148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269463|NCT02293148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269464|NCT02293148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93269465|NCT02293148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93269466|NCT02293148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93269467|NCT02293148|Glycine Agents|glycine agents|mesh-ancestor
93269468|NCT02293148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269469|NCT03519152|Diclofenac|diclofenac|mesh-list
93269470|NCT03519152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93269471|NCT03519152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93269472|NCT03519152|Analgesics|analgesics|mesh-ancestor
93269473|NCT03519152|Sensory System Agents|sensory system agents|mesh-ancestor
93269474|NCT03519152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269475|NCT03519152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269476|NCT03519152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93269477|NCT03519152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269478|NCT03519152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93269479|NCT03519152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269480|NCT03519152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269481|NCT02959983|Eluxadoline|eluxadoline|mesh-list
93269482|NCT02959983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269483|NCT03516188|Antacids|antacids|mesh-list
93269484|NCT03516188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269485|NCT03516188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269486|NCT03512990|Bupivacaine|bupivacaine|mesh-list
93269487|NCT03512990|Anesthetics, Local|anesthetics, local|mesh-ancestor
93269488|NCT03512990|Anesthetics|anesthetics|mesh-ancestor
93269489|NCT03512990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269490|NCT03512990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269491|NCT03512990|Sensory System Agents|sensory system agents|mesh-ancestor
93269492|NCT03512990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269493|NCT03512834|Paclitaxel|paclitaxel|mesh-list
93269494|NCT03512834|Avelumab|avelumab|mesh-list
93269495|NCT03512834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269496|NCT03512834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269497|NCT03512834|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269498|NCT03512834|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269499|NCT03512834|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269500|NCT03512834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269501|NCT03512834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269502|NCT03640221|Ertugliflozin|ertugliflozin|mesh-list
93269503|NCT03640221|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93269504|NCT03640221|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93269505|NCT03640221|Antihypertensive Agents|antihypertensive agents|mesh-list
93269506|NCT03640221|Diuretics|diuretics|mesh-ancestor
93269507|NCT03640221|Natriuretic Agents|natriuretic agents|mesh-ancestor
93269508|NCT03640221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269509|NCT03640221|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93269510|NCT03640221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269511|NCT03640221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269512|NCT03640221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93269513|NCT03518528|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93269514|NCT03518528|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93269515|NCT03518528|Estradiol|estradiol|mesh-list
93269516|NCT03518528|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93269517|NCT03518528|Estrogens|estrogens|mesh-ancestor
93269518|NCT03518528|Hormones|hormones|mesh-ancestor
93269519|NCT03518528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269520|NCT03518528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269521|NCT03518528|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93269522|NCT03518528|Contraceptive Agents|contraceptive agents|mesh-ancestor
93269523|NCT03518528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269524|NCT03518528|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93269525|NCT03515798|Paclitaxel|paclitaxel|mesh-list
93269526|NCT03515798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93269527|NCT03515798|Cyclophosphamide|cyclophosphamide|mesh-list
93269528|NCT03515798|Pembrolizumab|pembrolizumab|mesh-list
93269529|NCT03515798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269530|NCT03515798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269531|NCT03515798|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269532|NCT03515798|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269533|NCT03515798|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269534|NCT03515798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269535|NCT03515798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269536|NCT03515798|Immunologic Factors|immunologic factors|mesh-ancestor
93269537|NCT03515798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269538|NCT03515798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269539|NCT03515798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93269540|NCT03515798|Alkylating Agents|alkylating agents|mesh-ancestor
93269541|NCT03515798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93269542|NCT03515798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269543|NCT03515798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93269544|NCT03041701|Dasatinib|dasatinib|mesh-list
93269545|NCT03041701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269546|NCT03041701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269547|NCT03041701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269548|NCT03041701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269549|NCT02293694|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93269550|NCT02293694|Medroxyprogesterone|medroxyprogesterone|mesh-list
93269551|NCT02293694|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93269552|NCT02293694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93269553|NCT02293694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93269554|NCT02293694|Contraceptive Agents|contraceptive agents|mesh-ancestor
93269555|NCT02293694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269556|NCT02293694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269557|NCT02293694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93269558|NCT02293694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93269559|NCT02293694|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93269560|NCT02293694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269561|NCT02293694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941607|NCT00861874|Sirolimus|sirolimus|mesh-list
93269563|NCT02956629|Ruzasvir|ruzasvir|mesh-list
93269564|NCT02956629|Uprifosbuvir|uprifosbuvir|mesh-list
93269565|NCT02956629|Antimetabolites|antimetabolites|mesh-ancestor
93269566|NCT02956629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269567|NCT02956629|Antiviral Agents|antiviral agents|mesh-ancestor
93269568|NCT02956629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269569|NCT02297204|Aflibercept|aflibercept|mesh-list
93269570|NCT02297204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93269571|NCT02297204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93269572|NCT02297204|Growth Substances|growth substances|mesh-ancestor
93269573|NCT02297204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269574|NCT02297204|Growth Inhibitors|growth inhibitors|mesh-ancestor
93269575|NCT02297204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269576|NCT02294006|Metformin|metformin|mesh-list
93269577|NCT02294006|Everolimus|everolimus|mesh-list
93269578|NCT02294006|Octreotide|octreotide|mesh-list
93269579|NCT02294006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93269580|NCT02294006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269581|NCT02294006|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93269582|NCT02294006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269583|NCT02294006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269584|NCT02294006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269585|NCT02294006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93269586|NCT02294006|Immunologic Factors|immunologic factors|mesh-ancestor
93269587|NCT02294006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269588|NCT02294006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269589|NCT02294006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269590|NCT02294084|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93269591|NCT02294084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93269592|NCT02294084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269593|NCT02294084|Incretins|incretins|mesh-ancestor
93269594|NCT02294084|Hormones|hormones|mesh-ancestor
93269595|NCT02294084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269596|NCT02294084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93269597|NCT02294084|Protease Inhibitors|protease inhibitors|mesh-ancestor
93269598|NCT02294084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269599|NCT02294084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269600|NCT01597258|Crizotinib|crizotinib|mesh-list
93269601|NCT01597258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269602|NCT01597258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269603|NCT01597258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269604|NCT01597258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269605|NCT02958267|Hyaluronic Acid|hyaluronic acid|mesh-list
93269606|NCT02958267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93269607|NCT02958267|Immunologic Factors|immunologic factors|mesh-ancestor
93269608|NCT02958267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269609|NCT02958267|Viscosupplements|viscosupplements|mesh-ancestor
93269610|NCT02958267|Protective Agents|protective agents|mesh-ancestor
93269611|NCT02302430|Oxytocin|oxytocin|mesh-list
93269612|NCT02302430|Oxytocics|oxytocics|mesh-ancestor
93269613|NCT02302430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269614|NCT02302430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269615|NCT02300948|Folic Acid|folic acid|mesh-list
93269616|NCT02300948|Vitamin B Complex|vitamin b complex|mesh-list
93269617|NCT02300948|Hematinics|hematinics|mesh-ancestor
93269618|NCT02300948|Vitamins|vitamins|mesh-ancestor
93269619|NCT02300948|Micronutrients|micronutrients|mesh-ancestor
93269620|NCT02300948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269621|NCT02302508|Clopidogrel|clopidogrel|mesh-list
93269622|NCT02302508|Ticagrelor|ticagrelor|mesh-list
93269623|NCT02302508|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93269624|NCT02302508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93269625|NCT02302508|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93269626|NCT02302508|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93269627|NCT02302508|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93269628|NCT02302508|Purinergic Agents|purinergic agents|mesh-ancestor
93269629|NCT02302508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269630|NCT02302508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269631|NCT02302508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269632|NCT02297594|Ziresovir|ziresovir|mesh-list
93269633|NCT02297594|Antiviral Agents|antiviral agents|mesh-ancestor
93269634|NCT02297594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93269635|NCT02301026|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93269636|NCT02301026|Hematinics|hematinics|mesh-ancestor
93269637|NCT01952574|Erenumab|erenumab|mesh-list
93269638|NCT01952574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93269639|NCT01952574|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93269640|NCT01952574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269641|NCT01952574|Analgesics|analgesics|mesh-ancestor
93269642|NCT01952574|Sensory System Agents|sensory system agents|mesh-ancestor
93269643|NCT01952574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269644|NCT01952574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269645|NCT01952574|Immunologic Factors|immunologic factors|mesh-ancestor
93269646|NCT02302586|Morphine|morphine|mesh-list
93269647|NCT02302586|Bupivacaine|bupivacaine|mesh-list
93269648|NCT02302586|Anesthetics, Local|anesthetics, local|mesh-ancestor
93269649|NCT02302586|Anesthetics|anesthetics|mesh-ancestor
93269650|NCT02302586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269651|NCT02302586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269652|NCT02302586|Sensory System Agents|sensory system agents|mesh-ancestor
93269653|NCT02302586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269654|NCT02302586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93269655|NCT02302586|Narcotics|narcotics|mesh-ancestor
93269656|NCT02302586|Analgesics|analgesics|mesh-ancestor
93269657|NCT04484272|Analgesics, Opioid|analgesics, opioid|mesh-list
93269658|NCT04484272|Narcotics|narcotics|mesh-ancestor
93269659|NCT04484272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269660|NCT04484272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269661|NCT04484272|Analgesics|analgesics|mesh-ancestor
93269662|NCT04484272|Sensory System Agents|sensory system agents|mesh-ancestor
93269663|NCT04484272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269664|NCT01551472|Vitamin E|vitamin e|mesh-list
93269665|NCT01551472|Vitamins|vitamins|mesh-ancestor
93269666|NCT01551472|Micronutrients|micronutrients|mesh-ancestor
93269667|NCT01551472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269668|NCT01551472|Antioxidants|antioxidants|mesh-ancestor
93269669|NCT01551472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269670|NCT01551472|Protective Agents|protective agents|mesh-ancestor
93269671|NCT02254044|Maytansine|maytansine|mesh-list
93269672|NCT02254044|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
93269673|NCT02254044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269674|NCT02254044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269675|NCT02254044|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269676|NCT02254044|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269677|NCT02254044|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269678|NCT02254044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269679|NCT02254044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269680|NCT02254044|Immunotoxins|immunotoxins|mesh-ancestor
93269681|NCT02254044|Immunoconjugates|immunoconjugates|mesh-ancestor
93269682|NCT02254044|Immunologic Factors|immunologic factors|mesh-ancestor
93269683|NCT02254044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269684|NCT02959437|Pembrolizumab|pembrolizumab|mesh-list
93269685|NCT02959437|Azacitidine|azacitidine|mesh-list
93269686|NCT02959437|INCB057643|incb057643|mesh-list
93269687|NCT02959437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93269688|NCT02959437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269689|NCT02959437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93269690|NCT02959437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269691|NCT02959437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93269692|NCT02959437|Antimetabolites|antimetabolites|mesh-ancestor
93269693|NCT02959437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269694|NCT02297906|Ketorolac|ketorolac|mesh-list
93269695|NCT02297906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93269696|NCT02297906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93269697|NCT02297906|Analgesics|analgesics|mesh-ancestor
93269698|NCT02297906|Sensory System Agents|sensory system agents|mesh-ancestor
93269699|NCT02297906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269700|NCT02297906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269701|NCT02297906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93269702|NCT02297906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269703|NCT02297906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93269704|NCT02297906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269705|NCT02297906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269706|NCT03511820|Amphotericin B|amphotericin b|mesh-list
93269707|NCT03511820|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93269708|NCT03511820|Amebicides|amebicides|mesh-ancestor
93269709|NCT03511820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93269710|NCT03511820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93269711|NCT03511820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564302|NCT00163384|Hormones|hormones|mesh-ancestor
93269712|NCT03511820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93269713|NCT03511820|Antifungal Agents|antifungal agents|mesh-ancestor
92941756|NCT00804921|Natriuretic Agents|natriuretic agents|mesh-ancestor
93269714|NCT02957331|Propranolol|propranolol|mesh-list
93269715|NCT02957331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93269716|NCT02957331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93269717|NCT02957331|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269718|NCT02957331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269719|NCT02957331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269720|NCT02957331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269721|NCT02957331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269722|NCT02957331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269723|NCT02957331|Vasodilator Agents|vasodilator agents|mesh-ancestor
93269724|NCT02298062|Infliximab|infliximab|mesh-list
93269725|NCT02298062|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93269726|NCT02298062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93269727|NCT02298062|Dermatologic Agents|dermatologic agents|mesh-ancestor
93269728|NCT02298062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269729|NCT02298062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269730|NCT03515018|Imatinib Mesylate|imatinib mesylate|mesh-list
93269731|NCT03515018|Hydroxyurea|hydroxyurea|mesh-list
93269732|NCT03515018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269733|NCT03515018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93269734|NCT03515018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269735|NCT03515018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269736|NCT03515018|Antisickling Agents|antisickling agents|mesh-ancestor
93269737|NCT03515018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93269738|NCT03748966|Calcitriol|calcitriol|mesh-list
93269739|NCT03748966|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93269740|NCT03748966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93269741|NCT03748966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269742|NCT03748966|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93269743|NCT03748966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269744|NCT03748966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269745|NCT03748966|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93269746|NCT03748966|Vitamins|vitamins|mesh-ancestor
93269747|NCT03748966|Micronutrients|micronutrients|mesh-ancestor
93269748|NCT03748966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93269749|NCT05891249|Luspatercept|luspatercept|mesh-list
93269750|NCT05891249|Hematinics|hematinics|mesh-ancestor
93269751|NCT05891145|Midazolam|midazolam|mesh-list
93269752|NCT05891145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93269753|NCT05891145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93269754|NCT05891145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269755|NCT05891145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269756|NCT05891145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93269757|NCT05891145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93269758|NCT05891145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93269759|NCT05891145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93269760|NCT05891145|Anesthetics, General|anesthetics, general|mesh-ancestor
93269761|NCT05891145|Anesthetics|anesthetics|mesh-ancestor
93269762|NCT05891145|GABA Modulators|gaba modulators|mesh-ancestor
93269763|NCT05891145|GABA Agents|gaba agents|mesh-ancestor
93269764|NCT05891145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269765|NCT05891145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269766|NCT05891132|Lidocaine|lidocaine|mesh-list
93269767|NCT05891132|Prilocaine|prilocaine|mesh-list
93269768|NCT05891132|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93269769|NCT05891132|Anesthetics|anesthetics|mesh-list
93269770|NCT05891132|Anesthetics, Local|anesthetics, local|mesh-ancestor
93269771|NCT05891132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269772|NCT05891132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269773|NCT05891132|Sensory System Agents|sensory system agents|mesh-ancestor
93269774|NCT05891132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269775|NCT05891132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269776|NCT05891132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93269777|NCT05891132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93269778|NCT05891132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269779|NCT05891132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269780|NCT05891132|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93269781|NCT05891119|Vitamin K|vitamin k|mesh-list
93269782|NCT05891119|Metoprolol|metoprolol|mesh-list
93269783|NCT05891119|Midazolam|midazolam|mesh-list
93269784|NCT05891119|Caffeine|caffeine|mesh-list
93269785|NCT05891119|Caffeine citrate|caffeine citrate|mesh-list
93269786|NCT05891119|Omeprazole|omeprazole|mesh-list
93269787|NCT05891119|Warfarin|warfarin|mesh-list
93269788|NCT05891119|Vitamins|vitamins|mesh-ancestor
93269789|NCT05891119|Micronutrients|micronutrients|mesh-ancestor
93269790|NCT05891119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269791|NCT05891119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93269792|NCT05891119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93269793|NCT05891119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269794|NCT05891119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93269795|NCT05891119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93269796|NCT05891119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93269797|NCT05891119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93269798|NCT05891119|Anesthetics, General|anesthetics, general|mesh-ancestor
93269799|NCT05891119|Anesthetics|anesthetics|mesh-ancestor
93269800|NCT05891119|GABA Modulators|gaba modulators|mesh-ancestor
93269801|NCT05891119|GABA Agents|gaba agents|mesh-ancestor
93269802|NCT05891119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269803|NCT05891119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269804|NCT05891119|Anticoagulants|anticoagulants|mesh-ancestor
93269805|NCT05891119|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93269806|NCT05891119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93269807|NCT05891119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269808|NCT05891119|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93269809|NCT05891119|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93269810|NCT05891119|Purinergic Agents|purinergic agents|mesh-ancestor
93269811|NCT05891119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93269812|NCT05891119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93269813|NCT05891119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93269814|NCT05891119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269815|NCT05891119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93269816|NCT05891119|Sympatholytics|sympatholytics|mesh-ancestor
93269817|NCT05891119|Autonomic Agents|autonomic agents|mesh-ancestor
93269818|NCT05891119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269819|NCT05891119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93269820|NCT05891119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93269821|NCT05891119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93269822|NCT05891119|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269823|NCT05891119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93269824|NCT05891119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93269825|NCT05891119|Hemostatics|hemostatics|mesh-ancestor
93269826|NCT05891119|Coagulants|coagulants|mesh-ancestor
93269827|NCT05891093|Tamoxifen|tamoxifen|mesh-list
93269828|NCT05891093|Toremifene|toremifene|mesh-list
93269829|NCT05891093|Letrozole|letrozole|mesh-list
93269830|NCT05891093|Anastrozole|anastrozole|mesh-list
93269831|NCT05891093|Exemestane|exemestane|mesh-list
93269832|NCT05891093|Fluzoparib|fluzoparib|mesh-list
93269833|NCT05891093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269834|NCT05891093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93269835|NCT05891093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93269836|NCT05891093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269837|NCT05891093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269838|NCT05891093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93269839|NCT05891093|Hormone Antagonists|hormone antagonists|mesh-ancestor
93269840|NCT05891093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269841|NCT05891093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269842|NCT05891093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269843|NCT05891093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93269844|NCT05891093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93269845|NCT05891093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93269846|NCT05891093|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93269847|NCT05891080|Paclitaxel|paclitaxel|mesh-list
92564444|NCT00044928|Tazobactam|tazobactam|mesh-list
93269848|NCT05891080|Carboplatin|carboplatin|mesh-list
93269849|NCT05891080|Pemetrexed|pemetrexed|mesh-list
93269850|NCT05891080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93269851|NCT05891080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269852|NCT05891080|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269853|NCT05891080|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269854|NCT05891080|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269855|NCT05891080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269856|NCT05891080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269857|NCT05891080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93269858|NCT05891080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93269859|NCT05890911|Dopamine|dopamine|mesh-list
93269860|NCT05890911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93269861|NCT05890911|Sympathomimetics|sympathomimetics|mesh-ancestor
93269862|NCT05890911|Autonomic Agents|autonomic agents|mesh-ancestor
93269863|NCT05890911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269864|NCT05890911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269865|NCT05890911|Dopamine Agents|dopamine agents|mesh-ancestor
93269866|NCT05890911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269867|NCT05890911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269868|NCT05890911|Protective Agents|protective agents|mesh-ancestor
93269869|NCT05890768|Risperidone|risperidone|mesh-list
93269870|NCT05890768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93269871|NCT05890768|Serotonin Agents|serotonin agents|mesh-ancestor
93269872|NCT05890768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269873|NCT05890768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269874|NCT05890768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269875|NCT05890768|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93269876|NCT05890768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93269877|NCT05890768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269878|NCT05890768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93269879|NCT05890768|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93269880|NCT05890768|Dopamine Agents|dopamine agents|mesh-ancestor
93269881|NCT05890703|Lidocaine|lidocaine|mesh-list
93269882|NCT05890703|Tetracaine|tetracaine|mesh-list
93269883|NCT05890703|Anesthetics, Local|anesthetics, local|mesh-ancestor
93269884|NCT05890703|Anesthetics|anesthetics|mesh-ancestor
93269885|NCT05890703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269886|NCT05890703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269887|NCT05890703|Sensory System Agents|sensory system agents|mesh-ancestor
93269888|NCT05890703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269889|NCT05890703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269890|NCT05890703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93269891|NCT05890703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93269892|NCT05890703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269893|NCT05890703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269894|NCT05890664|Colchicine|colchicine|mesh-list
93269895|NCT05890664|Gout Suppressants|gout suppressants|mesh-ancestor
93269896|NCT05890664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269897|NCT05890664|Tubulin Modulators|tubulin modulators|mesh-ancestor
93269898|NCT05890664|Antimitotic Agents|antimitotic agents|mesh-ancestor
93269899|NCT05890664|Mitosis Modulators|mitosis modulators|mesh-ancestor
93269900|NCT05890664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269901|NCT05890664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269902|NCT05890638|Albuterol|albuterol|mesh-list
93269903|NCT05890638|Ipratropium|ipratropium|mesh-list
93269904|NCT05890638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93269905|NCT05890638|Autonomic Agents|autonomic agents|mesh-ancestor
93269906|NCT05890638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269907|NCT05890638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269908|NCT05890638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93269909|NCT05890638|Respiratory System Agents|respiratory system agents|mesh-ancestor
93269910|NCT05890638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93269911|NCT05890638|Cholinergic Agents|cholinergic agents|mesh-ancestor
93269912|NCT05890638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269913|NCT05890638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269914|NCT05890638|Tocolytic Agents|tocolytic agents|mesh-ancestor
93269915|NCT05890638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93269916|NCT05890638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93269917|NCT05890638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93269918|NCT05890638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93269919|NCT05890638|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269920|NCT05890586|Fluvoxamine|fluvoxamine|mesh-list
93269921|NCT05890586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269922|NCT05890586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269923|NCT05890586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93269924|NCT05890586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93269925|NCT05890586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269926|NCT05890586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269927|NCT05890586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93269928|NCT05890586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93269929|NCT05890586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93269930|NCT05890586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269931|NCT05890586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269932|NCT05890586|Serotonin Agents|serotonin agents|mesh-ancestor
93269933|NCT05890586|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93269934|NCT05890586|Antidepressive Agents|antidepressive agents|mesh-ancestor
93269935|NCT05890586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93269936|NCT05890586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93269937|NCT05890586|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93269938|NCT05890495|Lidocaine|lidocaine|mesh-list
92941990|NCT00862420|Ticlopidine|ticlopidine|mesh-list
93269939|NCT05890495|Anesthetics, Local|anesthetics, local|mesh-ancestor
93269940|NCT05890495|Anesthetics|anesthetics|mesh-ancestor
93269941|NCT05890495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93269942|NCT05890495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269943|NCT05890495|Sensory System Agents|sensory system agents|mesh-ancestor
93269944|NCT05890495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93269945|NCT05890495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93269946|NCT05890495|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93269947|NCT05890495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93269948|NCT05890495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93269949|NCT05890495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269950|NCT05890287|Tamoxifen|tamoxifen|mesh-list
93269951|NCT05890287|Letrozole|letrozole|mesh-list
93269952|NCT05890287|Fulvestrant|fulvestrant|mesh-list
93269953|NCT05890287|Anastrozole|anastrozole|mesh-list
93269954|NCT05890287|Exemestane|exemestane|mesh-list
93269955|NCT05890287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93269956|NCT05890287|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93269957|NCT05890287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93269958|NCT05890287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269959|NCT05890287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269960|NCT05890287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93269961|NCT05890287|Hormone Antagonists|hormone antagonists|mesh-ancestor
93269962|NCT05890287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93269963|NCT05890287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269964|NCT05890287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93269965|NCT05890287|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93269966|NCT05890287|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93269967|NCT05890287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93269968|NCT05890287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93269969|NCT05890235|Tamsulosin|tamsulosin|mesh-list
93269970|NCT05890235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93269971|NCT05890235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93269972|NCT05890235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93269973|NCT05890235|Adrenergic Agents|adrenergic agents|mesh-ancestor
93269974|NCT05890235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93269975|NCT05890235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269976|NCT05890235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269977|NCT05890235|Urological Agents|urological agents|mesh-ancestor
93269978|NCT05888233|Allopurinol|allopurinol|mesh-list
93269979|NCT05888233|Antimetabolites|antimetabolites|mesh-ancestor
93269980|NCT05888233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93269981|NCT05888233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93269982|NCT05888233|Gout Suppressants|gout suppressants|mesh-ancestor
93269983|NCT05888233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93269984|NCT05888233|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93269985|NCT05888233|Antioxidants|antioxidants|mesh-ancestor
93269986|NCT05888233|Protective Agents|protective agents|mesh-ancestor
93269987|NCT05888233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269988|NCT05887505|Vitamin D|vitamin d|mesh-list
93269989|NCT05887505|Vitamins|vitamins|mesh-ancestor
93269990|NCT05887505|Micronutrients|micronutrients|mesh-ancestor
93269991|NCT05887505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269992|NCT05887505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93269993|NCT05882162|Calcium|calcium|mesh-list
93269994|NCT05882162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93269995|NCT05882162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93269996|NCT05881486|Ondansetron|ondansetron|mesh-list
93269997|NCT05881486|Fosaprepitant|fosaprepitant|mesh-list
93269998|NCT05881486|Aprepitant|aprepitant|mesh-list
93269999|NCT05881486|Antiemetics|antiemetics|mesh-ancestor
93270000|NCT05881486|Autonomic Agents|autonomic agents|mesh-ancestor
93270001|NCT05881486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270002|NCT05881486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270003|NCT05881486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270004|NCT05881486|Antipruritics|antipruritics|mesh-ancestor
93270005|NCT05881486|Dermatologic Agents|dermatologic agents|mesh-ancestor
93270006|NCT05881486|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93270007|NCT05881486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93270008|NCT05881486|Serotonin Agents|serotonin agents|mesh-ancestor
93270009|NCT05881486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270010|NCT05881486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270011|NCT05881486|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93270012|NCT05874570|Metronidazole|metronidazole|mesh-list
93270013|NCT05874570|Doxycycline|doxycycline|mesh-list
93270014|NCT05874570|Tetracycline|tetracycline|mesh-list
93270015|NCT05874570|Potassium Citrate|potassium citrate|mesh-list
93270016|NCT05874570|Esomeprazole|esomeprazole|mesh-list
93270017|NCT05874570|Bismuth|bismuth|mesh-list
93270018|NCT05874570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270019|NCT05874570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270020|NCT05874570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93270021|NCT05874570|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270022|NCT05874570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270023|NCT05874570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93270024|NCT05874570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270025|NCT05874570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93270026|NCT05874570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270027|NCT05874570|Antimalarials|antimalarials|mesh-ancestor
93270028|NCT05874570|Antacids|antacids|mesh-ancestor
93270029|NCT05874570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93270030|NCT05874570|Diuretics|diuretics|mesh-ancestor
93270031|NCT05874570|Natriuretic Agents|natriuretic agents|mesh-ancestor
93270032|NCT05874570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270033|NCT05874570|Expectorants|expectorants|mesh-ancestor
93270034|NCT05874570|Respiratory System Agents|respiratory system agents|mesh-ancestor
93270035|NCT05870579|Fulvestrant|fulvestrant|mesh-list
93270036|NCT05870579|Goserelin|goserelin|mesh-list
93270037|NCT05870579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270038|NCT05870579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270039|NCT05870579|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93270040|NCT05870579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93270041|NCT05870579|Hormone Antagonists|hormone antagonists|mesh-ancestor
93270042|NCT05870579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270043|NCT05870579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270044|NCT05856136|Fentanyl|fentanyl|mesh-list
93270045|NCT05856136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93270046|NCT05856136|Narcotics|narcotics|mesh-ancestor
93270047|NCT05856136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270048|NCT05856136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270049|NCT05856136|Analgesics|analgesics|mesh-ancestor
93270050|NCT05856136|Sensory System Agents|sensory system agents|mesh-ancestor
93270051|NCT05856136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270052|NCT05856136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93270053|NCT05856136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93270054|NCT05856136|Anesthetics, General|anesthetics, general|mesh-ancestor
93270055|NCT05856136|Anesthetics|anesthetics|mesh-ancestor
93270056|NCT05835258|Melatonin|melatonin|mesh-list
93270057|NCT05835258|Capsaicin|capsaicin|mesh-list
93270058|NCT05835258|Antioxidants|antioxidants|mesh-ancestor
93270059|NCT05835258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270060|NCT05835258|Protective Agents|protective agents|mesh-ancestor
93270061|NCT05835258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270062|NCT05835258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270063|NCT05835258|Antipruritics|antipruritics|mesh-ancestor
93270064|NCT05835258|Dermatologic Agents|dermatologic agents|mesh-ancestor
93270065|NCT05835258|Sensory System Agents|sensory system agents|mesh-ancestor
93270066|NCT05835258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270067|NCT05826912|Minocycline|minocycline|mesh-list
93270068|NCT05826912|Candesartan|candesartan|mesh-list
93270069|NCT05826912|Candesartan cilexetil|candesartan cilexetil|mesh-list
93270070|NCT05826912|Atorvastatin|atorvastatin|mesh-list
93270071|NCT05826912|Calcium|calcium|mesh-list
93270072|NCT05826912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93270073|NCT05826912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270074|NCT05826912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93270075|NCT05826912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93270076|NCT05826912|Antimetabolites|antimetabolites|mesh-ancestor
93270077|NCT05826912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270078|NCT05826912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93270079|NCT05826912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93270080|NCT05826912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270081|NCT05826912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93270082|NCT05826912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270083|NCT05826912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93270084|NCT05826912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93270085|NCT05826912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93270086|NCT05814042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93270087|NCT05810649|Hyaluronic Acid|hyaluronic acid|mesh-list
93270088|NCT05810649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93270089|NCT05810649|Immunologic Factors|immunologic factors|mesh-ancestor
93270090|NCT05810649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270092|NCT05810649|Protective Agents|protective agents|mesh-ancestor
93270093|NCT05806060|Paclitaxel|paclitaxel|mesh-list
93270094|NCT05806060|Vinorelbine|vinorelbine|mesh-list
93270095|NCT05806060|Carboplatin|carboplatin|mesh-list
93270096|NCT05806060|Capecitabine|capecitabine|mesh-list
93270097|NCT05806060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93270098|NCT05806060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270099|NCT05806060|Tubulin Modulators|tubulin modulators|mesh-ancestor
93270100|NCT05806060|Antimitotic Agents|antimitotic agents|mesh-ancestor
93270101|NCT05806060|Mitosis Modulators|mitosis modulators|mesh-ancestor
93270102|NCT05806060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270103|NCT05806060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270104|NCT05806060|Antimetabolites|antimetabolites|mesh-ancestor
93270105|NCT05770297|Propolis|propolis|mesh-list
93270106|NCT05770297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270107|NCT05765513|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93270108|NCT05760378|Carboplatin|carboplatin|mesh-list
93270109|NCT05760378|Capecitabine|capecitabine|mesh-list
93270110|NCT05760378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270111|NCT05760378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270112|NCT05760378|Antimetabolites|antimetabolites|mesh-ancestor
93270113|NCT05760378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270114|NCT05744635|Tacrolimus|tacrolimus|mesh-list
93270115|NCT05744635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270116|NCT05744635|Immunologic Factors|immunologic factors|mesh-ancestor
93270117|NCT05744635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270118|NCT05744635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93270119|NCT05744635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270120|NCT05744635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270121|NCT05733689|Paclitaxel|paclitaxel|mesh-list
93270122|NCT05733689|Docetaxel|docetaxel|mesh-list
93270123|NCT05733689|Carboplatin|carboplatin|mesh-list
93270124|NCT05733689|Pembrolizumab|pembrolizumab|mesh-list
93270125|NCT05733689|Nivolumab|nivolumab|mesh-list
93270126|NCT05733689|Irinotecan|irinotecan|mesh-list
93270127|NCT05733689|Folfirinox|folfirinox|mesh-list
93270128|NCT05733689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93270129|NCT05733689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270130|NCT05733689|Tubulin Modulators|tubulin modulators|mesh-ancestor
93270131|NCT05733689|Antimitotic Agents|antimitotic agents|mesh-ancestor
93270132|NCT05733689|Mitosis Modulators|mitosis modulators|mesh-ancestor
93270133|NCT05733689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270134|NCT05733689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270135|NCT05733689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270136|NCT05733689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93270137|NCT05733689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93270138|NCT05733689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270139|NCT05723874|Bosentan|bosentan|mesh-list
93270140|NCT05723874|BI 425809|bi 425809|mesh-list
93270141|NCT05723874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93270142|NCT05723874|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93270143|NCT05723874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270144|NCT05723874|Nootropic Agents|nootropic agents|mesh-ancestor
93270145|NCT05663957|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93270146|NCT05663957|Antiviral Agents|antiviral agents|mesh-ancestor
93270147|NCT05663957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270148|NCT05650554|Vaccines|vaccines|mesh-list
93270149|NCT05650554|Immunologic Factors|immunologic factors|mesh-ancestor
93270150|NCT05650554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270151|NCT05650164|Avelumab|avelumab|mesh-list
93270152|NCT05650164|Axitinib|axitinib|mesh-list
93270153|NCT05650164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270154|NCT05650164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270155|NCT05650164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270156|NCT05650164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270157|NCT05650164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270158|NCT05610826|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93270159|NCT05610826|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93270160|NCT05610826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942235|NCT00732290|Fluoxetine|fluoxetine|mesh-list
93270161|NCT05608837|Dexamethasone|dexamethasone|mesh-list
93270162|NCT05608837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93270163|NCT05608837|Antiemetics|antiemetics|mesh-ancestor
93270164|NCT05608837|Autonomic Agents|autonomic agents|mesh-ancestor
93270165|NCT05608837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270166|NCT05608837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270167|NCT05608837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270168|NCT05608837|Glucocorticoids|glucocorticoids|mesh-ancestor
93270169|NCT05608837|Hormones|hormones|mesh-ancestor
93270170|NCT05608837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270171|NCT05608837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270172|NCT05608837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270173|NCT05555706|Paclitaxel|paclitaxel|mesh-list
93270174|NCT05555706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93270175|NCT05555706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270176|NCT05555706|Tubulin Modulators|tubulin modulators|mesh-ancestor
93270177|NCT05555706|Antimitotic Agents|antimitotic agents|mesh-ancestor
93270178|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
93270179|NCT05555706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270180|NCT05553132|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93270181|NCT05553132|Hemostatics|hemostatics|mesh-ancestor
93270182|NCT05553132|Coagulants|coagulants|mesh-ancestor
93270183|NCT05521880|Oritavancin|oritavancin|mesh-list
93270184|NCT05521880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93270185|NCT05521880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270186|NCT05489887|Ceritinib|ceritinib|mesh-list
93270187|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270188|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270189|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270190|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270191|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
93270192|NCT05466799|Irinotecan|irinotecan|mesh-list
93270193|NCT05466799|Folfirinox|folfirinox|mesh-list
93270194|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270195|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93270196|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93270197|NCT05466799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270198|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270199|NCT05446727|Ropivacaine|ropivacaine|mesh-list
93270200|NCT05446727|Anesthetics, Local|anesthetics, local|mesh-ancestor
93270201|NCT05446727|Anesthetics|anesthetics|mesh-ancestor
93270202|NCT05446727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270203|NCT05446727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270204|NCT05446727|Sensory System Agents|sensory system agents|mesh-ancestor
93270205|NCT05446727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270206|NCT05354102|Nivolumab|nivolumab|mesh-list
93270207|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270208|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270209|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270210|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270211|NCT05349890|Pembrolizumab|pembrolizumab|mesh-list
93270212|NCT05349890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270213|NCT05349890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270214|NCT05349890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270215|NCT05349890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270216|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
93270217|NCT05301517|Hematinics|hematinics|mesh-ancestor
93270218|NCT05296304|Bexarotene|bexarotene|mesh-list
93270219|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270220|NCT05271448|Losartan|losartan|mesh-list
93270221|NCT05271448|Valsartan|valsartan|mesh-list
93270222|NCT05271448|Candesartan|candesartan|mesh-list
93270223|NCT05271448|Candesartan cilexetil|candesartan cilexetil|mesh-list
93270224|NCT05271448|Ramipril|ramipril|mesh-list
93270225|NCT05271448|Enalapril|enalapril|mesh-list
93270226|NCT05271448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93270227|NCT05271448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93270228|NCT05271448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93270229|NCT05271448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93270230|NCT05271448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270231|NCT05271448|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93270232|NCT05271448|Protease Inhibitors|protease inhibitors|mesh-ancestor
93270233|NCT05271448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270234|NCT05254405|Brexanolone|brexanolone|mesh-list
93270235|NCT05254405|Neurosteroids|neurosteroids|mesh-ancestor
93270236|NCT05254405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270237|NCT05254405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270238|NCT05254405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942282|NCT00732446|Contraceptive Agents|contraceptive agents|mesh-ancestor
93270239|NCT05254405|GABA Modulators|gaba modulators|mesh-ancestor
93270240|NCT05254405|GABA Agents|gaba agents|mesh-ancestor
93270242|NCT05223231|Immunoglobulins|immunoglobulins|mesh-list
93270243|NCT05223231|Immunologic Factors|immunologic factors|mesh-ancestor
93270244|NCT05223231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270245|NCT05215106|Durvalumab|durvalumab|mesh-list
93270246|NCT05215106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270247|NCT05215106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270248|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
93270249|NCT05187182|Nivolumab|nivolumab|mesh-list
93270250|NCT05187182|Trastuzumab|trastuzumab|mesh-list
93270251|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270252|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270253|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270254|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270255|NCT05177731|Cytarabine|cytarabine|mesh-list
93270256|NCT05177731|Decitabine|decitabine|mesh-list
93270257|NCT05177731|Venetoclax|venetoclax|mesh-list
93270258|NCT05177731|Idarubicin|idarubicin|mesh-list
93270259|NCT05177731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270260|NCT05177731|Antimetabolites|antimetabolites|mesh-ancestor
93270261|NCT05177731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270262|NCT05177731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270263|NCT05177731|Antiviral Agents|antiviral agents|mesh-ancestor
93270264|NCT05177731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270265|NCT05177731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270266|NCT05177731|Immunologic Factors|immunologic factors|mesh-ancestor
93270267|NCT05177731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270268|NCT05177731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270269|NCT05177731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93270270|NCT05177731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93270271|NCT05177731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93270272|NCT05171387|Androgens|androgens|mesh-list
93270273|NCT05171387|Hormones|hormones|mesh-ancestor
93270274|NCT05171387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270275|NCT05171387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270276|NCT05156710|Rituximab|rituximab|mesh-list
93270277|NCT05156710|Tacrolimus|tacrolimus|mesh-list
93270278|NCT05156710|Immunoglobulins|immunoglobulins|mesh-list
93270279|NCT05156710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93270280|NCT05156710|Antibodies|antibodies|mesh-list
93270281|NCT05156710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93270282|NCT05156710|gamma-Globulins|gamma-globulins|mesh-list
93270283|NCT05156710|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93270284|NCT05156710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270285|NCT05156710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270286|NCT05156710|Immunologic Factors|immunologic factors|mesh-ancestor
93270287|NCT05156710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270288|NCT05156710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270289|NCT05156710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270290|NCT05156710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93270291|NCT05156710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270292|NCT05156710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270293|NCT05110482|Oxytocin|oxytocin|mesh-list
93270294|NCT05110482|Carbetocin|carbetocin|mesh-list
93270295|NCT05110482|Oxytocics|oxytocics|mesh-ancestor
93270296|NCT05110482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93270297|NCT05110482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270298|NCT05054348|Pembrolizumab|pembrolizumab|mesh-list
93270299|NCT05054348|Cemiplimab|cemiplimab|mesh-list
93270300|NCT05054348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270301|NCT05054348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270302|NCT05054348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270303|NCT05054348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270304|NCT05029960|Brivaracetam|brivaracetam|mesh-list
93270305|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
93270306|NCT05005000|Triamcinolone|triamcinolone|mesh-list
93270307|NCT05005000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93270308|NCT05005000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93270309|NCT05005000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93270310|NCT05005000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93270311|NCT05005000|Glucocorticoids|glucocorticoids|mesh-ancestor
93270312|NCT05005000|Hormones|hormones|mesh-ancestor
93270313|NCT05005000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270314|NCT05005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270315|NCT05005000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270316|NCT05005000|Immunologic Factors|immunologic factors|mesh-ancestor
93270317|NCT05005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270318|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270319|NCT04989946|Nivolumab|nivolumab|mesh-list
93270320|NCT04989946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270321|NCT04989946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270322|NCT04989946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270323|NCT04989946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270324|NCT04987996|Pembrolizumab|pembrolizumab|mesh-list
93270325|NCT04987996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270326|NCT04987996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270327|NCT04987996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270328|NCT04987996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270329|NCT04916509|Fulvestrant|fulvestrant|mesh-list
93270330|NCT04916509|Palbociclib|palbociclib|mesh-list
93270331|NCT04916509|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93270332|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270333|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270334|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93270335|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93270336|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
93270337|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270338|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270339|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270340|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270341|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270342|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93270343|NCT04900792|Ascorbic Acid|ascorbic acid|mesh-list
93270344|NCT04900792|Temozolomide|temozolomide|mesh-list
93270345|NCT04900792|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93270346|NCT04900792|Vitamins|vitamins|mesh-ancestor
93270347|NCT04900792|Micronutrients|micronutrients|mesh-ancestor
93270348|NCT04900792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270349|NCT04900792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270350|NCT04900792|Alkylating Agents|alkylating agents|mesh-ancestor
93270351|NCT04900792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270352|NCT04900792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270353|NCT04900792|Antioxidants|antioxidants|mesh-ancestor
93270354|NCT04900792|Protective Agents|protective agents|mesh-ancestor
93270355|NCT04900792|Hematinics|hematinics|mesh-ancestor
93270356|NCT04900792|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93270357|NCT04900792|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93270358|NCT04891770|Tenofovir|tenofovir|mesh-list
93270359|NCT04891770|Nivolumab|nivolumab|mesh-list
93270360|NCT04891770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270361|NCT04891770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270362|NCT04891770|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270363|NCT04891770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270364|NCT04891770|Antiviral Agents|antiviral agents|mesh-ancestor
93270365|NCT04891770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270366|NCT04891770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93270367|NCT04891770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93270368|NCT04891770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270369|NCT04891770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93270370|NCT04891770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93270371|NCT04882774|Treprostinil|treprostinil|mesh-list
93270372|NCT04882774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93270373|NCT04870125|Carbon Monoxide|carbon monoxide|mesh-list
93270374|NCT04870125|Antimetabolites|antimetabolites|mesh-ancestor
93270375|NCT04870125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270376|NCT04870125|Gasotransmitters|gasotransmitters|mesh-ancestor
93270377|NCT04870125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270378|NCT04870125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270379|NCT04846920|Belzutifan|belzutifan|mesh-list
93270380|NCT04846920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270381|NCT04840615|Ipilimumab|ipilimumab|mesh-list
93270382|NCT04840615|LMB-100|lmb-100|mesh-list
93270383|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270384|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270385|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270386|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270387|NCT04840615|Immunoconjugates|immunoconjugates|mesh-ancestor
93270388|NCT04840615|Immunologic Factors|immunologic factors|mesh-ancestor
93270389|NCT04840615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270390|NCT04774406|Olaparib|olaparib|mesh-list
93270391|NCT04774406|Niraparib|niraparib|mesh-list
93270392|NCT04774406|Talazoparib|talazoparib|mesh-list
93270393|NCT04774406|Veliparib|veliparib|mesh-list
93270394|NCT04774406|Fluzoparib|fluzoparib|mesh-list
93270395|NCT04774406|Rucaparib|rucaparib|mesh-list
93270396|NCT04774406|Pamiparib|pamiparib|mesh-list
93270397|NCT04774406|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93270398|NCT04774406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270399|NCT04774406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270400|NCT04774406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270401|NCT04759833|Prucalopride|prucalopride|mesh-list
93270402|NCT04759833|Laxatives|laxatives|mesh-ancestor
93270403|NCT04759833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270404|NCT04759833|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93270405|NCT04759833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93270406|NCT04759833|Serotonin Agents|serotonin agents|mesh-ancestor
93270407|NCT04759833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270408|NCT04759833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270409|NCT04759833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270410|NCT04752813|Vitamin K|vitamin k|mesh-list
93270411|NCT04752813|Vitamin K 1|vitamin k 1|mesh-list
93270412|NCT04752813|Temozolomide|temozolomide|mesh-list
93270413|NCT04752813|Vitamins|vitamins|mesh-ancestor
93270414|NCT04752813|Micronutrients|micronutrients|mesh-ancestor
93270415|NCT04752813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270416|NCT04752813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270417|NCT04752813|Alkylating Agents|alkylating agents|mesh-ancestor
93270418|NCT04752813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270419|NCT04752813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270420|NCT04752813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93270421|NCT04752813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93270422|NCT04752813|Hemostatics|hemostatics|mesh-ancestor
93270423|NCT04752813|Coagulants|coagulants|mesh-ancestor
93270424|NCT04735367|Letrozole|letrozole|mesh-list
93270425|NCT04735367|Palbociclib|palbociclib|mesh-list
93270426|NCT04735367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270427|NCT04735367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93270428|NCT04735367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93270429|NCT04735367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270430|NCT04735367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270431|NCT04735367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93270432|NCT04735367|Hormone Antagonists|hormone antagonists|mesh-ancestor
93270433|NCT04735367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270434|NCT04735367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270435|NCT04735367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270436|NCT04720963|Dexmedetomidine|dexmedetomidine|mesh-list
93270437|NCT04720963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93270438|NCT04720963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270439|NCT04720963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270440|NCT04720963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93270441|NCT04720963|Analgesics|analgesics|mesh-ancestor
93270442|NCT04720963|Sensory System Agents|sensory system agents|mesh-ancestor
93270443|NCT04720963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270444|NCT04720963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93270445|NCT04720963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93270446|NCT04720963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93270447|NCT04720963|Adrenergic Agents|adrenergic agents|mesh-ancestor
93270448|NCT04720963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270449|NCT04720963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270450|NCT04715113|Sildenafil Citrate|sildenafil citrate|mesh-list
93270451|NCT04715113|Vasodilator Agents|vasodilator agents|mesh-ancestor
93270452|NCT04715113|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93270453|NCT04715113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93270454|NCT04715113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270455|NCT04715113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270456|NCT04715113|Urological Agents|urological agents|mesh-ancestor
93270457|NCT04713657|Propranolol|propranolol|mesh-list
93270458|NCT04713657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93270459|NCT04713657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93270460|NCT04713657|Adrenergic Agents|adrenergic agents|mesh-ancestor
93270461|NCT04713657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270462|NCT04713657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270463|NCT04713657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270464|NCT04713657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93270465|NCT04713657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93270466|NCT04713657|Vasodilator Agents|vasodilator agents|mesh-ancestor
93270467|NCT04711343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93270468|NCT04711343|Immunologic Factors|immunologic factors|mesh-ancestor
93270469|NCT04711343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270470|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
93270471|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
93270472|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92565056|NCT00167908|Protective Agents|protective agents|mesh-ancestor
93270473|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93270474|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270475|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270476|NCT04706546|Urological Agents|urological agents|mesh-ancestor
93270477|NCT04704440|Sildenafil Citrate|sildenafil citrate|mesh-list
93270478|NCT04704440|Vasodilator Agents|vasodilator agents|mesh-ancestor
93270479|NCT04704440|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93270480|NCT04704440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93270481|NCT04704440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270482|NCT04704440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270483|NCT04704440|Urological Agents|urological agents|mesh-ancestor
93270484|NCT04697862|Sildenafil Citrate|sildenafil citrate|mesh-list
93270485|NCT04697862|Vasodilator Agents|vasodilator agents|mesh-ancestor
93270486|NCT04697862|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93270487|NCT04697862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93270488|NCT04697862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270489|NCT04697862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270490|NCT04697862|Urological Agents|urological agents|mesh-ancestor
93270492|NCT04696029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270493|NCT04696029|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93270494|NCT04696029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270495|NCT04696029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270496|NCT04696029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270497|NCT04696029|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93270498|NCT04696029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270499|NCT04696029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270500|NCT04666610|Brivaracetam|brivaracetam|mesh-list
93270501|NCT04666610|Anticonvulsants|anticonvulsants|mesh-ancestor
93270502|NCT04652544|Vitamin D|vitamin d|mesh-list
93270503|NCT04652544|Cholecalciferol|cholecalciferol|mesh-list
93270504|NCT04652544|Vitamins|vitamins|mesh-ancestor
93270505|NCT04652544|Micronutrients|micronutrients|mesh-ancestor
93270506|NCT04652544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270507|NCT04652544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93270508|NCT04652544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93270509|NCT04640545|Axitinib|axitinib|mesh-list
93270510|NCT04640545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270511|NCT04640545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270512|NCT04640545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270513|NCT04640545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270514|NCT04625699|Durvalumab|durvalumab|mesh-list
93270515|NCT04625699|Tremelimumab|tremelimumab|mesh-list
93270516|NCT04625699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270517|NCT04625699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270518|NCT04613492|Durvalumab|durvalumab|mesh-list
93270519|NCT04613492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270520|NCT04613492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270521|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93270522|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93270523|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93270524|NCT04510584|Bevacizumab|bevacizumab|mesh-list
93270525|NCT04510584|Atezolizumab|atezolizumab|mesh-list
93270526|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270527|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270528|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93270529|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93270530|NCT04510584|Growth Substances|growth substances|mesh-ancestor
93270531|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270532|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
93270533|NCT04510584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270534|NCT04510584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270535|NCT04500847|Emtricitabine|emtricitabine|mesh-list
93270536|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
93270537|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270538|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93270539|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93270540|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270541|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270542|NCT04500847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93270543|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93270544|NCT04484532|Vaccines|vaccines|mesh-list
93270545|NCT04484532|Immunologic Factors|immunologic factors|mesh-ancestor
93270546|NCT04484532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270547|NCT04483583|Clopidogrel|clopidogrel|mesh-list
93270548|NCT04483583|Ticagrelor|ticagrelor|mesh-list
93270549|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93270550|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93270551|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93270552|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93270553|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
93270554|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270555|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270556|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270557|NCT04447989|Sildenafil Citrate|sildenafil citrate|mesh-list
93270558|NCT04447989|Vasodilator Agents|vasodilator agents|mesh-ancestor
93270559|NCT04447989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93270560|NCT04447989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93270561|NCT04447989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270562|NCT04447989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270563|NCT04447989|Urological Agents|urological agents|mesh-ancestor
93270564|NCT04416750|Imatinib Mesylate|imatinib mesylate|mesh-list
93270565|NCT04416750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270566|NCT04416750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270567|NCT04416750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270568|NCT04416750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270569|NCT04382898|Cemiplimab|cemiplimab|mesh-list
93270570|NCT04382898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270571|NCT04382898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270572|NCT04375527|Nivolumab|nivolumab|mesh-list
93270573|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270574|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270575|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270576|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270577|NCT04362488|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93270578|NCT04362488|Dermatologic Agents|dermatologic agents|mesh-ancestor
93270579|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
93270580|NCT04336189|Piperaquine|piperaquine|mesh-list
93270581|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
93270582|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93270583|NCT04336189|Artenimol|artenimol|mesh-list
93270584|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
93270585|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270586|NCT04336189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270587|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270588|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93270589|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270590|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270591|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93270592|NCT04231877|Prednisone|prednisone|mesh-list
93270593|NCT04231877|Cortisone|cortisone|mesh-list
93270594|NCT04231877|Cyclophosphamide|cyclophosphamide|mesh-list
93270595|NCT04231877|Rituximab|rituximab|mesh-list
93270596|NCT04231877|Doxorubicin|doxorubicin|mesh-list
93270597|NCT04231877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93270598|NCT04231877|Etoposide|etoposide|mesh-list
93270599|NCT04231877|Daunorubicin|daunorubicin|mesh-list
93270600|NCT04231877|Podophyllotoxin|podophyllotoxin|mesh-list
93270601|NCT04231877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93270602|NCT04231877|Antibodies|antibodies|mesh-list
93270603|NCT04231877|Immunoglobulins|immunoglobulins|mesh-list
93270604|NCT04231877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93270605|NCT04231877|Lenograstim|lenograstim|mesh-list
93270606|NCT04231877|Immunoconjugates|immunoconjugates|mesh-list
93270607|NCT04231877|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93270608|NCT04231877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270609|NCT04231877|Immunologic Factors|immunologic factors|mesh-ancestor
93270610|NCT04231877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270611|NCT04231877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270612|NCT04231877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270613|NCT04231877|Alkylating Agents|alkylating agents|mesh-ancestor
93270614|NCT04231877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942659|NCT00799539|Prednisone|prednisone|mesh-list
93270615|NCT04231877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270616|NCT04231877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93270617|NCT04231877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93270618|NCT04231877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93270619|NCT04231877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93270620|NCT04231877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270621|NCT04231877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93270623|NCT04231877|Hormones|hormones|mesh-ancestor
93270624|NCT04231877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270625|NCT04231877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270626|NCT04231877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93270627|NCT04231877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93270628|NCT04231877|Keratolytic Agents|keratolytic agents|mesh-ancestor
93270629|NCT04231877|Dermatologic Agents|dermatologic agents|mesh-ancestor
93270630|NCT04231877|Tubulin Modulators|tubulin modulators|mesh-ancestor
93270631|NCT04231877|Antimitotic Agents|antimitotic agents|mesh-ancestor
93270632|NCT04231877|Mitosis Modulators|mitosis modulators|mesh-ancestor
93270633|NCT04218799|Chlorhexidine|chlorhexidine|mesh-list
93270634|NCT04218799|Mupirocin|mupirocin|mesh-list
93270635|NCT04218799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93270636|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270637|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
93270638|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93270639|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93270640|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270641|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270642|NCT04189445|Futibatinib|futibatinib|mesh-list
93270643|NCT04189445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270644|NCT04179032|Belimumab|belimumab|mesh-list
93270645|NCT04179032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270646|NCT04179032|Immunologic Factors|immunologic factors|mesh-ancestor
93270647|NCT04179032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270648|NCT04170153|Niraparib|niraparib|mesh-list
93270649|NCT04170153|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93270650|NCT04170153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270651|NCT04170153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270652|NCT04170153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270653|NCT04143594|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93270654|NCT04143594|Antiviral Agents|antiviral agents|mesh-ancestor
93270655|NCT04143594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270656|NCT04143594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93270657|NCT04143594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93270658|NCT04143594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270659|NCT04143594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270660|NCT04143594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93270661|NCT04143594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93270662|NCT04026776|Allopurinol|allopurinol|mesh-list
93270663|NCT04026776|Antimetabolites|antimetabolites|mesh-ancestor
93270664|NCT04026776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270665|NCT04026776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270666|NCT04026776|Gout Suppressants|gout suppressants|mesh-ancestor
93270667|NCT04026776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270668|NCT04026776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93270669|NCT04026776|Antioxidants|antioxidants|mesh-ancestor
93270670|NCT04026776|Protective Agents|protective agents|mesh-ancestor
93270671|NCT04026776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270672|NCT03871348|Cemiplimab|cemiplimab|mesh-list
93270673|NCT03871348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270674|NCT03871348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270675|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
93270676|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270677|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270678|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270679|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270680|NCT03831113|Buprenorphine|buprenorphine|mesh-list
93270681|NCT03831113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93270682|NCT03831113|Narcotics|narcotics|mesh-ancestor
93270683|NCT03831113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270684|NCT03831113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270685|NCT03831113|Analgesics|analgesics|mesh-ancestor
93270686|NCT03831113|Sensory System Agents|sensory system agents|mesh-ancestor
93270687|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270688|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93270689|NCT03824561|Vedolizumab|vedolizumab|mesh-list
93270690|NCT03824561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270691|NCT03821857|Corticosterone|corticosterone|mesh-list
93270692|NCT03821857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93270693|NCT04305236|Fulvestrant|fulvestrant|mesh-list
93270694|NCT04305236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270695|NCT04305236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270696|NCT04305236|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93270697|NCT04305236|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93270698|NCT04305236|Hormone Antagonists|hormone antagonists|mesh-ancestor
93270699|NCT04305236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270700|NCT04305236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270701|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
93270702|NCT03774472|Letrozole|letrozole|mesh-list
93270703|NCT03774472|Palbociclib|palbociclib|mesh-list
93270704|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270705|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93270706|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93270707|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270708|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270709|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93270710|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
93270711|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270712|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270713|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
93270714|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270715|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270716|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270717|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270718|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270719|NCT03727061|Carboplatin|carboplatin|mesh-list
93270720|NCT03727061|Pembrolizumab|pembrolizumab|mesh-list
93270721|NCT03727061|Fluorouracil|fluorouracil|mesh-list
93270722|NCT03727061|Nivolumab|nivolumab|mesh-list
93270723|NCT03727061|Cetuximab|cetuximab|mesh-list
93270724|NCT03727061|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
93270725|NCT03727061|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
93270726|NCT03727061|Trioxsalen|trioxsalen|mesh-list
93270727|NCT03727061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270728|NCT03727061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270729|NCT03727061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270730|NCT03727061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270731|NCT03727061|Antimetabolites|antimetabolites|mesh-ancestor
93270732|NCT03727061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270733|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270734|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
93270735|NCT03727061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270736|NCT03727061|Dermatologic Agents|dermatologic agents|mesh-ancestor
93270737|NCT03727061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93270738|NCT03668340|Adavosertib|adavosertib|mesh-list
93270739|NCT03668340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270740|NCT03668340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270741|NCT03657160|Vedolizumab|vedolizumab|mesh-list
93270742|NCT03657160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270743|NCT03640481|Belumosudil|belumosudil|mesh-list
93270744|NCT03640481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270745|NCT03640481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270746|NCT03640481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270747|NCT03530683|Dexamethasone|dexamethasone|mesh-list
93270748|NCT03530683|Azacitidine|azacitidine|mesh-list
93270749|NCT03530683|Venetoclax|venetoclax|mesh-list
93270750|NCT03530683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93270751|NCT03530683|Antiemetics|antiemetics|mesh-ancestor
93270752|NCT03530683|Autonomic Agents|autonomic agents|mesh-ancestor
93270753|NCT03530683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270754|NCT03530683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270755|NCT03530683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270756|NCT03530683|Glucocorticoids|glucocorticoids|mesh-ancestor
93270757|NCT03530683|Hormones|hormones|mesh-ancestor
93270758|NCT03530683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270759|NCT03530683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270760|NCT03530683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270761|NCT03530683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270762|NCT03530683|Antimetabolites|antimetabolites|mesh-ancestor
93270763|NCT03530683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270764|NCT03530683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270765|NCT03508726|Ascorbic Acid|ascorbic acid|mesh-list
93270766|NCT03508726|Vitamins|vitamins|mesh-ancestor
93270767|NCT03508726|Micronutrients|micronutrients|mesh-ancestor
93270768|NCT03508726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270769|NCT03508726|Antioxidants|antioxidants|mesh-ancestor
93270770|NCT03508726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270771|NCT03508726|Protective Agents|protective agents|mesh-ancestor
93270773|NCT03404661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270774|NCT03404661|Hormones|hormones|mesh-ancestor
93270775|NCT03404661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270776|NCT03404661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270777|NCT03399773|Cyclophosphamide|cyclophosphamide|mesh-list
93270778|NCT03399773|Thiotepa|thiotepa|mesh-list
93270779|NCT03399773|Fludarabine|fludarabine|mesh-list
93270780|NCT03399773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270781|NCT03399773|Immunologic Factors|immunologic factors|mesh-ancestor
93270782|NCT03399773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270783|NCT03399773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270784|NCT03399773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270785|NCT03399773|Alkylating Agents|alkylating agents|mesh-ancestor
93270786|NCT03399773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270787|NCT03399773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270788|NCT03399773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93270789|NCT03370172|Factor VIII|factor viii|mesh-list
93270790|NCT03370172|Coagulants|coagulants|mesh-ancestor
93270791|NCT03345784|Cisplatin|cisplatin|mesh-list
93270792|NCT03345784|Adavosertib|adavosertib|mesh-list
93270793|NCT03345784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270794|NCT03345784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270795|NCT03345784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270796|NCT03342196|Fludarabine|fludarabine|mesh-list
93270797|NCT03342196|Melphalan|melphalan|mesh-list
93270798|NCT03342196|Thiotepa|thiotepa|mesh-list
93270799|NCT03342196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270800|NCT03342196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270801|NCT03342196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270802|NCT03342196|Immunologic Factors|immunologic factors|mesh-ancestor
93270803|NCT03342196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270804|NCT03342196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270805|NCT03342196|Alkylating Agents|alkylating agents|mesh-ancestor
93270806|NCT03342196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93270807|NCT03319537|Pemetrexed|pemetrexed|mesh-list
93270808|NCT03319537|Pevonedistat|pevonedistat|mesh-list
93270809|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270810|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270811|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270812|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93270813|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93270814|NCT03279692|Pembrolizumab|pembrolizumab|mesh-list
93270815|NCT03279692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270816|NCT03279692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270817|NCT03279692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270818|NCT03279692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270819|NCT03237780|Atezolizumab|atezolizumab|mesh-list
93270820|NCT03237780|Halichondrin B|halichondrin b|mesh-list
93270821|NCT03237780|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93270822|NCT03237780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270823|NCT03237780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270824|NCT03237780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270825|NCT03237780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270826|NCT03237780|Immunologic Factors|immunologic factors|mesh-ancestor
93270827|NCT03237780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270828|NCT03237780|Tubulin Modulators|tubulin modulators|mesh-ancestor
93270829|NCT03237780|Antimitotic Agents|antimitotic agents|mesh-ancestor
93270830|NCT03237780|Mitosis Modulators|mitosis modulators|mesh-ancestor
93270831|NCT03158129|Cisplatin|cisplatin|mesh-list
93270832|NCT03158129|Carboplatin|carboplatin|mesh-list
93270833|NCT03158129|Docetaxel|docetaxel|mesh-list
93270834|NCT03158129|Nivolumab|nivolumab|mesh-list
93270835|NCT03158129|Pemetrexed|pemetrexed|mesh-list
93270836|NCT03158129|Ipilimumab|ipilimumab|mesh-list
93270837|NCT03158129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270838|NCT03158129|Tubulin Modulators|tubulin modulators|mesh-ancestor
93270839|NCT03158129|Antimitotic Agents|antimitotic agents|mesh-ancestor
93270840|NCT03158129|Mitosis Modulators|mitosis modulators|mesh-ancestor
93270841|NCT03158129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270842|NCT03158129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92942878|NCT00739622|Antiviral Agents|antiviral agents|mesh-ancestor
93270843|NCT03158129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270844|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270845|NCT03158129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93270846|NCT03158129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93270847|NCT03100786|Dexamethasone|dexamethasone|mesh-list
93270848|NCT03100786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93270849|NCT03100786|Antiemetics|antiemetics|mesh-ancestor
93270850|NCT03100786|Autonomic Agents|autonomic agents|mesh-ancestor
93270851|NCT03100786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270852|NCT03100786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270853|NCT03100786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93270854|NCT03100786|Glucocorticoids|glucocorticoids|mesh-ancestor
93270855|NCT03100786|Hormones|hormones|mesh-ancestor
93270856|NCT03100786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270857|NCT03100786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93270858|NCT03100786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270859|NCT03043053|Oxytocin|oxytocin|mesh-list
93270860|NCT03043053|Oxytocics|oxytocics|mesh-ancestor
93270861|NCT03043053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93270862|NCT03043053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270863|NCT03025035|Pembrolizumab|pembrolizumab|mesh-list
93270864|NCT03025035|Olaparib|olaparib|mesh-list
93270865|NCT03025035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270866|NCT03025035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270867|NCT03025035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270868|NCT03025035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270869|NCT03025035|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93270870|NCT03025035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270871|NCT03001882|Nivolumab|nivolumab|mesh-list
93270872|NCT03001882|Ipilimumab|ipilimumab|mesh-list
93270873|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270874|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270875|NCT03001882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93270876|NCT03001882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270877|NCT02981966|Dapagliflozin|dapagliflozin|mesh-list
93270878|NCT02981966|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93270879|NCT02981966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270880|NCT02981966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93270881|NCT02981966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270882|NCT02932956|Cyclophosphamide|cyclophosphamide|mesh-list
93270883|NCT02932956|Fludarabine|fludarabine|mesh-list
93270884|NCT02932956|Fludarabine phosphate|fludarabine phosphate|mesh-list
93270885|NCT02932956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270886|NCT02932956|Immunologic Factors|immunologic factors|mesh-ancestor
93270887|NCT02932956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270888|NCT02932956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270889|NCT02932956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270890|NCT02932956|Alkylating Agents|alkylating agents|mesh-ancestor
93270891|NCT02932956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270892|NCT02932956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270893|NCT02932956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93270894|NCT02932956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270895|NCT02932956|Antimetabolites|antimetabolites|mesh-ancestor
93270896|NCT02923778|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93270897|NCT02923778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270898|NCT02923778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270899|NCT02843165|Immunomodulating Agents|immunomodulating agents|mesh-list
93270900|NCT02843165|Immunologic Factors|immunologic factors|mesh-list
93270901|NCT02843165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270902|NCT02807467|Dexmedetomidine|dexmedetomidine|mesh-list
93270903|NCT02807467|Propofol|propofol|mesh-list
93270904|NCT02807467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93270905|NCT02807467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270906|NCT02807467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270907|NCT02807467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93270908|NCT02807467|Analgesics|analgesics|mesh-ancestor
93270909|NCT02807467|Sensory System Agents|sensory system agents|mesh-ancestor
93270910|NCT02807467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270911|NCT02807467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93270912|NCT02807467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93270913|NCT02807467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93270914|NCT02807467|Adrenergic Agents|adrenergic agents|mesh-ancestor
93270915|NCT02807467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942957|NCT00876226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93270916|NCT02807467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270917|NCT02807467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93270918|NCT02807467|Anesthetics, General|anesthetics, general|mesh-ancestor
93270920|NCT02794428|Eflornithine|eflornithine|mesh-list
93270921|NCT02794428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270922|NCT02794428|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93270923|NCT02794428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270924|NCT02794428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270925|NCT02794428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270926|NCT02794428|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93270927|NCT02794428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270928|NCT02794428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270929|NCT02740179|Eplerenone|eplerenone|mesh-list
93270930|NCT02740179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93270931|NCT02740179|Hormone Antagonists|hormone antagonists|mesh-ancestor
93270932|NCT02740179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93270933|NCT02740179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270934|NCT02740179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93270935|NCT02740179|Diuretics|diuretics|mesh-ancestor
93270936|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
93270937|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93270938|NCT02679144|Eflornithine|eflornithine|mesh-list
93270939|NCT02679144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270940|NCT02679144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93270941|NCT02679144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270942|NCT02679144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270943|NCT02679144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93270944|NCT02679144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93270945|NCT02679144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270946|NCT02679144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270947|NCT02650986|Cyclophosphamide|cyclophosphamide|mesh-list
93270948|NCT02650986|Decitabine|decitabine|mesh-list
93270949|NCT02650986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93270950|NCT02650986|Immunologic Factors|immunologic factors|mesh-ancestor
92565542|NCT00171106|Valsartan|valsartan|mesh-list
93270951|NCT02650986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270952|NCT02650986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93270953|NCT02650986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93270954|NCT02650986|Alkylating Agents|alkylating agents|mesh-ancestor
93270955|NCT02650986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270956|NCT02650986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270957|NCT02650986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93270958|NCT02650986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93270959|NCT02650986|Antimetabolites|antimetabolites|mesh-ancestor
93270960|NCT02650986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270961|NCT02619409|Bupivacaine|bupivacaine|mesh-list
93270962|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
93270963|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
93270964|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93270965|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270966|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
93270967|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93270968|NCT02606045|Tranexamic Acid|tranexamic acid|mesh-list
93270969|NCT02606045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93270970|NCT02606045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93270971|NCT02606045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270972|NCT02606045|Hemostatics|hemostatics|mesh-ancestor
93270973|NCT02606045|Coagulants|coagulants|mesh-ancestor
93270974|NCT02603432|Avelumab|avelumab|mesh-list
93270975|NCT02603432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93270976|NCT02603432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93270977|NCT02603432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270978|NCT02603432|Immunologic Factors|immunologic factors|mesh-ancestor
93270979|NCT02603432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93270980|NCT02582866|Lacosamide|lacosamide|mesh-list
93270981|NCT02582866|Anticonvulsants|anticonvulsants|mesh-ancestor
93270982|NCT02582866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93270983|NCT02582866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93270984|NCT02582866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93270985|NCT02582866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270986|NCT02559778|Eflornithine|eflornithine|mesh-list
93270987|NCT02559778|Sorafenib|sorafenib|mesh-list
93270988|NCT02559778|Dasatinib|dasatinib|mesh-list
93270989|NCT02559778|Vorinostat|vorinostat|mesh-list
93270990|NCT02559778|Ceritinib|ceritinib|mesh-list
93270991|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93270992|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93270993|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93270994|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93270995|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93270996|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93270997|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93270998|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93270999|NCT02559778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271000|NCT02559778|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93271001|NCT02465307|Hydrocortisone|hydrocortisone|mesh-list
93271002|NCT02465307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271003|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
93271004|NCT02453373|Plasminogen|plasminogen|mesh-list
93271005|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93271006|NCT02453373|Propofol|propofol|mesh-list
93271007|NCT02453373|Etomidate|etomidate|mesh-list
93271008|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93271009|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271010|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271011|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93271012|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
93271013|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
93271014|NCT02453373|Analgesics|analgesics|mesh-ancestor
93271015|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
93271016|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271017|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271018|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
93271019|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93271020|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93271021|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271022|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93271023|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
93271024|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93271025|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93271026|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271027|NCT02395666|Eflornithine|eflornithine|mesh-list
93271028|NCT02395666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271029|NCT02395666|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93271030|NCT02395666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93271031|NCT02395666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93271032|NCT02395666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271033|NCT02395666|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93271034|NCT02395666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271035|NCT02395666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271036|NCT02180867|Doxorubicin|doxorubicin|mesh-list
93271037|NCT02180867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93271038|NCT02180867|Daunorubicin|daunorubicin|mesh-list
93271039|NCT02180867|Ifosfamide|ifosfamide|mesh-list
93271040|NCT02180867|Isophosphamide mustard|isophosphamide mustard|mesh-list
93271041|NCT02180867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93271042|NCT02180867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271043|NCT02180867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93271044|NCT02180867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93271045|NCT02180867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271046|NCT02180867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271047|NCT02180867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93271048|NCT02180867|Alkylating Agents|alkylating agents|mesh-ancestor
93271049|NCT01734928|Thalidomide|thalidomide|mesh-list
93271050|NCT01734928|Dexamethasone|dexamethasone|mesh-list
93271051|NCT01734928|Bortezomib|bortezomib|mesh-list
93271052|NCT01734928|Pomalidomide|pomalidomide|mesh-list
93271053|NCT01734928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271054|NCT01734928|Antiemetics|antiemetics|mesh-ancestor
93271055|NCT01734928|Autonomic Agents|autonomic agents|mesh-ancestor
93271056|NCT01734928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271057|NCT01734928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271058|NCT01734928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271059|NCT01734928|Glucocorticoids|glucocorticoids|mesh-ancestor
93271060|NCT01734928|Hormones|hormones|mesh-ancestor
93271061|NCT01734928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271062|NCT01734928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93271063|NCT01734928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271064|NCT01734928|Immunologic Factors|immunologic factors|mesh-ancestor
93271065|NCT01734928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93271066|NCT01734928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93271067|NCT01734928|Growth Substances|growth substances|mesh-ancestor
93271068|NCT01734928|Growth Inhibitors|growth inhibitors|mesh-ancestor
93271069|NCT01734928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271070|NCT01734928|Leprostatic Agents|leprostatic agents|mesh-ancestor
93271071|NCT01734928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93271072|NCT01734928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271073|NCT01682616|Rituximab|rituximab|mesh-list
93271074|NCT01682616|Venetoclax|venetoclax|mesh-list
93271075|NCT01682616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271076|NCT01682616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271077|NCT01682616|Immunologic Factors|immunologic factors|mesh-ancestor
93271078|NCT01682616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271079|NCT01682616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271080|NCT01430572|Everolimus|everolimus|mesh-list
93271081|NCT01430572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93271082|NCT01430572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93271083|NCT01430572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271084|NCT01430572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271085|NCT01430572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271086|NCT01430572|Immunologic Factors|immunologic factors|mesh-ancestor
93271087|NCT01430572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271088|NCT01430572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271089|NCT00950430|Corticosterone|corticosterone|mesh-list
93271090|NCT00950430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271091|NCT00909051|Acarbose|acarbose|mesh-list
92565677|NCT00171652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271092|NCT00909051|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93271093|NCT00909051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271094|NCT00909051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271095|NCT00909051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271096|NCT00909051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271097|NCT00750841|Cediranib|cediranib|mesh-list
93271098|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271099|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93271100|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271101|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271102|NCT05015608|Carboplatin|carboplatin|mesh-list
93271103|NCT05015608|Pemetrexed|pemetrexed|mesh-list
93271104|NCT05015608|Osimertinib|osimertinib|mesh-list
93271105|NCT05015608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271106|NCT05015608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271107|NCT05015608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271108|NCT05015608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93271109|NCT05015608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93271110|NCT05015608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93271111|NCT03510416|Apatinib|apatinib|mesh-list
93271112|NCT03510416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271113|NCT03510416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93271114|NCT03510416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271115|NCT03510416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271116|NCT03510962|Chlorhexidine|chlorhexidine|mesh-list
93271117|NCT03510962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93271118|NCT03510962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271119|NCT03510962|Disinfectants|disinfectants|mesh-ancestor
93271120|NCT02646124|Naproxen|naproxen|mesh-list
93271121|NCT02646124|Diazepam|diazepam|mesh-list
93271122|NCT02646124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93271123|NCT02646124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93271124|NCT02646124|Analgesics|analgesics|mesh-ancestor
93271125|NCT02646124|Sensory System Agents|sensory system agents|mesh-ancestor
93271126|NCT02646124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271127|NCT02646124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271128|NCT02646124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271129|NCT02646124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271130|NCT02646124|Gout Suppressants|gout suppressants|mesh-ancestor
93271131|NCT02646124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93271132|NCT02646124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271133|NCT02646124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271134|NCT02646124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93271135|NCT02646124|Anticonvulsants|anticonvulsants|mesh-ancestor
93271136|NCT02646124|Antiemetics|antiemetics|mesh-ancestor
93271137|NCT02646124|Autonomic Agents|autonomic agents|mesh-ancestor
93271138|NCT02646124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271139|NCT02646124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93271140|NCT02646124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943179|NCT00616018|Analgesics|analgesics|mesh-ancestor
93271141|NCT02646124|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93271142|NCT02646124|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93271143|NCT02646124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93271144|NCT02646124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93271145|NCT02646124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93271146|NCT02646124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93271147|NCT02646124|Anesthetics, General|anesthetics, general|mesh-ancestor
93271148|NCT02646124|Anesthetics|anesthetics|mesh-ancestor
93271149|NCT02646124|GABA Modulators|gaba modulators|mesh-ancestor
93271150|NCT02646124|GABA Agents|gaba agents|mesh-ancestor
93271151|NCT02646124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271152|NCT02306564|Cabergoline|cabergoline|mesh-list
93271153|NCT02306564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93271154|NCT02306564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93271155|NCT02306564|Dopamine Agonists|dopamine agonists|mesh-ancestor
93271156|NCT02306564|Dopamine Agents|dopamine agents|mesh-ancestor
93271157|NCT02306564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271158|NCT02306564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271159|NCT02306564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271160|NCT02301494|Fluocinonide|fluocinonide|mesh-list
93271161|NCT02301494|Imiquimod|imiquimod|mesh-list
93271162|NCT02301494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93271163|NCT02301494|Immunologic Factors|immunologic factors|mesh-ancestor
93271164|NCT02301494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271165|NCT02301494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271166|NCT02301494|Interferon Inducers|interferon inducers|mesh-ancestor
93271167|NCT02301494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271168|NCT02301494|Glucocorticoids|glucocorticoids|mesh-ancestor
93271169|NCT02301494|Hormones|hormones|mesh-ancestor
93271170|NCT02301494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271171|NCT02301494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93271172|NCT03101800|Azathioprine|azathioprine|mesh-list
93271173|NCT03101800|Allopurinol|allopurinol|mesh-list
93271174|NCT03101800|Antimetabolites|antimetabolites|mesh-ancestor
93271175|NCT03101800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271176|NCT03101800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271177|NCT03101800|Gout Suppressants|gout suppressants|mesh-ancestor
93271178|NCT03101800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271179|NCT03101800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93271180|NCT03101800|Antioxidants|antioxidants|mesh-ancestor
93271181|NCT03101800|Protective Agents|protective agents|mesh-ancestor
93271182|NCT03101800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271183|NCT03101800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93271184|NCT03101800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271185|NCT03101800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271186|NCT03101800|Immunologic Factors|immunologic factors|mesh-ancestor
93271187|NCT03507842|Cytarabine|cytarabine|mesh-list
93271188|NCT03507842|Daunorubicin|daunorubicin|mesh-list
93271189|NCT03507842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93271190|NCT03507842|Antimetabolites|antimetabolites|mesh-ancestor
93271191|NCT03507842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271192|NCT03507842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271193|NCT03507842|Antiviral Agents|antiviral agents|mesh-ancestor
93271194|NCT03507842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271195|NCT03507842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271196|NCT03507842|Immunologic Factors|immunologic factors|mesh-ancestor
93271197|NCT03507842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271198|NCT03507842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93271199|NCT03507842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93271200|NCT03507842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93271201|NCT03507842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271202|NCT03132584|Cyclophosphamide|cyclophosphamide|mesh-list
93271203|NCT03132584|Alemtuzumab|alemtuzumab|mesh-list
93271204|NCT03132584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271205|NCT03132584|Immunologic Factors|immunologic factors|mesh-ancestor
93271206|NCT03132584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271207|NCT03132584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271208|NCT03132584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93271209|NCT03132584|Alkylating Agents|alkylating agents|mesh-ancestor
93271210|NCT03132584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271211|NCT03132584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271212|NCT03132584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93271213|NCT03132584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271214|NCT03656926|Cyclosporine|cyclosporine|mesh-list
93271215|NCT03656926|Cyclosporins|cyclosporins|mesh-list
93271216|NCT03656926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271217|NCT03656926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271218|NCT03656926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271219|NCT03656926|Immunologic Factors|immunologic factors|mesh-ancestor
93271220|NCT03656926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271221|NCT03656926|Antifungal Agents|antifungal agents|mesh-ancestor
93271222|NCT03656926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271223|NCT03656926|Dermatologic Agents|dermatologic agents|mesh-ancestor
93271224|NCT03656926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271225|NCT03656926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93271227|NCT02301650|Lamivudine|lamivudine|mesh-list
93271228|NCT02301650|Telbivudine|telbivudine|mesh-list
93271229|NCT02301650|Antiviral Agents|antiviral agents|mesh-ancestor
93271230|NCT02301650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271231|NCT02301650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93271232|NCT02301650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93271233|NCT02301650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271234|NCT02301650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271235|NCT02301650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93271236|NCT02301650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93271237|NCT03510338|Sildenafil Citrate|sildenafil citrate|mesh-list
93271238|NCT03510338|Vasodilator Agents|vasodilator agents|mesh-ancestor
93271239|NCT03510338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93271240|NCT03510338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93271241|NCT03510338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271242|NCT03510338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271243|NCT03510338|Urological Agents|urological agents|mesh-ancestor
93271244|NCT02303366|Pembrolizumab|pembrolizumab|mesh-list
93271245|NCT02303366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271246|NCT02303366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271247|NCT02303366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93271248|NCT02303366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271249|NCT02301806|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93271250|NCT02301806|Glimepiride|glimepiride|mesh-list
93271251|NCT02301806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271252|NCT02301806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271253|NCT02301806|Incretins|incretins|mesh-ancestor
93271254|NCT02301806|Hormones|hormones|mesh-ancestor
93271255|NCT02301806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271256|NCT02301806|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93271257|NCT02301806|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271258|NCT02301806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271259|NCT02301806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271260|NCT02301806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271261|NCT02301806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271262|NCT02301806|Immunologic Factors|immunologic factors|mesh-ancestor
93271263|NCT03103204|Chlorhexidine|chlorhexidine|mesh-list
93271264|NCT03103204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93271265|NCT03103204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271266|NCT03103204|Disinfectants|disinfectants|mesh-ancestor
93271267|NCT02301962|Panitumumab|panitumumab|mesh-list
93271268|NCT02301962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271269|NCT02301962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271270|NCT03507374|Alirocumab|alirocumab|mesh-list
93271271|NCT03507374|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93271272|NCT03507374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93271273|NCT03507374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93271274|NCT03507374|Antimetabolites|antimetabolites|mesh-ancestor
93271275|NCT03507374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271276|NCT03507374|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93271277|NCT03507374|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271278|NCT03507374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271279|NCT03507374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93271280|NCT02639650|Dactinomycin|dactinomycin|mesh-list
93271281|NCT02639650|Paclitaxel|paclitaxel|mesh-list
93271282|NCT02639650|Etoposide|etoposide|mesh-list
93271283|NCT02639650|Vincristine|vincristine|mesh-list
93271284|NCT02639650|Cyclophosphamide|cyclophosphamide|mesh-list
93271285|NCT02639650|Carboplatin|carboplatin|mesh-list
93271286|NCT02639650|Methotrexate|methotrexate|mesh-list
93271287|NCT02639650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93271288|NCT02639650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271289|NCT02639650|Tubulin Modulators|tubulin modulators|mesh-ancestor
93271290|NCT02639650|Antimitotic Agents|antimitotic agents|mesh-ancestor
92943329|NCT00735930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271291|NCT02639650|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271292|NCT02639650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271293|NCT02639650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271294|NCT02639650|Immunologic Factors|immunologic factors|mesh-ancestor
93271295|NCT02639650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271296|NCT02639650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271297|NCT02639650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93271298|NCT02639650|Alkylating Agents|alkylating agents|mesh-ancestor
93271299|NCT02639650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93271300|NCT02639650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93271301|NCT02639650|Abortifacient Agents|abortifacient agents|mesh-ancestor
93271302|NCT02639650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93271303|NCT02639650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93271305|NCT02639650|Dermatologic Agents|dermatologic agents|mesh-ancestor
93271306|NCT02639650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271307|NCT02639650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93271308|NCT02639650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93271309|NCT02639650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93271310|NCT02639650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93271311|NCT02639650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93271312|NCT02639650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271313|NCT02639650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93271314|NCT02639650|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93271315|NCT03581734|Vaccines|vaccines|mesh-list
93271316|NCT03581734|Immunologic Factors|immunologic factors|mesh-ancestor
93271317|NCT03581734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271318|NCT02306798|Mesalamine|mesalamine|mesh-list
93271319|NCT02306798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93271320|NCT02306798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93271321|NCT02306798|Analgesics|analgesics|mesh-ancestor
93271322|NCT02306798|Sensory System Agents|sensory system agents|mesh-ancestor
93271323|NCT02306798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271324|NCT02306798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271325|NCT02306798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93271326|NCT02306798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93271327|NCT02306954|Aldesleukin|aldesleukin|mesh-list
93271328|NCT02306954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271329|NCT02306954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93271330|NCT02306954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93271331|NCT02306954|Antiviral Agents|antiviral agents|mesh-ancestor
93271332|NCT02306954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271333|NCT03509714|Ascorbic Acid|ascorbic acid|mesh-list
93271334|NCT03509714|Antioxidants|antioxidants|mesh-ancestor
93271335|NCT03509714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271336|NCT03509714|Protective Agents|protective agents|mesh-ancestor
93271337|NCT03509714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271338|NCT03509714|Vitamins|vitamins|mesh-ancestor
93271339|NCT03509714|Micronutrients|micronutrients|mesh-ancestor
93271340|NCT02302274|Flecainide|flecainide|mesh-list
93271341|NCT02302274|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271342|NCT02302274|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93271343|NCT02302274|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93271344|NCT02302274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93271345|NCT02302274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271346|NCT02303600|Montelukast|montelukast|mesh-list
93271347|NCT02303600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93271348|NCT02303600|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271349|NCT02303600|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93271350|NCT02303600|Hormone Antagonists|hormone antagonists|mesh-ancestor
93271351|NCT02303600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271352|NCT02303600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271353|NCT02303600|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93271354|NCT02303600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93271355|NCT02303600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271356|NCT04463342|Methamphetamine|methamphetamine|mesh-list
93271357|NCT04463342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93271358|NCT04463342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271359|NCT04463342|Sympathomimetics|sympathomimetics|mesh-ancestor
93271360|NCT04463342|Autonomic Agents|autonomic agents|mesh-ancestor
93271361|NCT04463342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271362|NCT04463342|Dopamine Agents|dopamine agents|mesh-ancestor
93271363|NCT04463342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271364|NCT04463342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271365|NCT04463342|Adrenergic Agents|adrenergic agents|mesh-ancestor
93271366|NCT04463342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93271367|NCT04463342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93271368|NCT04463342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93271369|NCT04463342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93271370|NCT02303912|Carboplatin|carboplatin|mesh-list
93271371|NCT02303912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271372|NCT01597492|Belimumab|belimumab|mesh-list
93271373|NCT01597492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271374|NCT01597492|Immunologic Factors|immunologic factors|mesh-ancestor
93271375|NCT01597492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271376|NCT04569994|Insulin|insulin|mesh-list
93271377|NCT04569994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271378|NCT04569994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271379|NCT00109590|Ritonavir|ritonavir|mesh-list
93271380|NCT00109590|Lopinavir|lopinavir|mesh-list
93271381|NCT00109590|Zidovudine|zidovudine|mesh-list
93271382|NCT00109590|Nevirapine|nevirapine|mesh-list
93271383|NCT00109590|Didanosine|didanosine|mesh-list
93271384|NCT00109590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93271385|NCT00109590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93271386|NCT00109590|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271387|NCT00109590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271388|NCT00109590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271389|NCT00109590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93271390|NCT00109590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93271391|NCT00109590|Antiviral Agents|antiviral agents|mesh-ancestor
93271392|NCT00109590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271393|NCT00109590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93271394|NCT00109590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93271395|NCT00109590|Antimetabolites|antimetabolites|mesh-ancestor
93271396|NCT00109590|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93271397|NCT00109590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93271398|NCT00109590|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93271399|NCT00109590|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93271400|NCT03507062|Plasma-lyte 148|plasma-lyte 148|mesh-list
93271401|NCT03507062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93271402|NCT03507062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93271403|NCT05243446|Losartan|losartan|mesh-list
93271404|NCT05243446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271405|NCT05243446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93271406|NCT05243446|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93271407|NCT05243446|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93271408|NCT05243446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271409|NCT02143362|Remifentanil|remifentanil|mesh-list
93271410|NCT02143362|Anesthetics|anesthetics|mesh-list
93271411|NCT02143362|Propofol|propofol|mesh-list
93271412|NCT02143362|Cisatracurium|cisatracurium|mesh-list
93271413|NCT02143362|Atracurium|atracurium|mesh-list
93271414|NCT02143362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271415|NCT02143362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271416|NCT02143362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93271417|NCT02143362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93271418|NCT02143362|Anesthetics, General|anesthetics, general|mesh-ancestor
93271419|NCT02143362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93271420|NCT02143362|Narcotics|narcotics|mesh-ancestor
93271421|NCT02143362|Analgesics|analgesics|mesh-ancestor
93271422|NCT02143362|Sensory System Agents|sensory system agents|mesh-ancestor
93271423|NCT02143362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271424|NCT02143362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93271425|NCT02143362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93271426|NCT02143362|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93271427|NCT02143362|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93271428|NCT02143362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93271429|NCT02143362|Cholinergic Agents|cholinergic agents|mesh-ancestor
93271430|NCT02143362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271431|NCT02143362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271432|NCT03509324|Insulin Lispro|insulin lispro|mesh-list
93271433|NCT03509324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271434|NCT03509324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271435|NCT02143440|Insulin|insulin|mesh-list
93271436|NCT02143440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271437|NCT02143440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271438|NCT02143518|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93271439|NCT02143518|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
93271440|NCT02143518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93271441|NCT02143518|Immunologic Factors|immunologic factors|mesh-ancestor
93271442|NCT02143518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271443|NCT02143518|Antacids|antacids|mesh-ancestor
93271444|NCT02143518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271445|NCT02143518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271446|NCT03682770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93271447|NCT03682770|Immunologic Factors|immunologic factors|mesh-ancestor
93271448|NCT03682770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271450|NCT03506828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93271451|NCT03506828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271452|NCT03506828|Disinfectants|disinfectants|mesh-ancestor
93271453|NCT03506828|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93271454|NCT03506828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93271455|NCT00054964|Albuterol|albuterol|mesh-list
93271456|NCT00054964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93271457|NCT00054964|Autonomic Agents|autonomic agents|mesh-ancestor
93271458|NCT00054964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271459|NCT00054964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271460|NCT00054964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93271461|NCT00054964|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271462|NCT00054964|Tocolytic Agents|tocolytic agents|mesh-ancestor
93271463|NCT00054964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93271464|NCT00054964|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93271465|NCT00054964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93271466|NCT00054964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93271467|NCT00054964|Adrenergic Agents|adrenergic agents|mesh-ancestor
93271468|NCT00054964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271469|NCT00054964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271470|NCT02781558|Sofosbuvir|sofosbuvir|mesh-list
93271471|NCT02781558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93271472|NCT02781558|Velpatasvir|velpatasvir|mesh-list
93271473|NCT02781558|Antiviral Agents|antiviral agents|mesh-ancestor
93271474|NCT02781558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271475|NCT05073640|Pentoxifylline|pentoxifylline|mesh-list
93271476|NCT05073640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93271477|NCT05073640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271478|NCT05073640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271479|NCT05073640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93271480|NCT05073640|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93271481|NCT05073640|Protective Agents|protective agents|mesh-ancestor
93271482|NCT05073640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271483|NCT05073640|Vasodilator Agents|vasodilator agents|mesh-ancestor
93271484|NCT05073640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93271485|NCT05073640|Antioxidants|antioxidants|mesh-ancestor
93271486|NCT05073094|Esmolol|esmolol|mesh-list
93271487|NCT05073094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93271488|NCT05073094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93271489|NCT05073094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93271490|NCT05073094|Adrenergic Agents|adrenergic agents|mesh-ancestor
93271491|NCT05073094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271492|NCT05073094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271493|NCT05073094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271494|NCT03509246|Doxorubicin|doxorubicin|mesh-list
93271495|NCT03509246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93271496|NCT03509246|Bortezomib|bortezomib|mesh-list
93271497|NCT03509246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93271498|NCT03509246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271499|NCT03509246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93271500|NCT03509246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93271501|NCT03509246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271502|NCT03509246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271503|NCT03509168|Misoprostol|misoprostol|mesh-list
93271504|NCT03509168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93271505|NCT03509168|Abortifacient Agents|abortifacient agents|mesh-ancestor
93271506|NCT03509168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93271507|NCT03509168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271508|NCT03509168|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93271509|NCT03509168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271510|NCT03509168|Oxytocics|oxytocics|mesh-ancestor
93271511|NCT05072938|Nizatidine|nizatidine|mesh-list
93271512|NCT05072938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93271513|NCT05072938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271514|NCT05072938|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92943550|NCT00864760|Anticonvulsants|anticonvulsants|mesh-ancestor
93271515|NCT05072938|Histamine Antagonists|histamine antagonists|mesh-ancestor
93271516|NCT05072938|Histamine Agents|histamine agents|mesh-ancestor
93271517|NCT05072938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271518|NCT05072938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271519|NCT05072938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271520|NCT03041311|Carboplatin|carboplatin|mesh-list
93271521|NCT03041311|Etoposide|etoposide|mesh-list
93271522|NCT03041311|Atezolizumab|atezolizumab|mesh-list
93271523|NCT03041311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271524|NCT03041311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93271525|NCT03041311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93271526|NCT03041311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93271527|NCT03041311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271528|NCT03041311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271529|NCT03041311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93271530|NCT03041311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271531|NCT05072860|Tranexamic Acid|tranexamic acid|mesh-list
93271532|NCT05072860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93271533|NCT05072860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271534|NCT05072860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271535|NCT05072860|Hemostatics|hemostatics|mesh-ancestor
93271536|NCT05072860|Coagulants|coagulants|mesh-ancestor
93271537|NCT02311946|Palbociclib|palbociclib|mesh-list
93271538|NCT02311946|Rabeprazole|rabeprazole|mesh-list
93271539|NCT02311946|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93271540|NCT02311946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271541|NCT02311946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93271542|NCT02311946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271543|NCT02311946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271544|NCT02311946|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93271545|NCT02311946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271546|NCT04302766|Remdesivir|remdesivir|mesh-list
93271547|NCT04302766|Antimetabolites|antimetabolites|mesh-ancestor
93271548|NCT04302766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271549|NCT04302766|Antiviral Agents|antiviral agents|mesh-ancestor
93271550|NCT04302766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271551|NCT02312102|Lenalidomide|lenalidomide|mesh-list
93271552|NCT02312102|Bortezomib|bortezomib|mesh-list
93271553|NCT02312102|Immunologic Factors|immunologic factors|mesh-ancestor
93271554|NCT02312102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271555|NCT02312102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93271556|NCT02312102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93271557|NCT02312102|Growth Substances|growth substances|mesh-ancestor
93271558|NCT02312102|Growth Inhibitors|growth inhibitors|mesh-ancestor
93271559|NCT02312102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271560|NCT05408221|Lenvatinib|lenvatinib|mesh-list
93271561|NCT05408221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271562|NCT05408221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93271563|NCT05408221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271564|NCT05408221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271565|NCT02307968|Insulin|insulin|mesh-list
93271566|NCT02307968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271567|NCT02307968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271568|NCT02312180|Plasminogen|plasminogen|mesh-list
93271569|NCT02312180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93271570|NCT02312180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271571|NCT02312180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271572|NCT03504566|Empagliflozin|empagliflozin|mesh-list
93271573|NCT03504566|Linagliptin|linagliptin|mesh-list
93271574|NCT03504566|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
93271575|NCT03504566|Telmisartan|telmisartan|mesh-list
93271576|NCT03504566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93271577|NCT03504566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271578|NCT03504566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93271579|NCT03504566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271580|NCT03504566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93271581|NCT03504566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93271582|NCT03504566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93271583|NCT03504566|Incretins|incretins|mesh-ancestor
93271584|NCT03504566|Hormones|hormones|mesh-ancestor
93271585|NCT03504566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271586|NCT03504566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93271587|NCT03504566|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271588|NCT03504566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271589|NCT03504566|Anticoagulants|anticoagulants|mesh-ancestor
93271590|NCT03504566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93271591|NCT03504566|Antimetabolites|antimetabolites|mesh-ancestor
93271592|NCT03504566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93271593|NCT03504566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93271594|NCT03504566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271595|NCT05070520|Lumefantrine|lumefantrine|mesh-list
93271596|NCT05070520|Artemether|artemether|mesh-list
93271597|NCT05070520|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93271598|NCT05070520|Antimalarials|antimalarials|mesh-ancestor
93271599|NCT05070520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93271600|NCT05070520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93271601|NCT05070520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271602|NCT05070598|Paclitaxel|paclitaxel|mesh-list
93271603|NCT05070598|Tegafur|tegafur|mesh-list
93271604|NCT05070598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93271605|NCT05070598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271606|NCT05070598|Tubulin Modulators|tubulin modulators|mesh-ancestor
93271607|NCT05070598|Antimitotic Agents|antimitotic agents|mesh-ancestor
93271608|NCT05070598|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271609|NCT05070598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271610|NCT05070598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93271611|NCT05070598|Antimetabolites|antimetabolites|mesh-ancestor
93271612|NCT03884452|Atorvastatin|atorvastatin|mesh-list
93271613|NCT03884452|Simvastatin|simvastatin|mesh-list
93271614|NCT03884452|Ezetimibe|ezetimibe|mesh-list
93271615|NCT03884452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93271616|NCT03884452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93271617|NCT03884452|Antimetabolites|antimetabolites|mesh-ancestor
93271618|NCT03884452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271619|NCT03884452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93271620|NCT03884452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93271621|NCT03884452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271622|NCT03882892|Ezetimibe|ezetimibe|mesh-list
93271623|NCT03882892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93271624|NCT03882892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93271625|NCT03882892|Antimetabolites|antimetabolites|mesh-ancestor
93271626|NCT03882892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271627|NCT03882892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93271628|NCT02305160|Poractant alfa|poractant alfa|mesh-list
93271629|NCT02305160|Beractant|beractant|mesh-list
93271630|NCT02305160|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93271631|NCT02305160|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271632|NCT02305394|Ketamine|ketamine|mesh-list
93271633|NCT02305394|Propofol|propofol|mesh-list
93271634|NCT02305394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93271635|NCT02305394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271636|NCT02305394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271637|NCT02305394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93271638|NCT02305394|Anesthetics, General|anesthetics, general|mesh-ancestor
93271639|NCT02305394|Anesthetics|anesthetics|mesh-ancestor
93271640|NCT02305394|Analgesics|analgesics|mesh-ancestor
93271641|NCT02305394|Sensory System Agents|sensory system agents|mesh-ancestor
93271642|NCT02305394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271643|NCT02305394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93271644|NCT02305394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93271645|NCT02305394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93271646|NCT02305394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271647|NCT02305394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271648|NCT05068960|Bupivacaine|bupivacaine|mesh-list
93271649|NCT05068960|Anesthetics, Local|anesthetics, local|mesh-ancestor
93271650|NCT05068960|Anesthetics|anesthetics|mesh-ancestor
93271651|NCT05068960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271652|NCT05068960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271653|NCT05068960|Sensory System Agents|sensory system agents|mesh-ancestor
93271654|NCT05068960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271655|NCT02305550|Nitric Oxide|nitric oxide|mesh-list
93271656|NCT02305550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93271657|NCT02305550|Autonomic Agents|autonomic agents|mesh-ancestor
93271658|NCT02305550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271659|NCT02305550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271660|NCT02305550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93271661|NCT02305550|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271662|NCT02305550|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93271663|NCT02305550|Antioxidants|antioxidants|mesh-ancestor
93271664|NCT02305550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271665|NCT02305550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271666|NCT02305550|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93271667|NCT02305550|Vasodilator Agents|vasodilator agents|mesh-ancestor
92943711|NCT00736320|Bleomycin|bleomycin|mesh-list
93271668|NCT02305550|Gasotransmitters|gasotransmitters|mesh-ancestor
93271669|NCT02305550|Protective Agents|protective agents|mesh-ancestor
93271671|NCT03506516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93271672|NCT03506516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271673|NCT03506516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271674|NCT03506516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271675|NCT02312492|Palmitic Acid|palmitic acid|mesh-list
93271676|NCT02312492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271677|NCT02312492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271678|NCT02643394|Acetaminophen|acetaminophen|mesh-list
93271679|NCT02643394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93271680|NCT02643394|Analgesics|analgesics|mesh-ancestor
93271681|NCT02643394|Sensory System Agents|sensory system agents|mesh-ancestor
93271682|NCT02643394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271683|NCT02643394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271684|NCT02643394|Antipyretics|antipyretics|mesh-ancestor
93271685|NCT03101644|Darunavir|darunavir|mesh-list
93271686|NCT03101644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93271687|NCT03101644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93271688|NCT03101644|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271689|NCT03101644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271690|NCT03101644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271691|NCT03101644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93271692|NCT03101644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93271693|NCT03101644|Antiviral Agents|antiviral agents|mesh-ancestor
93271694|NCT03101644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271695|NCT03132272|Autoantibodies|autoantibodies|mesh-list
93271696|NCT03132272|Immunologic Factors|immunologic factors|mesh-ancestor
93271697|NCT03132272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271698|NCT03503786|Paclitaxel|paclitaxel|mesh-list
93271699|NCT03503786|Carboplatin|carboplatin|mesh-list
93271700|NCT03503786|Avelumab|avelumab|mesh-list
93271701|NCT03503786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93271702|NCT03503786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271703|NCT03503786|Tubulin Modulators|tubulin modulators|mesh-ancestor
93271704|NCT03503786|Antimitotic Agents|antimitotic agents|mesh-ancestor
93271705|NCT03503786|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271706|NCT03503786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271707|NCT03503786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271708|NCT02308982|Immunoglobulins|immunoglobulins|mesh-list
93271709|NCT02308982|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93271710|NCT02308982|Antibodies|antibodies|mesh-list
93271711|NCT02308982|gamma-Globulins|gamma-globulins|mesh-list
93271712|NCT02308982|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93271713|NCT02308982|Immunologic Factors|immunologic factors|mesh-ancestor
93271714|NCT02308982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271715|NCT05515627|Atezolizumab|atezolizumab|mesh-list
93271716|NCT05515627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93271717|NCT05515627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271718|NCT05515627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271719|NCT05515627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271720|NCT02178436|Paclitaxel|paclitaxel|mesh-list
93271721|NCT02178436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93271722|NCT02178436|Gemcitabine|gemcitabine|mesh-list
93271723|NCT02178436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93271724|NCT02178436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271725|NCT02178436|Tubulin Modulators|tubulin modulators|mesh-ancestor
93271726|NCT02178436|Antimitotic Agents|antimitotic agents|mesh-ancestor
93271727|NCT02178436|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271728|NCT02178436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271729|NCT02178436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93271730|NCT02178436|Antimetabolites|antimetabolites|mesh-ancestor
93271731|NCT02144064|Heparin|heparin|mesh-list
93271732|NCT02144064|Calcium heparin|calcium heparin|mesh-list
93271733|NCT02144064|Anticoagulants|anticoagulants|mesh-ancestor
93271734|NCT02144064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93271735|NCT02144064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271736|NCT02144064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271737|NCT02144142|Anti-Infective Agents|anti-infective agents|mesh-list
93271738|NCT02144142|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93271739|NCT02305862|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93271740|NCT02305862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93271741|NCT02305862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93271742|NCT02305862|Antimetabolites|antimetabolites|mesh-ancestor
93271743|NCT02305862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271744|NCT02305862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93271745|NCT02305862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93271746|NCT02305862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271747|NCT02305940|Doxycycline|doxycycline|mesh-list
93271748|NCT02305940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93271749|NCT02305940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271750|NCT02305940|Antimalarials|antimalarials|mesh-ancestor
93271751|NCT02305940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93271752|NCT02305940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93271754|NCT02312804|Carboplatin|carboplatin|mesh-list
93271755|NCT02312804|Infigratinib|infigratinib|mesh-list
93271756|NCT02312804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93271757|NCT02312804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271758|NCT02312804|Tubulin Modulators|tubulin modulators|mesh-ancestor
93271759|NCT02312804|Antimitotic Agents|antimitotic agents|mesh-ancestor
93271760|NCT02312804|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271761|NCT02312804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271762|NCT03099616|Propofol|propofol|mesh-list
93271763|NCT03099616|Desflurane|desflurane|mesh-list
93271764|NCT03099616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93271765|NCT03099616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271766|NCT03099616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271767|NCT03099616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93271768|NCT03099616|Anesthetics, General|anesthetics, general|mesh-ancestor
93271769|NCT03099616|Anesthetics|anesthetics|mesh-ancestor
93271770|NCT03099616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93271771|NCT04463966|Tranexamic Acid|tranexamic acid|mesh-list
93271772|NCT04463966|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93271773|NCT04463966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271774|NCT04463966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271775|NCT04463966|Hemostatics|hemostatics|mesh-ancestor
93271776|NCT04463966|Coagulants|coagulants|mesh-ancestor
93271777|NCT00794248|Fexofenadine|fexofenadine|mesh-list
93271778|NCT00794248|Desloratadine|desloratadine|mesh-list
93271779|NCT00794248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93271780|NCT00794248|Cholinergic Agents|cholinergic agents|mesh-ancestor
93271781|NCT00794248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271782|NCT00794248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271783|NCT00794248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271784|NCT00794248|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93271785|NCT00794248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93271786|NCT00794248|Histamine Antagonists|histamine antagonists|mesh-ancestor
93271787|NCT00794248|Histamine Agents|histamine agents|mesh-ancestor
93271788|NCT00794248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93271789|NCT02309450|Asunaprevir|asunaprevir|mesh-list
93271790|NCT02309450|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271791|NCT02309450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271792|NCT02309450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271793|NCT04475224|Mitogens|mitogens|mesh-list
93271794|NCT04475224|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271795|NCT04475224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271796|NCT05370235|Afamelanotide|afamelanotide|mesh-list
93271797|NCT05370235|Dermatologic Agents|dermatologic agents|mesh-ancestor
93271798|NCT00353496|Lanreotide|lanreotide|mesh-list
93271799|NCT00353496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271800|NCT00389896|Oxymetazoline|oxymetazoline|mesh-list
93271801|NCT00389896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93271802|NCT00389896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93271803|NCT00389896|Adrenergic Agents|adrenergic agents|mesh-ancestor
93271804|NCT00389896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271805|NCT00389896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271806|NCT00389896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271807|NCT00389896|Sympathomimetics|sympathomimetics|mesh-ancestor
93271808|NCT00389896|Autonomic Agents|autonomic agents|mesh-ancestor
93271809|NCT00389896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271810|NCT00389896|Nasal Decongestants|nasal decongestants|mesh-ancestor
93271811|NCT00389896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93271812|NCT00389896|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271813|NCT03388190|Leucovorin|leucovorin|mesh-list
93271814|NCT03388190|Fluorouracil|fluorouracil|mesh-list
93271815|NCT03388190|Oxaliplatin|oxaliplatin|mesh-list
93271816|NCT03388190|Nivolumab|nivolumab|mesh-list
93271817|NCT03388190|Levoleucovorin|levoleucovorin|mesh-list
93271818|NCT03388190|Antimetabolites|antimetabolites|mesh-ancestor
93271819|NCT03388190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271820|NCT03388190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93271821|NCT03388190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271822|NCT03388190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93271823|NCT03388190|Immunologic Factors|immunologic factors|mesh-ancestor
93271824|NCT03388190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271825|NCT03388190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271826|NCT03388190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93271827|NCT03388190|Antidotes|antidotes|mesh-ancestor
93271828|NCT03388190|Protective Agents|protective agents|mesh-ancestor
93271829|NCT03388190|Vitamin B Complex|vitamin b complex|mesh-ancestor
93271830|NCT03388190|Vitamins|vitamins|mesh-ancestor
93271831|NCT03388190|Micronutrients|micronutrients|mesh-ancestor
93271832|NCT02313272|Bevacizumab|bevacizumab|mesh-list
93271833|NCT02313272|Pembrolizumab|pembrolizumab|mesh-list
93271834|NCT02313272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93271835|NCT02313272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271836|NCT02313272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93271837|NCT02313272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93271838|NCT02313272|Growth Substances|growth substances|mesh-ancestor
93271839|NCT02313272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271840|NCT02313272|Growth Inhibitors|growth inhibitors|mesh-ancestor
93271841|NCT02313272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93271842|NCT02313272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271843|NCT03473977|Benralizumab|benralizumab|mesh-list
93271844|NCT03473977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93271845|NCT03473977|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271846|NCT01361464|Tipifarnib|tipifarnib|mesh-list
93271847|NCT01361464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271848|NCT04051255|Metronidazole|metronidazole|mesh-list
93271849|NCT04051255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271850|NCT04051255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93271851|NCT04051255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93271852|NCT04051255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93271853|NCT03505736|Adenosine|adenosine|mesh-list
93271854|NCT03505736|Regadenoson|regadenoson|mesh-list
93271855|NCT03505736|Analgesics|analgesics|mesh-ancestor
93271856|NCT03505736|Sensory System Agents|sensory system agents|mesh-ancestor
93271857|NCT03505736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271858|NCT03505736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271859|NCT03505736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271860|NCT03505736|Vasodilator Agents|vasodilator agents|mesh-ancestor
93271861|NCT03505736|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93271862|NCT03505736|Purinergic Agonists|purinergic agonists|mesh-ancestor
93271863|NCT03505736|Purinergic Agents|purinergic agents|mesh-ancestor
93271864|NCT03505736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271865|NCT03505736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271866|NCT03505736|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93271867|NCT02316626|Progesterone|progesterone|mesh-list
93271868|NCT02316626|Progestins|progestins|mesh-ancestor
93271869|NCT02316626|Hormones|hormones|mesh-ancestor
93271870|NCT02316626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271871|NCT02316626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271872|NCT03505502|Tranexamic Acid|tranexamic acid|mesh-list
93271873|NCT03505502|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93271874|NCT03505502|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271875|NCT03505502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271876|NCT03505502|Hemostatics|hemostatics|mesh-ancestor
93271877|NCT03505502|Coagulants|coagulants|mesh-ancestor
93271878|NCT03977896|Carbon-11 methionine|carbon-11 methionine|mesh-list
93271879|NCT03977896|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93271880|NCT03977896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271881|NCT02316704|Tacrine|tacrine|mesh-list
93271882|NCT02316704|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93271883|NCT02316704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271884|NCT02316704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271885|NCT02316704|Cholinergic Agents|cholinergic agents|mesh-ancestor
93271886|NCT02316704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271887|NCT02316704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271888|NCT02316704|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93271889|NCT02316704|Autonomic Agents|autonomic agents|mesh-ancestor
93271890|NCT02316704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271891|NCT02316704|Nootropic Agents|nootropic agents|mesh-ancestor
93271892|NCT03501680|Insulin|insulin|mesh-list
93271893|NCT03501680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92943926|NCT00879424|Vitamins|vitamins|mesh-ancestor
93271894|NCT03501680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271895|NCT02310074|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93271896|NCT02310074|Hormones|hormones|mesh-list
93271897|NCT02310074|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93271898|NCT02310074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93271899|NCT02310074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271900|NCT02310074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93271901|NCT02313584|Dabigatran|dabigatran|mesh-list
93271902|NCT02313584|Antithrombins|antithrombins|mesh-ancestor
93271903|NCT02313584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93271904|NCT02313584|Protease Inhibitors|protease inhibitors|mesh-ancestor
93271905|NCT02313584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271906|NCT02313584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271907|NCT02313584|Anticoagulants|anticoagulants|mesh-ancestor
93271908|NCT05063578|Lidocaine|lidocaine|mesh-list
93271909|NCT05063578|Anesthetics, Local|anesthetics, local|mesh-ancestor
93271910|NCT05063578|Anesthetics|anesthetics|mesh-ancestor
93271911|NCT05063578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93271912|NCT05063578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271913|NCT05063578|Sensory System Agents|sensory system agents|mesh-ancestor
93271914|NCT05063578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271915|NCT05063578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271916|NCT05063578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93271917|NCT05063578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93271918|NCT05063578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93271919|NCT05063578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271920|NCT05063422|Trimethoprim|trimethoprim|mesh-list
93271921|NCT05063422|Polymyxins|polymyxins|mesh-list
93271922|NCT05063422|Polymyxin B|polymyxin b|mesh-list
93271923|NCT05063422|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93271924|NCT05063422|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93271925|NCT05063422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93271926|NCT05063422|Antimalarials|antimalarials|mesh-ancestor
93271927|NCT05063422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93271928|NCT05063422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93271929|NCT05063422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93271930|NCT05063422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93271931|NCT05063422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271932|NCT05063422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93271933|NCT05063422|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93271934|NCT05063422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93271935|NCT05063422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93271936|NCT05063422|Laxatives|laxatives|mesh-ancestor
93271937|NCT05063422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93271938|NCT03782350|Tranexamic Acid|tranexamic acid|mesh-list
93271939|NCT03782350|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93271940|NCT03782350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93271941|NCT03782350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271942|NCT03782350|Hemostatics|hemostatics|mesh-ancestor
93271943|NCT03782350|Coagulants|coagulants|mesh-ancestor
93271944|NCT03636256|Docetaxel|docetaxel|mesh-list
93271945|NCT03636256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93271946|NCT03636256|Tubulin Modulators|tubulin modulators|mesh-ancestor
93271947|NCT03636256|Antimitotic Agents|antimitotic agents|mesh-ancestor
93271948|NCT03636256|Mitosis Modulators|mitosis modulators|mesh-ancestor
93271949|NCT03636256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271950|NCT03098680|Verapamil|verapamil|mesh-list
93271951|NCT03098680|Nicardipine|nicardipine|mesh-list
93271952|NCT03098680|Phentolamine|phentolamine|mesh-list
93271953|NCT03098680|Phenylephrine|phenylephrine|mesh-list
93271954|NCT03098680|Dobutamine|dobutamine|mesh-list
93271955|NCT03098680|Oxymetazoline|oxymetazoline|mesh-list
93271956|NCT03098680|Albuterol|albuterol|mesh-list
93271957|NCT03098680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93271958|NCT03098680|Autonomic Agents|autonomic agents|mesh-ancestor
93271959|NCT03098680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93271960|NCT03098680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271961|NCT03098680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93271962|NCT03098680|Respiratory System Agents|respiratory system agents|mesh-ancestor
93271963|NCT03098680|Tocolytic Agents|tocolytic agents|mesh-ancestor
93271964|NCT03098680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93271965|NCT03098680|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93271966|NCT03098680|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93271967|NCT03098680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93271968|NCT03098680|Adrenergic Agents|adrenergic agents|mesh-ancestor
93271969|NCT03098680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271970|NCT03098680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271971|NCT03098680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93271972|NCT03098680|Mydriatics|mydriatics|mesh-ancestor
93271973|NCT03098680|Sympathomimetics|sympathomimetics|mesh-ancestor
93271974|NCT03098680|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93271975|NCT03098680|Nasal Decongestants|nasal decongestants|mesh-ancestor
93271976|NCT03098680|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93271977|NCT03098680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93271978|NCT03098680|Protective Agents|protective agents|mesh-ancestor
93271979|NCT03098680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93271980|NCT03098680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93271981|NCT03098680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93271982|NCT03098680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93271983|NCT03098680|Vasodilator Agents|vasodilator agents|mesh-ancestor
93271984|NCT03098680|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93271985|NCT03098680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93271986|NCT03098680|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93271987|NCT03098680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93271988|NCT03098368|Rotigotine|rotigotine|mesh-list
93271989|NCT03098368|Dopamine Agonists|dopamine agonists|mesh-ancestor
93271990|NCT03098368|Dopamine Agents|dopamine agents|mesh-ancestor
93271991|NCT03098368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93271992|NCT03098368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93271993|NCT03098368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93271994|NCT05062486|Curcumin|curcumin|mesh-list
93271995|NCT05062486|Resveratrol|resveratrol|mesh-list
93271996|NCT05062486|Quercetin|quercetin|mesh-list
93271997|NCT05062486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93271998|NCT05062486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93271999|NCT05062486|Analgesics|analgesics|mesh-ancestor
93272000|NCT05062486|Sensory System Agents|sensory system agents|mesh-ancestor
93272001|NCT05062486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272002|NCT05062486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272003|NCT05062486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93272004|NCT05062486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272005|NCT05062486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272006|NCT05062486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272007|NCT05062486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272008|NCT05062486|Antioxidants|antioxidants|mesh-ancestor
93272009|NCT05062486|Protective Agents|protective agents|mesh-ancestor
93272010|NCT05062486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93272011|NCT04474600|Propofol|propofol|mesh-list
93272012|NCT04474600|Desflurane|desflurane|mesh-list
93272013|NCT04474600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93272014|NCT04474600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272015|NCT04474600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272016|NCT04474600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272017|NCT04474600|Anesthetics, General|anesthetics, general|mesh-ancestor
93272018|NCT04474600|Anesthetics|anesthetics|mesh-ancestor
93272019|NCT04474600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93272020|NCT02314208|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
93272021|NCT02314208|Resveratrol|resveratrol|mesh-list
93272022|NCT02314208|Atorvastatin|atorvastatin|mesh-list
93272023|NCT02314208|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93272024|NCT02314208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93272025|NCT02314208|Antimetabolites|antimetabolites|mesh-ancestor
93272026|NCT02314208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272027|NCT02314208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93272028|NCT02314208|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93272029|NCT02314208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272030|NCT02314208|Antioxidants|antioxidants|mesh-ancestor
93272031|NCT02314208|Protective Agents|protective agents|mesh-ancestor
93272032|NCT02314208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272033|NCT02314208|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93272034|NCT02314208|Cathartics|cathartics|mesh-ancestor
93272035|NCT02314208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93272036|NCT03100318|Dotinurad|dotinurad|mesh-list
93272037|NCT03100318|Benzbromarone|benzbromarone|mesh-list
93272038|NCT03100318|Uricosuric Agents|uricosuric agents|mesh-ancestor
93272039|NCT03100318|Gout Suppressants|gout suppressants|mesh-ancestor
93272040|NCT03100318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272041|NCT02311010|Tacrolimus|tacrolimus|mesh-list
93272042|NCT02311010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93272043|NCT02311010|Immunologic Factors|immunologic factors|mesh-ancestor
93272044|NCT02311010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272045|NCT02311010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93272046|NCT02311010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944078|NCT00414661|Tofacitinib|tofacitinib|mesh-list
93272047|NCT02311010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272048|NCT05020600|Pregabalin|pregabalin|mesh-list
93272049|NCT05020600|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93272050|NCT05020600|Amitriptyline|amitriptyline|mesh-list
93272051|NCT05020600|Analgesics|analgesics|mesh-ancestor
93272052|NCT05020600|Sensory System Agents|sensory system agents|mesh-ancestor
93272053|NCT05020600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272054|NCT05020600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272055|NCT05020600|Anticonvulsants|anticonvulsants|mesh-ancestor
93272056|NCT05020600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93272057|NCT05020600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272058|NCT05020600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272059|NCT05020600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272060|NCT05020600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93272061|NCT05020600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93272062|NCT05020600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272063|NCT05020600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93272064|NCT05020600|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93272065|NCT05020600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93272066|NCT05020600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272067|NCT05020600|Antidepressive Agents|antidepressive agents|mesh-ancestor
93272068|NCT05020600|Dopamine Agents|dopamine agents|mesh-ancestor
93272069|NCT05020600|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93272070|NCT05020600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93272071|NCT05020600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93272072|NCT05020600|Adrenergic Agents|adrenergic agents|mesh-ancestor
93272073|NCT02314286|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93272074|NCT02314286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93272075|NCT02314286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93272076|NCT02314286|Antimetabolites|antimetabolites|mesh-ancestor
93272077|NCT02314286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272078|NCT02314286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93272079|NCT02314286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93272080|NCT02314286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272081|NCT03132194|Dapsone|dapsone|mesh-list
93272082|NCT03132194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272083|NCT03132194|Antimalarials|antimalarials|mesh-ancestor
93272084|NCT03132194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272085|NCT03132194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272086|NCT03132194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93272087|NCT03132194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272088|NCT03132194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272089|NCT03132194|Leprostatic Agents|leprostatic agents|mesh-ancestor
93272090|NCT03132194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272091|NCT02311088|Caffeine|caffeine|mesh-list
93272092|NCT02311088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93272093|NCT02311088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272094|NCT02311088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93272095|NCT02311088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272096|NCT02311088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272097|NCT02311088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93272098|NCT02311088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93272099|NCT02311088|Purinergic Agents|purinergic agents|mesh-ancestor
93272100|NCT02311088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272101|NCT03501212|Anesthetics|anesthetics|mesh-list
93272102|NCT03501212|Anesthetics, Local|anesthetics, local|mesh-list
93272103|NCT03501212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272104|NCT03501212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272105|NCT03501212|Sensory System Agents|sensory system agents|mesh-ancestor
93272106|NCT03501212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272107|NCT02317484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93272108|NCT02317484|Ipragliflozin|ipragliflozin|mesh-list
93272109|NCT02317484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272110|NCT02317484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93272111|NCT02317484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272112|NCT04435210|Hydralazine|hydralazine|mesh-list
93272113|NCT04435210|Nifedipine|nifedipine|mesh-list
93272114|NCT04435210|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93272115|NCT04435210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272116|NCT04435210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272117|NCT04435210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272118|NCT04435210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272119|NCT04435210|Vasodilator Agents|vasodilator agents|mesh-ancestor
93272120|NCT04435210|Tocolytic Agents|tocolytic agents|mesh-ancestor
93272121|NCT04435210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272122|NCT04435210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93272123|NCT03501056|Antibodies|antibodies|mesh-list
93272124|NCT03501056|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93272125|NCT03501056|Immunologic Factors|immunologic factors|mesh-ancestor
93272126|NCT03501056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272127|NCT03292146|Denosumab|denosumab|mesh-list
93272128|NCT03292146|Alendronate|alendronate|mesh-list
93272129|NCT03292146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92566707|NCT00179686|Growth Substances|growth substances|mesh-ancestor
93272130|NCT03292146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272131|NCT02144376|Psyllium|psyllium|mesh-list
93272132|NCT02144376|Cathartics|cathartics|mesh-ancestor
93272133|NCT02144376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93272134|NCT02314754|Misoprostol|misoprostol|mesh-list
93272135|NCT02314754|Mifepristone|mifepristone|mesh-list
93272136|NCT02314754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93272137|NCT02314754|Abortifacient Agents|abortifacient agents|mesh-ancestor
93272138|NCT02314754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272139|NCT02314754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272140|NCT02314754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93272141|NCT02314754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93272142|NCT02314754|Oxytocics|oxytocics|mesh-ancestor
93272143|NCT02314754|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93272144|NCT02314754|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93272145|NCT02314754|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93272146|NCT02314754|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93272147|NCT02314754|Contraceptive Agents|contraceptive agents|mesh-ancestor
93272148|NCT02314754|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93272149|NCT02314754|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93272150|NCT02314754|Hormone Antagonists|hormone antagonists|mesh-ancestor
93272151|NCT02314754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272152|NCT02314754|Luteolytic Agents|luteolytic agents|mesh-ancestor
93272153|NCT02314754|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93272154|NCT02314754|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93272155|NCT02317640|Testosterone|testosterone|mesh-list
93272156|NCT02317640|Androgens|androgens|mesh-ancestor
93272157|NCT02317640|Hormones|hormones|mesh-ancestor
93272158|NCT02317640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272159|NCT02317640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272160|NCT02716948|Nivolumab|nivolumab|mesh-list
93272161|NCT02716948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93272162|NCT02716948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272163|NCT02716948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93272164|NCT02716948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272165|NCT03500900|Vildagliptin|vildagliptin|mesh-list
93272166|NCT03500900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93272167|NCT03500900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272168|NCT03500900|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93272169|NCT03500900|Protease Inhibitors|protease inhibitors|mesh-ancestor
93272170|NCT03500900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272171|NCT03500900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272172|NCT02144688|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93272173|NCT02144688|Antiviral Agents|antiviral agents|mesh-ancestor
93272174|NCT02144688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272175|NCT02141100|Thioguanine|thioguanine|mesh-list
93272176|NCT02141100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93272177|NCT02141100|Antimetabolites|antimetabolites|mesh-ancestor
93272178|NCT02141100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272179|NCT02141100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272180|NCT02141178|Bupivacaine|bupivacaine|mesh-list
93272181|NCT02141178|Anesthetics, Local|anesthetics, local|mesh-ancestor
93272182|NCT02141178|Anesthetics|anesthetics|mesh-ancestor
93272183|NCT02141178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272184|NCT02141178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272185|NCT02141178|Sensory System Agents|sensory system agents|mesh-ancestor
93272186|NCT02141178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272187|NCT02141412|Dexmedetomidine|dexmedetomidine|mesh-list
93272188|NCT02141412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93272189|NCT02141412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272190|NCT02141412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272191|NCT02141412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93272192|NCT02141412|Analgesics|analgesics|mesh-ancestor
93272193|NCT02141412|Sensory System Agents|sensory system agents|mesh-ancestor
92944232|NCT00712920|Azelastine|azelastine|mesh-list
93272194|NCT02141412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272195|NCT02141412|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93272196|NCT02141412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93272197|NCT02141412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93272198|NCT02141412|Adrenergic Agents|adrenergic agents|mesh-ancestor
93272199|NCT02141412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272200|NCT02141412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272201|NCT04463264|Nitazoxanide|nitazoxanide|mesh-list
93272202|NCT04463264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272203|NCT04463264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272204|NCT03210558|Testosterone|testosterone|mesh-list
93272205|NCT03210558|Androgens|androgens|mesh-ancestor
93272207|NCT03210558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272208|NCT03210558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272209|NCT05046262|Calcium|calcium|mesh-list
93272210|NCT05046262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272211|NCT05046262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272212|NCT05036824|Tinzaparin|tinzaparin|mesh-list
93272213|NCT05036824|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93272214|NCT05036824|Dalteparin|dalteparin|mesh-list
93272215|NCT05036824|Anticoagulants|anticoagulants|mesh-ancestor
93272216|NCT05036824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93272217|NCT05036824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93272218|NCT05036824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272219|NCT04462250|Analgesics, Opioid|analgesics, opioid|mesh-list
93272220|NCT04462250|Narcotics|narcotics|mesh-ancestor
93272221|NCT04462250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272222|NCT04462250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272223|NCT04462250|Analgesics|analgesics|mesh-ancestor
93272224|NCT04462250|Sensory System Agents|sensory system agents|mesh-ancestor
93272225|NCT04462250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272226|NCT02144766|Ropivacaine|ropivacaine|mesh-list
93272227|NCT02144766|Anesthetics, Local|anesthetics, local|mesh-ancestor
93272228|NCT02144766|Anesthetics|anesthetics|mesh-ancestor
93272229|NCT02144766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272230|NCT02144766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272231|NCT02144766|Sensory System Agents|sensory system agents|mesh-ancestor
93272232|NCT02144766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272233|NCT05045248|Apraclonidine|apraclonidine|mesh-list
93272234|NCT05045248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93272235|NCT05045248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93272236|NCT05045248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93272237|NCT05045248|Adrenergic Agents|adrenergic agents|mesh-ancestor
93272238|NCT05045248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272239|NCT05045248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272240|NCT05045248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272241|NCT02144922|Pitavastatin|pitavastatin|mesh-list
93272242|NCT02144922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93272243|NCT02144922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93272244|NCT02144922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93272245|NCT02144922|Antimetabolites|antimetabolites|mesh-ancestor
93272246|NCT02144922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272247|NCT02144922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272248|NCT02144922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93272249|NCT02261064|Amlodipine|amlodipine|mesh-list
93272250|NCT02261064|Telmisartan|telmisartan|mesh-list
93272251|NCT02261064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93272252|NCT02261064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93272253|NCT02261064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93272254|NCT02261064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272255|NCT02261064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272256|NCT02261064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272257|NCT02261064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272258|NCT02261064|Vasodilator Agents|vasodilator agents|mesh-ancestor
93272259|NCT02261064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93272260|NCT02261064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93272261|NCT02955966|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93272262|NCT02955966|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93272263|NCT02955966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272264|NCT05035498|Phenylephrine|phenylephrine|mesh-list
93272265|NCT05035498|Oxymetazoline|oxymetazoline|mesh-list
92944294|NCT00920868|Bevacizumab|bevacizumab|mesh-list
93272266|NCT05035498|Norepinephrine|norepinephrine|mesh-list
93272267|NCT05035498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93272268|NCT05035498|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93272269|NCT05035498|Mydriatics|mydriatics|mesh-ancestor
93272270|NCT05035498|Autonomic Agents|autonomic agents|mesh-ancestor
93272271|NCT05035498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272272|NCT05035498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272273|NCT05035498|Sympathomimetics|sympathomimetics|mesh-ancestor
93272274|NCT05035498|Nasal Decongestants|nasal decongestants|mesh-ancestor
93272275|NCT05035498|Respiratory System Agents|respiratory system agents|mesh-ancestor
93272276|NCT05035498|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93272277|NCT05035498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93272278|NCT05035498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93272279|NCT05035498|Adrenergic Agents|adrenergic agents|mesh-ancestor
93272280|NCT05035498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272281|NCT05035498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272282|NCT05035498|Protective Agents|protective agents|mesh-ancestor
93272283|NCT03498326|Celecoxib|celecoxib|mesh-list
93272284|NCT03498326|Gemcitabine|gemcitabine|mesh-list
93272285|NCT03498326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93272286|NCT03498326|Antimetabolites|antimetabolites|mesh-ancestor
93272287|NCT03498326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272288|NCT03498326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272289|NCT03498326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93272290|NCT03498326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93272291|NCT03498326|Analgesics|analgesics|mesh-ancestor
93272292|NCT03498326|Sensory System Agents|sensory system agents|mesh-ancestor
93272293|NCT03498326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272294|NCT03498326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272295|NCT03498326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93272296|NCT03498326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272297|NCT03498326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93272298|NCT03498326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93272299|NCT03498326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272300|NCT03498248|Lenograstim|lenograstim|mesh-list
93272301|NCT03498248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93272302|NCT03498248|Immunologic Factors|immunologic factors|mesh-ancestor
93272303|NCT03498248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272304|NCT01360996|Contraceptive Agents|contraceptive agents|mesh-list
93272305|NCT01360996|Contraceptives, Oral|contraceptives, oral|mesh-list
93272306|NCT01360996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272307|NCT01360996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272308|NCT01360996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93272309|NCT03498170|Itraconazole|itraconazole|mesh-list
93272310|NCT03498170|Acumapimod|acumapimod|mesh-list
93272311|NCT03498170|Antifungal Agents|antifungal agents|mesh-ancestor
93272312|NCT03498170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272313|NCT03498170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93272314|NCT03498170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93272315|NCT03498170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272316|NCT03498170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272317|NCT03498170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93272318|NCT03498170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93272319|NCT03498170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272320|NCT03498170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272321|NCT03498170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93272322|NCT03498170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93272323|NCT05055544|Fosfomycin|fosfomycin|mesh-list
93272324|NCT05055544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272325|NCT05055544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272326|NCT03498092|Dexmedetomidine|dexmedetomidine|mesh-list
93272327|NCT03498092|Bupivacaine|bupivacaine|mesh-list
93272328|NCT03498092|Anesthetics, Local|anesthetics, local|mesh-ancestor
93272329|NCT03498092|Anesthetics|anesthetics|mesh-ancestor
93272330|NCT03498092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272331|NCT03498092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272332|NCT03498092|Sensory System Agents|sensory system agents|mesh-ancestor
93272333|NCT03498092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272334|NCT03498092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93272335|NCT03498092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93272336|NCT03498092|Analgesics|analgesics|mesh-ancestor
93272337|NCT03498092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93272338|NCT03498092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93272339|NCT03498092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93272340|NCT03498092|Adrenergic Agents|adrenergic agents|mesh-ancestor
93272341|NCT03498092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272342|NCT03498092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272344|NCT03500432|Anesthetics, Local|anesthetics, local|mesh-ancestor
93272345|NCT03500432|Anesthetics|anesthetics|mesh-ancestor
93272346|NCT03500432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272347|NCT03500432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272348|NCT03500432|Sensory System Agents|sensory system agents|mesh-ancestor
93272349|NCT03500432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272350|NCT03500432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93272351|NCT03500432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93272352|NCT03500432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93272353|NCT03500432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272354|NCT03500432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272355|NCT01951885|Mycophenolic Acid|mycophenolic acid|mesh-list
93272356|NCT01951885|Methotrexate|methotrexate|mesh-list
93272357|NCT01951885|Tacrolimus|tacrolimus|mesh-list
93272358|NCT01951885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93272359|NCT01951885|Abortifacient Agents|abortifacient agents|mesh-ancestor
93272360|NCT01951885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272361|NCT01951885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272362|NCT01951885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93272363|NCT01951885|Antimetabolites|antimetabolites|mesh-ancestor
93272364|NCT01951885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272365|NCT01951885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272366|NCT01951885|Dermatologic Agents|dermatologic agents|mesh-ancestor
93272367|NCT01951885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272368|NCT01951885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93272369|NCT01951885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93272370|NCT01951885|Immunologic Factors|immunologic factors|mesh-ancestor
93272371|NCT01951885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272372|NCT01951885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93272373|NCT01951885|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93272374|NCT01951885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93272375|NCT01951885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93272376|NCT01951885|Antitubercular Agents|antitubercular agents|mesh-ancestor
93272377|NCT01951885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272378|NCT01951885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272379|NCT02315690|Piperaquine|piperaquine|mesh-list
93272380|NCT02315690|Artenimol|artenimol|mesh-list
93272381|NCT02315690|Antimalarials|antimalarials|mesh-ancestor
93272382|NCT02315690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272383|NCT02315690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272384|NCT02315690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272385|NCT02639338|Sofosbuvir|sofosbuvir|mesh-list
93272386|NCT02639338|Velpatasvir|velpatasvir|mesh-list
93272387|NCT02639338|Antiviral Agents|antiviral agents|mesh-ancestor
93272388|NCT02639338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272389|NCT01754857|Rituximab|rituximab|mesh-list
93272390|NCT01754857|Lenalidomide|lenalidomide|mesh-list
93272391|NCT01754857|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93272392|NCT01754857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93272393|NCT01754857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272394|NCT01754857|Immunologic Factors|immunologic factors|mesh-ancestor
93272395|NCT01754857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272396|NCT01754857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272397|NCT01754857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93272398|NCT01754857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93272399|NCT01754857|Growth Substances|growth substances|mesh-ancestor
93272400|NCT01754857|Growth Inhibitors|growth inhibitors|mesh-ancestor
93272401|NCT01754857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93272402|NCT01754857|Alkylating Agents|alkylating agents|mesh-ancestor
93272403|NCT01754857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272404|NCT03497702|Cyclophosphamide|cyclophosphamide|mesh-list
93272405|NCT03497702|Docetaxel|docetaxel|mesh-list
93272406|NCT03497702|Doxorubicin|doxorubicin|mesh-list
93272407|NCT03497702|Letrozole|letrozole|mesh-list
93272408|NCT03497702|Leuprolide|leuprolide|mesh-list
93272409|NCT03497702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93272410|NCT03497702|Immunologic Factors|immunologic factors|mesh-ancestor
93272411|NCT03497702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272412|NCT03497702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272413|NCT03497702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93272414|NCT03497702|Alkylating Agents|alkylating agents|mesh-ancestor
92944453|NCT00738192|Fentanyl|fentanyl|mesh-list
93272415|NCT03497702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272416|NCT03497702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272417|NCT03497702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93272418|NCT03497702|Tubulin Modulators|tubulin modulators|mesh-ancestor
93272419|NCT03497702|Antimitotic Agents|antimitotic agents|mesh-ancestor
93272420|NCT03497702|Mitosis Modulators|mitosis modulators|mesh-ancestor
93272421|NCT03497702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93272422|NCT03497702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93272423|NCT03497702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93272424|NCT03497702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272425|NCT03497702|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93272426|NCT03497702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93272427|NCT03497702|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93272428|NCT03497702|Hormone Antagonists|hormone antagonists|mesh-ancestor
93272429|NCT03497702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272430|NCT03497702|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93272431|NCT03497702|Fertility Agents|fertility agents|mesh-ancestor
93272432|NCT03497702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272433|NCT03497702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93272435|NCT02900352|Anticonvulsants|anticonvulsants|mesh-ancestor
93272436|NCT02900352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93272437|NCT02900352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272438|NCT02900352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272439|NCT02900352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272440|NCT02900352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272441|NCT05034406|Lidocaine|lidocaine|mesh-list
93272442|NCT05034406|Levobupivacaine|levobupivacaine|mesh-list
93272443|NCT05034406|Anesthetics, Local|anesthetics, local|mesh-ancestor
93272444|NCT05034406|Anesthetics|anesthetics|mesh-ancestor
93272445|NCT05034406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272446|NCT05034406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272447|NCT05034406|Sensory System Agents|sensory system agents|mesh-ancestor
93272448|NCT05034406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272449|NCT05034406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93272450|NCT05034406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93272451|NCT05034406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93272452|NCT05034406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272453|NCT05034406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272454|NCT02254668|Mycophenolic Acid|mycophenolic acid|mesh-list
93272455|NCT02254668|Everolimus|everolimus|mesh-list
93272456|NCT02254668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93272457|NCT02254668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93272458|NCT02254668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272459|NCT02254668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272460|NCT02254668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93272461|NCT02254668|Immunologic Factors|immunologic factors|mesh-ancestor
93272462|NCT02254668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272463|NCT02254668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272464|NCT02254668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93272465|NCT02254668|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93272466|NCT02254668|Antitubercular Agents|antitubercular agents|mesh-ancestor
93272467|NCT02254668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272468|NCT02254668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272469|NCT03095404|Lidocaine|lidocaine|mesh-list
93272470|NCT03095404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93272471|NCT03095404|Anesthetics, Local|anesthetics, local|mesh-ancestor
93272472|NCT03095404|Anesthetics|anesthetics|mesh-ancestor
93272473|NCT03095404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272474|NCT03095404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272475|NCT03095404|Sensory System Agents|sensory system agents|mesh-ancestor
93272476|NCT03095404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272477|NCT03095404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93272478|NCT03095404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93272479|NCT03095404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93272480|NCT03095404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272481|NCT03095404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272482|NCT02145546|Amiodarone|amiodarone|mesh-list
93272483|NCT02145546|Sotalol|sotalol|mesh-list
93272484|NCT02145546|Propafenone|propafenone|mesh-list
93272485|NCT02145546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93272486|NCT02145546|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944522|NCT00612508|Progestins|progestins|mesh-ancestor
93272488|NCT02145546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272489|NCT02145546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272490|NCT02145546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93272491|NCT02145546|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93272492|NCT02145546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93272493|NCT02145546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272494|NCT02145546|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93272495|NCT02145546|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93272496|NCT02145546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93272497|NCT02145546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93272498|NCT02145546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93272499|NCT02145546|Adrenergic Agents|adrenergic agents|mesh-ancestor
93272500|NCT02145546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272501|NCT02145546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272502|NCT02145546|Sympatholytics|sympatholytics|mesh-ancestor
93272503|NCT02145546|Autonomic Agents|autonomic agents|mesh-ancestor
93272504|NCT02145546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272505|NCT02145546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93272506|NCT03039673|Interleukin-2|interleukin-2|mesh-list
93272507|NCT03039673|Riluzole|riluzole|mesh-list
93272508|NCT03039673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272509|NCT03039673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93272510|NCT03039673|Analgesics|analgesics|mesh-ancestor
93272511|NCT03039673|Sensory System Agents|sensory system agents|mesh-ancestor
93272512|NCT03039673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272513|NCT03039673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272514|NCT03039673|Anticonvulsants|anticonvulsants|mesh-ancestor
93272515|NCT03039673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93272516|NCT03039673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93272517|NCT03039673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272518|NCT03039673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272519|NCT03039673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93272520|NCT03039673|Protective Agents|protective agents|mesh-ancestor
93272521|NCT02145624|Vaccines|vaccines|mesh-list
93272522|NCT02145624|Immunologic Factors|immunologic factors|mesh-ancestor
93272523|NCT02145624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272524|NCT02321384|Ritonavir|ritonavir|mesh-list
93272525|NCT02321384|Midazolam|midazolam|mesh-list
93272526|NCT02321384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93272527|NCT02321384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93272528|NCT02321384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272529|NCT02321384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272530|NCT02321384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93272531|NCT02321384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93272532|NCT02321384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93272533|NCT02321384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272534|NCT02321384|Anesthetics, General|anesthetics, general|mesh-ancestor
93272535|NCT02321384|Anesthetics|anesthetics|mesh-ancestor
93272536|NCT02321384|GABA Modulators|gaba modulators|mesh-ancestor
93272537|NCT02321384|GABA Agents|gaba agents|mesh-ancestor
93272538|NCT02321384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272539|NCT02321384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272540|NCT02321384|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93272541|NCT02321384|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93272542|NCT02321384|Protease Inhibitors|protease inhibitors|mesh-ancestor
93272543|NCT02321384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272544|NCT02321384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93272545|NCT02321384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93272546|NCT02321384|Antiviral Agents|antiviral agents|mesh-ancestor
93272547|NCT02321384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272548|NCT02321384|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93272549|NCT02321384|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93272550|NCT03095326|Zinc|zinc|mesh-list
93272551|NCT03095326|Zinc Sulfate|zinc sulfate|mesh-list
93272552|NCT03095326|Vaccines|vaccines|mesh-list
93272553|NCT03095326|Immunologic Factors|immunologic factors|mesh-ancestor
93272554|NCT03095326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272555|NCT03095326|Trace Elements|trace elements|mesh-ancestor
93272556|NCT03095326|Micronutrients|micronutrients|mesh-ancestor
93272557|NCT03095326|Astringents|astringents|mesh-ancestor
93272558|NCT03095326|Dermatologic Agents|dermatologic agents|mesh-ancestor
93272559|NCT02318810|Rocuronium|rocuronium|mesh-list
93272560|NCT02318810|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92944596|NCT00884494|Insulin|insulin|mesh-list
93272561|NCT02318810|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93272562|NCT02318810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93272563|NCT02318810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272564|NCT02318810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272565|NCT03500120|Fludrocortisone|fludrocortisone|mesh-list
93272566|NCT03500120|Captopril|captopril|mesh-list
93272567|NCT03500120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93272568|NCT03500120|Protease Inhibitors|protease inhibitors|mesh-ancestor
93272569|NCT03500120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272570|NCT03500120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272571|NCT03500120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93272572|NCT03500120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93272573|NCT02141958|Fenretinide|fenretinide|mesh-list
93272574|NCT02141958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272575|NCT02141958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93272576|NCT02141958|Protective Agents|protective agents|mesh-ancestor
93272577|NCT02141958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272578|NCT02142036|Trastuzumab|trastuzumab|mesh-list
93272579|NCT02142036|Cetuximab|cetuximab|mesh-list
93272580|NCT02142036|Panitumumab|panitumumab|mesh-list
93272581|NCT02142036|Everolimus|everolimus|mesh-list
93272582|NCT02142036|Sunitinib|sunitinib|mesh-list
93272583|NCT02142036|Dasatinib|dasatinib|mesh-list
93272584|NCT02142036|Lapatinib|lapatinib|mesh-list
93272585|NCT02142036|Gefitinib|gefitinib|mesh-list
93272586|NCT02142036|Temsirolimus|temsirolimus|mesh-list
93272587|NCT02142036|Afatinib|afatinib|mesh-list
93272588|NCT02142036|Vemurafenib|vemurafenib|mesh-list
93272589|NCT02142036|Dabrafenib|dabrafenib|mesh-list
93272590|NCT02142036|Crizotinib|crizotinib|mesh-list
93272591|NCT02142036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93272592|NCT02142036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272593|NCT02142036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93272594|NCT02142036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93272595|NCT02142036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272596|NCT02142036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272597|NCT02142036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93272598|NCT02142036|Immunologic Factors|immunologic factors|mesh-ancestor
93272599|NCT02142036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272600|NCT02142036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93272601|NCT02142036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93272602|NCT02142036|Growth Substances|growth substances|mesh-ancestor
93272603|NCT02142036|Growth Inhibitors|growth inhibitors|mesh-ancestor
93272604|NCT05053594|Neostigmine|neostigmine|mesh-list
93272605|NCT05053594|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93272606|NCT05053594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272607|NCT05053594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272608|NCT05053594|Cholinergic Agents|cholinergic agents|mesh-ancestor
93272609|NCT05053594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272610|NCT05053594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272611|NCT05053594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93272612|NCT05053594|Autonomic Agents|autonomic agents|mesh-ancestor
93272613|NCT05053594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272614|NCT02318888|Icodextrin|icodextrin|mesh-list
93272615|NCT02318888|Dialysis Solutions|dialysis solutions|mesh-ancestor
93272616|NCT02318888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93272617|NCT02142192|Natalizumab|natalizumab|mesh-list
93272618|NCT02142192|Immunologic Factors|immunologic factors|mesh-ancestor
93272619|NCT02142192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272620|NCT02324582|Pembrolizumab|pembrolizumab|mesh-list
93272621|NCT02324582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93272622|NCT02324582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272623|NCT02324582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93272624|NCT02324582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272625|NCT01255891|Androgens|androgens|mesh-list
93272626|NCT01255891|Hormones|hormones|mesh-ancestor
93272627|NCT01255891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272628|NCT01255891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272629|NCT02777190|Misoprostol|misoprostol|mesh-list
93272630|NCT02777190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93272631|NCT02777190|Abortifacient Agents|abortifacient agents|mesh-ancestor
93272632|NCT02777190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272633|NCT02777190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272634|NCT02777190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93272635|NCT02777190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93272636|NCT02777190|Oxytocics|oxytocics|mesh-ancestor
93272637|NCT03494426|Pregabalin|pregabalin|mesh-list
93272638|NCT03494426|Tramadol|tramadol|mesh-list
93272639|NCT03494426|Antidepressive Agents|antidepressive agents|mesh-list
93272640|NCT03494426|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
93272641|NCT03494426|Analgesics|analgesics|mesh-ancestor
93272642|NCT03494426|Sensory System Agents|sensory system agents|mesh-ancestor
93272643|NCT03494426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272644|NCT03494426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272645|NCT03494426|Anticonvulsants|anticonvulsants|mesh-ancestor
93272646|NCT03494426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93272647|NCT03494426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272648|NCT03494426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272649|NCT03494426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272650|NCT03494426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93272651|NCT03494426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93272652|NCT03494426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272653|NCT03494426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93272654|NCT03494426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93272655|NCT03494426|Narcotics|narcotics|mesh-ancestor
93272656|NCT02432209|Orlistat|orlistat|mesh-list
93272657|NCT02432209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272658|NCT02432209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272659|NCT02432209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93272660|NCT02432209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93272661|NCT00108732|Metronidazole|metronidazole|mesh-list
93272662|NCT00108732|Goserelin|goserelin|mesh-list
93272663|NCT00108732|Bicalutamide|bicalutamide|mesh-list
93272664|NCT00108732|Vaccines|vaccines|mesh-list
93272665|NCT00108732|Sargramostim|sargramostim|mesh-list
93272666|NCT00108732|Immunologic Factors|immunologic factors|mesh-ancestor
93272667|NCT00108732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272668|NCT00108732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272669|NCT00108732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93272670|NCT00108732|Androgen Antagonists|androgen antagonists|mesh-ancestor
93272671|NCT00108732|Hormone Antagonists|hormone antagonists|mesh-ancestor
93272672|NCT00108732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272673|NCT00108732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272674|NCT00108732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272675|NCT00108732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272676|NCT00108732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272677|NCT02319200|Metformin|metformin|mesh-list
93272678|NCT02319200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93272679|NCT02319200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272680|NCT02319278|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93272681|NCT02319278|Hematinics|hematinics|mesh-ancestor
93272682|NCT02319278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93272683|NCT02319278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93272684|NCT02324738|Piperaquine|piperaquine|mesh-list
93272685|NCT02324738|Artenimol|artenimol|mesh-list
93272686|NCT02324738|Mefloquine|mefloquine|mesh-list
93272687|NCT02324738|Antimalarials|antimalarials|mesh-ancestor
93272688|NCT02324738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272689|NCT02324738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272690|NCT02324738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272691|NCT02321852|Mannitol|mannitol|mesh-list
93272692|NCT02321852|Triflusal|triflusal|mesh-list
93272693|NCT02321852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93272694|NCT02321852|Diuretics|diuretics|mesh-ancestor
93272695|NCT02321852|Natriuretic Agents|natriuretic agents|mesh-ancestor
93272696|NCT02321852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272697|NCT02321852|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93272698|NCT03499886|Ketamine|ketamine|mesh-list
93272699|NCT03499886|Analgesics|analgesics|mesh-ancestor
93272700|NCT03499886|Sensory System Agents|sensory system agents|mesh-ancestor
93272701|NCT03499886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272702|NCT03499886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272703|NCT03499886|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93272704|NCT03499886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272705|NCT03499886|Anesthetics, General|anesthetics, general|mesh-ancestor
93272706|NCT03499886|Anesthetics|anesthetics|mesh-ancestor
93272707|NCT03499886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272708|NCT03499886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93272709|NCT03499886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93272710|NCT03499886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272711|NCT03499886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272712|NCT05084430|Pembrolizumab|pembrolizumab|mesh-list
93272713|NCT05084430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944747|NCT00810381|Nitroprusside|nitroprusside|mesh-list
93272714|NCT05084430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272715|NCT05084430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93272716|NCT05084430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272717|NCT02716038|Paclitaxel|paclitaxel|mesh-list
93272718|NCT02716038|Carboplatin|carboplatin|mesh-list
93272719|NCT02716038|Atezolizumab|atezolizumab|mesh-list
93272720|NCT02716038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93272721|NCT02716038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272722|NCT02716038|Tubulin Modulators|tubulin modulators|mesh-ancestor
93272723|NCT02716038|Antimitotic Agents|antimitotic agents|mesh-ancestor
93272724|NCT02716038|Mitosis Modulators|mitosis modulators|mesh-ancestor
93272725|NCT02716038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272726|NCT02716038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93272727|NCT02716038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93272728|NCT02325050|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93272729|NCT02325050|Antiviral Agents|antiviral agents|mesh-ancestor
93272730|NCT02325050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272731|NCT03544710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93272732|NCT03544710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272733|NCT02322008|Adalimumab|adalimumab|mesh-list
93272734|NCT02322008|Infliximab|infliximab|mesh-list
93272735|NCT02322008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93272736|NCT02322008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93272737|NCT02322008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93272738|NCT02322008|Dermatologic Agents|dermatologic agents|mesh-ancestor
93272739|NCT02322008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93272740|NCT02647554|Urinastatin|urinastatin|mesh-list
93272741|NCT02647554|Trypsin Inhibitors|trypsin inhibitors|mesh-list
93272742|NCT02647554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93272743|NCT02647554|Protease Inhibitors|protease inhibitors|mesh-ancestor
93272744|NCT02647554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272745|NCT02647554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272746|NCT03499730|Midazolam|midazolam|mesh-list
93272747|NCT03499730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93272748|NCT03499730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93272749|NCT03499730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272750|NCT03499730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272751|NCT03499730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93272752|NCT03499730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93272753|NCT03499730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93272754|NCT03499730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272755|NCT03499730|Anesthetics, General|anesthetics, general|mesh-ancestor
93272756|NCT03499730|Anesthetics|anesthetics|mesh-ancestor
93272757|NCT03499730|GABA Modulators|gaba modulators|mesh-ancestor
93272758|NCT03499730|GABA Agents|gaba agents|mesh-ancestor
93272759|NCT03499730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272760|NCT03499730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272761|NCT02143050|Metformin|metformin|mesh-list
93272762|NCT02143050|Trametinib|trametinib|mesh-list
93272763|NCT02143050|Dabrafenib|dabrafenib|mesh-list
93272764|NCT02143050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93272765|NCT02143050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272766|NCT02143050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272767|NCT02143050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93272768|NCT02143050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272769|NCT02143050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272770|NCT02325206|Dapagliflozin|dapagliflozin|mesh-list
93272771|NCT02325206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93272772|NCT02325206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272773|NCT02325206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93272774|NCT02325206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272775|NCT02325362|Miglustat|miglustat|mesh-list
93272776|NCT02325362|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
93272777|NCT02325362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272778|NCT02325362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272779|NCT02325362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93272780|NCT02325362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93272781|NCT02325362|Antiviral Agents|antiviral agents|mesh-ancestor
93272782|NCT02325362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272783|NCT02325362|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93272784|NCT02325362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93272785|NCT02325362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272786|NCT04462094|Ketamine|ketamine|mesh-list
93272787|NCT04462094|Anesthetics|anesthetics|mesh-ancestor
93272788|NCT04462094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272789|NCT04462094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272791|NCT04462094|Sensory System Agents|sensory system agents|mesh-ancestor
93272792|NCT04462094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272793|NCT04462094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93272794|NCT04462094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272795|NCT04462094|Anesthetics, General|anesthetics, general|mesh-ancestor
93272796|NCT04462094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93272797|NCT04462094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93272798|NCT04462094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272799|NCT04462094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272800|NCT02325440|Natalizumab|natalizumab|mesh-list
93272801|NCT02325440|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92567374|NCT00058448|Docetaxel|docetaxel|mesh-list
93272802|NCT02325440|Immunologic Factors|immunologic factors|mesh-ancestor
93272803|NCT02325440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272804|NCT02325440|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93272805|NCT02325440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272806|NCT02325440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93272807|NCT03499184|Metronidazole|metronidazole|mesh-list
93272808|NCT03499184|Amoxicillin|amoxicillin|mesh-list
93272809|NCT03499184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272810|NCT03499184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272811|NCT03499184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272812|NCT03499184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272813|NCT00107952|Vancomycin|vancomycin|mesh-list
93272814|NCT00107952|Telavancin|telavancin|mesh-list
93272815|NCT00107952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272816|NCT00107952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272817|NCT03499106|Itraconazole|itraconazole|mesh-list
93272818|NCT03499106|Praliciguat|praliciguat|mesh-list
93272819|NCT03499106|Antifungal Agents|antifungal agents|mesh-ancestor
93272820|NCT03499106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272821|NCT03499106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93272822|NCT03499106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93272823|NCT03499106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272824|NCT03499106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272825|NCT03499106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93272826|NCT03499106|Hormone Antagonists|hormone antagonists|mesh-ancestor
93272827|NCT03499106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272828|NCT03499106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272829|NCT03499106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93272830|NCT03499106|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93272831|NCT03499106|Enzyme Activators|enzyme activators|mesh-ancestor
93272832|NCT03499106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93272833|NCT02146638|Fentanyl|fentanyl|mesh-list
93272834|NCT02146638|Morphine|morphine|mesh-list
93272835|NCT02146638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93272836|NCT02146638|Narcotics|narcotics|mesh-ancestor
93272837|NCT02146638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272838|NCT02146638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272839|NCT02146638|Analgesics|analgesics|mesh-ancestor
93272840|NCT02146638|Sensory System Agents|sensory system agents|mesh-ancestor
93272841|NCT02146638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272842|NCT02146638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93272843|NCT02146638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272844|NCT02146638|Anesthetics, General|anesthetics, general|mesh-ancestor
93272845|NCT02146638|Anesthetics|anesthetics|mesh-ancestor
93272846|NCT02320448|Cisplatin|cisplatin|mesh-list
93272847|NCT02320448|Doxorubicin|doxorubicin|mesh-list
93272848|NCT02320448|Oxaliplatin|oxaliplatin|mesh-list
93272849|NCT02320448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272850|NCT02320448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93272851|NCT02320448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93272852|NCT02320448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93272853|NCT02320448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272854|NCT02320448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272855|NCT02320604|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93272856|NCT02320604|Antifungal Agents|antifungal agents|mesh-ancestor
93272857|NCT02320604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272858|NCT02320604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272859|NCT02320604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272860|NCT03493568|Dolutegravir|dolutegravir|mesh-list
93272861|NCT03493568|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93272862|NCT03493568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92944902|NCT00422383|Rituximab|rituximab|mesh-list
93272864|NCT03493568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272865|NCT03493568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272866|NCT03493568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93272867|NCT03493568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93272868|NCT03493568|Antiviral Agents|antiviral agents|mesh-ancestor
93272869|NCT03493568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272870|NCT01366638|Ribavirin|ribavirin|mesh-list
93272871|NCT01366638|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93272872|NCT01366638|Simeprevir|simeprevir|mesh-list
93272873|NCT01366638|Antimetabolites|antimetabolites|mesh-ancestor
93272874|NCT01366638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272875|NCT01366638|Antiviral Agents|antiviral agents|mesh-ancestor
93272876|NCT01366638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272877|NCT01366638|Protease Inhibitors|protease inhibitors|mesh-ancestor
93272878|NCT01366638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272879|NCT02147808|Midazolam|midazolam|mesh-list
93272880|NCT02147808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93272881|NCT02147808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93272882|NCT02147808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93272883|NCT02147808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272884|NCT02147808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93272885|NCT02147808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93272886|NCT02147808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93272887|NCT02147808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93272888|NCT02147808|Anesthetics, General|anesthetics, general|mesh-ancestor
93272889|NCT02147808|Anesthetics|anesthetics|mesh-ancestor
93272890|NCT02147808|GABA Modulators|gaba modulators|mesh-ancestor
93272891|NCT02147808|GABA Agents|gaba agents|mesh-ancestor
93272892|NCT02147808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93272893|NCT02147808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272894|NCT03543072|Diphosphonates|diphosphonates|mesh-list
93272895|NCT03543072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93272896|NCT03543072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272897|NCT03493412|Verapamil|verapamil|mesh-list
93272898|NCT03493412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93272899|NCT03493412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93272900|NCT03493412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93272901|NCT03493412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272902|NCT03493412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93272903|NCT03493412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272904|NCT03493412|Vasodilator Agents|vasodilator agents|mesh-ancestor
93272905|NCT02147964|Ketoconazole|ketoconazole|mesh-list
93272906|NCT02147964|Methyltestosterone|methyltestosterone|mesh-list
93272907|NCT02147964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93272908|NCT02147964|Testosterone|testosterone|mesh-list
93272909|NCT02147964|Testosterone undecanoate|testosterone undecanoate|mesh-list
93272910|NCT02147964|Testosterone enanthate|testosterone enanthate|mesh-list
93272911|NCT02147964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93272912|NCT02147964|Dutasteride|dutasteride|mesh-list
93272913|NCT02147964|Acyline|acyline|mesh-list
93272914|NCT02147964|Androgens|androgens|mesh-ancestor
93272915|NCT02147964|Hormones|hormones|mesh-ancestor
93272916|NCT02147964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93272917|NCT02147964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272918|NCT02147964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93272919|NCT02147964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272920|NCT02147964|Anabolic Agents|anabolic agents|mesh-ancestor
93272921|NCT02147964|Antifungal Agents|antifungal agents|mesh-ancestor
93272922|NCT02147964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272923|NCT02147964|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93272924|NCT02147964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93272925|NCT02147964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272926|NCT02147964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272927|NCT02147964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93272928|NCT02147964|Hormone Antagonists|hormone antagonists|mesh-ancestor
93272929|NCT02147964|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93272930|NCT02147964|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93272931|NCT02147964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93272932|NCT02780700|Capecitabine|capecitabine|mesh-list
93272933|NCT02780700|Nintedanib|nintedanib|mesh-list
93272934|NCT02780700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93272935|NCT02780700|Antimetabolites|antimetabolites|mesh-ancestor
93272936|NCT02780700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272937|NCT02780700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272938|NCT02780700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93272939|NCT02780700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272940|NCT02147262|Doxycycline|doxycycline|mesh-list
93272941|NCT02147262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272942|NCT02147262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272943|NCT02147262|Antimalarials|antimalarials|mesh-ancestor
92567521|NCT00186082|Cefoxitin|cefoxitin|mesh-list
93272944|NCT02147262|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93272945|NCT02147262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93272946|NCT02447276|Fasinumab|fasinumab|mesh-list
93272947|NCT02447276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93272948|NCT02447276|Analgesics|analgesics|mesh-ancestor
93272949|NCT02447276|Sensory System Agents|sensory system agents|mesh-ancestor
93272950|NCT02447276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93272951|NCT02447276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93272952|NCT05100134|Ceritinib|ceritinib|mesh-list
93272953|NCT05100134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272954|NCT05100134|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93272955|NCT05100134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272956|NCT05100134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272957|NCT05079620|Amoxicillin|amoxicillin|mesh-list
93272958|NCT05079620|Vancomycin|vancomycin|mesh-list
93272959|NCT05079620|Levofloxacin|levofloxacin|mesh-list
93272960|NCT05079620|Ceftriaxone|ceftriaxone|mesh-list
93272961|NCT05079620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93272962|NCT05079620|Clavulanic Acids|clavulanic acids|mesh-list
93272963|NCT05079620|Clavulanic Acid|clavulanic acid|mesh-list
93272964|NCT05079620|Cefepime|cefepime|mesh-list
93272965|NCT05079620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272966|NCT05079620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272967|NCT05079620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93272968|NCT05079620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93272969|NCT05079620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93272970|NCT05079620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272971|NCT05079620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272972|NCT05079620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93272973|NCT05079620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93272974|NCT05079620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93272975|NCT05079620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93272976|NCT02323412|Amoxicillin|amoxicillin|mesh-list
93272977|NCT02323412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93272978|NCT02323412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272979|NCT04537910|Bamlanivimab|bamlanivimab|mesh-list
93272980|NCT04537910|Antiviral Agents|antiviral agents|mesh-ancestor
93272981|NCT04537910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272982|NCT03109730|Tenofovir|tenofovir|mesh-list
93272983|NCT03109730|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93272984|NCT03109730|Entecavir|entecavir|mesh-list
93272985|NCT03109730|Antiviral Agents|antiviral agents|mesh-ancestor
93272986|NCT03109730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93272987|NCT03109730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93272988|NCT03109730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93272989|NCT03109730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93272990|NCT03109730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272991|NCT03109730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93272992|NCT03109730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93272993|NCT03495206|Edaravone|edaravone|mesh-list
93272994|NCT03495206|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93272995|NCT03495206|Antioxidants|antioxidants|mesh-ancestor
93272996|NCT03495206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93272997|NCT03495206|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93272998|NCT03495206|Protective Agents|protective agents|mesh-ancestor
93272999|NCT03495206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273000|NCT04223024|Nimotuzumab|nimotuzumab|mesh-list
93273001|NCT04223024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93273002|NCT04223024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273003|NCT03491696|Metyrapone|metyrapone|mesh-list
93273004|NCT03491696|Antimetabolites|antimetabolites|mesh-ancestor
93273005|NCT03491696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273006|NCT03491696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273007|NCT03492866|Gentamicins|gentamicins|mesh-list
93273008|NCT03492866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93273009|NCT03492866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273010|NCT03492866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93273011|NCT03492866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273012|NCT03492866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273013|NCT03492710|Immunoglobulins|immunoglobulins|mesh-list
93273014|NCT03492710|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93273015|NCT03492710|Antibodies|antibodies|mesh-list
93273016|NCT03492710|Immunologic Factors|immunologic factors|mesh-ancestor
92567583|NCT03551964|Cangrelor|cangrelor|mesh-list
93273017|NCT03492710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273018|NCT03954938|Cocaine|cocaine|mesh-list
93273019|NCT03954938|Anesthetics, Local|anesthetics, local|mesh-ancestor
93273020|NCT03954938|Anesthetics|anesthetics|mesh-ancestor
93273021|NCT03954938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273022|NCT03954938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273023|NCT03954938|Sensory System Agents|sensory system agents|mesh-ancestor
93273024|NCT03954938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273025|NCT03954938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93273026|NCT03954938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93273027|NCT03954938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93273028|NCT03954938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273029|NCT03954938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273030|NCT03954938|Dopamine Agents|dopamine agents|mesh-ancestor
93273031|NCT03954938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273032|NCT02148120|Beclomethasone|beclomethasone|mesh-list
93273033|NCT02148120|Formoterol Fumarate|formoterol fumarate|mesh-list
93273034|NCT02148120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93273035|NCT02148120|Autonomic Agents|autonomic agents|mesh-ancestor
93273036|NCT02148120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273037|NCT02148120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273038|NCT02148120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93273039|NCT02148120|Respiratory System Agents|respiratory system agents|mesh-ancestor
93273040|NCT02148120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93273041|NCT02148120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93273042|NCT02148120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93273043|NCT02148120|Adrenergic Agents|adrenergic agents|mesh-ancestor
93273044|NCT02148120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273045|NCT02148120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273046|NCT02148120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93273047|NCT02148120|Glucocorticoids|glucocorticoids|mesh-ancestor
93273048|NCT02148120|Hormones|hormones|mesh-ancestor
93273049|NCT02148120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273050|NCT03492632|Hormones|hormones|mesh-list
93273051|NCT03492632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273052|NCT03492632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273053|NCT02147574|Antidiarrheals|antidiarrheals|mesh-list
93273054|NCT02147574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93273055|NCT02147730|Anesthetics|anesthetics|mesh-list
93273056|NCT02147730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273057|NCT02147730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273058|NCT02151630|Salicylic Acid|salicylic acid|mesh-list
93273059|NCT02151630|Salicylates|salicylates|mesh-list
93273060|NCT02151630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273061|NCT02151630|Antifungal Agents|antifungal agents|mesh-ancestor
93273062|NCT02151630|Keratolytic Agents|keratolytic agents|mesh-ancestor
93273063|NCT02151630|Dermatologic Agents|dermatologic agents|mesh-ancestor
93273064|NCT02151630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93273065|NCT02151630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93273066|NCT02151630|Analgesics|analgesics|mesh-ancestor
93273067|NCT02151630|Sensory System Agents|sensory system agents|mesh-ancestor
93273068|NCT02151630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273069|NCT02151630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273070|NCT02151630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93273071|NCT02151630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93273072|NCT02151630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93273073|NCT02151630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273074|NCT02151630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273075|NCT03494972|Tetracycline|tetracycline|mesh-list
93273076|NCT03494972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93273077|NCT03494972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273078|NCT03494972|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93273079|NCT03494972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273080|NCT03494972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273081|NCT02224573|Cannabidiol|cannabidiol|mesh-list
93273082|NCT02224573|Anticonvulsants|anticonvulsants|mesh-ancestor
93273083|NCT03490058|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92567662|NCT00046917|Irinotecan|irinotecan|mesh-list
93273084|NCT03490058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93273085|NCT03490058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93273086|NCT03490058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945124|NCT00610714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93273087|NCT03490058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273088|NCT03490058|Antiviral Agents|antiviral agents|mesh-ancestor
93273089|NCT03490058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273090|NCT03490058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93273091|NCT03490058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93273092|NCT02148432|Dexmedetomidine|dexmedetomidine|mesh-list
93273093|NCT02148432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93273094|NCT02148432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273095|NCT02148432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273096|NCT02148432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93273097|NCT02148432|Analgesics|analgesics|mesh-ancestor
93273098|NCT02148432|Sensory System Agents|sensory system agents|mesh-ancestor
93273099|NCT02148432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273100|NCT02148432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93273101|NCT02148432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93273102|NCT02148432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93273103|NCT02148432|Adrenergic Agents|adrenergic agents|mesh-ancestor
93273104|NCT02148432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273105|NCT02148432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273106|NCT03756961|Lidocaine|lidocaine|mesh-list
93273107|NCT03756961|Dexmedetomidine|dexmedetomidine|mesh-list
93273108|NCT03756961|Remifentanil|remifentanil|mesh-list
93273109|NCT03756961|Oxycodone|oxycodone|mesh-list
93273110|NCT03756961|Propofol|propofol|mesh-list
93273111|NCT03756961|Desflurane|desflurane|mesh-list
93273112|NCT03756961|Esketamine|esketamine|mesh-list
93273113|NCT03756961|Anesthetics, Local|anesthetics, local|mesh-ancestor
93273114|NCT03756961|Anesthetics|anesthetics|mesh-ancestor
93273115|NCT03756961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273116|NCT03756961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273117|NCT03756961|Sensory System Agents|sensory system agents|mesh-ancestor
93273118|NCT03756961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273119|NCT03756961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93273120|NCT03756961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93273121|NCT03756961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93273122|NCT03756961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273123|NCT03756961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273124|NCT03756961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93273125|NCT03756961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93273126|NCT03756961|Analgesics|analgesics|mesh-ancestor
93273127|NCT03756961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93273128|NCT03756961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93273129|NCT03756961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93273130|NCT03756961|Adrenergic Agents|adrenergic agents|mesh-ancestor
93273131|NCT03756961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273132|NCT03756961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93273133|NCT03756961|Anesthetics, General|anesthetics, general|mesh-ancestor
93273134|NCT03756961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93273135|NCT03756961|Narcotics|narcotics|mesh-ancestor
93273136|NCT03756961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93273137|NCT03756961|Antidepressive Agents|antidepressive agents|mesh-ancestor
93273138|NCT03756961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93273139|NCT03350984|Insulin|insulin|mesh-list
93273140|NCT03350984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93273141|NCT03350984|Insulin Glargine|insulin glargine|mesh-list
93273142|NCT03350984|Insulin Lispro|insulin lispro|mesh-list
93273143|NCT03350984|Insulin, Isophane|insulin, isophane|mesh-list
93273144|NCT03350984|Isophane Insulin, Human|isophane insulin, human|mesh-list
93273145|NCT03350984|Isophane insulin, beef|isophane insulin, beef|mesh-list
93273146|NCT03350984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93273147|NCT03350984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273148|NCT05033314|Rivaroxaban|rivaroxaban|mesh-list
93273149|NCT05033314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93273150|NCT05033314|Antithrombins|antithrombins|mesh-ancestor
93273151|NCT05033314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93273152|NCT05033314|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273153|NCT05033314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273154|NCT05033314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273155|NCT05033314|Anticoagulants|anticoagulants|mesh-ancestor
93273156|NCT03504423|Leucovorin|leucovorin|mesh-list
93273157|NCT03504423|Folic Acid|folic acid|mesh-list
93273158|NCT03504423|Oxaliplatin|oxaliplatin|mesh-list
93273159|NCT03504423|Irinotecan|irinotecan|mesh-list
93273160|NCT03504423|Folfirinox|folfirinox|mesh-list
93273161|NCT03504423|Levoleucovorin|levoleucovorin|mesh-list
93273162|NCT03504423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273163|NCT03504423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93273164|NCT03504423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273165|NCT03504423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273166|NCT03504423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273167|NCT03504423|Antidotes|antidotes|mesh-ancestor
93273168|NCT03504423|Protective Agents|protective agents|mesh-ancestor
93273169|NCT03504423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273170|NCT03504423|Vitamin B Complex|vitamin b complex|mesh-ancestor
93273171|NCT03504423|Vitamins|vitamins|mesh-ancestor
93273172|NCT03504423|Micronutrients|micronutrients|mesh-ancestor
93273173|NCT03504423|Hematinics|hematinics|mesh-ancestor
93273174|NCT03097198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93273175|NCT03097198|Tropicamide|tropicamide|mesh-list
93273176|NCT03097198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93273177|NCT03097198|Mydriatics|mydriatics|mesh-ancestor
93273178|NCT03097198|Autonomic Agents|autonomic agents|mesh-ancestor
93273179|NCT03097198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273180|NCT03097198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273181|NCT03097198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93273182|NCT03097198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93273183|NCT03097198|Cholinergic Agents|cholinergic agents|mesh-ancestor
93273184|NCT03097198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273185|NCT03097198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273186|NCT02770248|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93273187|NCT02770248|Brinzolamide|brinzolamide|mesh-list
93273188|NCT02770248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93273189|NCT02770248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93273190|NCT02770248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93273191|NCT02770248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93273192|NCT02770248|Adrenergic Agents|adrenergic agents|mesh-ancestor
93273193|NCT02770248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273194|NCT02770248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273195|NCT02770248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273196|NCT02770248|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93273197|NCT02770248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273198|NCT03619005|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93273199|NCT03619005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93273200|NCT03619005|Immunologic Factors|immunologic factors|mesh-ancestor
93273201|NCT03619005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273202|NCT02686346|Etoposide|etoposide|mesh-list
93273203|NCT02686346|Ifosfamide|ifosfamide|mesh-list
93273204|NCT02686346|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93273205|NCT02686346|Carboplatin|carboplatin|mesh-list
93273206|NCT02686346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93273207|NCT02686346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273208|NCT02686346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93273209|NCT02686346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273210|NCT02686346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273211|NCT02686346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273212|NCT02686346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93273213|NCT02686346|Alkylating Agents|alkylating agents|mesh-ancestor
93273214|NCT02686346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93273215|NCT02686346|Immunotoxins|immunotoxins|mesh-ancestor
93273216|NCT02686346|Immunoconjugates|immunoconjugates|mesh-ancestor
93273217|NCT02686346|Immunologic Factors|immunologic factors|mesh-ancestor
93273218|NCT02686346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273219|NCT03489044|Levetiracetam|levetiracetam|mesh-list
93273220|NCT03489044|Anticonvulsants|anticonvulsants|mesh-ancestor
93273221|NCT03489044|Nootropic Agents|nootropic agents|mesh-ancestor
93273222|NCT01344369|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93273223|NCT01344369|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93273224|NCT01344369|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93273225|NCT01344369|Norethindrone|norethindrone|mesh-list
93273226|NCT01344369|Norethindrone Acetate|norethindrone acetate|mesh-list
93273227|NCT01344369|Estradiol|estradiol|mesh-list
93273228|NCT01344369|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93273229|NCT01344369|Estrogens|estrogens|mesh-ancestor
93273230|NCT01344369|Hormones|hormones|mesh-ancestor
93273231|NCT01344369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273232|NCT01344369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273233|NCT01344369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93273234|NCT01344369|Contraceptive Agents|contraceptive agents|mesh-ancestor
93273235|NCT01344369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93273236|NCT01344369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93273237|NCT01344369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93273238|NCT01344369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93273239|NCT01344369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92945271|NCT00642369|Haloperidol|haloperidol|mesh-list
93273240|NCT03491072|Fentanyl|fentanyl|mesh-list
93273241|NCT03491072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93273242|NCT03491072|Narcotics|narcotics|mesh-ancestor
93273243|NCT03491072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273244|NCT03491072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273245|NCT03491072|Analgesics|analgesics|mesh-ancestor
93273246|NCT03491072|Sensory System Agents|sensory system agents|mesh-ancestor
93273247|NCT03491072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273248|NCT03491072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93273249|NCT03491072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93273250|NCT03491072|Anesthetics, General|anesthetics, general|mesh-ancestor
93273251|NCT03491072|Anesthetics|anesthetics|mesh-ancestor
93273252|NCT03503409|Ivosidenib|ivosidenib|mesh-list
93273253|NCT03503409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273254|NCT03503409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273255|NCT03503409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273256|NCT03490994|Warfarin|warfarin|mesh-list
93273257|NCT03490994|Rivaroxaban|rivaroxaban|mesh-list
93273258|NCT03490994|Anticoagulants|anticoagulants|mesh-ancestor
93273259|NCT03490994|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93273260|NCT03490994|Antithrombins|antithrombins|mesh-ancestor
93273261|NCT03490994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93273262|NCT03490994|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273263|NCT03490994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273264|NCT03490994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273265|NCT01360762|Pentamidine|pentamidine|mesh-list
93273266|NCT01360762|Antifungal Agents|antifungal agents|mesh-ancestor
93273267|NCT01360762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273268|NCT01360762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93273269|NCT01360762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93273270|NCT01360762|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93273271|NCT04382924|Ifenprodil|ifenprodil|mesh-list
93273272|NCT04382924|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93273273|NCT04382924|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93273274|NCT04382924|Adrenergic Agents|adrenergic agents|mesh-ancestor
93273275|NCT04382924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273276|NCT04382924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273277|NCT04382924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273278|NCT04382924|Vasodilator Agents|vasodilator agents|mesh-ancestor
93273279|NCT04382924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93273280|NCT04382924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93273281|NCT00002601|Doxorubicin|doxorubicin|mesh-list
93273282|NCT00002601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93273283|NCT00002601|Melphalan|melphalan|mesh-list
93273284|NCT00002601|Ifosfamide|ifosfamide|mesh-list
93273285|NCT00002601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273286|NCT00002601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93273287|NCT00002601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93273288|NCT00002601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273289|NCT00002601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273290|NCT00002601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273291|NCT00002601|Immunologic Factors|immunologic factors|mesh-ancestor
93273292|NCT00002601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273293|NCT00002601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93273294|NCT00002601|Alkylating Agents|alkylating agents|mesh-ancestor
93273295|NCT00002601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93273296|NCT00002601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93273297|NCT05033704|Plasma protein fraction|plasma protein fraction|mesh-list
93273298|NCT05033704|Plasma Substitutes|plasma substitutes|mesh-ancestor
93273299|NCT05033704|Blood Substitutes|blood substitutes|mesh-ancestor
93273300|NCT05693077|Vancomycin|vancomycin|mesh-list
93273301|NCT05693077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93273302|NCT05693077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273303|NCT02031861|Nifedipine|nifedipine|mesh-list
93273304|NCT02031861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93273305|NCT02031861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273306|NCT02031861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273307|NCT02031861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273308|NCT02031861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273309|NCT02031861|Vasodilator Agents|vasodilator agents|mesh-ancestor
93273310|NCT02031861|Tocolytic Agents|tocolytic agents|mesh-ancestor
93273311|NCT02031861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93273312|NCT03455439|Rivaroxaban|rivaroxaban|mesh-list
93273313|NCT03455439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93273314|NCT03455439|Antithrombins|antithrombins|mesh-ancestor
93273315|NCT03455439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93273316|NCT03455439|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273318|NCT03455439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273319|NCT03455439|Anticoagulants|anticoagulants|mesh-ancestor
93273320|NCT02645474|Ropivacaine|ropivacaine|mesh-list
93273321|NCT02645474|Anesthetics, Local|anesthetics, local|mesh-ancestor
93273322|NCT02645474|Anesthetics|anesthetics|mesh-ancestor
93273323|NCT02645474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273324|NCT02645474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273325|NCT02645474|Sensory System Agents|sensory system agents|mesh-ancestor
93273326|NCT02645474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273327|NCT05052814|Chlorhexidine|chlorhexidine|mesh-list
93273328|NCT05052814|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93273329|NCT05052814|Root Canal Irrigants|root canal irrigants|mesh-list
93273330|NCT05052814|Calcium|calcium|mesh-list
93273331|NCT05052814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273332|NCT05052814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273333|NCT05052814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93273334|NCT05052814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273335|NCT05052814|Disinfectants|disinfectants|mesh-ancestor
93273336|NCT05052814|Dermatologic Agents|dermatologic agents|mesh-ancestor
93273337|NCT05052814|Dental Disinfectants|dental disinfectants|mesh-ancestor
93273338|NCT03615417|Anesthetics|anesthetics|mesh-list
93273339|NCT03615417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273340|NCT03615417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273341|NCT02155530|Atorvastatin|atorvastatin|mesh-list
93273342|NCT02155530|Pravastatin|pravastatin|mesh-list
93273343|NCT02155530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93273344|NCT02155530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93273345|NCT02155530|Antimetabolites|antimetabolites|mesh-ancestor
93273346|NCT02155530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273347|NCT02155530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93273348|NCT02155530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93273349|NCT02155530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273350|NCT05051956|Palbociclib|palbociclib|mesh-list
93273351|NCT05051956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273352|NCT05051956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93273353|NCT05051956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273354|NCT05051956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273355|NCT02769624|Treprostinil|treprostinil|mesh-list
93273356|NCT02769624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93273357|NCT03543774|Simvastatin|simvastatin|mesh-list
93273358|NCT03543774|Ezetimibe|ezetimibe|mesh-list
93273359|NCT03543774|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
93273360|NCT03543774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93273361|NCT03543774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93273362|NCT03543774|Antimetabolites|antimetabolites|mesh-ancestor
93273363|NCT03543774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273364|NCT03543774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93273365|NCT03543774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93273366|NCT03543774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273367|NCT03261830|Clindamycin|clindamycin|mesh-list
93273368|NCT03261830|Clindamycin palmitate|clindamycin palmitate|mesh-list
93273369|NCT03261830|Clindamycin phosphate|clindamycin phosphate|mesh-list
93273370|NCT03261830|Cefazolin|cefazolin|mesh-list
93273371|NCT03261830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93273372|NCT03261830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273373|NCT03261830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93273374|NCT03261830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273375|NCT03261830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273376|NCT02152176|Morphine|morphine|mesh-list
93273377|NCT02152176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93273378|NCT02152176|Narcotics|narcotics|mesh-ancestor
93273379|NCT02152176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273380|NCT02152176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273381|NCT02152176|Analgesics|analgesics|mesh-ancestor
93273382|NCT02152176|Sensory System Agents|sensory system agents|mesh-ancestor
93273383|NCT02152176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273384|NCT03617055|Cystatins|cystatins|mesh-list
93273385|NCT03617055|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93273386|NCT03617055|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273387|NCT03617055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273388|NCT03617055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273389|NCT03488888|Bupivacaine|bupivacaine|mesh-list
93273390|NCT03488888|Anesthetics, Local|anesthetics, local|mesh-ancestor
93273391|NCT03488888|Anesthetics|anesthetics|mesh-ancestor
93273392|NCT03488888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273393|NCT03488888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273394|NCT03488888|Sensory System Agents|sensory system agents|mesh-ancestor
93273395|NCT03488888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273396|NCT05031676|Analgesics, Opioid|analgesics, opioid|mesh-list
93273397|NCT05031676|Anesthetics|anesthetics|mesh-list
93273398|NCT05031676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273399|NCT05031676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273400|NCT05031676|Narcotics|narcotics|mesh-ancestor
93273401|NCT05031676|Analgesics|analgesics|mesh-ancestor
93273402|NCT05031676|Sensory System Agents|sensory system agents|mesh-ancestor
93273403|NCT05031676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273404|NCT03488810|Hormones|hormones|mesh-list
93273405|NCT03488810|Androgens|androgens|mesh-list
93273406|NCT03488810|Androgen Antagonists|androgen antagonists|mesh-list
93273407|NCT03488810|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
93273408|NCT03488810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273409|NCT03488810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273410|NCT03488810|Hormone Antagonists|hormone antagonists|mesh-ancestor
93273411|NCT03492242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93273412|NCT03492242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273413|NCT03492242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93273414|NCT03492242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273415|NCT03572283|Bethanechol|bethanechol|mesh-list
93273416|NCT03572283|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93273417|NCT03572283|Autonomic Agents|autonomic agents|mesh-ancestor
93273418|NCT03572283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273419|NCT03572283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273420|NCT03572283|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93273421|NCT03572283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93273422|NCT03572283|Cholinergic Agents|cholinergic agents|mesh-ancestor
93273423|NCT03572283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568005|NCT00189085|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93273424|NCT03572283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273425|NCT02254824|Atorvastatin|atorvastatin|mesh-list
93273426|NCT02254824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93273427|NCT02254824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93273428|NCT02254824|Antimetabolites|antimetabolites|mesh-ancestor
93273429|NCT02254824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273430|NCT02254824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93273431|NCT02254824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93273432|NCT02254824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273433|NCT01525316|Lactoferrin|lactoferrin|mesh-list
93273434|NCT01525316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273435|NCT01673386|Sunitinib|sunitinib|mesh-list
93273436|NCT01673386|Tivozanib|tivozanib|mesh-list
93273437|NCT01673386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273438|NCT01673386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93273439|NCT01673386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93273440|NCT01673386|Growth Substances|growth substances|mesh-ancestor
93273441|NCT01673386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273442|NCT01673386|Growth Inhibitors|growth inhibitors|mesh-ancestor
93273443|NCT01673386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93273444|NCT01673386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273445|NCT01673386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273446|NCT00103740|Vitamin D|vitamin d|mesh-list
93273447|NCT00103740|Zoledronic Acid|zoledronic acid|mesh-list
93273448|NCT00103740|Risedronic Acid|risedronic acid|mesh-list
93273449|NCT00103740|Etidronic Acid|etidronic acid|mesh-list
93273450|NCT00103740|Calcium|calcium|mesh-list
93273451|NCT00103740|Vitamins|vitamins|mesh-ancestor
93273452|NCT00103740|Micronutrients|micronutrients|mesh-ancestor
93273453|NCT00103740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273454|NCT00103740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273455|NCT00103740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93273456|NCT00103740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93273457|NCT00103740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273458|NCT00103740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273459|NCT03616509|Hormones|hormones|mesh-list
93273460|NCT03616509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273461|NCT03616509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273462|NCT02031939|Capecitabine|capecitabine|mesh-list
93273463|NCT02031939|Oxaliplatin|oxaliplatin|mesh-list
93273464|NCT02031939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93273465|NCT02031939|Antimetabolites|antimetabolites|mesh-ancestor
92945492|NCT00420199|Abatacept|abatacept|mesh-list
93273466|NCT02031939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273467|NCT02031939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273469|NCT02869893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93273470|NCT02869893|Hormones|hormones|mesh-ancestor
93273471|NCT02869893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273472|NCT02869893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273473|NCT02152332|Moxifloxacin|moxifloxacin|mesh-list
93273474|NCT02152332|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93273475|NCT02152332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93273476|NCT02152332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273477|NCT02152332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93273478|NCT02152332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273479|NCT02152332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273480|NCT02152332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273481|NCT02152332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273482|NCT02152332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93273483|NCT02152332|Contraceptive Agents|contraceptive agents|mesh-ancestor
93273484|NCT02152332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93273485|NCT02152332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273486|NCT02152332|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93273487|NCT02152332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93273488|NCT02152332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93273489|NCT05118308|Liver Extracts|liver extracts|mesh-list
93273490|NCT05118308|Hematinics|hematinics|mesh-ancestor
93273491|NCT03617289|Magnesium Sulfate|magnesium sulfate|mesh-list
93273492|NCT03617289|Analgesics|analgesics|mesh-ancestor
93273493|NCT03617289|Sensory System Agents|sensory system agents|mesh-ancestor
93273494|NCT03617289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273495|NCT03617289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273496|NCT03617289|Anesthetics|anesthetics|mesh-ancestor
93273497|NCT03617289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273498|NCT03617289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93273499|NCT03617289|Anticonvulsants|anticonvulsants|mesh-ancestor
93273500|NCT03617289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93273501|NCT03617289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273502|NCT03617289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273503|NCT03617289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273504|NCT03617289|Tocolytic Agents|tocolytic agents|mesh-ancestor
93273505|NCT03617289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93273506|NCT02152410|Morphine|morphine|mesh-list
93273507|NCT02152410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93273508|NCT02152410|Narcotics|narcotics|mesh-ancestor
93273509|NCT02152410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273510|NCT02152410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273511|NCT02152410|Analgesics|analgesics|mesh-ancestor
93273512|NCT02152410|Sensory System Agents|sensory system agents|mesh-ancestor
93273513|NCT02152410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273514|NCT05043688|Paclitaxel|paclitaxel|mesh-list
93273515|NCT05043688|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93273516|NCT05043688|Carboplatin|carboplatin|mesh-list
93273517|NCT05043688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93273518|NCT05043688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273519|NCT05043688|Tubulin Modulators|tubulin modulators|mesh-ancestor
93273520|NCT05043688|Antimitotic Agents|antimitotic agents|mesh-ancestor
93273521|NCT05043688|Mitosis Modulators|mitosis modulators|mesh-ancestor
93273522|NCT05043688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273523|NCT03614715|Interferons|interferons|mesh-list
93273524|NCT03614715|Interferon-beta|interferon-beta|mesh-list
93273525|NCT03614715|Interferon beta-1a|interferon beta-1a|mesh-list
93273526|NCT03614715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273527|NCT03614715|Antiviral Agents|antiviral agents|mesh-ancestor
93273528|NCT03614715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273529|NCT03614715|Immunologic Factors|immunologic factors|mesh-ancestor
93273530|NCT03614715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273531|NCT03614715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93273532|NCT00363038|Vitamins|vitamins|mesh-list
93273533|NCT00363038|Vitamin K|vitamin k|mesh-list
93273534|NCT00363038|Vitamin A|vitamin a|mesh-list
93273535|NCT00363038|Petrolatum|petrolatum|mesh-list
93273536|NCT00363038|Micronutrients|micronutrients|mesh-ancestor
92945564|NCT00704184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273537|NCT00363038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273538|NCT00363038|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93273539|NCT00363038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93273540|NCT00363038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273541|NCT00363038|Hemostatics|hemostatics|mesh-ancestor
93273542|NCT00363038|Coagulants|coagulants|mesh-ancestor
93273543|NCT00363038|Emollients|emollients|mesh-ancestor
93273544|NCT00363038|Dermatologic Agents|dermatologic agents|mesh-ancestor
93273545|NCT03489668|Metformin|metformin|mesh-list
93273546|NCT03489668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93273547|NCT03489668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273548|NCT02872311|Vaccines|vaccines|mesh-list
93273549|NCT02872311|Immunologic Factors|immunologic factors|mesh-ancestor
93273550|NCT02872311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273551|NCT03614403|Vitamin D|vitamin d|mesh-list
93273552|NCT03614403|Cholecalciferol|cholecalciferol|mesh-list
93273553|NCT03614403|Vitamins|vitamins|mesh-ancestor
93273554|NCT03614403|Micronutrients|micronutrients|mesh-ancestor
93273555|NCT03614403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273556|NCT03614403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93273557|NCT03614403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273558|NCT03488186|Lansoprazole|lansoprazole|mesh-list
93273559|NCT03488186|Dexlansoprazole|dexlansoprazole|mesh-list
93273560|NCT03488186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93273561|NCT03488186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93273562|NCT03488186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93273563|NCT03488186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273564|NCT03488186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273565|NCT05103644|Atorvastatin|atorvastatin|mesh-list
93273566|NCT05103644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93273567|NCT05103644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93273568|NCT05103644|Antimetabolites|antimetabolites|mesh-ancestor
93273569|NCT05103644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273570|NCT05103644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93273571|NCT05103644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93273572|NCT05103644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273573|NCT03887624|Ethosuximide|ethosuximide|mesh-list
93273574|NCT03887624|Escitalopram|escitalopram|mesh-list
93273575|NCT03887624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93273576|NCT03887624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93273577|NCT03887624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273578|NCT03887624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273579|NCT03887624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273580|NCT03887624|Serotonin Agents|serotonin agents|mesh-ancestor
93273581|NCT03887624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273582|NCT03887624|Anticonvulsants|anticonvulsants|mesh-ancestor
93273583|NCT02446028|Insulin Lispro|insulin lispro|mesh-list
93273584|NCT02446028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93273585|NCT02446028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273586|NCT03485846|Ritonavir|ritonavir|mesh-list
93273587|NCT03485846|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93273588|NCT03485846|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93273589|NCT03485846|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273590|NCT03485846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273591|NCT03485846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273592|NCT03485846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93273593|NCT03485846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93273594|NCT03485846|Antiviral Agents|antiviral agents|mesh-ancestor
93273595|NCT03485846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273596|NCT03485846|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93273597|NCT03485846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93273598|NCT02032095|Immunoglobulins|immunoglobulins|mesh-list
93273599|NCT02032095|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93273600|NCT02032095|gamma-Globulins|gamma-globulins|mesh-list
93273601|NCT02032095|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93273602|NCT02032095|Immunologic Factors|immunologic factors|mesh-ancestor
93273603|NCT02032095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273604|NCT03613857|Clopidogrel|clopidogrel|mesh-list
93273605|NCT03613857|Ticagrelor|ticagrelor|mesh-list
93273606|NCT03613857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93273607|NCT03613857|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93273608|NCT03613857|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93273609|NCT03613857|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93273610|NCT03613857|Purinergic Agents|purinergic agents|mesh-ancestor
93273611|NCT03613857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273612|NCT03613857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273613|NCT03613857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591157|NCT04318405|Iron|iron|mesh-list
93273614|NCT03613389|Vitamin E|vitamin e|mesh-list
93273615|NCT03613389|Vitamins|vitamins|mesh-ancestor
93273616|NCT03613389|Micronutrients|micronutrients|mesh-ancestor
93273617|NCT03613389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273618|NCT03613389|Antioxidants|antioxidants|mesh-ancestor
93273619|NCT03613389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273620|NCT03613389|Protective Agents|protective agents|mesh-ancestor
93273621|NCT03614013|Immunomodulating Agents|immunomodulating agents|mesh-list
93273622|NCT03614013|Immunologic Factors|immunologic factors|mesh-ancestor
93273623|NCT03614013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273624|NCT02259777|Amlodipine|amlodipine|mesh-list
93273625|NCT02259777|Telmisartan|telmisartan|mesh-list
93273626|NCT02259777|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93273627|NCT02259777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93273628|NCT02259777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93273629|NCT02259777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273630|NCT02259777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273631|NCT02259777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273632|NCT02259777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273633|NCT02259777|Vasodilator Agents|vasodilator agents|mesh-ancestor
93273634|NCT02259777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93273635|NCT02259777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93273636|NCT03261375|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93273637|NCT03261375|Antihypertensive Agents|antihypertensive agents|mesh-list
93273638|NCT03261375|Nifedipine|nifedipine|mesh-list
93273639|NCT03261375|Diuretics|diuretics|mesh-ancestor
93273640|NCT03261375|Natriuretic Agents|natriuretic agents|mesh-ancestor
93273641|NCT03261375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273642|NCT03261375|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93273643|NCT03261375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273644|NCT03261375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273645|NCT03261375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93273646|NCT03261375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273647|NCT03261375|Vasodilator Agents|vasodilator agents|mesh-ancestor
93273648|NCT03261375|Tocolytic Agents|tocolytic agents|mesh-ancestor
93273649|NCT03261375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93273650|NCT03613545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93273651|NCT03613545|Rifaximin|rifaximin|mesh-list
93273652|NCT03613545|Antidepressive Agents|antidepressive agents|mesh-list
93273653|NCT03613545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273654|NCT03613545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93273655|NCT03613545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93273656|NCT01361308|Paroxetine|paroxetine|mesh-list
93273657|NCT01361308|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93273658|NCT01361308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93273659|NCT01361308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273660|NCT01361308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273661|NCT01361308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273662|NCT01361308|Serotonin Agents|serotonin agents|mesh-ancestor
93273663|NCT01361308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273664|NCT01361308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93273665|NCT01361308|Antidepressive Agents|antidepressive agents|mesh-ancestor
93273666|NCT01361308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93273667|NCT01361308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93273668|NCT01361308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93273669|NCT01361308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273670|NCT05043142|Antibodies|antibodies|mesh-list
93273671|NCT05043142|Immunologic Factors|immunologic factors|mesh-ancestor
93273672|NCT05043142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273673|NCT03612297|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93273674|NCT03612297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273675|NCT02872935|Glycopyrrolate|glycopyrrolate|mesh-list
93273676|NCT02872935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93273677|NCT02872935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93273678|NCT02872935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93273679|NCT02872935|Cholinergic Agents|cholinergic agents|mesh-ancestor
93273680|NCT02872935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273681|NCT02872935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273682|NCT02872935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273683|NCT00103662|Plerixafor|plerixafor|mesh-list
93273684|NCT00103662|Lenograstim|lenograstim|mesh-list
93273685|NCT00103662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93273686|NCT00103662|Immunologic Factors|immunologic factors|mesh-ancestor
92945710|NCT00888082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93273687|NCT00103662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273688|NCT00103662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93273689|NCT00103662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93273690|NCT00103662|Antiviral Agents|antiviral agents|mesh-ancestor
93273691|NCT00103662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273692|NCT03612219|Apatinib|apatinib|mesh-list
93273693|NCT03612219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273694|NCT03612219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93273695|NCT03612219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273696|NCT03612219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273697|NCT05030116|Domperidone|domperidone|mesh-list
93273698|NCT05030116|Antiemetics|antiemetics|mesh-ancestor
93273699|NCT05030116|Autonomic Agents|autonomic agents|mesh-ancestor
93273700|NCT05030116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273701|NCT05030116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273702|NCT05030116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93273703|NCT05030116|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93273704|NCT05030116|Dopamine Agents|dopamine agents|mesh-ancestor
93273705|NCT05030116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273706|NCT05030116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273707|NCT03015129|Durvalumab|durvalumab|mesh-list
93273708|NCT03015129|Tremelimumab|tremelimumab|mesh-list
93273709|NCT03015129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93273710|NCT03015129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273711|NCT02148978|Saxagliptin|saxagliptin|mesh-list
93273712|NCT02148978|Incretins|incretins|mesh-ancestor
93273713|NCT02148978|Hormones|hormones|mesh-ancestor
93273714|NCT02148978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93273715|NCT02148978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273716|NCT02148978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93273717|NCT02148978|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273718|NCT02148978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273719|NCT02148978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273720|NCT02148978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93273721|NCT05048914|Acetaminophen|acetaminophen|mesh-list
93273722|NCT05048914|Dipyrone|dipyrone|mesh-list
93273723|NCT05048914|Ibuprofen|ibuprofen|mesh-list
93273724|NCT05048914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93273725|NCT05048914|Analgesics|analgesics|mesh-ancestor
93273726|NCT05048914|Sensory System Agents|sensory system agents|mesh-ancestor
93273727|NCT05048914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273728|NCT05048914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273729|NCT05048914|Antipyretics|antipyretics|mesh-ancestor
93273730|NCT05048914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93273731|NCT05048914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93273732|NCT05048914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93273733|NCT05048914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93273734|NCT05048914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273735|NCT05048914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273736|NCT03046017|Lidocaine|lidocaine|mesh-list
93273737|NCT03046017|Anesthetics, Local|anesthetics, local|mesh-ancestor
93273738|NCT03046017|Anesthetics|anesthetics|mesh-ancestor
93273739|NCT03046017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273740|NCT03046017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273741|NCT03046017|Sensory System Agents|sensory system agents|mesh-ancestor
92568323|NCT00190957|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93273742|NCT03046017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273743|NCT03046017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93273744|NCT03046017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93273745|NCT03046017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93273746|NCT03046017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273747|NCT03046017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273748|NCT04469686|Hydrocortisone|hydrocortisone|mesh-list
93273749|NCT04469686|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93273750|NCT04469686|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93273751|NCT04469686|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93273752|NCT04469686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93273753|NCT02149212|Aminaftone|aminaftone|mesh-list
93273754|NCT02149212|Hemostatics|hemostatics|mesh-ancestor
93273755|NCT02149212|Coagulants|coagulants|mesh-ancestor
93273756|NCT04667013|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
93273757|NCT04667013|Vasodilator Agents|vasodilator agents|mesh-ancestor
93273758|NCT03611985|Taxane|taxane|mesh-list
93273759|NCT03611985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273760|NCT03097900|Caffeine|caffeine|mesh-list
93273761|NCT03097900|Caffeine citrate|caffeine citrate|mesh-list
93273762|NCT03097900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273763|NCT03097900|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93273764|NCT03097900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273765|NCT03097900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93273766|NCT03097900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273767|NCT03097900|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93273768|NCT03097900|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93273769|NCT03097900|Purinergic Agents|purinergic agents|mesh-ancestor
93273770|NCT03097900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273771|NCT00104676|Paclitaxel|paclitaxel|mesh-list
93273772|NCT00104676|Etoposide|etoposide|mesh-list
93273773|NCT00104676|Oxaliplatin|oxaliplatin|mesh-list
93273774|NCT00104676|Ifosfamide|ifosfamide|mesh-list
93273775|NCT00104676|Bleomycin|bleomycin|mesh-list
93273776|NCT00104676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93273777|NCT00104676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273778|NCT00104676|Tubulin Modulators|tubulin modulators|mesh-ancestor
93273779|NCT00104676|Antimitotic Agents|antimitotic agents|mesh-ancestor
93273780|NCT00104676|Mitosis Modulators|mitosis modulators|mesh-ancestor
93273781|NCT00104676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273782|NCT00104676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93273783|NCT00104676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273784|NCT00104676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273785|NCT00104676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93273786|NCT00104676|Alkylating Agents|alkylating agents|mesh-ancestor
93273787|NCT00104676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93273788|NCT00354835|Dactinomycin|dactinomycin|mesh-list
93273789|NCT00354835|Cactinomycin|cactinomycin|mesh-list
93273790|NCT00354835|Cyclophosphamide|cyclophosphamide|mesh-list
93273791|NCT00354835|Irinotecan|irinotecan|mesh-list
93273792|NCT00354835|Vincristine|vincristine|mesh-list
93273793|NCT00354835|Camptothecin|camptothecin|mesh-list
93273794|NCT00354835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93273795|NCT00354835|Immunologic Factors|immunologic factors|mesh-ancestor
93273796|NCT00354835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273797|NCT00354835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93273798|NCT00354835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93273799|NCT00354835|Alkylating Agents|alkylating agents|mesh-ancestor
93273800|NCT00354835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273801|NCT00354835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273802|NCT00354835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93273803|NCT00354835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93273804|NCT00354835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273805|NCT00354835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273806|NCT00354835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93273807|NCT00354835|Tubulin Modulators|tubulin modulators|mesh-ancestor
93273808|NCT00354835|Antimitotic Agents|antimitotic agents|mesh-ancestor
93273809|NCT00354835|Mitosis Modulators|mitosis modulators|mesh-ancestor
93273810|NCT00354835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93273811|NCT00354835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273812|NCT00354835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93273813|NCT00354835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93273814|NCT00354835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93273815|NCT02768298|Enalapril|enalapril|mesh-list
93273816|NCT02768298|Enalaprilat|enalaprilat|mesh-list
93273817|NCT02768298|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93273818|NCT02768298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93273819|NCT02768298|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273820|NCT02768298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273821|NCT02768298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273822|NCT02768298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93273823|NCT02768298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93273824|NCT05028322|Imiquimod|imiquimod|mesh-list
93273825|NCT05028322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93273826|NCT05028322|Immunologic Factors|immunologic factors|mesh-ancestor
93273827|NCT05028322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273828|NCT05028322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273829|NCT05028322|Interferon Inducers|interferon inducers|mesh-ancestor
93273830|NCT03096340|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
93273831|NCT03096340|Irinotecan|irinotecan|mesh-list
93273832|NCT03096340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93273833|NCT03096340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273834|NCT03096340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93273835|NCT03096340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273836|NCT03096340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273837|NCT03096340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273839|NCT02152800|Antiviral Agents|antiviral agents|mesh-ancestor
93273840|NCT02152800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273841|NCT02149758|Etoricoxib|etoricoxib|mesh-list
93273842|NCT02149758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93273843|NCT02149758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93273844|NCT02149758|Analgesics|analgesics|mesh-ancestor
93273845|NCT02149758|Sensory System Agents|sensory system agents|mesh-ancestor
93273846|NCT02149758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273847|NCT02149758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273848|NCT02149758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93273849|NCT02149758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93273850|NCT02149758|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93273851|NCT02149758|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93273852|NCT02149758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273853|NCT02149758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273854|NCT03542214|Calcium|calcium|mesh-list
93273855|NCT03542214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273856|NCT03542214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273857|NCT03094468|Terbinafine|terbinafine|mesh-list
93273858|NCT03094468|Antifungal Agents|antifungal agents|mesh-ancestor
93273859|NCT03094468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273860|NCT03094468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273861|NCT03094468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273862|NCT03744546|Tilavonemab|tilavonemab|mesh-list
93273863|NCT03744546|Nootropic Agents|nootropic agents|mesh-ancestor
93273864|NCT02775864|Antipsychotic Agents|antipsychotic agents|mesh-list
92568454|NCT02470299|Ketorolac|ketorolac|mesh-list
93273865|NCT02775864|Antidepressive Agents|antidepressive agents|mesh-list
93273866|NCT02775864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93273867|NCT02775864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93273868|NCT02775864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273869|NCT02775864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273870|NCT03095872|Petrolatum|petrolatum|mesh-list
93273871|NCT03095872|Emollients|emollients|mesh-ancestor
93273872|NCT03095872|Dermatologic Agents|dermatologic agents|mesh-ancestor
93273873|NCT03096184|Apatinib|apatinib|mesh-list
93273874|NCT03096184|Tegafur|tegafur|mesh-list
93273875|NCT03096184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273876|NCT03096184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93273877|NCT03096184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273878|NCT03096184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273879|NCT03096184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93273880|NCT03096184|Antimetabolites|antimetabolites|mesh-ancestor
93273881|NCT02157012|Tofacitinib|tofacitinib|mesh-list
93273882|NCT02157012|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93273883|NCT02157012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93273884|NCT02157012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273885|NCT02157012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273886|NCT03096028|Vitamin B 12|vitamin b 12|mesh-list
93273887|NCT03096028|Hydroxocobalamin|hydroxocobalamin|mesh-list
93273888|NCT03096028|Vitamins|vitamins|mesh-ancestor
93273889|NCT03096028|Micronutrients|micronutrients|mesh-ancestor
93273890|NCT03096028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273891|NCT03096028|Vitamin B Complex|vitamin b complex|mesh-ancestor
93273892|NCT03096028|Hematinics|hematinics|mesh-ancestor
93273893|NCT02149914|Rabeprazole|rabeprazole|mesh-list
93273894|NCT02149914|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93273895|NCT02149914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93273896|NCT02149914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93273897|NCT02149914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273898|NCT02149914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273899|NCT02149992|Inositol|inositol|mesh-list
93273900|NCT02149992|Vitamin B Complex|vitamin b complex|mesh-ancestor
93273901|NCT02149992|Vitamins|vitamins|mesh-ancestor
93273902|NCT02149992|Micronutrients|micronutrients|mesh-ancestor
93273903|NCT02149992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273904|NCT04833582|Gemcitabine|gemcitabine|mesh-list
93273905|NCT04833582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93273906|NCT04833582|Antimetabolites|antimetabolites|mesh-ancestor
93273907|NCT04833582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273908|NCT04833582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273909|NCT05041582|Citalopram|citalopram|mesh-list
92945938|NCT00577122|Hormones|hormones|mesh-ancestor
93273910|NCT05041582|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93273911|NCT05041582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93273912|NCT05041582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273913|NCT05041582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273914|NCT05041582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273915|NCT05041582|Serotonin Agents|serotonin agents|mesh-ancestor
93273916|NCT05041582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273917|NCT05041582|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93273918|NCT05041582|Antidepressive Agents|antidepressive agents|mesh-ancestor
93273919|NCT05041582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93273920|NCT02150070|ASP2408|asp2408|mesh-list
93273921|NCT02150070|Immunoconjugates|immunoconjugates|mesh-ancestor
93273922|NCT02150070|Immunologic Factors|immunologic factors|mesh-ancestor
93273923|NCT02150070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273924|NCT05041036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93273925|NCT05041036|Nirogacestat|nirogacestat|mesh-list
93273926|NCT05041036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273927|NCT05041036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273928|NCT02153424|Apixaban|apixaban|mesh-list
93273929|NCT02153424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93273930|NCT02153424|Antithrombins|antithrombins|mesh-ancestor
93273931|NCT02153424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92568490|NCT00191932|Dopamine Agents|dopamine agents|mesh-ancestor
93273932|NCT02153424|Protease Inhibitors|protease inhibitors|mesh-ancestor
93273933|NCT02153424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273934|NCT02153424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273935|NCT02153424|Anticoagulants|anticoagulants|mesh-ancestor
93273936|NCT05027386|Irinotecan|irinotecan|mesh-list
93273937|NCT05027386|Temozolomide|temozolomide|mesh-list
93273938|NCT05027386|Apatinib|apatinib|mesh-list
93273939|NCT05027386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93273940|NCT05027386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93273941|NCT05027386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273942|NCT05027386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273943|NCT05027386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93273944|NCT05027386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93273945|NCT05027386|Alkylating Agents|alkylating agents|mesh-ancestor
93273946|NCT05027386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93273947|NCT04434430|Gabapentin|gabapentin|mesh-list
93273948|NCT04434430|Analgesics|analgesics|mesh-ancestor
93273949|NCT04434430|Sensory System Agents|sensory system agents|mesh-ancestor
93273950|NCT04434430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93273951|NCT04434430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273952|NCT04434430|Anticonvulsants|anticonvulsants|mesh-ancestor
93273953|NCT04434430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93273954|NCT04434430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93273955|NCT04434430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93273956|NCT04434430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93273957|NCT04434430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93273958|NCT04434430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93273959|NCT04434430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273960|NCT04434430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273961|NCT04434430|Antimanic Agents|antimanic agents|mesh-ancestor
93273962|NCT03094156|Resveratrol|resveratrol|mesh-list
93273963|NCT03094156|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
93273964|NCT03094156|Antioxidants|antioxidants|mesh-ancestor
93273965|NCT03094156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273966|NCT03094156|Protective Agents|protective agents|mesh-ancestor
93273967|NCT03094156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273968|NCT03094156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93273969|NCT03094156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93273970|NCT03094156|Dopamine Agents|dopamine agents|mesh-ancestor
93273971|NCT03094156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273972|NCT02964273|Tolvaptan|tolvaptan|mesh-list
93273973|NCT02964273|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93273974|NCT02964273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273975|NCT02964273|Natriuretic Agents|natriuretic agents|mesh-ancestor
93273976|NCT02964273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273977|NCT05040724|Ivermectin|ivermectin|mesh-list
93273978|NCT05040724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93273979|NCT05040724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93273980|NCT03542058|Carvedilol|carvedilol|mesh-list
93273981|NCT03542058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93273982|NCT03542058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93273983|NCT03542058|Adrenergic Agents|adrenergic agents|mesh-ancestor
93273984|NCT03542058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93273985|NCT03542058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93273986|NCT03542058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93273987|NCT03542058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93273988|NCT03542058|Antioxidants|antioxidants|mesh-ancestor
93273989|NCT03542058|Protective Agents|protective agents|mesh-ancestor
93273990|NCT03542058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93273991|NCT03542058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93273992|NCT03542058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93273993|NCT03542058|Vasodilator Agents|vasodilator agents|mesh-ancestor
93273994|NCT03542058|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93273995|NCT03542058|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93273996|NCT03321513|Bevacizumab|bevacizumab|mesh-list
93273997|NCT03321513|Aflibercept|aflibercept|mesh-list
93273998|NCT03321513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93273999|NCT03321513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274000|NCT03321513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93274001|NCT03321513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93274002|NCT03321513|Growth Substances|growth substances|mesh-ancestor
92568558|NCT02968901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274003|NCT03321513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274004|NCT03321513|Growth Inhibitors|growth inhibitors|mesh-ancestor
93274005|NCT02032797|Progesterone|progesterone|mesh-list
93274006|NCT02032797|Progestins|progestins|mesh-ancestor
93274007|NCT02032797|Hormones|hormones|mesh-ancestor
93274008|NCT02032797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274009|NCT02032797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274010|NCT05024266|Paclitaxel|paclitaxel|mesh-list
93274011|NCT05024266|Carboplatin|carboplatin|mesh-list
93274012|NCT05024266|Tislelizumab|tislelizumab|mesh-list
93274013|NCT05024266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274014|NCT05024266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274015|NCT05024266|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274016|NCT05024266|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274017|NCT05024266|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274018|NCT05024266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274019|NCT05024266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93274020|NCT02773368|Insulin|insulin|mesh-list
93274021|NCT02773368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93274022|NCT02773368|Insulin Glargine|insulin glargine|mesh-list
93274023|NCT02773368|Liraglutide|liraglutide|mesh-list
93274024|NCT02773368|Xultophy|xultophy|mesh-list
93274025|NCT02773368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274026|NCT02773368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274027|NCT02773368|Incretins|incretins|mesh-ancestor
93274028|NCT02773368|Hormones|hormones|mesh-ancestor
93274029|NCT02773368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274030|NCT02153658|Chlorhexidine|chlorhexidine|mesh-list
93274031|NCT02153658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93274032|NCT02153658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274033|NCT02153658|Disinfectants|disinfectants|mesh-ancestor
93274034|NCT02157558|Fexofenadine|fexofenadine|mesh-list
93274035|NCT02157558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93274036|NCT02157558|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93274037|NCT02157558|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93274038|NCT02157558|Histamine Antagonists|histamine antagonists|mesh-ancestor
93274039|NCT02157558|Histamine Agents|histamine agents|mesh-ancestor
93274040|NCT02157558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274041|NCT02157558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274042|NCT02157558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274043|NCT05018182|Leucovorin|leucovorin|mesh-list
93274044|NCT05018182|Folic Acid|folic acid|mesh-list
93274045|NCT05018182|Fluorouracil|fluorouracil|mesh-list
93274046|NCT05018182|Capecitabine|capecitabine|mesh-list
93274047|NCT05018182|Oxaliplatin|oxaliplatin|mesh-list
93274048|NCT05018182|Irinotecan|irinotecan|mesh-list
93274049|NCT05018182|Levoleucovorin|levoleucovorin|mesh-list
93274050|NCT05018182|Antimetabolites|antimetabolites|mesh-ancestor
93274051|NCT05018182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274052|NCT05018182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93274053|NCT05018182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274054|NCT05018182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274055|NCT05018182|Immunologic Factors|immunologic factors|mesh-ancestor
93274056|NCT05018182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274057|NCT05018182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93274058|NCT05018182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93274059|NCT05018182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274060|NCT05018182|Antidotes|antidotes|mesh-ancestor
93274061|NCT05018182|Protective Agents|protective agents|mesh-ancestor
93274062|NCT05018182|Vitamin B Complex|vitamin b complex|mesh-ancestor
93274063|NCT05018182|Vitamins|vitamins|mesh-ancestor
93274064|NCT05018182|Micronutrients|micronutrients|mesh-ancestor
93274065|NCT05018182|Hematinics|hematinics|mesh-ancestor
93274066|NCT01336569|Timolol|timolol|mesh-list
93274067|NCT01336569|Travoprost|travoprost|mesh-list
93274068|NCT01336569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274069|NCT01336569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93274070|NCT01336569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93274071|NCT01336569|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274072|NCT01336569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274073|NCT01336569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274074|NCT01336569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93274075|NCT01336569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93274076|NCT03092986|Paclitaxel|paclitaxel|mesh-list
93274077|NCT03092986|Vinblastine|vinblastine|mesh-list
93274078|NCT03092986|Carboplatin|carboplatin|mesh-list
93274079|NCT03092986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274080|NCT03092986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274081|NCT03092986|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274082|NCT03092986|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274083|NCT03092986|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274084|NCT03092986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274085|NCT03092908|Acetic Acid|acetic acid|mesh-list
93274086|NCT03092908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274087|NCT03092908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274088|NCT03543306|Trametinib|trametinib|mesh-list
93274089|NCT03543306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274090|NCT03543306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93274091|NCT03543306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274092|NCT03543306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274093|NCT02157792|Carboplatin|carboplatin|mesh-list
93274094|NCT02157792|Gemcitabine|gemcitabine|mesh-list
93274095|NCT02157792|Irinotecan|irinotecan|mesh-list
93274096|NCT02157792|Etoposide|etoposide|mesh-list
93274097|NCT02157792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274098|NCT02157792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93274099|NCT02157792|Antimetabolites|antimetabolites|mesh-ancestor
93274100|NCT02157792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274101|NCT02157792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93274102|NCT02157792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93274103|NCT02157792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274104|NCT02157792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274105|NCT02157792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93274106|NCT05023408|Bleomycin|bleomycin|mesh-list
93274107|NCT05023408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93274108|NCT05023408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274109|NCT02772978|Tolcapone|tolcapone|mesh-list
93274110|NCT02772978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93274111|NCT02772978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93274112|NCT02772978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93274113|NCT02772978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274114|NCT02772978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274115|NCT03090490|Antipsychotic Agents|antipsychotic agents|mesh-list
93274116|NCT03090490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93274117|NCT03090490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274118|NCT03090490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274119|NCT03090490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93274120|NCT05164549|Buprenorphine|buprenorphine|mesh-list
93274121|NCT05164549|Methadone|methadone|mesh-list
93274122|NCT05164549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93274123|NCT05164549|Narcotics|narcotics|mesh-ancestor
93274124|NCT05164549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274125|NCT05164549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274126|NCT05164549|Analgesics|analgesics|mesh-ancestor
93274127|NCT05164549|Sensory System Agents|sensory system agents|mesh-ancestor
93274128|NCT05164549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274129|NCT05164549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93274130|NCT05164549|Antitussive Agents|antitussive agents|mesh-ancestor
93274131|NCT05164549|Respiratory System Agents|respiratory system agents|mesh-ancestor
93274132|NCT00104052|Ribavirin|ribavirin|mesh-list
93274133|NCT00104052|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93274134|NCT00104052|Interferon-alpha|interferon-alpha|mesh-list
93274135|NCT00104052|Antimetabolites|antimetabolites|mesh-ancestor
93274136|NCT00104052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274137|NCT00104052|Antiviral Agents|antiviral agents|mesh-ancestor
93274138|NCT00104052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274139|NCT00104052|Immunologic Factors|immunologic factors|mesh-ancestor
93274140|NCT00104052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274141|NCT05038072|Triamcinolone|triamcinolone|mesh-list
93274142|NCT05038072|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93274143|NCT05038072|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93274144|NCT05038072|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93274145|NCT05038072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274146|NCT05038072|Glucocorticoids|glucocorticoids|mesh-ancestor
93274147|NCT05038072|Hormones|hormones|mesh-ancestor
93274148|NCT05038072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274149|NCT05038072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274150|NCT05038072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274151|NCT05038072|Immunologic Factors|immunologic factors|mesh-ancestor
93274152|NCT05038072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274153|NCT05038072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274154|NCT02777970|Acetaminophen|acetaminophen|mesh-list
93274155|NCT02777970|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93274156|NCT02777970|Tramadol|tramadol|mesh-list
93274157|NCT02777970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274158|NCT02777970|Analgesics|analgesics|mesh-ancestor
93274159|NCT02777970|Sensory System Agents|sensory system agents|mesh-ancestor
93274160|NCT02777970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274161|NCT02777970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274162|NCT02777970|Antipyretics|antipyretics|mesh-ancestor
93274163|NCT02777970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93274164|NCT02777970|Narcotics|narcotics|mesh-ancestor
93274165|NCT02777970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274166|NCT02777970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93274167|NCT02777970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274168|NCT02777970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274169|NCT02150616|Sevoflurane|sevoflurane|mesh-list
93274170|NCT02150616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93274171|NCT02150616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93274172|NCT02150616|Anesthetics, General|anesthetics, general|mesh-ancestor
93274173|NCT02150616|Anesthetics|anesthetics|mesh-ancestor
93274174|NCT02150616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274175|NCT02150616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274176|NCT01336023|Insulin|insulin|mesh-list
93274177|NCT01336023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93274178|NCT01336023|Liraglutide|liraglutide|mesh-list
93274179|NCT01336023|Insulin, Long-Acting|insulin, long-acting|mesh-list
93274180|NCT01336023|Xultophy|xultophy|mesh-list
93274181|NCT01336023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274182|NCT01336023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274183|NCT01336023|Incretins|incretins|mesh-ancestor
93274184|NCT01336023|Hormones|hormones|mesh-ancestor
93274185|NCT01336023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274186|NCT02255292|Cannabidiol|cannabidiol|mesh-list
93274187|NCT02255292|Anticonvulsants|anticonvulsants|mesh-ancestor
93274188|NCT03092206|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93274189|NCT03092206|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93274190|NCT03092206|Antiviral Agents|antiviral agents|mesh-ancestor
93274191|NCT03092206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274192|NCT03092206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93274193|NCT03092206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93274194|NCT03092206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274195|NCT03092206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274196|NCT03092206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93274197|NCT03092206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93274198|NCT02254980|Vitamin E|vitamin e|mesh-list
93274199|NCT02254980|Vitamins|vitamins|mesh-ancestor
93274200|NCT02254980|Micronutrients|micronutrients|mesh-ancestor
93274201|NCT02254980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274202|NCT02254980|Antioxidants|antioxidants|mesh-ancestor
93274203|NCT02254980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274204|NCT02254980|Protective Agents|protective agents|mesh-ancestor
93274205|NCT05281003|Paclitaxel|paclitaxel|mesh-list
93274206|NCT05281003|Pembrolizumab|pembrolizumab|mesh-list
93274207|NCT05281003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274208|NCT05281003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274209|NCT05281003|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274210|NCT05281003|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274211|NCT05281003|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274212|NCT05281003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274213|NCT05281003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93274214|NCT05281003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93274215|NCT02158182|Rifaximin|rifaximin|mesh-list
92946234|NCT01566565|Vasodilator Agents|vasodilator agents|mesh-ancestor
93274216|NCT02158182|Lactulose|lactulose|mesh-list
93274217|NCT02158182|N-Methylaspartate|n-methylaspartate|mesh-list
93274218|NCT02158182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274219|NCT02158182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274220|NCT02158182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274221|NCT02158182|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93274222|NCT02158182|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93274223|NCT02158182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274224|NCT02158182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274225|NCT02158182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274226|NCT02033187|Chlorhexidine|chlorhexidine|mesh-list
93274227|NCT02033187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93274228|NCT02033187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274229|NCT02033187|Disinfectants|disinfectants|mesh-ancestor
93274230|NCT02154360|Aprepitant|aprepitant|mesh-list
93274231|NCT02154360|Antiemetics|antiemetics|mesh-ancestor
93274232|NCT02154360|Autonomic Agents|autonomic agents|mesh-ancestor
93274233|NCT02154360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274234|NCT02154360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274235|NCT02154360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274236|NCT02154360|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93274237|NCT02154360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274238|NCT02154360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274239|NCT02033031|Bevacizumab|bevacizumab|mesh-list
93274240|NCT02033031|Ranibizumab|ranibizumab|mesh-list
93274241|NCT02033031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93274242|NCT02033031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274243|NCT02033031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93274244|NCT02033031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93274245|NCT02033031|Growth Substances|growth substances|mesh-ancestor
93274246|NCT02033031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274247|NCT02033031|Growth Inhibitors|growth inhibitors|mesh-ancestor
93274248|NCT05034367|Mannitol|mannitol|mesh-list
93274249|NCT05034367|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93274250|NCT05034367|Diuretics|diuretics|mesh-ancestor
93274251|NCT05034367|Natriuretic Agents|natriuretic agents|mesh-ancestor
93274252|NCT05034367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274253|NCT02150928|Asparaginase|asparaginase|mesh-list
93274254|NCT02150928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274255|NCT03611049|Vitamin D|vitamin d|mesh-list
93274256|NCT03611049|Ergocalciferols|ergocalciferols|mesh-list
93274257|NCT03611049|Cholecalciferol|cholecalciferol|mesh-list
93274258|NCT03611049|Vitamins|vitamins|mesh-list
93274259|NCT03611049|Micronutrients|micronutrients|mesh-ancestor
93274260|NCT03611049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274261|NCT03611049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93274262|NCT03611049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93274263|NCT04822350|Avelumab|avelumab|mesh-list
93274264|NCT04822350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93274265|NCT04822350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274266|NCT03610893|Dexamethasone|dexamethasone|mesh-list
93274267|NCT03610893|Dexmedetomidine|dexmedetomidine|mesh-list
93274268|NCT03610893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274269|NCT03610893|Antiemetics|antiemetics|mesh-ancestor
93274270|NCT03610893|Autonomic Agents|autonomic agents|mesh-ancestor
93274271|NCT03610893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274272|NCT03610893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274273|NCT03610893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274274|NCT03610893|Glucocorticoids|glucocorticoids|mesh-ancestor
93274275|NCT03610893|Hormones|hormones|mesh-ancestor
93274276|NCT03610893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274277|NCT03610893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93274278|NCT03610893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274279|NCT03610893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93274280|NCT03610893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274281|NCT03610893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274282|NCT03610893|Analgesics|analgesics|mesh-ancestor
93274283|NCT03610893|Sensory System Agents|sensory system agents|mesh-ancestor
93274284|NCT03610893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93274285|NCT03610893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93274286|NCT03610893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93274287|NCT03610893|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274288|NCT03610893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274289|NCT03610893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274290|NCT04737109|Ipatasertib|ipatasertib|mesh-list
93274291|NCT04737109|Androgens|androgens|mesh-list
93274293|NCT04737109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274294|NCT04737109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274295|NCT04737109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274296|NCT04737109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93274297|NCT04737109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274298|NCT04737109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274299|NCT02154438|Ketamine|ketamine|mesh-list
93274300|NCT02154438|Analgesics|analgesics|mesh-ancestor
93274301|NCT02154438|Sensory System Agents|sensory system agents|mesh-ancestor
93274302|NCT02154438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274303|NCT02154438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274304|NCT02154438|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93274305|NCT02154438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93274306|NCT02154438|Anesthetics, General|anesthetics, general|mesh-ancestor
93274307|NCT02154438|Anesthetics|anesthetics|mesh-ancestor
93274308|NCT02154438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274309|NCT02154438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93274310|NCT02154438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93274311|NCT02154438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274312|NCT02154438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274313|NCT02520921|Aspirin|aspirin|mesh-list
93274314|NCT02520921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93274315|NCT02520921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274316|NCT02520921|Analgesics|analgesics|mesh-ancestor
93274317|NCT02520921|Sensory System Agents|sensory system agents|mesh-ancestor
93274318|NCT02520921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274319|NCT02520921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274320|NCT02520921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274321|NCT02520921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274322|NCT02520921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93274323|NCT02520921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93274324|NCT02520921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274325|NCT02520921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93274326|NCT02520921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93274327|NCT02520921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274328|NCT02520921|Antipyretics|antipyretics|mesh-ancestor
93274329|NCT02154594|Chlorhexidine|chlorhexidine|mesh-list
93274330|NCT02154594|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93274331|NCT02154594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93274332|NCT02154594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274333|NCT02154594|Disinfectants|disinfectants|mesh-ancestor
93274334|NCT02154594|Dermatologic Agents|dermatologic agents|mesh-ancestor
93274335|NCT03610347|Paclitaxel|paclitaxel|mesh-list
93274336|NCT03610347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274337|NCT03610347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274338|NCT03610347|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274339|NCT03610347|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274340|NCT03610347|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274341|NCT03610347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274342|NCT01518517|Asparaginase|asparaginase|mesh-list
93274343|NCT01518517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274344|NCT02863575|Ibuprofen|ibuprofen|mesh-list
93274345|NCT02863575|Caffeine|caffeine|mesh-list
93274346|NCT02863575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93274347|NCT02863575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274348|NCT02863575|Analgesics|analgesics|mesh-ancestor
93274349|NCT02863575|Sensory System Agents|sensory system agents|mesh-ancestor
93274350|NCT02863575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274351|NCT02863575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274352|NCT02863575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274353|NCT02863575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274354|NCT02863575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93274355|NCT02863575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274356|NCT02863575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274357|NCT02863575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93274358|NCT02863575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93274359|NCT02863575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93274360|NCT02863575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93274361|NCT02863575|Purinergic Agents|purinergic agents|mesh-ancestor
93274362|NCT02863575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274363|NCT05021770|Thiotepa|thiotepa|mesh-list
93274364|NCT05021770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93274365|NCT05021770|Alkylating Agents|alkylating agents|mesh-ancestor
93274366|NCT05021770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274367|NCT05021770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274368|NCT05021770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93274369|NCT05021770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274370|NCT05021770|Immunologic Factors|immunologic factors|mesh-ancestor
93274371|NCT05021770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274372|NCT05230303|Caffeine|caffeine|mesh-list
93274373|NCT05230303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93274374|NCT05230303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274375|NCT05230303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93274376|NCT05230303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274377|NCT05230303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274378|NCT05230303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93274379|NCT05230303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93274380|NCT05230303|Purinergic Agents|purinergic agents|mesh-ancestor
93274381|NCT05230303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274382|NCT04287790|Naltrexone|naltrexone|mesh-list
93274383|NCT04287790|Disulfiram|disulfiram|mesh-list
93274384|NCT04287790|Acamprosate|acamprosate|mesh-list
93274385|NCT04287790|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93274386|NCT04287790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93274387|NCT04287790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274388|NCT04287790|Sensory System Agents|sensory system agents|mesh-ancestor
93274389|NCT04287790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274390|NCT04287790|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93274391|NCT04287790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274392|NCT04287790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274393|NCT03723967|Paclitaxel|paclitaxel|mesh-list
93274394|NCT03723967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93274395|NCT03723967|Carboplatin|carboplatin|mesh-list
93274396|NCT03723967|Durvalumab|durvalumab|mesh-list
93274397|NCT03723967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93274398|NCT03723967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274399|NCT03723967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274400|NCT03723967|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274401|NCT03723967|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274402|NCT03723967|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274403|NCT03723967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274404|NCT03723967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93274405|NCT03723967|Immunologic Factors|immunologic factors|mesh-ancestor
93274406|NCT03723967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274407|NCT05008666|Azacitidine|azacitidine|mesh-list
93274408|NCT05008666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93274409|NCT05008666|Antimetabolites|antimetabolites|mesh-ancestor
93274410|NCT05008666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274411|NCT05008666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274412|NCT05008666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274413|NCT03659461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93274414|NCT03659461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274415|NCT03659461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274416|NCT03659461|Incretins|incretins|mesh-ancestor
93274417|NCT03659461|Hormones|hormones|mesh-ancestor
93274418|NCT03659461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274419|NCT03659461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93274420|NCT03659461|Protease Inhibitors|protease inhibitors|mesh-ancestor
93274421|NCT03659461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568982|NCT00195598|Paroxetine|paroxetine|mesh-list
93274422|NCT03659461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274423|NCT01227187|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
93274424|NCT01227187|Protein C|protein c|mesh-list
93274425|NCT01227187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274426|NCT01227187|Anticoagulants|anticoagulants|mesh-ancestor
93274427|NCT01227187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93274428|NCT01227187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93274429|NCT01227187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274430|NCT03088072|Aspirin|aspirin|mesh-list
93274431|NCT03088072|Warfarin|warfarin|mesh-list
93274432|NCT03088072|Edoxaban|edoxaban|mesh-list
93274433|NCT03088072|Clopidogrel|clopidogrel|mesh-list
93274434|NCT03088072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93274435|NCT03088072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274436|NCT03088072|Analgesics|analgesics|mesh-ancestor
93274437|NCT03088072|Sensory System Agents|sensory system agents|mesh-ancestor
93274438|NCT03088072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946461|NCT02550483|Vitamins|vitamins|mesh-ancestor
93274439|NCT03088072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274440|NCT03088072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274441|NCT03088072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274442|NCT03088072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93274443|NCT03088072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93274444|NCT03088072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274445|NCT03088072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93274446|NCT03088072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93274447|NCT03088072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274448|NCT03088072|Antipyretics|antipyretics|mesh-ancestor
93274449|NCT03088072|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93274450|NCT03088072|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93274451|NCT03088072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93274452|NCT03088072|Purinergic Agents|purinergic agents|mesh-ancestor
93274453|NCT03088072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274454|NCT03088072|Anticoagulants|anticoagulants|mesh-ancestor
93274455|NCT03088072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93274456|NCT03088072|Antithrombins|antithrombins|mesh-ancestor
93274457|NCT03088072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93274458|NCT03088072|Protease Inhibitors|protease inhibitors|mesh-ancestor
93274459|NCT01077817|Alendronate|alendronate|mesh-list
93274460|NCT01077817|Risedronic Acid|risedronic acid|mesh-list
93274461|NCT01077817|Ibandronic Acid|ibandronic acid|mesh-list
93274462|NCT01077817|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93274463|NCT01077817|Etidronic Acid|etidronic acid|mesh-list
93274464|NCT01077817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93274465|NCT01077817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274466|NCT01077817|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93274467|NCT01077817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93274468|NCT01077817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274469|NCT01077817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93274470|NCT01077817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93274471|NCT01077817|Hormone Antagonists|hormone antagonists|mesh-ancestor
93274472|NCT01077817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274473|NCT01077817|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93274474|NCT01077817|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93274475|NCT02638012|Hemostatics|hemostatics|mesh-list
93274476|NCT02638012|Coagulants|coagulants|mesh-ancestor
93274477|NCT05014906|Minocycline|minocycline|mesh-list
93274478|NCT05014906|Azelaic acid|azelaic acid|mesh-list
93274479|NCT05014906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274480|NCT05014906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274481|NCT05014906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274482|NCT05014906|Dermatologic Agents|dermatologic agents|mesh-ancestor
93274483|NCT00103506|Doxorubicin|doxorubicin|mesh-list
93274484|NCT00103506|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93274485|NCT00103506|Bortezomib|bortezomib|mesh-list
93274486|NCT00103506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93274487|NCT00103506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274488|NCT00103506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93274489|NCT00103506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93274490|NCT00103506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274491|NCT00103506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274492|NCT02151240|Acyclovir|acyclovir|mesh-list
93274493|NCT02151240|Foscarnet|foscarnet|mesh-list
93274494|NCT02151240|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
93274495|NCT02151240|Antiviral Agents|antiviral agents|mesh-ancestor
93274496|NCT02151240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274497|NCT02151240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93274498|NCT02151240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93274499|NCT02151240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274500|NCT02151240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274501|NCT02159196|Acetylcysteine|acetylcysteine|mesh-list
93274502|NCT02159196|Albuterol|albuterol|mesh-list
93274503|NCT02159196|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93274504|NCT02159196|Antiviral Agents|antiviral agents|mesh-ancestor
93274505|NCT02159196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274506|NCT02159196|Expectorants|expectorants|mesh-ancestor
93274507|NCT02159196|Respiratory System Agents|respiratory system agents|mesh-ancestor
93274508|NCT02159196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93274509|NCT02159196|Antioxidants|antioxidants|mesh-ancestor
93274510|NCT02159196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274511|NCT02159196|Protective Agents|protective agents|mesh-ancestor
93274512|NCT02159196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274513|NCT02159196|Antidotes|antidotes|mesh-ancestor
92946534|NCT05324904|Vitamin D|vitamin d|mesh-list
93274514|NCT02159196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93274515|NCT02159196|Autonomic Agents|autonomic agents|mesh-ancestor
93274516|NCT02159196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274517|NCT02159196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93274518|NCT02159196|Tocolytic Agents|tocolytic agents|mesh-ancestor
93274519|NCT02159196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93274520|NCT02159196|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93274521|NCT02159196|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93274522|NCT02159196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93274523|NCT02159196|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274524|NCT02159196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274525|NCT02765490|Simeprevir|simeprevir|mesh-list
93274526|NCT02765490|Odalasvir|odalasvir|mesh-list
93274527|NCT02765490|Antiviral Agents|antiviral agents|mesh-ancestor
93274528|NCT02765490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274529|NCT02765490|Protease Inhibitors|protease inhibitors|mesh-ancestor
93274530|NCT02765490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274531|NCT02765490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274532|NCT02762370|Triamcinolone|triamcinolone|mesh-list
93274533|NCT02762370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93274534|NCT02762370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93274536|NCT02762370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93274537|NCT02762370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274538|NCT02762370|Glucocorticoids|glucocorticoids|mesh-ancestor
93274539|NCT02762370|Hormones|hormones|mesh-ancestor
93274540|NCT02762370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274541|NCT02762370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274542|NCT02762370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274543|NCT02762370|Immunologic Factors|immunologic factors|mesh-ancestor
93274544|NCT02762370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274545|NCT02762370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274546|NCT02639182|Axitinib|axitinib|mesh-list
93274547|NCT02639182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274548|NCT02639182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93274549|NCT02639182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274550|NCT02639182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274551|NCT02863419|Liraglutide|liraglutide|mesh-list
93274552|NCT02863419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274553|NCT02863419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274554|NCT02863419|Incretins|incretins|mesh-ancestor
93274555|NCT02863419|Hormones|hormones|mesh-ancestor
93274556|NCT02863419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274557|NCT03541668|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93274558|NCT03541668|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93274559|NCT03541668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93274560|NCT03541668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274561|NCT04961632|Tamoxifen|tamoxifen|mesh-list
93274562|NCT04961632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93274563|NCT04961632|Hormone Antagonists|hormone antagonists|mesh-ancestor
93274564|NCT04961632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274565|NCT04961632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274566|NCT04961632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93274567|NCT04961632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274568|NCT04961632|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93274569|NCT04961632|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93274570|NCT04961632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93274571|NCT02155374|Insulin|insulin|mesh-list
93274572|NCT02155374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93274573|NCT02155374|Insulin, Short-Acting|insulin, short-acting|mesh-list
93274574|NCT02155374|Antineoplastic Agents|antineoplastic agents|mesh-list
93274575|NCT02155374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274576|NCT02155374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274577|NCT04434118|Antirheumatic Agents|antirheumatic agents|mesh-list
93274578|NCT02765100|Minocycline|minocycline|mesh-list
93274579|NCT02765100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274580|NCT02765100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274581|NCT03091894|Dexmedetomidine|dexmedetomidine|mesh-list
93274582|NCT03091894|Propofol|propofol|mesh-list
93274583|NCT03091894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93274584|NCT03091894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274585|NCT03091894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274586|NCT03091894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274587|NCT03091894|Analgesics|analgesics|mesh-ancestor
93274588|NCT03091894|Sensory System Agents|sensory system agents|mesh-ancestor
93274589|NCT03091894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274590|NCT03091894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93274591|NCT03091894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93274592|NCT03091894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93274593|NCT03091894|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274594|NCT03091894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274595|NCT03091894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274596|NCT03091894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93274597|NCT03091894|Anesthetics, General|anesthetics, general|mesh-ancestor
93274599|NCT05014594|Dapagliflozin|dapagliflozin|mesh-list
93274600|NCT05014594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93274601|NCT05014594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274602|NCT05014594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274603|NCT05014594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274604|NCT02761980|Acetaminophen|acetaminophen|mesh-list
93274605|NCT02761980|Ibuprofen|ibuprofen|mesh-list
93274606|NCT02761980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274607|NCT02761980|Analgesics|analgesics|mesh-ancestor
93274608|NCT02761980|Sensory System Agents|sensory system agents|mesh-ancestor
93274609|NCT02761980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274610|NCT02761980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274611|NCT02761980|Antipyretics|antipyretics|mesh-ancestor
93274612|NCT02761980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93274613|NCT02761980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274614|NCT02761980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274615|NCT02761980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93274616|NCT02761980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274617|NCT02761980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274618|NCT05007340|Dimercaprol|dimercaprol|mesh-list
93274619|NCT05007340|Chelating Agents|chelating agents|mesh-ancestor
93274620|NCT05007340|Sequestering Agents|sequestering agents|mesh-ancestor
93274621|NCT05007340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274622|NCT05014048|Vitamin D|vitamin d|mesh-list
93274623|NCT05014048|Cholecalciferol|cholecalciferol|mesh-list
93274624|NCT05014048|Vitamins|vitamins|mesh-ancestor
93274625|NCT05014048|Micronutrients|micronutrients|mesh-ancestor
93274626|NCT05014048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274627|NCT05014048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93274628|NCT05014048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93274629|NCT02163174|Pentoxifylline|pentoxifylline|mesh-list
93274630|NCT02163174|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93274631|NCT02163174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274632|NCT02163174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274633|NCT02163174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93274634|NCT02163174|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93274635|NCT02163174|Protective Agents|protective agents|mesh-ancestor
93274636|NCT02163174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274637|NCT02163174|Vasodilator Agents|vasodilator agents|mesh-ancestor
93274638|NCT02163174|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93274639|NCT02163174|Antioxidants|antioxidants|mesh-ancestor
93274640|NCT01744912|Lenalidomide|lenalidomide|mesh-list
93274641|NCT01744912|Immunologic Factors|immunologic factors|mesh-ancestor
93274642|NCT01744912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274643|NCT01744912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93274644|NCT01744912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93274645|NCT01744912|Growth Substances|growth substances|mesh-ancestor
93274646|NCT01744912|Growth Inhibitors|growth inhibitors|mesh-ancestor
93274647|NCT01744912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274648|NCT03540810|Hydroxychloroquine|hydroxychloroquine|mesh-list
93274649|NCT03540810|Antimalarials|antimalarials|mesh-ancestor
93274650|NCT03540810|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93274651|NCT03540810|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93274652|NCT03540810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274653|NCT03540810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274654|NCT03540810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274655|NCT03540810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274656|NCT02159820|Paclitaxel|paclitaxel|mesh-list
93274657|NCT02159820|Carboplatin|carboplatin|mesh-list
93274658|NCT02159820|Decitabine|decitabine|mesh-list
93274659|NCT02159820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274660|NCT02159820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274661|NCT02159820|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274662|NCT02159820|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274663|NCT02159820|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274664|NCT02159820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274665|NCT02159820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93274666|NCT02159820|Antimetabolites|antimetabolites|mesh-ancestor
93274667|NCT02159820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274668|NCT02862171|Dapivirine|dapivirine|mesh-list
93274669|NCT02862171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93274670|NCT02862171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93274671|NCT02862171|Antiviral Agents|antiviral agents|mesh-ancestor
93274672|NCT02862171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274673|NCT05013112|Metformin|metformin|mesh-list
93274674|NCT05013112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93274675|NCT05013112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274676|NCT05013112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274677|NCT05013112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274678|NCT05013034|Basiliximab|basiliximab|mesh-list
93274679|NCT05013034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274680|NCT05013034|Immunologic Factors|immunologic factors|mesh-ancestor
93274681|NCT05013034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274682|NCT02638948|Methotrexate|methotrexate|mesh-list
93274683|NCT02638948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93274684|NCT02638948|Abortifacient Agents|abortifacient agents|mesh-ancestor
93274685|NCT02638948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93274686|NCT02638948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274687|NCT02638948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93274688|NCT02638948|Antimetabolites|antimetabolites|mesh-ancestor
93274689|NCT02638948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274690|NCT02638948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274691|NCT02638948|Dermatologic Agents|dermatologic agents|mesh-ancestor
93274692|NCT02638948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274693|NCT02638948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93274694|NCT02638948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274695|NCT02638948|Immunologic Factors|immunologic factors|mesh-ancestor
93274696|NCT02638948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274697|NCT02638948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93274698|NCT03091426|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
93274699|NCT03091426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274700|NCT04465864|Dexamethasone|dexamethasone|mesh-list
93274701|NCT04465864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274702|NCT04465864|Antiemetics|antiemetics|mesh-ancestor
93274703|NCT04465864|Autonomic Agents|autonomic agents|mesh-ancestor
93274704|NCT04465864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274705|NCT04465864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274706|NCT04465864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274707|NCT04465864|Glucocorticoids|glucocorticoids|mesh-ancestor
93274708|NCT04465864|Hormones|hormones|mesh-ancestor
93274709|NCT04465864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274710|NCT04465864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93274711|NCT04465864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274712|NCT03091504|Albuterol|albuterol|mesh-list
93274713|NCT03091504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93274714|NCT03091504|Autonomic Agents|autonomic agents|mesh-ancestor
93274715|NCT03091504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274716|NCT03091504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274717|NCT03091504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93274718|NCT03091504|Respiratory System Agents|respiratory system agents|mesh-ancestor
93274719|NCT03091504|Tocolytic Agents|tocolytic agents|mesh-ancestor
93274720|NCT03091504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93274721|NCT03091504|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93274722|NCT03091504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93274723|NCT03091504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93274724|NCT03091504|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274725|NCT03091504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274726|NCT03091504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274727|NCT05019586|Amoxicillin|amoxicillin|mesh-list
93274728|NCT05019586|Clarithromycin|clarithromycin|mesh-list
93274729|NCT05019586|Levofloxacin|levofloxacin|mesh-list
93274730|NCT05019586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274731|NCT05019586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274732|NCT05019586|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93274733|NCT05019586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274734|NCT05019586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274735|NCT05019586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93274736|NCT05019586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93274737|NCT05019586|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93274738|NCT05019586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93274739|NCT05019586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93274740|NCT05019586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274741|NCT05019586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93274742|NCT03081676|Glimepiride|glimepiride|mesh-list
93274743|NCT03081676|Glucagon|glucagon|mesh-list
93274744|NCT03081676|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
93274745|NCT03081676|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93274746|NCT03081676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93274747|NCT03081676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93274748|NCT03081676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274749|NCT03081676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274750|NCT03081676|Immunologic Factors|immunologic factors|mesh-ancestor
93274751|NCT03081676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274752|NCT03081676|Hormones|hormones|mesh-ancestor
93274753|NCT03081676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274754|NCT03081676|Incretins|incretins|mesh-ancestor
93274755|NCT05013268|Paclitaxel|paclitaxel|mesh-list
93274756|NCT05013268|Docetaxel|docetaxel|mesh-list
93274757|NCT05013268|Carboplatin|carboplatin|mesh-list
93274758|NCT05013268|Tislelizumab|tislelizumab|mesh-list
93274759|NCT05013268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274760|NCT05013268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274761|NCT05013268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274762|NCT05013268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274763|NCT05013268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274764|NCT05013268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274765|NCT05013268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93274766|NCT00102960|Ritonavir|ritonavir|mesh-list
93274767|NCT00102960|Lopinavir|lopinavir|mesh-list
93274768|NCT00102960|Lamivudine|lamivudine|mesh-list
93274769|NCT00102960|Zidovudine|zidovudine|mesh-list
93274770|NCT00102960|Nevirapine|nevirapine|mesh-list
93274771|NCT00102960|Abacavir|abacavir|mesh-list
93274772|NCT00102960|Didanosine|didanosine|mesh-list
93274773|NCT00102960|Efavirenz|efavirenz|mesh-list
93274774|NCT00102960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93274775|NCT00102960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93274776|NCT00102960|Protease Inhibitors|protease inhibitors|mesh-ancestor
93274777|NCT00102960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274778|NCT00102960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274779|NCT00102960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93274780|NCT00102960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93274781|NCT00102960|Antiviral Agents|antiviral agents|mesh-ancestor
93274782|NCT00102960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274783|NCT00102960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93274784|NCT00102960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93274785|NCT00102960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93274786|NCT00102960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93274787|NCT00102960|Antimetabolites|antimetabolites|mesh-ancestor
93274788|NCT00102960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93274789|NCT00102960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93274790|NCT00102960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93274791|NCT00102960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93274792|NCT00102960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93274793|NCT02858895|Interleukin-4|interleukin-4|mesh-list
93274794|NCT02858895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93274795|NCT02858895|Immunologic Factors|immunologic factors|mesh-ancestor
93274796|NCT02858895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274797|NCT02858895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274798|NCT02858895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93274799|NCT05018962|Paclitaxel|paclitaxel|mesh-list
93274800|NCT05018962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93274801|NCT05018962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274802|NCT05018962|Tubulin Modulators|tubulin modulators|mesh-ancestor
93274803|NCT05018962|Antimitotic Agents|antimitotic agents|mesh-ancestor
93274804|NCT05018962|Mitosis Modulators|mitosis modulators|mesh-ancestor
93274805|NCT05018962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274806|NCT02160054|Tacrolimus|tacrolimus|mesh-list
93274807|NCT02160054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274808|NCT02160054|Immunologic Factors|immunologic factors|mesh-ancestor
93274809|NCT02160054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274810|NCT02160054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93274811|NCT02160054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274812|NCT02160054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274813|NCT03609489|Capecitabine|capecitabine|mesh-list
93274814|NCT03609489|Apatinib|apatinib|mesh-list
93274815|NCT03609489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93274816|NCT03609489|Antimetabolites|antimetabolites|mesh-ancestor
93274817|NCT03609489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274818|NCT03609489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274819|NCT03609489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93274820|NCT03609489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274821|NCT02033967|Milrinone|milrinone|mesh-list
93274822|NCT02033967|Vasodilator Agents|vasodilator agents|mesh-list
93274823|NCT02033967|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93274824|NCT02033967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93274825|NCT02033967|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93274826|NCT02033967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93274827|NCT02033967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274828|NCT02033967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274829|NCT02033967|Protective Agents|protective agents|mesh-ancestor
93274830|NCT02033967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274831|NCT02163330|Acetazolamide|acetazolamide|mesh-list
93274832|NCT02163330|Anticonvulsants|anticonvulsants|mesh-ancestor
93274833|NCT02163330|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93274834|NCT02163330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274835|NCT02163330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274836|NCT02163330|Diuretics|diuretics|mesh-ancestor
93274837|NCT02163330|Natriuretic Agents|natriuretic agents|mesh-ancestor
93274838|NCT02163330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274839|NCT03610035|Immunoglobulins|immunoglobulins|mesh-list
93274840|NCT03610035|Immunoglobulin G|immunoglobulin g|mesh-list
93274841|NCT03610035|Immunologic Factors|immunologic factors|mesh-ancestor
93274842|NCT03610035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274843|NCT02160132|Methylprednisolone|methylprednisolone|mesh-list
93274844|NCT02160132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93274845|NCT02160132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93274846|NCT02160132|Prednisolone|prednisolone|mesh-list
93274847|NCT02160132|Prednisolone acetate|prednisolone acetate|mesh-list
93274848|NCT02160132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93274849|NCT02160132|Prednisolone phosphate|prednisolone phosphate|mesh-list
93274850|NCT02160132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93274851|NCT02160132|Antiemetics|antiemetics|mesh-ancestor
93274852|NCT02160132|Autonomic Agents|autonomic agents|mesh-ancestor
93274853|NCT02160132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274854|NCT02160132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274855|NCT02160132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274856|NCT02160132|Glucocorticoids|glucocorticoids|mesh-ancestor
93274857|NCT02160132|Hormones|hormones|mesh-ancestor
93274858|NCT02160132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93274859|NCT02160132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93274860|NCT02160132|Protective Agents|protective agents|mesh-ancestor
92569458|NCT00084708|Vitamins|vitamins|mesh-ancestor
93274861|NCT02160132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93274862|NCT02160132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274863|NCT02034201|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93274864|NCT02034201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93274865|NCT02034201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274866|NCT02034201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93274867|NCT02034201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93274868|NCT02034201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93274869|NCT02034201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274870|NCT02034201|Dopamine Agents|dopamine agents|mesh-ancestor
93274871|NCT02034201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274872|NCT02637856|Ocrelizumab|ocrelizumab|mesh-list
93274873|NCT02637856|Immunologic Factors|immunologic factors|mesh-ancestor
93274874|NCT02637856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274875|NCT02858037|Dapivirine|dapivirine|mesh-list
93274876|NCT02858037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93274877|NCT02858037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93274878|NCT02858037|Antiviral Agents|antiviral agents|mesh-ancestor
93274879|NCT02858037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274880|NCT01755975|Lenalidomide|lenalidomide|mesh-list
93274881|NCT01755975|Romidepsin|romidepsin|mesh-list
93274882|NCT01755975|Immunologic Factors|immunologic factors|mesh-ancestor
93274883|NCT01755975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274884|NCT01755975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93274885|NCT01755975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93274886|NCT01755975|Growth Substances|growth substances|mesh-ancestor
93274887|NCT01755975|Growth Inhibitors|growth inhibitors|mesh-ancestor
93274888|NCT01755975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946907|NCT00894634|Histamine Antagonists|histamine antagonists|mesh-ancestor
93274889|NCT01755975|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93274890|NCT01755975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93274891|NCT01755975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274892|NCT01755975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274893|NCT01541709|Imatinib Mesylate|imatinib mesylate|mesh-list
93274894|NCT01541709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274895|NCT01541709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93274896|NCT01541709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274897|NCT01541709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274898|NCT04266340|Midazolam|midazolam|mesh-list
93274899|NCT04266340|Dexmedetomidine|dexmedetomidine|mesh-list
93274900|NCT04266340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93274901|NCT04266340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274902|NCT04266340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274903|NCT04266340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93274904|NCT04266340|Analgesics|analgesics|mesh-ancestor
93274905|NCT04266340|Sensory System Agents|sensory system agents|mesh-ancestor
93274906|NCT04266340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274907|NCT04266340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93274908|NCT04266340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93274909|NCT04266340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93274910|NCT04266340|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274911|NCT04266340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274912|NCT04266340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274913|NCT04266340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93274914|NCT04266340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93274915|NCT04266340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93274916|NCT04266340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93274917|NCT04266340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93274918|NCT04266340|Anesthetics, General|anesthetics, general|mesh-ancestor
93274919|NCT04266340|Anesthetics|anesthetics|mesh-ancestor
93274920|NCT04266340|GABA Modulators|gaba modulators|mesh-ancestor
93274921|NCT04266340|GABA Agents|gaba agents|mesh-ancestor
93274922|NCT02856555|Firsocostat|firsocostat|mesh-list
93274923|NCT02856555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274924|NCT02856555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274925|NCT03609099|Moxifloxacin|moxifloxacin|mesh-list
93274926|NCT03609099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569483|NCT00060905|Valproic Acid|valproic acid|mesh-list
93274927|NCT03609099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274928|NCT03609099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93274929|NCT03609099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93274930|NCT03609099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93274931|NCT03609099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274932|NCT03609099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274933|NCT05000086|Diphosphonates|diphosphonates|mesh-list
93274934|NCT05000086|Methylene diphosphonate|methylene diphosphonate|mesh-list
93274935|NCT05000086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93274936|NCT05000086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274937|NCT05010538|Sarecycline|sarecycline|mesh-list
93274938|NCT05010538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274939|NCT05010538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274940|NCT05010538|Dermatologic Agents|dermatologic agents|mesh-ancestor
93274941|NCT01242267|Thalidomide|thalidomide|mesh-list
93274942|NCT01242267|Bortezomib|bortezomib|mesh-list
93274943|NCT01242267|Melphalan|melphalan|mesh-list
93274944|NCT01242267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93274945|NCT01242267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93274946|NCT01242267|Alkylating Agents|alkylating agents|mesh-ancestor
93274947|NCT01242267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274948|NCT01242267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93274949|NCT01242267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93274950|NCT01242267|Immunologic Factors|immunologic factors|mesh-ancestor
93274951|NCT01242267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274952|NCT01242267|Leprostatic Agents|leprostatic agents|mesh-ancestor
93274953|NCT01242267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274954|NCT01242267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274955|NCT01242267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93274956|NCT01242267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93274957|NCT01242267|Growth Substances|growth substances|mesh-ancestor
93274958|NCT01242267|Growth Inhibitors|growth inhibitors|mesh-ancestor
93274959|NCT02637232|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93274960|NCT02637232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93274961|NCT02637232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93274962|NCT02637232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93274963|NCT02637232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93274964|NCT02637232|Adrenergic Agents|adrenergic agents|mesh-ancestor
93274965|NCT02637232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274966|NCT02637232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274967|NCT02637232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274969|NCT02635984|Antiemetics|antiemetics|mesh-ancestor
93274970|NCT02635984|Autonomic Agents|autonomic agents|mesh-ancestor
93274971|NCT02635984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93274972|NCT02635984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274973|NCT02635984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93274974|NCT02635984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93274975|NCT02635984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93274976|NCT02635984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274977|NCT02635984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93274978|NCT02635984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93274979|NCT02635984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93274980|NCT02635984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93274981|NCT02635984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93274982|NCT02635984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93274983|NCT02635984|Serotonin Agents|serotonin agents|mesh-ancestor
93274984|NCT03073408|Propofol|propofol|mesh-list
93274985|NCT03073408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93274986|NCT03073408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93274987|NCT03073408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93274988|NCT03073408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93274989|NCT03073408|Anesthetics, General|anesthetics, general|mesh-ancestor
93274990|NCT03073408|Anesthetics|anesthetics|mesh-ancestor
93274991|NCT04993222|Amphotericin B|amphotericin b|mesh-list
93274992|NCT04993222|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93274993|NCT04993222|Amebicides|amebicides|mesh-ancestor
93274994|NCT04993222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93274995|NCT04993222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93274996|NCT04993222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93274997|NCT04993222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93274998|NCT04993222|Antifungal Agents|antifungal agents|mesh-ancestor
93274999|NCT03076762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93275000|NCT03076762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93275001|NCT03076762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93275002|NCT03076762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275003|NCT03076762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275004|NCT03076762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93275005|NCT03076762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275006|NCT03076762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275007|NCT03076762|Cholinergic Agents|cholinergic agents|mesh-ancestor
93275008|NCT03076762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275009|NCT02747043|Rituximab|rituximab|mesh-list
93275010|NCT02747043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93275011|NCT02747043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275012|NCT02747043|Immunologic Factors|immunologic factors|mesh-ancestor
93275013|NCT02747043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275014|NCT02747043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275015|NCT05004142|Letrozole|letrozole|mesh-list
93275016|NCT05004142|Fulvestrant|fulvestrant|mesh-list
93275017|NCT05004142|Goserelin|goserelin|mesh-list
93275018|NCT05004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275019|NCT05004142|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93275020|NCT05004142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93275021|NCT05004142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275022|NCT05004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275023|NCT05004142|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93275024|NCT05004142|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275025|NCT05004142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275026|NCT05004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275027|NCT05004142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275028|NCT05004142|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93275029|NCT03076684|Allopurinol|allopurinol|mesh-list
93275030|NCT03076684|Antimetabolites|antimetabolites|mesh-ancestor
93275031|NCT03076684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275032|NCT03076684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275033|NCT03076684|Gout Suppressants|gout suppressants|mesh-ancestor
93275034|NCT03076684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275035|NCT03076684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93275036|NCT03076684|Antioxidants|antioxidants|mesh-ancestor
93275037|NCT03076684|Protective Agents|protective agents|mesh-ancestor
93275038|NCT03076684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275040|NCT04999930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93275041|NCT04999930|Autonomic Agents|autonomic agents|mesh-ancestor
93275042|NCT04999930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275043|NCT04999930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275044|NCT04999930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93275045|NCT04999930|Respiratory System Agents|respiratory system agents|mesh-ancestor
93275046|NCT04999930|Parasympatholytics|parasympatholytics|mesh-ancestor
93275047|NCT04999930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93275048|NCT04999930|Cholinergic Agents|cholinergic agents|mesh-ancestor
93275049|NCT04999930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275050|NCT04999930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275051|NCT03607851|Lacosamide|lacosamide|mesh-list
93275052|NCT03607851|Anticonvulsants|anticonvulsants|mesh-ancestor
93275053|NCT03607851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93275054|NCT03607851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93275055|NCT03607851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275056|NCT03607851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275057|NCT04999540|Fulvestrant|fulvestrant|mesh-list
93275058|NCT04999540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275059|NCT04999540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275060|NCT04999540|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93275061|NCT04999540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93275062|NCT04999540|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275063|NCT04999540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275064|NCT04999540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275065|NCT03608007|Ensartinib|ensartinib|mesh-list
93275066|NCT03608007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275067|NCT03608007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93275068|NCT03608007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275069|NCT03608007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275070|NCT02637076|Sodium Oxybate|sodium oxybate|mesh-list
93275071|NCT02637076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93275072|NCT02637076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93275073|NCT02637076|Anesthetics, General|anesthetics, general|mesh-ancestor
93275074|NCT02637076|Anesthetics|anesthetics|mesh-ancestor
93275075|NCT02637076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275076|NCT02637076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275077|NCT03075358|Lidocaine|lidocaine|mesh-list
93275078|NCT03075358|Anesthetics, Local|anesthetics, local|mesh-ancestor
93275079|NCT03075358|Anesthetics|anesthetics|mesh-ancestor
93275080|NCT03075358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275081|NCT03075358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275082|NCT03075358|Sensory System Agents|sensory system agents|mesh-ancestor
93275083|NCT03075358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275084|NCT03075358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275085|NCT03075358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93275086|NCT03075358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93275087|NCT03075358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275088|NCT03075358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275089|NCT05003596|Methylprednisolone|methylprednisolone|mesh-list
93275090|NCT05003596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93275091|NCT05003596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93275092|NCT05003596|Prednisolone|prednisolone|mesh-list
93275093|NCT05003596|Prednisolone acetate|prednisolone acetate|mesh-list
93275094|NCT05003596|Narcotics|narcotics|mesh-list
93275095|NCT05003596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93275096|NCT05003596|Prednisolone phosphate|prednisolone phosphate|mesh-list
93275097|NCT05003596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275098|NCT05003596|Antiemetics|antiemetics|mesh-ancestor
93275099|NCT05003596|Autonomic Agents|autonomic agents|mesh-ancestor
93275100|NCT05003596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275101|NCT05003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275102|NCT05003596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275103|NCT05003596|Glucocorticoids|glucocorticoids|mesh-ancestor
93275104|NCT05003596|Hormones|hormones|mesh-ancestor
93275105|NCT05003596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275106|NCT05003596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93275107|NCT05003596|Protective Agents|protective agents|mesh-ancestor
93275108|NCT05003596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275109|NCT05003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275110|NCT05003596|Analgesics|analgesics|mesh-ancestor
93275111|NCT05003596|Sensory System Agents|sensory system agents|mesh-ancestor
93275112|NCT05003596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275113|NCT02854527|Metformin|metformin|mesh-list
93275114|NCT02854527|Digoxin|digoxin|mesh-list
93275115|NCT02854527|Furosemide|furosemide|mesh-list
93275116|NCT02854527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93275117|NCT02854527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275118|NCT02854527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275119|NCT02854527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93275120|NCT02854527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93275121|NCT02854527|Antimetabolites|antimetabolites|mesh-ancestor
93275122|NCT02854527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275123|NCT02854527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93275124|NCT02854527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93275125|NCT02854527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275126|NCT02854527|Diuretics|diuretics|mesh-ancestor
93275127|NCT02854527|Natriuretic Agents|natriuretic agents|mesh-ancestor
93275128|NCT02854527|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93275129|NCT02854527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275130|NCT02854527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275131|NCT02854527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93275132|NCT02854527|Protective Agents|protective agents|mesh-ancestor
93275133|NCT04433572|Sirolimus|sirolimus|mesh-list
93275134|NCT04433572|Temsirolimus|temsirolimus|mesh-list
93275135|NCT04433572|MTOR Inhibitors|mtor inhibitors|mesh-list
93275136|NCT04433572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93275137|NCT04433572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275138|NCT04433572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275139|NCT04433572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93275140|NCT04433572|Immunologic Factors|immunologic factors|mesh-ancestor
93275141|NCT04433572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275142|NCT04433572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275143|NCT04433572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275144|NCT04433572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275145|NCT04433572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93275146|NCT04433572|Antifungal Agents|antifungal agents|mesh-ancestor
93275147|NCT03073018|Fosinopril|fosinopril|mesh-list
93275148|NCT03073018|Pravastatin|pravastatin|mesh-list
93275149|NCT03073018|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93275150|NCT03073018|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93275151|NCT03073018|Antimetabolites|antimetabolites|mesh-ancestor
93275152|NCT03073018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275153|NCT03073018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93275154|NCT03073018|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93275155|NCT03073018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275156|NCT03073018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93275157|NCT03073018|Protease Inhibitors|protease inhibitors|mesh-ancestor
93275158|NCT03073018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93275159|NCT03608241|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93275160|NCT03608241|Contraceptive Agents|contraceptive agents|mesh-list
93275161|NCT03608241|Contraceptives, Oral|contraceptives, oral|mesh-list
93275162|NCT03608241|Estradiol|estradiol|mesh-list
93275163|NCT03608241|Estrogens|estrogens|mesh-ancestor
93275164|NCT03608241|Hormones|hormones|mesh-ancestor
93275165|NCT03608241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275166|NCT03608241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275167|NCT03608241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93275168|NCT03608241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275169|NCT03608241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93275170|NCT03608241|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93275171|NCT03606057|Moxifloxacin|moxifloxacin|mesh-list
93275172|NCT03606057|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93275173|NCT03606057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275174|NCT03606057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275175|NCT03606057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275176|NCT03606057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275177|NCT03606057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275178|NCT03606057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275179|NCT03606057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275180|NCT03606057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93275181|NCT03606057|Contraceptive Agents|contraceptive agents|mesh-ancestor
93275182|NCT03606057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275183|NCT03606057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275184|NCT03606057|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93275185|NCT03606057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93275186|NCT03606057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93275188|NCT03607383|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93275189|NCT03607383|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93275190|NCT03607383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93275191|NCT03607383|Antimetabolites|antimetabolites|mesh-ancestor
93275192|NCT03607383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275193|NCT03607383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275194|NCT03607383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93275195|NCT03607227|Levobupivacaine|levobupivacaine|mesh-list
93275196|NCT03607227|Anesthetics, Local|anesthetics, local|mesh-ancestor
93275197|NCT03607227|Anesthetics|anesthetics|mesh-ancestor
92569770|NCT00200434|Nebivolol|nebivolol|mesh-list
93275198|NCT03607227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275199|NCT03607227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275200|NCT03607227|Sensory System Agents|sensory system agents|mesh-ancestor
93275201|NCT03607227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275202|NCT03607149|Pemetrexed|pemetrexed|mesh-list
93275203|NCT03607149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275204|NCT03607149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275205|NCT03607149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275206|NCT03607149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93275207|NCT03607149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93275208|NCT04998838|Tenofovir|tenofovir|mesh-list
93275209|NCT04998838|Immunoglobulins|immunoglobulins|mesh-list
93275210|NCT04998838|Antibodies|antibodies|mesh-list
93275211|NCT04998838|gamma-Globulins|gamma-globulins|mesh-list
93275212|NCT04998838|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93275213|NCT04998838|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93275214|NCT04998838|Antiviral Agents|antiviral agents|mesh-ancestor
93275215|NCT04998838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275216|NCT04998838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93275217|NCT04998838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93275218|NCT04998838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275219|NCT04998838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275220|NCT04998838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93275221|NCT04998838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93275222|NCT04998838|Immunologic Factors|immunologic factors|mesh-ancestor
93275223|NCT04998838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275224|NCT03607071|Prednisolone|prednisolone|mesh-list
93275225|NCT03607071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275226|NCT03607071|Glucocorticoids|glucocorticoids|mesh-ancestor
93275227|NCT03607071|Hormones|hormones|mesh-ancestor
93275228|NCT03607071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275229|NCT03607071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275230|NCT03607071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275231|NCT03607071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275232|NCT02035215|Atorvastatin|atorvastatin|mesh-list
93275233|NCT02035215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93275234|NCT02035215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93275235|NCT02035215|Antimetabolites|antimetabolites|mesh-ancestor
93275236|NCT02035215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275237|NCT02035215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93275238|NCT02035215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93275239|NCT02035215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275240|NCT03605589|Pembrolizumab|pembrolizumab|mesh-list
93275241|NCT03605589|Blinatumomab|blinatumomab|mesh-list
93275242|NCT03605589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93275243|NCT03605589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275244|NCT03605589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93275245|NCT03605589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275246|NCT05002270|Cetuximab|cetuximab|mesh-list
93275247|NCT05002270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93275248|NCT05002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275249|NCT05002036|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93275250|NCT05002036|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93275251|NCT03074968|Benzydamine|benzydamine|mesh-list
93275252|NCT03074968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275253|NCT04991584|Amoxicillin|amoxicillin|mesh-list
93275254|NCT04991584|Levofloxacin|levofloxacin|mesh-list
93275255|NCT04991584|Tetracycline|tetracycline|mesh-list
93275256|NCT04991584|Furazolidone|furazolidone|mesh-list
93275257|NCT04991584|Esomeprazole|esomeprazole|mesh-list
93275258|NCT04991584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275259|NCT04991584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275260|NCT04991584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93275261|NCT04991584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275262|NCT04991584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93275263|NCT04991584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275264|NCT04991584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275265|NCT04991584|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93275266|NCT04991584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275267|NCT04991584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275268|NCT04991584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275269|NCT04991584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93275270|NCT04991584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93275271|NCT04991584|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93275272|NCT04991584|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93275273|NCT04991584|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93275274|NCT04991584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93275275|NCT04991584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93275276|NCT04991584|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93275277|NCT05001412|Carboplatin|carboplatin|mesh-list
93275278|NCT05001412|Etoposide|etoposide|mesh-list
93275279|NCT05001412|Apatinib|apatinib|mesh-list
93275280|NCT05001412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275281|NCT05001412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93275282|NCT05001412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275283|NCT05001412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275284|NCT05001412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275285|NCT05001412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275286|NCT05001412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93275287|NCT04991896|Metoprolol|metoprolol|mesh-list
93275288|NCT04991896|Sotalol|sotalol|mesh-list
93275289|NCT04991896|Flecainide|flecainide|mesh-list
93275290|NCT04991896|Bisoprolol|bisoprolol|mesh-list
93275291|NCT04991896|Betaxolol|betaxolol|mesh-list
93275292|NCT04991896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275293|NCT04991896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93275294|NCT04991896|Sympatholytics|sympatholytics|mesh-ancestor
93275295|NCT04991896|Autonomic Agents|autonomic agents|mesh-ancestor
93275296|NCT04991896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275297|NCT04991896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275298|NCT04991896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93275299|NCT04991896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93275300|NCT04991896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93275301|NCT04991896|Adrenergic Agents|adrenergic agents|mesh-ancestor
93275302|NCT04991896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275303|NCT04991896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275304|NCT04991896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93275305|NCT04991896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93275306|NCT04991896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275307|NCT03072394|Lidocaine|lidocaine|mesh-list
93275308|NCT03072394|Anesthetics, Local|anesthetics, local|mesh-list
93275309|NCT03072394|Anesthetics|anesthetics|mesh-list
93275310|NCT03072394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275311|NCT03072394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275312|NCT03072394|Sensory System Agents|sensory system agents|mesh-ancestor
93275313|NCT03072394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275314|NCT03072394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275315|NCT03072394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93275316|NCT03072394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93275317|NCT03072394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275318|NCT03072394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275319|NCT03072082|Aspirin|aspirin|mesh-list
93275320|NCT03072082|Metoprolol|metoprolol|mesh-list
93275321|NCT03072082|Isosorbide|isosorbide|mesh-list
93275322|NCT03072082|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93275323|NCT03072082|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93275324|NCT03072082|Trimetazidine|trimetazidine|mesh-list
93275325|NCT03072082|Clopidogrel|clopidogrel|mesh-list
93275326|NCT03072082|Atorvastatin|atorvastatin|mesh-list
93275327|NCT03072082|Calcium|calcium|mesh-list
93275328|NCT03072082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93275329|NCT03072082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275330|NCT03072082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93275331|NCT03072082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93275332|NCT03072082|Analgesics|analgesics|mesh-ancestor
93275333|NCT03072082|Sensory System Agents|sensory system agents|mesh-ancestor
93275334|NCT03072082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275335|NCT03072082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275336|NCT03072082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275337|NCT03072082|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93275338|NCT03072082|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93275339|NCT03072082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275340|NCT03072082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93275341|NCT03072082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93275342|NCT03072082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275343|NCT03072082|Antipyretics|antipyretics|mesh-ancestor
93275344|NCT03072082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93275345|NCT03072082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93275346|NCT03072082|Antimetabolites|antimetabolites|mesh-ancestor
93275347|NCT03072082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93275348|NCT03072082|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93275349|NCT03072082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93275350|NCT03072082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93275351|NCT03072082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93275352|NCT03072082|Purinergic Agents|purinergic agents|mesh-ancestor
93275353|NCT03072082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275354|NCT03072082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275355|NCT03072082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93275356|NCT03072082|Sympatholytics|sympatholytics|mesh-ancestor
93275357|NCT03072082|Autonomic Agents|autonomic agents|mesh-ancestor
93275358|NCT03072082|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93275359|NCT03072082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93275360|NCT03072082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93275361|NCT03072082|Adrenergic Agents|adrenergic agents|mesh-ancestor
93275362|NCT03072082|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93275363|NCT03072082|Diuretics|diuretics|mesh-ancestor
93275364|NCT03072082|Natriuretic Agents|natriuretic agents|mesh-ancestor
93275365|NCT03072082|Vasodilator Agents|vasodilator agents|mesh-ancestor
93275366|NCT03072082|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93275367|NCT04934020|Metronidazole|metronidazole|mesh-list
93275368|NCT04934020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275369|NCT04934020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275370|NCT04934020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93275371|NCT04934020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93275372|NCT04904614|Letermovir|letermovir|mesh-list
93275373|NCT04904614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93275374|NCT04904614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275375|NCT04904614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275376|NCT04904614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275377|NCT04904614|Antiviral Agents|antiviral agents|mesh-ancestor
93275378|NCT04904614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275379|NCT04987450|Prednisone|prednisone|mesh-list
93275380|NCT04987450|Methylprednisolone|methylprednisolone|mesh-list
93275381|NCT04987450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93275382|NCT04987450|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93275383|NCT04987450|Prednisolone|prednisolone|mesh-list
93275384|NCT04987450|Prednisolone acetate|prednisolone acetate|mesh-list
93275385|NCT04987450|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93275386|NCT04987450|Prednisolone phosphate|prednisolone phosphate|mesh-list
93275387|NCT04987450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275388|NCT04987450|Glucocorticoids|glucocorticoids|mesh-ancestor
93275389|NCT04987450|Hormones|hormones|mesh-ancestor
93275390|NCT04987450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275391|NCT04987450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275392|NCT04987450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275393|NCT04987450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275394|NCT04987450|Antiemetics|antiemetics|mesh-ancestor
93275395|NCT04987450|Autonomic Agents|autonomic agents|mesh-ancestor
93275396|NCT04987450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275397|NCT04987450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275398|NCT04987450|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93275399|NCT04987450|Protective Agents|protective agents|mesh-ancestor
93275400|NCT03074578|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93275401|NCT03074578|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93275402|NCT03074578|beta-Endorphin|beta-endorphin|mesh-list
93275403|NCT03074578|Hormones|hormones|mesh-ancestor
93275404|NCT03074578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275405|NCT03074578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275406|NCT03074578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275407|NCT03074578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275408|NCT04991194|Zamicastat|zamicastat|mesh-list
93275409|NCT04991194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275410|NCT04991194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275411|NCT02853435|Gepotidacin|gepotidacin|mesh-list
93275412|NCT02853435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275413|NCT02853435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275414|NCT02853435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275415|NCT02853435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275416|NCT03071770|Ivosidenib|ivosidenib|mesh-list
93275417|NCT03071770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275418|NCT03071770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275419|NCT03071770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275420|NCT04986982|Opicapone|opicapone|mesh-list
93275421|NCT04986982|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93275422|NCT04986982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275423|NCT04986982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275424|NCT04986982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93275425|NCT04986982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93275426|NCT04996498|Oxytocin|oxytocin|mesh-list
93275427|NCT04996498|Oxytocics|oxytocics|mesh-ancestor
93275428|NCT04996498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275429|NCT04996498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275430|NCT03074344|Hyaluronic Acid|hyaluronic acid|mesh-list
93275431|NCT03074344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93275432|NCT03074344|Immunologic Factors|immunologic factors|mesh-ancestor
93275433|NCT03074344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275434|NCT03074344|Viscosupplements|viscosupplements|mesh-ancestor
93275435|NCT03074344|Protective Agents|protective agents|mesh-ancestor
93275436|NCT03605511|Complement System Proteins|complement system proteins|mesh-list
93275437|NCT03605511|Immunologic Factors|immunologic factors|mesh-ancestor
93275438|NCT03605511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275439|NCT02035371|Insulin|insulin|mesh-list
93275440|NCT02035371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93275441|NCT02035371|Insulin Aspart|insulin aspart|mesh-list
93275442|NCT02035371|Insulin, Long-Acting|insulin, long-acting|mesh-list
93275443|NCT02035371|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93275444|NCT02035371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275445|NCT02035371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275446|NCT03069820|Docetaxel|docetaxel|mesh-list
93275447|NCT03069820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275448|NCT03069820|Tubulin Modulators|tubulin modulators|mesh-ancestor
93275449|NCT03069820|Antimitotic Agents|antimitotic agents|mesh-ancestor
93275450|NCT03069820|Mitosis Modulators|mitosis modulators|mesh-ancestor
93275451|NCT03069820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275452|NCT03605433|Rivaroxaban|rivaroxaban|mesh-list
93275453|NCT03605433|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93275454|NCT03605433|Antithrombins|antithrombins|mesh-ancestor
93275455|NCT03605433|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93275456|NCT03605433|Protease Inhibitors|protease inhibitors|mesh-ancestor
93275457|NCT03605433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275458|NCT03605433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275459|NCT03605433|Anticoagulants|anticoagulants|mesh-ancestor
93275460|NCT03071302|Tissue Inhibitor of Metalloproteinase-3|tissue inhibitor of metalloproteinase-3|mesh-list
93275461|NCT03071302|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
93275462|NCT03071302|Protease Inhibitors|protease inhibitors|mesh-ancestor
93275463|NCT03071302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275464|NCT03071302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275465|NCT03270501|Golimumab|golimumab|mesh-list
93275466|NCT03270501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93275467|NCT03270501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275468|NCT03270501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93275469|NCT03270501|Immunologic Factors|immunologic factors|mesh-ancestor
93275470|NCT03270501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275471|NCT03606681|Calcium, Dietary|calcium, dietary|mesh-list
93275472|NCT03606681|Calcium|calcium|mesh-list
93275473|NCT03606681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93275474|NCT03606681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275475|NCT03606681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93275476|NCT03071380|Rivaroxaban|rivaroxaban|mesh-list
93275477|NCT03071380|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93275478|NCT03071380|Antithrombins|antithrombins|mesh-ancestor
93275479|NCT03071380|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93275480|NCT03071380|Protease Inhibitors|protease inhibitors|mesh-ancestor
93275481|NCT03071380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275482|NCT03071380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275483|NCT03071380|Anticoagulants|anticoagulants|mesh-ancestor
93275484|NCT03605199|Denosumab|denosumab|mesh-list
93275485|NCT03605199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93275486|NCT03605199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275487|NCT03606369|Ondansetron|ondansetron|mesh-list
93275488|NCT03606369|Palonosetron|palonosetron|mesh-list
93275489|NCT03606369|Antiemetics|antiemetics|mesh-ancestor
93275490|NCT03606369|Autonomic Agents|autonomic agents|mesh-ancestor
93275491|NCT03606369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275492|NCT03606369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275493|NCT03606369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275494|NCT03606369|Antipruritics|antipruritics|mesh-ancestor
93275495|NCT03606369|Dermatologic Agents|dermatologic agents|mesh-ancestor
93275496|NCT03606369|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93275497|NCT03606369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93275498|NCT03606369|Serotonin Agents|serotonin agents|mesh-ancestor
93275499|NCT03606369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275500|NCT03606369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275501|NCT02635204|Clobetasol|clobetasol|mesh-list
93275502|NCT02635204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275503|NCT02635204|Glucocorticoids|glucocorticoids|mesh-ancestor
93275504|NCT02635204|Hormones|hormones|mesh-ancestor
93275505|NCT02635204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275506|NCT02635204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275507|NCT00102804|Pemetrexed|pemetrexed|mesh-list
93275508|NCT00102804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275509|NCT00102804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275510|NCT00102804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275511|NCT00102804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93275512|NCT00102804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93275513|NCT03038113|Immunomodulating Agents|immunomodulating agents|mesh-list
93275514|NCT03038113|Immunologic Factors|immunologic factors|mesh-ancestor
93275515|NCT03038113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275516|NCT02163720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93275517|NCT02163720|Doxorubicin|doxorubicin|mesh-list
93275518|NCT02163720|Trabectedin|trabectedin|mesh-list
93275519|NCT02163720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93275520|NCT02163720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275521|NCT02163720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275522|NCT02163720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275523|NCT02163720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275524|NCT02163720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275525|NCT02163720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93275526|NCT02163720|Alkylating Agents|alkylating agents|mesh-ancestor
93275527|NCT03487874|Ropivacaine|ropivacaine|mesh-list
93275528|NCT03487874|Anesthetics, Local|anesthetics, local|mesh-ancestor
93275529|NCT03487874|Anesthetics|anesthetics|mesh-ancestor
93275530|NCT03487874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275531|NCT03487874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275532|NCT03487874|Sensory System Agents|sensory system agents|mesh-ancestor
93275533|NCT03487874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275534|NCT04989400|Misoprostol|misoprostol|mesh-list
93275535|NCT04989400|Ulipristal acetate|ulipristal acetate|mesh-list
93275536|NCT04989400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93275537|NCT04989400|Abortifacient Agents|abortifacient agents|mesh-ancestor
93275538|NCT04989400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275539|NCT04989400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275540|NCT04989400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93275541|NCT04989400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275542|NCT04989400|Oxytocics|oxytocics|mesh-ancestor
93275543|NCT04989400|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93275544|NCT04989400|Contraceptive Agents|contraceptive agents|mesh-ancestor
93275545|NCT04989400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93275546|NCT02163954|Clopidogrel|clopidogrel|mesh-list
93275547|NCT02163954|Ticagrelor|ticagrelor|mesh-list
93275548|NCT02163954|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93275549|NCT02163954|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93275550|NCT02163954|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93275551|NCT02163954|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93275552|NCT02163954|Purinergic Agents|purinergic agents|mesh-ancestor
93275553|NCT02163954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275554|NCT02163954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275555|NCT02163954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275556|NCT04985656|Decitabine|decitabine|mesh-list
93275557|NCT04985656|Pevonedistat|pevonedistat|mesh-list
93275558|NCT04985656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92947636|NCT04035070|Eusol|eusol|mesh-list
93275559|NCT04985656|Antimetabolites|antimetabolites|mesh-ancestor
93275560|NCT04985656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275561|NCT04985656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275562|NCT04985656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275563|NCT02164032|Insulin|insulin|mesh-list
93275564|NCT02164032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93275565|NCT02164032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275566|NCT02164032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275567|NCT04682288|Levofloxacin|levofloxacin|mesh-list
93275568|NCT04682288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93275569|NCT04682288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275570|NCT04682288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275571|NCT04682288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275572|NCT04682288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275573|NCT04682288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275574|NCT04682288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275575|NCT04682288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275576|NCT04682288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93275577|NCT04682288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93275578|NCT00968149|Montelukast|montelukast|mesh-list
93275579|NCT00968149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93275580|NCT00968149|Respiratory System Agents|respiratory system agents|mesh-ancestor
93275581|NCT00968149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93275582|NCT00968149|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275583|NCT00968149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275584|NCT00968149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275585|NCT00968149|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93275586|NCT00968149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93275587|NCT00968149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275588|NCT04985344|Propranolol|propranolol|mesh-list
93275589|NCT04985344|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93275590|NCT04985344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93275591|NCT04985344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93275592|NCT04985344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275593|NCT04985344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275594|NCT04985344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275595|NCT04985344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275596|NCT04985344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93275597|NCT04985344|Vasodilator Agents|vasodilator agents|mesh-ancestor
93275598|NCT02164110|Vaccines|vaccines|mesh-list
93275599|NCT02164110|Immunologic Factors|immunologic factors|mesh-ancestor
93275600|NCT02164110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275601|NCT02167464|Coal Tar|coal tar|mesh-list
93275602|NCT02167464|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
93275603|NCT02167464|Keratolytic Agents|keratolytic agents|mesh-ancestor
93275604|NCT02167464|Dermatologic Agents|dermatologic agents|mesh-ancestor
93275605|NCT02167464|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275606|NCT02167464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275607|NCT02167464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275608|NCT02167464|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93275609|NCT02167464|Diuretics|diuretics|mesh-ancestor
93275610|NCT02167464|Natriuretic Agents|natriuretic agents|mesh-ancestor
93275611|NCT03485456|Tobramycin|tobramycin|mesh-list
93275612|NCT03485456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275613|NCT03485456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275614|NCT03487562|Amoxicillin|amoxicillin|mesh-list
93275615|NCT03487562|Clarithromycin|clarithromycin|mesh-list
93275616|NCT03487562|Lansoprazole|lansoprazole|mesh-list
93275617|NCT03487562|Dexlansoprazole|dexlansoprazole|mesh-list
93275618|NCT03487562|Fexuprazan|fexuprazan|mesh-list
93275619|NCT03487562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275620|NCT03487562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275621|NCT03487562|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93275622|NCT03487562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275623|NCT03487562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275624|NCT03487562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93275625|NCT03487562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93275626|NCT03487562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93275627|NCT03487562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275628|NCT03487562|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93275629|NCT03719924|Paclitaxel|paclitaxel|mesh-list
93275630|NCT03719924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93275631|NCT03719924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275632|NCT03719924|Tubulin Modulators|tubulin modulators|mesh-ancestor
93275633|NCT03719924|Antimitotic Agents|antimitotic agents|mesh-ancestor
93275634|NCT03719924|Mitosis Modulators|mitosis modulators|mesh-ancestor
93275635|NCT03719924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275636|NCT02167620|Metformin|metformin|mesh-list
93275637|NCT02167620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275638|NCT02167620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275639|NCT03485300|Warfarin|warfarin|mesh-list
93275640|NCT03485300|Anticoagulants|anticoagulants|mesh-ancestor
93275641|NCT00963469|Loratadine|loratadine|mesh-list
93275642|NCT00963469|Montelukast|montelukast|mesh-list
93275643|NCT00963469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93275644|NCT00963469|Respiratory System Agents|respiratory system agents|mesh-ancestor
93275645|NCT00963469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93275646|NCT00963469|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275647|NCT00963469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275648|NCT00963469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275649|NCT00963469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93275650|NCT00963469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93275651|NCT00963469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275652|NCT00963469|Antipruritics|antipruritics|mesh-ancestor
93275653|NCT00963469|Dermatologic Agents|dermatologic agents|mesh-ancestor
93275654|NCT00963469|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93275655|NCT00963469|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93275656|NCT00963469|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93275657|NCT00963469|Histamine Antagonists|histamine antagonists|mesh-ancestor
93275658|NCT00963469|Histamine Agents|histamine agents|mesh-ancestor
93275659|NCT00963469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275660|NCT00897949|Rizatriptan|rizatriptan|mesh-list
93275661|NCT00897949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93275662|NCT00897949|Serotonin Agents|serotonin agents|mesh-ancestor
93275663|NCT00897949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275664|NCT00897949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275665|NCT00897949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275666|NCT05119855|Vaccines|vaccines|mesh-list
93275667|NCT05119855|Immunologic Factors|immunologic factors|mesh-ancestor
93275668|NCT05119855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275669|NCT04741945|Metformin|metformin|mesh-list
93275670|NCT04741945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275671|NCT04741945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275672|NCT03487406|Aspirin|aspirin|mesh-list
93275673|NCT03487406|Ticagrelor|ticagrelor|mesh-list
93275674|NCT03487406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93275675|NCT03487406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93275676|NCT03487406|Analgesics|analgesics|mesh-ancestor
93275677|NCT03487406|Sensory System Agents|sensory system agents|mesh-ancestor
93275678|NCT03487406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275679|NCT03487406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275680|NCT03487406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275681|NCT03487406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275682|NCT03487406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93275683|NCT03487406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93275684|NCT03487406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275685|NCT03487406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93275686|NCT03487406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93275687|NCT03487406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275688|NCT03487406|Antipyretics|antipyretics|mesh-ancestor
93275689|NCT03487406|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93275690|NCT03487406|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93275691|NCT03487406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93275692|NCT03487406|Purinergic Agents|purinergic agents|mesh-ancestor
93275693|NCT03487406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275694|NCT00725491|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93275695|NCT00725491|Ganirelix|ganirelix|mesh-list
93275696|NCT00725491|Luteolytic Agents|luteolytic agents|mesh-ancestor
93275697|NCT00725491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93275698|NCT00725491|Contraceptive Agents|contraceptive agents|mesh-ancestor
93275699|NCT00725491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275700|NCT00725491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275701|NCT00725491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93275702|NCT00725491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275703|NCT00725491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275704|NCT00725491|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275705|NCT00725491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275706|NCT00724789|Ganirelix|ganirelix|mesh-list
93275707|NCT00724789|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275708|NCT00724789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275709|NCT00724789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275710|NCT00711607|Estradiol|estradiol|mesh-list
93275711|NCT00711607|Estrogens|estrogens|mesh-ancestor
93275712|NCT00711607|Hormones|hormones|mesh-ancestor
93275713|NCT00711607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275714|NCT00711607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275715|NCT02164578|Aspirin|aspirin|mesh-list
93275716|NCT02164578|Rivaroxaban|rivaroxaban|mesh-list
93275717|NCT02164578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93275718|NCT02164578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93275719|NCT02164578|Analgesics|analgesics|mesh-ancestor
93275720|NCT02164578|Sensory System Agents|sensory system agents|mesh-ancestor
93275721|NCT02164578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275722|NCT02164578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275723|NCT02164578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275724|NCT02164578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275725|NCT02164578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93275726|NCT02164578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93275727|NCT02164578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275728|NCT02164578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93275729|NCT02164578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93275730|NCT02164578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275731|NCT02164578|Antipyretics|antipyretics|mesh-ancestor
93275732|NCT02164578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93275733|NCT02164578|Antithrombins|antithrombins|mesh-ancestor
93275734|NCT02164578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93275735|NCT02164578|Protease Inhibitors|protease inhibitors|mesh-ancestor
93275736|NCT02164578|Anticoagulants|anticoagulants|mesh-ancestor
93275737|NCT03893318|Lidocaine|lidocaine|mesh-list
93275738|NCT03893318|Anesthetics, Local|anesthetics, local|mesh-ancestor
93275739|NCT03893318|Anesthetics|anesthetics|mesh-ancestor
93275740|NCT03893318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275741|NCT03893318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275742|NCT03893318|Sensory System Agents|sensory system agents|mesh-ancestor
93275743|NCT03893318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275744|NCT03893318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275745|NCT03893318|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93275746|NCT03893318|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93275747|NCT03893318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275748|NCT03893318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275749|NCT03625531|Letrozole|letrozole|mesh-list
93275750|NCT03625531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275751|NCT03625531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93275752|NCT03625531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93275753|NCT03625531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275754|NCT03625531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275755|NCT03625531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93275756|NCT03625531|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275757|NCT03625531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275758|NCT03625531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275759|NCT02167698|Methylprednisolone|methylprednisolone|mesh-list
93275760|NCT02167698|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93275761|NCT02167698|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93275762|NCT02167698|Prednisolone|prednisolone|mesh-list
93275763|NCT02167698|Prednisolone acetate|prednisolone acetate|mesh-list
93275764|NCT02167698|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93275765|NCT02167698|Prednisolone phosphate|prednisolone phosphate|mesh-list
93275766|NCT02167698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93275767|NCT02167698|Antiemetics|antiemetics|mesh-ancestor
93275768|NCT02167698|Autonomic Agents|autonomic agents|mesh-ancestor
93275769|NCT02167698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275770|NCT02167698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275771|NCT02167698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93275772|NCT02167698|Glucocorticoids|glucocorticoids|mesh-ancestor
93275773|NCT02167698|Hormones|hormones|mesh-ancestor
93275774|NCT02167698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275775|NCT02167698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93275776|NCT02167698|Protective Agents|protective agents|mesh-ancestor
93275777|NCT02167698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93275778|NCT02167698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275779|NCT02634580|Ezetimibe|ezetimibe|mesh-list
92947803|NCT01037101|Cycloserine|cycloserine|mesh-list
93275780|NCT02634580|Evolocumab|evolocumab|mesh-list
93275781|NCT02634580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93275782|NCT02634580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93275783|NCT02634580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93275784|NCT02634580|Antimetabolites|antimetabolites|mesh-ancestor
93275785|NCT02634580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275786|NCT02634580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93275787|NCT02634580|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93275788|NCT02634580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93275789|NCT02634580|Protease Inhibitors|protease inhibitors|mesh-ancestor
93275790|NCT02634580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275791|NCT02634580|Immunologic Factors|immunologic factors|mesh-ancestor
93275792|NCT02634580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275793|NCT00697255|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93275794|NCT00697255|Hormones|hormones|mesh-list
93275795|NCT00697255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93275796|NCT00697255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275797|NCT00697255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275798|NCT00697255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275799|NCT02164734|Remifentanil|remifentanil|mesh-list
93275800|NCT02164734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93275801|NCT02164734|Narcotics|narcotics|mesh-ancestor
93275802|NCT02164734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275803|NCT02164734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275804|NCT02164734|Analgesics|analgesics|mesh-ancestor
93275805|NCT02164734|Sensory System Agents|sensory system agents|mesh-ancestor
93275806|NCT02164734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275807|NCT00548912|Spironolactone|spironolactone|mesh-list
93275808|NCT00548912|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93275809|NCT00548912|Hormone Antagonists|hormone antagonists|mesh-ancestor
93275810|NCT00548912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275811|NCT00548912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275812|NCT00548912|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93275813|NCT00548912|Diuretics|diuretics|mesh-ancestor
93275814|NCT00548912|Natriuretic Agents|natriuretic agents|mesh-ancestor
93275815|NCT05002933|Insulin Glargine|insulin glargine|mesh-list
93275816|NCT05002933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275817|NCT05002933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275818|NCT03071068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93275819|NCT03071068|Antibodies|antibodies|mesh-list
93275820|NCT03071068|Immunoglobulins|immunoglobulins|mesh-list
93275821|NCT03071068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93275822|NCT03071068|Immunologic Factors|immunologic factors|mesh-ancestor
93275823|NCT03071068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275824|NCT03071068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275825|NCT03487172|Mannitol|mannitol|mesh-list
93275826|NCT03487172|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93275827|NCT03487172|Diuretics|diuretics|mesh-ancestor
93275828|NCT03487172|Natriuretic Agents|natriuretic agents|mesh-ancestor
93275829|NCT03487172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275830|NCT04995016|Pembrolizumab|pembrolizumab|mesh-list
93275831|NCT04995016|Axitinib|axitinib|mesh-list
93275832|NCT04995016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93275833|NCT04995016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275834|NCT04995016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93275835|NCT04995016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275836|NCT04995016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93275837|NCT04995016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275838|NCT04994860|Sildenafil Citrate|sildenafil citrate|mesh-list
93275839|NCT04994860|Zamicastat|zamicastat|mesh-list
93275840|NCT04994860|Vasodilator Agents|vasodilator agents|mesh-ancestor
93275841|NCT04994860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93275842|NCT04994860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93275843|NCT04994860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275844|NCT04994860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275845|NCT04994860|Urological Agents|urological agents|mesh-ancestor
93275846|NCT03481400|Calcitonin|calcitonin|mesh-list
93275847|NCT03481400|Salmon calcitonin|salmon calcitonin|mesh-list
93275848|NCT03481400|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93275849|NCT03481400|Katacalcin|katacalcin|mesh-list
93275850|NCT03481400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93275851|NCT03481400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275852|NCT03481400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93275853|NCT03481400|Vasodilator Agents|vasodilator agents|mesh-ancestor
92947882|NCT00396565|Dopamine Agents|dopamine agents|mesh-ancestor
93275854|NCT02851407|Defibrotide|defibrotide|mesh-list
93275855|NCT02851407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93275856|NCT02851407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93275857|NCT02851407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275858|NCT02851407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93275859|NCT02167854|Trastuzumab|trastuzumab|mesh-list
93275860|NCT02167854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93275861|NCT02167854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275862|NCT02161614|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93275863|NCT02161614|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93275864|NCT02161614|Estradiol|estradiol|mesh-list
93275865|NCT02161614|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93275866|NCT02161614|Estrogens|estrogens|mesh-ancestor
93275867|NCT02161614|Hormones|hormones|mesh-ancestor
93275868|NCT02161614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93275869|NCT02161614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275870|NCT02161614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93275871|NCT02161614|Contraceptive Agents|contraceptive agents|mesh-ancestor
93275872|NCT02161614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93275873|NCT02161614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93275874|NCT04994626|Rituximab|rituximab|mesh-list
93275875|NCT04994626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93275876|NCT04994626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275877|NCT04994626|Immunologic Factors|immunologic factors|mesh-ancestor
93275878|NCT04994626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275879|NCT04994626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275880|NCT02168010|Neurotropin|neurotropin|mesh-list
93275881|NCT02168010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93275882|NCT02168010|Immunologic Factors|immunologic factors|mesh-ancestor
93275883|NCT02168010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275884|NCT02168010|Analgesics|analgesics|mesh-ancestor
93275885|NCT02168010|Sensory System Agents|sensory system agents|mesh-ancestor
93275886|NCT02168010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275887|NCT02168010|Anticonvulsants|anticonvulsants|mesh-ancestor
93275888|NCT04994314|Fluorides|fluorides|mesh-list
93275889|NCT04994314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275890|NCT04994314|Cariostatic Agents|cariostatic agents|mesh-ancestor
93275891|NCT04994314|Protective Agents|protective agents|mesh-ancestor
93275892|NCT02161692|Cyclophosphamide|cyclophosphamide|mesh-list
93275893|NCT02161692|Carboplatin|carboplatin|mesh-list
93275894|NCT02161692|Etoposide|etoposide|mesh-list
93275895|NCT02161692|Bleomycin|bleomycin|mesh-list
93275896|NCT02161692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93275897|NCT02161692|Immunologic Factors|immunologic factors|mesh-ancestor
93275898|NCT02161692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275899|NCT02161692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93275900|NCT02161692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93275901|NCT02161692|Alkylating Agents|alkylating agents|mesh-ancestor
93275902|NCT02161692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275903|NCT02161692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275904|NCT02161692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92570464|NCT00224302|Antidepressive Agents|antidepressive agents|mesh-ancestor
93275905|NCT02161692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93275906|NCT02161692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275907|NCT02161692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275908|NCT02161692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275909|NCT02161692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93275910|NCT02746575|Metoprolol|metoprolol|mesh-list
93275911|NCT02746575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93275912|NCT02746575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93275913|NCT02746575|Sympatholytics|sympatholytics|mesh-ancestor
93275914|NCT02746575|Autonomic Agents|autonomic agents|mesh-ancestor
93275915|NCT02746575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275916|NCT02746575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275917|NCT02746575|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93275918|NCT02746575|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93275919|NCT02746575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93275920|NCT02746575|Adrenergic Agents|adrenergic agents|mesh-ancestor
93275921|NCT02746575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275922|NCT02746575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275923|NCT02161770|Osimertinib|osimertinib|mesh-list
93275924|NCT02161770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275925|NCT02161770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93275926|NCT02161770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275927|NCT02161770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275928|NCT03604575|Insulin|insulin|mesh-list
93275929|NCT03604575|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93275931|NCT03604575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275932|NCT03604575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275933|NCT04988932|Nitric Oxide|nitric oxide|mesh-list
93275934|NCT04988932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93275935|NCT04988932|Autonomic Agents|autonomic agents|mesh-ancestor
93275936|NCT04988932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275937|NCT04988932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275938|NCT04988932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93275939|NCT04988932|Respiratory System Agents|respiratory system agents|mesh-ancestor
93275940|NCT04988932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93275941|NCT04988932|Antioxidants|antioxidants|mesh-ancestor
93275942|NCT04988932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275943|NCT04988932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93275944|NCT04988932|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93275945|NCT04988932|Vasodilator Agents|vasodilator agents|mesh-ancestor
93275946|NCT04988932|Gasotransmitters|gasotransmitters|mesh-ancestor
93275947|NCT04988932|Protective Agents|protective agents|mesh-ancestor
93275948|NCT03625466|Ivacaftor|ivacaftor|mesh-list
93275949|NCT03625466|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93275950|NCT03625466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93275951|NCT03625466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275952|NCT03604419|Metformin|metformin|mesh-list
93275953|NCT03604419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93275954|NCT03604419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275955|NCT03484832|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93275956|NCT03484832|Ethyl Chloride|ethyl chloride|mesh-list
93275957|NCT03484832|Anesthetics, Local|anesthetics, local|mesh-ancestor
93275958|NCT03484832|Anesthetics|anesthetics|mesh-ancestor
93275959|NCT03484832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275960|NCT03484832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275961|NCT03484832|Sensory System Agents|sensory system agents|mesh-ancestor
93275962|NCT03484832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275963|NCT03484832|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93275964|NCT04985110|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93275965|NCT04985110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93275966|NCT04985110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275967|NCT04985110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275968|NCT04985110|Antimalarials|antimalarials|mesh-ancestor
93275969|NCT04985110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93275970|NCT04985110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93275971|NCT02164812|Moxifloxacin|moxifloxacin|mesh-list
93275972|NCT02164812|Efavirenz|efavirenz|mesh-list
93275973|NCT02164812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93275974|NCT02164812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93275975|NCT02164812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93275976|NCT02164812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93275977|NCT02164812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93275978|NCT02164812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93275979|NCT02164812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93275980|NCT02164812|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93275981|NCT02164812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93275982|NCT02164812|Antiviral Agents|antiviral agents|mesh-ancestor
93275983|NCT02164812|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93275984|NCT02164812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93275985|NCT02164812|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93275986|NCT02164812|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93275987|NCT02164812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93275988|NCT02164812|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93275989|NCT04988776|Bupivacaine|bupivacaine|mesh-list
93275990|NCT04988776|Anesthetics, Local|anesthetics, local|mesh-ancestor
93275991|NCT04988776|Anesthetics|anesthetics|mesh-ancestor
93275992|NCT04988776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93275993|NCT04988776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93275994|NCT04988776|Sensory System Agents|sensory system agents|mesh-ancestor
93275995|NCT04988776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93275996|NCT02853123|Tiotropium Bromide|tiotropium bromide|mesh-list
93275997|NCT02853123|Olodaterol|olodaterol|mesh-list
93275998|NCT02853123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93275999|NCT02853123|Autonomic Agents|autonomic agents|mesh-ancestor
93276000|NCT02853123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276001|NCT02853123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948028|NCT00907036|Dermatologic Agents|dermatologic agents|mesh-ancestor
93276002|NCT02853123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276003|NCT02853123|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276004|NCT02853123|Parasympatholytics|parasympatholytics|mesh-ancestor
93276005|NCT02853123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93276006|NCT02853123|Cholinergic Agents|cholinergic agents|mesh-ancestor
93276007|NCT02853123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276008|NCT02853123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276010|NCT02255370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93276011|NCT02255370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276012|NCT02255370|Analgesics|analgesics|mesh-ancestor
93276013|NCT02255370|Sensory System Agents|sensory system agents|mesh-ancestor
93276014|NCT02255370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276015|NCT02255370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276016|NCT02255370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276017|NCT02255370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276018|NCT02255370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276019|NCT02255370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276020|NCT02255370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276021|NCT04984408|Vaccines|vaccines|mesh-list
93276022|NCT04984408|Immunologic Factors|immunologic factors|mesh-ancestor
93276023|NCT04984408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276024|NCT03484754|Botulinum Toxins|botulinum toxins|mesh-list
93276025|NCT03484754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93276026|NCT03484754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276027|NCT03484754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276028|NCT03484754|Cholinergic Agents|cholinergic agents|mesh-ancestor
93276029|NCT03484754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276030|NCT03484754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276031|NCT04459676|Mitogens|mitogens|mesh-list
93276032|NCT04459676|Mitosis Modulators|mitosis modulators|mesh-ancestor
93276033|NCT04459676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276034|NCT02164890|Micafungin|micafungin|mesh-list
93276035|NCT02164890|Antifungal Agents|antifungal agents|mesh-ancestor
93276036|NCT02164890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276037|NCT02634346|Olanzapine|olanzapine|mesh-list
93276038|NCT02634346|Antiemetics|antiemetics|mesh-ancestor
93276039|NCT02634346|Autonomic Agents|autonomic agents|mesh-ancestor
93276040|NCT02634346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276041|NCT02634346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276042|NCT02634346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93276043|NCT02634346|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93276044|NCT02634346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570606|NCT00413023|Autonomic Agents|autonomic agents|mesh-ancestor
93276045|NCT02634346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276046|NCT02634346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93276047|NCT02634346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93276048|NCT02634346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93276049|NCT02634346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276050|NCT02634346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276051|NCT02634346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276052|NCT02634346|Serotonin Agents|serotonin agents|mesh-ancestor
93276053|NCT02168634|Botulinum Toxins|botulinum toxins|mesh-list
93276054|NCT02168634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93276055|NCT02168634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276056|NCT02168634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276057|NCT02168634|Cholinergic Agents|cholinergic agents|mesh-ancestor
93276058|NCT02168634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276059|NCT02168634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276060|NCT00812240|Imatinib Mesylate|imatinib mesylate|mesh-list
93276061|NCT00812240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276062|NCT00812240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93276063|NCT00812240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276064|NCT00812240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276065|NCT02165046|Budesonide|budesonide|mesh-list
93276066|NCT02165046|Procaterol|procaterol|mesh-list
93276067|NCT02165046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276068|NCT02165046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93276069|NCT02165046|Autonomic Agents|autonomic agents|mesh-ancestor
93276070|NCT02165046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276071|NCT02165046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276072|NCT02165046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276073|NCT02165046|Respiratory System Agents|respiratory system agents|mesh-ancestor
92948104|NCT00927004|Analgesics|analgesics|mesh-ancestor
93276074|NCT02165046|Glucocorticoids|glucocorticoids|mesh-ancestor
93276076|NCT02165046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276077|NCT02165046|Sympathomimetics|sympathomimetics|mesh-ancestor
93276078|NCT02165046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93276079|NCT02165046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93276080|NCT02165046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93276081|NCT02165046|Adrenergic Agents|adrenergic agents|mesh-ancestor
93276082|NCT02165046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276083|NCT02165046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276084|NCT03070678|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93276085|NCT03070678|Mefenamic Acid|mefenamic acid|mesh-list
93276086|NCT03070678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93276087|NCT03070678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276088|NCT03070678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93276089|NCT03070678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276090|NCT03070678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93276091|NCT03070678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276092|NCT03070678|Analgesics|analgesics|mesh-ancestor
93276093|NCT03070678|Sensory System Agents|sensory system agents|mesh-ancestor
93276094|NCT03070678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276095|NCT03070678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276096|NCT03070678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276097|NCT03070678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93276098|NCT03070678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276099|NCT00101166|Vaccines|vaccines|mesh-list
93276100|NCT00101166|Immunologic Factors|immunologic factors|mesh-ancestor
93276101|NCT00101166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276102|NCT04994236|Leucovorin|leucovorin|mesh-list
93276103|NCT04994236|Fluorouracil|fluorouracil|mesh-list
93276104|NCT04994236|Oxaliplatin|oxaliplatin|mesh-list
93276105|NCT04994236|Antimetabolites|antimetabolites|mesh-ancestor
93276106|NCT04994236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276107|NCT04994236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93276108|NCT04994236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276109|NCT04994236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93276110|NCT04994236|Immunologic Factors|immunologic factors|mesh-ancestor
93276111|NCT04994236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276112|NCT04994236|Antidotes|antidotes|mesh-ancestor
93276113|NCT04994236|Protective Agents|protective agents|mesh-ancestor
93276114|NCT04994236|Vitamin B Complex|vitamin b complex|mesh-ancestor
93276115|NCT04994236|Vitamins|vitamins|mesh-ancestor
93276116|NCT04994236|Micronutrients|micronutrients|mesh-ancestor
93276117|NCT03601611|Prednisolone|prednisolone|mesh-list
93276118|NCT03601611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276119|NCT03601611|Glucocorticoids|glucocorticoids|mesh-ancestor
93276120|NCT03601611|Hormones|hormones|mesh-ancestor
93276121|NCT03601611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276122|NCT03601611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276123|NCT03601611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93276124|NCT03601611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276125|NCT03597945|Lidocaine|lidocaine|mesh-list
93276126|NCT03597945|Magnesium Sulfate|magnesium sulfate|mesh-list
93276127|NCT03597945|Epinephrine|epinephrine|mesh-list
93276128|NCT03597945|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276129|NCT03597945|Anesthetics|anesthetics|mesh-ancestor
93276130|NCT03597945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276131|NCT03597945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276132|NCT03597945|Sensory System Agents|sensory system agents|mesh-ancestor
93276133|NCT03597945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276134|NCT03597945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93276135|NCT03597945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93276136|NCT03597945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93276137|NCT03597945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276138|NCT03597945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276139|NCT03597945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93276140|NCT03597945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93276141|NCT03597945|Adrenergic Agents|adrenergic agents|mesh-ancestor
93276142|NCT03597945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276143|NCT03597945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93276144|NCT03597945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93276145|NCT03597945|Autonomic Agents|autonomic agents|mesh-ancestor
93276146|NCT03597945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276147|NCT03597945|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276148|NCT03597945|Mydriatics|mydriatics|mesh-ancestor
93276149|NCT03597945|Sympathomimetics|sympathomimetics|mesh-ancestor
93276150|NCT03597945|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93276151|NCT03597945|Analgesics|analgesics|mesh-ancestor
93276152|NCT03597945|Anticonvulsants|anticonvulsants|mesh-ancestor
93276153|NCT03597945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93276154|NCT03597945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93276155|NCT03597945|Tocolytic Agents|tocolytic agents|mesh-ancestor
93276156|NCT03597945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276157|NCT03601533|Phenol|phenol|mesh-list
93276158|NCT03601533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93276159|NCT03601533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276160|NCT03601533|Disinfectants|disinfectants|mesh-ancestor
93276161|NCT03601533|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93276162|NCT03601533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93276163|NCT03486626|Metformin|metformin|mesh-list
93276164|NCT03486626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93276165|NCT03486626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276166|NCT04983550|Doxorubicin|doxorubicin|mesh-list
93276167|NCT04983550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93276168|NCT04983550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93276169|NCT04983550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276170|NCT04983550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93276171|NCT04983550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93276172|NCT04983550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276173|NCT04983550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276174|NCT02255682|Simvastatin|simvastatin|mesh-list
93276175|NCT02255682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93276176|NCT02255682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93276177|NCT02255682|Antimetabolites|antimetabolites|mesh-ancestor
93276178|NCT02255682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276179|NCT02255682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92570756|NCT00225511|Analgesics|analgesics|mesh-ancestor
93276180|NCT02255682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93276181|NCT02255682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276182|NCT05153486|Ethanol|ethanol|mesh-list
93276183|NCT05153486|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93276184|NCT05153486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276185|NCT05153486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276186|NCT05153486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276187|NCT03136263|Oxytocin|oxytocin|mesh-list
93276188|NCT03136263|Oxytocics|oxytocics|mesh-ancestor
93276189|NCT03136263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276190|NCT03136263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276191|NCT03486548|Dexamethasone|dexamethasone|mesh-list
93276192|NCT03486548|Lidocaine|lidocaine|mesh-list
93276193|NCT03486548|Bupivacaine|bupivacaine|mesh-list
93276194|NCT03486548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276195|NCT03486548|Antiemetics|antiemetics|mesh-ancestor
93276196|NCT03486548|Autonomic Agents|autonomic agents|mesh-ancestor
93276197|NCT03486548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276198|NCT03486548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276199|NCT03486548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93276200|NCT03486548|Glucocorticoids|glucocorticoids|mesh-ancestor
93276201|NCT03486548|Hormones|hormones|mesh-ancestor
93276202|NCT03486548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276203|NCT03486548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93276204|NCT03486548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276205|NCT03486548|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276206|NCT03486548|Anesthetics|anesthetics|mesh-ancestor
93276207|NCT03486548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276208|NCT03486548|Sensory System Agents|sensory system agents|mesh-ancestor
93276209|NCT03486548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93276210|NCT03486548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93276211|NCT03486548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93276212|NCT03486548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276213|NCT03486548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276214|NCT04983160|Allopurinol|allopurinol|mesh-list
93276215|NCT04983160|Antimetabolites|antimetabolites|mesh-ancestor
93276216|NCT04983160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276217|NCT04983160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276218|NCT04983160|Gout Suppressants|gout suppressants|mesh-ancestor
93276219|NCT04983160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276220|NCT04983160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93276221|NCT04983160|Antioxidants|antioxidants|mesh-ancestor
93276222|NCT04983160|Protective Agents|protective agents|mesh-ancestor
93276223|NCT04983160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276224|NCT02759016|BI 836826|bi 836826|mesh-list
93276225|NCT02759016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93276226|NCT02759016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276227|NCT05379166|Azacitidine|azacitidine|mesh-list
93276228|NCT05379166|Venetoclax|venetoclax|mesh-list
93276229|NCT05379166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93276230|NCT05379166|Antimetabolites|antimetabolites|mesh-ancestor
93276231|NCT05379166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276232|NCT05379166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276233|NCT05379166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276234|NCT02852967|Belumosudil|belumosudil|mesh-list
92570813|NCT00095667|Lapatinib|lapatinib|mesh-list
93276235|NCT02852967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93276236|NCT02852967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276237|NCT02852967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276238|NCT03593044|Atropine|atropine|mesh-list
93276239|NCT03593044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93276240|NCT03593044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93276241|NCT03593044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93276242|NCT03593044|Autonomic Agents|autonomic agents|mesh-ancestor
93276243|NCT03593044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276244|NCT03593044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276245|NCT03593044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276246|NCT03593044|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276247|NCT03593044|Mydriatics|mydriatics|mesh-ancestor
93276248|NCT03593044|Parasympatholytics|parasympatholytics|mesh-ancestor
93276249|NCT03593044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93276250|NCT03593044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93276251|NCT03593044|Cholinergic Agents|cholinergic agents|mesh-ancestor
93276252|NCT03593044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276253|NCT03593044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276254|NCT03597087|Anesthetics|anesthetics|mesh-list
93276255|NCT03597087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276256|NCT03597087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276257|NCT03603327|Antiviral Agents|antiviral agents|mesh-list
93276258|NCT03603327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276259|NCT03596775|Dexmedetomidine|dexmedetomidine|mesh-list
93276260|NCT03596775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93276261|NCT03596775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276262|NCT03596775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276263|NCT03596775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276264|NCT03596775|Analgesics|analgesics|mesh-ancestor
93276265|NCT03596775|Sensory System Agents|sensory system agents|mesh-ancestor
93276266|NCT03596775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276267|NCT03596775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93276268|NCT03596775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93276269|NCT03596775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93276270|NCT03596775|Adrenergic Agents|adrenergic agents|mesh-ancestor
93276271|NCT03596775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276272|NCT03596775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276273|NCT03066466|Methotrexate|methotrexate|mesh-list
93276274|NCT03066466|Atorvastatin|atorvastatin|mesh-list
93276275|NCT03066466|Tacrolimus|tacrolimus|mesh-list
93276276|NCT03066466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93276277|NCT03066466|Abortifacient Agents|abortifacient agents|mesh-ancestor
93276278|NCT03066466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276279|NCT03066466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276280|NCT03066466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93276281|NCT03066466|Antimetabolites|antimetabolites|mesh-ancestor
93276282|NCT03066466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276283|NCT03066466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276284|NCT03066466|Dermatologic Agents|dermatologic agents|mesh-ancestor
93276285|NCT03066466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276286|NCT03066466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93276287|NCT03066466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93276288|NCT03066466|Immunologic Factors|immunologic factors|mesh-ancestor
93276289|NCT03066466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276290|NCT03066466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93276291|NCT03066466|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93276292|NCT03066466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93276293|NCT03066466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93276294|NCT03066466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93276295|NCT03066466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93276296|NCT03603249|Trimetazidine|trimetazidine|mesh-list
93276297|NCT03603249|Vasodilator Agents|vasodilator agents|mesh-ancestor
93276298|NCT03068260|Acetaminophen|acetaminophen|mesh-list
93276299|NCT03068260|Ibuprofen|ibuprofen|mesh-list
93276300|NCT03068260|Morphine|morphine|mesh-list
93276301|NCT03068260|Ropivacaine|ropivacaine|mesh-list
93276302|NCT03068260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93276303|NCT03068260|Narcotics|narcotics|mesh-ancestor
93276304|NCT03068260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276305|NCT03068260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276306|NCT03068260|Analgesics|analgesics|mesh-ancestor
93276307|NCT03068260|Sensory System Agents|sensory system agents|mesh-ancestor
93276308|NCT03068260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276309|NCT03068260|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276310|NCT03068260|Anesthetics|anesthetics|mesh-ancestor
93276311|NCT03068260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276312|NCT03068260|Antipyretics|antipyretics|mesh-ancestor
93276313|NCT03068260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93276314|NCT03068260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276315|NCT03068260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276316|NCT03068260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93276317|NCT03068260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276318|NCT03068260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276319|NCT02237859|Vancomycin|vancomycin|mesh-list
93276320|NCT02237859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93276321|NCT02237859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276322|NCT03594825|Valsartan|valsartan|mesh-list
93276323|NCT03594825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93276324|NCT03594825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93276325|NCT03594825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93276326|NCT03594825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276327|NCT02162550|Exenatide|exenatide|mesh-list
93276328|NCT02162550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93276329|NCT02162550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276330|NCT02162550|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93276331|NCT02162550|Incretins|incretins|mesh-ancestor
93276332|NCT02162550|Hormones|hormones|mesh-ancestor
93276333|NCT02162550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276334|NCT03600831|Docetaxel|docetaxel|mesh-list
93276335|NCT03600831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276336|NCT03600831|Tubulin Modulators|tubulin modulators|mesh-ancestor
93276337|NCT03600831|Antimitotic Agents|antimitotic agents|mesh-ancestor
93276338|NCT03600831|Mitosis Modulators|mitosis modulators|mesh-ancestor
93276339|NCT03600831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276340|NCT02852265|Contraceptive Agents|contraceptive agents|mesh-list
93276341|NCT02852265|Etonogestrel|etonogestrel|mesh-list
93276342|NCT02852265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276343|NCT02852265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276344|NCT02852265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93276345|NCT02852265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93276346|NCT02162784|Budesonide|budesonide|mesh-list
93276347|NCT02162784|Albuterol|albuterol|mesh-list
93276348|NCT02162784|Procaterol|procaterol|mesh-list
93276349|NCT02162784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276350|NCT02162784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93276351|NCT02162784|Autonomic Agents|autonomic agents|mesh-ancestor
93276352|NCT02162784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276353|NCT02162784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276354|NCT02162784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276355|NCT02162784|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276356|NCT02162784|Glucocorticoids|glucocorticoids|mesh-ancestor
93276357|NCT02162784|Hormones|hormones|mesh-ancestor
93276358|NCT02162784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276359|NCT02162784|Tocolytic Agents|tocolytic agents|mesh-ancestor
93276360|NCT02162784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276361|NCT02162784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93276362|NCT02162784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93276363|NCT02162784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93276364|NCT02162784|Adrenergic Agents|adrenergic agents|mesh-ancestor
93276365|NCT02162784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276366|NCT02162784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276367|NCT02162784|Sympathomimetics|sympathomimetics|mesh-ancestor
93276368|NCT03539718|Taurolidine|taurolidine|mesh-list
93276369|NCT03539718|Heparin|heparin|mesh-list
93276370|NCT03539718|Calcium heparin|calcium heparin|mesh-list
93276371|NCT03539718|Anticoagulants|anticoagulants|mesh-ancestor
93276372|NCT03539718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93276373|NCT03539718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93276374|NCT03539718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276375|NCT03539718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276376|NCT03539718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93276377|NCT03539718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276378|NCT02166450|Nystatin|nystatin|mesh-list
93276379|NCT02166450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93276380|NCT02166450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276381|NCT02166450|Antifungal Agents|antifungal agents|mesh-ancestor
93276382|NCT02166450|Ionophores|ionophores|mesh-ancestor
93276383|NCT02166450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276384|NCT02166450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276385|NCT03600363|Metformin|metformin|mesh-list
93276386|NCT03600363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93276387|NCT03600363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276388|NCT03600129|Ropivacaine|ropivacaine|mesh-list
93276389|NCT03600129|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276390|NCT03600129|Anesthetics|anesthetics|mesh-ancestor
93276391|NCT03600129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276392|NCT03600129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276393|NCT03600129|Sensory System Agents|sensory system agents|mesh-ancestor
93276394|NCT03600129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276395|NCT02169570|Calcium, Dietary|calcium, dietary|mesh-list
93276396|NCT02169570|Vitamin D|vitamin d|mesh-list
93276397|NCT02169570|Ergocalciferols|ergocalciferols|mesh-list
93276398|NCT02169570|Cholecalciferol|cholecalciferol|mesh-list
93276399|NCT02169570|Vitamins|vitamins|mesh-list
93276400|NCT02169570|Calcium|calcium|mesh-list
93276401|NCT02169570|Micronutrients|micronutrients|mesh-ancestor
93276402|NCT02169570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276403|NCT02169570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93276404|NCT02169570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93276405|NCT02169648|Ranibizumab|ranibizumab|mesh-list
93276406|NCT02169648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93276407|NCT02169648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93276408|NCT02169648|Growth Substances|growth substances|mesh-ancestor
93276409|NCT02169648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276410|NCT02169648|Growth Inhibitors|growth inhibitors|mesh-ancestor
93276411|NCT02169648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276412|NCT03594591|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93276413|NCT03594591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276414|NCT02170896|Pantoprazole|pantoprazole|mesh-list
93276415|NCT02170896|Dabigatran|dabigatran|mesh-list
93276416|NCT02170896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93276417|NCT02170896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93276418|NCT02170896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93276419|NCT02170896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276420|NCT02170896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276421|NCT02170896|Antithrombins|antithrombins|mesh-ancestor
93276422|NCT02170896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276423|NCT02170896|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276424|NCT02170896|Anticoagulants|anticoagulants|mesh-ancestor
93276425|NCT03594513|Dipyrone|dipyrone|mesh-list
93276426|NCT03594513|Chlorhexidine|chlorhexidine|mesh-list
93276427|NCT03594513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93276428|NCT03594513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276429|NCT03594513|Disinfectants|disinfectants|mesh-ancestor
93276430|NCT03594513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93276431|NCT03594513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276432|NCT03594513|Analgesics|analgesics|mesh-ancestor
93276433|NCT03594513|Sensory System Agents|sensory system agents|mesh-ancestor
93276434|NCT03594513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276435|NCT03594513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276436|NCT03594513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276437|NCT03594513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276438|NCT03594513|Antipyretics|antipyretics|mesh-ancestor
93276439|NCT02633800|Carboplatin|carboplatin|mesh-list
93276440|NCT02633800|Cetuximab|cetuximab|mesh-list
93276441|NCT02633800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276442|NCT02633800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93276443|NCT02169804|Enclomiphene|enclomiphene|mesh-list
93276444|NCT02169804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93276445|NCT02169804|Hormone Antagonists|hormone antagonists|mesh-ancestor
93276446|NCT02169804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948477|NCT00838227|Modafinil|modafinil|mesh-list
93276447|NCT02169804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276448|NCT02169804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93276449|NCT02169804|Fertility Agents|fertility agents|mesh-ancestor
93276450|NCT02169804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276451|NCT02169804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93276452|NCT02169804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93276454|NCT02170974|Antithrombins|antithrombins|mesh-ancestor
93276455|NCT02170974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276456|NCT02170974|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276457|NCT02170974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276458|NCT02170974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276459|NCT02170974|Anticoagulants|anticoagulants|mesh-ancestor
93276460|NCT02174718|Vitamin D|vitamin d|mesh-list
93276461|NCT02174718|Cholecalciferol|cholecalciferol|mesh-list
93276462|NCT02174718|Vitamins|vitamins|mesh-ancestor
93276463|NCT02174718|Micronutrients|micronutrients|mesh-ancestor
93276464|NCT02174718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276465|NCT02174718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93276466|NCT02174718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93276467|NCT02238171|Ipratropium|ipratropium|mesh-list
93276468|NCT02238171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93276469|NCT02238171|Autonomic Agents|autonomic agents|mesh-ancestor
93276470|NCT02238171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276471|NCT02238171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276472|NCT02238171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276473|NCT02238171|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276474|NCT02238171|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93276475|NCT02238171|Cholinergic Agents|cholinergic agents|mesh-ancestor
93276476|NCT02238171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276477|NCT02238171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276478|NCT02169882|Rifampin|rifampin|mesh-list
93276479|NCT02169882|Dexamethasone|dexamethasone|mesh-list
93276480|NCT02169882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276481|NCT02169882|Antiemetics|antiemetics|mesh-ancestor
93276482|NCT02169882|Autonomic Agents|autonomic agents|mesh-ancestor
93276483|NCT02169882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276484|NCT02169882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276485|NCT02169882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93276486|NCT02169882|Glucocorticoids|glucocorticoids|mesh-ancestor
93276487|NCT02169882|Hormones|hormones|mesh-ancestor
93276488|NCT02169882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276489|NCT02169882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92571065|NCT00226954|Zoledronic Acid|zoledronic acid|mesh-list
93276490|NCT02169882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276491|NCT02169882|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93276492|NCT02169882|Antitubercular Agents|antitubercular agents|mesh-ancestor
93276493|NCT02169882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93276494|NCT02169882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276495|NCT02169882|Leprostatic Agents|leprostatic agents|mesh-ancestor
93276496|NCT02169882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93276497|NCT02169882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276498|NCT02169882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276499|NCT02169882|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93276500|NCT02169882|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93276501|NCT02169882|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93276502|NCT02169882|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93276503|NCT02169882|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93276504|NCT02169882|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93276505|NCT03602547|Vorolanib|vorolanib|mesh-list
93276506|NCT03602547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93276507|NCT03602547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276508|NCT03602547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276509|NCT03602469|Bupivacaine|bupivacaine|mesh-list
93276510|NCT03602469|Propofol|propofol|mesh-list
93276511|NCT03602469|Sevoflurane|sevoflurane|mesh-list
93276512|NCT03602469|Rocuronium|rocuronium|mesh-list
93276513|NCT03602469|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276514|NCT03602469|Anesthetics|anesthetics|mesh-ancestor
93276515|NCT03602469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276516|NCT03602469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276517|NCT03602469|Sensory System Agents|sensory system agents|mesh-ancestor
93276518|NCT03602469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276519|NCT03602469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93276520|NCT03602469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93276521|NCT03602469|Anesthetics, General|anesthetics, general|mesh-ancestor
93276522|NCT03602469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92948544|NCT00624585|Dasatinib|dasatinib|mesh-list
93276523|NCT03602469|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93276524|NCT03602469|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93276525|NCT03602469|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93276526|NCT03602469|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93276527|NCT02170038|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93276528|NCT02170038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93276529|NCT02170038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93276530|NCT02170038|Contraceptive Agents|contraceptive agents|mesh-ancestor
93276531|NCT02170038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276532|NCT02170038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276533|NCT02170038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93276534|NCT02170038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93276535|NCT02170038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93276536|NCT02170038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93276537|NCT02170038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93276538|NCT02170038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93276539|NCT02170038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93276540|NCT02170038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93276541|NCT05001373|Vaccines|vaccines|mesh-list
93276542|NCT05001373|Immunologic Factors|immunologic factors|mesh-ancestor
93276543|NCT05001373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276544|NCT02171052|Digoxin|digoxin|mesh-list
93276545|NCT02171052|Dabigatran|dabigatran|mesh-list
93276546|NCT02171052|Antithrombins|antithrombins|mesh-ancestor
93276547|NCT02171052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276548|NCT02171052|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276549|NCT02171052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276550|NCT02171052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276551|NCT02171052|Anticoagulants|anticoagulants|mesh-ancestor
93276552|NCT02171052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93276553|NCT02171052|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93276554|NCT02171052|Protective Agents|protective agents|mesh-ancestor
93276555|NCT02171052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276556|NCT03591549|Fulvestrant|fulvestrant|mesh-list
93276557|NCT03591549|Goserelin|goserelin|mesh-list
93276558|NCT03591549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93276559|NCT03591549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276560|NCT03591549|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93276561|NCT03591549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93276562|NCT03591549|Hormone Antagonists|hormone antagonists|mesh-ancestor
93276563|NCT03591549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276564|NCT03591549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276565|NCT02261220|Durvalumab|durvalumab|mesh-list
93276566|NCT02261220|Tremelimumab|tremelimumab|mesh-list
93276567|NCT02261220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93276568|NCT02261220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276569|NCT02237937|Amitriptyline|amitriptyline|mesh-list
93276570|NCT02237937|Citalopram|citalopram|mesh-list
93276571|NCT02237937|Paroxetine|paroxetine|mesh-list
93276572|NCT02237937|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93276573|NCT02237937|Sertraline|sertraline|mesh-list
93276574|NCT02237937|Nortriptyline|nortriptyline|mesh-list
93276575|NCT02237937|Trimipramine|trimipramine|mesh-list
93276576|NCT02237937|Escitalopram|escitalopram|mesh-list
93276577|NCT02237937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93276578|NCT02237937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93276579|NCT02237937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276580|NCT02237937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276581|NCT02237937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276582|NCT02237937|Serotonin Agents|serotonin agents|mesh-ancestor
93276583|NCT02237937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276584|NCT02237937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276585|NCT02237937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93276586|NCT02237937|Antidepressive Agents|antidepressive agents|mesh-ancestor
93276587|NCT02237937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93276588|NCT02237937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93276589|NCT02237937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93276590|NCT02237937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276591|NCT02237937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93276592|NCT02237937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93276593|NCT02237937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276594|NCT02237937|Analgesics|analgesics|mesh-ancestor
92948619|NCT00839163|Vitamin K|vitamin k|mesh-list
93276595|NCT02237937|Sensory System Agents|sensory system agents|mesh-ancestor
93276596|NCT02237937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93276598|NCT02170116|Dabigatran|dabigatran|mesh-list
93276599|NCT02170116|Antithrombins|antithrombins|mesh-ancestor
93276600|NCT02170116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276601|NCT02170116|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276602|NCT02170116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276603|NCT02170116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276604|NCT02170116|Anticoagulants|anticoagulants|mesh-ancestor
93276605|NCT03035227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93276606|NCT03539562|Promethazine|promethazine|mesh-list
93276607|NCT03539562|Diphenhydramine|diphenhydramine|mesh-list
93276608|NCT03539562|Morphine|morphine|mesh-list
93276609|NCT03539562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93276610|NCT03539562|Narcotics|narcotics|mesh-ancestor
93276611|NCT03539562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276612|NCT03539562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276613|NCT03539562|Analgesics|analgesics|mesh-ancestor
93276614|NCT03539562|Sensory System Agents|sensory system agents|mesh-ancestor
93276615|NCT03539562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276616|NCT03539562|Antipruritics|antipruritics|mesh-ancestor
93276617|NCT03539562|Dermatologic Agents|dermatologic agents|mesh-ancestor
93276618|NCT03539562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93276619|NCT03539562|Histamine Antagonists|histamine antagonists|mesh-ancestor
93276620|NCT03539562|Histamine Agents|histamine agents|mesh-ancestor
93276621|NCT03539562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276622|NCT03539562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276623|NCT03539562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93276624|NCT03539562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93276625|NCT03539562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93276626|NCT03539562|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276627|NCT03539562|Anesthetics|anesthetics|mesh-ancestor
93276628|NCT03539562|Antiemetics|antiemetics|mesh-ancestor
93276629|NCT03539562|Autonomic Agents|autonomic agents|mesh-ancestor
93276630|NCT03539562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93276631|NCT03604315|Deoxyglucose|deoxyglucose|mesh-list
93276632|NCT03604315|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93276633|NCT03604315|Fluorides|fluorides|mesh-list
93276634|NCT03604315|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93276635|NCT03604315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276636|NCT03604315|Cariostatic Agents|cariostatic agents|mesh-ancestor
93276637|NCT03604315|Protective Agents|protective agents|mesh-ancestor
93276638|NCT03604315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276639|NCT03604315|Antimetabolites|antimetabolites|mesh-ancestor
93276640|NCT03604315|Antiviral Agents|antiviral agents|mesh-ancestor
93276641|NCT03604315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276642|NCT03590769|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93276643|NCT03590769|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93276644|NCT03590769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276645|NCT00394069|Montelukast|montelukast|mesh-list
93276646|NCT00394069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276647|NCT00394069|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276648|NCT00394069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93276649|NCT00394069|Hormone Antagonists|hormone antagonists|mesh-ancestor
93276650|NCT00394069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276651|NCT00394069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276652|NCT00394069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93276653|NCT00394069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93276654|NCT00394069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276655|NCT03598959|Tofacitinib|tofacitinib|mesh-list
93276656|NCT03598959|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93276657|NCT03598959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93276658|NCT03598959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276659|NCT03598959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276660|NCT02238717|Pregabalin|pregabalin|mesh-list
93276661|NCT02238717|PF-06372865|pf-06372865|mesh-list
93276662|NCT02238717|Analgesics|analgesics|mesh-ancestor
93276663|NCT02238717|Sensory System Agents|sensory system agents|mesh-ancestor
93276664|NCT02238717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276665|NCT02238717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276666|NCT02238717|Anticonvulsants|anticonvulsants|mesh-ancestor
93276667|NCT02238717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93276668|NCT02238717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276669|NCT02238717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276670|NCT02238717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93276671|NCT02238717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93276672|NCT02238717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93276673|NCT02238717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276674|NCT02238717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93276675|NCT02238717|GABA Modulators|gaba modulators|mesh-ancestor
93276676|NCT02238717|GABA Agents|gaba agents|mesh-ancestor
93276677|NCT02238717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276678|NCT05266066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93276679|NCT05266066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93276680|NCT05266066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276681|NCT05266066|Antitubercular Agents|antitubercular agents|mesh-ancestor
93276682|NCT03470311|Benralizumab|benralizumab|mesh-list
93276683|NCT03470311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276684|NCT03470311|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276685|NCT03580005|Methylphenidate|methylphenidate|mesh-list
93276686|NCT03580005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93276687|NCT03580005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276688|NCT03580005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93276689|NCT03580005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93276690|NCT03580005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276691|NCT03580005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276692|NCT03580005|Dopamine Agents|dopamine agents|mesh-ancestor
93276693|NCT03580005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276694|NCT03579927|Cytarabine|cytarabine|mesh-list
93276695|NCT03579927|Rituximab|rituximab|mesh-list
93276696|NCT03579927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93276697|NCT03579927|Etoposide|etoposide|mesh-list
93276698|NCT03579927|Etoposide phosphate|etoposide phosphate|mesh-list
93276699|NCT03579927|Melphalan|melphalan|mesh-list
93276700|NCT03579927|Mechlorethamine|mechlorethamine|mesh-list
93276701|NCT03579927|Carmustine|carmustine|mesh-list
93276702|NCT03579927|Podophyllotoxin|podophyllotoxin|mesh-list
93276703|NCT03579927|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93276704|NCT03579927|Antibodies|antibodies|mesh-list
93276705|NCT03579927|Immunoglobulins|immunoglobulins|mesh-list
93276706|NCT03579927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93276707|NCT03579927|Lenograstim|lenograstim|mesh-list
93276708|NCT03579927|Immunologic Factors|immunologic factors|mesh-ancestor
93276709|NCT03579927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276710|NCT03579927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276711|NCT03579927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276712|NCT03579927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93276713|NCT03579927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93276714|NCT03579927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93276715|NCT03579927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276716|NCT03579927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276717|NCT03579927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93276718|NCT03579927|Antimetabolites|antimetabolites|mesh-ancestor
93276719|NCT03579927|Antiviral Agents|antiviral agents|mesh-ancestor
93276720|NCT03579927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276721|NCT03579927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93276722|NCT03579927|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93276723|NCT03579927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93276724|NCT03579927|Alkylating Agents|alkylating agents|mesh-ancestor
93276725|NCT03579927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93276726|NCT03579927|Keratolytic Agents|keratolytic agents|mesh-ancestor
93276727|NCT03579927|Dermatologic Agents|dermatologic agents|mesh-ancestor
93276728|NCT03579927|Tubulin Modulators|tubulin modulators|mesh-ancestor
93276729|NCT03579927|Antimitotic Agents|antimitotic agents|mesh-ancestor
93276730|NCT03579927|Mitosis Modulators|mitosis modulators|mesh-ancestor
93276731|NCT03587025|Amitriptyline|amitriptyline|mesh-list
93276732|NCT03587025|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93276733|NCT03587025|Antidepressive Agents|antidepressive agents|mesh-ancestor
93276734|NCT03587025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93276735|NCT03587025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276736|NCT03587025|Analgesics|analgesics|mesh-ancestor
93276737|NCT03587025|Sensory System Agents|sensory system agents|mesh-ancestor
93276738|NCT03587025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276739|NCT03587025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276740|NCT03587025|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93276741|NCT03587025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93276742|NCT03587025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93276743|NCT03587025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276744|NCT03587025|Adrenergic Agents|adrenergic agents|mesh-ancestor
93276745|NCT03587025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276746|NCT02171208|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93276747|NCT02171208|Dermatologic Agents|dermatologic agents|mesh-ancestor
93276748|NCT02171208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93276749|NCT02171208|Immunologic Factors|immunologic factors|mesh-ancestor
93276750|NCT02171208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276751|NCT00140881|Montelukast|montelukast|mesh-list
93276752|NCT00140881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276753|NCT00140881|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276754|NCT00140881|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93276755|NCT00140881|Hormone Antagonists|hormone antagonists|mesh-ancestor
93276756|NCT00140881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276757|NCT00140881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276758|NCT00140881|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93276759|NCT00140881|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93276760|NCT00140881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276761|NCT02848833|Empagliflozin|empagliflozin|mesh-list
93276762|NCT02848833|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93276763|NCT02848833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276764|NCT02848833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93276765|NCT02848833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276766|NCT03539328|Paclitaxel|paclitaxel|mesh-list
93276767|NCT03539328|Gemcitabine|gemcitabine|mesh-list
93276768|NCT03539328|Doxorubicin|doxorubicin|mesh-list
93276769|NCT03539328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93276770|NCT03539328|Pembrolizumab|pembrolizumab|mesh-list
93276771|NCT03539328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93276772|NCT03539328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276773|NCT03539328|Tubulin Modulators|tubulin modulators|mesh-ancestor
93276774|NCT03539328|Antimitotic Agents|antimitotic agents|mesh-ancestor
93276775|NCT03539328|Mitosis Modulators|mitosis modulators|mesh-ancestor
93276776|NCT03539328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276777|NCT03539328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93276778|NCT03539328|Antimetabolites|antimetabolites|mesh-ancestor
93276779|NCT03539328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93276780|NCT03539328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93276781|NCT03539328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93276782|NCT03539328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276783|NCT03539328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93276784|NCT03539328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93276785|NCT00111709|Rizatriptan|rizatriptan|mesh-list
93276786|NCT00111709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276787|NCT00111709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276788|NCT00111709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276789|NCT00111709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93276790|NCT00111709|Serotonin Agents|serotonin agents|mesh-ancestor
93276791|NCT02171442|Dabigatran|dabigatran|mesh-list
93276792|NCT02171442|Antithrombins|antithrombins|mesh-ancestor
93276793|NCT02171442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276794|NCT02171442|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276795|NCT02171442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276796|NCT02171442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276797|NCT02171442|Anticoagulants|anticoagulants|mesh-ancestor
93276798|NCT02035527|Docetaxel|docetaxel|mesh-list
93276799|NCT02035527|Sorafenib|sorafenib|mesh-list
93276800|NCT02035527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276801|NCT02035527|Tubulin Modulators|tubulin modulators|mesh-ancestor
93276802|NCT02035527|Antimitotic Agents|antimitotic agents|mesh-ancestor
93276803|NCT02035527|Mitosis Modulators|mitosis modulators|mesh-ancestor
93276804|NCT02035527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276805|NCT02035527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93276806|NCT02035527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276807|NCT00092131|Montelukast|montelukast|mesh-list
93276808|NCT00092131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276809|NCT00092131|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276810|NCT00092131|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93276811|NCT00092131|Hormone Antagonists|hormone antagonists|mesh-ancestor
93276812|NCT00092131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276813|NCT00092131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276814|NCT00092131|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93276815|NCT00092131|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93276816|NCT00092131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276817|NCT02170584|Dabigatran|dabigatran|mesh-list
93276818|NCT02170584|Antithrombins|antithrombins|mesh-ancestor
93276819|NCT02170584|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276820|NCT02170584|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276821|NCT02170584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276822|NCT02170584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276823|NCT02170584|Anticoagulants|anticoagulants|mesh-ancestor
93276824|NCT03577977|Interferons|interferons|mesh-list
93276825|NCT03577977|Interferon-beta|interferon-beta|mesh-list
93276826|NCT03577977|Interferon beta-1b|interferon beta-1b|mesh-list
93276827|NCT03577977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276828|NCT03577977|Antiviral Agents|antiviral agents|mesh-ancestor
93276829|NCT03577977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276830|NCT03577977|Immunologic Factors|immunologic factors|mesh-ancestor
93276831|NCT03577977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276832|NCT03577977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93276833|NCT02668783|Ibuprofen|ibuprofen|mesh-list
93276834|NCT02668783|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93276835|NCT02668783|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93276836|NCT02668783|Etonogestrel|etonogestrel|mesh-list
93276837|NCT02668783|Estradiol|estradiol|mesh-list
93276838|NCT02668783|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93276839|NCT02668783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93276840|NCT02668783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93276841|NCT02668783|Analgesics|analgesics|mesh-ancestor
93276842|NCT02668783|Sensory System Agents|sensory system agents|mesh-ancestor
93276843|NCT02668783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276844|NCT02668783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276845|NCT02668783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276846|NCT02668783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276847|NCT02668783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93276848|NCT02668783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276849|NCT02668783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276850|NCT02668783|Estrogens|estrogens|mesh-ancestor
93276851|NCT02668783|Hormones|hormones|mesh-ancestor
93276852|NCT02668783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276853|NCT02668783|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93276854|NCT02668783|Contraceptive Agents|contraceptive agents|mesh-ancestor
93276855|NCT02668783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276856|NCT02668783|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93276857|NCT05010304|Amoxicillin|amoxicillin|mesh-list
93276858|NCT05010304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93276859|NCT05010304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93276860|NCT03577899|Aflibercept|aflibercept|mesh-list
93276861|NCT03577899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93276862|NCT03577899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93276863|NCT03577899|Growth Substances|growth substances|mesh-ancestor
93276864|NCT03577899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276865|NCT03577899|Growth Inhibitors|growth inhibitors|mesh-ancestor
93276866|NCT03577899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276867|NCT02175342|Tiotropium Bromide|tiotropium bromide|mesh-list
93276868|NCT02175342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93276869|NCT02175342|Autonomic Agents|autonomic agents|mesh-ancestor
93276870|NCT02175342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276871|NCT02175342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276872|NCT02175342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276873|NCT02175342|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276874|NCT02175342|Parasympatholytics|parasympatholytics|mesh-ancestor
93276875|NCT02175342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93276876|NCT02175342|Cholinergic Agents|cholinergic agents|mesh-ancestor
93276877|NCT02175342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276878|NCT02175342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276879|NCT02171520|Dabigatran|dabigatran|mesh-list
93276880|NCT02171520|Antithrombins|antithrombins|mesh-ancestor
93276881|NCT02171520|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276882|NCT02171520|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276883|NCT02171520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276884|NCT02171520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276885|NCT02171520|Anticoagulants|anticoagulants|mesh-ancestor
93276886|NCT00092053|Ibandronic Acid|ibandronic acid|mesh-list
93276887|NCT00092053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93276888|NCT00092053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276889|NCT00101010|Prednisone|prednisone|mesh-list
93276890|NCT00101010|Cyclophosphamide|cyclophosphamide|mesh-list
93276891|NCT00101010|Rituximab|rituximab|mesh-list
93276892|NCT00101010|Doxorubicin|doxorubicin|mesh-list
93276893|NCT00101010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93276894|NCT00101010|Vincristine|vincristine|mesh-list
93276895|NCT00101010|Lenograstim|lenograstim|mesh-list
93276896|NCT00101010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93276897|NCT00101010|Immunologic Factors|immunologic factors|mesh-ancestor
93276898|NCT00101010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276899|NCT00101010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93276900|NCT00101010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93276901|NCT00101010|Alkylating Agents|alkylating agents|mesh-ancestor
93276902|NCT00101010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276903|NCT00101010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276904|NCT00101010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93276905|NCT00101010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93276906|NCT00101010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93276907|NCT00101010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93276908|NCT00101010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93276909|NCT00101010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276910|NCT00101010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276911|NCT00101010|Glucocorticoids|glucocorticoids|mesh-ancestor
93276913|NCT00101010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276914|NCT00101010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93276915|NCT00101010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93276916|NCT00101010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93276917|NCT00101010|Tubulin Modulators|tubulin modulators|mesh-ancestor
93276918|NCT00101010|Antimitotic Agents|antimitotic agents|mesh-ancestor
93276919|NCT00101010|Mitosis Modulators|mitosis modulators|mesh-ancestor
93276920|NCT03539172|Apatinib|apatinib|mesh-list
93276921|NCT03539172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276922|NCT03539172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93276923|NCT03539172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276924|NCT03539172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276925|NCT03209401|Carboplatin|carboplatin|mesh-list
93276926|NCT03209401|Niraparib|niraparib|mesh-list
93276927|NCT03209401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276928|NCT03209401|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93276929|NCT03209401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276930|NCT03209401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276931|NCT02175420|BCG Vaccine|bcg vaccine|mesh-list
93276932|NCT02175420|Immunologic Factors|immunologic factors|mesh-ancestor
93276933|NCT02175420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276934|NCT02175420|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93276935|NCT04576104|Metformin|metformin|mesh-list
93276936|NCT04576104|Megestrol|megestrol|mesh-list
93276937|NCT04576104|Megestrol Acetate|megestrol acetate|mesh-list
93276938|NCT04576104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93276939|NCT04576104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276940|NCT04576104|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93276941|NCT04576104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93276942|NCT04576104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93276943|NCT04576104|Contraceptive Agents|contraceptive agents|mesh-ancestor
93276944|NCT04576104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93276945|NCT04576104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93276946|NCT04576104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93276947|NCT04576104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93276948|NCT04576104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93276949|NCT04576104|Appetite Stimulants|appetite stimulants|mesh-ancestor
93276950|NCT04576104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93276951|NCT04859764|Betamethasone|betamethasone|mesh-list
93276952|NCT04859764|Bupivacaine|bupivacaine|mesh-list
93276953|NCT04859764|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276954|NCT04859764|Anesthetics|anesthetics|mesh-ancestor
93276955|NCT04859764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276956|NCT04859764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276957|NCT04859764|Sensory System Agents|sensory system agents|mesh-ancestor
93276958|NCT04859764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276959|NCT04859764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93276960|NCT04859764|Glucocorticoids|glucocorticoids|mesh-ancestor
93276961|NCT04859764|Hormones|hormones|mesh-ancestor
93276962|NCT04859764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93276963|NCT04859764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93276964|NCT04859764|Respiratory System Agents|respiratory system agents|mesh-ancestor
93276965|NCT02170740|Pantoprazole|pantoprazole|mesh-list
93276966|NCT02170740|Dabigatran|dabigatran|mesh-list
93276967|NCT02170740|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93276968|NCT02170740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93276969|NCT02170740|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93276970|NCT02170740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93276971|NCT02170740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276972|NCT02170740|Antithrombins|antithrombins|mesh-ancestor
93276973|NCT02170740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276974|NCT02170740|Protease Inhibitors|protease inhibitors|mesh-ancestor
93276975|NCT02170740|Anticoagulants|anticoagulants|mesh-ancestor
93276976|NCT02848599|Morphine|morphine|mesh-list
93276977|NCT02848599|Levobupivacaine|levobupivacaine|mesh-list
93276978|NCT02848599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93276979|NCT02848599|Narcotics|narcotics|mesh-ancestor
93276980|NCT02848599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93276981|NCT02848599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276982|NCT02848599|Analgesics|analgesics|mesh-ancestor
93276983|NCT02848599|Sensory System Agents|sensory system agents|mesh-ancestor
93276984|NCT02848599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93276985|NCT02848599|Anesthetics, Local|anesthetics, local|mesh-ancestor
93276986|NCT02848599|Anesthetics|anesthetics|mesh-ancestor
93276987|NCT02171598|Dabigatran|dabigatran|mesh-list
93276988|NCT02171598|Clopidogrel|clopidogrel|mesh-list
93276989|NCT02171598|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93276990|NCT02171598|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93276991|NCT02171598|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93276992|NCT02171598|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93276993|NCT02171598|Purinergic Agents|purinergic agents|mesh-ancestor
93276994|NCT02171598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93276995|NCT02171598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93276996|NCT02171598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93276997|NCT02171598|Antithrombins|antithrombins|mesh-ancestor
93276998|NCT02171598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93276999|NCT02171598|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277000|NCT02171598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277001|NCT02171598|Anticoagulants|anticoagulants|mesh-ancestor
93277002|NCT03068962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93277003|NCT03068962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277004|NCT02171676|Docetaxel|docetaxel|mesh-list
93277005|NCT02171676|Afatinib|afatinib|mesh-list
93277006|NCT02171676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277007|NCT02171676|Tubulin Modulators|tubulin modulators|mesh-ancestor
93277008|NCT02171676|Antimitotic Agents|antimitotic agents|mesh-ancestor
93277009|NCT02171676|Mitosis Modulators|mitosis modulators|mesh-ancestor
93277010|NCT02171676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277011|NCT02171676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277012|NCT02171676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277013|NCT03577743|Bevacizumab|bevacizumab|mesh-list
93277014|NCT03577743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277015|NCT03577743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277016|NCT03577743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93277017|NCT03577743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93277018|NCT03577743|Growth Substances|growth substances|mesh-ancestor
93277019|NCT03577743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277020|NCT03577743|Growth Inhibitors|growth inhibitors|mesh-ancestor
93277021|NCT04794790|Buprenorphine|buprenorphine|mesh-list
93277022|NCT04794790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93277023|NCT04794790|Naloxone|naloxone|mesh-list
93277024|NCT04794790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93277025|NCT04794790|Narcotics|narcotics|mesh-ancestor
93277026|NCT04794790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277027|NCT04794790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277028|NCT04794790|Analgesics|analgesics|mesh-ancestor
92571609|NCT00230035|Antiemetics|antiemetics|mesh-ancestor
93277029|NCT04794790|Sensory System Agents|sensory system agents|mesh-ancestor
93277030|NCT04794790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277031|NCT04794790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93277032|NCT02171754|Ritonavir|ritonavir|mesh-list
93277033|NCT02171754|Afatinib|afatinib|mesh-list
93277034|NCT02171754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93277035|NCT02171754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93277036|NCT02171754|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277037|NCT02171754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277038|NCT02171754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277039|NCT02171754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93277040|NCT02171754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93277041|NCT02171754|Antiviral Agents|antiviral agents|mesh-ancestor
93277042|NCT02171754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277043|NCT02171754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93277044|NCT02171754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93277045|NCT02171754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277046|NCT02171754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277047|NCT02171832|Olodaterol|olodaterol|mesh-list
93277048|NCT02171832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277049|NCT02171832|Autonomic Agents|autonomic agents|mesh-ancestor
93277050|NCT02171832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277051|NCT02171832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277052|NCT02171832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277053|NCT02171832|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277054|NCT02171910|Doxapram|doxapram|mesh-list
93277055|NCT02171910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93277056|NCT02171910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277057|NCT02171910|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277058|NCT02178306|Telmisartan|telmisartan|mesh-list
93277059|NCT02178306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277060|NCT02178306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93277061|NCT02178306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93277062|NCT02178306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277063|NCT05729386|Metformin|metformin|mesh-list
93277064|NCT05729386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277065|NCT05729386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277066|NCT05729308|Anesthetics|anesthetics|mesh-list
93277067|NCT05729308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277068|NCT05729308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277069|NCT00778999|Desogestrel|desogestrel|mesh-list
93277070|NCT00778999|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93277071|NCT00778999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93277072|NCT00778999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93277073|NCT00778999|Contraceptive Agents|contraceptive agents|mesh-ancestor
93277074|NCT00778999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277075|NCT00778999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277076|NCT00778999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93277077|NCT00778999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93277078|NCT00778999|Progestins|progestins|mesh-ancestor
93277079|NCT00778999|Hormones|hormones|mesh-ancestor
93277080|NCT00778999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277081|NCT02171988|Propranolol|propranolol|mesh-list
93277082|NCT02171988|Bisoprolol|bisoprolol|mesh-list
93277083|NCT02171988|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93277084|NCT02171988|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93277085|NCT02171988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93277086|NCT02171988|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277087|NCT02171988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277088|NCT02171988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277089|NCT02171988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277090|NCT02171988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93277091|NCT02171988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277092|NCT02171988|Vasodilator Agents|vasodilator agents|mesh-ancestor
93277093|NCT02171988|Sympatholytics|sympatholytics|mesh-ancestor
93277094|NCT02171988|Autonomic Agents|autonomic agents|mesh-ancestor
93277095|NCT02171988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277096|NCT02171988|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93277097|NCT02171988|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93277098|NCT02171988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277099|NCT02171988|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277100|NCT00725413|Etonogestrel|etonogestrel|mesh-list
93277101|NCT00725413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93277102|NCT00725413|Contraceptive Agents|contraceptive agents|mesh-ancestor
93277103|NCT00725413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277104|NCT00725413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277105|NCT00725413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93277106|NCT00103038|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93277107|NCT00103038|Hematinics|hematinics|mesh-ancestor
93277108|NCT00103038|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93277109|NCT00103038|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93277110|NCT00620035|Etonogestrel|etonogestrel|mesh-list
93277111|NCT00620035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93277112|NCT00620035|Contraceptive Agents|contraceptive agents|mesh-ancestor
93277113|NCT00620035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277114|NCT00620035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277115|NCT00620035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93277116|NCT02175888|Iron|iron|mesh-list
93277117|NCT02175888|Trace Elements|trace elements|mesh-ancestor
93277118|NCT02175888|Micronutrients|micronutrients|mesh-ancestor
93277119|NCT02175888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277120|NCT05577637|Tacrolimus|tacrolimus|mesh-list
93277121|NCT05577637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93277122|NCT05577637|Immunologic Factors|immunologic factors|mesh-ancestor
93277123|NCT05577637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277124|NCT05577637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93277125|NCT05577637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277126|NCT05577637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277127|NCT02763579|Carboplatin|carboplatin|mesh-list
93277128|NCT02763579|Etoposide|etoposide|mesh-list
93277129|NCT02763579|Atezolizumab|atezolizumab|mesh-list
93277130|NCT02763579|Antibodies|antibodies|mesh-list
93277131|NCT02763579|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93277132|NCT02763579|Immunologic Factors|immunologic factors|mesh-ancestor
93277133|NCT02763579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277134|NCT02763579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277135|NCT02763579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93277136|NCT02763579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93277137|NCT02763579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93277138|NCT02763579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277139|NCT02763579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277140|NCT02763579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277141|NCT02763579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277142|NCT02176044|Nitroprusside|nitroprusside|mesh-list
93277143|NCT02176044|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277144|NCT02176044|Vasodilator Agents|vasodilator agents|mesh-ancestor
93277145|NCT02176044|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93277146|NCT02176044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277147|NCT02176122|Meropenem|meropenem|mesh-list
93277148|NCT02176122|Tazobactam|tazobactam|mesh-list
93277149|NCT02176122|Piperacillin|piperacillin|mesh-list
93277150|NCT02176122|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93277151|NCT02176122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277152|NCT02176122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277153|NCT02176122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93277154|NCT02176122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277155|NCT02176122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277156|NCT04887064|Sotorasib|sotorasib|mesh-list
93277157|NCT04887064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277158|NCT04887064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277159|NCT04887064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277160|NCT04887064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277161|NCT02967757|Liraglutide|liraglutide|mesh-list
93277162|NCT02967757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277163|NCT02967757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277164|NCT02967757|Incretins|incretins|mesh-ancestor
93277165|NCT02967757|Hormones|hormones|mesh-ancestor
93277166|NCT02967757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277167|NCT02261298|Nivolumab|nivolumab|mesh-list
93277168|NCT02261298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277169|NCT02261298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277170|NCT02261298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277171|NCT02261298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277172|NCT02176200|Fenoterol|fenoterol|mesh-list
93277173|NCT02176200|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93277174|NCT02176200|Ipratropium|ipratropium|mesh-list
93277175|NCT02176200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277176|NCT02176200|Autonomic Agents|autonomic agents|mesh-ancestor
93277177|NCT02176200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277178|NCT02176200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277179|NCT02176200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277180|NCT02176200|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277181|NCT02176200|Sympathomimetics|sympathomimetics|mesh-ancestor
93277182|NCT02176200|Tocolytic Agents|tocolytic agents|mesh-ancestor
93277183|NCT02176200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277184|NCT02176200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93277185|NCT02176200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93277186|NCT02176200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277187|NCT02176200|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277188|NCT02176200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277189|NCT02176200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277190|NCT02176200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93277191|NCT02176200|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277192|NCT03537612|Clonidine|clonidine|mesh-list
93277193|NCT03537612|Morphine|morphine|mesh-list
93277194|NCT03537612|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93277195|NCT03537612|Narcotics|narcotics|mesh-ancestor
93277196|NCT03537612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277197|NCT03537612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277199|NCT03537612|Sensory System Agents|sensory system agents|mesh-ancestor
93277200|NCT03537612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277201|NCT03537612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277202|NCT03537612|Sympatholytics|sympatholytics|mesh-ancestor
93277203|NCT03537612|Autonomic Agents|autonomic agents|mesh-ancestor
93277204|NCT03537612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93277205|NCT03537612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93277206|NCT03537612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277207|NCT03537612|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277208|NCT03537612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277209|NCT03537612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277210|NCT00336063|Azacitidine|azacitidine|mesh-list
93277211|NCT00336063|Vorinostat|vorinostat|mesh-list
93277212|NCT00336063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93277213|NCT00336063|Antimetabolites|antimetabolites|mesh-ancestor
93277214|NCT00336063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277215|NCT00336063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277216|NCT00336063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277217|NCT00336063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93277218|NCT02172144|Moxifloxacin|moxifloxacin|mesh-list
93277219|NCT02172144|Olodaterol|olodaterol|mesh-list
93277220|NCT02172144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277221|NCT02172144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277222|NCT02172144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93277223|NCT02172144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93277224|NCT02172144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277225|NCT02172144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277226|NCT02172144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277227|NCT02172144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277228|NCT02172144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277229|NCT02172144|Autonomic Agents|autonomic agents|mesh-ancestor
93277230|NCT02172144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277231|NCT02172144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277232|NCT02172144|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277233|NCT05729074|Pimecrolimus|pimecrolimus|mesh-list
93277234|NCT05729074|Varespladib methyl|varespladib methyl|mesh-list
93277235|NCT05729074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93277236|NCT05729074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277237|NCT05729074|Analgesics|analgesics|mesh-ancestor
93277238|NCT05729074|Sensory System Agents|sensory system agents|mesh-ancestor
93277239|NCT05729074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277240|NCT05729074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277241|NCT05729074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277242|NCT05729074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277243|NCT05729074|Dermatologic Agents|dermatologic agents|mesh-ancestor
93277244|NCT05729074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93277245|NCT05729074|Immunologic Factors|immunologic factors|mesh-ancestor
93277246|NCT05729074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93277247|NCT05729074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277248|NCT05729074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277249|NCT05729074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93277250|NCT02176512|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93277251|NCT02176512|Telmisartan|telmisartan|mesh-list
93277252|NCT02176512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277253|NCT02176512|Diuretics|diuretics|mesh-ancestor
93277254|NCT02176512|Natriuretic Agents|natriuretic agents|mesh-ancestor
93277255|NCT02176512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277256|NCT02176512|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93277257|NCT02176512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93277258|NCT02176512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277259|NCT02176512|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93277260|NCT02176512|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93277261|NCT03537534|Lidocaine|lidocaine|mesh-list
93277262|NCT03537534|Anesthetics, Local|anesthetics, local|mesh-ancestor
93277263|NCT03537534|Anesthetics|anesthetics|mesh-ancestor
93277264|NCT03537534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277265|NCT03537534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277266|NCT03537534|Sensory System Agents|sensory system agents|mesh-ancestor
93277267|NCT03537534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277268|NCT03537534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93277269|NCT03537534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93277270|NCT03537534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93277271|NCT03537534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93277272|NCT03537534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277273|NCT03068650|Rindopepimut|rindopepimut|mesh-list
93277274|NCT03068650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277275|NCT03068650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277276|NCT04646005|Cemiplimab|cemiplimab|mesh-list
93277277|NCT04646005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277278|NCT04646005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277279|NCT02757768|Tamsulosin|tamsulosin|mesh-list
93277280|NCT02757768|Mirabegron|mirabegron|mesh-list
93277281|NCT02757768|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93277282|NCT02757768|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93277283|NCT02757768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93277284|NCT02757768|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277285|NCT02757768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277286|NCT02757768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277287|NCT02757768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277288|NCT02757768|Urological Agents|urological agents|mesh-ancestor
93277289|NCT02757768|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93277290|NCT02757768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93277291|NCT02757768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277292|NCT03066076|Propylthiouracil|propylthiouracil|mesh-list
93277293|NCT03066076|Antithyroid Agents|antithyroid agents|mesh-list
93277294|NCT03066076|Antimetabolites|antimetabolites|mesh-ancestor
93277295|NCT03066076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277296|NCT03066076|Hormone Antagonists|hormone antagonists|mesh-ancestor
93277297|NCT03066076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277298|NCT03066076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277299|NCT05225077|Dapagliflozin|dapagliflozin|mesh-list
93277300|NCT05225077|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93277301|NCT05225077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277302|NCT05225077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277303|NCT05225077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277304|NCT03067792|Leucovorin|leucovorin|mesh-list
93277305|NCT03067792|Docetaxel|docetaxel|mesh-list
93277306|NCT03067792|Fluorouracil|fluorouracil|mesh-list
93277307|NCT03067792|Irinotecan|irinotecan|mesh-list
93277308|NCT03067792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277309|NCT03067792|Tubulin Modulators|tubulin modulators|mesh-ancestor
93277310|NCT03067792|Antimitotic Agents|antimitotic agents|mesh-ancestor
93277311|NCT03067792|Mitosis Modulators|mitosis modulators|mesh-ancestor
93277312|NCT03067792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277313|NCT03067792|Antimetabolites|antimetabolites|mesh-ancestor
93277314|NCT03067792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93277315|NCT03067792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93277316|NCT03067792|Immunologic Factors|immunologic factors|mesh-ancestor
93277317|NCT03067792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277318|NCT03067792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93277319|NCT03067792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93277320|NCT03067792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277321|NCT03067792|Antidotes|antidotes|mesh-ancestor
93277322|NCT03067792|Protective Agents|protective agents|mesh-ancestor
93277323|NCT03067792|Vitamin B Complex|vitamin b complex|mesh-ancestor
93277324|NCT03067792|Vitamins|vitamins|mesh-ancestor
93277325|NCT03067792|Micronutrients|micronutrients|mesh-ancestor
93277326|NCT05224999|Nivolumab|nivolumab|mesh-list
93277327|NCT05224999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277328|NCT05224999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277329|NCT05224999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277330|NCT05224999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277331|NCT03066154|Ritonavir|ritonavir|mesh-list
93277332|NCT03066154|Docetaxel|docetaxel|mesh-list
93277333|NCT03066154|Androgens|androgens|mesh-list
93277334|NCT03066154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277335|NCT03066154|Tubulin Modulators|tubulin modulators|mesh-ancestor
93277336|NCT03066154|Antimitotic Agents|antimitotic agents|mesh-ancestor
93277337|NCT03066154|Mitosis Modulators|mitosis modulators|mesh-ancestor
93277338|NCT03066154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277339|NCT03066154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93277340|NCT03066154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93277341|NCT03066154|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277342|NCT03066154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277343|NCT03066154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93277344|NCT03066154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93277345|NCT03066154|Antiviral Agents|antiviral agents|mesh-ancestor
93277346|NCT03066154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277347|NCT03066154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93277348|NCT03066154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93277349|NCT03066154|Hormones|hormones|mesh-ancestor
93277350|NCT03066154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277351|NCT03066154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277352|NCT05224687|Daptomycin|daptomycin|mesh-list
93277353|NCT05224687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277354|NCT05224687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277355|NCT02753946|Tazobactam|tazobactam|mesh-list
93277356|NCT02753946|Piperacillin|piperacillin|mesh-list
93277357|NCT02753946|Fosfomycin|fosfomycin|mesh-list
93277358|NCT02753946|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93277359|NCT02753946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277360|NCT02753946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277361|NCT02753946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93277362|NCT02753946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277363|NCT02753946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277364|NCT00431431|Tibolone|tibolone|mesh-list
93277365|NCT00431431|Androgen Antagonists|androgen antagonists|mesh-ancestor
93277366|NCT00431431|Hormone Antagonists|hormone antagonists|mesh-ancestor
93277367|NCT00431431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277368|NCT00431431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277369|NCT00431431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277370|NCT00431431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93277371|NCT00431431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277372|NCT00431431|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93277373|NCT00431431|Anabolic Agents|anabolic agents|mesh-ancestor
93277374|NCT00431431|Hormones|hormones|mesh-ancestor
93277375|NCT02172222|Linagliptin|linagliptin|mesh-list
93277376|NCT02172222|Empagliflozin|empagliflozin|mesh-list
93277377|NCT02172222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277378|NCT02172222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277379|NCT02172222|Incretins|incretins|mesh-ancestor
93277380|NCT02172222|Hormones|hormones|mesh-ancestor
93277381|NCT02172222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277382|NCT02172222|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93277383|NCT02172222|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277384|NCT02172222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277385|NCT02172222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277386|NCT02172222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93277387|NCT03625219|Prednisone|prednisone|mesh-list
93277388|NCT03625219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277389|NCT03625219|Glucocorticoids|glucocorticoids|mesh-ancestor
93277390|NCT03625219|Hormones|hormones|mesh-ancestor
93277391|NCT03625219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277392|NCT03625219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277393|NCT03625219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93277394|NCT03625219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277395|NCT03065842|Contraceptive Agents|contraceptive agents|mesh-list
93277396|NCT03065842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277397|NCT03065842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277398|NCT02179008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93277399|NCT02179008|Latanoprost|latanoprost|mesh-list
93277400|NCT02179008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93277401|NCT02172300|Tiotropium Bromide|tiotropium bromide|mesh-list
93277402|NCT02172300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277403|NCT02172300|Autonomic Agents|autonomic agents|mesh-ancestor
93277404|NCT02172300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277405|NCT02172300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277406|NCT02172300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277407|NCT02172300|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277408|NCT02172300|Parasympatholytics|parasympatholytics|mesh-ancestor
93277409|NCT02172300|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93277410|NCT02172300|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277411|NCT02172300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277412|NCT02172300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277413|NCT05223907|Propofol|propofol|mesh-list
93277414|NCT05223907|Etomidate|etomidate|mesh-list
93277415|NCT05223907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93277416|NCT05223907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277417|NCT05223907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277418|NCT05223907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93277419|NCT05223907|Anesthetics, General|anesthetics, general|mesh-ancestor
93277420|NCT05223907|Anesthetics|anesthetics|mesh-ancestor
93277421|NCT03065998|Baclofen|baclofen|mesh-list
93277422|NCT03065998|Opipramol|opipramol|mesh-list
93277423|NCT03065998|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93277424|NCT03065998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277425|NCT03065998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93277426|NCT03065998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277427|NCT03065998|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93277428|NCT03065998|GABA Agonists|gaba agonists|mesh-ancestor
93277429|NCT03065998|GABA Agents|gaba agents|mesh-ancestor
93277430|NCT03065998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277431|NCT03065998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277432|NCT03065998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93277433|NCT03065998|Antidepressive Agents|antidepressive agents|mesh-ancestor
93277434|NCT03065998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93277435|NCT03065998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93277436|NCT03065998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93277437|NCT03065998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93277438|NCT03065998|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277439|NCT02172378|Tiotropium Bromide|tiotropium bromide|mesh-list
93277440|NCT02172378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277441|NCT02172378|Autonomic Agents|autonomic agents|mesh-ancestor
93277442|NCT02172378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277443|NCT02172378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277444|NCT02172378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277445|NCT02172378|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277446|NCT02172378|Parasympatholytics|parasympatholytics|mesh-ancestor
93277447|NCT02172378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93277448|NCT02172378|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277449|NCT02172378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277450|NCT02172378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277451|NCT05728528|Factor VIII|factor viii|mesh-list
93277452|NCT05728528|Coagulants|coagulants|mesh-ancestor
93277453|NCT02256228|Ropivacaine|ropivacaine|mesh-list
93277454|NCT02256228|Anesthetics, Local|anesthetics, local|mesh-ancestor
93277455|NCT02256228|Anesthetics|anesthetics|mesh-ancestor
93277456|NCT02256228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277457|NCT02256228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277458|NCT02256228|Sensory System Agents|sensory system agents|mesh-ancestor
93277459|NCT02256228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277460|NCT03067168|Bupivacaine|bupivacaine|mesh-list
93277461|NCT03067168|Anesthetics, Local|anesthetics, local|mesh-ancestor
93277462|NCT03067168|Anesthetics|anesthetics|mesh-ancestor
93277463|NCT03067168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277464|NCT03067168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277465|NCT03067168|Sensory System Agents|sensory system agents|mesh-ancestor
93277466|NCT03067168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277467|NCT04774237|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93277468|NCT04774237|Carbachol|carbachol|mesh-list
93277469|NCT04774237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277470|NCT04774237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93277471|NCT04774237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93277472|NCT04774237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277473|NCT04774237|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277474|NCT04774237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277475|NCT04774237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277476|NCT04774237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277477|NCT04774237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93277478|NCT04774237|Miotics|miotics|mesh-ancestor
93277479|NCT04774237|Autonomic Agents|autonomic agents|mesh-ancestor
93277480|NCT04774237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277481|NCT04774237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93277482|NCT04774237|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277483|NCT04774237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277484|NCT04774237|Analgesics|analgesics|mesh-ancestor
93277485|NCT04774237|Sensory System Agents|sensory system agents|mesh-ancestor
93277486|NCT04774237|Protective Agents|protective agents|mesh-ancestor
93277487|NCT02172456|Tiotropium Bromide|tiotropium bromide|mesh-list
93277488|NCT02172456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277489|NCT02172456|Autonomic Agents|autonomic agents|mesh-ancestor
93277490|NCT02172456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277491|NCT02172456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277492|NCT02172456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277493|NCT02172456|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277494|NCT02172456|Parasympatholytics|parasympatholytics|mesh-ancestor
93277495|NCT02172456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93277496|NCT02172456|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277497|NCT02172456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277498|NCT02172456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277499|NCT02172534|Bromides|bromides|mesh-list
93277500|NCT02172534|Tiotropium Bromide|tiotropium bromide|mesh-list
93277501|NCT02172534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277502|NCT02172534|Autonomic Agents|autonomic agents|mesh-ancestor
93277503|NCT02172534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277504|NCT02172534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277505|NCT02172534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277506|NCT02172534|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277507|NCT02172534|Parasympatholytics|parasympatholytics|mesh-ancestor
93277508|NCT02172534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93277509|NCT02172534|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277510|NCT02172534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277511|NCT02172534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277512|NCT02172534|Anticonvulsants|anticonvulsants|mesh-ancestor
93277513|NCT04713631|Artesunate|artesunate|mesh-list
93277514|NCT04713631|Curcumin|curcumin|mesh-list
93277515|NCT04713631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93277516|NCT04713631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277517|NCT04713631|Analgesics|analgesics|mesh-ancestor
93277518|NCT04713631|Sensory System Agents|sensory system agents|mesh-ancestor
93277519|NCT04713631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277520|NCT04713631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277521|NCT04713631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277522|NCT04713631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277523|NCT04713631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277524|NCT04713631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277525|NCT04713631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277526|NCT04713631|Antimalarials|antimalarials|mesh-ancestor
93277527|NCT04713631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93277528|NCT04713631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93277529|NCT04713631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277530|NCT04713631|Antiviral Agents|antiviral agents|mesh-ancestor
93277531|NCT04713631|Schistosomicides|schistosomicides|mesh-ancestor
93277532|NCT04713631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93277533|NCT04713631|Anthelmintics|anthelmintics|mesh-ancestor
93277534|NCT04459078|Apatinib|apatinib|mesh-list
93277535|NCT04459078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93277536|NCT04459078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277537|NCT04459078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277538|NCT04459078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277539|NCT04459078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277540|NCT04459078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277541|NCT02756832|Alogliptin|alogliptin|mesh-list
93277542|NCT02756832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277543|NCT02756832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277544|NCT02756832|Incretins|incretins|mesh-ancestor
93277545|NCT02756832|Hormones|hormones|mesh-ancestor
93277546|NCT02756832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277547|NCT02756832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93277548|NCT02756832|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277549|NCT02756832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277550|NCT02756832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277551|NCT00108810|Ketoprofen|ketoprofen|mesh-list
93277552|NCT00108810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93277553|NCT00108810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277554|NCT00108810|Analgesics|analgesics|mesh-ancestor
93277555|NCT00108810|Sensory System Agents|sensory system agents|mesh-ancestor
93277556|NCT00108810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277557|NCT00108810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277558|NCT00108810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277559|NCT00108810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277560|NCT00108810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93277561|NCT00108810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277562|NCT00108810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277563|NCT04448392|Valacyclovir|valacyclovir|mesh-list
93277564|NCT04448392|Antiviral Agents|antiviral agents|mesh-ancestor
93277565|NCT04448392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277566|NCT05588284|Rivaroxaban|rivaroxaban|mesh-list
93277567|NCT05588284|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93277568|NCT05588284|Antithrombins|antithrombins|mesh-ancestor
93277569|NCT05588284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93277570|NCT05588284|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277571|NCT05588284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277572|NCT05588284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277573|NCT05588284|Anticoagulants|anticoagulants|mesh-ancestor
93277575|NCT02256150|Cyclophosphamide|cyclophosphamide|mesh-list
93277576|NCT02256150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93277577|NCT02256150|Immunologic Factors|immunologic factors|mesh-ancestor
93277578|NCT02256150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277579|NCT02256150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277580|NCT02256150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93277581|NCT02256150|Alkylating Agents|alkylating agents|mesh-ancestor
93277582|NCT02256150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277583|NCT02256150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277584|NCT02256150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93277585|NCT02256150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93277586|NCT02256150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277587|NCT02256150|Analgesics|analgesics|mesh-ancestor
93277588|NCT02256150|Sensory System Agents|sensory system agents|mesh-ancestor
93277589|NCT02256150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277590|NCT02256150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277591|NCT02256150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277592|NCT02256150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277593|NCT02256150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93277594|NCT02256150|Antimalarials|antimalarials|mesh-ancestor
93277595|NCT02256150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93277596|NCT02256150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93277597|NCT02256150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277598|NCT02177370|Fenoterol|fenoterol|mesh-list
93277599|NCT02177370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277600|NCT02177370|Autonomic Agents|autonomic agents|mesh-ancestor
93277601|NCT02177370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277602|NCT02177370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277603|NCT02177370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277604|NCT02177370|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277605|NCT02177370|Sympathomimetics|sympathomimetics|mesh-ancestor
93277606|NCT02177370|Tocolytic Agents|tocolytic agents|mesh-ancestor
93277607|NCT02177370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277608|NCT02177370|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93277609|NCT02177370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93277610|NCT02177370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277611|NCT02177370|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277612|NCT02177370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277613|NCT02177370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277614|NCT03538704|Metformin|metformin|mesh-list
93277615|NCT03538704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277616|NCT03538704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277617|NCT02172768|Micafungin|micafungin|mesh-list
93277618|NCT02172768|Antifungal Agents|antifungal agents|mesh-ancestor
93277619|NCT02172768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277620|NCT02172846|Paclitaxel|paclitaxel|mesh-list
93277621|NCT02172846|Carboplatin|carboplatin|mesh-list
93277622|NCT02172846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93277623|NCT02172846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277624|NCT02172846|Tubulin Modulators|tubulin modulators|mesh-ancestor
93277625|NCT02172846|Antimitotic Agents|antimitotic agents|mesh-ancestor
93277626|NCT02172846|Mitosis Modulators|mitosis modulators|mesh-ancestor
93277627|NCT02172846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277628|NCT00106626|Pemetrexed|pemetrexed|mesh-list
93277629|NCT00106626|Vorinostat|vorinostat|mesh-list
93277630|NCT00106626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277631|NCT00106626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277632|NCT00106626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277633|NCT00106626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93277634|NCT00106626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93277635|NCT00106626|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93277636|NCT02177448|Enalapril|enalapril|mesh-list
93277637|NCT02177448|Enalaprilat|enalaprilat|mesh-list
93277638|NCT02177448|Telmisartan|telmisartan|mesh-list
93277639|NCT02177448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93277640|NCT02177448|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277641|NCT02177448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277642|NCT02177448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277643|NCT02177448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93277644|NCT02177448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93277645|NCT02177448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93277646|NCT03537144|Acetaminophen|acetaminophen|mesh-list
93277647|NCT03537144|Indomethacin|indomethacin|mesh-list
93277648|NCT03537144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277649|NCT03537144|Analgesics|analgesics|mesh-ancestor
93277650|NCT03537144|Sensory System Agents|sensory system agents|mesh-ancestor
93277651|NCT03537144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277652|NCT03537144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277653|NCT03537144|Antipyretics|antipyretics|mesh-ancestor
93277654|NCT03537144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93277655|NCT03537144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277656|NCT03537144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277657|NCT03537144|Gout Suppressants|gout suppressants|mesh-ancestor
93277658|NCT03537144|Tocolytic Agents|tocolytic agents|mesh-ancestor
93277659|NCT03537144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277660|NCT03537144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93277661|NCT03537144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277662|NCT03537144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277663|NCT03065764|Pembrolizumab|pembrolizumab|mesh-list
93277664|NCT03065764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277665|NCT03065764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277666|NCT03065764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277667|NCT03065764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277668|NCT02755818|Heparin|heparin|mesh-list
93277669|NCT02755818|Calcium heparin|calcium heparin|mesh-list
93277670|NCT02755818|Anticoagulants|anticoagulants|mesh-ancestor
93277671|NCT02755818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93277672|NCT02755818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93277673|NCT02755818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277674|NCT02177760|Sirolimus|sirolimus|mesh-list
93277675|NCT02177760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277676|NCT02177760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277677|NCT02177760|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93277678|NCT02177760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277679|NCT02177760|Antifungal Agents|antifungal agents|mesh-ancestor
93277680|NCT02177760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93277681|NCT02177760|Immunologic Factors|immunologic factors|mesh-ancestor
93277682|NCT02177760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277683|NCT02173782|Fenoterol|fenoterol|mesh-list
93277684|NCT02173782|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93277685|NCT02173782|Ipratropium|ipratropium|mesh-list
93277686|NCT02173782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277687|NCT02173782|Autonomic Agents|autonomic agents|mesh-ancestor
93277688|NCT02173782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277689|NCT02173782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277690|NCT02173782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277691|NCT02173782|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277692|NCT02173782|Sympathomimetics|sympathomimetics|mesh-ancestor
93277693|NCT02173782|Tocolytic Agents|tocolytic agents|mesh-ancestor
93277694|NCT02173782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277695|NCT02173782|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93277696|NCT02173782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93277697|NCT02173782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277698|NCT02173782|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277699|NCT02173782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277700|NCT02173782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277701|NCT02173782|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93277702|NCT02173782|Cholinergic Agents|cholinergic agents|mesh-ancestor
93277703|NCT05717374|Dexamethasone|dexamethasone|mesh-list
93277704|NCT05717374|Dexamethasone acetate|dexamethasone acetate|mesh-list
93277705|NCT05717374|Methylprednisolone|methylprednisolone|mesh-list
93277706|NCT05717374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93277707|NCT05717374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93277708|NCT05717374|Prednisolone|prednisolone|mesh-list
93277709|NCT05717374|Prednisolone acetate|prednisolone acetate|mesh-list
93277710|NCT05717374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93277711|NCT05717374|Prednisolone phosphate|prednisolone phosphate|mesh-list
93277712|NCT05717374|BB 1101|bb 1101|mesh-list
93277713|NCT05717374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277714|NCT05717374|Antiemetics|antiemetics|mesh-ancestor
93277715|NCT05717374|Autonomic Agents|autonomic agents|mesh-ancestor
93277716|NCT05717374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277717|NCT05717374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277718|NCT05717374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93277719|NCT05717374|Glucocorticoids|glucocorticoids|mesh-ancestor
93277721|NCT05717374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277722|NCT05717374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93277723|NCT05717374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277724|NCT05717374|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277725|NCT05717374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277726|NCT05717374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277727|NCT05717374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93277728|NCT05717374|Protective Agents|protective agents|mesh-ancestor
93277729|NCT03537768|Levonorgestrel|levonorgestrel|mesh-list
93277730|NCT03537768|Ulipristal acetate|ulipristal acetate|mesh-list
93277731|NCT03537768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93277732|NCT03537768|Contraceptive Agents|contraceptive agents|mesh-ancestor
93277733|NCT03537768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93277734|NCT03537768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277735|NCT03537768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93277736|NCT03537768|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93277737|NCT03537768|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93277738|NCT02174094|Clobazam|clobazam|mesh-list
93277739|NCT02174094|Anticonvulsants|anticonvulsants|mesh-ancestor
93277740|NCT02174094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93277741|NCT02174094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93277742|NCT02174094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277743|NCT02174094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277744|NCT02174094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93277745|NCT02174094|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93277746|NCT02174094|GABA Agonists|gaba agonists|mesh-ancestor
93277747|NCT02174094|GABA Agents|gaba agents|mesh-ancestor
93277748|NCT02174094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277749|NCT02174094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277750|NCT02174172|Interferons|interferons|mesh-list
93277751|NCT02174172|Interferon-alpha|interferon-alpha|mesh-list
93277752|NCT02174172|Interferon alpha-2|interferon alpha-2|mesh-list
93277753|NCT02174172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93277754|NCT02174172|Bevacizumab|bevacizumab|mesh-list
93277755|NCT02174172|Ipilimumab|ipilimumab|mesh-list
93277756|NCT02174172|Atezolizumab|atezolizumab|mesh-list
93277757|NCT02174172|Obinutuzumab|obinutuzumab|mesh-list
93277758|NCT02174172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277759|NCT02174172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277760|NCT02174172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93277761|NCT02174172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93277762|NCT02174172|Growth Substances|growth substances|mesh-ancestor
93277763|NCT02174172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277764|NCT02174172|Growth Inhibitors|growth inhibitors|mesh-ancestor
93277765|NCT02174172|Antiviral Agents|antiviral agents|mesh-ancestor
93277766|NCT02174172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572349|NCT00076284|Aplaviroc|aplaviroc|mesh-list
93277767|NCT02174172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277768|NCT02174172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277769|NCT02174172|Immunologic Factors|immunologic factors|mesh-ancestor
93277770|NCT02180334|Acetaminophen|acetaminophen|mesh-list
93277771|NCT02180334|Linagliptin|linagliptin|mesh-list
93277772|NCT02180334|Mosapride|mosapride|mesh-list
93277773|NCT02180334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277774|NCT02180334|Analgesics|analgesics|mesh-ancestor
93277775|NCT02180334|Sensory System Agents|sensory system agents|mesh-ancestor
93277776|NCT02180334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277777|NCT02180334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277778|NCT02180334|Antipyretics|antipyretics|mesh-ancestor
93277779|NCT02180334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277780|NCT02180334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277781|NCT02180334|Incretins|incretins|mesh-ancestor
93277782|NCT02180334|Hormones|hormones|mesh-ancestor
93277783|NCT02180334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277784|NCT02180334|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93277785|NCT02180334|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277786|NCT02180334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277787|NCT02180334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93277788|NCT02180334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93277789|NCT02180334|Serotonin Agents|serotonin agents|mesh-ancestor
93277790|NCT02180334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277791|NCT02174250|Rifampin|rifampin|mesh-list
93277792|NCT02174250|Istradefylline|istradefylline|mesh-list
93277793|NCT02174250|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93277794|NCT02174250|Antitubercular Agents|antitubercular agents|mesh-ancestor
93277795|NCT02174250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277796|NCT02174250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277797|NCT02174250|Leprostatic Agents|leprostatic agents|mesh-ancestor
93277798|NCT02174250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93277799|NCT02174250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277800|NCT02174250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277801|NCT02174250|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93277802|NCT02174250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93277803|NCT02174250|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93277804|NCT02174250|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93277805|NCT02174250|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93277806|NCT02174250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93277807|NCT02174250|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93277808|NCT02174250|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93277809|NCT02174250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93277810|NCT02174250|Purinergic Agents|purinergic agents|mesh-ancestor
93277811|NCT02174250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277812|NCT02174250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277814|NCT02174328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93277815|NCT02174328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93277816|NCT02174328|Analgesics|analgesics|mesh-ancestor
93277817|NCT02174328|Sensory System Agents|sensory system agents|mesh-ancestor
93277818|NCT02174328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277819|NCT02174328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277820|NCT02174328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277821|NCT02174328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277822|NCT02174328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93277823|NCT02174328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93277824|NCT02174328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277825|NCT02174328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93277826|NCT02174328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93277827|NCT02174328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277828|NCT02174328|Antipyretics|antipyretics|mesh-ancestor
93277829|NCT02177994|Ceftriaxone|ceftriaxone|mesh-list
93277830|NCT02177994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93277831|NCT02177994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277832|NCT02755116|Olanzapine|olanzapine|mesh-list
93277833|NCT02755116|Antiemetics|antiemetics|mesh-ancestor
93277834|NCT02755116|Autonomic Agents|autonomic agents|mesh-ancestor
93277835|NCT02755116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277836|NCT02755116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277837|NCT02755116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93277838|NCT02755116|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93277839|NCT02755116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93277840|NCT02755116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277841|NCT02755116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93277842|NCT02755116|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93277843|NCT02755116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93277844|NCT02755116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93277845|NCT02755116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277846|NCT02755116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277847|NCT02755116|Serotonin Agents|serotonin agents|mesh-ancestor
93277848|NCT02178150|Magnesium Oxide|magnesium oxide|mesh-list
93277849|NCT02178150|Antacids|antacids|mesh-ancestor
93277850|NCT02178150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277851|NCT02178150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93277852|NCT04411030|Itraconazole|itraconazole|mesh-list
93277853|NCT04411030|Midazolam|midazolam|mesh-list
93277854|NCT04411030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93277855|NCT04411030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93277856|NCT04411030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277857|NCT04411030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277858|NCT04411030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93277859|NCT04411030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93277860|NCT04411030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93277861|NCT04411030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93277862|NCT04411030|Anesthetics, General|anesthetics, general|mesh-ancestor
93277863|NCT04411030|Anesthetics|anesthetics|mesh-ancestor
93277864|NCT04411030|GABA Modulators|gaba modulators|mesh-ancestor
93277865|NCT04411030|GABA Agents|gaba agents|mesh-ancestor
93277866|NCT04411030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277867|NCT04411030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949894|NCT05107778|Entecavir|entecavir|mesh-list
93277868|NCT04411030|Antifungal Agents|antifungal agents|mesh-ancestor
93277869|NCT04411030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277870|NCT04411030|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93277871|NCT04411030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93277872|NCT04411030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277873|NCT04411030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93277874|NCT04411030|Hormone Antagonists|hormone antagonists|mesh-ancestor
93277875|NCT04411030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93277876|NCT04411030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93277878|NCT04437654|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93277879|NCT04437654|Antithrombins|antithrombins|mesh-ancestor
93277880|NCT04437654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93277881|NCT04437654|Protease Inhibitors|protease inhibitors|mesh-ancestor
93277882|NCT04437654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277883|NCT04437654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277884|NCT04437654|Anticoagulants|anticoagulants|mesh-ancestor
93277885|NCT02185638|Appetite Depressants|appetite depressants|mesh-list
93277886|NCT02185638|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93277887|NCT02185716|Levobupivacaine|levobupivacaine|mesh-list
93277888|NCT02185716|Anesthetics, Local|anesthetics, local|mesh-ancestor
93277889|NCT02185716|Anesthetics|anesthetics|mesh-ancestor
93277890|NCT02185716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277891|NCT02185716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277892|NCT02185716|Sensory System Agents|sensory system agents|mesh-ancestor
93277893|NCT02185716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277894|NCT02182050|Nintedanib|nintedanib|mesh-list
93277895|NCT02182050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277896|NCT02182050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277897|NCT02182050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277898|NCT02182050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277899|NCT02182128|Nintedanib|nintedanib|mesh-list
93277900|NCT02182128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277901|NCT02182128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277902|NCT02182128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277903|NCT02182128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277904|NCT02182206|Nintedanib|nintedanib|mesh-list
93277905|NCT02182206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277906|NCT02182206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277907|NCT02182206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277908|NCT02182206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277909|NCT03963544|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93277910|NCT03963544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93277911|NCT03963544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277912|NCT03963544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277913|NCT02180568|Ethiodized Oil|ethiodized oil|mesh-list
93277914|NCT02180568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277915|NCT02657889|Pembrolizumab|pembrolizumab|mesh-list
93277916|NCT02657889|Niraparib|niraparib|mesh-list
93277917|NCT02657889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277918|NCT02657889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277919|NCT02657889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277920|NCT02657889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277921|NCT02657889|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93277922|NCT02657889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93277923|NCT03536208|Warfarin|warfarin|mesh-list
93277924|NCT03536208|Anticoagulants|anticoagulants|mesh-ancestor
93277925|NCT03034915|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93277926|NCT03034915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277927|NCT03034915|Autonomic Agents|autonomic agents|mesh-ancestor
93277928|NCT03034915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277929|NCT03034915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277930|NCT03034915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277931|NCT03034915|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277932|NCT03034915|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93277933|NCT03034915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93277934|NCT03034915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93277935|NCT03034915|Adrenergic Agents|adrenergic agents|mesh-ancestor
93277936|NCT03034915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93277937|NCT03034915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277938|NCT02631538|Rituximab|rituximab|mesh-list
93277939|NCT02631538|Belimumab|belimumab|mesh-list
93277940|NCT02631538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277941|NCT02631538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277942|NCT02631538|Immunologic Factors|immunologic factors|mesh-ancestor
93277943|NCT02631538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277944|NCT02631538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277945|NCT02631538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93277946|NCT03578679|Ivermectin|ivermectin|mesh-list
93277947|NCT03578679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93277948|NCT03578679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277949|NCT04930783|Nivolumab|nivolumab|mesh-list
93277950|NCT04930783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93277951|NCT04930783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93277952|NCT04930783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93277953|NCT04930783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277954|NCT05666206|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93277955|NCT05666206|Hemostatics|hemostatics|mesh-ancestor
93277956|NCT05666206|Coagulants|coagulants|mesh-ancestor
93277957|NCT05459701|Dapagliflozin|dapagliflozin|mesh-list
93277958|NCT05459701|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93277959|NCT05459701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277960|NCT05459701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93277961|NCT05459701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277962|NCT05459389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93277963|NCT05459389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277964|NCT02256462|Adalimumab|adalimumab|mesh-list
93277965|NCT02256462|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93277966|NCT02256462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93277967|NCT02256462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93277968|NCT02631148|Melatonin|melatonin|mesh-list
93277969|NCT02631148|Antioxidants|antioxidants|mesh-ancestor
93277970|NCT02631148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572544|NCT00097734|Ertapenem|ertapenem|mesh-list
93277971|NCT02631148|Protective Agents|protective agents|mesh-ancestor
93277972|NCT02631148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277973|NCT02631148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93277974|NCT02239107|Acetylcysteine|acetylcysteine|mesh-list
93277975|NCT02239107|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93277976|NCT02239107|Antiviral Agents|antiviral agents|mesh-ancestor
93277977|NCT02239107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93277978|NCT02239107|Expectorants|expectorants|mesh-ancestor
93277979|NCT02239107|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277980|NCT02239107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93277981|NCT02239107|Antioxidants|antioxidants|mesh-ancestor
93277982|NCT02239107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93277983|NCT02239107|Protective Agents|protective agents|mesh-ancestor
93277984|NCT02239107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277985|NCT02239107|Antidotes|antidotes|mesh-ancestor
93277986|NCT02182518|Pseudoephedrine|pseudoephedrine|mesh-list
93277987|NCT02182518|Ephedrine|ephedrine|mesh-list
93277988|NCT02182518|Epinastine|epinastine|mesh-list
93277989|NCT02182518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93277990|NCT02182518|Autonomic Agents|autonomic agents|mesh-ancestor
93277991|NCT02182518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93277992|NCT02182518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93277993|NCT02182518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93277994|NCT02182518|Respiratory System Agents|respiratory system agents|mesh-ancestor
93277995|NCT02182518|Nasal Decongestants|nasal decongestants|mesh-ancestor
93277996|NCT02182518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93277997|NCT02182518|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93277998|NCT02182518|Sympathomimetics|sympathomimetics|mesh-ancestor
93277999|NCT02182518|Adrenergic Agents|adrenergic agents|mesh-ancestor
93278000|NCT02182518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278001|NCT02182518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278002|NCT02182518|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93278003|NCT02182518|Histamine Antagonists|histamine antagonists|mesh-ancestor
93278004|NCT02182518|Histamine Agents|histamine agents|mesh-ancestor
93278005|NCT03881488|Pembrolizumab|pembrolizumab|mesh-list
93278006|NCT03881488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278007|NCT03881488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278008|NCT03881488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93278009|NCT03881488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278010|NCT05486182|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93278011|NCT05486182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278012|NCT03574857|Metolazone|metolazone|mesh-list
93278013|NCT03574857|Chlorothiazide|chlorothiazide|mesh-list
93278014|NCT03574857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93278015|NCT03574857|Diuretics|diuretics|mesh-ancestor
93278016|NCT03574857|Natriuretic Agents|natriuretic agents|mesh-ancestor
93278017|NCT03574857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278018|NCT03574857|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93278019|NCT03574857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278020|NCT03574857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278021|NCT02238639|Fibrin fragment D|fibrin fragment d|mesh-list
93278022|NCT02238639|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93278023|NCT02238639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93278024|NCT02238639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278025|NCT02238639|Hemostatics|hemostatics|mesh-ancestor
93278026|NCT02238639|Coagulants|coagulants|mesh-ancestor
93278027|NCT02186028|Vitamin D|vitamin d|mesh-list
93278028|NCT02186028|Vitamins|vitamins|mesh-ancestor
93278029|NCT02186028|Micronutrients|micronutrients|mesh-ancestor
93278030|NCT02186028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278031|NCT02186028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93278032|NCT02182596|Gemtuzumab|gemtuzumab|mesh-list
93278033|NCT02182596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278034|NCT02182596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278035|NCT02182596|Immunotoxins|immunotoxins|mesh-ancestor
93278036|NCT02182596|Immunoconjugates|immunoconjugates|mesh-ancestor
93278037|NCT02182596|Immunologic Factors|immunologic factors|mesh-ancestor
93278038|NCT02182596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278039|NCT03574701|Vitamin A|vitamin a|mesh-list
93278040|NCT03574701|Vitamins|vitamins|mesh-ancestor
93278041|NCT03574701|Micronutrients|micronutrients|mesh-ancestor
93278042|NCT03574701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278043|NCT02180880|Pregabalin|pregabalin|mesh-list
93278044|NCT02180880|Oxcarbazepine|oxcarbazepine|mesh-list
93278045|NCT02180880|Analgesics|analgesics|mesh-ancestor
93278046|NCT02180880|Sensory System Agents|sensory system agents|mesh-ancestor
93278047|NCT02180880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278048|NCT02180880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278049|NCT02180880|Anticonvulsants|anticonvulsants|mesh-ancestor
93278050|NCT02180880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93278051|NCT02180880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278052|NCT02180880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278053|NCT02180880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93278054|NCT02180880|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93278055|NCT02180880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93278056|NCT02180880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278057|NCT02180880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93278058|NCT02180880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93278059|NCT02180880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93278060|NCT02180880|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93278061|NCT02180880|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93278062|NCT02186106|Cholecalciferol|cholecalciferol|mesh-list
93278063|NCT02186106|Vitamin D|vitamin d|mesh-list
93278064|NCT02186106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93278065|NCT02186106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278066|NCT02186106|Vitamins|vitamins|mesh-ancestor
93278067|NCT02186106|Micronutrients|micronutrients|mesh-ancestor
93278068|NCT02186106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93278069|NCT03943147|Mycophenolic Acid|mycophenolic acid|mesh-list
93278070|NCT03943147|Deucravacitinib|deucravacitinib|mesh-list
93278071|NCT03943147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93278072|NCT03943147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278073|NCT03943147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93278074|NCT03943147|Antitubercular Agents|antitubercular agents|mesh-ancestor
93278075|NCT03943147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93278076|NCT03943147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278077|NCT03943147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278078|NCT03943147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278079|NCT03943147|Dermatologic Agents|dermatologic agents|mesh-ancestor
93278080|NCT03943147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93278081|NCT02182752|Tramadol|tramadol|mesh-list
93278082|NCT02182752|Ropivacaine|ropivacaine|mesh-list
93278083|NCT02182752|Anesthetics, Local|anesthetics, local|mesh-ancestor
93278084|NCT02182752|Anesthetics|anesthetics|mesh-ancestor
93278085|NCT02182752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278086|NCT02182752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278087|NCT02182752|Sensory System Agents|sensory system agents|mesh-ancestor
93278088|NCT02182752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278089|NCT02182752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93278090|NCT02182752|Narcotics|narcotics|mesh-ancestor
93278091|NCT02182752|Analgesics|analgesics|mesh-ancestor
93278092|NCT03536598|Amlodipine|amlodipine|mesh-list
93278093|NCT03536598|Valsartan|valsartan|mesh-list
93278094|NCT03536598|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93278095|NCT03536598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93278096|NCT03536598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93278097|NCT03536598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278098|NCT03536598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278099|NCT03536598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93278100|NCT03536598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278101|NCT03536598|Vasodilator Agents|vasodilator agents|mesh-ancestor
93278102|NCT03536598|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93278103|NCT03536598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93278104|NCT03536598|Antimetabolites|antimetabolites|mesh-ancestor
93278105|NCT03536598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93278106|NCT03536598|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93278107|NCT03536598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278108|NCT03536598|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93278109|NCT03536598|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93278110|NCT03576963|Nivolumab|nivolumab|mesh-list
93278111|NCT03576963|Guadecitabine|guadecitabine|mesh-list
93278112|NCT03576963|Azacitidine|azacitidine|mesh-list
93278113|NCT03576963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278114|NCT03576963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278115|NCT03576963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93278116|NCT03576963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278117|NCT03576963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93278118|NCT03576963|Antimetabolites|antimetabolites|mesh-ancestor
93278119|NCT03576963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278120|NCT02186496|Amlodipine|amlodipine|mesh-list
93278121|NCT02186496|Candesartan|candesartan|mesh-list
93278122|NCT02186496|Candesartan cilexetil|candesartan cilexetil|mesh-list
93278123|NCT02186496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93278124|NCT02186496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93278125|NCT02186496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278126|NCT02186496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278127|NCT02186496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93278128|NCT02186496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278129|NCT02186496|Vasodilator Agents|vasodilator agents|mesh-ancestor
93278130|NCT02186496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93278131|NCT02186496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93278132|NCT05615194|Dexmedetomidine|dexmedetomidine|mesh-list
93278133|NCT05615194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93278134|NCT05615194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278135|NCT05615194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278136|NCT05615194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278137|NCT05615194|Analgesics|analgesics|mesh-ancestor
93278138|NCT05615194|Sensory System Agents|sensory system agents|mesh-ancestor
93278139|NCT05615194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278140|NCT05615194|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93278141|NCT05615194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93278142|NCT05615194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93278143|NCT05615194|Adrenergic Agents|adrenergic agents|mesh-ancestor
93278144|NCT05615194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278145|NCT05615194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278146|NCT02186574|Tenofovir|tenofovir|mesh-list
93278147|NCT02186574|Antiviral Agents|antiviral agents|mesh-ancestor
93278148|NCT02186574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278149|NCT02186574|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93278150|NCT02186574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93278151|NCT02186574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278152|NCT02186574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278153|NCT02186574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93278154|NCT02186574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93278155|NCT03066700|Hemostatics|hemostatics|mesh-list
93278156|NCT03066700|Coagulants|coagulants|mesh-ancestor
93278157|NCT03066544|Dexamethasone|dexamethasone|mesh-list
93278158|NCT03066544|Ketorolac|ketorolac|mesh-list
93278159|NCT03066544|Naratriptan|naratriptan|mesh-list
93278160|NCT03066544|Bupivacaine|bupivacaine|mesh-list
93278161|NCT03066544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278162|NCT03066544|Antiemetics|antiemetics|mesh-ancestor
93278163|NCT03066544|Autonomic Agents|autonomic agents|mesh-ancestor
93278164|NCT03066544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278165|NCT03066544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278166|NCT03066544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278168|NCT03066544|Hormones|hormones|mesh-ancestor
93278169|NCT03066544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278170|NCT03066544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278171|NCT03066544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278172|NCT03066544|Anesthetics, Local|anesthetics, local|mesh-ancestor
93278173|NCT03066544|Anesthetics|anesthetics|mesh-ancestor
93278174|NCT03066544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278175|NCT03066544|Sensory System Agents|sensory system agents|mesh-ancestor
93278176|NCT03066544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278177|NCT03066544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278178|NCT03066544|Analgesics|analgesics|mesh-ancestor
93278179|NCT03066544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278180|NCT03066544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278181|NCT03066544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278182|NCT03066544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278183|NCT03066544|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93278184|NCT03066544|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93278185|NCT03066544|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93278186|NCT03066544|Serotonin Agents|serotonin agents|mesh-ancestor
93278187|NCT03066544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278188|NCT03182179|Ondansetron|ondansetron|mesh-list
93278189|NCT03182179|Antiemetics|antiemetics|mesh-ancestor
93278190|NCT03182179|Autonomic Agents|autonomic agents|mesh-ancestor
93278191|NCT03182179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278192|NCT03182179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278193|NCT03182179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278194|NCT03182179|Antipruritics|antipruritics|mesh-ancestor
93278195|NCT03182179|Dermatologic Agents|dermatologic agents|mesh-ancestor
93278196|NCT03182179|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93278197|NCT03182179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93278198|NCT03182179|Serotonin Agents|serotonin agents|mesh-ancestor
93278199|NCT03182179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278200|NCT03182179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278201|NCT03576651|Bevacizumab|bevacizumab|mesh-list
93278202|NCT03576651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278203|NCT03576651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278204|NCT03576651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93278205|NCT03576651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93278206|NCT03576651|Growth Substances|growth substances|mesh-ancestor
93278207|NCT03576651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278208|NCT03576651|Growth Inhibitors|growth inhibitors|mesh-ancestor
93278209|NCT04116112|Labetalol|labetalol|mesh-list
93278210|NCT04116112|Hydralazine|hydralazine|mesh-list
93278211|NCT04116112|Nicardipine|nicardipine|mesh-list
93278212|NCT04116112|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93278213|NCT04116112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93278214|NCT04116112|Adrenergic Agents|adrenergic agents|mesh-ancestor
93278215|NCT04116112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278216|NCT04116112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278217|NCT04116112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278218|NCT04116112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93278219|NCT04116112|Sympathomimetics|sympathomimetics|mesh-ancestor
93278220|NCT04116112|Autonomic Agents|autonomic agents|mesh-ancestor
93278221|NCT04116112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278222|NCT04116112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93278223|NCT04116112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93278224|NCT04116112|Vasodilator Agents|vasodilator agents|mesh-ancestor
93278225|NCT04116112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93278226|NCT04116112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278227|NCT04116112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93278228|NCT03064906|Pancrelipase|pancrelipase|mesh-list
93278229|NCT03064906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278230|NCT03034135|Copper|copper|mesh-list
93278231|NCT03034135|Temozolomide|temozolomide|mesh-list
93278232|NCT03034135|Disulfiram|disulfiram|mesh-list
93278233|NCT03034135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93278234|NCT03034135|Alkylating Agents|alkylating agents|mesh-ancestor
93278235|NCT03034135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278236|NCT03034135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278237|NCT03034135|Trace Elements|trace elements|mesh-ancestor
93278238|NCT03034135|Micronutrients|micronutrients|mesh-ancestor
93278239|NCT03034135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278240|NCT03034135|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93278241|NCT03034135|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93278242|NCT03034135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278243|NCT02239731|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93278245|NCT02239731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278246|NCT02239731|Antimalarials|antimalarials|mesh-ancestor
93278247|NCT02239731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93278248|NCT02239731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93278249|NCT03571815|Listerine|listerine|mesh-list
93278250|NCT03571815|Fluorides|fluorides|mesh-list
93278251|NCT03571815|Sodium Fluoride|sodium fluoride|mesh-list
93278252|NCT03571815|Fluorides, Topical|fluorides, topical|mesh-list
93278253|NCT03571815|Cariostatic Agents|cariostatic agents|mesh-ancestor
93278254|NCT03571815|Protective Agents|protective agents|mesh-ancestor
93278255|NCT03571815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278256|NCT03571815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93278257|NCT03571815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278258|NCT03571737|Ibuprofen|ibuprofen|mesh-list
93278259|NCT03571737|Lidocaine|lidocaine|mesh-list
93278260|NCT03571737|Anesthetics, Local|anesthetics, local|mesh-ancestor
93278261|NCT03571737|Anesthetics|anesthetics|mesh-ancestor
93278262|NCT03571737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278263|NCT03571737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278264|NCT03571737|Sensory System Agents|sensory system agents|mesh-ancestor
93278265|NCT03571737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278266|NCT03571737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93278267|NCT03571737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93278268|NCT03571737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93278269|NCT03571737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278270|NCT03571737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278271|NCT03571737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278272|NCT03571737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278273|NCT03571737|Analgesics|analgesics|mesh-ancestor
93278274|NCT03571737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278275|NCT03571737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278276|NCT03571737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278277|NCT03571737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278278|NCT03573999|Mannitol|mannitol|mesh-list
93278279|NCT03573999|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93278280|NCT03573999|Diuretics|diuretics|mesh-ancestor
93278281|NCT03573999|Natriuretic Agents|natriuretic agents|mesh-ancestor
93278282|NCT03573999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278283|NCT04606069|Regadenoson|regadenoson|mesh-list
93278284|NCT04606069|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93278285|NCT04606069|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93278286|NCT04606069|Purinergic Agonists|purinergic agonists|mesh-ancestor
93278287|NCT04606069|Purinergic Agents|purinergic agents|mesh-ancestor
93278288|NCT04606069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278289|NCT04606069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278290|NCT04606069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278291|NCT03063190|Vitamin D|vitamin d|mesh-list
93278292|NCT03063190|Vitamins|vitamins|mesh-ancestor
93278293|NCT03063190|Micronutrients|micronutrients|mesh-ancestor
93278294|NCT03063190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278295|NCT03063190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93278296|NCT03573687|Caseins|caseins|mesh-list
93278297|NCT03573687|Chelating Agents|chelating agents|mesh-ancestor
93278298|NCT03573687|Sequestering Agents|sequestering agents|mesh-ancestor
93278299|NCT03573687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278300|NCT01671280|Azithromycin|azithromycin|mesh-list
93278301|NCT01671280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93278302|NCT01671280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278303|NCT04904302|Nivolumab|nivolumab|mesh-list
93278304|NCT04904302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278305|NCT04904302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278306|NCT04904302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93278307|NCT04904302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278308|NCT03575637|Olanzapine|olanzapine|mesh-list
93278309|NCT03575637|Antiemetics|antiemetics|mesh-ancestor
93278310|NCT03575637|Autonomic Agents|autonomic agents|mesh-ancestor
93278311|NCT03575637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278312|NCT03575637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278313|NCT03575637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278314|NCT03575637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93278315|NCT03575637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93278316|NCT03575637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278317|NCT03575637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93278318|NCT03575637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93278319|NCT03575637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93278320|NCT03575637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278321|NCT03575637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278322|NCT03575637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278323|NCT03575637|Serotonin Agents|serotonin agents|mesh-ancestor
93278324|NCT03062800|Thalidomide|thalidomide|mesh-list
93278325|NCT03062800|Carboplatin|carboplatin|mesh-list
93278326|NCT03062800|Pemetrexed|pemetrexed|mesh-list
93278327|NCT03062800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278328|NCT03062800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278329|NCT03062800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278330|NCT03062800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93278331|NCT03062800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93278332|NCT03062800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93278333|NCT03062800|Immunologic Factors|immunologic factors|mesh-ancestor
93278334|NCT03062800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278335|NCT03062800|Leprostatic Agents|leprostatic agents|mesh-ancestor
93278336|NCT03062800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93278337|NCT03062800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278338|NCT03062800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93278339|NCT03062800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93278340|NCT03062800|Growth Substances|growth substances|mesh-ancestor
93278341|NCT03062800|Growth Inhibitors|growth inhibitors|mesh-ancestor
93278342|NCT05709015|Chlorhexidine|chlorhexidine|mesh-list
93278343|NCT05709015|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93278344|NCT05709015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93278345|NCT05709015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278346|NCT05709015|Disinfectants|disinfectants|mesh-ancestor
93278347|NCT05709015|Dermatologic Agents|dermatologic agents|mesh-ancestor
93278348|NCT03418779|Prednisolone|prednisolone|mesh-list
93278349|NCT03418779|Cyclophosphamide|cyclophosphamide|mesh-list
93278350|NCT03418779|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93278351|NCT03418779|Immunologic Factors|immunologic factors|mesh-ancestor
93278352|NCT03418779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278353|NCT03418779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278354|NCT03418779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93278355|NCT03418779|Alkylating Agents|alkylating agents|mesh-ancestor
93278356|NCT03418779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278357|NCT03418779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278358|NCT03418779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93278359|NCT03418779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278360|NCT03418779|Glucocorticoids|glucocorticoids|mesh-ancestor
93278361|NCT03418779|Hormones|hormones|mesh-ancestor
93278362|NCT03418779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278363|NCT03418779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278364|NCT03573063|Androgens|androgens|mesh-list
93278365|NCT03573063|Hormones|hormones|mesh-ancestor
93278366|NCT03573063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278367|NCT03573063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278368|NCT03572829|Dexamethasone|dexamethasone|mesh-list
93278369|NCT03572829|Ondansetron|ondansetron|mesh-list
93278370|NCT03572829|Aprepitant|aprepitant|mesh-list
93278371|NCT03572829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278372|NCT03572829|Antiemetics|antiemetics|mesh-ancestor
93278373|NCT03572829|Autonomic Agents|autonomic agents|mesh-ancestor
93278374|NCT03572829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278375|NCT03572829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278376|NCT03572829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278377|NCT03572829|Glucocorticoids|glucocorticoids|mesh-ancestor
93278378|NCT03572829|Hormones|hormones|mesh-ancestor
93278379|NCT03572829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278380|NCT03572829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278381|NCT03572829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278382|NCT03572829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278383|NCT03572829|Antipruritics|antipruritics|mesh-ancestor
93278384|NCT03572829|Dermatologic Agents|dermatologic agents|mesh-ancestor
93278385|NCT03572829|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93278386|NCT03572829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93278387|NCT03572829|Serotonin Agents|serotonin agents|mesh-ancestor
93278388|NCT03572829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278389|NCT03572829|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93278390|NCT03575247|Glucocorticoids|glucocorticoids|mesh-list
93278391|NCT03575247|Hormones|hormones|mesh-ancestor
93278392|NCT03575247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278393|NCT03575247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278394|NCT03704623|Acetaminophen|acetaminophen|mesh-list
93278395|NCT03704623|Parecoxib|parecoxib|mesh-list
93278396|NCT03704623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278397|NCT03704623|Analgesics|analgesics|mesh-ancestor
93278398|NCT03704623|Sensory System Agents|sensory system agents|mesh-ancestor
93278399|NCT03704623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278400|NCT03704623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278401|NCT03704623|Antipyretics|antipyretics|mesh-ancestor
93278402|NCT03704623|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93278403|NCT03704623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278404|NCT03704623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278405|NCT03704623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278406|NCT03704623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278407|NCT03704623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278408|NCT03704623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278409|NCT03572595|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93278410|NCT03572595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93278411|NCT03572595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278412|NCT03572517|Morphine|morphine|mesh-list
93278413|NCT03572517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93278414|NCT03572517|Narcotics|narcotics|mesh-ancestor
93278415|NCT03572517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278416|NCT03572517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278417|NCT03572517|Analgesics|analgesics|mesh-ancestor
93278418|NCT03572517|Sensory System Agents|sensory system agents|mesh-ancestor
93278419|NCT03572517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278420|NCT03570645|Dexamethasone|dexamethasone|mesh-list
93278421|NCT03570645|Dexmedetomidine|dexmedetomidine|mesh-list
93278422|NCT03570645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278423|NCT03570645|Antiemetics|antiemetics|mesh-ancestor
93278424|NCT03570645|Autonomic Agents|autonomic agents|mesh-ancestor
93278425|NCT03570645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278426|NCT03570645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278427|NCT03570645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278428|NCT03570645|Glucocorticoids|glucocorticoids|mesh-ancestor
93278429|NCT03570645|Hormones|hormones|mesh-ancestor
93278430|NCT03570645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278431|NCT03570645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278432|NCT03570645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278433|NCT03570645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93278434|NCT03570645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278435|NCT03570645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278436|NCT03570645|Analgesics|analgesics|mesh-ancestor
93278437|NCT03570645|Sensory System Agents|sensory system agents|mesh-ancestor
93278438|NCT03570645|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93278439|NCT03570645|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93278440|NCT03570645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93278441|NCT03570645|Adrenergic Agents|adrenergic agents|mesh-ancestor
93278442|NCT03570645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278443|NCT03570645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278444|NCT03940690|Bevacizumab|bevacizumab|mesh-list
93278445|NCT03940690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278446|NCT03940690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278447|NCT03940690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93278448|NCT03940690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93278449|NCT03940690|Growth Substances|growth substances|mesh-ancestor
93278450|NCT03940690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278451|NCT03940690|Growth Inhibitors|growth inhibitors|mesh-ancestor
93278452|NCT03567135|Temozolomide|temozolomide|mesh-list
93278453|NCT03567135|Apatinib|apatinib|mesh-list
93278454|NCT03567135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93278455|NCT03567135|Alkylating Agents|alkylating agents|mesh-ancestor
93278456|NCT03567135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278457|NCT03567135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278458|NCT03567135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93278459|NCT03567135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278460|NCT03698383|Trastuzumab|trastuzumab|mesh-list
93278461|NCT03698383|Gedatolisib|gedatolisib|mesh-list
93278462|NCT03698383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278463|NCT03698383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278464|NCT03698383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93278465|NCT03698383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573054|NCT00065546|Choline|choline|mesh-list
93278466|NCT03698383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278467|NCT04760782|Abaloparatide|abaloparatide|mesh-list
93278468|NCT04760782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93278469|NCT04760782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278470|NCT04740580|Acetylcysteine|acetylcysteine|mesh-list
93278471|NCT04740580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93278472|NCT04740580|Glycine|glycine|mesh-list
93278473|NCT04740580|Antiviral Agents|antiviral agents|mesh-ancestor
93278474|NCT04740580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278475|NCT04740580|Expectorants|expectorants|mesh-ancestor
93278476|NCT04740580|Respiratory System Agents|respiratory system agents|mesh-ancestor
93278477|NCT04740580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93278478|NCT04740580|Antioxidants|antioxidants|mesh-ancestor
93278479|NCT04740580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278480|NCT04740580|Protective Agents|protective agents|mesh-ancestor
93278481|NCT04740580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278482|NCT04740580|Antidotes|antidotes|mesh-ancestor
93278483|NCT04740580|Glycine Agents|glycine agents|mesh-ancestor
93278484|NCT04740580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278485|NCT03064282|Papaverine|papaverine|mesh-list
93278486|NCT03064282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93278487|NCT03064282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278488|NCT03064282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278489|NCT03064282|Vasodilator Agents|vasodilator agents|mesh-ancestor
93278490|NCT03064282|Urological Agents|urological agents|mesh-ancestor
93278491|NCT04679818|Fentanyl|fentanyl|mesh-list
93278492|NCT04679818|Analgesics, Opioid|analgesics, opioid|mesh-list
93278493|NCT04679818|Narcotics|narcotics|mesh-ancestor
93278494|NCT04679818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278495|NCT04679818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278496|NCT04679818|Analgesics|analgesics|mesh-ancestor
93278497|NCT04679818|Sensory System Agents|sensory system agents|mesh-ancestor
93278498|NCT04679818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278499|NCT04679818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93278500|NCT04679818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93278501|NCT04679818|Anesthetics, General|anesthetics, general|mesh-ancestor
93278502|NCT04679818|Anesthetics|anesthetics|mesh-ancestor
93278503|NCT03027609|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93278504|NCT03027609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278505|NCT03063112|Ethanol|ethanol|mesh-list
93278506|NCT03063112|Lidocaine|lidocaine|mesh-list
93278507|NCT03063112|Anesthetics, Local|anesthetics, local|mesh-ancestor
93278508|NCT03063112|Anesthetics|anesthetics|mesh-ancestor
93278509|NCT03063112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278510|NCT03063112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278511|NCT03063112|Sensory System Agents|sensory system agents|mesh-ancestor
93278512|NCT03063112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278513|NCT03063112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93278514|NCT03063112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93278515|NCT03063112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93278516|NCT03063112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278517|NCT03063112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278518|NCT03063112|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93278519|NCT03063112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278520|NCT04767217|Lumefantrine|lumefantrine|mesh-list
93278521|NCT04767217|Artemether|artemether|mesh-list
93278522|NCT04767217|Piperaquine|piperaquine|mesh-list
93278523|NCT04767217|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93278524|NCT04767217|Artenimol|artenimol|mesh-list
93278525|NCT04767217|Antimalarials|antimalarials|mesh-ancestor
93278526|NCT04767217|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93278527|NCT04767217|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93278528|NCT04767217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278529|NCT03701503|Hormones|hormones|mesh-list
93278530|NCT03701503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278531|NCT03701503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278532|NCT03704155|Botulinum Toxins|botulinum toxins|mesh-list
93278533|NCT03704155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93278534|NCT03704155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93278535|NCT03704155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93278536|NCT03704155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278537|NCT03704155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278538|NCT03704155|Cholinergic Agents|cholinergic agents|mesh-ancestor
93278539|NCT03704155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278540|NCT03704155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950562|NCT01049815|Calcium|calcium|mesh-list
93278541|NCT03704155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93278542|NCT03704155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278543|NCT03698227|Doxorubicin|doxorubicin|mesh-list
93278544|NCT03698227|Dexrazoxane|dexrazoxane|mesh-list
93278545|NCT03698227|Razoxane|razoxane|mesh-list
93278546|NCT03698227|Olaratumab|olaratumab|mesh-list
93278547|NCT03698227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93278548|NCT03698227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278549|NCT03698227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93278550|NCT03698227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93278551|NCT03698227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278552|NCT03698227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278553|NCT03698227|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93278554|NCT03698227|Protective Agents|protective agents|mesh-ancestor
93278555|NCT03698227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278556|NCT03698227|Antimitotic Agents|antimitotic agents|mesh-ancestor
93278557|NCT03698227|Mitosis Modulators|mitosis modulators|mesh-ancestor
93278558|NCT01342965|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93278559|NCT01342965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278560|NCT01342965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93278561|NCT01342965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278562|NCT01342965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278563|NCT04434664|Metoprolol|metoprolol|mesh-list
93278564|NCT04434664|Amlodipine|amlodipine|mesh-list
93278565|NCT04434664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93278566|NCT04434664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93278567|NCT04434664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278568|NCT04434664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278569|NCT04434664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93278570|NCT04434664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278571|NCT04434664|Vasodilator Agents|vasodilator agents|mesh-ancestor
93278572|NCT04434664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93278573|NCT04434664|Sympatholytics|sympatholytics|mesh-ancestor
93278574|NCT04434664|Autonomic Agents|autonomic agents|mesh-ancestor
93278575|NCT04434664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278576|NCT04434664|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93278577|NCT04434664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93278578|NCT04434664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93278579|NCT04434664|Adrenergic Agents|adrenergic agents|mesh-ancestor
93278580|NCT04434664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278581|NCT02181348|Vitamin E|vitamin e|mesh-list
93278582|NCT02181348|Vitamins|vitamins|mesh-ancestor
93278583|NCT02181348|Micronutrients|micronutrients|mesh-ancestor
93278584|NCT02181348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278585|NCT02181348|Antioxidants|antioxidants|mesh-ancestor
93278586|NCT02181348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278587|NCT02181348|Protective Agents|protective agents|mesh-ancestor
93278588|NCT02186886|Golimumab|golimumab|mesh-list
93278589|NCT02186886|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93278590|NCT02186886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278591|NCT02186886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93278592|NCT02186886|Immunologic Factors|immunologic factors|mesh-ancestor
93278593|NCT02186886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278594|NCT03722680|Riluzole|riluzole|mesh-list
93278595|NCT03722680|Anticonvulsants|anticonvulsants|mesh-ancestor
93278596|NCT03722680|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93278597|NCT03722680|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93278598|NCT03722680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278599|NCT03722680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278600|NCT03722680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278601|NCT03722680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93278602|NCT03722680|Protective Agents|protective agents|mesh-ancestor
93278603|NCT02182986|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93278604|NCT02182986|Immunologic Factors|immunologic factors|mesh-ancestor
93278605|NCT02182986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278606|NCT03536910|Arginine Vasopressin|arginine vasopressin|mesh-list
93278607|NCT03536910|Hemostatics|hemostatics|mesh-ancestor
93278608|NCT03536910|Coagulants|coagulants|mesh-ancestor
93278609|NCT03536910|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93278610|NCT03536910|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93278611|NCT03536910|Natriuretic Agents|natriuretic agents|mesh-ancestor
93278612|NCT03536910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278613|NCT04308174|Durvalumab|durvalumab|mesh-list
93278614|NCT04308174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278615|NCT04308174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278616|NCT03697681|Tranexamic Acid|tranexamic acid|mesh-list
93278617|NCT03697681|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93278618|NCT03697681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93278619|NCT03697681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278620|NCT03697681|Hemostatics|hemostatics|mesh-ancestor
93278621|NCT03697681|Coagulants|coagulants|mesh-ancestor
93278622|NCT02187276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
93278623|NCT02187276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278624|NCT02187276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278625|NCT02187276|Cholinergic Agents|cholinergic agents|mesh-ancestor
93278626|NCT02187276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278627|NCT02187276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278628|NCT02683239|Fasinumab|fasinumab|mesh-list
93278629|NCT02683239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278630|NCT02683239|Analgesics|analgesics|mesh-ancestor
93278631|NCT02683239|Sensory System Agents|sensory system agents|mesh-ancestor
93278632|NCT02683239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278633|NCT02683239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278634|NCT02183064|Meloxicam|meloxicam|mesh-list
93278635|NCT02183064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278636|NCT02183064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278637|NCT02183064|Analgesics|analgesics|mesh-ancestor
93278638|NCT02183064|Sensory System Agents|sensory system agents|mesh-ancestor
93278639|NCT02183064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278640|NCT02183064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278641|NCT02183064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278642|NCT02183064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278643|NCT02183064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93278644|NCT02183064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278645|NCT02183064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278646|NCT02183064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278647|NCT03704077|Paclitaxel|paclitaxel|mesh-list
93278648|NCT03704077|Nivolumab|nivolumab|mesh-list
93278649|NCT03704077|Ramucirumab|ramucirumab|mesh-list
93278650|NCT03704077|Relatlimab|relatlimab|mesh-list
93278651|NCT03704077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93278652|NCT03704077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278653|NCT03704077|Tubulin Modulators|tubulin modulators|mesh-ancestor
93278654|NCT03704077|Antimitotic Agents|antimitotic agents|mesh-ancestor
93278655|NCT03704077|Mitosis Modulators|mitosis modulators|mesh-ancestor
93278656|NCT03704077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278657|NCT03704077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278658|NCT03704077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93278659|NCT03618550|Gemcitabine|gemcitabine|mesh-list
93278660|NCT03618550|Doxorubicin|doxorubicin|mesh-list
93278661|NCT03618550|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93278662|NCT03618550|Pembrolizumab|pembrolizumab|mesh-list
93278663|NCT03618550|Vinorelbine|vinorelbine|mesh-list
93278664|NCT03618550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93278665|NCT03618550|Antimetabolites|antimetabolites|mesh-ancestor
93278666|NCT03618550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278667|NCT03618550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278668|NCT03618550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93278669|NCT03618550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93278670|NCT03618550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93278671|NCT03618550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278672|NCT03618550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278673|NCT03618550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93278674|NCT03618550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93278675|NCT03618550|Tubulin Modulators|tubulin modulators|mesh-ancestor
93278676|NCT03618550|Antimitotic Agents|antimitotic agents|mesh-ancestor
93278677|NCT03618550|Mitosis Modulators|mitosis modulators|mesh-ancestor
93278678|NCT02183142|Meloxicam|meloxicam|mesh-list
93278679|NCT02183142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278680|NCT02183142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278681|NCT02183142|Analgesics|analgesics|mesh-ancestor
93278682|NCT02183142|Sensory System Agents|sensory system agents|mesh-ancestor
93278683|NCT02183142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278684|NCT02183142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278685|NCT02183142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278686|NCT02183142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278687|NCT02183142|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93278688|NCT02183142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278689|NCT02183142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278690|NCT02183142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950726|NCT00942526|Nystatin|nystatin|mesh-list
93278691|NCT02183220|Aspirin|aspirin|mesh-list
93278692|NCT02183220|Dipyrone|dipyrone|mesh-list
93278693|NCT02183220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278694|NCT02183220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278695|NCT02183220|Analgesics|analgesics|mesh-ancestor
93278696|NCT02183220|Sensory System Agents|sensory system agents|mesh-ancestor
93278697|NCT02183220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278698|NCT02183220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278699|NCT02183220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278700|NCT02183220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278701|NCT02183220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93278702|NCT02183220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93278703|NCT02183220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278704|NCT02183220|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93278705|NCT02183220|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278706|NCT02183220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278707|NCT02183220|Antipyretics|antipyretics|mesh-ancestor
93278708|NCT02187588|Ibuprofen|ibuprofen|mesh-list
93278709|NCT02187588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278710|NCT02187588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278711|NCT02187588|Analgesics|analgesics|mesh-ancestor
93278712|NCT02187588|Sensory System Agents|sensory system agents|mesh-ancestor
93278713|NCT02187588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278714|NCT02187588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278715|NCT02187588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278716|NCT02187588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278717|NCT02187588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278718|NCT02187588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278719|NCT02187588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278720|NCT05364489|Bevacizumab|bevacizumab|mesh-list
93278721|NCT05364489|Oxaliplatin|oxaliplatin|mesh-list
93278722|NCT05364489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278723|NCT05364489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278724|NCT05364489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93278725|NCT05364489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93278726|NCT05364489|Growth Substances|growth substances|mesh-ancestor
93278727|NCT05364489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278728|NCT05364489|Growth Inhibitors|growth inhibitors|mesh-ancestor
93278729|NCT02183298|Linagliptin|linagliptin|mesh-list
93278730|NCT02183298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93278731|NCT02183298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278732|NCT02183298|Incretins|incretins|mesh-ancestor
93278733|NCT02183298|Hormones|hormones|mesh-ancestor
93278734|NCT02183298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278735|NCT02183298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93278736|NCT02183298|Protease Inhibitors|protease inhibitors|mesh-ancestor
93278737|NCT02183298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278738|NCT02183298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278739|NCT03697057|Anesthetics|anesthetics|mesh-list
93278740|NCT03697057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278741|NCT03697057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278742|NCT02183376|Linagliptin|linagliptin|mesh-list
93278743|NCT02183376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93278744|NCT02183376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278745|NCT02183376|Incretins|incretins|mesh-ancestor
93278746|NCT02183376|Hormones|hormones|mesh-ancestor
93278747|NCT02183376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278748|NCT02183376|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93278749|NCT02183376|Protease Inhibitors|protease inhibitors|mesh-ancestor
93278750|NCT02183376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278751|NCT02183376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278752|NCT02187822|Taxane|taxane|mesh-list
93278753|NCT02187822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278754|NCT03696901|Dalbavancin|dalbavancin|mesh-list
93278755|NCT03696901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93278756|NCT03696901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278757|NCT02187900|Mycophenolic Acid|mycophenolic acid|mesh-list
93278758|NCT02187900|Cardiac Glycosides|cardiac glycosides|mesh-list
93278759|NCT02187900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93278760|NCT02187900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278761|NCT02187900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93278762|NCT02187900|Antitubercular Agents|antitubercular agents|mesh-ancestor
93278763|NCT02187900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93278764|NCT02187900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278765|NCT02187900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278766|NCT02187900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278768|NCT02187900|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93278769|NCT02187900|Protective Agents|protective agents|mesh-ancestor
93278770|NCT02187900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278771|NCT03062644|Celecoxib|celecoxib|mesh-list
93278772|NCT03062644|Tramadol|tramadol|mesh-list
93278773|NCT03062644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93278774|NCT03062644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278775|NCT03062644|Analgesics|analgesics|mesh-ancestor
93278776|NCT03062644|Sensory System Agents|sensory system agents|mesh-ancestor
93278777|NCT03062644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278778|NCT03062644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278779|NCT03062644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278780|NCT03062644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278781|NCT03062644|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92573356|NCT00239863|Immunologic Factors|immunologic factors|mesh-ancestor
93278782|NCT03062644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93278783|NCT03062644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278784|NCT03062644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278785|NCT03062644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93278786|NCT03062644|Narcotics|narcotics|mesh-ancestor
93278787|NCT03062644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278788|NCT02190318|Losartan|losartan|mesh-list
93278789|NCT02190318|Spironolactone|spironolactone|mesh-list
93278790|NCT02190318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93278791|NCT02190318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93278792|NCT02190318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93278793|NCT02190318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93278794|NCT02190318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278795|NCT02190318|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93278796|NCT02190318|Hormone Antagonists|hormone antagonists|mesh-ancestor
93278797|NCT02190318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278798|NCT02190318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278799|NCT02190318|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93278800|NCT02190318|Diuretics|diuretics|mesh-ancestor
93278801|NCT02190318|Natriuretic Agents|natriuretic agents|mesh-ancestor
93278802|NCT04743661|Antipyretics|antipyretics|mesh-list
93278803|NCT04743661|Dexamethasone|dexamethasone|mesh-list
93278804|NCT04743661|Bevacizumab|bevacizumab|mesh-list
93278805|NCT04743661|Irinotecan|irinotecan|mesh-list
93278806|NCT04743661|Temozolomide|temozolomide|mesh-list
93278807|NCT04743661|Antiemetics|antiemetics|mesh-list
93278808|NCT04743661|Emetics|emetics|mesh-list
93278809|NCT04743661|Histamine Antagonists|histamine antagonists|mesh-list
93278810|NCT04743661|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93278811|NCT04743661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278812|NCT04743661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278813|NCT04743661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93278814|NCT04743661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93278815|NCT04743661|Growth Substances|growth substances|mesh-ancestor
93278816|NCT04743661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278817|NCT04743661|Growth Inhibitors|growth inhibitors|mesh-ancestor
93278818|NCT04743661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278819|NCT04743661|Autonomic Agents|autonomic agents|mesh-ancestor
93278820|NCT04743661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278821|NCT04743661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278822|NCT04743661|Glucocorticoids|glucocorticoids|mesh-ancestor
93278823|NCT04743661|Hormones|hormones|mesh-ancestor
93278824|NCT04743661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278825|NCT04743661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278826|NCT04743661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93278827|NCT04743661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93278828|NCT04743661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278829|NCT04743661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278830|NCT04743661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93278831|NCT04743661|Alkylating Agents|alkylating agents|mesh-ancestor
93278832|NCT04743661|Histamine Agents|histamine agents|mesh-ancestor
93278833|NCT04743661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93278834|NCT02183532|Linagliptin|linagliptin|mesh-list
93278835|NCT02183532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93278836|NCT02183532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278837|NCT02183532|Incretins|incretins|mesh-ancestor
93278838|NCT02183532|Hormones|hormones|mesh-ancestor
92950866|NCT00755898|Analgesics|analgesics|mesh-ancestor
93278839|NCT02183532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278840|NCT02183532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93278841|NCT02183532|Protease Inhibitors|protease inhibitors|mesh-ancestor
93278842|NCT02183532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278843|NCT02183532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278844|NCT03569631|BPN14770|bpn14770|mesh-list
93278845|NCT03569631|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93278846|NCT03569631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93278847|NCT03569631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278848|NCT03569631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278849|NCT02629822|Tenofovir|tenofovir|mesh-list
93278850|NCT02629822|Lamivudine|lamivudine|mesh-list
93278851|NCT02629822|Antiviral Agents|antiviral agents|mesh-ancestor
93278852|NCT02629822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93278853|NCT02629822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93278854|NCT02629822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93278855|NCT02629822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278856|NCT02629822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278857|NCT02629822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93278858|NCT02629822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93278859|NCT03700801|Insulin|insulin|mesh-list
93278860|NCT03700801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93278861|NCT03700801|Metformin|metformin|mesh-list
93278862|NCT03700801|Insulin Aspart|insulin aspart|mesh-list
93278863|NCT03700801|Dapagliflozin|dapagliflozin|mesh-list
93278864|NCT03700801|Saxagliptin|saxagliptin|mesh-list
93278865|NCT03700801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93278866|NCT03700801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278867|NCT03700801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93278868|NCT03700801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278869|NCT03700801|Incretins|incretins|mesh-ancestor
93278870|NCT03700801|Hormones|hormones|mesh-ancestor
93278871|NCT03700801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278872|NCT03700801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93278873|NCT03700801|Protease Inhibitors|protease inhibitors|mesh-ancestor
93278874|NCT03700801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278875|NCT03700645|Allopurinol|allopurinol|mesh-list
93278876|NCT03700645|Antimetabolites|antimetabolites|mesh-ancestor
93278877|NCT03700645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278878|NCT03700645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278879|NCT03700645|Gout Suppressants|gout suppressants|mesh-ancestor
93278880|NCT03700645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278881|NCT03700645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93278882|NCT03700645|Antioxidants|antioxidants|mesh-ancestor
93278883|NCT03700645|Protective Agents|protective agents|mesh-ancestor
93278884|NCT03700645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278885|NCT04499053|Durvalumab|durvalumab|mesh-list
93278886|NCT04499053|Tremelimumab|tremelimumab|mesh-list
93278887|NCT04499053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278888|NCT04499053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278889|NCT03567681|Oxcarbazepine|oxcarbazepine|mesh-list
93278890|NCT03567681|Anticonvulsants|anticonvulsants|mesh-ancestor
93278891|NCT03567681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93278892|NCT03567681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93278893|NCT03567681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93278894|NCT03567681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278895|NCT03567681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93278896|NCT03567681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93278897|NCT03567447|Droxidopa|droxidopa|mesh-list
93278898|NCT03567447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93278899|NCT03567447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93278900|NCT03567369|Dexamethasone|dexamethasone|mesh-list
93278901|NCT03567369|Dexamethasone acetate|dexamethasone acetate|mesh-list
93278902|NCT03567369|BB 1101|bb 1101|mesh-list
93278903|NCT03567369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278904|NCT03567369|Antiemetics|antiemetics|mesh-ancestor
93278905|NCT03567369|Autonomic Agents|autonomic agents|mesh-ancestor
93278906|NCT03567369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278907|NCT03567369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278908|NCT03567369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278909|NCT03567369|Glucocorticoids|glucocorticoids|mesh-ancestor
93278910|NCT03567369|Hormones|hormones|mesh-ancestor
93278911|NCT03567369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278912|NCT03567369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92950943|NCT00952432|Analgesics|analgesics|mesh-ancestor
93278913|NCT03567369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278914|NCT03567369|Protease Inhibitors|protease inhibitors|mesh-ancestor
93278915|NCT03567369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278916|NCT03567369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278917|NCT03397654|Pembrolizumab|pembrolizumab|mesh-list
93278918|NCT03397654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278919|NCT03397654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278920|NCT03397654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93278921|NCT03397654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278922|NCT03266146|Methylprednisolone|methylprednisolone|mesh-list
93278923|NCT03266146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93278924|NCT03266146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93278925|NCT03266146|Prednisolone|prednisolone|mesh-list
93278926|NCT03266146|Prednisolone acetate|prednisolone acetate|mesh-list
93278927|NCT03266146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93278928|NCT03266146|Prednisolone phosphate|prednisolone phosphate|mesh-list
93278929|NCT03266146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278930|NCT03266146|Antiemetics|antiemetics|mesh-ancestor
93278931|NCT03266146|Autonomic Agents|autonomic agents|mesh-ancestor
93278932|NCT03266146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278933|NCT03266146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278934|NCT03266146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93278935|NCT03266146|Glucocorticoids|glucocorticoids|mesh-ancestor
93278936|NCT03266146|Hormones|hormones|mesh-ancestor
93278937|NCT03266146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93278938|NCT03266146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93278939|NCT03266146|Protective Agents|protective agents|mesh-ancestor
93278940|NCT03266146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278941|NCT03266146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278942|NCT03700489|Titanium dioxide|titanium dioxide|mesh-list
93278943|NCT03700489|Sunscreening Agents|sunscreening agents|mesh-ancestor
93278944|NCT03700489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93278945|NCT03700489|Protective Agents|protective agents|mesh-ancestor
93278946|NCT03700489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278947|NCT03700489|Dermatologic Agents|dermatologic agents|mesh-ancestor
93278948|NCT03700489|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93278949|NCT02800941|Warfarin|warfarin|mesh-list
93278950|NCT02800941|Anticoagulants|anticoagulants|mesh-list
93278951|NCT02800941|Acenocoumarol|acenocoumarol|mesh-list
93278952|NCT02800941|Fluindione|fluindione|mesh-list
93278953|NCT03695887|Nitrous Oxide|nitrous oxide|mesh-list
93278954|NCT03695887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93278955|NCT03695887|Anesthetics, General|anesthetics, general|mesh-ancestor
93278956|NCT03695887|Anesthetics|anesthetics|mesh-ancestor
93278957|NCT03695887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93278958|NCT03695887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278959|NCT03695887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93278960|NCT03695887|Analgesics|analgesics|mesh-ancestor
93278961|NCT03695887|Sensory System Agents|sensory system agents|mesh-ancestor
93278962|NCT03695887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93278963|NCT04432714|Prednisone|prednisone|mesh-list
93278964|NCT04432714|Cyclophosphamide|cyclophosphamide|mesh-list
93278965|NCT04432714|Rituximab|rituximab|mesh-list
93278966|NCT04432714|Doxorubicin|doxorubicin|mesh-list
93278967|NCT04432714|Etoposide|etoposide|mesh-list
93278968|NCT04432714|Vincristine|vincristine|mesh-list
93278969|NCT04432714|Lenalidomide|lenalidomide|mesh-list
93278970|NCT04432714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93278971|NCT04432714|Immunologic Factors|immunologic factors|mesh-ancestor
93278972|NCT04432714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93278973|NCT04432714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93278974|NCT04432714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93278975|NCT04432714|Alkylating Agents|alkylating agents|mesh-ancestor
93278976|NCT04432714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93278977|NCT04432714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93278978|NCT04432714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93278979|NCT04432714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278980|NCT04432714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93278981|NCT04432714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93278982|NCT04432714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93278983|NCT04432714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93278984|NCT04432714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93278985|NCT04432714|Glucocorticoids|glucocorticoids|mesh-ancestor
93278986|NCT04432714|Hormones|hormones|mesh-ancestor
93278987|NCT04432714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951020|NCT00861783|Oxaliplatin|oxaliplatin|mesh-list
93278988|NCT04432714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93278989|NCT04432714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93278990|NCT04432714|Tubulin Modulators|tubulin modulators|mesh-ancestor
93278991|NCT04432714|Antimitotic Agents|antimitotic agents|mesh-ancestor
93278992|NCT04432714|Mitosis Modulators|mitosis modulators|mesh-ancestor
93278993|NCT04432714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93278994|NCT04432714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93278995|NCT04432714|Growth Substances|growth substances|mesh-ancestor
93278996|NCT04432714|Growth Inhibitors|growth inhibitors|mesh-ancestor
93278997|NCT02752074|Pembrolizumab|pembrolizumab|mesh-list
93278998|NCT02752074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93278999|NCT02752074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279000|NCT02752074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93279001|NCT02752074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279002|NCT03564795|Sulfadiazine|sulfadiazine|mesh-list
93279003|NCT03564795|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93279004|NCT03564795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279005|NCT03564795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279006|NCT03564795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93279007|NCT03564795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93279008|NCT03564795|Coccidiostats|coccidiostats|mesh-ancestor
93279009|NCT03564795|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93279010|NCT03624595|Dexmedetomidine|dexmedetomidine|mesh-list
93279011|NCT03624595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93279012|NCT03624595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279013|NCT03624595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279014|NCT03624595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93279015|NCT03624595|Analgesics|analgesics|mesh-ancestor
93279016|NCT03624595|Sensory System Agents|sensory system agents|mesh-ancestor
93279017|NCT03624595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279018|NCT03624595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93279019|NCT03624595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93279020|NCT03624595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93279021|NCT03624595|Adrenergic Agents|adrenergic agents|mesh-ancestor
93279022|NCT03624595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279023|NCT03624595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279024|NCT03063892|Tranexamic Acid|tranexamic acid|mesh-list
93279025|NCT03063892|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93279026|NCT03063892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93279027|NCT03063892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279028|NCT03063892|Hemostatics|hemostatics|mesh-ancestor
93279029|NCT03063892|Coagulants|coagulants|mesh-ancestor
93279030|NCT03063580|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93279031|NCT03063580|Rifampin|rifampin|mesh-list
93279032|NCT03063580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93279033|NCT03063580|Antitubercular Agents|antitubercular agents|mesh-ancestor
93279034|NCT03063580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279035|NCT03063580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279036|NCT03063580|Leprostatic Agents|leprostatic agents|mesh-ancestor
93279037|NCT03063580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279038|NCT03063580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279039|NCT03063580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279040|NCT03063580|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93279041|NCT03063580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91933387|NCT02223377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93279042|NCT03063580|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93279043|NCT03063580|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93279044|NCT03063580|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93279045|NCT03063580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93279046|NCT03063580|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93279047|NCT03063580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93279048|NCT03063580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279049|NCT05353101|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93279050|NCT05353101|Cyclosporine|cyclosporine|mesh-list
93279051|NCT05353101|Tobramycin|tobramycin|mesh-list
93279052|NCT05353101|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93279053|NCT05353101|Cyclosporins|cyclosporins|mesh-list
93279054|NCT05353101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279055|NCT05353101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279056|NCT05353101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279057|NCT05353101|Immunologic Factors|immunologic factors|mesh-ancestor
93279058|NCT05353101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279059|NCT05353101|Antifungal Agents|antifungal agents|mesh-ancestor
93279060|NCT05353101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279061|NCT05353101|Dermatologic Agents|dermatologic agents|mesh-ancestor
93279062|NCT05353101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279063|NCT05353101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93279064|NCT05353101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93279065|NCT05353101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279066|NCT05353101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93279067|NCT03700333|Pemetrexed|pemetrexed|mesh-list
93279068|NCT03700333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279069|NCT03700333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279070|NCT03700333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279071|NCT03700333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93279072|NCT03700333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279073|NCT03700177|Dexamethasone|dexamethasone|mesh-list
93279074|NCT03700177|Ropivacaine|ropivacaine|mesh-list
93279075|NCT03700177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279076|NCT03700177|Antiemetics|antiemetics|mesh-ancestor
93279077|NCT03700177|Autonomic Agents|autonomic agents|mesh-ancestor
93279078|NCT03700177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279079|NCT03700177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279080|NCT03700177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279081|NCT03700177|Glucocorticoids|glucocorticoids|mesh-ancestor
93279082|NCT03700177|Hormones|hormones|mesh-ancestor
93279083|NCT03700177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279084|NCT03700177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279085|NCT03700177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279086|NCT03700177|Anesthetics, Local|anesthetics, local|mesh-ancestor
93279087|NCT03700177|Anesthetics|anesthetics|mesh-ancestor
93279088|NCT03700177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279089|NCT03700177|Sensory System Agents|sensory system agents|mesh-ancestor
93279090|NCT02183610|Linagliptin|linagliptin|mesh-list
93279091|NCT02183610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93279092|NCT02183610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93279093|NCT02183610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279094|NCT02183610|Incretins|incretins|mesh-ancestor
93279095|NCT02183610|Hormones|hormones|mesh-ancestor
93279096|NCT02183610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279097|NCT02183610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93279098|NCT02183610|Protease Inhibitors|protease inhibitors|mesh-ancestor
93279099|NCT02183610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279100|NCT02183610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279101|NCT02183688|Acetaminophen|acetaminophen|mesh-list
93279102|NCT02183688|Caffeine|caffeine|mesh-list
93279103|NCT02183688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93279104|NCT02183688|Analgesics|analgesics|mesh-ancestor
93279105|NCT02183688|Sensory System Agents|sensory system agents|mesh-ancestor
93279106|NCT02183688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279107|NCT02183688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279108|NCT02183688|Antipyretics|antipyretics|mesh-ancestor
93279109|NCT02183688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93279110|NCT02183688|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93279111|NCT02183688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279112|NCT02183688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279113|NCT02183688|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93279114|NCT02183688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93279115|NCT02183688|Purinergic Agents|purinergic agents|mesh-ancestor
93279116|NCT02183688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279117|NCT02190708|Midazolam|midazolam|mesh-list
93279118|NCT02190708|Omeprazole|omeprazole|mesh-list
93279119|NCT02190708|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93279120|NCT02190708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93279121|NCT02190708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93279122|NCT02190708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279123|NCT02190708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279124|NCT02190708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93279125|NCT02190708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93279126|NCT02190708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93279127|NCT02190708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93279128|NCT02190708|Anesthetics, General|anesthetics, general|mesh-ancestor
93279129|NCT02190708|Anesthetics|anesthetics|mesh-ancestor
93279130|NCT02190708|GABA Modulators|gaba modulators|mesh-ancestor
93279131|NCT02190708|GABA Agents|gaba agents|mesh-ancestor
93279132|NCT02190708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279133|NCT02190708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279134|NCT02190708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93279135|NCT02190708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279136|NCT02190708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279137|NCT05338983|Anesthetics|anesthetics|mesh-list
93279138|NCT05338983|Mepivacaine|mepivacaine|mesh-list
93279139|NCT05338983|Anesthetics, Local|anesthetics, local|mesh-list
93279140|NCT05338983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279141|NCT05338983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279142|NCT05338983|Sensory System Agents|sensory system agents|mesh-ancestor
93279143|NCT05338983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279144|NCT03063658|Acetaminophen|acetaminophen|mesh-list
93279146|NCT03063658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93279147|NCT03063658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93279148|NCT03063658|Analgesics|analgesics|mesh-ancestor
93279149|NCT03063658|Sensory System Agents|sensory system agents|mesh-ancestor
93279150|NCT03063658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279151|NCT03063658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279152|NCT03063658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279153|NCT03063658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279154|NCT03063658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93279155|NCT03063658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279156|NCT03063658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279157|NCT03063658|Antipyretics|antipyretics|mesh-ancestor
93279158|NCT03695107|Nifedipine|nifedipine|mesh-list
93279159|NCT03695107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93279160|NCT03695107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93279161|NCT03695107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279162|NCT03695107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93279163|NCT03695107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279164|NCT03695107|Vasodilator Agents|vasodilator agents|mesh-ancestor
93279165|NCT03695107|Tocolytic Agents|tocolytic agents|mesh-ancestor
93279166|NCT03695107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93279167|NCT02835339|Magnesium Sulfate|magnesium sulfate|mesh-list
93279168|NCT02835339|Analgesics|analgesics|mesh-ancestor
93279169|NCT02835339|Sensory System Agents|sensory system agents|mesh-ancestor
93279170|NCT02835339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279171|NCT02835339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279172|NCT02835339|Anesthetics|anesthetics|mesh-ancestor
93279173|NCT02835339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279174|NCT02835339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93279175|NCT02835339|Anticonvulsants|anticonvulsants|mesh-ancestor
93279176|NCT02835339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93279177|NCT02835339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93279178|NCT02835339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279179|NCT02835339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93279180|NCT02835339|Tocolytic Agents|tocolytic agents|mesh-ancestor
93279181|NCT02835339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93279182|NCT03695029|Tenofovir|tenofovir|mesh-list
93279183|NCT03695029|Antiviral Agents|antiviral agents|mesh-ancestor
93279184|NCT03695029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279185|NCT03695029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93279186|NCT03695029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279187|NCT03695029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279188|NCT03695029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279189|NCT03695029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279190|NCT03695029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279191|NCT02259855|Interferons|interferons|mesh-list
93279192|NCT02259855|Ritonavir|ritonavir|mesh-list
93279193|NCT02259855|Ribavirin|ribavirin|mesh-list
93279194|NCT02259855|Tipranavir|tipranavir|mesh-list
93279195|NCT02259855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279196|NCT02259855|Antiviral Agents|antiviral agents|mesh-ancestor
93279197|NCT02259855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279198|NCT02259855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93279199|NCT02259855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93279200|NCT02259855|Protease Inhibitors|protease inhibitors|mesh-ancestor
93279201|NCT02259855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279202|NCT02259855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279203|NCT02259855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279204|NCT02259855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279205|NCT02259855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279206|NCT02259855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279207|NCT02259855|Antimetabolites|antimetabolites|mesh-ancestor
93279208|NCT03703063|Leucovorin|leucovorin|mesh-list
93279209|NCT03703063|Paclitaxel|paclitaxel|mesh-list
93279210|NCT03703063|Gemcitabine|gemcitabine|mesh-list
93279211|NCT03703063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93279212|NCT03703063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279213|NCT03703063|Tubulin Modulators|tubulin modulators|mesh-ancestor
93279214|NCT03703063|Antimitotic Agents|antimitotic agents|mesh-ancestor
93279215|NCT03703063|Mitosis Modulators|mitosis modulators|mesh-ancestor
93279216|NCT03703063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279217|NCT03703063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93279218|NCT03703063|Antimetabolites|antimetabolites|mesh-ancestor
93279219|NCT03703063|Antidotes|antidotes|mesh-ancestor
93279220|NCT03703063|Protective Agents|protective agents|mesh-ancestor
93279221|NCT03703063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279222|NCT03703063|Vitamin B Complex|vitamin b complex|mesh-ancestor
93279223|NCT03703063|Vitamins|vitamins|mesh-ancestor
93279224|NCT03703063|Micronutrients|micronutrients|mesh-ancestor
93279225|NCT03702985|Capecitabine|capecitabine|mesh-list
93279226|NCT03702985|Irinotecan|irinotecan|mesh-list
93279227|NCT03702985|Amifostine|amifostine|mesh-list
93279228|NCT03702985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93279229|NCT03702985|Antimetabolites|antimetabolites|mesh-ancestor
93279230|NCT03702985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279231|NCT03702985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279232|NCT03702985|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93279233|NCT03702985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93279234|NCT03702985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279235|NCT03702985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93279236|NCT03702985|Protective Agents|protective agents|mesh-ancestor
93279237|NCT03702985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279238|NCT03064984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93279239|NCT03064984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93279240|NCT02184078|Nevirapine|nevirapine|mesh-list
93279241|NCT02184078|Rifabutin|rifabutin|mesh-list
93279242|NCT02184078|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93279243|NCT02184078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279244|NCT02184078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279245|NCT02184078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279246|NCT02184078|Antiviral Agents|antiviral agents|mesh-ancestor
93279247|NCT02184078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279248|NCT02184078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279249|NCT02184078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279250|NCT02184078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93279251|NCT02184078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93279252|NCT02184078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279253|NCT02184078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93279254|NCT02184078|Antitubercular Agents|antitubercular agents|mesh-ancestor
93279255|NCT04323436|Spartalizumab|spartalizumab|mesh-list
93279256|NCT04323436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93279257|NCT04323436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279258|NCT04323436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93279259|NCT04323436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279260|NCT03694873|Celecoxib|celecoxib|mesh-list
93279261|NCT03694873|Tramadol|tramadol|mesh-list
93279262|NCT03694873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93279263|NCT03694873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93279264|NCT03694873|Analgesics|analgesics|mesh-ancestor
93279265|NCT03694873|Sensory System Agents|sensory system agents|mesh-ancestor
93279266|NCT03694873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279267|NCT03694873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279268|NCT03694873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279269|NCT03694873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279270|NCT03694873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93279271|NCT03694873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93279272|NCT03694873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279273|NCT03694873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279274|NCT03694873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93279275|NCT03694873|Narcotics|narcotics|mesh-ancestor
93279276|NCT03694873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279277|NCT02191020|Acitretin|acitretin|mesh-list
93279278|NCT02191020|Keratolytic Agents|keratolytic agents|mesh-ancestor
93279279|NCT02191020|Dermatologic Agents|dermatologic agents|mesh-ancestor
93279280|NCT04476199|Decitabine|decitabine|mesh-list
93279281|NCT04476199|Venetoclax|venetoclax|mesh-list
93279282|NCT04476199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93279283|NCT04476199|Antimetabolites|antimetabolites|mesh-ancestor
93279284|NCT04476199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279285|NCT04476199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279286|NCT04476199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279287|NCT02188368|Clarithromycin|clarithromycin|mesh-list
93279289|NCT02188368|Prednisone|prednisone|mesh-list
93279290|NCT02188368|Cyclophosphamide|cyclophosphamide|mesh-list
93279291|NCT02188368|Bortezomib|bortezomib|mesh-list
93279292|NCT02188368|Pomalidomide|pomalidomide|mesh-list
93279293|NCT02188368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279294|NCT02188368|Immunologic Factors|immunologic factors|mesh-ancestor
93279295|NCT02188368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279296|NCT02188368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279297|NCT02188368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93279298|NCT02188368|Alkylating Agents|alkylating agents|mesh-ancestor
93279299|NCT02188368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279300|NCT02188368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279301|NCT02188368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93279302|NCT02188368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279303|NCT02188368|Antiemetics|antiemetics|mesh-ancestor
93279304|NCT02188368|Autonomic Agents|autonomic agents|mesh-ancestor
93279305|NCT02188368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279306|NCT02188368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279307|NCT02188368|Glucocorticoids|glucocorticoids|mesh-ancestor
93279308|NCT02188368|Hormones|hormones|mesh-ancestor
93279309|NCT02188368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279310|NCT02188368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279311|NCT02188368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279312|NCT02188368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279313|NCT02188368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279314|NCT02188368|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93279315|NCT02188368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279316|NCT02188368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279317|NCT02188368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93279318|NCT02188368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93279319|NCT02188368|Growth Substances|growth substances|mesh-ancestor
93279320|NCT02188368|Growth Inhibitors|growth inhibitors|mesh-ancestor
93279321|NCT02191176|Dextromethorphan|dextromethorphan|mesh-list
93279322|NCT02191176|Antitussive Agents|antitussive agents|mesh-ancestor
93279323|NCT02191176|Respiratory System Agents|respiratory system agents|mesh-ancestor
93279324|NCT02191176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93279325|NCT02191176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93279326|NCT02191176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279327|NCT02191176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279328|NCT02191176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279329|NCT02184312|Nevirapine|nevirapine|mesh-list
93279330|NCT02184312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93279331|NCT02184312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279332|NCT02184312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279333|NCT02184312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279334|NCT02184312|Antiviral Agents|antiviral agents|mesh-ancestor
93279335|NCT02184312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279336|NCT02184312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279337|NCT02184312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279338|NCT02184312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93279339|NCT02184312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93279340|NCT04301011|Pembrolizumab|pembrolizumab|mesh-list
93279341|NCT04301011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93279342|NCT04301011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279343|NCT04301011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93279344|NCT04301011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279345|NCT02191332|Nevirapine|nevirapine|mesh-list
93279346|NCT02191332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93279347|NCT02191332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279348|NCT02191332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279349|NCT02191332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279350|NCT02191332|Antiviral Agents|antiviral agents|mesh-ancestor
93279351|NCT02191332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279352|NCT02191332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279353|NCT02191332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279354|NCT02191332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93279355|NCT02191332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93279356|NCT02256774|Ritonavir|ritonavir|mesh-list
93279357|NCT02256774|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93279358|NCT02256774|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93279359|NCT02256774|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92951394|NCT00696410|Zinc|zinc|mesh-list
93279360|NCT02256774|Protease Inhibitors|protease inhibitors|mesh-ancestor
93279361|NCT02256774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279362|NCT02256774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279363|NCT02256774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279364|NCT02256774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279365|NCT02256774|Antiviral Agents|antiviral agents|mesh-ancestor
93279366|NCT02256774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279367|NCT02256774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279368|NCT02256774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279369|NCT02256774|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93279370|NCT02256774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279371|NCT02189304|Budesonide|budesonide|mesh-list
93279372|NCT02189304|Glycopyrrolate|glycopyrrolate|mesh-list
93279373|NCT02189304|Formoterol Fumarate|formoterol fumarate|mesh-list
93279374|NCT02189304|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93279375|NCT02189304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279376|NCT02189304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93279377|NCT02189304|Autonomic Agents|autonomic agents|mesh-ancestor
93279378|NCT02189304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279379|NCT02189304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279380|NCT02189304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93279381|NCT02189304|Respiratory System Agents|respiratory system agents|mesh-ancestor
93279382|NCT02189304|Glucocorticoids|glucocorticoids|mesh-ancestor
93279383|NCT02189304|Hormones|hormones|mesh-ancestor
93279384|NCT02189304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279385|NCT02189304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93279386|NCT02189304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93279387|NCT02189304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93279388|NCT02189304|Adrenergic Agents|adrenergic agents|mesh-ancestor
92573969|NCT00244153|Narcotics|narcotics|mesh-ancestor
93279389|NCT02189304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279390|NCT02189304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279391|NCT02189304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93279392|NCT02189304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93279393|NCT02189304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93279394|NCT02189304|Cholinergic Agents|cholinergic agents|mesh-ancestor
93279395|NCT02184858|Lisinopril|lisinopril|mesh-list
93279396|NCT02184858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93279397|NCT02184858|Protease Inhibitors|protease inhibitors|mesh-ancestor
93279398|NCT02184858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279399|NCT02184858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279400|NCT02184858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93279401|NCT02184858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93279402|NCT02184858|Protective Agents|protective agents|mesh-ancestor
93279403|NCT02184858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279404|NCT03535662|Itraconazole|itraconazole|mesh-list
93279405|NCT03535662|Antifungal Agents|antifungal agents|mesh-ancestor
93279406|NCT03535662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279407|NCT03535662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93279408|NCT03535662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279409|NCT03535662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279410|NCT03535662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279411|NCT03535662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93279412|NCT03535662|Hormone Antagonists|hormone antagonists|mesh-ancestor
93279413|NCT03535662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279414|NCT03535662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279415|NCT03535662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279416|NCT03702205|Betaine|betaine|mesh-list
93279417|NCT03702205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279418|NCT03702205|Lipotropic Agents|lipotropic agents|mesh-ancestor
93279419|NCT03702205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93279420|NCT03702205|Antimetabolites|antimetabolites|mesh-ancestor
93279421|NCT03702205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279422|NCT03702205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93279423|NCT03698851|Methamphetamine|methamphetamine|mesh-list
93279424|NCT03698851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93279425|NCT03698851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279426|NCT03698851|Sympathomimetics|sympathomimetics|mesh-ancestor
93279427|NCT03698851|Autonomic Agents|autonomic agents|mesh-ancestor
93279428|NCT03698851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279429|NCT03698851|Dopamine Agents|dopamine agents|mesh-ancestor
93279430|NCT03698851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279431|NCT03698851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279432|NCT03698851|Adrenergic Agents|adrenergic agents|mesh-ancestor
93279433|NCT03698851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93279434|NCT03698851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93279435|NCT03698851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93279436|NCT03698851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93279438|NCT03125902|Atezolizumab|atezolizumab|mesh-list
93279439|NCT03125902|Antibodies|antibodies|mesh-list
93279440|NCT03125902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93279441|NCT03125902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93279442|NCT03125902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279443|NCT03125902|Tubulin Modulators|tubulin modulators|mesh-ancestor
93279444|NCT03125902|Antimitotic Agents|antimitotic agents|mesh-ancestor
93279445|NCT03125902|Mitosis Modulators|mitosis modulators|mesh-ancestor
93279446|NCT03125902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279447|NCT03125902|Immunologic Factors|immunologic factors|mesh-ancestor
93279448|NCT03125902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279449|NCT03125902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93279450|NCT03125902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93279451|NCT02189694|Hormones|hormones|mesh-list
93279452|NCT02189694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279453|NCT02189694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279454|NCT02189772|Metadoxine|metadoxine|mesh-list
93279455|NCT02189772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93279456|NCT02192424|Insulin|insulin|mesh-list
93279457|NCT02192424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93279458|NCT02192424|Metformin|metformin|mesh-list
93279459|NCT02192424|Insulin Glargine|insulin glargine|mesh-list
93279460|NCT02192424|Insulin Lispro|insulin lispro|mesh-list
93279461|NCT02192424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93279462|NCT02192424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279463|NCT04276597|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
93279464|NCT04276597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93279465|NCT04276597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279466|NCT02257008|Ritonavir|ritonavir|mesh-list
93279467|NCT02257008|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93279468|NCT02257008|Nelfinavir|nelfinavir|mesh-list
93279469|NCT02257008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93279470|NCT02257008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93279471|NCT02257008|Protease Inhibitors|protease inhibitors|mesh-ancestor
93279472|NCT02257008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279473|NCT02257008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279474|NCT02257008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279475|NCT02257008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279476|NCT02257008|Antiviral Agents|antiviral agents|mesh-ancestor
93279477|NCT02257008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279478|NCT02257008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279479|NCT02257008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279480|NCT03693391|Fluorides|fluorides|mesh-list
93279481|NCT03693391|Cariostatic Agents|cariostatic agents|mesh-ancestor
93279482|NCT03693391|Protective Agents|protective agents|mesh-ancestor
93279483|NCT03693391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279484|NCT02193594|Oxaliplatin|oxaliplatin|mesh-list
93279485|NCT02193594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279486|NCT02185326|Hormones|hormones|mesh-list
93279487|NCT02185326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279488|NCT02185326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279489|NCT04412707|Dexamethasone|dexamethasone|mesh-list
93279490|NCT04412707|Melphalan|melphalan|mesh-list
93279491|NCT04412707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279492|NCT04412707|Antiemetics|antiemetics|mesh-ancestor
93279493|NCT04412707|Autonomic Agents|autonomic agents|mesh-ancestor
93279494|NCT04412707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279495|NCT04412707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279496|NCT04412707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279497|NCT04412707|Glucocorticoids|glucocorticoids|mesh-ancestor
93279498|NCT04412707|Hormones|hormones|mesh-ancestor
93279499|NCT04412707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279500|NCT04412707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279501|NCT04412707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279502|NCT04412707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93279503|NCT04412707|Alkylating Agents|alkylating agents|mesh-ancestor
93279504|NCT04412707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279505|NCT04412707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93279506|NCT04412707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279507|NCT04412707|Immunologic Factors|immunologic factors|mesh-ancestor
93279508|NCT03698695|Mefloquine|mefloquine|mesh-list
93279509|NCT03698695|Donepezil|donepezil|mesh-list
93279510|NCT03698695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93279511|NCT03698695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279512|NCT03698695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279513|NCT03698695|Cholinergic Agents|cholinergic agents|mesh-ancestor
93279514|NCT03698695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574114|NCT00244972|Sorafenib|sorafenib|mesh-list
93279515|NCT03698695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279516|NCT03698695|Nootropic Agents|nootropic agents|mesh-ancestor
93279517|NCT03698695|Antimalarials|antimalarials|mesh-ancestor
93279518|NCT03698695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93279519|NCT03698695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93279520|NCT03698695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279521|NCT04729296|Golimumab|golimumab|mesh-list
93279522|NCT04729296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93279523|NCT04729296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279524|NCT04729296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279525|NCT04729296|Immunologic Factors|immunologic factors|mesh-ancestor
93279526|NCT04729296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279527|NCT03698617|Propofol|propofol|mesh-list
93279528|NCT03698617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93279529|NCT03698617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279530|NCT03698617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279531|NCT03698617|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93279532|NCT03698617|Anesthetics, General|anesthetics, general|mesh-ancestor
93279533|NCT03698617|Anesthetics|anesthetics|mesh-ancestor
93279534|NCT02194374|Cyclophosphamide|cyclophosphamide|mesh-list
93279535|NCT02194374|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93279536|NCT02194374|Rituximab|rituximab|mesh-list
93279537|NCT02194374|Fludarabine|fludarabine|mesh-list
93279538|NCT02194374|Fludarabine phosphate|fludarabine phosphate|mesh-list
93279539|NCT02194374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279540|NCT02194374|Immunologic Factors|immunologic factors|mesh-ancestor
93279541|NCT02194374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279542|NCT02194374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279543|NCT02194374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93279544|NCT02194374|Alkylating Agents|alkylating agents|mesh-ancestor
93279545|NCT02194374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279546|NCT02194374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279547|NCT02194374|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93279548|NCT02194374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93279549|NCT02194374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93279550|NCT02194374|Antimetabolites|antimetabolites|mesh-ancestor
93279551|NCT02194452|Octreotide|octreotide|mesh-list
93279552|NCT02194452|Edotreotide|edotreotide|mesh-list
93279553|NCT02194452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279554|NCT02194452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279555|NCT02194452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279556|NCT02194452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93279557|NCT02194452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279558|NCT01358721|Nivolumab|nivolumab|mesh-list
93279559|NCT01358721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93279560|NCT01358721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279561|NCT01358721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93279562|NCT01358721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279563|NCT02194686|Cilostazol|cilostazol|mesh-list
93279564|NCT02194686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93279565|NCT02194686|Autonomic Agents|autonomic agents|mesh-ancestor
93279566|NCT02194686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279567|NCT02194686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279568|NCT02194686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93279569|NCT02194686|Respiratory System Agents|respiratory system agents|mesh-ancestor
93279570|NCT02194686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93279571|NCT02194686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93279572|NCT02194686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279573|NCT02194686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93279574|NCT02194686|Vasodilator Agents|vasodilator agents|mesh-ancestor
93279575|NCT02194686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93279576|NCT02194686|Protective Agents|protective agents|mesh-ancestor
93279577|NCT02194686|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93279578|NCT02194686|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93279579|NCT02194686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279580|NCT04622995|Diazepam|diazepam|mesh-list
93279581|NCT04622995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92951619|NCT00753168|Timolol|timolol|mesh-list
93279582|NCT04622995|Anticonvulsants|anticonvulsants|mesh-ancestor
93279583|NCT04622995|Antiemetics|antiemetics|mesh-ancestor
93279584|NCT04622995|Autonomic Agents|autonomic agents|mesh-ancestor
93279585|NCT04622995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574167|NCT00245206|Antidepressive Agents|antidepressive agents|mesh-ancestor
93279586|NCT04622995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279587|NCT04622995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279588|NCT04622995|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93279589|NCT04622995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279590|NCT04622995|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93279591|NCT04622995|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93279592|NCT04622995|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93279593|NCT04622995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93279594|NCT04622995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93279595|NCT04622995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93279596|NCT04622995|Anesthetics, General|anesthetics, general|mesh-ancestor
93279597|NCT04622995|Anesthetics|anesthetics|mesh-ancestor
93279598|NCT04622995|GABA Modulators|gaba modulators|mesh-ancestor
93279599|NCT04622995|GABA Agents|gaba agents|mesh-ancestor
93279600|NCT04622995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279601|NCT04622995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279602|NCT01341639|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93279603|NCT01341639|Immunologic Factors|immunologic factors|mesh-ancestor
93279604|NCT01341639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279605|NCT02194764|Naltrexone|naltrexone|mesh-list
93279606|NCT02194764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93279607|NCT02194764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93279608|NCT02194764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279609|NCT02194764|Sensory System Agents|sensory system agents|mesh-ancestor
93279610|NCT02194764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279611|NCT02967640|Ketamine|ketamine|mesh-list
93279612|NCT02967640|Analgesics|analgesics|mesh-ancestor
93279613|NCT02967640|Sensory System Agents|sensory system agents|mesh-ancestor
93279614|NCT02967640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279615|NCT02967640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279616|NCT02967640|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93279617|NCT02967640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93279618|NCT02967640|Anesthetics, General|anesthetics, general|mesh-ancestor
93279619|NCT02967640|Anesthetics|anesthetics|mesh-ancestor
93279620|NCT02967640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279621|NCT02967640|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93279622|NCT02967640|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93279623|NCT02967640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279624|NCT02967640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279625|NCT02194920|Parathyroid Hormone|parathyroid hormone|mesh-list
93279626|NCT02194920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93279627|NCT02194920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279628|NCT00005584|Prednisone|prednisone|mesh-list
93279629|NCT00005584|Epirubicin|epirubicin|mesh-list
93279630|NCT00005584|Bleomycin|bleomycin|mesh-list
93279631|NCT00005584|Vinblastine|vinblastine|mesh-list
93279632|NCT00005584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279633|NCT00005584|Glucocorticoids|glucocorticoids|mesh-ancestor
93279634|NCT00005584|Hormones|hormones|mesh-ancestor
93279635|NCT00005584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279636|NCT00005584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279637|NCT00005584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279638|NCT00005584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279639|NCT00005584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93279640|NCT00005584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93279641|NCT00005584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93279642|NCT00005584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279643|NCT00005584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279644|NCT00005584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93279645|NCT00005584|Tubulin Modulators|tubulin modulators|mesh-ancestor
93279646|NCT00005584|Antimitotic Agents|antimitotic agents|mesh-ancestor
93279647|NCT00005584|Mitosis Modulators|mitosis modulators|mesh-ancestor
93279648|NCT02194218|Nevirapine|nevirapine|mesh-list
93279649|NCT02194218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93279650|NCT02194218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93279651|NCT02194218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279652|NCT02194218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279653|NCT02194218|Antiviral Agents|antiviral agents|mesh-ancestor
93279654|NCT02194218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279655|NCT02194218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92951693|NCT00753246|Nimotuzumab|nimotuzumab|mesh-list
93279656|NCT02194218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279657|NCT02194218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93279658|NCT02194218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93279659|NCT02194296|Ambroxol|ambroxol|mesh-list
93279660|NCT02194296|Expectorants|expectorants|mesh-ancestor
93279661|NCT02194296|Respiratory System Agents|respiratory system agents|mesh-ancestor
93279662|NCT02197026|Hylan|hylan|mesh-list
93279663|NCT02197026|Viscosupplements|viscosupplements|mesh-ancestor
93279664|NCT02197026|Protective Agents|protective agents|mesh-ancestor
93279665|NCT02197026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279666|NCT02197104|Choline|choline|mesh-list
93279667|NCT02197104|Lipotropic Agents|lipotropic agents|mesh-ancestor
93279668|NCT02197104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93279669|NCT02197104|Antimetabolites|antimetabolites|mesh-ancestor
93279670|NCT02197104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279671|NCT02197104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279672|NCT02197104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93279673|NCT02197104|Nootropic Agents|nootropic agents|mesh-ancestor
93279674|NCT02197182|Copper|copper|mesh-list
93279675|NCT02197182|Metronidazole|metronidazole|mesh-list
93279676|NCT02197182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279677|NCT02197182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279678|NCT02197182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93279679|NCT02197182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93279680|NCT02197182|Trace Elements|trace elements|mesh-ancestor
93279681|NCT02197182|Micronutrients|micronutrients|mesh-ancestor
93279682|NCT02197182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279683|NCT02197260|Amoxicillin|amoxicillin|mesh-list
93279684|NCT02197260|Metronidazole|metronidazole|mesh-list
93279685|NCT02197260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279686|NCT02197260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279687|NCT02197260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93279688|NCT02197260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93279689|NCT03687931|Dexamethasone|dexamethasone|mesh-list
93279690|NCT03687931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279691|NCT03687931|Antiemetics|antiemetics|mesh-ancestor
93279692|NCT03687931|Autonomic Agents|autonomic agents|mesh-ancestor
93279693|NCT03687931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279694|NCT03687931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279695|NCT03687931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279696|NCT03687931|Glucocorticoids|glucocorticoids|mesh-ancestor
93279697|NCT03687931|Hormones|hormones|mesh-ancestor
93279698|NCT03687931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279699|NCT03687931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279700|NCT03687931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279701|NCT03534024|Curcumin|curcumin|mesh-list
93279702|NCT03534024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93279703|NCT03534024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93279704|NCT03534024|Analgesics|analgesics|mesh-ancestor
93279705|NCT03534024|Sensory System Agents|sensory system agents|mesh-ancestor
93279706|NCT03534024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279707|NCT03534024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279708|NCT03534024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279709|NCT03534024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279710|NCT03534024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279711|NCT03534024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279712|NCT03534024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279713|NCT02753686|Tamoxifen|tamoxifen|mesh-list
93279714|NCT02753686|Everolimus|everolimus|mesh-list
93279715|NCT02753686|Letrozole|letrozole|mesh-list
93279716|NCT02753686|Fulvestrant|fulvestrant|mesh-list
93279717|NCT02753686|Anastrozole|anastrozole|mesh-list
93279718|NCT02753686|Exemestane|exemestane|mesh-list
93279719|NCT02753686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93279720|NCT02753686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93279721|NCT02753686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279722|NCT02753686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279723|NCT02753686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279724|NCT02753686|Immunologic Factors|immunologic factors|mesh-ancestor
93279725|NCT02753686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279726|NCT02753686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279727|NCT02753686|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93279728|NCT02753686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93279729|NCT02753686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93279730|NCT02753686|Hormone Antagonists|hormone antagonists|mesh-ancestor
93279731|NCT02753686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279732|NCT02753686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279733|NCT02753686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93279734|NCT02753686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93279735|NCT02753686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93279736|NCT02753686|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93279737|NCT04216927|Nitric Oxide|nitric oxide|mesh-list
93279738|NCT04216927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93279739|NCT04216927|Autonomic Agents|autonomic agents|mesh-ancestor
93279740|NCT04216927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279741|NCT04216927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279742|NCT04216927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93279743|NCT04216927|Respiratory System Agents|respiratory system agents|mesh-ancestor
93279744|NCT04216927|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93279745|NCT04216927|Antioxidants|antioxidants|mesh-ancestor
93279746|NCT04216927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279747|NCT04216927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279748|NCT04216927|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93279749|NCT04216927|Vasodilator Agents|vasodilator agents|mesh-ancestor
93279750|NCT04216927|Gasotransmitters|gasotransmitters|mesh-ancestor
93279751|NCT04216927|Protective Agents|protective agents|mesh-ancestor
93279752|NCT02329834|Furosemide|furosemide|mesh-list
93279753|NCT02329834|Diuretics|diuretics|mesh-ancestor
93279754|NCT02329834|Natriuretic Agents|natriuretic agents|mesh-ancestor
93279755|NCT02329834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279756|NCT02329834|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93279757|NCT02329834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93279758|NCT02329834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279759|NCT02195466|Ritonavir|ritonavir|mesh-list
93279760|NCT02195466|Tipranavir|tipranavir|mesh-list
93279761|NCT02195466|Fluconazole|fluconazole|mesh-list
93279762|NCT02195466|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93279763|NCT02195466|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93279764|NCT02195466|Protease Inhibitors|protease inhibitors|mesh-ancestor
93279765|NCT02195466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279766|NCT02195466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279767|NCT02195466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93279768|NCT02195466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93279769|NCT02195466|Antiviral Agents|antiviral agents|mesh-ancestor
93279770|NCT02195466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279771|NCT02195466|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279772|NCT02195466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279773|NCT02195466|Antifungal Agents|antifungal agents|mesh-ancestor
93279774|NCT02195466|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93279775|NCT02195466|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93279776|NCT02195466|Hormone Antagonists|hormone antagonists|mesh-ancestor
93279777|NCT02195466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279778|NCT02195466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279779|NCT02195466|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93279780|NCT02195466|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93279781|NCT02195544|Hylan|hylan|mesh-list
93279782|NCT02195544|Viscosupplements|viscosupplements|mesh-ancestor
93279783|NCT02195544|Protective Agents|protective agents|mesh-ancestor
93279784|NCT02195544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279785|NCT02197494|Valsartan|valsartan|mesh-list
93279786|NCT02197494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93279787|NCT02197494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93279788|NCT02197494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93279789|NCT02197494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279790|NCT01340937|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93279791|NCT01340937|Immunologic Factors|immunologic factors|mesh-ancestor
93279792|NCT01340937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279793|NCT03692299|Metronidazole|metronidazole|mesh-list
93279794|NCT03692299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279795|NCT03692299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279796|NCT03692299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93279797|NCT03692299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93279798|NCT02197650|Asparaginase|asparaginase|mesh-list
93279799|NCT02197650|Eryaspase|eryaspase|mesh-list
93279800|NCT02197650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279801|NCT02650648|Cyclophosphamide|cyclophosphamide|mesh-list
93279802|NCT02650648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279803|NCT02650648|Immunologic Factors|immunologic factors|mesh-ancestor
93279804|NCT02650648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279805|NCT02650648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92951843|NCT00617409|Paclitaxel|paclitaxel|mesh-list
93279806|NCT02650648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93279807|NCT02650648|Alkylating Agents|alkylating agents|mesh-ancestor
93279808|NCT02650648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279809|NCT02650648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279810|NCT02650648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93279812|NCT03682939|Immunologic Factors|immunologic factors|mesh-ancestor
93279813|NCT03682939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279814|NCT02201992|Crizotinib|crizotinib|mesh-list
93279815|NCT02201992|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93279816|NCT02201992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93279817|NCT02201992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279818|NCT02201992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279819|NCT02201992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279820|NCT03534492|Durvalumab|durvalumab|mesh-list
93279821|NCT03534492|Olaparib|olaparib|mesh-list
93279822|NCT03534492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93279823|NCT03534492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279824|NCT03534492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93279825|NCT03534492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279826|NCT03534492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279827|NCT03624283|Betahistine|betahistine|mesh-list
93279828|NCT03624283|Vasodilator Agents|vasodilator agents|mesh-ancestor
93279829|NCT03624283|Histamine Agonists|histamine agonists|mesh-ancestor
93279830|NCT03624283|Histamine Agents|histamine agents|mesh-ancestor
93279831|NCT03624283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279832|NCT03624283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279833|NCT03624283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279834|NCT03687463|Decitabine|decitabine|mesh-list
93279835|NCT03687463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93279836|NCT03687463|Antimetabolites|antimetabolites|mesh-ancestor
93279837|NCT03687463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279838|NCT03687463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279839|NCT03687463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279840|NCT03692143|Alendronate|alendronate|mesh-list
93279841|NCT03692143|Teriparatide|teriparatide|mesh-list
93279842|NCT03692143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93279843|NCT03692143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279844|NCT03692143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93279845|NCT02201004|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
93279846|NCT02201004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93279847|NCT02201004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279848|NCT02201004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93279849|NCT02201004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279850|NCT02197884|Clarithromycin|clarithromycin|mesh-list
93279851|NCT02197884|Itraconazole|itraconazole|mesh-list
93279852|NCT02197884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279853|NCT02197884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279854|NCT02197884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93279855|NCT02197884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279856|NCT02197884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279857|NCT02197884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93279858|NCT02197884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279859|NCT02197884|Antifungal Agents|antifungal agents|mesh-ancestor
93279860|NCT02197884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93279861|NCT02197884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93279862|NCT02197884|Hormone Antagonists|hormone antagonists|mesh-ancestor
93279863|NCT02197884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279864|NCT02197884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279865|NCT04196491|Cyclophosphamide|cyclophosphamide|mesh-list
93279866|NCT04196491|Fludarabine|fludarabine|mesh-list
93279867|NCT04196491|Lenalidomide|lenalidomide|mesh-list
93279868|NCT04196491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93279869|NCT04196491|Immunologic Factors|immunologic factors|mesh-ancestor
93279870|NCT04196491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279871|NCT04196491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279872|NCT04196491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93279873|NCT04196491|Alkylating Agents|alkylating agents|mesh-ancestor
93279874|NCT04196491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279875|NCT04196491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279876|NCT04196491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93279877|NCT04196491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93279878|NCT04196491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93279879|NCT04196491|Growth Substances|growth substances|mesh-ancestor
93279880|NCT04196491|Growth Inhibitors|growth inhibitors|mesh-ancestor
93279881|NCT02201082|Amikacin|amikacin|mesh-list
93279882|NCT02201082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279883|NCT02201082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279884|NCT03687229|Insulin|insulin|mesh-list
93279885|NCT03687229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93279886|NCT03687229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279887|NCT05085054|Osimertinib|osimertinib|mesh-list
93279888|NCT05085054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279889|NCT05085054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93279890|NCT05085054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279891|NCT05085054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279892|NCT03969121|Palbociclib|palbociclib|mesh-list
93279893|NCT03969121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279894|NCT03969121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93279895|NCT03969121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279896|NCT03969121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279897|NCT02201238|Diclofenac|diclofenac|mesh-list
93279898|NCT02201238|Menthol|menthol|mesh-list
93279899|NCT02201238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93279900|NCT02201238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93279901|NCT02201238|Analgesics|analgesics|mesh-ancestor
93279902|NCT02201238|Sensory System Agents|sensory system agents|mesh-ancestor
93279903|NCT02201238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279904|NCT02201238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279905|NCT02201238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279906|NCT02201238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93279907|NCT02201238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93279908|NCT02201238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279909|NCT02201238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279910|NCT02201238|Antipruritics|antipruritics|mesh-ancestor
93279911|NCT02201238|Dermatologic Agents|dermatologic agents|mesh-ancestor
93279912|NCT02257398|Moxifloxacin|moxifloxacin|mesh-list
93279913|NCT02257398|Gepotidacin|gepotidacin|mesh-list
93279914|NCT02257398|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93279915|NCT02257398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93279916|NCT02257398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574509|NCT00247663|Letrozole|letrozole|mesh-list
93279917|NCT02257398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93279918|NCT02257398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93279919|NCT02257398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279920|NCT02257398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279921|NCT02257398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279922|NCT02257398|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93279923|NCT02257398|Contraceptive Agents|contraceptive agents|mesh-ancestor
93279924|NCT02257398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93279925|NCT02257398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279926|NCT02257398|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93279927|NCT02257398|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93279928|NCT02257398|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93279929|NCT02201316|Mosapride|mosapride|mesh-list
93279930|NCT02201316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279931|NCT02201316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279932|NCT02201316|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93279933|NCT02201316|Serotonin Agents|serotonin agents|mesh-ancestor
93279934|NCT02201316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279935|NCT02201316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279936|NCT02198820|Anesthetics|anesthetics|mesh-list
93279937|NCT02198820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93279938|NCT02198820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279939|NCT02257476|Dexamethasone|dexamethasone|mesh-list
93279940|NCT02257476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93279941|NCT02257476|Antiemetics|antiemetics|mesh-ancestor
93279942|NCT02257476|Autonomic Agents|autonomic agents|mesh-ancestor
93279943|NCT02257476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279944|NCT02257476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279945|NCT02257476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279946|NCT02257476|Glucocorticoids|glucocorticoids|mesh-ancestor
93279947|NCT02257476|Hormones|hormones|mesh-ancestor
93279948|NCT02257476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93279949|NCT02257476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93279950|NCT02257476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279951|NCT03946111|Naltrexone|naltrexone|mesh-list
93279952|NCT03946111|Bupropion|bupropion|mesh-list
93279953|NCT03946111|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93279954|NCT03946111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93279955|NCT03946111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279956|NCT03946111|Sensory System Agents|sensory system agents|mesh-ancestor
93279957|NCT03946111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279958|NCT03946111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93279959|NCT03946111|Antidepressive Agents|antidepressive agents|mesh-ancestor
93279960|NCT03946111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93279961|NCT03946111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93279962|NCT03946111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93279963|NCT03946111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93279964|NCT03946111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279965|NCT03946111|Dopamine Agents|dopamine agents|mesh-ancestor
93279966|NCT03946111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279967|NCT03946111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93279968|NCT03946111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93279969|NCT03946111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93279970|NCT03943927|Metoprolol|metoprolol|mesh-list
93279971|NCT03943927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93279972|NCT03943927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93279973|NCT03943927|Sympatholytics|sympatholytics|mesh-ancestor
93279974|NCT03943927|Autonomic Agents|autonomic agents|mesh-ancestor
93279975|NCT03943927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93279976|NCT03943927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279977|NCT03943927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93279978|NCT03943927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93279979|NCT03943927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93279980|NCT03943927|Adrenergic Agents|adrenergic agents|mesh-ancestor
93279981|NCT03943927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93279982|NCT03943927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93279983|NCT03533166|Chlorhexidine|chlorhexidine|mesh-list
93279984|NCT03533166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93279985|NCT03533166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93279986|NCT03533166|Disinfectants|disinfectants|mesh-ancestor
93279987|NCT03687073|Silybin|silybin|mesh-list
93279988|NCT03687073|Indole-3-carbinol|indole-3-carbinol|mesh-list
93279989|NCT03687073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93279990|NCT03687073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93279991|NCT03687073|Protective Agents|protective agents|mesh-ancestor
93279992|NCT03687073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93279993|NCT03687073|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93279994|NCT03682471|Deoxycholic Acid|deoxycholic acid|mesh-list
93279995|NCT03682471|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93279996|NCT03682471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93279997|NCT02198352|Olcegepant|olcegepant|mesh-list
93279998|NCT02198352|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93279999|NCT02198352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280000|NCT02198352|Analgesics|analgesics|mesh-ancestor
93280001|NCT02198352|Sensory System Agents|sensory system agents|mesh-ancestor
93280002|NCT02198352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280003|NCT02198352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280004|NCT02202564|Ganciclovir|ganciclovir|mesh-list
93280005|NCT02202564|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93280006|NCT02202564|Antiviral Agents|antiviral agents|mesh-ancestor
93280007|NCT02202564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280008|NCT02202564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93280009|NCT02202564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280010|NCT02202564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280011|NCT03029143|Vedolizumab|vedolizumab|mesh-list
93280012|NCT03029143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280013|NCT02198508|Deferasirox|deferasirox|mesh-list
93280014|NCT02198508|Deferiprone|deferiprone|mesh-list
93280015|NCT02198508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93280016|NCT02198508|Chelating Agents|chelating agents|mesh-ancestor
93280017|NCT02198508|Sequestering Agents|sequestering agents|mesh-ancestor
93280018|NCT02198508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280019|NCT02202720|Sevoflurane|sevoflurane|mesh-list
93280020|NCT02202720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93280021|NCT02202720|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93280022|NCT02202720|Anesthetics, General|anesthetics, general|mesh-ancestor
93280023|NCT02202720|Anesthetics|anesthetics|mesh-ancestor
93280024|NCT02202720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280026|NCT02206308|Antibodies|antibodies|mesh-list
93280027|NCT02206308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93280028|NCT02206308|Immunologic Factors|immunologic factors|mesh-ancestor
93280029|NCT02206308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280030|NCT03028129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93280031|NCT03028129|Isoniazid|isoniazid|mesh-list
93280032|NCT03028129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280033|NCT03028129|Antitubercular Agents|antitubercular agents|mesh-ancestor
93280034|NCT03028129|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93280035|NCT03028129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93280036|NCT03028129|Antimetabolites|antimetabolites|mesh-ancestor
93280037|NCT03028129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280038|NCT03028129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93280039|NCT04059679|Aspirin|aspirin|mesh-list
93280040|NCT04059679|Rivaroxaban|rivaroxaban|mesh-list
93280041|NCT04059679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93280042|NCT04059679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280043|NCT04059679|Analgesics|analgesics|mesh-ancestor
93280044|NCT04059679|Sensory System Agents|sensory system agents|mesh-ancestor
93280045|NCT04059679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280046|NCT04059679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280047|NCT04059679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280048|NCT04059679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280049|NCT04059679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93280050|NCT04059679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93280051|NCT04059679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280052|NCT04059679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93280053|NCT04059679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93280054|NCT04059679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280055|NCT04059679|Antipyretics|antipyretics|mesh-ancestor
93280056|NCT04059679|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93280057|NCT04059679|Antithrombins|antithrombins|mesh-ancestor
93280058|NCT04059679|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93280059|NCT04059679|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280060|NCT04059679|Anticoagulants|anticoagulants|mesh-ancestor
93280061|NCT03533556|Caffeine|caffeine|mesh-list
93280062|NCT03533556|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93280063|NCT03533556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280064|NCT03533556|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93280065|NCT03533556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280066|NCT03533556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280067|NCT03533556|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93280068|NCT03533556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93280069|NCT03533556|Purinergic Agents|purinergic agents|mesh-ancestor
93280070|NCT03533556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280071|NCT02206854|Flurbiprofen|flurbiprofen|mesh-list
93280072|NCT02206854|Tarenflurbil|tarenflurbil|mesh-list
93280073|NCT02206854|Analgesics|analgesics|mesh-ancestor
93280074|NCT02206854|Sensory System Agents|sensory system agents|mesh-ancestor
93280075|NCT02206854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280076|NCT02206854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280077|NCT02206854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93280078|NCT02206854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280079|NCT02206854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280080|NCT02206854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280081|NCT02206854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93280082|NCT02206854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280083|NCT02206854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280084|NCT02206854|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93280085|NCT03624205|Paclitaxel|paclitaxel|mesh-list
93280086|NCT03624205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93280087|NCT03624205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280088|NCT03624205|Tubulin Modulators|tubulin modulators|mesh-ancestor
93280089|NCT03624205|Antimitotic Agents|antimitotic agents|mesh-ancestor
93280090|NCT03624205|Mitosis Modulators|mitosis modulators|mesh-ancestor
93280091|NCT03624205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280092|NCT02206932|Sofosbuvir|sofosbuvir|mesh-list
93280093|NCT02206932|Simeprevir|simeprevir|mesh-list
93280094|NCT02206932|Antiviral Agents|antiviral agents|mesh-ancestor
93280095|NCT02206932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280096|NCT02206932|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280097|NCT02206932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952139|NCT00742976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93280098|NCT02206932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280099|NCT02207010|Adavosertib|adavosertib|mesh-list
93280100|NCT02207010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280101|NCT02207010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280102|NCT02203422|Cyclosporine|cyclosporine|mesh-list
93280103|NCT02203422|Cyclosporins|cyclosporins|mesh-list
93280104|NCT02203422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280105|NCT02203422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280106|NCT02203422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280107|NCT02203422|Immunologic Factors|immunologic factors|mesh-ancestor
93280108|NCT02203422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280109|NCT02203422|Antifungal Agents|antifungal agents|mesh-ancestor
93280110|NCT02203422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280111|NCT02203422|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280112|NCT02203422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280113|NCT02203422|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93280115|NCT03532854|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93280116|NCT03532854|Ezetimibe|ezetimibe|mesh-list
93280117|NCT03532854|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93280118|NCT03532854|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93280119|NCT03532854|Antimetabolites|antimetabolites|mesh-ancestor
93280120|NCT03532854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280121|NCT03532854|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93280122|NCT03532854|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93280123|NCT03532854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280124|NCT03532854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93280125|NCT03532854|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93280126|NCT03532854|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93280127|NCT02203500|Telmisartan|telmisartan|mesh-list
93280128|NCT02203500|Lacidipine|lacidipine|mesh-list
93280129|NCT02203500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93280130|NCT02203500|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93280131|NCT02203500|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93280132|NCT02203500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280133|NCT02203500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93280134|NCT02203500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93280135|NCT02203500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93280136|NCT02203500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280137|NCT02203656|Methyltestosterone|methyltestosterone|mesh-list
93280138|NCT02203656|Testosterone|testosterone|mesh-list
93280139|NCT02203656|Testosterone undecanoate|testosterone undecanoate|mesh-list
93280140|NCT02203656|Testosterone enanthate|testosterone enanthate|mesh-list
93280141|NCT02203656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93280142|NCT02203656|Androgens|androgens|mesh-ancestor
93280143|NCT02203656|Hormones|hormones|mesh-ancestor
93280144|NCT02203656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280145|NCT02203656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280146|NCT02203656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93280147|NCT02203656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280148|NCT02203656|Anabolic Agents|anabolic agents|mesh-ancestor
93280149|NCT04431388|Levobupivacaine|levobupivacaine|mesh-list
93280150|NCT04431388|Anesthetics, Local|anesthetics, local|mesh-ancestor
93280151|NCT04431388|Anesthetics|anesthetics|mesh-ancestor
93280152|NCT04431388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280153|NCT04431388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280154|NCT04431388|Sensory System Agents|sensory system agents|mesh-ancestor
93280155|NCT04431388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280156|NCT02199444|Sevelamer|sevelamer|mesh-list
93280157|NCT02199444|Chelating Agents|chelating agents|mesh-ancestor
93280158|NCT02199444|Sequestering Agents|sequestering agents|mesh-ancestor
93280159|NCT02199444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280160|NCT02199522|Propofol|propofol|mesh-list
93280161|NCT02199522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93280162|NCT02199522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280163|NCT02199522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280164|NCT02199522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93280165|NCT02199522|Anesthetics, General|anesthetics, general|mesh-ancestor
93280166|NCT02199522|Anesthetics|anesthetics|mesh-ancestor
93280167|NCT03532698|Aspirin|aspirin|mesh-list
93280168|NCT03532698|Osimertinib|osimertinib|mesh-list
93280169|NCT03532698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93280170|NCT03532698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280171|NCT03532698|Analgesics|analgesics|mesh-ancestor
93280172|NCT03532698|Sensory System Agents|sensory system agents|mesh-ancestor
93280173|NCT03532698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280174|NCT03532698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280175|NCT03532698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280176|NCT03532698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280177|NCT03532698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93280178|NCT03532698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93280179|NCT03532698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280180|NCT03532698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93280181|NCT03532698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93280182|NCT03532698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280184|NCT03532698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280185|NCT03532698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93280186|NCT04169737|Venetoclax|venetoclax|mesh-list
93280187|NCT04169737|Obinutuzumab|obinutuzumab|mesh-list
93280188|NCT04169737|Acalabrutinib|acalabrutinib|mesh-list
93280189|NCT04169737|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93280190|NCT04169737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280191|NCT04169737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93280192|NCT04169737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93280193|NCT04169737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280194|NCT04169737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280195|NCT03690739|Paclitaxel|paclitaxel|mesh-list
93280196|NCT03690739|Bevacizumab|bevacizumab|mesh-list
93280197|NCT03690739|Carboplatin|carboplatin|mesh-list
93280198|NCT03690739|Gemcitabine|gemcitabine|mesh-list
93280199|NCT03690739|Trabectedin|trabectedin|mesh-list
93280200|NCT03690739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93280201|NCT03690739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280202|NCT03690739|Tubulin Modulators|tubulin modulators|mesh-ancestor
93280203|NCT03690739|Antimitotic Agents|antimitotic agents|mesh-ancestor
93280204|NCT03690739|Mitosis Modulators|mitosis modulators|mesh-ancestor
93280205|NCT03690739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280206|NCT03690739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93280207|NCT03690739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93280208|NCT03690739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93280209|NCT03690739|Growth Substances|growth substances|mesh-ancestor
93280210|NCT03690739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280211|NCT03690739|Growth Inhibitors|growth inhibitors|mesh-ancestor
93280212|NCT03690739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280213|NCT03690739|Antimetabolites|antimetabolites|mesh-ancestor
93280214|NCT03690739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93280215|NCT03690739|Alkylating Agents|alkylating agents|mesh-ancestor
93280216|NCT02199678|Ketamine|ketamine|mesh-list
93280217|NCT02199678|Analgesics|analgesics|mesh-ancestor
93280218|NCT02199678|Sensory System Agents|sensory system agents|mesh-ancestor
93280219|NCT02199678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280220|NCT02199678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280221|NCT02199678|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93280222|NCT02199678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93280223|NCT02199678|Anesthetics, General|anesthetics, general|mesh-ancestor
93280224|NCT02199678|Anesthetics|anesthetics|mesh-ancestor
93280225|NCT02199678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280226|NCT02199678|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93280227|NCT02199678|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93280228|NCT02199678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280229|NCT02199678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280230|NCT03681613|Pyrantel|pyrantel|mesh-list
93280231|NCT03681613|Pyrantel Pamoate|pyrantel pamoate|mesh-list
93280232|NCT03681613|Antinematodal Agents|antinematodal agents|mesh-ancestor
93280233|NCT03681613|Anthelmintics|anthelmintics|mesh-ancestor
93280234|NCT03681613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93280235|NCT03681613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280236|NCT03681613|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93280237|NCT03681613|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93280238|NCT03681613|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93280239|NCT03681613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280240|NCT03681613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280241|NCT03690583|Zinc|zinc|mesh-list
93280242|NCT03690583|Zinc Sulfate|zinc sulfate|mesh-list
93280243|NCT03690583|Trace Elements|trace elements|mesh-ancestor
93280244|NCT03690583|Micronutrients|micronutrients|mesh-ancestor
93280245|NCT03690583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280246|NCT03690583|Astringents|astringents|mesh-ancestor
93280247|NCT03690583|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280248|NCT01309672|Prednisone|prednisone|mesh-list
93280249|NCT01309672|Abiraterone Acetate|abiraterone acetate|mesh-list
93280250|NCT01309672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280251|NCT01309672|Glucocorticoids|glucocorticoids|mesh-ancestor
93280252|NCT01309672|Hormones|hormones|mesh-ancestor
93280253|NCT01309672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280254|NCT01309672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280255|NCT01309672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93280256|NCT01309672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280257|NCT01309672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93280258|NCT01309672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280259|NCT01309672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280260|NCT01309672|Hormone Antagonists|hormone antagonists|mesh-ancestor
93280261|NCT01309672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93280262|NCT03026257|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93280263|NCT03026257|Contact Lens Solutions|contact lens solutions|mesh-list
93280264|NCT03026257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93280265|NCT03026257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93280266|NCT03026257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280267|NCT03026257|Disinfectants|disinfectants|mesh-ancestor
93280268|NCT02200146|Hydroxychloroquine|hydroxychloroquine|mesh-list
93280269|NCT02200146|Prednisone|prednisone|mesh-list
93280270|NCT02200146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280271|NCT02200146|Glucocorticoids|glucocorticoids|mesh-ancestor
93280272|NCT02200146|Hormones|hormones|mesh-ancestor
92574855|NCT00250315|Sympathomimetics|sympathomimetics|mesh-ancestor
93280273|NCT02200146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280274|NCT02200146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280275|NCT02200146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93280276|NCT02200146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280277|NCT02200146|Antimalarials|antimalarials|mesh-ancestor
93280278|NCT02200146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93280279|NCT02200146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93280280|NCT02200146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280281|NCT02200146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280282|NCT02200146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280283|NCT02200146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280284|NCT02208492|Levetiracetam|levetiracetam|mesh-list
93280285|NCT02208492|Anticonvulsants|anticonvulsants|mesh-ancestor
93280286|NCT02208492|Nootropic Agents|nootropic agents|mesh-ancestor
93280287|NCT01933048|Vaccines|vaccines|mesh-list
93280288|NCT01933048|Immunologic Factors|immunologic factors|mesh-ancestor
93280289|NCT01933048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280290|NCT02208882|Midazolam|midazolam|mesh-list
93280291|NCT02208882|BMS-986120|bms-986120|mesh-list
93280292|NCT02208882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93280293|NCT02208882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93280294|NCT02208882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280295|NCT02208882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280296|NCT02208882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93280297|NCT02208882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93280298|NCT02208882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93280299|NCT02208882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93280300|NCT02208882|Anesthetics, General|anesthetics, general|mesh-ancestor
93280301|NCT02208882|Anesthetics|anesthetics|mesh-ancestor
93280302|NCT02208882|GABA Modulators|gaba modulators|mesh-ancestor
93280303|NCT02208882|GABA Agents|gaba agents|mesh-ancestor
93280304|NCT02208882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280305|NCT02208882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280306|NCT02208882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93280307|NCT03690115|Ponatinib|ponatinib|mesh-list
93280308|NCT03690115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280309|NCT03690115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93280310|NCT03690115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280311|NCT03690115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280312|NCT02204202|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93280313|NCT02204202|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93280314|NCT02204202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280315|NCT01886794|Estrogens|estrogens|mesh-list
93280316|NCT01886794|Hormones|hormones|mesh-ancestor
93280317|NCT01886794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280318|NCT01886794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280319|NCT02209350|Aspirin|aspirin|mesh-list
93280320|NCT02209350|Clopidogrel|clopidogrel|mesh-list
93280321|NCT02209350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93280322|NCT02209350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280323|NCT02209350|Analgesics|analgesics|mesh-ancestor
93280324|NCT02209350|Sensory System Agents|sensory system agents|mesh-ancestor
93280325|NCT02209350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280326|NCT02209350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280327|NCT02209350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280328|NCT02209350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280329|NCT02209350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93280330|NCT02209350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93280331|NCT02209350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280332|NCT02209350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93280333|NCT02209350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93280334|NCT02209350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280335|NCT02209350|Antipyretics|antipyretics|mesh-ancestor
93280336|NCT02209350|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93280337|NCT02209350|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93280338|NCT02209350|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93280339|NCT02209350|Purinergic Agents|purinergic agents|mesh-ancestor
93280340|NCT02209350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280341|NCT02209428|Temozolomide|temozolomide|mesh-list
93280342|NCT02209428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93280343|NCT02209428|Alkylating Agents|alkylating agents|mesh-ancestor
93280344|NCT02209428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280345|NCT02209428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280346|NCT02200848|Rituximab|rituximab|mesh-list
93280347|NCT02200848|Lenalidomide|lenalidomide|mesh-list
93280348|NCT02200848|Glutarimide|glutarimide|mesh-list
93280349|NCT02200848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93280350|NCT02200848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280351|NCT02200848|Immunologic Factors|immunologic factors|mesh-ancestor
93280352|NCT02200848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280353|NCT02200848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280354|NCT02200848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93280355|NCT02200848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93280356|NCT02200848|Growth Substances|growth substances|mesh-ancestor
93280357|NCT02200848|Growth Inhibitors|growth inhibitors|mesh-ancestor
93280358|NCT02200848|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93280359|NCT02200848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280360|NCT02200848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280361|NCT02751450|Fluorides|fluorides|mesh-list
93280362|NCT02751450|Tin Fluorides|tin fluorides|mesh-list
93280363|NCT02751450|Fluorophosphate|fluorophosphate|mesh-list
93280364|NCT02751450|Cariostatic Agents|cariostatic agents|mesh-ancestor
93280365|NCT02751450|Protective Agents|protective agents|mesh-ancestor
93280366|NCT02751450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280367|NCT02209740|Tenofovir|tenofovir|mesh-list
93280368|NCT02209740|Antiviral Agents|antiviral agents|mesh-ancestor
93280369|NCT02209740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280370|NCT02209740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93280371|NCT02209740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93280372|NCT02209740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280373|NCT02209740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280374|NCT02209740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93280375|NCT02209740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93280376|NCT02257788|Leronlimab|leronlimab|mesh-list
93280377|NCT02257788|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93280378|NCT02257788|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93280379|NCT02257788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280380|NCT02257788|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93280381|NCT02257788|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93280382|NCT02257788|Antiviral Agents|antiviral agents|mesh-ancestor
93280383|NCT02257788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280384|NCT02220660|Olodaterol|olodaterol|mesh-list
93280385|NCT02220660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93280386|NCT02220660|Autonomic Agents|autonomic agents|mesh-ancestor
93280387|NCT02220660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280388|NCT02220660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280389|NCT02220660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93280390|NCT02220660|Respiratory System Agents|respiratory system agents|mesh-ancestor
93280391|NCT01515748|Docetaxel|docetaxel|mesh-list
93280392|NCT01515748|Fluorouracil|fluorouracil|mesh-list
93280393|NCT01515748|Oxaliplatin|oxaliplatin|mesh-list
93280394|NCT01515748|Tegafur|tegafur|mesh-list
93280395|NCT01515748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280396|NCT01515748|Tubulin Modulators|tubulin modulators|mesh-ancestor
93280397|NCT01515748|Antimitotic Agents|antimitotic agents|mesh-ancestor
93280398|NCT01515748|Mitosis Modulators|mitosis modulators|mesh-ancestor
93280399|NCT01515748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280400|NCT01515748|Antimetabolites|antimetabolites|mesh-ancestor
93280401|NCT01515748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280402|NCT01515748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280403|NCT01515748|Immunologic Factors|immunologic factors|mesh-ancestor
93280404|NCT01515748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280405|NCT04973722|Denosumab|denosumab|mesh-list
93280406|NCT04973722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93280407|NCT04973722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280408|NCT03284034|Deoxycholic Acid|deoxycholic acid|mesh-list
93280409|NCT03284034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93280410|NCT03284034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280411|NCT01358175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93280412|NCT01358175|Immunologic Factors|immunologic factors|mesh-ancestor
93280413|NCT01358175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280414|NCT02209974|Fluticasone|fluticasone|mesh-list
93280415|NCT02209974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280416|NCT02209974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93280417|NCT02209974|Autonomic Agents|autonomic agents|mesh-ancestor
93280418|NCT02209974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280419|NCT02209974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280420|NCT02209974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93280421|NCT02209974|Respiratory System Agents|respiratory system agents|mesh-ancestor
93280422|NCT02209974|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280423|NCT02209974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93280424|NCT02212392|Meropenem|meropenem|mesh-list
93280425|NCT02212392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93280426|NCT02212392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280427|NCT03679897|Ropivacaine|ropivacaine|mesh-list
93280428|NCT03679897|Levobupivacaine|levobupivacaine|mesh-list
93280429|NCT03679897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93280430|NCT03679897|Anesthetics, Local|anesthetics, local|mesh-ancestor
93280431|NCT03679897|Anesthetics|anesthetics|mesh-ancestor
93280432|NCT03679897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280433|NCT03679897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280434|NCT03679897|Sensory System Agents|sensory system agents|mesh-ancestor
93280435|NCT03679897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280436|NCT03060070|Dexmedetomidine|dexmedetomidine|mesh-list
93280437|NCT03060070|Ketamine|ketamine|mesh-list
93280438|NCT03060070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93280439|NCT03060070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280440|NCT03060070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280441|NCT03060070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280442|NCT03060070|Analgesics|analgesics|mesh-ancestor
93280443|NCT03060070|Sensory System Agents|sensory system agents|mesh-ancestor
93280444|NCT03060070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280445|NCT03060070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93280446|NCT03060070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93280447|NCT03060070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93280448|NCT03060070|Adrenergic Agents|adrenergic agents|mesh-ancestor
93280449|NCT03060070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280450|NCT03060070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280451|NCT03060070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93280452|NCT03060070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93280453|NCT03060070|Anesthetics, General|anesthetics, general|mesh-ancestor
93280454|NCT03060070|Anesthetics|anesthetics|mesh-ancestor
93280455|NCT03060070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93280456|NCT03060070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93280457|NCT03683563|Citric Acid|citric acid|mesh-list
93280458|NCT03683563|Sodium Citrate|sodium citrate|mesh-list
93280459|NCT03683563|Anticoagulants|anticoagulants|mesh-ancestor
93280460|NCT03683563|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93280461|NCT03683563|Chelating Agents|chelating agents|mesh-ancestor
93280462|NCT03683563|Sequestering Agents|sequestering agents|mesh-ancestor
93280463|NCT03683563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280464|NCT03563625|Bupivacaine|bupivacaine|mesh-list
93280465|NCT03563625|Anesthetics, Local|anesthetics, local|mesh-ancestor
93280466|NCT03563625|Anesthetics|anesthetics|mesh-ancestor
93280467|NCT03563625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280468|NCT03563625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280469|NCT03563625|Sensory System Agents|sensory system agents|mesh-ancestor
93280470|NCT03563625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280471|NCT02832375|Fluorides|fluorides|mesh-list
93280472|NCT02832375|Tin Fluorides|tin fluorides|mesh-list
93280473|NCT02832375|Fluorophosphate|fluorophosphate|mesh-list
93280474|NCT02832375|Cariostatic Agents|cariostatic agents|mesh-ancestor
93280475|NCT02832375|Protective Agents|protective agents|mesh-ancestor
93280476|NCT02832375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280477|NCT04834024|Antibodies|antibodies|mesh-list
93280478|NCT04834024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93280479|NCT04834024|Immunologic Factors|immunologic factors|mesh-ancestor
93280480|NCT04834024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280481|NCT03683329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93280482|NCT03683329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280483|NCT02218476|Coenzyme Q10|coenzyme q10|mesh-list
93280484|NCT02218476|Vitamins|vitamins|mesh-ancestor
93280485|NCT02218476|Micronutrients|micronutrients|mesh-ancestor
93280486|NCT02218476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280487|NCT02205996|Insulin|insulin|mesh-list
93280488|NCT02205996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93280489|NCT02205996|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93280490|NCT02205996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280491|NCT02220036|Magnesium Oxide|magnesium oxide|mesh-list
93280492|NCT02220036|Antacids|antacids|mesh-ancestor
93280493|NCT02220036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280494|NCT02220036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280495|NCT02220114|Vigabatrin|vigabatrin|mesh-list
93280496|NCT02220114|Anticonvulsants|anticonvulsants|mesh-ancestor
93280497|NCT02220114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280498|NCT02220114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280499|NCT02220114|GABA Agents|gaba agents|mesh-ancestor
93280500|NCT02220114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280501|NCT02220114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280502|NCT02221596|Vitamin D|vitamin d|mesh-list
93280503|NCT02221596|Vitamins|vitamins|mesh-ancestor
93280504|NCT02221596|Micronutrients|micronutrients|mesh-ancestor
93280505|NCT02221596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280506|NCT02221596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93280507|NCT02221752|Folic Acid|folic acid|mesh-list
93280508|NCT02221752|Vitamin B Complex|vitamin b complex|mesh-list
93280509|NCT02221752|Hematinics|hematinics|mesh-ancestor
93280510|NCT02221752|Vitamins|vitamins|mesh-ancestor
93280511|NCT02221752|Micronutrients|micronutrients|mesh-ancestor
93280512|NCT02221752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280513|NCT04971382|Curcumin|curcumin|mesh-list
93280514|NCT04971382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93280515|NCT04971382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280516|NCT04971382|Analgesics|analgesics|mesh-ancestor
93280517|NCT04971382|Sensory System Agents|sensory system agents|mesh-ancestor
93280518|NCT04971382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280519|NCT04971382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280520|NCT04971382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280521|NCT04971382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280522|NCT04971382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280523|NCT04971382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280524|NCT04971382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280525|NCT02220348|Linaclotide|linaclotide|mesh-list
93280526|NCT02220348|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93280527|NCT02220348|Enzyme Activators|enzyme activators|mesh-ancestor
93280528|NCT02220348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280529|NCT02220348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280530|NCT04151680|Rivaroxaban|rivaroxaban|mesh-list
93280531|NCT04151680|Apixaban|apixaban|mesh-list
93280532|NCT04151680|Edoxaban|edoxaban|mesh-list
93280533|NCT04151680|Dabigatran|dabigatran|mesh-list
93280534|NCT04151680|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93280535|NCT04151680|Antithrombins|antithrombins|mesh-ancestor
93280536|NCT04151680|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93280537|NCT04151680|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280538|NCT04151680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280539|NCT04151680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280540|NCT04151680|Anticoagulants|anticoagulants|mesh-ancestor
93280541|NCT02221830|Oxytocin|oxytocin|mesh-list
93280542|NCT02221830|Oxytocics|oxytocics|mesh-ancestor
93280543|NCT02221830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93280544|NCT02221830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280545|NCT02224950|Emollients|emollients|mesh-list
93280546|NCT02224950|Chitosan|chitosan|mesh-list
93280547|NCT02224950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93280548|NCT02224950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92952594|NCT02559648|Denosumab|denosumab|mesh-list
93280549|NCT02224950|Antimetabolites|antimetabolites|mesh-ancestor
93280550|NCT02224950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280551|NCT02224950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93280552|NCT02224950|Chelating Agents|chelating agents|mesh-ancestor
93280553|NCT02224950|Sequestering Agents|sequestering agents|mesh-ancestor
93280554|NCT02224950|Hemostatics|hemostatics|mesh-ancestor
93280555|NCT02224950|Coagulants|coagulants|mesh-ancestor
93280556|NCT02224950|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280557|NCT03039114|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93280558|NCT03039114|Obinutuzumab|obinutuzumab|mesh-list
93280559|NCT03039114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93280560|NCT03039114|Alkylating Agents|alkylating agents|mesh-ancestor
93280561|NCT03039114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280562|NCT03039114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280563|NCT03039114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93280564|NCT04970602|Methylene Blue|methylene blue|mesh-list
93280565|NCT04970602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280566|NCT04970602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280567|NCT04970446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93280568|NCT04970446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280569|NCT02831673|Tenofovir|tenofovir|mesh-list
93280570|NCT02831673|Lamivudine|lamivudine|mesh-list
93280571|NCT02831673|Emtricitabine|emtricitabine|mesh-list
93280572|NCT02831673|Dolutegravir|dolutegravir|mesh-list
93280573|NCT02831673|Antiviral Agents|antiviral agents|mesh-ancestor
93280574|NCT02831673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280575|NCT02831673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93280576|NCT02831673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93280577|NCT02831673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280578|NCT02831673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280579|NCT02831673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93280580|NCT02831673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93280581|NCT02831673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93280582|NCT02831673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93280583|NCT02220504|Antipsychotic Agents|antipsychotic agents|mesh-list
93280584|NCT02220504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93280585|NCT02220504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280586|NCT02220504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280587|NCT02220504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93280588|NCT04962958|Leucovorin|leucovorin|mesh-list
93280589|NCT04962958|Fluorouracil|fluorouracil|mesh-list
93280590|NCT04962958|Oxaliplatin|oxaliplatin|mesh-list
93280591|NCT04962958|Antimetabolites|antimetabolites|mesh-ancestor
93280592|NCT04962958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280593|NCT04962958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280594|NCT04962958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280595|NCT04962958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280596|NCT04962958|Immunologic Factors|immunologic factors|mesh-ancestor
93280597|NCT04962958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280598|NCT04962958|Antidotes|antidotes|mesh-ancestor
93280599|NCT04962958|Protective Agents|protective agents|mesh-ancestor
93280600|NCT04962958|Vitamin B Complex|vitamin b complex|mesh-ancestor
93280601|NCT04962958|Vitamins|vitamins|mesh-ancestor
93280602|NCT04962958|Micronutrients|micronutrients|mesh-ancestor
93280603|NCT02031510|Dexmedetomidine|dexmedetomidine|mesh-list
93280604|NCT02031510|Bupivacaine|bupivacaine|mesh-list
93280605|NCT02031510|Anesthetics, Local|anesthetics, local|mesh-ancestor
93280606|NCT02031510|Anesthetics|anesthetics|mesh-ancestor
93280607|NCT02031510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280608|NCT02031510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280609|NCT02031510|Sensory System Agents|sensory system agents|mesh-ancestor
93280610|NCT02031510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575212|NCT00104013|Xaliproden|xaliproden|mesh-list
93280611|NCT02031510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93280612|NCT02031510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280613|NCT02031510|Analgesics|analgesics|mesh-ancestor
93280614|NCT02031510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93280615|NCT02031510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93280616|NCT02031510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93280617|NCT02031510|Adrenergic Agents|adrenergic agents|mesh-ancestor
93280618|NCT02031510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280619|NCT02031510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280620|NCT04961788|Antibodies|antibodies|mesh-list
93280621|NCT04961788|Immunologic Factors|immunologic factors|mesh-ancestor
93280622|NCT04961788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280623|NCT02222142|Anesthetics|anesthetics|mesh-list
93280624|NCT02222142|Isoflurane|isoflurane|mesh-list
93280625|NCT02222142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280626|NCT02222142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280627|NCT02222142|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93280628|NCT02222142|Anesthetics, General|anesthetics, general|mesh-ancestor
93280629|NCT04426084|Antihypertensive Agents|antihypertensive agents|mesh-list
93280630|NCT04425382|Ritonavir|ritonavir|mesh-list
93280632|NCT04425382|Darunavir|darunavir|mesh-list
93280633|NCT04425382|Cobicistat|cobicistat|mesh-list
93280634|NCT04425382|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
93280635|NCT04425382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93280636|NCT04425382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93280637|NCT04425382|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280638|NCT04425382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280639|NCT04425382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280640|NCT04425382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93280641|NCT04425382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93280642|NCT04425382|Antiviral Agents|antiviral agents|mesh-ancestor
93280643|NCT04425382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280644|NCT04425382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93280645|NCT04425382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93280646|NCT03563937|Rivaroxaban|rivaroxaban|mesh-list
93280647|NCT03563937|Apixaban|apixaban|mesh-list
93280648|NCT03563937|Edoxaban|edoxaban|mesh-list
93280649|NCT03563937|Phenprocoumon|phenprocoumon|mesh-list
93280650|NCT03563937|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93280651|NCT03563937|Antithrombins|antithrombins|mesh-ancestor
93280652|NCT03563937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93280653|NCT03563937|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280654|NCT03563937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280655|NCT03563937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280656|NCT03563937|Anticoagulants|anticoagulants|mesh-ancestor
93280657|NCT02231346|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93280658|NCT02231346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93280659|NCT02231346|Autonomic Agents|autonomic agents|mesh-ancestor
93280660|NCT02231346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280661|NCT02231346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280662|NCT02231346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93280663|NCT02231346|Respiratory System Agents|respiratory system agents|mesh-ancestor
93280664|NCT02225418|Ropivacaine|ropivacaine|mesh-list
93280665|NCT02225418|Anesthetics, Local|anesthetics, local|mesh-ancestor
93280666|NCT02225418|Anesthetics|anesthetics|mesh-ancestor
93280667|NCT02225418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280668|NCT02225418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280669|NCT02225418|Sensory System Agents|sensory system agents|mesh-ancestor
93280670|NCT02225418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280671|NCT02231424|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93280672|NCT02231424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93280673|NCT02231424|Autonomic Agents|autonomic agents|mesh-ancestor
93280674|NCT02231424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280675|NCT02231424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280676|NCT02231424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93280677|NCT02231424|Respiratory System Agents|respiratory system agents|mesh-ancestor
93280678|NCT05057130|Cisplatin|cisplatin|mesh-list
93280679|NCT05057130|Doxorubicin|doxorubicin|mesh-list
93280680|NCT05057130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93280681|NCT05057130|Methotrexate|methotrexate|mesh-list
93280682|NCT05057130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280683|NCT05057130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93280684|NCT05057130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93280685|NCT05057130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93280686|NCT05057130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280687|NCT05057130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280688|NCT05057130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93280689|NCT05057130|Abortifacient Agents|abortifacient agents|mesh-ancestor
93280690|NCT05057130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93280691|NCT05057130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280692|NCT05057130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280693|NCT05057130|Antimetabolites|antimetabolites|mesh-ancestor
93280694|NCT05057130|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280695|NCT05057130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93280696|NCT05057130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280697|NCT05057130|Immunologic Factors|immunologic factors|mesh-ancestor
93280698|NCT05057130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280699|NCT05057130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93280700|NCT02222220|Metoclopramide|metoclopramide|mesh-list
93280701|NCT02222220|Antiemetics|antiemetics|mesh-ancestor
93280702|NCT02222220|Autonomic Agents|autonomic agents|mesh-ancestor
93280703|NCT02222220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280704|NCT02222220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280705|NCT02222220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280706|NCT02222220|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93280707|NCT02222220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93280708|NCT02222220|Dopamine Agents|dopamine agents|mesh-ancestor
93280709|NCT02222220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280710|NCT02222220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280711|NCT03677323|Sufentanil|sufentanil|mesh-list
93280712|NCT03677323|Droperidol|droperidol|mesh-list
93280713|NCT03677323|Propofol|propofol|mesh-list
93280714|NCT03677323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93280715|NCT03677323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93280716|NCT03677323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280717|NCT03677323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93280718|NCT03677323|Anesthetics, General|anesthetics, general|mesh-ancestor
93280719|NCT03677323|Anesthetics|anesthetics|mesh-ancestor
93280720|NCT03677323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93280721|NCT03677323|Narcotics|narcotics|mesh-ancestor
93280722|NCT03677323|Analgesics|analgesics|mesh-ancestor
93280723|NCT03677323|Sensory System Agents|sensory system agents|mesh-ancestor
93280724|NCT03677323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280725|NCT03677323|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93280726|NCT03677323|Antiemetics|antiemetics|mesh-ancestor
93280727|NCT03677323|Autonomic Agents|autonomic agents|mesh-ancestor
93280728|NCT03677323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280729|NCT03677323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93280730|NCT03677323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93280731|NCT03677323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93280732|NCT03677323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93280733|NCT03677323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93280734|NCT03677323|Dopamine Agents|dopamine agents|mesh-ancestor
93280735|NCT03677323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280736|NCT03677323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280737|NCT02225652|Paclitaxel|paclitaxel|mesh-list
93280738|NCT02225652|Cyclophosphamide|cyclophosphamide|mesh-list
93280739|NCT02225652|Fluorouracil|fluorouracil|mesh-list
93280740|NCT02225652|Epirubicin|epirubicin|mesh-list
93280741|NCT02225652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93280742|NCT02225652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280743|NCT02225652|Tubulin Modulators|tubulin modulators|mesh-ancestor
93280744|NCT02225652|Antimitotic Agents|antimitotic agents|mesh-ancestor
93280745|NCT02225652|Mitosis Modulators|mitosis modulators|mesh-ancestor
93280746|NCT02225652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280747|NCT02225652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280748|NCT02225652|Immunologic Factors|immunologic factors|mesh-ancestor
93280749|NCT02225652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280750|NCT02225652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280751|NCT02225652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93280752|NCT02225652|Alkylating Agents|alkylating agents|mesh-ancestor
93280753|NCT02225652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93280754|NCT02225652|Antimetabolites|antimetabolites|mesh-ancestor
93280755|NCT02225652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280756|NCT02225652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93280757|NCT02225652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93280758|NCT02225652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93280759|NCT02225652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280760|NCT02222376|Pirfenidone|pirfenidone|mesh-list
93280761|NCT02222376|Analgesics|analgesics|mesh-ancestor
93280762|NCT02222376|Sensory System Agents|sensory system agents|mesh-ancestor
93280763|NCT02222376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280764|NCT02222376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280765|NCT02222376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93280766|NCT02222376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93280767|NCT02222376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280768|NCT02222376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280769|NCT02222376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280770|NCT02231658|Liraglutide|liraglutide|mesh-list
93280771|NCT02231658|Lixisenatide|lixisenatide|mesh-list
93280772|NCT02231658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93280773|NCT02231658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280774|NCT02231658|Incretins|incretins|mesh-ancestor
93280775|NCT02231658|Hormones|hormones|mesh-ancestor
93280776|NCT02231658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280777|NCT04542408|Heparin|heparin|mesh-list
93280778|NCT04542408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93280779|NCT04542408|Tinzaparin|tinzaparin|mesh-list
93280780|NCT04542408|Dalteparin|dalteparin|mesh-list
93280781|NCT04542408|Edoxaban|edoxaban|mesh-list
93280782|NCT04542408|Anticoagulants|anticoagulants|mesh-list
93280783|NCT04542408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93280784|NCT04542408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93280785|NCT04542408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280786|NCT04542408|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93280787|NCT04542408|Antithrombins|antithrombins|mesh-ancestor
93280788|NCT04542408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93280789|NCT04542408|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280790|NCT04542408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280791|NCT03059134|Mirabegron|mirabegron|mesh-list
93280792|NCT03059134|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93280793|NCT03059134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93280794|NCT03059134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93280795|NCT03059134|Adrenergic Agents|adrenergic agents|mesh-ancestor
93280796|NCT03059134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280797|NCT03059134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280798|NCT03059134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280799|NCT03059134|Urological Agents|urological agents|mesh-ancestor
93280800|NCT02928991|Vidarabine|vidarabine|mesh-list
93280801|NCT02928991|Fludarabine|fludarabine|mesh-list
93280802|NCT02928991|Fludarabine phosphate|fludarabine phosphate|mesh-list
93280803|NCT02928991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280804|NCT02928991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280805|NCT02928991|Antimetabolites|antimetabolites|mesh-ancestor
93280806|NCT02928991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280807|NCT02928991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280808|NCT02928991|Immunologic Factors|immunologic factors|mesh-ancestor
93280809|NCT02928991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280810|NCT02928991|Antiviral Agents|antiviral agents|mesh-ancestor
93280811|NCT02928991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280812|NCT03554317|Nivolumab|nivolumab|mesh-list
93280813|NCT03554317|Methyltestosterone|methyltestosterone|mesh-list
93280814|NCT03554317|Testosterone|testosterone|mesh-list
93280815|NCT03554317|Testosterone undecanoate|testosterone undecanoate|mesh-list
93280816|NCT03554317|Testosterone enanthate|testosterone enanthate|mesh-list
93280817|NCT03554317|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93280818|NCT03554317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93280819|NCT03554317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280820|NCT03554317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93280821|NCT03554317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280822|NCT03554317|Androgens|androgens|mesh-ancestor
93280823|NCT03554317|Hormones|hormones|mesh-ancestor
93280824|NCT03554317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280825|NCT03554317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280826|NCT03554317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93280827|NCT03554317|Anabolic Agents|anabolic agents|mesh-ancestor
93280828|NCT03623425|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93280829|NCT03623425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93280830|NCT03623425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280831|NCT04957420|Rotigotine|rotigotine|mesh-list
93280832|NCT04957420|Dopamine Agonists|dopamine agonists|mesh-ancestor
93280833|NCT04957420|Dopamine Agents|dopamine agents|mesh-ancestor
93280834|NCT04957420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280835|NCT04957420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280836|NCT04957420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280837|NCT03350035|Ganaxolone|ganaxolone|mesh-list
93280838|NCT03350035|Neurosteroids|neurosteroids|mesh-ancestor
93280839|NCT03350035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280840|NCT03350035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280841|NCT03350035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280842|NCT03350035|GABA Modulators|gaba modulators|mesh-ancestor
93280843|NCT03350035|GABA Agents|gaba agents|mesh-ancestor
93280844|NCT02905188|Cyclophosphamide|cyclophosphamide|mesh-list
93280845|NCT02905188|Fludarabine|fludarabine|mesh-list
93280846|NCT02905188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280847|NCT02905188|Immunologic Factors|immunologic factors|mesh-ancestor
93280848|NCT02905188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280849|NCT02905188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280850|NCT02905188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93280851|NCT02905188|Alkylating Agents|alkylating agents|mesh-ancestor
93280852|NCT02905188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280853|NCT02905188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280854|NCT02905188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93280855|NCT03676933|Hydrocortisone|hydrocortisone|mesh-list
93280856|NCT03676933|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
93280857|NCT03676933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280858|NCT03676933|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280859|NCT03671941|Ticagrelor|ticagrelor|mesh-list
93280860|NCT03671941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93280861|NCT03671941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93280862|NCT03671941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93280863|NCT03671941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93280864|NCT03671941|Purinergic Agents|purinergic agents|mesh-ancestor
93280865|NCT03671941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280866|NCT03671941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280867|NCT03671941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280868|NCT03058900|Methotrexate|methotrexate|mesh-list
93280869|NCT03058900|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93280870|NCT03058900|Abortifacient Agents|abortifacient agents|mesh-ancestor
93280871|NCT03058900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93280872|NCT03058900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280873|NCT03058900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280874|NCT03058900|Antimetabolites|antimetabolites|mesh-ancestor
93280875|NCT03058900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280876|NCT03058900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280877|NCT03058900|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280878|NCT03058900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280879|NCT03058900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93280880|NCT03058900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93280881|NCT03058900|Immunologic Factors|immunologic factors|mesh-ancestor
93280882|NCT03058900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93280883|NCT03058900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93280884|NCT02226510|Metformin|metformin|mesh-list
93280885|NCT02226510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93280886|NCT02226510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280887|NCT04445688|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93280888|NCT04445688|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93280889|NCT04445688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93280890|NCT04445688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93280891|NCT04445688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280892|NCT04445688|Adrenergic Agents|adrenergic agents|mesh-ancestor
93280893|NCT04445688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280894|NCT04445688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280895|NCT02225886|Ascorbic Acid|ascorbic acid|mesh-list
93280896|NCT02225886|Antioxidants|antioxidants|mesh-ancestor
93280897|NCT02225886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280898|NCT02225886|Protective Agents|protective agents|mesh-ancestor
93280899|NCT02225886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280900|NCT02225886|Vitamins|vitamins|mesh-ancestor
93280901|NCT02225886|Micronutrients|micronutrients|mesh-ancestor
93280902|NCT04956094|Uric Acid|uric acid|mesh-list
93280903|NCT04956094|Antioxidants|antioxidants|mesh-ancestor
93280904|NCT04956094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280905|NCT04956094|Protective Agents|protective agents|mesh-ancestor
93280906|NCT04956094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280907|NCT03671707|Nicotine|nicotine|mesh-list
93280908|NCT03671707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93280909|NCT03671707|Autonomic Agents|autonomic agents|mesh-ancestor
93280910|NCT03671707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93280911|NCT03671707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280912|NCT03671707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93280913|NCT03671707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93280914|NCT03671707|Cholinergic Agents|cholinergic agents|mesh-ancestor
93280915|NCT03671707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280916|NCT03671707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280917|NCT02226588|Misoprostol|misoprostol|mesh-list
93280918|NCT02226588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93280919|NCT02226588|Abortifacient Agents|abortifacient agents|mesh-ancestor
93280920|NCT02226588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93280921|NCT02226588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280922|NCT02226588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93280923|NCT02226588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280924|NCT02226588|Oxytocics|oxytocics|mesh-ancestor
93280925|NCT03676621|Misoprostol|misoprostol|mesh-list
93280926|NCT03676621|Oxytocin|oxytocin|mesh-list
93280927|NCT03676621|Oxytocics|oxytocics|mesh-ancestor
93280928|NCT03676621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93280929|NCT03676621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280930|NCT03676621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93280931|NCT03676621|Abortifacient Agents|abortifacient agents|mesh-ancestor
93280932|NCT03676621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93280933|NCT03676621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93280934|NCT03678649|Capecitabine|capecitabine|mesh-list
93280935|NCT03678649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93280936|NCT03678649|Antimetabolites|antimetabolites|mesh-ancestor
93280937|NCT03678649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280938|NCT03678649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280939|NCT02845297|Pembrolizumab|pembrolizumab|mesh-list
93280940|NCT02845297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93280941|NCT02845297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280942|NCT02845297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93280943|NCT02845297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280944|NCT02232360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93280945|NCT02232360|Fenofibrate|fenofibrate|mesh-list
93280946|NCT02232360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93280947|NCT02232360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93280948|NCT02232360|Antimetabolites|antimetabolites|mesh-ancestor
93280949|NCT02232360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280950|NCT02232360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93280951|NCT02232360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93280952|NCT02232360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280953|NCT02226978|Ritonavir|ritonavir|mesh-list
93280954|NCT02226978|Tipranavir|tipranavir|mesh-list
93280955|NCT02226978|Valacyclovir|valacyclovir|mesh-list
93280956|NCT02226978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93280957|NCT02226978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93280958|NCT02226978|Protease Inhibitors|protease inhibitors|mesh-ancestor
93280959|NCT02226978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93280960|NCT02226978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280961|NCT02226978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93280962|NCT02226978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93280963|NCT02226978|Antiviral Agents|antiviral agents|mesh-ancestor
93280964|NCT02226978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93280965|NCT02226978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93280966|NCT02226978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93280967|NCT02227056|Methylphenidate|methylphenidate|mesh-list
93280968|NCT02227056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93280969|NCT02227056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280970|NCT02227056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93280971|NCT02227056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93280972|NCT02227056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93280973|NCT02227056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280974|NCT02227056|Dopamine Agents|dopamine agents|mesh-ancestor
93280975|NCT02227056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280976|NCT05708157|Histamine Antagonists|histamine antagonists|mesh-list
93280977|NCT05708157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93280978|NCT05708157|Histamine Agents|histamine agents|mesh-ancestor
93280979|NCT05708157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93280980|NCT05708157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280981|NCT05708157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280982|NCT03058744|Clobetasol|clobetasol|mesh-list
93280983|NCT03058744|Halobetasol|halobetasol|mesh-list
93280984|NCT03058744|Tazarotene|tazarotene|mesh-list
93280985|NCT03058744|Dermatologic Agents|dermatologic agents|mesh-ancestor
93280986|NCT03058744|Keratolytic Agents|keratolytic agents|mesh-ancestor
93280987|NCT03058744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93280988|NCT03058744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93280989|NCT03058744|Glucocorticoids|glucocorticoids|mesh-ancestor
93280990|NCT03058744|Hormones|hormones|mesh-ancestor
93280991|NCT03058744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93280992|NCT03058744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93280993|NCT02734537|Cisplatin|cisplatin|mesh-list
93280994|NCT02734537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93280995|NCT03059056|Empagliflozin|empagliflozin|mesh-list
93280996|NCT03059056|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93280997|NCT03059056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93280998|NCT03059056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93280999|NCT03059056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281000|NCT03058666|Calfactant|calfactant|mesh-list
93281001|NCT03058666|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93281002|NCT03058666|Respiratory System Agents|respiratory system agents|mesh-ancestor
93281003|NCT02227212|Insulin|insulin|mesh-list
93281004|NCT02227212|Insulin Glargine|insulin glargine|mesh-list
93281005|NCT02227212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93281006|NCT02227212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281008|NCT00303849|Carboplatin|carboplatin|mesh-list
93281009|NCT00303849|Etoposide|etoposide|mesh-list
92575584|NCT00255268|Goserelin|goserelin|mesh-list
93281010|NCT00303849|Etoposide phosphate|etoposide phosphate|mesh-list
93281011|NCT00303849|Melphalan|melphalan|mesh-list
93281012|NCT00303849|Mechlorethamine|mechlorethamine|mesh-list
93281013|NCT00303849|Podophyllotoxin|podophyllotoxin|mesh-list
93281014|NCT00303849|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93281015|NCT00303849|Mannitol|mannitol|mesh-list
93281016|NCT00303849|Antidotes|antidotes|mesh-list
93281017|NCT00303849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281018|NCT00303849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93281019|NCT00303849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93281020|NCT00303849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93281021|NCT00303849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281022|NCT00303849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281023|NCT00303849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93281024|NCT00303849|Alkylating Agents|alkylating agents|mesh-ancestor
93281025|NCT00303849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93281026|NCT00303849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281027|NCT00303849|Immunologic Factors|immunologic factors|mesh-ancestor
93281028|NCT00303849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281029|NCT00303849|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93281030|NCT00303849|Diuretics|diuretics|mesh-ancestor
93281031|NCT00303849|Natriuretic Agents|natriuretic agents|mesh-ancestor
93281032|NCT00303849|Keratolytic Agents|keratolytic agents|mesh-ancestor
93281033|NCT00303849|Dermatologic Agents|dermatologic agents|mesh-ancestor
93281034|NCT00303849|Tubulin Modulators|tubulin modulators|mesh-ancestor
93281035|NCT00303849|Antimitotic Agents|antimitotic agents|mesh-ancestor
93281036|NCT00303849|Mitosis Modulators|mitosis modulators|mesh-ancestor
93281037|NCT00303849|Protective Agents|protective agents|mesh-ancestor
93281038|NCT00303849|Antioxidants|antioxidants|mesh-ancestor
93281039|NCT00303849|Antitubercular Agents|antitubercular agents|mesh-ancestor
93281040|NCT00303849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93281041|NCT00303849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281042|NCT00303849|Chelating Agents|chelating agents|mesh-ancestor
93281043|NCT00303849|Sequestering Agents|sequestering agents|mesh-ancestor
93281044|NCT04952272|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
93281045|NCT04952272|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93281046|NCT04952272|Immunologic Factors|immunologic factors|mesh-ancestor
93281047|NCT04952272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281048|NCT01355523|Melatonin|melatonin|mesh-list
93281049|NCT01355523|Antioxidants|antioxidants|mesh-ancestor
93281050|NCT01355523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281051|NCT01355523|Protective Agents|protective agents|mesh-ancestor
93281052|NCT01355523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281053|NCT01355523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281054|NCT02227914|Sorafenib|sorafenib|mesh-list
93281055|NCT02227914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281056|NCT02227914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281057|NCT02227914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281058|NCT02227914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281059|NCT04161456|Apremilast|apremilast|mesh-list
93281060|NCT04161456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281061|NCT04161456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281062|NCT04161456|Analgesics|analgesics|mesh-ancestor
93281063|NCT04161456|Sensory System Agents|sensory system agents|mesh-ancestor
93281064|NCT04161456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281065|NCT04161456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281066|NCT04161456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281067|NCT04161456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281068|NCT04161456|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93281069|NCT04161456|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93281070|NCT04161456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281071|NCT04161456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281072|NCT02224014|Brotizolam|brotizolam|mesh-list
93281073|NCT02224014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93281074|NCT02224014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281075|NCT02224014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281076|NCT03671161|Insulin|insulin|mesh-list
93281077|NCT03671161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93281078|NCT03671161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281079|NCT04950400|Apatinib|apatinib|mesh-list
93281080|NCT04950400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281081|NCT04950400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281082|NCT04950400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281083|NCT04950400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281084|NCT04949932|Turmeric extract|turmeric extract|mesh-list
93281085|NCT04949932|Antioxidants|antioxidants|mesh-ancestor
93281086|NCT04949932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281087|NCT04949932|Protective Agents|protective agents|mesh-ancestor
93281088|NCT04949932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281089|NCT02826603|Ustekinumab|ustekinumab|mesh-list
93281090|NCT02826603|Dermatologic Agents|dermatologic agents|mesh-ancestor
93281091|NCT02224170|Dexamethasone|dexamethasone|mesh-list
93281092|NCT02224170|Lidocaine|lidocaine|mesh-list
93281093|NCT02224170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281094|NCT02224170|Antiemetics|antiemetics|mesh-ancestor
93281095|NCT02224170|Autonomic Agents|autonomic agents|mesh-ancestor
93281096|NCT02224170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281097|NCT02224170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281098|NCT02224170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281099|NCT02224170|Glucocorticoids|glucocorticoids|mesh-ancestor
93281100|NCT02224170|Hormones|hormones|mesh-ancestor
93281101|NCT02224170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281102|NCT02224170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93281103|NCT02224170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281104|NCT02224170|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281105|NCT02224170|Anesthetics|anesthetics|mesh-ancestor
93281106|NCT02224170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281107|NCT02224170|Sensory System Agents|sensory system agents|mesh-ancestor
93281108|NCT02224170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93281109|NCT02224170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93281110|NCT02224170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93281111|NCT02224170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281112|NCT02224170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281113|NCT05956821|Bevacizumab|bevacizumab|mesh-list
93281114|NCT05956821|Cetuximab|cetuximab|mesh-list
93281115|NCT05956821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281116|NCT05956821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281117|NCT05956821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93281118|NCT05956821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93281119|NCT05956821|Growth Substances|growth substances|mesh-ancestor
93281120|NCT05956821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281121|NCT05956821|Growth Inhibitors|growth inhibitors|mesh-ancestor
93281122|NCT05956769|Tranexamic Acid|tranexamic acid|mesh-list
93281123|NCT05956769|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93281124|NCT05956769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93281125|NCT05956769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281126|NCT05956769|Hemostatics|hemostatics|mesh-ancestor
93281127|NCT05956769|Coagulants|coagulants|mesh-ancestor
93281128|NCT05956639|Androgen Antagonists|androgen antagonists|mesh-list
93281129|NCT05956639|Hormone Antagonists|hormone antagonists|mesh-ancestor
93281130|NCT05956639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281131|NCT05956639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281132|NCT05956600|Amisulpride|amisulpride|mesh-list
93281133|NCT05956600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93281134|NCT05956600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93281135|NCT05956600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281136|NCT05956600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281137|NCT05956600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93281138|NCT05956600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93281139|NCT05956600|Dopamine Agents|dopamine agents|mesh-ancestor
93281140|NCT05956600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281141|NCT05956600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281142|NCT05956600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93281143|NCT05956600|Antidepressive Agents|antidepressive agents|mesh-ancestor
93281144|NCT05956561|Vitamin D|vitamin d|mesh-list
93281145|NCT05956561|Vitamins|vitamins|mesh-ancestor
93281146|NCT05956561|Micronutrients|micronutrients|mesh-ancestor
93281147|NCT05956561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281148|NCT05956561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93281149|NCT05956522|Empagliflozin|empagliflozin|mesh-list
93281150|NCT05956522|Linagliptin|linagliptin|mesh-list
93281151|NCT05956522|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93281152|NCT05956522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281153|NCT05956522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575740|NCT00070187|Analgesics|analgesics|mesh-ancestor
93281154|NCT05956522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281155|NCT05956522|Incretins|incretins|mesh-ancestor
92953190|NCT02534623|Fentanyl|fentanyl|mesh-list
93281156|NCT05956522|Hormones|hormones|mesh-ancestor
93281157|NCT05956522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281158|NCT05956522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93281159|NCT05956522|Protease Inhibitors|protease inhibitors|mesh-ancestor
93281160|NCT05956522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281161|NCT05956509|Botulinum Toxins|botulinum toxins|mesh-list
93281162|NCT05956509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93281163|NCT05956509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93281164|NCT05956509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93281165|NCT05956509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281166|NCT05956509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281167|NCT05956509|Cholinergic Agents|cholinergic agents|mesh-ancestor
93281168|NCT05956509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281169|NCT05956509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281170|NCT05956509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93281171|NCT05956509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281172|NCT05956431|Simendan|simendan|mesh-list
93281173|NCT05956431|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93281174|NCT05956431|Vasodilator Agents|vasodilator agents|mesh-ancestor
93281175|NCT05956431|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93281176|NCT05956431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93281177|NCT05956431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281178|NCT05956431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281179|NCT05956431|Protective Agents|protective agents|mesh-ancestor
93281180|NCT05956431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281181|NCT05956418|Citric Acid|citric acid|mesh-list
93281182|NCT05956418|Sodium Citrate|sodium citrate|mesh-list
93281183|NCT05956418|Anticoagulants|anticoagulants|mesh-ancestor
93281184|NCT05956418|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93281185|NCT05956418|Chelating Agents|chelating agents|mesh-ancestor
93281186|NCT05956418|Sequestering Agents|sequestering agents|mesh-ancestor
93281187|NCT05956418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281188|NCT05956275|Tramadol|tramadol|mesh-list
93281189|NCT05956275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93281190|NCT05956275|Narcotics|narcotics|mesh-ancestor
93281191|NCT05956275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281192|NCT05956275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281193|NCT05956275|Analgesics|analgesics|mesh-ancestor
93281194|NCT05956275|Sensory System Agents|sensory system agents|mesh-ancestor
93281195|NCT05956275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281196|NCT05956145|Colchicine|colchicine|mesh-list
93281197|NCT05956145|Gout Suppressants|gout suppressants|mesh-ancestor
93281198|NCT05956145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281199|NCT05956145|Tubulin Modulators|tubulin modulators|mesh-ancestor
93281200|NCT05956145|Antimitotic Agents|antimitotic agents|mesh-ancestor
93281201|NCT05956145|Mitosis Modulators|mitosis modulators|mesh-ancestor
93281202|NCT05956145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281203|NCT05956145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281204|NCT05956041|Pembrolizumab|pembrolizumab|mesh-list
93281205|NCT05956041|Mogamulizumab|mogamulizumab|mesh-list
93281206|NCT05956041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281207|NCT05956041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281208|NCT05956041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93281209|NCT05956041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281210|NCT05955924|Niacinamide|niacinamide|mesh-list
93281211|NCT05955924|Niacin|niacin|mesh-list
93281212|NCT05955924|Nicotinic Acids|nicotinic acids|mesh-list
93281213|NCT05955924|Vitamin B Complex|vitamin b complex|mesh-ancestor
93281214|NCT05955924|Vitamins|vitamins|mesh-ancestor
93281215|NCT05955924|Micronutrients|micronutrients|mesh-ancestor
93281216|NCT05955924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281217|NCT05955924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93281218|NCT05955924|Antimetabolites|antimetabolites|mesh-ancestor
93281219|NCT05955924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281220|NCT05955924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93281221|NCT05955924|Vasodilator Agents|vasodilator agents|mesh-ancestor
93281222|NCT05955833|Trastuzumab|trastuzumab|mesh-list
93281223|NCT05955833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281224|NCT05955833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281225|NCT05955768|Lidocaine|lidocaine|mesh-list
93281226|NCT05955768|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281227|NCT05955768|Anesthetics|anesthetics|mesh-ancestor
93281228|NCT05955768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281229|NCT05955768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953260|NCT00879723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281230|NCT05955768|Sensory System Agents|sensory system agents|mesh-ancestor
93281231|NCT05955768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281232|NCT05955768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93281233|NCT05955768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93281234|NCT05955768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93281235|NCT05955768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281236|NCT05955768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281237|NCT05955677|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93281238|NCT05955677|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93281239|NCT05955677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281240|NCT05955313|Naltrexone|naltrexone|mesh-list
93281241|NCT05955313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93281242|NCT05955313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93281243|NCT05955313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281244|NCT05955313|Sensory System Agents|sensory system agents|mesh-ancestor
93281245|NCT05955313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281246|NCT05955222|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
93281247|NCT05955222|Vasodilator Agents|vasodilator agents|mesh-ancestor
93281248|NCT05955222|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93281249|NCT05955222|Protective Agents|protective agents|mesh-ancestor
93281250|NCT05955222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281251|NCT05955209|Disitamab vedotin|disitamab vedotin|mesh-list
93281252|NCT05955209|Immunoconjugates|immunoconjugates|mesh-ancestor
93281253|NCT05955209|Immunologic Factors|immunologic factors|mesh-ancestor
93281254|NCT05955209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281255|NCT05955170|Trastuzumab|trastuzumab|mesh-list
93281256|NCT05955170|Tucatinib|tucatinib|mesh-list
93281257|NCT05955170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281258|NCT05955170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281259|NCT05955170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281260|NCT05955170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281261|NCT05955170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281262|NCT05955157|Tegafur|tegafur|mesh-list
93281263|NCT05955157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281264|NCT05955157|Antimetabolites|antimetabolites|mesh-ancestor
93281265|NCT05955157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281266|NCT05955157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281267|NCT05952349|Metformin|metformin|mesh-list
93281268|NCT05952349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93281269|NCT05952349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281270|NCT05952310|Immunomodulating Agents|immunomodulating agents|mesh-list
93281271|NCT05952310|Immunologic Factors|immunologic factors|mesh-ancestor
93281272|NCT05952310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281273|NCT05951504|Methylprednisolone|methylprednisolone|mesh-list
93281274|NCT05951504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93281275|NCT05951504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93281276|NCT05951504|Prednisolone|prednisolone|mesh-list
93281277|NCT05951504|Prednisolone acetate|prednisolone acetate|mesh-list
93281278|NCT05951504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93281279|NCT05951504|Prednisolone phosphate|prednisolone phosphate|mesh-list
93281280|NCT05951504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281281|NCT05951504|Antiemetics|antiemetics|mesh-ancestor
93281282|NCT05951504|Autonomic Agents|autonomic agents|mesh-ancestor
93281283|NCT05951504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281284|NCT05951504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281285|NCT05951504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281286|NCT05951504|Glucocorticoids|glucocorticoids|mesh-ancestor
93281287|NCT05951504|Hormones|hormones|mesh-ancestor
93281288|NCT05951504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281289|NCT05951504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93281290|NCT05951504|Protective Agents|protective agents|mesh-ancestor
93281291|NCT05951504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93281292|NCT05951504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281293|NCT05949684|Epoetin Alfa|epoetin alfa|mesh-list
93281294|NCT05949684|Luspatercept|luspatercept|mesh-list
93281295|NCT05949684|Hematinics|hematinics|mesh-ancestor
93281296|NCT05946200|Anesthetics|anesthetics|mesh-list
93281297|NCT05946200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281298|NCT05946200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281299|NCT05925166|Triamcinolone|triamcinolone|mesh-list
93281300|NCT05925166|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93281301|NCT05925166|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93281302|NCT05925166|Etanercept|etanercept|mesh-list
93281303|NCT05925166|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93281304|NCT05925166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281305|NCT05925166|Glucocorticoids|glucocorticoids|mesh-ancestor
93281306|NCT05925166|Hormones|hormones|mesh-ancestor
93281307|NCT05925166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281308|NCT05925166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281309|NCT05925166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281310|NCT05925166|Immunologic Factors|immunologic factors|mesh-ancestor
93281311|NCT05925166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281312|NCT05925166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281313|NCT05925166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281314|NCT05925166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281315|NCT05925166|Analgesics|analgesics|mesh-ancestor
93281316|NCT05925166|Sensory System Agents|sensory system agents|mesh-ancestor
93281317|NCT05925166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281318|NCT05925166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281319|NCT05925166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281321|NCT05914155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281322|NCT05914155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281323|NCT05914155|Immunologic Factors|immunologic factors|mesh-ancestor
93281324|NCT05914155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281325|NCT05914155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281326|NCT05896293|Hormones|hormones|mesh-list
93281327|NCT05896293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281328|NCT05896293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281329|NCT05881928|Lamotrigine|lamotrigine|mesh-list
93281330|NCT05881928|Valproic Acid|valproic acid|mesh-list
93281331|NCT05881928|Anticonvulsants|anticonvulsants|mesh-ancestor
93281332|NCT05881928|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93281333|NCT05881928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281334|NCT05881928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281335|NCT05881928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93281336|NCT05881928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281337|NCT05881928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93281338|NCT05881928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93281339|NCT05881928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281340|NCT05881928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93281341|NCT05881928|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93281342|NCT05881928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281343|NCT05881928|GABA Agents|gaba agents|mesh-ancestor
93281344|NCT05881928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281345|NCT05881928|Antimanic Agents|antimanic agents|mesh-ancestor
93281346|NCT05872893|Dexamethasone|dexamethasone|mesh-list
93281347|NCT05872893|Ondansetron|ondansetron|mesh-list
93281348|NCT05872893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281349|NCT05872893|Antiemetics|antiemetics|mesh-ancestor
93281350|NCT05872893|Autonomic Agents|autonomic agents|mesh-ancestor
93281351|NCT05872893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281352|NCT05872893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281353|NCT05872893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281354|NCT05872893|Glucocorticoids|glucocorticoids|mesh-ancestor
93281355|NCT05872893|Hormones|hormones|mesh-ancestor
93281356|NCT05872893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281357|NCT05872893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93281358|NCT05872893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281359|NCT05872893|Antipruritics|antipruritics|mesh-ancestor
93281360|NCT05872893|Dermatologic Agents|dermatologic agents|mesh-ancestor
93281361|NCT05872893|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93281362|NCT05872893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93281363|NCT05872893|Serotonin Agents|serotonin agents|mesh-ancestor
93281364|NCT05872893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281365|NCT05872893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281366|NCT05868122|Acetaminophen|acetaminophen|mesh-list
93281367|NCT05868122|Naproxen|naproxen|mesh-list
93281368|NCT05868122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281369|NCT05868122|Analgesics|analgesics|mesh-ancestor
93281370|NCT05868122|Sensory System Agents|sensory system agents|mesh-ancestor
93281371|NCT05868122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281372|NCT05868122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281373|NCT05868122|Antipyretics|antipyretics|mesh-ancestor
93281374|NCT05868122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281375|NCT05868122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281376|NCT05868122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281377|NCT05868122|Gout Suppressants|gout suppressants|mesh-ancestor
93281378|NCT05868122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93281379|NCT05868122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953410|NCT00881127|Cetirizine|cetirizine|mesh-list
93281380|NCT05868122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281382|NCT05853575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281383|NCT05845008|Acetaminophen|acetaminophen|mesh-list
93281384|NCT05845008|Naproxen|naproxen|mesh-list
93281385|NCT05845008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281386|NCT05845008|Analgesics|analgesics|mesh-ancestor
93281387|NCT05845008|Sensory System Agents|sensory system agents|mesh-ancestor
93281388|NCT05845008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281389|NCT05845008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281390|NCT05845008|Antipyretics|antipyretics|mesh-ancestor
93281391|NCT05845008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281392|NCT05845008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281393|NCT05845008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281394|NCT05845008|Gout Suppressants|gout suppressants|mesh-ancestor
93281395|NCT05845008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93281396|NCT05845008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281397|NCT05845008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281398|NCT05844995|Acetaminophen|acetaminophen|mesh-list
93281399|NCT05844995|Naproxen|naproxen|mesh-list
93281400|NCT05844995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281401|NCT05844995|Analgesics|analgesics|mesh-ancestor
93281402|NCT05844995|Sensory System Agents|sensory system agents|mesh-ancestor
93281403|NCT05844995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281404|NCT05844995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281405|NCT05844995|Antipyretics|antipyretics|mesh-ancestor
93281406|NCT05844995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281407|NCT05844995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281408|NCT05844995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281409|NCT05844995|Gout Suppressants|gout suppressants|mesh-ancestor
93281410|NCT05844995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93281411|NCT05844995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281412|NCT05844995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281413|NCT05843643|Upadacitinib|upadacitinib|mesh-list
93281414|NCT05843643|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93281415|NCT05843643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281416|NCT05843643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281417|NCT05843643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281418|NCT05843643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281419|NCT05826275|Pembrolizumab|pembrolizumab|mesh-list
93281420|NCT05826275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281421|NCT05826275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281422|NCT05826275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93281423|NCT05826275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281424|NCT05799079|Decitabine|decitabine|mesh-list
93281425|NCT05799079|Venetoclax|venetoclax|mesh-list
93281426|NCT05799079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281427|NCT05799079|Antimetabolites|antimetabolites|mesh-ancestor
93281428|NCT05799079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281429|NCT05799079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281430|NCT05799079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281431|NCT05781152|Adalimumab|adalimumab|mesh-list
93281432|NCT05781152|Infliximab|infliximab|mesh-list
93281433|NCT05781152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93281434|NCT05781152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281435|NCT05781152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281436|NCT05781152|Dermatologic Agents|dermatologic agents|mesh-ancestor
93281437|NCT05781152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281438|NCT05774249|Bupivacaine|bupivacaine|mesh-list
93281439|NCT05774249|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281440|NCT05774249|Anesthetics|anesthetics|mesh-ancestor
93281441|NCT05774249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281442|NCT05774249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281443|NCT05774249|Sensory System Agents|sensory system agents|mesh-ancestor
93281444|NCT05774249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281445|NCT05773053|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93281446|NCT05773053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93281447|NCT05773053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93281448|NCT05773053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281449|NCT05773053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281450|NCT05773053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93281451|NCT05773053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281452|NCT05773053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281453|NCT05773053|Cholinergic Agents|cholinergic agents|mesh-ancestor
93281454|NCT05773053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281455|NCT05767398|Zanubrutinib|zanubrutinib|mesh-list
93281456|NCT05767398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281457|NCT05767398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281458|NCT05767398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281459|NCT05767398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281460|NCT05761574|Acetaminophen|acetaminophen|mesh-list
93281461|NCT05761574|Naproxen|naproxen|mesh-list
93281462|NCT05761574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281463|NCT05761574|Analgesics|analgesics|mesh-ancestor
93281464|NCT05761574|Sensory System Agents|sensory system agents|mesh-ancestor
93281465|NCT05761574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281466|NCT05761574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281467|NCT05761574|Antipyretics|antipyretics|mesh-ancestor
93281468|NCT05761574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281469|NCT05761574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281470|NCT05761574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281471|NCT05761574|Gout Suppressants|gout suppressants|mesh-ancestor
93281472|NCT05761574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93281473|NCT05761574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281474|NCT05761574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281475|NCT05756673|Listerine|listerine|mesh-list
93281476|NCT05756673|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93281477|NCT05756673|Sodium Fluoride|sodium fluoride|mesh-list
93281478|NCT05756673|Cariostatic Agents|cariostatic agents|mesh-ancestor
93281479|NCT05756673|Protective Agents|protective agents|mesh-ancestor
93281480|NCT05756673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281481|NCT05756673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281482|NCT05756166|Interferons|interferons|mesh-list
93281483|NCT05756166|Interferon-alpha|interferon-alpha|mesh-list
93281484|NCT05756166|Interferon alpha-2|interferon alpha-2|mesh-list
93281485|NCT05756166|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
93281486|NCT05756166|Celecoxib|celecoxib|mesh-list
93281487|NCT05756166|Pembrolizumab|pembrolizumab|mesh-list
93281488|NCT05756166|Benzenesulfonamide|benzenesulfonamide|mesh-list
93281489|NCT05756166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281490|NCT05756166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281491|NCT05756166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93281492|NCT05756166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281493|NCT05756166|Antiviral Agents|antiviral agents|mesh-ancestor
93281494|NCT05756166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281495|NCT05756166|Immunologic Factors|immunologic factors|mesh-ancestor
93281496|NCT05756166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281497|NCT05756166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281498|NCT05756166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281499|NCT05756166|Analgesics|analgesics|mesh-ancestor
93281500|NCT05756166|Sensory System Agents|sensory system agents|mesh-ancestor
93281501|NCT05756166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281502|NCT05756166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281503|NCT05756166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281504|NCT05756166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93281505|NCT05756166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93281506|NCT05756166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281507|NCT05756166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93281508|NCT05742438|Lidocaine|lidocaine|mesh-list
93281509|NCT05742438|Dexmedetomidine|dexmedetomidine|mesh-list
93281510|NCT05742438|Morphine|morphine|mesh-list
93281511|NCT05742438|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281512|NCT05742438|Anesthetics|anesthetics|mesh-ancestor
93281513|NCT05742438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281514|NCT05742438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281515|NCT05742438|Sensory System Agents|sensory system agents|mesh-ancestor
93281516|NCT05742438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281517|NCT05742438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93281518|NCT05742438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93281519|NCT05742438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93281520|NCT05742438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281521|NCT05742438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281522|NCT05742438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93281523|NCT05742438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281524|NCT05742438|Analgesics|analgesics|mesh-ancestor
93281525|NCT05742438|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93281526|NCT05742438|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93281527|NCT05742438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92953559|NCT04638465|Cisplatin|cisplatin|mesh-list
93281528|NCT05742438|Adrenergic Agents|adrenergic agents|mesh-ancestor
93281530|NCT05742438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93281531|NCT05742438|Narcotics|narcotics|mesh-ancestor
93281532|NCT05732961|Luspatercept|luspatercept|mesh-list
93281533|NCT05732961|Hematinics|hematinics|mesh-ancestor
93281534|NCT05730751|Anesthetics|anesthetics|mesh-list
93281535|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281536|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281537|NCT05685225|Acetaminophen|acetaminophen|mesh-list
93281538|NCT05685225|Naltrexone|naltrexone|mesh-list
93281539|NCT05685225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281540|NCT05685225|Analgesics|analgesics|mesh-ancestor
93281541|NCT05685225|Sensory System Agents|sensory system agents|mesh-ancestor
93281542|NCT05685225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281543|NCT05685225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281544|NCT05685225|Antipyretics|antipyretics|mesh-ancestor
93281545|NCT05685225|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93281546|NCT05685225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93281547|NCT05681715|Rozanolixizumab|rozanolixizumab|mesh-list
93281548|NCT05681715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281549|NCT05681715|Immunologic Factors|immunologic factors|mesh-ancestor
93281550|NCT05681715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281551|NCT05678673|Nivolumab|nivolumab|mesh-list
93281552|NCT05678673|Sunitinib|sunitinib|mesh-list
93281553|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281554|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281555|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93281556|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281557|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93281558|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93281559|NCT05678673|Growth Substances|growth substances|mesh-ancestor
93281560|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281561|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
93281562|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281563|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281564|NCT05670743|Fluorides|fluorides|mesh-list
93281565|NCT05670743|Cariostatic Agents|cariostatic agents|mesh-ancestor
93281566|NCT05670743|Protective Agents|protective agents|mesh-ancestor
93281567|NCT05670743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281568|NCT05662319|Antithrombins|antithrombins|mesh-list
93281569|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
93281570|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93281571|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
93281572|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281573|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281574|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
93281575|NCT05656248|Cytarabine|cytarabine|mesh-list
93281576|NCT05656248|Hydrocortisone|hydrocortisone|mesh-list
93281577|NCT05656248|Methotrexate|methotrexate|mesh-list
93281578|NCT05656248|Daunorubicin|daunorubicin|mesh-list
93281579|NCT05656248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93281580|NCT05656248|Abortifacient Agents|abortifacient agents|mesh-ancestor
93281581|NCT05656248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93281582|NCT05656248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281583|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281584|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
93281585|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281586|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281587|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93281588|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281589|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93281590|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281591|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
93281592|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281593|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93281594|NCT05656248|Antiviral Agents|antiviral agents|mesh-ancestor
93281595|NCT05656248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281596|NCT05656248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281597|NCT05656248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93281598|NCT05656248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93281599|NCT05656248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93281600|NCT05650008|Anesthetics|anesthetics|mesh-list
93281601|NCT05650008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281602|NCT05650008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281603|NCT05644665|Ozanimod|ozanimod|mesh-list
93281604|NCT05644665|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93281605|NCT05644665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281606|NCT05644665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281607|NCT05644665|Immunologic Factors|immunologic factors|mesh-ancestor
93281608|NCT05644665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281610|NCT05634174|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93281611|NCT05634174|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93281612|NCT05634174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93281613|NCT05634174|Adrenergic Agents|adrenergic agents|mesh-ancestor
93281614|NCT05634174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281615|NCT05634174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281616|NCT05634174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281617|NCT05634174|Urological Agents|urological agents|mesh-ancestor
93281618|NCT05630976|Isavuconazole|isavuconazole|mesh-list
93281619|NCT05630976|Antifungal Agents|antifungal agents|mesh-ancestor
93281620|NCT05630976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281621|NCT05624554|Cyclophosphamide|cyclophosphamide|mesh-list
93281622|NCT05624554|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93281623|NCT05624554|Rituximab|rituximab|mesh-list
93281624|NCT05624554|Fludarabine|fludarabine|mesh-list
93281625|NCT05624554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281626|NCT05624554|Immunologic Factors|immunologic factors|mesh-ancestor
93281627|NCT05624554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281628|NCT05624554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281629|NCT05624554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93281630|NCT05624554|Alkylating Agents|alkylating agents|mesh-ancestor
93281631|NCT05624554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281632|NCT05624554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281633|NCT05624554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93281634|NCT05624554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281635|NCT05619705|Benzocaine|benzocaine|mesh-list
93281636|NCT05619705|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281637|NCT05619705|Anesthetics|anesthetics|mesh-ancestor
93281638|NCT05619705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281639|NCT05619705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281640|NCT05619705|Sensory System Agents|sensory system agents|mesh-ancestor
93281641|NCT05619705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281642|NCT05614739|Pembrolizumab|pembrolizumab|mesh-list
93281643|NCT05614739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281644|NCT05614739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281645|NCT05614739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93281646|NCT05614739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281647|NCT05610163|Leucovorin|leucovorin|mesh-list
93281648|NCT05610163|Fluorouracil|fluorouracil|mesh-list
93281649|NCT05610163|Capecitabine|capecitabine|mesh-list
93281650|NCT05610163|Oxaliplatin|oxaliplatin|mesh-list
93281651|NCT05610163|Irinotecan|irinotecan|mesh-list
93281652|NCT05610163|Calcium|calcium|mesh-list
93281653|NCT05610163|Levoleucovorin|levoleucovorin|mesh-list
93281654|NCT05610163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93281655|NCT05610163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281656|NCT05610163|Antimetabolites|antimetabolites|mesh-ancestor
93281657|NCT05610163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281658|NCT05610163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281659|NCT05610163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281660|NCT05610163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281661|NCT05610163|Immunologic Factors|immunologic factors|mesh-ancestor
93281662|NCT05610163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93281663|NCT05610163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93281664|NCT05610163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281665|NCT05610163|Antidotes|antidotes|mesh-ancestor
93281666|NCT05610163|Protective Agents|protective agents|mesh-ancestor
93281667|NCT05610163|Vitamin B Complex|vitamin b complex|mesh-ancestor
93281668|NCT05610163|Vitamins|vitamins|mesh-ancestor
93281669|NCT05610163|Micronutrients|micronutrients|mesh-ancestor
93281670|NCT05609565|Bupivacaine|bupivacaine|mesh-list
93281671|NCT05609565|Prilocaine|prilocaine|mesh-list
93281672|NCT05609565|Anesthetics|anesthetics|mesh-list
93281673|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281674|NCT05609565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281675|NCT05609565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281676|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
93281677|NCT05609565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281678|NCT05608291|Pembrolizumab|pembrolizumab|mesh-list
93281679|NCT05608291|Cemiplimab|cemiplimab|mesh-list
93281680|NCT05608291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281682|NCT05608291|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93281683|NCT05608291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281684|NCT05604859|Methylprednisolone|methylprednisolone|mesh-list
93281685|NCT05604859|Heparin|heparin|mesh-list
93281686|NCT05604859|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93281687|NCT05604859|Tinzaparin|tinzaparin|mesh-list
93281688|NCT05604859|Dalteparin|dalteparin|mesh-list
93281689|NCT05604859|Immunoglobulins|immunoglobulins|mesh-list
93281690|NCT05604859|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93281691|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
93281692|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93281693|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281694|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
93281695|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
93281696|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281697|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281698|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281699|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
93281700|NCT05604859|Hormones|hormones|mesh-ancestor
93281701|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281702|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93281703|NCT05604859|Protective Agents|protective agents|mesh-ancestor
93281704|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
93281705|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93281706|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93281707|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281708|NCT05604859|Immunologic Factors|immunologic factors|mesh-ancestor
93281709|NCT05593328|Bevacizumab|bevacizumab|mesh-list
93281710|NCT05593328|Onvansertib|onvansertib|mesh-list
93281711|NCT05593328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281712|NCT05593328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281713|NCT05593328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93281714|NCT05593328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93281715|NCT05593328|Growth Substances|growth substances|mesh-ancestor
93281716|NCT05593328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281717|NCT05593328|Growth Inhibitors|growth inhibitors|mesh-ancestor
93281718|NCT05593328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281719|NCT05593328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281720|NCT05593328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281721|NCT05590728|Apramycin|apramycin|mesh-list
93281722|NCT05590728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93281723|NCT05590728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281724|NCT05590585|Emollients|emollients|mesh-list
93281725|NCT05590585|Dermatologic Agents|dermatologic agents|mesh-ancestor
93281726|NCT05590234|Dexmedetomidine|dexmedetomidine|mesh-list
93281727|NCT05590234|Bupivacaine|bupivacaine|mesh-list
93281728|NCT05590234|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281729|NCT05590234|Anesthetics|anesthetics|mesh-ancestor
93281730|NCT05590234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281731|NCT05590234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281732|NCT05590234|Sensory System Agents|sensory system agents|mesh-ancestor
93281733|NCT05590234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281734|NCT05590234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93281735|NCT05590234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281736|NCT05590234|Analgesics|analgesics|mesh-ancestor
93281737|NCT05590234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93281738|NCT05590234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93281739|NCT05590234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93281740|NCT05590234|Adrenergic Agents|adrenergic agents|mesh-ancestor
93281741|NCT05590234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281742|NCT05590234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281743|NCT05572749|Metformin|metformin|mesh-list
93281744|NCT05572749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93281745|NCT05572749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281746|NCT05540522|Vaccines|vaccines|mesh-list
93281747|NCT05540522|Immunologic Factors|immunologic factors|mesh-ancestor
93281748|NCT05540522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281749|NCT05540223|Sirolimus|sirolimus|mesh-list
93281750|NCT05540223|Everolimus|everolimus|mesh-list
93281751|NCT05540223|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93281752|NCT05540223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281753|NCT05540223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281754|NCT05540223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281755|NCT05540223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281756|NCT05540223|Immunologic Factors|immunologic factors|mesh-ancestor
93281757|NCT05540223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281758|NCT05540223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281759|NCT05540223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93281760|NCT05540223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281761|NCT05540223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93281762|NCT05540223|Antifungal Agents|antifungal agents|mesh-ancestor
93281763|NCT05539027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93281765|NCT05539027|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93281766|NCT05539027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93281767|NCT05539027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93281768|NCT05539027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281769|NCT05539027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281770|NCT05526755|Osimertinib|osimertinib|mesh-list
93281771|NCT05526755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281772|NCT05526755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281773|NCT05526755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281774|NCT05526755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281775|NCT05512949|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93281776|NCT05512949|Antiviral Agents|antiviral agents|mesh-ancestor
93281777|NCT05512949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281778|NCT05511038|Aflibercept|aflibercept|mesh-list
93281779|NCT05511038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93281780|NCT05511038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93281781|NCT05511038|Growth Substances|growth substances|mesh-ancestor
93281782|NCT05511038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281783|NCT05511038|Growth Inhibitors|growth inhibitors|mesh-ancestor
93281784|NCT05511038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281785|NCT05476172|Dienogest|dienogest|mesh-list
93281786|NCT05476172|Norethindrone|norethindrone|mesh-list
93281787|NCT05476172|Norethindrone Acetate|norethindrone acetate|mesh-list
93281788|NCT05476172|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93281789|NCT05476172|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93281790|NCT05476172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93281791|NCT05476172|Contraceptive Agents|contraceptive agents|mesh-ancestor
93281792|NCT05476172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93281793|NCT05476172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281794|NCT05476172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93281795|NCT05476172|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93281796|NCT05476172|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93281797|NCT05476172|Hormone Antagonists|hormone antagonists|mesh-ancestor
93281798|NCT05476172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281799|NCT05476172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93281800|NCT05476172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281801|NCT05468619|Valacyclovir|valacyclovir|mesh-list
93281802|NCT05468619|Antiviral Agents|antiviral agents|mesh-ancestor
93281803|NCT05468619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281804|NCT05438043|Dexamethasone|dexamethasone|mesh-list
93281805|NCT05438043|Lenalidomide|lenalidomide|mesh-list
93281806|NCT05438043|Daratumumab|daratumumab|mesh-list
93281807|NCT05438043|Pomalidomide|pomalidomide|mesh-list
93281808|NCT05438043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281809|NCT05438043|Antiemetics|antiemetics|mesh-ancestor
93281810|NCT05438043|Autonomic Agents|autonomic agents|mesh-ancestor
93281811|NCT05438043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281812|NCT05438043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281813|NCT05438043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281814|NCT05438043|Glucocorticoids|glucocorticoids|mesh-ancestor
93281815|NCT05438043|Hormones|hormones|mesh-ancestor
93281816|NCT05438043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281817|NCT05438043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93281818|NCT05438043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281819|NCT05438043|Immunologic Factors|immunologic factors|mesh-ancestor
93281820|NCT05438043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93281821|NCT05438043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93281822|NCT05438043|Growth Substances|growth substances|mesh-ancestor
93281823|NCT05438043|Growth Inhibitors|growth inhibitors|mesh-ancestor
93281824|NCT05432518|Everolimus|everolimus|mesh-list
93281825|NCT05432518|Dasatinib|dasatinib|mesh-list
93281826|NCT05432518|Olaparib|olaparib|mesh-list
93281827|NCT05432518|Palbociclib|palbociclib|mesh-list
93281828|NCT05432518|Afatinib|afatinib|mesh-list
93281829|NCT05432518|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93281830|NCT05432518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953859|NCT00762060|Anesthetics, Local|anesthetics, local|mesh-list
93281831|NCT05432518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281832|NCT05432518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281833|NCT05432518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281834|NCT05432518|Immunologic Factors|immunologic factors|mesh-ancestor
93281835|NCT05432518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281836|NCT05432518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281837|NCT05432518|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93281838|NCT05413096|Propolis|propolis|mesh-list
93281839|NCT05413096|Diclofenac|diclofenac|mesh-list
93281840|NCT05413096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93281841|NCT05413096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93281842|NCT05413096|Analgesics|analgesics|mesh-ancestor
93281843|NCT05413096|Sensory System Agents|sensory system agents|mesh-ancestor
93281844|NCT05413096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281845|NCT05413096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281846|NCT05413096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93281847|NCT05413096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281848|NCT05413096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93281849|NCT05413096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281850|NCT05413096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281851|NCT05413096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281852|NCT05393037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93281853|NCT05393037|Immunologic Factors|immunologic factors|mesh-ancestor
93281854|NCT05393037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281855|NCT05391061|Abrocitinib|abrocitinib|mesh-list
92576422|NCT00260611|Tubulin Modulators|tubulin modulators|mesh-ancestor
93281856|NCT05391061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281857|NCT05391061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281858|NCT05391061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281859|NCT05388006|Durvalumab|durvalumab|mesh-list
93281860|NCT05388006|Venetoclax|venetoclax|mesh-list
93281861|NCT05388006|Acalabrutinib|acalabrutinib|mesh-list
93281862|NCT05388006|Immunoglobulins|immunoglobulins|mesh-list
93281863|NCT05388006|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93281864|NCT05388006|Immunoglobulin G|immunoglobulin g|mesh-list
93281865|NCT05388006|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93281866|NCT05388006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281867|NCT05388006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281868|NCT05388006|Immunologic Factors|immunologic factors|mesh-ancestor
93281869|NCT05388006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281870|NCT05388006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93281871|NCT05388006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281872|NCT05388006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281873|NCT05375994|Adagrasib|adagrasib|mesh-list
93281874|NCT05375994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281875|NCT05375903|Gemcitabine|gemcitabine|mesh-list
93281876|NCT05375903|Imiquimod|imiquimod|mesh-list
93281877|NCT05375903|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93281878|NCT05375903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281879|NCT05375903|Antimetabolites|antimetabolites|mesh-ancestor
93281880|NCT05375903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281881|NCT05375903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281882|NCT05375903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93281883|NCT05375903|Immunologic Factors|immunologic factors|mesh-ancestor
93281884|NCT05375903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281885|NCT05375903|Interferon Inducers|interferon inducers|mesh-ancestor
93281886|NCT05338320|Fentanyl|fentanyl|mesh-list
93281887|NCT05338320|Morphine|morphine|mesh-list
93281888|NCT05338320|Anesthetics|anesthetics|mesh-ancestor
93281889|NCT05338320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281890|NCT05338320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281891|NCT05338320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93281892|NCT05338320|Narcotics|narcotics|mesh-ancestor
93281893|NCT05338320|Analgesics|analgesics|mesh-ancestor
93281894|NCT05338320|Sensory System Agents|sensory system agents|mesh-ancestor
93281895|NCT05338320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281896|NCT05338320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93281897|NCT05338320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93281898|NCT05338320|Anesthetics, General|anesthetics, general|mesh-ancestor
93281899|NCT05337540|Hylan|hylan|mesh-list
93281900|NCT05337540|Viscosupplements|viscosupplements|mesh-ancestor
93281901|NCT05337540|Protective Agents|protective agents|mesh-ancestor
93281902|NCT05337540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281903|NCT05325866|Bemarituzumab|bemarituzumab|mesh-list
93281904|NCT05325866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281905|NCT05325866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281906|NCT05316129|Hormones|hormones|mesh-list
93281907|NCT05316129|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93281908|NCT05316129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281909|NCT05316129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281911|NCT05303532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281912|NCT05303532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281913|NCT05284747|Evolocumab|evolocumab|mesh-list
93281914|NCT05284747|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93281915|NCT05284747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93281916|NCT05284747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93281917|NCT05284747|Antimetabolites|antimetabolites|mesh-ancestor
93281918|NCT05284747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281919|NCT05284747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93281920|NCT05284747|Protease Inhibitors|protease inhibitors|mesh-ancestor
93281921|NCT05284747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281922|NCT05284747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93281923|NCT05281471|Paclitaxel|paclitaxel|mesh-list
93281924|NCT05281471|Docetaxel|docetaxel|mesh-list
93281925|NCT05281471|Bevacizumab|bevacizumab|mesh-list
93281926|NCT05281471|Carboplatin|carboplatin|mesh-list
93281927|NCT05281471|Gemcitabine|gemcitabine|mesh-list
93281928|NCT05281471|Doxorubicin|doxorubicin|mesh-list
93281929|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93281930|NCT05281471|Taxane|taxane|mesh-list
93281931|NCT05281471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93281932|NCT05281471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281933|NCT05281471|Tubulin Modulators|tubulin modulators|mesh-ancestor
93281934|NCT05281471|Antimitotic Agents|antimitotic agents|mesh-ancestor
93281935|NCT05281471|Mitosis Modulators|mitosis modulators|mesh-ancestor
93281936|NCT05281471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281937|NCT05281471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281938|NCT05281471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93281939|NCT05281471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93281940|NCT05281471|Growth Substances|growth substances|mesh-ancestor
93281941|NCT05281471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281942|NCT05281471|Growth Inhibitors|growth inhibitors|mesh-ancestor
93281943|NCT05281471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281944|NCT05281471|Antimetabolites|antimetabolites|mesh-ancestor
93281945|NCT05281471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93281946|NCT05281471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93281947|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93281948|NCT05281471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281949|NCT05279937|Lidocaine|lidocaine|mesh-list
93281950|NCT05279937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93281951|NCT05279937|Anesthetics, Local|anesthetics, local|mesh-ancestor
93281952|NCT05279937|Anesthetics|anesthetics|mesh-ancestor
93281953|NCT05279937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93281954|NCT05279937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281955|NCT05279937|Sensory System Agents|sensory system agents|mesh-ancestor
93281956|NCT05279937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93281957|NCT05279937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93281958|NCT05279937|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93281959|NCT05279937|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93281960|NCT05279937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93281961|NCT05279937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281962|NCT05267613|Esomeprazole|esomeprazole|mesh-list
93281963|NCT05267613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93281964|NCT05267613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93281965|NCT05267613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93281966|NCT05267613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281967|NCT05267613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281968|NCT05262400|Letrozole|letrozole|mesh-list
93281969|NCT05262400|Fulvestrant|fulvestrant|mesh-list
93281970|NCT05262400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281971|NCT05262400|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93281972|NCT05262400|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93281973|NCT05262400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281974|NCT05262400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281975|NCT05262400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93281976|NCT05262400|Hormone Antagonists|hormone antagonists|mesh-ancestor
93281977|NCT05262400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93281978|NCT05262400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281979|NCT05262400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954010|NCT05955040|Labetalol|labetalol|mesh-list
93281980|NCT05262400|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93281981|NCT05260073|Tirbanibulin|tirbanibulin|mesh-list
93281982|NCT05260073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93281983|NCT05260073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281984|NCT05249959|Cytarabine|cytarabine|mesh-list
93281985|NCT05249959|Rituximab|rituximab|mesh-list
93281986|NCT05249959|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93281987|NCT05249959|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93281988|NCT05249959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93281989|NCT05249959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93281990|NCT05249959|Immunologic Factors|immunologic factors|mesh-ancestor
93281991|NCT05249959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93281992|NCT05249959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93281993|NCT05249959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93281994|NCT05249959|Antimetabolites|antimetabolites|mesh-ancestor
93281995|NCT05249959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93281996|NCT05249959|Antiviral Agents|antiviral agents|mesh-ancestor
93281997|NCT05249959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93281998|NCT05249959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93281999|NCT05249959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93282000|NCT05249959|Alkylating Agents|alkylating agents|mesh-ancestor
93282001|NCT05242874|Dexamethasone|dexamethasone|mesh-list
93282002|NCT05242874|Dexamethasone acetate|dexamethasone acetate|mesh-list
93282003|NCT05242874|Olanzapine|olanzapine|mesh-list
93282004|NCT05242874|Fosaprepitant|fosaprepitant|mesh-list
93282005|NCT05242874|Aprepitant|aprepitant|mesh-list
93282006|NCT05242874|Antiemetics|antiemetics|mesh-list
93282007|NCT05242874|Tropisetron|tropisetron|mesh-list
93282008|NCT05242874|BB 1101|bb 1101|mesh-list
93282009|NCT05242874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282010|NCT05242874|Autonomic Agents|autonomic agents|mesh-ancestor
93282011|NCT05242874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282012|NCT05242874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282013|NCT05242874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282014|NCT05242874|Glucocorticoids|glucocorticoids|mesh-ancestor
93282015|NCT05242874|Hormones|hormones|mesh-ancestor
93282016|NCT05242874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282017|NCT05242874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282018|NCT05242874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282019|NCT05242874|Protease Inhibitors|protease inhibitors|mesh-ancestor
93282020|NCT05242874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282021|NCT05242874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282022|NCT05242874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93282023|NCT05242874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93282024|NCT05242874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282025|NCT05242874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93282026|NCT05242874|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93282027|NCT05242874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93282028|NCT05242874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93282029|NCT05242874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282030|NCT05242874|Serotonin Agents|serotonin agents|mesh-ancestor
93282031|NCT05242874|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93282032|NCT05242874|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93282033|NCT05242874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93282034|NCT05227001|Camphor|camphor|mesh-list
93282035|NCT05227001|Menthol|menthol|mesh-list
93282036|NCT05227001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93282037|NCT05227001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282038|NCT05227001|Antipruritics|antipruritics|mesh-ancestor
93282039|NCT05227001|Dermatologic Agents|dermatologic agents|mesh-ancestor
93282040|NCT05226871|Cetuximab|cetuximab|mesh-list
93282041|NCT05226871|Letrozole|letrozole|mesh-list
93282042|NCT05226871|Fulvestrant|fulvestrant|mesh-list
93282043|NCT05226871|Palbociclib|palbociclib|mesh-list
93282044|NCT05226871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282045|NCT05226871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282046|NCT05226871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93282047|NCT05226871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93282048|NCT05226871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282049|NCT05226871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282050|NCT05226871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93282051|NCT05226871|Hormone Antagonists|hormone antagonists|mesh-ancestor
93282052|NCT05226871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282053|NCT05226871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282054|NCT05226871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954091|NCT05954143|Pertuzumab|pertuzumab|mesh-list
93282055|NCT05226871|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93282056|NCT05226871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282057|NCT05218733|Fentanyl|fentanyl|mesh-list
93282058|NCT05218733|Morphine|morphine|mesh-list
93282059|NCT05218733|Anesthetics|anesthetics|mesh-ancestor
93282060|NCT05218733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282061|NCT05218733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282062|NCT05218733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93282063|NCT05218733|Narcotics|narcotics|mesh-ancestor
93282064|NCT05218733|Analgesics|analgesics|mesh-ancestor
93282065|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
93282066|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282067|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93282068|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93282069|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
93282070|NCT05216250|Botulinum Toxins|botulinum toxins|mesh-list
93282071|NCT05216250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93282072|NCT05216250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93282073|NCT05216250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93282074|NCT05216250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93282075|NCT05216250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282076|NCT05216250|Cholinergic Agents|cholinergic agents|mesh-ancestor
93282077|NCT05216250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282078|NCT05216250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282079|NCT05216250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93282080|NCT05216250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282082|NCT05214287|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93282083|NCT05214287|Protective Agents|protective agents|mesh-ancestor
93282084|NCT05214287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282085|NCT05182931|Trametinib|trametinib|mesh-list
93282086|NCT05182931|Dabrafenib|dabrafenib|mesh-list
93282087|NCT05182931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282088|NCT05182931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282089|NCT05182931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282090|NCT05182931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282091|NCT05178862|Fluconazole|fluconazole|mesh-list
93282092|NCT05178862|Caspofungin|caspofungin|mesh-list
93282093|NCT05178862|Micafungin|micafungin|mesh-list
93282094|NCT05178862|Anidulafungin|anidulafungin|mesh-list
93282095|NCT05178862|Ibrexafungerp|ibrexafungerp|mesh-list
93282096|NCT05178862|Echinocandins|echinocandins|mesh-list
93282097|NCT05178862|Antifungal Agents|antifungal agents|mesh-ancestor
93282098|NCT05178862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282099|NCT05178862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93282100|NCT05178862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93282101|NCT05178862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282102|NCT05178862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282103|NCT05178862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93282104|NCT05178862|Hormone Antagonists|hormone antagonists|mesh-ancestor
93282105|NCT05178862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282106|NCT05178862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282107|NCT05178862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93282108|NCT05178862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93282109|NCT05176483|Nivolumab|nivolumab|mesh-list
93282110|NCT05176483|Ipilimumab|ipilimumab|mesh-list
93282111|NCT05176483|Relatlimab|relatlimab|mesh-list
93282112|NCT05176483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282113|NCT05176483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282114|NCT05176483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282115|NCT05176483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282116|NCT05160922|Crizotinib|crizotinib|mesh-list
93282117|NCT05160922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282118|NCT05160922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282119|NCT05160922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282120|NCT05160922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282121|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
93282122|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
93282123|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282124|NCT05128734|Temozolomide|temozolomide|mesh-list
93282125|NCT05128734|Olaparib|olaparib|mesh-list
93282126|NCT05128734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93282127|NCT05128734|Alkylating Agents|alkylating agents|mesh-ancestor
93282128|NCT05128734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282129|NCT05128734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282130|NCT05128734|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93282131|NCT05128734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282132|NCT05126836|Cilostazol|cilostazol|mesh-list
93282133|NCT05126836|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93282134|NCT05126836|Autonomic Agents|autonomic agents|mesh-ancestor
93282135|NCT05126836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282136|NCT05126836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282137|NCT05126836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93282138|NCT05126836|Respiratory System Agents|respiratory system agents|mesh-ancestor
93282139|NCT05126836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93282140|NCT05126836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93282141|NCT05126836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282142|NCT05126836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93282143|NCT05126836|Vasodilator Agents|vasodilator agents|mesh-ancestor
93282144|NCT05126836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93282145|NCT05126836|Protective Agents|protective agents|mesh-ancestor
93282146|NCT05126836|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93282147|NCT05126836|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93282148|NCT05126836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282149|NCT05108688|Sumatriptan|sumatriptan|mesh-list
93282150|NCT05108688|Mirtazapine|mirtazapine|mesh-list
93282151|NCT05108688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93282152|NCT05108688|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93282153|NCT05108688|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93282154|NCT05108688|Serotonin Agents|serotonin agents|mesh-ancestor
93282155|NCT05108688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282156|NCT05108688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282157|NCT05108688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282158|NCT05108688|Antidepressive Agents|antidepressive agents|mesh-ancestor
93282159|NCT05108688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93282160|NCT05108688|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93282161|NCT05108688|Histamine Antagonists|histamine antagonists|mesh-ancestor
93282162|NCT05108688|Histamine Agents|histamine agents|mesh-ancestor
93282163|NCT05108688|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93282164|NCT05108688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93282165|NCT05108688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282166|NCT05108688|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93282167|NCT05108688|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93282168|NCT05108688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93282169|NCT05108688|Adrenergic Agents|adrenergic agents|mesh-ancestor
93282170|NCT05108688|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93282171|NCT05108688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93282172|NCT05108688|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93282173|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
93282174|NCT05092451|Fludarabine|fludarabine|mesh-list
93282175|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
93282176|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282177|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
93282178|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282179|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282180|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93282181|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
93282182|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282183|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282184|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93282185|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93282186|NCT05092451|Antimetabolites|antimetabolites|mesh-ancestor
93282187|NCT05085002|Letrozole|letrozole|mesh-list
93282188|NCT05085002|Fulvestrant|fulvestrant|mesh-list
93282189|NCT05085002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282190|NCT05085002|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93282191|NCT05085002|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93282192|NCT05085002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282193|NCT05085002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282194|NCT05085002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93282195|NCT05085002|Hormone Antagonists|hormone antagonists|mesh-ancestor
93282196|NCT05085002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282197|NCT05085002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282198|NCT05085002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282199|NCT05085002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93282200|NCT05077904|Alprazolam|alprazolam|mesh-list
93282201|NCT05077904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92954235|NCT05917509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282202|NCT05077904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282203|NCT05077904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282204|NCT05077904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93282205|NCT05077904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93282206|NCT05077904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93282207|NCT05077904|GABA Modulators|gaba modulators|mesh-ancestor
93282208|NCT05077904|GABA Agents|gaba agents|mesh-ancestor
93282209|NCT05077904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282210|NCT05077904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282211|NCT05076617|Alprazolam|alprazolam|mesh-list
93282212|NCT05076617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93282213|NCT05076617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282214|NCT05076617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282215|NCT05076617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93282216|NCT05076617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93282217|NCT05076617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93282218|NCT05076617|GABA Modulators|gaba modulators|mesh-ancestor
93282219|NCT05076617|GABA Agents|gaba agents|mesh-ancestor
93282220|NCT05076617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282221|NCT05076617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282222|NCT05067283|Leucovorin|leucovorin|mesh-list
93282223|NCT05067283|Carboplatin|carboplatin|mesh-list
93282224|NCT05067283|Pembrolizumab|pembrolizumab|mesh-list
93282225|NCT05067283|Fluorouracil|fluorouracil|mesh-list
93282226|NCT05067283|Oxaliplatin|oxaliplatin|mesh-list
93282227|NCT05067283|Pemetrexed|pemetrexed|mesh-list
93282228|NCT05067283|Cetuximab|cetuximab|mesh-list
93282229|NCT05067283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282230|NCT05067283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282231|NCT05067283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282232|NCT05067283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282233|NCT05067283|Antimetabolites|antimetabolites|mesh-ancestor
93282234|NCT05067283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93282235|NCT05067283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282236|NCT05067283|Immunologic Factors|immunologic factors|mesh-ancestor
93282237|NCT05067283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282238|NCT05067283|Antidotes|antidotes|mesh-ancestor
93282239|NCT05067283|Protective Agents|protective agents|mesh-ancestor
93282240|NCT05067283|Vitamin B Complex|vitamin b complex|mesh-ancestor
93282241|NCT05067283|Vitamins|vitamins|mesh-ancestor
93282242|NCT05067283|Micronutrients|micronutrients|mesh-ancestor
93282243|NCT05067283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282244|NCT05067283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93282245|NCT05067283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93282246|NCT05059522|Pemetrexed|pemetrexed|mesh-list
93282247|NCT05059522|Avelumab|avelumab|mesh-list
93282248|NCT05059522|Axitinib|axitinib|mesh-list
93282249|NCT05059522|Talazoparib|talazoparib|mesh-list
93282250|NCT05059522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282251|NCT05059522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282252|NCT05059522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282253|NCT05059522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93282254|NCT05059522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93282255|NCT05059522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282256|NCT05059522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282257|NCT05059522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93282258|NCT05050357|Norethindrone|norethindrone|mesh-list
93282259|NCT05050357|Norethindrone Acetate|norethindrone acetate|mesh-list
93282260|NCT05050357|Progestins|progestins|mesh-list
93282261|NCT05050357|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93282262|NCT05050357|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93282263|NCT05050357|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93282264|NCT05050357|Contraceptive Agents|contraceptive agents|mesh-ancestor
93282265|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93282266|NCT05050357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282267|NCT05050357|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93282268|NCT05050357|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93282269|NCT05050357|Hormones|hormones|mesh-ancestor
93282270|NCT05050357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282271|NCT05028829|Atorvastatin|atorvastatin|mesh-list
93282272|NCT05028829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93282273|NCT05028829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93282274|NCT05028829|Antimetabolites|antimetabolites|mesh-ancestor
93282275|NCT05028829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282276|NCT05028829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93282277|NCT05028829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93282278|NCT05028829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282279|NCT05017571|Colchicine|colchicine|mesh-list
93282280|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
93282281|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282282|NCT05017571|Tubulin Modulators|tubulin modulators|mesh-ancestor
93282283|NCT05017571|Antimitotic Agents|antimitotic agents|mesh-ancestor
93282284|NCT05017571|Mitosis Modulators|mitosis modulators|mesh-ancestor
93282285|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282286|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282287|NCT05008809|Leucovorin|leucovorin|mesh-list
92654062|NCT04542226|Bromides|bromides|mesh-list
93282288|NCT05008809|Fluorouracil|fluorouracil|mesh-list
93282289|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
93282290|NCT05008809|Irinotecan|irinotecan|mesh-list
93282291|NCT05008809|Levoleucovorin|levoleucovorin|mesh-list
93282292|NCT05008809|Antimetabolites|antimetabolites|mesh-ancestor
93282293|NCT05008809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576923|NCT00264472|Eniluracil|eniluracil|mesh-list
93282294|NCT05008809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93282295|NCT05008809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282296|NCT05008809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282297|NCT05008809|Immunologic Factors|immunologic factors|mesh-ancestor
93282298|NCT05008809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282299|NCT05008809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93282300|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93282301|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282302|NCT05008809|Antidotes|antidotes|mesh-ancestor
93282303|NCT05008809|Protective Agents|protective agents|mesh-ancestor
93282304|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
93282305|NCT05008809|Vitamins|vitamins|mesh-ancestor
93282306|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
93282307|NCT04994717|Blinatumomab|blinatumomab|mesh-list
93282308|NCT04994717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282309|NCT04975334|Naloxone|naloxone|mesh-list
93282310|NCT04975334|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93282311|NCT04975334|Hormones|hormones|mesh-ancestor
93282312|NCT04975334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282313|NCT04975334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282314|NCT04975334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93282315|NCT04975334|Sensory System Agents|sensory system agents|mesh-ancestor
93282316|NCT04975334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282317|NCT04969887|Nivolumab|nivolumab|mesh-list
93282318|NCT04969887|Ipilimumab|ipilimumab|mesh-list
93282319|NCT04969887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282320|NCT04969887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282321|NCT04969887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282322|NCT04969887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282323|NCT04964843|Acetylcysteine|acetylcysteine|mesh-list
93282324|NCT04964843|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93282325|NCT04964843|Antiviral Agents|antiviral agents|mesh-ancestor
93282326|NCT04964843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282327|NCT04964843|Expectorants|expectorants|mesh-ancestor
93282328|NCT04964843|Respiratory System Agents|respiratory system agents|mesh-ancestor
93282329|NCT04964843|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93282330|NCT04964843|Antioxidants|antioxidants|mesh-ancestor
93282331|NCT04964843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282332|NCT04964843|Protective Agents|protective agents|mesh-ancestor
93282333|NCT04964843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282334|NCT04964843|Antidotes|antidotes|mesh-ancestor
93282335|NCT04946825|Nicotine|nicotine|mesh-list
93282336|NCT04946825|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93282337|NCT04946825|Autonomic Agents|autonomic agents|mesh-ancestor
93282338|NCT04946825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282339|NCT04946825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282340|NCT04946825|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93282341|NCT04946825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93282342|NCT04946825|Cholinergic Agents|cholinergic agents|mesh-ancestor
93282343|NCT04946825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282344|NCT04946825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282345|NCT04938830|Palivizumab|palivizumab|mesh-list
93282346|NCT04938830|Antiviral Agents|antiviral agents|mesh-ancestor
93282347|NCT04938830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282348|NCT04908579|Ketamine|ketamine|mesh-list
93282349|NCT04908579|Bupivacaine|bupivacaine|mesh-list
93282350|NCT04908579|Anesthetics, Local|anesthetics, local|mesh-ancestor
93282351|NCT04908579|Anesthetics|anesthetics|mesh-ancestor
93282352|NCT04908579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282353|NCT04908579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282354|NCT04908579|Sensory System Agents|sensory system agents|mesh-ancestor
93282355|NCT04908579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282356|NCT04908579|Analgesics|analgesics|mesh-ancestor
92003924|NCT01351103|LGK974|lgk974|mesh-list
93282357|NCT04908579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93282358|NCT04908579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93282359|NCT04908579|Anesthetics, General|anesthetics, general|mesh-ancestor
93282360|NCT04908579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93282361|NCT04908579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93282362|NCT04908579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282363|NCT04908579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282364|NCT04898387|Timolol|timolol|mesh-list
92654477|NCT00238784|Hormones|hormones|mesh-ancestor
93282365|NCT04898387|Bimatoprost|bimatoprost|mesh-list
92576996|NCT00265291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282366|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93282367|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92654695|NCT05896748|Rilpivirine|rilpivirine|mesh-list
93282368|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
93282369|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282370|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282371|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282372|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93282373|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93282374|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
93282375|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93282376|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
92654836|NCT05815758|Ketotifen|ketotifen|mesh-list
93282377|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282378|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282379|NCT04895722|Pembrolizumab|pembrolizumab|mesh-list
93282380|NCT04895722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282381|NCT04895722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282382|NCT04895722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282383|NCT04895722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282384|NCT04860960|Betadex|betadex|mesh-list
93282385|NCT04860960|Sequestering Agents|sequestering agents|mesh-ancestor
92577015|NCT00265408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282386|NCT04860960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282387|NCT04848753|Paclitaxel|paclitaxel|mesh-list
93282388|NCT04848753|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93282389|NCT04848753|Cisplatin|cisplatin|mesh-list
92577020|NCT00265642|Irbesartan|irbesartan|mesh-list
93282390|NCT04848753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93282391|NCT04848753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282392|NCT04848753|Tubulin Modulators|tubulin modulators|mesh-ancestor
93282393|NCT04848753|Antimitotic Agents|antimitotic agents|mesh-ancestor
93282394|NCT04848753|Mitosis Modulators|mitosis modulators|mesh-ancestor
93282395|NCT04848753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282396|NCT04823247|Interleukin-23|interleukin-23|mesh-list
93282397|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93282398|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93282399|NCT04823247|Growth Substances|growth substances|mesh-ancestor
93282400|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282401|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
93282402|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282403|NCT04800822|Cetuximab|cetuximab|mesh-list
93282404|NCT04800822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282405|NCT04800822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282406|NCT04777994|Mitogens|mitogens|mesh-list
93282407|NCT04777994|Endothelial Growth Factors|endothelial growth factors|mesh-list
93282408|NCT04777994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93282409|NCT04777994|Mitosis Modulators|mitosis modulators|mesh-ancestor
93282410|NCT04777994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282411|NCT04777994|Growth Substances|growth substances|mesh-ancestor
93282412|NCT04777994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282413|NCT04777994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282414|NCT04777994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282415|NCT04775953|Vancomycin|vancomycin|mesh-list
93282416|NCT04775953|Cefazolin|cefazolin|mesh-list
93282417|NCT04775953|Daptomycin|daptomycin|mesh-list
93282418|NCT04775953|Dalbavancin|dalbavancin|mesh-list
93282419|NCT04775953|Oxacillin|oxacillin|mesh-list
93282420|NCT04775953|Nafcillin|nafcillin|mesh-list
93282421|NCT04775953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93282422|NCT04775953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282423|NCT04772222|Dexmedetomidine|dexmedetomidine|mesh-list
93282424|NCT04772222|Morphine|morphine|mesh-list
93282425|NCT04772222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93282426|NCT04772222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282427|NCT04772222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282428|NCT04772222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93282429|NCT04772222|Analgesics|analgesics|mesh-ancestor
93282430|NCT04772222|Sensory System Agents|sensory system agents|mesh-ancestor
93282431|NCT04772222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282432|NCT04772222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93282433|NCT04772222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93282434|NCT04772222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93282435|NCT04772222|Adrenergic Agents|adrenergic agents|mesh-ancestor
93282436|NCT04772222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577060|NCT00415792|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93282437|NCT04772222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577063|NCT00415831|Levodopa|levodopa|mesh-list
93282438|NCT04772222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93282439|NCT04772222|Narcotics|narcotics|mesh-ancestor
93282440|NCT04772079|Deucravacitinib|deucravacitinib|mesh-list
92577064|NCT00415831|Carbidopa|carbidopa|mesh-list
93282441|NCT04772079|Dermatologic Agents|dermatologic agents|mesh-ancestor
93282442|NCT04772079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282443|NCT04772079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282444|NCT04772079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282445|NCT04766723|Botulinum Toxins|botulinum toxins|mesh-list
93282446|NCT04766723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93282447|NCT04766723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93282448|NCT04766723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93282449|NCT04766723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93282450|NCT04766723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93282451|NCT04766723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282452|NCT04766723|Cholinergic Agents|cholinergic agents|mesh-ancestor
93282453|NCT04766723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577077|NCT00415831|Immunologic Factors|immunologic factors|mesh-ancestor
93282454|NCT04766723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282455|NCT04766723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93282456|NCT04766723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282457|NCT04766021|Mirabegron|mirabegron|mesh-list
93282458|NCT04766021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93282459|NCT04766021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93282460|NCT04766021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93282461|NCT04766021|Adrenergic Agents|adrenergic agents|mesh-ancestor
93282462|NCT04766021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282463|NCT04766021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282464|NCT04766021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282465|NCT04766021|Urological Agents|urological agents|mesh-ancestor
93282466|NCT04760613|Cannabidiol|cannabidiol|mesh-list
93282467|NCT04760613|Anticonvulsants|anticonvulsants|mesh-ancestor
93282468|NCT04739813|Prednisone|prednisone|mesh-list
93282469|NCT04739813|Lenalidomide|lenalidomide|mesh-list
93282470|NCT04739813|Venetoclax|venetoclax|mesh-list
93282471|NCT04739813|Obinutuzumab|obinutuzumab|mesh-list
93282472|NCT04739813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282473|NCT04739813|Glucocorticoids|glucocorticoids|mesh-ancestor
93282474|NCT04739813|Hormones|hormones|mesh-ancestor
93282475|NCT04739813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282476|NCT04739813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282477|NCT04739813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282478|NCT04739813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282479|NCT04739813|Immunologic Factors|immunologic factors|mesh-ancestor
93282480|NCT04739813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92577101|NCT00266344|Gaboxadol|gaboxadol|mesh-list
93282481|NCT04739813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93282482|NCT04739813|Growth Substances|growth substances|mesh-ancestor
93282483|NCT04739813|Growth Inhibitors|growth inhibitors|mesh-ancestor
92006517|NCT03138031|Ethanol|ethanol|mesh-list
93282484|NCT04739813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282485|NCT04736199|Androgens|androgens|mesh-list
93282486|NCT04736199|Hormones|hormones|mesh-ancestor
93282487|NCT04736199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577107|NCT00266344|Sensory System Agents|sensory system agents|mesh-ancestor
93282488|NCT04736199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282489|NCT04728360|Ustekinumab|ustekinumab|mesh-list
93282490|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
93282491|NCT04717414|Luspatercept|luspatercept|mesh-list
93282492|NCT04717414|Hematinics|hematinics|mesh-ancestor
93282493|NCT04677049|Niacin|niacin|mesh-list
93282494|NCT04677049|Nicotinic Acids|nicotinic acids|mesh-list
93282495|NCT04677049|Vitamins|vitamins|mesh-ancestor
93282496|NCT04677049|Micronutrients|micronutrients|mesh-ancestor
93282497|NCT04677049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282498|NCT04677049|Vitamin B Complex|vitamin b complex|mesh-ancestor
93282499|NCT04677049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93282500|NCT04677049|Antimetabolites|antimetabolites|mesh-ancestor
93282501|NCT04677049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282502|NCT04677049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93282503|NCT04677049|Vasodilator Agents|vasodilator agents|mesh-ancestor
93282504|NCT04667234|Sotorasib|sotorasib|mesh-list
93282505|NCT04667234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282506|NCT04667234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282507|NCT04667234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282508|NCT04667234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282509|NCT04650854|Rozanolixizumab|rozanolixizumab|mesh-list
93282510|NCT04650854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282511|NCT04650854|Immunologic Factors|immunologic factors|mesh-ancestor
93282512|NCT04650854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282513|NCT04648969|Hormones|hormones|mesh-list
92577134|NCT00266578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93282514|NCT04648969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282515|NCT04648969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282516|NCT04644029|Tenofovir|tenofovir|mesh-list
93282517|NCT04644029|Emtricitabine|emtricitabine|mesh-list
92007112|NCT04536805|Metformin|metformin|mesh-list
93282518|NCT04644029|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93282519|NCT04644029|Islatravir|islatravir|mesh-list
93282520|NCT04644029|Antiviral Agents|antiviral agents|mesh-ancestor
93282521|NCT04644029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282522|NCT04644029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93282523|NCT04644029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93282524|NCT04644029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282525|NCT04644029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282526|NCT04644029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93282527|NCT04644029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93282528|NCT04633252|Prednisone|prednisone|mesh-list
93282529|NCT04633252|Docetaxel|docetaxel|mesh-list
93282530|NCT04633252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282531|NCT04633252|Tubulin Modulators|tubulin modulators|mesh-ancestor
93282532|NCT04633252|Antimitotic Agents|antimitotic agents|mesh-ancestor
93282533|NCT04633252|Mitosis Modulators|mitosis modulators|mesh-ancestor
93282534|NCT04633252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282535|NCT04633252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282536|NCT04633252|Glucocorticoids|glucocorticoids|mesh-ancestor
93282537|NCT04633252|Hormones|hormones|mesh-ancestor
93282538|NCT04633252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282539|NCT04633252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282540|NCT04633252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282541|NCT04626141|Abaloparatide|abaloparatide|mesh-list
93282542|NCT04626141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92577165|NCT00267319|(T,G)-A-L|(t,g)-a-l|mesh-list
93282543|NCT04626141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282544|NCT04562129|Aldesleukin|aldesleukin|mesh-list
93282545|NCT04562129|Nivolumab|nivolumab|mesh-list
93282546|NCT04562129|Ipilimumab|ipilimumab|mesh-list
93282547|NCT04562129|Interleukin-2|interleukin-2|mesh-list
92577172|NCT00073385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282548|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282549|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282550|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282551|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282552|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93282553|NCT04562129|Analgesics|analgesics|mesh-ancestor
93282554|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
93282555|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282556|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282557|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93282558|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93282559|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
93282560|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282561|NCT04545866|Budesonide|budesonide|mesh-list
93282562|NCT04545866|Poractant alfa|poractant alfa|mesh-list
93282563|NCT04545866|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93282564|NCT04545866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282565|NCT04545866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93282566|NCT04545866|Autonomic Agents|autonomic agents|mesh-ancestor
93282567|NCT04545866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282568|NCT04545866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282569|NCT04545866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93282570|NCT04545866|Respiratory System Agents|respiratory system agents|mesh-ancestor
93282571|NCT04545866|Glucocorticoids|glucocorticoids|mesh-ancestor
93282572|NCT04545866|Hormones|hormones|mesh-ancestor
93282573|NCT04545866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282574|NCT04528082|Apremilast|apremilast|mesh-list
93282575|NCT04528082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93282576|NCT04528082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93282577|NCT04528082|Analgesics|analgesics|mesh-ancestor
93282578|NCT04528082|Sensory System Agents|sensory system agents|mesh-ancestor
93282579|NCT04528082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954609|NCT05722015|Pemetrexed|pemetrexed|mesh-list
93282580|NCT04528082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282582|NCT04528082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282583|NCT04528082|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93282584|NCT04528082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93282585|NCT04528082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282586|NCT04528082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282587|NCT04526899|Cemiplimab|cemiplimab|mesh-list
93282588|NCT04526899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282589|NCT04526899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282590|NCT04524000|Fulvestrant|fulvestrant|mesh-list
93282591|NCT04524000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282592|NCT04524000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282593|NCT04524000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93282594|NCT04524000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93282595|NCT04524000|Hormone Antagonists|hormone antagonists|mesh-ancestor
93092437|NCT00051636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282596|NCT04524000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282597|NCT04524000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282598|NCT04502849|Vitamin E|vitamin e|mesh-list
93282599|NCT04502849|Tocopherols|tocopherols|mesh-list
93282600|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
93282601|NCT04502849|Vitamins|vitamins|mesh-ancestor
93282602|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
93282603|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282604|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
93282605|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282606|NCT04502849|Protective Agents|protective agents|mesh-ancestor
93282607|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93282608|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282609|NCT04417465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92577226|NCT00425620|Amebicides|amebicides|mesh-ancestor
93282610|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282611|NCT04407442|Dexamethasone|dexamethasone|mesh-list
93282612|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
93282613|NCT04407442|Azacitidine|azacitidine|mesh-list
93282614|NCT04407442|Daratumumab|daratumumab|mesh-list
93282615|NCT04407442|Ichthammol|ichthammol|mesh-list
93282616|NCT04407442|BB 1101|bb 1101|mesh-list
93282617|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282618|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
93282619|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
93282620|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282621|NCT04407442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282622|NCT04407442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282623|NCT04407442|Glucocorticoids|glucocorticoids|mesh-ancestor
93282624|NCT04407442|Hormones|hormones|mesh-ancestor
93282625|NCT04407442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282626|NCT04407442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092438|NCT01294826|Cetuximab|cetuximab|mesh-list
93282627|NCT04407442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282628|NCT04407442|Protease Inhibitors|protease inhibitors|mesh-ancestor
93282629|NCT04407442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282630|NCT04407442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282631|NCT04407442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93282632|NCT04407442|Antimetabolites|antimetabolites|mesh-ancestor
93282633|NCT04407442|Dermatologic Agents|dermatologic agents|mesh-ancestor
93282634|NCT04348448|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93282635|NCT04348448|Immunologic Factors|immunologic factors|mesh-ancestor
93282636|NCT04348448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282637|NCT04345796|Empagliflozin|empagliflozin|mesh-list
93282638|NCT04345796|Carvedilol|carvedilol|mesh-list
93282639|NCT04345796|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92659339|NCT04455139|Topotecan|topotecan|mesh-list
93282640|NCT04345796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282641|NCT04345796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93282642|NCT04345796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282643|NCT04345796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93282644|NCT04345796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93282645|NCT04345796|Adrenergic Agents|adrenergic agents|mesh-ancestor
93282646|NCT04345796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282647|NCT04345796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93282648|NCT04345796|Antioxidants|antioxidants|mesh-ancestor
93282649|NCT04345796|Protective Agents|protective agents|mesh-ancestor
93282650|NCT04345796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93282651|NCT04345796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93282652|NCT04345796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92954684|NCT05663866|Dermatologic Agents|dermatologic agents|mesh-ancestor
93282653|NCT04345796|Vasodilator Agents|vasodilator agents|mesh-ancestor
92577270|NCT00268177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93282654|NCT04345796|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93282655|NCT04345796|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93282656|NCT04265612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93282657|NCT04265612|Laxatives|laxatives|mesh-ancestor
92577275|NCT00268216|Xhance|xhance|mesh-list
93282658|NCT04265612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282659|NCT04222088|Lumefantrine|lumefantrine|mesh-list
93282660|NCT04222088|Chloroquine|chloroquine|mesh-list
93282661|NCT04222088|Primaquine|primaquine|mesh-list
93282662|NCT04222088|Antimalarials|antimalarials|mesh-ancestor
93282663|NCT04222088|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93282664|NCT04222088|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93282665|NCT04222088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282666|NCT04222088|Amebicides|amebicides|mesh-ancestor
93282667|NCT04222088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282668|NCT04217694|Memantine|memantine|mesh-list
93282669|NCT04217694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93282670|NCT04217694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93282671|NCT04217694|Dopamine Agents|dopamine agents|mesh-ancestor
93282672|NCT04217694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282673|NCT04217694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282674|NCT04217694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282675|NCT04217694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93282676|NCT04217694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93282677|NCT04209595|Rucaparib|rucaparib|mesh-list
93282678|NCT04209595|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93282679|NCT04209595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282680|NCT04209595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282681|NCT04209595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282682|NCT04198506|Tacrolimus|tacrolimus|mesh-list
93282683|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282684|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
93282685|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282686|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93282687|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282688|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282689|NCT04192981|GDC-0084|gdc-0084|mesh-list
93282690|NCT04192981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282691|NCT04192981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282692|NCT04165317|BCG Vaccine|bcg vaccine|mesh-list
93282693|NCT04165317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93282694|NCT04165317|Immunologic Factors|immunologic factors|mesh-ancestor
93282695|NCT04165317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282696|NCT04137107|Oxaliplatin|oxaliplatin|mesh-list
91984657|NCT05515601|Mirikizumab|mirikizumab|mesh-list
93282697|NCT04137107|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93282698|NCT04137107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282699|NCT04137107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93282700|NCT04137107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93282701|NCT04137107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93282702|NCT04137107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282703|NCT04137107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93282704|NCT04137107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282705|NCT04137107|Analgesics|analgesics|mesh-ancestor
93282706|NCT04137107|Sensory System Agents|sensory system agents|mesh-ancestor
93282707|NCT04137107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282708|NCT04137107|Antidepressive Agents|antidepressive agents|mesh-ancestor
93282709|NCT04137107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93282710|NCT04137107|Dopamine Agents|dopamine agents|mesh-ancestor
93282711|NCT04053634|Benralizumab|benralizumab|mesh-list
92577314|NCT00073658|Dopamine Agents|dopamine agents|mesh-ancestor
93282712|NCT04053634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93282713|NCT04053634|Respiratory System Agents|respiratory system agents|mesh-ancestor
93282714|NCT04029480|Metformin|metformin|mesh-list
93282715|NCT04029480|Ertugliflozin|ertugliflozin|mesh-list
93282716|NCT04029480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93282717|NCT04029480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282718|NCT04029480|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93282719|NCT04029480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282720|NCT04026113|Linaclotide|linaclotide|mesh-list
93282721|NCT04026113|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93282722|NCT04026113|Enzyme Activators|enzyme activators|mesh-ancestor
93092439|NCT01294826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282723|NCT04026113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282724|NCT04026113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282725|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93282726|NCT04021043|Nivolumab|nivolumab|mesh-list
93282727|NCT04021043|Ipilimumab|ipilimumab|mesh-list
93282728|NCT04021043|Antibodies|antibodies|mesh-list
93282729|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
93282730|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93282731|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
93282732|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577347|NCT00268333|Vitamins|vitamins|mesh-ancestor
93282733|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282734|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282735|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282736|NCT04015180|Aflibercept|aflibercept|mesh-list
93282737|NCT04015180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93282738|NCT04015180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93282739|NCT04015180|Growth Substances|growth substances|mesh-ancestor
92011074|NCT05304169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93282740|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282741|NCT04015180|Growth Inhibitors|growth inhibitors|mesh-ancestor
93282742|NCT04015180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282743|NCT03981614|Trifluridine|trifluridine|mesh-list
93282744|NCT03981614|Palbociclib|palbociclib|mesh-list
93282745|NCT03981614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282746|NCT03981614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282747|NCT03981614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282748|NCT03981614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282749|NCT03981614|Antimetabolites|antimetabolites|mesh-ancestor
93282750|NCT03981614|Antiviral Agents|antiviral agents|mesh-ancestor
93282751|NCT03981614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282752|NCT03978520|Upadacitinib|upadacitinib|mesh-list
93282753|NCT03978520|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93282754|NCT03978520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282755|NCT03978520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282756|NCT03978520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661508|NCT02272582|Heparin|heparin|mesh-list
93282757|NCT03978520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282758|NCT03941743|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93282759|NCT03941743|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92577369|NCT00073697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93282760|NCT03941743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282761|NCT03941743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282762|NCT03941743|Immunologic Factors|immunologic factors|mesh-ancestor
92577374|NCT00268372|Antimitotic Agents|antimitotic agents|mesh-ancestor
93282763|NCT03941743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282764|NCT03899155|Nivolumab|nivolumab|mesh-list
93282765|NCT03899155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282766|NCT03899155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661814|NCT02961101|Decitabine|decitabine|mesh-list
93282767|NCT03899155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282768|NCT03899155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282769|NCT03896685|Linezolid|linezolid|mesh-list
93282770|NCT03896685|Bedaquiline|bedaquiline|mesh-list
93282771|NCT03896685|Clofazimine|clofazimine|mesh-list
93282772|NCT03896685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93282773|NCT03896685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282774|NCT03896685|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92577383|NCT00268411|Oxaliplatin|oxaliplatin|mesh-list
93282775|NCT03896685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282776|NCT03896685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282777|NCT03896685|Antitubercular Agents|antitubercular agents|mesh-ancestor
93282778|NCT03896685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282779|NCT03896685|Leprostatic Agents|leprostatic agents|mesh-ancestor
93282780|NCT03874715|Insulin|insulin|mesh-list
93282781|NCT03874715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93282782|NCT03874715|Insulin Glargine|insulin glargine|mesh-list
93282783|NCT03874715|Insulin Aspart|insulin aspart|mesh-list
93282784|NCT03874715|Insulin, Long-Acting|insulin, long-acting|mesh-list
93282785|NCT03874715|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93282786|NCT03874715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93282787|NCT03874715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282788|NCT03869996|Cytarabine|cytarabine|mesh-list
93282789|NCT03869996|Methotrexate|methotrexate|mesh-list
93282790|NCT03869996|Etoposide|etoposide|mesh-list
93282791|NCT03869996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93282792|NCT03869996|Antimetabolites|antimetabolites|mesh-ancestor
93282793|NCT03869996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282794|NCT03869996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282795|NCT03869996|Antiviral Agents|antiviral agents|mesh-ancestor
93282796|NCT03869996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282797|NCT03869996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282798|NCT03869996|Immunologic Factors|immunologic factors|mesh-ancestor
93282799|NCT03869996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282800|NCT03869996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93282801|NCT03869996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93282802|NCT03869996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93282803|NCT03869996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577406|NCT00268489|Growth Inhibitors|growth inhibitors|mesh-ancestor
93282804|NCT03869996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93282805|NCT03869996|Abortifacient Agents|abortifacient agents|mesh-ancestor
93282806|NCT03869996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93282807|NCT03869996|Dermatologic Agents|dermatologic agents|mesh-ancestor
93282808|NCT03869996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93282809|NCT03869996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282810|NCT03869996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93282811|NCT03832998|Erenumab|erenumab|mesh-list
93282812|NCT03832998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93092440|NCT01294826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282813|NCT03832998|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93282814|NCT03832998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282815|NCT03832998|Analgesics|analgesics|mesh-ancestor
93282816|NCT03832998|Sensory System Agents|sensory system agents|mesh-ancestor
93282817|NCT03832998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282818|NCT03832998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282819|NCT03832998|Immunologic Factors|immunologic factors|mesh-ancestor
93282820|NCT03819049|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93282821|NCT03819049|Immunologic Factors|immunologic factors|mesh-ancestor
93282822|NCT03819049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282823|NCT03801863|Ropivacaine|ropivacaine|mesh-list
93282824|NCT03801863|Anesthetics, Local|anesthetics, local|mesh-ancestor
93282825|NCT03801863|Anesthetics|anesthetics|mesh-ancestor
93282826|NCT03801863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282827|NCT03801863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282828|NCT03801863|Sensory System Agents|sensory system agents|mesh-ancestor
93282829|NCT03801863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282830|NCT03794999|Benralizumab|benralizumab|mesh-list
93282831|NCT03794999|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93282832|NCT03794999|Respiratory System Agents|respiratory system agents|mesh-ancestor
93282833|NCT03748641|Prednisone|prednisone|mesh-list
93282834|NCT03748641|Abiraterone Acetate|abiraterone acetate|mesh-list
93282835|NCT03748641|Niraparib|niraparib|mesh-list
93282836|NCT03748641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282837|NCT03748641|Glucocorticoids|glucocorticoids|mesh-ancestor
93282838|NCT03748641|Hormones|hormones|mesh-ancestor
93282839|NCT03748641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282840|NCT03748641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282841|NCT03748641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282842|NCT03748641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282843|NCT03748641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93282844|NCT03748641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663050|NCT00293475|Diuretics|diuretics|mesh-ancestor
93282845|NCT03748641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282846|NCT03748641|Hormone Antagonists|hormone antagonists|mesh-ancestor
93282847|NCT03748641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93282848|NCT03748641|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93282849|NCT03724747|BAY 2315497|bay 2315497|mesh-list
93282850|NCT03724747|Immunoconjugates|immunoconjugates|mesh-ancestor
93282851|NCT03724747|Immunologic Factors|immunologic factors|mesh-ancestor
93282852|NCT03724747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282853|NCT03718767|Nivolumab|nivolumab|mesh-list
93282854|NCT03718767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282855|NCT03718767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282856|NCT03718767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282857|NCT03718767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282858|NCT03692065|Apixaban|apixaban|mesh-list
93282859|NCT03692065|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93282860|NCT03692065|Antithrombins|antithrombins|mesh-ancestor
93282861|NCT03692065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93282862|NCT03692065|Protease Inhibitors|protease inhibitors|mesh-ancestor
93282863|NCT03692065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282864|NCT03692065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282865|NCT03692065|Anticoagulants|anticoagulants|mesh-ancestor
93282866|NCT03664037|Dexamethasone|dexamethasone|mesh-list
93282867|NCT03664037|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93282868|NCT03664037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282869|NCT03664037|Antiemetics|antiemetics|mesh-ancestor
93282870|NCT03664037|Autonomic Agents|autonomic agents|mesh-ancestor
93282871|NCT03664037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282872|NCT03664037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282873|NCT03664037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282874|NCT03664037|Glucocorticoids|glucocorticoids|mesh-ancestor
93282875|NCT03664037|Hormones|hormones|mesh-ancestor
93282876|NCT03664037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282877|NCT03664037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282878|NCT03664037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282879|NCT03652064|Dexamethasone|dexamethasone|mesh-list
93282880|NCT03652064|Lenalidomide|lenalidomide|mesh-list
93282881|NCT03652064|Bortezomib|bortezomib|mesh-list
93282882|NCT03652064|Daratumumab|daratumumab|mesh-list
92663757|NCT00301002|Alefacept|alefacept|mesh-list
93282883|NCT03652064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282884|NCT03652064|Antiemetics|antiemetics|mesh-ancestor
93282885|NCT03652064|Autonomic Agents|autonomic agents|mesh-ancestor
93282886|NCT03652064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092441|NCT03847922|Lidocaine|lidocaine|mesh-list
93282887|NCT03652064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282888|NCT03652064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282889|NCT03652064|Glucocorticoids|glucocorticoids|mesh-ancestor
93282890|NCT03652064|Hormones|hormones|mesh-ancestor
93282891|NCT03652064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282892|NCT03652064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282893|NCT03652064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282894|NCT03652064|Immunologic Factors|immunologic factors|mesh-ancestor
92020912|NCT02408523|Lacosamide|lacosamide|mesh-list
93282895|NCT03652064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93282896|NCT03652064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93282897|NCT03652064|Growth Substances|growth substances|mesh-ancestor
93282898|NCT03652064|Growth Inhibitors|growth inhibitors|mesh-ancestor
93282899|NCT03596645|Infliximab|infliximab|mesh-list
93282900|NCT03596645|Golimumab|golimumab|mesh-list
93092442|NCT03847922|Nitrous Oxide|nitrous oxide|mesh-list
93282901|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93282902|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282903|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
93092443|NCT03847922|Anesthetics, Local|anesthetics, local|mesh-ancestor
93282904|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282905|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282906|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282907|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
93282908|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282909|NCT03593473|Oxytocin|oxytocin|mesh-list
93282910|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
93282911|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93282912|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282913|NCT03581487|Durvalumab|durvalumab|mesh-list
93282914|NCT03581487|Ipilimumab|ipilimumab|mesh-list
93282915|NCT03581487|Tremelimumab|tremelimumab|mesh-list
93282916|NCT03581487|Immunoglobulins|immunoglobulins|mesh-list
93282917|NCT03581487|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93282918|NCT03581487|Immunoglobulin G|immunoglobulin g|mesh-list
93282919|NCT03581487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92577512|NCT00268840|Gemcitabine|gemcitabine|mesh-list
93282920|NCT03581487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282921|NCT03581487|Immunologic Factors|immunologic factors|mesh-ancestor
93282922|NCT03581487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282923|NCT03581487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282924|NCT03581487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282925|NCT03576547|Dexamethasone|dexamethasone|mesh-list
93282926|NCT03576547|Dexamethasone acetate|dexamethasone acetate|mesh-list
93282927|NCT03576547|Rituximab|rituximab|mesh-list
93282928|NCT03576547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93282929|NCT03576547|Venetoclax|venetoclax|mesh-list
93282930|NCT03576547|Ponatinib|ponatinib|mesh-list
93282931|NCT03576547|Antibodies|antibodies|mesh-list
93282932|NCT03576547|Immunoglobulins|immunoglobulins|mesh-list
93282933|NCT03576547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93282934|NCT03576547|BB 1101|bb 1101|mesh-list
93282935|NCT03576547|Immunologic Factors|immunologic factors|mesh-ancestor
93282936|NCT03576547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282937|NCT03576547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282938|NCT03576547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93282939|NCT03576547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93282940|NCT03576547|Antiemetics|antiemetics|mesh-ancestor
93282941|NCT03576547|Autonomic Agents|autonomic agents|mesh-ancestor
93282942|NCT03576547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577536|NCT00268957|Sevelamer|sevelamer|mesh-list
93282943|NCT03576547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93282944|NCT03576547|Glucocorticoids|glucocorticoids|mesh-ancestor
93282945|NCT03576547|Hormones|hormones|mesh-ancestor
93282946|NCT03576547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93282947|NCT03576547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93282948|NCT03576547|Protease Inhibitors|protease inhibitors|mesh-ancestor
93282949|NCT03576547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282950|NCT03576547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282951|NCT03576547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282952|NCT03547973|Carboplatin|carboplatin|mesh-list
93282953|NCT03547973|Gemcitabine|gemcitabine|mesh-list
93282954|NCT03547973|Pembrolizumab|pembrolizumab|mesh-list
93282955|NCT03547973|Avelumab|avelumab|mesh-list
93282956|NCT03547973|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93282957|NCT03547973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282958|NCT03547973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93282959|NCT03547973|Antimetabolites|antimetabolites|mesh-ancestor
93092444|NCT03847922|Anesthetics|anesthetics|mesh-ancestor
93282960|NCT03547973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282961|NCT03547973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93282962|NCT03547973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93282963|NCT03547973|Immunoconjugates|immunoconjugates|mesh-ancestor
93282964|NCT03547973|Immunologic Factors|immunologic factors|mesh-ancestor
93282965|NCT03547973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282967|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93282968|NCT03538457|Analgesics|analgesics|mesh-ancestor
93282969|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
93282970|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93282971|NCT03538457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665379|NCT00418704|Docetaxel|docetaxel|mesh-list
93282972|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
93282973|NCT03535376|Valsartan|valsartan|mesh-list
93282974|NCT03535376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93282975|NCT03535376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93282976|NCT03535376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92665456|NCT00273455|Timolol|timolol|mesh-list
93282977|NCT03535376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282978|NCT03521154|Osimertinib|osimertinib|mesh-list
93282979|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93282980|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93282981|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282982|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092445|NCT03847922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93282983|NCT03493945|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92665586|NCT00308451|Chromium|chromium|mesh-list
93282984|NCT03493945|Antiviral Agents|antiviral agents|mesh-ancestor
93282985|NCT03493945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93282986|NCT03492177|Selexipag|selexipag|mesh-list
93282987|NCT03492177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665753|NCT00308763|Bupropion|bupropion|mesh-list
93282988|NCT03485677|Eliglustat|eliglustat|mesh-list
93282989|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93282990|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282991|NCT03440385|Ozanimod|ozanimod|mesh-list
93282992|NCT03440385|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92577585|NCT00074087|Doxorubicin|doxorubicin|mesh-list
93282993|NCT03440385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93282994|NCT03440385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93282995|NCT03440385|Immunologic Factors|immunologic factors|mesh-ancestor
93282996|NCT03440385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93282997|NCT03436745|Zolpidem|zolpidem|mesh-list
93282998|NCT03436745|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93282999|NCT03436745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93283000|NCT03436745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93283001|NCT03436745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283002|NCT03436745|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92577593|NCT00269542|Iron|iron|mesh-list
93283003|NCT03436745|GABA Agonists|gaba agonists|mesh-ancestor
93283004|NCT03436745|GABA Agents|gaba agents|mesh-ancestor
93283005|NCT03436745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283006|NCT03436745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283007|NCT03414502|Hydroxychloroquine|hydroxychloroquine|mesh-list
93283008|NCT03414502|Minocycline|minocycline|mesh-list
93283009|NCT03414502|Sulfasalazine|sulfasalazine|mesh-list
93283010|NCT03414502|Adalimumab|adalimumab|mesh-list
93283011|NCT03414502|Infliximab|infliximab|mesh-list
93283012|NCT03414502|Golimumab|golimumab|mesh-list
93283013|NCT03414502|Certolizumab Pegol|certolizumab pegol|mesh-list
93283014|NCT03414502|Etanercept|etanercept|mesh-list
93283015|NCT03414502|Rituximab|rituximab|mesh-list
93283016|NCT03414502|Abatacept|abatacept|mesh-list
93283017|NCT03414502|Methotrexate|methotrexate|mesh-list
93283018|NCT03414502|Azathioprine|azathioprine|mesh-list
93283019|NCT03414502|Leflunomide|leflunomide|mesh-list
93283020|NCT03414502|Tofacitinib|tofacitinib|mesh-list
93283021|NCT03414502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283022|NCT03414502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283023|NCT03414502|Immunologic Factors|immunologic factors|mesh-ancestor
93283024|NCT03414502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283025|NCT03414502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283026|NCT03414502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93283027|NCT03414502|Abortifacient Agents|abortifacient agents|mesh-ancestor
93283028|NCT03414502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92666658|NCT00416897|Hormones|hormones|mesh-ancestor
93283029|NCT03414502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283030|NCT03414502|Antimetabolites|antimetabolites|mesh-ancestor
93283031|NCT03414502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283032|NCT03414502|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283033|NCT03414502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283034|NCT03414502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283035|NCT03414502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283036|NCT03414502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283037|NCT03414502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93283038|NCT03414502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283039|NCT03414502|Antimalarials|antimalarials|mesh-ancestor
93283040|NCT03414502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93283041|NCT03414502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93283042|NCT03414502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283043|NCT03414502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283044|NCT03414502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93283045|NCT03414502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93283046|NCT03414502|Analgesics|analgesics|mesh-ancestor
92666994|NCT00318552|Meropenem|meropenem|mesh-list
93283047|NCT03414502|Sensory System Agents|sensory system agents|mesh-ancestor
93283048|NCT03414502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283049|NCT03414502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93283050|NCT03414502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283051|NCT03414502|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93283052|NCT03414502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283053|NCT03402945|Vancomycin|vancomycin|mesh-list
93283054|NCT03402945|Cefazolin|cefazolin|mesh-list
93283055|NCT03402945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93283056|NCT03402945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283057|NCT03399981|Natalizumab|natalizumab|mesh-list
93283058|NCT03399981|Immunologic Factors|immunologic factors|mesh-ancestor
93283059|NCT03399981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283060|NCT03391973|Pembrolizumab|pembrolizumab|mesh-list
93283061|NCT03391973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283062|NCT03391973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283063|NCT03391973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283064|NCT03391973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283065|NCT03381183|Durvalumab|durvalumab|mesh-list
92577648|NCT00269737|Fentanyl|fentanyl|mesh-list
93283066|NCT03381183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283067|NCT03381183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283068|NCT03361306|Elotuzumab|elotuzumab|mesh-list
93283069|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283070|NCT03336242|Cannabidiol|cannabidiol|mesh-list
93283071|NCT03336242|Anticonvulsants|anticonvulsants|mesh-ancestor
93283072|NCT03333395|Heparin|heparin|mesh-list
93283073|NCT03333395|Albuterol|albuterol|mesh-list
93283074|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
93283075|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93283076|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93283077|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283078|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93283079|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
93283080|NCT03333395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283081|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283082|NCT03333395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93283083|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
93283084|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
93283085|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93283086|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93283087|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93283088|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93283089|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
93283090|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283091|NCT03328104|Cyclophosphamide|cyclophosphamide|mesh-list
93283092|NCT03328104|Etoposide|etoposide|mesh-list
93283093|NCT03328104|Everolimus|everolimus|mesh-list
93283094|NCT03328104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283095|NCT03328104|Immunologic Factors|immunologic factors|mesh-ancestor
93283096|NCT03328104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283097|NCT03328104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283098|NCT03328104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283099|NCT03328104|Alkylating Agents|alkylating agents|mesh-ancestor
93283100|NCT03328104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283101|NCT03328104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984971|NCT05676749|Aldesleukin|aldesleukin|mesh-list
93283102|NCT03328104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283103|NCT03328104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283104|NCT03328104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92955134|NCT05328297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283105|NCT03328104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283106|NCT03328104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283107|NCT03328104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93283108|NCT03328104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283109|NCT03274258|Nivolumab|nivolumab|mesh-list
93283110|NCT03274258|Ipilimumab|ipilimumab|mesh-list
93283111|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283112|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283113|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283114|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283115|NCT03255174|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93283116|NCT03255174|Hemostatics|hemostatics|mesh-ancestor
93283117|NCT03255174|Coagulants|coagulants|mesh-ancestor
93283118|NCT03232073|Ponesimod|ponesimod|mesh-list
93283119|NCT03232073|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93283120|NCT03232073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283121|NCT03232073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283122|NCT03232073|Immunologic Factors|immunologic factors|mesh-ancestor
92577704|NCT00102609|Dexamethasone|dexamethasone|mesh-list
93283123|NCT03232073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283124|NCT03201965|Dexamethasone|dexamethasone|mesh-list
93283125|NCT03201965|Cyclophosphamide|cyclophosphamide|mesh-list
93283126|NCT03201965|Bortezomib|bortezomib|mesh-list
93283127|NCT03201965|Daratumumab|daratumumab|mesh-list
93283128|NCT03201965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283129|NCT03201965|Immunologic Factors|immunologic factors|mesh-ancestor
93283130|NCT03201965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283131|NCT03201965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283132|NCT03201965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283133|NCT03201965|Alkylating Agents|alkylating agents|mesh-ancestor
93283134|NCT03201965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283135|NCT03201965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668736|NCT00292214|Acetaminophen|acetaminophen|mesh-list
93283136|NCT03201965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283137|NCT03201965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283138|NCT03201965|Antiemetics|antiemetics|mesh-ancestor
93283139|NCT03201965|Autonomic Agents|autonomic agents|mesh-ancestor
93283140|NCT03201965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283141|NCT03201965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283142|NCT03201965|Glucocorticoids|glucocorticoids|mesh-ancestor
93283143|NCT03201965|Hormones|hormones|mesh-ancestor
93092446|NCT03847922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283144|NCT03201965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283145|NCT03201965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283146|NCT03179904|Paclitaxel|paclitaxel|mesh-list
93283147|NCT03179904|Trastuzumab|trastuzumab|mesh-list
93283148|NCT03179904|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93283149|NCT03179904|Letrozole|letrozole|mesh-list
93283150|NCT03179904|Fulvestrant|fulvestrant|mesh-list
93283151|NCT03179904|Anastrozole|anastrozole|mesh-list
93283152|NCT03179904|Exemestane|exemestane|mesh-list
93283153|NCT03179904|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93283154|NCT03179904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93283155|NCT03179904|Antibodies|antibodies|mesh-list
93283156|NCT03179904|Immunoglobulins|immunoglobulins|mesh-list
93283157|NCT03179904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93283158|NCT03179904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283159|NCT03179904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283160|NCT03179904|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283161|NCT03179904|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283162|NCT03179904|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283163|NCT03179904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283164|NCT03179904|Immunologic Factors|immunologic factors|mesh-ancestor
93283165|NCT03179904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283166|NCT03179904|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93283167|NCT03179904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93283168|NCT03179904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283169|NCT03179904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93283170|NCT03179904|Hormone Antagonists|hormone antagonists|mesh-ancestor
93283171|NCT03179904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283172|NCT03179904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283173|NCT03179904|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93283174|NCT03161522|Fluorouracil|fluorouracil|mesh-list
93283175|NCT03161522|Capecitabine|capecitabine|mesh-list
93283176|NCT03161522|Antimetabolites|antimetabolites|mesh-ancestor
92577753|NCT00107016|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93283177|NCT03161522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283178|NCT03161522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283179|NCT03161522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283180|NCT03161522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283181|NCT03161522|Immunologic Factors|immunologic factors|mesh-ancestor
92577759|NCT00270127|Epoetin Alfa|epoetin alfa|mesh-list
93283182|NCT03161522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283183|NCT03143153|Fluorouracil|fluorouracil|mesh-list
93283185|NCT03143153|Ipilimumab|ipilimumab|mesh-list
93283186|NCT03143153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283187|NCT03143153|Antimetabolites|antimetabolites|mesh-ancestor
93283188|NCT03143153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283189|NCT03143153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283190|NCT03143153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577768|NCT00074399|Antiviral Agents|antiviral agents|mesh-ancestor
93283191|NCT03143153|Immunologic Factors|immunologic factors|mesh-ancestor
93283192|NCT03143153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283193|NCT03143153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283194|NCT03143153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283195|NCT03137771|Gemcitabine|gemcitabine|mesh-list
93283196|NCT03137771|Docetaxel|docetaxel|mesh-list
93283197|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
93283198|NCT03137771|Pemetrexed|pemetrexed|mesh-list
93283199|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92577775|NCT00270283|Hematinics|hematinics|mesh-ancestor
93283200|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283201|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
93283202|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283203|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283204|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283205|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283206|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283207|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670178|NCT00301730|Paclitaxel|paclitaxel|mesh-list
93283208|NCT03137771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283209|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283210|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92670265|NCT00301925|Epirubicin|epirubicin|mesh-list
93283211|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283212|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283213|NCT03033225|Verteporfin|verteporfin|mesh-list
93283214|NCT03033225|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93283215|NCT03033225|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283216|NCT03013218|Paclitaxel|paclitaxel|mesh-list
93283217|NCT03013218|Rituximab|rituximab|mesh-list
93283218|NCT03013218|Pembrolizumab|pembrolizumab|mesh-list
93283219|NCT03013218|Trastuzumab|trastuzumab|mesh-list
93283220|NCT03013218|Ramucirumab|ramucirumab|mesh-list
93283221|NCT03013218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283222|NCT03013218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283223|NCT03013218|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283224|NCT03013218|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283225|NCT03013218|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283226|NCT03013218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283227|NCT03013218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283228|NCT03013218|Immunologic Factors|immunologic factors|mesh-ancestor
93283229|NCT03013218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283230|NCT03013218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283231|NCT03013218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283232|NCT02998528|Paclitaxel|paclitaxel|mesh-list
93283233|NCT02998528|Vinorelbine|vinorelbine|mesh-list
93283234|NCT02998528|Docetaxel|docetaxel|mesh-list
93283235|NCT02998528|Carboplatin|carboplatin|mesh-list
93283236|NCT02998528|Gemcitabine|gemcitabine|mesh-list
93283237|NCT02998528|Nivolumab|nivolumab|mesh-list
93283238|NCT02998528|Pemetrexed|pemetrexed|mesh-list
93283239|NCT02998528|Ipilimumab|ipilimumab|mesh-list
93283240|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283241|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283242|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283243|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283244|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283245|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283246|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283247|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
93283248|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283249|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92670951|NCT00333021|PENTA|penta|mesh-list
93283250|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283251|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283252|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283253|NCT02960022|Prednisone|prednisone|mesh-list
93283254|NCT02960022|Abiraterone Acetate|abiraterone acetate|mesh-list
93283255|NCT02960022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283256|NCT02960022|Glucocorticoids|glucocorticoids|mesh-ancestor
93283257|NCT02960022|Hormones|hormones|mesh-ancestor
93283258|NCT02960022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283259|NCT02960022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283260|NCT02960022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283261|NCT02960022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283262|NCT02960022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93283263|NCT02960022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283264|NCT02960022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283265|NCT02960022|Hormone Antagonists|hormone antagonists|mesh-ancestor
93283266|NCT02960022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93283267|NCT02955758|Pembrolizumab|pembrolizumab|mesh-list
93283268|NCT02955758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283269|NCT02955758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283270|NCT02955758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283271|NCT02955758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283272|NCT02919449|Atezolizumab|atezolizumab|mesh-list
93283273|NCT02919449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283274|NCT02919449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283275|NCT02919449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283276|NCT02919449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283277|NCT02913482|Risdiplam|risdiplam|mesh-list
93283278|NCT02913482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93283279|NCT02913482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283280|NCT02913482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283281|NCT02904291|Amlodipine|amlodipine|mesh-list
93283282|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93283283|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93283284|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93283285|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283286|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93283287|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283288|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
93283289|NCT02891824|Bevacizumab|bevacizumab|mesh-list
93283290|NCT02891824|Atezolizumab|atezolizumab|mesh-list
93283291|NCT02891824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283292|NCT02891824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283293|NCT02891824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283294|NCT02891824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283295|NCT02891824|Growth Substances|growth substances|mesh-ancestor
93283296|NCT02891824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283297|NCT02891824|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283298|NCT02891824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283299|NCT02891824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283300|NCT02854436|Niraparib|niraparib|mesh-list
93283301|NCT02854436|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93283302|NCT02854436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283303|NCT02854436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283304|NCT02854436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283305|NCT02796859|Siltuximab|siltuximab|mesh-list
93283306|NCT02796859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283307|NCT02769832|Paclitaxel|paclitaxel|mesh-list
93283308|NCT02769832|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93283309|NCT02769832|Gemcitabine|gemcitabine|mesh-list
93283310|NCT02769832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283311|NCT02769832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283312|NCT02769832|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283313|NCT02769832|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283314|NCT02769832|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283315|NCT02769832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283316|NCT02769832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283317|NCT02769832|Antimetabolites|antimetabolites|mesh-ancestor
93283318|NCT02759419|Riociguat|riociguat|mesh-list
93283319|NCT02759419|Enzyme Activators|enzyme activators|mesh-ancestor
93283320|NCT02759419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283321|NCT02743494|Nivolumab|nivolumab|mesh-list
93283322|NCT02743494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283323|NCT02743494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283324|NCT02743494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93283325|NCT02743494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283326|NCT02723994|Leucovorin|leucovorin|mesh-list
93283327|NCT02723994|Cytarabine|cytarabine|mesh-list
93283328|NCT02723994|Dexamethasone|dexamethasone|mesh-list
93283329|NCT02723994|Prednisone|prednisone|mesh-list
93283330|NCT02723994|Cyclophosphamide|cyclophosphamide|mesh-list
93283331|NCT02723994|Doxorubicin|doxorubicin|mesh-list
92671488|NCT00334464|Warfarin|warfarin|mesh-list
93283332|NCT02723994|Methotrexate|methotrexate|mesh-list
93283333|NCT02723994|Vincristine|vincristine|mesh-list
93283334|NCT02723994|Asparaginase|asparaginase|mesh-list
93283335|NCT02723994|Mercaptopurine|mercaptopurine|mesh-list
93283336|NCT02723994|Pegaspargase|pegaspargase|mesh-list
93283337|NCT02723994|Thioguanine|thioguanine|mesh-list
93283338|NCT02723994|Levoleucovorin|levoleucovorin|mesh-list
93283339|NCT02723994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283340|NCT02723994|Immunologic Factors|immunologic factors|mesh-ancestor
93283341|NCT02723994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283342|NCT02723994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283343|NCT02723994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283344|NCT02723994|Alkylating Agents|alkylating agents|mesh-ancestor
93283345|NCT02723994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283346|NCT02723994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283347|NCT02723994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283348|NCT02723994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283349|NCT02723994|Antiemetics|antiemetics|mesh-ancestor
93283350|NCT02723994|Autonomic Agents|autonomic agents|mesh-ancestor
93283351|NCT02723994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283352|NCT02723994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283353|NCT02723994|Glucocorticoids|glucocorticoids|mesh-ancestor
93283354|NCT02723994|Hormones|hormones|mesh-ancestor
92671750|NCT00336219|Pantoprazole|pantoprazole|mesh-list
93283355|NCT02723994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283356|NCT02723994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283357|NCT02723994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93283358|NCT02723994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93283359|NCT02723994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283360|NCT02723994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283361|NCT02723994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93283362|NCT02723994|Abortifacient Agents|abortifacient agents|mesh-ancestor
93283363|NCT02723994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93283364|NCT02723994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283365|NCT02723994|Antimetabolites|antimetabolites|mesh-ancestor
93283366|NCT02723994|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283367|NCT02723994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283368|NCT02723994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283369|NCT02723994|Antiviral Agents|antiviral agents|mesh-ancestor
93283370|NCT02723994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283371|NCT02723994|Antidotes|antidotes|mesh-ancestor
93283372|NCT02723994|Protective Agents|protective agents|mesh-ancestor
93283373|NCT02723994|Vitamin B Complex|vitamin b complex|mesh-ancestor
93283374|NCT02723994|Vitamins|vitamins|mesh-ancestor
93283375|NCT02723994|Micronutrients|micronutrients|mesh-ancestor
93283376|NCT02723994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92577945|NCT00271414|Analgesics|analgesics|mesh-ancestor
93283377|NCT02723994|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283378|NCT02723994|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283379|NCT02723994|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283380|NCT02706704|Adalimumab|adalimumab|mesh-list
93283381|NCT02706704|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93283382|NCT02706704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283383|NCT02706704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283384|NCT02697227|Nicotine|nicotine|mesh-list
93283385|NCT02697227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93283386|NCT02697227|Autonomic Agents|autonomic agents|mesh-ancestor
93283387|NCT02697227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283388|NCT02697227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283389|NCT02697227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93283390|NCT02697227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93283391|NCT02697227|Cholinergic Agents|cholinergic agents|mesh-ancestor
93283392|NCT02697227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283393|NCT02697227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283394|NCT02684006|Sunitinib|sunitinib|mesh-list
93283395|NCT02684006|Avelumab|avelumab|mesh-list
93283396|NCT02684006|Axitinib|axitinib|mesh-list
93283397|NCT02684006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283398|NCT02684006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283399|NCT02684006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283400|NCT02684006|Growth Substances|growth substances|mesh-ancestor
93283401|NCT02684006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283402|NCT02684006|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283403|NCT02684006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283404|NCT02684006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283405|NCT02684006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283406|NCT02684006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283407|NCT02547662|Dexamethasone|dexamethasone|mesh-list
93283408|NCT02547662|Dexamethasone acetate|dexamethasone acetate|mesh-list
93283409|NCT02547662|Pomalidomide|pomalidomide|mesh-list
93283410|NCT02547662|Ixazomib|ixazomib|mesh-list
93283411|NCT02547662|Ichthammol|ichthammol|mesh-list
93283412|NCT02547662|BB 1101|bb 1101|mesh-list
93283413|NCT02547662|Glycine|glycine|mesh-list
93283414|NCT02547662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283415|NCT02547662|Antiemetics|antiemetics|mesh-ancestor
93283416|NCT02547662|Autonomic Agents|autonomic agents|mesh-ancestor
93283417|NCT02547662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283418|NCT02547662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283419|NCT02547662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283420|NCT02547662|Glucocorticoids|glucocorticoids|mesh-ancestor
93283421|NCT02547662|Hormones|hormones|mesh-ancestor
92577990|NCT00272428|Selenium|selenium|mesh-list
93283422|NCT02547662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283423|NCT02547662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283424|NCT02547662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283425|NCT02547662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283426|NCT02547662|Protease Inhibitors|protease inhibitors|mesh-ancestor
93283427|NCT02547662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283428|NCT02547662|Immunologic Factors|immunologic factors|mesh-ancestor
93283429|NCT02547662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283430|NCT02547662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283431|NCT02547662|Growth Substances|growth substances|mesh-ancestor
93283432|NCT02547662|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283433|NCT02547662|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283434|NCT02547662|Glycine Agents|glycine agents|mesh-ancestor
93283435|NCT02547662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283436|NCT02489318|Androgens|androgens|mesh-list
93283437|NCT02489318|Hormones|hormones|mesh-ancestor
93283438|NCT02489318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578007|NCT00272467|Antioxidants|antioxidants|mesh-ancestor
93283439|NCT02489318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283440|NCT02326311|Imatinib Mesylate|imatinib mesylate|mesh-list
93283441|NCT02326311|Dasatinib|dasatinib|mesh-list
93283442|NCT02326311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283443|NCT02326311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283444|NCT02326311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283445|NCT02326311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283446|NCT02324543|Gemcitabine|gemcitabine|mesh-list
93283447|NCT02324543|Docetaxel|docetaxel|mesh-list
93283448|NCT02324543|Capecitabine|capecitabine|mesh-list
93283449|NCT02324543|Irinotecan|irinotecan|mesh-list
92673200|NCT00348387|Vaccines|vaccines|mesh-list
93283450|NCT02324543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283451|NCT02324543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283452|NCT02324543|Antimetabolites|antimetabolites|mesh-ancestor
93283453|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283454|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283455|NCT02324543|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283456|NCT02324543|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283457|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93283458|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283459|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283460|NCT02281084|Azacitidine|azacitidine|mesh-list
93283461|NCT02281084|Durvalumab|durvalumab|mesh-list
93283462|NCT02281084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673643|NCT00316472|Niacin|niacin|mesh-list
93283463|NCT02281084|Antimetabolites|antimetabolites|mesh-ancestor
93283464|NCT02281084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283465|NCT02281084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283466|NCT02281084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283467|NCT02281084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283468|NCT02277444|Golimumab|golimumab|mesh-list
93283469|NCT02277444|Methotrexate|methotrexate|mesh-list
93283470|NCT02277444|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93283471|NCT02277444|Abortifacient Agents|abortifacient agents|mesh-ancestor
93283472|NCT02277444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93283473|NCT02277444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283474|NCT02277444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283475|NCT02277444|Antimetabolites|antimetabolites|mesh-ancestor
93092447|NCT03847922|Sensory System Agents|sensory system agents|mesh-ancestor
93283476|NCT02277444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283477|NCT02277444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283478|NCT02277444|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283479|NCT02277444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283480|NCT02277444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283481|NCT02277444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283482|NCT02277444|Immunologic Factors|immunologic factors|mesh-ancestor
92674038|NCT00350454|Temsirolimus|temsirolimus|mesh-list
93283483|NCT02277444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283484|NCT02277444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283485|NCT02277444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93283486|NCT02277444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283487|NCT02257736|Prednisone|prednisone|mesh-list
93283488|NCT02257736|Abiraterone Acetate|abiraterone acetate|mesh-list
93283489|NCT02257736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283490|NCT02257736|Glucocorticoids|glucocorticoids|mesh-ancestor
93092448|NCT03847922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283492|NCT02257736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283493|NCT02257736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283494|NCT02257736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283495|NCT02257736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283496|NCT02257736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93283497|NCT02257736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283498|NCT02257736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283499|NCT02257736|Hormone Antagonists|hormone antagonists|mesh-ancestor
93283500|NCT02257736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93283501|NCT02252172|Dexamethasone|dexamethasone|mesh-list
93283502|NCT02252172|Lenalidomide|lenalidomide|mesh-list
93283503|NCT02252172|Daratumumab|daratumumab|mesh-list
93283504|NCT02252172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93283505|NCT02252172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283506|NCT02252172|Antiemetics|antiemetics|mesh-ancestor
93283507|NCT02252172|Autonomic Agents|autonomic agents|mesh-ancestor
93283508|NCT02252172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283509|NCT02252172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283510|NCT02252172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283511|NCT02252172|Glucocorticoids|glucocorticoids|mesh-ancestor
93283512|NCT02252172|Hormones|hormones|mesh-ancestor
93283513|NCT02252172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283514|NCT02252172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283515|NCT02252172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283516|NCT02252172|Immunologic Factors|immunologic factors|mesh-ancestor
93283517|NCT02252172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92578079|NCT00273013|Montelukast|montelukast|mesh-list
93283518|NCT02252172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283519|NCT02252172|Growth Substances|growth substances|mesh-ancestor
93283520|NCT02252172|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283521|NCT02215265|Cisplatin|cisplatin|mesh-list
93283522|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283523|NCT02208375|Olaparib|olaparib|mesh-list
93283524|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93283525|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283526|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283527|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283528|NCT02136134|Dexamethasone|dexamethasone|mesh-list
93283529|NCT02136134|Bortezomib|bortezomib|mesh-list
93283530|NCT02136134|Daratumumab|daratumumab|mesh-list
93283531|NCT02136134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283532|NCT02136134|Antiemetics|antiemetics|mesh-ancestor
93283533|NCT02136134|Autonomic Agents|autonomic agents|mesh-ancestor
93283534|NCT02136134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283535|NCT02136134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283536|NCT02136134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283537|NCT02136134|Glucocorticoids|glucocorticoids|mesh-ancestor
93283538|NCT02136134|Hormones|hormones|mesh-ancestor
93283539|NCT02136134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283540|NCT02136134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283541|NCT02136134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283542|NCT02076009|Dexamethasone|dexamethasone|mesh-list
93283543|NCT02076009|Lenalidomide|lenalidomide|mesh-list
93283544|NCT02076009|Daratumumab|daratumumab|mesh-list
93283545|NCT02076009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283546|NCT02076009|Antiemetics|antiemetics|mesh-ancestor
93283547|NCT02076009|Autonomic Agents|autonomic agents|mesh-ancestor
93283548|NCT02076009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283549|NCT02076009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283550|NCT02076009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283551|NCT02076009|Glucocorticoids|glucocorticoids|mesh-ancestor
93283552|NCT02076009|Hormones|hormones|mesh-ancestor
93283553|NCT02076009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283554|NCT02076009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283555|NCT02076009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283556|NCT02076009|Immunologic Factors|immunologic factors|mesh-ancestor
93283557|NCT02076009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283558|NCT02076009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283559|NCT02076009|Growth Substances|growth substances|mesh-ancestor
93283560|NCT02076009|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283561|NCT02055638|SRX246|srx246|mesh-list
93283562|NCT02055638|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93283563|NCT02055638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283564|NCT02055638|Natriuretic Agents|natriuretic agents|mesh-ancestor
93283565|NCT02055638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283567|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283568|NCT01850524|Dexamethasone|dexamethasone|mesh-list
93283569|NCT01850524|Lenalidomide|lenalidomide|mesh-list
93283570|NCT01850524|Ixazomib|ixazomib|mesh-list
93283571|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283572|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
93283573|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
93283574|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283575|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283576|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283577|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
93283578|NCT01850524|Hormones|hormones|mesh-ancestor
93283579|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283580|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283581|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283582|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
93283583|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283584|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283585|NCT01850524|Growth Substances|growth substances|mesh-ancestor
93283586|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283587|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
93283588|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283589|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283590|NCT01776840|Rituximab|rituximab|mesh-list
93283591|NCT01776840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93283592|NCT01776840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283593|NCT01776840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283594|NCT01776840|Immunologic Factors|immunologic factors|mesh-ancestor
93283595|NCT01776840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283596|NCT01776840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283597|NCT01776840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283598|NCT01776840|Alkylating Agents|alkylating agents|mesh-ancestor
93283599|NCT01776840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283600|NCT01664910|Rituximab|rituximab|mesh-list
93283601|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93283602|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93283603|NCT01664910|Methotrexate|methotrexate|mesh-list
93283604|NCT01664910|Fludarabine|fludarabine|mesh-list
93283605|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
93283606|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93283607|NCT01664910|Antibodies|antibodies|mesh-list
93283608|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
93283609|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93283610|NCT01664910|Tacrolimus|tacrolimus|mesh-list
93283611|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
93283612|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93283613|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
93283614|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283615|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283616|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283617|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93283618|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
93283619|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93283620|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283621|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
93283622|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283623|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283624|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283625|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283626|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283627|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283628|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93283629|NCT01664910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283630|NCT01664910|Alkylating Agents|alkylating agents|mesh-ancestor
93283631|NCT01664910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93283632|NCT01664910|Immunotoxins|immunotoxins|mesh-ancestor
93283633|NCT01664910|Immunoconjugates|immunoconjugates|mesh-ancestor
93283634|NCT01615029|Dexamethasone|dexamethasone|mesh-list
93283635|NCT01615029|Lenalidomide|lenalidomide|mesh-list
93283636|NCT01615029|Daratumumab|daratumumab|mesh-list
93283637|NCT01615029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93283638|NCT01615029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283639|NCT01615029|Antiemetics|antiemetics|mesh-ancestor
93283640|NCT01615029|Autonomic Agents|autonomic agents|mesh-ancestor
93283641|NCT01615029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283642|NCT01615029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283643|NCT01615029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283644|NCT01615029|Glucocorticoids|glucocorticoids|mesh-ancestor
93283645|NCT01615029|Hormones|hormones|mesh-ancestor
93283646|NCT01615029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283647|NCT01615029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283648|NCT01615029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283649|NCT01615029|Immunologic Factors|immunologic factors|mesh-ancestor
93283650|NCT01615029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283651|NCT01615029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283652|NCT01615029|Growth Substances|growth substances|mesh-ancestor
93283653|NCT01615029|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283654|NCT01594580|Anti-Infective Agents|anti-infective agents|mesh-list
93283655|NCT01594580|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93283656|NCT01550003|Certolizumab Pegol|certolizumab pegol|mesh-list
93283657|NCT01550003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93283658|NCT01550003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283659|NCT01550003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283660|NCT01550003|Immunologic Factors|immunologic factors|mesh-ancestor
93283661|NCT01550003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283662|NCT01550003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283663|NCT01314118|Prednisone|prednisone|mesh-list
93283664|NCT01314118|Abiraterone Acetate|abiraterone acetate|mesh-list
93283665|NCT01314118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283666|NCT01314118|Glucocorticoids|glucocorticoids|mesh-ancestor
93283667|NCT01314118|Hormones|hormones|mesh-ancestor
93283668|NCT01314118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283669|NCT01314118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283670|NCT01314118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283671|NCT01314118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283672|NCT01314118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93283673|NCT01314118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283674|NCT01314118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283675|NCT01314118|Hormone Antagonists|hormone antagonists|mesh-ancestor
93283676|NCT01314118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93283677|NCT01093326|Ponesimod|ponesimod|mesh-list
93283678|NCT01093326|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93283679|NCT01093326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283680|NCT01093326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283681|NCT01093326|Immunologic Factors|immunologic factors|mesh-ancestor
93283682|NCT01093326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283683|NCT00980538|Etravirine|etravirine|mesh-list
93283684|NCT00980538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93283685|NCT00980538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283686|NCT00980538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283687|NCT00980538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283688|NCT00980538|Antiviral Agents|antiviral agents|mesh-ancestor
93283689|NCT00980538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283690|NCT00764595|Imatinib Mesylate|imatinib mesylate|mesh-list
93283691|NCT00764595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283692|NCT00764595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283693|NCT00764595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283694|NCT00764595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283695|NCT00694850|Riociguat|riociguat|mesh-list
93283696|NCT00694850|Enzyme Activators|enzyme activators|mesh-ancestor
93283697|NCT00694850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283698|NCT00576979|Cyclophosphamide|cyclophosphamide|mesh-list
93283699|NCT00576979|Etoposide|etoposide|mesh-list
93283700|NCT00576979|Etoposide phosphate|etoposide phosphate|mesh-list
93283701|NCT00576979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283702|NCT00576979|Immunologic Factors|immunologic factors|mesh-ancestor
93283703|NCT00576979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283704|NCT00576979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283705|NCT00576979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283706|NCT00576979|Alkylating Agents|alkylating agents|mesh-ancestor
93283707|NCT00576979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283708|NCT00576979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283709|NCT00576979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283710|NCT00576979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283711|NCT00576979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93283712|NCT00576979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283713|NCT00576979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283714|NCT00390793|Cytarabine|cytarabine|mesh-list
93283715|NCT00390793|Dexamethasone|dexamethasone|mesh-list
93283716|NCT00390793|Prednisone|prednisone|mesh-list
93283717|NCT00390793|Dexamethasone acetate|dexamethasone acetate|mesh-list
93283718|NCT00390793|Cortisone|cortisone|mesh-list
93283719|NCT00390793|Cyclophosphamide|cyclophosphamide|mesh-list
93283720|NCT00390793|Doxorubicin|doxorubicin|mesh-list
93283721|NCT00390793|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93283722|NCT00390793|Methotrexate|methotrexate|mesh-list
93283723|NCT00390793|Vincristine|vincristine|mesh-list
93283724|NCT00390793|Daunorubicin|daunorubicin|mesh-list
93283725|NCT00390793|Dasatinib|dasatinib|mesh-list
93283726|NCT00390793|BB 1101|bb 1101|mesh-list
93283727|NCT00390793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283728|NCT00390793|Immunologic Factors|immunologic factors|mesh-ancestor
93283729|NCT00390793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283730|NCT00390793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283731|NCT00390793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283732|NCT00390793|Alkylating Agents|alkylating agents|mesh-ancestor
93283733|NCT00390793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283734|NCT00390793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283735|NCT00390793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283736|NCT00390793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283737|NCT00390793|Antiemetics|antiemetics|mesh-ancestor
93283738|NCT00390793|Autonomic Agents|autonomic agents|mesh-ancestor
93283739|NCT00390793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283740|NCT00390793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283741|NCT00390793|Glucocorticoids|glucocorticoids|mesh-ancestor
93283742|NCT00390793|Hormones|hormones|mesh-ancestor
93283743|NCT00390793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283744|NCT00390793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93283745|NCT00390793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93283746|NCT00390793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93283747|NCT00390793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283748|NCT00390793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283749|NCT00390793|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93283750|NCT00390793|Abortifacient Agents|abortifacient agents|mesh-ancestor
93283751|NCT00390793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93283752|NCT00390793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283753|NCT00390793|Antimetabolites|antimetabolites|mesh-ancestor
93283754|NCT00390793|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283755|NCT00390793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283756|NCT00390793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283757|NCT00390793|Antiviral Agents|antiviral agents|mesh-ancestor
93283758|NCT00390793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283759|NCT00390793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283760|NCT00390793|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283761|NCT00390793|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283762|NCT00390793|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283763|NCT00390793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93283764|NCT00390793|Protease Inhibitors|protease inhibitors|mesh-ancestor
93283765|NCT03563235|Calcitriol|calcitriol|mesh-list
93283766|NCT03563235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93283767|NCT03563235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283768|NCT03563235|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93283769|NCT03563235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93283770|NCT03563235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283771|NCT03563235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93283772|NCT03563235|Vitamins|vitamins|mesh-ancestor
93283773|NCT03563235|Micronutrients|micronutrients|mesh-ancestor
93283774|NCT03563235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93283775|NCT01329900|Etoposide|etoposide|mesh-list
93283776|NCT01329900|Ifosfamide|ifosfamide|mesh-list
93283777|NCT01329900|Ofatumumab|ofatumumab|mesh-list
93283778|NCT01329900|Lenograstim|lenograstim|mesh-list
93283779|NCT01329900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283780|NCT01329900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283781|NCT01329900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93283782|NCT01329900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283783|NCT01329900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283784|NCT01329900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283785|NCT01329900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283786|NCT01329900|Alkylating Agents|alkylating agents|mesh-ancestor
93283787|NCT01329900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93283788|NCT01329900|Immunologic Factors|immunologic factors|mesh-ancestor
93283789|NCT01329900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283790|NCT04948294|Pyrithione zinc|pyrithione zinc|mesh-list
93283791|NCT04948294|Keratolytic Agents|keratolytic agents|mesh-ancestor
93283792|NCT04948294|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283793|NCT04948372|Terlipressin|terlipressin|mesh-list
93283794|NCT04948372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93283795|NCT04948372|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93283796|NCT04947748|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93283797|NCT04947748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283798|NCT04947826|Antibodies|antibodies|mesh-list
93283799|NCT04947826|Immunoglobulins|immunoglobulins|mesh-list
93283800|NCT04947826|Immunologic Factors|immunologic factors|mesh-ancestor
93283801|NCT04947826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283802|NCT05059977|Immunoglobulins|immunoglobulins|mesh-list
93283803|NCT05059977|gamma-Globulins|gamma-globulins|mesh-list
93283804|NCT05059977|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93283805|NCT05059977|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93283806|NCT05059977|Immunologic Factors|immunologic factors|mesh-ancestor
93283807|NCT05059977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283808|NCT02228616|Lactulose|lactulose|mesh-list
93283809|NCT02228616|Prucalopride|prucalopride|mesh-list
93283810|NCT02228616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283811|NCT02228616|Laxatives|laxatives|mesh-ancestor
93283812|NCT02228616|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93283813|NCT02228616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93283814|NCT02228616|Serotonin Agents|serotonin agents|mesh-ancestor
93283815|NCT02228616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283816|NCT02228616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283817|NCT02228616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283818|NCT03936894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93283819|NCT03936894|Immunologic Factors|immunologic factors|mesh-ancestor
93283820|NCT03936894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283821|NCT02228772|Cytarabine|cytarabine|mesh-list
93283822|NCT02228772|Cyclophosphamide|cyclophosphamide|mesh-list
93283823|NCT02228772|Doxorubicin|doxorubicin|mesh-list
93283824|NCT02228772|Methotrexate|methotrexate|mesh-list
93283825|NCT02228772|Vincristine|vincristine|mesh-list
93283826|NCT02228772|Mercaptopurine|mercaptopurine|mesh-list
93283827|NCT02228772|Ixazomib|ixazomib|mesh-list
93283828|NCT02228772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283829|NCT02228772|Immunologic Factors|immunologic factors|mesh-ancestor
93283830|NCT02228772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283831|NCT02228772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283832|NCT02228772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283833|NCT02228772|Alkylating Agents|alkylating agents|mesh-ancestor
93283834|NCT02228772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283835|NCT02228772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283836|NCT02228772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283837|NCT02228772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93283838|NCT02228772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93283839|NCT02228772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93283840|NCT02228772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283841|NCT02228772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93283842|NCT02228772|Abortifacient Agents|abortifacient agents|mesh-ancestor
93283843|NCT02228772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93283844|NCT02228772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283845|NCT02228772|Antimetabolites|antimetabolites|mesh-ancestor
93283846|NCT02228772|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283847|NCT02228772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93283848|NCT02228772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93283849|NCT02228772|Antiviral Agents|antiviral agents|mesh-ancestor
93283850|NCT02228772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283851|NCT02228772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93283852|NCT02228772|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283853|NCT02228772|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283854|NCT02228772|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283855|NCT02228772|Protease Inhibitors|protease inhibitors|mesh-ancestor
93283856|NCT03646968|Docetaxel|docetaxel|mesh-list
93283857|NCT03646968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283858|NCT03646968|Tubulin Modulators|tubulin modulators|mesh-ancestor
93283859|NCT03646968|Antimitotic Agents|antimitotic agents|mesh-ancestor
93283860|NCT03646968|Mitosis Modulators|mitosis modulators|mesh-ancestor
93283861|NCT03646968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283862|NCT02228850|Alprostadil|alprostadil|mesh-list
93283863|NCT02228850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93283864|NCT02228850|Vasodilator Agents|vasodilator agents|mesh-ancestor
93283865|NCT02228850|Urological Agents|urological agents|mesh-ancestor
93283866|NCT02822508|Laxatives|laxatives|mesh-list
93283867|NCT02822508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93283868|NCT03563001|Budesonide|budesonide|mesh-list
93283869|NCT03563001|Formoterol Fumarate|formoterol fumarate|mesh-list
93283870|NCT03563001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283871|NCT03563001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93283872|NCT03563001|Autonomic Agents|autonomic agents|mesh-ancestor
93283873|NCT03563001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283874|NCT03563001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283875|NCT03563001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93283876|NCT03563001|Respiratory System Agents|respiratory system agents|mesh-ancestor
93283877|NCT03563001|Glucocorticoids|glucocorticoids|mesh-ancestor
93283878|NCT03563001|Hormones|hormones|mesh-ancestor
93283879|NCT03563001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93283880|NCT03563001|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93283881|NCT03563001|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93283882|NCT03563001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93283883|NCT03563001|Adrenergic Agents|adrenergic agents|mesh-ancestor
93283884|NCT03563001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283885|NCT03563001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283886|NCT02228928|Capsaicin|capsaicin|mesh-list
93283887|NCT02228928|Antipruritics|antipruritics|mesh-ancestor
93283888|NCT02228928|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283889|NCT02228928|Sensory System Agents|sensory system agents|mesh-ancestor
93283890|NCT02228928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283891|NCT02228928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283892|NCT03888378|Minocycline|minocycline|mesh-list
93283893|NCT03888378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93283894|NCT03888378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283895|NCT03603288|Idebenone|idebenone|mesh-list
93283896|NCT03603288|Antioxidants|antioxidants|mesh-ancestor
93283897|NCT03603288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283898|NCT03603288|Protective Agents|protective agents|mesh-ancestor
93283899|NCT03603288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283900|NCT03857646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93283901|NCT03857646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93283902|NCT03857646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93283903|NCT03857646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93283904|NCT03844074|Bevacizumab|bevacizumab|mesh-list
93283905|NCT03844074|Ranibizumab|ranibizumab|mesh-list
93283906|NCT03844074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283907|NCT03844074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283908|NCT03844074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93283909|NCT03844074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93283910|NCT03844074|Growth Substances|growth substances|mesh-ancestor
93283911|NCT03844074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283912|NCT03844074|Growth Inhibitors|growth inhibitors|mesh-ancestor
93283913|NCT02624986|Rituximab|rituximab|mesh-list
93283914|NCT02624986|Obinutuzumab|obinutuzumab|mesh-list
93283915|NCT02624986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93283916|NCT02624986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283917|NCT02624986|Immunologic Factors|immunologic factors|mesh-ancestor
93283918|NCT02624986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283919|NCT02624986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283920|NCT04946734|Aspirin|aspirin|mesh-list
93283921|NCT04946734|Clopidogrel|clopidogrel|mesh-list
93283922|NCT04946734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93283923|NCT04946734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93283924|NCT04946734|Analgesics|analgesics|mesh-ancestor
93283925|NCT04946734|Sensory System Agents|sensory system agents|mesh-ancestor
93283926|NCT04946734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93283927|NCT04946734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283928|NCT04946734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93283929|NCT04946734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283930|NCT04946734|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93283931|NCT04946734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93283932|NCT04946734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283933|NCT04946734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93283934|NCT04946734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93283935|NCT04946734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283936|NCT04946734|Antipyretics|antipyretics|mesh-ancestor
93283937|NCT04946734|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93283938|NCT04946734|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93283939|NCT04946734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93283940|NCT04946734|Purinergic Agents|purinergic agents|mesh-ancestor
93283941|NCT04946734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93283942|NCT04945954|Cyclophosphamide|cyclophosphamide|mesh-list
92955959|NCT04492891|Cyclosporins|cyclosporins|mesh-list
93283943|NCT04945954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283944|NCT04945954|Immunologic Factors|immunologic factors|mesh-ancestor
93283945|NCT04945954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283946|NCT04945954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283947|NCT04945954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283948|NCT04945954|Alkylating Agents|alkylating agents|mesh-ancestor
93283949|NCT04945954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283950|NCT04945954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283951|NCT04945954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283952|NCT04945096|Cytarabine|cytarabine|mesh-list
93283953|NCT04945096|Acetylcysteine|acetylcysteine|mesh-list
93283954|NCT04945096|Cyclosporine|cyclosporine|mesh-list
93283955|NCT04945096|Cyclophosphamide|cyclophosphamide|mesh-list
93283956|NCT04945096|Busulfan|busulfan|mesh-list
93283957|NCT04945096|Semustine|semustine|mesh-list
93283958|NCT04945096|Decitabine|decitabine|mesh-list
93283959|NCT04945096|Cyclosporins|cyclosporins|mesh-list
93283960|NCT04945096|Thymoglobulin|thymoglobulin|mesh-list
93283961|NCT04945096|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93283962|NCT04945096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283963|NCT04945096|Immunologic Factors|immunologic factors|mesh-ancestor
93283964|NCT04945096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283965|NCT04945096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93283966|NCT04945096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93283967|NCT04945096|Alkylating Agents|alkylating agents|mesh-ancestor
93283968|NCT04945096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283969|NCT04945096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283970|NCT04945096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93283971|NCT04945096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283972|NCT04945096|Antimetabolites|antimetabolites|mesh-ancestor
93283973|NCT04945096|Antiviral Agents|antiviral agents|mesh-ancestor
93283974|NCT04945096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283975|NCT04945096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93283976|NCT04945096|Antifungal Agents|antifungal agents|mesh-ancestor
93283977|NCT04945096|Dermatologic Agents|dermatologic agents|mesh-ancestor
93283978|NCT04945096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93283979|NCT04945096|Expectorants|expectorants|mesh-ancestor
93283980|NCT04945096|Respiratory System Agents|respiratory system agents|mesh-ancestor
93283981|NCT04945096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93283982|NCT04945096|Antioxidants|antioxidants|mesh-ancestor
93283983|NCT04945096|Protective Agents|protective agents|mesh-ancestor
93283984|NCT04944082|Ivermectin|ivermectin|mesh-list
93283985|NCT04944082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93283986|NCT04944082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283987|NCT04943692|Metformin|metformin|mesh-list
93283988|NCT04943692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93283989|NCT04943692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93283990|NCT02587598|Cytarabine|cytarabine|mesh-list
93283991|NCT02587598|Azacitidine|azacitidine|mesh-list
93283992|NCT02587598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93283993|NCT02587598|Antimetabolites|antimetabolites|mesh-ancestor
93283994|NCT02587598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93283995|NCT02587598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93283996|NCT02587598|Antiviral Agents|antiviral agents|mesh-ancestor
93283997|NCT02587598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93283998|NCT02587598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93283999|NCT02587598|Immunologic Factors|immunologic factors|mesh-ancestor
93284000|NCT02587598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284001|NCT02587598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284002|NCT04943536|Bicalutamide|bicalutamide|mesh-list
93284003|NCT04943536|Androgen Antagonists|androgen antagonists|mesh-ancestor
93284004|NCT04943536|Hormone Antagonists|hormone antagonists|mesh-ancestor
93284005|NCT04943536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284006|NCT04943536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284007|NCT04943536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284008|NCT04943146|Aspirin|aspirin|mesh-list
93284009|NCT04943146|Prednisone|prednisone|mesh-list
93284010|NCT04943146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284011|NCT04943146|Glucocorticoids|glucocorticoids|mesh-ancestor
93284012|NCT04943146|Hormones|hormones|mesh-ancestor
93284013|NCT04943146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284014|NCT04943146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284015|NCT04943146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93284016|NCT04943146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284017|NCT04943146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93284018|NCT04943146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284019|NCT04943146|Analgesics|analgesics|mesh-ancestor
93284020|NCT04943146|Sensory System Agents|sensory system agents|mesh-ancestor
93284021|NCT04943146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284022|NCT04943146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284023|NCT04943146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93284024|NCT04943146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93284025|NCT04943146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284026|NCT04943146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93284027|NCT04943146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93284028|NCT04943146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284029|NCT04943146|Antipyretics|antipyretics|mesh-ancestor
93284031|NCT02485574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93284032|NCT02485574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284033|NCT04942834|Amiodarone|amiodarone|mesh-list
93284034|NCT04942834|Sotalol|sotalol|mesh-list
93284035|NCT04942834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93284036|NCT04942834|Dronedarone|dronedarone|mesh-list
93284037|NCT04942834|Propafenone|propafenone|mesh-list
93284038|NCT04942834|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284039|NCT04942834|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93284040|NCT04942834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93284041|NCT04942834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284042|NCT04942834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93284043|NCT04942834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93284044|NCT04942834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93284045|NCT04942834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284046|NCT04942834|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93284047|NCT04942834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93284048|NCT04942834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93284049|NCT04942834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93284050|NCT04942834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93284051|NCT04942834|Adrenergic Agents|adrenergic agents|mesh-ancestor
93284052|NCT04942834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284053|NCT04942834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284054|NCT04942834|Sympatholytics|sympatholytics|mesh-ancestor
93284055|NCT04942834|Autonomic Agents|autonomic agents|mesh-ancestor
93284056|NCT04942834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284057|NCT04942834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93284058|NCT04941976|Benzydamine|benzydamine|mesh-list
93284059|NCT04941976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284060|NCT01291004|Drospirenone|drospirenone|mesh-list
93284061|NCT01291004|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93284062|NCT01291004|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93284063|NCT01291004|Levonorgestrel|levonorgestrel|mesh-list
93284064|NCT01291004|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93284065|NCT01291004|Desogestrel|desogestrel|mesh-list
93284066|NCT01291004|Contraceptive Agents|contraceptive agents|mesh-list
93284067|NCT01291004|Contraceptives, Oral|contraceptives, oral|mesh-list
93284068|NCT01291004|Estradiol|estradiol|mesh-list
93284069|NCT01291004|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93284070|NCT01291004|Estrogens|estrogens|mesh-ancestor
93284071|NCT01291004|Hormones|hormones|mesh-ancestor
93284072|NCT01291004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284073|NCT01291004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284074|NCT01291004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93284075|NCT01291004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93284076|NCT01291004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93284077|NCT01291004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93284078|NCT01291004|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93284079|NCT01291004|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93284080|NCT01291004|Hormone Antagonists|hormone antagonists|mesh-ancestor
93284081|NCT01291004|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93284082|NCT01291004|Diuretics|diuretics|mesh-ancestor
93284083|NCT01291004|Natriuretic Agents|natriuretic agents|mesh-ancestor
93284084|NCT01291004|Progestins|progestins|mesh-ancestor
93284085|NCT04941118|Anesthetics|anesthetics|mesh-list
93284086|NCT04941118|Anesthetics, Local|anesthetics, local|mesh-list
93284087|NCT04941118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284088|NCT04941118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284089|NCT04941118|Sensory System Agents|sensory system agents|mesh-ancestor
93284090|NCT04941118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284091|NCT03483818|Antiviral Agents|antiviral agents|mesh-list
93284092|NCT03483818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284093|NCT00374660|Oxaliplatin|oxaliplatin|mesh-list
93284094|NCT00374660|Irofulven|irofulven|mesh-list
93284095|NCT00374660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284096|NCT00374660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93284097|NCT00374660|Alkylating Agents|alkylating agents|mesh-ancestor
93284098|NCT00374660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284100|NCT02624050|Methohexital|methohexital|mesh-list
93284101|NCT02624050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93284102|NCT02624050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284103|NCT02624050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284104|NCT02624050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93284105|NCT02624050|Anesthetics, General|anesthetics, general|mesh-ancestor
93284106|NCT02624050|Anesthetics|anesthetics|mesh-ancestor
93284107|NCT03131882|Triamcinolone|triamcinolone|mesh-list
93284108|NCT03131882|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93284109|NCT03131882|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93284110|NCT03131882|Hyaluronic Acid|hyaluronic acid|mesh-list
93284111|NCT03131882|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93284112|NCT03131882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284113|NCT03131882|Glucocorticoids|glucocorticoids|mesh-ancestor
93284114|NCT03131882|Hormones|hormones|mesh-ancestor
93284115|NCT03131882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284116|NCT03131882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284117|NCT03131882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284118|NCT03131882|Immunologic Factors|immunologic factors|mesh-ancestor
93284119|NCT03131882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284120|NCT03131882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284121|NCT03131882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93284122|NCT03131882|Viscosupplements|viscosupplements|mesh-ancestor
93284123|NCT03131882|Protective Agents|protective agents|mesh-ancestor
93284124|NCT03483350|Midazolam|midazolam|mesh-list
93284125|NCT03483350|Granisetron|granisetron|mesh-list
93284126|NCT03483350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93284127|NCT03483350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93284128|NCT03483350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284129|NCT03483350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284130|NCT03483350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93284131|NCT03483350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93284132|NCT03483350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284133|NCT03483350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93284134|NCT03483350|Anesthetics, General|anesthetics, general|mesh-ancestor
93284135|NCT03483350|Anesthetics|anesthetics|mesh-ancestor
93284136|NCT03483350|GABA Modulators|gaba modulators|mesh-ancestor
93284137|NCT03483350|GABA Agents|gaba agents|mesh-ancestor
93284138|NCT03483350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284139|NCT03483350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284140|NCT03483350|Antiemetics|antiemetics|mesh-ancestor
93284141|NCT03483350|Autonomic Agents|autonomic agents|mesh-ancestor
93284142|NCT03483350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284143|NCT03483350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284144|NCT03483350|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93284145|NCT03483350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93284146|NCT03483350|Serotonin Agents|serotonin agents|mesh-ancestor
93284147|NCT03480308|Dexamethasone|dexamethasone|mesh-list
93284148|NCT03480308|Fentanyl|fentanyl|mesh-list
93284149|NCT03480308|Bupivacaine|bupivacaine|mesh-list
93284150|NCT03480308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284151|NCT03480308|Antiemetics|antiemetics|mesh-ancestor
93284152|NCT03480308|Autonomic Agents|autonomic agents|mesh-ancestor
93284153|NCT03480308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284154|NCT03480308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284155|NCT03480308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284156|NCT03480308|Glucocorticoids|glucocorticoids|mesh-ancestor
93284157|NCT03480308|Hormones|hormones|mesh-ancestor
93284158|NCT03480308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284159|NCT03480308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93284160|NCT03480308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284161|NCT03480308|Anesthetics, Local|anesthetics, local|mesh-ancestor
93284162|NCT03480308|Anesthetics|anesthetics|mesh-ancestor
93284163|NCT03480308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284164|NCT03480308|Sensory System Agents|sensory system agents|mesh-ancestor
93284165|NCT03480308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93284166|NCT03480308|Narcotics|narcotics|mesh-ancestor
93284167|NCT03480308|Analgesics|analgesics|mesh-ancestor
93284168|NCT03480308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93284169|NCT03480308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93284170|NCT03480308|Anesthetics, General|anesthetics, general|mesh-ancestor
93284171|NCT05151614|Colchicine|colchicine|mesh-list
93284172|NCT05151614|Gout Suppressants|gout suppressants|mesh-ancestor
93284173|NCT05151614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284174|NCT05151614|Tubulin Modulators|tubulin modulators|mesh-ancestor
93284175|NCT05151614|Antimitotic Agents|antimitotic agents|mesh-ancestor
93284176|NCT05151614|Mitosis Modulators|mitosis modulators|mesh-ancestor
93284177|NCT05151614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284178|NCT05151614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284179|NCT04937140|Antibodies|antibodies|mesh-list
93284180|NCT04937140|Immunologic Factors|immunologic factors|mesh-ancestor
93284181|NCT04937140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284182|NCT04409314|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93284183|NCT04409314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93284184|NCT04409314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284185|NCT03482960|Xenon|xenon|mesh-list
93284186|NCT03482960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93284187|NCT03482960|Anesthetics, General|anesthetics, general|mesh-ancestor
93284188|NCT03482960|Anesthetics|anesthetics|mesh-ancestor
93284189|NCT03482960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284190|NCT03482960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284191|NCT03479996|Bupivacaine|bupivacaine|mesh-list
93284192|NCT03479996|Anesthetics, Local|anesthetics, local|mesh-ancestor
93284193|NCT03479996|Anesthetics|anesthetics|mesh-ancestor
93284194|NCT03479996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284195|NCT03479996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284196|NCT03479996|Sensory System Agents|sensory system agents|mesh-ancestor
93284197|NCT03479996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284198|NCT04936282|Tacrolimus|tacrolimus|mesh-list
93284199|NCT04936282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284200|NCT04936282|Immunologic Factors|immunologic factors|mesh-ancestor
93284201|NCT04936282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284202|NCT04936282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93284203|NCT04936282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284204|NCT04936282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284205|NCT02524184|Sildenafil Citrate|sildenafil citrate|mesh-list
93284206|NCT02524184|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284207|NCT02524184|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93284208|NCT02524184|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93284209|NCT02524184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284210|NCT02524184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284211|NCT02524184|Urological Agents|urological agents|mesh-ancestor
93284212|NCT04936204|Hyaluronic Acid|hyaluronic acid|mesh-list
93284213|NCT04936204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93284214|NCT04936204|Immunologic Factors|immunologic factors|mesh-ancestor
93284215|NCT04936204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284216|NCT04936204|Viscosupplements|viscosupplements|mesh-ancestor
93284217|NCT04936204|Protective Agents|protective agents|mesh-ancestor
93284218|NCT03486236|Ivacaftor|ivacaftor|mesh-list
93284219|NCT03486236|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93284220|NCT03486236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93284221|NCT03486236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284222|NCT04936126|Amantadine|amantadine|mesh-list
93284223|NCT04936126|Pramipexole|pramipexole|mesh-list
93284224|NCT04936126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93284225|NCT04936126|Antidepressive Agents|antidepressive agents|mesh-ancestor
93284226|NCT04936126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284227|NCT04936126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93284228|NCT04936126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93284229|NCT04936126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284230|NCT04936126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284231|NCT04936126|Antioxidants|antioxidants|mesh-ancestor
93284232|NCT04936126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284233|NCT04936126|Protective Agents|protective agents|mesh-ancestor
93284234|NCT04936126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93284235|NCT04936126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93284236|NCT04936126|Dopamine Agonists|dopamine agonists|mesh-ancestor
93284237|NCT04936126|Dopamine Agents|dopamine agents|mesh-ancestor
93284238|NCT04936126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284239|NCT04936126|Antiviral Agents|antiviral agents|mesh-ancestor
93284240|NCT04936126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284241|NCT04936126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284242|NCT04936126|Analgesics|analgesics|mesh-ancestor
93284243|NCT04936126|Sensory System Agents|sensory system agents|mesh-ancestor
93284244|NCT04936126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284245|NCT03479918|Prednisone|prednisone|mesh-list
93284246|NCT03479918|Cyclophosphamide|cyclophosphamide|mesh-list
93284247|NCT03479918|Doxorubicin|doxorubicin|mesh-list
93284248|NCT03479918|Etoposide|etoposide|mesh-list
93284249|NCT03479918|Vincristine|vincristine|mesh-list
93284250|NCT03479918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284251|NCT03479918|Immunologic Factors|immunologic factors|mesh-ancestor
93284252|NCT03479918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284253|NCT03479918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284254|NCT03479918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93284255|NCT03479918|Alkylating Agents|alkylating agents|mesh-ancestor
93284256|NCT03479918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284257|NCT03479918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284258|NCT03479918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93284259|NCT03479918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93284260|NCT03479918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93284261|NCT03479918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93284262|NCT03479918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284263|NCT03479918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93284264|NCT03479918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284265|NCT03479918|Glucocorticoids|glucocorticoids|mesh-ancestor
93284266|NCT03479918|Hormones|hormones|mesh-ancestor
93284267|NCT03479918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284268|NCT03479918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93284269|NCT03479918|Tubulin Modulators|tubulin modulators|mesh-ancestor
93284270|NCT03479918|Antimitotic Agents|antimitotic agents|mesh-ancestor
93284271|NCT03479918|Mitosis Modulators|mitosis modulators|mesh-ancestor
93284272|NCT03486080|Lenograstim|lenograstim|mesh-list
93284273|NCT03486080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93284274|NCT03486080|Immunologic Factors|immunologic factors|mesh-ancestor
93284275|NCT03486080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284276|NCT03479450|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93284277|NCT03479450|Respiratory System Agents|respiratory system agents|mesh-ancestor
93284278|NCT03477344|Dexmedetomidine|dexmedetomidine|mesh-list
93284279|NCT03477344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93284280|NCT03477344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284281|NCT03477344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284282|NCT03477344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284283|NCT03477344|Analgesics|analgesics|mesh-ancestor
93284284|NCT03477344|Sensory System Agents|sensory system agents|mesh-ancestor
93284285|NCT03477344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284286|NCT03477344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93284287|NCT03477344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93284288|NCT03477344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93284289|NCT03477344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93284290|NCT03477344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284291|NCT03477344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284292|NCT04933864|Methylene Blue|methylene blue|mesh-list
93284293|NCT04933864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284294|NCT04933864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284295|NCT03477266|Mosapride|mosapride|mesh-list
93284296|NCT03477266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284297|NCT03477266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93284298|NCT03477266|Serotonin Agents|serotonin agents|mesh-ancestor
93284299|NCT03477266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284300|NCT03477266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284301|NCT03477266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284302|NCT03479372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93284303|NCT03479372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93284304|NCT03131336|Fibrin Foam|fibrin foam|mesh-list
93284305|NCT03131336|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
93284306|NCT03131336|Hemostatics|hemostatics|mesh-ancestor
93284307|NCT03131336|Coagulants|coagulants|mesh-ancestor
93284308|NCT03482492|Acetaminophen|acetaminophen|mesh-list
93284309|NCT03482492|Tramadol|tramadol|mesh-list
93284310|NCT03482492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284311|NCT03482492|Analgesics|analgesics|mesh-ancestor
93284312|NCT03482492|Sensory System Agents|sensory system agents|mesh-ancestor
93284313|NCT03482492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284314|NCT03482492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284315|NCT03482492|Antipyretics|antipyretics|mesh-ancestor
93284316|NCT03482492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93284317|NCT03482492|Narcotics|narcotics|mesh-ancestor
93284318|NCT03482492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284319|NCT03477110|Temozolomide|temozolomide|mesh-list
93284320|NCT03477110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93284321|NCT03477110|Alkylating Agents|alkylating agents|mesh-ancestor
93092449|NCT03847922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93284322|NCT03477110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956336|NCT03924895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284323|NCT03477110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284324|NCT03874286|Liver Extracts|liver extracts|mesh-list
93284325|NCT03874286|Hematinics|hematinics|mesh-ancestor
93284326|NCT05259098|Sufentanil|sufentanil|mesh-list
93284327|NCT05259098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93284328|NCT05259098|Narcotics|narcotics|mesh-ancestor
93284329|NCT05259098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284330|NCT05259098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284331|NCT05259098|Analgesics|analgesics|mesh-ancestor
93284332|NCT05259098|Sensory System Agents|sensory system agents|mesh-ancestor
93284333|NCT05259098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284334|NCT05259098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93284335|NCT05259098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93284336|NCT05259098|Anesthetics, General|anesthetics, general|mesh-ancestor
93284337|NCT05259098|Anesthetics|anesthetics|mesh-ancestor
93284338|NCT03482180|Atorvastatin|atorvastatin|mesh-list
93284339|NCT03482180|Calcium|calcium|mesh-list
93284340|NCT03482180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93284341|NCT03482180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284342|NCT03482180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93284343|NCT03482180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93284344|NCT03482180|Antimetabolites|antimetabolites|mesh-ancestor
93284345|NCT03482180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284346|NCT03482180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93284347|NCT03482180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93284348|NCT03482180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284349|NCT04390646|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93284350|NCT04390646|Hormones|hormones|mesh-ancestor
93284351|NCT04390646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284352|NCT04390646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284353|NCT04294550|Naloxegol|naloxegol|mesh-list
93284354|NCT04294550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93284355|NCT04294550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284356|NCT04294550|Sensory System Agents|sensory system agents|mesh-ancestor
93284357|NCT04294550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284358|NCT03476564|Pentoxifylline|pentoxifylline|mesh-list
93284359|NCT03476564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93284360|NCT03476564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284361|NCT03476564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284362|NCT03476564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93284363|NCT03476564|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93284364|NCT03476564|Protective Agents|protective agents|mesh-ancestor
93284365|NCT03476564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284366|NCT03476564|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284367|NCT03476564|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93284368|NCT03476564|Antioxidants|antioxidants|mesh-ancestor
93284369|NCT05258474|Niacinamide|niacinamide|mesh-list
93284370|NCT05258474|Niacin|niacin|mesh-list
93284371|NCT05258474|Nicotinic Acids|nicotinic acids|mesh-list
93284372|NCT05258474|Vitamin B Complex|vitamin b complex|mesh-ancestor
93284373|NCT05258474|Vitamins|vitamins|mesh-ancestor
93284374|NCT05258474|Micronutrients|micronutrients|mesh-ancestor
93284375|NCT05258474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284376|NCT05258474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93284377|NCT05258474|Antimetabolites|antimetabolites|mesh-ancestor
93284378|NCT05258474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284379|NCT05258474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93284380|NCT05258474|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284381|NCT03478436|Doxycycline|doxycycline|mesh-list
93284382|NCT03478436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93284383|NCT03478436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284384|NCT03478436|Antimalarials|antimalarials|mesh-ancestor
93284385|NCT03478436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93284386|NCT03478436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93284387|NCT01338987|Alovudine|alovudine|mesh-list
93284388|NCT01338987|Cyclophosphamide|cyclophosphamide|mesh-list
93284389|NCT01338987|Busulfan|busulfan|mesh-list
93284390|NCT01338987|Methotrexate|methotrexate|mesh-list
93284391|NCT01338987|Fludarabine|fludarabine|mesh-list
93284392|NCT01338987|Leuprolide|leuprolide|mesh-list
93284393|NCT01338987|Tacrolimus|tacrolimus|mesh-list
93284394|NCT01338987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284395|NCT01338987|Immunologic Factors|immunologic factors|mesh-ancestor
93284396|NCT01338987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284397|NCT01338987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284398|NCT01338987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93284399|NCT01338987|Alkylating Agents|alkylating agents|mesh-ancestor
93284400|NCT01338987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284402|NCT01338987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93284403|NCT01338987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93284404|NCT01338987|Abortifacient Agents|abortifacient agents|mesh-ancestor
93284405|NCT01338987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93284406|NCT01338987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93284407|NCT01338987|Antimetabolites|antimetabolites|mesh-ancestor
93284408|NCT01338987|Dermatologic Agents|dermatologic agents|mesh-ancestor
93284409|NCT01338987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284410|NCT01338987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93284411|NCT01338987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93284412|NCT01338987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93284413|NCT01338987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93284414|NCT01338987|Fertility Agents|fertility agents|mesh-ancestor
93284415|NCT01338987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93284416|NCT01338987|Antiviral Agents|antiviral agents|mesh-ancestor
93284417|NCT01338987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284418|NCT03717896|Thiamine|thiamine|mesh-list
93284419|NCT03717896|Vitamins|vitamins|mesh-ancestor
93284420|NCT03717896|Micronutrients|micronutrients|mesh-ancestor
93284421|NCT03717896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284422|NCT03717896|Vitamin B Complex|vitamin b complex|mesh-ancestor
93284423|NCT03478280|Brodalumab|brodalumab|mesh-list
93284424|NCT03478280|Dermatologic Agents|dermatologic agents|mesh-ancestor
93284425|NCT04856007|Metformin|metformin|mesh-list
93284426|NCT04856007|Dapagliflozin|dapagliflozin|mesh-list
93284427|NCT04856007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93284428|NCT04856007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284429|NCT04856007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93284430|NCT04856007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284431|NCT04736979|Amoxicillin|amoxicillin|mesh-list
93284432|NCT04736979|Clavulanic Acid|clavulanic acid|mesh-list
93284433|NCT04736979|Clavulanic Acids|clavulanic acids|mesh-list
93284434|NCT04736979|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93284435|NCT04736979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93284436|NCT04736979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284437|NCT04736979|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93284438|NCT04736979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284439|NCT04736979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284440|NCT03562923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93284441|NCT03562923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93284442|NCT03562923|Autonomic Agents|autonomic agents|mesh-ancestor
93284443|NCT03562923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284444|NCT03562923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284445|NCT03562923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93284446|NCT03562923|Respiratory System Agents|respiratory system agents|mesh-ancestor
93284447|NCT03562923|Glucocorticoids|glucocorticoids|mesh-ancestor
93284448|NCT03562923|Hormones|hormones|mesh-ancestor
93284449|NCT03562923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284450|NCT03562923|Sympathomimetics|sympathomimetics|mesh-ancestor
93284451|NCT03593252|Metronidazole|metronidazole|mesh-list
93284452|NCT03593252|Cefazolin|cefazolin|mesh-list
93284453|NCT03593252|Neomycin|neomycin|mesh-list
93284454|NCT03593252|Picosulfate sodium|picosulfate sodium|mesh-list
93284455|NCT03593252|Magnesium Oxide|magnesium oxide|mesh-list
93284456|NCT03593252|Citric Acid|citric acid|mesh-list
93284457|NCT03593252|Sodium Citrate|sodium citrate|mesh-list
93284458|NCT03593252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284459|NCT03593252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93284460|NCT03593252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93284461|NCT03593252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93284462|NCT03593252|Cathartics|cathartics|mesh-ancestor
93284463|NCT03593252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284464|NCT03593252|Anticoagulants|anticoagulants|mesh-ancestor
93284465|NCT03593252|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93284466|NCT03593252|Chelating Agents|chelating agents|mesh-ancestor
93284467|NCT03593252|Sequestering Agents|sequestering agents|mesh-ancestor
93284468|NCT03593252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284469|NCT03593252|Antacids|antacids|mesh-ancestor
93284470|NCT03593252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93284471|NCT03593252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284472|NCT03476174|Pembrolizumab|pembrolizumab|mesh-list
93284473|NCT03476174|Interleukin-2|interleukin-2|mesh-list
93284474|NCT03476174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93284475|NCT03476174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284476|NCT03476174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956505|NCT03572582|Nivolumab|nivolumab|mesh-list
93284477|NCT03476174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284478|NCT03476174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284479|NCT03476174|Analgesics|analgesics|mesh-ancestor
93284480|NCT03476174|Sensory System Agents|sensory system agents|mesh-ancestor
93284481|NCT03476174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284482|NCT03476174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284483|NCT02523638|Interferons|interferons|mesh-list
93284484|NCT02523638|Interferon-alpha|interferon-alpha|mesh-list
93284485|NCT02523638|Interferon alpha-2|interferon alpha-2|mesh-list
93284486|NCT02523638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284487|NCT02523638|Antiviral Agents|antiviral agents|mesh-ancestor
93284488|NCT02523638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284489|NCT02523638|Immunologic Factors|immunologic factors|mesh-ancestor
93284490|NCT02523638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284491|NCT05257148|Nebivolol|nebivolol|mesh-list
93284492|NCT05257148|Zofenopril|zofenopril|mesh-list
93284493|NCT05257148|Captopril|captopril|mesh-list
93284494|NCT05257148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93284495|NCT05257148|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284496|NCT05257148|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93284497|NCT05257148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93284498|NCT05257148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93284499|NCT05257148|Adrenergic Agents|adrenergic agents|mesh-ancestor
93284500|NCT05257148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284501|NCT05257148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284502|NCT05257148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284503|NCT05257148|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93284504|NCT05257148|Protease Inhibitors|protease inhibitors|mesh-ancestor
93284505|NCT05257148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284506|NCT03481790|Folic Acid|folic acid|mesh-list
93284507|NCT03481790|Lactoferrin|lactoferrin|mesh-list
93284508|NCT03481790|Vitamins|vitamins|mesh-ancestor
93284509|NCT03481790|Micronutrients|micronutrients|mesh-ancestor
93284510|NCT03481790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284511|NCT03481790|Hematinics|hematinics|mesh-ancestor
93284512|NCT03481790|Vitamin B Complex|vitamin b complex|mesh-ancestor
93284513|NCT03481790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284514|NCT03475862|Oxycodone|oxycodone|mesh-list
93284515|NCT03475862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93284516|NCT03475862|Narcotics|narcotics|mesh-ancestor
93284517|NCT03475862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284518|NCT03475862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284519|NCT03475862|Analgesics|analgesics|mesh-ancestor
93284520|NCT03475862|Sensory System Agents|sensory system agents|mesh-ancestor
93284521|NCT03475862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284522|NCT03368066|Cosyntropin|cosyntropin|mesh-list
93284523|NCT03368066|Hormones|hormones|mesh-ancestor
93284524|NCT03368066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284525|NCT03368066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284526|NCT03475628|Daratumumab|daratumumab|mesh-list
93284527|NCT03475628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284528|NCT05195450|Tenofovir|tenofovir|mesh-list
93284529|NCT05195450|Antiviral Agents|antiviral agents|mesh-ancestor
93284530|NCT05195450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284531|NCT05195450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93284532|NCT05195450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93284533|NCT05195450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284534|NCT05195450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284535|NCT05195450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93284536|NCT05195450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93284537|NCT03477422|Meropenem|meropenem|mesh-list
93284538|NCT03477422|Ceftriaxone|ceftriaxone|mesh-list
93284539|NCT03477422|Sulbactam|sulbactam|mesh-list
93284540|NCT03477422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93284541|NCT03477422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284542|NCT03477422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93284543|NCT03477422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284544|NCT03477422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284545|NCT01355289|Interferons|interferons|mesh-list
93284546|NCT01355289|Ribavirin|ribavirin|mesh-list
93284547|NCT01355289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284548|NCT01355289|Antiviral Agents|antiviral agents|mesh-ancestor
93284549|NCT01355289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284550|NCT01355289|Antimetabolites|antimetabolites|mesh-ancestor
93284551|NCT01355289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284552|NCT03473210|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93284553|NCT03473210|Erythromycin|erythromycin|mesh-list
93284554|NCT03473210|Ampicillin|ampicillin|mesh-list
93284556|NCT03473210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284557|NCT03473210|Antiemetics|antiemetics|mesh-ancestor
93284558|NCT03473210|Autonomic Agents|autonomic agents|mesh-ancestor
93284559|NCT03473210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284560|NCT03473210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284561|NCT03473210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284562|NCT03473210|Glucocorticoids|glucocorticoids|mesh-ancestor
93284563|NCT03473210|Hormones|hormones|mesh-ancestor
93284564|NCT03473210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284565|NCT03473210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93284566|NCT03473210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284567|NCT03473210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284568|NCT03473210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284569|NCT03473210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284570|NCT03473210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93284571|NCT03473132|Thrombin|thrombin|mesh-list
93284572|NCT03473132|Hemostatics|hemostatics|mesh-ancestor
93284573|NCT03473132|Coagulants|coagulants|mesh-ancestor
93284574|NCT03475160|Sildenafil Citrate|sildenafil citrate|mesh-list
93284575|NCT03475160|Citric Acid|citric acid|mesh-list
93284576|NCT03475160|Sodium Citrate|sodium citrate|mesh-list
93284577|NCT03475160|Anticoagulants|anticoagulants|mesh-ancestor
93284578|NCT03475160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93284579|NCT03475160|Chelating Agents|chelating agents|mesh-ancestor
93284580|NCT03475160|Sequestering Agents|sequestering agents|mesh-ancestor
93284581|NCT03475160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284582|NCT03475160|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284583|NCT03475160|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93284584|NCT03475160|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93284585|NCT03475160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284586|NCT03475160|Urological Agents|urological agents|mesh-ancestor
93284587|NCT00308516|Leucovorin|leucovorin|mesh-list
93284588|NCT00308516|Bevacizumab|bevacizumab|mesh-list
93284589|NCT00308516|Fluorouracil|fluorouracil|mesh-list
93284590|NCT00308516|Oxaliplatin|oxaliplatin|mesh-list
93284591|NCT00308516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93284592|NCT00308516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284593|NCT00308516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93284594|NCT00308516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93284595|NCT00308516|Growth Substances|growth substances|mesh-ancestor
93284596|NCT00308516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284597|NCT00308516|Growth Inhibitors|growth inhibitors|mesh-ancestor
93284598|NCT00308516|Antimetabolites|antimetabolites|mesh-ancestor
93284599|NCT00308516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284600|NCT00308516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93284601|NCT00308516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284602|NCT00308516|Immunologic Factors|immunologic factors|mesh-ancestor
93284603|NCT00308516|Antidotes|antidotes|mesh-ancestor
93284604|NCT00308516|Protective Agents|protective agents|mesh-ancestor
93284605|NCT00308516|Vitamin B Complex|vitamin b complex|mesh-ancestor
93284606|NCT00308516|Vitamins|vitamins|mesh-ancestor
93284607|NCT00308516|Micronutrients|micronutrients|mesh-ancestor
93284608|NCT05155592|Adalimumab|adalimumab|mesh-list
93284609|NCT05155592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93284610|NCT05155592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284611|NCT05155592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284612|NCT03474614|Propranolol|propranolol|mesh-list
93284613|NCT03474614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93284614|NCT03474614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93284615|NCT03474614|Adrenergic Agents|adrenergic agents|mesh-ancestor
93284616|NCT03474614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284617|NCT03474614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284618|NCT03474614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284619|NCT03474614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93284620|NCT03474614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93284621|NCT03474614|Vasodilator Agents|vasodilator agents|mesh-ancestor
93284622|NCT05155202|Antihypertensive Agents|antihypertensive agents|mesh-list
93284623|NCT02737358|Acetylcysteine|acetylcysteine|mesh-list
93284624|NCT02737358|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93284625|NCT02737358|Antiviral Agents|antiviral agents|mesh-ancestor
93284626|NCT02737358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284627|NCT02737358|Expectorants|expectorants|mesh-ancestor
93284628|NCT02737358|Respiratory System Agents|respiratory system agents|mesh-ancestor
93284629|NCT02737358|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93284630|NCT02737358|Antioxidants|antioxidants|mesh-ancestor
93284631|NCT02737358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284632|NCT02737358|Protective Agents|protective agents|mesh-ancestor
93284633|NCT02737358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284634|NCT02737358|Antidotes|antidotes|mesh-ancestor
93284635|NCT05052710|Midazolam|midazolam|mesh-list
93284636|NCT05052710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93284637|NCT05052710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93284638|NCT05052710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284639|NCT05052710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284640|NCT05052710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93284641|NCT05052710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93284642|NCT05052710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284643|NCT05052710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93284644|NCT05052710|Anesthetics, General|anesthetics, general|mesh-ancestor
93284645|NCT05052710|Anesthetics|anesthetics|mesh-ancestor
93284646|NCT05052710|GABA Modulators|gaba modulators|mesh-ancestor
93284647|NCT05052710|GABA Agents|gaba agents|mesh-ancestor
93284648|NCT05052710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284649|NCT05052710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284650|NCT02866838|Tranexamic Acid|tranexamic acid|mesh-list
93284651|NCT02866838|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93284652|NCT02866838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93284653|NCT02866838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284654|NCT02866838|Hemostatics|hemostatics|mesh-ancestor
93284655|NCT02866838|Coagulants|coagulants|mesh-ancestor
93284656|NCT03474146|Chlorhexidine|chlorhexidine|mesh-list
93284657|NCT03474146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93284658|NCT03474146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93284659|NCT03474146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284660|NCT03474146|Disinfectants|disinfectants|mesh-ancestor
93284661|NCT03474146|Dermatologic Agents|dermatologic agents|mesh-ancestor
93284662|NCT01090154|Certolizumab Pegol|certolizumab pegol|mesh-list
93284663|NCT01090154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93284664|NCT01090154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284665|NCT01090154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284666|NCT01090154|Immunologic Factors|immunologic factors|mesh-ancestor
93284667|NCT01090154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284668|NCT01090154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284669|NCT01354431|Nivolumab|nivolumab|mesh-list
93284670|NCT01354431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93284671|NCT01354431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284672|NCT01354431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93284673|NCT01354431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284674|NCT02736578|Cetuximab|cetuximab|mesh-list
93284675|NCT02736578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93284676|NCT02736578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284677|NCT02478788|Amphetamine|amphetamine|mesh-list
93284678|NCT02478788|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93284679|NCT02478788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284680|NCT02478788|Sympathomimetics|sympathomimetics|mesh-ancestor
93284681|NCT02478788|Autonomic Agents|autonomic agents|mesh-ancestor
93284682|NCT02478788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284683|NCT02478788|Dopamine Agents|dopamine agents|mesh-ancestor
93284684|NCT02478788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284685|NCT02478788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284686|NCT02478788|Adrenergic Agents|adrenergic agents|mesh-ancestor
93284687|NCT02478788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93284688|NCT02478788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93284689|NCT02478788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93284690|NCT02478788|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93284691|NCT05157542|Paclitaxel|paclitaxel|mesh-list
93284692|NCT05157542|Durvalumab|durvalumab|mesh-list
93284693|NCT05157542|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93284694|NCT05157542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93284695|NCT05157542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284696|NCT05157542|Tubulin Modulators|tubulin modulators|mesh-ancestor
93284697|NCT05157542|Antimitotic Agents|antimitotic agents|mesh-ancestor
93284698|NCT05157542|Mitosis Modulators|mitosis modulators|mesh-ancestor
93284699|NCT05157542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284700|NCT05157542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93284701|NCT03472976|Imiquimod|imiquimod|mesh-list
93284702|NCT03472976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92956713|NCT03071406|Nivolumab|nivolumab|mesh-list
93284703|NCT03472976|Immunologic Factors|immunologic factors|mesh-ancestor
92956714|NCT03071406|Ipilimumab|ipilimumab|mesh-list
93284704|NCT03472976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284705|NCT03472976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284706|NCT03472976|Interferon Inducers|interferon inducers|mesh-ancestor
93284707|NCT03473600|Triamcinolone|triamcinolone|mesh-list
93284708|NCT03473600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93284709|NCT03473600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93284710|NCT03473600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93284711|NCT03473600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284712|NCT03473600|Glucocorticoids|glucocorticoids|mesh-ancestor
93284713|NCT03473600|Hormones|hormones|mesh-ancestor
93284714|NCT03473600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284715|NCT03473600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284716|NCT03473600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93284717|NCT03473600|Immunologic Factors|immunologic factors|mesh-ancestor
93284718|NCT03473600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284719|NCT03473600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284720|NCT04457648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93284721|NCT04457648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93284722|NCT02622724|Interferons|interferons|mesh-list
93284723|NCT02622724|Interferon-beta|interferon-beta|mesh-list
93284724|NCT02622724|Interferon beta-1a|interferon beta-1a|mesh-list
93284725|NCT02622724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284726|NCT02622724|Antiviral Agents|antiviral agents|mesh-ancestor
93284727|NCT02622724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284728|NCT02622724|Immunologic Factors|immunologic factors|mesh-ancestor
93284729|NCT02622724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284730|NCT02622724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93284731|NCT01354353|Aripiprazole|aripiprazole|mesh-list
93284732|NCT01354353|Antidepressive Agents|antidepressive agents|mesh-ancestor
93284733|NCT01354353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284734|NCT01354353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93284735|NCT01354353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93284736|NCT01354353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284737|NCT01354353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284738|NCT01354353|Dopamine Agonists|dopamine agonists|mesh-ancestor
93284739|NCT01354353|Dopamine Agents|dopamine agents|mesh-ancestor
93284740|NCT01354353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284741|NCT01354353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284742|NCT01354353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93284743|NCT01354353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93284744|NCT01354353|Serotonin Agents|serotonin agents|mesh-ancestor
93284745|NCT01354353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93284746|NCT01354353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93284747|NCT01354353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93284748|NCT01354353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93284749|NCT04931524|Mitogens|mitogens|mesh-list
93284750|NCT04931524|Mitosis Modulators|mitosis modulators|mesh-ancestor
93284751|NCT04931524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284752|NCT03562611|Flurbiprofen|flurbiprofen|mesh-list
93284753|NCT03562611|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
93284754|NCT03562611|Nalbuphine|nalbuphine|mesh-list
93284755|NCT03562611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93284756|NCT03562611|Narcotics|narcotics|mesh-ancestor
93284757|NCT03562611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284758|NCT03562611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284759|NCT03562611|Analgesics|analgesics|mesh-ancestor
93284760|NCT03562611|Sensory System Agents|sensory system agents|mesh-ancestor
93284761|NCT03562611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284762|NCT03562611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93284763|NCT03562611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284764|NCT03562611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284765|NCT03562611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284766|NCT03562611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93284767|NCT03562611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284768|NCT03562611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284769|NCT03057574|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93284770|NCT03057574|Hormones|hormones|mesh-ancestor
93284771|NCT03057574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93284772|NCT03057574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284773|NCT03057028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93284774|NCT03057028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284775|NCT04929652|Irinotecan|irinotecan|mesh-list
93284776|NCT04929652|Molgramostim|molgramostim|mesh-list
93284777|NCT04929652|Sargramostim|sargramostim|mesh-list
93284778|NCT04929652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93284779|NCT04929652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93284780|NCT04929652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284781|NCT04929652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284782|NCT04929652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284783|NCT04929652|Immunologic Factors|immunologic factors|mesh-ancestor
93284784|NCT04929652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284785|NCT01353963|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93284786|NCT01353963|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93284787|NCT01353963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93284788|NCT01353963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93284789|NCT01353963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284790|NCT01353963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284791|NCT01353963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284792|NCT01353963|Antidepressive Agents|antidepressive agents|mesh-ancestor
93284793|NCT01353963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284795|NCT04927936|Immunologic Factors|immunologic factors|mesh-ancestor
93284796|NCT04927936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284797|NCT04167813|Ondansetron|ondansetron|mesh-list
93284798|NCT04167813|Antiemetics|antiemetics|mesh-ancestor
93284799|NCT04167813|Autonomic Agents|autonomic agents|mesh-ancestor
93284800|NCT04167813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284801|NCT04167813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284802|NCT04167813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284803|NCT04167813|Antipruritics|antipruritics|mesh-ancestor
93284804|NCT04167813|Dermatologic Agents|dermatologic agents|mesh-ancestor
93284805|NCT04167813|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93284806|NCT04167813|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93284807|NCT04167813|Serotonin Agents|serotonin agents|mesh-ancestor
93284808|NCT04167813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284809|NCT04167813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284810|NCT03562533|Paclitaxel|paclitaxel|mesh-list
93284811|NCT03562533|Carboplatin|carboplatin|mesh-list
93284812|NCT03562533|Doxorubicin|doxorubicin|mesh-list
93284813|NCT03562533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93284814|NCT03562533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93284815|NCT03562533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284816|NCT03562533|Tubulin Modulators|tubulin modulators|mesh-ancestor
93284817|NCT03562533|Antimitotic Agents|antimitotic agents|mesh-ancestor
93284818|NCT03562533|Mitosis Modulators|mitosis modulators|mesh-ancestor
93284819|NCT03562533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284820|NCT03562533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93284821|NCT03562533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93284822|NCT03562533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93284823|NCT03562533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284824|NCT04927858|Empagliflozin|empagliflozin|mesh-list
93284825|NCT04927858|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93284826|NCT04927858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284827|NCT04927858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93284828|NCT04927858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284829|NCT04014387|Zolpidem|zolpidem|mesh-list
93284830|NCT04014387|Suvorexant|suvorexant|mesh-list
93284831|NCT04014387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93284832|NCT04014387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93284833|NCT04014387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284834|NCT04014387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284835|NCT04014387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93284836|NCT04014387|GABA Agonists|gaba agonists|mesh-ancestor
93284837|NCT04014387|GABA Agents|gaba agents|mesh-ancestor
93284838|NCT04014387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284839|NCT04014387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284840|NCT04014387|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93284841|NCT05707455|Chrysarobin|chrysarobin|mesh-list
93284842|NCT05707455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93284843|NCT05707455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93284844|NCT05707455|Analgesics|analgesics|mesh-ancestor
93284845|NCT05707455|Sensory System Agents|sensory system agents|mesh-ancestor
93284846|NCT05707455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284847|NCT05707455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284848|NCT05707455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93284849|NCT05707455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284850|NCT04927000|Tofacitinib|tofacitinib|mesh-list
93284851|NCT04927000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93284852|NCT04927000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93284853|NCT04927000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284854|NCT04927000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284855|NCT04926532|Sorafenib|sorafenib|mesh-list
93284856|NCT04926532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284857|NCT04926532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93284858|NCT04926532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284859|NCT04926532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284860|NCT03842709|Pramipexole|pramipexole|mesh-list
93284861|NCT03842709|Antioxidants|antioxidants|mesh-ancestor
93284862|NCT03842709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284863|NCT03842709|Protective Agents|protective agents|mesh-ancestor
93284864|NCT03842709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284865|NCT03842709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93284866|NCT03842709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93284867|NCT03842709|Dopamine Agonists|dopamine agonists|mesh-ancestor
93284868|NCT03842709|Dopamine Agents|dopamine agents|mesh-ancestor
93284869|NCT03842709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284870|NCT05707533|Cefoxitin|cefoxitin|mesh-list
93284871|NCT05707533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93284872|NCT05707533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284873|NCT03056482|Haloperidol|haloperidol|mesh-list
93284874|NCT03056482|Ondansetron|ondansetron|mesh-list
93284875|NCT03056482|Haloperidol decanoate|haloperidol decanoate|mesh-list
93284876|NCT03056482|Antiemetics|antiemetics|mesh-ancestor
93284877|NCT03056482|Autonomic Agents|autonomic agents|mesh-ancestor
93284878|NCT03056482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284879|NCT03056482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284880|NCT03056482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93284881|NCT03056482|Antipruritics|antipruritics|mesh-ancestor
93284882|NCT03056482|Dermatologic Agents|dermatologic agents|mesh-ancestor
93284883|NCT03056482|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93284884|NCT03056482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93284885|NCT03056482|Serotonin Agents|serotonin agents|mesh-ancestor
93284886|NCT03056482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284887|NCT03056482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284888|NCT03056482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93284889|NCT03056482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93284890|NCT03056482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284891|NCT03056482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284892|NCT03056482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93284893|NCT03056482|Dopamine Agents|dopamine agents|mesh-ancestor
93284894|NCT03056482|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93284895|NCT02817555|Epoetin Alfa|epoetin alfa|mesh-list
93284896|NCT02817555|Darbepoetin alfa|darbepoetin alfa|mesh-list
93284897|NCT02817555|Hematinics|hematinics|mesh-ancestor
93284898|NCT04924192|Irinotecan|irinotecan|mesh-list
93284899|NCT04924192|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93284900|NCT04924192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93284901|NCT04924192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284902|NCT04924192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284903|NCT04924192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284904|NCT02036073|Epoetin Alfa|epoetin alfa|mesh-list
93284905|NCT02036073|Hematinics|hematinics|mesh-ancestor
93284906|NCT02036229|Ivermectin|ivermectin|mesh-list
93284907|NCT02036229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93284908|NCT02036229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284909|NCT04404088|Rituximab|rituximab|mesh-list
93284910|NCT04404088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93284911|NCT04404088|Lenalidomide|lenalidomide|mesh-list
93284912|NCT04404088|Acalabrutinib|acalabrutinib|mesh-list
93284913|NCT04404088|Antibodies|antibodies|mesh-list
93284914|NCT04404088|Immunoglobulins|immunoglobulins|mesh-list
93284915|NCT04404088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93284916|NCT04404088|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93284917|NCT04404088|Immunologic Factors|immunologic factors|mesh-ancestor
93284918|NCT04404088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284919|NCT04404088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284920|NCT04404088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93284921|NCT04404088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93284922|NCT04404088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93284923|NCT04404088|Growth Substances|growth substances|mesh-ancestor
93284924|NCT04404088|Growth Inhibitors|growth inhibitors|mesh-ancestor
93284925|NCT04404088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93284926|NCT04404088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284927|NCT04404088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284928|NCT04922008|Capecitabine|capecitabine|mesh-list
93284929|NCT04922008|Trastuzumab|trastuzumab|mesh-list
93284930|NCT04922008|Vinorelbine|vinorelbine|mesh-list
93284931|NCT04922008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93284933|NCT04922008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284934|NCT04922008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284935|NCT04922008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93284936|NCT04922008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93284937|NCT04922008|Tubulin Modulators|tubulin modulators|mesh-ancestor
93284938|NCT04922008|Antimitotic Agents|antimitotic agents|mesh-ancestor
93284939|NCT04922008|Mitosis Modulators|mitosis modulators|mesh-ancestor
93284940|NCT03056092|Ranibizumab|ranibizumab|mesh-list
93284941|NCT03056092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93284942|NCT03056092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93284943|NCT03056092|Growth Substances|growth substances|mesh-ancestor
93284944|NCT03056092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284945|NCT03056092|Growth Inhibitors|growth inhibitors|mesh-ancestor
93284946|NCT03056092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93284947|NCT04921306|Clenbuterol|clenbuterol|mesh-list
93284948|NCT04921306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93284949|NCT04921306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93284950|NCT04921306|Adrenergic Agents|adrenergic agents|mesh-ancestor
93284951|NCT04921306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93284952|NCT04921306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284953|NCT04921306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284954|NCT04921306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93284955|NCT04921306|Autonomic Agents|autonomic agents|mesh-ancestor
93284956|NCT04921306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93284957|NCT04921306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93284958|NCT04921306|Respiratory System Agents|respiratory system agents|mesh-ancestor
93284959|NCT04921306|Sympathomimetics|sympathomimetics|mesh-ancestor
93284960|NCT04920760|Vitamin A|vitamin a|mesh-list
93284961|NCT04920760|Vitamins|vitamins|mesh-ancestor
93284962|NCT04920760|Micronutrients|micronutrients|mesh-ancestor
93284963|NCT04920760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284964|NCT03056248|Lithium Carbonate|lithium carbonate|mesh-list
93284965|NCT03056248|Antidepressive Agents|antidepressive agents|mesh-ancestor
93284966|NCT03056248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93284967|NCT03056248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284968|NCT03056248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284969|NCT03056248|Antimanic Agents|antimanic agents|mesh-ancestor
93284970|NCT03056248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93284971|NCT03056248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284972|NCT03056248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284973|NCT04920604|Anesthetics|anesthetics|mesh-list
93284974|NCT04920604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93284975|NCT04920604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284976|NCT04920448|Acetylcysteine|acetylcysteine|mesh-list
93284977|NCT04920448|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93284978|NCT04920448|Antiviral Agents|antiviral agents|mesh-ancestor
93284979|NCT04920448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93284980|NCT04920448|Expectorants|expectorants|mesh-ancestor
93284981|NCT04920448|Respiratory System Agents|respiratory system agents|mesh-ancestor
93284982|NCT04920448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93284983|NCT04920448|Antioxidants|antioxidants|mesh-ancestor
93284984|NCT04920448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284985|NCT04920448|Protective Agents|protective agents|mesh-ancestor
93284986|NCT04920448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284987|NCT04920448|Antidotes|antidotes|mesh-ancestor
93284988|NCT04969354|Immunomodulating Agents|immunomodulating agents|mesh-list
93284989|NCT04969354|Immunologic Factors|immunologic factors|mesh-ancestor
93284990|NCT04969354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93284991|NCT03061006|Warfarin|warfarin|mesh-list
93284992|NCT03061006|Dabigatran|dabigatran|mesh-list
93284993|NCT03061006|Anticoagulants|anticoagulants|mesh-ancestor
93284994|NCT03061006|Antithrombins|antithrombins|mesh-ancestor
93284995|NCT03061006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93284996|NCT03061006|Protease Inhibitors|protease inhibitors|mesh-ancestor
93284997|NCT03061006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93284998|NCT03061006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93284999|NCT03060850|Abivertinib|abivertinib|mesh-list
93285000|NCT03060850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93285001|NCT03060850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285002|NCT03060850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285003|NCT04432558|Acetaminophen|acetaminophen|mesh-list
93285004|NCT04432558|Diclofenac|diclofenac|mesh-list
93285005|NCT04432558|Tramadol|tramadol|mesh-list
93285006|NCT04432558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93285007|NCT04432558|Analgesics|analgesics|mesh-ancestor
93285008|NCT04432558|Sensory System Agents|sensory system agents|mesh-ancestor
93285009|NCT04432558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285010|NCT04432558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285011|NCT04432558|Antipyretics|antipyretics|mesh-ancestor
93285012|NCT04432558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93285013|NCT04432558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285014|NCT04432558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285015|NCT04432558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93285016|NCT04432558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579486|NCT00110604|Folic Acid|folic acid|mesh-list
93285017|NCT04432558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285018|NCT04432558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93285019|NCT04432558|Narcotics|narcotics|mesh-ancestor
93285020|NCT04432558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285021|NCT04979650|Methylprednisolone|methylprednisolone|mesh-list
93285022|NCT04979650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93285023|NCT04979650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93285024|NCT04979650|Prednisolone|prednisolone|mesh-list
93285025|NCT04979650|Prednisolone acetate|prednisolone acetate|mesh-list
93285026|NCT04979650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93285027|NCT04979650|Prednisolone phosphate|prednisolone phosphate|mesh-list
93285028|NCT04979650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285029|NCT04979650|Antiemetics|antiemetics|mesh-ancestor
93285030|NCT04979650|Autonomic Agents|autonomic agents|mesh-ancestor
93285031|NCT04979650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285032|NCT04979650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285033|NCT04979650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285034|NCT04979650|Glucocorticoids|glucocorticoids|mesh-ancestor
93285035|NCT04979650|Hormones|hormones|mesh-ancestor
93285036|NCT04979650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285037|NCT04979650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93285038|NCT04979650|Protective Agents|protective agents|mesh-ancestor
93285039|NCT04979650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285040|NCT04979650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285041|NCT04650152|Fenofibrate|fenofibrate|mesh-list
93285042|NCT04650152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93285043|NCT04650152|Antimetabolites|antimetabolites|mesh-ancestor
93285044|NCT04650152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285045|NCT04650152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93285046|NCT04967950|Methotrexate|methotrexate|mesh-list
93285047|NCT04967950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93285048|NCT04967950|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93285049|NCT04967950|Abortifacient Agents|abortifacient agents|mesh-ancestor
93285050|NCT04967950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93285051|NCT04967950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285052|NCT04967950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285053|NCT04967950|Antimetabolites|antimetabolites|mesh-ancestor
93285054|NCT04967950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285055|NCT04967950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285056|NCT04967950|Dermatologic Agents|dermatologic agents|mesh-ancestor
93285057|NCT04967950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285058|NCT04967950|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93285059|NCT04967950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285060|NCT04967950|Immunologic Factors|immunologic factors|mesh-ancestor
93285061|NCT04967950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285062|NCT04967950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93285063|NCT04967326|Carbamazepine|carbamazepine|mesh-list
93285064|NCT04967326|Phenytoin|phenytoin|mesh-list
93285065|NCT04967326|Valproic Acid|valproic acid|mesh-list
93285066|NCT04967326|Anticonvulsants|anticonvulsants|mesh-list
93285067|NCT04967326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285068|NCT04967326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285069|NCT04967326|GABA Agents|gaba agents|mesh-ancestor
93285070|NCT04967326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285071|NCT04967326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285072|NCT04967326|Antimanic Agents|antimanic agents|mesh-ancestor
93285073|NCT04967326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93285074|NCT04967326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285075|NCT04967326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93285076|NCT04967326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93285077|NCT04967326|Analgesics|analgesics|mesh-ancestor
93285078|NCT04967326|Sensory System Agents|sensory system agents|mesh-ancestor
93285079|NCT04967326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285080|NCT04967326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93285081|NCT04967326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957092|NCT02122562|Sensory System Agents|sensory system agents|mesh-ancestor
93285082|NCT04967326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93285083|NCT04967326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93285084|NCT04967326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93285085|NCT04967326|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93285086|NCT03062176|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93285087|NCT03062176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285088|NCT02620384|Metolazone|metolazone|mesh-list
93285089|NCT02620384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93285090|NCT02620384|Diuretics|diuretics|mesh-ancestor
93285091|NCT02620384|Natriuretic Agents|natriuretic agents|mesh-ancestor
93285092|NCT02620384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285093|NCT02620384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93285094|NCT02620384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285095|NCT02620384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285096|NCT04918576|Tranexamic Acid|tranexamic acid|mesh-list
93285097|NCT04918576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93285098|NCT04918576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93285099|NCT04918576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285100|NCT04918576|Hemostatics|hemostatics|mesh-ancestor
93285101|NCT04918576|Coagulants|coagulants|mesh-ancestor
93285102|NCT03472508|Folic Acid|folic acid|mesh-list
93285103|NCT03472508|Vitamin B Complex|vitamin b complex|mesh-list
93285104|NCT03472508|Enalapril|enalapril|mesh-list
93285105|NCT03472508|Enalaprilat|enalaprilat|mesh-list
93285106|NCT03472508|Hematinics|hematinics|mesh-ancestor
93285107|NCT03472508|Vitamins|vitamins|mesh-ancestor
93285108|NCT03472508|Micronutrients|micronutrients|mesh-ancestor
93285109|NCT03472508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285110|NCT03472508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285111|NCT03472508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285112|NCT03472508|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93285113|NCT03472508|Protease Inhibitors|protease inhibitors|mesh-ancestor
93285114|NCT03472508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93285115|NCT04966234|Posaconazole|posaconazole|mesh-list
93285116|NCT04966234|Antifungal Agents|antifungal agents|mesh-ancestor
93285117|NCT04966234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285118|NCT04966234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93285119|NCT04966234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93285120|NCT04966234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93285121|NCT04966234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93285122|NCT04966234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93285123|NCT04966234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285124|NCT04966234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285125|NCT04966234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93285126|NCT04966234|Hormone Antagonists|hormone antagonists|mesh-ancestor
93285127|NCT04966234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285128|NCT04966234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285129|NCT03915860|Trifarotene|trifarotene|mesh-list
93285130|NCT03915860|Dermatologic Agents|dermatologic agents|mesh-ancestor
93285131|NCT04170998|Metformin|metformin|mesh-list
93285132|NCT04170998|Dapagliflozin|dapagliflozin|mesh-list
93285133|NCT04170998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93285134|NCT04170998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285135|NCT04170998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93285136|NCT04170998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285137|NCT04965532|Anesthetics|anesthetics|mesh-list
93285138|NCT04965532|Propofol|propofol|mesh-list
93285139|NCT04965532|Sevoflurane|sevoflurane|mesh-list
93285140|NCT04965532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285141|NCT04965532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285142|NCT04965532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93285143|NCT04965532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93285144|NCT04965532|Anesthetics, General|anesthetics, general|mesh-ancestor
93285145|NCT04965532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93285146|NCT04965532|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93285147|NCT03055546|Oxytocin|oxytocin|mesh-list
93285148|NCT03055546|Oxytocics|oxytocics|mesh-ancestor
93285149|NCT03055546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93285150|NCT03055546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285151|NCT04918264|Capecitabine|capecitabine|mesh-list
93285152|NCT04918264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285153|NCT04918264|Antimetabolites|antimetabolites|mesh-ancestor
93285154|NCT04918264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285155|NCT04918264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285156|NCT04917718|Tacrolimus|tacrolimus|mesh-list
93285157|NCT04917718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285158|NCT04917718|Immunologic Factors|immunologic factors|mesh-ancestor
93285159|NCT04917718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285160|NCT04917718|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93285161|NCT04917718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285162|NCT04917718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285164|NCT04977778|Tin Fluorides|tin fluorides|mesh-list
93285165|NCT04977778|Cariostatic Agents|cariostatic agents|mesh-ancestor
93285166|NCT04977778|Protective Agents|protective agents|mesh-ancestor
93285167|NCT04977778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285168|NCT03055234|Treprostinil|treprostinil|mesh-list
93285169|NCT03055234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93285170|NCT03055312|Bicalutamide|bicalutamide|mesh-list
93285171|NCT03055312|Androgen Antagonists|androgen antagonists|mesh-ancestor
93285172|NCT03055312|Hormone Antagonists|hormone antagonists|mesh-ancestor
93285173|NCT03055312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285174|NCT03055312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285175|NCT03055312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285176|NCT04977544|Sertraline|sertraline|mesh-list
93285177|NCT04977544|Antidepressive Agents|antidepressive agents|mesh-ancestor
93285178|NCT04977544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93285179|NCT04977544|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93285180|NCT04977544|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93285181|NCT04977544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285182|NCT04977544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285183|NCT04977544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285184|NCT04977544|Serotonin Agents|serotonin agents|mesh-ancestor
93285185|NCT04977544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285186|NCT02626000|Pembrolizumab|pembrolizumab|mesh-list
93285187|NCT02626000|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93285188|NCT02626000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285189|NCT02626000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285190|NCT02626000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93285191|NCT02626000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285192|NCT03769376|Salvin|salvin|mesh-list
93285193|NCT03769376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93285194|NCT03769376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285195|NCT03769376|Antioxidants|antioxidants|mesh-ancestor
93285196|NCT03769376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285197|NCT03769376|Protective Agents|protective agents|mesh-ancestor
93285198|NCT03769376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285199|NCT05156450|Prednisone|prednisone|mesh-list
93285200|NCT05156450|Abiraterone Acetate|abiraterone acetate|mesh-list
93285201|NCT05156450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285202|NCT05156450|Glucocorticoids|glucocorticoids|mesh-ancestor
93285203|NCT05156450|Hormones|hormones|mesh-ancestor
93285204|NCT05156450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285205|NCT05156450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285206|NCT05156450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285207|NCT05156450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285208|NCT05156450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93285209|NCT05156450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285210|NCT05156450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285211|NCT05156450|Hormone Antagonists|hormone antagonists|mesh-ancestor
93285212|NCT05156450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93285213|NCT03060304|Tamoxifen|tamoxifen|mesh-list
93285214|NCT03060304|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93285215|NCT03060304|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93285216|NCT03060304|Estradiol|estradiol|mesh-list
93285217|NCT03060304|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93285218|NCT03060304|Estrogens|estrogens|mesh-ancestor
93285219|NCT03060304|Hormones|hormones|mesh-ancestor
93285220|NCT03060304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285221|NCT03060304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285222|NCT03060304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93285223|NCT03060304|Contraceptive Agents|contraceptive agents|mesh-ancestor
93285224|NCT03060304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93285225|NCT03060304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93285226|NCT03060304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93285227|NCT03060304|Hormone Antagonists|hormone antagonists|mesh-ancestor
93285228|NCT03060304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285229|NCT03060304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285230|NCT03060304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93285231|NCT03060304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93285232|NCT03060304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93285233|NCT04432402|Gemcitabine|gemcitabine|mesh-list
93285234|NCT04432402|Oxaliplatin|oxaliplatin|mesh-list
93285235|NCT04432402|Lenalidomide|lenalidomide|mesh-list
93285236|NCT04432402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285237|NCT04432402|Immunologic Factors|immunologic factors|mesh-ancestor
93285238|NCT04432402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285239|NCT04432402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285240|NCT04432402|Antimetabolites|antimetabolites|mesh-ancestor
93285241|NCT04432402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285242|NCT04432402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93285243|NCT04432402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93285244|NCT04432402|Growth Substances|growth substances|mesh-ancestor
93285245|NCT04432402|Growth Inhibitors|growth inhibitors|mesh-ancestor
93285246|NCT04432324|Immunoglobulins|immunoglobulins|mesh-list
93285247|NCT04432324|Antibodies|antibodies|mesh-list
93285248|NCT04432324|gamma-Globulins|gamma-globulins|mesh-list
93285249|NCT04432324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93285250|NCT04432324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93285251|NCT04432324|Immunologic Factors|immunologic factors|mesh-ancestor
93285252|NCT04432324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285253|NCT02736890|Botulinum Toxins|botulinum toxins|mesh-list
93285254|NCT02736890|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93285255|NCT02736890|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93285256|NCT02736890|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93285257|NCT02736890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285258|NCT02736890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285259|NCT02736890|Cholinergic Agents|cholinergic agents|mesh-ancestor
93285260|NCT02736890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285261|NCT02736890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285262|NCT02736890|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93285263|NCT02736890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285264|NCT04977388|Droxidopa|droxidopa|mesh-list
93285265|NCT04977388|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93285266|NCT04977388|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93285267|NCT03470480|Methamphetamine|methamphetamine|mesh-list
93285268|NCT03470480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93285269|NCT03470480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285270|NCT03470480|Sympathomimetics|sympathomimetics|mesh-ancestor
93285271|NCT03470480|Autonomic Agents|autonomic agents|mesh-ancestor
93285272|NCT03470480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285273|NCT03470480|Dopamine Agents|dopamine agents|mesh-ancestor
93285274|NCT03470480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285275|NCT03470480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285276|NCT03470480|Adrenergic Agents|adrenergic agents|mesh-ancestor
93285277|NCT03470480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93285278|NCT03470480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93285279|NCT03470480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285280|NCT03470480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93285281|NCT03469856|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93285282|NCT03469856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93285283|NCT04917250|Dexamethasone|dexamethasone|mesh-list
93285284|NCT04917250|Gemcitabine|gemcitabine|mesh-list
93285285|NCT04917250|Etoposide|etoposide|mesh-list
93285286|NCT04917250|Pegaspargase|pegaspargase|mesh-list
93285287|NCT04917250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285288|NCT04917250|Antiemetics|antiemetics|mesh-ancestor
93285289|NCT04917250|Autonomic Agents|autonomic agents|mesh-ancestor
93285290|NCT04917250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285291|NCT04917250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285292|NCT04917250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285293|NCT04917250|Glucocorticoids|glucocorticoids|mesh-ancestor
93285294|NCT04917250|Hormones|hormones|mesh-ancestor
93285295|NCT04917250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285296|NCT04917250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285297|NCT04917250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285298|NCT04917250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285299|NCT04917250|Antimetabolites|antimetabolites|mesh-ancestor
93285300|NCT04917250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285301|NCT04917250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93285302|NCT04917250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93285303|NCT04917250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93285304|NCT04917250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285305|NCT04859582|Pembrolizumab|pembrolizumab|mesh-list
93285306|NCT04859582|Fluorouracil|fluorouracil|mesh-list
93285307|NCT04859582|Capecitabine|capecitabine|mesh-list
93285308|NCT04859582|Oxaliplatin|oxaliplatin|mesh-list
93285309|NCT04859582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285310|NCT04859582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285311|NCT04859582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93285312|NCT04859582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285313|NCT04859582|Antimetabolites|antimetabolites|mesh-ancestor
93285314|NCT04859582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285315|NCT04859582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285316|NCT04859582|Immunologic Factors|immunologic factors|mesh-ancestor
93285317|NCT04859582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285318|NCT03469700|Anesthetics|anesthetics|mesh-list
93285319|NCT03469700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285320|NCT03469700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285321|NCT04912726|Sildenafil Citrate|sildenafil citrate|mesh-list
93285322|NCT04912726|Vasodilator Agents|vasodilator agents|mesh-ancestor
93285323|NCT04912726|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93285324|NCT04912726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93285325|NCT04912726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285326|NCT04912726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285327|NCT04912726|Urological Agents|urological agents|mesh-ancestor
93285328|NCT02603900|Bupivacaine|bupivacaine|mesh-list
93285329|NCT02603900|Ropivacaine|ropivacaine|mesh-list
93285330|NCT02603900|Anesthetics, Local|anesthetics, local|mesh-ancestor
93285331|NCT02603900|Anesthetics|anesthetics|mesh-ancestor
93285332|NCT02603900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285333|NCT02603900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285334|NCT02603900|Sensory System Agents|sensory system agents|mesh-ancestor
93285335|NCT02603900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285336|NCT01669798|Nintedanib|nintedanib|mesh-list
93285337|NCT01669798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285338|NCT01669798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93285339|NCT01669798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285340|NCT01669798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285341|NCT02334722|Levetiracetam|levetiracetam|mesh-list
93285342|NCT02334722|Anticonvulsants|anticonvulsants|mesh-ancestor
93285343|NCT02334722|Nootropic Agents|nootropic agents|mesh-ancestor
93285344|NCT04458116|Curcumin|curcumin|mesh-list
93285345|NCT04458116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93285346|NCT04458116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93285347|NCT04458116|Analgesics|analgesics|mesh-ancestor
93285348|NCT04458116|Sensory System Agents|sensory system agents|mesh-ancestor
93285349|NCT04458116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285350|NCT04458116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285351|NCT04458116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285352|NCT04458116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285353|NCT04458116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285354|NCT04458116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285355|NCT04458116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285356|NCT03469544|Hormones|hormones|mesh-list
93285357|NCT03469544|Antibodies|antibodies|mesh-list
93285358|NCT03469544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285359|NCT03469544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285360|NCT03469544|Immunologic Factors|immunologic factors|mesh-ancestor
93285361|NCT03062254|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93285362|NCT03062254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285363|NCT04912258|Irinotecan|irinotecan|mesh-list
93285364|NCT04912258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93285365|NCT04912258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93285366|NCT04912258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285367|NCT04912258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285368|NCT04912258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285369|NCT01952288|Simvastatin|simvastatin|mesh-list
92579837|NCT00111150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93285370|NCT01952288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93285371|NCT01952288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93285372|NCT01952288|Antimetabolites|antimetabolites|mesh-ancestor
93285373|NCT01952288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285374|NCT01952288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93285375|NCT01952288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92957400|NCT04017741|Hormones|hormones|mesh-ancestor
93285376|NCT01952288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285377|NCT03054532|Durvalumab|durvalumab|mesh-list
93285378|NCT03054532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285379|NCT03054532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285380|NCT04975360|Caffeine|caffeine|mesh-list
93285381|NCT04975360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93285382|NCT04975360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285383|NCT04975360|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93285384|NCT04975360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285385|NCT04975360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285386|NCT04975360|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93285387|NCT04975360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93285388|NCT04975360|Purinergic Agents|purinergic agents|mesh-ancestor
93285389|NCT04975360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285390|NCT00563576|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93285391|NCT00563576|Medroxyprogesterone|medroxyprogesterone|mesh-list
93285392|NCT00563576|Estradiol|estradiol|mesh-list
93285393|NCT00563576|Estrogens|estrogens|mesh-ancestor
93285394|NCT00563576|Hormones|hormones|mesh-ancestor
93285395|NCT00563576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285396|NCT00563576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285397|NCT00563576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93285398|NCT00563576|Contraceptive Agents|contraceptive agents|mesh-ancestor
93285399|NCT00563576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93285400|NCT00563576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93285401|NCT00563576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93285402|NCT00563576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93285403|NCT00563576|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93285404|NCT00563576|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93285405|NCT00563576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285406|NCT00563576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285407|NCT04915846|Tamoxifen|tamoxifen|mesh-list
93285408|NCT04915846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93285409|NCT04915846|Hormone Antagonists|hormone antagonists|mesh-ancestor
93285410|NCT04915846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285411|NCT04915846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285412|NCT04915846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285413|NCT04915846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285414|NCT04915846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93285415|NCT04915846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93285416|NCT04915846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93285417|NCT04974970|Immunomodulating Agents|immunomodulating agents|mesh-list
93285418|NCT04974970|Immunologic Factors|immunologic factors|mesh-ancestor
93285419|NCT04974970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285420|NCT03782636|Aldesleukin|aldesleukin|mesh-list
93285421|NCT03782636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285422|NCT03782636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93285423|NCT03782636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93285424|NCT03782636|Antiviral Agents|antiviral agents|mesh-ancestor
93285425|NCT03782636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285426|NCT04911244|Dimercaprol|dimercaprol|mesh-list
93285427|NCT04911244|Chelating Agents|chelating agents|mesh-ancestor
93285428|NCT04911244|Sequestering Agents|sequestering agents|mesh-ancestor
93285429|NCT04911244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285430|NCT03761810|Tretinoin|tretinoin|mesh-list
93285431|NCT03761810|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93285432|NCT03761810|Dermatologic Agents|dermatologic agents|mesh-ancestor
93285433|NCT03761810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285434|NCT03761810|Keratolytic Agents|keratolytic agents|mesh-ancestor
93285435|NCT04915456|Prednisolone|prednisolone|mesh-list
93285436|NCT04915456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285437|NCT04915456|Glucocorticoids|glucocorticoids|mesh-ancestor
93285438|NCT04915456|Hormones|hormones|mesh-ancestor
93285439|NCT04915456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285440|NCT04915456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285441|NCT04915456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285442|NCT04915456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285443|NCT04841668|Metformin|metformin|mesh-list
93285444|NCT04841668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93285445|NCT04841668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285446|NCT04914910|Insulin|insulin|mesh-list
93285447|NCT04914910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93285448|NCT04914910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285449|NCT03469310|Acetaminophen|acetaminophen|mesh-list
93285450|NCT03469310|Tramadol|tramadol|mesh-list
93285451|NCT03469310|Codeine|codeine|mesh-list
92957469|NCT00673920|Immunologic Factors|immunologic factors|mesh-ancestor
93285452|NCT03469310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93285453|NCT03469310|Analgesics|analgesics|mesh-ancestor
93285454|NCT03469310|Sensory System Agents|sensory system agents|mesh-ancestor
93285455|NCT03469310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285456|NCT03469310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285457|NCT03469310|Antipyretics|antipyretics|mesh-ancestor
93285458|NCT03469310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93285459|NCT03469310|Narcotics|narcotics|mesh-ancestor
93285460|NCT03469310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285461|NCT03469310|Antitussive Agents|antitussive agents|mesh-ancestor
93285462|NCT03469310|Respiratory System Agents|respiratory system agents|mesh-ancestor
93285463|NCT03527186|Risperidone|risperidone|mesh-list
93285464|NCT03527186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93285465|NCT03527186|Serotonin Agents|serotonin agents|mesh-ancestor
93285466|NCT03527186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285467|NCT03527186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285468|NCT03527186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285469|NCT03527186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93285470|NCT03527186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93285471|NCT03527186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285472|NCT03527186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93285473|NCT03527186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93285474|NCT03527186|Dopamine Agents|dopamine agents|mesh-ancestor
93285475|NCT05159882|Dapagliflozin|dapagliflozin|mesh-list
93285476|NCT05159882|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93285477|NCT05159882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285478|NCT05159882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93285479|NCT05159882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285480|NCT04910698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93285481|NCT04910698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285482|NCT04455464|Midodrine|midodrine|mesh-list
93285483|NCT04455464|Sympathomimetics|sympathomimetics|mesh-ancestor
93285484|NCT04455464|Autonomic Agents|autonomic agents|mesh-ancestor
93285485|NCT04455464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285486|NCT04455464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285487|NCT04455464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93285488|NCT04455464|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93285489|NCT04455464|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93285490|NCT04455464|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93285491|NCT04455464|Adrenergic Agents|adrenergic agents|mesh-ancestor
93285492|NCT04455464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285493|NCT04455464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285494|NCT04914598|Cisplatin|cisplatin|mesh-list
93285495|NCT04914598|Endostar protein|endostar protein|mesh-list
93285496|NCT04914598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285497|NCT04914598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93285498|NCT04914598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93285499|NCT04914598|Growth Substances|growth substances|mesh-ancestor
93285500|NCT04914598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285501|NCT04914598|Growth Inhibitors|growth inhibitors|mesh-ancestor
93285502|NCT03054220|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93285503|NCT03054220|Tramadol|tramadol|mesh-list
93285504|NCT03054220|Dextromethorphan|dextromethorphan|mesh-list
93285505|NCT03054220|Paroxetine|paroxetine|mesh-list
93285506|NCT03054220|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93285507|NCT03054220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93285508|NCT03054220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285509|NCT03054220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285510|NCT03054220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285511|NCT03054220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285512|NCT03054220|Analgesics|analgesics|mesh-ancestor
93285513|NCT03054220|Sensory System Agents|sensory system agents|mesh-ancestor
93285514|NCT03054220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285515|NCT03054220|Antidepressive Agents|antidepressive agents|mesh-ancestor
93285516|NCT03054220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93285517|NCT03054220|Dopamine Agents|dopamine agents|mesh-ancestor
93285518|NCT03054220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93285519|NCT03054220|Narcotics|narcotics|mesh-ancestor
93285520|NCT03054220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285521|NCT03054220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93285522|NCT03054220|Serotonin Agents|serotonin agents|mesh-ancestor
93285523|NCT03054220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93285524|NCT03054220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92957544|NCT00610155|Pregabalin|pregabalin|mesh-list
93285525|NCT03054220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93285526|NCT03054220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285527|NCT03054220|Antitussive Agents|antitussive agents|mesh-ancestor
93285528|NCT03054220|Respiratory System Agents|respiratory system agents|mesh-ancestor
93285529|NCT03054220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93285530|NCT03054220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93285531|NCT05388188|Sufentanil|sufentanil|mesh-list
93285532|NCT05388188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93285533|NCT05388188|Narcotics|narcotics|mesh-ancestor
93285534|NCT05388188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285535|NCT05388188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285536|NCT05388188|Analgesics|analgesics|mesh-ancestor
93285537|NCT05388188|Sensory System Agents|sensory system agents|mesh-ancestor
93285538|NCT05388188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285539|NCT05388188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93285540|NCT05388188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93285541|NCT05388188|Anesthetics, General|anesthetics, general|mesh-ancestor
93285542|NCT05388188|Anesthetics|anesthetics|mesh-ancestor
93285543|NCT04118036|Pembrolizumab|pembrolizumab|mesh-list
93285544|NCT04118036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285545|NCT04118036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285546|NCT04118036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93285547|NCT04118036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285548|NCT04909918|Dexamethasone|dexamethasone|mesh-list
93285549|NCT04909918|Methylprednisolone|methylprednisolone|mesh-list
93285550|NCT04909918|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93285551|NCT04909918|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93285552|NCT04909918|Prednisolone|prednisolone|mesh-list
93285553|NCT04909918|Prednisolone acetate|prednisolone acetate|mesh-list
93285554|NCT04909918|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93285555|NCT04909918|Prednisolone phosphate|prednisolone phosphate|mesh-list
93285556|NCT04909918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285557|NCT04909918|Antiemetics|antiemetics|mesh-ancestor
93285558|NCT04909918|Autonomic Agents|autonomic agents|mesh-ancestor
93285559|NCT04909918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285560|NCT04909918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285561|NCT04909918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285562|NCT04909918|Glucocorticoids|glucocorticoids|mesh-ancestor
93285563|NCT04909918|Hormones|hormones|mesh-ancestor
93285564|NCT04909918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285565|NCT04909918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285566|NCT04909918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285567|NCT04909918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93285568|NCT04909918|Protective Agents|protective agents|mesh-ancestor
93285569|NCT04903678|Melphalan|melphalan|mesh-list
93285570|NCT04903678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93285571|NCT04903678|Alkylating Agents|alkylating agents|mesh-ancestor
93285572|NCT04903678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285573|NCT04903678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285574|NCT04903678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93285575|NCT04903678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285576|NCT04903678|Immunologic Factors|immunologic factors|mesh-ancestor
93285577|NCT04903678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285578|NCT04903366|Timolol|timolol|mesh-list
93285579|NCT04903366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285580|NCT04903366|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93285581|NCT04903366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93285582|NCT04903366|Adrenergic Agents|adrenergic agents|mesh-ancestor
93285583|NCT04903366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285584|NCT04903366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285585|NCT04903366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93285586|NCT04903366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93285587|NCT03054610|Betamethasone|betamethasone|mesh-list
93285588|NCT03054610|Betamethasone Valerate|betamethasone valerate|mesh-list
93285589|NCT03054610|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93285590|NCT03054610|Betamethasone benzoate|betamethasone benzoate|mesh-list
93285591|NCT03054610|Ropivacaine|ropivacaine|mesh-list
93285592|NCT03054610|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
93285593|NCT03054610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93285594|NCT03054610|Botulinum Toxins|botulinum toxins|mesh-list
93285595|NCT03054610|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93285596|NCT03054610|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93285597|NCT03054610|Anesthetics, Local|anesthetics, local|mesh-ancestor
93285598|NCT03054610|Anesthetics|anesthetics|mesh-ancestor
93285599|NCT03054610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285600|NCT03054610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285601|NCT03054610|Sensory System Agents|sensory system agents|mesh-ancestor
93285602|NCT03054610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285603|NCT03054610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93285604|NCT03054610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285605|NCT03054610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285607|NCT03054610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285608|NCT03054610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285609|NCT03054610|Glucocorticoids|glucocorticoids|mesh-ancestor
93285610|NCT03054610|Hormones|hormones|mesh-ancestor
93285611|NCT03054610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285612|NCT03054610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93285613|NCT03054610|Respiratory System Agents|respiratory system agents|mesh-ancestor
93285614|NCT03054610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93285615|NCT03054610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93285616|NCT03054610|Autonomic Agents|autonomic agents|mesh-ancestor
93285617|NCT03053830|Ketamine|ketamine|mesh-list
93285618|NCT03053830|Analgesics|analgesics|mesh-ancestor
93285619|NCT03053830|Sensory System Agents|sensory system agents|mesh-ancestor
93285620|NCT03053830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285621|NCT03053830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285622|NCT03053830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93285623|NCT03053830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93285624|NCT03053830|Anesthetics, General|anesthetics, general|mesh-ancestor
93285625|NCT03053830|Anesthetics|anesthetics|mesh-ancestor
93285626|NCT03053830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285627|NCT03053830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93285628|NCT03053830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93285629|NCT03053830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285630|NCT03053830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285631|NCT04913896|Oxaliplatin|oxaliplatin|mesh-list
93285632|NCT04913896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93285633|NCT04913896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285634|NCT04913896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580104|NCT00288379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93285635|NCT04913896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285636|NCT03053284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93285637|NCT03053284|Pasireotide|pasireotide|mesh-list
93285638|NCT03053284|Hormones|hormones|mesh-ancestor
93285639|NCT03053284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285640|NCT03053284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285641|NCT04901884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93285642|NCT04901884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93285643|NCT04901884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285644|NCT04908982|Aspirin|aspirin|mesh-list
93285645|NCT04908982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93285646|NCT04908982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93285647|NCT04908982|Analgesics|analgesics|mesh-ancestor
93285648|NCT04908982|Sensory System Agents|sensory system agents|mesh-ancestor
93285649|NCT04908982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285650|NCT04908982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285651|NCT04908982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285652|NCT04908982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285653|NCT04908982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93285654|NCT04908982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93285655|NCT04908982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285656|NCT04908982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93285657|NCT04908982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93285658|NCT04908982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285659|NCT04908982|Antipyretics|antipyretics|mesh-ancestor
93285660|NCT04430998|Chlorhexidine|chlorhexidine|mesh-list
93285661|NCT04430998|Polaprezinc|polaprezinc|mesh-list
93285662|NCT04430998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93285663|NCT04430998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285664|NCT04430998|Disinfectants|disinfectants|mesh-ancestor
93285665|NCT04430998|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93285666|NCT04430998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285667|NCT04900948|Methylprednisolone|methylprednisolone|mesh-list
93285668|NCT04900948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93285669|NCT04900948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93285670|NCT04900948|Prednisolone|prednisolone|mesh-list
93285671|NCT04900948|Prednisolone acetate|prednisolone acetate|mesh-list
93285672|NCT04900948|Pimecrolimus|pimecrolimus|mesh-list
93285673|NCT04900948|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
93285674|NCT04900948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93285675|NCT04900948|Prednisolone phosphate|prednisolone phosphate|mesh-list
93285676|NCT04900948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285677|NCT04900948|Antiemetics|antiemetics|mesh-ancestor
93285678|NCT04900948|Autonomic Agents|autonomic agents|mesh-ancestor
93285679|NCT04900948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285680|NCT04900948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285681|NCT04900948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285682|NCT04900948|Glucocorticoids|glucocorticoids|mesh-ancestor
93285683|NCT04900948|Hormones|hormones|mesh-ancestor
93285684|NCT04900948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285685|NCT04900948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93285686|NCT04900948|Protective Agents|protective agents|mesh-ancestor
93285687|NCT04900948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285688|NCT04900948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285689|NCT04900948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93285690|NCT04900948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93285691|NCT04900948|Analgesics|analgesics|mesh-ancestor
93285692|NCT04900948|Sensory System Agents|sensory system agents|mesh-ancestor
93285693|NCT04900948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285694|NCT04900948|Dermatologic Agents|dermatologic agents|mesh-ancestor
93285695|NCT04900948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285696|NCT04900948|Immunologic Factors|immunologic factors|mesh-ancestor
93285697|NCT04900948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93285698|NCT04900948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285699|NCT04900948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285700|NCT04901104|Thymalfasin|thymalfasin|mesh-list
93285701|NCT04901104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93285702|NCT04901104|Immunologic Factors|immunologic factors|mesh-ancestor
93285703|NCT04901104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285704|NCT04907812|Tranexamic Acid|tranexamic acid|mesh-list
93285705|NCT04907812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93285706|NCT04907812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93285707|NCT04907812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285708|NCT04907812|Hemostatics|hemostatics|mesh-ancestor
93285709|NCT04907812|Coagulants|coagulants|mesh-ancestor
93285710|NCT01889186|Venetoclax|venetoclax|mesh-list
93285711|NCT01889186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285712|NCT04892212|Sirolimus|sirolimus|mesh-list
93285713|NCT04892212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93285714|NCT04892212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285715|NCT04892212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93285716|NCT04892212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285717|NCT04892212|Antifungal Agents|antifungal agents|mesh-ancestor
93285718|NCT04892212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285719|NCT04892212|Immunologic Factors|immunologic factors|mesh-ancestor
93285720|NCT04892212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285721|NCT01510184|Rituximab|rituximab|mesh-list
93285722|NCT01510184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93285723|NCT01510184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285724|NCT01510184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285725|NCT01510184|Immunologic Factors|immunologic factors|mesh-ancestor
93285726|NCT01510184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285727|NCT01510184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93285728|NCT04907344|Paclitaxel|paclitaxel|mesh-list
93285729|NCT04907344|Carboplatin|carboplatin|mesh-list
93285730|NCT04907344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93285731|NCT04907344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285732|NCT04907344|Tubulin Modulators|tubulin modulators|mesh-ancestor
93285733|NCT04907344|Antimitotic Agents|antimitotic agents|mesh-ancestor
93285734|NCT04907344|Mitosis Modulators|mitosis modulators|mesh-ancestor
93285735|NCT04907344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285736|NCT04906876|Gemcitabine|gemcitabine|mesh-list
93285737|NCT04906876|Docetaxel|docetaxel|mesh-list
93285738|NCT04906876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285739|NCT04906876|Antimetabolites|antimetabolites|mesh-ancestor
93285740|NCT04906876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285741|NCT04906876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285742|NCT04906876|Tubulin Modulators|tubulin modulators|mesh-ancestor
93285743|NCT04906876|Antimitotic Agents|antimitotic agents|mesh-ancestor
93285744|NCT04906876|Mitosis Modulators|mitosis modulators|mesh-ancestor
93285745|NCT04891744|Thalidomide|thalidomide|mesh-list
92957762|NCT00966082|Propranolol|propranolol|mesh-list
93285746|NCT04891744|Dexamethasone|dexamethasone|mesh-list
93285747|NCT04891744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285748|NCT04891744|Antiemetics|antiemetics|mesh-ancestor
93285750|NCT04891744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285751|NCT04891744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285752|NCT04891744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285753|NCT04891744|Glucocorticoids|glucocorticoids|mesh-ancestor
93285754|NCT04891744|Hormones|hormones|mesh-ancestor
93285755|NCT04891744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285756|NCT04891744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285757|NCT04891744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285758|NCT04891744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285759|NCT04891744|Immunologic Factors|immunologic factors|mesh-ancestor
93285760|NCT04891744|Leprostatic Agents|leprostatic agents|mesh-ancestor
93285761|NCT04891744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93285762|NCT04891744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285763|NCT04891744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93285764|NCT04891744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93285765|NCT04891744|Growth Substances|growth substances|mesh-ancestor
93285766|NCT04891744|Growth Inhibitors|growth inhibitors|mesh-ancestor
93285767|NCT04891900|Capecitabine|capecitabine|mesh-list
93285768|NCT04891900|Oxaliplatin|oxaliplatin|mesh-list
93285769|NCT04891900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93285770|NCT04891900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285771|NCT04891900|Antimetabolites|antimetabolites|mesh-ancestor
93285772|NCT04891900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285773|NCT04891900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285774|NCT04891900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285775|NCT04891588|Timolol|timolol|mesh-list
93285776|NCT04891588|Latanoprost|latanoprost|mesh-list
93285777|NCT04891588|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93285778|NCT04891588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93285779|NCT04891588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285780|NCT04891588|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93285781|NCT04891588|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93285782|NCT04891588|Adrenergic Agents|adrenergic agents|mesh-ancestor
93285783|NCT04891588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285784|NCT04891588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285785|NCT04891588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93285786|NCT04891588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93285787|NCT03050866|Antiemetics|antiemetics|mesh-list
93285788|NCT03050866|Histamine|histamine|mesh-list
93285789|NCT03050866|Histamine Antagonists|histamine antagonists|mesh-list
93285790|NCT03050866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93285791|NCT03050866|Histamine Agonists|histamine agonists|mesh-ancestor
93285792|NCT03050866|Histamine Agents|histamine agents|mesh-ancestor
93285793|NCT03050866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285794|NCT03050866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285795|NCT03050866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285796|NCT03050866|Autonomic Agents|autonomic agents|mesh-ancestor
93285797|NCT03050866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285798|NCT03050866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285799|NCT03052660|Midazolam|midazolam|mesh-list
93285800|NCT03052660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93285801|NCT03052660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93285802|NCT03052660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285803|NCT03052660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285804|NCT03052660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93285805|NCT03052660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93285806|NCT03052660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93285807|NCT03052660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93285808|NCT03052660|Anesthetics, General|anesthetics, general|mesh-ancestor
93285809|NCT03052660|Anesthetics|anesthetics|mesh-ancestor
93285810|NCT03052660|GABA Modulators|gaba modulators|mesh-ancestor
93285811|NCT03052660|GABA Agents|gaba agents|mesh-ancestor
93285812|NCT03052660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285813|NCT03052660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285814|NCT05162456|Antibodies|antibodies|mesh-list
93285815|NCT05162456|Immunoglobulins|immunoglobulins|mesh-list
93285816|NCT05162456|Immunoglobulin G|immunoglobulin g|mesh-list
93285817|NCT05162456|Immunologic Factors|immunologic factors|mesh-ancestor
93285818|NCT05162456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285819|NCT05137886|Decitabine|decitabine|mesh-list
93285820|NCT05137886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93285821|NCT05137886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285822|NCT05137886|Antimetabolites|antimetabolites|mesh-ancestor
93285823|NCT05137886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285824|NCT05137886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285825|NCT05137886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285826|NCT05137886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285827|NCT04890418|Ketamine|ketamine|mesh-list
93285828|NCT04890418|Analgesics|analgesics|mesh-ancestor
93285829|NCT04890418|Sensory System Agents|sensory system agents|mesh-ancestor
93285830|NCT04890418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285831|NCT04890418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285832|NCT04890418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93285833|NCT04890418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93285834|NCT04890418|Anesthetics, General|anesthetics, general|mesh-ancestor
93285835|NCT04890418|Anesthetics|anesthetics|mesh-ancestor
93285836|NCT04890418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285837|NCT04890418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93285838|NCT04890418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93285839|NCT04890418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285840|NCT04890418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285841|NCT04455932|Liver Extracts|liver extracts|mesh-list
93285842|NCT04455932|Hematinics|hematinics|mesh-ancestor
93285843|NCT03051022|Dexamethasone|dexamethasone|mesh-list
93285844|NCT03051022|Morphine|morphine|mesh-list
93285845|NCT03051022|Bupivacaine|bupivacaine|mesh-list
93285846|NCT03051022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285847|NCT03051022|Antiemetics|antiemetics|mesh-ancestor
93285848|NCT03051022|Autonomic Agents|autonomic agents|mesh-ancestor
93285849|NCT03051022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285850|NCT03051022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285851|NCT03051022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93285852|NCT03051022|Glucocorticoids|glucocorticoids|mesh-ancestor
93285853|NCT03051022|Hormones|hormones|mesh-ancestor
93285854|NCT03051022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285855|NCT03051022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93285856|NCT03051022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285857|NCT03051022|Anesthetics, Local|anesthetics, local|mesh-ancestor
93285858|NCT03051022|Anesthetics|anesthetics|mesh-ancestor
93285859|NCT03051022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285860|NCT03051022|Sensory System Agents|sensory system agents|mesh-ancestor
93285861|NCT03051022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93285862|NCT03051022|Narcotics|narcotics|mesh-ancestor
93285863|NCT03051022|Analgesics|analgesics|mesh-ancestor
93285864|NCT04648826|Azacitidine|azacitidine|mesh-list
93285865|NCT04648826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93285866|NCT04648826|Antimetabolites|antimetabolites|mesh-ancestor
93285867|NCT04648826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285868|NCT04648826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285869|NCT04648826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285870|NCT03052348|Fusidic Acid|fusidic acid|mesh-list
93285871|NCT03052348|Betamethasone|betamethasone|mesh-list
93285872|NCT03052348|Betamethasone Valerate|betamethasone valerate|mesh-list
93285873|NCT03052348|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93285874|NCT03052348|Betamethasone benzoate|betamethasone benzoate|mesh-list
93285875|NCT03052348|Ether|ether|mesh-list
93285876|NCT03052348|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93285877|NCT03052348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93285878|NCT03052348|Glucocorticoids|glucocorticoids|mesh-ancestor
93285879|NCT03052348|Hormones|hormones|mesh-ancestor
93285880|NCT03052348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93285881|NCT03052348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285882|NCT03052348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93285883|NCT03052348|Respiratory System Agents|respiratory system agents|mesh-ancestor
93285884|NCT03052348|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93285885|NCT03052348|Anesthetics, General|anesthetics, general|mesh-ancestor
93285886|NCT03052348|Anesthetics|anesthetics|mesh-ancestor
93285887|NCT03052348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285888|NCT03052348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93285889|NCT03052348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285890|NCT03052348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93285891|NCT03052348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285892|NCT03052348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285893|NCT03963518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93285894|NCT03963518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285895|NCT03963518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285896|NCT03963518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285897|NCT04101890|Zinc Oxide|zinc oxide|mesh-list
93285898|NCT04101890|Dermatologic Agents|dermatologic agents|mesh-ancestor
93285899|NCT04101890|Sunscreening Agents|sunscreening agents|mesh-ancestor
93285901|NCT04101890|Protective Agents|protective agents|mesh-ancestor
93285902|NCT04101890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285903|NCT04456712|Ciprofloxacin|ciprofloxacin|mesh-list
93285904|NCT04456712|Levofloxacin|levofloxacin|mesh-list
93285905|NCT04456712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93285906|NCT04456712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285907|NCT04456712|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93285908|NCT04456712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93285909|NCT04456712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93285910|NCT04456712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285911|NCT04456712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285912|NCT04456712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93285913|NCT04456712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93285914|NCT04456712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93285915|NCT04884490|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93285916|NCT04884490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93285917|NCT04884490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285918|NCT04884490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93285919|NCT04884490|Antimalarials|antimalarials|mesh-ancestor
93285920|NCT04884490|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93285921|NCT04884490|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92580393|NCT00291109|Letrozole|letrozole|mesh-list
93285922|NCT04854434|Trifluridine|trifluridine|mesh-list
93285923|NCT04854434|Pembrolizumab|pembrolizumab|mesh-list
93285924|NCT04854434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93285925|NCT04854434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285926|NCT04854434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93285927|NCT04854434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285928|NCT04854434|Antimetabolites|antimetabolites|mesh-ancestor
93285929|NCT04854434|Antiviral Agents|antiviral agents|mesh-ancestor
93285930|NCT04854434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285931|NCT04897984|Anti-Infective Agents|anti-infective agents|mesh-list
93285932|NCT04897984|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93285933|NCT04456088|Nitric Oxide|nitric oxide|mesh-list
93285934|NCT04456088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93285935|NCT04456088|Autonomic Agents|autonomic agents|mesh-ancestor
93285936|NCT04456088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285937|NCT04456088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285938|NCT04456088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93285939|NCT04456088|Respiratory System Agents|respiratory system agents|mesh-ancestor
93285940|NCT04456088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93285941|NCT04456088|Antioxidants|antioxidants|mesh-ancestor
93285942|NCT04456088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285943|NCT04456088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285944|NCT04456088|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93285945|NCT04456088|Vasodilator Agents|vasodilator agents|mesh-ancestor
93285946|NCT04456088|Gasotransmitters|gasotransmitters|mesh-ancestor
93285947|NCT04456088|Protective Agents|protective agents|mesh-ancestor
93285948|NCT04454840|Riluzole|riluzole|mesh-list
93285949|NCT04454840|Anticonvulsants|anticonvulsants|mesh-ancestor
93285950|NCT04454840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93285951|NCT04454840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93285952|NCT04454840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93285953|NCT04454840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285954|NCT04454840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285955|NCT04454840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93285956|NCT04454840|Protective Agents|protective agents|mesh-ancestor
93285957|NCT03050710|Lidocaine|lidocaine|mesh-list
93285958|NCT03050710|Anesthetics, Local|anesthetics, local|mesh-ancestor
93285959|NCT03050710|Anesthetics|anesthetics|mesh-ancestor
93285960|NCT03050710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285961|NCT03050710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285962|NCT03050710|Sensory System Agents|sensory system agents|mesh-ancestor
93285963|NCT03050710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285964|NCT03050710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93285965|NCT03050710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93285966|NCT03050710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93285967|NCT03050710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93285968|NCT03050710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285969|NCT03051568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93285970|NCT03051568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92957986|NCT00767286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93285971|NCT03051568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93285972|NCT04897516|Benzonidazole|benzonidazole|mesh-list
93285973|NCT04897516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285974|NCT04897516|Immunologic Factors|immunologic factors|mesh-ancestor
93285975|NCT04897516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285976|NCT04897516|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93285977|NCT04897516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93285978|NCT04897516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93285979|NCT04897516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93285980|NCT03993314|Bupivacaine|bupivacaine|mesh-list
93285981|NCT03993314|Chloroprocaine|chloroprocaine|mesh-list
93285982|NCT03993314|Anesthetics, Local|anesthetics, local|mesh-ancestor
93285983|NCT03993314|Anesthetics|anesthetics|mesh-ancestor
93285984|NCT03993314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93285985|NCT03993314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285986|NCT03993314|Sensory System Agents|sensory system agents|mesh-ancestor
93285987|NCT03993314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93285988|NCT04883164|Antibodies|antibodies|mesh-list
93285989|NCT04883164|Immunologic Factors|immunologic factors|mesh-ancestor
93285990|NCT04883164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285991|NCT03161054|Prednisone|prednisone|mesh-list
93285992|NCT03161054|Cyclophosphamide|cyclophosphamide|mesh-list
93285993|NCT03161054|Rituximab|rituximab|mesh-list
93285994|NCT03161054|Etoposide|etoposide|mesh-list
93285995|NCT03161054|Vinorelbine|vinorelbine|mesh-list
93285996|NCT03161054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93285997|NCT03161054|Immunologic Factors|immunologic factors|mesh-ancestor
93285998|NCT03161054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93285999|NCT03161054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286000|NCT03161054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93286001|NCT03161054|Alkylating Agents|alkylating agents|mesh-ancestor
93286002|NCT03161054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286003|NCT03161054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286004|NCT03161054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93286005|NCT03161054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286006|NCT03161054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286007|NCT03161054|Glucocorticoids|glucocorticoids|mesh-ancestor
93286008|NCT03161054|Hormones|hormones|mesh-ancestor
93286009|NCT03161054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286010|NCT03161054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286011|NCT03161054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93286012|NCT03161054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93286013|NCT03161054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93286014|NCT03161054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286015|NCT03161054|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286016|NCT03161054|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286017|NCT03161054|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286018|NCT03050554|Avelumab|avelumab|mesh-list
93286019|NCT03050554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286020|NCT03050554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286021|NCT03050164|Gefitinib|gefitinib|mesh-list
93286022|NCT03050164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286023|NCT03050164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286024|NCT03050164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286025|NCT03050164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286026|NCT03049930|Ketamine|ketamine|mesh-list
93286027|NCT03049930|Analgesics|analgesics|mesh-ancestor
93286028|NCT03049930|Sensory System Agents|sensory system agents|mesh-ancestor
93286029|NCT03049930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286030|NCT03049930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286031|NCT03049930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93286032|NCT03049930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286033|NCT03049930|Anesthetics, General|anesthetics, general|mesh-ancestor
93286034|NCT03049930|Anesthetics|anesthetics|mesh-ancestor
93286035|NCT03049930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286036|NCT03049930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93286037|NCT03049930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93286038|NCT03049930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286039|NCT03049930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286040|NCT02036463|Prednisone|prednisone|mesh-list
93286041|NCT02036463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286042|NCT02036463|Glucocorticoids|glucocorticoids|mesh-ancestor
93286043|NCT02036463|Hormones|hormones|mesh-ancestor
93286044|NCT02036463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286045|NCT02036463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286046|NCT02036463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286047|NCT02036463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286048|NCT04887844|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
93286049|NCT04887844|Lidocaine|lidocaine|mesh-list
93286050|NCT04887844|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286051|NCT04887844|Anesthetics|anesthetics|mesh-ancestor
93286052|NCT04887844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286053|NCT04887844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286054|NCT04887844|Sensory System Agents|sensory system agents|mesh-ancestor
93286055|NCT04887844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286056|NCT04887844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93286057|NCT04887844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93286058|NCT04887844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93286059|NCT04887844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92580537|NCT00078845|Amifostine|amifostine|mesh-list
93286060|NCT04887844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286061|NCT04887844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286062|NCT04887844|Glucocorticoids|glucocorticoids|mesh-ancestor
93286063|NCT04887844|Hormones|hormones|mesh-ancestor
93286064|NCT04887844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286065|NCT02595320|Capecitabine|capecitabine|mesh-list
93286066|NCT02595320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93286067|NCT02595320|Antimetabolites|antimetabolites|mesh-ancestor
93286068|NCT02595320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286069|NCT02595320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286070|NCT02809053|Rituximab|rituximab|mesh-list
93286071|NCT02809053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286072|NCT02809053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286073|NCT02809053|Immunologic Factors|immunologic factors|mesh-ancestor
93286074|NCT02809053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286075|NCT02809053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286076|NCT04666688|Paclitaxel|paclitaxel|mesh-list
93286077|NCT04666688|Gemcitabine|gemcitabine|mesh-list
93286078|NCT04666688|Tislelizumab|tislelizumab|mesh-list
93286079|NCT04666688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93286080|NCT04666688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286081|NCT04666688|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286082|NCT04666688|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286083|NCT04666688|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286084|NCT04666688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286085|NCT04666688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93286086|NCT04666688|Antimetabolites|antimetabolites|mesh-ancestor
93286087|NCT04666688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286088|NCT03462290|Botulinum Toxins|botulinum toxins|mesh-list
93286089|NCT03462290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93286090|NCT03462290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93286091|NCT03462290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93286092|NCT03462290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93286093|NCT03462290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286094|NCT03462290|Cholinergic Agents|cholinergic agents|mesh-ancestor
93286095|NCT03462290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286096|NCT03462290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286097|NCT03462290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93286098|NCT03462290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286099|NCT02047539|Aspirin|aspirin|mesh-list
93286100|NCT02047539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93286101|NCT02047539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286102|NCT02047539|Analgesics|analgesics|mesh-ancestor
93286103|NCT02047539|Sensory System Agents|sensory system agents|mesh-ancestor
93286104|NCT02047539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286105|NCT02047539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286106|NCT02047539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286107|NCT02047539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286108|NCT02047539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93286109|NCT02047539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93286110|NCT02047539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286111|NCT02047539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92580610|NCT00274963|Mitoxantrone|mitoxantrone|mesh-list
93286112|NCT02047539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93286113|NCT02047539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286114|NCT02047539|Antipyretics|antipyretics|mesh-ancestor
93286115|NCT02522858|Atropine|atropine|mesh-list
93286116|NCT02522858|Ephedrine|ephedrine|mesh-list
93286117|NCT02522858|Dexmedetomidine|dexmedetomidine|mesh-list
93286118|NCT02522858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93286119|NCT02522858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286120|NCT02522858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286121|NCT02522858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286122|NCT02522858|Analgesics|analgesics|mesh-ancestor
93286123|NCT02522858|Sensory System Agents|sensory system agents|mesh-ancestor
93286124|NCT02522858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286125|NCT02522858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93286126|NCT02522858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93286127|NCT02522858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93286128|NCT02522858|Adrenergic Agents|adrenergic agents|mesh-ancestor
93286129|NCT02522858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286130|NCT02522858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286131|NCT02522858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286132|NCT02522858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93286133|NCT02522858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93286134|NCT02522858|Autonomic Agents|autonomic agents|mesh-ancestor
93286135|NCT02522858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93286136|NCT02522858|Respiratory System Agents|respiratory system agents|mesh-ancestor
93286137|NCT02522858|Mydriatics|mydriatics|mesh-ancestor
93286138|NCT02522858|Parasympatholytics|parasympatholytics|mesh-ancestor
93286139|NCT02522858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93286140|NCT02522858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93286141|NCT02522858|Cholinergic Agents|cholinergic agents|mesh-ancestor
93286142|NCT02522858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93286143|NCT02522858|Sympathomimetics|sympathomimetics|mesh-ancestor
93286144|NCT02522858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93286146|NCT02036697|Morphine|morphine|mesh-list
93286147|NCT02036697|Bupivacaine|bupivacaine|mesh-list
93286148|NCT02036697|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286149|NCT02036697|Anesthetics|anesthetics|mesh-ancestor
93286150|NCT02036697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286151|NCT02036697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286152|NCT02036697|Sensory System Agents|sensory system agents|mesh-ancestor
93286153|NCT02036697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286154|NCT02036697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93286155|NCT02036697|Narcotics|narcotics|mesh-ancestor
93286156|NCT02036697|Analgesics|analgesics|mesh-ancestor
93286157|NCT02036697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286158|NCT02036697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286159|NCT02036697|Anesthetics, General|anesthetics, general|mesh-ancestor
93286160|NCT04882462|Nimotuzumab|nimotuzumab|mesh-list
93286161|NCT04882462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286162|NCT04882462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286163|NCT03106688|Carfentanil|carfentanil|mesh-list
93286164|NCT03106688|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93286165|NCT03106688|Narcotics|narcotics|mesh-ancestor
93286166|NCT03106688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286167|NCT03106688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286168|NCT03106688|Analgesics|analgesics|mesh-ancestor
93286169|NCT03106688|Sensory System Agents|sensory system agents|mesh-ancestor
93286170|NCT03106688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286171|NCT02037009|Anesthetics|anesthetics|mesh-list
93286172|NCT02037009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286173|NCT02037009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286174|NCT02260011|Bromides|bromides|mesh-list
93286175|NCT02260011|Norflurane|norflurane|mesh-list
93286176|NCT02260011|Ipratropium|ipratropium|mesh-list
93286177|NCT02260011|Anticonvulsants|anticonvulsants|mesh-ancestor
93286178|NCT02260011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93286179|NCT02260011|Autonomic Agents|autonomic agents|mesh-ancestor
93286180|NCT02260011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286181|NCT02260011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286182|NCT02260011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93286183|NCT02260011|Respiratory System Agents|respiratory system agents|mesh-ancestor
93286184|NCT02260011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93286185|NCT02260011|Cholinergic Agents|cholinergic agents|mesh-ancestor
93286186|NCT02260011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286187|NCT02260011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286188|NCT02260011|Anesthetics|anesthetics|mesh-ancestor
93286189|NCT02260011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286190|NCT02047773|Meropenem|meropenem|mesh-list
93286191|NCT02047773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286192|NCT02047773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286193|NCT04886752|Vitamins|vitamins|mesh-list
93286194|NCT04886752|Ascorbic Acid|ascorbic acid|mesh-list
93286195|NCT04886752|Vitamin B Complex|vitamin b complex|mesh-list
93286196|NCT04886752|Micronutrients|micronutrients|mesh-ancestor
93286197|NCT04886752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286198|NCT04886752|Antioxidants|antioxidants|mesh-ancestor
93286199|NCT04886752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286200|NCT04886752|Protective Agents|protective agents|mesh-ancestor
93286201|NCT04895800|Caffeine|caffeine|mesh-list
93286202|NCT04895800|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93286203|NCT04895800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286204|NCT04895800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93286205|NCT04895800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286206|NCT04895800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286207|NCT04895800|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93286208|NCT04895800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93286209|NCT04895800|Purinergic Agents|purinergic agents|mesh-ancestor
93286210|NCT04895800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286211|NCT04886362|Ivermectin|ivermectin|mesh-list
93286212|NCT04886362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93286213|NCT04886362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286214|NCT02048007|Azithromycin|azithromycin|mesh-list
93286215|NCT02048007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286216|NCT02048007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286217|NCT02048085|Clopidogrel|clopidogrel|mesh-list
93286218|NCT02048085|Ticagrelor|ticagrelor|mesh-list
93286219|NCT02048085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93286220|NCT02048085|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93286221|NCT02048085|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93286222|NCT02048085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93286223|NCT02048085|Purinergic Agents|purinergic agents|mesh-ancestor
93286224|NCT02048085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286225|NCT02048085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286226|NCT02048085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286227|NCT02808975|Adalimumab|adalimumab|mesh-list
93286228|NCT02808975|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93286229|NCT02808975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286230|NCT02808975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286231|NCT04885894|Ozanimod|ozanimod|mesh-list
93286232|NCT04885894|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93286233|NCT04885894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286234|NCT04885894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93286235|NCT04885894|Immunologic Factors|immunologic factors|mesh-ancestor
93286236|NCT04885894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286237|NCT04885660|Lisinopril|lisinopril|mesh-list
93286238|NCT04885660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93286239|NCT04885660|Protease Inhibitors|protease inhibitors|mesh-ancestor
93286240|NCT04885660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286241|NCT04885660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286242|NCT04885660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93286243|NCT04885660|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93286244|NCT04885660|Protective Agents|protective agents|mesh-ancestor
93286245|NCT04885660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286246|NCT02037633|Fentanyl|fentanyl|mesh-list
93286247|NCT02037633|Ropivacaine|ropivacaine|mesh-list
93286248|NCT02037633|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286249|NCT02037633|Anesthetics|anesthetics|mesh-ancestor
93286250|NCT02037633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286251|NCT02037633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286252|NCT02037633|Sensory System Agents|sensory system agents|mesh-ancestor
93286253|NCT02037633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286254|NCT02037633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93286255|NCT02037633|Narcotics|narcotics|mesh-ancestor
93286256|NCT02037633|Analgesics|analgesics|mesh-ancestor
93286257|NCT02037633|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286258|NCT02037633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286259|NCT02037633|Anesthetics, General|anesthetics, general|mesh-ancestor
93286260|NCT05684211|Cetuximab|cetuximab|mesh-list
93286261|NCT05684211|Antibodies|antibodies|mesh-list
93286262|NCT05684211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93286263|NCT05684211|Immunologic Factors|immunologic factors|mesh-ancestor
93286264|NCT05684211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286265|NCT05684211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286266|NCT05684211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286267|NCT03130634|Silymarin|silymarin|mesh-list
93286268|NCT03130634|Antioxidants|antioxidants|mesh-ancestor
93286269|NCT03130634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286270|NCT03130634|Protective Agents|protective agents|mesh-ancestor
93286271|NCT03130634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286272|NCT02124824|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
93286273|NCT02124824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93286274|NCT02124824|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93286275|NCT02124824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286276|NCT04880746|Cladribine|cladribine|mesh-list
93286277|NCT04880746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286278|NCT04880746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93286279|NCT04880746|Immunologic Factors|immunologic factors|mesh-ancestor
93286280|NCT04880746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286281|NCT03050086|Minocycline|minocycline|mesh-list
93286282|NCT03050086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286283|NCT03050086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286284|NCT03050242|Glycopyrrolate|glycopyrrolate|mesh-list
93286285|NCT03050242|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286286|NCT03050242|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93286287|NCT03050242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93286288|NCT03050242|Cholinergic Agents|cholinergic agents|mesh-ancestor
93286289|NCT03050242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286290|NCT03050242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286291|NCT03050242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286292|NCT04894630|Anti-Infective Agents|anti-infective agents|mesh-list
93286293|NCT04894630|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93286294|NCT04885270|Cisplatin|cisplatin|mesh-list
93286295|NCT04885270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286296|NCT04885426|Metformin|metformin|mesh-list
93286297|NCT04885426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93286298|NCT04885426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286299|NCT02808819|Benralizumab|benralizumab|mesh-list
93286300|NCT02808819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93286301|NCT02808819|Respiratory System Agents|respiratory system agents|mesh-ancestor
93286302|NCT04872244|Levonorgestrel|levonorgestrel|mesh-list
93286303|NCT04872244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93286304|NCT04872244|Contraceptive Agents|contraceptive agents|mesh-ancestor
93286305|NCT04872244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93286306|NCT04872244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286307|NCT04872244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93286308|NCT04872244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93286309|NCT04872244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93286310|NCT04872322|Ropivacaine|ropivacaine|mesh-list
93286311|NCT04872322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93286312|NCT04872322|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286313|NCT04872322|Anesthetics|anesthetics|mesh-ancestor
93286314|NCT04872322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580796|NCT00079157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93286315|NCT04872322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286316|NCT04872322|Sensory System Agents|sensory system agents|mesh-ancestor
93286317|NCT04872322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286318|NCT04879030|Moxifloxacin|moxifloxacin|mesh-list
93286319|NCT04879030|Ciprofloxacin|ciprofloxacin|mesh-list
93286320|NCT04879030|Levofloxacin|levofloxacin|mesh-list
93286321|NCT04879030|Meropenem|meropenem|mesh-list
93286322|NCT04879030|Ceftriaxone|ceftriaxone|mesh-list
93286323|NCT04879030|Tazobactam|tazobactam|mesh-list
93286324|NCT04879030|Piperacillin|piperacillin|mesh-list
93286325|NCT04879030|Clavulanic Acid|clavulanic acid|mesh-list
93286326|NCT04879030|Imipenem|imipenem|mesh-list
93286327|NCT04879030|Ceftazidime|ceftazidime|mesh-list
93286328|NCT04879030|Ertapenem|ertapenem|mesh-list
93286329|NCT04879030|Lactams|lactams|mesh-list
93286330|NCT04879030|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93286331|NCT04879030|Cefotaxime|cefotaxime|mesh-list
93286332|NCT04879030|Cefixime|cefixime|mesh-list
93286333|NCT04879030|beta-Lactams|beta-lactams|mesh-list
93286334|NCT04879030|Fluoroquinolones|fluoroquinolones|mesh-list
93286335|NCT04879030|Ticarcillin|ticarcillin|mesh-list
93286336|NCT04879030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286337|NCT04879030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286338|NCT04879030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93286339|NCT04879030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93286340|NCT04879030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286341|NCT04879030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286342|NCT04879030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286343|NCT04879030|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93286344|NCT04879030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92958360|NCT00968578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93286345|NCT04879030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93286346|NCT04879030|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93286347|NCT04879030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93286348|NCT04878718|Vancomycin|vancomycin|mesh-list
93286349|NCT04878718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286350|NCT04878718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286351|NCT04878016|Carboplatin|carboplatin|mesh-list
93286352|NCT04878016|Etoposide|etoposide|mesh-list
93286353|NCT04878016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286354|NCT04878016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93286355|NCT04878016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93286356|NCT04878016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93286357|NCT04878016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286358|NCT04878016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286359|NCT04871152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93286360|NCT04871152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93286361|NCT04871152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93286362|NCT04871152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286363|NCT04871152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286364|NCT04871152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93286365|NCT04871152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93286366|NCT04871152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286367|NCT04871152|Cholinergic Agents|cholinergic agents|mesh-ancestor
93286368|NCT04871152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286369|NCT04870372|Selegiline|selegiline|mesh-list
93286370|NCT04870372|Antidepressive Agents|antidepressive agents|mesh-ancestor
93286371|NCT04870372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93286372|NCT04870372|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93286373|NCT04870372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93286374|NCT04870372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93286375|NCT04870372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286376|NCT04870372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286377|NCT04870372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93286378|NCT04870372|Protective Agents|protective agents|mesh-ancestor
93286379|NCT04870372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286380|NCT02048319|Ethanol|ethanol|mesh-list
93286381|NCT02048319|Pasireotide|pasireotide|mesh-list
93286382|NCT02048319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93286383|NCT02048319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286384|NCT02048319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286385|NCT02048319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286386|NCT02048319|Hormones|hormones|mesh-ancestor
93286387|NCT02048319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286388|NCT01594762|Pexiganan|pexiganan|mesh-list
93286389|NCT01594762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286390|NCT01594762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286391|NCT02048475|Desflurane|desflurane|mesh-list
93286392|NCT02048475|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93286393|NCT02048475|Anesthetics, General|anesthetics, general|mesh-ancestor
93286394|NCT02048475|Anesthetics|anesthetics|mesh-ancestor
93286395|NCT02048475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286396|NCT02048475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286397|NCT03562143|Iron|iron|mesh-list
93286398|NCT03562143|Trace Elements|trace elements|mesh-ancestor
93286399|NCT03562143|Micronutrients|micronutrients|mesh-ancestor
93286400|NCT03562143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286401|NCT02048865|Apixaban|apixaban|mesh-list
93286402|NCT02048865|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93286403|NCT02048865|Antithrombins|antithrombins|mesh-ancestor
93286404|NCT02048865|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93286405|NCT02048865|Protease Inhibitors|protease inhibitors|mesh-ancestor
93286406|NCT02048865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286407|NCT02048865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286408|NCT02048865|Anticoagulants|anticoagulants|mesh-ancestor
93286409|NCT02048943|Paclitaxel|paclitaxel|mesh-list
93286410|NCT02048943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93286411|NCT02048943|Gemcitabine|gemcitabine|mesh-list
93286412|NCT02048943|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93286413|NCT02048943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93286414|NCT02048943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286415|NCT02048943|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286416|NCT02048943|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286417|NCT02048943|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286418|NCT02048943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286419|NCT02048943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93286420|NCT02048943|Antimetabolites|antimetabolites|mesh-ancestor
93286421|NCT02048943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286422|NCT02048943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286423|NCT02050893|Midazolam|midazolam|mesh-list
93286424|NCT02050893|Propofol|propofol|mesh-list
93286425|NCT02050893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93286426|NCT02050893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286427|NCT02050893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286428|NCT02050893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286429|NCT02050893|Anesthetics, General|anesthetics, general|mesh-ancestor
93286430|NCT02050893|Anesthetics|anesthetics|mesh-ancestor
93286431|NCT02050893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286432|NCT02050893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93286433|NCT02050893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93286434|NCT02050893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93286435|NCT02050893|GABA Modulators|gaba modulators|mesh-ancestor
93286436|NCT02050893|GABA Agents|gaba agents|mesh-ancestor
93286437|NCT02050893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286438|NCT02050893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286439|NCT02806947|Sirolimus|sirolimus|mesh-list
93286440|NCT02806947|Prednisone|prednisone|mesh-list
93286441|NCT02806947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286442|NCT02806947|Glucocorticoids|glucocorticoids|mesh-ancestor
93286443|NCT02806947|Hormones|hormones|mesh-ancestor
93286444|NCT02806947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286445|NCT02806947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286446|NCT02806947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286447|NCT02806947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286448|NCT02806947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286449|NCT02806947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286450|NCT02806947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93286451|NCT02806947|Antifungal Agents|antifungal agents|mesh-ancestor
93286452|NCT02806947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93286453|NCT02806947|Immunologic Factors|immunologic factors|mesh-ancestor
93286454|NCT03442114|Hydroxyurea|hydroxyurea|mesh-list
93286455|NCT03442114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286456|NCT03442114|Antisickling Agents|antisickling agents|mesh-ancestor
93286457|NCT03442114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286458|NCT03442114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286459|NCT03442114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93286460|NCT02037399|Dexamethasone|dexamethasone|mesh-list
93286461|NCT02037399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286462|NCT02037399|Antiemetics|antiemetics|mesh-ancestor
93286463|NCT02037399|Autonomic Agents|autonomic agents|mesh-ancestor
93286464|NCT02037399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286465|NCT02037399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286466|NCT02037399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93286467|NCT02037399|Glucocorticoids|glucocorticoids|mesh-ancestor
93286468|NCT02037399|Hormones|hormones|mesh-ancestor
93286469|NCT02037399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286470|NCT02037399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286471|NCT02037399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286472|NCT02260089|Telmisartan|telmisartan|mesh-list
93286473|NCT02260089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93286474|NCT02260089|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93286475|NCT02260089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93286476|NCT02260089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286477|NCT02049255|Bupivacaine|bupivacaine|mesh-list
93286478|NCT02049255|Chloroprocaine|chloroprocaine|mesh-list
93286479|NCT02049255|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286480|NCT02049255|Anesthetics|anesthetics|mesh-ancestor
93286481|NCT02049255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286482|NCT02049255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286483|NCT02049255|Sensory System Agents|sensory system agents|mesh-ancestor
93286484|NCT02049255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286485|NCT02037711|Levobupivacaine|levobupivacaine|mesh-list
93286486|NCT02037711|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286487|NCT02037711|Anesthetics|anesthetics|mesh-ancestor
93286488|NCT02037711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286489|NCT02037711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286490|NCT02037711|Sensory System Agents|sensory system agents|mesh-ancestor
93286491|NCT02037711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286492|NCT03561675|Acetazolamide|acetazolamide|mesh-list
93286493|NCT03561675|Anticonvulsants|anticonvulsants|mesh-ancestor
93286494|NCT03561675|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93286495|NCT03561675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286496|NCT03561675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286497|NCT03561675|Diuretics|diuretics|mesh-ancestor
93286498|NCT03561675|Natriuretic Agents|natriuretic agents|mesh-ancestor
93286499|NCT03561675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286501|NCT02049411|Analgesics|analgesics|mesh-ancestor
93286502|NCT02049411|Sensory System Agents|sensory system agents|mesh-ancestor
93286503|NCT02049411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286504|NCT02049411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286505|NCT02049411|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93286506|NCT02049411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286507|NCT02049411|Anesthetics, General|anesthetics, general|mesh-ancestor
93286508|NCT02049411|Anesthetics|anesthetics|mesh-ancestor
93286509|NCT02049411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286510|NCT02049411|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93286511|NCT02049411|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93286512|NCT02049411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286513|NCT02049411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286514|NCT02807493|Salicylic Acid|salicylic acid|mesh-list
93286515|NCT02807493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286516|NCT02807493|Antifungal Agents|antifungal agents|mesh-ancestor
93286517|NCT02807493|Keratolytic Agents|keratolytic agents|mesh-ancestor
93286518|NCT02807493|Dermatologic Agents|dermatologic agents|mesh-ancestor
93286519|NCT02051751|Paclitaxel|paclitaxel|mesh-list
93286520|NCT02051751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93286521|NCT02051751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286522|NCT02051751|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286523|NCT02051751|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286524|NCT02051751|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286525|NCT02051751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286526|NCT02049801|Cytarabine|cytarabine|mesh-list
93286527|NCT02049801|Idarubicin|idarubicin|mesh-list
93286528|NCT02049801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93286529|NCT02049801|Antimetabolites|antimetabolites|mesh-ancestor
93286530|NCT02049801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286531|NCT02049801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286532|NCT02049801|Antiviral Agents|antiviral agents|mesh-ancestor
93286533|NCT02049801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286534|NCT02049801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93286535|NCT02049801|Immunologic Factors|immunologic factors|mesh-ancestor
93286536|NCT02049801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286537|NCT02049801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93286538|NCT02049801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93286539|NCT02049801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93286540|NCT02049801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286541|NCT02802345|Nintedanib|nintedanib|mesh-list
93286542|NCT02802345|Sildenafil Citrate|sildenafil citrate|mesh-list
93286543|NCT02802345|Vasodilator Agents|vasodilator agents|mesh-ancestor
93286544|NCT02802345|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93286545|NCT02802345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93286546|NCT02802345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286547|NCT02802345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286548|NCT02802345|Urological Agents|urological agents|mesh-ancestor
93286549|NCT02802345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286550|NCT02802345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286551|NCT02053779|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93286552|NCT02053779|Luteolytic Agents|luteolytic agents|mesh-ancestor
93286553|NCT02053779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93286554|NCT02053779|Contraceptive Agents|contraceptive agents|mesh-ancestor
93286555|NCT02053779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93286556|NCT02053779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286557|NCT02053779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93286558|NCT02053779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286559|NCT02053779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286560|NCT02056041|Liver Extracts|liver extracts|mesh-list
93286561|NCT02056041|Hematinics|hematinics|mesh-ancestor
93286562|NCT02053857|Amoxicillin|amoxicillin|mesh-list
93286563|NCT02053857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286564|NCT02053857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286565|NCT02053935|Dopamine|dopamine|mesh-list
93286566|NCT02053935|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93286567|NCT02053935|Sympathomimetics|sympathomimetics|mesh-ancestor
93286568|NCT02053935|Autonomic Agents|autonomic agents|mesh-ancestor
93286569|NCT02053935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286570|NCT02053935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286571|NCT02053935|Dopamine Agents|dopamine agents|mesh-ancestor
93286572|NCT02053935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581055|NCT00079586|Protease Inhibitors|protease inhibitors|mesh-ancestor
93286573|NCT02053935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286575|NCT02056353|Insulin|insulin|mesh-list
93286576|NCT02056353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93286577|NCT02056353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286578|NCT02056587|Everolimus|everolimus|mesh-list
93286579|NCT02056587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93286580|NCT02056587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286581|NCT02056587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286582|NCT02056587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286583|NCT02056587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93286584|NCT02056587|Immunologic Factors|immunologic factors|mesh-ancestor
93286585|NCT02056587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286586|NCT02056587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286587|NCT02038335|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93286588|NCT02038335|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93286589|NCT02038335|Levonorgestrel|levonorgestrel|mesh-list
93286590|NCT02038335|Medroxyprogesterone|medroxyprogesterone|mesh-list
93286591|NCT02038335|Etonogestrel|etonogestrel|mesh-list
93286592|NCT02038335|Norethindrone|norethindrone|mesh-list
93286593|NCT02038335|Estradiol|estradiol|mesh-list
93286594|NCT02038335|Estrogens|estrogens|mesh-ancestor
93286595|NCT02038335|Hormones|hormones|mesh-ancestor
93286596|NCT02038335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286597|NCT02038335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286598|NCT02038335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93286599|NCT02038335|Contraceptive Agents|contraceptive agents|mesh-ancestor
93286600|NCT02038335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93286601|NCT02038335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93286602|NCT02038335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93286603|NCT02038335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93286604|NCT02038335|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93286605|NCT02038335|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93286606|NCT02038335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286607|NCT02038335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286608|NCT02056665|Minocycline|minocycline|mesh-list
93286609|NCT02056665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286610|NCT02056665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286611|NCT02056743|Fexofenadine|fexofenadine|mesh-list
93286612|NCT02056743|Losartan|losartan|mesh-list
93286613|NCT02056743|Midazolam|midazolam|mesh-list
93286614|NCT02056743|Dextromethorphan|dextromethorphan|mesh-list
93286615|NCT02056743|Caffeine|caffeine|mesh-list
93286616|NCT02056743|Omeprazole|omeprazole|mesh-list
93286617|NCT02056743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286618|NCT02056743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93286619|NCT02056743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286620|NCT02056743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286621|NCT02056743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93286622|NCT02056743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93286623|NCT02056743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93286624|NCT02056743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286625|NCT02056743|Anesthetics, General|anesthetics, general|mesh-ancestor
93286626|NCT02056743|Anesthetics|anesthetics|mesh-ancestor
93286627|NCT02056743|GABA Modulators|gaba modulators|mesh-ancestor
93286628|NCT02056743|GABA Agents|gaba agents|mesh-ancestor
93286629|NCT02056743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286630|NCT02056743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286631|NCT02056743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93286632|NCT02056743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93286633|NCT02056743|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93286634|NCT02056743|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93286635|NCT02056743|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93286636|NCT02056743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93286637|NCT02056743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286638|NCT02056743|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93286639|NCT02056743|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93286640|NCT02056743|Purinergic Agents|purinergic agents|mesh-ancestor
93286641|NCT02056743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93286642|NCT02056743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93286643|NCT02056743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93286644|NCT02056743|Antitussive Agents|antitussive agents|mesh-ancestor
93286645|NCT02056743|Respiratory System Agents|respiratory system agents|mesh-ancestor
93286646|NCT02056743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93286647|NCT02056743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92958672|NCT00976690|Mesalamine|mesalamine|mesh-list
93286648|NCT02056743|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93286649|NCT02056743|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93286650|NCT02056743|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93286651|NCT02056743|Histamine Antagonists|histamine antagonists|mesh-ancestor
93286652|NCT02056743|Histamine Agents|histamine agents|mesh-ancestor
93286653|NCT02052375|ASP2408|asp2408|mesh-list
93286654|NCT02052375|Immunoconjugates|immunoconjugates|mesh-ancestor
93286655|NCT02052375|Immunologic Factors|immunologic factors|mesh-ancestor
93286656|NCT02052375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286657|NCT02054637|Lanreotide|lanreotide|mesh-list
93286658|NCT02054637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286659|NCT02052609|Brodalumab|brodalumab|mesh-list
93286660|NCT02052609|Dermatologic Agents|dermatologic agents|mesh-ancestor
93286661|NCT02054793|Itraconazole|itraconazole|mesh-list
93286662|NCT02054793|Antifungal Agents|antifungal agents|mesh-ancestor
93286663|NCT02054793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286664|NCT02054793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93286665|NCT02054793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93286666|NCT02054793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286667|NCT02054793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286668|NCT02054793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93286669|NCT02054793|Hormone Antagonists|hormone antagonists|mesh-ancestor
93286670|NCT02054793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286671|NCT02054793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286672|NCT02054793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93286673|NCT02052687|Imiquimod|imiquimod|mesh-list
93286674|NCT02052687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93286675|NCT02052687|Immunologic Factors|immunologic factors|mesh-ancestor
93286676|NCT02052687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286677|NCT02052687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286678|NCT02052687|Interferon Inducers|interferon inducers|mesh-ancestor
93286679|NCT02057289|Micafungin|micafungin|mesh-list
93286680|NCT02057289|Antifungal Agents|antifungal agents|mesh-ancestor
93286681|NCT02057289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286682|NCT02057367|Bupivacaine|bupivacaine|mesh-list
93286683|NCT02057367|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286684|NCT02057367|Anesthetics|anesthetics|mesh-ancestor
93286685|NCT02057367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286686|NCT02057367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286687|NCT02057367|Sensory System Agents|sensory system agents|mesh-ancestor
93286688|NCT02057367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286689|NCT02054949|Acetylcysteine|acetylcysteine|mesh-list
93286690|NCT02054949|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93286691|NCT02054949|Antiviral Agents|antiviral agents|mesh-ancestor
93286692|NCT02054949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286693|NCT02054949|Expectorants|expectorants|mesh-ancestor
93286694|NCT02054949|Respiratory System Agents|respiratory system agents|mesh-ancestor
93286695|NCT02054949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93286696|NCT02054949|Antioxidants|antioxidants|mesh-ancestor
93286697|NCT02054949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286698|NCT02054949|Protective Agents|protective agents|mesh-ancestor
93286699|NCT02054949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286700|NCT02054949|Antidotes|antidotes|mesh-ancestor
93286701|NCT02748057|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93286702|NCT02748057|Ezetimibe|ezetimibe|mesh-list
93286703|NCT02748057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93286704|NCT02748057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93286705|NCT02748057|Antimetabolites|antimetabolites|mesh-ancestor
92581199|NCT00300040|HBOC 201|hboc 201|mesh-list
93286706|NCT02748057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286707|NCT02748057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93286708|NCT02748057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93286709|NCT02748057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286710|NCT02057601|Levobupivacaine|levobupivacaine|mesh-list
93286711|NCT02057601|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286712|NCT02057601|Anesthetics|anesthetics|mesh-ancestor
93286713|NCT02057601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286714|NCT02057601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286715|NCT02057601|Sensory System Agents|sensory system agents|mesh-ancestor
93286716|NCT02057601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286717|NCT02057679|Amoxicillin|amoxicillin|mesh-list
93286718|NCT02057679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93286719|NCT02057679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286720|NCT02038491|Anesthetics|anesthetics|mesh-list
93286721|NCT02038491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286722|NCT02038491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286723|NCT02055183|Antitoxins|antitoxins|mesh-list
93286724|NCT02055183|Botulinum Antitoxin|botulinum antitoxin|mesh-list
93286725|NCT02055183|Immunologic Factors|immunologic factors|mesh-ancestor
93286726|NCT02055183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286727|NCT02748213|Docetaxel|docetaxel|mesh-list
93286728|NCT02748213|Capecitabine|capecitabine|mesh-list
93286729|NCT02748213|Trastuzumab|trastuzumab|mesh-list
93286730|NCT02748213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286731|NCT02748213|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286732|NCT02748213|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286733|NCT02748213|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286734|NCT02748213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286735|NCT02748213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93286736|NCT02748213|Antimetabolites|antimetabolites|mesh-ancestor
93286737|NCT02748213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286738|NCT03804099|Aflibercept|aflibercept|mesh-list
93286739|NCT03804099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93286740|NCT03804099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93286741|NCT03804099|Growth Substances|growth substances|mesh-ancestor
93286742|NCT03804099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286743|NCT03804099|Growth Inhibitors|growth inhibitors|mesh-ancestor
93286744|NCT03804099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286745|NCT02058303|Bupivacaine|bupivacaine|mesh-list
93286746|NCT02058303|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286747|NCT02058303|Anesthetics|anesthetics|mesh-ancestor
93286748|NCT02058303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286749|NCT02058303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286750|NCT02058303|Sensory System Agents|sensory system agents|mesh-ancestor
93286751|NCT02058303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286752|NCT05256472|Axitinib|axitinib|mesh-list
93286753|NCT05256472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286754|NCT05256472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286755|NCT05256472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286756|NCT05256472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286757|NCT04870060|Curcumin|curcumin|mesh-list
93286758|NCT04870060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93286759|NCT04870060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286760|NCT04870060|Analgesics|analgesics|mesh-ancestor
93286761|NCT04870060|Sensory System Agents|sensory system agents|mesh-ancestor
93286762|NCT04870060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286763|NCT04870060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286764|NCT04870060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286765|NCT04870060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286766|NCT04870060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286767|NCT04870060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286768|NCT04870060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286769|NCT02613910|Acetaminophen|acetaminophen|mesh-list
93286770|NCT02613910|Cetirizine|cetirizine|mesh-list
93286771|NCT02613910|Prednisone|prednisone|mesh-list
93286772|NCT02613910|Prednisolone|prednisolone|mesh-list
93286773|NCT02613910|Ofatumumab|ofatumumab|mesh-list
93286774|NCT02613910|Histamine Antagonists|histamine antagonists|mesh-list
93286775|NCT02613910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93286776|NCT02613910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286777|NCT02613910|Glucocorticoids|glucocorticoids|mesh-ancestor
93286778|NCT02613910|Hormones|hormones|mesh-ancestor
93286779|NCT02613910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286780|NCT02613910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286781|NCT02613910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93286782|NCT02613910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286783|NCT02613910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286784|NCT02613910|Analgesics|analgesics|mesh-ancestor
93286785|NCT02613910|Sensory System Agents|sensory system agents|mesh-ancestor
93286786|NCT02613910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286787|NCT02613910|Antipyretics|antipyretics|mesh-ancestor
93286788|NCT02613910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93286789|NCT02613910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93286790|NCT02613910|Histamine Agents|histamine agents|mesh-ancestor
93286791|NCT02613910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286792|NCT02613910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286793|NCT02802735|Apremilast|apremilast|mesh-list
93286794|NCT02802735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93286795|NCT02802735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286796|NCT02802735|Analgesics|analgesics|mesh-ancestor
93286797|NCT02802735|Sensory System Agents|sensory system agents|mesh-ancestor
93286798|NCT02802735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286799|NCT02802735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286800|NCT02802735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286802|NCT02802735|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93286803|NCT02802735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93286804|NCT02802735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286805|NCT02802735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286806|NCT03048214|Anesthetics|anesthetics|mesh-list
93286807|NCT03048214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286808|NCT03048214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286809|NCT02060955|Bevacizumab|bevacizumab|mesh-list
93286810|NCT02060955|Irinotecan|irinotecan|mesh-list
93286811|NCT02060955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286812|NCT02060955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286813|NCT02060955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93286814|NCT02060955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93286815|NCT02060955|Growth Substances|growth substances|mesh-ancestor
93286816|NCT02060955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286817|NCT02060955|Growth Inhibitors|growth inhibitors|mesh-ancestor
93286818|NCT02060955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93286819|NCT02060955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93286820|NCT02060955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286821|NCT02060955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286822|NCT02273362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93286823|NCT02273362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286824|NCT02273362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286825|NCT02273362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286826|NCT02273362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286827|NCT04877626|Artesunate|artesunate|mesh-list
93286828|NCT04877626|Antimalarials|antimalarials|mesh-ancestor
93286829|NCT04877626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93286830|NCT04877626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93286831|NCT04877626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286832|NCT04877626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286833|NCT04877626|Antiviral Agents|antiviral agents|mesh-ancestor
93286834|NCT04877626|Schistosomicides|schistosomicides|mesh-ancestor
93286835|NCT04877626|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93286836|NCT04877626|Anthelmintics|anthelmintics|mesh-ancestor
93286837|NCT05255848|Heparin|heparin|mesh-list
93286838|NCT05255848|Calcium heparin|calcium heparin|mesh-list
93286839|NCT05255848|Anticoagulants|anticoagulants|mesh-ancestor
93286840|NCT05255848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93286841|NCT05255848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93286842|NCT05255848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286843|NCT04430062|Anesthetics|anesthetics|mesh-list
93286844|NCT04430062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286845|NCT04430062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286846|NCT02799381|Levodopa|levodopa|mesh-list
93286847|NCT02799381|Carbidopa|carbidopa|mesh-list
93286848|NCT02799381|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93286849|NCT02799381|Antiparkinson Agents|antiparkinson agents|mesh-list
93286850|NCT02799381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93286851|NCT02799381|Dopamine Agents|dopamine agents|mesh-ancestor
93286852|NCT02799381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286853|NCT02799381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286854|NCT02799381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286855|NCT02799381|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93286856|NCT02799381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286857|NCT02799381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93286858|NCT02799381|Immunologic Factors|immunologic factors|mesh-ancestor
93286859|NCT02799381|Dopamine Agonists|dopamine agonists|mesh-ancestor
93286860|NCT04387942|Aldesleukin|aldesleukin|mesh-list
93286861|NCT04387942|Interleukin-2|interleukin-2|mesh-list
93286862|NCT04387942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286863|NCT04387942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286864|NCT04387942|Analgesics|analgesics|mesh-ancestor
93286865|NCT04387942|Sensory System Agents|sensory system agents|mesh-ancestor
93286866|NCT04387942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286867|NCT04387942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286868|NCT04387942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93286869|NCT04387942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93286870|NCT04387942|Antiviral Agents|antiviral agents|mesh-ancestor
93286871|NCT04387942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93286872|NCT01333059|Fentanyl|fentanyl|mesh-list
93286873|NCT01333059|Midazolam|midazolam|mesh-list
93286874|NCT01333059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93286875|NCT01333059|Narcotics|narcotics|mesh-ancestor
92958928|NCT00971074|Hylan|hylan|mesh-list
93286876|NCT01333059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286877|NCT01333059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286879|NCT01333059|Sensory System Agents|sensory system agents|mesh-ancestor
93286880|NCT01333059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286881|NCT01333059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93286882|NCT01333059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93286883|NCT01333059|Anesthetics, General|anesthetics, general|mesh-ancestor
93286884|NCT01333059|Anesthetics|anesthetics|mesh-ancestor
93286885|NCT01333059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93286886|NCT01333059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93286887|NCT01333059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93286888|NCT01333059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93286889|NCT01333059|GABA Modulators|gaba modulators|mesh-ancestor
93286890|NCT01333059|GABA Agents|gaba agents|mesh-ancestor
93286891|NCT01333059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93286892|NCT01333059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286893|NCT02060253|Paclitaxel|paclitaxel|mesh-list
93286894|NCT02060253|Trastuzumab|trastuzumab|mesh-list
93286895|NCT02060253|Pertuzumab|pertuzumab|mesh-list
93286896|NCT02060253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93286897|NCT02060253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286898|NCT02060253|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286899|NCT02060253|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286900|NCT02060253|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286901|NCT02060253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286902|NCT02060253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286903|NCT04364620|Docetaxel|docetaxel|mesh-list
93286904|NCT04364620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286905|NCT04364620|Tubulin Modulators|tubulin modulators|mesh-ancestor
93286906|NCT04364620|Antimitotic Agents|antimitotic agents|mesh-ancestor
93286907|NCT04364620|Mitosis Modulators|mitosis modulators|mesh-ancestor
93286908|NCT04364620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286909|NCT03560973|Gemcitabine|gemcitabine|mesh-list
93286910|NCT03560973|Ramucirumab|ramucirumab|mesh-list
93286911|NCT03560973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93286912|NCT03560973|Antimetabolites|antimetabolites|mesh-ancestor
93286913|NCT03560973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286914|NCT03560973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286915|NCT04383574|Vaccines|vaccines|mesh-list
93286916|NCT04383574|Immunologic Factors|immunologic factors|mesh-ancestor
93286917|NCT04383574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286918|NCT03046108|Triamcinolone|triamcinolone|mesh-list
93286919|NCT03046108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93286920|NCT03046108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93286921|NCT03046108|Mepivacaine|mepivacaine|mesh-list
93286922|NCT03046108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93286923|NCT03046108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286924|NCT03046108|Glucocorticoids|glucocorticoids|mesh-ancestor
93286925|NCT03046108|Hormones|hormones|mesh-ancestor
93286926|NCT03046108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93286927|NCT03046108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286928|NCT03046108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93286929|NCT03046108|Immunologic Factors|immunologic factors|mesh-ancestor
93286930|NCT03046108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286931|NCT03046108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286932|NCT03046108|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286933|NCT03046108|Anesthetics|anesthetics|mesh-ancestor
93286934|NCT03046108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286935|NCT03046108|Sensory System Agents|sensory system agents|mesh-ancestor
93286936|NCT03046108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286937|NCT02061267|Niacin|niacin|mesh-list
93286938|NCT02061267|Nicotinic Acids|nicotinic acids|mesh-list
93286939|NCT02061267|Vitamins|vitamins|mesh-ancestor
93286940|NCT02061267|Micronutrients|micronutrients|mesh-ancestor
93286941|NCT02061267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286942|NCT02061267|Vitamin B Complex|vitamin b complex|mesh-ancestor
93286943|NCT02061267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93286944|NCT02061267|Antimetabolites|antimetabolites|mesh-ancestor
93286945|NCT02061267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286946|NCT02061267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93286947|NCT02061267|Vasodilator Agents|vasodilator agents|mesh-ancestor
93286948|NCT01370655|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93286949|NCT01370655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93286950|NCT01370655|Diuretics|diuretics|mesh-ancestor
93286951|NCT01370655|Natriuretic Agents|natriuretic agents|mesh-ancestor
93286952|NCT01370655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286953|NCT01370655|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93286954|NCT01370655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93286955|NCT01370655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286956|NCT02612194|Crizotinib|crizotinib|mesh-list
93286957|NCT02612194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286958|NCT02612194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93286959|NCT02612194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286960|NCT02612194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286961|NCT03044626|Nivolumab|nivolumab|mesh-list
93286962|NCT03044626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93286963|NCT03044626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93286964|NCT03044626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93286965|NCT03044626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286966|NCT04865224|Chrysarobin|chrysarobin|mesh-list
93286967|NCT04865224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93286968|NCT04865224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286969|NCT04865224|Analgesics|analgesics|mesh-ancestor
93286970|NCT04865224|Sensory System Agents|sensory system agents|mesh-ancestor
93286971|NCT04865224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286972|NCT04865224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286973|NCT04865224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286974|NCT04865224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286975|NCT04865380|Tranexamic Acid|tranexamic acid|mesh-list
93286976|NCT04865380|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93286977|NCT04865380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93286978|NCT04865380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286979|NCT04865380|Hemostatics|hemostatics|mesh-ancestor
93286980|NCT04865380|Coagulants|coagulants|mesh-ancestor
93286981|NCT04869046|Acetaminophen|acetaminophen|mesh-list
93286982|NCT04869046|Ibuprofen|ibuprofen|mesh-list
93286983|NCT04869046|Analgesics|analgesics|mesh-list
93286984|NCT04869046|Levobupivacaine|levobupivacaine|mesh-list
93286985|NCT04869046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93286986|NCT04869046|Sensory System Agents|sensory system agents|mesh-ancestor
93286987|NCT04869046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93286988|NCT04869046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93286989|NCT04869046|Antipyretics|antipyretics|mesh-ancestor
93286990|NCT04869046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93286991|NCT04869046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93286992|NCT04869046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93286993|NCT04869046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93286994|NCT04869046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93286995|NCT04869046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93286996|NCT04869046|Anesthetics, Local|anesthetics, local|mesh-ancestor
93286997|NCT04869046|Anesthetics|anesthetics|mesh-ancestor
93286998|NCT04869046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93286999|NCT04385680|Chlorhexidine|chlorhexidine|mesh-list
93287000|NCT04385680|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93287001|NCT04385680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93287002|NCT04385680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287003|NCT04385680|Disinfectants|disinfectants|mesh-ancestor
93287004|NCT04385680|Dermatologic Agents|dermatologic agents|mesh-ancestor
93287005|NCT02798211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93287006|NCT02798211|Immunologic Factors|immunologic factors|mesh-ancestor
93287007|NCT02798211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287008|NCT02060019|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
93287009|NCT02060019|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93287010|NCT02060019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93287011|NCT02060019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287012|NCT02060019|Antimetabolites|antimetabolites|mesh-ancestor
93287013|NCT02060019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287014|NCT02060019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287015|NCT02060019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93287016|NCT02060019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287017|NCT02060019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287018|NCT05654415|Melatonin|melatonin|mesh-list
93287019|NCT05654415|Antioxidants|antioxidants|mesh-ancestor
93287020|NCT05654415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287021|NCT05654415|Protective Agents|protective agents|mesh-ancestor
93287022|NCT05654415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287023|NCT05654415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287024|NCT03044938|Albuterol|albuterol|mesh-list
93287025|NCT03044938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93287026|NCT03044938|Autonomic Agents|autonomic agents|mesh-ancestor
93287027|NCT03044938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287028|NCT03044938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287029|NCT03044938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93287030|NCT03044938|Respiratory System Agents|respiratory system agents|mesh-ancestor
93287031|NCT03044938|Tocolytic Agents|tocolytic agents|mesh-ancestor
93287032|NCT03044938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287033|NCT03044938|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93287034|NCT03044938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93287035|NCT03044938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93287036|NCT03044938|Adrenergic Agents|adrenergic agents|mesh-ancestor
93287037|NCT03044938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287038|NCT03044938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287040|NCT03045484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93287041|NCT03045484|Narcotics|narcotics|mesh-ancestor
93287042|NCT03045484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287043|NCT03045484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287044|NCT03045484|Analgesics|analgesics|mesh-ancestor
93287045|NCT03045484|Sensory System Agents|sensory system agents|mesh-ancestor
93287046|NCT03045484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287047|NCT04874506|TEMPO|tempo|mesh-list
93287048|NCT04874506|TEMPOL-H|tempol-h|mesh-list
93287049|NCT04874506|Antioxidants|antioxidants|mesh-ancestor
93287050|NCT04874506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287051|NCT04874506|Protective Agents|protective agents|mesh-ancestor
93287052|NCT04874506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287053|NCT04874506|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93287054|NCT04874428|Rivaroxaban|rivaroxaban|mesh-list
93287055|NCT04874428|Apixaban|apixaban|mesh-list
93287056|NCT04874428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93287057|NCT04874428|Antithrombins|antithrombins|mesh-ancestor
93287058|NCT04874428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93287059|NCT04874428|Protease Inhibitors|protease inhibitors|mesh-ancestor
93287060|NCT04874428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287061|NCT04874428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287062|NCT04874428|Anticoagulants|anticoagulants|mesh-ancestor
93287063|NCT04867720|Everolimus|everolimus|mesh-list
93287064|NCT04867720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93287065|NCT04867720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287066|NCT04867720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287067|NCT04867720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287068|NCT04867720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93287069|NCT04867720|Immunologic Factors|immunologic factors|mesh-ancestor
93287070|NCT04867720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287071|NCT04867720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287072|NCT02799069|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93287073|NCT02799069|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93287074|NCT02799069|Dermatologic Agents|dermatologic agents|mesh-ancestor
93287075|NCT02062047|Chlorhexidine|chlorhexidine|mesh-list
93287076|NCT02062047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93287077|NCT02062047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287078|NCT02062047|Disinfectants|disinfectants|mesh-ancestor
93287079|NCT03045406|Dalteparin|dalteparin|mesh-list
93287080|NCT03045406|Tinzaparin|tinzaparin|mesh-list
93287081|NCT03045406|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93287082|NCT03045406|Apixaban|apixaban|mesh-list
93287083|NCT03045406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93287084|NCT03045406|Antithrombins|antithrombins|mesh-ancestor
93287085|NCT03045406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93287086|NCT03045406|Protease Inhibitors|protease inhibitors|mesh-ancestor
93287087|NCT03045406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287088|NCT03045406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287089|NCT03045406|Anticoagulants|anticoagulants|mesh-ancestor
93287090|NCT03045406|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93287091|NCT03045406|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93287092|NCT02798835|Dexamethasone|dexamethasone|mesh-list
93287093|NCT02798835|Dexamethasone acetate|dexamethasone acetate|mesh-list
93287094|NCT02798835|Fentanyl|fentanyl|mesh-list
93287095|NCT02798835|Bupivacaine|bupivacaine|mesh-list
93287096|NCT02798835|Ropivacaine|ropivacaine|mesh-list
93287097|NCT02798835|BB 1101|bb 1101|mesh-list
93287098|NCT02798835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287099|NCT02798835|Antiemetics|antiemetics|mesh-ancestor
93287100|NCT02798835|Autonomic Agents|autonomic agents|mesh-ancestor
93287101|NCT02798835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287102|NCT02798835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287103|NCT02798835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287104|NCT02798835|Glucocorticoids|glucocorticoids|mesh-ancestor
93287106|NCT02798835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287107|NCT02798835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93287108|NCT02798835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287109|NCT02798835|Protease Inhibitors|protease inhibitors|mesh-ancestor
93287110|NCT02798835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287111|NCT02798835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287112|NCT02798835|Anesthetics, Local|anesthetics, local|mesh-ancestor
93287113|NCT02798835|Anesthetics|anesthetics|mesh-ancestor
93287114|NCT02798835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287115|NCT02798835|Sensory System Agents|sensory system agents|mesh-ancestor
93287116|NCT02798835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93287117|NCT02798835|Narcotics|narcotics|mesh-ancestor
93287118|NCT02798835|Analgesics|analgesics|mesh-ancestor
93287119|NCT02798835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93287120|NCT02798835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93287121|NCT02798835|Anesthetics, General|anesthetics, general|mesh-ancestor
93287122|NCT02061657|Misoprostol|misoprostol|mesh-list
93287123|NCT02061657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93287124|NCT02061657|Abortifacient Agents|abortifacient agents|mesh-ancestor
93287125|NCT02061657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287126|NCT02061657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287127|NCT02061657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93287128|NCT02061657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287129|NCT02061657|Oxytocics|oxytocics|mesh-ancestor
93287130|NCT03048136|Nivolumab|nivolumab|mesh-list
93287131|NCT03048136|Ipilimumab|ipilimumab|mesh-list
93287132|NCT03048136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287133|NCT03048136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287134|NCT03048136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93287135|NCT03048136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287136|NCT02062203|Moxifloxacin|moxifloxacin|mesh-list
93287137|NCT02062203|Glycine|glycine|mesh-list
93287138|NCT02062203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287139|NCT02062203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287140|NCT02062203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93287141|NCT02062203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93287142|NCT02062203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287143|NCT02062203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287144|NCT02062203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287145|NCT02062203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287146|NCT02062203|Glycine Agents|glycine agents|mesh-ancestor
93287147|NCT02062203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287148|NCT04863742|Prednisolone|prednisolone|mesh-list
93287149|NCT04863742|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93287150|NCT04863742|Methylprednisolone|methylprednisolone|mesh-list
93287151|NCT04863742|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93287152|NCT04863742|Prednisolone acetate|prednisolone acetate|mesh-list
93287153|NCT04863742|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93287154|NCT04863742|Prednisolone phosphate|prednisolone phosphate|mesh-list
93287155|NCT04863742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287156|NCT04863742|Glucocorticoids|glucocorticoids|mesh-ancestor
93287157|NCT04863742|Hormones|hormones|mesh-ancestor
93287158|NCT04863742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287159|NCT04863742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287160|NCT04863742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93287161|NCT04863742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287162|NCT04863742|Antiemetics|antiemetics|mesh-ancestor
93287163|NCT04863742|Autonomic Agents|autonomic agents|mesh-ancestor
93287164|NCT04863742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287165|NCT04863742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287166|NCT04863742|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93287167|NCT04863742|Protective Agents|protective agents|mesh-ancestor
93287168|NCT02611882|Edetic Acid|edetic acid|mesh-list
93287169|NCT02611882|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
93287170|NCT02611882|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93287171|NCT02611882|Chelating Agents|chelating agents|mesh-ancestor
93287172|NCT02611882|Sequestering Agents|sequestering agents|mesh-ancestor
93287173|NCT02611882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287174|NCT02611882|Anticoagulants|anticoagulants|mesh-ancestor
93287175|NCT02611882|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93287176|NCT02611882|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93287177|NCT02062281|Vaccines|vaccines|mesh-list
93287178|NCT02062281|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93287179|NCT02062281|Immunologic Factors|immunologic factors|mesh-ancestor
93287180|NCT02062281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287181|NCT05590455|Adalimumab|adalimumab|mesh-list
93287182|NCT05590455|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93287183|NCT05590455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287184|NCT05590455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93287185|NCT03560583|Metoclopramide|metoclopramide|mesh-list
93287186|NCT03560583|Antiemetics|antiemetics|mesh-ancestor
93287187|NCT03560583|Autonomic Agents|autonomic agents|mesh-ancestor
93287188|NCT03560583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287189|NCT03560583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287190|NCT03560583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287191|NCT03560583|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93287192|NCT03560583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93287193|NCT03560583|Dopamine Agents|dopamine agents|mesh-ancestor
93287194|NCT03560583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287195|NCT03560583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287196|NCT03560427|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92581669|NCT00120120|Growth Substances|growth substances|mesh-ancestor
93287197|NCT03560427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93287198|NCT03560427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93287199|NCT03560427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287200|NCT03560427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287201|NCT03560427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287202|NCT03560427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287203|NCT03560427|Analgesics|analgesics|mesh-ancestor
93287204|NCT03560427|Sensory System Agents|sensory system agents|mesh-ancestor
93287205|NCT03560427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287206|NCT03560427|Antidepressive Agents|antidepressive agents|mesh-ancestor
93287207|NCT03560427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93287208|NCT03560427|Dopamine Agents|dopamine agents|mesh-ancestor
93287209|NCT03797547|Aflibercept|aflibercept|mesh-list
93287210|NCT03797547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93287211|NCT03797547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93287212|NCT03797547|Growth Substances|growth substances|mesh-ancestor
93287213|NCT03797547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287214|NCT03797547|Growth Inhibitors|growth inhibitors|mesh-ancestor
93287215|NCT03797547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287216|NCT04867252|Inositol|inositol|mesh-list
93287217|NCT04867252|Metformin|metformin|mesh-list
93287218|NCT04867252|Pioglitazone|pioglitazone|mesh-list
93287219|NCT04867252|Resveratrol|resveratrol|mesh-list
93287220|NCT04867252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93287221|NCT04867252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287222|NCT04867252|Antioxidants|antioxidants|mesh-ancestor
93287223|NCT04867252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287224|NCT04867252|Protective Agents|protective agents|mesh-ancestor
93287225|NCT04867252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287226|NCT04867252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93287227|NCT04867252|Vitamin B Complex|vitamin b complex|mesh-ancestor
93287228|NCT04867252|Vitamins|vitamins|mesh-ancestor
93287229|NCT04867252|Micronutrients|micronutrients|mesh-ancestor
93287230|NCT04863274|Atorvastatin|atorvastatin|mesh-list
93287231|NCT04863274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93287232|NCT04863274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287233|NCT04863274|Antimetabolites|antimetabolites|mesh-ancestor
93287234|NCT04863274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287235|NCT04863274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287236|NCT04863274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93287237|NCT04863274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287238|NCT02063373|Hyaluronic Acid|hyaluronic acid|mesh-list
93287239|NCT02063373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93287240|NCT02063373|Immunologic Factors|immunologic factors|mesh-ancestor
93287241|NCT02063373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287242|NCT02063373|Viscosupplements|viscosupplements|mesh-ancestor
93287243|NCT02063373|Protective Agents|protective agents|mesh-ancestor
93287244|NCT02062749|Oxaliplatin|oxaliplatin|mesh-list
93287245|NCT02062749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287246|NCT02796651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93287247|NCT02796651|Formoterol Fumarate|formoterol fumarate|mesh-list
93287248|NCT02796651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93287249|NCT02796651|Autonomic Agents|autonomic agents|mesh-ancestor
93287250|NCT02796651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287251|NCT02796651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287252|NCT02796651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93287253|NCT02796651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92959272|NCT00901875|Naloxone|naloxone|mesh-list
93287254|NCT02796651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93287255|NCT02796651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93287256|NCT02796651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93287257|NCT02796651|Adrenergic Agents|adrenergic agents|mesh-ancestor
93287258|NCT02796651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287259|NCT02796651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287260|NCT03044080|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93287261|NCT03044080|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93287262|NCT03044080|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93287263|NCT03044080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93287264|NCT03044080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287265|NCT03044080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581734|NCT00080951|Leucovorin|leucovorin|mesh-list
93287266|NCT03044080|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93287267|NCT03044080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287268|NCT03044080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287269|NCT03044080|Cholinergic Agents|cholinergic agents|mesh-ancestor
93287270|NCT03044080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287271|NCT04429282|Ibuprofen|ibuprofen|mesh-list
93287272|NCT04429282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93287273|NCT04429282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93287274|NCT04429282|Analgesics|analgesics|mesh-ancestor
93287275|NCT04429282|Sensory System Agents|sensory system agents|mesh-ancestor
93287276|NCT04429282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287277|NCT04429282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287278|NCT04429282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287279|NCT04429282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93287280|NCT04429282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93287281|NCT04429282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287282|NCT04429282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287283|NCT02063529|Leucovorin|leucovorin|mesh-list
93287284|NCT02063529|Fluorouracil|fluorouracil|mesh-list
93287285|NCT02063529|Oxaliplatin|oxaliplatin|mesh-list
93287286|NCT02063529|Irinotecan|irinotecan|mesh-list
93287287|NCT02063529|Cetuximab|cetuximab|mesh-list
93287288|NCT02063529|Levoleucovorin|levoleucovorin|mesh-list
93287289|NCT02063529|Antimetabolites|antimetabolites|mesh-ancestor
93287290|NCT02063529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287291|NCT02063529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93287292|NCT02063529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287293|NCT02063529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93287294|NCT02063529|Immunologic Factors|immunologic factors|mesh-ancestor
93287295|NCT02063529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287296|NCT02063529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93287297|NCT02063529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93287298|NCT02063529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287299|NCT02063529|Antidotes|antidotes|mesh-ancestor
93287300|NCT02063529|Protective Agents|protective agents|mesh-ancestor
93287301|NCT02063529|Vitamin B Complex|vitamin b complex|mesh-ancestor
93287302|NCT02063529|Vitamins|vitamins|mesh-ancestor
93287303|NCT02063529|Micronutrients|micronutrients|mesh-ancestor
93287304|NCT02063529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287305|NCT02062983|Trastuzumab|trastuzumab|mesh-list
93287306|NCT02062983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287307|NCT02062983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287308|NCT02613208|Paclitaxel|paclitaxel|mesh-list
93287309|NCT02613208|Bevacizumab|bevacizumab|mesh-list
93287310|NCT02613208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93287311|NCT02613208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287312|NCT02613208|Tubulin Modulators|tubulin modulators|mesh-ancestor
93287313|NCT02613208|Antimitotic Agents|antimitotic agents|mesh-ancestor
93287314|NCT02613208|Mitosis Modulators|mitosis modulators|mesh-ancestor
93287315|NCT02613208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287316|NCT02613208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287317|NCT02613208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93287318|NCT02613208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93287319|NCT02613208|Growth Substances|growth substances|mesh-ancestor
93287320|NCT02613208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287321|NCT02613208|Growth Inhibitors|growth inhibitors|mesh-ancestor
93287322|NCT02063841|Bismuth|bismuth|mesh-list
93287323|NCT02063841|Antacids|antacids|mesh-ancestor
93287324|NCT02063841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287325|NCT02063841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287326|NCT02064153|Dialysis Solutions|dialysis solutions|mesh-list
93287327|NCT02064153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93287328|NCT04872634|Cetuximab|cetuximab|mesh-list
92959333|NCT00359281|Vitamins|vitamins|mesh-ancestor
93287329|NCT04872634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287330|NCT04872634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287332|NCT01668784|Everolimus|everolimus|mesh-list
93287333|NCT01668784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287334|NCT01668784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287335|NCT01668784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93287336|NCT01668784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287337|NCT01668784|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93287338|NCT01668784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287339|NCT01668784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287340|NCT01668784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93287341|NCT01668784|Immunologic Factors|immunologic factors|mesh-ancestor
93287342|NCT01668784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287343|NCT02750514|Nivolumab|nivolumab|mesh-list
93287344|NCT02750514|Ipilimumab|ipilimumab|mesh-list
93287345|NCT02750514|Relatlimab|relatlimab|mesh-list
93287346|NCT02750514|Dasatinib|dasatinib|mesh-list
93287347|NCT02750514|Linrodostat|linrodostat|mesh-list
93287348|NCT02750514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287349|NCT02750514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287350|NCT02750514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93287351|NCT02750514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287352|NCT02750514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287353|NCT02750514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287354|NCT02229240|rGLP-1 protein|rglp-1 protein|mesh-list
93287355|NCT02229240|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93287356|NCT02229240|Incretins|incretins|mesh-ancestor
93287357|NCT02229240|Hormones|hormones|mesh-ancestor
93287358|NCT02229240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287359|NCT02229240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287360|NCT02820714|Laxatives|laxatives|mesh-list
93287361|NCT02820714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287362|NCT02259426|Primaquine|primaquine|mesh-list
93287363|NCT02259426|Piperaquine|piperaquine|mesh-list
93287364|NCT02259426|Artenimol|artenimol|mesh-list
93287365|NCT02259426|Antimalarials|antimalarials|mesh-ancestor
93287366|NCT02259426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93287367|NCT02259426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93287368|NCT02259426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287369|NCT03742518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93287370|NCT03738618|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93287371|NCT03738618|Hormones|hormones|mesh-ancestor
93287372|NCT03738618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287373|NCT03738618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287374|NCT03412890|Norethindrone|norethindrone|mesh-list
93287375|NCT03412890|Norethindrone Acetate|norethindrone acetate|mesh-list
93287376|NCT03412890|Estradiol|estradiol|mesh-list
93287377|NCT03412890|Relugolix|relugolix|mesh-list
93287378|NCT03412890|Estrogens|estrogens|mesh-ancestor
93287379|NCT03412890|Hormones|hormones|mesh-ancestor
93287380|NCT03412890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287381|NCT03412890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287382|NCT03412890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93287383|NCT03412890|Contraceptive Agents|contraceptive agents|mesh-ancestor
93287384|NCT03412890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287385|NCT03412890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93287386|NCT03412890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93287387|NCT03412890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93287388|NCT03412890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93287389|NCT03412890|Androgen Antagonists|androgen antagonists|mesh-ancestor
93287390|NCT03412890|Hormone Antagonists|hormone antagonists|mesh-ancestor
93287391|NCT03371082|Insulin Glargine|insulin glargine|mesh-list
93287392|NCT03371082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93287393|NCT03371082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287394|NCT03340974|Avasopasem manganese|avasopasem manganese|mesh-list
93287395|NCT03340974|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93287396|NCT03340974|Antioxidants|antioxidants|mesh-ancestor
93287397|NCT03340974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287398|NCT03340974|Protective Agents|protective agents|mesh-ancestor
93287399|NCT03340974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287400|NCT02229786|Acetaminophen|acetaminophen|mesh-list
93287401|NCT02229786|Scopolamine|scopolamine|mesh-list
93287402|NCT02229786|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93287403|NCT02229786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93287404|NCT02229786|Analgesics|analgesics|mesh-ancestor
93287405|NCT02229786|Sensory System Agents|sensory system agents|mesh-ancestor
93287406|NCT02229786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287407|NCT02229786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287409|NCT02229786|Parasympatholytics|parasympatholytics|mesh-ancestor
93287410|NCT02229786|Autonomic Agents|autonomic agents|mesh-ancestor
93287411|NCT02229786|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93287412|NCT02229786|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93287413|NCT02229786|Cholinergic Agents|cholinergic agents|mesh-ancestor
93287414|NCT02229786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287415|NCT02229786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287416|NCT02229786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93287417|NCT02229786|Antiemetics|antiemetics|mesh-ancestor
93287418|NCT02229786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287419|NCT02229786|Mydriatics|mydriatics|mesh-ancestor
93287420|NCT03287232|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93287421|NCT03287232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93287422|NCT03287232|Immunologic Factors|immunologic factors|mesh-ancestor
93287423|NCT03287232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287424|NCT02229942|Rituximab|rituximab|mesh-list
93287425|NCT02229942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287426|NCT02229942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287427|NCT02229942|Immunologic Factors|immunologic factors|mesh-ancestor
93287428|NCT02229942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287429|NCT02229942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93287430|NCT03047278|Cetirizine|cetirizine|mesh-list
93287431|NCT03047278|Gabapentin|gabapentin|mesh-list
93287432|NCT03047278|Analgesics|analgesics|mesh-ancestor
93287433|NCT03047278|Sensory System Agents|sensory system agents|mesh-ancestor
93287434|NCT03047278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287435|NCT03047278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287436|NCT03047278|Anticonvulsants|anticonvulsants|mesh-ancestor
93287437|NCT03047278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93287438|NCT03047278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93287439|NCT03047278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287440|NCT03047278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93287441|NCT03047278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93287442|NCT03047278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93287443|NCT03047278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287444|NCT03047278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287445|NCT03047278|Antimanic Agents|antimanic agents|mesh-ancestor
93287446|NCT03047278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93287447|NCT03047278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93287448|NCT03047278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93287449|NCT03047278|Histamine Antagonists|histamine antagonists|mesh-ancestor
93287450|NCT03047278|Histamine Agents|histamine agents|mesh-ancestor
93287451|NCT03045016|Prazosin|prazosin|mesh-list
93287452|NCT03045016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287453|NCT03045016|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93287454|NCT03045016|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93287455|NCT03045016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93287456|NCT03045016|Adrenergic Agents|adrenergic agents|mesh-ancestor
93287457|NCT03045016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287458|NCT03045016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287459|NCT03045016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287460|NCT04849858|Bupivacaine|bupivacaine|mesh-list
93287461|NCT04849858|Anesthetics, Local|anesthetics, local|mesh-ancestor
93287462|NCT04849858|Anesthetics|anesthetics|mesh-ancestor
93287463|NCT04849858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287464|NCT04849858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287465|NCT04849858|Sensory System Agents|sensory system agents|mesh-ancestor
93287466|NCT04849858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287467|NCT03043612|Doxazosin|doxazosin|mesh-list
93287468|NCT03043612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287469|NCT03043612|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93287470|NCT03043612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93287471|NCT03043612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93287472|NCT03043612|Adrenergic Agents|adrenergic agents|mesh-ancestor
93287473|NCT03043612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287474|NCT03043612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287475|NCT03043612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287476|NCT02230176|Sunitinib|sunitinib|mesh-list
93287477|NCT02230176|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93287478|NCT02230176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287479|NCT02230176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93287480|NCT02230176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93287481|NCT02230176|Growth Substances|growth substances|mesh-ancestor
93287482|NCT02230176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287483|NCT02230176|Growth Inhibitors|growth inhibitors|mesh-ancestor
93287484|NCT02230176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287485|NCT02230176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287486|NCT02230176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287487|NCT02230176|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93287488|NCT02232516|Lenalidomide|lenalidomide|mesh-list
93287489|NCT02232516|Romidepsin|romidepsin|mesh-list
93287490|NCT02232516|Immunologic Factors|immunologic factors|mesh-ancestor
93287491|NCT02232516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287492|NCT02232516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93287493|NCT02232516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93287494|NCT02232516|Growth Substances|growth substances|mesh-ancestor
93287495|NCT02232516|Growth Inhibitors|growth inhibitors|mesh-ancestor
93287496|NCT02232516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287497|NCT02232516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93287498|NCT02232516|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93287499|NCT02232516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287500|NCT02232516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287501|NCT04849390|Mometasone Furoate|mometasone furoate|mesh-list
93287502|NCT04849390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287503|NCT04849390|Dermatologic Agents|dermatologic agents|mesh-ancestor
93287504|NCT04849390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93287505|NCT03647592|Bevacizumab|bevacizumab|mesh-list
93287506|NCT03647592|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93287507|NCT03647592|Gefitinib|gefitinib|mesh-list
93287508|NCT03647592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287509|NCT03647592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287510|NCT03647592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93287511|NCT03647592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93287512|NCT03647592|Growth Substances|growth substances|mesh-ancestor
93287513|NCT03647592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287514|NCT03647592|Growth Inhibitors|growth inhibitors|mesh-ancestor
93287515|NCT03647592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287516|NCT03647592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287517|NCT03647592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287518|NCT02232594|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93287519|NCT02232594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93287520|NCT02232594|Autonomic Agents|autonomic agents|mesh-ancestor
93287521|NCT02232594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287522|NCT02232594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287523|NCT02232594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93287524|NCT02232594|Respiratory System Agents|respiratory system agents|mesh-ancestor
93287525|NCT03180684|Imiquimod|imiquimod|mesh-list
93287526|NCT03180684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93287527|NCT03180684|Immunologic Factors|immunologic factors|mesh-ancestor
93287528|NCT03180684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287529|NCT03180684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287530|NCT03180684|Interferon Inducers|interferon inducers|mesh-ancestor
93287531|NCT04858516|Trastuzumab|trastuzumab|mesh-list
93287532|NCT04858516|Palbociclib|palbociclib|mesh-list
93287533|NCT04858516|Exemestane|exemestane|mesh-list
93287534|NCT04858516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287535|NCT04858516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287536|NCT04858516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287537|NCT04858516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287538|NCT04858516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287539|NCT04858516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93287540|NCT04858516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93287541|NCT04858516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93287542|NCT04858516|Hormone Antagonists|hormone antagonists|mesh-ancestor
93287543|NCT04858516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287544|NCT04858516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287545|NCT03148860|Methotrexate|methotrexate|mesh-list
93287546|NCT03148860|Ustekinumab|ustekinumab|mesh-list
93287547|NCT03148860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93287548|NCT03148860|Abortifacient Agents|abortifacient agents|mesh-ancestor
93287549|NCT03148860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287550|NCT03148860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287551|NCT03148860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93287552|NCT03148860|Antimetabolites|antimetabolites|mesh-ancestor
92959558|NCT00349921|Adenosine|adenosine|mesh-list
93287553|NCT03148860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287554|NCT03148860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287555|NCT03148860|Dermatologic Agents|dermatologic agents|mesh-ancestor
93287556|NCT03148860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287557|NCT03148860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93287558|NCT03148860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93287559|NCT03148860|Immunologic Factors|immunologic factors|mesh-ancestor
93287560|NCT03148860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93287561|NCT03148860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93287562|NCT03131154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93287563|NCT03131154|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93287564|NCT02232672|Choline|choline|mesh-list
93287565|NCT02232672|Lipotropic Agents|lipotropic agents|mesh-ancestor
93287566|NCT02232672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287567|NCT02232672|Antimetabolites|antimetabolites|mesh-ancestor
93287568|NCT02232672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287569|NCT02232672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287570|NCT02232672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287571|NCT02232672|Nootropic Agents|nootropic agents|mesh-ancestor
93287572|NCT05072262|Dexamethasone|dexamethasone|mesh-list
93287573|NCT05072262|Nepafenac|nepafenac|mesh-list
93287574|NCT05072262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287575|NCT05072262|Antiemetics|antiemetics|mesh-ancestor
93287576|NCT05072262|Autonomic Agents|autonomic agents|mesh-ancestor
93287577|NCT05072262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287578|NCT05072262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287579|NCT05072262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287580|NCT05072262|Glucocorticoids|glucocorticoids|mesh-ancestor
93287581|NCT05072262|Hormones|hormones|mesh-ancestor
93287582|NCT05072262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287583|NCT05072262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93287584|NCT05072262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287585|NCT05072262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93287586|NCT05072262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93287587|NCT05072262|Analgesics|analgesics|mesh-ancestor
93287588|NCT05072262|Sensory System Agents|sensory system agents|mesh-ancestor
93287589|NCT05072262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93287590|NCT05001984|Alirocumab|alirocumab|mesh-list
93287591|NCT05001984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93287592|NCT05001984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93287593|NCT05001984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287594|NCT05001984|Antimetabolites|antimetabolites|mesh-ancestor
93287595|NCT05001984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287596|NCT05001984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93287597|NCT05001984|Protease Inhibitors|protease inhibitors|mesh-ancestor
93287598|NCT05001984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287599|NCT05001984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287600|NCT04858048|Anesthetics|anesthetics|mesh-list
93287601|NCT04858048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287602|NCT04858048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287603|NCT02234466|Dexamethasone|dexamethasone|mesh-list
93287604|NCT02234466|Ondansetron|ondansetron|mesh-list
93287605|NCT02234466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287606|NCT02234466|Antiemetics|antiemetics|mesh-ancestor
93287607|NCT02234466|Autonomic Agents|autonomic agents|mesh-ancestor
93287608|NCT02234466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287609|NCT02234466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287610|NCT02234466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287611|NCT02234466|Glucocorticoids|glucocorticoids|mesh-ancestor
93287612|NCT02234466|Hormones|hormones|mesh-ancestor
93287613|NCT02234466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287614|NCT02234466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93287615|NCT02234466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287616|NCT02234466|Antipruritics|antipruritics|mesh-ancestor
93287617|NCT02234466|Dermatologic Agents|dermatologic agents|mesh-ancestor
93287618|NCT02234466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93287619|NCT02234466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93287620|NCT02234466|Serotonin Agents|serotonin agents|mesh-ancestor
93287621|NCT02234466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287622|NCT02234466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959633|NCT00606021|Pemetrexed|pemetrexed|mesh-list
93287623|NCT02230800|Tocovid|tocovid|mesh-list
93287624|NCT02230800|Pentoxifylline|pentoxifylline|mesh-list
93287625|NCT02230800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93287626|NCT02230800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287627|NCT02230800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287628|NCT02230800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93287629|NCT02230800|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93287630|NCT02230800|Protective Agents|protective agents|mesh-ancestor
93287631|NCT02230800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287632|NCT02230800|Vasodilator Agents|vasodilator agents|mesh-ancestor
93287633|NCT02230800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93287634|NCT02230800|Antioxidants|antioxidants|mesh-ancestor
93287635|NCT02230800|Vitamins|vitamins|mesh-ancestor
93287636|NCT02230800|Micronutrients|micronutrients|mesh-ancestor
93287637|NCT02234544|Vitamin D|vitamin d|mesh-list
93287638|NCT02234544|Cholecalciferol|cholecalciferol|mesh-list
93287639|NCT02234544|Ezetimibe|ezetimibe|mesh-list
93287640|NCT02234544|Vitamins|vitamins|mesh-ancestor
93287641|NCT02234544|Micronutrients|micronutrients|mesh-ancestor
93287642|NCT02234544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287643|NCT02234544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93287644|NCT02234544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93287645|NCT02234544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93287646|NCT02234544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287647|NCT02234544|Antimetabolites|antimetabolites|mesh-ancestor
93287648|NCT02234544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287649|NCT02234544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287650|NCT03043066|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93287651|NCT03043066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93287652|NCT03043066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287653|NCT03043066|Antitubercular Agents|antitubercular agents|mesh-ancestor
93287654|NCT04860076|Pembrolizumab|pembrolizumab|mesh-list
93287655|NCT04860076|Nivolumab|nivolumab|mesh-list
93287656|NCT04860076|Ipilimumab|ipilimumab|mesh-list
93287657|NCT04860076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93287658|NCT04860076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287659|NCT04860076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93287660|NCT04860076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287661|NCT04856878|Vancomycin|vancomycin|mesh-list
93287662|NCT04856878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287663|NCT04856878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287664|NCT04856644|Moxifloxacin|moxifloxacin|mesh-list
93287665|NCT04856644|Rifapentine|rifapentine|mesh-list
93287666|NCT04856644|Rifampin|rifampin|mesh-list
93287667|NCT04856644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287668|NCT04856644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287669|NCT04856644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93287670|NCT04856644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93287671|NCT04856644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287672|NCT04856644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287673|NCT04856644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287674|NCT04856644|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93287675|NCT04856644|Antitubercular Agents|antitubercular agents|mesh-ancestor
93287676|NCT04856644|Leprostatic Agents|leprostatic agents|mesh-ancestor
93287677|NCT04856644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93287678|NCT04856644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93287679|NCT04856644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93287680|NCT04856644|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93287681|NCT04856644|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93287682|NCT04856644|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93287683|NCT04856644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93287684|NCT01329978|Sofosbuvir|sofosbuvir|mesh-list
93287685|NCT01329978|Antiviral Agents|antiviral agents|mesh-ancestor
93287686|NCT01329978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287687|NCT04984278|Nabiximols|nabiximols|mesh-list
93287688|NCT04984278|Analgesics|analgesics|mesh-ancestor
93287689|NCT04984278|Sensory System Agents|sensory system agents|mesh-ancestor
93287690|NCT04984278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287691|NCT04984278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287692|NCT02233218|Amlodipine|amlodipine|mesh-list
93287693|NCT02233218|Telmisartan|telmisartan|mesh-list
93287694|NCT02233218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93287695|NCT02233218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287696|NCT02233218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93287697|NCT02233218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287698|NCT02233218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287699|NCT02233218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93287700|NCT02233218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959704|NCT04035135|Immunoglobulins|immunoglobulins|mesh-list
93287701|NCT02233218|Vasodilator Agents|vasodilator agents|mesh-ancestor
93287702|NCT02233218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93287704|NCT02233218|Antimetabolites|antimetabolites|mesh-ancestor
93287705|NCT02233218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287706|NCT02233218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93287707|NCT02233218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287708|NCT02233218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93287709|NCT02233218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93287710|NCT02262546|Moxifloxacin|moxifloxacin|mesh-list
93287711|NCT02262546|Pramipexole|pramipexole|mesh-list
93287712|NCT02262546|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93287713|NCT02262546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287714|NCT02262546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287715|NCT02262546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93287716|NCT02262546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93287717|NCT02262546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287718|NCT02262546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287719|NCT02262546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287720|NCT02262546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93287721|NCT02262546|Contraceptive Agents|contraceptive agents|mesh-ancestor
93287722|NCT02262546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287723|NCT02262546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287724|NCT02262546|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93287725|NCT02262546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93287726|NCT02262546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93287727|NCT02262546|Antioxidants|antioxidants|mesh-ancestor
93287728|NCT02262546|Protective Agents|protective agents|mesh-ancestor
93287729|NCT02262546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93287730|NCT02262546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93287731|NCT02262546|Dopamine Agonists|dopamine agonists|mesh-ancestor
93287732|NCT02262546|Dopamine Agents|dopamine agents|mesh-ancestor
93287733|NCT02262546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287734|NCT03042052|Botulinum Toxins|botulinum toxins|mesh-list
93287735|NCT03042052|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93287736|NCT03042052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287737|NCT03042052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287738|NCT03042052|Cholinergic Agents|cholinergic agents|mesh-ancestor
93287739|NCT03042052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287740|NCT03042052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287741|NCT04856098|Glycopyrrolate|glycopyrrolate|mesh-list
93287742|NCT04856098|Bromides|bromides|mesh-list
93287743|NCT04856098|Maleic acid|maleic acid|mesh-list
93287744|NCT04856098|Charcoal|charcoal|mesh-list
93287745|NCT04856098|Anticonvulsants|anticonvulsants|mesh-ancestor
93287746|NCT04856098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287747|NCT04856098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287748|NCT04856098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93287749|NCT04856098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93287750|NCT04856098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93287751|NCT04856098|Cholinergic Agents|cholinergic agents|mesh-ancestor
93287752|NCT04856098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287753|NCT04856098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287754|NCT04856098|Antidotes|antidotes|mesh-ancestor
93287755|NCT04856098|Protective Agents|protective agents|mesh-ancestor
93287756|NCT04859452|Metformin|metformin|mesh-list
93287757|NCT04859452|Glyburide|glyburide|mesh-list
93287758|NCT04859452|Valsartan|valsartan|mesh-list
93287759|NCT04859452|Simvastatin|simvastatin|mesh-list
93287760|NCT04859452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93287761|NCT04859452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287762|NCT04859452|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93287763|NCT04859452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93287764|NCT04859452|Antimetabolites|antimetabolites|mesh-ancestor
93287765|NCT04859452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287766|NCT04859452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93287767|NCT04859452|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93287768|NCT04859452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287769|NCT04859452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287770|NCT04859452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93287771|NCT04859452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93287772|NCT02262624|Telmisartan|telmisartan|mesh-list
93287773|NCT02262624|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93287774|NCT02262624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287775|NCT02262624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93287776|NCT02262624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93287777|NCT02262624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287778|NCT02262624|Diuretics|diuretics|mesh-ancestor
93287779|NCT02262624|Natriuretic Agents|natriuretic agents|mesh-ancestor
93287780|NCT02262624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287781|NCT02262624|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93287782|NCT02262624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287783|NCT02233452|Ketamine|ketamine|mesh-list
93287784|NCT02233452|Methadone|methadone|mesh-list
93287785|NCT02233452|Analgesics|analgesics|mesh-ancestor
93287786|NCT02233452|Sensory System Agents|sensory system agents|mesh-ancestor
93287787|NCT02233452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287788|NCT02233452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287789|NCT02233452|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93287790|NCT02233452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93287791|NCT02233452|Anesthetics, General|anesthetics, general|mesh-ancestor
93287792|NCT02233452|Anesthetics|anesthetics|mesh-ancestor
93287793|NCT02233452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287794|NCT02233452|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93287795|NCT02233452|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93287796|NCT02233452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287797|NCT02233452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287798|NCT02233452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93287799|NCT02233452|Narcotics|narcotics|mesh-ancestor
93287800|NCT02233452|Antitussive Agents|antitussive agents|mesh-ancestor
93287801|NCT02233452|Respiratory System Agents|respiratory system agents|mesh-ancestor
93287802|NCT02262702|Acetaminophen|acetaminophen|mesh-list
93287803|NCT02262702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93287804|NCT02262702|Analgesics|analgesics|mesh-ancestor
93287805|NCT02262702|Sensory System Agents|sensory system agents|mesh-ancestor
93287806|NCT02262702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287807|NCT02262702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287808|NCT02262702|Antipyretics|antipyretics|mesh-ancestor
93287809|NCT04846894|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93287810|NCT04846894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93287811|NCT04846894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287812|NCT04845880|Myeloma Proteins|myeloma proteins|mesh-list
93287813|NCT04845880|Paraproteins|paraproteins|mesh-list
93287814|NCT04845880|Immunologic Factors|immunologic factors|mesh-ancestor
93287815|NCT04845880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287816|NCT04600752|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93287817|NCT04600752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287818|NCT04600752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287819|NCT04600752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93287820|NCT04600752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287821|NCT04600752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287822|NCT03041506|Lidocaine|lidocaine|mesh-list
93287823|NCT03041506|Midazolam|midazolam|mesh-list
93287824|NCT03041506|Ketamine|ketamine|mesh-list
93287825|NCT03041506|Anesthetics, Local|anesthetics, local|mesh-ancestor
93287826|NCT03041506|Anesthetics|anesthetics|mesh-ancestor
93287827|NCT03041506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287828|NCT03041506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287829|NCT03041506|Sensory System Agents|sensory system agents|mesh-ancestor
93287830|NCT03041506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287831|NCT03041506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93287832|NCT03041506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93287833|NCT03041506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93287834|NCT03041506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287835|NCT03041506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287836|NCT03041506|Analgesics|analgesics|mesh-ancestor
93287837|NCT03041506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93287838|NCT03041506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93287839|NCT03041506|Anesthetics, General|anesthetics, general|mesh-ancestor
93287840|NCT03041506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93287841|NCT03041506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93287842|NCT03041506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287843|NCT03041506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93287844|NCT03041506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93287845|NCT03041506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93287846|NCT03041506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93287847|NCT03041506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93287848|NCT03041506|GABA Modulators|gaba modulators|mesh-ancestor
93287849|NCT03041506|GABA Agents|gaba agents|mesh-ancestor
93287850|NCT02580708|Trametinib|trametinib|mesh-list
92959863|NCT00905229|Vitamins|vitamins|mesh-list
93287851|NCT02580708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287852|NCT02580708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93287853|NCT02580708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287854|NCT02580708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287855|NCT02262780|Telmisartan|telmisartan|mesh-list
93287856|NCT02262780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287857|NCT02262780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93287858|NCT02262780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93287859|NCT02262780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287860|NCT04845646|Itraconazole|itraconazole|mesh-list
93287861|NCT04845646|Phenytoin|phenytoin|mesh-list
93287862|NCT04845646|Antifungal Agents|antifungal agents|mesh-ancestor
93287863|NCT04845646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287864|NCT04845646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93287865|NCT04845646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93287866|NCT04845646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287867|NCT04845646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287868|NCT04845646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93287869|NCT04845646|Hormone Antagonists|hormone antagonists|mesh-ancestor
93287870|NCT04845646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287871|NCT04845646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287872|NCT04845646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93287873|NCT04845646|Anticonvulsants|anticonvulsants|mesh-ancestor
93287874|NCT04845646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93287875|NCT04845646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93287876|NCT04845646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287877|NCT04845646|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93287878|NCT04845646|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93287879|NCT03038776|Hemagglutinins|hemagglutinins|mesh-list
93287880|NCT03038776|Agglutinins|agglutinins|mesh-ancestor
93287881|NCT03038776|Immunologic Factors|immunologic factors|mesh-ancestor
93287882|NCT03038776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287883|NCT03038776|Coagulants|coagulants|mesh-ancestor
93287884|NCT02570490|Linezolid|linezolid|mesh-list
93287885|NCT02570490|Fusidic Acid|fusidic acid|mesh-list
93287886|NCT02570490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287887|NCT02570490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287888|NCT02570490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93287889|NCT02570490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287890|NCT02570490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287891|NCT02565732|Botulinum Toxins|botulinum toxins|mesh-list
93287892|NCT02565732|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93287893|NCT02565732|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93287894|NCT02565732|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93287895|NCT02565732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287896|NCT02565732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287897|NCT02565732|Cholinergic Agents|cholinergic agents|mesh-ancestor
93287898|NCT02565732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287899|NCT02565732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287900|NCT02565732|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93287901|NCT02565732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287902|NCT02561442|Ceftriaxone|ceftriaxone|mesh-list
93287903|NCT02561442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287904|NCT02561442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287905|NCT02262858|Telmisartan|telmisartan|mesh-list
93287906|NCT02262858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93287907|NCT02262858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93287908|NCT02262858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93287909|NCT02262858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93287910|NCT02262858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287911|NCT02262858|Diuretics|diuretics|mesh-ancestor
93287912|NCT02262858|Natriuretic Agents|natriuretic agents|mesh-ancestor
93287913|NCT02262858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287914|NCT02262858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93287915|NCT02262858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93287916|NCT02235012|Ketamine|ketamine|mesh-list
93287917|NCT02235012|Analgesics|analgesics|mesh-ancestor
93287918|NCT02235012|Sensory System Agents|sensory system agents|mesh-ancestor
93287919|NCT02235012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287920|NCT02235012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287921|NCT02235012|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93287922|NCT02235012|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93287923|NCT02235012|Anesthetics, General|anesthetics, general|mesh-ancestor
93287925|NCT02235012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93287926|NCT02235012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93287927|NCT02235012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93287928|NCT02235012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582407|NCT00304993|Niacin|niacin|mesh-list
93287929|NCT02235012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287930|NCT02262936|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93287931|NCT02262936|Fesoterodine|fesoterodine|mesh-list
93287932|NCT02262936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93287933|NCT02262936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93287934|NCT02262936|Cholinergic Agents|cholinergic agents|mesh-ancestor
93287935|NCT02262936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93287936|NCT02262936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287937|NCT02262936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287938|NCT02262936|Urological Agents|urological agents|mesh-ancestor
93287939|NCT02262936|Hemostatics|hemostatics|mesh-ancestor
93287940|NCT02262936|Coagulants|coagulants|mesh-ancestor
93287941|NCT02262936|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93287942|NCT02262936|Natriuretic Agents|natriuretic agents|mesh-ancestor
93287943|NCT04838704|Mycophenolic Acid|mycophenolic acid|mesh-list
93287944|NCT04838704|Methotrexate|methotrexate|mesh-list
93287945|NCT04838704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93287946|NCT04838704|Abortifacient Agents|abortifacient agents|mesh-ancestor
93287947|NCT04838704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287948|NCT04838704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287949|NCT04838704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93287950|NCT04838704|Antimetabolites|antimetabolites|mesh-ancestor
93287951|NCT04838704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93287952|NCT04838704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93287953|NCT04838704|Dermatologic Agents|dermatologic agents|mesh-ancestor
93287954|NCT04838704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93287955|NCT04838704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93287956|NCT04838704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93287957|NCT04838704|Immunologic Factors|immunologic factors|mesh-ancestor
93287958|NCT04838704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93287959|NCT04838704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93287960|NCT04838704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93287961|NCT04838704|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93287962|NCT04838704|Antitubercular Agents|antitubercular agents|mesh-ancestor
93287963|NCT04838704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93287964|NCT04838704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287965|NCT02259738|Kallikreins|kallikreins|mesh-list
93287966|NCT02259738|Coagulants|coagulants|mesh-ancestor
93287967|NCT02259738|Fertility Agents, Male|fertility agents, male|mesh-ancestor
93287968|NCT02259738|Fertility Agents|fertility agents|mesh-ancestor
93287969|NCT02259738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93287970|NCT02259738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287971|NCT04854460|Ivermectin|ivermectin|mesh-list
93287972|NCT04854460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93287973|NCT04854460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93287974|NCT04854538|Budesonide|budesonide|mesh-list
93287975|NCT04854538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287976|NCT04854538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93287977|NCT04854538|Autonomic Agents|autonomic agents|mesh-ancestor
93287978|NCT04854538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287979|NCT04854538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287980|NCT04854538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93287981|NCT04854538|Respiratory System Agents|respiratory system agents|mesh-ancestor
93287982|NCT04854538|Glucocorticoids|glucocorticoids|mesh-ancestor
93287983|NCT04854538|Hormones|hormones|mesh-ancestor
93287984|NCT04854538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287985|NCT05331690|Dexamethasone|dexamethasone|mesh-list
93287986|NCT05331690|Nepafenac|nepafenac|mesh-list
93287987|NCT05331690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93287988|NCT05331690|Antiemetics|antiemetics|mesh-ancestor
93287989|NCT05331690|Autonomic Agents|autonomic agents|mesh-ancestor
93287990|NCT05331690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93287991|NCT05331690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93287992|NCT05331690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93287993|NCT05331690|Glucocorticoids|glucocorticoids|mesh-ancestor
93287994|NCT05331690|Hormones|hormones|mesh-ancestor
93287995|NCT05331690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93287996|NCT05331690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960010|NCT01060423|Irinotecan|irinotecan|mesh-list
93287998|NCT05331690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93287999|NCT05331690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93288000|NCT05331690|Analgesics|analgesics|mesh-ancestor
93288001|NCT05331690|Sensory System Agents|sensory system agents|mesh-ancestor
93288002|NCT05331690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288003|NCT04373668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93288004|NCT04373668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288005|NCT04373668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288006|NCT02263170|Phenobarbital|phenobarbital|mesh-list
93288007|NCT02263170|Anticonvulsants|anticonvulsants|mesh-ancestor
93288008|NCT02263170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93288009|NCT02263170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288010|NCT02263170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288011|NCT02263170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93288012|NCT02263170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93288013|NCT02263170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288014|NCT02263170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288015|NCT02263170|GABA Modulators|gaba modulators|mesh-ancestor
93288016|NCT02263170|GABA Agents|gaba agents|mesh-ancestor
93288017|NCT02263170|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93288018|NCT02263170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93288019|NCT02263170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93288020|NCT02543268|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93288021|NCT02543268|Antiviral Agents|antiviral agents|mesh-ancestor
93288022|NCT02543268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288023|NCT05252988|Loperamide|loperamide|mesh-list
93288024|NCT05252988|Antidiarrheals|antidiarrheals|mesh-list
93288025|NCT05252988|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93288026|NCT05252988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288027|NCT05252988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93288028|NCT05252988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93288029|NCT05252988|Antimetabolites|antimetabolites|mesh-ancestor
93288030|NCT05252988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288031|NCT05252988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93288032|NCT03038230|Antibodies|antibodies|mesh-list
93288033|NCT03038230|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93288034|NCT03038230|Immunologic Factors|immunologic factors|mesh-ancestor
93288035|NCT03038230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288036|NCT04853758|Valsartan|valsartan|mesh-list
93288037|NCT04853758|Enalapril|enalapril|mesh-list
93288038|NCT04853758|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93288039|NCT04853758|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93288040|NCT04853758|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93288041|NCT04853758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93288042|NCT04853758|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93288043|NCT04853758|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93288044|NCT04853758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288045|NCT04853758|Protease Inhibitors|protease inhibitors|mesh-ancestor
93288046|NCT02784288|Paclitaxel|paclitaxel|mesh-list
93288047|NCT02784288|Carboplatin|carboplatin|mesh-list
93288048|NCT02784288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288049|NCT02784288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288050|NCT02784288|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288051|NCT02784288|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288052|NCT02784288|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288053|NCT02784288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288054|NCT03040180|Bleomycin|bleomycin|mesh-list
93288055|NCT03040180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93288056|NCT03040180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288057|NCT02235246|Magnesium Sulfate|magnesium sulfate|mesh-list
93288058|NCT02235246|Analgesics|analgesics|mesh-ancestor
93288059|NCT02235246|Sensory System Agents|sensory system agents|mesh-ancestor
93288060|NCT02235246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288061|NCT02235246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288062|NCT02235246|Anesthetics|anesthetics|mesh-ancestor
93288063|NCT02235246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288064|NCT02235246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93288065|NCT02235246|Anticonvulsants|anticonvulsants|mesh-ancestor
93288066|NCT02235246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93288067|NCT02235246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288068|NCT02235246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288069|NCT02235246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93288070|NCT02235246|Tocolytic Agents|tocolytic agents|mesh-ancestor
93288071|NCT02235246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93288072|NCT02235324|Leucovorin|leucovorin|mesh-list
93288073|NCT02235324|Fluorouracil|fluorouracil|mesh-list
93288074|NCT02235324|Aflibercept|aflibercept|mesh-list
93288075|NCT02235324|Calcium|calcium|mesh-list
93288076|NCT02235324|Levoleucovorin|levoleucovorin|mesh-list
93288077|NCT02235324|Endothelial Growth Factors|endothelial growth factors|mesh-list
93288078|NCT02235324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93288079|NCT02235324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288080|NCT02235324|Antimetabolites|antimetabolites|mesh-ancestor
93288081|NCT02235324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288082|NCT02235324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93288083|NCT02235324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288084|NCT02235324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93288085|NCT02235324|Immunologic Factors|immunologic factors|mesh-ancestor
93288086|NCT02235324|Antidotes|antidotes|mesh-ancestor
93288087|NCT02235324|Protective Agents|protective agents|mesh-ancestor
93288088|NCT02235324|Vitamin B Complex|vitamin b complex|mesh-ancestor
93288089|NCT02235324|Vitamins|vitamins|mesh-ancestor
93288090|NCT02235324|Micronutrients|micronutrients|mesh-ancestor
93288091|NCT02235324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93288092|NCT02235324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93288093|NCT02235324|Growth Substances|growth substances|mesh-ancestor
93288094|NCT02235324|Growth Inhibitors|growth inhibitors|mesh-ancestor
93288095|NCT01230242|Levonorgestrel|levonorgestrel|mesh-list
93288096|NCT01230242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93288097|NCT01230242|Contraceptive Agents|contraceptive agents|mesh-ancestor
93288098|NCT01230242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93288099|NCT01230242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288100|NCT01230242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93288101|NCT01230242|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93288102|NCT01230242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93288103|NCT02263248|Buprenorphine|buprenorphine|mesh-list
93288104|NCT02263248|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93288105|NCT02263248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93288106|NCT02263248|Narcotics|narcotics|mesh-ancestor
93288107|NCT02263248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288108|NCT02263248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288109|NCT02263248|Analgesics|analgesics|mesh-ancestor
93288110|NCT02263248|Sensory System Agents|sensory system agents|mesh-ancestor
93288111|NCT02263248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288112|NCT02263248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93288113|NCT02263248|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93288114|NCT02263248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93288115|NCT02263248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288116|NCT02263248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288117|NCT02263248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288118|NCT02263248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93288119|NCT02263248|Antidepressive Agents|antidepressive agents|mesh-ancestor
93288120|NCT02263248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93288121|NCT04838860|Siltuximab|siltuximab|mesh-list
93288122|NCT04838860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288123|NCT04853524|Tenofovir|tenofovir|mesh-list
93288124|NCT04853524|Emtricitabine|emtricitabine|mesh-list
93288125|NCT04853524|JNJ-56136379|jnj-56136379|mesh-list
93288126|NCT04853524|Antiviral Agents|antiviral agents|mesh-ancestor
93288127|NCT04853524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288128|NCT04853524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93288129|NCT04853524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93288130|NCT04853524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288131|NCT04853524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288132|NCT04853524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93288133|NCT04853524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93288134|NCT04852510|Metformin|metformin|mesh-list
93288135|NCT04852510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93288136|NCT04852510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288137|NCT05163704|Dexmedetomidine|dexmedetomidine|mesh-list
93288138|NCT05163704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93288139|NCT05163704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288140|NCT05163704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288141|NCT05163704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92960155|NCT00906867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93288142|NCT05163704|Analgesics|analgesics|mesh-ancestor
93288143|NCT05163704|Sensory System Agents|sensory system agents|mesh-ancestor
93288144|NCT05163704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288145|NCT05163704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93288146|NCT05163704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93288147|NCT05163704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93288148|NCT05163704|Adrenergic Agents|adrenergic agents|mesh-ancestor
93288149|NCT05163704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288150|NCT05163704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288151|NCT03130556|Rabeprazole|rabeprazole|mesh-list
93288152|NCT03130556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93288153|NCT03130556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288154|NCT03130556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93288155|NCT03130556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288156|NCT03130556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288157|NCT04838080|Vaccines|vaccines|mesh-list
93288158|NCT04838080|Immunologic Factors|immunologic factors|mesh-ancestor
93288159|NCT04838080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288160|NCT04842838|Paclitaxel|paclitaxel|mesh-list
93288161|NCT04842838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288162|NCT04842838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288163|NCT04842838|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288164|NCT04842838|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288165|NCT04842838|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288166|NCT04842838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288167|NCT03037606|Rabeprazole|rabeprazole|mesh-list
93288168|NCT03037606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93288169|NCT03037606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288170|NCT03037606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93288171|NCT03037606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288172|NCT03037606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288173|NCT04842370|PHI-101|phi-101|mesh-list
93288174|NCT04842370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93288175|NCT04842370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288176|NCT04842370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93288177|NCT04842370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288178|NCT03037372|Atorvastatin|atorvastatin|mesh-list
93288179|NCT03037372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93288180|NCT03037372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93288181|NCT03037372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93288182|NCT03037372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93288183|NCT03037372|Antimetabolites|antimetabolites|mesh-ancestor
93288184|NCT03037372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288185|NCT03037372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93288186|NCT03037372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288187|NCT04842526|Irinotecan|irinotecan|mesh-list
93288188|NCT04842526|Temozolomide|temozolomide|mesh-list
93288189|NCT04842526|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93288190|NCT04842526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93288191|NCT04842526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288192|NCT04842526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288193|NCT04842526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288194|NCT04842526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93288195|NCT04842526|Alkylating Agents|alkylating agents|mesh-ancestor
93288196|NCT04850950|Tenofovir|tenofovir|mesh-list
93288197|NCT04850950|Antiviral Agents|antiviral agents|mesh-ancestor
93288198|NCT04850950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288199|NCT04850950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93288200|NCT04850950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93288201|NCT04850950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288202|NCT04850950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288203|NCT04850950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93288204|NCT04850950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93288205|NCT05164952|Zoledronic Acid|zoledronic acid|mesh-list
93288206|NCT05164952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93288207|NCT05164952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288208|NCT04850560|Decitabine|decitabine|mesh-list
93288209|NCT04850560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93288210|NCT04850560|Antimetabolites|antimetabolites|mesh-ancestor
93288211|NCT04850560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288212|NCT04850560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288213|NCT04850560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288214|NCT04850404|Ropivacaine|ropivacaine|mesh-list
93288215|NCT04850404|Rocuronium|rocuronium|mesh-list
93288216|NCT04850404|Anesthetics, Local|anesthetics, local|mesh-ancestor
93288217|NCT04850404|Anesthetics|anesthetics|mesh-ancestor
93288218|NCT04850404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288219|NCT04850404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288220|NCT04850404|Sensory System Agents|sensory system agents|mesh-ancestor
93288221|NCT04850404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288222|NCT04850404|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93288223|NCT04850404|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93288224|NCT04850404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93288225|NCT04428814|Ustekinumab|ustekinumab|mesh-list
93288226|NCT04428814|Dermatologic Agents|dermatologic agents|mesh-ancestor
93288227|NCT03036514|Sufentanil|sufentanil|mesh-list
93288228|NCT03036514|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93288229|NCT03036514|Narcotics|narcotics|mesh-ancestor
93288230|NCT03036514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288231|NCT03036514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288232|NCT03036514|Analgesics|analgesics|mesh-ancestor
93288233|NCT03036514|Sensory System Agents|sensory system agents|mesh-ancestor
93288234|NCT03036514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288235|NCT03036514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93288236|NCT03036514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93288237|NCT03036514|Anesthetics, General|anesthetics, general|mesh-ancestor
93288238|NCT03036514|Anesthetics|anesthetics|mesh-ancestor
93288239|NCT04835896|Paclitaxel|paclitaxel|mesh-list
93288240|NCT04835896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288241|NCT04835896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288242|NCT04835896|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288243|NCT04835896|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288244|NCT04835896|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288245|NCT04835896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288246|NCT01668004|Golimumab|golimumab|mesh-list
93288247|NCT01668004|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93288248|NCT01668004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93288249|NCT01668004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93288250|NCT01668004|Immunologic Factors|immunologic factors|mesh-ancestor
93288251|NCT01668004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288252|NCT04835350|Pancrelipase|pancrelipase|mesh-list
93288253|NCT04835350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288254|NCT01667926|Ketamine|ketamine|mesh-list
93288255|NCT01667926|Analgesics|analgesics|mesh-ancestor
93288256|NCT01667926|Sensory System Agents|sensory system agents|mesh-ancestor
93288257|NCT01667926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288258|NCT01667926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288259|NCT01667926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93288260|NCT01667926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93288261|NCT01667926|Anesthetics, General|anesthetics, general|mesh-ancestor
93288262|NCT01667926|Anesthetics|anesthetics|mesh-ancestor
93288263|NCT01667926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288264|NCT01667926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93288265|NCT01667926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93288266|NCT01667926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288267|NCT01667926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288268|NCT03039478|Erythritol|erythritol|mesh-list
93288269|NCT03039478|Vasodilator Agents|vasodilator agents|mesh-ancestor
93288270|NCT04832776|Bevacizumab|bevacizumab|mesh-list
93288271|NCT04832776|Cetuximab|cetuximab|mesh-list
93288272|NCT04832776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93288273|NCT04832776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288274|NCT04832776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93288275|NCT04832776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93288276|NCT04832776|Growth Substances|growth substances|mesh-ancestor
93288277|NCT04832776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288278|NCT04832776|Growth Inhibitors|growth inhibitors|mesh-ancestor
93288279|NCT04835116|Acetaminophen|acetaminophen|mesh-list
93288280|NCT04835116|Tramadol|tramadol|mesh-list
93288281|NCT04835116|Analgesics|analgesics|mesh-list
93288282|NCT04835116|Orphenadrine|orphenadrine|mesh-list
93288283|NCT04835116|Dimenhydrinate|dimenhydrinate|mesh-list
93288284|NCT04835116|Bupivacaine|bupivacaine|mesh-list
93288285|NCT04835116|Anesthetics, Local|anesthetics, local|mesh-ancestor
93288286|NCT04835116|Anesthetics|anesthetics|mesh-ancestor
93288287|NCT04835116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288288|NCT04835116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288289|NCT04835116|Sensory System Agents|sensory system agents|mesh-ancestor
93288290|NCT04835116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288291|NCT04835116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93288292|NCT04835116|Antipyretics|antipyretics|mesh-ancestor
93288293|NCT04835116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93288294|NCT04835116|Narcotics|narcotics|mesh-ancestor
93288295|NCT04835116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93288296|NCT04835116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93288297|NCT04835116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93288298|NCT04835116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93288299|NCT04835116|Parasympatholytics|parasympatholytics|mesh-ancestor
93288300|NCT04835116|Autonomic Agents|autonomic agents|mesh-ancestor
93288301|NCT04835116|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93288302|NCT04835116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93288303|NCT04835116|Cholinergic Agents|cholinergic agents|mesh-ancestor
93288304|NCT04835116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288305|NCT04835116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288306|NCT04835116|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
93288307|NCT04835116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93288308|NCT04835116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288309|NCT04835116|Antiemetics|antiemetics|mesh-ancestor
93288310|NCT04835116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288311|NCT04835116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93288312|NCT04835116|Histamine Antagonists|histamine antagonists|mesh-ancestor
93288313|NCT04835116|Histamine Agents|histamine agents|mesh-ancestor
93288314|NCT03036826|Meropenem|meropenem|mesh-list
93288315|NCT03036826|Tazobactam|tazobactam|mesh-list
93288316|NCT03036826|Piperacillin|piperacillin|mesh-list
93288317|NCT03036826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93288318|NCT03036826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93288319|NCT03036826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288320|NCT03036826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93288321|NCT03036826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288322|NCT03036826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288323|NCT03036046|Fluconazole|fluconazole|mesh-list
93288324|NCT03036046|Posaconazole|posaconazole|mesh-list
93288325|NCT03036046|Olorofim|olorofim|mesh-list
93288326|NCT03036046|Antifungal Agents|antifungal agents|mesh-ancestor
93288327|NCT03036046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288328|NCT03036046|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93288329|NCT03036046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93288330|NCT03036046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288331|NCT03036046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288332|NCT03036046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93288333|NCT03036046|Hormone Antagonists|hormone antagonists|mesh-ancestor
93288334|NCT03036046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288335|NCT03036046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288336|NCT03036046|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93288337|NCT03036046|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93288338|NCT03036046|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93288339|NCT03036046|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93288340|NCT03036046|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93288341|NCT04831528|Bevacizumab|bevacizumab|mesh-list
93288342|NCT04831528|Trastuzumab|trastuzumab|mesh-list
93288343|NCT04831528|Cetuximab|cetuximab|mesh-list
93288344|NCT04831528|Pertuzumab|pertuzumab|mesh-list
93288345|NCT04831528|Lapatinib|lapatinib|mesh-list
93288346|NCT04831528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93288347|NCT04831528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288348|NCT04831528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93288349|NCT04831528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93288350|NCT04831528|Growth Substances|growth substances|mesh-ancestor
93288351|NCT04831528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288352|NCT04831528|Growth Inhibitors|growth inhibitors|mesh-ancestor
93288353|NCT04831528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93288354|NCT04831528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288355|NCT04831528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288356|NCT04824586|Insulin|insulin|mesh-list
93288357|NCT04824586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93288358|NCT04824586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93288359|NCT04824586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288360|NCT04824898|Simvastatin|simvastatin|mesh-list
93288361|NCT04824898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93288362|NCT04824898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93288363|NCT04824898|Antimetabolites|antimetabolites|mesh-ancestor
93288364|NCT04824898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288365|NCT04824898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93288366|NCT04824898|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93288367|NCT04824898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288368|NCT04824352|Apatinib|apatinib|mesh-list
93288369|NCT04824352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288370|NCT04824352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93288371|NCT04824352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288372|NCT04824352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288373|NCT04319614|Tranexamic Acid|tranexamic acid|mesh-list
93288374|NCT04319614|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93288375|NCT04319614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93288376|NCT04319614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288377|NCT04319614|Hemostatics|hemostatics|mesh-ancestor
93288378|NCT04319614|Coagulants|coagulants|mesh-ancestor
93288379|NCT01359904|Dialysis Solutions|dialysis solutions|mesh-list
93288380|NCT01359904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93288381|NCT04823260|Niacinamide|niacinamide|mesh-list
93288382|NCT04823260|Niacin|niacin|mesh-list
93288383|NCT04823260|Nicotinic Acids|nicotinic acids|mesh-list
93288384|NCT04823260|Vitamin B Complex|vitamin b complex|mesh-ancestor
93288385|NCT04823260|Vitamins|vitamins|mesh-ancestor
93288386|NCT04823260|Micronutrients|micronutrients|mesh-ancestor
93288387|NCT04823260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288388|NCT04823260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93288389|NCT04823260|Antimetabolites|antimetabolites|mesh-ancestor
93288390|NCT04823260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288391|NCT04823260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93288392|NCT04823260|Vasodilator Agents|vasodilator agents|mesh-ancestor
93288393|NCT04816240|Midodrine|midodrine|mesh-list
93288394|NCT04816240|Sympathomimetics|sympathomimetics|mesh-ancestor
93288395|NCT04816240|Autonomic Agents|autonomic agents|mesh-ancestor
93288396|NCT04816240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288397|NCT04816240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288398|NCT04816240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93288399|NCT04816240|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93288400|NCT04816240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93288401|NCT04816240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93288402|NCT04816240|Adrenergic Agents|adrenergic agents|mesh-ancestor
93288403|NCT04816240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288404|NCT04816240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288405|NCT04822012|Antibodies|antibodies|mesh-list
93288406|NCT04822012|Immunoglobulin G|immunoglobulin g|mesh-list
93288407|NCT04822012|Progesterone|progesterone|mesh-list
93288408|NCT04822012|Estrogens|estrogens|mesh-list
93288409|NCT04822012|Immunologic Factors|immunologic factors|mesh-ancestor
93288410|NCT04822012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288411|NCT04822012|Progestins|progestins|mesh-ancestor
93288412|NCT04822012|Hormones|hormones|mesh-ancestor
93288413|NCT04822012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288414|NCT05399732|Cyclosporine|cyclosporine|mesh-list
93288415|NCT05399732|Luspatercept|luspatercept|mesh-list
93288416|NCT05399732|Cyclosporins|cyclosporins|mesh-list
93288417|NCT05399732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288418|NCT05399732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288419|NCT05399732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93288420|NCT05399732|Immunologic Factors|immunologic factors|mesh-ancestor
93288421|NCT05399732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288422|NCT05399732|Antifungal Agents|antifungal agents|mesh-ancestor
93288423|NCT05399732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288424|NCT05399732|Dermatologic Agents|dermatologic agents|mesh-ancestor
93288425|NCT05399732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288426|NCT05399732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93288427|NCT05399732|Hematinics|hematinics|mesh-ancestor
93288428|NCT05399576|Nicorandil|nicorandil|mesh-list
93288429|NCT05399576|Verapamil|verapamil|mesh-list
93288430|NCT05399576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93288431|NCT05399576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93288432|NCT05399576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288433|NCT05399576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288434|NCT05399576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93288435|NCT05399576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288436|NCT05399576|Vasodilator Agents|vasodilator agents|mesh-ancestor
93288437|NCT05399576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93288438|NCT05399576|Vitamin B Complex|vitamin b complex|mesh-ancestor
93288439|NCT05399576|Vitamins|vitamins|mesh-ancestor
93288440|NCT05399576|Micronutrients|micronutrients|mesh-ancestor
93288441|NCT05398718|Sotrovimab|sotrovimab|mesh-list
93288442|NCT05398718|Antiviral Agents|antiviral agents|mesh-ancestor
93288443|NCT05398718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288444|NCT05255900|Metyrapone|metyrapone|mesh-list
93288445|NCT05255900|Antimetabolites|antimetabolites|mesh-ancestor
93288446|NCT05255900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288447|NCT05255900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288448|NCT04615286|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93288449|NCT04615286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93288450|NCT04615286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288451|NCT04615286|Antitubercular Agents|antitubercular agents|mesh-ancestor
93288452|NCT05397938|Alendronate|alendronate|mesh-list
93288453|NCT05397938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93288454|NCT05397938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288455|NCT05133674|Tamoxifen|tamoxifen|mesh-list
93288456|NCT05133674|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93288457|NCT05133674|Hormone Antagonists|hormone antagonists|mesh-ancestor
93288458|NCT05133674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288459|NCT05133674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288460|NCT05133674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93288461|NCT05133674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288462|NCT05133674|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93288463|NCT05133674|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93288464|NCT05133674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93288465|NCT02522936|Muramidase|muramidase|mesh-list
93288466|NCT02522936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288467|NCT04525898|Methadone|methadone|mesh-list
93288468|NCT04525898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93288469|NCT04525898|Narcotics|narcotics|mesh-ancestor
93288470|NCT04525898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288471|NCT04525898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288472|NCT04525898|Analgesics|analgesics|mesh-ancestor
93288473|NCT04525898|Sensory System Agents|sensory system agents|mesh-ancestor
93288474|NCT04525898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288475|NCT04525898|Antitussive Agents|antitussive agents|mesh-ancestor
93288476|NCT04525898|Respiratory System Agents|respiratory system agents|mesh-ancestor
93288477|NCT04282070|Paclitaxel|paclitaxel|mesh-list
93288478|NCT04282070|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93288479|NCT04282070|Cisplatin|cisplatin|mesh-list
93288480|NCT04282070|Gemcitabine|gemcitabine|mesh-list
93288481|NCT04282070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288482|NCT04282070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288483|NCT04282070|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288484|NCT04282070|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288485|NCT04282070|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288486|NCT04282070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288487|NCT04282070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93288488|NCT04282070|Antimetabolites|antimetabolites|mesh-ancestor
93288489|NCT04347122|Tranexamic Acid|tranexamic acid|mesh-list
93288490|NCT04347122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93288491|NCT04347122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93288492|NCT04347122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288493|NCT04347122|Hemostatics|hemostatics|mesh-ancestor
93288494|NCT04347122|Coagulants|coagulants|mesh-ancestor
93288495|NCT03467438|Polaprezinc|polaprezinc|mesh-list
93288496|NCT03467438|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93288497|NCT03467438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288498|NCT05397236|Dexamethasone|dexamethasone|mesh-list
93288499|NCT05397236|Bupivacaine|bupivacaine|mesh-list
93288500|NCT05397236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93288501|NCT05397236|Antiemetics|antiemetics|mesh-ancestor
93288502|NCT05397236|Autonomic Agents|autonomic agents|mesh-ancestor
93288503|NCT05397236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288504|NCT05397236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288505|NCT05397236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288506|NCT05397236|Glucocorticoids|glucocorticoids|mesh-ancestor
93288507|NCT05397236|Hormones|hormones|mesh-ancestor
93288508|NCT05397236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288509|NCT05397236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93288510|NCT05397236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288511|NCT05397236|Anesthetics, Local|anesthetics, local|mesh-ancestor
93288512|NCT05397236|Anesthetics|anesthetics|mesh-ancestor
93288513|NCT05397236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288514|NCT05397236|Sensory System Agents|sensory system agents|mesh-ancestor
93288515|NCT05439278|Temozolomide|temozolomide|mesh-list
93288516|NCT05439278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93288517|NCT05439278|Alkylating Agents|alkylating agents|mesh-ancestor
93288518|NCT05439278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288519|NCT05439278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288520|NCT03130010|Nefopam|nefopam|mesh-list
93288521|NCT03130010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93288522|NCT03130010|Analgesics|analgesics|mesh-ancestor
93288523|NCT03130010|Sensory System Agents|sensory system agents|mesh-ancestor
93288524|NCT03130010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288525|NCT03130010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288526|NCT05396144|Nitrous Oxide|nitrous oxide|mesh-list
93288527|NCT05396144|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93288528|NCT05396144|Anesthetics, General|anesthetics, general|mesh-ancestor
93288529|NCT05396144|Anesthetics|anesthetics|mesh-ancestor
93288530|NCT05396144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288531|NCT05396144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288532|NCT05396144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93288533|NCT05396144|Analgesics|analgesics|mesh-ancestor
93288534|NCT05396144|Sensory System Agents|sensory system agents|mesh-ancestor
93288535|NCT05396144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288536|NCT00157248|Dabigatran|dabigatran|mesh-list
93288537|NCT00157248|Antithrombins|antithrombins|mesh-ancestor
93288538|NCT00157248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93288539|NCT00157248|Protease Inhibitors|protease inhibitors|mesh-ancestor
93288540|NCT00157248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288541|NCT00157248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288542|NCT00157248|Anticoagulants|anticoagulants|mesh-ancestor
93288543|NCT02504580|Bupivacaine|bupivacaine|mesh-list
93288544|NCT02504580|Anesthetics, Local|anesthetics, local|mesh-ancestor
93288545|NCT02504580|Anesthetics|anesthetics|mesh-ancestor
93288546|NCT02504580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288547|NCT02504580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288548|NCT02504580|Sensory System Agents|sensory system agents|mesh-ancestor
93288549|NCT02504580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288550|NCT02235402|Lacidipine|lacidipine|mesh-list
93288551|NCT02235402|Bendroflumethiazide|bendroflumethiazide|mesh-list
93288552|NCT02235402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93288553|NCT02235402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93288554|NCT02235402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288555|NCT02235402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288556|NCT02235402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93288557|NCT02235402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288558|NCT02235402|Diuretics|diuretics|mesh-ancestor
93288559|NCT02235402|Natriuretic Agents|natriuretic agents|mesh-ancestor
93288560|NCT02235402|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93288561|NCT02235480|Tazarotene|tazarotene|mesh-list
93288562|NCT02235480|Dermatologic Agents|dermatologic agents|mesh-ancestor
93288563|NCT02235480|Keratolytic Agents|keratolytic agents|mesh-ancestor
93288564|NCT02235558|Verapamil|verapamil|mesh-list
93288565|NCT02235558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93288566|NCT02235558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93288567|NCT02235558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288568|NCT02235558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288569|NCT02235558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93288570|NCT02235558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288571|NCT02235558|Vasodilator Agents|vasodilator agents|mesh-ancestor
93288572|NCT04214418|Hydroxychloroquine|hydroxychloroquine|mesh-list
93288573|NCT04214418|Atezolizumab|atezolizumab|mesh-list
93288574|NCT04214418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93288575|NCT04214418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288576|NCT04214418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93288577|NCT04214418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288578|NCT04214418|Antimalarials|antimalarials|mesh-ancestor
93288579|NCT04214418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93288580|NCT04214418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93288581|NCT04214418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288582|NCT04214418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288583|NCT04214418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288584|NCT02233920|Oxitropium|oxitropium|mesh-list
93288585|NCT02233920|Parasympatholytics|parasympatholytics|mesh-ancestor
93288586|NCT02233920|Autonomic Agents|autonomic agents|mesh-ancestor
93288587|NCT02233920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288588|NCT02233920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288589|NCT02235948|Folic Acid|folic acid|mesh-list
93288590|NCT02235948|Hematinics|hematinics|mesh-ancestor
93288591|NCT02235948|Vitamin B Complex|vitamin b complex|mesh-ancestor
93288592|NCT02235948|Vitamins|vitamins|mesh-ancestor
93288593|NCT02235948|Micronutrients|micronutrients|mesh-ancestor
93288594|NCT02235948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288595|NCT02236026|Moxifloxacin|moxifloxacin|mesh-list
93288596|NCT02236026|ST 1435|st 1435|mesh-list
93288597|NCT02236026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93288598|NCT02236026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288599|NCT02236026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93288600|NCT02236026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93288601|NCT02236026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288602|NCT02236026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288603|NCT02236026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288604|NCT02236026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93288605|NCT02236026|Contraceptive Agents|contraceptive agents|mesh-ancestor
93288606|NCT02236026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93288607|NCT02236026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288608|NCT02236026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93288610|NCT02236182|Ipratropium|ipratropium|mesh-list
93288611|NCT02236182|Anticonvulsants|anticonvulsants|mesh-ancestor
93288612|NCT02236182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93288613|NCT02236182|Autonomic Agents|autonomic agents|mesh-ancestor
93288614|NCT02236182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288615|NCT02236182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288616|NCT02236182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93288617|NCT02236182|Respiratory System Agents|respiratory system agents|mesh-ancestor
93288618|NCT02236182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93288619|NCT02236182|Cholinergic Agents|cholinergic agents|mesh-ancestor
93288620|NCT02236182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288621|NCT02236182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288622|NCT04453280|Antibodies|antibodies|mesh-list
93288623|NCT04453280|Immunologic Factors|immunologic factors|mesh-ancestor
93288624|NCT04453280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288625|NCT01328756|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93288626|NCT01328756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93288627|NCT01328756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288628|NCT01328756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93288629|NCT01328756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93288630|NCT01328756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288631|NCT01328756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288632|NCT01328756|Dopamine Agents|dopamine agents|mesh-ancestor
93288633|NCT01328756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288634|NCT03466502|Vancomycin|vancomycin|mesh-list
93288635|NCT03466502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93288636|NCT03466502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288637|NCT05392634|Amoxicillin|amoxicillin|mesh-list
93288638|NCT05392634|Meropenem|meropenem|mesh-list
93288639|NCT05392634|Clavulanic Acids|clavulanic acids|mesh-list
93288640|NCT05392634|Clavulanic Acid|clavulanic acid|mesh-list
93288641|NCT05392634|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93288642|NCT05392634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93288643|NCT05392634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288644|NCT05392634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288645|NCT05392634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288646|NCT05392634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93288647|NCT01593228|Paclitaxel|paclitaxel|mesh-list
93288648|NCT01593228|Carboplatin|carboplatin|mesh-list
93288649|NCT01593228|Gemcitabine|gemcitabine|mesh-list
93288650|NCT01593228|Doxorubicin|doxorubicin|mesh-list
93288651|NCT01593228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93288652|NCT01593228|Irinotecan|irinotecan|mesh-list
93288653|NCT01593228|Topotecan|topotecan|mesh-list
93288654|NCT01593228|Iniparib|iniparib|mesh-list
93288655|NCT01593228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288656|NCT01593228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288657|NCT01593228|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288658|NCT01593228|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288659|NCT01593228|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288660|NCT01593228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288661|NCT01593228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93288662|NCT01593228|Antimetabolites|antimetabolites|mesh-ancestor
93288663|NCT01593228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93288664|NCT01593228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93288665|NCT01593228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93288666|NCT01593228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288667|NCT01593228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93288668|NCT01593228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93288669|NCT02263638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93288670|NCT02263638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288671|NCT02236260|Lidocaine|lidocaine|mesh-list
93288672|NCT02236260|Anesthetics, Local|anesthetics, local|mesh-ancestor
93288673|NCT02236260|Anesthetics|anesthetics|mesh-ancestor
92960679|NCT01581151|Ranibizumab|ranibizumab|mesh-list
93288674|NCT02236260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288675|NCT02236260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288676|NCT02236260|Sensory System Agents|sensory system agents|mesh-ancestor
93288677|NCT02236260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288678|NCT02236260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93288679|NCT02236260|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93288680|NCT02236260|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93288681|NCT02236260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288682|NCT02236260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288683|NCT01555554|Propranolol|propranolol|mesh-list
93288684|NCT01555554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93288685|NCT01555554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93288686|NCT01555554|Adrenergic Agents|adrenergic agents|mesh-ancestor
93288687|NCT01555554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288688|NCT01555554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288689|NCT01555554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288690|NCT01555554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93288691|NCT01555554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93288692|NCT01555554|Vasodilator Agents|vasodilator agents|mesh-ancestor
93288693|NCT01435044|Sofosbuvir|sofosbuvir|mesh-list
93288694|NCT01435044|Ribavirin|ribavirin|mesh-list
93288695|NCT01435044|Antiviral Agents|antiviral agents|mesh-ancestor
93288696|NCT01435044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288697|NCT01435044|Antimetabolites|antimetabolites|mesh-ancestor
93288698|NCT01435044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288699|NCT01434498|Ribavirin|ribavirin|mesh-list
93288700|NCT01434498|Ledipasvir|ledipasvir|mesh-list
93288701|NCT01434498|Antimetabolites|antimetabolites|mesh-ancestor
93288702|NCT01434498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288703|NCT01434498|Antiviral Agents|antiviral agents|mesh-ancestor
93288704|NCT01434498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288705|NCT03735966|Carboplatin|carboplatin|mesh-list
93288706|NCT03735966|Docetaxel|docetaxel|mesh-list
93288707|NCT03735966|Trastuzumab|trastuzumab|mesh-list
93288708|NCT03735966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288709|NCT03735966|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288710|NCT03735966|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288711|NCT03735966|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288712|NCT03735966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288713|NCT03735966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93288714|NCT01554696|Methotrexate|methotrexate|mesh-list
93288715|NCT01554696|Peficitinib|peficitinib|mesh-list
93288716|NCT01554696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93288717|NCT01554696|Abortifacient Agents|abortifacient agents|mesh-ancestor
93288718|NCT01554696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93288719|NCT01554696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288720|NCT01554696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93288721|NCT01554696|Antimetabolites|antimetabolites|mesh-ancestor
93288722|NCT01554696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288723|NCT01554696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288724|NCT01554696|Dermatologic Agents|dermatologic agents|mesh-ancestor
93288725|NCT01554696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288726|NCT01554696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93288727|NCT01554696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93288728|NCT01554696|Immunologic Factors|immunologic factors|mesh-ancestor
93288729|NCT01554696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288730|NCT01554696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93288731|NCT02265276|Pioglitazone|pioglitazone|mesh-list
93288732|NCT02265276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93288733|NCT02265276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288734|NCT02263872|Minocycline|minocycline|mesh-list
93288735|NCT02263872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93288736|NCT02263872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288737|NCT02261376|DS-1971a|ds-1971a|mesh-list
93288738|NCT02261376|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93288739|NCT02261376|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93288740|NCT02261376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288741|NCT02261376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288742|NCT01535508|Vitamin D|vitamin d|mesh-list
93288743|NCT01535508|Vitamins|vitamins|mesh-ancestor
93288744|NCT01535508|Micronutrients|micronutrients|mesh-ancestor
93288745|NCT01535508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288746|NCT01535508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93288747|NCT02626338|Cytarabine|cytarabine|mesh-list
93288748|NCT02626338|Fludarabine|fludarabine|mesh-list
93288750|NCT02626338|Etoposide|etoposide|mesh-list
93288751|NCT02626338|Etoposide phosphate|etoposide phosphate|mesh-list
93288752|NCT02626338|Mitoxantrone|mitoxantrone|mesh-list
93288753|NCT02626338|Idarubicin|idarubicin|mesh-list
93288754|NCT02626338|Crenolanib|crenolanib|mesh-list
93288755|NCT02626338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288756|NCT02626338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93288757|NCT02626338|Antimetabolites|antimetabolites|mesh-ancestor
93288758|NCT02626338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288759|NCT02626338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93288760|NCT02626338|Immunologic Factors|immunologic factors|mesh-ancestor
93288761|NCT02626338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288762|NCT02626338|Antiviral Agents|antiviral agents|mesh-ancestor
93288763|NCT02626338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288764|NCT02626338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288765|NCT02626338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93288766|NCT02626338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93288767|NCT02626338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288768|NCT02626338|Analgesics|analgesics|mesh-ancestor
93288769|NCT02626338|Sensory System Agents|sensory system agents|mesh-ancestor
93288770|NCT02626338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288771|NCT02626338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93288772|NCT01416402|Colchicine|colchicine|mesh-list
93288773|NCT01416402|Febuxostat|febuxostat|mesh-list
93288774|NCT01416402|Gout Suppressants|gout suppressants|mesh-ancestor
93288775|NCT01416402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288776|NCT01416402|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288777|NCT01416402|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288778|NCT01416402|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288779|NCT01416402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288780|NCT01416402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288781|NCT01414920|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93288782|NCT01414920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93288783|NCT01414920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288784|NCT01414920|Incretins|incretins|mesh-ancestor
93288785|NCT01414920|Hormones|hormones|mesh-ancestor
93288786|NCT01414920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288787|NCT01414920|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93288788|NCT01414920|Protease Inhibitors|protease inhibitors|mesh-ancestor
93288789|NCT01414920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288790|NCT01414920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288791|NCT02263950|Artemether|artemether|mesh-list
93288792|NCT02263950|Antimalarials|antimalarials|mesh-ancestor
93288793|NCT02263950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93288794|NCT02263950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93288795|NCT02263950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288796|NCT02261844|Resveratrol|resveratrol|mesh-list
93288797|NCT02261844|Antioxidants|antioxidants|mesh-ancestor
93288798|NCT02261844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288799|NCT02261844|Protective Agents|protective agents|mesh-ancestor
93288800|NCT02261844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288801|NCT02261844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288802|NCT02261844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93288803|NCT02261922|Ticagrelor|ticagrelor|mesh-list
93288804|NCT02261922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93288805|NCT02261922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93288806|NCT02261922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93288807|NCT02261922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93288808|NCT02261922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93288809|NCT02261922|Purinergic Agents|purinergic agents|mesh-ancestor
93288810|NCT02261922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288811|NCT02261922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288812|NCT02261922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288813|NCT02264028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93288814|NCT02264106|Pantoprazole|pantoprazole|mesh-list
93288815|NCT02264106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93288816|NCT02264106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93288817|NCT02264106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93288818|NCT02264106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288819|NCT02264106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288820|NCT02262156|Antidepressive Agents|antidepressive agents|mesh-list
93288821|NCT02262156|Serotonin|serotonin|mesh-list
93288822|NCT02262156|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93288823|NCT02262156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93288824|NCT02262156|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93288825|NCT02262156|Serotonin Agents|serotonin agents|mesh-ancestor
93288826|NCT02262156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288827|NCT02262156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288828|NCT02262156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288829|NCT02262156|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93288830|NCT02262156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288831|NCT02612922|Nitazoxanide|nitazoxanide|mesh-list
93288832|NCT02612922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93288833|NCT02612922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288834|NCT01516476|Liraglutide|liraglutide|mesh-list
93288835|NCT01516476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93288836|NCT01516476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288837|NCT01516476|Incretins|incretins|mesh-ancestor
93288838|NCT01516476|Hormones|hormones|mesh-ancestor
93288839|NCT01516476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288840|NCT01516086|Fluticasone|fluticasone|mesh-list
93288841|NCT01516086|Xhance|xhance|mesh-list
93288842|NCT01516086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93288843|NCT01516086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93288844|NCT01516086|Autonomic Agents|autonomic agents|mesh-ancestor
93288845|NCT01516086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288846|NCT01516086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288847|NCT01516086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93288848|NCT01516086|Respiratory System Agents|respiratory system agents|mesh-ancestor
93288849|NCT01516086|Dermatologic Agents|dermatologic agents|mesh-ancestor
93288850|NCT01516086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93288851|NCT01497834|Asunaprevir|asunaprevir|mesh-list
93288852|NCT01497834|Protease Inhibitors|protease inhibitors|mesh-ancestor
93288853|NCT01497834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288854|NCT01497834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288855|NCT02265822|Midazolam|midazolam|mesh-list
93288856|NCT02265822|Melatonin|melatonin|mesh-list
93288857|NCT02265822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93288858|NCT02265822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93288859|NCT02265822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288860|NCT02265822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288861|NCT02265822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93288862|NCT02265822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93288863|NCT02265822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93288864|NCT02265822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93288865|NCT02265822|Anesthetics, General|anesthetics, general|mesh-ancestor
93288866|NCT02265822|Anesthetics|anesthetics|mesh-ancestor
93288867|NCT02265822|GABA Modulators|gaba modulators|mesh-ancestor
93288868|NCT02265822|GABA Agents|gaba agents|mesh-ancestor
93288869|NCT02265822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288870|NCT02265822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288871|NCT02265822|Antioxidants|antioxidants|mesh-ancestor
93288872|NCT02265822|Protective Agents|protective agents|mesh-ancestor
93288873|NCT02607930|Lamivudine|lamivudine|mesh-list
93288874|NCT02607930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93288875|NCT02607930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93288876|NCT02607930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288877|NCT02607930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288878|NCT02607930|Antiviral Agents|antiviral agents|mesh-ancestor
93288879|NCT02607930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288880|NCT02607930|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93288881|NCT02607930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93288882|NCT02264184|Paroxetine|paroxetine|mesh-list
93288883|NCT02264184|Tamsulosin|tamsulosin|mesh-list
93288884|NCT02264184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93288885|NCT02264184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93288886|NCT02264184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93288887|NCT02264184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288888|NCT02264184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288889|NCT02264184|Serotonin Agents|serotonin agents|mesh-ancestor
93288890|NCT02264184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288891|NCT02264184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93288892|NCT02264184|Antidepressive Agents|antidepressive agents|mesh-ancestor
93288893|NCT02264184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93288894|NCT02264184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93288895|NCT02264184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93288896|NCT02264184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93288897|NCT02264184|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92960913|NCT04005430|Hormones|hormones|mesh-ancestor
93288898|NCT02264184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93288899|NCT02264184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93288901|NCT02264184|Urological Agents|urological agents|mesh-ancestor
93288902|NCT01260870|Paclitaxel|paclitaxel|mesh-list
93288903|NCT01260870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288904|NCT01260870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288905|NCT01260870|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288906|NCT01260870|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288907|NCT01260870|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288908|NCT01260870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288909|NCT02266056|Rocuronium|rocuronium|mesh-list
93288910|NCT02266056|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93288911|NCT02266056|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93288912|NCT02266056|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93288913|NCT02266056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288914|NCT02266056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288915|NCT01482390|Ribavirin|ribavirin|mesh-list
93288916|NCT01482390|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93288917|NCT01482390|Antimetabolites|antimetabolites|mesh-ancestor
93288918|NCT01482390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288919|NCT01482390|Antiviral Agents|antiviral agents|mesh-ancestor
93288920|NCT01482390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288921|NCT01478178|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
93288922|NCT01478178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93288923|NCT01478178|Alkylating Agents|alkylating agents|mesh-ancestor
93288924|NCT01478178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288925|NCT01478178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288926|NCT01366014|Oxycodone|oxycodone|mesh-list
93288927|NCT01366014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93288928|NCT01366014|Narcotics|narcotics|mesh-ancestor
93288929|NCT01366014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93288930|NCT01366014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288931|NCT01366014|Analgesics|analgesics|mesh-ancestor
93288932|NCT01366014|Sensory System Agents|sensory system agents|mesh-ancestor
93288933|NCT01366014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288934|NCT01361802|Ambroxol|ambroxol|mesh-list
93288935|NCT01361802|Expectorants|expectorants|mesh-ancestor
93288936|NCT01361802|Respiratory System Agents|respiratory system agents|mesh-ancestor
93288937|NCT01235754|Methyltestosterone|methyltestosterone|mesh-list
93288938|NCT01235754|Testosterone|testosterone|mesh-list
93288939|NCT01235754|Testosterone undecanoate|testosterone undecanoate|mesh-list
93288940|NCT01235754|Testosterone enanthate|testosterone enanthate|mesh-list
93288941|NCT01235754|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93288942|NCT01235754|Androgens|androgens|mesh-ancestor
93288943|NCT01235754|Hormones|hormones|mesh-ancestor
93288944|NCT01235754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93288945|NCT01235754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288946|NCT01235754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93288947|NCT01235754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288948|NCT01235754|Anabolic Agents|anabolic agents|mesh-ancestor
93288949|NCT01234038|Paclitaxel|paclitaxel|mesh-list
93288950|NCT01234038|Carboplatin|carboplatin|mesh-list
93288951|NCT01234038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93288952|NCT01234038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93288953|NCT01234038|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288954|NCT01234038|Antimitotic Agents|antimitotic agents|mesh-ancestor
93288955|NCT01234038|Mitosis Modulators|mitosis modulators|mesh-ancestor
93288956|NCT01234038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288957|NCT01233960|Remestemcel-l|remestemcel-l|mesh-list
93288958|NCT01233960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93288959|NCT01233960|Antiviral Agents|antiviral agents|mesh-ancestor
93288960|NCT01233960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288961|NCT01229982|Latanoprost|latanoprost|mesh-list
93288962|NCT01229982|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93288963|NCT01229982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93288964|NCT01225380|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93288965|NCT01225380|Interferon-alpha|interferon-alpha|mesh-list
93288966|NCT01225380|Ribavirin|ribavirin|mesh-list
93288967|NCT01225380|Antiviral Agents|antiviral agents|mesh-ancestor
93288968|NCT01225380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93288969|NCT01225380|Immunologic Factors|immunologic factors|mesh-ancestor
93288970|NCT01225380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288971|NCT01225380|Antimetabolites|antimetabolites|mesh-ancestor
93288972|NCT01225380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288973|NCT01349868|Formoterol Fumarate|formoterol fumarate|mesh-list
93288974|NCT01349868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93288975|NCT01349868|Autonomic Agents|autonomic agents|mesh-ancestor
93288976|NCT01349868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93288977|NCT01349868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288978|NCT01349868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93288979|NCT01349868|Respiratory System Agents|respiratory system agents|mesh-ancestor
93288980|NCT01349868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93288981|NCT01349868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93288982|NCT01349868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93288983|NCT01349868|Adrenergic Agents|adrenergic agents|mesh-ancestor
93288984|NCT01349868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288985|NCT01349868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288987|NCT02266524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93288988|NCT02266524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93288989|NCT02266524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93288990|NCT02266524|Adrenergic Agents|adrenergic agents|mesh-ancestor
93288991|NCT02266524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93288992|NCT02266524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93288993|NCT02266524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93288994|NCT02266524|Urological Agents|urological agents|mesh-ancestor
93288995|NCT01336686|Colchicine|colchicine|mesh-list
93288996|NCT01336686|Gout Suppressants|gout suppressants|mesh-ancestor
93288997|NCT01336686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93288998|NCT01336686|Tubulin Modulators|tubulin modulators|mesh-ancestor
93288999|NCT01336686|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289000|NCT01336686|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289001|NCT01336686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289002|NCT01336686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289003|NCT01455090|Ribavirin|ribavirin|mesh-list
93289004|NCT01455090|Asunaprevir|asunaprevir|mesh-list
93289005|NCT01455090|Antimetabolites|antimetabolites|mesh-ancestor
93289006|NCT01455090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289007|NCT01455090|Antiviral Agents|antiviral agents|mesh-ancestor
93289008|NCT01455090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289009|NCT01455090|Protease Inhibitors|protease inhibitors|mesh-ancestor
93289010|NCT01455090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289011|NCT02056782|Heparin|heparin|mesh-list
93289012|NCT02056782|Anticoagulants|anticoagulants|mesh-ancestor
93289013|NCT02056782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93289014|NCT02056782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93289015|NCT02056782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289016|NCT01198626|Moxifloxacin|moxifloxacin|mesh-list
93289017|NCT01198626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289018|NCT01198626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289019|NCT01198626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93289020|NCT01198626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93289021|NCT01198626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289022|NCT01198626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289023|NCT01198626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289024|NCT01194960|Docetaxel|docetaxel|mesh-list
93289025|NCT01194960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289026|NCT01194960|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289027|NCT01194960|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289028|NCT01194960|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289029|NCT01194960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289030|NCT01331850|Ritonavir|ritonavir|mesh-list
93289031|NCT01331850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93289032|NCT01331850|Interferon-alpha|interferon-alpha|mesh-list
93289033|NCT01331850|Ribavirin|ribavirin|mesh-list
93289034|NCT01331850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93289035|NCT01331850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93289036|NCT01331850|Protease Inhibitors|protease inhibitors|mesh-ancestor
93289037|NCT01331850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289038|NCT01331850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289039|NCT01331850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93289040|NCT01331850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93289041|NCT01331850|Antiviral Agents|antiviral agents|mesh-ancestor
93289042|NCT01331850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289043|NCT01331850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93289044|NCT01331850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93289045|NCT01331850|Immunologic Factors|immunologic factors|mesh-ancestor
93289046|NCT01331850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289047|NCT01331850|Antimetabolites|antimetabolites|mesh-ancestor
93289048|NCT02101034|Cetuximab|cetuximab|mesh-list
93289050|NCT02101034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289051|NCT02101034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289052|NCT02101034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93289053|NCT02101034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289054|NCT02101034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289055|NCT01328808|Acetaminophen|acetaminophen|mesh-list
93289056|NCT01328808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93289057|NCT01328808|Analgesics|analgesics|mesh-ancestor
93289058|NCT01328808|Sensory System Agents|sensory system agents|mesh-ancestor
93289059|NCT01328808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289060|NCT01328808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289061|NCT01328808|Antipyretics|antipyretics|mesh-ancestor
93289062|NCT01968590|Vitamin D|vitamin d|mesh-list
93289063|NCT01968590|Cholecalciferol|cholecalciferol|mesh-list
93289064|NCT01968590|Vitamins|vitamins|mesh-ancestor
93289065|NCT01968590|Micronutrients|micronutrients|mesh-ancestor
93289066|NCT01968590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289067|NCT01968590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93289068|NCT01968590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93289069|NCT05626998|Dexmedetomidine|dexmedetomidine|mesh-list
93289070|NCT05626998|Gabapentin|gabapentin|mesh-list
93289071|NCT05626998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93289072|NCT05626998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289073|NCT05626998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289074|NCT05626998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93289075|NCT05626998|Analgesics|analgesics|mesh-ancestor
93289076|NCT05626998|Sensory System Agents|sensory system agents|mesh-ancestor
93289077|NCT05626998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289078|NCT05626998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93289079|NCT05626998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93289080|NCT05626998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93289081|NCT05626998|Adrenergic Agents|adrenergic agents|mesh-ancestor
93289082|NCT05626998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289083|NCT05626998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289084|NCT05626998|Anticonvulsants|anticonvulsants|mesh-ancestor
93289085|NCT05626998|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93289086|NCT05626998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289087|NCT05626998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289088|NCT05626998|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93289089|NCT05626998|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93289090|NCT05626998|Antimanic Agents|antimanic agents|mesh-ancestor
93289091|NCT01314222|Pregabalin|pregabalin|mesh-list
93289092|NCT01314222|Analgesics|analgesics|mesh-ancestor
93289093|NCT01314222|Sensory System Agents|sensory system agents|mesh-ancestor
93289094|NCT01314222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289095|NCT01314222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289096|NCT01314222|Anticonvulsants|anticonvulsants|mesh-ancestor
93289097|NCT01314222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93289098|NCT01314222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289099|NCT01314222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289100|NCT01314222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93289101|NCT01314222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93289102|NCT01314222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289103|NCT01314222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289104|NCT01314222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289105|NCT05222828|Mepivacaine|mepivacaine|mesh-list
93289106|NCT05222828|Anesthetics, Local|anesthetics, local|mesh-ancestor
93289107|NCT05222828|Anesthetics|anesthetics|mesh-ancestor
93289108|NCT05222828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289109|NCT05222828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289110|NCT05222828|Sensory System Agents|sensory system agents|mesh-ancestor
93289111|NCT05222828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289112|NCT01309932|Interferons|interferons|mesh-list
93289113|NCT01309932|Ribavirin|ribavirin|mesh-list
93289114|NCT01309932|Interferon-alpha|interferon-alpha|mesh-list
93289115|NCT01309932|Interferon alpha-2|interferon alpha-2|mesh-list
93289116|NCT01309932|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93289117|NCT01309932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93289118|NCT01309932|Protease Inhibitors|protease inhibitors|mesh-list
93289119|NCT01309932|Asunaprevir|asunaprevir|mesh-list
93289120|NCT01309932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289121|NCT01309932|Antiviral Agents|antiviral agents|mesh-ancestor
93289122|NCT01309932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289123|NCT01309932|Antimetabolites|antimetabolites|mesh-ancestor
92961143|NCT00671034|Cytarabine|cytarabine|mesh-list
93289124|NCT01309932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289125|NCT01309932|Immunologic Factors|immunologic factors|mesh-ancestor
93289126|NCT01309932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289127|NCT01309932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289128|NCT01309932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93289129|NCT01309932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93289130|NCT01309932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93289131|NCT01733888|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93289132|NCT01733888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93289133|NCT01733888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289134|NCT01181622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93289135|NCT01101594|Doxorubicin|doxorubicin|mesh-list
93289136|NCT01101594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93289137|NCT01101594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289138|NCT01101594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93289139|NCT01101594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93289140|NCT01101594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289141|NCT01101594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289142|NCT02269176|Losartan|losartan|mesh-list
93289143|NCT02269176|Telmisartan|telmisartan|mesh-list
93289144|NCT02269176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93289145|NCT02269176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93289146|NCT02269176|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93289147|NCT02269176|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93289148|NCT02269176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289149|NCT01094262|Oxycodone|oxycodone|mesh-list
93289150|NCT01094262|Analgesics|analgesics|mesh-list
93289151|NCT01094262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93289152|NCT01094262|Narcotics|narcotics|mesh-ancestor
93289153|NCT01094262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289154|NCT01094262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289155|NCT01094262|Sensory System Agents|sensory system agents|mesh-ancestor
93289156|NCT01094262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289157|NCT04476186|Acyclovir|acyclovir|mesh-list
93289158|NCT04476186|Antiviral Agents|antiviral agents|mesh-ancestor
93289159|NCT04476186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289160|NCT03440216|Meropenem|meropenem|mesh-list
93289161|NCT03440216|Ceftriaxone|ceftriaxone|mesh-list
93289162|NCT03440216|Temocillin|temocillin|mesh-list
93289163|NCT03440216|Penicillins|penicillins|mesh-list
93289164|NCT03440216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289165|NCT03440216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289166|NCT01166412|Levonorgestrel|levonorgestrel|mesh-list
93289167|NCT01166412|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93289168|NCT01166412|Contraceptive Agents|contraceptive agents|mesh-ancestor
93289169|NCT01166412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93289170|NCT01166412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289171|NCT01166412|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93289172|NCT01166412|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93289173|NCT01166412|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93289174|NCT05370716|Pregabalin|pregabalin|mesh-list
93289175|NCT05370716|Analgesics|analgesics|mesh-ancestor
93289176|NCT05370716|Sensory System Agents|sensory system agents|mesh-ancestor
93289177|NCT05370716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289178|NCT05370716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289179|NCT05370716|Anticonvulsants|anticonvulsants|mesh-ancestor
93289180|NCT05370716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93289181|NCT05370716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289182|NCT05370716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289183|NCT05370716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93289184|NCT05370716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93289185|NCT05370716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289186|NCT05370716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289187|NCT05370716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289188|NCT01038804|Docetaxel|docetaxel|mesh-list
93289189|NCT01038804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289190|NCT01038804|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289191|NCT01038804|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289192|NCT01038804|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289193|NCT01038804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289194|NCT05118776|Bevacizumab|bevacizumab|mesh-list
93289195|NCT05118776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289196|NCT05118776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289197|NCT05118776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92961216|NCT00743678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289198|NCT05118776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93289200|NCT05118776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289201|NCT05118776|Growth Inhibitors|growth inhibitors|mesh-ancestor
93289202|NCT02269644|Azithromycin|azithromycin|mesh-list
93289203|NCT02269644|Linezolid|linezolid|mesh-list
93289204|NCT02269644|Dalbavancin|dalbavancin|mesh-list
93289205|NCT02269644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289206|NCT02269644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289207|NCT02269644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93289208|NCT02269644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289209|NCT02269644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289210|NCT03367988|Analgesics, Opioid|analgesics, opioid|mesh-list
93289211|NCT03367988|Anesthetics|anesthetics|mesh-list
93289212|NCT03367988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289213|NCT03367988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289214|NCT03367988|Narcotics|narcotics|mesh-ancestor
93289215|NCT03367988|Analgesics|analgesics|mesh-ancestor
93289216|NCT03367988|Sensory System Agents|sensory system agents|mesh-ancestor
93289217|NCT03367988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289218|NCT03465488|Albendazole|albendazole|mesh-list
93289219|NCT03465488|Anthelmintics|anthelmintics|mesh-ancestor
93289220|NCT03465488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93289221|NCT03465488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289222|NCT03465488|Anticestodal Agents|anticestodal agents|mesh-ancestor
93289223|NCT03465488|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93289224|NCT03465488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93289225|NCT03465488|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289226|NCT03465488|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289227|NCT03465488|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289228|NCT03465488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289229|NCT03465488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289230|NCT02267304|Morphine|morphine|mesh-list
93289231|NCT02267304|Naloxone|naloxone|mesh-list
93289232|NCT02267304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93289233|NCT02267304|Narcotics|narcotics|mesh-ancestor
93289234|NCT02267304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289235|NCT02267304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289236|NCT02267304|Analgesics|analgesics|mesh-ancestor
93289237|NCT02267304|Sensory System Agents|sensory system agents|mesh-ancestor
93289238|NCT02267304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289239|NCT02267304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93289240|NCT03465410|Tacrolimus|tacrolimus|mesh-list
93289241|NCT03465410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93289242|NCT03465410|Immunologic Factors|immunologic factors|mesh-ancestor
93289243|NCT03465410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289244|NCT03465410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93289245|NCT03465410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289246|NCT03465410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289247|NCT02522234|Lenograstim|lenograstim|mesh-list
93289248|NCT02522234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93289249|NCT02522234|Immunologic Factors|immunologic factors|mesh-ancestor
93289250|NCT02522234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289251|NCT00154284|Cyclosporine|cyclosporine|mesh-list
93289252|NCT00154284|Prednisone|prednisone|mesh-list
93289253|NCT00154284|Everolimus|everolimus|mesh-list
93289254|NCT00154284|Cyclosporins|cyclosporins|mesh-list
93289255|NCT00154284|Basiliximab|basiliximab|mesh-list
93289256|NCT00154284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93289257|NCT00154284|Glucocorticoids|glucocorticoids|mesh-ancestor
93289258|NCT00154284|Hormones|hormones|mesh-ancestor
93289259|NCT00154284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93289260|NCT00154284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289261|NCT00154284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93289262|NCT00154284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289263|NCT00154284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289264|NCT00154284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289265|NCT00154284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93289266|NCT00154284|Immunologic Factors|immunologic factors|mesh-ancestor
93289267|NCT00154284|Antifungal Agents|antifungal agents|mesh-ancestor
93289268|NCT00154284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289269|NCT00154284|Dermatologic Agents|dermatologic agents|mesh-ancestor
93289270|NCT00154284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93289271|NCT00154284|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93289272|NCT00154284|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93289273|NCT00154284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93289274|NCT04973306|Tislelizumab|tislelizumab|mesh-list
93289275|NCT04973306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289276|NCT04973306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289277|NCT01037166|Entecavir|entecavir|mesh-list
93289278|NCT01037166|Antiviral Agents|antiviral agents|mesh-ancestor
93289279|NCT01037166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289280|NCT04491032|Anesthetics|anesthetics|mesh-list
93289281|NCT04491032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289282|NCT04491032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289283|NCT02269800|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93289284|NCT02269800|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93289285|NCT02269800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289286|NCT04487756|Carboplatin|carboplatin|mesh-list
93289287|NCT04487756|Atezolizumab|atezolizumab|mesh-list
93289288|NCT04487756|Vaccines|vaccines|mesh-list
93289289|NCT04487756|Immunologic Factors|immunologic factors|mesh-ancestor
93289290|NCT04487756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289291|NCT04487756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289292|NCT04487756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93289293|NCT04487756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289294|NCT04487756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289295|NCT01281462|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93289296|NCT01281462|Cephalosporins|cephalosporins|mesh-list
93289297|NCT01281462|Avibactam|avibactam|mesh-list
93289298|NCT01281462|Doripenem|doripenem|mesh-list
93289299|NCT01281462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289300|NCT01281462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289301|NCT01281462|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93289302|NCT01281462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289303|NCT01281462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289304|NCT04453124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93289305|NCT04453124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289306|NCT01024062|Paclitaxel|paclitaxel|mesh-list
93289307|NCT01024062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93289308|NCT01024062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289309|NCT01024062|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289310|NCT01024062|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289311|NCT01024062|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289312|NCT01024062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289313|NCT04453436|Tenofovir|tenofovir|mesh-list
93289314|NCT04453436|Lamivudine|lamivudine|mesh-list
93289315|NCT04453436|Dolutegravir|dolutegravir|mesh-list
93289316|NCT04453436|Antiviral Agents|antiviral agents|mesh-ancestor
93289317|NCT04453436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289318|NCT04453436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93289319|NCT04453436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93289320|NCT04453436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289321|NCT04453436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289322|NCT04453436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93289323|NCT04453436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93289324|NCT04453436|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93289325|NCT04453436|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93289326|NCT02267616|Etonogestrel|etonogestrel|mesh-list
93289327|NCT02267616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93289328|NCT02267616|Contraceptive Agents|contraceptive agents|mesh-ancestor
93289329|NCT02267616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93289330|NCT02267616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289331|NCT02267616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93289332|NCT05232734|Caffeine|caffeine|mesh-list
93289333|NCT05232734|Caffeine citrate|caffeine citrate|mesh-list
93289334|NCT05232734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289335|NCT05232734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93289336|NCT05232734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289337|NCT05232734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93289338|NCT05232734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289339|NCT05232734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93289340|NCT05232734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93289341|NCT05232734|Purinergic Agents|purinergic agents|mesh-ancestor
93289342|NCT05232734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289343|NCT03465098|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93289344|NCT03465098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93289345|NCT03465098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289346|NCT01023204|Paclitaxel|paclitaxel|mesh-list
93289347|NCT01023204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93289348|NCT01023204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289349|NCT01023204|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289350|NCT01023204|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289351|NCT01023204|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289352|NCT01023204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289353|NCT04460456|Pembrolizumab|pembrolizumab|mesh-list
93289354|NCT04460456|Cemiplimab|cemiplimab|mesh-list
93289355|NCT04460456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289356|NCT04460456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289357|NCT04460456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93289358|NCT04460456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289359|NCT02268006|Capecitabine|capecitabine|mesh-list
93289360|NCT02268006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93289361|NCT02268006|Antimetabolites|antimetabolites|mesh-ancestor
93289362|NCT02268006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289363|NCT02268006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289364|NCT03462212|Paclitaxel|paclitaxel|mesh-list
93289365|NCT03462212|Bevacizumab|bevacizumab|mesh-list
93289366|NCT03462212|Carboplatin|carboplatin|mesh-list
93289367|NCT03462212|Rucaparib|rucaparib|mesh-list
93289368|NCT03462212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93289369|NCT03462212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289370|NCT03462212|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289371|NCT03462212|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289372|NCT03462212|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289373|NCT03462212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583839|NCT00089349|Methotrexate|methotrexate|mesh-list
93289374|NCT03462212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289375|NCT03462212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93289376|NCT03462212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93289377|NCT03462212|Growth Substances|growth substances|mesh-ancestor
93289378|NCT03462212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289379|NCT03462212|Growth Inhibitors|growth inhibitors|mesh-ancestor
93289380|NCT03462212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93289381|NCT03462212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289382|NCT01016808|Morphine|morphine|mesh-list
93289383|NCT01016808|Oxycodone|oxycodone|mesh-list
93289384|NCT01016808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93289385|NCT01016808|Narcotics|narcotics|mesh-ancestor
93289386|NCT01016808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289387|NCT01016808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289388|NCT01016808|Analgesics|analgesics|mesh-ancestor
93289389|NCT01016808|Sensory System Agents|sensory system agents|mesh-ancestor
93289390|NCT01016808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289391|NCT01014078|Azithromycin|azithromycin|mesh-list
93289392|NCT01014078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93289393|NCT01014078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93289394|NCT01014078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289395|NCT01014078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289396|NCT02522078|Misoprostol|misoprostol|mesh-list
93289397|NCT02522078|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93289398|NCT02522078|Abortifacient Agents|abortifacient agents|mesh-ancestor
93289399|NCT02522078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93289400|NCT02522078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289401|NCT02522078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93289402|NCT02522078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93289403|NCT02522078|Oxytocics|oxytocics|mesh-ancestor
93289404|NCT00911274|Mycophenolic Acid|mycophenolic acid|mesh-list
93289405|NCT00911274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93289406|NCT00911274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289407|NCT00911274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93289408|NCT00911274|Antitubercular Agents|antitubercular agents|mesh-ancestor
93289409|NCT00911274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289410|NCT00911274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289411|NCT00911274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289412|NCT00911274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289413|NCT03468296|Aflibercept|aflibercept|mesh-list
93289414|NCT03468296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93289415|NCT03468296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93289416|NCT03468296|Growth Substances|growth substances|mesh-ancestor
93289417|NCT03468296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289418|NCT03468296|Growth Inhibitors|growth inhibitors|mesh-ancestor
93289419|NCT03468296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289420|NCT01130142|Gemcitabine|gemcitabine|mesh-list
93289421|NCT01130142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93289422|NCT01130142|Antimetabolites|antimetabolites|mesh-ancestor
93289423|NCT01130142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289424|NCT01130142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289426|NCT03464864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93289427|NCT03468140|Eculizumab|eculizumab|mesh-list
93289428|NCT03468140|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93289429|NCT03468140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93289430|NCT03468140|Immunologic Factors|immunologic factors|mesh-ancestor
93289431|NCT03468140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289432|NCT01009242|Methotrexate|methotrexate|mesh-list
93289433|NCT01009242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93289434|NCT01009242|Abortifacient Agents|abortifacient agents|mesh-ancestor
93289435|NCT01009242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93289436|NCT01009242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289437|NCT01009242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93289438|NCT01009242|Antimetabolites|antimetabolites|mesh-ancestor
93289439|NCT01009242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289440|NCT01009242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289441|NCT01009242|Dermatologic Agents|dermatologic agents|mesh-ancestor
93289442|NCT01009242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289443|NCT01009242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93289444|NCT01009242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93289445|NCT01009242|Immunologic Factors|immunologic factors|mesh-ancestor
93289446|NCT01009242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93289447|NCT01009242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93289448|NCT03468062|Dexmedetomidine|dexmedetomidine|mesh-list
93289449|NCT03468062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93289450|NCT03468062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289451|NCT03468062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289452|NCT03468062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93289453|NCT03468062|Analgesics|analgesics|mesh-ancestor
93289454|NCT03468062|Sensory System Agents|sensory system agents|mesh-ancestor
93289455|NCT03468062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289456|NCT03468062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93289457|NCT03468062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93289458|NCT03468062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93289459|NCT03468062|Adrenergic Agents|adrenergic agents|mesh-ancestor
93289460|NCT03468062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289461|NCT03468062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289462|NCT03464552|Celecoxib|celecoxib|mesh-list
93289463|NCT03464552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93289464|NCT03464552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93289465|NCT03464552|Analgesics|analgesics|mesh-ancestor
93289466|NCT03464552|Sensory System Agents|sensory system agents|mesh-ancestor
93289467|NCT03464552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289468|NCT03464552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289469|NCT03464552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93289470|NCT03464552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93289471|NCT03464552|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93289472|NCT03464552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93289473|NCT03464552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289474|NCT03464552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289475|NCT05628558|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93289476|NCT05628558|Hemostatics|hemostatics|mesh-ancestor
93289477|NCT05628558|Coagulants|coagulants|mesh-ancestor
93289478|NCT05628558|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93289479|NCT05628558|Natriuretic Agents|natriuretic agents|mesh-ancestor
93289480|NCT05628558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289481|NCT01007292|Rituximab|rituximab|mesh-list
93289482|NCT01007292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289483|NCT01007292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289484|NCT01007292|Immunologic Factors|immunologic factors|mesh-ancestor
93289485|NCT01007292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289486|NCT01007292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93289487|NCT03467984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93289488|NCT03467984|Immunologic Factors|immunologic factors|mesh-ancestor
93289489|NCT03467984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289490|NCT01005108|Gabapentin|gabapentin|mesh-list
93289491|NCT01005108|Analgesics|analgesics|mesh-ancestor
93289492|NCT01005108|Sensory System Agents|sensory system agents|mesh-ancestor
93289493|NCT01005108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289494|NCT01005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289495|NCT01005108|Anticonvulsants|anticonvulsants|mesh-ancestor
93289496|NCT01005108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92961517|NCT00776334|Fosinopril|fosinopril|mesh-list
93289497|NCT01005108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289498|NCT01005108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289499|NCT01005108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289500|NCT01005108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93289501|NCT01005108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93289502|NCT01005108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289503|NCT01005108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289504|NCT01005108|Antimanic Agents|antimanic agents|mesh-ancestor
93289505|NCT00905346|Topiramate|topiramate|mesh-list
93289506|NCT00905346|Anticonvulsants|anticonvulsants|mesh-ancestor
93289507|NCT00905346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93289508|NCT00905346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289509|NCT00902928|Enoxaparin|enoxaparin|mesh-list
93289510|NCT00902928|Anticoagulants|anticoagulants|mesh-ancestor
93289511|NCT00902928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93289512|NCT00902928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93289513|NCT00902928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289514|NCT04316702|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93289515|NCT04316702|Analgesics|analgesics|mesh-ancestor
93289516|NCT04316702|Sensory System Agents|sensory system agents|mesh-ancestor
93289517|NCT04316702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289518|NCT04316702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289519|NCT04316702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289520|NCT04316702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289521|NCT04316702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289522|NCT04316702|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93289523|NCT04316702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93289524|NCT04316702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289525|NCT04316702|Antidepressive Agents|antidepressive agents|mesh-ancestor
93289526|NCT04316702|Dopamine Agents|dopamine agents|mesh-ancestor
93289527|NCT01129674|Olanzapine|olanzapine|mesh-list
93289528|NCT01129674|Risperidone|risperidone|mesh-list
93289529|NCT01129674|Aripiprazole|aripiprazole|mesh-list
93289530|NCT01129674|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93289531|NCT01129674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93289532|NCT01129674|Serotonin Agents|serotonin agents|mesh-ancestor
93289533|NCT01129674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289534|NCT01129674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289535|NCT01129674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289536|NCT01129674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93289537|NCT01129674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289538|NCT01129674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289539|NCT01129674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289540|NCT01129674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93289541|NCT01129674|Dopamine Agents|dopamine agents|mesh-ancestor
93289542|NCT01129674|Antiemetics|antiemetics|mesh-ancestor
93289543|NCT01129674|Autonomic Agents|autonomic agents|mesh-ancestor
93289544|NCT01129674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289545|NCT01129674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93289546|NCT01129674|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93289547|NCT01129674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93289548|NCT01129674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289549|NCT01129674|Antidepressive Agents|antidepressive agents|mesh-ancestor
93289550|NCT01129674|Dopamine Agonists|dopamine agonists|mesh-ancestor
93289551|NCT01129674|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93289552|NCT01129674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93289553|NCT01129674|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93289554|NCT01129674|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93289555|NCT05045378|Midazolam|midazolam|mesh-list
93289556|NCT05045378|Ketamine|ketamine|mesh-list
93289557|NCT05045378|Analgesics|analgesics|mesh-ancestor
93289558|NCT05045378|Sensory System Agents|sensory system agents|mesh-ancestor
93289559|NCT05045378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289560|NCT05045378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289561|NCT05045378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93289562|NCT05045378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93289563|NCT05045378|Anesthetics, General|anesthetics, general|mesh-ancestor
93289564|NCT05045378|Anesthetics|anesthetics|mesh-ancestor
93289565|NCT05045378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289566|NCT05045378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93289567|NCT05045378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93289568|NCT05045378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289569|NCT05045378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289570|NCT05045378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93289571|NCT05045378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93289572|NCT05045378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93289573|NCT05045378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289574|NCT05045378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289575|NCT05045378|GABA Modulators|gaba modulators|mesh-ancestor
93289576|NCT05045378|GABA Agents|gaba agents|mesh-ancestor
93289577|NCT05209152|Azacitidine|azacitidine|mesh-list
93289578|NCT05209152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93289579|NCT05209152|Antimetabolites|antimetabolites|mesh-ancestor
93289580|NCT05209152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289581|NCT05209152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289582|NCT05209152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289583|NCT03460964|Pilocarpine|pilocarpine|mesh-list
93289585|NCT03460964|Autonomic Agents|autonomic agents|mesh-ancestor
93289586|NCT03460964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289587|NCT03460964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289588|NCT03460964|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93289589|NCT03460964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93289590|NCT03460964|Cholinergic Agents|cholinergic agents|mesh-ancestor
93289591|NCT03460964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289592|NCT03460964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289593|NCT03460808|Acetylcysteine|acetylcysteine|mesh-list
93289594|NCT03460808|Atorvastatin|atorvastatin|mesh-list
93289595|NCT03460808|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93289596|NCT03460808|Danazol|danazol|mesh-list
93289597|NCT03460808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93289598|NCT03460808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93289599|NCT03460808|Antimetabolites|antimetabolites|mesh-ancestor
93289600|NCT03460808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289601|NCT03460808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93289602|NCT03460808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93289603|NCT03460808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289604|NCT03460808|Antiviral Agents|antiviral agents|mesh-ancestor
93289605|NCT03460808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289606|NCT03460808|Expectorants|expectorants|mesh-ancestor
93289607|NCT03460808|Respiratory System Agents|respiratory system agents|mesh-ancestor
93289608|NCT03460808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93289609|NCT03460808|Antioxidants|antioxidants|mesh-ancestor
93289610|NCT03460808|Protective Agents|protective agents|mesh-ancestor
93289611|NCT03460808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289612|NCT03460808|Antidotes|antidotes|mesh-ancestor
93289613|NCT03460808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93289614|NCT03460808|Hormone Antagonists|hormone antagonists|mesh-ancestor
93289615|NCT03460808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93289616|NCT04946630|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93289617|NCT04946630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93289618|NCT04946630|Autonomic Agents|autonomic agents|mesh-ancestor
93289619|NCT04946630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289620|NCT04946630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289621|NCT04946630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93289622|NCT04946630|Respiratory System Agents|respiratory system agents|mesh-ancestor
93289623|NCT04946630|Glucocorticoids|glucocorticoids|mesh-ancestor
93289624|NCT04946630|Hormones|hormones|mesh-ancestor
93289625|NCT04946630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93289626|NCT04946630|Sympathomimetics|sympathomimetics|mesh-ancestor
93289627|NCT00900900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93289628|NCT00900900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93289629|NCT00900900|Immunologic Factors|immunologic factors|mesh-ancestor
93289630|NCT00900900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289631|NCT03460730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93289632|NCT03460730|Immunologic Factors|immunologic factors|mesh-ancestor
93289633|NCT03460730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289634|NCT05627778|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93289635|NCT05627778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93289636|NCT05627778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289637|NCT01120470|Prednisone|prednisone|mesh-list
93289638|NCT01120470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93289639|NCT01120470|Glucocorticoids|glucocorticoids|mesh-ancestor
93289640|NCT01120470|Hormones|hormones|mesh-ancestor
93289641|NCT01120470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93289642|NCT01120470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289643|NCT01120470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93289644|NCT01120470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289645|NCT01117584|Metformin|metformin|mesh-list
93289646|NCT01117584|Ipragliflozin|ipragliflozin|mesh-list
93289647|NCT01117584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93289648|NCT01117584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289649|NCT01117584|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93289650|NCT01117584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289651|NCT03135054|Homoharringtonine|homoharringtonine|mesh-list
93289652|NCT03135054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93289653|NCT03135054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289654|NCT03135054|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93289655|NCT03135054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289656|NCT03135054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289657|NCT00991068|Lidocaine|lidocaine|mesh-list
93289658|NCT00991068|Tetracaine|tetracaine|mesh-list
93289659|NCT00991068|Anesthetics, Local|anesthetics, local|mesh-ancestor
93289660|NCT00991068|Anesthetics|anesthetics|mesh-ancestor
93289661|NCT00991068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289662|NCT00991068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289663|NCT00991068|Sensory System Agents|sensory system agents|mesh-ancestor
93289664|NCT00991068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289665|NCT00991068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93289666|NCT00991068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93289667|NCT00991068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93289668|NCT00991068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289669|NCT00991068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289670|NCT01114698|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93289671|NCT01114698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93289672|NCT01114698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93289673|NCT01114698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289674|NCT01114698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289675|NCT01114698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289676|NCT01114698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289677|NCT01114698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93289678|NCT01114698|Antidepressive Agents|antidepressive agents|mesh-ancestor
93289679|NCT01114698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289680|NCT01114308|Buprenorphine|buprenorphine|mesh-list
93289681|NCT01114308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93289682|NCT01114308|Narcotics|narcotics|mesh-ancestor
93289683|NCT01114308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289684|NCT01114308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289685|NCT01114308|Analgesics|analgesics|mesh-ancestor
93289686|NCT01114308|Sensory System Agents|sensory system agents|mesh-ancestor
93289687|NCT01114308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289688|NCT01114308|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93289689|NCT05469126|Clarithromycin|clarithromycin|mesh-list
93289690|NCT05469126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93289691|NCT05469126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289692|NCT05469126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93289693|NCT05469126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289694|NCT05469126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289695|NCT05469126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93289696|NCT05469126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93289697|NCT00887250|Losartan|losartan|mesh-list
93289698|NCT00887250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93289699|NCT00887250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93289700|NCT00887250|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93289701|NCT00887250|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93289702|NCT00887250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289703|NCT00990912|Carboplatin|carboplatin|mesh-list
93289704|NCT00990912|Irinotecan|irinotecan|mesh-list
93289705|NCT00990912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289706|NCT00990912|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93289707|NCT00990912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93289708|NCT00990912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289709|NCT00990912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289710|NCT00973284|Mannitol|mannitol|mesh-list
93289711|NCT00973284|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93289712|NCT00973284|Diuretics|diuretics|mesh-ancestor
93289713|NCT00973284|Natriuretic Agents|natriuretic agents|mesh-ancestor
93289714|NCT00973284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289715|NCT02599402|Nivolumab|nivolumab|mesh-list
93289716|NCT02599402|Ipilimumab|ipilimumab|mesh-list
92961744|NCT00400946|Antiemetics|antiemetics|mesh-ancestor
93289717|NCT02599402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289718|NCT02599402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289719|NCT02599402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93289720|NCT02599402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289721|NCT00879762|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93289722|NCT00879762|Antiviral Agents|antiviral agents|mesh-ancestor
93289723|NCT00879762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289725|NCT04768166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289726|NCT04768166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289727|NCT04768166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93289728|NCT04768166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93289729|NCT04768166|Antiviral Agents|antiviral agents|mesh-ancestor
93289730|NCT04768166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289731|NCT04768166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93289732|NCT04768166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93289733|NCT04768166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289734|NCT04822090|Immunoglobulins|immunoglobulins|mesh-list
93289735|NCT04822090|Antibodies|antibodies|mesh-list
93289736|NCT04822090|gamma-Globulins|gamma-globulins|mesh-list
93289737|NCT04822090|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93289738|NCT04822090|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93289739|NCT04822090|Immunologic Factors|immunologic factors|mesh-ancestor
93289740|NCT04822090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289741|NCT03463382|Bupivacaine|bupivacaine|mesh-list
93289742|NCT03463382|Anesthetics, Local|anesthetics, local|mesh-ancestor
93289743|NCT03463382|Anesthetics|anesthetics|mesh-ancestor
93289744|NCT03463382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289745|NCT03463382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289746|NCT03463382|Sensory System Agents|sensory system agents|mesh-ancestor
93289747|NCT03463382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289748|NCT05618236|Atropine|atropine|mesh-list
93289749|NCT05618236|Neostigmine|neostigmine|mesh-list
93289750|NCT05618236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93289751|NCT05618236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93289752|NCT05618236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93289753|NCT05618236|Autonomic Agents|autonomic agents|mesh-ancestor
93289754|NCT05618236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289755|NCT05618236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289756|NCT05618236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93289757|NCT05618236|Respiratory System Agents|respiratory system agents|mesh-ancestor
93289758|NCT05618236|Mydriatics|mydriatics|mesh-ancestor
93289759|NCT05618236|Parasympatholytics|parasympatholytics|mesh-ancestor
93289760|NCT05618236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93289761|NCT05618236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93289762|NCT05618236|Cholinergic Agents|cholinergic agents|mesh-ancestor
93289763|NCT05618236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289764|NCT05618236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289765|NCT05618236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93289766|NCT05618236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289767|NCT05618236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93289768|NCT00872430|Laxatives|laxatives|mesh-list
93289769|NCT00872430|Cathartics|cathartics|mesh-list
93289770|NCT00872430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93289771|NCT00871182|Tiotropium Bromide|tiotropium bromide|mesh-list
93289772|NCT00871182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93289773|NCT00871182|Autonomic Agents|autonomic agents|mesh-ancestor
93289774|NCT00871182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289775|NCT00871182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289776|NCT00871182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93289777|NCT00871182|Respiratory System Agents|respiratory system agents|mesh-ancestor
93289778|NCT00871182|Parasympatholytics|parasympatholytics|mesh-ancestor
93289779|NCT00871182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93289780|NCT00871182|Cholinergic Agents|cholinergic agents|mesh-ancestor
93289781|NCT00871182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289782|NCT00871182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289783|NCT04814056|Afatinib|afatinib|mesh-list
93289784|NCT04814056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289785|NCT04814056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93289786|NCT04814056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289787|NCT04814056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289788|NCT05627154|Citalopram|citalopram|mesh-list
93289789|NCT05627154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93289790|NCT05627154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93289791|NCT05627154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289792|NCT05627154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289793|NCT05627154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289794|NCT05627154|Serotonin Agents|serotonin agents|mesh-ancestor
93289795|NCT05627154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289796|NCT05627154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93289797|NCT05627154|Antidepressive Agents|antidepressive agents|mesh-ancestor
93289798|NCT05627154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289799|NCT03974854|Gemcitabine|gemcitabine|mesh-list
92584282|NCT00297661|Sirolimus|sirolimus|mesh-list
93289800|NCT03974854|Capecitabine|capecitabine|mesh-list
93289801|NCT03974854|Irinotecan|irinotecan|mesh-list
93289802|NCT03974854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93289803|NCT03974854|Antimetabolites|antimetabolites|mesh-ancestor
93289804|NCT03974854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289805|NCT03974854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289806|NCT03974854|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93289807|NCT03974854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93289808|NCT03974854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289809|NCT00957918|Nicotine|nicotine|mesh-list
93289810|NCT00957918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93289811|NCT00957918|Autonomic Agents|autonomic agents|mesh-ancestor
93289812|NCT00957918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289813|NCT00957918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289814|NCT00957918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93289815|NCT00957918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93289816|NCT00957918|Cholinergic Agents|cholinergic agents|mesh-ancestor
93289817|NCT00957918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289818|NCT00957918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289819|NCT02734862|Fluconazole|fluconazole|mesh-list
93289820|NCT02734862|Caspofungin|caspofungin|mesh-list
93289821|NCT02734862|Rezafungin|rezafungin|mesh-list
93289822|NCT02734862|Antifungal Agents|antifungal agents|mesh-ancestor
93289823|NCT02734862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93289824|NCT02734862|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93289825|NCT02734862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93289826|NCT02734862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289827|NCT02734862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289828|NCT02734862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93289829|NCT02734862|Hormone Antagonists|hormone antagonists|mesh-ancestor
93289830|NCT02734862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93289831|NCT02734862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289832|NCT02734862|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93289833|NCT02734862|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93289834|NCT00818844|Nepafenac|nepafenac|mesh-list
93289835|NCT00818844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93289836|NCT00818844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93289837|NCT00818844|Analgesics|analgesics|mesh-ancestor
93289838|NCT00818844|Sensory System Agents|sensory system agents|mesh-ancestor
93289839|NCT00818844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289840|NCT00818844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289841|NCT00818844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93289842|NCT00818844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93289843|NCT00862524|Gemcitabine|gemcitabine|mesh-list
93289844|NCT00862524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93289845|NCT00862524|Antimetabolites|antimetabolites|mesh-ancestor
93289846|NCT00862524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289847|NCT00862524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289848|NCT00858702|Olmesartan|olmesartan|mesh-list
93289849|NCT00858702|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93289850|NCT00858702|Diuretics|diuretics|mesh-list
93289851|NCT00858702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93289852|NCT00858702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93289853|NCT00858702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93289854|NCT00858702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289855|NCT00858702|Natriuretic Agents|natriuretic agents|mesh-ancestor
93289856|NCT00858702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289857|NCT00817986|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
93289858|NCT00817986|Baclofen|baclofen|mesh-list
93289859|NCT00817986|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93289860|NCT00817986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289861|NCT00817986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93289862|NCT00817986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961899|NCT00926055|Ezetimibe|ezetimibe|mesh-list
93289863|NCT00817986|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93289864|NCT00817986|GABA Agonists|gaba agonists|mesh-ancestor
93289865|NCT00817986|GABA Agents|gaba agents|mesh-ancestor
93289866|NCT00817986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289867|NCT00817986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289868|NCT02598934|Ibandronic Acid|ibandronic acid|mesh-list
93289869|NCT02598934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93289870|NCT02598934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289871|NCT00817362|Trastuzumab|trastuzumab|mesh-list
93289872|NCT00817362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289873|NCT00817362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289874|NCT04176848|Durvalumab|durvalumab|mesh-list
93289875|NCT04176848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93289876|NCT04176848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289877|NCT04163978|Budesonide|budesonide|mesh-list
93289878|NCT04163978|Nitric Oxide|nitric oxide|mesh-list
93289879|NCT04163978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93289880|NCT04163978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93289881|NCT04163978|Autonomic Agents|autonomic agents|mesh-ancestor
93289882|NCT04163978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289883|NCT04163978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289884|NCT04163978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93289885|NCT04163978|Respiratory System Agents|respiratory system agents|mesh-ancestor
93289886|NCT04163978|Glucocorticoids|glucocorticoids|mesh-ancestor
93289887|NCT04163978|Hormones|hormones|mesh-ancestor
93289888|NCT04163978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93289889|NCT04163978|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93289890|NCT04163978|Antioxidants|antioxidants|mesh-ancestor
93289891|NCT04163978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289892|NCT04163978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289893|NCT04163978|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93289894|NCT04163978|Vasodilator Agents|vasodilator agents|mesh-ancestor
93289895|NCT04163978|Gasotransmitters|gasotransmitters|mesh-ancestor
93289896|NCT04163978|Protective Agents|protective agents|mesh-ancestor
93289897|NCT02598622|Acetylcarnitine|acetylcarnitine|mesh-list
93289898|NCT02598622|Vitamin B Complex|vitamin b complex|mesh-ancestor
93289899|NCT02598622|Vitamins|vitamins|mesh-ancestor
93289900|NCT02598622|Micronutrients|micronutrients|mesh-ancestor
93289901|NCT02598622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289902|NCT02598622|Nootropic Agents|nootropic agents|mesh-ancestor
93289903|NCT03463070|Misoprostol|misoprostol|mesh-list
93289904|NCT03463070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93289905|NCT03463070|Abortifacient Agents|abortifacient agents|mesh-ancestor
93289906|NCT03463070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93289907|NCT03463070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289908|NCT03463070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93289909|NCT03463070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93289910|NCT03463070|Oxytocics|oxytocics|mesh-ancestor
93289911|NCT00807612|Paclitaxel|paclitaxel|mesh-list
93289912|NCT00807612|Carboplatin|carboplatin|mesh-list
93289913|NCT00807612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93289914|NCT00807612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93289915|NCT00807612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93289916|NCT00807612|Tubulin Modulators|tubulin modulators|mesh-ancestor
93289917|NCT00807612|Antimitotic Agents|antimitotic agents|mesh-ancestor
93289918|NCT00807612|Mitosis Modulators|mitosis modulators|mesh-ancestor
93289919|NCT00807612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289920|NCT00807612|Immunologic Factors|immunologic factors|mesh-ancestor
93289921|NCT00807612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289922|NCT00805350|SR 46349B|sr 46349b|mesh-list
93289923|NCT00805350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93289924|NCT00805350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93289925|NCT00805350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289926|NCT00805350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93289927|NCT00805350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93289928|NCT00805350|Serotonin Agents|serotonin agents|mesh-ancestor
93289929|NCT00805350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289930|NCT00805350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289931|NCT04546178|Antipsychotic Agents|antipsychotic agents|mesh-list
93289932|NCT04546178|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93289933|NCT04546178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289934|NCT04546178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289935|NCT04546178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289936|NCT03462836|Lidocaine|lidocaine|mesh-list
93289937|NCT03462836|Ketamine|ketamine|mesh-list
93289938|NCT03462836|Anesthetics, Local|anesthetics, local|mesh-ancestor
93289939|NCT03462836|Anesthetics|anesthetics|mesh-ancestor
93289940|NCT03462836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93289941|NCT03462836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289942|NCT03462836|Sensory System Agents|sensory system agents|mesh-ancestor
93289943|NCT03462836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289944|NCT03462836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93289945|NCT03462836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93289946|NCT03462836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93289947|NCT03462836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289948|NCT03462836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289949|NCT03462836|Analgesics|analgesics|mesh-ancestor
93289950|NCT03462836|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93289951|NCT03462836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93289952|NCT03462836|Anesthetics, General|anesthetics, general|mesh-ancestor
93289953|NCT03462836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93289954|NCT03462836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93289955|NCT03462836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289956|NCT00849576|Insulin|insulin|mesh-list
93289957|NCT00849576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93289958|NCT00849576|Insulin Lispro|insulin lispro|mesh-list
93289959|NCT00849576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93289960|NCT00849576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289961|NCT00841698|Paroxetine|paroxetine|mesh-list
93289962|NCT00841698|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93289963|NCT00841698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93289964|NCT00841698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289965|NCT00841698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289966|NCT00841698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289967|NCT00841698|Serotonin Agents|serotonin agents|mesh-ancestor
93289968|NCT00841698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289969|NCT00841698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93289970|NCT00841698|Antidepressive Agents|antidepressive agents|mesh-ancestor
93289971|NCT00841698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93289972|NCT00841698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93289973|NCT00841698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93289974|NCT00841698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93289975|NCT04383002|Nitric Oxide|nitric oxide|mesh-list
93289976|NCT04383002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93289977|NCT04383002|Autonomic Agents|autonomic agents|mesh-ancestor
93289978|NCT04383002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93289979|NCT04383002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289980|NCT04383002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93289981|NCT04383002|Respiratory System Agents|respiratory system agents|mesh-ancestor
93289982|NCT04383002|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93289983|NCT04383002|Antioxidants|antioxidants|mesh-ancestor
93289984|NCT04383002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289985|NCT04383002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93289986|NCT04383002|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93289987|NCT04383002|Vasodilator Agents|vasodilator agents|mesh-ancestor
93289988|NCT04383002|Gasotransmitters|gasotransmitters|mesh-ancestor
93289989|NCT04383002|Protective Agents|protective agents|mesh-ancestor
93289990|NCT00841542|Amlodipine|amlodipine|mesh-list
93289991|NCT00841542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93289992|NCT00841542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93289993|NCT00841542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93289994|NCT00841542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93289995|NCT00841542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93289996|NCT00841542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93289997|NCT00841542|Vasodilator Agents|vasodilator agents|mesh-ancestor
93289998|NCT03623750|Cyclophosphamide|cyclophosphamide|mesh-list
93289999|NCT03623750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290000|NCT03623750|Immunologic Factors|immunologic factors|mesh-ancestor
93290001|NCT03623750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290002|NCT03623750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290003|NCT03623750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93290004|NCT03623750|Alkylating Agents|alkylating agents|mesh-ancestor
93290005|NCT03623750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290006|NCT03623750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290007|NCT03623750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93290008|NCT00840840|Amoxicillin|amoxicillin|mesh-list
93290009|NCT00840840|Clavulanic Acid|clavulanic acid|mesh-list
93290010|NCT00840840|Clavulanic Acids|clavulanic acids|mesh-list
93290011|NCT00840840|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93290012|NCT00840840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290013|NCT00840840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290014|NCT00840840|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93290015|NCT00840840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290016|NCT00840840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290017|NCT03595982|Nifedipine|nifedipine|mesh-list
93290018|NCT03595982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93290019|NCT03595982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93290020|NCT03595982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290021|NCT03595982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93290022|NCT03595982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290023|NCT03595982|Vasodilator Agents|vasodilator agents|mesh-ancestor
93290024|NCT03595982|Tocolytic Agents|tocolytic agents|mesh-ancestor
93290025|NCT03595982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93290026|NCT00944970|Adenosine|adenosine|mesh-list
93290027|NCT00944970|Binodenoson|binodenoson|mesh-list
93290028|NCT00944970|Analgesics|analgesics|mesh-ancestor
93290029|NCT00944970|Sensory System Agents|sensory system agents|mesh-ancestor
93290030|NCT00944970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290031|NCT00944970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290032|NCT00944970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93290033|NCT00944970|Vasodilator Agents|vasodilator agents|mesh-ancestor
93290034|NCT00944970|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93290035|NCT00944970|Purinergic Agonists|purinergic agonists|mesh-ancestor
93290036|NCT00944970|Purinergic Agents|purinergic agents|mesh-ancestor
93290037|NCT00944970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290038|NCT00944970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290039|NCT00840216|Clarithromycin|clarithromycin|mesh-list
93290040|NCT00840216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290041|NCT00840216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290042|NCT00840216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93290043|NCT00840216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290044|NCT00840216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290045|NCT00840216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93290046|NCT00840216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93290047|NCT03462446|Vitamin K|vitamin k|mesh-list
93290048|NCT03462446|Rivaroxaban|rivaroxaban|mesh-list
93290049|NCT03462446|Vitamins|vitamins|mesh-ancestor
93290050|NCT03462446|Micronutrients|micronutrients|mesh-ancestor
93290051|NCT03462446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290052|NCT03462446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93290053|NCT03462446|Antithrombins|antithrombins|mesh-ancestor
93290054|NCT03462446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93290055|NCT03462446|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290056|NCT03462446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290057|NCT03462446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290058|NCT03462446|Anticoagulants|anticoagulants|mesh-ancestor
93290059|NCT03462446|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93290060|NCT03462446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93290061|NCT03462446|Hemostatics|hemostatics|mesh-ancestor
93290062|NCT03462446|Coagulants|coagulants|mesh-ancestor
93290063|NCT00944892|Fasinumab|fasinumab|mesh-list
93290064|NCT00944892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93290065|NCT00944892|Analgesics|analgesics|mesh-ancestor
93290066|NCT00944892|Sensory System Agents|sensory system agents|mesh-ancestor
93290067|NCT00944892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290068|NCT00944892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290069|NCT00939276|Nepafenac|nepafenac|mesh-list
93290070|NCT00939276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93290071|NCT00939276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93290072|NCT00939276|Analgesics|analgesics|mesh-ancestor
93290073|NCT00939276|Sensory System Agents|sensory system agents|mesh-ancestor
93290074|NCT00939276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290075|NCT00939276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290076|NCT00939276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290077|NCT00939276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290078|NCT03455426|Letrozole|letrozole|mesh-list
93290079|NCT03455426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290080|NCT03455426|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93290081|NCT03455426|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93290082|NCT03455426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290083|NCT03455426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290084|NCT03455426|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92962119|NCT00745004|Serotonin Agents|serotonin agents|mesh-ancestor
93290085|NCT03455426|Hormone Antagonists|hormone antagonists|mesh-ancestor
93290086|NCT03455426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290087|NCT03455426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290088|NCT03453632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93290089|NCT03453632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93290090|NCT03453632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93290091|NCT03453632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290092|NCT03453632|Cholinergic Agents|cholinergic agents|mesh-ancestor
93290093|NCT03453632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290094|NCT03453632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290095|NCT00791154|Carboplatin|carboplatin|mesh-list
93290096|NCT00791154|Etoposide|etoposide|mesh-list
93290097|NCT00791154|Rilotumumab|rilotumumab|mesh-list
93290098|NCT00791154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290099|NCT00791154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93290100|NCT00791154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93290101|NCT00791154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93290102|NCT00791154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290103|NCT00791154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290104|NCT00791154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290105|NCT00938652|Carboplatin|carboplatin|mesh-list
93290106|NCT00938652|Gemcitabine|gemcitabine|mesh-list
93290107|NCT00938652|Iniparib|iniparib|mesh-list
93290108|NCT00938652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290109|NCT00938652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290110|NCT00938652|Antimetabolites|antimetabolites|mesh-ancestor
93290111|NCT00938652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290112|NCT00938652|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93290113|NCT00938652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290114|NCT00928590|Timolol|timolol|mesh-list
93290115|NCT00928590|Travoprost|travoprost|mesh-list
93290116|NCT00928590|Cloprostenol|cloprostenol|mesh-list
93290117|NCT00928590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290118|NCT00928590|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93290119|NCT00928590|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93290120|NCT00928590|Adrenergic Agents|adrenergic agents|mesh-ancestor
93290121|NCT00928590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290122|NCT00928590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290123|NCT00928590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93290124|NCT00928590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93290125|NCT00928590|Luteolytic Agents|luteolytic agents|mesh-ancestor
93290126|NCT00928590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93290127|NCT00928590|Contraceptive Agents|contraceptive agents|mesh-ancestor
93290128|NCT00928590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93290129|NCT00928590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93290130|NCT03512756|Sirolimus|sirolimus|mesh-list
93290131|NCT03512756|Gemcitabine|gemcitabine|mesh-list
93290132|NCT03512756|Capecitabine|capecitabine|mesh-list
93290133|NCT03512756|Phenytoin|phenytoin|mesh-list
93290134|NCT03512756|Methoxsalen|methoxsalen|mesh-list
93290135|NCT03512756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290136|NCT03512756|Antimetabolites|antimetabolites|mesh-ancestor
93290137|NCT03512756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290138|NCT03512756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290139|NCT03512756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290140|NCT03512756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290141|NCT03512756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93290142|NCT03512756|Antifungal Agents|antifungal agents|mesh-ancestor
93290143|NCT03512756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290144|NCT03512756|Immunologic Factors|immunologic factors|mesh-ancestor
93290145|NCT03512756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290146|NCT03512756|Anticonvulsants|anticonvulsants|mesh-ancestor
93290147|NCT03512756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93290148|NCT03512756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93290149|NCT03512756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93290150|NCT03512756|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93290151|NCT03512756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93290152|NCT03512756|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93290153|NCT03512756|Dermatologic Agents|dermatologic agents|mesh-ancestor
93290154|NCT04697940|Cyclophosphamide|cyclophosphamide|mesh-list
93290155|NCT04697940|Fludarabine|fludarabine|mesh-list
93290156|NCT04697940|Fludarabine phosphate|fludarabine phosphate|mesh-list
93290157|NCT04697940|Decitabine|decitabine|mesh-list
93290158|NCT04697940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290159|NCT04697940|Immunologic Factors|immunologic factors|mesh-ancestor
93290160|NCT04697940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290162|NCT04697940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93290163|NCT04697940|Alkylating Agents|alkylating agents|mesh-ancestor
93290164|NCT04697940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290165|NCT04697940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290166|NCT04697940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93290167|NCT04697940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290168|NCT04697940|Antimetabolites|antimetabolites|mesh-ancestor
93290169|NCT04697940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290170|NCT00836706|Clarithromycin|clarithromycin|mesh-list
93290171|NCT00836706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290172|NCT00836706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290173|NCT00836706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93290174|NCT00836706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290175|NCT00836706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290176|NCT00836706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93290177|NCT00836706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93290178|NCT00836472|Metformin|metformin|mesh-list
93290179|NCT00836472|Glyburide|glyburide|mesh-list
93290180|NCT00836472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93290181|NCT00836472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290182|NCT04473846|Anesthetics|anesthetics|mesh-list
93290183|NCT04473846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290184|NCT04473846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290185|NCT03129698|Apatinib|apatinib|mesh-list
93290186|NCT03129698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290187|NCT03129698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93290188|NCT03129698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290189|NCT03129698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290190|NCT03355118|Anesthetics|anesthetics|mesh-list
93290191|NCT03355118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290192|NCT03355118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290193|NCT03263078|Propofol|propofol|mesh-list
93290194|NCT03263078|Sevoflurane|sevoflurane|mesh-list
93290195|NCT03263078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93290196|NCT03263078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290197|NCT03263078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290198|NCT03263078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93290199|NCT03263078|Anesthetics, General|anesthetics, general|mesh-ancestor
93290200|NCT03263078|Anesthetics|anesthetics|mesh-ancestor
93290201|NCT03263078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93290202|NCT03263078|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93290203|NCT05349006|Azathioprine|azathioprine|mesh-list
93290204|NCT05349006|Antimetabolites|antimetabolites|mesh-ancestor
93290205|NCT05349006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290206|NCT05349006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290207|NCT05349006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290208|NCT05349006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290209|NCT05349006|Immunologic Factors|immunologic factors|mesh-ancestor
93290210|NCT05349006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290211|NCT05349006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290212|NCT00785226|Sorafenib|sorafenib|mesh-list
93290213|NCT00785226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290214|NCT00785226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93290215|NCT00785226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290216|NCT00785226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290217|NCT02598388|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93290218|NCT02598388|Antiviral Agents|antiviral agents|mesh-ancestor
93290219|NCT02598388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290220|NCT03448640|Tropicamide|tropicamide|mesh-list
93290221|NCT03448640|Mydriatics|mydriatics|mesh-ancestor
93290222|NCT03448640|Autonomic Agents|autonomic agents|mesh-ancestor
93290223|NCT03448640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290224|NCT03448640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290225|NCT03448640|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93290226|NCT03448640|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93290227|NCT03448640|Cholinergic Agents|cholinergic agents|mesh-ancestor
93290228|NCT03448640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290229|NCT03448640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290230|NCT00836004|Clindamycin|clindamycin|mesh-list
93290231|NCT00836004|Clindamycin palmitate|clindamycin palmitate|mesh-list
93290232|NCT00836004|Clindamycin phosphate|clindamycin phosphate|mesh-list
93290233|NCT00836004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290234|NCT00836004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290235|NCT00836004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93290236|NCT00836004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290237|NCT00836004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290238|NCT00917826|Valganciclovir|valganciclovir|mesh-list
93290239|NCT00917826|Ganciclovir|ganciclovir|mesh-list
93290240|NCT00917826|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93290241|NCT00917826|Arginine butyrate|arginine butyrate|mesh-list
93290242|NCT00917826|Antiviral Agents|antiviral agents|mesh-ancestor
93290243|NCT00917826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290244|NCT00917826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93290245|NCT00917826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290246|NCT00917826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290247|NCT00917826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290248|NCT04819906|Moxifloxacin|moxifloxacin|mesh-list
93290249|NCT04819906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290250|NCT04819906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290251|NCT04819906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93290252|NCT04819906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93290253|NCT04819906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290254|NCT04819906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290255|NCT04819906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290256|NCT03102320|Gemcitabine|gemcitabine|mesh-list
93290257|NCT03102320|Maytansine|maytansine|mesh-list
93290258|NCT03102320|Anetumab ravtansine|anetumab ravtansine|mesh-list
93290259|NCT03102320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290260|NCT03102320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290261|NCT03102320|Antimetabolites|antimetabolites|mesh-ancestor
93290262|NCT03102320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290263|NCT03102320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93290264|NCT03102320|Tubulin Modulators|tubulin modulators|mesh-ancestor
93290265|NCT03102320|Antimitotic Agents|antimitotic agents|mesh-ancestor
93290266|NCT03102320|Mitosis Modulators|mitosis modulators|mesh-ancestor
93290267|NCT03102320|Immunoconjugates|immunoconjugates|mesh-ancestor
93290268|NCT03102320|Immunologic Factors|immunologic factors|mesh-ancestor
93290269|NCT03102320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290270|NCT00835692|Clarithromycin|clarithromycin|mesh-list
93290271|NCT00835692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290272|NCT00835692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290273|NCT00835692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93290274|NCT00835692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290275|NCT00835692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290276|NCT00835692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93290277|NCT00835692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93290278|NCT00835614|Cefprozil|cefprozil|mesh-list
93290279|NCT00835614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290280|NCT00835614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290281|NCT00835536|Ribavirin|ribavirin|mesh-list
93290282|NCT00835536|Antimetabolites|antimetabolites|mesh-ancestor
93290283|NCT00835536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290284|NCT00835536|Antiviral Agents|antiviral agents|mesh-ancestor
93290285|NCT00835536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290286|NCT04561362|Pembrolizumab|pembrolizumab|mesh-list
93290287|NCT04561362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290288|NCT04561362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290289|NCT04561362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93290290|NCT04561362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290291|NCT04060628|Docetaxel|docetaxel|mesh-list
93290292|NCT04060628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290293|NCT04060628|Tubulin Modulators|tubulin modulators|mesh-ancestor
93290294|NCT04060628|Antimitotic Agents|antimitotic agents|mesh-ancestor
93290295|NCT04060628|Mitosis Modulators|mitosis modulators|mesh-ancestor
93290296|NCT04060628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290297|NCT04356664|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93290298|NCT04356664|Luteolytic Agents|luteolytic agents|mesh-ancestor
93290299|NCT04356664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93290300|NCT04356664|Contraceptive Agents|contraceptive agents|mesh-ancestor
93290301|NCT04356664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93290302|NCT04356664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290303|NCT04356664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93290304|NCT04356664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962346|NCT00926835|Dopamine Agents|dopamine agents|mesh-ancestor
93290305|NCT04356664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290306|NCT04037072|Mitomycins|mitomycins|mesh-list
93290307|NCT04037072|Mitomycin|mitomycin|mesh-list
93290308|NCT04037072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93290309|NCT04037072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290310|NCT04037072|Alkylating Agents|alkylating agents|mesh-ancestor
93290311|NCT04037072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290312|NCT04037072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93290313|NCT04037072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290314|NCT04819438|Riluzole|riluzole|mesh-list
93290315|NCT04819438|Anticonvulsants|anticonvulsants|mesh-ancestor
93290316|NCT04819438|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93290317|NCT04819438|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93290318|NCT04819438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290319|NCT04819438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290320|NCT04819438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290321|NCT04819438|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93290322|NCT04819438|Protective Agents|protective agents|mesh-ancestor
93290323|NCT05616910|Nitric Oxide|nitric oxide|mesh-list
93290324|NCT05616910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93290325|NCT05616910|Autonomic Agents|autonomic agents|mesh-ancestor
93290326|NCT05616910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290327|NCT05616910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290328|NCT05616910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93290329|NCT05616910|Respiratory System Agents|respiratory system agents|mesh-ancestor
93290330|NCT05616910|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93290331|NCT05616910|Antioxidants|antioxidants|mesh-ancestor
93290332|NCT05616910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290333|NCT05616910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290334|NCT05616910|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93290335|NCT05616910|Vasodilator Agents|vasodilator agents|mesh-ancestor
93290336|NCT05616910|Gasotransmitters|gasotransmitters|mesh-ancestor
93290337|NCT05616910|Protective Agents|protective agents|mesh-ancestor
93290338|NCT04537026|Dexamethasone|dexamethasone|mesh-list
93290339|NCT04537026|Dexamethasone acetate|dexamethasone acetate|mesh-list
93290340|NCT04537026|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93290341|NCT04537026|BB 1101|bb 1101|mesh-list
93290342|NCT04537026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290343|NCT04537026|Antiemetics|antiemetics|mesh-ancestor
93290344|NCT04537026|Autonomic Agents|autonomic agents|mesh-ancestor
93290345|NCT04537026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290346|NCT04537026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290347|NCT04537026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290348|NCT04537026|Glucocorticoids|glucocorticoids|mesh-ancestor
93290349|NCT04537026|Hormones|hormones|mesh-ancestor
92584852|NCT04943627|Pemetrexed|pemetrexed|mesh-list
93290350|NCT04537026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290351|NCT04537026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93290352|NCT04537026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290353|NCT04537026|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290354|NCT04537026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290355|NCT04537026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290356|NCT04819828|Diclofenac|diclofenac|mesh-list
93290357|NCT04819828|Tamsulosin|tamsulosin|mesh-list
93290358|NCT04819828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93290359|NCT04819828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93290360|NCT04819828|Analgesics|analgesics|mesh-ancestor
93290361|NCT04819828|Sensory System Agents|sensory system agents|mesh-ancestor
93290362|NCT04819828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290363|NCT04819828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290364|NCT04819828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290365|NCT04819828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290366|NCT04819828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93290367|NCT04819828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290368|NCT04819828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290369|NCT04819828|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93290370|NCT04819828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93290371|NCT04819828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93290372|NCT04819828|Adrenergic Agents|adrenergic agents|mesh-ancestor
93290373|NCT04819828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290374|NCT04819828|Urological Agents|urological agents|mesh-ancestor
93290375|NCT02602288|Nicotine|nicotine|mesh-list
93290376|NCT02602288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93290377|NCT02602288|Autonomic Agents|autonomic agents|mesh-ancestor
93290378|NCT02602288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290379|NCT02602288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962420|NCT00930189|Triamcinolone|triamcinolone|mesh-list
93290380|NCT02602288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93290381|NCT02602288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93290382|NCT02602288|Cholinergic Agents|cholinergic agents|mesh-ancestor
93290383|NCT02602288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290384|NCT02602288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290385|NCT03745352|Azacitidine|azacitidine|mesh-list
93290386|NCT03745352|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93290387|NCT03745352|Pevonedistat|pevonedistat|mesh-list
93290388|NCT03745352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290389|NCT03745352|Antimetabolites|antimetabolites|mesh-ancestor
93290390|NCT03745352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290391|NCT03745352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290392|NCT03740126|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93290393|NCT03740126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93290394|NCT03740126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290395|NCT05617690|Propofol|propofol|mesh-list
93290396|NCT05617690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93290397|NCT05617690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290398|NCT05617690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290399|NCT05617690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93290400|NCT05617690|Anesthetics, General|anesthetics, general|mesh-ancestor
93290401|NCT05617690|Anesthetics|anesthetics|mesh-ancestor
93290402|NCT03448094|Resveratrol|resveratrol|mesh-list
93290403|NCT03448094|Antioxidants|antioxidants|mesh-ancestor
93290404|NCT03448094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290405|NCT03448094|Protective Agents|protective agents|mesh-ancestor
93290406|NCT03448094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290407|NCT03448094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290408|NCT03448094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93290409|NCT04819204|Cetrorelix|cetrorelix|mesh-list
93290410|NCT04819204|Testosterone|testosterone|mesh-list
93290411|NCT04819204|Androgens|androgens|mesh-ancestor
93290412|NCT04819204|Hormones|hormones|mesh-ancestor
93290413|NCT04819204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290414|NCT04819204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290415|NCT04819204|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93290416|NCT04819204|Fertility Agents|fertility agents|mesh-ancestor
93290417|NCT04819204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93290418|NCT04819204|Hormone Antagonists|hormone antagonists|mesh-ancestor
93290419|NCT02807454|Dexamethasone|dexamethasone|mesh-list
93290420|NCT02807454|Durvalumab|durvalumab|mesh-list
93290421|NCT02807454|Daratumumab|daratumumab|mesh-list
93290422|NCT02807454|Pomalidomide|pomalidomide|mesh-list
93290423|NCT02807454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290424|NCT02807454|Antiemetics|antiemetics|mesh-ancestor
93290425|NCT02807454|Autonomic Agents|autonomic agents|mesh-ancestor
93290426|NCT02807454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290427|NCT02807454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290428|NCT02807454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290429|NCT02807454|Glucocorticoids|glucocorticoids|mesh-ancestor
93290430|NCT02807454|Hormones|hormones|mesh-ancestor
93290431|NCT02807454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290432|NCT02807454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93290433|NCT02807454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290434|NCT02807454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290435|NCT02807454|Immunologic Factors|immunologic factors|mesh-ancestor
93290436|NCT02807454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93290437|NCT02807454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93290438|NCT02807454|Growth Substances|growth substances|mesh-ancestor
93290439|NCT02807454|Growth Inhibitors|growth inhibitors|mesh-ancestor
93290440|NCT03718286|Alirocumab|alirocumab|mesh-list
93290441|NCT03718286|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93290442|NCT03718286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93290443|NCT03718286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93290444|NCT03718286|Antimetabolites|antimetabolites|mesh-ancestor
93290445|NCT03718286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290446|NCT03718286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93290447|NCT03718286|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290448|NCT03718286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290449|NCT03718286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93290450|NCT05320874|Antibodies|antibodies|mesh-list
93290451|NCT05320874|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93290452|NCT05320874|Immunologic Factors|immunologic factors|mesh-ancestor
93290453|NCT05320874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290454|NCT04501614|Ponatinib|ponatinib|mesh-list
92962490|NCT00686972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290455|NCT04501614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290456|NCT04501614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93290457|NCT04501614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290458|NCT04501614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290459|NCT05320640|Decitabine|decitabine|mesh-list
93290460|NCT05320640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93290461|NCT05320640|Antibodies|antibodies|mesh-list
93290462|NCT05320640|Immunologic Factors|immunologic factors|mesh-ancestor
93290463|NCT05320640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290464|NCT05320640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290465|NCT05320640|Antimetabolites|antimetabolites|mesh-ancestor
93290466|NCT05320640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290467|NCT05320640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290468|NCT05320640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290469|NCT05320640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290470|NCT00835146|Ribavirin|ribavirin|mesh-list
93290471|NCT00835146|Antimetabolites|antimetabolites|mesh-ancestor
93290472|NCT00835146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290473|NCT00835146|Antiviral Agents|antiviral agents|mesh-ancestor
93290474|NCT00835146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290475|NCT04472910|Folfirinox|folfirinox|mesh-list
93290476|NCT04472910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290477|NCT01479842|Rituximab|rituximab|mesh-list
93290478|NCT01479842|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93290479|NCT01479842|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93290480|NCT01479842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290481|NCT01479842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290482|NCT01479842|Immunologic Factors|immunologic factors|mesh-ancestor
93290483|NCT01479842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290484|NCT01479842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290485|NCT01479842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93290486|NCT01479842|Alkylating Agents|alkylating agents|mesh-ancestor
93290487|NCT01479842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290488|NCT01479842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93290489|NCT01479842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290490|NCT04818736|Vaccines|vaccines|mesh-list
93290491|NCT04818736|Immunologic Factors|immunologic factors|mesh-ancestor
93290492|NCT04818736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290493|NCT03719430|Doxorubicin|doxorubicin|mesh-list
93290494|NCT03719430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93290495|NCT03719430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290496|NCT03719430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93290497|NCT03719430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93290498|NCT03719430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290499|NCT03719430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290500|NCT04811326|Latanoprost|latanoprost|mesh-list
93290501|NCT04811326|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93290502|NCT04811326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93290503|NCT00834990|Valproic Acid|valproic acid|mesh-list
93290504|NCT00834990|Anticonvulsants|anticonvulsants|mesh-ancestor
93290505|NCT00834990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290506|NCT00834990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290507|NCT00834990|GABA Agents|gaba agents|mesh-ancestor
93290508|NCT00834990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290509|NCT00834990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290510|NCT00834990|Antimanic Agents|antimanic agents|mesh-ancestor
93290511|NCT00834990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93290512|NCT00834990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290513|NCT00834990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93290514|NCT04479072|Aspirin|aspirin|mesh-list
93290515|NCT04479072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93290516|NCT04479072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93290517|NCT04479072|Analgesics|analgesics|mesh-ancestor
93290518|NCT04479072|Sensory System Agents|sensory system agents|mesh-ancestor
93290519|NCT04479072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290520|NCT04479072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290521|NCT04479072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290522|NCT04479072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290523|NCT04479072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93290524|NCT04479072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93290525|NCT04479072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290526|NCT04479072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93290527|NCT04479072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93290528|NCT04479072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290529|NCT04479072|Antipyretics|antipyretics|mesh-ancestor
93290530|NCT03036202|Epinephrine|epinephrine|mesh-list
93290531|NCT03036202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93290532|NCT03036202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93290533|NCT03036202|Adrenergic Agents|adrenergic agents|mesh-ancestor
93290534|NCT03036202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290535|NCT03036202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290536|NCT03036202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290537|NCT03036202|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93290538|NCT03036202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93290539|NCT03036202|Autonomic Agents|autonomic agents|mesh-ancestor
93290540|NCT03036202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290541|NCT03036202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93290542|NCT03036202|Respiratory System Agents|respiratory system agents|mesh-ancestor
93290544|NCT03036202|Sympathomimetics|sympathomimetics|mesh-ancestor
93290545|NCT03036202|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93290546|NCT03245918|Aprepitant|aprepitant|mesh-list
93290547|NCT03245918|Fosaprepitant|fosaprepitant|mesh-list
93290548|NCT03245918|Antiemetics|antiemetics|mesh-ancestor
93290549|NCT03245918|Autonomic Agents|autonomic agents|mesh-ancestor
93290550|NCT03245918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290551|NCT03245918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290552|NCT03245918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290553|NCT03245918|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93290554|NCT03245918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290555|NCT03245918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290556|NCT02597062|Dexamethasone|dexamethasone|mesh-list
93290557|NCT02597062|Cyclophosphamide|cyclophosphamide|mesh-list
93290558|NCT02597062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290559|NCT02597062|Immunologic Factors|immunologic factors|mesh-ancestor
93290560|NCT02597062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290561|NCT02597062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290562|NCT02597062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93290563|NCT02597062|Alkylating Agents|alkylating agents|mesh-ancestor
93290564|NCT02597062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290565|NCT02597062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290566|NCT02597062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93290567|NCT02597062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290568|NCT02597062|Antiemetics|antiemetics|mesh-ancestor
93290569|NCT02597062|Autonomic Agents|autonomic agents|mesh-ancestor
93290570|NCT02597062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290571|NCT02597062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290572|NCT02597062|Glucocorticoids|glucocorticoids|mesh-ancestor
93290573|NCT02597062|Hormones|hormones|mesh-ancestor
93290574|NCT02597062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290575|NCT02597062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93290576|NCT00834756|Azithromycin|azithromycin|mesh-list
93290577|NCT00834756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290578|NCT00834756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290579|NCT00828854|Entinostat|entinostat|mesh-list
93290580|NCT00828854|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93290581|NCT00828854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93290582|NCT00828854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290583|NCT00828854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290584|NCT00828854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93290585|NCT00828854|Hormone Antagonists|hormone antagonists|mesh-ancestor
93290586|NCT00828854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290587|NCT00828854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290588|NCT00828854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290589|NCT00828854|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93290590|NCT00834522|Granisetron|granisetron|mesh-list
93290591|NCT00834522|Antiemetics|antiemetics|mesh-ancestor
93290592|NCT00834522|Autonomic Agents|autonomic agents|mesh-ancestor
93290593|NCT00834522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290594|NCT00834522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290595|NCT00834522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290596|NCT00834522|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93290597|NCT00834522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93290598|NCT00834522|Serotonin Agents|serotonin agents|mesh-ancestor
93290599|NCT00834522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290600|NCT00834522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290601|NCT00834444|Famciclovir|famciclovir|mesh-list
93290602|NCT00834444|Antiviral Agents|antiviral agents|mesh-ancestor
93290603|NCT00834444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962654|NCT00932685|Midazolam|midazolam|mesh-list
93290604|NCT00834444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93290605|NCT00834444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290606|NCT00834444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290607|NCT05174858|Hemostatics|hemostatics|mesh-list
93290608|NCT05174858|Coagulants|coagulants|mesh-ancestor
93290609|NCT04831294|Cannabidiol|cannabidiol|mesh-list
93290610|NCT04831294|Anticonvulsants|anticonvulsants|mesh-ancestor
93290611|NCT00834132|Azithromycin|azithromycin|mesh-list
93290612|NCT00834132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290613|NCT00834132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290614|NCT00833586|Terbinafine|terbinafine|mesh-list
93290615|NCT00833586|Antifungal Agents|antifungal agents|mesh-ancestor
93290616|NCT00833586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290617|NCT00833586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290618|NCT00833586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290619|NCT02605954|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93290620|NCT02605954|Antiviral Agents|antiviral agents|mesh-ancestor
93290621|NCT02605954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290622|NCT03447470|Nivolumab|nivolumab|mesh-list
93290623|NCT03447470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290624|NCT03447470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290625|NCT03447470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93290626|NCT03447470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290627|NCT04817800|Azelastine|azelastine|mesh-list
93290628|NCT04817800|Beclomethasone|beclomethasone|mesh-list
93290629|NCT04817800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290630|NCT04817800|Glucocorticoids|glucocorticoids|mesh-ancestor
93290631|NCT04817800|Hormones|hormones|mesh-ancestor
93290632|NCT04817800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290633|NCT04817800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290634|NCT04817800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93290635|NCT04817800|Respiratory System Agents|respiratory system agents|mesh-ancestor
93290636|NCT04817800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93290637|NCT04817800|Autonomic Agents|autonomic agents|mesh-ancestor
93290638|NCT04817800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290639|NCT04817800|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93290640|NCT04817800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290641|NCT04817800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290642|NCT04817800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93290643|NCT04817800|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93290644|NCT04817800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93290645|NCT04817800|Histamine Antagonists|histamine antagonists|mesh-ancestor
93290646|NCT04817800|Histamine Agents|histamine agents|mesh-ancestor
93290647|NCT04817800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290648|NCT00765804|Dexamethasone|dexamethasone|mesh-list
93290649|NCT00765804|Citric Acid|citric acid|mesh-list
93290650|NCT00765804|Sodium Citrate|sodium citrate|mesh-list
93290651|NCT00765804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93290652|NCT00765804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93290653|NCT00765804|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93290654|NCT00765804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290655|NCT00765804|Antiemetics|antiemetics|mesh-ancestor
93290656|NCT00765804|Autonomic Agents|autonomic agents|mesh-ancestor
93290657|NCT00765804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290658|NCT00765804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290659|NCT00765804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290660|NCT00765804|Glucocorticoids|glucocorticoids|mesh-ancestor
93290661|NCT00765804|Hormones|hormones|mesh-ancestor
93290662|NCT00765804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290663|NCT00765804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93290664|NCT00765804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290665|NCT00765804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290666|NCT00765804|Anticoagulants|anticoagulants|mesh-ancestor
93290667|NCT00765804|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93290668|NCT00765804|Chelating Agents|chelating agents|mesh-ancestor
93290669|NCT00765804|Sequestering Agents|sequestering agents|mesh-ancestor
93290670|NCT00764634|Vaccines|vaccines|mesh-list
93290671|NCT00764634|Immunologic Factors|immunologic factors|mesh-ancestor
93290672|NCT00764634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290673|NCT04345146|Bevacizumab|bevacizumab|mesh-list
93290674|NCT04345146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290675|NCT04345146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290676|NCT04345146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93290677|NCT04345146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93290678|NCT04345146|Growth Substances|growth substances|mesh-ancestor
92962716|NCT00786552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93290679|NCT04345146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290681|NCT03443726|Epinephrine|epinephrine|mesh-list
93290682|NCT03443726|Carticaine|carticaine|mesh-list
93290683|NCT03443726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93290684|NCT03443726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93290685|NCT03443726|Adrenergic Agents|adrenergic agents|mesh-ancestor
93290686|NCT03443726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290687|NCT03443726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290688|NCT03443726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290689|NCT03443726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93290690|NCT03443726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93290691|NCT03443726|Autonomic Agents|autonomic agents|mesh-ancestor
93290692|NCT03443726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290693|NCT03443726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93290694|NCT03443726|Respiratory System Agents|respiratory system agents|mesh-ancestor
93290695|NCT03443726|Mydriatics|mydriatics|mesh-ancestor
93290696|NCT03443726|Sympathomimetics|sympathomimetics|mesh-ancestor
93290697|NCT03443726|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93290698|NCT03443726|Anesthetics, Local|anesthetics, local|mesh-ancestor
93290699|NCT03443726|Anesthetics|anesthetics|mesh-ancestor
93290700|NCT03443726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290701|NCT03443726|Sensory System Agents|sensory system agents|mesh-ancestor
93290702|NCT00760344|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93290703|NCT00760344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93290704|NCT00760344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290705|NCT00760344|Incretins|incretins|mesh-ancestor
93290706|NCT00760344|Hormones|hormones|mesh-ancestor
93290707|NCT00760344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290708|NCT00760344|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93290709|NCT00760344|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290710|NCT00760344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290711|NCT00760344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290712|NCT03443570|Rituximab|rituximab|mesh-list
93290713|NCT03443570|Bortezomib|bortezomib|mesh-list
93290714|NCT03443570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290715|NCT03443570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290716|NCT03443570|Immunologic Factors|immunologic factors|mesh-ancestor
93290717|NCT03443570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290718|NCT03443570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290719|NCT02718404|Analgesics|analgesics|mesh-list
93290720|NCT02718404|Sensory System Agents|sensory system agents|mesh-ancestor
93290721|NCT02718404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290722|NCT02718404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290723|NCT03443492|Leucovorin|leucovorin|mesh-list
93290724|NCT03443492|Gemcitabine|gemcitabine|mesh-list
93290725|NCT03443492|Oxaliplatin|oxaliplatin|mesh-list
93290726|NCT03443492|Irinotecan|irinotecan|mesh-list
93290727|NCT03443492|Levoleucovorin|levoleucovorin|mesh-list
93290728|NCT03443492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290729|NCT03443492|Antimetabolites|antimetabolites|mesh-ancestor
93290730|NCT03443492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290731|NCT03443492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290732|NCT03443492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93290733|NCT03443492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93290734|NCT03443492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290735|NCT03443492|Antidotes|antidotes|mesh-ancestor
93290736|NCT03443492|Protective Agents|protective agents|mesh-ancestor
93290737|NCT03443492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290738|NCT03443492|Vitamin B Complex|vitamin b complex|mesh-ancestor
93290739|NCT03443492|Vitamins|vitamins|mesh-ancestor
93290740|NCT03443492|Micronutrients|micronutrients|mesh-ancestor
93290741|NCT00724698|Desloratadine|desloratadine|mesh-list
93290742|NCT00724698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93290743|NCT00724698|Cholinergic Agents|cholinergic agents|mesh-ancestor
93290744|NCT00724698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290745|NCT00724698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290746|NCT00724698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290747|NCT00724698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93290748|NCT00724698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93290749|NCT00724698|Histamine Antagonists|histamine antagonists|mesh-ancestor
93290750|NCT00724698|Histamine Agents|histamine agents|mesh-ancestor
93290751|NCT00722592|Doxorubicin|doxorubicin|mesh-list
93290752|NCT00722592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93290753|NCT00722592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93290754|NCT00722592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290755|NCT00722592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93290756|NCT00722592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93290757|NCT00722592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290758|NCT00722592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290759|NCT00829998|Zaleplon|zaleplon|mesh-list
93290760|NCT00829998|Anticonvulsants|anticonvulsants|mesh-ancestor
93290761|NCT00829998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93290762|NCT00829998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290763|NCT00829998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290764|NCT00829998|GABA Modulators|gaba modulators|mesh-ancestor
93290765|NCT00829998|GABA Agents|gaba agents|mesh-ancestor
93290766|NCT00829998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290767|NCT00829998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290768|NCT00722358|Asunaprevir|asunaprevir|mesh-list
93290769|NCT00722358|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290770|NCT00722358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290771|NCT00722358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290772|NCT00719550|Capecitabine|capecitabine|mesh-list
93290773|NCT00719550|Epirubicin|epirubicin|mesh-list
93290774|NCT00719550|Rilotumumab|rilotumumab|mesh-list
93290775|NCT00719550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290776|NCT00719550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290777|NCT00719550|Antimetabolites|antimetabolites|mesh-ancestor
93290778|NCT00719550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290779|NCT00719550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93290780|NCT00719550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93290781|NCT00719550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93290782|NCT00719550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290783|NCT00719550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290784|NCT03443180|Trypsin Inhibitors|trypsin inhibitors|mesh-list
93290785|NCT03443180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93290786|NCT03443180|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290787|NCT03443180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290788|NCT03443180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290789|NCT05016518|Propofol|propofol|mesh-list
93290790|NCT05016518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93290791|NCT05016518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93290792|NCT05016518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290793|NCT05016518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93290794|NCT05016518|Anesthetics, General|anesthetics, general|mesh-ancestor
93290795|NCT05016518|Anesthetics|anesthetics|mesh-ancestor
93290796|NCT03446534|Amoxicillin|amoxicillin|mesh-list
93290797|NCT03446534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290798|NCT03446534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290799|NCT00829764|Doxycycline|doxycycline|mesh-list
93290800|NCT00829764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290801|NCT00829764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290802|NCT00829764|Antimalarials|antimalarials|mesh-ancestor
93290803|NCT00829764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93290804|NCT00829764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93290805|NCT00718224|Enoxaparin|enoxaparin|mesh-list
93290806|NCT00718224|Semuloparin|semuloparin|mesh-list
93290807|NCT00718224|Anticoagulants|anticoagulants|mesh-ancestor
93290808|NCT00718224|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93290809|NCT00718224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93290810|NCT00718224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290811|NCT03129542|Midodrine|midodrine|mesh-list
93290812|NCT03129542|Sympathomimetics|sympathomimetics|mesh-ancestor
93290813|NCT03129542|Autonomic Agents|autonomic agents|mesh-ancestor
93290814|NCT03129542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290815|NCT03129542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290816|NCT03129542|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93290817|NCT03129542|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93290818|NCT03129542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93290819|NCT03129542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93290820|NCT03129542|Adrenergic Agents|adrenergic agents|mesh-ancestor
93290821|NCT03129542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290822|NCT03129542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290823|NCT03129074|Capecitabine|capecitabine|mesh-list
93290824|NCT03129074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93290825|NCT03129074|Antimetabolites|antimetabolites|mesh-ancestor
93290826|NCT03129074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290827|NCT03129074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290828|NCT03449654|Liraglutide|liraglutide|mesh-list
92962867|NCT00663858|Cetrorelix|cetrorelix|mesh-list
93290829|NCT03449654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93290830|NCT03449654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290831|NCT03449654|Incretins|incretins|mesh-ancestor
93290832|NCT03449654|Hormones|hormones|mesh-ancestor
93290833|NCT03449654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290834|NCT03388008|Mycophenolic Acid|mycophenolic acid|mesh-list
93290835|NCT03388008|Prednisone|prednisone|mesh-list
93290836|NCT03388008|Methylprednisolone|methylprednisolone|mesh-list
93290837|NCT03388008|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93290838|NCT03388008|Abatacept|abatacept|mesh-list
93290839|NCT03388008|Tacrolimus|tacrolimus|mesh-list
93290840|NCT03388008|Thymoglobulin|thymoglobulin|mesh-list
93290841|NCT03388008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290842|NCT03388008|Glucocorticoids|glucocorticoids|mesh-ancestor
93290843|NCT03388008|Hormones|hormones|mesh-ancestor
93290844|NCT03388008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290845|NCT03388008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290846|NCT03388008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93290847|NCT03388008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290848|NCT03388008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290849|NCT03388008|Immunologic Factors|immunologic factors|mesh-ancestor
93290850|NCT03388008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93290851|NCT03388008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290852|NCT03388008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290853|NCT03388008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93290854|NCT03388008|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93290855|NCT03388008|Antitubercular Agents|antitubercular agents|mesh-ancestor
93290856|NCT03388008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290857|NCT03388008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290858|NCT03388008|Antiemetics|antiemetics|mesh-ancestor
93290859|NCT03388008|Autonomic Agents|autonomic agents|mesh-ancestor
93290860|NCT03388008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290861|NCT03388008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290862|NCT03388008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93290863|NCT03388008|Protective Agents|protective agents|mesh-ancestor
93290864|NCT03388008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93290865|NCT03388008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290866|NCT03388008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290867|NCT00710580|Etanercept|etanercept|mesh-list
93290868|NCT00710580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93290869|NCT00710580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93290870|NCT00710580|Analgesics|analgesics|mesh-ancestor
93290871|NCT00710580|Sensory System Agents|sensory system agents|mesh-ancestor
93290872|NCT00710580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290873|NCT00710580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290874|NCT00710580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290875|NCT00710580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93290876|NCT00710580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93290877|NCT00710580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93290878|NCT00710580|Immunologic Factors|immunologic factors|mesh-ancestor
93290879|NCT00829686|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93290880|NCT00829686|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93290881|NCT00829686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93290882|NCT00829686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93290883|NCT00829686|Antimalarials|antimalarials|mesh-ancestor
93290884|NCT00829686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93290885|NCT00829686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93290886|NCT00829530|Ramipril|ramipril|mesh-list
93290887|NCT00829530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93290888|NCT00829530|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290889|NCT00829530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290890|NCT00829530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290891|NCT00829530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93290892|NCT01377194|Milnacipran|milnacipran|mesh-list
93290893|NCT01377194|Levomilnacipran|levomilnacipran|mesh-list
93290894|NCT01377194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93290895|NCT01377194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93290896|NCT01377194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93290897|NCT01377194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290898|NCT01377194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290899|NCT01377194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290900|NCT01377194|Antidepressive Agents|antidepressive agents|mesh-ancestor
93290901|NCT01377194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93290902|NCT01377194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962940|NCT01060735|Micronutrients|micronutrients|mesh-ancestor
93290903|NCT01377194|Analgesics|analgesics|mesh-ancestor
93290904|NCT01377194|Sensory System Agents|sensory system agents|mesh-ancestor
93290905|NCT01377194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290906|NCT00829452|Ramipril|ramipril|mesh-list
93290907|NCT00829452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93290908|NCT00829452|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290909|NCT00829452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290910|NCT00829452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290911|NCT00829452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93290912|NCT00747318|Fluticasone|fluticasone|mesh-list
93290913|NCT00747318|Xhance|xhance|mesh-list
93290914|NCT00747318|Formoterol Fumarate|formoterol fumarate|mesh-list
93290915|NCT00747318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93290916|NCT00747318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93290917|NCT00747318|Autonomic Agents|autonomic agents|mesh-ancestor
93290918|NCT00747318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290919|NCT00747318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290920|NCT00747318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93290921|NCT00747318|Respiratory System Agents|respiratory system agents|mesh-ancestor
93290922|NCT00747318|Dermatologic Agents|dermatologic agents|mesh-ancestor
93290923|NCT00747318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93290924|NCT00747318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93290925|NCT00747318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93290926|NCT00747318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93290927|NCT00747318|Adrenergic Agents|adrenergic agents|mesh-ancestor
93290928|NCT00747318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290929|NCT00747318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290930|NCT00744276|Danazol|danazol|mesh-list
93290931|NCT00744276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93290932|NCT00744276|Hormone Antagonists|hormone antagonists|mesh-ancestor
93290933|NCT00744276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290934|NCT00744276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290935|NCT03438344|Vaccines|vaccines|mesh-list
93290936|NCT03438344|Immunologic Factors|immunologic factors|mesh-ancestor
93290937|NCT03438344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290938|NCT04640402|Vaccines|vaccines|mesh-list
93290939|NCT04640402|Immunologic Factors|immunologic factors|mesh-ancestor
93290940|NCT04640402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290941|NCT03445910|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93290942|NCT03445910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93290943|NCT03445910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290944|NCT00646542|Vildagliptin|vildagliptin|mesh-list
93290945|NCT00646542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93290946|NCT00646542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290947|NCT00646542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93290948|NCT00646542|Protease Inhibitors|protease inhibitors|mesh-ancestor
93290949|NCT00646542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93290950|NCT00646542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290951|NCT03256344|Atezolizumab|atezolizumab|mesh-list
93290952|NCT03256344|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93290953|NCT03256344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93290954|NCT03256344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290955|NCT03256344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93290956|NCT03256344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93290957|NCT02063139|Fluticasone|fluticasone|mesh-list
93290958|NCT02063139|Beclomethasone|beclomethasone|mesh-list
93290959|NCT02063139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585454|NCT00092079|Vitamin D|vitamin d|mesh-list
93290960|NCT02063139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93290961|NCT02063139|Autonomic Agents|autonomic agents|mesh-ancestor
93290962|NCT02063139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93290963|NCT02063139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290964|NCT02063139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93290965|NCT02063139|Respiratory System Agents|respiratory system agents|mesh-ancestor
93290966|NCT02063139|Dermatologic Agents|dermatologic agents|mesh-ancestor
93290967|NCT02063139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93290968|NCT02063139|Glucocorticoids|glucocorticoids|mesh-ancestor
93290969|NCT02063139|Hormones|hormones|mesh-ancestor
93290970|NCT02063139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290971|NCT00690456|Metformin|metformin|mesh-list
93290972|NCT00690456|Rimonabant|rimonabant|mesh-list
93290973|NCT00690456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93290974|NCT00690456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290975|NCT00690456|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93290976|NCT00690456|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93290977|NCT00690456|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93290978|NCT00690456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290979|NCT00690456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290980|NCT00690456|Hormones|hormones|mesh-ancestor
93290981|NCT00690456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93290982|NCT01370499|Serotonin|serotonin|mesh-list
93290983|NCT01370499|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93290984|NCT01370499|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93290985|NCT01370499|Serotonin Agents|serotonin agents|mesh-ancestor
93290986|NCT01370499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93290987|NCT01370499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93290988|NCT01370499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290989|NCT01370499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93290990|NCT01370499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93290991|NCT03445286|Fluorides|fluorides|mesh-list
93290992|NCT03445286|Cariostatic Agents|cariostatic agents|mesh-ancestor
93290993|NCT03445286|Protective Agents|protective agents|mesh-ancestor
93290994|NCT03445286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93290995|NCT00626106|Fulvestrant|fulvestrant|mesh-list
93290996|NCT00626106|Exemestane|exemestane|mesh-list
93290997|NCT00626106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93290998|NCT00626106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93290999|NCT00626106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291000|NCT00626106|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93291001|NCT00626106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93291002|NCT00626106|Hormone Antagonists|hormone antagonists|mesh-ancestor
93291003|NCT00626106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93291004|NCT00626106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291005|NCT00626106|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93291006|NCT00626106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93291007|NCT00626106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291008|NCT00626106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291009|NCT00626106|Immunologic Factors|immunologic factors|mesh-ancestor
93291010|NCT02064465|Lamotrigine|lamotrigine|mesh-list
93291011|NCT02064465|Anticonvulsants|anticonvulsants|mesh-list
93291012|NCT02064465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93291013|NCT02064465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291014|NCT02064465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291015|NCT02064465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93291016|NCT02064465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291017|NCT02064465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93291018|NCT02064465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93291019|NCT02064465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291020|NCT02064465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291021|NCT02064465|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93291022|NCT04530656|Vaccines|vaccines|mesh-list
93291023|NCT04530656|Immunologic Factors|immunologic factors|mesh-ancestor
93291024|NCT04530656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291025|NCT00690066|Remestemcel-l|remestemcel-l|mesh-list
93291026|NCT00690066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291027|NCT00690066|Antiviral Agents|antiviral agents|mesh-ancestor
93291028|NCT00690066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291029|NCT04509596|Capecitabine|capecitabine|mesh-list
93291030|NCT04509596|Trastuzumab|trastuzumab|mesh-list
93291031|NCT04509596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93291032|NCT04509596|Antimetabolites|antimetabolites|mesh-ancestor
93291033|NCT04509596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291034|NCT04509596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291035|NCT04509596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93291036|NCT01370265|Adenosine|adenosine|mesh-list
93291037|NCT01370265|Regadenoson|regadenoson|mesh-list
93291038|NCT01370265|Analgesics|analgesics|mesh-ancestor
93291039|NCT01370265|Sensory System Agents|sensory system agents|mesh-ancestor
93291040|NCT01370265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291041|NCT01370265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291042|NCT01370265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93291043|NCT01370265|Vasodilator Agents|vasodilator agents|mesh-ancestor
93291044|NCT01370265|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93291045|NCT01370265|Purinergic Agonists|purinergic agonists|mesh-ancestor
93291046|NCT01370265|Purinergic Agents|purinergic agents|mesh-ancestor
93291047|NCT01370265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291048|NCT01370265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291049|NCT01370265|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93291050|NCT00734292|Fluticasone|fluticasone|mesh-list
93291052|NCT00734292|Formoterol Fumarate|formoterol fumarate|mesh-list
93291053|NCT00734292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291054|NCT00734292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93291055|NCT00734292|Autonomic Agents|autonomic agents|mesh-ancestor
93291056|NCT00734292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291057|NCT00734292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291058|NCT00734292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93291059|NCT00734292|Respiratory System Agents|respiratory system agents|mesh-ancestor
93291060|NCT00734292|Dermatologic Agents|dermatologic agents|mesh-ancestor
93291061|NCT00734292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93291062|NCT00734292|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93291063|NCT00734292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93291064|NCT00734292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93291065|NCT00734292|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291066|NCT00734292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291067|NCT00734292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291068|NCT00687882|Anticoagulants|anticoagulants|mesh-list
93291069|NCT02064621|Amlodipine|amlodipine|mesh-list
93291070|NCT02064621|Candesartan|candesartan|mesh-list
93291071|NCT02064621|Candesartan cilexetil|candesartan cilexetil|mesh-list
93291072|NCT02064621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93291073|NCT02064621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93291074|NCT02064621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291075|NCT02064621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291076|NCT02064621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93291077|NCT02064621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291078|NCT02064621|Vasodilator Agents|vasodilator agents|mesh-ancestor
93291079|NCT02064621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93291080|NCT02064621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93291081|NCT00684918|Obatoclax|obatoclax|mesh-list
93291082|NCT00684918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291083|NCT00684918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291084|NCT00726336|Tenofovir|tenofovir|mesh-list
93291085|NCT00726336|Dolutegravir|dolutegravir|mesh-list
93291086|NCT00726336|Antiviral Agents|antiviral agents|mesh-ancestor
93291087|NCT00726336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291088|NCT00726336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93291089|NCT00726336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93291090|NCT00726336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291091|NCT00726336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291092|NCT00726336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93291093|NCT00726336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93291094|NCT00726336|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93291095|NCT00726336|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93291096|NCT02280720|Tryptophan|tryptophan|mesh-list
93291097|NCT02280720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93291098|NCT02280720|Antidepressive Agents|antidepressive agents|mesh-ancestor
93291099|NCT02280720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291100|NCT02068131|Capecitabine|capecitabine|mesh-list
93291101|NCT02068131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93291102|NCT02068131|Antimetabolites|antimetabolites|mesh-ancestor
93291103|NCT02068131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291104|NCT02068131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291105|NCT02068209|Tramadol|tramadol|mesh-list
93291106|NCT02068209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93291107|NCT02068209|Narcotics|narcotics|mesh-ancestor
93291108|NCT02068209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291109|NCT02068209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291110|NCT02068209|Analgesics|analgesics|mesh-ancestor
93291111|NCT02068209|Sensory System Agents|sensory system agents|mesh-ancestor
93291112|NCT02068209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291113|NCT00680784|Ketoprofen|ketoprofen|mesh-list
93291114|NCT00680784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93291115|NCT00680784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291116|NCT00680784|Analgesics|analgesics|mesh-ancestor
93291117|NCT00680784|Sensory System Agents|sensory system agents|mesh-ancestor
93291118|NCT00680784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291119|NCT00680784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291120|NCT00680784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291121|NCT00680784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291122|NCT00680784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93291123|NCT00680784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291124|NCT00680784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291126|NCT02068287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93291127|NCT02068287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93291128|NCT02068287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93291129|NCT02068287|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291130|NCT02068287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291131|NCT02068287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291132|NCT02068287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291133|NCT02280876|Andrographolide|andrographolide|mesh-list
93291134|NCT02280876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291135|NCT02280876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93291136|NCT02280876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291137|NCT02280876|Analgesics|analgesics|mesh-ancestor
93291138|NCT02280876|Sensory System Agents|sensory system agents|mesh-ancestor
93291139|NCT02280876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291140|NCT02280876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291141|NCT02280876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291142|NCT02280876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93291143|NCT02280876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93291144|NCT02280876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291145|NCT02280876|Antiviral Agents|antiviral agents|mesh-ancestor
93291146|NCT02280876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93291147|NCT00680472|Ketoprofen|ketoprofen|mesh-list
93291148|NCT00680472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93291149|NCT00680472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291150|NCT00680472|Analgesics|analgesics|mesh-ancestor
93291151|NCT00680472|Sensory System Agents|sensory system agents|mesh-ancestor
93291152|NCT00680472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291153|NCT00680472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291154|NCT00680472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291155|NCT00680472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291156|NCT00680472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93291157|NCT00680472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291158|NCT00680472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291159|NCT03444662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93291160|NCT03444662|Nootropic Agents|nootropic agents|mesh-ancestor
93291161|NCT03444506|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93291162|NCT03444506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93291163|NCT03444506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291164|NCT03444506|Analgesics|analgesics|mesh-ancestor
93291165|NCT03444506|Sensory System Agents|sensory system agents|mesh-ancestor
93291166|NCT03444506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291167|NCT03444506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291168|NCT03444506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291169|NCT03444506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291170|NCT03444506|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93291171|NCT03444506|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92585673|NCT03272477|Tamoxifen|tamoxifen|mesh-list
93291172|NCT03444506|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93291173|NCT03444506|Histamine Antagonists|histamine antagonists|mesh-ancestor
93291174|NCT03444506|Histamine Agents|histamine agents|mesh-ancestor
93291175|NCT03444506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291176|NCT03444506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291177|NCT02065947|Lidocaine|lidocaine|mesh-list
93291178|NCT02065947|Epinephrine|epinephrine|mesh-list
93291179|NCT02065947|Racepinephrine|racepinephrine|mesh-list
93291180|NCT02065947|Fentanyl|fentanyl|mesh-list
93291181|NCT02065947|Midazolam|midazolam|mesh-list
93291182|NCT02065947|Ketamine|ketamine|mesh-list
93291183|NCT02065947|Bupivacaine|bupivacaine|mesh-list
93291184|NCT02065947|Propofol|propofol|mesh-list
93291185|NCT02065947|Sevoflurane|sevoflurane|mesh-list
93291186|NCT02065947|Epinephryl borate|epinephryl borate|mesh-list
93291187|NCT02065947|Atracurium|atracurium|mesh-list
93291188|NCT02065947|Anesthetics, Local|anesthetics, local|mesh-ancestor
93291189|NCT02065947|Anesthetics|anesthetics|mesh-ancestor
93291190|NCT02065947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291191|NCT02065947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291192|NCT02065947|Sensory System Agents|sensory system agents|mesh-ancestor
93291193|NCT02065947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291194|NCT02065947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93291195|NCT02065947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93291196|NCT02065947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93291197|NCT02065947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291198|NCT02065947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963241|NCT00683384|Etanercept|etanercept|mesh-list
93291199|NCT02065947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93291200|NCT02065947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93291201|NCT02065947|Anesthetics, General|anesthetics, general|mesh-ancestor
93291202|NCT02065947|Analgesics|analgesics|mesh-ancestor
93291203|NCT02065947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93291204|NCT02065947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93291205|NCT02065947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93291206|NCT02065947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291207|NCT02065947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93291208|NCT02065947|Narcotics|narcotics|mesh-ancestor
93291209|NCT02065947|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93291210|NCT02065947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93291211|NCT02065947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93291212|NCT02065947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291213|NCT02065947|GABA Modulators|gaba modulators|mesh-ancestor
93291214|NCT02065947|GABA Agents|gaba agents|mesh-ancestor
93291215|NCT02065947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93291216|NCT02065947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93291217|NCT02065947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93291218|NCT02065947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93291219|NCT02065947|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291220|NCT02065947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93291221|NCT02065947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93291222|NCT02065947|Autonomic Agents|autonomic agents|mesh-ancestor
93291223|NCT02065947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93291224|NCT02065947|Respiratory System Agents|respiratory system agents|mesh-ancestor
93291225|NCT02065947|Mydriatics|mydriatics|mesh-ancestor
93291226|NCT02065947|Sympathomimetics|sympathomimetics|mesh-ancestor
93291227|NCT02065947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93291228|NCT02065947|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93291229|NCT02065947|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93291230|NCT02065947|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93291231|NCT02065947|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93291232|NCT02065947|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93291233|NCT02065947|Cholinergic Agents|cholinergic agents|mesh-ancestor
93291234|NCT03436472|Dexmedetomidine|dexmedetomidine|mesh-list
93291235|NCT03436472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93291236|NCT03436472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291237|NCT03436472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291238|NCT03436472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291239|NCT03436472|Analgesics|analgesics|mesh-ancestor
93291240|NCT03436472|Sensory System Agents|sensory system agents|mesh-ancestor
93291241|NCT03436472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291242|NCT03436472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93291243|NCT03436472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93291244|NCT03436472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93291245|NCT03436472|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291246|NCT03436472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291247|NCT03436472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291248|NCT02066103|Paclitaxel|paclitaxel|mesh-list
93291249|NCT02066103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93291250|NCT02066103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291251|NCT02066103|Tubulin Modulators|tubulin modulators|mesh-ancestor
93291252|NCT02066103|Antimitotic Agents|antimitotic agents|mesh-ancestor
93291253|NCT02066103|Mitosis Modulators|mitosis modulators|mesh-ancestor
93291254|NCT02066103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291255|NCT04809532|Tramadol|tramadol|mesh-list
93291256|NCT04809532|Bupivacaine|bupivacaine|mesh-list
93291257|NCT04809532|Anesthetics, Local|anesthetics, local|mesh-ancestor
93291258|NCT04809532|Anesthetics|anesthetics|mesh-ancestor
93291259|NCT04809532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291260|NCT04809532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291261|NCT04809532|Sensory System Agents|sensory system agents|mesh-ancestor
93291262|NCT04809532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291263|NCT04809532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93291264|NCT04809532|Narcotics|narcotics|mesh-ancestor
93291265|NCT04809532|Analgesics|analgesics|mesh-ancestor
93291266|NCT04809142|Gemcitabine|gemcitabine|mesh-list
93291267|NCT04809142|Capecitabine|capecitabine|mesh-list
93291268|NCT04809142|Oxaliplatin|oxaliplatin|mesh-list
93291269|NCT04809142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93291270|NCT04809142|Antimetabolites|antimetabolites|mesh-ancestor
93291271|NCT04809142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291272|NCT04809142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291273|NCT02064777|Tacrolimus|tacrolimus|mesh-list
93291274|NCT02064777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93291275|NCT02064777|Immunologic Factors|immunologic factors|mesh-ancestor
93291276|NCT02064777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291277|NCT02064777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93291278|NCT02064777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291279|NCT02064777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291281|NCT02069145|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93291282|NCT02069145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291283|NCT02069145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93291284|NCT02069145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291285|NCT02069145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291286|NCT02069145|Immunologic Factors|immunologic factors|mesh-ancestor
93291287|NCT02069145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291288|NCT04830358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93291289|NCT04830358|Immunologic Factors|immunologic factors|mesh-ancestor
93291290|NCT04830358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291291|NCT03444272|Sofosbuvir|sofosbuvir|mesh-list
93291292|NCT03444272|Antiviral Agents|antiviral agents|mesh-ancestor
93291293|NCT03444272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291294|NCT03347331|Befiradol|befiradol|mesh-list
93291295|NCT03347331|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93291296|NCT03347331|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93291297|NCT03347331|Serotonin Agents|serotonin agents|mesh-ancestor
93291298|NCT03347331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291299|NCT03347331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291300|NCT03347331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291301|NCT05573373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93291302|NCT05573373|Antineoplastic Agents|antineoplastic agents|mesh-list
93291303|NCT05573373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291304|NCT05573373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291305|NCT03109652|Tranexamic Acid|tranexamic acid|mesh-list
93291306|NCT03109652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93291307|NCT03109652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93291308|NCT03109652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291309|NCT03109652|Hemostatics|hemostatics|mesh-ancestor
93291310|NCT03109652|Coagulants|coagulants|mesh-ancestor
93291311|NCT02069301|Fluoxetine|fluoxetine|mesh-list
93291312|NCT02069301|Antidepressive Agents|antidepressive agents|mesh-list
93291313|NCT02069301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93291314|NCT02069301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93291315|NCT02069301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291316|NCT02069301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291317|NCT02069301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291318|NCT02069301|Serotonin Agents|serotonin agents|mesh-ancestor
93291319|NCT02069301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291320|NCT02069301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93291321|NCT02069301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291322|NCT02069301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93291323|NCT02069301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93291324|NCT02069301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291325|NCT03035656|Ropivacaine|ropivacaine|mesh-list
93291326|NCT03035656|Anesthetics, Local|anesthetics, local|mesh-ancestor
93291327|NCT03035656|Anesthetics|anesthetics|mesh-ancestor
93291328|NCT03035656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291329|NCT03035656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291330|NCT03035656|Sensory System Agents|sensory system agents|mesh-ancestor
93291331|NCT03035656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291332|NCT03443960|Amitriptyline|amitriptyline|mesh-list
93291333|NCT03443960|Cyclobenzaprine|cyclobenzaprine|mesh-list
93291334|NCT03443960|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93291335|NCT03443960|Antidepressive Agents|antidepressive agents|mesh-ancestor
93291336|NCT03443960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291337|NCT03443960|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93291338|NCT03443960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291339|NCT03443960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93291340|NCT03443960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291341|NCT03443960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93291342|NCT03443960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291343|NCT03443960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291344|NCT03443960|Analgesics|analgesics|mesh-ancestor
93291345|NCT03443960|Sensory System Agents|sensory system agents|mesh-ancestor
93291346|NCT03443960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92963391|NCT00990418|Anesthetics|anesthetics|mesh-ancestor
93291347|NCT03443960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93291348|NCT03443960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291349|NCT03443960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291351|NCT03443960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291352|NCT05616754|Vaccines|vaccines|mesh-list
93291353|NCT05616754|Immunologic Factors|immunologic factors|mesh-ancestor
93291354|NCT05616754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291355|NCT03440996|Listerine|listerine|mesh-list
93291356|NCT03440996|Sodium Fluoride|sodium fluoride|mesh-list
93291357|NCT03440996|Cariostatic Agents|cariostatic agents|mesh-ancestor
93291358|NCT03440996|Protective Agents|protective agents|mesh-ancestor
93291359|NCT03440996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291360|NCT03440996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93291361|NCT03440996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291362|NCT04451174|Prednisone|prednisone|mesh-list
93291363|NCT04451174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291364|NCT04451174|Glucocorticoids|glucocorticoids|mesh-ancestor
93291365|NCT04451174|Hormones|hormones|mesh-ancestor
93291366|NCT04451174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93291367|NCT04451174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291368|NCT04451174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93291369|NCT04451174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291370|NCT04828642|Vitamins|vitamins|mesh-list
93291371|NCT04828642|Ascorbic Acid|ascorbic acid|mesh-list
93291372|NCT04828642|Vitamin E|vitamin e|mesh-list
93291373|NCT04828642|Tocopherols|tocopherols|mesh-list
93291374|NCT04828642|Micronutrients|micronutrients|mesh-ancestor
93291375|NCT04828642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291376|NCT04828642|Antioxidants|antioxidants|mesh-ancestor
93291377|NCT04828642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291378|NCT04828642|Protective Agents|protective agents|mesh-ancestor
93291379|NCT03433352|Methimazole|methimazole|mesh-list
93291380|NCT03433352|Propylthiouracil|propylthiouracil|mesh-list
93291381|NCT03433352|Antithyroid Agents|antithyroid agents|mesh-ancestor
93291382|NCT03433352|Hormone Antagonists|hormone antagonists|mesh-ancestor
93291383|NCT03433352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93291384|NCT03433352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291385|NCT03433352|Antimetabolites|antimetabolites|mesh-ancestor
93291386|NCT03433352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291387|NCT04828564|Ribavirin|ribavirin|mesh-list
93291388|NCT04828564|Favipiravir|favipiravir|mesh-list
93291389|NCT04828564|Antimetabolites|antimetabolites|mesh-ancestor
93291390|NCT04828564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291391|NCT04828564|Antiviral Agents|antiviral agents|mesh-ancestor
93291392|NCT04828564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291393|NCT03435302|Temozolomide|temozolomide|mesh-list
93291394|NCT03435302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291395|NCT03435302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93291396|NCT03435302|Alkylating Agents|alkylating agents|mesh-ancestor
93291397|NCT03435302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291398|NCT04973150|Anesthetics|anesthetics|mesh-list
93291399|NCT04973150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291400|NCT04973150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291401|NCT03433196|Atorvastatin|atorvastatin|mesh-list
93291402|NCT03433196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93291403|NCT03433196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93291404|NCT03433196|Antimetabolites|antimetabolites|mesh-ancestor
93291405|NCT03433196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291406|NCT03433196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93291407|NCT03433196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93291408|NCT03433196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291409|NCT02792829|Lenvatinib|lenvatinib|mesh-list
93291410|NCT02792829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291411|NCT02792829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93291412|NCT02792829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291413|NCT02792829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291414|NCT02066571|Droxidopa|droxidopa|mesh-list
93291415|NCT02066571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93291416|NCT02066571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93291417|NCT02066649|Carvedilol|carvedilol|mesh-list
93291418|NCT02066649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92963470|NCT00990574|Anesthetics|anesthetics|mesh-list
93291419|NCT02066649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93291420|NCT02066649|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291421|NCT02066649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291422|NCT02066649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291423|NCT02066649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291424|NCT02066649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93291425|NCT02066649|Antioxidants|antioxidants|mesh-ancestor
93291426|NCT02066649|Protective Agents|protective agents|mesh-ancestor
93291427|NCT02066649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93291428|NCT02066649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291429|NCT02066649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93291430|NCT02066649|Vasodilator Agents|vasodilator agents|mesh-ancestor
93291431|NCT02066649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93291432|NCT02066649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93291433|NCT02070003|Analgesics, Opioid|analgesics, opioid|mesh-list
93291434|NCT02070003|Narcotics|narcotics|mesh-ancestor
93291435|NCT02070003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291436|NCT02070003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291437|NCT02070003|Analgesics|analgesics|mesh-ancestor
93291438|NCT02070003|Sensory System Agents|sensory system agents|mesh-ancestor
93291439|NCT02070003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291440|NCT02070159|Clopidogrel|clopidogrel|mesh-list
93291441|NCT02070159|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93291442|NCT02070159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93291443|NCT02070159|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93291444|NCT02070159|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93291445|NCT02070159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93291446|NCT02070159|Purinergic Agents|purinergic agents|mesh-ancestor
93291447|NCT02070159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291448|NCT02070159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291449|NCT02070159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291450|NCT05619328|Vitamins|vitamins|mesh-list
93291451|NCT05619328|Vitamin B Complex|vitamin b complex|mesh-list
93291452|NCT05619328|Micronutrients|micronutrients|mesh-ancestor
93291453|NCT05619328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291454|NCT05559099|Tecovirimat|tecovirimat|mesh-list
93291455|NCT05559099|Antiviral Agents|antiviral agents|mesh-ancestor
93291456|NCT05559099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291457|NCT03432884|Moxifloxacin|moxifloxacin|mesh-list
93291458|NCT03432884|Zanubrutinib|zanubrutinib|mesh-list
93291459|NCT03432884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93291460|NCT03432884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291461|NCT03432884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93291462|NCT03432884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93291463|NCT03432884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291464|NCT03432884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291465|NCT03432884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291466|NCT03432884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93291467|NCT04827784|Anesthetics|anesthetics|mesh-list
93291468|NCT04827784|Anesthetics, Local|anesthetics, local|mesh-list
93291469|NCT04827784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291470|NCT04827784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291471|NCT04827784|Sensory System Agents|sensory system agents|mesh-ancestor
93291472|NCT04827784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291473|NCT03986996|Amoxicillin|amoxicillin|mesh-list
93291474|NCT03986996|Metronidazole|metronidazole|mesh-list
93291475|NCT03986996|Doxycycline|doxycycline|mesh-list
93291476|NCT03986996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93291477|NCT03986996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291478|NCT03986996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93291479|NCT03986996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93291480|NCT03986996|Antimalarials|antimalarials|mesh-ancestor
93291481|NCT04827472|Fexuprazan|fexuprazan|mesh-list
93291482|NCT04827472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93291483|NCT04796428|Dapagliflozin|dapagliflozin|mesh-list
93291484|NCT04796428|Empagliflozin|empagliflozin|mesh-list
93291485|NCT04796428|Canagliflozin|canagliflozin|mesh-list
93291486|NCT04796428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93291487|NCT04796428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291488|NCT04796428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93291489|NCT04796428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291490|NCT03432728|Anesthetics|anesthetics|mesh-list
93291491|NCT03432728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291492|NCT03432728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291493|NCT04450160|Temozolomide|temozolomide|mesh-list
93291494|NCT04450160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93291495|NCT04450160|Alkylating Agents|alkylating agents|mesh-ancestor
93291496|NCT04450160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291497|NCT04450160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291499|NCT03432572|Thiamine|thiamine|mesh-list
93291500|NCT03432572|Vitamin B Complex|vitamin b complex|mesh-ancestor
93291501|NCT03432572|Vitamins|vitamins|mesh-ancestor
93291502|NCT03432572|Micronutrients|micronutrients|mesh-ancestor
93291503|NCT03432572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291504|NCT03432572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93291505|NCT03432572|Dermatologic Agents|dermatologic agents|mesh-ancestor
93291506|NCT03854370|Chlorhexidine|chlorhexidine|mesh-list
93291507|NCT03854370|Povidone-Iodine|povidone-iodine|mesh-list
93291508|NCT03854370|Povidone|povidone|mesh-list
93291509|NCT03854370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93291510|NCT03854370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291511|NCT03854370|Disinfectants|disinfectants|mesh-ancestor
93291512|NCT03854370|Plasma Substitutes|plasma substitutes|mesh-ancestor
93291513|NCT03854370|Blood Substitutes|blood substitutes|mesh-ancestor
93291514|NCT02260323|Antirheumatic Agents|antirheumatic agents|mesh-list
93291515|NCT02805504|Bupivacaine|bupivacaine|mesh-list
93291516|NCT02805504|Anesthetics, Local|anesthetics, local|mesh-ancestor
93291517|NCT02805504|Anesthetics|anesthetics|mesh-ancestor
93291518|NCT02805504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291519|NCT02805504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291520|NCT02805504|Sensory System Agents|sensory system agents|mesh-ancestor
93291521|NCT02805504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291522|NCT02783508|Meperidine|meperidine|mesh-list
93291523|NCT02783508|Nitrous Oxide|nitrous oxide|mesh-list
93291524|NCT02783508|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93291525|NCT02783508|Anesthetics, General|anesthetics, general|mesh-ancestor
93291526|NCT02783508|Anesthetics|anesthetics|mesh-ancestor
93291527|NCT02783508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291528|NCT02783508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291529|NCT02783508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291530|NCT02783508|Analgesics|analgesics|mesh-ancestor
93291531|NCT02783508|Sensory System Agents|sensory system agents|mesh-ancestor
93291532|NCT02783508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291533|NCT02783508|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93291534|NCT02783508|Narcotics|narcotics|mesh-ancestor
93291535|NCT02783508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93291536|NCT02071407|Midazolam|midazolam|mesh-list
93291537|NCT02071407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93291538|NCT02071407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93291539|NCT02071407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291540|NCT02071407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291541|NCT02071407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93291542|NCT02071407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93291543|NCT02071407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291544|NCT02071407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93291545|NCT02071407|Anesthetics, General|anesthetics, general|mesh-ancestor
93291546|NCT02071407|Anesthetics|anesthetics|mesh-ancestor
93291547|NCT02071407|GABA Modulators|gaba modulators|mesh-ancestor
93291548|NCT02071407|GABA Agents|gaba agents|mesh-ancestor
93291549|NCT02071407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291550|NCT02071407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291551|NCT02281266|Entecavir|entecavir|mesh-list
93291552|NCT02281266|Thymalfasin|thymalfasin|mesh-list
93291553|NCT02281266|Antiviral Agents|antiviral agents|mesh-ancestor
93291554|NCT02281266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291555|NCT02281266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93291556|NCT02281266|Immunologic Factors|immunologic factors|mesh-ancestor
93291557|NCT02281266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291558|NCT00625326|Calcipotriene|calcipotriene|mesh-list
93291559|NCT00625326|Dermatologic Agents|dermatologic agents|mesh-ancestor
93291560|NCT03434054|Losartan|losartan|mesh-list
93291561|NCT03434054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93291562|NCT03434054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93291563|NCT03434054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93291564|NCT03434054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93291565|NCT03434054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291566|NCT03433976|Anesthetics|anesthetics|mesh-list
93291567|NCT03433976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291568|NCT03433976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291569|NCT04473144|Urinastatin|urinastatin|mesh-list
93291570|NCT04473144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93291571|NCT04473144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93291572|NCT04473144|Protease Inhibitors|protease inhibitors|mesh-ancestor
93291573|NCT04473144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291574|NCT04473144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291576|NCT02605642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93291577|NCT02605642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291578|NCT02605642|Dermatologic Agents|dermatologic agents|mesh-ancestor
93291579|NCT02605642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93291580|NCT02605642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291581|NCT00624858|Naltrexone|naltrexone|mesh-list
93291582|NCT00624858|Bupropion|bupropion|mesh-list
93291583|NCT00624858|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93291584|NCT00624858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93291585|NCT00624858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291586|NCT00624858|Sensory System Agents|sensory system agents|mesh-ancestor
93291587|NCT00624858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291588|NCT00624858|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93291589|NCT00624858|Antidepressive Agents|antidepressive agents|mesh-ancestor
93291590|NCT00624858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291591|NCT00624858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93291592|NCT00624858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93291593|NCT00624858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291594|NCT00624858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291595|NCT00624858|Dopamine Agents|dopamine agents|mesh-ancestor
93291596|NCT00624858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291597|NCT00624858|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93291598|NCT00624858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93291599|NCT00624858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291600|NCT03128528|Empagliflozin|empagliflozin|mesh-list
93291601|NCT03128528|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93291602|NCT03128528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291603|NCT03128528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93291604|NCT03128528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291605|NCT02071641|Sunitinib|sunitinib|mesh-list
93291606|NCT02071641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291607|NCT02071641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93291608|NCT02071641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93291609|NCT02071641|Growth Substances|growth substances|mesh-ancestor
93291610|NCT02071641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291611|NCT02071641|Growth Inhibitors|growth inhibitors|mesh-ancestor
93291612|NCT02071641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93291613|NCT02071641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291614|NCT02071641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291615|NCT02253810|Tranexamic Acid|tranexamic acid|mesh-list
93291616|NCT02253810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93291617|NCT02253810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93291618|NCT02253810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291619|NCT02253810|Hemostatics|hemostatics|mesh-ancestor
93291620|NCT02253810|Coagulants|coagulants|mesh-ancestor
93291621|NCT03298893|Nivolumab|nivolumab|mesh-list
93291622|NCT03298893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291623|NCT03298893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93291624|NCT03298893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93291625|NCT03298893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291626|NCT00673062|Pseudoephedrine|pseudoephedrine|mesh-list
93291627|NCT00673062|Ephedrine|ephedrine|mesh-list
93291628|NCT00673062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93291629|NCT00673062|Autonomic Agents|autonomic agents|mesh-ancestor
93291630|NCT00673062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291631|NCT00673062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291632|NCT00673062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93291633|NCT00673062|Respiratory System Agents|respiratory system agents|mesh-ancestor
93291634|NCT00673062|Nasal Decongestants|nasal decongestants|mesh-ancestor
93291635|NCT00673062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93291636|NCT00673062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93291637|NCT00673062|Sympathomimetics|sympathomimetics|mesh-ancestor
93291638|NCT00673062|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291639|NCT00673062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291640|NCT00673062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291641|NCT03559803|Cisplatin|cisplatin|mesh-list
93291642|NCT03559803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291643|NCT03439358|Magnesium Sulfate|magnesium sulfate|mesh-list
93291644|NCT03439358|Analgesics|analgesics|mesh-ancestor
93291645|NCT03439358|Sensory System Agents|sensory system agents|mesh-ancestor
93291646|NCT03439358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291647|NCT03439358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291648|NCT03439358|Anesthetics|anesthetics|mesh-ancestor
93291649|NCT03439358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291650|NCT03439358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93291651|NCT03439358|Anticonvulsants|anticonvulsants|mesh-ancestor
93291652|NCT03439358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93291653|NCT03439358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291654|NCT03439358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291655|NCT03439358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93291656|NCT03439358|Tocolytic Agents|tocolytic agents|mesh-ancestor
93291657|NCT03439358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93291658|NCT02072031|Sunitinib|sunitinib|mesh-list
93291659|NCT02072031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291660|NCT02072031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93291661|NCT02072031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93291662|NCT02072031|Growth Substances|growth substances|mesh-ancestor
93291663|NCT02072031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291664|NCT02072031|Growth Inhibitors|growth inhibitors|mesh-ancestor
93291665|NCT02072031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93291666|NCT02072031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291667|NCT02072031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291668|NCT05616442|Vitamin E|vitamin e|mesh-list
93291669|NCT05616442|Ketotifen|ketotifen|mesh-list
93291670|NCT05616442|Vitamins|vitamins|mesh-ancestor
93291671|NCT05616442|Micronutrients|micronutrients|mesh-ancestor
93291672|NCT05616442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291673|NCT05616442|Antioxidants|antioxidants|mesh-ancestor
93291674|NCT05616442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291675|NCT05616442|Protective Agents|protective agents|mesh-ancestor
93291676|NCT05616442|Antipruritics|antipruritics|mesh-ancestor
93291677|NCT05616442|Dermatologic Agents|dermatologic agents|mesh-ancestor
93291678|NCT05616442|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93291679|NCT05616442|Histamine Antagonists|histamine antagonists|mesh-ancestor
93291680|NCT05616442|Histamine Agents|histamine agents|mesh-ancestor
93291681|NCT05616442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291682|NCT05616442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93291683|NCT02065401|Magnesium Hydroxide|magnesium hydroxide|mesh-list
93291684|NCT02065401|Antacids|antacids|mesh-ancestor
93291685|NCT02065401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291686|NCT02065401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93291687|NCT00620256|Timolol|timolol|mesh-list
93291688|NCT00620256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93291689|NCT00620256|Latanoprost|latanoprost|mesh-list
93291690|NCT00620256|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93291691|NCT00620256|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93291692|NCT00620256|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93291693|NCT00620256|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291694|NCT00620256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291695|NCT00620256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291696|NCT00620256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291697|NCT00620256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93291698|NCT00620256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93291699|NCT04805710|Rivaroxaban|rivaroxaban|mesh-list
93291700|NCT04805710|Clopidogrel|clopidogrel|mesh-list
93291701|NCT04805710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93291702|NCT04805710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93291703|NCT04805710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93291704|NCT04805710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93291705|NCT04805710|Purinergic Agents|purinergic agents|mesh-ancestor
93291706|NCT04805710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291707|NCT04805710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291708|NCT04805710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291709|NCT04805710|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93291710|NCT04805710|Antithrombins|antithrombins|mesh-ancestor
93291711|NCT04805710|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93291712|NCT04805710|Protease Inhibitors|protease inhibitors|mesh-ancestor
93291713|NCT04805710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291714|NCT04805710|Anticoagulants|anticoagulants|mesh-ancestor
93291715|NCT02076477|Docetaxel|docetaxel|mesh-list
93291716|NCT02076477|Pemetrexed|pemetrexed|mesh-list
93291717|NCT02076477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291718|NCT02076477|Tubulin Modulators|tubulin modulators|mesh-ancestor
93291719|NCT02076477|Antimitotic Agents|antimitotic agents|mesh-ancestor
93291720|NCT02076477|Mitosis Modulators|mitosis modulators|mesh-ancestor
93291721|NCT02076477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963766|NCT00797784|Etanercept|etanercept|mesh-list
93291722|NCT02076477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291723|NCT02076477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93291724|NCT02076477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93291725|NCT04472832|Mitapivat|mitapivat|mesh-list
93291726|NCT04472832|Enzyme Activators|enzyme activators|mesh-ancestor
93291727|NCT04472832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291728|NCT04879550|Antithrombins|antithrombins|mesh-list
93291729|NCT04879550|Antithrombin III|antithrombin iii|mesh-list
93291730|NCT04879550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93291731|NCT04879550|Protease Inhibitors|protease inhibitors|mesh-ancestor
93291732|NCT04879550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291733|NCT04879550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291734|NCT04879550|Anticoagulants|anticoagulants|mesh-ancestor
93291735|NCT00613002|Testosterone|testosterone|mesh-list
93291736|NCT00613002|Androgens|androgens|mesh-ancestor
93291737|NCT00613002|Hormones|hormones|mesh-ancestor
93291738|NCT00613002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93291739|NCT00613002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291740|NCT02076945|Lidocaine|lidocaine|mesh-list
93291741|NCT02076945|Bupivacaine|bupivacaine|mesh-list
93291742|NCT02076945|Anesthetics, Local|anesthetics, local|mesh-ancestor
93291743|NCT02076945|Anesthetics|anesthetics|mesh-ancestor
93291744|NCT02076945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291745|NCT02076945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291746|NCT02076945|Sensory System Agents|sensory system agents|mesh-ancestor
93291747|NCT02076945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291748|NCT02076945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93291749|NCT02076945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93291750|NCT02076945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93291751|NCT02076945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291752|NCT02076945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291753|NCT03438890|Chlorhexidine|chlorhexidine|mesh-list
93291754|NCT03438890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93291755|NCT03438890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291756|NCT03438890|Disinfectants|disinfectants|mesh-ancestor
93291757|NCT00668772|Tiotropium Bromide|tiotropium bromide|mesh-list
93291758|NCT00668772|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93291759|NCT00668772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93291760|NCT00668772|Autonomic Agents|autonomic agents|mesh-ancestor
93291761|NCT00668772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291762|NCT00668772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291763|NCT00668772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93291764|NCT00668772|Respiratory System Agents|respiratory system agents|mesh-ancestor
93291765|NCT00668772|Parasympatholytics|parasympatholytics|mesh-ancestor
93291766|NCT00668772|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93291767|NCT00668772|Cholinergic Agents|cholinergic agents|mesh-ancestor
93291768|NCT00668772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291769|NCT00668772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291770|NCT00668772|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93291771|NCT00668772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93291772|NCT00668772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93291773|NCT00668772|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291774|NCT03438812|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93291775|NCT03438812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93291776|NCT03438812|Immunologic Factors|immunologic factors|mesh-ancestor
93291777|NCT03438812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291778|NCT02077257|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93291779|NCT02077257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93291780|NCT02077257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93291781|NCT02077257|Antimetabolites|antimetabolites|mesh-ancestor
93291782|NCT02077257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291783|NCT02077257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93291784|NCT02077257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93291785|NCT02077257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291786|NCT02732912|Zopiclone|zopiclone|mesh-list
93291787|NCT02732912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93291788|NCT02732912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291789|NCT02732912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291790|NCT02792517|Erenumab|erenumab|mesh-list
93291791|NCT02792517|Norgestimate|norgestimate|mesh-list
93291792|NCT02792517|Contraceptive Agents|contraceptive agents|mesh-list
93291793|NCT02792517|Contraceptives, Oral|contraceptives, oral|mesh-list
93291794|NCT02792517|Estradiol|estradiol|mesh-list
93291795|NCT02792517|Estrogens|estrogens|mesh-ancestor
92963843|NCT00661362|Metformin|metformin|mesh-list
93291796|NCT02792517|Hormones|hormones|mesh-ancestor
93291797|NCT02792517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93291798|NCT02792517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291799|NCT02792517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93291800|NCT02792517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93291801|NCT02792517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93291802|NCT02792517|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93291803|NCT02792517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291804|NCT02792517|Analgesics|analgesics|mesh-ancestor
93291805|NCT02792517|Sensory System Agents|sensory system agents|mesh-ancestor
93291806|NCT02792517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291807|NCT02792517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93291808|NCT03431714|Artesunate|artesunate|mesh-list
93291809|NCT03431714|Piperaquine|piperaquine|mesh-list
93291810|NCT03431714|Amodiaquine|amodiaquine|mesh-list
93291811|NCT03431714|Artenimol|artenimol|mesh-list
93291812|NCT03431714|Antimalarials|antimalarials|mesh-ancestor
93291813|NCT03431714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93291814|NCT03431714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93291815|NCT03431714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291816|NCT03431714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291817|NCT03431714|Antiviral Agents|antiviral agents|mesh-ancestor
93291818|NCT03431714|Schistosomicides|schistosomicides|mesh-ancestor
93291819|NCT03431714|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93291820|NCT03431714|Anthelmintics|anthelmintics|mesh-ancestor
93291821|NCT03433586|Aspirin|aspirin|mesh-list
93291822|NCT03433586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93291823|NCT03433586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291824|NCT03433586|Analgesics|analgesics|mesh-ancestor
93291825|NCT03433586|Sensory System Agents|sensory system agents|mesh-ancestor
93291826|NCT03433586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291827|NCT03433586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291828|NCT03433586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291829|NCT03433586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291830|NCT03433586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93291831|NCT03433586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93291832|NCT03433586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291833|NCT03433586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93291834|NCT03433586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93291835|NCT03433586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291836|NCT03433586|Antipyretics|antipyretics|mesh-ancestor
93291837|NCT03431558|Lactoferrin|lactoferrin|mesh-list
93291838|NCT03431558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291839|NCT02273622|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
93291840|NCT02273622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291841|NCT02273622|Antioxidants|antioxidants|mesh-ancestor
93291842|NCT02273622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291843|NCT02273622|Protective Agents|protective agents|mesh-ancestor
93291844|NCT02273622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291845|NCT02273622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93291846|NCT02077803|Metformin|metformin|mesh-list
93291847|NCT02077803|Canagliflozin|canagliflozin|mesh-list
93291848|NCT02077803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93291849|NCT02077803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291850|NCT02077803|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93291851|NCT02077803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291852|NCT02072811|Cytarabine|cytarabine|mesh-list
93291853|NCT02072811|Daunorubicin|daunorubicin|mesh-list
93291854|NCT02072811|Mitoxantrone|mitoxantrone|mesh-list
93291855|NCT02072811|Cladribine|cladribine|mesh-list
93291856|NCT02072811|Lenograstim|lenograstim|mesh-list
93291857|NCT02072811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93291858|NCT02072811|Antimetabolites|antimetabolites|mesh-ancestor
93291859|NCT02072811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291860|NCT02072811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291861|NCT02072811|Antiviral Agents|antiviral agents|mesh-ancestor
93291862|NCT02072811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291863|NCT02072811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93291864|NCT02072811|Immunologic Factors|immunologic factors|mesh-ancestor
93291865|NCT02072811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291866|NCT02072811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93291867|NCT02072811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93291868|NCT02072811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93291869|NCT02072811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291870|NCT02072811|Analgesics|analgesics|mesh-ancestor
93291871|NCT02072811|Sensory System Agents|sensory system agents|mesh-ancestor
93291872|NCT02072811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291873|NCT02072811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93291874|NCT02080377|Glyburide|glyburide|mesh-list
93291875|NCT02080377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93291876|NCT02080377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291877|NCT02072967|Rituximab|rituximab|mesh-list
93291878|NCT02072967|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93291879|NCT02072967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93291880|NCT02072967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291881|NCT02072967|Immunologic Factors|immunologic factors|mesh-ancestor
93291882|NCT02072967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291883|NCT02072967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291884|NCT02072967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93291885|NCT02072967|Alkylating Agents|alkylating agents|mesh-ancestor
93291886|NCT02072967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291887|NCT02073357|Anesthetics|anesthetics|mesh-list
93291888|NCT02073357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291889|NCT02073357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291890|NCT02073669|Interferons|interferons|mesh-list
93291891|NCT02073669|Interferon-gamma|interferon-gamma|mesh-list
93291892|NCT02073669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291893|NCT02073669|Antiviral Agents|antiviral agents|mesh-ancestor
93291894|NCT02073669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93291895|NCT03428282|Anesthetics|anesthetics|mesh-list
93291896|NCT03428282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291897|NCT03428282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291898|NCT00463242|Agomelatine|agomelatine|mesh-list
93291899|NCT00463242|Paroxetine|paroxetine|mesh-list
93291900|NCT00463242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93291901|NCT00463242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93291902|NCT00463242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93291903|NCT00463242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291904|NCT00463242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291905|NCT00463242|Serotonin Agents|serotonin agents|mesh-ancestor
93291906|NCT00463242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291907|NCT00463242|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93291908|NCT00463242|Antidepressive Agents|antidepressive agents|mesh-ancestor
93291909|NCT00463242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93291910|NCT00463242|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93291911|NCT00463242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93291912|NCT00463242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291913|NCT00463242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93291914|NCT00463242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291915|NCT02074137|Prednisone|prednisone|mesh-list
93291916|NCT02074137|Prednisolone|prednisolone|mesh-list
93291917|NCT02074137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291918|NCT02074137|Glucocorticoids|glucocorticoids|mesh-ancestor
93291919|NCT02074137|Hormones|hormones|mesh-ancestor
93291920|NCT02074137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93291921|NCT02074137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291922|NCT02074137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93291923|NCT02074137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291924|NCT00600288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93291925|NCT00600288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93291926|NCT00594984|Irinotecan|irinotecan|mesh-list
93291927|NCT00594984|Cetuximab|cetuximab|mesh-list
93291928|NCT00594984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93291929|NCT00594984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93291930|NCT00594984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291931|NCT00594984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291932|NCT00594984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93291933|NCT00594984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93291934|NCT01369485|Caffeine|caffeine|mesh-list
93291935|NCT01369485|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93291936|NCT01369485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291937|NCT01369485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93291938|NCT01369485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291939|NCT01369485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291940|NCT01369485|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93291941|NCT01369485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93291942|NCT01369485|Purinergic Agents|purinergic agents|mesh-ancestor
93291943|NCT01369485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291944|NCT03422978|Dexmedetomidine|dexmedetomidine|mesh-list
93291945|NCT03422978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93291946|NCT03422978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93291947|NCT03422978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291948|NCT03422978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291949|NCT03422978|Analgesics|analgesics|mesh-ancestor
93291950|NCT03422978|Sensory System Agents|sensory system agents|mesh-ancestor
93291951|NCT03422978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291952|NCT03422978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93291953|NCT03422978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93291954|NCT03422978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93291955|NCT03422978|Adrenergic Agents|adrenergic agents|mesh-ancestor
93291956|NCT03422978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291957|NCT03422978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291958|NCT02278692|Vitamin K|vitamin k|mesh-list
93291959|NCT02278692|Vitamins|vitamins|mesh-ancestor
93291960|NCT02278692|Micronutrients|micronutrients|mesh-ancestor
93291961|NCT02278692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291962|NCT02278692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93291963|NCT02278692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93291964|NCT02278692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291965|NCT02278692|Hemostatics|hemostatics|mesh-ancestor
93291966|NCT02278692|Coagulants|coagulants|mesh-ancestor
93291967|NCT02281968|Naproxen|naproxen|mesh-list
93291968|NCT02281968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93291969|NCT02281968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93291970|NCT02281968|Analgesics|analgesics|mesh-ancestor
93291971|NCT02281968|Sensory System Agents|sensory system agents|mesh-ancestor
93291972|NCT02281968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586469|NCT00084695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93291973|NCT02281968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291974|NCT02281968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93291975|NCT02281968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93291976|NCT02281968|Gout Suppressants|gout suppressants|mesh-ancestor
93291977|NCT02281968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93291978|NCT02281968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291979|NCT02281968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291980|NCT02080845|Theobromine|theobromine|mesh-list
93291981|NCT02080845|Caffeine|caffeine|mesh-list
93291982|NCT02080845|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93291983|NCT02080845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93291984|NCT02080845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93291985|NCT02080845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93291986|NCT02080845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93291987|NCT02080845|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93291988|NCT02080845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93291989|NCT02080845|Purinergic Agents|purinergic agents|mesh-ancestor
93291990|NCT02080845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93291991|NCT02080845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93291992|NCT02080845|Autonomic Agents|autonomic agents|mesh-ancestor
93291993|NCT02080845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93291994|NCT02080845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93291995|NCT02080845|Respiratory System Agents|respiratory system agents|mesh-ancestor
93291996|NCT02080845|Vasodilator Agents|vasodilator agents|mesh-ancestor
93291997|NCT02284230|Liraglutide|liraglutide|mesh-list
93291998|NCT02284230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93291999|NCT02284230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292000|NCT02284230|Incretins|incretins|mesh-ancestor
93292001|NCT02284230|Hormones|hormones|mesh-ancestor
93292002|NCT02284230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292003|NCT02792088|Tenofovir|tenofovir|mesh-list
93292004|NCT02792088|Antiviral Agents|antiviral agents|mesh-ancestor
93292005|NCT02792088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292006|NCT02792088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93292007|NCT02792088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93292008|NCT02792088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292009|NCT02792088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292010|NCT02792088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93292011|NCT02792088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93292012|NCT02074293|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93292013|NCT02074293|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93292014|NCT02074293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93292015|NCT02074293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292016|NCT02074293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292017|NCT02074293|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93292018|NCT02074293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292019|NCT02074293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292020|NCT02074293|Cholinergic Agents|cholinergic agents|mesh-ancestor
93292021|NCT02074293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292022|NCT00451152|Hydrocortisone|hydrocortisone|mesh-list
93292023|NCT00451152|Anecortave|anecortave|mesh-list
93292024|NCT00451152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93292025|NCT00451152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93292026|NCT00451152|Growth Substances|growth substances|mesh-ancestor
93292027|NCT00451152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292028|NCT00451152|Growth Inhibitors|growth inhibitors|mesh-ancestor
93292029|NCT00451152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292030|NCT00451152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292031|NCT02078583|Fentanyl|fentanyl|mesh-list
93292032|NCT02078583|Remifentanil|remifentanil|mesh-list
93292033|NCT02078583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292034|NCT02078583|Narcotics|narcotics|mesh-ancestor
93292035|NCT02078583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292036|NCT02078583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292037|NCT02078583|Analgesics|analgesics|mesh-ancestor
93292038|NCT02078583|Sensory System Agents|sensory system agents|mesh-ancestor
93292039|NCT02078583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292040|NCT02078583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93292041|NCT02078583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93292042|NCT02078583|Anesthetics, General|anesthetics, general|mesh-ancestor
93292043|NCT02078583|Anesthetics|anesthetics|mesh-ancestor
93292044|NCT03069638|Dexmedetomidine|dexmedetomidine|mesh-list
93292045|NCT03069638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
91933388|NCT02223377|Narcotics|narcotics|mesh-ancestor
93292046|NCT03069638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292047|NCT03069638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292048|NCT03069638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292049|NCT03069638|Analgesics|analgesics|mesh-ancestor
93292050|NCT03069638|Sensory System Agents|sensory system agents|mesh-ancestor
93292051|NCT03069638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292052|NCT03069638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93292053|NCT03069638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93292054|NCT03069638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93292055|NCT03069638|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292056|NCT03069638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292057|NCT03069638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292058|NCT02948660|Zolpidem|zolpidem|mesh-list
93292059|NCT02948660|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93292060|NCT02948660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93292061|NCT02948660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292062|NCT02948660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292063|NCT02948660|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93292064|NCT02948660|GABA Agonists|gaba agonists|mesh-ancestor
93292065|NCT02948660|GABA Agents|gaba agents|mesh-ancestor
93292066|NCT02948660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292067|NCT02948660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292068|NCT02074605|Interferons|interferons|mesh-list
93292069|NCT02074605|Interferon-alpha|interferon-alpha|mesh-list
93292070|NCT02074605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292071|NCT02074605|Antiviral Agents|antiviral agents|mesh-ancestor
93292072|NCT02074605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292073|NCT02074605|Immunologic Factors|immunologic factors|mesh-ancestor
93292074|NCT02074605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292075|NCT00448422|Prulifloxacin|prulifloxacin|mesh-list
93292076|NCT00448422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93292077|NCT00448422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292078|NCT00448422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93292079|NCT00448422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93292080|NCT00448422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292081|NCT00448422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292082|NCT00448422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292083|NCT00583830|Paclitaxel|paclitaxel|mesh-list
93292084|NCT00583830|Carboplatin|carboplatin|mesh-list
93292085|NCT00583830|Mapatumumab|mapatumumab|mesh-list
93292086|NCT00583830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93292087|NCT00583830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93292088|NCT00583830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292089|NCT00583830|Tubulin Modulators|tubulin modulators|mesh-ancestor
93292090|NCT00583830|Antimitotic Agents|antimitotic agents|mesh-ancestor
93292091|NCT00583830|Mitosis Modulators|mitosis modulators|mesh-ancestor
93292092|NCT00583830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964138|NCT00757874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292093|NCT00583830|Immunologic Factors|immunologic factors|mesh-ancestor
93292094|NCT00583830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292095|NCT03430544|Cariprazine|cariprazine|mesh-list
93292096|NCT03430544|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93292097|NCT03430544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93292098|NCT03430544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292099|NCT03430544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292100|NCT03430544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93292101|NCT00583674|Cisplatin|cisplatin|mesh-list
93292102|NCT00583674|Capecitabine|capecitabine|mesh-list
93292103|NCT00583674|Trebananib|trebananib|mesh-list
93292104|NCT00583674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292105|NCT00583674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93292106|NCT00583674|Antimetabolites|antimetabolites|mesh-ancestor
93292107|NCT00583674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292108|NCT00583674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93292109|NCT00583674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93292110|NCT00583674|Growth Substances|growth substances|mesh-ancestor
93292111|NCT00583674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292112|NCT00583674|Growth Inhibitors|growth inhibitors|mesh-ancestor
93292113|NCT03422510|CXA-10|cxa-10|mesh-list
93292114|NCT03422510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292115|NCT03430466|Fulvestrant|fulvestrant|mesh-list
93292116|NCT03430466|Tremelimumab|tremelimumab|mesh-list
93292117|NCT03430466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93292118|NCT03430466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586611|NCT00402441|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93292119|NCT03430466|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93292120|NCT03430466|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93292121|NCT03430466|Hormone Antagonists|hormone antagonists|mesh-ancestor
93292122|NCT03430466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292123|NCT03430466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292124|NCT02280174|Linagliptin|linagliptin|mesh-list
93292125|NCT02280174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93292126|NCT02280174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292127|NCT02280174|Incretins|incretins|mesh-ancestor
93292128|NCT02280174|Hormones|hormones|mesh-ancestor
93292129|NCT02280174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292130|NCT02280174|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93292131|NCT02280174|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292132|NCT02280174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292133|NCT02280174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292134|NCT00447564|Buprenorphine|buprenorphine|mesh-list
93292135|NCT00447564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292136|NCT00447564|Narcotics|narcotics|mesh-ancestor
93292137|NCT00447564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292138|NCT00447564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292139|NCT00447564|Analgesics|analgesics|mesh-ancestor
93292140|NCT00447564|Sensory System Agents|sensory system agents|mesh-ancestor
93292141|NCT00447564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292142|NCT00447564|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93292143|NCT00576810|Picosulfate sodium|picosulfate sodium|mesh-list
93292144|NCT00576810|Cathartics|cathartics|mesh-ancestor
93292145|NCT00576810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292146|NCT00576342|Timolol|timolol|mesh-list
93292147|NCT00576342|Dorzolamide|dorzolamide|mesh-list
93292148|NCT00576342|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93292149|NCT00576342|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93292150|NCT00576342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93292151|NCT00576342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93292152|NCT00576342|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292153|NCT00576342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292154|NCT00576342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292155|NCT00576342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292156|NCT00576342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93292157|NCT00576342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292158|NCT00576342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93292159|NCT00576342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292160|NCT02282280|Prilocaine|prilocaine|mesh-list
93292161|NCT02282280|Anesthetics, Local|anesthetics, local|mesh-ancestor
93292162|NCT02282280|Anesthetics|anesthetics|mesh-ancestor
93292163|NCT02282280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292164|NCT02282280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292165|NCT02282280|Sensory System Agents|sensory system agents|mesh-ancestor
93292166|NCT02282280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292167|NCT03429998|Evolocumab|evolocumab|mesh-list
93292168|NCT03429998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92964214|NCT00576056|Sorafenib|sorafenib|mesh-list
93292169|NCT03429998|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93292170|NCT03429998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93292171|NCT03429998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93292172|NCT03429998|Antimetabolites|antimetabolites|mesh-ancestor
93292173|NCT03429998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292174|NCT03429998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93292175|NCT03429998|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292176|NCT03429998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292177|NCT03429998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93292178|NCT03429998|Immunologic Factors|immunologic factors|mesh-ancestor
93292179|NCT03429998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292180|NCT00658008|Paroxetine|paroxetine|mesh-list
93292181|NCT00658008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93292182|NCT00658008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93292183|NCT00658008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292184|NCT00658008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292185|NCT00658008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292186|NCT00658008|Serotonin Agents|serotonin agents|mesh-ancestor
93292187|NCT00658008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292188|NCT00658008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93292189|NCT00658008|Antidepressive Agents|antidepressive agents|mesh-ancestor
93292190|NCT00658008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93292191|NCT00658008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93292192|NCT00658008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93292193|NCT00658008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292194|NCT03427502|Epinephrine|epinephrine|mesh-list
93292195|NCT03427502|Bupivacaine|bupivacaine|mesh-list
93292196|NCT03427502|Anesthetics, Local|anesthetics, local|mesh-ancestor
93292197|NCT03427502|Anesthetics|anesthetics|mesh-ancestor
93292198|NCT03427502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292199|NCT03427502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292200|NCT03427502|Sensory System Agents|sensory system agents|mesh-ancestor
93292201|NCT03427502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292202|NCT03427502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93292203|NCT03427502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93292204|NCT03427502|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292205|NCT03427502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292206|NCT03427502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292207|NCT03427502|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93292208|NCT03427502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93292209|NCT03427502|Autonomic Agents|autonomic agents|mesh-ancestor
93292210|NCT03427502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93292211|NCT03427502|Respiratory System Agents|respiratory system agents|mesh-ancestor
93292212|NCT03427502|Mydriatics|mydriatics|mesh-ancestor
93292213|NCT03427502|Sympathomimetics|sympathomimetics|mesh-ancestor
93292214|NCT03427502|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93292215|NCT00440388|Rituximab|rituximab|mesh-list
93292216|NCT00440388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292217|NCT00440388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292218|NCT00440388|Immunologic Factors|immunologic factors|mesh-ancestor
93292219|NCT00440388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292220|NCT00440388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292221|NCT03422042|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93292222|NCT03422042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93292223|NCT03422042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292224|NCT03422042|Antitubercular Agents|antitubercular agents|mesh-ancestor
93292225|NCT04449224|Etanercept|etanercept|mesh-list
93292226|NCT04449224|Abatacept|abatacept|mesh-list
93292227|NCT04449224|Tofacitinib|tofacitinib|mesh-list
93292228|NCT04449224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93292229|NCT04449224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292230|NCT04449224|Analgesics|analgesics|mesh-ancestor
93292231|NCT04449224|Sensory System Agents|sensory system agents|mesh-ancestor
93292232|NCT04449224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292233|NCT04449224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292234|NCT04449224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292235|NCT04449224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292236|NCT04449224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292237|NCT04449224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93292238|NCT04449224|Immunologic Factors|immunologic factors|mesh-ancestor
93292239|NCT04449224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93292240|NCT04449224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292241|NCT04449224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292242|NCT04449224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292243|NCT04449224|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93292244|NCT04449224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93292246|NCT00437112|Insulin|insulin|mesh-list
93292247|NCT00437112|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93292248|NCT00437112|Insulin Glargine|insulin glargine|mesh-list
93292249|NCT00437112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93292250|NCT00437112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292251|NCT00434850|Gusperimus|gusperimus|mesh-list
93292252|NCT00434850|Sirolimus|sirolimus|mesh-list
93292253|NCT00434850|Etanercept|etanercept|mesh-list
93292254|NCT00434850|Tacrolimus|tacrolimus|mesh-list
93292255|NCT00434850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93292256|NCT00434850|Basiliximab|basiliximab|mesh-list
93292257|NCT00434850|Daclizumab|daclizumab|mesh-list
93292258|NCT00434850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93292259|NCT00434850|Immunologic Factors|immunologic factors|mesh-ancestor
93292260|NCT00434850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292261|NCT00434850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93292262|NCT00434850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292263|NCT00434850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292264|NCT00434850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93292265|NCT00434850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292266|NCT00434850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93292267|NCT00434850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292268|NCT00434850|Antifungal Agents|antifungal agents|mesh-ancestor
93292269|NCT00434850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93292270|NCT00434850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292271|NCT00434850|Analgesics|analgesics|mesh-ancestor
93292272|NCT00434850|Sensory System Agents|sensory system agents|mesh-ancestor
93292273|NCT00434850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292274|NCT00434850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292275|NCT00434850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292276|NCT00434850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292277|NCT00434850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93292278|NCT00434850|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93292279|NCT00434850|Protective Agents|protective agents|mesh-ancestor
93292280|NCT04449380|Interferons|interferons|mesh-list
93292281|NCT04449380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292282|NCT04449380|Antiviral Agents|antiviral agents|mesh-ancestor
93292283|NCT04449380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292284|NCT03128216|Bupivacaine|bupivacaine|mesh-list
93292285|NCT03128216|Ropivacaine|ropivacaine|mesh-list
93292286|NCT03128216|Anesthetics, Local|anesthetics, local|mesh-list
93292287|NCT03128216|Anesthetics|anesthetics|mesh-list
93292288|NCT03128216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292289|NCT03128216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292290|NCT03128216|Sensory System Agents|sensory system agents|mesh-ancestor
93292291|NCT03128216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292292|NCT00566202|Escitalopram|escitalopram|mesh-list
93292293|NCT00566202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93292294|NCT00566202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93292295|NCT00566202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292296|NCT00566202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292297|NCT00566202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292298|NCT00566202|Serotonin Agents|serotonin agents|mesh-ancestor
93292299|NCT00566202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292300|NCT02280486|Glimepiride|glimepiride|mesh-list
93292301|NCT02280486|Saxagliptin|saxagliptin|mesh-list
93292302|NCT02280486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93292303|NCT02280486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93292304|NCT02280486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292305|NCT02280486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93292306|NCT02280486|Immunologic Factors|immunologic factors|mesh-ancestor
93292307|NCT02280486|Incretins|incretins|mesh-ancestor
93292308|NCT02280486|Hormones|hormones|mesh-ancestor
93292309|NCT02280486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292310|NCT02280486|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93292311|NCT02280486|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292312|NCT02280486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292313|NCT02280486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292314|NCT00434226|Paclitaxel|paclitaxel|mesh-list
93292315|NCT00434226|Bevacizumab|bevacizumab|mesh-list
93292316|NCT00434226|Carboplatin|carboplatin|mesh-list
93292317|NCT00434226|Sunitinib|sunitinib|mesh-list
92964363|NCT00658632|Rabeprazole|rabeprazole|mesh-list
93292318|NCT00434226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93292319|NCT00434226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292320|NCT00434226|Tubulin Modulators|tubulin modulators|mesh-ancestor
93292321|NCT00434226|Antimitotic Agents|antimitotic agents|mesh-ancestor
93292322|NCT00434226|Mitosis Modulators|mitosis modulators|mesh-ancestor
93292323|NCT00434226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292324|NCT00434226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292325|NCT00434226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93292326|NCT00434226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93292327|NCT00434226|Growth Substances|growth substances|mesh-ancestor
93292328|NCT00434226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292329|NCT00434226|Growth Inhibitors|growth inhibitors|mesh-ancestor
93292330|NCT00434226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93292331|NCT00434226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292332|NCT00430950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93292334|NCT00430950|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93292335|NCT00430950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292336|NCT00430950|Diuretics|diuretics|mesh-ancestor
93292337|NCT00430950|Natriuretic Agents|natriuretic agents|mesh-ancestor
92586829|NCT00093678|Analgesics|analgesics|mesh-ancestor
93292338|NCT00430950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292339|NCT00430950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93292340|NCT00430950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292341|NCT00430950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292342|NCT00430950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93292343|NCT00430950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93292344|NCT00549744|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
93292345|NCT00549744|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93292346|NCT00549744|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93292347|NCT00549744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292348|NCT00549744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292349|NCT02081391|Tapentadol|tapentadol|mesh-list
93292350|NCT02081391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93292351|NCT02081391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292352|NCT02081391|Narcotics|narcotics|mesh-ancestor
93292353|NCT02081391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292354|NCT02081391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292355|NCT02081391|Analgesics|analgesics|mesh-ancestor
93292356|NCT02081391|Sensory System Agents|sensory system agents|mesh-ancestor
93292357|NCT02081391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292358|NCT02081391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93292359|NCT02081391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93292360|NCT02081391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292361|NCT02081391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292362|NCT02081391|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292363|NCT02081391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292364|NCT00549510|Lisinopril|lisinopril|mesh-list
93292365|NCT00549510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93292366|NCT00549510|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292367|NCT00549510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292368|NCT00549510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292369|NCT00549510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292370|NCT00549510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93292371|NCT00549510|Protective Agents|protective agents|mesh-ancestor
93292372|NCT00549510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292373|NCT00430092|Fluprednisolone|fluprednisolone|mesh-list
93292374|NCT00430092|Difluprednate|difluprednate|mesh-list
93292375|NCT00430092|Glucocorticoids|glucocorticoids|mesh-ancestor
93292376|NCT00430092|Hormones|hormones|mesh-ancestor
93292377|NCT00430092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292378|NCT00430092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292379|NCT00430092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292380|NCT00427440|Rilotumumab|rilotumumab|mesh-list
93292381|NCT00427440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93292382|NCT00427440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292383|NCT00427440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292384|NCT00427440|Immunologic Factors|immunologic factors|mesh-ancestor
93292385|NCT00427440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292386|NCT00650832|Darunavir|darunavir|mesh-list
93292387|NCT00650832|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93292388|NCT00650832|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92964442|NCT00571688|Dopamine Agents|dopamine agents|mesh-ancestor
93292390|NCT00650832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292391|NCT00650832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292392|NCT00650832|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93292393|NCT00650832|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93292394|NCT00650832|Antiviral Agents|antiviral agents|mesh-ancestor
93292395|NCT00650832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292396|NCT00425100|Fesoterodine|fesoterodine|mesh-list
93292397|NCT00425100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93292398|NCT00425100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93292399|NCT00425100|Cholinergic Agents|cholinergic agents|mesh-ancestor
93292400|NCT00425100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292401|NCT00425100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292402|NCT00425100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292403|NCT00425100|Urological Agents|urological agents|mesh-ancestor
93292404|NCT00546780|Bortezomib|bortezomib|mesh-list
93292405|NCT00546780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292406|NCT00420888|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93292407|NCT00420888|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
93292408|NCT00420888|Immunoconjugates|immunoconjugates|mesh-list
93292409|NCT00420888|Immunologic Factors|immunologic factors|mesh-ancestor
93292410|NCT00420888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292411|NCT00543582|Azacitidine|azacitidine|mesh-list
93292412|NCT00543582|Mocetinostat|mocetinostat|mesh-list
93292413|NCT00543582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93292414|NCT00543582|Antimetabolites|antimetabolites|mesh-ancestor
93292415|NCT00543582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292416|NCT00543582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292417|NCT00543582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292418|NCT00543582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93292419|NCT00542724|Insulin|insulin|mesh-list
93292420|NCT00542724|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93292421|NCT00542724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93292422|NCT00542724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292423|NCT00412932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93292424|NCT00412932|Olmesartan|olmesartan|mesh-list
93292425|NCT00412932|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93292426|NCT00412932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292427|NCT00412932|Diuretics|diuretics|mesh-ancestor
93292428|NCT00412932|Natriuretic Agents|natriuretic agents|mesh-ancestor
93292429|NCT00412932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292430|NCT00412932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93292431|NCT00412932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292432|NCT00412932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292433|NCT00412932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93292434|NCT00412932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93292435|NCT00411528|Prednisone|prednisone|mesh-list
93292436|NCT00411528|Docetaxel|docetaxel|mesh-list
93292437|NCT00411528|Epothilone B|epothilone b|mesh-list
93292438|NCT00411528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292439|NCT00411528|Tubulin Modulators|tubulin modulators|mesh-ancestor
93292440|NCT00411528|Antimitotic Agents|antimitotic agents|mesh-ancestor
93292441|NCT00411528|Mitosis Modulators|mitosis modulators|mesh-ancestor
93292442|NCT00411528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292443|NCT00411528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292444|NCT00411528|Glucocorticoids|glucocorticoids|mesh-ancestor
93292445|NCT00411528|Hormones|hormones|mesh-ancestor
93292446|NCT00411528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292447|NCT00411528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292448|NCT00411528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93292449|NCT00384150|Galiximab|galiximab|mesh-list
93292450|NCT00384150|Rituximab|rituximab|mesh-list
93292451|NCT00384150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292452|NCT00384150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292453|NCT00384150|Immunologic Factors|immunologic factors|mesh-ancestor
93292454|NCT00384150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292455|NCT00384150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292456|NCT00384150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292457|NCT00532038|Ketoprofen|ketoprofen|mesh-list
93292458|NCT00532038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93292459|NCT00532038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292460|NCT00532038|Analgesics|analgesics|mesh-ancestor
93292461|NCT00532038|Sensory System Agents|sensory system agents|mesh-ancestor
93292462|NCT00532038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292463|NCT00532038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292464|NCT00532038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292465|NCT00532038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292466|NCT00532038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93292467|NCT00532038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586968|NCT00085826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292468|NCT00532038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292469|NCT00403416|Mycophenolic Acid|mycophenolic acid|mesh-list
93292470|NCT00403416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93292471|NCT00403416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292472|NCT00403416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93292473|NCT00403416|Antitubercular Agents|antitubercular agents|mesh-ancestor
93292474|NCT00403416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93292475|NCT00403416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292476|NCT00403416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292477|NCT00403416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292478|NCT00401388|Allopurinol|allopurinol|mesh-list
93292479|NCT00401388|Antiemetics|antiemetics|mesh-list
93292480|NCT00401388|Loperamide|loperamide|mesh-list
93292481|NCT00401388|Antidiarrheals|antidiarrheals|mesh-list
93292482|NCT00401388|Antimetabolites|antimetabolites|mesh-ancestor
93292483|NCT00401388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292484|NCT00401388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292485|NCT00401388|Gout Suppressants|gout suppressants|mesh-ancestor
93292486|NCT00401388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292487|NCT00401388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93292488|NCT00401388|Antioxidants|antioxidants|mesh-ancestor
93292489|NCT00401388|Protective Agents|protective agents|mesh-ancestor
93292490|NCT00401388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292491|NCT00401388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292492|NCT00401388|Autonomic Agents|autonomic agents|mesh-ancestor
93292493|NCT00401388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292494|NCT02282826|Acyclovir|acyclovir|mesh-list
93292495|NCT02282826|Antiviral Agents|antiviral agents|mesh-ancestor
93292496|NCT02282826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292497|NCT00374166|Paroxetine|paroxetine|mesh-list
93292498|NCT00374166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93292499|NCT00374166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93292500|NCT00374166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292501|NCT00374166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292502|NCT00374166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292503|NCT00374166|Serotonin Agents|serotonin agents|mesh-ancestor
93292504|NCT00374166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292505|NCT00374166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93292506|NCT00374166|Antidepressive Agents|antidepressive agents|mesh-ancestor
93292507|NCT00374166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93292508|NCT00374166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93292509|NCT00374166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93292510|NCT00374166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292511|NCT03559413|Imiquimod|imiquimod|mesh-list
93292512|NCT03559413|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93292513|NCT03559413|Immunologic Factors|immunologic factors|mesh-ancestor
93292514|NCT03559413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292515|NCT03559413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292516|NCT03559413|Interferon Inducers|interferon inducers|mesh-ancestor
93292517|NCT02078895|Botulinum Toxins|botulinum toxins|mesh-list
93292518|NCT02078895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93292519|NCT02078895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93292520|NCT02078895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93292521|NCT02078895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292522|NCT02078895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292523|NCT02078895|Cholinergic Agents|cholinergic agents|mesh-ancestor
93292524|NCT02078895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292525|NCT02078895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292526|NCT02078895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93292527|NCT02078895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292528|NCT02078973|Tolvaptan|tolvaptan|mesh-list
93292529|NCT02078973|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93292530|NCT02078973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292531|NCT02078973|Natriuretic Agents|natriuretic agents|mesh-ancestor
93292532|NCT02078973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292533|NCT00397254|Rizatriptan|rizatriptan|mesh-list
93292534|NCT00397254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93292535|NCT00397254|Serotonin Agents|serotonin agents|mesh-ancestor
93292536|NCT00397254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964600|NCT00562965|Hormones|hormones|mesh-ancestor
93292537|NCT00397254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292538|NCT00397254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292540|NCT01369641|Cisplatin|cisplatin|mesh-list
93292541|NCT01369641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292542|NCT01369641|Antidotes|antidotes|mesh-ancestor
93292543|NCT01369641|Protective Agents|protective agents|mesh-ancestor
93292544|NCT01369641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292545|NCT01369641|Antioxidants|antioxidants|mesh-ancestor
93292546|NCT01369641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292547|NCT01369641|Antitubercular Agents|antitubercular agents|mesh-ancestor
93292548|NCT01369641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93292549|NCT01369641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292550|NCT01369641|Chelating Agents|chelating agents|mesh-ancestor
93292551|NCT01369641|Sequestering Agents|sequestering agents|mesh-ancestor
93292552|NCT02283060|Tenofovir|tenofovir|mesh-list
93292553|NCT02283060|Emtricitabine|emtricitabine|mesh-list
93292554|NCT02283060|Efavirenz|efavirenz|mesh-list
93292555|NCT02283060|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93292556|NCT02283060|Cobicistat|cobicistat|mesh-list
93292557|NCT02283060|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93292558|NCT02283060|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93292559|NCT02283060|Elvitegravir|elvitegravir|mesh-list
93292560|NCT02283060|Antiviral Agents|antiviral agents|mesh-ancestor
93292561|NCT02283060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292562|NCT02283060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93292563|NCT02283060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93292564|NCT02283060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292565|NCT02283060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292566|NCT02283060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93292567|NCT02283060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93292568|NCT02283060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93292569|NCT02283060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93292570|NCT02283060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93292571|NCT02283060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93292572|NCT02283060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93292573|NCT02283060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93292574|NCT02283060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93292575|NCT02283060|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93292576|NCT03559725|Menthol|menthol|mesh-list
93292577|NCT03559725|Nicotine|nicotine|mesh-list
93292578|NCT03559725|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93292579|NCT03559725|Autonomic Agents|autonomic agents|mesh-ancestor
93292580|NCT03559725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292581|NCT03559725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292582|NCT03559725|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93292583|NCT03559725|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93292584|NCT03559725|Cholinergic Agents|cholinergic agents|mesh-ancestor
93292585|NCT03559725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292586|NCT03559725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292587|NCT03559725|Antipruritics|antipruritics|mesh-ancestor
93292588|NCT03559725|Dermatologic Agents|dermatologic agents|mesh-ancestor
93292589|NCT00529152|Deferiprone|deferiprone|mesh-list
93292590|NCT00529152|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93292591|NCT00529152|Chelating Agents|chelating agents|mesh-ancestor
93292592|NCT00529152|Sequestering Agents|sequestering agents|mesh-ancestor
93292593|NCT00529152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292594|NCT00525330|Metformin|metformin|mesh-list
93292595|NCT00525330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93292596|NCT00525330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292597|NCT02287272|Cimetidine|cimetidine|mesh-list
93292598|NCT02287272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93292599|NCT02287272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292600|NCT02287272|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93292601|NCT02287272|Histamine Antagonists|histamine antagonists|mesh-ancestor
93292602|NCT02287272|Histamine Agents|histamine agents|mesh-ancestor
93292603|NCT02287272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292604|NCT02287272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292605|NCT02287272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292606|NCT02287272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93292607|NCT02287272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92964688|NCT00794976|BB 1101|bb 1101|mesh-list
93292608|NCT02287272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292609|NCT00392574|Prulifloxacin|prulifloxacin|mesh-list
93292610|NCT00392574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93292611|NCT00392574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292612|NCT00392574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93292613|NCT00392574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93292614|NCT00392574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292615|NCT00392574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292616|NCT00392574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292617|NCT04470414|Antibodies|antibodies|mesh-list
93292618|NCT04470414|Immunoglobulin G|immunoglobulin g|mesh-list
93292619|NCT04470414|Immunologic Factors|immunologic factors|mesh-ancestor
93292620|NCT04470414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292621|NCT00363636|Galiximab|galiximab|mesh-list
93292622|NCT00363636|Rituximab|rituximab|mesh-list
93292623|NCT00363636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292624|NCT00363636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292625|NCT00363636|Immunologic Factors|immunologic factors|mesh-ancestor
93292626|NCT00363636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292627|NCT00363636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292628|NCT00363636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292629|NCT02605174|Lasmiditan|lasmiditan|mesh-list
93292630|NCT02605174|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93292631|NCT02605174|Serotonin Agents|serotonin agents|mesh-ancestor
93292632|NCT02605174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292633|NCT02605174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292634|NCT02605174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292635|NCT00522834|Paclitaxel|paclitaxel|mesh-list
93292636|NCT00522834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93292637|NCT00522834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292638|NCT00522834|Tubulin Modulators|tubulin modulators|mesh-ancestor
93292639|NCT00522834|Antimitotic Agents|antimitotic agents|mesh-ancestor
93292640|NCT00522834|Mitosis Modulators|mitosis modulators|mesh-ancestor
93292641|NCT00522834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292642|NCT02075619|Amlodipine|amlodipine|mesh-list
93292643|NCT02075619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93292644|NCT02075619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292645|NCT02075619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93292646|NCT02075619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292647|NCT02075619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292648|NCT02075619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93292649|NCT02075619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292650|NCT02075619|Vasodilator Agents|vasodilator agents|mesh-ancestor
93292651|NCT02075619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93292652|NCT02075619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93292653|NCT02075619|Antimetabolites|antimetabolites|mesh-ancestor
93292654|NCT02075619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93292655|NCT02075619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93292656|NCT02075619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292657|NCT00358878|Satavaptan|satavaptan|mesh-list
93292658|NCT00358878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93292659|NCT00358878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292660|NCT00358878|Natriuretic Agents|natriuretic agents|mesh-ancestor
93292661|NCT00358878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292662|NCT02283372|Paclitaxel|paclitaxel|mesh-list
93292663|NCT02283372|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93292664|NCT02283372|Gemcitabine|gemcitabine|mesh-list
93292665|NCT02283372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93292666|NCT02283372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292667|NCT02283372|Tubulin Modulators|tubulin modulators|mesh-ancestor
93292668|NCT02283372|Antimitotic Agents|antimitotic agents|mesh-ancestor
93292669|NCT02283372|Mitosis Modulators|mitosis modulators|mesh-ancestor
93292670|NCT02283372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292671|NCT02283372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93292672|NCT02283372|Antimetabolites|antimetabolites|mesh-ancestor
93292673|NCT00507936|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93292674|NCT00507936|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93292675|NCT00507936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93292676|NCT00507936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93292677|NCT00507936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292678|NCT00507936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292679|NCT00507936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964737|NCT00803166|Hormones|hormones|mesh-ancestor
93292680|NCT00507936|Analgesics|analgesics|mesh-ancestor
93292681|NCT00507936|Sensory System Agents|sensory system agents|mesh-ancestor
93292682|NCT00507936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292683|NCT00507936|Antidepressive Agents|antidepressive agents|mesh-ancestor
93292684|NCT00507936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93292685|NCT00507936|Dopamine Agents|dopamine agents|mesh-ancestor
93292686|NCT04427020|Caseins|caseins|mesh-list
93292687|NCT04427020|Chelating Agents|chelating agents|mesh-ancestor
93292688|NCT04427020|Sequestering Agents|sequestering agents|mesh-ancestor
93292689|NCT04427020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292690|NCT02083575|Vitamins|vitamins|mesh-list
93292691|NCT02083575|Ascorbic Acid|ascorbic acid|mesh-list
93292692|NCT02083575|Deferiprone|deferiprone|mesh-list
93292693|NCT02083575|Micronutrients|micronutrients|mesh-ancestor
93292694|NCT02083575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292695|NCT02083575|Antioxidants|antioxidants|mesh-ancestor
93292696|NCT02083575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292697|NCT02083575|Protective Agents|protective agents|mesh-ancestor
93292698|NCT02083575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93292699|NCT02083575|Chelating Agents|chelating agents|mesh-ancestor
93292700|NCT02083575|Sequestering Agents|sequestering agents|mesh-ancestor
93292701|NCT02286258|Calcium, Dietary|calcium, dietary|mesh-list
93292702|NCT02286258|Edetic Acid|edetic acid|mesh-list
93292703|NCT02286258|Calcium|calcium|mesh-list
93292704|NCT02286258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93292705|NCT02286258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292706|NCT02286258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93292707|NCT02286258|Chelating Agents|chelating agents|mesh-ancestor
93292708|NCT02286258|Sequestering Agents|sequestering agents|mesh-ancestor
93292709|NCT02286258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292710|NCT02286258|Anticoagulants|anticoagulants|mesh-ancestor
93292711|NCT02286258|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93292712|NCT02088411|Diclofenac|diclofenac|mesh-list
93292713|NCT02088411|Wobenzym|wobenzym|mesh-list
93292714|NCT02088411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93292715|NCT02088411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292716|NCT02088411|Analgesics|analgesics|mesh-ancestor
93292717|NCT02088411|Sensory System Agents|sensory system agents|mesh-ancestor
93292718|NCT02088411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292719|NCT02088411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292720|NCT02088411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292721|NCT02088411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292722|NCT02088411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93292723|NCT02088411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292724|NCT02088411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292725|NCT02088411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93292726|NCT02088411|Immunologic Factors|immunologic factors|mesh-ancestor
93292727|NCT02082327|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
93292728|NCT02082327|Antiviral Agents|antiviral agents|mesh-ancestor
93292729|NCT02082327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292730|NCT02082327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292731|NCT02082327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292732|NCT02604550|Naproxen|naproxen|mesh-list
93292733|NCT02604550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93292734|NCT02604550|Ropivacaine|ropivacaine|mesh-list
93292735|NCT02604550|Anesthetics, Local|anesthetics, local|mesh-ancestor
93292736|NCT02604550|Anesthetics|anesthetics|mesh-ancestor
93292737|NCT02604550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292738|NCT02604550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292739|NCT02604550|Sensory System Agents|sensory system agents|mesh-ancestor
93292740|NCT02604550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292741|NCT02604550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93292742|NCT02604550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292743|NCT02604550|Analgesics|analgesics|mesh-ancestor
93292744|NCT02604550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292745|NCT02604550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292746|NCT02604550|Gout Suppressants|gout suppressants|mesh-ancestor
93292747|NCT02604550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93292748|NCT02604550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292749|NCT02604550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292750|NCT02604550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292751|NCT02604550|Narcotics|narcotics|mesh-ancestor
93292752|NCT02084043|Amikacin|amikacin|mesh-list
93292753|NCT02084043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93292754|NCT02084043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292755|NCT03530670|Midazolam|midazolam|mesh-list
93292756|NCT03530670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93292757|NCT03530670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93292758|NCT03530670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292759|NCT03530670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292760|NCT03530670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93292761|NCT03530670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93292762|NCT03530670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93292763|NCT03530670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93292764|NCT03530670|Anesthetics, General|anesthetics, general|mesh-ancestor
93292765|NCT03530670|Anesthetics|anesthetics|mesh-ancestor
93292766|NCT03530670|GABA Modulators|gaba modulators|mesh-ancestor
93292767|NCT03530670|GABA Agents|gaba agents|mesh-ancestor
93292768|NCT03530670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292769|NCT03530670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292770|NCT00120042|Misoprostol|misoprostol|mesh-list
93292772|NCT00120042|Oxytocics|oxytocics|mesh-ancestor
93292773|NCT00120042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93292774|NCT00120042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292775|NCT00120042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93292776|NCT00120042|Abortifacient Agents|abortifacient agents|mesh-ancestor
93292777|NCT00120042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93292778|NCT00120042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292779|NCT02084355|Fentanyl|fentanyl|mesh-list
93292780|NCT02084355|Oxycodone|oxycodone|mesh-list
93292781|NCT02084355|Hydromorphone|hydromorphone|mesh-list
93292782|NCT02084355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292783|NCT02084355|Narcotics|narcotics|mesh-ancestor
93292784|NCT02084355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292785|NCT02084355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292786|NCT02084355|Analgesics|analgesics|mesh-ancestor
93292787|NCT02084355|Sensory System Agents|sensory system agents|mesh-ancestor
93292788|NCT02084355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292789|NCT02084355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93292790|NCT02084355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93292791|NCT02084355|Anesthetics, General|anesthetics, general|mesh-ancestor
93292792|NCT02084355|Anesthetics|anesthetics|mesh-ancestor
93292793|NCT00353574|Darusentan|darusentan|mesh-list
93292794|NCT00353574|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93292795|NCT00353574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292796|NCT02082405|Dexamethasone|dexamethasone|mesh-list
93292797|NCT02082405|Cyclophosphamide|cyclophosphamide|mesh-list
93292798|NCT02082405|Bortezomib|bortezomib|mesh-list
93292799|NCT02082405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93292800|NCT02082405|Immunologic Factors|immunologic factors|mesh-ancestor
93292801|NCT02082405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292802|NCT02082405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292803|NCT02082405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93292804|NCT02082405|Alkylating Agents|alkylating agents|mesh-ancestor
93292805|NCT02082405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292806|NCT02082405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292807|NCT02082405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93292808|NCT02082405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292809|NCT02082405|Antiemetics|antiemetics|mesh-ancestor
93292810|NCT02082405|Autonomic Agents|autonomic agents|mesh-ancestor
93292811|NCT02082405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292812|NCT02082405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93292813|NCT02082405|Glucocorticoids|glucocorticoids|mesh-ancestor
93292814|NCT02082405|Hormones|hormones|mesh-ancestor
93292815|NCT02082405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93292816|NCT02082405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93292817|NCT04428268|Chloroquine|chloroquine|mesh-list
93292818|NCT04428268|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93292819|NCT04428268|Losartan|losartan|mesh-list
93292820|NCT04428268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93292821|NCT04428268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292822|NCT04428268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93292823|NCT04428268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92587317|NCT05457751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93292824|NCT04428268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292825|NCT04428268|Amebicides|amebicides|mesh-ancestor
93292826|NCT04428268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93292827|NCT04428268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92964886|NCT00936195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93292828|NCT04428268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292829|NCT04428268|Antimalarials|antimalarials|mesh-ancestor
93292830|NCT04428268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93292831|NCT04428268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93292832|NCT04428268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292834|NCT04428268|Sensory System Agents|sensory system agents|mesh-ancestor
93292835|NCT04428268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292836|NCT04428268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292837|NCT04428268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292838|NCT04428268|Filaricides|filaricides|mesh-ancestor
93292839|NCT04428268|Antinematodal Agents|antinematodal agents|mesh-ancestor
93292840|NCT04428268|Anthelmintics|anthelmintics|mesh-ancestor
93292841|NCT02084433|Anesthetics|anesthetics|mesh-list
93292842|NCT02084433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292843|NCT02084433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292844|NCT04427098|Enoxaparin|enoxaparin|mesh-list
93292845|NCT04427098|Enoxaparin sodium|enoxaparin sodium|mesh-list
93292846|NCT04427098|Anticoagulants|anticoagulants|mesh-ancestor
93292847|NCT04427098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93292848|NCT04427098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93292849|NCT04427098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292850|NCT00352560|Irbesartan|irbesartan|mesh-list
93292851|NCT00352560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93292852|NCT00352560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93292853|NCT00352560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93292854|NCT00352560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292855|NCT00115050|Darunavir|darunavir|mesh-list
93292856|NCT00115050|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93292857|NCT00115050|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93292858|NCT00115050|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292859|NCT00115050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292860|NCT00115050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292861|NCT00115050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93292862|NCT00115050|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93292863|NCT00115050|Antiviral Agents|antiviral agents|mesh-ancestor
93292864|NCT00115050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292865|NCT05616364|Dexmedetomidine|dexmedetomidine|mesh-list
93292866|NCT05616364|Tramadol|tramadol|mesh-list
93292867|NCT05616364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93292868|NCT05616364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292869|NCT05616364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292870|NCT05616364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292871|NCT05616364|Analgesics|analgesics|mesh-ancestor
93292872|NCT05616364|Sensory System Agents|sensory system agents|mesh-ancestor
93292873|NCT05616364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292874|NCT05616364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93292875|NCT05616364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93292876|NCT05616364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93292877|NCT05616364|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292878|NCT05616364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292879|NCT05616364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292880|NCT05616364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292881|NCT05616364|Narcotics|narcotics|mesh-ancestor
93292882|NCT00345618|Biotin|biotin|mesh-list
93292883|NCT00345618|Enoxaparin|enoxaparin|mesh-list
93292884|NCT00345618|Warfarin|warfarin|mesh-list
93292885|NCT00345618|Idraparinux|idraparinux|mesh-list
93292886|NCT00345618|Idrabiotaparinux|idrabiotaparinux|mesh-list
93292887|NCT00345618|Anticoagulants|anticoagulants|mesh-ancestor
93292888|NCT00345618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93292889|NCT00345618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93292890|NCT00345618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292891|NCT00345618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93292892|NCT00345618|Antithrombins|antithrombins|mesh-ancestor
93292893|NCT00345618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93292894|NCT00345618|Protease Inhibitors|protease inhibitors|mesh-ancestor
93292895|NCT00345618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292896|NCT00345618|Vitamin B Complex|vitamin b complex|mesh-ancestor
93292897|NCT00345618|Vitamins|vitamins|mesh-ancestor
93292898|NCT00345618|Micronutrients|micronutrients|mesh-ancestor
93292899|NCT00345618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292900|NCT03611868|Pembrolizumab|pembrolizumab|mesh-list
93292901|NCT03611868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93292902|NCT03611868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292903|NCT03611868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93292904|NCT03611868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292905|NCT00116298|Lamivudine|lamivudine|mesh-list
92964960|NCT00323479|Anastrozole|anastrozole|mesh-list
93292906|NCT00116298|Efavirenz|efavirenz|mesh-list
93292907|NCT00116298|Stavudine|stavudine|mesh-list
93292908|NCT00116298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93292909|NCT00116298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93292910|NCT00116298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93292911|NCT00116298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292912|NCT00116298|Antiviral Agents|antiviral agents|mesh-ancestor
93292913|NCT00116298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93292914|NCT00116298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93292915|NCT00116298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93292916|NCT00116298|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93292917|NCT00116298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93292918|NCT00116298|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93292919|NCT00116298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93292920|NCT00116298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93292921|NCT00116298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93292922|NCT00116298|Antimetabolites|antimetabolites|mesh-ancestor
93292923|NCT01866111|Cenobamate|cenobamate|mesh-list
93292924|NCT01866111|Anticonvulsants|anticonvulsants|mesh-ancestor
93292925|NCT02084589|Fentanyl|fentanyl|mesh-list
93292926|NCT02084589|Ropivacaine|ropivacaine|mesh-list
93292927|NCT02084589|Anesthetics, Local|anesthetics, local|mesh-ancestor
93292928|NCT02084589|Anesthetics|anesthetics|mesh-ancestor
93292929|NCT02084589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292930|NCT02084589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292931|NCT02084589|Sensory System Agents|sensory system agents|mesh-ancestor
93292932|NCT02084589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292933|NCT02084589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93292934|NCT02084589|Narcotics|narcotics|mesh-ancestor
93292935|NCT02084589|Analgesics|analgesics|mesh-ancestor
93292936|NCT02084589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93292937|NCT02084589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93292938|NCT02084589|Anesthetics, General|anesthetics, general|mesh-ancestor
93292939|NCT03557853|Golimumab|golimumab|mesh-list
93292940|NCT03557853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93292941|NCT03557853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93292942|NCT03557853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93292943|NCT03557853|Immunologic Factors|immunologic factors|mesh-ancestor
93292944|NCT03557853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292945|NCT04346290|Dexmedetomidine|dexmedetomidine|mesh-list
93292946|NCT04346290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93292947|NCT04346290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292948|NCT04346290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292949|NCT04346290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292950|NCT04346290|Analgesics|analgesics|mesh-ancestor
93292951|NCT04346290|Sensory System Agents|sensory system agents|mesh-ancestor
93292952|NCT04346290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292953|NCT04346290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93292954|NCT04346290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93292955|NCT04346290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93292956|NCT04346290|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292957|NCT04346290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292958|NCT04346290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292959|NCT04426552|Dexmedetomidine|dexmedetomidine|mesh-list
93292960|NCT04426552|Sevoflurane|sevoflurane|mesh-list
93292961|NCT04426552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93292962|NCT04426552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93292963|NCT04426552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292964|NCT04426552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93292965|NCT04426552|Analgesics|analgesics|mesh-ancestor
93292966|NCT04426552|Sensory System Agents|sensory system agents|mesh-ancestor
93292967|NCT04426552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93292968|NCT04426552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93292969|NCT04426552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93292970|NCT04426552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93292971|NCT04426552|Adrenergic Agents|adrenergic agents|mesh-ancestor
93292972|NCT04426552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93292973|NCT04426552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292974|NCT04426552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93292975|NCT04426552|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93292976|NCT04426552|Anesthetics, General|anesthetics, general|mesh-ancestor
93292977|NCT04426552|Anesthetics|anesthetics|mesh-ancestor
93292978|NCT04803370|Antibodies|antibodies|mesh-list
93292979|NCT04803370|Immunologic Factors|immunologic factors|mesh-ancestor
93292980|NCT04803370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93292981|NCT01369329|Ustekinumab|ustekinumab|mesh-list
93292982|NCT01369329|Dermatologic Agents|dermatologic agents|mesh-ancestor
93292983|NCT04802980|Paclitaxel|paclitaxel|mesh-list
93292984|NCT04802980|Carboplatin|carboplatin|mesh-list
93292985|NCT04802980|Gemcitabine|gemcitabine|mesh-list
93292986|NCT04802980|Capecitabine|capecitabine|mesh-list
93292987|NCT04802980|Oxaliplatin|oxaliplatin|mesh-list
93292988|NCT04802980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93292989|NCT04802980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93292990|NCT04802980|Tubulin Modulators|tubulin modulators|mesh-ancestor
93292991|NCT04802980|Antimitotic Agents|antimitotic agents|mesh-ancestor
93292992|NCT04802980|Mitosis Modulators|mitosis modulators|mesh-ancestor
93292993|NCT04802980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93292994|NCT04802980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93292995|NCT04802980|Antimetabolites|antimetabolites|mesh-ancestor
93292996|NCT02088645|Cholecystokinin|cholecystokinin|mesh-list
93292997|NCT02088645|Gastrins|gastrins|mesh-list
93292998|NCT02088645|Hormones|hormones|mesh-ancestor
93292999|NCT02088645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293000|NCT02088645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293001|NCT02088645|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93293002|NCT02088645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293003|NCT03558477|Esomeprazole|esomeprazole|mesh-list
93293004|NCT03558477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93293005|NCT03558477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293006|NCT03558477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93293007|NCT03558477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293008|NCT03558477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293009|NCT04792840|Letrozole|letrozole|mesh-list
93293010|NCT04792840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293011|NCT04792840|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93293012|NCT04792840|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93293013|NCT04792840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293014|NCT04792840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293015|NCT04792840|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93293016|NCT04792840|Hormone Antagonists|hormone antagonists|mesh-ancestor
93293017|NCT04792840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293018|NCT04792840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293019|NCT02085213|Nitroglycerin|nitroglycerin|mesh-list
93293020|NCT02085213|Vasodilator Agents|vasodilator agents|mesh-ancestor
93293021|NCT02088801|Pyrithione zinc|pyrithione zinc|mesh-list
93293022|NCT02088801|Keratolytic Agents|keratolytic agents|mesh-ancestor
93293023|NCT02088801|Dermatologic Agents|dermatologic agents|mesh-ancestor
93293024|NCT02085291|Norepinephrine|norepinephrine|mesh-list
93293025|NCT02085291|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93293026|NCT02085291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93293027|NCT02085291|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293028|NCT02085291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293029|NCT02085291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293030|NCT02085291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293031|NCT02085291|Sympathomimetics|sympathomimetics|mesh-ancestor
93293032|NCT02085291|Autonomic Agents|autonomic agents|mesh-ancestor
93293033|NCT02085291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293034|NCT02085291|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93293035|NCT04792138|Phenobarbital|phenobarbital|mesh-list
92587530|NCT00322114|Lycopene|lycopene|mesh-list
93293036|NCT04792138|Anticonvulsants|anticonvulsants|mesh-ancestor
93293037|NCT04792138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93293038|NCT04792138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293039|NCT04792138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293040|NCT04792138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93293041|NCT04792138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93293042|NCT04792138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293043|NCT04792138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293044|NCT04792138|GABA Modulators|gaba modulators|mesh-ancestor
93293045|NCT04792138|GABA Agents|gaba agents|mesh-ancestor
93293046|NCT04792138|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93293047|NCT04792138|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93293048|NCT04792138|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93293049|NCT04802122|Propofol|propofol|mesh-list
93293050|NCT04802122|Sevoflurane|sevoflurane|mesh-list
93293051|NCT04802122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93293052|NCT04802122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293053|NCT04802122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293054|NCT04802122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93293055|NCT04802122|Anesthetics, General|anesthetics, general|mesh-ancestor
93293056|NCT04802122|Anesthetics|anesthetics|mesh-ancestor
93293057|NCT04802122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93293059|NCT04784728|Lidocaine|lidocaine|mesh-list
93293060|NCT04784728|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293061|NCT04784728|Anesthetics|anesthetics|mesh-ancestor
93293062|NCT04784728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293063|NCT04784728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293064|NCT04784728|Sensory System Agents|sensory system agents|mesh-ancestor
93293065|NCT04784728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293066|NCT04784728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93293067|NCT04784728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93293068|NCT04784728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93293069|NCT04784728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293070|NCT04784728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293071|NCT02085603|Saracatinib|saracatinib|mesh-list
93293072|NCT02085603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293073|NCT02085603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293074|NCT02085603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293075|NCT02090829|Oxytocin|oxytocin|mesh-list
93293076|NCT02090829|Oxytocics|oxytocics|mesh-ancestor
93293077|NCT02090829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93293078|NCT02090829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293079|NCT04801888|Vaccines|vaccines|mesh-list
93293080|NCT04801888|Immunologic Factors|immunologic factors|mesh-ancestor
93293081|NCT04801888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293082|NCT02089503|Ranibizumab|ranibizumab|mesh-list
93293083|NCT02089503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93293084|NCT02089503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93293085|NCT02089503|Growth Substances|growth substances|mesh-ancestor
93293086|NCT02089503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293087|NCT02089503|Growth Inhibitors|growth inhibitors|mesh-ancestor
93293088|NCT02089503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293089|NCT02091063|Ricolinostat|ricolinostat|mesh-list
93293090|NCT02091063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293091|NCT02091063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93293092|NCT02091063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293093|NCT02091063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293094|NCT02091219|Vitamin D|vitamin d|mesh-list
93293095|NCT02091219|Cholecalciferol|cholecalciferol|mesh-list
93293096|NCT02091219|Calcifediol|calcifediol|mesh-list
93293097|NCT02091219|Vitamins|vitamins|mesh-ancestor
93293098|NCT02091219|Micronutrients|micronutrients|mesh-ancestor
93293099|NCT02091219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293100|NCT02091219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93293101|NCT02091219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93293102|NCT02091297|Acetaminophen|acetaminophen|mesh-list
93293103|NCT02091297|Morphine|morphine|mesh-list
93293104|NCT02091297|Ropivacaine|ropivacaine|mesh-list
93293105|NCT02091297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93293106|NCT02091297|Narcotics|narcotics|mesh-ancestor
93293107|NCT02091297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293108|NCT02091297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293109|NCT02091297|Analgesics|analgesics|mesh-ancestor
93293110|NCT02091297|Sensory System Agents|sensory system agents|mesh-ancestor
93293111|NCT02091297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293112|NCT02091297|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293113|NCT02091297|Anesthetics|anesthetics|mesh-ancestor
93293114|NCT02091297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93293115|NCT02091297|Antipyretics|antipyretics|mesh-ancestor
93293116|NCT04791202|Methylprednisolone|methylprednisolone|mesh-list
93293117|NCT04791202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93293118|NCT04791202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93293119|NCT04791202|Prednisolone|prednisolone|mesh-list
93293120|NCT04791202|Prednisolone acetate|prednisolone acetate|mesh-list
93293121|NCT04791202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93293122|NCT04791202|Prednisolone phosphate|prednisolone phosphate|mesh-list
93293123|NCT04791202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93293124|NCT04791202|Antiemetics|antiemetics|mesh-ancestor
93293125|NCT04791202|Autonomic Agents|autonomic agents|mesh-ancestor
93293126|NCT04791202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293127|NCT04791202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293128|NCT04791202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293129|NCT04791202|Glucocorticoids|glucocorticoids|mesh-ancestor
93293130|NCT04791202|Hormones|hormones|mesh-ancestor
93293131|NCT04791202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293132|NCT04791202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93293133|NCT04791202|Protective Agents|protective agents|mesh-ancestor
93293134|NCT04791202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93293135|NCT04791202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293136|NCT04801342|Memantine|memantine|mesh-list
93293137|NCT04801342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93293138|NCT04801342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93293139|NCT04801342|Dopamine Agents|dopamine agents|mesh-ancestor
93293140|NCT04801342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293141|NCT04801342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293142|NCT04801342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293143|NCT04801342|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93293144|NCT04801342|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93293145|NCT04801264|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93293146|NCT04801264|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
93293147|NCT04801264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93293148|NCT04801264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293149|NCT02590588|Idelalisib|idelalisib|mesh-list
93293150|NCT02590588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293151|NCT02590588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293152|NCT02590588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293153|NCT02086227|Glucagon|glucagon|mesh-list
93293154|NCT02086227|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93293155|NCT02086227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293156|NCT02086227|Hormones|hormones|mesh-ancestor
93293157|NCT02086227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293158|NCT02086227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293159|NCT02086227|Incretins|incretins|mesh-ancestor
93293160|NCT02086929|Trazodone|trazodone|mesh-list
93293161|NCT02086929|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93293162|NCT02086929|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93293163|NCT02086929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93293164|NCT02086929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293165|NCT02086929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293166|NCT02086929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293167|NCT02086929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293168|NCT02086929|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93293169|NCT02086929|Antidepressive Agents|antidepressive agents|mesh-ancestor
93293170|NCT02086929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293171|NCT02086929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93293172|NCT02086929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293173|NCT02086929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293174|NCT02086929|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93293175|NCT02086929|Serotonin Agents|serotonin agents|mesh-ancestor
93293176|NCT02249013|Paclitaxel|paclitaxel|mesh-list
93293177|NCT02249013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93293178|NCT02249013|Carboplatin|carboplatin|mesh-list
93293179|NCT02249013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93293180|NCT02249013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293181|NCT02249013|Tubulin Modulators|tubulin modulators|mesh-ancestor
93293182|NCT02249013|Antimitotic Agents|antimitotic agents|mesh-ancestor
93293183|NCT02249013|Mitosis Modulators|mitosis modulators|mesh-ancestor
93293184|NCT02249013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293185|NCT02249871|Omeprazole|omeprazole|mesh-list
93293186|NCT02249871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93293187|NCT02249871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293188|NCT02249871|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93293189|NCT02249871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293190|NCT02249871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293191|NCT02087007|Cilostazol|cilostazol|mesh-list
93293192|NCT02087007|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93293193|NCT02087007|Autonomic Agents|autonomic agents|mesh-ancestor
93293194|NCT02087007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293195|NCT02087007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293196|NCT02087007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93293197|NCT02087007|Respiratory System Agents|respiratory system agents|mesh-ancestor
93293198|NCT02087007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93293199|NCT02087007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93293200|NCT02087007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293201|NCT02087007|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93293202|NCT02087007|Vasodilator Agents|vasodilator agents|mesh-ancestor
93293203|NCT02087007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93293204|NCT02087007|Protective Agents|protective agents|mesh-ancestor
93293205|NCT02087007|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93293206|NCT02087007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93293208|NCT01434602|Everolimus|everolimus|mesh-list
93293209|NCT01434602|Sorafenib|sorafenib|mesh-list
93293210|NCT01434602|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93293211|NCT01434602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93293212|NCT01434602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293213|NCT01434602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293214|NCT01434602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293215|NCT01434602|Immunologic Factors|immunologic factors|mesh-ancestor
93293216|NCT01434602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293217|NCT01434602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293218|NCT02087475|Fluorouracil|fluorouracil|mesh-list
93293219|NCT02087475|Irinotecan|irinotecan|mesh-list
93293220|NCT02087475|Antimetabolites|antimetabolites|mesh-ancestor
93293221|NCT02087475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293222|NCT02087475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93293223|NCT02087475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293224|NCT02087475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293225|NCT02087475|Immunologic Factors|immunologic factors|mesh-ancestor
93293226|NCT02087475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293227|NCT02087475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93293228|NCT02087475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93293229|NCT02087475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293230|NCT05486949|Itraconazole|itraconazole|mesh-list
93293231|NCT05486949|Carbamazepine|carbamazepine|mesh-list
93293232|NCT05486949|Antifungal Agents|antifungal agents|mesh-ancestor
93293233|NCT05486949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293234|NCT05486949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93293235|NCT05486949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93293236|NCT05486949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293237|NCT05486949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293238|NCT05486949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93293239|NCT05486949|Hormone Antagonists|hormone antagonists|mesh-ancestor
93293240|NCT05486949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293241|NCT05486949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293242|NCT05486949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93293243|NCT05486949|Anticonvulsants|anticonvulsants|mesh-ancestor
93293244|NCT05486949|Antimanic Agents|antimanic agents|mesh-ancestor
93293245|NCT05486949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293246|NCT05486949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293247|NCT05486949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293248|NCT05486949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93293249|NCT05486949|Analgesics|analgesics|mesh-ancestor
93293250|NCT05486949|Sensory System Agents|sensory system agents|mesh-ancestor
93293251|NCT05486949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293252|NCT05486949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93293253|NCT05486949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293254|NCT05486949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93293255|NCT05486949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93293256|NCT03558243|Hemostatics|hemostatics|mesh-list
93293257|NCT03558243|Coagulants|coagulants|mesh-ancestor
93293258|NCT03426956|Canagliflozin|canagliflozin|mesh-list
93293259|NCT03426956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93293260|NCT03426956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293261|NCT03426956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93293262|NCT03426956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293263|NCT03557229|Vitamins|vitamins|mesh-list
93293264|NCT03557229|Vitamin E|vitamin e|mesh-list
93293265|NCT03557229|Acetylcysteine|acetylcysteine|mesh-list
93293266|NCT03557229|Melatonin|melatonin|mesh-list
93293267|NCT03557229|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93293268|NCT03557229|Micronutrients|micronutrients|mesh-ancestor
93293269|NCT03557229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293270|NCT03557229|Antioxidants|antioxidants|mesh-ancestor
93293271|NCT03557229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293272|NCT03557229|Protective Agents|protective agents|mesh-ancestor
93293273|NCT03557229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293274|NCT03557229|Antiviral Agents|antiviral agents|mesh-ancestor
93293275|NCT03557229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293276|NCT03557229|Expectorants|expectorants|mesh-ancestor
93293277|NCT03557229|Respiratory System Agents|respiratory system agents|mesh-ancestor
93293278|NCT03557229|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93293279|NCT03557229|Antidotes|antidotes|mesh-ancestor
93293280|NCT02087631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92965330|NCT00309907|Glucocorticoids|glucocorticoids|mesh-ancestor
93293281|NCT02087631|Antidepressive Agents|antidepressive agents|mesh-ancestor
93293282|NCT02087631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293283|NCT02087631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93293284|NCT02087631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293285|NCT02087631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293286|NCT02087631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293287|NCT00940940|Vaccines|vaccines|mesh-list
93293288|NCT00940940|Immunologic Factors|immunologic factors|mesh-ancestor
93293289|NCT00940940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293290|NCT03557840|Temocillin|temocillin|mesh-list
93293291|NCT03557840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93293292|NCT03557840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293293|NCT02092701|Cholecalciferol|cholecalciferol|mesh-list
93293294|NCT02092701|Vitamin D|vitamin d|mesh-list
93293295|NCT02092701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93293296|NCT02092701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293297|NCT02092701|Vitamins|vitamins|mesh-ancestor
93293298|NCT02092701|Micronutrients|micronutrients|mesh-ancestor
93293299|NCT02092701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93293300|NCT01767129|Quinidine|quinidine|mesh-list
93293301|NCT01767129|Dextromethorphan|dextromethorphan|mesh-list
93293302|NCT01767129|Antitussive Agents|antitussive agents|mesh-ancestor
93293303|NCT01767129|Respiratory System Agents|respiratory system agents|mesh-ancestor
93293304|NCT01767129|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93293305|NCT01767129|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93293306|NCT01767129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293307|NCT01767129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293308|NCT01767129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293309|NCT01767129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93293310|NCT01767129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93293311|NCT01767129|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293312|NCT01767129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93293313|NCT01767129|Antimalarials|antimalarials|mesh-ancestor
93293314|NCT01767129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93293315|NCT01767129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93293316|NCT01767129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293317|NCT01767129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293318|NCT01767129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93293319|NCT01767129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93293320|NCT01767129|Cholinergic Agents|cholinergic agents|mesh-ancestor
93293321|NCT01767129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93293322|NCT01767129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93293323|NCT01767129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293324|NCT01767129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93293325|NCT01767129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93293326|NCT01309191|Minoxidil|minoxidil|mesh-list
93293327|NCT01309191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93293328|NCT01309191|Vasodilator Agents|vasodilator agents|mesh-ancestor
93293329|NCT03420638|Epinephrine|epinephrine|mesh-list
93293330|NCT03420638|Bupivacaine|bupivacaine|mesh-list
93293331|NCT03420638|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293332|NCT03420638|Anesthetics|anesthetics|mesh-ancestor
93293333|NCT03420638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293334|NCT03420638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293335|NCT03420638|Sensory System Agents|sensory system agents|mesh-ancestor
93293336|NCT03420638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293337|NCT03420638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93293338|NCT03420638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93293339|NCT03420638|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293340|NCT03420638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293341|NCT03420638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293342|NCT03420638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93293343|NCT03420638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93293344|NCT03420638|Autonomic Agents|autonomic agents|mesh-ancestor
93293345|NCT03420638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93293346|NCT03420638|Respiratory System Agents|respiratory system agents|mesh-ancestor
93293347|NCT03420638|Mydriatics|mydriatics|mesh-ancestor
93293348|NCT03420638|Sympathomimetics|sympathomimetics|mesh-ancestor
93293349|NCT03420638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93293350|NCT00715988|Methadone|methadone|mesh-list
93293351|NCT00715988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93293352|NCT00715988|Narcotics|narcotics|mesh-ancestor
93293353|NCT00715988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293354|NCT00715988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293355|NCT00715988|Analgesics|analgesics|mesh-ancestor
93293356|NCT00715988|Sensory System Agents|sensory system agents|mesh-ancestor
93293357|NCT00715988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293358|NCT00715988|Antitussive Agents|antitussive agents|mesh-ancestor
93293359|NCT00715988|Respiratory System Agents|respiratory system agents|mesh-ancestor
93293360|NCT02093091|Vitremer|vitremer|mesh-list
93293361|NCT02093091|Cariostatic Agents|cariostatic agents|mesh-ancestor
93293362|NCT02093091|Protective Agents|protective agents|mesh-ancestor
93293363|NCT02093091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293364|NCT02791269|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93293365|NCT02791269|Antiviral Agents|antiviral agents|mesh-ancestor
93293366|NCT02791269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293367|NCT03556917|Caffeine|caffeine|mesh-list
93293368|NCT03556917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93293369|NCT03556917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293370|NCT03556917|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93293371|NCT03556917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293372|NCT03556917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293373|NCT03556917|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93293374|NCT03556917|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93293375|NCT03556917|Purinergic Agents|purinergic agents|mesh-ancestor
93293376|NCT03556917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293377|NCT02090439|Silodosin|silodosin|mesh-list
93293378|NCT02090439|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93293379|NCT02090439|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93293380|NCT02090439|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93293381|NCT02090439|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293382|NCT02090439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293383|NCT02090439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293384|NCT02090439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293385|NCT02090439|Urological Agents|urological agents|mesh-ancestor
93293386|NCT02696564|Losartan|losartan|mesh-list
93293387|NCT02696564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93293388|NCT02696564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93293389|NCT02696564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93293390|NCT02696564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93293391|NCT02696564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293392|NCT02093403|Decitabine|decitabine|mesh-list
93293393|NCT02093403|Azacitidine|azacitidine|mesh-list
93293394|NCT02093403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93293395|NCT02093403|Antimetabolites|antimetabolites|mesh-ancestor
92118142|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93293396|NCT02093403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293397|NCT02093403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293398|NCT02093403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293399|NCT03426176|Oxytocin|oxytocin|mesh-list
93293400|NCT03426176|Oxytocics|oxytocics|mesh-ancestor
93293401|NCT03426176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93293402|NCT03426176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293403|NCT02095899|Rufinamide|rufinamide|mesh-list
93293404|NCT02095899|Anticonvulsants|anticonvulsants|mesh-ancestor
93293405|NCT02095899|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93293406|NCT02095899|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93293407|NCT02095899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293408|NCT02095899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366409|NCT03560375|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93366410|NCT03560375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366411|NCT03560375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93366412|NCT03560375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366413|NCT02382016|Macitentan|macitentan|mesh-list
93366414|NCT02382016|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93366415|NCT02382016|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93366416|NCT02382016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366417|NCT02382016|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93366418|NCT02422186|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93366419|NCT02422186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93366420|NCT02422186|Sertraline|sertraline|mesh-list
93366421|NCT02422186|Antidepressive Agents|antidepressive agents|mesh-list
93366422|NCT02422186|Esketamine|esketamine|mesh-list
93366423|NCT02422186|Escitalopram|escitalopram|mesh-list
93366424|NCT02422186|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93366425|NCT02422186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93366426|NCT02422186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366427|NCT02422186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366428|NCT02422186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293409|NCT03525002|Bromocriptine|bromocriptine|mesh-list
93293410|NCT03525002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93293411|NCT03525002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93293412|NCT03525002|Hormone Antagonists|hormone antagonists|mesh-ancestor
93293413|NCT03525002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293414|NCT03525002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293415|NCT03525002|Dopamine Agonists|dopamine agonists|mesh-ancestor
93293416|NCT03525002|Dopamine Agents|dopamine agents|mesh-ancestor
93293417|NCT03525002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293418|NCT03525002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293419|NCT03426020|Midazolam|midazolam|mesh-list
93293420|NCT03426020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93293421|NCT03426020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93293422|NCT03426020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293423|NCT03426020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293424|NCT03426020|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93293425|NCT03426020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293426|NCT03426020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293427|NCT03426020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93293428|NCT03426020|Anesthetics, General|anesthetics, general|mesh-ancestor
93293429|NCT03426020|Anesthetics|anesthetics|mesh-ancestor
93293430|NCT03426020|GABA Modulators|gaba modulators|mesh-ancestor
93293431|NCT03426020|GABA Agents|gaba agents|mesh-ancestor
93293432|NCT03426020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293433|NCT03426020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293434|NCT03428906|Oxytocin|oxytocin|mesh-list
93293435|NCT03428906|Oxytocics|oxytocics|mesh-ancestor
93293436|NCT03428906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93293437|NCT03428906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293438|NCT02521298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93293439|NCT02521298|Methylprednisolone|methylprednisolone|mesh-list
93293440|NCT02521298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93293441|NCT02521298|Prednisolone|prednisolone|mesh-list
93293442|NCT02521298|Prednisolone acetate|prednisolone acetate|mesh-list
93293443|NCT02521298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93293444|NCT02521298|Prednisolone phosphate|prednisolone phosphate|mesh-list
93293445|NCT02521298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93293446|NCT02521298|Antiemetics|antiemetics|mesh-ancestor
93293447|NCT02521298|Autonomic Agents|autonomic agents|mesh-ancestor
92587962|NCT00087737|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93293448|NCT02521298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293449|NCT02521298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293450|NCT02521298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293451|NCT02521298|Glucocorticoids|glucocorticoids|mesh-ancestor
93293452|NCT02521298|Hormones|hormones|mesh-ancestor
93293453|NCT02521298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293454|NCT02521298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93293455|NCT02521298|Protective Agents|protective agents|mesh-ancestor
93293456|NCT02521298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93293457|NCT02521298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293458|NCT00389870|Cyclosporine|cyclosporine|mesh-list
93293459|NCT00389870|Irinotecan|irinotecan|mesh-list
93293460|NCT00389870|Panitumumab|panitumumab|mesh-list
93293461|NCT00389870|Cyclosporins|cyclosporins|mesh-list
93293462|NCT00389870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93293463|NCT00389870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93293464|NCT00389870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293465|NCT00389870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293466|NCT00389870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293467|NCT00389870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293468|NCT00389870|Immunologic Factors|immunologic factors|mesh-ancestor
93293469|NCT00389870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293470|NCT00389870|Antifungal Agents|antifungal agents|mesh-ancestor
93293471|NCT00389870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293472|NCT00389870|Dermatologic Agents|dermatologic agents|mesh-ancestor
93293473|NCT00389870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93293474|NCT00389870|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93293475|NCT00389870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293476|NCT03419858|Naloxone|naloxone|mesh-list
93293477|NCT03419858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93293478|NCT03419858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293479|NCT03419858|Sensory System Agents|sensory system agents|mesh-ancestor
93293480|NCT03419858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293481|NCT03417206|Remifentanil|remifentanil|mesh-list
93293482|NCT03417206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93293483|NCT03417206|Narcotics|narcotics|mesh-ancestor
92965556|NCT00759824|Antimanic Agents|antimanic agents|mesh-ancestor
93366429|NCT02422186|Serotonin Agents|serotonin agents|mesh-ancestor
93293484|NCT03417206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293485|NCT03417206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293487|NCT03417206|Sensory System Agents|sensory system agents|mesh-ancestor
93293488|NCT03417206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293489|NCT00003716|Rituximab|rituximab|mesh-list
93293490|NCT00003716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293491|NCT00003716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293492|NCT00003716|Immunologic Factors|immunologic factors|mesh-ancestor
93293493|NCT00003716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293494|NCT00003716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93293495|NCT02593786|Nivolumab|nivolumab|mesh-list
93293496|NCT02593786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293497|NCT02593786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293498|NCT02593786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93293499|NCT02593786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293500|NCT03425708|Febuxostat|febuxostat|mesh-list
93293501|NCT03425708|Gout Suppressants|gout suppressants|mesh-ancestor
93293502|NCT03425708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93293503|NCT03425552|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93293504|NCT03425552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93293505|NCT03425552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293506|NCT03425552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293507|NCT03425552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293508|NCT03425552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293509|NCT03425552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93293510|NCT03425552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93293511|NCT03425552|Serotonin Agents|serotonin agents|mesh-ancestor
93293512|NCT03425552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293513|NCT03425552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293514|NCT03425552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93293515|NCT03425552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93293516|NCT03425552|Dopamine Agents|dopamine agents|mesh-ancestor
93293517|NCT04791046|Antihypertensive Agents|antihypertensive agents|mesh-list
93293518|NCT03425474|Propofol|propofol|mesh-list
93293519|NCT03425474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93293520|NCT03425474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293521|NCT03425474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293522|NCT03425474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93293523|NCT03425474|Anesthetics, General|anesthetics, general|mesh-ancestor
93293524|NCT03425474|Anesthetics|anesthetics|mesh-ancestor
93293525|NCT03419624|Metformin|metformin|mesh-list
93293526|NCT03419624|Dapagliflozin|dapagliflozin|mesh-list
93293527|NCT03419624|Exenatide|exenatide|mesh-list
93293528|NCT03419624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93293529|NCT03419624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293530|NCT03419624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93293531|NCT03419624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293532|NCT03419624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93293533|NCT03419624|Incretins|incretins|mesh-ancestor
93293534|NCT03419624|Hormones|hormones|mesh-ancestor
93293535|NCT03419624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293536|NCT02096055|Idarubicin|idarubicin|mesh-list
93293537|NCT02096055|Cladribine|cladribine|mesh-list
93293538|NCT02096055|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93293539|NCT02096055|Guadecitabine|guadecitabine|mesh-list
93293540|NCT02096055|Azacitidine|azacitidine|mesh-list
93293541|NCT02096055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93293542|NCT02096055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293543|NCT02096055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93293544|NCT02096055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93293545|NCT02096055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293546|NCT02096055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293547|NCT02096055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293548|NCT02096055|Immunologic Factors|immunologic factors|mesh-ancestor
93293549|NCT02096055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293550|NCT02096055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93293551|NCT02096055|Antimetabolites|antimetabolites|mesh-ancestor
93293552|NCT03425162|Morphine|morphine|mesh-list
93293553|NCT03425162|Bupivacaine|bupivacaine|mesh-list
93293554|NCT03425162|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293555|NCT03425162|Anesthetics|anesthetics|mesh-ancestor
93293556|NCT03425162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293557|NCT03425162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293558|NCT03425162|Sensory System Agents|sensory system agents|mesh-ancestor
93293559|NCT03425162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293560|NCT03425162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93293561|NCT03425162|Narcotics|narcotics|mesh-ancestor
93293562|NCT03425162|Analgesics|analgesics|mesh-ancestor
93293563|NCT02096133|Cholecalciferol|cholecalciferol|mesh-list
93293564|NCT02096133|Vitamin D|vitamin d|mesh-list
93293565|NCT02096133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93293566|NCT02096133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293567|NCT02096133|Vitamins|vitamins|mesh-ancestor
93293568|NCT02096133|Micronutrients|micronutrients|mesh-ancestor
93293569|NCT02096133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93293570|NCT02096289|Thioridazine|thioridazine|mesh-list
93293571|NCT02096289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93293572|NCT02096289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293573|NCT02096289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293574|NCT02096289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293575|NCT02096289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293576|NCT02096289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93293577|NCT02096289|Dopamine Agents|dopamine agents|mesh-ancestor
93293578|NCT02096289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293579|NCT02096289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293580|NCT02090673|Exenatide|exenatide|mesh-list
93293581|NCT02090673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93293582|NCT02090673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293583|NCT02090673|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93293584|NCT02090673|Incretins|incretins|mesh-ancestor
93293585|NCT02090673|Hormones|hormones|mesh-ancestor
93293586|NCT02090673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293587|NCT03556371|Acetylcysteine|acetylcysteine|mesh-list
93293588|NCT03556371|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93293589|NCT03556371|Antiviral Agents|antiviral agents|mesh-ancestor
93293590|NCT03556371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293591|NCT03556371|Expectorants|expectorants|mesh-ancestor
93293592|NCT03556371|Respiratory System Agents|respiratory system agents|mesh-ancestor
93293593|NCT03556371|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93293594|NCT03556371|Antioxidants|antioxidants|mesh-ancestor
92588107|NCT05831345|Dsuvia|dsuvia|mesh-list
93293595|NCT03556371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293596|NCT03556371|Protective Agents|protective agents|mesh-ancestor
93293597|NCT03556371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293598|NCT03556371|Antidotes|antidotes|mesh-ancestor
93293599|NCT02827526|Ketamine|ketamine|mesh-list
93293600|NCT02827526|Analgesics|analgesics|mesh-ancestor
93293601|NCT02827526|Sensory System Agents|sensory system agents|mesh-ancestor
93293602|NCT02827526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293603|NCT02827526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293604|NCT02827526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93293605|NCT02827526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93293606|NCT02827526|Anesthetics, General|anesthetics, general|mesh-ancestor
93293607|NCT02827526|Anesthetics|anesthetics|mesh-ancestor
93293608|NCT02827526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293609|NCT02827526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93293610|NCT02827526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93293611|NCT02827526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293612|NCT02827526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293613|NCT04799314|Tislelizumab|tislelizumab|mesh-list
93293614|NCT04799314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93293615|NCT04799314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293616|NCT04799314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293617|NCT04799314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293618|NCT03425084|Morphine|morphine|mesh-list
93293619|NCT03425084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93293620|NCT03425084|Narcotics|narcotics|mesh-ancestor
93293621|NCT03425084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293622|NCT03425084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293623|NCT03425084|Analgesics|analgesics|mesh-ancestor
93293624|NCT03425084|Sensory System Agents|sensory system agents|mesh-ancestor
93293625|NCT03425084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293626|NCT03424928|Thalidomide|thalidomide|mesh-list
93293627|NCT03424928|Pomalidomide|pomalidomide|mesh-list
93293628|NCT03424928|Immunologic Factors|immunologic factors|mesh-ancestor
93293629|NCT03424928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293630|NCT03424928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93293631|NCT03424928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93293632|NCT03424928|Growth Substances|growth substances|mesh-ancestor
93293633|NCT03424928|Growth Inhibitors|growth inhibitors|mesh-ancestor
93293634|NCT03424928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293635|NCT03424928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293636|NCT03424928|Leprostatic Agents|leprostatic agents|mesh-ancestor
93293637|NCT03424928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93293638|NCT03424928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293639|NCT04799002|Melphalan|melphalan|mesh-list
93293640|NCT04799002|Topotecan|topotecan|mesh-list
93293641|NCT04799002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93293642|NCT04799002|Alkylating Agents|alkylating agents|mesh-ancestor
93293643|NCT04799002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293644|NCT04799002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293645|NCT04799002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93293646|NCT04799002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293647|NCT04799002|Immunologic Factors|immunologic factors|mesh-ancestor
93293648|NCT04799002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293649|NCT04799002|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93293650|NCT04799002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93293651|NCT04799002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293652|NCT02098785|Caffeine|caffeine|mesh-list
93293653|NCT02098785|Caffeine citrate|caffeine citrate|mesh-list
93293654|NCT02098785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293655|NCT02098785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93293656|NCT02098785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293657|NCT02098785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93293658|NCT02098785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293659|NCT02098785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93293660|NCT02098785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93293661|NCT02098785|Purinergic Agents|purinergic agents|mesh-ancestor
93293662|NCT02098785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293663|NCT04798612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93293664|NCT04798612|Antiviral Agents|antiviral agents|mesh-ancestor
93293665|NCT04798612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293666|NCT02521064|Prednisone|prednisone|mesh-list
93293667|NCT02521064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93293668|NCT02521064|Glucocorticoids|glucocorticoids|mesh-ancestor
93293669|NCT02521064|Hormones|hormones|mesh-ancestor
93293670|NCT02521064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293671|NCT02521064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293672|NCT02521064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93293673|NCT02521064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293674|NCT02096913|Ibuprofen|ibuprofen|mesh-list
93293675|NCT02096913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93293676|NCT02096913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93293677|NCT02096913|Analgesics|analgesics|mesh-ancestor
93293678|NCT02096913|Sensory System Agents|sensory system agents|mesh-ancestor
93293679|NCT02096913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293680|NCT02096913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293681|NCT02096913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93293682|NCT02096913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93293683|NCT02096913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93293684|NCT02096913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293685|NCT02096913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293686|NCT03418610|Azelaic acid|azelaic acid|mesh-list
93293687|NCT03418610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293688|NCT03418610|Dermatologic Agents|dermatologic agents|mesh-ancestor
93293689|NCT04604366|Alprostadil|alprostadil|mesh-list
93293690|NCT04604366|Misoprostol|misoprostol|mesh-list
93293691|NCT04604366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93293692|NCT04604366|Abortifacient Agents|abortifacient agents|mesh-ancestor
93293693|NCT04604366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93293694|NCT04604366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293695|NCT04604366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93293696|NCT04604366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293697|NCT04604366|Oxytocics|oxytocics|mesh-ancestor
93293698|NCT04604366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93293699|NCT04604366|Vasodilator Agents|vasodilator agents|mesh-ancestor
93293700|NCT04604366|Urological Agents|urological agents|mesh-ancestor
93293701|NCT02099253|Dexmedetomidine|dexmedetomidine|mesh-list
93293702|NCT02099253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93293703|NCT02099253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293704|NCT02099253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293705|NCT02099253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93293706|NCT02099253|Analgesics|analgesics|mesh-ancestor
93293707|NCT02099253|Sensory System Agents|sensory system agents|mesh-ancestor
93293708|NCT02099253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293709|NCT02099253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93293710|NCT02099253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93293711|NCT02099253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93293712|NCT02099253|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293713|NCT02099253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293714|NCT02099253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293715|NCT05818111|Lidocaine|lidocaine|mesh-list
93293716|NCT05818111|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293717|NCT05818111|Anesthetics|anesthetics|mesh-ancestor
93293718|NCT05818111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293719|NCT05818111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293720|NCT05818111|Sensory System Agents|sensory system agents|mesh-ancestor
93293721|NCT05818111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293722|NCT05818111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93293723|NCT05818111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93293724|NCT05818111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93293725|NCT05818111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293726|NCT05818111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293727|NCT05818007|Hyaluronic Acid|hyaluronic acid|mesh-list
93293728|NCT05818007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93293729|NCT05818007|Immunologic Factors|immunologic factors|mesh-ancestor
93293730|NCT05818007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293731|NCT05818007|Viscosupplements|viscosupplements|mesh-ancestor
93293732|NCT05818007|Protective Agents|protective agents|mesh-ancestor
93293733|NCT05817955|Azacitidine|azacitidine|mesh-list
93293734|NCT05817955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93293735|NCT05817955|Antimetabolites|antimetabolites|mesh-ancestor
93293736|NCT05817955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293737|NCT05817955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293738|NCT05817955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293739|NCT05817409|Baclofen|baclofen|mesh-list
93293740|NCT05817409|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93293741|NCT05817409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293742|NCT05817409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93293743|NCT05817409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293744|NCT05817409|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93293745|NCT05817409|GABA Agonists|gaba agonists|mesh-ancestor
93293746|NCT05817409|GABA Agents|gaba agents|mesh-ancestor
93293747|NCT05817409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293748|NCT05817409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293749|NCT05817253|Coal Tar|coal tar|mesh-list
93293750|NCT05817253|Keratolytic Agents|keratolytic agents|mesh-ancestor
93293751|NCT05817253|Dermatologic Agents|dermatologic agents|mesh-ancestor
93293752|NCT05817201|Tegafur|tegafur|mesh-list
93293753|NCT05817201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93293754|NCT05817201|Antimetabolites|antimetabolites|mesh-ancestor
93293755|NCT05817201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293756|NCT05817201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293757|NCT05817019|Neostigmine|neostigmine|mesh-list
93293758|NCT05817019|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93293759|NCT05817019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293760|NCT05817019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293761|NCT05817019|Cholinergic Agents|cholinergic agents|mesh-ancestor
93293762|NCT05817019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293763|NCT05817019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293764|NCT05817019|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93293765|NCT05817019|Autonomic Agents|autonomic agents|mesh-ancestor
93293766|NCT05817019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293767|NCT05816772|Calcium|calcium|mesh-list
93293768|NCT05816772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93293769|NCT05816772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293770|NCT05816733|Dapagliflozin|dapagliflozin|mesh-list
93293771|NCT05816733|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93293772|NCT05816733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293773|NCT05816733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93293774|NCT05816733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293775|NCT05816720|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93293776|NCT05816720|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93293777|NCT05816720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293778|NCT05816707|Turmeric extract|turmeric extract|mesh-list
93293779|NCT05816707|Antioxidants|antioxidants|mesh-ancestor
93293780|NCT05816707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293781|NCT05816707|Protective Agents|protective agents|mesh-ancestor
93293782|NCT05816707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293784|NCT05816694|Cyclophosphamide|cyclophosphamide|mesh-list
93293785|NCT05816694|Cisplatin|cisplatin|mesh-list
93293786|NCT05816694|Epirubicin|epirubicin|mesh-list
93293787|NCT05816694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93293788|NCT05816694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293789|NCT05816694|Tubulin Modulators|tubulin modulators|mesh-ancestor
93293790|NCT05816694|Antimitotic Agents|antimitotic agents|mesh-ancestor
93293791|NCT05816694|Mitosis Modulators|mitosis modulators|mesh-ancestor
93293792|NCT05816694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293793|NCT05816694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293794|NCT05816694|Immunologic Factors|immunologic factors|mesh-ancestor
93293795|NCT05816694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293796|NCT05816694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93293797|NCT05816694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93293798|NCT05816694|Alkylating Agents|alkylating agents|mesh-ancestor
93293799|NCT05816694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93293800|NCT05816694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93293801|NCT05816694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93293802|NCT05816694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93293803|NCT05816694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293804|NCT05816668|Tranexamic Acid|tranexamic acid|mesh-list
93293805|NCT05816668|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92588323|NCT05574400|Caffeine|caffeine|mesh-list
93293806|NCT05816668|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93293807|NCT05816668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293808|NCT05816668|Hemostatics|hemostatics|mesh-ancestor
93293809|NCT05816668|Coagulants|coagulants|mesh-ancestor
93293810|NCT05816655|Fulvestrant|fulvestrant|mesh-list
93293811|NCT05816655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93293812|NCT05816655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293813|NCT05816655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93293814|NCT05816655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93293815|NCT05816655|Hormone Antagonists|hormone antagonists|mesh-ancestor
93293816|NCT05816655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293817|NCT05816655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293818|NCT05816642|Sunitinib|sunitinib|mesh-list
93293819|NCT05816642|Axitinib|axitinib|mesh-list
93293820|NCT05816642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93293821|NCT05816642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293822|NCT05816642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93293823|NCT05816642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93293824|NCT05816642|Growth Substances|growth substances|mesh-ancestor
93293825|NCT05816642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293826|NCT05816642|Growth Inhibitors|growth inhibitors|mesh-ancestor
93293827|NCT05816642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93293828|NCT05816642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293829|NCT05816642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293830|NCT05816642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293831|NCT05816538|Anesthetics|anesthetics|mesh-list
93293832|NCT05816538|Levobupivacaine|levobupivacaine|mesh-list
93293833|NCT05816538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293834|NCT05816538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293835|NCT05816538|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293836|NCT05816538|Sensory System Agents|sensory system agents|mesh-ancestor
93293837|NCT05816538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293838|NCT05813847|Anesthetics|anesthetics|mesh-list
93293839|NCT05813847|Anesthetics, Local|anesthetics, local|mesh-list
93293840|NCT05813847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293841|NCT05813847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293842|NCT05813847|Sensory System Agents|sensory system agents|mesh-ancestor
93293843|NCT05813847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293844|NCT05809583|Ozanimod|ozanimod|mesh-list
93293845|NCT05809583|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93293846|NCT05809583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293847|NCT05809583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293848|NCT05809583|Immunologic Factors|immunologic factors|mesh-ancestor
93293849|NCT05809583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293850|NCT05809453|Lidocaine|lidocaine|mesh-list
93293851|NCT05809453|Cocaine|cocaine|mesh-list
93293852|NCT05809453|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293853|NCT05809453|Anesthetics|anesthetics|mesh-ancestor
93293854|NCT05809453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965934|NCT00658320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293855|NCT05809453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293857|NCT05809453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293858|NCT05809453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93293859|NCT05809453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93293860|NCT05809453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93293861|NCT05809453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293862|NCT05809453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293863|NCT05809453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93293864|NCT05809453|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93293865|NCT05809453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93293866|NCT05809453|Dopamine Agents|dopamine agents|mesh-ancestor
93293867|NCT05809453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293868|NCT05803629|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93293869|NCT05803629|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93293870|NCT05803629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293871|NCT05803434|Cannabidiol|cannabidiol|mesh-list
93293872|NCT05803434|Anticonvulsants|anticonvulsants|mesh-ancestor
93293873|NCT05784246|Mirikizumab|mirikizumab|mesh-list
93293874|NCT05784246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93293875|NCT05784246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93293876|NCT05784246|Analgesics|analgesics|mesh-ancestor
93293877|NCT05784246|Sensory System Agents|sensory system agents|mesh-ancestor
93293878|NCT05784246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293879|NCT05784246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293880|NCT05784246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93293881|NCT05784246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93293882|NCT05784246|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93293883|NCT05784246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93293884|NCT05781542|MEDI9197|medi9197|mesh-list
93293885|NCT05781542|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93293886|NCT05781542|Immunologic Factors|immunologic factors|mesh-ancestor
93293887|NCT05781542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293888|NCT05777226|Epalrestat|epalrestat|mesh-list
93293889|NCT05777226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93293890|NCT05777226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293891|NCT05776160|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93293892|NCT05776160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293893|NCT05776160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293894|NCT05769920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93293895|NCT05769920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93293896|NCT05769010|Bevacizumab|bevacizumab|mesh-list
93293897|NCT05769010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293898|NCT05769010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293899|NCT05769010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93293900|NCT05769010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93293901|NCT05769010|Growth Substances|growth substances|mesh-ancestor
93293902|NCT05769010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293903|NCT05769010|Growth Inhibitors|growth inhibitors|mesh-ancestor
93293904|NCT05719883|Sirolimus|sirolimus|mesh-list
93293905|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93293906|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93293907|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93293908|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293909|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
93293910|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93293911|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
93293912|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293913|NCT05716607|Hydrocortisone|hydrocortisone|mesh-list
93293914|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93293915|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93293916|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93293917|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93293918|NCT05715411|Methamphetamine|methamphetamine|mesh-list
93293919|NCT05715411|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93293920|NCT05715411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293921|NCT05715411|Sympathomimetics|sympathomimetics|mesh-ancestor
93293922|NCT05715411|Autonomic Agents|autonomic agents|mesh-ancestor
93293923|NCT05715411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293924|NCT05715411|Dopamine Agents|dopamine agents|mesh-ancestor
93293925|NCT05715411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293926|NCT05715411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293927|NCT05715411|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293928|NCT05715411|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93293929|NCT05715411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93293930|NCT05715411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293931|NCT05715411|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93293932|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
93293933|NCT05688579|Mineralocorticoids|mineralocorticoids|mesh-list
93293934|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
93293935|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93293936|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293937|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93293938|NCT05688579|Diuretics|diuretics|mesh-ancestor
93293939|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
93293940|NCT05688579|Hormones|hormones|mesh-ancestor
93293941|NCT05675501|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93293942|NCT05675501|Dermatologic Agents|dermatologic agents|mesh-ancestor
93293943|NCT05662111|Etidronic Acid|etidronic acid|mesh-list
93293944|NCT05662111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93293945|NCT05662111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293946|NCT05659927|Antibodies|antibodies|mesh-list
93293947|NCT05659927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93293948|NCT05659927|Immunologic Factors|immunologic factors|mesh-ancestor
93293949|NCT05659927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293950|NCT05659823|Fentanyl|fentanyl|mesh-list
93293951|NCT05659823|Morphine|morphine|mesh-list
93293952|NCT05659823|Bupivacaine|bupivacaine|mesh-list
93293953|NCT05659823|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293954|NCT05659823|Anesthetics|anesthetics|mesh-ancestor
93293955|NCT05659823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293956|NCT05659823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293957|NCT05659823|Sensory System Agents|sensory system agents|mesh-ancestor
93293958|NCT05659823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293959|NCT05659823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93293960|NCT05659823|Narcotics|narcotics|mesh-ancestor
93293961|NCT05659823|Analgesics|analgesics|mesh-ancestor
93293962|NCT05659823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93293963|NCT05659823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93293964|NCT05659823|Anesthetics, General|anesthetics, general|mesh-ancestor
93293965|NCT05640453|Pregabalin|pregabalin|mesh-list
93293966|NCT05640453|Dexmedetomidine|dexmedetomidine|mesh-list
93293967|NCT05640453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93293968|NCT05640453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293969|NCT05640453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293970|NCT05640453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93293971|NCT05640453|Analgesics|analgesics|mesh-ancestor
93293972|NCT05640453|Sensory System Agents|sensory system agents|mesh-ancestor
93293973|NCT05640453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93293974|NCT05640453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93293975|NCT05640453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93293976|NCT05640453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93293977|NCT05640453|Adrenergic Agents|adrenergic agents|mesh-ancestor
93293978|NCT05640453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93293979|NCT05640453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93293980|NCT05640453|Anticonvulsants|anticonvulsants|mesh-ancestor
93293981|NCT05640453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93293982|NCT05640453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93293983|NCT05640453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93293984|NCT05640453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93293985|NCT05640453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93293986|NCT05640453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93293987|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
93293988|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
93293989|NCT05622071|Tislelizumab|tislelizumab|mesh-list
93293990|NCT05622071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93293991|NCT05622071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93293992|NCT05603832|Acetaminophen|acetaminophen|mesh-list
93293993|NCT05603832|Bupivacaine|bupivacaine|mesh-list
93293994|NCT05603832|Methocarbamol|methocarbamol|mesh-list
93293995|NCT05603832|Anesthetics, Local|anesthetics, local|mesh-ancestor
93293996|NCT05603832|Anesthetics|anesthetics|mesh-ancestor
93293997|NCT05603832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93293998|NCT05603832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93293999|NCT05603832|Sensory System Agents|sensory system agents|mesh-ancestor
93294000|NCT05603832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294001|NCT05603832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93294002|NCT05603832|Analgesics|analgesics|mesh-ancestor
93294003|NCT05603832|Antipyretics|antipyretics|mesh-ancestor
93294004|NCT05603832|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93294005|NCT05603832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93294006|NCT05599789|Docetaxel|docetaxel|mesh-list
93294007|NCT05599789|Pembrolizumab|pembrolizumab|mesh-list
93294008|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294009|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
93294010|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
93294011|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
93294012|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294013|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294014|NCT05599789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294015|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
93294016|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93294017|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294018|NCT05583617|Lenalidomide|lenalidomide|mesh-list
93294019|NCT05583617|Immunologic Factors|immunologic factors|mesh-ancestor
93294020|NCT05583617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294021|NCT05583617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93294022|NCT05583617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93294023|NCT05583617|Growth Substances|growth substances|mesh-ancestor
93294024|NCT05583617|Growth Inhibitors|growth inhibitors|mesh-ancestor
93294025|NCT05583617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294026|NCT05581901|Methadone|methadone|mesh-list
93294027|NCT05581901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93294028|NCT05581901|Narcotics|narcotics|mesh-ancestor
93294029|NCT05581901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294030|NCT05581901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294031|NCT05581901|Analgesics|analgesics|mesh-ancestor
93294032|NCT05581901|Sensory System Agents|sensory system agents|mesh-ancestor
93294033|NCT05581901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294034|NCT05581901|Antitussive Agents|antitussive agents|mesh-ancestor
93294035|NCT05581901|Respiratory System Agents|respiratory system agents|mesh-ancestor
93294036|NCT05564637|Treprostinil|treprostinil|mesh-list
93294037|NCT05564637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93294038|NCT05520814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93294039|NCT05520814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294040|NCT05520814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294041|NCT05520814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294042|NCT05508061|Insulin|insulin|mesh-list
93294043|NCT05508061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93294044|NCT05508061|Insulin Lispro|insulin lispro|mesh-list
93294045|NCT05508061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93294046|NCT05508061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294047|NCT05504642|Nivolumab|nivolumab|mesh-list
93294048|NCT05504642|Ipilimumab|ipilimumab|mesh-list
93294049|NCT05504642|Immunomodulating Agents|immunomodulating agents|mesh-list
93294050|NCT05504642|Immunologic Factors|immunologic factors|mesh-list
93294051|NCT05504642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294052|NCT05504642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294053|NCT05504642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294054|NCT05504642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294055|NCT05504642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294056|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
93294057|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93294058|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294059|NCT05490953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294060|NCT05490953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93294061|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93294062|NCT05490953|Protective Agents|protective agents|mesh-ancestor
93294063|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294064|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
93294065|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93294066|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
93294067|NCT05475483|Bevantolol|bevantolol|mesh-list
93294068|NCT05475483|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93294069|NCT05475483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93294070|NCT05475483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93294071|NCT05475483|Adrenergic Agents|adrenergic agents|mesh-ancestor
93294072|NCT05475483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294073|NCT05475483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294074|NCT05475483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294075|NCT05474729|Minocycline|minocycline|mesh-list
93294076|NCT05474729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93294077|NCT05474729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294078|NCT05474001|Fentanyl|fentanyl|mesh-list
93294079|NCT05474001|Bupivacaine|bupivacaine|mesh-list
92966155|NCT02558114|Antiviral Agents|antiviral agents|mesh-ancestor
93294080|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
93294081|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
93294082|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294083|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294084|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
93294085|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294086|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93294087|NCT05474001|Narcotics|narcotics|mesh-ancestor
93294088|NCT05474001|Analgesics|analgesics|mesh-ancestor
93294089|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93294090|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93294091|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
93294092|NCT05445232|Midazolam|midazolam|mesh-list
93294093|NCT05445232|Caffeine|caffeine|mesh-list
93294094|NCT05445232|Warfarin|warfarin|mesh-list
93294095|NCT05445232|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93294096|NCT05445232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93294097|NCT05445232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294098|NCT05445232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294099|NCT05445232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93294100|NCT05445232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93294101|NCT05445232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93294102|NCT05445232|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93294103|NCT05445232|Anesthetics, General|anesthetics, general|mesh-ancestor
93294104|NCT05445232|Anesthetics|anesthetics|mesh-ancestor
93294105|NCT05445232|GABA Modulators|gaba modulators|mesh-ancestor
93294106|NCT05445232|GABA Agents|gaba agents|mesh-ancestor
93294107|NCT05445232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294108|NCT05445232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294109|NCT05445232|Anticoagulants|anticoagulants|mesh-ancestor
93294110|NCT05445232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93294111|NCT05445232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93294112|NCT05445232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294113|NCT05445232|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93294114|NCT05445232|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93294115|NCT05445232|Purinergic Agents|purinergic agents|mesh-ancestor
93294116|NCT05420805|Zinc Oxide|zinc oxide|mesh-list
93294117|NCT05420805|Butyric Acid|butyric acid|mesh-list
93294118|NCT05420805|Dermatologic Agents|dermatologic agents|mesh-ancestor
93294119|NCT05420805|Sunscreening Agents|sunscreening agents|mesh-ancestor
93294120|NCT05420805|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93294121|NCT05420805|Protective Agents|protective agents|mesh-ancestor
93294122|NCT05420805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294123|NCT05420805|Histamine Antagonists|histamine antagonists|mesh-ancestor
93294124|NCT05420805|Histamine Agents|histamine agents|mesh-ancestor
93294125|NCT05420805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294126|NCT05420805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294127|NCT05419830|Antihypertensive Agents|antihypertensive agents|mesh-list
93294128|NCT05406583|Dolutegravir|dolutegravir|mesh-list
93294129|NCT05406583|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93294130|NCT05406583|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93294131|NCT05406583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294132|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294133|NCT05406583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93294134|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93294135|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
93294136|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294137|NCT05395533|Antibodies|antibodies|mesh-list
93294138|NCT05395533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93294139|NCT05395533|Immunologic Factors|immunologic factors|mesh-ancestor
93294140|NCT05395533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294141|NCT05389527|Pembrolizumab|pembrolizumab|mesh-list
93294142|NCT05389527|Lenvatinib|lenvatinib|mesh-list
93294143|NCT05389527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294144|NCT05389527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294145|NCT05389527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294146|NCT05389527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294147|NCT05389527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93294148|NCT05389527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294149|NCT05358522|Analgesics, Opioid|analgesics, opioid|mesh-list
93294150|NCT05358522|Narcotics|narcotics|mesh-ancestor
93294151|NCT05358522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294152|NCT05358522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294153|NCT05358522|Analgesics|analgesics|mesh-ancestor
93294154|NCT05358522|Sensory System Agents|sensory system agents|mesh-ancestor
93294155|NCT05358522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294156|NCT05355974|Norepinephrine|norepinephrine|mesh-list
93294157|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
93294158|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93294159|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93294160|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
93294161|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294162|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294163|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294164|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
93294165|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
93294166|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294167|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93294168|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93294169|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93294170|NCT05340413|Olaparib|olaparib|mesh-list
93294171|NCT05340413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93294172|NCT05340413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294173|NCT05340413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294174|NCT05340413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294175|NCT05323955|Trastuzumab|trastuzumab|mesh-list
93294176|NCT05323955|Pertuzumab|pertuzumab|mesh-list
93294177|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93294178|NCT05323955|Maytansine|maytansine|mesh-list
93294179|NCT05323955|Tucatinib|tucatinib|mesh-list
93294180|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294181|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294182|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93294183|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
93294184|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
93294185|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
93294186|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294187|NCT05323955|Immunotoxins|immunotoxins|mesh-ancestor
93294188|NCT05323955|Immunoconjugates|immunoconjugates|mesh-ancestor
93294189|NCT05323955|Immunologic Factors|immunologic factors|mesh-ancestor
93294190|NCT05323955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294191|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93294192|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294193|NCT05312385|Propofol|propofol|mesh-list
93294194|NCT05312385|Isoflurane|isoflurane|mesh-list
93294195|NCT05312385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93294196|NCT05312385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294197|NCT05312385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294198|NCT05312385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93294199|NCT05312385|Anesthetics, General|anesthetics, general|mesh-ancestor
93294200|NCT05312385|Anesthetics|anesthetics|mesh-ancestor
93294201|NCT05312385|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93294202|NCT05291338|Doxorubicin|doxorubicin|mesh-list
93294203|NCT05291338|Ethiodized Oil|ethiodized oil|mesh-list
93294204|NCT05291338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93294205|NCT05291338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294206|NCT05291338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93294207|NCT05291338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93294208|NCT05291338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294209|NCT05291338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294210|NCT05289193|Nivolumab|nivolumab|mesh-list
93294211|NCT05289193|Ipilimumab|ipilimumab|mesh-list
93294212|NCT05289193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294213|NCT05289193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294214|NCT05289193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294215|NCT05289193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294216|NCT05259137|Enalaprilat|enalaprilat|mesh-list
93294217|NCT05259137|Enalapril|enalapril|mesh-list
93294218|NCT05259137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93294219|NCT05259137|Protease Inhibitors|protease inhibitors|mesh-ancestor
93294220|NCT05259137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294221|NCT05259137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294222|NCT05259137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93294223|NCT05225558|Vancomycin|vancomycin|mesh-list
93294224|NCT05225558|Delpazolid|delpazolid|mesh-list
93294225|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
93294226|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93294227|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294228|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93294229|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294230|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294231|NCT05200988|Nivolumab|nivolumab|mesh-list
93294232|NCT05200988|Ipilimumab|ipilimumab|mesh-list
92588753|NCT04294628|Trastuzumab|trastuzumab|mesh-list
93294233|NCT05200988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294234|NCT05200988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294235|NCT05200988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294236|NCT05200988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294237|NCT05159830|Cannabidiol|cannabidiol|mesh-list
93294238|NCT05159830|Anticonvulsants|anticonvulsants|mesh-ancestor
93294239|NCT05148715|Tacrolimus|tacrolimus|mesh-list
93294240|NCT05148715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294241|NCT05148715|Immunologic Factors|immunologic factors|mesh-ancestor
93294242|NCT05148715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294243|NCT05148715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93294244|NCT05148715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294245|NCT05148715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294246|NCT05121883|Edaravone|edaravone|mesh-list
93294247|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93294248|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
93294249|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294250|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93294251|NCT05121883|Protective Agents|protective agents|mesh-ancestor
93294252|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294253|NCT05112211|Doxycycline|doxycycline|mesh-list
93294254|NCT05112211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93294255|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294256|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
93294257|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93294258|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93294259|NCT05110040|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93294260|NCT05110040|Immunologic Factors|immunologic factors|mesh-ancestor
93294261|NCT05110040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294262|NCT05107427|Avelumab|avelumab|mesh-list
93294263|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294264|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294265|NCT05042609|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93294266|NCT05042609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93294267|NCT05036226|Metformin|metformin|mesh-list
93294268|NCT05036226|Sirolimus|sirolimus|mesh-list
93294269|NCT05036226|Hydroxychloroquine|hydroxychloroquine|mesh-list
93294270|NCT05036226|Nelfinavir|nelfinavir|mesh-list
93294271|NCT05036226|Temsirolimus|temsirolimus|mesh-list
93294272|NCT05036226|Dasatinib|dasatinib|mesh-list
93294273|NCT05036226|MTOR Inhibitors|mtor inhibitors|mesh-list
93294274|NCT05036226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93294275|NCT05036226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294276|NCT05036226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93294277|NCT05036226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294278|NCT05036226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93294279|NCT05036226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294280|NCT05036226|Antifungal Agents|antifungal agents|mesh-ancestor
93294281|NCT05036226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294282|NCT05036226|Immunologic Factors|immunologic factors|mesh-ancestor
93294283|NCT05036226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93294284|NCT05036226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294285|NCT05036226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294286|NCT05036226|Antimalarials|antimalarials|mesh-ancestor
93294287|NCT05036226|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93294288|NCT05036226|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93294289|NCT05036226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294290|NCT05036226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93294291|NCT05036226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93294292|NCT05036226|Protease Inhibitors|protease inhibitors|mesh-ancestor
93294293|NCT05036226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93294294|NCT05036226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93294295|NCT05036226|Antiviral Agents|antiviral agents|mesh-ancestor
93294296|NCT05035745|Talazoparib|talazoparib|mesh-list
93294297|NCT05035745|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93294298|NCT05035745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294299|NCT05035745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294300|NCT05035745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294301|NCT05033080|Ivacaftor|ivacaftor|mesh-list
93294302|NCT05033080|Elexacaftor|elexacaftor|mesh-list
93294303|NCT05033080|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93294304|NCT05033080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294305|NCT05033080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294306|NCT05005897|Vitamin B 12|vitamin b 12|mesh-list
92966403|NCT00807534|Bromides|bromides|mesh-list
93294307|NCT05005897|Hydroxocobalamin|hydroxocobalamin|mesh-list
93294308|NCT05005897|Vitamins|vitamins|mesh-ancestor
93294309|NCT05005897|Micronutrients|micronutrients|mesh-ancestor
93294310|NCT05005897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294311|NCT05005897|Vitamin B Complex|vitamin b complex|mesh-ancestor
93294312|NCT05005897|Hematinics|hematinics|mesh-ancestor
93294313|NCT04994977|Carboplatin|carboplatin|mesh-list
93294315|NCT04994977|Topotecan|topotecan|mesh-list
93294316|NCT04994977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294317|NCT04994977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93294318|NCT04994977|Alkylating Agents|alkylating agents|mesh-ancestor
93294319|NCT04994977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294320|NCT04994977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93294321|NCT04994977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294322|NCT04994977|Immunologic Factors|immunologic factors|mesh-ancestor
93294323|NCT04994977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294324|NCT04994977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93294325|NCT04994977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93294326|NCT04994977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294327|NCT04931615|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93294328|NCT04931615|Thrombin|thrombin|mesh-list
93294329|NCT04931615|Hemostatics|hemostatics|mesh-ancestor
93294330|NCT04931615|Coagulants|coagulants|mesh-ancestor
93294331|NCT04869943|Exemestane|exemestane|mesh-list
93294332|NCT04869943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294333|NCT04869943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93294334|NCT04869943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93294335|NCT04869943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294336|NCT04869943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294337|NCT04869943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93294338|NCT04869943|Hormone Antagonists|hormone antagonists|mesh-ancestor
93294339|NCT04869943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294340|NCT04869943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294341|NCT04866706|Hyaluronic Acid|hyaluronic acid|mesh-list
93294342|NCT04866706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93294343|NCT04866706|Immunologic Factors|immunologic factors|mesh-ancestor
93294344|NCT04866706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294345|NCT04866706|Viscosupplements|viscosupplements|mesh-ancestor
93294346|NCT04866706|Protective Agents|protective agents|mesh-ancestor
93294347|NCT04846478|Talazoparib|talazoparib|mesh-list
93294348|NCT04846478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93294349|NCT04846478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294350|NCT04846478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294351|NCT04846478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294352|NCT04844606|Mirikizumab|mirikizumab|mesh-list
93294353|NCT04844606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93294354|NCT04844606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93294355|NCT04844606|Analgesics|analgesics|mesh-ancestor
93294356|NCT04844606|Sensory System Agents|sensory system agents|mesh-ancestor
93294357|NCT04844606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294358|NCT04844606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294359|NCT04844606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294360|NCT04844606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294361|NCT04844606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93294362|NCT04844606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294363|NCT04834973|Pembrolizumab|pembrolizumab|mesh-list
93294364|NCT04834973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294365|NCT04834973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294366|NCT04834973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294367|NCT04834973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294368|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
93294369|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294370|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294371|NCT04798781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294372|NCT04798781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294373|NCT04764825|Morphine|morphine|mesh-list
93294374|NCT04764825|Methadone|methadone|mesh-list
93294375|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93294376|NCT04764825|Narcotics|narcotics|mesh-ancestor
93294377|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294378|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294379|NCT04764825|Analgesics|analgesics|mesh-ancestor
93294380|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
93294381|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294382|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
93294383|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
93294384|NCT04760743|Aluminum sulfate|aluminum sulfate|mesh-list
92966450|NCT00669110|Antidepressive Agents|antidepressive agents|mesh-ancestor
93294385|NCT04760743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93294386|NCT04760743|Immunologic Factors|immunologic factors|mesh-ancestor
93294387|NCT04760743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294389|NCT04756687|Dermatologic Agents|dermatologic agents|mesh-ancestor
93294390|NCT04756687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294391|NCT04756687|Immunologic Factors|immunologic factors|mesh-ancestor
93294392|NCT04756687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294393|NCT04742738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93294394|NCT04742738|Aluminum sulfate|aluminum sulfate|mesh-list
93294395|NCT04742738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93294396|NCT04742738|Immunologic Factors|immunologic factors|mesh-ancestor
93294397|NCT04742738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294398|NCT04706910|Furosemide|furosemide|mesh-list
93294399|NCT04706910|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
93294400|NCT04706910|Diuretics|diuretics|mesh-ancestor
93294401|NCT04706910|Natriuretic Agents|natriuretic agents|mesh-ancestor
93294402|NCT04706910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294403|NCT04706910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93294404|NCT04706910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294405|NCT04706910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294406|NCT04706910|Dopamine Agents|dopamine agents|mesh-ancestor
93294407|NCT04706910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294408|NCT04704271|Dronabinol|dronabinol|mesh-list
93294409|NCT04704271|Hallucinogens|hallucinogens|mesh-ancestor
93294410|NCT04704271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294411|NCT04704271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93294412|NCT04704271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93294413|NCT04704271|Analgesics|analgesics|mesh-ancestor
93294414|NCT04704271|Sensory System Agents|sensory system agents|mesh-ancestor
93294415|NCT04704271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294416|NCT04704271|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93294417|NCT04704271|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93294418|NCT04704271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294419|NCT04704271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294420|NCT04704271|Hormones|hormones|mesh-ancestor
93294421|NCT04704271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294422|NCT04693234|Tislelizumab|tislelizumab|mesh-list
93294423|NCT04693234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294424|NCT04693234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294425|NCT04680286|Methadone|methadone|mesh-list
93294426|NCT04680286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93294427|NCT04680286|Narcotics|narcotics|mesh-ancestor
93294428|NCT04680286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294429|NCT04680286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294430|NCT04680286|Analgesics|analgesics|mesh-ancestor
93294431|NCT04680286|Sensory System Agents|sensory system agents|mesh-ancestor
93294432|NCT04680286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294433|NCT04680286|Antitussive Agents|antitussive agents|mesh-ancestor
93294434|NCT04680286|Respiratory System Agents|respiratory system agents|mesh-ancestor
93294435|NCT04675762|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93294436|NCT04675762|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93294437|NCT04675762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294438|NCT04675762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294439|NCT04675762|Immunologic Factors|immunologic factors|mesh-ancestor
93294440|NCT04675762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294441|NCT04672018|Omeprazole|omeprazole|mesh-list
93294442|NCT04672018|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93294443|NCT04672018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294444|NCT04672018|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93294445|NCT04672018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294446|NCT04672018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294447|NCT04656184|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93294448|NCT04656184|Immunoglobulins|immunoglobulins|mesh-list
93294449|NCT04656184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93294450|NCT04656184|Antibodies|antibodies|mesh-list
93294451|NCT04656184|gamma-Globulins|gamma-globulins|mesh-list
93294452|NCT04656184|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93294453|NCT04656184|Immunologic Factors|immunologic factors|mesh-ancestor
93294454|NCT04656184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294455|NCT04656184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294456|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
93294457|NCT04638881|Analgesics|analgesics|mesh-ancestor
93294458|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
93294459|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294460|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294462|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294463|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93294464|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
93294465|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93294466|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294467|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294468|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93294469|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
93294470|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93294471|NCT04627753|Rituximab|rituximab|mesh-list
93294472|NCT04627753|Lenalidomide|lenalidomide|mesh-list
93294473|NCT04627753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294474|NCT04627753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294475|NCT04627753|Immunologic Factors|immunologic factors|mesh-ancestor
93294476|NCT04627753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294477|NCT04627753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294478|NCT04627753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93294479|NCT04627753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93294480|NCT04627753|Growth Substances|growth substances|mesh-ancestor
93294481|NCT04627753|Growth Inhibitors|growth inhibitors|mesh-ancestor
93294482|NCT04564612|Itraconazole|itraconazole|mesh-list
93294483|NCT04564612|Rabeprazole|rabeprazole|mesh-list
93294484|NCT04564612|Antifungal Agents|antifungal agents|mesh-ancestor
93294485|NCT04564612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294486|NCT04564612|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93294487|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93294488|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294489|NCT04564612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294490|NCT04564612|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93294491|NCT04564612|Hormone Antagonists|hormone antagonists|mesh-ancestor
93294492|NCT04564612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294493|NCT04564612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294494|NCT04564612|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93294495|NCT04564612|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93294496|NCT04564612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294497|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93294498|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93294499|NCT04549311|Amoxicillin|amoxicillin|mesh-list
93294500|NCT04549311|Metronidazole|metronidazole|mesh-list
93294501|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
93294502|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
93294503|NCT04549311|Clavulanic Acid|clavulanic acid|mesh-list
93294504|NCT04549311|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93294505|NCT04549311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93294506|NCT04549311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294507|NCT04549311|Antitubercular Agents|antitubercular agents|mesh-ancestor
93294508|NCT04549311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93294509|NCT04549311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93294510|NCT04549311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93294511|NCT04549311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93294512|NCT04549311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294513|NCT04549311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294514|NCT04549311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294515|NCT04549311|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93294516|NCT04549311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93294517|NCT04549311|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93294518|NCT04533451|Carboplatin|carboplatin|mesh-list
93294519|NCT04533451|Pembrolizumab|pembrolizumab|mesh-list
93294520|NCT04533451|Pemetrexed|pemetrexed|mesh-list
93294521|NCT04533451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294522|NCT04533451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294523|NCT04533451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294524|NCT04533451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294525|NCT04533451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294526|NCT04533451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93294527|NCT04533451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93294528|NCT04518319|Olanzapine|olanzapine|mesh-list
93294529|NCT04518319|Antiemetics|antiemetics|mesh-ancestor
93294530|NCT04518319|Autonomic Agents|autonomic agents|mesh-ancestor
93294531|NCT04518319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294532|NCT04518319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294533|NCT04518319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294534|NCT04518319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93294535|NCT04518319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93294536|NCT04518319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294537|NCT04518319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93294538|NCT04518319|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93294539|NCT04518319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93294540|NCT04518319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294541|NCT04518319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294542|NCT04518319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294543|NCT04518319|Serotonin Agents|serotonin agents|mesh-ancestor
93294544|NCT04516226|Chlorhexidine|chlorhexidine|mesh-list
93294545|NCT04516226|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93294546|NCT04516226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93294547|NCT04516226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294548|NCT04516226|Disinfectants|disinfectants|mesh-ancestor
93294549|NCT04516226|Dermatologic Agents|dermatologic agents|mesh-ancestor
93294550|NCT04495868|Lidocaine|lidocaine|mesh-list
93294551|NCT04495868|Anesthetics, Local|anesthetics, local|mesh-ancestor
93294552|NCT04495868|Anesthetics|anesthetics|mesh-ancestor
93294553|NCT04495868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294554|NCT04495868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294555|NCT04495868|Sensory System Agents|sensory system agents|mesh-ancestor
93294556|NCT04495868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294557|NCT04495868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93294558|NCT04495868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93294559|NCT04495868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93294560|NCT04495868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294561|NCT04495868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294562|NCT04483544|Pembrolizumab|pembrolizumab|mesh-list
93294563|NCT04483544|Olaparib|olaparib|mesh-list
93294564|NCT04483544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294565|NCT04483544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294566|NCT04483544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294567|NCT04483544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294568|NCT04483544|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93294569|NCT04483544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294570|NCT04475029|Morphine|morphine|mesh-list
93294571|NCT04475029|Methadone|methadone|mesh-list
93294572|NCT04475029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93294573|NCT04475029|Narcotics|narcotics|mesh-ancestor
93294574|NCT04475029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294575|NCT04475029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294576|NCT04475029|Analgesics|analgesics|mesh-ancestor
93294577|NCT04475029|Sensory System Agents|sensory system agents|mesh-ancestor
93294578|NCT04475029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294579|NCT04475029|Antitussive Agents|antitussive agents|mesh-ancestor
93294580|NCT04475029|Respiratory System Agents|respiratory system agents|mesh-ancestor
93294581|NCT04457089|Simvastatin|simvastatin|mesh-list
93294582|NCT04457089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93294583|NCT04457089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93294584|NCT04457089|Antimetabolites|antimetabolites|mesh-ancestor
93294585|NCT04457089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294586|NCT04457089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93294587|NCT04457089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93294588|NCT04457089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294589|NCT04455750|Leuprolide|leuprolide|mesh-list
93294590|NCT04455750|Goserelin|goserelin|mesh-list
93294591|NCT04455750|Rucaparib|rucaparib|mesh-list
93294592|NCT04455750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93294593|NCT04455750|Fertility Agents|fertility agents|mesh-ancestor
93294594|NCT04455750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93294595|NCT04455750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294596|NCT04455750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93294597|NCT04455750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294598|NCT04455750|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93294599|NCT04455750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294600|NCT04455750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294601|NCT04443062|177Lu-PSMA-617|177lu-psma-617|mesh-list
93294602|NCT04443062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93294603|NCT04443062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294604|NCT04307485|Ticagrelor|ticagrelor|mesh-list
92966683|NCT00552669|Sirolimus|sirolimus|mesh-list
93294605|NCT04307485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93294606|NCT04307485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93294607|NCT04307485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93294608|NCT04307485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93294609|NCT04307485|Purinergic Agents|purinergic agents|mesh-ancestor
93294610|NCT04307485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294611|NCT04307485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294612|NCT04307485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294613|NCT04289467|Fenfluramine|fenfluramine|mesh-list
93294614|NCT04289467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93294615|NCT04289467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93294616|NCT04289467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294617|NCT04289467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294618|NCT04289467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294619|NCT04289467|Serotonin Agents|serotonin agents|mesh-ancestor
93294620|NCT04289467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294621|NCT04279574|Lithium Carbonate|lithium carbonate|mesh-list
93294622|NCT04279574|Antidepressive Agents|antidepressive agents|mesh-ancestor
93294623|NCT04279574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93294624|NCT04279574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294625|NCT04279574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294626|NCT04279574|Antimanic Agents|antimanic agents|mesh-ancestor
93294627|NCT04279574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93294628|NCT04279574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294629|NCT04279574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294630|NCT04253561|Trastuzumab|trastuzumab|mesh-list
93294631|NCT04253561|Pertuzumab|pertuzumab|mesh-list
93294632|NCT04253561|Ipatasertib|ipatasertib|mesh-list
93294633|NCT04253561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294634|NCT04253561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294635|NCT04253561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93294636|NCT04253561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294637|NCT04253561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294638|NCT04248569|Nivolumab|nivolumab|mesh-list
93294639|NCT04248569|Ipilimumab|ipilimumab|mesh-list
93294640|NCT04248569|Poly ICLC|poly iclc|mesh-list
93294641|NCT04248569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294642|NCT04248569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294643|NCT04248569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294644|NCT04248569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294645|NCT04248569|Interferon Inducers|interferon inducers|mesh-ancestor
93294646|NCT04248569|Immunologic Factors|immunologic factors|mesh-ancestor
93294647|NCT04248569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294648|NCT04240171|Dapagliflozin|dapagliflozin|mesh-list
93294649|NCT04240171|Glimepiride|glimepiride|mesh-list
93294650|NCT04240171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93294651|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294652|NCT04240171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93294653|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294654|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93294655|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294656|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
93294657|NCT04191616|Dexamethasone|dexamethasone|mesh-list
93294658|NCT04191616|Pomalidomide|pomalidomide|mesh-list
93294659|NCT04191616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294660|NCT04191616|Antiemetics|antiemetics|mesh-ancestor
93294661|NCT04191616|Autonomic Agents|autonomic agents|mesh-ancestor
93294662|NCT04191616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294663|NCT04191616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294664|NCT04191616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294665|NCT04191616|Glucocorticoids|glucocorticoids|mesh-ancestor
93294666|NCT04191616|Hormones|hormones|mesh-ancestor
93294667|NCT04191616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294668|NCT04191616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93294669|NCT04191616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294670|NCT04191616|Immunologic Factors|immunologic factors|mesh-ancestor
93294671|NCT04191616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93294672|NCT04191616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93294673|NCT04191616|Growth Substances|growth substances|mesh-ancestor
93294674|NCT04191616|Growth Inhibitors|growth inhibitors|mesh-ancestor
93294675|NCT04170738|Amphetamine|amphetamine|mesh-list
93294676|NCT04170738|Adderall|adderall|mesh-list
93294677|NCT04170738|Dextroamphetamine|dextroamphetamine|mesh-list
93294678|NCT04170738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93294679|NCT04170738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294680|NCT04170738|Sympathomimetics|sympathomimetics|mesh-ancestor
93294681|NCT04170738|Autonomic Agents|autonomic agents|mesh-ancestor
93294682|NCT04170738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294683|NCT04170738|Dopamine Agents|dopamine agents|mesh-ancestor
93294684|NCT04170738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294685|NCT04170738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294686|NCT04170738|Adrenergic Agents|adrenergic agents|mesh-ancestor
93294687|NCT04170738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93294688|NCT04170738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93294689|NCT04170738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294690|NCT04170738|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93294692|NCT04094142|Acalabrutinib|acalabrutinib|mesh-list
93294693|NCT04094142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294694|NCT04094142|Immunologic Factors|immunologic factors|mesh-ancestor
93294695|NCT04094142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294696|NCT04094142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93294697|NCT04094142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93294698|NCT04094142|Growth Substances|growth substances|mesh-ancestor
93294699|NCT04094142|Growth Inhibitors|growth inhibitors|mesh-ancestor
93294700|NCT04089514|Adalimumab|adalimumab|mesh-list
93294701|NCT04089514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93294702|NCT04089514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294703|NCT04089514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294704|NCT04088409|Adalimumab|adalimumab|mesh-list
93294705|NCT04088409|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93294706|NCT04088409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294707|NCT04088409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294708|NCT04084314|Erenumab|erenumab|mesh-list
93294709|NCT04084314|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93294710|NCT04084314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294711|NCT04084314|Analgesics|analgesics|mesh-ancestor
93294712|NCT04084314|Sensory System Agents|sensory system agents|mesh-ancestor
93294713|NCT04084314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294714|NCT04084314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294715|NCT04068207|Minocycline|minocycline|mesh-list
93294716|NCT04068207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93294717|NCT04068207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294718|NCT04024761|Cyclophosphamide|cyclophosphamide|mesh-list
93294719|NCT04024761|Fludarabine|fludarabine|mesh-list
93294720|NCT04024761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294721|NCT04024761|Immunologic Factors|immunologic factors|mesh-ancestor
93294722|NCT04024761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294723|NCT04024761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294724|NCT04024761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93294725|NCT04024761|Alkylating Agents|alkylating agents|mesh-ancestor
93294726|NCT04024761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294727|NCT04024761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294728|NCT04024761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93294729|NCT04013854|Nivolumab|nivolumab|mesh-list
93294730|NCT04013854|Ipilimumab|ipilimumab|mesh-list
93294731|NCT04013854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294732|NCT04013854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294733|NCT04013854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589255|NCT02807805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294734|NCT04013854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294735|NCT04004988|Tirzepatide|tirzepatide|mesh-list
93294736|NCT04004988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93294737|NCT04004988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294738|NCT04004988|Incretins|incretins|mesh-ancestor
93294739|NCT04004988|Hormones|hormones|mesh-ancestor
93294740|NCT04004988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294741|NCT03950817|Ketamine|ketamine|mesh-list
93294742|NCT03950817|Analgesics|analgesics|mesh-ancestor
93294743|NCT03950817|Sensory System Agents|sensory system agents|mesh-ancestor
93294744|NCT03950817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294745|NCT03950817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294746|NCT03950817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93294747|NCT03950817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93294748|NCT03950817|Anesthetics, General|anesthetics, general|mesh-ancestor
93294749|NCT03950817|Anesthetics|anesthetics|mesh-ancestor
93294750|NCT03950817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294751|NCT03950817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93294752|NCT03950817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93294753|NCT03950817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294754|NCT03950817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294755|NCT03934840|Prednisone|prednisone|mesh-list
93294756|NCT03934840|Carboplatin|carboplatin|mesh-list
93294757|NCT03934840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294758|NCT03934840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294759|NCT03934840|Glucocorticoids|glucocorticoids|mesh-ancestor
93294760|NCT03934840|Hormones|hormones|mesh-ancestor
93294761|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294762|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294763|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93294764|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
93294765|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93294766|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
93294767|NCT03879538|Anesthetics|anesthetics|mesh-ancestor
93294768|NCT03879538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294769|NCT03879538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294770|NCT03879538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93294771|NCT03879538|Analgesics|analgesics|mesh-ancestor
93294772|NCT03879538|Sensory System Agents|sensory system agents|mesh-ancestor
93294773|NCT03879538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294774|NCT03783442|Paclitaxel|paclitaxel|mesh-list
93294775|NCT03783442|Fluorouracil|fluorouracil|mesh-list
93294776|NCT03783442|Capecitabine|capecitabine|mesh-list
93294777|NCT03783442|Oxaliplatin|oxaliplatin|mesh-list
93294778|NCT03783442|Tislelizumab|tislelizumab|mesh-list
93294779|NCT03783442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93294780|NCT03783442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294781|NCT03783442|Tubulin Modulators|tubulin modulators|mesh-ancestor
93294782|NCT03783442|Antimitotic Agents|antimitotic agents|mesh-ancestor
93294783|NCT03783442|Mitosis Modulators|mitosis modulators|mesh-ancestor
93294784|NCT03783442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294785|NCT03783442|Antimetabolites|antimetabolites|mesh-ancestor
93294786|NCT03783442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93294787|NCT03783442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93294788|NCT03783442|Immunologic Factors|immunologic factors|mesh-ancestor
93294789|NCT03783442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294790|NCT03783442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294791|NCT03781765|Methylphenidate|methylphenidate|mesh-list
93294792|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93294793|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93294794|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294795|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93294796|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93294797|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294798|NCT03781765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294799|NCT03781765|Dopamine Agents|dopamine agents|mesh-ancestor
93294800|NCT03781765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294801|NCT03781765|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93294802|NCT03781765|Adrenergic Agents|adrenergic agents|mesh-ancestor
93294803|NCT03781752|Methylphenidate|methylphenidate|mesh-list
93294804|NCT03781752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93294805|NCT03781752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294806|NCT03781752|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93294807|NCT03781752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93294808|NCT03781752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294809|NCT03781752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294810|NCT03781752|Dopamine Agents|dopamine agents|mesh-ancestor
93294811|NCT03781752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294812|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
93294813|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93294814|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
93294815|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93294816|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
93294817|NCT03772457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294818|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294819|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
93294820|NCT03714958|Trametinib|trametinib|mesh-list
93294821|NCT03714958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294822|NCT03714958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93294823|NCT03714958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294824|NCT03714958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294825|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
93294826|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93294827|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294828|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294829|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93294831|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
93294832|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294833|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93294834|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93294835|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93294836|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
93294837|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294838|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294839|NCT03693300|Durvalumab|durvalumab|mesh-list
93294840|NCT03693300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294841|NCT03693300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294842|NCT03582033|Dexamethasone|dexamethasone|mesh-list
93294843|NCT03582033|Pomalidomide|pomalidomide|mesh-list
93294844|NCT03582033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294845|NCT03582033|Antiemetics|antiemetics|mesh-ancestor
93294846|NCT03582033|Autonomic Agents|autonomic agents|mesh-ancestor
93294847|NCT03582033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294848|NCT03582033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294849|NCT03582033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294850|NCT03582033|Glucocorticoids|glucocorticoids|mesh-ancestor
93294851|NCT03582033|Hormones|hormones|mesh-ancestor
93294852|NCT03582033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294853|NCT03582033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93294854|NCT03582033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294855|NCT03582033|Immunologic Factors|immunologic factors|mesh-ancestor
93294856|NCT03582033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93294857|NCT03582033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93294858|NCT03582033|Growth Substances|growth substances|mesh-ancestor
93294859|NCT03582033|Growth Inhibitors|growth inhibitors|mesh-ancestor
93294860|NCT03579966|Amifampridine|amifampridine|mesh-list
93294861|NCT03579966|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93294862|NCT03579966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294863|NCT03579966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294864|NCT03579966|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93294865|NCT03579966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294866|NCT03579966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294867|NCT03551691|Omeprazole|omeprazole|mesh-list
93294868|NCT03551691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93294869|NCT03551691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294870|NCT03551691|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93294871|NCT03551691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294872|NCT03551691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294873|NCT03543189|Nivolumab|nivolumab|mesh-list
93294874|NCT03543189|Androgens|androgens|mesh-list
93294875|NCT03543189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294876|NCT03543189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294877|NCT03543189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294878|NCT03543189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294879|NCT03543189|Hormones|hormones|mesh-ancestor
93294880|NCT03543189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294881|NCT03543189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294882|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93294883|NCT03510208|Panitumumab|panitumumab|mesh-list
93294884|NCT03510208|Antibodies|antibodies|mesh-list
93294885|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
93294886|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93294887|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
93294888|NCT03510208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294889|NCT03510208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294890|NCT03508869|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93294891|NCT03508869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93294892|NCT03508869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93294893|NCT03508869|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93294894|NCT03508869|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93294895|NCT03508869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93294896|NCT03508869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93294897|NCT03508869|Adrenergic Agents|adrenergic agents|mesh-ancestor
93294898|NCT03508869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93294899|NCT03508869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294900|NCT03508869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294901|NCT03508869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93294902|NCT03508869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294903|NCT03508869|Cholinergic Agents|cholinergic agents|mesh-ancestor
93294904|NCT03508869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93294905|NCT03508869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294906|NCT03507699|Nivolumab|nivolumab|mesh-list
93294907|NCT03507699|Ipilimumab|ipilimumab|mesh-list
93294908|NCT03507699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294909|NCT03507699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294910|NCT03507699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294911|NCT03507699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294912|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
93294913|NCT03497923|Analgesics|analgesics|mesh-ancestor
93294914|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
93294915|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294916|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294917|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
93294918|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93294919|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93294920|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
93294921|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93294922|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93294923|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294924|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93294925|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
93294926|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93294927|NCT03383692|Ritonavir|ritonavir|mesh-list
93294928|NCT03383692|Itraconazole|itraconazole|mesh-list
93294929|NCT03383692|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93294930|NCT03383692|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93294931|NCT03383692|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93294932|NCT03383692|Protease Inhibitors|protease inhibitors|mesh-ancestor
93294933|NCT03383692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294934|NCT03383692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294935|NCT03383692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93294936|NCT03383692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93294937|NCT03383692|Antiviral Agents|antiviral agents|mesh-ancestor
93294938|NCT03383692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93294939|NCT03383692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93294940|NCT03383692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93294941|NCT03383692|Antifungal Agents|antifungal agents|mesh-ancestor
93294942|NCT03383692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93294943|NCT03383692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93294944|NCT03383692|Hormone Antagonists|hormone antagonists|mesh-ancestor
93294945|NCT03383692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294946|NCT03383692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294947|NCT03383692|Immunoconjugates|immunoconjugates|mesh-ancestor
93294948|NCT03383692|Immunologic Factors|immunologic factors|mesh-ancestor
93294949|NCT03377387|Capecitabine|capecitabine|mesh-list
93294950|NCT03377387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93294951|NCT03377387|Antimetabolites|antimetabolites|mesh-ancestor
93294952|NCT03377387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294953|NCT03377387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294954|NCT03372837|Rituximab|rituximab|mesh-list
93294955|NCT03372837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294956|NCT03372837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294957|NCT03372837|Immunologic Factors|immunologic factors|mesh-ancestor
93294958|NCT03372837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294959|NCT03372837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93294960|NCT03312699|Vaccines|vaccines|mesh-list
93294961|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
93294962|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294963|NCT03300557|Exemestane|exemestane|mesh-list
93294964|NCT03300557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294965|NCT03300557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93294966|NCT03300557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93294967|NCT03300557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294968|NCT03300557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294969|NCT03300557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93294970|NCT03300557|Hormone Antagonists|hormone antagonists|mesh-ancestor
93294971|NCT03300557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93294972|NCT03300557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294973|NCT03290079|Pembrolizumab|pembrolizumab|mesh-list
93294974|NCT03290079|Lenvatinib|lenvatinib|mesh-list
93294975|NCT03290079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93294976|NCT03290079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93294977|NCT03290079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93294978|NCT03290079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93294979|NCT03290079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93294980|NCT03290079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93294981|NCT03269136|Thalidomide|thalidomide|mesh-list
93294982|NCT03269136|Dexamethasone|dexamethasone|mesh-list
93294983|NCT03269136|Dexamethasone acetate|dexamethasone acetate|mesh-list
93294984|NCT03269136|Lenalidomide|lenalidomide|mesh-list
93294985|NCT03269136|Pomalidomide|pomalidomide|mesh-list
93294986|NCT03269136|Antibodies|antibodies|mesh-list
93294987|NCT03269136|Immunoglobulins|immunoglobulins|mesh-list
93294988|NCT03269136|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93294989|NCT03269136|BB 1101|bb 1101|mesh-list
93294990|NCT03269136|Immunologic Factors|immunologic factors|mesh-ancestor
93294991|NCT03269136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93294992|NCT03269136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93294993|NCT03269136|Antiemetics|antiemetics|mesh-ancestor
93294994|NCT03269136|Autonomic Agents|autonomic agents|mesh-ancestor
93294995|NCT03269136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93294996|NCT03269136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93294997|NCT03269136|Glucocorticoids|glucocorticoids|mesh-ancestor
93294998|NCT03269136|Hormones|hormones|mesh-ancestor
93294999|NCT03269136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295000|NCT03269136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295001|NCT03269136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295002|NCT03269136|Protease Inhibitors|protease inhibitors|mesh-ancestor
93295003|NCT03269136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295004|NCT03269136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295005|NCT03269136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93295006|NCT03269136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93295007|NCT03269136|Growth Substances|growth substances|mesh-ancestor
93295008|NCT03269136|Growth Inhibitors|growth inhibitors|mesh-ancestor
93295009|NCT03269136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93295010|NCT03269136|Leprostatic Agents|leprostatic agents|mesh-ancestor
93295011|NCT03269136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93295012|NCT03269136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295013|NCT03261284|Heparin|heparin|mesh-list
93295014|NCT03261284|Calcium heparin|calcium heparin|mesh-list
93295015|NCT03261284|Anticoagulants|anticoagulants|mesh-ancestor
93295016|NCT03261284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93295017|NCT03261284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93295018|NCT03261284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295019|NCT03238326|Brexpiprazole|brexpiprazole|mesh-list
93295020|NCT03238326|Serotonin Agents|serotonin agents|mesh-ancestor
93295021|NCT03238326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295022|NCT03238326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295023|NCT03238326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295024|NCT03238326|Dopamine Agonists|dopamine agonists|mesh-ancestor
93295025|NCT03238326|Dopamine Agents|dopamine agents|mesh-ancestor
93295026|NCT03219450|Cyclophosphamide|cyclophosphamide|mesh-list
93295027|NCT03219450|Pembrolizumab|pembrolizumab|mesh-list
93295028|NCT03219450|Immunologic Factors|immunologic factors|mesh-ancestor
93295029|NCT03219450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295030|NCT03219450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93295031|NCT03219450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295032|NCT03219450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93295033|NCT03219450|Alkylating Agents|alkylating agents|mesh-ancestor
93295034|NCT03219450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295035|NCT03219450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295036|NCT03219450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93295037|NCT03219450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295038|NCT03219450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295039|NCT03198078|Aripiprazole|aripiprazole|mesh-list
93295040|NCT03198078|Brexpiprazole|brexpiprazole|mesh-list
93295041|NCT03198078|Antidepressive Agents|antidepressive agents|mesh-ancestor
93295042|NCT03198078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295043|NCT03198078|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93295044|NCT03198078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93295045|NCT03198078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295046|NCT03198078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295047|NCT03198078|Dopamine Agonists|dopamine agonists|mesh-ancestor
93295048|NCT03198078|Dopamine Agents|dopamine agents|mesh-ancestor
93295049|NCT03198078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295050|NCT03198078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295051|NCT03198078|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93295052|NCT03198078|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93295053|NCT03198078|Serotonin Agents|serotonin agents|mesh-ancestor
93295054|NCT03198078|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93295055|NCT03198078|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93295056|NCT03198078|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93295057|NCT03198078|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93295058|NCT03127267|Riluzole|riluzole|mesh-list
93295059|NCT03127267|Anticonvulsants|anticonvulsants|mesh-ancestor
93295060|NCT03127267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93295061|NCT03127267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93295062|NCT03127267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295063|NCT03127267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295064|NCT03127267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295065|NCT03127267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93295066|NCT03127267|Protective Agents|protective agents|mesh-ancestor
93295067|NCT03092466|Ropivacaine|ropivacaine|mesh-list
93295068|NCT03092466|Anesthetics, Local|anesthetics, local|mesh-ancestor
93295069|NCT03092466|Anesthetics|anesthetics|mesh-ancestor
93295070|NCT03092466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295071|NCT03092466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295072|NCT03092466|Sensory System Agents|sensory system agents|mesh-ancestor
93295073|NCT03092466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295074|NCT03017872|Ritonavir|ritonavir|mesh-list
93295075|NCT03017872|Darunavir|darunavir|mesh-list
93295076|NCT03017872|Dolutegravir|dolutegravir|mesh-list
93295077|NCT03017872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93295078|NCT03017872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93295079|NCT03017872|Protease Inhibitors|protease inhibitors|mesh-ancestor
93295080|NCT03017872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295081|NCT03017872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295082|NCT03017872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93295083|NCT03017872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93295084|NCT03017872|Antiviral Agents|antiviral agents|mesh-ancestor
93295085|NCT03017872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295086|NCT03017872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93295087|NCT03017872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93295088|NCT03017872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93295089|NCT03017872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93295090|NCT03000205|Lidocaine|lidocaine|mesh-list
93295091|NCT03000205|Anesthetics, Local|anesthetics, local|mesh-ancestor
93295092|NCT03000205|Anesthetics|anesthetics|mesh-ancestor
93295093|NCT03000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295094|NCT03000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295095|NCT03000205|Sensory System Agents|sensory system agents|mesh-ancestor
93295096|NCT03000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295097|NCT03000205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93295098|NCT03000205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93295099|NCT03000205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93295100|NCT03000205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93295101|NCT03000205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295102|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93295103|NCT02942095|Ixazomib|ixazomib|mesh-list
93295104|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295105|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93295106|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295107|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295108|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
93295109|NCT02882282|Pembrolizumab|pembrolizumab|mesh-list
93295110|NCT02882282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295111|NCT02882282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295112|NCT02882282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295113|NCT02882282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295114|NCT02872467|Oxytocin|oxytocin|mesh-list
93295115|NCT02872467|Oxytocics|oxytocics|mesh-ancestor
93295116|NCT02872467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93295117|NCT02872467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295118|NCT02781519|Dronabinol|dronabinol|mesh-list
93295119|NCT02781519|Hallucinogens|hallucinogens|mesh-ancestor
93295120|NCT02781519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295121|NCT02781519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295122|NCT02781519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93295123|NCT02781519|Analgesics|analgesics|mesh-ancestor
93295124|NCT02781519|Sensory System Agents|sensory system agents|mesh-ancestor
93295125|NCT02781519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295126|NCT02781519|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93295127|NCT02781519|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93295128|NCT02781519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295129|NCT02781519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295130|NCT02781519|Hormones|hormones|mesh-ancestor
93295131|NCT02781519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295132|NCT02706353|Pembrolizumab|pembrolizumab|mesh-list
93295133|NCT02706353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295134|NCT02706353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295135|NCT02706353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295136|NCT02706353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295137|NCT02638090|Pembrolizumab|pembrolizumab|mesh-list
93295138|NCT02638090|Vorinostat|vorinostat|mesh-list
93295139|NCT02638090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295140|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295141|NCT02638090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295142|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295143|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93295144|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295145|NCT02617277|Durvalumab|durvalumab|mesh-list
93295146|NCT02617277|Adavosertib|adavosertib|mesh-list
93295147|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295148|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295149|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295150|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295151|NCT02584465|Tamoxifen|tamoxifen|mesh-list
93295152|NCT02584465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93295153|NCT02584465|Hormone Antagonists|hormone antagonists|mesh-ancestor
93295154|NCT02584465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295155|NCT02584465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295156|NCT02584465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295157|NCT02584465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295158|NCT02584465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93295159|NCT02584465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93295160|NCT02584465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295161|NCT02536664|Rituximab|rituximab|mesh-list
93295162|NCT02536664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295163|NCT02536664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295164|NCT02536664|Immunologic Factors|immunologic factors|mesh-ancestor
93295165|NCT02536664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295166|NCT02536664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295167|NCT02426892|Nivolumab|nivolumab|mesh-list
93295168|NCT02426892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295169|NCT02426892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295170|NCT02426892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295171|NCT02426892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295172|NCT02375555|Dexamethasone|dexamethasone|mesh-list
93295173|NCT02375555|Lenalidomide|lenalidomide|mesh-list
93295174|NCT02375555|Bortezomib|bortezomib|mesh-list
93295175|NCT02375555|Elotuzumab|elotuzumab|mesh-list
93295176|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295177|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
93295178|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
93295179|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295180|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295181|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93295182|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
93295183|NCT02375555|Hormones|hormones|mesh-ancestor
93295184|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295185|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295186|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295187|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
93295188|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93295189|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93295190|NCT02375555|Growth Substances|growth substances|mesh-ancestor
93295191|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
93295192|NCT02364713|Paclitaxel|paclitaxel|mesh-list
93295193|NCT02364713|Bevacizumab|bevacizumab|mesh-list
93295194|NCT02364713|Gemcitabine|gemcitabine|mesh-list
93295195|NCT02364713|Doxorubicin|doxorubicin|mesh-list
93295196|NCT02364713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93295197|NCT02364713|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93295198|NCT02364713|Topotecan|topotecan|mesh-list
93295199|NCT02364713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93295200|NCT02364713|Endothelial Growth Factors|endothelial growth factors|mesh-list
93295201|NCT02364713|Antibodies|antibodies|mesh-list
93295202|NCT02364713|Immunoglobulins|immunoglobulins|mesh-list
93295203|NCT02364713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93295204|NCT02364713|Immunoglobulin G|immunoglobulin g|mesh-list
93295205|NCT02364713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93295206|NCT02364713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295207|NCT02364713|Tubulin Modulators|tubulin modulators|mesh-ancestor
93295208|NCT02364713|Antimitotic Agents|antimitotic agents|mesh-ancestor
93295209|NCT02364713|Mitosis Modulators|mitosis modulators|mesh-ancestor
93295210|NCT02364713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295211|NCT02364713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93295212|NCT02364713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93295213|NCT02364713|Growth Substances|growth substances|mesh-ancestor
93295214|NCT02364713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295215|NCT02364713|Growth Inhibitors|growth inhibitors|mesh-ancestor
93295216|NCT02364713|Immunologic Factors|immunologic factors|mesh-ancestor
93295217|NCT02364713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93295218|NCT02364713|Antimetabolites|antimetabolites|mesh-ancestor
93295219|NCT02364713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93295220|NCT02364713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93295221|NCT02364713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93295222|NCT02364713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295223|NCT02364713|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93295224|NCT02231775|Trametinib|trametinib|mesh-list
93295225|NCT02231775|Dabrafenib|dabrafenib|mesh-list
93295226|NCT02231775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589754|NCT05951842|Anesthetics|anesthetics|mesh-list
93295227|NCT02231775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93295228|NCT02231775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295229|NCT02231775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295230|NCT02107703|Fulvestrant|fulvestrant|mesh-list
93295231|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295232|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295233|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93295234|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93295235|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
93295236|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295237|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295238|NCT02094625|Acetylcysteine|acetylcysteine|mesh-list
93295239|NCT02094625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93295240|NCT02094625|Antiviral Agents|antiviral agents|mesh-ancestor
93295241|NCT02094625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295242|NCT02094625|Expectorants|expectorants|mesh-ancestor
93295243|NCT02094625|Respiratory System Agents|respiratory system agents|mesh-ancestor
93295244|NCT02094625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93295245|NCT02094625|Antioxidants|antioxidants|mesh-ancestor
93295246|NCT02094625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295247|NCT02094625|Protective Agents|protective agents|mesh-ancestor
93295248|NCT02094625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295249|NCT02094625|Antidotes|antidotes|mesh-ancestor
93295250|NCT02054520|Pembrolizumab|pembrolizumab|mesh-list
93295251|NCT02054520|Nivolumab|nivolumab|mesh-list
93295252|NCT02054520|Ipilimumab|ipilimumab|mesh-list
93295253|NCT02054520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295254|NCT02054520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295255|NCT02054520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295256|NCT02054520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295257|NCT01922921|polysaccharide-K|polysaccharide-k|mesh-list
93295258|NCT01922921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93295259|NCT01922921|Trastuzumab|trastuzumab|mesh-list
93295260|NCT01922921|Pertuzumab|pertuzumab|mesh-list
93295261|NCT01922921|Antibodies|antibodies|mesh-list
93295262|NCT01922921|Immunoglobulins|immunoglobulins|mesh-list
93295263|NCT01922921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93295264|NCT01922921|Immunologic Factors|immunologic factors|mesh-ancestor
93295265|NCT01922921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295266|NCT01922921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295267|NCT01922921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93295268|NCT01922921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93295269|NCT01922921|Antiviral Agents|antiviral agents|mesh-ancestor
93295270|NCT01922921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295271|NCT01922921|Interferon Inducers|interferon inducers|mesh-ancestor
93295272|NCT01922921|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93295273|NCT01922921|Protective Agents|protective agents|mesh-ancestor
93295274|NCT01546987|Leuprolide|leuprolide|mesh-list
93295275|NCT01546987|Goserelin|goserelin|mesh-list
93295276|NCT01546987|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93295277|NCT01546987|Flutamide|flutamide|mesh-list
93295278|NCT01546987|Bicalutamide|bicalutamide|mesh-list
93295279|NCT01546987|Buserelin|buserelin|mesh-list
93295280|NCT01546987|Androgens|androgens|mesh-list
93295281|NCT01546987|Androgen Antagonists|androgen antagonists|mesh-list
93295282|NCT01546987|Hormones|hormones|mesh-ancestor
93295283|NCT01546987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295284|NCT01546987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295285|NCT01546987|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93295286|NCT01546987|Fertility Agents|fertility agents|mesh-ancestor
93295287|NCT01546987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93295288|NCT01546987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295289|NCT01546987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295290|NCT01546987|Hormone Antagonists|hormone antagonists|mesh-ancestor
93295291|NCT01546987|Luteolytic Agents|luteolytic agents|mesh-ancestor
93295292|NCT01546987|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93295293|NCT01546987|Contraceptive Agents|contraceptive agents|mesh-ancestor
93295294|NCT01546987|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93295295|NCT00977691|Sirolimus|sirolimus|mesh-list
93295296|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
93295297|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
93295298|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93295299|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
93295300|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295301|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295302|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93295303|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
93295304|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295305|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295306|NCT00977691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93295307|NCT00977691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93295308|NCT00977691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295309|NCT00977691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93295310|NCT00977691|Antifungal Agents|antifungal agents|mesh-ancestor
93295311|NCT00977691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295312|NCT00588185|Deoxyglucose|deoxyglucose|mesh-list
93295313|NCT00588185|Testosterone|testosterone|mesh-list
93295314|NCT00588185|Dihydrotestosterone|dihydrotestosterone|mesh-list
93295315|NCT00588185|Androgens|androgens|mesh-ancestor
93295316|NCT00588185|Hormones|hormones|mesh-ancestor
93295317|NCT00588185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295318|NCT00588185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295319|NCT00588185|Antimetabolites|antimetabolites|mesh-ancestor
93295320|NCT00588185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295321|NCT00588185|Antiviral Agents|antiviral agents|mesh-ancestor
93295322|NCT00588185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295323|NCT00268476|Zoledronic Acid|zoledronic acid|mesh-list
93295324|NCT00268476|Metformin|metformin|mesh-list
93295325|NCT00268476|Prednisone|prednisone|mesh-list
93295326|NCT00268476|Prednisolone|prednisolone|mesh-list
93295327|NCT00268476|Celecoxib|celecoxib|mesh-list
93295328|NCT00268476|Docetaxel|docetaxel|mesh-list
93295329|NCT00268476|Estradiol|estradiol|mesh-list
93295330|NCT00268476|Androgens|androgens|mesh-list
93295331|NCT00268476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93295332|NCT00268476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295333|NCT00268476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295334|NCT00268476|Tubulin Modulators|tubulin modulators|mesh-ancestor
93295335|NCT00268476|Antimitotic Agents|antimitotic agents|mesh-ancestor
93295336|NCT00268476|Mitosis Modulators|mitosis modulators|mesh-ancestor
93295337|NCT00268476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295338|NCT00268476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295339|NCT00268476|Glucocorticoids|glucocorticoids|mesh-ancestor
93295340|NCT00268476|Hormones|hormones|mesh-ancestor
93295341|NCT00268476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295342|NCT00268476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295343|NCT00268476|Estrogens|estrogens|mesh-ancestor
93295344|NCT00268476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295345|NCT00268476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93295346|NCT00268476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93295347|NCT00268476|Analgesics|analgesics|mesh-ancestor
93295348|NCT00268476|Sensory System Agents|sensory system agents|mesh-ancestor
92967428|NCT05123092|Analgesics|analgesics|mesh-ancestor
93295349|NCT00268476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295350|NCT00268476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93295351|NCT00268476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93295352|NCT00268476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295353|NCT00268476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295354|NCT00261443|Valproic Acid|valproic acid|mesh-list
93295355|NCT00261443|Aripiprazole|aripiprazole|mesh-list
93295356|NCT00261443|Lithium Carbonate|lithium carbonate|mesh-list
93295357|NCT00261443|Antidepressive Agents|antidepressive agents|mesh-ancestor
93295358|NCT00261443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295359|NCT00261443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93295360|NCT00261443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93295361|NCT00261443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295362|NCT00261443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295363|NCT00261443|Dopamine Agonists|dopamine agonists|mesh-ancestor
93295364|NCT00261443|Dopamine Agents|dopamine agents|mesh-ancestor
93295365|NCT00261443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295366|NCT00261443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295367|NCT00261443|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93295368|NCT00261443|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93295369|NCT00261443|Serotonin Agents|serotonin agents|mesh-ancestor
93295370|NCT00261443|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93295371|NCT00261443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92118143|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
93295372|NCT00261443|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93295373|NCT00261443|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93295374|NCT00261443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295375|NCT00261443|Antimanic Agents|antimanic agents|mesh-ancestor
93295376|NCT00261443|Anticonvulsants|anticonvulsants|mesh-ancestor
93295377|NCT00261443|GABA Agents|gaba agents|mesh-ancestor
93295378|NCT00093379|Capecitabine|capecitabine|mesh-list
93295379|NCT00093379|Oxaliplatin|oxaliplatin|mesh-list
93295380|NCT00093379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93295381|NCT00093379|Antimetabolites|antimetabolites|mesh-ancestor
93295382|NCT00093379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295383|NCT00093379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295384|NCT00000524|Cyclosporine|cyclosporine|mesh-list
93295385|NCT00000524|Prednisone|prednisone|mesh-list
93295386|NCT00000524|Cyclosporins|cyclosporins|mesh-list
93295387|NCT00000524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295388|NCT00000524|Glucocorticoids|glucocorticoids|mesh-ancestor
93295389|NCT00000524|Hormones|hormones|mesh-ancestor
93295390|NCT00000524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295391|NCT00000524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295392|NCT00000524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295393|NCT00000524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295394|NCT00000524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295395|NCT00000524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295396|NCT00000524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93295397|NCT00000524|Immunologic Factors|immunologic factors|mesh-ancestor
93295398|NCT00000524|Antifungal Agents|antifungal agents|mesh-ancestor
93295399|NCT00000524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295400|NCT00000524|Dermatologic Agents|dermatologic agents|mesh-ancestor
93295401|NCT00000524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295402|NCT00000524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93295403|NCT02099331|Melatonin|melatonin|mesh-list
93295404|NCT02099331|Antioxidants|antioxidants|mesh-ancestor
93295405|NCT02099331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295406|NCT02099331|Protective Agents|protective agents|mesh-ancestor
93295407|NCT02099331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295408|NCT02099331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295409|NCT05328388|Lycopene|lycopene|mesh-list
93295410|NCT05328388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295411|NCT05328388|Antioxidants|antioxidants|mesh-ancestor
93295412|NCT05328388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295413|NCT05328388|Protective Agents|protective agents|mesh-ancestor
93295414|NCT05328388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295415|NCT05328388|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93295416|NCT05328388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93295417|NCT05328388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295418|NCT02097069|Folic Acid|folic acid|mesh-list
93295419|NCT02097069|Inositol|inositol|mesh-list
93295420|NCT02097069|Hematinics|hematinics|mesh-ancestor
93295421|NCT02097069|Vitamin B Complex|vitamin b complex|mesh-ancestor
93295422|NCT02097069|Vitamins|vitamins|mesh-ancestor
93295423|NCT02097069|Micronutrients|micronutrients|mesh-ancestor
93295424|NCT02097069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295425|NCT03424226|Acetazolamide|acetazolamide|mesh-list
93295426|NCT03424226|Anticonvulsants|anticonvulsants|mesh-ancestor
93295427|NCT03424226|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93295428|NCT03424226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295429|NCT03424226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295430|NCT03424226|Diuretics|diuretics|mesh-ancestor
93295431|NCT03424226|Natriuretic Agents|natriuretic agents|mesh-ancestor
93295432|NCT03424226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295433|NCT02250729|Pholcodine|pholcodine|mesh-list
93295434|NCT02250729|Analgesics|analgesics|mesh-ancestor
93295435|NCT02250729|Sensory System Agents|sensory system agents|mesh-ancestor
93295436|NCT02250729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295437|NCT02250729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295438|NCT02250729|Antitussive Agents|antitussive agents|mesh-ancestor
93295439|NCT02250729|Respiratory System Agents|respiratory system agents|mesh-ancestor
93295440|NCT02097147|Paroxetine|paroxetine|mesh-list
93295441|NCT02097147|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
93295442|NCT02097147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93295443|NCT02097147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93295444|NCT02097147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93295445|NCT02097147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295446|NCT02097147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295447|NCT02097147|Serotonin Agents|serotonin agents|mesh-ancestor
93295448|NCT02097147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295449|NCT02097147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93295450|NCT02097147|Antidepressive Agents|antidepressive agents|mesh-ancestor
93295451|NCT02097147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295452|NCT02097147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93295453|NCT02097147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93295454|NCT02097147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295455|NCT02097147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93295456|NCT02097147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93295457|NCT00304070|Cisplatin|cisplatin|mesh-list
93295458|NCT00304070|Doxorubicin|doxorubicin|mesh-list
93295459|NCT00304070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93295460|NCT00304070|Etoposide|etoposide|mesh-list
93295461|NCT00304070|Etoposide phosphate|etoposide phosphate|mesh-list
93295462|NCT00304070|Podophyllotoxin|podophyllotoxin|mesh-list
93295463|NCT00304070|Mitotane|mitotane|mesh-list
93295464|NCT00304070|Lenograstim|lenograstim|mesh-list
93295465|NCT00304070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295466|NCT00304070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93295467|NCT00304070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93295468|NCT00304070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93295469|NCT00304070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295470|NCT00304070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295471|NCT00304070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93295472|NCT00304070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93295473|NCT00304070|Immunologic Factors|immunologic factors|mesh-ancestor
93295474|NCT00304070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295475|NCT00304070|Keratolytic Agents|keratolytic agents|mesh-ancestor
93295476|NCT00304070|Dermatologic Agents|dermatologic agents|mesh-ancestor
93295477|NCT00304070|Tubulin Modulators|tubulin modulators|mesh-ancestor
93295478|NCT00304070|Antimitotic Agents|antimitotic agents|mesh-ancestor
93295479|NCT00304070|Mitosis Modulators|mitosis modulators|mesh-ancestor
93295480|NCT00304070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295481|NCT03556839|Paclitaxel|paclitaxel|mesh-list
93295482|NCT03556839|Bevacizumab|bevacizumab|mesh-list
93295483|NCT03556839|Carboplatin|carboplatin|mesh-list
93295484|NCT03556839|Atezolizumab|atezolizumab|mesh-list
93295485|NCT03556839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93295486|NCT03556839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295487|NCT03556839|Tubulin Modulators|tubulin modulators|mesh-ancestor
93295488|NCT03556839|Antimitotic Agents|antimitotic agents|mesh-ancestor
93295489|NCT03556839|Mitosis Modulators|mitosis modulators|mesh-ancestor
93295490|NCT03556839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295491|NCT03556839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295492|NCT03556839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93295493|NCT03556839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93295494|NCT03556839|Growth Substances|growth substances|mesh-ancestor
93295495|NCT03556839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295496|NCT03556839|Growth Inhibitors|growth inhibitors|mesh-ancestor
93295497|NCT03556839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295498|NCT03415802|Paclitaxel|paclitaxel|mesh-list
93295499|NCT03415802|Tegafur|tegafur|mesh-list
93295500|NCT03415802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93295501|NCT03415802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295502|NCT03415802|Tubulin Modulators|tubulin modulators|mesh-ancestor
93295503|NCT03415802|Antimitotic Agents|antimitotic agents|mesh-ancestor
93295504|NCT03415802|Mitosis Modulators|mitosis modulators|mesh-ancestor
93295505|NCT03415802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295506|NCT03415802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93295507|NCT03415802|Antimetabolites|antimetabolites|mesh-ancestor
93295508|NCT02099877|Fentanyl|fentanyl|mesh-list
93295509|NCT02099877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93295510|NCT02099877|Narcotics|narcotics|mesh-ancestor
93295511|NCT02099877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295512|NCT02099877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295513|NCT02099877|Analgesics|analgesics|mesh-ancestor
93295514|NCT02099877|Sensory System Agents|sensory system agents|mesh-ancestor
93295515|NCT02099877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295516|NCT02099877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92590044|NCT05860933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93295517|NCT02099877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93295518|NCT02099877|Anesthetics, General|anesthetics, general|mesh-ancestor
93295519|NCT02099877|Anesthetics|anesthetics|mesh-ancestor
93295520|NCT02097381|Ritonavir|ritonavir|mesh-list
93295521|NCT02097381|Lopinavir|lopinavir|mesh-list
93295522|NCT02097381|Darunavir|darunavir|mesh-list
93295523|NCT02097381|Tenofovir|tenofovir|mesh-list
93295524|NCT02097381|Emtricitabine|emtricitabine|mesh-list
93295525|NCT02097381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93295526|NCT02097381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93295527|NCT02097381|Protease Inhibitors|protease inhibitors|mesh-ancestor
93295528|NCT02097381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295529|NCT02097381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295530|NCT02097381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93295531|NCT02097381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93295532|NCT02097381|Antiviral Agents|antiviral agents|mesh-ancestor
93295533|NCT02097381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295534|NCT02097381|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93295535|NCT02097381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93295536|NCT02097381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93295537|NCT02097381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93295538|NCT02099955|Vitamin D|vitamin d|mesh-list
93295539|NCT02099955|Cholecalciferol|cholecalciferol|mesh-list
93295540|NCT02099955|Vitamins|vitamins|mesh-ancestor
93295541|NCT02099955|Micronutrients|micronutrients|mesh-ancestor
93295542|NCT02099955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295543|NCT02099955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295544|NCT02099955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93295545|NCT02097459|Tamoxifen|tamoxifen|mesh-list
93295546|NCT02097459|Toremifene|toremifene|mesh-list
93295547|NCT02097459|Anastrozole|anastrozole|mesh-list
93295548|NCT02097459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93295549|NCT02097459|Hormone Antagonists|hormone antagonists|mesh-ancestor
93295550|NCT02097459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295551|NCT02097459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295552|NCT02097459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295553|NCT02097459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295554|NCT02097459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93295555|NCT02097459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93295556|NCT02097459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295557|NCT02097459|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93295558|NCT02097459|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93295559|NCT02097459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295560|NCT02097459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295561|NCT02097615|Chlorhexidine|chlorhexidine|mesh-list
93295562|NCT02097615|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93295563|NCT02097615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93295564|NCT02097615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295565|NCT02097615|Disinfectants|disinfectants|mesh-ancestor
93295566|NCT02097615|Dermatologic Agents|dermatologic agents|mesh-ancestor
93295567|NCT02590432|Linaclotide|linaclotide|mesh-list
93295568|NCT02590432|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93295569|NCT02590432|Enzyme Activators|enzyme activators|mesh-ancestor
93295570|NCT02590432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295571|NCT02590432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93295572|NCT02094339|Analgesics|analgesics|mesh-list
93295573|NCT02094339|Ropivacaine|ropivacaine|mesh-list
93295574|NCT02094339|Anesthetics, Local|anesthetics, local|mesh-ancestor
93295575|NCT02094339|Anesthetics|anesthetics|mesh-ancestor
93295576|NCT02094339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295577|NCT02094339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295578|NCT02094339|Sensory System Agents|sensory system agents|mesh-ancestor
93295579|NCT02094339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295581|NCT03415646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93295582|NCT03415646|Narcotics|narcotics|mesh-ancestor
93295583|NCT03415646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295584|NCT03415646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295585|NCT03415646|Analgesics|analgesics|mesh-ancestor
93295586|NCT03415646|Sensory System Agents|sensory system agents|mesh-ancestor
93295587|NCT03415646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295588|NCT03417518|Propofol|propofol|mesh-list
93295589|NCT03417518|Desflurane|desflurane|mesh-list
93295590|NCT03417518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93295591|NCT03417518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295592|NCT03417518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295593|NCT03417518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93295594|NCT03417518|Anesthetics, General|anesthetics, general|mesh-ancestor
93295595|NCT03417518|Anesthetics|anesthetics|mesh-ancestor
93295596|NCT03417518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93295597|NCT02094651|Valproic Acid|valproic acid|mesh-list
93295598|NCT02094651|Anticonvulsants|anticonvulsants|mesh-ancestor
93295599|NCT02094651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295600|NCT02094651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295601|NCT02094651|GABA Agents|gaba agents|mesh-ancestor
93295602|NCT02094651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295603|NCT02094651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295604|NCT02094651|Antimanic Agents|antimanic agents|mesh-ancestor
93295605|NCT02094651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93295606|NCT02094651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295607|NCT02094651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295608|NCT02094807|Acetaminophen|acetaminophen|mesh-list
93295609|NCT02094807|Diclofenac|diclofenac|mesh-list
93295610|NCT02094807|Oxycodone|oxycodone|mesh-list
93295611|NCT02094807|Tramadol|tramadol|mesh-list
93295612|NCT02094807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295613|NCT02094807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295614|NCT02094807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93295615|NCT02094807|Analgesics|analgesics|mesh-ancestor
93295616|NCT02094807|Sensory System Agents|sensory system agents|mesh-ancestor
93295617|NCT02094807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295618|NCT02094807|Antipyretics|antipyretics|mesh-ancestor
93295619|NCT02094807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93295620|NCT02094807|Narcotics|narcotics|mesh-ancestor
93295621|NCT02094807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93295622|NCT02094807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295623|NCT02094807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295624|NCT02094807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93295625|NCT02094807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295626|NCT02094807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295627|NCT05139472|Empagliflozin|empagliflozin|mesh-list
93295628|NCT05139472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93295629|NCT05139472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295630|NCT05139472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93295631|NCT05139472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295632|NCT04757090|Trastuzumab|trastuzumab|mesh-list
93295633|NCT04757090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295634|NCT04757090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295635|NCT03397862|Donepezil|donepezil|mesh-list
93295636|NCT03397862|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93295637|NCT03397862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295638|NCT03397862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295639|NCT03397862|Cholinergic Agents|cholinergic agents|mesh-ancestor
93295640|NCT03397862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295641|NCT03397862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295642|NCT03397862|Nootropic Agents|nootropic agents|mesh-ancestor
93295643|NCT02100267|Methacholine Chloride|methacholine chloride|mesh-list
93295644|NCT02100267|Miotics|miotics|mesh-ancestor
93295645|NCT02100267|Autonomic Agents|autonomic agents|mesh-ancestor
93295646|NCT02100267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295647|NCT02100267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295648|NCT02100267|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93295649|NCT02100267|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93295650|NCT02100267|Respiratory System Agents|respiratory system agents|mesh-ancestor
93295651|NCT02100267|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93295652|NCT02100267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93295653|NCT02100267|Cholinergic Agents|cholinergic agents|mesh-ancestor
93295654|NCT02100267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967731|NCT00808392|Vaccines|vaccines|mesh-list
93295655|NCT02100267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295656|NCT02094963|Clopidogrel|clopidogrel|mesh-list
93295657|NCT02094963|Ticagrelor|ticagrelor|mesh-list
93295658|NCT02094963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93295659|NCT02094963|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93295660|NCT02094963|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93295661|NCT02094963|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93295662|NCT02094963|Purinergic Agents|purinergic agents|mesh-ancestor
93295663|NCT02094963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295664|NCT02094963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295665|NCT02094963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295666|NCT03982810|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93295667|NCT03982810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93295668|NCT03982810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295669|NCT03982810|Antitubercular Agents|antitubercular agents|mesh-ancestor
93295670|NCT02098317|Vitamin D|vitamin d|mesh-list
93295671|NCT02098317|Vitamins|vitamins|mesh-ancestor
93295672|NCT02098317|Micronutrients|micronutrients|mesh-ancestor
93295673|NCT02098317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295674|NCT02098317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295675|NCT02100423|Vitamin D|vitamin d|mesh-list
93295676|NCT02100423|Cholecalciferol|cholecalciferol|mesh-list
93295677|NCT02100423|Curcumin|curcumin|mesh-list
93295678|NCT02100423|Vitamins|vitamins|mesh-ancestor
93295679|NCT02100423|Micronutrients|micronutrients|mesh-ancestor
93295680|NCT02100423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295681|NCT02100423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295682|NCT02100423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93295683|NCT02100423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93295684|NCT02100423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93295685|NCT02100423|Analgesics|analgesics|mesh-ancestor
93295686|NCT02100423|Sensory System Agents|sensory system agents|mesh-ancestor
93295687|NCT02100423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295688|NCT02100423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295689|NCT02100423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295690|NCT02100423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295691|NCT02100423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295692|NCT02100423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295693|NCT05614648|Clonidine|clonidine|mesh-list
93295694|NCT05614648|Analgesics|analgesics|mesh-ancestor
93295695|NCT05614648|Sensory System Agents|sensory system agents|mesh-ancestor
93295696|NCT05614648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295697|NCT05614648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295698|NCT05614648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93295699|NCT05614648|Sympatholytics|sympatholytics|mesh-ancestor
93295700|NCT05614648|Autonomic Agents|autonomic agents|mesh-ancestor
93295701|NCT05614648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93295702|NCT05614648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93295703|NCT05614648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93295704|NCT05614648|Adrenergic Agents|adrenergic agents|mesh-ancestor
93295705|NCT05614648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295706|NCT05614648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295707|NCT02520752|Midazolam|midazolam|mesh-list
93295708|NCT02520752|Caffeine|caffeine|mesh-list
93295709|NCT02520752|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93295710|NCT02520752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93295711|NCT02520752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295712|NCT02520752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295713|NCT02520752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93295714|NCT02520752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93295715|NCT02520752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295716|NCT02520752|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93295717|NCT02520752|Anesthetics, General|anesthetics, general|mesh-ancestor
93295718|NCT02520752|Anesthetics|anesthetics|mesh-ancestor
93295719|NCT02520752|GABA Modulators|gaba modulators|mesh-ancestor
93295720|NCT02520752|GABA Agents|gaba agents|mesh-ancestor
93295721|NCT02520752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295722|NCT02520752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295723|NCT02520752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93295724|NCT02520752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93295725|NCT02520752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295726|NCT02520752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93295727|NCT02520752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93295728|NCT02520752|Purinergic Agents|purinergic agents|mesh-ancestor
92967806|NCT00780182|Brincidofovir|brincidofovir|mesh-list
93295730|NCT02095119|Nimotuzumab|nimotuzumab|mesh-list
93295731|NCT02095119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295732|NCT02095119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93295733|NCT02095119|Antimetabolites|antimetabolites|mesh-ancestor
93295734|NCT02095119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295735|NCT02095119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295736|NCT02098629|Milrinone|milrinone|mesh-list
93295737|NCT02098629|Esmolol|esmolol|mesh-list
93295738|NCT02098629|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93295739|NCT02098629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93295740|NCT02098629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93295741|NCT02098629|Adrenergic Agents|adrenergic agents|mesh-ancestor
93295742|NCT02098629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295743|NCT02098629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295744|NCT02098629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295745|NCT02098629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93295746|NCT02098629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93295747|NCT02098629|Vasodilator Agents|vasodilator agents|mesh-ancestor
93295748|NCT02098629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93295749|NCT02098629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93295750|NCT02098629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295751|NCT02098629|Protective Agents|protective agents|mesh-ancestor
93295752|NCT02095509|Enoxaparin|enoxaparin|mesh-list
93295753|NCT02095509|Anticoagulants|anticoagulants|mesh-ancestor
93295754|NCT02095509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93295755|NCT02095509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93295756|NCT02095509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295757|NCT03397082|Lidocaine|lidocaine|mesh-list
93295758|NCT03397082|Anesthetics, Local|anesthetics, local|mesh-ancestor
93295759|NCT03397082|Anesthetics|anesthetics|mesh-ancestor
93295760|NCT03397082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295761|NCT03397082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295762|NCT03397082|Sensory System Agents|sensory system agents|mesh-ancestor
93295763|NCT03397082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295764|NCT03397082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93295765|NCT03397082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93295766|NCT03397082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93295767|NCT03397082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93295768|NCT03397082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295769|NCT02101047|Phenylephrine|phenylephrine|mesh-list
93295770|NCT02101047|Oxymetazoline|oxymetazoline|mesh-list
93295771|NCT02101047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93295772|NCT02101047|Mydriatics|mydriatics|mesh-ancestor
93295773|NCT02101047|Autonomic Agents|autonomic agents|mesh-ancestor
93295774|NCT02101047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295775|NCT02101047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295776|NCT02101047|Sympathomimetics|sympathomimetics|mesh-ancestor
93295777|NCT02101047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93295778|NCT02101047|Nasal Decongestants|nasal decongestants|mesh-ancestor
93295779|NCT02101047|Respiratory System Agents|respiratory system agents|mesh-ancestor
93295780|NCT02101047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93295781|NCT02101047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93295782|NCT02101047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93295783|NCT02101047|Adrenergic Agents|adrenergic agents|mesh-ancestor
93295784|NCT02101047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295785|NCT02101047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295786|NCT02101047|Protective Agents|protective agents|mesh-ancestor
93295787|NCT02095665|Acetaminophen|acetaminophen|mesh-list
93295788|NCT02095665|Tamsulosin|tamsulosin|mesh-list
93295789|NCT02095665|Mirabegron|mirabegron|mesh-list
93295790|NCT02095665|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93295791|NCT02095665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93295792|NCT02095665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93295793|NCT02095665|Adrenergic Agents|adrenergic agents|mesh-ancestor
93295794|NCT02095665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295795|NCT02095665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295796|NCT02095665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295797|NCT02095665|Urological Agents|urological agents|mesh-ancestor
93295798|NCT02095665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93295799|NCT02095665|Analgesics|analgesics|mesh-ancestor
93295800|NCT02095665|Sensory System Agents|sensory system agents|mesh-ancestor
93295801|NCT02095665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295802|NCT02095665|Antipyretics|antipyretics|mesh-ancestor
93295803|NCT02095665|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93295804|NCT02095665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93295805|NCT02095665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93295806|NCT03548428|Atezolizumab|atezolizumab|mesh-list
93295807|NCT03548428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295808|NCT03548428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295809|NCT03548428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295810|NCT03548428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295811|NCT02101125|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93295812|NCT02101125|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93295813|NCT02101125|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93295814|NCT02101125|Antimetabolites|antimetabolites|mesh-ancestor
93295815|NCT02101125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295816|NCT02101125|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93295817|NCT02101125|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93295818|NCT02101125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295819|NCT02101203|Buspirone|buspirone|mesh-list
93295820|NCT02101203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93295821|NCT02101203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93295822|NCT02101203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295823|NCT02101203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295824|NCT02101203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93295825|NCT02101203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93295826|NCT02101203|Serotonin Agents|serotonin agents|mesh-ancestor
93295827|NCT02101203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93295828|NCT02101203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295829|NCT04523246|Vaccines|vaccines|mesh-list
93295830|NCT04523246|Immunologic Factors|immunologic factors|mesh-ancestor
93295831|NCT04523246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295832|NCT03396380|Calcium, Dietary|calcium, dietary|mesh-list
93295833|NCT03396380|Vitamin D|vitamin d|mesh-list
93295834|NCT03396380|Citric Acid|citric acid|mesh-list
93295835|NCT03396380|Sodium Citrate|sodium citrate|mesh-list
93295836|NCT03396380|Clomiphene|clomiphene|mesh-list
93295837|NCT03396380|Enclomiphene|enclomiphene|mesh-list
93295838|NCT03396380|Zuclomiphene|zuclomiphene|mesh-list
93295839|NCT03396380|Calcium|calcium|mesh-list
93295840|NCT03396380|Vitamins|vitamins|mesh-ancestor
93295841|NCT03396380|Micronutrients|micronutrients|mesh-ancestor
93295842|NCT03396380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295843|NCT03396380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93295844|NCT03396380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93295845|NCT03396380|Anticoagulants|anticoagulants|mesh-ancestor
93295846|NCT03396380|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93295847|NCT03396380|Chelating Agents|chelating agents|mesh-ancestor
93295848|NCT03396380|Sequestering Agents|sequestering agents|mesh-ancestor
93295849|NCT03396380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295850|NCT03396380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93295851|NCT03396380|Hormone Antagonists|hormone antagonists|mesh-ancestor
93295852|NCT03396380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295853|NCT03396380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93295854|NCT03396380|Fertility Agents|fertility agents|mesh-ancestor
93295855|NCT03396380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93295856|NCT03396380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93295857|NCT03396380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93295858|NCT05040568|Cyclophosphamide|cyclophosphamide|mesh-list
93295859|NCT05040568|Fludarabine|fludarabine|mesh-list
93295860|NCT05040568|Fludarabine phosphate|fludarabine phosphate|mesh-list
93295861|NCT05040568|Cetuximab|cetuximab|mesh-list
93295862|NCT05040568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93295863|NCT05040568|Immunologic Factors|immunologic factors|mesh-ancestor
93295864|NCT05040568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295865|NCT05040568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295866|NCT05040568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93295867|NCT05040568|Alkylating Agents|alkylating agents|mesh-ancestor
93295868|NCT05040568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295869|NCT05040568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295870|NCT05040568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93295871|NCT05040568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93295872|NCT05040568|Antimetabolites|antimetabolites|mesh-ancestor
93295873|NCT05040568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295874|NCT03414164|Procyanidin|procyanidin|mesh-list
93295875|NCT03414164|Antioxidants|antioxidants|mesh-ancestor
93295876|NCT03414164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295877|NCT03414164|Protective Agents|protective agents|mesh-ancestor
93295878|NCT03414164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295879|NCT05613478|Apatinib|apatinib|mesh-list
93295880|NCT05613478|Chlorotrianisene|chlorotrianisene|mesh-list
93295881|NCT05613478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295882|NCT05613478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93295883|NCT05613478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295884|NCT05613478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295885|NCT05613478|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93295886|NCT05613478|Estrogens|estrogens|mesh-ancestor
93295887|NCT05613478|Hormones|hormones|mesh-ancestor
93295888|NCT05613478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295889|NCT05613478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295890|NCT05613478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93295891|NCT04412018|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93295892|NCT04412018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93295893|NCT04412018|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93295894|NCT03406988|Nifedipine|nifedipine|mesh-list
93295895|NCT03406988|Iloprost|iloprost|mesh-list
93295896|NCT03406988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93295897|NCT03406988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93295898|NCT03406988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295899|NCT03406988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93295900|NCT03406988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295901|NCT03406988|Vasodilator Agents|vasodilator agents|mesh-ancestor
93295902|NCT03406988|Tocolytic Agents|tocolytic agents|mesh-ancestor
93295903|NCT03406988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93295904|NCT03406988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93295905|NCT03406832|Nitroprusside|nitroprusside|mesh-list
93295906|NCT03406832|Tirofiban|tirofiban|mesh-list
93295907|NCT03406832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93295908|NCT03406832|Vasodilator Agents|vasodilator agents|mesh-ancestor
93295909|NCT03406832|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93295910|NCT03406832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295911|NCT03406832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93295912|NCT03406832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93295913|NCT03406832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93295914|NCT03405974|Aspirin|aspirin|mesh-list
93295915|NCT03405974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93295916|NCT03405974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93295917|NCT03405974|Analgesics|analgesics|mesh-ancestor
93295918|NCT03405974|Sensory System Agents|sensory system agents|mesh-ancestor
93295919|NCT03405974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295920|NCT03405974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295921|NCT03405974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93295922|NCT03405974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93295923|NCT03405974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93295924|NCT03405974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93295925|NCT03405974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295926|NCT03405974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93295927|NCT03405974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93295928|NCT03405974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295929|NCT03405974|Antipyretics|antipyretics|mesh-ancestor
93295930|NCT04337060|Lidocaine|lidocaine|mesh-list
93295931|NCT04337060|Morphine|morphine|mesh-list
93295932|NCT04337060|Bupivacaine|bupivacaine|mesh-list
93295933|NCT04337060|Anesthetics, Local|anesthetics, local|mesh-ancestor
93295934|NCT04337060|Anesthetics|anesthetics|mesh-ancestor
93295935|NCT04337060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93295936|NCT04337060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295937|NCT04337060|Sensory System Agents|sensory system agents|mesh-ancestor
93295938|NCT04337060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93295939|NCT04337060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93295940|NCT04337060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93295941|NCT04337060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93295942|NCT04337060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93295943|NCT04337060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295944|NCT04337060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93295945|NCT04337060|Narcotics|narcotics|mesh-ancestor
93295946|NCT04337060|Analgesics|analgesics|mesh-ancestor
93295947|NCT04339036|Capecitabine|capecitabine|mesh-list
93295948|NCT04339036|Temozolomide|temozolomide|mesh-list
93295949|NCT04339036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93295950|NCT04339036|Antimetabolites|antimetabolites|mesh-ancestor
93295951|NCT04339036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295952|NCT04339036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295953|NCT04339036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93295954|NCT04339036|Alkylating Agents|alkylating agents|mesh-ancestor
93295955|NCT04447274|Apatinib|apatinib|mesh-list
93295956|NCT04447274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295957|NCT04447274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93295958|NCT04447274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295959|NCT04447274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295960|NCT02977156|Ipilimumab|ipilimumab|mesh-list
93295961|NCT02977156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295962|NCT02977156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295963|NCT02977156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295964|NCT02977156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295965|NCT02413138|Hormones|hormones|mesh-list
93295966|NCT02413138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93295967|NCT02413138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295968|NCT01014598|Cisplatin|cisplatin|mesh-list
93295969|NCT01014598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295970|NCT03404804|Amoxicillin|amoxicillin|mesh-list
93295971|NCT03404804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93295972|NCT03404804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295973|NCT03403946|Pyrithione zinc|pyrithione zinc|mesh-list
93295974|NCT03403946|Keratolytic Agents|keratolytic agents|mesh-ancestor
93295975|NCT03403946|Dermatologic Agents|dermatologic agents|mesh-ancestor
93295976|NCT05611372|Rasagiline|rasagiline|mesh-list
93295977|NCT05611372|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93295978|NCT05611372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295979|NCT05611372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295980|NCT05611372|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93295981|NCT05611372|Protective Agents|protective agents|mesh-ancestor
93295982|NCT05611372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93295983|NCT04776148|Trifluridine|trifluridine|mesh-list
93295984|NCT04776148|Pembrolizumab|pembrolizumab|mesh-list
93295985|NCT04776148|Lenvatinib|lenvatinib|mesh-list
93295986|NCT04776148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93295987|NCT04776148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93295988|NCT04776148|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93295989|NCT04776148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93295990|NCT04776148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93295991|NCT04776148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93295992|NCT04776148|Antimetabolites|antimetabolites|mesh-ancestor
93295993|NCT04776148|Antiviral Agents|antiviral agents|mesh-ancestor
93295994|NCT04776148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93295995|NCT03395756|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93295996|NCT03395756|Medroxyprogesterone|medroxyprogesterone|mesh-list
93295997|NCT03395756|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93295998|NCT03395756|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93295999|NCT03395756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93296000|NCT03395756|Contraceptive Agents|contraceptive agents|mesh-ancestor
93296001|NCT03395756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93296002|NCT03395756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296003|NCT03395756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93296004|NCT03395756|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93296005|NCT03395756|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93296006|NCT03395756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93296007|NCT03395756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296008|NCT05613166|Everolimus|everolimus|mesh-list
93296009|NCT05613166|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93296010|NCT05613166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93296011|NCT05613166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296012|NCT05613166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296013|NCT05613166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296014|NCT05613166|Immunologic Factors|immunologic factors|mesh-ancestor
93296015|NCT05613166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296016|NCT05613166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296017|NCT05166668|Letrozole|letrozole|mesh-list
93296018|NCT05166668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296019|NCT05166668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93296020|NCT05166668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93296021|NCT05166668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296022|NCT05166668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296023|NCT05166668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93296024|NCT05166668|Hormone Antagonists|hormone antagonists|mesh-ancestor
93366430|NCT02422186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296025|NCT05166668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296026|NCT05166668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296027|NCT05558176|Sildenafil Citrate|sildenafil citrate|mesh-list
93296028|NCT05558176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296029|NCT05558176|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296030|NCT05558176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93296031|NCT05558176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93296032|NCT05558176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296033|NCT05558176|Urological Agents|urological agents|mesh-ancestor
93296034|NCT04748224|Dexmedetomidine|dexmedetomidine|mesh-list
93296035|NCT04748224|Bupivacaine|bupivacaine|mesh-list
93296036|NCT04748224|Anesthetics, Local|anesthetics, local|mesh-ancestor
93296037|NCT04748224|Anesthetics|anesthetics|mesh-ancestor
93296038|NCT04748224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296039|NCT04748224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296040|NCT04748224|Sensory System Agents|sensory system agents|mesh-ancestor
93296041|NCT04748224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296042|NCT04748224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93296043|NCT04748224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296044|NCT04748224|Analgesics|analgesics|mesh-ancestor
93296045|NCT04748224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93296046|NCT04748224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93296047|NCT04748224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93296048|NCT04748224|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296049|NCT04748224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296050|NCT04748224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296051|NCT03413150|Amiodarone|amiodarone|mesh-list
93296052|NCT03413150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93296053|NCT03413150|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296054|NCT03413150|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93296055|NCT03413150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296056|NCT03413150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296057|NCT03413150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93296058|NCT03413150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93296059|NCT03413150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93296060|NCT03413150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296061|NCT03413150|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93296062|NCT03413150|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93296063|NCT03413150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93296064|NCT05474716|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93296065|NCT05474716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93296066|NCT05474716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93296067|NCT05474716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93296068|NCT05474716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93296069|NCT05474716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93296070|NCT05474716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93296071|NCT05474716|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296072|NCT05474716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296073|NCT05474716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296074|NCT05474716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296075|NCT03126578|Midazolam|midazolam|mesh-list
93296076|NCT03126578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93296077|NCT03126578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93296078|NCT03126578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296079|NCT03126578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296080|NCT03126578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93296081|NCT03126578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93296082|NCT03126578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93296083|NCT03126578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93296084|NCT03126578|Anesthetics, General|anesthetics, general|mesh-ancestor
93296085|NCT03126578|Anesthetics|anesthetics|mesh-ancestor
93296086|NCT03126578|GABA Modulators|gaba modulators|mesh-ancestor
93296087|NCT03126578|GABA Agents|gaba agents|mesh-ancestor
93296088|NCT03126578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296089|NCT03126578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296090|NCT03412994|Apatinib|apatinib|mesh-list
93296091|NCT03412994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296092|NCT03412994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93296093|NCT03412994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296094|NCT03412994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296095|NCT02588248|Peppermint oil|peppermint oil|mesh-list
93296096|NCT02588248|Menthol|menthol|mesh-list
93296097|NCT02588248|Antipruritics|antipruritics|mesh-ancestor
93296098|NCT02588248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93296099|NCT02588248|Antiemetics|antiemetics|mesh-ancestor
93296100|NCT02588248|Autonomic Agents|autonomic agents|mesh-ancestor
93296101|NCT02588248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296102|NCT02588248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296103|NCT02588248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296104|NCT02588248|Parasympatholytics|parasympatholytics|mesh-ancestor
93296105|NCT03412682|Budesonide|budesonide|mesh-list
93296106|NCT03412682|Mesalamine|mesalamine|mesh-list
93296107|NCT03412682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296108|NCT03412682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93296109|NCT03412682|Autonomic Agents|autonomic agents|mesh-ancestor
93296110|NCT03412682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296111|NCT03412682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296112|NCT03412682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93296113|NCT03412682|Respiratory System Agents|respiratory system agents|mesh-ancestor
93296114|NCT03412682|Glucocorticoids|glucocorticoids|mesh-ancestor
93296115|NCT03412682|Hormones|hormones|mesh-ancestor
93296116|NCT03412682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296117|NCT03412682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93296118|NCT03412682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296119|NCT03412682|Analgesics|analgesics|mesh-ancestor
93296120|NCT03412682|Sensory System Agents|sensory system agents|mesh-ancestor
93296121|NCT03412682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296122|NCT03412526|Fludarabine|fludarabine|mesh-list
93296123|NCT03412526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296124|NCT03126422|Dexmedetomidine|dexmedetomidine|mesh-list
93296125|NCT03126422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93296126|NCT03126422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296127|NCT03126422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296128|NCT03126422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296129|NCT03126422|Analgesics|analgesics|mesh-ancestor
93296130|NCT03126422|Sensory System Agents|sensory system agents|mesh-ancestor
93296131|NCT03126422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296132|NCT03126422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93296133|NCT03126422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93296134|NCT03126422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93296135|NCT03126422|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296136|NCT03126422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296137|NCT03126422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296138|NCT03395132|Fusidic Acid|fusidic acid|mesh-list
93296139|NCT03395132|Betamethasone|betamethasone|mesh-list
93296140|NCT03395132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296141|NCT03395132|Glucocorticoids|glucocorticoids|mesh-ancestor
93296142|NCT03395132|Hormones|hormones|mesh-ancestor
93296143|NCT03395132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296144|NCT03395132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296145|NCT03395132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93296146|NCT03395132|Respiratory System Agents|respiratory system agents|mesh-ancestor
93296147|NCT03395132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93296148|NCT03395132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296149|NCT03395132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93296150|NCT03395132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296151|NCT03395132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296152|NCT03127124|Leucovorin|leucovorin|mesh-list
93296153|NCT03127124|Fluorouracil|fluorouracil|mesh-list
93296154|NCT03127124|Bevacizumab|bevacizumab|mesh-list
93296155|NCT03127124|Oxaliplatin|oxaliplatin|mesh-list
93296156|NCT03127124|Calcium|calcium|mesh-list
93296157|NCT03127124|Levoleucovorin|levoleucovorin|mesh-list
93296158|NCT03127124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93296159|NCT03127124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296160|NCT03127124|Antimetabolites|antimetabolites|mesh-ancestor
93296161|NCT03127124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296162|NCT03127124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93296163|NCT03127124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296164|NCT03127124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296165|NCT03127124|Immunologic Factors|immunologic factors|mesh-ancestor
93296166|NCT03127124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93296167|NCT03127124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93296168|NCT03127124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93296169|NCT03127124|Growth Substances|growth substances|mesh-ancestor
93296170|NCT03127124|Growth Inhibitors|growth inhibitors|mesh-ancestor
93296171|NCT03127124|Antidotes|antidotes|mesh-ancestor
93296172|NCT03127124|Protective Agents|protective agents|mesh-ancestor
93296173|NCT03127124|Vitamin B Complex|vitamin b complex|mesh-ancestor
93296174|NCT03127124|Vitamins|vitamins|mesh-ancestor
93296175|NCT03127124|Micronutrients|micronutrients|mesh-ancestor
93296176|NCT03399110|Capecitabine|capecitabine|mesh-list
93296177|NCT03399110|Oxaliplatin|oxaliplatin|mesh-list
93296178|NCT03399110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93296179|NCT03399110|Antimetabolites|antimetabolites|mesh-ancestor
93296180|NCT03399110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296181|NCT03399110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296182|NCT05111912|Liraglutide|liraglutide|mesh-list
93296183|NCT05111912|Glucagon|glucagon|mesh-list
93296184|NCT05111912|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93296185|NCT05111912|Incretins|incretins|mesh-ancestor
93296186|NCT05111912|Hormones|hormones|mesh-ancestor
93296187|NCT05111912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296188|NCT05111912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296189|NCT05111912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296190|NCT05111912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93296191|NCT03127046|Aceclofenac|aceclofenac|mesh-list
93296192|NCT03127046|Diclofenac|diclofenac|mesh-list
93296193|NCT03127046|Esomeprazole|esomeprazole|mesh-list
93296194|NCT03127046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93296195|NCT03127046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296196|NCT03127046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93296197|NCT03127046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296198|NCT03127046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296199|NCT03127046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93296200|NCT03127046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296201|NCT03127046|Analgesics|analgesics|mesh-ancestor
93296202|NCT03127046|Sensory System Agents|sensory system agents|mesh-ancestor
93296203|NCT03127046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296204|NCT03127046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296205|NCT03127046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296206|NCT03127046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296207|NCT03127046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93296208|NCT05105672|Cisplatin|cisplatin|mesh-list
93296209|NCT05105672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296210|NCT03399032|Caspofungin|caspofungin|mesh-list
93296211|NCT03399032|Antifungal Agents|antifungal agents|mesh-ancestor
93296212|NCT03399032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296213|NCT03399032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296214|NCT03399032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296215|NCT03394820|Dexamethasone|dexamethasone|mesh-list
93296216|NCT03394820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296217|NCT03394820|Antiemetics|antiemetics|mesh-ancestor
93296218|NCT03394820|Autonomic Agents|autonomic agents|mesh-ancestor
93296219|NCT03394820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296220|NCT03394820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296221|NCT03394820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296222|NCT03394820|Glucocorticoids|glucocorticoids|mesh-ancestor
93296223|NCT03394820|Hormones|hormones|mesh-ancestor
93296224|NCT03394820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296225|NCT03394820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93296226|NCT03394820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296227|NCT01328054|Lapatinib|lapatinib|mesh-list
93296228|NCT01328054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296229|NCT01328054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93296230|NCT01328054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296231|NCT01328054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296232|NCT05067920|Antibodies|antibodies|mesh-list
93296233|NCT05067920|Immunologic Factors|immunologic factors|mesh-ancestor
92590773|NCT05020236|Daratumumab|daratumumab|mesh-list
93296234|NCT05067920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296235|NCT05002244|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93296236|NCT05002244|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93296237|NCT05002244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93296238|NCT05002244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93296239|NCT05002244|Antimetabolites|antimetabolites|mesh-ancestor
93296240|NCT05002244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296241|NCT05002244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93296242|NCT05002244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93296243|NCT05002244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296244|NCT05002244|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93296245|NCT05002244|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93296246|NCT03398876|Nicotine|nicotine|mesh-list
93296247|NCT03398876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93296248|NCT03398876|Autonomic Agents|autonomic agents|mesh-ancestor
93296249|NCT03398876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296250|NCT03398876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296251|NCT03398876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93296252|NCT03398876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93296253|NCT03398876|Cholinergic Agents|cholinergic agents|mesh-ancestor
93296254|NCT03398876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296255|NCT03398876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296256|NCT03394586|Golimumab|golimumab|mesh-list
93296257|NCT03394586|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93296258|NCT03394586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296259|NCT03394586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296260|NCT03394586|Immunologic Factors|immunologic factors|mesh-ancestor
93296261|NCT03394586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296262|NCT03394430|Midazolam|midazolam|mesh-list
93296263|NCT03394430|Dexmedetomidine|dexmedetomidine|mesh-list
93296264|NCT03394430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93296265|NCT03394430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296266|NCT03394430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296267|NCT03394430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296268|NCT03394430|Analgesics|analgesics|mesh-ancestor
93296269|NCT03394430|Sensory System Agents|sensory system agents|mesh-ancestor
93296270|NCT03394430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296271|NCT03394430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93296272|NCT03394430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93296273|NCT03394430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93296274|NCT03394430|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296275|NCT03394430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296276|NCT03394430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296277|NCT03394430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93296278|NCT03394430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93296279|NCT03394430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93296280|NCT03394430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93296281|NCT03394430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93296282|NCT03394430|Anesthetics, General|anesthetics, general|mesh-ancestor
93296283|NCT03394430|Anesthetics|anesthetics|mesh-ancestor
93296284|NCT03394430|GABA Modulators|gaba modulators|mesh-ancestor
93296285|NCT03394430|GABA Agents|gaba agents|mesh-ancestor
93296286|NCT03394196|Ritonavir|ritonavir|mesh-list
93296287|NCT03394196|Lopinavir|lopinavir|mesh-list
93296288|NCT03394196|Darunavir|darunavir|mesh-list
93296289|NCT03394196|Tenofovir|tenofovir|mesh-list
93296290|NCT03394196|Lamivudine|lamivudine|mesh-list
93296291|NCT03394196|Emtricitabine|emtricitabine|mesh-list
93296292|NCT03394196|Zidovudine|zidovudine|mesh-list
93296293|NCT03394196|Raltegravir Potassium|raltegravir potassium|mesh-list
93296294|NCT03394196|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93296295|NCT03394196|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93296296|NCT03394196|Protease Inhibitors|protease inhibitors|mesh-ancestor
93296297|NCT03394196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296298|NCT03394196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296299|NCT03394196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93296300|NCT03394196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93296301|NCT03394196|Antiviral Agents|antiviral agents|mesh-ancestor
93296302|NCT03394196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296303|NCT03394196|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93296304|NCT03394196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93296305|NCT03394196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93296306|NCT03394196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93296307|NCT03394196|Antimetabolites|antimetabolites|mesh-ancestor
93296308|NCT03394196|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93296309|NCT03394196|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93296310|NCT03398018|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93296311|NCT03398018|Hormones|hormones|mesh-ancestor
93296312|NCT03398018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296313|NCT03398018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296314|NCT03411434|Methylphenidate|methylphenidate|mesh-list
93296315|NCT03411434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93296316|NCT03411434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296317|NCT03411434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93296318|NCT03411434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93296319|NCT03411434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296320|NCT03411434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296321|NCT03411434|Dopamine Agents|dopamine agents|mesh-ancestor
93296322|NCT03411434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296323|NCT03126656|Methyltestosterone|methyltestosterone|mesh-list
93296324|NCT03126656|Testosterone|testosterone|mesh-list
92968401|NCT00319501|Anesthetics|anesthetics|mesh-ancestor
93296325|NCT03126656|Testosterone undecanoate|testosterone undecanoate|mesh-list
93296326|NCT03126656|Testosterone enanthate|testosterone enanthate|mesh-list
93296327|NCT03126656|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93296328|NCT03126656|Androgens|androgens|mesh-ancestor
93296329|NCT03126656|Hormones|hormones|mesh-ancestor
93296330|NCT03126656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296331|NCT03126656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296332|NCT03126656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93296333|NCT03126656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296334|NCT03126656|Anabolic Agents|anabolic agents|mesh-ancestor
93296335|NCT03385382|Dexamethasone|dexamethasone|mesh-list
93296336|NCT03385382|Ranibizumab|ranibizumab|mesh-list
93296337|NCT03385382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296338|NCT03385382|Antiemetics|antiemetics|mesh-ancestor
93296339|NCT03385382|Autonomic Agents|autonomic agents|mesh-ancestor
93296340|NCT03385382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296341|NCT03385382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296342|NCT03385382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296343|NCT03385382|Glucocorticoids|glucocorticoids|mesh-ancestor
93296344|NCT03385382|Hormones|hormones|mesh-ancestor
93296345|NCT03385382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296346|NCT03385382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93296347|NCT03385382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296348|NCT03385382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93296349|NCT03385382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93296350|NCT03385382|Growth Substances|growth substances|mesh-ancestor
93296351|NCT03385382|Growth Inhibitors|growth inhibitors|mesh-ancestor
93296352|NCT03394118|Osimertinib|osimertinib|mesh-list
93296353|NCT03394118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296354|NCT03394118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93296355|NCT03394118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296356|NCT03394118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296357|NCT03389672|Anesthetics|anesthetics|mesh-list
93296358|NCT03389672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296359|NCT03389672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296360|NCT01941446|Moxifloxacin|moxifloxacin|mesh-list
93296361|NCT01941446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93296362|NCT01941446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296363|NCT01941446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93296364|NCT01941446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93296365|NCT01941446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296366|NCT01941446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296367|NCT01941446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296368|NCT01907360|Methylphenidate|methylphenidate|mesh-list
93296369|NCT01907360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93296370|NCT01907360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296371|NCT01907360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93296372|NCT01907360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93296373|NCT01907360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296374|NCT01907360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296375|NCT01907360|Dopamine Agents|dopamine agents|mesh-ancestor
93296376|NCT01907360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296377|NCT03126188|Sertraline|sertraline|mesh-list
93296378|NCT03126188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93296379|NCT03126188|Antidepressive Agents|antidepressive agents|mesh-ancestor
93296380|NCT03126188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93296381|NCT03126188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93296382|NCT03126188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93296383|NCT03126188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296384|NCT03126188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296385|NCT03126188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296386|NCT03126188|Serotonin Agents|serotonin agents|mesh-ancestor
93296387|NCT03126188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296388|NCT03126188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93296389|NCT03126188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93296390|NCT04446338|Antibodies|antibodies|mesh-list
93296391|NCT04446338|Immunologic Factors|immunologic factors|mesh-ancestor
93296392|NCT04446338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296393|NCT03393728|Propranolol|propranolol|mesh-list
93296394|NCT03393728|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93296395|NCT03393728|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93296396|NCT03393728|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296397|NCT03393728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296398|NCT03393728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296399|NCT03393728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296400|NCT03393728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93296401|NCT03393728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93296402|NCT03393728|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296403|NCT03393572|Magnesium Sulfate|magnesium sulfate|mesh-list
93296404|NCT03393572|Nalbuphine|nalbuphine|mesh-list
93296405|NCT03393572|Bupivacaine|bupivacaine|mesh-list
93296406|NCT03393572|Anesthetics, Local|anesthetics, local|mesh-ancestor
93296407|NCT03393572|Anesthetics|anesthetics|mesh-ancestor
93296408|NCT03393572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296409|NCT03393572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296410|NCT03393572|Sensory System Agents|sensory system agents|mesh-ancestor
93296411|NCT03393572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296412|NCT03393572|Analgesics|analgesics|mesh-ancestor
93296413|NCT03393572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93296414|NCT03393572|Anticonvulsants|anticonvulsants|mesh-ancestor
93296415|NCT03393572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93296416|NCT03393572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296417|NCT03393572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296418|NCT03393572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93296419|NCT03393572|Tocolytic Agents|tocolytic agents|mesh-ancestor
93296420|NCT03393572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93296421|NCT03393572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93296422|NCT03393572|Narcotics|narcotics|mesh-ancestor
93296423|NCT03393416|Antibodies|antibodies|mesh-list
93296424|NCT03393416|Immunologic Factors|immunologic factors|mesh-ancestor
93296425|NCT03393416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296426|NCT04445948|Amoxicillin|amoxicillin|mesh-list
93296427|NCT04445948|Metronidazole|metronidazole|mesh-list
93296428|NCT04445948|Clarithromycin|clarithromycin|mesh-list
93296429|NCT04445948|Lactoferrin|lactoferrin|mesh-list
93296430|NCT04445948|Esomeprazole|esomeprazole|mesh-list
93296431|NCT04445948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93296432|NCT04445948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296433|NCT04445948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93296434|NCT04445948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93296435|NCT04445948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93296436|NCT04445948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296437|NCT04445948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93296438|NCT04445948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296439|NCT04445948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296440|NCT04445948|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93296441|NCT04445948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93296442|NCT04445948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93296443|NCT02479646|Lenograstim|lenograstim|mesh-list
93296444|NCT02479646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93296445|NCT02479646|Immunologic Factors|immunologic factors|mesh-ancestor
93296446|NCT02479646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296447|NCT02467868|Lenograstim|lenograstim|mesh-list
93296448|NCT02467868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93296449|NCT02467868|Immunologic Factors|immunologic factors|mesh-ancestor
93296450|NCT02467868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296451|NCT02103465|Rotigotine|rotigotine|mesh-list
93296452|NCT02103465|Dopamine Agonists|dopamine agonists|mesh-ancestor
93296453|NCT02103465|Dopamine Agents|dopamine agents|mesh-ancestor
93296454|NCT02103465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296455|NCT02103465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296456|NCT02103465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296457|NCT02102139|Propofol|propofol|mesh-list
93296458|NCT02102139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93296459|NCT02102139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296460|NCT02102139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296461|NCT02102139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93296462|NCT02102139|Anesthetics, General|anesthetics, general|mesh-ancestor
93296463|NCT02102139|Anesthetics|anesthetics|mesh-ancestor
93296464|NCT02102295|Ascorbic Acid|ascorbic acid|mesh-list
93296465|NCT02102295|Ascorbate-2-phosphate|ascorbate-2-phosphate|mesh-list
93296466|NCT02102295|Fluorides|fluorides|mesh-list
93296467|NCT02102295|Cariostatic Agents|cariostatic agents|mesh-ancestor
93296468|NCT02102295|Protective Agents|protective agents|mesh-ancestor
93296469|NCT02102295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296470|NCT02102295|Antioxidants|antioxidants|mesh-ancestor
93296471|NCT02102295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296472|NCT02102295|Vitamins|vitamins|mesh-ancestor
93296473|NCT02102295|Micronutrients|micronutrients|mesh-ancestor
93296474|NCT02102295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296475|NCT02102373|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93296477|NCT02102373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296478|NCT02103777|Caffeine|caffeine|mesh-list
93296479|NCT02103777|Caffeine citrate|caffeine citrate|mesh-list
93296480|NCT02103777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296481|NCT02103777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93296482|NCT02103777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296483|NCT02103777|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93296484|NCT02103777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296485|NCT02103777|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93296486|NCT02103777|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93296487|NCT02103777|Purinergic Agents|purinergic agents|mesh-ancestor
93296488|NCT02103777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296489|NCT02104011|Propranolol|propranolol|mesh-list
93296490|NCT02104011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93296491|NCT02104011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93296492|NCT02104011|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296493|NCT02104011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296494|NCT02104011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296495|NCT02104011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296496|NCT02104011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93296497|NCT02104011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93296498|NCT02104011|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296499|NCT03554889|Nimotuzumab|nimotuzumab|mesh-list
93296500|NCT03554889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93296501|NCT03554889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296502|NCT02251041|Tocopherols|tocopherols|mesh-list
93296503|NCT02251041|Vitamin E|vitamin e|mesh-list
93296504|NCT02251041|alpha-Tocopherol|alpha-tocopherol|mesh-list
93296505|NCT02251041|Infliximab|infliximab|mesh-list
93296506|NCT02251041|Epoprostenol|epoprostenol|mesh-list
93296507|NCT02251041|Tezosentan|tezosentan|mesh-list
93296508|NCT02251041|Melatonin|melatonin|mesh-list
93296509|NCT02251041|Antithrombins|antithrombins|mesh-list
93296510|NCT02251041|Antithrombin III|antithrombin iii|mesh-list
93296511|NCT02251041|Epoetin Alfa|epoetin alfa|mesh-list
93296512|NCT02251041|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93296513|NCT02251041|Antioxidants|antioxidants|mesh-ancestor
93296514|NCT02251041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296515|NCT02251041|Protective Agents|protective agents|mesh-ancestor
93296516|NCT02251041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296517|NCT02251041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296518|NCT02251041|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93296519|NCT02251041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296520|NCT02251041|Dermatologic Agents|dermatologic agents|mesh-ancestor
93296521|NCT02251041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296522|NCT02251041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296523|NCT02251041|Hematinics|hematinics|mesh-ancestor
93296524|NCT02251041|Vitamins|vitamins|mesh-ancestor
93296525|NCT02251041|Micronutrients|micronutrients|mesh-ancestor
93296526|NCT02251041|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93296527|NCT02251041|Protease Inhibitors|protease inhibitors|mesh-ancestor
93296528|NCT02251041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296529|NCT02251041|Anticoagulants|anticoagulants|mesh-ancestor
93296530|NCT02251041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93296531|NCT02251041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93296532|NCT02251041|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296533|NCT02251041|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93296534|NCT02251041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296535|NCT02251041|Immunologic Factors|immunologic factors|mesh-ancestor
93296536|NCT02104323|Endostatins|endostatins|mesh-list
93296537|NCT02104323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296538|NCT02104323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93296539|NCT02104323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93296540|NCT02104323|Growth Substances|growth substances|mesh-ancestor
93296541|NCT02104323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296542|NCT02104323|Growth Inhibitors|growth inhibitors|mesh-ancestor
93296543|NCT02107365|Interferons|interferons|mesh-list
93296544|NCT02107365|Ribavirin|ribavirin|mesh-list
93296545|NCT02107365|Interferon-alpha|interferon-alpha|mesh-list
93296546|NCT02107365|Interferon alpha-2|interferon alpha-2|mesh-list
93296547|NCT02107365|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93296548|NCT02107365|Asunaprevir|asunaprevir|mesh-list
92968627|NCT00994786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93296549|NCT02107365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296550|NCT02107365|Antiviral Agents|antiviral agents|mesh-ancestor
93296551|NCT02107365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296552|NCT02107365|Antimetabolites|antimetabolites|mesh-ancestor
93296553|NCT02107365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296554|NCT02107365|Immunologic Factors|immunologic factors|mesh-ancestor
93296555|NCT02107365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296556|NCT02107365|Protease Inhibitors|protease inhibitors|mesh-ancestor
93296557|NCT02107365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296558|NCT02110719|Acetaminophen|acetaminophen|mesh-list
93296559|NCT02110719|Dexamethasone|dexamethasone|mesh-list
93296560|NCT02110719|Ibuprofen|ibuprofen|mesh-list
93296561|NCT02110719|Celecoxib|celecoxib|mesh-list
93296562|NCT02110719|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93296563|NCT02110719|Oxycodone|oxycodone|mesh-list
93296564|NCT02110719|Gabapentin|gabapentin|mesh-list
93296565|NCT02110719|Hydromorphone|hydromorphone|mesh-list
93296566|NCT02110719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296567|NCT02110719|Antiemetics|antiemetics|mesh-ancestor
93296568|NCT02110719|Autonomic Agents|autonomic agents|mesh-ancestor
93296569|NCT02110719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296570|NCT02110719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296571|NCT02110719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296572|NCT02110719|Glucocorticoids|glucocorticoids|mesh-ancestor
93296573|NCT02110719|Hormones|hormones|mesh-ancestor
93296574|NCT02110719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296575|NCT02110719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93296576|NCT02110719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296577|NCT02110719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296578|NCT02110719|Analgesics|analgesics|mesh-ancestor
93296579|NCT02110719|Sensory System Agents|sensory system agents|mesh-ancestor
93296580|NCT02110719|Antipyretics|antipyretics|mesh-ancestor
93296581|NCT02110719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93296582|NCT02110719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296583|NCT02110719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93296584|NCT02110719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296585|NCT02110719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296586|NCT02110719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93296587|NCT02110719|Narcotics|narcotics|mesh-ancestor
93296588|NCT02110719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296589|NCT02110719|Anticonvulsants|anticonvulsants|mesh-ancestor
93296590|NCT02110719|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93296591|NCT02110719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93296592|NCT02110719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92591141|NCT04500899|Protective Agents|protective agents|mesh-ancestor
93296593|NCT02110719|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93296594|NCT02110719|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93296595|NCT02110719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296596|NCT02110719|Antimanic Agents|antimanic agents|mesh-ancestor
93296597|NCT02110719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93296598|NCT02105103|Insulin|insulin|mesh-list
93296599|NCT02105103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93296600|NCT02105103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296601|NCT03012165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93296602|NCT03012165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93296603|NCT02107755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93296604|NCT02107755|Ipilimumab|ipilimumab|mesh-list
93296605|NCT02107755|Antibodies|antibodies|mesh-list
93296606|NCT02107755|Immunoglobulins|immunoglobulins|mesh-list
93296607|NCT02107755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93296608|NCT02107755|Immunologic Factors|immunologic factors|mesh-ancestor
93296609|NCT02107755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296610|NCT02107755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296611|NCT02107755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93296612|NCT02107755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296613|NCT02110953|Irinotecan|irinotecan|mesh-list
93296614|NCT02110953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93296615|NCT02110953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93296616|NCT02110953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296617|NCT02110953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296618|NCT02110953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296619|NCT03554109|Leucovorin|leucovorin|mesh-list
93296620|NCT03554109|Paclitaxel|paclitaxel|mesh-list
93296621|NCT03554109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93296622|NCT03554109|Cyclophosphamide|cyclophosphamide|mesh-list
93296623|NCT03554109|Doxorubicin|doxorubicin|mesh-list
93296624|NCT03554109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93296625|NCT03554109|Fluorouracil|fluorouracil|mesh-list
93296626|NCT03554109|Avelumab|avelumab|mesh-list
93296627|NCT03554109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93296628|NCT03554109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296629|NCT03554109|Tubulin Modulators|tubulin modulators|mesh-ancestor
93296630|NCT03554109|Antimitotic Agents|antimitotic agents|mesh-ancestor
93296631|NCT03554109|Mitosis Modulators|mitosis modulators|mesh-ancestor
93296632|NCT03554109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296633|NCT03554109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296634|NCT03554109|Immunologic Factors|immunologic factors|mesh-ancestor
93296635|NCT03554109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296636|NCT03554109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296637|NCT03554109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93296638|NCT03554109|Alkylating Agents|alkylating agents|mesh-ancestor
93296639|NCT03554109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93296640|NCT03554109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93296641|NCT03554109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93296642|NCT03554109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93296643|NCT03554109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296644|NCT03554109|Antimetabolites|antimetabolites|mesh-ancestor
93296645|NCT03554109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93296646|NCT03554109|Antidotes|antidotes|mesh-ancestor
93296647|NCT03554109|Protective Agents|protective agents|mesh-ancestor
93296648|NCT03554109|Vitamin B Complex|vitamin b complex|mesh-ancestor
93296649|NCT03554109|Vitamins|vitamins|mesh-ancestor
93296650|NCT03554109|Micronutrients|micronutrients|mesh-ancestor
93296651|NCT03554109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93296652|NCT03554031|Hormones|hormones|mesh-list
93296653|NCT03554031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296654|NCT03554031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296655|NCT02111265|Sufentanil|sufentanil|mesh-list
93296656|NCT02111265|Remifentanil|remifentanil|mesh-list
93296657|NCT02111265|Cisatracurium|cisatracurium|mesh-list
93296658|NCT02111265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93296659|NCT02111265|Narcotics|narcotics|mesh-ancestor
93296660|NCT02111265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296661|NCT02111265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296662|NCT02111265|Analgesics|analgesics|mesh-ancestor
93296663|NCT02111265|Sensory System Agents|sensory system agents|mesh-ancestor
93296664|NCT02111265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296665|NCT02111265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93296666|NCT02111265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93296667|NCT02111265|Anesthetics, General|anesthetics, general|mesh-ancestor
93296668|NCT02111265|Anesthetics|anesthetics|mesh-ancestor
93296669|NCT02111265|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93296670|NCT02111265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93296671|NCT02251119|Ritonavir|ritonavir|mesh-list
93296672|NCT02251119|Tipranavir|tipranavir|mesh-list
93296673|NCT02251119|Loperamide|loperamide|mesh-list
93296674|NCT02251119|Antidiarrheals|antidiarrheals|mesh-list
93296675|NCT02251119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93296676|NCT02251119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93296677|NCT02251119|Protease Inhibitors|protease inhibitors|mesh-ancestor
93296678|NCT02251119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296679|NCT02251119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296680|NCT02251119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93296681|NCT02251119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93296682|NCT02251119|Antiviral Agents|antiviral agents|mesh-ancestor
93296683|NCT02251119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296684|NCT02251119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93296685|NCT02251119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93296686|NCT02251119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296687|NCT02105493|Nitroglycerin|nitroglycerin|mesh-list
93296688|NCT02105493|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296689|NCT02111421|Dexmedetomidine|dexmedetomidine|mesh-list
93296690|NCT02111421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93296691|NCT02111421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296692|NCT02111421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296693|NCT02111421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296694|NCT02111421|Analgesics|analgesics|mesh-ancestor
93296695|NCT02111421|Sensory System Agents|sensory system agents|mesh-ancestor
93296696|NCT02111421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296697|NCT02111421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93296698|NCT02111421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93296699|NCT02111421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93296700|NCT02111421|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296701|NCT02111421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968776|NCT03999580|Cholecalciferol|cholecalciferol|mesh-list
93296702|NCT02111421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296703|NCT02108301|Cyclosporine|cyclosporine|mesh-list
93296704|NCT02108301|Tacrolimus|tacrolimus|mesh-list
93296705|NCT02108301|Cyclosporins|cyclosporins|mesh-list
93296706|NCT02108301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296707|NCT02108301|Immunologic Factors|immunologic factors|mesh-ancestor
93296708|NCT02108301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296709|NCT02108301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93296710|NCT02108301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296711|NCT02108301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296712|NCT02108301|Antifungal Agents|antifungal agents|mesh-ancestor
93296713|NCT02108301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296714|NCT02108301|Dermatologic Agents|dermatologic agents|mesh-ancestor
93296715|NCT02108301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296716|NCT02108535|Sulfadiazine|sulfadiazine|mesh-list
93296717|NCT02108535|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93296718|NCT02108535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93296719|NCT02108535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296720|NCT02108535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93296721|NCT02108535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93296722|NCT02108535|Coccidiostats|coccidiostats|mesh-ancestor
93296723|NCT02108535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93296724|NCT02114073|Cyclosporine|cyclosporine|mesh-list
93296725|NCT02114073|Betamethasone|betamethasone|mesh-list
93296726|NCT02114073|Cyclosporins|cyclosporins|mesh-list
93296727|NCT02114073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296728|NCT02114073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296729|NCT02114073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296730|NCT02114073|Immunologic Factors|immunologic factors|mesh-ancestor
93296731|NCT02114073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296732|NCT02114073|Antifungal Agents|antifungal agents|mesh-ancestor
93296733|NCT02114073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296734|NCT02114073|Dermatologic Agents|dermatologic agents|mesh-ancestor
93296735|NCT02114073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296736|NCT02114073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93296737|NCT02114073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296738|NCT02114073|Glucocorticoids|glucocorticoids|mesh-ancestor
93296739|NCT02114073|Hormones|hormones|mesh-ancestor
93296740|NCT02114073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296741|NCT02114073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93296742|NCT02114073|Respiratory System Agents|respiratory system agents|mesh-ancestor
93296743|NCT02114463|Flurbiprofen|flurbiprofen|mesh-list
93296744|NCT02114463|Analgesics|analgesics|mesh-list
93296745|NCT02114463|Ropivacaine|ropivacaine|mesh-list
93296746|NCT02114463|Anesthetics, Local|anesthetics, local|mesh-ancestor
93296747|NCT02114463|Anesthetics|anesthetics|mesh-ancestor
93296748|NCT02114463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296749|NCT02114463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296750|NCT02114463|Sensory System Agents|sensory system agents|mesh-ancestor
93296751|NCT02114463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296752|NCT02114463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93296753|NCT02114463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296754|NCT02114463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296755|NCT02114463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296756|NCT02114463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93296757|NCT02114463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296758|NCT02114463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296759|NCT02114697|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93296760|NCT02114697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93296761|NCT02114697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93296762|NCT02114697|Antimetabolites|antimetabolites|mesh-ancestor
93296763|NCT02114697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296764|NCT02114697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93296765|NCT02114697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93296766|NCT02114697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296767|NCT02114775|Sildenafil Citrate|sildenafil citrate|mesh-list
93296768|NCT02114775|Hormones|hormones|mesh-list
93296769|NCT02114775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296770|NCT02114775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296771|NCT02114775|Vasodilator Agents|vasodilator agents|mesh-ancestor
93296772|NCT02114775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93296773|NCT02114775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93296774|NCT02114775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296775|NCT02114775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296776|NCT02114775|Urological Agents|urological agents|mesh-ancestor
93296777|NCT02108847|Ropivacaine|ropivacaine|mesh-list
93296778|NCT02108847|Anesthetics, Local|anesthetics, local|mesh-ancestor
93296779|NCT02108847|Anesthetics|anesthetics|mesh-ancestor
93296780|NCT02108847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296781|NCT02108847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296783|NCT02108847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296784|NCT03553329|Trametinib|trametinib|mesh-list
93296785|NCT03553329|Dabrafenib|dabrafenib|mesh-list
93296786|NCT03553329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296787|NCT03553329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93296788|NCT03553329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296789|NCT03553329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296790|NCT02115087|Morphine|morphine|mesh-list
93296791|NCT02115087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93296792|NCT02115087|Narcotics|narcotics|mesh-ancestor
93296793|NCT02115087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296794|NCT02115087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296795|NCT02115087|Analgesics|analgesics|mesh-ancestor
93296796|NCT02115087|Sensory System Agents|sensory system agents|mesh-ancestor
93296797|NCT02115087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296798|NCT02115243|Ipilimumab|ipilimumab|mesh-list
93296799|NCT02115243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93296800|NCT02115243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296801|NCT02115243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93296802|NCT02115243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296803|NCT02109315|Liraglutide|liraglutide|mesh-list
93296804|NCT02109315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296805|NCT02109315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93296806|NCT02109315|Incretins|incretins|mesh-ancestor
93296807|NCT02109315|Hormones|hormones|mesh-ancestor
93296808|NCT02109315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296809|NCT02112903|Vortioxetine|vortioxetine|mesh-list
93296810|NCT02112903|Antidepressive Agents|antidepressive agents|mesh-ancestor
93296811|NCT02112903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93296812|NCT02112903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93296813|NCT02112903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93296814|NCT02112903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296815|NCT02112903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296816|NCT02112903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93296817|NCT02112903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93296818|NCT02112903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296819|NCT02112903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296820|NCT02112903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296821|NCT02112903|Serotonin Agents|serotonin agents|mesh-ancestor
93296822|NCT02112903|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93296823|NCT02112903|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93296824|NCT02112903|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93296825|NCT02112903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93296826|NCT02112981|Sirolimus|sirolimus|mesh-list
93296827|NCT02112981|Everolimus|everolimus|mesh-list
93296828|NCT02112981|MTOR Inhibitors|mtor inhibitors|mesh-list
93296829|NCT02112981|Temsirolimus|temsirolimus|mesh-list
93296830|NCT02112981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93296831|NCT02112981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296832|NCT02112981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296833|NCT02112981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296834|NCT02112981|Immunologic Factors|immunologic factors|mesh-ancestor
93296835|NCT02112981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296836|NCT02112981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296837|NCT02112981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93296838|NCT02112981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296839|NCT02112981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93296840|NCT02112981|Antifungal Agents|antifungal agents|mesh-ancestor
93296841|NCT02113137|Chlorine dioxide|chlorine dioxide|mesh-list
93296842|NCT02113137|Dental Disinfectants|dental disinfectants|mesh-ancestor
93296843|NCT02113137|Disinfectants|disinfectants|mesh-ancestor
93296844|NCT02113137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296845|NCT02116257|Propacetamol|propacetamol|mesh-list
93296846|NCT02116257|Analgesics|analgesics|mesh-ancestor
93296847|NCT02116257|Sensory System Agents|sensory system agents|mesh-ancestor
93296848|NCT02116257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296849|NCT02116257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296850|NCT02116257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93296851|NCT02116257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93296852|NCT02116257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296853|NCT02116257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93296854|NCT02109627|Cytarabine|cytarabine|mesh-list
93296855|NCT02109627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93296856|NCT02109627|Antimetabolites|antimetabolites|mesh-ancestor
93296857|NCT02109627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296858|NCT02109627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296859|NCT02109627|Antiviral Agents|antiviral agents|mesh-ancestor
93296860|NCT02109627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296861|NCT02109627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296862|NCT02109627|Immunologic Factors|immunologic factors|mesh-ancestor
93296863|NCT02109627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296864|NCT02116569|Daratumumab|daratumumab|mesh-list
93296865|NCT02116569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296866|NCT02109783|Caffeine|caffeine|mesh-list
93296867|NCT02109783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93296868|NCT02109783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296869|NCT02109783|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93296870|NCT02109783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296871|NCT02109783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296872|NCT02109783|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93296873|NCT02109783|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93296874|NCT02109783|Purinergic Agents|purinergic agents|mesh-ancestor
93296875|NCT02109783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296876|NCT02109861|Dexamethasone|dexamethasone|mesh-list
93296877|NCT02109861|Bortezomib|bortezomib|mesh-list
93296878|NCT02109861|Melphalan|melphalan|mesh-list
93296879|NCT02109861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93296880|NCT02109861|Antiemetics|antiemetics|mesh-ancestor
93296881|NCT02109861|Autonomic Agents|autonomic agents|mesh-ancestor
93296882|NCT02109861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296883|NCT02109861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296884|NCT02109861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93296885|NCT02109861|Glucocorticoids|glucocorticoids|mesh-ancestor
93296886|NCT02109861|Hormones|hormones|mesh-ancestor
93296887|NCT02109861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296888|NCT02109861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93296889|NCT02109861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296890|NCT02109861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93296891|NCT02109861|Alkylating Agents|alkylating agents|mesh-ancestor
93296892|NCT02109861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296893|NCT02109861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93296894|NCT02109861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296895|NCT02109861|Immunologic Factors|immunologic factors|mesh-ancestor
93296896|NCT02118753|Eplerenone|eplerenone|mesh-list
93296897|NCT02118753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93296898|NCT02118753|Hormone Antagonists|hormone antagonists|mesh-ancestor
93296899|NCT02118753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296900|NCT02118753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296901|NCT02118753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93296902|NCT02118753|Diuretics|diuretics|mesh-ancestor
93296903|NCT02118753|Natriuretic Agents|natriuretic agents|mesh-ancestor
93296904|NCT02118753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93296905|NCT02118909|Itraconazole|itraconazole|mesh-list
93296906|NCT02118909|Ciprofloxacin|ciprofloxacin|mesh-list
93296907|NCT02118909|Antifungal Agents|antifungal agents|mesh-ancestor
93296908|NCT02118909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93296909|NCT02118909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93296910|NCT02118909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93296911|NCT02118909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296912|NCT02118909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296913|NCT02118909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93296914|NCT02118909|Hormone Antagonists|hormone antagonists|mesh-ancestor
93296915|NCT02118909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93296916|NCT02118909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296917|NCT02118909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93296918|NCT02118909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93296919|NCT02118909|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93296920|NCT02118909|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93296921|NCT02118909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296922|NCT02118909|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93296923|NCT02118987|Omalizumab|omalizumab|mesh-list
93296924|NCT02118987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93296925|NCT02118987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93296926|NCT02118987|Respiratory System Agents|respiratory system agents|mesh-ancestor
93296927|NCT02119143|Vitamins|vitamins|mesh-list
93296928|NCT02119143|Micronutrients|micronutrients|mesh-ancestor
93296929|NCT02119143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296930|NCT02116959|Carboplatin|carboplatin|mesh-list
93296931|NCT02116959|Etoposide|etoposide|mesh-list
93296932|NCT02116959|Vincristine|vincristine|mesh-list
93296933|NCT02116959|Melphalan|melphalan|mesh-list
93296934|NCT02116959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93296935|NCT02116959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93296936|NCT02116959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93296937|NCT02116959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93296938|NCT02116959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296939|NCT02116959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296940|NCT02116959|Tubulin Modulators|tubulin modulators|mesh-ancestor
93296941|NCT02116959|Antimitotic Agents|antimitotic agents|mesh-ancestor
93296942|NCT02116959|Mitosis Modulators|mitosis modulators|mesh-ancestor
93296943|NCT02116959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93296944|NCT02116959|Alkylating Agents|alkylating agents|mesh-ancestor
93296945|NCT02116959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93296946|NCT02116959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93296947|NCT02116959|Immunologic Factors|immunologic factors|mesh-ancestor
93296948|NCT02116959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296949|NCT03553173|Bupropion|bupropion|mesh-list
93296950|NCT03553173|Varenicline|varenicline|mesh-list
93296951|NCT03553173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92316369|NCT02997722|Ketamine|ketamine|mesh-list
93296952|NCT03553173|Antidepressive Agents|antidepressive agents|mesh-ancestor
93296953|NCT03553173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93296954|NCT03553173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93296955|NCT03553173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93296956|NCT03553173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93296957|NCT03553173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296958|NCT03553173|Dopamine Agents|dopamine agents|mesh-ancestor
93296959|NCT03553173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296960|NCT03553173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296961|NCT03553173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93296962|NCT03553173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93296963|NCT03553173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93296964|NCT03553173|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93296965|NCT03553173|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93296966|NCT03553173|Cholinergic Agents|cholinergic agents|mesh-ancestor
93296967|NCT01330017|Loratadine|loratadine|mesh-list
93296968|NCT01330017|Phenylephrine|phenylephrine|mesh-list
93296969|NCT01330017|Oxymetazoline|oxymetazoline|mesh-list
93296970|NCT01330017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93296971|NCT01330017|Mydriatics|mydriatics|mesh-ancestor
93296972|NCT01330017|Autonomic Agents|autonomic agents|mesh-ancestor
93296973|NCT01330017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93296974|NCT01330017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296975|NCT01330017|Sympathomimetics|sympathomimetics|mesh-ancestor
93296976|NCT01330017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93296977|NCT01330017|Nasal Decongestants|nasal decongestants|mesh-ancestor
93296978|NCT01330017|Respiratory System Agents|respiratory system agents|mesh-ancestor
93296979|NCT01330017|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93296980|NCT01330017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93296981|NCT01330017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93296982|NCT01330017|Adrenergic Agents|adrenergic agents|mesh-ancestor
93296983|NCT01330017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93296984|NCT01330017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93296985|NCT01330017|Protective Agents|protective agents|mesh-ancestor
93296986|NCT01330017|Antipruritics|antipruritics|mesh-ancestor
93296987|NCT01330017|Dermatologic Agents|dermatologic agents|mesh-ancestor
93296988|NCT01330017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93296989|NCT01330017|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93296990|NCT01330017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93296991|NCT01330017|Histamine Antagonists|histamine antagonists|mesh-ancestor
93296992|NCT01330017|Histamine Agents|histamine agents|mesh-ancestor
93296993|NCT02117583|Oxycodone|oxycodone|mesh-list
93296994|NCT02117583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93296995|NCT02117583|Narcotics|narcotics|mesh-ancestor
93296996|NCT02117583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93296997|NCT02117583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93296998|NCT02117583|Analgesics|analgesics|mesh-ancestor
93296999|NCT02117583|Sensory System Agents|sensory system agents|mesh-ancestor
93297000|NCT02117583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297001|NCT02117739|Dapsone|dapsone|mesh-list
93297002|NCT02117739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297003|NCT02117739|Antimalarials|antimalarials|mesh-ancestor
93297004|NCT02117739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93297005|NCT02117739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93297006|NCT02117739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93297007|NCT02117739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297008|NCT02117739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297009|NCT02117739|Leprostatic Agents|leprostatic agents|mesh-ancestor
93297010|NCT02117739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93297012|NCT02251509|Carvedilol|carvedilol|mesh-list
93297013|NCT02251509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93297014|NCT02251509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297015|NCT02251509|Sympatholytics|sympatholytics|mesh-ancestor
93297016|NCT02251509|Autonomic Agents|autonomic agents|mesh-ancestor
93297017|NCT02251509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297018|NCT02251509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297019|NCT02251509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93297020|NCT02251509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93297021|NCT02251509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93297022|NCT02251509|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297023|NCT02251509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297024|NCT02251509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297025|NCT02251509|Antioxidants|antioxidants|mesh-ancestor
93297026|NCT02251509|Protective Agents|protective agents|mesh-ancestor
93297027|NCT02251509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93297028|NCT02251509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93297029|NCT02251509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93297030|NCT02251509|Vasodilator Agents|vasodilator agents|mesh-ancestor
93297031|NCT02251509|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93297032|NCT02251509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93297033|NCT02986659|Metformin|metformin|mesh-list
93297034|NCT02986659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93297035|NCT02986659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297036|NCT02118051|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93297037|NCT02118051|Progesterone|progesterone|mesh-list
93297038|NCT02118051|Ganirelix|ganirelix|mesh-list
93297039|NCT02118051|Progestins|progestins|mesh-ancestor
93297040|NCT02118051|Hormones|hormones|mesh-ancestor
93297041|NCT02118051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297042|NCT02118051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297043|NCT02118051|Hormone Antagonists|hormone antagonists|mesh-ancestor
93297044|NCT02118051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93297045|NCT02123355|Dexmedetomidine|dexmedetomidine|mesh-list
93297046|NCT02123355|Remifentanil|remifentanil|mesh-list
93297047|NCT02123355|Sevoflurane|sevoflurane|mesh-list
93297048|NCT02123355|Vecuronium Bromide|vecuronium bromide|mesh-list
93297049|NCT02123355|Anesthetics|anesthetics|mesh-ancestor
93297050|NCT02123355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297051|NCT02123355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297052|NCT02123355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93297053|NCT02123355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297054|NCT02123355|Analgesics|analgesics|mesh-ancestor
93297055|NCT02123355|Sensory System Agents|sensory system agents|mesh-ancestor
93297056|NCT02123355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297057|NCT02123355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93297058|NCT02123355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93297059|NCT02123355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93297060|NCT02123355|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297061|NCT02123355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297062|NCT02123355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297063|NCT02123355|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93297064|NCT02123355|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93297065|NCT02123355|Anesthetics, General|anesthetics, general|mesh-ancestor
93297066|NCT02123355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93297067|NCT02123355|Narcotics|narcotics|mesh-ancestor
93297068|NCT02123355|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93297069|NCT02123355|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93297070|NCT02123355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93297071|NCT02123355|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93297072|NCT02123355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93297073|NCT02123355|Cholinergic Agents|cholinergic agents|mesh-ancestor
93297074|NCT02123433|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93297075|NCT02123433|Immunologic Factors|immunologic factors|mesh-ancestor
93297076|NCT02123433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297077|NCT02123589|Fentanyl|fentanyl|mesh-list
93297078|NCT02123589|Midazolam|midazolam|mesh-list
93297079|NCT02123589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93297080|NCT02123589|Narcotics|narcotics|mesh-ancestor
93297081|NCT02123589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297082|NCT02123589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297083|NCT02123589|Analgesics|analgesics|mesh-ancestor
93297084|NCT02123589|Sensory System Agents|sensory system agents|mesh-ancestor
93297085|NCT02123589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297086|NCT02123589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93297087|NCT02123589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93297088|NCT02123589|Anesthetics, General|anesthetics, general|mesh-ancestor
93297089|NCT02123589|Anesthetics|anesthetics|mesh-ancestor
93297090|NCT02123589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93297091|NCT02123589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93297092|NCT02123589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93297093|NCT02123589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297094|NCT02123589|GABA Modulators|gaba modulators|mesh-ancestor
93297095|NCT02123589|GABA Agents|gaba agents|mesh-ancestor
93297096|NCT02123589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297097|NCT02123589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297098|NCT02120547|Cenicriviroc|cenicriviroc|mesh-list
93297099|NCT02120547|Liver Extracts|liver extracts|mesh-list
93297100|NCT02120547|Hematinics|hematinics|mesh-ancestor
93297101|NCT02120547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93297102|NCT02120547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297103|NCT02120547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93297104|NCT02120547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93297105|NCT02120547|Antiviral Agents|antiviral agents|mesh-ancestor
93297106|NCT02120547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297108|NCT02120703|Gabapentin|gabapentin|mesh-list
93297109|NCT02120703|Analgesics|analgesics|mesh-ancestor
93297110|NCT02120703|Sensory System Agents|sensory system agents|mesh-ancestor
93297111|NCT02120703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297112|NCT02120703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297113|NCT02120703|Anticonvulsants|anticonvulsants|mesh-ancestor
93297114|NCT02120703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93297115|NCT02120703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93297116|NCT02120703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297117|NCT02120703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93297118|NCT02120703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93297119|NCT02120703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93297120|NCT02120703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297121|NCT02120703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297122|NCT02120703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93297123|NCT02120703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93297124|NCT02120703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297125|NCT02120703|Antimanic Agents|antimanic agents|mesh-ancestor
93297126|NCT02118285|Cyclophosphamide|cyclophosphamide|mesh-list
93297127|NCT02118285|Fludarabine|fludarabine|mesh-list
93297128|NCT02118285|Interleukin-2|interleukin-2|mesh-list
93297129|NCT02118285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297130|NCT02118285|Immunologic Factors|immunologic factors|mesh-ancestor
93297131|NCT02118285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297132|NCT02118285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297133|NCT02118285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93297134|NCT02118285|Alkylating Agents|alkylating agents|mesh-ancestor
93297135|NCT02118285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297136|NCT02118285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297137|NCT02118285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93297138|NCT02118285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297139|NCT02118285|Analgesics|analgesics|mesh-ancestor
93297140|NCT02118285|Sensory System Agents|sensory system agents|mesh-ancestor
93297141|NCT02118285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297142|NCT03552705|Tranexamic Acid|tranexamic acid|mesh-list
93297143|NCT03552705|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93297144|NCT03552705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93297145|NCT03552705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297146|NCT03552705|Hemostatics|hemostatics|mesh-ancestor
93297147|NCT03552705|Coagulants|coagulants|mesh-ancestor
93297148|NCT02118675|Deuterium Oxide|deuterium oxide|mesh-list
93297149|NCT02118675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297150|NCT02118675|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93297151|NCT02118675|Protective Agents|protective agents|mesh-ancestor
93297152|NCT02118675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297153|NCT02123979|Rotigotine|rotigotine|mesh-list
93297154|NCT02123979|Dopamine Agonists|dopamine agonists|mesh-ancestor
93297155|NCT02123979|Dopamine Agents|dopamine agents|mesh-ancestor
93297156|NCT02123979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297157|NCT02123979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297158|NCT02123979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297159|NCT03552315|Chromium|chromium|mesh-list
93297160|NCT03552315|Trace Elements|trace elements|mesh-ancestor
93297161|NCT03552315|Micronutrients|micronutrients|mesh-ancestor
93297162|NCT03552315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297163|NCT02120859|Paclitaxel|paclitaxel|mesh-list
93297164|NCT02120859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93297165|NCT02120859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297166|NCT02120859|Tubulin Modulators|tubulin modulators|mesh-ancestor
93297167|NCT02120859|Antimitotic Agents|antimitotic agents|mesh-ancestor
93297168|NCT02120859|Mitosis Modulators|mitosis modulators|mesh-ancestor
93297169|NCT02120859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297170|NCT02126943|Macitentan|macitentan|mesh-list
93297171|NCT02126943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93297172|NCT02126943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93297173|NCT02126943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297174|NCT02126943|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93297175|NCT03551847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93297176|NCT03551847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93297177|NCT03551847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297178|NCT03551847|Antitubercular Agents|antitubercular agents|mesh-ancestor
93297179|NCT00150462|Dexamethasone|dexamethasone|mesh-list
93297180|NCT00150462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297181|NCT00150462|Antiemetics|antiemetics|mesh-ancestor
93297182|NCT00150462|Autonomic Agents|autonomic agents|mesh-ancestor
93297183|NCT00150462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297184|NCT00150462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297185|NCT00150462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93297186|NCT00150462|Glucocorticoids|glucocorticoids|mesh-ancestor
93297187|NCT00150462|Hormones|hormones|mesh-ancestor
93297188|NCT00150462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297189|NCT00150462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93297190|NCT00150462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297191|NCT00095550|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93297192|NCT00095550|Irbesartan|irbesartan|mesh-list
93297193|NCT00095550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297194|NCT00095550|Diuretics|diuretics|mesh-ancestor
93297195|NCT00095550|Natriuretic Agents|natriuretic agents|mesh-ancestor
93297196|NCT00095550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297197|NCT00095550|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93297198|NCT00095550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93297199|NCT00095550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297200|NCT00095550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93297201|NCT00095550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93297202|NCT00095394|Irbesartan|irbesartan|mesh-list
93297203|NCT00095394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297204|NCT00095394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93297205|NCT00095394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93297206|NCT00095394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297207|NCT00093132|Satraplatin|satraplatin|mesh-list
93297208|NCT00093132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297209|NCT05717400|Ribavirin|ribavirin|mesh-list
93297210|NCT05717400|Sofosbuvir|sofosbuvir|mesh-list
93297211|NCT05717400|Velpatasvir|velpatasvir|mesh-list
93297212|NCT05717400|Bevacizumab|bevacizumab|mesh-list
93297213|NCT05717400|Atezolizumab|atezolizumab|mesh-list
93297214|NCT05717400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93297215|NCT05717400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297216|NCT05717400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93297217|NCT05717400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93297218|NCT05717400|Growth Substances|growth substances|mesh-ancestor
93297219|NCT05717400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297220|NCT05717400|Growth Inhibitors|growth inhibitors|mesh-ancestor
93297221|NCT05717400|Antimetabolites|antimetabolites|mesh-ancestor
93297222|NCT05717400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297223|NCT05717400|Antiviral Agents|antiviral agents|mesh-ancestor
93297224|NCT05717400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297225|NCT05717400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93297226|NCT00080106|Vaccines|vaccines|mesh-list
93297227|NCT00080106|Immunologic Factors|immunologic factors|mesh-ancestor
93297228|NCT00080106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297229|NCT00333216|Hydrocortisone|hydrocortisone|mesh-list
93297230|NCT00333216|Anecortave|anecortave|mesh-list
93297231|NCT00333216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93297232|NCT00333216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93297233|NCT00333216|Growth Substances|growth substances|mesh-ancestor
93297234|NCT00333216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297235|NCT00333216|Growth Inhibitors|growth inhibitors|mesh-ancestor
93297236|NCT00333216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297237|NCT00333216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297238|NCT00332748|Taxane|taxane|mesh-list
93297239|NCT00332748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297240|NCT03530436|Curcumin|curcumin|mesh-list
93297241|NCT03530436|Turmeric extract|turmeric extract|mesh-list
93297242|NCT03530436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93297243|NCT03530436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297244|NCT03530436|Analgesics|analgesics|mesh-ancestor
93297245|NCT03530436|Sensory System Agents|sensory system agents|mesh-ancestor
93297246|NCT03530436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297247|NCT03530436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297248|NCT03530436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297249|NCT03530436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297250|NCT03530436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297251|NCT03530436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297252|NCT03530436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297253|NCT03530436|Antioxidants|antioxidants|mesh-ancestor
93297254|NCT03530436|Protective Agents|protective agents|mesh-ancestor
93297255|NCT03530280|Pregabalin|pregabalin|mesh-list
93297256|NCT03530280|Bupivacaine|bupivacaine|mesh-list
93297257|NCT03530280|Anesthetics, Local|anesthetics, local|mesh-ancestor
93297258|NCT03530280|Anesthetics|anesthetics|mesh-ancestor
93297259|NCT03530280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297260|NCT03530280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297261|NCT03530280|Sensory System Agents|sensory system agents|mesh-ancestor
93297262|NCT03530280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297263|NCT03530280|Analgesics|analgesics|mesh-ancestor
93297264|NCT03530280|Anticonvulsants|anticonvulsants|mesh-ancestor
93297265|NCT03530280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93297266|NCT03530280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93297267|NCT03530280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297268|NCT03530280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93297269|NCT03530280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93297270|NCT03530280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93297271|NCT03530280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297272|NCT00079482|Cytarabine|cytarabine|mesh-list
93297273|NCT00079482|Etoposide|etoposide|mesh-list
93297274|NCT00079482|Mitoxantrone|mitoxantrone|mesh-list
93297275|NCT00079482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93297276|NCT00079482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297277|NCT00079482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93297278|NCT00079482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93297279|NCT00079482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297280|NCT00079482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297281|NCT00079482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297282|NCT00079482|Antimetabolites|antimetabolites|mesh-ancestor
93297283|NCT00079482|Antiviral Agents|antiviral agents|mesh-ancestor
93297284|NCT00079482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297285|NCT00079482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297286|NCT00079482|Immunologic Factors|immunologic factors|mesh-ancestor
93297287|NCT00079482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297288|NCT00079482|Analgesics|analgesics|mesh-ancestor
93297289|NCT00079482|Sensory System Agents|sensory system agents|mesh-ancestor
93297290|NCT00079482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297291|NCT00073866|Celecoxib|celecoxib|mesh-list
93297292|NCT00073866|Docetaxel|docetaxel|mesh-list
93297293|NCT00073866|Irinotecan|irinotecan|mesh-list
93297294|NCT00073866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297295|NCT00073866|Tubulin Modulators|tubulin modulators|mesh-ancestor
93297296|NCT00073866|Antimitotic Agents|antimitotic agents|mesh-ancestor
93297297|NCT00073866|Mitosis Modulators|mitosis modulators|mesh-ancestor
93297298|NCT00073866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297299|NCT00073866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93297300|NCT00073866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93297301|NCT00073866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297302|NCT00073866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93297303|NCT00073866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297304|NCT00073866|Analgesics|analgesics|mesh-ancestor
93297305|NCT00073866|Sensory System Agents|sensory system agents|mesh-ancestor
93297306|NCT00073866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297307|NCT00073866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297309|NCT00073866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297310|NCT00073866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93297311|NCT00073866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93297312|NCT00325650|Rimonabant|rimonabant|mesh-list
93297313|NCT00325650|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93297314|NCT00325650|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93297315|NCT00325650|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93297316|NCT00325650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297317|NCT00325650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297318|NCT00325650|Hormones|hormones|mesh-ancestor
93297319|NCT00325650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297320|NCT00325650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297321|NCT00070590|Bosentan|bosentan|mesh-list
93297322|NCT00070590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297323|NCT00070590|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93297324|NCT00070590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297325|NCT00067782|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93297326|NCT00067782|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93297327|NCT00067782|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93297328|NCT00067782|Protease Inhibitors|protease inhibitors|mesh-ancestor
93297329|NCT00067782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297330|NCT00067782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297331|NCT00067782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93297332|NCT00067782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93297333|NCT00067782|Antiviral Agents|antiviral agents|mesh-ancestor
93297334|NCT00067782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297335|NCT00058266|Genistein|genistein|mesh-list
93297336|NCT00058266|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93297337|NCT00058266|Protective Agents|protective agents|mesh-ancestor
93297338|NCT00058266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297339|NCT00058266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297340|NCT00058266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93297341|NCT00058266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297342|NCT00058266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297343|NCT00058266|Phytoestrogens|phytoestrogens|mesh-ancestor
93297344|NCT00058266|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93297345|NCT00058266|Estrogens|estrogens|mesh-ancestor
93297346|NCT00058266|Hormones|hormones|mesh-ancestor
93297347|NCT00058266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297348|NCT00313794|Tremelimumab|tremelimumab|mesh-list
93297349|NCT00313794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297350|NCT00313248|Sagopilone|sagopilone|mesh-list
93297351|NCT00313248|Epothilones|epothilones|mesh-list
93297352|NCT00313248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297353|NCT00313248|Tubulin Modulators|tubulin modulators|mesh-ancestor
93297354|NCT00313248|Antimitotic Agents|antimitotic agents|mesh-ancestor
93297355|NCT00313248|Mitosis Modulators|mitosis modulators|mesh-ancestor
93297356|NCT00313248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297357|NCT00310830|Bosentan|bosentan|mesh-list
93297358|NCT00310830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297359|NCT00310830|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93297360|NCT00310830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297361|NCT00035568|Metformin|metformin|mesh-list
93297362|NCT00035568|Glyburide|glyburide|mesh-list
93297363|NCT00035568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93297364|NCT00035568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297365|NCT00031512|Pleconaril|pleconaril|mesh-list
93297366|NCT00031512|Antiviral Agents|antiviral agents|mesh-ancestor
93297367|NCT00031512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297368|NCT00307398|Hydrocortisone|hydrocortisone|mesh-list
93297369|NCT00307398|Anecortave|anecortave|mesh-list
93297370|NCT00307398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93297371|NCT00307398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93297372|NCT00307398|Growth Substances|growth substances|mesh-ancestor
93297373|NCT00307398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297374|NCT00307398|Growth Inhibitors|growth inhibitors|mesh-ancestor
93297375|NCT00307398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297376|NCT00307398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297377|NCT01368081|Metformin|metformin|mesh-list
93297378|NCT01368081|Empagliflozin|empagliflozin|mesh-list
93297379|NCT01368081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93297380|NCT01368081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297381|NCT01368081|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93297382|NCT01368081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297383|NCT02127489|Bupivacaine|bupivacaine|mesh-list
93297384|NCT02127489|Anesthetics, Local|anesthetics, local|mesh-ancestor
93297385|NCT02127489|Anesthetics|anesthetics|mesh-ancestor
93297386|NCT02127489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297387|NCT02127489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297388|NCT02127489|Sensory System Agents|sensory system agents|mesh-ancestor
93297389|NCT02127489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297390|NCT00004914|Epoetin Alfa|epoetin alfa|mesh-list
93297391|NCT00004914|Hematinics|hematinics|mesh-ancestor
93297392|NCT00286806|Gossypol acetic acid|gossypol acetic acid|mesh-list
93297393|NCT00286806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93297394|NCT00286806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297395|NCT00286806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93297396|NCT00286806|Contraceptive Agents|contraceptive agents|mesh-ancestor
93297397|NCT00286806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93297398|NCT00286806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297399|NCT00286806|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
93297400|NCT00286806|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
93297401|NCT00286806|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93297402|NCT00004908|Cyclophosphamide|cyclophosphamide|mesh-list
93297403|NCT00004908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297404|NCT00004908|Immunologic Factors|immunologic factors|mesh-ancestor
93297405|NCT00004908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297406|NCT00004908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297407|NCT00004908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93297408|NCT00004908|Alkylating Agents|alkylating agents|mesh-ancestor
93297409|NCT00004908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297410|NCT00004908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297411|NCT00004908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93297412|NCT00004902|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
93297413|NCT00004902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297414|NCT00004902|Immunologic Factors|immunologic factors|mesh-ancestor
93297415|NCT00004902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297416|NCT04441398|Nitazoxanide|nitazoxanide|mesh-list
93297417|NCT04441398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93297418|NCT04441398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297419|NCT03551067|Midazolam|midazolam|mesh-list
93297420|NCT03551067|Dexmedetomidine|dexmedetomidine|mesh-list
93297421|NCT03551067|Ketamine|ketamine|mesh-list
93297422|NCT03551067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93297423|NCT03551067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297424|NCT03551067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297425|NCT03551067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297426|NCT03551067|Analgesics|analgesics|mesh-ancestor
93297427|NCT03551067|Sensory System Agents|sensory system agents|mesh-ancestor
93297428|NCT03551067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297429|NCT03551067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93297430|NCT03551067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93297431|NCT03551067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93297432|NCT03551067|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297433|NCT03551067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297434|NCT03551067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297435|NCT03551067|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93297436|NCT03551067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93297437|NCT03551067|Anesthetics, General|anesthetics, general|mesh-ancestor
93297438|NCT03551067|Anesthetics|anesthetics|mesh-ancestor
93297439|NCT03551067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93297440|NCT03551067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93297441|NCT03551067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93297442|NCT03551067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93297443|NCT03551067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93297444|NCT03551067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297445|NCT03551067|GABA Modulators|gaba modulators|mesh-ancestor
93297446|NCT03551067|GABA Agents|gaba agents|mesh-ancestor
93297447|NCT03529266|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93297448|NCT03529266|Hemostatics|hemostatics|mesh-ancestor
93297449|NCT03529266|Coagulants|coagulants|mesh-ancestor
93297450|NCT02128191|Ibuprofen|ibuprofen|mesh-list
92591998|NCT00859781|Ketoconazole|ketoconazole|mesh-list
93297451|NCT02128191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93297452|NCT02128191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297453|NCT02128191|Analgesics|analgesics|mesh-ancestor
93297454|NCT02128191|Sensory System Agents|sensory system agents|mesh-ancestor
93297455|NCT02128191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297456|NCT02128191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297457|NCT02128191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297458|NCT02128191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297459|NCT02128191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93297460|NCT02128191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297461|NCT02128191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297462|NCT00004896|Cyclophosphamide|cyclophosphamide|mesh-list
93297463|NCT00004896|Busulfan|busulfan|mesh-list
93297464|NCT00004896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297465|NCT00004896|Immunologic Factors|immunologic factors|mesh-ancestor
93297466|NCT00004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297467|NCT00004896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297468|NCT00004896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93297469|NCT00004896|Alkylating Agents|alkylating agents|mesh-ancestor
93297470|NCT00004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297471|NCT00004896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297472|NCT00004896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93297473|NCT02121951|Lidocaine|lidocaine|mesh-list
93297474|NCT02121951|Fentanyl|fentanyl|mesh-list
93297475|NCT02121951|Midazolam|midazolam|mesh-list
93297476|NCT02121951|Anesthetics|anesthetics|mesh-list
93297477|NCT02121951|Levobupivacaine|levobupivacaine|mesh-list
93297478|NCT02121951|Anesthetics, Local|anesthetics, local|mesh-list
93297479|NCT02121951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93297480|NCT02121951|Narcotics|narcotics|mesh-ancestor
93297481|NCT02121951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297482|NCT02121951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297483|NCT02121951|Analgesics|analgesics|mesh-ancestor
93297484|NCT02121951|Sensory System Agents|sensory system agents|mesh-ancestor
93297485|NCT02121951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297486|NCT02121951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93297487|NCT02121951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93297488|NCT02121951|Anesthetics, General|anesthetics, general|mesh-ancestor
93297489|NCT02121951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93297490|NCT02121951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93297491|NCT02121951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93297492|NCT02121951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297493|NCT02121951|GABA Modulators|gaba modulators|mesh-ancestor
93297494|NCT02121951|GABA Agents|gaba agents|mesh-ancestor
93297495|NCT02121951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297496|NCT02121951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297497|NCT02121951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93297498|NCT02121951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93297499|NCT02121951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93297500|NCT02121951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93297501|NCT05473858|Phentolamine|phentolamine|mesh-list
93297502|NCT05473858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93297503|NCT05473858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93297504|NCT05473858|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297505|NCT05473858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297506|NCT05473858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297507|NCT05473858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297508|NCT05473858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297509|NCT00004584|Ritonavir|ritonavir|mesh-list
93297510|NCT00004584|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93297511|NCT00004584|Saquinavir|saquinavir|mesh-list
93297512|NCT00004584|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93297513|NCT00004584|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93297514|NCT00004584|Protease Inhibitors|protease inhibitors|mesh-ancestor
93297515|NCT00004584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297516|NCT00004584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297517|NCT00004584|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93297518|NCT00004584|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93297519|NCT00004584|Antiviral Agents|antiviral agents|mesh-ancestor
93297520|NCT00004584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297521|NCT00004584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93297522|NCT00004584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93297523|NCT00004230|Cyclophosphamide|cyclophosphamide|mesh-list
93297524|NCT00004230|Captopril|captopril|mesh-list
93297525|NCT00004230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297526|NCT00004230|Immunologic Factors|immunologic factors|mesh-ancestor
93297527|NCT00004230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297528|NCT00004230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297529|NCT00004230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93297530|NCT00004230|Alkylating Agents|alkylating agents|mesh-ancestor
93366431|NCT02422186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297531|NCT00004230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297532|NCT00004230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297533|NCT00004230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93297534|NCT00004230|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93297535|NCT00004230|Protease Inhibitors|protease inhibitors|mesh-ancestor
93297536|NCT00004230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297537|NCT00004230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297538|NCT02252367|Tadalafil|tadalafil|mesh-list
93297539|NCT02252367|Vasodilator Agents|vasodilator agents|mesh-ancestor
93297540|NCT02252367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93297541|NCT02252367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93297542|NCT02252367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297543|NCT02252367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297544|NCT02252367|Urological Agents|urological agents|mesh-ancestor
93297545|NCT00004182|Irinotecan|irinotecan|mesh-list
93297546|NCT00004182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93297547|NCT00004182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93297548|NCT00004182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297549|NCT00004182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297550|NCT00004182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297551|NCT02124525|Acetylcysteine|acetylcysteine|mesh-list
93297552|NCT02124525|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93297553|NCT02124525|Antiviral Agents|antiviral agents|mesh-ancestor
93297554|NCT02124525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297555|NCT02124525|Expectorants|expectorants|mesh-ancestor
93297556|NCT02124525|Respiratory System Agents|respiratory system agents|mesh-ancestor
93297557|NCT02124525|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93297558|NCT02124525|Antioxidants|antioxidants|mesh-ancestor
93297559|NCT02124525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297560|NCT02124525|Protective Agents|protective agents|mesh-ancestor
93297561|NCT02124525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297562|NCT02124525|Antidotes|antidotes|mesh-ancestor
93297563|NCT05725512|Prednisolone|prednisolone|mesh-list
93297564|NCT05725512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297565|NCT05725512|Glucocorticoids|glucocorticoids|mesh-ancestor
93297566|NCT05725512|Hormones|hormones|mesh-ancestor
93297567|NCT05725512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297568|NCT05725512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297569|NCT05725512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93297570|NCT05725512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297571|NCT02124681|Hydroxychloroquine|hydroxychloroquine|mesh-list
93297572|NCT02124681|Antimalarials|antimalarials|mesh-ancestor
93297573|NCT02124681|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93297574|NCT02124681|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93297575|NCT02124681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297576|NCT02124681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297577|NCT02124681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297578|NCT02124681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297579|NCT02128425|Leucovorin|leucovorin|mesh-list
93297580|NCT02128425|Fluorouracil|fluorouracil|mesh-list
93297581|NCT02128425|Oxaliplatin|oxaliplatin|mesh-list
93297582|NCT02128425|Irinotecan|irinotecan|mesh-list
93297583|NCT02128425|Levoleucovorin|levoleucovorin|mesh-list
93297584|NCT02128425|Antimetabolites|antimetabolites|mesh-ancestor
93297585|NCT02128425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297586|NCT02128425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297587|NCT02128425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297588|NCT02128425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297589|NCT02128425|Immunologic Factors|immunologic factors|mesh-ancestor
93297590|NCT02128425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297591|NCT02128425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93297592|NCT02128425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93297593|NCT02128425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297594|NCT02128425|Antidotes|antidotes|mesh-ancestor
93297595|NCT02128425|Protective Agents|protective agents|mesh-ancestor
93297596|NCT02128425|Vitamin B Complex|vitamin b complex|mesh-ancestor
93297597|NCT02128425|Vitamins|vitamins|mesh-ancestor
93297598|NCT02128425|Micronutrients|micronutrients|mesh-ancestor
93297599|NCT05641194|Caffeine|caffeine|mesh-list
93297600|NCT05641194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93297601|NCT05641194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297602|NCT05641194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93297603|NCT05641194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297604|NCT05641194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297605|NCT05641194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93297606|NCT05641194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93297607|NCT05641194|Purinergic Agents|purinergic agents|mesh-ancestor
93297608|NCT05641194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297609|NCT03532620|Calcium, Dietary|calcium, dietary|mesh-list
93297610|NCT03532620|Atorvastatin|atorvastatin|mesh-list
93297611|NCT03532620|Pitavastatin|pitavastatin|mesh-list
93297612|NCT03532620|Calcium|calcium|mesh-list
93297613|NCT03532620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93297614|NCT03532620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297615|NCT03532620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93297616|NCT03532620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93297617|NCT03532620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93297618|NCT03532620|Antimetabolites|antimetabolites|mesh-ancestor
93297619|NCT03532620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297620|NCT03532620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93297621|NCT03532620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93297622|NCT03532620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297623|NCT02288130|Ulipristal acetate|ulipristal acetate|mesh-list
93297624|NCT02288130|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93297625|NCT02288130|Contraceptive Agents|contraceptive agents|mesh-ancestor
93297626|NCT02288130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93297627|NCT02288130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297628|NCT02288130|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93297629|NCT03529032|Methadone|methadone|mesh-list
93297630|NCT03529032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93297631|NCT03529032|Narcotics|narcotics|mesh-ancestor
93297632|NCT03529032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297633|NCT03529032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297634|NCT03529032|Analgesics|analgesics|mesh-ancestor
93297635|NCT03529032|Sensory System Agents|sensory system agents|mesh-ancestor
93297636|NCT03529032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297637|NCT03529032|Antitussive Agents|antitussive agents|mesh-ancestor
93297638|NCT03529032|Respiratory System Agents|respiratory system agents|mesh-ancestor
93297639|NCT02122731|Amiloride|amiloride|mesh-list
93297640|NCT02122731|Diuretics|diuretics|mesh-ancestor
93297641|NCT02122731|Natriuretic Agents|natriuretic agents|mesh-ancestor
93297642|NCT02122731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297643|NCT02122731|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93297644|NCT02122731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93297645|NCT02122731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93297646|NCT02122731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297647|NCT02122731|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92592196|NCT00333034|Immunologic Factors|immunologic factors|mesh-ancestor
93297648|NCT02122731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93297649|NCT05458726|Paclitaxel|paclitaxel|mesh-list
93297650|NCT05458726|Carboplatin|carboplatin|mesh-list
93297651|NCT05458726|Pemetrexed|pemetrexed|mesh-list
93297652|NCT05458726|Osimertinib|osimertinib|mesh-list
93297653|NCT05458726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93297654|NCT05458726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297655|NCT05458726|Tubulin Modulators|tubulin modulators|mesh-ancestor
93297656|NCT05458726|Antimitotic Agents|antimitotic agents|mesh-ancestor
93297657|NCT05458726|Mitosis Modulators|mitosis modulators|mesh-ancestor
93297658|NCT05458726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297659|NCT05458726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297660|NCT05458726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93297661|NCT05458726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93297662|NCT05458726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93297663|NCT02122809|Chiauranib|chiauranib|mesh-list
93297664|NCT02122809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297665|NCT02122809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93297666|NCT02122809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297667|NCT02122809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297668|NCT00150618|Guanfacine|guanfacine|mesh-list
93297669|NCT00150618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93297670|NCT00150618|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93297671|NCT00150618|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93297672|NCT00150618|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93297673|NCT00150618|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297674|NCT00150618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297675|NCT00150618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297676|NCT00150618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297677|NCT03532464|Azithromycin|azithromycin|mesh-list
93297678|NCT03532464|Doxycycline|doxycycline|mesh-list
93297679|NCT03532464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93297680|NCT03532464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297681|NCT03532464|Antimalarials|antimalarials|mesh-ancestor
93297682|NCT03532464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93297683|NCT03532464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93297684|NCT02128893|Isavuconazole|isavuconazole|mesh-list
93297685|NCT02128893|Esomeprazole|esomeprazole|mesh-list
93297686|NCT02128893|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93297687|NCT02128893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93297688|NCT02128893|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93297689|NCT02128893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297690|NCT02128893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297691|NCT02128893|Antifungal Agents|antifungal agents|mesh-ancestor
93297692|NCT02128893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297693|NCT02124369|Paclitaxel|paclitaxel|mesh-list
93297694|NCT02124369|Gemcitabine|gemcitabine|mesh-list
93297695|NCT02124369|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93297696|NCT02124369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93297697|NCT02124369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297698|NCT02124369|Tubulin Modulators|tubulin modulators|mesh-ancestor
93297699|NCT02124369|Antimitotic Agents|antimitotic agents|mesh-ancestor
93297700|NCT02124369|Mitosis Modulators|mitosis modulators|mesh-ancestor
93297701|NCT02124369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297702|NCT02124369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297703|NCT02124369|Antimetabolites|antimetabolites|mesh-ancestor
93297704|NCT02128971|Ferrous fumarate|ferrous fumarate|mesh-list
93297705|NCT02128971|Trace Elements|trace elements|mesh-ancestor
93297706|NCT02128971|Micronutrients|micronutrients|mesh-ancestor
93297707|NCT02128971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297708|NCT02288208|Tenofovir|tenofovir|mesh-list
93297709|NCT02288208|Entecavir|entecavir|mesh-list
93297710|NCT02288208|Antiviral Agents|antiviral agents|mesh-list
93297711|NCT02288208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297712|NCT02288208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93297713|NCT02288208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93297714|NCT02288208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297715|NCT02288208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297716|NCT02288208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93297717|NCT02288208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93297718|NCT02288286|Vaccines|vaccines|mesh-list
93297719|NCT02288286|Immunologic Factors|immunologic factors|mesh-ancestor
93297720|NCT02288286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297721|NCT02251977|Leucovorin|leucovorin|mesh-list
93297722|NCT02251977|Fluorouracil|fluorouracil|mesh-list
93297723|NCT02251977|Capecitabine|capecitabine|mesh-list
93297724|NCT02251977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297725|NCT02251977|Antimetabolites|antimetabolites|mesh-ancestor
93297726|NCT02251977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297727|NCT02251977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297728|NCT02251977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297729|NCT02251977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297730|NCT02251977|Immunologic Factors|immunologic factors|mesh-ancestor
93297731|NCT02251977|Antidotes|antidotes|mesh-ancestor
93297732|NCT02251977|Protective Agents|protective agents|mesh-ancestor
93297733|NCT02251977|Vitamin B Complex|vitamin b complex|mesh-ancestor
93297734|NCT02251977|Vitamins|vitamins|mesh-ancestor
93297735|NCT02251977|Micronutrients|micronutrients|mesh-ancestor
93297736|NCT03528954|Propofol|propofol|mesh-list
93297737|NCT03528954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93297738|NCT03528954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297739|NCT03528954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297740|NCT03528954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93297741|NCT03528954|Anesthetics, General|anesthetics, general|mesh-ancestor
93297742|NCT03528954|Anesthetics|anesthetics|mesh-ancestor
93297743|NCT02125227|Metformin|metformin|mesh-list
93297744|NCT02125227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93297745|NCT02125227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93297746|NCT02125227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297747|NCT02125227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93297748|NCT02125227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93297749|NCT02125227|Antimetabolites|antimetabolites|mesh-ancestor
93297750|NCT02125227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297751|NCT02125227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93297752|NCT02125227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93297753|NCT02125227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297754|NCT02129127|Paclitaxel|paclitaxel|mesh-list
93297755|NCT02129127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93297756|NCT02129127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297757|NCT02129127|Tubulin Modulators|tubulin modulators|mesh-ancestor
93297758|NCT02129127|Antimitotic Agents|antimitotic agents|mesh-ancestor
93297759|NCT02129127|Mitosis Modulators|mitosis modulators|mesh-ancestor
93297760|NCT02129127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297761|NCT05554822|Aspirin|aspirin|mesh-list
93297762|NCT05554822|Clopidogrel|clopidogrel|mesh-list
93297763|NCT05554822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93297764|NCT05554822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93297765|NCT05554822|Analgesics|analgesics|mesh-ancestor
93297766|NCT05554822|Sensory System Agents|sensory system agents|mesh-ancestor
93297767|NCT05554822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297768|NCT05554822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297769|NCT05554822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297770|NCT05554822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297771|NCT05554822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93297772|NCT05554822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93297773|NCT05554822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297774|NCT05554822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93297775|NCT05554822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93297776|NCT05554822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297777|NCT05554822|Antipyretics|antipyretics|mesh-ancestor
93297778|NCT05554822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93297779|NCT05554822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93297780|NCT05554822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93297781|NCT05554822|Purinergic Agents|purinergic agents|mesh-ancestor
93297782|NCT05554822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297783|NCT02125305|Metformin|metformin|mesh-list
93297784|NCT02125305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93297785|NCT02125305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297786|NCT00254904|Cisplatin|cisplatin|mesh-list
93297787|NCT00254904|Gemcitabine|gemcitabine|mesh-list
93297788|NCT00254904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297789|NCT00254904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297790|NCT00254904|Antimetabolites|antimetabolites|mesh-ancestor
93297791|NCT00254904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297792|NCT05725122|Tamsulosin|tamsulosin|mesh-list
93297793|NCT05725122|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93297794|NCT05725122|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93297795|NCT05725122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93297796|NCT05725122|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297797|NCT05725122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297798|NCT05725122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297799|NCT05725122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297800|NCT05725122|Urological Agents|urological agents|mesh-ancestor
93297801|NCT03880396|Cisplatin|cisplatin|mesh-list
93297802|NCT03880396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297803|NCT00253968|SR 46349B|sr 46349b|mesh-list
93297804|NCT00253968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93297805|NCT00253968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93297806|NCT00253968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297807|NCT00253968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93297808|NCT00253968|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93297809|NCT00253968|Serotonin Agents|serotonin agents|mesh-ancestor
93297810|NCT00253968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297811|NCT00253968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297812|NCT03544606|Pyridoxine|pyridoxine|mesh-list
93297813|NCT03544606|Isosorbide|isosorbide|mesh-list
93297814|NCT03544606|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93297815|NCT03544606|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93297816|NCT03544606|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93297817|NCT03544606|Diuretics|diuretics|mesh-ancestor
93297818|NCT03544606|Natriuretic Agents|natriuretic agents|mesh-ancestor
93297819|NCT03544606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297820|NCT03544606|Vasodilator Agents|vasodilator agents|mesh-ancestor
93297821|NCT03544606|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93297822|NCT03544606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297823|NCT03544606|Vitamin B Complex|vitamin b complex|mesh-ancestor
93297824|NCT03544606|Vitamins|vitamins|mesh-ancestor
93297825|NCT03544606|Micronutrients|micronutrients|mesh-ancestor
93297826|NCT02741310|Sumatriptan|sumatriptan|mesh-list
93297827|NCT02741310|Erenumab|erenumab|mesh-list
93297828|NCT02741310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93297829|NCT02741310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93297830|NCT02741310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93297831|NCT02741310|Serotonin Agents|serotonin agents|mesh-ancestor
93297832|NCT02741310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297833|NCT02741310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297834|NCT02741310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297835|NCT02741310|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93297836|NCT02741310|Analgesics|analgesics|mesh-ancestor
93297837|NCT02741310|Sensory System Agents|sensory system agents|mesh-ancestor
93297838|NCT02741310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297839|NCT05700448|Gemcitabine|gemcitabine|mesh-list
93297840|NCT05700448|Oxaliplatin|oxaliplatin|mesh-list
93297841|NCT05700448|Pegaspargase|pegaspargase|mesh-list
93297842|NCT05700448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297843|NCT05700448|Antimetabolites|antimetabolites|mesh-ancestor
93297844|NCT05700448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297845|NCT05700448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297846|NCT00243906|Plasminogen|plasminogen|mesh-list
93297847|NCT00243906|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93297848|NCT00243906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93297849|NCT00243906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93297850|NCT00243906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297851|NCT03532360|Immunomodulating Agents|immunomodulating agents|mesh-list
93297852|NCT03532360|Immunologic Factors|immunologic factors|mesh-ancestor
93297853|NCT03532360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297854|NCT01367457|Sirolimus|sirolimus|mesh-list
93297855|NCT01367457|Temsirolimus|temsirolimus|mesh-list
93297856|NCT01367457|MTOR Inhibitors|mtor inhibitors|mesh-list
93297857|NCT01367457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93297858|NCT01367457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297859|NCT01367457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297860|NCT01367457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297861|NCT01367457|Immunologic Factors|immunologic factors|mesh-ancestor
93297862|NCT01367457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297863|NCT01367457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297864|NCT01367457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93297865|NCT01367457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297866|NCT01367457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93297867|NCT01367457|Antifungal Agents|antifungal agents|mesh-ancestor
93297868|NCT05553496|Cyclosporine|cyclosporine|mesh-list
93297869|NCT05553496|Dexamethasone|dexamethasone|mesh-list
93297870|NCT05553496|Dexamethasone acetate|dexamethasone acetate|mesh-list
93297871|NCT05553496|Cyclophosphamide|cyclophosphamide|mesh-list
93297872|NCT05553496|Rituximab|rituximab|mesh-list
93297873|NCT05553496|Tacrolimus|tacrolimus|mesh-list
93297874|NCT05553496|Cyclosporins|cyclosporins|mesh-list
93297875|NCT05553496|BB 1101|bb 1101|mesh-list
93297876|NCT05553496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297877|NCT05553496|Immunologic Factors|immunologic factors|mesh-ancestor
93297878|NCT05553496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297879|NCT05553496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297880|NCT05553496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93297881|NCT05553496|Alkylating Agents|alkylating agents|mesh-ancestor
93297882|NCT05553496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297883|NCT05553496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297884|NCT05553496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93297885|NCT05553496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93297886|NCT05553496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297887|NCT05553496|Antiemetics|antiemetics|mesh-ancestor
93297888|NCT05553496|Autonomic Agents|autonomic agents|mesh-ancestor
93297889|NCT05553496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297890|NCT05553496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93297891|NCT05553496|Glucocorticoids|glucocorticoids|mesh-ancestor
93297892|NCT05553496|Hormones|hormones|mesh-ancestor
93297893|NCT05553496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297894|NCT05553496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93297895|NCT05553496|Protease Inhibitors|protease inhibitors|mesh-ancestor
93297896|NCT05553496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297897|NCT05553496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93297898|NCT05553496|Antifungal Agents|antifungal agents|mesh-ancestor
93297899|NCT05553496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297900|NCT05553496|Dermatologic Agents|dermatologic agents|mesh-ancestor
93297901|NCT00239694|Vaccines|vaccines|mesh-list
93297902|NCT00239694|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93297903|NCT00239694|Immunologic Factors|immunologic factors|mesh-ancestor
93297904|NCT00239694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297905|NCT05549284|Rituximab|rituximab|mesh-list
93297906|NCT05549284|Methotrexate|methotrexate|mesh-list
93297907|NCT05549284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93297908|NCT05549284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297909|NCT05549284|Immunologic Factors|immunologic factors|mesh-ancestor
93297910|NCT05549284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297911|NCT05549284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93297912|NCT05549284|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93297913|NCT05549284|Abortifacient Agents|abortifacient agents|mesh-ancestor
93297914|NCT05549284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93297915|NCT05549284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93297916|NCT05549284|Antimetabolites|antimetabolites|mesh-ancestor
93297917|NCT05549284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297918|NCT05549284|Dermatologic Agents|dermatologic agents|mesh-ancestor
93297919|NCT05549284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297920|NCT05549284|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93297921|NCT05549284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297922|NCT05549284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93297923|NCT03065218|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
93297924|NCT03065218|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93297925|NCT03065218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297926|NCT00232752|Sirolimus|sirolimus|mesh-list
93297927|NCT00232752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93297928|NCT00232752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297929|NCT00232752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93297930|NCT00232752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297931|NCT00232752|Antifungal Agents|antifungal agents|mesh-ancestor
93297932|NCT00232752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93297933|NCT00232752|Immunologic Factors|immunologic factors|mesh-ancestor
93297934|NCT00232752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297935|NCT02125617|Prednisolone|prednisolone|mesh-list
93297936|NCT02125617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93297937|NCT02125617|Glucocorticoids|glucocorticoids|mesh-ancestor
93297938|NCT02125617|Hormones|hormones|mesh-ancestor
93297939|NCT02125617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93297940|NCT02125617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297941|NCT02125617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93297942|NCT02125617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93297943|NCT02131545|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93297944|NCT02131545|Antidepressive Agents|antidepressive agents|mesh-ancestor
93297945|NCT02131545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297946|NCT02131545|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93297947|NCT02131545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93297948|NCT02131545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93297949|NCT02131545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297950|NCT00229008|Linezolid|linezolid|mesh-list
93297951|NCT00229008|Ceftazidime|ceftazidime|mesh-list
93297952|NCT00229008|Ceftobiprole|ceftobiprole|mesh-list
93297953|NCT00229008|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93297954|NCT00229008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93297955|NCT00229008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297956|NCT00229008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93297957|NCT00229008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93297958|NCT00229008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297959|NCT05553184|Niacin|niacin|mesh-list
93297960|NCT05553184|Nicotinic Acids|nicotinic acids|mesh-list
93297961|NCT05553184|Niacinamide|niacinamide|mesh-list
93297962|NCT05553184|Formoterol Fumarate|formoterol fumarate|mesh-list
93297963|NCT05553184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93297964|NCT05553184|Autonomic Agents|autonomic agents|mesh-ancestor
93297965|NCT05553184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93297966|NCT05553184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297967|NCT05553184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93297968|NCT05553184|Respiratory System Agents|respiratory system agents|mesh-ancestor
93297969|NCT05553184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93297970|NCT05553184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93297971|NCT05553184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93297972|NCT05553184|Adrenergic Agents|adrenergic agents|mesh-ancestor
93297973|NCT05553184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93297974|NCT05553184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297975|NCT05553184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93297976|NCT05553184|Antimetabolites|antimetabolites|mesh-ancestor
93297977|NCT05553184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93297978|NCT05553184|Vasodilator Agents|vasodilator agents|mesh-ancestor
93297979|NCT05553184|Vitamin B Complex|vitamin b complex|mesh-ancestor
93297980|NCT05553184|Vitamins|vitamins|mesh-ancestor
93297981|NCT05553184|Micronutrients|micronutrients|mesh-ancestor
93297982|NCT03059992|Ibrexafungerp|ibrexafungerp|mesh-list
93297983|NCT03059992|Antifungal Agents|antifungal agents|mesh-ancestor
93297984|NCT03059992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93297985|NCT05242029|Psilocybin|psilocybin|mesh-list
93297986|NCT05242029|Hallucinogens|hallucinogens|mesh-ancestor
93297987|NCT05242029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93297988|NCT05242029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93297989|NCT03528564|Epoetin Alfa|epoetin alfa|mesh-list
93297990|NCT03528564|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93297991|NCT03528564|Hematinics|hematinics|mesh-ancestor
93297992|NCT03531372|Antacids|antacids|mesh-list
93297993|NCT03531372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297994|NCT03531372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93297995|NCT02129595|Resveratrol|resveratrol|mesh-list
93297996|NCT02129595|Antioxidants|antioxidants|mesh-ancestor
93297997|NCT02129595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93297998|NCT02129595|Protective Agents|protective agents|mesh-ancestor
93297999|NCT02129595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298000|NCT02129595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298001|NCT02129595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93298002|NCT02129673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93298003|NCT02129673|Latanoprost|latanoprost|mesh-list
93298004|NCT02129673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93298005|NCT02260557|Selexipag|selexipag|mesh-list
93298006|NCT02260557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93298007|NCT02129829|Tenofovir|tenofovir|mesh-list
93298008|NCT02129829|Antiviral Agents|antiviral agents|mesh-ancestor
93298009|NCT02129829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298010|NCT02129829|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93298011|NCT02129829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93298012|NCT02129829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298013|NCT02129829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298014|NCT02129829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93298015|NCT02129829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93298016|NCT02129985|Metformin|metformin|mesh-list
93298017|NCT02129985|Exenatide|exenatide|mesh-list
93298018|NCT02129985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93298019|NCT02129985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298020|NCT02129985|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93298021|NCT02129985|Incretins|incretins|mesh-ancestor
93298022|NCT02129985|Hormones|hormones|mesh-ancestor
93298023|NCT02129985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298024|NCT01730638|Histamine|histamine|mesh-list
93298025|NCT01730638|Glycine|glycine|mesh-list
93298026|NCT01730638|Histamine Agonists|histamine agonists|mesh-ancestor
93298027|NCT01730638|Histamine Agents|histamine agents|mesh-ancestor
93298028|NCT01730638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298029|NCT01730638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298030|NCT01730638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298031|NCT01730638|Glycine Agents|glycine agents|mesh-ancestor
93298032|NCT02252523|Dexmedetomidine|dexmedetomidine|mesh-list
93298033|NCT02252523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93298034|NCT02252523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298035|NCT02252523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298036|NCT02252523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298037|NCT02252523|Analgesics|analgesics|mesh-ancestor
93298038|NCT02252523|Sensory System Agents|sensory system agents|mesh-ancestor
93298039|NCT02252523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298040|NCT02252523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93298041|NCT02252523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93298042|NCT02252523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93298043|NCT02252523|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298044|NCT02252523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298045|NCT02252523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298046|NCT02132091|Vitamins|vitamins|mesh-list
93298047|NCT02132091|Vitamin E|vitamin e|mesh-list
93298048|NCT02132091|Micronutrients|micronutrients|mesh-ancestor
93298049|NCT02132091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298050|NCT02132091|Antioxidants|antioxidants|mesh-ancestor
93298051|NCT02132091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298052|NCT02132091|Protective Agents|protective agents|mesh-ancestor
93298053|NCT05548348|Aflutinib|aflutinib|mesh-list
93298054|NCT05548348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93298055|NCT05548348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298056|NCT05548348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298057|NCT05726370|Carboplatin|carboplatin|mesh-list
93298058|NCT05726370|Docetaxel|docetaxel|mesh-list
93298059|NCT05726370|Pembrolizumab|pembrolizumab|mesh-list
93298060|NCT05726370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970117|NCT03573024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298061|NCT05726370|Tubulin Modulators|tubulin modulators|mesh-ancestor
93298062|NCT05726370|Antimitotic Agents|antimitotic agents|mesh-ancestor
93298063|NCT05726370|Mitosis Modulators|mitosis modulators|mesh-ancestor
93298064|NCT05726370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298065|NCT05726370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298066|NCT05726370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93298067|NCT04469010|Iron|iron|mesh-list
93298068|NCT04469010|Chelating Agents|chelating agents|mesh-list
93298069|NCT04469010|Micronutrients|micronutrients|mesh-ancestor
93298070|NCT04469010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298071|NCT04469010|Trace Elements|trace elements|mesh-ancestor
93298072|NCT04469010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298073|NCT04469010|Sequestering Agents|sequestering agents|mesh-ancestor
93298074|NCT01121224|Clopidogrel|clopidogrel|mesh-list
93298075|NCT01121224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93298076|NCT01121224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93298077|NCT01121224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93298078|NCT01121224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93298079|NCT01121224|Purinergic Agents|purinergic agents|mesh-ancestor
93298080|NCT01121224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298081|NCT01121224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298082|NCT01121224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298083|NCT00138762|Atorvastatin|atorvastatin|mesh-list
93298084|NCT00138762|Torcetrapib|torcetrapib|mesh-list
93298085|NCT00138762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93298086|NCT00138762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93298087|NCT00138762|Antimetabolites|antimetabolites|mesh-ancestor
93298088|NCT00138762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298089|NCT00138762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93298090|NCT00138762|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93298091|NCT00138762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298092|NCT03531294|Aflibercept|aflibercept|mesh-list
93298093|NCT03531294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93298094|NCT03531294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93298095|NCT03531294|Growth Substances|growth substances|mesh-ancestor
93298096|NCT03531294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298097|NCT03531294|Growth Inhibitors|growth inhibitors|mesh-ancestor
93298098|NCT03531294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298099|NCT03549975|Botulinum Toxins|botulinum toxins|mesh-list
93298100|NCT03549975|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93298101|NCT03549975|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93298102|NCT03549975|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93298103|NCT03549975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298104|NCT03549975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298105|NCT03549975|Cholinergic Agents|cholinergic agents|mesh-ancestor
93298106|NCT03549975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298107|NCT03549975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298108|NCT03549975|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93298109|NCT03549975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298110|NCT05551624|Acetylcysteine|acetylcysteine|mesh-list
93298111|NCT05551624|Atorvastatin|atorvastatin|mesh-list
93298112|NCT05551624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93298113|NCT05551624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93298114|NCT05551624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93298115|NCT05551624|Antimetabolites|antimetabolites|mesh-ancestor
93298116|NCT05551624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298117|NCT05551624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93298118|NCT05551624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93298119|NCT05551624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298120|NCT05551624|Antiviral Agents|antiviral agents|mesh-ancestor
93298121|NCT05551624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298122|NCT05551624|Expectorants|expectorants|mesh-ancestor
93298123|NCT05551624|Respiratory System Agents|respiratory system agents|mesh-ancestor
93298124|NCT05551624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93298125|NCT05551624|Antioxidants|antioxidants|mesh-ancestor
93298126|NCT05551624|Protective Agents|protective agents|mesh-ancestor
93298127|NCT05551624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298128|NCT05551624|Antidotes|antidotes|mesh-ancestor
93298129|NCT00134238|Atorvastatin|atorvastatin|mesh-list
93298130|NCT00134238|Torcetrapib|torcetrapib|mesh-list
93298131|NCT00134238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93298132|NCT00134238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93298133|NCT00134238|Antimetabolites|antimetabolites|mesh-ancestor
93298134|NCT00134238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298135|NCT00134238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93298136|NCT00134238|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93298137|NCT00134238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298138|NCT02786901|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92592677|NCT00335179|Imiquimod|imiquimod|mesh-list
93298139|NCT02786901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93298140|NCT03550677|Anesthetics|anesthetics|mesh-list
93298141|NCT03550677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298142|NCT03550677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298143|NCT03634488|Hydroxyurea|hydroxyurea|mesh-list
93298144|NCT03634488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298145|NCT03634488|Antisickling Agents|antisickling agents|mesh-ancestor
93298146|NCT03634488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298147|NCT03634488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298148|NCT03634488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93298149|NCT02132403|Milk fat globule|milk fat globule|mesh-list
93298150|NCT02132403|Gemcitabine|gemcitabine|mesh-list
93298151|NCT02132403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93298152|NCT02132403|Antimetabolites|antimetabolites|mesh-ancestor
93298153|NCT02132403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298154|NCT02132403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298155|NCT02132403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298156|NCT04264806|Azacitidine|azacitidine|mesh-list
93298157|NCT04264806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93298158|NCT04264806|Antimetabolites|antimetabolites|mesh-ancestor
93298159|NCT04264806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298160|NCT04264806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298161|NCT04264806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298162|NCT05699824|Carvedilol|carvedilol|mesh-list
93298163|NCT05699824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93298164|NCT05699824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93298165|NCT05699824|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298166|NCT05699824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298167|NCT05699824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298168|NCT05699824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298169|NCT05699824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93298170|NCT05699824|Antioxidants|antioxidants|mesh-ancestor
93298171|NCT05699824|Protective Agents|protective agents|mesh-ancestor
93298172|NCT05699824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93298173|NCT05699824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298174|NCT05699824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93298175|NCT05699824|Vasodilator Agents|vasodilator agents|mesh-ancestor
93298176|NCT05699824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93298177|NCT05699824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93298178|NCT02132559|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93298179|NCT02132559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93298180|NCT02132559|Immunologic Factors|immunologic factors|mesh-ancestor
93298181|NCT02132559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298182|NCT00126984|Vaccines|vaccines|mesh-list
93298183|NCT00126984|Immunologic Factors|immunologic factors|mesh-ancestor
93298184|NCT00126984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298185|NCT02136147|Guanfacine|guanfacine|mesh-list
93298186|NCT02136147|Methylphenidate|methylphenidate|mesh-list
93298187|NCT02136147|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93298188|NCT02136147|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93298189|NCT02136147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93298190|NCT02136147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298191|NCT02136147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93298192|NCT02136147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93298193|NCT02136147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298194|NCT02136147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298195|NCT02136147|Dopamine Agents|dopamine agents|mesh-ancestor
93298196|NCT02136147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298197|NCT02136147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93298198|NCT02136147|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298199|NCT02136147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93298200|NCT02136147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93298201|NCT02136147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93298202|NCT02136147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93298203|NCT05699746|Capecitabine|capecitabine|mesh-list
93298204|NCT05699746|Oxaliplatin|oxaliplatin|mesh-list
93298205|NCT05699746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93298206|NCT05699746|Antimetabolites|antimetabolites|mesh-ancestor
92592752|NCT00343369|Antimitotic Agents|antimitotic agents|mesh-ancestor
93298207|NCT05699746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298208|NCT05699746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298209|NCT03549897|Albuterol|albuterol|mesh-list
93298210|NCT03549897|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93298212|NCT03549897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298213|NCT03549897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298214|NCT03549897|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93298215|NCT03549897|Respiratory System Agents|respiratory system agents|mesh-ancestor
93298216|NCT03549897|Tocolytic Agents|tocolytic agents|mesh-ancestor
93298217|NCT03549897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93298218|NCT03549897|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93298219|NCT03549897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93298220|NCT03549897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93298221|NCT03549897|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298222|NCT03549897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298223|NCT03549897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298224|NCT02133105|Simendan|simendan|mesh-list
93298225|NCT02133105|Dobutamine|dobutamine|mesh-list
93298226|NCT02133105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93298227|NCT02133105|Vasodilator Agents|vasodilator agents|mesh-ancestor
93298228|NCT02133105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93298229|NCT02133105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93298230|NCT02133105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298231|NCT02133105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298232|NCT02133105|Protective Agents|protective agents|mesh-ancestor
93298233|NCT02133105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298234|NCT02133105|Sympathomimetics|sympathomimetics|mesh-ancestor
93298235|NCT02133105|Autonomic Agents|autonomic agents|mesh-ancestor
93298236|NCT02133105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298237|NCT02133105|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93298238|NCT02133105|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93298239|NCT02133105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93298240|NCT02133105|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298241|NCT02133105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298242|NCT04468464|Salicylic Acid|salicylic acid|mesh-list
93298243|NCT04468464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298244|NCT04468464|Antifungal Agents|antifungal agents|mesh-ancestor
93298245|NCT04468464|Keratolytic Agents|keratolytic agents|mesh-ancestor
93298246|NCT04468464|Dermatologic Agents|dermatologic agents|mesh-ancestor
93298247|NCT02136693|Psyllium|psyllium|mesh-list
93298248|NCT02136693|Cathartics|cathartics|mesh-ancestor
93298249|NCT02136693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93298250|NCT02136771|Vitamin D|vitamin d|mesh-list
93298251|NCT02136771|Cholecalciferol|cholecalciferol|mesh-list
93298252|NCT02136771|Vitamins|vitamins|mesh-ancestor
93298253|NCT02136771|Micronutrients|micronutrients|mesh-ancestor
93298254|NCT02136771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298255|NCT02136771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93298256|NCT02136771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93298257|NCT00125970|Vaccines|vaccines|mesh-list
93298258|NCT00125970|Immunologic Factors|immunologic factors|mesh-ancestor
93298259|NCT00125970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298260|NCT03549663|Prednisone|prednisone|mesh-list
93298261|NCT03549663|Glucocorticoids|glucocorticoids|mesh-list
93298262|NCT03549663|Tacrolimus|tacrolimus|mesh-list
93298263|NCT03549663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298264|NCT03549663|Hormones|hormones|mesh-ancestor
93298265|NCT03549663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298266|NCT03549663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298267|NCT03549663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93298268|NCT03549663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298269|NCT03549663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298270|NCT03549663|Immunologic Factors|immunologic factors|mesh-ancestor
93298271|NCT03549663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93298272|NCT03549663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298273|NCT03549663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298274|NCT02137083|Docetaxel|docetaxel|mesh-list
93298275|NCT02137083|Fulvestrant|fulvestrant|mesh-list
93298276|NCT02137083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298277|NCT02137083|Tubulin Modulators|tubulin modulators|mesh-ancestor
93298278|NCT02137083|Antimitotic Agents|antimitotic agents|mesh-ancestor
93298279|NCT02137083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592824|NCT00127920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298280|NCT02137083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298281|NCT02137083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93298282|NCT02137083|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93298283|NCT02137083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93298284|NCT02137083|Hormone Antagonists|hormone antagonists|mesh-ancestor
93298285|NCT02137083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298286|NCT02137083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298287|NCT02137161|Tobramycin|tobramycin|mesh-list
93298288|NCT02137161|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93298289|NCT02137161|Dexamethasone|dexamethasone|mesh-list
93298290|NCT02137161|Bromfenac|bromfenac|mesh-list
93298291|NCT02137161|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93298292|NCT02137161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298293|NCT02137161|Antiemetics|antiemetics|mesh-ancestor
93298294|NCT02137161|Autonomic Agents|autonomic agents|mesh-ancestor
93298295|NCT02137161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298296|NCT02137161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298297|NCT02137161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93298298|NCT02137161|Glucocorticoids|glucocorticoids|mesh-ancestor
93298299|NCT02137161|Hormones|hormones|mesh-ancestor
93298300|NCT02137161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298301|NCT02137161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93298302|NCT02137161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298303|NCT02137161|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93298304|NCT02137161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93298305|NCT02137161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298306|NCT02137161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93298307|NCT02137161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298308|NCT02137161|Analgesics|analgesics|mesh-ancestor
93298309|NCT02137161|Sensory System Agents|sensory system agents|mesh-ancestor
93298310|NCT02137161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298311|NCT02253069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93298312|NCT02253069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298313|NCT03527628|Cyclophosphamide|cyclophosphamide|mesh-list
93298314|NCT03527628|Dacarbazine|dacarbazine|mesh-list
93298315|NCT03527628|Doxorubicin|doxorubicin|mesh-list
93298316|NCT03527628|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93298317|NCT03527628|Bleomycin|bleomycin|mesh-list
93298318|NCT03527628|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93298319|NCT03527628|Vinblastine|vinblastine|mesh-list
93298320|NCT03527628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298321|NCT03527628|Immunologic Factors|immunologic factors|mesh-ancestor
93298322|NCT03527628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298323|NCT03527628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298324|NCT03527628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93298325|NCT03527628|Alkylating Agents|alkylating agents|mesh-ancestor
93298326|NCT03527628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298327|NCT03527628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298328|NCT03527628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93298329|NCT03527628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93298330|NCT03527628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93298331|NCT03527628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93298332|NCT03527628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298333|NCT03527628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298334|NCT03527628|Immunotoxins|immunotoxins|mesh-ancestor
93298335|NCT03527628|Immunoconjugates|immunoconjugates|mesh-ancestor
93298336|NCT03527628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93298337|NCT03527628|Tubulin Modulators|tubulin modulators|mesh-ancestor
93298338|NCT03527628|Antimitotic Agents|antimitotic agents|mesh-ancestor
93298339|NCT03527628|Mitosis Modulators|mitosis modulators|mesh-ancestor
93298340|NCT04466670|Aspirin|aspirin|mesh-list
93298341|NCT04466670|Heparin|heparin|mesh-list
93298342|NCT04466670|Calcium heparin|calcium heparin|mesh-list
93298343|NCT04466670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93298344|NCT04466670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298345|NCT04466670|Analgesics|analgesics|mesh-ancestor
93298346|NCT04466670|Sensory System Agents|sensory system agents|mesh-ancestor
93298347|NCT04466670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298348|NCT04466670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298349|NCT04466670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298350|NCT04466670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298351|NCT04466670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93298352|NCT04466670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93298353|NCT04466670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298354|NCT04466670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93298355|NCT04466670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93298356|NCT04466670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298357|NCT04466670|Antipyretics|antipyretics|mesh-ancestor
93298358|NCT04466670|Anticoagulants|anticoagulants|mesh-ancestor
93298359|NCT04468542|Triamcinolone|triamcinolone|mesh-list
93298360|NCT04468542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93298361|NCT04468542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93298362|NCT04468542|Bupivacaine|bupivacaine|mesh-list
93298363|NCT04468542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93298364|NCT04468542|Anesthetics, Local|anesthetics, local|mesh-ancestor
93298366|NCT04468542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298367|NCT04468542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298368|NCT04468542|Sensory System Agents|sensory system agents|mesh-ancestor
93298369|NCT04468542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298370|NCT04468542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298371|NCT04468542|Glucocorticoids|glucocorticoids|mesh-ancestor
93298372|NCT04468542|Hormones|hormones|mesh-ancestor
93298373|NCT04468542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298374|NCT04468542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298375|NCT04468542|Immunologic Factors|immunologic factors|mesh-ancestor
93298376|NCT04468542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298377|NCT04468542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298378|NCT03525522|Betamethasone|betamethasone|mesh-list
93298379|NCT03525522|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93298380|NCT03525522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298381|NCT03525522|Glucocorticoids|glucocorticoids|mesh-ancestor
93298382|NCT03525522|Hormones|hormones|mesh-ancestor
93298383|NCT03525522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298384|NCT03525522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298385|NCT03525522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93298386|NCT03525522|Respiratory System Agents|respiratory system agents|mesh-ancestor
93298387|NCT03228732|Fluoxetine|fluoxetine|mesh-list
93298388|NCT03228732|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93298389|NCT03228732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93298390|NCT03228732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93298391|NCT03228732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298392|NCT03228732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298393|NCT03228732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298394|NCT03228732|Serotonin Agents|serotonin agents|mesh-ancestor
93298395|NCT03228732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298396|NCT03228732|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93298397|NCT03228732|Antidepressive Agents|antidepressive agents|mesh-ancestor
93298398|NCT03228732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298399|NCT03228732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93298400|NCT03228732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93298401|NCT03228732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298402|NCT03228732|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93298403|NCT03228732|Immunologic Factors|immunologic factors|mesh-ancestor
93298404|NCT03222492|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93298405|NCT03222492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93298406|NCT03222492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298407|NCT03222492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298408|NCT03222492|Immunotoxins|immunotoxins|mesh-ancestor
93298409|NCT03222492|Immunoconjugates|immunoconjugates|mesh-ancestor
93298410|NCT03222492|Immunologic Factors|immunologic factors|mesh-ancestor
93298411|NCT03222492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298412|NCT04466436|Tryptophan|tryptophan|mesh-list
93298413|NCT04466436|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93298414|NCT04466436|Antidepressive Agents|antidepressive agents|mesh-ancestor
93298415|NCT04466436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298416|NCT04467450|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93298417|NCT04467450|Botulinum Toxins|botulinum toxins|mesh-list
93298418|NCT04467450|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93298419|NCT04467450|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93298420|NCT04467450|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93298421|NCT04467450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298422|NCT04467450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298423|NCT04467450|Cholinergic Agents|cholinergic agents|mesh-ancestor
93298424|NCT04467450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298425|NCT04467450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298426|NCT04467450|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93298427|NCT04467450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298428|NCT04467450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298429|NCT05230758|Metformin|metformin|mesh-list
93298430|NCT05230758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93298431|NCT05230758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298432|NCT03008382|Metoprolol|metoprolol|mesh-list
93298433|NCT03008382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93298434|NCT03008382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93298435|NCT03008382|Sympatholytics|sympatholytics|mesh-ancestor
93298436|NCT03008382|Autonomic Agents|autonomic agents|mesh-ancestor
93298437|NCT03008382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298438|NCT03008382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298439|NCT03008382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93298440|NCT03008382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93298441|NCT03008382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93298442|NCT03008382|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298443|NCT03008382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298444|NCT03008382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298445|NCT02137239|Mycophenolic Acid|mycophenolic acid|mesh-list
93298446|NCT02137239|Prednisone|prednisone|mesh-list
93298447|NCT02137239|Methylprednisolone|methylprednisolone|mesh-list
93298448|NCT02137239|Everolimus|everolimus|mesh-list
93298449|NCT02137239|Abatacept|abatacept|mesh-list
93298450|NCT02137239|Tacrolimus|tacrolimus|mesh-list
93298451|NCT02137239|Thymoglobulin|thymoglobulin|mesh-list
93298452|NCT02137239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298453|NCT02137239|Glucocorticoids|glucocorticoids|mesh-ancestor
93298454|NCT02137239|Hormones|hormones|mesh-ancestor
93298455|NCT02137239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298456|NCT02137239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298457|NCT02137239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93298458|NCT02137239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298459|NCT02137239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298460|NCT02137239|Immunologic Factors|immunologic factors|mesh-ancestor
93298461|NCT02137239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93298462|NCT02137239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298463|NCT02137239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298464|NCT02137239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93298465|NCT02137239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93298466|NCT02137239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93298467|NCT02137239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93298468|NCT02137239|Antitubercular Agents|antitubercular agents|mesh-ancestor
93298469|NCT02137239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93298470|NCT02137239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298471|NCT02137239|Antiemetics|antiemetics|mesh-ancestor
93298472|NCT02137239|Autonomic Agents|autonomic agents|mesh-ancestor
93298473|NCT02137239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298474|NCT02137239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93298475|NCT02137239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93298476|NCT02137239|Protective Agents|protective agents|mesh-ancestor
93298477|NCT02137239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93298478|NCT02137239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298479|NCT02137239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298480|NCT02137395|Dexamethasone|dexamethasone|mesh-list
93298481|NCT02137395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298482|NCT02137395|Antiemetics|antiemetics|mesh-ancestor
93298483|NCT02137395|Autonomic Agents|autonomic agents|mesh-ancestor
93298484|NCT02137395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298485|NCT02137395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298486|NCT02137395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93298487|NCT02137395|Glucocorticoids|glucocorticoids|mesh-ancestor
93298488|NCT02137395|Hormones|hormones|mesh-ancestor
93298489|NCT02137395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298490|NCT02137395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93298491|NCT02137395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298492|NCT02137629|Azacitidine|azacitidine|mesh-list
93298493|NCT02137629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93298494|NCT02137629|Antimetabolites|antimetabolites|mesh-ancestor
93298495|NCT02137629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298496|NCT02137629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298497|NCT02137629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298498|NCT02137707|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93298499|NCT02137707|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93298500|NCT02137707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298501|NCT02137707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298502|NCT02137707|Immunologic Factors|immunologic factors|mesh-ancestor
93298503|NCT02137707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298504|NCT02261025|Aspirin|aspirin|mesh-list
93298505|NCT02261025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93298506|NCT02261025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298507|NCT02261025|Analgesics|analgesics|mesh-ancestor
93298508|NCT02261025|Sensory System Agents|sensory system agents|mesh-ancestor
93298509|NCT02261025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970603|NCT00816816|Docetaxel|docetaxel|mesh-list
93298510|NCT02261025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298511|NCT02261025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298513|NCT02261025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93298514|NCT02261025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93298515|NCT02261025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298516|NCT02261025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93298517|NCT02261025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93298518|NCT02261025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298519|NCT02261025|Antipyretics|antipyretics|mesh-ancestor
93298520|NCT02925234|Bevacizumab|bevacizumab|mesh-list
93298521|NCT02925234|Pembrolizumab|pembrolizumab|mesh-list
93298522|NCT02925234|Nivolumab|nivolumab|mesh-list
93298523|NCT02925234|Trastuzumab|trastuzumab|mesh-list
93298524|NCT02925234|Ipilimumab|ipilimumab|mesh-list
93298525|NCT02925234|Atezolizumab|atezolizumab|mesh-list
93298526|NCT02925234|Durvalumab|durvalumab|mesh-list
93298527|NCT02925234|Pertuzumab|pertuzumab|mesh-list
93298528|NCT02925234|Panitumumab|panitumumab|mesh-list
93298529|NCT02925234|Sunitinib|sunitinib|mesh-list
93298530|NCT02925234|Lenvatinib|lenvatinib|mesh-list
93298531|NCT02925234|Olaparib|olaparib|mesh-list
93298532|NCT02925234|Palbociclib|palbociclib|mesh-list
93298533|NCT02925234|Trametinib|trametinib|mesh-list
93298534|NCT02925234|Axitinib|axitinib|mesh-list
93298535|NCT02925234|Afatinib|afatinib|mesh-list
93298536|NCT02925234|Vemurafenib|vemurafenib|mesh-list
93298537|NCT02925234|Dabrafenib|dabrafenib|mesh-list
93298538|NCT02925234|Crizotinib|crizotinib|mesh-list
93298539|NCT02925234|Talazoparib|talazoparib|mesh-list
93298540|NCT02925234|Rucaparib|rucaparib|mesh-list
93298541|NCT02925234|Entrectinib|entrectinib|mesh-list
93298542|NCT02925234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298543|NCT02925234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298544|NCT02925234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93298545|NCT02925234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93298546|NCT02925234|Growth Substances|growth substances|mesh-ancestor
93298547|NCT02925234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298548|NCT02925234|Growth Inhibitors|growth inhibitors|mesh-ancestor
93298549|NCT02925234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93298550|NCT02925234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298551|NCT02925234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93298552|NCT02925234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298553|NCT02925234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93298554|NCT02137863|Dexmedetomidine|dexmedetomidine|mesh-list
93298555|NCT02137863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93298556|NCT02137863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298557|NCT02137863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298558|NCT02137863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298559|NCT02137863|Analgesics|analgesics|mesh-ancestor
93298560|NCT02137863|Sensory System Agents|sensory system agents|mesh-ancestor
93298561|NCT02137863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298562|NCT02137863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93298563|NCT02137863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93298564|NCT02137863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93298565|NCT02137863|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298566|NCT02137863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298567|NCT02137863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298568|NCT05177796|Paclitaxel|paclitaxel|mesh-list
93298569|NCT05177796|Cyclophosphamide|cyclophosphamide|mesh-list
93298570|NCT05177796|Carboplatin|carboplatin|mesh-list
93298571|NCT05177796|Doxorubicin|doxorubicin|mesh-list
93298572|NCT05177796|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93298573|NCT05177796|Pembrolizumab|pembrolizumab|mesh-list
93298574|NCT05177796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93298575|NCT05177796|Daunorubicin|daunorubicin|mesh-list
93298576|NCT05177796|Panitumumab|panitumumab|mesh-list
93298577|NCT05177796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93298578|NCT05177796|Antibodies|antibodies|mesh-list
93298579|NCT05177796|Immunoglobulins|immunoglobulins|mesh-list
93298580|NCT05177796|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93298581|NCT05177796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93298582|NCT05177796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298583|NCT05177796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92970650|NCT00822744|Escitalopram|escitalopram|mesh-list
93298584|NCT05177796|Antimitotic Agents|antimitotic agents|mesh-ancestor
93298585|NCT05177796|Mitosis Modulators|mitosis modulators|mesh-ancestor
93298586|NCT05177796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298587|NCT05177796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298588|NCT05177796|Immunologic Factors|immunologic factors|mesh-ancestor
93298589|NCT05177796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298590|NCT05177796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298591|NCT05177796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93298592|NCT05177796|Alkylating Agents|alkylating agents|mesh-ancestor
93298593|NCT05177796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93298594|NCT05177796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93298595|NCT05177796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93298596|NCT05177796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93298597|NCT05177796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298598|NCT05177796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93298599|NCT02138019|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93298600|NCT02138019|Hemostatics|hemostatics|mesh-ancestor
93298601|NCT02138019|Coagulants|coagulants|mesh-ancestor
93298602|NCT02133885|Minocycline|minocycline|mesh-list
93298603|NCT02133885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93298604|NCT02133885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298605|NCT02138409|Fentanyl|fentanyl|mesh-list
93298606|NCT02138409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93298607|NCT02138409|Narcotics|narcotics|mesh-ancestor
93298608|NCT02138409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298609|NCT02138409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298610|NCT02138409|Analgesics|analgesics|mesh-ancestor
93298611|NCT02138409|Sensory System Agents|sensory system agents|mesh-ancestor
93298612|NCT02138409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298613|NCT02138409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93298614|NCT02138409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93298615|NCT02138409|Anesthetics, General|anesthetics, general|mesh-ancestor
93298616|NCT02138409|Anesthetics|anesthetics|mesh-ancestor
93298617|NCT02138799|Rifampin|rifampin|mesh-list
93298618|NCT02138799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93298619|NCT02138799|Antitubercular Agents|antitubercular agents|mesh-ancestor
93298620|NCT02138799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93298621|NCT02138799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298622|NCT02138799|Leprostatic Agents|leprostatic agents|mesh-ancestor
93298623|NCT02138799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93298624|NCT02138799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298625|NCT02138799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298626|NCT02138799|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93298627|NCT02138799|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93298628|NCT02138799|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93298629|NCT02138799|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93298630|NCT02138799|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93298631|NCT02138799|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93298632|NCT05578287|Celecoxib|celecoxib|mesh-list
93298633|NCT05578287|Tislelizumab|tislelizumab|mesh-list
93298634|NCT05578287|Disitamab vedotin|disitamab vedotin|mesh-list
93298635|NCT05578287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93298636|NCT05578287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298637|NCT05578287|Analgesics|analgesics|mesh-ancestor
93298638|NCT05578287|Sensory System Agents|sensory system agents|mesh-ancestor
93298639|NCT05578287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298640|NCT05578287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298641|NCT05578287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93298642|NCT05578287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298643|NCT05578287|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93298644|NCT05578287|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93298645|NCT05578287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593186|NCT04708249|Micronutrients|micronutrients|mesh-ancestor
93298646|NCT05578287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298647|NCT05578287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298648|NCT05578287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298649|NCT05578287|Immunoconjugates|immunoconjugates|mesh-ancestor
93298650|NCT05578287|Immunologic Factors|immunologic factors|mesh-ancestor
93298651|NCT02975271|Serlopitant|serlopitant|mesh-list
93298652|NCT02975271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93298653|NCT02975271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298654|NCT02975271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298655|NCT02975271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298656|NCT02741076|Oxymorphone|oxymorphone|mesh-list
93298657|NCT02741076|Morphine|morphine|mesh-list
93298658|NCT02741076|Oxycodone|oxycodone|mesh-list
93298659|NCT02741076|Analgesics, Opioid|analgesics, opioid|mesh-list
93298660|NCT02741076|Narcotics|narcotics|mesh-ancestor
93298661|NCT02741076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298662|NCT02741076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298663|NCT02741076|Analgesics|analgesics|mesh-ancestor
93298664|NCT02741076|Sensory System Agents|sensory system agents|mesh-ancestor
93298665|NCT02741076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298666|NCT02741076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93298667|NCT02973633|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
93298668|NCT02973633|Chelating Agents|chelating agents|mesh-ancestor
93298669|NCT02973633|Sequestering Agents|sequestering agents|mesh-ancestor
93298670|NCT02973633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298672|NCT01666444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93298673|NCT01666444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93298674|NCT01666444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298675|NCT01666444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93298676|NCT01666444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93298677|NCT01666444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298678|NCT01666444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298679|NCT05543122|Fluconazole|fluconazole|mesh-list
93298680|NCT05543122|Methotrexate|methotrexate|mesh-list
93298681|NCT05543122|Atenolol|atenolol|mesh-list
93298682|NCT05543122|Lamotrigine|lamotrigine|mesh-list
93298683|NCT05543122|Lacosamide|lacosamide|mesh-list
93298684|NCT05543122|Levetiracetam|levetiracetam|mesh-list
93298685|NCT05543122|Brivaracetam|brivaracetam|mesh-list
93298686|NCT05543122|Bupropion|bupropion|mesh-list
93298687|NCT05543122|Ezetimibe|ezetimibe|mesh-list
93298688|NCT05543122|Escitalopram|escitalopram|mesh-list
93298689|NCT05543122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93298690|NCT05543122|Abortifacient Agents|abortifacient agents|mesh-ancestor
93298691|NCT05543122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93298692|NCT05543122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298693|NCT05543122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93298694|NCT05543122|Antimetabolites|antimetabolites|mesh-ancestor
93298695|NCT05543122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298696|NCT05543122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298697|NCT05543122|Dermatologic Agents|dermatologic agents|mesh-ancestor
93298698|NCT05543122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298699|NCT05543122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93298700|NCT05543122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298701|NCT05543122|Immunologic Factors|immunologic factors|mesh-ancestor
93298702|NCT05543122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93298703|NCT05543122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93298704|NCT05543122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93298705|NCT05543122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93298706|NCT05543122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298707|NCT05543122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298708|NCT05543122|Serotonin Agents|serotonin agents|mesh-ancestor
93298709|NCT05543122|Autonomic Agents|autonomic agents|mesh-ancestor
93298710|NCT05543122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298711|NCT05543122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93298712|NCT05543122|Antidepressive Agents|antidepressive agents|mesh-ancestor
93298713|NCT05543122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298714|NCT05543122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93298715|NCT05543122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93298716|NCT05543122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93298717|NCT05543122|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93298718|NCT05543122|Dopamine Agents|dopamine agents|mesh-ancestor
93298719|NCT05543122|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93298720|NCT05543122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93298721|NCT05543122|Anticonvulsants|anticonvulsants|mesh-ancestor
93298722|NCT05543122|Nootropic Agents|nootropic agents|mesh-ancestor
93298723|NCT05543122|Antifungal Agents|antifungal agents|mesh-ancestor
93298724|NCT05543122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298725|NCT05543122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93298726|NCT05543122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93298727|NCT05543122|Hormone Antagonists|hormone antagonists|mesh-ancestor
93298728|NCT05543122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298729|NCT05543122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93298730|NCT05543122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93298731|NCT05543122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93298732|NCT05543122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93298733|NCT05543122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93298734|NCT05543122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93298735|NCT05543122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298736|NCT05543122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93298737|NCT05543122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93298738|NCT05543122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93298739|NCT05543122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93298740|NCT05543122|Sympatholytics|sympatholytics|mesh-ancestor
93298741|NCT05543122|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93298742|NCT05543122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93298743|NCT05543122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93298744|NCT05543122|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298745|NCT05120934|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93298746|NCT05120934|Amitriptyline|amitriptyline|mesh-list
93298747|NCT05120934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93298748|NCT05120934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93298749|NCT05120934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298750|NCT05120934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298751|NCT05120934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298752|NCT05120934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298753|NCT05120934|Analgesics|analgesics|mesh-ancestor
93298754|NCT05120934|Sensory System Agents|sensory system agents|mesh-ancestor
93298755|NCT05120934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298756|NCT05120934|Antidepressive Agents|antidepressive agents|mesh-ancestor
93298757|NCT05120934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298758|NCT05120934|Dopamine Agents|dopamine agents|mesh-ancestor
93298759|NCT05120934|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93298760|NCT05120934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298761|NCT05120934|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93298762|NCT05120934|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298763|NCT03548493|Magnesium Sulfate|magnesium sulfate|mesh-list
93298764|NCT03548493|Fentanyl|fentanyl|mesh-list
93298765|NCT03548493|Propofol|propofol|mesh-list
93298766|NCT03548493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93298767|NCT03548493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298768|NCT03548493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298769|NCT03548493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93298770|NCT03548493|Anesthetics, General|anesthetics, general|mesh-ancestor
93298771|NCT03548493|Anesthetics|anesthetics|mesh-ancestor
93298772|NCT03548493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93298773|NCT03548493|Narcotics|narcotics|mesh-ancestor
93298774|NCT03548493|Analgesics|analgesics|mesh-ancestor
93298775|NCT03548493|Sensory System Agents|sensory system agents|mesh-ancestor
93298776|NCT03548493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298777|NCT03548493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93298778|NCT03548493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93298779|NCT03548493|Anticonvulsants|anticonvulsants|mesh-ancestor
93298780|NCT03548493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93298781|NCT03548493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93298782|NCT03548493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298783|NCT03548493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93298784|NCT03548493|Tocolytic Agents|tocolytic agents|mesh-ancestor
93298785|NCT03548493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93298786|NCT02139267|Vaccines|vaccines|mesh-list
93298787|NCT02139267|Immunologic Factors|immunologic factors|mesh-ancestor
93298788|NCT02139267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298789|NCT02139345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93298790|NCT03549819|Cannabidiol|cannabidiol|mesh-list
93298791|NCT03549819|Anticonvulsants|anticonvulsants|mesh-ancestor
93298792|NCT03549741|Cabergoline|cabergoline|mesh-list
93298793|NCT03549741|Clomiphene|clomiphene|mesh-list
93298794|NCT03549741|Enclomiphene|enclomiphene|mesh-list
93298795|NCT03549741|Zuclomiphene|zuclomiphene|mesh-list
93298796|NCT03549741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298797|NCT03549741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93298798|NCT03549741|Hormone Antagonists|hormone antagonists|mesh-ancestor
93298799|NCT03549741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93298800|NCT03549741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298801|NCT03549741|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93298802|NCT03549741|Fertility Agents|fertility agents|mesh-ancestor
93298803|NCT03549741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93298804|NCT03549741|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93298805|NCT03549741|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93298806|NCT03549741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93298807|NCT03549741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93298808|NCT03549741|Dopamine Agonists|dopamine agonists|mesh-ancestor
92970888|NCT01067989|Analgesics|analgesics|mesh-ancestor
93298809|NCT03549741|Dopamine Agents|dopamine agents|mesh-ancestor
93298810|NCT03549741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298811|NCT03522402|Sevoflurane|sevoflurane|mesh-list
93298812|NCT03522402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93298813|NCT03522402|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93298814|NCT03522402|Anesthetics, General|anesthetics, general|mesh-ancestor
93298815|NCT03522402|Anesthetics|anesthetics|mesh-ancestor
93298816|NCT03522402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298817|NCT03522402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298818|NCT02134899|Everolimus|everolimus|mesh-list
93298819|NCT02134899|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93298820|NCT02134899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93298821|NCT02134899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93298822|NCT02134899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298823|NCT02134899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298824|NCT02134899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298825|NCT02134899|Immunologic Factors|immunologic factors|mesh-ancestor
93298826|NCT02134899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298827|NCT02134899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298828|NCT05577819|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
93298829|NCT05577819|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93298830|NCT05577819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298831|NCT02135055|Midazolam|midazolam|mesh-list
93298832|NCT02135055|Morphine|morphine|mesh-list
93298833|NCT02135055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93298834|NCT02135055|Narcotics|narcotics|mesh-ancestor
93298835|NCT02135055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298836|NCT02135055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298837|NCT02135055|Analgesics|analgesics|mesh-ancestor
93298838|NCT02135055|Sensory System Agents|sensory system agents|mesh-ancestor
93298839|NCT02135055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298840|NCT02135055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93298841|NCT02135055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93298842|NCT02135055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93298843|NCT02135055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93298844|NCT02135055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298845|NCT02135055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93298846|NCT02135055|Anesthetics, General|anesthetics, general|mesh-ancestor
93298847|NCT02135055|Anesthetics|anesthetics|mesh-ancestor
93298848|NCT02135055|GABA Modulators|gaba modulators|mesh-ancestor
93298849|NCT02135055|GABA Agents|gaba agents|mesh-ancestor
93298850|NCT02135055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298851|NCT02135055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298852|NCT05546710|Anesthetics|anesthetics|mesh-list
93298853|NCT05546710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298854|NCT05546710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298855|NCT02139579|Bevacizumab|bevacizumab|mesh-list
93298856|NCT02139579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298857|NCT02139579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298858|NCT02139579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93298859|NCT02139579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93298860|NCT02139579|Growth Substances|growth substances|mesh-ancestor
93298861|NCT02139579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298862|NCT02139579|Growth Inhibitors|growth inhibitors|mesh-ancestor
93298863|NCT02139657|Immunoglobulins|immunoglobulins|mesh-list
93298864|NCT02139657|Immunologic Factors|immunologic factors|mesh-ancestor
93298865|NCT02139657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298866|NCT05550064|Contraceptive Agents|contraceptive agents|mesh-list
93298867|NCT05550064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93298868|NCT05550064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298869|NCT04076826|Midazolam|midazolam|mesh-list
93298870|NCT04076826|Dexmedetomidine|dexmedetomidine|mesh-list
93298871|NCT04076826|Propofol|propofol|mesh-list
93298872|NCT04076826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93298873|NCT04076826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298874|NCT04076826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298875|NCT04076826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93298876|NCT04076826|Analgesics|analgesics|mesh-ancestor
93298877|NCT04076826|Sensory System Agents|sensory system agents|mesh-ancestor
93298878|NCT04076826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298879|NCT04076826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93298880|NCT04076826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93298881|NCT04076826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93298882|NCT04076826|Adrenergic Agents|adrenergic agents|mesh-ancestor
93298883|NCT04076826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298884|NCT04076826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298885|NCT04076826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93298886|NCT04076826|Anesthetics, General|anesthetics, general|mesh-ancestor
93298888|NCT04076826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93298889|NCT04076826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93298890|NCT04076826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93298891|NCT04076826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298892|NCT04076826|GABA Modulators|gaba modulators|mesh-ancestor
93298893|NCT04076826|GABA Agents|gaba agents|mesh-ancestor
93298894|NCT05577585|Midazolam|midazolam|mesh-list
93298895|NCT05577585|Ketamine|ketamine|mesh-list
93298896|NCT05577585|Analgesics|analgesics|mesh-ancestor
93298897|NCT05577585|Sensory System Agents|sensory system agents|mesh-ancestor
93298898|NCT05577585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298899|NCT05577585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298900|NCT05577585|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93298901|NCT05577585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93298902|NCT05577585|Anesthetics, General|anesthetics, general|mesh-ancestor
93298903|NCT05577585|Anesthetics|anesthetics|mesh-ancestor
93298904|NCT05577585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93298905|NCT05577585|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93298906|NCT05577585|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93298907|NCT05577585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298908|NCT05577585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298909|NCT05577585|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93298910|NCT05577585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93298911|NCT05577585|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93298912|NCT05577585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93298913|NCT05577585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93298914|NCT05577585|GABA Modulators|gaba modulators|mesh-ancestor
93298915|NCT05577585|GABA Agents|gaba agents|mesh-ancestor
93298916|NCT04465968|Durvalumab|durvalumab|mesh-list
93298917|NCT04465968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93298918|NCT04465968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298919|NCT04465968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93298920|NCT04465968|Immunologic Factors|immunologic factors|mesh-ancestor
93298921|NCT04465968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298922|NCT03526770|Chlorhexidine|chlorhexidine|mesh-list
93298923|NCT03526770|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93298924|NCT03526770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298925|NCT03526770|Disinfectants|disinfectants|mesh-ancestor
93298926|NCT05577507|Calcium Carbonate|calcium carbonate|mesh-list
93298927|NCT05577507|Cholestyramine Resin|cholestyramine resin|mesh-list
93298928|NCT05577507|Calcium|calcium|mesh-list
93298929|NCT05577507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93298930|NCT05577507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298931|NCT05577507|Antacids|antacids|mesh-ancestor
93298932|NCT05577507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298933|NCT05577507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93298934|NCT05577507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93298935|NCT05577507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93298936|NCT05577507|Antimetabolites|antimetabolites|mesh-ancestor
93298937|NCT05577507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93298938|NCT01565655|Peficitinib|peficitinib|mesh-list
93298939|NCT01565655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298940|NCT01565655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298941|NCT01565655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93298942|NCT01565655|Immunologic Factors|immunologic factors|mesh-ancestor
93298943|NCT01565655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298944|NCT05535322|Insulin|insulin|mesh-list
93298945|NCT05535322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93298946|NCT05535322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298947|NCT05577273|Trimethoprim|trimethoprim|mesh-list
93298948|NCT05577273|Sulfamethoxazole|sulfamethoxazole|mesh-list
93298949|NCT05577273|Penicillins|penicillins|mesh-list
93298950|NCT05577273|Cefuroxime|cefuroxime|mesh-list
93298951|NCT05577273|Cefuroxime axetil|cefuroxime axetil|mesh-list
93298952|NCT05577273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93298953|NCT05577273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93298954|NCT05577273|Antimalarials|antimalarials|mesh-ancestor
93298955|NCT05577273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93298956|NCT05577273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93298957|NCT05577273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93298958|NCT05577273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93298959|NCT05577273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298960|NCT05577273|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93298961|NCT05577273|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93298962|NCT05577273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93298963|NCT05577273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93298964|NCT02252913|Docetaxel|docetaxel|mesh-list
93298965|NCT02252913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298966|NCT02252913|Tubulin Modulators|tubulin modulators|mesh-ancestor
93298967|NCT02252913|Antimitotic Agents|antimitotic agents|mesh-ancestor
93298968|NCT02252913|Mitosis Modulators|mitosis modulators|mesh-ancestor
93298969|NCT02252913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298970|NCT02253459|Capecitabine|capecitabine|mesh-list
93298971|NCT02253459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93298972|NCT02253459|Antimetabolites|antimetabolites|mesh-ancestor
93298973|NCT02253459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298974|NCT02253459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93298975|NCT02140047|Vaccines|vaccines|mesh-list
93298976|NCT02140047|Immunologic Factors|immunologic factors|mesh-ancestor
93298977|NCT02140047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298978|NCT02135913|Vitamin D|vitamin d|mesh-list
93298979|NCT02135913|Vitamins|vitamins|mesh-ancestor
93298980|NCT02135913|Micronutrients|micronutrients|mesh-ancestor
93298981|NCT02135913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298982|NCT02135913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93298983|NCT02140125|ASP2408|asp2408|mesh-list
93298984|NCT02140125|Immunoconjugates|immunoconjugates|mesh-ancestor
93298985|NCT02140125|Immunologic Factors|immunologic factors|mesh-ancestor
92318394|NCT03591068|Xhance|xhance|mesh-list
93298986|NCT02140125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298987|NCT05505279|Nicotine|nicotine|mesh-list
93298988|NCT05505279|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93298989|NCT05505279|Autonomic Agents|autonomic agents|mesh-ancestor
93298990|NCT05505279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93298991|NCT05505279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93298992|NCT05505279|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93298993|NCT05505279|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93298994|NCT05505279|Cholinergic Agents|cholinergic agents|mesh-ancestor
93298995|NCT05505279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93298996|NCT05505279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93298997|NCT05541640|Lidocaine|lidocaine|mesh-list
93298998|NCT05541640|Anesthetics, Local|anesthetics, local|mesh-ancestor
93298999|NCT05541640|Anesthetics|anesthetics|mesh-ancestor
93299000|NCT05541640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299001|NCT05541640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299002|NCT05541640|Sensory System Agents|sensory system agents|mesh-ancestor
93299003|NCT05541640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299004|NCT05541640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93299005|NCT05541640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93299006|NCT05541640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93299007|NCT05541640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299008|NCT05541640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299009|NCT02739594|Ibandronic Acid|ibandronic acid|mesh-list
93299010|NCT02739594|Zoledronic Acid|zoledronic acid|mesh-list
93299011|NCT02739594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93299012|NCT02739594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299013|NCT05545618|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93299014|NCT05545618|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93299015|NCT05545618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299016|NCT02140281|Cefadroxil|cefadroxil|mesh-list
93299017|NCT02140281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93299018|NCT02140281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299019|NCT05541328|Tisagenlecleucel|tisagenlecleucel|mesh-list
93299020|NCT05541328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299021|NCT05541328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299022|NCT05545462|Doxycycline|doxycycline|mesh-list
93299023|NCT05545462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93299024|NCT05545462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299025|NCT05545462|Antimalarials|antimalarials|mesh-ancestor
93299026|NCT05545462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93299027|NCT05545462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93299028|NCT05541172|Methyltestosterone|methyltestosterone|mesh-list
93299029|NCT05541172|Testosterone|testosterone|mesh-list
93299030|NCT05541172|Testosterone undecanoate|testosterone undecanoate|mesh-list
93299031|NCT05541172|Testosterone enanthate|testosterone enanthate|mesh-list
93299032|NCT05541172|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93299033|NCT05541172|Androgens|androgens|mesh-ancestor
93299034|NCT05541172|Hormones|hormones|mesh-ancestor
93299035|NCT05541172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299036|NCT05541172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299037|NCT05541172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93299038|NCT05541172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299039|NCT05541172|Anabolic Agents|anabolic agents|mesh-ancestor
93299040|NCT05478993|Dexamethasone|dexamethasone|mesh-list
93299041|NCT05478993|Pomalidomide|pomalidomide|mesh-list
93299042|NCT05478993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299043|NCT05478993|Antiemetics|antiemetics|mesh-ancestor
93299044|NCT05478993|Autonomic Agents|autonomic agents|mesh-ancestor
93299045|NCT05478993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299046|NCT05478993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299047|NCT05478993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93299048|NCT05478993|Glucocorticoids|glucocorticoids|mesh-ancestor
93299049|NCT05478993|Hormones|hormones|mesh-ancestor
93299050|NCT05478993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299051|NCT05478993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93299052|NCT05478993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299053|NCT05478993|Immunologic Factors|immunologic factors|mesh-ancestor
93299054|NCT05478993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93299055|NCT05478993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93299056|NCT05478993|Growth Substances|growth substances|mesh-ancestor
93299057|NCT05478993|Growth Inhibitors|growth inhibitors|mesh-ancestor
93299058|NCT05699356|Estrogens|estrogens|mesh-list
93299059|NCT05699356|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93299060|NCT05699356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299061|NCT05699356|Hormones|hormones|mesh-ancestor
93299062|NCT05699356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299063|NCT05699356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93299064|NCT05699356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299065|NCT05699356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299066|NCT05699356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93299067|NCT05699356|Hormone Antagonists|hormone antagonists|mesh-ancestor
93299068|NCT02140437|Fulvestrant|fulvestrant|mesh-list
93299069|NCT02140437|Anastrozole|anastrozole|mesh-list
93299070|NCT02140437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93299071|NCT02140437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299072|NCT02140437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93299073|NCT02140437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93299074|NCT02140437|Hormone Antagonists|hormone antagonists|mesh-ancestor
93299075|NCT02140437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299076|NCT02140437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299077|NCT02140437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93299078|NCT02140437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93299079|NCT02140437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299080|NCT02140437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299081|NCT05591560|Itraconazole|itraconazole|mesh-list
93299082|NCT05591560|Antifungal Agents|antifungal agents|mesh-ancestor
93299083|NCT05591560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299084|NCT05591560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93299085|NCT05591560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93299086|NCT05591560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299087|NCT05591560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299088|NCT05591560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93299089|NCT05591560|Hormone Antagonists|hormone antagonists|mesh-ancestor
93299090|NCT05591560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299091|NCT05591560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299092|NCT05591560|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93299093|NCT05540470|Chloroquine|chloroquine|mesh-list
93299094|NCT05540470|Primaquine|primaquine|mesh-list
93299095|NCT05540470|Tafenoquine|tafenoquine|mesh-list
93299096|NCT05540470|Amebicides|amebicides|mesh-ancestor
93299097|NCT05540470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93299098|NCT05540470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93299099|NCT05540470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299100|NCT05540470|Antimalarials|antimalarials|mesh-ancestor
93299101|NCT05540470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299102|NCT05575167|Vitamin D|vitamin d|mesh-list
93299103|NCT05575167|Alendronate|alendronate|mesh-list
93299104|NCT05575167|Zoledronic Acid|zoledronic acid|mesh-list
93299105|NCT05575167|Vitamins|vitamins|mesh-ancestor
93299106|NCT05575167|Micronutrients|micronutrients|mesh-ancestor
93299107|NCT05575167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299108|NCT05575167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93299109|NCT02140515|Hormones|hormones|mesh-list
93299110|NCT02140515|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93299111|NCT02140515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299112|NCT02140515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299113|NCT02260947|Ibuprofen|ibuprofen|mesh-list
93299115|NCT02260947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93299116|NCT02260947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93299117|NCT02260947|Analgesics|analgesics|mesh-ancestor
93299118|NCT02260947|Sensory System Agents|sensory system agents|mesh-ancestor
93299119|NCT02260947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299120|NCT02260947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299121|NCT02260947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299122|NCT02260947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299123|NCT02260947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93299124|NCT02260947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299125|NCT02260947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299126|NCT02260947|Anticonvulsants|anticonvulsants|mesh-ancestor
93299127|NCT02260947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93299128|NCT02260947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299129|NCT02260947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93299130|NCT02260947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93299131|NCT02260947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93299132|NCT02260947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299133|NCT02260947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93299134|NCT03547791|Betamethasone|betamethasone|mesh-list
93299135|NCT03547791|Betamethasone Valerate|betamethasone valerate|mesh-list
93299136|NCT03547791|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93299137|NCT03547791|Betamethasone benzoate|betamethasone benzoate|mesh-list
93299138|NCT03547791|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93299139|NCT03547791|Glucocorticoids|glucocorticoids|mesh-ancestor
93299140|NCT03547791|Hormones|hormones|mesh-ancestor
93299141|NCT03547791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299142|NCT03547791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299143|NCT03547791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299144|NCT03547791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299145|NCT03547791|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299146|NCT04818177|Immunoglobulins|immunoglobulins|mesh-list
93299147|NCT04818177|Antibodies|antibodies|mesh-list
93299148|NCT04818177|gamma-Globulins|gamma-globulins|mesh-list
93299149|NCT04818177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93299150|NCT04818177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93299151|NCT04818177|Immunologic Factors|immunologic factors|mesh-ancestor
93299152|NCT04818177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299153|NCT05544292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93299154|NCT04425460|Favipiravir|favipiravir|mesh-list
93299155|NCT04425460|Antiviral Agents|antiviral agents|mesh-ancestor
93299156|NCT04425460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299157|NCT05576272|Gemcitabine|gemcitabine|mesh-list
93299158|NCT05576272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299159|NCT05576272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93299160|NCT05576272|Antimetabolites|antimetabolites|mesh-ancestor
93299161|NCT05576272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299162|NCT05576116|Pancrelipase|pancrelipase|mesh-list
93299163|NCT05576116|Pancreatin|pancreatin|mesh-list
93299164|NCT05576116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93299165|NCT04765137|Atorvastatin|atorvastatin|mesh-list
93299166|NCT04765137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93299167|NCT04765137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93299168|NCT04765137|Antimetabolites|antimetabolites|mesh-ancestor
93299169|NCT04765137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299170|NCT04765137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93299171|NCT04765137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93299172|NCT04765137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299173|NCT05543824|Levobupivacaine|levobupivacaine|mesh-list
93299174|NCT05543824|Anesthetics, Local|anesthetics, local|mesh-ancestor
93299175|NCT05543824|Anesthetics|anesthetics|mesh-ancestor
93299176|NCT05543824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299177|NCT05543824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299178|NCT05543824|Sensory System Agents|sensory system agents|mesh-ancestor
93299179|NCT05543824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299180|NCT04703673|Nasal Decongestants|nasal decongestants|mesh-list
93299181|NCT04703673|Pseudoephedrine|pseudoephedrine|mesh-list
93299182|NCT04703673|Ephedrine|ephedrine|mesh-list
93299183|NCT04703673|Sympathomimetics|sympathomimetics|mesh-list
93299184|NCT04703673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93299185|NCT04703673|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299186|NCT04703673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93299187|NCT04703673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299188|NCT04703673|Autonomic Agents|autonomic agents|mesh-ancestor
93299189|NCT04703673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299190|NCT04703673|Adrenergic Agents|adrenergic agents|mesh-ancestor
93299191|NCT04703673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299192|NCT04703673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299193|NCT04703673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93299194|NCT04703673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299195|NCT05543746|Brexanolone|brexanolone|mesh-list
93299196|NCT05543746|Neurosteroids|neurosteroids|mesh-ancestor
93299197|NCT05543746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299198|NCT05543746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299199|NCT05543746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299200|NCT05543746|GABA Modulators|gaba modulators|mesh-ancestor
93299201|NCT05543746|GABA Agents|gaba agents|mesh-ancestor
93299202|NCT03526536|Insulin|insulin|mesh-list
93299203|NCT03526536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93299204|NCT03526536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93299205|NCT03526536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299206|NCT05306301|Ponatinib|ponatinib|mesh-list
93299207|NCT05306301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299208|NCT05306301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299209|NCT05306301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299210|NCT05306301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299211|NCT05543434|Hyaluronic Acid|hyaluronic acid|mesh-list
93299212|NCT05543434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93299213|NCT05543434|Immunologic Factors|immunologic factors|mesh-ancestor
93299214|NCT05543434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299215|NCT05543434|Viscosupplements|viscosupplements|mesh-ancestor
93299216|NCT05543434|Protective Agents|protective agents|mesh-ancestor
93299217|NCT01858896|Glucagon|glucagon|mesh-list
93299218|NCT01858896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93299219|NCT01858896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93299220|NCT01858896|Hormones|hormones|mesh-ancestor
93299221|NCT01858896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299222|NCT01858896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299223|NCT01858896|Incretins|incretins|mesh-ancestor
93299224|NCT04940286|Paclitaxel|paclitaxel|mesh-list
93299225|NCT04940286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93299226|NCT04940286|Gemcitabine|gemcitabine|mesh-list
93299227|NCT04940286|Durvalumab|durvalumab|mesh-list
93299228|NCT04940286|Immunoglobulins|immunoglobulins|mesh-list
93299229|NCT04940286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93299230|NCT04940286|Immunoglobulin G|immunoglobulin g|mesh-list
93299231|NCT04940286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93299232|NCT04940286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299233|NCT04940286|Tubulin Modulators|tubulin modulators|mesh-ancestor
93299234|NCT04940286|Antimitotic Agents|antimitotic agents|mesh-ancestor
93299235|NCT04940286|Mitosis Modulators|mitosis modulators|mesh-ancestor
93299236|NCT04940286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299237|NCT04940286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93299238|NCT04940286|Antimetabolites|antimetabolites|mesh-ancestor
93299239|NCT04940286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299240|NCT04940286|Immunologic Factors|immunologic factors|mesh-ancestor
93299241|NCT04940286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299242|NCT05538988|Cemiplimab|cemiplimab|mesh-list
93299243|NCT05538988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299244|NCT05538988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299245|NCT04667637|Edaravone|edaravone|mesh-list
93299246|NCT04667637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93299247|NCT04667637|Antioxidants|antioxidants|mesh-ancestor
93299248|NCT04667637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299249|NCT04667637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93299250|NCT04667637|Protective Agents|protective agents|mesh-ancestor
93299251|NCT04667637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299252|NCT02253927|Ritonavir|ritonavir|mesh-list
93299253|NCT02253927|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93299254|NCT02253927|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93299255|NCT02253927|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299256|NCT02253927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299257|NCT02253927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299258|NCT02253927|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93299259|NCT02253927|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93299260|NCT02253927|Antiviral Agents|antiviral agents|mesh-ancestor
92971321|NCT00821262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93299261|NCT02253927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299262|NCT02253927|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93299263|NCT02253927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93299264|NCT03745144|Cladribine|cladribine|mesh-list
93299265|NCT03745144|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93299266|NCT03745144|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93299267|NCT03745144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299268|NCT03745144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299269|NCT03745144|Immunologic Factors|immunologic factors|mesh-ancestor
93299270|NCT03745144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299271|NCT03745144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93299272|NCT03745144|Contraceptive Agents|contraceptive agents|mesh-ancestor
93299273|NCT03745144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93299274|NCT03745144|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93299275|NCT03745144|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93299276|NCT03745144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93299277|NCT03745144|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93299278|NCT03745144|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93299279|NCT03745144|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93299280|NCT03745144|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93299281|NCT03745144|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93299282|NCT05697016|Sivelestat|sivelestat|mesh-list
93299283|NCT05697016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93299284|NCT05697016|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299285|NCT05697016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299286|NCT05697016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299287|NCT04634877|Paclitaxel|paclitaxel|mesh-list
93299288|NCT04634877|Docetaxel|docetaxel|mesh-list
93299289|NCT04634877|Cisplatin|cisplatin|mesh-list
93299290|NCT04634877|Carboplatin|carboplatin|mesh-list
93299291|NCT04634877|Pembrolizumab|pembrolizumab|mesh-list
93299292|NCT04634877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93299293|NCT04634877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299294|NCT04634877|Tubulin Modulators|tubulin modulators|mesh-ancestor
93299295|NCT04634877|Antimitotic Agents|antimitotic agents|mesh-ancestor
93299296|NCT04634877|Mitosis Modulators|mitosis modulators|mesh-ancestor
93299297|NCT04634877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299298|NCT04634877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299299|NCT04634877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93299300|NCT04629495|Sirolimus|sirolimus|mesh-list
93299301|NCT04629495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93299302|NCT04629495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299303|NCT04629495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93299304|NCT04629495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299305|NCT04629495|Antifungal Agents|antifungal agents|mesh-ancestor
93299306|NCT04629495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299307|NCT04629495|Immunologic Factors|immunologic factors|mesh-ancestor
93299308|NCT04629495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299309|NCT01567995|Clobetasone butyrate|clobetasone butyrate|mesh-list
93299310|NCT01567995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299311|NCT01567995|Glucocorticoids|glucocorticoids|mesh-ancestor
93299312|NCT01567995|Hormones|hormones|mesh-ancestor
93299313|NCT01567995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299314|NCT01567995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299315|NCT05567523|Midazolam|midazolam|mesh-list
93299316|NCT05567523|Dexmedetomidine|dexmedetomidine|mesh-list
93299317|NCT05567523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93299318|NCT05567523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299319|NCT05567523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299320|NCT05567523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93299321|NCT05567523|Analgesics|analgesics|mesh-ancestor
93299322|NCT05567523|Sensory System Agents|sensory system agents|mesh-ancestor
93299323|NCT05567523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299324|NCT05567523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93299325|NCT05567523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93299326|NCT05567523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93299327|NCT05567523|Adrenergic Agents|adrenergic agents|mesh-ancestor
93299328|NCT05567523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299329|NCT05567523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299330|NCT05567523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93299331|NCT05567523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93299332|NCT05567523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93299333|NCT05567523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93299334|NCT05567523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93299335|NCT05567523|Anesthetics, General|anesthetics, general|mesh-ancestor
93299336|NCT05567523|Anesthetics|anesthetics|mesh-ancestor
93299337|NCT05567523|GABA Modulators|gaba modulators|mesh-ancestor
93299338|NCT05567523|GABA Agents|gaba agents|mesh-ancestor
93299339|NCT02584504|Atorvastatin|atorvastatin|mesh-list
93299340|NCT02584504|Alirocumab|alirocumab|mesh-list
93299341|NCT02584504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93299342|NCT02584504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93299343|NCT02584504|Antimetabolites|antimetabolites|mesh-ancestor
93299344|NCT02584504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299345|NCT02584504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93299346|NCT02584504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93299347|NCT02584504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299348|NCT02584504|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93299349|NCT02584504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93299350|NCT02584504|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299351|NCT04599777|Sorafenib|sorafenib|mesh-list
93299352|NCT04599777|Tislelizumab|tislelizumab|mesh-list
93299353|NCT04599777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299354|NCT04599777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299355|NCT04599777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299356|NCT04599777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299357|NCT04599777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299358|NCT05180799|Nivolumab|nivolumab|mesh-list
93299359|NCT05180799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299360|NCT05180799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299361|NCT05180799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93299362|NCT05180799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299363|NCT05044468|Lidocaine|lidocaine|mesh-list
93299364|NCT05044468|Bupivacaine|bupivacaine|mesh-list
93299365|NCT05044468|Anesthetics, Local|anesthetics, local|mesh-ancestor
93299366|NCT05044468|Anesthetics|anesthetics|mesh-ancestor
93299367|NCT05044468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299368|NCT05044468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299369|NCT05044468|Sensory System Agents|sensory system agents|mesh-ancestor
93299370|NCT05044468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299371|NCT05044468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93299372|NCT05044468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93299373|NCT05044468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93299374|NCT05044468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299375|NCT05044468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299376|NCT05176509|Pembrolizumab|pembrolizumab|mesh-list
93299377|NCT05176509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299378|NCT05176509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299379|NCT05176509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93299380|NCT05176509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299381|NCT05007262|Calcium Dobesilate|calcium dobesilate|mesh-list
93299382|NCT05007262|Calcium|calcium|mesh-list
93299383|NCT05007262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93299384|NCT05007262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299385|NCT05007262|Hemostatics|hemostatics|mesh-ancestor
93299386|NCT05007262|Coagulants|coagulants|mesh-ancestor
93299387|NCT03546075|Resveratrol|resveratrol|mesh-list
93299388|NCT03546075|Antioxidants|antioxidants|mesh-ancestor
93299389|NCT03546075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299390|NCT03546075|Protective Agents|protective agents|mesh-ancestor
93299391|NCT03546075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299392|NCT03546075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299393|NCT03546075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93299394|NCT05537584|Bupropion|bupropion|mesh-list
93299395|NCT05537584|Sertraline|sertraline|mesh-list
93299396|NCT05537584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93299397|NCT05537584|Antidepressive Agents|antidepressive agents|mesh-ancestor
93299398|NCT05537584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93299399|NCT05537584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93299400|NCT05537584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93299401|NCT05537584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299402|NCT05537584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299403|NCT05537584|Dopamine Agents|dopamine agents|mesh-ancestor
93299404|NCT05537584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299405|NCT05537584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299406|NCT05537584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93299407|NCT05537584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93299408|NCT05537584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299409|NCT05537584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93299410|NCT05537584|Serotonin Agents|serotonin agents|mesh-ancestor
93299412|NCT01801072|Anticonvulsants|anticonvulsants|mesh-ancestor
93299413|NCT01801072|Nootropic Agents|nootropic agents|mesh-ancestor
93299414|NCT04459377|Ketamine|ketamine|mesh-list
93299415|NCT04459377|Esketamine|esketamine|mesh-list
93299416|NCT04459377|Analgesics|analgesics|mesh-ancestor
93299417|NCT04459377|Sensory System Agents|sensory system agents|mesh-ancestor
93299418|NCT04459377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299419|NCT04459377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299420|NCT04459377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93299421|NCT04459377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93299422|NCT04459377|Anesthetics, General|anesthetics, general|mesh-ancestor
93299423|NCT04459377|Anesthetics|anesthetics|mesh-ancestor
93299424|NCT04459377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299425|NCT04459377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93299426|NCT04459377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93299427|NCT04459377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299428|NCT04459377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299429|NCT04459377|Antidepressive Agents|antidepressive agents|mesh-ancestor
93299430|NCT04459377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93299431|NCT00748618|Vitamin D|vitamin d|mesh-list
93299432|NCT00748618|Ergocalciferols|ergocalciferols|mesh-list
93299433|NCT00748618|Cholecalciferol|cholecalciferol|mesh-list
93299434|NCT00748618|Vitamins|vitamins|mesh-list
93299435|NCT00748618|Micronutrients|micronutrients|mesh-ancestor
93299436|NCT00748618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299437|NCT00748618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93299438|NCT00748618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93299439|NCT04447755|Lenvatinib|lenvatinib|mesh-list
93299440|NCT04447755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299441|NCT04447755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299442|NCT04447755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299443|NCT04447755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299444|NCT02254005|Maytansine|maytansine|mesh-list
93299445|NCT02254005|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
93299446|NCT02254005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93299447|NCT02254005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299448|NCT02254005|Tubulin Modulators|tubulin modulators|mesh-ancestor
93299449|NCT02254005|Antimitotic Agents|antimitotic agents|mesh-ancestor
93299450|NCT02254005|Mitosis Modulators|mitosis modulators|mesh-ancestor
93299451|NCT02254005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299452|NCT02254005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299453|NCT02254005|Immunotoxins|immunotoxins|mesh-ancestor
93299454|NCT02254005|Immunoconjugates|immunoconjugates|mesh-ancestor
93299455|NCT02254005|Immunologic Factors|immunologic factors|mesh-ancestor
93299456|NCT02254005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299457|NCT04404387|Ascorbic Acid|ascorbic acid|mesh-list
93299458|NCT04404387|Vitamins|vitamins|mesh-ancestor
93299459|NCT04404387|Micronutrients|micronutrients|mesh-ancestor
93299460|NCT04404387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299461|NCT04404387|Antioxidants|antioxidants|mesh-ancestor
93299462|NCT04404387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299463|NCT04404387|Protective Agents|protective agents|mesh-ancestor
93299464|NCT03546855|Apatinib|apatinib|mesh-list
93299465|NCT03546855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299466|NCT03546855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299467|NCT03546855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299468|NCT03546855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299469|NCT05679310|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
93299470|NCT05679310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299471|NCT05679310|Antioxidants|antioxidants|mesh-ancestor
93299472|NCT05679310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299473|NCT05679310|Protective Agents|protective agents|mesh-ancestor
93299474|NCT05679310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299475|NCT05679310|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93299476|NCT05537272|Ascorbic Acid|ascorbic acid|mesh-list
93299477|NCT05537272|Tadalafil|tadalafil|mesh-list
93299478|NCT05537272|Tamsulosin|tamsulosin|mesh-list
93299479|NCT05537272|Vitamins|vitamins|mesh-ancestor
93299480|NCT05537272|Micronutrients|micronutrients|mesh-ancestor
93299481|NCT05537272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299482|NCT05537272|Antioxidants|antioxidants|mesh-ancestor
93299483|NCT05537272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299484|NCT05537272|Protective Agents|protective agents|mesh-ancestor
93299485|NCT05537272|Vasodilator Agents|vasodilator agents|mesh-ancestor
93299486|NCT05537272|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93299487|NCT05537272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93299488|NCT05537272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299489|NCT05537272|Urological Agents|urological agents|mesh-ancestor
93299490|NCT05537272|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93299491|NCT05537272|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93299492|NCT05537272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93299493|NCT05537272|Adrenergic Agents|adrenergic agents|mesh-ancestor
93299494|NCT05537272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299495|NCT05537194|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
93299496|NCT05537194|Calcium|calcium|mesh-list
93299497|NCT05537194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93299498|NCT05537194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299499|NCT05537194|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93299500|NCT05537194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299501|NCT05537194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299502|NCT05536882|Adapalene|adapalene|mesh-list
93299503|NCT05536882|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93299504|NCT05536882|Dermatologic Agents|dermatologic agents|mesh-ancestor
93299505|NCT05536882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93299506|NCT05536882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93299507|NCT05536882|Analgesics|analgesics|mesh-ancestor
93299508|NCT05536882|Sensory System Agents|sensory system agents|mesh-ancestor
93299509|NCT05536882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299510|NCT05536882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299511|NCT05536882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299512|NCT05536882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299513|NCT04605094|Benralizumab|benralizumab|mesh-list
93299514|NCT04605094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299515|NCT04605094|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299516|NCT03931161|Evolocumab|evolocumab|mesh-list
93299517|NCT03931161|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93299518|NCT03931161|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93299519|NCT03931161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93299520|NCT03931161|Antimetabolites|antimetabolites|mesh-ancestor
93299521|NCT03931161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299522|NCT03931161|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93299523|NCT03931161|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299524|NCT03931161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299525|NCT03931161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93299526|NCT05037123|Ketamine|ketamine|mesh-list
93299527|NCT05037123|Analgesics|analgesics|mesh-ancestor
93299528|NCT05037123|Sensory System Agents|sensory system agents|mesh-ancestor
93299529|NCT05037123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299530|NCT05037123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299531|NCT05037123|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93299532|NCT05037123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93299533|NCT05037123|Anesthetics, General|anesthetics, general|mesh-ancestor
93299534|NCT05037123|Anesthetics|anesthetics|mesh-ancestor
93299535|NCT05037123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299536|NCT05037123|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93299537|NCT05037123|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93299538|NCT05037123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299539|NCT05037123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299540|NCT04354155|Enoxaparin|enoxaparin|mesh-list
93299541|NCT04354155|Anticoagulants|anticoagulants|mesh-ancestor
93299542|NCT04354155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93299543|NCT04354155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93299544|NCT04354155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299545|NCT04450654|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93299546|NCT04450654|Immunologic Factors|immunologic factors|mesh-ancestor
93299547|NCT04450654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299548|NCT04350021|Cyclophosphamide|cyclophosphamide|mesh-list
93299549|NCT04350021|Capecitabine|capecitabine|mesh-list
93299550|NCT04350021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299551|NCT04350021|Immunologic Factors|immunologic factors|mesh-ancestor
93299552|NCT04350021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299553|NCT04350021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299554|NCT04350021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93299555|NCT04350021|Alkylating Agents|alkylating agents|mesh-ancestor
93299556|NCT04350021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299557|NCT04350021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299558|NCT04350021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93299559|NCT04350021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93299560|NCT04350021|Antimetabolites|antimetabolites|mesh-ancestor
93299561|NCT05536570|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93299562|NCT05536570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93299563|NCT05536570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299564|NCT05536570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299565|NCT05536570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93299566|NCT05536570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299567|NCT05536570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299568|NCT05536570|Cholinergic Agents|cholinergic agents|mesh-ancestor
93299569|NCT05536570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299570|NCT03877965|Digoxin|digoxin|mesh-list
93299571|NCT03877965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93299572|NCT03877965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93299573|NCT03877965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299574|NCT03877965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299575|NCT03877965|Protective Agents|protective agents|mesh-ancestor
93299576|NCT03877965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299577|NCT02253849|Ritonavir|ritonavir|mesh-list
93299578|NCT02253849|Tipranavir|tipranavir|mesh-list
93299579|NCT02253849|Carbamazepine|carbamazepine|mesh-list
93299580|NCT02253849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93299581|NCT02253849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93299582|NCT02253849|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299583|NCT02253849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299584|NCT02253849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299585|NCT02253849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93299586|NCT02253849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93299587|NCT02253849|Antiviral Agents|antiviral agents|mesh-ancestor
93299588|NCT02253849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299589|NCT02253849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93299590|NCT02253849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93299591|NCT02253849|Anticonvulsants|anticonvulsants|mesh-ancestor
93299592|NCT02253849|Antimanic Agents|antimanic agents|mesh-ancestor
93299593|NCT02253849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93299594|NCT02253849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299595|NCT02253849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299596|NCT02253849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93299597|NCT02253849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93299598|NCT02253849|Analgesics|analgesics|mesh-ancestor
93299599|NCT02253849|Sensory System Agents|sensory system agents|mesh-ancestor
93299600|NCT02253849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299601|NCT02253849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93299602|NCT02253849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299603|NCT02253849|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93299604|NCT02253849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93299605|NCT03545997|Montelukast|montelukast|mesh-list
93299606|NCT03545997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299607|NCT03545997|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299608|NCT03545997|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93299609|NCT03545997|Hormone Antagonists|hormone antagonists|mesh-ancestor
93299610|NCT03545997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299611|NCT03545997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299612|NCT03545997|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93299613|NCT03545997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93299614|NCT03545997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299615|NCT05696548|Nivolumab|nivolumab|mesh-list
93299616|NCT05696548|Lenvatinib|lenvatinib|mesh-list
93299617|NCT05696548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299618|NCT05696548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299619|NCT05696548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93299620|NCT05696548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299621|NCT05696548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299622|NCT05696548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299623|NCT03810495|Naltrexone|naltrexone|mesh-list
93299624|NCT03810495|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93299625|NCT03810495|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93299626|NCT03810495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299627|NCT03810495|Sensory System Agents|sensory system agents|mesh-ancestor
93299628|NCT03810495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299629|NCT04980885|Azacitidine|azacitidine|mesh-list
93299630|NCT04980885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93299631|NCT04980885|Antimetabolites|antimetabolites|mesh-ancestor
93299632|NCT04980885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299633|NCT04980885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299634|NCT04980885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299635|NCT04184505|Azacitidine|azacitidine|mesh-list
93299636|NCT04184505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93299637|NCT04184505|Antimetabolites|antimetabolites|mesh-ancestor
93299638|NCT04184505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299639|NCT04184505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299640|NCT04184505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299641|NCT03691935|Ropivacaine|ropivacaine|mesh-list
93299642|NCT03691935|Anesthetics|anesthetics|mesh-list
93299643|NCT03691935|Anesthetics, Local|anesthetics, local|mesh-ancestor
93299644|NCT03691935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299645|NCT03691935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299646|NCT03691935|Sensory System Agents|sensory system agents|mesh-ancestor
93299647|NCT03691935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299648|NCT03760458|Lamivudine|lamivudine|mesh-list
93299649|NCT03760458|Abacavir|abacavir|mesh-list
93299650|NCT03760458|Dideoxynucleosides|dideoxynucleosides|mesh-list
93299651|NCT03760458|Dolutegravir|dolutegravir|mesh-list
93299652|NCT03760458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93299653|NCT03760458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93299654|NCT03760458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299655|NCT03760458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299656|NCT03760458|Antiviral Agents|antiviral agents|mesh-ancestor
93299657|NCT03760458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299658|NCT03760458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93299659|NCT03760458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93299660|NCT03760458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93299661|NCT03760458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93299662|NCT03760458|Antimetabolites|antimetabolites|mesh-ancestor
93299663|NCT02066415|Erenumab|erenumab|mesh-list
93299664|NCT02066415|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93299665|NCT02066415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299666|NCT02066415|Analgesics|analgesics|mesh-ancestor
93299667|NCT02066415|Sensory System Agents|sensory system agents|mesh-ancestor
93299668|NCT02066415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299669|NCT02066415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299670|NCT04467918|Cannabidiol|cannabidiol|mesh-list
93299671|NCT04467918|Anticonvulsants|anticonvulsants|mesh-ancestor
93299672|NCT04720612|Omalizumab|omalizumab|mesh-list
93299673|NCT04720612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93299674|NCT04720612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299675|NCT04720612|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299676|NCT01981551|Nirogacestat|nirogacestat|mesh-list
93299677|NCT01981551|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93299678|NCT01981551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299679|NCT01981551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299680|NCT02584660|Rivaroxaban|rivaroxaban|mesh-list
93299681|NCT02584660|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93299682|NCT02584660|Antithrombins|antithrombins|mesh-ancestor
93299683|NCT02584660|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93299684|NCT02584660|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299685|NCT02584660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299686|NCT02584660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299687|NCT02584660|Anticoagulants|anticoagulants|mesh-ancestor
93299688|NCT04862286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93299689|NCT04862286|Immunologic Factors|immunologic factors|mesh-ancestor
93299690|NCT04862286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299691|NCT02143323|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93299692|NCT02143323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93299693|NCT02143323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299694|NCT02143323|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93299695|NCT02143323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299696|NCT02143323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299697|NCT04315558|Bromides|bromides|mesh-list
93299698|NCT04315558|Ipratropium|ipratropium|mesh-list
93299699|NCT04315558|Anticonvulsants|anticonvulsants|mesh-ancestor
93299700|NCT04315558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93299701|NCT04315558|Autonomic Agents|autonomic agents|mesh-ancestor
93299702|NCT04315558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299703|NCT04315558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299704|NCT04315558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299705|NCT04315558|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299706|NCT04315558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93299707|NCT04315558|Cholinergic Agents|cholinergic agents|mesh-ancestor
93299708|NCT04315558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299709|NCT04315558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299711|NCT04466904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93299712|NCT04466904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299713|NCT03524274|Antibodies|antibodies|mesh-list
93299714|NCT03524274|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93299715|NCT03524274|Immunologic Factors|immunologic factors|mesh-ancestor
93299716|NCT03524274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299717|NCT02143479|Tacrolimus|tacrolimus|mesh-list
93299718|NCT02143479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299719|NCT02143479|Immunologic Factors|immunologic factors|mesh-ancestor
93299720|NCT02143479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299721|NCT02143479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93299722|NCT02143479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299723|NCT02143479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299724|NCT02254239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93299725|NCT02254239|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93299726|NCT02254239|Everolimus|everolimus|mesh-list
93299727|NCT02254239|Antibodies|antibodies|mesh-list
93299728|NCT02254239|Immunoglobulins|immunoglobulins|mesh-list
93299729|NCT02254239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93299730|NCT02254239|Immunoconjugates|immunoconjugates|mesh-list
93299731|NCT02254239|Immunologic Factors|immunologic factors|mesh-ancestor
93299732|NCT02254239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299733|NCT02254239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299734|NCT02254239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93299735|NCT02254239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299736|NCT02254239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299737|NCT02254239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299738|NCT02254239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299739|NCT02254239|Immunotoxins|immunotoxins|mesh-ancestor
93299740|NCT05088369|Adrenomedullin|adrenomedullin|mesh-list
93299741|NCT05088369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93299742|NCT05088369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93299743|NCT05088369|Autonomic Agents|autonomic agents|mesh-ancestor
93299744|NCT05088369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299745|NCT05088369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299746|NCT05088369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299747|NCT05088369|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299748|NCT05088369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93299749|NCT05088369|Vasodilator Agents|vasodilator agents|mesh-ancestor
93299750|NCT05088369|Protective Agents|protective agents|mesh-ancestor
93299751|NCT05681182|Amiodarone|amiodarone|mesh-list
93299752|NCT05681182|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93299753|NCT05681182|Vasodilator Agents|vasodilator agents|mesh-ancestor
93299754|NCT05681182|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93299755|NCT05681182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93299756|NCT05681182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299757|NCT05681182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93299758|NCT05681182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93299759|NCT05681182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93299760|NCT05681182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299761|NCT05681182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93299762|NCT05681182|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93299763|NCT05681182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93299764|NCT03521700|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93299765|NCT03521700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93299766|NCT03521700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93299767|NCT03521700|Antimetabolites|antimetabolites|mesh-ancestor
93299768|NCT03521700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299769|NCT03521700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93299770|NCT03521700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93299771|NCT03521700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299772|NCT02144025|Cyclosporine|cyclosporine|mesh-list
93299773|NCT02144025|Cyclosporins|cyclosporins|mesh-list
93299774|NCT02144025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299775|NCT02144025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299776|NCT02144025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299777|NCT02144025|Immunologic Factors|immunologic factors|mesh-ancestor
93299778|NCT02144025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299779|NCT02144025|Antifungal Agents|antifungal agents|mesh-ancestor
93299780|NCT02144025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299781|NCT02144025|Dermatologic Agents|dermatologic agents|mesh-ancestor
92971844|NCT02599337|Sorafenib|sorafenib|mesh-list
93299782|NCT02144025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299783|NCT02144025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93299784|NCT03523650|Propranolol|propranolol|mesh-list
93299785|NCT03523650|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93299786|NCT03523650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93299787|NCT03523650|Adrenergic Agents|adrenergic agents|mesh-ancestor
93299788|NCT03523650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93299789|NCT03523650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299790|NCT03523650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299791|NCT03523650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93299792|NCT03523650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93299793|NCT03523650|Vasodilator Agents|vasodilator agents|mesh-ancestor
93299794|NCT01025505|Imatinib Mesylate|imatinib mesylate|mesh-list
93299795|NCT01025505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299796|NCT01025505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299797|NCT01025505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299798|NCT01025505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299800|NCT02582632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93299801|NCT02582632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93299802|NCT02582632|Protease Inhibitors|protease inhibitors|mesh-ancestor
93299803|NCT02582632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299804|NCT02582632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299805|NCT02582632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93299806|NCT02582632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93299807|NCT02582632|Antiviral Agents|antiviral agents|mesh-ancestor
93299808|NCT02582632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299809|NCT02582632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93299810|NCT02582632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93299811|NCT03656562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93299812|NCT03656562|Immunologic Factors|immunologic factors|mesh-ancestor
93299813|NCT03656562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299814|NCT05381974|Psilocybin|psilocybin|mesh-list
93299815|NCT05381974|Hallucinogens|hallucinogens|mesh-ancestor
93299816|NCT05381974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299817|NCT05381974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93299818|NCT02178722|Pembrolizumab|pembrolizumab|mesh-list
93299819|NCT02178722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299820|NCT02178722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299821|NCT02178722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93299822|NCT02178722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299823|NCT03523572|Nivolumab|nivolumab|mesh-list
93299824|NCT03523572|Trastuzumab|trastuzumab|mesh-list
93299825|NCT03523572|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93299826|NCT03523572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299827|NCT03523572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299828|NCT03523572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93299829|NCT03523572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299830|NCT03523572|Immunoconjugates|immunoconjugates|mesh-ancestor
93299831|NCT03523572|Immunologic Factors|immunologic factors|mesh-ancestor
93299832|NCT03523572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299833|NCT00972309|Vaccines|vaccines|mesh-list
93299834|NCT00972309|Immunologic Factors|immunologic factors|mesh-ancestor
93299835|NCT00972309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299836|NCT03526224|Teriflunomide|teriflunomide|mesh-list
93299837|NCT03526224|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93299838|NCT03526224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93299839|NCT03526224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299840|NCT03526224|Immunologic Factors|immunologic factors|mesh-ancestor
93299841|NCT03526224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299842|NCT03526224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93299843|NCT03526224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93299844|NCT03526224|Analgesics|analgesics|mesh-ancestor
93299845|NCT03526224|Sensory System Agents|sensory system agents|mesh-ancestor
93299846|NCT03526224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299847|NCT03526224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299848|NCT03526224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299849|NCT03639246|Paclitaxel|paclitaxel|mesh-list
93299850|NCT03639246|Doxorubicin|doxorubicin|mesh-list
93299851|NCT03639246|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93299852|NCT03639246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93299853|NCT03639246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299854|NCT03639246|Tubulin Modulators|tubulin modulators|mesh-ancestor
93299855|NCT03639246|Antimitotic Agents|antimitotic agents|mesh-ancestor
93299856|NCT03639246|Mitosis Modulators|mitosis modulators|mesh-ancestor
93299857|NCT03639246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299858|NCT03639246|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93299859|NCT03639246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93299860|NCT03639246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93299861|NCT03639246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299862|NCT00545324|Fluticasone|fluticasone|mesh-list
93299863|NCT00545324|Montelukast|montelukast|mesh-list
93299864|NCT00545324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93299865|NCT00545324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93299866|NCT00545324|Autonomic Agents|autonomic agents|mesh-ancestor
93299867|NCT00545324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299868|NCT00545324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299869|NCT00545324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93299870|NCT00545324|Respiratory System Agents|respiratory system agents|mesh-ancestor
93299871|NCT00545324|Dermatologic Agents|dermatologic agents|mesh-ancestor
93299872|NCT00545324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93299873|NCT00545324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299874|NCT00545324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93299875|NCT00545324|Hormone Antagonists|hormone antagonists|mesh-ancestor
93299876|NCT00545324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93299877|NCT00545324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93299878|NCT00545324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93299879|NCT02582242|Insulin Aspart|insulin aspart|mesh-list
93299880|NCT02582242|Biphasic Insulins|biphasic insulins|mesh-list
93299881|NCT02582242|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93299882|NCT02582242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93299883|NCT02582242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299884|NCT05004038|BCG Vaccine|bcg vaccine|mesh-list
93299885|NCT05004038|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93299886|NCT05004038|Immunologic Factors|immunologic factors|mesh-ancestor
93299887|NCT05004038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299888|NCT04217356|Hydroxyurea|hydroxyurea|mesh-list
93299889|NCT04217356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299890|NCT04217356|Antisickling Agents|antisickling agents|mesh-ancestor
93299891|NCT04217356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299892|NCT04217356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299893|NCT04217356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93299894|NCT03609840|Thiotepa|thiotepa|mesh-list
93299895|NCT03609840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-list
93299896|NCT03609840|Antineoplastic Agents|antineoplastic agents|mesh-list
93299897|NCT03609840|Alkylating Agents|alkylating agents|mesh-ancestor
93299898|NCT03609840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299899|NCT03609840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93299900|NCT03609840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93299901|NCT03609840|Immunologic Factors|immunologic factors|mesh-ancestor
93299902|NCT03609840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299903|NCT03389126|Avelumab|avelumab|mesh-list
93299904|NCT03389126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93299905|NCT03389126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299906|NCT04212364|Naloxone|naloxone|mesh-list
93299907|NCT04212364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93299908|NCT04212364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299909|NCT04212364|Sensory System Agents|sensory system agents|mesh-ancestor
93299910|NCT04212364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299911|NCT04446104|Hydroxychloroquine|hydroxychloroquine|mesh-list
93299912|NCT04446104|Ivermectin|ivermectin|mesh-list
93299913|NCT04446104|Povidone-Iodine|povidone-iodine|mesh-list
93299914|NCT04446104|Povidone|povidone|mesh-list
93299915|NCT04446104|Antimalarials|antimalarials|mesh-ancestor
93299916|NCT04446104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93299917|NCT04446104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93299918|NCT04446104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299919|NCT04446104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299920|NCT04446104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299921|NCT04446104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93299922|NCT04446104|Plasma Substitutes|plasma substitutes|mesh-ancestor
93299923|NCT04446104|Blood Substitutes|blood substitutes|mesh-ancestor
93299924|NCT04446104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93299925|NCT03388970|Vitamin K|vitamin k|mesh-list
93299926|NCT03388970|Vitamin K 1|vitamin k 1|mesh-list
93299927|NCT03388970|Vitamins|vitamins|mesh-ancestor
93299928|NCT03388970|Micronutrients|micronutrients|mesh-ancestor
93299929|NCT03388970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299930|NCT03388970|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93299931|NCT03388970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93299932|NCT03388970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299933|NCT03388970|Hemostatics|hemostatics|mesh-ancestor
93299934|NCT03388970|Coagulants|coagulants|mesh-ancestor
93299935|NCT00616941|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93299936|NCT00616941|Poly ICLC|poly iclc|mesh-list
93299937|NCT00616941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93299938|NCT00616941|Immunologic Factors|immunologic factors|mesh-ancestor
93299939|NCT00616941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299940|NCT00616941|Interferon Inducers|interferon inducers|mesh-ancestor
93299941|NCT03388892|Paclitaxel|paclitaxel|mesh-list
93299942|NCT03388892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93299943|NCT03388892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299944|NCT03388892|Tubulin Modulators|tubulin modulators|mesh-ancestor
93299945|NCT03388892|Antimitotic Agents|antimitotic agents|mesh-ancestor
93299946|NCT03388892|Mitosis Modulators|mitosis modulators|mesh-ancestor
93299947|NCT03388892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299948|NCT02577718|Ethanol|ethanol|mesh-list
93299949|NCT02577718|Nitroglycerin|nitroglycerin|mesh-list
93299950|NCT02577718|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93299951|NCT02577718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93299952|NCT02577718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299953|NCT02577718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299954|NCT02577718|Vasodilator Agents|vasodilator agents|mesh-ancestor
93299955|NCT00520533|Sunitinib|sunitinib|mesh-list
93299956|NCT00520533|Antibodies|antibodies|mesh-list
93299957|NCT00520533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93299958|NCT00520533|Immunologic Factors|immunologic factors|mesh-ancestor
93299959|NCT00520533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299960|NCT00520533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299961|NCT00520533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93299962|NCT00520533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93299963|NCT00520533|Growth Substances|growth substances|mesh-ancestor
93299964|NCT00520533|Growth Inhibitors|growth inhibitors|mesh-ancestor
93299965|NCT00520533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299966|NCT00520533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299967|NCT00520533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299968|NCT03388814|Bupivacaine|bupivacaine|mesh-list
93299969|NCT03388814|Anesthetics, Local|anesthetics, local|mesh-ancestor
93299970|NCT03388814|Anesthetics|anesthetics|mesh-ancestor
93299971|NCT03388814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299972|NCT03388814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93299973|NCT03388814|Sensory System Agents|sensory system agents|mesh-ancestor
93299974|NCT03388814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93299975|NCT04680988|Paclitaxel|paclitaxel|mesh-list
93299976|NCT04680988|Gemcitabine|gemcitabine|mesh-list
93299977|NCT04680988|Pemetrexed|pemetrexed|mesh-list
93299978|NCT04680988|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93299979|NCT04680988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92594544|NCT00429559|Topotecan|topotecan|mesh-list
93299980|NCT04680988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299981|NCT04680988|Tubulin Modulators|tubulin modulators|mesh-ancestor
93299982|NCT04680988|Antimitotic Agents|antimitotic agents|mesh-ancestor
93299983|NCT04680988|Mitosis Modulators|mitosis modulators|mesh-ancestor
93299984|NCT04680988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299985|NCT04680988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93299986|NCT04680988|Antimetabolites|antimetabolites|mesh-ancestor
93299987|NCT04680988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299988|NCT04680988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93299989|NCT04680988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93299990|NCT02289144|Ceritinib|ceritinib|mesh-list
93299991|NCT02289144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93299992|NCT02289144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93299993|NCT02289144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93299994|NCT02289144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93299995|NCT03393026|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93299996|NCT03393026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93299997|NCT03393026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93299998|NCT03393026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93299999|NCT03393026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300000|NCT03393026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93300001|NCT03393026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93300002|NCT03393026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93300003|NCT03393026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93300004|NCT03393026|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300005|NCT03393026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300006|NCT03393026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300007|NCT03393026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93300008|NCT03393026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93300009|NCT03393026|Serotonin Agents|serotonin agents|mesh-ancestor
93300010|NCT03393026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93300011|NCT03393026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93300012|NCT03393026|Dopamine Agents|dopamine agents|mesh-ancestor
93300013|NCT02144415|Amphetamine|amphetamine|mesh-list
93300014|NCT02144415|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93300015|NCT02144415|Dextroamphetamine|dextroamphetamine|mesh-list
93300016|NCT02144415|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93300017|NCT02144415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300018|NCT02144415|Sympathomimetics|sympathomimetics|mesh-ancestor
93300019|NCT02144415|Autonomic Agents|autonomic agents|mesh-ancestor
93300020|NCT02144415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300021|NCT02144415|Dopamine Agents|dopamine agents|mesh-ancestor
93300022|NCT02144415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300023|NCT02144415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300024|NCT02144415|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300025|NCT02144415|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93300026|NCT02144415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93300027|NCT02144415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300028|NCT02144415|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93300029|NCT02739984|Evolocumab|evolocumab|mesh-list
93300030|NCT02739984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93300031|NCT02739984|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93300032|NCT02739984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93300033|NCT02739984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93300034|NCT02739984|Antimetabolites|antimetabolites|mesh-ancestor
93300035|NCT02739984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300036|NCT02739984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93300037|NCT02739984|Protease Inhibitors|protease inhibitors|mesh-ancestor
93300038|NCT02739984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300039|NCT02739984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93300040|NCT02739984|Immunologic Factors|immunologic factors|mesh-ancestor
93300041|NCT02739984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300042|NCT00496730|Atorvastatin|atorvastatin|mesh-list
93300043|NCT00496730|Simvastatin|simvastatin|mesh-list
93300044|NCT00496730|Ezetimibe|ezetimibe|mesh-list
93300045|NCT00496730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93300046|NCT00496730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93300047|NCT00496730|Antimetabolites|antimetabolites|mesh-ancestor
93300048|NCT00496730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300049|NCT00496730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93300050|NCT00496730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93300051|NCT00496730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300052|NCT00446186|Montelukast|montelukast|mesh-list
93300053|NCT00446186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300054|NCT00446186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300055|NCT00446186|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300056|NCT00446186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93300057|NCT00446186|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93300058|NCT00446186|Hormone Antagonists|hormone antagonists|mesh-ancestor
93300059|NCT00446186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300060|NCT00446186|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93300061|NCT00446186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93300062|NCT02140983|Liraglutide|liraglutide|mesh-list
93300063|NCT02140983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93300064|NCT02140983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300065|NCT02140983|Incretins|incretins|mesh-ancestor
93300066|NCT02140983|Hormones|hormones|mesh-ancestor
93300067|NCT02140983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300068|NCT00394160|Montelukast|montelukast|mesh-list
93300069|NCT00394160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93300070|NCT00394160|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300071|NCT00394160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93300072|NCT00394160|Hormone Antagonists|hormone antagonists|mesh-ancestor
93300073|NCT00394160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300074|NCT00394160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300075|NCT00394160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93300076|NCT00394160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93300077|NCT00394160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300078|NCT03392792|Plasminogen|plasminogen|mesh-list
93300079|NCT03392792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93300080|NCT03392792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93300081|NCT03392792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93300082|NCT03392792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300083|NCT02739828|Adalimumab|adalimumab|mesh-list
93300084|NCT02739828|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93300085|NCT02739828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300086|NCT02739828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300087|NCT02141139|Ibuprofen|ibuprofen|mesh-list
93300088|NCT02141139|Ketorolac|ketorolac|mesh-list
93300089|NCT02141139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93300090|NCT02141139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93300091|NCT02141139|Analgesics|analgesics|mesh-ancestor
93300092|NCT02141139|Sensory System Agents|sensory system agents|mesh-ancestor
93300093|NCT02141139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300094|NCT02141139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300095|NCT02141139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300096|NCT02141139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300097|NCT02141139|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93300098|NCT02141139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300099|NCT02141139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300100|NCT03108495|Pembrolizumab|pembrolizumab|mesh-list
93300101|NCT03108495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300102|NCT03108495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300103|NCT03108495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93300104|NCT03108495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300105|NCT05297032|Quercetin|quercetin|mesh-list
93300106|NCT05297032|Antioxidants|antioxidants|mesh-ancestor
93300107|NCT05297032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300108|NCT05297032|Protective Agents|protective agents|mesh-ancestor
93300109|NCT05297032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300110|NCT03388580|Dimercaprol|dimercaprol|mesh-list
93300111|NCT03388580|Chelating Agents|chelating agents|mesh-ancestor
93300112|NCT03388580|Sequestering Agents|sequestering agents|mesh-ancestor
93300113|NCT03388580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300114|NCT03525912|Ketamine|ketamine|mesh-list
93300115|NCT03525912|Analgesics|analgesics|mesh-list
93300116|NCT03525912|Sensory System Agents|sensory system agents|mesh-ancestor
93300117|NCT03525912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300118|NCT03525912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300119|NCT03525912|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93300120|NCT03525912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93300121|NCT03525912|Anesthetics, General|anesthetics, general|mesh-ancestor
93300122|NCT03525912|Anesthetics|anesthetics|mesh-ancestor
93300123|NCT03525912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300124|NCT03525912|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93300125|NCT03525912|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93300126|NCT03525912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300127|NCT03525912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300128|NCT02289378|Docetaxel|docetaxel|mesh-list
93300129|NCT02289378|Oxaliplatin|oxaliplatin|mesh-list
93300130|NCT02289378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300131|NCT02289378|Tubulin Modulators|tubulin modulators|mesh-ancestor
93300132|NCT02289378|Antimitotic Agents|antimitotic agents|mesh-ancestor
93300133|NCT02289378|Mitosis Modulators|mitosis modulators|mesh-ancestor
93300134|NCT02289378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300135|NCT03851614|Durvalumab|durvalumab|mesh-list
93300136|NCT03851614|Olaparib|olaparib|mesh-list
93300137|NCT03851614|Cediranib|cediranib|mesh-list
93300138|NCT03851614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300139|NCT03851614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300140|NCT03851614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93300141|NCT03851614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300142|NCT03851614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300143|NCT03851614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93300144|NCT04565600|Etoricoxib|etoricoxib|mesh-list
93300145|NCT04565600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93300146|NCT04565600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93300147|NCT04565600|Analgesics|analgesics|mesh-ancestor
93300148|NCT04565600|Sensory System Agents|sensory system agents|mesh-ancestor
93300149|NCT04565600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300150|NCT04565600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300151|NCT04565600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300152|NCT04565600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300153|NCT04565600|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93300154|NCT04565600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93300155|NCT04565600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300156|NCT04565600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300157|NCT04435808|Hydroxychloroquine|hydroxychloroquine|mesh-list
93300158|NCT04435808|Antimalarials|antimalarials|mesh-ancestor
93300159|NCT04435808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93300160|NCT04435808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93300161|NCT04435808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300162|NCT04435808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300163|NCT04435808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300164|NCT04435808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300165|NCT03388346|Edetic Acid|edetic acid|mesh-list
93300166|NCT03388346|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93300167|NCT03388346|Chelating Agents|chelating agents|mesh-ancestor
93300168|NCT03388346|Sequestering Agents|sequestering agents|mesh-ancestor
93300169|NCT03388346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300170|NCT03388346|Anticoagulants|anticoagulants|mesh-ancestor
93300171|NCT03388346|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93300172|NCT03388346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93300173|NCT05631730|Metoprolol|metoprolol|mesh-list
93300174|NCT05631730|Flecainide|flecainide|mesh-list
93300175|NCT05631730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93300176|NCT05631730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93300177|NCT05631730|Sympatholytics|sympatholytics|mesh-ancestor
93300178|NCT05631730|Autonomic Agents|autonomic agents|mesh-ancestor
93300179|NCT05631730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300180|NCT05631730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300181|NCT05631730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93300182|NCT05631730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93300183|NCT05631730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93300184|NCT05631730|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300185|NCT05631730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300186|NCT05631730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300187|NCT05631730|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93300188|NCT05631730|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93300189|NCT05631730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300190|NCT00092144|Montelukast|montelukast|mesh-list
93300191|NCT00092144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300192|NCT00092144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300193|NCT00092144|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300194|NCT00092144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93300195|NCT00092144|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93300196|NCT00092144|Hormone Antagonists|hormone antagonists|mesh-ancestor
93300197|NCT00092144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300198|NCT00092144|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93300199|NCT00092144|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93300200|NCT02289768|Salicylic Acid|salicylic acid|mesh-list
93300201|NCT02289768|Salicylates|salicylates|mesh-list
93300202|NCT02289768|Fluorouracil|fluorouracil|mesh-list
93300203|NCT02289768|Antimetabolites|antimetabolites|mesh-ancestor
93300204|NCT02289768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300205|NCT02289768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93300206|NCT02289768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300207|NCT02289768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300208|NCT02289768|Immunologic Factors|immunologic factors|mesh-ancestor
93300209|NCT02289768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300210|NCT02289768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300211|NCT02289768|Antifungal Agents|antifungal agents|mesh-ancestor
93300212|NCT02289768|Keratolytic Agents|keratolytic agents|mesh-ancestor
93300213|NCT02289768|Dermatologic Agents|dermatologic agents|mesh-ancestor
93300214|NCT02289768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93300215|NCT02289768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93300216|NCT02289768|Analgesics|analgesics|mesh-ancestor
93300217|NCT02289768|Sensory System Agents|sensory system agents|mesh-ancestor
93300218|NCT02289768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300219|NCT02289768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300220|NCT02289768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300221|NCT02289768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93300222|NCT02289768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300223|NCT05526586|Ethanol|ethanol|mesh-list
93300224|NCT05526586|Listerine|listerine|mesh-list
93300225|NCT05526586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93300226|NCT05526586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300227|NCT05526586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300228|NCT05526586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300229|NCT04330430|Nivolumab|nivolumab|mesh-list
93300230|NCT04330430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300231|NCT04330430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300232|NCT04330430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93300233|NCT04330430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300234|NCT03387956|Dexamethasone|dexamethasone|mesh-list
93300235|NCT03387956|Atropine|atropine|mesh-list
93300236|NCT03387956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300237|NCT03387956|Antiemetics|antiemetics|mesh-ancestor
93300238|NCT03387956|Autonomic Agents|autonomic agents|mesh-ancestor
93300239|NCT03387956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300240|NCT03387956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300241|NCT03387956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93300242|NCT03387956|Glucocorticoids|glucocorticoids|mesh-ancestor
93300243|NCT03387956|Hormones|hormones|mesh-ancestor
93300244|NCT03387956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300245|NCT03387956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93300246|NCT03387956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300247|NCT03387956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93300248|NCT03387956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93300249|NCT03387956|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93300250|NCT03387956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93300251|NCT03387956|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300252|NCT03387956|Mydriatics|mydriatics|mesh-ancestor
93300253|NCT03387956|Parasympatholytics|parasympatholytics|mesh-ancestor
93300254|NCT03387956|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93300255|NCT03387956|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93300256|NCT03387956|Cholinergic Agents|cholinergic agents|mesh-ancestor
93300257|NCT03387956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300258|NCT03387956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300259|NCT03384524|Metoprolol|metoprolol|mesh-list
93300260|NCT03384524|Bromocriptine|bromocriptine|mesh-list
93300261|NCT03384524|Tamsulosin|tamsulosin|mesh-list
93300262|NCT03384524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93300263|NCT03384524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93300264|NCT03384524|Sympatholytics|sympatholytics|mesh-ancestor
93300265|NCT03384524|Autonomic Agents|autonomic agents|mesh-ancestor
93300266|NCT03384524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300267|NCT03384524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300268|NCT03384524|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93300269|NCT03384524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93300270|NCT03384524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93300271|NCT03384524|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300272|NCT03384524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300273|NCT03384524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300274|NCT03384524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93300275|NCT03384524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93300276|NCT03384524|Urological Agents|urological agents|mesh-ancestor
93300277|NCT03384524|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93300278|NCT03384524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93300279|NCT03384524|Hormone Antagonists|hormone antagonists|mesh-ancestor
93300280|NCT03384524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300281|NCT03384524|Dopamine Agonists|dopamine agonists|mesh-ancestor
93300282|NCT03384524|Dopamine Agents|dopamine agents|mesh-ancestor
93300283|NCT02289924|Aflibercept|aflibercept|mesh-list
93300284|NCT02289924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93300285|NCT02289924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93300286|NCT02289924|Growth Substances|growth substances|mesh-ancestor
93300287|NCT02289924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300288|NCT02289924|Growth Inhibitors|growth inhibitors|mesh-ancestor
93300289|NCT02289924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300290|NCT03387644|Pregabalin|pregabalin|mesh-list
93300291|NCT03387644|Analgesics|analgesics|mesh-ancestor
93300292|NCT03387644|Sensory System Agents|sensory system agents|mesh-ancestor
93300293|NCT03387644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300294|NCT03387644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300295|NCT03387644|Anticonvulsants|anticonvulsants|mesh-ancestor
93300296|NCT03387644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93300297|NCT03387644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300298|NCT03387644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300299|NCT03387644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93300300|NCT03387644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93300301|NCT03387644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93300302|NCT03387644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300303|NCT03387644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93300304|NCT02290002|Calcium Dobesilate|calcium dobesilate|mesh-list
93300306|NCT02290002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93300307|NCT02290002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300308|NCT02290002|Hemostatics|hemostatics|mesh-ancestor
93300309|NCT02290002|Coagulants|coagulants|mesh-ancestor
93300310|NCT02294292|Carvedilol|carvedilol|mesh-list
93300311|NCT02294292|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93300312|NCT02294292|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93300313|NCT02294292|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300314|NCT02294292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300315|NCT02294292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300316|NCT02294292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300317|NCT02294292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93300318|NCT02294292|Antioxidants|antioxidants|mesh-ancestor
93300319|NCT02294292|Protective Agents|protective agents|mesh-ancestor
93300320|NCT02294292|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93300321|NCT02294292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300322|NCT02294292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93300323|NCT02294292|Vasodilator Agents|vasodilator agents|mesh-ancestor
93300324|NCT02294292|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93300325|NCT02294292|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93300326|NCT03387566|Immunoglobulins|immunoglobulins|mesh-list
93300327|NCT03387566|Endothelial Growth Factors|endothelial growth factors|mesh-list
93300328|NCT03387566|Immunologic Factors|immunologic factors|mesh-ancestor
93300329|NCT03387566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300330|NCT03387566|Growth Substances|growth substances|mesh-ancestor
93300331|NCT03391856|Acetylcysteine|acetylcysteine|mesh-list
93300332|NCT03391856|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93300333|NCT03391856|Antiviral Agents|antiviral agents|mesh-ancestor
93300334|NCT03391856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300335|NCT03391856|Expectorants|expectorants|mesh-ancestor
93300336|NCT03391856|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300337|NCT03391856|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93300338|NCT03391856|Antioxidants|antioxidants|mesh-ancestor
93300339|NCT03391856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300340|NCT03391856|Protective Agents|protective agents|mesh-ancestor
93300341|NCT03391856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300342|NCT03391856|Antidotes|antidotes|mesh-ancestor
93300343|NCT01664494|Capecitabine|capecitabine|mesh-list
93300344|NCT01664494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93300345|NCT01664494|Antimetabolites|antimetabolites|mesh-ancestor
93300346|NCT01664494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300347|NCT01664494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300348|NCT02290470|Dexamethasone|dexamethasone|mesh-list
93300349|NCT02290470|Dexamethasone acetate|dexamethasone acetate|mesh-list
93300350|NCT02290470|Paclitaxel|paclitaxel|mesh-list
93300351|NCT02290470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93300352|NCT02290470|Carboplatin|carboplatin|mesh-list
93300353|NCT02290470|Olanzapine|olanzapine|mesh-list
93300354|NCT02290470|Palonosetron|palonosetron|mesh-list
93300355|NCT02290470|BB 1101|bb 1101|mesh-list
93300356|NCT02290470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93300357|NCT02290470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300358|NCT02290470|Tubulin Modulators|tubulin modulators|mesh-ancestor
93300359|NCT02290470|Antimitotic Agents|antimitotic agents|mesh-ancestor
93300360|NCT02290470|Mitosis Modulators|mitosis modulators|mesh-ancestor
93300361|NCT02290470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300362|NCT02290470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300363|NCT02290470|Antiemetics|antiemetics|mesh-ancestor
93300364|NCT02290470|Autonomic Agents|autonomic agents|mesh-ancestor
93300365|NCT02290470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300366|NCT02290470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300367|NCT02290470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93300368|NCT02290470|Glucocorticoids|glucocorticoids|mesh-ancestor
93300369|NCT02290470|Hormones|hormones|mesh-ancestor
93300370|NCT02290470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300371|NCT02290470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93300372|NCT02290470|Protease Inhibitors|protease inhibitors|mesh-ancestor
93300373|NCT02290470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300374|NCT02290470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93300375|NCT02290470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93300376|NCT02290470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300377|NCT02290470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93300378|NCT02290470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93300379|NCT02290470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93300380|NCT02290470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300381|NCT02290470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300382|NCT02290470|Serotonin Agents|serotonin agents|mesh-ancestor
93300383|NCT02290470|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93300384|NCT02290470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93300385|NCT05172518|Capecitabine|capecitabine|mesh-list
93300386|NCT05172518|Taxane|taxane|mesh-list
93300387|NCT05172518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93300388|NCT05172518|Antimetabolites|antimetabolites|mesh-ancestor
93300389|NCT05172518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300390|NCT05172518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300391|NCT03724084|Cytarabine|cytarabine|mesh-list
93300392|NCT03724084|Daunorubicin|daunorubicin|mesh-list
93300393|NCT03724084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93300394|NCT03724084|Antimetabolites|antimetabolites|mesh-ancestor
93300395|NCT03724084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300396|NCT03724084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300397|NCT03724084|Antiviral Agents|antiviral agents|mesh-ancestor
93300398|NCT03724084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300399|NCT03724084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300400|NCT03724084|Immunologic Factors|immunologic factors|mesh-ancestor
93300401|NCT03724084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300402|NCT03724084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93300403|NCT03724084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93300404|NCT03724084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93300405|NCT03724084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300406|NCT05172440|Tislelizumab|tislelizumab|mesh-list
93300407|NCT05172440|Axitinib|axitinib|mesh-list
93300408|NCT05172440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300409|NCT05172440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300410|NCT05172440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93300411|NCT05172440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300412|NCT05172440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300413|NCT02298582|Fentanyl|fentanyl|mesh-list
93300414|NCT02298582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93300415|NCT02298582|Narcotics|narcotics|mesh-ancestor
93300416|NCT02298582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300417|NCT02298582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300418|NCT02298582|Analgesics|analgesics|mesh-ancestor
93300419|NCT02298582|Sensory System Agents|sensory system agents|mesh-ancestor
93300420|NCT02298582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300421|NCT02298582|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93300422|NCT02298582|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93300423|NCT02298582|Anesthetics, General|anesthetics, general|mesh-ancestor
93300424|NCT02298582|Anesthetics|anesthetics|mesh-ancestor
93300425|NCT04446416|Bevacizumab|bevacizumab|mesh-list
93300426|NCT04446416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300427|NCT04446416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300428|NCT04446416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93300429|NCT04446416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93300430|NCT04446416|Growth Substances|growth substances|mesh-ancestor
93300431|NCT04446416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300432|NCT04446416|Growth Inhibitors|growth inhibitors|mesh-ancestor
93300433|NCT02298660|Botulinum Toxins|botulinum toxins|mesh-list
93300434|NCT02298660|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93300435|NCT02298660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93300436|NCT02298660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93300437|NCT02298660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300438|NCT02298660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300439|NCT02298660|Cholinergic Agents|cholinergic agents|mesh-ancestor
93300440|NCT02298660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300441|NCT02298660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300442|NCT02298660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93300443|NCT02298660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300444|NCT01396408|Sirolimus|sirolimus|mesh-list
93300445|NCT01396408|Sunitinib|sunitinib|mesh-list
93300446|NCT01396408|Temsirolimus|temsirolimus|mesh-list
93300447|NCT01396408|MTOR Inhibitors|mtor inhibitors|mesh-list
93300448|NCT01396408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300449|NCT01396408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93300450|NCT01396408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93300451|NCT01396408|Growth Substances|growth substances|mesh-ancestor
93300452|NCT01396408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300453|NCT01396408|Growth Inhibitors|growth inhibitors|mesh-ancestor
93300454|NCT01396408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93300455|NCT01396408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300456|NCT01396408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300457|NCT01396408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300458|NCT01396408|Immunologic Factors|immunologic factors|mesh-ancestor
93300459|NCT01396408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300460|NCT01396408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300461|NCT01396408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93300462|NCT01396408|Antifungal Agents|antifungal agents|mesh-ancestor
93300463|NCT03571334|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93300464|NCT03571334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93300465|NCT03571334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300466|NCT03571334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300467|NCT03571334|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93300468|NCT03571334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300469|NCT03571334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300470|NCT03571334|Cholinergic Agents|cholinergic agents|mesh-ancestor
93300471|NCT03571334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300473|NCT05440942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300474|NCT05440942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93300475|NCT05440942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300476|NCT05440942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300477|NCT02291094|Lidocaine|lidocaine|mesh-list
93300478|NCT02291094|Remifentanil|remifentanil|mesh-list
93300479|NCT02291094|Anesthetics, Local|anesthetics, local|mesh-ancestor
93300480|NCT02291094|Anesthetics|anesthetics|mesh-ancestor
93300481|NCT02291094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300482|NCT02291094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300483|NCT02291094|Sensory System Agents|sensory system agents|mesh-ancestor
93300484|NCT02291094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300485|NCT02291094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93300486|NCT02291094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93300487|NCT02291094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93300488|NCT02291094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300489|NCT02291094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300490|NCT02291094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93300491|NCT02291094|Narcotics|narcotics|mesh-ancestor
93300492|NCT02291094|Analgesics|analgesics|mesh-ancestor
93300493|NCT03387098|Leucovorin|leucovorin|mesh-list
93300494|NCT03387098|Paclitaxel|paclitaxel|mesh-list
93300495|NCT03387098|Cyclophosphamide|cyclophosphamide|mesh-list
93300496|NCT03387098|Bevacizumab|bevacizumab|mesh-list
93300497|NCT03387098|Fluorouracil|fluorouracil|mesh-list
93300498|NCT03387098|Capecitabine|capecitabine|mesh-list
93300499|NCT03387098|Oxaliplatin|oxaliplatin|mesh-list
93300500|NCT03387098|Avelumab|avelumab|mesh-list
93300501|NCT03387098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93300502|NCT03387098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300503|NCT03387098|Tubulin Modulators|tubulin modulators|mesh-ancestor
93300504|NCT03387098|Antimitotic Agents|antimitotic agents|mesh-ancestor
93300505|NCT03387098|Mitosis Modulators|mitosis modulators|mesh-ancestor
93300506|NCT03387098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300507|NCT03387098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300508|NCT03387098|Immunologic Factors|immunologic factors|mesh-ancestor
93300509|NCT03387098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300510|NCT03387098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300511|NCT03387098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93300512|NCT03387098|Alkylating Agents|alkylating agents|mesh-ancestor
93300513|NCT03387098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93300514|NCT03387098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300515|NCT03387098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93300516|NCT03387098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93300517|NCT03387098|Growth Substances|growth substances|mesh-ancestor
93300518|NCT03387098|Growth Inhibitors|growth inhibitors|mesh-ancestor
93300519|NCT03387098|Antimetabolites|antimetabolites|mesh-ancestor
93300520|NCT03387098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93300521|NCT03387098|Antidotes|antidotes|mesh-ancestor
93300522|NCT03387098|Protective Agents|protective agents|mesh-ancestor
93300523|NCT03387098|Vitamin B Complex|vitamin b complex|mesh-ancestor
93300524|NCT03387098|Vitamins|vitamins|mesh-ancestor
93300525|NCT03387098|Micronutrients|micronutrients|mesh-ancestor
93300526|NCT02577016|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93300527|NCT02577016|Ipragliflozin|ipragliflozin|mesh-list
92972590|NCT02547402|CXA-10|cxa-10|mesh-list
93300529|NCT02577016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300530|NCT02577016|Incretins|incretins|mesh-ancestor
93300531|NCT02577016|Hormones|hormones|mesh-ancestor
93300532|NCT02577016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300533|NCT02577016|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93300534|NCT02577016|Protease Inhibitors|protease inhibitors|mesh-ancestor
93300535|NCT02577016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300536|NCT02577016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300537|NCT02577016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93300538|NCT04465110|Grape Seed Extract|grape seed extract|mesh-list
93300539|NCT04465110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93300540|NCT04465110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300541|NCT04465110|Antioxidants|antioxidants|mesh-ancestor
93300542|NCT04465110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300543|NCT04465110|Protective Agents|protective agents|mesh-ancestor
93300544|NCT04465110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300545|NCT03391700|Rocuronium|rocuronium|mesh-list
93300546|NCT03391700|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93300547|NCT03391700|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93300548|NCT03391700|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93300549|NCT03391700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300550|NCT03391700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300551|NCT02294838|Citric Acid|citric acid|mesh-list
93300552|NCT02294838|Sodium Citrate|sodium citrate|mesh-list
93300553|NCT02294838|Anticoagulants|anticoagulants|mesh-ancestor
93300554|NCT02294838|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93300555|NCT02294838|Chelating Agents|chelating agents|mesh-ancestor
93300556|NCT02294838|Sequestering Agents|sequestering agents|mesh-ancestor
93300557|NCT02294838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300558|NCT03383822|Insulin|insulin|mesh-list
93300559|NCT03383822|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93300560|NCT03383822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93300561|NCT03383822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300562|NCT03514446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93300563|NCT03514446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300564|NCT03383744|Vitamin A|vitamin a|mesh-list
93300565|NCT03383744|Vitamins|vitamins|mesh-ancestor
93300566|NCT03383744|Micronutrients|micronutrients|mesh-ancestor
93300567|NCT03383744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300568|NCT05662358|Denosumab|denosumab|mesh-list
93300569|NCT05662358|Alendronate|alendronate|mesh-list
93300570|NCT05662358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93300571|NCT05662358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300572|NCT02294994|Tirofiban|tirofiban|mesh-list
93300573|NCT02294994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93300574|NCT02294994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93300575|NCT02294994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300576|NCT02294994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93300577|NCT03386630|Sufentanil|sufentanil|mesh-list
93300578|NCT03386630|Morphine|morphine|mesh-list
93300579|NCT03386630|Dsuvia|dsuvia|mesh-list
93300580|NCT03386630|Bupivacaine|bupivacaine|mesh-list
93300581|NCT03386630|Anesthetics, Local|anesthetics, local|mesh-ancestor
93300582|NCT03386630|Anesthetics|anesthetics|mesh-ancestor
93300583|NCT03386630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300584|NCT03386630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300585|NCT03386630|Sensory System Agents|sensory system agents|mesh-ancestor
93300586|NCT03386630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300587|NCT03386630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93300588|NCT03386630|Narcotics|narcotics|mesh-ancestor
93300589|NCT03386630|Analgesics|analgesics|mesh-ancestor
93300590|NCT03386630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93300591|NCT03386630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93300592|NCT03386630|Anesthetics, General|anesthetics, general|mesh-ancestor
93300593|NCT03132714|Amoxicillin|amoxicillin|mesh-list
93300594|NCT03132714|Metronidazole|metronidazole|mesh-list
93300595|NCT03132714|Clarithromycin|clarithromycin|mesh-list
93300596|NCT03132714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300597|NCT03132714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300598|NCT03132714|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93300599|NCT03132714|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93300600|NCT03132714|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93300601|NCT03132714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300602|NCT03132714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300603|NCT03132714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93300604|NCT03132714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93300605|NCT03386318|Oxycodone|oxycodone|mesh-list
93300606|NCT03386318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93300607|NCT03386318|Narcotics|narcotics|mesh-ancestor
93300608|NCT03386318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300609|NCT03386318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300610|NCT03386318|Analgesics|analgesics|mesh-ancestor
93300611|NCT03386318|Sensory System Agents|sensory system agents|mesh-ancestor
93300612|NCT03386318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300613|NCT03339284|Dexamethasone|dexamethasone|mesh-list
93300614|NCT03339284|Dexamethasone acetate|dexamethasone acetate|mesh-list
93300615|NCT03339284|Ropivacaine|ropivacaine|mesh-list
93300616|NCT03339284|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93300617|NCT03339284|BB 1101|bb 1101|mesh-list
93300618|NCT03339284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300619|NCT03339284|Antiemetics|antiemetics|mesh-ancestor
93300620|NCT03339284|Autonomic Agents|autonomic agents|mesh-ancestor
93300621|NCT03339284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300622|NCT03339284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300623|NCT03339284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93300624|NCT03339284|Glucocorticoids|glucocorticoids|mesh-ancestor
93300625|NCT03339284|Hormones|hormones|mesh-ancestor
93300626|NCT03339284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300627|NCT03339284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93300628|NCT03339284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300629|NCT03339284|Anesthetics, Local|anesthetics, local|mesh-ancestor
93300630|NCT03339284|Anesthetics|anesthetics|mesh-ancestor
93300631|NCT03339284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320038|NCT01974284|Ethanol|ethanol|mesh-list
93300632|NCT03339284|Sensory System Agents|sensory system agents|mesh-ancestor
93300633|NCT03339284|Protease Inhibitors|protease inhibitors|mesh-ancestor
93300634|NCT03339284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300635|NCT03339284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300636|NCT02291562|Dronabinol|dronabinol|mesh-list
93300637|NCT02291562|Cannabidiol|cannabidiol|mesh-list
93300638|NCT02291562|Anticonvulsants|anticonvulsants|mesh-ancestor
93300639|NCT02291562|Hallucinogens|hallucinogens|mesh-ancestor
93300640|NCT02291562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300641|NCT02291562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93300642|NCT02291562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93300643|NCT02291562|Analgesics|analgesics|mesh-ancestor
93300644|NCT02291562|Sensory System Agents|sensory system agents|mesh-ancestor
93300645|NCT02291562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300646|NCT02291562|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93300647|NCT02291562|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93300648|NCT02291562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300649|NCT02291562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300650|NCT02291562|Hormones|hormones|mesh-ancestor
93300651|NCT02291562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300652|NCT03316586|Nivolumab|nivolumab|mesh-list
93300653|NCT03316586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300654|NCT03316586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300655|NCT03316586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93300656|NCT03316586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300657|NCT02994927|Prednisone|prednisone|mesh-list
93300658|NCT02994927|Cyclophosphamide|cyclophosphamide|mesh-list
93300659|NCT02994927|Rituximab|rituximab|mesh-list
93300660|NCT02994927|Azathioprine|azathioprine|mesh-list
93300661|NCT02994927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300662|NCT02994927|Immunologic Factors|immunologic factors|mesh-ancestor
93300663|NCT02994927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300664|NCT02994927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300665|NCT02994927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93300666|NCT02994927|Alkylating Agents|alkylating agents|mesh-ancestor
93300667|NCT02994927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300668|NCT02994927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300669|NCT02994927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93300670|NCT02994927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300671|NCT02994927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300672|NCT02994927|Glucocorticoids|glucocorticoids|mesh-ancestor
93300673|NCT02994927|Hormones|hormones|mesh-ancestor
93300674|NCT02994927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300675|NCT02994927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93300676|NCT02994927|Antimetabolites|antimetabolites|mesh-ancestor
93300677|NCT02994927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972773|NCT00949377|Bromides|bromides|mesh-list
93300678|NCT03383276|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93300679|NCT03383276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300680|NCT02295150|Nadroparin|nadroparin|mesh-list
93300681|NCT02295150|Anticoagulants|anticoagulants|mesh-ancestor
93300682|NCT02295150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93300683|NCT02295150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93300684|NCT02295150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300685|NCT03390608|Trastuzumab|trastuzumab|mesh-list
93300686|NCT03390608|Estrogens|estrogens|mesh-list
93300687|NCT03390608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300688|NCT03390608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300689|NCT03390608|Hormones|hormones|mesh-ancestor
93300690|NCT03390608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300691|NCT03390608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300692|NCT03513822|Midazolam|midazolam|mesh-list
93300693|NCT03513822|Ketamine|ketamine|mesh-list
93300694|NCT03513822|Analgesics|analgesics|mesh-ancestor
93300695|NCT03513822|Sensory System Agents|sensory system agents|mesh-ancestor
93300696|NCT03513822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300697|NCT03513822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300698|NCT03513822|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93300699|NCT03513822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93300700|NCT03513822|Anesthetics, General|anesthetics, general|mesh-ancestor
93300701|NCT03513822|Anesthetics|anesthetics|mesh-ancestor
92595261|NCT00097877|Insulin Aspart|insulin aspart|mesh-list
93300702|NCT03513822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300703|NCT03513822|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93300704|NCT03513822|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93300705|NCT03513822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300706|NCT03513822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300707|NCT03513822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93300708|NCT03513822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93300709|NCT03513822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93300710|NCT03513822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93300711|NCT03513822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93300712|NCT03513822|GABA Modulators|gaba modulators|mesh-ancestor
93300713|NCT03513822|GABA Agents|gaba agents|mesh-ancestor
93300714|NCT03383120|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93300715|NCT03383120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300716|NCT03513432|Ethanol|ethanol|mesh-list
93300717|NCT03513432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93300718|NCT03513432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300719|NCT03513432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300720|NCT03513432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300721|NCT02299440|Ketamine|ketamine|mesh-list
93300722|NCT02299440|Analgesics|analgesics|mesh-ancestor
93300723|NCT02299440|Sensory System Agents|sensory system agents|mesh-ancestor
93300724|NCT02299440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300725|NCT02299440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300726|NCT02299440|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93300727|NCT02299440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93300728|NCT02299440|Anesthetics, General|anesthetics, general|mesh-ancestor
93300729|NCT02299440|Anesthetics|anesthetics|mesh-ancestor
93300730|NCT02299440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300731|NCT02299440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93300732|NCT02299440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93300733|NCT02299440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300734|NCT02299440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300735|NCT02145195|Vitamin D|vitamin d|mesh-list
93300736|NCT02145195|Cholecalciferol|cholecalciferol|mesh-list
93300737|NCT02145195|Vitamins|vitamins|mesh-ancestor
93300738|NCT02145195|Micronutrients|micronutrients|mesh-ancestor
93300739|NCT02145195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300740|NCT02145195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93300741|NCT02145195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93300742|NCT03517020|Nebivolol|nebivolol|mesh-list
93300743|NCT03517020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93300744|NCT03517020|Vasodilator Agents|vasodilator agents|mesh-ancestor
93300745|NCT03517020|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93300746|NCT03517020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93300747|NCT03517020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93300748|NCT03517020|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300749|NCT03517020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300750|NCT03517020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300751|NCT03517020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972817|NCT00955695|Gefitinib|gefitinib|mesh-list
93300752|NCT02254629|Laxatives|laxatives|mesh-list
93300753|NCT02254629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93300754|NCT02145585|Anesthetics|anesthetics|mesh-list
93300755|NCT02145585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300756|NCT02145585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300757|NCT02291796|Bezafibrate|bezafibrate|mesh-list
93300758|NCT02291796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93300759|NCT02291796|Antimetabolites|antimetabolites|mesh-ancestor
93300760|NCT02291796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300761|NCT02291796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93300762|NCT03544827|Atropine|atropine|mesh-list
93300763|NCT03544827|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93300764|NCT03544827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93300765|NCT03544827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93300766|NCT03544827|Autonomic Agents|autonomic agents|mesh-ancestor
93300767|NCT03544827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300768|NCT03544827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300769|NCT03544827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93300770|NCT03544827|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300771|NCT03544827|Mydriatics|mydriatics|mesh-ancestor
93300772|NCT03544827|Parasympatholytics|parasympatholytics|mesh-ancestor
92595333|NCT00131313|Rituximab|rituximab|mesh-list
93300773|NCT03544827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93300774|NCT03544827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93300775|NCT03544827|Cholinergic Agents|cholinergic agents|mesh-ancestor
93300776|NCT03544827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300777|NCT03544827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300778|NCT00107991|Etanercept|etanercept|mesh-list
93300779|NCT00107991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93300780|NCT00107991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93300781|NCT00107991|Analgesics|analgesics|mesh-ancestor
93300782|NCT00107991|Sensory System Agents|sensory system agents|mesh-ancestor
93300783|NCT00107991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300784|NCT00107991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300785|NCT00107991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93300786|NCT00107991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300787|NCT00107991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93300788|NCT00107991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300789|NCT00107991|Immunologic Factors|immunologic factors|mesh-ancestor
93300790|NCT03513276|Epinephrine|epinephrine|mesh-list
93300791|NCT03513276|Racepinephrine|racepinephrine|mesh-list
93300792|NCT03513276|Ropivacaine|ropivacaine|mesh-list
93300793|NCT03513276|Epinephryl borate|epinephryl borate|mesh-list
93300794|NCT03513276|Anesthetics, Local|anesthetics, local|mesh-ancestor
93300795|NCT03513276|Anesthetics|anesthetics|mesh-ancestor
93300796|NCT03513276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300797|NCT03513276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300798|NCT03513276|Sensory System Agents|sensory system agents|mesh-ancestor
93300799|NCT03513276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300800|NCT03513276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93300801|NCT03513276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93300802|NCT03513276|Adrenergic Agents|adrenergic agents|mesh-ancestor
93300803|NCT03513276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300804|NCT03513276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300805|NCT03513276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93300806|NCT03513276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93300807|NCT03513276|Autonomic Agents|autonomic agents|mesh-ancestor
93300808|NCT03513276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93300809|NCT03513276|Respiratory System Agents|respiratory system agents|mesh-ancestor
93300810|NCT03513276|Mydriatics|mydriatics|mesh-ancestor
93300811|NCT03513276|Sympathomimetics|sympathomimetics|mesh-ancestor
93300812|NCT03513276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93300813|NCT02291874|Ipragliflozin|ipragliflozin|mesh-list
93300814|NCT02291874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93300815|NCT02291874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300816|NCT02291874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93300817|NCT02291874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300818|NCT03516630|Moxifloxacin|moxifloxacin|mesh-list
93300819|NCT03516630|Trazodone|trazodone|mesh-list
93300820|NCT03516630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300821|NCT03516630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300822|NCT03516630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93300823|NCT03516630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93300824|NCT03516630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300825|NCT03516630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972892|NCT05170659|Relatlimab|relatlimab|mesh-list
93300826|NCT03516630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300827|NCT03516630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300828|NCT03516630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93300829|NCT03516630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93300830|NCT03516630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300831|NCT03516630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93300832|NCT03516630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93300833|NCT03516630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93300834|NCT03516630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300835|NCT03516630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93300836|NCT03516630|Serotonin Agents|serotonin agents|mesh-ancestor
93300837|NCT03516630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93300838|NCT03516630|Antidepressive Agents|antidepressive agents|mesh-ancestor
93300839|NCT02142075|Daptomycin|daptomycin|mesh-list
93300840|NCT02142075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300841|NCT02142075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300842|NCT02145975|Fentanyl|fentanyl|mesh-list
93300843|NCT02145975|Morphine|morphine|mesh-list
93300844|NCT02145975|Analgesics, Opioid|analgesics, opioid|mesh-list
93300845|NCT02145975|Narcotics|narcotics|mesh-ancestor
93300846|NCT02145975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300847|NCT02145975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300848|NCT02145975|Analgesics|analgesics|mesh-ancestor
93300849|NCT02145975|Sensory System Agents|sensory system agents|mesh-ancestor
93300850|NCT02145975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300851|NCT02145975|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93300852|NCT02145975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93300853|NCT02145975|Anesthetics, General|anesthetics, general|mesh-ancestor
93300854|NCT02145975|Anesthetics|anesthetics|mesh-ancestor
93300855|NCT02295852|Calcium|calcium|mesh-list
93300856|NCT02295852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93300857|NCT02295852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300858|NCT02295930|Bevacizumab|bevacizumab|mesh-list
93300859|NCT02295930|Cetuximab|cetuximab|mesh-list
93300860|NCT02295930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300861|NCT02295930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300862|NCT02295930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93300863|NCT02295930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93300864|NCT02295930|Growth Substances|growth substances|mesh-ancestor
93300865|NCT02295930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300866|NCT02295930|Growth Inhibitors|growth inhibitors|mesh-ancestor
93300867|NCT02142309|Pioglitazone|pioglitazone|mesh-list
93300868|NCT02142309|Glimepiride|glimepiride|mesh-list
93300869|NCT02142309|Canagliflozin|canagliflozin|mesh-list
93300870|NCT02142309|Vildagliptin|vildagliptin|mesh-list
93300871|NCT02142309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93300872|NCT02142309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300873|NCT02142309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93300874|NCT02142309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300875|NCT02142309|Immunologic Factors|immunologic factors|mesh-ancestor
93300876|NCT02142309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93300877|NCT02142309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300878|NCT02142309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93300879|NCT02142309|Protease Inhibitors|protease inhibitors|mesh-ancestor
93300880|NCT02142309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300881|NCT02146209|Metronidazole|metronidazole|mesh-list
93300882|NCT02146209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300883|NCT02146209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300884|NCT02146209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93300885|NCT02146209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93300886|NCT02299908|Bupivacaine|bupivacaine|mesh-list
93300887|NCT02299908|Anesthetics, Local|anesthetics, local|mesh-list
93300888|NCT02299908|Anesthetics|anesthetics|mesh-list
93300889|NCT02299908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93300890|NCT02299908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93300891|NCT02299908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300892|NCT02299908|Sensory System Agents|sensory system agents|mesh-ancestor
93300893|NCT02299908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93300894|NCT02142543|Zinc Oxide|zinc oxide|mesh-list
93300895|NCT02142543|Dermatologic Agents|dermatologic agents|mesh-ancestor
93300896|NCT02142543|Sunscreening Agents|sunscreening agents|mesh-ancestor
93300897|NCT02142543|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93300898|NCT02142543|Protective Agents|protective agents|mesh-ancestor
93300899|NCT02142543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300900|NCT03390374|Nystatin|nystatin|mesh-list
93300901|NCT03390374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300902|NCT03390374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300903|NCT03390374|Antifungal Agents|antifungal agents|mesh-ancestor
93300905|NCT03390374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300906|NCT03390374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300907|NCT03545373|Amoxicillin|amoxicillin|mesh-list
93300908|NCT03545373|Azithromycin|azithromycin|mesh-list
93300909|NCT03545373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93300910|NCT03545373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93300911|NCT00492856|Methotrexate|methotrexate|mesh-list
93300912|NCT00492856|Mercaptopurine|mercaptopurine|mesh-list
93300913|NCT00492856|Tretinoin|tretinoin|mesh-list
93300914|NCT00492856|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93300915|NCT00492856|Abortifacient Agents|abortifacient agents|mesh-ancestor
93300916|NCT00492856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93300917|NCT00492856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300918|NCT00492856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93300919|NCT00492856|Antimetabolites|antimetabolites|mesh-ancestor
93300920|NCT00492856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300921|NCT00492856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300922|NCT00492856|Dermatologic Agents|dermatologic agents|mesh-ancestor
93300923|NCT00492856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300924|NCT00492856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93300925|NCT00492856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300926|NCT00492856|Immunologic Factors|immunologic factors|mesh-ancestor
93300927|NCT00492856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93300928|NCT00492856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93300929|NCT00492856|Keratolytic Agents|keratolytic agents|mesh-ancestor
93300931|NCT02142777|Phytoestrogens|phytoestrogens|mesh-ancestor
93300932|NCT02142777|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93300933|NCT02142777|Estrogens|estrogens|mesh-ancestor
93300934|NCT02142777|Hormones|hormones|mesh-ancestor
93300935|NCT02142777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300936|NCT02142777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300937|NCT02143167|4-Aminopyridine|4-aminopyridine|mesh-list
93300938|NCT02143167|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93300939|NCT02143167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93300940|NCT02143167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300941|NCT03544671|Vitamin D|vitamin d|mesh-list
93300942|NCT03544671|Vitamins|vitamins|mesh-ancestor
93300943|NCT03544671|Micronutrients|micronutrients|mesh-ancestor
93300944|NCT03544671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300945|NCT03544671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93300946|NCT03390062|Apatinib|apatinib|mesh-list
93300947|NCT03390062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300948|NCT03390062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93300949|NCT03390062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300950|NCT03390062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300951|NCT03382886|Bevacizumab|bevacizumab|mesh-list
93300952|NCT03382886|Nivolumab|nivolumab|mesh-list
93300953|NCT03382886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300954|NCT03382886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300955|NCT03382886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93300956|NCT03382886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93300957|NCT03382886|Growth Substances|growth substances|mesh-ancestor
93300958|NCT03382886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300959|NCT03382886|Growth Inhibitors|growth inhibitors|mesh-ancestor
93300960|NCT03382886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93300961|NCT03382886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300962|NCT03125486|Belimumab|belimumab|mesh-list
93300963|NCT03125486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93300964|NCT03125486|Immunologic Factors|immunologic factors|mesh-ancestor
93300965|NCT03125486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300966|NCT02147925|Metformin|metformin|mesh-list
93300967|NCT02147925|Insulin Glargine|insulin glargine|mesh-list
93300968|NCT02147925|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93300969|NCT02147925|Liraglutide|liraglutide|mesh-list
93300970|NCT02147925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93300971|NCT02147925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300972|NCT02147925|Incretins|incretins|mesh-ancestor
93300973|NCT02147925|Hormones|hormones|mesh-ancestor
93300974|NCT02147925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93300975|NCT02147925|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93300976|NCT02147925|Protease Inhibitors|protease inhibitors|mesh-ancestor
93300977|NCT02147925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973046|NCT00962637|Citric Acid|citric acid|mesh-list
93300978|NCT02147925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300979|NCT03544047|Paclitaxel|paclitaxel|mesh-list
93300980|NCT03544047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93300981|NCT03544047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300982|NCT03544047|Tubulin Modulators|tubulin modulators|mesh-ancestor
93300983|NCT03544047|Antimitotic Agents|antimitotic agents|mesh-ancestor
93300984|NCT03544047|Mitosis Modulators|mitosis modulators|mesh-ancestor
93300985|NCT03544047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300986|NCT03544125|Durvalumab|durvalumab|mesh-list
93300987|NCT03544125|Olaparib|olaparib|mesh-list
93300988|NCT03544125|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93300989|NCT03544125|Immunoglobulins|immunoglobulins|mesh-list
93300990|NCT03544125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93300991|NCT03544125|Immunoglobulin G|immunoglobulin g|mesh-list
93300992|NCT03544125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93300993|NCT03544125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93300994|NCT03544125|Immunologic Factors|immunologic factors|mesh-ancestor
93300995|NCT03544125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93300996|NCT03544125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93300997|NCT03544125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93300998|NCT02146911|Bupropion|bupropion|mesh-list
93300999|NCT02146911|Varenicline|varenicline|mesh-list
93301000|NCT02146911|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93301001|NCT02146911|Antidepressive Agents|antidepressive agents|mesh-ancestor
93301002|NCT02146911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93301003|NCT02146911|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93301004|NCT02146911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93301005|NCT02146911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301006|NCT02146911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301007|NCT02146911|Dopamine Agents|dopamine agents|mesh-ancestor
93301008|NCT02146911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301009|NCT02146911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301010|NCT02146911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93301011|NCT02146911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93301012|NCT02146911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301013|NCT02146911|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93301014|NCT02146911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93301015|NCT02146911|Cholinergic Agents|cholinergic agents|mesh-ancestor
93301016|NCT02776683|Bevacizumab|bevacizumab|mesh-list
93301017|NCT02776683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301018|NCT02776683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301019|NCT02776683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93301020|NCT02776683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93301021|NCT02776683|Growth Substances|growth substances|mesh-ancestor
93301022|NCT02776683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301023|NCT02776683|Growth Inhibitors|growth inhibitors|mesh-ancestor
93301024|NCT02963714|Vaccines|vaccines|mesh-list
93301025|NCT02963714|Immunologic Factors|immunologic factors|mesh-ancestor
93301026|NCT02963714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301027|NCT02148393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93301028|NCT02148393|Estradiol|estradiol|mesh-list
93301029|NCT02148393|Progesterone|progesterone|mesh-list
93301030|NCT02148393|Estrogens|estrogens|mesh-ancestor
93301031|NCT02148393|Hormones|hormones|mesh-ancestor
93301032|NCT02148393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301033|NCT02148393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301034|NCT02148393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301035|NCT02148393|Progestins|progestins|mesh-ancestor
93301036|NCT00104871|Bortezomib|bortezomib|mesh-list
93301037|NCT00104871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301038|NCT03385538|Clopidogrel|clopidogrel|mesh-list
93301039|NCT03385538|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93301040|NCT03385538|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93301041|NCT03385538|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93301042|NCT03385538|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93301043|NCT03385538|Purinergic Agents|purinergic agents|mesh-ancestor
93301044|NCT03385538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301045|NCT03385538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301046|NCT03385538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301047|NCT02147379|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93301048|NCT02147379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93301049|NCT02147379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93301050|NCT02147379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301051|NCT02147379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301052|NCT02147379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93301053|NCT02147379|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93301054|NCT02147379|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93301055|NCT02147379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93301056|NCT02147379|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301057|NCT02147379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301058|NCT02147379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301059|NCT02147379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93301060|NCT02147379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93301061|NCT02147379|Serotonin Agents|serotonin agents|mesh-ancestor
93301062|NCT02147379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93301063|NCT02147379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93301064|NCT02147379|Dopamine Agents|dopamine agents|mesh-ancestor
93301065|NCT02148549|Oxaliplatin|oxaliplatin|mesh-list
93301066|NCT02148549|Irinotecan|irinotecan|mesh-list
93301067|NCT02148549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301068|NCT02148549|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93301069|NCT02148549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93301070|NCT02148549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301071|NCT02148549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301072|NCT03375398|PAZ320|paz320|mesh-list
93301073|NCT03375398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93301074|NCT03375398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301075|NCT02147535|Methylphenidate|methylphenidate|mesh-list
93301076|NCT02147535|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93301077|NCT02147535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301078|NCT02147535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93301079|NCT02147535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93301080|NCT02147535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301081|NCT02147535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301082|NCT02147535|Dopamine Agents|dopamine agents|mesh-ancestor
93301083|NCT02147535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301084|NCT03446612|Nitroprusside|nitroprusside|mesh-list
93301085|NCT03446612|Acetylcholine|acetylcholine|mesh-list
93301086|NCT03446612|Darbepoetin alfa|darbepoetin alfa|mesh-list
93301087|NCT03446612|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
93301088|NCT03446612|Hematinics|hematinics|mesh-ancestor
93301089|NCT03446612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93301090|NCT03446612|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301091|NCT03446612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93301092|NCT03446612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301093|NCT03446612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93301094|NCT03446612|Cholinergic Agents|cholinergic agents|mesh-ancestor
93301095|NCT03446612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301096|NCT03446612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301097|NCT03446612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301098|NCT02148783|Methylphenidate|methylphenidate|mesh-list
93301099|NCT02148783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93301100|NCT02148783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301101|NCT02148783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93301102|NCT02148783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93301103|NCT02148783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301104|NCT02148783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301105|NCT02148783|Dopamine Agents|dopamine agents|mesh-ancestor
93301106|NCT02148783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301107|NCT02155803|Hormones|hormones|mesh-list
93301108|NCT02155803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93301109|NCT02155803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93301110|NCT02155803|beta-Endorphin|beta-endorphin|mesh-list
93301111|NCT02155803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301112|NCT02155803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301113|NCT02155803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301114|NCT02155803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301115|NCT02148861|Insulin|insulin|mesh-list
93301116|NCT02148861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93301117|NCT02148861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93301118|NCT02148861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301119|NCT02152059|Nintedanib|nintedanib|mesh-list
93301120|NCT02152059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301121|NCT02152059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93301122|NCT02152059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301123|NCT02152059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301124|NCT02149095|Treprostinil|treprostinil|mesh-list
93301125|NCT02149095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93301126|NCT02149329|Meropenem|meropenem|mesh-list
93301127|NCT02149329|Imipenem|imipenem|mesh-list
93301128|NCT02149329|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
93301129|NCT02149329|Cilastatin|cilastatin|mesh-list
93301130|NCT02149329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93301131|NCT02149329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301132|NCT02149329|Protease Inhibitors|protease inhibitors|mesh-ancestor
93301133|NCT02149329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301134|NCT02149329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301135|NCT03255512|Isosorbide|isosorbide|mesh-list
93301136|NCT03255512|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93301137|NCT03255512|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93301138|NCT03255512|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93301139|NCT03255512|Diuretics|diuretics|mesh-ancestor
93301140|NCT03255512|Natriuretic Agents|natriuretic agents|mesh-ancestor
93301141|NCT03255512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301142|NCT03255512|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301143|NCT03255512|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93301144|NCT03255512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301145|NCT02149407|Glycerol|glycerol|mesh-list
93301146|NCT02149407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93301147|NCT02149407|Protective Agents|protective agents|mesh-ancestor
93301148|NCT02149407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301149|NCT03543657|Darbepoetin alfa|darbepoetin alfa|mesh-list
93301150|NCT03543657|Hematinics|hematinics|mesh-ancestor
93301151|NCT04925193|Dexamethasone|dexamethasone|mesh-list
93301152|NCT04925193|Daratumumab|daratumumab|mesh-list
93301153|NCT04925193|Pomalidomide|pomalidomide|mesh-list
93301154|NCT04925193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301155|NCT04925193|Antiemetics|antiemetics|mesh-ancestor
93301156|NCT04925193|Autonomic Agents|autonomic agents|mesh-ancestor
93301157|NCT04925193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301158|NCT04925193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301159|NCT04925193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93301160|NCT04925193|Glucocorticoids|glucocorticoids|mesh-ancestor
93301161|NCT04925193|Hormones|hormones|mesh-ancestor
93301162|NCT04925193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301163|NCT04925193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93301164|NCT04925193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301165|NCT04925193|Immunologic Factors|immunologic factors|mesh-ancestor
93301166|NCT04925193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93301167|NCT04925193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93301168|NCT04925193|Growth Substances|growth substances|mesh-ancestor
93301169|NCT04925193|Growth Inhibitors|growth inhibitors|mesh-ancestor
93301170|NCT03542955|Etoricoxib|etoricoxib|mesh-list
93301171|NCT03542955|Analgesics|analgesics|mesh-list
93301172|NCT03542955|Sensory System Agents|sensory system agents|mesh-ancestor
93301173|NCT03542955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301174|NCT03542955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301175|NCT03542955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93301176|NCT03542955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301177|NCT03542955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301178|NCT03542955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301179|NCT03542955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93301180|NCT03542955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93301181|NCT03542955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301182|NCT03542955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301183|NCT03542331|Ethiodized Oil|ethiodized oil|mesh-list
93301184|NCT03542331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301185|NCT03458260|Rituximab|rituximab|mesh-list
93301186|NCT03458260|Etoposide|etoposide|mesh-list
93301187|NCT03458260|Ifosfamide|ifosfamide|mesh-list
93301188|NCT03458260|Pixantrone|pixantrone|mesh-list
93301189|NCT03458260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301190|NCT03458260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301191|NCT03458260|Immunologic Factors|immunologic factors|mesh-ancestor
93301192|NCT03458260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301193|NCT03458260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301194|NCT03458260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93301195|NCT03458260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93301196|NCT03458260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93301197|NCT03458260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301198|NCT03458260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301199|NCT03458260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93301200|NCT03458260|Alkylating Agents|alkylating agents|mesh-ancestor
93301201|NCT04988074|Cemiplimab|cemiplimab|mesh-list
93301202|NCT04988074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301203|NCT04988074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301204|NCT00104637|Sildenafil Citrate|sildenafil citrate|mesh-list
93301205|NCT00104637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301206|NCT00104637|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301207|NCT00104637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93301208|NCT00104637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93301209|NCT00104637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301210|NCT00104637|Urological Agents|urological agents|mesh-ancestor
93301211|NCT04810208|Docetaxel|docetaxel|mesh-list
93301212|NCT04810208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301213|NCT04810208|Tubulin Modulators|tubulin modulators|mesh-ancestor
93301214|NCT04810208|Antimitotic Agents|antimitotic agents|mesh-ancestor
93301215|NCT04810208|Mitosis Modulators|mitosis modulators|mesh-ancestor
93301216|NCT04810208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301217|NCT04445636|Dexmedetomidine|dexmedetomidine|mesh-list
93301218|NCT04445636|Morphine|morphine|mesh-list
93301219|NCT04445636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93301220|NCT04445636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301221|NCT04445636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301222|NCT04445636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301223|NCT04445636|Analgesics|analgesics|mesh-ancestor
93301224|NCT04445636|Sensory System Agents|sensory system agents|mesh-ancestor
93301225|NCT04445636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301226|NCT04445636|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93301227|NCT04445636|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93301228|NCT04445636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93301229|NCT04445636|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301230|NCT04445636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301231|NCT04445636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301232|NCT04445636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93301233|NCT04445636|Narcotics|narcotics|mesh-ancestor
93301234|NCT02152917|Tranexamic Acid|tranexamic acid|mesh-list
93301235|NCT02152917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93301236|NCT02152917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93301237|NCT02152917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301238|NCT02152917|Hemostatics|hemostatics|mesh-ancestor
93301239|NCT02152917|Coagulants|coagulants|mesh-ancestor
93301240|NCT03111212|Iloprost|iloprost|mesh-list
93301241|NCT03111212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93301242|NCT03111212|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301243|NCT03170206|Palbociclib|palbociclib|mesh-list
93301244|NCT03170206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301245|NCT03170206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93301246|NCT03170206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301247|NCT03170206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301248|NCT05424016|Propranolol|propranolol|mesh-list
93301249|NCT05424016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93301250|NCT05424016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93301251|NCT05424016|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301252|NCT05424016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301253|NCT05424016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301254|NCT05424016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301255|NCT05424016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93301256|NCT05424016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93301257|NCT05424016|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301258|NCT02149953|Glycine|glycine|mesh-list
93301259|NCT02149953|Glycine Agents|glycine agents|mesh-ancestor
93301260|NCT02149953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301261|NCT02149953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301262|NCT02149953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301263|NCT03380936|Tacrolimus|tacrolimus|mesh-list
93301264|NCT03380936|Immunoglobulins|immunoglobulins|mesh-list
93301265|NCT03380936|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93301266|NCT03380936|Antibodies|antibodies|mesh-list
93301267|NCT03380936|gamma-Globulins|gamma-globulins|mesh-list
93301268|NCT03380936|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93301269|NCT03380936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301270|NCT03380936|Immunologic Factors|immunologic factors|mesh-ancestor
93301271|NCT03380936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301272|NCT03380936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93301273|NCT03380936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301274|NCT03380936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301275|NCT02150031|Chlorhexidine|chlorhexidine|mesh-list
93301276|NCT02150031|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93301277|NCT02150031|Lidocaine|lidocaine|mesh-list
93301278|NCT02150031|Epinephrine|epinephrine|mesh-list
93301279|NCT02150031|Racepinephrine|racepinephrine|mesh-list
93301280|NCT02150031|Epinephryl borate|epinephryl borate|mesh-list
93301281|NCT02150031|Anesthetics, Local|anesthetics, local|mesh-ancestor
93301282|NCT02150031|Anesthetics|anesthetics|mesh-ancestor
93301283|NCT02150031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301284|NCT02150031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301285|NCT02150031|Sensory System Agents|sensory system agents|mesh-ancestor
93301286|NCT02150031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301287|NCT02150031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93301288|NCT02150031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93301289|NCT02150031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93301290|NCT02150031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301291|NCT02150031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301292|NCT02150031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93301293|NCT02150031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301294|NCT02150031|Disinfectants|disinfectants|mesh-ancestor
93301295|NCT02150031|Dermatologic Agents|dermatologic agents|mesh-ancestor
93301296|NCT02150031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93301297|NCT02150031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93301298|NCT02150031|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301299|NCT02150031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301300|NCT02150031|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93301301|NCT02150031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93301302|NCT02150031|Autonomic Agents|autonomic agents|mesh-ancestor
93301303|NCT02150031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93301304|NCT02150031|Respiratory System Agents|respiratory system agents|mesh-ancestor
93301305|NCT02150031|Mydriatics|mydriatics|mesh-ancestor
93301306|NCT02150031|Sympathomimetics|sympathomimetics|mesh-ancestor
93301307|NCT02150031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93301308|NCT04655170|Albuterol|albuterol|mesh-list
93301309|NCT04655170|Formoterol Fumarate|formoterol fumarate|mesh-list
93301310|NCT04655170|Ipratropium|ipratropium|mesh-list
93301311|NCT04655170|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93301312|NCT04655170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93301313|NCT04655170|Autonomic Agents|autonomic agents|mesh-ancestor
93301314|NCT04655170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301315|NCT04655170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301316|NCT04655170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93301317|NCT04655170|Respiratory System Agents|respiratory system agents|mesh-ancestor
93301318|NCT04655170|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93301319|NCT04655170|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93301320|NCT04655170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93301321|NCT04655170|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301322|NCT04655170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301323|NCT04655170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301324|NCT04655170|Tocolytic Agents|tocolytic agents|mesh-ancestor
93301325|NCT04655170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301326|NCT04655170|Cholinergic Agents|cholinergic agents|mesh-ancestor
93301327|NCT04651348|Antibodies|antibodies|mesh-list
93301328|NCT04651348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93301329|NCT04651348|Immunologic Factors|immunologic factors|mesh-ancestor
93301330|NCT04651348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301331|NCT02156661|Oxytocin|oxytocin|mesh-list
93301332|NCT02156661|Oxytocics|oxytocics|mesh-ancestor
93301333|NCT02156661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301334|NCT02156661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301335|NCT03065062|Palbociclib|palbociclib|mesh-list
93301336|NCT03065062|Gedatolisib|gedatolisib|mesh-list
93301337|NCT03065062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301338|NCT03065062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93301339|NCT03065062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301340|NCT03065062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301341|NCT03374774|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93301342|NCT03374774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93301343|NCT03374774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301344|NCT04827862|Pembrolizumab|pembrolizumab|mesh-list
93301345|NCT04827862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301346|NCT04827862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301347|NCT04827862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93301348|NCT04827862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301349|NCT03374540|Vitamin K|vitamin k|mesh-list
93301350|NCT03374540|Rivaroxaban|rivaroxaban|mesh-list
93301351|NCT03374540|Vitamins|vitamins|mesh-ancestor
93301352|NCT03374540|Micronutrients|micronutrients|mesh-ancestor
93301353|NCT03374540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301354|NCT03374540|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93301355|NCT03374540|Antithrombins|antithrombins|mesh-ancestor
93301356|NCT03374540|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93301357|NCT03374540|Protease Inhibitors|protease inhibitors|mesh-ancestor
93301358|NCT03374540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301359|NCT03374540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301360|NCT03374540|Anticoagulants|anticoagulants|mesh-ancestor
93301361|NCT03374540|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93301362|NCT03374540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93301363|NCT03374540|Hemostatics|hemostatics|mesh-ancestor
93301364|NCT03374540|Coagulants|coagulants|mesh-ancestor
93301365|NCT02780115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93301366|NCT02780115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93301367|NCT03378674|Remifentanil|remifentanil|mesh-list
93301368|NCT03378674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93301369|NCT03378674|Narcotics|narcotics|mesh-ancestor
93301370|NCT03378674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301371|NCT03378674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301372|NCT03378674|Analgesics|analgesics|mesh-ancestor
93301373|NCT03378674|Sensory System Agents|sensory system agents|mesh-ancestor
93301374|NCT03378674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301375|NCT02157207|Vitamins|vitamins|mesh-list
93301376|NCT02157207|Vitamin E|vitamin e|mesh-list
93301377|NCT02157207|Antioxidants|antioxidants|mesh-list
93301378|NCT02157207|Micronutrients|micronutrients|mesh-ancestor
93301379|NCT02157207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301380|NCT02157207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301381|NCT02157207|Protective Agents|protective agents|mesh-ancestor
93301382|NCT02261103|Pramipexole|pramipexole|mesh-list
93301383|NCT02261103|Antioxidants|antioxidants|mesh-ancestor
93301384|NCT02261103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301385|NCT02261103|Protective Agents|protective agents|mesh-ancestor
93301386|NCT02261103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301387|NCT02261103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93301388|NCT02261103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93301389|NCT02261103|Dopamine Agonists|dopamine agonists|mesh-ancestor
93301390|NCT02261103|Dopamine Agents|dopamine agents|mesh-ancestor
93301391|NCT02261103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301392|NCT04703686|Obinutuzumab|obinutuzumab|mesh-list
93301393|NCT04703686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301394|NCT04703686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301395|NCT02766777|Lubiprostone|lubiprostone|mesh-list
93301396|NCT02766777|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93301397|NCT02766777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301398|NCT02766777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301399|NCT03374306|Atropine|atropine|mesh-list
93301400|NCT03374306|Lubricant Eye Drops|lubricant eye drops|mesh-list
93301401|NCT03374306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93301402|NCT03374306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93301403|NCT03374306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93301404|NCT03374306|Autonomic Agents|autonomic agents|mesh-ancestor
93301405|NCT03374306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301406|NCT03374306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301407|NCT03374306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93301408|NCT03374306|Respiratory System Agents|respiratory system agents|mesh-ancestor
93301409|NCT03374306|Mydriatics|mydriatics|mesh-ancestor
93301410|NCT03374306|Parasympatholytics|parasympatholytics|mesh-ancestor
93301411|NCT03374306|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93301412|NCT03374306|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93301413|NCT03374306|Cholinergic Agents|cholinergic agents|mesh-ancestor
93301414|NCT03374306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301415|NCT03374306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301416|NCT03374306|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93301417|NCT03374306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93301418|NCT05534230|Dexmedetomidine|dexmedetomidine|mesh-list
93301419|NCT05534230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93301420|NCT05534230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93301421|NCT05534230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301422|NCT05534230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301423|NCT05534230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301424|NCT05534230|Analgesics|analgesics|mesh-ancestor
93301425|NCT05534230|Sensory System Agents|sensory system agents|mesh-ancestor
93301426|NCT05534230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301427|NCT05534230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93301428|NCT05534230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93301430|NCT05534230|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301431|NCT05534230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301432|NCT05534230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301433|NCT03369782|Rocuronium|rocuronium|mesh-list
93301434|NCT03369782|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93301435|NCT03369782|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93301436|NCT03369782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93301437|NCT03369782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301438|NCT03369782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301439|NCT00157014|Cyclosporine|cyclosporine|mesh-list
93301440|NCT00157014|Mycophenolic Acid|mycophenolic acid|mesh-list
93301441|NCT00157014|Prednisone|prednisone|mesh-list
93301442|NCT00157014|Methylprednisolone|methylprednisolone|mesh-list
93301443|NCT00157014|Tacrolimus|tacrolimus|mesh-list
93301444|NCT00157014|Cyclosporins|cyclosporins|mesh-list
93301445|NCT00157014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301446|NCT00157014|Glucocorticoids|glucocorticoids|mesh-ancestor
93301447|NCT00157014|Hormones|hormones|mesh-ancestor
93301448|NCT00157014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301449|NCT00157014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301450|NCT00157014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93301451|NCT00157014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301452|NCT00157014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301453|NCT00157014|Immunologic Factors|immunologic factors|mesh-ancestor
93301454|NCT00157014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93301455|NCT00157014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301456|NCT00157014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301457|NCT00157014|Antifungal Agents|antifungal agents|mesh-ancestor
93301458|NCT00157014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301459|NCT00157014|Dermatologic Agents|dermatologic agents|mesh-ancestor
93301460|NCT00157014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301461|NCT00157014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93301462|NCT00157014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93301463|NCT00157014|Antitubercular Agents|antitubercular agents|mesh-ancestor
93301464|NCT00157014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93301465|NCT00157014|Antiemetics|antiemetics|mesh-ancestor
93301466|NCT00157014|Autonomic Agents|autonomic agents|mesh-ancestor
93301467|NCT00157014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301468|NCT00157014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93301469|NCT00157014|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93301470|NCT00157014|Protective Agents|protective agents|mesh-ancestor
93301471|NCT03374228|Linrodostat|linrodostat|mesh-list
93301472|NCT03374228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301473|NCT03374228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301474|NCT02778867|Fluticasone|fluticasone|mesh-list
93301475|NCT02778867|Xhance|xhance|mesh-list
93301476|NCT02778867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301477|NCT02778867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93301478|NCT02778867|Autonomic Agents|autonomic agents|mesh-ancestor
93301479|NCT02778867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301480|NCT02778867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301481|NCT02778867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93301482|NCT02778867|Respiratory System Agents|respiratory system agents|mesh-ancestor
93301483|NCT02778867|Dermatologic Agents|dermatologic agents|mesh-ancestor
93301484|NCT02778867|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93301485|NCT04232072|Ibuprofen|ibuprofen|mesh-list
93301486|NCT04232072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93301487|NCT04232072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301488|NCT04232072|Analgesics|analgesics|mesh-ancestor
93301489|NCT04232072|Sensory System Agents|sensory system agents|mesh-ancestor
93301490|NCT04232072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301491|NCT04232072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301492|NCT04232072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301493|NCT04232072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301494|NCT04232072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93301495|NCT04232072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301496|NCT04232072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301497|NCT02300064|Antioxidants|antioxidants|mesh-list
93301498|NCT02300064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301499|NCT02300064|Protective Agents|protective agents|mesh-ancestor
93301500|NCT02300064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301501|NCT02688712|Fluorouracil|fluorouracil|mesh-list
93301502|NCT02688712|Capecitabine|capecitabine|mesh-list
93301503|NCT02688712|Antimetabolites|antimetabolites|mesh-ancestor
93301504|NCT02688712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301505|NCT02688712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93301506|NCT02688712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301507|NCT02688712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301508|NCT02688712|Immunologic Factors|immunologic factors|mesh-ancestor
93301509|NCT02688712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301510|NCT03373994|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93301511|NCT03373994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93301512|NCT03373994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301513|NCT02617550|Nitroglycerin|nitroglycerin|mesh-list
93301514|NCT02617550|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301515|NCT03512808|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93301516|NCT03512808|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93301517|NCT03512808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93301518|NCT02519582|Niclosamide|niclosamide|mesh-list
93301519|NCT02519582|Anticestodal Agents|anticestodal agents|mesh-ancestor
93301520|NCT02519582|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93301521|NCT02519582|Anthelmintics|anthelmintics|mesh-ancestor
93301522|NCT02519582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93301523|NCT02519582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301524|NCT02519582|Antinematodal Agents|antinematodal agents|mesh-ancestor
93301526|NCT02467582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93301527|NCT02467582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301528|NCT02467582|Analgesics|analgesics|mesh-ancestor
93301529|NCT02467582|Sensory System Agents|sensory system agents|mesh-ancestor
93301530|NCT02467582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301531|NCT02467582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301532|NCT02467582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301533|NCT02467582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301534|NCT02467582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93301535|NCT02467582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93301536|NCT02467582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301537|NCT02467582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93301538|NCT02467582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93301539|NCT02467582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301540|NCT02467582|Antipyretics|antipyretics|mesh-ancestor
93301541|NCT05467462|Tranexamic Acid|tranexamic acid|mesh-list
93301542|NCT05467462|Oxytocin|oxytocin|mesh-list
93301543|NCT05467462|Carbetocin|carbetocin|mesh-list
93301544|NCT05467462|Oxytocics|oxytocics|mesh-ancestor
93301545|NCT05467462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301546|NCT05467462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301547|NCT05467462|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93301548|NCT05467462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93301549|NCT05467462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301550|NCT05467462|Hemostatics|hemostatics|mesh-ancestor
93301551|NCT05467462|Coagulants|coagulants|mesh-ancestor
93301552|NCT03369002|Seladelpar|seladelpar|mesh-list
93301553|NCT03369002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93301554|NCT03369002|Antimetabolites|antimetabolites|mesh-ancestor
93301555|NCT03369002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301556|NCT03369002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93301557|NCT05533606|Lactams|lactams|mesh-list
93301558|NCT05533606|beta-Lactams|beta-lactams|mesh-list
93301559|NCT05533606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93301560|NCT05533606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301561|NCT02300376|Edetic Acid|edetic acid|mesh-list
93301562|NCT02300376|Calcium|calcium|mesh-list
93301563|NCT02300376|Pentetic Acid|pentetic acid|mesh-list
93301564|NCT02300376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93301565|NCT02300376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301566|NCT02300376|Anticoagulants|anticoagulants|mesh-ancestor
93301567|NCT02300376|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93301568|NCT02300376|Chelating Agents|chelating agents|mesh-ancestor
93301569|NCT02300376|Sequestering Agents|sequestering agents|mesh-ancestor
93301570|NCT02300376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301571|NCT02300376|Antidotes|antidotes|mesh-ancestor
93301572|NCT02300376|Protective Agents|protective agents|mesh-ancestor
93301573|NCT02300376|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93301574|NCT02296398|Romidepsin|romidepsin|mesh-list
93301575|NCT02296398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93301576|NCT02296398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301577|NCT02296398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93301578|NCT02296398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301579|NCT02296398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301581|NCT03520062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93301582|NCT03520062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301583|NCT03520062|Incretins|incretins|mesh-ancestor
93301584|NCT03520062|Hormones|hormones|mesh-ancestor
93301585|NCT03520062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301586|NCT02206984|Tamoxifen|tamoxifen|mesh-list
93301587|NCT02206984|Fulvestrant|fulvestrant|mesh-list
93301588|NCT02206984|Anastrozole|anastrozole|mesh-list
93301589|NCT02206984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93301590|NCT02206984|Hormone Antagonists|hormone antagonists|mesh-ancestor
93301591|NCT02206984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301592|NCT02206984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301593|NCT02206984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93301594|NCT02206984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301595|NCT02206984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93301596|NCT02206984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93301597|NCT02206984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93301598|NCT02206984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93301599|NCT02206984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93301600|NCT02206984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93301601|NCT02206984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301602|NCT02206984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301603|NCT03512574|Pregabalin|pregabalin|mesh-list
93301604|NCT03512574|Dexmedetomidine|dexmedetomidine|mesh-list
93301605|NCT03512574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93301606|NCT03512574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301607|NCT03512574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301608|NCT03512574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301609|NCT03512574|Analgesics|analgesics|mesh-ancestor
93301610|NCT03512574|Sensory System Agents|sensory system agents|mesh-ancestor
93301611|NCT03512574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301612|NCT03512574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93301613|NCT03512574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93301614|NCT03512574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93301615|NCT03512574|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301616|NCT03512574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301617|NCT03512574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301618|NCT03512574|Anticonvulsants|anticonvulsants|mesh-ancestor
93301619|NCT03512574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93301620|NCT03512574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301621|NCT03512574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93301622|NCT03512574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93301623|NCT03512574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93301624|NCT03512574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93301625|NCT01994980|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93301626|NCT01994980|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93301627|NCT01994980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301628|NCT01994980|Antitubercular Agents|antitubercular agents|mesh-ancestor
93301629|NCT03377348|Triamcinolone|triamcinolone|mesh-list
93301630|NCT03377348|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93301631|NCT03377348|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93301632|NCT03377348|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93301633|NCT03377348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301634|NCT03377348|Glucocorticoids|glucocorticoids|mesh-ancestor
93301635|NCT03377348|Hormones|hormones|mesh-ancestor
93301636|NCT03377348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301637|NCT03377348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301638|NCT03377348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301639|NCT03377348|Immunologic Factors|immunologic factors|mesh-ancestor
93301640|NCT03377348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301641|NCT03377348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301642|NCT02255253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93301643|NCT02255253|Telmisartan|telmisartan|mesh-list
93301644|NCT02255253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93301645|NCT02255253|Diuretics|diuretics|mesh-ancestor
93301646|NCT02255253|Natriuretic Agents|natriuretic agents|mesh-ancestor
93301647|NCT02255253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596201|NCT00133185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93301648|NCT02255253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93301649|NCT02255253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301650|NCT02255253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301651|NCT02255253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93301652|NCT02255253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93301653|NCT02300688|Maleic acid|maleic acid|mesh-list
93301654|NCT02300688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301655|NCT02300688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301656|NCT03896984|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93301657|NCT03896984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301658|NCT02151279|Chitosan|chitosan|mesh-list
93301659|NCT02151279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93301660|NCT02151279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93301661|NCT02151279|Antimetabolites|antimetabolites|mesh-ancestor
93301662|NCT02151279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301663|NCT02151279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93301664|NCT02151279|Chelating Agents|chelating agents|mesh-ancestor
93301665|NCT02151279|Sequestering Agents|sequestering agents|mesh-ancestor
93301666|NCT02151279|Hemostatics|hemostatics|mesh-ancestor
93301667|NCT02151279|Coagulants|coagulants|mesh-ancestor
93301668|NCT02159313|Riociguat|riociguat|mesh-list
93301669|NCT02159313|Enzyme Activators|enzyme activators|mesh-ancestor
93301670|NCT02159313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301671|NCT03515772|Darunavir|darunavir|mesh-list
93301672|NCT03515772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93301673|NCT03515772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93301674|NCT03515772|Protease Inhibitors|protease inhibitors|mesh-ancestor
93301675|NCT03515772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301676|NCT03515772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301677|NCT03515772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93301678|NCT03515772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93301679|NCT03515772|Antiviral Agents|antiviral agents|mesh-ancestor
93301680|NCT03515772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301681|NCT03519750|Melatonin|melatonin|mesh-list
93301682|NCT03519750|Antioxidants|antioxidants|mesh-ancestor
93301683|NCT03519750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301684|NCT03519750|Protective Agents|protective agents|mesh-ancestor
93301685|NCT03519750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301686|NCT03519750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301687|NCT02158143|Vitamin D|vitamin d|mesh-list
93301688|NCT02158143|Cholecalciferol|cholecalciferol|mesh-list
93301689|NCT02158143|Vitamins|vitamins|mesh-ancestor
93301690|NCT02158143|Micronutrients|micronutrients|mesh-ancestor
93301691|NCT02158143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301692|NCT02158143|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93301693|NCT02158143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93301694|NCT02158221|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
93301695|NCT02158221|Growth Substances|growth substances|mesh-ancestor
93301696|NCT02158221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301697|NCT02158221|Vasodilator Agents|vasodilator agents|mesh-ancestor
93301698|NCT02158221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301699|NCT02158221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301700|NCT02519816|Plasma-lyte 148|plasma-lyte 148|mesh-list
93301701|NCT02519816|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93301702|NCT02519816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93301703|NCT02301000|Metronidazole|metronidazole|mesh-list
93301704|NCT02301000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301705|NCT02301000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93301706|NCT02301000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93301707|NCT02301000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93301708|NCT02292732|Trametinib|trametinib|mesh-list
93301709|NCT02292732|Norinyl|norinyl|mesh-list
93301710|NCT02292732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301711|NCT02292732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93301712|NCT02292732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301713|NCT02292732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301714|NCT02292732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93301715|NCT02292732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93301716|NCT02292732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93301717|NCT02292732|Contraceptive Agents|contraceptive agents|mesh-ancestor
93301718|NCT02292732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301719|NCT02292732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301720|NCT02292732|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93301721|NCT02292732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93301722|NCT03376958|Apatinib|apatinib|mesh-list
93301723|NCT03376958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301724|NCT03376958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93301725|NCT03376958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301726|NCT03376958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301728|NCT03367676|Trastuzumab|trastuzumab|mesh-list
93301729|NCT03367676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301730|NCT03367676|Tubulin Modulators|tubulin modulators|mesh-ancestor
93301731|NCT03367676|Antimitotic Agents|antimitotic agents|mesh-ancestor
93301732|NCT03367676|Mitosis Modulators|mitosis modulators|mesh-ancestor
93301733|NCT03367676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301734|NCT03367676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301735|NCT03515538|Cisplatin|cisplatin|mesh-list
93301736|NCT03515538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301737|NCT02158689|Letrozole|letrozole|mesh-list
93301738|NCT02158689|Menotropins|menotropins|mesh-list
93301739|NCT02158689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301740|NCT02158689|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93301741|NCT02158689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93301742|NCT02158689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301743|NCT02158689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301744|NCT02158689|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93301745|NCT02158689|Hormone Antagonists|hormone antagonists|mesh-ancestor
93301746|NCT02158689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301747|NCT02158689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301748|NCT02158689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93301749|NCT02158689|Fertility Agents|fertility agents|mesh-ancestor
93301750|NCT02158689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301751|NCT03372200|Febuxostat|febuxostat|mesh-list
93301752|NCT03372200|Dotinurad|dotinurad|mesh-list
93301753|NCT03372200|Gout Suppressants|gout suppressants|mesh-ancestor
93301754|NCT03372200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301755|NCT03372200|Uricosuric Agents|uricosuric agents|mesh-ancestor
93301756|NCT03372122|Chlorhexidine|chlorhexidine|mesh-list
93301757|NCT03372122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93301758|NCT03372122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93301759|NCT03372122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301760|NCT03372122|Disinfectants|disinfectants|mesh-ancestor
93301761|NCT03372122|Dermatologic Agents|dermatologic agents|mesh-ancestor
93301762|NCT02158845|Leuprolide|leuprolide|mesh-list
93301763|NCT02158845|Levonorgestrel|levonorgestrel|mesh-list
93301764|NCT02158845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93301765|NCT02158845|Fertility Agents|fertility agents|mesh-ancestor
93301766|NCT02158845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93301767|NCT02158845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301768|NCT02158845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93301769|NCT02158845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301770|NCT02158845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93301771|NCT02158845|Contraceptive Agents|contraceptive agents|mesh-ancestor
93301772|NCT02158845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93301773|NCT02158845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93301774|NCT02158845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93301775|NCT02292966|Asunaprevir|asunaprevir|mesh-list
93301776|NCT02292966|Protease Inhibitors|protease inhibitors|mesh-ancestor
93301777|NCT02292966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596351|NCT00102284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93301778|NCT02292966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301779|NCT02519660|Lidocaine|lidocaine|mesh-list
93301780|NCT02519660|Tetracaine|tetracaine|mesh-list
93301781|NCT02519660|Prilocaine|prilocaine|mesh-list
93301782|NCT02519660|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93301783|NCT02519660|Anesthetics, Local|anesthetics, local|mesh-ancestor
93301784|NCT02519660|Anesthetics|anesthetics|mesh-ancestor
93301785|NCT02519660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301786|NCT02519660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301787|NCT02519660|Sensory System Agents|sensory system agents|mesh-ancestor
93301788|NCT02519660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301789|NCT02519660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93301790|NCT02519660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93301791|NCT02519660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93301792|NCT02519660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301793|NCT02519660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301794|NCT02519660|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93301795|NCT02297490|Immunomodulating Agents|immunomodulating agents|mesh-list
93301796|NCT02297490|Immunologic Factors|immunologic factors|mesh-ancestor
93301797|NCT02297490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301798|NCT02297568|Vitamin D|vitamin d|mesh-list
93301799|NCT02297568|Ergocalciferols|ergocalciferols|mesh-list
93301800|NCT02297568|Vitamins|vitamins|mesh-ancestor
93301801|NCT02297568|Micronutrients|micronutrients|mesh-ancestor
93301802|NCT02297568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301803|NCT02297568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93301804|NCT02297568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93301805|NCT03515382|Itraconazole|itraconazole|mesh-list
93301806|NCT03515382|Voriconazole|voriconazole|mesh-list
93301807|NCT03515382|Antifungal Agents|antifungal agents|mesh-ancestor
93301808|NCT03515382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301809|NCT03515382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93301810|NCT03515382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93301811|NCT03515382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301812|NCT03515382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301813|NCT03515382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93301814|NCT03515382|Hormone Antagonists|hormone antagonists|mesh-ancestor
93301815|NCT03515382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301816|NCT03515382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301817|NCT03515382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93301818|NCT03511560|Tacrolimus|tacrolimus|mesh-list
93301819|NCT03511560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301820|NCT03511560|Immunologic Factors|immunologic factors|mesh-ancestor
93301821|NCT03511560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301822|NCT03511560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93301823|NCT03511560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301824|NCT03511560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301825|NCT03688802|Varenicline|varenicline|mesh-list
93301826|NCT03688802|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93301827|NCT03688802|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93301828|NCT03688802|Cholinergic Agents|cholinergic agents|mesh-ancestor
93301829|NCT03688802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301830|NCT03688802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301831|NCT03688802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301832|NCT02293356|Nimotuzumab|nimotuzumab|mesh-list
93301833|NCT02293356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301834|NCT02293356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301835|NCT03616418|Antihypertensive Agents|antihypertensive agents|mesh-list
93301836|NCT03616418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93301837|NCT03371498|Methylprednisolone|methylprednisolone|mesh-list
93301838|NCT03371498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93301839|NCT03371498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93301840|NCT03371498|Prednisolone|prednisolone|mesh-list
93301841|NCT03371498|Prednisolone acetate|prednisolone acetate|mesh-list
92596402|NCT00102479|Serotonin Agents|serotonin agents|mesh-ancestor
93301842|NCT03371498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93301843|NCT03371498|Prednisolone phosphate|prednisolone phosphate|mesh-list
93301844|NCT03371498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301845|NCT03371498|Antiemetics|antiemetics|mesh-ancestor
93301846|NCT03371498|Autonomic Agents|autonomic agents|mesh-ancestor
93301847|NCT03371498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301848|NCT03371498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301849|NCT03371498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93301850|NCT03371498|Glucocorticoids|glucocorticoids|mesh-ancestor
93301851|NCT03371498|Hormones|hormones|mesh-ancestor
93301852|NCT03371498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93301853|NCT03371498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93301854|NCT03371498|Protective Agents|protective agents|mesh-ancestor
93301855|NCT03371498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93301856|NCT03371498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301857|NCT03376178|Lidocaine|lidocaine|mesh-list
93301858|NCT03376178|Ropivacaine|ropivacaine|mesh-list
93301859|NCT03376178|Anesthetics, Local|anesthetics, local|mesh-ancestor
93301860|NCT03376178|Anesthetics|anesthetics|mesh-ancestor
93301861|NCT03376178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301862|NCT03376178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301863|NCT03376178|Sensory System Agents|sensory system agents|mesh-ancestor
93301864|NCT03376178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301865|NCT03376178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93301866|NCT03376178|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93301867|NCT03376178|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93301868|NCT03376178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301869|NCT03376178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301870|NCT03514836|Cyclophosphamide|cyclophosphamide|mesh-list
93301871|NCT03514836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301872|NCT03514836|Immunologic Factors|immunologic factors|mesh-ancestor
93301873|NCT03514836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301874|NCT03514836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301875|NCT03514836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93301876|NCT03514836|Alkylating Agents|alkylating agents|mesh-ancestor
93301877|NCT03514836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301878|NCT03514836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301879|NCT03514836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93301880|NCT03371342|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93301881|NCT03371342|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93301882|NCT03371342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301883|NCT03371342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301884|NCT03371342|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93301885|NCT03371342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301886|NCT03371342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301887|NCT03371342|Cholinergic Agents|cholinergic agents|mesh-ancestor
93301888|NCT03371342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301889|NCT02302326|Folic Acid|folic acid|mesh-list
93301890|NCT02302326|Inositol|inositol|mesh-list
93301891|NCT02302326|Metformin|metformin|mesh-list
93301892|NCT02302326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93301893|NCT02302326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301894|NCT02302326|Hematinics|hematinics|mesh-ancestor
93301895|NCT02302326|Vitamin B Complex|vitamin b complex|mesh-ancestor
93301896|NCT02302326|Vitamins|vitamins|mesh-ancestor
93301897|NCT02302326|Micronutrients|micronutrients|mesh-ancestor
93301898|NCT02293590|Sulfasalazine|sulfasalazine|mesh-list
93301899|NCT02293590|Certolizumab Pegol|certolizumab pegol|mesh-list
93301900|NCT02293590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93301901|NCT02293590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301902|NCT02293590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301903|NCT02293590|Immunologic Factors|immunologic factors|mesh-ancestor
93301904|NCT02293590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301905|NCT02293590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301906|NCT02293590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93301907|NCT02293590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93301908|NCT02293590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301909|NCT02293590|Analgesics|analgesics|mesh-ancestor
93301910|NCT02293590|Sensory System Agents|sensory system agents|mesh-ancestor
93301911|NCT02293590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301912|NCT02293590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596468|NCT00102713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301913|NCT02302404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93301914|NCT03124082|Lidocaine|lidocaine|mesh-list
93301915|NCT03124082|Clonidine|clonidine|mesh-list
93301916|NCT03124082|Ketamine|ketamine|mesh-list
93301917|NCT03124082|Remifentanil|remifentanil|mesh-list
93301918|NCT03124082|Anesthetics, Local|anesthetics, local|mesh-ancestor
93301919|NCT03124082|Anesthetics|anesthetics|mesh-ancestor
93301920|NCT03124082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93301921|NCT03124082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301922|NCT03124082|Sensory System Agents|sensory system agents|mesh-ancestor
93301923|NCT03124082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301924|NCT03124082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93301925|NCT03124082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93301926|NCT03124082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93301927|NCT03124082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93301928|NCT03124082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301929|NCT03124082|Analgesics|analgesics|mesh-ancestor
93301930|NCT03124082|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93301931|NCT03124082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93301932|NCT03124082|Anesthetics, General|anesthetics, general|mesh-ancestor
93301933|NCT03124082|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93301934|NCT03124082|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93301935|NCT03124082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93301936|NCT03124082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93301937|NCT03124082|Narcotics|narcotics|mesh-ancestor
93301938|NCT03124082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93301939|NCT03124082|Sympatholytics|sympatholytics|mesh-ancestor
93301940|NCT03124082|Autonomic Agents|autonomic agents|mesh-ancestor
93301941|NCT03124082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93301942|NCT03124082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93301943|NCT03124082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93301944|NCT03124082|Adrenergic Agents|adrenergic agents|mesh-ancestor
93301945|NCT03518502|Sorafenib|sorafenib|mesh-list
93301946|NCT03518502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301947|NCT03518502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93301948|NCT03518502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301949|NCT03518502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301950|NCT02301780|Aspirin|aspirin|mesh-list
92974027|NCT00854802|Ribavirin|ribavirin|mesh-list
93301951|NCT02301780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93301952|NCT02301780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93301953|NCT02301780|Analgesics|analgesics|mesh-ancestor
93301954|NCT02301780|Sensory System Agents|sensory system agents|mesh-ancestor
93301955|NCT02301780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93301956|NCT02301780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301957|NCT02301780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93301958|NCT02301780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301959|NCT02301780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93301960|NCT02301780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93301961|NCT02301780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301962|NCT02301780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93301963|NCT02301780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93301964|NCT02301780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301965|NCT02301780|Antipyretics|antipyretics|mesh-ancestor
93301966|NCT04527068|Bevacizumab|bevacizumab|mesh-list
93301967|NCT04527068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93301968|NCT04527068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596541|NCT00102947|Daptomycin|daptomycin|mesh-list
93301969|NCT04527068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93301970|NCT04527068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93301971|NCT04527068|Growth Substances|growth substances|mesh-ancestor
93301972|NCT04527068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301973|NCT04527068|Growth Inhibitors|growth inhibitors|mesh-ancestor
93301974|NCT02739360|Idelalisib|idelalisib|mesh-list
93301975|NCT02739360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301976|NCT02739360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301977|NCT02739360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301978|NCT03123770|Cyclophosphamide|cyclophosphamide|mesh-list
93301979|NCT03123770|Docetaxel|docetaxel|mesh-list
93301980|NCT03123770|Doxorubicin|doxorubicin|mesh-list
93301981|NCT03123770|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93301982|NCT03123770|Epirubicin|epirubicin|mesh-list
93301983|NCT03123770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93301984|NCT03123770|Immunologic Factors|immunologic factors|mesh-ancestor
93301985|NCT03123770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93301986|NCT03123770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93301987|NCT03123770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93301988|NCT03123770|Alkylating Agents|alkylating agents|mesh-ancestor
93301989|NCT03123770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93301990|NCT03123770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93301991|NCT03123770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93301992|NCT03123770|Tubulin Modulators|tubulin modulators|mesh-ancestor
93301993|NCT03123770|Antimitotic Agents|antimitotic agents|mesh-ancestor
93301994|NCT03123770|Mitosis Modulators|mitosis modulators|mesh-ancestor
93301995|NCT03123770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93301996|NCT03123770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93301997|NCT03123770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93301998|NCT03123770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93301999|NCT04464642|Methotrexate|methotrexate|mesh-list
93302000|NCT04464642|Tofacitinib|tofacitinib|mesh-list
93302001|NCT04464642|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93302002|NCT04464642|Abortifacient Agents|abortifacient agents|mesh-ancestor
93302003|NCT04464642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302004|NCT04464642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302005|NCT04464642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93302006|NCT04464642|Antimetabolites|antimetabolites|mesh-ancestor
93302007|NCT04464642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302008|NCT04464642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302009|NCT04464642|Dermatologic Agents|dermatologic agents|mesh-ancestor
93302010|NCT04464642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302011|NCT04464642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93302012|NCT04464642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302013|NCT04464642|Immunologic Factors|immunologic factors|mesh-ancestor
93302014|NCT04464642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302015|NCT04464642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93302016|NCT04464642|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93302017|NCT04464642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93302018|NCT02293668|Letrozole|letrozole|mesh-list
93302019|NCT02293668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302020|NCT02293668|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93302021|NCT02293668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93302022|NCT02293668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302023|NCT02293668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302024|NCT02293668|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92974103|NCT00970905|Ondansetron|ondansetron|mesh-list
93302026|NCT02293668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302027|NCT02293668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302028|NCT03123692|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
93302029|NCT03123692|Chelating Agents|chelating agents|mesh-ancestor
93302030|NCT03123692|Sequestering Agents|sequestering agents|mesh-ancestor
93302031|NCT03123692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302032|NCT04526210|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
93302033|NCT04526210|Choline|choline|mesh-list
93302034|NCT04526210|Bupropion|bupropion|mesh-list
93302035|NCT04526210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93302036|NCT04526210|Antidepressive Agents|antidepressive agents|mesh-ancestor
93302037|NCT04526210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93302038|NCT04526210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93302039|NCT04526210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93302040|NCT04526210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93302041|NCT04526210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302042|NCT04526210|Dopamine Agents|dopamine agents|mesh-ancestor
93302043|NCT04526210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302044|NCT04526210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302045|NCT04526210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93302046|NCT04526210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93302047|NCT04526210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302048|NCT04526210|Lipotropic Agents|lipotropic agents|mesh-ancestor
93302049|NCT04526210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93302050|NCT04526210|Antimetabolites|antimetabolites|mesh-ancestor
93302051|NCT04526210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302052|NCT04526210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93302053|NCT04526210|Nootropic Agents|nootropic agents|mesh-ancestor
93302054|NCT04526210|Chelating Agents|chelating agents|mesh-ancestor
93302055|NCT04526210|Sequestering Agents|sequestering agents|mesh-ancestor
93302056|NCT04526210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93302057|NCT04526210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93302058|NCT04526210|Growth Substances|growth substances|mesh-ancestor
93302059|NCT04526210|Growth Inhibitors|growth inhibitors|mesh-ancestor
93302060|NCT04526210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302061|NCT03375632|Dotinurad|dotinurad|mesh-list
93302062|NCT03375632|Uricosuric Agents|uricosuric agents|mesh-ancestor
93302063|NCT03375632|Gout Suppressants|gout suppressants|mesh-ancestor
93302064|NCT03375632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302065|NCT02302170|Vaccines|vaccines|mesh-list
93302066|NCT02302170|Immunologic Factors|immunologic factors|mesh-ancestor
93302067|NCT02302170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302068|NCT03371186|Contraceptive Agents|contraceptive agents|mesh-list
93302069|NCT03371186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302070|NCT03371186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302071|NCT02302950|Raltegravir Potassium|raltegravir potassium|mesh-list
93302072|NCT02302950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93302073|NCT02302950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93302074|NCT02302950|Antiviral Agents|antiviral agents|mesh-ancestor
93302075|NCT02302950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302076|NCT02302950|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93302077|NCT02302950|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93302078|NCT02302950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302079|NCT02302950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302080|NCT02293824|Caffeine|caffeine|mesh-list
93302081|NCT02293824|Caffeine citrate|caffeine citrate|mesh-list
93302082|NCT02293824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302083|NCT02293824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93302084|NCT02293824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302085|NCT02293824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93302086|NCT02293824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302087|NCT02293824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93302088|NCT02293824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93302089|NCT02293824|Purinergic Agents|purinergic agents|mesh-ancestor
93302090|NCT02293824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302091|NCT03366584|Vitamin D|vitamin d|mesh-list
93302092|NCT03366584|Cholecalciferol|cholecalciferol|mesh-list
93302093|NCT03366584|Beta Carotene|beta carotene|mesh-list
93302094|NCT03366584|Zinc|zinc|mesh-list
93302095|NCT03366584|Dexamethasone|dexamethasone|mesh-list
93302096|NCT03366584|Carotenoids|carotenoids|mesh-list
93302097|NCT03366584|Picolinic acid|picolinic acid|mesh-list
93302098|NCT03366584|Vitamins|vitamins|mesh-ancestor
93302099|NCT03366584|Micronutrients|micronutrients|mesh-ancestor
92974172|NCT00959439|Naproxen|naproxen|mesh-list
92596660|NCT00103298|Antidotes|antidotes|mesh-ancestor
93302100|NCT03366584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302102|NCT03366584|Antiemetics|antiemetics|mesh-ancestor
93302103|NCT03366584|Autonomic Agents|autonomic agents|mesh-ancestor
93302104|NCT03366584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302105|NCT03366584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302106|NCT03366584|Glucocorticoids|glucocorticoids|mesh-ancestor
93302107|NCT03366584|Hormones|hormones|mesh-ancestor
93302108|NCT03366584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302109|NCT03366584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93302110|NCT03366584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302111|NCT03366584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93302112|NCT03366584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93302113|NCT03366584|Trace Elements|trace elements|mesh-ancestor
93302114|NCT03366584|Antioxidants|antioxidants|mesh-ancestor
93302115|NCT03366584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302116|NCT03366584|Protective Agents|protective agents|mesh-ancestor
93302117|NCT03366584|Provitamins|provitamins|mesh-ancestor
93302118|NCT03366584|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93302119|NCT03366584|Chelating Agents|chelating agents|mesh-ancestor
93302120|NCT03366584|Sequestering Agents|sequestering agents|mesh-ancestor
93302121|NCT03370562|Dexmedetomidine|dexmedetomidine|mesh-list
93302122|NCT03370562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93302123|NCT03370562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302124|NCT03370562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302125|NCT03370562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302126|NCT03370562|Analgesics|analgesics|mesh-ancestor
93302127|NCT03370562|Sensory System Agents|sensory system agents|mesh-ancestor
93302128|NCT03370562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302129|NCT03370562|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93302130|NCT03370562|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93302131|NCT03370562|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93302132|NCT03370562|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302133|NCT03370562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302134|NCT03370562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302135|NCT03370328|Peppermint oil|peppermint oil|mesh-list
93302136|NCT03370328|Antiemetics|antiemetics|mesh-ancestor
93302137|NCT03370328|Autonomic Agents|autonomic agents|mesh-ancestor
93302138|NCT03370328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302139|NCT03370328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302140|NCT03370328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302141|NCT03370328|Parasympatholytics|parasympatholytics|mesh-ancestor
93302142|NCT02303106|Lamotrigine|lamotrigine|mesh-list
93302143|NCT02303106|Anticonvulsants|anticonvulsants|mesh-ancestor
93302144|NCT02303106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93302145|NCT02303106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93302146|NCT02303106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302147|NCT02303106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93302148|NCT02303106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302149|NCT02303106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93302150|NCT02303106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93302151|NCT02303106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302152|NCT02303106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93302153|NCT02303106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93302154|NCT04525664|Amoxicillin|amoxicillin|mesh-list
93302155|NCT04525664|Clarithromycin|clarithromycin|mesh-list
93302156|NCT04525664|Omeprazole|omeprazole|mesh-list
93302157|NCT04525664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302158|NCT04525664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302159|NCT04525664|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93302160|NCT04525664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302161|NCT04525664|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93302162|NCT04525664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302163|NCT04525664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302164|NCT04525664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93302165|NCT04525664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93302166|NCT04525664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93302167|NCT03510546|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93302168|NCT03510546|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93302169|NCT03510546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302170|NCT03510546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302171|NCT03510546|Cholinergic Agents|cholinergic agents|mesh-ancestor
93302172|NCT03510546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302173|NCT03510546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302174|NCT03505008|Adalimumab|adalimumab|mesh-list
93302175|NCT03505008|Methotrexate|methotrexate|mesh-list
93302176|NCT03505008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93302177|NCT03505008|Abortifacient Agents|abortifacient agents|mesh-ancestor
93302178|NCT03505008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302179|NCT03505008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302180|NCT03505008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93302181|NCT03505008|Antimetabolites|antimetabolites|mesh-ancestor
93302182|NCT03505008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302183|NCT03505008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302184|NCT03505008|Dermatologic Agents|dermatologic agents|mesh-ancestor
93302185|NCT03505008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302186|NCT03505008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93302187|NCT03505008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302188|NCT03505008|Immunologic Factors|immunologic factors|mesh-ancestor
93302189|NCT03505008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302190|NCT03505008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93302191|NCT03505008|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93302192|NCT03505008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302193|NCT03507426|Ketamine|ketamine|mesh-list
93302194|NCT03507426|Analgesics|analgesics|mesh-ancestor
93302195|NCT03507426|Sensory System Agents|sensory system agents|mesh-ancestor
93302196|NCT03507426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302197|NCT03507426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302198|NCT03507426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93302199|NCT03507426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93302200|NCT03507426|Anesthetics, General|anesthetics, general|mesh-ancestor
93302201|NCT03507426|Anesthetics|anesthetics|mesh-ancestor
93302202|NCT03507426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302203|NCT03507426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93302204|NCT03507426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93302205|NCT03507426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302206|NCT03507426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302207|NCT02311530|Felodipine|felodipine|mesh-list
93302208|NCT02311530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93302209|NCT02311530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93302210|NCT02311530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93302211|NCT02311530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93302212|NCT02311530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302213|NCT02311530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93302214|NCT02311530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302215|NCT02311530|Vasodilator Agents|vasodilator agents|mesh-ancestor
93302216|NCT04522466|Hydroxychloroquine|hydroxychloroquine|mesh-list
93302217|NCT04522466|Antimalarials|antimalarials|mesh-ancestor
93302218|NCT04522466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93302219|NCT04522466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93302220|NCT04522466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302221|NCT04522466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302222|NCT04522466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302223|NCT04522466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302224|NCT02306772|Mesalamine|mesalamine|mesh-list
93302225|NCT02306772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93302226|NCT02306772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302227|NCT02306772|Analgesics|analgesics|mesh-ancestor
93302228|NCT02306772|Sensory System Agents|sensory system agents|mesh-ancestor
93302229|NCT02306772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302230|NCT02306772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302231|NCT02306772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302232|NCT02306772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302233|NCT03507348|Rituximab|rituximab|mesh-list
93302234|NCT03507348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302235|NCT03507348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302236|NCT03507348|Immunologic Factors|immunologic factors|mesh-ancestor
93302237|NCT03507348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302238|NCT03507348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302239|NCT02518802|Pemetrexed|pemetrexed|mesh-list
93302240|NCT02518802|Gefitinib|gefitinib|mesh-list
93302241|NCT02518802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302242|NCT02518802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302243|NCT02518802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302244|NCT02518802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93302245|NCT02518802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93302246|NCT02518802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93302247|NCT04524026|Letrozole|letrozole|mesh-list
93302248|NCT04524026|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93302249|NCT04524026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302250|NCT04524026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93302251|NCT04524026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302252|NCT04524026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302253|NCT04524026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93302254|NCT04524026|Hormone Antagonists|hormone antagonists|mesh-ancestor
93302255|NCT04524026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302256|NCT04524026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302257|NCT02311608|Octreotide|octreotide|mesh-list
93302258|NCT02311608|Terlipressin|terlipressin|mesh-list
93302259|NCT02311608|Somatostatin|somatostatin|mesh-list
93302260|NCT02311608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302261|NCT02311608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93302262|NCT02311608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302263|NCT02311608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93302264|NCT02311608|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93302265|NCT02311608|Hormones|hormones|mesh-ancestor
93302266|NCT02311608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302267|NCT02311608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302268|NCT02307006|Vancomycin|vancomycin|mesh-list
93302269|NCT02307006|Cefazolin|cefazolin|mesh-list
93302270|NCT02307006|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93302271|NCT02307006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302272|NCT02307006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302273|NCT03362684|Cetuximab|cetuximab|mesh-list
93302274|NCT03362684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302275|NCT03362684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302276|NCT02311686|Ethanol|ethanol|mesh-list
93302277|NCT02311686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93302278|NCT02311686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302279|NCT02311686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302280|NCT02311686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302281|NCT02311764|Carboplatin|carboplatin|mesh-list
93302282|NCT02311764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302283|NCT03365726|Dobutamine|dobutamine|mesh-list
93302284|NCT03365726|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93302285|NCT03365726|Sympathomimetics|sympathomimetics|mesh-ancestor
93302286|NCT03365726|Autonomic Agents|autonomic agents|mesh-ancestor
93302287|NCT03365726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302288|NCT03365726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302289|NCT03365726|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93302290|NCT03365726|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93302291|NCT03365726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93302292|NCT03365726|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302293|NCT03365726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302294|NCT03365726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302295|NCT03365726|Protective Agents|protective agents|mesh-ancestor
93302296|NCT02303418|Oxytocin|oxytocin|mesh-list
93302297|NCT02303418|Carbetocin|carbetocin|mesh-list
93302298|NCT02303418|Oxytocics|oxytocics|mesh-ancestor
93302299|NCT02303418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302300|NCT02303418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302301|NCT03510000|Empagliflozin|empagliflozin|mesh-list
93302302|NCT03510000|Pancrelipase|pancrelipase|mesh-list
93302303|NCT03510000|Hormones|hormones|mesh-list
93302304|NCT03510000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302305|NCT03510000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302306|NCT03510000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93302307|NCT03510000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302308|NCT03510000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93302309|NCT03510000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302310|NCT03358082|Hydrocortisone|hydrocortisone|mesh-list
93302311|NCT03358082|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93302312|NCT03358082|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92596874|NCT00134355|Vatalanib|vatalanib|mesh-list
93302313|NCT03358082|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93302314|NCT03358082|Tacrolimus|tacrolimus|mesh-list
93302315|NCT03358082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302316|NCT03358082|Immunologic Factors|immunologic factors|mesh-ancestor
93302317|NCT03358082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302318|NCT03358082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93302319|NCT03358082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302320|NCT03358082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302321|NCT03358082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302322|NCT03358004|Capecitabine|capecitabine|mesh-list
93302323|NCT03358004|Vinorelbine|vinorelbine|mesh-list
93302324|NCT03358004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93302325|NCT03358004|Antimetabolites|antimetabolites|mesh-ancestor
93302326|NCT03358004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302327|NCT03358004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302328|NCT03358004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93302329|NCT03358004|Tubulin Modulators|tubulin modulators|mesh-ancestor
93302330|NCT03358004|Antimitotic Agents|antimitotic agents|mesh-ancestor
93302331|NCT03358004|Mitosis Modulators|mitosis modulators|mesh-ancestor
93302332|NCT03509922|Sarpogrelate|sarpogrelate|mesh-list
93302333|NCT03509922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93302334|NCT03509922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93302335|NCT03509922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302336|NCT03509922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93302337|NCT03509922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93302338|NCT03509922|Serotonin Agents|serotonin agents|mesh-ancestor
93302339|NCT03509922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302340|NCT03509922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302341|NCT03365336|Oseltamivir|oseltamivir|mesh-list
93302342|NCT03365336|Antiviral Agents|antiviral agents|mesh-ancestor
93302343|NCT03365336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302344|NCT03365336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302345|NCT03365336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302346|NCT03362216|Diclofenac|diclofenac|mesh-list
93302347|NCT03362216|Salicylates|salicylates|mesh-list
93302348|NCT03362216|Methyl salicylate|methyl salicylate|mesh-list
93302349|NCT03362216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93302350|NCT03362216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302351|NCT03362216|Analgesics|analgesics|mesh-ancestor
93302352|NCT03362216|Sensory System Agents|sensory system agents|mesh-ancestor
93302353|NCT03362216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302354|NCT03362216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302355|NCT03362216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302356|NCT03362216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302357|NCT03362216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93302358|NCT03362216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302359|NCT03362216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302360|NCT02312076|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93302361|NCT02312076|Luteolytic Agents|luteolytic agents|mesh-ancestor
93302362|NCT02312076|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93302363|NCT02312076|Contraceptive Agents|contraceptive agents|mesh-ancestor
93302364|NCT02312076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302365|NCT02312076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302366|NCT02312076|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93302367|NCT02312076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93302368|NCT02312076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302369|NCT02307396|Haloperidol|haloperidol|mesh-list
93302370|NCT02307396|Pimozide|pimozide|mesh-list
93302371|NCT02307396|Olanzapine|olanzapine|mesh-list
93302372|NCT02307396|Risperidone|risperidone|mesh-list
93302373|NCT02307396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93302374|NCT02307396|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93302375|NCT02307396|Ziprasidone|ziprasidone|mesh-list
93302376|NCT02307396|Amisulpride|amisulpride|mesh-list
93302377|NCT02307396|Perphenazine|perphenazine|mesh-list
93302378|NCT02307396|Sertindole|sertindole|mesh-list
93302379|NCT02307396|Sulpiride|sulpiride|mesh-list
93302380|NCT02307396|Fluphenazine|fluphenazine|mesh-list
93302381|NCT02307396|Fluphenazine depot|fluphenazine depot|mesh-list
93302382|NCT02307396|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
93302383|NCT02307396|Thioridazine|thioridazine|mesh-list
93302384|NCT02307396|Clopenthixol|clopenthixol|mesh-list
93302385|NCT02307396|Fluspirilene|fluspirilene|mesh-list
93302386|NCT02307396|Benperidol|benperidol|mesh-list
93302387|NCT02307396|Bromperidol|bromperidol|mesh-list
93302388|NCT02307396|Perazine|perazine|mesh-list
93302389|NCT02307396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93302390|NCT02307396|Serotonin Agents|serotonin agents|mesh-ancestor
93302391|NCT02307396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302392|NCT02307396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302393|NCT02307396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302394|NCT02307396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93302395|NCT02307396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93302396|NCT02307396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302397|NCT02307396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93302398|NCT02307396|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93302399|NCT02307396|Dopamine Agents|dopamine agents|mesh-ancestor
93302400|NCT02307396|Antiemetics|antiemetics|mesh-ancestor
93302401|NCT02307396|Autonomic Agents|autonomic agents|mesh-ancestor
93302402|NCT02307396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302403|NCT02307396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302404|NCT02307396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93302405|NCT02307396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93302406|NCT02307396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93302407|NCT02307396|Antidepressive Agents|antidepressive agents|mesh-ancestor
93302408|NCT02307396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93302409|NCT02307396|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93302410|NCT02307396|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93302411|NCT02307396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93302412|NCT03509688|Entecavir|entecavir|mesh-list
93302413|NCT03509688|Resveratrol|resveratrol|mesh-list
93302414|NCT03509688|Antiviral Agents|antiviral agents|mesh-ancestor
93302415|NCT03509688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302416|NCT03509688|Antioxidants|antioxidants|mesh-ancestor
93302417|NCT03509688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302418|NCT03509688|Protective Agents|protective agents|mesh-ancestor
93302419|NCT03509688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302420|NCT03509688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302421|NCT03509688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93302422|NCT02303730|Insulin Glargine|insulin glargine|mesh-list
93302423|NCT02303730|Exenatide|exenatide|mesh-list
93302424|NCT02303730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93302425|NCT02303730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302426|NCT02303730|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93302427|NCT02303730|Incretins|incretins|mesh-ancestor
93302428|NCT02303730|Hormones|hormones|mesh-ancestor
93302429|NCT02303730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302430|NCT04524728|Letrozole|letrozole|mesh-list
93302431|NCT04524728|Fulvestrant|fulvestrant|mesh-list
93302432|NCT04524728|Palbociclib|palbociclib|mesh-list
93302433|NCT04524728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302434|NCT04524728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93302435|NCT04524728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93302436|NCT04524728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302437|NCT04524728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302438|NCT04524728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93302439|NCT04524728|Hormone Antagonists|hormone antagonists|mesh-ancestor
93302440|NCT04524728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302441|NCT04524728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302442|NCT04524728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93302443|NCT04524728|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93302444|NCT04524728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93302445|NCT04523792|Buprenorphine|buprenorphine|mesh-list
93302446|NCT04523792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93302447|NCT04523792|Narcotics|narcotics|mesh-ancestor
93302448|NCT04523792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302449|NCT04523792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302450|NCT04523792|Analgesics|analgesics|mesh-ancestor
93302451|NCT04523792|Sensory System Agents|sensory system agents|mesh-ancestor
93302452|NCT04523792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302453|NCT04523792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93302454|NCT02312232|Levodopa|levodopa|mesh-list
93302455|NCT02312232|Carbidopa|carbidopa|mesh-list
93302456|NCT02312232|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93302457|NCT02312232|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93302458|NCT02312232|Dopamine Agents|dopamine agents|mesh-ancestor
93302459|NCT02312232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302460|NCT02312232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302461|NCT02312232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302462|NCT02312232|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93302463|NCT02312232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302464|NCT02303886|Methylene Blue|methylene blue|mesh-list
93302465|NCT02303886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302466|NCT02303886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302467|NCT02518958|Nivolumab|nivolumab|mesh-list
93302468|NCT02518958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302469|NCT02518958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302470|NCT02518958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93302471|NCT02518958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302472|NCT03506802|Aldesleukin|aldesleukin|mesh-list
93302473|NCT03506802|Plerixafor|plerixafor|mesh-list
93302474|NCT03506802|Lenalidomide|lenalidomide|mesh-list
92974548|NCT00792350|Sorafenib|sorafenib|mesh-list
93302476|NCT03506802|Interleukin-2|interleukin-2|mesh-list
93302477|NCT03506802|Mechlorethamine|mechlorethamine|mesh-list
93302478|NCT03506802|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93302479|NCT03506802|Lenograstim|lenograstim|mesh-list
93302480|NCT03506802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93302481|NCT03506802|Immunologic Factors|immunologic factors|mesh-ancestor
93302482|NCT03506802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302483|NCT03506802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93302484|NCT03506802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93302485|NCT03506802|Growth Substances|growth substances|mesh-ancestor
93302486|NCT03506802|Growth Inhibitors|growth inhibitors|mesh-ancestor
93302487|NCT03506802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302488|NCT03506802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93302489|NCT03506802|Alkylating Agents|alkylating agents|mesh-ancestor
93302490|NCT03506802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302491|NCT03506802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93302492|NCT03506802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302493|NCT03506802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302494|NCT03506802|Analgesics|analgesics|mesh-ancestor
93302495|NCT03506802|Sensory System Agents|sensory system agents|mesh-ancestor
93302496|NCT03506802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302497|NCT03506802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93302498|NCT03506802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93302499|NCT03506802|Antiviral Agents|antiviral agents|mesh-ancestor
93302500|NCT03506802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302501|NCT02307864|Moxifloxacin|moxifloxacin|mesh-list
93302502|NCT02307864|Tramadol|tramadol|mesh-list
93302503|NCT02307864|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93302504|NCT02307864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302505|NCT02307864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302506|NCT02307864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93302507|NCT02307864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93302508|NCT02307864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302509|NCT02307864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302510|NCT02307864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302511|NCT02307864|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93302512|NCT02307864|Contraceptive Agents|contraceptive agents|mesh-ancestor
93302513|NCT02307864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302514|NCT02307864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302515|NCT02307864|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93302516|NCT02307864|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93302517|NCT02307864|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93302518|NCT02307864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93302519|NCT02307864|Narcotics|narcotics|mesh-ancestor
93302520|NCT02307864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302521|NCT02307864|Analgesics|analgesics|mesh-ancestor
93302522|NCT02307864|Sensory System Agents|sensory system agents|mesh-ancestor
93302523|NCT02307864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302524|NCT02304042|Oxytocin|oxytocin|mesh-list
93302525|NCT02304042|Carbetocin|carbetocin|mesh-list
93302526|NCT02304042|Oxytocics|oxytocics|mesh-ancestor
93302527|NCT02304042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302528|NCT02304042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302529|NCT02308098|Budesonide|budesonide|mesh-list
93302530|NCT02308098|Formoterol Fumarate|formoterol fumarate|mesh-list
93302531|NCT02308098|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93302532|NCT02308098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302533|NCT02308098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93302534|NCT02308098|Autonomic Agents|autonomic agents|mesh-ancestor
93302535|NCT02308098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302536|NCT02308098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302537|NCT02308098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93302538|NCT02308098|Respiratory System Agents|respiratory system agents|mesh-ancestor
93302539|NCT02308098|Glucocorticoids|glucocorticoids|mesh-ancestor
93302540|NCT02308098|Hormones|hormones|mesh-ancestor
93302541|NCT02308098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302542|NCT02308098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93302543|NCT02308098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93302544|NCT02308098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93302545|NCT02308098|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302546|NCT02308098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302547|NCT02308098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302548|NCT03504072|Etanercept|etanercept|mesh-list
93302549|NCT03504072|Tofacitinib|tofacitinib|mesh-list
93302550|NCT03504072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93302552|NCT03504072|Analgesics|analgesics|mesh-ancestor
93302553|NCT03504072|Sensory System Agents|sensory system agents|mesh-ancestor
93302554|NCT03504072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302555|NCT03504072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302556|NCT03504072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302557|NCT03504072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302558|NCT03504072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302559|NCT03504072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302560|NCT03504072|Immunologic Factors|immunologic factors|mesh-ancestor
93302561|NCT03504072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93302562|NCT03504072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93302563|NCT03504072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302564|NCT03504072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302565|NCT03361280|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93302566|NCT03361280|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93302567|NCT03361280|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302568|NCT03361280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302569|NCT03361280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302570|NCT03361280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302571|NCT02308254|Lixisenatide|lixisenatide|mesh-list
93302572|NCT02308254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93302573|NCT02308254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302574|NCT03361124|Oxytocin|oxytocin|mesh-list
93302575|NCT03361124|Oxytocics|oxytocics|mesh-ancestor
93302576|NCT03361124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302577|NCT03361124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302578|NCT03364088|Oxycodone|oxycodone|mesh-list
93302579|NCT03364088|Anesthetics|anesthetics|mesh-list
93302580|NCT03364088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302581|NCT03364088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302582|NCT03364088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93302583|NCT03364088|Narcotics|narcotics|mesh-ancestor
93302584|NCT03364088|Analgesics|analgesics|mesh-ancestor
93302585|NCT03364088|Sensory System Agents|sensory system agents|mesh-ancestor
93302586|NCT03364088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302587|NCT02304198|Udenafil|udenafil|mesh-list
93302588|NCT02304198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93302589|NCT02304198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93302590|NCT02304198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302591|NCT02304198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302592|NCT02304276|Calcium|calcium|mesh-list
93302593|NCT02304276|Fluorides|fluorides|mesh-list
93302594|NCT02304276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93302595|NCT02304276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302596|NCT02304276|Cariostatic Agents|cariostatic agents|mesh-ancestor
93302597|NCT02304276|Protective Agents|protective agents|mesh-ancestor
93302598|NCT04524260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93302599|NCT02308332|Tenofovir|tenofovir|mesh-list
93302600|NCT02308332|Emtricitabine|emtricitabine|mesh-list
93302601|NCT02308332|Rilpivirine|rilpivirine|mesh-list
93302602|NCT02308332|Antiviral Agents|antiviral agents|mesh-ancestor
93302603|NCT02308332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597159|NCT00105404|Hormones|hormones|mesh-ancestor
93302604|NCT02308332|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93302605|NCT02308332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93302606|NCT02308332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302607|NCT02308332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302608|NCT02308332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93302609|NCT02308332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93302610|NCT03509298|Antibodies|antibodies|mesh-list
93302611|NCT03509298|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93302612|NCT03509298|Immunologic Factors|immunologic factors|mesh-ancestor
93302613|NCT03509298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302614|NCT03503994|Beclomethasone|beclomethasone|mesh-list
93302615|NCT03503994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302616|NCT03503994|Glucocorticoids|glucocorticoids|mesh-ancestor
93302617|NCT03503994|Hormones|hormones|mesh-ancestor
93302618|NCT03503994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302619|NCT03503994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302620|NCT03503994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93302621|NCT03503994|Respiratory System Agents|respiratory system agents|mesh-ancestor
93302622|NCT01796002|Romidepsin|romidepsin|mesh-list
93302623|NCT01796002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93302624|NCT01796002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302625|NCT01796002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93302626|NCT01796002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302627|NCT01796002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302628|NCT03509142|Sirolimus|sirolimus|mesh-list
93302629|NCT03509142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302630|NCT03509142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302631|NCT03509142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93302632|NCT03509142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302633|NCT03509142|Antifungal Agents|antifungal agents|mesh-ancestor
93302634|NCT03509142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302635|NCT03509142|Immunologic Factors|immunologic factors|mesh-ancestor
93302636|NCT03509142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302637|NCT03356912|Prednisone|prednisone|mesh-list
93302638|NCT03356912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302639|NCT03356912|Glucocorticoids|glucocorticoids|mesh-ancestor
93302640|NCT03356912|Hormones|hormones|mesh-ancestor
93302641|NCT03356912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302642|NCT03356912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302643|NCT03356912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93302644|NCT03356912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302645|NCT00102687|Azacitidine|azacitidine|mesh-list
93302646|NCT00102687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93302647|NCT00102687|Antimetabolites|antimetabolites|mesh-ancestor
93302648|NCT00102687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302649|NCT00102687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302650|NCT00102687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302651|NCT04509440|Triamcinolone|triamcinolone|mesh-list
93302652|NCT04509440|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93302653|NCT04509440|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93302654|NCT04509440|Anesthetics|anesthetics|mesh-list
93302655|NCT04509440|Mepivacaine|mepivacaine|mesh-list
93302656|NCT04509440|Anesthetics, Local|anesthetics, local|mesh-list
93302657|NCT04509440|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93302658|NCT04509440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302659|NCT04509440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302660|NCT04509440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302661|NCT04509440|Glucocorticoids|glucocorticoids|mesh-ancestor
93302662|NCT04509440|Hormones|hormones|mesh-ancestor
93302663|NCT04509440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302664|NCT04509440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302665|NCT04509440|Immunologic Factors|immunologic factors|mesh-ancestor
93302666|NCT04509440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302667|NCT04509440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302668|NCT04509440|Sensory System Agents|sensory system agents|mesh-ancestor
93302669|NCT04509440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302670|NCT02312544|Timolol|timolol|mesh-list
93302671|NCT02312544|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93302672|NCT02312544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93302673|NCT02312544|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302674|NCT02312544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302675|NCT02312544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302676|NCT02312544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302677|NCT02312544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93302678|NCT02312544|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93302679|NCT03360734|Cetuximab|cetuximab|mesh-list
93302680|NCT03360734|Panitumumab|panitumumab|mesh-list
93302681|NCT03360734|Necitumumab|necitumumab|mesh-list
93302682|NCT03360734|Antibodies|antibodies|mesh-list
93302683|NCT03360734|Immunologic Factors|immunologic factors|mesh-ancestor
93302684|NCT03360734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302685|NCT03360734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302686|NCT03360734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302687|NCT02308644|Bevacizumab|bevacizumab|mesh-list
93302688|NCT02308644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302689|NCT02308644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302690|NCT02308644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93302691|NCT02308644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93302692|NCT02308644|Growth Substances|growth substances|mesh-ancestor
93302693|NCT02308644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302694|NCT02308644|Growth Inhibitors|growth inhibitors|mesh-ancestor
93302695|NCT04510636|Pembrolizumab|pembrolizumab|mesh-list
93302696|NCT04510636|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93302697|NCT04510636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302698|NCT04510636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974768|NCT00917345|Protease Inhibitors|protease inhibitors|mesh-ancestor
93302699|NCT04510636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93302700|NCT04510636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302701|NCT04510636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93302702|NCT04510636|Alkylating Agents|alkylating agents|mesh-ancestor
93302703|NCT03540849|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93302704|NCT03540849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302705|NCT03540849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302706|NCT03540849|Immunotoxins|immunotoxins|mesh-ancestor
93302707|NCT03540849|Immunoconjugates|immunoconjugates|mesh-ancestor
93302708|NCT03540849|Immunologic Factors|immunologic factors|mesh-ancestor
93302709|NCT03540849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302710|NCT04520126|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
93302711|NCT04520126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302712|NCT04520126|Antioxidants|antioxidants|mesh-ancestor
93302713|NCT04520126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302714|NCT04520126|Protective Agents|protective agents|mesh-ancestor
93302715|NCT04520126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302716|NCT04520126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93302717|NCT02304354|Rituximab|rituximab|mesh-list
93302718|NCT02304354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302719|NCT02304354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302720|NCT02304354|Immunologic Factors|immunologic factors|mesh-ancestor
93302721|NCT02304354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302722|NCT02304354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302723|NCT03356600|Apatinib|apatinib|mesh-list
93302724|NCT03356600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302725|NCT03356600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93302726|NCT03356600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302727|NCT03356600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302728|NCT00102531|Cisplatin|cisplatin|mesh-list
93302729|NCT00102531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302730|NCT05347654|Sulfadiazine|sulfadiazine|mesh-list
93302731|NCT05347654|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93302732|NCT05347654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302733|NCT05347654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302734|NCT05347654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93302735|NCT05347654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93302736|NCT05347654|Coccidiostats|coccidiostats|mesh-ancestor
93302737|NCT05347654|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93302738|NCT03360266|Listerine|listerine|mesh-list
93302739|NCT03360266|Fluorides|fluorides|mesh-list
93302740|NCT03360266|Sodium Fluoride|sodium fluoride|mesh-list
93302741|NCT03360266|Fluorides, Topical|fluorides, topical|mesh-list
93302742|NCT03360266|Cariostatic Agents|cariostatic agents|mesh-ancestor
93302743|NCT03360266|Protective Agents|protective agents|mesh-ancestor
93302744|NCT03360266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302745|NCT03360266|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93302746|NCT03360266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302747|NCT02154789|Polidocanol|polidocanol|mesh-list
93302748|NCT02154789|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93302749|NCT02154789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93302750|NCT02771145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93302751|NCT03506256|Norfloxacin|norfloxacin|mesh-list
93302752|NCT03506256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302753|NCT03506256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302754|NCT03506256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93302755|NCT03506256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93302756|NCT03506256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302757|NCT03506256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302758|NCT03506256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302759|NCT03506256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93302760|NCT03506256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93302761|NCT03356444|Docetaxel|docetaxel|mesh-list
93302762|NCT03356444|Abiraterone Acetate|abiraterone acetate|mesh-list
93302763|NCT03356444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302764|NCT03356444|Tubulin Modulators|tubulin modulators|mesh-ancestor
93302765|NCT03356444|Antimitotic Agents|antimitotic agents|mesh-ancestor
93302766|NCT03356444|Mitosis Modulators|mitosis modulators|mesh-ancestor
93302767|NCT03356444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302768|NCT03356444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93302769|NCT03356444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302770|NCT03356444|Hormone Antagonists|hormone antagonists|mesh-ancestor
93302771|NCT03356444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302772|NCT03356444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302773|NCT03356444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93302775|NCT03503604|Paclitaxel|paclitaxel|mesh-list
93302776|NCT03503604|Carboplatin|carboplatin|mesh-list
93302777|NCT03503604|Gemcitabine|gemcitabine|mesh-list
93302778|NCT03503604|Fluorouracil|fluorouracil|mesh-list
93302779|NCT03503604|Oxaliplatin|oxaliplatin|mesh-list
93302780|NCT03503604|Irinotecan|irinotecan|mesh-list
93302781|NCT03503604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93302782|NCT03503604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302783|NCT03503604|Tubulin Modulators|tubulin modulators|mesh-ancestor
93302784|NCT03503604|Antimitotic Agents|antimitotic agents|mesh-ancestor
93302785|NCT03503604|Mitosis Modulators|mitosis modulators|mesh-ancestor
93302786|NCT03503604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302787|NCT03503604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93302788|NCT03503604|Antimetabolites|antimetabolites|mesh-ancestor
93302789|NCT03503604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93302790|NCT03503604|Immunologic Factors|immunologic factors|mesh-ancestor
93302791|NCT03503604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302792|NCT03503604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93302793|NCT03503604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93302794|NCT03503604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302795|NCT03503604|Antidotes|antidotes|mesh-ancestor
93302796|NCT03503604|Protective Agents|protective agents|mesh-ancestor
93302797|NCT03503604|Vitamin B Complex|vitamin b complex|mesh-ancestor
93302798|NCT03503604|Vitamins|vitamins|mesh-ancestor
93302799|NCT03503604|Micronutrients|micronutrients|mesh-ancestor
93302800|NCT04508816|Cetuximab|cetuximab|mesh-list
93302801|NCT04508816|Nimotuzumab|nimotuzumab|mesh-list
93302802|NCT04508816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302803|NCT04508816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302804|NCT03359876|Warfarin|warfarin|mesh-list
93302805|NCT03359876|Rivaroxaban|rivaroxaban|mesh-list
93302806|NCT03359876|Anticoagulants|anticoagulants|mesh-ancestor
93302807|NCT03359876|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93302808|NCT03359876|Antithrombins|antithrombins|mesh-ancestor
93302809|NCT03359876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93302810|NCT03359876|Protease Inhibitors|protease inhibitors|mesh-ancestor
93302811|NCT03359876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302812|NCT03359876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302813|NCT04508894|Dexmedetomidine|dexmedetomidine|mesh-list
93302814|NCT04508894|Ketamine|ketamine|mesh-list
93302815|NCT04508894|Bupivacaine|bupivacaine|mesh-list
93302816|NCT04508894|Anesthetics, Local|anesthetics, local|mesh-ancestor
93302817|NCT04508894|Anesthetics|anesthetics|mesh-ancestor
93302818|NCT04508894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302819|NCT04508894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302820|NCT04508894|Sensory System Agents|sensory system agents|mesh-ancestor
93302821|NCT04508894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302822|NCT04508894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93302823|NCT04508894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302824|NCT04508894|Analgesics|analgesics|mesh-ancestor
93302825|NCT04508894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93302826|NCT04508894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93302827|NCT04508894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93302828|NCT04508894|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302829|NCT04508894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302830|NCT04508894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302831|NCT04508894|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93302832|NCT04508894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93302833|NCT04508894|Anesthetics, General|anesthetics, general|mesh-ancestor
93302834|NCT04508894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93302835|NCT04508894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93302836|NCT05226832|Triamcinolone|triamcinolone|mesh-list
93302837|NCT05226832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302838|NCT05226832|Glucocorticoids|glucocorticoids|mesh-ancestor
93302839|NCT05226832|Hormones|hormones|mesh-ancestor
93302840|NCT05226832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302841|NCT05226832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302842|NCT03354572|Acetylcysteine|acetylcysteine|mesh-list
93302843|NCT03354572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93302844|NCT03354572|Antiviral Agents|antiviral agents|mesh-ancestor
93302845|NCT03354572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302846|NCT03354572|Expectorants|expectorants|mesh-ancestor
93302847|NCT03354572|Respiratory System Agents|respiratory system agents|mesh-ancestor
93302848|NCT03354572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93302849|NCT03354572|Antioxidants|antioxidants|mesh-ancestor
93302850|NCT03354572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974920|NCT00263575|Analgesics|analgesics|mesh-ancestor
93302851|NCT03354572|Protective Agents|protective agents|mesh-ancestor
93302852|NCT03354572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302853|NCT03354572|Antidotes|antidotes|mesh-ancestor
93302855|NCT03359798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302856|NCT03359798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302857|NCT03359798|Analgesics|analgesics|mesh-ancestor
93302858|NCT03359798|Sensory System Agents|sensory system agents|mesh-ancestor
93302859|NCT03359798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302860|NCT02309346|Clindamycin|clindamycin|mesh-list
93302861|NCT02309346|Clindamycin palmitate|clindamycin palmitate|mesh-list
93302862|NCT02309346|Clindamycin phosphate|clindamycin phosphate|mesh-list
93302863|NCT02309346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302864|NCT02309346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302865|NCT02309346|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93302866|NCT02309346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302867|NCT02309346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302868|NCT03356054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93302869|NCT03356054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93302870|NCT03356054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302871|NCT03356054|Immunotoxins|immunotoxins|mesh-ancestor
93302872|NCT03356054|Immunoconjugates|immunoconjugates|mesh-ancestor
93302873|NCT03356054|Immunologic Factors|immunologic factors|mesh-ancestor
93302874|NCT03356054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302875|NCT03354494|Desogestrel|desogestrel|mesh-list
93302876|NCT03354494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93302877|NCT03354494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93302878|NCT03354494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93302879|NCT03354494|Contraceptive Agents|contraceptive agents|mesh-ancestor
93302880|NCT03354494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93302881|NCT03354494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302882|NCT03354494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93302883|NCT03354494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93302884|NCT03354494|Progestins|progestins|mesh-ancestor
93302885|NCT03354494|Hormones|hormones|mesh-ancestor
93302886|NCT03354494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302887|NCT05530954|Calcium|calcium|mesh-list
93302888|NCT05530954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93302889|NCT05530954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302890|NCT03354338|Amoxicillin|amoxicillin|mesh-list
93302891|NCT03354338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302892|NCT03354338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302893|NCT02304822|Ciprofloxacin|ciprofloxacin|mesh-list
93302894|NCT02304822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302895|NCT02304822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302896|NCT02304822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93302897|NCT02304822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93302898|NCT02304822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302899|NCT02304822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302900|NCT02304822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302901|NCT02304822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93302902|NCT02304822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93302903|NCT02309424|Acetic Acid|acetic acid|mesh-list
93302904|NCT02309424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93302905|NCT02309424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93302906|NCT03506178|Phenylephrine|phenylephrine|mesh-list
93302907|NCT03506178|Oxymetazoline|oxymetazoline|mesh-list
93302908|NCT03506178|Menthol|menthol|mesh-list
93302909|NCT03506178|Antipruritics|antipruritics|mesh-ancestor
93302910|NCT03506178|Dermatologic Agents|dermatologic agents|mesh-ancestor
93302911|NCT03506178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93302912|NCT03506178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93302913|NCT03506178|Adrenergic Agents|adrenergic agents|mesh-ancestor
93302914|NCT03506178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302915|NCT03506178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302916|NCT03506178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302917|NCT03506178|Sympathomimetics|sympathomimetics|mesh-ancestor
93302918|NCT03506178|Autonomic Agents|autonomic agents|mesh-ancestor
93302919|NCT03506178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302920|NCT03506178|Nasal Decongestants|nasal decongestants|mesh-ancestor
93302921|NCT03506178|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93302922|NCT03506178|Respiratory System Agents|respiratory system agents|mesh-ancestor
93302923|NCT03506178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93302924|NCT03506178|Mydriatics|mydriatics|mesh-ancestor
93302925|NCT03506178|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93302927|NCT05210374|Copper|copper|mesh-list
93302928|NCT05210374|Doxorubicin|doxorubicin|mesh-list
93302929|NCT05210374|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93302930|NCT05210374|Disulfiram|disulfiram|mesh-list
93302931|NCT05210374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93302932|NCT05210374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302933|NCT05210374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93302934|NCT05210374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93302935|NCT05210374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302936|NCT05210374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302937|NCT05210374|Trace Elements|trace elements|mesh-ancestor
93302938|NCT05210374|Micronutrients|micronutrients|mesh-ancestor
93302939|NCT05210374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302940|NCT05210374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93302941|NCT05210374|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93302942|NCT02578186|Diphenhydramine|diphenhydramine|mesh-list
93302943|NCT02578186|Promethazine|promethazine|mesh-list
93302944|NCT02578186|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93302945|NCT02578186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93302946|NCT02578186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93302947|NCT02578186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302948|NCT02578186|Anesthetics, Local|anesthetics, local|mesh-ancestor
93302949|NCT02578186|Anesthetics|anesthetics|mesh-ancestor
93302950|NCT02578186|Sensory System Agents|sensory system agents|mesh-ancestor
93302951|NCT02578186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302952|NCT02578186|Antiemetics|antiemetics|mesh-ancestor
93302953|NCT02578186|Autonomic Agents|autonomic agents|mesh-ancestor
93302954|NCT02578186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93302955|NCT02578186|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93302956|NCT02578186|Histamine Antagonists|histamine antagonists|mesh-ancestor
93302957|NCT02578186|Histamine Agents|histamine agents|mesh-ancestor
93302958|NCT02578186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93302959|NCT02578186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302960|NCT02578186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93302961|NCT02578186|Antipruritics|antipruritics|mesh-ancestor
93302962|NCT02578186|Dermatologic Agents|dermatologic agents|mesh-ancestor
93302963|NCT04128436|Progesterone|progesterone|mesh-list
93302964|NCT04128436|Progestins|progestins|mesh-ancestor
93302965|NCT04128436|Hormones|hormones|mesh-ancestor
93302966|NCT04128436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93302967|NCT04128436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302968|NCT02309658|Cisplatin|cisplatin|mesh-list
93302969|NCT02309658|Gemcitabine|gemcitabine|mesh-list
93302970|NCT02309658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93302971|NCT02309658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93302972|NCT02309658|Antimetabolites|antimetabolites|mesh-ancestor
93302973|NCT02309658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302974|NCT05532280|Etoricoxib|etoricoxib|mesh-list
93302975|NCT05532280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93302976|NCT05532280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93302977|NCT05532280|Analgesics|analgesics|mesh-ancestor
93302978|NCT05532280|Sensory System Agents|sensory system agents|mesh-ancestor
93302979|NCT05532280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93302980|NCT05532280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302981|NCT05532280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93302982|NCT05532280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93302983|NCT05532280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93302984|NCT05532280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93302985|NCT05532280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93302986|NCT05532280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93302987|NCT04517162|Povidone|povidone|mesh-list
93302988|NCT04517162|Plasma Substitutes|plasma substitutes|mesh-ancestor
93302989|NCT04517162|Blood Substitutes|blood substitutes|mesh-ancestor
93302990|NCT02155023|Insulin|insulin|mesh-list
93302991|NCT02155023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93302992|NCT02155023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93302993|NCT02155023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302994|NCT02163213|Immunoglobulins|immunoglobulins|mesh-list
93302995|NCT02163213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93302996|NCT02163213|Antibodies|antibodies|mesh-list
93302997|NCT02163213|Immunologic Factors|immunologic factors|mesh-ancestor
93302998|NCT02163213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93302999|NCT04443920|Tranexamic Acid|tranexamic acid|mesh-list
93303000|NCT04443920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93303001|NCT04443920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93303002|NCT04443920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303004|NCT04443920|Coagulants|coagulants|mesh-ancestor
93303005|NCT03359018|Apatinib|apatinib|mesh-list
93303006|NCT03359018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303007|NCT03359018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93303008|NCT03359018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303009|NCT03359018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303010|NCT05530252|Minocycline|minocycline|mesh-list
93303011|NCT05530252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93303012|NCT05530252|Anti-Infective Agents|anti-infective agents|mesh-list
93303013|NCT02163291|Paclitaxel|paclitaxel|mesh-list
93303014|NCT02163291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93303015|NCT02163291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303016|NCT02163291|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303017|NCT02163291|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303018|NCT02163291|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303019|NCT02163291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303020|NCT03505788|Acetazolamide|acetazolamide|mesh-list
93303021|NCT03505788|Anticonvulsants|anticonvulsants|mesh-ancestor
93303022|NCT03505788|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93303023|NCT03505788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303024|NCT03505788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303025|NCT03505788|Diuretics|diuretics|mesh-ancestor
93303026|NCT03505788|Natriuretic Agents|natriuretic agents|mesh-ancestor
93303027|NCT03505788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303028|NCT02309970|Aspirin|aspirin|mesh-list
93303029|NCT02309970|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93303030|NCT02309970|Warfarin|warfarin|mesh-list
93303031|NCT02309970|Rivaroxaban|rivaroxaban|mesh-list
93303032|NCT02309970|Dabigatran|dabigatran|mesh-list
93303033|NCT02309970|Apixaban|apixaban|mesh-list
93303034|NCT02309970|Clopidogrel|clopidogrel|mesh-list
93303035|NCT02309970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93303036|NCT02309970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93303037|NCT02309970|Analgesics|analgesics|mesh-ancestor
93303038|NCT02309970|Sensory System Agents|sensory system agents|mesh-ancestor
93303039|NCT02309970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303040|NCT02309970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303041|NCT02309970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303042|NCT02309970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303043|NCT02309970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93303044|NCT02309970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93303045|NCT02309970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303046|NCT02309970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93303047|NCT02309970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93303048|NCT02309970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303049|NCT02309970|Antipyretics|antipyretics|mesh-ancestor
93303050|NCT02309970|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93303051|NCT02309970|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93303052|NCT02309970|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93303053|NCT02309970|Purinergic Agents|purinergic agents|mesh-ancestor
93303054|NCT02309970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303055|NCT02309970|Anticoagulants|anticoagulants|mesh-ancestor
93303056|NCT02309970|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93303057|NCT02309970|Antithrombins|antithrombins|mesh-ancestor
93303058|NCT02309970|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93303059|NCT02309970|Protease Inhibitors|protease inhibitors|mesh-ancestor
93303060|NCT03353948|Metformin|metformin|mesh-list
93303061|NCT03353948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93303062|NCT03353948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303063|NCT02161653|Pyridoxine|pyridoxine|mesh-list
93303064|NCT02161653|Prednisone|prednisone|mesh-list
93303065|NCT02161653|Pentoxifylline|pentoxifylline|mesh-list
93303066|NCT02161653|Metadoxine|metadoxine|mesh-list
93303067|NCT02161653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303068|NCT02161653|Glucocorticoids|glucocorticoids|mesh-ancestor
93303069|NCT02161653|Hormones|hormones|mesh-ancestor
93303070|NCT02161653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303071|NCT02161653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303072|NCT02161653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93303073|NCT02161653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303074|NCT02161653|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93303075|NCT02161653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303076|NCT02161653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303077|NCT02161653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93303078|NCT02161653|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93303079|NCT02161653|Protective Agents|protective agents|mesh-ancestor
93303080|NCT02161653|Vasodilator Agents|vasodilator agents|mesh-ancestor
93303081|NCT02161653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93303082|NCT02161653|Antioxidants|antioxidants|mesh-ancestor
93303083|NCT02161653|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93303084|NCT02161653|Vitamin B Complex|vitamin b complex|mesh-ancestor
93303085|NCT02161653|Vitamins|vitamins|mesh-ancestor
93303086|NCT02161653|Micronutrients|micronutrients|mesh-ancestor
93303087|NCT02576938|Triamcinolone|triamcinolone|mesh-list
93303088|NCT02576938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303089|NCT02576938|Glucocorticoids|glucocorticoids|mesh-ancestor
93303090|NCT02576938|Hormones|hormones|mesh-ancestor
93303091|NCT02576938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303092|NCT02576938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303093|NCT02305836|Donepezil|donepezil|mesh-list
93303094|NCT02305836|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93303095|NCT02305836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303096|NCT02305836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303097|NCT02305836|Cholinergic Agents|cholinergic agents|mesh-ancestor
93303098|NCT02305836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303099|NCT02305836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303100|NCT02305836|Nootropic Agents|nootropic agents|mesh-ancestor
93303101|NCT03503136|Cisplatin|cisplatin|mesh-list
93303102|NCT03503136|Docetaxel|docetaxel|mesh-list
93303103|NCT03503136|Fluorouracil|fluorouracil|mesh-list
93303104|NCT03503136|Capecitabine|capecitabine|mesh-list
93303105|NCT03503136|Nedaplatin|nedaplatin|mesh-list
93303106|NCT03503136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303107|NCT03503136|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303108|NCT03503136|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303109|NCT03503136|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303110|NCT03503136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303111|NCT03503136|Antimetabolites|antimetabolites|mesh-ancestor
93303112|NCT03503136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303113|NCT03503136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303114|NCT03503136|Immunologic Factors|immunologic factors|mesh-ancestor
93303115|NCT03503136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303116|NCT02305992|Bupivacaine|bupivacaine|mesh-list
93303117|NCT02305992|Anesthetics, Local|anesthetics, local|mesh-list
93303118|NCT02305992|Anesthetics|anesthetics|mesh-list
93303119|NCT02305992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303120|NCT02305992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303121|NCT02305992|Sensory System Agents|sensory system agents|mesh-ancestor
93303122|NCT02305992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303123|NCT03355352|Sufentanil|sufentanil|mesh-list
93303124|NCT03355352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93303125|NCT03355352|Narcotics|narcotics|mesh-ancestor
93303126|NCT03355352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303127|NCT03355352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303128|NCT03355352|Analgesics|analgesics|mesh-ancestor
93303129|NCT03355352|Sensory System Agents|sensory system agents|mesh-ancestor
93303130|NCT03355352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303131|NCT03355352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93303132|NCT03355352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93303133|NCT03355352|Anesthetics, General|anesthetics, general|mesh-ancestor
93303134|NCT03355352|Anesthetics|anesthetics|mesh-ancestor
93303135|NCT05529940|Folfirinox|folfirinox|mesh-list
93303136|NCT05529940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303137|NCT04463784|Efavirenz|efavirenz|mesh-list
93303138|NCT04463784|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93303139|NCT04463784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93303140|NCT04463784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303141|NCT04463784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303142|NCT04463784|Antiviral Agents|antiviral agents|mesh-ancestor
93303143|NCT04463784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303144|NCT04463784|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93303145|NCT04463784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93303146|NCT04463784|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93303147|NCT04463784|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93303148|NCT04463784|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93303149|NCT04463784|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93303150|NCT02310360|Fallypride|fallypride|mesh-list
92597707|NCT00438217|Hormones|hormones|mesh-ancestor
93303151|NCT02310360|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93303152|NCT02310360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93303153|NCT02310360|Dopamine Agents|dopamine agents|mesh-ancestor
92975182|NCT00973245|Warfarin|warfarin|mesh-list
93303154|NCT02310360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303155|NCT02310360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303156|NCT02310360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303157|NCT03353480|Azithromycin|azithromycin|mesh-list
93303158|NCT03353480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303159|NCT03353480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303160|NCT02306070|Metformin|metformin|mesh-list
93303161|NCT02306070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93303162|NCT02306070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303163|NCT03502824|Anti-Infective Agents|anti-infective agents|mesh-list
93303164|NCT03502824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93303165|NCT03353324|Bevacizumab|bevacizumab|mesh-list
93303166|NCT03353324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303167|NCT03353324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303168|NCT03353324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93303169|NCT03353324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93303170|NCT03353324|Growth Substances|growth substances|mesh-ancestor
93303171|NCT03353324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303172|NCT03353324|Growth Inhibitors|growth inhibitors|mesh-ancestor
93303173|NCT03354962|Nivolumab|nivolumab|mesh-list
93303174|NCT03354962|Ipilimumab|ipilimumab|mesh-list
93303175|NCT03354962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303176|NCT03354962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303177|NCT03354962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303178|NCT03354962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303179|NCT04511468|Copper|copper|mesh-list
93303180|NCT04511468|Chromium|chromium|mesh-list
93303181|NCT04511468|Micronutrients|micronutrients|mesh-ancestor
93303182|NCT04511468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303183|NCT04511468|Trace Elements|trace elements|mesh-ancestor
93303184|NCT05531422|Fentanyl|fentanyl|mesh-list
93303185|NCT05531422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93303186|NCT05531422|Narcotics|narcotics|mesh-ancestor
93303187|NCT05531422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303188|NCT05531422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303189|NCT05531422|Analgesics|analgesics|mesh-ancestor
93303190|NCT05531422|Sensory System Agents|sensory system agents|mesh-ancestor
93303191|NCT05531422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303192|NCT05531422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93303193|NCT05531422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93303194|NCT05531422|Anesthetics, General|anesthetics, general|mesh-ancestor
93303195|NCT05531422|Anesthetics|anesthetics|mesh-ancestor
93303196|NCT03354806|Analgesics|analgesics|mesh-list
93303197|NCT03354806|Sensory System Agents|sensory system agents|mesh-ancestor
93303198|NCT03354806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303199|NCT03354806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303200|NCT05529082|Analgesics, Opioid|analgesics, opioid|mesh-list
93303201|NCT05529082|Narcotics|narcotics|mesh-ancestor
93303202|NCT05529082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303203|NCT05529082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303204|NCT05529082|Analgesics|analgesics|mesh-ancestor
93303205|NCT05529082|Sensory System Agents|sensory system agents|mesh-ancestor
93303206|NCT05529082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303207|NCT03350126|Nivolumab|nivolumab|mesh-list
93303208|NCT03350126|Ipilimumab|ipilimumab|mesh-list
93303209|NCT03350126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303210|NCT03350126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303211|NCT03350126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303212|NCT03350126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303213|NCT05285878|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93303214|NCT05285878|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93303215|NCT05285878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303216|NCT05285878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303217|NCT05285878|Immunologic Factors|immunologic factors|mesh-ancestor
93303218|NCT05285878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303219|NCT02314182|Bevacizumab|bevacizumab|mesh-list
93303220|NCT02314182|Capecitabine|capecitabine|mesh-list
93303221|NCT02314182|Oxaliplatin|oxaliplatin|mesh-list
93303222|NCT02314182|Irinotecan|irinotecan|mesh-list
93303223|NCT02314182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303224|NCT02314182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303225|NCT02314182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975267|NCT03945981|Lamivudine|lamivudine|mesh-list
93303226|NCT02314182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93303227|NCT02314182|Growth Substances|growth substances|mesh-ancestor
93303228|NCT02314182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303229|NCT02314182|Growth Inhibitors|growth inhibitors|mesh-ancestor
93303230|NCT02314182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303231|NCT02314182|Antimetabolites|antimetabolites|mesh-ancestor
93303232|NCT02314182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303233|NCT02314182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93303234|NCT02314182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93303235|NCT02314182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303236|NCT05531344|Tamsulosin|tamsulosin|mesh-list
93303237|NCT05531344|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93303238|NCT05531344|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93303239|NCT05531344|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93303240|NCT05531344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93303241|NCT05531344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303242|NCT05531344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303243|NCT05531344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303244|NCT05531344|Urological Agents|urological agents|mesh-ancestor
93303245|NCT05531266|Glucocorticoids|glucocorticoids|mesh-list
93303246|NCT05531266|Hormones|hormones|mesh-ancestor
93303247|NCT05531266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303248|NCT05531266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303249|NCT03349658|Anesthetics|anesthetics|mesh-list
93303250|NCT03349658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303251|NCT03349658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303252|NCT03353012|Levonorgestrel|levonorgestrel|mesh-list
93303253|NCT03353012|Etonogestrel|etonogestrel|mesh-list
93303254|NCT03353012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93303255|NCT03353012|Contraceptive Agents|contraceptive agents|mesh-ancestor
93303256|NCT03353012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93303257|NCT03353012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303258|NCT03353012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93303259|NCT03353012|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93303260|NCT03353012|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93303261|NCT04462614|Heparin|heparin|mesh-list
93303262|NCT04462614|Anticoagulants|anticoagulants|mesh-ancestor
93303263|NCT04462614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93303264|NCT04462614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93303265|NCT04462614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303266|NCT03349424|Somatostatin|somatostatin|mesh-list
93303267|NCT03349424|Hormones|hormones|mesh-ancestor
93303268|NCT03349424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303269|NCT03349424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303270|NCT03349346|Rituximab|rituximab|mesh-list
93303271|NCT03349346|Carboplatin|carboplatin|mesh-list
93303272|NCT03349346|Etoposide|etoposide|mesh-list
93303273|NCT03349346|Ifosfamide|ifosfamide|mesh-list
93303274|NCT03349346|Idelalisib|idelalisib|mesh-list
93303275|NCT03349346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303276|NCT03349346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303277|NCT03349346|Immunologic Factors|immunologic factors|mesh-ancestor
93303278|NCT03349346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303279|NCT03349346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303280|NCT03349346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93303281|NCT03349346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93303282|NCT03349346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93303283|NCT03349346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303284|NCT03349346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303285|NCT03349346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93303286|NCT03349346|Alkylating Agents|alkylating agents|mesh-ancestor
93303287|NCT03502434|Petrolatum|petrolatum|mesh-list
93303288|NCT03502434|Emollients|emollients|mesh-ancestor
93303289|NCT03502434|Dermatologic Agents|dermatologic agents|mesh-ancestor
93303290|NCT03352700|Dyclonine|dyclonine|mesh-list
93303291|NCT03352700|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303292|NCT03352700|Anesthetics|anesthetics|mesh-ancestor
93303293|NCT03352700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303294|NCT03352700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303295|NCT03352700|Sensory System Agents|sensory system agents|mesh-ancestor
91934005|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93303296|NCT03352700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303297|NCT05522998|Propofol|propofol|mesh-list
93303298|NCT05522998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93303299|NCT05522998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303300|NCT05522998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303301|NCT05522998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93303302|NCT05522998|Anesthetics, General|anesthetics, general|mesh-ancestor
93303303|NCT05522998|Anesthetics|anesthetics|mesh-ancestor
93303304|NCT03349190|Ulipristal acetate|ulipristal acetate|mesh-list
93303305|NCT03349190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93303306|NCT03349190|Contraceptive Agents|contraceptive agents|mesh-ancestor
93303307|NCT03349190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93303308|NCT03349190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303309|NCT03349190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93303310|NCT03498534|Isoniazid|isoniazid|mesh-list
93303311|NCT03498534|Antitubercular Agents|antitubercular agents|mesh-ancestor
93303312|NCT03498534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303313|NCT03498534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303314|NCT03498534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93303315|NCT03498534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93303316|NCT03498534|Antimetabolites|antimetabolites|mesh-ancestor
93303317|NCT03498534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303318|NCT03498534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93303319|NCT03502356|Azithromycin|azithromycin|mesh-list
93303320|NCT03502356|Cefazolin|cefazolin|mesh-list
93303321|NCT03502356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303322|NCT03502356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303323|NCT03498456|Amoxicillin|amoxicillin|mesh-list
93303324|NCT03498456|Clarithromycin|clarithromycin|mesh-list
93303325|NCT03498456|Lansoprazole|lansoprazole|mesh-list
93303326|NCT03498456|Dexlansoprazole|dexlansoprazole|mesh-list
93303327|NCT03498456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303328|NCT03498456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303329|NCT03498456|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93303330|NCT03498456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303331|NCT03498456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303332|NCT03498456|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93303333|NCT03498456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93303334|NCT03498456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93303335|NCT03498456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93303336|NCT03498456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93303337|NCT02317146|Magnesium Sulfate|magnesium sulfate|mesh-list
93303338|NCT02317146|Analgesics|analgesics|mesh-ancestor
93303339|NCT02317146|Sensory System Agents|sensory system agents|mesh-ancestor
93303340|NCT02317146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303341|NCT02317146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303342|NCT02317146|Anesthetics|anesthetics|mesh-ancestor
93303343|NCT02317146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303344|NCT02317146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93303345|NCT02317146|Anticonvulsants|anticonvulsants|mesh-ancestor
93303346|NCT02317146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93303347|NCT02317146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303348|NCT02317146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303349|NCT02317146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93303350|NCT02317146|Tocolytic Agents|tocolytic agents|mesh-ancestor
93303351|NCT02317146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93303352|NCT05528146|Psyllium|psyllium|mesh-list
93303353|NCT05528146|Cathartics|cathartics|mesh-ancestor
93303354|NCT05528146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93303355|NCT03349112|Lidocaine|lidocaine|mesh-list
93303356|NCT03349112|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303357|NCT03349112|Anesthetics|anesthetics|mesh-ancestor
93303358|NCT03349112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303359|NCT03349112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303360|NCT03349112|Sensory System Agents|sensory system agents|mesh-ancestor
93303361|NCT03349112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303362|NCT03349112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93303363|NCT03349112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93303364|NCT03349112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93303365|NCT03349112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303366|NCT03349112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303367|NCT03498222|Carboplatin|carboplatin|mesh-list
93303368|NCT03498222|Pemetrexed|pemetrexed|mesh-list
93303369|NCT03498222|Atezolizumab|atezolizumab|mesh-list
93303370|NCT03498222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303371|NCT03498222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303372|NCT03498222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303373|NCT03498222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93303374|NCT03498222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93303375|NCT03498222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303376|NCT03498222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303377|NCT02518022|Insulin|insulin|mesh-list
93303378|NCT02518022|Insulin Lispro|insulin lispro|mesh-list
93303379|NCT02518022|Insulin Aspart|insulin aspart|mesh-list
93303380|NCT02518022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93303381|NCT02518022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303382|NCT05504252|Fluorouracil|fluorouracil|mesh-list
93303383|NCT05504252|Oxaliplatin|oxaliplatin|mesh-list
93303384|NCT05504252|Nivolumab|nivolumab|mesh-list
93303385|NCT05504252|Antimetabolites|antimetabolites|mesh-ancestor
93303386|NCT05504252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303387|NCT05504252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303388|NCT05504252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303389|NCT05504252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303390|NCT05504252|Immunologic Factors|immunologic factors|mesh-ancestor
93303391|NCT05504252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303392|NCT05504252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303393|NCT05504252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303394|NCT03497988|Oxytocin|oxytocin|mesh-list
93303395|NCT03497988|Oxytocics|oxytocics|mesh-ancestor
93303396|NCT03497988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93303397|NCT03497988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303398|NCT04610476|Sulfasalazine|sulfasalazine|mesh-list
93303399|NCT04610476|Prednisolone|prednisolone|mesh-list
93303400|NCT04610476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93303401|NCT04610476|Methylprednisolone|methylprednisolone|mesh-list
93303402|NCT04610476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93303403|NCT04610476|Prednisolone acetate|prednisolone acetate|mesh-list
93303404|NCT04610476|Adalimumab|adalimumab|mesh-list
93303405|NCT04610476|Infliximab|infliximab|mesh-list
93303406|NCT04610476|Etanercept|etanercept|mesh-list
93303407|NCT04610476|Apremilast|apremilast|mesh-list
93303408|NCT04610476|Golimumab|golimumab|mesh-list
93303409|NCT04610476|Certolizumab Pegol|certolizumab pegol|mesh-list
93303410|NCT04610476|Methotrexate|methotrexate|mesh-list
93303411|NCT04610476|Abatacept|abatacept|mesh-list
93303412|NCT04610476|Ustekinumab|ustekinumab|mesh-list
93303413|NCT04610476|Ixekizumab|ixekizumab|mesh-list
93303414|NCT04610476|Tofacitinib|tofacitinib|mesh-list
93303415|NCT04610476|Leflunomide|leflunomide|mesh-list
93303416|NCT04610476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93303417|NCT04610476|Prednisolone phosphate|prednisolone phosphate|mesh-list
93303418|NCT04610476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93303419|NCT04610476|Abortifacient Agents|abortifacient agents|mesh-ancestor
93303420|NCT04610476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93303421|NCT04610476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303422|NCT04610476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303423|NCT04610476|Antimetabolites|antimetabolites|mesh-ancestor
93303424|NCT04610476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303425|NCT04610476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303426|NCT04610476|Dermatologic Agents|dermatologic agents|mesh-ancestor
93303427|NCT04610476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303428|NCT04610476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93303429|NCT04610476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303430|NCT04610476|Immunologic Factors|immunologic factors|mesh-ancestor
93303431|NCT04610476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303432|NCT04610476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93303433|NCT04610476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303434|NCT04610476|Glucocorticoids|glucocorticoids|mesh-ancestor
93303435|NCT04610476|Hormones|hormones|mesh-ancestor
93303436|NCT04610476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303437|NCT04610476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93303438|NCT04610476|Antiemetics|antiemetics|mesh-ancestor
93303439|NCT04610476|Autonomic Agents|autonomic agents|mesh-ancestor
93303440|NCT04610476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303441|NCT04610476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93303442|NCT04610476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93303443|NCT04610476|Protective Agents|protective agents|mesh-ancestor
93303444|NCT04610476|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93303445|NCT04610476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93303446|NCT04610476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93303447|NCT04610476|Analgesics|analgesics|mesh-ancestor
93303448|NCT04610476|Sensory System Agents|sensory system agents|mesh-ancestor
93303449|NCT04610476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303450|NCT04610476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303451|NCT04610476|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93303452|NCT04610476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93303453|NCT04610476|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93303454|NCT04610476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93303455|NCT04610476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303456|NCT03348800|Anesthetics|anesthetics|mesh-list
93303457|NCT03348800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303458|NCT03348800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303459|NCT02314806|Clindamycin|clindamycin|mesh-list
93303460|NCT02314806|Clindamycin palmitate|clindamycin palmitate|mesh-list
93303461|NCT02314806|Clindamycin phosphate|clindamycin phosphate|mesh-list
93303462|NCT02314806|Gentamicins|gentamicins|mesh-list
93303463|NCT02314806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93303464|NCT02314806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303465|NCT02314806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303466|NCT02314806|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93303467|NCT02314806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303468|NCT02314806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303469|NCT00709202|Betahistine|betahistine|mesh-list
93303470|NCT00709202|Vasodilator Agents|vasodilator agents|mesh-ancestor
93303471|NCT00709202|Histamine Agonists|histamine agonists|mesh-ancestor
93303472|NCT00709202|Histamine Agents|histamine agents|mesh-ancestor
93303473|NCT00709202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303474|NCT00709202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303475|NCT00709202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303476|NCT05517538|Botulinum Toxins|botulinum toxins|mesh-list
93303477|NCT05517538|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93303478|NCT05517538|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93303479|NCT05517538|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93303480|NCT05517538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303481|NCT05517538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598056|NCT00440284|Insulin|insulin|mesh-list
93303482|NCT05517538|Cholinergic Agents|cholinergic agents|mesh-ancestor
93303483|NCT05517538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303484|NCT05517538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303485|NCT05517538|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93303486|NCT05517538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303487|NCT02321280|Denosumab|denosumab|mesh-list
93303488|NCT02321280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93303489|NCT02321280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303490|NCT05527444|Thalidomide|thalidomide|mesh-list
93303491|NCT05527444|Adalimumab|adalimumab|mesh-list
93303492|NCT05527444|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93303493|NCT05527444|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93303494|NCT05527444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303495|NCT05527444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303496|NCT05527444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303497|NCT05527444|Immunologic Factors|immunologic factors|mesh-ancestor
93303498|NCT05527444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303499|NCT05527444|Leprostatic Agents|leprostatic agents|mesh-ancestor
93303500|NCT05527444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303501|NCT05527444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303502|NCT05527444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93303503|NCT05527444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93303504|NCT05527444|Growth Substances|growth substances|mesh-ancestor
93303505|NCT05527444|Growth Inhibitors|growth inhibitors|mesh-ancestor
93303506|NCT05527444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303507|NCT05439902|Tamsulosin|tamsulosin|mesh-list
93303508|NCT05439902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93303509|NCT05439902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93303510|NCT05439902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93303511|NCT05439902|Adrenergic Agents|adrenergic agents|mesh-ancestor
93303512|NCT05439902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303513|NCT05439902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303514|NCT05439902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303515|NCT05439902|Urological Agents|urological agents|mesh-ancestor
93303516|NCT02315118|Rituximab|rituximab|mesh-list
93303517|NCT02315118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303518|NCT02315118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303519|NCT02315118|Immunologic Factors|immunologic factors|mesh-ancestor
93303520|NCT02315118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303521|NCT02315118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303522|NCT03122756|Dexamethasone|dexamethasone|mesh-list
93303523|NCT03122756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303524|NCT03122756|Antiemetics|antiemetics|mesh-ancestor
93303525|NCT03122756|Autonomic Agents|autonomic agents|mesh-ancestor
93303526|NCT03122756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303527|NCT03122756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303528|NCT03122756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93303529|NCT03122756|Glucocorticoids|glucocorticoids|mesh-ancestor
93303530|NCT03122756|Hormones|hormones|mesh-ancestor
93366432|NCT02422186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93303531|NCT03122756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303532|NCT03122756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93303533|NCT03122756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303534|NCT03122678|Thiamine|thiamine|mesh-list
93303535|NCT03122678|Vitamins|vitamins|mesh-ancestor
93303536|NCT03122678|Micronutrients|micronutrients|mesh-ancestor
93303537|NCT03122678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303538|NCT03122678|Vitamin B Complex|vitamin b complex|mesh-ancestor
93303539|NCT02317770|Lidocaine|lidocaine|mesh-list
93303540|NCT02317770|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303541|NCT02317770|Anesthetics|anesthetics|mesh-ancestor
93303542|NCT02317770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303543|NCT02317770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303544|NCT02317770|Sensory System Agents|sensory system agents|mesh-ancestor
93303545|NCT02317770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303546|NCT02317770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93303547|NCT02317770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93303548|NCT02317770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93303549|NCT02317770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303550|NCT02317770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303551|NCT05527054|Diuretics|diuretics|mesh-list
93303552|NCT05527054|Natriuretic Agents|natriuretic agents|mesh-ancestor
93303553|NCT05527054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303554|NCT04506242|Apatinib|apatinib|mesh-list
93303555|NCT04506242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303556|NCT04506242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93303557|NCT04506242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303558|NCT04506242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303559|NCT05526898|Triamcinolone|triamcinolone|mesh-list
93303560|NCT05526898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303561|NCT05526898|Glucocorticoids|glucocorticoids|mesh-ancestor
93303562|NCT05526898|Hormones|hormones|mesh-ancestor
93303563|NCT05526898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303564|NCT05526898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303565|NCT05526820|Vaccines|vaccines|mesh-list
93303566|NCT05526820|Immunologic Factors|immunologic factors|mesh-ancestor
93303567|NCT05526820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303568|NCT03352076|Danazol|danazol|mesh-list
93303569|NCT03352076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93303570|NCT03352076|Hormone Antagonists|hormone antagonists|mesh-ancestor
93303571|NCT03352076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303572|NCT03352076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303573|NCT03497442|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93303574|NCT03497442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93303575|NCT03497442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93303576|NCT03497442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93303577|NCT03497442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93303578|NCT03497442|Adrenergic Agents|adrenergic agents|mesh-ancestor
93303579|NCT03497442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303580|NCT03497442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303581|NCT03497442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303582|NCT02738580|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93303583|NCT02738580|Hormones|hormones|mesh-ancestor
93303584|NCT02738580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303585|NCT02738580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303586|NCT03497364|Bupivacaine|bupivacaine|mesh-list
93303587|NCT03497364|Ropivacaine|ropivacaine|mesh-list
93303588|NCT03497364|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303589|NCT03497364|Anesthetics|anesthetics|mesh-ancestor
93303590|NCT03497364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303591|NCT03497364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303592|NCT03497364|Sensory System Agents|sensory system agents|mesh-ancestor
93303593|NCT03497364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303594|NCT03348254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93303595|NCT03348254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93303596|NCT03348254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303597|NCT03348254|Antitubercular Agents|antitubercular agents|mesh-ancestor
93303598|NCT05521048|Doxycycline|doxycycline|mesh-list
93303599|NCT05521048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303600|NCT05521048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303601|NCT05521048|Antimalarials|antimalarials|mesh-ancestor
93303602|NCT05521048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93303603|NCT05521048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93303604|NCT05516446|Chromium|chromium|mesh-list
93303606|NCT05516446|Everolimus|everolimus|mesh-list
93303607|NCT05516446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93303608|NCT05516446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303609|NCT05516446|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303610|NCT05516446|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303611|NCT05516446|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303612|NCT05516446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303613|NCT05516446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93303614|NCT05516446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93303615|NCT05516446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303616|NCT05516446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303617|NCT05516446|Immunologic Factors|immunologic factors|mesh-ancestor
93303618|NCT05516446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303619|NCT05516446|Trace Elements|trace elements|mesh-ancestor
93303620|NCT05516446|Micronutrients|micronutrients|mesh-ancestor
93303621|NCT02318082|Aldesleukin|aldesleukin|mesh-list
93303622|NCT02318082|Interleukin-2|interleukin-2|mesh-list
93303623|NCT02318082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303624|NCT02318082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93303625|NCT02318082|Analgesics|analgesics|mesh-ancestor
93303626|NCT02318082|Sensory System Agents|sensory system agents|mesh-ancestor
93303627|NCT02318082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303628|NCT02318082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303629|NCT02318082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93303630|NCT02318082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93303631|NCT02318082|Antiviral Agents|antiviral agents|mesh-ancestor
93303632|NCT02318082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303633|NCT03348098|Paclitaxel|paclitaxel|mesh-list
93303634|NCT03348098|Apatinib|apatinib|mesh-list
93303635|NCT03348098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93303636|NCT03348098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303637|NCT03348098|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303638|NCT03348098|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303639|NCT03348098|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303640|NCT03348098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303641|NCT03348098|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93303642|NCT03348098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303643|NCT03351842|Cisplatin|cisplatin|mesh-list
93303644|NCT03351842|Carboplatin|carboplatin|mesh-list
93303645|NCT03351842|Pemetrexed|pemetrexed|mesh-list
93303646|NCT03351842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303647|NCT03351842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303648|NCT03351842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303649|NCT03351842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93303650|NCT03351842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93303651|NCT02447406|Docetaxel|docetaxel|mesh-list
93303652|NCT02447406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303653|NCT02447406|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303654|NCT02447406|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303655|NCT02447406|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303656|NCT02447406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303657|NCT04505228|Atropine|atropine|mesh-list
93303658|NCT04505228|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93303659|NCT04505228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93303660|NCT04505228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93303661|NCT04505228|Autonomic Agents|autonomic agents|mesh-ancestor
93303662|NCT04505228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303663|NCT04505228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303664|NCT04505228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93303665|NCT04505228|Respiratory System Agents|respiratory system agents|mesh-ancestor
93303666|NCT04505228|Mydriatics|mydriatics|mesh-ancestor
93303667|NCT04505228|Parasympatholytics|parasympatholytics|mesh-ancestor
93303668|NCT04505228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93303669|NCT04505228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93303670|NCT04505228|Cholinergic Agents|cholinergic agents|mesh-ancestor
93303671|NCT04505228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303672|NCT04505228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303673|NCT05584826|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93303674|NCT05584826|Hallucinogens|hallucinogens|mesh-ancestor
93303675|NCT05584826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303676|NCT05584826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93303677|NCT05584826|Serotonin Agents|serotonin agents|mesh-ancestor
93303678|NCT05584826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303679|NCT05584826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303680|NCT05584826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93303681|NCT05584826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93303682|NCT05584826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303683|NCT05584826|Adrenergic Agents|adrenergic agents|mesh-ancestor
93303685|NCT03161028|Antioxidants|antioxidants|mesh-ancestor
93303686|NCT03161028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303687|NCT03161028|Protective Agents|protective agents|mesh-ancestor
93303688|NCT03161028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303689|NCT03161028|Vitamin B Complex|vitamin b complex|mesh-ancestor
93303690|NCT03161028|Vitamins|vitamins|mesh-ancestor
93303691|NCT03161028|Micronutrients|micronutrients|mesh-ancestor
93303692|NCT02322372|Bupivacaine|bupivacaine|mesh-list
93303693|NCT02322372|Anesthetics|anesthetics|mesh-ancestor
93303694|NCT02322372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303695|NCT02322372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303696|NCT02322372|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303697|NCT02322372|Sensory System Agents|sensory system agents|mesh-ancestor
93303698|NCT02322372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303699|NCT01376804|Valganciclovir|valganciclovir|mesh-list
93303700|NCT01376804|Antiviral Agents|antiviral agents|mesh-ancestor
93303701|NCT01376804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303702|NCT05526118|Tenofovir|tenofovir|mesh-list
93303703|NCT05526118|Emtricitabine|emtricitabine|mesh-list
93303704|NCT05526118|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93303705|NCT05526118|Antiviral Agents|antiviral agents|mesh-ancestor
93303706|NCT05526118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303707|NCT05526118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93303708|NCT05526118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93303709|NCT05526118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303710|NCT05526118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303711|NCT05526118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93303712|NCT05526118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93303713|NCT03122132|Ritonavir|ritonavir|mesh-list
93303714|NCT03122132|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93303715|NCT03122132|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93303716|NCT03122132|Protease Inhibitors|protease inhibitors|mesh-ancestor
93303717|NCT03122132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303718|NCT03122132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303719|NCT03122132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93303720|NCT03122132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93303721|NCT03122132|Antiviral Agents|antiviral agents|mesh-ancestor
93303722|NCT03122132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303723|NCT03122132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93303724|NCT03122132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93303725|NCT03351686|Tranexamic Acid|tranexamic acid|mesh-list
93303726|NCT03351686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93303727|NCT03351686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93303728|NCT03351686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303729|NCT03351686|Hemostatics|hemostatics|mesh-ancestor
93303730|NCT03351686|Coagulants|coagulants|mesh-ancestor
93303731|NCT03347864|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
93303732|NCT03347864|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93303733|NCT03347864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303734|NCT02319018|Calcium, Dietary|calcium, dietary|mesh-list
93303735|NCT02319018|Leucovorin|leucovorin|mesh-list
93303736|NCT02319018|Folic Acid|folic acid|mesh-list
93303737|NCT02319018|Fluorouracil|fluorouracil|mesh-list
93303738|NCT02319018|Oxaliplatin|oxaliplatin|mesh-list
93303739|NCT02319018|Calcium|calcium|mesh-list
93303740|NCT02319018|Levoleucovorin|levoleucovorin|mesh-list
93303741|NCT02319018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93303742|NCT02319018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303743|NCT02319018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93303744|NCT02319018|Antimetabolites|antimetabolites|mesh-ancestor
93303745|NCT02319018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303746|NCT02319018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303747|NCT02319018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303748|NCT02319018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303749|NCT02319018|Immunologic Factors|immunologic factors|mesh-ancestor
93303750|NCT02319018|Antidotes|antidotes|mesh-ancestor
93303751|NCT02319018|Protective Agents|protective agents|mesh-ancestor
93303752|NCT02319018|Vitamin B Complex|vitamin b complex|mesh-ancestor
93303753|NCT02319018|Vitamins|vitamins|mesh-ancestor
93303754|NCT02319018|Micronutrients|micronutrients|mesh-ancestor
93303755|NCT02319018|Hematinics|hematinics|mesh-ancestor
93303756|NCT02574520|Bupivacaine|bupivacaine|mesh-list
93303757|NCT02574520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93303758|NCT02574520|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303759|NCT02574520|Anesthetics|anesthetics|mesh-ancestor
93303760|NCT02574520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303761|NCT02574520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303762|NCT02574520|Sensory System Agents|sensory system agents|mesh-ancestor
93303763|NCT02574520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303764|NCT04425226|Pembrolizumab|pembrolizumab|mesh-list
93303765|NCT04425226|Lenvatinib|lenvatinib|mesh-list
93303766|NCT04425226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303767|NCT04425226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303768|NCT04425226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303769|NCT04425226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303770|NCT04425226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93303771|NCT04425226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303772|NCT05520658|Fluorouracil|fluorouracil|mesh-list
93303773|NCT05520658|Digoxin|digoxin|mesh-list
93303774|NCT05520658|Furosemide|furosemide|mesh-list
93303775|NCT05520658|Antimetabolites|antimetabolites|mesh-ancestor
93303776|NCT05520658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303777|NCT05520658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303778|NCT05520658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303779|NCT05520658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303780|NCT05520658|Immunologic Factors|immunologic factors|mesh-ancestor
93303781|NCT05520658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303782|NCT05520658|Diuretics|diuretics|mesh-ancestor
93303783|NCT05520658|Natriuretic Agents|natriuretic agents|mesh-ancestor
93303784|NCT05520658|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93303785|NCT05520658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303786|NCT05520658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93303787|NCT05520658|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93303788|NCT05520658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303789|NCT05520658|Protective Agents|protective agents|mesh-ancestor
93303790|NCT04462926|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93303791|NCT04462926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93303792|NCT04462926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303793|NCT05140954|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93303794|NCT05140954|Antiviral Agents|antiviral agents|mesh-ancestor
93303795|NCT05140954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303796|NCT05140954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92598336|NCT00442585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303797|NCT05140954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93303798|NCT05140954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303799|NCT05140954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303800|NCT05140954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93303801|NCT05140954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93303802|NCT03351062|Tamoxifen|tamoxifen|mesh-list
93303803|NCT03351062|Toremifene|toremifene|mesh-list
93303804|NCT03351062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93303805|NCT03351062|Hormone Antagonists|hormone antagonists|mesh-ancestor
93303806|NCT03351062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303807|NCT03351062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303808|NCT03351062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93303809|NCT03351062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303810|NCT03351062|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93303811|NCT03351062|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93303812|NCT03351062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93303813|NCT03496740|Bupivacaine|bupivacaine|mesh-list
93303814|NCT03496740|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303815|NCT03496740|Anesthetics|anesthetics|mesh-ancestor
93303816|NCT03496740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303817|NCT03496740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303818|NCT03496740|Sensory System Agents|sensory system agents|mesh-ancestor
93303819|NCT03496740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303820|NCT05515822|Oxycodone|oxycodone|mesh-list
93303821|NCT05515822|Dezocine|dezocine|mesh-list
93303822|NCT05515822|Esketamine|esketamine|mesh-list
93303823|NCT05515822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93303824|NCT05515822|Narcotics|narcotics|mesh-ancestor
93303825|NCT05515822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303826|NCT05515822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303827|NCT05515822|Analgesics|analgesics|mesh-ancestor
93303828|NCT05515822|Sensory System Agents|sensory system agents|mesh-ancestor
93303829|NCT05515822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303830|NCT05515822|Antidepressive Agents|antidepressive agents|mesh-ancestor
92975854|NCT00801866|Bevacizumab|bevacizumab|mesh-list
93303831|NCT05515822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93303832|NCT04294654|Vortioxetine|vortioxetine|mesh-list
93303833|NCT04294654|Antidepressive Agents|antidepressive agents|mesh-ancestor
93303834|NCT04294654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93303835|NCT04294654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93303836|NCT04294654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93303837|NCT04294654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303838|NCT04294654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303839|NCT04294654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93303840|NCT04294654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93303841|NCT04294654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303842|NCT04294654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303843|NCT04294654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303844|NCT04294654|Serotonin Agents|serotonin agents|mesh-ancestor
93303845|NCT04294654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93303846|NCT04294654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93303847|NCT04294654|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93303848|NCT04294654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93303849|NCT03496506|Selexipag|selexipag|mesh-list
93303850|NCT03496506|Clopidogrel|clopidogrel|mesh-list
93303851|NCT03496506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93303852|NCT03496506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93303853|NCT03496506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93303854|NCT03496506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93303855|NCT03496506|Purinergic Agents|purinergic agents|mesh-ancestor
93303856|NCT03496506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303857|NCT03496506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303858|NCT03496506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303859|NCT03496506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93303860|NCT04766684|Lidocaine|lidocaine|mesh-list
93303861|NCT04766684|Anesthetics, Local|anesthetics, local|mesh-ancestor
93303862|NCT04766684|Anesthetics|anesthetics|mesh-ancestor
93303863|NCT04766684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93303864|NCT04766684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303865|NCT04766684|Sensory System Agents|sensory system agents|mesh-ancestor
93303866|NCT04766684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303867|NCT04766684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93303868|NCT04766684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93303869|NCT04766684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93303870|NCT04766684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93303871|NCT04766684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303872|NCT02325024|Nabiximols|nabiximols|mesh-list
93303873|NCT02325024|Analgesics|analgesics|mesh-ancestor
93303874|NCT02325024|Sensory System Agents|sensory system agents|mesh-ancestor
93303875|NCT02325024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303876|NCT02325024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303877|NCT02319564|Beclomethasone|beclomethasone|mesh-list
93303878|NCT02319564|Albuterol|albuterol|mesh-list
93303879|NCT02319564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93303880|NCT02319564|Autonomic Agents|autonomic agents|mesh-ancestor
93303881|NCT02319564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303882|NCT02319564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303883|NCT02319564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93303884|NCT02319564|Respiratory System Agents|respiratory system agents|mesh-ancestor
93303885|NCT02319564|Tocolytic Agents|tocolytic agents|mesh-ancestor
93303886|NCT02319564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93303887|NCT02319564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93303888|NCT02319564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93303889|NCT02319564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93303890|NCT02319564|Adrenergic Agents|adrenergic agents|mesh-ancestor
93303891|NCT02319564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303892|NCT02319564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303893|NCT02319564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303894|NCT02319564|Glucocorticoids|glucocorticoids|mesh-ancestor
93303895|NCT02319564|Hormones|hormones|mesh-ancestor
93303896|NCT02319564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93303897|NCT05056402|Vaccines|vaccines|mesh-list
93303898|NCT05056402|Immunologic Factors|immunologic factors|mesh-ancestor
93303899|NCT05056402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303900|NCT02325180|Lumefantrine|lumefantrine|mesh-list
93303901|NCT02325180|Artemether|artemether|mesh-list
93303902|NCT02325180|Piperaquine|piperaquine|mesh-list
93303903|NCT02325180|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92975929|NCT00868764|Serotonin Agents|serotonin agents|mesh-ancestor
93303904|NCT02325180|Artenimol|artenimol|mesh-list
93303905|NCT02325180|Antimalarials|antimalarials|mesh-ancestor
93303906|NCT02325180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93303907|NCT02325180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93303908|NCT02325180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303909|NCT00709592|Mycophenolic Acid|mycophenolic acid|mesh-list
93303910|NCT00709592|Tacrolimus|tacrolimus|mesh-list
93303911|NCT00709592|Thymoglobulin|thymoglobulin|mesh-list
93303912|NCT00709592|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93303913|NCT00709592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303914|NCT00709592|Immunologic Factors|immunologic factors|mesh-ancestor
93303915|NCT00709592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303916|NCT00709592|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93303917|NCT00709592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303918|NCT00709592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303919|NCT00709592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93303920|NCT00709592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303921|NCT00709592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93303922|NCT00709592|Antitubercular Agents|antitubercular agents|mesh-ancestor
93303923|NCT00709592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93303924|NCT00709592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93303925|NCT05515354|Nicotine|nicotine|mesh-list
93303926|NCT05515354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93303927|NCT05515354|Autonomic Agents|autonomic agents|mesh-ancestor
93303928|NCT05515354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303929|NCT05515354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303930|NCT05515354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93303931|NCT05515354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93303932|NCT05515354|Cholinergic Agents|cholinergic agents|mesh-ancestor
93303933|NCT05515354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93303934|NCT05515354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303935|NCT02437370|Gemcitabine|gemcitabine|mesh-list
93303936|NCT02437370|Docetaxel|docetaxel|mesh-list
93303937|NCT02437370|Pembrolizumab|pembrolizumab|mesh-list
93303938|NCT02437370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303939|NCT02437370|Antimetabolites|antimetabolites|mesh-ancestor
93303940|NCT02437370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303941|NCT02437370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303942|NCT02437370|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303943|NCT02437370|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303944|NCT02437370|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303945|NCT02437370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93303946|NCT02437370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93303947|NCT05515120|Aspirin|aspirin|mesh-list
93303948|NCT05515120|Vitamin K|vitamin k|mesh-list
93303949|NCT05515120|Rivaroxaban|rivaroxaban|mesh-list
93303950|NCT05515120|Acenocoumarol|acenocoumarol|mesh-list
93303951|NCT05515120|Vitamins|vitamins|mesh-ancestor
93303952|NCT05515120|Micronutrients|micronutrients|mesh-ancestor
93303953|NCT05515120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303954|NCT05515120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93303955|NCT05515120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93303956|NCT05515120|Analgesics|analgesics|mesh-ancestor
93303957|NCT05515120|Sensory System Agents|sensory system agents|mesh-ancestor
93303958|NCT05515120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93303959|NCT05515120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93303960|NCT05515120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303961|NCT05515120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93303962|NCT05515120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93303963|NCT05515120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303964|NCT05515120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93303965|NCT05515120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93303966|NCT05515120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93303967|NCT05515120|Antipyretics|antipyretics|mesh-ancestor
93303968|NCT05515120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93303969|NCT05515120|Antithrombins|antithrombins|mesh-ancestor
93303970|NCT05515120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93303971|NCT05515120|Protease Inhibitors|protease inhibitors|mesh-ancestor
93303972|NCT05515120|Anticoagulants|anticoagulants|mesh-ancestor
93303973|NCT05515120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93303974|NCT05515120|Hemostatics|hemostatics|mesh-ancestor
93303975|NCT05515120|Coagulants|coagulants|mesh-ancestor
93303976|NCT02323230|Cyclophosphamide|cyclophosphamide|mesh-list
93303977|NCT02323230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93303978|NCT02323230|Immunologic Factors|immunologic factors|mesh-ancestor
93303979|NCT02323230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93303980|NCT02323230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93303981|NCT02323230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93303982|NCT02323230|Alkylating Agents|alkylating agents|mesh-ancestor
93303983|NCT02323230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303984|NCT02323230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303985|NCT02323230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93303986|NCT05042128|Paclitaxel|paclitaxel|mesh-list
93303987|NCT05042128|Gemcitabine|gemcitabine|mesh-list
93303988|NCT05042128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93303989|NCT05042128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93303990|NCT05042128|Tubulin Modulators|tubulin modulators|mesh-ancestor
93303991|NCT05042128|Antimitotic Agents|antimitotic agents|mesh-ancestor
93303992|NCT05042128|Mitosis Modulators|mitosis modulators|mesh-ancestor
93303993|NCT05042128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93303994|NCT05042128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93303995|NCT05042128|Antimetabolites|antimetabolites|mesh-ancestor
93303996|NCT03495804|Mannitol|mannitol|mesh-list
93303997|NCT03495804|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93303998|NCT03495804|Diuretics|diuretics|mesh-ancestor
93303999|NCT03495804|Natriuretic Agents|natriuretic agents|mesh-ancestor
93304000|NCT03495804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304001|NCT05519410|Lenvatinib|lenvatinib|mesh-list
93304002|NCT05519410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304003|NCT05519410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93304004|NCT05519410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304005|NCT05519410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304006|NCT05578586|Meropenem|meropenem|mesh-list
93304007|NCT05578586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304008|NCT05578586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304009|NCT02570074|Fosfomycin|fosfomycin|mesh-list
93304010|NCT02570074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304011|NCT02570074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304012|NCT02569996|Rituximab|rituximab|mesh-list
93304013|NCT02569996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304014|NCT02569996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304015|NCT02569996|Immunologic Factors|immunologic factors|mesh-ancestor
93304016|NCT02569996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304017|NCT02569996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304018|NCT02325882|Fentanyl|fentanyl|mesh-list
93304019|NCT02325882|Dexmedetomidine|dexmedetomidine|mesh-list
93304020|NCT02325882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93304021|NCT02325882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304022|NCT02325882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304023|NCT02325882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304024|NCT02325882|Analgesics|analgesics|mesh-ancestor
93304025|NCT02325882|Sensory System Agents|sensory system agents|mesh-ancestor
93304026|NCT02325882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304027|NCT02325882|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93304028|NCT02325882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93304029|NCT02325882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93304030|NCT02325882|Adrenergic Agents|adrenergic agents|mesh-ancestor
93304031|NCT02325882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304032|NCT02325882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304033|NCT02325882|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93304034|NCT02325882|Narcotics|narcotics|mesh-ancestor
93304035|NCT02325882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93304036|NCT02325882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304037|NCT02325882|Anesthetics, General|anesthetics, general|mesh-ancestor
93304038|NCT02325882|Anesthetics|anesthetics|mesh-ancestor
93304039|NCT00708500|Interferons|interferons|mesh-list
93304040|NCT00708500|Ribavirin|ribavirin|mesh-list
93304041|NCT00708500|Interferon-alpha|interferon-alpha|mesh-list
93304042|NCT00708500|Interferon alpha-2|interferon alpha-2|mesh-list
93304043|NCT00708500|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93304044|NCT00708500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304045|NCT00708500|Antiviral Agents|antiviral agents|mesh-ancestor
93304046|NCT00708500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304047|NCT00708500|Antimetabolites|antimetabolites|mesh-ancestor
93304048|NCT00708500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304049|NCT00708500|Immunologic Factors|immunologic factors|mesh-ancestor
93304050|NCT00708500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304051|NCT05144100|Cisplatin|cisplatin|mesh-list
93304052|NCT05144100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304053|NCT02320032|Aripiprazole|aripiprazole|mesh-list
93304054|NCT02320032|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
93304055|NCT02320032|Antidepressive Agents|antidepressive agents|mesh-ancestor
93304056|NCT02320032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93304057|NCT02320032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93304058|NCT02320032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93366433|NCT02422186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93304059|NCT02320032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304060|NCT02320032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304061|NCT02320032|Dopamine Agonists|dopamine agonists|mesh-ancestor
92598616|NCT00443950|Etanercept|etanercept|mesh-list
93304062|NCT02320032|Dopamine Agents|dopamine agents|mesh-ancestor
93304063|NCT02320032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304064|NCT02320032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304065|NCT02320032|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93304066|NCT02320032|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93304067|NCT02320032|Serotonin Agents|serotonin agents|mesh-ancestor
93304068|NCT02320032|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93304069|NCT02320032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93304070|NCT02320032|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93304071|NCT02320032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93304072|NCT05514652|Analgesics, Opioid|analgesics, opioid|mesh-list
93304073|NCT05514652|Anesthetics|anesthetics|mesh-list
93304074|NCT05514652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304075|NCT05514652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304076|NCT05514652|Narcotics|narcotics|mesh-ancestor
93304077|NCT05514652|Analgesics|analgesics|mesh-ancestor
93304078|NCT05514652|Sensory System Agents|sensory system agents|mesh-ancestor
93304079|NCT05514652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304080|NCT00673244|Furosemide|furosemide|mesh-list
93304081|NCT00673244|Diuretics|diuretics|mesh-ancestor
93304082|NCT00673244|Natriuretic Agents|natriuretic agents|mesh-ancestor
93304083|NCT00673244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304084|NCT00673244|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93304085|NCT00673244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93304086|NCT00673244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304087|NCT02517788|Interferons|interferons|mesh-list
93304088|NCT02517788|Interferon-beta|interferon-beta|mesh-list
93304089|NCT02517788|Interferon beta-1a|interferon beta-1a|mesh-list
93304090|NCT02517788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304091|NCT02517788|Antiviral Agents|antiviral agents|mesh-ancestor
93304092|NCT02517788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304093|NCT02517788|Immunologic Factors|immunologic factors|mesh-ancestor
93304094|NCT02517788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304095|NCT02517788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93304096|NCT04599790|Lenvatinib|lenvatinib|mesh-list
93304097|NCT04599790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304098|NCT04599790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93304099|NCT04599790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304100|NCT04599790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304101|NCT03132168|Anesthetics|anesthetics|mesh-list
93304102|NCT03132168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304103|NCT03132168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304104|NCT04937062|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93304105|NCT04937062|Glycerol|glycerol|mesh-list
93304106|NCT04937062|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93304107|NCT04937062|Protective Agents|protective agents|mesh-ancestor
93304108|NCT04937062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304109|NCT04937062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304110|NCT02324010|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93304111|NCT02324010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93304112|NCT02324010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304113|NCT02324010|Incretins|incretins|mesh-ancestor
93304114|NCT02324010|Hormones|hormones|mesh-ancestor
93304115|NCT02324010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304116|NCT02324010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93304117|NCT02324010|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304118|NCT02324010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304119|NCT02324010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304120|NCT02320734|Rocuronium|rocuronium|mesh-list
93304121|NCT02320734|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93304122|NCT02320734|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93304123|NCT02320734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93304124|NCT02320734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304125|NCT02320734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304126|NCT03346226|Dexmedetomidine|dexmedetomidine|mesh-list
93304127|NCT03346226|Propofol|propofol|mesh-list
93304128|NCT03346226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93304129|NCT03346226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304130|NCT03346226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304131|NCT03346226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304132|NCT03346226|Analgesics|analgesics|mesh-ancestor
93304133|NCT03346226|Sensory System Agents|sensory system agents|mesh-ancestor
93304134|NCT03346226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304135|NCT03346226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93304136|NCT03346226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93304137|NCT03346226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93304138|NCT03346226|Adrenergic Agents|adrenergic agents|mesh-ancestor
93304139|NCT03346226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304140|NCT03346226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304141|NCT03346226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304142|NCT03346226|Anesthetics, General|anesthetics, general|mesh-ancestor
93304143|NCT03346226|Anesthetics|anesthetics|mesh-ancestor
93304144|NCT03347240|Baclofen|baclofen|mesh-list
93304145|NCT03347240|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93304146|NCT03347240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304147|NCT03347240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93304148|NCT03347240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304149|NCT03347240|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93304150|NCT03347240|GABA Agonists|gaba agonists|mesh-ancestor
93304151|NCT03347240|GABA Agents|gaba agents|mesh-ancestor
93304152|NCT03347240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304153|NCT03347240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304154|NCT02324088|Cyclophosphamide|cyclophosphamide|mesh-list
93304155|NCT02324088|Docetaxel|docetaxel|mesh-list
93304156|NCT02324088|Epirubicin|epirubicin|mesh-list
93304157|NCT02324088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93304158|NCT02324088|Immunologic Factors|immunologic factors|mesh-ancestor
93304159|NCT02324088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304160|NCT02324088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304161|NCT02324088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93304162|NCT02324088|Alkylating Agents|alkylating agents|mesh-ancestor
93304163|NCT02324088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304164|NCT02324088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304165|NCT02324088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93304166|NCT02324088|Tubulin Modulators|tubulin modulators|mesh-ancestor
93304167|NCT02324088|Antimitotic Agents|antimitotic agents|mesh-ancestor
93304168|NCT02324088|Mitosis Modulators|mitosis modulators|mesh-ancestor
93304169|NCT02324088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93304170|NCT02324088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93304171|NCT02324088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93304172|NCT02324088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304173|NCT02324166|Cefazolin|cefazolin|mesh-list
93304174|NCT02324166|Lidocaine|lidocaine|mesh-list
93304175|NCT02324166|Anesthetics, Local|anesthetics, local|mesh-ancestor
93304176|NCT02324166|Anesthetics|anesthetics|mesh-ancestor
93304177|NCT02324166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304178|NCT02324166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304179|NCT02324166|Sensory System Agents|sensory system agents|mesh-ancestor
93304180|NCT02324166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304181|NCT02324166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93304182|NCT02324166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93304183|NCT02324166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93304184|NCT02324166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93304185|NCT02324166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304186|NCT02324166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304187|NCT02324166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304188|NCT03346538|Edaravone|edaravone|mesh-list
93304189|NCT03346538|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93304190|NCT03346538|Antioxidants|antioxidants|mesh-ancestor
93304191|NCT03346538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304192|NCT03346538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93304193|NCT03346538|Protective Agents|protective agents|mesh-ancestor
93304194|NCT03346538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304195|NCT02513342|Docetaxel|docetaxel|mesh-list
93304196|NCT02513342|Endostar protein|endostar protein|mesh-list
93304197|NCT02513342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304198|NCT02513342|Tubulin Modulators|tubulin modulators|mesh-ancestor
93304199|NCT02513342|Antimitotic Agents|antimitotic agents|mesh-ancestor
93304200|NCT02513342|Mitosis Modulators|mitosis modulators|mesh-ancestor
93304201|NCT02513342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304202|NCT02513342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93304203|NCT02513342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93304204|NCT02513342|Growth Substances|growth substances|mesh-ancestor
93304205|NCT02513342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304206|NCT02513342|Growth Inhibitors|growth inhibitors|mesh-ancestor
93304207|NCT03495024|Varenicline|varenicline|mesh-list
93304209|NCT03495024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93304210|NCT03495024|Cholinergic Agents|cholinergic agents|mesh-ancestor
93304211|NCT03495024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304212|NCT03495024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304213|NCT03495024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304214|NCT04188314|Desflurane|desflurane|mesh-list
93304215|NCT04188314|Isoflurane|isoflurane|mesh-list
93304216|NCT04188314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93304217|NCT04188314|Anesthetics, General|anesthetics, general|mesh-ancestor
93304218|NCT04188314|Anesthetics|anesthetics|mesh-ancestor
93304219|NCT04188314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304220|NCT04188314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304221|NCT05512780|Letrozole|letrozole|mesh-list
93304222|NCT05512780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304223|NCT05512780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93304224|NCT05512780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93304225|NCT05512780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304226|NCT05512780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304227|NCT05512780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93304228|NCT05512780|Hormone Antagonists|hormone antagonists|mesh-ancestor
93304229|NCT05512780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304230|NCT05512780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304231|NCT02517164|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93304232|NCT02517164|Calcifediol|calcifediol|mesh-list
93304233|NCT02517164|Vitamins|vitamins|mesh-ancestor
93304234|NCT02517164|Micronutrients|micronutrients|mesh-ancestor
93304235|NCT02517164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304236|NCT02517164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93304237|NCT04834362|Insulin|insulin|mesh-list
93304238|NCT04834362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93304239|NCT04834362|Insulin Glargine|insulin glargine|mesh-list
93304240|NCT04834362|Insulin Aspart|insulin aspart|mesh-list
93304241|NCT04834362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93304242|NCT04834362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304243|NCT05512702|Heparin|heparin|mesh-list
93304244|NCT05512702|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93304245|NCT05512702|Plasminogen|plasminogen|mesh-list
93304246|NCT05512702|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93304247|NCT05512702|Tinzaparin|tinzaparin|mesh-list
93304248|NCT05512702|Dalteparin|dalteparin|mesh-list
93304249|NCT05512702|Anticoagulants|anticoagulants|mesh-ancestor
93304250|NCT05512702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93304251|NCT05512702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93304252|NCT05512702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304253|NCT05512546|Aspirin|aspirin|mesh-list
93304254|NCT05512546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93304255|NCT05512546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304256|NCT05512546|Analgesics|analgesics|mesh-ancestor
93304257|NCT05512546|Sensory System Agents|sensory system agents|mesh-ancestor
93304258|NCT05512546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304259|NCT05512546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304260|NCT05512546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93304261|NCT05512546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304262|NCT05512546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93304263|NCT05512546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93304264|NCT05512546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304265|NCT05512546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93304266|NCT05512546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93304267|NCT05512546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304268|NCT05512546|Antipyretics|antipyretics|mesh-ancestor
93304269|NCT03345134|Pembrolizumab|pembrolizumab|mesh-list
93304270|NCT03345134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304271|NCT03345134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304272|NCT03345134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93304273|NCT03345134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304274|NCT02512562|Simeprevir|simeprevir|mesh-list
93304275|NCT02512562|Odalasvir|odalasvir|mesh-list
93304276|NCT02512562|Antiviral Agents|antiviral agents|mesh-ancestor
93304277|NCT02512562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304278|NCT02512562|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304279|NCT02512562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304280|NCT02512562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304281|NCT02516774|Adalimumab|adalimumab|mesh-list
93304282|NCT02516774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92976302|NCT00871104|Vancomycin|vancomycin|mesh-list
93304284|NCT02516774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304285|NCT05510986|Fentanyl|fentanyl|mesh-list
93304286|NCT05510986|Oxycodone|oxycodone|mesh-list
93304287|NCT05510986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93304288|NCT05510986|Narcotics|narcotics|mesh-ancestor
93304289|NCT05510986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304290|NCT05510986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304291|NCT05510986|Analgesics|analgesics|mesh-ancestor
93304292|NCT05510986|Sensory System Agents|sensory system agents|mesh-ancestor
93304293|NCT05510986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304294|NCT05510986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93304295|NCT05510986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304296|NCT05510986|Anesthetics, General|anesthetics, general|mesh-ancestor
93304297|NCT05510986|Anesthetics|anesthetics|mesh-ancestor
93304298|NCT04872400|Vancomycin|vancomycin|mesh-list
93304299|NCT04872400|Tobramycin|tobramycin|mesh-list
93304300|NCT04872400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304301|NCT04872400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304302|NCT00101907|Gemcitabine|gemcitabine|mesh-list
93304303|NCT00101907|Panitumumab|panitumumab|mesh-list
93304304|NCT00101907|Motesanib diphosphate|motesanib diphosphate|mesh-list
93304305|NCT00101907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304306|NCT00101907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93304307|NCT00101907|Antimetabolites|antimetabolites|mesh-ancestor
93304308|NCT00101907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304309|NCT00101907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304310|NCT00101907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93304311|NCT00101907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304312|NCT03491748|Cefpodoxime|cefpodoxime|mesh-list
93304313|NCT03491748|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
93304314|NCT03491748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304315|NCT03491748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304316|NCT04769206|Galantamine|galantamine|mesh-list
93304317|NCT04769206|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93304318|NCT04769206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304319|NCT04769206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304320|NCT04769206|Cholinergic Agents|cholinergic agents|mesh-ancestor
93304321|NCT04769206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304322|NCT04769206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304323|NCT04769206|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93304324|NCT04769206|Autonomic Agents|autonomic agents|mesh-ancestor
93304325|NCT04769206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304326|NCT04769206|Nootropic Agents|nootropic agents|mesh-ancestor
93304327|NCT03492996|Delpazolid|delpazolid|mesh-list
93304328|NCT03492996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304329|NCT03492996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304330|NCT03492996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93304331|NCT03492996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304332|NCT03492996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304333|NCT03772028|Cisplatin|cisplatin|mesh-list
93304334|NCT03772028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304335|NCT02161965|Warfarin|warfarin|mesh-list
93304336|NCT02161965|Rivaroxaban|rivaroxaban|mesh-list
93304337|NCT02161965|Fluindione|fluindione|mesh-list
93304338|NCT02161965|Phenindione|phenindione|mesh-list
93304339|NCT02161965|Anticoagulants|anticoagulants|mesh-ancestor
93304340|NCT02161965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93304341|NCT02161965|Antithrombins|antithrombins|mesh-ancestor
93304342|NCT02161965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93304343|NCT02161965|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304344|NCT02161965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304345|NCT02161965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304346|NCT02050308|Nicotine|nicotine|mesh-list
93304347|NCT02050308|Varenicline|varenicline|mesh-list
93304348|NCT02050308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93304349|NCT02050308|Autonomic Agents|autonomic agents|mesh-ancestor
93304350|NCT02050308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304351|NCT02050308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304352|NCT02050308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93304353|NCT02050308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93304354|NCT02050308|Cholinergic Agents|cholinergic agents|mesh-ancestor
93304355|NCT02050308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304356|NCT02050308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304357|NCT02516618|Fasinumab|fasinumab|mesh-list
93304358|NCT02516618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304359|NCT02516618|Analgesics|analgesics|mesh-ancestor
93304360|NCT02516618|Sensory System Agents|sensory system agents|mesh-ancestor
93304361|NCT02516618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304362|NCT02516618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304363|NCT05507554|Analgesics|analgesics|mesh-list
93304364|NCT05507554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
93304365|NCT05507554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304366|NCT05507554|Sensory System Agents|sensory system agents|mesh-ancestor
93304367|NCT05507554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304368|NCT02516462|Hormones|hormones|mesh-list
93304369|NCT02516462|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93304370|NCT02516462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304371|NCT02516462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304372|NCT04650204|Anticonvulsants|anticonvulsants|mesh-list
93304373|NCT04501250|Insulin|insulin|mesh-list
93304374|NCT04501250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93304375|NCT04501250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93304376|NCT04501250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304377|NCT02761629|Interferons|interferons|mesh-list
93304378|NCT02761629|Ribavirin|ribavirin|mesh-list
93304379|NCT02761629|Interferon-alpha|interferon-alpha|mesh-list
93304380|NCT02761629|Interferon alpha-2|interferon alpha-2|mesh-list
93304381|NCT02761629|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93304382|NCT02761629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304383|NCT02761629|Antiviral Agents|antiviral agents|mesh-ancestor
93304384|NCT02761629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304385|NCT02761629|Antimetabolites|antimetabolites|mesh-ancestor
93304386|NCT02761629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304387|NCT02761629|Immunologic Factors|immunologic factors|mesh-ancestor
93304388|NCT02761629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304389|NCT03345992|Clarithromycin|clarithromycin|mesh-list
93304390|NCT03345992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304391|NCT03345992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304392|NCT03345992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93304393|NCT03345992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304394|NCT03345992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304395|NCT03345992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93304396|NCT03345992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93304397|NCT02162121|Ketorolac|ketorolac|mesh-list
93304398|NCT02162121|Buprenorphine|buprenorphine|mesh-list
93304399|NCT02162121|Anesthetics|anesthetics|mesh-list
93304400|NCT02162121|Ropivacaine|ropivacaine|mesh-list
93304401|NCT02162121|Levobupivacaine|levobupivacaine|mesh-list
93304402|NCT02162121|Mepivacaine|mepivacaine|mesh-list
93304403|NCT02162121|Anesthetics, Local|anesthetics, local|mesh-list
93304404|NCT02162121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304405|NCT02162121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304406|NCT02162121|Sensory System Agents|sensory system agents|mesh-ancestor
93304407|NCT02162121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304408|NCT02162121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93304409|NCT02162121|Narcotics|narcotics|mesh-ancestor
93304410|NCT02162121|Analgesics|analgesics|mesh-ancestor
93304411|NCT02162121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93304412|NCT02162121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93304413|NCT02162121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304414|NCT02162121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93304415|NCT02162121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304416|NCT02162121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93304417|NCT02162121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304418|NCT02162121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304419|NCT02511704|Nicotine|nicotine|mesh-list
93304420|NCT02511704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93304421|NCT02511704|Autonomic Agents|autonomic agents|mesh-ancestor
93304422|NCT02511704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304423|NCT02511704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304424|NCT02511704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93304425|NCT02511704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93304426|NCT02511704|Cholinergic Agents|cholinergic agents|mesh-ancestor
93304427|NCT02511704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304428|NCT02511704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304429|NCT04500704|Carboplatin|carboplatin|mesh-list
93304430|NCT04500704|Pemetrexed|pemetrexed|mesh-list
93304431|NCT04500704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304432|NCT04500704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304433|NCT04500704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304434|NCT04500704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93304435|NCT04500704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93304436|NCT02164773|Magnesium Sulfate|magnesium sulfate|mesh-list
93304437|NCT02164773|Analgesics|analgesics|mesh-ancestor
93304438|NCT02164773|Sensory System Agents|sensory system agents|mesh-ancestor
93304439|NCT02164773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598963|NCT00109382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93304440|NCT02164773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304441|NCT02164773|Anesthetics|anesthetics|mesh-ancestor
93304442|NCT02164773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304443|NCT02164773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93304444|NCT02164773|Anticonvulsants|anticonvulsants|mesh-ancestor
93304445|NCT02164773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93304446|NCT02164773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93304447|NCT02164773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304448|NCT02164773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93304449|NCT02164773|Tocolytic Agents|tocolytic agents|mesh-ancestor
93304450|NCT02164773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93304451|NCT00101439|Ezetimibe|ezetimibe|mesh-list
93304452|NCT00101439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93304453|NCT00101439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93304454|NCT00101439|Antimetabolites|antimetabolites|mesh-ancestor
93304455|NCT00101439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304456|NCT00101439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93304457|NCT03344822|Choline|choline|mesh-list
93304458|NCT03344822|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93304459|NCT03344822|Lipotropic Agents|lipotropic agents|mesh-ancestor
93304460|NCT03344822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93304461|NCT03344822|Antimetabolites|antimetabolites|mesh-ancestor
93304462|NCT03344822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304463|NCT03344822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304464|NCT03344822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93304465|NCT03344822|Nootropic Agents|nootropic agents|mesh-ancestor
93304466|NCT03344822|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93304467|NCT02162745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93304468|NCT02506790|Toremifene|toremifene|mesh-list
93304469|NCT02506790|Metformin|metformin|mesh-list
93304470|NCT02506790|Melatonin|melatonin|mesh-list
93304471|NCT02506790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93304472|NCT02506790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304473|NCT02506790|Antioxidants|antioxidants|mesh-ancestor
93304474|NCT02506790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304475|NCT02506790|Protective Agents|protective agents|mesh-ancestor
93304476|NCT02506790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304477|NCT02506790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93304478|NCT02506790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304479|NCT02506790|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93304480|NCT02506790|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93304481|NCT02506790|Hormone Antagonists|hormone antagonists|mesh-ancestor
93304482|NCT02506790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304483|NCT02506790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93304484|NCT04500002|Isoniazid|isoniazid|mesh-list
93304485|NCT04500002|Misoprostol|misoprostol|mesh-list
93304486|NCT04500002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93304487|NCT04500002|Abortifacient Agents|abortifacient agents|mesh-ancestor
93304488|NCT04500002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93304489|NCT04500002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304490|NCT04500002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93304491|NCT04500002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304492|NCT04500002|Oxytocics|oxytocics|mesh-ancestor
93304493|NCT04500002|Antitubercular Agents|antitubercular agents|mesh-ancestor
93304494|NCT04500002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304495|NCT04500002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304496|NCT04500002|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93304497|NCT04500002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93304498|NCT04500002|Antimetabolites|antimetabolites|mesh-ancestor
93304499|NCT04500002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304500|NCT04500002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93304501|NCT02515682|Equol|equol|mesh-list
93304502|NCT02515682|Phytoestrogens|phytoestrogens|mesh-ancestor
93304503|NCT02515682|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93304504|NCT02515682|Estrogens|estrogens|mesh-ancestor
93304505|NCT02515682|Hormones|hormones|mesh-ancestor
93304506|NCT02515682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304507|NCT02515682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304508|NCT02515604|Misoprostol|misoprostol|mesh-list
93304509|NCT02515604|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93304510|NCT02515604|Abortifacient Agents|abortifacient agents|mesh-ancestor
93304511|NCT02515604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93304512|NCT02515604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304513|NCT02515604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93304514|NCT02515604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304516|NCT02510534|Menotropins|menotropins|mesh-list
93304517|NCT02510534|Progesterone|progesterone|mesh-list
93304518|NCT02510534|Progestins|progestins|mesh-ancestor
93304519|NCT02510534|Hormones|hormones|mesh-ancestor
93304520|NCT02510534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304521|NCT02510534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304522|NCT02510534|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93304523|NCT02510534|Fertility Agents|fertility agents|mesh-ancestor
93304524|NCT02510534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93304525|NCT02510612|Dexmedetomidine|dexmedetomidine|mesh-list
93304526|NCT02510612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93304527|NCT02510612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304528|NCT02510612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304529|NCT02510612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304530|NCT02510612|Analgesics|analgesics|mesh-ancestor
93304531|NCT02510612|Sensory System Agents|sensory system agents|mesh-ancestor
93304532|NCT02510612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304533|NCT02510612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93304534|NCT02510612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93304535|NCT02510612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93304536|NCT02510612|Adrenergic Agents|adrenergic agents|mesh-ancestor
93304537|NCT02510612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304538|NCT02510612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304539|NCT03749616|Acetaminophen|acetaminophen|mesh-list
93304540|NCT03749616|Ibuprofen|ibuprofen|mesh-list
93304541|NCT03749616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304542|NCT03749616|Analgesics|analgesics|mesh-ancestor
93304543|NCT03749616|Sensory System Agents|sensory system agents|mesh-ancestor
93304544|NCT03749616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304545|NCT03749616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304546|NCT03749616|Antipyretics|antipyretics|mesh-ancestor
93304547|NCT03749616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93304548|NCT03749616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93304549|NCT03749616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304550|NCT03749616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93304551|NCT03749616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304552|NCT03749616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304553|NCT04532502|Anesthetics|anesthetics|mesh-list
93304554|NCT04532502|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
93304555|NCT04532502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304556|NCT04532502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304557|NCT04532502|Anesthetics, General|anesthetics, general|mesh-ancestor
93304558|NCT02515526|Tolbutamide|tolbutamide|mesh-list
93304559|NCT02515526|Ethanol|ethanol|mesh-list
93304560|NCT02515526|Digoxin|digoxin|mesh-list
93304561|NCT02515526|Midazolam|midazolam|mesh-list
93304562|NCT02515526|Dextromethorphan|dextromethorphan|mesh-list
93304563|NCT02515526|Caffeine|caffeine|mesh-list
93304564|NCT02515526|Omeprazole|omeprazole|mesh-list
93304565|NCT02515526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93304566|NCT02515526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93304567|NCT02515526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304568|NCT02515526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304569|NCT02515526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93304570|NCT02515526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93304571|NCT02515526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93304572|NCT02515526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304573|NCT02515526|Anesthetics, General|anesthetics, general|mesh-ancestor
93304574|NCT02515526|Anesthetics|anesthetics|mesh-ancestor
93304575|NCT02515526|GABA Modulators|gaba modulators|mesh-ancestor
93304576|NCT02515526|GABA Agents|gaba agents|mesh-ancestor
93304577|NCT02515526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304578|NCT02515526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304579|NCT02515526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93304580|NCT02515526|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93304581|NCT02515526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599105|NCT00454480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93304582|NCT02515526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93304583|NCT02515526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93304584|NCT02515526|Purinergic Agents|purinergic agents|mesh-ancestor
93304585|NCT02515526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93304586|NCT02515526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304587|NCT02515526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93304588|NCT02515526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93304589|NCT02515526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304590|NCT02515526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93304591|NCT02515526|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93304592|NCT02515526|Protective Agents|protective agents|mesh-ancestor
93304593|NCT02515526|Antitussive Agents|antitussive agents|mesh-ancestor
93304594|NCT02515526|Respiratory System Agents|respiratory system agents|mesh-ancestor
93304595|NCT02515526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93304596|NCT02515526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93304597|NCT02515526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93304598|NCT02515448|Gentamicins|gentamicins|mesh-list
93304599|NCT02515448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304600|NCT02515448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304601|NCT02515448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93304602|NCT02515448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304603|NCT02515448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304604|NCT02170857|Hyaluronic Acid|hyaluronic acid|mesh-list
93304605|NCT02170857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93304606|NCT02170857|Immunologic Factors|immunologic factors|mesh-ancestor
93304607|NCT02170857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304608|NCT02170857|Viscosupplements|viscosupplements|mesh-ancestor
93304609|NCT02170857|Protective Agents|protective agents|mesh-ancestor
93304610|NCT04460820|Doxorubicin|doxorubicin|mesh-list
93304611|NCT04460820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93304612|NCT04460820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93304613|NCT04460820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304614|NCT04460820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93304615|NCT04460820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93304616|NCT04460820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304617|NCT04460820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304618|NCT02170935|Dabigatran|dabigatran|mesh-list
93304619|NCT02170935|Antithrombins|antithrombins|mesh-ancestor
93304620|NCT02170935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93304621|NCT02170935|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304622|NCT02170935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304623|NCT02170935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304624|NCT02170935|Anticoagulants|anticoagulants|mesh-ancestor
93304625|NCT03488316|Calcium|calcium|mesh-list
93304626|NCT03488316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93304627|NCT03488316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304628|NCT02510222|Magnesium Sulfate|magnesium sulfate|mesh-list
93304629|NCT02510222|Analgesics|analgesics|mesh-ancestor
93304630|NCT02510222|Sensory System Agents|sensory system agents|mesh-ancestor
93304631|NCT02510222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304632|NCT02510222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304633|NCT02510222|Anesthetics|anesthetics|mesh-ancestor
93304634|NCT02510222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304635|NCT02510222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93304636|NCT02510222|Anticonvulsants|anticonvulsants|mesh-ancestor
93304637|NCT02510222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93304638|NCT02510222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93304639|NCT02510222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304640|NCT02510222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93304641|NCT02510222|Tocolytic Agents|tocolytic agents|mesh-ancestor
93304642|NCT02510222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93304643|NCT05100264|Acetic Acid|acetic acid|mesh-list
93304644|NCT05100264|Retinol acetate|retinol acetate|mesh-list
93304645|NCT05100264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304646|NCT05100264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304647|NCT05100264|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93304648|NCT05100264|Immunologic Factors|immunologic factors|mesh-ancestor
93304649|NCT05100264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304650|NCT05100264|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93304651|NCT05100264|Protective Agents|protective agents|mesh-ancestor
93304652|NCT05100264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304653|NCT02505776|Bimatoprost|bimatoprost|mesh-list
93304654|NCT02505776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93304655|NCT02171013|Dabigatran|dabigatran|mesh-list
93304656|NCT02171013|Antithrombins|antithrombins|mesh-ancestor
93304657|NCT02171013|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93304658|NCT02171013|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304659|NCT02171013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304660|NCT02171013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304661|NCT02171013|Anticoagulants|anticoagulants|mesh-ancestor
93304662|NCT02167425|Methadone|methadone|mesh-list
93304663|NCT02167425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93304664|NCT02167425|Narcotics|narcotics|mesh-ancestor
93304665|NCT02167425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304666|NCT02167425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304667|NCT02167425|Analgesics|analgesics|mesh-ancestor
93304668|NCT02167425|Sensory System Agents|sensory system agents|mesh-ancestor
93304669|NCT02167425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304670|NCT02167425|Antitussive Agents|antitussive agents|mesh-ancestor
93304671|NCT02167425|Respiratory System Agents|respiratory system agents|mesh-ancestor
93304672|NCT03111732|Pembrolizumab|pembrolizumab|mesh-list
93304673|NCT03111732|Capecitabine|capecitabine|mesh-list
93304674|NCT03111732|Oxaliplatin|oxaliplatin|mesh-list
93304675|NCT03111732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304676|NCT03111732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304677|NCT03111732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93304678|NCT03111732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304679|NCT03111732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93304680|NCT03111732|Antimetabolites|antimetabolites|mesh-ancestor
93304681|NCT01663714|Tositumomab I-131|tositumomab i-131|mesh-list
93304682|NCT01663714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304683|NCT02505386|Ertapenem|ertapenem|mesh-list
93304684|NCT02505386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304685|NCT02505386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304686|NCT05507086|Anti-Infective Agents|anti-infective agents|mesh-list
93304687|NCT05507086|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93304688|NCT02514980|Ketamine|ketamine|mesh-list
93304689|NCT02514980|Bupivacaine|bupivacaine|mesh-list
93304690|NCT02514980|Anesthetics, Local|anesthetics, local|mesh-ancestor
93304691|NCT02514980|Anesthetics|anesthetics|mesh-ancestor
93304692|NCT02514980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304693|NCT02514980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304694|NCT02514980|Sensory System Agents|sensory system agents|mesh-ancestor
93304695|NCT02514980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304696|NCT02514980|Analgesics|analgesics|mesh-ancestor
93304697|NCT02514980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93304698|NCT02514980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304699|NCT02514980|Anesthetics, General|anesthetics, general|mesh-ancestor
93304700|NCT02514980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93304701|NCT02514980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93304702|NCT02514980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304703|NCT02514980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304704|NCT02165475|Loperamide|loperamide|mesh-list
93304705|NCT02165475|Antidiarrheals|antidiarrheals|mesh-list
93304706|NCT02165475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304707|NCT04862338|Niacinamide|niacinamide|mesh-list
93304708|NCT04862338|Niacin|niacin|mesh-list
92599247|NCT00110240|Vildagliptin|vildagliptin|mesh-list
93304709|NCT04862338|Nicotinic Acids|nicotinic acids|mesh-list
93304710|NCT04862338|Vitamin B Complex|vitamin b complex|mesh-ancestor
93304711|NCT04862338|Vitamins|vitamins|mesh-ancestor
93304712|NCT04862338|Micronutrients|micronutrients|mesh-ancestor
93304713|NCT04862338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304714|NCT04862338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93304715|NCT04862338|Antimetabolites|antimetabolites|mesh-ancestor
93304716|NCT04862338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304717|NCT04862338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93304718|NCT04862338|Vasodilator Agents|vasodilator agents|mesh-ancestor
93304719|NCT02171325|Irinotecan|irinotecan|mesh-list
93304720|NCT02171325|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93304721|NCT02171325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93304722|NCT02171325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304723|NCT02171325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304724|NCT02171325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304725|NCT02509286|Leucovorin|leucovorin|mesh-list
93304726|NCT02509286|Paclitaxel|paclitaxel|mesh-list
93304727|NCT02509286|Docetaxel|docetaxel|mesh-list
93304728|NCT02509286|Carboplatin|carboplatin|mesh-list
93304729|NCT02509286|Fluorouracil|fluorouracil|mesh-list
93304730|NCT02509286|Oxaliplatin|oxaliplatin|mesh-list
93304731|NCT02509286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93304732|NCT02509286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304733|NCT02509286|Tubulin Modulators|tubulin modulators|mesh-ancestor
93304734|NCT02509286|Antimitotic Agents|antimitotic agents|mesh-ancestor
93304735|NCT02509286|Mitosis Modulators|mitosis modulators|mesh-ancestor
93304736|NCT02509286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304737|NCT02509286|Antimetabolites|antimetabolites|mesh-ancestor
93304738|NCT02509286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93304739|NCT02509286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93304740|NCT02509286|Immunologic Factors|immunologic factors|mesh-ancestor
93304741|NCT02509286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304742|NCT02509286|Antidotes|antidotes|mesh-ancestor
93304743|NCT02509286|Protective Agents|protective agents|mesh-ancestor
93304744|NCT02509286|Vitamin B Complex|vitamin b complex|mesh-ancestor
93304745|NCT02509286|Vitamins|vitamins|mesh-ancestor
93304746|NCT02509286|Micronutrients|micronutrients|mesh-ancestor
93304747|NCT03065244|Infliximab|infliximab|mesh-list
93304748|NCT03065244|Immunoglobulins|immunoglobulins|mesh-list
93304749|NCT03065244|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93304750|NCT03065244|gamma-Globulins|gamma-globulins|mesh-list
93304751|NCT03065244|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93304752|NCT03065244|Immunologic Factors|immunologic factors|mesh-ancestor
93304753|NCT03065244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304754|NCT03065244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93304755|NCT03065244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93304756|NCT03065244|Dermatologic Agents|dermatologic agents|mesh-ancestor
93304757|NCT03065244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304758|NCT03065244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93304759|NCT02171481|Dabigatran|dabigatran|mesh-list
93304760|NCT02171481|Antithrombins|antithrombins|mesh-ancestor
93304761|NCT02171481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93304762|NCT02171481|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304763|NCT02171481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304764|NCT02171481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304765|NCT02171481|Anticoagulants|anticoagulants|mesh-ancestor
93304766|NCT02171559|Enoxaparin|enoxaparin|mesh-list
93304767|NCT02171559|Dabigatran|dabigatran|mesh-list
93304768|NCT02171559|Anticoagulants|anticoagulants|mesh-ancestor
93304769|NCT02171559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93304770|NCT02171559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93304771|NCT02171559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304772|NCT02171559|Antithrombins|antithrombins|mesh-ancestor
93304773|NCT02171559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93304774|NCT02171559|Protease Inhibitors|protease inhibitors|mesh-ancestor
93304775|NCT02171559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304776|NCT04901754|Apatinib|apatinib|mesh-list
93304777|NCT04901754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304778|NCT04901754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93304779|NCT04901754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304780|NCT04901754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304781|NCT02509208|Hemostatics|hemostatics|mesh-list
93304782|NCT02509208|Coagulants|coagulants|mesh-ancestor
93304783|NCT02504996|Acetaminophen|acetaminophen|mesh-list
93304784|NCT02504996|Morphine|morphine|mesh-list
93304785|NCT02504996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93304786|NCT02504996|Narcotics|narcotics|mesh-ancestor
92599304|NCT00455806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304787|NCT02504996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304788|NCT02504996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304789|NCT02504996|Analgesics|analgesics|mesh-ancestor
93304790|NCT02504996|Sensory System Agents|sensory system agents|mesh-ancestor
93304791|NCT02504996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304792|NCT02504996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93304793|NCT02504996|Antipyretics|antipyretics|mesh-ancestor
93304794|NCT02509052|Leflunomide|leflunomide|mesh-list
93304795|NCT02509052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304796|NCT02509052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304797|NCT02509052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93304798|NCT02509052|Immunologic Factors|immunologic factors|mesh-ancestor
93304799|NCT02509052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304800|NCT00100815|Bevacizumab|bevacizumab|mesh-list
93304801|NCT00100815|Gemcitabine|gemcitabine|mesh-list
93304802|NCT00100815|Capecitabine|capecitabine|mesh-list
93304803|NCT00100815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304804|NCT00100815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304805|NCT00100815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93304806|NCT00100815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93304807|NCT00100815|Growth Substances|growth substances|mesh-ancestor
93304808|NCT00100815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304809|NCT00100815|Growth Inhibitors|growth inhibitors|mesh-ancestor
93304810|NCT00100815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93304811|NCT00100815|Antimetabolites|antimetabolites|mesh-ancestor
93304812|NCT00100815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304813|NCT00708422|Travoprost|travoprost|mesh-list
93304814|NCT00708422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93304815|NCT00708422|Latanoprost|latanoprost|mesh-list
92976817|NCT00872664|Carotenoids|carotenoids|mesh-list
93304816|NCT00708422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93304817|NCT00708422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93304818|NCT02514200|Riboflavin|riboflavin|mesh-list
93304819|NCT02514200|Vitamin B Complex|vitamin b complex|mesh-ancestor
93304820|NCT02514200|Vitamins|vitamins|mesh-ancestor
93304821|NCT02514200|Micronutrients|micronutrients|mesh-ancestor
93304822|NCT02514200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304823|NCT02514200|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93304824|NCT02514200|Dermatologic Agents|dermatologic agents|mesh-ancestor
93304825|NCT02504450|Haloperidol|haloperidol|mesh-list
93304826|NCT02504450|Ziprasidone|ziprasidone|mesh-list
93304827|NCT02504450|Loxapine|loxapine|mesh-list
93304828|NCT02504450|Antiemetics|antiemetics|mesh-ancestor
93304829|NCT02504450|Autonomic Agents|autonomic agents|mesh-ancestor
93304830|NCT02504450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304831|NCT02504450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304832|NCT02504450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304833|NCT02504450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93304834|NCT02504450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93304835|NCT02504450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304836|NCT02504450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93304837|NCT02504450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93304838|NCT02504450|Dopamine Agents|dopamine agents|mesh-ancestor
93304839|NCT02504450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304840|NCT02504450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304841|NCT02504450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93304842|NCT02504450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93304843|NCT02504450|Serotonin Agents|serotonin agents|mesh-ancestor
93304844|NCT02171637|Afatinib|afatinib|mesh-list
93304845|NCT02171637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304846|NCT02171637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93304847|NCT02171637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304848|NCT02171637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304849|NCT02171715|Afatinib|afatinib|mesh-list
93304850|NCT02171715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304851|NCT02171715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93304852|NCT02171715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304853|NCT02171715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304854|NCT02504372|Pembrolizumab|pembrolizumab|mesh-list
93304855|NCT02504372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304856|NCT02504372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304857|NCT02504372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92599377|NCT00456313|Hormones|hormones|mesh-ancestor
93304858|NCT02504372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304859|NCT02760069|Ondansetron|ondansetron|mesh-list
93304860|NCT02760069|Antiemetics|antiemetics|mesh-ancestor
93304861|NCT02760069|Autonomic Agents|autonomic agents|mesh-ancestor
93304862|NCT02760069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304863|NCT02760069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304864|NCT02760069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93304865|NCT02760069|Antipruritics|antipruritics|mesh-ancestor
93304866|NCT02760069|Dermatologic Agents|dermatologic agents|mesh-ancestor
93304867|NCT02760069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93304868|NCT02760069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93304869|NCT02760069|Serotonin Agents|serotonin agents|mesh-ancestor
93304870|NCT02760069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304871|NCT02760069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304872|NCT02504138|Anesthetics|anesthetics|mesh-list
93304873|NCT02504138|Propofol|propofol|mesh-list
93304874|NCT02504138|Desflurane|desflurane|mesh-list
93304875|NCT02504138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304876|NCT02504138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304877|NCT02504138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93304878|NCT02504138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304879|NCT02504138|Anesthetics, General|anesthetics, general|mesh-ancestor
93304880|NCT02504138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93304881|NCT02508584|Antibodies|antibodies|mesh-list
93304882|NCT02508584|Immunologic Factors|immunologic factors|mesh-ancestor
93304883|NCT02508584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304884|NCT02171793|Olodaterol|olodaterol|mesh-list
93304885|NCT02171793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93304886|NCT02171793|Autonomic Agents|autonomic agents|mesh-ancestor
93304887|NCT02171793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304888|NCT02171793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304889|NCT02171793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93304890|NCT02171793|Respiratory System Agents|respiratory system agents|mesh-ancestor
93304891|NCT02171871|Respiratory System Agents|respiratory system agents|mesh-list
93304892|NCT02508350|Daptomycin|daptomycin|mesh-list
93304893|NCT02508350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93304894|NCT02508350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304895|NCT02503826|Midazolam|midazolam|mesh-list
93304896|NCT02503826|Sufentanil|sufentanil|mesh-list
93304897|NCT02503826|Dsuvia|dsuvia|mesh-list
93304898|NCT02503826|Propofol|propofol|mesh-list
93304899|NCT02503826|Cisatracurium|cisatracurium|mesh-list
93304900|NCT02503826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93304901|NCT02503826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304902|NCT02503826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304903|NCT02503826|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93304904|NCT02503826|Anesthetics, General|anesthetics, general|mesh-ancestor
93304905|NCT02503826|Anesthetics|anesthetics|mesh-ancestor
93304906|NCT02503826|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93304907|NCT02503826|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93304908|NCT02503826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93304909|NCT02503826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93304910|NCT02503826|GABA Modulators|gaba modulators|mesh-ancestor
93304911|NCT02503826|GABA Agents|gaba agents|mesh-ancestor
93304912|NCT02503826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304913|NCT02503826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304914|NCT02503826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93304915|NCT02503826|Narcotics|narcotics|mesh-ancestor
93304916|NCT02503826|Analgesics|analgesics|mesh-ancestor
93304917|NCT02503826|Sensory System Agents|sensory system agents|mesh-ancestor
93304918|NCT02503826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304919|NCT02503826|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93304920|NCT02503826|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93304921|NCT03121664|Itraconazole|itraconazole|mesh-list
93304922|NCT03121664|Antifungal Agents|antifungal agents|mesh-ancestor
93304923|NCT03121664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304924|NCT03121664|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93304925|NCT03121664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93304926|NCT03121664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93304927|NCT03121664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304928|NCT03121664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93304929|NCT03121664|Hormone Antagonists|hormone antagonists|mesh-ancestor
93304930|NCT03121664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93304931|NCT03121664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304932|NCT03121664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93304933|NCT02503904|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93304934|NCT02503904|Metronidazole|metronidazole|mesh-list
93304935|NCT02503904|Lidocaine|lidocaine|mesh-list
93304936|NCT02503904|Epinephrine|epinephrine|mesh-list
93304937|NCT02503904|Anesthetics, Local|anesthetics, local|mesh-ancestor
93304938|NCT02503904|Anesthetics|anesthetics|mesh-ancestor
93304939|NCT02503904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304940|NCT02503904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304941|NCT02503904|Sensory System Agents|sensory system agents|mesh-ancestor
93304942|NCT02503904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304943|NCT02503904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93304944|NCT02503904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93304945|NCT02503904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93304946|NCT02503904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93304947|NCT02503904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304948|NCT02503904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93304949|NCT02503904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93304950|NCT02503904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93304951|NCT02503904|Adrenergic Agents|adrenergic agents|mesh-ancestor
93304952|NCT02503904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93304953|NCT02503904|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93304954|NCT02503904|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93304955|NCT02503904|Autonomic Agents|autonomic agents|mesh-ancestor
93304956|NCT02503904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93304957|NCT02503904|Respiratory System Agents|respiratory system agents|mesh-ancestor
93304958|NCT02503904|Mydriatics|mydriatics|mesh-ancestor
93304959|NCT02503904|Sympathomimetics|sympathomimetics|mesh-ancestor
93304960|NCT02503904|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93304961|NCT02503904|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93304962|NCT02503904|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93304963|NCT02172105|Olodaterol|olodaterol|mesh-list
93304964|NCT02172105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93304965|NCT02172105|Autonomic Agents|autonomic agents|mesh-ancestor
93304966|NCT02172105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93304967|NCT02172105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304968|NCT02172105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93304969|NCT02172105|Respiratory System Agents|respiratory system agents|mesh-ancestor
93304970|NCT03121352|Paclitaxel|paclitaxel|mesh-list
93304971|NCT03121352|Carboplatin|carboplatin|mesh-list
93304972|NCT03121352|Pembrolizumab|pembrolizumab|mesh-list
92976982|NCT00881088|PENTA|penta|mesh-list
93304973|NCT03121352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93304974|NCT03121352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93304975|NCT03121352|Tubulin Modulators|tubulin modulators|mesh-ancestor
93304976|NCT03121352|Antimitotic Agents|antimitotic agents|mesh-ancestor
93304977|NCT03121352|Mitosis Modulators|mitosis modulators|mesh-ancestor
93304978|NCT03121352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304979|NCT03121352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93304980|NCT03121352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93304981|NCT02513654|Lamotrigine|lamotrigine|mesh-list
93304982|NCT02513654|Anticonvulsants|anticonvulsants|mesh-ancestor
93304983|NCT02513654|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93304984|NCT02513654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93304985|NCT02513654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93304986|NCT02513654|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93304987|NCT02513654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304988|NCT02513654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93304989|NCT02513654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93304990|NCT02513654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93304991|NCT02513654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93304992|NCT02513654|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93304993|NCT02513888|Vitamin D|vitamin d|mesh-list
93304994|NCT02513888|Vitamins|vitamins|mesh-ancestor
93304995|NCT02513888|Micronutrients|micronutrients|mesh-ancestor
93304996|NCT02513888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93304997|NCT02513888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93304998|NCT00101595|Dasatinib|dasatinib|mesh-list
93304999|NCT00101595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305000|NCT00101595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93305001|NCT00101595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599515|NCT00457054|Antimanic Agents|antimanic agents|mesh-ancestor
93305002|NCT00101595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305003|NCT02174757|Doxycycline|doxycycline|mesh-list
93305004|NCT02174757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93305005|NCT02174757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305006|NCT02174757|Antimalarials|antimalarials|mesh-ancestor
93305007|NCT02174757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93305008|NCT02174757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93305009|NCT02168127|Methylphenidate|methylphenidate|mesh-list
93305010|NCT02168127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93305011|NCT02168127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305012|NCT02168127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93305013|NCT02168127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93305014|NCT02168127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305015|NCT02168127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305016|NCT02168127|Dopamine Agents|dopamine agents|mesh-ancestor
93305017|NCT02168127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305018|NCT02255955|Acetaminophen|acetaminophen|mesh-list
93305019|NCT02255955|Naproxen|naproxen|mesh-list
93305020|NCT02255955|Codeine|codeine|mesh-list
93305021|NCT02255955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305022|NCT02255955|Analgesics|analgesics|mesh-ancestor
93305023|NCT02255955|Sensory System Agents|sensory system agents|mesh-ancestor
93305024|NCT02255955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305025|NCT02255955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305026|NCT02255955|Antipyretics|antipyretics|mesh-ancestor
93305027|NCT02255955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305028|NCT02255955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305029|NCT02255955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305030|NCT02255955|Gout Suppressants|gout suppressants|mesh-ancestor
93305031|NCT02255955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305032|NCT02255955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305033|NCT02255955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305034|NCT02255955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93305035|NCT02255955|Narcotics|narcotics|mesh-ancestor
93305036|NCT02255955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305037|NCT02255955|Antitussive Agents|antitussive agents|mesh-ancestor
93305038|NCT02255955|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305039|NCT02172261|Glimepiride|glimepiride|mesh-list
93305040|NCT02172261|Empagliflozin|empagliflozin|mesh-list
93305041|NCT02172261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93305042|NCT02172261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93305043|NCT02172261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305044|NCT02172261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93305045|NCT02172261|Immunologic Factors|immunologic factors|mesh-ancestor
93305046|NCT02172261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93305047|NCT02172261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305049|NCT02501564|Codeine|codeine|mesh-list
93305050|NCT02501564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305051|NCT02501564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305052|NCT02501564|Analgesics|analgesics|mesh-ancestor
93305053|NCT02501564|Sensory System Agents|sensory system agents|mesh-ancestor
93305054|NCT02501564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305055|NCT02501564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305056|NCT02501564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305057|NCT02501564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305058|NCT02501564|Gout Suppressants|gout suppressants|mesh-ancestor
93305059|NCT02501564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305060|NCT02501564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305061|NCT02501564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305062|NCT02501564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93305063|NCT02501564|Narcotics|narcotics|mesh-ancestor
93305064|NCT02501564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305065|NCT02501564|Antitussive Agents|antitussive agents|mesh-ancestor
93305066|NCT02501564|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305067|NCT02172339|Tiotropium Bromide|tiotropium bromide|mesh-list
93305068|NCT02172339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93305069|NCT02172339|Autonomic Agents|autonomic agents|mesh-ancestor
93305070|NCT02172339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305071|NCT02172339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305072|NCT02172339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305073|NCT02172339|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305074|NCT02172339|Parasympatholytics|parasympatholytics|mesh-ancestor
93305075|NCT02172339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93305076|NCT02172339|Cholinergic Agents|cholinergic agents|mesh-ancestor
93305077|NCT02172339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305078|NCT02172339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305079|NCT02172417|Ranitidine|ranitidine|mesh-list
93305080|NCT02172417|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93305081|NCT02172417|Cimetidine|cimetidine|mesh-list
93305082|NCT02172417|Tiotropium Bromide|tiotropium bromide|mesh-list
93305083|NCT02172417|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93305084|NCT02172417|Autonomic Agents|autonomic agents|mesh-ancestor
93305085|NCT02172417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305086|NCT02172417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305087|NCT02172417|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305088|NCT02172417|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305089|NCT02172417|Parasympatholytics|parasympatholytics|mesh-ancestor
93305090|NCT02172417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93305091|NCT02172417|Cholinergic Agents|cholinergic agents|mesh-ancestor
93305092|NCT02172417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305093|NCT02172417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305094|NCT02172417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93305095|NCT02172417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93305096|NCT02172417|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93305097|NCT02172417|Histamine Antagonists|histamine antagonists|mesh-ancestor
93305098|NCT02172417|Histamine Agents|histamine agents|mesh-ancestor
93305099|NCT02172417|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93305100|NCT02172417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93305101|NCT02172417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305102|NCT02168205|Pomalidomide|pomalidomide|mesh-list
93305103|NCT02168205|Caffeine|caffeine|mesh-list
93305104|NCT02168205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93305105|NCT02168205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305106|NCT02168205|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93305107|NCT02168205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305108|NCT02168205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305109|NCT02168205|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93305110|NCT02168205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93305111|NCT02168205|Purinergic Agents|purinergic agents|mesh-ancestor
93305112|NCT02168205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305113|NCT02168205|Immunologic Factors|immunologic factors|mesh-ancestor
93305114|NCT02168205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93305115|NCT02168205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93305116|NCT02168205|Growth Substances|growth substances|mesh-ancestor
93305117|NCT02168205|Growth Inhibitors|growth inhibitors|mesh-ancestor
93305118|NCT02168205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305119|NCT03343652|Nivolumab|nivolumab|mesh-list
93305120|NCT03343652|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93305121|NCT03343652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305122|NCT03343652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305123|NCT03343652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93305124|NCT03343652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305125|NCT03343652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93305126|NCT03343652|Alkylating Agents|alkylating agents|mesh-ancestor
93305127|NCT02175069|Ropivacaine|ropivacaine|mesh-list
93305128|NCT02175069|Anesthetics, Local|anesthetics, local|mesh-ancestor
93305129|NCT02175069|Anesthetics|anesthetics|mesh-ancestor
93305130|NCT02175069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305131|NCT02175069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305132|NCT02175069|Sensory System Agents|sensory system agents|mesh-ancestor
93305133|NCT02175069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305134|NCT04498520|Fulvestrant|fulvestrant|mesh-list
93305135|NCT04498520|Palbociclib|palbociclib|mesh-list
93305136|NCT04498520|Abexinostat|abexinostat|mesh-list
93305137|NCT04498520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93305138|NCT04498520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305139|NCT04498520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93305140|NCT04498520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93305141|NCT04498520|Hormone Antagonists|hormone antagonists|mesh-ancestor
93305142|NCT04498520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305143|NCT04498520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305144|NCT04498520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93305145|NCT04498520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305146|NCT04498520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305147|NCT04498520|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93305148|NCT02172495|Bromides|bromides|mesh-list
93305149|NCT02172495|Tiotropium Bromide|tiotropium bromide|mesh-list
93305150|NCT02172495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93305151|NCT02172495|Autonomic Agents|autonomic agents|mesh-ancestor
93305152|NCT02172495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305153|NCT02172495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305154|NCT02172495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305155|NCT02172495|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305156|NCT02172495|Parasympatholytics|parasympatholytics|mesh-ancestor
93305157|NCT02172495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93305158|NCT02172495|Cholinergic Agents|cholinergic agents|mesh-ancestor
93305159|NCT02172495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305160|NCT02172495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305161|NCT02172495|Anticonvulsants|anticonvulsants|mesh-ancestor
93305162|NCT02172573|Pramipexole|pramipexole|mesh-list
93305163|NCT02172573|Bromocriptine|bromocriptine|mesh-list
93305164|NCT02172573|Antioxidants|antioxidants|mesh-ancestor
93305165|NCT02172573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305166|NCT02172573|Protective Agents|protective agents|mesh-ancestor
93305167|NCT02172573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305168|NCT02172573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93305169|NCT02172573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93305170|NCT02172573|Dopamine Agonists|dopamine agonists|mesh-ancestor
93305171|NCT02172573|Dopamine Agents|dopamine agents|mesh-ancestor
93305172|NCT02172573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305173|NCT02172573|Hormone Antagonists|hormone antagonists|mesh-ancestor
93305174|NCT02172573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305175|NCT02175381|Carboplatin|carboplatin|mesh-list
93305176|NCT02175381|Gemcitabine|gemcitabine|mesh-list
93305177|NCT02175381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305178|NCT02175381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93305179|NCT02175381|Antimetabolites|antimetabolites|mesh-ancestor
93305180|NCT02175381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305181|NCT03540225|Progesterone|progesterone|mesh-list
93305182|NCT03540225|Progestins|progestins|mesh-ancestor
93305183|NCT03540225|Hormones|hormones|mesh-ancestor
93305184|NCT03540225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305185|NCT03540225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305186|NCT02507648|Oseltamivir|oseltamivir|mesh-list
93305187|NCT02507648|Antiviral Agents|antiviral agents|mesh-ancestor
93305188|NCT02507648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305189|NCT02507648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305190|NCT02507648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305191|NCT02172729|Lidocaine|lidocaine|mesh-list
93305192|NCT02172729|Anesthetics, Local|anesthetics, local|mesh-ancestor
93305193|NCT02172729|Anesthetics|anesthetics|mesh-ancestor
93305194|NCT02172729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305195|NCT02172729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305196|NCT02172729|Sensory System Agents|sensory system agents|mesh-ancestor
93305197|NCT02172729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305198|NCT02172729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93305199|NCT02172729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93305200|NCT02172729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93305201|NCT02172729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305202|NCT02172729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305203|NCT02172807|Tiotropium Bromide|tiotropium bromide|mesh-list
93305204|NCT02172807|Oxitropium|oxitropium|mesh-list
93305205|NCT02172807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93305206|NCT02172807|Autonomic Agents|autonomic agents|mesh-ancestor
93305207|NCT02172807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305208|NCT02172807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305209|NCT02172807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305210|NCT02172807|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305211|NCT02172807|Parasympatholytics|parasympatholytics|mesh-ancestor
93305212|NCT02172807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93305213|NCT02172807|Cholinergic Agents|cholinergic agents|mesh-ancestor
93305214|NCT02172807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305215|NCT02172807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305216|NCT04568421|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93305217|NCT04568421|Immunologic Factors|immunologic factors|mesh-ancestor
93305218|NCT04568421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305219|NCT02502968|Cytarabine|cytarabine|mesh-list
93305220|NCT02502968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93305221|NCT02502968|Antimetabolites|antimetabolites|mesh-ancestor
93305222|NCT02502968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305223|NCT02502968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305224|NCT02502968|Antiviral Agents|antiviral agents|mesh-ancestor
93305225|NCT02502968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305226|NCT02502968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93305227|NCT02502968|Immunologic Factors|immunologic factors|mesh-ancestor
93305228|NCT02502968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305229|NCT02168751|Propofol|propofol|mesh-list
93305230|NCT02168751|Sevoflurane|sevoflurane|mesh-list
93305231|NCT02168751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93305232|NCT02168751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305233|NCT02168751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305234|NCT02168751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93305235|NCT02168751|Anesthetics, General|anesthetics, general|mesh-ancestor
93305236|NCT02168751|Anesthetics|anesthetics|mesh-ancestor
93305237|NCT02168751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93305238|NCT02168751|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93305239|NCT02507570|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93305240|NCT02507570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305241|NCT03344042|Fentanyl|fentanyl|mesh-list
93305242|NCT03344042|Sufentanil|sufentanil|mesh-list
93305243|NCT03344042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93305244|NCT03344042|Narcotics|narcotics|mesh-ancestor
93305245|NCT03344042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305246|NCT03344042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305247|NCT03344042|Analgesics|analgesics|mesh-ancestor
93305248|NCT03344042|Sensory System Agents|sensory system agents|mesh-ancestor
93305249|NCT03344042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305250|NCT03344042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93305251|NCT03344042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93305252|NCT03344042|Anesthetics, General|anesthetics, general|mesh-ancestor
93305253|NCT03344042|Anesthetics|anesthetics|mesh-ancestor
93305254|NCT02175927|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93305255|NCT02175927|Amoxicillin|amoxicillin|mesh-list
93305256|NCT02175927|Metronidazole|metronidazole|mesh-list
93305257|NCT02175927|Tetracycline|tetracycline|mesh-list
93305258|NCT02175927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93305259|NCT02175927|Potassium Citrate|potassium citrate|mesh-list
93305260|NCT02175927|Lansoprazole|lansoprazole|mesh-list
93305261|NCT02175927|Bismuth|bismuth|mesh-list
93305262|NCT02175927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93305263|NCT02175927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305264|NCT02175927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305265|NCT02175927|Antitubercular Agents|antitubercular agents|mesh-ancestor
93305266|NCT02175927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93305267|NCT02175927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93305268|NCT02175927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93305269|NCT02175927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93305270|NCT02175927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305271|NCT02175927|Antacids|antacids|mesh-ancestor
93305272|NCT02175927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93305273|NCT02175927|Diuretics|diuretics|mesh-ancestor
93305274|NCT02175927|Natriuretic Agents|natriuretic agents|mesh-ancestor
93305275|NCT02175927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305276|NCT02175927|Expectorants|expectorants|mesh-ancestor
93305277|NCT02175927|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305278|NCT00707486|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
93305279|NCT00707486|Hemostatics|hemostatics|mesh-ancestor
93305280|NCT00707486|Coagulants|coagulants|mesh-ancestor
93305281|NCT02496182|Pirfenidone|pirfenidone|mesh-list
93305282|NCT02496182|Analgesics|analgesics|mesh-ancestor
93305283|NCT02496182|Sensory System Agents|sensory system agents|mesh-ancestor
93305284|NCT02496182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305285|NCT02496182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305286|NCT02496182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305287|NCT02496182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305288|NCT02496182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305289|NCT02496182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305290|NCT02496182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305291|NCT02168907|Thioctic Acid|thioctic acid|mesh-list
93305292|NCT02168907|Rituximab|rituximab|mesh-list
93305293|NCT02168907|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93305294|NCT02168907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305295|NCT02168907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305296|NCT02168907|Immunologic Factors|immunologic factors|mesh-ancestor
93305297|NCT02168907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305298|NCT02168907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305299|NCT02168907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93305300|NCT02168907|Alkylating Agents|alkylating agents|mesh-ancestor
93305301|NCT02168907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305302|NCT02168907|Antioxidants|antioxidants|mesh-ancestor
93305303|NCT02168907|Protective Agents|protective agents|mesh-ancestor
93305304|NCT02168907|Vitamin B Complex|vitamin b complex|mesh-ancestor
93305305|NCT02168907|Vitamins|vitamins|mesh-ancestor
93305306|NCT02168907|Micronutrients|micronutrients|mesh-ancestor
93305307|NCT02500784|Formoterol Fumarate|formoterol fumarate|mesh-list
93305308|NCT02500784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93305309|NCT02500784|Autonomic Agents|autonomic agents|mesh-ancestor
93305310|NCT02500784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305311|NCT02500784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305312|NCT02500784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305313|NCT02500784|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305314|NCT02500784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93305315|NCT02500784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93305316|NCT02500784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93305317|NCT02500784|Adrenergic Agents|adrenergic agents|mesh-ancestor
93305318|NCT02500784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305319|NCT02500784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305320|NCT02500940|Leucovorin|leucovorin|mesh-list
93305321|NCT02500940|Fluorouracil|fluorouracil|mesh-list
93305322|NCT02500940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305323|NCT02500940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305324|NCT02500940|Antimetabolites|antimetabolites|mesh-ancestor
93305325|NCT02500940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305326|NCT02500940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93305327|NCT02500940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93305328|NCT02500940|Immunologic Factors|immunologic factors|mesh-ancestor
93305329|NCT02500940|Antidotes|antidotes|mesh-ancestor
93305330|NCT02500940|Protective Agents|protective agents|mesh-ancestor
93305331|NCT02500940|Vitamin B Complex|vitamin b complex|mesh-ancestor
93305332|NCT02500940|Vitamins|vitamins|mesh-ancestor
93305333|NCT02500940|Micronutrients|micronutrients|mesh-ancestor
93305334|NCT02495636|Atezolizumab|atezolizumab|mesh-list
93305335|NCT02495636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93305336|NCT02495636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305337|NCT02495636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305338|NCT02495636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305339|NCT02169063|Listerine|listerine|mesh-list
93305340|NCT02169063|Fluorides|fluorides|mesh-list
93305341|NCT02169063|Sodium Fluoride|sodium fluoride|mesh-list
93305342|NCT02169063|Cariostatic Agents|cariostatic agents|mesh-ancestor
93305343|NCT02169063|Protective Agents|protective agents|mesh-ancestor
93305344|NCT02169063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305345|NCT02169063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93305346|NCT02169063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305347|NCT04496882|Tenofovir|tenofovir|mesh-list
93305348|NCT04496882|Antiviral Agents|antiviral agents|mesh-ancestor
93305349|NCT04496882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305350|NCT04496882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93305351|NCT04496882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93305352|NCT04496882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305353|NCT04496882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305354|NCT04496882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93305355|NCT04496882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93305356|NCT02502500|Celecoxib|celecoxib|mesh-list
93305357|NCT02502500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305358|NCT02502500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305359|NCT02502500|Analgesics|analgesics|mesh-ancestor
93305360|NCT02502500|Sensory System Agents|sensory system agents|mesh-ancestor
93305361|NCT02502500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305362|NCT02502500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305363|NCT02502500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305364|NCT02502500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305365|NCT02502500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93305366|NCT02502500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305367|NCT02502500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305368|NCT02502500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305369|NCT02173665|Linagliptin|linagliptin|mesh-list
93305370|NCT02173665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93305371|NCT02173665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305372|NCT02173665|Incretins|incretins|mesh-ancestor
93305373|NCT02173665|Hormones|hormones|mesh-ancestor
93305374|NCT02173665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305375|NCT02173665|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93305376|NCT02173665|Protease Inhibitors|protease inhibitors|mesh-ancestor
93305377|NCT02173665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305378|NCT02173665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305379|NCT02495324|Valsartan|valsartan|mesh-list
93305380|NCT02495324|Olmesartan|olmesartan|mesh-list
93305381|NCT02495324|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93305382|NCT02495324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93305383|NCT02495324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93305384|NCT02495324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93305385|NCT02495324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305386|NCT02500238|Carbon Monoxide|carbon monoxide|mesh-list
93305387|NCT02500238|Antimetabolites|antimetabolites|mesh-ancestor
93305388|NCT02500238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305389|NCT02500238|Gasotransmitters|gasotransmitters|mesh-ancestor
93305390|NCT02500238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305391|NCT02500238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305392|NCT04625283|Ketamine|ketamine|mesh-list
93305393|NCT04625283|Analgesics|analgesics|mesh-ancestor
93305394|NCT04625283|Sensory System Agents|sensory system agents|mesh-ancestor
93305395|NCT04625283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305396|NCT04625283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305397|NCT04625283|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93305398|NCT04625283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93305399|NCT04625283|Anesthetics, General|anesthetics, general|mesh-ancestor
93305400|NCT04625283|Anesthetics|anesthetics|mesh-ancestor
93305401|NCT04625283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305402|NCT04625283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93305403|NCT04625283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93305404|NCT04625283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305405|NCT04625283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305406|NCT02256033|Istradefylline|istradefylline|mesh-list
93305407|NCT02256033|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93305408|NCT02256033|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93305409|NCT02256033|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93305410|NCT02256033|Purinergic Agents|purinergic agents|mesh-ancestor
93305411|NCT02256033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305412|NCT02256033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305413|NCT02256033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305414|NCT02502110|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93305415|NCT02502110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93305416|NCT02502110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93305417|NCT02502110|Antimetabolites|antimetabolites|mesh-ancestor
93305418|NCT02502110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305419|NCT02502110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93305420|NCT02502110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93305421|NCT02502110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305422|NCT02502344|Metformin|metformin|mesh-list
93305423|NCT02502344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93305424|NCT02502344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305425|NCT02174211|Ranibizumab|ranibizumab|mesh-list
93305426|NCT02174211|Aflibercept|aflibercept|mesh-list
93305427|NCT02174211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93305428|NCT02174211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93305429|NCT02174211|Growth Substances|growth substances|mesh-ancestor
93305430|NCT02174211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305431|NCT02174211|Growth Inhibitors|growth inhibitors|mesh-ancestor
93305432|NCT02174211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305433|NCT04496492|Tocotrienols|tocotrienols|mesh-list
93305434|NCT04496492|Vitamin E|vitamin e|mesh-list
93305435|NCT04496492|Tocopherols|tocopherols|mesh-list
93305436|NCT04496492|Antioxidants|antioxidants|mesh-ancestor
93305437|NCT04496492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305438|NCT04496492|Protective Agents|protective agents|mesh-ancestor
93305439|NCT04496492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305440|NCT04496492|Vitamins|vitamins|mesh-ancestor
93305441|NCT04496492|Micronutrients|micronutrients|mesh-ancestor
93305442|NCT02500004|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93305443|NCT02500004|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93305444|NCT02500004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305445|NCT02502032|Cisatracurium|cisatracurium|mesh-list
93305446|NCT02502032|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93305447|NCT02502032|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93305448|NCT02502032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305449|NCT02502032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305450|NCT02494856|Naproxen|naproxen|mesh-list
93305451|NCT02494856|Esomeprazole|esomeprazole|mesh-list
93305452|NCT02494856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93305453|NCT02494856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93305454|NCT02494856|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93305455|NCT02494856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305456|NCT02494856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305457|NCT02494856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305458|NCT02494856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305459|NCT02494856|Analgesics|analgesics|mesh-ancestor
93305460|NCT02494856|Sensory System Agents|sensory system agents|mesh-ancestor
93305461|NCT02494856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305462|NCT02494856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305463|NCT02494856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305464|NCT02494856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305465|NCT02494856|Gout Suppressants|gout suppressants|mesh-ancestor
93305466|NCT02494856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305467|NCT04495010|Nivolumab|nivolumab|mesh-list
93305468|NCT04495010|Ipilimumab|ipilimumab|mesh-list
93305469|NCT04495010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305470|NCT04495010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305471|NCT04495010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93305472|NCT04495010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305473|NCT03343418|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93305474|NCT03343418|Hemostatics|hemostatics|mesh-ancestor
93305475|NCT03343418|Coagulants|coagulants|mesh-ancestor
93305476|NCT03343418|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93305477|NCT03343418|Natriuretic Agents|natriuretic agents|mesh-ancestor
93305478|NCT03343418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305479|NCT02501798|Methylphenidate|methylphenidate|mesh-list
93305480|NCT02501798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93305481|NCT02501798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305482|NCT02501798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93305483|NCT02501798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93305484|NCT02501798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305485|NCT02501798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305486|NCT02501798|Dopamine Agents|dopamine agents|mesh-ancestor
93305487|NCT02501798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305488|NCT02169609|Interleukin-2|interleukin-2|mesh-list
93305489|NCT02169609|Dinutuximab|dinutuximab|mesh-list
93305490|NCT02169609|Isotretinoin|isotretinoin|mesh-list
93305491|NCT02169609|Sargramostim|sargramostim|mesh-list
93305492|NCT02169609|Immunologic Factors|immunologic factors|mesh-ancestor
93305493|NCT02169609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305494|NCT02169609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305495|NCT02169609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305497|NCT02169609|Sensory System Agents|sensory system agents|mesh-ancestor
93305498|NCT02169609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305499|NCT02169609|Dermatologic Agents|dermatologic agents|mesh-ancestor
93305500|NCT02499614|Crizotinib|crizotinib|mesh-list
93305501|NCT02499614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305502|NCT02499614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93305503|NCT02499614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305504|NCT02499614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305505|NCT02169843|Dexmedetomidine|dexmedetomidine|mesh-list
93305506|NCT02169843|Sevoflurane|sevoflurane|mesh-list
93305507|NCT02169843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93305508|NCT02169843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305509|NCT02169843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305510|NCT02169843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305511|NCT02169843|Analgesics|analgesics|mesh-ancestor
93305512|NCT02169843|Sensory System Agents|sensory system agents|mesh-ancestor
93305513|NCT02169843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305514|NCT02169843|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93305515|NCT02169843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93305516|NCT02169843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93305517|NCT02169843|Adrenergic Agents|adrenergic agents|mesh-ancestor
93305518|NCT02169843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305519|NCT02169843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305520|NCT02169843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93305521|NCT02169843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93305522|NCT02169843|Anesthetics, General|anesthetics, general|mesh-ancestor
93305523|NCT02169843|Anesthetics|anesthetics|mesh-ancestor
93305524|NCT03341390|Aspirin|aspirin|mesh-list
93305525|NCT03341390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305526|NCT03341390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305527|NCT03341390|Analgesics|analgesics|mesh-ancestor
93305528|NCT03341390|Sensory System Agents|sensory system agents|mesh-ancestor
93305529|NCT03341390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305530|NCT03341390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305531|NCT03341390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305532|NCT03341390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305533|NCT03341390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93305534|NCT03341390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93305535|NCT03341390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305536|NCT03341390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93305537|NCT03341390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305538|NCT03341390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305539|NCT03341390|Antipyretics|antipyretics|mesh-ancestor
93305540|NCT02174445|Imatinib Mesylate|imatinib mesylate|mesh-list
93305541|NCT02174445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305542|NCT02174445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93305543|NCT02174445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305544|NCT02174445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305545|NCT00707174|Imiquimod|imiquimod|mesh-list
93305546|NCT00707174|Tazarotene|tazarotene|mesh-list
93305547|NCT00707174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93305548|NCT00707174|Immunologic Factors|immunologic factors|mesh-ancestor
93305549|NCT00707174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305550|NCT00707174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305551|NCT00707174|Interferon Inducers|interferon inducers|mesh-ancestor
93305552|NCT00707174|Dermatologic Agents|dermatologic agents|mesh-ancestor
93305553|NCT00707174|Keratolytic Agents|keratolytic agents|mesh-ancestor
93305554|NCT03341234|Bupivacaine|bupivacaine|mesh-list
93305555|NCT03341234|Anesthetics, Local|anesthetics, local|mesh-ancestor
93305556|NCT03341234|Anesthetics|anesthetics|mesh-ancestor
93305557|NCT03341234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305558|NCT03341234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305559|NCT03341234|Sensory System Agents|sensory system agents|mesh-ancestor
93305560|NCT03341234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305561|NCT02499224|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
93305562|NCT02499224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305563|NCT03120494|Tenofovir|tenofovir|mesh-list
93305564|NCT03120494|Emtricitabine|emtricitabine|mesh-list
93305565|NCT03120494|Antiviral Agents|antiviral agents|mesh-ancestor
93305566|NCT03120494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305567|NCT03120494|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93305568|NCT03120494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93305569|NCT03120494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977575|NCT00881790|Fluorides|fluorides|mesh-list
93305570|NCT03120494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305571|NCT03120494|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93305572|NCT03120494|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93305573|NCT03537573|Analgesics, Opioid|analgesics, opioid|mesh-list
93305574|NCT03537573|Narcotics|narcotics|mesh-ancestor
93305575|NCT03537573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305576|NCT03537573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305577|NCT03537573|Analgesics|analgesics|mesh-ancestor
93305578|NCT03537573|Sensory System Agents|sensory system agents|mesh-ancestor
93305579|NCT03537573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305580|NCT03120962|Famciclovir|famciclovir|mesh-list
93305581|NCT03120962|Oxycodone|oxycodone|mesh-list
93305582|NCT03120962|Gabapentin|gabapentin|mesh-list
93305583|NCT03120962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93305584|NCT03120962|Narcotics|narcotics|mesh-ancestor
93305585|NCT03120962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305586|NCT03120962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305587|NCT03120962|Analgesics|analgesics|mesh-ancestor
93305588|NCT03120962|Sensory System Agents|sensory system agents|mesh-ancestor
93305589|NCT03120962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305590|NCT03120962|Anticonvulsants|anticonvulsants|mesh-ancestor
93305591|NCT03120962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93305592|NCT03120962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93305593|NCT03120962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93305594|NCT03120962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93305595|NCT03120962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93305596|NCT03120962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305597|NCT03120962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305598|NCT03120962|Antimanic Agents|antimanic agents|mesh-ancestor
93305599|NCT03120962|Antiviral Agents|antiviral agents|mesh-ancestor
93305600|NCT03120962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305601|NCT03120962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93305602|NCT03120962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305603|NCT02178813|Minocycline|minocycline|mesh-list
93305604|NCT02178813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93305605|NCT02178813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305606|NCT03340922|Long-Acting Thyroid Stimulator|long-acting thyroid stimulator|mesh-list
93305607|NCT03340922|Immunologic Factors|immunologic factors|mesh-ancestor
93305608|NCT03340922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305609|NCT02177253|Bromides|bromides|mesh-list
93305610|NCT02177253|Albuterol|albuterol|mesh-list
93305611|NCT02177253|Ipratropium|ipratropium|mesh-list
93305612|NCT02177253|Anticonvulsants|anticonvulsants|mesh-ancestor
93305613|NCT02177253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93305614|NCT02177253|Autonomic Agents|autonomic agents|mesh-ancestor
93305615|NCT02177253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305616|NCT02177253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305617|NCT02177253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305618|NCT02177253|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305619|NCT02177253|Tocolytic Agents|tocolytic agents|mesh-ancestor
93305620|NCT02177253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93305621|NCT02177253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93305622|NCT02177253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93305623|NCT02177253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93305624|NCT02177253|Adrenergic Agents|adrenergic agents|mesh-ancestor
93305625|NCT02177253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305626|NCT02177253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305627|NCT02177253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93305628|NCT02177253|Cholinergic Agents|cholinergic agents|mesh-ancestor
93305629|NCT02177331|Lacidipine|lacidipine|mesh-list
93305630|NCT02177331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93305631|NCT02177331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93305632|NCT02177331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305633|NCT02177331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305634|NCT02177331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93305635|NCT02177331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305636|NCT02177409|Amlodipine|amlodipine|mesh-list
93305637|NCT02177409|Telmisartan|telmisartan|mesh-list
93305638|NCT02177409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93305639|NCT02177409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93305640|NCT02177409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305641|NCT02177409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600171|NCT00350467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93305642|NCT02177409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92977646|NCT00874926|Coagulants|coagulants|mesh-ancestor
93305643|NCT02177409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305644|NCT02177409|Vasodilator Agents|vasodilator agents|mesh-ancestor
93305645|NCT02177409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93305646|NCT02177409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93305647|NCT02170623|Pantoprazole|pantoprazole|mesh-list
93305648|NCT02170623|Dabigatran|dabigatran|mesh-list
93305649|NCT02170623|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93305650|NCT02170623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93305651|NCT02170623|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93305652|NCT02170623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305653|NCT02170623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305654|NCT02170623|Antithrombins|antithrombins|mesh-ancestor
93305655|NCT02170623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93305656|NCT02170623|Protease Inhibitors|protease inhibitors|mesh-ancestor
93305657|NCT02170623|Anticoagulants|anticoagulants|mesh-ancestor
93305658|NCT02170701|Dabigatran|dabigatran|mesh-list
93305659|NCT02170701|Antithrombins|antithrombins|mesh-ancestor
93305660|NCT02170701|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93305661|NCT02170701|Protease Inhibitors|protease inhibitors|mesh-ancestor
93305662|NCT02170701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305663|NCT02170701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305664|NCT02170701|Anticoagulants|anticoagulants|mesh-ancestor
93305665|NCT02498756|Ipilimumab|ipilimumab|mesh-list
93305666|NCT02498756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305667|NCT02498756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305668|NCT02498756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93305669|NCT02498756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305670|NCT03336632|Cyclosporine|cyclosporine|mesh-list
93305671|NCT03336632|Cyclophosphamide|cyclophosphamide|mesh-list
93305672|NCT03336632|Cyclosporins|cyclosporins|mesh-list
93305673|NCT03336632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93305674|NCT03336632|Immunologic Factors|immunologic factors|mesh-ancestor
93305675|NCT03336632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305676|NCT03336632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305677|NCT03336632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93305678|NCT03336632|Alkylating Agents|alkylating agents|mesh-ancestor
93305679|NCT03336632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305680|NCT03336632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305681|NCT03336632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93305682|NCT03336632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305683|NCT03336632|Antifungal Agents|antifungal agents|mesh-ancestor
93305684|NCT03336632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305685|NCT03336632|Dermatologic Agents|dermatologic agents|mesh-ancestor
93305686|NCT03336632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93305687|NCT02498288|Isotretinoin|isotretinoin|mesh-list
93305688|NCT02498288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93305689|NCT02756403|Azithromycin|azithromycin|mesh-list
93305690|NCT02756403|Metronidazole|metronidazole|mesh-list
93305691|NCT02756403|Doxycycline|doxycycline|mesh-list
93305692|NCT02756403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93305693|NCT02756403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305694|NCT02756403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93305695|NCT02756403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93305696|NCT02756403|Antimalarials|antimalarials|mesh-ancestor
93305697|NCT02494466|Montelukast|montelukast|mesh-list
93305698|NCT02494466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93305699|NCT02494466|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305700|NCT02494466|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93305701|NCT02494466|Hormone Antagonists|hormone antagonists|mesh-ancestor
93305702|NCT02494466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305703|NCT02494466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305704|NCT02494466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93305705|NCT02494466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93305706|NCT02494466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305707|NCT02177487|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93305708|NCT02177487|Telmisartan|telmisartan|mesh-list
93305709|NCT02177487|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
93305710|NCT02177487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93305711|NCT02177487|Diuretics|diuretics|mesh-ancestor
93305712|NCT02177487|Natriuretic Agents|natriuretic agents|mesh-ancestor
93305713|NCT02177487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305714|NCT02177487|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93305715|NCT02177487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305716|NCT02177487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305717|NCT02177487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93305718|NCT02177487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93305719|NCT02177643|Diacerein|diacerein|mesh-list
93305720|NCT02177643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305721|NCT03340376|Doxorubicin|doxorubicin|mesh-list
93305722|NCT03340376|Atezolizumab|atezolizumab|mesh-list
93305723|NCT03340376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93305724|NCT03340376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305725|NCT03340376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93305726|NCT03340376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93305727|NCT03340376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305728|NCT03340376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305729|NCT03340376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93305730|NCT03340376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305731|NCT02182167|Acetylcysteine|acetylcysteine|mesh-list
93305732|NCT02182167|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93305733|NCT02182167|Antiviral Agents|antiviral agents|mesh-ancestor
93305734|NCT02182167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305735|NCT02182167|Expectorants|expectorants|mesh-ancestor
93305736|NCT02182167|Respiratory System Agents|respiratory system agents|mesh-ancestor
93305737|NCT02182167|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93305738|NCT02182167|Antioxidants|antioxidants|mesh-ancestor
93305739|NCT02182167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305740|NCT02182167|Protective Agents|protective agents|mesh-ancestor
93305741|NCT02182167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305742|NCT02182167|Antidotes|antidotes|mesh-ancestor
93305743|NCT02182245|Paclitaxel|paclitaxel|mesh-list
93305744|NCT02182245|Carboplatin|carboplatin|mesh-list
93305745|NCT02182245|Nintedanib|nintedanib|mesh-list
93305746|NCT02182245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93305747|NCT02182245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305748|NCT02182245|Tubulin Modulators|tubulin modulators|mesh-ancestor
93305749|NCT02182245|Antimitotic Agents|antimitotic agents|mesh-ancestor
93305750|NCT02182245|Mitosis Modulators|mitosis modulators|mesh-ancestor
93305751|NCT02182245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305752|NCT02182245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93305753|NCT02182245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305754|NCT05233124|Aspirin|aspirin|mesh-list
93305755|NCT05233124|Rivaroxaban|rivaroxaban|mesh-list
93305756|NCT05233124|Clopidogrel|clopidogrel|mesh-list
93305757|NCT05233124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305758|NCT05233124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305759|NCT05233124|Analgesics|analgesics|mesh-ancestor
93305760|NCT05233124|Sensory System Agents|sensory system agents|mesh-ancestor
93305761|NCT05233124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305762|NCT05233124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305763|NCT05233124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305764|NCT05233124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305765|NCT05233124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93305766|NCT05233124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93305767|NCT05233124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305768|NCT05233124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93305769|NCT05233124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305770|NCT05233124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305771|NCT05233124|Antipyretics|antipyretics|mesh-ancestor
93305772|NCT05233124|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93305773|NCT05233124|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93305774|NCT05233124|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93305775|NCT05233124|Purinergic Agents|purinergic agents|mesh-ancestor
93305776|NCT05233124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305777|NCT05233124|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93305778|NCT05233124|Antithrombins|antithrombins|mesh-ancestor
93305779|NCT05233124|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93305780|NCT05233124|Protease Inhibitors|protease inhibitors|mesh-ancestor
93305781|NCT05233124|Anticoagulants|anticoagulants|mesh-ancestor
93305782|NCT03339752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93305783|NCT03339752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93305784|NCT03339752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93305785|NCT03339752|Antimetabolites|antimetabolites|mesh-ancestor
93305786|NCT03339752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305787|NCT03339752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93305788|NCT03339752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93305789|NCT03339752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305790|NCT03339362|Methylprednisolone|methylprednisolone|mesh-list
93305791|NCT03339362|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93305792|NCT03339362|Bupivacaine|bupivacaine|mesh-list
93305793|NCT03339362|Anesthetics, Local|anesthetics, local|mesh-ancestor
93305794|NCT03339362|Anesthetics|anesthetics|mesh-ancestor
93305795|NCT03339362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305796|NCT03339362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305797|NCT03339362|Sensory System Agents|sensory system agents|mesh-ancestor
93305798|NCT03339362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305799|NCT03339362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305800|NCT03339362|Antiemetics|antiemetics|mesh-ancestor
93305801|NCT03339362|Autonomic Agents|autonomic agents|mesh-ancestor
93305802|NCT03339362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93305803|NCT03339362|Glucocorticoids|glucocorticoids|mesh-ancestor
93305804|NCT03339362|Hormones|hormones|mesh-ancestor
93305805|NCT03339362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305806|NCT03339362|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93305807|NCT03339362|Protective Agents|protective agents|mesh-ancestor
93305808|NCT02497820|Aspirin|aspirin|mesh-list
93305809|NCT02497820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93305810|NCT02497820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305811|NCT02497820|Analgesics|analgesics|mesh-ancestor
93305812|NCT02497820|Sensory System Agents|sensory system agents|mesh-ancestor
93305813|NCT02497820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305814|NCT02497820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305815|NCT02497820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305816|NCT02497820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305817|NCT02497820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93305818|NCT02497820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93305819|NCT02497820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305820|NCT02497820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93305821|NCT02497820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93305822|NCT02497820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305823|NCT02497820|Antipyretics|antipyretics|mesh-ancestor
93305824|NCT02497508|Nivolumab|nivolumab|mesh-list
93305825|NCT02497508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305826|NCT02497508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305827|NCT02497508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93305828|NCT02497508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305829|NCT03338426|Atorvastatin|atorvastatin|mesh-list
93305830|NCT03338426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93305831|NCT03338426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93305832|NCT03338426|Antimetabolites|antimetabolites|mesh-ancestor
93305833|NCT03338426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305834|NCT03338426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93305835|NCT03338426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93305836|NCT03338426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305837|NCT03338348|Azacitidine|azacitidine|mesh-list
93305838|NCT03338348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93305839|NCT03338348|Antimetabolites|antimetabolites|mesh-ancestor
93305840|NCT03338348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305841|NCT03338348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305842|NCT03338348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305843|NCT03334838|Nifurtimox|nifurtimox|mesh-list
93305844|NCT03334838|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93305845|NCT03334838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93305846|NCT03334838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93305847|NCT03334838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93305848|NCT02497118|Vinorelbine|vinorelbine|mesh-list
93305849|NCT02497118|Endostatins|endostatins|mesh-list
93305850|NCT02497118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305851|NCT02497118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93305852|NCT02497118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93305853|NCT02497118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93305854|NCT02497118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93305855|NCT02497118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305856|NCT02497118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92600376|NCT00351637|Methadone|methadone|mesh-list
93305857|NCT02497118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93305858|NCT02497118|Growth Substances|growth substances|mesh-ancestor
93305859|NCT02497118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305860|NCT02497118|Growth Inhibitors|growth inhibitors|mesh-ancestor
93305861|NCT02496962|Atorvastatin|atorvastatin|mesh-list
93305862|NCT02496962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93305863|NCT02496962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93305864|NCT02496962|Antimetabolites|antimetabolites|mesh-ancestor
93305865|NCT02496962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305866|NCT02496962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93305867|NCT02496962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93305868|NCT02496962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305869|NCT03334136|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93305870|NCT03334136|Calcifediol|calcifediol|mesh-list
93305871|NCT03334136|Vitamins|vitamins|mesh-ancestor
93305872|NCT03334136|Micronutrients|micronutrients|mesh-ancestor
93305873|NCT03334136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305874|NCT03334136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93305875|NCT03120728|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93305876|NCT03120728|Etonogestrel|etonogestrel|mesh-list
93305877|NCT03120728|NuvaRing|nuvaring|mesh-list
93305878|NCT03120728|Contraceptive Agents|contraceptive agents|mesh-list
93305879|NCT03120728|Estradiol|estradiol|mesh-list
93305880|NCT03120728|Estrogens|estrogens|mesh-ancestor
93305881|NCT03120728|Hormones|hormones|mesh-ancestor
93305882|NCT03120728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93305883|NCT03120728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305884|NCT03120728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93305885|NCT03120728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93305886|NCT03120728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93305887|NCT03120728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93305888|NCT03120728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93305889|NCT02496650|Dexmedetomidine|dexmedetomidine|mesh-list
93305890|NCT02496650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93305891|NCT02496650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305892|NCT02496650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305893|NCT02496650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93305894|NCT02496650|Analgesics|analgesics|mesh-ancestor
93305895|NCT02496650|Sensory System Agents|sensory system agents|mesh-ancestor
93305896|NCT02496650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305897|NCT02496650|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93305898|NCT02496650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93305899|NCT02496650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93305900|NCT02496650|Adrenergic Agents|adrenergic agents|mesh-ancestor
93305901|NCT02496650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305902|NCT02496650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305903|NCT02492438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93305904|NCT02492438|Immunologic Factors|immunologic factors|mesh-ancestor
93305905|NCT02492438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305906|NCT03342170|Thrombin|thrombin|mesh-list
93305907|NCT03342170|Hemostatics|hemostatics|mesh-ancestor
93305908|NCT03342170|Coagulants|coagulants|mesh-ancestor
93305909|NCT03333824|Midazolam|midazolam|mesh-list
93305910|NCT03333824|Granisetron|granisetron|mesh-list
93305911|NCT03333824|Caffeine|caffeine|mesh-list
93305912|NCT03333824|Omeprazole|omeprazole|mesh-list
93305913|NCT03333824|Adavosertib|adavosertib|mesh-list
93305914|NCT03333824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93305915|NCT03333824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93305916|NCT03333824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305917|NCT03333824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305918|NCT03333824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93305919|NCT03333824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93305920|NCT03333824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93305921|NCT03333824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93305922|NCT03333824|Anesthetics, General|anesthetics, general|mesh-ancestor
93305923|NCT03333824|Anesthetics|anesthetics|mesh-ancestor
93305924|NCT03333824|GABA Modulators|gaba modulators|mesh-ancestor
93305925|NCT03333824|GABA Agents|gaba agents|mesh-ancestor
93305926|NCT03333824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305927|NCT03333824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305928|NCT03333824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93305929|NCT03333824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93305930|NCT03333824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305931|NCT03333824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93305932|NCT03333824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93305933|NCT03333824|Purinergic Agents|purinergic agents|mesh-ancestor
93305934|NCT03333824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93305935|NCT03333824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93305936|NCT03333824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93305937|NCT03333824|Antiemetics|antiemetics|mesh-ancestor
93305938|NCT03333824|Autonomic Agents|autonomic agents|mesh-ancestor
93305939|NCT03333824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93305940|NCT03333824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93305941|NCT03333824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93305942|NCT03333824|Serotonin Agents|serotonin agents|mesh-ancestor
93305943|NCT02496494|Tacrolimus|tacrolimus|mesh-list
92977973|NCT00882570|Cefdinir|cefdinir|mesh-list
93305944|NCT02496494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93305946|NCT02496494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305947|NCT02496494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93305948|NCT02496494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305949|NCT02496494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305950|NCT03333278|Vitamins|vitamins|mesh-list
93305951|NCT03333278|Ascorbic Acid|ascorbic acid|mesh-list
93305952|NCT03333278|Thiamine|thiamine|mesh-list
93305953|NCT03333278|Hydrocortisone|hydrocortisone|mesh-list
93305954|NCT03333278|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93305955|NCT03333278|Micronutrients|micronutrients|mesh-ancestor
93305956|NCT03333278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305957|NCT03333278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93305958|NCT03333278|Antioxidants|antioxidants|mesh-ancestor
93305959|NCT03333278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305960|NCT03333278|Protective Agents|protective agents|mesh-ancestor
93305961|NCT03333278|Vitamin B Complex|vitamin b complex|mesh-ancestor
93305962|NCT04847596|Ofatumumab|ofatumumab|mesh-list
93305963|NCT04847596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305964|NCT00706628|Nintedanib|nintedanib|mesh-list
93305965|NCT00706628|Afatinib|afatinib|mesh-list
93305966|NCT00706628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305967|NCT00706628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93305968|NCT00706628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93305969|NCT00706628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305970|NCT05465330|Propofol|propofol|mesh-list
93305971|NCT05465330|Desflurane|desflurane|mesh-list
93305972|NCT05465330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93305973|NCT05465330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93305974|NCT05465330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305975|NCT05465330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93305976|NCT05465330|Anesthetics, General|anesthetics, general|mesh-ancestor
93305977|NCT05465330|Anesthetics|anesthetics|mesh-ancestor
93305978|NCT05465330|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93305979|NCT05463614|Propranolol|propranolol|mesh-list
93305980|NCT05463614|Propafenone|propafenone|mesh-list
93305981|NCT05463614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93305982|NCT05463614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93305983|NCT05463614|Adrenergic Agents|adrenergic agents|mesh-ancestor
93305984|NCT05463614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93305985|NCT05463614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93305986|NCT05463614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305987|NCT05463614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93305988|NCT05463614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93305989|NCT05463614|Vasodilator Agents|vasodilator agents|mesh-ancestor
93305990|NCT05463614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93305991|NCT05463614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93305992|NCT05463614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93305993|NCT03332888|Rituximab|rituximab|mesh-list
92600519|NCT00352339|Dopamine Agents|dopamine agents|mesh-ancestor
93305994|NCT03332888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93305995|NCT03332888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93305996|NCT03332888|Immunologic Factors|immunologic factors|mesh-ancestor
93305997|NCT03332888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93305998|NCT03332888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93305999|NCT03332732|Metronidazole|metronidazole|mesh-list
93306000|NCT03332732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306001|NCT03332732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93306002|NCT03332732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93306003|NCT03332732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93306004|NCT02492360|Cisplatin|cisplatin|mesh-list
93306005|NCT02492360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306006|NCT02492282|Remifentanil|remifentanil|mesh-list
93306007|NCT02492282|Propofol|propofol|mesh-list
93306008|NCT02492282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306009|NCT02492282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306010|NCT02492282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306011|NCT02492282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306012|NCT02492282|Anesthetics, General|anesthetics, general|mesh-ancestor
93306013|NCT02492282|Anesthetics|anesthetics|mesh-ancestor
93306014|NCT02492282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93306015|NCT02492282|Narcotics|narcotics|mesh-ancestor
93306016|NCT02492282|Analgesics|analgesics|mesh-ancestor
93306017|NCT02492282|Sensory System Agents|sensory system agents|mesh-ancestor
93306018|NCT02492282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306019|NCT02492126|Citric Acid|citric acid|mesh-list
93306020|NCT02492126|Sodium Citrate|sodium citrate|mesh-list
92978026|NCT00611130|Vigabatrin|vigabatrin|mesh-list
93306021|NCT02492126|Anticoagulants|anticoagulants|mesh-ancestor
93306022|NCT02492126|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93306023|NCT02492126|Chelating Agents|chelating agents|mesh-ancestor
93306024|NCT02492126|Sequestering Agents|sequestering agents|mesh-ancestor
93306025|NCT02492126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306027|NCT05464862|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306028|NCT05464862|Anesthetics|anesthetics|mesh-ancestor
93306029|NCT05464862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306030|NCT05464862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306031|NCT05464862|Sensory System Agents|sensory system agents|mesh-ancestor
93306032|NCT05464862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306033|NCT05464862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93306034|NCT05464862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93306035|NCT05464862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93306036|NCT05464862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93306037|NCT05464862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306038|NCT03324776|Insulin|insulin|mesh-list
93306039|NCT03324776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93306040|NCT03324776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93306041|NCT03324776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306042|NCT02561806|Ustekinumab|ustekinumab|mesh-list
93306043|NCT02561806|Ixekizumab|ixekizumab|mesh-list
93306044|NCT02561806|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306045|NCT03332576|Cyclophosphamide|cyclophosphamide|mesh-list
93306046|NCT03332576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306047|NCT03332576|Immunologic Factors|immunologic factors|mesh-ancestor
93306048|NCT03332576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306049|NCT03332576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306050|NCT03332576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93306051|NCT03332576|Alkylating Agents|alkylating agents|mesh-ancestor
93306052|NCT03332576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306053|NCT03332576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306054|NCT03332576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93306055|NCT03330860|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93306056|NCT03330860|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93306057|NCT03330860|beta-Endorphin|beta-endorphin|mesh-list
93306058|NCT03330860|Hormones|hormones|mesh-ancestor
93306059|NCT03330860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306060|NCT03330860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306061|NCT03330860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306062|NCT03330860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306063|NCT03324542|Ranibizumab|ranibizumab|mesh-list
93306064|NCT03324542|Aflibercept|aflibercept|mesh-list
93306065|NCT03324542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306066|NCT03324542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93306067|NCT03324542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93306068|NCT03324542|Growth Substances|growth substances|mesh-ancestor
93306069|NCT03324542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306070|NCT03324542|Growth Inhibitors|growth inhibitors|mesh-ancestor
93306071|NCT03330782|Remifentanil|remifentanil|mesh-list
93306072|NCT03330782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93306073|NCT03330782|Narcotics|narcotics|mesh-ancestor
93306074|NCT03330782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306075|NCT03330782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306076|NCT03330782|Analgesics|analgesics|mesh-ancestor
93306077|NCT03330782|Sensory System Agents|sensory system agents|mesh-ancestor
93306078|NCT03330782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306079|NCT05506462|Ketamine|ketamine|mesh-list
93306080|NCT05506462|Analgesics|analgesics|mesh-ancestor
93306081|NCT05506462|Sensory System Agents|sensory system agents|mesh-ancestor
93306082|NCT05506462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306083|NCT05506462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306084|NCT05506462|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93306085|NCT05506462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306086|NCT05506462|Anesthetics, General|anesthetics, general|mesh-ancestor
93306087|NCT05506462|Anesthetics|anesthetics|mesh-ancestor
93306088|NCT05506462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306089|NCT05506462|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93306090|NCT05506462|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93306091|NCT05506462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306092|NCT05506462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306093|NCT05501704|Tamoxifen|tamoxifen|mesh-list
93306094|NCT05501704|Anastrozole|anastrozole|mesh-list
93306095|NCT05501704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93306096|NCT05501704|Hormone Antagonists|hormone antagonists|mesh-ancestor
93306097|NCT05501704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306098|NCT05501704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306099|NCT05501704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93306100|NCT05501704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306101|NCT05501704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93306102|NCT05501704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93306103|NCT05501704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93306104|NCT05501704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93306105|NCT05501704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93306106|NCT05501704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306107|NCT05501704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306108|NCT05505994|Dapagliflozin|dapagliflozin|mesh-list
93306109|NCT05505994|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93306110|NCT05505994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306111|NCT05505994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93306112|NCT05505994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306113|NCT02491268|Cilostazol|cilostazol|mesh-list
93306114|NCT02491268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93306115|NCT02491268|Autonomic Agents|autonomic agents|mesh-ancestor
93306116|NCT02491268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306117|NCT02491268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306118|NCT02491268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93306119|NCT02491268|Respiratory System Agents|respiratory system agents|mesh-ancestor
93306120|NCT02491268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93306121|NCT02491268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93306122|NCT02491268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306123|NCT02491268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93306124|NCT02491268|Vasodilator Agents|vasodilator agents|mesh-ancestor
93306125|NCT02491268|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93306126|NCT02491268|Protective Agents|protective agents|mesh-ancestor
93306127|NCT02491268|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93306128|NCT02491268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93306129|NCT02491268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306130|NCT03323684|Acetaminophen|acetaminophen|mesh-list
93306131|NCT03323684|Ketorolac|ketorolac|mesh-list
93306132|NCT03323684|Fentanyl|fentanyl|mesh-list
93306133|NCT03323684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93306134|NCT03323684|Narcotics|narcotics|mesh-ancestor
93306135|NCT03323684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306136|NCT03323684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306137|NCT03323684|Analgesics|analgesics|mesh-ancestor
93306138|NCT03323684|Sensory System Agents|sensory system agents|mesh-ancestor
93306139|NCT03323684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306140|NCT03323684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93306141|NCT03323684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306142|NCT03323684|Anesthetics, General|anesthetics, general|mesh-ancestor
93306143|NCT03323684|Anesthetics|anesthetics|mesh-ancestor
93306144|NCT03323684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306145|NCT03323684|Antipyretics|antipyretics|mesh-ancestor
93306146|NCT03323684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306147|NCT03323684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306148|NCT03323684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306149|NCT03323684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306150|NCT03323684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306151|NCT03323684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306152|NCT02182401|Tolbutamide|tolbutamide|mesh-list
93306153|NCT02182401|Midazolam|midazolam|mesh-list
93306154|NCT02182401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93306155|NCT02182401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306156|NCT02182401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306157|NCT02182401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306158|NCT02182401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93306159|NCT02182401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93306160|NCT02182401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93306161|NCT02182401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306162|NCT02182401|Anesthetics, General|anesthetics, general|mesh-ancestor
93306163|NCT02182401|Anesthetics|anesthetics|mesh-ancestor
93306164|NCT02182401|GABA Modulators|gaba modulators|mesh-ancestor
93306165|NCT02182401|GABA Agents|gaba agents|mesh-ancestor
93306166|NCT02182401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306167|NCT02182401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306168|NCT02182401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93306169|NCT04292080|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93306170|NCT04292080|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306171|NCT04292080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306172|NCT04292080|Immunologic Factors|immunologic factors|mesh-ancestor
93306173|NCT04292080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306174|NCT02177955|Midazolam|midazolam|mesh-list
93306175|NCT02177955|Diazepam|diazepam|mesh-list
93306176|NCT02177955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93306177|NCT02177955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306178|NCT02177955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306179|NCT02177955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306180|NCT02177955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93306181|NCT02177955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93306182|NCT02177955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93306183|NCT02177955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306184|NCT02177955|Anesthetics, General|anesthetics, general|mesh-ancestor
93306185|NCT02177955|Anesthetics|anesthetics|mesh-ancestor
93306186|NCT02177955|GABA Modulators|gaba modulators|mesh-ancestor
93306187|NCT02177955|GABA Agents|gaba agents|mesh-ancestor
93306188|NCT02177955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306189|NCT02177955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306190|NCT02177955|Anticonvulsants|anticonvulsants|mesh-ancestor
93306191|NCT02177955|Antiemetics|antiemetics|mesh-ancestor
93306192|NCT02177955|Autonomic Agents|autonomic agents|mesh-ancestor
93306193|NCT02177955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306194|NCT02177955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93306195|NCT02177955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93306196|NCT02177955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93306197|NCT03323528|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93306198|NCT03323528|Benzocaine|benzocaine|mesh-list
93306199|NCT03323528|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306200|NCT03323528|Anesthetics|anesthetics|mesh-ancestor
93306201|NCT03323528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306202|NCT03323528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306203|NCT03323528|Sensory System Agents|sensory system agents|mesh-ancestor
93306204|NCT03323528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306205|NCT03323528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93306206|NCT03323528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306207|NCT05501158|Tamoxifen|tamoxifen|mesh-list
93306208|NCT05501158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93306209|NCT05501158|Hormone Antagonists|hormone antagonists|mesh-ancestor
93306210|NCT05501158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306211|NCT05501158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306212|NCT05501158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93306213|NCT05501158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306214|NCT05501158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93306215|NCT05501158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93306216|NCT05501158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93306217|NCT03537807|Riluzole|riluzole|mesh-list
93306218|NCT03537807|Anticonvulsants|anticonvulsants|mesh-ancestor
93306219|NCT03537807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93306220|NCT03537807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93306221|NCT03537807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306222|NCT03537807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306223|NCT03537807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306224|NCT03537807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93306225|NCT03537807|Protective Agents|protective agents|mesh-ancestor
93306226|NCT02182479|Fenoterol|fenoterol|mesh-list
93306227|NCT02182479|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93306228|NCT02182479|Ipratropium|ipratropium|mesh-list
93306229|NCT02182479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93306230|NCT02182479|Autonomic Agents|autonomic agents|mesh-ancestor
93306231|NCT02182479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306232|NCT02182479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306233|NCT02182479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93306234|NCT02182479|Respiratory System Agents|respiratory system agents|mesh-ancestor
93306235|NCT02182479|Sympathomimetics|sympathomimetics|mesh-ancestor
93306236|NCT02182479|Tocolytic Agents|tocolytic agents|mesh-ancestor
93306237|NCT02182479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93306238|NCT02182479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93306239|NCT02182479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93306240|NCT02182479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93306241|NCT02182479|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306242|NCT02182479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306243|NCT02182479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306244|NCT02182479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93306245|NCT02182479|Cholinergic Agents|cholinergic agents|mesh-ancestor
93306247|NCT02560558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93306248|NCT02560558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306249|NCT02560558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93306250|NCT02560558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306251|NCT02560558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306252|NCT02560558|Immunologic Factors|immunologic factors|mesh-ancestor
93306253|NCT02560558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306254|NCT02560558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306255|NCT03329456|Ropivacaine|ropivacaine|mesh-list
93306256|NCT03329456|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306257|NCT03329456|Anesthetics|anesthetics|mesh-ancestor
93306258|NCT03329456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306259|NCT03329456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306260|NCT03329456|Sensory System Agents|sensory system agents|mesh-ancestor
93306261|NCT03329456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306262|NCT02178033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93306263|NCT02491736|Ketoprofen|ketoprofen|mesh-list
93306264|NCT02491736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306265|NCT02491736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306266|NCT02491736|Analgesics|analgesics|mesh-ancestor
93306267|NCT02491736|Sensory System Agents|sensory system agents|mesh-ancestor
93306268|NCT02491736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306269|NCT02491736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306270|NCT02491736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306271|NCT02491736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306272|NCT02491736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306273|NCT02491736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306274|NCT02491736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306275|NCT05501080|Spironolactone|spironolactone|mesh-list
93306276|NCT05501080|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93306277|NCT05501080|Hormone Antagonists|hormone antagonists|mesh-ancestor
93306278|NCT05501080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306279|NCT05501080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306280|NCT05501080|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93306281|NCT05501080|Diuretics|diuretics|mesh-ancestor
93306282|NCT05501080|Natriuretic Agents|natriuretic agents|mesh-ancestor
93306283|NCT02491970|Fluticasone|fluticasone|mesh-list
93306284|NCT02491970|Xhance|xhance|mesh-list
93306285|NCT02491970|Formoterol Fumarate|formoterol fumarate|mesh-list
93306286|NCT02491970|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93306287|NCT02491970|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93306288|NCT02491970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306289|NCT02491970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93306290|NCT02491970|Autonomic Agents|autonomic agents|mesh-ancestor
93306291|NCT02491970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306292|NCT02491970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306293|NCT02491970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93306294|NCT02491970|Respiratory System Agents|respiratory system agents|mesh-ancestor
93306295|NCT02491970|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306296|NCT02491970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93306297|NCT02491970|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93306298|NCT02491970|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93306299|NCT02491970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93306300|NCT02491970|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306301|NCT02491970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306302|NCT02491970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306303|NCT02491970|Glucocorticoids|glucocorticoids|mesh-ancestor
93306304|NCT02491970|Hormones|hormones|mesh-ancestor
93306305|NCT02491970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306306|NCT02491970|Sympathomimetics|sympathomimetics|mesh-ancestor
93306307|NCT02182557|Ketotifen|ketotifen|mesh-list
93306308|NCT02182557|Epinastine|epinastine|mesh-list
93306309|NCT02182557|Antipruritics|antipruritics|mesh-ancestor
93306310|NCT02182557|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306311|NCT02182557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93306312|NCT02182557|Histamine Antagonists|histamine antagonists|mesh-ancestor
93306313|NCT02182557|Histamine Agents|histamine agents|mesh-ancestor
93306314|NCT02182557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306315|NCT02182557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306316|NCT02182557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306317|NCT02182557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93306318|NCT02182635|Oxitropium|oxitropium|mesh-list
93306320|NCT02182635|Autonomic Agents|autonomic agents|mesh-ancestor
93306321|NCT02182635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306322|NCT02182635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306323|NCT02182713|Bromides|bromides|mesh-list
93306324|NCT02182713|Albuterol|albuterol|mesh-list
93306325|NCT02182713|Ipratropium|ipratropium|mesh-list
93306326|NCT02182713|Anticonvulsants|anticonvulsants|mesh-ancestor
93306327|NCT02182713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93306328|NCT02182713|Autonomic Agents|autonomic agents|mesh-ancestor
93306329|NCT02182713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306330|NCT02182713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306331|NCT02182713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93306332|NCT02182713|Respiratory System Agents|respiratory system agents|mesh-ancestor
93306333|NCT02182713|Tocolytic Agents|tocolytic agents|mesh-ancestor
93306334|NCT02182713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93306335|NCT02182713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93306336|NCT02182713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93306337|NCT02182713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93306338|NCT02182713|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306339|NCT02182713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306340|NCT02182713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306341|NCT02182713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93306342|NCT02182713|Cholinergic Agents|cholinergic agents|mesh-ancestor
93306343|NCT03323372|Listerine|listerine|mesh-list
93306344|NCT03323372|Fluorides|fluorides|mesh-list
93306345|NCT03323372|Sodium Fluoride|sodium fluoride|mesh-list
93306346|NCT03323372|Cariostatic Agents|cariostatic agents|mesh-ancestor
93306347|NCT03323372|Protective Agents|protective agents|mesh-ancestor
93306348|NCT03323372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306349|NCT03323372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93306350|NCT03323372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306351|NCT02180529|Methylphenidate|methylphenidate|mesh-list
93306352|NCT02180529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93306353|NCT02180529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306354|NCT02180529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93306355|NCT02180529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93306356|NCT02180529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93306357|NCT02180529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306358|NCT02180529|Dopamine Agents|dopamine agents|mesh-ancestor
93306359|NCT02180529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306360|NCT02182791|Nevirapine|nevirapine|mesh-list
93306361|NCT02182791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93306362|NCT02182791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93306363|NCT02182791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306364|NCT02182791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306365|NCT02182791|Antiviral Agents|antiviral agents|mesh-ancestor
93306366|NCT02182791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306367|NCT02182791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93306368|NCT02182791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93306369|NCT02182791|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93306370|NCT02182791|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93306371|NCT03536325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93306372|NCT03536325|Immunologic Factors|immunologic factors|mesh-ancestor
93306373|NCT03536325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306374|NCT03536637|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93306375|NCT03536637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93306376|NCT03536637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306377|NCT02488538|Fluoxetine|fluoxetine|mesh-list
93306378|NCT02488538|Contraceptive Agents|contraceptive agents|mesh-list
93306379|NCT02488538|Contraceptives, Oral|contraceptives, oral|mesh-list
93306380|NCT02488538|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93306381|NCT02488538|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93306382|NCT02488538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93306383|NCT02488538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93306384|NCT02488538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306385|NCT02488538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306386|NCT02488538|Serotonin Agents|serotonin agents|mesh-ancestor
93306387|NCT02488538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306388|NCT02488538|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93306389|NCT02488538|Antidepressive Agents|antidepressive agents|mesh-ancestor
93306390|NCT02488538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93306391|NCT02488538|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93306392|NCT02488538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93306393|NCT02488538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306394|NCT02488538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93306395|NCT02488538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93306397|NCT02568046|Fluorouracil|fluorouracil|mesh-list
93306398|NCT02568046|Irinotecan|irinotecan|mesh-list
93306399|NCT02568046|Antimetabolites|antimetabolites|mesh-ancestor
93306400|NCT02568046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306401|NCT02568046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93306402|NCT02568046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306403|NCT02568046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306404|NCT02568046|Immunologic Factors|immunologic factors|mesh-ancestor
93306405|NCT02568046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306406|NCT02568046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93306407|NCT02568046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93306408|NCT02568046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306409|NCT02568046|Antidotes|antidotes|mesh-ancestor
93306410|NCT02568046|Protective Agents|protective agents|mesh-ancestor
93306411|NCT02568046|Vitamin B Complex|vitamin b complex|mesh-ancestor
93306412|NCT02568046|Vitamins|vitamins|mesh-ancestor
93306413|NCT02568046|Micronutrients|micronutrients|mesh-ancestor
93306414|NCT03536481|Ensartinib|ensartinib|mesh-list
93306415|NCT03536481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306416|NCT03536481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93306417|NCT03536481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306418|NCT03536481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306419|NCT02488616|Insulin|insulin|mesh-list
93306420|NCT02488616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93306421|NCT02488616|Hormones|hormones|mesh-list
93306422|NCT02488616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93306423|NCT02488616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600933|NCT00444652|Anticoagulants|anticoagulants|mesh-ancestor
93306424|NCT02488616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306425|NCT02256423|Ibuprofen|ibuprofen|mesh-list
93306426|NCT02256423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306427|NCT02256423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306428|NCT02256423|Analgesics|analgesics|mesh-ancestor
93306429|NCT02256423|Sensory System Agents|sensory system agents|mesh-ancestor
93306430|NCT02256423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306431|NCT02256423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306432|NCT02256423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306433|NCT02256423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306434|NCT02256423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306435|NCT02256423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306436|NCT02256423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306437|NCT03320486|Ketoconazole|ketoconazole|mesh-list
93306438|NCT03320486|Antifungal Agents|antifungal agents|mesh-ancestor
93306439|NCT03320486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306440|NCT03320486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93306441|NCT03320486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93306442|NCT03320486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306443|NCT03320486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306444|NCT03320486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93306445|NCT03320486|Hormone Antagonists|hormone antagonists|mesh-ancestor
93306446|NCT03320486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306447|NCT03320486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306448|NCT03320486|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93306449|NCT02567656|Tenalisib|tenalisib|mesh-list
93306450|NCT02567656|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93306451|NCT02567656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306452|NCT02567656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306453|NCT02185833|Dirithromycin|dirithromycin|mesh-list
93306454|NCT02185833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93306455|NCT02185833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306456|NCT02180997|Tamsulosin|tamsulosin|mesh-list
93306457|NCT02180997|Solifenacin Succinate|solifenacin succinate|mesh-list
93306458|NCT02180997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93306459|NCT02180997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93306460|NCT02180997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93306461|NCT02180997|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306462|NCT02180997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306463|NCT02180997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306464|NCT02180997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306465|NCT02180997|Urological Agents|urological agents|mesh-ancestor
93306466|NCT02180997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93306467|NCT02180997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93306468|NCT02180997|Cholinergic Agents|cholinergic agents|mesh-ancestor
93306469|NCT02560012|Sirolimus|sirolimus|mesh-list
93306470|NCT02560012|Everolimus|everolimus|mesh-list
93306471|NCT02560012|Temsirolimus|temsirolimus|mesh-list
93306472|NCT02560012|MTOR Inhibitors|mtor inhibitors|mesh-list
93306473|NCT02560012|Sorafenib|sorafenib|mesh-list
93306474|NCT02560012|Sunitinib|sunitinib|mesh-list
93306475|NCT02560012|Axitinib|axitinib|mesh-list
93306476|NCT02560012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93306477|NCT02560012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306478|NCT02560012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306479|NCT02560012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306480|NCT02560012|Immunologic Factors|immunologic factors|mesh-ancestor
93306481|NCT02560012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306482|NCT02560012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306483|NCT02560012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93306484|NCT02560012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93306485|NCT02560012|Growth Substances|growth substances|mesh-ancestor
93306486|NCT02560012|Growth Inhibitors|growth inhibitors|mesh-ancestor
93306487|NCT02560012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93306488|NCT02560012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306489|NCT02560012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93306490|NCT02560012|Antifungal Agents|antifungal agents|mesh-ancestor
93306491|NCT03320174|Tafenoquine|tafenoquine|mesh-list
93306492|NCT03320174|Antimalarials|antimalarials|mesh-ancestor
93306493|NCT03320174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93306494|NCT03320174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93306495|NCT03320174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306496|NCT03328364|Docetaxel|docetaxel|mesh-list
93306497|NCT03328364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306498|NCT03328364|Tubulin Modulators|tubulin modulators|mesh-ancestor
93306499|NCT03328364|Antimitotic Agents|antimitotic agents|mesh-ancestor
93306500|NCT03328364|Mitosis Modulators|mitosis modulators|mesh-ancestor
93306501|NCT03328364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306502|NCT03328052|Antidepressive Agents|antidepressive agents|mesh-list
93306503|NCT03328052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93306504|NCT04514302|Immunoglobulins|immunoglobulins|mesh-list
93306505|NCT04514302|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93306506|NCT04514302|Antibodies|antibodies|mesh-list
93306507|NCT04514302|Immunologic Factors|immunologic factors|mesh-ancestor
93306508|NCT04514302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306509|NCT03319784|Triamcinolone|triamcinolone|mesh-list
93306510|NCT03319784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93306511|NCT03319784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93306512|NCT03319784|Ketorolac|ketorolac|mesh-list
93306513|NCT03319784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93306514|NCT03319784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306515|NCT03319784|Glucocorticoids|glucocorticoids|mesh-ancestor
93306516|NCT03319784|Hormones|hormones|mesh-ancestor
93306517|NCT03319784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306518|NCT03319784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306519|NCT03319784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306520|NCT03319784|Immunologic Factors|immunologic factors|mesh-ancestor
93306521|NCT03319784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306522|NCT03319784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306523|NCT03319784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306524|NCT03319784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306525|NCT03319784|Analgesics|analgesics|mesh-ancestor
93306526|NCT03319784|Sensory System Agents|sensory system agents|mesh-ancestor
93306527|NCT03319784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306528|NCT03319784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306529|NCT03319784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306530|NCT03319706|Olmesartan|olmesartan|mesh-list
93306531|NCT03319706|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93306532|NCT03319706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93306533|NCT03319706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93306534|NCT03319706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93306535|NCT03319706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306536|NCT03322358|Diphenhydramine|diphenhydramine|mesh-list
93306537|NCT03322358|Promethazine|promethazine|mesh-list
93306538|NCT03322358|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93306539|NCT03322358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306540|NCT03322358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306541|NCT03322358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306542|NCT03322358|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306543|NCT03322358|Anesthetics|anesthetics|mesh-ancestor
93306544|NCT03322358|Sensory System Agents|sensory system agents|mesh-ancestor
93306545|NCT03322358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306546|NCT03322358|Antiemetics|antiemetics|mesh-ancestor
93306547|NCT03322358|Autonomic Agents|autonomic agents|mesh-ancestor
93306548|NCT03322358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93306549|NCT03322358|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93306550|NCT03322358|Histamine Antagonists|histamine antagonists|mesh-ancestor
93306551|NCT03322358|Histamine Agents|histamine agents|mesh-ancestor
93306552|NCT03322358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306553|NCT03322358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306554|NCT03322358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93306555|NCT03322358|Antipruritics|antipruritics|mesh-ancestor
93306556|NCT03322358|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306557|NCT05045170|Dexmedetomidine|dexmedetomidine|mesh-list
93306559|NCT05045170|Anesthetics|anesthetics|mesh-ancestor
93306560|NCT05045170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306561|NCT05045170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306562|NCT05045170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306563|NCT05045170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306564|NCT05045170|Analgesics|analgesics|mesh-ancestor
93306565|NCT05045170|Sensory System Agents|sensory system agents|mesh-ancestor
93306566|NCT05045170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306567|NCT05045170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93306568|NCT05045170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93306569|NCT05045170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93306570|NCT05045170|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306571|NCT05045170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306572|NCT05045170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306573|NCT05045170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306574|NCT05045170|Anesthetics, General|anesthetics, general|mesh-ancestor
93306575|NCT05500690|Folic Acid|folic acid|mesh-list
93306576|NCT05500690|Hematinics|hematinics|mesh-ancestor
93306577|NCT05500690|Vitamin B Complex|vitamin b complex|mesh-ancestor
93306578|NCT05500690|Vitamins|vitamins|mesh-ancestor
93306579|NCT05500690|Micronutrients|micronutrients|mesh-ancestor
93306580|NCT05500690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306581|NCT03322124|Octenidine|octenidine|mesh-list
93306582|NCT03322124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306583|NCT03322124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93306584|NCT04442984|Leucovorin|leucovorin|mesh-list
93306585|NCT04442984|Oxaliplatin|oxaliplatin|mesh-list
93306586|NCT04442984|Irinotecan|irinotecan|mesh-list
93306587|NCT04442984|Fluorouracil|fluorouracil|mesh-list
93306588|NCT04442984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306589|NCT04442984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93306590|NCT04442984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93306591|NCT04442984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306592|NCT04442984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306593|NCT04442984|Antidotes|antidotes|mesh-ancestor
93306594|NCT04442984|Protective Agents|protective agents|mesh-ancestor
93306595|NCT04442984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306596|NCT04442984|Vitamin B Complex|vitamin b complex|mesh-ancestor
93306597|NCT04442984|Vitamins|vitamins|mesh-ancestor
93306598|NCT04442984|Micronutrients|micronutrients|mesh-ancestor
93306599|NCT04442984|Antimetabolites|antimetabolites|mesh-ancestor
93306600|NCT04442984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93306601|NCT04442984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306602|NCT04442984|Immunologic Factors|immunologic factors|mesh-ancestor
93306603|NCT03327506|Alprazolam|alprazolam|mesh-list
93306604|NCT03327506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306605|NCT03327506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306606|NCT03327506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306607|NCT03327506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93306608|NCT03327506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93306609|NCT03327506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93306610|NCT03327506|GABA Modulators|gaba modulators|mesh-ancestor
93306611|NCT03327506|GABA Agents|gaba agents|mesh-ancestor
93306612|NCT03327506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306613|NCT03327506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306614|NCT02487914|Lidocaine|lidocaine|mesh-list
93306615|NCT02487914|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306616|NCT02487914|Anesthetics|anesthetics|mesh-ancestor
93306617|NCT02487914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306618|NCT02487914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306619|NCT02487914|Sensory System Agents|sensory system agents|mesh-ancestor
93306620|NCT02487914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306621|NCT02487914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93306622|NCT02487914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93306623|NCT02487914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93306624|NCT02487914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93306625|NCT02487914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306626|NCT02487680|Chromium|chromium|mesh-list
93306627|NCT02487680|Picolinic acid|picolinic acid|mesh-list
93306628|NCT02487680|Trace Elements|trace elements|mesh-ancestor
93306629|NCT02487680|Micronutrients|micronutrients|mesh-ancestor
93306630|NCT02487680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306631|NCT02487680|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93306632|NCT02487680|Chelating Agents|chelating agents|mesh-ancestor
93306633|NCT02487680|Sequestering Agents|sequestering agents|mesh-ancestor
93306634|NCT02487680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306635|NCT03319550|Caseins|caseins|mesh-list
93306636|NCT03319550|Chelating Agents|chelating agents|mesh-ancestor
93306637|NCT03319550|Sequestering Agents|sequestering agents|mesh-ancestor
93306638|NCT03319550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306639|NCT04442906|Fentanyl|fentanyl|mesh-list
93306640|NCT04442906|Dexmedetomidine|dexmedetomidine|mesh-list
93306641|NCT04442906|Bupivacaine|bupivacaine|mesh-list
93306642|NCT04442906|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306643|NCT04442906|Anesthetics|anesthetics|mesh-ancestor
93306644|NCT04442906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306645|NCT04442906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306646|NCT04442906|Sensory System Agents|sensory system agents|mesh-ancestor
93306647|NCT04442906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306648|NCT04442906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306649|NCT04442906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306650|NCT04442906|Analgesics|analgesics|mesh-ancestor
93306651|NCT04442906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93306652|NCT04442906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93306653|NCT04442906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93306654|NCT04442906|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306655|NCT04442906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306656|NCT04442906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306657|NCT04442906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93306658|NCT04442906|Narcotics|narcotics|mesh-ancestor
93306659|NCT04442906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93306660|NCT04442906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306661|NCT04442906|Anesthetics, General|anesthetics, general|mesh-ancestor
93306662|NCT04510012|Complement System Proteins|complement system proteins|mesh-list
93306663|NCT04510012|Immunologic Factors|immunologic factors|mesh-ancestor
93306664|NCT04510012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306665|NCT03327350|Anticoagulants|anticoagulants|mesh-list
93306666|NCT03327272|Methylprednisolone|methylprednisolone|mesh-list
93306667|NCT03327272|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93306668|NCT03327272|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93306669|NCT03327272|Prednisolone|prednisolone|mesh-list
93306670|NCT03327272|Prednisolone acetate|prednisolone acetate|mesh-list
93306671|NCT03327272|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93306672|NCT03327272|Prednisolone phosphate|prednisolone phosphate|mesh-list
93306673|NCT03327272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306674|NCT03327272|Antiemetics|antiemetics|mesh-ancestor
93306675|NCT03327272|Autonomic Agents|autonomic agents|mesh-ancestor
93306676|NCT03327272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306677|NCT03327272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306678|NCT03327272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93306679|NCT03327272|Glucocorticoids|glucocorticoids|mesh-ancestor
93306680|NCT03327272|Hormones|hormones|mesh-ancestor
93306681|NCT03327272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306682|NCT03327272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93306683|NCT03327272|Protective Agents|protective agents|mesh-ancestor
93306684|NCT03327272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93306685|NCT03327272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306686|NCT05508178|Vaccines|vaccines|mesh-list
93306687|NCT05508178|Immunologic Factors|immunologic factors|mesh-ancestor
93306688|NCT05508178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306689|NCT03327116|Methotrexate|methotrexate|mesh-list
93306690|NCT03327116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93306691|NCT03327116|Abortifacient Agents|abortifacient agents|mesh-ancestor
93306692|NCT03327116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93306693|NCT03327116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306694|NCT03327116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93306695|NCT03327116|Antimetabolites|antimetabolites|mesh-ancestor
93306696|NCT03327116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306697|NCT03327116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306698|NCT03327116|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306699|NCT03327116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306700|NCT03327116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93306701|NCT03327116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306702|NCT03327116|Immunologic Factors|immunologic factors|mesh-ancestor
93306703|NCT03327116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306704|NCT03327116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93306706|NCT03326960|Sevoflurane|sevoflurane|mesh-list
93306707|NCT03326960|Desflurane|desflurane|mesh-list
93306708|NCT03326960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93306709|NCT03326960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306710|NCT03326960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306711|NCT03326960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306712|NCT03326960|Anesthetics, General|anesthetics, general|mesh-ancestor
93306713|NCT03326960|Anesthetics|anesthetics|mesh-ancestor
93306714|NCT03326960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93306715|NCT03326960|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93306716|NCT03319238|Ketamine|ketamine|mesh-list
93306717|NCT03319238|Analgesics|analgesics|mesh-ancestor
93306718|NCT03319238|Sensory System Agents|sensory system agents|mesh-ancestor
93306719|NCT03319238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306720|NCT03319238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306721|NCT03319238|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93306722|NCT03319238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93306723|NCT03319238|Anesthetics, General|anesthetics, general|mesh-ancestor
93306724|NCT03319238|Anesthetics|anesthetics|mesh-ancestor
93306725|NCT03319238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306726|NCT03319238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93306727|NCT03319238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93306728|NCT03319238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306729|NCT03319238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306730|NCT03321890|Prednisone|prednisone|mesh-list
93306731|NCT03321890|Cyclophosphamide|cyclophosphamide|mesh-list
93306732|NCT03321890|Methotrexate|methotrexate|mesh-list
93306733|NCT03321890|Etoposide|etoposide|mesh-list
93306734|NCT03321890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306735|NCT03321890|Immunologic Factors|immunologic factors|mesh-ancestor
93306736|NCT03321890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306737|NCT03321890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306738|NCT03321890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93306739|NCT03321890|Alkylating Agents|alkylating agents|mesh-ancestor
93306740|NCT03321890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306741|NCT03321890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306742|NCT03321890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93306743|NCT03321890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306744|NCT03321890|Glucocorticoids|glucocorticoids|mesh-ancestor
93306745|NCT03321890|Hormones|hormones|mesh-ancestor
93306746|NCT03321890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306747|NCT03321890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93306748|NCT03321890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93306749|NCT03321890|Abortifacient Agents|abortifacient agents|mesh-ancestor
93306750|NCT03321890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93306751|NCT03321890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93306752|NCT03321890|Antimetabolites|antimetabolites|mesh-ancestor
93306753|NCT03321890|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306754|NCT03321890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306755|NCT03321890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93306756|NCT03321890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93306757|NCT03321890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93306758|NCT03321890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93306759|NCT03321890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93306760|NCT05464394|Tranexamic Acid|tranexamic acid|mesh-list
93306761|NCT05464394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93306762|NCT05464394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93306763|NCT05464394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306764|NCT05464394|Hemostatics|hemostatics|mesh-ancestor
93306765|NCT05464394|Coagulants|coagulants|mesh-ancestor
93306766|NCT05499598|Vitamin A|vitamin a|mesh-list
93306767|NCT05499598|Vitamins|vitamins|mesh-ancestor
93306768|NCT05499598|Micronutrients|micronutrients|mesh-ancestor
93306769|NCT05499598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306770|NCT03321734|Caffeine|caffeine|mesh-list
93306771|NCT03321734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93306772|NCT03321734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306773|NCT03321734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93306774|NCT03321734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306775|NCT03321734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306776|NCT03321734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93306777|NCT03321734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93306778|NCT03321734|Purinergic Agents|purinergic agents|mesh-ancestor
93306779|NCT03321734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306780|NCT04442750|Bupivacaine|bupivacaine|mesh-list
93306781|NCT04442750|Anesthetics, Local|anesthetics, local|mesh-ancestor
93306782|NCT04442750|Anesthetics|anesthetics|mesh-ancestor
93306783|NCT04442750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93306784|NCT04442750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306785|NCT04442750|Sensory System Agents|sensory system agents|mesh-ancestor
93306786|NCT04442750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306787|NCT02753127|Leucovorin|leucovorin|mesh-list
93306788|NCT02753127|Bevacizumab|bevacizumab|mesh-list
93306789|NCT02753127|Fluorouracil|fluorouracil|mesh-list
93306790|NCT02753127|Irinotecan|irinotecan|mesh-list
93306791|NCT02753127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93306792|NCT02753127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306793|NCT02753127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93306794|NCT02753127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93306795|NCT02753127|Growth Substances|growth substances|mesh-ancestor
93306796|NCT02753127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306797|NCT02753127|Growth Inhibitors|growth inhibitors|mesh-ancestor
93306798|NCT02753127|Antimetabolites|antimetabolites|mesh-ancestor
93306799|NCT02753127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306800|NCT02753127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93306801|NCT02753127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306802|NCT02753127|Immunologic Factors|immunologic factors|mesh-ancestor
93306803|NCT02753127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93306804|NCT02753127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93306805|NCT02753127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306806|NCT02753127|Antidotes|antidotes|mesh-ancestor
93306807|NCT02753127|Protective Agents|protective agents|mesh-ancestor
93306808|NCT02753127|Vitamin B Complex|vitamin b complex|mesh-ancestor
93306809|NCT02753127|Vitamins|vitamins|mesh-ancestor
93306810|NCT02753127|Micronutrients|micronutrients|mesh-ancestor
93306811|NCT03326258|Nivolumab|nivolumab|mesh-list
93306812|NCT03326258|Ipilimumab|ipilimumab|mesh-list
93306813|NCT03326258|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
93306814|NCT03326258|Antibodies|antibodies|mesh-list
93306815|NCT03326258|Immunoglobulins|immunoglobulins|mesh-list
93306816|NCT03326258|Immunotoxins|immunotoxins|mesh-list
93306817|NCT03326258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93306818|NCT03326258|Immunoconjugates|immunoconjugates|mesh-list
93306819|NCT03326258|Immunologic Factors|immunologic factors|mesh-ancestor
93306820|NCT03326258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306821|NCT03326258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93306822|NCT03326258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306823|NCT03326258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93306824|NCT03326258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306825|NCT03326102|Paclitaxel|paclitaxel|mesh-list
93306826|NCT03326102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93306827|NCT03326102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93306828|NCT03326102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306829|NCT03326102|Tubulin Modulators|tubulin modulators|mesh-ancestor
93306830|NCT03326102|Antimitotic Agents|antimitotic agents|mesh-ancestor
93306831|NCT03326102|Mitosis Modulators|mitosis modulators|mesh-ancestor
93306832|NCT03326102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306833|NCT02487212|Clobetasol|clobetasol|mesh-list
93306834|NCT02487212|Petrolatum|petrolatum|mesh-list
93306835|NCT02487212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306836|NCT02487212|Glucocorticoids|glucocorticoids|mesh-ancestor
93306837|NCT02487212|Hormones|hormones|mesh-ancestor
93306838|NCT02487212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306839|NCT02487212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306840|NCT02487212|Emollients|emollients|mesh-ancestor
93306841|NCT02487212|Dermatologic Agents|dermatologic agents|mesh-ancestor
93306842|NCT04583488|Docetaxel|docetaxel|mesh-list
93306843|NCT04583488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306844|NCT04583488|Tubulin Modulators|tubulin modulators|mesh-ancestor
93306845|NCT04583488|Antimitotic Agents|antimitotic agents|mesh-ancestor
93306846|NCT04583488|Mitosis Modulators|mitosis modulators|mesh-ancestor
93306847|NCT04583488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306848|NCT03318536|Granisetron|granisetron|mesh-list
93306849|NCT03318536|Serotonin|serotonin|mesh-list
93306850|NCT03318536|Antiemetics|antiemetics|mesh-ancestor
93306851|NCT03318536|Autonomic Agents|autonomic agents|mesh-ancestor
93306852|NCT03318536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306853|NCT03318536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306854|NCT03318536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93306855|NCT03318536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93306856|NCT03318536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93306857|NCT03318536|Serotonin Agents|serotonin agents|mesh-ancestor
93306858|NCT03318536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306859|NCT03318536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601365|NCT00401856|Hormone Antagonists|hormone antagonists|mesh-ancestor
93306860|NCT03318536|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93306861|NCT03537027|Vitamin D|vitamin d|mesh-list
93306862|NCT03537027|Cholecalciferol|cholecalciferol|mesh-list
93306863|NCT03537027|Vitamins|vitamins|mesh-ancestor
93306864|NCT03537027|Micronutrients|micronutrients|mesh-ancestor
93306865|NCT03537027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306866|NCT03537027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93306867|NCT03537027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93306868|NCT02183025|Meloxicam|meloxicam|mesh-list
93306869|NCT02183025|Mefenamic Acid|mefenamic acid|mesh-list
93306870|NCT02183025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306871|NCT02183025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306872|NCT02183025|Analgesics|analgesics|mesh-ancestor
93306873|NCT02183025|Sensory System Agents|sensory system agents|mesh-ancestor
93306874|NCT02183025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306875|NCT02183025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306876|NCT02183025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306877|NCT02183025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306878|NCT02183025|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93306879|NCT02183025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306880|NCT02183025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306881|NCT02183025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306882|NCT04282174|Cyclophosphamide|cyclophosphamide|mesh-list
93306883|NCT04282174|Melphalan|melphalan|mesh-list
93306884|NCT04282174|Busulfan|busulfan|mesh-list
93306885|NCT04282174|Thiotepa|thiotepa|mesh-list
93306886|NCT04282174|Fludarabine|fludarabine|mesh-list
93306887|NCT04282174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93306888|NCT04282174|Immunologic Factors|immunologic factors|mesh-ancestor
93306889|NCT04282174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306890|NCT04282174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306891|NCT04282174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93306892|NCT04282174|Alkylating Agents|alkylating agents|mesh-ancestor
93306893|NCT04282174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306894|NCT04282174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306895|NCT04282174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93306896|NCT02181309|Meloxicam|meloxicam|mesh-list
93306897|NCT02181309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306898|NCT02181309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306899|NCT02181309|Analgesics|analgesics|mesh-ancestor
93306900|NCT02181309|Sensory System Agents|sensory system agents|mesh-ancestor
93306901|NCT02181309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306902|NCT02181309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306903|NCT02181309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306904|NCT02181309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306905|NCT02181309|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93306906|NCT02181309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306907|NCT02181309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306908|NCT02181309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306909|NCT02186145|Metronidazole|metronidazole|mesh-list
93306910|NCT02186145|Nystatin|nystatin|mesh-list
93306911|NCT02186145|Dexamethasone|dexamethasone|mesh-list
93306912|NCT02186145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306913|NCT02186145|Antiemetics|antiemetics|mesh-ancestor
93306914|NCT02186145|Autonomic Agents|autonomic agents|mesh-ancestor
93306915|NCT02186145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306916|NCT02186145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306917|NCT02186145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93306918|NCT02186145|Glucocorticoids|glucocorticoids|mesh-ancestor
93306919|NCT02186145|Hormones|hormones|mesh-ancestor
93306920|NCT02186145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306921|NCT02186145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93306922|NCT02186145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93306923|NCT02186145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306924|NCT02186145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93306925|NCT02186145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93306926|NCT02186145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93306927|NCT02186145|Antifungal Agents|antifungal agents|mesh-ancestor
93306928|NCT02186145|Ionophores|ionophores|mesh-ancestor
93306929|NCT02186145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93306930|NCT02186145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306931|NCT03325868|Ulipristal acetate|ulipristal acetate|mesh-list
93306932|NCT03325868|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93306933|NCT03325868|Contraceptive Agents|contraceptive agents|mesh-ancestor
93306934|NCT03325868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93306935|NCT03325868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306936|NCT03325868|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93306937|NCT02183103|Meloxicam|meloxicam|mesh-list
93306938|NCT02183103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306939|NCT02183103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306940|NCT02183103|Analgesics|analgesics|mesh-ancestor
93306941|NCT02183103|Sensory System Agents|sensory system agents|mesh-ancestor
93306942|NCT02183103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306943|NCT02183103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306944|NCT02183103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306945|NCT02183103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306946|NCT02183103|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93306947|NCT02183103|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306948|NCT02183103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306949|NCT02183103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306950|NCT03325790|Ebselen|ebselen|mesh-list
93306951|NCT03325790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306952|NCT03325790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306953|NCT03325790|Analgesics|analgesics|mesh-ancestor
93306954|NCT03325790|Sensory System Agents|sensory system agents|mesh-ancestor
93306955|NCT03325790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306956|NCT03325790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306957|NCT03325790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306958|NCT03325790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93306959|NCT03325790|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93306960|NCT03325790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93306961|NCT03325790|Antioxidants|antioxidants|mesh-ancestor
93306962|NCT03325790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306963|NCT03325790|Protective Agents|protective agents|mesh-ancestor
93306964|NCT03325790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93306965|NCT03325790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93306966|NCT03325790|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93306967|NCT02181543|Clonidine|clonidine|mesh-list
93306968|NCT02181543|Analgesics|analgesics|mesh-ancestor
93306969|NCT02181543|Sensory System Agents|sensory system agents|mesh-ancestor
93306970|NCT02181543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306971|NCT02181543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306972|NCT02181543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93306973|NCT02181543|Sympatholytics|sympatholytics|mesh-ancestor
93306974|NCT02181543|Autonomic Agents|autonomic agents|mesh-ancestor
93306975|NCT02181543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93306976|NCT02181543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93306977|NCT02181543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93306978|NCT02181543|Adrenergic Agents|adrenergic agents|mesh-ancestor
93306979|NCT02181543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93306980|NCT02181543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93306981|NCT02181621|Cadexomer iodine|cadexomer iodine|mesh-list
93306982|NCT02181621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93306983|NCT02181621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93306984|NCT02490176|Liraglutide|liraglutide|mesh-list
93306985|NCT02490176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93306986|NCT02490176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306987|NCT02490176|Incretins|incretins|mesh-ancestor
93306988|NCT02490176|Hormones|hormones|mesh-ancestor
93306989|NCT02490176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93306990|NCT02183181|Meloxicam|meloxicam|mesh-list
93306991|NCT02183181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93306992|NCT02183181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93306993|NCT02183181|Analgesics|analgesics|mesh-ancestor
93306994|NCT02183181|Sensory System Agents|sensory system agents|mesh-ancestor
93306995|NCT02183181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93306996|NCT02183181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93306997|NCT02183181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93306999|NCT02183181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93307000|NCT02183181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93307001|NCT02183181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307002|NCT02183181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307003|NCT02490098|Insulin|insulin|mesh-list
93307004|NCT02490098|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93307005|NCT02490098|Glucagon|glucagon|mesh-list
93307006|NCT02490098|Hormones|hormones|mesh-list
93307007|NCT02490098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307008|NCT02490098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307009|NCT02490098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307010|NCT02490098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307011|NCT02486822|Oxytocin|oxytocin|mesh-list
93307012|NCT02486822|Oxytocics|oxytocics|mesh-ancestor
93307013|NCT02486822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93307014|NCT02486822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307015|NCT02186457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93307016|NCT02186457|Polymyxins|polymyxins|mesh-list
93307017|NCT02186457|Polymyxin B|polymyxin b|mesh-list
93307018|NCT02186457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307019|NCT02186535|Vitamin D|vitamin d|mesh-list
93307020|NCT02186535|Calcium|calcium|mesh-list
93307021|NCT02186535|Vitamins|vitamins|mesh-ancestor
93307022|NCT02186535|Micronutrients|micronutrients|mesh-ancestor
93307023|NCT02186535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307024|NCT02186535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93307025|NCT02186535|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93307026|NCT03325400|Fluorides|fluorides|mesh-list
93307027|NCT03325400|Cariostatic Agents|cariostatic agents|mesh-ancestor
93307028|NCT03325400|Protective Agents|protective agents|mesh-ancestor
93307029|NCT03325400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307030|NCT02181933|Lamivudine|lamivudine|mesh-list
93307031|NCT02181933|Zidovudine|zidovudine|mesh-list
93307032|NCT02181933|Nevirapine|nevirapine|mesh-list
93307033|NCT02181933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93307034|NCT02181933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93307035|NCT02181933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307036|NCT02181933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307037|NCT02181933|Antiviral Agents|antiviral agents|mesh-ancestor
93307038|NCT02181933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307039|NCT02181933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93307040|NCT02181933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93307041|NCT02181933|Antimetabolites|antimetabolites|mesh-ancestor
93307042|NCT02181933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93307043|NCT02181933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93307044|NCT02183337|Pioglitazone|pioglitazone|mesh-list
93307045|NCT02183337|Linagliptin|linagliptin|mesh-list
93307046|NCT02183337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307047|NCT02183337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307048|NCT02183337|Incretins|incretins|mesh-ancestor
93307049|NCT02183337|Hormones|hormones|mesh-ancestor
93307050|NCT02183337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307051|NCT02183337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93307052|NCT02183337|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307053|NCT02183337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307054|NCT02183337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307055|NCT02489786|Digoxin|digoxin|mesh-list
93307056|NCT02489786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93307057|NCT02489786|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93307058|NCT02489786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307059|NCT02489786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307060|NCT02489786|Protective Agents|protective agents|mesh-ancestor
93307061|NCT02489786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307062|NCT02489864|Terlipressin|terlipressin|mesh-list
93307063|NCT02489864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93307064|NCT02489864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93307065|NCT02182011|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93307066|NCT02182011|Tenecteplase|tenecteplase|mesh-list
93307067|NCT02182011|Streptokinase|streptokinase|mesh-list
93307068|NCT02182011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93307069|NCT02182011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93307070|NCT02182011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307071|NCT02486744|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93307072|NCT02486744|Hormones|hormones|mesh-ancestor
93307073|NCT02486744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307074|NCT02486744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307075|NCT02186769|Risperidone|risperidone|mesh-list
93307076|NCT02186769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93307077|NCT02186769|Serotonin Agents|serotonin agents|mesh-ancestor
93307078|NCT02186769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307079|NCT02186769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307080|NCT02186769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307081|NCT02186769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93307082|NCT02186769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93307083|NCT02186769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307084|NCT02186769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93307085|NCT02186769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93307086|NCT02186769|Dopamine Agents|dopamine agents|mesh-ancestor
93307087|NCT02486432|Levodopa|levodopa|mesh-list
93307088|NCT02486432|Carbidopa|carbidopa|mesh-list
93307089|NCT02486432|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93307090|NCT02486432|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93307091|NCT02486432|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93307092|NCT02486432|Dopamine Agents|dopamine agents|mesh-ancestor
93307093|NCT02486432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307094|NCT02486432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307095|NCT02486432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307096|NCT02486432|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93307097|NCT02486432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307098|NCT02486432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93307099|NCT02486432|Immunologic Factors|immunologic factors|mesh-ancestor
93307100|NCT02486432|Dopamine Agonists|dopamine agonists|mesh-ancestor
93307101|NCT02489240|Vitamin D|vitamin d|mesh-list
93307102|NCT02489240|Cholecalciferol|cholecalciferol|mesh-list
93307103|NCT02489240|Vitamins|vitamins|mesh-ancestor
93307104|NCT02489240|Micronutrients|micronutrients|mesh-ancestor
93307105|NCT02489240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307106|NCT02489240|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93307107|NCT02489240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93307108|NCT02183415|Linagliptin|linagliptin|mesh-list
93307109|NCT02183415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307110|NCT02183415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307111|NCT02183415|Incretins|incretins|mesh-ancestor
93307112|NCT02183415|Hormones|hormones|mesh-ancestor
93307113|NCT02183415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307114|NCT02183415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93307115|NCT02183415|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307116|NCT02183415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307117|NCT02183415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307118|NCT02486510|Maraviroc|maraviroc|mesh-list
93307119|NCT02486510|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93307120|NCT02486510|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93307121|NCT02486510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307122|NCT02486510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93307123|NCT02486510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93307124|NCT02486510|Antiviral Agents|antiviral agents|mesh-ancestor
93307125|NCT02486510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307126|NCT02486510|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93307127|NCT04493528|Lidocaine|lidocaine|mesh-list
93307128|NCT04493528|Anesthetics, Local|anesthetics, local|mesh-ancestor
93307129|NCT04493528|Anesthetics|anesthetics|mesh-ancestor
93307130|NCT04493528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307131|NCT04493528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307132|NCT04493528|Sensory System Agents|sensory system agents|mesh-ancestor
93307133|NCT04493528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307134|NCT04493528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93307135|NCT04493528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93307136|NCT04493528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93307137|NCT04493528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307138|NCT04493528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307139|NCT02183493|Linagliptin|linagliptin|mesh-list
93307140|NCT02183493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307141|NCT02183493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307142|NCT02183493|Incretins|incretins|mesh-ancestor
93307143|NCT02183493|Hormones|hormones|mesh-ancestor
93307144|NCT02183493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307145|NCT02183493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93307146|NCT02183493|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307147|NCT02183493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601657|NCT00450736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93307148|NCT02183493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307149|NCT02187081|Sorafenib|sorafenib|mesh-list
93307150|NCT02187081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307151|NCT02187081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93307152|NCT02187081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307153|NCT02187081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307154|NCT02485106|Rifaximin|rifaximin|mesh-list
93307155|NCT02485106|Pentoxifylline|pentoxifylline|mesh-list
93307156|NCT02485106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93307157|NCT02485106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307158|NCT02485106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307159|NCT02485106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93307160|NCT02485106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307161|NCT02485106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307162|NCT02485106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93307163|NCT02485106|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93307164|NCT02485106|Protective Agents|protective agents|mesh-ancestor
93307165|NCT02485106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307166|NCT02485106|Vasodilator Agents|vasodilator agents|mesh-ancestor
93307167|NCT02485106|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93307168|NCT02485106|Antioxidants|antioxidants|mesh-ancestor
93307169|NCT02485028|Mirodenafil|mirodenafil|mesh-list
93307170|NCT02485028|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93307171|NCT02485028|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93307172|NCT02485028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307173|NCT02485028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307174|NCT02183571|Metformin|metformin|mesh-list
93307175|NCT02183571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307176|NCT02183571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307177|NCT03318146|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93307178|NCT03318146|Latanoprost|latanoprost|mesh-list
93307179|NCT03318146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93307180|NCT02183649|Carbetapentane|carbetapentane|mesh-list
93307181|NCT02183649|Antitussive Agents|antitussive agents|mesh-ancestor
93307182|NCT02183649|Respiratory System Agents|respiratory system agents|mesh-ancestor
93307183|NCT02187315|Cisplatin|cisplatin|mesh-list
93307184|NCT02187315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307185|NCT02256735|Moxifloxacin|moxifloxacin|mesh-list
93307186|NCT02256735|p-Hydroxyamphetamine|p-hydroxyamphetamine|mesh-list
93307187|NCT02256735|Ritobegron|ritobegron|mesh-list
93307188|NCT02256735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93307189|NCT02256735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307190|NCT02256735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93307191|NCT02256735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93307192|NCT02256735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307193|NCT02256735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307194|NCT02256735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307195|NCT02256735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307196|NCT02256735|Mydriatics|mydriatics|mesh-ancestor
93307197|NCT02256735|Autonomic Agents|autonomic agents|mesh-ancestor
93307198|NCT02256735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307199|NCT02256735|Sympathomimetics|sympathomimetics|mesh-ancestor
93307200|NCT02256735|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93307201|NCT02256735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93307202|NCT02256735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93307203|NCT02256735|Adrenergic Agents|adrenergic agents|mesh-ancestor
93307204|NCT02256735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307205|NCT02183805|Cyclophosphamide|cyclophosphamide|mesh-list
93307206|NCT02183805|Carboplatin|carboplatin|mesh-list
93307207|NCT02183805|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93307208|NCT02183805|Paclitaxel|paclitaxel|mesh-list
93307209|NCT02183805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93307210|NCT02183805|Immunologic Factors|immunologic factors|mesh-ancestor
93307211|NCT02183805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307212|NCT02183805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307213|NCT02183805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93307214|NCT02183805|Alkylating Agents|alkylating agents|mesh-ancestor
93307215|NCT02183805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307216|NCT02183805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307217|NCT02183805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93307218|NCT02183805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93307219|NCT02183805|Tubulin Modulators|tubulin modulators|mesh-ancestor
93307220|NCT02183805|Antimitotic Agents|antimitotic agents|mesh-ancestor
93307221|NCT02183805|Mitosis Modulators|mitosis modulators|mesh-ancestor
93307222|NCT03316352|Bupivacaine|bupivacaine|mesh-list
93307223|NCT03316352|Anesthetics|anesthetics|mesh-list
93307224|NCT03316352|Anesthetics, Local|anesthetics, local|mesh-ancestor
93307225|NCT03316352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307226|NCT03316352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307227|NCT03316352|Sensory System Agents|sensory system agents|mesh-ancestor
93307228|NCT03316352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307229|NCT02187705|Telmisartan|telmisartan|mesh-list
93307230|NCT02187705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93307231|NCT02187705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93307232|NCT02187705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93307233|NCT02187705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307234|NCT03317912|Lidocaine|lidocaine|mesh-list
93307235|NCT03317912|Anesthetics, Local|anesthetics, local|mesh-ancestor
93307236|NCT03317912|Anesthetics|anesthetics|mesh-ancestor
93307237|NCT03317912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307238|NCT03317912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307239|NCT03317912|Sensory System Agents|sensory system agents|mesh-ancestor
93307240|NCT03317912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307241|NCT03317912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93307242|NCT03317912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93307243|NCT03317912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93307244|NCT03317912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307245|NCT03317912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307246|NCT03321110|Ubiquinone|ubiquinone|mesh-list
93307247|NCT03321110|Coenzyme Q10|coenzyme q10|mesh-list
93307248|NCT03321110|Micronutrients|micronutrients|mesh-ancestor
93307249|NCT03321110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307250|NCT03321110|Vitamins|vitamins|mesh-ancestor
93307251|NCT03317600|Lidocaine|lidocaine|mesh-list
93307252|NCT03317600|Anesthetics, Local|anesthetics, local|mesh-ancestor
93307253|NCT03317600|Anesthetics|anesthetics|mesh-ancestor
93307254|NCT03317600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307255|NCT03317600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307256|NCT03317600|Sensory System Agents|sensory system agents|mesh-ancestor
93307257|NCT03317600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307258|NCT03317600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93307259|NCT03317600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93307260|NCT03317600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93307261|NCT03317600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307262|NCT03317600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307263|NCT02184117|Adenosine|adenosine|mesh-list
93307264|NCT02184117|Analgesics|analgesics|mesh-ancestor
93307265|NCT02184117|Sensory System Agents|sensory system agents|mesh-ancestor
93307266|NCT02184117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307267|NCT02184117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307268|NCT02184117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93307269|NCT02184117|Vasodilator Agents|vasodilator agents|mesh-ancestor
93307270|NCT02184117|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93307271|NCT02184117|Purinergic Agonists|purinergic agonists|mesh-ancestor
93307272|NCT02184117|Purinergic Agents|purinergic agents|mesh-ancestor
93307273|NCT02184117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307274|NCT02184117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307275|NCT02184273|Dipyrone|dipyrone|mesh-list
93307276|NCT02184273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93307277|NCT02184273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93307278|NCT02184273|Analgesics|analgesics|mesh-ancestor
93307279|NCT02184273|Sensory System Agents|sensory system agents|mesh-ancestor
93307280|NCT02184273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307281|NCT02184273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307282|NCT02184273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307283|NCT02184273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307284|NCT02184273|Antipyretics|antipyretics|mesh-ancestor
93307285|NCT02486198|Oxaliplatin|oxaliplatin|mesh-list
93307286|NCT02486198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307287|NCT02188173|Dexamethasone|dexamethasone|mesh-list
93307288|NCT02188173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307289|NCT02188173|Antiemetics|antiemetics|mesh-ancestor
93307290|NCT02188173|Autonomic Agents|autonomic agents|mesh-ancestor
93307291|NCT02188173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307292|NCT02188173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307293|NCT02188173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307294|NCT02188173|Glucocorticoids|glucocorticoids|mesh-ancestor
93307295|NCT02188173|Hormones|hormones|mesh-ancestor
93307296|NCT02188173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979304|NCT00162097|Efavirenz|efavirenz|mesh-list
93307297|NCT02188173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93307298|NCT02188173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307299|NCT02184351|Clotrimazole|clotrimazole|mesh-list
93307300|NCT02184351|Miconazole|miconazole|mesh-list
93307301|NCT02184351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93307302|NCT02184351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307303|NCT02184351|Antifungal Agents|antifungal agents|mesh-ancestor
93307304|NCT02184351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93307305|NCT02184351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93307306|NCT02184351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307307|NCT02184351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307308|NCT02184351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93307309|NCT02184351|Hormone Antagonists|hormone antagonists|mesh-ancestor
93307310|NCT02184351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307311|NCT02184351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307312|NCT02184351|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93307313|NCT02184351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93307314|NCT02184429|PF-06669571|pf-06669571|mesh-list
93307315|NCT02184429|Dopamine Agonists|dopamine agonists|mesh-ancestor
93307316|NCT02184429|Dopamine Agents|dopamine agents|mesh-ancestor
93307317|NCT02184429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307318|NCT02184429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307319|NCT02184429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307320|NCT02484170|Mannitol|mannitol|mesh-list
93307321|NCT02484170|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93307322|NCT02484170|Diuretics|diuretics|mesh-ancestor
93307323|NCT02484170|Natriuretic Agents|natriuretic agents|mesh-ancestor
93307324|NCT02484170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307325|NCT02188407|Propofol|propofol|mesh-list
93307326|NCT02188407|Sevoflurane|sevoflurane|mesh-list
93307327|NCT02188407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93307328|NCT02188407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307329|NCT02188407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307330|NCT02188407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93307331|NCT02188407|Anesthetics, General|anesthetics, general|mesh-ancestor
93307332|NCT02188407|Anesthetics|anesthetics|mesh-ancestor
93307333|NCT02188407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93307334|NCT02188407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93307335|NCT03317210|Epoetin Alfa|epoetin alfa|mesh-list
93307336|NCT03317210|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93307337|NCT03317210|Hematinics|hematinics|mesh-ancestor
93307338|NCT02488694|Pemetrexed|pemetrexed|mesh-list
93307339|NCT02488694|Afatinib|afatinib|mesh-list
93307340|NCT02488694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307341|NCT02488694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307342|NCT02488694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307343|NCT02488694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93307344|NCT02488694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93307345|NCT02488694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93307346|NCT03316898|Memantine|memantine|mesh-list
93307347|NCT03316898|Donepezil|donepezil|mesh-list
93307348|NCT03316898|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93307349|NCT03316898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307350|NCT03316898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307351|NCT03316898|Cholinergic Agents|cholinergic agents|mesh-ancestor
93307352|NCT03316898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307353|NCT03316898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307354|NCT03316898|Nootropic Agents|nootropic agents|mesh-ancestor
93307355|NCT03316898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93307356|NCT03316898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93307357|NCT03316898|Dopamine Agents|dopamine agents|mesh-ancestor
93307358|NCT03316898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93307359|NCT03316898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93307360|NCT02188953|Calcium, Dietary|calcium, dietary|mesh-list
93307361|NCT02188953|Calcium Carbonate|calcium carbonate|mesh-list
93307362|NCT02188953|Calcium|calcium|mesh-list
93307363|NCT02188953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93307364|NCT02188953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307365|NCT02188953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93307366|NCT02188953|Antacids|antacids|mesh-ancestor
93307367|NCT02188953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307368|NCT02188953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307369|NCT02184819|Riboflavin|riboflavin|mesh-list
93307370|NCT02184819|Simendan|simendan|mesh-list
93307371|NCT02184819|Vitamin B Complex|vitamin b complex|mesh-ancestor
93307372|NCT02184819|Vitamins|vitamins|mesh-ancestor
93307373|NCT02184819|Micronutrients|micronutrients|mesh-ancestor
93307374|NCT02184819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307375|NCT02184819|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93307376|NCT02184819|Dermatologic Agents|dermatologic agents|mesh-ancestor
93307377|NCT02184819|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93307378|NCT02184819|Vasodilator Agents|vasodilator agents|mesh-ancestor
93307379|NCT02184819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93307380|NCT02184819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93307381|NCT02184819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307382|NCT02184819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307383|NCT02184819|Protective Agents|protective agents|mesh-ancestor
93307384|NCT02256813|Vitamin K|vitamin k|mesh-list
93307385|NCT02256813|Vitamin K 1|vitamin k 1|mesh-list
93307386|NCT02256813|Midazolam|midazolam|mesh-list
93307387|NCT02256813|Dextromethorphan|dextromethorphan|mesh-list
93307388|NCT02256813|Caffeine|caffeine|mesh-list
93307389|NCT02256813|Omeprazole|omeprazole|mesh-list
93307390|NCT02256813|Warfarin|warfarin|mesh-list
93307391|NCT02256813|Vitamins|vitamins|mesh-ancestor
93307392|NCT02256813|Micronutrients|micronutrients|mesh-ancestor
93307393|NCT02256813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307394|NCT02256813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93307395|NCT02256813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93307396|NCT02256813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307397|NCT02256813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93307398|NCT02256813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93307399|NCT02256813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93307400|NCT02256813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93307401|NCT02256813|Anesthetics, General|anesthetics, general|mesh-ancestor
93307402|NCT02256813|Anesthetics|anesthetics|mesh-ancestor
93307403|NCT02256813|GABA Modulators|gaba modulators|mesh-ancestor
93307404|NCT02256813|GABA Agents|gaba agents|mesh-ancestor
93307405|NCT02256813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307406|NCT02256813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307407|NCT02256813|Anticoagulants|anticoagulants|mesh-ancestor
93307408|NCT02256813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93307409|NCT02256813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93307410|NCT02256813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307411|NCT02256813|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93307412|NCT02256813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93307413|NCT02256813|Purinergic Agents|purinergic agents|mesh-ancestor
93307414|NCT02256813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93307415|NCT02256813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307416|NCT02256813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93307417|NCT02256813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93307418|NCT02256813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93307419|NCT02256813|Hemostatics|hemostatics|mesh-ancestor
93307420|NCT02256813|Coagulants|coagulants|mesh-ancestor
92601932|NCT00460759|Moxifloxacin|moxifloxacin|mesh-list
93307421|NCT02256813|Antitussive Agents|antitussive agents|mesh-ancestor
93307422|NCT02256813|Respiratory System Agents|respiratory system agents|mesh-ancestor
93307423|NCT02256813|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93307424|NCT02256813|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93307425|NCT02479958|Chlorhexidine|chlorhexidine|mesh-list
93307426|NCT02479958|Anti-Infective Agents|anti-infective agents|mesh-list
93307427|NCT02479958|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93307428|NCT02479958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93307429|NCT02479958|Disinfectants|disinfectants|mesh-ancestor
93307430|NCT02483624|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
93307431|NCT02483624|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93307432|NCT02483624|Protective Agents|protective agents|mesh-ancestor
93307433|NCT02483624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307434|NCT02483624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307435|NCT02184897|Lenograstim|lenograstim|mesh-list
93307436|NCT02184897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93307437|NCT02184897|Immunologic Factors|immunologic factors|mesh-ancestor
93307438|NCT02184897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307439|NCT02184975|Hemostatics|hemostatics|mesh-list
93307440|NCT02184975|Coagulants|coagulants|mesh-ancestor
93307441|NCT02189343|Thalidomide|thalidomide|mesh-list
93307442|NCT02189343|Dexamethasone|dexamethasone|mesh-list
93307443|NCT02189343|Dexamethasone acetate|dexamethasone acetate|mesh-list
93307444|NCT02189343|Pomalidomide|pomalidomide|mesh-list
93307445|NCT02189343|Ricolinostat|ricolinostat|mesh-list
93307446|NCT02189343|BB 1101|bb 1101|mesh-list
93307447|NCT02189343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307448|NCT02189343|Antiemetics|antiemetics|mesh-ancestor
93307449|NCT02189343|Autonomic Agents|autonomic agents|mesh-ancestor
93307450|NCT02189343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307451|NCT02189343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307452|NCT02189343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307453|NCT02189343|Glucocorticoids|glucocorticoids|mesh-ancestor
93307454|NCT02189343|Hormones|hormones|mesh-ancestor
93307455|NCT02189343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307456|NCT02189343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93307457|NCT02189343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307458|NCT02189343|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307459|NCT02189343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307460|NCT02189343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307461|NCT02189343|Immunologic Factors|immunologic factors|mesh-ancestor
93307462|NCT02189343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93307463|NCT02189343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93307464|NCT02189343|Growth Substances|growth substances|mesh-ancestor
93307465|NCT02189343|Growth Inhibitors|growth inhibitors|mesh-ancestor
93307466|NCT02189343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93307467|NCT02189343|Leprostatic Agents|leprostatic agents|mesh-ancestor
93307468|NCT02189343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93307469|NCT02189343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307470|NCT02189343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93307471|NCT03535701|Paclitaxel|paclitaxel|mesh-list
93307472|NCT03535701|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93307473|NCT03535701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93307474|NCT03535701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307475|NCT03535701|Tubulin Modulators|tubulin modulators|mesh-ancestor
93307476|NCT03535701|Antimitotic Agents|antimitotic agents|mesh-ancestor
93307477|NCT03535701|Mitosis Modulators|mitosis modulators|mesh-ancestor
93307478|NCT03535701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307479|NCT02486276|Cilostazol|cilostazol|mesh-list
93307480|NCT02486276|Sumatriptan|sumatriptan|mesh-list
93307481|NCT02486276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93307482|NCT02486276|Autonomic Agents|autonomic agents|mesh-ancestor
93307483|NCT02486276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307484|NCT02486276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307485|NCT02486276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93307486|NCT02486276|Respiratory System Agents|respiratory system agents|mesh-ancestor
93307487|NCT02486276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93307488|NCT02486276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93307489|NCT02486276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307490|NCT02486276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93307491|NCT02486276|Vasodilator Agents|vasodilator agents|mesh-ancestor
93307492|NCT02486276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93307493|NCT02486276|Protective Agents|protective agents|mesh-ancestor
92602003|NCT03273634|Dexlansoprazole|dexlansoprazole|mesh-list
93307494|NCT02486276|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93307495|NCT02486276|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93307496|NCT02486276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307497|NCT02486276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93307498|NCT02486276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93307499|NCT02486276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93307500|NCT02486276|Serotonin Agents|serotonin agents|mesh-ancestor
93307501|NCT02486276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307502|NCT02189577|Glycopyrrolate|glycopyrrolate|mesh-list
93307503|NCT02189577|Bromides|bromides|mesh-list
93307504|NCT02189577|Anticonvulsants|anticonvulsants|mesh-ancestor
93307505|NCT02189577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93307506|NCT02189577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93307507|NCT02189577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93307508|NCT02189577|Cholinergic Agents|cholinergic agents|mesh-ancestor
93307509|NCT02189577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307510|NCT02189577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307511|NCT02189577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307512|NCT02189655|Bupivacaine|bupivacaine|mesh-list
93307513|NCT02189655|Anesthetics, Local|anesthetics, local|mesh-ancestor
93307514|NCT02189655|Anesthetics|anesthetics|mesh-ancestor
93307515|NCT02189655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307516|NCT02189655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307517|NCT02189655|Sensory System Agents|sensory system agents|mesh-ancestor
93307518|NCT02189655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307519|NCT04633863|Lubricant Eye Drops|lubricant eye drops|mesh-list
93307520|NCT04633863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93307521|NCT04633863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93307522|NCT02193633|Paclitaxel|paclitaxel|mesh-list
93307523|NCT02193633|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93307524|NCT02193633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93307525|NCT02193633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307526|NCT02193633|Tubulin Modulators|tubulin modulators|mesh-ancestor
93307527|NCT02193633|Antimitotic Agents|antimitotic agents|mesh-ancestor
93307528|NCT02193633|Mitosis Modulators|mitosis modulators|mesh-ancestor
93307529|NCT02193633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307530|NCT03315338|Prednisone|prednisone|mesh-list
93307531|NCT03315338|Cortisone|cortisone|mesh-list
93307532|NCT03315338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307533|NCT03315338|Glucocorticoids|glucocorticoids|mesh-ancestor
93307534|NCT03315338|Hormones|hormones|mesh-ancestor
93307535|NCT03315338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307536|NCT03315338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307537|NCT03315338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93307538|NCT03315338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307539|NCT05713838|Durvalumab|durvalumab|mesh-list
93307540|NCT05713838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93307541|NCT05713838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307542|NCT02483156|Ribavirin|ribavirin|mesh-list
93307543|NCT02483156|Sofosbuvir|sofosbuvir|mesh-list
93307544|NCT02483156|Antimetabolites|antimetabolites|mesh-ancestor
93307545|NCT02483156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307546|NCT02483156|Antiviral Agents|antiviral agents|mesh-ancestor
93307547|NCT02483156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307548|NCT00706004|Lubiprostone|lubiprostone|mesh-list
93307549|NCT00706004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93307550|NCT00706004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307551|NCT00706004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307552|NCT02485340|Isosorbide|isosorbide|mesh-list
93307553|NCT02485340|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93307554|NCT02485340|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93307555|NCT02485340|Sumatriptan|sumatriptan|mesh-list
93307556|NCT02485340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93307557|NCT02485340|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93307558|NCT02485340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93307559|NCT02485340|Serotonin Agents|serotonin agents|mesh-ancestor
93307560|NCT02485340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307561|NCT02485340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307562|NCT02485340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307563|NCT02485340|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93307564|NCT02485340|Diuretics|diuretics|mesh-ancestor
93307565|NCT02485340|Natriuretic Agents|natriuretic agents|mesh-ancestor
93307566|NCT02485340|Vasodilator Agents|vasodilator agents|mesh-ancestor
93307567|NCT02485340|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93307568|NCT04492514|Mavrilimumab|mavrilimumab|mesh-list
93307569|NCT04492514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307570|NCT02485262|Sofosbuvir|sofosbuvir|mesh-list
93307571|NCT02485262|Simeprevir|simeprevir|mesh-list
93307572|NCT02485262|Antiviral Agents|antiviral agents|mesh-ancestor
93307573|NCT02485262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307574|NCT02485262|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307575|NCT02485262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307576|NCT02485262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307577|NCT02479490|Prednisone|prednisone|mesh-list
93307578|NCT02479490|Everolimus|everolimus|mesh-list
93307579|NCT02479490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307580|NCT02479490|Glucocorticoids|glucocorticoids|mesh-ancestor
93307581|NCT02479490|Hormones|hormones|mesh-ancestor
93307582|NCT02479490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307583|NCT02479490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307584|NCT02479490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93307585|NCT02479490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307586|NCT02479490|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93307587|NCT02479490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93307588|NCT02479490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307589|NCT02479490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307590|NCT02479490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93307591|NCT02479490|Immunologic Factors|immunologic factors|mesh-ancestor
93307592|NCT02479256|Tamoxifen|tamoxifen|mesh-list
93307593|NCT02479256|Citric Acid|citric acid|mesh-list
93307594|NCT02479256|Sodium Citrate|sodium citrate|mesh-list
93307595|NCT02479256|Clomiphene|clomiphene|mesh-list
93307596|NCT02479256|Enclomiphene|enclomiphene|mesh-list
93307597|NCT02479256|Zuclomiphene|zuclomiphene|mesh-list
93307598|NCT02479256|Anticoagulants|anticoagulants|mesh-ancestor
93307599|NCT02479256|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93307600|NCT02479256|Chelating Agents|chelating agents|mesh-ancestor
93307601|NCT02479256|Sequestering Agents|sequestering agents|mesh-ancestor
93307602|NCT02479256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307603|NCT02479256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93307604|NCT02479256|Hormone Antagonists|hormone antagonists|mesh-ancestor
92979614|NCT00893724|Vitamin E|vitamin e|mesh-list
93307605|NCT02479256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307606|NCT02479256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307607|NCT02479256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93307608|NCT02479256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307609|NCT02479256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93307610|NCT02479256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93307611|NCT02479256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93307612|NCT02479256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93307613|NCT02479256|Fertility Agents|fertility agents|mesh-ancestor
93307614|NCT02479256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93307615|NCT02482766|Poractant alfa|poractant alfa|mesh-list
93307616|NCT02482766|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93307617|NCT02482766|Respiratory System Agents|respiratory system agents|mesh-ancestor
93307618|NCT04492280|Hydrocortisone|hydrocortisone|mesh-list
93307619|NCT04492280|Fludrocortisone|fludrocortisone|mesh-list
93307620|NCT04492280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307621|NCT02479178|Docetaxel|docetaxel|mesh-list
93307622|NCT02479178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307623|NCT02479178|Tubulin Modulators|tubulin modulators|mesh-ancestor
93307624|NCT02479178|Antimitotic Agents|antimitotic agents|mesh-ancestor
93307625|NCT02479178|Mitosis Modulators|mitosis modulators|mesh-ancestor
93307626|NCT02479178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307627|NCT03314792|Oxycodone|oxycodone|mesh-list
93307628|NCT03314792|Tapentadol|tapentadol|mesh-list
93307629|NCT03314792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93307630|NCT03314792|Narcotics|narcotics|mesh-ancestor
93307631|NCT03314792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307632|NCT03314792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307633|NCT03314792|Analgesics|analgesics|mesh-ancestor
93307634|NCT03314792|Sensory System Agents|sensory system agents|mesh-ancestor
93307635|NCT03314792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307636|NCT03314792|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93307637|NCT03314792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93307638|NCT03314792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307639|NCT03314792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307640|NCT03314792|Adrenergic Agents|adrenergic agents|mesh-ancestor
93307641|NCT03314792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307642|NCT02476526|Acetylcysteine|acetylcysteine|mesh-list
93307643|NCT02476526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93307644|NCT02476526|Antiviral Agents|antiviral agents|mesh-ancestor
93307645|NCT02476526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307646|NCT02476526|Expectorants|expectorants|mesh-ancestor
93307647|NCT02476526|Respiratory System Agents|respiratory system agents|mesh-ancestor
93307648|NCT02476526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93307649|NCT02476526|Antioxidants|antioxidants|mesh-ancestor
93307650|NCT02476526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307651|NCT02476526|Protective Agents|protective agents|mesh-ancestor
93307652|NCT02476526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307653|NCT02476526|Antidotes|antidotes|mesh-ancestor
93307654|NCT02479022|Insulin|insulin|mesh-list
93307655|NCT02479022|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93307656|NCT02479022|Insulin Glargine|insulin glargine|mesh-list
93307657|NCT02479022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307658|NCT02479022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307659|NCT02476760|Insulin|insulin|mesh-list
93307660|NCT02476760|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93307661|NCT02476760|Metformin|metformin|mesh-list
93307662|NCT02476760|Pioglitazone|pioglitazone|mesh-list
93307663|NCT02476760|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93307664|NCT02476760|Liraglutide|liraglutide|mesh-list
93307665|NCT02476760|Exenatide|exenatide|mesh-list
93307666|NCT02476760|Glimepiride|glimepiride|mesh-list
93307667|NCT02476760|Rosiglitazone|rosiglitazone|mesh-list
93307668|NCT02476760|Vildagliptin|vildagliptin|mesh-list
93307669|NCT02476760|Saxagliptin|saxagliptin|mesh-list
93307670|NCT02476760|Acarbose|acarbose|mesh-list
93307671|NCT02476760|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93307672|NCT02476760|Repaglinide|repaglinide|mesh-list
93307673|NCT02476760|Gliclazide|gliclazide|mesh-list
93307674|NCT02476760|Glipizide|glipizide|mesh-list
93307675|NCT02476760|Biguanides|biguanides|mesh-list
93307676|NCT02476760|Tolbutamide|tolbutamide|mesh-list
93307677|NCT02476760|Voglibose|voglibose|mesh-list
93307678|NCT02476760|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93307679|NCT02476760|Nateglinide|nateglinide|mesh-list
93307680|NCT02476760|Miglitol|miglitol|mesh-list
93307681|NCT02476760|Meglitinide|meglitinide|mesh-list
93307682|NCT02476760|Troglitazone|troglitazone|mesh-list
93307683|NCT02476760|Acetohexamide|acetohexamide|mesh-list
93307684|NCT02476760|Phenformin|phenformin|mesh-list
93307685|NCT02476760|Chlorpropamide|chlorpropamide|mesh-list
93307686|NCT02476760|Buformin|buformin|mesh-list
93307687|NCT02476760|Glibornuride|glibornuride|mesh-list
93307688|NCT02476760|Tolazamide|tolazamide|mesh-list
93307689|NCT02476760|Carbutamide|carbutamide|mesh-list
93307690|NCT02476760|Gliquidone|gliquidone|mesh-list
93307691|NCT02476760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93307692|NCT02476760|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
93307693|NCT02476760|Incretins|incretins|mesh-list
93307694|NCT02476760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307695|NCT02476760|Hormones|hormones|mesh-ancestor
93307696|NCT02476760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307697|NCT02476760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307698|NCT02476760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307699|NCT02476760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307700|NCT02476760|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93307701|NCT02476760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93307702|NCT02476760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93307703|NCT02476760|Immunologic Factors|immunologic factors|mesh-ancestor
93307704|NCT05460338|Cholecalciferol|cholecalciferol|mesh-list
93307705|NCT05460338|Vitamin D|vitamin d|mesh-list
93307706|NCT05460338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93307707|NCT05460338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307708|NCT05460338|Vitamins|vitamins|mesh-ancestor
93307709|NCT05460338|Micronutrients|micronutrients|mesh-ancestor
93307710|NCT05460338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93307711|NCT02476136|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93307712|NCT02476136|Fluoxetine|fluoxetine|mesh-list
93307713|NCT02476136|Paroxetine|paroxetine|mesh-list
93307714|NCT02476136|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93307715|NCT02476136|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93307716|NCT02476136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93307717|NCT02476136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307718|NCT02476136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307719|NCT02476136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307720|NCT02476136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307721|NCT02476136|Analgesics|analgesics|mesh-ancestor
93307722|NCT02476136|Sensory System Agents|sensory system agents|mesh-ancestor
93307723|NCT02476136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307724|NCT02476136|Antidepressive Agents|antidepressive agents|mesh-ancestor
93307725|NCT02476136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93307726|NCT02476136|Dopamine Agents|dopamine agents|mesh-ancestor
93307727|NCT02476136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93307728|NCT02476136|Serotonin Agents|serotonin agents|mesh-ancestor
93307729|NCT02476136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93307730|NCT02476136|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93307731|NCT02476136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93307732|NCT02476136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307733|NCT05437094|Itraconazole|itraconazole|mesh-list
93307734|NCT05437094|Antifungal Agents|antifungal agents|mesh-ancestor
93307735|NCT05437094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307736|NCT05437094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93307737|NCT05437094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93307738|NCT05437094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307739|NCT05437094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307740|NCT05437094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93307741|NCT05437094|Hormone Antagonists|hormone antagonists|mesh-ancestor
93307742|NCT05437094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307743|NCT05437094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307744|NCT05437094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93307745|NCT05413772|Temocillin|temocillin|mesh-list
93307746|NCT05413772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93307747|NCT05413772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307748|NCT05713292|Pirfenidone|pirfenidone|mesh-list
93307749|NCT05713292|Analgesics|analgesics|mesh-ancestor
93307750|NCT05713292|Sensory System Agents|sensory system agents|mesh-ancestor
93307751|NCT05713292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307752|NCT05713292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307753|NCT05713292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93307754|NCT05713292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93307755|NCT05713292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307756|NCT05713292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307757|NCT05713292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307758|NCT02475824|Midazolam|midazolam|mesh-list
93307759|NCT02475824|Meperidine|meperidine|mesh-list
93307760|NCT02475824|Dexmedetomidine|dexmedetomidine|mesh-list
93307762|NCT02475824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93307763|NCT02475824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307764|NCT02475824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307765|NCT02475824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93307766|NCT02475824|Analgesics|analgesics|mesh-ancestor
93307767|NCT02475824|Sensory System Agents|sensory system agents|mesh-ancestor
93307768|NCT02475824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307769|NCT02475824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93307770|NCT02475824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93307771|NCT02475824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93307772|NCT02475824|Adrenergic Agents|adrenergic agents|mesh-ancestor
93307773|NCT02475824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307774|NCT02475824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307775|NCT02475824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93307776|NCT02475824|Anesthetics, General|anesthetics, general|mesh-ancestor
93307777|NCT02475824|Anesthetics|anesthetics|mesh-ancestor
93307778|NCT02475824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93307779|NCT02475824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93307780|NCT02475824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93307781|NCT02475824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93307782|NCT02475824|GABA Modulators|gaba modulators|mesh-ancestor
93307783|NCT02475824|GABA Agents|gaba agents|mesh-ancestor
93307784|NCT02475824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93307785|NCT02475824|Narcotics|narcotics|mesh-ancestor
93307786|NCT02478242|Nafamostat|nafamostat|mesh-list
93307787|NCT02478242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93307788|NCT02478242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93307789|NCT02478242|Analgesics|analgesics|mesh-ancestor
93307790|NCT02478242|Sensory System Agents|sensory system agents|mesh-ancestor
93307791|NCT02478242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307792|NCT02478242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307793|NCT02478242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307794|NCT02478242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307795|NCT02478242|Anticoagulants|anticoagulants|mesh-ancestor
93307796|NCT02478242|Protease Inhibitors|protease inhibitors|mesh-ancestor
93307797|NCT02478242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307798|NCT02478242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307799|NCT02478242|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93307800|NCT02478242|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93307801|NCT02478242|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93307802|NCT02478242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93307803|NCT02478242|Immunologic Factors|immunologic factors|mesh-ancestor
93307804|NCT02475746|Itraconazole|itraconazole|mesh-list
93307805|NCT02475746|PF-06372865|pf-06372865|mesh-list
93307806|NCT02475746|Antifungal Agents|antifungal agents|mesh-ancestor
93307807|NCT02475746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307808|NCT02475746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93307809|NCT02475746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93307810|NCT02475746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307811|NCT02475746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307812|NCT02475746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93307813|NCT02475746|Hormone Antagonists|hormone antagonists|mesh-ancestor
93307814|NCT02475746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307815|NCT02475746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307816|NCT02475746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93307817|NCT02475746|GABA Modulators|gaba modulators|mesh-ancestor
93307818|NCT02475746|GABA Agents|gaba agents|mesh-ancestor
93307819|NCT02475746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307820|NCT05715164|Nicotine|nicotine|mesh-list
93307821|NCT05715164|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93307822|NCT05715164|Autonomic Agents|autonomic agents|mesh-ancestor
93307823|NCT05715164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307824|NCT05715164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307825|NCT05715164|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93307826|NCT05715164|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93307827|NCT05715164|Cholinergic Agents|cholinergic agents|mesh-ancestor
93307828|NCT05715164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307829|NCT05715164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307830|NCT02475356|Levonorgestrel|levonorgestrel|mesh-list
93307831|NCT02475356|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93307832|NCT02475356|Contraceptive Agents|contraceptive agents|mesh-ancestor
93307833|NCT02475356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93307834|NCT02475356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307835|NCT02475356|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93307836|NCT02475356|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93307837|NCT02475356|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93307838|NCT02480894|Maraviroc|maraviroc|mesh-list
93307839|NCT02480894|Fostemsavir|fostemsavir|mesh-list
93307840|NCT02480894|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93307841|NCT02480894|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93307842|NCT02480894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307843|NCT02480894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93307844|NCT02480894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93307845|NCT02480894|Antiviral Agents|antiviral agents|mesh-ancestor
93307846|NCT02480894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307847|NCT02480894|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93307848|NCT02474654|Ketorolac|ketorolac|mesh-list
93307849|NCT02474654|Epinephrine|epinephrine|mesh-list
93307850|NCT02474654|Racepinephrine|racepinephrine|mesh-list
93307851|NCT02474654|Fentanyl|fentanyl|mesh-list
93307852|NCT02474654|Bupivacaine|bupivacaine|mesh-list
93307853|NCT02474654|Epinephryl borate|epinephryl borate|mesh-list
93307854|NCT02474654|Anesthetics, Local|anesthetics, local|mesh-ancestor
93307855|NCT02474654|Anesthetics|anesthetics|mesh-ancestor
93307856|NCT02474654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93307857|NCT02474654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307858|NCT02474654|Sensory System Agents|sensory system agents|mesh-ancestor
93307859|NCT02474654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307860|NCT02474654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93307861|NCT02474654|Narcotics|narcotics|mesh-ancestor
93307862|NCT02474654|Analgesics|analgesics|mesh-ancestor
93307863|NCT02474654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93307864|NCT02474654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93307865|NCT02474654|Anesthetics, General|anesthetics, general|mesh-ancestor
93307866|NCT02474654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93307867|NCT02474654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93307868|NCT02474654|Adrenergic Agents|adrenergic agents|mesh-ancestor
93307869|NCT02474654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93307870|NCT02474654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307871|NCT02474654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93307872|NCT02474654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93307873|NCT02474654|Autonomic Agents|autonomic agents|mesh-ancestor
93307874|NCT02474654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93307875|NCT02474654|Respiratory System Agents|respiratory system agents|mesh-ancestor
93307876|NCT02474654|Mydriatics|mydriatics|mesh-ancestor
93307877|NCT02474654|Sympathomimetics|sympathomimetics|mesh-ancestor
93307878|NCT02474654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93307879|NCT02474654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93307880|NCT02474654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93307881|NCT02474654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307882|NCT02474654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93307883|NCT02474654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93307884|NCT02474654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307885|NCT02477852|Rifampin|rifampin|mesh-list
93307886|NCT02477852|Isoniazid|isoniazid|mesh-list
93307887|NCT02477852|Pyrazinamide|pyrazinamide|mesh-list
93307888|NCT02477852|Ethambutol|ethambutol|mesh-list
93307889|NCT02477852|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93307890|NCT02477852|Antitubercular Agents|antitubercular agents|mesh-ancestor
93307891|NCT02477852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93307892|NCT02477852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307893|NCT02477852|Leprostatic Agents|leprostatic agents|mesh-ancestor
93307894|NCT02477852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93307895|NCT02477852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307896|NCT02477852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307897|NCT02477852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93307898|NCT02477852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93307899|NCT02477852|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93307900|NCT02477852|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93307901|NCT02477852|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93307902|NCT02477852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93307903|NCT02477852|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93307904|NCT02477852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93307905|NCT02477852|Antimetabolites|antimetabolites|mesh-ancestor
93307906|NCT02477852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93307907|NCT02474810|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93307908|NCT02474810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93307909|NCT02474810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93307910|NCT02474810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307912|NCT02725268|Serabelisib|serabelisib|mesh-list
93307913|NCT02725268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93307914|NCT02725268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307915|NCT02725268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93307916|NCT02725268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93307917|NCT02725268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93307918|NCT02725268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307919|NCT02725268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307920|NCT05038592|Decitabine|decitabine|mesh-list
93307921|NCT05038592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93307922|NCT05038592|Antimetabolites|antimetabolites|mesh-ancestor
93307923|NCT05038592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307924|NCT05038592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307925|NCT05038592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307926|NCT00705536|Insulin|insulin|mesh-list
93307927|NCT00705536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93307928|NCT00705536|Insulin Lispro|insulin lispro|mesh-list
93307929|NCT00705536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93307930|NCT00705536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307931|NCT02474420|Amlodipine|amlodipine|mesh-list
93307932|NCT02474420|Deferasirox|deferasirox|mesh-list
93307933|NCT02474420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93307934|NCT02474420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93307935|NCT02474420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93307936|NCT02474420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307937|NCT02474420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93307938|NCT02474420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307939|NCT02474420|Vasodilator Agents|vasodilator agents|mesh-ancestor
93307940|NCT02474420|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93307941|NCT02474420|Chelating Agents|chelating agents|mesh-ancestor
93307942|NCT02474420|Sequestering Agents|sequestering agents|mesh-ancestor
93307943|NCT02474186|Paclitaxel|paclitaxel|mesh-list
93307944|NCT02474186|Docetaxel|docetaxel|mesh-list
93307945|NCT02474186|Capecitabine|capecitabine|mesh-list
93307946|NCT02474186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93307947|NCT02474186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307948|NCT02474186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93307949|NCT02474186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93307950|NCT02474186|Mitosis Modulators|mitosis modulators|mesh-ancestor
93307951|NCT02474186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307952|NCT02474186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93307953|NCT02474186|Antimetabolites|antimetabolites|mesh-ancestor
93307954|NCT02477306|Rabeprazole|rabeprazole|mesh-list
93307955|NCT02477306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93307956|NCT02477306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307957|NCT02477306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93307958|NCT02477306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307959|NCT02477306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307960|NCT04868786|Mycophenolic Acid|mycophenolic acid|mesh-list
93307961|NCT04868786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93307962|NCT04868786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307963|NCT04868786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93307964|NCT04868786|Antitubercular Agents|antitubercular agents|mesh-ancestor
93307965|NCT04868786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93307966|NCT04868786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307967|NCT04868786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307968|NCT04868786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307969|NCT04862468|Dexamethasone|dexamethasone|mesh-list
93307970|NCT04862468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93307971|NCT04862468|Antiemetics|antiemetics|mesh-ancestor
93307972|NCT04862468|Autonomic Agents|autonomic agents|mesh-ancestor
93307973|NCT04862468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93307974|NCT04862468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307975|NCT04862468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93307976|NCT04862468|Glucocorticoids|glucocorticoids|mesh-ancestor
93307977|NCT04862468|Hormones|hormones|mesh-ancestor
93307978|NCT04862468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93307979|NCT04862468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93307980|NCT04862468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307981|NCT02472626|Thioctic Acid|thioctic acid|mesh-list
93307982|NCT02472626|Cytarabine|cytarabine|mesh-list
93307983|NCT02472626|Daunorubicin|daunorubicin|mesh-list
93307984|NCT02472626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93307985|NCT02472626|Antimetabolites|antimetabolites|mesh-ancestor
92979977|NCT04086719|Pyrimethamine|pyrimethamine|mesh-list
93307986|NCT02472626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93307987|NCT02472626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93307988|NCT02472626|Antiviral Agents|antiviral agents|mesh-ancestor
93307989|NCT02472626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93307990|NCT02472626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93307991|NCT02472626|Immunologic Factors|immunologic factors|mesh-ancestor
93307992|NCT02472626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93307993|NCT02472626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93307994|NCT02472626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93307995|NCT02472626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93307996|NCT02472626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93307997|NCT02472626|Antioxidants|antioxidants|mesh-ancestor
93307998|NCT02472626|Protective Agents|protective agents|mesh-ancestor
93307999|NCT02472626|Vitamin B Complex|vitamin b complex|mesh-ancestor
93308000|NCT02472626|Vitamins|vitamins|mesh-ancestor
93308001|NCT02472626|Micronutrients|micronutrients|mesh-ancestor
93308002|NCT02472392|Cyclophosphamide|cyclophosphamide|mesh-list
93308003|NCT02472392|Melphalan|melphalan|mesh-list
93308004|NCT02472392|Busulfan|busulfan|mesh-list
93308005|NCT02472392|Fludarabine|fludarabine|mesh-list
93308006|NCT02472392|Thymoglobulin|thymoglobulin|mesh-list
93308007|NCT02472392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93308008|NCT02472392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308009|NCT02472392|Immunologic Factors|immunologic factors|mesh-ancestor
93308010|NCT02472392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308011|NCT02472392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308012|NCT02472392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93308013|NCT02472392|Alkylating Agents|alkylating agents|mesh-ancestor
93308014|NCT02472392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308015|NCT02472392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308016|NCT02472392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93308017|NCT02472158|Chlorhexidine|chlorhexidine|mesh-list
93308018|NCT02472158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93308019|NCT02472158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308020|NCT02472158|Disinfectants|disinfectants|mesh-ancestor
93308021|NCT02472080|Gemcitabine|gemcitabine|mesh-list
93308022|NCT02472080|Oxaliplatin|oxaliplatin|mesh-list
93308023|NCT02472080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93308024|NCT02472080|Antimetabolites|antimetabolites|mesh-ancestor
93308025|NCT02472080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308026|NCT02472080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308027|NCT02473562|Varenicline|varenicline|mesh-list
93308028|NCT02473562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93308029|NCT02473562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93308030|NCT02473562|Cholinergic Agents|cholinergic agents|mesh-ancestor
93308031|NCT02473562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308032|NCT02473562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308033|NCT02473562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308034|NCT02724020|Everolimus|everolimus|mesh-list
93308035|NCT02724020|Serabelisib|serabelisib|mesh-list
93308036|NCT02724020|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93308037|NCT02724020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93308038|NCT02724020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308039|NCT02724020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308040|NCT02724020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308041|NCT02724020|Immunologic Factors|immunologic factors|mesh-ancestor
93308042|NCT02724020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308043|NCT02724020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308044|NCT02660034|Tislelizumab|tislelizumab|mesh-list
93308045|NCT02660034|Pamiparib|pamiparib|mesh-list
93308046|NCT02660034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308047|NCT02660034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308048|NCT02660034|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93308049|NCT02660034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308050|NCT02660034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308051|NCT02816736|Valsartan|valsartan|mesh-list
93308052|NCT02816736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93308053|NCT02816736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93308054|NCT02816736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93308055|NCT02816736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93308056|NCT02816736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308057|NCT02477072|Heparin|heparin|mesh-list
93308058|NCT02477072|Calcium heparin|calcium heparin|mesh-list
93308059|NCT02477072|Anticoagulants|anticoagulants|mesh-ancestor
93308060|NCT02477072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93308061|NCT02477072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93308062|NCT02477072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308063|NCT05103410|Aripiprazole|aripiprazole|mesh-list
93308064|NCT05103410|Antidepressive Agents|antidepressive agents|mesh-ancestor
93308065|NCT05103410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93308066|NCT05103410|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93308067|NCT05103410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93308068|NCT05103410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308069|NCT05103410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308070|NCT05103410|Dopamine Agonists|dopamine agonists|mesh-ancestor
93308071|NCT05103410|Dopamine Agents|dopamine agents|mesh-ancestor
93308072|NCT05103410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602573|NCT00473980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308073|NCT05103410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308074|NCT05103410|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93308075|NCT05103410|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93308076|NCT05103410|Serotonin Agents|serotonin agents|mesh-ancestor
93308077|NCT05103410|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93308078|NCT05103410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93308079|NCT05103410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93308080|NCT05103410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93308081|NCT02472236|Digoxin|digoxin|mesh-list
93308082|NCT02472236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308083|NCT02472236|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93308084|NCT02472236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308085|NCT02472236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308086|NCT02472236|Protective Agents|protective agents|mesh-ancestor
93308087|NCT02472236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308088|NCT03108872|Anticoagulants|anticoagulants|mesh-list
93308089|NCT02194491|AS2471907|as2471907|mesh-list
93308090|NCT02194491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93308091|NCT02194491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308092|NCT03487770|Aripiprazole|aripiprazole|mesh-list
93308093|NCT03487770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93308094|NCT03487770|Antidepressive Agents|antidepressive agents|mesh-ancestor
93308095|NCT03487770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93308096|NCT03487770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93308097|NCT03487770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93308098|NCT03487770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308099|NCT03487770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308100|NCT03487770|Dopamine Agonists|dopamine agonists|mesh-ancestor
93308101|NCT03487770|Dopamine Agents|dopamine agents|mesh-ancestor
93308102|NCT03487770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308103|NCT03487770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308104|NCT03487770|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93308105|NCT03487770|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93308106|NCT03487770|Serotonin Agents|serotonin agents|mesh-ancestor
93308107|NCT03487770|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93308108|NCT03487770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93308109|NCT03487770|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93308110|NCT03487770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93308111|NCT02473328|Ritonavir|ritonavir|mesh-list
93308112|NCT02473328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93308113|NCT02473328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93308114|NCT02473328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93308115|NCT02473328|Protease Inhibitors|protease inhibitors|mesh-ancestor
93308116|NCT02473328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308117|NCT02473328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308118|NCT02473328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308119|NCT02473328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308120|NCT02473328|Antiviral Agents|antiviral agents|mesh-ancestor
93308121|NCT02473328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308122|NCT02473328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93308123|NCT02473328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93308124|NCT02473406|Thymalfasin|thymalfasin|mesh-list
93308125|NCT02473406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93308126|NCT02473406|Immunologic Factors|immunologic factors|mesh-ancestor
93308127|NCT02473406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308128|NCT02473094|Metformin|metformin|mesh-list
93308129|NCT02473094|Capecitabine|capecitabine|mesh-list
93308130|NCT02473094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93308131|NCT02473094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308132|NCT02473094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93308133|NCT02473094|Antimetabolites|antimetabolites|mesh-ancestor
93308134|NCT02473094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980129|NCT00904176|Digoxin|digoxin|mesh-list
93308135|NCT02473094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308136|NCT03492138|Dexamethasone|dexamethasone|mesh-list
93308137|NCT03492138|Ixazomib|ixazomib|mesh-list
93308138|NCT03492138|TIC10 compound|tic10 compound|mesh-list
93308139|NCT03492138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308140|NCT03492138|Antiemetics|antiemetics|mesh-ancestor
93308141|NCT03492138|Autonomic Agents|autonomic agents|mesh-ancestor
93308142|NCT03492138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308143|NCT03492138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308144|NCT03492138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308145|NCT03492138|Glucocorticoids|glucocorticoids|mesh-ancestor
93308146|NCT03492138|Hormones|hormones|mesh-ancestor
93308147|NCT03492138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308148|NCT03492138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93308149|NCT03492138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308150|NCT03492138|Protease Inhibitors|protease inhibitors|mesh-ancestor
93308151|NCT03492138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308152|NCT03492138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308153|NCT02472938|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93308154|NCT02472938|Dermatologic Agents|dermatologic agents|mesh-ancestor
93308155|NCT02472938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308156|NCT02472938|Immunologic Factors|immunologic factors|mesh-ancestor
93308157|NCT02472938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308158|NCT03131700|Bevacizumab|bevacizumab|mesh-list
93308159|NCT03131700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308160|NCT03131700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308161|NCT03131700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308162|NCT03131700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308163|NCT03131700|Growth Substances|growth substances|mesh-ancestor
93308164|NCT03131700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308165|NCT03131700|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308166|NCT04706936|Cyclophosphamide|cyclophosphamide|mesh-list
93308167|NCT04706936|Fludarabine|fludarabine|mesh-list
93308168|NCT04706936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308169|NCT04706936|Immunologic Factors|immunologic factors|mesh-ancestor
93308170|NCT04706936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308171|NCT04706936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308172|NCT04706936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93308173|NCT04706936|Alkylating Agents|alkylating agents|mesh-ancestor
93308174|NCT04706936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308175|NCT04706936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308176|NCT04706936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93308177|NCT02194881|Ivacaftor|ivacaftor|mesh-list
93308178|NCT02194881|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93308179|NCT02194881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308180|NCT02194881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308181|NCT02194179|Nevirapine|nevirapine|mesh-list
93308182|NCT02194179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93308183|NCT02194179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93308184|NCT02194179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308185|NCT02194179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308186|NCT02194179|Antiviral Agents|antiviral agents|mesh-ancestor
93308187|NCT02194179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308188|NCT02194179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308189|NCT02194179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308190|NCT02194179|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93308191|NCT02194179|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93308192|NCT02194257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93308193|NCT02194257|Ambroxol|ambroxol|mesh-list
93308194|NCT02194257|Expectorants|expectorants|mesh-ancestor
93308195|NCT02194257|Respiratory System Agents|respiratory system agents|mesh-ancestor
93308196|NCT02195115|Amitriptyline|amitriptyline|mesh-list
93308197|NCT02195115|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93308198|NCT02195115|Antidepressive Agents|antidepressive agents|mesh-ancestor
93308199|NCT02195115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93308200|NCT02195115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308201|NCT02195115|Analgesics|analgesics|mesh-ancestor
93308202|NCT02195115|Sensory System Agents|sensory system agents|mesh-ancestor
93308203|NCT02195115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308204|NCT02195115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308205|NCT02195115|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93308206|NCT02195115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93308207|NCT02195115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308208|NCT02195115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308209|NCT02195115|Adrenergic Agents|adrenergic agents|mesh-ancestor
93308210|NCT02195115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308211|NCT02194335|Olcegepant|olcegepant|mesh-list
93308212|NCT02194335|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93308213|NCT02194335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308214|NCT02194335|Analgesics|analgesics|mesh-ancestor
93308215|NCT02194335|Sensory System Agents|sensory system agents|mesh-ancestor
93308216|NCT02194335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308217|NCT02194335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308218|NCT02195973|Paclitaxel|paclitaxel|mesh-list
93308219|NCT02195973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93308220|NCT02195973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308221|NCT02195973|Tubulin Modulators|tubulin modulators|mesh-ancestor
93308222|NCT02195973|Antimitotic Agents|antimitotic agents|mesh-ancestor
93308223|NCT02195973|Mitosis Modulators|mitosis modulators|mesh-ancestor
93308224|NCT02195973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308225|NCT02196207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93308226|NCT02196207|Immunologic Factors|immunologic factors|mesh-ancestor
93308227|NCT02196207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308228|NCT02195271|Melatonin|melatonin|mesh-list
93308229|NCT02195271|Antioxidants|antioxidants|mesh-ancestor
93308230|NCT02195271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308231|NCT02195271|Protective Agents|protective agents|mesh-ancestor
93308232|NCT02195271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308233|NCT02195271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308234|NCT02196285|Vaccines|vaccines|mesh-list
93308235|NCT02196285|Immunologic Factors|immunologic factors|mesh-ancestor
93308236|NCT02196285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308237|NCT04229979|Cytarabine|cytarabine|mesh-list
93308238|NCT04229979|Azacitidine|azacitidine|mesh-list
93308239|NCT04229979|Decitabine|decitabine|mesh-list
93308240|NCT04229979|Venetoclax|venetoclax|mesh-list
93308241|NCT04229979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93308242|NCT04229979|Antimetabolites|antimetabolites|mesh-ancestor
93308243|NCT04229979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308244|NCT04229979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308245|NCT04229979|Antiviral Agents|antiviral agents|mesh-ancestor
93308246|NCT04229979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308247|NCT04229979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308248|NCT04229979|Immunologic Factors|immunologic factors|mesh-ancestor
93308249|NCT04229979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308250|NCT04229979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308251|NCT02196441|Bupivacaine|bupivacaine|mesh-list
93308252|NCT02196441|Anesthetics, Local|anesthetics, local|mesh-list
93308253|NCT02196441|Tetracaine|tetracaine|mesh-list
93308254|NCT02196441|Anesthetics|anesthetics|mesh-list
93308255|NCT02196441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308256|NCT02196441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308257|NCT02196441|Sensory System Agents|sensory system agents|mesh-ancestor
93308258|NCT02196441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308259|NCT02195661|Melatonin|melatonin|mesh-list
93308260|NCT02195661|Chloral Hydrate|chloral hydrate|mesh-list
93308261|NCT02195661|Antioxidants|antioxidants|mesh-ancestor
93308262|NCT02195661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308263|NCT02195661|Protective Agents|protective agents|mesh-ancestor
93308264|NCT02195661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308265|NCT02195661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308266|NCT02195661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93308267|NCT03534297|Dapansutrile|dapansutrile|mesh-list
93308268|NCT03534297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308269|NCT02195817|Nalmefene|nalmefene|mesh-list
93308270|NCT02195817|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93308271|NCT02195817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308272|NCT02195817|Sensory System Agents|sensory system agents|mesh-ancestor
93308273|NCT02195817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308274|NCT03534063|Analgesics, Opioid|analgesics, opioid|mesh-list
93308275|NCT03534063|Narcotics|narcotics|mesh-ancestor
93308276|NCT03534063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308277|NCT03534063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308278|NCT03534063|Analgesics|analgesics|mesh-ancestor
93308279|NCT03534063|Sensory System Agents|sensory system agents|mesh-ancestor
93308280|NCT03534063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308281|NCT02197143|Esomeprazole|esomeprazole|mesh-list
93308282|NCT02197143|Ranitidine|ranitidine|mesh-list
92602791|NCT00475462|Adrenergic Agents|adrenergic agents|mesh-ancestor
93308283|NCT02197143|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93308284|NCT02197143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92980273|NCT00906360|Antibodies|antibodies|mesh-list
93308285|NCT02197143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308286|NCT02197143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93308287|NCT02197143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308288|NCT02197143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308289|NCT02197143|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93308290|NCT02197143|Histamine Antagonists|histamine antagonists|mesh-ancestor
93308291|NCT02197143|Histamine Agents|histamine agents|mesh-ancestor
93308292|NCT02197143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308293|NCT02197143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308294|NCT02096874|Bevacizumab|bevacizumab|mesh-list
93308295|NCT02096874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308296|NCT02096874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308297|NCT02096874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308298|NCT02096874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308299|NCT02096874|Growth Substances|growth substances|mesh-ancestor
93308300|NCT02096874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308301|NCT02096874|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308302|NCT02198547|Magnesium Sulfate|magnesium sulfate|mesh-list
93308303|NCT02198547|Ropivacaine|ropivacaine|mesh-list
93308304|NCT02198547|Anesthetics, Local|anesthetics, local|mesh-ancestor
93308305|NCT02198547|Anesthetics|anesthetics|mesh-ancestor
93308306|NCT02198547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308307|NCT02198547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308308|NCT02198547|Sensory System Agents|sensory system agents|mesh-ancestor
93308309|NCT02198547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308310|NCT02198547|Analgesics|analgesics|mesh-ancestor
93308311|NCT02198547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308312|NCT02198547|Anticonvulsants|anticonvulsants|mesh-ancestor
93308313|NCT02198547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93308314|NCT02198547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308315|NCT02198547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308316|NCT02198547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93308317|NCT02198547|Tocolytic Agents|tocolytic agents|mesh-ancestor
93308318|NCT02198547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93308319|NCT01024608|Beclomethasone|beclomethasone|mesh-list
93308320|NCT01024608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308321|NCT01024608|Glucocorticoids|glucocorticoids|mesh-ancestor
93308322|NCT01024608|Hormones|hormones|mesh-ancestor
93308323|NCT01024608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308324|NCT01024608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308325|NCT01024608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93308326|NCT01024608|Respiratory System Agents|respiratory system agents|mesh-ancestor
93308327|NCT03489798|Alprostadil|alprostadil|mesh-list
93308328|NCT03489798|Misoprostol|misoprostol|mesh-list
93308329|NCT03489798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93308330|NCT03489798|Abortifacient Agents|abortifacient agents|mesh-ancestor
93308331|NCT03489798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93308332|NCT03489798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308333|NCT03489798|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93308334|NCT03489798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308335|NCT03489798|Oxytocics|oxytocics|mesh-ancestor
93308336|NCT03489798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93308337|NCT03489798|Vasodilator Agents|vasodilator agents|mesh-ancestor
93308338|NCT03489798|Urological Agents|urological agents|mesh-ancestor
93308339|NCT02031081|Prucalopride|prucalopride|mesh-list
93308340|NCT02031081|Laxatives|laxatives|mesh-ancestor
93308341|NCT02031081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308342|NCT02031081|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93308343|NCT02031081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93308344|NCT02031081|Serotonin Agents|serotonin agents|mesh-ancestor
93308345|NCT02031081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308346|NCT02031081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308347|NCT02031081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308348|NCT02198859|Lithium Carbonate|lithium carbonate|mesh-list
93308349|NCT02198859|Antidepressive Agents|antidepressive agents|mesh-ancestor
93308350|NCT02198859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93308351|NCT02198859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308352|NCT02198859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308353|NCT02198859|Antimanic Agents|antimanic agents|mesh-ancestor
93308354|NCT02198859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93308355|NCT02198859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308356|NCT02198859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308357|NCT02199171|Carboplatin|carboplatin|mesh-list
93308358|NCT02199171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308359|NCT00910650|Aldesleukin|aldesleukin|mesh-list
93308360|NCT00910650|Interleukin-2|interleukin-2|mesh-list
93308361|NCT00910650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308362|NCT00910650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308363|NCT00910650|Analgesics|analgesics|mesh-ancestor
93308364|NCT00910650|Sensory System Agents|sensory system agents|mesh-ancestor
93308365|NCT00910650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308366|NCT00910650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308367|NCT00910650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308368|NCT00910650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308369|NCT00910650|Antiviral Agents|antiviral agents|mesh-ancestor
93308370|NCT00910650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308371|NCT02199327|Interferons|interferons|mesh-list
93308372|NCT02199327|Interferon-alpha|interferon-alpha|mesh-list
93308373|NCT02199327|Interferon alpha-2|interferon alpha-2|mesh-list
93308374|NCT02199327|Mitomycins|mitomycins|mesh-list
93308375|NCT02199327|Mitomycin|mitomycin|mesh-list
93308376|NCT02199327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308377|NCT02199327|Antiviral Agents|antiviral agents|mesh-ancestor
93308378|NCT02199327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308379|NCT02199327|Immunologic Factors|immunologic factors|mesh-ancestor
93308380|NCT02199327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308381|NCT02199327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93308382|NCT02199327|Alkylating Agents|alkylating agents|mesh-ancestor
93308383|NCT02199327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308384|NCT02199327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93308385|NCT02199327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308386|NCT00756288|Photosensitizing Agents|photosensitizing agents|mesh-list
93308387|NCT00756288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93308388|NCT02198001|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93308389|NCT02198001|Amoxicillin|amoxicillin|mesh-list
93308390|NCT02198001|Clavulanic Acid|clavulanic acid|mesh-list
93308391|NCT02198001|Clavulanic Acids|clavulanic acids|mesh-list
93308392|NCT02198001|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93308393|NCT02198001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308394|NCT02198001|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93308395|NCT02198001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308396|NCT02198001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308397|NCT05116800|Gemcitabine|gemcitabine|mesh-list
93308398|NCT05116800|Docetaxel|docetaxel|mesh-list
93308399|NCT05116800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93308400|NCT05116800|Antimetabolites|antimetabolites|mesh-ancestor
93308401|NCT05116800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308402|NCT05116800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308403|NCT05116800|Tubulin Modulators|tubulin modulators|mesh-ancestor
93308404|NCT05116800|Antimitotic Agents|antimitotic agents|mesh-ancestor
93308405|NCT05116800|Mitosis Modulators|mitosis modulators|mesh-ancestor
93308406|NCT04078737|Aspirin|aspirin|mesh-list
93308407|NCT04078737|Clopidogrel|clopidogrel|mesh-list
93308408|NCT04078737|Ticagrelor|ticagrelor|mesh-list
93308409|NCT04078737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93308410|NCT04078737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308411|NCT04078737|Analgesics|analgesics|mesh-ancestor
93308412|NCT04078737|Sensory System Agents|sensory system agents|mesh-ancestor
93308413|NCT04078737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308414|NCT04078737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308415|NCT04078737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308416|NCT04078737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308417|NCT04078737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93308418|NCT04078737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93308419|NCT04078737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308420|NCT04078737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93308421|NCT04078737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93308422|NCT04078737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308423|NCT04078737|Antipyretics|antipyretics|mesh-ancestor
93308424|NCT04078737|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93308425|NCT04078737|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93308426|NCT04078737|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93308427|NCT04078737|Purinergic Agents|purinergic agents|mesh-ancestor
93308428|NCT04078737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308429|NCT03491904|Fasinumab|fasinumab|mesh-list
93308430|NCT03491904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308431|NCT03491904|Analgesics|analgesics|mesh-ancestor
93308432|NCT03491904|Sensory System Agents|sensory system agents|mesh-ancestor
93308433|NCT03491904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308434|NCT03491904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308435|NCT02199951|Piperaquine|piperaquine|mesh-list
93308437|NCT02199951|Antimalarials|antimalarials|mesh-ancestor
93308438|NCT02199951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93308439|NCT02199951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93308440|NCT02199951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308441|NCT03533361|Lenvatinib|lenvatinib|mesh-list
93308442|NCT03533361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308443|NCT03533361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93308444|NCT03533361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308445|NCT03533361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308446|NCT01433328|Lidocaine|lidocaine|mesh-list
93308447|NCT01433328|Anesthetics, Local|anesthetics, local|mesh-ancestor
93308448|NCT01433328|Anesthetics|anesthetics|mesh-ancestor
93308449|NCT01433328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308450|NCT01433328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308451|NCT01433328|Sensory System Agents|sensory system agents|mesh-ancestor
93308452|NCT01433328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308453|NCT01433328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308454|NCT01433328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93308455|NCT01433328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93308456|NCT01433328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308457|NCT01433328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308458|NCT02198469|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93308459|NCT02198469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93308460|NCT02198469|Dermatologic Agents|dermatologic agents|mesh-ancestor
93308461|NCT02200185|Morphine|morphine|mesh-list
93308462|NCT02200185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93308463|NCT02200185|Narcotics|narcotics|mesh-ancestor
93308464|NCT02200185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308465|NCT02200185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308466|NCT02200185|Analgesics|analgesics|mesh-ancestor
93308467|NCT02200185|Sensory System Agents|sensory system agents|mesh-ancestor
93308468|NCT02200185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308469|NCT02201043|Thalidomide|thalidomide|mesh-list
93308470|NCT02201043|Tolnaftate|tolnaftate|mesh-list
93308471|NCT02201043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308472|NCT02201043|Immunologic Factors|immunologic factors|mesh-ancestor
93308473|NCT02201043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308474|NCT02201043|Leprostatic Agents|leprostatic agents|mesh-ancestor
93308475|NCT02201043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93308476|NCT02201043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308477|NCT02201043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308478|NCT02201043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308479|NCT02201043|Growth Substances|growth substances|mesh-ancestor
93308480|NCT02201043|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308481|NCT02201043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308482|NCT02201043|Antifungal Agents|antifungal agents|mesh-ancestor
93308483|NCT02201121|Phenylephrine|phenylephrine|mesh-list
93308484|NCT02201121|Dopamine|dopamine|mesh-list
93308485|NCT02201121|Oxymetazoline|oxymetazoline|mesh-list
93308486|NCT02201121|Ephedrine|ephedrine|mesh-list
93308487|NCT02201121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93308488|NCT02201121|Mydriatics|mydriatics|mesh-ancestor
93308489|NCT02201121|Autonomic Agents|autonomic agents|mesh-ancestor
93308490|NCT02201121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308491|NCT02201121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308492|NCT02201121|Sympathomimetics|sympathomimetics|mesh-ancestor
93308493|NCT02201121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93308494|NCT02201121|Nasal Decongestants|nasal decongestants|mesh-ancestor
93308495|NCT02201121|Respiratory System Agents|respiratory system agents|mesh-ancestor
93308496|NCT02201121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93308497|NCT02201121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93308498|NCT02201121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93308499|NCT02201121|Adrenergic Agents|adrenergic agents|mesh-ancestor
93308500|NCT02201121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603022|NCT00117728|Nevirapine|nevirapine|mesh-list
93308501|NCT02201121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308502|NCT02201121|Protective Agents|protective agents|mesh-ancestor
93308503|NCT02201121|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93308504|NCT02201121|Dopamine Agents|dopamine agents|mesh-ancestor
93308505|NCT02200575|Telmisartan|telmisartan|mesh-list
93308506|NCT02200575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93308507|NCT02200575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93308508|NCT02200575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93308509|NCT02200575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980507|NCT00821600|Dopamine Agents|dopamine agents|mesh-ancestor
93308510|NCT02201199|Insulin|insulin|mesh-list
93308511|NCT02201199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93308512|NCT02201199|Insulin Glargine|insulin glargine|mesh-list
93308513|NCT02201199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93308514|NCT02201199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308515|NCT02200653|Losartan|losartan|mesh-list
93308516|NCT02200653|Telmisartan|telmisartan|mesh-list
93308517|NCT02200653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308518|NCT02200653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93308519|NCT02200653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93308520|NCT02200653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93308521|NCT02200653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308522|NCT03999411|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93308523|NCT03999411|Nicotine|nicotine|mesh-list
93308524|NCT03999411|Antiviral Agents|antiviral agents|mesh-ancestor
93308525|NCT03999411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308526|NCT03999411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93308527|NCT03999411|Autonomic Agents|autonomic agents|mesh-ancestor
93308528|NCT03999411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308529|NCT03999411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308530|NCT03999411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93308531|NCT03999411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93308532|NCT03999411|Cholinergic Agents|cholinergic agents|mesh-ancestor
93308533|NCT03999411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308534|NCT03999411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308535|NCT05261997|Metformin|metformin|mesh-list
93308536|NCT05261997|Acarbose|acarbose|mesh-list
93308537|NCT05261997|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93308538|NCT05261997|Pancreatin|pancreatin|mesh-list
93308539|NCT05261997|Pancrelipase|pancrelipase|mesh-list
93308540|NCT05261997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308541|NCT05261997|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93308542|NCT05261997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308543|NCT05261997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308544|NCT05261997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308545|NCT02206425|Ascorbic Acid|ascorbic acid|mesh-list
93308546|NCT02206425|Dexamethasone|dexamethasone|mesh-list
93308547|NCT02206425|Dexamethasone acetate|dexamethasone acetate|mesh-list
93308548|NCT02206425|Prednisone|prednisone|mesh-list
93308549|NCT02206425|Cyclophosphamide|cyclophosphamide|mesh-list
93308550|NCT02206425|Melphalan|melphalan|mesh-list
93308551|NCT02206425|Doxorubicin|doxorubicin|mesh-list
93308552|NCT02206425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93308553|NCT02206425|Lenalidomide|lenalidomide|mesh-list
93308554|NCT02206425|Pomalidomide|pomalidomide|mesh-list
93308555|NCT02206425|BB 1101|bb 1101|mesh-list
93308556|NCT02206425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308557|NCT02206425|Immunologic Factors|immunologic factors|mesh-ancestor
93308558|NCT02206425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308559|NCT02206425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308560|NCT02206425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93308561|NCT02206425|Alkylating Agents|alkylating agents|mesh-ancestor
93308562|NCT02206425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308563|NCT02206425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308564|NCT02206425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93308565|NCT02206425|Vitamins|vitamins|mesh-ancestor
93308566|NCT02206425|Micronutrients|micronutrients|mesh-ancestor
93308567|NCT02206425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308568|NCT02206425|Antiemetics|antiemetics|mesh-ancestor
93308569|NCT02206425|Autonomic Agents|autonomic agents|mesh-ancestor
93308570|NCT02206425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308571|NCT02206425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308572|NCT02206425|Glucocorticoids|glucocorticoids|mesh-ancestor
93308573|NCT02206425|Hormones|hormones|mesh-ancestor
93308574|NCT02206425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308575|NCT02206425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93308576|NCT02206425|Protease Inhibitors|protease inhibitors|mesh-ancestor
93308577|NCT02206425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308578|NCT02206425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93308579|NCT02206425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93308580|NCT02206425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93308581|NCT02206425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308582|NCT02206425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308583|NCT02206425|Growth Substances|growth substances|mesh-ancestor
93308584|NCT02206425|Growth Inhibitors|growth inhibitors|mesh-ancestor
92980574|NCT02936622|Tubulin Modulators|tubulin modulators|mesh-ancestor
93308585|NCT02206425|Antioxidants|antioxidants|mesh-ancestor
93308586|NCT02206425|Protective Agents|protective agents|mesh-ancestor
93308587|NCT02201667|Aspirin|aspirin|mesh-list
93308588|NCT02201667|Clopidogrel|clopidogrel|mesh-list
93308590|NCT02201667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93308591|NCT02201667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308592|NCT02201667|Analgesics|analgesics|mesh-ancestor
93308593|NCT02201667|Sensory System Agents|sensory system agents|mesh-ancestor
93308594|NCT02201667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308595|NCT02201667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308596|NCT02201667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308597|NCT02201667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308598|NCT02201667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93308599|NCT02201667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93308600|NCT02201667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308601|NCT02201667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93308602|NCT02201667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93308603|NCT02201667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308604|NCT02201667|Antipyretics|antipyretics|mesh-ancestor
93308605|NCT02201667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93308606|NCT02201667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93308607|NCT02201667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93308608|NCT02201667|Purinergic Agents|purinergic agents|mesh-ancestor
93308609|NCT02201667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308610|NCT02206503|Dexamethasone|dexamethasone|mesh-list
93308611|NCT02206503|Cyclophosphamide|cyclophosphamide|mesh-list
93308612|NCT02206503|Lenalidomide|lenalidomide|mesh-list
93308613|NCT02206503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308614|NCT02206503|Immunologic Factors|immunologic factors|mesh-ancestor
93308615|NCT02206503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308616|NCT02206503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308617|NCT02206503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93308618|NCT02206503|Alkylating Agents|alkylating agents|mesh-ancestor
93308619|NCT02206503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308620|NCT02206503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308621|NCT02206503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93308622|NCT02206503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308623|NCT02206503|Antiemetics|antiemetics|mesh-ancestor
93308624|NCT02206503|Autonomic Agents|autonomic agents|mesh-ancestor
93308625|NCT02206503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308626|NCT02206503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308627|NCT02206503|Glucocorticoids|glucocorticoids|mesh-ancestor
93308628|NCT02206503|Hormones|hormones|mesh-ancestor
93308629|NCT02206503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308630|NCT02206503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93308631|NCT02206503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308632|NCT02206503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308633|NCT02206503|Growth Substances|growth substances|mesh-ancestor
93308634|NCT02206503|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308635|NCT02206659|Telmisartan|telmisartan|mesh-list
93308636|NCT02206659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93308637|NCT02206659|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93308638|NCT02206659|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93308639|NCT02206659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308640|NCT02206737|Nicotine|nicotine|mesh-list
93308641|NCT02206737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93308642|NCT02206737|Autonomic Agents|autonomic agents|mesh-ancestor
93308643|NCT02206737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308644|NCT02206737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308645|NCT02206737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93308646|NCT02206737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93308647|NCT02206737|Cholinergic Agents|cholinergic agents|mesh-ancestor
93308648|NCT02206737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308649|NCT02206737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308650|NCT03533127|Bevacizumab|bevacizumab|mesh-list
93308651|NCT03533127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308652|NCT03533127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308653|NCT03533127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308654|NCT03533127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308655|NCT03533127|Growth Substances|growth substances|mesh-ancestor
93308656|NCT03533127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308657|NCT03533127|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308658|NCT02207361|Paclitaxel|paclitaxel|mesh-list
93308659|NCT02207361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93308660|NCT02207361|Carboplatin|carboplatin|mesh-list
93308661|NCT02207361|Epirubicin|epirubicin|mesh-list
92980650|NCT04005417|Fluorides|fluorides|mesh-list
93308662|NCT02207361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93308664|NCT02207361|Tubulin Modulators|tubulin modulators|mesh-ancestor
93308665|NCT02207361|Antimitotic Agents|antimitotic agents|mesh-ancestor
93308666|NCT02207361|Mitosis Modulators|mitosis modulators|mesh-ancestor
93308667|NCT02207361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308668|NCT02207361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93308669|NCT02207361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93308670|NCT02207361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93308671|NCT02207361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308672|NCT02202525|Telmisartan|telmisartan|mesh-list
93308673|NCT02202525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93308674|NCT02202525|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93308675|NCT02202525|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93308676|NCT02202525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308677|NCT02202603|Teriparatide|teriparatide|mesh-list
93308678|NCT02202603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93308679|NCT02202603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308680|NCT02202603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93308681|NCT02202993|Mibefradil|mibefradil|mesh-list
93308682|NCT02202993|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93308683|NCT02202993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93308684|NCT02202993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308685|NCT02202993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308686|NCT02202993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93308687|NCT02202993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308688|NCT02202993|Vasodilator Agents|vasodilator agents|mesh-ancestor
93308689|NCT02202993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93308690|NCT02202993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93308691|NCT02202993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308692|NCT02190357|Rifaximin|rifaximin|mesh-list
93308693|NCT02190357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93308694|NCT02190357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308695|NCT02190357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308696|NCT02257671|Levonorgestrel|levonorgestrel|mesh-list
93308697|NCT02257671|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93308698|NCT02257671|Contraceptive Agents|contraceptive agents|mesh-list
93308699|NCT02257671|Contraceptives, Oral|contraceptives, oral|mesh-list
93308700|NCT02257671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93308701|NCT02257671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93308702|NCT02257671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308703|NCT02257671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93308704|NCT02257671|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93308705|NCT02257671|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93308706|NCT02257671|Estrogens|estrogens|mesh-ancestor
93308707|NCT02257671|Hormones|hormones|mesh-ancestor
93308708|NCT02257671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308709|NCT01460160|Dasatinib|dasatinib|mesh-list
93308710|NCT01460160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308711|NCT01460160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93308712|NCT01460160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308713|NCT01460160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308714|NCT02203227|Turmeric extract|turmeric extract|mesh-list
93308715|NCT02203227|Antioxidants|antioxidants|mesh-ancestor
93308716|NCT02203227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308717|NCT02203227|Protective Agents|protective agents|mesh-ancestor
93308718|NCT02203227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308719|NCT01170702|Ropivacaine|ropivacaine|mesh-list
93308720|NCT01170702|Anesthetics, Local|anesthetics, local|mesh-ancestor
93308721|NCT01170702|Anesthetics|anesthetics|mesh-ancestor
93308722|NCT01170702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308723|NCT01170702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308724|NCT01170702|Sensory System Agents|sensory system agents|mesh-ancestor
93308725|NCT01170702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308726|NCT02203461|Ritonavir|ritonavir|mesh-list
93308727|NCT02203461|Lopinavir|lopinavir|mesh-list
93308728|NCT02203461|Darunavir|darunavir|mesh-list
93308729|NCT02203461|Tenofovir|tenofovir|mesh-list
93308730|NCT02203461|Emtricitabine|emtricitabine|mesh-list
93308731|NCT02203461|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93308732|NCT02203461|Cobicistat|cobicistat|mesh-list
93308733|NCT02203461|Elvitegravir|elvitegravir|mesh-list
93308734|NCT02203461|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93308735|NCT02203461|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93308736|NCT02203461|Protease Inhibitors|protease inhibitors|mesh-ancestor
93308737|NCT02203461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308738|NCT02203461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308739|NCT02203461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308740|NCT02203461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308741|NCT02203461|Antiviral Agents|antiviral agents|mesh-ancestor
93308742|NCT02203461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308743|NCT02203461|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93308744|NCT02203461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93308745|NCT02203461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93308746|NCT02203461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93308747|NCT02203461|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93308748|NCT02191059|Docetaxel|docetaxel|mesh-list
93308749|NCT02191059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308750|NCT02191059|Tubulin Modulators|tubulin modulators|mesh-ancestor
93308751|NCT02191059|Antimitotic Agents|antimitotic agents|mesh-ancestor
93308752|NCT02191059|Mitosis Modulators|mitosis modulators|mesh-ancestor
93308753|NCT02191059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308754|NCT02191215|Nevirapine|nevirapine|mesh-list
93308755|NCT02191215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93308756|NCT02191215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93308757|NCT02191215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308758|NCT02191215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308759|NCT02191215|Antiviral Agents|antiviral agents|mesh-ancestor
93308760|NCT02191215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308761|NCT02191215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308762|NCT02191215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308763|NCT02191215|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93308764|NCT02191215|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93308765|NCT02209155|Verapamil|verapamil|mesh-list
93308766|NCT02209155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308767|NCT02209155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93308768|NCT02209155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308769|NCT02209155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308770|NCT02209155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93308771|NCT02209155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308772|NCT02209155|Vasodilator Agents|vasodilator agents|mesh-ancestor
93308773|NCT03485118|Rituximab|rituximab|mesh-list
93308774|NCT03485118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308775|NCT03485118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308776|NCT03485118|Immunologic Factors|immunologic factors|mesh-ancestor
93308777|NCT03485118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308778|NCT03485118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308779|NCT02191293|Nevirapine|nevirapine|mesh-list
93308780|NCT02191293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93308781|NCT02191293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93308782|NCT02191293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308783|NCT02191293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308784|NCT02191293|Antiviral Agents|antiviral agents|mesh-ancestor
93308785|NCT02191293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308786|NCT02191293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308787|NCT02191293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308788|NCT02191293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93308789|NCT02191293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93308790|NCT02880540|Fentanyl|fentanyl|mesh-list
93308791|NCT02880540|Dexmedetomidine|dexmedetomidine|mesh-list
93308792|NCT02880540|Morphine|morphine|mesh-list
93308793|NCT02880540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93308794|NCT02880540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308795|NCT02880540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308796|NCT02880540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308797|NCT02880540|Analgesics|analgesics|mesh-ancestor
93308798|NCT02880540|Sensory System Agents|sensory system agents|mesh-ancestor
93308799|NCT02880540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308800|NCT02880540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93308801|NCT02880540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93308802|NCT02880540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93308803|NCT02880540|Adrenergic Agents|adrenergic agents|mesh-ancestor
93308804|NCT02880540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308805|NCT02880540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308806|NCT02880540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92980800|NCT04085627|Amlodipine|amlodipine|mesh-list
93308807|NCT02880540|Narcotics|narcotics|mesh-ancestor
93308808|NCT02880540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93308809|NCT02880540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93308810|NCT02880540|Anesthetics, General|anesthetics, general|mesh-ancestor
93308811|NCT02880540|Anesthetics|anesthetics|mesh-ancestor
93308812|NCT02191371|Propofol|propofol|mesh-list
93308813|NCT02191371|Desflurane|desflurane|mesh-list
93308814|NCT02191371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93308815|NCT02191371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308816|NCT02191371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308817|NCT02191371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93308818|NCT02191371|Anesthetics, General|anesthetics, general|mesh-ancestor
93308819|NCT02191371|Anesthetics|anesthetics|mesh-ancestor
93308820|NCT02191371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93308821|NCT03532737|Pembrolizumab|pembrolizumab|mesh-list
93308822|NCT03532737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308823|NCT03532737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308824|NCT03532737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93308825|NCT03532737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308826|NCT02741388|Cytarabine|cytarabine|mesh-list
93308827|NCT02741388|Dexamethasone|dexamethasone|mesh-list
93308828|NCT02741388|Rituximab|rituximab|mesh-list
93308829|NCT02741388|Gemcitabine|gemcitabine|mesh-list
93308830|NCT02741388|Oxaliplatin|oxaliplatin|mesh-list
93308831|NCT02741388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308832|NCT02741388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308833|NCT02741388|Immunologic Factors|immunologic factors|mesh-ancestor
93308834|NCT02741388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308835|NCT02741388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308836|NCT02741388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308837|NCT02741388|Antiemetics|antiemetics|mesh-ancestor
93308838|NCT02741388|Autonomic Agents|autonomic agents|mesh-ancestor
93308839|NCT02741388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308840|NCT02741388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308841|NCT02741388|Glucocorticoids|glucocorticoids|mesh-ancestor
93308842|NCT02741388|Hormones|hormones|mesh-ancestor
93308843|NCT02741388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308844|NCT02741388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93308845|NCT02741388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93308846|NCT02741388|Antimetabolites|antimetabolites|mesh-ancestor
93308847|NCT02741388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308848|NCT02741388|Antiviral Agents|antiviral agents|mesh-ancestor
93308849|NCT02741388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308850|NCT02741388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93308851|NCT02191527|Chrysarobin|chrysarobin|mesh-list
93308852|NCT02191527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93308853|NCT02191527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93308854|NCT02191527|Analgesics|analgesics|mesh-ancestor
93308855|NCT02191527|Sensory System Agents|sensory system agents|mesh-ancestor
93308856|NCT02191527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308857|NCT02191527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308858|NCT02191527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603371|NCT00479908|Nitroglycerin|nitroglycerin|mesh-list
93308859|NCT02191527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93308860|NCT03484962|Antibodies|antibodies|mesh-list
93308861|NCT03484962|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93308862|NCT03484962|Immunologic Factors|immunologic factors|mesh-ancestor
93308863|NCT03484962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308864|NCT01331616|Bevacizumab|bevacizumab|mesh-list
93308865|NCT01331616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93308866|NCT01331616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308867|NCT01331616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308868|NCT01331616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308869|NCT01331616|Growth Substances|growth substances|mesh-ancestor
93308870|NCT01331616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308871|NCT01331616|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308872|NCT02209701|Porfiromycin|porfiromycin|mesh-list
93308873|NCT02209701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93308874|NCT02209701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308875|NCT02191839|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93308876|NCT02191839|Protein C Inhibitor|protein c inhibitor|mesh-list
93308877|NCT02191839|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93308878|NCT02191839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93308879|NCT02191839|Protease Inhibitors|protease inhibitors|mesh-ancestor
93308880|NCT02191839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308881|NCT02191839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308882|NCT02204397|Ustekinumab|ustekinumab|mesh-list
93308883|NCT02204397|Dermatologic Agents|dermatologic agents|mesh-ancestor
93308884|NCT02192229|Vitamin D|vitamin d|mesh-list
93308885|NCT02192229|Cholecalciferol|cholecalciferol|mesh-list
93308886|NCT02192229|Vitamins|vitamins|mesh-ancestor
93308887|NCT02192229|Micronutrients|micronutrients|mesh-ancestor
93308888|NCT02192229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308889|NCT02192229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93308890|NCT02192229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93308891|NCT02192463|Nevirapine|nevirapine|mesh-list
93308892|NCT02192463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93308893|NCT02192463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93308894|NCT02192463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308895|NCT02192463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308896|NCT02192463|Antiviral Agents|antiviral agents|mesh-ancestor
93308897|NCT02192463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308898|NCT02192463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93308899|NCT02192463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93308900|NCT02192463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93308901|NCT02192463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93308902|NCT02204475|Interferons|interferons|mesh-list
93308903|NCT02204475|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93308904|NCT02204475|Grazoprevir|grazoprevir|mesh-list
93308905|NCT02204475|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93308906|NCT02204475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308907|NCT02204475|Antiviral Agents|antiviral agents|mesh-ancestor
93308908|NCT02204475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308909|NCT02210169|Vancomycin|vancomycin|mesh-list
93308910|NCT02210169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93308911|NCT02210169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308912|NCT02210949|Epoetin Alfa|epoetin alfa|mesh-list
93308913|NCT02210949|Hematinics|hematinics|mesh-ancestor
93308914|NCT02204553|Panobinostat|panobinostat|mesh-list
93308915|NCT02204553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308916|NCT02204553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93308917|NCT02204553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308918|NCT02204553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308919|NCT01109004|Dexamethasone|dexamethasone|mesh-list
93308920|NCT01109004|Lenalidomide|lenalidomide|mesh-list
93308921|NCT01109004|Bortezomib|bortezomib|mesh-list
93308922|NCT01109004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93308923|NCT01109004|Antiemetics|antiemetics|mesh-ancestor
93308924|NCT01109004|Autonomic Agents|autonomic agents|mesh-ancestor
93308925|NCT01109004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308926|NCT01109004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308927|NCT01109004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93308928|NCT01109004|Glucocorticoids|glucocorticoids|mesh-ancestor
93308929|NCT01109004|Hormones|hormones|mesh-ancestor
93308930|NCT01109004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93308931|NCT01109004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93308932|NCT01109004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308933|NCT01109004|Immunologic Factors|immunologic factors|mesh-ancestor
93308934|NCT01109004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93308935|NCT01109004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93308936|NCT01109004|Growth Substances|growth substances|mesh-ancestor
93308937|NCT01109004|Growth Inhibitors|growth inhibitors|mesh-ancestor
93308938|NCT02211729|Azithromycin|azithromycin|mesh-list
93308939|NCT02211729|Pyrimethamine|pyrimethamine|mesh-list
93308940|NCT02211729|Sulfadoxine|sulfadoxine|mesh-list
93308941|NCT02211729|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93308942|NCT02211729|Amodiaquine|amodiaquine|mesh-list
93308943|NCT02211729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93308944|NCT02211729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93308945|NCT02211729|Antimalarials|antimalarials|mesh-ancestor
93308946|NCT02211729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93308947|NCT02211729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93308948|NCT02211729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93308949|NCT02211729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308950|NCT02211729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308951|NCT02211729|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93308952|NCT05151510|Lidocaine|lidocaine|mesh-list
93308953|NCT05151510|Anesthetics, Local|anesthetics, local|mesh-ancestor
93308954|NCT05151510|Anesthetics|anesthetics|mesh-ancestor
93308955|NCT05151510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308956|NCT05151510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308957|NCT05151510|Sensory System Agents|sensory system agents|mesh-ancestor
93308958|NCT05151510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308959|NCT05151510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308960|NCT05151510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93308961|NCT05151510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93308962|NCT05151510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308963|NCT05151510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308964|NCT02212119|Botulinum Toxins|botulinum toxins|mesh-list
93308965|NCT02212119|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93308966|NCT02212119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308967|NCT02212119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308968|NCT02212119|Cholinergic Agents|cholinergic agents|mesh-ancestor
93308969|NCT02212119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93308970|NCT02212119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308971|NCT03484650|Lidocaine|lidocaine|mesh-list
93308972|NCT03484650|Anesthetics, Local|anesthetics, local|mesh-ancestor
93308973|NCT03484650|Anesthetics|anesthetics|mesh-ancestor
93308974|NCT03484650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93308975|NCT03484650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308976|NCT03484650|Sensory System Agents|sensory system agents|mesh-ancestor
93308977|NCT03484650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93308978|NCT03484650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93308979|NCT03484650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93308980|NCT03484650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93308981|NCT03484650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93308982|NCT03484650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308983|NCT02192697|Naquotinib|naquotinib|mesh-list
93308984|NCT02192697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93308985|NCT02192697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93308986|NCT02192697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93308987|NCT02192697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93308988|NCT05153928|Norethindrone|norethindrone|mesh-list
93308989|NCT05153928|Norethindrone Acetate|norethindrone acetate|mesh-list
93308990|NCT05153928|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93308991|NCT05153928|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93308992|NCT05153928|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93308993|NCT05153928|Contraceptive Agents|contraceptive agents|mesh-ancestor
93308994|NCT05153928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93308995|NCT05153928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93308996|NCT05153928|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93308997|NCT05153928|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93308998|NCT02214771|Fidaxomicin|fidaxomicin|mesh-list
93308999|NCT02214771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309000|NCT02214771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309001|NCT02192853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93309002|NCT02192853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93309003|NCT02192853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309004|NCT02192853|Incretins|incretins|mesh-ancestor
93309005|NCT02192853|Hormones|hormones|mesh-ancestor
93309006|NCT02192853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309007|NCT02192853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93309008|NCT02192853|Protease Inhibitors|protease inhibitors|mesh-ancestor
93309009|NCT02192853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309010|NCT02192853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309011|NCT05151042|Salicylic Acid|salicylic acid|mesh-list
93309012|NCT05151042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309013|NCT05151042|Antifungal Agents|antifungal agents|mesh-ancestor
93309014|NCT05151042|Keratolytic Agents|keratolytic agents|mesh-ancestor
93309015|NCT05151042|Dermatologic Agents|dermatologic agents|mesh-ancestor
93309016|NCT04574154|Anesthetics|anesthetics|mesh-list
93309017|NCT04574154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309018|NCT04574154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309019|NCT03484416|Vitamin D|vitamin d|mesh-list
93309020|NCT03484416|Calcium Carbonate|calcium carbonate|mesh-list
93309021|NCT03484416|Calcium|calcium|mesh-list
93309022|NCT03484416|Vitamins|vitamins|mesh-ancestor
93309023|NCT03484416|Micronutrients|micronutrients|mesh-ancestor
93309024|NCT03484416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309025|NCT03484416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93309026|NCT03484416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93309027|NCT03484416|Antacids|antacids|mesh-ancestor
93309028|NCT03484416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309029|NCT03484416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309030|NCT02205255|Azithromycin|azithromycin|mesh-list
93309031|NCT02205255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309032|NCT02205255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309033|NCT02220153|Rozanolixizumab|rozanolixizumab|mesh-list
92981020|NCT00822380|Vitamins|vitamins|mesh-ancestor
93309035|NCT02220153|Immunologic Factors|immunologic factors|mesh-ancestor
93309036|NCT02220153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309037|NCT03476772|Nalbuphine|nalbuphine|mesh-list
93309038|NCT03476772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93309039|NCT03476772|Narcotics|narcotics|mesh-ancestor
93309040|NCT03476772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309041|NCT03476772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309042|NCT03476772|Analgesics|analgesics|mesh-ancestor
93309043|NCT03476772|Sensory System Agents|sensory system agents|mesh-ancestor
93309044|NCT03476772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309045|NCT03535233|Triamcinolone|triamcinolone|mesh-list
93309046|NCT03535233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93309047|NCT03535233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93309048|NCT03535233|Clobetasol|clobetasol|mesh-list
93309049|NCT03535233|Minoxidil|minoxidil|mesh-list
93309050|NCT03535233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93309051|NCT03535233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93309052|NCT03535233|Glucocorticoids|glucocorticoids|mesh-ancestor
93309053|NCT03535233|Hormones|hormones|mesh-ancestor
93309054|NCT03535233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309055|NCT03535233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309056|NCT03535233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309057|NCT03535233|Immunologic Factors|immunologic factors|mesh-ancestor
93309058|NCT03535233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309059|NCT03535233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309060|NCT03535233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93309061|NCT03535233|Vasodilator Agents|vasodilator agents|mesh-ancestor
93309062|NCT02205489|Cetirizine|cetirizine|mesh-list
93309063|NCT02205489|Acyclovir|acyclovir|mesh-list
93309064|NCT02205489|Ibuprofen|ibuprofen|mesh-list
93309065|NCT02205489|Methylprednisolone|methylprednisolone|mesh-list
93309066|NCT02205489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93309067|NCT02205489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93309068|NCT02205489|Prednisolone|prednisolone|mesh-list
93309069|NCT02205489|Prednisolone acetate|prednisolone acetate|mesh-list
93309070|NCT02205489|Alemtuzumab|alemtuzumab|mesh-list
93309071|NCT02205489|Esomeprazole|esomeprazole|mesh-list
93309072|NCT02205489|Ranitidine|ranitidine|mesh-list
93309073|NCT02205489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93309074|NCT02205489|Prednisolone phosphate|prednisolone phosphate|mesh-list
93309075|NCT02205489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93309076|NCT02205489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93309077|NCT02205489|Analgesics|analgesics|mesh-ancestor
93309078|NCT02205489|Sensory System Agents|sensory system agents|mesh-ancestor
93309079|NCT02205489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309080|NCT02205489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309081|NCT02205489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93309082|NCT02205489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309083|NCT02205489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93309084|NCT02205489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309085|NCT02205489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309086|NCT02205489|Antiemetics|antiemetics|mesh-ancestor
93309087|NCT02205489|Autonomic Agents|autonomic agents|mesh-ancestor
93309088|NCT02205489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309089|NCT02205489|Glucocorticoids|glucocorticoids|mesh-ancestor
93309090|NCT02205489|Hormones|hormones|mesh-ancestor
93309091|NCT02205489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309092|NCT02205489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93309093|NCT02205489|Protective Agents|protective agents|mesh-ancestor
93309094|NCT02205489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93309095|NCT02205489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309096|NCT02205489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93309097|NCT02205489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93309098|NCT02205489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309099|NCT02205489|Antiviral Agents|antiviral agents|mesh-ancestor
93309100|NCT02205489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309101|NCT02205489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93309102|NCT02205489|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93309103|NCT02205489|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93309104|NCT02205489|Histamine Antagonists|histamine antagonists|mesh-ancestor
93309105|NCT02205489|Histamine Agents|histamine agents|mesh-ancestor
93309106|NCT02205489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309107|NCT02205489|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93309108|NCT02523846|Morphine|morphine|mesh-list
93309109|NCT02523846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93309110|NCT02523846|Narcotics|narcotics|mesh-ancestor
93309111|NCT02523846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309112|NCT02523846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309113|NCT02523846|Analgesics|analgesics|mesh-ancestor
93309114|NCT02523846|Sensory System Agents|sensory system agents|mesh-ancestor
93309115|NCT02523846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309116|NCT03484260|Testosterone|testosterone|mesh-list
93309117|NCT03484260|Androgens|androgens|mesh-ancestor
93309118|NCT03484260|Hormones|hormones|mesh-ancestor
93309119|NCT03484260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309120|NCT03484260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309121|NCT05195775|Tadalafil|tadalafil|mesh-list
93309122|NCT05195775|Vasodilator Agents|vasodilator agents|mesh-ancestor
93309123|NCT05195775|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93309124|NCT05195775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93309125|NCT05195775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309126|NCT05195775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309127|NCT05195775|Urological Agents|urological agents|mesh-ancestor
93309128|NCT03480906|Latanoprost|latanoprost|mesh-list
93309129|NCT03480906|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93309130|NCT03480906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93309131|NCT05262465|Azacitidine|azacitidine|mesh-list
93309132|NCT05262465|Venetoclax|venetoclax|mesh-list
93309133|NCT05262465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309134|NCT05262465|Antimetabolites|antimetabolites|mesh-ancestor
93309135|NCT05262465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309136|NCT05262465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309137|NCT05262465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309138|NCT02220621|Hyaluronic Acid|hyaluronic acid|mesh-list
93309139|NCT02220621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93309140|NCT02220621|Immunologic Factors|immunologic factors|mesh-ancestor
93309141|NCT02220621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309142|NCT02220621|Viscosupplements|viscosupplements|mesh-ancestor
93309143|NCT02220621|Protective Agents|protective agents|mesh-ancestor
93309144|NCT04370418|Fluorouracil|fluorouracil|mesh-list
93309145|NCT04370418|Antimetabolites|antimetabolites|mesh-ancestor
93309146|NCT04370418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603654|NCT00119990|Icodextrin|icodextrin|mesh-list
93309147|NCT04370418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309148|NCT04370418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309149|NCT04370418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309150|NCT04370418|Immunologic Factors|immunologic factors|mesh-ancestor
93309151|NCT04370418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309152|NCT02220777|Omeprazole|omeprazole|mesh-list
93309153|NCT02220777|ASP8477|asp8477|mesh-list
93309154|NCT02220777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93309155|NCT02220777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309156|NCT02220777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93309157|NCT02220777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309158|NCT02220777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309159|NCT03476616|Valsartan|valsartan|mesh-list
93309160|NCT03476616|Eplerenone|eplerenone|mesh-list
93309161|NCT03476616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93309162|NCT03476616|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93309163|NCT03476616|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93309164|NCT03476616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309165|NCT03476616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93309166|NCT03476616|Hormone Antagonists|hormone antagonists|mesh-ancestor
93309167|NCT03476616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309168|NCT03476616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309169|NCT03476616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93309170|NCT03476616|Diuretics|diuretics|mesh-ancestor
93309171|NCT03476616|Natriuretic Agents|natriuretic agents|mesh-ancestor
93309172|NCT02205879|Pregabalin|pregabalin|mesh-list
93309173|NCT02205879|Analgesics|analgesics|mesh-ancestor
93309174|NCT02205879|Sensory System Agents|sensory system agents|mesh-ancestor
93309175|NCT02205879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309176|NCT02205879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309177|NCT02205879|Anticonvulsants|anticonvulsants|mesh-ancestor
93309178|NCT02205879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93309179|NCT02205879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93309180|NCT02205879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309181|NCT02205879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93309182|NCT02205879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93309183|NCT02205879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93309184|NCT02205879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309185|NCT02205879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93309186|NCT03483948|Azacitidine|azacitidine|mesh-list
93309187|NCT03483948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309188|NCT03483948|Antimetabolites|antimetabolites|mesh-ancestor
93309189|NCT03483948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309190|NCT03483948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309191|NCT03483948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309192|NCT03483870|Morphine|morphine|mesh-list
93309193|NCT03483870|Granisetron|granisetron|mesh-list
93309194|NCT03483870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93309195|NCT03483870|Narcotics|narcotics|mesh-ancestor
93309196|NCT03483870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309197|NCT03483870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309198|NCT03483870|Analgesics|analgesics|mesh-ancestor
93309199|NCT03483870|Sensory System Agents|sensory system agents|mesh-ancestor
93309200|NCT03483870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309201|NCT03483870|Antiemetics|antiemetics|mesh-ancestor
93309202|NCT03483870|Autonomic Agents|autonomic agents|mesh-ancestor
93309203|NCT03483870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309204|NCT03483870|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93309205|NCT03483870|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93309206|NCT03483870|Serotonin Agents|serotonin agents|mesh-ancestor
93309207|NCT03483870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309208|NCT03483870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309209|NCT02221323|Insulin Lispro|insulin lispro|mesh-list
93309210|NCT02221323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93309211|NCT02221323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309212|NCT03480516|Fluorides|fluorides|mesh-list
93309213|NCT03480516|Sodium Fluoride|sodium fluoride|mesh-list
93309214|NCT03480516|Fluorides, Topical|fluorides, topical|mesh-list
93309215|NCT03480516|Cariostatic Agents|cariostatic agents|mesh-ancestor
93309216|NCT03480516|Protective Agents|protective agents|mesh-ancestor
93309217|NCT03480516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309218|NCT02221401|Metformin|metformin|mesh-list
93309219|NCT02221401|Linagliptin|linagliptin|mesh-list
93309220|NCT02221401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93309221|NCT02221401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309222|NCT02221401|Incretins|incretins|mesh-ancestor
93309223|NCT02221401|Hormones|hormones|mesh-ancestor
93309224|NCT02221401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309225|NCT02221401|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93309226|NCT02221401|Protease Inhibitors|protease inhibitors|mesh-ancestor
93309227|NCT02221401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309228|NCT02221401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309229|NCT03483636|Lemborexant|lemborexant|mesh-list
93309230|NCT03483636|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93309231|NCT03483636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309232|NCT03483636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309233|NCT03483636|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93309234|NCT03483636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93309235|NCT03483636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309236|NCT03483636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309237|NCT02221479|Plerixafor|plerixafor|mesh-list
93309238|NCT02221479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93309239|NCT02221479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93309240|NCT02221479|Antiviral Agents|antiviral agents|mesh-ancestor
93309241|NCT02221479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309242|NCT02221635|Risperidone|risperidone|mesh-list
93309243|NCT02221635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93309244|NCT02221635|Serotonin Agents|serotonin agents|mesh-ancestor
93309245|NCT02221635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309246|NCT02221635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309247|NCT02221635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309248|NCT02221635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93309249|NCT02221635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93309250|NCT02221635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309251|NCT02221635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93309252|NCT02221635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93309253|NCT02221635|Dopamine Agents|dopamine agents|mesh-ancestor
93309254|NCT03480360|Mycophenolic Acid|mycophenolic acid|mesh-list
93309255|NCT03480360|Cyclophosphamide|cyclophosphamide|mesh-list
93309256|NCT03480360|Fludarabine|fludarabine|mesh-list
93309257|NCT03480360|Tacrolimus|tacrolimus|mesh-list
92981247|NCT00626522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93309258|NCT03480360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309259|NCT03480360|Immunologic Factors|immunologic factors|mesh-ancestor
93309260|NCT03480360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309261|NCT03480360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309262|NCT03480360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93309263|NCT03480360|Alkylating Agents|alkylating agents|mesh-ancestor
93309264|NCT03480360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309265|NCT03480360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309266|NCT03480360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93309267|NCT03480360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93309268|NCT03480360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309269|NCT03480360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93309270|NCT03480360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93309271|NCT03480360|Antitubercular Agents|antitubercular agents|mesh-ancestor
93309272|NCT03480360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309273|NCT03480360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309274|NCT02723864|Veliparib|veliparib|mesh-list
93309275|NCT02723864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309276|NCT02723864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93309277|NCT02723864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309278|NCT02723864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309279|NCT02471690|Oritavancin|oritavancin|mesh-list
93309280|NCT02471690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309281|NCT02471690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309282|NCT02225067|Calcium|calcium|mesh-list
93309283|NCT02225067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92603796|NCT00482716|Epoetin Alfa|epoetin alfa|mesh-list
93309284|NCT02225067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309285|NCT03475758|Goserelin|goserelin|mesh-list
93309286|NCT03475758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93309287|NCT03475758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309288|NCT02231385|Acetic Acid|acetic acid|mesh-list
93309289|NCT02231385|Retinol acetate|retinol acetate|mesh-list
93309290|NCT02231385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309291|NCT02231385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309292|NCT02231385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93309293|NCT02231385|Immunologic Factors|immunologic factors|mesh-ancestor
93309294|NCT02231385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309295|NCT02231385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93309296|NCT02231385|Protective Agents|protective agents|mesh-ancestor
93309297|NCT02231385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309298|NCT02523768|Basiliximab|basiliximab|mesh-list
93309299|NCT02523768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309300|NCT02523768|Immunologic Factors|immunologic factors|mesh-ancestor
93309301|NCT02523768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309302|NCT03479736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93309303|NCT03479736|Fluoroquinolones|fluoroquinolones|mesh-list
93309304|NCT03479736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93309305|NCT03479736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309306|NCT03479736|Antitubercular Agents|antitubercular agents|mesh-ancestor
93309307|NCT03479736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93309308|NCT03479736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309309|NCT03479736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309310|NCT03203642|XL647|xl647|mesh-list
93309311|NCT03203642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309312|NCT03203642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93309313|NCT03203642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309314|NCT03203642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309315|NCT03475680|Gentamicins|gentamicins|mesh-list
93309316|NCT03475680|Ornidazole|ornidazole|mesh-list
93309317|NCT03475680|Sennosides|sennosides|mesh-list
93309318|NCT03475680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309319|NCT03475680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309320|NCT03475680|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93309321|NCT03475680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309322|NCT03475680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309323|NCT03475680|Laxatives|laxatives|mesh-ancestor
93309324|NCT03475680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309325|NCT03475680|Amebicides|amebicides|mesh-ancestor
93309326|NCT03475680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93309327|NCT03475680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93309328|NCT03475680|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93309329|NCT04621136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93309330|NCT04621136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93309331|NCT03475524|Metformin|metformin|mesh-list
93309332|NCT03475524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93309333|NCT03475524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309334|NCT02259075|Botulinum Toxins|botulinum toxins|mesh-list
92981322|NCT00823004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93309335|NCT02259075|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93309336|NCT02259075|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93309337|NCT02259075|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93309338|NCT02259075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93309339|NCT02259075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309340|NCT02259075|Cholinergic Agents|cholinergic agents|mesh-ancestor
93309341|NCT02259075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309342|NCT02259075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309343|NCT02259075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93309344|NCT02259075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309345|NCT02471846|Atezolizumab|atezolizumab|mesh-list
93309346|NCT02471846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93309347|NCT02471846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309348|NCT02471846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309349|NCT02471846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309350|NCT02472782|Teriparatide|teriparatide|mesh-list
93309351|NCT02472782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93309352|NCT02472782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309353|NCT02472782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93309354|NCT02258607|Trametinib|trametinib|mesh-list
92603866|NCT05176470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93309355|NCT02258607|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
93309356|NCT02258607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309357|NCT02258607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93309358|NCT02258607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309359|NCT02258607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309360|NCT03792750|Nivolumab|nivolumab|mesh-list
93309361|NCT03792750|Linrodostat|linrodostat|mesh-list
93309362|NCT03792750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309363|NCT03792750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309364|NCT03792750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93309365|NCT03792750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309366|NCT03792750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309367|NCT02258763|Amoxicillin|amoxicillin|mesh-list
93309368|NCT02258763|Clavulanic Acid|clavulanic acid|mesh-list
93309369|NCT02258763|Clavulanic Acids|clavulanic acids|mesh-list
93309370|NCT02258763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93309371|NCT02258763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309372|NCT02258763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309373|NCT02258763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93309374|NCT02258763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309375|NCT02258763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309376|NCT02469974|Busulfan|busulfan|mesh-list
93309377|NCT02469974|Immunologic Factors|immunologic factors|mesh-ancestor
93309378|NCT02469974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309379|NCT02469974|Alkylating Agents|alkylating agents|mesh-ancestor
93309380|NCT02469974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309381|NCT02469974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309382|NCT02469974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93309383|NCT02469974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309384|NCT02469974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93309385|NCT02231931|Metformin|metformin|mesh-list
93309386|NCT02231931|Digoxin|digoxin|mesh-list
93309387|NCT02231931|Furosemide|furosemide|mesh-list
93309388|NCT02231931|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93309389|NCT02231931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93309390|NCT02231931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309391|NCT02231931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93309392|NCT02231931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93309393|NCT02231931|Antimetabolites|antimetabolites|mesh-ancestor
93309394|NCT02231931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309395|NCT02231931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93309396|NCT02231931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93309397|NCT02231931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309398|NCT02231931|Diuretics|diuretics|mesh-ancestor
93309399|NCT02231931|Natriuretic Agents|natriuretic agents|mesh-ancestor
93309400|NCT02231931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93309401|NCT02231931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93309402|NCT02231931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93309403|NCT02231931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93309404|NCT02231931|Protective Agents|protective agents|mesh-ancestor
93309405|NCT03131622|Coal Tar|coal tar|mesh-list
93309406|NCT03131622|Keratolytic Agents|keratolytic agents|mesh-ancestor
93309407|NCT03131622|Dermatologic Agents|dermatologic agents|mesh-ancestor
93309408|NCT03482544|Pregabalin|pregabalin|mesh-list
93309409|NCT03482544|Analgesics|analgesics|mesh-ancestor
93309410|NCT03482544|Sensory System Agents|sensory system agents|mesh-ancestor
93309411|NCT03482544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309412|NCT03482544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309413|NCT03482544|Anticonvulsants|anticonvulsants|mesh-ancestor
93309414|NCT03482544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93309415|NCT03482544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93309416|NCT03482544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309417|NCT03482544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93309418|NCT03482544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93309419|NCT03482544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93309420|NCT03482544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309421|NCT03482544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93309422|NCT02750709|Nitisinone|nitisinone|mesh-list
93309423|NCT02750709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309424|NCT02750709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309425|NCT02222649|Vitamin D|vitamin d|mesh-list
93309426|NCT02222649|Cholecalciferol|cholecalciferol|mesh-list
93309427|NCT02222649|Vitamins|vitamins|mesh-ancestor
93309428|NCT02222649|Micronutrients|micronutrients|mesh-ancestor
93309429|NCT02222649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309430|NCT02222649|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93309431|NCT02222649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93309432|NCT02222727|Donepezil|donepezil|mesh-list
93309433|NCT02222727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93309434|NCT02222727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309435|NCT02222727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309436|NCT02222727|Cholinergic Agents|cholinergic agents|mesh-ancestor
93309437|NCT02222727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309438|NCT02222727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309439|NCT02222727|Nootropic Agents|nootropic agents|mesh-ancestor
93309440|NCT02723786|Mycophenolic Acid|mycophenolic acid|mesh-list
93309441|NCT02723786|Azathioprine|azathioprine|mesh-list
93309442|NCT02723786|Tacrolimus|tacrolimus|mesh-list
93309443|NCT02723786|Basiliximab|basiliximab|mesh-list
93309444|NCT02723786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309445|NCT02723786|Immunologic Factors|immunologic factors|mesh-ancestor
93309446|NCT02723786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309447|NCT02723786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93309448|NCT02723786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309449|NCT02723786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309450|NCT02723786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93309451|NCT02723786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309452|NCT02723786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93309453|NCT02723786|Antitubercular Agents|antitubercular agents|mesh-ancestor
93309454|NCT02723786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309455|NCT02723786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309456|NCT02723786|Antimetabolites|antimetabolites|mesh-ancestor
93309457|NCT02723786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309458|NCT02723786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309459|NCT03310736|Hepcidins|hepcidins|mesh-list
93309460|NCT03310736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309461|NCT02226783|Omeprazole|omeprazole|mesh-list
93309462|NCT02226783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93309463|NCT02226783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309464|NCT02226783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93309465|NCT02226783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309466|NCT02226783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309467|NCT03482232|Acetaminophen|acetaminophen|mesh-list
93309468|NCT03482232|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93309469|NCT03482232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93309470|NCT03482232|Anti-Infective Agents|anti-infective agents|mesh-list
93309471|NCT03482232|Ibuprofen|ibuprofen|mesh-list
93309472|NCT03482232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93309473|NCT03482232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93309474|NCT03482232|Hypolipidemic Agents|hypolipidemic agents|mesh-list
93309475|NCT03482232|Expectorants|expectorants|mesh-list
93309476|NCT03482232|Antitubercular Agents|antitubercular agents|mesh-ancestor
93309477|NCT03482232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93309478|NCT03482232|Analgesics|analgesics|mesh-ancestor
93309479|NCT03482232|Sensory System Agents|sensory system agents|mesh-ancestor
93309480|NCT03482232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309481|NCT03482232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309482|NCT03482232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309483|NCT03482232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93309484|NCT03482232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309485|NCT03482232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309486|NCT03482232|Antipyretics|antipyretics|mesh-ancestor
93309487|NCT03482232|Antimetabolites|antimetabolites|mesh-ancestor
93309488|NCT03482232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93309489|NCT03482232|Respiratory System Agents|respiratory system agents|mesh-ancestor
93309490|NCT02227017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93309491|NCT04542200|Antibodies|antibodies|mesh-list
93309492|NCT04542200|Immunologic Factors|immunologic factors|mesh-ancestor
93309493|NCT04542200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309494|NCT02227173|Flurbiprofen|flurbiprofen|mesh-list
93309495|NCT02227173|Digoxin|digoxin|mesh-list
93309496|NCT02227173|Montelukast|montelukast|mesh-list
93309497|NCT02227173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93309498|NCT02227173|Respiratory System Agents|respiratory system agents|mesh-ancestor
93309499|NCT02227173|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93309500|NCT02227173|Hormone Antagonists|hormone antagonists|mesh-ancestor
93309501|NCT02227173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309502|NCT02227173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309503|NCT02227173|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93309504|NCT02227173|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93309505|NCT02227173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309506|NCT02227173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93309507|NCT02227173|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93309508|NCT02227173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309509|NCT02227173|Protective Agents|protective agents|mesh-ancestor
93309510|NCT02227173|Analgesics|analgesics|mesh-ancestor
93309511|NCT02227173|Sensory System Agents|sensory system agents|mesh-ancestor
93309512|NCT02227173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309513|NCT02227173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93309514|NCT02227173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93309515|NCT02227173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93309516|NCT02227173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309517|NCT02227173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93309518|NCT02469740|Clopidogrel|clopidogrel|mesh-list
93309519|NCT02469740|Ticagrelor|ticagrelor|mesh-list
93309520|NCT02469740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93309521|NCT02469740|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93309522|NCT02469740|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93309523|NCT02469740|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93309524|NCT02469740|Purinergic Agents|purinergic agents|mesh-ancestor
93309525|NCT02469740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309526|NCT02469740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309527|NCT02469740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309528|NCT04432220|Apixaban|apixaban|mesh-list
93309529|NCT04432220|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93309530|NCT04432220|Antithrombins|antithrombins|mesh-ancestor
93309531|NCT04432220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93309532|NCT04432220|Protease Inhibitors|protease inhibitors|mesh-ancestor
93309533|NCT04432220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309534|NCT04432220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309535|NCT04432220|Anticoagulants|anticoagulants|mesh-ancestor
93309536|NCT03520842|Methotrexate|methotrexate|mesh-list
93309537|NCT03520842|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93309538|NCT03520842|Abortifacient Agents|abortifacient agents|mesh-ancestor
93309539|NCT03520842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93309540|NCT03520842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309541|NCT03520842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309542|NCT03520842|Antimetabolites|antimetabolites|mesh-ancestor
93309543|NCT03520842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309544|NCT03520842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309545|NCT03520842|Dermatologic Agents|dermatologic agents|mesh-ancestor
93309546|NCT03520842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309547|NCT03520842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93309548|NCT03520842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309549|NCT03520842|Immunologic Factors|immunologic factors|mesh-ancestor
93309550|NCT03520842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309551|NCT03520842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93309552|NCT04405622|Gemcitabine|gemcitabine|mesh-list
93309553|NCT04405622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309554|NCT04405622|Antimetabolites|antimetabolites|mesh-ancestor
93309555|NCT04405622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309556|NCT04405622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309557|NCT03481998|Letrozole|letrozole|mesh-list
93309558|NCT03481998|Fulvestrant|fulvestrant|mesh-list
93309559|NCT03481998|Anastrozole|anastrozole|mesh-list
93309560|NCT03481998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309561|NCT03481998|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93309562|NCT03481998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93309563|NCT03481998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309564|NCT03481998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309565|NCT03481998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93309566|NCT03481998|Hormone Antagonists|hormone antagonists|mesh-ancestor
93309567|NCT03481998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309568|NCT03481998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309569|NCT03481998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93309570|NCT03481998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93309571|NCT02723084|Ribavirin|ribavirin|mesh-list
93309572|NCT02723084|Sofosbuvir|sofosbuvir|mesh-list
93309573|NCT02723084|Antimetabolites|antimetabolites|mesh-ancestor
93309574|NCT02723084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309575|NCT02723084|Antiviral Agents|antiviral agents|mesh-ancestor
93309576|NCT02723084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309577|NCT02750943|Fluorides|fluorides|mesh-list
93309578|NCT02750943|Tin Fluorides|tin fluorides|mesh-list
93309579|NCT02750943|Fluorophosphate|fluorophosphate|mesh-list
93309580|NCT02750943|Cariostatic Agents|cariostatic agents|mesh-ancestor
93309581|NCT02750943|Protective Agents|protective agents|mesh-ancestor
93309582|NCT02750943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309583|NCT03481920|Avelumab|avelumab|mesh-list
93309584|NCT03481920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309585|NCT03481920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309586|NCT02227797|Voriconazole|voriconazole|mesh-list
93309587|NCT02227797|Antifungal Agents|antifungal agents|mesh-ancestor
93309588|NCT02227797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309589|NCT02227797|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93309590|NCT02227797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93309591|NCT02227797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309592|NCT02227797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309593|NCT02227797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93309594|NCT02227797|Hormone Antagonists|hormone antagonists|mesh-ancestor
93309595|NCT02227797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309596|NCT02227797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309597|NCT02227797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93309598|NCT05784311|Metronidazole|metronidazole|mesh-list
93309599|NCT05784311|Cefuroxime|cefuroxime|mesh-list
93309600|NCT05784311|Cefuroxime axetil|cefuroxime axetil|mesh-list
93309601|NCT05784311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309602|NCT05784311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93309603|NCT05784311|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93309604|NCT05784311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93309605|NCT05783921|Paclitaxel|paclitaxel|mesh-list
93309606|NCT05783921|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93309607|NCT05783921|Cisplatin|cisplatin|mesh-list
93309608|NCT05783921|Carboplatin|carboplatin|mesh-list
93309609|NCT05783921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93309610|NCT05783921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309611|NCT05783921|Tubulin Modulators|tubulin modulators|mesh-ancestor
93309612|NCT05783921|Antimitotic Agents|antimitotic agents|mesh-ancestor
93309613|NCT05783921|Mitosis Modulators|mitosis modulators|mesh-ancestor
93309614|NCT05783921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309615|NCT05783778|Testosterone|testosterone|mesh-list
93309616|NCT05783778|Androgens|androgens|mesh-ancestor
93309617|NCT05783778|Hormones|hormones|mesh-ancestor
93309618|NCT05783778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309619|NCT05783778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309620|NCT05783661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93309621|NCT05783661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309622|NCT05783648|Tranexamic Acid|tranexamic acid|mesh-list
93309623|NCT05783648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93309624|NCT05783648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93309625|NCT05783648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309626|NCT05783648|Hemostatics|hemostatics|mesh-ancestor
93309627|NCT05783648|Coagulants|coagulants|mesh-ancestor
93309628|NCT05783609|Rituximab|rituximab|mesh-list
93309629|NCT05783609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309630|NCT05783609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309631|NCT05783609|Immunologic Factors|immunologic factors|mesh-ancestor
93309632|NCT05783609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309633|NCT05783609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309634|NCT05783557|Clevidipine|clevidipine|mesh-list
93309635|NCT05783557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93309636|NCT05783557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93309637|NCT05783557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309638|NCT05783557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93309639|NCT05783557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309640|NCT05783544|Interferons|interferons|mesh-list
93309641|NCT05783544|Interferon-gamma|interferon-gamma|mesh-list
93309642|NCT05783544|Interleukin-4|interleukin-4|mesh-list
93309643|NCT05783544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309644|NCT05783544|Antiviral Agents|antiviral agents|mesh-ancestor
93309645|NCT05783544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309646|NCT05783544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93309647|NCT05783544|Immunologic Factors|immunologic factors|mesh-ancestor
93309648|NCT05783544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309649|NCT05783544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309650|NCT05783518|Propofol|propofol|mesh-list
93309651|NCT05783518|Desflurane|desflurane|mesh-list
93309652|NCT05783518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93309653|NCT05783518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309654|NCT05783518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309655|NCT05783518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93309656|NCT05783518|Anesthetics, General|anesthetics, general|mesh-ancestor
93309657|NCT05783518|Anesthetics|anesthetics|mesh-ancestor
93309658|NCT05783518|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93309659|NCT05783492|Ketamine|ketamine|mesh-list
93309660|NCT05783492|Analgesics|analgesics|mesh-ancestor
93309661|NCT05783492|Sensory System Agents|sensory system agents|mesh-ancestor
93309662|NCT05783492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309663|NCT05783492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309664|NCT05783492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93309665|NCT05783492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93309666|NCT05783492|Anesthetics, General|anesthetics, general|mesh-ancestor
93309667|NCT05783492|Anesthetics|anesthetics|mesh-ancestor
93309668|NCT05783492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309669|NCT05783492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93309670|NCT05783492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93309671|NCT05783492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309672|NCT05783492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309673|NCT05783479|Estradiol|estradiol|mesh-list
93309674|NCT05783479|Hyaluronic Acid|hyaluronic acid|mesh-list
93309675|NCT05783479|Estrogens|estrogens|mesh-ancestor
93309676|NCT05783479|Hormones|hormones|mesh-ancestor
93309677|NCT05783479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309678|NCT05783479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309679|NCT05783479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93309680|NCT05783479|Immunologic Factors|immunologic factors|mesh-ancestor
93309681|NCT05783479|Viscosupplements|viscosupplements|mesh-ancestor
93309682|NCT05783479|Protective Agents|protective agents|mesh-ancestor
93309683|NCT05783453|Emollients|emollients|mesh-list
93309684|NCT05783453|Dermatologic Agents|dermatologic agents|mesh-ancestor
93309685|NCT05782933|Rituximab|rituximab|mesh-list
93309686|NCT05782933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309687|NCT05782933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309688|NCT05782933|Immunologic Factors|immunologic factors|mesh-ancestor
93309689|NCT05782933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309690|NCT05782933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309691|NCT05782920|Hyaluronic Acid|hyaluronic acid|mesh-list
93309692|NCT05782920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93309693|NCT05782920|Immunologic Factors|immunologic factors|mesh-ancestor
93309694|NCT05782920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309695|NCT05782920|Viscosupplements|viscosupplements|mesh-ancestor
93309696|NCT05782920|Protective Agents|protective agents|mesh-ancestor
93309697|NCT05782881|Glucagon|glucagon|mesh-list
93309698|NCT05782881|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93309699|NCT05782881|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93309700|NCT05782881|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93309701|NCT05782881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309702|NCT05782881|Hormones|hormones|mesh-ancestor
93309703|NCT05782881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309704|NCT05782881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309705|NCT05782881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309706|NCT05782881|Incretins|incretins|mesh-ancestor
93309707|NCT05782881|Protease Inhibitors|protease inhibitors|mesh-ancestor
93309708|NCT05782777|Ezetimibe|ezetimibe|mesh-list
93309709|NCT05782777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93309710|NCT05782777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93309711|NCT05782777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93309712|NCT05782777|Antimetabolites|antimetabolites|mesh-ancestor
93309713|NCT05782777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309714|NCT05782777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93309715|NCT05782777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309716|NCT05782764|Endostar protein|endostar protein|mesh-list
93309717|NCT05782764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93309718|NCT05782764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93309719|NCT05782764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93309720|NCT05782764|Growth Substances|growth substances|mesh-ancestor
93309721|NCT05782764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309722|NCT05782764|Growth Inhibitors|growth inhibitors|mesh-ancestor
93309723|NCT05782764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309724|NCT05782764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309725|NCT05782764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309727|NCT05782751|Mitosis Modulators|mitosis modulators|mesh-ancestor
93309728|NCT05782751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309729|NCT05781074|Lenvatinib|lenvatinib|mesh-list
93309730|NCT05781074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309731|NCT05781074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93309732|NCT05781074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309733|NCT05781074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309734|NCT05780541|Remdesivir|remdesivir|mesh-list
93309735|NCT05780541|Antimetabolites|antimetabolites|mesh-ancestor
93309736|NCT05780541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309737|NCT05780541|Antiviral Agents|antiviral agents|mesh-ancestor
93309738|NCT05780541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309739|NCT05780463|Remdesivir|remdesivir|mesh-list
93309740|NCT05780463|Antimetabolites|antimetabolites|mesh-ancestor
93309741|NCT05780463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309742|NCT05780463|Antiviral Agents|antiviral agents|mesh-ancestor
93309743|NCT05780463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309744|NCT05780281|Remdesivir|remdesivir|mesh-list
93309745|NCT05780281|Sotrovimab|sotrovimab|mesh-list
93309746|NCT05780281|Antimetabolites|antimetabolites|mesh-ancestor
93309747|NCT05780281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309748|NCT05780281|Antiviral Agents|antiviral agents|mesh-ancestor
93309749|NCT05780281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309750|NCT05780268|Remdesivir|remdesivir|mesh-list
93309751|NCT05780268|Bamlanivimab|bamlanivimab|mesh-list
93309752|NCT05780268|Antimetabolites|antimetabolites|mesh-ancestor
93309753|NCT05780268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309754|NCT05780268|Antiviral Agents|antiviral agents|mesh-ancestor
93309755|NCT05780268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309756|NCT05779657|Midazolam|midazolam|mesh-list
93309757|NCT05779657|Ketamine|ketamine|mesh-list
93309758|NCT05779657|Analgesics|analgesics|mesh-ancestor
93309759|NCT05779657|Sensory System Agents|sensory system agents|mesh-ancestor
93309760|NCT05779657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309761|NCT05779657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309762|NCT05779657|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93309763|NCT05779657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93309764|NCT05779657|Anesthetics, General|anesthetics, general|mesh-ancestor
93309765|NCT05779657|Anesthetics|anesthetics|mesh-ancestor
93309766|NCT05779657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309767|NCT05779657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93309768|NCT05779657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93309769|NCT05779657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309770|NCT05779657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309771|NCT05779657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93309772|NCT05779657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93309773|NCT05779657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93309774|NCT05779657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93309775|NCT05779657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93309776|NCT05779657|GABA Modulators|gaba modulators|mesh-ancestor
93309777|NCT05779657|GABA Agents|gaba agents|mesh-ancestor
93309778|NCT05774054|Norepinephrine|norepinephrine|mesh-list
93309779|NCT05774054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93309780|NCT05774054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93309781|NCT05774054|Adrenergic Agents|adrenergic agents|mesh-ancestor
93309782|NCT05774054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309783|NCT05774054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309784|NCT05774054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309785|NCT05774054|Sympathomimetics|sympathomimetics|mesh-ancestor
93309786|NCT05774054|Autonomic Agents|autonomic agents|mesh-ancestor
93309787|NCT05774054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309788|NCT05774054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93309789|NCT05751148|Bupivacaine|bupivacaine|mesh-list
93309790|NCT05751148|Prilocaine|prilocaine|mesh-list
93309791|NCT05751148|Anesthetics, Local|anesthetics, local|mesh-ancestor
92604351|NCT00486460|Curcumin|curcumin|mesh-list
93309792|NCT05751148|Anesthetics|anesthetics|mesh-ancestor
93309793|NCT05751148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309794|NCT05751148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309795|NCT05751148|Sensory System Agents|sensory system agents|mesh-ancestor
92604365|NCT00486460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309796|NCT05751148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309797|NCT05711199|Nitroglycerin|nitroglycerin|mesh-list
93309798|NCT05711199|Vasodilator Agents|vasodilator agents|mesh-ancestor
93309799|NCT05703971|Atezolizumab|atezolizumab|mesh-list
93309800|NCT05703971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93309801|NCT05703971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309802|NCT05703971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309803|NCT05703971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309804|NCT05703074|Niacinamide|niacinamide|mesh-list
93309806|NCT05703074|Nicotinic Acids|nicotinic acids|mesh-list
93309807|NCT05703074|Vitamin B Complex|vitamin b complex|mesh-ancestor
93309808|NCT05703074|Vitamins|vitamins|mesh-ancestor
93309809|NCT05703074|Micronutrients|micronutrients|mesh-ancestor
93309810|NCT05703074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309811|NCT05703074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93309812|NCT05703074|Antimetabolites|antimetabolites|mesh-ancestor
93309813|NCT05703074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309814|NCT05703074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93309815|NCT05703074|Vasodilator Agents|vasodilator agents|mesh-ancestor
93309816|NCT05701865|Ethanol|ethanol|mesh-list
93309817|NCT05701865|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93309818|NCT05701865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309819|NCT05701865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309820|NCT05701865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309821|NCT05701345|Antidepressive Agents|antidepressive agents|mesh-list
93309822|NCT05701345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93309823|NCT05674721|Ibuprofen|ibuprofen|mesh-list
93309824|NCT05674721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93309825|NCT05674721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93309826|NCT05674721|Analgesics|analgesics|mesh-ancestor
93309827|NCT05674721|Sensory System Agents|sensory system agents|mesh-ancestor
93309828|NCT05674721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309829|NCT05674721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604391|NCT00486694|Amebicides|amebicides|mesh-ancestor
93309830|NCT05674721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93309831|NCT05674721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309832|NCT05674721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93309833|NCT05674721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309834|NCT05674721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309835|NCT05664464|Sulfasalazine|sulfasalazine|mesh-list
93309836|NCT05664464|Temozolomide|temozolomide|mesh-list
93309837|NCT05664464|Gabapentin|gabapentin|mesh-list
93309838|NCT05664464|Memantine|memantine|mesh-list
93309839|NCT05664464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93309840|NCT05664464|Alkylating Agents|alkylating agents|mesh-ancestor
93309841|NCT05664464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309842|NCT05664464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309843|NCT05664464|Analgesics|analgesics|mesh-ancestor
93309844|NCT05664464|Sensory System Agents|sensory system agents|mesh-ancestor
93309845|NCT05664464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309846|NCT05664464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309847|NCT05664464|Anticonvulsants|anticonvulsants|mesh-ancestor
93309848|NCT05664464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93309849|NCT05664464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93309850|NCT05664464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309851|NCT05664464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93309852|NCT05664464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93309853|NCT05664464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93309854|NCT05664464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309855|NCT05664464|Antimanic Agents|antimanic agents|mesh-ancestor
93309856|NCT05664464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93309857|NCT05664464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93309858|NCT05664464|Dopamine Agents|dopamine agents|mesh-ancestor
93309859|NCT05664464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309860|NCT05664464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93309862|NCT05664464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93309863|NCT05664464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309864|NCT05664464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309865|NCT05657457|Tenecteplase|tenecteplase|mesh-list
93309866|NCT05657457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93309867|NCT05657457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92011899|NCT03042923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93309868|NCT05657457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309869|NCT05646316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93309870|NCT05635344|Pembrolizumab|pembrolizumab|mesh-list
93309871|NCT05635344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309872|NCT05635344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309873|NCT05635344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93309874|NCT05635344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309875|NCT05630989|Hydroxychloroquine|hydroxychloroquine|mesh-list
93309876|NCT05630989|Mitogens|mitogens|mesh-list
93309877|NCT05630989|Antimalarials|antimalarials|mesh-ancestor
93309878|NCT05630989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93309879|NCT05630989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93309880|NCT05630989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309881|NCT05630989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604441|NCT00119145|Antiviral Agents|antiviral agents|mesh-ancestor
93309882|NCT05630989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309883|NCT05630989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93309884|NCT05630989|Mitosis Modulators|mitosis modulators|mesh-ancestor
93309885|NCT05626530|Letermovir|letermovir|mesh-list
93309886|NCT05626530|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93309887|NCT05626530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93309888|NCT05626530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309889|NCT05626530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309890|NCT05626530|Antiviral Agents|antiviral agents|mesh-ancestor
93309891|NCT05626530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93309892|NCT05601674|Anesthetics|anesthetics|mesh-list
93309893|NCT05601674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309894|NCT05601674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309895|NCT05567835|Leucovorin|leucovorin|mesh-list
93309896|NCT05567835|Docetaxel|docetaxel|mesh-list
93309897|NCT05567835|Fluorouracil|fluorouracil|mesh-list
93309898|NCT05567835|Oxaliplatin|oxaliplatin|mesh-list
93309899|NCT05567835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309900|NCT05567835|Tubulin Modulators|tubulin modulators|mesh-ancestor
93309901|NCT05567835|Antimitotic Agents|antimitotic agents|mesh-ancestor
93309902|NCT05567835|Mitosis Modulators|mitosis modulators|mesh-ancestor
93309903|NCT05567835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309904|NCT05567835|Antimetabolites|antimetabolites|mesh-ancestor
93309905|NCT05567835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309906|NCT05567835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309907|NCT05567835|Immunologic Factors|immunologic factors|mesh-ancestor
93309908|NCT05567835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309909|NCT05567835|Antidotes|antidotes|mesh-ancestor
93309910|NCT05567835|Protective Agents|protective agents|mesh-ancestor
93309911|NCT05567835|Vitamin B Complex|vitamin b complex|mesh-ancestor
93309912|NCT05567835|Vitamins|vitamins|mesh-ancestor
93309913|NCT05567835|Micronutrients|micronutrients|mesh-ancestor
93309914|NCT05527314|Fentanyl|fentanyl|mesh-list
93309915|NCT05527314|Remifentanil|remifentanil|mesh-list
93309916|NCT05527314|Sevoflurane|sevoflurane|mesh-list
93309917|NCT05527314|Cisatracurium|cisatracurium|mesh-list
93309918|NCT05527314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93309919|NCT05527314|Narcotics|narcotics|mesh-ancestor
93309920|NCT05527314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93309921|NCT05527314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309922|NCT05527314|Analgesics|analgesics|mesh-ancestor
93309923|NCT05527314|Sensory System Agents|sensory system agents|mesh-ancestor
93309924|NCT05527314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309925|NCT05527314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93309926|NCT05527314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93309927|NCT05527314|Anesthetics, General|anesthetics, general|mesh-ancestor
93309928|NCT05527314|Anesthetics|anesthetics|mesh-ancestor
93309929|NCT05527314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93309930|NCT05527314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93309931|NCT05527314|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93309932|NCT05527314|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93309933|NCT05517122|Niacinamide|niacinamide|mesh-list
93309934|NCT05517122|Niacin|niacin|mesh-list
93309935|NCT05517122|Nicotinic Acids|nicotinic acids|mesh-list
93309936|NCT05517122|Vitamin B Complex|vitamin b complex|mesh-ancestor
93309937|NCT05517122|Vitamins|vitamins|mesh-ancestor
93309938|NCT05517122|Micronutrients|micronutrients|mesh-ancestor
93309939|NCT05517122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309940|NCT05517122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93309941|NCT05517122|Antimetabolites|antimetabolites|mesh-ancestor
93309942|NCT05517122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309943|NCT05517122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93309944|NCT05517122|Vasodilator Agents|vasodilator agents|mesh-ancestor
93309945|NCT05484505|Nicotine|nicotine|mesh-list
93309946|NCT05484505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93309947|NCT05484505|Autonomic Agents|autonomic agents|mesh-ancestor
93309948|NCT05484505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93309949|NCT05484505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309950|NCT05484505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93309951|NCT05484505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93309952|NCT05484505|Cholinergic Agents|cholinergic agents|mesh-ancestor
93309953|NCT05484505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309954|NCT05484505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309955|NCT05478161|Fexofenadine|fexofenadine|mesh-list
93309956|NCT05478161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93309957|NCT05478161|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93309958|NCT05478161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93309959|NCT05478161|Histamine Antagonists|histamine antagonists|mesh-ancestor
93309960|NCT05478161|Histamine Agents|histamine agents|mesh-ancestor
93309961|NCT05478161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93309962|NCT05478161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309963|NCT05478161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309964|NCT05476822|Antibodies|antibodies|mesh-list
93309965|NCT05476822|Immunologic Factors|immunologic factors|mesh-ancestor
93309966|NCT05476822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309967|NCT05473364|Acetazolamide|acetazolamide|mesh-list
93309968|NCT05473364|Anticonvulsants|anticonvulsants|mesh-ancestor
93309969|NCT05473364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93309970|NCT05473364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604515|NCT00488527|Insulin Glargine|insulin glargine|mesh-list
93309971|NCT05473364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309972|NCT05473364|Diuretics|diuretics|mesh-ancestor
93309973|NCT05473364|Natriuretic Agents|natriuretic agents|mesh-ancestor
93309974|NCT05473364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309975|NCT05413811|Fluorouracil|fluorouracil|mesh-list
93309976|NCT05413811|Antimetabolites|antimetabolites|mesh-ancestor
93309977|NCT05413811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93309978|NCT05413811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93309979|NCT05413811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309980|NCT05413811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93309981|NCT05413811|Immunologic Factors|immunologic factors|mesh-ancestor
93309982|NCT05413811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93309983|NCT05393804|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93309984|NCT05393804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93309985|NCT05393804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309986|NCT05392608|Fulvestrant|fulvestrant|mesh-list
93309987|NCT05392608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93309988|NCT05392608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93309989|NCT05392608|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93309990|NCT05392608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93309991|NCT05392608|Hormone Antagonists|hormone antagonists|mesh-ancestor
93309992|NCT05392608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93309993|NCT05392608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604555|NCT00488605|Antidotes|antidotes|mesh-ancestor
93309994|NCT05382494|Mometasone Furoate|mometasone furoate|mesh-list
93309995|NCT05382494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93309996|NCT05382494|Dermatologic Agents|dermatologic agents|mesh-ancestor
93309997|NCT05382494|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93309998|NCT05351346|Prednisone|prednisone|mesh-list
93309999|NCT05351346|Cyclophosphamide|cyclophosphamide|mesh-list
93310000|NCT05351346|Rituximab|rituximab|mesh-list
93310001|NCT05351346|Doxorubicin|doxorubicin|mesh-list
93310002|NCT05351346|Vincristine|vincristine|mesh-list
93310003|NCT05351346|Lenalidomide|lenalidomide|mesh-list
93310004|NCT05351346|Decitabine|decitabine|mesh-list
93310005|NCT05351346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310006|NCT05351346|Immunologic Factors|immunologic factors|mesh-ancestor
93310007|NCT05351346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310008|NCT05351346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93310009|NCT05351346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93310010|NCT05351346|Alkylating Agents|alkylating agents|mesh-ancestor
93310011|NCT05351346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310012|NCT05351346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310013|NCT05351346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93310014|NCT05351346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310015|NCT05351346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310016|NCT05351346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310018|NCT05351346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310019|NCT05351346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93310020|NCT05351346|Glucocorticoids|glucocorticoids|mesh-ancestor
93310021|NCT05351346|Hormones|hormones|mesh-ancestor
93310022|NCT05351346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310023|NCT05351346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93310024|NCT05351346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310025|NCT05351346|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310026|NCT05351346|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310027|NCT05351346|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310028|NCT05351346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93310029|NCT05351346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93310030|NCT05351346|Growth Substances|growth substances|mesh-ancestor
93310031|NCT05351346|Growth Inhibitors|growth inhibitors|mesh-ancestor
93310032|NCT05351346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310033|NCT05351346|Antimetabolites|antimetabolites|mesh-ancestor
93310034|NCT05323019|Ketamine|ketamine|mesh-list
93310035|NCT05323019|Esketamine|esketamine|mesh-list
93310036|NCT05323019|Analgesics|analgesics|mesh-ancestor
93310037|NCT05323019|Sensory System Agents|sensory system agents|mesh-ancestor
93310038|NCT05323019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310039|NCT05323019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310040|NCT05323019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93310041|NCT05323019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93310042|NCT05323019|Anesthetics, General|anesthetics, general|mesh-ancestor
93310043|NCT05323019|Anesthetics|anesthetics|mesh-ancestor
93310044|NCT05323019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310045|NCT05323019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93310046|NCT05323019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93310047|NCT05323019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310048|NCT05323019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310049|NCT05323019|Antidepressive Agents|antidepressive agents|mesh-ancestor
93310050|NCT05323019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93310051|NCT05280743|Oxycodone|oxycodone|mesh-list
93310052|NCT05280743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93310053|NCT05280743|Narcotics|narcotics|mesh-ancestor
92675967|NCT00428649|Selenium|selenium|mesh-list
93310054|NCT05280743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310055|NCT05280743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310056|NCT05280743|Analgesics|analgesics|mesh-ancestor
93310057|NCT05280743|Sensory System Agents|sensory system agents|mesh-ancestor
93310058|NCT05280743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310059|NCT05276258|Bupivacaine|bupivacaine|mesh-list
93310060|NCT05276258|Anesthetics, Local|anesthetics, local|mesh-ancestor
93310061|NCT05276258|Anesthetics|anesthetics|mesh-ancestor
93310062|NCT05276258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310063|NCT05276258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310064|NCT05276258|Sensory System Agents|sensory system agents|mesh-ancestor
93310065|NCT05276258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310066|NCT05233982|Olaparib|olaparib|mesh-list
93310067|NCT05233982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93310068|NCT05233982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604618|NCT00489073|Analgesics|analgesics|mesh-ancestor
93310069|NCT05233982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310070|NCT05233982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310071|NCT05200845|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93310072|NCT05199493|Angiotensin II|angiotensin ii|mesh-list
93310073|NCT05199493|Giapreza|giapreza|mesh-list
93310074|NCT05199493|Angiotensinogen|angiotensinogen|mesh-list
93310075|NCT05199493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93310076|NCT05199493|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93310077|NCT05199493|Protease Inhibitors|protease inhibitors|mesh-ancestor
93310078|NCT05199493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310079|NCT05199493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310080|NCT05169658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93310081|NCT05169658|Obinutuzumab|obinutuzumab|mesh-list
93310082|NCT05169658|Antibodies|antibodies|mesh-list
93310083|NCT05169658|Immunoglobulins|immunoglobulins|mesh-list
93310084|NCT05169658|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93310085|NCT05169658|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93310086|NCT05169658|Immunoconjugates|immunoconjugates|mesh-list
93310087|NCT05169658|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93310088|NCT05169658|Immunologic Factors|immunologic factors|mesh-ancestor
93310089|NCT05169658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310090|NCT05169658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310091|NCT05112536|Paclitaxel|paclitaxel|mesh-list
93310092|NCT05112536|Carboplatin|carboplatin|mesh-list
93310093|NCT05112536|Doxorubicin|doxorubicin|mesh-list
93310094|NCT05112536|Pembrolizumab|pembrolizumab|mesh-list
93310095|NCT05112536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310096|NCT05112536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310097|NCT05112536|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310098|NCT05112536|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310099|NCT05112536|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310100|NCT05112536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310101|NCT05112536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310102|NCT05112536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310103|NCT05112536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310104|NCT05112536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310105|NCT05112536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310106|NCT05112536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310107|NCT05109455|Proanthocyanidin|proanthocyanidin|mesh-list
93310108|NCT05109455|Procyanidin|procyanidin|mesh-list
93310109|NCT05109455|Antioxidants|antioxidants|mesh-ancestor
93310110|NCT05109455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310111|NCT05109455|Protective Agents|protective agents|mesh-ancestor
93310112|NCT05109455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310113|NCT05109455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93310114|NCT05109455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93310115|NCT05109455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310116|NCT05098028|Rifaximin|rifaximin|mesh-list
93310117|NCT05098028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93310118|NCT05098028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310119|NCT05098028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93310120|NCT05079360|Everolimus|everolimus|mesh-list
93310121|NCT05079360|Exemestane|exemestane|mesh-list
93310122|NCT05079360|Estrogens|estrogens|mesh-list
93310123|NCT05079360|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
93310124|NCT05079360|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
93310125|NCT05079360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92676515|NCT00430170|Dipyridamole|dipyridamole|mesh-list
93310126|NCT05079360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93310127|NCT05079360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310128|NCT05079360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310129|NCT05079360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310130|NCT05079360|Immunologic Factors|immunologic factors|mesh-ancestor
93310131|NCT05079360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310132|NCT05079360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310133|NCT05079360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93310134|NCT05079360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93310135|NCT05079360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93310136|NCT05079360|Hormone Antagonists|hormone antagonists|mesh-ancestor
93310137|NCT05079360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310138|NCT05079360|Hormones|hormones|mesh-ancestor
93310139|NCT05078060|Vaccines|vaccines|mesh-list
93310140|NCT05078060|Immunologic Factors|immunologic factors|mesh-ancestor
93310141|NCT05078060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310142|NCT05063786|Capecitabine|capecitabine|mesh-list
93310143|NCT05063786|Trastuzumab|trastuzumab|mesh-list
93310144|NCT05063786|Vinorelbine|vinorelbine|mesh-list
93310145|NCT05063786|Fulvestrant|fulvestrant|mesh-list
93310146|NCT05063786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310147|NCT05063786|Antimetabolites|antimetabolites|mesh-ancestor
92012154|NCT05069779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93310148|NCT05063786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310149|NCT05063786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310150|NCT05063786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310151|NCT05063786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310152|NCT05063786|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310153|NCT05063786|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310154|NCT05063786|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310155|NCT05063786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93310156|NCT05063786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93310157|NCT05063786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93310158|NCT05063786|Hormone Antagonists|hormone antagonists|mesh-ancestor
93310159|NCT05063786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310160|NCT05063786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310161|NCT05035836|Tamoxifen|tamoxifen|mesh-list
93310162|NCT05035836|Letrozole|letrozole|mesh-list
93310163|NCT05035836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982144|NCT00833534|Rituximab|rituximab|mesh-list
93310164|NCT05035836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93310165|NCT05035836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93310166|NCT05035836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310167|NCT05035836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310168|NCT05035836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93310169|NCT05035836|Hormone Antagonists|hormone antagonists|mesh-ancestor
93310170|NCT05035836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310171|NCT05035836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310172|NCT05035836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93310173|NCT05035836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93310174|NCT05035836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93310175|NCT05035836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93310176|NCT05012787|Vaccines|vaccines|mesh-list
93310177|NCT05012787|1018 oligonucleotide|1018 oligonucleotide|mesh-list
93310178|NCT05012787|Immunologic Factors|immunologic factors|mesh-ancestor
93310179|NCT05012787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310180|NCT05012787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93310181|NCT05005260|Bupivacaine|bupivacaine|mesh-list
93310182|NCT05005260|Anesthetics, Local|anesthetics, local|mesh-ancestor
93310183|NCT05005260|Anesthetics|anesthetics|mesh-ancestor
93310184|NCT05005260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310185|NCT05005260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310186|NCT05005260|Sensory System Agents|sensory system agents|mesh-ancestor
93310187|NCT05005260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310188|NCT04990167|Bromides|bromides|mesh-list
93310189|NCT04990167|Tiotropium Bromide|tiotropium bromide|mesh-list
93310190|NCT04990167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93310191|NCT04990167|Autonomic Agents|autonomic agents|mesh-ancestor
93310192|NCT04990167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310193|NCT04990167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310194|NCT04990167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93310195|NCT04990167|Respiratory System Agents|respiratory system agents|mesh-ancestor
93310196|NCT04990167|Parasympatholytics|parasympatholytics|mesh-ancestor
93310197|NCT04990167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93310198|NCT04990167|Cholinergic Agents|cholinergic agents|mesh-ancestor
93310199|NCT04990167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310200|NCT04990167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310201|NCT04990167|Anticonvulsants|anticonvulsants|mesh-ancestor
93310202|NCT04926181|Androgens|androgens|mesh-list
93310203|NCT04926181|Hormones|hormones|mesh-ancestor
93310204|NCT04926181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310205|NCT04926181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310206|NCT04918927|Nitazoxanide|nitazoxanide|mesh-list
93310207|NCT04918927|Favipiravir|favipiravir|mesh-list
93310208|NCT04918927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93310209|NCT04918927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310210|NCT04918927|Antiviral Agents|antiviral agents|mesh-ancestor
93310211|NCT04907825|Warfarin|warfarin|mesh-list
93310212|NCT04907825|Anticoagulants|anticoagulants|mesh-list
93310213|NCT04907084|Fenofibrate|fenofibrate|mesh-list
93310214|NCT04907084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93310215|NCT04907084|Antimetabolites|antimetabolites|mesh-ancestor
93310216|NCT04907084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310217|NCT04907084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93310218|NCT04893356|Dacarbazine|dacarbazine|mesh-list
93310219|NCT04893356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93310220|NCT04893356|Alkylating Agents|alkylating agents|mesh-ancestor
93310221|NCT04893356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310222|NCT04893356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310223|NCT04857983|Memantine|memantine|mesh-list
93310224|NCT04857983|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93310225|NCT04857983|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93310226|NCT04857983|Dopamine Agents|dopamine agents|mesh-ancestor
93310227|NCT04857983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310228|NCT04857983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310229|NCT04857983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310230|NCT04857983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93310231|NCT04857983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93310232|NCT04777708|Pembrolizumab|pembrolizumab|mesh-list
93310233|NCT04777708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310234|NCT04777708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310235|NCT04777708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310236|NCT04777708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982225|NCT00622388|Ofatumumab|ofatumumab|mesh-list
93310237|NCT04763512|Caseins|caseins|mesh-list
93310238|NCT04763512|Chelating Agents|chelating agents|mesh-ancestor
93310239|NCT04763512|Sequestering Agents|sequestering agents|mesh-ancestor
93310240|NCT04763512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310241|NCT04730349|Nivolumab|nivolumab|mesh-list
93310242|NCT04730349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310243|NCT04730349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310244|NCT04730349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310245|NCT04730349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310246|NCT04602117|Paclitaxel|paclitaxel|mesh-list
93310247|NCT04602117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93310248|NCT04602117|Trastuzumab|trastuzumab|mesh-list
93310249|NCT04602117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310250|NCT04602117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310251|NCT04602117|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310252|NCT04602117|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310253|NCT04602117|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310254|NCT04602117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310255|NCT04602117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310256|NCT04601857|Pembrolizumab|pembrolizumab|mesh-list
93310257|NCT04601857|Futibatinib|futibatinib|mesh-list
93310258|NCT04601857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310259|NCT04601857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310260|NCT04601857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310261|NCT04601857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310262|NCT04541355|Sodium thiosulfate|sodium thiosulfate|mesh-list
93310263|NCT04541355|Cisplatin|cisplatin|mesh-list
93310264|NCT04541355|Antidotes|antidotes|mesh-list
93310265|NCT04541355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310266|NCT04541355|Protective Agents|protective agents|mesh-ancestor
93310267|NCT04541355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310268|NCT04541355|Antioxidants|antioxidants|mesh-ancestor
93310269|NCT04541355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310270|NCT04541355|Antitubercular Agents|antitubercular agents|mesh-ancestor
93310271|NCT04541355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93310272|NCT04541355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310273|NCT04541355|Chelating Agents|chelating agents|mesh-ancestor
93310274|NCT04541355|Sequestering Agents|sequestering agents|mesh-ancestor
93310275|NCT04517396|Fenofibrate|fenofibrate|mesh-list
93310276|NCT04517396|Fenofibric acid|fenofibric acid|mesh-list
93310277|NCT04517396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93310278|NCT04517396|Antimetabolites|antimetabolites|mesh-ancestor
93310279|NCT04517396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310280|NCT04517396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93310281|NCT04517396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93310282|NCT04501978|Remdesivir|remdesivir|mesh-list
93310283|NCT04501978|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93310284|NCT04501978|Bamlanivimab|bamlanivimab|mesh-list
93310285|NCT04501978|Sotrovimab|sotrovimab|mesh-list
93310286|NCT04501978|Antimetabolites|antimetabolites|mesh-ancestor
93310287|NCT04501978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310288|NCT04501978|Antiviral Agents|antiviral agents|mesh-ancestor
93310289|NCT04501978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310290|NCT04382352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93310291|NCT04382352|Trastuzumab|trastuzumab|mesh-list
93310292|NCT04382352|Antibodies|antibodies|mesh-list
93310293|NCT04382352|Immunoglobulins|immunoglobulins|mesh-list
93310294|NCT04382352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93310295|NCT04382352|Immunologic Factors|immunologic factors|mesh-ancestor
92604835|NCT04844385|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310296|NCT04382352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310297|NCT04382352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310298|NCT04354246|Pembrolizumab|pembrolizumab|mesh-list
93310299|NCT04354246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310300|NCT04354246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310301|NCT04354246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310302|NCT04354246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310303|NCT04311424|Tirzepatide|tirzepatide|mesh-list
93310304|NCT04311424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93310305|NCT04311424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310306|NCT04311424|Incretins|incretins|mesh-ancestor
93310307|NCT04311424|Hormones|hormones|mesh-ancestor
92604839|NCT00490633|Ethanol|ethanol|mesh-list
92604846|NCT00490711|Paclitaxel|paclitaxel|mesh-list
93310308|NCT04311424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310309|NCT04301765|Testosterone|testosterone|mesh-list
93310310|NCT04301765|Androgens|androgens|mesh-ancestor
93310311|NCT04301765|Hormones|hormones|mesh-ancestor
93310312|NCT04301765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310313|NCT04301765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310314|NCT04296396|Oxycodone|oxycodone|mesh-list
93310315|NCT04296396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93310316|NCT04296396|Narcotics|narcotics|mesh-ancestor
93310317|NCT04296396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310318|NCT04296396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310319|NCT04296396|Analgesics|analgesics|mesh-ancestor
93310320|NCT04296396|Sensory System Agents|sensory system agents|mesh-ancestor
93310321|NCT04296396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310322|NCT04291456|Minocycline|minocycline|mesh-list
93310323|NCT04291456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93310324|NCT04291456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310325|NCT04266977|Dexamethasone|dexamethasone|mesh-list
93310326|NCT04266977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93310327|NCT04266977|Antiemetics|antiemetics|mesh-ancestor
93310328|NCT04266977|Autonomic Agents|autonomic agents|mesh-ancestor
93310329|NCT04266977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310330|NCT04266977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310331|NCT04266977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93310332|NCT04266977|Glucocorticoids|glucocorticoids|mesh-ancestor
93310333|NCT04266977|Hormones|hormones|mesh-ancestor
93310334|NCT04266977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310335|NCT04266977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93310336|NCT04266977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310337|NCT04195945|Cytarabine|cytarabine|mesh-list
93310338|NCT04195945|Daunorubicin|daunorubicin|mesh-list
93310339|NCT04195945|Mitoxantrone|mitoxantrone|mesh-list
93310340|NCT04195945|Cladribine|cladribine|mesh-list
93310341|NCT04195945|Lenograstim|lenograstim|mesh-list
93310342|NCT04195945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310343|NCT04195945|Antimetabolites|antimetabolites|mesh-ancestor
93310344|NCT04195945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310345|NCT04195945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310346|NCT04195945|Antiviral Agents|antiviral agents|mesh-ancestor
93310347|NCT04195945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310348|NCT04195945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310349|NCT04195945|Immunologic Factors|immunologic factors|mesh-ancestor
93310350|NCT04195945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310351|NCT04195945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310352|NCT04195945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310353|NCT04195945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310354|NCT04195945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310355|NCT04195945|Analgesics|analgesics|mesh-ancestor
93310356|NCT04195945|Sensory System Agents|sensory system agents|mesh-ancestor
93310357|NCT04195945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310358|NCT04195945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93310359|NCT04172922|Sirolimus|sirolimus|mesh-list
93310360|NCT04172922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93310361|NCT04172922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310362|NCT04172922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310363|NCT04172922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310364|NCT04172922|Antifungal Agents|antifungal agents|mesh-ancestor
93310365|NCT04172922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310366|NCT04172922|Immunologic Factors|immunologic factors|mesh-ancestor
93310367|NCT04172922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310368|NCT04139772|Docetaxel|docetaxel|mesh-list
93310369|NCT04139772|Abiraterone Acetate|abiraterone acetate|mesh-list
93310370|NCT04139772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310371|NCT04139772|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310372|NCT04139772|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310373|NCT04139772|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310374|NCT04139772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310375|NCT04139772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93310376|NCT04139772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310377|NCT04139772|Hormone Antagonists|hormone antagonists|mesh-ancestor
93310378|NCT04139772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310379|NCT04139772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310380|NCT04139772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93310381|NCT04136353|Hormones|hormones|mesh-list
93310382|NCT04136353|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93310383|NCT04136353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310384|NCT04136353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310385|NCT04094688|Vitamin D|vitamin d|mesh-list
93310386|NCT04094688|Cholecalciferol|cholecalciferol|mesh-list
93310387|NCT04094688|Leucovorin|leucovorin|mesh-list
93310388|NCT04094688|Bevacizumab|bevacizumab|mesh-list
93310389|NCT04094688|Fluorouracil|fluorouracil|mesh-list
93310390|NCT04094688|Oxaliplatin|oxaliplatin|mesh-list
93310391|NCT04094688|Irinotecan|irinotecan|mesh-list
93310392|NCT04094688|Levoleucovorin|levoleucovorin|mesh-list
93310393|NCT04094688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310394|NCT04094688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310395|NCT04094688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93310396|NCT04094688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93310397|NCT04094688|Growth Substances|growth substances|mesh-ancestor
93310398|NCT04094688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310399|NCT04094688|Growth Inhibitors|growth inhibitors|mesh-ancestor
93310400|NCT04094688|Vitamins|vitamins|mesh-ancestor
92012396|NCT04832945|Ivermectin|ivermectin|mesh-list
93310401|NCT04094688|Micronutrients|micronutrients|mesh-ancestor
93310402|NCT04094688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93310403|NCT04094688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93310404|NCT04094688|Antimetabolites|antimetabolites|mesh-ancestor
93310405|NCT04094688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310406|NCT04094688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310407|NCT04094688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310408|NCT04094688|Immunologic Factors|immunologic factors|mesh-ancestor
93310409|NCT04094688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93310410|NCT04094688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310411|NCT04094688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310412|NCT04094688|Antidotes|antidotes|mesh-ancestor
93310413|NCT04094688|Protective Agents|protective agents|mesh-ancestor
93310414|NCT04094688|Vitamin B Complex|vitamin b complex|mesh-ancestor
93310415|NCT04091204|Olaparib|olaparib|mesh-list
93310416|NCT04091204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93310417|NCT04091204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604939|NCT00122603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93310418|NCT04091204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310419|NCT04091204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310420|NCT04028245|Spartalizumab|spartalizumab|mesh-list
93310421|NCT04028245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310422|NCT04028245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310423|NCT04028245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310424|NCT04028245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310425|NCT04017650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93310426|NCT04017650|Nivolumab|nivolumab|mesh-list
93310427|NCT04017650|Cetuximab|cetuximab|mesh-list
93310428|NCT04017650|Antibodies|antibodies|mesh-list
93310429|NCT04017650|Immunoglobulins|immunoglobulins|mesh-list
93310430|NCT04017650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93310431|NCT04017650|Immunologic Factors|immunologic factors|mesh-ancestor
93310432|NCT04017650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310433|NCT04017650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310434|NCT04017650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310435|NCT04017650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310436|NCT03975114|Durvalumab|durvalumab|mesh-list
93310437|NCT03975114|Tremelimumab|tremelimumab|mesh-list
93310438|NCT03975114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310439|NCT03975114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310440|NCT03955783|Venetoclax|venetoclax|mesh-list
93310441|NCT03955783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310442|NCT03942120|Ustekinumab|ustekinumab|mesh-list
93310443|NCT03942120|Dermatologic Agents|dermatologic agents|mesh-ancestor
93310444|NCT03940742|Tirzepatide|tirzepatide|mesh-list
93310445|NCT03940742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93310446|NCT03940742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310447|NCT03940742|Incretins|incretins|mesh-ancestor
93310448|NCT03940742|Hormones|hormones|mesh-ancestor
93310449|NCT03940742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310450|NCT03893240|Antibodies|antibodies|mesh-list
92604985|NCT01243528|Vitamin D|vitamin d|mesh-list
93310451|NCT03893240|Antibodies, Blocking|antibodies, blocking|mesh-list
93310452|NCT03893240|Immunologic Factors|immunologic factors|mesh-ancestor
93310453|NCT03893240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310454|NCT03878199|Cytarabine|cytarabine|mesh-list
93310455|NCT03878199|Daunorubicin|daunorubicin|mesh-list
93310456|NCT03878199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
93310457|NCT03878199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310458|NCT03878199|Antimetabolites|antimetabolites|mesh-ancestor
93310459|NCT03878199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310460|NCT03878199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310461|NCT03878199|Antiviral Agents|antiviral agents|mesh-ancestor
93310462|NCT03878199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310463|NCT03878199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310464|NCT03878199|Immunologic Factors|immunologic factors|mesh-ancestor
93310465|NCT03878199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310466|NCT03878199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310467|NCT03878199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310468|NCT03878199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310469|NCT03878199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310470|NCT03878199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93310471|NCT03875274|Morphine|morphine|mesh-list
93310472|NCT03875274|Ropivacaine|ropivacaine|mesh-list
93310473|NCT03875274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93310474|NCT03875274|Narcotics|narcotics|mesh-ancestor
93310475|NCT03875274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310476|NCT03875274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310477|NCT03875274|Analgesics|analgesics|mesh-ancestor
93310478|NCT03875274|Sensory System Agents|sensory system agents|mesh-ancestor
93310479|NCT03875274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310480|NCT03875274|Anesthetics, Local|anesthetics, local|mesh-ancestor
93310481|NCT03875274|Anesthetics|anesthetics|mesh-ancestor
93310482|NCT03775850|Pembrolizumab|pembrolizumab|mesh-list
93310483|NCT03775850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310484|NCT03775850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310485|NCT03775850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310486|NCT03775850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310487|NCT03762109|Dantrolene|dantrolene|mesh-list
93310488|NCT03762109|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93310489|NCT03762109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310490|NCT03762109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93310491|NCT03762109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310492|NCT03732664|Pembrolizumab|pembrolizumab|mesh-list
93310493|NCT03732664|Nivolumab|nivolumab|mesh-list
93310494|NCT03732664|Durvalumab|durvalumab|mesh-list
93310495|NCT03732664|Tislelizumab|tislelizumab|mesh-list
93310496|NCT03732664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310497|NCT03732664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310498|NCT03732664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310499|NCT03732664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310500|NCT03620032|Vinorelbine|vinorelbine|mesh-list
93310501|NCT03620032|Nimotuzumab|nimotuzumab|mesh-list
93310502|NCT03620032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310503|NCT03620032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310504|NCT03620032|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310505|NCT03620032|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310506|NCT03620032|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310507|NCT03620032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310508|NCT03620032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310509|NCT03410784|Paclitaxel|paclitaxel|mesh-list
93310510|NCT03410784|Carboplatin|carboplatin|mesh-list
93310511|NCT03410784|Pembrolizumab|pembrolizumab|mesh-list
93310512|NCT03410784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310513|NCT03410784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310514|NCT03410784|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310515|NCT03410784|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310516|NCT03410784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92012508|NCT04470973|Cefuroxime|cefuroxime|mesh-list
93310517|NCT03410784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310518|NCT03410784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310519|NCT03410784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310520|NCT03363841|Ibrexafungerp|ibrexafungerp|mesh-list
93310521|NCT03363841|Antifungal Agents|antifungal agents|mesh-ancestor
93310522|NCT03363841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310523|NCT03355482|Methylprednisolone|methylprednisolone|mesh-list
93310524|NCT03355482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93310525|NCT03355482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93310526|NCT03355482|Prednisolone|prednisolone|mesh-list
93310527|NCT03355482|Prednisolone acetate|prednisolone acetate|mesh-list
93310528|NCT03355482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93310529|NCT03355482|Prednisolone phosphate|prednisolone phosphate|mesh-list
93310530|NCT03355482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93310531|NCT03355482|Antiemetics|antiemetics|mesh-ancestor
93310532|NCT03355482|Autonomic Agents|autonomic agents|mesh-ancestor
93310533|NCT03355482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310534|NCT03355482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310535|NCT03355482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93310536|NCT03355482|Glucocorticoids|glucocorticoids|mesh-ancestor
93310537|NCT03355482|Hormones|hormones|mesh-ancestor
93310538|NCT03355482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310539|NCT03355482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93310540|NCT03355482|Protective Agents|protective agents|mesh-ancestor
93310541|NCT03355482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93310542|NCT03355482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310543|NCT03340064|Levetiracetam|levetiracetam|mesh-list
93310544|NCT03340064|Anticonvulsants|anticonvulsants|mesh-ancestor
93310545|NCT03340064|Nootropic Agents|nootropic agents|mesh-ancestor
93310546|NCT03326921|Vidarabine|vidarabine|mesh-list
93310547|NCT03326921|Fludarabine|fludarabine|mesh-list
93310548|NCT03326921|Fludarabine phosphate|fludarabine phosphate|mesh-list
93310549|NCT03326921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310550|NCT03326921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310551|NCT03326921|Antimetabolites|antimetabolites|mesh-ancestor
93310552|NCT03326921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310553|NCT03326921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310554|NCT03326921|Immunologic Factors|immunologic factors|mesh-ancestor
93310555|NCT03326921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310556|NCT03326921|Antiviral Agents|antiviral agents|mesh-ancestor
93310557|NCT03326921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310558|NCT03315260|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93310559|NCT03315260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310560|NCT03310619|Nivolumab|nivolumab|mesh-list
93310561|NCT03310619|Durvalumab|durvalumab|mesh-list
93310562|NCT03310619|Relatlimab|relatlimab|mesh-list
93310563|NCT03310619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310564|NCT03310619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310565|NCT03310619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310566|NCT03310619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310567|NCT03190785|Benzoic Acid|benzoic acid|mesh-list
93310568|NCT03190785|Antifungal Agents|antifungal agents|mesh-ancestor
93310569|NCT03190785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310570|NCT03093064|Natalizumab|natalizumab|mesh-list
93310571|NCT03093064|Immunologic Factors|immunologic factors|mesh-ancestor
93310572|NCT03093064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310573|NCT03060577|Evolocumab|evolocumab|mesh-list
93310574|NCT03060577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93310575|NCT03060577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93310576|NCT03060577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93310577|NCT03060577|Antimetabolites|antimetabolites|mesh-ancestor
92678304|NCT00446082|Pasireotide|pasireotide|mesh-list
93310578|NCT03060577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310579|NCT03060577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93310580|NCT03060577|Protease Inhibitors|protease inhibitors|mesh-ancestor
93310581|NCT03060577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310582|NCT03060577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93310583|NCT02797275|Albuterol|albuterol|mesh-list
93310584|NCT02797275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93310585|NCT02797275|Autonomic Agents|autonomic agents|mesh-ancestor
93310586|NCT02797275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310587|NCT02797275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310588|NCT02797275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93310589|NCT02797275|Respiratory System Agents|respiratory system agents|mesh-ancestor
93310590|NCT02797275|Tocolytic Agents|tocolytic agents|mesh-ancestor
92012589|NCT03097003|Apremilast|apremilast|mesh-list
93310591|NCT02797275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93310592|NCT02797275|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93310593|NCT02797275|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93310594|NCT02797275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93310595|NCT02797275|Adrenergic Agents|adrenergic agents|mesh-ancestor
93310596|NCT02797275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310597|NCT02797275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310598|NCT02787005|Pembrolizumab|pembrolizumab|mesh-list
93310599|NCT02787005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310600|NCT02787005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310601|NCT02787005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310602|NCT02787005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310603|NCT02734290|Paclitaxel|paclitaxel|mesh-list
93310604|NCT02734290|Pembrolizumab|pembrolizumab|mesh-list
93310605|NCT02734290|Capecitabine|capecitabine|mesh-list
93310606|NCT02734290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310607|NCT02734290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310608|NCT02734290|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310609|NCT02734290|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310610|NCT02734290|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310611|NCT02734290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310612|NCT02734290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310613|NCT02734290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310614|NCT02734290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310615|NCT02734290|Antimetabolites|antimetabolites|mesh-ancestor
93310616|NCT02673333|Pembrolizumab|pembrolizumab|mesh-list
93310617|NCT02673333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310618|NCT02673333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310619|NCT02673333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310620|NCT02673333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310621|NCT02633189|Bevacizumab|bevacizumab|mesh-list
93310622|NCT02633189|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93310623|NCT02633189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310624|NCT02633189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310625|NCT02633189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93310626|NCT02633189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93310627|NCT02633189|Growth Substances|growth substances|mesh-ancestor
93310628|NCT02633189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310629|NCT02633189|Growth Inhibitors|growth inhibitors|mesh-ancestor
93310630|NCT02633189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93310631|NCT02633189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310632|NCT02633189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310633|NCT02621242|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93310634|NCT02621242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93310635|NCT02621242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93310636|NCT02621242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310637|NCT02621242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310638|NCT02621242|Antiviral Agents|antiviral agents|mesh-ancestor
93310639|NCT02621242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310640|NCT02621242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93310641|NCT02621242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93310642|NCT02601313|Cyclophosphamide|cyclophosphamide|mesh-list
93310643|NCT02601313|Fludarabine|fludarabine|mesh-list
93310644|NCT02601313|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93310645|NCT02601313|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
93310646|NCT02601313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310647|NCT02601313|Immunologic Factors|immunologic factors|mesh-ancestor
93310648|NCT02601313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310649|NCT02601313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93310650|NCT02601313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93310651|NCT02601313|Alkylating Agents|alkylating agents|mesh-ancestor
93310652|NCT02601313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310653|NCT02601313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310654|NCT02601313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93310655|NCT02601313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310656|NCT02526368|Carbamide Peroxide|carbamide peroxide|mesh-list
93310657|NCT02526368|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93310658|NCT02526368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310659|NCT02514083|Fludarabine|fludarabine|mesh-list
93310660|NCT02514083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310661|NCT02500576|Aldesleukin|aldesleukin|mesh-list
93310662|NCT02500576|Cyclophosphamide|cyclophosphamide|mesh-list
93310663|NCT02500576|Pembrolizumab|pembrolizumab|mesh-list
93310664|NCT02500576|Fludarabine|fludarabine|mesh-list
93310665|NCT02500576|Fludarabine phosphate|fludarabine phosphate|mesh-list
93310666|NCT02500576|Interleukin-2|interleukin-2|mesh-list
93310667|NCT02500576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310668|NCT02500576|Immunologic Factors|immunologic factors|mesh-ancestor
93310669|NCT02500576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310670|NCT02500576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93310671|NCT02500576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93310672|NCT02500576|Alkylating Agents|alkylating agents|mesh-ancestor
93310673|NCT02500576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310674|NCT02500576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310675|NCT02500576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93310676|NCT02500576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310677|NCT02500576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310678|NCT02500576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310679|NCT02500576|Antimetabolites|antimetabolites|mesh-ancestor
93310680|NCT02500576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93310681|NCT02500576|Analgesics|analgesics|mesh-ancestor
93310682|NCT02500576|Sensory System Agents|sensory system agents|mesh-ancestor
93310683|NCT02500576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310684|NCT02500576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93310685|NCT02500576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93310686|NCT02500576|Antiviral Agents|antiviral agents|mesh-ancestor
93310687|NCT02500576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310688|NCT02395848|Fidaxomicin|fidaxomicin|mesh-list
93310689|NCT02395848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93310690|NCT02395848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310691|NCT02214381|Paclitaxel|paclitaxel|mesh-list
93310692|NCT02214381|Cyclophosphamide|cyclophosphamide|mesh-list
93310693|NCT02214381|Doxorubicin|doxorubicin|mesh-list
93310694|NCT02214381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310695|NCT02214381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310696|NCT02214381|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310697|NCT02214381|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310698|NCT02214381|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310699|NCT02214381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310700|NCT02214381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310701|NCT02214381|Immunologic Factors|immunologic factors|mesh-ancestor
93310702|NCT02214381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310703|NCT02214381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93310704|NCT02214381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93310705|NCT02214381|Alkylating Agents|alkylating agents|mesh-ancestor
93310706|NCT02214381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93310707|NCT02214381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310708|NCT02214381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310709|NCT02214381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310710|NCT02214381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310711|NCT02081326|BCG Vaccine|bcg vaccine|mesh-list
93310712|NCT02081326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93310713|NCT02081326|Immunologic Factors|immunologic factors|mesh-ancestor
93310714|NCT02081326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310715|NCT02061761|Nivolumab|nivolumab|mesh-list
93310716|NCT02061761|Relatlimab|relatlimab|mesh-list
93310717|NCT02061761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310718|NCT02061761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310719|NCT02061761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93310720|NCT02061761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310721|NCT01927068|Paclitaxel|paclitaxel|mesh-list
93310722|NCT01927068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310723|NCT01927068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310724|NCT01927068|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310725|NCT01927068|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310726|NCT01927068|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310727|NCT01927068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310728|NCT01898104|Capecitabine|capecitabine|mesh-list
93310729|NCT01898104|Valproic Acid|valproic acid|mesh-list
93310730|NCT01898104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310731|NCT01898104|Antimetabolites|antimetabolites|mesh-ancestor
93310732|NCT01898104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310733|NCT01898104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310734|NCT01898104|Anticonvulsants|anticonvulsants|mesh-ancestor
93310735|NCT01898104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310736|NCT01898104|GABA Agents|gaba agents|mesh-ancestor
93310737|NCT01898104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310738|NCT01898104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310739|NCT01898104|Antimanic Agents|antimanic agents|mesh-ancestor
93310740|NCT01898104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93310741|NCT01898104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310742|NCT01898104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93310743|NCT01817452|Paclitaxel|paclitaxel|mesh-list
93310744|NCT01817452|Trastuzumab|trastuzumab|mesh-list
93310745|NCT01817452|Pertuzumab|pertuzumab|mesh-list
93310746|NCT01817452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310747|NCT01817452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310748|NCT01817452|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310749|NCT01817452|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310750|NCT01817452|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310751|NCT01817452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310752|NCT01817452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310753|NCT01815242|Paclitaxel|paclitaxel|mesh-list
93310754|NCT01815242|Carboplatin|carboplatin|mesh-list
93310755|NCT01815242|Gemcitabine|gemcitabine|mesh-list
93310756|NCT01815242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310757|NCT01815242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310758|NCT01815242|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310759|NCT01815242|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310760|NCT01815242|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310761|NCT01815242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310762|NCT01815242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310763|NCT01815242|Antimetabolites|antimetabolites|mesh-ancestor
93310764|NCT01802749|Paclitaxel|paclitaxel|mesh-list
93310765|NCT01802749|Bevacizumab|bevacizumab|mesh-list
93310766|NCT01802749|Carboplatin|carboplatin|mesh-list
93310767|NCT01802749|Gemcitabine|gemcitabine|mesh-list
93310768|NCT01802749|Doxorubicin|doxorubicin|mesh-list
93310769|NCT01802749|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93310770|NCT01802749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310771|NCT01802749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310772|NCT01802749|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310773|NCT01802749|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310774|NCT01802749|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310775|NCT01802749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310776|NCT01802749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310777|NCT01802749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93310778|NCT01802749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93310779|NCT01802749|Growth Substances|growth substances|mesh-ancestor
93310780|NCT01802749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310781|NCT01802749|Growth Inhibitors|growth inhibitors|mesh-ancestor
93310782|NCT01802749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605308|NCT00127010|Vaccines|vaccines|mesh-list
93310783|NCT01802749|Antimetabolites|antimetabolites|mesh-ancestor
93310784|NCT01802749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310785|NCT01802749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310786|NCT01802749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310787|NCT01802749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310788|NCT01801904|Panitumumab|panitumumab|mesh-list
93310789|NCT01801904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310790|NCT01801904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310791|NCT01779206|Paclitaxel|paclitaxel|mesh-list
93310792|NCT01779206|Docetaxel|docetaxel|mesh-list
93310793|NCT01779206|Cyclophosphamide|cyclophosphamide|mesh-list
93310794|NCT01779206|Epirubicin|epirubicin|mesh-list
93310795|NCT01779206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310796|NCT01779206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310797|NCT01779206|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310798|NCT01779206|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310799|NCT01779206|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310800|NCT01779206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310801|NCT01779206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310802|NCT01779206|Immunologic Factors|immunologic factors|mesh-ancestor
93310803|NCT01779206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310804|NCT01779206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93310805|NCT01779206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93310806|NCT01779206|Alkylating Agents|alkylating agents|mesh-ancestor
93310807|NCT01779206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93310808|NCT01779206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310809|NCT01779206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310810|NCT01779206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310811|NCT01779206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310812|NCT01745965|Trastuzumab|trastuzumab|mesh-list
93310813|NCT01745965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310814|NCT01745965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310815|NCT01706120|Paclitaxel|paclitaxel|mesh-list
93310816|NCT01706120|Bevacizumab|bevacizumab|mesh-list
93310817|NCT01706120|Carboplatin|carboplatin|mesh-list
93310818|NCT01706120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310819|NCT01706120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310820|NCT01706120|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310821|NCT01706120|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310822|NCT01706120|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310823|NCT01706120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310824|NCT01706120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310825|NCT01706120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93310826|NCT01706120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93310827|NCT01706120|Growth Substances|growth substances|mesh-ancestor
93310828|NCT01706120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310829|NCT01706120|Growth Inhibitors|growth inhibitors|mesh-ancestor
93310830|NCT01682941|Phytoestrogens|phytoestrogens|mesh-list
93310831|NCT01682941|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93310832|NCT01682941|Estrogens|estrogens|mesh-ancestor
93310833|NCT01682941|Hormones|hormones|mesh-ancestor
93310834|NCT01682941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310835|NCT01682941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310836|NCT01656551|Gemcitabine|gemcitabine|mesh-list
93310837|NCT01656551|Pemetrexed|pemetrexed|mesh-list
93310838|NCT01656551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310839|NCT01656551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310840|NCT01656551|Antimetabolites|antimetabolites|mesh-ancestor
93310841|NCT01656551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310842|NCT01656551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310843|NCT01656551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93310844|NCT01656551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93310845|NCT01649674|Magnesium citrate|magnesium citrate|mesh-list
93310846|NCT01649674|Picosulfate sodium|picosulfate sodium|mesh-list
93310847|NCT01649674|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93310848|NCT01649674|Cathartics|cathartics|mesh-ancestor
93310849|NCT01649674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93310850|NCT01628211|Leucovorin|leucovorin|mesh-list
93310851|NCT01628211|Folic Acid|folic acid|mesh-list
92605347|NCT02957877|Heparin|heparin|mesh-list
93310852|NCT01628211|Fluorouracil|fluorouracil|mesh-list
93310853|NCT01628211|Oxaliplatin|oxaliplatin|mesh-list
93310854|NCT01628211|Levoleucovorin|levoleucovorin|mesh-list
93310855|NCT01628211|Antimetabolites|antimetabolites|mesh-ancestor
93310856|NCT01628211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310857|NCT01628211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310858|NCT01628211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310859|NCT01628211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310860|NCT01628211|Immunologic Factors|immunologic factors|mesh-ancestor
93310861|NCT01628211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310862|NCT01628211|Antidotes|antidotes|mesh-ancestor
93310863|NCT01628211|Protective Agents|protective agents|mesh-ancestor
93310864|NCT01628211|Vitamin B Complex|vitamin b complex|mesh-ancestor
93310865|NCT01628211|Vitamins|vitamins|mesh-ancestor
93310866|NCT01628211|Micronutrients|micronutrients|mesh-ancestor
93310867|NCT01628211|Hematinics|hematinics|mesh-ancestor
93310868|NCT01593488|Cytarabine|cytarabine|mesh-list
93310869|NCT01593488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310870|NCT01593488|Antimetabolites|antimetabolites|mesh-ancestor
93310871|NCT01593488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310872|NCT01593488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310873|NCT01593488|Antiviral Agents|antiviral agents|mesh-ancestor
93310874|NCT01593488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93310875|NCT01593488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93310876|NCT01593488|Immunologic Factors|immunologic factors|mesh-ancestor
93310877|NCT01593488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310878|NCT01405586|Gemcitabine|gemcitabine|mesh-list
93310879|NCT01405586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310880|NCT01405586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310881|NCT01405586|Antimetabolites|antimetabolites|mesh-ancestor
93310882|NCT01405586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310883|NCT01309230|Immunomodulating Agents|immunomodulating agents|mesh-list
93310884|NCT01309230|Immunologic Factors|immunologic factors|mesh-ancestor
93310885|NCT01309230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310886|NCT01238692|Rituximab|rituximab|mesh-list
93310887|NCT01238692|Panobinostat|panobinostat|mesh-list
93310888|NCT01238692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310889|NCT01238692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310890|NCT01238692|Immunologic Factors|immunologic factors|mesh-ancestor
93310891|NCT01238692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310892|NCT01238692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93310893|NCT01238692|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93310894|NCT01238692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310895|NCT01238692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310896|NCT01209871|Immunoglobulins|immunoglobulins|mesh-list
93310897|NCT01209871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93310898|NCT01209871|Antibodies|antibodies|mesh-list
93310899|NCT01209871|Immunologic Factors|immunologic factors|mesh-ancestor
93310900|NCT01209871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310901|NCT00996983|Ziconotide|ziconotide|mesh-list
93310902|NCT00996983|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93310903|NCT00996983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93310904|NCT00996983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310905|NCT00996983|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93310906|NCT00996983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310907|NCT00996983|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93310908|NCT00996983|Protective Agents|protective agents|mesh-ancestor
93310909|NCT00996983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93310910|NCT00996983|Analgesics|analgesics|mesh-ancestor
93310911|NCT00996983|Sensory System Agents|sensory system agents|mesh-ancestor
93310912|NCT00996983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310913|NCT00660842|Paclitaxel|paclitaxel|mesh-list
93310914|NCT00660842|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93310915|NCT00660842|Carboplatin|carboplatin|mesh-list
93310916|NCT00660842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310917|NCT00660842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310918|NCT00660842|Tubulin Modulators|tubulin modulators|mesh-ancestor
92982884|NCT00836654|Catumaxomab|catumaxomab|mesh-list
93310919|NCT00660842|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310920|NCT00660842|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310921|NCT00660842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310923|NCT00657878|Carboplatin|carboplatin|mesh-list
93310924|NCT00657878|Gemcitabine|gemcitabine|mesh-list
93310925|NCT00657878|Doxorubicin|doxorubicin|mesh-list
93310926|NCT00657878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93310927|NCT00657878|Topotecan|topotecan|mesh-list
93310928|NCT00657878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310929|NCT00657878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310930|NCT00657878|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310931|NCT00657878|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310932|NCT00657878|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310933|NCT00657878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310934|NCT00657878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93310935|NCT00657878|Antimetabolites|antimetabolites|mesh-ancestor
93310936|NCT00657878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93310937|NCT00657878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310938|NCT00657878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310939|NCT00657878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310940|NCT00657878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93310941|NCT00642057|Tetrabenazine|tetrabenazine|mesh-list
93310942|NCT00642057|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93310943|NCT00642057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93310944|NCT00642057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93310945|NCT00642057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310946|NCT00642057|Adrenergic Agents|adrenergic agents|mesh-ancestor
93310947|NCT00642057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310948|NCT00642057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310949|NCT00526396|Cisplatin|cisplatin|mesh-list
93310950|NCT00526396|Etoposide|etoposide|mesh-list
93310951|NCT00526396|Etoposide phosphate|etoposide phosphate|mesh-list
93310952|NCT00526396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310953|NCT00526396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310954|NCT00526396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93310955|NCT00526396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93310956|NCT00526396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310957|NCT00526396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310958|NCT00431704|Carboplatin|carboplatin|mesh-list
93310959|NCT00431704|Trastuzumab|trastuzumab|mesh-list
93310960|NCT00431704|Vinorelbine|vinorelbine|mesh-list
93310961|NCT00431704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310962|NCT00431704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93310963|NCT00431704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93310964|NCT00431704|Tubulin Modulators|tubulin modulators|mesh-ancestor
93310965|NCT00431704|Antimitotic Agents|antimitotic agents|mesh-ancestor
93310966|NCT00431704|Mitosis Modulators|mitosis modulators|mesh-ancestor
93310967|NCT00431704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310968|NCT00412022|Tamoxifen|tamoxifen|mesh-list
93310969|NCT00412022|Zoledronic Acid|zoledronic acid|mesh-list
93310970|NCT00412022|Letrozole|letrozole|mesh-list
93310971|NCT00412022|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93310972|NCT00412022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93310973|NCT00412022|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93310974|NCT00412022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93310975|NCT00412022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93310976|NCT00412022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93310977|NCT00412022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93310978|NCT00412022|Hormone Antagonists|hormone antagonists|mesh-ancestor
93310979|NCT00412022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93310980|NCT00412022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310981|NCT00412022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93310982|NCT00412022|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93310983|NCT00412022|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93310984|NCT00412022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93310985|NCT00412022|Luteolytic Agents|luteolytic agents|mesh-ancestor
93310986|NCT00412022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93310987|NCT00412022|Contraceptive Agents|contraceptive agents|mesh-ancestor
93310988|NCT00412022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93310989|NCT00412022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93310990|NCT03474510|Bupivacaine|bupivacaine|mesh-list
93310991|NCT03474510|Ropivacaine|ropivacaine|mesh-list
93310992|NCT03474510|Anesthetics, Local|anesthetics, local|mesh-ancestor
92982955|NCT00837044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93310993|NCT03474510|Anesthetics|anesthetics|mesh-ancestor
93310994|NCT03474510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93310995|NCT03474510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93310996|NCT03474510|Sensory System Agents|sensory system agents|mesh-ancestor
93310997|NCT03474510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93310998|NCT02470832|Itraconazole|itraconazole|mesh-list
93310999|NCT02470832|Antifungal Agents|antifungal agents|mesh-ancestor
93311000|NCT02470832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311001|NCT02470832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93311002|NCT02470832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93311003|NCT02470832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311004|NCT02470832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311005|NCT02470832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93311006|NCT02470832|Hormone Antagonists|hormone antagonists|mesh-ancestor
93311007|NCT02470832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311008|NCT02470832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311009|NCT02470832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93311010|NCT05258682|Acetylcysteine|acetylcysteine|mesh-list
93311011|NCT05258682|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93311012|NCT05258682|Antiviral Agents|antiviral agents|mesh-ancestor
93311013|NCT05258682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311014|NCT05258682|Expectorants|expectorants|mesh-ancestor
93311015|NCT05258682|Respiratory System Agents|respiratory system agents|mesh-ancestor
93311016|NCT05258682|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93311017|NCT05258682|Antioxidants|antioxidants|mesh-ancestor
93311018|NCT05258682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311019|NCT05258682|Protective Agents|protective agents|mesh-ancestor
93311020|NCT05258682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311021|NCT05258682|Antidotes|antidotes|mesh-ancestor
93311022|NCT02228031|Oxytocin|oxytocin|mesh-list
93311023|NCT02228031|Oxytocics|oxytocics|mesh-ancestor
93311024|NCT02228031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93311025|NCT02228031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311026|NCT04458948|Azithromycin|azithromycin|mesh-list
93311027|NCT04458948|Hydroxychloroquine|hydroxychloroquine|mesh-list
93311028|NCT04458948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93311029|NCT04458948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311030|NCT04458948|Antimalarials|antimalarials|mesh-ancestor
93311031|NCT04458948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93311032|NCT04458948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678917|NCT00344942|Hormones|hormones|mesh-ancestor
93311033|NCT04458948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311034|NCT04458948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311035|NCT04458948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93311036|NCT02232399|Simendan|simendan|mesh-list
93311037|NCT02232399|Milrinone|milrinone|mesh-list
93311038|NCT02232399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93311039|NCT02232399|Vasodilator Agents|vasodilator agents|mesh-ancestor
93311040|NCT02232399|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93311041|NCT02232399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93311042|NCT02232399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311043|NCT02232399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311044|NCT02232399|Protective Agents|protective agents|mesh-ancestor
93311045|NCT02232399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311046|NCT02232399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311047|NCT00704522|Ribavirin|ribavirin|mesh-list
93311048|NCT00704522|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93311049|NCT00704522|Antimetabolites|antimetabolites|mesh-ancestor
93311050|NCT00704522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311051|NCT00704522|Antiviral Agents|antiviral agents|mesh-ancestor
93311052|NCT00704522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311053|NCT04458558|Mifepristone|mifepristone|mesh-list
93311054|NCT04458558|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93311055|NCT04458558|Abortifacient Agents|abortifacient agents|mesh-ancestor
93311056|NCT04458558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93311057|NCT04458558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311058|NCT04458558|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93311059|NCT04458558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93311060|NCT04458558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93311061|NCT04458558|Contraceptive Agents|contraceptive agents|mesh-ancestor
93311062|NCT04458558|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93311063|NCT04458558|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93311064|NCT04458558|Hormone Antagonists|hormone antagonists|mesh-ancestor
93311065|NCT04458558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311066|NCT04458558|Luteolytic Agents|luteolytic agents|mesh-ancestor
93311067|NCT04458558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93311068|NCT04458558|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93311069|NCT03478332|Nitroglycerin|nitroglycerin|mesh-list
93311070|NCT03478332|Vasodilator Agents|vasodilator agents|mesh-ancestor
93311071|NCT03930498|Antibodies|antibodies|mesh-list
93311072|NCT03930498|Antibodies, Blocking|antibodies, blocking|mesh-list
93311073|NCT03930498|Immunologic Factors|immunologic factors|mesh-ancestor
93311074|NCT03930498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311075|NCT03817554|Dopamine|dopamine|mesh-list
93311076|NCT03817554|Pramipexole|pramipexole|mesh-list
93311077|NCT03817554|Dopamine Agonists|dopamine agonists|mesh-list
93311078|NCT03817554|Antioxidants|antioxidants|mesh-ancestor
93311079|NCT03817554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311080|NCT03817554|Protective Agents|protective agents|mesh-ancestor
93311081|NCT03817554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311082|NCT03817554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93311083|NCT03817554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93311084|NCT03817554|Dopamine Agents|dopamine agents|mesh-ancestor
93311085|NCT03817554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311086|NCT03817554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93311087|NCT03817554|Sympathomimetics|sympathomimetics|mesh-ancestor
93311088|NCT03817554|Autonomic Agents|autonomic agents|mesh-ancestor
93311089|NCT03817554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311090|NCT02223819|Crizotinib|crizotinib|mesh-list
93311091|NCT02223819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311092|NCT02223819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93311093|NCT02223819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311094|NCT02223819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311095|NCT03474198|Levofloxacin|levofloxacin|mesh-list
93311096|NCT03474198|Rifampin|rifampin|mesh-list
93311097|NCT03474198|Isoniazid|isoniazid|mesh-list
93311098|NCT03474198|Linezolid|linezolid|mesh-list
93311099|NCT03474198|Pyrazinamide|pyrazinamide|mesh-list
93311100|NCT03474198|Ethambutol|ethambutol|mesh-list
93311101|NCT03474198|Rifapentine|rifapentine|mesh-list
93311102|NCT03474198|Bedaquiline|bedaquiline|mesh-list
93311103|NCT03474198|Clofazimine|clofazimine|mesh-list
93311104|NCT03474198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93311105|NCT03474198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311106|NCT03474198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93311107|NCT03474198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93311108|NCT03474198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93311109|NCT03474198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311110|NCT03474198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311111|NCT03474198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311112|NCT03474198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93311113|NCT03474198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93311114|NCT03474198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93311115|NCT03474198|Antitubercular Agents|antitubercular agents|mesh-ancestor
93311116|NCT03474198|Leprostatic Agents|leprostatic agents|mesh-ancestor
93311117|NCT03474198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93311118|NCT03474198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93311119|NCT03474198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93311120|NCT03474198|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93311121|NCT03474198|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93311122|NCT03474198|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93311123|NCT03474198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93311124|NCT03474198|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93311125|NCT03474198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93311126|NCT03474198|Antimetabolites|antimetabolites|mesh-ancestor
93311127|NCT03474198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93311128|NCT03474198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93311129|NCT03474198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311130|NCT02723630|Lenvatinib|lenvatinib|mesh-list
93311131|NCT02723630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311132|NCT02723630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93311133|NCT02723630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311134|NCT02723630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311135|NCT02866227|TOL-463|tol-463|mesh-list
92013117|NCT03094507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93311136|NCT02866227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311137|NCT05258136|Antibodies|antibodies|mesh-list
93311138|NCT05258136|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93311139|NCT05258136|Immunologic Factors|immunologic factors|mesh-ancestor
93311140|NCT05258136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311141|NCT04356326|Aspirin|aspirin|mesh-list
93311142|NCT04356326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93311143|NCT04356326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93311145|NCT04356326|Sensory System Agents|sensory system agents|mesh-ancestor
93311146|NCT04356326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311147|NCT04356326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311148|NCT04356326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311149|NCT04356326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93311150|NCT04356326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93311151|NCT04356326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93311152|NCT04356326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311153|NCT04356326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311154|NCT04356326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93311155|NCT04356326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311156|NCT04356326|Antipyretics|antipyretics|mesh-ancestor
93311157|NCT02224131|Aspirin|aspirin|mesh-list
93311158|NCT02224131|Clopidogrel|clopidogrel|mesh-list
93311159|NCT02224131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93311160|NCT02224131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93311161|NCT02224131|Analgesics|analgesics|mesh-ancestor
93311162|NCT02224131|Sensory System Agents|sensory system agents|mesh-ancestor
93311163|NCT02224131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311164|NCT02224131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311165|NCT02224131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311166|NCT02224131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93311167|NCT02224131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93311168|NCT02224131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93311169|NCT02224131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311170|NCT02224131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311171|NCT02224131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93311172|NCT02224131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311173|NCT02224131|Antipyretics|antipyretics|mesh-ancestor
93311174|NCT02224131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93311175|NCT02224131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93311176|NCT02224131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93311177|NCT02224131|Purinergic Agents|purinergic agents|mesh-ancestor
93311178|NCT02224131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311179|NCT02068586|Sunitinib|sunitinib|mesh-list
93311180|NCT02068586|Valproic Acid|valproic acid|mesh-list
93311181|NCT02068586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311182|NCT02068586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93311183|NCT02068586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93311184|NCT02068586|Growth Substances|growth substances|mesh-ancestor
93311185|NCT02068586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311186|NCT02068586|Growth Inhibitors|growth inhibitors|mesh-ancestor
93311187|NCT02068586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93311188|NCT02068586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311189|NCT02068586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311190|NCT02068586|Anticonvulsants|anticonvulsants|mesh-ancestor
93311191|NCT02068586|GABA Agents|gaba agents|mesh-ancestor
93311192|NCT02068586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311193|NCT02068586|Antimanic Agents|antimanic agents|mesh-ancestor
93311194|NCT02068586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93311195|NCT02068586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311196|NCT02068586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311197|NCT03473964|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93311198|NCT03473964|Hormones|hormones|mesh-ancestor
93311199|NCT03473964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311200|NCT03473964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311201|NCT03309644|Iodine|iodine|mesh-list
93311202|NCT03309644|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93311203|NCT03309644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311204|NCT03309644|Trace Elements|trace elements|mesh-ancestor
93311205|NCT03309644|Micronutrients|micronutrients|mesh-ancestor
93311206|NCT03309644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311207|NCT03478020|Contraceptive Agents|contraceptive agents|mesh-list
93311208|NCT03478020|Contraceptives, Oral|contraceptives, oral|mesh-list
93311209|NCT03478020|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93311210|NCT03478020|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93311211|NCT03478020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311212|NCT03478020|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93311213|NCT02008292|Physostigmine|physostigmine|mesh-list
93311214|NCT02008292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93311215|NCT02008292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013200|NCT05009953|Leucovorin|leucovorin|mesh-list
93311216|NCT02008292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311217|NCT02008292|Cholinergic Agents|cholinergic agents|mesh-ancestor
93311218|NCT02008292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311219|NCT02008292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311220|NCT02008292|Miotics|miotics|mesh-ancestor
93311221|NCT02008292|Autonomic Agents|autonomic agents|mesh-ancestor
93311222|NCT02008292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311223|NCT03477864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93311224|NCT03477864|Ipilimumab|ipilimumab|mesh-list
93311225|NCT03477864|Cemiplimab|cemiplimab|mesh-list
93311226|NCT03477864|Antibodies|antibodies|mesh-list
93311227|NCT03477864|Immunoglobulins|immunoglobulins|mesh-list
93311228|NCT03477864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93311229|NCT03477864|Immunologic Factors|immunologic factors|mesh-ancestor
93311230|NCT03477864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311231|NCT03477864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311232|NCT03477864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93311233|NCT03477864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311234|NCT02229045|Paclitaxel|paclitaxel|mesh-list
93311235|NCT02229045|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93311236|NCT02229045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93311237|NCT02229045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311238|NCT02229045|Tubulin Modulators|tubulin modulators|mesh-ancestor
93311239|NCT02229045|Antimitotic Agents|antimitotic agents|mesh-ancestor
93311240|NCT02229045|Mitosis Modulators|mitosis modulators|mesh-ancestor
93311241|NCT02229045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311242|NCT02229123|Levetiracetam|levetiracetam|mesh-list
93311243|NCT02229123|Anticonvulsants|anticonvulsants|mesh-ancestor
93311244|NCT02229123|Nootropic Agents|nootropic agents|mesh-ancestor
93311245|NCT02229201|Propofol|propofol|mesh-list
93311246|NCT02229201|Sevoflurane|sevoflurane|mesh-list
93311247|NCT02229201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93311248|NCT02229201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311249|NCT02229201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311250|NCT02229201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93311251|NCT02229201|Anesthetics, General|anesthetics, general|mesh-ancestor
93311252|NCT02229201|Anesthetics|anesthetics|mesh-ancestor
93311253|NCT02229201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311254|NCT02229201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93311255|NCT02224443|Fentanyl|fentanyl|mesh-list
93311256|NCT02224443|Midazolam|midazolam|mesh-list
93311257|NCT02224443|Dexmedetomidine|dexmedetomidine|mesh-list
92679559|NCT03274323|Travoprost|travoprost|mesh-list
93311258|NCT02224443|Remifentanil|remifentanil|mesh-list
93311259|NCT02224443|Propofol|propofol|mesh-list
93311260|NCT02224443|Etomidate|etomidate|mesh-list
93311261|NCT02224443|Sevoflurane|sevoflurane|mesh-list
93311262|NCT02224443|Atracurium|atracurium|mesh-list
93311263|NCT02224443|Cisatracurium|cisatracurium|mesh-list
93311264|NCT02224443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93311265|NCT02224443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311266|NCT02224443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311267|NCT02224443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93311268|NCT02224443|Analgesics|analgesics|mesh-ancestor
93311269|NCT02224443|Sensory System Agents|sensory system agents|mesh-ancestor
93311270|NCT02224443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311271|NCT02224443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93311272|NCT02224443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93311273|NCT02224443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93311274|NCT02224443|Adrenergic Agents|adrenergic agents|mesh-ancestor
93311275|NCT02224443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311276|NCT02224443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311277|NCT02224443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93311278|NCT02224443|Anesthetics, General|anesthetics, general|mesh-ancestor
93311279|NCT02224443|Anesthetics|anesthetics|mesh-ancestor
93311280|NCT02224443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93311281|NCT02224443|Narcotics|narcotics|mesh-ancestor
93311282|NCT02224443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93311283|NCT02224443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93311284|NCT02224443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93311285|NCT02224443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311286|NCT02224443|GABA Modulators|gaba modulators|mesh-ancestor
93311287|NCT02224443|GABA Agents|gaba agents|mesh-ancestor
93311288|NCT02224443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311289|NCT02224443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93311290|NCT02224443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93311291|NCT02224443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93311292|NCT02224443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93311293|NCT02224443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93311294|NCT02224443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93311295|NCT02224443|Cholinergic Agents|cholinergic agents|mesh-ancestor
93311296|NCT05183126|Paclitaxel|paclitaxel|mesh-list
93311297|NCT05183126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93311298|NCT05183126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93311299|NCT05183126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311300|NCT05183126|Tubulin Modulators|tubulin modulators|mesh-ancestor
93311301|NCT05183126|Antimitotic Agents|antimitotic agents|mesh-ancestor
93311302|NCT05183126|Mitosis Modulators|mitosis modulators|mesh-ancestor
93311303|NCT05183126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311304|NCT01944800|Ticagrelor|ticagrelor|mesh-list
93311305|NCT01944800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93311306|NCT01944800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311307|NCT01944800|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93311308|NCT01944800|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93311309|NCT01944800|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93311310|NCT01944800|Purinergic Agents|purinergic agents|mesh-ancestor
93311311|NCT01944800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311312|NCT01944800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311313|NCT01944800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311314|NCT03617367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93311315|NCT03617367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93311316|NCT03617367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93311317|NCT03617367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311318|NCT03617367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311319|NCT03617367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93311320|NCT03617367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311321|NCT03617367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311322|NCT03617367|Cholinergic Agents|cholinergic agents|mesh-ancestor
93311323|NCT03617367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311324|NCT02470676|Progesterone|progesterone|mesh-list
93311325|NCT02470676|Progestins|progestins|mesh-ancestor
93311326|NCT02470676|Hormones|hormones|mesh-ancestor
93311327|NCT02470676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311328|NCT02470676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311329|NCT01933724|Prednisone|prednisone|mesh-list
93311330|NCT01933724|Glucocorticoids|glucocorticoids|mesh-list
93311331|NCT01933724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311332|NCT01933724|Hormones|hormones|mesh-ancestor
93311333|NCT01933724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311334|NCT01933724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311335|NCT01933724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93311336|NCT01933724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311337|NCT02229747|Diclofenac|diclofenac|mesh-list
93311338|NCT02229747|Meloxicam|meloxicam|mesh-list
93311339|NCT02229747|Nimesulide|nimesulide|mesh-list
93311340|NCT02229747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93311341|NCT02229747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93311342|NCT02229747|Analgesics|analgesics|mesh-ancestor
93311343|NCT02229747|Sensory System Agents|sensory system agents|mesh-ancestor
93311344|NCT02229747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311345|NCT02229747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311346|NCT02229747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311347|NCT02229747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93311348|NCT02229747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93311349|NCT02229747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311350|NCT02229747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311351|NCT02229747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93311352|NCT02232789|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93311353|NCT02232789|Hallucinogens|hallucinogens|mesh-ancestor
93311354|NCT02232789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311355|NCT02232789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311356|NCT02232789|Serotonin Agents|serotonin agents|mesh-ancestor
93311357|NCT02232789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311358|NCT02232789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311359|NCT02232789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93311360|NCT02232789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93311361|NCT02232789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311362|NCT02232789|Adrenergic Agents|adrenergic agents|mesh-ancestor
93311363|NCT03030222|Empagliflozin|empagliflozin|mesh-list
93311364|NCT03030222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93311365|NCT03030222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311366|NCT03030222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93311367|NCT03030222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983331|NCT00852566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311368|NCT02232945|Oseltamivir|oseltamivir|mesh-list
93311369|NCT02232945|Antiviral Agents|antiviral agents|mesh-ancestor
93311370|NCT02232945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311371|NCT02232945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311372|NCT02232945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311373|NCT02546622|Factor VIII|factor viii|mesh-list
93311374|NCT02546622|Coagulants|coagulants|mesh-ancestor
93311375|NCT02229825|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93311376|NCT02229825|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93311377|NCT02229825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93311378|NCT02229825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311379|NCT02229825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311380|NCT02229825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311381|NCT02229825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311382|NCT02229825|Analgesics|analgesics|mesh-ancestor
93311383|NCT02229825|Sensory System Agents|sensory system agents|mesh-ancestor
93311384|NCT02229825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311385|NCT02229825|Antidepressive Agents|antidepressive agents|mesh-ancestor
93311386|NCT02229825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311387|NCT02229825|Dopamine Agents|dopamine agents|mesh-ancestor
93311388|NCT03309566|Tenofovir|tenofovir|mesh-list
93311389|NCT03309566|Emtricitabine|emtricitabine|mesh-list
93311390|NCT03309566|Efavirenz|efavirenz|mesh-list
93311391|NCT03309566|Antiviral Agents|antiviral agents|mesh-ancestor
93311392|NCT03309566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311393|NCT03309566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93311394|NCT03309566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93311395|NCT03309566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311396|NCT03309566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311397|NCT03309566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93311398|NCT03309566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93311399|NCT03309566|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93311400|NCT03309566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93311401|NCT03309566|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93311402|NCT03309566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93311403|NCT03309566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93311404|NCT03309566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93311405|NCT00735657|Iodine|iodine|mesh-list
93311406|NCT00735657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93311407|NCT00735657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311408|NCT00735657|Trace Elements|trace elements|mesh-ancestor
93311409|NCT00735657|Micronutrients|micronutrients|mesh-ancestor
93311410|NCT00735657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311411|NCT04030143|Aripiprazole|aripiprazole|mesh-list
93311412|NCT04030143|Antidepressive Agents|antidepressive agents|mesh-ancestor
92605921|NCT00127985|Glucocorticoids|glucocorticoids|mesh-ancestor
93311413|NCT04030143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311414|NCT04030143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93311415|NCT04030143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93311416|NCT04030143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311417|NCT04030143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311418|NCT04030143|Dopamine Agonists|dopamine agonists|mesh-ancestor
93311419|NCT04030143|Dopamine Agents|dopamine agents|mesh-ancestor
93311420|NCT04030143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311421|NCT04030143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311422|NCT04030143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93311423|NCT04030143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93311424|NCT04030143|Serotonin Agents|serotonin agents|mesh-ancestor
93311425|NCT04030143|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93311426|NCT04030143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93311427|NCT04030143|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93311428|NCT04030143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93311429|NCT02470442|Sevoflurane|sevoflurane|mesh-list
93311430|NCT02470442|Desflurane|desflurane|mesh-list
93311431|NCT02470442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93311432|NCT02470442|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93311433|NCT02470442|Anesthetics, General|anesthetics, general|mesh-ancestor
93311434|NCT02470442|Anesthetics|anesthetics|mesh-ancestor
93311435|NCT02470442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311436|NCT02470442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311437|NCT01329939|Montelukast|montelukast|mesh-list
93311438|NCT01329939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93311439|NCT01329939|Respiratory System Agents|respiratory system agents|mesh-ancestor
93311440|NCT01329939|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93311441|NCT01329939|Hormone Antagonists|hormone antagonists|mesh-ancestor
93311442|NCT01329939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311443|NCT01329939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311444|NCT01329939|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93311445|NCT01329939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93311446|NCT01329939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311448|NCT02499900|(T,G)-A-L|(t,g)-a-l|mesh-list
93311449|NCT02499900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93311450|NCT02499900|Immunologic Factors|immunologic factors|mesh-ancestor
93311451|NCT02499900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311452|NCT02499900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93311453|NCT02499900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93311454|NCT04554693|Metronidazole|metronidazole|mesh-list
93311455|NCT04554693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311456|NCT04554693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93311457|NCT04554693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93311458|NCT04554693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93311459|NCT02230371|Granisetron|granisetron|mesh-list
93311460|NCT02230371|Antiemetics|antiemetics|mesh-ancestor
93311461|NCT02230371|Autonomic Agents|autonomic agents|mesh-ancestor
93311462|NCT02230371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311463|NCT02230371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311464|NCT02230371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311465|NCT02230371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93311466|NCT02230371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93311467|NCT02230371|Serotonin Agents|serotonin agents|mesh-ancestor
93311468|NCT02230371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311469|NCT02230371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311470|NCT03313934|Hyaluronic Acid|hyaluronic acid|mesh-list
93311471|NCT03313934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93311472|NCT03313934|Immunologic Factors|immunologic factors|mesh-ancestor
93311473|NCT03313934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311474|NCT03313934|Viscosupplements|viscosupplements|mesh-ancestor
93311475|NCT03313934|Protective Agents|protective agents|mesh-ancestor
93311476|NCT03313856|Magnesium Oxide|magnesium oxide|mesh-list
93311477|NCT03313856|Antacids|antacids|mesh-ancestor
92605981|NCT00424203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311478|NCT03313856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311479|NCT03313856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311480|NCT05137626|Digoxin|digoxin|mesh-list
93311481|NCT05137626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93311482|NCT05137626|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93311483|NCT05137626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311484|NCT05137626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311485|NCT05137626|Protective Agents|protective agents|mesh-ancestor
93311486|NCT05137626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311487|NCT02233023|Dopamine|dopamine|mesh-list
93311488|NCT02233023|Pramipexole|pramipexole|mesh-list
93311489|NCT02233023|Bromocriptine|bromocriptine|mesh-list
93311490|NCT02233023|Dopamine Agonists|dopamine agonists|mesh-list
93311491|NCT02233023|Antioxidants|antioxidants|mesh-ancestor
93311492|NCT02233023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311493|NCT02233023|Protective Agents|protective agents|mesh-ancestor
93311494|NCT02233023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311495|NCT02233023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93311496|NCT02233023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93311497|NCT02233023|Dopamine Agents|dopamine agents|mesh-ancestor
93311498|NCT02233023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311499|NCT02233023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93311500|NCT02233023|Sympathomimetics|sympathomimetics|mesh-ancestor
93311501|NCT02233023|Autonomic Agents|autonomic agents|mesh-ancestor
93311502|NCT02233023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311503|NCT02233023|Hormone Antagonists|hormone antagonists|mesh-ancestor
93311504|NCT02233023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311505|NCT03710642|Prazosin|prazosin|mesh-list
93311506|NCT03710642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93311507|NCT03710642|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93311508|NCT03710642|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92606022|NCT00499876|Mefloquine|mefloquine|mesh-list
93311509|NCT03710642|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93311510|NCT03710642|Adrenergic Agents|adrenergic agents|mesh-ancestor
93311511|NCT03710642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311512|NCT03710642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311513|NCT03710642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311514|NCT02259309|Misoprostol|misoprostol|mesh-list
93311515|NCT02259309|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93311516|NCT02259309|Abortifacient Agents|abortifacient agents|mesh-ancestor
93311517|NCT02259309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93311518|NCT02259309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311519|NCT02259309|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93311520|NCT02259309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311521|NCT02259309|Oxytocics|oxytocics|mesh-ancestor
93311522|NCT04459026|Ropivacaine|ropivacaine|mesh-list
93311523|NCT04459026|Anesthetics, Local|anesthetics, local|mesh-ancestor
93311524|NCT04459026|Anesthetics|anesthetics|mesh-ancestor
93311525|NCT04459026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311526|NCT04459026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311527|NCT04459026|Sensory System Agents|sensory system agents|mesh-ancestor
92680284|NCT00458328|Z 338|z 338|mesh-list
93311528|NCT04459026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311529|NCT03473418|Ketoconazole|ketoconazole|mesh-list
93311530|NCT03473418|Terconazole|terconazole|mesh-list
93311531|NCT03473418|Antifungal Agents|antifungal agents|mesh-ancestor
93311532|NCT03473418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311533|NCT03473418|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93311534|NCT03473418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93311535|NCT03473418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311536|NCT03473418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311537|NCT03473418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93311538|NCT03473418|Hormone Antagonists|hormone antagonists|mesh-ancestor
93311539|NCT03473418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311540|NCT03473418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311541|NCT03473418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93311542|NCT04282278|Apatinib|apatinib|mesh-list
93311543|NCT04282278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311544|NCT04282278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93311545|NCT04282278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311546|NCT04282278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311547|NCT00705224|Interferons|interferons|mesh-list
93311548|NCT00705224|Ribavirin|ribavirin|mesh-list
93311549|NCT00705224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311550|NCT00705224|Antiviral Agents|antiviral agents|mesh-ancestor
93311551|NCT00705224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311552|NCT00705224|Antimetabolites|antimetabolites|mesh-ancestor
93311553|NCT00705224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311554|NCT02457156|Octreotide|octreotide|mesh-list
93311555|NCT02457156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606052|NCT04710914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93311556|NCT02457156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93311557|NCT02457156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311558|NCT02523300|Methylprednisolone|methylprednisolone|mesh-list
93311559|NCT02523300|Glucocorticoids|glucocorticoids|mesh-list
93311560|NCT02523300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311561|NCT02523300|Antiemetics|antiemetics|mesh-ancestor
93311562|NCT02523300|Autonomic Agents|autonomic agents|mesh-ancestor
93311563|NCT02523300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311564|NCT02523300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311565|NCT02523300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311566|NCT02523300|Hormones|hormones|mesh-ancestor
93311567|NCT02523300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311568|NCT02523300|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93311569|NCT02523300|Protective Agents|protective agents|mesh-ancestor
93311570|NCT02325960|Insulin Glargine|insulin glargine|mesh-list
93311571|NCT02325960|Exenatide|exenatide|mesh-list
93311572|NCT02325960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93311573|NCT02325960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311574|NCT02325960|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93311575|NCT02325960|Incretins|incretins|mesh-ancestor
93311576|NCT02325960|Hormones|hormones|mesh-ancestor
93311577|NCT02325960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311578|NCT05265650|Nivolumab|nivolumab|mesh-list
93311579|NCT05265650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93311580|NCT05265650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311581|NCT05265650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93311582|NCT05265650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311583|NCT02234349|Pancrelipase|pancrelipase|mesh-list
93311584|NCT02234349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311585|NCT04458636|Prednisolone|prednisolone|mesh-list
93311586|NCT04458636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311587|NCT04458636|Glucocorticoids|glucocorticoids|mesh-ancestor
93311588|NCT04458636|Hormones|hormones|mesh-ancestor
93311589|NCT04458636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983553|NCT00620282|Glimepiride|glimepiride|mesh-list
93311590|NCT04458636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311591|NCT04458636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93311592|NCT04458636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311593|NCT03304652|Zaleplon|zaleplon|mesh-list
93311594|NCT03304652|Anticonvulsants|anticonvulsants|mesh-ancestor
93311595|NCT03304652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93311596|NCT03304652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311597|NCT03304652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311598|NCT03304652|GABA Modulators|gaba modulators|mesh-ancestor
93311599|NCT03304652|GABA Agents|gaba agents|mesh-ancestor
93311600|NCT03304652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311601|NCT03304652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311602|NCT03162783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93311603|NCT03162783|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93311604|NCT02523144|Dexmedetomidine|dexmedetomidine|mesh-list
92606121|NCT00501124|Clevudine|clevudine|mesh-list
93311605|NCT02523144|Chloral Hydrate|chloral hydrate|mesh-list
93311606|NCT02523144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93311607|NCT02523144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311608|NCT02523144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311609|NCT02523144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93311610|NCT02523144|Analgesics|analgesics|mesh-ancestor
93311611|NCT02523144|Sensory System Agents|sensory system agents|mesh-ancestor
93311612|NCT02523144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311613|NCT02523144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93311614|NCT02523144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93311615|NCT02523144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93311616|NCT02523144|Adrenergic Agents|adrenergic agents|mesh-ancestor
93311617|NCT02523144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311618|NCT02523144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311619|NCT00704132|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93311620|NCT00704132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93311621|NCT00704132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311622|NCT00704132|Incretins|incretins|mesh-ancestor
93311623|NCT00704132|Hormones|hormones|mesh-ancestor
93092450|NCT03847922|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93311624|NCT00704132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311625|NCT00704132|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93311626|NCT00704132|Protease Inhibitors|protease inhibitors|mesh-ancestor
93311627|NCT00704132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311628|NCT00704132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311629|NCT03304496|Nitroglycerin|nitroglycerin|mesh-list
93311630|NCT03304496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93311631|NCT03304496|Vasodilator Agents|vasodilator agents|mesh-ancestor
93311632|NCT03840837|Rivastigmine|rivastigmine|mesh-list
93311633|NCT03840837|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93311634|NCT03840837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311635|NCT03840837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311636|NCT03840837|Cholinergic Agents|cholinergic agents|mesh-ancestor
93311637|NCT03840837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311638|NCT03840837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311639|NCT03840837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93311640|NCT03840837|Protective Agents|protective agents|mesh-ancestor
93311641|NCT03527238|Tacrolimus|tacrolimus|mesh-list
93311642|NCT03527238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93311643|NCT03527238|Immunologic Factors|immunologic factors|mesh-ancestor
93311644|NCT03527238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311645|NCT03527238|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93311646|NCT03527238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311647|NCT03527238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311648|NCT03832179|Dexamethasone|dexamethasone|mesh-list
93311649|NCT03832179|Bevacizumab|bevacizumab|mesh-list
93311650|NCT03832179|Ranibizumab|ranibizumab|mesh-list
93311651|NCT03832179|Aflibercept|aflibercept|mesh-list
93311652|NCT03832179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93311653|NCT03832179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311654|NCT03832179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93311655|NCT03832179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93311656|NCT03832179|Growth Substances|growth substances|mesh-ancestor
93311657|NCT03832179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311658|NCT03832179|Growth Inhibitors|growth inhibitors|mesh-ancestor
93311659|NCT03832179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311660|NCT03832179|Antiemetics|antiemetics|mesh-ancestor
93311661|NCT03832179|Autonomic Agents|autonomic agents|mesh-ancestor
93311662|NCT03832179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311663|NCT03832179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311664|NCT03832179|Glucocorticoids|glucocorticoids|mesh-ancestor
93311665|NCT03832179|Hormones|hormones|mesh-ancestor
93311666|NCT03832179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606175|NCT00501514|Hormones|hormones|mesh-list
93311667|NCT03832179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93311668|NCT03123783|Nivolumab|nivolumab|mesh-list
93311669|NCT03123783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93311670|NCT03123783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311671|NCT03123783|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93311672|NCT03123783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311673|NCT05154396|Loperamide|loperamide|mesh-list
93311674|NCT05154396|Antidiarrheals|antidiarrheals|mesh-ancestor
93311675|NCT05154396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311676|NCT04740645|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93311677|NCT04740645|Hemostatics|hemostatics|mesh-ancestor
93311678|NCT04740645|Coagulants|coagulants|mesh-ancestor
93311679|NCT04740645|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93311680|NCT04740645|Natriuretic Agents|natriuretic agents|mesh-ancestor
93311681|NCT04740645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311682|NCT04735185|Anesthetics|anesthetics|mesh-list
93311683|NCT04735185|Anesthetics, Local|anesthetics, local|mesh-list
93311684|NCT04735185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311685|NCT04735185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311686|NCT04735185|Sensory System Agents|sensory system agents|mesh-ancestor
93311687|NCT04735185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311688|NCT02802813|Primaquine|primaquine|mesh-list
93311689|NCT02802813|Piperaquine|piperaquine|mesh-list
93311690|NCT02802813|Artenimol|artenimol|mesh-list
93311691|NCT02802813|Artemisinins|artemisinins|mesh-list
93311692|NCT02802813|Antimalarials|antimalarials|mesh-ancestor
93311693|NCT02802813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93311694|NCT02802813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93311695|NCT02802813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311696|NCT05134584|Lactulose|lactulose|mesh-list
93311697|NCT05134584|Linaclotide|linaclotide|mesh-list
93311698|NCT05134584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311699|NCT05134584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93311700|NCT05134584|Enzyme Activators|enzyme activators|mesh-ancestor
93311701|NCT05134584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311702|NCT05633277|Polidocanol|polidocanol|mesh-list
93311703|NCT05633277|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93311704|NCT05633277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93311705|NCT04692831|Pertuzumab|pertuzumab|mesh-list
93311706|NCT04692831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93311707|NCT04692831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311708|NCT03312140|Choline|choline|mesh-list
93311709|NCT03312140|Lipotropic Agents|lipotropic agents|mesh-ancestor
93311710|NCT03312140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93311711|NCT03312140|Antimetabolites|antimetabolites|mesh-ancestor
93311712|NCT03312140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311713|NCT03312140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311714|NCT03312140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93311715|NCT03312140|Nootropic Agents|nootropic agents|mesh-ancestor
93311716|NCT02233179|Calpastatin|calpastatin|mesh-list
93311717|NCT02233179|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93311718|NCT02233179|Protease Inhibitors|protease inhibitors|mesh-ancestor
93311719|NCT02233179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311720|NCT02233179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311721|NCT03311984|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93311722|NCT03311984|Dalteparin|dalteparin|mesh-list
93311723|NCT03311984|Anticoagulants|anticoagulants|mesh-ancestor
93311724|NCT03311984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93311725|NCT03311984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93311726|NCT03311984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311727|NCT03311906|Hyaluronic Acid|hyaluronic acid|mesh-list
93311728|NCT03311906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93311729|NCT03311906|Immunologic Factors|immunologic factors|mesh-ancestor
93311730|NCT03311906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311731|NCT03311906|Viscosupplements|viscosupplements|mesh-ancestor
93311732|NCT03311906|Protective Agents|protective agents|mesh-ancestor
93311733|NCT04554459|Ponatinib|ponatinib|mesh-list
93311734|NCT04554459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311735|NCT04554459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93311736|NCT04554459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311737|NCT04554459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311738|NCT03311750|Panitumumab|panitumumab|mesh-list
93311739|NCT03311750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606238|NCT00502294|Visilizumab|visilizumab|mesh-list
93311740|NCT03311750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311741|NCT03311672|Pembrolizumab|pembrolizumab|mesh-list
93311742|NCT03311672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93311743|NCT03311672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311744|NCT03311672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93311745|NCT03311672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311747|NCT03311516|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93311748|NCT03311516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93311749|NCT03311516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311750|NCT04528329|Dexamethasone|dexamethasone|mesh-list
93311751|NCT04528329|Dexamethasone acetate|dexamethasone acetate|mesh-list
93311752|NCT04528329|BB 1101|bb 1101|mesh-list
93311753|NCT04528329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311754|NCT04528329|Antiemetics|antiemetics|mesh-ancestor
93311755|NCT04528329|Autonomic Agents|autonomic agents|mesh-ancestor
93311756|NCT04528329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311757|NCT04528329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311758|NCT04528329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311759|NCT04528329|Glucocorticoids|glucocorticoids|mesh-ancestor
93311760|NCT04528329|Hormones|hormones|mesh-ancestor
93311761|NCT04528329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311762|NCT04528329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93311763|NCT04528329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311764|NCT04528329|Protease Inhibitors|protease inhibitors|mesh-ancestor
93311765|NCT04528329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311766|NCT04528329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311767|NCT02811939|Dronabinol|dronabinol|mesh-list
93311768|NCT02811939|Hallucinogens|hallucinogens|mesh-ancestor
93311769|NCT02811939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311770|NCT02811939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311771|NCT02811939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93311772|NCT02811939|Analgesics|analgesics|mesh-ancestor
93311773|NCT02811939|Sensory System Agents|sensory system agents|mesh-ancestor
93311774|NCT02811939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311775|NCT02811939|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93311776|NCT02811939|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93311777|NCT02811939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311778|NCT02811939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311779|NCT02811939|Hormones|hormones|mesh-ancestor
93311780|NCT02811939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311781|NCT01329549|Carboplatin|carboplatin|mesh-list
93311782|NCT01329549|Nintedanib|nintedanib|mesh-list
93311783|NCT01329549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311784|NCT01329549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93311785|NCT01329549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311786|NCT01329549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311787|NCT02234739|Voriconazole|voriconazole|mesh-list
93311788|NCT02234739|Antifungal Agents|antifungal agents|mesh-ancestor
93311789|NCT02234739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311790|NCT02234739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93311791|NCT02234739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93311792|NCT02234739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311793|NCT02234739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311794|NCT02234739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93311795|NCT02234739|Hormone Antagonists|hormone antagonists|mesh-ancestor
93311796|NCT02234739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311797|NCT02234739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311798|NCT02234739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93311799|NCT02736474|Naltrexone|naltrexone|mesh-list
93311800|NCT02736474|Bupropion|bupropion|mesh-list
93311801|NCT02736474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93311802|NCT02736474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93311803|NCT02736474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311804|NCT02736474|Sensory System Agents|sensory system agents|mesh-ancestor
93311805|NCT02736474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311806|NCT02736474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93311807|NCT02736474|Antidepressive Agents|antidepressive agents|mesh-ancestor
93311808|NCT02736474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311809|NCT02736474|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93311810|NCT02736474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93311811|NCT02736474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311812|NCT02736474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983784|NCT00862472|Timolol|timolol|mesh-list
93311813|NCT02736474|Dopamine Agents|dopamine agents|mesh-ancestor
93311814|NCT02736474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311815|NCT02736474|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93311816|NCT02736474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93311817|NCT02736474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311818|NCT03302390|Lidocaine|lidocaine|mesh-list
93311819|NCT03302390|Epinephrine|epinephrine|mesh-list
93311820|NCT03302390|Anesthetics, Local|anesthetics, local|mesh-ancestor
93311821|NCT03302390|Anesthetics|anesthetics|mesh-ancestor
93311822|NCT03302390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311823|NCT03302390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311824|NCT03302390|Sensory System Agents|sensory system agents|mesh-ancestor
93311825|NCT03302390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311826|NCT03302390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93311827|NCT03302390|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93311828|NCT03302390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93311829|NCT03302390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311830|NCT03302390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311831|NCT03302390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93311832|NCT03302390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92606350|NCT00503386|Autonomic Agents|autonomic agents|mesh-ancestor
93311833|NCT03302390|Adrenergic Agents|adrenergic agents|mesh-ancestor
93311834|NCT03302390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311835|NCT03302390|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93311836|NCT03302390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93311837|NCT03302390|Autonomic Agents|autonomic agents|mesh-ancestor
93311838|NCT03302390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93311839|NCT03302390|Respiratory System Agents|respiratory system agents|mesh-ancestor
93311840|NCT03302390|Mydriatics|mydriatics|mesh-ancestor
93311841|NCT03302390|Sympathomimetics|sympathomimetics|mesh-ancestor
93311842|NCT03302390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93311843|NCT03712371|Chitosan|chitosan|mesh-list
93311844|NCT03712371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93311845|NCT03712371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93311846|NCT03712371|Antimetabolites|antimetabolites|mesh-ancestor
93311847|NCT03712371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311848|NCT03712371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93311849|NCT03712371|Chelating Agents|chelating agents|mesh-ancestor
93311850|NCT03712371|Sequestering Agents|sequestering agents|mesh-ancestor
93311851|NCT03712371|Hemostatics|hemostatics|mesh-ancestor
93311852|NCT03712371|Coagulants|coagulants|mesh-ancestor
93311853|NCT03472950|Ranolazine|ranolazine|mesh-list
93311854|NCT03472950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93311855|NCT03472950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311856|NCT03472950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311857|NCT03706521|Lorecivivint|lorecivivint|mesh-list
93311858|NCT03706521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311859|NCT02259543|Tetracycline|tetracycline|mesh-list
93311860|NCT02259543|Citric Acid|citric acid|mesh-list
93311861|NCT02259543|Sodium Citrate|sodium citrate|mesh-list
93311862|NCT02259543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93311863|NCT02259543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311864|NCT02259543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93311865|NCT02259543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311866|NCT02259543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311867|NCT02259543|Anticoagulants|anticoagulants|mesh-ancestor
93311868|NCT02259543|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93311869|NCT02259543|Chelating Agents|chelating agents|mesh-ancestor
93311870|NCT02259543|Sequestering Agents|sequestering agents|mesh-ancestor
93311871|NCT03301454|Paclitaxel|paclitaxel|mesh-list
93311872|NCT03301454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93311873|NCT03301454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311874|NCT03301454|Tubulin Modulators|tubulin modulators|mesh-ancestor
93311875|NCT03301454|Antimitotic Agents|antimitotic agents|mesh-ancestor
93311876|NCT03301454|Mitosis Modulators|mitosis modulators|mesh-ancestor
93311877|NCT03301454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311878|NCT04343235|Labetalol|labetalol|mesh-list
93311879|NCT04343235|Furosemide|furosemide|mesh-list
93311880|NCT04343235|Diuretics|diuretics|mesh-ancestor
93311881|NCT04343235|Natriuretic Agents|natriuretic agents|mesh-ancestor
93311882|NCT04343235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311883|NCT04343235|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93311884|NCT04343235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311885|NCT04343235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311886|NCT04343235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93311887|NCT04343235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93311888|NCT04343235|Adrenergic Agents|adrenergic agents|mesh-ancestor
93311889|NCT04343235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311890|NCT04343235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93311891|NCT04343235|Sympathomimetics|sympathomimetics|mesh-ancestor
93311892|NCT04343235|Autonomic Agents|autonomic agents|mesh-ancestor
93311893|NCT04343235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311894|NCT04343235|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93311895|NCT04343235|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93311896|NCT05727410|Docetaxel|docetaxel|mesh-list
93311897|NCT05727410|Nivolumab|nivolumab|mesh-list
93311898|NCT05727410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311899|NCT05727410|Tubulin Modulators|tubulin modulators|mesh-ancestor
93311900|NCT05727410|Antimitotic Agents|antimitotic agents|mesh-ancestor
93311901|NCT05727410|Mitosis Modulators|mitosis modulators|mesh-ancestor
93311902|NCT05727410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311903|NCT05727410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93311904|NCT05727410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93311905|NCT02467010|Dexamethasone|dexamethasone|mesh-list
93311906|NCT02467010|Cyclophosphamide|cyclophosphamide|mesh-list
93311907|NCT02467010|Bortezomib|bortezomib|mesh-list
93311908|NCT02467010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93311909|NCT02467010|Immunologic Factors|immunologic factors|mesh-ancestor
93311910|NCT02467010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311911|NCT02467010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93311912|NCT02467010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93311913|NCT02467010|Alkylating Agents|alkylating agents|mesh-ancestor
93311914|NCT02467010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311915|NCT02467010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311916|NCT02467010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93311917|NCT02467010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93311918|NCT02467010|Antiemetics|antiemetics|mesh-ancestor
93311919|NCT02467010|Autonomic Agents|autonomic agents|mesh-ancestor
93311920|NCT02467010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311921|NCT02467010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93311922|NCT02467010|Glucocorticoids|glucocorticoids|mesh-ancestor
93311923|NCT02467010|Hormones|hormones|mesh-ancestor
93311924|NCT02467010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311925|NCT02467010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93311926|NCT02232555|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93311927|NCT02232555|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93311928|NCT02232555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93311929|NCT02232555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93311930|NCT02232555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311931|NCT02232555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311932|NCT02232555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311933|NCT02232555|Analgesics|analgesics|mesh-ancestor
93311934|NCT02232555|Sensory System Agents|sensory system agents|mesh-ancestor
92606459|NCT05560919|Vitamins|vitamins|mesh-ancestor
93311935|NCT02232555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311936|NCT02232555|Antidepressive Agents|antidepressive agents|mesh-ancestor
93311937|NCT02232555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93311938|NCT02232555|Dopamine Agents|dopamine agents|mesh-ancestor
93311939|NCT02235519|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93311940|NCT02235519|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93311941|NCT02235519|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93311942|NCT02235519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311943|NCT00702650|Testosterone|testosterone|mesh-list
93311944|NCT00702650|Androgens|androgens|mesh-ancestor
93311945|NCT00702650|Hormones|hormones|mesh-ancestor
93311946|NCT00702650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93311947|NCT00702650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311948|NCT03230916|Relebactam|relebactam|mesh-list
93311949|NCT03230916|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93311950|NCT03230916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93311951|NCT03230916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311952|NCT03230916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93311953|NCT03230916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311954|NCT04210713|Minocycline|minocycline|mesh-list
93311955|NCT04210713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93311956|NCT04210713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93311957|NCT01337115|Ropivacaine|ropivacaine|mesh-list
93311958|NCT01337115|Anesthetics, Local|anesthetics, local|mesh-list
93311959|NCT01337115|Anesthetics|anesthetics|mesh-list
93311960|NCT01337115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311961|NCT01337115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983978|NCT00864812|Xhance|xhance|mesh-list
93311962|NCT01337115|Sensory System Agents|sensory system agents|mesh-ancestor
93311963|NCT01337115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311964|NCT03761784|Tretinoin|tretinoin|mesh-list
93311965|NCT03761784|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93311966|NCT03761784|Dermatologic Agents|dermatologic agents|mesh-ancestor
93311967|NCT03761784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93311968|NCT03761784|Keratolytic Agents|keratolytic agents|mesh-ancestor
93311969|NCT03300440|Vitamins|vitamins|mesh-list
93311970|NCT03300440|Biotin|biotin|mesh-list
93311971|NCT03300440|Vitamin B Complex|vitamin b complex|mesh-list
92606487|NCT04063163|Etoposide|etoposide|mesh-list
93311972|NCT03300440|Micronutrients|micronutrients|mesh-ancestor
93311973|NCT03300440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311974|NCT02236065|Lenograstim|lenograstim|mesh-list
93311975|NCT02236065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93311976|NCT02236065|Immunologic Factors|immunologic factors|mesh-ancestor
93311977|NCT02236065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311978|NCT02467556|Morphine|morphine|mesh-list
93311979|NCT02467556|Memantine|memantine|mesh-list
93311980|NCT02467556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93311981|NCT02467556|Narcotics|narcotics|mesh-ancestor
93311982|NCT02467556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93311983|NCT02467556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93311984|NCT02467556|Analgesics|analgesics|mesh-ancestor
93311985|NCT02467556|Sensory System Agents|sensory system agents|mesh-ancestor
93311986|NCT02467556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93311987|NCT02467556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93311988|NCT02467556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93311989|NCT02467556|Dopamine Agents|dopamine agents|mesh-ancestor
93311990|NCT02467556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93311991|NCT02467556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311992|NCT02467556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93311993|NCT02467556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93311994|NCT02262585|Telmisartan|telmisartan|mesh-list
93311995|NCT02262585|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93311996|NCT02262585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93311997|NCT02262585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93311998|NCT02262585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93311999|NCT03309176|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93312000|NCT03309176|Medroxyprogesterone|medroxyprogesterone|mesh-list
93312001|NCT03309176|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93312002|NCT03309176|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93312003|NCT03309176|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93312004|NCT03309176|Contraceptive Agents|contraceptive agents|mesh-ancestor
93312005|NCT03309176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93312006|NCT03309176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312007|NCT03309176|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93312008|NCT03309176|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93312009|NCT03309176|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93312010|NCT03309176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93312011|NCT03309176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312012|NCT02602353|Loxoprofen|loxoprofen|mesh-list
92606515|NCT01247311|Vitamins|vitamins|mesh-list
93312013|NCT02602353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93312014|NCT02602353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93312015|NCT02602353|Analgesics|analgesics|mesh-ancestor
93312016|NCT02602353|Sensory System Agents|sensory system agents|mesh-ancestor
93312017|NCT02602353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312018|NCT02602353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312019|NCT02602353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93312020|NCT02602353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93312021|NCT04983498|Ondansetron|ondansetron|mesh-list
93312022|NCT04983498|Antiemetics|antiemetics|mesh-ancestor
93312023|NCT04983498|Autonomic Agents|autonomic agents|mesh-ancestor
93312024|NCT04983498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312025|NCT04983498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312026|NCT04983498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312027|NCT04983498|Antipruritics|antipruritics|mesh-ancestor
93312028|NCT04983498|Dermatologic Agents|dermatologic agents|mesh-ancestor
93312029|NCT04983498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93312030|NCT04983498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93312031|NCT04983498|Serotonin Agents|serotonin agents|mesh-ancestor
93312032|NCT04983498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312033|NCT04983498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312034|NCT03300362|Vaccines|vaccines|mesh-list
93312035|NCT03300362|Immunologic Factors|immunologic factors|mesh-ancestor
93312036|NCT03300362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312037|NCT02467400|Propranolol|propranolol|mesh-list
93312038|NCT02467400|Atenolol|atenolol|mesh-list
93312039|NCT02467400|Nebivolol|nebivolol|mesh-list
93312040|NCT02467400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93312041|NCT02467400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93312042|NCT02467400|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312043|NCT02467400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312044|NCT02467400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312045|NCT02467400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312046|NCT02467400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92606570|NCT02275039|Vaccines|vaccines|mesh-list
93312047|NCT02467400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93312048|NCT02467400|Vasodilator Agents|vasodilator agents|mesh-ancestor
93312049|NCT02467400|Sympatholytics|sympatholytics|mesh-ancestor
93312050|NCT02467400|Autonomic Agents|autonomic agents|mesh-ancestor
93312051|NCT02467400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312052|NCT02467400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93312053|NCT02467400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93312054|NCT02467400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93312055|NCT02467400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93312056|NCT04002141|Letrozole|letrozole|mesh-list
92681149|NCT04704245|Petrolatum|petrolatum|mesh-list
93312057|NCT04002141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312058|NCT04002141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93312059|NCT04002141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93312060|NCT04002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312061|NCT04002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312062|NCT04002141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93312063|NCT04002141|Hormone Antagonists|hormone antagonists|mesh-ancestor
93312064|NCT04002141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312065|NCT04002141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312066|NCT03308708|Norepinephrine|norepinephrine|mesh-list
93312067|NCT03308708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93312068|NCT03308708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93312069|NCT03308708|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312070|NCT03308708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312071|NCT03308708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312072|NCT03308708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606598|NCT01248481|Acarbose|acarbose|mesh-list
93312073|NCT03308708|Sympathomimetics|sympathomimetics|mesh-ancestor
93312074|NCT03308708|Autonomic Agents|autonomic agents|mesh-ancestor
93312075|NCT03308708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312076|NCT03308708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93312077|NCT02262741|Durvalumab|durvalumab|mesh-list
93312078|NCT02262741|Tremelimumab|tremelimumab|mesh-list
93312079|NCT02262741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312080|NCT02262741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312081|NCT00250341|Beclomethasone|beclomethasone|mesh-list
93312082|NCT00250341|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93312083|NCT00250341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606604|NCT01249339|Lobeline|lobeline|mesh-list
93312084|NCT00250341|Glucocorticoids|glucocorticoids|mesh-ancestor
93312085|NCT00250341|Hormones|hormones|mesh-ancestor
93312086|NCT00250341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312087|NCT00250341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312088|NCT00250341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93312089|NCT00250341|Respiratory System Agents|respiratory system agents|mesh-ancestor
93312090|NCT00250341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93312091|NCT00250341|Autonomic Agents|autonomic agents|mesh-ancestor
93312092|NCT00250341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312093|NCT00250341|Sympathomimetics|sympathomimetics|mesh-ancestor
93312094|NCT05156970|Carboplatin|carboplatin|mesh-list
93312095|NCT05156970|Docetaxel|docetaxel|mesh-list
93312096|NCT05156970|Apatinib|apatinib|mesh-list
93312097|NCT05156970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312098|NCT05156970|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312099|NCT05156970|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312100|NCT05156970|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312101|NCT05156970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312102|NCT05156970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93312103|NCT05156970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312104|NCT02233881|Ipratropium|ipratropium|mesh-list
93312105|NCT02233881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93312106|NCT02233881|Autonomic Agents|autonomic agents|mesh-ancestor
93312107|NCT02233881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606628|NCT00504127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93312108|NCT02233881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312109|NCT02233881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93312110|NCT02233881|Respiratory System Agents|respiratory system agents|mesh-ancestor
93312111|NCT02233881|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93312112|NCT02233881|Cholinergic Agents|cholinergic agents|mesh-ancestor
93312113|NCT02233881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312114|NCT02233881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312116|NCT02234037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93312117|NCT02234037|Antimetabolites|antimetabolites|mesh-ancestor
93312118|NCT02234037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312119|NCT02234037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312120|NCT02234037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312121|NCT02234193|Lidocaine|lidocaine|mesh-list
93312122|NCT02234193|Epinephrine|epinephrine|mesh-list
93312123|NCT02234193|Anesthetics, Local|anesthetics, local|mesh-ancestor
93312124|NCT02234193|Anesthetics|anesthetics|mesh-ancestor
93312125|NCT02234193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312126|NCT02234193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312127|NCT02234193|Sensory System Agents|sensory system agents|mesh-ancestor
93312128|NCT02234193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312129|NCT02234193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93092451|NCT03847922|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93312130|NCT02234193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93312131|NCT02234193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93312132|NCT02234193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312133|NCT02234193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312134|NCT02234193|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93312135|NCT02234193|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93312136|NCT02234193|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312137|NCT02234193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606653|NCT01249690|Thalidomide|thalidomide|mesh-list
93312138|NCT02234193|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93312139|NCT02234193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93312140|NCT02234193|Autonomic Agents|autonomic agents|mesh-ancestor
93312141|NCT02234193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93312142|NCT02234193|Respiratory System Agents|respiratory system agents|mesh-ancestor
93312143|NCT02234193|Mydriatics|mydriatics|mesh-ancestor
93312144|NCT02234193|Sympathomimetics|sympathomimetics|mesh-ancestor
93312145|NCT02234193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93312146|NCT04476459|Apatinib|apatinib|mesh-list
93312147|NCT04476459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312148|NCT04476459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93312149|NCT04476459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312150|NCT04476459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312151|NCT02262897|Paclitaxel|paclitaxel|mesh-list
93312152|NCT02262897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93312153|NCT02262897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312154|NCT02262897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312155|NCT02262897|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312156|NCT02262897|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312157|NCT02262897|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312158|NCT02262897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312159|NCT02723006|Nivolumab|nivolumab|mesh-list
93312160|NCT02723006|Ipilimumab|ipilimumab|mesh-list
93312161|NCT02723006|Vedolizumab|vedolizumab|mesh-list
93312162|NCT02723006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312163|NCT02723006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312164|NCT02723006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93312165|NCT02723006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312166|NCT02723006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312167|NCT03308552|Paclitaxel|paclitaxel|mesh-list
92606675|NCT01249690|Immunologic Factors|immunologic factors|mesh-ancestor
93312168|NCT03308552|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93312169|NCT03308552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312170|NCT03308552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312171|NCT03308552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312172|NCT03308552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312173|NCT03308552|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312174|NCT03308552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312175|NCT03308084|Dexamethasone|dexamethasone|mesh-list
93312176|NCT03308084|Methylprednisolone|methylprednisolone|mesh-list
93312177|NCT03308084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93312178|NCT03308084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93312179|NCT03308084|Prednisolone|prednisolone|mesh-list
93312180|NCT03308084|Prednisolone acetate|prednisolone acetate|mesh-list
93312181|NCT03308084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93312182|NCT03308084|Prednisolone phosphate|prednisolone phosphate|mesh-list
93312183|NCT03308084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93312184|NCT03308084|Antiemetics|antiemetics|mesh-ancestor
93312185|NCT03308084|Autonomic Agents|autonomic agents|mesh-ancestor
93312186|NCT03308084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984162|NCT00918593|Bleomycin|bleomycin|mesh-list
93312187|NCT03308084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312188|NCT03308084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312189|NCT03308084|Glucocorticoids|glucocorticoids|mesh-ancestor
93312190|NCT03308084|Hormones|hormones|mesh-ancestor
93312191|NCT03308084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312192|NCT03308084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93312193|NCT03308084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312194|NCT03308084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93312195|NCT03308084|Protective Agents|protective agents|mesh-ancestor
93312196|NCT00702962|Carboplatin|carboplatin|mesh-list
93312197|NCT00702962|Etoposide|etoposide|mesh-list
93312198|NCT00702962|Vorinostat|vorinostat|mesh-list
93312199|NCT00702962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312200|NCT00702962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312201|NCT00702962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606692|NCT01249846|Disinfectants|disinfectants|mesh-ancestor
93312202|NCT00702962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93312203|NCT00702962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312204|NCT00702962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312205|NCT00702962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93312206|NCT01379508|Tenofovir|tenofovir|mesh-list
93312207|NCT01379508|Telbivudine|telbivudine|mesh-list
93312208|NCT01379508|Antiviral Agents|antiviral agents|mesh-ancestor
93312209|NCT01379508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312210|NCT01379508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93312211|NCT01379508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93312212|NCT01379508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040436|NCT05720455|Ephedrine|ephedrine|mesh-list
93312213|NCT01379508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682749|NCT04701242|Ezetimibe|ezetimibe|mesh-list
93312214|NCT01379508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93312215|NCT01379508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93312216|NCT05162430|Propofol|propofol|mesh-list
93312217|NCT05162430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93312218|NCT05162430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312219|NCT05162430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312220|NCT05162430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93312221|NCT05162430|Anesthetics, General|anesthetics, general|mesh-ancestor
93312222|NCT05162430|Anesthetics|anesthetics|mesh-ancestor
93312223|NCT05031026|Dexmedetomidine|dexmedetomidine|mesh-list
93312224|NCT05031026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93312225|NCT05031026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606743|NCT00504400|Growth Inhibitors|growth inhibitors|mesh-ancestor
93312226|NCT05031026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312227|NCT05031026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93312228|NCT05031026|Analgesics|analgesics|mesh-ancestor
93312229|NCT05031026|Sensory System Agents|sensory system agents|mesh-ancestor
92683135|NCT00476268|Beclomethasone|beclomethasone|mesh-list
93312230|NCT05031026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312231|NCT05031026|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93312232|NCT05031026|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93312233|NCT05031026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93312234|NCT05031026|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312235|NCT05031026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606752|NCT00504439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312236|NCT05031026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312237|NCT02264769|Carbetocin|carbetocin|mesh-list
93312238|NCT02264769|Oxytocics|oxytocics|mesh-ancestor
93312239|NCT02264769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93312240|NCT02264769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312241|NCT02264847|Clomiphene|clomiphene|mesh-list
93312242|NCT02264847|Enclomiphene|enclomiphene|mesh-list
93312243|NCT02264847|Zuclomiphene|zuclomiphene|mesh-list
93312244|NCT02264847|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93312245|NCT02264847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93312246|NCT02264847|Hormone Antagonists|hormone antagonists|mesh-ancestor
93312247|NCT02264847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312248|NCT02264847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312249|NCT02264847|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93312250|NCT02264847|Fertility Agents|fertility agents|mesh-ancestor
93312251|NCT02264847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93312252|NCT02264847|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93312253|NCT02264847|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93312254|NCT04965506|Dulaglutide|dulaglutide|mesh-list
93312255|NCT04965506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92606774|NCT03999723|Vitamins|vitamins|mesh-ancestor
93312256|NCT04965506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312257|NCT03469128|Sertraline|sertraline|mesh-list
93312258|NCT03469128|Antidepressive Agents|antidepressive agents|mesh-ancestor
93312259|NCT03469128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93312260|NCT03469128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93312261|NCT03469128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93312262|NCT03469128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312263|NCT03469128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312264|NCT03469128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312265|NCT03469128|Serotonin Agents|serotonin agents|mesh-ancestor
93312266|NCT03469128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312267|NCT05161572|Oxaliplatin|oxaliplatin|mesh-list
93312268|NCT05161572|Tegafur|tegafur|mesh-list
93312269|NCT05161572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312270|NCT05161572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92014228|NCT04809935|Ethanol|ethanol|mesh-list
93312271|NCT05161572|Antimetabolites|antimetabolites|mesh-ancestor
93312272|NCT05161572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312273|NCT03472170|Lactoferrin|lactoferrin|mesh-list
93312274|NCT03472170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312275|NCT04156698|Docetaxel|docetaxel|mesh-list
93312276|NCT04156698|Capecitabine|capecitabine|mesh-list
93312277|NCT04156698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312278|NCT04156698|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312279|NCT04156698|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312280|NCT04156698|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312281|NCT04156698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312282|NCT04156698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93312283|NCT04156698|Antimetabolites|antimetabolites|mesh-ancestor
93312284|NCT03108326|Infliximab|infliximab|mesh-list
93312285|NCT03108326|Ustekinumab|ustekinumab|mesh-list
93312286|NCT03108326|Vedolizumab|vedolizumab|mesh-list
93312287|NCT03108326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92683700|NCT00477945|Clofarabine|clofarabine|mesh-list
93312288|NCT03108326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93312289|NCT03108326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93312290|NCT03108326|Dermatologic Agents|dermatologic agents|mesh-ancestor
93312291|NCT03108326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312292|NCT04964024|Antibodies|antibodies|mesh-list
93312293|NCT04964024|Immunologic Factors|immunologic factors|mesh-ancestor
93312294|NCT04964024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312295|NCT02466542|Esmolol|esmolol|mesh-list
93312296|NCT02466542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93312297|NCT02466542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93312298|NCT02466542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93312299|NCT02466542|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312300|NCT02466542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312301|NCT02466542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312302|NCT02466542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312303|NCT05067270|Insulin Lispro|insulin lispro|mesh-list
93312304|NCT05067270|Treprostinil|treprostinil|mesh-list
92683910|NCT00441051|Diclofenac|diclofenac|mesh-list
93312305|NCT05067270|Citric Acid|citric acid|mesh-list
93312306|NCT05067270|Sodium Citrate|sodium citrate|mesh-list
93312307|NCT05067270|Anticoagulants|anticoagulants|mesh-ancestor
93312308|NCT05067270|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93312309|NCT05067270|Chelating Agents|chelating agents|mesh-ancestor
93312310|NCT05067270|Sequestering Agents|sequestering agents|mesh-ancestor
93312311|NCT05067270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312312|NCT05067270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93312313|NCT05067270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312314|NCT05067270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93312315|NCT01437735|Montelukast|montelukast|mesh-list
93312316|NCT01437735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93312317|NCT01437735|Respiratory System Agents|respiratory system agents|mesh-ancestor
93312318|NCT01437735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93312319|NCT01437735|Hormone Antagonists|hormone antagonists|mesh-ancestor
93312320|NCT01437735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312321|NCT01437735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312322|NCT01437735|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93312323|NCT01437735|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93312324|NCT01437735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312325|NCT02722304|Protease Inhibitors|protease inhibitors|mesh-list
93312326|NCT02722304|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93312327|NCT02722304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312328|NCT02722304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312329|NCT02722304|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93312330|NCT02722304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93312331|NCT03470610|Estradiol|estradiol|mesh-list
93312332|NCT03470610|Progesterone|progesterone|mesh-list
93312333|NCT03470610|Estrogens|estrogens|mesh-ancestor
93312334|NCT03470610|Hormones|hormones|mesh-ancestor
93312335|NCT03470610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312336|NCT03470610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312337|NCT03470610|Progestins|progestins|mesh-ancestor
93312338|NCT02509845|Anti-Infective Agents|anti-infective agents|mesh-list
93312339|NCT02509845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93312340|NCT03307148|Paclitaxel|paclitaxel|mesh-list
93312341|NCT03307148|Gemcitabine|gemcitabine|mesh-list
93312342|NCT03307148|Tretinoin|tretinoin|mesh-list
93312343|NCT03307148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312344|NCT03307148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312345|NCT03307148|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312346|NCT03307148|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312347|NCT03307148|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312348|NCT03307148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312349|NCT03307148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92684157|NCT00479739|Xhance|xhance|mesh-list
93312350|NCT03307148|Antimetabolites|antimetabolites|mesh-ancestor
92606859|NCT03868722|Venetoclax|venetoclax|mesh-list
93312351|NCT03307148|Keratolytic Agents|keratolytic agents|mesh-ancestor
93312352|NCT03307148|Dermatologic Agents|dermatologic agents|mesh-ancestor
93312353|NCT03984591|Eplerenone|eplerenone|mesh-list
93312354|NCT03984591|Spironolactone|spironolactone|mesh-list
93312355|NCT03984591|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93312356|NCT03984591|Hormone Antagonists|hormone antagonists|mesh-ancestor
93312357|NCT03984591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312358|NCT03984591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312359|NCT03984591|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93312360|NCT03984591|Diuretics|diuretics|mesh-ancestor
93312361|NCT03984591|Natriuretic Agents|natriuretic agents|mesh-ancestor
93312362|NCT03984591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93312363|NCT02503137|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93312364|NCT03470532|Epinephrine|epinephrine|mesh-list
93312365|NCT03470532|Racepinephrine|racepinephrine|mesh-list
93312366|NCT03470532|Carticaine|carticaine|mesh-list
93312367|NCT03470532|Mepivacaine|mepivacaine|mesh-list
93312368|NCT03470532|Epinephryl borate|epinephryl borate|mesh-list
93312369|NCT03470532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93312370|NCT03470532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93312371|NCT03470532|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312372|NCT03470532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312373|NCT03470532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312374|NCT03470532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312375|NCT03470532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93312376|NCT03470532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93312377|NCT03470532|Autonomic Agents|autonomic agents|mesh-ancestor
92606883|NCT02824523|Analgesics|analgesics|mesh-ancestor
93312378|NCT03470532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312379|NCT03470532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93312380|NCT03470532|Respiratory System Agents|respiratory system agents|mesh-ancestor
93312381|NCT03470532|Mydriatics|mydriatics|mesh-ancestor
93312382|NCT03470532|Sympathomimetics|sympathomimetics|mesh-ancestor
93312383|NCT03470532|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93312384|NCT03470532|Anesthetics, Local|anesthetics, local|mesh-ancestor
93312385|NCT03470532|Anesthetics|anesthetics|mesh-ancestor
93312386|NCT03470532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312387|NCT03470532|Sensory System Agents|sensory system agents|mesh-ancestor
93312388|NCT02502669|Finasteride|finasteride|mesh-list
93312389|NCT02502669|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93312390|NCT02502669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93312391|NCT02502669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092452|NCT03847922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312392|NCT02502669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312393|NCT02502669|Hormone Antagonists|hormone antagonists|mesh-ancestor
93312394|NCT02502669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312395|NCT02502669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312396|NCT02502669|Urological Agents|urological agents|mesh-ancestor
93312397|NCT03306914|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93312398|NCT03306914|Plasma Substitutes|plasma substitutes|mesh-ancestor
93312399|NCT03306914|Blood Substitutes|blood substitutes|mesh-ancestor
93312400|NCT03306836|Heparin|heparin|mesh-list
93312401|NCT03306836|Calcium heparin|calcium heparin|mesh-list
93312402|NCT03306836|Anticoagulants|anticoagulants|mesh-ancestor
93312403|NCT03306836|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93312404|NCT03306836|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93312405|NCT03306836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312406|NCT04487145|Piperaquine|piperaquine|mesh-list
93312407|NCT04487145|Artenimol|artenimol|mesh-list
93312408|NCT04487145|Antimalarials|antimalarials|mesh-ancestor
93312409|NCT04487145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93312410|NCT04487145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93312411|NCT04487145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312412|NCT04780568|Osimertinib|osimertinib|mesh-list
93312413|NCT04780568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312414|NCT04780568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93312415|NCT04780568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312416|NCT04780568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312417|NCT00709956|Iloprost|iloprost|mesh-list
93312418|NCT00709956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93312419|NCT00709956|Vasodilator Agents|vasodilator agents|mesh-ancestor
93312420|NCT02268201|Tacrolimus|tacrolimus|mesh-list
93312421|NCT02268201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93312422|NCT02268201|Immunologic Factors|immunologic factors|mesh-ancestor
93312423|NCT02268201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312424|NCT02268201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92685684|NCT00497601|Amphotericin B|amphotericin b|mesh-list
93312425|NCT02268201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312426|NCT02268201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312428|NCT03306602|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93312429|NCT03306602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93312430|NCT03306602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606935|NCT00139230|Vitamins|vitamins|mesh-ancestor
93312431|NCT03306602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312432|NCT03306602|Hormone Antagonists|hormone antagonists|mesh-ancestor
93312433|NCT03306602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312434|NCT03306602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312435|NCT02268279|Solithromycin|solithromycin|mesh-list
93312436|NCT02268279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93312437|NCT02268279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312438|NCT02268357|Propranolol|propranolol|mesh-list
93312439|NCT02268357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93312440|NCT02268357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93312441|NCT02268357|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312442|NCT02268357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312443|NCT02268357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312444|NCT02268357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312445|NCT02268357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93312446|NCT02268357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93312447|NCT02268357|Vasodilator Agents|vasodilator agents|mesh-ancestor
93312448|NCT02268435|Imatinib Mesylate|imatinib mesylate|mesh-list
93312449|NCT02268435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312450|NCT02268435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93312451|NCT02268435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312452|NCT02268435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312453|NCT02466464|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
93312454|NCT02466464|Hemostatics|hemostatics|mesh-ancestor
93312455|NCT02466464|Coagulants|coagulants|mesh-ancestor
93312456|NCT01423149|Fosbretabulin|fosbretabulin|mesh-list
93312457|NCT01423149|Combretastatin|combretastatin|mesh-list
93312458|NCT01423149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312459|NCT01423149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312460|NCT01423149|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312461|NCT01423149|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312462|NCT01423149|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312463|NCT01423149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312464|NCT03470454|Linagliptin|linagliptin|mesh-list
93312465|NCT03470454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93312466|NCT03470454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312467|NCT03470454|Incretins|incretins|mesh-ancestor
93312468|NCT03470454|Hormones|hormones|mesh-ancestor
93312469|NCT03470454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312470|NCT03470454|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93312471|NCT03470454|Protease Inhibitors|protease inhibitors|mesh-ancestor
93312472|NCT03470454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312473|NCT03470454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312474|NCT03130842|Midazolam|midazolam|mesh-list
93312475|NCT03130842|Alprazolam|alprazolam|mesh-list
93312476|NCT03130842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93312477|NCT03130842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93312478|NCT03130842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312479|NCT03130842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312480|NCT03130842|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93312481|NCT03130842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93312482|NCT03130842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93312483|NCT03130842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93312484|NCT03130842|Anesthetics, General|anesthetics, general|mesh-ancestor
93312485|NCT03130842|Anesthetics|anesthetics|mesh-ancestor
93312486|NCT03130842|GABA Modulators|gaba modulators|mesh-ancestor
92984463|NCT01564329|Growth Substances|growth substances|mesh-ancestor
93312487|NCT03130842|GABA Agents|gaba agents|mesh-ancestor
93312488|NCT03130842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312489|NCT03130842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312490|NCT03130764|Durvalumab|durvalumab|mesh-list
93312491|NCT03130764|Tremelimumab|tremelimumab|mesh-list
92607001|NCT00403442|Growth Inhibitors|growth inhibitors|mesh-ancestor
93312492|NCT03130764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312493|NCT03130764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312494|NCT01234779|Olanzapine|olanzapine|mesh-list
93312495|NCT01234779|Antiemetics|antiemetics|mesh-ancestor
93312496|NCT01234779|Autonomic Agents|autonomic agents|mesh-ancestor
93312497|NCT01234779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312498|NCT01234779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312499|NCT01234779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312500|NCT01234779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92607011|NCT00402974|Vitamin K|vitamin k|mesh-list
93312501|NCT01234779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93312502|NCT01234779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312503|NCT01234779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93312504|NCT01234779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93312505|NCT01234779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93312506|NCT01234779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312507|NCT01234779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312508|NCT01234779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312509|NCT01234779|Serotonin Agents|serotonin agents|mesh-ancestor
93312510|NCT03223350|Capsaicin|capsaicin|mesh-list
93312511|NCT03223350|Antipruritics|antipruritics|mesh-ancestor
93312512|NCT03223350|Dermatologic Agents|dermatologic agents|mesh-ancestor
93312513|NCT03223350|Sensory System Agents|sensory system agents|mesh-ancestor
93312514|NCT03223350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312515|NCT03223350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312516|NCT03306368|Analgesics, Opioid|analgesics, opioid|mesh-list
93312517|NCT03306368|Narcotics|narcotics|mesh-ancestor
92607026|NCT01731236|Choline|choline|mesh-list
93312518|NCT03306368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312519|NCT03306368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312520|NCT03306368|Analgesics|analgesics|mesh-ancestor
93312521|NCT03306368|Sensory System Agents|sensory system agents|mesh-ancestor
93312522|NCT03306368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312523|NCT02840136|Meropenem|meropenem|mesh-list
93312524|NCT02840136|Tazobactam|tazobactam|mesh-list
93312525|NCT02840136|Piperacillin|piperacillin|mesh-list
93312526|NCT02840136|Ceftazidime|ceftazidime|mesh-list
93312527|NCT02840136|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93312528|NCT02840136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93312529|NCT02840136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312530|NCT02840136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93312531|NCT02840136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312532|NCT02840136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312533|NCT03306290|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93312534|NCT03306290|Cefoxitin|cefoxitin|mesh-list
93312535|NCT03306290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312536|NCT01616199|Vemurafenib|vemurafenib|mesh-list
93312537|NCT01616199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312538|NCT01616199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93312539|NCT01616199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312540|NCT01616199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312541|NCT03306212|Botulinum Toxins|botulinum toxins|mesh-list
93312542|NCT03306212|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93312543|NCT03306212|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93312544|NCT03306212|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93312545|NCT03306212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312546|NCT03306212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312547|NCT03306212|Cholinergic Agents|cholinergic agents|mesh-ancestor
93312548|NCT03306212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312549|NCT03306212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312550|NCT03306212|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93312551|NCT03306212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312552|NCT04506138|Paclitaxel|paclitaxel|mesh-list
93312553|NCT04506138|Carboplatin|carboplatin|mesh-list
93312554|NCT04506138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312555|NCT04506138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312556|NCT04506138|Tubulin Modulators|tubulin modulators|mesh-ancestor
92687803|NCT00470561|Antipyretics|antipyretics|mesh-ancestor
93312557|NCT04506138|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312558|NCT04506138|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607070|NCT00139581|Immunologic Factors|immunologic factors|mesh-ancestor
93312559|NCT04506138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312560|NCT01407003|Licogliflozin|licogliflozin|mesh-list
93312561|NCT01407003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93312562|NCT01407003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312563|NCT01407003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93312564|NCT01407003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312565|NCT05346302|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93312566|NCT05346302|Immunologic Factors|immunologic factors|mesh-ancestor
93312567|NCT05346302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312569|NCT01232595|LFF571|lff571|mesh-list
93312570|NCT01232595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688052|NCT00494598|Sufentanil|sufentanil|mesh-list
93312571|NCT01232595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312572|NCT01231347|Gemcitabine|gemcitabine|mesh-list
93312573|NCT01231347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93312574|NCT01231347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93312575|NCT01231347|Antimetabolites|antimetabolites|mesh-ancestor
93312576|NCT01231347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312577|NCT01231347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312578|NCT01231347|Immunologic Factors|immunologic factors|mesh-ancestor
93312579|NCT01231347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312580|NCT01230957|Vaccines|vaccines|mesh-list
93312581|NCT01230957|Immunologic Factors|immunologic factors|mesh-ancestor
93312582|NCT01230957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312583|NCT01228383|Vaccines|vaccines|mesh-list
93312584|NCT01228383|Antibodies|antibodies|mesh-list
93312585|NCT01228383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93312586|NCT01228383|Immunoglobulins|immunoglobulins|mesh-list
93312587|NCT01228383|gamma-Globulins|gamma-globulins|mesh-list
93312588|NCT01228383|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93312589|NCT01228383|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93312590|NCT01228383|Immunologic Factors|immunologic factors|mesh-ancestor
93312591|NCT01228383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312592|NCT03305978|Ivermectin|ivermectin|mesh-list
93312593|NCT03305978|Selamectin|selamectin|mesh-list
93312594|NCT03305978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92688409|NCT00477581|Hormones|hormones|mesh-ancestor
93312595|NCT03305978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312596|NCT01594983|Fenofibrate|fenofibrate|mesh-list
93312597|NCT01594983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93312598|NCT01594983|Antimetabolites|antimetabolites|mesh-ancestor
93312599|NCT01594983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312600|NCT01594983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93312601|NCT03305510|Vitamin D|vitamin d|mesh-list
93312602|NCT03305510|Vitamins|vitamins|mesh-ancestor
93312603|NCT03305510|Micronutrients|micronutrients|mesh-ancestor
93312604|NCT03305510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046023|NCT01627327|Xhance|xhance|mesh-list
93312605|NCT03305510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93312606|NCT01224795|Peramivir|peramivir|mesh-list
93312607|NCT01224795|Antiviral Agents|antiviral agents|mesh-ancestor
93312608|NCT01224795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312609|NCT01224795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312610|NCT01224795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312611|NCT01402401|Trastuzumab|trastuzumab|mesh-list
93312612|NCT01402401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312613|NCT01402401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312614|NCT02720510|Dexamethasone|dexamethasone|mesh-list
93312615|NCT02720510|Lenalidomide|lenalidomide|mesh-list
93312616|NCT02720510|Bortezomib|bortezomib|mesh-list
93312617|NCT02720510|Panobinostat|panobinostat|mesh-list
93312618|NCT02720510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93312619|NCT02720510|Antiemetics|antiemetics|mesh-ancestor
93312620|NCT02720510|Autonomic Agents|autonomic agents|mesh-ancestor
93312621|NCT02720510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312622|NCT02720510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312623|NCT02720510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312624|NCT02720510|Glucocorticoids|glucocorticoids|mesh-ancestor
93312625|NCT02720510|Hormones|hormones|mesh-ancestor
93312626|NCT02720510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312627|NCT02720510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93312628|NCT02720510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312629|NCT02720510|Immunologic Factors|immunologic factors|mesh-ancestor
93312630|NCT02720510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93312631|NCT02720510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93312632|NCT02720510|Growth Substances|growth substances|mesh-ancestor
93312633|NCT02720510|Growth Inhibitors|growth inhibitors|mesh-ancestor
93312634|NCT02720510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93312635|NCT02720510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312636|NCT02720510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312637|NCT01220271|Temozolomide|temozolomide|mesh-list
93312638|NCT01220271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93312639|NCT01220271|Alkylating Agents|alkylating agents|mesh-ancestor
93312640|NCT01220271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312641|NCT01220271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312643|NCT02468102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93312644|NCT02468102|Antithrombins|antithrombins|mesh-ancestor
93312645|NCT02468102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93312646|NCT02468102|Protease Inhibitors|protease inhibitors|mesh-ancestor
93312647|NCT02468102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607142|NCT00130910|Anthelmintics|anthelmintics|mesh-ancestor
93312648|NCT02468102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312649|NCT02468102|Anticoagulants|anticoagulants|mesh-ancestor
93312650|NCT01205061|Lidocaine|lidocaine|mesh-list
93312651|NCT01205061|Anesthetics, Local|anesthetics, local|mesh-ancestor
93312652|NCT01205061|Anesthetics|anesthetics|mesh-ancestor
93312653|NCT01205061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688997|NCT00480116|Vaccines|vaccines|mesh-list
93312654|NCT01205061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312655|NCT01205061|Sensory System Agents|sensory system agents|mesh-ancestor
93312656|NCT01205061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312657|NCT01205061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93312658|NCT01205061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93312659|NCT01205061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93312660|NCT01205061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312661|NCT01205061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312662|NCT01204749|Paclitaxel|paclitaxel|mesh-list
93312663|NCT01204749|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93312664|NCT01204749|Trebananib|trebananib|mesh-list
93312665|NCT01204749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93312666|NCT01204749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312667|NCT01204749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312668|NCT01204749|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312669|NCT01204749|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312670|NCT01204749|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312671|NCT01204749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312672|NCT01204749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92607168|NCT00131027|Cytarabine|cytarabine|mesh-list
93312673|NCT01204749|Growth Substances|growth substances|mesh-ancestor
93312674|NCT01204749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312675|NCT01204749|Growth Inhibitors|growth inhibitors|mesh-ancestor
93312676|NCT02466698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93312677|NCT02466698|Metronidazole|metronidazole|mesh-list
93312678|NCT02466698|Vancomycin|vancomycin|mesh-list
93312679|NCT02466698|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93312680|NCT02466698|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93312681|NCT02466698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312682|NCT02466698|Antitubercular Agents|antitubercular agents|mesh-ancestor
93312683|NCT02466698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93312684|NCT02466698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93312685|NCT02466698|Laxatives|laxatives|mesh-ancestor
93312686|NCT02466698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312687|NCT02720198|Milnacipran|milnacipran|mesh-list
93312688|NCT02720198|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93312689|NCT02720198|Levomilnacipran|levomilnacipran|mesh-list
93312690|NCT02720198|Antidepressive Agents|antidepressive agents|mesh-ancestor
93312691|NCT02720198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93312692|NCT02720198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92689805|NCT02890771|Turmeric extract|turmeric extract|mesh-list
93312693|NCT02720198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93312694|NCT02720198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689863|NCT04515420|Autonomic Agents|autonomic agents|mesh-ancestor
93312695|NCT02720198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312696|NCT02720198|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93312697|NCT02720198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93312698|NCT02720198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312699|NCT02720198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312700|NCT02720198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312701|NCT02720198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93312702|NCT02720198|Analgesics|analgesics|mesh-ancestor
93312703|NCT02720198|Sensory System Agents|sensory system agents|mesh-ancestor
92607190|NCT00131027|Autonomic Agents|autonomic agents|mesh-ancestor
93312704|NCT02720198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312705|NCT01193361|Interferons|interferons|mesh-list
93312706|NCT01193361|Ribavirin|ribavirin|mesh-list
92047579|NCT04801589|Midazolam|midazolam|mesh-list
93312707|NCT01193361|Interferon-alpha|interferon-alpha|mesh-list
93312708|NCT01193361|Interferon alpha-2|interferon alpha-2|mesh-list
93312709|NCT01193361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93312710|NCT01193361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312711|NCT01193361|Antiviral Agents|antiviral agents|mesh-ancestor
93312712|NCT01193361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312713|NCT01193361|Antimetabolites|antimetabolites|mesh-ancestor
93312714|NCT01193361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312715|NCT01193361|Immunologic Factors|immunologic factors|mesh-ancestor
93312716|NCT01193361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312717|NCT02263677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93312718|NCT02263677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93312719|NCT02263677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312720|NCT02263677|Incretins|incretins|mesh-ancestor
93312721|NCT02263677|Hormones|hormones|mesh-ancestor
93312722|NCT02263677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312723|NCT02263677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93312724|NCT02263677|Protease Inhibitors|protease inhibitors|mesh-ancestor
93312725|NCT02263677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312726|NCT02263677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312727|NCT01390545|Veltuzumab|veltuzumab|mesh-list
93312728|NCT01390545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690368|NCT00485342|Ribavirin|ribavirin|mesh-list
93312729|NCT01591473|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
93312730|NCT01591473|Poly I-C|poly i-c|mesh-list
93312731|NCT01591473|Antiviral Agents|antiviral agents|mesh-ancestor
93312732|NCT01591473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312733|NCT01591473|Interferon Inducers|interferon inducers|mesh-ancestor
92690437|NCT04697511|Midazolam|midazolam|mesh-list
93312734|NCT01591473|Immunologic Factors|immunologic factors|mesh-ancestor
93312735|NCT01591473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312736|NCT01192035|Ritonavir|ritonavir|mesh-list
93312737|NCT01192035|Lopinavir|lopinavir|mesh-list
93312738|NCT01192035|Nevirapine|nevirapine|mesh-list
93312739|NCT01192035|Efavirenz|efavirenz|mesh-list
93312740|NCT01192035|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93312741|NCT01192035|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93312742|NCT01192035|Protease Inhibitors|protease inhibitors|mesh-ancestor
93312743|NCT01192035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312744|NCT01192035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312745|NCT01192035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93312746|NCT01192035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93312747|NCT01192035|Antiviral Agents|antiviral agents|mesh-ancestor
93312748|NCT01192035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312749|NCT01192035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93312750|NCT01192035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93312751|NCT01192035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93312752|NCT01192035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93312753|NCT01192035|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93312754|NCT01192035|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93312755|NCT01192035|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93312756|NCT01192035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93312757|NCT01192035|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93312758|NCT01384383|Ledipasvir|ledipasvir|mesh-list
93312759|NCT01384383|Antiviral Agents|antiviral agents|mesh-ancestor
93312760|NCT01384383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312761|NCT01557777|Navitoclax|navitoclax|mesh-list
93312762|NCT01557777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312763|NCT02268825|Pembrolizumab|pembrolizumab|mesh-list
93312764|NCT02268825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312765|NCT02268825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607237|NCT00139893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93312766|NCT02268825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93312767|NCT02268825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312768|NCT01381731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93312769|NCT01381731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93312770|NCT02268903|Furosemide|furosemide|mesh-list
93312771|NCT02268903|Diuretics|diuretics|mesh-list
92690905|NCT01301833|Biguanides|biguanides|mesh-list
93312772|NCT02268903|Natriuretic Agents|natriuretic agents|mesh-ancestor
92690976|NCT01242098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93312773|NCT02268903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312774|NCT02268903|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93312775|NCT02268903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607259|NCT00131261|Dexamethasone|dexamethasone|mesh-list
93312776|NCT02268903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312777|NCT01369095|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93312778|NCT01369095|Escitalopram|escitalopram|mesh-list
92607262|NCT00131261|Antiemetics|antiemetics|mesh-ancestor
93312779|NCT01369095|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93312780|NCT01369095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93312781|NCT01369095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93312782|NCT01369095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312783|NCT01369095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312784|NCT01369095|Serotonin Agents|serotonin agents|mesh-ancestor
93312785|NCT01369095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312786|NCT01369095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312787|NCT01369095|Antidepressive Agents|antidepressive agents|mesh-ancestor
93312788|NCT01369095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607275|NCT00131300|Hylan|hylan|mesh-list
93312789|NCT01369095|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93312790|NCT01369095|Analgesics|analgesics|mesh-ancestor
93312791|NCT01369095|Sensory System Agents|sensory system agents|mesh-ancestor
93312792|NCT01369095|Dopamine Agents|dopamine agents|mesh-ancestor
93312793|NCT02266173|Pertuzumab|pertuzumab|mesh-list
93312794|NCT02266173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312795|NCT02266173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312796|NCT01168713|Levofloxacin|levofloxacin|mesh-list
93312797|NCT01168713|Solithromycin|solithromycin|mesh-list
93312798|NCT01168713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93312799|NCT01168713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312800|NCT01168713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93312801|NCT01168713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93312802|NCT01168713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93312803|NCT01168713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312804|NCT01168713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312805|NCT01168713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312806|NCT01168713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93312807|NCT01168713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93312808|NCT02269293|Paclitaxel|paclitaxel|mesh-list
93312809|NCT02269293|Carboplatin|carboplatin|mesh-list
93312810|NCT02269293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312811|NCT02269293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312812|NCT02269293|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312813|NCT02269293|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312814|NCT02269293|Mitosis Modulators|mitosis modulators|mesh-ancestor
92049224|NCT02105636|Docetaxel|docetaxel|mesh-list
93312815|NCT02269293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312816|NCT01545453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93312817|NCT01545453|Immunologic Factors|immunologic factors|mesh-ancestor
92607302|NCT04726631|Protamines|protamines|mesh-list
93312818|NCT01545453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312819|NCT01366131|Paclitaxel|paclitaxel|mesh-list
93312820|NCT01366131|Bevacizumab|bevacizumab|mesh-list
93312821|NCT01366131|Carboplatin|carboplatin|mesh-list
93312822|NCT01366131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312823|NCT01366131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312824|NCT01366131|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312825|NCT01366131|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312826|NCT01366131|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607307|NCT04726631|Coagulants|coagulants|mesh-ancestor
93312827|NCT01366131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312828|NCT01366131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312829|NCT01366131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92607314|NCT03117309|Nivolumab|nivolumab|mesh-list
93312830|NCT01366131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93312831|NCT01366131|Growth Substances|growth substances|mesh-ancestor
93312832|NCT01366131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312833|NCT01366131|Growth Inhibitors|growth inhibitors|mesh-ancestor
93312834|NCT01365195|Ketamine|ketamine|mesh-list
93312835|NCT01365195|Analgesics|analgesics|mesh-ancestor
93312836|NCT01365195|Sensory System Agents|sensory system agents|mesh-ancestor
93312837|NCT01365195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312838|NCT01365195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312839|NCT01365195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93312840|NCT01365195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93312841|NCT01365195|Anesthetics, General|anesthetics, general|mesh-ancestor
93312842|NCT01365195|Anesthetics|anesthetics|mesh-ancestor
93312843|NCT01365195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312844|NCT01365195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93312845|NCT01365195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93312846|NCT01365195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312847|NCT01365195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312848|NCT02269449|Hemostatics|hemostatics|mesh-list
93312849|NCT02269449|Coagulants|coagulants|mesh-ancestor
93312850|NCT01160601|Paclitaxel|paclitaxel|mesh-list
93312851|NCT01160601|Carboplatin|carboplatin|mesh-list
93312852|NCT01160601|Bavituximab|bavituximab|mesh-list
93312853|NCT01160601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312854|NCT01160601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312855|NCT01160601|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312856|NCT01160601|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312857|NCT01160601|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312858|NCT01160601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312859|NCT01160601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93312860|NCT02269605|Bryostatin 1|bryostatin 1|mesh-list
93312861|NCT02269605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93312862|NCT02269605|Immunologic Factors|immunologic factors|mesh-ancestor
93312863|NCT02269605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312864|NCT02269605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312865|NCT01356849|Atrasentan|atrasentan|mesh-list
93312866|NCT01356849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312867|NCT01356849|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93312868|NCT01356849|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93312869|NCT01356849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312870|NCT02266485|Pravastatin|pravastatin|mesh-list
93312871|NCT02266485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93312872|NCT02266485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93312873|NCT02266485|Antimetabolites|antimetabolites|mesh-ancestor
93312874|NCT02266485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312875|NCT02266485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93312876|NCT02266485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93312877|NCT02266485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312878|NCT02263989|Telmisartan|telmisartan|mesh-list
93312879|NCT02263989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93312880|NCT02263989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92607363|NCT04696666|Viscosupplements|viscosupplements|mesh-ancestor
93312881|NCT02263989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93312882|NCT02263989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312883|NCT01516203|Rifampin|rifampin|mesh-list
93312884|NCT01516203|Isoniazid|isoniazid|mesh-list
93312885|NCT01516203|Pyrazinamide|pyrazinamide|mesh-list
93312886|NCT01516203|Ethambutol|ethambutol|mesh-list
93312887|NCT01516203|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93312888|NCT01516203|Antitubercular Agents|antitubercular agents|mesh-ancestor
93312889|NCT01516203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93312890|NCT01516203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312891|NCT01516203|Leprostatic Agents|leprostatic agents|mesh-ancestor
92607366|NCT01248793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93312892|NCT01516203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93312893|NCT01516203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312894|NCT01516203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312895|NCT01516203|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92607379|NCT00140361|Artesunate|artesunate|mesh-list
93312896|NCT01516203|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93312897|NCT01516203|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93312898|NCT01516203|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93312899|NCT01516203|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93312900|NCT01516203|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93312901|NCT01516203|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93312902|NCT01516203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93312903|NCT01516203|Antimetabolites|antimetabolites|mesh-ancestor
93312904|NCT01516203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93312905|NCT01321359|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
92607382|NCT00140361|Pyrimethamine|pyrimethamine|mesh-list
93312906|NCT01321359|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
93312907|NCT01321359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312908|NCT01321359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312909|NCT00703118|Ribavirin|ribavirin|mesh-list
93312910|NCT00703118|Interferon alpha-2|interferon alpha-2|mesh-list
93312911|NCT00703118|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93312912|NCT00703118|Antimetabolites|antimetabolites|mesh-ancestor
93312913|NCT00703118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312914|NCT00703118|Antiviral Agents|antiviral agents|mesh-ancestor
93312915|NCT00703118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312916|NCT00703118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312917|NCT01510119|Hydroxychloroquine|hydroxychloroquine|mesh-list
93312918|NCT01510119|Everolimus|everolimus|mesh-list
93312919|NCT01510119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93312920|NCT01510119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93312921|NCT01510119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93312922|NCT01510119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312923|NCT01510119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93312924|NCT01510119|Immunologic Factors|immunologic factors|mesh-ancestor
93312925|NCT01510119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312926|NCT01510119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312927|NCT01510119|Antimalarials|antimalarials|mesh-ancestor
93312928|NCT01510119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93312929|NCT01510119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93312930|NCT01510119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93312931|NCT01510119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93312932|NCT01150695|Vaccines|vaccines|mesh-list
93312933|NCT01150695|Immunologic Factors|immunologic factors|mesh-ancestor
93312934|NCT01150695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312935|NCT01302249|Timolol|timolol|mesh-list
93312936|NCT01302249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93312937|NCT01302249|Latanoprost|latanoprost|mesh-list
93312938|NCT01302249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92607410|NCT00131963|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312939|NCT01302249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312940|NCT01302249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93312941|NCT01302249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93312942|NCT01302249|Adrenergic Agents|adrenergic agents|mesh-ancestor
93312943|NCT01302249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93312944|NCT01302249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312945|NCT01302249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93312946|NCT01302249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93312947|NCT02261636|Mesalamine|mesalamine|mesh-list
92693670|NCT00504764|Arsenic Trioxide|arsenic trioxide|mesh-list
93312948|NCT02261636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93312949|NCT02261636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93312950|NCT02261636|Analgesics|analgesics|mesh-ancestor
93312951|NCT02261636|Sensory System Agents|sensory system agents|mesh-ancestor
93312952|NCT02261636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693742|NCT00513162|GABA Agents|gaba agents|mesh-ancestor
93312953|NCT02261636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312954|NCT02261636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93312955|NCT02261636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93312956|NCT05191706|Dexamethasone|dexamethasone|mesh-list
93312957|NCT05191706|Prednisolone|prednisolone|mesh-list
93312958|NCT05191706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93312959|NCT05191706|Methylprednisolone|methylprednisolone|mesh-list
93312960|NCT05191706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93312961|NCT05191706|Prednisolone acetate|prednisolone acetate|mesh-list
93312962|NCT05191706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93312963|NCT05191706|Prednisolone phosphate|prednisolone phosphate|mesh-list
93312964|NCT05191706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93312965|NCT05191706|Antiemetics|antiemetics|mesh-ancestor
93312966|NCT05191706|Autonomic Agents|autonomic agents|mesh-ancestor
92694144|NCT00516009|Dexamethasone|dexamethasone|mesh-list
93312967|NCT05191706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93312968|NCT05191706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312969|NCT05191706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93312970|NCT05191706|Glucocorticoids|glucocorticoids|mesh-ancestor
93312971|NCT05191706|Hormones|hormones|mesh-ancestor
93312972|NCT05191706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93312973|NCT05191706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93312974|NCT05191706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312975|NCT05191706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93312976|NCT05191706|Protective Agents|protective agents|mesh-ancestor
93312977|NCT01493505|Paclitaxel|paclitaxel|mesh-list
93312978|NCT01493505|Carboplatin|carboplatin|mesh-list
93312979|NCT01493505|Trebananib|trebananib|mesh-list
93312980|NCT01493505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93312981|NCT01493505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93312982|NCT01493505|Tubulin Modulators|tubulin modulators|mesh-ancestor
93312983|NCT01493505|Antimitotic Agents|antimitotic agents|mesh-ancestor
93312984|NCT01493505|Mitosis Modulators|mitosis modulators|mesh-ancestor
93312985|NCT01493505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93312986|NCT01493505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93312987|NCT01493505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93312988|NCT01493505|Growth Substances|growth substances|mesh-ancestor
93312989|NCT01493505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312990|NCT01493505|Growth Inhibitors|growth inhibitors|mesh-ancestor
93312991|NCT01301157|Calcipotriene|calcipotriene|mesh-list
93312992|NCT01301157|Dermatologic Agents|dermatologic agents|mesh-ancestor
93312993|NCT02264145|Norflurane|norflurane|mesh-list
93312994|NCT02264145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93312995|NCT02264145|Anesthetics|anesthetics|mesh-ancestor
93312996|NCT02264145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93312997|NCT02264145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93312998|NCT02264301|Puerarin|puerarin|mesh-list
93312999|NCT02264301|Vasodilator Agents|vasodilator agents|mesh-ancestor
93092453|NCT03847922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092454|NCT03847922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92694751|NCT00517725|Antioxidants|antioxidants|mesh-ancestor
93313000|NCT02267109|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93313001|NCT02267109|Antiviral Agents|antiviral agents|mesh-ancestor
93313002|NCT02267109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313003|NCT04476069|Ibuprofen|ibuprofen|mesh-list
92114662|NCT05739682|Carticaine|carticaine|mesh-list
93313004|NCT04476069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93313005|NCT04476069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313006|NCT04476069|Analgesics|analgesics|mesh-ancestor
93313007|NCT04476069|Sensory System Agents|sensory system agents|mesh-ancestor
93313008|NCT04476069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313009|NCT04476069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313010|NCT04476069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313011|NCT04476069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313012|NCT04476069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93313013|NCT04476069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313014|NCT04476069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313015|NCT01480479|Temozolomide|temozolomide|mesh-list
93313016|NCT01480479|Molgramostim|molgramostim|mesh-list
93313017|NCT01480479|Rindopepimut|rindopepimut|mesh-list
93313018|NCT01480479|Sargramostim|sargramostim|mesh-list
93313019|NCT01480479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93313020|NCT01480479|Alkylating Agents|alkylating agents|mesh-ancestor
93313021|NCT01480479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313022|NCT01480479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313023|NCT01480479|Immunologic Factors|immunologic factors|mesh-ancestor
93313024|NCT01480479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695055|NCT00520338|Celecoxib|celecoxib|mesh-list
93313025|NCT01480479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313027|NCT01116141|Methotrexate|methotrexate|mesh-list
93313028|NCT01116141|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93313029|NCT01116141|Abortifacient Agents|abortifacient agents|mesh-ancestor
93313030|NCT01116141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93313031|NCT01116141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092455|NCT03847922|Anesthetics, General|anesthetics, general|mesh-ancestor
93313032|NCT01116141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313033|NCT01116141|Antimetabolites|antimetabolites|mesh-ancestor
93313034|NCT01116141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313035|NCT01116141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313036|NCT01116141|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313037|NCT01116141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313038|NCT01116141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93313039|NCT01116141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313040|NCT01116141|Immunologic Factors|immunologic factors|mesh-ancestor
93313041|NCT01116141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313042|NCT01116141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93313043|NCT01116141|Hematinics|hematinics|mesh-ancestor
93313044|NCT01116141|Vitamin B Complex|vitamin b complex|mesh-ancestor
93313045|NCT01116141|Vitamins|vitamins|mesh-ancestor
93313046|NCT01116141|Micronutrients|micronutrients|mesh-ancestor
93313047|NCT01280565|Dacarbazine|dacarbazine|mesh-list
93313048|NCT01280565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93313049|NCT01280565|Alkylating Agents|alkylating agents|mesh-ancestor
93092456|NCT03847922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313050|NCT01280565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313051|NCT01280565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313052|NCT05627739|Mycophenolic Acid|mycophenolic acid|mesh-list
93313053|NCT05627739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93313054|NCT05627739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313055|NCT05627739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93313056|NCT05627739|Antitubercular Agents|antitubercular agents|mesh-ancestor
93313057|NCT05627739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93313058|NCT05627739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313059|NCT05627739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313060|NCT05627739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313061|NCT01113957|Doxorubicin|doxorubicin|mesh-list
93313062|NCT01113957|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93313063|NCT01113957|Temozolomide|temozolomide|mesh-list
93313064|NCT01113957|Veliparib|veliparib|mesh-list
93313065|NCT01113957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93313066|NCT01113957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313067|NCT01113957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93313068|NCT01113957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93313069|NCT01113957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313070|NCT01113957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313071|NCT01113957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93313072|NCT01113957|Alkylating Agents|alkylating agents|mesh-ancestor
93313073|NCT01113957|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93313074|NCT01111773|Lidocaine|lidocaine|mesh-list
93313075|NCT01111773|Tetracaine|tetracaine|mesh-list
93313076|NCT01111773|Anesthetics, Local|anesthetics, local|mesh-ancestor
93313077|NCT01111773|Anesthetics|anesthetics|mesh-ancestor
93313078|NCT01111773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607529|NCT00132548|Pyrimethamine|pyrimethamine|mesh-list
93313079|NCT01111773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313080|NCT01111773|Sensory System Agents|sensory system agents|mesh-ancestor
92607541|NCT00132548|Anthelmintics|anthelmintics|mesh-ancestor
93313081|NCT01111773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313082|NCT01111773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93313083|NCT01111773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93313084|NCT01111773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93313085|NCT01111773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93313086|NCT01111773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313087|NCT01280331|Morphine|morphine|mesh-list
93313088|NCT01280331|Oxycodone|oxycodone|mesh-list
93313089|NCT01280331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93313090|NCT01280331|Narcotics|narcotics|mesh-ancestor
93313091|NCT01280331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93313092|NCT01280331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313093|NCT01280331|Analgesics|analgesics|mesh-ancestor
93313094|NCT01280331|Sensory System Agents|sensory system agents|mesh-ancestor
93313095|NCT01280331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313096|NCT01266525|Donepezil|donepezil|mesh-list
93313097|NCT01266525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93313098|NCT01266525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313099|NCT01266525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313100|NCT01266525|Cholinergic Agents|cholinergic agents|mesh-ancestor
93313101|NCT01266525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313102|NCT01266525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313103|NCT01266525|Nootropic Agents|nootropic agents|mesh-ancestor
93313104|NCT01265901|Cyclophosphamide|cyclophosphamide|mesh-list
93313105|NCT01265901|Sunitinib|sunitinib|mesh-list
93313106|NCT01265901|Molgramostim|molgramostim|mesh-list
93313107|NCT01265901|Sargramostim|sargramostim|mesh-list
93313108|NCT01265901|Immunologic Factors|immunologic factors|mesh-ancestor
93313109|NCT01265901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313110|NCT01265901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313111|NCT01265901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313112|NCT01265901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93313113|NCT01265901|Alkylating Agents|alkylating agents|mesh-ancestor
93313114|NCT01265901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313115|NCT01265901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313116|NCT01265901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93313117|NCT01265901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93092457|NCT03847922|Analgesics|analgesics|mesh-ancestor
93313118|NCT01265901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93313119|NCT01265901|Growth Substances|growth substances|mesh-ancestor
93313120|NCT01265901|Growth Inhibitors|growth inhibitors|mesh-ancestor
93313121|NCT01265901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93313122|NCT01265901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313123|NCT05231382|Leucovorin|leucovorin|mesh-list
93313124|NCT05231382|Fluorouracil|fluorouracil|mesh-list
93313125|NCT05231382|Raltitrexed|raltitrexed|mesh-list
93313126|NCT05231382|Oxaliplatin|oxaliplatin|mesh-list
93313127|NCT05231382|Antimetabolites|antimetabolites|mesh-ancestor
92696836|NCT00513032|Methylene Blue|methylene blue|mesh-list
93313128|NCT05231382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313129|NCT05231382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313130|NCT05231382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313131|NCT05231382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313132|NCT05231382|Immunologic Factors|immunologic factors|mesh-ancestor
93313133|NCT05231382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313134|NCT05231382|Antidotes|antidotes|mesh-ancestor
93313135|NCT05231382|Protective Agents|protective agents|mesh-ancestor
93313136|NCT05231382|Vitamin B Complex|vitamin b complex|mesh-ancestor
93313137|NCT05231382|Vitamins|vitamins|mesh-ancestor
93313138|NCT05231382|Micronutrients|micronutrients|mesh-ancestor
93313139|NCT05231382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93313140|NCT05231382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313141|NCT01262235|TKM-080301|tkm-080301|mesh-list
93313142|NCT01262235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93313143|NCT01262235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313144|NCT01262235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313145|NCT01262001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93313146|NCT01262001|Immunologic Factors|immunologic factors|mesh-ancestor
93313147|NCT01262001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313148|NCT01460511|Epinephrine|epinephrine|mesh-list
93313149|NCT01460511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93313150|NCT01460511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93313151|NCT01460511|Adrenergic Agents|adrenergic agents|mesh-ancestor
93313152|NCT01460511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697504|NCT00516191|Doxorubicin|doxorubicin|mesh-list
93313153|NCT01460511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313154|NCT01460511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313155|NCT01460511|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93313156|NCT01460511|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93313157|NCT01460511|Autonomic Agents|autonomic agents|mesh-ancestor
93313158|NCT01460511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313159|NCT01460511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93313160|NCT01460511|Respiratory System Agents|respiratory system agents|mesh-ancestor
93313161|NCT01460511|Mydriatics|mydriatics|mesh-ancestor
93313162|NCT01460511|Sympathomimetics|sympathomimetics|mesh-ancestor
93313163|NCT01460511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93313164|NCT03135171|Trastuzumab|trastuzumab|mesh-list
93313165|NCT03135171|Pertuzumab|pertuzumab|mesh-list
93313166|NCT03135171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313167|NCT03135171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313168|NCT01449591|Metronidazole|metronidazole|mesh-list
93313169|NCT01449591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313170|NCT01449591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93313171|NCT01449591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93313172|NCT01449591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93313173|NCT00909753|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93313174|NCT00909753|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93313175|NCT00909753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697798|NCT02940912|Apomorphine|apomorphine|mesh-list
93313176|NCT01444365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93313177|NCT01444365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313178|NCT01444365|Analgesics|analgesics|mesh-ancestor
93313179|NCT01444365|Sensory System Agents|sensory system agents|mesh-ancestor
93313180|NCT01444365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313181|NCT01444365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313182|NCT01444365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313183|NCT01444365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313184|NCT01098435|ALKS-33|alks-33|mesh-list
93313185|NCT01098435|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93313186|NCT01098435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313187|NCT01098435|Sensory System Agents|sensory system agents|mesh-ancestor
93313188|NCT01098435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313189|NCT00909597|Pioglitazone|pioglitazone|mesh-list
93313190|NCT00909597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93313191|NCT00909597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93313192|NCT00909597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313193|NCT00909597|Incretins|incretins|mesh-ancestor
93313194|NCT00909597|Hormones|hormones|mesh-ancestor
93313195|NCT00909597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93313196|NCT01077297|Tezosentan|tezosentan|mesh-list
93313197|NCT01077297|Vasodilator Agents|vasodilator agents|mesh-ancestor
92698335|NCT02931357|Lidocaine|lidocaine|mesh-list
93313198|NCT05653245|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
93313199|NCT05653245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313200|NCT05379855|Atropine|atropine|mesh-list
93313201|NCT05379855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93313202|NCT05379855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93313203|NCT05379855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93313204|NCT05379855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92118400|NCT03238482|Xhance|xhance|mesh-list
93313205|NCT05379855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93313206|NCT05379855|Autonomic Agents|autonomic agents|mesh-ancestor
93313207|NCT05379855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313208|NCT05379855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313209|NCT05379855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93313210|NCT05379855|Respiratory System Agents|respiratory system agents|mesh-ancestor
93313211|NCT05379855|Mydriatics|mydriatics|mesh-ancestor
93313212|NCT05379855|Parasympatholytics|parasympatholytics|mesh-ancestor
93313213|NCT05379855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93313214|NCT05379855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93313215|NCT05379855|Cholinergic Agents|cholinergic agents|mesh-ancestor
93313216|NCT05379855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607649|NCT00140868|Phenobarbital|phenobarbital|mesh-list
93313217|NCT05379855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313218|NCT02718326|Aflibercept|aflibercept|mesh-list
93313219|NCT02718326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93313220|NCT02718326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93313221|NCT02718326|Growth Substances|growth substances|mesh-ancestor
93313222|NCT02718326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313223|NCT02718326|Growth Inhibitors|growth inhibitors|mesh-ancestor
93313224|NCT02718326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313225|NCT03691584|Dimercaprol|dimercaprol|mesh-list
93313226|NCT03691584|Chelating Agents|chelating agents|mesh-ancestor
93313227|NCT03691584|Sequestering Agents|sequestering agents|mesh-ancestor
93313228|NCT03691584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313229|NCT04655144|Dexamethasone|dexamethasone|mesh-list
93313230|NCT04655144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313231|NCT04655144|Antiemetics|antiemetics|mesh-ancestor
93313232|NCT04655144|Autonomic Agents|autonomic agents|mesh-ancestor
93313233|NCT04655144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607663|NCT00132938|Telithromycin|telithromycin|mesh-list
93313234|NCT04655144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313235|NCT04655144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313236|NCT04655144|Glucocorticoids|glucocorticoids|mesh-ancestor
92985216|NCT04080323|Dinoprostone|dinoprostone|mesh-list
93313237|NCT04655144|Hormones|hormones|mesh-ancestor
93366434|NCT02422186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93313238|NCT04655144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93313239|NCT04655144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93313240|NCT04655144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313241|NCT03468972|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93313242|NCT03468972|Immunologic Factors|immunologic factors|mesh-ancestor
93313243|NCT03468972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313244|NCT03600714|Interferons|interferons|mesh-list
93313245|NCT03600714|Ritonavir|ritonavir|mesh-list
93313246|NCT03600714|Lonafarnib|lonafarnib|mesh-list
93313247|NCT03600714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313248|NCT03600714|Antiviral Agents|antiviral agents|mesh-ancestor
93313249|NCT03600714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313250|NCT03600714|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93313251|NCT03600714|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92699486|NCT00528515|Propofol|propofol|mesh-list
93313252|NCT03600714|Protease Inhibitors|protease inhibitors|mesh-ancestor
93313253|NCT03600714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313254|NCT03600714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313255|NCT03600714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93313256|NCT03600714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93092458|NCT01194284|Mifamurtide|mifamurtide|mesh-list
93313257|NCT03600714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93313258|NCT03600714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93313259|NCT04590326|Cemiplimab|cemiplimab|mesh-list
93313260|NCT04590326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313261|NCT04590326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313262|NCT05163366|Ketamine|ketamine|mesh-list
93313263|NCT05163366|Morphine|morphine|mesh-list
93313264|NCT05163366|Analgesics|analgesics|mesh-ancestor
93313265|NCT05163366|Sensory System Agents|sensory system agents|mesh-ancestor
93313266|NCT05163366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313267|NCT05163366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313268|NCT05163366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93313269|NCT05163366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93313270|NCT05163366|Anesthetics, General|anesthetics, general|mesh-ancestor
93313271|NCT05163366|Anesthetics|anesthetics|mesh-ancestor
93313272|NCT05163366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93313273|NCT05163366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93313274|NCT05163366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93313275|NCT05163366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313276|NCT05163366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607707|NCT01154439|Analgesics|analgesics|mesh-ancestor
93313277|NCT05163366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93313278|NCT05163366|Narcotics|narcotics|mesh-ancestor
93313279|NCT00900783|Valacyclovir|valacyclovir|mesh-list
93313280|NCT00900783|Antiviral Agents|antiviral agents|mesh-ancestor
93313281|NCT00900783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607714|NCT00133172|Prednisone|prednisone|mesh-list
93313282|NCT01035879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93313283|NCT01035879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93313284|NCT01035879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313285|NCT01035879|Incretins|incretins|mesh-ancestor
93313286|NCT01035879|Hormones|hormones|mesh-ancestor
93313287|NCT01035879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93313288|NCT01035879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93313289|NCT01035879|Protease Inhibitors|protease inhibitors|mesh-ancestor
93313290|NCT01035879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313291|NCT01035879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313292|NCT04978298|Phenelzine|phenelzine|mesh-list
93313293|NCT04978298|Ozanimod|ozanimod|mesh-list
93092459|NCT01194284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93313294|NCT04978298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93313295|NCT04978298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313296|NCT04978298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313297|NCT04978298|Immunologic Factors|immunologic factors|mesh-ancestor
93313298|NCT04978298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313299|NCT04978298|Antidepressive Agents|antidepressive agents|mesh-ancestor
93313300|NCT04978298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93313301|NCT04978298|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93313302|NCT04978298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313303|NCT01029873|Cisplatin|cisplatin|mesh-list
93313304|NCT01029873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313305|NCT01024101|Paclitaxel|paclitaxel|mesh-list
93313306|NCT01024101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93313307|NCT01024101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313308|NCT01024101|Tubulin Modulators|tubulin modulators|mesh-ancestor
93313309|NCT01024101|Antimitotic Agents|antimitotic agents|mesh-ancestor
93313310|NCT01024101|Mitosis Modulators|mitosis modulators|mesh-ancestor
93313311|NCT01024101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985290|NCT03890367|Vaccines|vaccines|mesh-list
93313312|NCT04489706|Arsenic Trioxide|arsenic trioxide|mesh-list
93313313|NCT04489706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313314|NCT00818571|Vildagliptin|vildagliptin|mesh-list
93313315|NCT00818571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93313316|NCT00818571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313317|NCT00818571|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93313318|NCT00818571|Protease Inhibitors|protease inhibitors|mesh-ancestor
93313319|NCT00818571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313320|NCT00818571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313321|NCT00818493|Acetaminophen|acetaminophen|mesh-list
93313322|NCT00818493|Morphine|morphine|mesh-list
93313323|NCT00818493|Oxycodone|oxycodone|mesh-list
93313324|NCT00818493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93313325|NCT00818493|Narcotics|narcotics|mesh-ancestor
93092460|NCT01194284|Immunologic Factors|immunologic factors|mesh-ancestor
93313326|NCT00818493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93313327|NCT00818493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313328|NCT00818493|Analgesics|analgesics|mesh-ancestor
93313329|NCT00818493|Sensory System Agents|sensory system agents|mesh-ancestor
93313330|NCT00818493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313331|NCT00818493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313332|NCT00818493|Antipyretics|antipyretics|mesh-ancestor
93313333|NCT04455126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93313334|NCT04455126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93313335|NCT00893139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93313336|NCT00893139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93313337|NCT01378962|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93313338|NCT01378962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313339|NCT01378962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93313340|NCT01378962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313341|NCT01378962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313342|NCT00892203|Sumatriptan|sumatriptan|mesh-list
93313343|NCT00892203|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93313344|NCT00892203|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93313345|NCT00892203|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92058341|NCT04060342|Paclitaxel|paclitaxel|mesh-list
93313346|NCT00892203|Serotonin Agents|serotonin agents|mesh-ancestor
93313347|NCT00892203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313348|NCT00892203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313349|NCT00892203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313350|NCT00810147|BMS 708163|bms 708163|mesh-list
93313351|NCT00810147|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93313352|NCT00810147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313353|NCT00810147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313354|NCT04375956|Pembrolizumab|pembrolizumab|mesh-list
92607782|NCT00141258|Anticonvulsants|anticonvulsants|mesh-ancestor
93313355|NCT04375956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313356|NCT04375956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313357|NCT04375956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93313358|NCT04375956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313359|NCT04495478|Ramucirumab|ramucirumab|mesh-list
93313360|NCT04495478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93313361|NCT04495478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313362|NCT04495478|Immunologic Factors|immunologic factors|mesh-ancestor
93313363|NCT04495478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313364|NCT04487444|Thymalfasin|thymalfasin|mesh-list
93313365|NCT04487444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93313366|NCT04487444|Immunologic Factors|immunologic factors|mesh-ancestor
93313367|NCT04487444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313368|NCT02717156|Pembrolizumab|pembrolizumab|mesh-list
93313369|NCT02717156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313370|NCT02717156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313371|NCT02717156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93313372|NCT02717156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313373|NCT00884715|Octreotide|octreotide|mesh-list
93313374|NCT00884715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313375|NCT00884715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93313376|NCT00884715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313377|NCT03603080|Metformin|metformin|mesh-list
93313378|NCT03603080|Topiramate|topiramate|mesh-list
93313379|NCT03603080|Anti-Obesity Agents|anti-obesity agents|mesh-list
93313380|NCT03603080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93313381|NCT03603080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313382|NCT03603080|Anticonvulsants|anticonvulsants|mesh-ancestor
93313383|NCT01019187|Modafinil|modafinil|mesh-list
92702005|NCT05466708|Anesthetics|anesthetics|mesh-ancestor
93313384|NCT01019187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93313385|NCT01019187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313386|NCT01019187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92607809|NCT00141336|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93313387|NCT01019187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93313388|NCT01019187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93313389|NCT01019187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313390|NCT05088876|Acetaminophen|acetaminophen|mesh-list
93313391|NCT05088876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313392|NCT05088876|Analgesics|analgesics|mesh-ancestor
93313393|NCT05088876|Sensory System Agents|sensory system agents|mesh-ancestor
93313394|NCT05088876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313395|NCT05088876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313396|NCT05088876|Antipyretics|antipyretics|mesh-ancestor
93313397|NCT05084508|Vaccines|vaccines|mesh-list
93313398|NCT05084508|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93313399|NCT05084508|Immunologic Factors|immunologic factors|mesh-ancestor
93313400|NCT05084508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313401|NCT01018875|Donepezil|donepezil|mesh-list
93313402|NCT01018875|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93313403|NCT01018875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313404|NCT01018875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313405|NCT01018875|Cholinergic Agents|cholinergic agents|mesh-ancestor
93313406|NCT01018875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313407|NCT01018875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313408|NCT01018875|Nootropic Agents|nootropic agents|mesh-ancestor
93313409|NCT05390736|Vitamin D|vitamin d|mesh-list
93313410|NCT05390736|Vitamins|vitamins|mesh-ancestor
93313411|NCT05390736|Micronutrients|micronutrients|mesh-ancestor
93313412|NCT05390736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313413|NCT05390736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93313414|NCT00806403|Reteplase|reteplase|mesh-list
93313415|NCT00806403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93313416|NCT00806403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93313417|NCT00806403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313418|NCT01007721|Fluticasone|fluticasone|mesh-list
93313419|NCT01007721|Xhance|xhance|mesh-list
93313420|NCT01007721|Montelukast|montelukast|mesh-list
93313421|NCT01007721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607838|NCT00133523|Vaccines|vaccines|mesh-list
93313422|NCT01007721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93313423|NCT01007721|Autonomic Agents|autonomic agents|mesh-ancestor
93313424|NCT01007721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313425|NCT01007721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313426|NCT01007721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93313427|NCT01007721|Respiratory System Agents|respiratory system agents|mesh-ancestor
93313428|NCT01007721|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313429|NCT01007721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93313430|NCT01007721|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92702866|NCT04942730|Busulfan|busulfan|mesh-list
93313431|NCT01007721|Hormone Antagonists|hormone antagonists|mesh-ancestor
93313432|NCT01007721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93313433|NCT01007721|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93313434|NCT01007721|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93092461|NCT01194284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313435|NCT01007721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313436|NCT00701558|Gemcitabine|gemcitabine|mesh-list
93313437|NCT00701558|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93313438|NCT00701558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313439|NCT00701558|Antimetabolites|antimetabolites|mesh-ancestor
93313440|NCT00701558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313441|NCT00701558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313442|NCT00701558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93313443|NCT00701558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313444|NCT03233828|Aldesleukin|aldesleukin|mesh-list
93313445|NCT03233828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313446|NCT03233828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93313447|NCT03233828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93313448|NCT03233828|Antiviral Agents|antiviral agents|mesh-ancestor
93313449|NCT03233828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313450|NCT03882177|Vitamin B 6|vitamin b 6|mesh-list
93313451|NCT03882177|Pyridoxal|pyridoxal|mesh-list
93313452|NCT03882177|Pyridoxine|pyridoxine|mesh-list
93313453|NCT03882177|Pravastatin|pravastatin|mesh-list
93313454|NCT03882177|Vitamins|vitamins|mesh-ancestor
93313455|NCT03882177|Micronutrients|micronutrients|mesh-ancestor
92607864|NCT00144807|Cyclophosphamide|cyclophosphamide|mesh-list
93313456|NCT03882177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313457|NCT03882177|Vitamin B Complex|vitamin b complex|mesh-ancestor
93313458|NCT03882177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93313459|NCT03882177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93313460|NCT03882177|Antimetabolites|antimetabolites|mesh-ancestor
93313461|NCT03882177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313462|NCT03882177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93313463|NCT03882177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93313464|NCT03882177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313465|NCT01007097|Glimepiride|glimepiride|mesh-list
93313466|NCT01007097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93313467|NCT01007097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092462|NCT03255382|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93313468|NCT01007097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313469|NCT01007097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313470|NCT01007097|Immunologic Factors|immunologic factors|mesh-ancestor
93313471|NCT01663402|Alirocumab|alirocumab|mesh-list
93313472|NCT01663402|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93313473|NCT01663402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93313474|NCT01663402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92607882|NCT00133640|Vitamin D|vitamin d|mesh-list
93313475|NCT01663402|Antimetabolites|antimetabolites|mesh-ancestor
93313476|NCT01663402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313477|NCT01663402|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93313478|NCT01663402|Protease Inhibitors|protease inhibitors|mesh-ancestor
93313479|NCT01663402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313480|NCT01663402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93313481|NCT05115903|Adalimumab|adalimumab|mesh-list
93313482|NCT05115903|Infliximab|infliximab|mesh-list
93313483|NCT05115903|Golimumab|golimumab|mesh-list
93313484|NCT05115903|Certolizumab Pegol|certolizumab pegol|mesh-list
93313485|NCT05115903|Etanercept|etanercept|mesh-list
93313486|NCT05115903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93313487|NCT05115903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93313488|NCT05115903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313489|NCT05115903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313490|NCT05115903|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313491|NCT05115903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313492|NCT05115903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93313493|NCT05115903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313494|NCT05115903|Analgesics|analgesics|mesh-ancestor
93313495|NCT05115903|Sensory System Agents|sensory system agents|mesh-ancestor
93313496|NCT05115903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313497|NCT05115903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313498|NCT05115903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313499|NCT05115903|Immunologic Factors|immunologic factors|mesh-ancestor
93313500|NCT03695250|Nivolumab|nivolumab|mesh-list
93313501|NCT03695250|Linrodostat|linrodostat|mesh-list
92704073|NCT05467878|Anesthetics|anesthetics|mesh-list
93313502|NCT03695250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313503|NCT03695250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313504|NCT03695250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93313505|NCT03695250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313506|NCT03695250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313507|NCT03223298|Botulinum Toxins|botulinum toxins|mesh-list
93313508|NCT03223298|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93313509|NCT03223298|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93313510|NCT03223298|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93313511|NCT03223298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93313512|NCT03223298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313513|NCT03223298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92607915|NCT00133757|Dopamine Agents|dopamine agents|mesh-ancestor
93313514|NCT03223298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313515|NCT03223298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313516|NCT03223298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93313517|NCT03223298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313518|NCT00869661|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93313519|NCT00869661|Interferon-alpha|interferon-alpha|mesh-list
93313520|NCT00869661|Ribavirin|ribavirin|mesh-list
93313521|NCT00869661|Antiviral Agents|antiviral agents|mesh-ancestor
93313522|NCT00869661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313523|NCT00869661|Immunologic Factors|immunologic factors|mesh-ancestor
93313524|NCT00869661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313525|NCT00869661|Antimetabolites|antimetabolites|mesh-ancestor
93313526|NCT00869661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313527|NCT03192566|Acetaminophen|acetaminophen|mesh-list
93313528|NCT03192566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313529|NCT03192566|Analgesics|analgesics|mesh-ancestor
93313530|NCT03192566|Sensory System Agents|sensory system agents|mesh-ancestor
93313531|NCT03192566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313532|NCT03192566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313533|NCT03192566|Antipyretics|antipyretics|mesh-ancestor
93313534|NCT03296930|Ritonavir|ritonavir|mesh-list
93313535|NCT03296930|Ribavirin|ribavirin|mesh-list
93313536|NCT03296930|Sofosbuvir|sofosbuvir|mesh-list
93313537|NCT03296930|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93313538|NCT03296930|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92985511|NCT00534495|Rilonacept|rilonacept|mesh-list
93313539|NCT03296930|Protease Inhibitors|protease inhibitors|mesh-ancestor
93313540|NCT03296930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313541|NCT03296930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061290|NCT04278781|Ivosidenib|ivosidenib|mesh-list
93313543|NCT03296930|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93313544|NCT03296930|Antiviral Agents|antiviral agents|mesh-ancestor
93313545|NCT03296930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313546|NCT03296930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93313547|NCT03296930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93313548|NCT03296930|Antimetabolites|antimetabolites|mesh-ancestor
93313549|NCT04607772|Rituximab|rituximab|mesh-list
93313550|NCT04607772|Gemcitabine|gemcitabine|mesh-list
93313551|NCT04607772|Oxaliplatin|oxaliplatin|mesh-list
93313552|NCT04607772|Lenalidomide|lenalidomide|mesh-list
93313553|NCT04607772|Venetoclax|venetoclax|mesh-list
93313554|NCT04607772|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93313555|NCT04607772|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93313556|NCT04607772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313557|NCT04607772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313558|NCT04607772|Immunologic Factors|immunologic factors|mesh-ancestor
93313559|NCT04607772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313560|NCT04607772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313561|NCT04607772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313562|NCT04607772|Antimetabolites|antimetabolites|mesh-ancestor
93313563|NCT04607772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313564|NCT04607772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93313565|NCT04607772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93313566|NCT04607772|Growth Substances|growth substances|mesh-ancestor
92607960|NCT00141492|Testosterone|testosterone|mesh-list
93313567|NCT04607772|Growth Inhibitors|growth inhibitors|mesh-ancestor
93313568|NCT04607772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93313569|NCT04607772|Alkylating Agents|alkylating agents|mesh-ancestor
93313570|NCT04607772|Immunoconjugates|immunoconjugates|mesh-ancestor
93313571|NCT02464124|Nitazoxanide|nitazoxanide|mesh-list
93313572|NCT02464124|Lactulose|lactulose|mesh-list
93313573|NCT02464124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313574|NCT02464124|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93313575|NCT02464124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313576|NCT00859521|Levetiracetam|levetiracetam|mesh-list
93313577|NCT00859521|Anticonvulsants|anticonvulsants|mesh-ancestor
93313578|NCT00859521|Nootropic Agents|nootropic agents|mesh-ancestor
93313579|NCT05398770|Vitamin D|vitamin d|mesh-list
93313580|NCT05398770|Vitamins|vitamins|mesh-ancestor
92607970|NCT00134069|Sorafenib|sorafenib|mesh-list
93313581|NCT05398770|Micronutrients|micronutrients|mesh-ancestor
93313582|NCT05398770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313583|NCT05398770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93313584|NCT03033914|Doxorubicin|doxorubicin|mesh-list
93313585|NCT03033914|Bleomycin|bleomycin|mesh-list
93313586|NCT03033914|Nivolumab|nivolumab|mesh-list
93313587|NCT03033914|Dacarbazine|dacarbazine|mesh-list
93313588|NCT03033914|Vinblastine|vinblastine|mesh-list
93092463|NCT03255382|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313589|NCT03033914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92607983|NCT00141570|Estrogens|estrogens|mesh-list
93313590|NCT03033914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313591|NCT03033914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93313592|NCT03033914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93313593|NCT03033914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313594|NCT03033914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313595|NCT03033914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313596|NCT03033914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93313597|NCT03033914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93313598|NCT03033914|Alkylating Agents|alkylating agents|mesh-ancestor
93313599|NCT03033914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93313600|NCT03033914|Tubulin Modulators|tubulin modulators|mesh-ancestor
93313601|NCT03033914|Antimitotic Agents|antimitotic agents|mesh-ancestor
93313602|NCT03033914|Mitosis Modulators|mitosis modulators|mesh-ancestor
93313603|NCT00843687|Risperidone|risperidone|mesh-list
93313604|NCT00843687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93313605|NCT00843687|Serotonin Agents|serotonin agents|mesh-ancestor
92607994|NCT00141570|Anabolic Agents|anabolic agents|mesh-ancestor
93313606|NCT00843687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313607|NCT00843687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313608|NCT00843687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313609|NCT00843687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93313610|NCT00843687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92706446|NCT00551850|MP 412|mp 412|mesh-list
93313611|NCT00843687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93313612|NCT00843687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93313613|NCT00843687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93313614|NCT00843687|Dopamine Agents|dopamine agents|mesh-ancestor
93313615|NCT04642131|Caffeine|caffeine|mesh-list
93313616|NCT04642131|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93313617|NCT04642131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313618|NCT04642131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93313619|NCT04642131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313620|NCT04642131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313621|NCT04642131|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93313622|NCT04642131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93313623|NCT04642131|Purinergic Agents|purinergic agents|mesh-ancestor
93313624|NCT04642131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313625|NCT01001715|Fasinumab|fasinumab|mesh-list
93313626|NCT01001715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313627|NCT01001715|Analgesics|analgesics|mesh-ancestor
93313628|NCT01001715|Sensory System Agents|sensory system agents|mesh-ancestor
93313629|NCT01001715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313630|NCT01001715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313631|NCT02463812|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92608022|NCT00141648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313632|NCT02463812|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93313633|NCT02463812|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93313634|NCT02463812|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93313635|NCT00789633|Gemcitabine|gemcitabine|mesh-list
93313636|NCT00789633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313637|NCT00789633|Antimetabolites|antimetabolites|mesh-ancestor
92608029|NCT00141648|Tubulin Modulators|tubulin modulators|mesh-ancestor
93313638|NCT00789633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313639|NCT00789633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313640|NCT00788541|Hydrocortisone|hydrocortisone|mesh-list
93313641|NCT00788541|Anecortave|anecortave|mesh-list
93313642|NCT00788541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93313643|NCT00788541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93313644|NCT00788541|Growth Substances|growth substances|mesh-ancestor
93313645|NCT00788541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707257|NCT02469155|Risperidone|risperidone|mesh-list
93313646|NCT00788541|Growth Inhibitors|growth inhibitors|mesh-ancestor
93313647|NCT00788541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313648|NCT00788541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313649|NCT03296540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93313650|NCT03296540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93313651|NCT04489160|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93313652|NCT04489160|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93313653|NCT04489160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313654|NCT04489160|Immunologic Factors|immunologic factors|mesh-ancestor
92063331|NCT03594058|Solabegron|solabegron|mesh-list
93313655|NCT04489160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313656|NCT00786201|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93313657|NCT00786201|Immunologic Factors|immunologic factors|mesh-ancestor
93313658|NCT00786201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313659|NCT05514483|Ondansetron|ondansetron|mesh-list
93313660|NCT05514483|Antiemetics|antiemetics|mesh-ancestor
93313661|NCT05514483|Autonomic Agents|autonomic agents|mesh-ancestor
93313662|NCT05514483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313663|NCT05514483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313664|NCT05514483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313665|NCT05514483|Antipruritics|antipruritics|mesh-ancestor
93313666|NCT05514483|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313667|NCT05514483|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93313668|NCT05514483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93313669|NCT05514483|Serotonin Agents|serotonin agents|mesh-ancestor
93313670|NCT05514483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313671|NCT05514483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313672|NCT00841815|Amlodipine|amlodipine|mesh-list
93313673|NCT00841815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93313674|NCT00841815|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93313675|NCT00841815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93313676|NCT00841815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313677|NCT00841815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93313678|NCT00841815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313679|NCT00841815|Vasodilator Agents|vasodilator agents|mesh-ancestor
93313680|NCT03296306|Cisplatin|cisplatin|mesh-list
93313681|NCT03296306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313682|NCT04440280|Acetylcysteine|acetylcysteine|mesh-list
93313683|NCT04440280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93313684|NCT04440280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93313685|NCT04440280|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93313686|NCT04440280|Antiviral Agents|antiviral agents|mesh-ancestor
93313687|NCT04440280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313688|NCT04440280|Expectorants|expectorants|mesh-ancestor
93313689|NCT04440280|Respiratory System Agents|respiratory system agents|mesh-ancestor
93313690|NCT04440280|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93313691|NCT04440280|Antioxidants|antioxidants|mesh-ancestor
93313692|NCT04440280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313693|NCT04440280|Protective Agents|protective agents|mesh-ancestor
93313694|NCT04440280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313695|NCT04440280|Antidotes|antidotes|mesh-ancestor
93313696|NCT00841659|Paroxetine|paroxetine|mesh-list
92608081|NCT00141882|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93313697|NCT00841659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93313698|NCT00841659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93313699|NCT00841659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93313700|NCT00841659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313701|NCT00841659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313702|NCT00841659|Serotonin Agents|serotonin agents|mesh-ancestor
93313703|NCT00841659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313704|NCT00841659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93313705|NCT00841659|Antidepressive Agents|antidepressive agents|mesh-ancestor
93313706|NCT00841659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93313707|NCT00841659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93313708|NCT00841659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93313709|NCT00841659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313710|NCT04061252|Brodalumab|brodalumab|mesh-list
93313711|NCT04061252|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313712|NCT04473417|Dapagliflozin|dapagliflozin|mesh-list
93313713|NCT04473417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93313714|NCT04473417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313715|NCT04473417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93313716|NCT04473417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313717|NCT01001091|Dexamethasone|dexamethasone|mesh-list
93313718|NCT01001091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93313719|NCT01001091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93313720|NCT01001091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313721|NCT01001091|Antiemetics|antiemetics|mesh-ancestor
93313722|NCT01001091|Autonomic Agents|autonomic agents|mesh-ancestor
93313723|NCT01001091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313724|NCT01001091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313725|NCT01001091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313726|NCT01001091|Glucocorticoids|glucocorticoids|mesh-ancestor
93313727|NCT01001091|Hormones|hormones|mesh-ancestor
93313728|NCT01001091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93313729|NCT01001091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93313730|NCT01001091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313731|NCT05076682|Cromolyn Sodium|cromolyn sodium|mesh-list
93313732|NCT05076682|Efavirenz|efavirenz|mesh-list
93313733|NCT05076682|Choline|choline|mesh-list
93313734|NCT05076682|Antibodies|antibodies|mesh-list
93313735|NCT05076682|Immunologic Factors|immunologic factors|mesh-ancestor
93313736|NCT05076682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313737|NCT05076682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93313738|NCT05076682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93313739|NCT05076682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313740|NCT05076682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313741|NCT05076682|Antiviral Agents|antiviral agents|mesh-ancestor
93313742|NCT05076682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313743|NCT05076682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93313744|NCT05076682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93313745|NCT05076682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93313746|NCT05076682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93313747|NCT05076682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93313748|NCT05076682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93313749|NCT05076682|Lipotropic Agents|lipotropic agents|mesh-ancestor
93313750|NCT05076682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93313751|NCT05076682|Antimetabolites|antimetabolites|mesh-ancestor
93313752|NCT05076682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313753|NCT05076682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93313754|NCT05076682|Nootropic Agents|nootropic agents|mesh-ancestor
93313755|NCT05076682|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
93313756|NCT05076682|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93313757|NCT05076682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313758|NCT05076682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93313759|NCT05076682|Respiratory System Agents|respiratory system agents|mesh-ancestor
93313760|NCT00840879|Meloxicam|meloxicam|mesh-list
93313761|NCT00840879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93313762|NCT00840879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313763|NCT00840879|Analgesics|analgesics|mesh-ancestor
93366435|NCT02422186|Analgesics|analgesics|mesh-ancestor
93313765|NCT00840879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313766|NCT00840879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313767|NCT00840879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313768|NCT00840879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313769|NCT00840879|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93313770|NCT00840879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93313771|NCT00840879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313772|NCT00840879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313773|NCT02163434|Gabapentin|gabapentin|mesh-list
93313774|NCT02163434|Metoclopramide|metoclopramide|mesh-list
93313775|NCT02163434|Analgesics|analgesics|mesh-ancestor
93313776|NCT02163434|Sensory System Agents|sensory system agents|mesh-ancestor
93313777|NCT02163434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313778|NCT02163434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313779|NCT02163434|Anticonvulsants|anticonvulsants|mesh-ancestor
93313780|NCT02163434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93313781|NCT02163434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93313782|NCT02163434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93313783|NCT02163434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93313784|NCT02163434|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93313785|NCT02163434|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93313786|NCT02163434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313787|NCT02163434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313788|NCT02163434|Antimanic Agents|antimanic agents|mesh-ancestor
93313789|NCT02163434|Antiemetics|antiemetics|mesh-ancestor
93313790|NCT02163434|Autonomic Agents|autonomic agents|mesh-ancestor
93313791|NCT02163434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313792|NCT02163434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93313793|NCT02163434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93313794|NCT02163434|Dopamine Agents|dopamine agents|mesh-ancestor
93313795|NCT04015622|Docetaxel|docetaxel|mesh-list
93313796|NCT04015622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608174|NCT00134888|Buprenorphine|buprenorphine|mesh-list
93313797|NCT04015622|Tubulin Modulators|tubulin modulators|mesh-ancestor
93313798|NCT04015622|Antimitotic Agents|antimitotic agents|mesh-ancestor
93313799|NCT04015622|Mitosis Modulators|mitosis modulators|mesh-ancestor
93313800|NCT04015622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313801|NCT00840411|Clarithromycin|clarithromycin|mesh-list
93313802|NCT00840411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93313803|NCT00840411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313804|NCT00840411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92064476|NCT03582280|Calcium|calcium|mesh-list
93313805|NCT00840411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092464|NCT03255382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313806|NCT00840411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313807|NCT00840411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93313808|NCT00840411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93313809|NCT00840099|Amoxicillin|amoxicillin|mesh-list
93313810|NCT00840099|Clavulanic Acid|clavulanic acid|mesh-list
93313811|NCT00840099|Clavulanic Acids|clavulanic acids|mesh-list
93313812|NCT00840099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93313813|NCT00840099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93313814|NCT00840099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313815|NCT00840099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93313816|NCT00840099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313817|NCT00840099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313818|NCT03108248|Doxorubicin|doxorubicin|mesh-list
93313819|NCT03108248|Ethiodized Oil|ethiodized oil|mesh-list
93313820|NCT03108248|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
93313821|NCT03108248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93313822|NCT03108248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313823|NCT03108248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93313824|NCT03108248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93313825|NCT03108248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313826|NCT03108248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313827|NCT03108248|Hemostatics|hemostatics|mesh-ancestor
93313828|NCT03108248|Coagulants|coagulants|mesh-ancestor
93313829|NCT00836901|Amoxicillin|amoxicillin|mesh-list
93092465|NCT03255382|Immunologic Factors|immunologic factors|mesh-ancestor
93313830|NCT00836901|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93313831|NCT00836901|Clavulanic Acids|clavulanic acids|mesh-list
93313832|NCT00836901|Clavulanic Acid|clavulanic acid|mesh-list
92709801|NCT00559286|Telmisartan|telmisartan|mesh-list
93313833|NCT00836901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93313834|NCT00836901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608224|NCT00135122|Prednisolone|prednisolone|mesh-list
93313835|NCT00836901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93313836|NCT00836901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985814|NCT04077905|Glucocorticoids|glucocorticoids|mesh-ancestor
93313837|NCT00836901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313838|NCT04460560|Terlipressin|terlipressin|mesh-list
92608232|NCT00135122|Glucocorticoids|glucocorticoids|mesh-ancestor
93313839|NCT04460560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93313840|NCT04460560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93313841|NCT04537689|Cyclosporine|cyclosporine|mesh-list
93313842|NCT04537689|Methotrexate|methotrexate|mesh-list
93313843|NCT04537689|Ixekizumab|ixekizumab|mesh-list
93313844|NCT04537689|Acitretin|acitretin|mesh-list
93313845|NCT04537689|Cyclosporins|cyclosporins|mesh-list
93313846|NCT04537689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93313847|NCT04537689|Abortifacient Agents|abortifacient agents|mesh-ancestor
93313848|NCT04537689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93313849|NCT04537689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313850|NCT04537689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313851|NCT04537689|Antimetabolites|antimetabolites|mesh-ancestor
93313852|NCT04537689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313853|NCT04537689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313854|NCT04537689|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313855|NCT04537689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313856|NCT04537689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93313857|NCT04537689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313858|NCT04537689|Immunologic Factors|immunologic factors|mesh-ancestor
93313859|NCT04537689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608251|NCT00142350|Immunologic Factors|immunologic factors|mesh-ancestor
93313860|NCT04537689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93313861|NCT04537689|Antifungal Agents|antifungal agents|mesh-ancestor
93313862|NCT04537689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313863|NCT04537689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93313864|NCT04537689|Keratolytic Agents|keratolytic agents|mesh-ancestor
93313865|NCT03295760|Ubiquinone|ubiquinone|mesh-list
93313866|NCT03295760|Coenzyme Q10|coenzyme q10|mesh-list
93313867|NCT03295760|Micronutrients|micronutrients|mesh-ancestor
93313868|NCT03295760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313869|NCT03295760|Vitamins|vitamins|mesh-ancestor
93313870|NCT05563012|Capecitabine|capecitabine|mesh-list
93313871|NCT05563012|Oxaliplatin|oxaliplatin|mesh-list
93313872|NCT05563012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313873|NCT05563012|Antimetabolites|antimetabolites|mesh-ancestor
93313874|NCT05563012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313875|NCT05563012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313876|NCT04501653|Methylphenidate|methylphenidate|mesh-list
93313877|NCT04501653|Psilocybin|psilocybin|mesh-list
93313878|NCT04501653|Psilocin|psilocin|mesh-list
93313879|NCT04501653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93313880|NCT04501653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313881|NCT04501653|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93313882|NCT04501653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93313883|NCT04501653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93313884|NCT04501653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313885|NCT04501653|Dopamine Agents|dopamine agents|mesh-ancestor
93313886|NCT04501653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313887|NCT04501653|Hallucinogens|hallucinogens|mesh-ancestor
93313888|NCT04501653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93313889|NCT04730206|Molnupiravir|molnupiravir|mesh-list
93313890|NCT04730206|Camostat|camostat|mesh-list
93313891|NCT04730206|Protease Inhibitors|protease inhibitors|mesh-ancestor
93313892|NCT04730206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313893|NCT04730206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313894|NCT04730206|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93313895|NCT04730206|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93313896|NCT04730206|Antiviral Agents|antiviral agents|mesh-ancestor
93313897|NCT04730206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313898|NCT00990327|Adenosine|adenosine|mesh-list
93313899|NCT00990327|Analgesics|analgesics|mesh-ancestor
93313900|NCT00990327|Sensory System Agents|sensory system agents|mesh-ancestor
93313901|NCT00990327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313902|NCT00990327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313903|NCT00990327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93313904|NCT00990327|Vasodilator Agents|vasodilator agents|mesh-ancestor
93313905|NCT00990327|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93313906|NCT00990327|Purinergic Agonists|purinergic agonists|mesh-ancestor
93313907|NCT00990327|Purinergic Agents|purinergic agents|mesh-ancestor
93313908|NCT00990327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608295|NCT00135551|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93313909|NCT00990327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313910|NCT03050814|Leucovorin|leucovorin|mesh-list
93313911|NCT03050814|Bevacizumab|bevacizumab|mesh-list
93313912|NCT03050814|Avelumab|avelumab|mesh-list
93313913|NCT03050814|Fluorouracil|fluorouracil|mesh-list
93313914|NCT03050814|Capecitabine|capecitabine|mesh-list
93313915|NCT03050814|Oxaliplatin|oxaliplatin|mesh-list
92710800|NCT00446810|Benphothiamine|benphothiamine|mesh-list
93313916|NCT03050814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93313917|NCT03050814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313918|NCT03050814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93313919|NCT03050814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93313920|NCT03050814|Growth Substances|growth substances|mesh-ancestor
93313921|NCT03050814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313922|NCT03050814|Growth Inhibitors|growth inhibitors|mesh-ancestor
93313923|NCT03050814|Antimetabolites|antimetabolites|mesh-ancestor
93313924|NCT03050814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313925|NCT03050814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015551|NCT05019885|Ketamine|ketamine|mesh-list
93313926|NCT03050814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313927|NCT03050814|Immunologic Factors|immunologic factors|mesh-ancestor
93313928|NCT03050814|Antidotes|antidotes|mesh-ancestor
93313929|NCT03050814|Protective Agents|protective agents|mesh-ancestor
93313930|NCT03050814|Vitamin B Complex|vitamin b complex|mesh-ancestor
93313932|NCT03050814|Micronutrients|micronutrients|mesh-ancestor
93313933|NCT02462174|Ketamine|ketamine|mesh-list
93313934|NCT02462174|Bupivacaine|bupivacaine|mesh-list
93313935|NCT02462174|Anesthetics, Local|anesthetics, local|mesh-ancestor
93313936|NCT02462174|Anesthetics|anesthetics|mesh-ancestor
93313937|NCT02462174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93313938|NCT02462174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313939|NCT02462174|Sensory System Agents|sensory system agents|mesh-ancestor
93313940|NCT02462174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313941|NCT02462174|Analgesics|analgesics|mesh-ancestor
92711368|NCT00450203|Epirubicin|epirubicin|mesh-list
93313942|NCT02462174|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93313943|NCT02462174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92015568|NCT05016609|Antibodies|antibodies|mesh-list
93313944|NCT02462174|Anesthetics, General|anesthetics, general|mesh-ancestor
93313945|NCT02462174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93313946|NCT02462174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93313947|NCT02462174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93313948|NCT02462174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313949|NCT02564146|Paclitaxel|paclitaxel|mesh-list
93313950|NCT02564146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92711590|NCT03993132|Glucagon|glucagon|mesh-list
93313951|NCT02564146|Gemcitabine|gemcitabine|mesh-list
93313952|NCT02564146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93313953|NCT02564146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93313954|NCT02564146|Tubulin Modulators|tubulin modulators|mesh-ancestor
93313955|NCT02564146|Antimitotic Agents|antimitotic agents|mesh-ancestor
93313956|NCT02564146|Mitosis Modulators|mitosis modulators|mesh-ancestor
93313957|NCT02564146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313958|NCT02564146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93313959|NCT02564146|Antimetabolites|antimetabolites|mesh-ancestor
93313960|NCT00981357|Naproxen|naproxen|mesh-list
93313961|NCT00981357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93313962|NCT00981357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93313963|NCT00981357|Analgesics|analgesics|mesh-ancestor
93313964|NCT00981357|Sensory System Agents|sensory system agents|mesh-ancestor
92608352|NCT00135746|Nicotine|nicotine|mesh-list
93313965|NCT00981357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313966|NCT00981357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712013|NCT02116998|Antacids|antacids|mesh-ancestor
93313967|NCT00981357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313968|NCT00981357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313969|NCT00981357|Gout Suppressants|gout suppressants|mesh-ancestor
93313970|NCT00981357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93313971|NCT00981357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313972|NCT00981357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313973|NCT02462252|Cyclosporine|cyclosporine|mesh-list
93313974|NCT02462252|Methylprednisolone|methylprednisolone|mesh-list
93313975|NCT02462252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93313976|NCT02462252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93313977|NCT02462252|Cyclosporins|cyclosporins|mesh-list
93313978|NCT02462252|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93313979|NCT02462252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93313980|NCT02462252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93313981|NCT02462252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93313982|NCT02462252|Immunologic Factors|immunologic factors|mesh-ancestor
93313983|NCT02462252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93313984|NCT02462252|Antifungal Agents|antifungal agents|mesh-ancestor
93313985|NCT02462252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93313986|NCT02462252|Dermatologic Agents|dermatologic agents|mesh-ancestor
93313987|NCT02462252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93313988|NCT02462252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93313989|NCT02462252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93313990|NCT02462252|Antiemetics|antiemetics|mesh-ancestor
93313991|NCT02462252|Autonomic Agents|autonomic agents|mesh-ancestor
93313992|NCT02462252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93313993|NCT02462252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93313994|NCT02462252|Glucocorticoids|glucocorticoids|mesh-ancestor
93313995|NCT02462252|Hormones|hormones|mesh-ancestor
93313996|NCT02462252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93313997|NCT02462252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93313998|NCT02462252|Protective Agents|protective agents|mesh-ancestor
93313999|NCT02462252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608376|NCT00159081|Haloperidol|haloperidol|mesh-list
93314000|NCT02462252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314001|NCT03130452|Amoxicillin|amoxicillin|mesh-list
93314002|NCT03130452|Metronidazole|metronidazole|mesh-list
93314003|NCT03130452|Clarithromycin|clarithromycin|mesh-list
93314004|NCT03130452|Lansoprazole|lansoprazole|mesh-list
93314005|NCT03130452|Dexlansoprazole|dexlansoprazole|mesh-list
93314006|NCT03130452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314007|NCT03130452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314008|NCT03130452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93314009|NCT03130452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93314010|NCT03130452|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93314011|NCT03130452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314012|NCT03130452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608387|NCT00159081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314013|NCT03130452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93314014|NCT03130452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93314015|NCT03130452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93314016|NCT03130452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93314017|NCT03130452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93314018|NCT00979251|Oseltamivir|oseltamivir|mesh-list
93314019|NCT00979251|Amantadine|amantadine|mesh-list
93314020|NCT00979251|Antiviral Agents|antiviral agents|mesh-ancestor
92713053|NCT00555087|Hormones|hormones|mesh-ancestor
93314021|NCT00979251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314022|NCT00979251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092466|NCT03255382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314023|NCT00979251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314024|NCT00979251|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93314025|NCT00979251|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93314026|NCT00979251|Dopamine Agents|dopamine agents|mesh-ancestor
93314027|NCT00979251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314028|NCT00979251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713399|NCT01712451|Fluticasone|fluticasone|mesh-list
93314029|NCT00979251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314030|NCT00979251|Analgesics|analgesics|mesh-ancestor
93314031|NCT00979251|Sensory System Agents|sensory system agents|mesh-ancestor
93314032|NCT00979251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314033|NCT04551352|Adalimumab|adalimumab|mesh-list
93314034|NCT04551352|Obinutuzumab|obinutuzumab|mesh-list
93314035|NCT04551352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93314036|NCT04551352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314037|NCT04551352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314038|NCT04551352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314039|NCT04551352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314040|NCT05398224|Rituximab|rituximab|mesh-list
93314041|NCT05398224|Methotrexate|methotrexate|mesh-list
93314042|NCT05398224|Zanubrutinib|zanubrutinib|mesh-list
93314043|NCT05398224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92608419|NCT00135824|Povidone|povidone|mesh-list
93314044|NCT05398224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314045|NCT05398224|Immunologic Factors|immunologic factors|mesh-ancestor
93092467|NCT01191554|Tranexamic Acid|tranexamic acid|mesh-list
92608425|NCT00135863|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93314046|NCT05398224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314047|NCT05398224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314048|NCT05398224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93314049|NCT05398224|Abortifacient Agents|abortifacient agents|mesh-ancestor
93314050|NCT05398224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92608426|NCT00135863|Dalteparin|dalteparin|mesh-list
93314051|NCT05398224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93314052|NCT05398224|Antimetabolites|antimetabolites|mesh-ancestor
93314053|NCT05398224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314054|NCT05398224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93314055|NCT05398224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314056|NCT05398224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93314057|NCT05398224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314058|NCT05398224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93314059|NCT05398224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93314060|NCT04542304|Metolazone|metolazone|mesh-list
93314061|NCT04542304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314062|NCT04542304|Diuretics|diuretics|mesh-ancestor
93314063|NCT04542304|Natriuretic Agents|natriuretic agents|mesh-ancestor
93314064|NCT04542304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314065|NCT04542304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93314066|NCT04542304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314067|NCT04542304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314069|NCT02463110|Antidepressive Agents|antidepressive agents|mesh-ancestor
93314070|NCT02463110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314071|NCT02463110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93314072|NCT02463110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92608442|NCT00135941|Insulin Glargine|insulin glargine|mesh-list
93314073|NCT02463110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314074|NCT02463110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314075|NCT02463110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314076|NCT02463110|Serotonin Agents|serotonin agents|mesh-ancestor
93314077|NCT02463110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314078|NCT04495257|Nivolumab|nivolumab|mesh-list
93314079|NCT04495257|Ipilimumab|ipilimumab|mesh-list
92608453|NCT00152919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314080|NCT04495257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314081|NCT04495257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314082|NCT04495257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93314083|NCT04495257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314084|NCT05502952|Pentoxifylline|pentoxifylline|mesh-list
93314085|NCT05502952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93314086|NCT05502952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314087|NCT05502952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314088|NCT05502952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93314089|NCT05502952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93314090|NCT05502952|Protective Agents|protective agents|mesh-ancestor
93314091|NCT05502952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314092|NCT05502952|Vasodilator Agents|vasodilator agents|mesh-ancestor
93314093|NCT05502952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93314094|NCT05502952|Antioxidants|antioxidants|mesh-ancestor
93314095|NCT00835575|Mirtazapine|mirtazapine|mesh-list
93314096|NCT00835575|Antidepressive Agents|antidepressive agents|mesh-ancestor
93314097|NCT00835575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314098|NCT00835575|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93314099|NCT00835575|Histamine Antagonists|histamine antagonists|mesh-ancestor
93314100|NCT00835575|Histamine Agents|histamine agents|mesh-ancestor
93314101|NCT00835575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314102|NCT00835575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314103|NCT00835575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314104|NCT00835575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93314105|NCT00835575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608484|NCT00152958|Protective Agents|protective agents|mesh-ancestor
93314106|NCT00835575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314107|NCT00835575|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93314108|NCT00835575|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93314109|NCT00835575|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93314110|NCT00835575|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314111|NCT00835575|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93314112|NCT00835575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93314113|NCT00835575|Serotonin Agents|serotonin agents|mesh-ancestor
93314114|NCT00835575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93314115|NCT00777309|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93314116|NCT00777309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314117|NCT00777309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93314118|NCT00777309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314119|NCT00777309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314120|NCT03295214|Acetaminophen|acetaminophen|mesh-list
93314121|NCT03295214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314122|NCT03295214|Analgesics|analgesics|mesh-ancestor
93314123|NCT03295214|Sensory System Agents|sensory system agents|mesh-ancestor
93314124|NCT03295214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314125|NCT03295214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314126|NCT03295214|Antipyretics|antipyretics|mesh-ancestor
93314127|NCT04604704|Niacinamide|niacinamide|mesh-list
93314128|NCT04604704|Naltrexone|naltrexone|mesh-list
93314129|NCT04604704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93314130|NCT04604704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93314131|NCT04604704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314132|NCT04604704|Sensory System Agents|sensory system agents|mesh-ancestor
93314133|NCT04604704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015741|NCT02519595|Ketamine|ketamine|mesh-list
93314134|NCT04604704|Vitamin B Complex|vitamin b complex|mesh-ancestor
93314135|NCT04604704|Vitamins|vitamins|mesh-ancestor
93314136|NCT04604704|Micronutrients|micronutrients|mesh-ancestor
93314137|NCT00776373|Cytarabine|cytarabine|mesh-list
93314138|NCT00776373|Sirolimus|sirolimus|mesh-list
93314139|NCT00776373|Etoposide|etoposide|mesh-list
93314140|NCT00776373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93314141|NCT00776373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314142|NCT00776373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93314143|NCT00776373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93314144|NCT00776373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314145|NCT00776373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314146|NCT00776373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93314147|NCT00776373|Antimetabolites|antimetabolites|mesh-ancestor
93314148|NCT00776373|Antiviral Agents|antiviral agents|mesh-ancestor
93314149|NCT00776373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314150|NCT00776373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314151|NCT00776373|Immunologic Factors|immunologic factors|mesh-ancestor
93314152|NCT00776373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314153|NCT00776373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314154|NCT00776373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93314155|NCT00776373|Antifungal Agents|antifungal agents|mesh-ancestor
93314156|NCT00772785|Buprenorphine|buprenorphine|mesh-list
93314157|NCT00772785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314158|NCT00772785|Narcotics|narcotics|mesh-ancestor
93314159|NCT00772785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314160|NCT00772785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314161|NCT00772785|Analgesics|analgesics|mesh-ancestor
93314162|NCT00772785|Sensory System Agents|sensory system agents|mesh-ancestor
93314163|NCT00772785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314164|NCT00772785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93314165|NCT02461706|Cannabidiol|cannabidiol|mesh-list
93314166|NCT02461706|Anticonvulsants|anticonvulsants|mesh-ancestor
93314167|NCT05497570|Tenoxicam|tenoxicam|mesh-list
93314168|NCT05497570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93314169|NCT05497570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314170|NCT05497570|Analgesics|analgesics|mesh-ancestor
93314171|NCT05497570|Sensory System Agents|sensory system agents|mesh-ancestor
93314172|NCT05497570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314173|NCT05497570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314174|NCT05497570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314175|NCT05497570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314176|NCT05497570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93314177|NCT05497570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314178|NCT05497570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314179|NCT00963885|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93314180|NCT00963885|Lactams|lactams|mesh-list
93314181|NCT00963885|Antiviral Agents|antiviral agents|mesh-ancestor
93314182|NCT00963885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314183|NCT00963885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314184|NCT05497492|Lidocaine|lidocaine|mesh-list
93314185|NCT05497492|Sufentanil|sufentanil|mesh-list
93314186|NCT05497492|Propofol|propofol|mesh-list
93314187|NCT05497492|Esketamine|esketamine|mesh-list
93314188|NCT05497492|Anesthetics, Local|anesthetics, local|mesh-ancestor
93314189|NCT05497492|Anesthetics|anesthetics|mesh-ancestor
93314190|NCT05497492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314191|NCT05497492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314192|NCT05497492|Sensory System Agents|sensory system agents|mesh-ancestor
93314193|NCT05497492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314194|NCT05497492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93314195|NCT05497492|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93314196|NCT05497492|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93314197|NCT05497492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314198|NCT05497492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314199|NCT05497492|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92608574|NCT00136448|Cytarabine|cytarabine|mesh-list
93314200|NCT05497492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93314201|NCT05497492|Anesthetics, General|anesthetics, general|mesh-ancestor
93314202|NCT05497492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314203|NCT05497492|Narcotics|narcotics|mesh-ancestor
92716061|NCT03266783|Apixaban|apixaban|mesh-list
93314204|NCT05497492|Analgesics|analgesics|mesh-ancestor
93314205|NCT05497492|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93314206|NCT05497492|Antidepressive Agents|antidepressive agents|mesh-ancestor
93314207|NCT05497492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314208|NCT00835497|Metformin|metformin|mesh-list
93314209|NCT00835497|Glipizide|glipizide|mesh-list
93314210|NCT00835497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93314211|NCT00835497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314212|NCT05005689|Fluorides|fluorides|mesh-list
93314213|NCT05005689|Sodium Fluoride|sodium fluoride|mesh-list
93314214|NCT05005689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314215|NCT05005689|Cariostatic Agents|cariostatic agents|mesh-ancestor
92986190|NCT02580773|Tinzaparin|tinzaparin|mesh-list
93314216|NCT05005689|Protective Agents|protective agents|mesh-ancestor
93314217|NCT00763503|Calcitriol|calcitriol|mesh-list
93314218|NCT00763503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314219|NCT00763503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314220|NCT00763503|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93314221|NCT00763503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314222|NCT00763503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314223|NCT00763503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93314224|NCT00763503|Vitamins|vitamins|mesh-ancestor
93314225|NCT00763503|Micronutrients|micronutrients|mesh-ancestor
93314226|NCT00763503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93314227|NCT00761709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93314228|NCT00761709|Latanoprost|latanoprost|mesh-list
93314229|NCT00761709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93314230|NCT00760539|Timolol|timolol|mesh-list
93314231|NCT00760539|Travoprost|travoprost|mesh-list
93314232|NCT00760539|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93314233|NCT00760539|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93314234|NCT00760539|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93314235|NCT00760539|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93314236|NCT00760539|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314237|NCT00760539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314238|NCT00760539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314239|NCT00760539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314240|NCT00760539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93314241|NCT00760539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314242|NCT04976049|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93314243|NCT04976049|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93314244|NCT04976049|Dermatologic Agents|dermatologic agents|mesh-ancestor
93314245|NCT00759135|Finasteride|finasteride|mesh-list
93314246|NCT00759135|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93314247|NCT00759135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93314248|NCT00759135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314249|NCT00759135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314250|NCT00759135|Hormone Antagonists|hormone antagonists|mesh-ancestor
93314251|NCT00759135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314252|NCT00759135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314253|NCT00759135|Urological Agents|urological agents|mesh-ancestor
93314254|NCT00835263|Lamotrigine|lamotrigine|mesh-list
93314255|NCT00835263|Anticonvulsants|anticonvulsants|mesh-ancestor
93314256|NCT00835263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93314257|NCT00835263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314258|NCT00835263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314259|NCT00835263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314260|NCT00835263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314261|NCT00835263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93314262|NCT00835263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93314263|NCT00835263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314264|NCT00835263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314265|NCT00835263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93314266|NCT02639910|Venetoclax|venetoclax|mesh-list
93314267|NCT02639910|Idelalisib|idelalisib|mesh-list
92608638|NCT00136565|Prednisone|prednisone|mesh-list
93314268|NCT02639910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314269|NCT02639910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314270|NCT02639910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314271|NCT04454580|Azacitidine|azacitidine|mesh-list
93314272|NCT04454580|Decitabine|decitabine|mesh-list
93314273|NCT04454580|Venetoclax|venetoclax|mesh-list
93314274|NCT04454580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93314275|NCT04454580|Antimetabolites|antimetabolites|mesh-ancestor
93314276|NCT04454580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314277|NCT04454580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314278|NCT04454580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314279|NCT00948909|Donepezil|donepezil|mesh-list
93314280|NCT00948909|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93314281|NCT00948909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314282|NCT00948909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314283|NCT00948909|Cholinergic Agents|cholinergic agents|mesh-ancestor
93314284|NCT00948909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314285|NCT00948909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314286|NCT00948909|Nootropic Agents|nootropic agents|mesh-ancestor
93314287|NCT02522910|Docetaxel|docetaxel|mesh-list
93314288|NCT02522910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314289|NCT02522910|Tubulin Modulators|tubulin modulators|mesh-ancestor
93314290|NCT02522910|Antimitotic Agents|antimitotic agents|mesh-ancestor
93314291|NCT02522910|Mitosis Modulators|mitosis modulators|mesh-ancestor
93314292|NCT02522910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314294|NCT00948753|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93314295|NCT00948753|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93314296|NCT00948753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314297|NCT00948753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93314298|NCT00948753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93314299|NCT00948753|Antiviral Agents|antiviral agents|mesh-ancestor
93314300|NCT00948753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314301|NCT00948753|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93314302|NCT05397834|Fluticasone|fluticasone|mesh-list
93314303|NCT05397834|Xhance|xhance|mesh-list
93314304|NCT05397834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314305|NCT05397834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93314306|NCT05397834|Autonomic Agents|autonomic agents|mesh-ancestor
92015899|NCT02521415|Narcotics|narcotics|mesh-ancestor
93314307|NCT05397834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314308|NCT05397834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314309|NCT05397834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92717235|NCT01214239|Incretins|incretins|mesh-ancestor
93314310|NCT05397834|Respiratory System Agents|respiratory system agents|mesh-ancestor
93314311|NCT05397834|Dermatologic Agents|dermatologic agents|mesh-ancestor
93314312|NCT05397834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93314313|NCT03134547|Sevoflurane|sevoflurane|mesh-list
93314314|NCT03134547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93314315|NCT03134547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93314316|NCT03134547|Anesthetics, General|anesthetics, general|mesh-ancestor
93314317|NCT03134547|Anesthetics|anesthetics|mesh-ancestor
93314318|NCT03134547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314319|NCT03134547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314320|NCT01963208|Ganaxolone|ganaxolone|mesh-list
93314321|NCT01963208|Neurosteroids|neurosteroids|mesh-ancestor
93314322|NCT01963208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608696|NCT00159705|Analgesics|analgesics|mesh-ancestor
93314323|NCT01963208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314324|NCT01963208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314325|NCT01963208|GABA Modulators|gaba modulators|mesh-ancestor
93314326|NCT01963208|GABA Agents|gaba agents|mesh-ancestor
93314327|NCT00834873|Carvedilol|carvedilol|mesh-list
93314328|NCT00834873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92717646|NCT04653792|Pregabalin|pregabalin|mesh-list
93314329|NCT00834873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93314330|NCT00834873|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314331|NCT00834873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717706|NCT04652739|Lycopene|lycopene|mesh-list
93314332|NCT00834873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314333|NCT00834873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314334|NCT00834873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314335|NCT00834873|Antioxidants|antioxidants|mesh-ancestor
93314336|NCT00834873|Protective Agents|protective agents|mesh-ancestor
93314337|NCT00834873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93314338|NCT00834873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314339|NCT00834873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314340|NCT00834873|Vasodilator Agents|vasodilator agents|mesh-ancestor
93314341|NCT00834873|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93314342|NCT00834873|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93314343|NCT01377480|Posaconazole|posaconazole|mesh-list
93314344|NCT01377480|Benzonidazole|benzonidazole|mesh-list
93314345|NCT01377480|Antifungal Agents|antifungal agents|mesh-ancestor
93314346|NCT01377480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314347|NCT01377480|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93314348|NCT01377480|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93314349|NCT01377480|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93314350|NCT01377480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93314351|NCT01377480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93314352|NCT01377480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314353|NCT01377480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314354|NCT01377480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93314355|NCT01377480|Hormone Antagonists|hormone antagonists|mesh-ancestor
93314356|NCT01377480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608729|NCT00137033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314357|NCT01377480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314358|NCT01377480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314359|NCT01377480|Immunologic Factors|immunologic factors|mesh-ancestor
93314360|NCT04263909|Sufentanil|sufentanil|mesh-list
93314361|NCT04263909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314362|NCT04263909|Narcotics|narcotics|mesh-ancestor
93314363|NCT04263909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314364|NCT04263909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314365|NCT04263909|Analgesics|analgesics|mesh-ancestor
93314366|NCT04263909|Sensory System Agents|sensory system agents|mesh-ancestor
93314367|NCT04263909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314368|NCT04263909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93314369|NCT04263909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93314370|NCT04263909|Anesthetics, General|anesthetics, general|mesh-ancestor
93314371|NCT04263909|Anesthetics|anesthetics|mesh-ancestor
93314373|NCT01421264|Analgesics|analgesics|mesh-ancestor
93314374|NCT01421264|Sensory System Agents|sensory system agents|mesh-ancestor
93314375|NCT01421264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314376|NCT01421264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314377|NCT01421264|Anticonvulsants|anticonvulsants|mesh-ancestor
93314378|NCT01421264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93314379|NCT01421264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93314380|NCT01421264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314381|NCT01421264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314382|NCT01421264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92413621|NCT01466712|Hormones|hormones|mesh-ancestor
93314383|NCT01421264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93314384|NCT01421264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092468|NCT01191554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93314385|NCT01421264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314386|NCT01421264|Antimanic Agents|antimanic agents|mesh-ancestor
93314387|NCT04415840|Acetic Acid|acetic acid|mesh-list
93314388|NCT04415840|Retinol acetate|retinol acetate|mesh-list
93314389|NCT04415840|Lugol's solution|lugol's solution|mesh-list
93314390|NCT04415840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314391|NCT04415840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314392|NCT04415840|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93314393|NCT04415840|Immunologic Factors|immunologic factors|mesh-ancestor
93314394|NCT04415840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314395|NCT04415840|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93314396|NCT04415840|Protective Agents|protective agents|mesh-ancestor
93314397|NCT04415840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314398|NCT04415840|Hemostatics|hemostatics|mesh-ancestor
93314399|NCT04415840|Coagulants|coagulants|mesh-ancestor
93314400|NCT04488614|Zoledronic Acid|zoledronic acid|mesh-list
93314401|NCT04488614|Estrogens|estrogens|mesh-list
93314402|NCT04488614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93314403|NCT04488614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314404|NCT04488614|Hormones|hormones|mesh-ancestor
93314405|NCT04488614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314406|NCT00834795|Carvedilol|carvedilol|mesh-list
93314407|NCT00834795|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93314408|NCT00834795|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92608778|NCT00137501|Nifedipine|nifedipine|mesh-list
93314409|NCT00834795|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314410|NCT00834795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414202|NCT01470092|Hormones|hormones|mesh-ancestor
93314411|NCT00834795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314412|NCT00834795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314413|NCT00834795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314414|NCT00834795|Antioxidants|antioxidants|mesh-ancestor
93314415|NCT00834795|Protective Agents|protective agents|mesh-ancestor
93314416|NCT00834795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92608787|NCT00137540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93314417|NCT00834795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314418|NCT00834795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314419|NCT00834795|Vasodilator Agents|vasodilator agents|mesh-ancestor
93314420|NCT00834795|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93314421|NCT00834795|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93314422|NCT00834717|Granisetron|granisetron|mesh-list
93314423|NCT00834717|Antiemetics|antiemetics|mesh-ancestor
93314424|NCT00834717|Autonomic Agents|autonomic agents|mesh-ancestor
93314425|NCT00834717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314426|NCT00834717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314427|NCT00834717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93314428|NCT00834717|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93314429|NCT00834717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93314430|NCT00834717|Serotonin Agents|serotonin agents|mesh-ancestor
93314431|NCT00834717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314432|NCT00834717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314433|NCT00834639|Valproic Acid|valproic acid|mesh-list
93314434|NCT00834639|Anticonvulsants|anticonvulsants|mesh-ancestor
93314435|NCT00834639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314436|NCT00834639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314437|NCT00834639|GABA Agents|gaba agents|mesh-ancestor
93314438|NCT00834639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314439|NCT00834639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314441|NCT00834639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93314442|NCT00834639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314443|NCT00834639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314444|NCT00834561|Lamotrigine|lamotrigine|mesh-list
93314445|NCT00834561|Anticonvulsants|anticonvulsants|mesh-ancestor
93314446|NCT00834561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93314447|NCT00834561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314448|NCT00834561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314449|NCT00834561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314450|NCT00834561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314451|NCT00834561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93314452|NCT00834561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93314453|NCT00834561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314454|NCT00834561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314455|NCT00834561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93314456|NCT00754221|Reboxetine|reboxetine|mesh-list
93314457|NCT00754221|Antidepressive Agents|antidepressive agents|mesh-ancestor
93314458|NCT00754221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314459|NCT00754221|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93314460|NCT00754221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93314461|NCT00754221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608829|NCT00137735|Anticonvulsants|anticonvulsants|mesh-ancestor
93314462|NCT00754221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314463|NCT00754221|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314464|NCT00754221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314465|NCT00754221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314466|NCT00834405|Leflunomide|leflunomide|mesh-list
93314467|NCT00834405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314468|NCT00834405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314469|NCT00834405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314470|NCT00834405|Immunologic Factors|immunologic factors|mesh-ancestor
93314471|NCT00834405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314472|NCT00834249|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93314473|NCT00834249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92608842|NCT00137774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314474|NCT00834249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93314475|NCT00834249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415056|NCT01476410|Immunotoxins|immunotoxins|mesh-ancestor
93314476|NCT00834249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314477|NCT00834249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314478|NCT00834249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314479|NCT00834249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93314480|NCT00834249|Antidepressive Agents|antidepressive agents|mesh-ancestor
93314481|NCT00834249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314482|NCT00751803|Eletriptan|eletriptan|mesh-list
93314483|NCT00751803|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93314484|NCT00751803|Serotonin Agents|serotonin agents|mesh-ancestor
93314485|NCT00751803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314486|NCT00751803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314487|NCT00751803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314488|NCT05420961|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93314489|NCT05420961|Immunologic Factors|immunologic factors|mesh-ancestor
93314490|NCT05420961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314491|NCT05402397|Losartan|losartan|mesh-list
93314492|NCT05402397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93314493|NCT05402397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314494|NCT05402397|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93314495|NCT05402397|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93314496|NCT05402397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314497|NCT00833937|Zolpidem|zolpidem|mesh-list
93314498|NCT00833937|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93314499|NCT00833937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93314500|NCT00833937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314501|NCT00833937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314502|NCT00833937|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93314503|NCT00833937|GABA Agonists|gaba agonists|mesh-ancestor
93314504|NCT00833937|GABA Agents|gaba agents|mesh-ancestor
93314505|NCT00833937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314506|NCT00833937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314507|NCT00831051|Morphine|morphine|mesh-list
93314508|NCT00831051|Oxycodone|oxycodone|mesh-list
93314509|NCT00831051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314510|NCT00831051|Narcotics|narcotics|mesh-ancestor
93314511|NCT00831051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314512|NCT00831051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314514|NCT00831051|Sensory System Agents|sensory system agents|mesh-ancestor
92415843|NCT01481194|Dexamethasone|dexamethasone|mesh-list
93314515|NCT00831051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314516|NCT00750633|Moxifloxacin|moxifloxacin|mesh-list
93314517|NCT00750633|Dexamethasone|dexamethasone|mesh-list
93314518|NCT00750633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93314519|NCT00750633|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93314520|NCT00750633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016090|NCT05547659|Celecoxib|celecoxib|mesh-list
93314521|NCT00750633|Antiemetics|antiemetics|mesh-ancestor
93314522|NCT00750633|Autonomic Agents|autonomic agents|mesh-ancestor
93314523|NCT00750633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314524|NCT00750633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314525|NCT00750633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93314526|NCT00750633|Glucocorticoids|glucocorticoids|mesh-ancestor
93314527|NCT00750633|Hormones|hormones|mesh-ancestor
92416164|NCT01482936|Oxycodone|oxycodone|mesh-list
93314528|NCT00750633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314529|NCT00750633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608897|NCT00153933|Bortezomib|bortezomib|mesh-list
93314530|NCT00750633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314531|NCT00750633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314532|NCT00750633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314533|NCT00750633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93314534|NCT00750633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93314535|NCT00750633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314536|NCT00750633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314537|NCT00750243|Naproxen|naproxen|mesh-list
93314538|NCT00750243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93314539|NCT00750243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314540|NCT00750243|Analgesics|analgesics|mesh-ancestor
93314541|NCT00750243|Sensory System Agents|sensory system agents|mesh-ancestor
93314542|NCT00750243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314543|NCT00750243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314544|NCT00750243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314545|NCT00750243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314546|NCT00750243|Gout Suppressants|gout suppressants|mesh-ancestor
93314547|NCT00750243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93314548|NCT00750243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314549|NCT00750243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314550|NCT00924170|Cyclophosphamide|cyclophosphamide|mesh-list
93314551|NCT00924170|Fludarabine|fludarabine|mesh-list
93314552|NCT00924170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314553|NCT00924170|Immunologic Factors|immunologic factors|mesh-ancestor
93314554|NCT00924170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314555|NCT00924170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314556|NCT00924170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93314557|NCT00924170|Alkylating Agents|alkylating agents|mesh-ancestor
93314558|NCT00924170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314559|NCT00924170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314560|NCT00924170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93314561|NCT04809285|Insulin|insulin|mesh-list
93314562|NCT04809285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93314563|NCT04809285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314564|NCT00920985|Contraceptive Agents|contraceptive agents|mesh-list
93314565|NCT00920985|Gestodene|gestodene|mesh-list
92076460|NCT04271332|Baclofen|baclofen|mesh-list
93314566|NCT00920985|Contraceptives, Oral|contraceptives, oral|mesh-list
93314567|NCT00920985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93314568|NCT00920985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314569|NCT00920985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93314570|NCT00920985|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93314571|NCT00920985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93314572|NCT00920985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93314573|NCT00920985|Progestins|progestins|mesh-ancestor
93314574|NCT00920985|Hormones|hormones|mesh-ancestor
92608938|NCT00154011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93314575|NCT00920985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314576|NCT05388747|Cefuroxime|cefuroxime|mesh-list
93314577|NCT05388747|Cefuroxime axetil|cefuroxime axetil|mesh-list
93314578|NCT05388747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314579|NCT05388747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314580|NCT00828321|Ramipril|ramipril|mesh-list
93314581|NCT00828321|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93314582|NCT00828321|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986567|NCT01006863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93314583|NCT00828321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314584|NCT00828321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314586|NCT01352715|Ritonavir|ritonavir|mesh-list
93314587|NCT01352715|Lopinavir|lopinavir|mesh-list
93314588|NCT01352715|Tenofovir|tenofovir|mesh-list
93314589|NCT01352715|Lamivudine|lamivudine|mesh-list
93314590|NCT01352715|Emtricitabine|emtricitabine|mesh-list
93314591|NCT01352715|Zidovudine|zidovudine|mesh-list
93314592|NCT01352715|Raltegravir Potassium|raltegravir potassium|mesh-list
93314593|NCT01352715|Abacavir|abacavir|mesh-list
93314594|NCT01352715|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93314595|NCT01352715|Dideoxynucleosides|dideoxynucleosides|mesh-list
93314596|NCT01352715|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93314597|NCT01352715|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93314598|NCT01352715|Protease Inhibitors|protease inhibitors|mesh-ancestor
93314599|NCT01352715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092469|NCT01191554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93314600|NCT01352715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314601|NCT01352715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93314602|NCT01352715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93314603|NCT01352715|Antiviral Agents|antiviral agents|mesh-ancestor
93314604|NCT01352715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608964|NCT00160602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314605|NCT01352715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93314606|NCT01352715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92608972|NCT00154050|Candesartan|candesartan|mesh-list
93314607|NCT01352715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93314608|NCT01352715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93314609|NCT01352715|Antimetabolites|antimetabolites|mesh-ancestor
93314610|NCT01352715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93314611|NCT01352715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93314612|NCT00743925|Atorvastatin|atorvastatin|mesh-list
92608974|NCT00154050|Quinapril|quinapril|mesh-list
93314613|NCT00743925|Varespladib methyl|varespladib methyl|mesh-list
93314614|NCT00743925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93314615|NCT00743925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93314616|NCT00743925|Antimetabolites|antimetabolites|mesh-ancestor
93314617|NCT00743925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314618|NCT00743925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93314619|NCT00743925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93314620|NCT00743925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314621|NCT00743925|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93314622|NCT00738387|Docetaxel|docetaxel|mesh-list
93314623|NCT00738387|Vadimezan|vadimezan|mesh-list
93314624|NCT00738387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314625|NCT00738387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92417518|NCT01490944|Iron|iron|mesh-list
93314626|NCT00738387|Antimitotic Agents|antimitotic agents|mesh-ancestor
93314627|NCT00738387|Mitosis Modulators|mitosis modulators|mesh-ancestor
93314628|NCT00738387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314629|NCT03710421|Cyclophosphamide|cyclophosphamide|mesh-list
93314630|NCT03710421|Fludarabine|fludarabine|mesh-list
92417588|NCT01491139|Olaparib|olaparib|mesh-list
93314631|NCT03710421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314632|NCT03710421|Immunologic Factors|immunologic factors|mesh-ancestor
93314633|NCT03710421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314634|NCT03710421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609000|NCT00138359|Anthelmintics|anthelmintics|mesh-ancestor
93314635|NCT03710421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93314636|NCT03710421|Alkylating Agents|alkylating agents|mesh-ancestor
93314637|NCT03710421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314638|NCT03710421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314639|NCT03710421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93314640|NCT00645177|Paclitaxel|paclitaxel|mesh-list
93314641|NCT00645177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93314642|NCT00645177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314643|NCT00645177|Tubulin Modulators|tubulin modulators|mesh-ancestor
93314644|NCT00645177|Antimitotic Agents|antimitotic agents|mesh-ancestor
93314645|NCT00645177|Mitosis Modulators|mitosis modulators|mesh-ancestor
93314646|NCT00645177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314647|NCT00643383|Acetaminophen|acetaminophen|mesh-list
93314648|NCT00643383|Tramadol|tramadol|mesh-list
93314649|NCT00643383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314650|NCT00643383|Analgesics|analgesics|mesh-ancestor
93314651|NCT00643383|Sensory System Agents|sensory system agents|mesh-ancestor
93314652|NCT00643383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314653|NCT00643383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314654|NCT00643383|Antipyretics|antipyretics|mesh-ancestor
93314655|NCT00643383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314656|NCT00643383|Narcotics|narcotics|mesh-ancestor
93314657|NCT00643383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314658|NCT02559622|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93314659|NCT02559622|Immunologic Factors|immunologic factors|mesh-ancestor
93314660|NCT02559622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314662|NCT04285450|Vitamins|vitamins|mesh-ancestor
93314663|NCT04285450|Micronutrients|micronutrients|mesh-ancestor
93314664|NCT04285450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314665|NCT04285450|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93314666|NCT04285450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93314667|NCT04285450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314668|NCT04285450|Hemostatics|hemostatics|mesh-ancestor
93314669|NCT04285450|Coagulants|coagulants|mesh-ancestor
93314670|NCT05497102|Lenalidomide|lenalidomide|mesh-list
93314671|NCT05497102|Immunologic Factors|immunologic factors|mesh-ancestor
93314672|NCT05497102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314673|NCT05497102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93314674|NCT05497102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93314675|NCT05497102|Growth Substances|growth substances|mesh-ancestor
93314676|NCT05497102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016210|NCT05551247|Endostatins|endostatins|mesh-list
93314677|NCT05497102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314678|NCT04017442|Morphine|morphine|mesh-list
93314679|NCT04017442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314680|NCT04017442|Narcotics|narcotics|mesh-ancestor
93314681|NCT04017442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314682|NCT04017442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314683|NCT04017442|Analgesics|analgesics|mesh-ancestor
93314684|NCT04017442|Sensory System Agents|sensory system agents|mesh-ancestor
93314685|NCT04017442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314686|NCT04016818|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92609041|NCT00138593|Vildagliptin|vildagliptin|mesh-list
93314687|NCT04016818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93314688|NCT04016818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314689|NCT05490160|Tranexamic Acid|tranexamic acid|mesh-list
93314690|NCT05490160|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93314691|NCT05490160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93314692|NCT05490160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314693|NCT05490160|Hemostatics|hemostatics|mesh-ancestor
93314694|NCT05490160|Coagulants|coagulants|mesh-ancestor
93314695|NCT05495620|Dexamethasone|dexamethasone|mesh-list
93314696|NCT05495620|Lenalidomide|lenalidomide|mesh-list
93314697|NCT05495620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314698|NCT05495620|Antiemetics|antiemetics|mesh-ancestor
93314699|NCT05495620|Autonomic Agents|autonomic agents|mesh-ancestor
93314700|NCT05495620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314701|NCT05495620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314702|NCT05495620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93314703|NCT05495620|Glucocorticoids|glucocorticoids|mesh-ancestor
93314704|NCT05495620|Hormones|hormones|mesh-ancestor
93314705|NCT05495620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314706|NCT05495620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93314707|NCT05495620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314708|NCT05495620|Immunologic Factors|immunologic factors|mesh-ancestor
93314709|NCT05495620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93314710|NCT05495620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93314711|NCT05495620|Growth Substances|growth substances|mesh-ancestor
93314712|NCT05495620|Growth Inhibitors|growth inhibitors|mesh-ancestor
93314713|NCT05490082|Solifenacin Succinate|solifenacin succinate|mesh-list
93314714|NCT05490082|Mirabegron|mirabegron|mesh-list
93314715|NCT05490082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93314716|NCT05490082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93314717|NCT05490082|Cholinergic Agents|cholinergic agents|mesh-ancestor
93314718|NCT05490082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314719|NCT05490082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314720|NCT05490082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314721|NCT05490082|Urological Agents|urological agents|mesh-ancestor
93314722|NCT05490082|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93314723|NCT05490082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93314724|NCT05490082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93314725|NCT05490082|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314726|NCT02559310|Moxifloxacin|moxifloxacin|mesh-list
93314727|NCT02559310|Linezolid|linezolid|mesh-list
93314728|NCT02559310|Lefamulin|lefamulin|mesh-list
93314729|NCT02559310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314730|NCT02559310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314731|NCT02559310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93314732|NCT02559310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93314733|NCT02559310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314734|NCT02559310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314735|NCT02559310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314736|NCT02559310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93314737|NCT05489926|Pamiparib|pamiparib|mesh-list
93314738|NCT05489926|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93314739|NCT05489926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314740|NCT05489926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314741|NCT05489926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314742|NCT05489848|Paclitaxel|paclitaxel|mesh-list
93314743|NCT05489848|Carboplatin|carboplatin|mesh-list
93314744|NCT05489848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93314745|NCT05489848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314746|NCT05489848|Tubulin Modulators|tubulin modulators|mesh-ancestor
93314747|NCT05489848|Antimitotic Agents|antimitotic agents|mesh-ancestor
93314748|NCT05489848|Mitosis Modulators|mitosis modulators|mesh-ancestor
93314749|NCT05489848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314750|NCT03517449|Paclitaxel|paclitaxel|mesh-list
93314751|NCT03517449|Doxorubicin|doxorubicin|mesh-list
93314752|NCT03517449|Pembrolizumab|pembrolizumab|mesh-list
93314753|NCT03517449|Lenvatinib|lenvatinib|mesh-list
93314754|NCT03517449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93314755|NCT03517449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314756|NCT03517449|Tubulin Modulators|tubulin modulators|mesh-ancestor
93314757|NCT03517449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92418453|NCT01496742|Paclitaxel|paclitaxel|mesh-list
93314758|NCT03517449|Mitosis Modulators|mitosis modulators|mesh-ancestor
93314759|NCT03517449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314760|NCT03517449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93314761|NCT03517449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93314762|NCT03517449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93314763|NCT03517449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314764|NCT03517449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314765|NCT03517449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93314766|NCT03517449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93314767|NCT05489692|Leucovorin|leucovorin|mesh-list
93314768|NCT05489692|Fluorouracil|fluorouracil|mesh-list
93314769|NCT05489692|Oxaliplatin|oxaliplatin|mesh-list
93314770|NCT05489692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93314771|NCT05489692|Antimetabolites|antimetabolites|mesh-ancestor
93314772|NCT05489692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314773|NCT05489692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93314774|NCT05489692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609124|NCT00138944|Diuretics|diuretics|mesh-ancestor
93314775|NCT05489692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314776|NCT05489692|Immunologic Factors|immunologic factors|mesh-ancestor
93314777|NCT05489692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314778|NCT05489692|Antidotes|antidotes|mesh-ancestor
93314779|NCT05489692|Protective Agents|protective agents|mesh-ancestor
93314780|NCT05489692|Vitamin B Complex|vitamin b complex|mesh-ancestor
93314781|NCT05489692|Vitamins|vitamins|mesh-ancestor
93314782|NCT05489692|Micronutrients|micronutrients|mesh-ancestor
93314783|NCT05489692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314784|NCT00721695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93314785|NCT00721695|Mydriatics|mydriatics|mesh-list
93314786|NCT00721695|Autonomic Agents|autonomic agents|mesh-ancestor
93314787|NCT00721695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314788|NCT00721695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314789|NCT00625833|Reboxetine|reboxetine|mesh-list
93314790|NCT00625833|Antidepressive Agents|antidepressive agents|mesh-ancestor
93314791|NCT00625833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314792|NCT00625833|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93314793|NCT00625833|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92418677|NCT01497977|Phytoestrogens|phytoestrogens|mesh-list
93314794|NCT00625833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314795|NCT00625833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314796|NCT00625833|Adrenergic Agents|adrenergic agents|mesh-ancestor
93314797|NCT00625833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314798|NCT00625833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314799|NCT03299036|Doxorubicin|doxorubicin|mesh-list
93314800|NCT03299036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93314801|NCT03299036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314802|NCT03299036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92609147|NCT00138983|Alendronate|alendronate|mesh-list
93314803|NCT03299036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93314804|NCT03299036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314805|NCT03299036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314806|NCT03290846|Secretin|secretin|mesh-list
93314807|NCT03290846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93314808|NCT03290846|Hormones|hormones|mesh-ancestor
93314809|NCT03290846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314810|NCT03290846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314812|NCT03298958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314813|NCT03298958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314814|NCT03298958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93314815|NCT03298958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314816|NCT03298958|Antifungal Agents|antifungal agents|mesh-ancestor
93314817|NCT03298958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93314818|NCT03298958|Immunologic Factors|immunologic factors|mesh-ancestor
93314819|NCT03298958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314820|NCT04488926|Palmidrol|palmidrol|mesh-list
93314821|NCT04488926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314822|NCT04488926|Analgesics|analgesics|mesh-ancestor
93314823|NCT04488926|Sensory System Agents|sensory system agents|mesh-ancestor
93314824|NCT04488926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609168|NCT01243177|Sensory System Agents|sensory system agents|mesh-ancestor
93314825|NCT04488926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314826|NCT04488926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93314827|NCT04488926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314828|NCT04488926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419280|NCT01501370|BB 1101|bb 1101|mesh-list
93314829|NCT04488926|Antiviral Agents|antiviral agents|mesh-ancestor
93314830|NCT04488926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314831|NCT04488926|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93314832|NCT04488926|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93314833|NCT04488926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314834|NCT04488926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314835|NCT04488926|Hormones|hormones|mesh-ancestor
92609180|NCT00154440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93314836|NCT04488926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314837|NCT04328714|Interferons|interferons|mesh-list
93314838|NCT04328714|Interferon-gamma|interferon-gamma|mesh-list
93314839|NCT04328714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314840|NCT04328714|Antiviral Agents|antiviral agents|mesh-ancestor
93314841|NCT04328714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314842|NCT03290456|Prednisone|prednisone|mesh-list
93314843|NCT03290456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314844|NCT03290456|Glucocorticoids|glucocorticoids|mesh-ancestor
93314845|NCT03290456|Hormones|hormones|mesh-ancestor
92609187|NCT00139061|Fenofibrate|fenofibrate|mesh-list
93314846|NCT03290456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314847|NCT03290456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314848|NCT03290456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93314849|NCT03290456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314850|NCT02555878|Rivaroxaban|rivaroxaban|mesh-list
93314851|NCT02555878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93314852|NCT02555878|Antithrombins|antithrombins|mesh-ancestor
93314853|NCT02555878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93314854|NCT02555878|Protease Inhibitors|protease inhibitors|mesh-ancestor
93314855|NCT02555878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314856|NCT02555878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314857|NCT02555878|Anticoagulants|anticoagulants|mesh-ancestor
93314858|NCT03298646|Diclofenac|diclofenac|mesh-list
93314859|NCT03298646|Lidocaine|lidocaine|mesh-list
93314860|NCT03298646|Anesthetics, Local|anesthetics, local|mesh-ancestor
93314861|NCT03298646|Anesthetics|anesthetics|mesh-ancestor
93314862|NCT03298646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420001|NCT01504256|Vitamins|vitamins|mesh-ancestor
93314863|NCT03298646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314864|NCT03298646|Sensory System Agents|sensory system agents|mesh-ancestor
93314865|NCT03298646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314866|NCT03298646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92420077|NCT01504659|Anesthetics|anesthetics|mesh-ancestor
93314867|NCT03298646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93314868|NCT03298646|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93314869|NCT03298646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314870|NCT03298646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609215|NCT04705584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314871|NCT03298646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92609216|NCT00139217|Nitric Oxide|nitric oxide|mesh-list
93314872|NCT03298646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314873|NCT03298646|Analgesics|analgesics|mesh-ancestor
93314874|NCT03298646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93314875|NCT03298646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93314876|NCT03298646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92420427|NCT01506388|Oxytocics|oxytocics|mesh-ancestor
93314877|NCT03298646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314878|NCT02460692|Dronabinol|dronabinol|mesh-list
93314879|NCT02460692|Hallucinogens|hallucinogens|mesh-ancestor
93314880|NCT02460692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314881|NCT02460692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93314882|NCT02460692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93314883|NCT02460692|Analgesics|analgesics|mesh-ancestor
92986865|NCT03412643|Trastuzumab|trastuzumab|mesh-list
93314884|NCT02460692|Sensory System Agents|sensory system agents|mesh-ancestor
93314885|NCT02460692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314886|NCT02460692|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93314887|NCT02460692|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93314888|NCT02460692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314889|NCT02460692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314891|NCT02460692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93314892|NCT05494060|Capecitabine|capecitabine|mesh-list
93314893|NCT05494060|Oxaliplatin|oxaliplatin|mesh-list
93314894|NCT05494060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93314895|NCT05494060|Antimetabolites|antimetabolites|mesh-ancestor
93314896|NCT05494060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314897|NCT05494060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314898|NCT05488990|Calcitriol|calcitriol|mesh-list
93314899|NCT05488990|Calcipotriene|calcipotriene|mesh-list
93314900|NCT05488990|Dermatologic Agents|dermatologic agents|mesh-ancestor
92609244|NCT00139256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314901|NCT05488990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314902|NCT05488990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314903|NCT05488990|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93314904|NCT05488990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93314905|NCT05488990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314906|NCT05488990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93314907|NCT05488990|Vitamins|vitamins|mesh-ancestor
93314908|NCT05488990|Micronutrients|micronutrients|mesh-ancestor
93314909|NCT05488990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93314910|NCT02715284|Dostarlimab|dostarlimab|mesh-list
93314911|NCT02715284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314912|NCT03289520|Clopidogrel|clopidogrel|mesh-list
93314913|NCT03289520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93314914|NCT03289520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93314915|NCT03289520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93314916|NCT03289520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93314917|NCT03289520|Purinergic Agents|purinergic agents|mesh-ancestor
93314918|NCT03289520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93314919|NCT03289520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421250|NCT01510522|Metformin|metformin|mesh-list
93314920|NCT03289520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314921|NCT03293108|Vitamin D|vitamin d|mesh-list
93314922|NCT03293108|Denosumab|denosumab|mesh-list
93314923|NCT03293108|Calcium|calcium|mesh-list
93314924|NCT03293108|Vitamins|vitamins|mesh-ancestor
93314925|NCT03293108|Micronutrients|micronutrients|mesh-ancestor
93314926|NCT03293108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314927|NCT03293108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93314928|NCT03293108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93314929|NCT03292796|Bimatoprost|bimatoprost|mesh-list
93314930|NCT03292796|Latanoprost|latanoprost|mesh-list
93314931|NCT03292796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93314932|NCT03292796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93314933|NCT03292796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93314934|NCT03288896|Ethanol|ethanol|mesh-list
93314935|NCT03288896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93314936|NCT03288896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314937|NCT03288896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314938|NCT03288896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314939|NCT03288818|Mechlorethamine|mechlorethamine|mesh-list
93314940|NCT03288818|Alkylating Agents|alkylating agents|mesh-ancestor
93314941|NCT03288818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314942|NCT03288818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93314943|NCT03288818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314944|NCT03292172|Atezolizumab|atezolizumab|mesh-list
93314945|NCT03292172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93314946|NCT03292172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314947|NCT03292172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314948|NCT03292172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314949|NCT02461004|Ezetimibe|ezetimibe|mesh-list
92609293|NCT00139646|Diclofenac|diclofenac|mesh-list
93314950|NCT02461004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93314951|NCT02461004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93314952|NCT02461004|Antimetabolites|antimetabolites|mesh-ancestor
93314953|NCT02461004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609294|NCT00139646|Parecoxib|parecoxib|mesh-list
93314954|NCT02461004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93314955|NCT03288428|Morphine|morphine|mesh-list
93314956|NCT03288428|Nalbuphine|nalbuphine|mesh-list
93314957|NCT03288428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93314958|NCT03288428|Narcotics|narcotics|mesh-ancestor
93314959|NCT03288428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93314960|NCT03288428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314961|NCT03288428|Analgesics|analgesics|mesh-ancestor
93314962|NCT03288428|Sensory System Agents|sensory system agents|mesh-ancestor
93314963|NCT03288428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93314964|NCT03288350|Avelumab|avelumab|mesh-list
93314965|NCT03288350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314966|NCT03288350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314967|NCT00003224|Vaccines|vaccines|mesh-list
93314968|NCT00003224|Freund's Adjuvant|freund's adjuvant|mesh-list
93314969|NCT00003224|Immunologic Factors|immunologic factors|mesh-ancestor
93314970|NCT00003224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314971|NCT00003224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93314972|NCT03288038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93314973|NCT03288038|Ezetimibe|ezetimibe|mesh-list
93314974|NCT03288038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92422236|NCT01515553|Hormones|hormones|mesh-ancestor
93314975|NCT03288038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93314976|NCT03288038|Antimetabolites|antimetabolites|mesh-ancestor
93314977|NCT03288038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314978|NCT03288038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93314979|NCT03288038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93314980|NCT03288038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314981|NCT03287882|Micronutrients|micronutrients|mesh-list
92422295|NCT01515826|BB 1101|bb 1101|mesh-list
93314982|NCT03287882|Trace Elements|trace elements|mesh-list
93314983|NCT03287882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93314984|NCT03291314|Avelumab|avelumab|mesh-list
93314985|NCT03291314|Axitinib|axitinib|mesh-list
92016502|NCT03063541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93314986|NCT03291314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93314987|NCT03291314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93314988|NCT03291314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93314989|NCT03291314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609327|NCT00139685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93314990|NCT03291314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93314991|NCT03291158|Minocycline|minocycline|mesh-list
93314992|NCT03291158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93314993|NCT03291158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93314994|NCT03283202|Prednisone|prednisone|mesh-list
93314995|NCT03283202|Prednisolone|prednisolone|mesh-list
93314996|NCT03283202|Cyclophosphamide|cyclophosphamide|mesh-list
93314997|NCT03283202|Rituximab|rituximab|mesh-list
93314998|NCT03283202|Vincristine|vincristine|mesh-list
93314999|NCT03283202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315000|NCT03283202|Immunologic Factors|immunologic factors|mesh-ancestor
93315001|NCT03283202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315002|NCT03283202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315003|NCT03283202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315004|NCT03283202|Alkylating Agents|alkylating agents|mesh-ancestor
92609340|NCT00139724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315005|NCT03283202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315006|NCT03283202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315007|NCT03283202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93315008|NCT03283202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315009|NCT03283202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315010|NCT03283202|Glucocorticoids|glucocorticoids|mesh-ancestor
93315011|NCT03283202|Hormones|hormones|mesh-ancestor
92422999|NCT01519336|Ritonavir|ritonavir|mesh-list
93315012|NCT03283202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315013|NCT03283202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315014|NCT03283202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93315015|NCT03283202|Tubulin Modulators|tubulin modulators|mesh-ancestor
93315016|NCT03283202|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315017|NCT03283202|Mitosis Modulators|mitosis modulators|mesh-ancestor
93315018|NCT03283046|Dexamethasone|dexamethasone|mesh-list
93315019|NCT03283046|Nivolumab|nivolumab|mesh-list
93315020|NCT03283046|Lenalidomide|lenalidomide|mesh-list
93315021|NCT03283046|Ipilimumab|ipilimumab|mesh-list
93315022|NCT03283046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315023|NCT03283046|Antiemetics|antiemetics|mesh-ancestor
93315024|NCT03283046|Autonomic Agents|autonomic agents|mesh-ancestor
93315025|NCT03283046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315026|NCT03283046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315027|NCT03283046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315028|NCT03283046|Glucocorticoids|glucocorticoids|mesh-ancestor
93315029|NCT03283046|Hormones|hormones|mesh-ancestor
93315030|NCT03283046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315031|NCT03283046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315032|NCT03283046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315033|NCT03283046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315034|NCT03283046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93315035|NCT03283046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315036|NCT03283046|Immunologic Factors|immunologic factors|mesh-ancestor
93315037|NCT03283046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93315038|NCT03283046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93315039|NCT03283046|Growth Substances|growth substances|mesh-ancestor
93315040|NCT03283046|Growth Inhibitors|growth inhibitors|mesh-ancestor
93315041|NCT03287180|Buprenorphine|buprenorphine|mesh-list
92423678|NCT01523327|Uric Acid|uric acid|mesh-list
93315042|NCT03287180|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93315043|NCT03287180|Naloxone|naloxone|mesh-list
93315044|NCT03287180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93315045|NCT03287180|Narcotics|narcotics|mesh-ancestor
93315046|NCT03287180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315047|NCT03287180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315048|NCT03287180|Analgesics|analgesics|mesh-ancestor
93315049|NCT03287180|Sensory System Agents|sensory system agents|mesh-ancestor
93315050|NCT03287180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315051|NCT03287180|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93315052|NCT02460146|CXA-10|cxa-10|mesh-list
93315053|NCT02460146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315054|NCT02460302|Progesterone|progesterone|mesh-list
93315055|NCT02460302|Progestins|progestins|mesh-ancestor
93315056|NCT02460302|Hormones|hormones|mesh-ancestor
93315057|NCT02460302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315058|NCT02460302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315059|NCT03282188|Sargramostim|sargramostim|mesh-list
93315060|NCT03282188|Immunologic Factors|immunologic factors|mesh-ancestor
93315061|NCT03282188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315062|NCT03384212|Cytarabine|cytarabine|mesh-list
93315063|NCT03384212|Fludarabine|fludarabine|mesh-list
93315064|NCT03384212|Busulfan|busulfan|mesh-list
93315065|NCT03384212|Cladribine|cladribine|mesh-list
93315066|NCT03384212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315067|NCT03384212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315068|NCT03384212|Antimetabolites|antimetabolites|mesh-ancestor
92609401|NCT00161655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93315069|NCT03384212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315070|NCT03384212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315071|NCT03384212|Immunologic Factors|immunologic factors|mesh-ancestor
93315072|NCT03384212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315073|NCT03384212|Antiviral Agents|antiviral agents|mesh-ancestor
93315074|NCT03384212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315075|NCT03384212|Alkylating Agents|alkylating agents|mesh-ancestor
93315076|NCT03384212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315077|NCT03384212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93315078|NCT02460068|Nivolumab|nivolumab|mesh-list
93315079|NCT02460068|Ipilimumab|ipilimumab|mesh-list
93315080|NCT02460068|Fotemustine|fotemustine|mesh-list
93315081|NCT02460068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315082|NCT02460068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315083|NCT02460068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93315084|NCT02460068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315085|NCT03286244|Paclitaxel|paclitaxel|mesh-list
93315086|NCT03286244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93315087|NCT03286244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315088|NCT03286244|Tubulin Modulators|tubulin modulators|mesh-ancestor
93315089|NCT03286244|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315090|NCT03286244|Mitosis Modulators|mitosis modulators|mesh-ancestor
93315091|NCT03286244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315092|NCT03282110|Citalopram|citalopram|mesh-list
93315093|NCT03282110|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93315094|NCT03282110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93315095|NCT03282110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315096|NCT03282110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315097|NCT03282110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315098|NCT03282110|Serotonin Agents|serotonin agents|mesh-ancestor
93315099|NCT03282110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315100|NCT03282110|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93315101|NCT03282110|Antidepressive Agents|antidepressive agents|mesh-ancestor
93315102|NCT03282110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93315103|NCT03269786|Bilirubin|bilirubin|mesh-list
93315104|NCT03269786|Antioxidants|antioxidants|mesh-ancestor
93315105|NCT03269786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315106|NCT03269786|Protective Agents|protective agents|mesh-ancestor
93315107|NCT03269786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315108|NCT02459600|Cyclopentolate|cyclopentolate|mesh-list
93315109|NCT02459600|Mydriatics|mydriatics|mesh-ancestor
93315110|NCT02459600|Autonomic Agents|autonomic agents|mesh-ancestor
93315111|NCT02459600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315112|NCT02459600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315113|NCT02459600|Parasympatholytics|parasympatholytics|mesh-ancestor
93315114|NCT02459600|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93315115|NCT02459600|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93315116|NCT02459600|Cholinergic Agents|cholinergic agents|mesh-ancestor
93315117|NCT02459600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315118|NCT02459600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315119|NCT03269318|Theophylline|theophylline|mesh-list
93315120|NCT03269318|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93315121|NCT03269318|Montelukast|montelukast|mesh-list
93315122|NCT03269318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93315123|NCT03269318|Autonomic Agents|autonomic agents|mesh-ancestor
93315124|NCT03269318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315125|NCT03269318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315126|NCT03269318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93315127|NCT03269318|Respiratory System Agents|respiratory system agents|mesh-ancestor
93315128|NCT03269318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93315129|NCT03269318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93315130|NCT03269318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315131|NCT03269318|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315132|NCT03269318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315133|NCT03269318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315134|NCT03269318|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93315135|NCT03269318|Hormone Antagonists|hormone antagonists|mesh-ancestor
93315136|NCT03269318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315137|NCT03269318|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93315138|NCT03269318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93315139|NCT03269318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93315140|NCT03269318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315141|NCT03269318|Vasodilator Agents|vasodilator agents|mesh-ancestor
93315142|NCT03269318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93315143|NCT03269318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93315144|NCT03269318|Purinergic Agents|purinergic agents|mesh-ancestor
93315145|NCT03284762|Rivaroxaban|rivaroxaban|mesh-list
93315146|NCT03284762|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93315147|NCT03284762|Antithrombins|antithrombins|mesh-ancestor
92609469|NCT00140075|Cyclophosphamide|cyclophosphamide|mesh-list
93315148|NCT03284762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93315149|NCT03284762|Protease Inhibitors|protease inhibitors|mesh-ancestor
93315150|NCT03284762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315151|NCT03284762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315152|NCT03284762|Anticoagulants|anticoagulants|mesh-ancestor
93315153|NCT04186598|Nifedipine|nifedipine|mesh-list
93315154|NCT04186598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93315155|NCT04186598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315156|NCT04186598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315157|NCT04186598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93315158|NCT04186598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315159|NCT04186598|Vasodilator Agents|vasodilator agents|mesh-ancestor
93315160|NCT04186598|Tocolytic Agents|tocolytic agents|mesh-ancestor
93315161|NCT04186598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93315162|NCT04172558|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93315163|NCT04172558|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93315164|NCT04172558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93315165|NCT04172558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315166|NCT04172558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315167|NCT04172558|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93315168|NCT04172558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315169|NCT04172558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315170|NCT04172558|Cholinergic Agents|cholinergic agents|mesh-ancestor
93315171|NCT04172558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315172|NCT03107858|Dopamine|dopamine|mesh-list
93315173|NCT03107858|Norepinephrine|norepinephrine|mesh-list
93315174|NCT03107858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93315175|NCT03107858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315176|NCT03107858|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315177|NCT03107858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315178|NCT03107858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315179|NCT03107858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315180|NCT03107858|Sympathomimetics|sympathomimetics|mesh-ancestor
93315181|NCT03107858|Autonomic Agents|autonomic agents|mesh-ancestor
93315182|NCT03107858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987180|NCT00201643|Hormones|hormones|mesh-ancestor
92424788|NCT01529177|Metformin|metformin|mesh-list
93315183|NCT03107858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93315184|NCT03107858|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93315185|NCT03107858|Dopamine Agents|dopamine agents|mesh-ancestor
93315186|NCT03107858|Protective Agents|protective agents|mesh-ancestor
93315187|NCT03269162|Docetaxel|docetaxel|mesh-list
93315188|NCT03269162|Pemetrexed|pemetrexed|mesh-list
93315189|NCT03269162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315190|NCT03269162|Tubulin Modulators|tubulin modulators|mesh-ancestor
93315191|NCT03269162|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315192|NCT03269162|Mitosis Modulators|mitosis modulators|mesh-ancestor
93315193|NCT03269162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315194|NCT03269162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315195|NCT03269162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93315196|NCT03269162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93315197|NCT03284294|Cholecalciferol|cholecalciferol|mesh-list
93315198|NCT03284294|Vitamin D|vitamin d|mesh-list
92609528|NCT00140348|Immunologic Factors|immunologic factors|mesh-ancestor
93315199|NCT03284294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93315200|NCT03284294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315201|NCT03284294|Vitamins|vitamins|mesh-ancestor
93315202|NCT03284294|Micronutrients|micronutrients|mesh-ancestor
93315203|NCT03284294|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93315204|NCT02558296|Bexagliflozin|bexagliflozin|mesh-list
93315205|NCT02558296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93315206|NCT02558296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315207|NCT03268226|Beclomethasone|beclomethasone|mesh-list
93315208|NCT03268226|Glycopyrrolate|glycopyrrolate|mesh-list
93315209|NCT03268226|Formoterol Fumarate|formoterol fumarate|mesh-list
93315210|NCT03268226|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93315211|NCT03268226|Autonomic Agents|autonomic agents|mesh-ancestor
93315212|NCT03268226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315213|NCT03268226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315214|NCT03268226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93315215|NCT03268226|Respiratory System Agents|respiratory system agents|mesh-ancestor
93315216|NCT03268226|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93315217|NCT03268226|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93315218|NCT03268226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315219|NCT03268226|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315220|NCT03268226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609552|NCT00140465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315221|NCT03268226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315222|NCT03268226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93315223|NCT03268226|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93315224|NCT03268226|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93315225|NCT03268226|Cholinergic Agents|cholinergic agents|mesh-ancestor
93315226|NCT03268226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315227|NCT03268226|Glucocorticoids|glucocorticoids|mesh-ancestor
93315228|NCT03268226|Hormones|hormones|mesh-ancestor
93315229|NCT03268226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315230|NCT02737475|Cyclophosphamide|cyclophosphamide|mesh-list
93315231|NCT02737475|Nivolumab|nivolumab|mesh-list
93315232|NCT02737475|Ipilimumab|ipilimumab|mesh-list
93315233|NCT02737475|Vaccines|vaccines|mesh-list
93315234|NCT02737475|Immunologic Factors|immunologic factors|mesh-ancestor
93315235|NCT02737475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315236|NCT02737475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315237|NCT02737475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315238|NCT02737475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315239|NCT02737475|Alkylating Agents|alkylating agents|mesh-ancestor
92609572|NCT01247701|Alkylating Agents|alkylating agents|mesh-ancestor
93315240|NCT02737475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315241|NCT02737475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315242|NCT02737475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93315243|NCT02737475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92609579|NCT00140543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315244|NCT02737475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93315245|NCT02457806|Phenylephrine|phenylephrine|mesh-list
93315246|NCT02457806|Oxymetazoline|oxymetazoline|mesh-list
93315247|NCT02457806|Tetracaine|tetracaine|mesh-list
93315248|NCT02457806|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315249|NCT02457806|Anesthetics|anesthetics|mesh-ancestor
93315250|NCT02457806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426018|NCT01536002|Anesthetics|anesthetics|mesh-ancestor
93315251|NCT02457806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315252|NCT02457806|Sensory System Agents|sensory system agents|mesh-ancestor
93315253|NCT02457806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315254|NCT02457806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93315255|NCT02457806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315256|NCT02457806|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315257|NCT02457806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609588|NCT00140543|Immunologic Factors|immunologic factors|mesh-ancestor
93315258|NCT02457806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315259|NCT02457806|Sympathomimetics|sympathomimetics|mesh-ancestor
93315260|NCT02457806|Autonomic Agents|autonomic agents|mesh-ancestor
93315261|NCT02457806|Nasal Decongestants|nasal decongestants|mesh-ancestor
93315262|NCT02457806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93315263|NCT02457806|Respiratory System Agents|respiratory system agents|mesh-ancestor
93315264|NCT02457806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93315265|NCT02457806|Mydriatics|mydriatics|mesh-ancestor
92609601|NCT00140582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315266|NCT02457806|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93315267|NCT02457806|Protective Agents|protective agents|mesh-ancestor
93315268|NCT02459756|Citric Acid|citric acid|mesh-list
93315269|NCT02459756|Sodium Citrate|sodium citrate|mesh-list
92609602|NCT00154869|Ribavirin|ribavirin|mesh-list
93315270|NCT02459756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315271|NCT02459756|Anticoagulants|anticoagulants|mesh-ancestor
93315272|NCT02459756|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93315273|NCT02459756|Chelating Agents|chelating agents|mesh-ancestor
93315274|NCT02459756|Sequestering Agents|sequestering agents|mesh-ancestor
93315275|NCT02557672|Thrombin|thrombin|mesh-list
93315276|NCT02557672|Hemostatics|hemostatics|mesh-ancestor
92426571|NCT01538953|Eusol|eusol|mesh-list
93315277|NCT02557672|Coagulants|coagulants|mesh-ancestor
93315278|NCT02458274|Dimercaprol|dimercaprol|mesh-list
93315279|NCT02458274|Chelating Agents|chelating agents|mesh-ancestor
93315280|NCT02458274|Sequestering Agents|sequestering agents|mesh-ancestor
93315281|NCT02458274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315282|NCT02632175|Adalimumab|adalimumab|mesh-list
93315283|NCT02632175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93315284|NCT02632175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609614|NCT00162006|Immunoglobulins|immunoglobulins|mesh-list
93315285|NCT02632175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315286|NCT02458196|Mycophenolic Acid|mycophenolic acid|mesh-list
93315287|NCT02458196|Prednisone|prednisone|mesh-list
93315288|NCT02458196|Prednisolone|prednisolone|mesh-list
93315289|NCT02458196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315290|NCT02458196|Glucocorticoids|glucocorticoids|mesh-ancestor
93315291|NCT02458196|Hormones|hormones|mesh-ancestor
93315292|NCT02458196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609624|NCT02964572|Empagliflozin|empagliflozin|mesh-list
93315293|NCT02458196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315294|NCT02458196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315295|NCT02458196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315296|NCT02458196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93315297|NCT02458196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92426893|NCT01540812|Dexamethasone|dexamethasone|mesh-list
93315298|NCT02458196|Antitubercular Agents|antitubercular agents|mesh-ancestor
93315299|NCT02458196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93315300|NCT02458196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315301|NCT02458196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315302|NCT02458196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315303|NCT05207735|Capecitabine|capecitabine|mesh-list
93315304|NCT05207735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315305|NCT05207735|Antimetabolites|antimetabolites|mesh-ancestor
93315306|NCT05207735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315307|NCT05207735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315308|NCT03264638|Cyproterone Acetate|cyproterone acetate|mesh-list
93315309|NCT03264638|Cyproterone|cyproterone|mesh-list
93315310|NCT03264638|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
93315311|NCT03264638|Androgen Antagonists|androgen antagonists|mesh-ancestor
93315312|NCT03264638|Hormone Antagonists|hormone antagonists|mesh-ancestor
93315313|NCT03264638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315314|NCT03264638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315315|NCT03264638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315316|NCT03264638|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93315317|NCT03264638|Contraceptive Agents|contraceptive agents|mesh-ancestor
93315318|NCT03264638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93315319|NCT04502381|Amphotericin B|amphotericin b|mesh-list
93315320|NCT04502381|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93315321|NCT04502381|Deoxycholic Acid|deoxycholic acid|mesh-list
93315322|NCT04502381|Amebicides|amebicides|mesh-ancestor
93315323|NCT04502381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93315324|NCT04502381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93315325|NCT04502381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315326|NCT04502381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93315327|NCT04502381|Antifungal Agents|antifungal agents|mesh-ancestor
93315328|NCT04502381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93315329|NCT04502381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315330|NCT03264794|Gefitinib|gefitinib|mesh-list
93315331|NCT03264794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315332|NCT03264794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93315333|NCT03264794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366436|NCT02422186|Sensory System Agents|sensory system agents|mesh-ancestor
92987322|NCT00881114|Cetuximab|cetuximab|mesh-list
93315334|NCT03264794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315335|NCT02925923|Clopidogrel|clopidogrel|mesh-list
93315336|NCT02925923|Ticagrelor|ticagrelor|mesh-list
93315337|NCT02925923|Eptifibatide|eptifibatide|mesh-list
93315338|NCT02925923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93315339|NCT02925923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93315340|NCT02925923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93315341|NCT02925923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93315342|NCT02925923|Purinergic Agents|purinergic agents|mesh-ancestor
93315343|NCT02925923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315344|NCT02925923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315345|NCT02925923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315346|NCT03280316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93315347|NCT03280316|Botulinum Toxins|botulinum toxins|mesh-list
93315348|NCT03280316|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93315349|NCT03280316|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93315350|NCT03280316|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92427281|NCT01542827|Analgesics|analgesics|mesh-list
93315351|NCT03280316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315352|NCT03280316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315353|NCT03280316|Cholinergic Agents|cholinergic agents|mesh-ancestor
93315354|NCT03280316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315355|NCT03280316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315356|NCT03280316|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93315357|NCT03280316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315358|NCT03280316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93315359|NCT03280316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93315360|NCT03280316|Urological Agents|urological agents|mesh-ancestor
93315361|NCT02410343|Hormones|hormones|mesh-list
93315362|NCT02410343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609696|NCT04515628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93315363|NCT02410343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315364|NCT05234840|Triamcinolone|triamcinolone|mesh-list
93315365|NCT05234840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315366|NCT05234840|Glucocorticoids|glucocorticoids|mesh-ancestor
93315367|NCT05234840|Hormones|hormones|mesh-ancestor
92609700|NCT00407043|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92609704|NCT00141011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93315368|NCT05234840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427737|NCT01545830|Vitamin D|vitamin d|mesh-list
93315369|NCT05234840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315370|NCT03280004|Moxifloxacin|moxifloxacin|mesh-list
93315371|NCT03280004|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93315372|NCT03280004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93315373|NCT03280004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315374|NCT03280004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93315375|NCT03280004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93315376|NCT03280004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609712|NCT00504946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315377|NCT03280004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427956|NCT01547416|Analgesics|analgesics|mesh-ancestor
93315378|NCT03280004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315379|NCT03280004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93315380|NCT03280004|Contraceptive Agents|contraceptive agents|mesh-ancestor
92609722|NCT00504946|Hormone Antagonists|hormone antagonists|mesh-ancestor
93315381|NCT03280004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93315382|NCT03280004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315383|NCT03280004|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93315384|NCT03280004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93315385|NCT03280004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93315386|NCT03434379|Bevacizumab|bevacizumab|mesh-list
93315387|NCT03434379|Atezolizumab|atezolizumab|mesh-list
93315388|NCT03434379|Sorafenib|sorafenib|mesh-list
93315389|NCT03434379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315390|NCT03434379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315391|NCT03434379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93315392|NCT03434379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93315393|NCT03434379|Growth Substances|growth substances|mesh-ancestor
93315394|NCT03434379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315395|NCT03434379|Growth Inhibitors|growth inhibitors|mesh-ancestor
93315396|NCT03434379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93315397|NCT03434379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609730|NCT00504946|Vitamins|vitamins|mesh-ancestor
93315398|NCT03434379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315399|NCT03434379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93315400|NCT02459288|Clopidogrel|clopidogrel|mesh-list
93315401|NCT02459288|Ticagrelor|ticagrelor|mesh-list
93315402|NCT02459288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93315403|NCT02459288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93315404|NCT02459288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93315405|NCT02459288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93315406|NCT02459288|Purinergic Agents|purinergic agents|mesh-ancestor
93315407|NCT02459288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315408|NCT02459288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315409|NCT02459288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315410|NCT00734253|Pyridoxamine|pyridoxamine|mesh-list
93315411|NCT00734253|Vitamin B Complex|vitamin b complex|mesh-ancestor
93315412|NCT00734253|Vitamins|vitamins|mesh-ancestor
93315413|NCT00734253|Micronutrients|micronutrients|mesh-ancestor
93315414|NCT00734253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315415|NCT00730665|Esomeprazole|esomeprazole|mesh-list
93315416|NCT00730665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93315417|NCT00730665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315418|NCT00730665|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93315419|NCT00730665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315420|NCT00730665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315421|NCT00714597|Enoxaparin|enoxaparin|mesh-list
93315422|NCT00714597|Semuloparin|semuloparin|mesh-list
93315423|NCT00714597|Enoxaparin sodium|enoxaparin sodium|mesh-list
93315424|NCT00714597|Anticoagulants|anticoagulants|mesh-ancestor
93315425|NCT00714597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93315426|NCT00714597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92609760|NCT00407121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92609765|NCT00141167|Varenicline|varenicline|mesh-list
93315427|NCT00714597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315428|NCT03265886|Bupivacaine|bupivacaine|mesh-list
93315429|NCT03265886|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315430|NCT03265886|Anesthetics|anesthetics|mesh-ancestor
93315431|NCT03265886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315432|NCT03265886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315433|NCT03265886|Sensory System Agents|sensory system agents|mesh-ancestor
93315434|NCT03265886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315435|NCT00728091|Satavaptan|satavaptan|mesh-list
93315436|NCT00728091|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93315437|NCT00728091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315438|NCT00728091|Natriuretic Agents|natriuretic agents|mesh-ancestor
93315439|NCT00728091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315440|NCT03275090|SMOFlipid|smoflipid|mesh-list
93315441|NCT03275090|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93315442|NCT03275090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93315443|NCT03275090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93315444|NCT03382821|Dexamethasone|dexamethasone|mesh-list
92609780|NCT00141245|Analgesics|analgesics|mesh-ancestor
93315445|NCT03382821|Dexamethasone acetate|dexamethasone acetate|mesh-list
93315446|NCT03382821|Triamcinolone|triamcinolone|mesh-list
93315447|NCT03382821|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93315448|NCT03382821|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93315449|NCT03382821|Lidocaine|lidocaine|mesh-list
92429104|NCT01555710|Etoposide|etoposide|mesh-list
93315450|NCT03382821|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93315451|NCT03382821|BB 1101|bb 1101|mesh-list
93315452|NCT03382821|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93315453|NCT03382821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315454|NCT03382821|Antiemetics|antiemetics|mesh-ancestor
93315455|NCT03382821|Autonomic Agents|autonomic agents|mesh-ancestor
93315456|NCT03382821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609792|NCT00141245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93315457|NCT03382821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315458|NCT03382821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315459|NCT03382821|Glucocorticoids|glucocorticoids|mesh-ancestor
93315460|NCT03382821|Hormones|hormones|mesh-ancestor
93315461|NCT03382821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315462|NCT03382821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315463|NCT03382821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315464|NCT03382821|Protease Inhibitors|protease inhibitors|mesh-ancestor
93315465|NCT03382821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315466|NCT03382821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315467|NCT03382821|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315468|NCT03382821|Anesthetics|anesthetics|mesh-ancestor
93315469|NCT03382821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315470|NCT03382821|Sensory System Agents|sensory system agents|mesh-ancestor
93315471|NCT03382821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93315472|NCT03382821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93315473|NCT03382821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93315474|NCT03382821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315475|NCT03382821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315476|NCT03382821|Immunologic Factors|immunologic factors|mesh-ancestor
93315477|NCT03263624|Tazarotene|tazarotene|mesh-list
93315478|NCT03263624|Dermatologic Agents|dermatologic agents|mesh-ancestor
93315479|NCT03263624|Keratolytic Agents|keratolytic agents|mesh-ancestor
93315480|NCT00711555|Dexamethasone|dexamethasone|mesh-list
93315481|NCT00711555|Ondansetron|ondansetron|mesh-list
92987486|NCT00141037|Prednisone|prednisone|mesh-list
93315482|NCT00711555|Aprepitant|aprepitant|mesh-list
93315483|NCT00711555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315484|NCT00711555|Antiemetics|antiemetics|mesh-ancestor
93315485|NCT00711555|Autonomic Agents|autonomic agents|mesh-ancestor
93315486|NCT00711555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315487|NCT00711555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315488|NCT00711555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315489|NCT00711555|Glucocorticoids|glucocorticoids|mesh-ancestor
93315490|NCT00711555|Hormones|hormones|mesh-ancestor
92609827|NCT00141401|Analgesics|analgesics|mesh-ancestor
92718276|NCT01165996|Decitabine|decitabine|mesh-list
93315491|NCT00711555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718326|NCT01188811|Vitamins|vitamins|mesh-ancestor
93315492|NCT00711555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315493|NCT00711555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315494|NCT00711555|Antipruritics|antipruritics|mesh-ancestor
93315495|NCT00711555|Dermatologic Agents|dermatologic agents|mesh-ancestor
93315496|NCT00711555|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93315497|NCT00711555|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93315498|NCT00711555|Serotonin Agents|serotonin agents|mesh-ancestor
92089169|NCT03643744|Celecoxib|celecoxib|mesh-list
93315499|NCT00711555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315500|NCT00711555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315501|NCT00711555|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93315502|NCT03263390|Anti-Obesity Agents|anti-obesity agents|mesh-list
93315503|NCT02280993|Dexamethasone|dexamethasone|mesh-list
93315504|NCT02280993|Cisplatin|cisplatin|mesh-list
93315505|NCT02280993|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93315506|NCT02280993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315507|NCT02280993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315508|NCT02280993|Antiemetics|antiemetics|mesh-ancestor
93315509|NCT02280993|Autonomic Agents|autonomic agents|mesh-ancestor
93315510|NCT02280993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315511|NCT02280993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315512|NCT02280993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315513|NCT02280993|Glucocorticoids|glucocorticoids|mesh-ancestor
93315514|NCT02280993|Hormones|hormones|mesh-ancestor
93315515|NCT02280993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315516|NCT02280993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315517|NCT02280993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315518|NCT02280993|Immunotoxins|immunotoxins|mesh-ancestor
93315519|NCT02280993|Immunoconjugates|immunoconjugates|mesh-ancestor
93315520|NCT02280993|Immunologic Factors|immunologic factors|mesh-ancestor
93315521|NCT05488522|Bevacizumab|bevacizumab|mesh-list
93315522|NCT05488522|Atezolizumab|atezolizumab|mesh-list
93315523|NCT05488522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315524|NCT05488522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315525|NCT05488522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93315526|NCT05488522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93315527|NCT05488522|Growth Substances|growth substances|mesh-ancestor
93315528|NCT05488522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315529|NCT05488522|Growth Inhibitors|growth inhibitors|mesh-ancestor
93315530|NCT05488522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93315531|NCT05488522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315532|NCT05492968|Phenylephrine|phenylephrine|mesh-list
93315533|NCT05492968|Epinephrine|epinephrine|mesh-list
93315534|NCT05492968|Oxymetazoline|oxymetazoline|mesh-list
93315535|NCT05492968|Norepinephrine|norepinephrine|mesh-list
93315536|NCT05492968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93315537|NCT05492968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315538|NCT05492968|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315539|NCT05492968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315540|NCT05492968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315541|NCT05492968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315542|NCT05492968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93315543|NCT05492968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93315544|NCT05492968|Autonomic Agents|autonomic agents|mesh-ancestor
93315545|NCT05492968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315546|NCT05492968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93315547|NCT05492968|Respiratory System Agents|respiratory system agents|mesh-ancestor
93315548|NCT05492968|Mydriatics|mydriatics|mesh-ancestor
93315549|NCT05492968|Sympathomimetics|sympathomimetics|mesh-ancestor
93315550|NCT05492968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93315551|NCT05492968|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93315552|NCT05492968|Nasal Decongestants|nasal decongestants|mesh-ancestor
93315553|NCT05492968|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93315554|NCT05492968|Protective Agents|protective agents|mesh-ancestor
93315555|NCT02457026|Triamcinolone|triamcinolone|mesh-list
93315556|NCT02457026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92987540|NCT00923390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93315557|NCT02457026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93315558|NCT02457026|Aflibercept|aflibercept|mesh-list
93315559|NCT02457026|Verteporfin|verteporfin|mesh-list
93315560|NCT02457026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93315561|NCT02457026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315562|NCT02457026|Glucocorticoids|glucocorticoids|mesh-ancestor
93315564|NCT02457026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315565|NCT02457026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315566|NCT02457026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315567|NCT02457026|Immunologic Factors|immunologic factors|mesh-ancestor
93315568|NCT02457026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315569|NCT02457026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315570|NCT02457026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93315571|NCT02457026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93315572|NCT02457026|Growth Substances|growth substances|mesh-ancestor
93315573|NCT02457026|Growth Inhibitors|growth inhibitors|mesh-ancestor
93315574|NCT02457026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609898|NCT00404456|Melatonin|melatonin|mesh-list
93315575|NCT02457026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93315576|NCT02457026|Dermatologic Agents|dermatologic agents|mesh-ancestor
93315577|NCT03919526|Cyclophosphamide|cyclophosphamide|mesh-list
93315578|NCT03919526|Fludarabine|fludarabine|mesh-list
93315579|NCT03919526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315580|NCT03919526|Immunologic Factors|immunologic factors|mesh-ancestor
93315581|NCT03919526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315582|NCT03919526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315583|NCT03919526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315584|NCT03919526|Alkylating Agents|alkylating agents|mesh-ancestor
92609908|NCT00404534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315585|NCT03919526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315586|NCT03919526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315587|NCT03919526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93315588|NCT05492812|Melatonin|melatonin|mesh-list
93315589|NCT05492812|Chloral Hydrate|chloral hydrate|mesh-list
93315590|NCT05492812|Hydroxyzine|hydroxyzine|mesh-list
93315591|NCT05492812|Antioxidants|antioxidants|mesh-ancestor
93315592|NCT05492812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315593|NCT05492812|Protective Agents|protective agents|mesh-ancestor
93315594|NCT05492812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315595|NCT05492812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315596|NCT05492812|Antipruritics|antipruritics|mesh-ancestor
93315597|NCT05492812|Dermatologic Agents|dermatologic agents|mesh-ancestor
93315598|NCT05492812|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93315599|NCT05492812|Histamine Antagonists|histamine antagonists|mesh-ancestor
93315600|NCT05492812|Histamine Agents|histamine agents|mesh-ancestor
93315601|NCT05492812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315602|NCT05492812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93315603|NCT02458118|Secretin|secretin|mesh-list
93315604|NCT02458118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315605|NCT02458118|Hormones|hormones|mesh-ancestor
93315606|NCT02458118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315607|NCT02458118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315608|NCT05487742|Dexmedetomidine|dexmedetomidine|mesh-list
93315609|NCT05487742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93315610|NCT05487742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315611|NCT05487742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315612|NCT05487742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93315613|NCT05487742|Analgesics|analgesics|mesh-ancestor
93315614|NCT05487742|Sensory System Agents|sensory system agents|mesh-ancestor
93315615|NCT05487742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315616|NCT05487742|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93315617|NCT05487742|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93315618|NCT05487742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315619|NCT05487742|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315620|NCT05487742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017087|NCT05041907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93315621|NCT05487742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315622|NCT02457650|Cyclophosphamide|cyclophosphamide|mesh-list
93315623|NCT02457650|Fludarabine|fludarabine|mesh-list
93315624|NCT02457650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315625|NCT02457650|Immunologic Factors|immunologic factors|mesh-ancestor
93315626|NCT02457650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315627|NCT02457650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315628|NCT02457650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315629|NCT02457650|Alkylating Agents|alkylating agents|mesh-ancestor
93315630|NCT02457650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315631|NCT02457650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315632|NCT02457650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93315634|NCT02456948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93315635|NCT02456948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315636|NCT05487508|Dexamethasone|dexamethasone|mesh-list
93315637|NCT05487508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93315638|NCT05487508|Antiemetics|antiemetics|mesh-ancestor
93315639|NCT05487508|Autonomic Agents|autonomic agents|mesh-ancestor
93315640|NCT05487508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315641|NCT05487508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315642|NCT05487508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93315643|NCT05487508|Glucocorticoids|glucocorticoids|mesh-ancestor
93315644|NCT05487508|Hormones|hormones|mesh-ancestor
93315645|NCT05487508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315646|NCT05487508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93315647|NCT05487508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720418|NCT01158118|Plerixafor|plerixafor|mesh-list
93315648|NCT02713490|Bupivacaine|bupivacaine|mesh-list
93315649|NCT02713490|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315650|NCT02713490|Anesthetics|anesthetics|mesh-ancestor
93315651|NCT02713490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315652|NCT02713490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315653|NCT02713490|Sensory System Agents|sensory system agents|mesh-ancestor
93315654|NCT02713490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315655|NCT04401904|Dapagliflozin|dapagliflozin|mesh-list
92609973|NCT00162474|Phenytoin|phenytoin|mesh-list
93315656|NCT04401904|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93315657|NCT04401904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315658|NCT04401904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93315659|NCT04401904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315660|NCT05491720|Risperidone|risperidone|mesh-list
93315661|NCT05491720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93315662|NCT05491720|Serotonin Agents|serotonin agents|mesh-ancestor
93315663|NCT05491720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315664|NCT05491720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315665|NCT05491720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315666|NCT05491720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93315667|NCT05491720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93315668|NCT05491720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315669|NCT05491720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92609985|NCT00505336|Eplerenone|eplerenone|mesh-list
93315670|NCT05491720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93315671|NCT05491720|Dopamine Agents|dopamine agents|mesh-ancestor
93315672|NCT05387954|Anticoagulants|anticoagulants|mesh-list
93315673|NCT05387954|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
93315674|NCT05387954|Antithrombins|antithrombins|mesh-ancestor
93315675|NCT05387954|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93315676|NCT05387954|Protease Inhibitors|protease inhibitors|mesh-ancestor
93315677|NCT05387954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315678|NCT05387954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315679|NCT03262688|Bupivacaine|bupivacaine|mesh-list
93315680|NCT03262688|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315681|NCT03262688|Anesthetics|anesthetics|mesh-ancestor
93315682|NCT03262688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315683|NCT03262688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315684|NCT03262688|Sensory System Agents|sensory system agents|mesh-ancestor
93315685|NCT03262688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315686|NCT05486884|Benzocaine|benzocaine|mesh-list
93315687|NCT05486884|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315688|NCT05486884|Anesthetics|anesthetics|mesh-ancestor
93315689|NCT05486884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315690|NCT05486884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315691|NCT05486884|Sensory System Agents|sensory system agents|mesh-ancestor
92091869|NCT01046110|Hormones|hormones|mesh-ancestor
93315692|NCT05486884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315693|NCT05485792|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93315694|NCT05485792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93315695|NCT05485792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315696|NCT05485402|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
93315697|NCT05485402|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
93315698|NCT05485402|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
93315699|NCT05485402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315700|NCT05485402|Antioxidants|antioxidants|mesh-ancestor
93315701|NCT05485402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315702|NCT05485402|Protective Agents|protective agents|mesh-ancestor
92092163|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
92610020|NCT04517890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315703|NCT05485402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315704|NCT05485402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93315705|NCT05485402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93315706|NCT05485402|Disinfectants|disinfectants|mesh-ancestor
93315707|NCT05485402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93315708|NCT03797924|Ropivacaine|ropivacaine|mesh-list
93315709|NCT03797924|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315710|NCT03797924|Anesthetics|anesthetics|mesh-ancestor
92610026|NCT00141596|Amiloride|amiloride|mesh-list
93315711|NCT03797924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315712|NCT03797924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315713|NCT03797924|Sensory System Agents|sensory system agents|mesh-ancestor
93315714|NCT03797924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315715|NCT05486650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93315716|NCT05486650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315717|NCT05486650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315718|NCT05486650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315719|NCT05074628|Nitrofurantoin|nitrofurantoin|mesh-list
93315720|NCT05074628|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93315721|NCT05074628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315722|NCT05074628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93315723|NCT04273516|Rivaroxaban|rivaroxaban|mesh-list
93315724|NCT04273516|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93315725|NCT04273516|Antithrombins|antithrombins|mesh-ancestor
93315726|NCT04273516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93315727|NCT04273516|Protease Inhibitors|protease inhibitors|mesh-ancestor
93315728|NCT04273516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315729|NCT04273516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315730|NCT04273516|Anticoagulants|anticoagulants|mesh-ancestor
93315731|NCT02458742|Morphine|morphine|mesh-list
93315732|NCT02458742|Bupivacaine|bupivacaine|mesh-list
93315733|NCT02458742|Anesthetics, Local|anesthetics, local|mesh-ancestor
93315734|NCT02458742|Anesthetics|anesthetics|mesh-ancestor
93315735|NCT02458742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315736|NCT02458742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315737|NCT02458742|Sensory System Agents|sensory system agents|mesh-ancestor
93315738|NCT02458742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315739|NCT02458742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93315740|NCT02458742|Narcotics|narcotics|mesh-ancestor
93315741|NCT02458742|Analgesics|analgesics|mesh-ancestor
93315742|NCT02403310|Cytarabine|cytarabine|mesh-list
93315743|NCT02403310|Daunorubicin|daunorubicin|mesh-list
93315744|NCT02403310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315745|NCT02403310|Antimetabolites|antimetabolites|mesh-ancestor
93315746|NCT02403310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315747|NCT02403310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315748|NCT02403310|Antiviral Agents|antiviral agents|mesh-ancestor
93315749|NCT02403310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315750|NCT02403310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315751|NCT02403310|Immunologic Factors|immunologic factors|mesh-ancestor
93315752|NCT02403310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315753|NCT02403310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92610063|NCT04518163|Tranexamic Acid|tranexamic acid|mesh-list
93315754|NCT02403310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93315755|NCT02403310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93315756|NCT02403310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315757|NCT01665274|Capecitabine|capecitabine|mesh-list
93315758|NCT01665274|Oxaliplatin|oxaliplatin|mesh-list
93315759|NCT01665274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315760|NCT01665274|Antimetabolites|antimetabolites|mesh-ancestor
93315761|NCT01665274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315762|NCT01665274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315763|NCT05387876|Vitamin D|vitamin d|mesh-list
93315764|NCT05387876|Vitamins|vitamins|mesh-ancestor
93315765|NCT05387876|Micronutrients|micronutrients|mesh-ancestor
93315766|NCT05387876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315767|NCT05387876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93315768|NCT04560166|Irinotecan|irinotecan|mesh-list
93315769|NCT04560166|Temozolomide|temozolomide|mesh-list
93315770|NCT04560166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92610080|NCT00141713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315771|NCT04560166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93315772|NCT04560166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315773|NCT04560166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315774|NCT04560166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315775|NCT04560166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315776|NCT04560166|Alkylating Agents|alkylating agents|mesh-ancestor
93315777|NCT03262376|Vitamins|vitamins|mesh-list
93315778|NCT03262376|Micronutrients|micronutrients|mesh-ancestor
92610084|NCT04517188|Iodine|iodine|mesh-list
93315779|NCT03262376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315780|NCT02456714|Folfirinox|folfirinox|mesh-list
92987820|NCT04074317|Insulin|insulin|mesh-list
93315781|NCT02456714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315782|NCT03258866|Rituximab|rituximab|mesh-list
93315783|NCT03258866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315784|NCT03258866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315785|NCT03258866|Immunologic Factors|immunologic factors|mesh-ancestor
93315786|NCT03258866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315787|NCT03258866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315788|NCT03258476|Guanfacine|guanfacine|mesh-list
92722851|NCT04592666|Pemetrexed|pemetrexed|mesh-list
93315789|NCT03258476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93315790|NCT03258476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93315791|NCT03258476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93315792|NCT03258476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93315793|NCT03258476|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315794|NCT03258476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315795|NCT03258476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315796|NCT03258476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315797|NCT03258398|Avelumab|avelumab|mesh-list
93315798|NCT03258398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315799|NCT03258398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315800|NCT03261596|Mebendazole|mebendazole|mesh-list
93315801|NCT03261596|Piperazine|piperazine|mesh-list
93315802|NCT03261596|Piperazine citrate|piperazine citrate|mesh-list
93315803|NCT03261596|DMP 777|dmp 777|mesh-list
93315804|NCT03261596|Antinematodal Agents|antinematodal agents|mesh-ancestor
93315805|NCT03261596|Anthelmintics|anthelmintics|mesh-ancestor
93315806|NCT03261596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93315807|NCT03261596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315808|NCT03261596|Tubulin Modulators|tubulin modulators|mesh-ancestor
93315809|NCT03261596|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315810|NCT03261596|Mitosis Modulators|mitosis modulators|mesh-ancestor
93315811|NCT03261596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315812|NCT03261596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315813|NCT03261596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315814|NCT03825874|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93315815|NCT03825874|Amikacin|amikacin|mesh-list
93315816|NCT03825874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315817|NCT03786614|Antidepressive Agents|antidepressive agents|mesh-list
93315818|NCT03786614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93315819|NCT03772574|Nicotine|nicotine|mesh-list
93315820|NCT03772574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93315821|NCT03772574|Autonomic Agents|autonomic agents|mesh-ancestor
93315822|NCT03772574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315823|NCT03772574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315824|NCT03772574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93315825|NCT03772574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93315826|NCT03772574|Cholinergic Agents|cholinergic agents|mesh-ancestor
93315827|NCT03772574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610117|NCT00141791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315828|NCT03772574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315829|NCT02456558|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93315830|NCT02456558|Deferiprone|deferiprone|mesh-list
93315831|NCT02456558|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93315832|NCT02456558|Chelating Agents|chelating agents|mesh-ancestor
93315833|NCT02456558|Sequestering Agents|sequestering agents|mesh-ancestor
93315834|NCT02456558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315835|NCT03798080|Insulin|insulin|mesh-list
93315836|NCT03798080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93315837|NCT03798080|Metformin|metformin|mesh-list
93315838|NCT03798080|Insulin Glargine|insulin glargine|mesh-list
93315839|NCT03798080|Lixisenatide|lixisenatide|mesh-list
93315840|NCT03798080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93315841|NCT03798080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315842|NCT03257930|Ethanol|ethanol|mesh-list
93315843|NCT03257930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93315844|NCT03257930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315845|NCT03257930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93315846|NCT03257930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315847|NCT03257852|Methotrexate|methotrexate|mesh-list
93315848|NCT03257852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93315849|NCT03257852|Abortifacient Agents|abortifacient agents|mesh-ancestor
93315850|NCT03257852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93315851|NCT03257852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315852|NCT03257852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315853|NCT03257852|Antimetabolites|antimetabolites|mesh-ancestor
92987847|NCT00609674|Fluticasone|fluticasone|mesh-list
92610142|NCT00505492|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315854|NCT03257852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315855|NCT03257852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315856|NCT03257852|Dermatologic Agents|dermatologic agents|mesh-ancestor
93315857|NCT03257852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315858|NCT03257852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93315859|NCT03257852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315860|NCT03257852|Immunologic Factors|immunologic factors|mesh-ancestor
93315861|NCT03257852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92610145|NCT00141830|Methotrexate|methotrexate|mesh-list
93315862|NCT03257852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93315863|NCT05498896|Paclitaxel|paclitaxel|mesh-list
93315864|NCT05498896|Cyclophosphamide|cyclophosphamide|mesh-list
93315865|NCT05498896|Doxorubicin|doxorubicin|mesh-list
93315866|NCT05498896|Atezolizumab|atezolizumab|mesh-list
93315867|NCT05498896|Ipatasertib|ipatasertib|mesh-list
93315868|NCT05498896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93315869|NCT05498896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315870|NCT05498896|Tubulin Modulators|tubulin modulators|mesh-ancestor
93315871|NCT05498896|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315872|NCT05498896|Mitosis Modulators|mitosis modulators|mesh-ancestor
93315873|NCT05498896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315874|NCT05498896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315875|NCT05498896|Immunologic Factors|immunologic factors|mesh-ancestor
93315876|NCT05498896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315877|NCT05498896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315878|NCT05498896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93315879|NCT05498896|Alkylating Agents|alkylating agents|mesh-ancestor
93315880|NCT05498896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93315881|NCT05498896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93315882|NCT05498896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93315883|NCT05498896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93315884|NCT05498896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315885|NCT05498896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93315886|NCT05498896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315887|NCT05498896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93315888|NCT02743221|Trifluridine|trifluridine|mesh-list
93315889|NCT02743221|Bevacizumab|bevacizumab|mesh-list
93315890|NCT02743221|Capecitabine|capecitabine|mesh-list
93315891|NCT02743221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315892|NCT02743221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315893|NCT02743221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92095063|NCT05688345|Propofol|propofol|mesh-list
93315894|NCT02743221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93315895|NCT02743221|Growth Substances|growth substances|mesh-ancestor
93315896|NCT02743221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315897|NCT02743221|Growth Inhibitors|growth inhibitors|mesh-ancestor
93315898|NCT02743221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315899|NCT02743221|Antimetabolites|antimetabolites|mesh-ancestor
93315900|NCT02743221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315901|NCT02743221|Antiviral Agents|antiviral agents|mesh-ancestor
93315902|NCT02743221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315903|NCT03955887|Dimercaprol|dimercaprol|mesh-list
93315904|NCT03955887|Chelating Agents|chelating agents|mesh-ancestor
93315905|NCT03955887|Sequestering Agents|sequestering agents|mesh-ancestor
93315906|NCT03955887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315907|NCT03260972|Chloroprocaine|chloroprocaine|mesh-list
93315908|NCT03260972|Anesthetics, Local|anesthetics, local|mesh-ancestor
92723982|NCT04572867|Diuretics|diuretics|mesh-list
93315909|NCT03260972|Anesthetics|anesthetics|mesh-ancestor
93315910|NCT03260972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724041|NCT03451110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93315911|NCT03260972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315912|NCT03260972|Sensory System Agents|sensory system agents|mesh-ancestor
92610185|NCT04515979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315913|NCT03260972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315914|NCT03370263|Belimumab|belimumab|mesh-list
93315915|NCT03370263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93315916|NCT03370263|Immunologic Factors|immunologic factors|mesh-ancestor
93315917|NCT03370263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315918|NCT00692445|Mecamylamine|mecamylamine|mesh-list
93315919|NCT00692445|Dexetimide|dexetimide|mesh-list
93315920|NCT00692445|Citalopram|citalopram|mesh-list
93315921|NCT00692445|Escitalopram|escitalopram|mesh-list
93315922|NCT00692445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93315923|NCT00692445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93315924|NCT00692445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315925|NCT00692445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315926|NCT00692445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315927|NCT00692445|Serotonin Agents|serotonin agents|mesh-ancestor
93315928|NCT00692445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315929|NCT00692445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93315930|NCT00692445|Antidepressive Agents|antidepressive agents|mesh-ancestor
93315931|NCT00692445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93315932|NCT00692445|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93315933|NCT00692445|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93315934|NCT00692445|Parasympatholytics|parasympatholytics|mesh-ancestor
93315935|NCT00692445|Autonomic Agents|autonomic agents|mesh-ancestor
93315936|NCT00692445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93315937|NCT00692445|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93315938|NCT00692445|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93315939|NCT00692445|Cholinergic Agents|cholinergic agents|mesh-ancestor
93315940|NCT00692445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93315941|NCT00692445|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
93315942|NCT00692445|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93315943|NCT03929757|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93315944|NCT03929757|Antiviral Agents|antiviral agents|mesh-ancestor
93315945|NCT03929757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315946|NCT03256292|Testosterone|testosterone|mesh-list
93315947|NCT03256292|Androgens|androgens|mesh-ancestor
93315948|NCT03256292|Hormones|hormones|mesh-ancestor
93315949|NCT03256292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93315950|NCT03256292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315951|NCT04473261|Iodine|iodine|mesh-list
93315952|NCT04473261|Cadexomer iodine|cadexomer iodine|mesh-list
93315953|NCT04473261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93315954|NCT04473261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315955|NCT04473261|Trace Elements|trace elements|mesh-ancestor
93315956|NCT04473261|Micronutrients|micronutrients|mesh-ancestor
93315957|NCT04473261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315958|NCT01358968|Gemcitabine|gemcitabine|mesh-list
93315959|NCT01358968|Pemetrexed|pemetrexed|mesh-list
93315960|NCT01358968|Desipramine|desipramine|mesh-list
93315961|NCT01358968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93315962|NCT01358968|Antimetabolites|antimetabolites|mesh-ancestor
93315963|NCT01358968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315964|NCT01358968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315965|NCT01358968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315966|NCT01358968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93315967|NCT01358968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93315968|NCT01358968|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93315969|NCT01358968|Antidepressive Agents|antidepressive agents|mesh-ancestor
93315970|NCT01358968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93315971|NCT01358968|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93315972|NCT01358968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92610246|NCT04514731|Analgesics|analgesics|mesh-ancestor
93315973|NCT01358968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93315974|NCT01358968|Adrenergic Agents|adrenergic agents|mesh-ancestor
93315975|NCT01358968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93315976|NCT01358968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93315977|NCT02281305|Colchicine|colchicine|mesh-list
93315978|NCT02281305|Gout Suppressants|gout suppressants|mesh-ancestor
93315979|NCT02281305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93315980|NCT02281305|Tubulin Modulators|tubulin modulators|mesh-ancestor
93315981|NCT02281305|Antimitotic Agents|antimitotic agents|mesh-ancestor
93315982|NCT02281305|Mitosis Modulators|mitosis modulators|mesh-ancestor
93315983|NCT02281305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315984|NCT02281305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315985|NCT00624351|Epratuzumab|epratuzumab|mesh-list
92610250|NCT04514731|Anesthetics|anesthetics|mesh-ancestor
93315986|NCT00624351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93315987|NCT00624351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93315988|NCT03251690|Tenofovir|tenofovir|mesh-list
93315989|NCT03251690|Emtricitabine|emtricitabine|mesh-list
93315990|NCT03251690|Efavirenz|efavirenz|mesh-list
93315991|NCT03251690|Rilpivirine|rilpivirine|mesh-list
93315992|NCT03251690|Antiviral Agents|antiviral agents|mesh-ancestor
93315993|NCT03251690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93315994|NCT03251690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93315995|NCT03251690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93315996|NCT03251690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93315997|NCT03251690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93315998|NCT03251690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93315999|NCT03251690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93316000|NCT03251690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93316001|NCT03251690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93316002|NCT03251690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93316003|NCT03251690|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93316004|NCT03251690|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93316005|NCT03251690|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93316006|NCT03251768|Lenograstim|lenograstim|mesh-list
93316007|NCT03251768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93316008|NCT03251768|Immunologic Factors|immunologic factors|mesh-ancestor
93316009|NCT03251768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316011|NCT00687687|Carboplatin|carboplatin|mesh-list
93316012|NCT00687687|Iniparib|iniparib|mesh-list
93316013|NCT00687687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93316014|NCT00687687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316015|NCT00687687|Tubulin Modulators|tubulin modulators|mesh-ancestor
93316016|NCT00687687|Antimitotic Agents|antimitotic agents|mesh-ancestor
93316017|NCT00687687|Mitosis Modulators|mitosis modulators|mesh-ancestor
93316018|NCT00687687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316019|NCT00687687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93316020|NCT00687687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316021|NCT00701090|Metformin|metformin|mesh-list
93316022|NCT00701090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93316023|NCT00701090|Glimepiride|glimepiride|mesh-list
93316024|NCT00701090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93316025|NCT00701090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316026|NCT00701090|Incretins|incretins|mesh-ancestor
93316027|NCT00701090|Hormones|hormones|mesh-ancestor
92610291|NCT00162786|Hydroxyzine|hydroxyzine|mesh-list
93316028|NCT00701090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316029|NCT00701090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93316030|NCT00701090|Protease Inhibitors|protease inhibitors|mesh-ancestor
93316031|NCT00701090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316032|NCT00701090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316033|NCT00701090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93316034|NCT00701090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93316035|NCT00701090|Immunologic Factors|immunologic factors|mesh-ancestor
93316036|NCT00614601|Vaccines|vaccines|mesh-list
93316037|NCT00614601|Immunologic Factors|immunologic factors|mesh-ancestor
93316038|NCT00614601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316039|NCT02283489|Paclitaxel|paclitaxel|mesh-list
93316040|NCT02283489|Endostatins|endostatins|mesh-list
93316041|NCT02283489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93316042|NCT02283489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316043|NCT02283489|Tubulin Modulators|tubulin modulators|mesh-ancestor
93316044|NCT02283489|Antimitotic Agents|antimitotic agents|mesh-ancestor
93316045|NCT02283489|Mitosis Modulators|mitosis modulators|mesh-ancestor
93316046|NCT02283489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316047|NCT02283489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93316048|NCT02283489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93316049|NCT02283489|Growth Substances|growth substances|mesh-ancestor
93316050|NCT02283489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316051|NCT02283489|Growth Inhibitors|growth inhibitors|mesh-ancestor
93316052|NCT02455232|Lidocaine|lidocaine|mesh-list
93316053|NCT02455232|Anesthetics, Local|anesthetics, local|mesh-ancestor
93316054|NCT02455232|Anesthetics|anesthetics|mesh-ancestor
93316055|NCT02455232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316056|NCT02455232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316057|NCT02455232|Sensory System Agents|sensory system agents|mesh-ancestor
93316058|NCT02455232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316059|NCT02455232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93316060|NCT02455232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93316061|NCT02455232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93316062|NCT02455232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316063|NCT02455232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316064|NCT03259958|Donepezil|donepezil|mesh-list
93316065|NCT03259958|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93316066|NCT03259958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316067|NCT03259958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316068|NCT03259958|Cholinergic Agents|cholinergic agents|mesh-ancestor
92610315|NCT00505804|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93316069|NCT03259958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316070|NCT03259958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316071|NCT03259958|Nootropic Agents|nootropic agents|mesh-ancestor
93316072|NCT02923947|Osimertinib|osimertinib|mesh-list
93316073|NCT02923947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316074|NCT02923947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93316075|NCT02923947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316076|NCT02923947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316077|NCT00679731|Methotrexate|methotrexate|mesh-list
93316078|NCT00679731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93316079|NCT00679731|Abortifacient Agents|abortifacient agents|mesh-ancestor
93316080|NCT00679731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93316081|NCT00679731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610328|NCT00505843|Levodopa|levodopa|mesh-list
93316082|NCT00679731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93316083|NCT00679731|Antimetabolites|antimetabolites|mesh-ancestor
93316084|NCT00679731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316085|NCT00679731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316086|NCT00679731|Dermatologic Agents|dermatologic agents|mesh-ancestor
93316087|NCT00679731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316088|NCT00679731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93316089|NCT00679731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93316090|NCT00679731|Immunologic Factors|immunologic factors|mesh-ancestor
93316091|NCT00679731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93316092|NCT00679731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93316094|NCT02455856|Antifungal Agents|antifungal agents|mesh-ancestor
93316095|NCT02455856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316096|NCT02455856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93316097|NCT02455856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93316098|NCT02455856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316099|NCT02455856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316100|NCT02455856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93316101|NCT02455856|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316102|NCT02455856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316103|NCT02455856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316104|NCT02455856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93316105|NCT02283645|Minoxidil|minoxidil|mesh-list
93316106|NCT02283645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93316107|NCT02283645|Vasodilator Agents|vasodilator agents|mesh-ancestor
93316108|NCT00602745|Fluorouracil|fluorouracil|mesh-list
93316109|NCT00602745|Antimetabolites|antimetabolites|mesh-ancestor
93316110|NCT00602745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316111|NCT00602745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93316112|NCT00602745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316113|NCT00602745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93316114|NCT00602745|Immunologic Factors|immunologic factors|mesh-ancestor
93316115|NCT00602745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316116|NCT03251222|Dexmedetomidine|dexmedetomidine|mesh-list
93316117|NCT03251222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93316118|NCT03251222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316119|NCT03251222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316120|NCT03251222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93316121|NCT03251222|Analgesics|analgesics|mesh-ancestor
93316122|NCT03251222|Sensory System Agents|sensory system agents|mesh-ancestor
93316123|NCT03251222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316124|NCT03251222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93316125|NCT03251222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93316126|NCT03251222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92610362|NCT04512313|Rocuronium|rocuronium|mesh-list
93316127|NCT03251222|Adrenergic Agents|adrenergic agents|mesh-ancestor
93316128|NCT03251222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610365|NCT04512313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93316129|NCT03251222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316130|NCT04487834|Simethicone|simethicone|mesh-list
93316131|NCT04487834|Antifoaming Agents|antifoaming agents|mesh-ancestor
93316132|NCT04487834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316133|NCT04487834|Emollients|emollients|mesh-ancestor
93316134|NCT04487834|Dermatologic Agents|dermatologic agents|mesh-ancestor
93316135|NCT03250910|Ribavirin|ribavirin|mesh-list
93316136|NCT03250910|Sofosbuvir|sofosbuvir|mesh-list
93316137|NCT03250910|Velpatasvir|velpatasvir|mesh-list
93316138|NCT03250910|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93316139|NCT03250910|Antimetabolites|antimetabolites|mesh-ancestor
93316140|NCT03250910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316141|NCT03250910|Antiviral Agents|antiviral agents|mesh-ancestor
93316142|NCT03250910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316143|NCT02283801|Lamotrigine|lamotrigine|mesh-list
93316144|NCT02283801|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
93316145|NCT02283801|Anticonvulsants|anticonvulsants|mesh-ancestor
93316146|NCT02283801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93316147|NCT02283801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610368|NCT00142493|Midazolam|midazolam|mesh-list
93316148|NCT02283801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316149|NCT02283801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93316150|NCT02283801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316151|NCT02283801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92988145|NCT00886574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93316152|NCT02283801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610372|NCT00142493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93316153|NCT02283801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316154|NCT02283801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93316155|NCT02283801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93316156|NCT02283801|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93316157|NCT02455154|Letrozole|letrozole|mesh-list
93316158|NCT02455154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316159|NCT02455154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93316160|NCT02455154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93316161|NCT02455154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316162|NCT02455154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316163|NCT02455154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93316164|NCT02455154|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316165|NCT02455154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316166|NCT02455154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316167|NCT03254810|Adalimumab|adalimumab|mesh-list
92610387|NCT00142493|Anesthetics|anesthetics|mesh-ancestor
93316168|NCT03254810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93316169|NCT03254810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93316170|NCT03254810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93316171|NCT03255044|Atorvastatin|atorvastatin|mesh-list
93316172|NCT03255044|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93316173|NCT03255044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92610394|NCT00142493|Anticonvulsants|anticonvulsants|mesh-ancestor
93316174|NCT03255044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93316175|NCT03255044|Antimetabolites|antimetabolites|mesh-ancestor
93316176|NCT03255044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316177|NCT03255044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93316178|NCT03255044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93316179|NCT03255044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316180|NCT00677079|Iniparib|iniparib|mesh-list
93316181|NCT00677079|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93316182|NCT00677079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316183|NCT00677079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316184|NCT00677079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316185|NCT03245996|Atenolol|atenolol|mesh-list
93316186|NCT03245996|Nebivolol|nebivolol|mesh-list
93316187|NCT03245996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92610408|NCT04511299|SMOFlipid|smoflipid|mesh-list
93316188|NCT03245996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93316189|NCT03245996|Sympatholytics|sympatholytics|mesh-ancestor
93316190|NCT03245996|Autonomic Agents|autonomic agents|mesh-ancestor
93316191|NCT03245996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316192|NCT03245996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316193|NCT03245996|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93316194|NCT03245996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93316195|NCT03245996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93316196|NCT03245996|Adrenergic Agents|adrenergic agents|mesh-ancestor
93316197|NCT03245996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316198|NCT03245996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316199|NCT03245996|Vasodilator Agents|vasodilator agents|mesh-ancestor
93316200|NCT03245996|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93316201|NCT03245996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93316202|NCT03245996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93316203|NCT02281929|Amoxicillin|amoxicillin|mesh-list
93316204|NCT02281929|Clavulanic Acids|clavulanic acids|mesh-list
93316205|NCT02281929|Clavulanic Acid|clavulanic acid|mesh-list
93316206|NCT02281929|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93316207|NCT02281929|Prednisolone|prednisolone|mesh-list
93316208|NCT02281929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92610421|NCT00142610|Vitamins|vitamins|mesh-list
93316209|NCT02281929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316210|NCT02281929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93316211|NCT02281929|Glucocorticoids|glucocorticoids|mesh-ancestor
93316212|NCT02281929|Hormones|hormones|mesh-ancestor
93316213|NCT02281929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316214|NCT02281929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316215|NCT02281929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93316216|NCT02281929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316217|NCT02281929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316218|NCT02281929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316219|NCT02281929|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93316220|NCT04424056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93316221|NCT04424056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93316222|NCT05478772|Fluconazole|fluconazole|mesh-list
93316223|NCT05478772|Antifungal Agents|antifungal agents|mesh-ancestor
93316224|NCT05478772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316225|NCT05478772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93316226|NCT05478772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93316227|NCT05478772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316228|NCT05478772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316229|NCT05478772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93316230|NCT05478772|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316231|NCT05478772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316232|NCT05478772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316233|NCT05478772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93316234|NCT05478772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93316236|NCT02945852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610451|NCT00142727|Methadone|methadone|mesh-list
93316237|NCT02945852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93316238|NCT02945852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316239|NCT02945852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316240|NCT03245528|Angiotensin II|angiotensin ii|mesh-list
93316241|NCT03245528|Giapreza|giapreza|mesh-list
93316242|NCT03245528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93316243|NCT00495885|Volinanserin|volinanserin|mesh-list
93316244|NCT00495885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93316245|NCT00495885|Serotonin Agents|serotonin agents|mesh-ancestor
93316246|NCT00495885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316247|NCT00495885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316248|NCT00495885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316249|NCT03254186|Propranolol|propranolol|mesh-list
93316250|NCT03254186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92610461|NCT04510402|Povidone-Iodine|povidone-iodine|mesh-list
93316251|NCT03254186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93316252|NCT03254186|Adrenergic Agents|adrenergic agents|mesh-ancestor
93316253|NCT03254186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316254|NCT03254186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316255|NCT03254186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316256|NCT03254186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93316257|NCT03254186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93316258|NCT03254186|Vasodilator Agents|vasodilator agents|mesh-ancestor
93316259|NCT00589875|Valacyclovir|valacyclovir|mesh-list
93316260|NCT00589875|Antiviral Agents|antiviral agents|mesh-ancestor
93316261|NCT00589875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316262|NCT03250598|Mitapivat|mitapivat|mesh-list
93316263|NCT03250598|Enzyme Activators|enzyme activators|mesh-ancestor
93316264|NCT03250598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316265|NCT05483062|Fluorides|fluorides|mesh-list
93316266|NCT05483062|Tin Fluorides|tin fluorides|mesh-list
93316267|NCT05483062|Cariostatic Agents|cariostatic agents|mesh-ancestor
93316268|NCT05483062|Protective Agents|protective agents|mesh-ancestor
93316269|NCT05483062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316270|NCT02282085|Olanzapine|olanzapine|mesh-list
93316271|NCT02282085|Risperidone|risperidone|mesh-list
93316272|NCT02282085|Aripiprazole|aripiprazole|mesh-list
93316273|NCT02282085|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93316274|NCT02282085|Ziprasidone|ziprasidone|mesh-list
93316275|NCT02282085|Antipsychotic Agents|antipsychotic agents|mesh-list
93316276|NCT02282085|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93316277|NCT02282085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93316278|NCT02282085|Serotonin Agents|serotonin agents|mesh-ancestor
93316279|NCT02282085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316280|NCT02282085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316281|NCT02282085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316282|NCT02282085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93316283|NCT02282085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316284|NCT02282085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93316285|NCT02282085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93316286|NCT02282085|Dopamine Agents|dopamine agents|mesh-ancestor
93316287|NCT02282085|Antiemetics|antiemetics|mesh-ancestor
93316288|NCT02282085|Autonomic Agents|autonomic agents|mesh-ancestor
93316289|NCT02282085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017596|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
93316290|NCT02282085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316291|NCT02282085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93316292|NCT02282085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93316293|NCT02282085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316294|NCT02282085|Antidepressive Agents|antidepressive agents|mesh-ancestor
93316295|NCT02282085|Dopamine Agonists|dopamine agonists|mesh-ancestor
92988295|NCT00191113|Hormones|hormones|mesh-ancestor
93316296|NCT02282085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93316297|NCT02282085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92730102|NCT02219178|Bortezomib|bortezomib|mesh-list
93316298|NCT02282085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93316299|NCT02282085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93316300|NCT02282085|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93316301|NCT02282085|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93316302|NCT02282085|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93316303|NCT02282085|Adrenergic Agents|adrenergic agents|mesh-ancestor
93316304|NCT03244592|Minocycline|minocycline|mesh-list
93316305|NCT03244592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93316306|NCT03244592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316307|NCT03253328|Acetylcysteine|acetylcysteine|mesh-list
93316308|NCT03253328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93316309|NCT03253328|Antiviral Agents|antiviral agents|mesh-ancestor
93316310|NCT03253328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316311|NCT03253328|Expectorants|expectorants|mesh-ancestor
93316312|NCT03253328|Respiratory System Agents|respiratory system agents|mesh-ancestor
93316313|NCT03253328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93316314|NCT03253328|Antioxidants|antioxidants|mesh-ancestor
93316315|NCT03253328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316316|NCT03253328|Protective Agents|protective agents|mesh-ancestor
92610521|NCT04517851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316317|NCT03253328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316318|NCT03253328|Antidotes|antidotes|mesh-ancestor
93316319|NCT03253250|Tenofovir|tenofovir|mesh-list
93316320|NCT03253250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93316321|NCT03253250|Entecavir|entecavir|mesh-list
93316322|NCT03253250|Adefovir|adefovir|mesh-list
93316323|NCT03253250|Antiviral Agents|antiviral agents|mesh-ancestor
93316324|NCT03253250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316325|NCT03253250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93316326|NCT03253250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93316327|NCT03253250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316328|NCT03253250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316329|NCT03253250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93316330|NCT03253250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93316331|NCT03253562|Metformin|metformin|mesh-list
93316332|NCT03253562|Vildagliptin|vildagliptin|mesh-list
93316333|NCT03253562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93316334|NCT03253562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316335|NCT03253562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93316336|NCT03253562|Protease Inhibitors|protease inhibitors|mesh-ancestor
93316337|NCT03253562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316338|NCT03253562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316339|NCT03250052|Linagliptin|linagliptin|mesh-list
93316340|NCT03250052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93316341|NCT03250052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316342|NCT03250052|Incretins|incretins|mesh-ancestor
93316343|NCT03250052|Hormones|hormones|mesh-ancestor
93316344|NCT03250052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610544|NCT00143000|Ribavirin|ribavirin|mesh-list
93316345|NCT03250052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93316346|NCT03250052|Protease Inhibitors|protease inhibitors|mesh-ancestor
93316347|NCT03250052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316348|NCT03250052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316349|NCT05478382|Pregabalin|pregabalin|mesh-list
93316350|NCT05478382|Analgesics|analgesics|mesh-ancestor
93316351|NCT05478382|Sensory System Agents|sensory system agents|mesh-ancestor
93316352|NCT05478382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316353|NCT05478382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316354|NCT05478382|Anticonvulsants|anticonvulsants|mesh-ancestor
93316355|NCT05478382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610558|NCT04514029|Glucocorticoids|glucocorticoids|mesh-ancestor
93316356|NCT05478382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316357|NCT05478382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316358|NCT05478382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731017|NCT04544228|Ketamine|ketamine|mesh-list
93316359|NCT05478382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93316360|NCT05478382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610561|NCT04514029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93316361|NCT05478382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316362|NCT05478382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93316363|NCT03244358|Epalrestat|epalrestat|mesh-list
93316364|NCT03244358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316365|NCT03244358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316366|NCT03249740|Sunitinib|sunitinib|mesh-list
93316367|NCT03249740|Aflibercept|aflibercept|mesh-list
93316368|NCT03249740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316369|NCT03249740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93316370|NCT03249740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92731314|NCT01682421|BB 1101|bb 1101|mesh-list
93316371|NCT03249740|Growth Substances|growth substances|mesh-ancestor
93316372|NCT03249740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316373|NCT03249740|Growth Inhibitors|growth inhibitors|mesh-ancestor
93316374|NCT03249740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93316375|NCT03249740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316376|NCT03249740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316377|NCT03057977|Empagliflozin|empagliflozin|mesh-list
93316378|NCT03057977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93316379|NCT03057977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316380|NCT03057977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93316381|NCT03057977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316382|NCT03249506|Dapagliflozin|dapagliflozin|mesh-list
93316383|NCT03249506|Empagliflozin|empagliflozin|mesh-list
93316384|NCT03249506|Canagliflozin|canagliflozin|mesh-list
93316385|NCT03249506|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93316386|NCT03249506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92610582|NCT00506506|Antiviral Agents|antiviral agents|mesh-ancestor
93316388|NCT03249506|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93316389|NCT03249506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93316390|NCT03249506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316391|NCT03249506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93316392|NCT03249506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316393|NCT03249506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316394|NCT03249506|Hormones|hormones|mesh-ancestor
93316395|NCT03249506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316396|NCT03249506|Incretins|incretins|mesh-ancestor
93316397|NCT03249506|Protease Inhibitors|protease inhibitors|mesh-ancestor
93316398|NCT03249506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316399|NCT03249662|Bupivacaine|bupivacaine|mesh-list
93316400|NCT03249662|Anesthetics, Local|anesthetics, local|mesh-ancestor
93316401|NCT03249662|Anesthetics|anesthetics|mesh-ancestor
93316402|NCT03249662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316403|NCT03249662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316404|NCT03249662|Sensory System Agents|sensory system agents|mesh-ancestor
93316405|NCT03249662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316406|NCT03249428|Nicotine|nicotine|mesh-list
93316407|NCT03249428|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93316408|NCT03249428|Autonomic Agents|autonomic agents|mesh-ancestor
93316409|NCT03249428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316410|NCT03249428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316411|NCT03249428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93316412|NCT03249428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93316413|NCT03249428|Cholinergic Agents|cholinergic agents|mesh-ancestor
93316414|NCT03249428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316415|NCT03249428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316416|NCT03243500|Lidocaine|lidocaine|mesh-list
93316417|NCT03243500|Bupivacaine|bupivacaine|mesh-list
93316418|NCT03243500|Atracurium|atracurium|mesh-list
93316419|NCT03243500|Anesthetics, Local|anesthetics, local|mesh-ancestor
93316420|NCT03243500|Anesthetics|anesthetics|mesh-ancestor
93316421|NCT03243500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316422|NCT03243500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316423|NCT03243500|Sensory System Agents|sensory system agents|mesh-ancestor
93316424|NCT03243500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316425|NCT03243500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93316426|NCT03243500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93316427|NCT03243500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93316428|NCT03243500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316429|NCT03243500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316430|NCT03243500|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93316431|NCT03243500|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93316432|NCT03243500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93316433|NCT03243500|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93316434|NCT03243500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93316435|NCT03243500|Cholinergic Agents|cholinergic agents|mesh-ancestor
93316436|NCT03243500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316437|NCT03238898|Botulinum Toxins|botulinum toxins|mesh-list
93316438|NCT03238898|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93316439|NCT03238898|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93316440|NCT03238898|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93316441|NCT03238898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92732203|NCT05126121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93316442|NCT03238898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316443|NCT03238898|Cholinergic Agents|cholinergic agents|mesh-ancestor
93316444|NCT03238898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316445|NCT03238898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316446|NCT03238898|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93316447|NCT03238898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316448|NCT03249194|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93316449|NCT03249194|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93316450|NCT03249194|Antiviral Agents|antiviral agents|mesh-list
93316451|NCT03249194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316452|NCT04486508|Heparin|heparin|mesh-list
93316453|NCT04486508|Calcium heparin|calcium heparin|mesh-list
93316454|NCT04486508|Enoxaparin|enoxaparin|mesh-list
93316455|NCT04486508|Enoxaparin sodium|enoxaparin sodium|mesh-list
93316456|NCT04486508|Atorvastatin|atorvastatin|mesh-list
93316457|NCT04486508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93316458|NCT04486508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93316459|NCT04486508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93316460|NCT04486508|Antimetabolites|antimetabolites|mesh-ancestor
93316461|NCT04486508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316462|NCT04486508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93316463|NCT04486508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316464|NCT04486508|Anticoagulants|anticoagulants|mesh-ancestor
93316465|NCT04486508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93316466|NCT04486508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93316467|NCT02552212|Certolizumab Pegol|certolizumab pegol|mesh-list
92732623|NCT01177540|Decitabine|decitabine|mesh-list
93316468|NCT02552212|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93316469|NCT02552212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93316470|NCT02552212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93316471|NCT02552212|Immunologic Factors|immunologic factors|mesh-ancestor
93316472|NCT02552212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316473|NCT02552212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732758|NCT01641224|Pinaverium|pinaverium|mesh-list
93316474|NCT02454764|Interferons|interferons|mesh-list
93316475|NCT02454764|Tenofovir|tenofovir|mesh-list
93316476|NCT02454764|Interferon-alpha|interferon-alpha|mesh-list
93316477|NCT02454764|Interferon alpha-2|interferon alpha-2|mesh-list
93316478|NCT02454764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316479|NCT02454764|Antiviral Agents|antiviral agents|mesh-ancestor
93316480|NCT02454764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316481|NCT02454764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92732892|NCT04488237|Vitamins|vitamins|mesh-ancestor
93316482|NCT02454764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93316483|NCT02454764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316484|NCT02454764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316485|NCT02454764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92610664|NCT00143351|Serotonin Agents|serotonin agents|mesh-ancestor
93316486|NCT02454764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93316487|NCT02454764|Immunologic Factors|immunologic factors|mesh-ancestor
93316488|NCT02454764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316489|NCT00685919|Carbidopa|carbidopa|mesh-list
93316490|NCT00685919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93316491|NCT00685919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93316492|NCT00685919|Dopamine Agents|dopamine agents|mesh-ancestor
93316493|NCT00685919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316494|NCT00685919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610672|NCT00143351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93316495|NCT00685919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316496|NCT00685919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93316497|NCT00685919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316498|NCT03243344|Surgiflo|surgiflo|mesh-list
93316499|NCT03243344|Hemostatics|hemostatics|mesh-ancestor
93316500|NCT03243344|Coagulants|coagulants|mesh-ancestor
93316501|NCT03243032|Ibuprofen|ibuprofen|mesh-list
93316502|NCT03243032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93316503|NCT03243032|Anesthetics|anesthetics|mesh-list
93316504|NCT03243032|Anesthetics, Local|anesthetics, local|mesh-list
93316505|NCT03243032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610684|NCT02598583|Immunologic Factors|immunologic factors|mesh-ancestor
93316506|NCT03243032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316507|NCT03243032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93316508|NCT03243032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93316509|NCT03243032|Analgesics|analgesics|mesh-ancestor
93316510|NCT03243032|Sensory System Agents|sensory system agents|mesh-ancestor
93316511|NCT03243032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316512|NCT03243032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93316513|NCT03243032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93316514|NCT03243032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610692|NCT02598895|Tubulin Modulators|tubulin modulators|mesh-ancestor
93316515|NCT03243032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316516|NCT03249038|Chrysarobin|chrysarobin|mesh-list
93316517|NCT03249038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93316518|NCT03249038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93316519|NCT03249038|Analgesics|analgesics|mesh-ancestor
93316520|NCT03249038|Sensory System Agents|sensory system agents|mesh-ancestor
93316521|NCT03249038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610698|NCT05147272|Antimetabolites|antimetabolites|mesh-ancestor
93316522|NCT03249038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316523|NCT03249038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93316524|NCT03249038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93316525|NCT03061331|Ivacaftor|ivacaftor|mesh-list
93316526|NCT03061331|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92610701|NCT00143546|Defibrotide|defibrotide|mesh-list
93316527|NCT03061331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316528|NCT03061331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316529|NCT00700778|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93316530|NCT00700778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93316531|NCT00700778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316532|NCT05213585|Ivermectin|ivermectin|mesh-list
93316533|NCT05213585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93316534|NCT05213585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316535|NCT01568177|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
93316536|NCT01568177|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93316537|NCT01568177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316538|NCT05482282|Vaccines|vaccines|mesh-list
93316539|NCT05482282|Immunologic Factors|immunologic factors|mesh-ancestor
93316540|NCT05482282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316541|NCT05209529|Durvalumab|durvalumab|mesh-list
93316542|NCT05209529|Olaparib|olaparib|mesh-list
92610715|NCT00155883|Antidotes|antidotes|mesh-ancestor
93316543|NCT05209529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93316544|NCT05209529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316545|NCT05209529|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93316546|NCT05209529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316547|NCT05209529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316548|NCT04424134|Spironolactone|spironolactone|mesh-list
93316549|NCT04424134|Bromhexine|bromhexine|mesh-list
93316550|NCT04424134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93316551|NCT04424134|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316552|NCT04424134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316553|NCT04424134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316554|NCT04424134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93316555|NCT04424134|Diuretics|diuretics|mesh-ancestor
93316556|NCT04424134|Natriuretic Agents|natriuretic agents|mesh-ancestor
93316557|NCT04424134|Expectorants|expectorants|mesh-ancestor
93316558|NCT04424134|Respiratory System Agents|respiratory system agents|mesh-ancestor
93316559|NCT04486430|Salicylates|salicylates|mesh-list
93316560|NCT04486430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93316561|NCT04486430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93316562|NCT04486430|Analgesics|analgesics|mesh-ancestor
93316563|NCT04486430|Sensory System Agents|sensory system agents|mesh-ancestor
93316564|NCT04486430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316565|NCT04486430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316566|NCT04486430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93316567|NCT04486430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93316568|NCT04486430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93316569|NCT04486430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316570|NCT04486430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316571|NCT03248726|Bisacodyl|bisacodyl|mesh-list
93316572|NCT03248726|Cathartics|cathartics|mesh-ancestor
93316573|NCT03248726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316574|NCT03248726|Laxatives|laxatives|mesh-ancestor
93316575|NCT05208827|Vitamin D|vitamin d|mesh-list
93316576|NCT05208827|Ergocalciferols|ergocalciferols|mesh-list
93316577|NCT05208827|Cholecalciferol|cholecalciferol|mesh-list
93316578|NCT05208827|Vitamins|vitamins|mesh-list
93316579|NCT05208827|Micronutrients|micronutrients|mesh-ancestor
92610745|NCT00143702|Thiamine|thiamine|mesh-list
93316580|NCT05208827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316581|NCT05208827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93316582|NCT05208827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93316583|NCT04947059|Gemcitabine|gemcitabine|mesh-list
93316584|NCT04947059|Epirubicin|epirubicin|mesh-list
93316585|NCT04947059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93316586|NCT04947059|Antimetabolites|antimetabolites|mesh-ancestor
93316587|NCT04947059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316588|NCT04947059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316589|NCT04947059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92610756|NCT00143702|Vitamins|vitamins|mesh-ancestor
93316590|NCT04947059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93316591|NCT04947059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93316592|NCT04947059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316593|NCT05481970|Dexamethasone|dexamethasone|mesh-list
93316594|NCT05481970|Lidocaine|lidocaine|mesh-list
93316595|NCT05481970|Fentanyl|fentanyl|mesh-list
92988601|NCT00897026|Paclitaxel|paclitaxel|mesh-list
93316596|NCT05481970|Dexmedetomidine|dexmedetomidine|mesh-list
93316597|NCT05481970|Ketamine|ketamine|mesh-list
93316598|NCT05481970|Propofol|propofol|mesh-list
93316599|NCT05481970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93316600|NCT05481970|Antiemetics|antiemetics|mesh-ancestor
93316601|NCT05481970|Autonomic Agents|autonomic agents|mesh-ancestor
93316602|NCT05481970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316603|NCT05481970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316604|NCT05481970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316605|NCT05481970|Glucocorticoids|glucocorticoids|mesh-ancestor
93316606|NCT05481970|Hormones|hormones|mesh-ancestor
92734986|NCT04389294|Antibodies|antibodies|mesh-list
93316607|NCT05481970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316608|NCT05481970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93316609|NCT05481970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610771|NCT00156078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93316610|NCT05481970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316611|NCT05481970|Anesthetics, Local|anesthetics, local|mesh-ancestor
93316612|NCT05481970|Anesthetics|anesthetics|mesh-ancestor
93316613|NCT05481970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316614|NCT05481970|Sensory System Agents|sensory system agents|mesh-ancestor
92610775|NCT00506623|Capecitabine|capecitabine|mesh-list
93316615|NCT05481970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93316616|NCT05481970|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93316617|NCT05481970|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92735209|NCT00591708|Calcium|calcium|mesh-list
93316618|NCT05481970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316619|NCT05481970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93316620|NCT05481970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93316621|NCT05481970|Analgesics|analgesics|mesh-ancestor
93316622|NCT05481970|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93316623|NCT05481970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93316624|NCT05481970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93316625|NCT05481970|Adrenergic Agents|adrenergic agents|mesh-ancestor
93316626|NCT05481970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316627|NCT05481970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93316628|NCT05481970|Anesthetics, General|anesthetics, general|mesh-ancestor
92610783|NCT00506623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316629|NCT05481970|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93316630|NCT05481970|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93316631|NCT05481970|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93316632|NCT05481970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93316633|NCT05481970|Narcotics|narcotics|mesh-ancestor
93316634|NCT05481970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93316635|NCT03248648|Ketamine|ketamine|mesh-list
93316636|NCT03248648|Neostigmine|neostigmine|mesh-list
93316637|NCT03248648|Analgesics|analgesics|mesh-ancestor
93316638|NCT03248648|Sensory System Agents|sensory system agents|mesh-ancestor
93316639|NCT03248648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316640|NCT03248648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316641|NCT03248648|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93316642|NCT03248648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93316643|NCT03248648|Anesthetics, General|anesthetics, general|mesh-ancestor
93316644|NCT03248648|Anesthetics|anesthetics|mesh-ancestor
92610795|NCT02276365|Pioglitazone|pioglitazone|mesh-list
93316645|NCT03248648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316646|NCT03248648|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93316647|NCT03248648|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93316648|NCT03248648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316649|NCT03248648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316650|NCT03248648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93316651|NCT03248648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316652|NCT03248648|Cholinergic Agents|cholinergic agents|mesh-ancestor
93316653|NCT03248648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93316654|NCT03248648|Autonomic Agents|autonomic agents|mesh-ancestor
93316655|NCT03241784|Interleukin-2|interleukin-2|mesh-list
93316656|NCT03241784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316657|NCT03241784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93316658|NCT03241784|Analgesics|analgesics|mesh-ancestor
93316659|NCT03241784|Sensory System Agents|sensory system agents|mesh-ancestor
93316660|NCT03241784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316661|NCT03241784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316662|NCT03242096|Sirolimus|sirolimus|mesh-list
93316663|NCT03242096|Paclitaxel|paclitaxel|mesh-list
93316664|NCT03242096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93316665|NCT03242096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316666|NCT03242096|Tubulin Modulators|tubulin modulators|mesh-ancestor
93316667|NCT03242096|Antimitotic Agents|antimitotic agents|mesh-ancestor
93316668|NCT03242096|Mitosis Modulators|mitosis modulators|mesh-ancestor
93316669|NCT03242096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988676|NCT05225961|Aspirin|aspirin|mesh-list
93316670|NCT03242096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93316671|NCT03242096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316672|NCT03242096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93316673|NCT03242096|Antifungal Agents|antifungal agents|mesh-ancestor
93316674|NCT03242096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93316675|NCT03242096|Immunologic Factors|immunologic factors|mesh-ancestor
93316676|NCT03242096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316677|NCT03241472|Letrozole|letrozole|mesh-list
93316678|NCT03241472|Clomiphene|clomiphene|mesh-list
93316679|NCT03241472|Enclomiphene|enclomiphene|mesh-list
93316680|NCT03241472|Zuclomiphene|zuclomiphene|mesh-list
93316681|NCT03241472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316682|NCT03241472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316683|NCT03241472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93316684|NCT03241472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93316685|NCT03241472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316686|NCT03241472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93316687|NCT03241472|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316688|NCT03241472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316689|NCT03241472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316690|NCT03241472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93316691|NCT03241472|Fertility Agents|fertility agents|mesh-ancestor
93316692|NCT03241472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93316693|NCT03241472|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93316694|NCT03241472|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93316695|NCT04313075|Leronlimab|leronlimab|mesh-list
93316696|NCT04313075|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93316697|NCT04313075|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93316698|NCT04313075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316699|NCT04313075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93316700|NCT04313075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93316701|NCT04313075|Antiviral Agents|antiviral agents|mesh-ancestor
93316702|NCT04313075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316703|NCT03241550|Isavuconazole|isavuconazole|mesh-list
93316704|NCT03241550|Antifungal Agents|antifungal agents|mesh-ancestor
93316705|NCT03241550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316706|NCT03241706|Glucagon|glucagon|mesh-list
93316707|NCT03241706|Somatostatin|somatostatin|mesh-list
93316708|NCT03241706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316709|NCT03241706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316710|NCT03241706|Hormones|hormones|mesh-ancestor
93316711|NCT03241706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316712|NCT03237416|Midazolam|midazolam|mesh-list
93316713|NCT03237416|Dabigatran|dabigatran|mesh-list
93316714|NCT03237416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93316715|NCT03237416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93316716|NCT03237416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316717|NCT03237416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316718|NCT03237416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93316719|NCT03237416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93316720|NCT03237416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93316721|NCT03237416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93316722|NCT03237416|Anesthetics, General|anesthetics, general|mesh-ancestor
93316723|NCT03237416|Anesthetics|anesthetics|mesh-ancestor
93316724|NCT03237416|GABA Modulators|gaba modulators|mesh-ancestor
93316725|NCT03237416|GABA Agents|gaba agents|mesh-ancestor
93316726|NCT03237416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316727|NCT03237416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316728|NCT03237416|Antithrombins|antithrombins|mesh-ancestor
93316729|NCT03237416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93316730|NCT03237416|Protease Inhibitors|protease inhibitors|mesh-ancestor
93316731|NCT03237416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316732|NCT03237416|Anticoagulants|anticoagulants|mesh-ancestor
93316733|NCT05211011|Fosfomycin|fosfomycin|mesh-list
93316734|NCT05211011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93316735|NCT05211011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316736|NCT03312400|Danazol|danazol|mesh-list
93316737|NCT03312400|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93316738|NCT03312400|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316739|NCT03312400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316740|NCT03312400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316741|NCT03247868|Botulinum Toxins|botulinum toxins|mesh-list
93316742|NCT03247868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93316743|NCT03247868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316744|NCT03247868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316745|NCT03247868|Cholinergic Agents|cholinergic agents|mesh-ancestor
93316746|NCT03247868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610839|NCT05147857|Misoprostol|misoprostol|mesh-list
93316747|NCT03247868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316749|NCT04094519|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93316750|NCT04094519|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93316751|NCT04094519|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93316752|NCT04094519|Antimetabolites|antimetabolites|mesh-ancestor
93316753|NCT04094519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316754|NCT04094519|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92610846|NCT05147857|Oxytocics|oxytocics|mesh-ancestor
93316755|NCT04094519|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93316756|NCT04094519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316757|NCT04094519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93316758|NCT04094519|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93316759|NCT04094519|Protective Agents|protective agents|mesh-ancestor
93316760|NCT04094519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316761|NCT02189798|Imidacloprid|imidacloprid|mesh-list
93316762|NCT02189798|Cholinergic Agents|cholinergic agents|mesh-ancestor
93316763|NCT02189798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316764|NCT02189798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316765|NCT02189798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316766|NCT03107702|Melatonin|melatonin|mesh-list
93316767|NCT03107702|Antioxidants|antioxidants|mesh-ancestor
93316768|NCT03107702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316769|NCT03107702|Protective Agents|protective agents|mesh-ancestor
92610861|NCT05147194|Vasodilator Agents|vasodilator agents|mesh-ancestor
93316770|NCT03107702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316771|NCT03107702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316772|NCT02554318|Rifampin|rifampin|mesh-list
93316773|NCT02554318|Isoniazid|isoniazid|mesh-list
93316774|NCT02554318|Pyrazinamide|pyrazinamide|mesh-list
93316775|NCT02554318|Ethambutol|ethambutol|mesh-list
93316776|NCT02554318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93316777|NCT02554318|Antitubercular Agents|antitubercular agents|mesh-ancestor
93316778|NCT02554318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93316779|NCT02554318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316780|NCT02554318|Leprostatic Agents|leprostatic agents|mesh-ancestor
93316781|NCT02554318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93316782|NCT02554318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316783|NCT02554318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316784|NCT02554318|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92610877|NCT05149339|Cholecalciferol|cholecalciferol|mesh-list
93316785|NCT02554318|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93316786|NCT02554318|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93316787|NCT02554318|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93316788|NCT02554318|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93316789|NCT02554318|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93316790|NCT02554318|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93316791|NCT02554318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93316792|NCT02554318|Antimetabolites|antimetabolites|mesh-ancestor
93316793|NCT02554318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93316794|NCT03587662|Gemcitabine|gemcitabine|mesh-list
93316795|NCT03587662|Doxorubicin|doxorubicin|mesh-list
93316796|NCT03587662|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93316797|NCT03587662|Daunorubicin|daunorubicin|mesh-list
93316798|NCT03587662|Ixazomib|ixazomib|mesh-list
93316799|NCT03587662|Glycine|glycine|mesh-list
93316800|NCT03587662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93316801|NCT03587662|Antimetabolites|antimetabolites|mesh-ancestor
93316802|NCT03587662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316803|NCT03587662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316804|NCT03587662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93316805|NCT03587662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93316806|NCT03587662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93316807|NCT03587662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316808|NCT03587662|Protease Inhibitors|protease inhibitors|mesh-ancestor
93316809|NCT03587662|Glycine Agents|glycine agents|mesh-ancestor
93316810|NCT03587662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316811|NCT03587662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316812|NCT03976973|Acetylcysteine|acetylcysteine|mesh-list
93316813|NCT03976973|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93316814|NCT03976973|Antiviral Agents|antiviral agents|mesh-ancestor
93316815|NCT03976973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316816|NCT03976973|Expectorants|expectorants|mesh-ancestor
93316817|NCT03976973|Respiratory System Agents|respiratory system agents|mesh-ancestor
93316818|NCT03976973|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93316819|NCT03976973|Antioxidants|antioxidants|mesh-ancestor
93316820|NCT03976973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316821|NCT03976973|Protective Agents|protective agents|mesh-ancestor
93316822|NCT03976973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316823|NCT03976973|Antidotes|antidotes|mesh-ancestor
93316824|NCT04066751|Ivacaftor|ivacaftor|mesh-list
93316825|NCT04066751|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92610900|NCT00144287|Ritonavir|ritonavir|mesh-list
93316826|NCT04066751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93316827|NCT04066751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316828|NCT02550106|Omalizumab|omalizumab|mesh-list
93316829|NCT02550106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93316830|NCT02550106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93316831|NCT02550106|Respiratory System Agents|respiratory system agents|mesh-ancestor
93316832|NCT03237260|Vedolizumab|vedolizumab|mesh-list
93316833|NCT03237260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316834|NCT03247400|Atorvastatin|atorvastatin|mesh-list
93316835|NCT03247400|Simvastatin|simvastatin|mesh-list
93316836|NCT03247400|Calcium|calcium|mesh-list
93316837|NCT03247400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93316838|NCT03247400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316839|NCT03247400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93316840|NCT03247400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93316841|NCT03247400|Antimetabolites|antimetabolites|mesh-ancestor
93316842|NCT03247400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316843|NCT03247400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93316844|NCT03247400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93316845|NCT03247400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316846|NCT05480566|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
93316847|NCT05480566|Autonomic Agents|autonomic agents|mesh-ancestor
93316848|NCT05480566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316849|NCT05480566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316850|NCT05480566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93316851|NCT05480566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93316852|NCT05480566|Respiratory System Agents|respiratory system agents|mesh-ancestor
93316853|NCT02453516|Epinephrine|epinephrine|mesh-list
93316854|NCT02453516|Ropivacaine|ropivacaine|mesh-list
93316855|NCT02453516|Anesthetics, Local|anesthetics, local|mesh-ancestor
93316856|NCT02453516|Anesthetics|anesthetics|mesh-ancestor
93316857|NCT02453516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316858|NCT02453516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316859|NCT02453516|Sensory System Agents|sensory system agents|mesh-ancestor
93316860|NCT02453516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316861|NCT02453516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93316862|NCT02453516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93316863|NCT02453516|Adrenergic Agents|adrenergic agents|mesh-ancestor
93316864|NCT02453516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316865|NCT02453516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316866|NCT02453516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93316867|NCT02453516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93316868|NCT02453516|Autonomic Agents|autonomic agents|mesh-ancestor
93316869|NCT02453516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93316870|NCT02453516|Respiratory System Agents|respiratory system agents|mesh-ancestor
93316871|NCT02453516|Mydriatics|mydriatics|mesh-ancestor
93316872|NCT02453516|Sympathomimetics|sympathomimetics|mesh-ancestor
93316873|NCT02453516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93316874|NCT03716609|Magnesium citrate|magnesium citrate|mesh-list
93316875|NCT03716609|Citric Acid|citric acid|mesh-list
93316876|NCT03716609|Sodium Citrate|sodium citrate|mesh-list
93316877|NCT03716609|Anticoagulants|anticoagulants|mesh-ancestor
93316878|NCT03716609|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93316879|NCT03716609|Chelating Agents|chelating agents|mesh-ancestor
93316880|NCT03716609|Sequestering Agents|sequestering agents|mesh-ancestor
93316881|NCT03716609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316882|NCT03716609|Cathartics|cathartics|mesh-ancestor
93316883|NCT03716609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316884|NCT03709355|Clarithromycin|clarithromycin|mesh-list
93316885|NCT03709355|Rifampin|rifampin|mesh-list
93316886|NCT03709355|Rifabutin|rifabutin|mesh-list
93316887|NCT03709355|Elsulfavirine|elsulfavirine|mesh-list
93316888|NCT03709355|Omeprazole|omeprazole|mesh-list
93316889|NCT03709355|Atorvastatin|atorvastatin|mesh-list
93316890|NCT03709355|Levonorgestrel|levonorgestrel|mesh-list
93316891|NCT03709355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93316892|NCT03709355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93316893|NCT03709355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92610959|NCT00507052|Expectorants|expectorants|mesh-ancestor
93316894|NCT03709355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93316895|NCT03709355|Antimetabolites|antimetabolites|mesh-ancestor
93316896|NCT03709355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316897|NCT03709355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93316898|NCT03709355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93316899|NCT03709355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316900|NCT03709355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93316901|NCT03709355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316902|NCT03709355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93316903|NCT03709355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93316904|NCT03709355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93316905|NCT03709355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93316906|NCT03709355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93316907|NCT03709355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93316908|NCT03709355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93316909|NCT03709355|Contraceptive Agents|contraceptive agents|mesh-ancestor
93316910|NCT03709355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93316911|NCT03709355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316912|NCT03709355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93316913|NCT03709355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93316914|NCT03709355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93316915|NCT03709355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93316916|NCT03709355|Antitubercular Agents|antitubercular agents|mesh-ancestor
93316917|NCT03709355|Leprostatic Agents|leprostatic agents|mesh-ancestor
93316918|NCT03709355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93316919|NCT03709355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93316920|NCT03709355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93316921|NCT03709355|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93316922|NCT03709355|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93316923|NCT03709355|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93316924|NCT03709355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93316925|NCT03709355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93316926|NCT03709355|Estrogens|estrogens|mesh-ancestor
93316928|NCT03709355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316929|NCT03709355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93316930|NCT03709355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93316931|NCT03709355|Antiviral Agents|antiviral agents|mesh-ancestor
93316932|NCT03709355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93316933|NCT05209217|Ketamine|ketamine|mesh-list
93316934|NCT05209217|Analgesics|analgesics|mesh-ancestor
93316935|NCT05209217|Sensory System Agents|sensory system agents|mesh-ancestor
93316936|NCT05209217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93316937|NCT05209217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316938|NCT05209217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93316939|NCT05209217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93316940|NCT05209217|Anesthetics, General|anesthetics, general|mesh-ancestor
93316941|NCT05209217|Anesthetics|anesthetics|mesh-ancestor
93316942|NCT05209217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316943|NCT05209217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93316944|NCT05209217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93316945|NCT05209217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316946|NCT05209217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316947|NCT01662310|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93316948|NCT01662310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93316949|NCT01662310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93316950|NCT01662310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93316951|NCT01662310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316952|NCT01662310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93316953|NCT01662310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93316954|NCT01662310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93316955|NCT01662310|Serotonin Agents|serotonin agents|mesh-ancestor
93316956|NCT01662310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316957|NCT01662310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316958|NCT01662310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93316959|NCT01662310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93316960|NCT01662310|Dopamine Agents|dopamine agents|mesh-ancestor
93316961|NCT00700622|Insulin|insulin|mesh-list
93316962|NCT00700622|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93316963|NCT00700622|Insulin Glargine|insulin glargine|mesh-list
93316964|NCT00700622|Insulin Lispro|insulin lispro|mesh-list
93316965|NCT00700622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93316966|NCT00700622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316967|NCT03628625|Letrozole|letrozole|mesh-list
93316968|NCT03628625|Misoprostol|misoprostol|mesh-list
93316969|NCT03628625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93316970|NCT03628625|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93316971|NCT03628625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93316972|NCT03628625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93316973|NCT03628625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316974|NCT03628625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93316975|NCT03628625|Hormone Antagonists|hormone antagonists|mesh-ancestor
93316976|NCT03628625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93316977|NCT03628625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316978|NCT03628625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93316979|NCT03628625|Abortifacient Agents|abortifacient agents|mesh-ancestor
93316980|NCT03628625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93316981|NCT03628625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93316982|NCT03628625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93316983|NCT03628625|Oxytocics|oxytocics|mesh-ancestor
93316984|NCT02553928|Memantine|memantine|mesh-list
93316985|NCT02553928|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93316986|NCT02553928|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93316987|NCT02553928|Dopamine Agents|dopamine agents|mesh-ancestor
93316988|NCT02553928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93316989|NCT02553928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93316990|NCT02553928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611064|NCT05148637|Sensory System Agents|sensory system agents|mesh-ancestor
93316991|NCT02553928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93316992|NCT02553928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93316993|NCT03908255|Vitamins|vitamins|mesh-list
93316994|NCT03908255|Micronutrients|micronutrients|mesh-ancestor
93316995|NCT03908255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93316996|NCT03246776|Triclosan|triclosan|mesh-list
93316997|NCT03246776|Halometasone|halometasone|mesh-list
93316998|NCT03246776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93316999|NCT03246776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317000|NCT03246776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93317001|NCT03246776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93317002|NCT03246776|Antimetabolites|antimetabolites|mesh-ancestor
93317003|NCT03246776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611076|NCT05148637|Anesthetics, General|anesthetics, general|mesh-ancestor
93317004|NCT03246776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93317005|NCT03246776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317006|NCT03246776|Dermatologic Agents|dermatologic agents|mesh-ancestor
93317007|NCT03246776|Glucocorticoids|glucocorticoids|mesh-ancestor
93317008|NCT03246776|Hormones|hormones|mesh-ancestor
93317009|NCT03246776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317010|NCT03246776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317011|NCT03246386|Posaconazole|posaconazole|mesh-list
93317012|NCT03246386|Antifungal Agents|antifungal agents|mesh-ancestor
93317013|NCT03246386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317014|NCT03246386|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92611079|NCT00148278|Dobutamine|dobutamine|mesh-list
93317015|NCT03246386|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93317016|NCT03246386|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93317017|NCT03246386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93317018|NCT03246386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93317019|NCT03246386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317020|NCT03246386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317021|NCT03246386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93317022|NCT03246386|Hormone Antagonists|hormone antagonists|mesh-ancestor
93317023|NCT03246386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317024|NCT03246386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317025|NCT03851081|Vincristine|vincristine|mesh-list
92611090|NCT00148278|Autonomic Agents|autonomic agents|mesh-ancestor
93317026|NCT03851081|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93317027|NCT03851081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317028|NCT03851081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317029|NCT03851081|Tubulin Modulators|tubulin modulators|mesh-ancestor
93317030|NCT03851081|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317031|NCT03851081|Mitosis Modulators|mitosis modulators|mesh-ancestor
93317032|NCT03851081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317033|NCT03851081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93317034|NCT03851081|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93317035|NCT03851081|Immunotoxins|immunotoxins|mesh-ancestor
93317036|NCT03851081|Immunoconjugates|immunoconjugates|mesh-ancestor
93317037|NCT03851081|Immunologic Factors|immunologic factors|mesh-ancestor
93317038|NCT03851081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317039|NCT03239600|Methotrexate|methotrexate|mesh-list
93317040|NCT03239600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93317041|NCT03239600|Abortifacient Agents|abortifacient agents|mesh-ancestor
93317042|NCT03239600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92611111|NCT00507247|Daptomycin|daptomycin|mesh-list
93317043|NCT03239600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317044|NCT03239600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989052|NCT04073537|Paclitaxel|paclitaxel|mesh-list
93317045|NCT03239600|Antimetabolites|antimetabolites|mesh-ancestor
93317046|NCT03239600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317047|NCT03239600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317048|NCT03239600|Dermatologic Agents|dermatologic agents|mesh-ancestor
93317049|NCT03239600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317050|NCT03239600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93317051|NCT03239600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93317052|NCT03239600|Immunologic Factors|immunologic factors|mesh-ancestor
93317053|NCT03239600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317054|NCT03239600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93317055|NCT02966093|Lenvatinib|lenvatinib|mesh-list
93317056|NCT02966093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317057|NCT02966093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93317058|NCT02966093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317059|NCT02966093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317060|NCT03229616|Cyclophosphamide|cyclophosphamide|mesh-list
93317061|NCT03229616|Busulfan|busulfan|mesh-list
93317062|NCT03229616|Etoposide|etoposide|mesh-list
93317063|NCT03229616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93317064|NCT03229616|Immunologic Factors|immunologic factors|mesh-ancestor
93317065|NCT03229616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317066|NCT03229616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317067|NCT03229616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93317068|NCT03229616|Alkylating Agents|alkylating agents|mesh-ancestor
93317069|NCT03229616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317070|NCT03229616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317071|NCT03229616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93317072|NCT03229616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317073|NCT03229616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93317074|NCT03229616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93317075|NCT03229616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317076|NCT03234764|Immunomodulating Agents|immunomodulating agents|mesh-list
93317077|NCT03234764|Immunologic Factors|immunologic factors|mesh-ancestor
93317078|NCT03234764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317079|NCT03234842|Paclitaxel|paclitaxel|mesh-list
93317080|NCT03234842|Carboplatin|carboplatin|mesh-list
93317081|NCT03234842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317082|NCT03234842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317083|NCT03234842|Tubulin Modulators|tubulin modulators|mesh-ancestor
93317084|NCT03234842|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317085|NCT03234842|Mitosis Modulators|mitosis modulators|mesh-ancestor
92611152|NCT00424281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93317086|NCT03234842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317087|NCT03229148|Anesthetics|anesthetics|mesh-list
93317088|NCT03229148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317089|NCT03229148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317090|NCT03228992|Ibuprofen|ibuprofen|mesh-list
93317091|NCT03228992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93317092|NCT03228992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317093|NCT03228992|Analgesics|analgesics|mesh-ancestor
93317094|NCT03228992|Sensory System Agents|sensory system agents|mesh-ancestor
93317095|NCT03228992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317096|NCT03228992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317097|NCT03228992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317098|NCT03228992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317099|NCT03228992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93317100|NCT03228992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317101|NCT03228992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317102|NCT02452502|Atorvastatin|atorvastatin|mesh-list
93317103|NCT02452502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93317104|NCT02452502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93317105|NCT02452502|Antimetabolites|antimetabolites|mesh-ancestor
93317106|NCT02452502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317107|NCT02452502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93317108|NCT02452502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93317109|NCT02452502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317110|NCT03234296|Metronidazole|metronidazole|mesh-list
93317111|NCT03234296|Levofloxacin|levofloxacin|mesh-list
93317112|NCT03234296|Ertapenem|ertapenem|mesh-list
93317113|NCT03234296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317114|NCT03234296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93317115|NCT03234296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93317116|NCT03234296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93317117|NCT03234296|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93317118|NCT03234296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92989120|NCT00493636|Gemcitabine|gemcitabine|mesh-list
93317119|NCT03234296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92611191|NCT03451825|Avelumab|avelumab|mesh-list
93317120|NCT03234296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317121|NCT03234296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317122|NCT03234296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317123|NCT03234296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93317124|NCT03234296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93317125|NCT03228368|Atezolizumab|atezolizumab|mesh-list
93317126|NCT03228368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93317127|NCT03228368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317128|NCT03228368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93317129|NCT03228368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317130|NCT03665129|Avdoralimab|avdoralimab|mesh-list
93317131|NCT03665129|Durvalumab|durvalumab|mesh-list
93317132|NCT03665129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93317133|NCT03665129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317134|NCT03665129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317135|NCT03665129|Antiviral Agents|antiviral agents|mesh-ancestor
93317136|NCT03665129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317137|NCT03235700|Nicorandil|nicorandil|mesh-list
93317138|NCT03235700|Adenosine|adenosine|mesh-list
93317139|NCT03235700|Analgesics|analgesics|mesh-ancestor
93317140|NCT03235700|Sensory System Agents|sensory system agents|mesh-ancestor
93317141|NCT03235700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317142|NCT03235700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317143|NCT03235700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93317144|NCT03235700|Vasodilator Agents|vasodilator agents|mesh-ancestor
93317145|NCT03235700|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93317146|NCT03235700|Purinergic Agonists|purinergic agonists|mesh-ancestor
93317147|NCT03235700|Purinergic Agents|purinergic agents|mesh-ancestor
93317148|NCT03235700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317149|NCT03235700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317150|NCT03235700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93317151|NCT03235700|Vitamin B Complex|vitamin b complex|mesh-ancestor
93317152|NCT03235700|Vitamins|vitamins|mesh-ancestor
93317153|NCT03235700|Micronutrients|micronutrients|mesh-ancestor
93317154|NCT03234062|Choline|choline|mesh-list
93317155|NCT03234062|Lipotropic Agents|lipotropic agents|mesh-ancestor
93317156|NCT03234062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93317157|NCT03234062|Antimetabolites|antimetabolites|mesh-ancestor
92611226|NCT00156975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93317158|NCT03234062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317159|NCT03234062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317160|NCT03234062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93317161|NCT03234062|Nootropic Agents|nootropic agents|mesh-ancestor
93317162|NCT05702879|Prednisolone|prednisolone|mesh-list
93317163|NCT05702879|Adalimumab|adalimumab|mesh-list
93317164|NCT05702879|Infliximab|infliximab|mesh-list
93317165|NCT05702879|Etanercept|etanercept|mesh-list
93317166|NCT05702879|Golimumab|golimumab|mesh-list
93317167|NCT05702879|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93317168|NCT05702879|Ustekinumab|ustekinumab|mesh-list
93317169|NCT05702879|Vedolizumab|vedolizumab|mesh-list
93317170|NCT05702879|Ozanimod|ozanimod|mesh-list
93317171|NCT05702879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317172|NCT05702879|Glucocorticoids|glucocorticoids|mesh-ancestor
93317173|NCT05702879|Hormones|hormones|mesh-ancestor
92611243|NCT00148473|Oxytocics|oxytocics|mesh-ancestor
93317174|NCT05702879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317175|NCT05702879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317176|NCT05702879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93317177|NCT05702879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611244|NCT00507637|Botulinum Toxins|botulinum toxins|mesh-list
93317178|NCT05702879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317179|NCT05702879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317180|NCT05702879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317181|NCT05702879|Dermatologic Agents|dermatologic agents|mesh-ancestor
93317182|NCT05702879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611251|NCT00507637|Cholinergic Agents|cholinergic agents|mesh-ancestor
93317183|NCT05702879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317184|NCT05702879|Analgesics|analgesics|mesh-ancestor
93317185|NCT05702879|Sensory System Agents|sensory system agents|mesh-ancestor
93317186|NCT05702879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93317187|NCT05702879|Immunologic Factors|immunologic factors|mesh-ancestor
93317188|NCT05702879|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93317189|NCT05702879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317190|NCT03235778|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
93317191|NCT03235778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93317192|NCT03235778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317193|NCT03235778|Analgesics|analgesics|mesh-ancestor
93317194|NCT03235778|Sensory System Agents|sensory system agents|mesh-ancestor
93317195|NCT03235778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317196|NCT03235778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317197|NCT03235778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317198|NCT03235778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317199|NCT04439513|Hemostatics|hemostatics|mesh-list
93317200|NCT04439513|Coagulants|coagulants|mesh-ancestor
93317201|NCT02452970|Gemcitabine|gemcitabine|mesh-list
93317202|NCT02452970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317203|NCT02452970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93317204|NCT02452970|Antimetabolites|antimetabolites|mesh-ancestor
93317205|NCT02452970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317206|NCT03227900|Lidocaine|lidocaine|mesh-list
93317207|NCT03227900|Anesthetics, Local|anesthetics, local|mesh-ancestor
93317208|NCT03227900|Anesthetics|anesthetics|mesh-ancestor
93317209|NCT03227900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317210|NCT03227900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317211|NCT03227900|Sensory System Agents|sensory system agents|mesh-ancestor
93317212|NCT03227900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317213|NCT03227900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93317214|NCT03227900|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93317215|NCT03227900|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92611265|NCT05594342|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317216|NCT03227900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317217|NCT03227900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317218|NCT03120182|Aspirin|aspirin|mesh-list
93317219|NCT03120182|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93317220|NCT03120182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317221|NCT03120182|Analgesics|analgesics|mesh-ancestor
93317222|NCT03120182|Sensory System Agents|sensory system agents|mesh-ancestor
93317223|NCT03120182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317224|NCT03120182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317225|NCT03120182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317226|NCT03120182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317227|NCT03120182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93317228|NCT03120182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93317229|NCT03120182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611271|NCT00507793|Cyclosporine|cyclosporine|mesh-list
93317230|NCT03120182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93317231|NCT03120182|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93317232|NCT03120182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317233|NCT03120182|Antipyretics|antipyretics|mesh-ancestor
93317234|NCT02074436|Aminocaproic Acid|aminocaproic acid|mesh-list
93317235|NCT02074436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93317236|NCT02074436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93317237|NCT02074436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317238|NCT02074436|Hemostatics|hemostatics|mesh-ancestor
93317239|NCT02074436|Coagulants|coagulants|mesh-ancestor
93317240|NCT03227432|Dexamethasone|dexamethasone|mesh-list
93317241|NCT03227432|Nivolumab|nivolumab|mesh-list
93317242|NCT03227432|Pomalidomide|pomalidomide|mesh-list
93317243|NCT03227432|Elotuzumab|elotuzumab|mesh-list
93317244|NCT03227432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317245|NCT03227432|Antiemetics|antiemetics|mesh-ancestor
93317246|NCT03227432|Autonomic Agents|autonomic agents|mesh-ancestor
93317247|NCT03227432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018342|NCT01653327|Analgesics|analgesics|mesh-ancestor
93317248|NCT03227432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317249|NCT03227432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317250|NCT03227432|Glucocorticoids|glucocorticoids|mesh-ancestor
93317251|NCT03227432|Hormones|hormones|mesh-ancestor
93317252|NCT03227432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317253|NCT03227432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93317254|NCT03227432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317255|NCT03227432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93317256|NCT03227432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93317257|NCT03227432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317258|NCT03227432|Immunologic Factors|immunologic factors|mesh-ancestor
93317259|NCT03227432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93317260|NCT03227432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93317261|NCT03227432|Growth Substances|growth substances|mesh-ancestor
93317262|NCT03227432|Growth Inhibitors|growth inhibitors|mesh-ancestor
93317263|NCT03222518|Acetaminophen|acetaminophen|mesh-list
93317264|NCT03222518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93317265|NCT03222518|Piroxicam|piroxicam|mesh-list
93317266|NCT03222518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317267|NCT03222518|Analgesics|analgesics|mesh-ancestor
93317268|NCT03222518|Sensory System Agents|sensory system agents|mesh-ancestor
93317269|NCT03222518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317270|NCT03222518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317271|NCT03222518|Antipyretics|antipyretics|mesh-ancestor
93317272|NCT03222518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317273|NCT03222518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317274|NCT03222518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93317275|NCT03222518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317276|NCT03222518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317277|NCT01750281|Docetaxel|docetaxel|mesh-list
93317278|NCT01750281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317279|NCT01750281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92740727|NCT01090414|Idelalisib|idelalisib|mesh-list
93317280|NCT01750281|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317281|NCT01750281|Mitosis Modulators|mitosis modulators|mesh-ancestor
93317282|NCT01750281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317283|NCT03222206|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
93317284|NCT03222206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93317285|NCT03222206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317286|NCT03222206|Analgesics|analgesics|mesh-ancestor
93317287|NCT03222206|Sensory System Agents|sensory system agents|mesh-ancestor
93317288|NCT03222206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317289|NCT03222206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317290|NCT03222206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317291|NCT03222206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317292|NCT03221816|Folic Acid|folic acid|mesh-list
93317293|NCT03221816|Pyridoxine|pyridoxine|mesh-list
93317294|NCT03221816|Vitamin B 12|vitamin b 12|mesh-list
93317295|NCT03221816|Hematinics|hematinics|mesh-ancestor
93317296|NCT03221816|Vitamin B Complex|vitamin b complex|mesh-ancestor
93317297|NCT03221816|Vitamins|vitamins|mesh-ancestor
93317298|NCT03221816|Micronutrients|micronutrients|mesh-ancestor
93317299|NCT03221816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317300|NCT03119636|Levodopa|levodopa|mesh-list
93317301|NCT03119636|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93317302|NCT03119636|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93317303|NCT03119636|Dopamine Agents|dopamine agents|mesh-ancestor
93317304|NCT03119636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741099|NCT01011673|Ketorolac|ketorolac|mesh-list
93317305|NCT03119636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317306|NCT03119636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317307|NCT03226340|Niacin|niacin|mesh-list
93317308|NCT03226340|Amlodipine|amlodipine|mesh-list
93317309|NCT03226340|Telmisartan|telmisartan|mesh-list
93317310|NCT03226340|Chlorthalidone|chlorthalidone|mesh-list
93317311|NCT03226340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93317312|NCT03226340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93317313|NCT03226340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317314|NCT03226340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317315|NCT03226340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93317316|NCT03226340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317317|NCT03226340|Vasodilator Agents|vasodilator agents|mesh-ancestor
93317318|NCT03226340|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92611332|NCT00148551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611335|NCT05594186|Levonorgestrel|levonorgestrel|mesh-list
93317319|NCT03226340|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93317320|NCT03226340|Diuretics|diuretics|mesh-ancestor
93317321|NCT03226340|Natriuretic Agents|natriuretic agents|mesh-ancestor
93317322|NCT03226340|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93317323|NCT03226340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93317324|NCT03226340|Antimetabolites|antimetabolites|mesh-ancestor
93317325|NCT03226340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93317326|NCT03226340|Vitamin B Complex|vitamin b complex|mesh-ancestor
93317327|NCT03226340|Vitamins|vitamins|mesh-ancestor
93317328|NCT03226340|Micronutrients|micronutrients|mesh-ancestor
93317329|NCT03221504|Oxymetazoline|oxymetazoline|mesh-list
93317330|NCT03221504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93317331|NCT03221504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317332|NCT03221504|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317333|NCT03221504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317334|NCT03221504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317335|NCT03221504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317336|NCT03221504|Sympathomimetics|sympathomimetics|mesh-ancestor
93317337|NCT03221504|Autonomic Agents|autonomic agents|mesh-ancestor
93317338|NCT03221504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317339|NCT03221504|Nasal Decongestants|nasal decongestants|mesh-ancestor
93317340|NCT03221504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93317341|NCT03221504|Respiratory System Agents|respiratory system agents|mesh-ancestor
93317342|NCT03221582|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93317343|NCT03221582|Antiviral Agents|antiviral agents|mesh-ancestor
93317344|NCT03221582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317345|NCT03232034|Calcium|calcium|mesh-list
93366437|NCT02422186|Dopamine Agents|dopamine agents|mesh-ancestor
93317346|NCT03232034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93317347|NCT03232034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317349|NCT03225950|Immunologic Factors|immunologic factors|mesh-ancestor
93317350|NCT03225950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317351|NCT03119948|Botulinum Toxins|botulinum toxins|mesh-list
93317352|NCT03119948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93317353|NCT03119948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317354|NCT03119948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317355|NCT03119948|Cholinergic Agents|cholinergic agents|mesh-ancestor
93317356|NCT03119948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317357|NCT03119948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317358|NCT03232112|Exenatide|exenatide|mesh-list
93317359|NCT03232112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93317360|NCT03232112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317361|NCT03232112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93317362|NCT03232112|Incretins|incretins|mesh-ancestor
93317363|NCT03232112|Hormones|hormones|mesh-ancestor
92611367|NCT02954068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93317364|NCT03232112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317365|NCT03000569|Levodopa|levodopa|mesh-list
93317366|NCT03000569|Antiparkinson Agents|antiparkinson agents|mesh-list
93317367|NCT03000569|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93317368|NCT03000569|Dopamine Agents|dopamine agents|mesh-ancestor
93317369|NCT03000569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317370|NCT03000569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317371|NCT03000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317372|NCT02554786|Fluticasone|fluticasone|mesh-list
93317373|NCT02554786|Xhance|xhance|mesh-list
92742290|NCT04319601|Rituximab|rituximab|mesh-list
93317374|NCT02554786|Mometasone Furoate|mometasone furoate|mesh-list
93317375|NCT02554786|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93317376|NCT02554786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317377|NCT02554786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93317378|NCT02554786|Autonomic Agents|autonomic agents|mesh-ancestor
93317379|NCT02554786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317380|NCT02554786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317381|NCT02554786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93317382|NCT02554786|Respiratory System Agents|respiratory system agents|mesh-ancestor
93317383|NCT02554786|Dermatologic Agents|dermatologic agents|mesh-ancestor
93317384|NCT02554786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92611382|NCT00508495|Analgesics|analgesics|mesh-ancestor
93317385|NCT02554786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93317386|NCT02554786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93317387|NCT02554786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317388|NCT02554786|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317389|NCT02554786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317390|NCT02554786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317391|NCT05202314|Immunomodulating Agents|immunomodulating agents|mesh-list
93317392|NCT05202314|Immunologic Factors|immunologic factors|mesh-ancestor
93317393|NCT05202314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317394|NCT03225326|Carticaine|carticaine|mesh-list
93317395|NCT03225326|Anesthetics, Local|anesthetics, local|mesh-ancestor
93317396|NCT03225326|Anesthetics|anesthetics|mesh-ancestor
93317397|NCT03225326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317398|NCT03225326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317399|NCT03225326|Sensory System Agents|sensory system agents|mesh-ancestor
93317400|NCT03225326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317401|NCT03220880|Dexmedetomidine|dexmedetomidine|mesh-list
93317402|NCT03220880|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93317403|NCT03220880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92611409|NCT00148746|Tacrolimus|tacrolimus|mesh-list
93317404|NCT03220880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317405|NCT03220880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317406|NCT03220880|Analgesics|analgesics|mesh-ancestor
93317407|NCT03220880|Sensory System Agents|sensory system agents|mesh-ancestor
93317408|NCT03220880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317409|NCT03220880|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93317410|NCT03220880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93317411|NCT03220880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317412|NCT03220880|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317413|NCT03220880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611417|NCT00148746|Antifungal Agents|antifungal agents|mesh-ancestor
93317414|NCT03220880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317415|NCT02929589|Ibuprofen|ibuprofen|mesh-list
93317416|NCT02929589|Analgesics, Opioid|analgesics, opioid|mesh-list
93317417|NCT02929589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93317418|NCT02929589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317419|NCT02929589|Analgesics|analgesics|mesh-ancestor
93317420|NCT02929589|Sensory System Agents|sensory system agents|mesh-ancestor
93317421|NCT02929589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317422|NCT02929589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317423|NCT02929589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317424|NCT02929589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317425|NCT02929589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93317426|NCT02929589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317427|NCT02929589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317428|NCT02929589|Narcotics|narcotics|mesh-ancestor
93317429|NCT02929589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317430|NCT02910635|Moxifloxacin|moxifloxacin|mesh-list
92611432|NCT00148785|Ritonavir|ritonavir|mesh-list
93317431|NCT02910635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93317432|NCT02910635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317433|NCT02910635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92098892|NCT01859741|Carboplatin|carboplatin|mesh-list
93317434|NCT02910635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93317435|NCT02910635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317436|NCT02910635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317437|NCT02910635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317438|NCT02614547|Brexanolone|brexanolone|mesh-list
93317439|NCT02614547|Neurosteroids|neurosteroids|mesh-ancestor
93317440|NCT02614547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317441|NCT02614547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317442|NCT02614547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317443|NCT02614547|GABA Modulators|gaba modulators|mesh-ancestor
93317444|NCT02614547|GABA Agents|gaba agents|mesh-ancestor
93317445|NCT04472481|Ergocalciferols|ergocalciferols|mesh-list
93317447|NCT04472481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92611446|NCT00148824|Vaccines|vaccines|mesh-list
92611450|NCT00466570|Moxifloxacin|moxifloxacin|mesh-list
93317448|NCT04472481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317449|NCT04472481|Vitamins|vitamins|mesh-ancestor
93317450|NCT04472481|Micronutrients|micronutrients|mesh-ancestor
93317451|NCT04472481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93317452|NCT01233297|Azithromycin|azithromycin|mesh-list
93317453|NCT01233297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93317454|NCT01233297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317455|NCT04681079|Albuterol|albuterol|mesh-list
93317456|NCT04681079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93317457|NCT04681079|Autonomic Agents|autonomic agents|mesh-ancestor
93317458|NCT04681079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317459|NCT04681079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317460|NCT04681079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93317461|NCT04681079|Respiratory System Agents|respiratory system agents|mesh-ancestor
93317462|NCT04681079|Tocolytic Agents|tocolytic agents|mesh-ancestor
93317463|NCT04681079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93317464|NCT04681079|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93317465|NCT04681079|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93317466|NCT04681079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317467|NCT04681079|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317468|NCT04681079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744152|NCT01215357|Ecopipam|ecopipam|mesh-list
93317469|NCT04681079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317470|NCT00580125|Aripiprazole|aripiprazole|mesh-list
93317471|NCT00580125|Antidepressive Agents|antidepressive agents|mesh-ancestor
93317472|NCT00580125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93317473|NCT00580125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93317474|NCT00580125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92744366|NCT00978757|Ketamine|ketamine|mesh-list
93317475|NCT00580125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317476|NCT00580125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317477|NCT00580125|Dopamine Agonists|dopamine agonists|mesh-ancestor
93317478|NCT00580125|Dopamine Agents|dopamine agents|mesh-ancestor
93317479|NCT00580125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317480|NCT00580125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317481|NCT00580125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93317482|NCT00580125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93317483|NCT00580125|Serotonin Agents|serotonin agents|mesh-ancestor
93317484|NCT00580125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93317485|NCT00580125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93317486|NCT00580125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93317487|NCT00580125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93317488|NCT01179009|Clonidine|clonidine|mesh-list
93317489|NCT01179009|Scopolamine|scopolamine|mesh-list
93317490|NCT01179009|Ketamine|ketamine|mesh-list
93317491|NCT01179009|Lorazepam|lorazepam|mesh-list
93317492|NCT01179009|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93317493|NCT01179009|Analgesics|analgesics|mesh-ancestor
93317494|NCT01179009|Sensory System Agents|sensory system agents|mesh-ancestor
93317495|NCT01179009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317496|NCT01179009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317497|NCT01179009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93317498|NCT01179009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93317499|NCT01179009|Anesthetics, General|anesthetics, general|mesh-ancestor
93317500|NCT01179009|Anesthetics|anesthetics|mesh-ancestor
93317501|NCT01179009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317502|NCT01179009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93317503|NCT01179009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93317504|NCT01179009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317505|NCT01179009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317506|NCT01179009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93317507|NCT01179009|Sympatholytics|sympatholytics|mesh-ancestor
93317508|NCT01179009|Autonomic Agents|autonomic agents|mesh-ancestor
93317509|NCT01179009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93317510|NCT01179009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93317511|NCT01179009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317512|NCT01179009|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317513|NCT01179009|Anticonvulsants|anticonvulsants|mesh-ancestor
93317514|NCT01179009|Antiemetics|antiemetics|mesh-ancestor
93317515|NCT01179009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317516|NCT01179009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93317517|NCT01179009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93317518|NCT01179009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93317519|NCT01179009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93317520|NCT01179009|GABA Modulators|gaba modulators|mesh-ancestor
93317521|NCT01179009|GABA Agents|gaba agents|mesh-ancestor
93317522|NCT01179009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93317523|NCT01179009|Mydriatics|mydriatics|mesh-ancestor
93317524|NCT01179009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93317525|NCT01179009|Cholinergic Agents|cholinergic agents|mesh-ancestor
93317526|NCT01179009|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93317527|NCT01179009|Parasympatholytics|parasympatholytics|mesh-ancestor
93317528|NCT00579189|Moxifloxacin|moxifloxacin|mesh-list
93317529|NCT00579189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93317530|NCT00579189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93317531|NCT00579189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317532|NCT00579189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93317533|NCT00579189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93317534|NCT00579189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317535|NCT00579189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317536|NCT00579189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317537|NCT00667953|Temozolomide|temozolomide|mesh-list
93317538|NCT00667953|Imatinib Mesylate|imatinib mesylate|mesh-list
93317539|NCT00667953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93317540|NCT00667953|Alkylating Agents|alkylating agents|mesh-ancestor
93317541|NCT00667953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317542|NCT00667953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317543|NCT00667953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93317544|NCT00667953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317545|NCT00578955|Azithromycin|azithromycin|mesh-list
93317546|NCT00578955|Dexamethasone|dexamethasone|mesh-list
93317547|NCT00578955|Dexamethasone acetate|dexamethasone acetate|mesh-list
93317548|NCT00578955|BB 1101|bb 1101|mesh-list
92611536|NCT00467194|Sirolimus|sirolimus|mesh-list
93317549|NCT00578955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317550|NCT00578955|Antiemetics|antiemetics|mesh-ancestor
93317551|NCT00578955|Autonomic Agents|autonomic agents|mesh-ancestor
93317552|NCT00578955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317553|NCT00578955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317554|NCT00578955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745028|NCT01193517|Decitabine|decitabine|mesh-list
93317555|NCT00578955|Glucocorticoids|glucocorticoids|mesh-ancestor
93317556|NCT00578955|Hormones|hormones|mesh-ancestor
93317557|NCT00578955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317558|NCT00578955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93317559|NCT00578955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317560|NCT00578955|Protease Inhibitors|protease inhibitors|mesh-ancestor
93317561|NCT00578955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317562|NCT00578955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317563|NCT00578955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93317564|NCT00578955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317565|NCT00576537|Immunomodulating Agents|immunomodulating agents|mesh-list
93317566|NCT00576537|Immunologic Factors|immunologic factors|mesh-ancestor
92611550|NCT00467194|Immunologic Factors|immunologic factors|mesh-ancestor
93317567|NCT00576537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317568|NCT02282241|Melatonin|melatonin|mesh-list
93317569|NCT02282241|Antioxidants|antioxidants|mesh-ancestor
93366438|NCT02796677|Bromides|bromides|mesh-list
93317570|NCT02282241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317571|NCT02282241|Protective Agents|protective agents|mesh-ancestor
93317572|NCT02282241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317573|NCT02282241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317574|NCT02424851|Thalidomide|thalidomide|mesh-list
93317575|NCT02424851|Dexamethasone|dexamethasone|mesh-list
93317576|NCT02424851|Bortezomib|bortezomib|mesh-list
93317577|NCT02424851|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93317578|NCT02424851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317579|NCT02424851|Antiemetics|antiemetics|mesh-ancestor
93317580|NCT02424851|Autonomic Agents|autonomic agents|mesh-ancestor
92611564|NCT05507645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93317581|NCT02424851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317582|NCT02424851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317583|NCT02424851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317584|NCT02424851|Glucocorticoids|glucocorticoids|mesh-ancestor
93317585|NCT02424851|Hormones|hormones|mesh-ancestor
93317586|NCT02424851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317587|NCT02424851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93317588|NCT02424851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317589|NCT02424851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93317590|NCT02424851|Alkylating Agents|alkylating agents|mesh-ancestor
93317591|NCT02424851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317592|NCT02424851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93317593|NCT02424851|Immunologic Factors|immunologic factors|mesh-ancestor
93317594|NCT02424851|Leprostatic Agents|leprostatic agents|mesh-ancestor
93317595|NCT02424851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745648|NCT05798481|Antidotes|antidotes|mesh-ancestor
93317596|NCT02424851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317597|NCT02424851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93317598|NCT02424851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93317599|NCT02424851|Growth Substances|growth substances|mesh-ancestor
93317600|NCT02424851|Growth Inhibitors|growth inhibitors|mesh-ancestor
92745731|NCT05679401|Hormones|hormones|mesh-ancestor
93317601|NCT02284035|Raltegravir Potassium|raltegravir potassium|mesh-list
93317602|NCT02284035|Lamivudine|lamivudine|mesh-list
93317603|NCT02284035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93317604|NCT02284035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93317605|NCT02284035|Antiviral Agents|antiviral agents|mesh-ancestor
93317606|NCT02284035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317607|NCT02284035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93317608|NCT02284035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93317609|NCT02284035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317610|NCT02284035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611595|NCT00467506|Antibodies|antibodies|mesh-list
93317611|NCT02284035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93317612|NCT02284035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93317613|NCT00484419|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93317614|NCT00484419|Rosiglitazone|rosiglitazone|mesh-list
93317615|NCT00484419|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93317616|NCT00484419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93317617|NCT00484419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317618|NCT00484419|Incretins|incretins|mesh-ancestor
93317619|NCT00484419|Hormones|hormones|mesh-ancestor
93317620|NCT00484419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317621|NCT00484419|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93317622|NCT00484419|Protease Inhibitors|protease inhibitors|mesh-ancestor
93317623|NCT00484419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317624|NCT00484419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317625|NCT00484419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93317626|NCT00484419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93317627|NCT00484419|Antimetabolites|antimetabolites|mesh-ancestor
93317628|NCT00484419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93317629|NCT02273895|Scopolamine|scopolamine|mesh-list
93317630|NCT02273895|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93317631|NCT02273895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93317632|NCT02273895|Antiemetics|antiemetics|mesh-ancestor
93317633|NCT02273895|Autonomic Agents|autonomic agents|mesh-ancestor
93317634|NCT02273895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611621|NCT00149019|Antibodies|antibodies|mesh-list
93317635|NCT02273895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317636|NCT02273895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317637|NCT02273895|Mydriatics|mydriatics|mesh-ancestor
93317638|NCT02273895|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93317639|NCT02273895|Cholinergic Agents|cholinergic agents|mesh-ancestor
93317640|NCT02273895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317641|NCT02273895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317642|NCT02273895|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93317643|NCT02273895|Parasympatholytics|parasympatholytics|mesh-ancestor
93317644|NCT00480831|Paclitaxel|paclitaxel|mesh-list
93317646|NCT00480831|Carboplatin|carboplatin|mesh-list
93317647|NCT00480831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317648|NCT00480831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317649|NCT00480831|Tubulin Modulators|tubulin modulators|mesh-ancestor
93317650|NCT00480831|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317651|NCT00480831|Mitosis Modulators|mitosis modulators|mesh-ancestor
93317652|NCT00480831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317653|NCT00480831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93317654|NCT00480831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93317655|NCT00480831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93317656|NCT00480831|Growth Substances|growth substances|mesh-ancestor
93317657|NCT00480831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317658|NCT00480831|Growth Inhibitors|growth inhibitors|mesh-ancestor
93317659|NCT02549092|Levodopa|levodopa|mesh-list
93317660|NCT02549092|Carbidopa|carbidopa|mesh-list
93317661|NCT02549092|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93317662|NCT02549092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92611646|NCT00468364|Isophane insulin, beef|isophane insulin, beef|mesh-list
93317663|NCT02549092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93317664|NCT02549092|Dopamine Agents|dopamine agents|mesh-ancestor
93317665|NCT02549092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317666|NCT02549092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317667|NCT02549092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611649|NCT00149058|Epoetin Alfa|epoetin alfa|mesh-list
93317668|NCT02549092|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92611655|NCT03271450|Warfarin|warfarin|mesh-list
93317669|NCT02549092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317670|NCT02549092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93317671|NCT02549092|Immunologic Factors|immunologic factors|mesh-ancestor
93317672|NCT02549092|Dopamine Agonists|dopamine agonists|mesh-ancestor
93317673|NCT03220256|Lamotrigine|lamotrigine|mesh-list
93317674|NCT03220256|Anticonvulsants|anticonvulsants|mesh-ancestor
93317675|NCT03220256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93317676|NCT03220256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317677|NCT03220256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317678|NCT03220256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93317679|NCT03220256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317680|NCT03220256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93317681|NCT03220256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93317682|NCT03220256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317683|NCT03220256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92018681|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
93317684|NCT03220256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93317685|NCT03220490|Timolol|timolol|mesh-list
93317686|NCT03220490|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92611670|NCT00468871|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93317687|NCT03220490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92611673|NCT00468871|Glucocorticoids|glucocorticoids|mesh-ancestor
93317688|NCT03220490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93317689|NCT03220490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317690|NCT03220490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317691|NCT03220490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317692|NCT03220490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317693|NCT03220490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93317694|NCT03220490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93317695|NCT03220490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93317696|NCT03220490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93317697|NCT03220490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317698|NCT02553772|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93317699|NCT02553772|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93317700|NCT02553772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93317701|NCT02553772|Laxatives|laxatives|mesh-ancestor
93317702|NCT02553772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317703|NCT03119714|Pemirolast|pemirolast|mesh-list
93317704|NCT03119714|Histamine Antagonists|histamine antagonists|mesh-ancestor
93317705|NCT03119714|Histamine Agents|histamine agents|mesh-ancestor
93317706|NCT03119714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611678|NCT00468988|Travoprost|travoprost|mesh-list
93317707|NCT03119714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611692|NCT00469261|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93317708|NCT03119714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317709|NCT00562887|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93317710|NCT00562887|Immunologic Factors|immunologic factors|mesh-ancestor
93317711|NCT00562887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317712|NCT05468554|Metformin|metformin|mesh-list
93317713|NCT05468554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93317714|NCT05468554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317715|NCT04617821|Paclitaxel|paclitaxel|mesh-list
93317716|NCT04617821|Gemcitabine|gemcitabine|mesh-list
93317717|NCT04617821|Folfirinox|folfirinox|mesh-list
93317718|NCT04617821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317719|NCT04617821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317720|NCT04617821|Tubulin Modulators|tubulin modulators|mesh-ancestor
93317721|NCT04617821|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317722|NCT04617821|Mitosis Modulators|mitosis modulators|mesh-ancestor
92611706|NCT04697641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92747501|NCT00335140|Antiviral Agents|antiviral agents|mesh-ancestor
93317723|NCT04617821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317724|NCT04617821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93317725|NCT04617821|Antimetabolites|antimetabolites|mesh-ancestor
93317726|NCT03219008|Lithium Carbonate|lithium carbonate|mesh-list
93317727|NCT03219008|Mirtazapine|mirtazapine|mesh-list
93317728|NCT03219008|Fluvoxamine|fluvoxamine|mesh-list
93317729|NCT03219008|Fluoxetine|fluoxetine|mesh-list
93317730|NCT03219008|Bupropion|bupropion|mesh-list
93317731|NCT03219008|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
93317732|NCT03219008|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93317733|NCT03219008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93317734|NCT03219008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317735|NCT03219008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317736|NCT03219008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317737|NCT03219008|Serotonin Agents|serotonin agents|mesh-ancestor
93317738|NCT03219008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317739|NCT03219008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93317740|NCT03219008|Antidepressive Agents|antidepressive agents|mesh-ancestor
93317741|NCT03219008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93317742|NCT03219008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93317743|NCT03219008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93317744|NCT03219008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317745|NCT03219008|Antimanic Agents|antimanic agents|mesh-ancestor
93317746|NCT03219008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93317747|NCT03219008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317748|NCT03219008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93317749|NCT03219008|Histamine Antagonists|histamine antagonists|mesh-ancestor
93317750|NCT03219008|Histamine Agents|histamine agents|mesh-ancestor
93317751|NCT03219008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93317752|NCT03219008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93317753|NCT03219008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93317754|NCT03219008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93317755|NCT03219008|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317756|NCT03219008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93317757|NCT03219008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93317758|NCT03219008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93317759|NCT03219008|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93317760|NCT03219008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93317761|NCT03219008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93317762|NCT03219008|Dopamine Agents|dopamine agents|mesh-ancestor
93317763|NCT03218930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93317764|NCT03218930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93317765|NCT03218930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317766|NCT03218930|Antitubercular Agents|antitubercular agents|mesh-ancestor
93317767|NCT00562497|Remestemcel-l|remestemcel-l|mesh-list
93317768|NCT00562497|Prednisone|prednisone|mesh-list
93317769|NCT00562497|Methylprednisolone|methylprednisolone|mesh-list
93317770|NCT00562497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317771|NCT00562497|Glucocorticoids|glucocorticoids|mesh-ancestor
93317772|NCT00562497|Hormones|hormones|mesh-ancestor
93317773|NCT00562497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317774|NCT00562497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317775|NCT00562497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93317776|NCT00562497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317777|NCT00562497|Antiemetics|antiemetics|mesh-ancestor
93317778|NCT00562497|Autonomic Agents|autonomic agents|mesh-ancestor
93317779|NCT00562497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317780|NCT00562497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317781|NCT00562497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93317782|NCT00562497|Protective Agents|protective agents|mesh-ancestor
93317783|NCT00562497|Antiviral Agents|antiviral agents|mesh-ancestor
93317784|NCT00562497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317785|NCT00468975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93317786|NCT00468975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93317787|NCT00468975|Autonomic Agents|autonomic agents|mesh-ancestor
93317788|NCT00468975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317789|NCT00468975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317790|NCT00468975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93317791|NCT00468975|Respiratory System Agents|respiratory system agents|mesh-ancestor
93366439|NCT02796677|Formoterol Fumarate|formoterol fumarate|mesh-list
93317792|NCT00468975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93317793|NCT00468975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93317794|NCT00468975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93317795|NCT00468975|Adrenergic Agents|adrenergic agents|mesh-ancestor
93317796|NCT00468975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317797|NCT00468975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317798|NCT01503515|Fluconazole|fluconazole|mesh-list
93317799|NCT01503515|Voriconazole|voriconazole|mesh-list
93317800|NCT01503515|Caspofungin|caspofungin|mesh-list
93317801|NCT01503515|Antifungal Agents|antifungal agents|mesh-ancestor
93317802|NCT01503515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317803|NCT01503515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93317804|NCT01503515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93317805|NCT01503515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317806|NCT01503515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317807|NCT01503515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93317808|NCT01503515|Hormone Antagonists|hormone antagonists|mesh-ancestor
93317809|NCT01503515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317810|NCT01503515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317811|NCT01503515|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93317812|NCT01503515|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93317813|NCT01503515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93317814|NCT00468273|Immunoglobulins|immunoglobulins|mesh-list
93317815|NCT00468273|Antibodies|antibodies|mesh-list
93317816|NCT00468273|gamma-Globulins|gamma-globulins|mesh-list
93317817|NCT00468273|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93317818|NCT00468273|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93317819|NCT00468273|Immunologic Factors|immunologic factors|mesh-ancestor
93317820|NCT00468273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317821|NCT03217916|polysaccharide-K|polysaccharide-k|mesh-list
93317822|NCT03217916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93317823|NCT03217916|Immunologic Factors|immunologic factors|mesh-ancestor
93317824|NCT03217916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317825|NCT03217916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93317826|NCT03217916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317827|NCT03217916|Antiviral Agents|antiviral agents|mesh-ancestor
93317828|NCT03217916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93317829|NCT03217916|Interferon Inducers|interferon inducers|mesh-ancestor
93317830|NCT03217916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93317831|NCT03217916|Protective Agents|protective agents|mesh-ancestor
93317832|NCT00468117|Etanercept|etanercept|mesh-list
93317833|NCT00468117|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93317834|NCT00468117|Basiliximab|basiliximab|mesh-list
93317835|NCT00468117|Daclizumab|daclizumab|mesh-list
93317836|NCT00468117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93317837|NCT00468117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93317838|NCT00468117|Analgesics|analgesics|mesh-ancestor
93317839|NCT00468117|Sensory System Agents|sensory system agents|mesh-ancestor
93317840|NCT00468117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317841|NCT00468117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317842|NCT00468117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93317843|NCT00468117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93317844|NCT00468117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317845|NCT00468117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93317846|NCT00468117|Immunologic Factors|immunologic factors|mesh-ancestor
93317847|NCT00468039|Metformin|metformin|mesh-list
93317848|NCT00468039|Vildagliptin|vildagliptin|mesh-list
93317849|NCT00468039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93317850|NCT00468039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317851|NCT00468039|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93317852|NCT00468039|Protease Inhibitors|protease inhibitors|mesh-ancestor
93317853|NCT00468039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317854|NCT00468039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317855|NCT02742519|Ivacaftor|ivacaftor|mesh-list
93317856|NCT02742519|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93317857|NCT02742519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317858|NCT02742519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317859|NCT01375010|Vitamin D|vitamin d|mesh-list
93317860|NCT01375010|Cholecalciferol|cholecalciferol|mesh-list
93317861|NCT01375010|Vitamins|vitamins|mesh-list
93317862|NCT01375010|Micronutrients|micronutrients|mesh-ancestor
93317863|NCT01375010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317864|NCT01375010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93317865|NCT01375010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92989873|NCT00463840|Immunologic Factors|immunologic factors|mesh-ancestor
93317866|NCT03231176|Capecitabine|capecitabine|mesh-list
93317867|NCT03231176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93317868|NCT03231176|Antimetabolites|antimetabolites|mesh-ancestor
93317869|NCT03231176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317870|NCT03231176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317871|NCT00467025|Sorafenib|sorafenib|mesh-list
93317872|NCT00467025|Trebananib|trebananib|mesh-list
93317873|NCT00467025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317874|NCT00467025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93317875|NCT00467025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317876|NCT00467025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317877|NCT00467025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93317878|NCT00467025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93317879|NCT00467025|Growth Substances|growth substances|mesh-ancestor
93317880|NCT00467025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317881|NCT00467025|Growth Inhibitors|growth inhibitors|mesh-ancestor
93317882|NCT03230786|Metformin|metformin|mesh-list
93317883|NCT03230786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93317884|NCT03230786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317885|NCT02451098|Atorvastatin|atorvastatin|mesh-list
93317886|NCT02451098|Ezetimibe|ezetimibe|mesh-list
93317887|NCT02451098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93317888|NCT02451098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93317889|NCT02451098|Antimetabolites|antimetabolites|mesh-ancestor
93317890|NCT02451098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317891|NCT02451098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93317892|NCT02451098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93317893|NCT02451098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317894|NCT00546273|Vaccines|vaccines|mesh-list
93317895|NCT00546273|Immunologic Factors|immunologic factors|mesh-ancestor
93317896|NCT00546273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317897|NCT02452112|Lidocaine|lidocaine|mesh-list
93317898|NCT02452112|Anesthetics, Local|anesthetics, local|mesh-ancestor
93317899|NCT02452112|Anesthetics|anesthetics|mesh-ancestor
93317900|NCT02452112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317901|NCT02452112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317902|NCT02452112|Sensory System Agents|sensory system agents|mesh-ancestor
92611819|NCT00470197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93317903|NCT02452112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317904|NCT02452112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93317905|NCT02452112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93317906|NCT02452112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93317907|NCT02452112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93317908|NCT02452112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317909|NCT00659061|Micronutrients|micronutrients|mesh-list
93317910|NCT00659061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317911|NCT02451956|Paclitaxel|paclitaxel|mesh-list
93317912|NCT02451956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317913|NCT02451956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317914|NCT02451956|Tubulin Modulators|tubulin modulators|mesh-ancestor
93317915|NCT02451956|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317916|NCT02451956|Mitosis Modulators|mitosis modulators|mesh-ancestor
93317917|NCT02451956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317918|NCT02725372|Nitric Oxide|nitric oxide|mesh-list
93317919|NCT02725372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93317920|NCT02725372|Autonomic Agents|autonomic agents|mesh-ancestor
93317921|NCT02725372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317922|NCT02725372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317923|NCT02725372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93317924|NCT02725372|Respiratory System Agents|respiratory system agents|mesh-ancestor
93317925|NCT02725372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93317926|NCT02725372|Antioxidants|antioxidants|mesh-ancestor
93317927|NCT02725372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317928|NCT02725372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317929|NCT02725372|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93317930|NCT02725372|Vasodilator Agents|vasodilator agents|mesh-ancestor
93317931|NCT02725372|Gasotransmitters|gasotransmitters|mesh-ancestor
93317932|NCT02725372|Protective Agents|protective agents|mesh-ancestor
93317933|NCT02450786|Donepezil|donepezil|mesh-list
93317934|NCT02450786|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93317935|NCT02450786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317936|NCT02450786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317937|NCT02450786|Cholinergic Agents|cholinergic agents|mesh-ancestor
93317938|NCT02450786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317939|NCT02450786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317940|NCT02450786|Nootropic Agents|nootropic agents|mesh-ancestor
93317941|NCT00539721|Ondansetron|ondansetron|mesh-list
93317942|NCT00539721|Rolapitant|rolapitant|mesh-list
93317943|NCT00539721|Antiemetics|antiemetics|mesh-ancestor
93317944|NCT00539721|Autonomic Agents|autonomic agents|mesh-ancestor
93317945|NCT00539721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93317946|NCT00539721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317947|NCT00539721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93317948|NCT00539721|Antipruritics|antipruritics|mesh-ancestor
93317949|NCT00539721|Dermatologic Agents|dermatologic agents|mesh-ancestor
93317950|NCT00539721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93317951|NCT00539721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93317952|NCT00539721|Serotonin Agents|serotonin agents|mesh-ancestor
93317953|NCT00539721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317954|NCT00539721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317955|NCT00539721|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93317956|NCT00464061|Volinanserin|volinanserin|mesh-list
93317957|NCT00464061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93317958|NCT00464061|Serotonin Agents|serotonin agents|mesh-ancestor
93317959|NCT00464061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93317960|NCT00464061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317961|NCT00464061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317962|NCT03230630|Melatonin|melatonin|mesh-list
93317963|NCT03230630|Antioxidants|antioxidants|mesh-ancestor
93317964|NCT03230630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317965|NCT03230630|Protective Agents|protective agents|mesh-ancestor
93317966|NCT03230630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317967|NCT03230630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93317968|NCT00460941|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93317969|NCT00460941|Incretins|incretins|mesh-ancestor
93317970|NCT00460941|Hormones|hormones|mesh-ancestor
93317971|NCT00460941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93317972|NCT00460941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317973|NCT00460317|Paclitaxel|paclitaxel|mesh-list
93317974|NCT00460317|Carboplatin|carboplatin|mesh-list
93317975|NCT00460317|Motesanib diphosphate|motesanib diphosphate|mesh-list
93317976|NCT00460317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93317977|NCT00460317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317978|NCT00460317|Tubulin Modulators|tubulin modulators|mesh-ancestor
93317979|NCT00460317|Antimitotic Agents|antimitotic agents|mesh-ancestor
93317980|NCT00460317|Mitosis Modulators|mitosis modulators|mesh-ancestor
93317981|NCT00460317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93317982|NCT00460317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93317983|NCT00460317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93317984|NCT03213548|Daminozide|daminozide|mesh-list
93317985|NCT03213548|Plant Growth Regulators|plant growth regulators|mesh-ancestor
93317986|NCT03213548|Growth Substances|growth substances|mesh-ancestor
93317987|NCT03213548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317988|NCT00534027|Conatumumab|conatumumab|mesh-list
93317989|NCT00534027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93317990|NCT00534027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93317991|NCT02548078|Vaccines|vaccines|mesh-list
93317992|NCT02548078|Immunologic Factors|immunologic factors|mesh-ancestor
93317993|NCT02548078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93317994|NCT00532311|Atorvastatin|atorvastatin|mesh-list
93317995|NCT00532311|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93317996|NCT00532311|Simvastatin|simvastatin|mesh-list
93317997|NCT00532311|Pravastatin|pravastatin|mesh-list
93317998|NCT00532311|Lovastatin|lovastatin|mesh-list
93317999|NCT00532311|L 647318|l 647318|mesh-list
93318000|NCT00532311|Dihydromevinolin|dihydromevinolin|mesh-list
93318001|NCT00532311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93318002|NCT00532311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93318003|NCT00532311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93318004|NCT00532311|Antimetabolites|antimetabolites|mesh-ancestor
93318005|NCT00532311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318006|NCT00532311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93318007|NCT00532311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318008|NCT03230474|Morphine|morphine|mesh-list
93318009|NCT03230474|Naloxone|naloxone|mesh-list
93318010|NCT03230474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93318011|NCT03230474|Narcotics|narcotics|mesh-ancestor
93318012|NCT03230474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318013|NCT03230474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318014|NCT03230474|Analgesics|analgesics|mesh-ancestor
93318015|NCT03230474|Sensory System Agents|sensory system agents|mesh-ancestor
93318016|NCT03230474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318017|NCT03230474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93318018|NCT02671435|Bevacizumab|bevacizumab|mesh-list
93318019|NCT02671435|Cetuximab|cetuximab|mesh-list
93318020|NCT02671435|Durvalumab|durvalumab|mesh-list
93318021|NCT02671435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318022|NCT02671435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318023|NCT02671435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93318024|NCT02671435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93318025|NCT02671435|Growth Substances|growth substances|mesh-ancestor
93318026|NCT02671435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318027|NCT02671435|Growth Inhibitors|growth inhibitors|mesh-ancestor
93318028|NCT05476354|Amlodipine|amlodipine|mesh-list
93318029|NCT05476354|Irbesartan|irbesartan|mesh-list
93318030|NCT05476354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93318031|NCT05476354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93318032|NCT05476354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93318033|NCT05476354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318034|NCT05476354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93318035|NCT05476354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318036|NCT05476354|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318037|NCT05476354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93318038|NCT05476354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93318039|NCT00529503|Rituximab|rituximab|mesh-list
93318040|NCT00529503|Dacetuzumab|dacetuzumab|mesh-list
93318041|NCT00529503|Carboplatin|carboplatin|mesh-list
93318042|NCT00529503|Etoposide|etoposide|mesh-list
93318043|NCT00529503|Ifosfamide|ifosfamide|mesh-list
93318044|NCT00529503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318045|NCT00529503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318046|NCT00529503|Immunologic Factors|immunologic factors|mesh-ancestor
93318047|NCT00529503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318048|NCT00529503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318049|NCT00529503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93318050|NCT00529503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93318051|NCT00529503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93318052|NCT00529503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318053|NCT00529503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318054|NCT00529503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93318055|NCT00529503|Alkylating Agents|alkylating agents|mesh-ancestor
93318056|NCT05459194|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93318057|NCT05459194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93318058|NCT05459194|Autonomic Agents|autonomic agents|mesh-ancestor
93318059|NCT05459194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318060|NCT05459194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318061|NCT05459194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93318062|NCT05459194|Respiratory System Agents|respiratory system agents|mesh-ancestor
93318063|NCT05459194|Glucocorticoids|glucocorticoids|mesh-ancestor
93318064|NCT05459194|Hormones|hormones|mesh-ancestor
93318065|NCT05459194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318066|NCT05459194|Sympathomimetics|sympathomimetics|mesh-ancestor
93318067|NCT05476198|Anesthetics|anesthetics|mesh-list
93318068|NCT05476198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318069|NCT05476198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318070|NCT02280057|Metformin|metformin|mesh-list
93318071|NCT02280057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93318072|NCT02280057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318073|NCT02279589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93318074|NCT02279589|Immunologic Factors|immunologic factors|mesh-ancestor
93318075|NCT02279589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318076|NCT02282709|Asunaprevir|asunaprevir|mesh-list
93318077|NCT02282709|Protease Inhibitors|protease inhibitors|mesh-ancestor
93318078|NCT02282709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318079|NCT02282709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318080|NCT02282787|Dexmedetomidine|dexmedetomidine|mesh-list
93318081|NCT02282787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93318082|NCT02282787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318083|NCT02282787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318084|NCT02282787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318085|NCT02282787|Analgesics|analgesics|mesh-ancestor
93318086|NCT02282787|Sensory System Agents|sensory system agents|mesh-ancestor
93318087|NCT02282787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318088|NCT02282787|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93318089|NCT02282787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92990098|NCT03961308|Vedolizumab|vedolizumab|mesh-list
93318090|NCT02282787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93318091|NCT02282787|Adrenergic Agents|adrenergic agents|mesh-ancestor
93318092|NCT02282787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318093|NCT02282787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318094|NCT03223844|Dextroamphetamine|dextroamphetamine|mesh-list
93318095|NCT03223844|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93318096|NCT03223844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318097|NCT03223844|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93318098|NCT03223844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93318099|NCT03223844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93318100|NCT03223844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318101|NCT03223844|Dopamine Agents|dopamine agents|mesh-ancestor
93318102|NCT03223844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318103|NCT00458601|Temozolomide|temozolomide|mesh-list
93318104|NCT00458601|Molgramostim|molgramostim|mesh-list
93318105|NCT00458601|Rindopepimut|rindopepimut|mesh-list
93318106|NCT00458601|Sargramostim|sargramostim|mesh-list
93318107|NCT00458601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93318108|NCT00458601|Alkylating Agents|alkylating agents|mesh-ancestor
93318109|NCT00458601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318110|NCT00458601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318111|NCT00458601|Immunologic Factors|immunologic factors|mesh-ancestor
93318112|NCT00458601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318113|NCT00458601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318114|NCT00658047|Methotrexate|methotrexate|mesh-list
93318115|NCT00658047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93318116|NCT00658047|Abortifacient Agents|abortifacient agents|mesh-ancestor
93318117|NCT00658047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93318118|NCT00658047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318119|NCT00658047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318120|NCT00658047|Antimetabolites|antimetabolites|mesh-ancestor
93318121|NCT00658047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318122|NCT00658047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318123|NCT00658047|Dermatologic Agents|dermatologic agents|mesh-ancestor
93318124|NCT00658047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318125|NCT00658047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93318126|NCT00658047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318127|NCT00658047|Immunologic Factors|immunologic factors|mesh-ancestor
93318128|NCT00658047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318129|NCT00658047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318130|NCT03230162|Heparin|heparin|mesh-list
93318131|NCT03230162|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93318132|NCT03230162|Tinzaparin|tinzaparin|mesh-list
93318133|NCT03230162|Dalteparin|dalteparin|mesh-list
93318134|NCT03230162|Sildenafil Citrate|sildenafil citrate|mesh-list
93318135|NCT03230162|Anticoagulants|anticoagulants|mesh-ancestor
93318136|NCT03230162|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93318137|NCT03230162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93318138|NCT03230162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318139|NCT03230162|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318140|NCT03230162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93318141|NCT03230162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93318142|NCT03230162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318143|NCT03230162|Urological Agents|urological agents|mesh-ancestor
93318144|NCT00455559|Imatinib Mesylate|imatinib mesylate|mesh-list
93318145|NCT00455559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318146|NCT00455559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93318147|NCT00455559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318148|NCT00455559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318149|NCT02916433|Octreotide|octreotide|mesh-list
93318150|NCT02916433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318151|NCT02916433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93318152|NCT02916433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318153|NCT02284269|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93318154|NCT02284269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318155|NCT02284269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93318156|NCT02284269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318157|NCT04059523|Tretinoin|tretinoin|mesh-list
93318158|NCT04059523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318159|NCT04059523|Keratolytic Agents|keratolytic agents|mesh-ancestor
93318160|NCT04059523|Dermatologic Agents|dermatologic agents|mesh-ancestor
93318161|NCT00657501|Testosterone|testosterone|mesh-list
93318162|NCT00657501|Androgens|androgens|mesh-ancestor
93318163|NCT00657501|Hormones|hormones|mesh-ancestor
92990176|NCT00714623|Sirolimus|sirolimus|mesh-list
93318164|NCT00657501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318165|NCT00657501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318167|NCT03675841|Pazufloxacin|pazufloxacin|mesh-list
93318168|NCT03675841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93318169|NCT03675841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318170|NCT03675841|Antitubercular Agents|antitubercular agents|mesh-ancestor
93318171|NCT03675841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93318172|NCT03675841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93318173|NCT03675841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93318174|NCT03675841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318175|NCT03675841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318176|NCT03675841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318177|NCT03229694|Bosentan|bosentan|mesh-list
93318178|NCT03229694|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
93318179|NCT03229694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93318180|NCT03229694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318181|NCT03223064|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93318182|NCT03223064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92612099|NCT00471991|Contraceptive Agents|contraceptive agents|mesh-ancestor
93318183|NCT03223064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318184|NCT03209648|Itraconazole|itraconazole|mesh-list
93318185|NCT03209648|Antifungal Agents|antifungal agents|mesh-ancestor
93318186|NCT03209648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318187|NCT03209648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93318188|NCT03209648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93318189|NCT03209648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318190|NCT03209648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318191|NCT03209648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93318192|NCT03209648|Hormone Antagonists|hormone antagonists|mesh-ancestor
93318193|NCT03209648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318194|NCT03209648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318195|NCT03209648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93318196|NCT04058899|Dexmedetomidine|dexmedetomidine|mesh-list
93318197|NCT04058899|Nalbuphine|nalbuphine|mesh-list
93318198|NCT04058899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93318199|NCT04058899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318200|NCT04058899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318201|NCT04058899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318202|NCT04058899|Analgesics|analgesics|mesh-ancestor
93318203|NCT04058899|Sensory System Agents|sensory system agents|mesh-ancestor
93318204|NCT04058899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318205|NCT04058899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93318206|NCT04058899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93318207|NCT04058899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93318208|NCT04058899|Adrenergic Agents|adrenergic agents|mesh-ancestor
93318209|NCT04058899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318210|NCT04058899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318211|NCT04058899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93318212|NCT04058899|Narcotics|narcotics|mesh-ancestor
93318213|NCT00657189|Sifalimumab|sifalimumab|mesh-list
93318214|NCT00657189|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93318215|NCT00657189|Immunologic Factors|immunologic factors|mesh-ancestor
93318216|NCT00657189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318217|NCT03209180|Carvedilol|carvedilol|mesh-list
93318218|NCT03209180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93318219|NCT03209180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93318220|NCT03209180|Adrenergic Agents|adrenergic agents|mesh-ancestor
93318221|NCT03209180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318222|NCT03209180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318223|NCT03209180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318224|NCT03209180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93318225|NCT03209180|Antioxidants|antioxidants|mesh-ancestor
93318226|NCT03209180|Protective Agents|protective agents|mesh-ancestor
93318227|NCT03209180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93318228|NCT03209180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93318229|NCT03209180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93318230|NCT03209180|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318231|NCT03209180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93318232|NCT03209180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93318233|NCT03215017|Loperamide|loperamide|mesh-list
93318234|NCT03215017|Sorbitol|sorbitol|mesh-list
93318235|NCT03215017|Antidiarrheals|antidiarrheals|mesh-ancestor
93318236|NCT03215017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318237|NCT03215017|Cathartics|cathartics|mesh-ancestor
93318238|NCT02500849|Busulfan|busulfan|mesh-list
93318239|NCT02500849|Alkylating Agents|alkylating agents|mesh-ancestor
93318240|NCT02500849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318241|NCT02500849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318242|NCT02500849|Immunologic Factors|immunologic factors|mesh-ancestor
93318243|NCT02500849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318244|NCT02500849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93318245|NCT02500849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318246|NCT02500849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93318247|NCT03209102|Hydrocortisone|hydrocortisone|mesh-list
93318248|NCT03209102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318249|NCT02280447|Vaccines|vaccines|mesh-list
93318250|NCT02280447|Immunologic Factors|immunologic factors|mesh-ancestor
93318251|NCT02280447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318252|NCT00528333|Cytarabine|cytarabine|mesh-list
93318253|NCT00528333|Lintuzumab|lintuzumab|mesh-list
93318254|NCT00528333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318255|NCT00528333|Antimetabolites|antimetabolites|mesh-ancestor
93318256|NCT00528333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318257|NCT00528333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318258|NCT00528333|Antiviral Agents|antiviral agents|mesh-ancestor
93318259|NCT00528333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318260|NCT00528333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318261|NCT00528333|Immunologic Factors|immunologic factors|mesh-ancestor
93318262|NCT00528333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318263|NCT00528333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318264|NCT00526227|Clotrimazole|clotrimazole|mesh-list
93318265|NCT00526227|Miconazole|miconazole|mesh-list
93318266|NCT00526227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93318267|NCT00526227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318268|NCT00526227|Antifungal Agents|antifungal agents|mesh-ancestor
93318269|NCT00526227|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93318270|NCT00526227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93318271|NCT00526227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318272|NCT00526227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318273|NCT00526227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93318274|NCT00526227|Hormone Antagonists|hormone antagonists|mesh-ancestor
93318275|NCT00526227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318276|NCT00526227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318277|NCT00526227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93318278|NCT00526227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93318279|NCT02280603|Minoxidil|minoxidil|mesh-list
93318280|NCT02280603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93318281|NCT02280603|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318282|NCT00524277|Molgramostim|molgramostim|mesh-list
93318283|NCT00524277|Vaccines|vaccines|mesh-list
93318284|NCT00524277|Sargramostim|sargramostim|mesh-list
93318285|NCT00524277|Immunologic Factors|immunologic factors|mesh-ancestor
93318286|NCT00524277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318287|NCT00524277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318288|NCT02284503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93318289|NCT02284503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93318290|NCT02284503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93318291|NCT02284503|Antimetabolites|antimetabolites|mesh-ancestor
93318292|NCT02284503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318293|NCT02284503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93318294|NCT02284503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93318295|NCT02284503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318296|NCT00650949|Carboplatin|carboplatin|mesh-list
93318297|NCT00650949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318298|NCT00520923|Olanzapine|olanzapine|mesh-list
93318299|NCT00520923|Antiemetics|antiemetics|mesh-ancestor
93318300|NCT00520923|Autonomic Agents|autonomic agents|mesh-ancestor
93318301|NCT00520923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318302|NCT00520923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318303|NCT00520923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318304|NCT00520923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93318305|NCT00520923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93318306|NCT00520923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318307|NCT00520923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93318308|NCT00520923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93318309|NCT00520923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92990319|NCT03964753|Paclitaxel|paclitaxel|mesh-list
93318310|NCT00520923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93318311|NCT00520923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318312|NCT00520923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318313|NCT00520923|Serotonin Agents|serotonin agents|mesh-ancestor
93318315|NCT02283177|Daunorubicin|daunorubicin|mesh-list
93318316|NCT02283177|Idarubicin|idarubicin|mesh-list
93318317|NCT02283177|Crenolanib|crenolanib|mesh-list
93318318|NCT02283177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318319|NCT02283177|Antimetabolites|antimetabolites|mesh-ancestor
93318320|NCT02283177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318321|NCT02283177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318322|NCT02283177|Antiviral Agents|antiviral agents|mesh-ancestor
93318323|NCT02283177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318324|NCT02283177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318325|NCT02283177|Immunologic Factors|immunologic factors|mesh-ancestor
93318326|NCT02283177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318327|NCT02283177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93318328|NCT02283177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93318329|NCT02283177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93318330|NCT02283177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318331|NCT00514371|Bortezomib|bortezomib|mesh-list
93318332|NCT00514371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318333|NCT02547766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93318334|NCT02547766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318335|NCT04470531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93318336|NCT04470531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93318337|NCT04470531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318338|NCT04470531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93318339|NCT04470531|Antimalarials|antimalarials|mesh-ancestor
93318340|NCT04470531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93318341|NCT04470531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93318342|NCT02286453|Diclofenac|diclofenac|mesh-list
93318343|NCT02286453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93318344|NCT02286453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318345|NCT02286453|Analgesics|analgesics|mesh-ancestor
93318346|NCT02286453|Sensory System Agents|sensory system agents|mesh-ancestor
93318347|NCT02286453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318348|NCT02286453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318349|NCT02286453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318350|NCT02286453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318351|NCT02286453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93318352|NCT02286453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318353|NCT02286453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318354|NCT00385515|Meclocycline|meclocycline|mesh-list
93318355|NCT00385515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93318356|NCT00385515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318357|NCT02286609|Deflazacort|deflazacort|mesh-list
93318358|NCT02286609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318359|NCT02286609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318360|NCT02286609|Immunologic Factors|immunologic factors|mesh-ancestor
93318361|NCT02286609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318362|NCT00508989|Niacin|niacin|mesh-list
93318363|NCT00508989|Acetylcholine|acetylcholine|mesh-list
93318364|NCT00508989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93318365|NCT00508989|Antimetabolites|antimetabolites|mesh-ancestor
93318366|NCT00508989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318367|NCT00508989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93318368|NCT00508989|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318369|NCT00508989|Vitamin B Complex|vitamin b complex|mesh-ancestor
93318370|NCT00508989|Vitamins|vitamins|mesh-ancestor
93318371|NCT00508989|Micronutrients|micronutrients|mesh-ancestor
93318372|NCT00508989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318373|NCT00508989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93318374|NCT00508989|Cholinergic Agents|cholinergic agents|mesh-ancestor
93318375|NCT00508989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318376|NCT03104842|Dexamethasone|dexamethasone|mesh-list
93318377|NCT03104842|Lenalidomide|lenalidomide|mesh-list
93318378|NCT03104842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318379|NCT03104842|Antiemetics|antiemetics|mesh-ancestor
93318380|NCT03104842|Autonomic Agents|autonomic agents|mesh-ancestor
93318381|NCT03104842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318382|NCT03104842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318383|NCT03104842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318384|NCT03104842|Glucocorticoids|glucocorticoids|mesh-ancestor
93318385|NCT03104842|Hormones|hormones|mesh-ancestor
92990396|NCT02573597|Narcotics|narcotics|mesh-ancestor
93318386|NCT03104842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318387|NCT03104842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93318388|NCT03104842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318389|NCT03104842|Immunologic Factors|immunologic factors|mesh-ancestor
93318390|NCT03104842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93318391|NCT03104842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93318392|NCT03104842|Growth Substances|growth substances|mesh-ancestor
93318393|NCT03104842|Growth Inhibitors|growth inhibitors|mesh-ancestor
93318395|NCT00436683|Chelating Agents|chelating agents|mesh-ancestor
93318396|NCT00436683|Sequestering Agents|sequestering agents|mesh-ancestor
93318397|NCT00436683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318398|NCT00434811|Sirolimus|sirolimus|mesh-list
93318399|NCT00434811|Etanercept|etanercept|mesh-list
93318400|NCT00434811|Tacrolimus|tacrolimus|mesh-list
93318401|NCT00434811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93318402|NCT00434811|Basiliximab|basiliximab|mesh-list
93318403|NCT00434811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318404|NCT00434811|Immunologic Factors|immunologic factors|mesh-ancestor
93318405|NCT00434811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318406|NCT00434811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93318407|NCT00434811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318408|NCT00434811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318409|NCT00434811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93318410|NCT00434811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318411|NCT00434811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93318412|NCT00434811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318413|NCT00434811|Antifungal Agents|antifungal agents|mesh-ancestor
93318414|NCT00434811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93318415|NCT00434811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318416|NCT00434811|Analgesics|analgesics|mesh-ancestor
93318417|NCT00434811|Sensory System Agents|sensory system agents|mesh-ancestor
93318418|NCT00434811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318419|NCT00434811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318420|NCT00434811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318421|NCT00434811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318422|NCT03133845|Fentanyl|fentanyl|mesh-list
93318423|NCT03133845|Midazolam|midazolam|mesh-list
93318424|NCT03133845|Morphine|morphine|mesh-list
93318425|NCT03133845|Anesthetics|anesthetics|mesh-list
93318426|NCT03133845|Propofol|propofol|mesh-list
93318427|NCT03133845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318428|NCT03133845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318429|NCT03133845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93318430|NCT03133845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93318431|NCT03133845|Anesthetics, General|anesthetics, general|mesh-ancestor
93318432|NCT03133845|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93318433|NCT03133845|Narcotics|narcotics|mesh-ancestor
93318434|NCT03133845|Analgesics|analgesics|mesh-ancestor
93318435|NCT03133845|Sensory System Agents|sensory system agents|mesh-ancestor
93318436|NCT03133845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318437|NCT03133845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93318438|NCT03133845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93318439|NCT03133845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93318440|NCT03133845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93318441|NCT03133845|GABA Modulators|gaba modulators|mesh-ancestor
93318442|NCT03133845|GABA Agents|gaba agents|mesh-ancestor
93318443|NCT03133845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318444|NCT03133845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318445|NCT00120393|Ritonavir|ritonavir|mesh-list
93318446|NCT00120393|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93318447|NCT00120393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93318448|NCT00120393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93318449|NCT00120393|Protease Inhibitors|protease inhibitors|mesh-ancestor
93318450|NCT00120393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318451|NCT00120393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318452|NCT00120393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93318453|NCT00120393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93318454|NCT00120393|Antiviral Agents|antiviral agents|mesh-ancestor
93318455|NCT00120393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318456|NCT00120393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93318457|NCT00120393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93318458|NCT05726019|Colchicine|colchicine|mesh-list
93318459|NCT05726019|Gout Suppressants|gout suppressants|mesh-ancestor
93318460|NCT05726019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318461|NCT05726019|Tubulin Modulators|tubulin modulators|mesh-ancestor
93318462|NCT05726019|Antimitotic Agents|antimitotic agents|mesh-ancestor
93318463|NCT05726019|Mitosis Modulators|mitosis modulators|mesh-ancestor
93318464|NCT05726019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318465|NCT05726019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318466|NCT00116415|Lamivudine|lamivudine|mesh-list
93318467|NCT00116415|Efavirenz|efavirenz|mesh-list
93318468|NCT00116415|Didanosine|didanosine|mesh-list
93318469|NCT00116415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93318470|NCT00116415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318471|NCT00116415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318472|NCT00116415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318473|NCT00116415|Antiviral Agents|antiviral agents|mesh-ancestor
93318474|NCT00116415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318475|NCT00116415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93318476|NCT00116415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93318477|NCT00116415|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93318478|NCT00116415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93318479|NCT00116415|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93318480|NCT00116415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93318481|NCT00116415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93318482|NCT00116415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93318483|NCT00116415|Antimetabolites|antimetabolites|mesh-ancestor
93318484|NCT03207698|Metformin|metformin|mesh-list
93318485|NCT03207698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93318486|NCT03207698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318487|NCT03208712|Atezolizumab|atezolizumab|mesh-list
93318488|NCT03208712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93318489|NCT03208712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318490|NCT03208712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318491|NCT03208712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318492|NCT03201380|Choline|choline|mesh-list
93318493|NCT03201380|Lipotropic Agents|lipotropic agents|mesh-ancestor
93318494|NCT03201380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93318495|NCT03201380|Antimetabolites|antimetabolites|mesh-ancestor
93318496|NCT03201380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318497|NCT03201380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318498|NCT03201380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93318499|NCT03201380|Nootropic Agents|nootropic agents|mesh-ancestor
93318500|NCT03208556|Cyclophosphamide|cyclophosphamide|mesh-list
93318501|NCT03208556|Fludarabine|fludarabine|mesh-list
93318502|NCT03208556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318503|NCT03208556|Immunologic Factors|immunologic factors|mesh-ancestor
93318504|NCT03208556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318505|NCT03208556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318506|NCT03208556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93318507|NCT03208556|Alkylating Agents|alkylating agents|mesh-ancestor
93318508|NCT03208556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318509|NCT03208556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318510|NCT03208556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93318511|NCT00429429|Immunomodulating Agents|immunomodulating agents|mesh-list
93318512|NCT00429429|Immunologic Factors|immunologic factors|mesh-ancestor
93318513|NCT00429429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318514|NCT03201146|Cisplatin|cisplatin|mesh-list
93318515|NCT03201146|Carboplatin|carboplatin|mesh-list
93318516|NCT03201146|Pemetrexed|pemetrexed|mesh-list
93318517|NCT03201146|Apatinib|apatinib|mesh-list
93318518|NCT03201146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318519|NCT03201146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318520|NCT03201146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318521|NCT03201146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93318522|NCT03201146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318523|NCT03201146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93318524|NCT00370383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93318525|NCT00370383|Satraplatin|satraplatin|mesh-list
93318526|NCT00370383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318527|NCT00370383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93318528|NCT00370383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318529|NCT00370383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318530|NCT00367887|Ribavirin|ribavirin|mesh-list
93318531|NCT00367887|Interferon alpha-2|interferon alpha-2|mesh-list
93318532|NCT00367887|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93318533|NCT00367887|Interferon-alpha|interferon-alpha|mesh-list
93318534|NCT00367887|Antimetabolites|antimetabolites|mesh-ancestor
92612457|NCT02953366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318535|NCT00367887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318536|NCT00367887|Antiviral Agents|antiviral agents|mesh-ancestor
92990546|NCT00947466|Buprenorphine|buprenorphine|mesh-list
93318537|NCT00367887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318538|NCT00367887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318539|NCT00367887|Immunologic Factors|immunologic factors|mesh-ancestor
93318540|NCT00367887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318541|NCT02547220|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93318542|NCT02547220|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93318543|NCT02547220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318544|NCT02547220|Immunologic Factors|immunologic factors|mesh-ancestor
93318545|NCT02547220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318546|NCT03207308|Vitamin A|vitamin a|mesh-list
93318547|NCT03207308|Vitamins|vitamins|mesh-ancestor
93318548|NCT03207308|Micronutrients|micronutrients|mesh-ancestor
93318549|NCT03207308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318550|NCT00366795|Satavaptan|satavaptan|mesh-list
93318551|NCT00366795|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93318552|NCT00366795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318553|NCT00366795|Natriuretic Agents|natriuretic agents|mesh-ancestor
93318554|NCT00366795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318555|NCT00422019|Rilotumumab|rilotumumab|mesh-list
93318556|NCT00422019|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93318557|NCT00422019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318558|NCT00422019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318559|NCT00422019|Immunologic Factors|immunologic factors|mesh-ancestor
93318560|NCT00422019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318561|NCT03207542|Daratumumab|daratumumab|mesh-list
93318562|NCT03207542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318563|NCT00360867|Motesanib diphosphate|motesanib diphosphate|mesh-list
93318564|NCT00360867|Imetelstat|imetelstat|mesh-list
93318565|NCT00360867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93318566|NCT00360867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318567|NCT00360867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318568|NCT02287389|Mitomycins|mitomycins|mesh-list
93318569|NCT02287389|Mitomycin|mitomycin|mesh-list
93318570|NCT02287389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93318571|NCT02287389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318572|NCT02287389|Alkylating Agents|alkylating agents|mesh-ancestor
93318573|NCT02287389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318574|NCT02287389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318575|NCT02287389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318576|NCT00057993|Trastuzumab|trastuzumab|mesh-list
93318577|NCT00057993|Exemestane|exemestane|mesh-list
93318578|NCT00057993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318579|NCT00057993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318580|NCT00057993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93318581|NCT00057993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93318582|NCT00057993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318583|NCT00057993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318584|NCT00057993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93318585|NCT00057993|Hormone Antagonists|hormone antagonists|mesh-ancestor
93318586|NCT00057993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318587|NCT00057993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318588|NCT02284737|Sildenafil Citrate|sildenafil citrate|mesh-list
93318589|NCT02284737|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318590|NCT02284737|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93318591|NCT02284737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93318592|NCT02284737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318593|NCT02284737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318594|NCT02284737|Urological Agents|urological agents|mesh-ancestor
93318595|NCT02448290|Docetaxel|docetaxel|mesh-list
93318596|NCT02448290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318597|NCT02448290|Tubulin Modulators|tubulin modulators|mesh-ancestor
93318598|NCT02448290|Antimitotic Agents|antimitotic agents|mesh-ancestor
93318599|NCT02448290|Mitosis Modulators|mitosis modulators|mesh-ancestor
93318600|NCT02448290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318601|NCT00357279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93318602|NCT04484558|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93318603|NCT04484558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93318604|NCT04484558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92612528|NCT02953210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318605|NCT04484558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318606|NCT00055575|Scopolamine|scopolamine|mesh-list
93318607|NCT00055575|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93318608|NCT00055575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93318609|NCT00055575|Antiemetics|antiemetics|mesh-ancestor
93318610|NCT00055575|Autonomic Agents|autonomic agents|mesh-ancestor
93318611|NCT00055575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318612|NCT00055575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318613|NCT00055575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318614|NCT00055575|Mydriatics|mydriatics|mesh-ancestor
93318615|NCT00055575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93318616|NCT00055575|Cholinergic Agents|cholinergic agents|mesh-ancestor
93318617|NCT00055575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318618|NCT00055575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318619|NCT00055575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93318620|NCT00055575|Parasympatholytics|parasympatholytics|mesh-ancestor
93318621|NCT00051129|Hydrocortisone|hydrocortisone|mesh-list
93318622|NCT00051129|Anecortave|anecortave|mesh-list
93318623|NCT00051129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93318624|NCT00051129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93318625|NCT00051129|Growth Substances|growth substances|mesh-ancestor
93318626|NCT00051129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318627|NCT00051129|Growth Inhibitors|growth inhibitors|mesh-ancestor
93318628|NCT00051129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318629|NCT00051129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318630|NCT03200600|Dexamethasone|dexamethasone|mesh-list
93318631|NCT03200600|Dexamethasone acetate|dexamethasone acetate|mesh-list
93318632|NCT03200600|Flurbiprofen|flurbiprofen|mesh-list
93318633|NCT03200600|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
93318634|NCT03200600|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93318635|NCT03200600|BB 1101|bb 1101|mesh-list
93318636|NCT03200600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318637|NCT03200600|Antiemetics|antiemetics|mesh-ancestor
93318638|NCT03200600|Autonomic Agents|autonomic agents|mesh-ancestor
93318639|NCT03200600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318640|NCT03200600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318641|NCT03200600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318642|NCT03200600|Glucocorticoids|glucocorticoids|mesh-ancestor
93318643|NCT03200600|Hormones|hormones|mesh-ancestor
93318644|NCT03200600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318645|NCT03200600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93318646|NCT03200600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318647|NCT03200600|Protease Inhibitors|protease inhibitors|mesh-ancestor
93318648|NCT03200600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318649|NCT03200600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318650|NCT03200600|Analgesics|analgesics|mesh-ancestor
93318651|NCT03200600|Sensory System Agents|sensory system agents|mesh-ancestor
93318652|NCT03200600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93318653|NCT03200600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318654|NCT03200600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318655|NCT03200600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93318656|NCT02547454|Epoetin Alfa|epoetin alfa|mesh-list
93318657|NCT02547454|Hematinics|hematinics|mesh-ancestor
93318658|NCT01491893|Vaccines|vaccines|mesh-list
93318659|NCT01491893|Immunologic Factors|immunologic factors|mesh-ancestor
93318660|NCT01491893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318661|NCT00049959|Verteporfin|verteporfin|mesh-list
93318662|NCT00049959|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93318663|NCT00049959|Dermatologic Agents|dermatologic agents|mesh-ancestor
93318664|NCT03119324|Nimesulide|nimesulide|mesh-list
93318665|NCT03119324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93318666|NCT03119324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318667|NCT03119324|Analgesics|analgesics|mesh-ancestor
93318668|NCT03119324|Sensory System Agents|sensory system agents|mesh-ancestor
93318669|NCT03119324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318670|NCT03119324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318671|NCT03119324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318672|NCT03119324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318673|NCT03119324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93318674|NCT03119324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318675|NCT03119324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318676|NCT00415623|Amlodipine|amlodipine|mesh-list
93318677|NCT00415623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93318678|NCT00415623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93318679|NCT00415623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93318680|NCT00415623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318681|NCT00415623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93318682|NCT00415623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318683|NCT00415623|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318684|NCT03133923|Vaccines|vaccines|mesh-list
93318685|NCT03133923|Immunologic Factors|immunologic factors|mesh-ancestor
93318686|NCT03133923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318687|NCT03134001|Analgesics|analgesics|mesh-list
93318688|NCT03134001|Sensory System Agents|sensory system agents|mesh-ancestor
93318689|NCT03134001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318690|NCT03134001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318691|NCT01969409|Rituximab|rituximab|mesh-list
93318692|NCT01969409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318693|NCT01969409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318694|NCT01969409|Immunologic Factors|immunologic factors|mesh-ancestor
93318695|NCT01969409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318696|NCT01969409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318697|NCT05218577|Selenium|selenium|mesh-list
93318698|NCT05218577|Antioxidants|antioxidants|mesh-ancestor
93318699|NCT05218577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318700|NCT05218577|Protective Agents|protective agents|mesh-ancestor
93318701|NCT05218577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318702|NCT05218577|Trace Elements|trace elements|mesh-ancestor
93318703|NCT05218577|Micronutrients|micronutrients|mesh-ancestor
93318704|NCT00150813|Levetiracetam|levetiracetam|mesh-list
93318705|NCT00150813|Anticonvulsants|anticonvulsants|mesh-ancestor
93318706|NCT00150813|Nootropic Agents|nootropic agents|mesh-ancestor
93318707|NCT02712788|Milrinone|milrinone|mesh-list
93318708|NCT02712788|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93318709|NCT02712788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93318710|NCT02712788|Vasodilator Agents|vasodilator agents|mesh-ancestor
93318711|NCT02712788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93318712|NCT02712788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93318713|NCT02712788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318714|NCT02712788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318715|NCT02712788|Protective Agents|protective agents|mesh-ancestor
93318716|NCT02712788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318717|NCT00035529|Abatacept|abatacept|mesh-list
93318718|NCT00035529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93318719|NCT00035529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318720|NCT00035529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318721|NCT00035529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318722|NCT00035529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318723|NCT00035529|Immunologic Factors|immunologic factors|mesh-ancestor
93318724|NCT00035529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318725|NCT00035529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318726|NCT04470609|Vaccines|vaccines|mesh-list
93318727|NCT04470609|Immunologic Factors|immunologic factors|mesh-ancestor
93318728|NCT04470609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318729|NCT00356109|Insulin|insulin|mesh-list
93318730|NCT00356109|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93318731|NCT00356109|Insulin Glargine|insulin glargine|mesh-list
93318732|NCT00356109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93318733|NCT00356109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318734|NCT03206138|Imiquimod|imiquimod|mesh-list
93318735|NCT03206138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93318736|NCT03206138|Immunologic Factors|immunologic factors|mesh-ancestor
93318737|NCT03206138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318738|NCT03206138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318739|NCT03206138|Interferon Inducers|interferon inducers|mesh-ancestor
93318740|NCT04530305|Upadacitinib|upadacitinib|mesh-list
93318741|NCT04530305|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93318742|NCT04530305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93318743|NCT04530305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318744|NCT04530305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318745|NCT04530305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318746|NCT00006225|Flt3 ligand protein|flt3 ligand protein|mesh-list
93318747|NCT00006225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93318748|NCT00006225|Immunologic Factors|immunologic factors|mesh-ancestor
93318749|NCT00006225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318750|NCT00006225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93318751|NCT00006225|Protective Agents|protective agents|mesh-ancestor
93318752|NCT00005595|Arsenic Trioxide|arsenic trioxide|mesh-list
93318753|NCT00005595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318754|NCT02447822|Thymoglobulin|thymoglobulin|mesh-list
93318755|NCT02447822|Immunologic Factors|immunologic factors|mesh-ancestor
93318756|NCT02447822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318757|NCT02447822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318758|NCT04477265|Solifenacin Succinate|solifenacin succinate|mesh-list
93318759|NCT04477265|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93318760|NCT04477265|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93318761|NCT04477265|Cholinergic Agents|cholinergic agents|mesh-ancestor
92990766|NCT00958386|Irinotecan|irinotecan|mesh-list
93318762|NCT04477265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318763|NCT04477265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318764|NCT04477265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318765|NCT04477265|Urological Agents|urological agents|mesh-ancestor
93318766|NCT00353457|Capecitabine|capecitabine|mesh-list
93318767|NCT00353457|Oxaliplatin|oxaliplatin|mesh-list
93318768|NCT00353457|Cetuximab|cetuximab|mesh-list
93318769|NCT00353457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318770|NCT00353457|Antimetabolites|antimetabolites|mesh-ancestor
93318771|NCT00353457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318772|NCT00353457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318773|NCT00353457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318774|NCT00411099|Agomelatine|agomelatine|mesh-list
93318775|NCT00411099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93318776|NCT00411099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318777|NCT00411099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318778|NCT03195530|Propofol|propofol|mesh-list
93318779|NCT03195530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93318780|NCT03195530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318781|NCT03195530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318782|NCT03195530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93318783|NCT03195530|Anesthetics, General|anesthetics, general|mesh-ancestor
93318784|NCT03195530|Anesthetics|anesthetics|mesh-ancestor
93318785|NCT03195452|Raltegravir Potassium|raltegravir potassium|mesh-list
93318786|NCT03195452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93318787|NCT03195452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93318788|NCT03195452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93318789|NCT03195452|Antiviral Agents|antiviral agents|mesh-ancestor
93318790|NCT03195452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318791|NCT03195452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93318792|NCT03195452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93318793|NCT03195452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318794|NCT03195452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318795|NCT03195452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318796|NCT00406809|Navitoclax|navitoclax|mesh-list
93318797|NCT00406809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318798|NCT03200210|Febuxostat|febuxostat|mesh-list
93318799|NCT03200210|Gout Suppressants|gout suppressants|mesh-ancestor
93318800|NCT03200210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318801|NCT00004899|Etoposide|etoposide|mesh-list
93318802|NCT00004899|Busulfan|busulfan|mesh-list
93318803|NCT00004899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93318804|NCT00004899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318805|NCT00004899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93318806|NCT00004899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93318807|NCT00004899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318808|NCT00004899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318809|NCT00004899|Immunologic Factors|immunologic factors|mesh-ancestor
93318810|NCT00004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318811|NCT00004899|Alkylating Agents|alkylating agents|mesh-ancestor
93318812|NCT00004899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318813|NCT00004899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93318814|NCT00004899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93318815|NCT03199976|Fluticasone|fluticasone|mesh-list
93318816|NCT03199976|Xhance|xhance|mesh-list
93318817|NCT03199976|Bromides|bromides|mesh-list
93318818|NCT03199976|Albuterol|albuterol|mesh-list
93318819|NCT03199976|Tiotropium Bromide|tiotropium bromide|mesh-list
93318820|NCT03199976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318821|NCT03199976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93318822|NCT03199976|Autonomic Agents|autonomic agents|mesh-ancestor
93318823|NCT03199976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318824|NCT03199976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318825|NCT03199976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93318826|NCT03199976|Respiratory System Agents|respiratory system agents|mesh-ancestor
93318827|NCT03199976|Dermatologic Agents|dermatologic agents|mesh-ancestor
93318828|NCT03199976|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93318829|NCT03199976|Parasympatholytics|parasympatholytics|mesh-ancestor
93318830|NCT03199976|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93318831|NCT03199976|Cholinergic Agents|cholinergic agents|mesh-ancestor
93318832|NCT03199976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93318833|NCT03199976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318834|NCT03199976|Anticonvulsants|anticonvulsants|mesh-ancestor
93318835|NCT03199976|Tocolytic Agents|tocolytic agents|mesh-ancestor
93318836|NCT03199976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93318837|NCT03199976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93318838|NCT03199976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93318839|NCT03199976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93318840|NCT03199976|Adrenergic Agents|adrenergic agents|mesh-ancestor
93318841|NCT00369317|Cytarabine|cytarabine|mesh-list
93318842|NCT00369317|Etoposide|etoposide|mesh-list
93318843|NCT00369317|Daunorubicin|daunorubicin|mesh-list
93318844|NCT00369317|Etoposide phosphate|etoposide phosphate|mesh-list
93318845|NCT00369317|Asparaginase|asparaginase|mesh-list
93318846|NCT00369317|Thioguanine|thioguanine|mesh-list
93318847|NCT00369317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93318848|NCT00369317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318849|NCT00369317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93318850|NCT00369317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93318851|NCT00369317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318852|NCT00369317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318853|NCT00369317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318854|NCT00369317|Antimetabolites|antimetabolites|mesh-ancestor
93318855|NCT00369317|Antiviral Agents|antiviral agents|mesh-ancestor
93318856|NCT00369317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318857|NCT00369317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318858|NCT00369317|Immunologic Factors|immunologic factors|mesh-ancestor
93318859|NCT00369317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318860|NCT00369317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93318861|NCT02447666|Azacitidine|azacitidine|mesh-list
93318862|NCT02447666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318863|NCT02447666|Antimetabolites|antimetabolites|mesh-ancestor
93318864|NCT02447666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318865|NCT02447666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318866|NCT02447666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318867|NCT04469829|Methotrexate|methotrexate|mesh-list
93318868|NCT04469829|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93318869|NCT04469829|Abortifacient Agents|abortifacient agents|mesh-ancestor
93318870|NCT04469829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93318871|NCT04469829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318872|NCT04469829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318873|NCT04469829|Antimetabolites|antimetabolites|mesh-ancestor
93318874|NCT04469829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318875|NCT04469829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318876|NCT04469829|Dermatologic Agents|dermatologic agents|mesh-ancestor
93318877|NCT04469829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318878|NCT04469829|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93318879|NCT04469829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318880|NCT04469829|Immunologic Factors|immunologic factors|mesh-ancestor
93318881|NCT04469829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318882|NCT04469829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318883|NCT00405951|Docetaxel|docetaxel|mesh-list
93318884|NCT00405951|Obatoclax|obatoclax|mesh-list
93318885|NCT00405951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318886|NCT00405951|Tubulin Modulators|tubulin modulators|mesh-ancestor
93318887|NCT00405951|Antimitotic Agents|antimitotic agents|mesh-ancestor
93318888|NCT00405951|Mitosis Modulators|mitosis modulators|mesh-ancestor
93318889|NCT00405951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318890|NCT00405951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318891|NCT03194984|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93318892|NCT03194984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93318893|NCT03194984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318894|NCT03669757|Betamethasone|betamethasone|mesh-list
93318895|NCT03669757|Betamethasone Valerate|betamethasone valerate|mesh-list
93318896|NCT03669757|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93318897|NCT03669757|Betamethasone benzoate|betamethasone benzoate|mesh-list
93318898|NCT03669757|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93318899|NCT03669757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318900|NCT03669757|Glucocorticoids|glucocorticoids|mesh-ancestor
93318901|NCT03669757|Hormones|hormones|mesh-ancestor
93318902|NCT03669757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318903|NCT03669757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318904|NCT03669757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93318905|NCT03669757|Respiratory System Agents|respiratory system agents|mesh-ancestor
93318906|NCT02303821|Cytarabine|cytarabine|mesh-list
93318907|NCT02303821|Dexamethasone|dexamethasone|mesh-list
93318908|NCT02303821|Hydrocortisone|hydrocortisone|mesh-list
93318909|NCT02303821|Cyclophosphamide|cyclophosphamide|mesh-list
93318910|NCT02303821|Methotrexate|methotrexate|mesh-list
93318911|NCT02303821|Vincristine|vincristine|mesh-list
93318912|NCT02303821|Daunorubicin|daunorubicin|mesh-list
93318913|NCT02303821|Asparaginase|asparaginase|mesh-list
93318914|NCT02303821|Mitoxantrone|mitoxantrone|mesh-list
93318915|NCT02303821|Mercaptopurine|mercaptopurine|mesh-list
93318916|NCT02303821|Pegaspargase|pegaspargase|mesh-list
93318917|NCT02303821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318918|NCT02303821|Immunologic Factors|immunologic factors|mesh-ancestor
93318919|NCT02303821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318920|NCT02303821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93318921|NCT02303821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93318922|NCT02303821|Alkylating Agents|alkylating agents|mesh-ancestor
93318923|NCT02303821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318924|NCT02303821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318925|NCT02303821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93318926|NCT02303821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93318927|NCT02303821|Antiemetics|antiemetics|mesh-ancestor
93318928|NCT02303821|Autonomic Agents|autonomic agents|mesh-ancestor
93318929|NCT02303821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318930|NCT02303821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93318931|NCT02303821|Glucocorticoids|glucocorticoids|mesh-ancestor
93318932|NCT02303821|Hormones|hormones|mesh-ancestor
93318933|NCT02303821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93318934|NCT02303821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93318935|NCT02303821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93318936|NCT02303821|Abortifacient Agents|abortifacient agents|mesh-ancestor
93318937|NCT02303821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93318938|NCT02303821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93318939|NCT02303821|Antimetabolites|antimetabolites|mesh-ancestor
93318940|NCT02303821|Dermatologic Agents|dermatologic agents|mesh-ancestor
93318941|NCT02303821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318942|NCT02303821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93318943|NCT02303821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318944|NCT02303821|Antiviral Agents|antiviral agents|mesh-ancestor
93318945|NCT02303821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93318946|NCT02303821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93318947|NCT02303821|Tubulin Modulators|tubulin modulators|mesh-ancestor
93318948|NCT02303821|Antimitotic Agents|antimitotic agents|mesh-ancestor
93318949|NCT02303821|Mitosis Modulators|mitosis modulators|mesh-ancestor
93318950|NCT02303821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93318951|NCT02303821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93318952|NCT02303821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93318953|NCT02303821|Analgesics|analgesics|mesh-ancestor
93318954|NCT02303821|Sensory System Agents|sensory system agents|mesh-ancestor
93318955|NCT03913091|Bupivacaine|bupivacaine|mesh-list
93318956|NCT03913091|Anesthetics, Local|anesthetics, local|mesh-ancestor
93318957|NCT03913091|Anesthetics|anesthetics|mesh-ancestor
93318958|NCT03913091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93318959|NCT03913091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318960|NCT03913091|Sensory System Agents|sensory system agents|mesh-ancestor
93318961|NCT03913091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318962|NCT00330369|Darusentan|darusentan|mesh-list
93318963|NCT00330369|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93318964|NCT00330369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318965|NCT03199664|Tacrolimus|tacrolimus|mesh-list
93318966|NCT03199664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93318967|NCT03199664|Immunologic Factors|immunologic factors|mesh-ancestor
93318968|NCT03199664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318969|NCT03199664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93318970|NCT03199664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318971|NCT03199664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318972|NCT02447510|Mitogens|mitogens|mesh-list
93318973|NCT02447510|Mitosis Modulators|mitosis modulators|mesh-ancestor
93318974|NCT02447510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318975|NCT05674643|Acetaminophen|acetaminophen|mesh-list
93318976|NCT05674643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93318977|NCT05674643|Analgesics|analgesics|mesh-ancestor
93318978|NCT05674643|Sensory System Agents|sensory system agents|mesh-ancestor
93318979|NCT05674643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93318980|NCT05674643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93318981|NCT05674643|Antipyretics|antipyretics|mesh-ancestor
93318982|NCT02149537|Hydroxyurea|hydroxyurea|mesh-list
93318983|NCT02149537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318984|NCT02149537|Antisickling Agents|antisickling agents|mesh-ancestor
93318985|NCT02149537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318986|NCT02149537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318987|NCT02149537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93318988|NCT03179917|Pembrolizumab|pembrolizumab|mesh-list
93318989|NCT03179917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93318990|NCT03179917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318991|NCT03179917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93318992|NCT03179917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93318993|NCT05216237|Oxaliplatin|oxaliplatin|mesh-list
93318994|NCT05216237|Apatinib|apatinib|mesh-list
93318995|NCT05216237|Tegafur|tegafur|mesh-list
93318996|NCT05216237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93318997|NCT05216237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93318998|NCT05216237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93318999|NCT05216237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319000|NCT05216237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319001|NCT05216237|Antimetabolites|antimetabolites|mesh-ancestor
93319002|NCT00322257|Insulin|insulin|mesh-list
93319003|NCT00322257|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93319004|NCT00322257|Insulin Aspart|insulin aspart|mesh-list
93319005|NCT00322257|Insulin Detemir|insulin detemir|mesh-list
93319006|NCT00322257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319007|NCT00322257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319008|NCT03674671|Ketamine|ketamine|mesh-list
93319009|NCT03674671|Analgesics|analgesics|mesh-ancestor
93319010|NCT03674671|Sensory System Agents|sensory system agents|mesh-ancestor
93319011|NCT03674671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319012|NCT03674671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319013|NCT03674671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93319014|NCT03674671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93319015|NCT03674671|Anesthetics, General|anesthetics, general|mesh-ancestor
93319016|NCT03674671|Anesthetics|anesthetics|mesh-ancestor
93319017|NCT03674671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319018|NCT03674671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93319019|NCT03674671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93319020|NCT03674671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319021|NCT03674671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319022|NCT00312975|Tremelimumab|tremelimumab|mesh-list
93319023|NCT00312975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319024|NCT03199820|Dinoprostone|dinoprostone|mesh-list
93319025|NCT03199820|Oxytocics|oxytocics|mesh-ancestor
93319026|NCT03199820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93319027|NCT03199820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319028|NCT03199430|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93319029|NCT03199430|Antioxidants|antioxidants|mesh-ancestor
93319030|NCT03199430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319031|NCT03199430|Protective Agents|protective agents|mesh-ancestor
93319032|NCT03199430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319033|NCT03199430|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93319034|NCT03199430|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93319035|NCT03199430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319036|NCT03199430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93319037|NCT02287857|Tenofovir|tenofovir|mesh-list
93319038|NCT02287857|Antiviral Agents|antiviral agents|mesh-ancestor
93319039|NCT02287857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319040|NCT02287857|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93319041|NCT02287857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93319042|NCT02287857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319043|NCT02287857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319044|NCT02287857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93319045|NCT02287857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93319046|NCT01318499|Nepafenac|nepafenac|mesh-list
93319047|NCT01318499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93319048|NCT01318499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93319049|NCT01318499|Analgesics|analgesics|mesh-ancestor
93319050|NCT01318499|Sensory System Agents|sensory system agents|mesh-ancestor
93319051|NCT01318499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319052|NCT01318499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319053|NCT01318499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319054|NCT01318499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319055|NCT00397293|Topotecan|topotecan|mesh-list
93319056|NCT00397293|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93319057|NCT00397293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93319058|NCT00397293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319059|NCT00397293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319060|NCT00397293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319061|NCT03628079|Mebendazole|mebendazole|mesh-list
93319062|NCT03628079|Antinematodal Agents|antinematodal agents|mesh-ancestor
93319063|NCT03628079|Anthelmintics|anthelmintics|mesh-ancestor
93319064|NCT03628079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93319065|NCT03628079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319066|NCT03628079|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319067|NCT03628079|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319068|NCT03628079|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319069|NCT03628079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319070|NCT03628079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319071|NCT03204734|Capecitabine|capecitabine|mesh-list
93319072|NCT03204734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319073|NCT03204734|Antimetabolites|antimetabolites|mesh-ancestor
93319074|NCT03204734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319075|NCT03204734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319076|NCT00396357|Metformin|metformin|mesh-list
93319077|NCT00396357|Vildagliptin|vildagliptin|mesh-list
93319078|NCT00396357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319079|NCT00396357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319080|NCT00396357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93319081|NCT00396357|Protease Inhibitors|protease inhibitors|mesh-ancestor
93319082|NCT00396357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319083|NCT00396357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319084|NCT00394563|Tanezumab|tanezumab|mesh-list
93319085|NCT00394563|Analgesics|analgesics|mesh-ancestor
93319086|NCT00394563|Sensory System Agents|sensory system agents|mesh-ancestor
93319087|NCT00394563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319088|NCT00394563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319089|NCT02449538|Everolimus|everolimus|mesh-list
93319090|NCT02449538|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93319091|NCT02449538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93319092|NCT02449538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319093|NCT02449538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319094|NCT02449538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319095|NCT02449538|Immunologic Factors|immunologic factors|mesh-ancestor
93319096|NCT02449538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319097|NCT02449538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319098|NCT02446652|Paclitaxel|paclitaxel|mesh-list
93319099|NCT02446652|Carboplatin|carboplatin|mesh-list
93319100|NCT02446652|Hydralazine|hydralazine|mesh-list
93319101|NCT02446652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93319102|NCT02446652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319103|NCT02446652|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319104|NCT02446652|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319105|NCT02446652|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319106|NCT02446652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319107|NCT02446652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93319108|NCT02446652|Vasodilator Agents|vasodilator agents|mesh-ancestor
93319109|NCT00299715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93319110|NCT00299715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93319111|NCT00299715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93319112|NCT00299715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319113|NCT00299715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319114|NCT00299715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93319115|NCT00299715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93319116|NCT00299715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93319117|NCT00299715|Serotonin Agents|serotonin agents|mesh-ancestor
93319118|NCT00299715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319119|NCT00299715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319120|NCT00299715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93319121|NCT00299715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93319122|NCT00299715|Dopamine Agents|dopamine agents|mesh-ancestor
93319123|NCT00299325|Rimonabant|rimonabant|mesh-list
93319124|NCT00299325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93319125|NCT00299325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93319126|NCT00299325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93319127|NCT00299325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319128|NCT00299325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319129|NCT00299325|Hormones|hormones|mesh-ancestor
93319130|NCT00299325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319131|NCT00299325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319132|NCT00391209|Insulin|insulin|mesh-list
93319133|NCT00391209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93319134|NCT00391209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319135|NCT00391209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319136|NCT02446574|Paclitaxel|paclitaxel|mesh-list
93319137|NCT02446574|Cisplatin|cisplatin|mesh-list
92991143|NCT00461500|Adrenergic Agents|adrenergic agents|mesh-ancestor
93319138|NCT02446574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93319139|NCT02446574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319140|NCT02446574|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319141|NCT02446574|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319142|NCT02446574|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319143|NCT02446574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319144|NCT01775813|Metformin|metformin|mesh-list
93319145|NCT01775813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319146|NCT01775813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319147|NCT00287547|Abatacept|abatacept|mesh-list
93319148|NCT00287547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93319149|NCT00287547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319150|NCT00287547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93319151|NCT00287547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319152|NCT00287547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319153|NCT00287547|Immunologic Factors|immunologic factors|mesh-ancestor
93319154|NCT00287547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319155|NCT00287547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319156|NCT03204578|Midazolam|midazolam|mesh-list
93319157|NCT03204578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93319158|NCT03204578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93319159|NCT03204578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319160|NCT03204578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319161|NCT03204578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93319162|NCT03204578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93319163|NCT03204578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93319164|NCT03204578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93319165|NCT03204578|Anesthetics, General|anesthetics, general|mesh-ancestor
93319166|NCT03204578|Anesthetics|anesthetics|mesh-ancestor
93319167|NCT03204578|GABA Modulators|gaba modulators|mesh-ancestor
93319168|NCT03204578|GABA Agents|gaba agents|mesh-ancestor
93319169|NCT03204578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319170|NCT03204578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319171|NCT01694069|Tazobactam|tazobactam|mesh-list
93319172|NCT01694069|Piperacillin|piperacillin|mesh-list
93319173|NCT01694069|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93319174|NCT01694069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93319175|NCT01694069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319176|NCT01694069|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93319177|NCT01694069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319178|NCT01694069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319179|NCT03204032|Thalidomide|thalidomide|mesh-list
93319180|NCT03204032|Temozolomide|temozolomide|mesh-list
93319181|NCT03204032|Tegafur|tegafur|mesh-list
93319182|NCT03204032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93319183|NCT03204032|Alkylating Agents|alkylating agents|mesh-ancestor
93319184|NCT03204032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319185|NCT03204032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319186|NCT03204032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319187|NCT03204032|Immunologic Factors|immunologic factors|mesh-ancestor
93319188|NCT03204032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319189|NCT03204032|Leprostatic Agents|leprostatic agents|mesh-ancestor
93319190|NCT03204032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93319191|NCT03204032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319192|NCT03204032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93319193|NCT03204032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93319194|NCT03204032|Growth Substances|growth substances|mesh-ancestor
93319195|NCT03204032|Growth Inhibitors|growth inhibitors|mesh-ancestor
93319196|NCT03204032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319197|NCT03204032|Antimetabolites|antimetabolites|mesh-ancestor
93319198|NCT02285751|Aspirin|aspirin|mesh-list
93319199|NCT02285751|Clopidogrel|clopidogrel|mesh-list
93319200|NCT02285751|Ticagrelor|ticagrelor|mesh-list
93319201|NCT02285751|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93319202|NCT02285751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93319203|NCT02285751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93319204|NCT02285751|Analgesics|analgesics|mesh-ancestor
93319205|NCT02285751|Sensory System Agents|sensory system agents|mesh-ancestor
93319206|NCT02285751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319207|NCT02285751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319208|NCT02285751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319209|NCT02285751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319210|NCT02285751|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93319211|NCT02285751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93319212|NCT02285751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319213|NCT02285751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93319214|NCT02285751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93319215|NCT02285751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319216|NCT02285751|Antipyretics|antipyretics|mesh-ancestor
93319217|NCT02285751|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93319218|NCT02285751|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93319219|NCT02285751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93319220|NCT02285751|Purinergic Agents|purinergic agents|mesh-ancestor
93319221|NCT02285751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319222|NCT02446730|Clopidogrel|clopidogrel|mesh-list
93319223|NCT02446730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93319224|NCT02446730|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93319225|NCT02446730|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93319226|NCT02446730|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93319227|NCT02446730|Purinergic Agents|purinergic agents|mesh-ancestor
93319228|NCT02446730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319229|NCT02446730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319230|NCT02446730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319231|NCT05114915|Docetaxel|docetaxel|mesh-list
93319232|NCT05114915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319233|NCT05114915|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319234|NCT05114915|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319235|NCT05114915|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319236|NCT05114915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319237|NCT03532035|Brincidofovir|brincidofovir|mesh-list
93319238|NCT03532035|Antiviral Agents|antiviral agents|mesh-ancestor
93319239|NCT03532035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319240|NCT00282867|Insulin|insulin|mesh-list
93319241|NCT00282867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319242|NCT00282867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319243|NCT03198338|Bupivacaine|bupivacaine|mesh-list
93319244|NCT03198338|Anesthetics, Local|anesthetics, local|mesh-ancestor
93319245|NCT03198338|Anesthetics|anesthetics|mesh-ancestor
93319246|NCT03198338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319247|NCT03198338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319248|NCT03198338|Sensory System Agents|sensory system agents|mesh-ancestor
93319249|NCT03198338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319250|NCT05222633|Ranibizumab|ranibizumab|mesh-list
93319251|NCT05222633|Aflibercept|aflibercept|mesh-list
93319252|NCT05222633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93319253|NCT05222633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93319254|NCT05222633|Growth Substances|growth substances|mesh-ancestor
93319255|NCT05222633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319256|NCT05222633|Growth Inhibitors|growth inhibitors|mesh-ancestor
93319257|NCT05222633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319258|NCT05222243|Calcium|calcium|mesh-list
93319259|NCT05222243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93319260|NCT05222243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319261|NCT04469283|Caffeine|caffeine|mesh-list
93319262|NCT04469283|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93319263|NCT04469283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319264|NCT04469283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93319265|NCT04469283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319266|NCT04469283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319267|NCT04469283|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93319268|NCT04469283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93319269|NCT04469283|Purinergic Agents|purinergic agents|mesh-ancestor
93319270|NCT04469283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319271|NCT02285829|Bromides|bromides|mesh-list
93319272|NCT02285829|Rocuronium|rocuronium|mesh-list
93319273|NCT02285829|Cisatracurium|cisatracurium|mesh-list
93319274|NCT02285829|Anticonvulsants|anticonvulsants|mesh-ancestor
93319275|NCT02285829|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93319276|NCT02285829|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93319277|NCT02285829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93319278|NCT02285829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319279|NCT02285829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319280|NCT03203408|Hylan|hylan|mesh-list
93319281|NCT03203408|Viscosupplements|viscosupplements|mesh-ancestor
93319282|NCT03203408|Protective Agents|protective agents|mesh-ancestor
93319283|NCT03203408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319284|NCT02285985|Saxagliptin|saxagliptin|mesh-list
93319285|NCT02285985|Incretins|incretins|mesh-ancestor
93319286|NCT02285985|Hormones|hormones|mesh-ancestor
93319287|NCT02285985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319288|NCT02285985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319289|NCT02285985|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92991296|NCT04920149|Mesalamine|mesalamine|mesh-list
93319290|NCT02285985|Protease Inhibitors|protease inhibitors|mesh-ancestor
93319291|NCT02285985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319292|NCT02285985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319293|NCT02285985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319294|NCT02445872|Dexamethasone|dexamethasone|mesh-list
93319295|NCT02445872|Aprepitant|aprepitant|mesh-list
93319296|NCT02445872|Palonosetron|palonosetron|mesh-list
93319297|NCT02445872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319298|NCT02445872|Antiemetics|antiemetics|mesh-ancestor
93319299|NCT02445872|Autonomic Agents|autonomic agents|mesh-ancestor
93319300|NCT02445872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319301|NCT02445872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319302|NCT02445872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319303|NCT02445872|Glucocorticoids|glucocorticoids|mesh-ancestor
93319304|NCT02445872|Hormones|hormones|mesh-ancestor
93319305|NCT02445872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319306|NCT02445872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319307|NCT02445872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319308|NCT02445872|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93319309|NCT02445872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319310|NCT02445872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319311|NCT02445872|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93319312|NCT02445872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93319313|NCT02445872|Serotonin Agents|serotonin agents|mesh-ancestor
93319314|NCT05221775|Lenvatinib|lenvatinib|mesh-list
93319315|NCT05221775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319316|NCT05221775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93319317|NCT05221775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319318|NCT05221775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319319|NCT04700423|Ivermectin|ivermectin|mesh-list
93319320|NCT04700423|Albendazole|albendazole|mesh-list
93319321|NCT04700423|Moxidectin|moxidectin|mesh-list
93319322|NCT04700423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93319323|NCT04700423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319324|NCT04700423|Anthelmintics|anthelmintics|mesh-ancestor
93319325|NCT04700423|Anticestodal Agents|anticestodal agents|mesh-ancestor
93319326|NCT04700423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93319327|NCT04700423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93319328|NCT04700423|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319329|NCT04700423|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319330|NCT04700423|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319331|NCT04700423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319332|NCT04700423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319333|NCT04700423|Antinematodal Agents|antinematodal agents|mesh-ancestor
93319334|NCT02286219|Immunoglobulins|immunoglobulins|mesh-list
93319335|NCT02286219|Immunoglobulin G|immunoglobulin g|mesh-list
93319336|NCT02286219|Immunologic Factors|immunologic factors|mesh-ancestor
93319337|NCT02286219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319338|NCT02445716|Methyltestosterone|methyltestosterone|mesh-list
93319339|NCT02445716|Testosterone|testosterone|mesh-list
93319340|NCT02445716|Testosterone undecanoate|testosterone undecanoate|mesh-list
93319341|NCT02445716|Testosterone enanthate|testosterone enanthate|mesh-list
93319342|NCT02445716|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93319343|NCT02445716|Androgens|androgens|mesh-ancestor
93319344|NCT02445716|Hormones|hormones|mesh-ancestor
93319345|NCT02445716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319346|NCT02445716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319347|NCT02445716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319348|NCT02445716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319349|NCT02445716|Anabolic Agents|anabolic agents|mesh-ancestor
93319350|NCT03197636|Pembrolizumab|pembrolizumab|mesh-list
93319351|NCT03197636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93319352|NCT03197636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319353|NCT03197636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93319354|NCT03197636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319355|NCT05724381|Phenol|phenol|mesh-list
93319356|NCT05724381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93319357|NCT05724381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319358|NCT05724381|Disinfectants|disinfectants|mesh-ancestor
93319359|NCT05724381|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93319360|NCT05724381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93319361|NCT03194594|Dexamethasone|dexamethasone|mesh-list
93319362|NCT03194594|Ketamine|ketamine|mesh-list
93319363|NCT03194594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319364|NCT03194594|Antiemetics|antiemetics|mesh-ancestor
93319365|NCT03194594|Autonomic Agents|autonomic agents|mesh-ancestor
93319366|NCT03194594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319367|NCT03194594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319368|NCT03194594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319369|NCT03194594|Glucocorticoids|glucocorticoids|mesh-ancestor
93319370|NCT03194594|Hormones|hormones|mesh-ancestor
93319371|NCT03194594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613294|NCT00514072|BCG Vaccine|bcg vaccine|mesh-list
93319372|NCT03194594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319373|NCT03194594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319374|NCT03194594|Analgesics|analgesics|mesh-ancestor
93319375|NCT03194594|Sensory System Agents|sensory system agents|mesh-ancestor
93319376|NCT03194594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93319377|NCT03194594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93319378|NCT03194594|Anesthetics, General|anesthetics, general|mesh-ancestor
93319379|NCT03194594|Anesthetics|anesthetics|mesh-ancestor
93319380|NCT03194594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319381|NCT03194594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93319382|NCT03194594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93319383|NCT03194594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319384|NCT03194594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319385|NCT04407377|Cyclobenzaprine|cyclobenzaprine|mesh-list
93319386|NCT04407377|Tolperisone|tolperisone|mesh-list
93319387|NCT04407377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93319388|NCT04407377|Antidepressive Agents|antidepressive agents|mesh-ancestor
93319389|NCT04407377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93319390|NCT04407377|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93319391|NCT04407377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319392|NCT04407377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93319393|NCT04407377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319394|NCT04407377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93319395|NCT04407377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319396|NCT03203174|Botulinum Toxins|botulinum toxins|mesh-list
93319397|NCT03203174|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93319398|NCT03203174|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93319399|NCT03203174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93319400|NCT03203174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93319401|NCT03203174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319402|NCT03203174|Cholinergic Agents|cholinergic agents|mesh-ancestor
93319403|NCT03203174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319404|NCT03203174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319405|NCT03203174|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93319406|NCT03203174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319407|NCT00257205|Temozolomide|temozolomide|mesh-list
93319408|NCT00257205|Dacarbazine|dacarbazine|mesh-list
93319409|NCT00257205|Tremelimumab|tremelimumab|mesh-list
93319410|NCT00257205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93319411|NCT00257205|Alkylating Agents|alkylating agents|mesh-ancestor
93319412|NCT00257205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319413|NCT00257205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319414|NCT03194204|Doxycycline|doxycycline|mesh-list
93319415|NCT03194204|Uric Acid|uric acid|mesh-list
93319416|NCT03194204|Rheumatoid Factor|rheumatoid factor|mesh-list
93319417|NCT03194204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93319418|NCT03194204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319419|NCT03194204|Antimalarials|antimalarials|mesh-ancestor
93319420|NCT03194204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93319421|NCT03194204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93319422|NCT03194204|Antioxidants|antioxidants|mesh-ancestor
93319423|NCT03194204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319424|NCT03194204|Protective Agents|protective agents|mesh-ancestor
93319425|NCT03194204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319426|NCT03194204|Immunologic Factors|immunologic factors|mesh-ancestor
93319427|NCT04045301|Omalizumab|omalizumab|mesh-list
93319428|NCT04045301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93319429|NCT04045301|Immunologic Factors|immunologic factors|mesh-ancestor
93319430|NCT04045301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319431|NCT04045301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93319432|NCT04045301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93319433|NCT04045301|Respiratory System Agents|respiratory system agents|mesh-ancestor
93319434|NCT03197480|Aflibercept|aflibercept|mesh-list
93319435|NCT03197480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93319436|NCT03197480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93319437|NCT03197480|Growth Substances|growth substances|mesh-ancestor
93319438|NCT03197480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319439|NCT03197480|Growth Inhibitors|growth inhibitors|mesh-ancestor
93319440|NCT03197480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991443|NCT00722579|Cobalt|cobalt|mesh-list
93319441|NCT00151281|Thalidomide|thalidomide|mesh-list
93319442|NCT00151281|Prednisone|prednisone|mesh-list
93319443|NCT00151281|Cyclophosphamide|cyclophosphamide|mesh-list
93319444|NCT00151281|Rituximab|rituximab|mesh-list
93319445|NCT00151281|Etoposide|etoposide|mesh-list
93319446|NCT00151281|Procarbazine|procarbazine|mesh-list
93319447|NCT00151281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319448|NCT00151281|Immunologic Factors|immunologic factors|mesh-ancestor
93319449|NCT00151281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319450|NCT00151281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319451|NCT00151281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93319452|NCT00151281|Alkylating Agents|alkylating agents|mesh-ancestor
93319453|NCT00151281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319454|NCT00151281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319455|NCT00151281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93319456|NCT00151281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93319457|NCT00151281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319458|NCT00151281|Glucocorticoids|glucocorticoids|mesh-ancestor
93319459|NCT00151281|Hormones|hormones|mesh-ancestor
93319460|NCT00151281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319461|NCT00151281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319462|NCT00151281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93319463|NCT00151281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93319464|NCT00151281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93319465|NCT00151281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319466|NCT00151281|Leprostatic Agents|leprostatic agents|mesh-ancestor
93319467|NCT00151281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93319468|NCT00151281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319469|NCT00151281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93319470|NCT00151281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93319471|NCT00151281|Growth Substances|growth substances|mesh-ancestor
93319472|NCT00151281|Growth Inhibitors|growth inhibitors|mesh-ancestor
93319473|NCT03202862|Fulvestrant|fulvestrant|mesh-list
93319474|NCT03202862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319475|NCT03202862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319476|NCT03202862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93319477|NCT03202862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93319478|NCT03202862|Hormone Antagonists|hormone antagonists|mesh-ancestor
93319479|NCT03202862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319480|NCT03202862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319481|NCT00255099|Etravirine|etravirine|mesh-list
93319482|NCT00255099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93319483|NCT00255099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93319484|NCT00255099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319485|NCT00255099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319486|NCT00255099|Antiviral Agents|antiviral agents|mesh-ancestor
93319487|NCT00255099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319488|NCT00231153|Povidone-Iodine|povidone-iodine|mesh-list
93319489|NCT00231153|Povidone|povidone|mesh-list
93319490|NCT00231153|Plasma Substitutes|plasma substitutes|mesh-ancestor
93319491|NCT00231153|Blood Substitutes|blood substitutes|mesh-ancestor
93319492|NCT00231153|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93319493|NCT00231153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319494|NCT03202784|Berotralstat|berotralstat|mesh-list
93319495|NCT03202784|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93319496|NCT03202784|Protease Inhibitors|protease inhibitors|mesh-ancestor
93319497|NCT03202784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319498|NCT03202784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319499|NCT05220527|Triamcinolone|triamcinolone|mesh-list
93319500|NCT05220527|Hyaluronic Acid|hyaluronic acid|mesh-list
93319501|NCT05220527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319502|NCT05220527|Glucocorticoids|glucocorticoids|mesh-ancestor
93319503|NCT05220527|Hormones|hormones|mesh-ancestor
93319504|NCT05220527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319505|NCT05220527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319506|NCT05220527|Immunologic Factors|immunologic factors|mesh-ancestor
93319507|NCT05220527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93319508|NCT05220527|Viscosupplements|viscosupplements|mesh-ancestor
93319509|NCT05220527|Protective Agents|protective agents|mesh-ancestor
93319510|NCT03197402|Caseins|caseins|mesh-list
93319511|NCT03197402|Chelating Agents|chelating agents|mesh-ancestor
93319512|NCT03197402|Sequestering Agents|sequestering agents|mesh-ancestor
93319513|NCT03197402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319514|NCT05723991|Gemcitabine|gemcitabine|mesh-list
93319515|NCT05723991|Disitamab vedotin|disitamab vedotin|mesh-list
93366440|NCT02796677|Tiotropium Bromide|tiotropium bromide|mesh-list
93319516|NCT05723991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319517|NCT05723991|Antimetabolites|antimetabolites|mesh-ancestor
93319518|NCT05723991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319519|NCT05723991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319520|NCT05723991|Immunoconjugates|immunoconjugates|mesh-ancestor
93319521|NCT05723991|Immunologic Factors|immunologic factors|mesh-ancestor
93319522|NCT05723991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319523|NCT01318109|Metformin|metformin|mesh-list
93319524|NCT01318109|Alogliptin|alogliptin|mesh-list
93319525|NCT01318109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319526|NCT01318109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319527|NCT01318109|Incretins|incretins|mesh-ancestor
93319528|NCT01318109|Hormones|hormones|mesh-ancestor
93319529|NCT01318109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319530|NCT01318109|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93319531|NCT01318109|Protease Inhibitors|protease inhibitors|mesh-ancestor
93319532|NCT01318109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319533|NCT01318109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319534|NCT05721027|Dexamethasone|dexamethasone|mesh-list
93319535|NCT05721027|Ibuprofen|ibuprofen|mesh-list
93319536|NCT05721027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319537|NCT05721027|Antiemetics|antiemetics|mesh-ancestor
93319538|NCT05721027|Autonomic Agents|autonomic agents|mesh-ancestor
93319539|NCT05721027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319540|NCT05721027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319541|NCT05721027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319542|NCT05721027|Glucocorticoids|glucocorticoids|mesh-ancestor
93319543|NCT05721027|Hormones|hormones|mesh-ancestor
93319544|NCT05721027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319545|NCT05721027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319546|NCT05721027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319547|NCT05721027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93319548|NCT05721027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93319549|NCT05721027|Analgesics|analgesics|mesh-ancestor
93319550|NCT05721027|Sensory System Agents|sensory system agents|mesh-ancestor
93319551|NCT05721027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319552|NCT05721027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93319553|NCT05721027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319554|NCT05721027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319555|NCT05720871|Capsaicin|capsaicin|mesh-list
93319556|NCT05720871|Antipruritics|antipruritics|mesh-ancestor
93319557|NCT05720871|Dermatologic Agents|dermatologic agents|mesh-ancestor
93319558|NCT05720871|Sensory System Agents|sensory system agents|mesh-ancestor
93319559|NCT05720871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319560|NCT05720871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319561|NCT05672927|Vaccines|vaccines|mesh-list
93319562|NCT05672927|Immunologic Factors|immunologic factors|mesh-ancestor
93319563|NCT05672927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319564|NCT05636267|Carboplatin|carboplatin|mesh-list
93319565|NCT05636267|Pemetrexed|pemetrexed|mesh-list
93319566|NCT05636267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319567|NCT05636267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319568|NCT05636267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319569|NCT05636267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93319570|NCT05636267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93319571|NCT03873311|Cytarabine|cytarabine|mesh-list
93319572|NCT03873311|Azacitidine|azacitidine|mesh-list
93319573|NCT03873311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319574|NCT03873311|Antimetabolites|antimetabolites|mesh-ancestor
93319575|NCT03873311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319576|NCT03873311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319577|NCT03873311|Antiviral Agents|antiviral agents|mesh-ancestor
93319578|NCT03873311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319579|NCT03873311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319580|NCT03873311|Immunologic Factors|immunologic factors|mesh-ancestor
93319581|NCT03873311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319582|NCT03873311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319583|NCT00162279|Abatacept|abatacept|mesh-list
93319584|NCT00162279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93319585|NCT00162279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319586|NCT00162279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93319587|NCT00162279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319588|NCT00162279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319589|NCT00162279|Immunologic Factors|immunologic factors|mesh-ancestor
93319590|NCT00162279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319591|NCT00162279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319592|NCT00145431|Atorvastatin|atorvastatin|mesh-list
93319593|NCT00145431|Torcetrapib|torcetrapib|mesh-list
93319594|NCT00145431|Fenofibrate|fenofibrate|mesh-list
93319595|NCT00145431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93319596|NCT00145431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93319597|NCT00145431|Antimetabolites|antimetabolites|mesh-ancestor
93319598|NCT00145431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319599|NCT00145431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93319600|NCT00145431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93319601|NCT00145431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319602|NCT00135369|Lamivudine|lamivudine|mesh-list
93319603|NCT00135369|Efavirenz|efavirenz|mesh-list
93319604|NCT00135369|Stavudine|stavudine|mesh-list
93319605|NCT00135369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93319606|NCT00135369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93319607|NCT00135369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319608|NCT00135369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319609|NCT00135369|Antiviral Agents|antiviral agents|mesh-ancestor
93319610|NCT00135369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319611|NCT00135369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93319612|NCT00135369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93319613|NCT00135369|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93319614|NCT00135369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93319615|NCT00135369|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93319616|NCT00135369|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93319617|NCT00135369|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93319618|NCT00135369|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93319619|NCT00135369|Antimetabolites|antimetabolites|mesh-ancestor
93319620|NCT03530319|Azithromycin|azithromycin|mesh-list
93319621|NCT03530319|Doxycycline|doxycycline|mesh-list
93319622|NCT03530319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93319623|NCT03530319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319624|NCT03530319|Antimalarials|antimalarials|mesh-ancestor
93319625|NCT03530319|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93319626|NCT03530319|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93319627|NCT05726253|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93319628|NCT05726253|Amoxicillin|amoxicillin|mesh-list
93319629|NCT05726253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319630|NCT02445404|Dexamethasone|dexamethasone|mesh-list
93319631|NCT02445404|Prednisone|prednisone|mesh-list
93319632|NCT02445404|Cyclophosphamide|cyclophosphamide|mesh-list
93319633|NCT02445404|Ifosfamide|ifosfamide|mesh-list
93319634|NCT02445404|Carboplatin|carboplatin|mesh-list
93319635|NCT02445404|Etoposide|etoposide|mesh-list
93319636|NCT02445404|Vincristine|vincristine|mesh-list
93319637|NCT02445404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319638|NCT02445404|Immunologic Factors|immunologic factors|mesh-ancestor
93319639|NCT02445404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319640|NCT02445404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319641|NCT02445404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93319642|NCT02445404|Alkylating Agents|alkylating agents|mesh-ancestor
93319643|NCT02445404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319644|NCT02445404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319645|NCT02445404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93319646|NCT02445404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319647|NCT02445404|Antiemetics|antiemetics|mesh-ancestor
93319648|NCT02445404|Autonomic Agents|autonomic agents|mesh-ancestor
93319649|NCT02445404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319650|NCT02445404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319651|NCT02445404|Glucocorticoids|glucocorticoids|mesh-ancestor
93319652|NCT02445404|Hormones|hormones|mesh-ancestor
93319653|NCT02445404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319654|NCT02445404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319655|NCT02445404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319656|NCT02445404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93319657|NCT02445404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93319658|NCT02445404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93319659|NCT02445404|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319660|NCT02445404|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319661|NCT02445404|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319662|NCT05726175|Disitamab vedotin|disitamab vedotin|mesh-list
93319663|NCT05726175|Immunoconjugates|immunoconjugates|mesh-ancestor
93319664|NCT05726175|Immunologic Factors|immunologic factors|mesh-ancestor
93319665|NCT05726175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991675|NCT00724529|Infliximab|infliximab|mesh-list
93319666|NCT03530085|Fludarabine|fludarabine|mesh-list
93319667|NCT03530085|Busulfan|busulfan|mesh-list
93319668|NCT03530085|Decitabine|decitabine|mesh-list
93319669|NCT03530085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319670|NCT03530085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319671|NCT03530085|Antimetabolites|antimetabolites|mesh-ancestor
93319672|NCT03530085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319673|NCT03530085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319674|NCT03530085|Immunologic Factors|immunologic factors|mesh-ancestor
93319675|NCT03530085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319676|NCT03530085|Alkylating Agents|alkylating agents|mesh-ancestor
93319677|NCT03530085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93319678|NCT03530085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93319679|NCT03530085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319680|NCT03196934|Cannabidiol|cannabidiol|mesh-list
93319681|NCT03196934|Anticonvulsants|anticonvulsants|mesh-ancestor
93319682|NCT05304351|Vaccines|vaccines|mesh-list
93319683|NCT05304351|Immunologic Factors|immunologic factors|mesh-ancestor
93319684|NCT05304351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319685|NCT03197012|Octreotide|octreotide|mesh-list
93319686|NCT03197012|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93319687|NCT03197012|Edotreotide|edotreotide|mesh-list
93319688|NCT03197012|Chelating Agents|chelating agents|mesh-ancestor
93319689|NCT03197012|Sequestering Agents|sequestering agents|mesh-ancestor
93319690|NCT03197012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319691|NCT03197012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93319692|NCT03197012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319693|NCT03197012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319694|NCT03197012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319695|NCT03530007|Ondansetron|ondansetron|mesh-list
93319696|NCT03530007|Antiemetics|antiemetics|mesh-ancestor
93319697|NCT03530007|Autonomic Agents|autonomic agents|mesh-ancestor
93319698|NCT03530007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319699|NCT03530007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319700|NCT03530007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319701|NCT03530007|Antipruritics|antipruritics|mesh-ancestor
93319702|NCT03530007|Dermatologic Agents|dermatologic agents|mesh-ancestor
93319703|NCT03530007|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93319704|NCT03530007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93319705|NCT03530007|Serotonin Agents|serotonin agents|mesh-ancestor
93319706|NCT03530007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319707|NCT03530007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319708|NCT03529929|Methylprednisolone|methylprednisolone|mesh-list
93319709|NCT03529929|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93319710|NCT03529929|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93319711|NCT03529929|Prednisolone|prednisolone|mesh-list
93319712|NCT03529929|Prednisolone acetate|prednisolone acetate|mesh-list
93319713|NCT03529929|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93319714|NCT03529929|Prednisolone phosphate|prednisolone phosphate|mesh-list
93319715|NCT03529929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319716|NCT03529929|Antiemetics|antiemetics|mesh-ancestor
93319717|NCT03529929|Autonomic Agents|autonomic agents|mesh-ancestor
93319718|NCT03529929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319719|NCT03529929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319720|NCT03529929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319721|NCT03529929|Glucocorticoids|glucocorticoids|mesh-ancestor
93319722|NCT03529929|Hormones|hormones|mesh-ancestor
93319723|NCT03529929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93319724|NCT03529929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93319725|NCT03529929|Protective Agents|protective agents|mesh-ancestor
93319726|NCT03529929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93319727|NCT03529929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319728|NCT03052751|Rozanolixizumab|rozanolixizumab|mesh-list
93319729|NCT03052751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319730|NCT03052751|Immunologic Factors|immunologic factors|mesh-ancestor
92613653|NCT05861154|Sensory System Agents|sensory system agents|mesh-ancestor
93319731|NCT03052751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319732|NCT03525561|Acetazolamide|acetazolamide|mesh-list
93319733|NCT03525561|Anticonvulsants|anticonvulsants|mesh-ancestor
93319734|NCT03525561|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93319735|NCT03525561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319736|NCT03525561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319737|NCT03525561|Diuretics|diuretics|mesh-ancestor
93319738|NCT03525561|Natriuretic Agents|natriuretic agents|mesh-ancestor
93319739|NCT03525561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319740|NCT05696691|Ketamine|ketamine|mesh-list
93319741|NCT05696691|Analgesics|analgesics|mesh-ancestor
93319742|NCT05696691|Sensory System Agents|sensory system agents|mesh-ancestor
93319743|NCT05696691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319744|NCT05696691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319745|NCT05696691|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93319746|NCT05696691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93319747|NCT05696691|Anesthetics, General|anesthetics, general|mesh-ancestor
93319748|NCT05696691|Anesthetics|anesthetics|mesh-ancestor
93319749|NCT05696691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319750|NCT05696691|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93319751|NCT05696691|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93319752|NCT05696691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319753|NCT05696691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319755|NCT03527355|Immunologic Factors|immunologic factors|mesh-ancestor
93319756|NCT03527355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319757|NCT05707169|Lidocaine|lidocaine|mesh-list
93319758|NCT05707169|Epinephrine|epinephrine|mesh-list
93319759|NCT05707169|Racepinephrine|racepinephrine|mesh-list
93319760|NCT05707169|Levobupivacaine|levobupivacaine|mesh-list
93319761|NCT05707169|Epinephryl borate|epinephryl borate|mesh-list
93319762|NCT05707169|Anesthetics, Local|anesthetics, local|mesh-ancestor
93319763|NCT05707169|Anesthetics|anesthetics|mesh-ancestor
93319764|NCT05707169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319765|NCT05707169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319766|NCT05707169|Sensory System Agents|sensory system agents|mesh-ancestor
93319767|NCT05707169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319768|NCT05707169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93319769|NCT05707169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93319770|NCT05707169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93319771|NCT05707169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93319772|NCT05707169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319773|NCT05707169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93319774|NCT05707169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93319775|NCT05707169|Adrenergic Agents|adrenergic agents|mesh-ancestor
93319776|NCT05707169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319777|NCT05707169|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93319778|NCT05707169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93319779|NCT05707169|Autonomic Agents|autonomic agents|mesh-ancestor
93319780|NCT05707169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93319781|NCT05707169|Respiratory System Agents|respiratory system agents|mesh-ancestor
93319782|NCT05707169|Mydriatics|mydriatics|mesh-ancestor
93319783|NCT05707169|Sympathomimetics|sympathomimetics|mesh-ancestor
93319784|NCT05707169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93319785|NCT05052827|Caseins|caseins|mesh-list
93319786|NCT05052827|Chelating Agents|chelating agents|mesh-ancestor
93319787|NCT05052827|Sequestering Agents|sequestering agents|mesh-ancestor
93319788|NCT05052827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319789|NCT02712008|Aflibercept|aflibercept|mesh-list
93319790|NCT02712008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93319791|NCT02712008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93319792|NCT02712008|Growth Substances|growth substances|mesh-ancestor
93319793|NCT02712008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319794|NCT02712008|Growth Inhibitors|growth inhibitors|mesh-ancestor
93319795|NCT02712008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319796|NCT05130515|Niraparib|niraparib|mesh-list
93319797|NCT05130515|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93319798|NCT05130515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319799|NCT05130515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319800|NCT05130515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319801|NCT03193814|Apatinib|apatinib|mesh-list
93319802|NCT03193814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319803|NCT03193814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93319804|NCT03193814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319805|NCT03193814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319806|NCT05706779|Cetuximab|cetuximab|mesh-list
93319807|NCT05706779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93319808|NCT05706779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319809|NCT02450084|Fentanyl|fentanyl|mesh-list
93319810|NCT02450084|Ropivacaine|ropivacaine|mesh-list
93319811|NCT02450084|Anesthetics, Local|anesthetics, local|mesh-ancestor
93319812|NCT02450084|Anesthetics|anesthetics|mesh-ancestor
93319813|NCT02450084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319814|NCT02450084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319815|NCT02450084|Sensory System Agents|sensory system agents|mesh-ancestor
93319816|NCT02450084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319817|NCT02450084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93319818|NCT02450084|Narcotics|narcotics|mesh-ancestor
93319820|NCT02450084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93319821|NCT02450084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93319822|NCT02450084|Anesthetics, General|anesthetics, general|mesh-ancestor
93319823|NCT03201770|Artesunate|artesunate|mesh-list
93319824|NCT03201770|Pyronaridine|pyronaridine|mesh-list
93319825|NCT03201770|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93319826|NCT03201770|Antimalarials|antimalarials|mesh-ancestor
93319827|NCT03201770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93319828|NCT03201770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93319829|NCT03201770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319830|NCT03201770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319831|NCT03201770|Antiviral Agents|antiviral agents|mesh-ancestor
93319832|NCT03201770|Schistosomicides|schistosomicides|mesh-ancestor
93319833|NCT03201770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93319834|NCT03201770|Anthelmintics|anthelmintics|mesh-ancestor
93319835|NCT04213209|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93319836|NCT04213209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93319837|NCT04213209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319838|NCT04213209|Immunotoxins|immunotoxins|mesh-ancestor
93319839|NCT04213209|Immunoconjugates|immunoconjugates|mesh-ancestor
93319840|NCT04213209|Immunologic Factors|immunologic factors|mesh-ancestor
93319841|NCT04213209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319842|NCT04188405|Decitabine|decitabine|mesh-list
93319843|NCT04188405|Venetoclax|venetoclax|mesh-list
93319844|NCT04188405|Ponatinib|ponatinib|mesh-list
93319845|NCT04188405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319846|NCT04188405|Antimetabolites|antimetabolites|mesh-ancestor
93319847|NCT04188405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319848|NCT04188405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319849|NCT04188405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319850|NCT04188405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93319851|NCT04176393|Ivosidenib|ivosidenib|mesh-list
93319852|NCT04176393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319853|NCT04176393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319854|NCT04176393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319855|NCT02449070|Nicorandil|nicorandil|mesh-list
93319856|NCT02449070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93319857|NCT02449070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93319858|NCT02449070|Vasodilator Agents|vasodilator agents|mesh-ancestor
93319859|NCT02449070|Vitamin B Complex|vitamin b complex|mesh-ancestor
93319860|NCT02449070|Vitamins|vitamins|mesh-ancestor
93319861|NCT02449070|Micronutrients|micronutrients|mesh-ancestor
93319862|NCT02449070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319863|NCT03529149|Diltiazem|diltiazem|mesh-list
93319864|NCT03529149|Urapidil|urapidil|mesh-list
93319865|NCT03529149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93319866|NCT03529149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93319867|NCT03529149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93319868|NCT03529149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319869|NCT03529149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93319870|NCT03529149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319871|NCT03529149|Vasodilator Agents|vasodilator agents|mesh-ancestor
93319872|NCT03529149|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93319873|NCT03529149|Serotonin Agents|serotonin agents|mesh-ancestor
93319874|NCT03529149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319875|NCT03529149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93319876|NCT03529149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93319877|NCT03529149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93319878|NCT03529149|Adrenergic Agents|adrenergic agents|mesh-ancestor
93319879|NCT03193502|Rivaroxaban|rivaroxaban|mesh-list
93319880|NCT03193502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93319881|NCT03193502|Antithrombins|antithrombins|mesh-ancestor
93319882|NCT03193502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93319883|NCT03193502|Protease Inhibitors|protease inhibitors|mesh-ancestor
93319884|NCT03193502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319885|NCT03193502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319886|NCT03193502|Anticoagulants|anticoagulants|mesh-ancestor
93319887|NCT02711306|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93319888|NCT02711306|Cathartics|cathartics|mesh-ancestor
93319889|NCT02711306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319890|NCT03193112|Agomelatine|agomelatine|mesh-list
93319891|NCT03193112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93319892|NCT03193112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991895|NCT00725231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319893|NCT03193112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319894|NCT03196154|Insulin|insulin|mesh-list
93319895|NCT03196154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93319896|NCT03196154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319897|NCT03193424|Docetaxel|docetaxel|mesh-list
93319898|NCT03193424|Apatinib|apatinib|mesh-list
93319899|NCT03193424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319900|NCT03193424|Tubulin Modulators|tubulin modulators|mesh-ancestor
93319901|NCT03193424|Antimitotic Agents|antimitotic agents|mesh-ancestor
93319902|NCT03193424|Mitosis Modulators|mitosis modulators|mesh-ancestor
93319903|NCT03193424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319904|NCT03193424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93319905|NCT03193424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93319906|NCT03193346|Botulinum Toxins|botulinum toxins|mesh-list
93319907|NCT03193346|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93319908|NCT03193346|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93319909|NCT03193346|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93319910|NCT03193346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93319911|NCT03193346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319912|NCT03193346|Cholinergic Agents|cholinergic agents|mesh-ancestor
93319913|NCT03193346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319914|NCT03193346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319915|NCT03193346|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93319916|NCT03193346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319917|NCT03118076|Dexmedetomidine|dexmedetomidine|mesh-list
93319918|NCT03118076|Ropivacaine|ropivacaine|mesh-list
93319919|NCT03118076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93319920|NCT03118076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319921|NCT03118076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319922|NCT03118076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93319923|NCT03118076|Analgesics|analgesics|mesh-ancestor
93319924|NCT03118076|Sensory System Agents|sensory system agents|mesh-ancestor
93319925|NCT03118076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319926|NCT03118076|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93319927|NCT03118076|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93319928|NCT03118076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93319929|NCT03118076|Adrenergic Agents|adrenergic agents|mesh-ancestor
93319930|NCT03118076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319931|NCT03118076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319932|NCT03118076|Anesthetics, Local|anesthetics, local|mesh-ancestor
93319933|NCT03118076|Anesthetics|anesthetics|mesh-ancestor
93319934|NCT03528915|Rifamycins|rifamycins|mesh-list
93319935|NCT03528915|Rifamycin SV|rifamycin sv|mesh-list
93319936|NCT03528915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93319937|NCT03528915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93319938|NCT03528915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319939|NCT03192878|Infliximab|infliximab|mesh-list
93319940|NCT03192878|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93319941|NCT03192878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93319942|NCT03192878|Dermatologic Agents|dermatologic agents|mesh-ancestor
93319943|NCT03192878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93319944|NCT03192878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319945|NCT03241940|Cyclophosphamide|cyclophosphamide|mesh-list
93319946|NCT03241940|Fludarabine|fludarabine|mesh-list
93319947|NCT03241940|Fludarabine phosphate|fludarabine phosphate|mesh-list
93319948|NCT03241940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93319949|NCT03241940|Immunologic Factors|immunologic factors|mesh-ancestor
93319950|NCT03241940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319951|NCT03241940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93319952|NCT03241940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93319953|NCT03241940|Alkylating Agents|alkylating agents|mesh-ancestor
93319954|NCT03241940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319955|NCT03241940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319956|NCT03241940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93319957|NCT03241940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93319958|NCT03241940|Antimetabolites|antimetabolites|mesh-ancestor
93319959|NCT00294320|Imiquimod|imiquimod|mesh-list
93319960|NCT00294320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93319961|NCT00294320|Immunologic Factors|immunologic factors|mesh-ancestor
93319962|NCT00294320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319963|NCT00294320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319964|NCT00294320|Interferon Inducers|interferon inducers|mesh-ancestor
93319965|NCT03526575|Zaleplon|zaleplon|mesh-list
93319966|NCT03526575|Zolpidem|zolpidem|mesh-list
93319967|NCT03526575|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93319968|NCT03526575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93319969|NCT03526575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319970|NCT03526575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319971|NCT03526575|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93319972|NCT03526575|GABA Agonists|gaba agonists|mesh-ancestor
93319973|NCT03526575|GABA Agents|gaba agents|mesh-ancestor
93319974|NCT03526575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93319975|NCT03526575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93319976|NCT03526575|Anticonvulsants|anticonvulsants|mesh-ancestor
93319977|NCT03526575|GABA Modulators|gaba modulators|mesh-ancestor
93319978|NCT00189254|Imiquimod|imiquimod|mesh-list
93319979|NCT00189254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93319980|NCT00189254|Immunologic Factors|immunologic factors|mesh-ancestor
93319981|NCT00189254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319982|NCT00189254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319983|NCT00189254|Interferon Inducers|interferon inducers|mesh-ancestor
93319984|NCT03526419|Bupivacaine|bupivacaine|mesh-list
93319985|NCT03526419|Anesthetics, Local|anesthetics, local|mesh-ancestor
93319986|NCT03526419|Anesthetics|anesthetics|mesh-ancestor
93319987|NCT03526419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93319988|NCT03526419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93319989|NCT03526419|Sensory System Agents|sensory system agents|mesh-ancestor
93319990|NCT03526419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93319991|NCT03192644|Leucovorin|leucovorin|mesh-list
93319992|NCT03192644|Oxaliplatin|oxaliplatin|mesh-list
93319993|NCT03192644|Ethiodized Oil|ethiodized oil|mesh-list
93319994|NCT03192644|Epirubicin|epirubicin|mesh-list
93319995|NCT03192644|Calcium|calcium|mesh-list
93319996|NCT03192644|Levoleucovorin|levoleucovorin|mesh-list
93319997|NCT03192644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93319998|NCT03192644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93319999|NCT03192644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320000|NCT03192644|Antidotes|antidotes|mesh-ancestor
93320001|NCT03192644|Protective Agents|protective agents|mesh-ancestor
93320002|NCT03192644|Vitamin B Complex|vitamin b complex|mesh-ancestor
93320003|NCT03192644|Vitamins|vitamins|mesh-ancestor
93320004|NCT03192644|Micronutrients|micronutrients|mesh-ancestor
93320005|NCT03192644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93320006|NCT03192644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93320007|NCT03192644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93320008|NCT03192644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320009|NCT03192644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320010|NCT03110055|Grazoprevir|grazoprevir|mesh-list
93320011|NCT03110055|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93320012|NCT03110055|Antiviral Agents|antiviral agents|mesh-ancestor
93320013|NCT03110055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320014|NCT01190852|Fluticasone|fluticasone|mesh-list
93320015|NCT01190852|Azelastine|azelastine|mesh-list
93320016|NCT01190852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320017|NCT01190852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93320018|NCT01190852|Autonomic Agents|autonomic agents|mesh-ancestor
93320019|NCT01190852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320020|NCT01190852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320021|NCT01190852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93320022|NCT01190852|Respiratory System Agents|respiratory system agents|mesh-ancestor
93320023|NCT01190852|Dermatologic Agents|dermatologic agents|mesh-ancestor
93320024|NCT01190852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93320025|NCT01190852|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93320026|NCT01190852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320027|NCT01190852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320028|NCT01190852|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93320029|NCT01190852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93320030|NCT01190852|Histamine Antagonists|histamine antagonists|mesh-ancestor
93320031|NCT01190852|Histamine Agents|histamine agents|mesh-ancestor
93320032|NCT01190852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320033|NCT02710214|Estrogens|estrogens|mesh-list
93320034|NCT02710214|Hormones|hormones|mesh-ancestor
93320035|NCT02710214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320036|NCT02710214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320037|NCT03782415|Temozolomide|temozolomide|mesh-list
93320038|NCT03782415|Ibudilast|ibudilast|mesh-list
93320039|NCT03782415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93320040|NCT03782415|Alkylating Agents|alkylating agents|mesh-ancestor
93320041|NCT03782415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320042|NCT03782415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320043|NCT03782415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93320044|NCT03782415|Autonomic Agents|autonomic agents|mesh-ancestor
93320045|NCT03782415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320046|NCT03782415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992044|NCT01028404|Insulin|insulin|mesh-list
93320047|NCT03782415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93320048|NCT03782415|Respiratory System Agents|respiratory system agents|mesh-ancestor
93320049|NCT03782415|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93320050|NCT03782415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320051|NCT03782415|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93320052|NCT03782415|Vasodilator Agents|vasodilator agents|mesh-ancestor
93320053|NCT05561205|Methylphenidate|methylphenidate|mesh-list
93320054|NCT05561205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93320055|NCT05561205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320056|NCT05561205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93320057|NCT05561205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320058|NCT05561205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320059|NCT05561205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320060|NCT05561205|Dopamine Agents|dopamine agents|mesh-ancestor
93320061|NCT05561205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320062|NCT03052517|Indoleacetic Acids|indoleacetic acids|mesh-list
93320063|NCT03052517|Plant Growth Regulators|plant growth regulators|mesh-ancestor
93320064|NCT03052517|Growth Substances|growth substances|mesh-ancestor
93320065|NCT03052517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320066|NCT02443844|Tamsulosin|tamsulosin|mesh-list
93320067|NCT02443844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93320068|NCT02443844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93320069|NCT02443844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93320070|NCT02443844|Adrenergic Agents|adrenergic agents|mesh-ancestor
93320071|NCT02443844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320072|NCT02443844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613997|NCT05576792|Ranibizumab|ranibizumab|mesh-list
93320073|NCT02443844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320074|NCT02443844|Urological Agents|urological agents|mesh-ancestor
93320075|NCT02440100|Midazolam|midazolam|mesh-list
93320076|NCT02440100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93320077|NCT02440100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320078|NCT02440100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320079|NCT02440100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320080|NCT02440100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93320081|NCT02440100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93320082|NCT02440100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320083|NCT02440100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93320084|NCT02440100|Anesthetics, General|anesthetics, general|mesh-ancestor
93320085|NCT02440100|Anesthetics|anesthetics|mesh-ancestor
93320086|NCT02440100|GABA Modulators|gaba modulators|mesh-ancestor
93320087|NCT02440100|GABA Agents|gaba agents|mesh-ancestor
93320088|NCT02440100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320089|NCT02440100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320090|NCT03524313|Carbon Monoxide|carbon monoxide|mesh-list
93320091|NCT03524313|Antimetabolites|antimetabolites|mesh-ancestor
93320092|NCT03524313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320093|NCT03524313|Gasotransmitters|gasotransmitters|mesh-ancestor
93320094|NCT03524313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320095|NCT03524313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320096|NCT02439944|Nicotine|nicotine|mesh-list
93320097|NCT02439944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93320098|NCT02439944|Autonomic Agents|autonomic agents|mesh-ancestor
93320099|NCT02439944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320100|NCT02439944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320101|NCT02439944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93320102|NCT02439944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93320103|NCT02439944|Cholinergic Agents|cholinergic agents|mesh-ancestor
93320104|NCT02439944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320105|NCT02439944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320106|NCT03133065|Antiviral Agents|antiviral agents|mesh-list
93320107|NCT03133065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320108|NCT03190616|Apatinib|apatinib|mesh-list
93320109|NCT03190616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320110|NCT03190616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93320111|NCT03190616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320112|NCT03190616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320113|NCT02443922|Metformin|metformin|mesh-list
93320114|NCT02443922|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93320115|NCT02443922|Glimepiride|glimepiride|mesh-list
93320116|NCT02443922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93320117|NCT02443922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320118|NCT02443922|Incretins|incretins|mesh-ancestor
93320119|NCT02443922|Hormones|hormones|mesh-ancestor
93320120|NCT02443922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320121|NCT02443922|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93320122|NCT02443922|Protease Inhibitors|protease inhibitors|mesh-ancestor
93320123|NCT02443922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320124|NCT02443922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320125|NCT02443922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93320126|NCT02443922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320127|NCT02443922|Immunologic Factors|immunologic factors|mesh-ancestor
93320128|NCT04799847|Catumaxomab|catumaxomab|mesh-list
93320129|NCT04799847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320130|NCT02439866|Methylprednisolone|methylprednisolone|mesh-list
93320131|NCT02439866|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93320132|NCT02439866|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93320133|NCT02439866|Prednisolone|prednisolone|mesh-list
93320134|NCT02439866|Prednisolone acetate|prednisolone acetate|mesh-list
93320135|NCT02439866|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93320136|NCT02439866|Prednisolone phosphate|prednisolone phosphate|mesh-list
93320137|NCT02439866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320138|NCT02439866|Antiemetics|antiemetics|mesh-ancestor
93320139|NCT02439866|Autonomic Agents|autonomic agents|mesh-ancestor
93320140|NCT02439866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320141|NCT02439866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320142|NCT02439866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320143|NCT02439866|Glucocorticoids|glucocorticoids|mesh-ancestor
93320144|NCT02439866|Hormones|hormones|mesh-ancestor
93320145|NCT02439866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320146|NCT02439866|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93320147|NCT02439866|Protective Agents|protective agents|mesh-ancestor
93320148|NCT02439866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320149|NCT02439866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320150|NCT02439788|Cyclophosphamide|cyclophosphamide|mesh-list
93320151|NCT02439788|Fludarabine|fludarabine|mesh-list
93320152|NCT02439788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320153|NCT02439788|Immunologic Factors|immunologic factors|mesh-ancestor
93320154|NCT02439788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320155|NCT02439788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320156|NCT02439788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93320157|NCT02439788|Alkylating Agents|alkylating agents|mesh-ancestor
93320158|NCT02439788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320159|NCT02439788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320160|NCT02439788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93320161|NCT03188510|Mirikizumab|mirikizumab|mesh-list
93320162|NCT03188510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93320163|NCT03188510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93320164|NCT03188510|Analgesics|analgesics|mesh-ancestor
93320165|NCT03188510|Sensory System Agents|sensory system agents|mesh-ancestor
93320166|NCT03188510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320167|NCT03188510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320168|NCT03188510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320169|NCT03188510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320170|NCT03188510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93320171|NCT03188510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320172|NCT03188198|Prednisone|prednisone|mesh-list
93320173|NCT03188198|Cyclophosphamide|cyclophosphamide|mesh-list
93320174|NCT03188198|Rituximab|rituximab|mesh-list
93320175|NCT03188198|Doxorubicin|doxorubicin|mesh-list
93320176|NCT03188198|Etoposide|etoposide|mesh-list
93320177|NCT03188198|Etoposide phosphate|etoposide phosphate|mesh-list
93320178|NCT03188198|Vincristine|vincristine|mesh-list
93320179|NCT03188198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320180|NCT03188198|Immunologic Factors|immunologic factors|mesh-ancestor
93320181|NCT03188198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320182|NCT03188198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320183|NCT03188198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93320184|NCT03188198|Alkylating Agents|alkylating agents|mesh-ancestor
93320185|NCT03188198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320186|NCT03188198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320187|NCT03188198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93320188|NCT03188198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93320189|NCT03188198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93320190|NCT03188198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93320191|NCT03188198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93320192|NCT03188198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320193|NCT03188198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320194|NCT03188198|Glucocorticoids|glucocorticoids|mesh-ancestor
93320195|NCT03188198|Hormones|hormones|mesh-ancestor
92992191|NCT02538302|Autonomic Agents|autonomic agents|mesh-ancestor
93320196|NCT03188198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320197|NCT03188198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320198|NCT03188198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93320199|NCT03188198|Tubulin Modulators|tubulin modulators|mesh-ancestor
93320200|NCT03188198|Antimitotic Agents|antimitotic agents|mesh-ancestor
93320201|NCT03188198|Mitosis Modulators|mitosis modulators|mesh-ancestor
93320202|NCT03188276|Sofosbuvir|sofosbuvir|mesh-list
93320203|NCT03188276|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93320204|NCT03188276|Ledipasvir|ledipasvir|mesh-list
93320205|NCT03188276|Antiviral Agents|antiviral agents|mesh-ancestor
93320206|NCT03188276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320207|NCT03190304|Enalapril|enalapril|mesh-list
93320208|NCT03190304|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93320209|NCT03190304|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93320210|NCT03190304|Protease Inhibitors|protease inhibitors|mesh-ancestor
93320211|NCT03190304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320212|NCT03190304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93320213|NCT02439632|Levofloxacin|levofloxacin|mesh-list
93320214|NCT02439632|Ofloxacin|ofloxacin|mesh-list
93320215|NCT02439632|Prulifloxacin|prulifloxacin|mesh-list
93320216|NCT02439632|Fluoroquinolones|fluoroquinolones|mesh-list
93320217|NCT02439632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93320218|NCT02439632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320219|NCT02439632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320220|NCT02439632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93320221|NCT02439632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93320222|NCT02439632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320223|NCT02439632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320224|NCT02439632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320225|NCT02439632|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93320226|NCT02439632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93320227|NCT02439632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93320228|NCT02443064|Vancomycin|vancomycin|mesh-list
93320229|NCT02443064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320230|NCT02443064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320231|NCT02741271|Mometasone Furoate|mometasone furoate|mesh-list
93320232|NCT02741271|Prednisone|prednisone|mesh-list
93320233|NCT02741271|Prednisolone|prednisolone|mesh-list
93320234|NCT02741271|Albuterol|albuterol|mesh-list
93320235|NCT02741271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320236|NCT02741271|Glucocorticoids|glucocorticoids|mesh-ancestor
93320237|NCT02741271|Hormones|hormones|mesh-ancestor
93320238|NCT02741271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320239|NCT02741271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320240|NCT02741271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320241|NCT02741271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320242|NCT02741271|Autonomic Agents|autonomic agents|mesh-ancestor
93320243|NCT02741271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320244|NCT02741271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93320245|NCT02741271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93320246|NCT02741271|Respiratory System Agents|respiratory system agents|mesh-ancestor
93320247|NCT02741271|Tocolytic Agents|tocolytic agents|mesh-ancestor
93320248|NCT02741271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93320249|NCT02741271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93320250|NCT02741271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93320251|NCT02741271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93320252|NCT02741271|Adrenergic Agents|adrenergic agents|mesh-ancestor
93320253|NCT02741271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320254|NCT02741271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320255|NCT02741271|Dermatologic Agents|dermatologic agents|mesh-ancestor
93320256|NCT02741271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93320257|NCT02443142|Acetaminophen|acetaminophen|mesh-list
93320258|NCT02443142|Ibuprofen|ibuprofen|mesh-list
93320259|NCT02443142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93320260|NCT02443142|Analgesics|analgesics|mesh-ancestor
93320261|NCT02443142|Sensory System Agents|sensory system agents|mesh-ancestor
93320262|NCT02443142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320263|NCT02443142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320264|NCT02443142|Antipyretics|antipyretics|mesh-ancestor
93320265|NCT02443142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93320266|NCT02443142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320267|NCT02443142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320268|NCT02443142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93320269|NCT02443142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320270|NCT02443142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320271|NCT03524079|Ajmaline|ajmaline|mesh-list
93320272|NCT03524079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93320273|NCT03524079|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93320274|NCT03524079|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93320275|NCT03524079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320276|NCT03524079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320277|NCT02438852|Ropivacaine|ropivacaine|mesh-list
93320278|NCT02438852|Anesthetics, Local|anesthetics, local|mesh-ancestor
93320279|NCT02438852|Anesthetics|anesthetics|mesh-ancestor
93320280|NCT02438852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320281|NCT02438852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320282|NCT02438852|Sensory System Agents|sensory system agents|mesh-ancestor
93320283|NCT02438852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320284|NCT02442674|Tolvaptan|tolvaptan|mesh-list
93320285|NCT02442674|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93320286|NCT02442674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320287|NCT02442674|Natriuretic Agents|natriuretic agents|mesh-ancestor
93320288|NCT02442674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320289|NCT02442752|Dexlansoprazole|dexlansoprazole|mesh-list
93320290|NCT02442752|Lansoprazole|lansoprazole|mesh-list
93320291|NCT02442752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93320292|NCT02442752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320293|NCT02442752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93320294|NCT02442752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320295|NCT02442752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320296|NCT02442362|Paclitaxel|paclitaxel|mesh-list
93320297|NCT02442362|Fluorouracil|fluorouracil|mesh-list
93320298|NCT02442362|Oxaliplatin|oxaliplatin|mesh-list
93320299|NCT02442362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93320300|NCT02442362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320301|NCT02442362|Tubulin Modulators|tubulin modulators|mesh-ancestor
93320302|NCT02442362|Antimitotic Agents|antimitotic agents|mesh-ancestor
93320303|NCT02442362|Mitosis Modulators|mitosis modulators|mesh-ancestor
93320304|NCT02442362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320305|NCT02442362|Antimetabolites|antimetabolites|mesh-ancestor
93320306|NCT02442362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93320307|NCT02442362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320308|NCT02442362|Immunologic Factors|immunologic factors|mesh-ancestor
93320309|NCT02442362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320310|NCT04440488|Protease Inhibitors|protease inhibitors|mesh-list
93320311|NCT04440488|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93320312|NCT04440488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320313|NCT04440488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320314|NCT04440488|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93320315|NCT04440488|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93320316|NCT02433860|Nicotine|nicotine|mesh-list
93320317|NCT02433860|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93320318|NCT02433860|Autonomic Agents|autonomic agents|mesh-ancestor
93320319|NCT02433860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320320|NCT02433860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320321|NCT02433860|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93320322|NCT02433860|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93320323|NCT02433860|Cholinergic Agents|cholinergic agents|mesh-ancestor
93320324|NCT02433860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320325|NCT02433860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320326|NCT03189914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93320327|NCT03189914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320328|NCT03523455|Iron protein succinylate|iron protein succinylate|mesh-list
93320329|NCT03523455|Hematinics|hematinics|mesh-ancestor
93320330|NCT03189836|Rituximab|rituximab|mesh-list
93320331|NCT03189836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93320332|NCT03189836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320333|NCT03189836|Immunologic Factors|immunologic factors|mesh-ancestor
93320334|NCT03189836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320335|NCT03189836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320336|NCT04466943|Rocuronium|rocuronium|mesh-list
93320337|NCT04466943|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93320338|NCT04466943|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93320339|NCT04466943|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93320340|NCT04466943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320341|NCT04466943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320342|NCT03212469|Durvalumab|durvalumab|mesh-list
93320343|NCT03212469|Tremelimumab|tremelimumab|mesh-list
92992342|NCT00728195|Olanzapine|olanzapine|mesh-list
93320344|NCT03212469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93320345|NCT03212469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320346|NCT02442440|Anisodamine|anisodamine|mesh-list
93320347|NCT02442440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93320348|NCT02442440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93320349|NCT02442440|Adrenergic Agents|adrenergic agents|mesh-ancestor
93320350|NCT02442440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320351|NCT02442440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320352|NCT02442440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320353|NCT02442440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93320354|NCT02442440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93320355|NCT02442440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93320356|NCT02442440|Analgesics|analgesics|mesh-ancestor
93320357|NCT02442440|Sensory System Agents|sensory system agents|mesh-ancestor
93320358|NCT02442440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320359|NCT02442440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320360|NCT02442440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320361|NCT02442440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93320362|NCT02442440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320363|NCT02442440|Parasympatholytics|parasympatholytics|mesh-ancestor
93320364|NCT02442440|Autonomic Agents|autonomic agents|mesh-ancestor
93320365|NCT02442440|Vasodilator Agents|vasodilator agents|mesh-ancestor
93320366|NCT02442440|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93320367|NCT02442440|Antioxidants|antioxidants|mesh-ancestor
93320368|NCT02442440|Protective Agents|protective agents|mesh-ancestor
93320369|NCT03187496|Midazolam|midazolam|mesh-list
93320370|NCT03187496|Caffeine|caffeine|mesh-list
93320371|NCT03187496|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93320372|NCT03187496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93320373|NCT03187496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320374|NCT03187496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320375|NCT03187496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320376|NCT03187496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93320377|NCT03187496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93320378|NCT03187496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320379|NCT03187496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93320380|NCT03187496|Anesthetics, General|anesthetics, general|mesh-ancestor
93320381|NCT03187496|Anesthetics|anesthetics|mesh-ancestor
93320382|NCT03187496|GABA Modulators|gaba modulators|mesh-ancestor
93320383|NCT03187496|GABA Agents|gaba agents|mesh-ancestor
93320384|NCT03187496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320385|NCT03187496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320386|NCT03187496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93320387|NCT03187496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93320388|NCT03187496|Antimetabolites|antimetabolites|mesh-ancestor
93320389|NCT03187496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93320390|NCT03187496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93320391|NCT03187496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320392|NCT03187496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93320393|NCT03187496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93320394|NCT03187496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93320395|NCT03187496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93320396|NCT03187496|Purinergic Agents|purinergic agents|mesh-ancestor
93320397|NCT02438072|Fexofenadine|fexofenadine|mesh-list
93320398|NCT02438072|Flurbiprofen|flurbiprofen|mesh-list
93320399|NCT02438072|Midazolam|midazolam|mesh-list
93320400|NCT02438072|Dextromethorphan|dextromethorphan|mesh-list
93320401|NCT02438072|Caffeine|caffeine|mesh-list
93320402|NCT02438072|Bupropion|bupropion|mesh-list
93320403|NCT02438072|Omeprazole|omeprazole|mesh-list
93320404|NCT02438072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93320405|NCT02438072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320406|NCT02438072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320407|NCT02438072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320408|NCT02438072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93320409|NCT02438072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93320410|NCT02438072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320411|NCT02438072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93320412|NCT02438072|Anesthetics, General|anesthetics, general|mesh-ancestor
93320413|NCT02438072|Anesthetics|anesthetics|mesh-ancestor
93320414|NCT02438072|GABA Modulators|gaba modulators|mesh-ancestor
93320415|NCT02438072|GABA Agents|gaba agents|mesh-ancestor
93320416|NCT02438072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320417|NCT02438072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320418|NCT02438072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93320419|NCT02438072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93320420|NCT02438072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320421|NCT02438072|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93320422|NCT02438072|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93320423|NCT02438072|Purinergic Agents|purinergic agents|mesh-ancestor
93320424|NCT02438072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93320425|NCT02438072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320426|NCT02438072|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93320427|NCT02438072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93320428|NCT02438072|Antidepressive Agents|antidepressive agents|mesh-ancestor
93320429|NCT02438072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93320430|NCT02438072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320431|NCT02438072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320432|NCT02438072|Dopamine Agents|dopamine agents|mesh-ancestor
93320433|NCT02438072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93320434|NCT02438072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93320435|NCT02438072|Antitussive Agents|antitussive agents|mesh-ancestor
93320436|NCT02438072|Respiratory System Agents|respiratory system agents|mesh-ancestor
93320437|NCT02438072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93320438|NCT02438072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93320439|NCT02438072|Analgesics|analgesics|mesh-ancestor
93320440|NCT02438072|Sensory System Agents|sensory system agents|mesh-ancestor
93320441|NCT02438072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320442|NCT02438072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93320443|NCT02438072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93320444|NCT02438072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320445|NCT02438072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320446|NCT02438072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93320447|NCT02438072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93320448|NCT02438072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93320449|NCT02438072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93320450|NCT02438072|Histamine Antagonists|histamine antagonists|mesh-ancestor
93320451|NCT02438072|Histamine Agents|histamine agents|mesh-ancestor
93320452|NCT03522987|Escitalopram|escitalopram|mesh-list
93320453|NCT03522987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93320454|NCT03522987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320455|NCT03522987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320456|NCT03522987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320457|NCT03522987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320458|NCT03522987|Serotonin Agents|serotonin agents|mesh-ancestor
93320459|NCT03522987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320460|NCT02433626|Cisplatin|cisplatin|mesh-list
93320461|NCT02433626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320462|NCT02442128|Fentanyl|fentanyl|mesh-list
93320463|NCT02442128|Propofol|propofol|mesh-list
93320464|NCT02442128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320465|NCT02442128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320466|NCT02442128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320467|NCT02442128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93320468|NCT02442128|Anesthetics, General|anesthetics, general|mesh-ancestor
93320469|NCT02442128|Anesthetics|anesthetics|mesh-ancestor
93320470|NCT02442128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93320471|NCT02442128|Narcotics|narcotics|mesh-ancestor
93320472|NCT02442128|Analgesics|analgesics|mesh-ancestor
93320473|NCT02442128|Sensory System Agents|sensory system agents|mesh-ancestor
93320474|NCT02442128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320475|NCT02442128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93320476|NCT04465773|Remifentanil|remifentanil|mesh-list
93320477|NCT04465773|Propofol|propofol|mesh-list
93320478|NCT04465773|Anesthetics|anesthetics|mesh-ancestor
93320479|NCT04465773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320480|NCT04465773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320481|NCT04465773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320482|NCT04465773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93320483|NCT04465773|Anesthetics, General|anesthetics, general|mesh-ancestor
93320484|NCT04465773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93320485|NCT04465773|Narcotics|narcotics|mesh-ancestor
93320486|NCT04465773|Analgesics|analgesics|mesh-ancestor
93320487|NCT04465773|Sensory System Agents|sensory system agents|mesh-ancestor
93320488|NCT04465773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320489|NCT02709746|Vortioxetine|vortioxetine|mesh-list
93320490|NCT02709746|Fluoxetine|fluoxetine|mesh-list
93320491|NCT02709746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93320492|NCT02709746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320493|NCT02709746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320494|NCT02709746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320495|NCT02709746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320496|NCT02709746|Serotonin Agents|serotonin agents|mesh-ancestor
93320497|NCT02709746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320498|NCT02709746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93320499|NCT02709746|Antidepressive Agents|antidepressive agents|mesh-ancestor
93320500|NCT02709746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320501|NCT02709746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93320502|NCT02709746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93320503|NCT02709746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320504|NCT02709746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93320505|NCT02709746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93320506|NCT02709746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320507|NCT02709746|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93320508|NCT02709746|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93320509|NCT02709746|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93320510|NCT02709746|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93320511|NCT02441894|Diphenhydramine|diphenhydramine|mesh-list
93320512|NCT02441894|Promethazine|promethazine|mesh-list
93320513|NCT02441894|Dexamethasone|dexamethasone|mesh-list
93320514|NCT02441894|Prednisolone|prednisolone|mesh-list
93320515|NCT02441894|Ondansetron|ondansetron|mesh-list
93320516|NCT02441894|Metoclopramide|metoclopramide|mesh-list
93320517|NCT02441894|Granisetron|granisetron|mesh-list
93320518|NCT02441894|Ranitidine|ranitidine|mesh-list
93320519|NCT02441894|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93320520|NCT02441894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320521|NCT02441894|Antiemetics|antiemetics|mesh-ancestor
93320522|NCT02441894|Autonomic Agents|autonomic agents|mesh-ancestor
93320523|NCT02441894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320524|NCT02441894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320525|NCT02441894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320526|NCT02441894|Glucocorticoids|glucocorticoids|mesh-ancestor
93320527|NCT02441894|Hormones|hormones|mesh-ancestor
93320528|NCT02441894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320529|NCT02441894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320530|NCT02441894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320531|NCT02441894|Antipruritics|antipruritics|mesh-ancestor
93320532|NCT02441894|Dermatologic Agents|dermatologic agents|mesh-ancestor
93320533|NCT02441894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93320534|NCT02441894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93320535|NCT02441894|Serotonin Agents|serotonin agents|mesh-ancestor
93320536|NCT02441894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320537|NCT02441894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320538|NCT02441894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93320539|NCT02441894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320540|NCT02441894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320541|NCT02441894|Anesthetics, Local|anesthetics, local|mesh-ancestor
93320542|NCT02441894|Anesthetics|anesthetics|mesh-ancestor
93320543|NCT02441894|Sensory System Agents|sensory system agents|mesh-ancestor
93320544|NCT02441894|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93320545|NCT02441894|Histamine Antagonists|histamine antagonists|mesh-ancestor
93320546|NCT02441894|Histamine Agents|histamine agents|mesh-ancestor
93320547|NCT02441894|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93320548|NCT02441894|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93320549|NCT02441894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93320550|NCT02441894|Dopamine Agents|dopamine agents|mesh-ancestor
93320551|NCT02441894|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93320552|NCT02441894|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93320553|NCT02433704|Cefazolin|cefazolin|mesh-list
93320554|NCT02433704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320555|NCT02433704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320556|NCT05453825|Paclitaxel|paclitaxel|mesh-list
93320557|NCT05453825|Irinotecan|irinotecan|mesh-list
93320558|NCT05453825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93320559|NCT05453825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320560|NCT05453825|Tubulin Modulators|tubulin modulators|mesh-ancestor
93320561|NCT05453825|Antimitotic Agents|antimitotic agents|mesh-ancestor
93320562|NCT05453825|Mitosis Modulators|mitosis modulators|mesh-ancestor
93320563|NCT05453825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320564|NCT05453825|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93320565|NCT05453825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93320566|NCT05453825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320567|NCT02441816|Aflibercept|aflibercept|mesh-list
93320568|NCT02441816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93320569|NCT02441816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93320570|NCT02441816|Growth Substances|growth substances|mesh-ancestor
93320571|NCT02441816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320572|NCT02441816|Growth Inhibitors|growth inhibitors|mesh-ancestor
93320573|NCT02441816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320574|NCT02433314|Brexanolone|brexanolone|mesh-list
93320575|NCT02433314|Neurosteroids|neurosteroids|mesh-ancestor
93320576|NCT02433314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320577|NCT02433314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320578|NCT02433314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320579|NCT02433314|GABA Modulators|gaba modulators|mesh-ancestor
93320580|NCT02433314|GABA Agents|gaba agents|mesh-ancestor
93320581|NCT02290431|Dexamethasone|dexamethasone|mesh-list
93320582|NCT02290431|Bortezomib|bortezomib|mesh-list
93320583|NCT02290431|Panobinostat|panobinostat|mesh-list
93320584|NCT02290431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320585|NCT02290431|Antiemetics|antiemetics|mesh-ancestor
93320586|NCT02290431|Autonomic Agents|autonomic agents|mesh-ancestor
93320587|NCT02290431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320588|NCT02290431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320589|NCT02290431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320590|NCT02290431|Glucocorticoids|glucocorticoids|mesh-ancestor
93320591|NCT02290431|Hormones|hormones|mesh-ancestor
92614577|NCT04300231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320592|NCT02290431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320593|NCT02290431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320594|NCT02290431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320595|NCT02290431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93320596|NCT02290431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320597|NCT02290431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320598|NCT02441270|Cyclophosphamide|cyclophosphamide|mesh-list
93320599|NCT02441270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320600|NCT02441270|Immunologic Factors|immunologic factors|mesh-ancestor
93320601|NCT02441270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320602|NCT02441270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320603|NCT02441270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93320604|NCT02441270|Alkylating Agents|alkylating agents|mesh-ancestor
93320605|NCT02441270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320606|NCT02441270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320607|NCT02441270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93320608|NCT02436980|Midazolam|midazolam|mesh-list
93320609|NCT02436980|Tramadol|tramadol|mesh-list
93320610|NCT02436980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93320611|NCT02436980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93320612|NCT02436980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320613|NCT02436980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320614|NCT02436980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93320615|NCT02436980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93320616|NCT02436980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320617|NCT02436980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93320618|NCT02436980|Anesthetics, General|anesthetics, general|mesh-ancestor
93320619|NCT02436980|Anesthetics|anesthetics|mesh-ancestor
93320620|NCT02436980|GABA Modulators|gaba modulators|mesh-ancestor
93320621|NCT02436980|GABA Agents|gaba agents|mesh-ancestor
93320622|NCT02436980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320623|NCT02436980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320624|NCT02436980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93320625|NCT02436980|Narcotics|narcotics|mesh-ancestor
93320626|NCT02436980|Analgesics|analgesics|mesh-ancestor
93320627|NCT02436980|Sensory System Agents|sensory system agents|mesh-ancestor
93320628|NCT02436980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320629|NCT02436902|Sorafenib|sorafenib|mesh-list
93320630|NCT02436902|Chlorotrianisene|chlorotrianisene|mesh-list
93320631|NCT02436902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320632|NCT02436902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93320633|NCT02436902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748341|NCT01294397|Denosumab|denosumab|mesh-list
93320634|NCT02436902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320635|NCT02436902|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93320636|NCT02436902|Estrogens|estrogens|mesh-ancestor
93320637|NCT02436902|Hormones|hormones|mesh-ancestor
92748408|NCT01170663|Paclitaxel|paclitaxel|mesh-list
93320638|NCT02436902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320639|NCT02436902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320640|NCT02436902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320641|NCT02436512|Nitric Oxide|nitric oxide|mesh-list
93320642|NCT02436512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93320643|NCT02436512|Autonomic Agents|autonomic agents|mesh-ancestor
93320644|NCT02436512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320645|NCT02436512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320646|NCT02436512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93320647|NCT02436512|Respiratory System Agents|respiratory system agents|mesh-ancestor
93320648|NCT02436512|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93320649|NCT02436512|Antioxidants|antioxidants|mesh-ancestor
93320650|NCT02436512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320651|NCT02436512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320652|NCT02436512|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93320653|NCT02436512|Vasodilator Agents|vasodilator agents|mesh-ancestor
93320654|NCT02436512|Gasotransmitters|gasotransmitters|mesh-ancestor
93320655|NCT02436512|Protective Agents|protective agents|mesh-ancestor
93320656|NCT04466241|Ritonavir|ritonavir|mesh-list
93320657|NCT04466241|Lopinavir|lopinavir|mesh-list
93320658|NCT04466241|Telmisartan|telmisartan|mesh-list
93320659|NCT04466241|Atorvastatin|atorvastatin|mesh-list
93320660|NCT04466241|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93320661|NCT04466241|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93320662|NCT04466241|Antimetabolites|antimetabolites|mesh-ancestor
93320663|NCT04466241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320664|NCT04466241|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93320665|NCT04466241|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93320666|NCT04466241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320667|NCT04466241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92614653|NCT03914612|Paclitaxel|paclitaxel|mesh-list
93320668|NCT04466241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93320669|NCT04466241|Protease Inhibitors|protease inhibitors|mesh-ancestor
93320670|NCT04466241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93320671|NCT04466241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93320672|NCT04466241|Antiviral Agents|antiviral agents|mesh-ancestor
93320673|NCT04466241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748960|NCT02857777|Esketamine|esketamine|mesh-list
93320674|NCT04466241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93320675|NCT04466241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93320676|NCT04466241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93320677|NCT04466241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93320678|NCT04466241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93320679|NCT02440880|Dexamethasone|dexamethasone|mesh-list
93320680|NCT02440880|Dexamethasone acetate|dexamethasone acetate|mesh-list
93320681|NCT02440880|BB 1101|bb 1101|mesh-list
93320682|NCT02440880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320683|NCT02440880|Antiemetics|antiemetics|mesh-ancestor
93320684|NCT02440880|Autonomic Agents|autonomic agents|mesh-ancestor
93320685|NCT02440880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320686|NCT02440880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320687|NCT02440880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320688|NCT02440880|Glucocorticoids|glucocorticoids|mesh-ancestor
93320689|NCT02440880|Hormones|hormones|mesh-ancestor
93320690|NCT02440880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93320691|NCT02440880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93320692|NCT02440880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749184|NCT01962415|Melphalan|melphalan|mesh-list
93320693|NCT02440880|Protease Inhibitors|protease inhibitors|mesh-ancestor
93320694|NCT02440880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320695|NCT02440880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320696|NCT03186482|Rifampin|rifampin|mesh-list
93320697|NCT03186482|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93320698|NCT03186482|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93320699|NCT03186482|Antitubercular Agents|antitubercular agents|mesh-ancestor
93320700|NCT03186482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320701|NCT03186482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320702|NCT03186482|Leprostatic Agents|leprostatic agents|mesh-ancestor
93320703|NCT03186482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93320704|NCT03186482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320705|NCT03186482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320706|NCT03186482|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93320707|NCT03186482|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93320708|NCT03186482|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93320709|NCT03186482|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93320710|NCT03186482|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93320711|NCT03186482|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93320712|NCT03186482|Antiviral Agents|antiviral agents|mesh-ancestor
93320713|NCT03186482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93320714|NCT03186482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93320715|NCT03186482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93320716|NCT03522207|Trazodone|trazodone|mesh-list
93320717|NCT03522207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93320718|NCT03522207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92021690|NCT05611879|Paclitaxel|paclitaxel|mesh-list
93320719|NCT03522207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320720|NCT03522207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992715|NCT00738569|Raltegravir Potassium|raltegravir potassium|mesh-list
93320721|NCT03522207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320722|NCT03522207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93320723|NCT03522207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320724|NCT03522207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320725|NCT03522207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320726|NCT03522207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320727|NCT03522207|Serotonin Agents|serotonin agents|mesh-ancestor
93320728|NCT03522207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93320729|NCT03522207|Antidepressive Agents|antidepressive agents|mesh-ancestor
93320730|NCT03528057|Hemostatics|hemostatics|mesh-list
93320731|NCT03528057|Coagulants|coagulants|mesh-ancestor
93320732|NCT05018273|Atezolizumab|atezolizumab|mesh-list
93320733|NCT05018273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93320734|NCT05018273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320735|NCT05018273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93320736|NCT05018273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320737|NCT02707952|Ritonavir|ritonavir|mesh-list
93320738|NCT02707952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93320739|NCT02707952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93320740|NCT02707952|Protease Inhibitors|protease inhibitors|mesh-ancestor
93320741|NCT02707952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320742|NCT02707952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320743|NCT02707952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93320744|NCT02707952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93320745|NCT02707952|Antiviral Agents|antiviral agents|mesh-ancestor
93320746|NCT02707952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320747|NCT02707952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93320748|NCT02707952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93320749|NCT02720445|Nicotine|nicotine|mesh-list
93320750|NCT02720445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93320751|NCT02720445|Autonomic Agents|autonomic agents|mesh-ancestor
93320752|NCT02720445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320753|NCT02720445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614727|NCT03815019|Megestrol|megestrol|mesh-list
93320754|NCT02720445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93320755|NCT02720445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93320756|NCT02720445|Cholinergic Agents|cholinergic agents|mesh-ancestor
93320757|NCT02720445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320758|NCT02720445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320759|NCT02291211|Cisplatin|cisplatin|mesh-list
93320760|NCT02291211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320761|NCT05392101|Deferasirox|deferasirox|mesh-list
93320762|NCT05392101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93320763|NCT05392101|Chelating Agents|chelating agents|mesh-ancestor
93320764|NCT05392101|Sequestering Agents|sequestering agents|mesh-ancestor
93320765|NCT05392101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320766|NCT02291367|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93320767|NCT02291367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92750038|NCT00941863|Sorafenib|sorafenib|mesh-list
93320768|NCT02291367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320769|NCT02291367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92614742|NCT03767218|Hormones|hormones|mesh-ancestor
93320770|NCT02291367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320771|NCT02291367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320772|NCT02291367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320773|NCT02291367|Analgesics|analgesics|mesh-ancestor
93320774|NCT02291367|Sensory System Agents|sensory system agents|mesh-ancestor
93320775|NCT02291367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320776|NCT02291367|Antidepressive Agents|antidepressive agents|mesh-ancestor
93320777|NCT02291367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320778|NCT02291367|Dopamine Agents|dopamine agents|mesh-ancestor
93320779|NCT02440958|Folfirinox|folfirinox|mesh-list
93320780|NCT02440958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320781|NCT02432534|Atorvastatin|atorvastatin|mesh-list
93320782|NCT02432534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93320783|NCT02432534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93320784|NCT02432534|Antimetabolites|antimetabolites|mesh-ancestor
92614753|NCT03695237|Leuprolide|leuprolide|mesh-list
93320785|NCT02432534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750291|NCT05378503|Topiramate|topiramate|mesh-list
93320786|NCT02432534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93320787|NCT02432534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93320788|NCT02432534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320789|NCT02432612|Nabiximols|nabiximols|mesh-list
93320790|NCT02432612|Analgesics|analgesics|mesh-ancestor
93320791|NCT02432612|Sensory System Agents|sensory system agents|mesh-ancestor
93320792|NCT02432612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320793|NCT02432612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320794|NCT05705843|Vancomycin|vancomycin|mesh-list
93320795|NCT05705843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320796|NCT05705843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320797|NCT02436044|Leucovorin|leucovorin|mesh-list
93320798|NCT02436044|Fluorouracil|fluorouracil|mesh-list
93320799|NCT02436044|Oxaliplatin|oxaliplatin|mesh-list
93320800|NCT02436044|Levoleucovorin|levoleucovorin|mesh-list
93320801|NCT02436044|Antimetabolites|antimetabolites|mesh-ancestor
93320802|NCT02436044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320803|NCT02436044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93320804|NCT02436044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320805|NCT02436044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320806|NCT02436044|Immunologic Factors|immunologic factors|mesh-ancestor
93320807|NCT02436044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320808|NCT02436044|Antidotes|antidotes|mesh-ancestor
93320809|NCT02436044|Protective Agents|protective agents|mesh-ancestor
93320810|NCT02436044|Vitamin B Complex|vitamin b complex|mesh-ancestor
93320811|NCT02436044|Vitamins|vitamins|mesh-ancestor
93320812|NCT02436044|Micronutrients|micronutrients|mesh-ancestor
93320813|NCT02435732|Heparin|heparin|mesh-list
93320814|NCT02435732|Anticoagulants|anticoagulants|mesh-ancestor
93320815|NCT02435732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93320816|NCT02435732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93320817|NCT02435732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320818|NCT02435654|Olanzapine|olanzapine|mesh-list
93320819|NCT02435654|Antiemetics|antiemetics|mesh-ancestor
93320820|NCT02435654|Autonomic Agents|autonomic agents|mesh-ancestor
93320821|NCT02435654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320822|NCT02435654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320823|NCT02435654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320824|NCT02435654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93320825|NCT02435654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93320826|NCT02435654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320827|NCT02435654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320828|NCT02435654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92614793|NCT03361345|Hemostatics|hemostatics|mesh-ancestor
93320829|NCT02435654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320830|NCT02435654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320831|NCT02435654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320832|NCT02435654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320833|NCT02435654|Serotonin Agents|serotonin agents|mesh-ancestor
93320834|NCT03191162|Benzonidazole|benzonidazole|mesh-list
93320835|NCT03191162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93320836|NCT03191162|Immunologic Factors|immunologic factors|mesh-ancestor
93320837|NCT03191162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320838|NCT03191162|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92614807|NCT03216187|Pregabalin|pregabalin|mesh-list
93320839|NCT03191162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93320840|NCT03191162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93320841|NCT03191162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320842|NCT05571527|Hyaluronic Acid|hyaluronic acid|mesh-list
92021789|NCT05240131|Atezolizumab|atezolizumab|mesh-list
93320843|NCT05571527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93320844|NCT05571527|Immunologic Factors|immunologic factors|mesh-ancestor
93320845|NCT05571527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320846|NCT05571527|Viscosupplements|viscosupplements|mesh-ancestor
93320847|NCT05571527|Protective Agents|protective agents|mesh-ancestor
92614813|NCT03216187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93320848|NCT02432066|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
93320849|NCT02432066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93320850|NCT02432066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93320851|NCT02432066|Cholinergic Agents|cholinergic agents|mesh-ancestor
93320852|NCT02432066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320853|NCT02432066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320854|NCT02432066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320855|NCT04824599|Ropivacaine|ropivacaine|mesh-list
93320856|NCT04824599|Anesthetics, Local|anesthetics, local|mesh-list
93320857|NCT04824599|Anesthetics|anesthetics|mesh-list
93320858|NCT04824599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320859|NCT04824599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320860|NCT04824599|Sensory System Agents|sensory system agents|mesh-ancestor
93320861|NCT04824599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320862|NCT05233514|Metformin|metformin|mesh-list
93320863|NCT05233514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93320864|NCT05233514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320865|NCT02431832|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93320866|NCT02431832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320867|NCT02431832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320868|NCT02431832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93320869|NCT02431832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320870|NCT02431832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320871|NCT02435186|Paclitaxel|paclitaxel|mesh-list
93320872|NCT02435186|Cisplatin|cisplatin|mesh-list
93320873|NCT02435186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93320874|NCT02435186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320875|NCT02435186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93320876|NCT02435186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93320877|NCT02435186|Mitosis Modulators|mitosis modulators|mesh-ancestor
93320878|NCT02435186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320879|NCT02435108|Crizotinib|crizotinib|mesh-list
93320880|NCT02435108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320881|NCT02435108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93320882|NCT02435108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320883|NCT02435108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320884|NCT02434952|Primaquine|primaquine|mesh-list
93320885|NCT02434952|Piperaquine|piperaquine|mesh-list
93320886|NCT02434952|Artenimol|artenimol|mesh-list
93320887|NCT02434952|Antimalarials|antimalarials|mesh-ancestor
93320888|NCT02434952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93320889|NCT02434952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93320890|NCT02434952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614855|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320891|NCT03117920|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
93320892|NCT03117920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93320893|NCT03117920|Alkylating Agents|alkylating agents|mesh-ancestor
93320894|NCT03117920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320895|NCT03117920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320896|NCT03626753|Acetaminophen|acetaminophen|mesh-list
93320897|NCT03626753|Piroxicam|piroxicam|mesh-list
93320898|NCT03626753|Nefopam|nefopam|mesh-list
93320899|NCT03626753|Proroxan|proroxan|mesh-list
93320900|NCT03626753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93320901|NCT03626753|Analgesics|analgesics|mesh-ancestor
93320902|NCT03626753|Sensory System Agents|sensory system agents|mesh-ancestor
92614869|NCT03007238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93320903|NCT03626753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320904|NCT03626753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320905|NCT03626753|Antipyretics|antipyretics|mesh-ancestor
93320906|NCT03626753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93320907|NCT03626753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320908|NCT03626753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320909|NCT03626753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93320910|NCT03626753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320911|NCT03626753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320912|NCT03626753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93320913|NCT03626753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93320914|NCT03626753|Adrenergic Agents|adrenergic agents|mesh-ancestor
93320915|NCT03626753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320916|NCT03626753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92751687|NCT04024462|Pertuzumab|pertuzumab|mesh-list
93320917|NCT02440256|Analgesics, Opioid|analgesics, opioid|mesh-list
93320918|NCT02440256|Narcotics|narcotics|mesh-ancestor
93320919|NCT02440256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93320920|NCT02440256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320921|NCT02440256|Analgesics|analgesics|mesh-ancestor
93320922|NCT02440256|Sensory System Agents|sensory system agents|mesh-ancestor
93320923|NCT02440256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320924|NCT05157698|Naltrexone|naltrexone|mesh-list
93320925|NCT05157698|Bupropion|bupropion|mesh-list
93320926|NCT05157698|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93320927|NCT05157698|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93320928|NCT05157698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320929|NCT05157698|Sensory System Agents|sensory system agents|mesh-ancestor
93320930|NCT05157698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320931|NCT05157698|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93320932|NCT05157698|Antidepressive Agents|antidepressive agents|mesh-ancestor
93320933|NCT05157698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93320934|NCT05157698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93320935|NCT05157698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93320936|NCT05157698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93320937|NCT05157698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320938|NCT05157698|Dopamine Agents|dopamine agents|mesh-ancestor
93320939|NCT05157698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320940|NCT05157698|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93320941|NCT05157698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93320942|NCT05157698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320943|NCT03185624|Rifaximin|rifaximin|mesh-list
93320944|NCT03185624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93320945|NCT03185624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320946|NCT03185624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320947|NCT02707640|Acetylcysteine|acetylcysteine|mesh-list
93320948|NCT02707640|Pirfenidone|pirfenidone|mesh-list
93320949|NCT02707640|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93320950|NCT02707640|Antiviral Agents|antiviral agents|mesh-ancestor
93320951|NCT02707640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93320952|NCT02707640|Expectorants|expectorants|mesh-ancestor
93320953|NCT02707640|Respiratory System Agents|respiratory system agents|mesh-ancestor
93320954|NCT02707640|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93320955|NCT02707640|Antioxidants|antioxidants|mesh-ancestor
93320956|NCT02707640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320957|NCT02707640|Protective Agents|protective agents|mesh-ancestor
93320958|NCT02707640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320959|NCT02707640|Antidotes|antidotes|mesh-ancestor
93320960|NCT02707640|Analgesics|analgesics|mesh-ancestor
93320961|NCT02707640|Sensory System Agents|sensory system agents|mesh-ancestor
93320962|NCT02707640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320963|NCT02707640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93320964|NCT02707640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93320965|NCT02707640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320966|NCT02707640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93320967|NCT02707640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93320968|NCT03190694|Dapagliflozin|dapagliflozin|mesh-list
93320969|NCT03190694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93320970|NCT03190694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320971|NCT03190694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93320972|NCT03190694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320973|NCT02430272|Glycopyrrolate|glycopyrrolate|mesh-list
93320974|NCT02430272|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93320975|NCT02430272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93320976|NCT02430272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93320977|NCT02430272|Cholinergic Agents|cholinergic agents|mesh-ancestor
93320978|NCT02430272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93320979|NCT02430272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320980|NCT02430272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320981|NCT03188978|Atorvastatin|atorvastatin|mesh-list
93320982|NCT03188978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93320983|NCT03188978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93320984|NCT03188978|Antimetabolites|antimetabolites|mesh-ancestor
92614945|NCT02611258|Urological Agents|urological agents|mesh-ancestor
93320985|NCT03188978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93320986|NCT03188978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93320987|NCT03188978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93320988|NCT03188978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93320989|NCT02431286|Dexamethasone|dexamethasone|mesh-list
93320990|NCT02431286|Aprepitant|aprepitant|mesh-list
93320991|NCT02431286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93320992|NCT02431286|Antiemetics|antiemetics|mesh-ancestor
93320993|NCT02431286|Autonomic Agents|autonomic agents|mesh-ancestor
93320994|NCT02431286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93320995|NCT02431286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93320996|NCT02431286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93320997|NCT02431286|Glucocorticoids|glucocorticoids|mesh-ancestor
93320998|NCT02431286|Hormones|hormones|mesh-ancestor
93320999|NCT02431286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321000|NCT02431286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93321001|NCT02431286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321002|NCT02431286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93321003|NCT02431286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321004|NCT02431286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321005|NCT04579367|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93321006|NCT04579367|Ezetimibe|ezetimibe|mesh-list
93321007|NCT04579367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93321008|NCT04579367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93321009|NCT04579367|Antimetabolites|antimetabolites|mesh-ancestor
93321010|NCT04579367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321011|NCT04579367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93321012|NCT04579367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321013|NCT04579367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321014|NCT04579367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321015|NCT02431208|Dexamethasone|dexamethasone|mesh-list
93321016|NCT02431208|Lenalidomide|lenalidomide|mesh-list
93321017|NCT02431208|Atezolizumab|atezolizumab|mesh-list
93321018|NCT02431208|Daratumumab|daratumumab|mesh-list
92993011|NCT00459706|Etanercept|etanercept|mesh-list
93321019|NCT02431208|Pomalidomide|pomalidomide|mesh-list
93321020|NCT02431208|Antibodies|antibodies|mesh-list
93321021|NCT02431208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93321022|NCT02431208|Immunologic Factors|immunologic factors|mesh-ancestor
93321023|NCT02431208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321024|NCT02431208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321025|NCT02431208|Antiemetics|antiemetics|mesh-ancestor
93321026|NCT02431208|Autonomic Agents|autonomic agents|mesh-ancestor
93321027|NCT02431208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321028|NCT02431208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321029|NCT02431208|Glucocorticoids|glucocorticoids|mesh-ancestor
93321030|NCT02431208|Hormones|hormones|mesh-ancestor
93321031|NCT02431208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321032|NCT02431208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93321033|NCT02431208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321034|NCT02431208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93321035|NCT02431208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93321036|NCT02431208|Growth Substances|growth substances|mesh-ancestor
93321037|NCT02431208|Growth Inhibitors|growth inhibitors|mesh-ancestor
93321038|NCT02431208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93321039|NCT02431208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321040|NCT02431208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321041|NCT03107078|Methylprednisolone|methylprednisolone|mesh-list
93321042|NCT03107078|Glucocorticoids|glucocorticoids|mesh-list
93321043|NCT03107078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321044|NCT03107078|Antiemetics|antiemetics|mesh-ancestor
93321045|NCT03107078|Autonomic Agents|autonomic agents|mesh-ancestor
93321046|NCT03107078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321047|NCT03107078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321048|NCT03107078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321049|NCT03107078|Hormones|hormones|mesh-ancestor
93321050|NCT03107078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321051|NCT03107078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93321052|NCT03107078|Protective Agents|protective agents|mesh-ancestor
93321053|NCT02430350|Edaravone|edaravone|mesh-list
93321054|NCT02430350|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93321055|NCT02430350|Antioxidants|antioxidants|mesh-ancestor
93321056|NCT02430350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321057|NCT02430350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93321058|NCT02430350|Protective Agents|protective agents|mesh-ancestor
93321059|NCT02430350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321060|NCT02429960|Remifentanil|remifentanil|mesh-list
93321061|NCT02429960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93321062|NCT02429960|Narcotics|narcotics|mesh-ancestor
93321063|NCT02429960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321064|NCT02429960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321065|NCT02429960|Analgesics|analgesics|mesh-ancestor
93321066|NCT02429960|Sensory System Agents|sensory system agents|mesh-ancestor
93321067|NCT02429960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321068|NCT02429804|Listerine|listerine|mesh-list
93321069|NCT02429804|Deoxyglucose|deoxyglucose|mesh-list
93321070|NCT02429804|Fluorides|fluorides|mesh-list
93321071|NCT02429804|Sodium Fluoride|sodium fluoride|mesh-list
93321072|NCT02429804|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93321073|NCT02429804|Cariostatic Agents|cariostatic agents|mesh-ancestor
93321074|NCT02429804|Protective Agents|protective agents|mesh-ancestor
93321075|NCT02429804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321076|NCT02429804|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93321077|NCT02429804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321078|NCT02429804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93321079|NCT02429804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321080|NCT02429804|Antimetabolites|antimetabolites|mesh-ancestor
93321081|NCT02429804|Antiviral Agents|antiviral agents|mesh-ancestor
93321082|NCT03185156|Propofol|propofol|mesh-list
93321083|NCT03185156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93321084|NCT03185156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321085|NCT03185156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321086|NCT03185156|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93321087|NCT03185156|Anesthetics, General|anesthetics, general|mesh-ancestor
93321088|NCT03185156|Anesthetics|anesthetics|mesh-ancestor
93321089|NCT02429726|Cisplatin|cisplatin|mesh-list
93321090|NCT02429726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321091|NCT02429882|Brodalumab|brodalumab|mesh-list
93321092|NCT02429882|Dermatologic Agents|dermatologic agents|mesh-ancestor
93321093|NCT02430896|Methylphenidate|methylphenidate|mesh-list
93321094|NCT02430896|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93321095|NCT02430896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93321096|NCT02430896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321097|NCT02430896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93321098|NCT02430896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93321099|NCT02430896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93321100|NCT02430896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321101|NCT02430896|Dopamine Agents|dopamine agents|mesh-ancestor
93321102|NCT02430896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321103|NCT02430896|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93321104|NCT02430896|Adrenergic Agents|adrenergic agents|mesh-ancestor
93321105|NCT03184844|Thalidomide|thalidomide|mesh-list
93321106|NCT03184844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321107|NCT03184844|Immunologic Factors|immunologic factors|mesh-ancestor
93321108|NCT03184844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321109|NCT03184844|Leprostatic Agents|leprostatic agents|mesh-ancestor
93321110|NCT03184844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321111|NCT03184844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321112|NCT03184844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93321113|NCT03184844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93321114|NCT03184844|Growth Substances|growth substances|mesh-ancestor
93321115|NCT03184844|Growth Inhibitors|growth inhibitors|mesh-ancestor
93321116|NCT03184844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321117|NCT02425202|Ketamine|ketamine|mesh-list
93321118|NCT02425202|Analgesics|analgesics|mesh-ancestor
93321119|NCT02425202|Sensory System Agents|sensory system agents|mesh-ancestor
93321120|NCT02425202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321121|NCT02425202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321122|NCT02425202|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93321123|NCT02425202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93321124|NCT02425202|Anesthetics, General|anesthetics, general|mesh-ancestor
93321125|NCT02425202|Anesthetics|anesthetics|mesh-ancestor
93321126|NCT02425202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321127|NCT02425202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93321128|NCT02425202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93321129|NCT02425202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321130|NCT02425202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321131|NCT03182504|Meropenem|meropenem|mesh-list
93321132|NCT03182504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321133|NCT03182504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321134|NCT02428946|Bromocriptine|bromocriptine|mesh-list
93321135|NCT02428946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93321136|NCT02428946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93321137|NCT02428946|Hormone Antagonists|hormone antagonists|mesh-ancestor
93321138|NCT02428946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321139|NCT02428946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321140|NCT02428946|Dopamine Agonists|dopamine agonists|mesh-ancestor
93321141|NCT02428946|Dopamine Agents|dopamine agents|mesh-ancestor
93321142|NCT02428946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321143|NCT02428946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321144|NCT02424656|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93321145|NCT02424656|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93321146|NCT02424656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321147|NCT02428868|Tranexamic Acid|tranexamic acid|mesh-list
93321148|NCT02428868|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93321149|NCT02428868|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93321150|NCT02428868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321151|NCT02428868|Hemostatics|hemostatics|mesh-ancestor
93321152|NCT02428868|Coagulants|coagulants|mesh-ancestor
93321153|NCT03181880|Bromides|bromides|mesh-list
93321154|NCT03181880|Formoterol Fumarate|formoterol fumarate|mesh-list
93321155|NCT03181880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93321156|NCT03181880|Autonomic Agents|autonomic agents|mesh-ancestor
93321157|NCT03181880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321158|NCT03181880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321159|NCT03181880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93321160|NCT03181880|Respiratory System Agents|respiratory system agents|mesh-ancestor
93321161|NCT03181880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93321162|NCT03181880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93321163|NCT03181880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93321164|NCT03181880|Adrenergic Agents|adrenergic agents|mesh-ancestor
93321165|NCT03181880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321166|NCT03181880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321167|NCT03181880|Anticonvulsants|anticonvulsants|mesh-ancestor
93321168|NCT03178994|Ketoconazole|ketoconazole|mesh-list
93321169|NCT03178994|Antifungal Agents|antifungal agents|mesh-ancestor
93321171|NCT03178994|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93321172|NCT03178994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93321173|NCT03178994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321174|NCT03178994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321175|NCT03178994|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93321176|NCT03178994|Hormone Antagonists|hormone antagonists|mesh-ancestor
93321177|NCT03178994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321178|NCT03178994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321179|NCT03178994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93321180|NCT03182114|Bupivacaine|bupivacaine|mesh-list
93321181|NCT03182114|Anesthetics, Local|anesthetics, local|mesh-ancestor
93321182|NCT03182114|Anesthetics|anesthetics|mesh-ancestor
93321183|NCT03182114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321184|NCT03182114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321185|NCT03182114|Sensory System Agents|sensory system agents|mesh-ancestor
93321186|NCT03182114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321187|NCT02428322|Vitamin D|vitamin d|mesh-list
93321188|NCT02428322|Cholecalciferol|cholecalciferol|mesh-list
93321189|NCT02428322|Vitamins|vitamins|mesh-ancestor
93321190|NCT02428322|Micronutrients|micronutrients|mesh-ancestor
93321191|NCT02428322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321192|NCT02428322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93321193|NCT02428322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93321194|NCT03053063|Selonsertib|selonsertib|mesh-list
93321195|NCT03053063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93321196|NCT03053063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321197|NCT03053063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321198|NCT00702338|Hormones|hormones|mesh-list
93321199|NCT00702338|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93321200|NCT00702338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321201|NCT00702338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321202|NCT05484557|Enoxaparin|enoxaparin|mesh-list
93321203|NCT05484557|Enoxaparin sodium|enoxaparin sodium|mesh-list
93321204|NCT05484557|Apixaban|apixaban|mesh-list
93321205|NCT05484557|Anticoagulants|anticoagulants|mesh-ancestor
93321206|NCT05484557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93321207|NCT05484557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93321208|NCT05484557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321209|NCT05484557|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93321210|NCT05484557|Antithrombins|antithrombins|mesh-ancestor
93321211|NCT05484557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93321212|NCT05484557|Protease Inhibitors|protease inhibitors|mesh-ancestor
93321213|NCT05484557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321214|NCT02427932|Gentamicins|gentamicins|mesh-list
93321215|NCT02427932|Ampicillin|ampicillin|mesh-list
93321216|NCT02427932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321217|NCT02427932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321218|NCT02427932|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93321219|NCT02427932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321220|NCT02427932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321221|NCT03626519|Menthol|menthol|mesh-list
93321222|NCT03626519|Antipruritics|antipruritics|mesh-ancestor
93321223|NCT03626519|Dermatologic Agents|dermatologic agents|mesh-ancestor
93321224|NCT03184766|Ibuprofen|ibuprofen|mesh-list
93321225|NCT03184766|Pseudoephedrine|pseudoephedrine|mesh-list
93321226|NCT03184766|Ephedrine|ephedrine|mesh-list
93321227|NCT03184766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93321228|NCT03184766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93321229|NCT03184766|Analgesics|analgesics|mesh-ancestor
93321230|NCT03184766|Sensory System Agents|sensory system agents|mesh-ancestor
93321231|NCT03184766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321232|NCT03184766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321233|NCT03184766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321234|NCT03184766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321235|NCT03184766|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93321236|NCT03184766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321237|NCT03184766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321238|NCT03184766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93321239|NCT03184766|Autonomic Agents|autonomic agents|mesh-ancestor
93321240|NCT03184766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93321241|NCT03184766|Respiratory System Agents|respiratory system agents|mesh-ancestor
93321242|NCT03184766|Nasal Decongestants|nasal decongestants|mesh-ancestor
93321243|NCT03184766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93321244|NCT03184766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93321245|NCT03184766|Sympathomimetics|sympathomimetics|mesh-ancestor
93321246|NCT03184766|Adrenergic Agents|adrenergic agents|mesh-ancestor
93321247|NCT03184766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321248|NCT03181646|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93321249|NCT03181646|Nootropic Agents|nootropic agents|mesh-ancestor
93321250|NCT02420834|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93321251|NCT02420834|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93321252|NCT02420834|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93321253|NCT02420834|Laxatives|laxatives|mesh-ancestor
93321254|NCT02420834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321255|NCT02423954|Sirolimus|sirolimus|mesh-list
93321256|NCT02423954|Capecitabine|capecitabine|mesh-list
93321257|NCT02423954|Nivolumab|nivolumab|mesh-list
93321258|NCT02423954|Irinotecan|irinotecan|mesh-list
93321259|NCT02423954|Temsirolimus|temsirolimus|mesh-list
93321260|NCT02423954|MTOR Inhibitors|mtor inhibitors|mesh-list
93321261|NCT02423954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321262|NCT02423954|Antimetabolites|antimetabolites|mesh-ancestor
93321263|NCT02423954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321264|NCT02423954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321265|NCT02423954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321266|NCT02423954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93321267|NCT02423954|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93321268|NCT02423954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93321269|NCT02423954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321270|NCT02423954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93321271|NCT02423954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321272|NCT02423954|Immunologic Factors|immunologic factors|mesh-ancestor
93321273|NCT02423954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321274|NCT02423954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321275|NCT02423954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321276|NCT02423954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93321277|NCT02423954|Antifungal Agents|antifungal agents|mesh-ancestor
93321278|NCT04221503|Niraparib|niraparib|mesh-list
93321279|NCT04221503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93321280|NCT04221503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321281|NCT04221503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321282|NCT04221503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321283|NCT02427308|Miltefosine|miltefosine|mesh-list
93321284|NCT02427308|Antifungal Agents|antifungal agents|mesh-ancestor
93321285|NCT02427308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321286|NCT02427308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321287|NCT02427308|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93321288|NCT02427308|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93321289|NCT03178292|Levofloxacin|levofloxacin|mesh-list
93321290|NCT03178292|Ofloxacin|ofloxacin|mesh-list
93321291|NCT03178292|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93321292|NCT03178292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321293|NCT03178292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321294|NCT03178292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93321295|NCT03178292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93321296|NCT03178292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321297|NCT03178292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321298|NCT03178292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321299|NCT03178292|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93321300|NCT03178292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93321301|NCT02427386|Estradiol|estradiol|mesh-list
93321302|NCT02427386|Estrogens|estrogens|mesh-list
93321303|NCT02427386|Hormones|hormones|mesh-ancestor
93321304|NCT02427386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321305|NCT02427386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321306|NCT03181178|Micronutrients|micronutrients|mesh-list
93321307|NCT03181178|Trace Elements|trace elements|mesh-list
93321308|NCT03181178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321309|NCT05478551|Botulinum Toxins|botulinum toxins|mesh-list
93321310|NCT05478551|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93321311|NCT05478551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93321312|NCT05478551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93321313|NCT05478551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321314|NCT05478551|Cholinergic Agents|cholinergic agents|mesh-ancestor
93321315|NCT05478551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321316|NCT05478551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321317|NCT02420444|BCG Vaccine|bcg vaccine|mesh-list
93321318|NCT02420444|Immunologic Factors|immunologic factors|mesh-ancestor
93321319|NCT02420444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321320|NCT02420444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93321321|NCT03180944|Lugol's solution|lugol's solution|mesh-list
93321322|NCT03180944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93321323|NCT03180944|Hemostatics|hemostatics|mesh-ancestor
93321324|NCT03180944|Coagulants|coagulants|mesh-ancestor
93321325|NCT04025879|Paclitaxel|paclitaxel|mesh-list
93321326|NCT04025879|Docetaxel|docetaxel|mesh-list
93321327|NCT04025879|Carboplatin|carboplatin|mesh-list
93321328|NCT04025879|Nivolumab|nivolumab|mesh-list
93321329|NCT04025879|Pemetrexed|pemetrexed|mesh-list
93321330|NCT04025879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93321331|NCT04025879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321332|NCT04025879|Tubulin Modulators|tubulin modulators|mesh-ancestor
93321333|NCT04025879|Antimitotic Agents|antimitotic agents|mesh-ancestor
93321334|NCT04025879|Mitosis Modulators|mitosis modulators|mesh-ancestor
93321335|NCT04025879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321336|NCT04025879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321337|NCT04025879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93321338|NCT04025879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321339|NCT04025879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93321340|NCT04025879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93321341|NCT03180710|Insulin Lispro|insulin lispro|mesh-list
93321342|NCT03180710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321343|NCT03180710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321344|NCT04322669|Pidotimod|pidotimod|mesh-list
93321345|NCT04322669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93321346|NCT04322669|Immunologic Factors|immunologic factors|mesh-ancestor
93321347|NCT04322669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321348|NCT03180476|Apatinib|apatinib|mesh-list
93321349|NCT03180476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321350|NCT03180476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93321351|NCT03180476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321352|NCT03180476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321353|NCT03180632|Lorazepam|lorazepam|mesh-list
93321354|NCT03180632|Anticonvulsants|anticonvulsants|mesh-ancestor
93321355|NCT03180632|Antiemetics|antiemetics|mesh-ancestor
93321356|NCT03180632|Autonomic Agents|autonomic agents|mesh-ancestor
93321357|NCT03180632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321358|NCT03180632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321359|NCT03180632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321360|NCT03180632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93321361|NCT03180632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321362|NCT03180632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93321363|NCT03180632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93321364|NCT03180632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93321365|NCT03180632|GABA Modulators|gaba modulators|mesh-ancestor
93321366|NCT03180632|GABA Agents|gaba agents|mesh-ancestor
93321367|NCT03180632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321368|NCT03180632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321369|NCT02420132|Ranibizumab|ranibizumab|mesh-list
93321370|NCT02420132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93321371|NCT02420132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93321372|NCT02420132|Growth Substances|growth substances|mesh-ancestor
93321373|NCT02420132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321374|NCT02420132|Growth Inhibitors|growth inhibitors|mesh-ancestor
93321375|NCT02420132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321376|NCT03183752|Metformin|metformin|mesh-list
93321377|NCT03183752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321378|NCT03183752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321379|NCT03183674|Oxytocin|oxytocin|mesh-list
93321380|NCT03183674|Oxytocics|oxytocics|mesh-ancestor
93321381|NCT03183674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93321382|NCT03183674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321383|NCT03117530|Minocycline|minocycline|mesh-list
93321384|NCT03117530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321385|NCT03117530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321386|NCT03889925|Hyaluronic Acid|hyaluronic acid|mesh-list
93321387|NCT03889925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93321388|NCT03889925|Immunologic Factors|immunologic factors|mesh-ancestor
93321389|NCT03889925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321390|NCT03889925|Viscosupplements|viscosupplements|mesh-ancestor
93321391|NCT03889925|Protective Agents|protective agents|mesh-ancestor
93321392|NCT05103254|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93321393|NCT05103254|Ezetimibe|ezetimibe|mesh-list
93321394|NCT05103254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93321395|NCT05103254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93321396|NCT05103254|Antimetabolites|antimetabolites|mesh-ancestor
93321397|NCT05103254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321398|NCT05103254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93321399|NCT05103254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321400|NCT05103254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321401|NCT05103254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321402|NCT02426840|Calcium, Dietary|calcium, dietary|mesh-list
93321403|NCT02426840|Vitamin D|vitamin d|mesh-list
93321404|NCT02426840|Ergocalciferols|ergocalciferols|mesh-list
93321405|NCT02426840|Cholecalciferol|cholecalciferol|mesh-list
93321406|NCT02426840|Vitamins|vitamins|mesh-list
93321407|NCT02426840|Calcium|calcium|mesh-list
93321408|NCT02426840|Micronutrients|micronutrients|mesh-ancestor
93321409|NCT02426840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321410|NCT02426840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93321411|NCT02426840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93321412|NCT03178526|Lovastatin|lovastatin|mesh-list
93321413|NCT03178526|L 647318|l 647318|mesh-list
93321414|NCT03178526|Dihydromevinolin|dihydromevinolin|mesh-list
93321415|NCT03178526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93321416|NCT03178526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93321417|NCT03178526|Antimetabolites|antimetabolites|mesh-ancestor
93321418|NCT03178526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321419|NCT03178526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93321420|NCT03178526|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93321421|NCT03178526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321422|NCT03857321|Insulin|insulin|mesh-list
93321423|NCT03857321|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93321424|NCT03857321|Insulin, Isophane|insulin, isophane|mesh-list
93321425|NCT03857321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321426|NCT03857321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321427|NCT02423642|Heparin|heparin|mesh-list
93321428|NCT02423642|Anticoagulants|anticoagulants|mesh-ancestor
93321429|NCT02423642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321430|NCT02423642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93321431|NCT02423642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93321432|NCT03180242|Trastuzumab|trastuzumab|mesh-list
93321433|NCT03180242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321434|NCT03180242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321435|NCT00709904|Semuloparin|semuloparin|mesh-list
93321436|NCT00709904|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93321437|NCT00709904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93321438|NCT00709904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93321439|NCT00709904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321440|NCT00709904|Anticoagulants|anticoagulants|mesh-ancestor
93321441|NCT04356989|Rivaroxaban|rivaroxaban|mesh-list
93321442|NCT04356989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93321443|NCT04356989|Antithrombins|antithrombins|mesh-ancestor
93321444|NCT04356989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93321445|NCT04356989|Protease Inhibitors|protease inhibitors|mesh-ancestor
93321446|NCT04356989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321447|NCT04356989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321448|NCT04356989|Anticoagulants|anticoagulants|mesh-ancestor
93321449|NCT03183596|Dexamethasone|dexamethasone|mesh-list
93321450|NCT03183596|Bupivacaine|bupivacaine|mesh-list
93321451|NCT03183596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321452|NCT03183596|Antiemetics|antiemetics|mesh-ancestor
93321453|NCT03183596|Autonomic Agents|autonomic agents|mesh-ancestor
93321454|NCT03183596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321455|NCT03183596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321456|NCT03183596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321457|NCT03183596|Glucocorticoids|glucocorticoids|mesh-ancestor
93321458|NCT03183596|Hormones|hormones|mesh-ancestor
93321459|NCT03183596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321460|NCT03183596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93321461|NCT03183596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321462|NCT03183596|Anesthetics, Local|anesthetics, local|mesh-ancestor
93321463|NCT03183596|Anesthetics|anesthetics|mesh-ancestor
93321464|NCT03183596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321465|NCT03183596|Sensory System Agents|sensory system agents|mesh-ancestor
93321466|NCT03117062|Salicylic Acid|salicylic acid|mesh-list
93321467|NCT03117062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321468|NCT03117062|Antifungal Agents|antifungal agents|mesh-ancestor
93321469|NCT03117062|Keratolytic Agents|keratolytic agents|mesh-ancestor
93321470|NCT03117062|Dermatologic Agents|dermatologic agents|mesh-ancestor
93321471|NCT03620669|Durvalumab|durvalumab|mesh-list
93321472|NCT03620669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993476|NCT00736931|Levetiracetam|levetiracetam|mesh-list
93321473|NCT03620669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321474|NCT04325243|Sildenafil Citrate|sildenafil citrate|mesh-list
93321475|NCT04325243|Vasodilator Agents|vasodilator agents|mesh-ancestor
93321476|NCT04325243|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93321477|NCT04325243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93321478|NCT04325243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321479|NCT04325243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321480|NCT04325243|Urological Agents|urological agents|mesh-ancestor
93321481|NCT02419820|Aspirin|aspirin|mesh-list
93321482|NCT02419820|Clopidogrel|clopidogrel|mesh-list
93321483|NCT02419820|APD791|apd791|mesh-list
93321484|NCT02419820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93321485|NCT02419820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93321486|NCT02419820|Analgesics|analgesics|mesh-ancestor
93321487|NCT02419820|Sensory System Agents|sensory system agents|mesh-ancestor
93321488|NCT02419820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321489|NCT02419820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321490|NCT02419820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321491|NCT02419820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321492|NCT02419820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93321493|NCT02419820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93321494|NCT02419820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321495|NCT02419820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93321496|NCT02419820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93321497|NCT02419820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321498|NCT02419820|Antipyretics|antipyretics|mesh-ancestor
93321499|NCT02419820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93321500|NCT02419820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93321501|NCT02419820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93321502|NCT02419820|Purinergic Agents|purinergic agents|mesh-ancestor
93321503|NCT02419820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321504|NCT02419820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93321505|NCT02419820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93321506|NCT02419820|Serotonin Agents|serotonin agents|mesh-ancestor
93321507|NCT05692739|Cyclosporine|cyclosporine|mesh-list
93321508|NCT05692739|Lubricant Eye Drops|lubricant eye drops|mesh-list
93321509|NCT05692739|Cyclosporins|cyclosporins|mesh-list
93321510|NCT05692739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321511|NCT05692739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321512|NCT05692739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321513|NCT05692739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321514|NCT05692739|Immunologic Factors|immunologic factors|mesh-ancestor
93321515|NCT05692739|Antifungal Agents|antifungal agents|mesh-ancestor
93321516|NCT05692739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321517|NCT05692739|Dermatologic Agents|dermatologic agents|mesh-ancestor
93321518|NCT05692739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321519|NCT05692739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93321520|NCT05692739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93321521|NCT05692739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93321522|NCT02419352|Atropine|atropine|mesh-list
93321523|NCT02419352|Neostigmine|neostigmine|mesh-list
93321524|NCT02419352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93321525|NCT02419352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93321526|NCT02419352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93321527|NCT02419352|Autonomic Agents|autonomic agents|mesh-ancestor
93321528|NCT02419352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321529|NCT02419352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321530|NCT02419352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93321531|NCT02419352|Respiratory System Agents|respiratory system agents|mesh-ancestor
93321532|NCT02419352|Mydriatics|mydriatics|mesh-ancestor
93321533|NCT02419352|Parasympatholytics|parasympatholytics|mesh-ancestor
93321534|NCT02419352|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93321535|NCT02419352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93321536|NCT02419352|Cholinergic Agents|cholinergic agents|mesh-ancestor
93321537|NCT02419352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321538|NCT02419352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321539|NCT02419352|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93321540|NCT02419352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321541|NCT02419352|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93321542|NCT03365687|Vitamin D|vitamin d|mesh-list
93321543|NCT03365687|Cholecalciferol|cholecalciferol|mesh-list
93321544|NCT03365687|Vitamins|vitamins|mesh-ancestor
93321545|NCT03365687|Micronutrients|micronutrients|mesh-ancestor
93321546|NCT03365687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321547|NCT03365687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993538|NCT00931580|Cholecalciferol|cholecalciferol|mesh-list
93321548|NCT03365687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93321549|NCT02419118|Dexamethasone|dexamethasone|mesh-list
93321550|NCT02419118|Lenalidomide|lenalidomide|mesh-list
93321551|NCT02419118|Daratumumab|daratumumab|mesh-list
93321552|NCT02419118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321553|NCT02419118|Antiemetics|antiemetics|mesh-ancestor
93321554|NCT02419118|Autonomic Agents|autonomic agents|mesh-ancestor
93321555|NCT02419118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321556|NCT02419118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321557|NCT02419118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321558|NCT02419118|Glucocorticoids|glucocorticoids|mesh-ancestor
93321559|NCT02419118|Hormones|hormones|mesh-ancestor
93321560|NCT02419118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321561|NCT02419118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93321562|NCT02419118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321563|NCT02419118|Immunologic Factors|immunologic factors|mesh-ancestor
93321564|NCT02419118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93321565|NCT02419118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93321566|NCT02419118|Growth Substances|growth substances|mesh-ancestor
93321567|NCT02419118|Growth Inhibitors|growth inhibitors|mesh-ancestor
93321568|NCT02426294|Pioglitazone|pioglitazone|mesh-list
93321569|NCT02426294|Glimepiride|glimepiride|mesh-list
93321570|NCT02426294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321571|NCT02426294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321572|NCT02426294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93321573|NCT02426294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321574|NCT02426294|Immunologic Factors|immunologic factors|mesh-ancestor
93321575|NCT02426450|Leucovorin|leucovorin|mesh-list
93321576|NCT02426450|Fluorouracil|fluorouracil|mesh-list
93321577|NCT02426450|Oxaliplatin|oxaliplatin|mesh-list
93321578|NCT02426450|Antimetabolites|antimetabolites|mesh-ancestor
93321579|NCT02426450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321580|NCT02426450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321581|NCT02426450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321582|NCT02426450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321583|NCT02426450|Immunologic Factors|immunologic factors|mesh-ancestor
93321584|NCT02426450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321585|NCT02426450|Antidotes|antidotes|mesh-ancestor
93321586|NCT02426450|Protective Agents|protective agents|mesh-ancestor
93321587|NCT02426450|Vitamin B Complex|vitamin b complex|mesh-ancestor
93321588|NCT02426450|Vitamins|vitamins|mesh-ancestor
93321589|NCT02426450|Micronutrients|micronutrients|mesh-ancestor
93321590|NCT02426060|Warfarin|warfarin|mesh-list
93321591|NCT02426060|Anticoagulants|anticoagulants|mesh-ancestor
93321592|NCT02422784|Vitamin D|vitamin d|mesh-list
93321593|NCT02422784|Ergocalciferols|ergocalciferols|mesh-list
93321594|NCT02422784|Cholecalciferol|cholecalciferol|mesh-list
93321595|NCT02422784|Vitamins|vitamins|mesh-list
93321596|NCT02422784|Micronutrients|micronutrients|mesh-ancestor
93321597|NCT02422784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321598|NCT02422784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93321599|NCT02422784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93321600|NCT03740009|Bazedoxifene|bazedoxifene|mesh-list
93321601|NCT03740009|Estrogens|estrogens|mesh-list
93321602|NCT03740009|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93321603|NCT03740009|Hormones|hormones|mesh-ancestor
93321604|NCT03740009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321605|NCT03740009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321606|NCT03740009|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93321607|NCT03740009|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93321608|NCT03740009|Hormone Antagonists|hormone antagonists|mesh-ancestor
93321609|NCT03740009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93321610|NCT03179618|Vasodilator Agents|vasodilator agents|mesh-list
93321611|NCT03179618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93321612|NCT03179618|Lipid Regulating Agents|lipid regulating agents|mesh-list
93321613|NCT03182894|Pembrolizumab|pembrolizumab|mesh-list
93321614|NCT03182894|Azacitidine|azacitidine|mesh-list
93321615|NCT03182894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321616|NCT03182894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321617|NCT03182894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93321618|NCT03182894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321619|NCT03182894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321620|NCT03182894|Antimetabolites|antimetabolites|mesh-ancestor
93321621|NCT03182894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321622|NCT02418884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93321623|NCT02418884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93321624|NCT02418884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93321625|NCT02418884|Antimetabolites|antimetabolites|mesh-ancestor
93321626|NCT02418884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321627|NCT02418884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93321628|NCT02418884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93321629|NCT02418884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321631|NCT02423096|Olanzapine|olanzapine|mesh-list
93321632|NCT02423096|Risperidone|risperidone|mesh-list
93321633|NCT02423096|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93321634|NCT02423096|Sulpiride|sulpiride|mesh-list
93321635|NCT02423096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93321636|NCT02423096|Serotonin Agents|serotonin agents|mesh-ancestor
93321637|NCT02423096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321638|NCT02423096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321639|NCT02423096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321640|NCT02423096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93321641|NCT02423096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93321642|NCT02423096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321643|NCT02423096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93321644|NCT02423096|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93321645|NCT02423096|Dopamine Agents|dopamine agents|mesh-ancestor
93321646|NCT02423096|Antiemetics|antiemetics|mesh-ancestor
93321647|NCT02423096|Autonomic Agents|autonomic agents|mesh-ancestor
93321648|NCT02423096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321649|NCT02423096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321650|NCT02423096|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93321651|NCT02423096|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93321652|NCT02423096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93321653|NCT02423096|Antidepressive Agents|antidepressive agents|mesh-ancestor
93321654|NCT02423096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93321655|NCT02423096|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93321656|NCT03629951|Antipsychotic Agents|antipsychotic agents|mesh-list
93321657|NCT03629951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93321658|NCT03629951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321659|NCT03629951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321660|NCT03629951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93321661|NCT02423018|Pregabalin|pregabalin|mesh-list
93321662|NCT02423018|Analgesics|analgesics|mesh-ancestor
93321663|NCT02423018|Sensory System Agents|sensory system agents|mesh-ancestor
93321664|NCT02423018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321665|NCT02423018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321666|NCT02423018|Anticonvulsants|anticonvulsants|mesh-ancestor
93321667|NCT02423018|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93321668|NCT02423018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93321669|NCT02423018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321670|NCT02423018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93321671|NCT02423018|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93321672|NCT02423018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93321673|NCT02423018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321674|NCT02423018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93321675|NCT03179384|Ceftriaxone|ceftriaxone|mesh-list
93321676|NCT03179384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321677|NCT03179384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321678|NCT05691959|Calcium|calcium|mesh-list
93321679|NCT05691959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93321680|NCT05691959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321681|NCT02422706|Metronidazole|metronidazole|mesh-list
93321682|NCT02422706|Clarithromycin|clarithromycin|mesh-list
93321683|NCT02422706|Levofloxacin|levofloxacin|mesh-list
93321684|NCT02422706|Ofloxacin|ofloxacin|mesh-list
93321685|NCT02422706|Nitazoxanide|nitazoxanide|mesh-list
93321686|NCT02422706|Doxycycline|doxycycline|mesh-list
93321687|NCT02422706|Omeprazole|omeprazole|mesh-list
93321688|NCT02422706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321689|NCT02422706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321690|NCT02422706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93321691|NCT02422706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93321692|NCT02422706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93321693|NCT02422706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321694|NCT02422706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93321695|NCT02422706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321696|NCT02422706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321697|NCT02422706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93321698|NCT02422706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93321699|NCT02422706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93321700|NCT02422706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92993687|NCT00566696|Mycophenolic Acid|mycophenolic acid|mesh-list
93321701|NCT02422706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93321702|NCT02422706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93321703|NCT02422706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321704|NCT02422706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93321705|NCT02422706|Antimalarials|antimalarials|mesh-ancestor
93321706|NCT03058757|Mitomycins|mitomycins|mesh-list
93321707|NCT03058757|Mitomycin|mitomycin|mesh-list
93321708|NCT03058757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93321709|NCT03058757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321710|NCT03058757|Alkylating Agents|alkylating agents|mesh-ancestor
93321711|NCT03058757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321712|NCT03058757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93321713|NCT03058757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321714|NCT03138889|Paclitaxel|paclitaxel|mesh-list
93321715|NCT03138889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93321716|NCT03138889|Carboplatin|carboplatin|mesh-list
93321717|NCT03138889|Pembrolizumab|pembrolizumab|mesh-list
93321718|NCT03138889|Pemetrexed|pemetrexed|mesh-list
93321719|NCT03138889|Atezolizumab|atezolizumab|mesh-list
93321720|NCT03138889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93321721|NCT03138889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321722|NCT03138889|Tubulin Modulators|tubulin modulators|mesh-ancestor
93321723|NCT03138889|Antimitotic Agents|antimitotic agents|mesh-ancestor
93321724|NCT03138889|Mitosis Modulators|mitosis modulators|mesh-ancestor
93321725|NCT03138889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321726|NCT03138889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321727|NCT03138889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93321728|NCT03138889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321729|NCT03138889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93321730|NCT03138889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93321731|NCT01881763|Ketamine|ketamine|mesh-list
93321732|NCT01881763|Methohexital|methohexital|mesh-list
93321733|NCT01881763|Analgesics|analgesics|mesh-ancestor
93321734|NCT01881763|Sensory System Agents|sensory system agents|mesh-ancestor
93321735|NCT01881763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321736|NCT01881763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321737|NCT01881763|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93321738|NCT01881763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93321739|NCT01881763|Anesthetics, General|anesthetics, general|mesh-ancestor
93321740|NCT01881763|Anesthetics|anesthetics|mesh-ancestor
93321741|NCT01881763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321742|NCT01881763|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93321743|NCT01881763|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93321744|NCT01881763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321745|NCT01881763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321746|NCT03669601|Gemcitabine|gemcitabine|mesh-list
93321747|NCT03669601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321748|NCT03669601|Antimetabolites|antimetabolites|mesh-ancestor
93321749|NCT03669601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321750|NCT03669601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321751|NCT02959463|Pembrolizumab|pembrolizumab|mesh-list
93321752|NCT02959463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93321753|NCT02959463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321754|NCT02959463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93321755|NCT02959463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321756|NCT02416388|Cytarabine|cytarabine|mesh-list
93321757|NCT02416388|Cyclosporine|cyclosporine|mesh-list
93321758|NCT02416388|Mycophenolic Acid|mycophenolic acid|mesh-list
93321759|NCT02416388|Dexamethasone|dexamethasone|mesh-list
93321760|NCT02416388|Methotrexate|methotrexate|mesh-list
93321761|NCT02416388|Daunorubicin|daunorubicin|mesh-list
93321762|NCT02416388|Venetoclax|venetoclax|mesh-list
93321763|NCT02416388|Idarubicin|idarubicin|mesh-list
93321764|NCT02416388|Cyclosporins|cyclosporins|mesh-list
93321765|NCT02416388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321766|NCT02416388|Antiemetics|antiemetics|mesh-ancestor
93321767|NCT02416388|Autonomic Agents|autonomic agents|mesh-ancestor
93321768|NCT02416388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321769|NCT02416388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321770|NCT02416388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321771|NCT02416388|Glucocorticoids|glucocorticoids|mesh-ancestor
93321772|NCT02416388|Hormones|hormones|mesh-ancestor
93321773|NCT02416388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321774|NCT02416388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93321775|NCT02416388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321776|NCT02416388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93321777|NCT02416388|Abortifacient Agents|abortifacient agents|mesh-ancestor
93321778|NCT02416388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93321779|NCT02416388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321780|NCT02416388|Antimetabolites|antimetabolites|mesh-ancestor
93321781|NCT02416388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321782|NCT02416388|Dermatologic Agents|dermatologic agents|mesh-ancestor
93321783|NCT02416388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321784|NCT02416388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93321785|NCT02416388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321786|NCT02416388|Immunologic Factors|immunologic factors|mesh-ancestor
93321787|NCT02416388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321788|NCT02416388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93321789|NCT02416388|Antiviral Agents|antiviral agents|mesh-ancestor
93321790|NCT02416388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321791|NCT02416388|Antifungal Agents|antifungal agents|mesh-ancestor
93321792|NCT02416388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93321793|NCT02416388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93321794|NCT02416388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93321795|NCT02416388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93321796|NCT02416388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93321797|NCT02416388|Antitubercular Agents|antitubercular agents|mesh-ancestor
93321798|NCT02416388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93321799|NCT02886065|Lenalidomide|lenalidomide|mesh-list
93321801|NCT02886065|Citarinostat|citarinostat|mesh-list
93321802|NCT02886065|Immunologic Factors|immunologic factors|mesh-ancestor
93321803|NCT02886065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321804|NCT02886065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93321805|NCT02886065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93321806|NCT02886065|Growth Substances|growth substances|mesh-ancestor
93321807|NCT02886065|Growth Inhibitors|growth inhibitors|mesh-ancestor
93321808|NCT02886065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321809|NCT02886065|Interferon Inducers|interferon inducers|mesh-ancestor
93321810|NCT02886065|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93321811|NCT02886065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321812|NCT02886065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321813|NCT03392441|Insulin|insulin|mesh-list
93321814|NCT03392441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321815|NCT03392441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321816|NCT03177824|Sildenafil Citrate|sildenafil citrate|mesh-list
93321817|NCT03177824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321818|NCT03177824|Vasodilator Agents|vasodilator agents|mesh-ancestor
93321819|NCT03177824|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93321820|NCT03177824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93321821|NCT03177824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321822|NCT03177824|Urological Agents|urological agents|mesh-ancestor
93321823|NCT02416232|Trametinib|trametinib|mesh-list
93321824|NCT02416232|Dabrafenib|dabrafenib|mesh-list
93321825|NCT02416232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321826|NCT02416232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93321827|NCT02416232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321828|NCT02416232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321829|NCT04482842|Warfarin|warfarin|mesh-list
93321830|NCT04482842|Anticoagulants|anticoagulants|mesh-ancestor
93321831|NCT02767661|Capecitabine|capecitabine|mesh-list
93321832|NCT02767661|Letrozole|letrozole|mesh-list
93321833|NCT02767661|Anastrozole|anastrozole|mesh-list
93321834|NCT02767661|Exemestane|exemestane|mesh-list
93321835|NCT02767661|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93321836|NCT02767661|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321837|NCT02767661|Antimetabolites|antimetabolites|mesh-ancestor
93321838|NCT02767661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321839|NCT02767661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321840|NCT02767661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93321841|NCT02767661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321842|NCT02767661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93321843|NCT02767661|Hormone Antagonists|hormone antagonists|mesh-ancestor
93321844|NCT02767661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93321845|NCT02767661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321846|NCT02767661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93321847|NCT02415920|Oxytocin|oxytocin|mesh-list
93321848|NCT02415920|Oxytocics|oxytocics|mesh-ancestor
93321849|NCT02415920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93321850|NCT02415920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321851|NCT03389243|Acetaminophen|acetaminophen|mesh-list
93321852|NCT03389243|Dipyrone|dipyrone|mesh-list
93321853|NCT03389243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93321855|NCT03389243|Sensory System Agents|sensory system agents|mesh-ancestor
93321856|NCT03389243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321857|NCT03389243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321858|NCT03389243|Antipyretics|antipyretics|mesh-ancestor
93321859|NCT03389243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93321860|NCT03389243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321861|NCT03389243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321862|NCT02421926|Imatinib Mesylate|imatinib mesylate|mesh-list
93321863|NCT02421926|Dasatinib|dasatinib|mesh-list
93321864|NCT02421926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321865|NCT02421926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93321866|NCT02421926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321867|NCT02421926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321868|NCT02410460|Lidocaine|lidocaine|mesh-list
93321869|NCT02410460|Clonidine|clonidine|mesh-list
93321870|NCT02410460|Midazolam|midazolam|mesh-list
93321871|NCT02410460|Glycopyrrolate|glycopyrrolate|mesh-list
93321872|NCT02410460|Scopolamine|scopolamine|mesh-list
93321873|NCT02410460|Ketamine|ketamine|mesh-list
93321874|NCT02410460|Ondansetron|ondansetron|mesh-list
93321875|NCT02410460|Metoclopramide|metoclopramide|mesh-list
93321876|NCT02410460|Bupivacaine|bupivacaine|mesh-list
93321877|NCT02410460|Propofol|propofol|mesh-list
93321878|NCT02410460|Sevoflurane|sevoflurane|mesh-list
93321879|NCT02410460|Desflurane|desflurane|mesh-list
93321880|NCT02410460|Famotidine|famotidine|mesh-list
93321881|NCT02410460|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93321882|NCT02410460|Anesthetics, Local|anesthetics, local|mesh-ancestor
93321883|NCT02410460|Anesthetics|anesthetics|mesh-ancestor
93321884|NCT02410460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321885|NCT02410460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321886|NCT02410460|Sensory System Agents|sensory system agents|mesh-ancestor
93321887|NCT02410460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321888|NCT02410460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93321889|NCT02410460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93321890|NCT02410460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93321891|NCT02410460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93321892|NCT02410460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321893|NCT02410460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93321894|NCT02410460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93321895|NCT02410460|Anesthetics, General|anesthetics, general|mesh-ancestor
93321896|NCT02410460|Analgesics|analgesics|mesh-ancestor
93321897|NCT02410460|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93321898|NCT02410460|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93321899|NCT02410460|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93321900|NCT02410460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93321901|NCT02410460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93321902|NCT02410460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93321903|NCT02410460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93321904|NCT02410460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93321905|NCT02410460|GABA Modulators|gaba modulators|mesh-ancestor
93321906|NCT02410460|GABA Agents|gaba agents|mesh-ancestor
93321907|NCT02410460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93321908|NCT02410460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93321909|NCT02410460|Antiemetics|antiemetics|mesh-ancestor
93321910|NCT02410460|Autonomic Agents|autonomic agents|mesh-ancestor
93321911|NCT02410460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93321912|NCT02410460|Antipruritics|antipruritics|mesh-ancestor
93321913|NCT02410460|Dermatologic Agents|dermatologic agents|mesh-ancestor
93321914|NCT02410460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93321915|NCT02410460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93321916|NCT02410460|Serotonin Agents|serotonin agents|mesh-ancestor
93321917|NCT02410460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93321918|NCT02410460|Sympatholytics|sympatholytics|mesh-ancestor
93321919|NCT02410460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93321920|NCT02410460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93321921|NCT02410460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93321922|NCT02410460|Adrenergic Agents|adrenergic agents|mesh-ancestor
93321923|NCT02410460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93321924|NCT02410460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93321925|NCT02410460|Dopamine Agents|dopamine agents|mesh-ancestor
93321926|NCT02410460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93321927|NCT02410460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93321928|NCT02410460|Cholinergic Agents|cholinergic agents|mesh-ancestor
93321929|NCT02410460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93321930|NCT02410460|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93321931|NCT02410460|Histamine Antagonists|histamine antagonists|mesh-ancestor
93321932|NCT02410460|Histamine Agents|histamine agents|mesh-ancestor
93321933|NCT02410460|Mydriatics|mydriatics|mesh-ancestor
93321934|NCT02410460|Parasympatholytics|parasympatholytics|mesh-ancestor
93321935|NCT02410226|Anesthetics|anesthetics|mesh-list
93321936|NCT02410226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321937|NCT02410226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321938|NCT03116672|Diclofenac|diclofenac|mesh-list
93321939|NCT03116672|Ketorolac|ketorolac|mesh-list
93321940|NCT03116672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93321941|NCT03116672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93321942|NCT03116672|Analgesics|analgesics|mesh-ancestor
93321943|NCT03116672|Sensory System Agents|sensory system agents|mesh-ancestor
93321944|NCT03116672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321945|NCT03116672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321946|NCT03116672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321947|NCT03116672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321948|NCT03116672|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93321949|NCT03116672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321950|NCT03116672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321951|NCT03174860|Diclofenac|diclofenac|mesh-list
93321952|NCT03174860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93321953|NCT03174860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93321954|NCT03174860|Analgesics|analgesics|mesh-ancestor
93321955|NCT03174860|Sensory System Agents|sensory system agents|mesh-ancestor
93321956|NCT03174860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321957|NCT03174860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321958|NCT03174860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93321959|NCT03174860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93321960|NCT03174860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93321961|NCT03174860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321962|NCT03174860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321963|NCT03174548|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93321964|NCT03174548|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93321965|NCT03174548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321966|NCT03174548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321967|NCT03174548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321968|NCT02417090|Metformin|metformin|mesh-list
93321969|NCT02417090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93321970|NCT02417090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321971|NCT00703820|Cytarabine|cytarabine|mesh-list
93321972|NCT00703820|Etoposide|etoposide|mesh-list
93321973|NCT00703820|Daunorubicin|daunorubicin|mesh-list
93321974|NCT00703820|Clofarabine|clofarabine|mesh-list
93321975|NCT00703820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93321976|NCT00703820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93321977|NCT00703820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93321978|NCT00703820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93321979|NCT00703820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93321980|NCT00703820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93321981|NCT00703820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93321982|NCT00703820|Antimetabolites|antimetabolites|mesh-ancestor
93321983|NCT00703820|Antiviral Agents|antiviral agents|mesh-ancestor
93321984|NCT00703820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93321985|NCT00703820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93321986|NCT00703820|Immunologic Factors|immunologic factors|mesh-ancestor
93321987|NCT00703820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321988|NCT00703820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93321989|NCT03177980|Clonidine|clonidine|mesh-list
93321990|NCT03177980|Fentanyl|fentanyl|mesh-list
93321991|NCT03177980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93321992|NCT03177980|Narcotics|narcotics|mesh-ancestor
93321993|NCT03177980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93321994|NCT03177980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93321995|NCT03177980|Analgesics|analgesics|mesh-ancestor
93321996|NCT03177980|Sensory System Agents|sensory system agents|mesh-ancestor
93321997|NCT03177980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93321998|NCT03177980|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93321999|NCT03177980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93322000|NCT03177980|Anesthetics, General|anesthetics, general|mesh-ancestor
93322001|NCT03177980|Anesthetics|anesthetics|mesh-ancestor
93322002|NCT03177980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92993996|NCT00934154|Thalidomide|thalidomide|mesh-list
93322003|NCT03177980|Sympatholytics|sympatholytics|mesh-ancestor
93322004|NCT03177980|Autonomic Agents|autonomic agents|mesh-ancestor
93322005|NCT03177980|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93322006|NCT03177980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93322007|NCT03177980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93322008|NCT03177980|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322009|NCT03177980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322010|NCT03177980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322011|NCT03177434|Lactulose|lactulose|mesh-list
93322012|NCT03177434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322013|NCT02587325|Sirolimus|sirolimus|mesh-list
93322014|NCT02587325|Temsirolimus|temsirolimus|mesh-list
93322015|NCT02587325|MTOR Inhibitors|mtor inhibitors|mesh-list
93322016|NCT02587325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322017|NCT02587325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322018|NCT02587325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93322019|NCT02587325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322020|NCT02587325|Antifungal Agents|antifungal agents|mesh-ancestor
93322021|NCT02587325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322022|NCT02587325|Immunologic Factors|immunologic factors|mesh-ancestor
93322023|NCT02587325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322024|NCT02587325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93322025|NCT02587325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322026|NCT02587325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322027|NCT02414984|Golimumab|golimumab|mesh-list
93322028|NCT02414984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93322029|NCT02414984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322030|NCT02414984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322031|NCT02414984|Immunologic Factors|immunologic factors|mesh-ancestor
93322032|NCT02414984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322033|NCT02415062|Donepezil|donepezil|mesh-list
93322034|NCT02415062|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93322035|NCT02415062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322036|NCT02415062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322037|NCT02415062|Cholinergic Agents|cholinergic agents|mesh-ancestor
93322038|NCT02415062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322039|NCT02415062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322040|NCT02415062|Nootropic Agents|nootropic agents|mesh-ancestor
93322041|NCT02408978|Naproxen|naproxen|mesh-list
93322042|NCT02408978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322043|NCT02408978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322044|NCT02408978|Analgesics|analgesics|mesh-ancestor
93322045|NCT02408978|Sensory System Agents|sensory system agents|mesh-ancestor
93322046|NCT02408978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322047|NCT02408978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322048|NCT02408978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322049|NCT02408978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322050|NCT02408978|Gout Suppressants|gout suppressants|mesh-ancestor
93322051|NCT02408978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322052|NCT02408978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322053|NCT02408978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322054|NCT02408744|Pirfenidone|pirfenidone|mesh-list
93322055|NCT02408744|Analgesics|analgesics|mesh-ancestor
93322056|NCT02408744|Sensory System Agents|sensory system agents|mesh-ancestor
93322057|NCT02408744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322058|NCT02408744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322059|NCT02408744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322060|NCT02408744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322061|NCT02408744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322062|NCT02408744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322063|NCT02408744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322064|NCT03174080|Fluorides|fluorides|mesh-list
93322065|NCT03174080|Cariostatic Agents|cariostatic agents|mesh-ancestor
93322066|NCT03174080|Protective Agents|protective agents|mesh-ancestor
93322067|NCT03174080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322068|NCT03116516|Amlodipine|amlodipine|mesh-list
93322069|NCT03116516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93322070|NCT03116516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93322071|NCT03116516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93322072|NCT03116516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322073|NCT03116516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322074|NCT03116516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93322075|NCT03116516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322076|NCT03116516|Vasodilator Agents|vasodilator agents|mesh-ancestor
93322077|NCT03116516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93322078|NCT03116516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92994060|NCT01013571|Insulin|insulin|mesh-list
93322080|NCT03116516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93322081|NCT03116516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93322082|NCT03116516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322083|NCT01564537|Dexamethasone|dexamethasone|mesh-list
93322084|NCT01564537|Lenalidomide|lenalidomide|mesh-list
93322085|NCT01564537|Ixazomib|ixazomib|mesh-list
93322086|NCT01564537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322087|NCT01564537|Antiemetics|antiemetics|mesh-ancestor
93322088|NCT01564537|Autonomic Agents|autonomic agents|mesh-ancestor
93322089|NCT01564537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322090|NCT01564537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322091|NCT01564537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322092|NCT01564537|Glucocorticoids|glucocorticoids|mesh-ancestor
93322093|NCT01564537|Hormones|hormones|mesh-ancestor
93322094|NCT01564537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322095|NCT01564537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322096|NCT01564537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322097|NCT01564537|Immunologic Factors|immunologic factors|mesh-ancestor
93322098|NCT01564537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93322099|NCT01564537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93322100|NCT01564537|Growth Substances|growth substances|mesh-ancestor
93322101|NCT01564537|Growth Inhibitors|growth inhibitors|mesh-ancestor
93322102|NCT01564537|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322103|NCT01564537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322104|NCT01564537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322105|NCT02446457|Rituximab|rituximab|mesh-list
93322106|NCT02446457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93322107|NCT02446457|Pembrolizumab|pembrolizumab|mesh-list
93322108|NCT02446457|Lenalidomide|lenalidomide|mesh-list
93322109|NCT02446457|Antibodies|antibodies|mesh-list
93322110|NCT02446457|Immunoglobulins|immunoglobulins|mesh-list
93322111|NCT02446457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93322112|NCT02446457|Immunologic Factors|immunologic factors|mesh-ancestor
93322113|NCT02446457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322114|NCT02446457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322115|NCT02446457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322116|NCT02446457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93322117|NCT02446457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322118|NCT02446457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93322119|NCT02446457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93322120|NCT02446457|Growth Substances|growth substances|mesh-ancestor
93322121|NCT02446457|Growth Inhibitors|growth inhibitors|mesh-ancestor
93322122|NCT03174236|Metronidazole|metronidazole|mesh-list
93322123|NCT03174236|Gentamicins|gentamicins|mesh-list
93322124|NCT03174236|Ceftriaxone|ceftriaxone|mesh-list
93322125|NCT03174236|Penicillins|penicillins|mesh-list
93322126|NCT03174236|Penicillin G|penicillin g|mesh-list
93322127|NCT03174236|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93322128|NCT03174236|Penicillin G Procaine|penicillin g procaine|mesh-list
93322129|NCT03174236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322130|NCT03174236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322131|NCT03174236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93322132|NCT03174236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93322133|NCT03174236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93322134|NCT03174236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322135|NCT03174236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322136|NCT03172052|Streptokinase|streptokinase|mesh-list
93322137|NCT03172052|Mesna|mesna|mesh-list
93322138|NCT03172052|Protective Agents|protective agents|mesh-ancestor
93322139|NCT03172052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322140|NCT03172052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93322141|NCT03172052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93322142|NCT03172052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322143|NCT03171818|Darbepoetin alfa|darbepoetin alfa|mesh-list
93322144|NCT03171818|Hematinics|hematinics|mesh-ancestor
93322145|NCT02408354|Glycerol|glycerol|mesh-list
93322146|NCT02408354|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93322147|NCT02408354|Protective Agents|protective agents|mesh-ancestor
93322148|NCT02408354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322149|NCT03176264|Bevacizumab|bevacizumab|mesh-list
93322150|NCT03176264|Spartalizumab|spartalizumab|mesh-list
93322151|NCT03176264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93322152|NCT03176264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322153|NCT03176264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93322154|NCT03176264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93322155|NCT03176264|Growth Substances|growth substances|mesh-ancestor
93322156|NCT03176264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322158|NCT03176264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93322159|NCT03176264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322160|NCT02406170|Paclitaxel|paclitaxel|mesh-list
93322161|NCT02406170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93322162|NCT02406170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322163|NCT02406170|Tubulin Modulators|tubulin modulators|mesh-ancestor
93322164|NCT02406170|Antimitotic Agents|antimitotic agents|mesh-ancestor
93322165|NCT02406170|Mitosis Modulators|mitosis modulators|mesh-ancestor
93322166|NCT02406170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322167|NCT02413658|Phenytoin|phenytoin|mesh-list
93322168|NCT02413658|Anticonvulsants|anticonvulsants|mesh-ancestor
93322169|NCT02413658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93322170|NCT02413658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93322171|NCT02413658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322172|NCT02413658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322173|NCT02413658|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93322174|NCT02413658|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93322175|NCT02406014|Diclofenac|diclofenac|mesh-list
93322176|NCT02406014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322177|NCT02406014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322178|NCT02406014|Analgesics|analgesics|mesh-ancestor
93322179|NCT02406014|Sensory System Agents|sensory system agents|mesh-ancestor
93322180|NCT02406014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322181|NCT02406014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322182|NCT02406014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322183|NCT02406014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322184|NCT02406014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322185|NCT02406014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322186|NCT02406014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322187|NCT02406092|Prednisone|prednisone|mesh-list
93322188|NCT02406092|Cyclophosphamide|cyclophosphamide|mesh-list
93322189|NCT02406092|Rituximab|rituximab|mesh-list
93322190|NCT02406092|Doxorubicin|doxorubicin|mesh-list
93322191|NCT02406092|Fludarabine|fludarabine|mesh-list
93322192|NCT02406092|Vincristine|vincristine|mesh-list
93322193|NCT02406092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322194|NCT02406092|Immunologic Factors|immunologic factors|mesh-ancestor
93322195|NCT02406092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322196|NCT02406092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322197|NCT02406092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93322198|NCT02406092|Alkylating Agents|alkylating agents|mesh-ancestor
93322199|NCT02406092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322200|NCT02406092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322201|NCT02406092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93322202|NCT02406092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93322203|NCT02406092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93322204|NCT02406092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93322205|NCT02406092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93322206|NCT02406092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322207|NCT02406092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322208|NCT02406092|Glucocorticoids|glucocorticoids|mesh-ancestor
93322209|NCT02406092|Hormones|hormones|mesh-ancestor
93322210|NCT02406092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322211|NCT02406092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322212|NCT02406092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93322213|NCT02406092|Tubulin Modulators|tubulin modulators|mesh-ancestor
93322214|NCT02406092|Antimitotic Agents|antimitotic agents|mesh-ancestor
93322215|NCT02406092|Mitosis Modulators|mitosis modulators|mesh-ancestor
93322216|NCT02413268|Nitroglycerin|nitroglycerin|mesh-list
93322217|NCT02413268|Vasodilator Agents|vasodilator agents|mesh-ancestor
93322218|NCT02405858|Prednisolone|prednisolone|mesh-list
93322219|NCT02405858|Abiraterone Acetate|abiraterone acetate|mesh-list
93322220|NCT02405858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322221|NCT02405858|Glucocorticoids|glucocorticoids|mesh-ancestor
93322222|NCT02405858|Hormones|hormones|mesh-ancestor
93322223|NCT02405858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322224|NCT02405858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322225|NCT02405858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322226|NCT02405858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322227|NCT02405858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93322228|NCT02405858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322229|NCT02405858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322230|NCT02405858|Hormone Antagonists|hormone antagonists|mesh-ancestor
93322231|NCT02405858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93322233|NCT03171740|Dexmedetomidine|dexmedetomidine|mesh-list
93322234|NCT03171740|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93322235|NCT03171740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93322236|NCT03171740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322237|NCT03171740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322238|NCT03171740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322239|NCT03171740|Analgesics|analgesics|mesh-ancestor
93322240|NCT03171740|Sensory System Agents|sensory system agents|mesh-ancestor
93322241|NCT03171740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322242|NCT03171740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93322243|NCT03171740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93322244|NCT03171740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93322245|NCT03171740|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322246|NCT03171740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322247|NCT03171740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322248|NCT03171740|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93322249|NCT03171740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93322250|NCT03171740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93322251|NCT03171740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93322252|NCT03171740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93322253|NCT03171740|Anesthetics, General|anesthetics, general|mesh-ancestor
93322254|NCT03171740|Anesthetics|anesthetics|mesh-ancestor
93322255|NCT03171740|GABA Modulators|gaba modulators|mesh-ancestor
93322256|NCT03171740|GABA Agents|gaba agents|mesh-ancestor
93322257|NCT03176186|Xenon|xenon|mesh-list
93322258|NCT03176186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93322259|NCT03176186|Anesthetics, General|anesthetics, general|mesh-ancestor
93322260|NCT03176186|Anesthetics|anesthetics|mesh-ancestor
93322261|NCT03176186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322262|NCT03176186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322263|NCT04482764|Valproic Acid|valproic acid|mesh-list
93322264|NCT04482764|Anticonvulsants|anticonvulsants|mesh-ancestor
93322265|NCT04482764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322266|NCT04482764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322267|NCT04482764|GABA Agents|gaba agents|mesh-ancestor
93322268|NCT04482764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322269|NCT04482764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322270|NCT04482764|Antimanic Agents|antimanic agents|mesh-ancestor
93322271|NCT04482764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93322272|NCT04482764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322273|NCT04482764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93322274|NCT02408042|Rituximab|rituximab|mesh-list
93322275|NCT02408042|Pembrolizumab|pembrolizumab|mesh-list
93322276|NCT02408042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93322277|NCT02408042|Carboplatin|carboplatin|mesh-list
93322278|NCT02408042|Etoposide|etoposide|mesh-list
93322279|NCT02408042|Ifosfamide|ifosfamide|mesh-list
93322280|NCT02408042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93322281|NCT02408042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322282|NCT02408042|Immunologic Factors|immunologic factors|mesh-ancestor
93322283|NCT02408042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322284|NCT02408042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322285|NCT02408042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93322286|NCT02408042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322287|NCT02408042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93322288|NCT02408042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93322289|NCT02408042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93322290|NCT02408042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322291|NCT02408042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93322292|NCT02408042|Alkylating Agents|alkylating agents|mesh-ancestor
93322293|NCT02408042|Immunotoxins|immunotoxins|mesh-ancestor
93322294|NCT02408042|Immunoconjugates|immunoconjugates|mesh-ancestor
93322295|NCT03172988|Dexamethasone|dexamethasone|mesh-list
93322296|NCT03172988|Dexamethasone acetate|dexamethasone acetate|mesh-list
93322297|NCT03172988|Flurbiprofen|flurbiprofen|mesh-list
93322298|NCT03172988|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
93322299|NCT03172988|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93322300|NCT03172988|BB 1101|bb 1101|mesh-list
93322301|NCT03172988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322302|NCT03172988|Antiemetics|antiemetics|mesh-ancestor
93322303|NCT03172988|Autonomic Agents|autonomic agents|mesh-ancestor
93322304|NCT03172988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994288|NCT00699335|Anesthetics, General|anesthetics, general|mesh-ancestor
93322305|NCT03172988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322306|NCT03172988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322307|NCT03172988|Glucocorticoids|glucocorticoids|mesh-ancestor
93322308|NCT03172988|Hormones|hormones|mesh-ancestor
93322309|NCT03172988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322310|NCT03172988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322311|NCT03172988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322312|NCT03172988|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322313|NCT03172988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322314|NCT03172988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322315|NCT03172988|Analgesics|analgesics|mesh-ancestor
93322316|NCT03172988|Sensory System Agents|sensory system agents|mesh-ancestor
93322317|NCT03172988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322318|NCT03172988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322319|NCT03172988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322320|NCT03172988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322321|NCT03042611|Apatinib|apatinib|mesh-list
93322322|NCT03042611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322323|NCT03042611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93322324|NCT03042611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322325|NCT03042611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322326|NCT03171584|Itraconazole|itraconazole|mesh-list
93322327|NCT03171584|Fluconazole|fluconazole|mesh-list
93322328|NCT03171584|Terbinafine|terbinafine|mesh-list
93322329|NCT03171584|Antifungal Agents|antifungal agents|mesh-ancestor
93322330|NCT03171584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322331|NCT03171584|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93322332|NCT03171584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93322333|NCT03171584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322334|NCT03171584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322335|NCT03171584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93322336|NCT03171584|Hormone Antagonists|hormone antagonists|mesh-ancestor
93322337|NCT03171584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322338|NCT03171584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322339|NCT03171584|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93322340|NCT03171584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93322341|NCT03171584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93322342|NCT02950259|Indomethacin|indomethacin|mesh-list
93322343|NCT02950259|Cyclophosphamide|cyclophosphamide|mesh-list
93322344|NCT02950259|Omeprazole|omeprazole|mesh-list
93322345|NCT02950259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322346|NCT02950259|Immunologic Factors|immunologic factors|mesh-ancestor
93322347|NCT02950259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322348|NCT02950259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322349|NCT02950259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93322350|NCT02950259|Alkylating Agents|alkylating agents|mesh-ancestor
93322351|NCT02950259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322352|NCT02950259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322353|NCT02950259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93322354|NCT02950259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93322355|NCT02950259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322356|NCT02950259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93322357|NCT02950259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322358|NCT02950259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322359|NCT02950259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322360|NCT02950259|Analgesics|analgesics|mesh-ancestor
93322361|NCT02950259|Sensory System Agents|sensory system agents|mesh-ancestor
93322362|NCT02950259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322363|NCT02950259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322364|NCT02950259|Gout Suppressants|gout suppressants|mesh-ancestor
93322365|NCT02950259|Tocolytic Agents|tocolytic agents|mesh-ancestor
93322366|NCT02950259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322367|NCT02950259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322368|NCT02349815|Levonorgestrel|levonorgestrel|mesh-list
93322369|NCT02349815|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93322370|NCT02349815|Contraceptive Agents|contraceptive agents|mesh-ancestor
93322371|NCT02349815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322372|NCT02349815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322373|NCT02349815|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93322374|NCT02349815|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93322375|NCT02349815|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93322376|NCT02818517|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92994372|NCT05280236|Propofol|propofol|mesh-list
93322377|NCT02818517|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93322378|NCT02818517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93322379|NCT02818517|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322380|NCT02818517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322381|NCT02818517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322382|NCT02818517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322383|NCT02818517|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322384|NCT02818517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322385|NCT02407340|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93322386|NCT02407340|Oxytocin|oxytocin|mesh-list
93322387|NCT02407340|Oxytocics|oxytocics|mesh-ancestor
93322388|NCT02407340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322389|NCT02407340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322390|NCT02407340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93322391|NCT02407340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322392|NCT02405156|Letrozole|letrozole|mesh-list
93322393|NCT02405156|Misoprostol|misoprostol|mesh-list
93322394|NCT02405156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322395|NCT02405156|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93322396|NCT02405156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93322397|NCT02405156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322398|NCT02405156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322399|NCT02405156|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93322400|NCT02405156|Hormone Antagonists|hormone antagonists|mesh-ancestor
93322401|NCT02405156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322402|NCT02405156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322403|NCT02405156|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93322404|NCT02405156|Abortifacient Agents|abortifacient agents|mesh-ancestor
93322405|NCT02405156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322406|NCT02405156|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93322407|NCT02405156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322408|NCT02405156|Oxytocics|oxytocics|mesh-ancestor
93322409|NCT02411942|Adapalene|adapalene|mesh-list
93322410|NCT02411942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322411|NCT02411942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322412|NCT02411942|Analgesics|analgesics|mesh-ancestor
93322413|NCT02411942|Sensory System Agents|sensory system agents|mesh-ancestor
93322414|NCT02411942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322415|NCT02411942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322416|NCT02411942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322417|NCT02411942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322418|NCT02411942|Dermatologic Agents|dermatologic agents|mesh-ancestor
93322419|NCT02406950|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93322420|NCT02406950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93322421|NCT02406950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322422|NCT02406950|Incretins|incretins|mesh-ancestor
93322423|NCT02406950|Hormones|hormones|mesh-ancestor
93322424|NCT02406950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322425|NCT02406950|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93322426|NCT02406950|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322427|NCT02406950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322428|NCT02406950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322429|NCT02406872|Propofol|propofol|mesh-list
93322430|NCT02406872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93322431|NCT02406872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322432|NCT02406872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322433|NCT02406872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93322434|NCT02406872|Anesthetics, General|anesthetics, general|mesh-ancestor
93322435|NCT02406872|Anesthetics|anesthetics|mesh-ancestor
93322436|NCT03172676|Amoxicillin|amoxicillin|mesh-list
93322437|NCT03172676|Clarithromycin|clarithromycin|mesh-list
93322438|NCT03172676|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93322439|NCT03172676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322440|NCT03172676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322441|NCT03172676|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93322442|NCT03172676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322443|NCT03172676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322444|NCT03172676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93322445|NCT03172676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93322446|NCT02404844|Tamoxifen|tamoxifen|mesh-list
93322447|NCT02404844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93322448|NCT02404844|Hormone Antagonists|hormone antagonists|mesh-ancestor
93322449|NCT02404844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994441|NCT02566733|Remifentanil|remifentanil|mesh-list
93322450|NCT02404844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322451|NCT02404844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322452|NCT02404844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322453|NCT02404844|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93322454|NCT02404844|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93322455|NCT02404844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93322457|NCT04482296|Astringents|astringents|mesh-ancestor
93322458|NCT04482296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322459|NCT04482296|Dermatologic Agents|dermatologic agents|mesh-ancestor
93322460|NCT03116282|Ethanol|ethanol|mesh-list
93322461|NCT03116282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93322462|NCT03116282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322463|NCT03116282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322464|NCT03116282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322465|NCT02404454|Hyaluronic Acid|hyaluronic acid|mesh-list
93322466|NCT02404454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93322467|NCT02404454|Immunologic Factors|immunologic factors|mesh-ancestor
93322468|NCT02404454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322469|NCT02404454|Viscosupplements|viscosupplements|mesh-ancestor
93322470|NCT02404454|Protective Agents|protective agents|mesh-ancestor
93322471|NCT03115892|Chlorhexidine|chlorhexidine|mesh-list
93322472|NCT03115892|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93322473|NCT03115892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322474|NCT03115892|Disinfectants|disinfectants|mesh-ancestor
93322475|NCT02411786|Molgramostim|molgramostim|mesh-list
93322476|NCT02411786|Sargramostim|sargramostim|mesh-list
93322477|NCT02411786|Immunologic Factors|immunologic factors|mesh-ancestor
93322478|NCT02411786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322479|NCT02411786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322480|NCT02404376|Exenatide|exenatide|mesh-list
93322481|NCT02404376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93322482|NCT02404376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322483|NCT02404376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93322484|NCT02404376|Incretins|incretins|mesh-ancestor
93322485|NCT02404376|Hormones|hormones|mesh-ancestor
93322486|NCT02404376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322487|NCT04466085|Vaccines|vaccines|mesh-list
93322488|NCT04466085|Immunologic Factors|immunologic factors|mesh-ancestor
93322489|NCT04466085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322490|NCT03517995|Sulforaphane|sulforaphane|mesh-list
93322491|NCT03517995|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93322492|NCT03517995|Protective Agents|protective agents|mesh-ancestor
93322493|NCT03517995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322494|NCT03517995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322495|NCT02411630|Tenofovir|tenofovir|mesh-list
93322496|NCT02411630|Emtricitabine|emtricitabine|mesh-list
93322497|NCT02411630|Antiviral Agents|antiviral agents|mesh-ancestor
93322498|NCT02411630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322499|NCT02411630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93322500|NCT02411630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93322501|NCT02411630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322502|NCT02411630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322503|NCT02411630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93322504|NCT02411630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93322505|NCT02411318|Ethanol|ethanol|mesh-list
93322506|NCT02411318|Caffeine|caffeine|mesh-list
93322507|NCT02411318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93322508|NCT02411318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322509|NCT02411318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93322510|NCT02411318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322511|NCT02411318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322512|NCT02411318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93322513|NCT02411318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93322514|NCT02411318|Purinergic Agents|purinergic agents|mesh-ancestor
93322515|NCT02411318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322516|NCT02411318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93322517|NCT02411318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322518|NCT02411318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322519|NCT03133299|Vitamin D|vitamin d|mesh-list
93322520|NCT03133299|Glucocorticoids|glucocorticoids|mesh-list
93322521|NCT03133299|Vitamins|vitamins|mesh-ancestor
93322522|NCT03133299|Micronutrients|micronutrients|mesh-ancestor
93322523|NCT03133299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322524|NCT03133299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93322525|NCT03133299|Hormones|hormones|mesh-ancestor
93322526|NCT03133299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322528|NCT04465695|Interferon-beta|interferon-beta|mesh-list
93322529|NCT04465695|Clofazimine|clofazimine|mesh-list
93322530|NCT04465695|Interferon beta-1b|interferon beta-1b|mesh-list
93322531|NCT04465695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322532|NCT04465695|Antiviral Agents|antiviral agents|mesh-ancestor
93322533|NCT04465695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322534|NCT04465695|Immunologic Factors|immunologic factors|mesh-ancestor
93322535|NCT04465695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322536|NCT04465695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93322537|NCT04465695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322538|NCT04465695|Leprostatic Agents|leprostatic agents|mesh-ancestor
93322539|NCT04465695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322540|NCT03115736|Tenofovir|tenofovir|mesh-list
93322541|NCT03115736|Antiviral Agents|antiviral agents|mesh-ancestor
93322542|NCT03115736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322543|NCT03115736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93322544|NCT03115736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93322545|NCT03115736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322546|NCT03115736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322547|NCT03115736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93322548|NCT03115736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93322549|NCT04465851|Curcumin|curcumin|mesh-list
93322550|NCT04465851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322551|NCT04465851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322552|NCT04465851|Analgesics|analgesics|mesh-ancestor
93322553|NCT04465851|Sensory System Agents|sensory system agents|mesh-ancestor
93322554|NCT04465851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322555|NCT04465851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322556|NCT04465851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322557|NCT04465851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322558|NCT04465851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322559|NCT04465851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322560|NCT04465851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322561|NCT04465539|Hydrocortisone|hydrocortisone|mesh-list
93322562|NCT04465539|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93322563|NCT04465539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322564|NCT04465539|Plasma Substitutes|plasma substitutes|mesh-ancestor
93322565|NCT04465539|Blood Substitutes|blood substitutes|mesh-ancestor
93322566|NCT02404142|Atracurium|atracurium|mesh-list
93322567|NCT02404142|Curare|curare|mesh-list
93322568|NCT02404142|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93322569|NCT02404142|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93322570|NCT02404142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93322571|NCT02404142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322572|NCT02404142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322573|NCT02404142|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93322574|NCT02404142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93322575|NCT02404142|Cholinergic Agents|cholinergic agents|mesh-ancestor
93322576|NCT02404142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322577|NCT02404142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322578|NCT03522051|Calcium|calcium|mesh-list
93322579|NCT03522051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93322580|NCT03522051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322581|NCT03171974|Dexamethasone|dexamethasone|mesh-list
93322582|NCT03171974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322583|NCT03171974|Antiemetics|antiemetics|mesh-ancestor
93322584|NCT03171974|Autonomic Agents|autonomic agents|mesh-ancestor
93322585|NCT03171974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322586|NCT03171974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322587|NCT03171974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322588|NCT03171974|Glucocorticoids|glucocorticoids|mesh-ancestor
93322589|NCT03171974|Hormones|hormones|mesh-ancestor
93322590|NCT03171974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322591|NCT03171974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322592|NCT03171974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322593|NCT02292069|Amlodipine|amlodipine|mesh-list
93322594|NCT02292069|Atorvastatin|atorvastatin|mesh-list
93322595|NCT02292069|Calcium|calcium|mesh-list
93322596|NCT02292069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93322597|NCT02292069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322598|NCT02292069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93322599|NCT02292069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93322600|NCT02292069|Antimetabolites|antimetabolites|mesh-ancestor
93322601|NCT02292069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322602|NCT02292069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93322603|NCT02292069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93322605|NCT02292069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93322606|NCT02292069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93322607|NCT02292069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322608|NCT02292069|Vasodilator Agents|vasodilator agents|mesh-ancestor
93322609|NCT02404064|Metronidazole|metronidazole|mesh-list
93322610|NCT02404064|Cefotaxime|cefotaxime|mesh-list
93322611|NCT02404064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322612|NCT02404064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322613|NCT02404064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93322614|NCT02404064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93322615|NCT02294643|Aspirin|aspirin|mesh-list
93322616|NCT02294643|Sarpogrelate|sarpogrelate|mesh-list
93322617|NCT02294643|Clopidogrel|clopidogrel|mesh-list
93322618|NCT02294643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322619|NCT02294643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322620|NCT02294643|Analgesics|analgesics|mesh-ancestor
93322621|NCT02294643|Sensory System Agents|sensory system agents|mesh-ancestor
93322622|NCT02294643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322623|NCT02294643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322624|NCT02294643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322625|NCT02294643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322626|NCT02294643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93322627|NCT02294643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93322628|NCT02294643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322629|NCT02294643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93322630|NCT02294643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322631|NCT02294643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322632|NCT02294643|Antipyretics|antipyretics|mesh-ancestor
93322633|NCT02294643|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93322634|NCT02294643|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93322635|NCT02294643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93322636|NCT02294643|Purinergic Agents|purinergic agents|mesh-ancestor
93322637|NCT02294643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322638|NCT02294643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93322639|NCT02294643|Serotonin Agents|serotonin agents|mesh-ancestor
93322640|NCT02410694|Thalidomide|thalidomide|mesh-list
93322641|NCT02410694|Dexamethasone|dexamethasone|mesh-list
93322642|NCT02410694|Ixazomib|ixazomib|mesh-list
93322643|NCT02410694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322644|NCT02410694|Antiemetics|antiemetics|mesh-ancestor
93322645|NCT02410694|Autonomic Agents|autonomic agents|mesh-ancestor
93322646|NCT02410694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322647|NCT02410694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322648|NCT02410694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322649|NCT02410694|Glucocorticoids|glucocorticoids|mesh-ancestor
93322650|NCT02410694|Hormones|hormones|mesh-ancestor
93322651|NCT02410694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322652|NCT02410694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93322653|NCT02410694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322654|NCT02410694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322655|NCT02410694|Immunologic Factors|immunologic factors|mesh-ancestor
93322656|NCT02410694|Leprostatic Agents|leprostatic agents|mesh-ancestor
93322657|NCT02410694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322658|NCT02410694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322659|NCT02410694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93322660|NCT02410694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93322661|NCT02410694|Growth Substances|growth substances|mesh-ancestor
93322662|NCT02410694|Growth Inhibitors|growth inhibitors|mesh-ancestor
93322663|NCT02410694|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322664|NCT02410694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322665|NCT02410694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322666|NCT03521895|Aflibercept|aflibercept|mesh-list
93322667|NCT03521895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93322668|NCT03521895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93322669|NCT03521895|Growth Substances|growth substances|mesh-ancestor
93322670|NCT03521895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322671|NCT03521895|Growth Inhibitors|growth inhibitors|mesh-ancestor
93322672|NCT03521895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322673|NCT02401880|Empagliflozin|empagliflozin|mesh-list
93322674|NCT02401880|Linagliptin|linagliptin|mesh-list
93322675|NCT02401880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93322676|NCT02401880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322678|NCT02401880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322679|NCT02401880|Incretins|incretins|mesh-ancestor
93322680|NCT02401880|Hormones|hormones|mesh-ancestor
92616551|NCT00173667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322681|NCT02401880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322682|NCT02401880|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93322683|NCT02401880|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322684|NCT02401880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322685|NCT03170726|Ibuprofen|ibuprofen|mesh-list
93322686|NCT03170726|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93322687|NCT03170726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322688|NCT03170726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322689|NCT03170726|Analgesics|analgesics|mesh-ancestor
93322690|NCT03170726|Sensory System Agents|sensory system agents|mesh-ancestor
93322691|NCT03170726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322692|NCT03170726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322693|NCT03170726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322694|NCT03170726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322695|NCT03170726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322696|NCT03170726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322697|NCT03170726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322698|NCT03175016|Irinotecan|irinotecan|mesh-list
93322699|NCT03175016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93322700|NCT03175016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93322701|NCT03175016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322702|NCT03175016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322703|NCT03175016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322704|NCT03174938|Flutemetamol|flutemetamol|mesh-list
93322705|NCT03174938|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93322706|NCT03174938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322707|NCT03520257|Apatinib|apatinib|mesh-list
93322708|NCT03520257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322709|NCT03520257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93322710|NCT03520257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322711|NCT03520257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322712|NCT02292303|Zinc|zinc|mesh-list
93322713|NCT02292303|Zinc Oxide|zinc oxide|mesh-list
93322714|NCT02292303|Trace Elements|trace elements|mesh-ancestor
93322715|NCT02292303|Micronutrients|micronutrients|mesh-ancestor
93322716|NCT02292303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322717|NCT02292303|Dermatologic Agents|dermatologic agents|mesh-ancestor
93322718|NCT02292303|Sunscreening Agents|sunscreening agents|mesh-ancestor
93322719|NCT02292303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93322720|NCT02292303|Protective Agents|protective agents|mesh-ancestor
93322721|NCT02294955|Amiodarone|amiodarone|mesh-list
93322722|NCT02294955|Sotalol|sotalol|mesh-list
93322723|NCT02294955|Flecainide|flecainide|mesh-list
93322724|NCT02294955|Dronedarone|dronedarone|mesh-list
93322725|NCT02294955|Propafenone|propafenone|mesh-list
93322726|NCT02294955|Disopyramide|disopyramide|mesh-list
93322727|NCT02294955|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93322728|NCT02294955|Vasodilator Agents|vasodilator agents|mesh-ancestor
93322729|NCT02294955|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93322730|NCT02294955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322731|NCT02294955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322732|NCT02294955|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93322733|NCT02294955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93322734|NCT02294955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93322735|NCT02294955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322736|NCT02294955|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93322737|NCT02294955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93322738|NCT02294955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93322739|NCT02294955|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93322740|NCT02294955|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93322741|NCT02294955|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322742|NCT02294955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322743|NCT02294955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322744|NCT02294955|Sympatholytics|sympatholytics|mesh-ancestor
93322745|NCT02294955|Autonomic Agents|autonomic agents|mesh-ancestor
93322746|NCT02294955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322747|NCT02294955|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93322748|NCT02396888|Insulin|insulin|mesh-list
93322749|NCT02396888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93322750|NCT02396888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322751|NCT03517683|Methamphetamine|methamphetamine|mesh-list
93322752|NCT03517683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93322753|NCT03517683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322754|NCT03517683|Sympathomimetics|sympathomimetics|mesh-ancestor
93322755|NCT03517683|Autonomic Agents|autonomic agents|mesh-ancestor
93322756|NCT03517683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322757|NCT03517683|Dopamine Agents|dopamine agents|mesh-ancestor
93322758|NCT03517683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322759|NCT03517683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322760|NCT03517683|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322761|NCT03517683|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93322762|NCT03517683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93322763|NCT03517683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322764|NCT03517683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93322765|NCT02401334|Anti-Infective Agents|anti-infective agents|mesh-list
93322766|NCT02401334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93322767|NCT00801489|Cytarabine|cytarabine|mesh-list
93322768|NCT00801489|Fludarabine|fludarabine|mesh-list
93322769|NCT00801489|Fludarabine phosphate|fludarabine phosphate|mesh-list
93322770|NCT00801489|Decitabine|decitabine|mesh-list
93322771|NCT00801489|Idarubicin|idarubicin|mesh-list
93322772|NCT00801489|Gemtuzumab|gemtuzumab|mesh-list
93322773|NCT00801489|Calicheamicins|calicheamicins|mesh-list
93322774|NCT00801489|Lenograstim|lenograstim|mesh-list
93322775|NCT00801489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322776|NCT00801489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93322777|NCT00801489|Antimetabolites|antimetabolites|mesh-ancestor
93322778|NCT00801489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322779|NCT00801489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322780|NCT00801489|Immunologic Factors|immunologic factors|mesh-ancestor
93322781|NCT00801489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322782|NCT00801489|Antiviral Agents|antiviral agents|mesh-ancestor
93322783|NCT00801489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322784|NCT00801489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93322785|NCT00801489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322786|NCT00801489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93322787|NCT00801489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93322788|NCT00801489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93322789|NCT00801489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93322790|NCT00801489|Immunotoxins|immunotoxins|mesh-ancestor
93322791|NCT00801489|Immunoconjugates|immunoconjugates|mesh-ancestor
93322792|NCT02164643|Flutemetamol|flutemetamol|mesh-list
93322793|NCT02164643|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93322794|NCT02164643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322795|NCT02292459|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93322796|NCT02292459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93322797|NCT02292459|Laxatives|laxatives|mesh-ancestor
93322798|NCT02292459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322799|NCT04465071|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93322800|NCT04465071|Lubricant Eye Drops|lubricant eye drops|mesh-list
93322801|NCT04465071|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93322802|NCT03170336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93322803|NCT03170336|Amiloride|amiloride|mesh-list
93322804|NCT03170336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93322805|NCT03170336|Diuretics|diuretics|mesh-ancestor
93322806|NCT03170336|Natriuretic Agents|natriuretic agents|mesh-ancestor
93322807|NCT03170336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322808|NCT03170336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93322809|NCT03170336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322810|NCT03170336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322811|NCT03170336|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93322812|NCT03170336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93322813|NCT03170336|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93322814|NCT03170336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93322815|NCT02699684|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93322816|NCT02699684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93322817|NCT02699684|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92616703|NCT00529867|Artemether|artemether|mesh-list
93322818|NCT02699684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322819|NCT02295189|Triamcinolone|triamcinolone|mesh-list
93322820|NCT02295189|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93322821|NCT02295189|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93322822|NCT02295189|Ketorolac|ketorolac|mesh-list
93322823|NCT02295189|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93322824|NCT02295189|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93322825|NCT02295189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93322826|NCT02295189|Glucocorticoids|glucocorticoids|mesh-ancestor
93322827|NCT02295189|Hormones|hormones|mesh-ancestor
93322828|NCT02295189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322829|NCT02295189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322830|NCT02295189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322831|NCT02295189|Immunologic Factors|immunologic factors|mesh-ancestor
93322832|NCT02295189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322833|NCT02295189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322834|NCT02295189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93322835|NCT02295189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322836|NCT02295189|Analgesics|analgesics|mesh-ancestor
93322837|NCT02295189|Sensory System Agents|sensory system agents|mesh-ancestor
93322838|NCT02295189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322839|NCT02295189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322840|NCT02295189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93322841|NCT03519633|Neostigmine|neostigmine|mesh-list
93322842|NCT03519633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93322843|NCT03519633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322844|NCT03519633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322845|NCT03519633|Cholinergic Agents|cholinergic agents|mesh-ancestor
93322846|NCT03519633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322847|NCT03519633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322848|NCT03519633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93322849|NCT03519633|Autonomic Agents|autonomic agents|mesh-ancestor
93322850|NCT03519633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322851|NCT02289027|Vaccines|vaccines|mesh-list
93322852|NCT02289027|Immunologic Factors|immunologic factors|mesh-ancestor
93322853|NCT02289027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322854|NCT02396030|Magnesium Sulfate|magnesium sulfate|mesh-list
93322855|NCT02396030|Analgesics|analgesics|mesh-ancestor
93322856|NCT02396030|Sensory System Agents|sensory system agents|mesh-ancestor
93322857|NCT02396030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322858|NCT02396030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322859|NCT02396030|Anesthetics|anesthetics|mesh-ancestor
93322860|NCT02396030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322861|NCT02396030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93322862|NCT02396030|Anticonvulsants|anticonvulsants|mesh-ancestor
93322863|NCT02396030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93322864|NCT02396030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93322865|NCT02396030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322866|NCT02396030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93322867|NCT02396030|Tocolytic Agents|tocolytic agents|mesh-ancestor
93322868|NCT02396030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322869|NCT02289261|Dexmedetomidine|dexmedetomidine|mesh-list
93322870|NCT02289261|Morphine|morphine|mesh-list
93322871|NCT02289261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93322872|NCT02289261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322873|NCT02289261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322874|NCT02289261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93322875|NCT02289261|Analgesics|analgesics|mesh-ancestor
93322876|NCT02289261|Sensory System Agents|sensory system agents|mesh-ancestor
93322877|NCT02289261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322878|NCT02289261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92616761|NCT04692376|Hormones|hormones|mesh-ancestor
93322879|NCT02289261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93322880|NCT02289261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93322881|NCT02289261|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322882|NCT02289261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322883|NCT02289261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322884|NCT02289261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93322885|NCT02289261|Narcotics|narcotics|mesh-ancestor
93322886|NCT03168074|Lenvatinib|lenvatinib|mesh-list
93322887|NCT03168074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322888|NCT03168074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93322889|NCT03168074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322890|NCT03168074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322891|NCT02396108|Paclitaxel|paclitaxel|mesh-list
93322892|NCT02396108|Carboplatin|carboplatin|mesh-list
93322893|NCT02396108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93322894|NCT02396108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322895|NCT02396108|Tubulin Modulators|tubulin modulators|mesh-ancestor
93322896|NCT02396108|Antimitotic Agents|antimitotic agents|mesh-ancestor
93322897|NCT02396108|Mitosis Modulators|mitosis modulators|mesh-ancestor
93322898|NCT02396108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322899|NCT02403596|Tranexamic Acid|tranexamic acid|mesh-list
93322900|NCT02403596|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93322901|NCT02403596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93322902|NCT02403596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322903|NCT02403596|Hemostatics|hemostatics|mesh-ancestor
93322904|NCT02403596|Coagulants|coagulants|mesh-ancestor
93322905|NCT02289495|Ritonavir|ritonavir|mesh-list
93322906|NCT02289495|GSK-2838232|gsk-2838232|mesh-list
93322907|NCT02289495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93322908|NCT02289495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93322909|NCT02289495|Protease Inhibitors|protease inhibitors|mesh-ancestor
93322910|NCT02289495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322911|NCT02289495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322912|NCT02289495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93322913|NCT02289495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93322914|NCT02289495|Antiviral Agents|antiviral agents|mesh-ancestor
93322915|NCT02289495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322916|NCT02289495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93322917|NCT02289495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93322918|NCT01774721|Gefitinib|gefitinib|mesh-list
93322919|NCT01774721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322920|NCT01774721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93322921|NCT01774721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322922|NCT01774721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322923|NCT02395952|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93322924|NCT02395952|Laxatives|laxatives|mesh-ancestor
93322925|NCT02395952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93322926|NCT03516903|Folic Acid|folic acid|mesh-list
93322927|NCT03516903|Methotrexate|methotrexate|mesh-list
93322928|NCT03516903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93322929|NCT03516903|Abortifacient Agents|abortifacient agents|mesh-ancestor
93322930|NCT03516903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322931|NCT03516903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322932|NCT03516903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93322933|NCT03516903|Antimetabolites|antimetabolites|mesh-ancestor
93322934|NCT03516903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322935|NCT03516903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322936|NCT03516903|Dermatologic Agents|dermatologic agents|mesh-ancestor
93322937|NCT03516903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322938|NCT03516903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93322939|NCT03516903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93322940|NCT03516903|Immunologic Factors|immunologic factors|mesh-ancestor
93322941|NCT03516903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93322942|NCT03516903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93322943|NCT03516903|Hematinics|hematinics|mesh-ancestor
93322944|NCT03516903|Vitamin B Complex|vitamin b complex|mesh-ancestor
93322945|NCT03516903|Vitamins|vitamins|mesh-ancestor
93322946|NCT03516903|Micronutrients|micronutrients|mesh-ancestor
93322947|NCT03516747|Hormones|hormones|mesh-list
93322948|NCT03516747|Parathyroid Hormone|parathyroid hormone|mesh-list
93322949|NCT03516747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93322950|NCT03516747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322951|NCT03516747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93322952|NCT03516669|Amoxicillin|amoxicillin|mesh-list
93322953|NCT03516669|Clarithromycin|clarithromycin|mesh-list
93322954|NCT03516669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93322955|NCT03516669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93322956|NCT03516669|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93322957|NCT03516669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93322958|NCT03516669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322959|NCT03516669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93322960|NCT03516669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93322961|NCT02289807|Cisplatin|cisplatin|mesh-list
93322962|NCT02289807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322963|NCT02298153|Atezolizumab|atezolizumab|mesh-list
93322964|NCT02298153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93322965|NCT02298153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322966|NCT02298153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93322967|NCT02298153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93322968|NCT02298387|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93322969|NCT02298387|Immunologic Factors|immunologic factors|mesh-ancestor
93322970|NCT02298387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322971|NCT02293551|Insulin Lispro|insulin lispro|mesh-list
93322972|NCT02293551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93322973|NCT02293551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322974|NCT02296047|Bromides|bromides|mesh-list
93322975|NCT02296047|Albuterol|albuterol|mesh-list
93322976|NCT02296047|Ipratropium|ipratropium|mesh-list
93322977|NCT02296047|Anticonvulsants|anticonvulsants|mesh-ancestor
93322978|NCT02296047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93322979|NCT02296047|Autonomic Agents|autonomic agents|mesh-ancestor
93322980|NCT02296047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93322981|NCT02296047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93322982|NCT02296047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93322983|NCT02296047|Respiratory System Agents|respiratory system agents|mesh-ancestor
93322984|NCT02296047|Tocolytic Agents|tocolytic agents|mesh-ancestor
93322985|NCT02296047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93322986|NCT02296047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93322987|NCT02296047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93322988|NCT02296047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93322989|NCT02296047|Adrenergic Agents|adrenergic agents|mesh-ancestor
93322990|NCT02296047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93322991|NCT02296047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93322992|NCT02296047|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93322993|NCT02296047|Cholinergic Agents|cholinergic agents|mesh-ancestor
93322994|NCT02293785|Oxycodone|oxycodone|mesh-list
93322995|NCT02293785|Naloxone|naloxone|mesh-list
93322996|NCT02293785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93322997|NCT02293785|Narcotics|narcotics|mesh-ancestor
93322998|NCT02293785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93322999|NCT02293785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323000|NCT02293785|Analgesics|analgesics|mesh-ancestor
93323001|NCT02293785|Sensory System Agents|sensory system agents|mesh-ancestor
93323002|NCT02293785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323003|NCT02293785|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93323004|NCT01162109|Zinc Sulfate|zinc sulfate|mesh-list
93323005|NCT01162109|Astringents|astringents|mesh-ancestor
93323006|NCT01162109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323007|NCT01162109|Dermatologic Agents|dermatologic agents|mesh-ancestor
93323008|NCT02296203|Irinotecan|irinotecan|mesh-list
93323009|NCT02296203|Cetuximab|cetuximab|mesh-list
93323010|NCT02296203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93323011|NCT02296203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93323012|NCT02296203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323013|NCT02296203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323014|NCT02296203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323015|NCT02296203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323016|NCT03514251|Parathyroid Hormone|parathyroid hormone|mesh-list
93323017|NCT03514251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93323018|NCT03514251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323019|NCT02296281|Pirfenidone|pirfenidone|mesh-list
93323020|NCT02296281|Analgesics|analgesics|mesh-ancestor
93323021|NCT02296281|Sensory System Agents|sensory system agents|mesh-ancestor
93323022|NCT02296281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323023|NCT02296281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323024|NCT02296281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93323025|NCT02296281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93323026|NCT02296281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323027|NCT02296281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323028|NCT02296281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323029|NCT02299245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93323030|NCT02299245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93323031|NCT02299245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93323032|NCT02299245|Antimetabolites|antimetabolites|mesh-ancestor
93323033|NCT02299245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323034|NCT02299245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93323035|NCT02299245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93323036|NCT02299245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323037|NCT03513549|Loxapine|loxapine|mesh-list
93323038|NCT03513549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93323039|NCT03513549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93323040|NCT03513549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323041|NCT03513549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323042|NCT03513549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93323043|NCT03513549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93323044|NCT03513549|Dopamine Agents|dopamine agents|mesh-ancestor
93323045|NCT03513549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323046|NCT03513549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323047|NCT03513471|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93323048|NCT03513471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323049|NCT03513393|Velpatasvir|velpatasvir|mesh-list
93323050|NCT03513393|Omeprazole|omeprazole|mesh-list
93323051|NCT03513393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93323052|NCT03513393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93323053|NCT03513393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93323054|NCT03513393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323055|NCT03513393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323056|NCT03513393|Antiviral Agents|antiviral agents|mesh-ancestor
93323057|NCT03513393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323058|NCT02299401|Misoprostol|misoprostol|mesh-list
93323059|NCT02299401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93323060|NCT02299401|Abortifacient Agents|abortifacient agents|mesh-ancestor
93323061|NCT02299401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323062|NCT02299401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323063|NCT02299401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93323064|NCT02299401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93323065|NCT02299401|Oxytocics|oxytocics|mesh-ancestor
93323066|NCT02699450|Ranibizumab|ranibizumab|mesh-list
93323067|NCT02699450|Faricimab|faricimab|mesh-list
93323068|NCT02699450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93323069|NCT02699450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93323070|NCT02699450|Growth Substances|growth substances|mesh-ancestor
93323071|NCT02699450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323072|NCT02699450|Growth Inhibitors|growth inhibitors|mesh-ancestor
93323073|NCT02699450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323074|NCT02299557|Phenylephrine|phenylephrine|mesh-list
93323075|NCT02299557|Oxymetazoline|oxymetazoline|mesh-list
93323076|NCT02299557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93323077|NCT02299557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323078|NCT02299557|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323079|NCT02299557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323080|NCT02299557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323081|NCT02299557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323082|NCT02299557|Sympathomimetics|sympathomimetics|mesh-ancestor
93323083|NCT02299557|Autonomic Agents|autonomic agents|mesh-ancestor
93323084|NCT02299557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323085|NCT02299557|Nasal Decongestants|nasal decongestants|mesh-ancestor
93323086|NCT02299557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93323087|NCT02299557|Respiratory System Agents|respiratory system agents|mesh-ancestor
93323088|NCT02299557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93323089|NCT02299557|Mydriatics|mydriatics|mesh-ancestor
92616960|NCT00144911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323090|NCT02299557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93323091|NCT02299557|Protective Agents|protective agents|mesh-ancestor
93323092|NCT02302989|Ranibizumab|ranibizumab|mesh-list
93323093|NCT02302989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93323094|NCT02302989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93323095|NCT02302989|Growth Substances|growth substances|mesh-ancestor
93323096|NCT02302989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323097|NCT02302989|Growth Inhibitors|growth inhibitors|mesh-ancestor
93323098|NCT02302989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323099|NCT02296671|Leucovorin|leucovorin|mesh-list
93323100|NCT02296671|Fluorouracil|fluorouracil|mesh-list
93323101|NCT02296671|Oxaliplatin|oxaliplatin|mesh-list
93323102|NCT02296671|Pemetrexed|pemetrexed|mesh-list
93323103|NCT02296671|Antimetabolites|antimetabolites|mesh-ancestor
93323104|NCT02296671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323105|NCT02296671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323106|NCT02296671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323107|NCT02296671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93323108|NCT02296671|Immunologic Factors|immunologic factors|mesh-ancestor
93323109|NCT02296671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323110|NCT02296671|Antidotes|antidotes|mesh-ancestor
93323111|NCT02296671|Protective Agents|protective agents|mesh-ancestor
93323112|NCT02296671|Vitamin B Complex|vitamin b complex|mesh-ancestor
93323113|NCT02296671|Vitamins|vitamins|mesh-ancestor
93323114|NCT02296671|Micronutrients|micronutrients|mesh-ancestor
93323115|NCT02296671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323116|NCT02296671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93323117|NCT02296671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93323118|NCT02296749|Sirolimus|sirolimus|mesh-list
93323119|NCT02296749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93323120|NCT02296749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323121|NCT02296749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93323122|NCT02296749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995120|NCT00951236|Cortisone|cortisone|mesh-list
93323123|NCT02296749|Antifungal Agents|antifungal agents|mesh-ancestor
93323124|NCT02296749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93323125|NCT02296749|Immunologic Factors|immunologic factors|mesh-ancestor
93323126|NCT02296749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323127|NCT04481750|Edaravone|edaravone|mesh-list
93323128|NCT04481750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93323129|NCT04481750|Antioxidants|antioxidants|mesh-ancestor
93323130|NCT04481750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323131|NCT04481750|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93323132|NCT04481750|Protective Agents|protective agents|mesh-ancestor
93323133|NCT04481750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323134|NCT02303223|Propofol|propofol|mesh-list
93323135|NCT02303223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93323136|NCT02303223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323137|NCT02303223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323138|NCT02303223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93323139|NCT02303223|Anesthetics, General|anesthetics, general|mesh-ancestor
93323140|NCT02303223|Anesthetics|anesthetics|mesh-ancestor
93323141|NCT03168698|Oxytocin|oxytocin|mesh-list
93323142|NCT03168698|Carbetocin|carbetocin|mesh-list
93323143|NCT03168698|Oxytocics|oxytocics|mesh-ancestor
93323144|NCT03168698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323145|NCT03168698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323146|NCT04464135|Acetic Acid|acetic acid|mesh-list
93323147|NCT04464135|Retinol acetate|retinol acetate|mesh-list
93323148|NCT04464135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93323149|NCT04464135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323150|NCT04464135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93323151|NCT04464135|Immunologic Factors|immunologic factors|mesh-ancestor
93323152|NCT04464135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323153|NCT04464135|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93323154|NCT04464135|Protective Agents|protective agents|mesh-ancestor
93323155|NCT04464135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323156|NCT03510351|Tazobactam|tazobactam|mesh-list
93323157|NCT03510351|Ceftolozane|ceftolozane|mesh-list
93323158|NCT03510351|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
93323159|NCT03510351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93323160|NCT03510351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323161|NCT03510351|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93323162|NCT03510351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323163|NCT03510351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323164|NCT03510351|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93323165|NCT02403284|Liraglutide|liraglutide|mesh-list
93323166|NCT02403284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323167|NCT02403284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323168|NCT02403284|Incretins|incretins|mesh-ancestor
93323169|NCT02403284|Hormones|hormones|mesh-ancestor
93323170|NCT02403284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323171|NCT02400866|Olanzapine|olanzapine|mesh-list
93323172|NCT02400866|Antiemetics|antiemetics|mesh-ancestor
93323173|NCT02400866|Autonomic Agents|autonomic agents|mesh-ancestor
93323174|NCT02400866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323175|NCT02400866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323176|NCT02400866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93323177|NCT02400866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93323178|NCT02400866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93323179|NCT02400866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323180|NCT02400866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93323181|NCT02400866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93323182|NCT02400866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93323183|NCT02400866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93323184|NCT02400866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323185|NCT02400866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323186|NCT02400866|Serotonin Agents|serotonin agents|mesh-ancestor
93323187|NCT02400788|Sorafenib|sorafenib|mesh-list
93323188|NCT02400788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323189|NCT02400788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93323190|NCT02400788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323191|NCT02400788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323192|NCT02403128|Aflibercept|aflibercept|mesh-list
93323193|NCT02403128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93323194|NCT02403128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93323195|NCT02403128|Growth Substances|growth substances|mesh-ancestor
93323196|NCT02403128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323197|NCT02403128|Growth Inhibitors|growth inhibitors|mesh-ancestor
93323198|NCT02403128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323199|NCT02297217|Paclitaxel|paclitaxel|mesh-list
93323200|NCT02297217|Carboplatin|carboplatin|mesh-list
93323201|NCT02297217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93323202|NCT02297217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323203|NCT02297217|Tubulin Modulators|tubulin modulators|mesh-ancestor
93323204|NCT02297217|Antimitotic Agents|antimitotic agents|mesh-ancestor
93323205|NCT02297217|Mitosis Modulators|mitosis modulators|mesh-ancestor
93323206|NCT02297217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323207|NCT03515577|Edetic Acid|edetic acid|mesh-list
93323208|NCT03515577|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93323209|NCT03515577|Chelating Agents|chelating agents|mesh-ancestor
93323210|NCT03515577|Sequestering Agents|sequestering agents|mesh-ancestor
93323211|NCT03515577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323212|NCT03515577|Anticoagulants|anticoagulants|mesh-ancestor
93323213|NCT03515577|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93323214|NCT03515577|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93323215|NCT02300649|Dexmedetomidine|dexmedetomidine|mesh-list
93323216|NCT02300649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93323217|NCT02300649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323218|NCT02300649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323219|NCT02300649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93323220|NCT02300649|Analgesics|analgesics|mesh-ancestor
93323221|NCT02300649|Sensory System Agents|sensory system agents|mesh-ancestor
93323222|NCT02300649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323223|NCT02300649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93323224|NCT02300649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93323225|NCT02300649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323226|NCT02300649|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323227|NCT02300649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323228|NCT02300649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323229|NCT02449161|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93323230|NCT02449161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93323231|NCT02449161|Contraceptive Agents|contraceptive agents|mesh-ancestor
93323232|NCT02449161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323233|NCT02449161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323234|NCT02449161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93323235|NCT02449161|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93323236|NCT02449161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93323237|NCT02449161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323238|NCT02297529|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93323239|NCT02297529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323240|NCT02297529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323242|NCT02303769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93323243|NCT02303769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93323244|NCT02303769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93323245|NCT02303769|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323246|NCT02303769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323247|NCT02303769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323248|NCT02303769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323249|NCT02303769|Urological Agents|urological agents|mesh-ancestor
93323250|NCT02303847|Ketamine|ketamine|mesh-list
93323251|NCT02303847|Analgesics|analgesics|mesh-ancestor
93323252|NCT02303847|Sensory System Agents|sensory system agents|mesh-ancestor
93323253|NCT02303847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323254|NCT02303847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323255|NCT02303847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93323256|NCT02303847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93323257|NCT02303847|Anesthetics, General|anesthetics, general|mesh-ancestor
93323258|NCT02303847|Anesthetics|anesthetics|mesh-ancestor
93323259|NCT02303847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323260|NCT02303847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93323261|NCT02303847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93323262|NCT02303847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323263|NCT02303847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323264|NCT02297763|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93323265|NCT02297763|Antidepressive Agents|antidepressive agents|mesh-ancestor
93323266|NCT02297763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93323267|NCT02297763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93323268|NCT02297763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93323269|NCT02297763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323270|NCT02297763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323271|NCT03511833|Ketamine|ketamine|mesh-list
93323272|NCT03511833|Morphine|morphine|mesh-list
93323273|NCT03511833|Analgesics|analgesics|mesh-ancestor
93323274|NCT03511833|Sensory System Agents|sensory system agents|mesh-ancestor
93323275|NCT03511833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323276|NCT03511833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323277|NCT03511833|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93323278|NCT03511833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93323279|NCT03511833|Anesthetics, General|anesthetics, general|mesh-ancestor
93323280|NCT03511833|Anesthetics|anesthetics|mesh-ancestor
93323281|NCT03511833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323282|NCT03511833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93323283|NCT03511833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93323284|NCT03511833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323285|NCT03511833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323286|NCT03511833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93323287|NCT03511833|Narcotics|narcotics|mesh-ancestor
93323288|NCT03511755|Neurotransmitter Agents|neurotransmitter agents|mesh-list
93323289|NCT03511755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323290|NCT03511755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323292|NCT02696798|Dermatologic Agents|dermatologic agents|mesh-ancestor
93323293|NCT02304081|Saxagliptin|saxagliptin|mesh-list
93323294|NCT02304081|Incretins|incretins|mesh-ancestor
93323295|NCT02304081|Hormones|hormones|mesh-ancestor
93323296|NCT02304081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323297|NCT02304081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323298|NCT02304081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93323299|NCT02304081|Protease Inhibitors|protease inhibitors|mesh-ancestor
93323300|NCT02304081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323301|NCT02304081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323302|NCT02304081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323303|NCT02304237|Progesterone|progesterone|mesh-list
93323304|NCT02304237|Progestins|progestins|mesh-ancestor
93323305|NCT02304237|Hormones|hormones|mesh-ancestor
93323306|NCT02304237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323307|NCT02304237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323308|NCT03515187|Bromides|bromides|mesh-list
93323309|NCT03515187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93323310|NCT03515187|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93323311|NCT03515187|Hyaluronic Acid|hyaluronic acid|mesh-list
93323312|NCT03515187|Anticonvulsants|anticonvulsants|mesh-ancestor
93323313|NCT03515187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93323314|NCT03515187|Immunologic Factors|immunologic factors|mesh-ancestor
93323315|NCT03515187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323316|NCT03515187|Viscosupplements|viscosupplements|mesh-ancestor
93323317|NCT03515187|Protective Agents|protective agents|mesh-ancestor
93323318|NCT02297997|Cetylpyridinium|cetylpyridinium|mesh-list
93323319|NCT02297997|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93323320|NCT02297997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323321|NCT02395016|Gemcitabine|gemcitabine|mesh-list
93323322|NCT02395016|Nimotuzumab|nimotuzumab|mesh-list
93323323|NCT02395016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323324|NCT02395016|Antimetabolites|antimetabolites|mesh-ancestor
93323325|NCT02395016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323326|NCT02395016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323327|NCT02395016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323328|NCT04480268|Paclitaxel|paclitaxel|mesh-list
93323329|NCT04480268|Gemcitabine|gemcitabine|mesh-list
93323330|NCT04480268|Capecitabine|capecitabine|mesh-list
93323331|NCT04480268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93323332|NCT04480268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323333|NCT04480268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93323334|NCT04480268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93323335|NCT04480268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93323336|NCT04480268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323337|NCT04480268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323338|NCT04480268|Antimetabolites|antimetabolites|mesh-ancestor
93323339|NCT03510975|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93323340|NCT03510975|Hemostatics|hemostatics|mesh-ancestor
93323341|NCT03510975|Coagulants|coagulants|mesh-ancestor
93323342|NCT03510975|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93323343|NCT03510975|Natriuretic Agents|natriuretic agents|mesh-ancestor
93323344|NCT03510975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323345|NCT03169790|Leucovorin|leucovorin|mesh-list
93323346|NCT03169790|Paclitaxel|paclitaxel|mesh-list
93323347|NCT03169790|Cyclophosphamide|cyclophosphamide|mesh-list
93323348|NCT03169790|Bevacizumab|bevacizumab|mesh-list
93323349|NCT03169790|Rituximab|rituximab|mesh-list
93323350|NCT03169790|Fluorouracil|fluorouracil|mesh-list
93323351|NCT03169790|Capecitabine|capecitabine|mesh-list
92995343|NCT00949026|Sirolimus|sirolimus|mesh-list
93323352|NCT03169790|Oxaliplatin|oxaliplatin|mesh-list
93323353|NCT03169790|Avelumab|avelumab|mesh-list
93323354|NCT03169790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93323355|NCT03169790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323356|NCT03169790|Tubulin Modulators|tubulin modulators|mesh-ancestor
93323357|NCT03169790|Antimitotic Agents|antimitotic agents|mesh-ancestor
93323358|NCT03169790|Mitosis Modulators|mitosis modulators|mesh-ancestor
93323359|NCT03169790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323360|NCT03169790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93323361|NCT03169790|Immunologic Factors|immunologic factors|mesh-ancestor
93323362|NCT03169790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323363|NCT03169790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323364|NCT03169790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93323365|NCT03169790|Alkylating Agents|alkylating agents|mesh-ancestor
93323366|NCT03169790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93323367|NCT03169790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323368|NCT03169790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93323369|NCT03169790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93323370|NCT03169790|Growth Substances|growth substances|mesh-ancestor
93323371|NCT03169790|Growth Inhibitors|growth inhibitors|mesh-ancestor
93323372|NCT03169790|Antimetabolites|antimetabolites|mesh-ancestor
93323373|NCT03169790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323374|NCT03169790|Antidotes|antidotes|mesh-ancestor
93323375|NCT03169790|Protective Agents|protective agents|mesh-ancestor
93323376|NCT03169790|Vitamin B Complex|vitamin b complex|mesh-ancestor
93323377|NCT03169790|Vitamins|vitamins|mesh-ancestor
93323378|NCT03169790|Micronutrients|micronutrients|mesh-ancestor
93323379|NCT02304393|Atezolizumab|atezolizumab|mesh-list
93323380|NCT02304393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93323381|NCT02304393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323382|NCT02304393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323383|NCT02304393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323384|NCT02402972|Leucovorin|leucovorin|mesh-list
93323385|NCT02402972|Oxaliplatin|oxaliplatin|mesh-list
93323386|NCT02402972|Floxuridine|floxuridine|mesh-list
93323387|NCT02402972|Levoleucovorin|levoleucovorin|mesh-list
93323388|NCT02402972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323389|NCT02402972|Antidotes|antidotes|mesh-ancestor
93323390|NCT02402972|Protective Agents|protective agents|mesh-ancestor
93323391|NCT02402972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323392|NCT02402972|Vitamin B Complex|vitamin b complex|mesh-ancestor
93323393|NCT02402972|Vitamins|vitamins|mesh-ancestor
93323394|NCT02402972|Micronutrients|micronutrients|mesh-ancestor
93323395|NCT02402972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323396|NCT02402972|Antimetabolites|antimetabolites|mesh-ancestor
93323397|NCT02402972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323398|NCT02394470|Deuterium Oxide|deuterium oxide|mesh-list
93323399|NCT02394470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323400|NCT02394470|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93323401|NCT02394470|Protective Agents|protective agents|mesh-ancestor
93323402|NCT02394470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323403|NCT02304627|Insulin|insulin|mesh-list
93323404|NCT02304627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323405|NCT02304627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323406|NCT03508713|Antirheumatic Agents|antirheumatic agents|mesh-list
93323407|NCT02394158|Metformin|metformin|mesh-list
93323408|NCT02394158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323409|NCT02394158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323410|NCT03508635|Prednisone|prednisone|mesh-list
93323411|NCT03508635|Cortisone|cortisone|mesh-list
93323412|NCT03508635|Mifepristone|mifepristone|mesh-list
93323413|NCT03508635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323414|NCT03508635|Glucocorticoids|glucocorticoids|mesh-ancestor
93323415|NCT03508635|Hormones|hormones|mesh-ancestor
93323416|NCT03508635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323417|NCT03508635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323418|NCT03508635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93323419|NCT03508635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323420|NCT03508635|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93323421|NCT03508635|Abortifacient Agents|abortifacient agents|mesh-ancestor
93323422|NCT03508635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323423|NCT03508635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93323424|NCT03508635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93323425|NCT03508635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93323426|NCT03508635|Contraceptive Agents|contraceptive agents|mesh-ancestor
93323427|NCT03508635|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93323428|NCT03508635|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93323429|NCT03508635|Hormone Antagonists|hormone antagonists|mesh-ancestor
93323430|NCT03508635|Luteolytic Agents|luteolytic agents|mesh-ancestor
93323431|NCT03508635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93323432|NCT03508635|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93323434|NCT04481282|Danazol|danazol|mesh-list
93323435|NCT04481282|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93323436|NCT04481282|Autonomic Agents|autonomic agents|mesh-ancestor
93323437|NCT04481282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323438|NCT04481282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323439|NCT04481282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93323440|NCT04481282|Respiratory System Agents|respiratory system agents|mesh-ancestor
93323441|NCT04481282|Sympathomimetics|sympathomimetics|mesh-ancestor
93323442|NCT04481282|Tocolytic Agents|tocolytic agents|mesh-ancestor
93323443|NCT04481282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323444|NCT04481282|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93323445|NCT04481282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93323446|NCT04481282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323447|NCT04481282|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323448|NCT04481282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323449|NCT04481282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323450|NCT04481282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93323451|NCT04481282|Hormone Antagonists|hormone antagonists|mesh-ancestor
93323452|NCT04481282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323453|NCT02541604|Atezolizumab|atezolizumab|mesh-list
93323454|NCT02541604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93323455|NCT02541604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323456|NCT02541604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323457|NCT02541604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323458|NCT02393846|Ketoprofen|ketoprofen|mesh-list
93323459|NCT02393846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93323460|NCT02393846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93323461|NCT02393846|Analgesics|analgesics|mesh-ancestor
93323462|NCT02393846|Sensory System Agents|sensory system agents|mesh-ancestor
93323463|NCT02393846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323464|NCT02393846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323465|NCT02393846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323466|NCT02393846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323467|NCT02393846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93323468|NCT02393846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323469|NCT02393846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323470|NCT02302209|Oxytocin|oxytocin|mesh-list
93323471|NCT02302209|Oxytocics|oxytocics|mesh-ancestor
93323472|NCT02302209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323473|NCT02302209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323474|NCT02394002|Propofol|propofol|mesh-list
93323475|NCT02394002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93323476|NCT02394002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323477|NCT02394002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323478|NCT02394002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93323479|NCT02394002|Anesthetics, General|anesthetics, general|mesh-ancestor
93323480|NCT02394002|Anesthetics|anesthetics|mesh-ancestor
93323481|NCT02306577|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93323482|NCT02306577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93323483|NCT02306577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93323484|NCT02306577|Antiviral Agents|antiviral agents|mesh-ancestor
93323485|NCT02306577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323486|NCT02402348|Metformin|metformin|mesh-list
93323487|NCT02402348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323488|NCT02402348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323489|NCT02399462|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93323490|NCT02399462|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93323491|NCT02399462|beta-Endorphin|beta-endorphin|mesh-list
93323492|NCT02399462|Hormones|hormones|mesh-ancestor
93323493|NCT02399462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323494|NCT02399462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323495|NCT02399462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323496|NCT02399462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323497|NCT02305173|Dexamethasone|dexamethasone|mesh-list
93323498|NCT02305173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323499|NCT02305173|Antiemetics|antiemetics|mesh-ancestor
93323500|NCT02305173|Autonomic Agents|autonomic agents|mesh-ancestor
92995493|NCT01031992|Hemostatics|hemostatics|mesh-ancestor
93323501|NCT02305173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323502|NCT02305173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323504|NCT02305173|Glucocorticoids|glucocorticoids|mesh-ancestor
93323505|NCT02305173|Hormones|hormones|mesh-ancestor
93323506|NCT02305173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323507|NCT02305173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93323508|NCT02305173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323509|NCT03505047|Copper|copper|mesh-list
93323510|NCT03505047|Trace Elements|trace elements|mesh-ancestor
93323511|NCT03505047|Micronutrients|micronutrients|mesh-ancestor
93323512|NCT03505047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323513|NCT02402114|Hydrocortisone|hydrocortisone|mesh-list
93323514|NCT02402114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323515|NCT02305485|Everolimus|everolimus|mesh-list
93323516|NCT02305485|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93323517|NCT02305485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93323518|NCT02305485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323519|NCT02305485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323520|NCT02305485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93323521|NCT02305485|Immunologic Factors|immunologic factors|mesh-ancestor
93323522|NCT02305485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323523|NCT02305485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323524|NCT02311569|Mirabegron|mirabegron|mesh-list
93323525|NCT02311569|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93323526|NCT02311569|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93323527|NCT02311569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323528|NCT02311569|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323529|NCT02311569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323530|NCT02311569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323531|NCT02311569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323532|NCT02311569|Urological Agents|urological agents|mesh-ancestor
93323533|NCT02393456|Oxytocin|oxytocin|mesh-list
93323534|NCT02393456|Oxytocics|oxytocics|mesh-ancestor
93323535|NCT02393456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323536|NCT02393456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323537|NCT02393612|Sarpogrelate|sarpogrelate|mesh-list
93323538|NCT02393612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93323539|NCT02393612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93323540|NCT02393612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323541|NCT02393612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93323542|NCT02393612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93323543|NCT02393612|Serotonin Agents|serotonin agents|mesh-ancestor
93323544|NCT02393612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323545|NCT02393612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323546|NCT02306733|Oxytocin|oxytocin|mesh-list
93323547|NCT02306733|Ergonovine|ergonovine|mesh-list
93323548|NCT02306733|Oxytocics|oxytocics|mesh-ancestor
93323549|NCT02306733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323550|NCT02306733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323551|NCT02698436|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93323552|NCT02698436|Dermatologic Agents|dermatologic agents|mesh-ancestor
93323553|NCT03507465|Capecitabine|capecitabine|mesh-list
93323554|NCT03507465|Letrozole|letrozole|mesh-list
93323555|NCT03507465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323556|NCT03507465|Antimetabolites|antimetabolites|mesh-ancestor
93323557|NCT03507465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323558|NCT03507465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323559|NCT03507465|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93323560|NCT03507465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93323561|NCT03507465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323562|NCT03507465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93323563|NCT03507465|Hormone Antagonists|hormone antagonists|mesh-ancestor
93323564|NCT03507465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323565|NCT03507465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323566|NCT05476042|Epoetin Alfa|epoetin alfa|mesh-list
93323567|NCT05476042|Hematinics|hematinics|mesh-ancestor
93323568|NCT03507387|Phenylephrine|phenylephrine|mesh-list
93323569|NCT03507387|Oxymetazoline|oxymetazoline|mesh-list
93323570|NCT03507387|Bupivacaine|bupivacaine|mesh-list
93323571|NCT03507387|Anesthetics, Local|anesthetics, local|mesh-ancestor
93323572|NCT03507387|Anesthetics|anesthetics|mesh-ancestor
93323573|NCT03507387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323574|NCT03507387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323575|NCT03507387|Sensory System Agents|sensory system agents|mesh-ancestor
92995561|NCT00560066|Vaccines|vaccines|mesh-list
93323576|NCT03507387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323577|NCT03507387|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93323578|NCT03507387|Mydriatics|mydriatics|mesh-ancestor
93323579|NCT03507387|Autonomic Agents|autonomic agents|mesh-ancestor
93323580|NCT03507387|Sympathomimetics|sympathomimetics|mesh-ancestor
93323581|NCT03507387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93323582|NCT03507387|Nasal Decongestants|nasal decongestants|mesh-ancestor
93323583|NCT03507387|Respiratory System Agents|respiratory system agents|mesh-ancestor
93323584|NCT03507387|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93323585|NCT03507387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93323586|NCT03507387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323587|NCT03507387|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323588|NCT03507387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323589|NCT03507387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323590|NCT03507387|Protective Agents|protective agents|mesh-ancestor
93323591|NCT05454358|Letrozole|letrozole|mesh-list
93323592|NCT05454358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323593|NCT05454358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93323594|NCT05454358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93323595|NCT05454358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323596|NCT05454358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323597|NCT05454358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93323598|NCT05454358|Hormone Antagonists|hormone antagonists|mesh-ancestor
93323599|NCT05454358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323600|NCT05454358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323601|NCT02694536|Gemcitabine|gemcitabine|mesh-list
93323602|NCT02694536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93323603|NCT02694536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323604|NCT02694536|Antimetabolites|antimetabolites|mesh-ancestor
93323605|NCT02694536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323606|NCT02694536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323607|NCT02694536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93323608|NCT02694536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323609|NCT02312037|Gemtuzumab|gemtuzumab|mesh-list
93323610|NCT02312037|Antibodies|antibodies|mesh-list
93323611|NCT02312037|Immunoconjugates|immunoconjugates|mesh-list
93323612|NCT02312037|Immunologic Factors|immunologic factors|mesh-ancestor
93323613|NCT02312037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323614|NCT02312037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323615|NCT02312037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323616|NCT02312037|Immunotoxins|immunotoxins|mesh-ancestor
93323617|NCT03167918|Calcium, Dietary|calcium, dietary|mesh-list
93323618|NCT03167918|Metformin|metformin|mesh-list
93323619|NCT03167918|Calcium Dobesilate|calcium dobesilate|mesh-list
93323620|NCT03167918|Calcium|calcium|mesh-list
93323621|NCT03167918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323622|NCT03167918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323623|NCT03167918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93323624|NCT03167918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93323625|NCT03167918|Hemostatics|hemostatics|mesh-ancestor
93323626|NCT03167918|Coagulants|coagulants|mesh-ancestor
93323627|NCT05745818|Colchicine|colchicine|mesh-list
93323628|NCT05745818|Gout Suppressants|gout suppressants|mesh-ancestor
93323629|NCT05745818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323630|NCT05745818|Tubulin Modulators|tubulin modulators|mesh-ancestor
93323631|NCT05745818|Antimitotic Agents|antimitotic agents|mesh-ancestor
93323632|NCT05745818|Mitosis Modulators|mitosis modulators|mesh-ancestor
93323633|NCT05745818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323634|NCT05745818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323635|NCT02393300|Tranexamic Acid|tranexamic acid|mesh-list
93323636|NCT02393300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93323637|NCT02393300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93323638|NCT02393300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323639|NCT02393300|Hemostatics|hemostatics|mesh-ancestor
93323640|NCT02393300|Coagulants|coagulants|mesh-ancestor
93323641|NCT03106610|Nivolumab|nivolumab|mesh-list
93323642|NCT03106610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323643|NCT03106610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323644|NCT03106610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93323645|NCT03106610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323646|NCT02678884|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93323647|NCT02678884|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93323648|NCT02678884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323649|NCT03504735|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92995637|NCT00549848|Cytarabine|cytarabine|mesh-list
93323650|NCT03504735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93323651|NCT03504735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93323652|NCT03504735|Antimetabolites|antimetabolites|mesh-ancestor
93323653|NCT03504735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323654|NCT03504735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93323655|NCT03504735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93323656|NCT03504735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93323657|NCT03504735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93323658|NCT03504735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93323659|NCT03504735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323660|NCT03504735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93323661|NCT03504735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323662|NCT05475886|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93323663|NCT05475886|Plasma Substitutes|plasma substitutes|mesh-ancestor
93323664|NCT05475886|Blood Substitutes|blood substitutes|mesh-ancestor
93323666|NCT02312115|Diuretics|diuretics|mesh-ancestor
93323667|NCT02312115|Natriuretic Agents|natriuretic agents|mesh-ancestor
93323668|NCT02312115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323669|NCT02312115|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93323670|NCT02312115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93323671|NCT02312115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323672|NCT03106532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93323673|NCT03106532|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93323674|NCT03026140|Celecoxib|celecoxib|mesh-list
93323675|NCT03026140|Nivolumab|nivolumab|mesh-list
93323676|NCT03026140|Ipilimumab|ipilimumab|mesh-list
93323677|NCT03026140|Relatlimab|relatlimab|mesh-list
93323678|NCT03026140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323679|NCT03026140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323680|NCT03026140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93323681|NCT03026140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323682|NCT03026140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93323683|NCT03026140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93323684|NCT03026140|Analgesics|analgesics|mesh-ancestor
93323685|NCT03026140|Sensory System Agents|sensory system agents|mesh-ancestor
93323686|NCT03026140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323687|NCT03026140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323688|NCT03026140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323689|NCT03026140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323690|NCT03026140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93323691|NCT03026140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93323692|NCT03026140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323693|NCT02398994|Methylprednisolone|methylprednisolone|mesh-list
93323694|NCT02398994|Immunoglobulins|immunoglobulins|mesh-list
93323695|NCT02398994|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93323696|NCT02398994|gamma-Globulins|gamma-globulins|mesh-list
93323697|NCT02398994|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93323698|NCT02398994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323699|NCT02398994|Antiemetics|antiemetics|mesh-ancestor
93323700|NCT02398994|Autonomic Agents|autonomic agents|mesh-ancestor
93323701|NCT02398994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323702|NCT02398994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323703|NCT02398994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93323704|NCT02398994|Glucocorticoids|glucocorticoids|mesh-ancestor
93323705|NCT02398994|Hormones|hormones|mesh-ancestor
93323706|NCT02398994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323707|NCT02398994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93323708|NCT02398994|Protective Agents|protective agents|mesh-ancestor
93323709|NCT02398994|Immunologic Factors|immunologic factors|mesh-ancestor
93323710|NCT02306889|Fenofibrate|fenofibrate|mesh-list
93323711|NCT02306889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93323712|NCT02306889|Antimetabolites|antimetabolites|mesh-ancestor
93323713|NCT02306889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323714|NCT02306889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93323715|NCT02393144|Meperidine|meperidine|mesh-list
93323716|NCT02393144|Analgesics, Opioid|analgesics, opioid|mesh-list
93323717|NCT02393144|Analgesics|analgesics|mesh-list
93323718|NCT02393144|Oxytocin|oxytocin|mesh-list
93323719|NCT02393144|Dinoprostone|dinoprostone|mesh-list
93323720|NCT02393144|Oxytocics|oxytocics|mesh-ancestor
93323721|NCT02393144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323722|NCT02393144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323723|NCT02393144|Narcotics|narcotics|mesh-ancestor
93323724|NCT02393144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323725|NCT02393144|Sensory System Agents|sensory system agents|mesh-ancestor
93323726|NCT02393144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323727|NCT02393144|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93323728|NCT02306031|Diclofenac|diclofenac|mesh-list
93323729|NCT02306031|Lubricant Eye Drops|lubricant eye drops|mesh-list
93323730|NCT02306031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93323731|NCT02306031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93323732|NCT02306031|Analgesics|analgesics|mesh-ancestor
93323733|NCT02306031|Sensory System Agents|sensory system agents|mesh-ancestor
93323734|NCT02306031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323735|NCT02306031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323736|NCT02306031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93323737|NCT02306031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323738|NCT02306031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93323739|NCT02306031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323740|NCT02306031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323741|NCT02306031|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93323742|NCT02306031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93323743|NCT02392910|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93323744|NCT02392910|Hematinics|hematinics|mesh-ancestor
93323745|NCT02307045|Nicotine|nicotine|mesh-list
93323746|NCT02307045|Varenicline|varenicline|mesh-list
93323747|NCT02307045|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93323748|NCT02307045|Autonomic Agents|autonomic agents|mesh-ancestor
93323749|NCT02307045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323750|NCT02307045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323751|NCT02307045|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93323752|NCT02307045|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93323753|NCT02307045|Cholinergic Agents|cholinergic agents|mesh-ancestor
93323754|NCT02307045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323755|NCT02307045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323756|NCT03167372|Imidacloprid|imidacloprid|mesh-list
93323757|NCT03167372|Cholinergic Agents|cholinergic agents|mesh-ancestor
93323758|NCT03167372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323759|NCT03167372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323760|NCT03167372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323761|NCT03504345|Progesterone|progesterone|mesh-list
93323762|NCT03504345|Progestins|progestins|mesh-ancestor
93323763|NCT03504345|Hormones|hormones|mesh-ancestor
93323764|NCT03504345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323765|NCT03504345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323766|NCT02307201|Magnesium Sulfate|magnesium sulfate|mesh-list
93323767|NCT02307201|Analgesics|analgesics|mesh-ancestor
93323768|NCT02307201|Sensory System Agents|sensory system agents|mesh-ancestor
93323769|NCT02307201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323770|NCT02307201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323771|NCT02307201|Anesthetics|anesthetics|mesh-ancestor
93323772|NCT02307201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323773|NCT02307201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93323774|NCT02307201|Anticonvulsants|anticonvulsants|mesh-ancestor
93323775|NCT02307201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93323776|NCT02307201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93323777|NCT02307201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323778|NCT02307201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93323779|NCT02307201|Tocolytic Agents|tocolytic agents|mesh-ancestor
93323780|NCT02307201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323781|NCT02306187|Eldecalcitol|eldecalcitol|mesh-list
93323782|NCT02306187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93323783|NCT02306187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323784|NCT03167216|Cetirizine|cetirizine|mesh-list
93323785|NCT03167216|Cromolyn Sodium|cromolyn sodium|mesh-list
93323786|NCT03167216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93323787|NCT03167216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93323788|NCT03167216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93323789|NCT03167216|Histamine Antagonists|histamine antagonists|mesh-ancestor
93323790|NCT03167216|Histamine Agents|histamine agents|mesh-ancestor
93323791|NCT03167216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323792|NCT03167216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323793|NCT03167216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323794|NCT03167216|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
93323795|NCT03167216|Immunologic Factors|immunologic factors|mesh-ancestor
93323796|NCT03167216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995789|NCT00956202|Immunologic Factors|immunologic factors|mesh-ancestor
93323797|NCT03167216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93323798|NCT03167216|Respiratory System Agents|respiratory system agents|mesh-ancestor
93323799|NCT02393066|Dexmedetomidine|dexmedetomidine|mesh-list
93323800|NCT02393066|Propofol|propofol|mesh-list
93323801|NCT02393066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93323802|NCT02393066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323803|NCT02393066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323804|NCT02393066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93323805|NCT02393066|Analgesics|analgesics|mesh-ancestor
93323806|NCT02393066|Sensory System Agents|sensory system agents|mesh-ancestor
93323807|NCT02393066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323808|NCT02393066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93323809|NCT02393066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93323810|NCT02393066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323811|NCT02393066|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323812|NCT02393066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323813|NCT02393066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323814|NCT02393066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93323815|NCT02393066|Anesthetics, General|anesthetics, general|mesh-ancestor
93323816|NCT02393066|Anesthetics|anesthetics|mesh-ancestor
93323817|NCT02398838|Misoprostol|misoprostol|mesh-list
93323818|NCT02398838|Mifepristone|mifepristone|mesh-list
93323819|NCT02398838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93323820|NCT02398838|Abortifacient Agents|abortifacient agents|mesh-ancestor
93323821|NCT02398838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323822|NCT02398838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323823|NCT02398838|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93323824|NCT02398838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93323825|NCT02398838|Oxytocics|oxytocics|mesh-ancestor
93323826|NCT02398838|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93323827|NCT02398838|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93323828|NCT02398838|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93323829|NCT02398838|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93323830|NCT02398838|Contraceptive Agents|contraceptive agents|mesh-ancestor
93323831|NCT02398838|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93323832|NCT02398838|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93323833|NCT02398838|Hormone Antagonists|hormone antagonists|mesh-ancestor
93323834|NCT02398838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323835|NCT02398838|Luteolytic Agents|luteolytic agents|mesh-ancestor
93323836|NCT02398838|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93323837|NCT02398838|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93323838|NCT02398682|Tin Fluorides|tin fluorides|mesh-list
93323839|NCT02398682|Cariostatic Agents|cariostatic agents|mesh-ancestor
93323840|NCT02398682|Protective Agents|protective agents|mesh-ancestor
93323841|NCT02398682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323842|NCT02312427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93323843|NCT02312427|Protease Inhibitors|protease inhibitors|mesh-ancestor
93323844|NCT02312427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323845|NCT02312427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323846|NCT02312427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323847|NCT02312427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323848|NCT03504033|Desflurane|desflurane|mesh-list
93323849|NCT03504033|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93323850|NCT03504033|Anesthetics, General|anesthetics, general|mesh-ancestor
93323851|NCT03504033|Anesthetics|anesthetics|mesh-ancestor
93323852|NCT03504033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323853|NCT03504033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323854|NCT03132519|Remifentanil|remifentanil|mesh-list
93323855|NCT03132519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93323856|NCT03132519|Narcotics|narcotics|mesh-ancestor
93323857|NCT03132519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323858|NCT03132519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323859|NCT03132519|Analgesics|analgesics|mesh-ancestor
93323860|NCT03132519|Sensory System Agents|sensory system agents|mesh-ancestor
93323861|NCT03132519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323862|NCT02398448|Allopurinol|allopurinol|mesh-list
93323863|NCT02398448|Antimetabolites|antimetabolites|mesh-ancestor
93323864|NCT02398448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323865|NCT02398448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323866|NCT02398448|Gout Suppressants|gout suppressants|mesh-ancestor
93323867|NCT02398448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93323868|NCT02398448|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93323869|NCT02398448|Antioxidants|antioxidants|mesh-ancestor
93323870|NCT02398448|Protective Agents|protective agents|mesh-ancestor
93323871|NCT02398448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323872|NCT02392520|Cetrorelix|cetrorelix|mesh-list
93323873|NCT02392520|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93323874|NCT02392520|Fertility Agents|fertility agents|mesh-ancestor
93323875|NCT02392520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93323876|NCT02392520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323877|NCT02392520|Hormone Antagonists|hormone antagonists|mesh-ancestor
93323878|NCT02392520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323879|NCT02316249|Estradiol|estradiol|mesh-list
93323880|NCT02316249|Hormones|hormones|mesh-ancestor
93323881|NCT02316249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93323882|NCT02316249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323883|NCT02316249|Estrogens|estrogens|mesh-ancestor
93323884|NCT02696096|Buprenorphine|buprenorphine|mesh-list
93323885|NCT02696096|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93323886|NCT02696096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93323887|NCT02696096|Narcotics|narcotics|mesh-ancestor
93323888|NCT02696096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323889|NCT02696096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323890|NCT02696096|Analgesics|analgesics|mesh-ancestor
93323891|NCT02696096|Sensory System Agents|sensory system agents|mesh-ancestor
93323892|NCT02696096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323893|NCT02696096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93323894|NCT02316327|Bevacizumab|bevacizumab|mesh-list
93323895|NCT02316327|Gemcitabine|gemcitabine|mesh-list
93323896|NCT02316327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323897|NCT02316327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323898|NCT02316327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93323899|NCT02316327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93323900|NCT02316327|Growth Substances|growth substances|mesh-ancestor
93323901|NCT02316327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323902|NCT02316327|Growth Inhibitors|growth inhibitors|mesh-ancestor
93323903|NCT02316327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93323904|NCT02316327|Antimetabolites|antimetabolites|mesh-ancestor
93323905|NCT02316327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323906|NCT02695628|Misonidazole|misonidazole|mesh-list
93323907|NCT02695628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323908|NCT02695628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93323909|NCT02695628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93323910|NCT02695628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93323911|NCT02392364|Aflibercept|aflibercept|mesh-list
93323912|NCT02392364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93323913|NCT02392364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93323914|NCT02392364|Growth Substances|growth substances|mesh-ancestor
93323915|NCT02392364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323916|NCT02392364|Growth Inhibitors|growth inhibitors|mesh-ancestor
93323917|NCT02392364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323918|NCT02392676|Olaparib|olaparib|mesh-list
93323919|NCT02392676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93323920|NCT02392676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323921|NCT02392676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323922|NCT02392676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323923|NCT03106298|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93323924|NCT03106298|Hematinics|hematinics|mesh-ancestor
93323925|NCT02307591|Amiodarone|amiodarone|mesh-list
93323926|NCT02307591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93323927|NCT02307591|Vasodilator Agents|vasodilator agents|mesh-ancestor
93323928|NCT02307591|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93323929|NCT02307591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93323930|NCT02307591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323931|NCT02307591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93323932|NCT02307591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93323933|NCT02307591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93323934|NCT02307591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323935|NCT02307591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93323936|NCT02307591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93323937|NCT02307591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93323938|NCT03506997|Pembrolizumab|pembrolizumab|mesh-list
93323939|NCT03506997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93323940|NCT03506997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323941|NCT03506997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93323942|NCT03506997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323943|NCT02398136|Midazolam|midazolam|mesh-list
93323944|NCT02398136|Ketamine|ketamine|mesh-list
93323945|NCT02398136|Analgesics|analgesics|mesh-ancestor
93323946|NCT02398136|Sensory System Agents|sensory system agents|mesh-ancestor
93323947|NCT02398136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93323948|NCT02398136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323949|NCT02398136|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93323950|NCT02398136|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93323951|NCT02398136|Anesthetics, General|anesthetics, general|mesh-ancestor
93323952|NCT02398136|Anesthetics|anesthetics|mesh-ancestor
93323953|NCT02398136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93323954|NCT02398136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93323955|NCT02398136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93323956|NCT02398136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323957|NCT02398136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323958|NCT02398136|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93323959|NCT02398136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93323960|NCT02398136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93323961|NCT02398136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93323962|NCT02398136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93323963|NCT02398136|GABA Modulators|gaba modulators|mesh-ancestor
93323964|NCT02398136|GABA Agents|gaba agents|mesh-ancestor
93323965|NCT05745584|Mirabegron|mirabegron|mesh-list
93323966|NCT05745584|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93323967|NCT05745584|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93323968|NCT05745584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93323969|NCT05745584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93323970|NCT05745584|Adrenergic Agents|adrenergic agents|mesh-ancestor
93323971|NCT05745584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93323972|NCT05745584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323973|NCT05745584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323974|NCT05745584|Urological Agents|urological agents|mesh-ancestor
93323975|NCT05745584|Cholinergic Agents|cholinergic agents|mesh-ancestor
93323976|NCT02312661|Metformin|metformin|mesh-list
93323977|NCT02312661|Paclitaxel|paclitaxel|mesh-list
93323978|NCT02312661|Carboplatin|carboplatin|mesh-list
93323979|NCT02312661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93323980|NCT02312661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323981|NCT02312661|Tubulin Modulators|tubulin modulators|mesh-ancestor
93323982|NCT02312661|Antimitotic Agents|antimitotic agents|mesh-ancestor
93323983|NCT02312661|Mitosis Modulators|mitosis modulators|mesh-ancestor
93323984|NCT02312661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323985|NCT02312661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93323986|NCT02312661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93323987|NCT02398058|Olaparib|olaparib|mesh-list
93323988|NCT02398058|Trabectedin|trabectedin|mesh-list
93323989|NCT02398058|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93323990|NCT02398058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93323991|NCT02398058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93323992|NCT02398058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93323993|NCT02398058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93323994|NCT02398058|Alkylating Agents|alkylating agents|mesh-ancestor
93323995|NCT03501615|Immunotoxin HA22|immunotoxin ha22|mesh-list
93323996|NCT03501615|Immunotoxins|immunotoxins|mesh-ancestor
93323997|NCT03501615|Immunoconjugates|immunoconjugates|mesh-ancestor
93323998|NCT03501615|Immunologic Factors|immunologic factors|mesh-ancestor
93323999|NCT03501615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324000|NCT03501615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324001|NCT05745350|Pembrolizumab|pembrolizumab|mesh-list
93324002|NCT05745350|Etoposide|etoposide|mesh-list
93324003|NCT05745350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324004|NCT05745350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324005|NCT05745350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93324006|NCT05745350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324007|NCT05745350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93324008|NCT05745350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93324009|NCT05745350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93324010|NCT05745350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324011|NCT03506919|Allopurinol|allopurinol|mesh-list
93324012|NCT03506919|Antimetabolites|antimetabolites|mesh-ancestor
93324013|NCT03506919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324014|NCT03506919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324015|NCT03506919|Gout Suppressants|gout suppressants|mesh-ancestor
93324016|NCT03506919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93324017|NCT03506919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93324018|NCT03506919|Antioxidants|antioxidants|mesh-ancestor
93324019|NCT03506919|Protective Agents|protective agents|mesh-ancestor
93324020|NCT03506919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324021|NCT02545504|Leucovorin|leucovorin|mesh-list
93324022|NCT02545504|Fluorouracil|fluorouracil|mesh-list
93324023|NCT02545504|Oxaliplatin|oxaliplatin|mesh-list
93324024|NCT02545504|Antimetabolites|antimetabolites|mesh-ancestor
93324025|NCT02545504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324026|NCT02545504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324027|NCT02545504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324028|NCT02545504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324029|NCT02545504|Immunologic Factors|immunologic factors|mesh-ancestor
93324030|NCT02545504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324031|NCT02545504|Antidotes|antidotes|mesh-ancestor
93324032|NCT02545504|Protective Agents|protective agents|mesh-ancestor
93324033|NCT02545504|Vitamin B Complex|vitamin b complex|mesh-ancestor
93324034|NCT02545504|Vitamins|vitamins|mesh-ancestor
93324035|NCT02545504|Micronutrients|micronutrients|mesh-ancestor
93324036|NCT03506841|Cerebrolysin|cerebrolysin|mesh-list
93324037|NCT03506841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93324038|NCT03506841|Protective Agents|protective agents|mesh-ancestor
93324039|NCT03506841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324040|NCT03506841|Nootropic Agents|nootropic agents|mesh-ancestor
93324041|NCT02397512|Lactulose|lactulose|mesh-list
93324042|NCT02397512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324043|NCT02313051|Everolimus|everolimus|mesh-list
93324044|NCT02313051|Letrozole|letrozole|mesh-list
93324045|NCT02313051|Goserelin|goserelin|mesh-list
93324046|NCT02313051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93324047|NCT02313051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93324048|NCT02313051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324049|NCT02313051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324050|NCT02313051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324051|NCT02313051|Immunologic Factors|immunologic factors|mesh-ancestor
93324052|NCT02313051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324053|NCT02313051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324054|NCT02313051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93324055|NCT02313051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93324056|NCT02313051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93324057|NCT02313051|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324058|NCT02313051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324059|NCT02313051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324060|NCT02397590|Atorvastatin|atorvastatin|mesh-list
93324061|NCT02397590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93324062|NCT02397590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93324063|NCT02397590|Antimetabolites|antimetabolites|mesh-ancestor
93324064|NCT02397590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324065|NCT02397590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92617931|NCT00146900|Escitalopram|escitalopram|mesh-list
93324066|NCT02397590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93324067|NCT02397590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324068|NCT02397356|Ketamine|ketamine|mesh-list
93324069|NCT02397356|Analgesics|analgesics|mesh-ancestor
93324070|NCT02397356|Sensory System Agents|sensory system agents|mesh-ancestor
93324071|NCT02397356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324072|NCT02397356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324073|NCT02397356|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93324074|NCT02397356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93324075|NCT02397356|Anesthetics, General|anesthetics, general|mesh-ancestor
93324076|NCT02397356|Anesthetics|anesthetics|mesh-ancestor
93324077|NCT02397356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324078|NCT02397356|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93324079|NCT02397356|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93324080|NCT02397356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324081|NCT02397356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324082|NCT02307825|Azithromycin|azithromycin|mesh-list
93324083|NCT02307825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93324084|NCT02307825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324085|NCT02540668|Warfarin|warfarin|mesh-list
93324086|NCT02540668|Anticoagulants|anticoagulants|mesh-ancestor
93324087|NCT03506763|Diclofenac|diclofenac|mesh-list
93324088|NCT03506763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93324089|NCT03506763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93324090|NCT03506763|Analgesics|analgesics|mesh-ancestor
93324091|NCT03506763|Sensory System Agents|sensory system agents|mesh-ancestor
93324092|NCT03506763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324093|NCT03506763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324094|NCT03506763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324095|NCT03506763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93324096|NCT03506763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93324097|NCT03506763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324098|NCT03506763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324100|NCT02441439|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93324101|NCT02441439|Trace Elements|trace elements|mesh-ancestor
93324102|NCT02441439|Micronutrients|micronutrients|mesh-ancestor
93324103|NCT02441439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324104|NCT02441439|Hematinics|hematinics|mesh-ancestor
93324105|NCT02308137|Domperidone|domperidone|mesh-list
93324106|NCT02308137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324107|NCT02308137|Antiemetics|antiemetics|mesh-ancestor
93324108|NCT02308137|Autonomic Agents|autonomic agents|mesh-ancestor
93324109|NCT02308137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324110|NCT02308137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324111|NCT02308137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324112|NCT02308137|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93324113|NCT02308137|Dopamine Agents|dopamine agents|mesh-ancestor
93324114|NCT02308137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324115|NCT03501459|Rituximab|rituximab|mesh-list
93324116|NCT03501459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324117|NCT03501459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324118|NCT03501459|Immunologic Factors|immunologic factors|mesh-ancestor
93324119|NCT03501459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324120|NCT03501459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93324121|NCT02317263|Testosterone|testosterone|mesh-list
93324122|NCT02317263|Androgens|androgens|mesh-ancestor
93324123|NCT02317263|Hormones|hormones|mesh-ancestor
93324124|NCT02317263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324125|NCT02317263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324126|NCT02317341|Midazolam|midazolam|mesh-list
93324127|NCT02317341|Ketamine|ketamine|mesh-list
93324128|NCT02317341|Analgesics|analgesics|mesh-ancestor
93324129|NCT02317341|Sensory System Agents|sensory system agents|mesh-ancestor
93324130|NCT02317341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324131|NCT02317341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324132|NCT02317341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92618002|NCT02938741|Thymoglobulin|thymoglobulin|mesh-list
93324133|NCT02317341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93324134|NCT02317341|Anesthetics, General|anesthetics, general|mesh-ancestor
93324135|NCT02317341|Anesthetics|anesthetics|mesh-ancestor
93324136|NCT02317341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324137|NCT02317341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93324138|NCT02317341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93324139|NCT02317341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324140|NCT02317341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324141|NCT02317341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93324142|NCT02317341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93324143|NCT02317341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93324144|NCT02317341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93324145|NCT02317341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93324146|NCT02317341|GABA Modulators|gaba modulators|mesh-ancestor
93324147|NCT02317341|GABA Agents|gaba agents|mesh-ancestor
93324148|NCT02339740|Vitamins|vitamins|mesh-list
93324149|NCT02339740|Vitamin A|vitamin a|mesh-list
93324150|NCT02339740|Cytarabine|cytarabine|mesh-list
93324151|NCT02339740|Dexamethasone|dexamethasone|mesh-list
93324152|NCT02339740|Dexamethasone acetate|dexamethasone acetate|mesh-list
93324153|NCT02339740|Mitoxantrone|mitoxantrone|mesh-list
93324154|NCT02339740|Idarubicin|idarubicin|mesh-list
93324155|NCT02339740|Tretinoin|tretinoin|mesh-list
93324156|NCT02339740|Retinol palmitate|retinol palmitate|mesh-list
93324157|NCT02339740|Arsenic Trioxide|arsenic trioxide|mesh-list
93324158|NCT02339740|BB 1101|bb 1101|mesh-list
93324159|NCT02339740|Micronutrients|micronutrients|mesh-ancestor
93324160|NCT02339740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324161|NCT02339740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324162|NCT02339740|Antiemetics|antiemetics|mesh-ancestor
93324163|NCT02339740|Autonomic Agents|autonomic agents|mesh-ancestor
93324164|NCT02339740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324165|NCT02339740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324166|NCT02339740|Glucocorticoids|glucocorticoids|mesh-ancestor
93324167|NCT02339740|Hormones|hormones|mesh-ancestor
93324168|NCT02339740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324169|NCT02339740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324170|NCT02339740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324171|NCT02339740|Protease Inhibitors|protease inhibitors|mesh-ancestor
93324172|NCT02339740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324173|NCT02339740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324174|NCT02339740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324175|NCT02339740|Antimetabolites|antimetabolites|mesh-ancestor
93324176|NCT02339740|Antiviral Agents|antiviral agents|mesh-ancestor
93324177|NCT02339740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324178|NCT02339740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324179|NCT02339740|Immunologic Factors|immunologic factors|mesh-ancestor
93324180|NCT02339740|Analgesics|analgesics|mesh-ancestor
93324181|NCT02339740|Sensory System Agents|sensory system agents|mesh-ancestor
93324182|NCT02339740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93324183|NCT02339740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93324184|NCT02339740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93324185|NCT02339740|Keratolytic Agents|keratolytic agents|mesh-ancestor
93324186|NCT02339740|Dermatologic Agents|dermatologic agents|mesh-ancestor
93324187|NCT02339740|Antioxidants|antioxidants|mesh-ancestor
93324188|NCT02339740|Protective Agents|protective agents|mesh-ancestor
93324189|NCT02339740|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93324190|NCT02317419|Paclitaxel|paclitaxel|mesh-list
93324191|NCT02317419|Gemcitabine|gemcitabine|mesh-list
93324192|NCT02317419|LMB-100|lmb-100|mesh-list
93324193|NCT02317419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93324194|NCT02317419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324195|NCT02317419|Tubulin Modulators|tubulin modulators|mesh-ancestor
93324196|NCT02317419|Antimitotic Agents|antimitotic agents|mesh-ancestor
93324197|NCT02317419|Mitosis Modulators|mitosis modulators|mesh-ancestor
93324198|NCT02317419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324199|NCT02317419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324200|NCT02317419|Antimetabolites|antimetabolites|mesh-ancestor
93324201|NCT02317419|Immunoconjugates|immunoconjugates|mesh-ancestor
93324202|NCT02317419|Immunologic Factors|immunologic factors|mesh-ancestor
93324203|NCT02317419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324204|NCT02317497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93324205|NCT02957968|Paclitaxel|paclitaxel|mesh-list
93324206|NCT02957968|Cyclophosphamide|cyclophosphamide|mesh-list
93324207|NCT02957968|Carboplatin|carboplatin|mesh-list
93324208|NCT02957968|Doxorubicin|doxorubicin|mesh-list
93324209|NCT02957968|Pembrolizumab|pembrolizumab|mesh-list
93324210|NCT02957968|Decitabine|decitabine|mesh-list
93324211|NCT02957968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93324212|NCT02957968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324213|NCT02957968|Tubulin Modulators|tubulin modulators|mesh-ancestor
93324214|NCT02957968|Antimitotic Agents|antimitotic agents|mesh-ancestor
93324215|NCT02957968|Mitosis Modulators|mitosis modulators|mesh-ancestor
93324216|NCT02957968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324217|NCT02957968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324218|NCT02957968|Immunologic Factors|immunologic factors|mesh-ancestor
93324219|NCT02957968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324220|NCT02957968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93324221|NCT02957968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93324222|NCT02957968|Alkylating Agents|alkylating agents|mesh-ancestor
93324223|NCT02957968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93324224|NCT02957968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93324225|NCT02957968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93324226|NCT02957968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93324227|NCT02957968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324228|NCT02957968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324229|NCT02957968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93324230|NCT02957968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324231|NCT02957968|Antimetabolites|antimetabolites|mesh-ancestor
93324232|NCT05452174|Mirtazapine|mirtazapine|mesh-list
93324233|NCT05452174|Antidepressive Agents|antidepressive agents|mesh-ancestor
93324234|NCT05452174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93324235|NCT05452174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93324236|NCT05452174|Histamine Antagonists|histamine antagonists|mesh-ancestor
93324237|NCT05452174|Histamine Agents|histamine agents|mesh-ancestor
93324238|NCT05452174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324239|NCT05452174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324240|NCT05452174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324241|NCT05452174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93324242|NCT05452174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93324243|NCT05452174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324244|NCT05452174|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93324245|NCT05452174|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93324246|NCT05452174|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93324247|NCT05452174|Adrenergic Agents|adrenergic agents|mesh-ancestor
93324248|NCT05452174|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93324249|NCT05452174|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93324250|NCT05452174|Serotonin Agents|serotonin agents|mesh-ancestor
93324251|NCT05452174|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93324252|NCT03943888|Atropine|atropine|mesh-list
93324253|NCT03943888|Neostigmine|neostigmine|mesh-list
93324254|NCT03943888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93324255|NCT03943888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93324256|NCT03943888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93324257|NCT03943888|Autonomic Agents|autonomic agents|mesh-ancestor
93324258|NCT03943888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324259|NCT03943888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324260|NCT03943888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324261|NCT03943888|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324262|NCT03943888|Mydriatics|mydriatics|mesh-ancestor
93324263|NCT03943888|Parasympatholytics|parasympatholytics|mesh-ancestor
93324264|NCT03943888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93324265|NCT03943888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93324266|NCT03943888|Cholinergic Agents|cholinergic agents|mesh-ancestor
93324267|NCT03943888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324268|NCT03943888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324269|NCT03943888|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93324270|NCT03943888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324271|NCT03943888|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93324272|NCT03502551|Ketamine|ketamine|mesh-list
93324273|NCT03502551|Analgesics|analgesics|mesh-ancestor
93324274|NCT03502551|Sensory System Agents|sensory system agents|mesh-ancestor
93324275|NCT03502551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324276|NCT03502551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324277|NCT03502551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93324278|NCT03502551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93324279|NCT03502551|Anesthetics, General|anesthetics, general|mesh-ancestor
93324280|NCT03502551|Anesthetics|anesthetics|mesh-ancestor
92618137|NCT02941198|Micronutrients|micronutrients|mesh-ancestor
93324281|NCT03502551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324282|NCT03502551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93324283|NCT03502551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93324284|NCT03502551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324285|NCT03502551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324286|NCT02314377|Bevacizumab|bevacizumab|mesh-list
93324287|NCT02314377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324288|NCT02314377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324289|NCT02314377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93324290|NCT02314377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93324291|NCT02314377|Growth Substances|growth substances|mesh-ancestor
93324292|NCT02314377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324293|NCT02314377|Growth Inhibitors|growth inhibitors|mesh-ancestor
93324294|NCT02942290|Azacitidine|azacitidine|mesh-list
93324295|NCT02942290|Venetoclax|venetoclax|mesh-list
93324296|NCT02942290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324297|NCT02942290|Antimetabolites|antimetabolites|mesh-ancestor
93324298|NCT02942290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324299|NCT02942290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324300|NCT02942290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324301|NCT02540356|Antibodies|antibodies|mesh-list
93324302|NCT02540356|Immunoglobulins|immunoglobulins|mesh-list
93324303|NCT02540356|Immunologic Factors|immunologic factors|mesh-ancestor
93324304|NCT02540356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324305|NCT05463094|Metformin|metformin|mesh-list
93324306|NCT05463094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93324307|NCT05463094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324308|NCT05431348|Hydrocortisone|hydrocortisone|mesh-list
93324309|NCT05431348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324310|NCT05461378|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93324311|NCT05461378|Antiviral Agents|antiviral agents|mesh-ancestor
93324312|NCT05461378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324313|NCT02392130|Clobetasol|clobetasol|mesh-list
93324314|NCT02392130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324315|NCT02392130|Glucocorticoids|glucocorticoids|mesh-ancestor
93324316|NCT02392130|Hormones|hormones|mesh-ancestor
93324317|NCT02392130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324318|NCT02392130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324319|NCT05356091|Sevoflurane|sevoflurane|mesh-list
93324320|NCT05356091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93324321|NCT05356091|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93324322|NCT05356091|Anesthetics, General|anesthetics, general|mesh-ancestor
93324323|NCT05356091|Anesthetics|anesthetics|mesh-ancestor
93324324|NCT05356091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324325|NCT05356091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324326|NCT05351021|Metformin|metformin|mesh-list
93324327|NCT05351021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93324328|NCT05351021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324329|NCT02688764|Calcium|calcium|mesh-list
93324330|NCT02688764|Calcium acetate|calcium acetate|mesh-list
93324331|NCT02688764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93324332|NCT02688764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324333|NCT02688764|Chelating Agents|chelating agents|mesh-ancestor
93324334|NCT02688764|Sequestering Agents|sequestering agents|mesh-ancestor
93324335|NCT02688764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324336|NCT02688608|Pembrolizumab|pembrolizumab|mesh-list
93324337|NCT02688608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324338|NCT02688608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324339|NCT02688608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93324340|NCT02688608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324341|NCT02688530|Dexamethasone|dexamethasone|mesh-list
93324342|NCT02688530|Dexamethasone acetate|dexamethasone acetate|mesh-list
93324343|NCT02688530|BB 1101|bb 1101|mesh-list
93324344|NCT02688530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324345|NCT02688530|Antiemetics|antiemetics|mesh-ancestor
93324346|NCT02688530|Autonomic Agents|autonomic agents|mesh-ancestor
93324347|NCT02688530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324348|NCT02688530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324349|NCT02688530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324350|NCT02688530|Glucocorticoids|glucocorticoids|mesh-ancestor
93324351|NCT02688530|Hormones|hormones|mesh-ancestor
93324352|NCT02688530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324353|NCT02688530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324354|NCT02688530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324355|NCT02688530|Protease Inhibitors|protease inhibitors|mesh-ancestor
93324356|NCT02688530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324357|NCT02688530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324358|NCT05744804|Aspirin|aspirin|mesh-list
93324359|NCT05744804|Rivaroxaban|rivaroxaban|mesh-list
93324360|NCT05744804|Clopidogrel|clopidogrel|mesh-list
93324361|NCT05744804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93324362|NCT05744804|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93324363|NCT05744804|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93324364|NCT05744804|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93324365|NCT05744804|Purinergic Agents|purinergic agents|mesh-ancestor
93324366|NCT05744804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324367|NCT05744804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324368|NCT05744804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324369|NCT05744804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93324370|NCT05744804|Antithrombins|antithrombins|mesh-ancestor
93324371|NCT05744804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93324372|NCT05744804|Protease Inhibitors|protease inhibitors|mesh-ancestor
93324373|NCT05744804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324374|NCT05744804|Anticoagulants|anticoagulants|mesh-ancestor
93324375|NCT05744804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93324376|NCT05744804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93324377|NCT05744804|Analgesics|analgesics|mesh-ancestor
93324378|NCT05744804|Sensory System Agents|sensory system agents|mesh-ancestor
93324379|NCT05744804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324380|NCT05744804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324381|NCT05744804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93324382|NCT05744804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93324383|NCT05744804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93324384|NCT05744804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93324385|NCT05744804|Antipyretics|antipyretics|mesh-ancestor
93324386|NCT05744726|Bone wax|bone wax|mesh-list
93324387|NCT05744726|Hemostatics|hemostatics|mesh-ancestor
93324388|NCT05744726|Coagulants|coagulants|mesh-ancestor
93324389|NCT02467270|Ponatinib|ponatinib|mesh-list
93324390|NCT02467270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324391|NCT02467270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93324392|NCT02467270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324393|NCT02467270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324394|NCT05150795|Pregabalin|pregabalin|mesh-list
93324395|NCT05150795|Fentanyl|fentanyl|mesh-list
93324396|NCT05150795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93324397|NCT05150795|Narcotics|narcotics|mesh-ancestor
93324398|NCT05150795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324399|NCT05150795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324400|NCT05150795|Analgesics|analgesics|mesh-ancestor
93324401|NCT05150795|Sensory System Agents|sensory system agents|mesh-ancestor
93324402|NCT05150795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324403|NCT05150795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93324404|NCT05150795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93324405|NCT05150795|Anesthetics, General|anesthetics, general|mesh-ancestor
93324406|NCT05150795|Anesthetics|anesthetics|mesh-ancestor
93324407|NCT05150795|Anticonvulsants|anticonvulsants|mesh-ancestor
93324408|NCT05150795|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93324409|NCT05150795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93324410|NCT05150795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324411|NCT05150795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93324412|NCT05150795|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93324413|NCT05150795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93324414|NCT05150795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93324415|NCT03166280|Sofosbuvir|sofosbuvir|mesh-list
93324416|NCT03166280|Antiviral Agents|antiviral agents|mesh-ancestor
93324417|NCT03166280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324418|NCT02533570|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92618283|NCT02930707|Anticonvulsants|anticonvulsants|mesh-ancestor
93324419|NCT02533570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93324420|NCT02533570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324421|NCT02533570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324422|NCT02533570|Immunotoxins|immunotoxins|mesh-ancestor
93324423|NCT02533570|Immunoconjugates|immunoconjugates|mesh-ancestor
93324424|NCT02533570|Immunologic Factors|immunologic factors|mesh-ancestor
93324425|NCT02533570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324426|NCT02268448|Clonidine|clonidine|mesh-list
93324427|NCT02268448|Naltrexone|naltrexone|mesh-list
93324428|NCT02268448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93324429|NCT02268448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93324430|NCT02268448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324431|NCT02268448|Sensory System Agents|sensory system agents|mesh-ancestor
93324432|NCT02268448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324433|NCT02268448|Analgesics|analgesics|mesh-ancestor
93324434|NCT02268448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93324435|NCT02268448|Sympatholytics|sympatholytics|mesh-ancestor
93324436|NCT02268448|Autonomic Agents|autonomic agents|mesh-ancestor
93324437|NCT02268448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93324438|NCT02268448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93324439|NCT02268448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93324440|NCT02268448|Adrenergic Agents|adrenergic agents|mesh-ancestor
93324441|NCT02268448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324442|NCT02268448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324443|NCT05744570|Anesthetics|anesthetics|mesh-list
93324444|NCT05744570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324445|NCT05744570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324446|NCT03036839|Sofosbuvir|sofosbuvir|mesh-list
93324447|NCT03036839|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93324448|NCT03036839|Ledipasvir|ledipasvir|mesh-list
93324449|NCT03036839|Antiviral Agents|antiviral agents|mesh-ancestor
93324450|NCT03036839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324451|NCT04977791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93324452|NCT04977791|Antibodies|antibodies|mesh-list
93324453|NCT04977791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93324454|NCT04977791|Immunologic Factors|immunologic factors|mesh-ancestor
93324455|NCT04977791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324456|NCT04977791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324457|NCT04977791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324458|NCT04977791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324459|NCT03625739|Amoxicillin|amoxicillin|mesh-list
93324460|NCT03625739|Moxifloxacin|moxifloxacin|mesh-list
93324461|NCT03625739|Levofloxacin|levofloxacin|mesh-list
93324462|NCT03625739|Isoniazid|isoniazid|mesh-list
93324463|NCT03625739|Cycloserine|cycloserine|mesh-list
93324464|NCT03625739|Clavulanic Acid|clavulanic acid|mesh-list
93324465|NCT03625739|Imipenem|imipenem|mesh-list
93324466|NCT03625739|Amikacin|amikacin|mesh-list
93324467|NCT03625739|Pyrazinamide|pyrazinamide|mesh-list
93324468|NCT03625739|Ethambutol|ethambutol|mesh-list
93324469|NCT03625739|Bedaquiline|bedaquiline|mesh-list
93324470|NCT03625739|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93324471|NCT03625739|Clofazimine|clofazimine|mesh-list
93324472|NCT03625739|Gatifloxacin|gatifloxacin|mesh-list
93324473|NCT03625739|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93324474|NCT03625739|Streptomycin|streptomycin|mesh-list
93324475|NCT03625739|Ethionamide|ethionamide|mesh-list
93324476|NCT03625739|Kanamycin|kanamycin|mesh-list
93324477|NCT03625739|Capreomycin|capreomycin|mesh-list
93324478|NCT03625739|Thioacetazone|thioacetazone|mesh-list
93324479|NCT03625739|Antitubercular Agents|antitubercular agents|mesh-list
93324480|NCT03625739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996467|NCT00957866|Interferons|interferons|mesh-list
93324481|NCT03625739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324482|NCT03625739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93324483|NCT03625739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93324484|NCT03625739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324485|NCT03625739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324486|NCT03625739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324487|NCT03625739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93324488|NCT03625739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93324489|NCT03625739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93324490|NCT03625739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93324491|NCT03625739|Leprostatic Agents|leprostatic agents|mesh-ancestor
93324492|NCT03625739|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93324493|NCT03625739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93324494|NCT03625739|Antimetabolites|antimetabolites|mesh-ancestor
93324495|NCT03625739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93324496|NCT03625739|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93324497|NCT03625739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324498|NCT03625739|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93324499|NCT03625739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93324500|NCT03625739|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93324501|NCT03904199|Insulin|insulin|mesh-list
93324502|NCT03904199|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93324503|NCT03904199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93324504|NCT03904199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324505|NCT03902951|Leuprolide|leuprolide|mesh-list
93324506|NCT03902951|Abiraterone Acetate|abiraterone acetate|mesh-list
93324507|NCT03902951|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93324508|NCT03902951|Fertility Agents|fertility agents|mesh-ancestor
93324509|NCT03902951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93324510|NCT03902951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324511|NCT03902951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324512|NCT03902951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324513|NCT03902951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93324514|NCT03902951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324515|NCT03902951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324516|NCT03902951|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324517|NCT03902951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324518|NCT03902951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93324519|NCT01286207|Rizatriptan|rizatriptan|mesh-list
93324520|NCT01286207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93324521|NCT01286207|Serotonin Agents|serotonin agents|mesh-ancestor
93324522|NCT01286207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324523|NCT01286207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324524|NCT01286207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324525|NCT05408026|Dexamethasone|dexamethasone|mesh-list
93324526|NCT05408026|Bortezomib|bortezomib|mesh-list
93324527|NCT05408026|Daratumumab|daratumumab|mesh-list
93324528|NCT05408026|Pomalidomide|pomalidomide|mesh-list
93324529|NCT05408026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324530|NCT05408026|Antiemetics|antiemetics|mesh-ancestor
93324531|NCT05408026|Autonomic Agents|autonomic agents|mesh-ancestor
93324532|NCT05408026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324533|NCT05408026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324534|NCT05408026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324535|NCT05408026|Glucocorticoids|glucocorticoids|mesh-ancestor
93324536|NCT05408026|Hormones|hormones|mesh-ancestor
93324537|NCT05408026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324538|NCT05408026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324539|NCT05408026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324540|NCT05408026|Immunologic Factors|immunologic factors|mesh-ancestor
93324541|NCT05408026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93324542|NCT05408026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93324543|NCT05408026|Growth Substances|growth substances|mesh-ancestor
93324544|NCT05408026|Growth Inhibitors|growth inhibitors|mesh-ancestor
93324545|NCT02170090|Gemcitabine|gemcitabine|mesh-list
93324546|NCT02170090|Capecitabine|capecitabine|mesh-list
93324547|NCT02170090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324548|NCT02170090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324549|NCT02170090|Antimetabolites|antimetabolites|mesh-ancestor
93324550|NCT02170090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324551|NCT04423510|Phenol|phenol|mesh-list
93324552|NCT04423510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93324553|NCT04423510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324554|NCT04423510|Disinfectants|disinfectants|mesh-ancestor
93324555|NCT04423510|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93324556|NCT04423510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93324557|NCT00968201|Montelukast|montelukast|mesh-list
93324558|NCT00968201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324559|NCT00968201|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324560|NCT00968201|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93324561|NCT00968201|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324562|NCT00968201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324563|NCT00968201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324564|NCT00968201|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93324565|NCT00968201|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93324566|NCT00968201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324567|NCT00943397|Montelukast|montelukast|mesh-list
93324568|NCT00943397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324569|NCT00943397|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324570|NCT00943397|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93324571|NCT00943397|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324572|NCT00943397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324573|NCT00943397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324574|NCT00943397|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93324575|NCT00943397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93324576|NCT00943397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324577|NCT00817817|Mometasone Furoate|mometasone furoate|mesh-list
93324578|NCT00817817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324579|NCT00817817|Dermatologic Agents|dermatologic agents|mesh-ancestor
93324580|NCT00817817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93324581|NCT00702845|Hormones|hormones|mesh-list
93324582|NCT00702845|Progesterone|progesterone|mesh-list
93324583|NCT00702845|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93324584|NCT00702845|Ganirelix|ganirelix|mesh-list
93324585|NCT00702845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324586|NCT00702845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324587|NCT00702845|Progestins|progestins|mesh-ancestor
93324588|NCT00702845|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324589|NCT00647933|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93324590|NCT00647933|Lynestrenol|lynestrenol|mesh-list
93324591|NCT00647933|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93324592|NCT00647933|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93324593|NCT00647933|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93324594|NCT00647933|Contraceptive Agents|contraceptive agents|mesh-ancestor
93324595|NCT00647933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93324596|NCT00647933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324597|NCT00647933|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93324598|NCT00647933|Estrogens|estrogens|mesh-ancestor
93324599|NCT00647933|Hormones|hormones|mesh-ancestor
93324600|NCT00647933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324601|NCT00647933|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93324602|NCT00641771|Cholecalciferol|cholecalciferol|mesh-list
93324603|NCT00641771|Vitamin D|vitamin d|mesh-list
93324604|NCT00641771|Alendronate|alendronate|mesh-list
93324605|NCT00641771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93324606|NCT00641771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324607|NCT00641771|Vitamins|vitamins|mesh-ancestor
93324608|NCT00641771|Micronutrients|micronutrients|mesh-ancestor
93324609|NCT00641771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93324610|NCT00519857|Tibolone|tibolone|mesh-list
93324611|NCT00519857|Androgen Antagonists|androgen antagonists|mesh-ancestor
93324612|NCT00519857|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324613|NCT00519857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324614|NCT00519857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324615|NCT00519857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93324616|NCT00519857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324617|NCT00519857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324618|NCT00519857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93324619|NCT00519857|Anabolic Agents|anabolic agents|mesh-ancestor
93324620|NCT00519857|Hormones|hormones|mesh-ancestor
93324621|NCT00431093|Tibolone|tibolone|mesh-list
93324622|NCT00431093|Estradiol|estradiol|mesh-list
93324623|NCT00431093|Estrogens|estrogens|mesh-ancestor
93324624|NCT00431093|Hormones|hormones|mesh-ancestor
93324625|NCT00431093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324626|NCT00431093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324627|NCT00431093|Androgen Antagonists|androgen antagonists|mesh-ancestor
93324628|NCT00431093|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324629|NCT00431093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93324630|NCT00431093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324631|NCT00431093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324632|NCT00431093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93324634|NCT03665597|Pembrolizumab|pembrolizumab|mesh-list
93324635|NCT03665597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324636|NCT03665597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324637|NCT03665597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93324638|NCT03665597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324639|NCT00092963|Rizatriptan|rizatriptan|mesh-list
93324640|NCT00092963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324641|NCT00092963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324642|NCT00092963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324643|NCT00092963|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93324644|NCT00092963|Serotonin Agents|serotonin agents|mesh-ancestor
93324645|NCT00092885|Montelukast|montelukast|mesh-list
93324646|NCT00092885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324647|NCT00092885|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324648|NCT00092885|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93324649|NCT00092885|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324650|NCT00092885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324651|NCT00092885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324652|NCT00092885|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93324653|NCT00092885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93324654|NCT00092885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324655|NCT03673735|Durvalumab|durvalumab|mesh-list
93324656|NCT03673735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324657|NCT03673735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324658|NCT01272037|Tamoxifen|tamoxifen|mesh-list
93324659|NCT01272037|Letrozole|letrozole|mesh-list
93324660|NCT01272037|Anastrozole|anastrozole|mesh-list
93324661|NCT01272037|Exemestane|exemestane|mesh-list
93324662|NCT01272037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324663|NCT01272037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324664|NCT01272037|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93324665|NCT01272037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93324666|NCT01272037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324667|NCT01272037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93324668|NCT01272037|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324669|NCT01272037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324670|NCT01272037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324671|NCT01272037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324672|NCT01272037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93324673|NCT01272037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93324674|NCT01272037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93324675|NCT00092105|Montelukast|montelukast|mesh-list
93324676|NCT00092105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324677|NCT00092105|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324678|NCT00092105|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93324679|NCT00092105|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324680|NCT00092105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324681|NCT00092105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324682|NCT00092105|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93324683|NCT00092105|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93324684|NCT00092105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324685|NCT00092027|Alendronate|alendronate|mesh-list
93324686|NCT00092027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324687|NCT00092027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93324688|NCT00076973|Montelukast|montelukast|mesh-list
93324689|NCT00076973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324690|NCT00076973|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324691|NCT00076973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93324692|NCT00076973|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324693|NCT00076973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324694|NCT00076973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324695|NCT00076973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93324696|NCT00076973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93324697|NCT00076973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324698|NCT03565991|Avelumab|avelumab|mesh-list
93324699|NCT03565991|Talazoparib|talazoparib|mesh-list
93324700|NCT03565991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324701|NCT03565991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324702|NCT03565991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93324703|NCT03565991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324704|NCT03565991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324706|NCT02314533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93324707|NCT02314533|Antimetabolites|antimetabolites|mesh-ancestor
93324708|NCT02314533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324709|NCT02314533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93324710|NCT03502395|Lidocaine|lidocaine|mesh-list
93324711|NCT03502395|Anesthetics, Local|anesthetics, local|mesh-ancestor
93324712|NCT03502395|Anesthetics|anesthetics|mesh-ancestor
93324713|NCT03502395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324714|NCT03502395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324715|NCT03502395|Sensory System Agents|sensory system agents|mesh-ancestor
93324716|NCT03502395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324717|NCT03502395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93324718|NCT03502395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93324719|NCT03502395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93324720|NCT03502395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93324721|NCT03502395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324722|NCT02318043|Fluticasone|fluticasone|mesh-list
93324723|NCT02318043|Budesonide|budesonide|mesh-list
93324724|NCT02318043|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93324725|NCT02318043|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93324726|NCT02318043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324727|NCT02318043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92618602|NCT02926885|Liver Extracts|liver extracts|mesh-list
93324728|NCT02318043|Autonomic Agents|autonomic agents|mesh-ancestor
93324729|NCT02318043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324730|NCT02318043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324731|NCT02318043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324732|NCT02318043|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324733|NCT02318043|Dermatologic Agents|dermatologic agents|mesh-ancestor
93324734|NCT02318043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93324735|NCT02318043|Glucocorticoids|glucocorticoids|mesh-ancestor
93324736|NCT02318043|Hormones|hormones|mesh-ancestor
93324737|NCT02318043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324738|NCT02318043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93324739|NCT02318043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93324740|NCT02318043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93324741|NCT02318043|Adrenergic Agents|adrenergic agents|mesh-ancestor
93324742|NCT02318043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324743|NCT02318043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324744|NCT02318043|Sympathomimetics|sympathomimetics|mesh-ancestor
93324745|NCT03433313|Trastuzumab|trastuzumab|mesh-list
93324746|NCT03433313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93324747|NCT03433313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324748|NCT02318121|Oxytocin|oxytocin|mesh-list
93324749|NCT02318121|Oxytocics|oxytocics|mesh-ancestor
93324750|NCT02318121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93324751|NCT02318121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324752|NCT02318199|Anesthetics|anesthetics|mesh-list
93324753|NCT02318199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93324754|NCT02318199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324755|NCT05225597|Carbachol|carbachol|mesh-list
93324756|NCT05225597|Epinephrine|epinephrine|mesh-list
93324757|NCT05225597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93324758|NCT05225597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93324759|NCT05225597|Adrenergic Agents|adrenergic agents|mesh-ancestor
93324760|NCT05225597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324761|NCT05225597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324762|NCT05225597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324763|NCT05225597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93324764|NCT05225597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93324765|NCT05225597|Autonomic Agents|autonomic agents|mesh-ancestor
93324766|NCT05225597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324767|NCT05225597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93324768|NCT05225597|Respiratory System Agents|respiratory system agents|mesh-ancestor
93324769|NCT05225597|Mydriatics|mydriatics|mesh-ancestor
93324770|NCT05225597|Sympathomimetics|sympathomimetics|mesh-ancestor
93324771|NCT05225597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93324772|NCT05225597|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93324773|NCT05225597|Miotics|miotics|mesh-ancestor
93324774|NCT05225597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93324775|NCT05225597|Cholinergic Agents|cholinergic agents|mesh-ancestor
93324776|NCT05225597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93324777|NCT05225597|Analgesics|analgesics|mesh-ancestor
93324778|NCT05225597|Sensory System Agents|sensory system agents|mesh-ancestor
93324779|NCT05225597|Protective Agents|protective agents|mesh-ancestor
93324780|NCT03070327|Cyclophosphamide|cyclophosphamide|mesh-list
93324781|NCT03070327|Lenalidomide|lenalidomide|mesh-list
93324782|NCT03070327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324783|NCT03070327|Immunologic Factors|immunologic factors|mesh-ancestor
93324784|NCT03070327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324785|NCT03070327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93324786|NCT03070327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93324787|NCT03070327|Alkylating Agents|alkylating agents|mesh-ancestor
93324788|NCT03070327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324789|NCT03070327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324790|NCT03070327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93324791|NCT03070327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93324792|NCT03070327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93324793|NCT03070327|Growth Substances|growth substances|mesh-ancestor
93324794|NCT03070327|Growth Inhibitors|growth inhibitors|mesh-ancestor
93324795|NCT00543127|Fulvestrant|fulvestrant|mesh-list
93324796|NCT00543127|Anastrozole|anastrozole|mesh-list
93324797|NCT00543127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324798|NCT00543127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324799|NCT00543127|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93324800|NCT00543127|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93324801|NCT00543127|Hormone Antagonists|hormone antagonists|mesh-ancestor
93324802|NCT00543127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324803|NCT00543127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324804|NCT00543127|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93324805|NCT00543127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93324806|NCT00543127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324807|NCT00543127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324808|NCT00409435|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93324809|NCT00409435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93324810|NCT00409435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324811|NCT00409435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324812|NCT00409435|Cholinergic Agents|cholinergic agents|mesh-ancestor
93324813|NCT00409435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324814|NCT00409435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324816|NCT03673501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324817|NCT03673501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93324818|NCT03673501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93324819|NCT03673501|Growth Substances|growth substances|mesh-ancestor
93324820|NCT03673501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324821|NCT03673501|Growth Inhibitors|growth inhibitors|mesh-ancestor
93324822|NCT03673501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93324823|NCT03673501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324824|NCT03673501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324825|NCT02309385|Dexamethasone|dexamethasone|mesh-list
93324826|NCT02309385|Dexamethasone acetate|dexamethasone acetate|mesh-list
93324827|NCT02309385|Prednisolone|prednisolone|mesh-list
93324828|NCT02309385|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93324829|NCT02309385|Methylprednisolone|methylprednisolone|mesh-list
93324830|NCT02309385|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93324831|NCT02309385|Prednisolone acetate|prednisolone acetate|mesh-list
93324832|NCT02309385|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93324833|NCT02309385|Prednisolone phosphate|prednisolone phosphate|mesh-list
93324834|NCT02309385|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93324835|NCT02309385|BB 1101|bb 1101|mesh-list
93324836|NCT02309385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324837|NCT02309385|Antiemetics|antiemetics|mesh-ancestor
93324838|NCT02309385|Autonomic Agents|autonomic agents|mesh-ancestor
93324839|NCT02309385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324840|NCT02309385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324841|NCT02309385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324842|NCT02309385|Glucocorticoids|glucocorticoids|mesh-ancestor
93324843|NCT02309385|Hormones|hormones|mesh-ancestor
93324844|NCT02309385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324845|NCT02309385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324846|NCT02309385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324847|NCT02309385|Protease Inhibitors|protease inhibitors|mesh-ancestor
92996839|NCT00746681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93324848|NCT02309385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324849|NCT02309385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324850|NCT02309385|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92618742|NCT00170820|Everolimus|everolimus|mesh-list
93324851|NCT02309385|Protective Agents|protective agents|mesh-ancestor
93324852|NCT02315001|Liraglutide|liraglutide|mesh-list
93324853|NCT02315001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93324854|NCT02315001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324855|NCT02315001|Incretins|incretins|mesh-ancestor
93324856|NCT02315001|Hormones|hormones|mesh-ancestor
93324857|NCT02315001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324858|NCT02315157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93324859|NCT02315157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93324860|NCT02315157|Alkylating Agents|alkylating agents|mesh-ancestor
93324861|NCT02315157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324862|NCT02315157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324863|NCT02309463|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-list
93324864|NCT02309463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324865|NCT03500367|Sirolimus|sirolimus|mesh-list
93324866|NCT03500367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93324867|NCT03500367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324868|NCT03500367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93324869|NCT03500367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324870|NCT03500367|Antifungal Agents|antifungal agents|mesh-ancestor
93324871|NCT03500367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324872|NCT03500367|Immunologic Factors|immunologic factors|mesh-ancestor
93324873|NCT03500367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324874|NCT02318433|Dexamethasone|dexamethasone|mesh-list
93324875|NCT02318433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324876|NCT02318433|Antiemetics|antiemetics|mesh-ancestor
93324877|NCT02318433|Autonomic Agents|autonomic agents|mesh-ancestor
93324878|NCT02318433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324879|NCT02318433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324880|NCT02318433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324881|NCT02318433|Glucocorticoids|glucocorticoids|mesh-ancestor
93324882|NCT02318433|Hormones|hormones|mesh-ancestor
93324883|NCT02318433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324884|NCT02318433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324885|NCT02318433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324886|NCT02318511|Hyaluronic Acid|hyaluronic acid|mesh-list
93324887|NCT02318511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93324888|NCT02318511|Immunologic Factors|immunologic factors|mesh-ancestor
93324889|NCT02318511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324890|NCT02318511|Viscosupplements|viscosupplements|mesh-ancestor
93324891|NCT02318511|Protective Agents|protective agents|mesh-ancestor
93324892|NCT02315391|Glycine|glycine|mesh-list
93324893|NCT02315391|Glycine Agents|glycine agents|mesh-ancestor
93324894|NCT02315391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324895|NCT02315391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324896|NCT02315391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324897|NCT03022981|Sofosbuvir|sofosbuvir|mesh-list
93324898|NCT03022981|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93324899|NCT03022981|Velpatasvir|velpatasvir|mesh-list
93324900|NCT03022981|Antiviral Agents|antiviral agents|mesh-ancestor
93324901|NCT03022981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324902|NCT03164967|Immunoglobulin G|immunoglobulin g|mesh-list
93324903|NCT03164967|Immunologic Factors|immunologic factors|mesh-ancestor
93324904|NCT03164967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324905|NCT03502005|Tenofovir|tenofovir|mesh-list
93324906|NCT03502005|Emtricitabine|emtricitabine|mesh-list
93324907|NCT03502005|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93324908|NCT03502005|Antiviral Agents|antiviral agents|mesh-ancestor
93324909|NCT03502005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324910|NCT03502005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93324911|NCT03502005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93324912|NCT03502005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324913|NCT03502005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324914|NCT03502005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93324915|NCT03502005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93324916|NCT02315547|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93324917|NCT02315547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324918|NCT03669445|Dexamethasone|dexamethasone|mesh-list
93324919|NCT03669445|Lenalidomide|lenalidomide|mesh-list
93324920|NCT03669445|Daratumumab|daratumumab|mesh-list
92996914|NCT02562287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93324921|NCT03669445|Ixazomib|ixazomib|mesh-list
92618794|NCT00170898|Analgesics|analgesics|mesh-ancestor
93324922|NCT03669445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324923|NCT03669445|Antiemetics|antiemetics|mesh-ancestor
93324924|NCT03669445|Autonomic Agents|autonomic agents|mesh-ancestor
93324925|NCT03669445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324926|NCT03669445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324927|NCT03669445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324928|NCT03669445|Glucocorticoids|glucocorticoids|mesh-ancestor
93324929|NCT03669445|Hormones|hormones|mesh-ancestor
93324930|NCT03669445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324931|NCT03669445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93324932|NCT03669445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324933|NCT03669445|Immunologic Factors|immunologic factors|mesh-ancestor
93324934|NCT03669445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93324935|NCT03669445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93324936|NCT03669445|Growth Substances|growth substances|mesh-ancestor
93324937|NCT03669445|Growth Inhibitors|growth inhibitors|mesh-ancestor
93324938|NCT03669445|Protease Inhibitors|protease inhibitors|mesh-ancestor
93324939|NCT03669445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324940|NCT03669445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324941|NCT03500133|Cytarabine|cytarabine|mesh-list
93324942|NCT03500133|Methylprednisolone|methylprednisolone|mesh-list
93324943|NCT03500133|Cisplatin|cisplatin|mesh-list
93324944|NCT03500133|Etoposide|etoposide|mesh-list
93324945|NCT03500133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324946|NCT03500133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93324947|NCT03500133|Antimetabolites|antimetabolites|mesh-ancestor
93324948|NCT03500133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324949|NCT03500133|Antiviral Agents|antiviral agents|mesh-ancestor
93324950|NCT03500133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93324951|NCT03500133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93324952|NCT03500133|Immunologic Factors|immunologic factors|mesh-ancestor
93324953|NCT03500133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324954|NCT03500133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93324955|NCT03500133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93324956|NCT03500133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93324957|NCT03500133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324958|NCT03500133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93324959|NCT03500133|Antiemetics|antiemetics|mesh-ancestor
93324960|NCT03500133|Autonomic Agents|autonomic agents|mesh-ancestor
93324961|NCT03500133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93324962|NCT03500133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93324963|NCT03500133|Glucocorticoids|glucocorticoids|mesh-ancestor
93324964|NCT03500133|Hormones|hormones|mesh-ancestor
93324965|NCT03500133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93324966|NCT03500133|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93324967|NCT03500133|Protective Agents|protective agents|mesh-ancestor
93324968|NCT04462809|Talazoparib|talazoparib|mesh-list
93324969|NCT04462809|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93324970|NCT04462809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324971|NCT04462809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324972|NCT04462809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324973|NCT02320773|Mirabegron|mirabegron|mesh-list
93324974|NCT02320773|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93324975|NCT02320773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93324976|NCT02320773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93324977|NCT02320773|Adrenergic Agents|adrenergic agents|mesh-ancestor
93324978|NCT02320773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93324979|NCT02320773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93324980|NCT02320773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324981|NCT02320773|Urological Agents|urological agents|mesh-ancestor
93324982|NCT03377699|Insulin|insulin|mesh-list
93324983|NCT03377699|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93324984|NCT03377699|Insulin Aspart|insulin aspart|mesh-list
93324985|NCT03377699|Insulin Detemir|insulin detemir|mesh-list
93324986|NCT03377699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93324987|NCT03377699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93324988|NCT04463901|Mitomycins|mitomycins|mesh-list
93324989|NCT04463901|Mitomycin|mitomycin|mesh-list
93324990|NCT04463901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93324991|NCT04463901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93324992|NCT04463901|Alkylating Agents|alkylating agents|mesh-ancestor
93324993|NCT04463901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618859|NCT02916121|Vitamins|vitamins|mesh-ancestor
93324994|NCT04463901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93324995|NCT04463901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93324996|NCT01314443|Vitamin E|vitamin e|mesh-list
93324997|NCT01314443|Tocopherols|tocopherols|mesh-list
93324998|NCT01314443|Tocotrienols|tocotrienols|mesh-list
93324999|NCT01314443|alpha-Tocopherol|alpha-tocopherol|mesh-list
93325000|NCT01314443|gamma-Tocopherol|gamma-tocopherol|mesh-list
93325001|NCT01314443|Nicotine|nicotine|mesh-list
93325002|NCT01314443|Vitamins|vitamins|mesh-ancestor
93325003|NCT01314443|Micronutrients|micronutrients|mesh-ancestor
93325004|NCT01314443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325005|NCT01314443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93325006|NCT01314443|Autonomic Agents|autonomic agents|mesh-ancestor
93325007|NCT01314443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325008|NCT01314443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93325009|NCT01314443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93325010|NCT01314443|Cholinergic Agents|cholinergic agents|mesh-ancestor
93325011|NCT01314443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325012|NCT01314443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325013|NCT01314443|Antioxidants|antioxidants|mesh-ancestor
93325014|NCT01314443|Protective Agents|protective agents|mesh-ancestor
93325015|NCT02310009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93325016|NCT02310009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325017|NCT03498417|Antibodies|antibodies|mesh-list
93325018|NCT03498417|Immunologic Factors|immunologic factors|mesh-ancestor
93325019|NCT03498417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325020|NCT03212651|Pembrolizumab|pembrolizumab|mesh-list
93325021|NCT03212651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325022|NCT03212651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325023|NCT03212651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93325024|NCT03212651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325025|NCT02319135|Cytarabine|cytarabine|mesh-list
93325026|NCT02319135|Fludarabine|fludarabine|mesh-list
93325027|NCT02319135|Lenograstim|lenograstim|mesh-list
93325028|NCT02319135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325029|NCT02319135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325030|NCT02319135|Antimetabolites|antimetabolites|mesh-ancestor
93325031|NCT02319135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325032|NCT02319135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325033|NCT02319135|Immunologic Factors|immunologic factors|mesh-ancestor
93325034|NCT02319135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325035|NCT02319135|Antiviral Agents|antiviral agents|mesh-ancestor
93325036|NCT02319135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325037|NCT02319135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93325038|NCT04738097|Clopidogrel|clopidogrel|mesh-list
93325039|NCT04738097|Ticagrelor|ticagrelor|mesh-list
93325040|NCT04738097|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93325041|NCT04738097|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93325042|NCT04738097|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93325043|NCT04738097|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93325044|NCT04738097|Purinergic Agents|purinergic agents|mesh-ancestor
93325045|NCT04738097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325046|NCT04738097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325047|NCT04738097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325048|NCT03499743|Celecoxib|celecoxib|mesh-list
93325049|NCT03499743|Scopolamine|scopolamine|mesh-list
93325050|NCT03499743|Bromides|bromides|mesh-list
93325051|NCT03499743|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93325052|NCT03499743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93325053|NCT03499743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93325054|NCT03499743|Analgesics|analgesics|mesh-ancestor
93325055|NCT03499743|Sensory System Agents|sensory system agents|mesh-ancestor
93325056|NCT03499743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325057|NCT03499743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325058|NCT03499743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325059|NCT03499743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325060|NCT03499743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93325061|NCT03499743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93325062|NCT03499743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325063|NCT03499743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325064|NCT03499743|Anticonvulsants|anticonvulsants|mesh-ancestor
93325065|NCT03499743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93325066|NCT03499743|Antiemetics|antiemetics|mesh-ancestor
93325067|NCT03499743|Autonomic Agents|autonomic agents|mesh-ancestor
93325068|NCT03499743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325069|NCT03499743|Mydriatics|mydriatics|mesh-ancestor
93325070|NCT03499743|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93325071|NCT03499743|Cholinergic Agents|cholinergic agents|mesh-ancestor
93325072|NCT03499743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325073|NCT03499743|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93325074|NCT03499743|Parasympatholytics|parasympatholytics|mesh-ancestor
93325075|NCT02310087|Vitamin E|vitamin e|mesh-list
93325076|NCT02310087|Vitamins|vitamins|mesh-ancestor
93325077|NCT02310087|Micronutrients|micronutrients|mesh-ancestor
93325078|NCT02310087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325079|NCT02310087|Antioxidants|antioxidants|mesh-ancestor
93325080|NCT02310087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325081|NCT02310087|Protective Agents|protective agents|mesh-ancestor
93325082|NCT02923921|Leucovorin|leucovorin|mesh-list
93325083|NCT02923921|Oxaliplatin|oxaliplatin|mesh-list
93325084|NCT02923921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325085|NCT02923921|Antidotes|antidotes|mesh-ancestor
93325086|NCT02923921|Protective Agents|protective agents|mesh-ancestor
93325087|NCT02923921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325088|NCT02923921|Vitamin B Complex|vitamin b complex|mesh-ancestor
93325089|NCT02923921|Vitamins|vitamins|mesh-ancestor
93325090|NCT02923921|Micronutrients|micronutrients|mesh-ancestor
93325091|NCT02310243|Palbociclib|palbociclib|mesh-list
93325092|NCT02310243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325093|NCT02310243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93325094|NCT02310243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325095|NCT02310243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325096|NCT03497715|Ibuprofen|ibuprofen|mesh-list
93325097|NCT03497715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93325098|NCT03497715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93325099|NCT03497715|Analgesics|analgesics|mesh-ancestor
93325100|NCT03497715|Sensory System Agents|sensory system agents|mesh-ancestor
93325101|NCT03497715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325102|NCT03497715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325103|NCT03497715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325104|NCT03497715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325105|NCT03497715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93325106|NCT03497715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325107|NCT03497715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325108|NCT02321241|Aflibercept|aflibercept|mesh-list
93325109|NCT02321241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93325110|NCT02321241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93325111|NCT02321241|Growth Substances|growth substances|mesh-ancestor
93325112|NCT02321241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325113|NCT02321241|Growth Inhibitors|growth inhibitors|mesh-ancestor
93325114|NCT02321241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325115|NCT03583307|Sirolimus|sirolimus|mesh-list
93325116|NCT03583307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93325117|NCT03583307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325118|NCT03583307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93325119|NCT03583307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325120|NCT03583307|Antifungal Agents|antifungal agents|mesh-ancestor
93325121|NCT03583307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325122|NCT03583307|Immunologic Factors|immunologic factors|mesh-ancestor
93325123|NCT03583307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325124|NCT03039023|Choline|choline|mesh-list
93325125|NCT03039023|Lipotropic Agents|lipotropic agents|mesh-ancestor
93325126|NCT03039023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93325127|NCT03039023|Antimetabolites|antimetabolites|mesh-ancestor
93325128|NCT03039023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325129|NCT03039023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325130|NCT03039023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93325131|NCT03039023|Nootropic Agents|nootropic agents|mesh-ancestor
93325132|NCT02321397|Oxycodone|oxycodone|mesh-list
93325133|NCT02321397|Naloxone|naloxone|mesh-list
93325134|NCT02321397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93325135|NCT02321397|Narcotics|narcotics|mesh-ancestor
93325136|NCT02321397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325137|NCT02321397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325138|NCT02321397|Analgesics|analgesics|mesh-ancestor
93325139|NCT02321397|Sensory System Agents|sensory system agents|mesh-ancestor
93325140|NCT02321397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325141|NCT02321397|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93325142|NCT02319915|Tranexamic Acid|tranexamic acid|mesh-list
93325143|NCT02319915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93325144|NCT02319915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93325145|NCT02319915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325146|NCT02319915|Hemostatics|hemostatics|mesh-ancestor
93325147|NCT02319915|Coagulants|coagulants|mesh-ancestor
93325148|NCT04898309|Complement C1s|complement c1s|mesh-list
93325149|NCT04898309|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93325150|NCT04898309|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
93325151|NCT04898309|Immunologic Factors|immunologic factors|mesh-ancestor
93325152|NCT04898309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325153|NCT04898309|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93325154|NCT04898309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325156|NCT03498963|Chelating Agents|chelating agents|mesh-ancestor
93325157|NCT03498963|Sequestering Agents|sequestering agents|mesh-ancestor
93325158|NCT03498963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325159|NCT02311101|Mitomycins|mitomycins|mesh-list
93325160|NCT02311101|Mitomycin|mitomycin|mesh-list
93325161|NCT02311101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93325162|NCT02311101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325163|NCT02311101|Alkylating Agents|alkylating agents|mesh-ancestor
93325164|NCT02311101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325165|NCT02311101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93325166|NCT02311101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325167|NCT04620187|Cisplatin|cisplatin|mesh-list
93325168|NCT04620187|Carboplatin|carboplatin|mesh-list
93325169|NCT04620187|Trastuzumab|trastuzumab|mesh-list
93325170|NCT04620187|Maytansine|maytansine|mesh-list
93325171|NCT04620187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325172|NCT04620187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325173|NCT04620187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93325174|NCT04620187|Tubulin Modulators|tubulin modulators|mesh-ancestor
93325175|NCT04620187|Antimitotic Agents|antimitotic agents|mesh-ancestor
93325176|NCT04620187|Mitosis Modulators|mitosis modulators|mesh-ancestor
93325177|NCT04620187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325178|NCT03668665|Hyaluronic Acid|hyaluronic acid|mesh-list
93325179|NCT03668665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93325180|NCT03668665|Immunologic Factors|immunologic factors|mesh-ancestor
93325181|NCT03668665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325182|NCT03668665|Viscosupplements|viscosupplements|mesh-ancestor
93325183|NCT03668665|Protective Agents|protective agents|mesh-ancestor
93325184|NCT02320383|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93325185|NCT02320383|Obinutuzumab|obinutuzumab|mesh-list
93325186|NCT02320383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93325187|NCT02320383|Alkylating Agents|alkylating agents|mesh-ancestor
93325188|NCT02320383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325189|NCT02320383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325190|NCT02320383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325191|NCT03704909|Epinephrine|epinephrine|mesh-list
93325192|NCT03704909|Racepinephrine|racepinephrine|mesh-list
93325193|NCT03704909|Ephedrine|ephedrine|mesh-list
93325194|NCT03704909|Epinephryl borate|epinephryl borate|mesh-list
93325195|NCT03704909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93325196|NCT03704909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93325197|NCT03704909|Adrenergic Agents|adrenergic agents|mesh-ancestor
93325198|NCT03704909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325199|NCT03704909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325200|NCT03704909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325201|NCT03704909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93325202|NCT03704909|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93325203|NCT03704909|Autonomic Agents|autonomic agents|mesh-ancestor
93325204|NCT03704909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325205|NCT03704909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93325206|NCT03704909|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325207|NCT03704909|Mydriatics|mydriatics|mesh-ancestor
93325208|NCT03704909|Sympathomimetics|sympathomimetics|mesh-ancestor
93325209|NCT03704909|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93325210|NCT03704909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93325211|NCT03704831|Anesthetics|anesthetics|mesh-list
93325212|NCT03704831|Anesthetics, Local|anesthetics, local|mesh-list
93325213|NCT03704831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325214|NCT03704831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325215|NCT03704831|Sensory System Agents|sensory system agents|mesh-ancestor
93325216|NCT03704831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325217|NCT03704675|Vactosertib|vactosertib|mesh-list
93325218|NCT03704675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92619075|NCT05782894|Narcotics|narcotics|mesh-ancestor
93325219|NCT03704675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325220|NCT03704675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325221|NCT03494517|Magnesium Sulfate|magnesium sulfate|mesh-list
93325222|NCT03494517|Analgesics|analgesics|mesh-ancestor
93325223|NCT03494517|Sensory System Agents|sensory system agents|mesh-ancestor
93325224|NCT03494517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325225|NCT03494517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325226|NCT03494517|Anesthetics|anesthetics|mesh-ancestor
93325227|NCT03494517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997210|NCT00747305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325228|NCT03494517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93325229|NCT03494517|Anticonvulsants|anticonvulsants|mesh-ancestor
93325230|NCT03494517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93325231|NCT03494517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93325232|NCT03494517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325233|NCT03494517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93325234|NCT03494517|Tocolytic Agents|tocolytic agents|mesh-ancestor
93325235|NCT03494517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325236|NCT04912505|Aspirin|aspirin|mesh-list
93325237|NCT04912505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93325238|NCT04912505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93325239|NCT04912505|Analgesics|analgesics|mesh-ancestor
93325240|NCT04912505|Sensory System Agents|sensory system agents|mesh-ancestor
93325241|NCT04912505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325242|NCT04912505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325243|NCT04912505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325244|NCT04912505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325245|NCT04912505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93325246|NCT04912505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93325247|NCT04912505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325248|NCT04912505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93325249|NCT04912505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93325250|NCT04912505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325251|NCT04912505|Antipyretics|antipyretics|mesh-ancestor
93325252|NCT04912427|Dexamethasone|dexamethasone|mesh-list
93325253|NCT04912427|Bortezomib|bortezomib|mesh-list
93325254|NCT04912427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325255|NCT04912427|Antiemetics|antiemetics|mesh-ancestor
93325256|NCT04912427|Autonomic Agents|autonomic agents|mesh-ancestor
93325257|NCT04912427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325258|NCT04912427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325259|NCT04912427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325260|NCT04912427|Glucocorticoids|glucocorticoids|mesh-ancestor
93325261|NCT04912427|Hormones|hormones|mesh-ancestor
93325262|NCT04912427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325263|NCT04912427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93325264|NCT04912427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325265|NCT02322645|Eszopiclone|eszopiclone|mesh-list
93325266|NCT02322645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93325267|NCT02322645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325268|NCT02322645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325269|NCT04050761|Nivolumab|nivolumab|mesh-list
93325270|NCT04050761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325271|NCT04050761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325272|NCT04050761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93325273|NCT04050761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325274|NCT04785261|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93325275|NCT04785261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93325276|NCT03496389|Acetaminophen|acetaminophen|mesh-list
93325277|NCT03496389|Gabapentin|gabapentin|mesh-list
93325278|NCT03496389|Tramadol|tramadol|mesh-list
93325279|NCT03496389|Analgesics|analgesics|mesh-ancestor
93325280|NCT03496389|Sensory System Agents|sensory system agents|mesh-ancestor
93325281|NCT03496389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325282|NCT03496389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325283|NCT03496389|Anticonvulsants|anticonvulsants|mesh-ancestor
93325284|NCT03496389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93325285|NCT03496389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93325286|NCT03496389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325287|NCT03496389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93325288|NCT03496389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92619156|NCT05750017|Vaccines|vaccines|mesh-list
93325289|NCT03496389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93325290|NCT03496389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325291|NCT03496389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325292|NCT03496389|Antimanic Agents|antimanic agents|mesh-ancestor
93325293|NCT03496389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93325294|NCT03496389|Narcotics|narcotics|mesh-ancestor
93325295|NCT03496389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93325296|NCT03496389|Antipyretics|antipyretics|mesh-ancestor
93325297|NCT03491709|Cetuximab|cetuximab|mesh-list
93325298|NCT03491709|Antibodies|antibodies|mesh-list
93325299|NCT03491709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93325300|NCT03491709|Immunologic Factors|immunologic factors|mesh-ancestor
93325301|NCT03491709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325302|NCT03491709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325303|NCT03491709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325304|NCT02325063|Botulinum Toxins|botulinum toxins|mesh-list
93325305|NCT02325063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93325306|NCT02325063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93325307|NCT02325063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325308|NCT02325063|Cholinergic Agents|cholinergic agents|mesh-ancestor
93325309|NCT02325063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325310|NCT02325063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325311|NCT02323191|Atezolizumab|atezolizumab|mesh-list
93325312|NCT02323191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93325313|NCT02323191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325314|NCT02323191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325315|NCT02323191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325316|NCT02323269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93325317|NCT02323269|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325318|NCT02323269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325319|NCT02323269|Immunologic Factors|immunologic factors|mesh-ancestor
93325320|NCT02323269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325321|NCT02323347|Progesterone|progesterone|mesh-list
93325322|NCT02323347|Progestins|progestins|mesh-ancestor
93325323|NCT02323347|Hormones|hormones|mesh-ancestor
93325324|NCT02323347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325325|NCT02323347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325326|NCT03495765|Ranibizumab|ranibizumab|mesh-list
93325327|NCT03495765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93325328|NCT03495765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93325329|NCT03495765|Growth Substances|growth substances|mesh-ancestor
93325330|NCT03495765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325331|NCT03495765|Growth Inhibitors|growth inhibitors|mesh-ancestor
93325332|NCT03495765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325333|NCT03495609|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93325334|NCT03495609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325335|NCT03495609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325336|NCT03491475|Ajmaline|ajmaline|mesh-list
93325337|NCT03491475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93325338|NCT03491475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93325339|NCT03491475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93325340|NCT03491475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93325341|NCT03491475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325342|NCT03499119|Erenumab|erenumab|mesh-list
93325343|NCT03499119|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93325344|NCT03499119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325345|NCT03499119|Analgesics|analgesics|mesh-ancestor
93325346|NCT03499119|Sensory System Agents|sensory system agents|mesh-ancestor
93325347|NCT03499119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325348|NCT03499119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325349|NCT03328845|Insulin|insulin|mesh-list
93325350|NCT03328845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93325351|NCT03328845|Insulin Lispro|insulin lispro|mesh-list
93325352|NCT03328845|Insulin Aspart|insulin aspart|mesh-list
93325353|NCT03328845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93325354|NCT03328845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325355|NCT02323737|Cisplatin|cisplatin|mesh-list
93325356|NCT02323737|Irinotecan|irinotecan|mesh-list
93325357|NCT02323737|Etoposide|etoposide|mesh-list
93325358|NCT02323737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325359|NCT02323737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93325360|NCT02323737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93325361|NCT02323737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325362|NCT02323737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325363|NCT02323737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93325364|NCT02323737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93325365|NCT03037359|Immunoglobulin G|immunoglobulin g|mesh-list
93325366|NCT03037359|Immunologic Factors|immunologic factors|mesh-ancestor
93325367|NCT03037359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325368|NCT03491085|Amoxicillin|amoxicillin|mesh-list
93325369|NCT03491085|Clavulanic Acid|clavulanic acid|mesh-list
93325370|NCT03491085|Clavulanic Acids|clavulanic acids|mesh-list
93325371|NCT03491085|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93325372|NCT03491085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93325373|NCT03491085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325374|NCT03491085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93325375|NCT03491085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366441|NCT02796677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93325376|NCT03491085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325377|NCT02323971|Ticagrelor|ticagrelor|mesh-list
93325378|NCT02323971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93325379|NCT02323971|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93325380|NCT02323971|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93325381|NCT02323971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93325382|NCT02323971|Purinergic Agents|purinergic agents|mesh-ancestor
93325383|NCT02323971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325384|NCT02323971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325385|NCT02323971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325386|NCT03148899|Oxytocin|oxytocin|mesh-list
93325387|NCT03148899|Oxytocics|oxytocics|mesh-ancestor
93325388|NCT03148899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325389|NCT03148899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325390|NCT03495063|Caffeine|caffeine|mesh-list
93325391|NCT03495063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93325392|NCT03495063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325393|NCT03495063|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93325394|NCT03495063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325395|NCT03495063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325396|NCT03495063|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93325397|NCT03495063|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93325398|NCT03495063|Purinergic Agents|purinergic agents|mesh-ancestor
93325399|NCT03495063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325400|NCT03490617|Misoprostol|misoprostol|mesh-list
93325401|NCT03490617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93325402|NCT03490617|Abortifacient Agents|abortifacient agents|mesh-ancestor
93325403|NCT03490617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325404|NCT03490617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325405|NCT03490617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93325406|NCT03490617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325407|NCT03490617|Oxytocics|oxytocics|mesh-ancestor
93325408|NCT03494907|Moxifloxacin|moxifloxacin|mesh-list
93325409|NCT03494907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93325410|NCT03494907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93325411|NCT03494907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325412|NCT03494907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93325413|NCT03494907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93325414|NCT03494907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325415|NCT03494907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325416|NCT03494907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325417|NCT03494907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93325418|NCT03494907|Contraceptive Agents|contraceptive agents|mesh-ancestor
93325419|NCT03494907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325420|NCT03494907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325421|NCT03494907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93325422|NCT03494907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93325423|NCT03494907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93325424|NCT03490539|Mycophenolic Acid|mycophenolic acid|mesh-list
93325425|NCT03490539|Azathioprine|azathioprine|mesh-list
93325426|NCT03490539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93325427|NCT03490539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325428|NCT03490539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93325429|NCT03490539|Antitubercular Agents|antitubercular agents|mesh-ancestor
93325430|NCT03490539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93325431|NCT03490539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325432|NCT03490539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325433|NCT03490539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325434|NCT03490539|Antimetabolites|antimetabolites|mesh-ancestor
93325435|NCT03490539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325436|NCT03490539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325437|NCT03490539|Immunologic Factors|immunologic factors|mesh-ancestor
93325438|NCT03490539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325439|NCT03490539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325440|NCT03493503|Albuterol|albuterol|mesh-list
93325441|NCT03493503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93325442|NCT03493503|Autonomic Agents|autonomic agents|mesh-ancestor
93325443|NCT03493503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325444|NCT03493503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325445|NCT03493503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93325446|NCT03493503|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325447|NCT03493503|Tocolytic Agents|tocolytic agents|mesh-ancestor
92997438|NCT00502203|Paclitaxel|paclitaxel|mesh-list
93325448|NCT03493503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325449|NCT03493503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93325450|NCT03493503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93325451|NCT03493503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93325452|NCT03493503|Adrenergic Agents|adrenergic agents|mesh-ancestor
93325453|NCT03493503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325454|NCT03493503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325455|NCT02143414|Prednisone|prednisone|mesh-list
93325456|NCT02143414|Cortisone|cortisone|mesh-list
93325457|NCT02143414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93325458|NCT02143414|Methotrexate|methotrexate|mesh-list
93325459|NCT02143414|Vincristine|vincristine|mesh-list
93325460|NCT02143414|Dasatinib|dasatinib|mesh-list
93325461|NCT02143414|Mercaptopurine|mercaptopurine|mesh-list
93325462|NCT02143414|Blinatumomab|blinatumomab|mesh-list
93325463|NCT02143414|Antibodies|antibodies|mesh-list
93325464|NCT02143414|Immunoglobulins|immunoglobulins|mesh-list
93325465|NCT02143414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93325466|NCT02143414|Muromonab-CD3|muromonab-cd3|mesh-list
93325467|NCT02143414|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93325468|NCT02143414|Immunologic Factors|immunologic factors|mesh-ancestor
93325469|NCT02143414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325470|NCT02143414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325471|NCT02143414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325472|NCT02143414|Glucocorticoids|glucocorticoids|mesh-ancestor
93325473|NCT02143414|Hormones|hormones|mesh-ancestor
93325474|NCT02143414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325475|NCT02143414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93325476|NCT02143414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93325477|NCT02143414|Abortifacient Agents|abortifacient agents|mesh-ancestor
93325478|NCT02143414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325479|NCT02143414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325480|NCT02143414|Antimetabolites|antimetabolites|mesh-ancestor
93325481|NCT02143414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325482|NCT02143414|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325483|NCT02143414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325484|NCT02143414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93325485|NCT02143414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325486|NCT02143414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325487|NCT02143414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93325488|NCT02143414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93325489|NCT02143414|Tubulin Modulators|tubulin modulators|mesh-ancestor
93325490|NCT02143414|Antimitotic Agents|antimitotic agents|mesh-ancestor
93325491|NCT02143414|Mitosis Modulators|mitosis modulators|mesh-ancestor
93325492|NCT02143414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93325493|NCT04791761|Acetaminophen|acetaminophen|mesh-list
93325494|NCT04791761|Ibuprofen|ibuprofen|mesh-list
93325495|NCT04791761|Oxycodone|oxycodone|mesh-list
93325496|NCT04791761|Analgesics, Opioid|analgesics, opioid|mesh-list
93325497|NCT04791761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93325498|NCT04791761|Analgesics|analgesics|mesh-ancestor
92619365|NCT05091242|Clonidine|clonidine|mesh-list
93325499|NCT04791761|Sensory System Agents|sensory system agents|mesh-ancestor
93325500|NCT04791761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325501|NCT04791761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325502|NCT04791761|Antipyretics|antipyretics|mesh-ancestor
93325503|NCT04791761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93325504|NCT04791761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325505|NCT04791761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325506|NCT04791761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93325507|NCT04791761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325508|NCT04791761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325509|NCT04791761|Narcotics|narcotics|mesh-ancestor
93325510|NCT04791761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325511|NCT03667963|Lactulose|lactulose|mesh-list
93325512|NCT03667963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325513|NCT03489837|Dipropizine|dipropizine|mesh-list
93325514|NCT03489837|Antitussive Agents|antitussive agents|mesh-ancestor
93325515|NCT03489837|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325516|NCT03014479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93325517|NCT03014479|Protease Inhibitors|protease inhibitors|mesh-ancestor
93325518|NCT03014479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325519|NCT03014479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325520|NCT03014479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93325521|NCT03014479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325522|NCT03625505|Venetoclax|venetoclax|mesh-list
93325523|NCT03625505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325524|NCT03493269|Midazolam|midazolam|mesh-list
93325525|NCT03493269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93325526|NCT03493269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93325527|NCT03493269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325528|NCT03493269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325529|NCT03493269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93325530|NCT03493269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93325531|NCT03493269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93325532|NCT03493269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93325533|NCT03493269|Anesthetics, General|anesthetics, general|mesh-ancestor
93325534|NCT03493269|Anesthetics|anesthetics|mesh-ancestor
93325535|NCT03493269|GABA Modulators|gaba modulators|mesh-ancestor
93325536|NCT03493269|GABA Agents|gaba agents|mesh-ancestor
93325537|NCT03493269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325538|NCT03493269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325539|NCT04257682|Bupivacaine|bupivacaine|mesh-list
93325540|NCT04257682|Ropivacaine|ropivacaine|mesh-list
93325541|NCT04257682|Anesthetics, Local|anesthetics, local|mesh-list
93325542|NCT04257682|Mepivacaine|mepivacaine|mesh-list
93325543|NCT04257682|Anesthetics|anesthetics|mesh-list
93325544|NCT04257682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325545|NCT04257682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325546|NCT04257682|Sensory System Agents|sensory system agents|mesh-ancestor
93325547|NCT04257682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325548|NCT05426434|Pyrimethamine|pyrimethamine|mesh-list
93325549|NCT05426434|Piperaquine|piperaquine|mesh-list
93325550|NCT05426434|Sulfadoxine|sulfadoxine|mesh-list
93325551|NCT05426434|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93325552|NCT05426434|Artenimol|artenimol|mesh-list
93325553|NCT05426434|Antimalarials|antimalarials|mesh-ancestor
93325554|NCT05426434|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93325555|NCT05426434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93325556|NCT05426434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325557|NCT05426434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93325558|NCT05426434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325559|NCT05426434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325560|NCT05426434|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93325561|NCT05404906|Azacitidine|azacitidine|mesh-list
93325562|NCT05404906|Venetoclax|venetoclax|mesh-list
93325563|NCT05404906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325564|NCT05404906|Antimetabolites|antimetabolites|mesh-ancestor
93325565|NCT05404906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325566|NCT05404906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325567|NCT05404906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325568|NCT03020407|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93325569|NCT03020407|Dopamine|dopamine|mesh-list
93325570|NCT03020407|Epinephrine|epinephrine|mesh-list
93325571|NCT03020407|Norepinephrine|norepinephrine|mesh-list
93325572|NCT03020407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93325573|NCT03020407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325574|NCT03020407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93325575|NCT03020407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93325576|NCT03020407|Adrenergic Agents|adrenergic agents|mesh-ancestor
93325577|NCT03020407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325578|NCT03020407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325579|NCT03020407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325580|NCT03020407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93325581|NCT03020407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93325582|NCT03020407|Autonomic Agents|autonomic agents|mesh-ancestor
93325583|NCT03020407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325584|NCT03020407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93325585|NCT03020407|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325586|NCT03020407|Mydriatics|mydriatics|mesh-ancestor
93325587|NCT03020407|Sympathomimetics|sympathomimetics|mesh-ancestor
93325588|NCT03020407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93325589|NCT03020407|Dopamine Agents|dopamine agents|mesh-ancestor
93325590|NCT03020407|Protective Agents|protective agents|mesh-ancestor
93325591|NCT03624959|Itraconazole|itraconazole|mesh-list
93325592|NCT03624959|Rifampin|rifampin|mesh-list
93325593|NCT03624959|Gemfibrozil|gemfibrozil|mesh-list
93325594|NCT03624959|Ozanimod|ozanimod|mesh-list
93325595|NCT03624959|Antifungal Agents|antifungal agents|mesh-ancestor
93325596|NCT03624959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93325597|NCT03624959|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92997585|NCT00082381|Exenatide|exenatide|mesh-list
93325598|NCT03624959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93325599|NCT03624959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325600|NCT03624959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325601|NCT03624959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93325602|NCT03624959|Hormone Antagonists|hormone antagonists|mesh-ancestor
93325603|NCT03624959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325604|NCT03624959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325605|NCT03624959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93325606|NCT03624959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93325607|NCT03624959|Antitubercular Agents|antitubercular agents|mesh-ancestor
93325608|NCT03624959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93325609|NCT03624959|Leprostatic Agents|leprostatic agents|mesh-ancestor
93325610|NCT03624959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93325611|NCT03624959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93325612|NCT03624959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93325613|NCT03624959|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93325614|NCT03624959|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93325615|NCT03624959|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93325616|NCT03624959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93325617|NCT03624959|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93325618|NCT03624959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325619|NCT03624959|Immunologic Factors|immunologic factors|mesh-ancestor
93325620|NCT03624959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93325621|NCT03624959|Antimetabolites|antimetabolites|mesh-ancestor
93325622|NCT03624959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93325623|NCT03624959|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93325624|NCT02536846|Olanzapine|olanzapine|mesh-list
93325625|NCT02536846|Antiemetics|antiemetics|mesh-ancestor
93325626|NCT02536846|Autonomic Agents|autonomic agents|mesh-ancestor
93325627|NCT02536846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325628|NCT02536846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325629|NCT02536846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325630|NCT02536846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93325631|NCT02536846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93325632|NCT02536846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325633|NCT02536846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93325634|NCT02536846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93325635|NCT02536846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93325636|NCT02536846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93325637|NCT02536846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325638|NCT02536846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325639|NCT02536846|Serotonin Agents|serotonin agents|mesh-ancestor
93325640|NCT03014011|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93325641|NCT03014011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325642|NCT02293655|Methylphenidate|methylphenidate|mesh-list
93325643|NCT02293655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93325644|NCT02293655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325645|NCT02293655|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93325646|NCT02293655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93325647|NCT02293655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93325648|NCT02293655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325649|NCT02293655|Dopamine Agents|dopamine agents|mesh-ancestor
93325650|NCT02293655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325651|NCT01764191|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93325652|NCT01764191|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93325653|NCT01764191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325654|NCT05439460|Phenylephrine|phenylephrine|mesh-list
93325655|NCT05439460|Vasopressins|vasopressins|mesh-list
93325656|NCT05439460|Arginine Vasopressin|arginine vasopressin|mesh-list
93325657|NCT05439460|Epinephrine|epinephrine|mesh-list
93325658|NCT05439460|Racepinephrine|racepinephrine|mesh-list
93325659|NCT05439460|Oxymetazoline|oxymetazoline|mesh-list
93325660|NCT05439460|Epinephryl borate|epinephryl borate|mesh-list
93325661|NCT05439460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93325662|NCT05439460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93325663|NCT05439460|Adrenergic Agents|adrenergic agents|mesh-ancestor
93325664|NCT05439460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325665|NCT05439460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325666|NCT05439460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325667|NCT05439460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93325668|NCT05439460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93325669|NCT05439460|Autonomic Agents|autonomic agents|mesh-ancestor
93325670|NCT05439460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325671|NCT05439460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93325672|NCT05439460|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325673|NCT05439460|Mydriatics|mydriatics|mesh-ancestor
93325674|NCT05439460|Sympathomimetics|sympathomimetics|mesh-ancestor
93325675|NCT05439460|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93325676|NCT05439460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93325677|NCT05439460|Nasal Decongestants|nasal decongestants|mesh-ancestor
93325678|NCT05439460|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93325679|NCT05439460|Protective Agents|protective agents|mesh-ancestor
93325681|NCT05439460|Coagulants|coagulants|mesh-ancestor
93325682|NCT05439460|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93325683|NCT05439460|Natriuretic Agents|natriuretic agents|mesh-ancestor
93325684|NCT01661140|Methotrexate|methotrexate|mesh-list
93325685|NCT01661140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93325686|NCT01661140|Abortifacient Agents|abortifacient agents|mesh-ancestor
93325687|NCT01661140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325688|NCT01661140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325689|NCT01661140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325690|NCT01661140|Antimetabolites|antimetabolites|mesh-ancestor
93325691|NCT01661140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325692|NCT01661140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325693|NCT01661140|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325694|NCT01661140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325695|NCT01661140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93325696|NCT01661140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325697|NCT01661140|Immunologic Factors|immunologic factors|mesh-ancestor
93325698|NCT01661140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325699|NCT01661140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93325700|NCT03019549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93325701|NCT03019549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93325702|NCT03019549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93325703|NCT03019549|Antimetabolites|antimetabolites|mesh-ancestor
93325704|NCT03019549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325705|NCT03019549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93325706|NCT03019549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93325707|NCT03019549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325708|NCT05399602|Anesthetics|anesthetics|mesh-list
93325709|NCT05399602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325710|NCT05399602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325711|NCT05397886|Propofol|propofol|mesh-list
93325712|NCT05397886|Flumazenil|flumazenil|mesh-list
93325713|NCT05397886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93325714|NCT05397886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325715|NCT05397886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325716|NCT05397886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93325717|NCT05397886|Anesthetics, General|anesthetics, general|mesh-ancestor
93325718|NCT05397886|Anesthetics|anesthetics|mesh-ancestor
93325719|NCT05397886|Antidotes|antidotes|mesh-ancestor
93325720|NCT05397886|Protective Agents|protective agents|mesh-ancestor
93325721|NCT05397886|GABA Modulators|gaba modulators|mesh-ancestor
93325722|NCT05397886|GABA Agents|gaba agents|mesh-ancestor
93325723|NCT05397886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325724|NCT05397886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325725|NCT05436886|Gabapentin|gabapentin|mesh-list
93325726|NCT05436886|Analgesics|analgesics|mesh-ancestor
93325727|NCT05436886|Sensory System Agents|sensory system agents|mesh-ancestor
93325728|NCT05436886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325729|NCT05436886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325730|NCT05436886|Anticonvulsants|anticonvulsants|mesh-ancestor
93325731|NCT05436886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93325732|NCT05436886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93325733|NCT05436886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325734|NCT05436886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93325735|NCT05436886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93325736|NCT05436886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93325737|NCT05436886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325738|NCT05436886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325739|NCT05436886|Antimanic Agents|antimanic agents|mesh-ancestor
93325740|NCT01373151|Adalimumab|adalimumab|mesh-list
93325741|NCT01373151|Methotrexate|methotrexate|mesh-list
93325742|NCT01373151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93325743|NCT01373151|Abortifacient Agents|abortifacient agents|mesh-ancestor
93325744|NCT01373151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325745|NCT01373151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997733|NCT02878083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325746|NCT01373151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325747|NCT01373151|Antimetabolites|antimetabolites|mesh-ancestor
93325748|NCT01373151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325749|NCT01373151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325750|NCT01373151|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325751|NCT01373151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325752|NCT01373151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93325753|NCT01373151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325754|NCT01373151|Immunologic Factors|immunologic factors|mesh-ancestor
93325755|NCT01373151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325756|NCT01373151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93325757|NCT01373151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93325758|NCT01373151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325759|NCT05436652|Prednisolone|prednisolone|mesh-list
93325760|NCT05436652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93325761|NCT05436652|Methylprednisolone|methylprednisolone|mesh-list
93325762|NCT05436652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93325763|NCT05436652|Prednisolone acetate|prednisolone acetate|mesh-list
93325764|NCT05436652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93325765|NCT05436652|Prednisolone phosphate|prednisolone phosphate|mesh-list
93325766|NCT05436652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325767|NCT05436652|Glucocorticoids|glucocorticoids|mesh-ancestor
93325769|NCT05436652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325770|NCT05436652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325771|NCT05436652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93325772|NCT05436652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325773|NCT05436652|Antiemetics|antiemetics|mesh-ancestor
93325774|NCT05436652|Autonomic Agents|autonomic agents|mesh-ancestor
93325775|NCT05436652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325776|NCT05436652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325777|NCT05436652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93325778|NCT05436652|Protective Agents|protective agents|mesh-ancestor
93325779|NCT01660906|Dasatinib|dasatinib|mesh-list
93325780|NCT01660906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325781|NCT01660906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93325782|NCT01660906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325783|NCT01660906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325784|NCT05435014|Ethiodized Oil|ethiodized oil|mesh-list
93325785|NCT05435014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325786|NCT03666949|Anesthetics|anesthetics|mesh-list
93325787|NCT03666949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325788|NCT03666949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325789|NCT00886691|Bevacizumab|bevacizumab|mesh-list
93325790|NCT00886691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93325791|NCT00886691|Everolimus|everolimus|mesh-list
93325792|NCT00886691|Endothelial Growth Factors|endothelial growth factors|mesh-list
93325793|NCT00886691|Antibodies|antibodies|mesh-list
93325794|NCT00886691|Immunoglobulins|immunoglobulins|mesh-list
93325795|NCT00886691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93325796|NCT00886691|Immunoglobulin G|immunoglobulin g|mesh-list
93325797|NCT00886691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325798|NCT00886691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93325799|NCT00886691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93325800|NCT00886691|Growth Substances|growth substances|mesh-ancestor
93325801|NCT00886691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325802|NCT00886691|Growth Inhibitors|growth inhibitors|mesh-ancestor
93325803|NCT00886691|Immunologic Factors|immunologic factors|mesh-ancestor
93325804|NCT00886691|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93325805|NCT00886691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93325806|NCT00886691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325807|NCT00886691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325808|NCT00886691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325809|NCT00960297|Paclitaxel|paclitaxel|mesh-list
93325810|NCT00960297|Bevacizumab|bevacizumab|mesh-list
93325811|NCT00960297|Carboplatin|carboplatin|mesh-list
93325812|NCT00960297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93325813|NCT00960297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325814|NCT00960297|Tubulin Modulators|tubulin modulators|mesh-ancestor
93325815|NCT00960297|Antimitotic Agents|antimitotic agents|mesh-ancestor
93325816|NCT00960297|Mitosis Modulators|mitosis modulators|mesh-ancestor
93325817|NCT00960297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325818|NCT00960297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325819|NCT00960297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93325820|NCT00960297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93325821|NCT00960297|Growth Substances|growth substances|mesh-ancestor
93325822|NCT00960297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325823|NCT00960297|Growth Inhibitors|growth inhibitors|mesh-ancestor
93325824|NCT05112861|Bevacizumab|bevacizumab|mesh-list
93325825|NCT05112861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325826|NCT05112861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325827|NCT05112861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93325828|NCT05112861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93325829|NCT05112861|Growth Substances|growth substances|mesh-ancestor
93325830|NCT05112861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325831|NCT05112861|Growth Inhibitors|growth inhibitors|mesh-ancestor
93325832|NCT03012061|Fluticasone|fluticasone|mesh-list
93325833|NCT03012061|Xhance|xhance|mesh-list
93325834|NCT03012061|Albuterol|albuterol|mesh-list
93325835|NCT03012061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325836|NCT03012061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93325837|NCT03012061|Autonomic Agents|autonomic agents|mesh-ancestor
93325838|NCT03012061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325839|NCT03012061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325840|NCT03012061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93325841|NCT03012061|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325842|NCT03012061|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325843|NCT03012061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93325844|NCT03012061|Tocolytic Agents|tocolytic agents|mesh-ancestor
93325845|NCT03012061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325846|NCT03012061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93325847|NCT03012061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93325848|NCT03012061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93325849|NCT03012061|Adrenergic Agents|adrenergic agents|mesh-ancestor
93325850|NCT03012061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325851|NCT03012061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325852|NCT00408863|Tibolone|tibolone|mesh-list
93325853|NCT00408863|Androgen Antagonists|androgen antagonists|mesh-ancestor
93325854|NCT00408863|Hormone Antagonists|hormone antagonists|mesh-ancestor
93325855|NCT00408863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325856|NCT00408863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325857|NCT00408863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93325858|NCT00408863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93325859|NCT00408863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325860|NCT00408863|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93325861|NCT00408863|Anabolic Agents|anabolic agents|mesh-ancestor
93325862|NCT00408863|Hormones|hormones|mesh-ancestor
93325863|NCT05085327|Sunscreening Agents|sunscreening agents|mesh-list
93325864|NCT05085327|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93325865|NCT05085327|Protective Agents|protective agents|mesh-ancestor
93325866|NCT05085327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325867|NCT05085327|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325868|NCT03666715|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93325869|NCT03666715|Antipsychotic Agents|antipsychotic agents|mesh-list
93325870|NCT03666715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93325871|NCT03666715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325872|NCT03666715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325873|NCT03666715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93325874|NCT03666715|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93325875|NCT03666715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93325876|NCT03666715|Serotonin Agents|serotonin agents|mesh-ancestor
93325877|NCT03666715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325878|NCT03666715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325879|NCT03666715|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93325880|NCT03666715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93325881|NCT03666715|Dopamine Agents|dopamine agents|mesh-ancestor
93325882|NCT04949399|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93325883|NCT04949399|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93325884|NCT04949399|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93325885|NCT04949399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325886|NCT04949399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325887|NCT04949399|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93325888|NCT04949399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93325889|NCT04949399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325890|NCT04949399|Cholinergic Agents|cholinergic agents|mesh-ancestor
93325891|NCT04949399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325892|NCT03131973|Leucovorin|leucovorin|mesh-list
93325893|NCT03131973|Flurbiprofen|flurbiprofen|mesh-list
93325894|NCT03131973|Methotrexate|methotrexate|mesh-list
93325895|NCT03131973|Digoxin|digoxin|mesh-list
93325896|NCT03131973|Midazolam|midazolam|mesh-list
93325897|NCT03131973|Caffeine|caffeine|mesh-list
93325898|NCT03131973|Omeprazole|omeprazole|mesh-list
93325899|NCT03131973|Pravastatin|pravastatin|mesh-list
93325900|NCT03131973|Montelukast|montelukast|mesh-list
93325901|NCT03131973|Branebrutinib|branebrutinib|mesh-list
93325902|NCT03131973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93325903|NCT03131973|Abortifacient Agents|abortifacient agents|mesh-ancestor
93325904|NCT03131973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93325905|NCT03131973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325906|NCT03131973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93325907|NCT03131973|Antimetabolites|antimetabolites|mesh-ancestor
93325908|NCT03131973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325909|NCT03131973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325910|NCT03131973|Dermatologic Agents|dermatologic agents|mesh-ancestor
93325911|NCT03131973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325912|NCT03131973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93325913|NCT03131973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325914|NCT03131973|Immunologic Factors|immunologic factors|mesh-ancestor
93325915|NCT03131973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325916|NCT03131973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93325917|NCT03131973|Antidotes|antidotes|mesh-ancestor
93325918|NCT03131973|Protective Agents|protective agents|mesh-ancestor
93325919|NCT03131973|Vitamin B Complex|vitamin b complex|mesh-ancestor
93325920|NCT03131973|Vitamins|vitamins|mesh-ancestor
93325921|NCT03131973|Micronutrients|micronutrients|mesh-ancestor
93325922|NCT03131973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93325923|NCT03131973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93325924|NCT03131973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93325925|NCT03131973|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93325926|NCT03131973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93325927|NCT03131973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93325928|NCT03131973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93325929|NCT03131973|Anesthetics, General|anesthetics, general|mesh-ancestor
93325930|NCT03131973|Anesthetics|anesthetics|mesh-ancestor
93325931|NCT03131973|GABA Modulators|gaba modulators|mesh-ancestor
93325932|NCT03131973|GABA Agents|gaba agents|mesh-ancestor
93325933|NCT03131973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93325934|NCT03131973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93325935|NCT03131973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93325936|NCT03131973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93325937|NCT03131973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93325938|NCT03131973|Purinergic Agents|purinergic agents|mesh-ancestor
93325939|NCT03131973|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93325940|NCT03131973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93325941|NCT03131973|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93325942|NCT03131973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93325943|NCT03131973|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325944|NCT03131973|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93325945|NCT03131973|Hormone Antagonists|hormone antagonists|mesh-ancestor
93325946|NCT03131973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93325947|NCT03131973|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93325948|NCT03131973|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93325949|NCT03131973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93325950|NCT03131973|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93325951|NCT03131973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93325952|NCT03131973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93325953|NCT03131973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93325954|NCT03131973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93325955|NCT03131973|Analgesics|analgesics|mesh-ancestor
93325956|NCT03131973|Sensory System Agents|sensory system agents|mesh-ancestor
93325957|NCT03131973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93325958|NCT03131973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93325959|NCT03131973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93325960|NCT03131973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93325961|NCT03131973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93325962|NCT03131973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93325963|NCT05078931|Pembrolizumab|pembrolizumab|mesh-list
93325964|NCT05078931|Lenvatinib|lenvatinib|mesh-list
93325965|NCT05078931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93325966|NCT05078931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325967|NCT05078931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93325968|NCT05078931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325969|NCT05078931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93325970|NCT05078931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325971|NCT04825197|Poractant alfa|poractant alfa|mesh-list
92997965|NCT00425308|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93325972|NCT04825197|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93325973|NCT04825197|Respiratory System Agents|respiratory system agents|mesh-ancestor
93325974|NCT04187105|Cyclophosphamide|cyclophosphamide|mesh-list
93325975|NCT04187105|Fludarabine|fludarabine|mesh-list
93325976|NCT04187105|Tacrolimus|tacrolimus|mesh-list
93325977|NCT04187105|Complement Factor H|complement factor h|mesh-list
93325978|NCT04187105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93325979|NCT04187105|Immunologic Factors|immunologic factors|mesh-ancestor
93325980|NCT04187105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93325981|NCT04187105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93325982|NCT04187105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93325983|NCT04187105|Alkylating Agents|alkylating agents|mesh-ancestor
93325984|NCT04187105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325985|NCT04187105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93325986|NCT04187105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93325987|NCT04187105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93325988|NCT04187105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93325989|NCT04187105|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93325991|NCT04703361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93325992|NCT04703361|Antimetabolites|antimetabolites|mesh-ancestor
93325993|NCT04703361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93325994|NCT04703361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93325995|NCT04703361|Vasodilator Agents|vasodilator agents|mesh-ancestor
93325996|NCT04703361|Vitamin B Complex|vitamin b complex|mesh-ancestor
93325997|NCT04703361|Vitamins|vitamins|mesh-ancestor
93325998|NCT04703361|Micronutrients|micronutrients|mesh-ancestor
93325999|NCT04703361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326000|NCT03010423|Nicorandil|nicorandil|mesh-list
93326001|NCT03010423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93326002|NCT03010423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93326003|NCT03010423|Vasodilator Agents|vasodilator agents|mesh-ancestor
93326004|NCT03010423|Vitamin B Complex|vitamin b complex|mesh-ancestor
93326005|NCT03010423|Vitamins|vitamins|mesh-ancestor
93326006|NCT03010423|Micronutrients|micronutrients|mesh-ancestor
93326007|NCT03010423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326008|NCT05576597|Butyric Acid|butyric acid|mesh-list
93326009|NCT05576597|Histamine Antagonists|histamine antagonists|mesh-ancestor
93326010|NCT05576597|Histamine Agents|histamine agents|mesh-ancestor
93326011|NCT05576597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326012|NCT05576597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326013|NCT05576597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326014|NCT03665779|Pyridoxine|pyridoxine|mesh-list
93326015|NCT03665779|Isosorbide|isosorbide|mesh-list
93326016|NCT03665779|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93326017|NCT03665779|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93326018|NCT03665779|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93326019|NCT03665779|Diuretics|diuretics|mesh-ancestor
93326020|NCT03665779|Natriuretic Agents|natriuretic agents|mesh-ancestor
93326021|NCT03665779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326022|NCT03665779|Vasodilator Agents|vasodilator agents|mesh-ancestor
93326023|NCT03665779|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93326024|NCT03665779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326025|NCT03665779|Vitamin B Complex|vitamin b complex|mesh-ancestor
93326026|NCT03665779|Vitamins|vitamins|mesh-ancestor
93326027|NCT03665779|Micronutrients|micronutrients|mesh-ancestor
93326028|NCT03703505|Mitapivat|mitapivat|mesh-list
93326029|NCT03703505|Enzyme Activators|enzyme activators|mesh-ancestor
93326030|NCT03703505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326031|NCT04946435|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93326032|NCT04946435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326033|NCT04944017|Ketamine|ketamine|mesh-list
93326034|NCT04944017|Analgesics|analgesics|mesh-ancestor
93326035|NCT04944017|Sensory System Agents|sensory system agents|mesh-ancestor
93326036|NCT04944017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326037|NCT04944017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326038|NCT04944017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93326039|NCT04944017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93326040|NCT04944017|Anesthetics, General|anesthetics, general|mesh-ancestor
93326041|NCT04944017|Anesthetics|anesthetics|mesh-ancestor
93326042|NCT04944017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326043|NCT04944017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93326044|NCT04944017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93326045|NCT04944017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326046|NCT04944017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326047|NCT03703427|Capecitabine|capecitabine|mesh-list
93326048|NCT03703427|Vinorelbine|vinorelbine|mesh-list
93326049|NCT03703427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326050|NCT03703427|Antimetabolites|antimetabolites|mesh-ancestor
93326051|NCT03703427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326052|NCT03703427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326053|NCT03703427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326054|NCT03703427|Tubulin Modulators|tubulin modulators|mesh-ancestor
93326055|NCT03703427|Antimitotic Agents|antimitotic agents|mesh-ancestor
93326056|NCT03703427|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326057|NCT03703349|Magnesium Sulfate|magnesium sulfate|mesh-list
92619925|NCT03056040|Eculizumab|eculizumab|mesh-list
93326059|NCT03703349|Sensory System Agents|sensory system agents|mesh-ancestor
93326060|NCT03703349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326061|NCT03703349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326062|NCT03703349|Anesthetics|anesthetics|mesh-ancestor
93326063|NCT03703349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326064|NCT03703349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93326065|NCT03703349|Anticonvulsants|anticonvulsants|mesh-ancestor
93326066|NCT03703349|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93326067|NCT03703349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93326068|NCT03703349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326069|NCT03703349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93326070|NCT03703349|Tocolytic Agents|tocolytic agents|mesh-ancestor
93326071|NCT03703349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93326072|NCT03008005|Dronabinol|dronabinol|mesh-list
93326073|NCT03008005|Hallucinogens|hallucinogens|mesh-ancestor
93326074|NCT03008005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326075|NCT03008005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93326076|NCT03008005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326077|NCT03008005|Analgesics|analgesics|mesh-ancestor
93326078|NCT03008005|Sensory System Agents|sensory system agents|mesh-ancestor
93326079|NCT03008005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326080|NCT03008005|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93326081|NCT03008005|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93326082|NCT03008005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326083|NCT03008005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326084|NCT03008005|Hormones|hormones|mesh-ancestor
93326085|NCT03008005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326086|NCT03666325|Pembrolizumab|pembrolizumab|mesh-list
93326087|NCT03666325|Cetuximab|cetuximab|mesh-list
93326088|NCT03666325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326089|NCT03666325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326090|NCT03666325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93326091|NCT03666325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326092|NCT02440425|Paclitaxel|paclitaxel|mesh-list
93326093|NCT02440425|Pembrolizumab|pembrolizumab|mesh-list
93326094|NCT02440425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326095|NCT02440425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326096|NCT02440425|Tubulin Modulators|tubulin modulators|mesh-ancestor
93326097|NCT02440425|Antimitotic Agents|antimitotic agents|mesh-ancestor
93326098|NCT02440425|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326099|NCT02440425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326100|NCT02440425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326101|NCT02440425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93326102|NCT04931511|Betamethasone|betamethasone|mesh-list
93326103|NCT04931511|Betamethasone Valerate|betamethasone valerate|mesh-list
93326104|NCT04931511|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93326105|NCT04931511|Betamethasone benzoate|betamethasone benzoate|mesh-list
93326106|NCT04931511|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93326107|NCT04931511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326108|NCT04931511|Glucocorticoids|glucocorticoids|mesh-ancestor
93326109|NCT04931511|Hormones|hormones|mesh-ancestor
93326110|NCT04931511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326111|NCT04931511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326112|NCT04931511|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93326113|NCT04931511|Respiratory System Agents|respiratory system agents|mesh-ancestor
93326114|NCT04182321|Metformin|metformin|mesh-list
93326115|NCT04182321|Entecavir|entecavir|mesh-list
93326116|NCT04182321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93326117|NCT04182321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326118|NCT04182321|Antiviral Agents|antiviral agents|mesh-ancestor
92620003|NCT02282059|Sunitinib|sunitinib|mesh-list
93326119|NCT04182321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326120|NCT03702959|Betamethasone|betamethasone|mesh-list
93326121|NCT03702959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326122|NCT03702959|Glucocorticoids|glucocorticoids|mesh-ancestor
93326123|NCT03702959|Hormones|hormones|mesh-ancestor
93326124|NCT03702959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326125|NCT03702959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326126|NCT03702959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93326127|NCT03702959|Respiratory System Agents|respiratory system agents|mesh-ancestor
93326128|NCT04879823|Acetaminophen|acetaminophen|mesh-list
93326129|NCT04879823|Dexamethasone|dexamethasone|mesh-list
93326130|NCT04879823|Ibuprofen|ibuprofen|mesh-list
93326131|NCT04879823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326132|NCT04879823|Antiemetics|antiemetics|mesh-ancestor
93326133|NCT04879823|Autonomic Agents|autonomic agents|mesh-ancestor
93326134|NCT04879823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326135|NCT04879823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326136|NCT04879823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326137|NCT04879823|Glucocorticoids|glucocorticoids|mesh-ancestor
93326138|NCT04879823|Hormones|hormones|mesh-ancestor
93326139|NCT04879823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326140|NCT04879823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93326141|NCT04879823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326142|NCT04879823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326143|NCT04879823|Analgesics|analgesics|mesh-ancestor
93326144|NCT04879823|Sensory System Agents|sensory system agents|mesh-ancestor
93326145|NCT04879823|Antipyretics|antipyretics|mesh-ancestor
93326146|NCT04879823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93326147|NCT04879823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326148|NCT04879823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93326149|NCT04879823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326150|NCT04879823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326151|NCT03001219|Methotrexate|methotrexate|mesh-list
93326152|NCT03001219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93326153|NCT03001219|Abortifacient Agents|abortifacient agents|mesh-ancestor
93326154|NCT03001219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93326155|NCT03001219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326156|NCT03001219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326157|NCT03001219|Antimetabolites|antimetabolites|mesh-ancestor
93326158|NCT03001219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326159|NCT03001219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326160|NCT03001219|Dermatologic Agents|dermatologic agents|mesh-ancestor
93326161|NCT03001219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326162|NCT03001219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93326163|NCT03001219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93326164|NCT03001219|Immunologic Factors|immunologic factors|mesh-ancestor
93326165|NCT03001219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326166|NCT03001219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93326167|NCT03702803|Alprazolam|alprazolam|mesh-list
93326168|NCT03702803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93326169|NCT03702803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326170|NCT03702803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326171|NCT03702803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93326172|NCT03702803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93326173|NCT03702803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93326174|NCT03702803|GABA Modulators|gaba modulators|mesh-ancestor
93326175|NCT03702803|GABA Agents|gaba agents|mesh-ancestor
93326176|NCT03702803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326177|NCT03702803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326178|NCT03487809|Budesonide|budesonide|mesh-list
93326179|NCT03487809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326180|NCT03487809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93326181|NCT03487809|Autonomic Agents|autonomic agents|mesh-ancestor
92620066|NCT01303341|Protective Agents|protective agents|mesh-ancestor
93326182|NCT03487809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326183|NCT03487809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326184|NCT03487809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93326185|NCT03487809|Respiratory System Agents|respiratory system agents|mesh-ancestor
93326186|NCT03487809|Glucocorticoids|glucocorticoids|mesh-ancestor
93326187|NCT03487809|Hormones|hormones|mesh-ancestor
93326188|NCT03487809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326189|NCT03702647|Ropivacaine|ropivacaine|mesh-list
93326190|NCT03702647|Anesthetics, Local|anesthetics, local|mesh-ancestor
93326191|NCT03702647|Anesthetics|anesthetics|mesh-ancestor
93326192|NCT03702647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326193|NCT03702647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326194|NCT03702647|Sensory System Agents|sensory system agents|mesh-ancestor
93326195|NCT03702647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326196|NCT04583787|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
93326197|NCT04583787|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93326198|NCT04583787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326199|NCT03000673|Heparin|heparin|mesh-list
93326200|NCT03000673|Enoxaparin|enoxaparin|mesh-list
93326201|NCT03000673|Calcium heparin|calcium heparin|mesh-list
93326202|NCT03000673|Anticoagulants|anticoagulants|mesh-ancestor
93326203|NCT03000673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93326204|NCT03000673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93326205|NCT03000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326206|NCT05423249|Ascorbic Acid|ascorbic acid|mesh-list
93326207|NCT05423249|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
93326208|NCT05423249|Antioxidants|antioxidants|mesh-ancestor
93326209|NCT05423249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326210|NCT05423249|Protective Agents|protective agents|mesh-ancestor
93326211|NCT05423249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326212|NCT05423249|Vitamins|vitamins|mesh-ancestor
93326213|NCT05423249|Micronutrients|micronutrients|mesh-ancestor
93326214|NCT05423249|Antidiarrheals|antidiarrheals|mesh-ancestor
93326215|NCT05423249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326216|NCT02912455|Canagliflozin|canagliflozin|mesh-list
93326217|NCT02912455|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93326218|NCT02912455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326219|NCT02912455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93326220|NCT02912455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326221|NCT03702491|Oxaliplatin|oxaliplatin|mesh-list
93326222|NCT03702491|Apatinib|apatinib|mesh-list
93326223|NCT03702491|Tegafur|tegafur|mesh-list
93326224|NCT03702491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326225|NCT03702491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93326226|NCT03702491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326227|NCT03702491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326228|NCT03702491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326229|NCT03702491|Antimetabolites|antimetabolites|mesh-ancestor
93326230|NCT03663751|Decitabine|decitabine|mesh-list
93326231|NCT03663751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326232|NCT03663751|Antimetabolites|antimetabolites|mesh-ancestor
93326233|NCT03663751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326234|NCT03663751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326235|NCT03663751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326236|NCT04054687|Tranexamic Acid|tranexamic acid|mesh-list
93326237|NCT04054687|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93326238|NCT04054687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93326239|NCT04054687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326240|NCT04054687|Hemostatics|hemostatics|mesh-ancestor
93326241|NCT04054687|Coagulants|coagulants|mesh-ancestor
93326242|NCT03492489|Cemiplimab|cemiplimab|mesh-list
93326243|NCT03492489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326244|NCT03492489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326245|NCT02531698|Vaccines|vaccines|mesh-list
93326246|NCT02531698|Immunologic Factors|immunologic factors|mesh-ancestor
93326247|NCT02531698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326248|NCT04308837|Diphenhydramine|diphenhydramine|mesh-list
93326249|NCT04308837|Promethazine|promethazine|mesh-list
93326250|NCT04308837|Dexamethasone|dexamethasone|mesh-list
93326251|NCT04308837|Paclitaxel|paclitaxel|mesh-list
93326252|NCT04308837|Carboplatin|carboplatin|mesh-list
93326253|NCT04308837|Palonosetron|palonosetron|mesh-list
93326254|NCT04308837|Famotidine|famotidine|mesh-list
93326255|NCT04308837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326256|NCT04308837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326257|NCT04308837|Tubulin Modulators|tubulin modulators|mesh-ancestor
93326258|NCT04308837|Antimitotic Agents|antimitotic agents|mesh-ancestor
93326259|NCT04308837|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326260|NCT04308837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326261|NCT04308837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326262|NCT04308837|Antiemetics|antiemetics|mesh-ancestor
93326263|NCT04308837|Autonomic Agents|autonomic agents|mesh-ancestor
93326264|NCT04308837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326265|NCT04308837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326266|NCT04308837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326267|NCT04308837|Glucocorticoids|glucocorticoids|mesh-ancestor
93326268|NCT04308837|Hormones|hormones|mesh-ancestor
93326269|NCT04308837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326270|NCT04308837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93326271|NCT04308837|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93326272|NCT04308837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93326273|NCT04308837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326274|NCT04308837|Anesthetics, Local|anesthetics, local|mesh-ancestor
93326275|NCT04308837|Anesthetics|anesthetics|mesh-ancestor
93326276|NCT04308837|Sensory System Agents|sensory system agents|mesh-ancestor
93326277|NCT04308837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93326278|NCT04308837|Histamine Antagonists|histamine antagonists|mesh-ancestor
93326279|NCT04308837|Histamine Agents|histamine agents|mesh-ancestor
93326280|NCT04308837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326281|NCT04308837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93326282|NCT04308837|Antipruritics|antipruritics|mesh-ancestor
93326283|NCT04308837|Dermatologic Agents|dermatologic agents|mesh-ancestor
93326284|NCT04308837|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93326285|NCT04308837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93326286|NCT04308837|Serotonin Agents|serotonin agents|mesh-ancestor
93326287|NCT04308837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93326288|NCT04308837|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93326289|NCT04692467|Amlodipine|amlodipine|mesh-list
93326290|NCT04692467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93326291|NCT04692467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93326292|NCT04692467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93326293|NCT04692467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326294|NCT04692467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93326295|NCT04692467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326296|NCT04692467|Vasodilator Agents|vasodilator agents|mesh-ancestor
93326297|NCT03664375|Botulinum Toxins|botulinum toxins|mesh-list
93326298|NCT03664375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93326299|NCT03664375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93326300|NCT03664375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93326301|NCT03664375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93326302|NCT03664375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326303|NCT03664375|Cholinergic Agents|cholinergic agents|mesh-ancestor
93326304|NCT03664375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326305|NCT03664375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326306|NCT03664375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93326307|NCT03664375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326308|NCT00403793|Methyltestosterone|methyltestosterone|mesh-list
93326309|NCT00403793|Etonogestrel|etonogestrel|mesh-list
93326310|NCT00403793|Testosterone|testosterone|mesh-list
93326311|NCT00403793|Testosterone undecanoate|testosterone undecanoate|mesh-list
93326312|NCT00403793|Testosterone enanthate|testosterone enanthate|mesh-list
93326313|NCT00403793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93326314|NCT00403793|Androgens|androgens|mesh-ancestor
93326315|NCT00403793|Hormones|hormones|mesh-ancestor
93326316|NCT00403793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326317|NCT00403793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326318|NCT00403793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93326319|NCT00403793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326320|NCT00403793|Anabolic Agents|anabolic agents|mesh-ancestor
93326321|NCT00403793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93326322|NCT00403793|Contraceptive Agents|contraceptive agents|mesh-ancestor
93326323|NCT00403793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93326324|NCT00403793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93326325|NCT05597098|Cantharidin|cantharidin|mesh-list
93326326|NCT05597098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326327|NCT05597098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326328|NCT03034577|Neostigmine|neostigmine|mesh-list
93326329|NCT03034577|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93326330|NCT03034577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326331|NCT03034577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326332|NCT03034577|Cholinergic Agents|cholinergic agents|mesh-ancestor
93326333|NCT03034577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326334|NCT03034577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326335|NCT03034577|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93326336|NCT03034577|Autonomic Agents|autonomic agents|mesh-ancestor
93326337|NCT03034577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326338|NCT04364997|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93326339|NCT04364997|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93326340|NCT04364997|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93326341|NCT04364997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93326342|NCT04364997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93326343|NCT04364997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326344|NCT04364997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326345|NCT04364997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326346|NCT04364997|Analgesics|analgesics|mesh-ancestor
93326347|NCT04364997|Sensory System Agents|sensory system agents|mesh-ancestor
93326348|NCT04364997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326349|NCT04364997|Antidepressive Agents|antidepressive agents|mesh-ancestor
93326350|NCT04364997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93326351|NCT04364997|Dopamine Agents|dopamine agents|mesh-ancestor
93326353|NCT05417386|Fluorouracil|fluorouracil|mesh-list
93326354|NCT05417386|Capecitabine|capecitabine|mesh-list
93326355|NCT05417386|Oxaliplatin|oxaliplatin|mesh-list
93326356|NCT05417386|Irinotecan|irinotecan|mesh-list
93326357|NCT05417386|Camptothecin|camptothecin|mesh-list
93326358|NCT05417386|Folfirinox|folfirinox|mesh-list
93326359|NCT05417386|Levoleucovorin|levoleucovorin|mesh-list
93326360|NCT05417386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326361|NCT05417386|Antimetabolites|antimetabolites|mesh-ancestor
93326362|NCT05417386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326363|NCT05417386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326364|NCT05417386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326365|NCT05417386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93326366|NCT05417386|Immunologic Factors|immunologic factors|mesh-ancestor
93326367|NCT05417386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93326368|NCT05417386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93326369|NCT05417386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326370|NCT05417386|Antidotes|antidotes|mesh-ancestor
93326371|NCT05417386|Protective Agents|protective agents|mesh-ancestor
93326372|NCT05417386|Vitamin B Complex|vitamin b complex|mesh-ancestor
93326373|NCT05417386|Vitamins|vitamins|mesh-ancestor
93326374|NCT05417386|Micronutrients|micronutrients|mesh-ancestor
93326375|NCT05417386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326376|NCT04005729|Cangrelor|cangrelor|mesh-list
93326377|NCT04005729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93326378|NCT04005729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93326379|NCT04005729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93326380|NCT04005729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93326381|NCT04005729|Purinergic Agents|purinergic agents|mesh-ancestor
93326382|NCT04005729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326383|NCT04005729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326384|NCT04005729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326385|NCT03487107|Sofosbuvir|sofosbuvir|mesh-list
93326386|NCT03487107|Yimitasvir|yimitasvir|mesh-list
93326387|NCT03487107|Antiviral Agents|antiviral agents|mesh-ancestor
93326388|NCT03487107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326389|NCT02997163|Talazoparib|talazoparib|mesh-list
93326390|NCT02997163|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93326391|NCT02997163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326392|NCT02997163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326393|NCT02997163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326394|NCT03705065|Bupivacaine|bupivacaine|mesh-list
93326395|NCT03705065|Anesthetics, Local|anesthetics, local|mesh-ancestor
93326396|NCT03705065|Anesthetics|anesthetics|mesh-ancestor
93326397|NCT03705065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326398|NCT03705065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326399|NCT03705065|Sensory System Agents|sensory system agents|mesh-ancestor
93326400|NCT03705065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326401|NCT03702023|Acetaminophen|acetaminophen|mesh-list
93326402|NCT03702023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326403|NCT03702023|Analgesics|analgesics|mesh-ancestor
93326404|NCT03702023|Sensory System Agents|sensory system agents|mesh-ancestor
93326405|NCT03702023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326406|NCT03702023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326407|NCT03702023|Antipyretics|antipyretics|mesh-ancestor
93326408|NCT04259944|Capecitabine|capecitabine|mesh-list
93326409|NCT04259944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326410|NCT04259944|Antimetabolites|antimetabolites|mesh-ancestor
93326411|NCT04259944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326412|NCT04259944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326413|NCT03698513|Aspirin|aspirin|mesh-list
93326414|NCT03698513|Clopidogrel|clopidogrel|mesh-list
93326415|NCT03698513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93326416|NCT03698513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326417|NCT03698513|Analgesics|analgesics|mesh-ancestor
93326418|NCT03698513|Sensory System Agents|sensory system agents|mesh-ancestor
93326419|NCT03698513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326420|NCT03698513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326421|NCT03698513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326422|NCT03698513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326423|NCT03698513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93326424|NCT03698513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93326425|NCT03698513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326426|NCT03698513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93326427|NCT03698513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93326428|NCT03698513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326429|NCT03698513|Antipyretics|antipyretics|mesh-ancestor
93326430|NCT03698513|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93326431|NCT03698513|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93326432|NCT03698513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93326433|NCT03698513|Purinergic Agents|purinergic agents|mesh-ancestor
93326434|NCT03698513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326435|NCT03698435|Valganciclovir|valganciclovir|mesh-list
93326436|NCT03698435|Ganciclovir|ganciclovir|mesh-list
93326437|NCT03698435|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93326438|NCT03698435|Antiviral Agents|antiviral agents|mesh-ancestor
93326439|NCT03698435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326440|NCT03698435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93326441|NCT03698435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326442|NCT03698435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326444|NCT01652092|Cyclophosphamide|cyclophosphamide|mesh-list
93326445|NCT01652092|Melphalan|melphalan|mesh-list
93326446|NCT01652092|Busulfan|busulfan|mesh-list
93326447|NCT01652092|Fludarabine|fludarabine|mesh-list
93326448|NCT01652092|Fludarabine phosphate|fludarabine phosphate|mesh-list
93326449|NCT01652092|Alemtuzumab|alemtuzumab|mesh-list
93326450|NCT01652092|Mesna|mesna|mesh-list
93326451|NCT01652092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93326452|NCT01652092|Immunologic Factors|immunologic factors|mesh-ancestor
93326453|NCT01652092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326454|NCT01652092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326455|NCT01652092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93326456|NCT01652092|Alkylating Agents|alkylating agents|mesh-ancestor
93326457|NCT01652092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326458|NCT01652092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326459|NCT01652092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92620339|NCT02913469|Morphine|morphine|mesh-list
93326460|NCT01652092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326461|NCT01652092|Antimetabolites|antimetabolites|mesh-ancestor
93326462|NCT01652092|Antiviral Agents|antiviral agents|mesh-ancestor
93326463|NCT01652092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326464|NCT01652092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326465|NCT01652092|Protective Agents|protective agents|mesh-ancestor
93326466|NCT04572815|Interleukin-12|interleukin-12|mesh-list
93326467|NCT04572815|Ustekinumab|ustekinumab|mesh-list
93326468|NCT04572815|Immunoglobulins|immunoglobulins|mesh-list
93326469|NCT04572815|Immunoglobulin G|immunoglobulin g|mesh-list
93326470|NCT04572815|Immunologic Factors|immunologic factors|mesh-ancestor
93326471|NCT04572815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326472|NCT04572815|Dermatologic Agents|dermatologic agents|mesh-ancestor
93326473|NCT04572815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93326474|NCT04572815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93326475|NCT04572815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93326476|NCT04572815|Growth Substances|growth substances|mesh-ancestor
93326477|NCT04572815|Growth Inhibitors|growth inhibitors|mesh-ancestor
93326478|NCT04572815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326479|NCT03698045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93326480|NCT03698045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93326481|NCT03697889|Naproxen|naproxen|mesh-list
93326482|NCT03697889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93326483|NCT03697889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326484|NCT03697889|Analgesics|analgesics|mesh-ancestor
93326485|NCT03697889|Sensory System Agents|sensory system agents|mesh-ancestor
93326486|NCT03697889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326487|NCT03697889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326488|NCT03697889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326489|NCT03697889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326490|NCT03697889|Gout Suppressants|gout suppressants|mesh-ancestor
93326491|NCT03697889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93326492|NCT03697889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326493|NCT03697889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326494|NCT03692819|Amoxicillin|amoxicillin|mesh-list
93326495|NCT03692819|Metronidazole|metronidazole|mesh-list
93326496|NCT03692819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93326497|NCT03692819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326498|NCT03692819|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93326499|NCT03692819|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93326500|NCT00458536|Molgramostim|molgramostim|mesh-list
93326501|NCT00458536|Sargramostim|sargramostim|mesh-list
93326502|NCT00458536|Immunologic Factors|immunologic factors|mesh-ancestor
93326503|NCT00458536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326504|NCT00458536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326505|NCT03697811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93326506|NCT03697811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93326507|NCT05577364|Prednisone|prednisone|mesh-list
93326508|NCT05577364|Cyclophosphamide|cyclophosphamide|mesh-list
93326509|NCT05577364|Doxorubicin|doxorubicin|mesh-list
93326510|NCT05577364|Vincristine|vincristine|mesh-list
93326511|NCT05577364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93326512|NCT05577364|Immunologic Factors|immunologic factors|mesh-ancestor
93326513|NCT05577364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326514|NCT05577364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326515|NCT05577364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93326516|NCT05577364|Alkylating Agents|alkylating agents|mesh-ancestor
93326517|NCT05577364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326518|NCT05577364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326519|NCT05577364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93326520|NCT05577364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93326521|NCT05577364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93326522|NCT05577364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93326523|NCT05577364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326524|NCT05577364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326525|NCT05577364|Glucocorticoids|glucocorticoids|mesh-ancestor
93326526|NCT05577364|Hormones|hormones|mesh-ancestor
92620401|NCT00150332|Linezolid|linezolid|mesh-list
93326527|NCT05577364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326528|NCT05577364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93326529|NCT05577364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326530|NCT05577364|Tubulin Modulators|tubulin modulators|mesh-ancestor
93326531|NCT05577364|Antimitotic Agents|antimitotic agents|mesh-ancestor
93326532|NCT05577364|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326533|NCT03697655|Daratumumab|daratumumab|mesh-list
93326534|NCT03697655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326535|NCT03701321|Dexamethasone|dexamethasone|mesh-list
93326536|NCT03701321|Dexamethasone acetate|dexamethasone acetate|mesh-list
93326537|NCT03701321|Bortezomib|bortezomib|mesh-list
93326538|NCT03701321|Venetoclax|venetoclax|mesh-list
93326539|NCT03701321|Daratumumab|daratumumab|mesh-list
93326540|NCT03701321|Ichthammol|ichthammol|mesh-list
93326541|NCT03701321|BB 1101|bb 1101|mesh-list
93326542|NCT03701321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326543|NCT03701321|Antiemetics|antiemetics|mesh-ancestor
93326544|NCT03701321|Autonomic Agents|autonomic agents|mesh-ancestor
93326545|NCT03701321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326546|NCT03701321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326547|NCT03701321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326548|NCT03701321|Glucocorticoids|glucocorticoids|mesh-ancestor
93326549|NCT03701321|Hormones|hormones|mesh-ancestor
93326550|NCT03701321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326551|NCT03701321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93326552|NCT03701321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326553|NCT03701321|Protease Inhibitors|protease inhibitors|mesh-ancestor
93326554|NCT03701321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326555|NCT03701321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326556|NCT03701321|Dermatologic Agents|dermatologic agents|mesh-ancestor
93326557|NCT02526550|Vaccines|vaccines|mesh-list
93326558|NCT02526550|Immunologic Factors|immunologic factors|mesh-ancestor
93326559|NCT02526550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326560|NCT05565352|Ketamine|ketamine|mesh-list
93326561|NCT05565352|Analgesics|analgesics|mesh-ancestor
93326562|NCT05565352|Sensory System Agents|sensory system agents|mesh-ancestor
93326563|NCT05565352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326564|NCT05565352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326565|NCT05565352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93326566|NCT05565352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93326567|NCT05565352|Anesthetics, General|anesthetics, general|mesh-ancestor
93326568|NCT05565352|Anesthetics|anesthetics|mesh-ancestor
93326569|NCT05565352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326570|NCT05565352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93326571|NCT05565352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93326572|NCT05565352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326573|NCT05565352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326574|NCT04423276|Donepezil|donepezil|mesh-list
93326575|NCT04423276|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93326576|NCT04423276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998556|NCT04008186|Verapamil|verapamil|mesh-list
93366442|NCT02796677|Autonomic Agents|autonomic agents|mesh-ancestor
93326577|NCT04423276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326579|NCT04423276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326580|NCT04423276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326581|NCT04423276|Nootropic Agents|nootropic agents|mesh-ancestor
93326582|NCT05564416|Atezolizumab|atezolizumab|mesh-list
93326583|NCT05564416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93326584|NCT05564416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93326585|NCT05564416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326586|NCT05564416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326587|NCT05564416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326588|NCT05564416|Immunologic Factors|immunologic factors|mesh-ancestor
93326589|NCT05564416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326590|NCT03701087|Vitamin D|vitamin d|mesh-list
93326591|NCT03701087|Vitamins|vitamins|mesh-ancestor
93326592|NCT03701087|Micronutrients|micronutrients|mesh-ancestor
93326593|NCT03701087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326594|NCT03701087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93326595|NCT03697265|Pregnanolone|pregnanolone|mesh-list
93326596|NCT03697265|Anesthetics|anesthetics|mesh-ancestor
93326597|NCT03697265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326598|NCT03697265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326599|NCT04523129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93326600|NCT04523129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93326601|NCT04513067|Pembrolizumab|pembrolizumab|mesh-list
93326602|NCT04513067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326603|NCT04513067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326604|NCT04513067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93326605|NCT04513067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326606|NCT04336943|Durvalumab|durvalumab|mesh-list
93326607|NCT04336943|Olaparib|olaparib|mesh-list
93326608|NCT04336943|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93326609|NCT04336943|Immunoglobulins|immunoglobulins|mesh-list
93326610|NCT04336943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93326611|NCT04336943|Immunoglobulin G|immunoglobulin g|mesh-list
93326612|NCT04336943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326613|NCT04336943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326614|NCT04336943|Immunologic Factors|immunologic factors|mesh-ancestor
93326615|NCT04336943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326616|NCT04336943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326617|NCT04336943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326618|NCT03030989|Chlorhexidine|chlorhexidine|mesh-list
93326619|NCT03030989|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93326620|NCT03030989|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93326621|NCT03030989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326622|NCT03030989|Disinfectants|disinfectants|mesh-ancestor
93326623|NCT03030989|Dermatologic Agents|dermatologic agents|mesh-ancestor
93326624|NCT03696641|Lithium Carbonate|lithium carbonate|mesh-list
93326625|NCT03696641|Antidepressive Agents|antidepressive agents|mesh-ancestor
93326626|NCT03696641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93326627|NCT03696641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326628|NCT03696641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326629|NCT03696641|Antimanic Agents|antimanic agents|mesh-ancestor
93326630|NCT03696641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93326631|NCT03696641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326632|NCT03696641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326633|NCT03696329|Tetrabenazine|tetrabenazine|mesh-list
93326634|NCT03696329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93326635|NCT03696329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93326636|NCT03696329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93326637|NCT03696329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326638|NCT03696329|Adrenergic Agents|adrenergic agents|mesh-ancestor
93326639|NCT03696329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326640|NCT03696329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326641|NCT03696095|Ropivacaine|ropivacaine|mesh-list
93326642|NCT03696095|Anesthetics, Local|anesthetics, local|mesh-ancestor
93326643|NCT03696095|Anesthetics|anesthetics|mesh-ancestor
93326644|NCT03696095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326645|NCT03696095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326646|NCT03696095|Sensory System Agents|sensory system agents|mesh-ancestor
93326647|NCT03696095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326648|NCT03700229|Rituximab|rituximab|mesh-list
93326649|NCT03700229|Bortezomib|bortezomib|mesh-list
92998634|NCT00982722|Vitamins|vitamins|mesh-ancestor
93326650|NCT03700229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326651|NCT03700229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326653|NCT03700229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326654|NCT03700229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326655|NCT03695861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93326656|NCT03695861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93326657|NCT03695861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326658|NCT03695705|Rifaximin|rifaximin|mesh-list
93326659|NCT03695705|Norfloxacin|norfloxacin|mesh-list
93326660|NCT03695705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93326661|NCT03695705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326662|NCT03695705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326663|NCT03695705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93326664|NCT03695705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93326665|NCT03695705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326666|NCT03695705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326667|NCT03695705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620537|NCT00171366|Vasodilator Agents|vasodilator agents|mesh-ancestor
93326668|NCT03695705|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93326669|NCT03695705|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93326670|NCT03699839|Vaccines|vaccines|mesh-list
93326671|NCT03699839|Immunologic Factors|immunologic factors|mesh-ancestor
93326672|NCT03699839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326673|NCT04050215|Edetic Acid|edetic acid|mesh-list
93326674|NCT04050215|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93326675|NCT04050215|Chelating Agents|chelating agents|mesh-ancestor
93326676|NCT04050215|Sequestering Agents|sequestering agents|mesh-ancestor
93326677|NCT04050215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326678|NCT04050215|Anticoagulants|anticoagulants|mesh-ancestor
93326679|NCT04050215|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93326680|NCT04050215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93326681|NCT03691649|Timolol|timolol|mesh-list
93326682|NCT03691649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93326683|NCT03691649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93326684|NCT03691649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326685|NCT03691649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93326686|NCT03691649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93326687|NCT03691649|Adrenergic Agents|adrenergic agents|mesh-ancestor
93326688|NCT03691649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326689|NCT03691649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326690|NCT03691649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93326691|NCT03691649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93326692|NCT03699449|Paclitaxel|paclitaxel|mesh-list
93326693|NCT03699449|Durvalumab|durvalumab|mesh-list
93326694|NCT03699449|Olaparib|olaparib|mesh-list
93326695|NCT03699449|Tremelimumab|tremelimumab|mesh-list
93326696|NCT03699449|Cediranib|cediranib|mesh-list
93326697|NCT03699449|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93326698|NCT03699449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326699|NCT03699449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326700|NCT03699449|Tubulin Modulators|tubulin modulators|mesh-ancestor
93326701|NCT03699449|Antimitotic Agents|antimitotic agents|mesh-ancestor
93326702|NCT03699449|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326703|NCT03699449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326704|NCT03699449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326705|NCT03699449|Immunologic Factors|immunologic factors|mesh-ancestor
93326706|NCT03699449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326707|NCT03699449|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93326708|NCT03699449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326709|NCT03699449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93326710|NCT04475939|Pembrolizumab|pembrolizumab|mesh-list
93326711|NCT04475939|Niraparib|niraparib|mesh-list
93326712|NCT04475939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93326713|NCT04475939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326714|NCT04475939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93326715|NCT04475939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326716|NCT04475939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93326717|NCT04475939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326718|NCT03699293|Aspirin|aspirin|mesh-list
93326719|NCT03699293|Celecoxib|celecoxib|mesh-list
93326720|NCT03699293|Naproxen|naproxen|mesh-list
93326721|NCT03699293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93326722|NCT03699293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326723|NCT03699293|Analgesics|analgesics|mesh-ancestor
93326724|NCT03699293|Sensory System Agents|sensory system agents|mesh-ancestor
93326725|NCT03699293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326726|NCT03699293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326727|NCT03699293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326728|NCT03699293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326729|NCT03699293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93326730|NCT03699293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93326731|NCT03699293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326732|NCT03699293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93326733|NCT03699293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93326734|NCT03699293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326735|NCT03699293|Antipyretics|antipyretics|mesh-ancestor
93326736|NCT03699293|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93326737|NCT03699293|Gout Suppressants|gout suppressants|mesh-ancestor
93326738|NCT03029819|Nicotine|nicotine|mesh-list
93326739|NCT03029819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93326740|NCT03029819|Autonomic Agents|autonomic agents|mesh-ancestor
93326741|NCT03029819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326742|NCT03029819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326743|NCT03029819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93326744|NCT03029819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93326745|NCT03029819|Cholinergic Agents|cholinergic agents|mesh-ancestor
93326746|NCT03029819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326747|NCT03029819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326748|NCT03105830|Acetaminophen|acetaminophen|mesh-list
93326749|NCT03105830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326750|NCT03105830|Analgesics|analgesics|mesh-ancestor
93326751|NCT03105830|Sensory System Agents|sensory system agents|mesh-ancestor
93326752|NCT03105830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326753|NCT03105830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326754|NCT03105830|Antipyretics|antipyretics|mesh-ancestor
93326755|NCT03691415|Deoxycholic Acid|deoxycholic acid|mesh-list
93326756|NCT03691415|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93326757|NCT03691415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326758|NCT03699215|Simendan|simendan|mesh-list
93326759|NCT03699215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93326760|NCT03699215|Vasodilator Agents|vasodilator agents|mesh-ancestor
93326761|NCT03699215|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93326762|NCT03699215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93326763|NCT03699215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326764|NCT03699215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326765|NCT03699215|Protective Agents|protective agents|mesh-ancestor
93326766|NCT03699215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326767|NCT03694535|Mitomycins|mitomycins|mesh-list
93326768|NCT03694535|Mitomycin|mitomycin|mesh-list
93326769|NCT03694535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93326770|NCT03694535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326771|NCT03694535|Alkylating Agents|alkylating agents|mesh-ancestor
93326772|NCT03694535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326773|NCT03694535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93326774|NCT03694535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326775|NCT03115034|Melatonin|melatonin|mesh-list
93326776|NCT03115034|Antioxidants|antioxidants|mesh-ancestor
93326777|NCT03115034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326778|NCT03115034|Protective Agents|protective agents|mesh-ancestor
93326779|NCT03115034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326780|NCT03115034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326781|NCT05525546|Vaccines|vaccines|mesh-list
93326782|NCT05525546|Immunologic Factors|immunologic factors|mesh-ancestor
93326783|NCT05525546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326784|NCT03027557|Denosumab|denosumab|mesh-list
93326785|NCT03027557|Cinacalcet|cinacalcet|mesh-list
93326786|NCT03027557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93326787|NCT03027557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326788|NCT03027557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93326789|NCT03027557|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93326790|NCT03027557|Hormone Antagonists|hormone antagonists|mesh-ancestor
93326791|NCT03027557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326792|NCT03698825|Vactosertib|vactosertib|mesh-list
93326793|NCT03698825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93326794|NCT03698825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326795|NCT03698825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326796|NCT02691572|Acetaminophen|acetaminophen|mesh-list
93326797|NCT02691572|Ketorolac|ketorolac|mesh-list
93326798|NCT02691572|Fentanyl|fentanyl|mesh-list
92998787|NCT01037608|Nabiximols|nabiximols|mesh-list
93326799|NCT02691572|Bupivacaine|bupivacaine|mesh-list
93326800|NCT02691572|Anesthetics, Local|anesthetics, local|mesh-ancestor
93326801|NCT02691572|Anesthetics|anesthetics|mesh-ancestor
93326802|NCT02691572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326803|NCT02691572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326804|NCT02691572|Sensory System Agents|sensory system agents|mesh-ancestor
93326805|NCT02691572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326806|NCT02691572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93326807|NCT02691572|Narcotics|narcotics|mesh-ancestor
93326808|NCT02691572|Analgesics|analgesics|mesh-ancestor
93326809|NCT02691572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93326810|NCT02691572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93326811|NCT02691572|Anesthetics, General|anesthetics, general|mesh-ancestor
93326812|NCT02691572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93326813|NCT02691572|Antipyretics|antipyretics|mesh-ancestor
92620675|NCT04723836|Vitamins|vitamins|mesh-ancestor
93326814|NCT02691572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93326815|NCT02691572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326816|NCT02691572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326817|NCT02691572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93326818|NCT02691572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326819|NCT02691572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326820|NCT05320172|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93326821|NCT05320172|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93326822|NCT03693833|Cannabidiol|cannabidiol|mesh-list
93326823|NCT03693833|Anticonvulsants|anticonvulsants|mesh-ancestor
93326824|NCT03693599|Carbetocin|carbetocin|mesh-list
93326825|NCT03693599|Syntometrine|syntometrine|mesh-list
93326826|NCT03693599|Oxytocics|oxytocics|mesh-ancestor
93326827|NCT03693599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93326828|NCT03693599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326829|NCT04277663|Interferons|interferons|mesh-list
93326830|NCT04277663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326831|NCT04277663|Antiviral Agents|antiviral agents|mesh-ancestor
93326832|NCT04277663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326833|NCT04270643|Vitamin D|vitamin d|mesh-list
93326834|NCT04270643|Cholecalciferol|cholecalciferol|mesh-list
93326835|NCT04270643|Vitamins|vitamins|mesh-ancestor
93326836|NCT04270643|Micronutrients|micronutrients|mesh-ancestor
93326837|NCT04270643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326838|NCT04270643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93326839|NCT04270643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93326840|NCT03693131|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93326841|NCT03693131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93326842|NCT03693131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93326843|NCT02677844|Loperamide|loperamide|mesh-list
93326844|NCT02677844|Antidiarrheals|antidiarrheals|mesh-list
93326845|NCT02677844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93326846|NCT03687905|Hydroxychloroquine|hydroxychloroquine|mesh-list
93326847|NCT03687905|Chloroquine|chloroquine|mesh-list
93326848|NCT03687905|Antimalarials|antimalarials|mesh-ancestor
93326849|NCT03687905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93326850|NCT03687905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93326851|NCT03687905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326852|NCT03687905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326853|NCT03687905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326854|NCT03687905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326855|NCT03687905|Amebicides|amebicides|mesh-ancestor
93326856|NCT03687515|Prednisone|prednisone|mesh-list
93326857|NCT03687515|Budesonide|budesonide|mesh-list
93326858|NCT03687515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93326859|NCT03687515|Glucocorticoids|glucocorticoids|mesh-ancestor
93326860|NCT03687515|Hormones|hormones|mesh-ancestor
93326861|NCT03687515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326862|NCT03687515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326863|NCT03687515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93326864|NCT03687515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326865|NCT03687515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93326866|NCT03687515|Autonomic Agents|autonomic agents|mesh-ancestor
93326867|NCT03687515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326868|NCT03687515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93326869|NCT03687515|Respiratory System Agents|respiratory system agents|mesh-ancestor
93326870|NCT02691494|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93326871|NCT02691494|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93326872|NCT02691494|Norethindrone|norethindrone|mesh-list
93326873|NCT02691494|Norethindrone Acetate|norethindrone acetate|mesh-list
93326874|NCT02691494|Estradiol|estradiol|mesh-list
93326875|NCT02691494|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93326876|NCT02691494|Estrogens|estrogens|mesh-ancestor
93326877|NCT02691494|Hormones|hormones|mesh-ancestor
93326878|NCT02691494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93326879|NCT02691494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326880|NCT02691494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93326881|NCT02691494|Contraceptive Agents|contraceptive agents|mesh-ancestor
93326882|NCT02691494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93326883|NCT02691494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93326884|NCT02691494|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93326885|NCT02691494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93326886|NCT02691494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93326887|NCT02682602|Tacrine|tacrine|mesh-list
93326888|NCT02682602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93326889|NCT02682602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326890|NCT02682602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326891|NCT02682602|Cholinergic Agents|cholinergic agents|mesh-ancestor
93326892|NCT02682602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326893|NCT02682602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326894|NCT02682602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93326895|NCT02682602|Autonomic Agents|autonomic agents|mesh-ancestor
93326896|NCT02682602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326897|NCT02682602|Nootropic Agents|nootropic agents|mesh-ancestor
93326898|NCT03691337|Bupivacaine|bupivacaine|mesh-list
93326899|NCT03691337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93326900|NCT03691337|Anesthetics, Local|anesthetics, local|mesh-ancestor
93326901|NCT03691337|Anesthetics|anesthetics|mesh-ancestor
93326902|NCT03691337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326903|NCT03691337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326904|NCT03691337|Sensory System Agents|sensory system agents|mesh-ancestor
93326905|NCT03691337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326906|NCT02681510|Nicotine|nicotine|mesh-list
93326907|NCT02681510|Varenicline|varenicline|mesh-list
93326908|NCT02681510|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93326909|NCT02681510|Autonomic Agents|autonomic agents|mesh-ancestor
93326910|NCT02681510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326911|NCT02681510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326912|NCT02681510|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93326913|NCT02681510|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93326914|NCT02681510|Cholinergic Agents|cholinergic agents|mesh-ancestor
93326915|NCT02681510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326916|NCT02681510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326917|NCT03690323|Paclitaxel|paclitaxel|mesh-list
93326918|NCT03690323|Gemcitabine|gemcitabine|mesh-list
93326919|NCT03690323|Folfirinox|folfirinox|mesh-list
93326920|NCT03690323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93326921|NCT03690323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326922|NCT03690323|Tubulin Modulators|tubulin modulators|mesh-ancestor
93326923|NCT03690323|Antimitotic Agents|antimitotic agents|mesh-ancestor
93326924|NCT03690323|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326925|NCT03690323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326926|NCT03690323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93326927|NCT03690323|Antimetabolites|antimetabolites|mesh-ancestor
93326928|NCT03682211|Fentanyl|fentanyl|mesh-list
93326929|NCT03682211|Morphine|morphine|mesh-list
93326930|NCT03682211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93326931|NCT03682211|Narcotics|narcotics|mesh-ancestor
93326932|NCT03682211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326933|NCT03682211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326934|NCT03682211|Analgesics|analgesics|mesh-ancestor
93326935|NCT03682211|Sensory System Agents|sensory system agents|mesh-ancestor
93326936|NCT03682211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93326937|NCT03682211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93326938|NCT03682211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93326939|NCT03682211|Anesthetics, General|anesthetics, general|mesh-ancestor
93326940|NCT03682211|Anesthetics|anesthetics|mesh-ancestor
93326941|NCT04132505|Hydroxychloroquine|hydroxychloroquine|mesh-list
93326942|NCT04132505|Antimalarials|antimalarials|mesh-ancestor
93326943|NCT04132505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93326944|NCT04132505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93326945|NCT04132505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93326946|NCT04132505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326947|NCT04132505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326948|NCT04132505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326949|NCT02690714|Plasminogen|plasminogen|mesh-list
93326950|NCT02690714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92998937|NCT00987636|Zoledronic Acid|zoledronic acid|mesh-list
93326951|NCT02690714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93326952|NCT02690714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326953|NCT03690167|Mitogens|mitogens|mesh-list
93326954|NCT03690167|Mitosis Modulators|mitosis modulators|mesh-ancestor
93326955|NCT03690167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326956|NCT03165890|Acetazolamide|acetazolamide|mesh-list
93326957|NCT03165890|Anticonvulsants|anticonvulsants|mesh-ancestor
93326958|NCT03165890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93326959|NCT03165890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326960|NCT03165890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326961|NCT03165890|Diuretics|diuretics|mesh-ancestor
93326962|NCT03165890|Natriuretic Agents|natriuretic agents|mesh-ancestor
93326963|NCT03165890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326964|NCT03681509|Pramipexole|pramipexole|mesh-list
93326965|NCT03681509|Antioxidants|antioxidants|mesh-ancestor
93326966|NCT03681509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326967|NCT03681509|Protective Agents|protective agents|mesh-ancestor
93326968|NCT03681509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326969|NCT03681509|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93326970|NCT03681509|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93326971|NCT03681509|Dopamine Agonists|dopamine agonists|mesh-ancestor
93326972|NCT03681509|Dopamine Agents|dopamine agents|mesh-ancestor
93326973|NCT03681509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93326974|NCT03686267|Lithium Carbonate|lithium carbonate|mesh-list
93326975|NCT03686267|Antidepressive Agents|antidepressive agents|mesh-ancestor
93326976|NCT03686267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93326977|NCT03686267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93326978|NCT03686267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326979|NCT03686267|Antimanic Agents|antimanic agents|mesh-ancestor
93326980|NCT03686267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93326981|NCT03686267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326982|NCT03686267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326983|NCT03161210|Anesthetics|anesthetics|mesh-list
93326984|NCT03161210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93326985|NCT03161210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326986|NCT01898793|Aldesleukin|aldesleukin|mesh-list
93326987|NCT01898793|Cyclophosphamide|cyclophosphamide|mesh-list
93326988|NCT01898793|Fludarabine|fludarabine|mesh-list
93326989|NCT01898793|Fludarabine phosphate|fludarabine phosphate|mesh-list
93326990|NCT01898793|Interleukin-2|interleukin-2|mesh-list
93326991|NCT01898793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93326992|NCT01898793|Immunologic Factors|immunologic factors|mesh-ancestor
93326993|NCT01898793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93326994|NCT01898793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93326995|NCT01898793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93326996|NCT01898793|Alkylating Agents|alkylating agents|mesh-ancestor
93326997|NCT01898793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93326998|NCT01898793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93326999|NCT01898793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93327000|NCT01898793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93327001|NCT01898793|Antimetabolites|antimetabolites|mesh-ancestor
93327002|NCT01898793|Antiviral Agents|antiviral agents|mesh-ancestor
93327003|NCT01898793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327004|NCT01898793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327005|NCT01898793|Analgesics|analgesics|mesh-ancestor
93327006|NCT01898793|Sensory System Agents|sensory system agents|mesh-ancestor
93327007|NCT01898793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327008|NCT01898793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93327009|NCT01898793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93327010|NCT03164096|Bupivacaine|bupivacaine|mesh-list
93327011|NCT03164096|Anesthetics, Local|anesthetics, local|mesh-ancestor
93327012|NCT03164096|Anesthetics|anesthetics|mesh-ancestor
93327013|NCT03164096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327014|NCT03164096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327015|NCT03164096|Sensory System Agents|sensory system agents|mesh-ancestor
93327016|NCT03164096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327017|NCT03164018|4-Aminopyridine|4-aminopyridine|mesh-list
93327018|NCT03164018|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93327019|NCT03164018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620890|NCT00171678|Analgesics|analgesics|mesh-ancestor
93327020|NCT03164018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327021|NCT03163784|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93327022|NCT03163784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93327023|NCT03163784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327024|NCT03163784|Antitubercular Agents|antitubercular agents|mesh-ancestor
93327025|NCT03681431|Ceftriaxone|ceftriaxone|mesh-list
93327026|NCT03681431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327027|NCT03681431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327028|NCT03681197|Metformin|metformin|mesh-list
93327029|NCT03681197|Clomiphene|clomiphene|mesh-list
93327030|NCT03681197|Enclomiphene|enclomiphene|mesh-list
93327031|NCT03681197|Zuclomiphene|zuclomiphene|mesh-list
93327032|NCT03681197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93327033|NCT03681197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327034|NCT03681197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93327035|NCT03681197|Hormone Antagonists|hormone antagonists|mesh-ancestor
93327036|NCT03681197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327037|NCT03681197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93327038|NCT03681197|Fertility Agents|fertility agents|mesh-ancestor
93327039|NCT03681197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93327040|NCT03681197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93327041|NCT03681197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93327042|NCT03485703|Azithromycin|azithromycin|mesh-list
93327043|NCT03485703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327044|NCT03485703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327045|NCT03165344|Prednisone|prednisone|mesh-list
93327046|NCT03165344|Triamcinolone|triamcinolone|mesh-list
93327047|NCT03165344|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93327048|NCT03165344|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93327049|NCT03165344|Hydrocortisone|hydrocortisone|mesh-list
93327050|NCT03165344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93327051|NCT03165344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93327052|NCT03165344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93327053|NCT03165344|Aluminum phosphate|aluminum phosphate|mesh-list
93327054|NCT03165344|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93327055|NCT03165344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327056|NCT03165344|Glucocorticoids|glucocorticoids|mesh-ancestor
93327057|NCT03165344|Hormones|hormones|mesh-ancestor
93327058|NCT03165344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327059|NCT03165344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327060|NCT03165344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93327061|NCT03165344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327062|NCT03165344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327063|NCT03165344|Immunologic Factors|immunologic factors|mesh-ancestor
93327064|NCT03165344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327065|NCT03165344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327066|NCT03165344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93327067|NCT03165344|Antacids|antacids|mesh-ancestor
93327068|NCT03165344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327069|NCT03487029|Oxymetazoline|oxymetazoline|mesh-list
93327070|NCT03487029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327071|NCT03487029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327072|NCT03487029|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327073|NCT03487029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327074|NCT03487029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327075|NCT03487029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327076|NCT03487029|Sympathomimetics|sympathomimetics|mesh-ancestor
93327077|NCT03487029|Autonomic Agents|autonomic agents|mesh-ancestor
93327078|NCT03487029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327079|NCT03487029|Nasal Decongestants|nasal decongestants|mesh-ancestor
93327080|NCT03487029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93327081|NCT03487029|Respiratory System Agents|respiratory system agents|mesh-ancestor
93327082|NCT03689465|Cyclosporine|cyclosporine|mesh-list
93327083|NCT03689465|Mycophenolic Acid|mycophenolic acid|mesh-list
93327084|NCT03689465|Methotrexate|methotrexate|mesh-list
93327085|NCT03689465|Cyclosporins|cyclosporins|mesh-list
93327086|NCT03689465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93327087|NCT03689465|Abortifacient Agents|abortifacient agents|mesh-ancestor
93327088|NCT03689465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93327089|NCT03689465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327090|NCT03689465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93327091|NCT03689465|Antimetabolites|antimetabolites|mesh-ancestor
93327092|NCT03689465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327093|NCT03689465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327094|NCT03689465|Dermatologic Agents|dermatologic agents|mesh-ancestor
93327095|NCT03689465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327096|NCT03689465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93327097|NCT03689465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327098|NCT03689465|Immunologic Factors|immunologic factors|mesh-ancestor
93327099|NCT03689465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327100|NCT03689465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93327101|NCT03689465|Antifungal Agents|antifungal agents|mesh-ancestor
93327102|NCT03689465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327103|NCT03689465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92999080|NCT04005612|Vitamin D|vitamin d|mesh-list
93327104|NCT03689465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93327105|NCT03689465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93327106|NCT03689465|Antitubercular Agents|antitubercular agents|mesh-ancestor
93327107|NCT03689465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327108|NCT03485625|Acetaminophen|acetaminophen|mesh-list
93327109|NCT03485625|Ketorolac|ketorolac|mesh-list
93327110|NCT03485625|Lidocaine|lidocaine|mesh-list
93327111|NCT03485625|Anesthetics, Local|anesthetics, local|mesh-ancestor
93327112|NCT03485625|Anesthetics|anesthetics|mesh-ancestor
93327113|NCT03485625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327114|NCT03485625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327115|NCT03485625|Sensory System Agents|sensory system agents|mesh-ancestor
93327116|NCT03485625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327117|NCT03485625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93327118|NCT03485625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93327119|NCT03485625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93327120|NCT03485625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327121|NCT03485625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327122|NCT03485625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327123|NCT03485625|Analgesics|analgesics|mesh-ancestor
93327124|NCT03485625|Antipyretics|antipyretics|mesh-ancestor
93327125|NCT03485625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93327126|NCT03485625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327127|NCT03485625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327128|NCT03485625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93327129|NCT03485625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327130|NCT03680885|Lidocaine|lidocaine|mesh-list
93327131|NCT03680885|Anesthetics, Local|anesthetics, local|mesh-ancestor
93327132|NCT03680885|Anesthetics|anesthetics|mesh-ancestor
93327133|NCT03680885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327134|NCT03680885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327135|NCT03680885|Sensory System Agents|sensory system agents|mesh-ancestor
93327136|NCT03680885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327137|NCT03680885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93327138|NCT03680885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93327139|NCT03680885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93327140|NCT03680885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327141|NCT03680885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327142|NCT03033069|Sertraline|sertraline|mesh-list
93327143|NCT03033069|Brexpiprazole|brexpiprazole|mesh-list
93327144|NCT03033069|Antidepressive Agents|antidepressive agents|mesh-ancestor
93327145|NCT03033069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93327146|NCT03033069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93327147|NCT03033069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93327148|NCT03033069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327149|NCT03033069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327150|NCT03033069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327151|NCT03033069|Serotonin Agents|serotonin agents|mesh-ancestor
93327152|NCT03033069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327153|NCT03033069|Dopamine Agonists|dopamine agonists|mesh-ancestor
93327154|NCT03033069|Dopamine Agents|dopamine agents|mesh-ancestor
93327155|NCT03685409|Metformin|metformin|mesh-list
93327156|NCT03685409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93327157|NCT03685409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327158|NCT03165500|Midazolam|midazolam|mesh-list
93327159|NCT03165500|Diazepam|diazepam|mesh-list
93327160|NCT03165500|Nitrous Oxide|nitrous oxide|mesh-list
93327161|NCT03165500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93327162|NCT03165500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93327163|NCT03165500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327164|NCT03165500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327165|NCT03165500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93327166|NCT03165500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93327167|NCT03165500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93327168|NCT03165500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93327169|NCT03165500|Anesthetics, General|anesthetics, general|mesh-ancestor
93327170|NCT03165500|Anesthetics|anesthetics|mesh-ancestor
93327171|NCT03165500|GABA Modulators|gaba modulators|mesh-ancestor
93327172|NCT03165500|GABA Agents|gaba agents|mesh-ancestor
93327173|NCT03165500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327174|NCT03165500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327175|NCT03165500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93327176|NCT03165500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327177|NCT03165500|Analgesics|analgesics|mesh-ancestor
93327178|NCT03165500|Sensory System Agents|sensory system agents|mesh-ancestor
93327179|NCT03165500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327180|NCT03165500|Anticonvulsants|anticonvulsants|mesh-ancestor
93327181|NCT03165500|Antiemetics|antiemetics|mesh-ancestor
93327182|NCT03165500|Autonomic Agents|autonomic agents|mesh-ancestor
93327183|NCT03165500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327184|NCT03165500|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93327185|NCT03165500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93327186|NCT03163238|Dexmedetomidine|dexmedetomidine|mesh-list
93327187|NCT03163238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93327188|NCT03163238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327189|NCT03163238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327190|NCT03163238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327191|NCT03163238|Analgesics|analgesics|mesh-ancestor
93327192|NCT03163238|Sensory System Agents|sensory system agents|mesh-ancestor
93327193|NCT03163238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327194|NCT03163238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93327195|NCT03163238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327196|NCT03163238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327197|NCT03163238|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327198|NCT03163238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327199|NCT03163238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327200|NCT03486561|Ranolazine|ranolazine|mesh-list
93327201|NCT03486561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93327202|NCT03486561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327203|NCT03486561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327204|NCT03680573|Allopurinol|allopurinol|mesh-list
93327205|NCT03680573|Nitroprusside|nitroprusside|mesh-list
93327206|NCT03680573|Nitroarginine|nitroarginine|mesh-list
93327207|NCT03680573|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
93327208|NCT03680573|Antimetabolites|antimetabolites|mesh-ancestor
93327209|NCT03680573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327210|NCT03680573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327211|NCT03680573|Gout Suppressants|gout suppressants|mesh-ancestor
93327212|NCT03680573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327213|NCT03680573|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93327214|NCT03680573|Antioxidants|antioxidants|mesh-ancestor
93327215|NCT03680573|Protective Agents|protective agents|mesh-ancestor
93327216|NCT03680573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327217|NCT03680573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93327218|NCT03680573|Vasodilator Agents|vasodilator agents|mesh-ancestor
93327219|NCT03680573|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93327220|NCT03689075|Tacrolimus|tacrolimus|mesh-list
93327221|NCT03689075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327222|NCT03689075|Immunologic Factors|immunologic factors|mesh-ancestor
93327223|NCT03689075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327224|NCT03689075|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93327225|NCT03689075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327226|NCT03689075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327227|NCT03680495|Methylprednisolone|methylprednisolone|mesh-list
93327228|NCT03680495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93327229|NCT03680495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93327230|NCT03680495|Prednisolone|prednisolone|mesh-list
93327231|NCT03680495|Prednisolone acetate|prednisolone acetate|mesh-list
93327232|NCT03680495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93327233|NCT03680495|Prednisolone phosphate|prednisolone phosphate|mesh-list
93327234|NCT03680495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327235|NCT03680495|Antiemetics|antiemetics|mesh-ancestor
93327236|NCT03680495|Autonomic Agents|autonomic agents|mesh-ancestor
93327237|NCT03680495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327238|NCT03680495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327239|NCT03680495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327240|NCT03680495|Glucocorticoids|glucocorticoids|mesh-ancestor
93327241|NCT03680495|Hormones|hormones|mesh-ancestor
93327242|NCT03680495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327243|NCT03680495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93327244|NCT03680495|Protective Agents|protective agents|mesh-ancestor
93327245|NCT03680495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93327246|NCT03680495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327247|NCT03492255|Mycophenolic Acid|mycophenolic acid|mesh-list
93327248|NCT03492255|Prednisone|prednisone|mesh-list
93327249|NCT03492255|Methylprednisolone|methylprednisolone|mesh-list
93327250|NCT03492255|Cyclophosphamide|cyclophosphamide|mesh-list
93327251|NCT03492255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327252|NCT03492255|Immunologic Factors|immunologic factors|mesh-ancestor
93327253|NCT03492255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327254|NCT03492255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327255|NCT03492255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93327256|NCT03492255|Alkylating Agents|alkylating agents|mesh-ancestor
93327257|NCT03492255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327258|NCT03492255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327259|NCT03492255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93327260|NCT03492255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327261|NCT03492255|Glucocorticoids|glucocorticoids|mesh-ancestor
93327263|NCT03492255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327264|NCT03492255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93327265|NCT03492255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93327266|NCT03492255|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93327267|NCT03492255|Antitubercular Agents|antitubercular agents|mesh-ancestor
93327268|NCT03492255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327269|NCT03492255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327270|NCT03492255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327271|NCT03492255|Antiemetics|antiemetics|mesh-ancestor
93327272|NCT03492255|Autonomic Agents|autonomic agents|mesh-ancestor
93327273|NCT03492255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327274|NCT03492255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327275|NCT03492255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93327276|NCT03492255|Protective Agents|protective agents|mesh-ancestor
93327277|NCT03684863|Capecitabine|capecitabine|mesh-list
93327278|NCT03684863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93327279|NCT03684863|Antimetabolites|antimetabolites|mesh-ancestor
93327280|NCT03684863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327281|NCT03684863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327282|NCT03680339|Misoprostol|misoprostol|mesh-list
93327283|NCT03680339|Oxytocin|oxytocin|mesh-list
93327284|NCT03680339|Oxytocics|oxytocics|mesh-ancestor
93327285|NCT03680339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93327286|NCT03680339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327287|NCT03680339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93327288|NCT03680339|Abortifacient Agents|abortifacient agents|mesh-ancestor
93327289|NCT03680339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93327290|NCT03680339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327291|NCT03680183|Entecavir|entecavir|mesh-list
93327292|NCT03680183|Antiviral Agents|antiviral agents|mesh-ancestor
93327293|NCT03680183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327294|NCT02136069|Infliximab|infliximab|mesh-list
93327295|NCT02136069|Etrolizumab|etrolizumab|mesh-list
93327296|NCT02136069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93327297|NCT02136069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327298|NCT02136069|Dermatologic Agents|dermatologic agents|mesh-ancestor
93327299|NCT02136069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327300|NCT02136069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327301|NCT02136069|Immunologic Factors|immunologic factors|mesh-ancestor
93327302|NCT02136069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327303|NCT02917031|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93327304|NCT02917031|Saxagliptin|saxagliptin|mesh-list
93327305|NCT02917031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93327306|NCT02917031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327307|NCT02917031|Incretins|incretins|mesh-ancestor
93327308|NCT02917031|Hormones|hormones|mesh-ancestor
93327309|NCT02917031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327310|NCT02917031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93327311|NCT02917031|Protease Inhibitors|protease inhibitors|mesh-ancestor
93327312|NCT02917031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327313|NCT02917031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327314|NCT04460547|Interferons|interferons|mesh-list
93327315|NCT04460547|Interferon-beta|interferon-beta|mesh-list
93327316|NCT04460547|Interferon beta-1a|interferon beta-1a|mesh-list
93327317|NCT04460547|Hydroxychloroquine|hydroxychloroquine|mesh-list
93327318|NCT04460547|Ivermectin|ivermectin|mesh-list
93327319|NCT04460547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327320|NCT04460547|Antiviral Agents|antiviral agents|mesh-ancestor
93327321|NCT04460547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327322|NCT04460547|Antimalarials|antimalarials|mesh-ancestor
93327323|NCT04460547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93327324|NCT04460547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93327325|NCT04460547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327326|NCT04460547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327327|NCT04460547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327328|NCT04460547|Immunologic Factors|immunologic factors|mesh-ancestor
93327329|NCT04460547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327330|NCT04460547|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93327331|NCT03132051|Triamcinolone|triamcinolone|mesh-list
93327332|NCT03132051|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93327333|NCT03132051|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93327334|NCT03132051|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93327335|NCT03132051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327336|NCT03132051|Glucocorticoids|glucocorticoids|mesh-ancestor
93327338|NCT03132051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327339|NCT03132051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327340|NCT03132051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327341|NCT03132051|Immunologic Factors|immunologic factors|mesh-ancestor
93327342|NCT03132051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327343|NCT03132051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327344|NCT03684707|Metformin|metformin|mesh-list
93327345|NCT03684707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93327346|NCT03684707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327347|NCT01018563|Farletuzumab|farletuzumab|mesh-list
93327348|NCT01018563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327349|NCT02528188|Tanezumab|tanezumab|mesh-list
93327350|NCT02528188|Analgesics|analgesics|mesh-ancestor
93327351|NCT02528188|Sensory System Agents|sensory system agents|mesh-ancestor
93327352|NCT02528188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327353|NCT02528188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327354|NCT03684395|Warfarin|warfarin|mesh-list
93327355|NCT03684395|Rivaroxaban|rivaroxaban|mesh-list
93327356|NCT03684395|Dabigatran|dabigatran|mesh-list
93327357|NCT03684395|Apixaban|apixaban|mesh-list
93327358|NCT03684395|Anticoagulants|anticoagulants|mesh-ancestor
93327359|NCT03684395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93327360|NCT03684395|Antithrombins|antithrombins|mesh-ancestor
93327361|NCT03684395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93327362|NCT03684395|Protease Inhibitors|protease inhibitors|mesh-ancestor
93327363|NCT03684395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327364|NCT03684395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327365|NCT04460001|Triamcinolone|triamcinolone|mesh-list
93327366|NCT04460001|Ranibizumab|ranibizumab|mesh-list
93327367|NCT04460001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93327368|NCT04460001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93327369|NCT04460001|Growth Substances|growth substances|mesh-ancestor
93327370|NCT04460001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327371|NCT04460001|Growth Inhibitors|growth inhibitors|mesh-ancestor
93327372|NCT04460001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327373|NCT04460001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327374|NCT04460001|Glucocorticoids|glucocorticoids|mesh-ancestor
93327375|NCT04460001|Hormones|hormones|mesh-ancestor
93327376|NCT04460001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327377|NCT03484845|Ferrous fumarate|ferrous fumarate|mesh-list
93327378|NCT03484845|Lactoferrin|lactoferrin|mesh-list
93327379|NCT03484845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327380|NCT03484845|Trace Elements|trace elements|mesh-ancestor
93327381|NCT03484845|Micronutrients|micronutrients|mesh-ancestor
93327382|NCT03484845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327383|NCT03679481|Tranexamic Acid|tranexamic acid|mesh-list
93327384|NCT03679481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93327385|NCT03679481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93327386|NCT03679481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327387|NCT03679481|Hemostatics|hemostatics|mesh-ancestor
93327388|NCT03679481|Coagulants|coagulants|mesh-ancestor
93327389|NCT04461249|Travoprost|travoprost|mesh-list
93327390|NCT04461249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93327391|NCT04461249|Latanoprost|latanoprost|mesh-list
93327392|NCT04461249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93327393|NCT04461249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93327394|NCT05151549|Carboplatin|carboplatin|mesh-list
93327395|NCT05151549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327396|NCT05151393|Vitamin D|vitamin d|mesh-list
93327397|NCT05151393|Cholecalciferol|cholecalciferol|mesh-list
93327398|NCT05151393|Vitamins|vitamins|mesh-ancestor
93327399|NCT05151393|Micronutrients|micronutrients|mesh-ancestor
93327400|NCT05151393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327401|NCT05151393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93327402|NCT05151393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93327403|NCT03484611|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93327404|NCT03484611|Cetrorelix|cetrorelix|mesh-list
93327405|NCT03484611|Menotropins|menotropins|mesh-list
93327406|NCT03484611|Progesterone|progesterone|mesh-list
93327407|NCT03484611|Progestins|progestins|mesh-ancestor
93327408|NCT03484611|Hormones|hormones|mesh-ancestor
93327409|NCT03484611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327410|NCT03484611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327411|NCT03484611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93327412|NCT03484611|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93327413|NCT03484611|Fertility Agents|fertility agents|mesh-ancestor
93327414|NCT03484611|Hormone Antagonists|hormone antagonists|mesh-ancestor
93327415|NCT03679325|Vitamin D|vitamin d|mesh-list
93327416|NCT03679325|Vitamins|vitamins|mesh-ancestor
93327417|NCT03679325|Micronutrients|micronutrients|mesh-ancestor
93327418|NCT03679325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327419|NCT03679325|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93327420|NCT03878927|Gemtuzumab|gemtuzumab|mesh-list
93327421|NCT03878927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93327422|NCT03878927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327423|NCT03878927|Immunotoxins|immunotoxins|mesh-ancestor
93327424|NCT03878927|Immunoconjugates|immunoconjugates|mesh-ancestor
93327425|NCT03878927|Immunologic Factors|immunologic factors|mesh-ancestor
93327426|NCT03878927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327427|NCT03623555|Hydrocortisone|hydrocortisone|mesh-list
93327428|NCT03623555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327429|NCT03623711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93327430|NCT03623711|Bupropion|bupropion|mesh-list
93327431|NCT03623711|Escitalopram|escitalopram|mesh-list
93327432|NCT03623711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93327433|NCT03623711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93327434|NCT03623711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327435|NCT03623711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327436|NCT03623711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327437|NCT03623711|Serotonin Agents|serotonin agents|mesh-ancestor
93327438|NCT03623711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327439|NCT03623711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327440|NCT03623711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93327441|NCT03623711|Antidepressive Agents|antidepressive agents|mesh-ancestor
93327442|NCT03623711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93327443|NCT03623711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93327444|NCT03623711|Dopamine Agents|dopamine agents|mesh-ancestor
93327445|NCT03623711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93327446|NCT03623711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93327447|NCT03623711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327448|NCT03623711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93327449|NCT03623711|Analgesics|analgesics|mesh-ancestor
93327450|NCT03623711|Sensory System Agents|sensory system agents|mesh-ancestor
93327451|NCT05368090|Epinephrine|epinephrine|mesh-list
93327452|NCT05368090|Racepinephrine|racepinephrine|mesh-list
93327453|NCT05368090|Epinephryl borate|epinephryl borate|mesh-list
93327454|NCT05368090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327455|NCT05368090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327456|NCT05368090|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327457|NCT05368090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327458|NCT05368090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327459|NCT05368090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327460|NCT05368090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93327461|NCT05368090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93327462|NCT05368090|Autonomic Agents|autonomic agents|mesh-ancestor
93327463|NCT05368090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327464|NCT05368090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93327465|NCT05368090|Respiratory System Agents|respiratory system agents|mesh-ancestor
93327466|NCT05368090|Mydriatics|mydriatics|mesh-ancestor
93327467|NCT05368090|Sympathomimetics|sympathomimetics|mesh-ancestor
93327468|NCT05368090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93327469|NCT05382442|Leucovorin|leucovorin|mesh-list
93327470|NCT05382442|Bevacizumab|bevacizumab|mesh-list
93327471|NCT05382442|Fluorouracil|fluorouracil|mesh-list
93327472|NCT05382442|Capecitabine|capecitabine|mesh-list
93327473|NCT05382442|Oxaliplatin|oxaliplatin|mesh-list
93327474|NCT05382442|Irinotecan|irinotecan|mesh-list
93327475|NCT05382442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93327476|NCT05382442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327477|NCT05382442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93327478|NCT05382442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93327479|NCT05382442|Growth Substances|growth substances|mesh-ancestor
93327480|NCT05382442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327481|NCT05382442|Growth Inhibitors|growth inhibitors|mesh-ancestor
93327482|NCT05382442|Antimetabolites|antimetabolites|mesh-ancestor
93327483|NCT05382442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327484|NCT05382442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93327485|NCT05382442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327486|NCT05382442|Immunologic Factors|immunologic factors|mesh-ancestor
93327487|NCT05382442|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93327488|NCT05382442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93327489|NCT05382442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327490|NCT05382442|Antidotes|antidotes|mesh-ancestor
93327491|NCT05382442|Protective Agents|protective agents|mesh-ancestor
93327492|NCT05382442|Vitamin B Complex|vitamin b complex|mesh-ancestor
93327493|NCT05382442|Vitamins|vitamins|mesh-ancestor
93327494|NCT05382442|Micronutrients|micronutrients|mesh-ancestor
93327495|NCT05362474|Montelukast|montelukast|mesh-list
93327496|NCT05362474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93327497|NCT05362474|Respiratory System Agents|respiratory system agents|mesh-ancestor
93327498|NCT05362474|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93327499|NCT05362474|Hormone Antagonists|hormone antagonists|mesh-ancestor
93327500|NCT05362474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327501|NCT05362474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327502|NCT05362474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93327503|NCT05362474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93327504|NCT05362474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327505|NCT05542342|Tislelizumab|tislelizumab|mesh-list
93327506|NCT05542342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93327507|NCT05542342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327508|NCT05599516|Vaccines|vaccines|mesh-list
93327509|NCT05599516|Immunologic Factors|immunologic factors|mesh-ancestor
93327510|NCT05599516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327511|NCT05380024|Ensartinib|ensartinib|mesh-list
93327512|NCT05380024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327513|NCT05380024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93327514|NCT05380024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327515|NCT05380024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327516|NCT04251910|Dexmedetomidine|dexmedetomidine|mesh-list
93327517|NCT04251910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93327518|NCT04251910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327519|NCT04251910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327520|NCT04251910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327521|NCT04251910|Analgesics|analgesics|mesh-ancestor
93327522|NCT04251910|Sensory System Agents|sensory system agents|mesh-ancestor
93327523|NCT04251910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327524|NCT04251910|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93327525|NCT04251910|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327526|NCT04251910|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327527|NCT04251910|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327528|NCT04251910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327529|NCT04251910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327530|NCT05342194|Gemcitabine|gemcitabine|mesh-list
93327531|NCT05342194|Oxaliplatin|oxaliplatin|mesh-list
93327532|NCT05342194|Lenvatinib|lenvatinib|mesh-list
93327533|NCT05342194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327534|NCT05342194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93327535|NCT05342194|Antimetabolites|antimetabolites|mesh-ancestor
93327536|NCT05342194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327537|NCT05342194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93327538|NCT05342194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327539|NCT03623789|Tranylcypromine|tranylcypromine|mesh-list
93327540|NCT03623789|Tranexamic Acid|tranexamic acid|mesh-list
93327541|NCT03623789|Hemostatics|hemostatics|mesh-list
93327542|NCT03623789|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93327543|NCT03623789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93327544|NCT03623789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327545|NCT03623789|Coagulants|coagulants|mesh-ancestor
93327546|NCT03623789|Antidepressive Agents|antidepressive agents|mesh-ancestor
93327547|NCT03623789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93327548|NCT03623789|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93327549|NCT03623789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327550|NCT03623789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93327551|NCT03623789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93327552|NCT03623789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327553|NCT03623789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327554|NCT04247074|Botulinum Toxins|botulinum toxins|mesh-list
93327555|NCT04247074|Neurotransmitter Agents|neurotransmitter agents|mesh-list
93327556|NCT04247074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93327557|NCT04247074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327558|NCT04247074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999532|NCT05525858|Entrectinib|entrectinib|mesh-list
93327560|NCT04247074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327561|NCT05306548|Triamcinolone|triamcinolone|mesh-list
93327562|NCT05306548|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93327563|NCT05306548|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93327564|NCT05306548|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93327565|NCT05306548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327566|NCT05306548|Glucocorticoids|glucocorticoids|mesh-ancestor
93327567|NCT05306548|Hormones|hormones|mesh-ancestor
93327568|NCT05306548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327569|NCT05306548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327570|NCT05306548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327571|NCT05306548|Immunologic Factors|immunologic factors|mesh-ancestor
93327572|NCT05306548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327573|NCT05306548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327574|NCT05306470|Lidocaine|lidocaine|mesh-list
93327575|NCT05306470|Ethyl Chloride|ethyl chloride|mesh-list
93327576|NCT05306470|Anesthetics, Local|anesthetics, local|mesh-ancestor
93327577|NCT05306470|Anesthetics|anesthetics|mesh-ancestor
93327578|NCT05306470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327579|NCT05306470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327580|NCT05306470|Sensory System Agents|sensory system agents|mesh-ancestor
93327581|NCT05306470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327582|NCT05306470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93327583|NCT05306470|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93327584|NCT05306470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93327585|NCT05306470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327586|NCT05306470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327587|NCT05340010|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93327588|NCT05340010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93327589|NCT05340010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327590|NCT05339386|Xenon|xenon|mesh-list
93327591|NCT05339386|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93327592|NCT05339386|Anesthetics, General|anesthetics, general|mesh-ancestor
93327593|NCT05339386|Anesthetics|anesthetics|mesh-ancestor
93327594|NCT05339386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327595|NCT05339386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327596|NCT05339074|Ketamine|ketamine|mesh-list
93327597|NCT05339074|Analgesics|analgesics|mesh-ancestor
93327598|NCT05339074|Sensory System Agents|sensory system agents|mesh-ancestor
93327599|NCT05339074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327600|NCT05339074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327601|NCT05339074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93327602|NCT05339074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93327603|NCT05339074|Anesthetics, General|anesthetics, general|mesh-ancestor
93327604|NCT05339074|Anesthetics|anesthetics|mesh-ancestor
93327605|NCT05339074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327606|NCT05339074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93327607|NCT05339074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93327608|NCT05339074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327609|NCT05339074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327610|NCT05560282|Fenfluramine|fenfluramine|mesh-list
93327611|NCT05560282|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93327612|NCT05560282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93327613|NCT05560282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93327614|NCT05560282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327615|NCT05560282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327616|NCT05560282|Serotonin Agents|serotonin agents|mesh-ancestor
93327617|NCT05560282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327618|NCT03530267|Aflibercept|aflibercept|mesh-list
93327619|NCT03530267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93327620|NCT03530267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93327621|NCT03530267|Growth Substances|growth substances|mesh-ancestor
93327622|NCT03530267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327623|NCT03530267|Growth Inhibitors|growth inhibitors|mesh-ancestor
93327624|NCT03530267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327625|NCT05338450|Clemastine|clemastine|mesh-list
93327626|NCT05338450|Antipruritics|antipruritics|mesh-ancestor
93327627|NCT05338450|Dermatologic Agents|dermatologic agents|mesh-ancestor
93327628|NCT05338450|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93327629|NCT05338450|Histamine Antagonists|histamine antagonists|mesh-ancestor
93327630|NCT05338450|Histamine Agents|histamine agents|mesh-ancestor
93327631|NCT05338450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327632|NCT05338450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327633|NCT05338450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327634|NCT05338450|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93327635|NCT03677297|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93327636|NCT03677297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93327637|NCT03677297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93327638|NCT03677297|Antimetabolites|antimetabolites|mesh-ancestor
93327639|NCT03677297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327640|NCT03677297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93327641|NCT03677297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93327642|NCT03677297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327643|NCT03676985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93327644|NCT03676985|Antibodies|antibodies|mesh-list
93327645|NCT03676985|Immunoglobulins|immunoglobulins|mesh-list
93327646|NCT03676985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93327647|NCT03676985|Immunologic Factors|immunologic factors|mesh-ancestor
93327648|NCT03676985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327649|NCT03676985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327650|NCT05348824|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93327651|NCT05348824|Eusol|eusol|mesh-list
93327652|NCT05348824|Disinfectants|disinfectants|mesh-ancestor
93327653|NCT05348824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327654|NCT02988401|Insulin|insulin|mesh-list
93327655|NCT02988401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93327656|NCT02988401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327657|NCT02960555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93327658|NCT02960555|Immunologic Factors|immunologic factors|mesh-ancestor
93327659|NCT02960555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327660|NCT05266924|Hormones|hormones|mesh-list
93327661|NCT05266924|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93327662|NCT05266924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327663|NCT05266924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327664|NCT05266456|Vaccines|vaccines|mesh-list
93327665|NCT05266456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93327666|NCT05266456|Immunologic Factors|immunologic factors|mesh-ancestor
93327667|NCT05266456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327668|NCT05486416|Propofol|propofol|mesh-list
93327669|NCT05486416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93327670|NCT05486416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327671|NCT05486416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327672|NCT05486416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93327673|NCT05486416|Anesthetics, General|anesthetics, general|mesh-ancestor
93327674|NCT05486416|Anesthetics|anesthetics|mesh-ancestor
93327675|NCT02269917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93327676|NCT02269917|Protease Inhibitors|protease inhibitors|mesh-list
93327677|NCT02269917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327678|NCT02269917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327679|NCT02269917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93327680|NCT02269917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93327681|NCT02269917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93327682|NCT02269917|Antiviral Agents|antiviral agents|mesh-ancestor
93327683|NCT02269917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327684|NCT05294146|Clofazimine|clofazimine|mesh-list
93327685|NCT05294146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327686|NCT05294146|Leprostatic Agents|leprostatic agents|mesh-ancestor
93327687|NCT05294146|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327688|NCT05294146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327689|NCT05293288|Anesthetics|anesthetics|mesh-list
93327690|NCT05293288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327691|NCT05293288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327692|NCT03484221|Fluorouracil|fluorouracil|mesh-list
93327693|NCT03484221|Capecitabine|capecitabine|mesh-list
93327694|NCT03484221|Oxaliplatin|oxaliplatin|mesh-list
93327695|NCT03484221|Irinotecan|irinotecan|mesh-list
93327696|NCT03484221|Antimetabolites|antimetabolites|mesh-ancestor
93327697|NCT03484221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327698|NCT03484221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93327699|NCT03484221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327700|NCT03484221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93327701|NCT03484221|Immunologic Factors|immunologic factors|mesh-ancestor
93327702|NCT03484221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327703|NCT03484221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93327704|NCT03484221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93327705|NCT03484221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327706|NCT03857139|Nicotine|nicotine|mesh-list
93327707|NCT03857139|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93327708|NCT03857139|Autonomic Agents|autonomic agents|mesh-ancestor
93327709|NCT03857139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327710|NCT03857139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327711|NCT03857139|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93327712|NCT03857139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93327713|NCT03857139|Cholinergic Agents|cholinergic agents|mesh-ancestor
93327714|NCT03857139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327715|NCT03857139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327716|NCT01658020|Moxifloxacin|moxifloxacin|mesh-list
93327717|NCT01658020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327718|NCT01658020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327719|NCT01658020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93327720|NCT01658020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93327721|NCT01658020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327722|NCT01658020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327723|NCT01658020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327724|NCT05255770|Benzocaine|benzocaine|mesh-list
93327725|NCT05255770|Anesthetics, Local|anesthetics, local|mesh-ancestor
93327726|NCT05255770|Anesthetics|anesthetics|mesh-ancestor
93327727|NCT05255770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327728|NCT05255770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327729|NCT05255770|Sensory System Agents|sensory system agents|mesh-ancestor
93327730|NCT05255770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327731|NCT05322538|Vitamin D|vitamin d|mesh-list
93327732|NCT05322538|Ergocalciferols|ergocalciferols|mesh-list
93327733|NCT05322538|Cholecalciferol|cholecalciferol|mesh-list
93327734|NCT05322538|Vitamins|vitamins|mesh-list
93327735|NCT05322538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93327736|NCT05322538|Micronutrients|micronutrients|mesh-ancestor
93327737|NCT05322538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327738|NCT05322538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93327739|NCT05322538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93327740|NCT04965220|Trametinib|trametinib|mesh-list
93327741|NCT04965220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327742|NCT04965220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93327743|NCT04965220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327744|NCT04965220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327745|NCT05322070|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93327746|NCT05322070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327747|NCT05322070|Glucocorticoids|glucocorticoids|mesh-ancestor
93327748|NCT05322070|Hormones|hormones|mesh-ancestor
93327749|NCT05322070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327750|NCT05322070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327751|NCT03483753|Vasopressins|vasopressins|mesh-list
93327752|NCT03483753|Arginine Vasopressin|arginine vasopressin|mesh-list
93327753|NCT03483753|Norepinephrine|norepinephrine|mesh-list
93327754|NCT03483753|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327755|NCT03483753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327756|NCT03483753|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327757|NCT03483753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327758|NCT03483753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327759|NCT03483753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327760|NCT03483753|Sympathomimetics|sympathomimetics|mesh-ancestor
93327761|NCT03483753|Autonomic Agents|autonomic agents|mesh-ancestor
93327762|NCT03483753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327763|NCT03483753|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93327764|NCT03483753|Hemostatics|hemostatics|mesh-ancestor
93327765|NCT03483753|Coagulants|coagulants|mesh-ancestor
93327766|NCT03483753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93327767|NCT03483753|Natriuretic Agents|natriuretic agents|mesh-ancestor
93327768|NCT03389477|Cisplatin|cisplatin|mesh-list
93327769|NCT03389477|Cetuximab|cetuximab|mesh-list
93327770|NCT03389477|Palbociclib|palbociclib|mesh-list
93327771|NCT03389477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327772|NCT03389477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93327773|NCT03389477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93327774|NCT03389477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327775|NCT03389477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327776|NCT02680574|Darbepoetin alfa|darbepoetin alfa|mesh-list
93327777|NCT02680574|Hematinics|hematinics|mesh-ancestor
93327778|NCT03672149|Cefazolin|cefazolin|mesh-list
93327779|NCT03672149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327780|NCT03672149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327781|NCT03672071|Ephedrine|ephedrine|mesh-list
93327782|NCT03672071|Pseudoephedrine|pseudoephedrine|mesh-list
93327783|NCT03672071|Norepinephrine|norepinephrine|mesh-list
93327784|NCT03672071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93327785|NCT03672071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327786|NCT03672071|Sympathomimetics|sympathomimetics|mesh-ancestor
93327787|NCT03672071|Autonomic Agents|autonomic agents|mesh-ancestor
92621643|NCT02935114|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93327788|NCT03672071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327789|NCT03672071|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93327790|NCT03672071|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327791|NCT03672071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327792|NCT03672071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327793|NCT03672071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93327794|NCT03672071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93327795|NCT03672071|Respiratory System Agents|respiratory system agents|mesh-ancestor
93327796|NCT03672071|Nasal Decongestants|nasal decongestants|mesh-ancestor
93327797|NCT03672071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327798|NCT03672071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327799|NCT03480945|Nitroprusside|nitroprusside|mesh-list
93327800|NCT03480945|Serotonin|serotonin|mesh-list
93327801|NCT03480945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93327802|NCT03480945|Serotonin Agents|serotonin agents|mesh-ancestor
93327803|NCT03480945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327804|NCT03480945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327805|NCT03480945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327806|NCT03480945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93327807|NCT03480945|Vasodilator Agents|vasodilator agents|mesh-ancestor
93327808|NCT03480945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93327809|NCT03483207|Heparin|heparin|mesh-list
93327810|NCT03483207|Warfarin|warfarin|mesh-list
93327811|NCT03483207|Anticoagulants|anticoagulants|mesh-ancestor
93327812|NCT03483207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93327813|NCT03483207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93327814|NCT03483207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327815|NCT05132985|Carboplatin|carboplatin|mesh-list
93327816|NCT05132985|Pemetrexed|pemetrexed|mesh-list
93327817|NCT05132985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327818|NCT05132985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327819|NCT05132985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327820|NCT05132985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93327821|NCT05132985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93327822|NCT03739593|Dexamethasone|dexamethasone|mesh-list
93327823|NCT03739593|Dexamethasone acetate|dexamethasone acetate|mesh-list
93327824|NCT03739593|BB 1101|bb 1101|mesh-list
93327825|NCT03739593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327826|NCT03739593|Antiemetics|antiemetics|mesh-ancestor
93327827|NCT03739593|Autonomic Agents|autonomic agents|mesh-ancestor
93327828|NCT03739593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327829|NCT03739593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327830|NCT03739593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327831|NCT03739593|Glucocorticoids|glucocorticoids|mesh-ancestor
93327832|NCT03739593|Hormones|hormones|mesh-ancestor
93327833|NCT03739593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327834|NCT03739593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93327835|NCT03739593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327836|NCT03739593|Protease Inhibitors|protease inhibitors|mesh-ancestor
93327837|NCT03739593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327838|NCT03739593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327839|NCT03480867|Temozolomide|temozolomide|mesh-list
93327840|NCT03480867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93327841|NCT03480867|Alkylating Agents|alkylating agents|mesh-ancestor
93327842|NCT03480867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327843|NCT03480867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327844|NCT05254912|Sunscreening Agents|sunscreening agents|mesh-list
93327845|NCT05254912|Petrolatum|petrolatum|mesh-list
93327846|NCT05254912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93327847|NCT05254912|Protective Agents|protective agents|mesh-ancestor
93327848|NCT05254912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327849|NCT05254912|Dermatologic Agents|dermatologic agents|mesh-ancestor
93327850|NCT05254912|Emollients|emollients|mesh-ancestor
93327851|NCT03480789|Dexmedetomidine|dexmedetomidine|mesh-list
93327852|NCT03480789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93327853|NCT03480789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327854|NCT03480789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327855|NCT03480789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327856|NCT03480789|Analgesics|analgesics|mesh-ancestor
93327857|NCT03480789|Sensory System Agents|sensory system agents|mesh-ancestor
93327858|NCT03480789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327859|NCT03480789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93327860|NCT03480789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93327861|NCT03480789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93327862|NCT03480789|Adrenergic Agents|adrenergic agents|mesh-ancestor
93327863|NCT03480789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327864|NCT03480789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327865|NCT05251636|Aflibercept|aflibercept|mesh-list
93327866|NCT05251636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93327867|NCT05251636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93327868|NCT05251636|Growth Substances|growth substances|mesh-ancestor
93327869|NCT05251636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327870|NCT05251636|Growth Inhibitors|growth inhibitors|mesh-ancestor
93327871|NCT05251636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327872|NCT03475407|Dexamethasone|dexamethasone|mesh-list
93327873|NCT03475407|Dexamethasone acetate|dexamethasone acetate|mesh-list
93327874|NCT03475407|BB 1101|bb 1101|mesh-list
93327875|NCT03475407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327876|NCT03475407|Antiemetics|antiemetics|mesh-ancestor
93327877|NCT03475407|Autonomic Agents|autonomic agents|mesh-ancestor
93327878|NCT03475407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327879|NCT03475407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327880|NCT03475407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327881|NCT03475407|Glucocorticoids|glucocorticoids|mesh-ancestor
93327882|NCT03475407|Hormones|hormones|mesh-ancestor
93327883|NCT03475407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327884|NCT03475407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93327885|NCT03475407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327886|NCT03475407|Protease Inhibitors|protease inhibitors|mesh-ancestor
93327887|NCT03475407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327888|NCT03475407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327889|NCT03655197|Doxycycline|doxycycline|mesh-list
93327890|NCT03655197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93327891|NCT03655197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93327892|NCT03655197|Antimalarials|antimalarials|mesh-ancestor
93327893|NCT03655197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93327894|NCT03655197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93327895|NCT05317624|Methylprednisolone|methylprednisolone|mesh-list
93327896|NCT05317624|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93327897|NCT05317624|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93327898|NCT05317624|Prednisolone|prednisolone|mesh-list
93327899|NCT05317624|Prednisolone acetate|prednisolone acetate|mesh-list
93327900|NCT05317624|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93327901|NCT05317624|Prednisolone phosphate|prednisolone phosphate|mesh-list
93327902|NCT05317624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327903|NCT05317624|Antiemetics|antiemetics|mesh-ancestor
93327904|NCT05317624|Autonomic Agents|autonomic agents|mesh-ancestor
93327905|NCT05317624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327906|NCT05317624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327907|NCT05317624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93327908|NCT05317624|Glucocorticoids|glucocorticoids|mesh-ancestor
93327909|NCT05317624|Hormones|hormones|mesh-ancestor
93327910|NCT05317624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93327911|NCT05317624|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93327912|NCT05317624|Protective Agents|protective agents|mesh-ancestor
93327913|NCT05317624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93327914|NCT05317624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327915|NCT03475017|Curcumin|curcumin|mesh-list
93327916|NCT03475017|Piperine|piperine|mesh-list
93327917|NCT03475017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93327918|NCT03475017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93327919|NCT03475017|Analgesics|analgesics|mesh-ancestor
93327920|NCT03475017|Sensory System Agents|sensory system agents|mesh-ancestor
93327921|NCT03475017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327922|NCT03475017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327923|NCT03475017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93327924|NCT03475017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327925|NCT03475017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327926|NCT03475017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621779|NCT02934061|Anticonvulsants|anticonvulsants|mesh-ancestor
93327927|NCT03475017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327928|NCT03475017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93327929|NCT02674568|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
93327930|NCT02674568|Immunoconjugates|immunoconjugates|mesh-ancestor
93327931|NCT02674568|Immunologic Factors|immunologic factors|mesh-ancestor
93327932|NCT02674568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327933|NCT03474939|Midazolam|midazolam|mesh-list
93327934|NCT03474939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93327935|NCT03474939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93327936|NCT03474939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327937|NCT03474939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327938|NCT03474939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93327939|NCT03474939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93327940|NCT03474939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93327941|NCT03474939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93327942|NCT03474939|Anesthetics, General|anesthetics, general|mesh-ancestor
93327943|NCT03474939|Anesthetics|anesthetics|mesh-ancestor
93327944|NCT03474939|GABA Modulators|gaba modulators|mesh-ancestor
93327945|NCT03474939|GABA Agents|gaba agents|mesh-ancestor
93327946|NCT03474939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93327947|NCT03474939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327948|NCT03131583|Colchicine|colchicine|mesh-list
93327949|NCT03131583|Febuxostat|febuxostat|mesh-list
93327950|NCT03131583|Gout Suppressants|gout suppressants|mesh-ancestor
93327951|NCT03131583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93327952|NCT03131583|Tubulin Modulators|tubulin modulators|mesh-ancestor
93327953|NCT03131583|Antimitotic Agents|antimitotic agents|mesh-ancestor
93327954|NCT03131583|Mitosis Modulators|mitosis modulators|mesh-ancestor
93327955|NCT03131583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327956|NCT03131583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327957|NCT04672928|Paclitaxel|paclitaxel|mesh-list
93327958|NCT04672928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93327959|NCT04672928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93327960|NCT04672928|Tubulin Modulators|tubulin modulators|mesh-ancestor
93327961|NCT04672928|Antimitotic Agents|antimitotic agents|mesh-ancestor
93327962|NCT04672928|Mitosis Modulators|mitosis modulators|mesh-ancestor
93327963|NCT04672928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327964|NCT03480321|Cilostazol|cilostazol|mesh-list
93327965|NCT03480321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93327966|NCT03480321|Autonomic Agents|autonomic agents|mesh-ancestor
93327967|NCT03480321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93327968|NCT03480321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327969|NCT03480321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93327970|NCT03480321|Respiratory System Agents|respiratory system agents|mesh-ancestor
93327971|NCT03480321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93327972|NCT03480321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93327973|NCT03480321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327974|NCT03480321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93327975|NCT03480321|Vasodilator Agents|vasodilator agents|mesh-ancestor
93327976|NCT03480321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93327977|NCT03480321|Protective Agents|protective agents|mesh-ancestor
93327978|NCT03480321|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93327979|NCT03480321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93327980|NCT03480321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93327981|NCT04928950|Charcoal|charcoal|mesh-list
93327982|NCT04928950|Antidotes|antidotes|mesh-ancestor
93327983|NCT04928950|Protective Agents|protective agents|mesh-ancestor
93327984|NCT04928950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327985|NCT03482115|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93327986|NCT03482115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93327987|NCT02986269|Anesthetics|anesthetics|mesh-list
93327988|NCT02986269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327989|NCT02986269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327990|NCT05313256|Lidocaine|lidocaine|mesh-list
93327991|NCT05313256|Epinephrine|epinephrine|mesh-list
93327992|NCT05313256|Racepinephrine|racepinephrine|mesh-list
92621842|NCT00165399|Bicalutamide|bicalutamide|mesh-list
93327993|NCT05313256|Epinephryl borate|epinephryl borate|mesh-list
93327994|NCT05313256|Anesthetics, Local|anesthetics, local|mesh-ancestor
93327995|NCT05313256|Anesthetics|anesthetics|mesh-ancestor
93327996|NCT05313256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93327997|NCT05313256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93327998|NCT05313256|Sensory System Agents|sensory system agents|mesh-ancestor
93327999|NCT05313256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328000|NCT05313256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93328001|NCT05313256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93328002|NCT05313256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93328003|NCT05313256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328004|NCT05313256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328005|NCT05313256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93328006|NCT05313256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93328007|NCT05313256|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328008|NCT05313256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999982|NCT04636437|Tenofovir|tenofovir|mesh-list
93328009|NCT05313256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93328010|NCT05313256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93328011|NCT05313256|Autonomic Agents|autonomic agents|mesh-ancestor
93328012|NCT05313256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93328013|NCT05313256|Respiratory System Agents|respiratory system agents|mesh-ancestor
93328014|NCT05313256|Mydriatics|mydriatics|mesh-ancestor
93328015|NCT05313256|Sympathomimetics|sympathomimetics|mesh-ancestor
93328016|NCT05313256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93328017|NCT03474237|Hormones|hormones|mesh-list
93328018|NCT03474237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328019|NCT03474237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328020|NCT05276830|Dexmedetomidine|dexmedetomidine|mesh-list
93328021|NCT05276830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93328022|NCT05276830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328023|NCT05276830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328024|NCT05276830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328025|NCT05276830|Analgesics|analgesics|mesh-ancestor
93328026|NCT05276830|Sensory System Agents|sensory system agents|mesh-ancestor
93328027|NCT05276830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328028|NCT05276830|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93328029|NCT05276830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93328030|NCT05276830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93328031|NCT05276830|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328032|NCT05276830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328033|NCT05276830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328034|NCT03480165|Parecoxib|parecoxib|mesh-list
93328035|NCT03480165|Ropivacaine|ropivacaine|mesh-list
93328036|NCT03480165|Anesthetics, Local|anesthetics, local|mesh-ancestor
93328037|NCT03480165|Anesthetics|anesthetics|mesh-ancestor
93328038|NCT03480165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328039|NCT03480165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328040|NCT03480165|Sensory System Agents|sensory system agents|mesh-ancestor
93328041|NCT03480165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328042|NCT03480165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93328043|NCT03480165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328044|NCT03480165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328045|NCT03480165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328046|NCT03480165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328047|NCT03480165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328048|NCT03480165|Analgesics|analgesics|mesh-ancestor
93328049|NCT03480165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328050|NCT03480165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328051|NCT05311852|Palmidrol|palmidrol|mesh-list
93328052|NCT05311852|Antioxidants|antioxidants|mesh-list
93328053|NCT05311852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328054|NCT05311852|Protective Agents|protective agents|mesh-ancestor
93328055|NCT05311852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328056|NCT05311852|Analgesics|analgesics|mesh-ancestor
93328057|NCT05311852|Sensory System Agents|sensory system agents|mesh-ancestor
93328058|NCT05311852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328059|NCT05311852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328060|NCT05311852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328061|NCT05311852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328062|NCT05311852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328063|NCT05311852|Antiviral Agents|antiviral agents|mesh-ancestor
93328064|NCT05311852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328065|NCT05311852|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93328066|NCT05311852|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93328067|NCT05311852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328068|NCT05311852|Hormones|hormones|mesh-ancestor
93328069|NCT05311852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328070|NCT03948867|Hydroxyurea|hydroxyurea|mesh-list
93328071|NCT03948867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328072|NCT03948867|Antisickling Agents|antisickling agents|mesh-ancestor
93328073|NCT03948867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328074|NCT03948867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328075|NCT03948867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93328076|NCT01373918|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93328077|NCT01373918|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93328078|NCT01373918|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93328079|NCT01373918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93328080|NCT03671915|Insulin|insulin|mesh-list
93328081|NCT03671915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93328082|NCT03671915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328083|NCT03302195|Heparin|heparin|mesh-list
93328084|NCT03302195|Anticoagulants|anticoagulants|mesh-ancestor
93328085|NCT03302195|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93328086|NCT03302195|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93328087|NCT03302195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328088|NCT02515773|Metformin|metformin|mesh-list
93328089|NCT02515773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93328090|NCT02515773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328091|NCT05275426|Gemcitabine|gemcitabine|mesh-list
93328092|NCT05275426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328093|NCT05275426|Antimetabolites|antimetabolites|mesh-ancestor
93328094|NCT05275426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328095|NCT05275426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328096|NCT03114020|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93328097|NCT03114020|Hyaluronic Acid|hyaluronic acid|mesh-list
93328098|NCT03114020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93328099|NCT03114020|Immunologic Factors|immunologic factors|mesh-ancestor
93328100|NCT03114020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328101|NCT03114020|Viscosupplements|viscosupplements|mesh-ancestor
93328102|NCT03114020|Protective Agents|protective agents|mesh-ancestor
93328103|NCT04460079|Lenograstim|lenograstim|mesh-list
93328104|NCT04460079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93328105|NCT04460079|Immunologic Factors|immunologic factors|mesh-ancestor
93328106|NCT04460079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328107|NCT03473691|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
93328108|NCT03473691|Immunoconjugates|immunoconjugates|mesh-ancestor
93328109|NCT03473691|Immunologic Factors|immunologic factors|mesh-ancestor
93328110|NCT03473691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328111|NCT03473691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328112|NCT03473691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328113|NCT03676361|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93328114|NCT03676361|Hemostatics|hemostatics|mesh-ancestor
93328115|NCT03676361|Coagulants|coagulants|mesh-ancestor
93328116|NCT03676361|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93328117|NCT03676361|Natriuretic Agents|natriuretic agents|mesh-ancestor
93328118|NCT03676361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328119|NCT01712763|Goserelin|goserelin|mesh-list
93328120|NCT01712763|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93328121|NCT01712763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93328122|NCT01712763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328123|NCT01712763|Luteolytic Agents|luteolytic agents|mesh-ancestor
93328124|NCT01712763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93328125|NCT01712763|Contraceptive Agents|contraceptive agents|mesh-ancestor
93328126|NCT01712763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93328127|NCT01712763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621974|NCT00153725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328128|NCT01712763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93328129|NCT02827877|Copper|copper|mesh-list
93328130|NCT02827877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93328131|NCT02827877|Trastuzumab|trastuzumab|mesh-list
93328132|NCT02827877|Pertuzumab|pertuzumab|mesh-list
93328133|NCT02827877|Antibodies|antibodies|mesh-list
93328134|NCT02827877|Immunoglobulins|immunoglobulins|mesh-list
93328135|NCT02827877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93328136|NCT02827877|Immunologic Factors|immunologic factors|mesh-ancestor
93328137|NCT02827877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328138|NCT02827877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328139|NCT02827877|Trace Elements|trace elements|mesh-ancestor
93328140|NCT02827877|Micronutrients|micronutrients|mesh-ancestor
93328141|NCT05218486|Isotretinoin|isotretinoin|mesh-list
93328142|NCT05218486|Dermatologic Agents|dermatologic agents|mesh-ancestor
93328143|NCT05216770|Bupivacaine|bupivacaine|mesh-list
93328144|NCT05216770|Anesthetics, Local|anesthetics, local|mesh-ancestor
93328145|NCT05216770|Anesthetics|anesthetics|mesh-ancestor
93328146|NCT05216770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328147|NCT05216770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328148|NCT05216770|Sensory System Agents|sensory system agents|mesh-ancestor
93328149|NCT05216770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328150|NCT05236036|Mycophenolic Acid|mycophenolic acid|mesh-list
93328151|NCT05236036|Temozolomide|temozolomide|mesh-list
93328152|NCT05236036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93328153|NCT05236036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328154|NCT05236036|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93328155|NCT05236036|Antitubercular Agents|antitubercular agents|mesh-ancestor
93000132|NCT04231851|Antimetabolites|antimetabolites|mesh-ancestor
93328156|NCT05236036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93328157|NCT05236036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328158|NCT05236036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328159|NCT05236036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328160|NCT05236036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93328162|NCT02781779|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93328163|NCT02781779|Laxatives|laxatives|mesh-ancestor
93328164|NCT02781779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328165|NCT05270200|Azacitidine|azacitidine|mesh-list
93328166|NCT05270200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328167|NCT05270200|Antimetabolites|antimetabolites|mesh-ancestor
93328168|NCT05270200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328169|NCT05270200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328170|NCT05270200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328171|NCT04953104|Nivolumab|nivolumab|mesh-list
93328172|NCT04953104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328173|NCT04953104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328174|NCT04953104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93328175|NCT04953104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328176|NCT03671057|Midazolam|midazolam|mesh-list
93328177|NCT03671057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93328178|NCT03671057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93328179|NCT03671057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328180|NCT03671057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328181|NCT03671057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93328182|NCT03671057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93328183|NCT03671057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93328184|NCT03671057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93328185|NCT03671057|Anesthetics, General|anesthetics, general|mesh-ancestor
93328186|NCT03671057|Anesthetics|anesthetics|mesh-ancestor
93328187|NCT03671057|GABA Modulators|gaba modulators|mesh-ancestor
93328188|NCT03671057|GABA Agents|gaba agents|mesh-ancestor
93328189|NCT03671057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328190|NCT03671057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328191|NCT03670901|Rituximab|rituximab|mesh-list
93328192|NCT03670901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328193|NCT03670901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328194|NCT03670901|Immunologic Factors|immunologic factors|mesh-ancestor
93328195|NCT03670901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328196|NCT03670901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328197|NCT05166616|Osimertinib|osimertinib|mesh-list
93328198|NCT05166616|Triptolide|triptolide|mesh-list
93328199|NCT05166616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328200|NCT05166616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93328201|NCT05166616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328202|NCT05166616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328203|NCT05166616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93328204|NCT05166616|Alkylating Agents|alkylating agents|mesh-ancestor
93328205|NCT05166616|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
93328206|NCT05166616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328207|NCT05166616|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93328208|NCT05166616|Contraceptive Agents|contraceptive agents|mesh-ancestor
93328209|NCT05166616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93328210|NCT05166616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328211|NCT05166616|Immunologic Factors|immunologic factors|mesh-ancestor
93328212|NCT05213728|Vaccines|vaccines|mesh-list
93328213|NCT05213728|Immunologic Factors|immunologic factors|mesh-ancestor
93328214|NCT05213728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328215|NCT05165836|Dexmedetomidine|dexmedetomidine|mesh-list
93328216|NCT05165836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93328217|NCT05165836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328218|NCT05165836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328219|NCT05165836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328220|NCT05165836|Analgesics|analgesics|mesh-ancestor
93328221|NCT05165836|Sensory System Agents|sensory system agents|mesh-ancestor
93328222|NCT05165836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328223|NCT05165836|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93328224|NCT05165836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93328225|NCT05165836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93328226|NCT05165836|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328227|NCT05165836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328228|NCT05165836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328229|NCT05213104|Flecainide|flecainide|mesh-list
93328230|NCT05213104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93328231|NCT05213104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93328232|NCT05213104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93000211|NCT04061421|Decitabine|decitabine|mesh-list
93328233|NCT05213104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328234|NCT05213104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328235|NCT04238416|Lactulose|lactulose|mesh-list
93328236|NCT04238416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328237|NCT05162014|Empagliflozin|empagliflozin|mesh-list
93328238|NCT05162014|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93328239|NCT05162014|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93328240|NCT05162014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328241|NCT05162014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328242|NCT05226754|Diacerein|diacerein|mesh-list
93328243|NCT05226754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328244|NCT01657162|Alendronate|alendronate|mesh-list
93328245|NCT01657162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93328246|NCT01657162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328247|NCT05209906|Fentanyl|fentanyl|mesh-list
93328248|NCT05209906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93328249|NCT05209906|Narcotics|narcotics|mesh-ancestor
93328250|NCT05209906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328251|NCT05209906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328252|NCT05209906|Analgesics|analgesics|mesh-ancestor
93328253|NCT05209906|Sensory System Agents|sensory system agents|mesh-ancestor
93328254|NCT05209906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328255|NCT05209906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93328256|NCT05209906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93328257|NCT05209906|Anesthetics, General|anesthetics, general|mesh-ancestor
93328258|NCT05209906|Anesthetics|anesthetics|mesh-ancestor
93328259|NCT04422184|Potassium Citrate|potassium citrate|mesh-list
93328260|NCT04422184|Diuretics|diuretics|mesh-ancestor
93328261|NCT04422184|Natriuretic Agents|natriuretic agents|mesh-ancestor
93328262|NCT04422184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328263|NCT04422184|Expectorants|expectorants|mesh-ancestor
93328264|NCT04422184|Respiratory System Agents|respiratory system agents|mesh-ancestor
93328265|NCT05633810|Aspirin|aspirin|mesh-list
93328266|NCT05633810|Colchicine|colchicine|mesh-list
93328267|NCT05633810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328268|NCT05633810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328269|NCT05633810|Analgesics|analgesics|mesh-ancestor
93328270|NCT05633810|Sensory System Agents|sensory system agents|mesh-ancestor
93328271|NCT05633810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328272|NCT05633810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328273|NCT05633810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328274|NCT05633810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328275|NCT05633810|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93328276|NCT05633810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93328277|NCT05633810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328278|NCT05633810|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93328279|NCT05633810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328280|NCT05633810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328281|NCT05633810|Antipyretics|antipyretics|mesh-ancestor
93328282|NCT05633810|Gout Suppressants|gout suppressants|mesh-ancestor
93328283|NCT05633810|Tubulin Modulators|tubulin modulators|mesh-ancestor
93328284|NCT05633810|Antimitotic Agents|antimitotic agents|mesh-ancestor
93328285|NCT05633810|Mitosis Modulators|mitosis modulators|mesh-ancestor
93328286|NCT05633810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328287|NCT05152576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93328288|NCT05152576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93328289|NCT05152576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93328290|NCT05152576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328291|NCT05152576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328292|NCT05152576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93328293|NCT05152576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328294|NCT05152576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328295|NCT05152576|Cholinergic Agents|cholinergic agents|mesh-ancestor
93328296|NCT05152576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328297|NCT05203822|Itraconazole|itraconazole|mesh-list
93328298|NCT05203822|Tepotinib|tepotinib|mesh-list
93328299|NCT05203822|Antifungal Agents|antifungal agents|mesh-ancestor
93328300|NCT05203822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328301|NCT05203822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93328302|NCT05203822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93328303|NCT05203822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328304|NCT05203822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328305|NCT05203822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93328306|NCT05203822|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000282|NCT03743636|Niacinamide|niacinamide|mesh-list
93328307|NCT05203822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328308|NCT05203822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328309|NCT05203822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93328310|NCT05203822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328311|NCT01373294|Lenalidomide|lenalidomide|mesh-list
93328312|NCT01373294|BCG Vaccine|bcg vaccine|mesh-list
93328313|NCT01373294|Immunologic Factors|immunologic factors|mesh-ancestor
93328314|NCT01373294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328315|NCT01373294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93328316|NCT01373294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93328317|NCT01373294|Growth Substances|growth substances|mesh-ancestor
93328318|NCT01373294|Growth Inhibitors|growth inhibitors|mesh-ancestor
93328319|NCT01373294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328320|NCT01373294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93328321|NCT05220358|Fostemsavir|fostemsavir|mesh-list
93328322|NCT05220358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93328323|NCT05220358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93328324|NCT05220358|Antiviral Agents|antiviral agents|mesh-ancestor
93328325|NCT05220358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328326|NCT05220358|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93328327|NCT05220358|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93328328|NCT05220358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328329|NCT04422028|Desogestrel|desogestrel|mesh-list
93328330|NCT04422028|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93328331|NCT04422028|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93328332|NCT04422028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93328333|NCT04422028|Contraceptive Agents|contraceptive agents|mesh-ancestor
93328334|NCT04422028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93328335|NCT04422028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328336|NCT04422028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93328337|NCT04422028|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93328338|NCT04422028|Progestins|progestins|mesh-ancestor
93328339|NCT04422028|Hormones|hormones|mesh-ancestor
93328340|NCT04422028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328341|NCT01656304|Bevacizumab|bevacizumab|mesh-list
93328342|NCT01656304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93328343|NCT01656304|Antibodies|antibodies|mesh-list
93328344|NCT01656304|Immunoglobulins|immunoglobulins|mesh-list
93328345|NCT01656304|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93328346|NCT01656304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328347|NCT01656304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93328348|NCT01656304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93328349|NCT01656304|Growth Substances|growth substances|mesh-ancestor
93328350|NCT01656304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328351|NCT01656304|Growth Inhibitors|growth inhibitors|mesh-ancestor
93328352|NCT01656304|Immunologic Factors|immunologic factors|mesh-ancestor
93328353|NCT04421872|Anesthetics|anesthetics|mesh-list
93328354|NCT04421872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328355|NCT04421872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328356|NCT04227028|Bevacizumab|bevacizumab|mesh-list
93328357|NCT04227028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93328358|NCT04227028|Endothelial Growth Factors|endothelial growth factors|mesh-list
93328359|NCT04227028|Antibodies|antibodies|mesh-list
93328360|NCT04227028|Immunoglobulins|immunoglobulins|mesh-list
93328361|NCT04227028|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93328362|NCT04227028|Immunoglobulin G|immunoglobulin g|mesh-list
93328363|NCT04227028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328364|NCT04227028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93328365|NCT04227028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93328366|NCT04227028|Growth Substances|growth substances|mesh-ancestor
93328367|NCT04227028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328368|NCT04227028|Growth Inhibitors|growth inhibitors|mesh-ancestor
93328369|NCT04227028|Immunologic Factors|immunologic factors|mesh-ancestor
93328370|NCT03023423|Atezolizumab|atezolizumab|mesh-list
93328371|NCT03023423|Daratumumab|daratumumab|mesh-list
93328372|NCT03023423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93328373|NCT03023423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328374|NCT03023423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328375|NCT03023423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328376|NCT03675191|Orlistat|orlistat|mesh-list
93328377|NCT03675191|Phentermine|phentermine|mesh-list
93328378|NCT03675191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328379|NCT03675191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328380|NCT03675191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93328381|NCT03675191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93328382|NCT03675191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93328383|NCT03675191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328384|NCT03675191|Appetite Depressants|appetite depressants|mesh-ancestor
93328386|NCT03675191|Autonomic Agents|autonomic agents|mesh-ancestor
93328387|NCT03675191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328388|NCT03675191|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328389|NCT03675191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328390|NCT03198689|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93328391|NCT03198689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328392|NCT03198689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328393|NCT03198689|Immunotoxins|immunotoxins|mesh-ancestor
93328394|NCT03198689|Immunoconjugates|immunoconjugates|mesh-ancestor
93328395|NCT03198689|Immunologic Factors|immunologic factors|mesh-ancestor
93328396|NCT03198689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328397|NCT02635061|Nivolumab|nivolumab|mesh-list
93328398|NCT02635061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328399|NCT02635061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328400|NCT02635061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93328401|NCT02635061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328402|NCT05096728|Nifedipine|nifedipine|mesh-list
93328403|NCT05096728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93328404|NCT05096728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328405|NCT05096728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328406|NCT05096728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93328407|NCT05096728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328408|NCT05096728|Vasodilator Agents|vasodilator agents|mesh-ancestor
93328409|NCT05096728|Tocolytic Agents|tocolytic agents|mesh-ancestor
93328410|NCT05096728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93328411|NCT04421716|Ursolic acid|ursolic acid|mesh-list
93328412|NCT04421716|Curcumin|curcumin|mesh-list
93328413|NCT04421716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328414|NCT04421716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328415|NCT04421716|Analgesics|analgesics|mesh-ancestor
93328416|NCT04421716|Sensory System Agents|sensory system agents|mesh-ancestor
93328417|NCT04421716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328418|NCT04421716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328419|NCT04421716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328420|NCT04421716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328421|NCT04421716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328422|NCT04421716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328423|NCT04421716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328424|NCT04421716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328425|NCT04421716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93328426|NCT04421716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328427|NCT05184868|Insulin Aspart|insulin aspart|mesh-list
93328428|NCT05184868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93328429|NCT05184868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328430|NCT04226950|Interferons|interferons|mesh-list
93328431|NCT04226950|Interferon-alpha|interferon-alpha|mesh-list
93328432|NCT04226950|Interferon alpha-2|interferon alpha-2|mesh-list
93328433|NCT04226950|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93328434|NCT04226950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328435|NCT04226950|Antiviral Agents|antiviral agents|mesh-ancestor
93328436|NCT04226950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328437|NCT04226950|Immunologic Factors|immunologic factors|mesh-ancestor
93328438|NCT04226950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328439|NCT05085574|Celecoxib|celecoxib|mesh-list
93328440|NCT05085574|Famotidine|famotidine|mesh-list
93328441|NCT05085574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328442|NCT05085574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328443|NCT05085574|Analgesics|analgesics|mesh-ancestor
93328444|NCT05085574|Sensory System Agents|sensory system agents|mesh-ancestor
93328445|NCT05085574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328446|NCT05085574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328447|NCT05085574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328448|NCT05085574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328449|NCT05085574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93328450|NCT05085574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328451|NCT05085574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328452|NCT05085574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328453|NCT05085574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93328454|NCT05085574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328455|NCT05085574|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93328456|NCT05085574|Histamine Antagonists|histamine antagonists|mesh-ancestor
93328457|NCT05085574|Histamine Agents|histamine agents|mesh-ancestor
93328458|NCT05085574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328459|NCT05085340|Pyrimethamine|pyrimethamine|mesh-list
93328460|NCT05085340|Sulfadoxine|sulfadoxine|mesh-list
93328461|NCT05085340|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93328462|NCT05085340|Antimalarials|antimalarials|mesh-ancestor
93328463|NCT05085340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93328464|NCT05085340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93328465|NCT05085340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328466|NCT05085340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93328467|NCT05085340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328468|NCT05085340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328469|NCT05085340|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93328470|NCT02667236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93328471|NCT01126749|Gemcitabine|gemcitabine|mesh-list
93328472|NCT01126749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328473|NCT01126749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328474|NCT01126749|Antimetabolites|antimetabolites|mesh-ancestor
93328475|NCT01126749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328476|NCT03674411|Mycophenolic Acid|mycophenolic acid|mesh-list
93328477|NCT03674411|Cyclophosphamide|cyclophosphamide|mesh-list
93328478|NCT03674411|Melphalan|melphalan|mesh-list
93328479|NCT03674411|Busulfan|busulfan|mesh-list
93328480|NCT03674411|Fludarabine|fludarabine|mesh-list
93328481|NCT03674411|Tacrolimus|tacrolimus|mesh-list
93328482|NCT03674411|Lenograstim|lenograstim|mesh-list
93328483|NCT03674411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328484|NCT03674411|Immunologic Factors|immunologic factors|mesh-ancestor
93328485|NCT03674411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328486|NCT03674411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328487|NCT03674411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93328488|NCT03674411|Alkylating Agents|alkylating agents|mesh-ancestor
93328489|NCT03674411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328490|NCT03674411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328491|NCT03674411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93328492|NCT03674411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93328493|NCT03674411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328494|NCT03674411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93328495|NCT03674411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93328496|NCT03674411|Antitubercular Agents|antitubercular agents|mesh-ancestor
93328497|NCT03674411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93328498|NCT03674411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328499|NCT03674411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93328500|NCT03674333|Folic Acid|folic acid|mesh-list
93328501|NCT03674333|Hematinics|hematinics|mesh-ancestor
93328502|NCT03674333|Vitamin B Complex|vitamin b complex|mesh-ancestor
93328503|NCT03674333|Vitamins|vitamins|mesh-ancestor
93328504|NCT03674333|Micronutrients|micronutrients|mesh-ancestor
93328505|NCT03674333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328506|NCT03674099|Methylprednisolone|methylprednisolone|mesh-list
93328507|NCT03674099|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93328508|NCT03674099|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93328509|NCT03674099|Prednisolone|prednisolone|mesh-list
93328510|NCT03674099|Prednisolone acetate|prednisolone acetate|mesh-list
93328511|NCT03674099|Imatinib Mesylate|imatinib mesylate|mesh-list
93328512|NCT03674099|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93328513|NCT03674099|Prednisolone phosphate|prednisolone phosphate|mesh-list
93328514|NCT03674099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328515|NCT03674099|Antiemetics|antiemetics|mesh-ancestor
93328516|NCT03674099|Autonomic Agents|autonomic agents|mesh-ancestor
93328517|NCT03674099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328518|NCT03674099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328519|NCT03674099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328520|NCT03674099|Glucocorticoids|glucocorticoids|mesh-ancestor
93328521|NCT03674099|Hormones|hormones|mesh-ancestor
93328522|NCT03674099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328523|NCT03674099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93328524|NCT03674099|Protective Agents|protective agents|mesh-ancestor
93328525|NCT03674099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93328526|NCT03674099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328527|NCT03674099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93328528|NCT03674099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328529|NCT03674099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328530|NCT05124340|Vaccines|vaccines|mesh-list
93328531|NCT05124340|Immunologic Factors|immunologic factors|mesh-ancestor
93328532|NCT05124340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328533|NCT05084404|Guanabenz|guanabenz|mesh-list
93328534|NCT05084404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93328535|NCT05084404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93328536|NCT05084404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93328537|NCT05084404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93328538|NCT05084404|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328539|NCT05084404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328540|NCT05084404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328541|NCT05084404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328542|NCT03473613|Calcium, Dietary|calcium, dietary|mesh-list
93328543|NCT03473613|Cabergoline|cabergoline|mesh-list
93328544|NCT03473613|Calcium|calcium|mesh-list
93328545|NCT03473613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93328546|NCT03473613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328547|NCT03473613|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93328548|NCT03473613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93328549|NCT03473613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93328550|NCT03473613|Dopamine Agonists|dopamine agonists|mesh-ancestor
93328551|NCT03473613|Dopamine Agents|dopamine agents|mesh-ancestor
93328552|NCT03473613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328553|NCT03473613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328554|NCT03670043|Metformin|metformin|mesh-list
93328555|NCT03670043|Psyllium|psyllium|mesh-list
93328556|NCT03670043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93328557|NCT03670043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328558|NCT03670043|Cathartics|cathartics|mesh-ancestor
93328559|NCT03670043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328560|NCT01701986|Mycophenolic Acid|mycophenolic acid|mesh-list
93328561|NCT01701986|Rituximab|rituximab|mesh-list
93328562|NCT01701986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93328563|NCT01701986|Gemcitabine|gemcitabine|mesh-list
93328564|NCT01701986|Busulfan|busulfan|mesh-list
93328565|NCT01701986|Clofarabine|clofarabine|mesh-list
93328566|NCT01701986|Antibodies|antibodies|mesh-list
93328567|NCT01701986|Immunoglobulins|immunoglobulins|mesh-list
93328568|NCT01701986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93328569|NCT01701986|Tacrolimus|tacrolimus|mesh-list
93328570|NCT01701986|Thymoglobulin|thymoglobulin|mesh-list
93328571|NCT01701986|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93328572|NCT01701986|Immunologic Factors|immunologic factors|mesh-ancestor
93328573|NCT01701986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328574|NCT01701986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328575|NCT01701986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328576|NCT01701986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328577|NCT01701986|Antimetabolites|antimetabolites|mesh-ancestor
93328578|NCT01701986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328579|NCT01701986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328580|NCT01701986|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93328581|NCT01701986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328582|NCT01701986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93328583|NCT01701986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93328584|NCT01701986|Antitubercular Agents|antitubercular agents|mesh-ancestor
93328585|NCT01701986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93328586|NCT01701986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328587|NCT01701986|Alkylating Agents|alkylating agents|mesh-ancestor
93328588|NCT01701986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93328589|NCT01701986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93328590|NCT05561660|Aspirin|aspirin|mesh-list
93328591|NCT05561660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328592|NCT05561660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328593|NCT05561660|Analgesics|analgesics|mesh-ancestor
93328594|NCT05561660|Sensory System Agents|sensory system agents|mesh-ancestor
93328595|NCT05561660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328596|NCT05561660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328597|NCT05561660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328598|NCT05561660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328599|NCT05561660|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93328600|NCT05561660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93328601|NCT05561660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328602|NCT05561660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93328603|NCT05561660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328604|NCT05561660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328605|NCT05561660|Antipyretics|antipyretics|mesh-ancestor
93328606|NCT03042819|Doxorubicin|doxorubicin|mesh-list
93328607|NCT03042819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93328608|NCT03042819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328609|NCT03042819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93328610|NCT03042819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93328611|NCT03042819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328612|NCT03042819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328613|NCT02832687|Acetaminophen|acetaminophen|mesh-list
93328614|NCT02832687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328615|NCT02832687|Analgesics|analgesics|mesh-ancestor
93328616|NCT02832687|Sensory System Agents|sensory system agents|mesh-ancestor
93328617|NCT02832687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328618|NCT02832687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328619|NCT02832687|Antipyretics|antipyretics|mesh-ancestor
93328620|NCT04372017|Vitamin D|vitamin d|mesh-list
93328621|NCT04372017|Hydroxychloroquine|hydroxychloroquine|mesh-list
93328622|NCT04372017|Vitamins|vitamins|mesh-ancestor
93328623|NCT04372017|Micronutrients|micronutrients|mesh-ancestor
93328624|NCT04372017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328625|NCT04372017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93328626|NCT04372017|Antimalarials|antimalarials|mesh-ancestor
93328627|NCT04372017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93328628|NCT04372017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93328629|NCT04372017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328630|NCT04372017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328631|NCT04372017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328632|NCT04372017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328633|NCT05233358|Pembrolizumab|pembrolizumab|mesh-list
93328634|NCT05233358|Nivolumab|nivolumab|mesh-list
92622482|NCT00154778|Vitamins|vitamins|mesh-ancestor
93328635|NCT05233358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93328636|NCT05233358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328637|NCT05233358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328638|NCT05233358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328639|NCT02387918|Dexamethasone|dexamethasone|mesh-list
93328640|NCT02387918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328641|NCT02387918|Antiemetics|antiemetics|mesh-ancestor
93328642|NCT02387918|Autonomic Agents|autonomic agents|mesh-ancestor
93328643|NCT02387918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328644|NCT02387918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328645|NCT02387918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328646|NCT02387918|Glucocorticoids|glucocorticoids|mesh-ancestor
93328647|NCT02387918|Hormones|hormones|mesh-ancestor
93328648|NCT02387918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328649|NCT02387918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93328650|NCT02387918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328651|NCT04312971|Norepinephrine|norepinephrine|mesh-list
93328652|NCT04312971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93328653|NCT04312971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93328654|NCT04312971|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328655|NCT04312971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328656|NCT04312971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328657|NCT04312971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328658|NCT04312971|Sympathomimetics|sympathomimetics|mesh-ancestor
93328659|NCT04312971|Autonomic Agents|autonomic agents|mesh-ancestor
93328660|NCT04312971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328661|NCT04312971|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93328662|NCT05231330|Fluorides|fluorides|mesh-list
93328663|NCT05231330|Cariostatic Agents|cariostatic agents|mesh-ancestor
93328664|NCT05231330|Protective Agents|protective agents|mesh-ancestor
93328665|NCT05231330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328666|NCT03179475|Oxycodone|oxycodone|mesh-list
93328667|NCT03179475|Naloxone|naloxone|mesh-list
93328668|NCT03179475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93328669|NCT03179475|Narcotics|narcotics|mesh-ancestor
93328670|NCT03179475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328671|NCT03179475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328672|NCT03179475|Analgesics|analgesics|mesh-ancestor
93328673|NCT03179475|Sensory System Agents|sensory system agents|mesh-ancestor
93328674|NCT03179475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328675|NCT03179475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93328676|NCT03105986|Probenecid|probenecid|mesh-list
93328677|NCT03105986|Uricosuric Agents|uricosuric agents|mesh-ancestor
93328678|NCT03105986|Gout Suppressants|gout suppressants|mesh-ancestor
93328679|NCT03105986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328680|NCT03132129|Manganese|manganese|mesh-list
93328681|NCT03132129|Calcium|calcium|mesh-list
93328682|NCT03132129|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93328683|NCT03132129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328684|NCT03132129|Trace Elements|trace elements|mesh-ancestor
93328685|NCT03132129|Micronutrients|micronutrients|mesh-ancestor
93328686|NCT02391662|Paclitaxel|paclitaxel|mesh-list
93328687|NCT02391662|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93328688|NCT02391662|Gemcitabine|gemcitabine|mesh-list
93328689|NCT02391662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93328690|NCT02391662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328691|NCT02391662|Tubulin Modulators|tubulin modulators|mesh-ancestor
93328692|NCT02391662|Antimitotic Agents|antimitotic agents|mesh-ancestor
93328693|NCT02391662|Mitosis Modulators|mitosis modulators|mesh-ancestor
93328694|NCT02391662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328695|NCT02391662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328696|NCT02391662|Antimetabolites|antimetabolites|mesh-ancestor
93328697|NCT05076604|Cardioplegic Solutions|cardioplegic solutions|mesh-list
93328698|NCT05076604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93328699|NCT05258955|Chlorhexidine|chlorhexidine|mesh-list
93328700|NCT05258955|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93328701|NCT05258955|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93328702|NCT05258955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328703|NCT05258955|Disinfectants|disinfectants|mesh-ancestor
93328704|NCT05258955|Dermatologic Agents|dermatologic agents|mesh-ancestor
93328705|NCT05173324|Vaccines|vaccines|mesh-list
93328706|NCT05173324|Immunologic Factors|immunologic factors|mesh-ancestor
93328707|NCT05173324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328708|NCT04029038|Cyclophosphamide|cyclophosphamide|mesh-list
93328709|NCT04029038|Fludarabine|fludarabine|mesh-list
93328710|NCT04029038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328711|NCT04029038|Immunologic Factors|immunologic factors|mesh-ancestor
93328712|NCT04029038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328713|NCT04029038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328714|NCT04029038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93328715|NCT04029038|Alkylating Agents|alkylating agents|mesh-ancestor
93328716|NCT04029038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328717|NCT04029038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328718|NCT04029038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93328719|NCT04223518|Immunoglobulins|immunoglobulins|mesh-list
93328720|NCT04223518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93328721|NCT04223518|Antibodies|antibodies|mesh-list
93328722|NCT04223518|Immunologic Factors|immunologic factors|mesh-ancestor
93328723|NCT04223518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328724|NCT02387450|Sildenafil Citrate|sildenafil citrate|mesh-list
93328725|NCT02387450|Vasodilator Agents|vasodilator agents|mesh-ancestor
93328726|NCT02387450|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93328727|NCT02387450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93328728|NCT02387450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328729|NCT02387450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328730|NCT02387450|Urological Agents|urological agents|mesh-ancestor
93328731|NCT02390882|Tamsulosin|tamsulosin|mesh-list
93328732|NCT02390882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93328733|NCT02390882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93328734|NCT02390882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93328735|NCT02390882|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328736|NCT02390882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328737|NCT02390882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328738|NCT02390882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328739|NCT02390882|Urological Agents|urological agents|mesh-ancestor
93328740|NCT02387138|Oxaliplatin|oxaliplatin|mesh-list
93328741|NCT02387138|Irinotecan|irinotecan|mesh-list
93328742|NCT02387138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328743|NCT02387138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93328744|NCT02387138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93328745|NCT02387138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328746|NCT02387138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328747|NCT02387060|Fentanyl|fentanyl|mesh-list
93328748|NCT02387060|Bupivacaine|bupivacaine|mesh-list
93328749|NCT02387060|Anesthetics, Local|anesthetics, local|mesh-ancestor
93328750|NCT02387060|Anesthetics|anesthetics|mesh-ancestor
93328751|NCT02387060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328752|NCT02387060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328753|NCT02387060|Sensory System Agents|sensory system agents|mesh-ancestor
93328754|NCT02387060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328755|NCT02387060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93328756|NCT02387060|Narcotics|narcotics|mesh-ancestor
93328757|NCT02387060|Analgesics|analgesics|mesh-ancestor
93328758|NCT02387060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93328759|NCT02387060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93328760|NCT02387060|Anesthetics, General|anesthetics, general|mesh-ancestor
93328761|NCT01365052|Naproxen|naproxen|mesh-list
93328762|NCT01365052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93328763|NCT01365052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328764|NCT01365052|Analgesics|analgesics|mesh-ancestor
93328765|NCT01365052|Sensory System Agents|sensory system agents|mesh-ancestor
93328766|NCT01365052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328767|NCT01365052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328768|NCT01365052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328769|NCT01365052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328770|NCT01365052|Gout Suppressants|gout suppressants|mesh-ancestor
93328771|NCT01365052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328772|NCT01365052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328773|NCT01365052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328774|NCT05155215|Cyclophosphamide|cyclophosphamide|mesh-list
93328775|NCT05155215|Fludarabine|fludarabine|mesh-list
93328776|NCT05155215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328777|NCT05155215|Immunologic Factors|immunologic factors|mesh-ancestor
93328778|NCT05155215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328779|NCT05155215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328780|NCT05155215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93328781|NCT05155215|Alkylating Agents|alkylating agents|mesh-ancestor
93328782|NCT05155215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328783|NCT05155215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328784|NCT05155215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93328785|NCT03471585|Dronabinol|dronabinol|mesh-list
93328786|NCT03471585|Hallucinogens|hallucinogens|mesh-ancestor
93328787|NCT03471585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328788|NCT03471585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93328789|NCT03471585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328790|NCT03471585|Analgesics|analgesics|mesh-ancestor
93328791|NCT03471585|Sensory System Agents|sensory system agents|mesh-ancestor
93328792|NCT03471585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328793|NCT03471585|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93328794|NCT03471585|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93328795|NCT03471585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328796|NCT03471585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328797|NCT03471585|Hormones|hormones|mesh-ancestor
93328798|NCT03471585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328799|NCT05072782|Infliximab|infliximab|mesh-list
93328800|NCT05072782|Methotrexate|methotrexate|mesh-list
93328801|NCT05072782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93328802|NCT05072782|Abortifacient Agents|abortifacient agents|mesh-ancestor
93328803|NCT05072782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93328804|NCT05072782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328805|NCT05072782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328806|NCT05072782|Antimetabolites|antimetabolites|mesh-ancestor
93328807|NCT05072782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328808|NCT05072782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328809|NCT05072782|Dermatologic Agents|dermatologic agents|mesh-ancestor
93328810|NCT05072782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328811|NCT05072782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93328812|NCT05072782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328813|NCT05072782|Immunologic Factors|immunologic factors|mesh-ancestor
93328814|NCT05072782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328815|NCT05072782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93328816|NCT05072782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93328817|NCT05072782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328818|NCT05072782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328819|NCT03379389|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93328820|NCT03379389|Methenamine hippurate|methenamine hippurate|mesh-list
93328821|NCT03379389|Methenamine mandelate|methenamine mandelate|mesh-list
93328822|NCT03379389|Methenamine|methenamine|mesh-list
93328823|NCT03379389|Acriflavine|acriflavine|mesh-list
93328824|NCT03379389|Methylene Blue|methylene blue|mesh-list
93328825|NCT03379389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328826|NCT03379389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328827|NCT03379389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328828|NCT03379389|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93328829|NCT03379389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93328830|NCT05170438|Paclitaxel|paclitaxel|mesh-list
93328831|NCT05170438|Lenvatinib|lenvatinib|mesh-list
93328832|NCT05170438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93328833|NCT05170438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328834|NCT05170438|Tubulin Modulators|tubulin modulators|mesh-ancestor
93328835|NCT05170438|Antimitotic Agents|antimitotic agents|mesh-ancestor
93328836|NCT05170438|Mitosis Modulators|mitosis modulators|mesh-ancestor
93328837|NCT05170438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328838|NCT05170438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93328839|NCT05170438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328840|NCT05109520|Insulin Glargine|insulin glargine|mesh-list
93328841|NCT05109520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93328842|NCT05109520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328843|NCT03478605|Dexamethasone|dexamethasone|mesh-list
93328844|NCT03478605|Ondansetron|ondansetron|mesh-list
93328845|NCT03478605|Olanzapine|olanzapine|mesh-list
93328846|NCT03478605|Aprepitant|aprepitant|mesh-list
93328847|NCT03478605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328848|NCT03478605|Antiemetics|antiemetics|mesh-ancestor
93328849|NCT03478605|Autonomic Agents|autonomic agents|mesh-ancestor
93328850|NCT03478605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328851|NCT03478605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328852|NCT03478605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93328853|NCT03478605|Glucocorticoids|glucocorticoids|mesh-ancestor
93328854|NCT03478605|Hormones|hormones|mesh-ancestor
93328855|NCT03478605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328856|NCT03478605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93328857|NCT03478605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328858|NCT03478605|Antipruritics|antipruritics|mesh-ancestor
93328859|NCT03478605|Dermatologic Agents|dermatologic agents|mesh-ancestor
93328860|NCT03478605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93328861|NCT03478605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93328862|NCT03478605|Serotonin Agents|serotonin agents|mesh-ancestor
93328863|NCT03478605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328864|NCT03478605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328865|NCT03478605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93328866|NCT03478605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93328867|NCT03478605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328868|NCT03478605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93328869|NCT03478605|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93328870|NCT03478605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93328871|NCT03478605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328872|NCT03478605|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93328873|NCT05109364|Terazosin|terazosin|mesh-list
93328874|NCT05109364|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93328875|NCT05109364|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93328876|NCT05109364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93328877|NCT05109364|Adrenergic Agents|adrenergic agents|mesh-ancestor
93328878|NCT05109364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93328879|NCT05109364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328880|NCT05109364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328881|NCT05109364|Urological Agents|urological agents|mesh-ancestor
93328882|NCT05258799|Cytarabine|cytarabine|mesh-list
93328883|NCT05258799|Decitabine|decitabine|mesh-list
93328884|NCT05258799|Aclarubicin|aclarubicin|mesh-list
93328885|NCT05258799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93328886|NCT05258799|Antimetabolites|antimetabolites|mesh-ancestor
93328887|NCT05258799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328888|NCT05258799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328889|NCT05258799|Antiviral Agents|antiviral agents|mesh-ancestor
93328890|NCT05258799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328891|NCT05258799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328892|NCT05258799|Immunologic Factors|immunologic factors|mesh-ancestor
93328893|NCT05258799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328894|NCT05258799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328895|NCT05258799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93328896|NCT05258799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93328897|NCT05258799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93328898|NCT05053750|Paclitaxel|paclitaxel|mesh-list
93328899|NCT05053750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93328900|NCT05053750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93328901|NCT05053750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328902|NCT05053750|Tubulin Modulators|tubulin modulators|mesh-ancestor
93328903|NCT05053750|Antimitotic Agents|antimitotic agents|mesh-ancestor
93328904|NCT05053750|Mitosis Modulators|mitosis modulators|mesh-ancestor
93328905|NCT05053750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328906|NCT04233892|Estrogens|estrogens|mesh-list
93328907|NCT04233892|Hormones|hormones|mesh-ancestor
93328908|NCT04233892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328909|NCT04233892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328910|NCT02386358|Benzonidazole|benzonidazole|mesh-list
93328911|NCT02386358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93328912|NCT02386358|Immunologic Factors|immunologic factors|mesh-ancestor
93328913|NCT02386358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328914|NCT02386358|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93328915|NCT02386358|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93328916|NCT02386358|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93328917|NCT02386358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328918|NCT03283371|Natalizumab|natalizumab|mesh-list
93328919|NCT03283371|Immunologic Factors|immunologic factors|mesh-ancestor
93328920|NCT03283371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328921|NCT05069350|Bupivacaine|bupivacaine|mesh-list
93328922|NCT05069350|Anesthetics, Local|anesthetics, local|mesh-ancestor
93328923|NCT05069350|Anesthetics|anesthetics|mesh-ancestor
93328924|NCT05069350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328925|NCT05069350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328926|NCT05069350|Sensory System Agents|sensory system agents|mesh-ancestor
93328927|NCT05069350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328928|NCT03471351|Pembrolizumab|pembrolizumab|mesh-list
93328929|NCT03471351|Tenalisib|tenalisib|mesh-list
93328930|NCT03471351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93328931|NCT03471351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328932|NCT03471351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93328933|NCT03471351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328934|NCT03471351|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93328935|NCT03471351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328936|NCT02386592|Chlorhexidine|chlorhexidine|mesh-list
93328937|NCT02386592|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93328938|NCT02386592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93328939|NCT02386592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93328940|NCT02386592|Disinfectants|disinfectants|mesh-ancestor
93328941|NCT02386592|Dermatologic Agents|dermatologic agents|mesh-ancestor
93328942|NCT02390258|S66913|s66913|mesh-list
93328943|NCT02390258|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93328944|NCT02390258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328945|NCT02390258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328946|NCT03891446|Bimatoprost|bimatoprost|mesh-list
93328947|NCT03891446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93328948|NCT03059511|Nalbuphine|nalbuphine|mesh-list
93328949|NCT03059511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93328950|NCT03059511|Narcotics|narcotics|mesh-ancestor
93328951|NCT03059511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328952|NCT03059511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328953|NCT03059511|Analgesics|analgesics|mesh-ancestor
93328954|NCT03059511|Sensory System Agents|sensory system agents|mesh-ancestor
93328955|NCT03059511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328956|NCT04439786|Lidocaine|lidocaine|mesh-list
93328957|NCT04439786|Anesthetics, Local|anesthetics, local|mesh-ancestor
93328958|NCT04439786|Anesthetics|anesthetics|mesh-ancestor
93328959|NCT04439786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93328960|NCT04439786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328961|NCT04439786|Sensory System Agents|sensory system agents|mesh-ancestor
93328962|NCT04439786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328963|NCT04439786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93328964|NCT04439786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93328965|NCT04439786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93328966|NCT04439786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93328967|NCT04439786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328968|NCT03821792|Prednisone|prednisone|mesh-list
93328969|NCT03821792|Cortisone|cortisone|mesh-list
93328970|NCT03821792|Abiraterone Acetate|abiraterone acetate|mesh-list
93328971|NCT03821792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93328972|NCT03821792|Glucocorticoids|glucocorticoids|mesh-ancestor
93328973|NCT03821792|Hormones|hormones|mesh-ancestor
93328974|NCT03821792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93328975|NCT03821792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328976|NCT03821792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93328977|NCT03821792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93328978|NCT03821792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93328979|NCT03821792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328980|NCT03821792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328981|NCT03821792|Hormone Antagonists|hormone antagonists|mesh-ancestor
93328982|NCT03821792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93328983|NCT02665286|Naproxen|naproxen|mesh-list
93328984|NCT02665286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93328985|NCT02665286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93328986|NCT02665286|Orphenadrine|orphenadrine|mesh-list
93328987|NCT02665286|Methocarbamol|methocarbamol|mesh-list
93328988|NCT02665286|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93328989|NCT02665286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93328991|NCT02665286|Sensory System Agents|sensory system agents|mesh-ancestor
93328992|NCT02665286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93328993|NCT02665286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93328994|NCT02665286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93328995|NCT02665286|Gout Suppressants|gout suppressants|mesh-ancestor
93328996|NCT02665286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93328997|NCT02665286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93328998|NCT02665286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93328999|NCT02665286|Cholinergic Agents|cholinergic agents|mesh-ancestor
93329000|NCT02665286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329001|NCT02665286|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93329002|NCT02665286|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93329003|NCT02665286|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93329004|NCT02665286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93329005|NCT02665286|Parasympatholytics|parasympatholytics|mesh-ancestor
93329006|NCT02665286|Autonomic Agents|autonomic agents|mesh-ancestor
93329007|NCT02665286|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93329008|NCT02665286|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
93329009|NCT02665286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93329010|NCT02390102|Epoetin Alfa|epoetin alfa|mesh-list
93329011|NCT02390102|Hematinics|hematinics|mesh-ancestor
93329012|NCT02134925|Poly ICLC|poly iclc|mesh-list
93329013|NCT02134925|Interferon Inducers|interferon inducers|mesh-ancestor
93329014|NCT02134925|Immunologic Factors|immunologic factors|mesh-ancestor
93329015|NCT02134925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329016|NCT03663673|Decanoic acid|decanoic acid|mesh-list
93329017|NCT03663673|Antifungal Agents|antifungal agents|mesh-ancestor
93329018|NCT03663673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329019|NCT04058743|Cobalt|cobalt|mesh-list
93329020|NCT04058743|Chromium|chromium|mesh-list
93329021|NCT04058743|Nickel|nickel|mesh-list
93329022|NCT04058743|Trace Elements|trace elements|mesh-ancestor
93329023|NCT04058743|Micronutrients|micronutrients|mesh-ancestor
93329024|NCT04058743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329025|NCT03664063|Azithromycin|azithromycin|mesh-list
93329026|NCT03664063|Ivermectin|ivermectin|mesh-list
93329027|NCT03664063|Albendazole|albendazole|mesh-list
93329028|NCT03664063|Diethylcarbamazine|diethylcarbamazine|mesh-list
93329029|NCT03664063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93329030|NCT03664063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329031|NCT03664063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93329032|NCT03664063|Anthelmintics|anthelmintics|mesh-ancestor
93329033|NCT03664063|Anticestodal Agents|anticestodal agents|mesh-ancestor
93329034|NCT03664063|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93329035|NCT03664063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93329036|NCT03664063|Tubulin Modulators|tubulin modulators|mesh-ancestor
93329037|NCT03664063|Antimitotic Agents|antimitotic agents|mesh-ancestor
93329038|NCT03664063|Mitosis Modulators|mitosis modulators|mesh-ancestor
93329039|NCT03664063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329040|NCT03664063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329041|NCT03664063|Filaricides|filaricides|mesh-ancestor
93329042|NCT03664063|Antinematodal Agents|antinematodal agents|mesh-ancestor
93329043|NCT03664063|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93329044|NCT03664063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329045|NCT02911285|Acetylcysteine|acetylcysteine|mesh-list
93329046|NCT02911285|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93329047|NCT02911285|Antiviral Agents|antiviral agents|mesh-ancestor
93329048|NCT02911285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329049|NCT02911285|Expectorants|expectorants|mesh-ancestor
93329050|NCT02911285|Respiratory System Agents|respiratory system agents|mesh-ancestor
93329051|NCT02911285|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93329052|NCT02911285|Antioxidants|antioxidants|mesh-ancestor
93329053|NCT02911285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329054|NCT02911285|Protective Agents|protective agents|mesh-ancestor
93329055|NCT02911285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329056|NCT02911285|Antidotes|antidotes|mesh-ancestor
93329057|NCT04997902|Tipifarnib|tipifarnib|mesh-list
93329058|NCT04997902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329059|NCT01061515|Bevacizumab|bevacizumab|mesh-list
93329060|NCT01061515|Capecitabine|capecitabine|mesh-list
93329061|NCT01061515|Oxaliplatin|oxaliplatin|mesh-list
93329062|NCT01061515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329063|NCT01061515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329064|NCT01061515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93329065|NCT01061515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93329066|NCT01061515|Growth Substances|growth substances|mesh-ancestor
93329067|NCT01061515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329068|NCT01061515|Growth Inhibitors|growth inhibitors|mesh-ancestor
93329069|NCT01061515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329070|NCT01061515|Antimetabolites|antimetabolites|mesh-ancestor
93329071|NCT01061515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329072|NCT01069939|Esomeprazole|esomeprazole|mesh-list
93329073|NCT01069939|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93329074|NCT01069939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329075|NCT01069939|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93329076|NCT01069939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329077|NCT01069939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329078|NCT01069705|Tobramycin|tobramycin|mesh-list
93329079|NCT01069705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93329080|NCT01069705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329081|NCT01996865|Rituximab|rituximab|mesh-list
93329082|NCT01996865|Lenalidomide|lenalidomide|mesh-list
93329083|NCT01996865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329084|NCT01996865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329085|NCT01996865|Immunologic Factors|immunologic factors|mesh-ancestor
93329086|NCT01996865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329087|NCT01996865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329088|NCT01996865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93329089|NCT01996865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93329090|NCT01996865|Growth Substances|growth substances|mesh-ancestor
93329091|NCT01996865|Growth Inhibitors|growth inhibitors|mesh-ancestor
93329092|NCT01069627|Bevacizumab|bevacizumab|mesh-list
93329093|NCT01069627|Fotemustine|fotemustine|mesh-list
93329094|NCT01069627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329095|NCT01069627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329096|NCT01069627|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93329097|NCT01069627|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93329098|NCT01069627|Growth Substances|growth substances|mesh-ancestor
93329099|NCT01069627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329100|NCT01069627|Growth Inhibitors|growth inhibitors|mesh-ancestor
93329101|NCT04057261|Liraglutide|liraglutide|mesh-list
93329102|NCT04057261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93329103|NCT04057261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329104|NCT04057261|Incretins|incretins|mesh-ancestor
93329105|NCT04057261|Hormones|hormones|mesh-ancestor
93329106|NCT04057261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329107|NCT01947023|Lapatinib|lapatinib|mesh-list
93329108|NCT01947023|Dabrafenib|dabrafenib|mesh-list
93329109|NCT01947023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329110|NCT01947023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329111|NCT01947023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329112|NCT01947023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329113|NCT01064245|Mannitol|mannitol|mesh-list
93329114|NCT01064245|Methacholine Chloride|methacholine chloride|mesh-list
93329115|NCT01064245|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93329116|NCT01064245|Diuretics|diuretics|mesh-ancestor
93329117|NCT01064245|Natriuretic Agents|natriuretic agents|mesh-ancestor
93329118|NCT01064245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329119|NCT01064245|Miotics|miotics|mesh-ancestor
93329120|NCT01064245|Autonomic Agents|autonomic agents|mesh-ancestor
93329121|NCT01064245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329122|NCT01064245|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93329123|NCT01064245|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93329124|NCT01064245|Respiratory System Agents|respiratory system agents|mesh-ancestor
93329125|NCT01064245|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93329126|NCT01064245|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93329127|NCT01064245|Cholinergic Agents|cholinergic agents|mesh-ancestor
93329128|NCT01064245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329129|NCT01064245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329130|NCT04056949|Paclitaxel|paclitaxel|mesh-list
93329131|NCT04056949|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93329132|NCT04056949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93329133|NCT04056949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329134|NCT04056949|Tubulin Modulators|tubulin modulators|mesh-ancestor
93329135|NCT04056949|Antimitotic Agents|antimitotic agents|mesh-ancestor
93329136|NCT04056949|Mitosis Modulators|mitosis modulators|mesh-ancestor
93329137|NCT04056949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329138|NCT03662425|Oxytocin|oxytocin|mesh-list
93329139|NCT03662425|Oxytocics|oxytocics|mesh-ancestor
93329140|NCT03662425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93329141|NCT03662425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001110|NCT01019265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329142|NCT03673163|Lidocaine|lidocaine|mesh-list
93329143|NCT03673163|Anesthetics, Local|anesthetics, local|mesh-ancestor
93329144|NCT03673163|Anesthetics|anesthetics|mesh-ancestor
93329145|NCT03673163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329146|NCT03673163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329147|NCT03673163|Sensory System Agents|sensory system agents|mesh-ancestor
93329148|NCT03673163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329149|NCT03673163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93329150|NCT03673163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93329151|NCT03673163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93329152|NCT03673163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93329153|NCT03673163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329154|NCT03662269|Indomethacin|indomethacin|mesh-list
93329155|NCT03662269|Omeprazole|omeprazole|mesh-list
93329156|NCT03662269|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93329157|NCT03662269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329158|NCT03662269|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93329159|NCT03662269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329160|NCT03662269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329161|NCT03662269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93329162|NCT03662269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329163|NCT03662269|Analgesics|analgesics|mesh-ancestor
93329164|NCT03662269|Sensory System Agents|sensory system agents|mesh-ancestor
93329165|NCT03662269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329166|NCT03662269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329167|NCT03662269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329168|NCT03662269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329169|NCT03662269|Gout Suppressants|gout suppressants|mesh-ancestor
93329170|NCT03662269|Tocolytic Agents|tocolytic agents|mesh-ancestor
93329171|NCT03662269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93329172|NCT03662269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93329173|NCT04056325|Ivermectin|ivermectin|mesh-list
93329174|NCT04056325|Moxidectin|moxidectin|mesh-list
93329175|NCT04056325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93329176|NCT04056325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329177|NCT04056325|Anthelmintics|anthelmintics|mesh-ancestor
93329178|NCT04056325|Antinematodal Agents|antinematodal agents|mesh-ancestor
93329179|NCT03662971|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93329180|NCT03662971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93329181|NCT03662893|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93329182|NCT03662893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93329183|NCT03662893|Cholinergic Agents|cholinergic agents|mesh-ancestor
93329184|NCT03662893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329185|NCT03662893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329186|NCT03662893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329187|NCT01624805|Cyclosporine|cyclosporine|mesh-list
93329188|NCT01624805|Methylprednisolone|methylprednisolone|mesh-list
93329189|NCT01624805|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93329190|NCT01624805|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93329191|NCT01624805|Prednisolone|prednisolone|mesh-list
93329192|NCT01624805|Prednisolone acetate|prednisolone acetate|mesh-list
93329193|NCT01624805|Lenograstim|lenograstim|mesh-list
93329194|NCT01624805|Cyclosporins|cyclosporins|mesh-list
93329195|NCT01624805|Thymoglobulin|thymoglobulin|mesh-list
93329196|NCT01624805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93329197|NCT01624805|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93329198|NCT01624805|Prednisolone phosphate|prednisolone phosphate|mesh-list
93329199|NCT01624805|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93329200|NCT01624805|Immunologic Factors|immunologic factors|mesh-ancestor
93329201|NCT01624805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329202|NCT01624805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329203|NCT01624805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329204|NCT01624805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329205|NCT01624805|Antifungal Agents|antifungal agents|mesh-ancestor
93329206|NCT01624805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329207|NCT01624805|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329208|NCT01624805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329209|NCT01624805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93329210|NCT01624805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329211|NCT01624805|Antiemetics|antiemetics|mesh-ancestor
93329212|NCT01624805|Autonomic Agents|autonomic agents|mesh-ancestor
93329213|NCT01624805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329214|NCT01624805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329215|NCT01624805|Glucocorticoids|glucocorticoids|mesh-ancestor
93329216|NCT01624805|Hormones|hormones|mesh-ancestor
93329217|NCT01624805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329218|NCT01624805|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93329219|NCT01624805|Protective Agents|protective agents|mesh-ancestor
93329220|NCT01624805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93329221|NCT01624805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329222|NCT01585025|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
93329223|NCT01585025|Cathartics|cathartics|mesh-ancestor
93329224|NCT01585025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329225|NCT00328653|Cyclosporine|cyclosporine|mesh-list
93329226|NCT00328653|Cyclosporins|cyclosporins|mesh-list
93329227|NCT00328653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329228|NCT00328653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329229|NCT00328653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329230|NCT00328653|Immunologic Factors|immunologic factors|mesh-ancestor
93329231|NCT00328653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329232|NCT00328653|Antifungal Agents|antifungal agents|mesh-ancestor
93329233|NCT00328653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329234|NCT00328653|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329235|NCT00328653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329236|NCT00328653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93329237|NCT03662113|Domperidone|domperidone|mesh-list
93329238|NCT03662113|Simethicone|simethicone|mesh-list
93329239|NCT03662113|Antiemetics|antiemetics|mesh-ancestor
93329240|NCT03662113|Autonomic Agents|autonomic agents|mesh-ancestor
93329241|NCT03662113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329242|NCT03662113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329243|NCT03662113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329244|NCT03662113|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93329245|NCT03662113|Dopamine Agents|dopamine agents|mesh-ancestor
93329246|NCT03662113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329247|NCT03662113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329248|NCT03662113|Antifoaming Agents|antifoaming agents|mesh-ancestor
93329249|NCT03662113|Emollients|emollients|mesh-ancestor
93329250|NCT03662113|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329252|NCT03662035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329253|NCT03662035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329254|NCT03662035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329255|NCT03662035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329256|NCT05798546|Cyclophosphamide|cyclophosphamide|mesh-list
93329257|NCT05798546|Fludarabine|fludarabine|mesh-list
93329258|NCT05798546|Interleukin-2|interleukin-2|mesh-list
93329259|NCT05798546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329260|NCT05798546|Immunologic Factors|immunologic factors|mesh-ancestor
93329261|NCT05798546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329262|NCT05798546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329263|NCT05798546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93329264|NCT05798546|Alkylating Agents|alkylating agents|mesh-ancestor
93329265|NCT05798546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329266|NCT05798546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329267|NCT05798546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93329268|NCT05798546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329269|NCT05798546|Analgesics|analgesics|mesh-ancestor
93329270|NCT05798546|Sensory System Agents|sensory system agents|mesh-ancestor
93329271|NCT05798546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329272|NCT05798195|Dexamethasone|dexamethasone|mesh-list
93329273|NCT05798195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329274|NCT05798195|Antiemetics|antiemetics|mesh-ancestor
93329275|NCT05798195|Autonomic Agents|autonomic agents|mesh-ancestor
93329276|NCT05798195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329277|NCT05798195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329278|NCT05798195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329279|NCT05798195|Glucocorticoids|glucocorticoids|mesh-ancestor
93329280|NCT05798195|Hormones|hormones|mesh-ancestor
93329281|NCT05798195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329282|NCT05798195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93329283|NCT05798195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329284|NCT05797948|Cyclophosphamide|cyclophosphamide|mesh-list
93329285|NCT05797948|Fludarabine|fludarabine|mesh-list
93329286|NCT05797948|Lenalidomide|lenalidomide|mesh-list
93329287|NCT05797948|Azacitidine|azacitidine|mesh-list
93329288|NCT05797948|Obinutuzumab|obinutuzumab|mesh-list
93329289|NCT05797948|Zanubrutinib|zanubrutinib|mesh-list
93329290|NCT05797948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329291|NCT05797948|Immunologic Factors|immunologic factors|mesh-ancestor
93329292|NCT05797948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329293|NCT05797948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329294|NCT05797948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93329295|NCT05797948|Alkylating Agents|alkylating agents|mesh-ancestor
93329296|NCT05797948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329297|NCT05797948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329298|NCT05797948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93329299|NCT05797948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329300|NCT05797948|Antimetabolites|antimetabolites|mesh-ancestor
93329301|NCT05797948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93329302|NCT05797948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93329303|NCT05797948|Growth Substances|growth substances|mesh-ancestor
93329304|NCT05797948|Growth Inhibitors|growth inhibitors|mesh-ancestor
93329305|NCT05797948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329306|NCT05797948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329307|NCT05797948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329309|NCT05797870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329310|NCT05797818|Chlorhexidine|chlorhexidine|mesh-list
93329311|NCT05797818|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93329312|NCT05797818|Methylene Blue|methylene blue|mesh-list
93329313|NCT05797818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93329314|NCT05797818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329315|NCT05797818|Disinfectants|disinfectants|mesh-ancestor
93329316|NCT05797818|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329317|NCT05797818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329318|NCT05797818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329319|NCT05797805|Pembrolizumab|pembrolizumab|mesh-list
93329320|NCT05797805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329321|NCT05797805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329322|NCT05797805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93329323|NCT05797805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329324|NCT05797792|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93329325|NCT05797792|Plasminogen|plasminogen|mesh-list
93329326|NCT05797792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93329327|NCT05797792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93329328|NCT05797792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329329|NCT05797753|Itraconazole|itraconazole|mesh-list
93329330|NCT05797753|Erythromycin|erythromycin|mesh-list
93329331|NCT05797753|Erythromycin Estolate|erythromycin estolate|mesh-list
93329332|NCT05797753|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93329333|NCT05797753|Erythromycin stearate|erythromycin stearate|mesh-list
93329334|NCT05797753|Antifungal Agents|antifungal agents|mesh-ancestor
93329335|NCT05797753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329336|NCT05797753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93329337|NCT05797753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93329338|NCT05797753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329339|NCT05797753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329340|NCT05797753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93329341|NCT05797753|Hormone Antagonists|hormone antagonists|mesh-ancestor
93329342|NCT05797753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329343|NCT05797753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329344|NCT05797753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93329345|NCT05797753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93329346|NCT05797753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329347|NCT05797753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93329348|NCT05797740|Cladribine|cladribine|mesh-list
93329349|NCT05797740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329350|NCT05797740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329351|NCT05797740|Immunologic Factors|immunologic factors|mesh-ancestor
93329352|NCT05797740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329353|NCT05797714|Tenofovir|tenofovir|mesh-list
93329354|NCT05797714|Antiviral Agents|antiviral agents|mesh-ancestor
93329355|NCT05797714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329356|NCT05797714|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93329357|NCT05797714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93329358|NCT05797714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329359|NCT05797714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329360|NCT05797714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93329361|NCT05797714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93329362|NCT05797623|Cyclosporine|cyclosporine|mesh-list
93329363|NCT05797623|Cyclosporins|cyclosporins|mesh-list
93329364|NCT05797623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329365|NCT05797623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329366|NCT05797623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001336|NCT02561117|Metronidazole|metronidazole|mesh-list
93329367|NCT05797623|Immunologic Factors|immunologic factors|mesh-ancestor
93329368|NCT05797623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329369|NCT05797623|Antifungal Agents|antifungal agents|mesh-ancestor
93329370|NCT05797623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329371|NCT05797623|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329372|NCT05797623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329373|NCT05797623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93329375|NCT05797584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93329376|NCT05797584|Sympathomimetics|sympathomimetics|mesh-ancestor
93329377|NCT05797584|Autonomic Agents|autonomic agents|mesh-ancestor
93329378|NCT05797584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329379|NCT05797584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329380|NCT05797584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93329381|NCT05797584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93329382|NCT05797584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93329383|NCT05797584|Adrenergic Agents|adrenergic agents|mesh-ancestor
93329384|NCT05797584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329385|NCT05797584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329386|NCT05797584|Protective Agents|protective agents|mesh-ancestor
93329387|NCT05797493|Atezolizumab|atezolizumab|mesh-list
93329388|NCT05797493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93329389|NCT05797493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329390|NCT05797493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329391|NCT05797493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329392|NCT05797220|Diltiazem|diltiazem|mesh-list
93329393|NCT05797220|Botulinum Toxins|botulinum toxins|mesh-list
93329394|NCT05797220|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93329395|NCT05797220|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93329396|NCT05797220|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93329397|NCT05797220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93329398|NCT05797220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329399|NCT05797220|Cholinergic Agents|cholinergic agents|mesh-ancestor
93329400|NCT05797220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329401|NCT05797220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329402|NCT05797220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93329403|NCT05797220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329404|NCT05797220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93329405|NCT05797220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93329406|NCT05797220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93329407|NCT05797220|Vasodilator Agents|vasodilator agents|mesh-ancestor
93329408|NCT05797077|Capecitabine|capecitabine|mesh-list
93329409|NCT05797077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329410|NCT05797077|Antimetabolites|antimetabolites|mesh-ancestor
93329411|NCT05797077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329412|NCT05797077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329413|NCT05797038|Tacrolimus|tacrolimus|mesh-list
93329414|NCT05797038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329415|NCT05797038|Immunologic Factors|immunologic factors|mesh-ancestor
93329416|NCT05797038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329417|NCT05797038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93329418|NCT05797038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329419|NCT05797038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329420|NCT05795933|Vitamin D|vitamin d|mesh-list
93329421|NCT05795933|Cholecalciferol|cholecalciferol|mesh-list
93329422|NCT05795933|Vitamins|vitamins|mesh-ancestor
93329423|NCT05795933|Micronutrients|micronutrients|mesh-ancestor
93329424|NCT05795933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329425|NCT05795933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93329426|NCT05795933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93329427|NCT05792774|Bupivacaine|bupivacaine|mesh-list
93329428|NCT05792774|Anesthetics, Local|anesthetics, local|mesh-ancestor
93329429|NCT05792774|Anesthetics|anesthetics|mesh-ancestor
93329430|NCT05792774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329431|NCT05792774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329432|NCT05792774|Sensory System Agents|sensory system agents|mesh-ancestor
93329433|NCT05792774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329434|NCT05782127|Venetoclax|venetoclax|mesh-list
93329435|NCT05782127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329436|NCT05703854|Cyclophosphamide|cyclophosphamide|mesh-list
93329437|NCT05703854|Fludarabine|fludarabine|mesh-list
93329438|NCT05703854|Fludarabine phosphate|fludarabine phosphate|mesh-list
93329439|NCT05703854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001412|NCT00483717|Ketorolac|ketorolac|mesh-list
93329440|NCT05703854|Immunologic Factors|immunologic factors|mesh-ancestor
93329441|NCT05703854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329442|NCT05703854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329443|NCT05703854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93329444|NCT05703854|Alkylating Agents|alkylating agents|mesh-ancestor
93329445|NCT05703854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329446|NCT05703854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329447|NCT05703854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93329448|NCT05703854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329449|NCT05703854|Antimetabolites|antimetabolites|mesh-ancestor
93329450|NCT05692999|Pembrolizumab|pembrolizumab|mesh-list
93329451|NCT05692999|Pemetrexed|pemetrexed|mesh-list
93329452|NCT05692999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329453|NCT05692999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329454|NCT05692999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93329455|NCT05692999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329456|NCT05692999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329457|NCT05692999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93329458|NCT05692999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93329459|NCT05665140|Dexamethasone|dexamethasone|mesh-list
93329460|NCT05665140|Lenalidomide|lenalidomide|mesh-list
93329461|NCT05665140|Bortezomib|bortezomib|mesh-list
93329462|NCT05665140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329463|NCT05665140|Antiemetics|antiemetics|mesh-ancestor
93329464|NCT05665140|Autonomic Agents|autonomic agents|mesh-ancestor
93329465|NCT05665140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329466|NCT05665140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329467|NCT05665140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329468|NCT05665140|Glucocorticoids|glucocorticoids|mesh-ancestor
93329469|NCT05665140|Hormones|hormones|mesh-ancestor
93329470|NCT05665140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329471|NCT05665140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93329472|NCT05665140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329473|NCT05665140|Immunologic Factors|immunologic factors|mesh-ancestor
93329474|NCT05665140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93329475|NCT05665140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93329476|NCT05665140|Growth Substances|growth substances|mesh-ancestor
93329477|NCT05665140|Growth Inhibitors|growth inhibitors|mesh-ancestor
93329478|NCT05661591|Fluconazole|fluconazole|mesh-list
93329479|NCT05661591|Antifungal Agents|antifungal agents|mesh-ancestor
93329480|NCT05661591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329481|NCT05661591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93329482|NCT05661591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93329483|NCT05661591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329484|NCT05661591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329485|NCT05661591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93329486|NCT05661591|Hormone Antagonists|hormone antagonists|mesh-ancestor
93329487|NCT05661591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329488|NCT05661591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329489|NCT05661591|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93329490|NCT05661591|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93329491|NCT05661201|Doxorubicin|doxorubicin|mesh-list
93329492|NCT05661201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93329493|NCT05661201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329494|NCT05661201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93329495|NCT05661201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93329496|NCT05661201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329497|NCT05661201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329498|NCT05634148|Dexmedetomidine|dexmedetomidine|mesh-list
93329499|NCT05634148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93329500|NCT05634148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329501|NCT05634148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329502|NCT05634148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329503|NCT05634148|Analgesics|analgesics|mesh-ancestor
93329504|NCT05634148|Sensory System Agents|sensory system agents|mesh-ancestor
93329505|NCT05634148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623350|NCT00157079|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93329506|NCT05634148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93329507|NCT05634148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93329508|NCT05634148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93329509|NCT05634148|Adrenergic Agents|adrenergic agents|mesh-ancestor
93329510|NCT05634148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329511|NCT05634148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329512|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
93329513|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93329514|NCT05631899|Paclitaxel|paclitaxel|mesh-list
93329515|NCT05631899|Antibodies|antibodies|mesh-list
93329516|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
93329517|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
93329518|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329519|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
93329520|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329521|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329522|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93329523|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
93329524|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329525|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329526|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93329527|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93329528|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
93329529|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
93329530|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
93329531|NCT05622123|Exenatide|exenatide|mesh-list
93329532|NCT05622123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93329533|NCT05622123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329534|NCT05622123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93329535|NCT05622123|Incretins|incretins|mesh-ancestor
93329536|NCT05622123|Hormones|hormones|mesh-ancestor
93329537|NCT05622123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329538|NCT05594082|Trastuzumab|trastuzumab|mesh-list
93329539|NCT05594082|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93329540|NCT05594082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329541|NCT05594082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329542|NCT05594082|Immunoconjugates|immunoconjugates|mesh-ancestor
93329543|NCT05594082|Immunologic Factors|immunologic factors|mesh-ancestor
93329544|NCT05594082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329545|NCT05574374|Fexuprazan|fexuprazan|mesh-list
93329546|NCT05574374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329547|NCT05566639|Vaccines|vaccines|mesh-list
93329548|NCT05566639|Immunologic Factors|immunologic factors|mesh-ancestor
93329549|NCT05566639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329550|NCT05542394|Curcumin|curcumin|mesh-list
93329551|NCT05542394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93329552|NCT05542394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329553|NCT05542394|Analgesics|analgesics|mesh-ancestor
93329554|NCT05542394|Sensory System Agents|sensory system agents|mesh-ancestor
93329555|NCT05542394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329556|NCT05542394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329557|NCT05542394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329558|NCT05542394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329559|NCT05542394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329560|NCT05542394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329561|NCT05542394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329562|NCT05525078|Nicotine|nicotine|mesh-list
93329563|NCT05525078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93329564|NCT05525078|Autonomic Agents|autonomic agents|mesh-ancestor
93329565|NCT05525078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329566|NCT05525078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329567|NCT05525078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93329568|NCT05525078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93329569|NCT05525078|Cholinergic Agents|cholinergic agents|mesh-ancestor
93329570|NCT05525078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329571|NCT05525078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329572|NCT05506787|Esketamine|esketamine|mesh-list
93329573|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
93329574|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93329575|NCT05503511|Bumetanide|bumetanide|mesh-list
93329576|NCT05503511|Diuretics|diuretics|mesh-ancestor
93329577|NCT05503511|Natriuretic Agents|natriuretic agents|mesh-ancestor
93329578|NCT05503511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329579|NCT05503511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93329580|NCT05503511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93329581|NCT05503511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329582|NCT05503355|Venetoclax|venetoclax|mesh-list
93329583|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329584|NCT05453851|Pancrelipase|pancrelipase|mesh-list
93329585|NCT05453851|Pancreatin|pancreatin|mesh-list
93001552|NCT00755963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329586|NCT05453851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329587|NCT05453500|Prednisone|prednisone|mesh-list
93329588|NCT05453500|Cortisone|cortisone|mesh-list
93329589|NCT05453500|Cyclophosphamide|cyclophosphamide|mesh-list
93329590|NCT05453500|Rituximab|rituximab|mesh-list
93329591|NCT05453500|Doxorubicin|doxorubicin|mesh-list
93329592|NCT05453500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93329593|NCT05453500|Etoposide|etoposide|mesh-list
93329594|NCT05453500|Vincristine|vincristine|mesh-list
93329595|NCT05453500|Etoposide phosphate|etoposide phosphate|mesh-list
93329596|NCT05453500|Daunorubicin|daunorubicin|mesh-list
93329597|NCT05453500|Podophyllotoxin|podophyllotoxin|mesh-list
93329598|NCT05453500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93329599|NCT05453500|Antibodies|antibodies|mesh-list
93329600|NCT05453500|Immunoglobulins|immunoglobulins|mesh-list
93329601|NCT05453500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93329602|NCT05453500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329603|NCT05453500|Immunologic Factors|immunologic factors|mesh-ancestor
93329604|NCT05453500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329605|NCT05453500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329606|NCT05453500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93329607|NCT05453500|Alkylating Agents|alkylating agents|mesh-ancestor
93329608|NCT05453500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329609|NCT05453500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329610|NCT05453500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93329611|NCT05453500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93329612|NCT05453500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93329613|NCT05453500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93329614|NCT05453500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329615|NCT05453500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329616|NCT05453500|Glucocorticoids|glucocorticoids|mesh-ancestor
93329617|NCT05453500|Hormones|hormones|mesh-ancestor
93329618|NCT05453500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329619|NCT05453500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93329620|NCT05453500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93329621|NCT05453500|Tubulin Modulators|tubulin modulators|mesh-ancestor
93329622|NCT05453500|Antimitotic Agents|antimitotic agents|mesh-ancestor
93329623|NCT05453500|Mitosis Modulators|mitosis modulators|mesh-ancestor
93329624|NCT05453500|Keratolytic Agents|keratolytic agents|mesh-ancestor
93329625|NCT05453500|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329626|NCT05445024|Sufentanil|sufentanil|mesh-list
93329627|NCT05445024|Nalbuphine|nalbuphine|mesh-list
93329628|NCT05445024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93329629|NCT05445024|Narcotics|narcotics|mesh-ancestor
93329630|NCT05445024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329631|NCT05445024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329632|NCT05445024|Analgesics|analgesics|mesh-ancestor
93329633|NCT05445024|Sensory System Agents|sensory system agents|mesh-ancestor
93329634|NCT05445024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329635|NCT05445024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93329636|NCT05445024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93329637|NCT05445024|Anesthetics, General|anesthetics, general|mesh-ancestor
93329638|NCT05445024|Anesthetics|anesthetics|mesh-ancestor
93329639|NCT05429814|Menthol|menthol|mesh-list
93329640|NCT05429814|Antipruritics|antipruritics|mesh-ancestor
93329641|NCT05429814|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329642|NCT05420337|Morphine|morphine|mesh-list
93329643|NCT05420337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93329644|NCT05420337|Narcotics|narcotics|mesh-ancestor
93329645|NCT05420337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329646|NCT05420337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329647|NCT05420337|Analgesics|analgesics|mesh-ancestor
93329648|NCT05420337|Sensory System Agents|sensory system agents|mesh-ancestor
93329649|NCT05420337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329650|NCT05409872|Vitamin D|vitamin d|mesh-list
93329651|NCT05409872|Vitamins|vitamins|mesh-list
93329652|NCT05409872|Inositol|inositol|mesh-list
93329653|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
93329654|NCT05409872|Pyridoxal|pyridoxal|mesh-list
93329655|NCT05409872|Pyridoxine|pyridoxine|mesh-list
93329656|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93329657|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
92623497|NCT00182715|Protective Agents|protective agents|mesh-ancestor
93329658|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329659|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93329660|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
93329661|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
93329662|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329663|NCT05409872|Protective Agents|protective agents|mesh-ancestor
93329664|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93329665|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93329666|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329667|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93329668|NCT05390905|Tramadol|tramadol|mesh-list
93329669|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93329670|NCT05390905|Narcotics|narcotics|mesh-ancestor
93329671|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329672|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329673|NCT05390905|Analgesics|analgesics|mesh-ancestor
93329674|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
93329675|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329676|NCT05366621|Denosumab|denosumab|mesh-list
93329677|NCT05366621|Diphosphonates|diphosphonates|mesh-list
93329678|NCT05366621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329679|NCT05366621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93329680|NCT05359146|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
93329681|NCT05359146|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93329682|NCT05359146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329683|NCT05335252|Dronabinol|dronabinol|mesh-list
93329684|NCT05335252|Hallucinogens|hallucinogens|mesh-ancestor
93329685|NCT05335252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329686|NCT05335252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93329687|NCT05335252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329688|NCT05335252|Analgesics|analgesics|mesh-ancestor
93329689|NCT05335252|Sensory System Agents|sensory system agents|mesh-ancestor
93329690|NCT05335252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329691|NCT05335252|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93329692|NCT05335252|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93329693|NCT05335252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329694|NCT05335252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329695|NCT05335252|Hormones|hormones|mesh-ancestor
93329696|NCT05335252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329697|NCT05325775|SR 142801|sr 142801|mesh-list
93329698|NCT05325775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93329699|NCT05325775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93329700|NCT05325775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329701|NCT05325775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329702|NCT05325775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93329703|NCT05289908|Folic Acid|folic acid|mesh-list
93329704|NCT05289908|Vitamin B 12|vitamin b 12|mesh-list
93329705|NCT05289908|Dexamethasone|dexamethasone|mesh-list
93329706|NCT05289908|Pemetrexed|pemetrexed|mesh-list
93329707|NCT05289908|Vitamins|vitamins|mesh-ancestor
93329708|NCT05289908|Micronutrients|micronutrients|mesh-ancestor
93329709|NCT05289908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329710|NCT05289908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329711|NCT05289908|Antiemetics|antiemetics|mesh-ancestor
93329712|NCT05289908|Autonomic Agents|autonomic agents|mesh-ancestor
93329713|NCT05289908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329714|NCT05289908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329715|NCT05289908|Glucocorticoids|glucocorticoids|mesh-ancestor
93329716|NCT05289908|Hormones|hormones|mesh-ancestor
93329717|NCT05289908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329718|NCT05289908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93329719|NCT05289908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329720|NCT05289908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329721|NCT05289908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329722|NCT05289908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93329723|NCT05289908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93329724|NCT05289908|Hematinics|hematinics|mesh-ancestor
93329725|NCT05289908|Vitamin B Complex|vitamin b complex|mesh-ancestor
93329726|NCT05284084|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
93329727|NCT05284084|Histamine Antagonists|histamine antagonists|mesh-ancestor
93329728|NCT05284084|Histamine Agents|histamine agents|mesh-ancestor
93329729|NCT05284084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329730|NCT05284084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329731|NCT05284084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329732|NCT05254171|Paclitaxel|paclitaxel|mesh-list
93329733|NCT05254171|Gemcitabine|gemcitabine|mesh-list
93329734|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93329735|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329736|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
93329737|NCT05254171|Antimitotic Agents|antimitotic agents|mesh-ancestor
93329738|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
93329739|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329740|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329741|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
93329742|NCT05247905|Capecitabine|capecitabine|mesh-list
93329743|NCT05247905|Temozolomide|temozolomide|mesh-list
93329744|NCT05247905|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93329745|NCT05247905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329747|NCT05247905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329748|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329749|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93329750|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
93329751|NCT05247905|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93329752|NCT05226351|Dronabinol|dronabinol|mesh-list
93329753|NCT05226351|Hallucinogens|hallucinogens|mesh-ancestor
93329754|NCT05226351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329755|NCT05226351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93329756|NCT05226351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329757|NCT05226351|Analgesics|analgesics|mesh-ancestor
93329758|NCT05226351|Sensory System Agents|sensory system agents|mesh-ancestor
93329759|NCT05226351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329760|NCT05226351|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93329761|NCT05226351|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93329762|NCT05226351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329763|NCT05226351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329764|NCT05226351|Hormones|hormones|mesh-ancestor
93329765|NCT05226351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329766|NCT05215548|Afatinib|afatinib|mesh-list
93329767|NCT05215548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329768|NCT05215548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329769|NCT05215548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329770|NCT05215548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329771|NCT05209555|Pilocarpine|pilocarpine|mesh-list
93329772|NCT05209555|Miotics|miotics|mesh-ancestor
93329773|NCT05209555|Autonomic Agents|autonomic agents|mesh-ancestor
93329774|NCT05209555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329775|NCT05209555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329776|NCT05209555|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93329777|NCT05209555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93329778|NCT05209555|Cholinergic Agents|cholinergic agents|mesh-ancestor
93329779|NCT05209555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329780|NCT05209555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329781|NCT05202145|Cyclosporine|cyclosporine|mesh-list
93329782|NCT05202145|Tacrolimus|tacrolimus|mesh-list
93329783|NCT05202145|Cyclosporins|cyclosporins|mesh-list
93329784|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329785|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
93329786|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329787|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93329788|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329789|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329790|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
93329791|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329792|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329793|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329794|NCT05150938|Vitamin K|vitamin k|mesh-list
93329795|NCT05150938|Heparin|heparin|mesh-list
93329796|NCT05150938|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93329797|NCT05150938|Tinzaparin|tinzaparin|mesh-list
93329798|NCT05150938|Dalteparin|dalteparin|mesh-list
93329799|NCT05150938|Rivaroxaban|rivaroxaban|mesh-list
93329800|NCT05150938|Vitamins|vitamins|mesh-ancestor
93329801|NCT05150938|Micronutrients|micronutrients|mesh-ancestor
93329802|NCT05150938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329803|NCT05150938|Anticoagulants|anticoagulants|mesh-ancestor
93329804|NCT05150938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93329805|NCT05150938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93329806|NCT05150938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329807|NCT05150938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93329808|NCT05150938|Antithrombins|antithrombins|mesh-ancestor
93329809|NCT05150938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93329810|NCT05150938|Protease Inhibitors|protease inhibitors|mesh-ancestor
93329811|NCT05150938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329812|NCT05150938|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93329813|NCT05150938|Hemostatics|hemostatics|mesh-ancestor
93329814|NCT05150938|Coagulants|coagulants|mesh-ancestor
93329815|NCT05142904|Iodine|iodine|mesh-list
93329816|NCT05142904|Cadexomer iodine|cadexomer iodine|mesh-list
93329817|NCT05142904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93001775|NCT00682643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93329818|NCT05142904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329819|NCT05142904|Trace Elements|trace elements|mesh-ancestor
93329820|NCT05142904|Micronutrients|micronutrients|mesh-ancestor
93329821|NCT05142904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329823|NCT05107856|Venetoclax|venetoclax|mesh-list
93329824|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329825|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
93329826|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329827|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329828|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329829|NCT05042648|Buprenorphine|buprenorphine|mesh-list
93329830|NCT05042648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93329831|NCT05042648|Narcotics|narcotics|mesh-ancestor
93329832|NCT05042648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93329833|NCT05042648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329834|NCT05042648|Analgesics|analgesics|mesh-ancestor
93329835|NCT05042648|Sensory System Agents|sensory system agents|mesh-ancestor
93329836|NCT05042648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329837|NCT05042648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93329838|NCT05036317|Empagliflozin|empagliflozin|mesh-list
93329839|NCT05036317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93329840|NCT05036317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329841|NCT05036317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93329842|NCT05036317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329843|NCT04990388|Acetaminophen|acetaminophen|mesh-list
93329844|NCT04990388|Antipyretics|antipyretics|mesh-list
93329845|NCT04990388|Cetirizine|cetirizine|mesh-list
93329846|NCT04990388|Ibuprofen|ibuprofen|mesh-list
93329847|NCT04990388|Famotidine|famotidine|mesh-list
93329848|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329849|NCT04990388|Analgesics|analgesics|mesh-ancestor
93329850|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
93329851|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329852|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329853|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93329854|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329855|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329856|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93329857|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329858|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329859|NCT04990388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92623725|NCT00157898|Ertapenem|ertapenem|mesh-list
93329860|NCT04990388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329861|NCT04990388|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93329862|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
93329863|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
93329864|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329865|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93329866|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93329867|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93329868|NCT04916002|Cemiplimab|cemiplimab|mesh-list
93329869|NCT04916002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329870|NCT04916002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329871|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
93329872|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93329873|NCT04871269|Dronabinol|dronabinol|mesh-list
93329874|NCT04871269|Hallucinogens|hallucinogens|mesh-ancestor
93329875|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329876|NCT04871269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93329877|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93329878|NCT04871269|Analgesics|analgesics|mesh-ancestor
93329879|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
93329880|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329881|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93329882|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93329883|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93329884|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329885|NCT04871269|Hormones|hormones|mesh-ancestor
93329886|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329887|NCT04837131|Ixazomib|ixazomib|mesh-list
93329888|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329889|NCT04837131|Protease Inhibitors|protease inhibitors|mesh-ancestor
93329890|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329891|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329892|NCT04768010|Misoprostol|misoprostol|mesh-list
93329893|NCT04768010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93329894|NCT04768010|Abortifacient Agents|abortifacient agents|mesh-ancestor
93001850|NCT00482001|Donepezil|donepezil|mesh-list
93329895|NCT04768010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93329896|NCT04768010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329898|NCT04768010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329899|NCT04768010|Oxytocics|oxytocics|mesh-ancestor
93329900|NCT04764214|Osimertinib|osimertinib|mesh-list
93329901|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329902|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329903|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329904|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329905|NCT04744116|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
93329906|NCT04744116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329907|NCT04744116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329908|NCT04744116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329909|NCT04675710|Pembrolizumab|pembrolizumab|mesh-list
93329910|NCT04675710|Trametinib|trametinib|mesh-list
93329911|NCT04675710|Dabrafenib|dabrafenib|mesh-list
93329912|NCT04675710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329913|NCT04675710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329914|NCT04675710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93329915|NCT04675710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329916|NCT04675710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93329917|NCT04675710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623782|NCT00158132|Amantadine|amantadine|mesh-list
93329918|NCT04710030|Valacyclovir|valacyclovir|mesh-list
93329919|NCT04710030|Antiviral Agents|antiviral agents|mesh-ancestor
93329920|NCT04710030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329921|NCT04653818|Sofosbuvir|sofosbuvir|mesh-list
93329922|NCT04653818|Velpatasvir|velpatasvir|mesh-list
93329923|NCT04653818|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93329924|NCT04653818|Antiviral Agents|antiviral agents|mesh-ancestor
93329925|NCT04653818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329926|NCT04608955|Bedaquiline|bedaquiline|mesh-list
93329927|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
93329928|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93329929|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329930|NCT04579848|Folic Acid|folic acid|mesh-list
93329931|NCT04579848|Methotrexate|methotrexate|mesh-list
93329932|NCT04579848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93329933|NCT04579848|Abortifacient Agents|abortifacient agents|mesh-ancestor
93329934|NCT04579848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93329935|NCT04579848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329936|NCT04579848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93329937|NCT04579848|Antimetabolites|antimetabolites|mesh-ancestor
93329938|NCT04579848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329939|NCT04579848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329940|NCT04579848|Dermatologic Agents|dermatologic agents|mesh-ancestor
93329941|NCT04579848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329942|NCT04579848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93329943|NCT04579848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329944|NCT04579848|Immunologic Factors|immunologic factors|mesh-ancestor
93329945|NCT04579848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93329946|NCT04579848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93329947|NCT04579848|Hematinics|hematinics|mesh-ancestor
93329948|NCT04579848|Vitamin B Complex|vitamin b complex|mesh-ancestor
93329949|NCT04579848|Vitamins|vitamins|mesh-ancestor
93329950|NCT04579848|Micronutrients|micronutrients|mesh-ancestor
93329951|NCT04578652|Metformin|metformin|mesh-list
93329952|NCT04578652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93329953|NCT04578652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329954|NCT04570631|Dexamethasone|dexamethasone|mesh-list
93329955|NCT04570631|Bortezomib|bortezomib|mesh-list
93329956|NCT04570631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93329957|NCT04570631|Antiemetics|antiemetics|mesh-ancestor
93329958|NCT04570631|Autonomic Agents|autonomic agents|mesh-ancestor
93329959|NCT04570631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93329960|NCT04570631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329961|NCT04570631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93329962|NCT04570631|Glucocorticoids|glucocorticoids|mesh-ancestor
93329963|NCT04570631|Hormones|hormones|mesh-ancestor
93329964|NCT04570631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93329965|NCT04570631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93329966|NCT04570631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329967|NCT04555837|Pembrolizumab|pembrolizumab|mesh-list
93329968|NCT04555837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93329969|NCT04555837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329970|NCT04555837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93329971|NCT04555837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329972|NCT04550832|Moxifloxacin|moxifloxacin|mesh-list
93329973|NCT04550832|Bedaquiline|bedaquiline|mesh-list
93329974|NCT04550832|Delpazolid|delpazolid|mesh-list
93329975|NCT04550832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93329976|NCT04550832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329977|NCT04550832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93329978|NCT04550832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93329979|NCT04550832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329980|NCT04550832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329981|NCT04550832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329982|NCT04550832|Antitubercular Agents|antitubercular agents|mesh-ancestor
93329983|NCT04550832|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93329984|NCT04477629|Mycophenolic Acid|mycophenolic acid|mesh-list
93329985|NCT04477629|Abatacept|abatacept|mesh-list
93329986|NCT04477629|Tacrolimus|tacrolimus|mesh-list
93329987|NCT04477629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93329988|NCT04477629|Immunologic Factors|immunologic factors|mesh-ancestor
93329989|NCT04477629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93329990|NCT04477629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93329991|NCT04477629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93329992|NCT04477629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93329993|NCT04477629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93329994|NCT04477629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93329995|NCT04477629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93329996|NCT04477629|Antitubercular Agents|antitubercular agents|mesh-ancestor
93329997|NCT04477629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93329998|NCT04477629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93329999|NCT04477629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330000|NCT04477629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330001|NCT04477629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330002|NCT04476277|Biotin|biotin|mesh-list
93330003|NCT04476277|Vitamin B Complex|vitamin b complex|mesh-ancestor
93330004|NCT04476277|Vitamins|vitamins|mesh-ancestor
93330005|NCT04476277|Micronutrients|micronutrients|mesh-ancestor
93330006|NCT04476277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330007|NCT04430517|Niacinamide|niacinamide|mesh-list
93330008|NCT04430517|Niacin|niacin|mesh-list
93330009|NCT04430517|Nicotinic Acids|nicotinic acids|mesh-list
93330010|NCT04430517|Vitamin B Complex|vitamin b complex|mesh-ancestor
93330011|NCT04430517|Vitamins|vitamins|mesh-ancestor
93330012|NCT04430517|Micronutrients|micronutrients|mesh-ancestor
93330013|NCT04430517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330014|NCT04430517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93330015|NCT04430517|Antimetabolites|antimetabolites|mesh-ancestor
93330016|NCT04430517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330017|NCT04430517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93330018|NCT04430517|Vasodilator Agents|vasodilator agents|mesh-ancestor
93330019|NCT04414943|Ketamine|ketamine|mesh-list
93330020|NCT04414943|Esketamine|esketamine|mesh-list
93330021|NCT04414943|Analgesics|analgesics|mesh-ancestor
93330022|NCT04414943|Sensory System Agents|sensory system agents|mesh-ancestor
93330023|NCT04414943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330024|NCT04414943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330025|NCT04414943|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93330026|NCT04414943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93330027|NCT04414943|Anesthetics, General|anesthetics, general|mesh-ancestor
93330028|NCT04414943|Anesthetics|anesthetics|mesh-ancestor
93330029|NCT04414943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93330030|NCT04414943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93330031|NCT04414943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93330032|NCT04414943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330033|NCT04414943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330034|NCT04414943|Antidepressive Agents|antidepressive agents|mesh-ancestor
93330035|NCT04414943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93330036|NCT04354025|Cytarabine|cytarabine|mesh-list
93330037|NCT04354025|Fludarabine|fludarabine|mesh-list
93330038|NCT04354025|Interleukin-2|interleukin-2|mesh-list
93330039|NCT04354025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330040|NCT04354025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330041|NCT04354025|Antimetabolites|antimetabolites|mesh-ancestor
93330042|NCT04354025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330043|NCT04354025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330044|NCT04354025|Immunologic Factors|immunologic factors|mesh-ancestor
93330045|NCT04354025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330046|NCT04354025|Antiviral Agents|antiviral agents|mesh-ancestor
93330047|NCT04354025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330048|NCT04354025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93330050|NCT04354025|Sensory System Agents|sensory system agents|mesh-ancestor
93330051|NCT04354025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330052|NCT04347720|Acetaminophen|acetaminophen|mesh-list
93330053|NCT04347720|Ibuprofen|ibuprofen|mesh-list
93330054|NCT04347720|Indomethacin|indomethacin|mesh-list
93330055|NCT04347720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93330056|NCT04347720|Analgesics|analgesics|mesh-ancestor
93330057|NCT04347720|Sensory System Agents|sensory system agents|mesh-ancestor
93330058|NCT04347720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330059|NCT04347720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330060|NCT04347720|Antipyretics|antipyretics|mesh-ancestor
93330061|NCT04347720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93330062|NCT04347720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330063|NCT04347720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330064|NCT04347720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93330065|NCT04347720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330066|NCT04347720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330067|NCT04347720|Gout Suppressants|gout suppressants|mesh-ancestor
93330068|NCT04347720|Tocolytic Agents|tocolytic agents|mesh-ancestor
93330069|NCT04347720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93330070|NCT04325802|Naltrexone|naltrexone|mesh-list
93330071|NCT04325802|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93330072|NCT04325802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93330073|NCT04325802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330074|NCT04325802|Sensory System Agents|sensory system agents|mesh-ancestor
93330075|NCT04325802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330076|NCT04285346|Ganaxolone|ganaxolone|mesh-list
93330077|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
93330078|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330079|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330080|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330081|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
93330082|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
93330083|NCT04241562|Mitogens|mitogens|mesh-list
93330084|NCT04241562|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330085|NCT04241562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330086|NCT04209192|Amikacin|amikacin|mesh-list
93330087|NCT04209192|Fosfomycin|fosfomycin|mesh-list
93330088|NCT04209192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93330089|NCT04209192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330090|NCT04199468|Ketamine|ketamine|mesh-list
93330091|NCT04199468|Dronabinol|dronabinol|mesh-list
93330092|NCT04199468|Analgesics|analgesics|mesh-ancestor
93330093|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
93330094|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330095|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330096|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93330097|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93330098|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
93330099|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
93330100|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93330101|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93330102|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93330103|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330104|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330105|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
93330106|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93330107|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93330108|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93330109|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93330110|NCT04199468|Hormones|hormones|mesh-ancestor
93330111|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330112|NCT04178148|Amikacin|amikacin|mesh-list
93330113|NCT04178148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93330114|NCT04178148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330115|NCT04126681|Interferons|interferons|mesh-list
93330116|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
93330117|NCT04126681|Dasatinib|dasatinib|mesh-list
93330118|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
93330119|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
93330120|NCT04126681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330121|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
93330122|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330123|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330124|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330125|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330126|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
93330127|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93330128|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330129|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93330130|NCT04118855|Axitinib|axitinib|mesh-list
93330131|NCT04118855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330132|NCT04118855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330133|NCT04118855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330134|NCT04118855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330135|NCT04084860|Ketamine|ketamine|mesh-list
93330136|NCT04084860|Analgesics|analgesics|mesh-ancestor
93330137|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
93330138|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330139|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330140|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93330141|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93330142|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
93330143|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
93330144|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93330145|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93330146|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93330147|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330148|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330149|NCT04011150|Fentanyl|fentanyl|mesh-list
93330150|NCT04011150|Ropivacaine|ropivacaine|mesh-list
93330151|NCT04011150|Anesthetics, Local|anesthetics, local|mesh-list
93330152|NCT04011150|Anesthetics|anesthetics|mesh-list
93330153|NCT04011150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93330154|NCT04011150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330155|NCT04011150|Sensory System Agents|sensory system agents|mesh-ancestor
93330156|NCT04011150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330157|NCT04011150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93330158|NCT04011150|Narcotics|narcotics|mesh-ancestor
93330159|NCT04011150|Analgesics|analgesics|mesh-ancestor
93330160|NCT04011150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93330161|NCT04011150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93330162|NCT04011150|Anesthetics, General|anesthetics, general|mesh-ancestor
93330163|NCT03994796|Adagrasib|adagrasib|mesh-list
93330164|NCT03994796|Entrectinib|entrectinib|mesh-list
93330165|NCT03994796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330166|NCT03994796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330167|NCT03994796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330168|NCT03994796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330169|NCT03927378|Ketamine|ketamine|mesh-list
93330170|NCT03927378|Esketamine|esketamine|mesh-list
93330171|NCT03927378|Analgesics|analgesics|mesh-ancestor
93330172|NCT03927378|Sensory System Agents|sensory system agents|mesh-ancestor
93330173|NCT03927378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330174|NCT03927378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330175|NCT03927378|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93330176|NCT03927378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93330177|NCT03927378|Anesthetics, General|anesthetics, general|mesh-ancestor
93330178|NCT03927378|Anesthetics|anesthetics|mesh-ancestor
93330179|NCT03927378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93330180|NCT03927378|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93330181|NCT03927378|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93330182|NCT03927378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330183|NCT03927378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330184|NCT03927378|Antidepressive Agents|antidepressive agents|mesh-ancestor
93330185|NCT03927378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93330186|NCT03875391|Oxytocin|oxytocin|mesh-list
93330187|NCT03875391|Oxytocics|oxytocics|mesh-ancestor
93330188|NCT03875391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93330189|NCT03875391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330190|NCT03836066|Bevacizumab|bevacizumab|mesh-list
93330191|NCT03836066|Atezolizumab|atezolizumab|mesh-list
93330192|NCT03836066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330193|NCT03836066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330194|NCT03836066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330195|NCT03836066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330196|NCT03836066|Growth Substances|growth substances|mesh-ancestor
93330197|NCT03836066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330198|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330199|NCT03836066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330200|NCT03836066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330201|NCT03778242|Tranexamic Acid|tranexamic acid|mesh-list
93330202|NCT03778242|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93330203|NCT03778242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93330204|NCT03778242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330205|NCT03778242|Hemostatics|hemostatics|mesh-ancestor
93330206|NCT03778242|Coagulants|coagulants|mesh-ancestor
93330207|NCT03772613|Heparin|heparin|mesh-list
93330208|NCT03772613|Calcium heparin|calcium heparin|mesh-list
93330209|NCT03772613|Anticoagulants|anticoagulants|mesh-ancestor
93330210|NCT03772613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93330211|NCT03772613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93330212|NCT03772613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330213|NCT03730194|Melatonin|melatonin|mesh-list
93330214|NCT03730194|Antioxidants|antioxidants|mesh-ancestor
93330215|NCT03730194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330216|NCT03730194|Protective Agents|protective agents|mesh-ancestor
93330217|NCT03730194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330218|NCT03730194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93330219|NCT03698461|Leucovorin|leucovorin|mesh-list
93330220|NCT03698461|Bevacizumab|bevacizumab|mesh-list
93330221|NCT03698461|Atezolizumab|atezolizumab|mesh-list
93330222|NCT03698461|Fluorouracil|fluorouracil|mesh-list
93330223|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
93330224|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
93330225|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330226|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330227|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330228|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330229|NCT03698461|Growth Substances|growth substances|mesh-ancestor
93330230|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330231|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330232|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
93330233|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330234|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330235|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330236|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
93330237|NCT03698461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330238|NCT03698461|Antidotes|antidotes|mesh-ancestor
93330239|NCT03698461|Protective Agents|protective agents|mesh-ancestor
93330240|NCT03698461|Vitamin B Complex|vitamin b complex|mesh-ancestor
93330241|NCT03698461|Vitamins|vitamins|mesh-ancestor
93330242|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
93330243|NCT03601923|Niraparib|niraparib|mesh-list
93330244|NCT03601923|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93330245|NCT03601923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330246|NCT03601923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330247|NCT03601923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330248|NCT03590652|Dexamethasone|dexamethasone|mesh-list
93330249|NCT03590652|Daratumumab|daratumumab|mesh-list
93330250|NCT03590652|Pomalidomide|pomalidomide|mesh-list
93330251|NCT03590652|Ixazomib|ixazomib|mesh-list
93330252|NCT03590652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330253|NCT03590652|Antiemetics|antiemetics|mesh-ancestor
93330254|NCT03590652|Autonomic Agents|autonomic agents|mesh-ancestor
93330255|NCT03590652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330256|NCT03590652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330257|NCT03590652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93330258|NCT03590652|Glucocorticoids|glucocorticoids|mesh-ancestor
93330259|NCT03590652|Hormones|hormones|mesh-ancestor
93330260|NCT03590652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330261|NCT03590652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93330262|NCT03590652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330263|NCT03590652|Immunologic Factors|immunologic factors|mesh-ancestor
93330264|NCT03590652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330265|NCT03590652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330266|NCT03590652|Growth Substances|growth substances|mesh-ancestor
93330267|NCT03590652|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330268|NCT03590652|Protease Inhibitors|protease inhibitors|mesh-ancestor
93330269|NCT03590652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330270|NCT03590652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330271|NCT03535363|Osimertinib|osimertinib|mesh-list
93330272|NCT03535363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330273|NCT03535363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330274|NCT03535363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330275|NCT03535363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330276|NCT03483038|Irinotecan|irinotecan|mesh-list
93330277|NCT03483038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93330278|NCT03483038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330279|NCT03483038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330280|NCT03483038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330281|NCT03483038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330282|NCT03417284|Melphalan|melphalan|mesh-list
93330283|NCT03417284|Lenograstim|lenograstim|mesh-list
93330284|NCT03417284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93330285|NCT03417284|Immunologic Factors|immunologic factors|mesh-ancestor
93330286|NCT03417284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330287|NCT03417284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330288|NCT03417284|Alkylating Agents|alkylating agents|mesh-ancestor
93330289|NCT03417284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330290|NCT03417284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330291|NCT03417284|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330292|NCT03417284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330293|NCT03384836|Pembrolizumab|pembrolizumab|mesh-list
93330294|NCT03384836|Propranolol|propranolol|mesh-list
93330295|NCT03384836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330296|NCT03384836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330297|NCT03384836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330298|NCT03384836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330299|NCT03384836|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93330300|NCT03384836|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93330301|NCT03384836|Adrenergic Agents|adrenergic agents|mesh-ancestor
93330302|NCT03384836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330303|NCT03384836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330304|NCT03384836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93330305|NCT03384836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93330306|NCT03384836|Vasodilator Agents|vasodilator agents|mesh-ancestor
93330307|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
93330308|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
93330309|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93330310|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93330311|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330312|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330313|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330314|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330315|NCT03290937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93330316|NCT03290937|Cetuximab|cetuximab|mesh-list
93330317|NCT03290937|Irinotecan|irinotecan|mesh-list
93330318|NCT03290937|Camptothecin|camptothecin|mesh-list
93330319|NCT03290937|Antibodies|antibodies|mesh-list
93330320|NCT03290937|Immunoglobulins|immunoglobulins|mesh-list
93330321|NCT03290937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330322|NCT03290937|Immunoglobulin G|immunoglobulin g|mesh-list
93330323|NCT03290937|Immunologic Factors|immunologic factors|mesh-ancestor
93330324|NCT03290937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330325|NCT03290937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330326|NCT03290937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93330327|NCT03290937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330328|NCT03290937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330329|NCT03290937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330330|NCT03290937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330331|NCT03261102|Adalimumab|adalimumab|mesh-list
93330332|NCT03261102|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93330333|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330334|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330335|NCT03241732|Acetylcysteine|acetylcysteine|mesh-list
93330336|NCT03241732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93330337|NCT03241732|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93330338|NCT03241732|Antiviral Agents|antiviral agents|mesh-ancestor
93330339|NCT03241732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330340|NCT03241732|Expectorants|expectorants|mesh-ancestor
93330341|NCT03241732|Respiratory System Agents|respiratory system agents|mesh-ancestor
93330342|NCT03241732|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93330343|NCT03241732|Antioxidants|antioxidants|mesh-ancestor
93330344|NCT03241732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330345|NCT03241732|Protective Agents|protective agents|mesh-ancestor
93330346|NCT03241732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330347|NCT03241732|Antidotes|antidotes|mesh-ancestor
93330348|NCT03224767|Vemurafenib|vemurafenib|mesh-list
93330349|NCT03224767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330350|NCT03224767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330351|NCT03224767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330352|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330353|NCT03206047|Poly I-C|poly i-c|mesh-list
93330354|NCT03206047|Atezolizumab|atezolizumab|mesh-list
93330355|NCT03206047|Guadecitabine|guadecitabine|mesh-list
93330356|NCT03206047|Azacitidine|azacitidine|mesh-list
93330357|NCT03206047|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93330358|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330359|NCT03206047|Poly ICLC|poly iclc|mesh-list
93330360|NCT03206047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330361|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330362|NCT03206047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330363|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330364|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
93330365|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330366|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
93330367|NCT03206047|Laxatives|laxatives|mesh-ancestor
93330368|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93330369|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
93330370|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330371|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330372|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
93330373|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330374|NCT03150693|Cytarabine|cytarabine|mesh-list
93330375|NCT03150693|Dexamethasone|dexamethasone|mesh-list
93330376|NCT03150693|Cyclophosphamide|cyclophosphamide|mesh-list
93330377|NCT03150693|Rituximab|rituximab|mesh-list
93330378|NCT03150693|Doxorubicin|doxorubicin|mesh-list
93330379|NCT03150693|Methotrexate|methotrexate|mesh-list
93330380|NCT03150693|Vincristine|vincristine|mesh-list
93330381|NCT03150693|Daunorubicin|daunorubicin|mesh-list
93330382|NCT03150693|Asparaginase|asparaginase|mesh-list
93330383|NCT03150693|Mercaptopurine|mercaptopurine|mesh-list
93330384|NCT03150693|Thioguanine|thioguanine|mesh-list
93330385|NCT03150693|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93330386|NCT03150693|Pegaspargase|pegaspargase|mesh-list
93330387|NCT03150693|Allopurinol|allopurinol|mesh-list
93330388|NCT03150693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330389|NCT03150693|Immunologic Factors|immunologic factors|mesh-ancestor
93330390|NCT03150693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330391|NCT03150693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330392|NCT03150693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330393|NCT03150693|Alkylating Agents|alkylating agents|mesh-ancestor
93330394|NCT03150693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330395|NCT03150693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330396|NCT03150693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330397|NCT03150693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330398|NCT03150693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330399|NCT03150693|Antiemetics|antiemetics|mesh-ancestor
93330400|NCT03150693|Autonomic Agents|autonomic agents|mesh-ancestor
93330401|NCT03150693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330402|NCT03150693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93330403|NCT03150693|Glucocorticoids|glucocorticoids|mesh-ancestor
93330404|NCT03150693|Hormones|hormones|mesh-ancestor
93330405|NCT03150693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330406|NCT03150693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93330407|NCT03150693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330408|NCT03150693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330409|NCT03150693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330410|NCT03150693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330411|NCT03150693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93330412|NCT03150693|Abortifacient Agents|abortifacient agents|mesh-ancestor
93330413|NCT03150693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93330414|NCT03150693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330415|NCT03150693|Antimetabolites|antimetabolites|mesh-ancestor
93330416|NCT03150693|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330417|NCT03150693|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93330418|NCT03150693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93330419|NCT03150693|Antiviral Agents|antiviral agents|mesh-ancestor
93330420|NCT03150693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330421|NCT03150693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92624275|NCT00540202|Artemether|artemether|mesh-list
93330422|NCT03150693|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330423|NCT03150693|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330424|NCT03150693|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330425|NCT03150693|Gout Suppressants|gout suppressants|mesh-ancestor
93330426|NCT03150693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93002376|NCT00970580|Paclitaxel|paclitaxel|mesh-list
93330427|NCT03150693|Antioxidants|antioxidants|mesh-ancestor
93330428|NCT03150693|Protective Agents|protective agents|mesh-ancestor
93330429|NCT03150693|Immunotoxins|immunotoxins|mesh-ancestor
93330430|NCT03150693|Immunoconjugates|immunoconjugates|mesh-ancestor
93330431|NCT02968212|Clofazimine|clofazimine|mesh-list
93330432|NCT02968212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330433|NCT02968212|Leprostatic Agents|leprostatic agents|mesh-ancestor
93330434|NCT02968212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93330435|NCT02968212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330436|NCT02931253|Metformin|metformin|mesh-list
93330437|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93330438|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330439|NCT02848131|Dasatinib|dasatinib|mesh-list
93330440|NCT02848131|Quercetin|quercetin|mesh-list
93330441|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330442|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330443|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330444|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330445|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
93330446|NCT02848131|Protective Agents|protective agents|mesh-ancestor
93330447|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330448|NCT02846376|Nivolumab|nivolumab|mesh-list
93330449|NCT02846376|Ipilimumab|ipilimumab|mesh-list
93330450|NCT02846376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330451|NCT02846376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330452|NCT02846376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330453|NCT02846376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330454|NCT02590601|Bromocriptine|bromocriptine|mesh-list
93330455|NCT02590601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93330456|NCT02590601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93330457|NCT02590601|Hormone Antagonists|hormone antagonists|mesh-ancestor
93330458|NCT02590601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330459|NCT02590601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330460|NCT02590601|Dopamine Agonists|dopamine agonists|mesh-ancestor
93330461|NCT02590601|Dopamine Agents|dopamine agents|mesh-ancestor
93330462|NCT02590601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93330463|NCT02590601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330464|NCT02484443|Dinutuximab|dinutuximab|mesh-list
93330465|NCT02484443|Sargramostim|sargramostim|mesh-list
93330466|NCT02484443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330467|NCT02484443|Immunologic Factors|immunologic factors|mesh-ancestor
93330468|NCT02484443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330469|NCT02484443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330470|NCT02451982|Cyclophosphamide|cyclophosphamide|mesh-list
93330471|NCT02451982|Nivolumab|nivolumab|mesh-list
93330472|NCT02451982|Immunologic Factors|immunologic factors|mesh-ancestor
93330473|NCT02451982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330474|NCT02451982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330475|NCT02451982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330476|NCT02451982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330477|NCT02451982|Alkylating Agents|alkylating agents|mesh-ancestor
93330478|NCT02451982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330479|NCT02451982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330480|NCT02451982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330481|NCT02451982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330482|NCT02451982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93330483|NCT02306161|Cyclophosphamide|cyclophosphamide|mesh-list
93330484|NCT02306161|Ifosfamide|ifosfamide|mesh-list
93330485|NCT02306161|Isophosphamide mustard|isophosphamide mustard|mesh-list
93330486|NCT02306161|Doxorubicin|doxorubicin|mesh-list
93330487|NCT02306161|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93330488|NCT02306161|Etoposide|etoposide|mesh-list
93330489|NCT02306161|Etoposide phosphate|etoposide phosphate|mesh-list
93330490|NCT02306161|Vincristine|vincristine|mesh-list
93330491|NCT02306161|Daunorubicin|daunorubicin|mesh-list
93330492|NCT02306161|Podophyllotoxin|podophyllotoxin|mesh-list
93330493|NCT02306161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330494|NCT02306161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330495|NCT02306161|Immunologic Factors|immunologic factors|mesh-ancestor
93330496|NCT02306161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330497|NCT02306161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330498|NCT02306161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330499|NCT02306161|Alkylating Agents|alkylating agents|mesh-ancestor
93330500|NCT02306161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330501|NCT02306161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330502|NCT02306161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330503|NCT02306161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330504|NCT02306161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93002450|NCT00970892|Warfarin|warfarin|mesh-list
93330505|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330506|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330507|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330508|NCT02306161|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330509|NCT02306161|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330510|NCT02306161|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330511|NCT02306161|Keratolytic Agents|keratolytic agents|mesh-ancestor
93330512|NCT02306161|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330513|NCT02254278|Cisplatin|cisplatin|mesh-list
93330514|NCT02254278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330515|NCT02253316|Dexamethasone|dexamethasone|mesh-list
93330516|NCT02253316|Dexamethasone acetate|dexamethasone acetate|mesh-list
93330517|NCT02253316|Lenalidomide|lenalidomide|mesh-list
93330518|NCT02253316|Ixazomib|ixazomib|mesh-list
93330519|NCT02253316|BB 1101|bb 1101|mesh-list
93330520|NCT02253316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330521|NCT02253316|Antiemetics|antiemetics|mesh-ancestor
93330522|NCT02253316|Autonomic Agents|autonomic agents|mesh-ancestor
93330523|NCT02253316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330524|NCT02253316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330525|NCT02253316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93330526|NCT02253316|Glucocorticoids|glucocorticoids|mesh-ancestor
93330527|NCT02253316|Hormones|hormones|mesh-ancestor
93330528|NCT02253316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330529|NCT02253316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93330530|NCT02253316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330531|NCT02253316|Protease Inhibitors|protease inhibitors|mesh-ancestor
93330532|NCT02253316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330533|NCT02253316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330534|NCT02253316|Immunologic Factors|immunologic factors|mesh-ancestor
93330535|NCT02253316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330536|NCT02253316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330537|NCT02253316|Growth Substances|growth substances|mesh-ancestor
93330538|NCT02253316|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330539|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93330540|NCT02240498|Methylene Blue|methylene blue|mesh-list
93330541|NCT02240498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330542|NCT02240498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330543|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93330544|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93330545|NCT02240498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93330546|NCT02178098|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93330547|NCT02178098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93330548|NCT02178098|Antimetabolites|antimetabolites|mesh-ancestor
93330549|NCT02178098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330550|NCT02178098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93330551|NCT02178098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330552|NCT02178098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93330553|NCT02178098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330554|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
93330555|NCT02101853|Leucovorin|leucovorin|mesh-list
93330556|NCT02101853|Folic Acid|folic acid|mesh-list
93330557|NCT02101853|Cytarabine|cytarabine|mesh-list
93330558|NCT02101853|Dexamethasone|dexamethasone|mesh-list
93330559|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
93330560|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
93330561|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93330562|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93330563|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93330564|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
93330565|NCT02101853|Methotrexate|methotrexate|mesh-list
93330566|NCT02101853|Etoposide|etoposide|mesh-list
93330567|NCT02101853|Vincristine|vincristine|mesh-list
93330568|NCT02101853|Etoposide phosphate|etoposide phosphate|mesh-list
93330569|NCT02101853|Asparaginase|asparaginase|mesh-list
93330570|NCT02101853|Mitoxantrone|mitoxantrone|mesh-list
93330571|NCT02101853|Mercaptopurine|mercaptopurine|mesh-list
93330572|NCT02101853|Podophyllotoxin|podophyllotoxin|mesh-list
93330573|NCT02101853|Pegaspargase|pegaspargase|mesh-list
93330574|NCT02101853|Thioguanine|thioguanine|mesh-list
93330575|NCT02101853|Blinatumomab|blinatumomab|mesh-list
93330576|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93330577|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
93330578|NCT02101853|Antibodies|antibodies|mesh-list
93330579|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
93330580|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330581|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93330582|NCT02101853|BB 1101|bb 1101|mesh-list
93330583|NCT02101853|Calcium|calcium|mesh-list
93330584|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
93330585|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
93330586|NCT02101853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330587|NCT02101853|Immunologic Factors|immunologic factors|mesh-ancestor
93330588|NCT02101853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330589|NCT02101853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330590|NCT02101853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330591|NCT02101853|Alkylating Agents|alkylating agents|mesh-ancestor
93330592|NCT02101853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330593|NCT02101853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330594|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330595|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330596|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
93330597|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
93330598|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330599|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93330600|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
93330601|NCT02101853|Hormones|hormones|mesh-ancestor
93330602|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330603|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93330604|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
93330605|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330606|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93330607|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93330608|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93330609|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
93330610|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93330611|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330612|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
93330613|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330614|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93330615|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93330616|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330617|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330618|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330619|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
93330620|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330621|NCT02101853|Antidotes|antidotes|mesh-ancestor
93330622|NCT02101853|Protective Agents|protective agents|mesh-ancestor
93330623|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
93330624|NCT02101853|Vitamins|vitamins|mesh-ancestor
93330625|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
93330626|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330627|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330628|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330629|NCT02101853|Hematinics|hematinics|mesh-ancestor
93330630|NCT02101853|Analgesics|analgesics|mesh-ancestor
93330631|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
93330632|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
93330633|NCT01885689|Sirolimus|sirolimus|mesh-list
93330634|NCT01885689|Melphalan|melphalan|mesh-list
93330635|NCT01885689|Clofarabine|clofarabine|mesh-list
93330636|NCT01885689|Tacrolimus|tacrolimus|mesh-list
93330637|NCT01885689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330638|NCT01885689|Immunologic Factors|immunologic factors|mesh-ancestor
93330639|NCT01885689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330640|NCT01885689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93330641|NCT01885689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330642|NCT01885689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330643|NCT01885689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93330644|NCT01885689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330645|NCT01885689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330646|NCT01885689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624480|NCT00159536|Metformin|metformin|mesh-list
93330647|NCT01885689|Antifungal Agents|antifungal agents|mesh-ancestor
93330648|NCT01885689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330649|NCT01885689|Alkylating Agents|alkylating agents|mesh-ancestor
93330650|NCT01885689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330651|NCT01885689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330652|NCT01885689|Antimetabolites|antimetabolites|mesh-ancestor
93330653|NCT01798004|Cyclophosphamide|cyclophosphamide|mesh-list
93330654|NCT01798004|Melphalan|melphalan|mesh-list
93330655|NCT01798004|Busulfan|busulfan|mesh-list
93330656|NCT01798004|Mechlorethamine|mechlorethamine|mesh-list
93330657|NCT01798004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93330658|NCT01798004|Cisplatin|cisplatin|mesh-list
93330659|NCT01798004|Doxorubicin|doxorubicin|mesh-list
93330660|NCT01798004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93330661|NCT01798004|Etoposide|etoposide|mesh-list
93330662|NCT01798004|Vincristine|vincristine|mesh-list
93330663|NCT01798004|Etoposide phosphate|etoposide phosphate|mesh-list
93330664|NCT01798004|Topotecan|topotecan|mesh-list
93330665|NCT01798004|Podophyllotoxin|podophyllotoxin|mesh-list
93330666|NCT01798004|Lenograstim|lenograstim|mesh-list
93330667|NCT01798004|Mesna|mesna|mesh-list
93330668|NCT01798004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330669|NCT01798004|Immunologic Factors|immunologic factors|mesh-ancestor
93330670|NCT01798004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330671|NCT01798004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330672|NCT01798004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330673|NCT01798004|Alkylating Agents|alkylating agents|mesh-ancestor
93330674|NCT01798004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330675|NCT01798004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330676|NCT01798004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330677|NCT01798004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330678|NCT01798004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330679|NCT01798004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330680|NCT01798004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330681|NCT01798004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330682|NCT01798004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93330683|NCT01798004|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330684|NCT01798004|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330685|NCT01798004|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330686|NCT01798004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93330687|NCT01798004|Protective Agents|protective agents|mesh-ancestor
93330688|NCT01798004|Keratolytic Agents|keratolytic agents|mesh-ancestor
93330689|NCT01798004|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330690|NCT01693380|Vaccines|vaccines|mesh-list
93330691|NCT01693380|Immunologic Factors|immunologic factors|mesh-ancestor
93330692|NCT01693380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330693|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93330694|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93330695|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93330696|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330697|NCT01542879|Hematinics|hematinics|mesh-ancestor
93330698|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93330699|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93330700|NCT01492972|Leuprolide|leuprolide|mesh-list
93330701|NCT01492972|Goserelin|goserelin|mesh-list
93330702|NCT01492972|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93330703|NCT01492972|Buserelin|buserelin|mesh-list
93330704|NCT01492972|Androgens|androgens|mesh-list
93330705|NCT01492972|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93330706|NCT01492972|Fertility Agents|fertility agents|mesh-ancestor
93330707|NCT01492972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93330708|NCT01492972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330709|NCT01492972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93330710|NCT01492972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330711|NCT01492972|Hormones|hormones|mesh-ancestor
93330712|NCT01492972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330713|NCT01492972|Luteolytic Agents|luteolytic agents|mesh-ancestor
93330714|NCT01492972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93330715|NCT01492972|Contraceptive Agents|contraceptive agents|mesh-ancestor
93330716|NCT01492972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93330717|NCT01256398|Calcium, Dietary|calcium, dietary|mesh-list
93330718|NCT01256398|Leucovorin|leucovorin|mesh-list
93330719|NCT01256398|Folic Acid|folic acid|mesh-list
93330720|NCT01256398|Cytarabine|cytarabine|mesh-list
93330721|NCT01256398|Dexamethasone|dexamethasone|mesh-list
93330722|NCT01256398|Dexamethasone acetate|dexamethasone acetate|mesh-list
93330723|NCT01256398|Cyclophosphamide|cyclophosphamide|mesh-list
93330724|NCT01256398|Melphalan|melphalan|mesh-list
93330725|NCT01256398|Mechlorethamine|mechlorethamine|mesh-list
93330726|NCT01256398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93330727|NCT01256398|Methotrexate|methotrexate|mesh-list
93330728|NCT01256398|Fludarabine|fludarabine|mesh-list
93330729|NCT01256398|Fludarabine phosphate|fludarabine phosphate|mesh-list
93330730|NCT01256398|Etoposide|etoposide|mesh-list
93330731|NCT01256398|Vincristine|vincristine|mesh-list
93330732|NCT01256398|Daunorubicin|daunorubicin|mesh-list
93330733|NCT01256398|Dasatinib|dasatinib|mesh-list
93330734|NCT01256398|Mercaptopurine|mercaptopurine|mesh-list
93330735|NCT01256398|Alemtuzumab|alemtuzumab|mesh-list
93330736|NCT01256398|Etoposide phosphate|etoposide phosphate|mesh-list
93330737|NCT01256398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93330738|NCT01256398|Tacrolimus|tacrolimus|mesh-list
93330739|NCT01256398|Antibodies|antibodies|mesh-list
93330740|NCT01256398|Immunoglobulins|immunoglobulins|mesh-list
93330741|NCT01256398|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330742|NCT01256398|Lenograstim|lenograstim|mesh-list
93330743|NCT01256398|BB 1101|bb 1101|mesh-list
93330744|NCT01256398|Calcium|calcium|mesh-list
93330745|NCT01256398|Levoleucovorin|levoleucovorin|mesh-list
93330746|NCT01256398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330747|NCT01256398|Immunologic Factors|immunologic factors|mesh-ancestor
93330748|NCT01256398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330749|NCT01256398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330750|NCT01256398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330751|NCT01256398|Alkylating Agents|alkylating agents|mesh-ancestor
93330752|NCT01256398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330753|NCT01256398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330754|NCT01256398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330755|NCT01256398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93330756|NCT01256398|Antiemetics|antiemetics|mesh-ancestor
93330757|NCT01256398|Autonomic Agents|autonomic agents|mesh-ancestor
93330758|NCT01256398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93330759|NCT01256398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93330760|NCT01256398|Glucocorticoids|glucocorticoids|mesh-ancestor
93330761|NCT01256398|Hormones|hormones|mesh-ancestor
93330762|NCT01256398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93330763|NCT01256398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93330764|NCT01256398|Protease Inhibitors|protease inhibitors|mesh-ancestor
93330765|NCT01256398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330766|NCT01256398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93330767|NCT01256398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93330768|NCT01256398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93330769|NCT01256398|Abortifacient Agents|abortifacient agents|mesh-ancestor
93330770|NCT01256398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93330771|NCT01256398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330772|NCT01256398|Antimetabolites|antimetabolites|mesh-ancestor
93330773|NCT01256398|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330774|NCT01256398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93330775|NCT01256398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93330776|NCT01256398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330777|NCT01256398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330778|NCT01256398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330779|NCT01256398|Antiviral Agents|antiviral agents|mesh-ancestor
93330780|NCT01256398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330781|NCT01256398|Antidotes|antidotes|mesh-ancestor
93330782|NCT01256398|Protective Agents|protective agents|mesh-ancestor
93330783|NCT01256398|Vitamin B Complex|vitamin b complex|mesh-ancestor
93330784|NCT01256398|Vitamins|vitamins|mesh-ancestor
93330785|NCT01256398|Micronutrients|micronutrients|mesh-ancestor
93330786|NCT01256398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93330787|NCT01256398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93330788|NCT01256398|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330789|NCT01256398|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330790|NCT01256398|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330791|NCT01256398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330792|NCT01256398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330793|NCT01256398|Hematinics|hematinics|mesh-ancestor
93330794|NCT01175356|Vitamin A|vitamin a|mesh-list
93330795|NCT01175356|Cyclophosphamide|cyclophosphamide|mesh-list
93330796|NCT01175356|Melphalan|melphalan|mesh-list
93330797|NCT01175356|Busulfan|busulfan|mesh-list
93330798|NCT01175356|Mechlorethamine|mechlorethamine|mesh-list
93330799|NCT01175356|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93330800|NCT01175356|Cisplatin|cisplatin|mesh-list
93330801|NCT01175356|Doxorubicin|doxorubicin|mesh-list
93330802|NCT01175356|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93330803|NCT01175356|Etoposide|etoposide|mesh-list
93330804|NCT01175356|Vincristine|vincristine|mesh-list
93330805|NCT01175356|Topotecan|topotecan|mesh-list
93330806|NCT01175356|Tretinoin|tretinoin|mesh-list
93330807|NCT01175356|Etoposide phosphate|etoposide phosphate|mesh-list
93330808|NCT01175356|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93330809|NCT01175356|Isotretinoin|isotretinoin|mesh-list
93330810|NCT01175356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330811|NCT01175356|Immunologic Factors|immunologic factors|mesh-ancestor
93330812|NCT01175356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330813|NCT01175356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330814|NCT01175356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330815|NCT01175356|Alkylating Agents|alkylating agents|mesh-ancestor
93330816|NCT01175356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330817|NCT01175356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330818|NCT01175356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330819|NCT01175356|Vitamins|vitamins|mesh-ancestor
93330820|NCT01175356|Micronutrients|micronutrients|mesh-ancestor
93330821|NCT01175356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330822|NCT01175356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330823|NCT01175356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330824|NCT01175356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330825|NCT01175356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330826|NCT01175356|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330827|NCT01175356|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330828|NCT01175356|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330829|NCT01175356|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93330830|NCT01175356|Keratolytic Agents|keratolytic agents|mesh-ancestor
93330831|NCT01175356|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330832|NCT01175356|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93330833|NCT01081262|Paclitaxel|paclitaxel|mesh-list
93330834|NCT01081262|Bevacizumab|bevacizumab|mesh-list
93330835|NCT01081262|Carboplatin|carboplatin|mesh-list
93330836|NCT01081262|Capecitabine|capecitabine|mesh-list
93330837|NCT01081262|Oxaliplatin|oxaliplatin|mesh-list
93330838|NCT01081262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93330839|NCT01081262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93330840|NCT01081262|Endothelial Growth Factors|endothelial growth factors|mesh-list
93330841|NCT01081262|Antibodies|antibodies|mesh-list
93330842|NCT01081262|Immunoglobulins|immunoglobulins|mesh-list
93330843|NCT01081262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330844|NCT01081262|Immunoglobulin G|immunoglobulin g|mesh-list
93330845|NCT01081262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330846|NCT01081262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330847|NCT01081262|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330848|NCT01081262|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330849|NCT01081262|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330850|NCT01081262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330851|NCT01081262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330852|NCT01081262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330853|NCT01081262|Growth Substances|growth substances|mesh-ancestor
93330854|NCT01081262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330855|NCT01081262|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330856|NCT01081262|Immunologic Factors|immunologic factors|mesh-ancestor
93330857|NCT01081262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330858|NCT01081262|Antimetabolites|antimetabolites|mesh-ancestor
93330859|NCT01020383|Abciximab|abciximab|mesh-list
93330860|NCT01020383|Anticoagulants|anticoagulants|mesh-ancestor
93330861|NCT01020383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93330862|NCT00977574|Sirolimus|sirolimus|mesh-list
93330863|NCT00977574|Paclitaxel|paclitaxel|mesh-list
93330864|NCT00977574|Epothilones|epothilones|mesh-list
93330865|NCT00977574|Epothilone B|epothilone b|mesh-list
93330866|NCT00977574|Bevacizumab|bevacizumab|mesh-list
93330867|NCT00977574|Carboplatin|carboplatin|mesh-list
93330868|NCT00977574|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93330869|NCT00977574|Temsirolimus|temsirolimus|mesh-list
93330870|NCT00977574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93330871|NCT00977574|MTOR Inhibitors|mtor inhibitors|mesh-list
93330872|NCT00977574|Endothelial Growth Factors|endothelial growth factors|mesh-list
93330873|NCT00977574|Antibodies|antibodies|mesh-list
93330874|NCT00977574|Immunoglobulins|immunoglobulins|mesh-list
93330875|NCT00977574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330876|NCT00977574|Immunoglobulin G|immunoglobulin g|mesh-list
93330877|NCT00977574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330878|NCT00977574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330879|NCT00977574|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330880|NCT00977574|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330881|NCT00977574|Mitosis Modulators|mitosis modulators|mesh-ancestor
92624699|NCT00542893|Alkylating Agents|alkylating agents|mesh-ancestor
93330882|NCT00977574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330883|NCT00977574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330884|NCT00977574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330885|NCT00977574|Growth Substances|growth substances|mesh-ancestor
93330886|NCT00977574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330887|NCT00977574|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330888|NCT00977574|Immunologic Factors|immunologic factors|mesh-ancestor
93330889|NCT00977574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93330890|NCT00977574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330891|NCT00977574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330892|NCT00977574|Antifungal Agents|antifungal agents|mesh-ancestor
93330893|NCT00977574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330894|NCT00977574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330895|NCT00977574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330896|NCT00889876|Metformin|metformin|mesh-list
93330897|NCT00889876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93330898|NCT00889876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330899|NCT00673010|Iodine|iodine|mesh-list
93330900|NCT00673010|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93330901|NCT00673010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330902|NCT00673010|Trace Elements|trace elements|mesh-ancestor
93330903|NCT00673010|Micronutrients|micronutrients|mesh-ancestor
93330904|NCT00673010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330905|NCT00587067|Floxuridine|floxuridine|mesh-list
93330906|NCT00587067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330907|NCT00587067|Antimetabolites|antimetabolites|mesh-ancestor
93330908|NCT00587067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330909|NCT00587067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330910|NCT00577278|Sirolimus|sirolimus|mesh-list
93330911|NCT00577278|Rituximab|rituximab|mesh-list
93330912|NCT00577278|Fludarabine|fludarabine|mesh-list
93330913|NCT00577278|Fludarabine phosphate|fludarabine phosphate|mesh-list
93330914|NCT00577278|Melphalan|melphalan|mesh-list
93330915|NCT00577278|Tacrolimus|tacrolimus|mesh-list
93330916|NCT00577278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330917|NCT00577278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93330918|NCT00577278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330919|NCT00577278|Immunologic Factors|immunologic factors|mesh-ancestor
93330920|NCT00577278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330921|NCT00577278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93330922|NCT00577278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93330923|NCT00577278|Antimetabolites|antimetabolites|mesh-ancestor
93330924|NCT00577278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330925|NCT00577278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93330926|NCT00577278|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93330927|NCT00577278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330928|NCT00577278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93330929|NCT00577278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93330930|NCT00577278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93330931|NCT00577278|Antifungal Agents|antifungal agents|mesh-ancestor
93330932|NCT00577278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93330933|NCT00577278|Alkylating Agents|alkylating agents|mesh-ancestor
93330934|NCT00577278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93330935|NCT00453154|Cisplatin|cisplatin|mesh-list
93330936|NCT00453154|Carboplatin|carboplatin|mesh-list
93330937|NCT00453154|Etoposide|etoposide|mesh-list
93330938|NCT00453154|Etoposide phosphate|etoposide phosphate|mesh-list
93330939|NCT00453154|Sunitinib|sunitinib|mesh-list
93330940|NCT00453154|Podophyllotoxin|podophyllotoxin|mesh-list
93330941|NCT00453154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330942|NCT00453154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330943|NCT00453154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330944|NCT00453154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330945|NCT00453154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330946|NCT00453154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330947|NCT00453154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330948|NCT00453154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330949|NCT00453154|Growth Substances|growth substances|mesh-ancestor
93330950|NCT00453154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330951|NCT00453154|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330952|NCT00453154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93330953|NCT00453154|Keratolytic Agents|keratolytic agents|mesh-ancestor
93330954|NCT00453154|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330955|NCT00453154|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330956|NCT00453154|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330957|NCT00453154|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330958|NCT00334815|Bevacizumab|bevacizumab|mesh-list
93330959|NCT00334815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93330960|NCT00334815|Cisplatin|cisplatin|mesh-list
93330961|NCT00334815|Docetaxel|docetaxel|mesh-list
93330962|NCT00334815|Etoposide|etoposide|mesh-list
93330963|NCT00334815|Etoposide phosphate|etoposide phosphate|mesh-list
93330964|NCT00334815|Podophyllotoxin|podophyllotoxin|mesh-list
93330965|NCT00334815|Endothelial Growth Factors|endothelial growth factors|mesh-list
93330966|NCT00334815|Antibodies|antibodies|mesh-list
93330967|NCT00334815|Immunoglobulins|immunoglobulins|mesh-list
93330968|NCT00334815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93330969|NCT00334815|Lenograstim|lenograstim|mesh-list
93330970|NCT00334815|Immunoglobulin G|immunoglobulin g|mesh-list
93330971|NCT00334815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93330972|NCT00334815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93330973|NCT00334815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93330974|NCT00334815|Growth Substances|growth substances|mesh-ancestor
93330975|NCT00334815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93330976|NCT00334815|Growth Inhibitors|growth inhibitors|mesh-ancestor
93330977|NCT00334815|Immunologic Factors|immunologic factors|mesh-ancestor
93330978|NCT00334815|Tubulin Modulators|tubulin modulators|mesh-ancestor
93330979|NCT00334815|Antimitotic Agents|antimitotic agents|mesh-ancestor
93330980|NCT00334815|Mitosis Modulators|mitosis modulators|mesh-ancestor
93330981|NCT00334815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330982|NCT00334815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93330983|NCT00334815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93330984|NCT00334815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93330985|NCT00334815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330986|NCT00334815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93330987|NCT00334815|Keratolytic Agents|keratolytic agents|mesh-ancestor
93330988|NCT00334815|Dermatologic Agents|dermatologic agents|mesh-ancestor
93330989|NCT00309257|Valsartan|valsartan|mesh-list
93330990|NCT00309257|Benazepril|benazepril|mesh-list
93330991|NCT00309257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93330992|NCT00309257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93330993|NCT00309257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93330994|NCT00309257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93330995|NCT00309257|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93330996|NCT00309257|Protease Inhibitors|protease inhibitors|mesh-ancestor
93330997|NCT00309257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93330998|NCT00258960|Cyclophosphamide|cyclophosphamide|mesh-list
93330999|NCT00258960|Doxorubicin|doxorubicin|mesh-list
93331000|NCT00258960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93331001|NCT00258960|Trastuzumab|trastuzumab|mesh-list
93331002|NCT00258960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331003|NCT00258960|Immunologic Factors|immunologic factors|mesh-ancestor
93331004|NCT00258960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331005|NCT00258960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331006|NCT00258960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93331007|NCT00258960|Alkylating Agents|alkylating agents|mesh-ancestor
93331008|NCT00258960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331009|NCT00258960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331010|NCT00258960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93331011|NCT00258960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93331012|NCT00258960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93331013|NCT00258960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93331014|NCT00258960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331015|NCT00258960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331016|NCT00121992|Cyclophosphamide|cyclophosphamide|mesh-list
93331017|NCT00121992|Docetaxel|docetaxel|mesh-list
93331018|NCT00121992|Doxorubicin|doxorubicin|mesh-list
93331019|NCT00121992|Fluorouracil|fluorouracil|mesh-list
93331020|NCT00121992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331021|NCT00121992|Immunologic Factors|immunologic factors|mesh-ancestor
93331022|NCT00121992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331023|NCT00121992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331024|NCT00121992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93331025|NCT00121992|Alkylating Agents|alkylating agents|mesh-ancestor
93331026|NCT00121992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331027|NCT00121992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331028|NCT00121992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93331029|NCT00121992|Tubulin Modulators|tubulin modulators|mesh-ancestor
93331030|NCT00121992|Antimitotic Agents|antimitotic agents|mesh-ancestor
93331031|NCT00121992|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331032|NCT00121992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93331033|NCT00121992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93331034|NCT00121992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93331035|NCT00121992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331036|NCT00121992|Antimetabolites|antimetabolites|mesh-ancestor
93331037|NCT00121992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331038|NCT00070564|Paclitaxel|paclitaxel|mesh-list
93331039|NCT00070564|Cyclophosphamide|cyclophosphamide|mesh-list
93331040|NCT00070564|Doxorubicin|doxorubicin|mesh-list
93331041|NCT00070564|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93331042|NCT00070564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93331043|NCT00070564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331044|NCT00070564|Tubulin Modulators|tubulin modulators|mesh-ancestor
93331045|NCT00070564|Antimitotic Agents|antimitotic agents|mesh-ancestor
93331046|NCT00070564|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331047|NCT00070564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331048|NCT00070564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331049|NCT00070564|Immunologic Factors|immunologic factors|mesh-ancestor
93331050|NCT00070564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331051|NCT00070564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331052|NCT00070564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93331053|NCT00070564|Alkylating Agents|alkylating agents|mesh-ancestor
93331054|NCT00070564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93002982|NCT00990990|Linezolid|linezolid|mesh-list
93331055|NCT00070564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93331056|NCT00070564|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93331057|NCT00070564|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93331058|NCT00070564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331059|NCT05158647|Magnesium Sulfate|magnesium sulfate|mesh-list
93331060|NCT05158647|Analgesics|analgesics|mesh-ancestor
93331061|NCT05158647|Sensory System Agents|sensory system agents|mesh-ancestor
93331062|NCT05158647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331063|NCT05158647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331064|NCT05158647|Anesthetics|anesthetics|mesh-ancestor
93331065|NCT05158647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331066|NCT05158647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93331067|NCT05158647|Anticonvulsants|anticonvulsants|mesh-ancestor
93331068|NCT05158647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93331069|NCT05158647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331070|NCT05158647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331071|NCT05158647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93331072|NCT05158647|Tocolytic Agents|tocolytic agents|mesh-ancestor
93331073|NCT05158647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93331074|NCT02738151|Insulin|insulin|mesh-list
93331075|NCT02738151|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93331076|NCT02738151|Insulin Glargine|insulin glargine|mesh-list
93331077|NCT02738151|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93331078|NCT02738151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331079|NCT05212389|Contraceptive Agents|contraceptive agents|mesh-list
93331080|NCT05212389|Contraceptives, Oral|contraceptives, oral|mesh-list
93331081|NCT05212389|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93331082|NCT05212389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93331083|NCT05212389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331084|NCT05212389|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93331085|NCT03471039|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
93331086|NCT03471039|Growth Substances|growth substances|mesh-ancestor
93331087|NCT03471039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331088|NCT03471039|Vasodilator Agents|vasodilator agents|mesh-ancestor
93331089|NCT03471039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331090|NCT03471039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331091|NCT03472677|Capsaicin|capsaicin|mesh-list
93331092|NCT03472677|Antipruritics|antipruritics|mesh-ancestor
93331093|NCT03472677|Dermatologic Agents|dermatologic agents|mesh-ancestor
93331094|NCT03472677|Sensory System Agents|sensory system agents|mesh-ancestor
93331095|NCT03472677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331096|NCT03472677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331097|NCT02673567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93331098|NCT02673567|Antibodies|antibodies|mesh-list
93331099|NCT02673567|Immunoglobulins|immunoglobulins|mesh-list
93331100|NCT02673567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93331101|NCT02673567|Immunologic Factors|immunologic factors|mesh-ancestor
93331102|NCT02673567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331103|NCT02673567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331104|NCT00702195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93331105|NCT00702195|Hormones|hormones|mesh-ancestor
93331106|NCT00702195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331107|NCT00702195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331108|NCT02993731|Paclitaxel|paclitaxel|mesh-list
93331109|NCT02993731|Gemcitabine|gemcitabine|mesh-list
93331110|NCT02993731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93331111|NCT02993731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331112|NCT02993731|Tubulin Modulators|tubulin modulators|mesh-ancestor
93331113|NCT02993731|Antimitotic Agents|antimitotic agents|mesh-ancestor
93331114|NCT02993731|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331115|NCT02993731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331116|NCT02993731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331117|NCT02993731|Antimetabolites|antimetabolites|mesh-ancestor
93331118|NCT02915159|Abatacept|abatacept|mesh-list
93331119|NCT02915159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93331120|NCT02915159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331121|NCT02915159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331122|NCT02915159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331123|NCT02915159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331124|NCT02915159|Immunologic Factors|immunologic factors|mesh-ancestor
93331125|NCT02915159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331126|NCT02915159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331127|NCT03669263|Fentanyl|fentanyl|mesh-list
93331128|NCT03669263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93331130|NCT03669263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331131|NCT03669263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331132|NCT03669263|Analgesics|analgesics|mesh-ancestor
93331133|NCT03669263|Sensory System Agents|sensory system agents|mesh-ancestor
93331134|NCT03669263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331135|NCT03669263|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93331136|NCT03669263|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93331137|NCT03669263|Anesthetics, General|anesthetics, general|mesh-ancestor
93331138|NCT03669263|Anesthetics|anesthetics|mesh-ancestor
93331139|NCT02669264|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93331140|NCT02669264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331141|NCT02669264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331142|NCT02521870|Pembrolizumab|pembrolizumab|mesh-list
93331143|NCT02521870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331144|NCT02521870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331145|NCT02521870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93331146|NCT02521870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331147|NCT02385656|Modafinil|modafinil|mesh-list
93331148|NCT02385656|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93331149|NCT02385656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331150|NCT02385656|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93331151|NCT02385656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93331152|NCT02385656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93331153|NCT02385656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331154|NCT02389868|Lovastatin|lovastatin|mesh-list
93331155|NCT02389868|L 647318|l 647318|mesh-list
93331156|NCT02389868|Dihydromevinolin|dihydromevinolin|mesh-list
93331157|NCT02389868|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93331158|NCT02389868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93331159|NCT02389868|Antimetabolites|antimetabolites|mesh-ancestor
93331160|NCT02389868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331161|NCT02389868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93331162|NCT02389868|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93331163|NCT02389868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331164|NCT03623087|Dexamethasone|dexamethasone|mesh-list
93331165|NCT03623087|Gemcitabine|gemcitabine|mesh-list
93331166|NCT03623087|Etoposide|etoposide|mesh-list
93331167|NCT03623087|Asparaginase|asparaginase|mesh-list
93331168|NCT03623087|Ifosfamide|ifosfamide|mesh-list
93331169|NCT03623087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931890|NCT01565499|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331170|NCT03623087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331171|NCT03623087|Antiemetics|antiemetics|mesh-ancestor
93331172|NCT03623087|Autonomic Agents|autonomic agents|mesh-ancestor
93331173|NCT03623087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331174|NCT03623087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331175|NCT03623087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331176|NCT03623087|Glucocorticoids|glucocorticoids|mesh-ancestor
93331177|NCT03623087|Hormones|hormones|mesh-ancestor
93331178|NCT03623087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331179|NCT03623087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93331180|NCT03623087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331181|NCT03623087|Antimetabolites|antimetabolites|mesh-ancestor
93331182|NCT03623087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331183|NCT03623087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93331184|NCT03623087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93331185|NCT03623087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93331186|NCT03623087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331187|NCT03623087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93331188|NCT03623087|Alkylating Agents|alkylating agents|mesh-ancestor
93331189|NCT05420636|Paclitaxel|paclitaxel|mesh-list
93331190|NCT05420636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93331191|NCT05420636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331192|NCT05420636|Tubulin Modulators|tubulin modulators|mesh-ancestor
93331193|NCT05420636|Antimitotic Agents|antimitotic agents|mesh-ancestor
93331194|NCT05420636|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331195|NCT05420636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331196|NCT05066308|Cannabidiol|cannabidiol|mesh-list
93331197|NCT05066308|Anticonvulsants|anticonvulsants|mesh-ancestor
93331198|NCT03113396|Baclofen|baclofen|mesh-list
93331199|NCT03113396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93331200|NCT03113396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331201|NCT03113396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93003126|NCT00676403|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93331202|NCT03113396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331203|NCT03113396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93331205|NCT03113396|GABA Agents|gaba agents|mesh-ancestor
93331206|NCT03113396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331207|NCT03113396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331208|NCT05065372|Metformin|metformin|mesh-list
93331209|NCT05065372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331210|NCT05065372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331211|NCT03020615|Hydroxyurea|hydroxyurea|mesh-list
93331212|NCT03020615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331213|NCT03020615|Antisickling Agents|antisickling agents|mesh-ancestor
93331214|NCT03020615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331215|NCT03020615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331216|NCT03020615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93331217|NCT05063500|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
93331218|NCT05063500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93331219|NCT05063500|Antimetabolites|antimetabolites|mesh-ancestor
93331220|NCT05063500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331221|NCT05063500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93331222|NCT03693170|Cetuximab|cetuximab|mesh-list
93331223|NCT03693170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331224|NCT03693170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331225|NCT05062954|Proanthocyanidin|proanthocyanidin|mesh-list
93331226|NCT05062954|Procyanidin|procyanidin|mesh-list
93331227|NCT05062954|Antioxidants|antioxidants|mesh-ancestor
93331228|NCT05062954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331229|NCT05062954|Protective Agents|protective agents|mesh-ancestor
93331230|NCT05062954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331231|NCT05062954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93331232|NCT05062954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93331233|NCT05062954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331234|NCT05048524|Leucovorin|leucovorin|mesh-list
93331235|NCT05048524|Gemcitabine|gemcitabine|mesh-list
93331236|NCT05048524|Oxaliplatin|oxaliplatin|mesh-list
93331237|NCT05048524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331238|NCT05048524|Antimetabolites|antimetabolites|mesh-ancestor
93331239|NCT05048524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331240|NCT05048524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331241|NCT05048524|Antidotes|antidotes|mesh-ancestor
93331242|NCT05048524|Protective Agents|protective agents|mesh-ancestor
93331243|NCT05048524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331244|NCT05048524|Vitamin B Complex|vitamin b complex|mesh-ancestor
93331245|NCT05048524|Vitamins|vitamins|mesh-ancestor
93331246|NCT05048524|Micronutrients|micronutrients|mesh-ancestor
93331247|NCT02389400|Methotrexate|methotrexate|mesh-list
93331248|NCT02389400|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93331249|NCT02389400|Abortifacient Agents|abortifacient agents|mesh-ancestor
93331250|NCT02389400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93331251|NCT02389400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331252|NCT02389400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331253|NCT02389400|Antimetabolites|antimetabolites|mesh-ancestor
93331254|NCT02389400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331255|NCT02389400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331256|NCT02389400|Dermatologic Agents|dermatologic agents|mesh-ancestor
93331257|NCT02389400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331258|NCT02389400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93331259|NCT02389400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331260|NCT02389400|Immunologic Factors|immunologic factors|mesh-ancestor
93331261|NCT02389400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331262|NCT02389400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93331263|NCT02389322|BCG Vaccine|bcg vaccine|mesh-list
93331264|NCT02389322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93331265|NCT02389322|Immunologic Factors|immunologic factors|mesh-ancestor
93331266|NCT02389322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331267|NCT03669029|Golimumab|golimumab|mesh-list
93331268|NCT03669029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93331269|NCT03669029|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93331270|NCT03669029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331271|NCT03669029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331272|NCT03669029|Immunologic Factors|immunologic factors|mesh-ancestor
93331273|NCT03669029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331274|NCT03668015|Sorbitol|sorbitol|mesh-list
93331275|NCT03668015|Cathartics|cathartics|mesh-ancestor
93331276|NCT03668015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331277|NCT02385734|Mitogens|mitogens|mesh-list
93331278|NCT02385734|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331279|NCT02385734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331280|NCT02385500|Fesoterodine|fesoterodine|mesh-list
93331281|NCT02385500|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93331282|NCT02385500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93331283|NCT02385500|Cholinergic Agents|cholinergic agents|mesh-ancestor
93331284|NCT02385500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331285|NCT02385500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331286|NCT02385500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331287|NCT02385500|Urological Agents|urological agents|mesh-ancestor
93331289|NCT05058976|Zoledronic Acid|zoledronic acid|mesh-list
93331290|NCT05058976|Calcium|calcium|mesh-list
93331291|NCT05058976|Vitamins|vitamins|mesh-ancestor
93331292|NCT05058976|Micronutrients|micronutrients|mesh-ancestor
93331293|NCT05058976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331294|NCT05058976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93331295|NCT05058976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93331296|NCT02385422|Propranolol|propranolol|mesh-list
93331297|NCT02385422|Carvedilol|carvedilol|mesh-list
93331298|NCT02385422|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93331299|NCT02385422|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93331300|NCT02385422|Adrenergic Agents|adrenergic agents|mesh-ancestor
93331301|NCT02385422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331302|NCT02385422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331303|NCT02385422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331304|NCT02385422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93331305|NCT02385422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93331306|NCT02385422|Vasodilator Agents|vasodilator agents|mesh-ancestor
93331307|NCT02385422|Antioxidants|antioxidants|mesh-ancestor
93331308|NCT02385422|Protective Agents|protective agents|mesh-ancestor
93331309|NCT02385422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93331310|NCT02385422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331311|NCT02385422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93331312|NCT02385422|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93331313|NCT02385422|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93331314|NCT02520388|Methylphenidate|methylphenidate|mesh-list
92625119|NCT00191022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331315|NCT02520388|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93331316|NCT02520388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331317|NCT02520388|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93331318|NCT02520388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93331319|NCT02520388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331320|NCT02520388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331321|NCT02520388|Dopamine Agents|dopamine agents|mesh-ancestor
93331322|NCT02520388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331323|NCT03667937|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93331324|NCT03667937|Laxatives|laxatives|mesh-ancestor
93331325|NCT03667937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331326|NCT03667235|Glutaral|glutaral|mesh-list
93331327|NCT03667235|Disinfectants|disinfectants|mesh-ancestor
93331328|NCT03667235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331329|NCT02668640|Adalimumab|adalimumab|mesh-list
93331330|NCT02668640|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93331331|NCT02668640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331332|NCT02668640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331333|NCT05043766|Naltrexone|naltrexone|mesh-list
93331334|NCT05043766|Oxycodone|oxycodone|mesh-list
93331335|NCT05043766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93331336|NCT05043766|Narcotics|narcotics|mesh-ancestor
93331337|NCT05043766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331338|NCT05043766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331339|NCT05043766|Analgesics|analgesics|mesh-ancestor
93331340|NCT05043766|Sensory System Agents|sensory system agents|mesh-ancestor
93331341|NCT05043766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331342|NCT05043766|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93331343|NCT05043766|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93331344|NCT03462368|Anti-Infective Agents|anti-infective agents|mesh-list
93331345|NCT03462368|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93331346|NCT02383238|Dapagliflozin|dapagliflozin|mesh-list
93331347|NCT02383238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93331348|NCT02383238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331349|NCT02383238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331350|NCT02383238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331351|NCT03011333|Epinephrine|epinephrine|mesh-list
93331352|NCT03011333|Bupivacaine|bupivacaine|mesh-list
93331353|NCT03011333|Anesthetics, Local|anesthetics, local|mesh-ancestor
93331354|NCT03011333|Anesthetics|anesthetics|mesh-ancestor
93331355|NCT03011333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331356|NCT03011333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331357|NCT03011333|Sensory System Agents|sensory system agents|mesh-ancestor
93331358|NCT03011333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331359|NCT03011333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93331360|NCT03011333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93331361|NCT03011333|Adrenergic Agents|adrenergic agents|mesh-ancestor
93331362|NCT03011333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331363|NCT03011333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331364|NCT03011333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93331365|NCT03011333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93331366|NCT03011333|Autonomic Agents|autonomic agents|mesh-ancestor
93331367|NCT03011333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93331368|NCT03011333|Respiratory System Agents|respiratory system agents|mesh-ancestor
93331369|NCT03011333|Mydriatics|mydriatics|mesh-ancestor
93331370|NCT03011333|Sympathomimetics|sympathomimetics|mesh-ancestor
93331371|NCT03011333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93331372|NCT04570397|Ravulizumab|ravulizumab|mesh-list
93331373|NCT04570397|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93331374|NCT04570397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331375|NCT04570397|Immunologic Factors|immunologic factors|mesh-ancestor
93331376|NCT04570397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331377|NCT02385188|Acetaminophen|acetaminophen|mesh-list
93331378|NCT02385188|Imiquimod|imiquimod|mesh-list
93331379|NCT02385188|Lidocaine|lidocaine|mesh-list
93331380|NCT02385188|Petrolatum|petrolatum|mesh-list
93331381|NCT02385188|Anesthetics, Local|anesthetics, local|mesh-ancestor
93331382|NCT02385188|Anesthetics|anesthetics|mesh-ancestor
93331383|NCT02385188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331384|NCT02385188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331385|NCT02385188|Sensory System Agents|sensory system agents|mesh-ancestor
93331386|NCT02385188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331387|NCT02385188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93331388|NCT02385188|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93331389|NCT02385188|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93331390|NCT02385188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331391|NCT02385188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331392|NCT02385188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93331393|NCT02385188|Analgesics|analgesics|mesh-ancestor
93331394|NCT02385188|Antipyretics|antipyretics|mesh-ancestor
93331395|NCT02385188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93331396|NCT02385188|Immunologic Factors|immunologic factors|mesh-ancestor
93331397|NCT02385188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331398|NCT02385188|Interferon Inducers|interferon inducers|mesh-ancestor
93331399|NCT02385188|Emollients|emollients|mesh-ancestor
93331400|NCT02385188|Dermatologic Agents|dermatologic agents|mesh-ancestor
93331401|NCT02385032|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93331402|NCT02385032|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93331403|NCT02385032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331404|NCT02384954|Rituximab|rituximab|mesh-list
93331405|NCT02384954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331406|NCT02384954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331407|NCT02384954|Immunologic Factors|immunologic factors|mesh-ancestor
93331408|NCT02384954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331409|NCT02384954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331410|NCT02384876|Ephedrine|ephedrine|mesh-list
93331411|NCT02384876|Pseudoephedrine|pseudoephedrine|mesh-list
93331412|NCT02384876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93331413|NCT02384876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93331414|NCT02384876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331415|NCT02384876|Sympathomimetics|sympathomimetics|mesh-ancestor
93331416|NCT02384876|Autonomic Agents|autonomic agents|mesh-ancestor
93331417|NCT02384876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331418|NCT02384876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93331419|NCT02384876|Adrenergic Agents|adrenergic agents|mesh-ancestor
93331420|NCT02384876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331421|NCT02384876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331422|NCT02384876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93331423|NCT02384876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93331424|NCT02384876|Respiratory System Agents|respiratory system agents|mesh-ancestor
93331425|NCT02384876|Nasal Decongestants|nasal decongestants|mesh-ancestor
93331426|NCT03013985|Insulin Glargine|insulin glargine|mesh-list
93331427|NCT03013985|Insulin glulisine|insulin glulisine|mesh-list
93331428|NCT03013985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331429|NCT03013985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331430|NCT02377388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93331431|NCT02377388|Saxagliptin|saxagliptin|mesh-list
93331432|NCT02377388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331433|NCT02377388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331434|NCT02377388|Incretins|incretins|mesh-ancestor
93331435|NCT02377388|Hormones|hormones|mesh-ancestor
93331436|NCT02377388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331437|NCT02377388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93331438|NCT02377388|Protease Inhibitors|protease inhibitors|mesh-ancestor
93331439|NCT02377388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331440|NCT02377388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331441|NCT02382380|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
93331442|NCT02382380|Chelating Agents|chelating agents|mesh-ancestor
93331443|NCT02382380|Sequestering Agents|sequestering agents|mesh-ancestor
93331444|NCT02382380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331445|NCT02382146|Dexamethasone|dexamethasone|mesh-list
93331446|NCT02382146|Dexamethasone acetate|dexamethasone acetate|mesh-list
93331447|NCT02382146|Ondansetron|ondansetron|mesh-list
93331448|NCT02382146|BB 1101|bb 1101|mesh-list
93331449|NCT02382146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331450|NCT02382146|Antiemetics|antiemetics|mesh-ancestor
93331451|NCT02382146|Autonomic Agents|autonomic agents|mesh-ancestor
93331452|NCT02382146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331453|NCT02382146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331454|NCT02382146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331455|NCT02382146|Glucocorticoids|glucocorticoids|mesh-ancestor
93331456|NCT02382146|Hormones|hormones|mesh-ancestor
93331457|NCT02382146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331458|NCT02382146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93331459|NCT02382146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331460|NCT02382146|Protease Inhibitors|protease inhibitors|mesh-ancestor
93331461|NCT02382146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331462|NCT02382146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331463|NCT02382146|Antipruritics|antipruritics|mesh-ancestor
93331464|NCT02382146|Dermatologic Agents|dermatologic agents|mesh-ancestor
93331465|NCT02382146|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93331466|NCT02382146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93331467|NCT02382146|Serotonin Agents|serotonin agents|mesh-ancestor
93331468|NCT02382146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331469|NCT02382068|Dexamethasone|dexamethasone|mesh-list
93331470|NCT02382068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331471|NCT02382068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331472|NCT02382068|Antiemetics|antiemetics|mesh-ancestor
93331473|NCT02382068|Autonomic Agents|autonomic agents|mesh-ancestor
93331474|NCT02382068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331475|NCT02382068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331476|NCT02382068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331477|NCT02382068|Glucocorticoids|glucocorticoids|mesh-ancestor
93331478|NCT02382068|Hormones|hormones|mesh-ancestor
93331479|NCT02382068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331480|NCT02382068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93331481|NCT04731272|Dulaglutide|dulaglutide|mesh-list
93331482|NCT04731272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331483|NCT04731272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331484|NCT02381600|Vitamin D|vitamin d|mesh-list
93331485|NCT02381600|Vitamins|vitamins|mesh-ancestor
93331486|NCT02381600|Micronutrients|micronutrients|mesh-ancestor
93331487|NCT02381600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331488|NCT02381600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93331489|NCT03113084|Heparin|heparin|mesh-list
93331490|NCT03113084|Calcium heparin|calcium heparin|mesh-list
93331491|NCT03113084|Anticoagulants|anticoagulants|mesh-ancestor
93331492|NCT03113084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93331493|NCT03113084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93331494|NCT03113084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331495|NCT02377076|Calcium, Dietary|calcium, dietary|mesh-list
93331496|NCT02377076|Calcium|calcium|mesh-list
93331497|NCT02377076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93331498|NCT02377076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331499|NCT02377076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93331500|NCT04439474|Vitamin D|vitamin d|mesh-list
93003428|NCT00979160|Dasatinib|dasatinib|mesh-list
93331501|NCT04439474|Cholecalciferol|cholecalciferol|mesh-list
93331502|NCT04439474|Vitamins|vitamins|mesh-ancestor
93331503|NCT04439474|Micronutrients|micronutrients|mesh-ancestor
93331504|NCT04439474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331505|NCT04439474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93331506|NCT04439474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93331507|NCT02662556|Sufentanil|sufentanil|mesh-list
93331508|NCT02662556|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93331509|NCT02662556|Narcotics|narcotics|mesh-ancestor
93331510|NCT02662556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331511|NCT02662556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331512|NCT02662556|Analgesics|analgesics|mesh-ancestor
93331513|NCT02662556|Sensory System Agents|sensory system agents|mesh-ancestor
93331514|NCT02662556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331515|NCT02662556|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93331516|NCT02662556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93331517|NCT02662556|Anesthetics, General|anesthetics, general|mesh-ancestor
93331518|NCT02662556|Anesthetics|anesthetics|mesh-ancestor
93331519|NCT02376452|Leucovorin|leucovorin|mesh-list
93331520|NCT02376452|Fluorouracil|fluorouracil|mesh-list
93331521|NCT02376452|Raltitrexed|raltitrexed|mesh-list
93331522|NCT02376452|Irinotecan|irinotecan|mesh-list
93331523|NCT02376452|Antimetabolites|antimetabolites|mesh-ancestor
93331524|NCT02376452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331525|NCT02376452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625332|NCT00547417|Tadalafil|tadalafil|mesh-list
93331526|NCT02376452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331527|NCT02376452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331528|NCT02376452|Immunologic Factors|immunologic factors|mesh-ancestor
93331529|NCT02376452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331530|NCT02376452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93331531|NCT02376452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93331532|NCT02376452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331533|NCT02376452|Antidotes|antidotes|mesh-ancestor
93331534|NCT02376452|Protective Agents|protective agents|mesh-ancestor
93331535|NCT02376452|Vitamin B Complex|vitamin b complex|mesh-ancestor
93331536|NCT02376452|Vitamins|vitamins|mesh-ancestor
93331537|NCT02376452|Micronutrients|micronutrients|mesh-ancestor
93331538|NCT02376452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93331539|NCT02516098|Scopolamine|scopolamine|mesh-list
93331540|NCT02516098|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93331541|NCT02516098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93331542|NCT02516098|Antiemetics|antiemetics|mesh-ancestor
93331543|NCT02516098|Autonomic Agents|autonomic agents|mesh-ancestor
93331544|NCT02516098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331545|NCT02516098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331546|NCT02516098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331547|NCT02516098|Mydriatics|mydriatics|mesh-ancestor
93331548|NCT02516098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93331549|NCT02516098|Cholinergic Agents|cholinergic agents|mesh-ancestor
93331550|NCT02516098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331551|NCT02516098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331552|NCT02516098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93331553|NCT02516098|Parasympatholytics|parasympatholytics|mesh-ancestor
93331554|NCT02372318|Nalmefene|nalmefene|mesh-list
93331555|NCT02372318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93331556|NCT02372318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331557|NCT02372318|Sensory System Agents|sensory system agents|mesh-ancestor
93331558|NCT02372318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331559|NCT03105674|Anesthetics|anesthetics|mesh-list
93331560|NCT03105674|Anesthetics, Local|anesthetics, local|mesh-list
93331561|NCT03105674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331562|NCT03105674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331563|NCT03105674|Sensory System Agents|sensory system agents|mesh-ancestor
93331564|NCT03105674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331565|NCT02380898|Ketorolac|ketorolac|mesh-list
93331566|NCT02380898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93331567|NCT02380898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93331568|NCT02380898|Analgesics|analgesics|mesh-ancestor
93331569|NCT02380898|Sensory System Agents|sensory system agents|mesh-ancestor
93331570|NCT02380898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331571|NCT02380898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331572|NCT02380898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331573|NCT02380898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331574|NCT02380898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93331575|NCT02380898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331576|NCT02380898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331577|NCT02376296|Docetaxel|docetaxel|mesh-list
93331578|NCT02376296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331579|NCT02376296|Tubulin Modulators|tubulin modulators|mesh-ancestor
93331580|NCT02376296|Antimitotic Agents|antimitotic agents|mesh-ancestor
93331582|NCT02376296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331583|NCT01364428|Insulin|insulin|mesh-list
93331584|NCT01364428|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93331585|NCT01364428|Insulin, Long-Acting|insulin, long-acting|mesh-list
93331586|NCT01364428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331587|NCT01364428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331588|NCT02380586|Anesthetics|anesthetics|mesh-list
93331589|NCT02380586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331590|NCT02380586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331591|NCT02375828|Glyburide|glyburide|mesh-list
93331592|NCT02375828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331593|NCT02375828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331594|NCT02371226|Insulin|insulin|mesh-list
93331595|NCT02371226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93331596|NCT02371226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331597|NCT02371226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331598|NCT02371304|Capecitabine|capecitabine|mesh-list
93331599|NCT02371304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331600|NCT02371304|Antimetabolites|antimetabolites|mesh-ancestor
93331601|NCT02371304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331602|NCT02371304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331603|NCT02380352|Amoxicillin|amoxicillin|mesh-list
93331604|NCT02380352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93331605|NCT02380352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331606|NCT02380118|Midazolam|midazolam|mesh-list
93331607|NCT02380118|Haloperidol|haloperidol|mesh-list
93331608|NCT02380118|Olanzapine|olanzapine|mesh-list
93331609|NCT02380118|Haloperidol decanoate|haloperidol decanoate|mesh-list
93331610|NCT02380118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93331611|NCT02380118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93331612|NCT02380118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331613|NCT02380118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331614|NCT02380118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93331615|NCT02380118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93331616|NCT02380118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93331617|NCT02380118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93331618|NCT02380118|Anesthetics, General|anesthetics, general|mesh-ancestor
93331619|NCT02380118|Anesthetics|anesthetics|mesh-ancestor
93331620|NCT02380118|GABA Modulators|gaba modulators|mesh-ancestor
93331621|NCT02380118|GABA Agents|gaba agents|mesh-ancestor
93331622|NCT02380118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331623|NCT02380118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331624|NCT02380118|Antiemetics|antiemetics|mesh-ancestor
93331625|NCT02380118|Autonomic Agents|autonomic agents|mesh-ancestor
93331626|NCT02380118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331627|NCT02380118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331628|NCT02380118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93331629|NCT02380118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93331630|NCT02380118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93331631|NCT02380118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331632|NCT02380118|Serotonin Agents|serotonin agents|mesh-ancestor
93331633|NCT02380118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93331634|NCT02380118|Dopamine Agents|dopamine agents|mesh-ancestor
93331635|NCT02380118|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93331636|NCT03113708|Heparin|heparin|mesh-list
93331637|NCT03113708|Calcium heparin|calcium heparin|mesh-list
93331638|NCT03113708|Anticoagulants|anticoagulants|mesh-ancestor
93331639|NCT03113708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93331640|NCT03113708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93331641|NCT03113708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331642|NCT02371148|Rituximab|rituximab|mesh-list
93331643|NCT02371148|Bortezomib|bortezomib|mesh-list
93331644|NCT02371148|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93331645|NCT02371148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331646|NCT02371148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331647|NCT02371148|Immunologic Factors|immunologic factors|mesh-ancestor
93331648|NCT02371148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331649|NCT02371148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331650|NCT02371148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93331651|NCT02371148|Alkylating Agents|alkylating agents|mesh-ancestor
93331652|NCT02371148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331653|NCT02375360|Immunomodulating Agents|immunomodulating agents|mesh-list
93331654|NCT02375360|Immunologic Factors|immunologic factors|mesh-ancestor
93331655|NCT02375360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331656|NCT02370680|Aspirin|aspirin|mesh-list
93331657|NCT02370680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93331658|NCT02370680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93331659|NCT02370680|Analgesics|analgesics|mesh-ancestor
93331660|NCT02370680|Sensory System Agents|sensory system agents|mesh-ancestor
93331661|NCT02370680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331662|NCT02370680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331663|NCT02370680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331664|NCT02370680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331665|NCT02370680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93331666|NCT02370680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93331667|NCT02370680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331668|NCT02370680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93331669|NCT02370680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93331670|NCT02370680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331671|NCT02370680|Antipyretics|antipyretics|mesh-ancestor
93331672|NCT02370758|Valganciclovir|valganciclovir|mesh-list
93331673|NCT02370758|Ganciclovir|ganciclovir|mesh-list
93331674|NCT02370758|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93331675|NCT02370758|Antiviral Agents|antiviral agents|mesh-ancestor
93331676|NCT02370758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331677|NCT02370758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93331678|NCT02370758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331679|NCT02370758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331680|NCT04661150|Capecitabine|capecitabine|mesh-list
93331681|NCT04661150|Oxaliplatin|oxaliplatin|mesh-list
93331682|NCT04661150|Trastuzumab|trastuzumab|mesh-list
93331683|NCT04661150|Atezolizumab|atezolizumab|mesh-list
93331684|NCT04661150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93331685|NCT04661150|Antimetabolites|antimetabolites|mesh-ancestor
93331686|NCT04661150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331687|NCT04661150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331688|NCT04661150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331689|NCT04661150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93331690|NCT02379026|Vitamin D|vitamin d|mesh-list
93331691|NCT02379026|Cholecalciferol|cholecalciferol|mesh-list
93331692|NCT02379026|Vitamins|vitamins|mesh-ancestor
93331693|NCT02379026|Micronutrients|micronutrients|mesh-ancestor
93331694|NCT02379026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331695|NCT02379026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93331696|NCT02379026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93331697|NCT02991859|Fluticasone|fluticasone|mesh-list
93331698|NCT02991859|Xhance|xhance|mesh-list
93331699|NCT02991859|Budesonide|budesonide|mesh-list
93331700|NCT02991859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331701|NCT02991859|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93331702|NCT02991859|Autonomic Agents|autonomic agents|mesh-ancestor
93331703|NCT02991859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331704|NCT02991859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331705|NCT02991859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93331706|NCT02991859|Respiratory System Agents|respiratory system agents|mesh-ancestor
93331707|NCT02991859|Dermatologic Agents|dermatologic agents|mesh-ancestor
93331708|NCT02991859|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93331709|NCT02991859|Glucocorticoids|glucocorticoids|mesh-ancestor
93331710|NCT02991859|Hormones|hormones|mesh-ancestor
93331711|NCT02991859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331712|NCT02374736|Immunoglobulins|immunoglobulins|mesh-list
93331713|NCT02374736|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93331714|NCT02374736|Antibodies|antibodies|mesh-list
93331715|NCT02374736|Immunoglobulin G|immunoglobulin g|mesh-list
93331716|NCT02374736|Immunologic Factors|immunologic factors|mesh-ancestor
93331717|NCT02374736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331718|NCT02369978|Benzonidazole|benzonidazole|mesh-list
93331719|NCT02369978|Nifurtimox|nifurtimox|mesh-list
93331720|NCT02369978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331721|NCT02369978|Immunologic Factors|immunologic factors|mesh-ancestor
93331722|NCT02369978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331723|NCT02369978|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93331724|NCT02369978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93331725|NCT02369978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93331726|NCT02369978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331727|NCT03661489|Propofol|propofol|mesh-list
93331728|NCT03661489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93331729|NCT03661489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331730|NCT03661489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331731|NCT03661489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93003649|NCT01563614|Immunologic Factors|immunologic factors|mesh-ancestor
93331732|NCT03661489|Anesthetics, General|anesthetics, general|mesh-ancestor
93331733|NCT03661489|Anesthetics|anesthetics|mesh-ancestor
93331734|NCT04056169|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93331735|NCT04056169|Ezetimibe|ezetimibe|mesh-list
93331736|NCT04056169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93331737|NCT04056169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93331738|NCT04056169|Antimetabolites|antimetabolites|mesh-ancestor
93331739|NCT04056169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331740|NCT04056169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93331741|NCT04056169|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93331742|NCT04056169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331743|NCT05030194|Nicotine|nicotine|mesh-list
93331744|NCT05030194|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93331745|NCT05030194|Autonomic Agents|autonomic agents|mesh-ancestor
93331746|NCT05030194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331747|NCT05030194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331748|NCT05030194|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93331749|NCT05030194|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93331750|NCT05030194|Cholinergic Agents|cholinergic agents|mesh-ancestor
93331751|NCT05030194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331752|NCT05030194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331753|NCT02988115|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93331754|NCT02988115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93331755|NCT02988115|Antimetabolites|antimetabolites|mesh-ancestor
93331756|NCT02988115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331757|NCT02988115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93331758|NCT02988115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331759|NCT02988115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93331760|NCT02988115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331761|NCT04209946|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93331762|NCT04209946|Respiratory System Agents|respiratory system agents|mesh-ancestor
93331763|NCT03008915|Aspirin|aspirin|mesh-list
93331764|NCT03008915|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93331765|NCT03008915|Protein C Inhibitor|protein c inhibitor|mesh-list
93331766|NCT03008915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93331767|NCT03008915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93331768|NCT03008915|Analgesics|analgesics|mesh-ancestor
93331769|NCT03008915|Sensory System Agents|sensory system agents|mesh-ancestor
93331770|NCT03008915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331771|NCT03008915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331772|NCT03008915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331773|NCT03008915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331774|NCT03008915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93331775|NCT03008915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93331776|NCT03008915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331777|NCT03008915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93331778|NCT03008915|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93331779|NCT03008915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331780|NCT03008915|Antipyretics|antipyretics|mesh-ancestor
93331781|NCT03008915|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93331782|NCT03008915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93331783|NCT03008915|Protease Inhibitors|protease inhibitors|mesh-ancestor
93331784|NCT03622489|Acetaminophen|acetaminophen|mesh-list
93331785|NCT03622489|Dipyrone|dipyrone|mesh-list
93331786|NCT03622489|Ibuprofen|ibuprofen|mesh-list
93331787|NCT03622489|Morphine|morphine|mesh-list
93331788|NCT03622489|Tramadol|tramadol|mesh-list
93331789|NCT03622489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93331790|NCT03622489|Narcotics|narcotics|mesh-ancestor
93331791|NCT03622489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331792|NCT03622489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331793|NCT03622489|Analgesics|analgesics|mesh-ancestor
93331794|NCT03622489|Sensory System Agents|sensory system agents|mesh-ancestor
93331795|NCT03622489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331796|NCT03622489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93331797|NCT03622489|Antipyretics|antipyretics|mesh-ancestor
93331798|NCT03622489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93331799|NCT03622489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93331800|NCT03622489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331801|NCT03622489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93331802|NCT03622489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331803|NCT03622489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331804|NCT03667001|Lidocaine|lidocaine|mesh-list
93331805|NCT03667001|Anesthetics, Local|anesthetics, local|mesh-ancestor
93331806|NCT03667001|Anesthetics|anesthetics|mesh-ancestor
93331807|NCT03667001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003725|NCT04003350|Anticonvulsants|anticonvulsants|mesh-ancestor
93331808|NCT03667001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331809|NCT03667001|Sensory System Agents|sensory system agents|mesh-ancestor
93331810|NCT03667001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331811|NCT03667001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93331812|NCT03667001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93331813|NCT03667001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93331814|NCT03667001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331815|NCT03667001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331816|NCT02379650|Hydroxychloroquine|hydroxychloroquine|mesh-list
93331817|NCT02379650|Antimalarials|antimalarials|mesh-ancestor
93331818|NCT02379650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93331819|NCT02379650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93331820|NCT02379650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331821|NCT02379650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331822|NCT02379650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331823|NCT02379650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331824|NCT03666299|Lidocaine|lidocaine|mesh-list
93331825|NCT03666299|Anesthetics, Local|anesthetics, local|mesh-ancestor
93331826|NCT03666299|Anesthetics|anesthetics|mesh-ancestor
93331827|NCT03666299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331828|NCT03666299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331829|NCT03666299|Sensory System Agents|sensory system agents|mesh-ancestor
93331830|NCT03666299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331831|NCT03666299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93331832|NCT03666299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93331833|NCT03666299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93331834|NCT03666299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93331835|NCT03666299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331836|NCT03660397|Antihypertensive Agents|antihypertensive agents|mesh-list
93331837|NCT03591380|Belimumab|belimumab|mesh-list
93331838|NCT03591380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93331839|NCT03591380|Immunologic Factors|immunologic factors|mesh-ancestor
93331840|NCT03591380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331841|NCT04057469|Tulobuterol|tulobuterol|mesh-list
93331842|NCT04057469|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93331843|NCT04057469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93331844|NCT04057469|Adrenergic Agents|adrenergic agents|mesh-ancestor
93331845|NCT04057469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331846|NCT04057469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331847|NCT04057469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331848|NCT04057469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93331849|NCT04057469|Autonomic Agents|autonomic agents|mesh-ancestor
93331850|NCT04057469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331851|NCT04057469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93331852|NCT04057469|Respiratory System Agents|respiratory system agents|mesh-ancestor
93331853|NCT03666221|Nimotuzumab|nimotuzumab|mesh-list
93331854|NCT03666221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331855|NCT03666221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331856|NCT03658291|Levofloxacin|levofloxacin|mesh-list
93331857|NCT03658291|Ofloxacin|ofloxacin|mesh-list
93331858|NCT03658291|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93331859|NCT03658291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331860|NCT03658291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93331861|NCT03658291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93331862|NCT03658291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93331863|NCT03658291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331864|NCT03658291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331865|NCT03658291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331866|NCT03658291|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93331867|NCT03658291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93331868|NCT03658213|Goserelin|goserelin|mesh-list
93331869|NCT03658213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93331870|NCT03658213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331871|NCT03006887|Pembrolizumab|pembrolizumab|mesh-list
93331872|NCT03006887|Lenvatinib|lenvatinib|mesh-list
93331873|NCT03006887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331874|NCT03006887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331875|NCT03006887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93331876|NCT03006887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331877|NCT03006887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93331878|NCT03006887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331879|NCT02377856|Interferons|interferons|mesh-list
93003802|NCT00541970|Vaccines|vaccines|mesh-list
93331880|NCT02377856|Ribavirin|ribavirin|mesh-list
93331881|NCT02377856|Interferon-alpha|interferon-alpha|mesh-list
93331882|NCT02377856|Interferon alpha-2|interferon alpha-2|mesh-list
93331883|NCT02377856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93331884|NCT02377856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331885|NCT02377856|Antiviral Agents|antiviral agents|mesh-ancestor
93331886|NCT02377856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331887|NCT02377856|Antimetabolites|antimetabolites|mesh-ancestor
93331888|NCT02377856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331889|NCT02377856|Immunologic Factors|immunologic factors|mesh-ancestor
93331890|NCT02377856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331891|NCT02377778|Thiopental|thiopental|mesh-list
93331892|NCT02377778|Propofol|propofol|mesh-list
93331893|NCT02377778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93331894|NCT02377778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331895|NCT02377778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331896|NCT02377778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93331897|NCT02377778|Anesthetics, General|anesthetics, general|mesh-ancestor
93331898|NCT02377778|Anesthetics|anesthetics|mesh-ancestor
93331899|NCT02377778|Anticonvulsants|anticonvulsants|mesh-ancestor
93331900|NCT02377778|GABA Modulators|gaba modulators|mesh-ancestor
93331901|NCT02377778|GABA Agents|gaba agents|mesh-ancestor
93331902|NCT02377778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93331903|NCT02377778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331904|NCT02514772|Rituximab|rituximab|mesh-list
93331905|NCT02514772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331906|NCT02514772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331907|NCT02514772|Immunologic Factors|immunologic factors|mesh-ancestor
93331908|NCT02514772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331909|NCT02514772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93331910|NCT03658057|Rocuronium|rocuronium|mesh-list
93331911|NCT03658057|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93331912|NCT03658057|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93331913|NCT03658057|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93331914|NCT03658057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331915|NCT03658057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331916|NCT03657979|Ropivacaine|ropivacaine|mesh-list
93331917|NCT03657979|Anesthetics, Local|anesthetics, local|mesh-ancestor
93331918|NCT03657979|Anesthetics|anesthetics|mesh-ancestor
93331919|NCT03657979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331920|NCT03657979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331921|NCT03657979|Sensory System Agents|sensory system agents|mesh-ancestor
93331922|NCT03657979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331923|NCT03659851|Simendan|simendan|mesh-list
93331924|NCT03659851|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93331925|NCT03659851|Vasodilator Agents|vasodilator agents|mesh-ancestor
93331926|NCT03659851|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93331927|NCT03659851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93331928|NCT03659851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93331929|NCT03659851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331930|NCT03659851|Protective Agents|protective agents|mesh-ancestor
93331931|NCT03659851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331932|NCT03659383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93331933|NCT03659383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331934|NCT02368730|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93331935|NCT02368730|Hemostatics|hemostatics|mesh-ancestor
93331936|NCT02368730|Coagulants|coagulants|mesh-ancestor
93331937|NCT02368730|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93331938|NCT02368730|Natriuretic Agents|natriuretic agents|mesh-ancestor
93331939|NCT02368730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331940|NCT03659305|Bevacizumab|bevacizumab|mesh-list
93331941|NCT03659305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331942|NCT03659305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331943|NCT03659305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93331944|NCT03659305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93331945|NCT03659305|Growth Substances|growth substances|mesh-ancestor
93331946|NCT03659305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331947|NCT03659305|Growth Inhibitors|growth inhibitors|mesh-ancestor
93331948|NCT02788981|Paclitaxel|paclitaxel|mesh-list
93331949|NCT02788981|Mifepristone|mifepristone|mesh-list
93331950|NCT02788981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93331951|NCT02788981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331952|NCT02788981|Tubulin Modulators|tubulin modulators|mesh-ancestor
93331953|NCT02788981|Antimitotic Agents|antimitotic agents|mesh-ancestor
93331954|NCT02788981|Mitosis Modulators|mitosis modulators|mesh-ancestor
93331955|NCT02788981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93331956|NCT02788981|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93331957|NCT02788981|Abortifacient Agents|abortifacient agents|mesh-ancestor
93331958|NCT02788981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93331959|NCT02788981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331960|NCT02788981|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93331961|NCT02788981|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93331962|NCT02788981|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93331963|NCT02788981|Contraceptive Agents|contraceptive agents|mesh-ancestor
93331964|NCT02788981|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93331965|NCT02788981|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93331966|NCT02788981|Hormone Antagonists|hormone antagonists|mesh-ancestor
93331967|NCT02788981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93331968|NCT02788981|Luteolytic Agents|luteolytic agents|mesh-ancestor
93331969|NCT02788981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93331970|NCT02788981|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93331971|NCT02368964|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93331972|NCT02368964|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93331973|NCT02368964|Luteolytic Agents|luteolytic agents|mesh-ancestor
93331974|NCT02368964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93331975|NCT02368964|Contraceptive Agents|contraceptive agents|mesh-ancestor
93331976|NCT02368964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93331977|NCT02368964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331978|NCT02368964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93331979|NCT02368964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93331980|NCT02368964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331981|NCT02373722|Petrolatum|petrolatum|mesh-list
93331982|NCT02373722|Mineral Oil|mineral oil|mesh-list
93331983|NCT02373722|Emollients|emollients|mesh-ancestor
93331984|NCT02373722|Dermatologic Agents|dermatologic agents|mesh-ancestor
93331985|NCT03000179|Avelumab|avelumab|mesh-list
93331986|NCT03000179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93331987|NCT03000179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93331988|NCT03658993|Rifaximin|rifaximin|mesh-list
93331989|NCT03658993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93331990|NCT03658993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93331991|NCT03658993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93331992|NCT02373410|Bupivacaine|bupivacaine|mesh-list
93331993|NCT02373410|Anesthetics, Local|anesthetics, local|mesh-ancestor
93331994|NCT02373410|Anesthetics|anesthetics|mesh-ancestor
93331995|NCT02373410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93331996|NCT02373410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93331997|NCT02373410|Sensory System Agents|sensory system agents|mesh-ancestor
93331998|NCT02373410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93331999|NCT02920177|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93332000|NCT02920177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332001|NCT02920177|Glucocorticoids|glucocorticoids|mesh-ancestor
93332002|NCT02920177|Hormones|hormones|mesh-ancestor
93332003|NCT02920177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332004|NCT02920177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332005|NCT02920177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93332006|NCT02920177|Immunologic Factors|immunologic factors|mesh-ancestor
93332007|NCT03006341|Telmisartan|telmisartan|mesh-list
93332008|NCT03006341|Warfarin|warfarin|mesh-list
93332009|NCT03006341|Dabigatran|dabigatran|mesh-list
93332010|NCT03006341|Anticoagulants|anticoagulants|mesh-ancestor
93332011|NCT03006341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93332012|NCT03006341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93332013|NCT03006341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93332014|NCT03006341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332015|NCT03006341|Antithrombins|antithrombins|mesh-ancestor
93332016|NCT03006341|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93332017|NCT03006341|Protease Inhibitors|protease inhibitors|mesh-ancestor
93332018|NCT03006341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332019|NCT05022784|Nintedanib|nintedanib|mesh-list
93332020|NCT05022784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332021|NCT05022784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93332022|NCT05022784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332023|NCT05022784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332024|NCT04413799|Lidocaine|lidocaine|mesh-list
93332025|NCT04413799|Ketamine|ketamine|mesh-list
93332026|NCT04413799|Anesthetics, Local|anesthetics, local|mesh-ancestor
93332027|NCT04413799|Anesthetics|anesthetics|mesh-ancestor
93332028|NCT04413799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332029|NCT04413799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003946|NCT00987038|Anesthetics|anesthetics|mesh-ancestor
93332030|NCT04413799|Sensory System Agents|sensory system agents|mesh-ancestor
93332031|NCT04413799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332032|NCT04413799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332033|NCT04413799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93332034|NCT04413799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93332035|NCT04413799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332036|NCT04413799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332037|NCT04413799|Analgesics|analgesics|mesh-ancestor
93332038|NCT04413799|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93332039|NCT04413799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93332040|NCT04413799|Anesthetics, General|anesthetics, general|mesh-ancestor
93332041|NCT04413799|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93332042|NCT04413799|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93332043|NCT04413799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332044|NCT03665753|Ketorolac|ketorolac|mesh-list
93332045|NCT03665753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332046|NCT03665753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332047|NCT03665753|Analgesics|analgesics|mesh-ancestor
93332048|NCT03665753|Sensory System Agents|sensory system agents|mesh-ancestor
93332049|NCT03665753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332050|NCT03665753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332051|NCT03665753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332052|NCT03665753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332053|NCT03665753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93332054|NCT03665753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332055|NCT03665753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332056|NCT02512042|Brinzolamide|brinzolamide|mesh-list
93332057|NCT02512042|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93332058|NCT02512042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332059|NCT02512042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332060|NCT03665519|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93332061|NCT03665519|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93332062|NCT03665519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332063|NCT04386746|Gemcitabine|gemcitabine|mesh-list
93332064|NCT04386746|Docetaxel|docetaxel|mesh-list
93332065|NCT04386746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93332066|NCT04386746|Antimetabolites|antimetabolites|mesh-ancestor
93332067|NCT04386746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332068|NCT04386746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332069|NCT04386746|Tubulin Modulators|tubulin modulators|mesh-ancestor
93332070|NCT04386746|Antimitotic Agents|antimitotic agents|mesh-ancestor
93332071|NCT04386746|Mitosis Modulators|mitosis modulators|mesh-ancestor
93332072|NCT01066897|Pramipexole|pramipexole|mesh-list
93332073|NCT01066897|Antioxidants|antioxidants|mesh-ancestor
93332074|NCT01066897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332075|NCT01066897|Protective Agents|protective agents|mesh-ancestor
93332076|NCT01066897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332077|NCT01066897|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93332078|NCT01066897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93332079|NCT01066897|Dopamine Agonists|dopamine agonists|mesh-ancestor
93332080|NCT01066897|Dopamine Agents|dopamine agents|mesh-ancestor
93332081|NCT01066897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332082|NCT02373254|Acetaminophen|acetaminophen|mesh-list
93332083|NCT02373254|Ibuprofen|ibuprofen|mesh-list
93332084|NCT02373254|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93332085|NCT02373254|Hydrocodone|hydrocodone|mesh-list
93332086|NCT02373254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332087|NCT02373254|Analgesics|analgesics|mesh-ancestor
93332088|NCT02373254|Sensory System Agents|sensory system agents|mesh-ancestor
93332089|NCT02373254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332090|NCT02373254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332091|NCT02373254|Antipyretics|antipyretics|mesh-ancestor
93332092|NCT02373254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332093|NCT02373254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332094|NCT02373254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332095|NCT02373254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93332096|NCT02373254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332097|NCT02373254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332098|NCT02373254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93332099|NCT02373254|Narcotics|narcotics|mesh-ancestor
93332100|NCT02373254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332101|NCT02373254|Antitussive Agents|antitussive agents|mesh-ancestor
93332102|NCT02373254|Respiratory System Agents|respiratory system agents|mesh-ancestor
93332103|NCT03657355|Zolpidem|zolpidem|mesh-list
93332104|NCT03657355|Suvorexant|suvorexant|mesh-list
93332105|NCT03657355|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93332106|NCT03657355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93332107|NCT03657355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332108|NCT03657355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332109|NCT03657355|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93332110|NCT03657355|GABA Agonists|gaba agonists|mesh-ancestor
93332111|NCT03657355|GABA Agents|gaba agents|mesh-ancestor
93332112|NCT03657355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332113|NCT03657355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332114|NCT03657355|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93332115|NCT02985541|Levonorgestrel|levonorgestrel|mesh-list
93332116|NCT02985541|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93332117|NCT02985541|Contraceptive Agents|contraceptive agents|mesh-ancestor
93332118|NCT02985541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93332119|NCT02985541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332120|NCT02985541|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93332121|NCT02985541|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93332122|NCT02985541|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93332123|NCT02365532|Dofetilide|dofetilide|mesh-list
93332124|NCT02365532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332125|NCT02365532|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93332126|NCT02365532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332127|NCT02365532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332128|NCT03113162|Cytarabine|cytarabine|mesh-list
93332129|NCT03113162|Etoposide|etoposide|mesh-list
93332130|NCT03113162|Melphalan|melphalan|mesh-list
93332131|NCT03113162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93332132|NCT03113162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332133|NCT03113162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93332134|NCT03113162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93332135|NCT03113162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332136|NCT03113162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332137|NCT03113162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93332138|NCT03113162|Antimetabolites|antimetabolites|mesh-ancestor
93332139|NCT03113162|Antiviral Agents|antiviral agents|mesh-ancestor
93332140|NCT03113162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332141|NCT03113162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93332142|NCT03113162|Immunologic Factors|immunologic factors|mesh-ancestor
93332143|NCT03113162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332144|NCT03113162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93332145|NCT03113162|Alkylating Agents|alkylating agents|mesh-ancestor
93332146|NCT03113162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93332147|NCT02356705|Lidocaine|lidocaine|mesh-list
93332148|NCT02356705|Midazolam|midazolam|mesh-list
93332149|NCT02356705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93332150|NCT02356705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93332151|NCT02356705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332152|NCT02356705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332153|NCT02356705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93332154|NCT02356705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93332155|NCT02356705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93332156|NCT02356705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93332157|NCT02356705|Anesthetics, General|anesthetics, general|mesh-ancestor
93332158|NCT02356705|Anesthetics|anesthetics|mesh-ancestor
93332159|NCT02356705|GABA Modulators|gaba modulators|mesh-ancestor
93332160|NCT02356705|GABA Agents|gaba agents|mesh-ancestor
93332161|NCT02356705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332162|NCT02356705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332163|NCT02356705|Anesthetics, Local|anesthetics, local|mesh-ancestor
93332164|NCT02356705|Sensory System Agents|sensory system agents|mesh-ancestor
93332165|NCT02356705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332166|NCT02356705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332167|NCT02356705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93332168|NCT02356705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93332169|NCT02356705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332170|NCT03541850|Ascorbic Acid|ascorbic acid|mesh-list
93332171|NCT03541850|Methyltestosterone|methyltestosterone|mesh-list
93332172|NCT03541850|Hormones|hormones|mesh-list
93332173|NCT03541850|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93332174|NCT03541850|Androgens|androgens|mesh-list
93332175|NCT03541850|Androgen Antagonists|androgen antagonists|mesh-list
93332176|NCT03541850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332177|NCT03541850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332178|NCT03541850|Antioxidants|antioxidants|mesh-ancestor
93332179|NCT03541850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332180|NCT03541850|Protective Agents|protective agents|mesh-ancestor
93332181|NCT03541850|Vitamins|vitamins|mesh-ancestor
93332182|NCT03541850|Micronutrients|micronutrients|mesh-ancestor
93332183|NCT03541850|Estrogens|estrogens|mesh-ancestor
93332184|NCT03541850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93332185|NCT03541850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332186|NCT03541850|Anabolic Agents|anabolic agents|mesh-ancestor
93332187|NCT03541850|Hormone Antagonists|hormone antagonists|mesh-ancestor
93332188|NCT02511184|Pembrolizumab|pembrolizumab|mesh-list
93332189|NCT02511184|Crizotinib|crizotinib|mesh-list
93332190|NCT02511184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93332191|NCT02511184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332192|NCT02511184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93332193|NCT02511184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332194|NCT02511184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93332195|NCT02511184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332196|NCT02367560|Methylprednisolone|methylprednisolone|mesh-list
93332197|NCT02367560|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93332198|NCT02367560|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93332199|NCT02367560|Prednisolone|prednisolone|mesh-list
93332200|NCT02367560|Prednisolone acetate|prednisolone acetate|mesh-list
93332201|NCT02367560|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93332202|NCT02367560|Prednisolone phosphate|prednisolone phosphate|mesh-list
93332203|NCT02367560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332204|NCT02367560|Antiemetics|antiemetics|mesh-ancestor
93332205|NCT02367560|Autonomic Agents|autonomic agents|mesh-ancestor
93332206|NCT02367560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332207|NCT02367560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332208|NCT02367560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332209|NCT02367560|Glucocorticoids|glucocorticoids|mesh-ancestor
93332210|NCT02367560|Hormones|hormones|mesh-ancestor
93332211|NCT02367560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332212|NCT02367560|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93332213|NCT02367560|Protective Agents|protective agents|mesh-ancestor
93332214|NCT02367560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93332215|NCT02367560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332216|NCT02372942|Progesterone|progesterone|mesh-list
93332217|NCT02372942|Progestins|progestins|mesh-ancestor
93332218|NCT02372942|Hormones|hormones|mesh-ancestor
93332219|NCT02372942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332220|NCT02372942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332221|NCT02364986|Interferons|interferons|mesh-list
93332222|NCT02364986|Interferon-beta|interferon-beta|mesh-list
93332223|NCT02364986|Interferon beta-1a|interferon beta-1a|mesh-list
93332224|NCT02364986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332225|NCT02364986|Antiviral Agents|antiviral agents|mesh-ancestor
93332226|NCT02364986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332227|NCT02364986|Immunologic Factors|immunologic factors|mesh-ancestor
93332228|NCT02364986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332229|NCT02364986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93332230|NCT02372786|Lidocaine|lidocaine|mesh-list
93332231|NCT02372786|Tetracaine|tetracaine|mesh-list
93332232|NCT02372786|Prilocaine|prilocaine|mesh-list
93332233|NCT02372786|Anesthetics, Local|anesthetics, local|mesh-ancestor
93332234|NCT02372786|Anesthetics|anesthetics|mesh-ancestor
93332235|NCT02372786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332236|NCT02372786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332237|NCT02372786|Sensory System Agents|sensory system agents|mesh-ancestor
93332238|NCT02372786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332239|NCT02372786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332240|NCT02372786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93332241|NCT02372786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93332242|NCT02372786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332243|NCT02372786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332244|NCT02367404|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93332245|NCT02367404|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91932708|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
93332246|NCT02367404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93332247|NCT02367404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332248|NCT02367404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332249|NCT02367404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332250|NCT02367404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332251|NCT02367404|Analgesics|analgesics|mesh-ancestor
93332252|NCT02367404|Sensory System Agents|sensory system agents|mesh-ancestor
93004171|NCT00086515|Pioglitazone|pioglitazone|mesh-list
93332253|NCT02367404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332254|NCT02367404|Antidepressive Agents|antidepressive agents|mesh-ancestor
93332255|NCT02367404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93332256|NCT02367404|Dopamine Agents|dopamine agents|mesh-ancestor
93332257|NCT02367248|Deferoxamine|deferoxamine|mesh-list
93332258|NCT02367248|Siderophores|siderophores|mesh-ancestor
93332259|NCT02367248|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93332260|NCT02367248|Chelating Agents|chelating agents|mesh-ancestor
93332261|NCT02367248|Sequestering Agents|sequestering agents|mesh-ancestor
93332262|NCT02367248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332264|NCT03656965|Antiviral Agents|antiviral agents|mesh-ancestor
93332265|NCT03656965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332266|NCT02384239|Tamoxifen|tamoxifen|mesh-list
93332267|NCT02384239|Fulvestrant|fulvestrant|mesh-list
93332268|NCT02384239|Palbociclib|palbociclib|mesh-list
93332269|NCT02384239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93332270|NCT02384239|Hormone Antagonists|hormone antagonists|mesh-ancestor
93332271|NCT02384239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332272|NCT02384239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332273|NCT02384239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93332274|NCT02384239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332275|NCT02384239|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93332276|NCT02384239|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93332277|NCT02384239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93332278|NCT02384239|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93332279|NCT02384239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93332280|NCT02384239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332281|NCT02384239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332282|NCT02364752|Diuretics|diuretics|mesh-list
93332283|NCT02364752|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
93332284|NCT02364752|Natriuretic Agents|natriuretic agents|mesh-ancestor
93332285|NCT02364752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332286|NCT02364752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332287|NCT02364752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332288|NCT02372240|Dexamethasone|dexamethasone|mesh-list
93332289|NCT02372240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332290|NCT02372240|Antiemetics|antiemetics|mesh-ancestor
93332291|NCT02372240|Autonomic Agents|autonomic agents|mesh-ancestor
93332292|NCT02372240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332293|NCT02372240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332294|NCT02372240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332295|NCT02372240|Glucocorticoids|glucocorticoids|mesh-ancestor
93332296|NCT02372240|Hormones|hormones|mesh-ancestor
93332297|NCT02372240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332298|NCT02372240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93332299|NCT02372240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332300|NCT02364206|Temozolomide|temozolomide|mesh-list
93332301|NCT02364206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93332302|NCT02364206|Alkylating Agents|alkylating agents|mesh-ancestor
93332303|NCT02364206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626122|NCT04382326|Vaccines|vaccines|mesh-list
93332304|NCT02364206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332305|NCT02366546|Cyclophosphamide|cyclophosphamide|mesh-list
93332306|NCT02366546|Fludarabine|fludarabine|mesh-list
93332307|NCT02366546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93332308|NCT02366546|Immunologic Factors|immunologic factors|mesh-ancestor
93332309|NCT02366546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332310|NCT02366546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332311|NCT02366546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93332312|NCT02366546|Alkylating Agents|alkylating agents|mesh-ancestor
93332313|NCT02366546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332314|NCT02366546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332315|NCT02366546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93332316|NCT03029702|Metformin|metformin|mesh-list
93332317|NCT03029702|Glyburide|glyburide|mesh-list
93332318|NCT03029702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93332319|NCT03029702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332320|NCT02364362|Docetaxel|docetaxel|mesh-list
93332321|NCT02364362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332322|NCT02364362|Tubulin Modulators|tubulin modulators|mesh-ancestor
93332323|NCT02364362|Antimitotic Agents|antimitotic agents|mesh-ancestor
93332324|NCT02364362|Mitosis Modulators|mitosis modulators|mesh-ancestor
93332325|NCT02364362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332326|NCT03004469|Finasteride|finasteride|mesh-list
93332327|NCT03004469|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93332328|NCT03004469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93332329|NCT03004469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332330|NCT03004469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332331|NCT03004469|Hormone Antagonists|hormone antagonists|mesh-ancestor
93332332|NCT03004469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332333|NCT03004469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332334|NCT03004469|Urological Agents|urological agents|mesh-ancestor
93332335|NCT02358824|Amlodipine|amlodipine|mesh-list
93332336|NCT02358824|Telmisartan|telmisartan|mesh-list
93332337|NCT02358824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93332338|NCT02358824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93332339|NCT02358824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332340|NCT02358824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332341|NCT02358824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93332342|NCT02358824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332343|NCT02358824|Vasodilator Agents|vasodilator agents|mesh-ancestor
93332344|NCT02358824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93332345|NCT02358824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93332346|NCT02359136|Epinephrine|epinephrine|mesh-list
93332347|NCT02359136|Analgesics|analgesics|mesh-list
93332348|NCT02359136|Anesthetics|anesthetics|mesh-list
93332349|NCT02359136|Ropivacaine|ropivacaine|mesh-list
93332350|NCT02359136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332351|NCT02359136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332352|NCT02359136|Anesthetics, Local|anesthetics, local|mesh-ancestor
93332353|NCT02359136|Sensory System Agents|sensory system agents|mesh-ancestor
93332354|NCT02359136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332355|NCT02359136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93332356|NCT02359136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93332357|NCT02359136|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332358|NCT02359136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332359|NCT02359136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332360|NCT02359136|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93332361|NCT02359136|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93332362|NCT02359136|Autonomic Agents|autonomic agents|mesh-ancestor
93332363|NCT02359136|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93332364|NCT02359136|Respiratory System Agents|respiratory system agents|mesh-ancestor
93332365|NCT02359136|Mydriatics|mydriatics|mesh-ancestor
93332366|NCT02359136|Sympathomimetics|sympathomimetics|mesh-ancestor
93332367|NCT02359136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93332368|NCT02998151|Minocycline|minocycline|mesh-list
93332369|NCT02998151|Acamprosate|acamprosate|mesh-list
93332370|NCT02998151|Baclofen|baclofen|mesh-list
93332371|NCT02998151|Lovastatin|lovastatin|mesh-list
93332372|NCT02998151|L 647318|l 647318|mesh-list
93332373|NCT02998151|Dihydromevinolin|dihydromevinolin|mesh-list
93332374|NCT02998151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93332375|NCT02998151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332376|NCT02998151|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93332377|NCT02998151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332378|NCT02998151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93332379|NCT02998151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332380|NCT02998151|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93332381|NCT02998151|GABA Agonists|gaba agonists|mesh-ancestor
93332382|NCT02998151|GABA Agents|gaba agents|mesh-ancestor
93332383|NCT02998151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332384|NCT02998151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332385|NCT02998151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93332386|NCT02998151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93332387|NCT02998151|Antimetabolites|antimetabolites|mesh-ancestor
93332388|NCT02998151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93332389|NCT02998151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93332390|NCT02998151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332391|NCT02998151|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93332392|NCT01066819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93332393|NCT01066819|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93332394|NCT01066819|Antiviral Agents|antiviral agents|mesh-ancestor
93332395|NCT01066819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332396|NCT04057937|Apremilast|apremilast|mesh-list
93332397|NCT04057937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332398|NCT04057937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332399|NCT04057937|Analgesics|analgesics|mesh-ancestor
93332400|NCT04057937|Sensory System Agents|sensory system agents|mesh-ancestor
93332401|NCT04057937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332402|NCT04057937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332403|NCT04057937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332404|NCT04057937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332405|NCT04057937|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93332406|NCT04057937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93332407|NCT04057937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332408|NCT04057937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332409|NCT01069523|Guanfacine|guanfacine|mesh-list
93332410|NCT01069523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93332411|NCT01069523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93332412|NCT01069523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93332413|NCT01069523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93332414|NCT01069523|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332415|NCT01069523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332416|NCT01069523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332417|NCT01069523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332418|NCT01069289|Budesonide|budesonide|mesh-list
93332419|NCT01069289|Formoterol Fumarate|formoterol fumarate|mesh-list
93332420|NCT01069289|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93332421|NCT01069289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332422|NCT01069289|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93332423|NCT01069289|Autonomic Agents|autonomic agents|mesh-ancestor
93332424|NCT01069289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332425|NCT01069289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332426|NCT01069289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93332427|NCT01069289|Respiratory System Agents|respiratory system agents|mesh-ancestor
93332428|NCT01069289|Glucocorticoids|glucocorticoids|mesh-ancestor
93332429|NCT01069289|Hormones|hormones|mesh-ancestor
93332430|NCT01069289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332431|NCT01069289|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93332432|NCT01069289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93332433|NCT01069289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93332434|NCT01069289|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332435|NCT01069289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332436|NCT01069289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332437|NCT03303989|Mycophenolic Acid|mycophenolic acid|mesh-list
93332438|NCT03303989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93332439|NCT03303989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332440|NCT03303989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93332441|NCT03303989|Antitubercular Agents|antitubercular agents|mesh-ancestor
92626253|NCT00162734|Interferons|interferons|mesh-list
93332442|NCT03303989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93332443|NCT03303989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332444|NCT03303989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332445|NCT03303989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332446|NCT02510794|Ranibizumab|ranibizumab|mesh-list
93332447|NCT02510794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93332448|NCT02510794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93332449|NCT02510794|Growth Substances|growth substances|mesh-ancestor
93332450|NCT02510794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332451|NCT02510794|Growth Inhibitors|growth inhibitors|mesh-ancestor
93332452|NCT02510794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332453|NCT04056923|Methylene Blue|methylene blue|mesh-list
93332454|NCT04056923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332455|NCT04056923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332456|NCT03664115|Itraconazole|itraconazole|mesh-list
93332457|NCT03664115|Antifungal Agents|antifungal agents|mesh-ancestor
93332458|NCT03664115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332459|NCT03664115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93332460|NCT03664115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93332461|NCT03664115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332462|NCT03664115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332463|NCT03664115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93332464|NCT03664115|Hormone Antagonists|hormone antagonists|mesh-ancestor
93332465|NCT03664115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332466|NCT03664115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332467|NCT03664115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93332468|NCT04056845|Acetaminophen|acetaminophen|mesh-list
93332469|NCT04056845|Diclofenac|diclofenac|mesh-list
93332470|NCT04056845|Analgesics|analgesics|mesh-list
93332471|NCT04056845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332472|NCT04056845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93004439|NCT05361278|Eusol|eusol|mesh-list
93332473|NCT04056845|Sensory System Agents|sensory system agents|mesh-ancestor
93332474|NCT04056845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332475|NCT04056845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332476|NCT04056845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332478|NCT04056845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93332479|NCT04056845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332480|NCT04056845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332481|NCT04056845|Antipyretics|antipyretics|mesh-ancestor
93332482|NCT02510014|Buprenorphine|buprenorphine|mesh-list
93332483|NCT02510014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93332484|NCT02510014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93332485|NCT02510014|Narcotics|narcotics|mesh-ancestor
93332486|NCT02510014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332487|NCT02510014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332488|NCT02510014|Analgesics|analgesics|mesh-ancestor
93332489|NCT02510014|Sensory System Agents|sensory system agents|mesh-ancestor
93332490|NCT02510014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332491|NCT02510014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93332492|NCT02509312|Ketorolac|ketorolac|mesh-list
93332493|NCT02509312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332494|NCT02509312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332495|NCT02509312|Analgesics|analgesics|mesh-ancestor
93332496|NCT02509312|Sensory System Agents|sensory system agents|mesh-ancestor
93332497|NCT02509312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332498|NCT02509312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332499|NCT02509312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332500|NCT02509312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332501|NCT02509312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93332502|NCT02509312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332503|NCT02509312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332504|NCT02362958|Capecitabine|capecitabine|mesh-list
93332505|NCT02362958|Vinorelbine|vinorelbine|mesh-list
93332506|NCT02362958|Lapatinib|lapatinib|mesh-list
93332507|NCT02362958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93332508|NCT02362958|Antimetabolites|antimetabolites|mesh-ancestor
93332509|NCT02362958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332510|NCT02362958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332511|NCT02362958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93332512|NCT02362958|Tubulin Modulators|tubulin modulators|mesh-ancestor
93332513|NCT02362958|Antimitotic Agents|antimitotic agents|mesh-ancestor
93332514|NCT02362958|Mitosis Modulators|mitosis modulators|mesh-ancestor
93332515|NCT02362958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93332516|NCT02362958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332517|NCT04973800|Simvastatin|simvastatin|mesh-list
93332518|NCT04973800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93332519|NCT04973800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93332520|NCT04973800|Antimetabolites|antimetabolites|mesh-ancestor
93332521|NCT04973800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332522|NCT04973800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93332523|NCT04973800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93332524|NCT04973800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332525|NCT05020522|Phenobarbital|phenobarbital|mesh-list
93332526|NCT05020522|Anticonvulsants|anticonvulsants|mesh-ancestor
93332527|NCT05020522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93332528|NCT05020522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332529|NCT05020522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332530|NCT05020522|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93332531|NCT05020522|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93332532|NCT05020522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332533|NCT05020522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332534|NCT05020522|GABA Modulators|gaba modulators|mesh-ancestor
93332535|NCT05020522|GABA Agents|gaba agents|mesh-ancestor
93332536|NCT05020522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93332537|NCT05020522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93332538|NCT05020522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93332539|NCT02519842|Dexamethasone|dexamethasone|mesh-list
93332540|NCT02519842|Ondansetron|ondansetron|mesh-list
93332541|NCT02519842|Fosaprepitant|fosaprepitant|mesh-list
93332542|NCT02519842|Aprepitant|aprepitant|mesh-list
93332543|NCT02519842|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
93332544|NCT02519842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332545|NCT02519842|Antiemetics|antiemetics|mesh-ancestor
93332546|NCT02519842|Autonomic Agents|autonomic agents|mesh-ancestor
93332547|NCT02519842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332548|NCT02519842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332549|NCT02519842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332550|NCT02519842|Glucocorticoids|glucocorticoids|mesh-ancestor
93332551|NCT02519842|Hormones|hormones|mesh-ancestor
93332552|NCT02519842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332553|NCT02519842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93332554|NCT02519842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332555|NCT02519842|Antipruritics|antipruritics|mesh-ancestor
93332556|NCT02519842|Dermatologic Agents|dermatologic agents|mesh-ancestor
93332557|NCT02519842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93332558|NCT02519842|Serotonin Agents|serotonin agents|mesh-ancestor
93332559|NCT02519842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332560|NCT02519842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332561|NCT02519842|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93332562|NCT02509078|Cisatracurium|cisatracurium|mesh-list
93332563|NCT02509078|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93332564|NCT02509078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93332565|NCT02509078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332566|NCT02509078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332567|NCT02993783|Vedolizumab|vedolizumab|mesh-list
93332568|NCT02993783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332569|NCT03661775|Magnesium Sulfate|magnesium sulfate|mesh-list
93332570|NCT03661775|Analgesics|analgesics|mesh-ancestor
93332571|NCT03661775|Sensory System Agents|sensory system agents|mesh-ancestor
93332572|NCT03661775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332573|NCT03661775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332574|NCT03661775|Anesthetics|anesthetics|mesh-ancestor
93332575|NCT03661775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332576|NCT03661775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332577|NCT03661775|Anticonvulsants|anticonvulsants|mesh-ancestor
93332578|NCT03661775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93332579|NCT03661775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332580|NCT03661775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332581|NCT03661775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93332582|NCT03661775|Tocolytic Agents|tocolytic agents|mesh-ancestor
93332583|NCT03661775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93332584|NCT03660761|Apatinib|apatinib|mesh-list
93332585|NCT03660761|Temozolomide|temozolomide|mesh-list
93332586|NCT03660761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332587|NCT03660761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93332588|NCT03660761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332589|NCT03660761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332590|NCT03660761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93332591|NCT03660761|Alkylating Agents|alkylating agents|mesh-ancestor
93332592|NCT02993471|Vitamin K|vitamin k|mesh-list
93332593|NCT02993471|Midazolam|midazolam|mesh-list
93332594|NCT02993471|Dextromethorphan|dextromethorphan|mesh-list
93332595|NCT02993471|Caffeine|caffeine|mesh-list
93332596|NCT02993471|Ixekizumab|ixekizumab|mesh-list
93332597|NCT02993471|Omeprazole|omeprazole|mesh-list
93332598|NCT02993471|Warfarin|warfarin|mesh-list
93332599|NCT02993471|Vitamins|vitamins|mesh-ancestor
93332600|NCT02993471|Micronutrients|micronutrients|mesh-ancestor
93332601|NCT02993471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332602|NCT02993471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93332603|NCT02993471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93332604|NCT02993471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332605|NCT02993471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93332606|NCT02993471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93332607|NCT02993471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93332608|NCT02993471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93332609|NCT02993471|Anesthetics, General|anesthetics, general|mesh-ancestor
93332610|NCT02993471|Anesthetics|anesthetics|mesh-ancestor
93332611|NCT02993471|GABA Modulators|gaba modulators|mesh-ancestor
93332612|NCT02993471|GABA Agents|gaba agents|mesh-ancestor
93332613|NCT02993471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332614|NCT02993471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332615|NCT02993471|Anticoagulants|anticoagulants|mesh-ancestor
93332616|NCT02993471|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93332617|NCT02993471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93332618|NCT02993471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332619|NCT02993471|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93332620|NCT02993471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93004550|NCT03026036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93332621|NCT02993471|Purinergic Agents|purinergic agents|mesh-ancestor
93332622|NCT02993471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93332623|NCT02993471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332624|NCT02993471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93332625|NCT02993471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93332626|NCT02993471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93332627|NCT02993471|Hemostatics|hemostatics|mesh-ancestor
93332628|NCT02993471|Coagulants|coagulants|mesh-ancestor
93332629|NCT02993471|Antitussive Agents|antitussive agents|mesh-ancestor
93332630|NCT02993471|Respiratory System Agents|respiratory system agents|mesh-ancestor
93332631|NCT02993471|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93332632|NCT02993471|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93332633|NCT02993471|Dermatologic Agents|dermatologic agents|mesh-ancestor
93332634|NCT01068743|Metformin|metformin|mesh-list
93332635|NCT01068743|Saxagliptin|saxagliptin|mesh-list
93332636|NCT01068743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93332637|NCT01068743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332638|NCT01068743|Incretins|incretins|mesh-ancestor
93332639|NCT01068743|Hormones|hormones|mesh-ancestor
93332640|NCT01068743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332641|NCT01068743|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93332642|NCT01068743|Protease Inhibitors|protease inhibitors|mesh-ancestor
93332643|NCT01068743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332644|NCT01068743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332645|NCT03622541|Sorafenib|sorafenib|mesh-list
93332646|NCT03622541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332647|NCT03622541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93332648|NCT03622541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332649|NCT03622541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332650|NCT03658733|Amoxicillin|amoxicillin|mesh-list
93332651|NCT03658733|Tetracycline|tetracycline|mesh-list
93332652|NCT03658733|Furazolidone|furazolidone|mesh-list
93332653|NCT03658733|Esomeprazole|esomeprazole|mesh-list
93332654|NCT03658733|Rabeprazole|rabeprazole|mesh-list
93332655|NCT03658733|Bismuth|bismuth|mesh-list
93332656|NCT03658733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93332657|NCT03658733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332658|NCT03658733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93332659|NCT03658733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332660|NCT03658733|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93332661|NCT03658733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332662|NCT03658733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332663|NCT03658733|Antacids|antacids|mesh-ancestor
93332664|NCT03658733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93332665|NCT03658733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93332666|NCT03658733|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93332667|NCT03658733|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93332668|NCT03658733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93332669|NCT03658733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93332670|NCT03658733|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93332671|NCT04056143|Rivaroxaban|rivaroxaban|mesh-list
93332672|NCT04056143|Apixaban|apixaban|mesh-list
93332673|NCT04056143|Edoxaban|edoxaban|mesh-list
93332674|NCT04056143|Dabigatran|dabigatran|mesh-list
93332675|NCT04056143|Thromboplastin|thromboplastin|mesh-list
93332676|NCT04056143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93332677|NCT04056143|Antithrombins|antithrombins|mesh-ancestor
93332678|NCT04056143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93332679|NCT04056143|Protease Inhibitors|protease inhibitors|mesh-ancestor
93332680|NCT04056143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332681|NCT04056143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332682|NCT04056143|Anticoagulants|anticoagulants|mesh-ancestor
93332683|NCT04056143|Hemostatics|hemostatics|mesh-ancestor
93332684|NCT04056143|Coagulants|coagulants|mesh-ancestor
93332685|NCT03661463|Aspirin|aspirin|mesh-list
93332686|NCT03661463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332687|NCT03661463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332688|NCT03661463|Analgesics|analgesics|mesh-ancestor
93332689|NCT03661463|Sensory System Agents|sensory system agents|mesh-ancestor
93332690|NCT03661463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332691|NCT03661463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332692|NCT03661463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332693|NCT03661463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332694|NCT03661463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93004629|NCT00766181|Lidocaine|lidocaine|mesh-list
93332695|NCT03661463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93332696|NCT03661463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332697|NCT03661463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93332698|NCT03661463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93332699|NCT03661463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332700|NCT03661463|Antipyretics|antipyretics|mesh-ancestor
93332701|NCT03658421|Dexmedetomidine|dexmedetomidine|mesh-list
93332702|NCT03658421|Morphine|morphine|mesh-list
93332703|NCT03658421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93332704|NCT03658421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332705|NCT03658421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332706|NCT03658421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332707|NCT03658421|Analgesics|analgesics|mesh-ancestor
93332708|NCT03658421|Sensory System Agents|sensory system agents|mesh-ancestor
93332709|NCT03658421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332710|NCT03658421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93332711|NCT03658421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93332712|NCT03658421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93332713|NCT03658421|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332714|NCT03658421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332715|NCT03658421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332716|NCT03658421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93332717|NCT03658421|Narcotics|narcotics|mesh-ancestor
93332718|NCT03660293|Captopril|captopril|mesh-list
93332719|NCT03660293|Atorvastatin|atorvastatin|mesh-list
93332720|NCT03660293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93332721|NCT03660293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93332722|NCT03660293|Antimetabolites|antimetabolites|mesh-ancestor
93332723|NCT03660293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332724|NCT03660293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93332725|NCT03660293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93332726|NCT03660293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332727|NCT03660293|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93332728|NCT03660293|Protease Inhibitors|protease inhibitors|mesh-ancestor
93332729|NCT03660293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93332730|NCT02986139|Etanercept|etanercept|mesh-list
93332731|NCT02986139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93332732|NCT02986139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93332733|NCT02986139|Analgesics|analgesics|mesh-ancestor
93332734|NCT02986139|Sensory System Agents|sensory system agents|mesh-ancestor
93332735|NCT02986139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332736|NCT02986139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332737|NCT02986139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93332738|NCT02986139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332739|NCT02986139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332740|NCT02986139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93332741|NCT02986139|Immunologic Factors|immunologic factors|mesh-ancestor
93332742|NCT02906917|Insulin|insulin|mesh-list
93332743|NCT02906917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93332744|NCT02906917|Insulin Glargine|insulin glargine|mesh-list
93332745|NCT02906917|Insulin Aspart|insulin aspart|mesh-list
93332746|NCT02906917|Insulin, Long-Acting|insulin, long-acting|mesh-list
93332747|NCT02906917|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93332748|NCT02906917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93332749|NCT02906917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332750|NCT01066585|Ivermectin|ivermectin|mesh-list
93332751|NCT01066585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93332752|NCT01066585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332753|NCT03654703|Cyclophosphamide|cyclophosphamide|mesh-list
93332754|NCT03654703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93332755|NCT03654703|Immunologic Factors|immunologic factors|mesh-ancestor
93332756|NCT03654703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332757|NCT03654703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93332758|NCT03654703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93332759|NCT03654703|Alkylating Agents|alkylating agents|mesh-ancestor
93332760|NCT03654703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332761|NCT03654703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332762|NCT03654703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93332763|NCT02980783|Lidocaine|lidocaine|mesh-list
93332764|NCT02980783|Anesthetics, Local|anesthetics, local|mesh-ancestor
93332765|NCT02980783|Anesthetics|anesthetics|mesh-ancestor
93332766|NCT02980783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332767|NCT02980783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332768|NCT02980783|Sensory System Agents|sensory system agents|mesh-ancestor
93332769|NCT02980783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626580|NCT00066040|Fluorides|fluorides|mesh-list
93332770|NCT02980783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332771|NCT02980783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93332772|NCT02980783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93332773|NCT02980783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332774|NCT02980783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332775|NCT02989649|Metformin|metformin|mesh-list
93332776|NCT02989649|Pioglitazone|pioglitazone|mesh-list
93332777|NCT02989649|Alogliptin|alogliptin|mesh-list
93332778|NCT02989649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93332779|NCT02989649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332780|NCT02989649|Incretins|incretins|mesh-ancestor
93332781|NCT02989649|Hormones|hormones|mesh-ancestor
93332782|NCT02989649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332783|NCT02989649|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93332784|NCT02989649|Protease Inhibitors|protease inhibitors|mesh-ancestor
93332785|NCT02989649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332786|NCT02989649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332787|NCT03659435|Rivastigmine|rivastigmine|mesh-list
93332788|NCT03659435|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93332789|NCT03659435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332790|NCT03659435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332791|NCT03659435|Cholinergic Agents|cholinergic agents|mesh-ancestor
93332792|NCT03659435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332793|NCT03659435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332794|NCT03659435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93332795|NCT03659435|Protective Agents|protective agents|mesh-ancestor
93332796|NCT01067339|Darapladib|darapladib|mesh-list
93332797|NCT01067339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93332798|NCT01067339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332799|NCT01067339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332800|NCT04484675|Milrinone|milrinone|mesh-list
93332801|NCT04484675|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93332802|NCT04484675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93332803|NCT04484675|Vasodilator Agents|vasodilator agents|mesh-ancestor
93332804|NCT04484675|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93332805|NCT04484675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93332806|NCT04484675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332807|NCT04484675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332808|NCT04484675|Protective Agents|protective agents|mesh-ancestor
93332809|NCT04484675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332810|NCT03658109|Lidocaine|lidocaine|mesh-list
93332811|NCT03658109|Anesthetics, Local|anesthetics, local|mesh-ancestor
93332812|NCT03658109|Anesthetics|anesthetics|mesh-ancestor
93332813|NCT03658109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332814|NCT03658109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332815|NCT03658109|Sensory System Agents|sensory system agents|mesh-ancestor
93332816|NCT03658109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332817|NCT03658109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93332818|NCT03658109|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93332819|NCT03658109|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93332820|NCT03658109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332821|NCT03658109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332822|NCT03658031|Dapagliflozin|dapagliflozin|mesh-list
93332823|NCT03658031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93332824|NCT03658031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332825|NCT03658031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93332826|NCT03658031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332827|NCT03660917|Riluzole|riluzole|mesh-list
93332828|NCT03660917|Anticonvulsants|anticonvulsants|mesh-ancestor
93332829|NCT03660917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93332830|NCT03660917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93332831|NCT03660917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332832|NCT03660917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332833|NCT03660917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332834|NCT03660917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93332835|NCT03660917|Protective Agents|protective agents|mesh-ancestor
93332836|NCT02977507|Sunscreening Agents|sunscreening agents|mesh-list
93332837|NCT02977507|Hydroquinone|hydroquinone|mesh-list
93332838|NCT02977507|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93332839|NCT02977507|Protective Agents|protective agents|mesh-ancestor
93332840|NCT02977507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332841|NCT02977507|Dermatologic Agents|dermatologic agents|mesh-ancestor
93332842|NCT02977507|Antioxidants|antioxidants|mesh-ancestor
93332843|NCT02977507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332844|NCT04471415|Atezolizumab|atezolizumab|mesh-list
93332845|NCT04471415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93004778|NCT00762983|Loratadine|loratadine|mesh-list
93332846|NCT04471415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332847|NCT04471415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93332848|NCT04471415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332849|NCT02976103|Analgesics|analgesics|mesh-list
93332850|NCT02976103|Sensory System Agents|sensory system agents|mesh-ancestor
93332851|NCT02976103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332852|NCT02976103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332853|NCT05157243|Nitazoxanide|nitazoxanide|mesh-list
93332854|NCT05157243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93332855|NCT05157243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332856|NCT03653845|Epinephrine|epinephrine|mesh-list
93332857|NCT03653845|Racepinephrine|racepinephrine|mesh-list
93332858|NCT03653845|Epinephryl borate|epinephryl borate|mesh-list
93332859|NCT03653845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93332860|NCT03653845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93332861|NCT03653845|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332862|NCT03653845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332863|NCT03653845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332864|NCT03653845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332865|NCT03653845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93332866|NCT03653845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93332867|NCT03653845|Autonomic Agents|autonomic agents|mesh-ancestor
93332868|NCT03653845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332869|NCT03653845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93332870|NCT03653845|Respiratory System Agents|respiratory system agents|mesh-ancestor
93332871|NCT03653845|Mydriatics|mydriatics|mesh-ancestor
93332872|NCT03653845|Sympathomimetics|sympathomimetics|mesh-ancestor
93332873|NCT03653845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93332874|NCT03470961|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93332875|NCT03470961|Immunologic Factors|immunologic factors|mesh-ancestor
93332876|NCT03470961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332877|NCT03470961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93332878|NCT01066039|Bisoprolol|bisoprolol|mesh-list
93332879|NCT01066039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93332880|NCT01066039|Sympatholytics|sympatholytics|mesh-ancestor
93332881|NCT01066039|Autonomic Agents|autonomic agents|mesh-ancestor
93332882|NCT01066039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332883|NCT01066039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332884|NCT01066039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93332885|NCT01066039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93332886|NCT01066039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93332887|NCT01066039|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332888|NCT01066039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332889|NCT01066039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332890|NCT04217967|Lenalidomide|lenalidomide|mesh-list
93332891|NCT04217967|Ixazomib|ixazomib|mesh-list
93332892|NCT04217967|Immunologic Factors|immunologic factors|mesh-ancestor
93332893|NCT04217967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332894|NCT04217967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93332895|NCT04217967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93332896|NCT04217967|Growth Substances|growth substances|mesh-ancestor
93332897|NCT04217967|Growth Inhibitors|growth inhibitors|mesh-ancestor
93332898|NCT04217967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332899|NCT04217967|Protease Inhibitors|protease inhibitors|mesh-ancestor
93332900|NCT04217967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93332901|NCT04217967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332902|NCT02919761|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93332903|NCT02919761|Hormones|hormones|mesh-ancestor
93332904|NCT02919761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332905|NCT02919761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332906|NCT02910167|Acetaminophen|acetaminophen|mesh-list
93332907|NCT02910167|Scopolamine|scopolamine|mesh-list
93332908|NCT02910167|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93332909|NCT02910167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92626721|NCT05807347|Venetoclax|venetoclax|mesh-list
93332910|NCT02910167|Analgesics|analgesics|mesh-ancestor
93332911|NCT02910167|Sensory System Agents|sensory system agents|mesh-ancestor
93332912|NCT02910167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332913|NCT02910167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332914|NCT02910167|Antipyretics|antipyretics|mesh-ancestor
93332915|NCT02910167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93332916|NCT02910167|Antiemetics|antiemetics|mesh-ancestor
93332917|NCT02910167|Autonomic Agents|autonomic agents|mesh-ancestor
93332918|NCT02910167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93332919|NCT02910167|Mydriatics|mydriatics|mesh-ancestor
93332920|NCT02910167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93332921|NCT02910167|Cholinergic Agents|cholinergic agents|mesh-ancestor
93332922|NCT02910167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332923|NCT02910167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332924|NCT02910167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93332926|NCT04458285|Valsartan|valsartan|mesh-list
93332927|NCT04458285|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93332928|NCT04458285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93332929|NCT04458285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93332930|NCT04458285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93332931|NCT04458285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332932|NCT05156541|Interferons|interferons|mesh-list
93332933|NCT05156541|Interferon-gamma|interferon-gamma|mesh-list
93332934|NCT05156541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332935|NCT05156541|Antiviral Agents|antiviral agents|mesh-ancestor
93332936|NCT05156541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332937|NCT01067105|Ciclesonide|ciclesonide|mesh-list
93332938|NCT01067105|Glucocorticoids|glucocorticoids|mesh-ancestor
93332939|NCT01067105|Hormones|hormones|mesh-ancestor
93332940|NCT01067105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93332941|NCT01067105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332942|NCT01067105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93332943|NCT03470727|Dialysis Solutions|dialysis solutions|mesh-list
93332944|NCT03470727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93332945|NCT03470649|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93332946|NCT03470649|Hematinics|hematinics|mesh-ancestor
93332947|NCT02910011|Doxycycline|doxycycline|mesh-list
93332948|NCT02910011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93332949|NCT02910011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93332950|NCT02910011|Antimalarials|antimalarials|mesh-ancestor
93332951|NCT02910011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93332952|NCT02910011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93332953|NCT04456803|Sevelamer|sevelamer|mesh-list
93332954|NCT04456803|Chelating Agents|chelating agents|mesh-ancestor
93332955|NCT04456803|Sequestering Agents|sequestering agents|mesh-ancestor
93332956|NCT04456803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332957|NCT02908529|Oxybutynin|oxybutynin|mesh-list
93332958|NCT02908529|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93332959|NCT02908529|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93332960|NCT02908529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93332961|NCT02908529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93332962|NCT02908529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332963|NCT02908529|Adrenergic Agents|adrenergic agents|mesh-ancestor
93332964|NCT02908529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332965|NCT02908529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332966|NCT02908529|Parasympatholytics|parasympatholytics|mesh-ancestor
93332967|NCT02908529|Autonomic Agents|autonomic agents|mesh-ancestor
93332968|NCT02908529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332969|NCT02908529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93332970|NCT02908529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93332971|NCT02908529|Cholinergic Agents|cholinergic agents|mesh-ancestor
93332972|NCT02908529|Urological Agents|urological agents|mesh-ancestor
93332973|NCT03469557|Capecitabine|capecitabine|mesh-list
93332974|NCT03469557|Oxaliplatin|oxaliplatin|mesh-list
93332975|NCT03469557|Tislelizumab|tislelizumab|mesh-list
93332976|NCT03469557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93332977|NCT03469557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93332978|NCT03469557|Antimetabolites|antimetabolites|mesh-ancestor
93332979|NCT03469557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332980|NCT03469557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93332981|NCT02643381|Ketamine|ketamine|mesh-list
93332982|NCT02643381|Etomidate|etomidate|mesh-list
93332983|NCT02643381|Analgesics|analgesics|mesh-ancestor
93332984|NCT02643381|Sensory System Agents|sensory system agents|mesh-ancestor
93332985|NCT02643381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93332986|NCT02643381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93332987|NCT02643381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93332988|NCT02643381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93332989|NCT02643381|Anesthetics, General|anesthetics, general|mesh-ancestor
93332990|NCT02643381|Anesthetics|anesthetics|mesh-ancestor
93332991|NCT02643381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93332992|NCT02643381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93332993|NCT02643381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93332994|NCT02643381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93332995|NCT02643381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93332996|NCT02643381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93332997|NCT04328961|Ascorbic Acid|ascorbic acid|mesh-list
93332998|NCT04328961|Hydroxychloroquine|hydroxychloroquine|mesh-list
93332999|NCT04328961|Antimalarials|antimalarials|mesh-ancestor
93333000|NCT04328961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93333001|NCT04328961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93333002|NCT04328961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333003|NCT04328961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333004|NCT04328961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333005|NCT04328961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333006|NCT04328961|Antioxidants|antioxidants|mesh-ancestor
93333007|NCT04328961|Protective Agents|protective agents|mesh-ancestor
93333008|NCT04328961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333009|NCT04328961|Vitamins|vitamins|mesh-ancestor
93333010|NCT04328961|Micronutrients|micronutrients|mesh-ancestor
93333011|NCT00455403|Chloroquine|chloroquine|mesh-list
93333012|NCT00455403|Amebicides|amebicides|mesh-ancestor
93333013|NCT00455403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93333014|NCT00455403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93333015|NCT00455403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333016|NCT00455403|Antimalarials|antimalarials|mesh-ancestor
93333017|NCT00455403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333018|NCT03470337|Wobenzym|wobenzym|mesh-list
93333019|NCT03470337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93333020|NCT03470337|Immunologic Factors|immunologic factors|mesh-ancestor
93333021|NCT03470337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333022|NCT03576261|Polygeline|polygeline|mesh-list
93333023|NCT03576261|Plasma Substitutes|plasma substitutes|mesh-ancestor
93333024|NCT03576261|Blood Substitutes|blood substitutes|mesh-ancestor
93333025|NCT03469323|Succinylcholine|succinylcholine|mesh-list
93333026|NCT03469323|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93333027|NCT03469323|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93333028|NCT03469323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93333029|NCT03469323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333030|NCT03469323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333031|NCT05160285|Nivolumab|nivolumab|mesh-list
93333032|NCT05160285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333033|NCT05160285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333034|NCT05160285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93333035|NCT05160285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333036|NCT05160051|FAPI-46|fapi-46|mesh-list
93333037|NCT05160051|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93333038|NCT05160051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333039|NCT03471819|Serotonin|serotonin|mesh-list
93333040|NCT03471819|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93333041|NCT03471819|Serotonin Agents|serotonin agents|mesh-ancestor
93333042|NCT03471819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333043|NCT03471819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333044|NCT03471819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333045|NCT03618693|Anesthetics|anesthetics|mesh-list
93333046|NCT03618693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333047|NCT03618693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333048|NCT01064167|Tranexamic Acid|tranexamic acid|mesh-list
92626923|NCT05550662|Xenon|xenon|mesh-list
93333049|NCT01064167|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93333050|NCT01064167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93333051|NCT01064167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333052|NCT01064167|Hemostatics|hemostatics|mesh-ancestor
93333053|NCT01064167|Coagulants|coagulants|mesh-ancestor
93333054|NCT04205305|Labetalol|labetalol|mesh-list
93333055|NCT04205305|Nicardipine|nicardipine|mesh-list
93333056|NCT04205305|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93333057|NCT04205305|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93333058|NCT04205305|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333059|NCT04205305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333060|NCT04205305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333061|NCT04205305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333062|NCT04205305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93333063|NCT04205305|Sympathomimetics|sympathomimetics|mesh-ancestor
93333064|NCT04205305|Autonomic Agents|autonomic agents|mesh-ancestor
93333065|NCT04205305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333066|NCT04205305|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93333067|NCT04205305|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93333068|NCT04205305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93333069|NCT04205305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93333070|NCT04205305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93333071|NCT04205305|Vasodilator Agents|vasodilator agents|mesh-ancestor
93333072|NCT03470103|Aflibercept|aflibercept|mesh-list
93333073|NCT03470103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93333074|NCT03470103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333075|NCT03470103|Growth Substances|growth substances|mesh-ancestor
93333076|NCT03470103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333077|NCT03470103|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333078|NCT03470103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333079|NCT01064947|Retapamulin|retapamulin|mesh-list
93333080|NCT01064947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93333081|NCT01064947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333082|NCT03469947|Tranexamic Acid|tranexamic acid|mesh-list
93333083|NCT03469947|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93333084|NCT03469947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93333085|NCT03469947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333086|NCT03469947|Hemostatics|hemostatics|mesh-ancestor
93333087|NCT03469947|Coagulants|coagulants|mesh-ancestor
93333088|NCT05157087|Omalizumab|omalizumab|mesh-list
93333089|NCT05157087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93333090|NCT05157087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93333091|NCT05157087|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333092|NCT05163249|Osimertinib|osimertinib|mesh-list
93333093|NCT05163249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333094|NCT05163249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93333095|NCT05163249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333096|NCT05163249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333097|NCT04054063|Etomidate|etomidate|mesh-list
93333098|NCT04054063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93333099|NCT04054063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333100|NCT04054063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333101|NCT04054063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93333102|NCT04054063|Anesthetics, General|anesthetics, general|mesh-ancestor
93333103|NCT04054063|Anesthetics|anesthetics|mesh-ancestor
93333104|NCT03652441|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93333105|NCT03652441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333106|NCT03652441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333107|NCT03652441|Immunotoxins|immunotoxins|mesh-ancestor
93333108|NCT03652441|Immunoconjugates|immunoconjugates|mesh-ancestor
93333109|NCT03652441|Immunologic Factors|immunologic factors|mesh-ancestor
93333110|NCT03652441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333111|NCT05097651|Cannabidiol|cannabidiol|mesh-list
93333112|NCT05097651|Anticonvulsants|anticonvulsants|mesh-ancestor
93333113|NCT02918071|Benralizumab|benralizumab|mesh-list
93333114|NCT02918071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93333115|NCT02918071|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333116|NCT05162625|Moxifloxacin|moxifloxacin|mesh-list
93333117|NCT05162625|Ciprofloxacin|ciprofloxacin|mesh-list
93333118|NCT05162625|Cefazolin|cefazolin|mesh-list
93333119|NCT05162625|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93333120|NCT05162625|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93333121|NCT05162625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93333122|NCT05162625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333123|NCT05162625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91932188|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
93333124|NCT05162625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93333125|NCT05162625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333126|NCT05162625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333127|NCT05162625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333128|NCT05162625|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93333129|NCT05162625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93333130|NCT04698603|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93333131|NCT04698603|Hallucinogens|hallucinogens|mesh-ancestor
93333132|NCT04698603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333133|NCT04698603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93333134|NCT04698603|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93333135|NCT04698603|Serotonin Agents|serotonin agents|mesh-ancestor
93333136|NCT04698603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333137|NCT04698603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333138|NCT04698603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93333139|NCT02506816|Olaparib|olaparib|mesh-list
93333140|NCT02506816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93333141|NCT02506816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333142|NCT02506816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333143|NCT02506816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333144|NCT05009901|Thioctic Acid|thioctic acid|mesh-list
93333145|NCT05009901|Antioxidants|antioxidants|mesh-ancestor
93333146|NCT05009901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005072|NCT01037140|Vitamin D|vitamin d|mesh-list
93333147|NCT05009901|Protective Agents|protective agents|mesh-ancestor
93333148|NCT05009901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333149|NCT05009901|Vitamin B Complex|vitamin b complex|mesh-ancestor
93333151|NCT05009901|Micronutrients|micronutrients|mesh-ancestor
93333152|NCT01063855|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
93333153|NCT01063855|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93333154|NCT01063855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333155|NCT01063855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333156|NCT05162001|Disulfiram|disulfiram|mesh-list
93333157|NCT05162001|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93333158|NCT05162001|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93333159|NCT05162001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333160|NCT05162001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333161|NCT03469167|Epinephrine|epinephrine|mesh-list
93333162|NCT03469167|CEGP-003|cegp-003|mesh-list
93333163|NCT03469167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93333164|NCT03469167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93333165|NCT03469167|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333166|NCT03469167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333167|NCT03469167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333168|NCT03469167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333169|NCT03469167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93333170|NCT03469167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93333171|NCT03469167|Autonomic Agents|autonomic agents|mesh-ancestor
93333172|NCT03469167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333173|NCT03469167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93333174|NCT03469167|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333175|NCT03469167|Mydriatics|mydriatics|mesh-ancestor
93333176|NCT03469167|Sympathomimetics|sympathomimetics|mesh-ancestor
93333177|NCT03469167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93333178|NCT03469167|Hemostatics|hemostatics|mesh-ancestor
93333179|NCT03469167|Coagulants|coagulants|mesh-ancestor
93333180|NCT01063153|Methylphenidate|methylphenidate|mesh-list
93333181|NCT01063153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93333182|NCT01063153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333183|NCT01063153|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93333184|NCT01063153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93333185|NCT01063153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93333186|NCT01063153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333187|NCT01063153|Dopamine Agents|dopamine agents|mesh-ancestor
93333188|NCT01063153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333189|NCT05161221|Acetaminophen|acetaminophen|mesh-list
93333190|NCT05161221|Naproxen|naproxen|mesh-list
93333191|NCT05161221|Oxycodone|oxycodone|mesh-list
93333192|NCT05161221|Bupivacaine|bupivacaine|mesh-list
93333193|NCT05161221|Anesthetics, Local|anesthetics, local|mesh-ancestor
93333194|NCT05161221|Anesthetics|anesthetics|mesh-ancestor
92627003|NCT05075603|Tisagenlecleucel|tisagenlecleucel|mesh-list
93333195|NCT05161221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333196|NCT05161221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333197|NCT05161221|Sensory System Agents|sensory system agents|mesh-ancestor
93333198|NCT05161221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333199|NCT05161221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93333200|NCT05161221|Narcotics|narcotics|mesh-ancestor
93333201|NCT05161221|Analgesics|analgesics|mesh-ancestor
93333202|NCT05161221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93333203|NCT05161221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93333204|NCT05161221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93333205|NCT05161221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333206|NCT05161221|Gout Suppressants|gout suppressants|mesh-ancestor
93333207|NCT05161221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93333208|NCT05161221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333209|NCT05161221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333210|NCT05161221|Antipyretics|antipyretics|mesh-ancestor
93333211|NCT02505334|Liraglutide|liraglutide|mesh-list
93333212|NCT02505334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333213|NCT02505334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333214|NCT02505334|Incretins|incretins|mesh-ancestor
93333215|NCT02505334|Hormones|hormones|mesh-ancestor
93333216|NCT02505334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333217|NCT03469089|Ketamine|ketamine|mesh-list
93333218|NCT03469089|Modafinil|modafinil|mesh-list
93333219|NCT03469089|Analgesics|analgesics|mesh-ancestor
93333220|NCT03469089|Sensory System Agents|sensory system agents|mesh-ancestor
93333221|NCT03469089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005150|NCT01420250|Hormones|hormones|mesh-list
93333222|NCT03469089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333223|NCT03469089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93333224|NCT03469089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93333225|NCT03469089|Anesthetics, General|anesthetics, general|mesh-ancestor
93333226|NCT03469089|Anesthetics|anesthetics|mesh-ancestor
93333227|NCT03469089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333228|NCT03469089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93333229|NCT03469089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93333230|NCT03469089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333231|NCT03469089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333232|NCT03469089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93333233|NCT03469089|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93333234|NCT03469089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93333235|NCT03469089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93333236|NCT04969510|Pramoxine|pramoxine|mesh-list
93333237|NCT04969510|Anesthetics, Local|anesthetics, local|mesh-ancestor
93333238|NCT04969510|Anesthetics|anesthetics|mesh-ancestor
93333239|NCT04969510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333240|NCT04969510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333241|NCT04969510|Sensory System Agents|sensory system agents|mesh-ancestor
93333242|NCT04969510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333243|NCT02504320|Febuxostat|febuxostat|mesh-list
93333244|NCT02504320|Gout Suppressants|gout suppressants|mesh-ancestor
93333245|NCT02504320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333246|NCT05014516|Xenon|xenon|mesh-list
93333247|NCT05014516|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93333248|NCT05014516|Anesthetics, General|anesthetics, general|mesh-ancestor
93333249|NCT05014516|Anesthetics|anesthetics|mesh-ancestor
93333250|NCT05014516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333251|NCT05014516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333252|NCT01061671|Simvastatin|simvastatin|mesh-list
93333253|NCT01061671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93333254|NCT01061671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93333255|NCT01061671|Antimetabolites|antimetabolites|mesh-ancestor
93333256|NCT01061671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333257|NCT01061671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93333258|NCT01061671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93333259|NCT01061671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333260|NCT04969120|Metoclopramide|metoclopramide|mesh-list
93333261|NCT04969120|Antiemetics|antiemetics|mesh-ancestor
93333262|NCT04969120|Autonomic Agents|autonomic agents|mesh-ancestor
93333263|NCT04969120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333264|NCT04969120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333265|NCT04969120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93333266|NCT04969120|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93333267|NCT04969120|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93333268|NCT04969120|Dopamine Agents|dopamine agents|mesh-ancestor
93333269|NCT04969120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333270|NCT04969120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333271|NCT00709995|Sunitinib|sunitinib|mesh-list
93333272|NCT00709995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333273|NCT00709995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93333274|NCT00709995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333275|NCT00709995|Growth Substances|growth substances|mesh-ancestor
93333276|NCT00709995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333277|NCT00709995|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333278|NCT00709995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93333279|NCT00709995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333280|NCT00709995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333281|NCT02503540|Aflibercept|aflibercept|mesh-list
93333282|NCT02503540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93333283|NCT02503540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333284|NCT02503540|Growth Substances|growth substances|mesh-ancestor
93333285|NCT02503540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333286|NCT02503540|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333287|NCT02503540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333288|NCT04053985|Lenvatinib|lenvatinib|mesh-list
93333289|NCT04053985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333290|NCT04053985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93333291|NCT04053985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333292|NCT04053985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333293|NCT04455243|Acetylcysteine|acetylcysteine|mesh-list
93333294|NCT04455243|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93333295|NCT04455243|Antiviral Agents|antiviral agents|mesh-ancestor
93333296|NCT04455243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333297|NCT04455243|Expectorants|expectorants|mesh-ancestor
93333298|NCT04455243|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333299|NCT04455243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93333300|NCT04455243|Antioxidants|antioxidants|mesh-ancestor
93333301|NCT04455243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333302|NCT04455243|Protective Agents|protective agents|mesh-ancestor
93333303|NCT04455243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333304|NCT04455243|Antidotes|antidotes|mesh-ancestor
93333305|NCT04454775|Protein C|protein c|mesh-list
93333306|NCT04454775|Antithrombins|antithrombins|mesh-list
93333307|NCT04454775|Antithrombin III|antithrombin iii|mesh-list
93333308|NCT04454775|Protein S|protein s|mesh-list
93333309|NCT04454775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93333310|NCT04454775|Protease Inhibitors|protease inhibitors|mesh-ancestor
93333311|NCT04454775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333312|NCT04454775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333313|NCT04454775|Anticoagulants|anticoagulants|mesh-ancestor
93333314|NCT04454775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93333315|NCT04454775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93333316|NCT03651661|Insulin|insulin|mesh-list
93333317|NCT03651661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93333318|NCT03651661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333319|NCT03651661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333320|NCT01060111|Topiramate|topiramate|mesh-list
93333321|NCT01060111|Propranolol|propranolol|mesh-list
93333322|NCT01060111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93333323|NCT01060111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93333324|NCT01060111|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333325|NCT01060111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333326|NCT01060111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333327|NCT01060111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333328|NCT01060111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93333329|NCT01060111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93333330|NCT01060111|Vasodilator Agents|vasodilator agents|mesh-ancestor
93333331|NCT01060111|Anticonvulsants|anticonvulsants|mesh-ancestor
93333332|NCT01060111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333333|NCT02969863|Pancrelipase|pancrelipase|mesh-list
93333334|NCT02969863|Pancreatin|pancreatin|mesh-list
93333335|NCT02969863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93333336|NCT03651427|Estradiol|estradiol|mesh-list
93333337|NCT03651427|Estrogens|estrogens|mesh-ancestor
93333338|NCT03651427|Hormones|hormones|mesh-ancestor
93333339|NCT03651427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333340|NCT03651427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333341|NCT05285293|Vitamin A|vitamin a|mesh-list
93333342|NCT05285293|Vitamins|vitamins|mesh-ancestor
93333343|NCT05285293|Micronutrients|micronutrients|mesh-ancestor
93333344|NCT05285293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333345|NCT03650257|Temozolomide|temozolomide|mesh-list
93333346|NCT03650257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93333347|NCT03650257|Alkylating Agents|alkylating agents|mesh-ancestor
93333348|NCT03650257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333349|NCT03650257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333350|NCT03649243|Propolis|propolis|mesh-list
93333351|NCT03649243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333352|NCT03649165|Acetaminophen|acetaminophen|mesh-list
93333353|NCT03649165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93333354|NCT03649165|Analgesics|analgesics|mesh-ancestor
93333355|NCT03649165|Sensory System Agents|sensory system agents|mesh-ancestor
93333356|NCT03649165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333357|NCT03649165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333358|NCT03649165|Antipyretics|antipyretics|mesh-ancestor
93333359|NCT03649009|Thiamine|thiamine|mesh-list
93333360|NCT03649009|Hydrocortisone|hydrocortisone|mesh-list
93333361|NCT03649009|Metoclopramide|metoclopramide|mesh-list
93333362|NCT03649009|Vitamins|vitamins|mesh-ancestor
93333363|NCT03649009|Micronutrients|micronutrients|mesh-ancestor
93333364|NCT03649009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333365|NCT03649009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93333366|NCT03649009|Vitamin B Complex|vitamin b complex|mesh-ancestor
93333367|NCT03649009|Antiemetics|antiemetics|mesh-ancestor
93333368|NCT03649009|Autonomic Agents|autonomic agents|mesh-ancestor
93333369|NCT03649009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333370|NCT03649009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93333371|NCT03649009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93005301|NCT00398866|Hylan|hylan|mesh-list
93333372|NCT03649009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93333373|NCT03649009|Dopamine Agents|dopamine agents|mesh-ancestor
93333374|NCT03649009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333375|NCT03649009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333376|NCT03650023|Chitosan|chitosan|mesh-list
93333377|NCT03650023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93333378|NCT03650023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93333379|NCT03650023|Antimetabolites|antimetabolites|mesh-ancestor
93333380|NCT03650023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333381|NCT03650023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93333382|NCT03650023|Chelating Agents|chelating agents|mesh-ancestor
93333383|NCT03650023|Sequestering Agents|sequestering agents|mesh-ancestor
93333384|NCT03650023|Hemostatics|hemostatics|mesh-ancestor
93333385|NCT03650023|Coagulants|coagulants|mesh-ancestor
93333386|NCT04054999|Hydroxocobalamin|hydroxocobalamin|mesh-list
93333387|NCT04054999|Vitamin B 12|vitamin b 12|mesh-list
93333388|NCT04054999|Methylene Blue|methylene blue|mesh-list
93333389|NCT04054999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333390|NCT04054999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333391|NCT04054999|Hematinics|hematinics|mesh-ancestor
93333392|NCT04054999|Vitamin B Complex|vitamin b complex|mesh-ancestor
93333393|NCT04054999|Vitamins|vitamins|mesh-ancestor
93333394|NCT04054999|Micronutrients|micronutrients|mesh-ancestor
93333395|NCT04054999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333396|NCT03649945|Docetaxel|docetaxel|mesh-list
93333397|NCT03649945|Endostar protein|endostar protein|mesh-list
93333398|NCT03649945|Nedaplatin|nedaplatin|mesh-list
93333399|NCT03649945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333400|NCT03649945|Tubulin Modulators|tubulin modulators|mesh-ancestor
93333401|NCT03649945|Antimitotic Agents|antimitotic agents|mesh-ancestor
93333402|NCT03649945|Mitosis Modulators|mitosis modulators|mesh-ancestor
93333403|NCT03649945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333404|NCT03649945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627218|NCT04303390|Cefuroxime axetil|cefuroxime axetil|mesh-list
93333405|NCT03649945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333406|NCT03649945|Growth Substances|growth substances|mesh-ancestor
93333407|NCT03649945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333408|NCT03649945|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333409|NCT03650881|Adapalene|adapalene|mesh-list
93333410|NCT03650881|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93333411|NCT03650881|Dermatologic Agents|dermatologic agents|mesh-ancestor
93333412|NCT03650881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93333413|NCT03650881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93333414|NCT03650881|Analgesics|analgesics|mesh-ancestor
93333415|NCT03650881|Sensory System Agents|sensory system agents|mesh-ancestor
93333416|NCT03650881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333417|NCT03650881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333418|NCT03650881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93333419|NCT03650881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333420|NCT02904265|Acetazolamide|acetazolamide|mesh-list
93333421|NCT02904265|Diazepam|diazepam|mesh-list
93333422|NCT02904265|Anticonvulsants|anticonvulsants|mesh-ancestor
93333423|NCT02904265|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93333424|NCT02904265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333425|NCT02904265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333426|NCT02904265|Diuretics|diuretics|mesh-ancestor
93333427|NCT02904265|Natriuretic Agents|natriuretic agents|mesh-ancestor
93333428|NCT02904265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333429|NCT02904265|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93333430|NCT02904265|Antiemetics|antiemetics|mesh-ancestor
93333431|NCT02904265|Autonomic Agents|autonomic agents|mesh-ancestor
93333432|NCT02904265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333433|NCT02904265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93333434|NCT02904265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93333435|NCT02904265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333436|NCT02904265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93333437|NCT02904265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93333438|NCT02904265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93333439|NCT02904265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93333440|NCT02904265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93333441|NCT02904265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93333442|NCT02904265|Anesthetics, General|anesthetics, general|mesh-ancestor
93333443|NCT02904265|Anesthetics|anesthetics|mesh-ancestor
93333444|NCT02904265|GABA Modulators|gaba modulators|mesh-ancestor
93333445|NCT02904265|GABA Agents|gaba agents|mesh-ancestor
93333446|NCT02904265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333447|NCT03648229|Timolol|timolol|mesh-list
93333448|NCT03648229|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93333449|NCT03648229|Latanoprost|latanoprost|mesh-list
93333450|NCT03648229|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93333451|NCT03648229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93333452|NCT03648229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93333453|NCT03648229|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333454|NCT03648229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333455|NCT03648229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333456|NCT03648229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333457|NCT03648229|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93333458|NCT03648229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93333460|NCT03648697|Fludarabine|fludarabine|mesh-list
93333461|NCT03648697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333462|NCT03648697|Immunologic Factors|immunologic factors|mesh-ancestor
93333463|NCT03648697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333464|NCT03648697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333465|NCT03648697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93333466|NCT03648697|Alkylating Agents|alkylating agents|mesh-ancestor
93333467|NCT03648697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333468|NCT03648697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333469|NCT03648697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93333470|NCT04535037|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93333471|NCT04535037|Immunologic Factors|immunologic factors|mesh-ancestor
93333472|NCT04535037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333473|NCT02967679|Biotin|biotin|mesh-list
93333474|NCT02967679|Vitamin B Complex|vitamin b complex|mesh-ancestor
93333475|NCT02967679|Vitamins|vitamins|mesh-ancestor
93333476|NCT02967679|Micronutrients|micronutrients|mesh-ancestor
93333477|NCT02967679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333478|NCT04447053|Belimumab|belimumab|mesh-list
93333479|NCT04447053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333480|NCT04447053|Immunologic Factors|immunologic factors|mesh-ancestor
93333481|NCT04447053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333482|NCT04361799|Insulin|insulin|mesh-list
93333483|NCT04361799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333484|NCT04361799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333485|NCT05390073|Hormones|hormones|mesh-list
93333486|NCT05390073|Mitogens|mitogens|mesh-list
93333487|NCT05390073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333488|NCT05390073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333489|NCT05390073|Mitosis Modulators|mitosis modulators|mesh-ancestor
93333490|NCT05390073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333491|NCT03647839|Nivolumab|nivolumab|mesh-list
93333492|NCT03647839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333493|NCT03647839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333494|NCT03647839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93333495|NCT03647839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333496|NCT04454619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93333497|NCT04454307|Tramadol|tramadol|mesh-list
93333498|NCT04454307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93333499|NCT04454307|Narcotics|narcotics|mesh-ancestor
93333500|NCT04454307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333501|NCT04454307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333502|NCT04454307|Analgesics|analgesics|mesh-ancestor
93333503|NCT04454307|Sensory System Agents|sensory system agents|mesh-ancestor
93333504|NCT04454307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333505|NCT05388123|Rituximab|rituximab|mesh-list
93333506|NCT05388123|Vemurafenib|vemurafenib|mesh-list
93333507|NCT05388123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333508|NCT05388123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333509|NCT05388123|Immunologic Factors|immunologic factors|mesh-ancestor
93333510|NCT05388123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333511|NCT05388123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333512|NCT05388123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93333513|NCT05388123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333514|NCT05388123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333515|NCT04455711|Lidocaine|lidocaine|mesh-list
93333516|NCT04455711|Remifentanil|remifentanil|mesh-list
93333517|NCT04455711|Anesthetics, Local|anesthetics, local|mesh-ancestor
93333518|NCT04455711|Anesthetics|anesthetics|mesh-ancestor
93333519|NCT04455711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333520|NCT04455711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333521|NCT04455711|Sensory System Agents|sensory system agents|mesh-ancestor
93333522|NCT04455711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333523|NCT04455711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93333524|NCT04455711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93333525|NCT04455711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93333526|NCT04455711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005499|NCT00772187|Fentanyl|fentanyl|mesh-list
93333527|NCT04455711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333528|NCT04455711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93333529|NCT04455711|Narcotics|narcotics|mesh-ancestor
93333530|NCT04455711|Analgesics|analgesics|mesh-ancestor
93333531|NCT03717987|Botulinum Toxins|botulinum toxins|mesh-list
93333532|NCT03717987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93333533|NCT03717987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93333534|NCT03717987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93333535|NCT03717987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93333536|NCT03717987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333537|NCT03717987|Cholinergic Agents|cholinergic agents|mesh-ancestor
93333538|NCT03717987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333539|NCT03717987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333540|NCT03717987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93333541|NCT03717987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333542|NCT04062669|Vaccines|vaccines|mesh-list
93333543|NCT04062669|Immunologic Factors|immunologic factors|mesh-ancestor
93333544|NCT04062669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333545|NCT05387967|Valsartan|valsartan|mesh-list
93333546|NCT05387967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93333547|NCT05387967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93333548|NCT05387967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93333549|NCT05387967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93333550|NCT05387967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333551|NCT03856359|Rifaximin|rifaximin|mesh-list
93333552|NCT03856359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93333553|NCT03856359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333554|NCT03856359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93333555|NCT04052659|Azacitidine|azacitidine|mesh-list
93333556|NCT04052659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93333557|NCT04052659|Antimetabolites|antimetabolites|mesh-ancestor
93333558|NCT04052659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333559|NCT04052659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333560|NCT04052659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333561|NCT02964247|Liraglutide|liraglutide|mesh-list
93333562|NCT02964247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333563|NCT02964247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333564|NCT02964247|Incretins|incretins|mesh-ancestor
93333565|NCT02964247|Hormones|hormones|mesh-ancestor
93333566|NCT02964247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333567|NCT03654729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
93333568|NCT03654729|Edetic Acid|edetic acid|mesh-list
93333569|NCT03654729|Anticoagulants|anticoagulants|mesh-ancestor
93333570|NCT03654729|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93333571|NCT03654729|Chelating Agents|chelating agents|mesh-ancestor
93333572|NCT03654729|Sequestering Agents|sequestering agents|mesh-ancestor
93333573|NCT03654729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333574|NCT03654729|Vitamin B Complex|vitamin b complex|mesh-ancestor
93333575|NCT03654729|Vitamins|vitamins|mesh-ancestor
93333576|NCT03654729|Micronutrients|micronutrients|mesh-ancestor
93333577|NCT03654729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333578|NCT04052269|Sildenafil Citrate|sildenafil citrate|mesh-list
93333579|NCT04052269|Tadalafil|tadalafil|mesh-list
93333580|NCT04052269|Vasodilator Agents|vasodilator agents|mesh-ancestor
93333581|NCT04052269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93333582|NCT04052269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93333583|NCT04052269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333584|NCT04052269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333585|NCT04052269|Urological Agents|urological agents|mesh-ancestor
93333586|NCT01377987|Acetazolamide|acetazolamide|mesh-list
93333587|NCT01377987|Anticonvulsants|anticonvulsants|mesh-ancestor
93333588|NCT01377987|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93333589|NCT01377987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333590|NCT01377987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333591|NCT01377987|Diuretics|diuretics|mesh-ancestor
93333592|NCT01377987|Natriuretic Agents|natriuretic agents|mesh-ancestor
93333593|NCT01377987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333594|NCT03645187|Celecoxib|celecoxib|mesh-list
93333595|NCT03645187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93333596|NCT03645187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93333597|NCT03645187|Analgesics|analgesics|mesh-ancestor
93333598|NCT03645187|Sensory System Agents|sensory system agents|mesh-ancestor
93333599|NCT03645187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333600|NCT03645187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005528|NCT02556437|Antibodies|antibodies|mesh-list
93333601|NCT03645187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93333602|NCT03645187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333603|NCT03645187|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93333604|NCT03645187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93333605|NCT03645187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333606|NCT03645187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333607|NCT03645109|Vitamin D|vitamin d|mesh-list
93333608|NCT03645109|Cholecalciferol|cholecalciferol|mesh-list
93333609|NCT03645109|Vitamins|vitamins|mesh-ancestor
93333610|NCT03645109|Micronutrients|micronutrients|mesh-ancestor
93333611|NCT03645109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333612|NCT03645109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93333613|NCT03645109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93333614|NCT04455555|Rotigotine|rotigotine|mesh-list
93333615|NCT04455555|Dopamine Agonists|dopamine agonists|mesh-ancestor
93333616|NCT04455555|Dopamine Agents|dopamine agents|mesh-ancestor
93333617|NCT04455555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627420|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
93333618|NCT04455555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333619|NCT04455555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333620|NCT02898259|Rituximab|rituximab|mesh-list
93333621|NCT02898259|Lenalidomide|lenalidomide|mesh-list
93333622|NCT02898259|Ixazomib|ixazomib|mesh-list
93333623|NCT02898259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333624|NCT02898259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333625|NCT02898259|Immunologic Factors|immunologic factors|mesh-ancestor
93333626|NCT02898259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333627|NCT02898259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333628|NCT02898259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93333629|NCT02898259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333630|NCT02898259|Growth Substances|growth substances|mesh-ancestor
93333631|NCT02898259|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333632|NCT02898259|Protease Inhibitors|protease inhibitors|mesh-ancestor
93333633|NCT02898259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333634|NCT02898259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333635|NCT03646357|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93333636|NCT03646357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93333637|NCT03646357|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333638|NCT03646357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333639|NCT03646357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333640|NCT03646357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333641|NCT02963935|Liraglutide|liraglutide|mesh-list
93333642|NCT02963935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333643|NCT02963935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333644|NCT02963935|Incretins|incretins|mesh-ancestor
93333645|NCT02963935|Hormones|hormones|mesh-ancestor
93333646|NCT02963935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333647|NCT03644641|Propofol|propofol|mesh-list
93333648|NCT03644641|Desflurane|desflurane|mesh-list
93333649|NCT03644641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93333650|NCT03644641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333651|NCT03644641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333652|NCT03644641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93333653|NCT03644641|Anesthetics, General|anesthetics, general|mesh-ancestor
93333654|NCT03644641|Anesthetics|anesthetics|mesh-ancestor
93333655|NCT03644641|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93333656|NCT05283421|Estrogens|estrogens|mesh-list
93333657|NCT05283421|Hormones|hormones|mesh-ancestor
93333658|NCT05283421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333659|NCT05283421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333660|NCT03630991|Calcium, Dietary|calcium, dietary|mesh-list
93333661|NCT03630991|Edetic Acid|edetic acid|mesh-list
93333662|NCT03630991|Calcium|calcium|mesh-list
93333663|NCT03630991|Pentetic Acid|pentetic acid|mesh-list
93333664|NCT03630991|Succimer|succimer|mesh-list
93333665|NCT03630991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333666|NCT03630991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93333667|NCT03630991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93333668|NCT03630991|Anticoagulants|anticoagulants|mesh-ancestor
93333669|NCT03630991|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93333670|NCT03630991|Chelating Agents|chelating agents|mesh-ancestor
93333671|NCT03630991|Sequestering Agents|sequestering agents|mesh-ancestor
93333672|NCT03630991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333673|NCT03630991|Antidotes|antidotes|mesh-ancestor
93333674|NCT03630991|Protective Agents|protective agents|mesh-ancestor
93333675|NCT03630991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93333676|NCT02963701|Ibuprofen|ibuprofen|mesh-list
93333677|NCT02963701|Pseudoephedrine|pseudoephedrine|mesh-list
93333678|NCT02963701|Ephedrine|ephedrine|mesh-list
93333679|NCT02963701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93333680|NCT02963701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93333681|NCT02963701|Analgesics|analgesics|mesh-ancestor
93333682|NCT02963701|Sensory System Agents|sensory system agents|mesh-ancestor
93333683|NCT02963701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333684|NCT02963701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333685|NCT02963701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93333686|NCT02963701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333687|NCT02963701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93333688|NCT02963701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333689|NCT02963701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333690|NCT02963701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92627495|NCT03214562|Cytarabine|cytarabine|mesh-list
93333691|NCT02963701|Autonomic Agents|autonomic agents|mesh-ancestor
93333692|NCT02963701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93333693|NCT02963701|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333694|NCT02963701|Nasal Decongestants|nasal decongestants|mesh-ancestor
93333695|NCT02963701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93333696|NCT02963701|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93333697|NCT02963701|Sympathomimetics|sympathomimetics|mesh-ancestor
93333698|NCT02963701|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333699|NCT02963701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333700|NCT02961751|Ciprofloxacin|ciprofloxacin|mesh-list
93333701|NCT02961751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93333702|NCT02961751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333703|NCT02961751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93333704|NCT02961751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93333705|NCT02961751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333706|NCT02961751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333707|NCT02961751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333708|NCT02961751|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93333709|NCT02961751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93333710|NCT03643549|Temozolomide|temozolomide|mesh-list
93333711|NCT03643549|Bortezomib|bortezomib|mesh-list
93333712|NCT03643549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93333713|NCT03643549|Alkylating Agents|alkylating agents|mesh-ancestor
93333714|NCT03643549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333715|NCT03643549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333716|NCT05262205|Anesthetics|anesthetics|mesh-list
93333717|NCT05262205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333718|NCT05262205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333719|NCT03641053|Iodine|iodine|mesh-list
93333720|NCT03641053|Povidone-Iodine|povidone-iodine|mesh-list
93333721|NCT03641053|Povidone|povidone|mesh-list
93333722|NCT03641053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93333723|NCT03641053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333724|NCT03641053|Trace Elements|trace elements|mesh-ancestor
93333725|NCT03641053|Micronutrients|micronutrients|mesh-ancestor
93333726|NCT03641053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333727|NCT03641053|Plasma Substitutes|plasma substitutes|mesh-ancestor
93333728|NCT03641053|Blood Substitutes|blood substitutes|mesh-ancestor
93333729|NCT04455477|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93333730|NCT04455477|Natriuretic Agents|natriuretic agents|mesh-ancestor
93333731|NCT04455477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333732|NCT05165277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93333733|NCT03468777|Lansoprazole|lansoprazole|mesh-list
93333734|NCT03468777|Dexlansoprazole|dexlansoprazole|mesh-list
93333735|NCT03468777|Ranitidine|ranitidine|mesh-list
93333736|NCT03468777|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93333737|NCT03468777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93333738|NCT03468777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93333739|NCT03468777|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93333740|NCT03468777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333741|NCT03468777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333742|NCT03468777|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93333743|NCT03468777|Histamine Antagonists|histamine antagonists|mesh-ancestor
93333744|NCT03468777|Histamine Agents|histamine agents|mesh-ancestor
93333745|NCT03468777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333746|NCT03468777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333747|NCT03640377|Praziquantel|praziquantel|mesh-list
93333748|NCT03640377|Anthelmintics|anthelmintics|mesh-ancestor
93333749|NCT03640377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93333750|NCT03640377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333751|NCT05323149|Tranexamic Acid|tranexamic acid|mesh-list
93333752|NCT05323149|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93333753|NCT05323149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93333754|NCT05323149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333755|NCT05323149|Hemostatics|hemostatics|mesh-ancestor
93333756|NCT05323149|Coagulants|coagulants|mesh-ancestor
93333757|NCT05303805|Sevoflurane|sevoflurane|mesh-list
93333758|NCT05303805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93333759|NCT05303805|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93333760|NCT05303805|Anesthetics, General|anesthetics, general|mesh-ancestor
93333761|NCT05303805|Anesthetics|anesthetics|mesh-ancestor
93333762|NCT05303805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333763|NCT05303805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333764|NCT03642847|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93333765|NCT03642847|Immunologic Factors|immunologic factors|mesh-ancestor
93333766|NCT03642847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333767|NCT03621163|Lithium Carbonate|lithium carbonate|mesh-list
93333768|NCT03621163|Antidepressive Agents|antidepressive agents|mesh-ancestor
93333769|NCT03621163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93333770|NCT03621163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333771|NCT03621163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333772|NCT03621163|Antimanic Agents|antimanic agents|mesh-ancestor
93333773|NCT03621163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93333774|NCT03621163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333775|NCT03621163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333776|NCT03632187|Abatacept|abatacept|mesh-list
93333777|NCT03632187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93333778|NCT03632187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333779|NCT03632187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333780|NCT03632187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333781|NCT03632187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333782|NCT03632187|Immunologic Factors|immunologic factors|mesh-ancestor
93333783|NCT03632187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333784|NCT03632187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333785|NCT05110209|Bevacizumab|bevacizumab|mesh-list
93333786|NCT05110209|Ranibizumab|ranibizumab|mesh-list
93333787|NCT05110209|Aflibercept|aflibercept|mesh-list
93333788|NCT05110209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333789|NCT05110209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333790|NCT05110209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93333791|NCT05110209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333792|NCT05110209|Growth Substances|growth substances|mesh-ancestor
93333793|NCT05110209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333794|NCT05110209|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333795|NCT04454151|Azithromycin|azithromycin|mesh-list
93333796|NCT04454151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93333797|NCT04454151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333798|NCT05272683|Itraconazole|itraconazole|mesh-list
93333799|NCT05272683|Antifungal Agents|antifungal agents|mesh-ancestor
93333800|NCT05272683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333801|NCT05272683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93333802|NCT05272683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93333803|NCT05272683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333804|NCT05272683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333805|NCT05272683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93333806|NCT05272683|Hormone Antagonists|hormone antagonists|mesh-ancestor
93333807|NCT05272683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333808|NCT05272683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333809|NCT05272683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93333810|NCT03934671|Antioxidants|antioxidants|mesh-list
93333811|NCT03934671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333812|NCT03934671|Protective Agents|protective agents|mesh-ancestor
93333813|NCT03934671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333814|NCT03130179|Nicotine|nicotine|mesh-list
93333815|NCT03130179|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93333816|NCT03130179|Autonomic Agents|autonomic agents|mesh-ancestor
93333817|NCT03130179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333818|NCT03130179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333819|NCT03130179|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93333820|NCT03130179|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93333821|NCT03130179|Cholinergic Agents|cholinergic agents|mesh-ancestor
93333822|NCT03130179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333823|NCT03130179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333824|NCT03466983|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93005748|NCT00776633|Aspirin|aspirin|mesh-list
93333826|NCT05439213|Epinephrine|epinephrine|mesh-list
93333827|NCT05439213|Racepinephrine|racepinephrine|mesh-list
93333828|NCT05439213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93333829|NCT05439213|Epinephryl borate|epinephryl borate|mesh-list
93333830|NCT05439213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93333831|NCT05439213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93333832|NCT05439213|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333833|NCT05439213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333834|NCT05439213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333835|NCT05439213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333836|NCT05439213|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93333837|NCT05439213|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93333838|NCT05439213|Autonomic Agents|autonomic agents|mesh-ancestor
93333839|NCT05439213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333840|NCT05439213|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93333841|NCT05439213|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333842|NCT05439213|Mydriatics|mydriatics|mesh-ancestor
93333843|NCT05439213|Sympathomimetics|sympathomimetics|mesh-ancestor
93333844|NCT05439213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93333845|NCT05398653|Cyclosporine|cyclosporine|mesh-list
93333846|NCT05398653|Cyclosporins|cyclosporins|mesh-list
93333847|NCT05398653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333848|NCT05398653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333849|NCT05398653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333850|NCT05398653|Immunologic Factors|immunologic factors|mesh-ancestor
93333851|NCT05398653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333852|NCT05398653|Antifungal Agents|antifungal agents|mesh-ancestor
93333853|NCT05398653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333854|NCT05398653|Dermatologic Agents|dermatologic agents|mesh-ancestor
93333855|NCT05398653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333856|NCT05398653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93333857|NCT03466749|Paclitaxel|paclitaxel|mesh-list
93333858|NCT03466749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93333859|NCT03466749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333860|NCT03466749|Tubulin Modulators|tubulin modulators|mesh-ancestor
93333861|NCT03466749|Antimitotic Agents|antimitotic agents|mesh-ancestor
93333862|NCT03466749|Mitosis Modulators|mitosis modulators|mesh-ancestor
93333863|NCT03466749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333864|NCT03466437|Methamphetamine|methamphetamine|mesh-list
93333865|NCT03466437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93333866|NCT03466437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333867|NCT03466437|Sympathomimetics|sympathomimetics|mesh-ancestor
93333868|NCT03466437|Autonomic Agents|autonomic agents|mesh-ancestor
93333869|NCT03466437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333870|NCT03466437|Dopamine Agents|dopamine agents|mesh-ancestor
93333871|NCT03466437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333872|NCT03466437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333873|NCT03466437|Adrenergic Agents|adrenergic agents|mesh-ancestor
93333874|NCT03466437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93333875|NCT03466437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93333876|NCT03466437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93333877|NCT03466437|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93333878|NCT03466359|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
93333879|NCT03466359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333880|NCT03466359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333881|NCT01909245|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93333882|NCT01909245|Gastrins|gastrins|mesh-list
93333883|NCT01909245|Immunologic Factors|immunologic factors|mesh-ancestor
93333884|NCT01909245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333885|NCT01909245|Hormones|hormones|mesh-ancestor
93333886|NCT01909245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93333887|NCT04459065|Nimotuzumab|nimotuzumab|mesh-list
93333888|NCT04459065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333889|NCT04459065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333890|NCT03465969|Tacrolimus|tacrolimus|mesh-list
93333891|NCT03465969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333892|NCT03465969|Immunologic Factors|immunologic factors|mesh-ancestor
93333893|NCT03465969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333894|NCT03465969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93333895|NCT03465969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333896|NCT03465969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333897|NCT05397795|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92627703|NCT01527149|Antimetabolites|antimetabolites|mesh-ancestor
93005823|NCT00536978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93333898|NCT05397795|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93333899|NCT05397795|Luteolytic Agents|luteolytic agents|mesh-ancestor
93333900|NCT05397795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93333901|NCT05397795|Contraceptive Agents|contraceptive agents|mesh-ancestor
93333902|NCT05397795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93333903|NCT05397795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333904|NCT05397795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93333905|NCT05397795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93333906|NCT05397795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333907|NCT03130101|Insulin|insulin|mesh-list
93333908|NCT03130101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333909|NCT03130101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333910|NCT01067521|Glatiramer Acetate|glatiramer acetate|mesh-list
93333911|NCT01067521|(T,G)-A-L|(t,g)-a-l|mesh-list
93333912|NCT01067521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93333913|NCT01067521|Immunologic Factors|immunologic factors|mesh-ancestor
93333914|NCT01067521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333915|NCT01067521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333916|NCT01067521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93333917|NCT02735577|Disulfiram|disulfiram|mesh-list
93333918|NCT02735577|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93333919|NCT02735577|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93333920|NCT02735577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333921|NCT02735577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333922|NCT03642535|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93333923|NCT03642535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93333924|NCT03642535|Dermatologic Agents|dermatologic agents|mesh-ancestor
93333925|NCT05171257|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93333926|NCT05171257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93333927|NCT05171257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333928|NCT05171257|Antitubercular Agents|antitubercular agents|mesh-ancestor
93333929|NCT01068613|Tiotropium Bromide|tiotropium bromide|mesh-list
93333930|NCT01068613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93333931|NCT01068613|Autonomic Agents|autonomic agents|mesh-ancestor
93333932|NCT01068613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333933|NCT01068613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333934|NCT01068613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93333935|NCT01068613|Respiratory System Agents|respiratory system agents|mesh-ancestor
93333936|NCT01068613|Parasympatholytics|parasympatholytics|mesh-ancestor
93333937|NCT01068613|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93333938|NCT01068613|Cholinergic Agents|cholinergic agents|mesh-ancestor
93333939|NCT01068613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333940|NCT01068613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333941|NCT05396937|Bevacizumab|bevacizumab|mesh-list
93333942|NCT05396937|Atezolizumab|atezolizumab|mesh-list
93333943|NCT05396937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93333944|NCT05396937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333945|NCT05396937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93333946|NCT05396937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93333947|NCT05396937|Growth Substances|growth substances|mesh-ancestor
93333948|NCT05396937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333949|NCT05396937|Growth Inhibitors|growth inhibitors|mesh-ancestor
93333950|NCT05396937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93333951|NCT05396937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333952|NCT05424315|Dapagliflozin|dapagliflozin|mesh-list
93333953|NCT05424315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93333954|NCT05424315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333955|NCT05424315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93333956|NCT05424315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333957|NCT03642145|Deflazacort|deflazacort|mesh-list
93333958|NCT03642145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93333959|NCT03642145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333960|NCT03642145|Immunologic Factors|immunologic factors|mesh-ancestor
93333961|NCT03642145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333962|NCT01064791|Mycophenolic Acid|mycophenolic acid|mesh-list
93333963|NCT01064791|Tacrolimus|tacrolimus|mesh-list
93333964|NCT01064791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93333965|NCT01064791|Immunologic Factors|immunologic factors|mesh-ancestor
93333966|NCT01064791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333967|NCT01064791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93333968|NCT01064791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93333969|NCT01064791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333970|NCT01064791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93333971|NCT01064791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93333972|NCT01064791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93333973|NCT01064791|Antitubercular Agents|antitubercular agents|mesh-ancestor
93333974|NCT01064791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93333975|NCT01064791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93333976|NCT03465423|Propofol|propofol|mesh-list
93333977|NCT03465423|Anesthetics|anesthetics|mesh-ancestor
93333978|NCT03465423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93333979|NCT03465423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333980|NCT03465423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93333981|NCT03465423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93333982|NCT03465423|Anesthetics, General|anesthetics, general|mesh-ancestor
93333983|NCT05161351|Vitamin D|vitamin d|mesh-list
93333984|NCT05161351|Cholecalciferol|cholecalciferol|mesh-list
93333985|NCT05161351|Baclofen|baclofen|mesh-list
93333986|NCT05161351|Vitamins|vitamins|mesh-ancestor
93333987|NCT05161351|Micronutrients|micronutrients|mesh-ancestor
93333988|NCT05161351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93333989|NCT05161351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93333990|NCT05161351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93333991|NCT05161351|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93333992|NCT05161351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93333993|NCT05161351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93333994|NCT05161351|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93333995|NCT05161351|GABA Agonists|gaba agonists|mesh-ancestor
93333996|NCT05161351|GABA Agents|gaba agents|mesh-ancestor
93333997|NCT05161351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93333998|NCT05161351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93333999|NCT03465345|Metformin|metformin|mesh-list
93334000|NCT03465345|Proanthocyanidin|proanthocyanidin|mesh-list
93334001|NCT03465345|Procyanidin|procyanidin|mesh-list
93334002|NCT03465345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334003|NCT03465345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334004|NCT03465345|Antioxidants|antioxidants|mesh-ancestor
93334005|NCT03465345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334006|NCT03465345|Protective Agents|protective agents|mesh-ancestor
93334007|NCT03465345|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93334008|NCT03465345|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93334009|NCT03465345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334010|NCT02983799|Olaparib|olaparib|mesh-list
93334011|NCT02983799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93334012|NCT02983799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334013|NCT02983799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334014|NCT02983799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334015|NCT05385705|Cyclophosphamide|cyclophosphamide|mesh-list
93334016|NCT05385705|Trastuzumab|trastuzumab|mesh-list
93334017|NCT05385705|Interleukin-2|interleukin-2|mesh-list
93334018|NCT05385705|Pertuzumab|pertuzumab|mesh-list
93334019|NCT05385705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93334020|NCT05385705|Immunologic Factors|immunologic factors|mesh-ancestor
93334021|NCT05385705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334022|NCT05385705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334023|NCT05385705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93334024|NCT05385705|Alkylating Agents|alkylating agents|mesh-ancestor
93334025|NCT05385705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334026|NCT05385705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334027|NCT05385705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93334028|NCT05385705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334029|NCT05385705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334030|NCT05385705|Analgesics|analgesics|mesh-ancestor
93334031|NCT05385705|Sensory System Agents|sensory system agents|mesh-ancestor
93334032|NCT05385705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334033|NCT03912831|Cyclophosphamide|cyclophosphamide|mesh-list
93334034|NCT03912831|Fludarabine|fludarabine|mesh-list
93334035|NCT03912831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93334036|NCT03912831|Immunologic Factors|immunologic factors|mesh-ancestor
93334037|NCT03912831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334038|NCT03912831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334039|NCT03912831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93334040|NCT03912831|Alkylating Agents|alkylating agents|mesh-ancestor
93334041|NCT03912831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334042|NCT03912831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334043|NCT03912831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93334044|NCT04373265|Pembrolizumab|pembrolizumab|mesh-list
93334045|NCT04373265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334046|NCT04373265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005973|NCT00057811|Doxorubicin|doxorubicin|mesh-list
93334047|NCT04373265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93334048|NCT04373265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334049|NCT02186847|Metformin|metformin|mesh-list
93334050|NCT02186847|Paclitaxel|paclitaxel|mesh-list
93334051|NCT02186847|Carboplatin|carboplatin|mesh-list
93334052|NCT02186847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93334053|NCT02186847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334054|NCT02186847|Tubulin Modulators|tubulin modulators|mesh-ancestor
93334055|NCT02186847|Antimitotic Agents|antimitotic agents|mesh-ancestor
93334056|NCT02186847|Mitosis Modulators|mitosis modulators|mesh-ancestor
93334057|NCT02186847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334058|NCT02186847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334059|NCT02186847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334060|NCT05274789|Dexmedetomidine|dexmedetomidine|mesh-list
93334061|NCT05274789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93334062|NCT05274789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334063|NCT05274789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334064|NCT05274789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334065|NCT05274789|Analgesics|analgesics|mesh-ancestor
93334066|NCT05274789|Sensory System Agents|sensory system agents|mesh-ancestor
93334067|NCT05274789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334068|NCT05274789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93334069|NCT05274789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93334070|NCT05274789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334071|NCT05274789|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334072|NCT05274789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334073|NCT05274789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334074|NCT02353247|Norethindrone|norethindrone|mesh-list
93334075|NCT02353247|Norethindrone Acetate|norethindrone acetate|mesh-list
93334076|NCT02353247|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93334077|NCT02353247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93334078|NCT02353247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93334079|NCT02353247|Contraceptive Agents|contraceptive agents|mesh-ancestor
93334080|NCT02353247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93334081|NCT02353247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334082|NCT02353247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93334083|NCT02353247|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93334084|NCT04343651|Leronlimab|leronlimab|mesh-list
93334085|NCT04343651|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93334086|NCT04343651|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93334087|NCT04343651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334088|NCT04343651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93334089|NCT04343651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93334090|NCT04343651|Antiviral Agents|antiviral agents|mesh-ancestor
93334091|NCT04343651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334092|NCT03343431|Tenofovir|tenofovir|mesh-list
93334093|NCT03343431|Antiviral Agents|antiviral agents|mesh-list
93334094|NCT03343431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334095|NCT03343431|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93334096|NCT03343431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93334097|NCT03343431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334098|NCT03343431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334099|NCT03343431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93334100|NCT03343431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93334101|NCT05226897|Metformin|metformin|mesh-list
93334102|NCT05226897|Dapagliflozin|dapagliflozin|mesh-list
93334103|NCT05226897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334104|NCT05226897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334105|NCT05226897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93334106|NCT05226897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334107|NCT04453761|Vitamin B Complex|vitamin b complex|mesh-list
93334108|NCT04453761|Vitamins|vitamins|mesh-ancestor
93334109|NCT04453761|Micronutrients|micronutrients|mesh-ancestor
93334110|NCT04453761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334111|NCT03463317|Aspirin|aspirin|mesh-list
93334112|NCT03463317|Warfarin|warfarin|mesh-list
93334113|NCT03463317|Rivaroxaban|rivaroxaban|mesh-list
93334114|NCT03463317|Dabigatran|dabigatran|mesh-list
93334115|NCT03463317|Apixaban|apixaban|mesh-list
93334116|NCT03463317|Edoxaban|edoxaban|mesh-list
93334117|NCT03463317|Phenprocoumon|phenprocoumon|mesh-list
93334118|NCT03463317|Clopidogrel|clopidogrel|mesh-list
93334119|NCT03463317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93334120|NCT03463317|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93006050|NCT01094275|Omeprazole|omeprazole|mesh-list
93334121|NCT03463317|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93334122|NCT03463317|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93334123|NCT03463317|Purinergic Agents|purinergic agents|mesh-ancestor
93334124|NCT03463317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334125|NCT03463317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334126|NCT03463317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334127|NCT03463317|Anticoagulants|anticoagulants|mesh-ancestor
93334128|NCT03463317|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93334129|NCT03463317|Antithrombins|antithrombins|mesh-ancestor
93334130|NCT03463317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93334131|NCT03463317|Protease Inhibitors|protease inhibitors|mesh-ancestor
93334132|NCT03463317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334133|NCT03463317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93334134|NCT03463317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334135|NCT03463317|Analgesics|analgesics|mesh-ancestor
93334136|NCT03463317|Sensory System Agents|sensory system agents|mesh-ancestor
93334137|NCT03463317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334138|NCT03463317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93334139|NCT03463317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334140|NCT03463317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93334141|NCT03463317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93334142|NCT03463317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93334143|NCT03463317|Antipyretics|antipyretics|mesh-ancestor
93334144|NCT05049213|Povidone-Iodine|povidone-iodine|mesh-list
93334145|NCT05049213|Povidone|povidone|mesh-list
93334146|NCT05049213|Plasma Substitutes|plasma substitutes|mesh-ancestor
93334147|NCT05049213|Blood Substitutes|blood substitutes|mesh-ancestor
93334148|NCT05049213|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93334149|NCT05049213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334150|NCT02906579|Praliciguat|praliciguat|mesh-list
93334151|NCT02906579|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93334152|NCT02906579|Enzyme Activators|enzyme activators|mesh-ancestor
93334153|NCT02906579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334154|NCT02906579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334155|NCT04975347|Naloxone|naloxone|mesh-list
93334156|NCT04975347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334157|NCT04975347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93334158|NCT04975347|Sensory System Agents|sensory system agents|mesh-ancestor
93334159|NCT04975347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334160|NCT03463083|Fentanyl|fentanyl|mesh-list
93334161|NCT03463083|Dexmedetomidine|dexmedetomidine|mesh-list
93334162|NCT03463083|Bupivacaine|bupivacaine|mesh-list
93334163|NCT03463083|Anesthetics, Local|anesthetics, local|mesh-ancestor
93334164|NCT03463083|Anesthetics|anesthetics|mesh-ancestor
93334165|NCT03463083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334166|NCT03463083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334167|NCT03463083|Sensory System Agents|sensory system agents|mesh-ancestor
93334168|NCT03463083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334169|NCT03463083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93334170|NCT03463083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334171|NCT03463083|Analgesics|analgesics|mesh-ancestor
93334172|NCT03463083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93334173|NCT03463083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93334174|NCT03463083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334175|NCT03463083|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334176|NCT03463083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334177|NCT03463083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334178|NCT03463083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93334179|NCT03463083|Narcotics|narcotics|mesh-ancestor
93334180|NCT03463083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93334181|NCT03463083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93334182|NCT03463083|Anesthetics, General|anesthetics, general|mesh-ancestor
93334183|NCT04971837|Cannabidiol|cannabidiol|mesh-list
93334184|NCT04971837|Sorbitol|sorbitol|mesh-list
93334185|NCT04971837|Anticonvulsants|anticonvulsants|mesh-ancestor
93334186|NCT04971837|Cathartics|cathartics|mesh-ancestor
93334187|NCT04971837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334188|NCT01328535|Temozolomide|temozolomide|mesh-list
93334189|NCT01328535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93334190|NCT01328535|Alkylating Agents|alkylating agents|mesh-ancestor
93334191|NCT01328535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334192|NCT01328535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334193|NCT03463005|Propolis|propolis|mesh-list
93334194|NCT03463005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334195|NCT02522169|Infliximab|infliximab|mesh-list
93334196|NCT02522169|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93334197|NCT02522169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93334198|NCT02522169|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334199|NCT02522169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334200|NCT02522169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334201|NCT03656393|Carboplatin|carboplatin|mesh-list
93334202|NCT03656393|Vinorelbine|vinorelbine|mesh-list
93334203|NCT03656393|Gefitinib|gefitinib|mesh-list
93334204|NCT03656393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334205|NCT03656393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93334206|NCT03656393|Tubulin Modulators|tubulin modulators|mesh-ancestor
93334207|NCT03656393|Antimitotic Agents|antimitotic agents|mesh-ancestor
93334208|NCT03656393|Mitosis Modulators|mitosis modulators|mesh-ancestor
93334209|NCT03656393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334210|NCT03656393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334211|NCT03656393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334212|NCT02979197|Celecoxib|celecoxib|mesh-list
93334213|NCT02979197|Amlodipine|amlodipine|mesh-list
93334214|NCT02979197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93334215|NCT02979197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93334216|NCT02979197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334217|NCT02979197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334218|NCT02979197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93334219|NCT02979197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334220|NCT02979197|Vasodilator Agents|vasodilator agents|mesh-ancestor
93334221|NCT02979197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93334222|NCT02979197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334223|NCT02979197|Analgesics|analgesics|mesh-ancestor
93334224|NCT02979197|Sensory System Agents|sensory system agents|mesh-ancestor
93334225|NCT02979197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334226|NCT02979197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93334227|NCT02979197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334228|NCT02979197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93334229|NCT02979197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93334230|NCT02979197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334231|NCT01837277|Efavirenz|efavirenz|mesh-list
93334232|NCT01837277|Dolutegravir|dolutegravir|mesh-list
93334233|NCT01837277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93334234|NCT01837277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93334235|NCT01837277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334236|NCT01837277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334237|NCT01837277|Antiviral Agents|antiviral agents|mesh-ancestor
93334238|NCT01837277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334239|NCT01837277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93334240|NCT01837277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93334241|NCT01837277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93334242|NCT01837277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93334243|NCT01837277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93334244|NCT01837277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93334245|NCT01837277|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93334246|NCT01837277|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93334247|NCT01837277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93334248|NCT01837277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93334250|NCT03655535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334251|NCT03655535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334252|NCT03654365|Caffeine|caffeine|mesh-list
93334253|NCT03654365|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93334254|NCT03654365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334255|NCT03654365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93334256|NCT03654365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334257|NCT03654365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628071|NCT04902703|Sargramostim|sargramostim|mesh-list
93334258|NCT03654365|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93334259|NCT03654365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93334260|NCT03654365|Purinergic Agents|purinergic agents|mesh-ancestor
93334261|NCT03654365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334262|NCT03655847|Dexmedetomidine|dexmedetomidine|mesh-list
93334263|NCT03655847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93334264|NCT03655847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334265|NCT03655847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334266|NCT03655847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334267|NCT03655847|Analgesics|analgesics|mesh-ancestor
93334268|NCT03655847|Sensory System Agents|sensory system agents|mesh-ancestor
93334269|NCT03655847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334270|NCT03655847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93334271|NCT03655847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93334272|NCT03655847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334273|NCT03655847|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334274|NCT03655847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334275|NCT03655847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334276|NCT03655457|Poractant alfa|poractant alfa|mesh-list
93334277|NCT03655457|Beractant|beractant|mesh-list
93334278|NCT03655457|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93334279|NCT03655457|Respiratory System Agents|respiratory system agents|mesh-ancestor
93334280|NCT01066793|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93334281|NCT01066793|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93334282|NCT01066793|Antiviral Agents|antiviral agents|mesh-ancestor
93334283|NCT01066793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334284|NCT04453371|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93334285|NCT04453371|Plasminogen|plasminogen|mesh-list
93334286|NCT04453371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93334287|NCT04453371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93334288|NCT04453371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334289|NCT02980523|Moxifloxacin|moxifloxacin|mesh-list
93334290|NCT02980523|Gatifloxacin|gatifloxacin|mesh-list
93334291|NCT02980523|Pazufloxacin|pazufloxacin|mesh-list
93334292|NCT02980523|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93334293|NCT02980523|Hyaluronic Acid|hyaluronic acid|mesh-list
93334294|NCT02980523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93334295|NCT02980523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93334296|NCT02980523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334297|NCT02980523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93334298|NCT02980523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93334299|NCT02980523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334300|NCT02980523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334301|NCT02980523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334302|NCT02980523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334303|NCT02980523|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93334304|NCT02980523|Immunologic Factors|immunologic factors|mesh-ancestor
93334305|NCT02980523|Viscosupplements|viscosupplements|mesh-ancestor
93334306|NCT02980523|Protective Agents|protective agents|mesh-ancestor
93334307|NCT02980523|Antitubercular Agents|antitubercular agents|mesh-ancestor
93334308|NCT03468465|Solifenacin Succinate|solifenacin succinate|mesh-list
93334309|NCT03468465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93334310|NCT03468465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93334311|NCT03468465|Cholinergic Agents|cholinergic agents|mesh-ancestor
93334312|NCT03468465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334313|NCT03468465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334314|NCT03468465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334315|NCT03468465|Urological Agents|urological agents|mesh-ancestor
93334316|NCT03460743|Hemagglutinins|hemagglutinins|mesh-list
93334317|NCT03460743|Vaccines|vaccines|mesh-list
93334318|NCT03460743|Immunologic Factors|immunologic factors|mesh-ancestor
93334319|NCT03460743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334320|NCT03460743|Agglutinins|agglutinins|mesh-ancestor
93334321|NCT03460743|Coagulants|coagulants|mesh-ancestor
93334322|NCT02980133|Fluticasone|fluticasone|mesh-list
93334324|NCT02980133|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93334325|NCT02980133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93334326|NCT02980133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93334327|NCT02980133|Autonomic Agents|autonomic agents|mesh-ancestor
93334328|NCT02980133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334329|NCT02980133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334330|NCT02980133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93334331|NCT02980133|Respiratory System Agents|respiratory system agents|mesh-ancestor
93334332|NCT02980133|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334333|NCT02980133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93334334|NCT02980133|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93334335|NCT02980133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93334336|NCT02980133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334337|NCT02980133|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334338|NCT02980133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334339|NCT02980133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334340|NCT03653663|Simvastatin|simvastatin|mesh-list
93334341|NCT03653663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93334342|NCT03653663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93334343|NCT03653663|Antimetabolites|antimetabolites|mesh-ancestor
93334344|NCT03653663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334345|NCT03653663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93334346|NCT03653663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93334347|NCT03653663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334348|NCT02979431|Gontivimab|gontivimab|mesh-list
93334349|NCT02979431|Antiviral Agents|antiviral agents|mesh-ancestor
93334350|NCT02979431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334351|NCT03460275|Osimertinib|osimertinib|mesh-list
93334352|NCT03460275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334353|NCT03460275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334354|NCT03460275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334355|NCT03460275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334356|NCT03468231|Leucovorin|leucovorin|mesh-list
93334357|NCT03468231|Fluorouracil|fluorouracil|mesh-list
93334358|NCT03468231|Oxaliplatin|oxaliplatin|mesh-list
93334359|NCT03468231|Sorafenib|sorafenib|mesh-list
93334360|NCT03468231|Antimetabolites|antimetabolites|mesh-ancestor
93334361|NCT03468231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334362|NCT03468231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93334363|NCT03468231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334364|NCT03468231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93334365|NCT03468231|Immunologic Factors|immunologic factors|mesh-ancestor
93334366|NCT03468231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334367|NCT03468231|Antidotes|antidotes|mesh-ancestor
93334368|NCT03468231|Protective Agents|protective agents|mesh-ancestor
93334369|NCT03468231|Vitamin B Complex|vitamin b complex|mesh-ancestor
93334370|NCT03468231|Vitamins|vitamins|mesh-ancestor
93334371|NCT03468231|Micronutrients|micronutrients|mesh-ancestor
93334372|NCT03468231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334373|NCT03468231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334374|NCT03468153|Immunomodulating Agents|immunomodulating agents|mesh-list
93334375|NCT03468153|Immunologic Factors|immunologic factors|mesh-ancestor
93334376|NCT03468153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334377|NCT03460041|Magnesium Sulfate|magnesium sulfate|mesh-list
93334378|NCT03460041|Bupivacaine|bupivacaine|mesh-list
93334379|NCT03460041|Anesthetics, Local|anesthetics, local|mesh-ancestor
93334380|NCT03460041|Anesthetics|anesthetics|mesh-ancestor
93334381|NCT03460041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334382|NCT03460041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334383|NCT03460041|Sensory System Agents|sensory system agents|mesh-ancestor
93334384|NCT03460041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334385|NCT03460041|Analgesics|analgesics|mesh-ancestor
93334386|NCT03460041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93334387|NCT03460041|Anticonvulsants|anticonvulsants|mesh-ancestor
93334388|NCT03460041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93334389|NCT03460041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334390|NCT03460041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334391|NCT03460041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93334392|NCT03460041|Tocolytic Agents|tocolytic agents|mesh-ancestor
93334393|NCT03460041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93334394|NCT02522013|Aminophylline|aminophylline|mesh-list
93334395|NCT02522013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93334396|NCT02522013|Autonomic Agents|autonomic agents|mesh-ancestor
93334397|NCT02522013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334398|NCT02522013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334399|NCT02522013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93334400|NCT02522013|Respiratory System Agents|respiratory system agents|mesh-ancestor
93334401|NCT02522013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93334402|NCT02522013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93334403|NCT02522013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334404|NCT02522013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334405|NCT02522013|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93334406|NCT02522013|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93334407|NCT02522013|Purinergic Agents|purinergic agents|mesh-ancestor
93334408|NCT02522013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334409|NCT02522013|Protective Agents|protective agents|mesh-ancestor
93334410|NCT02978417|Naltrexone|naltrexone|mesh-list
93334411|NCT02978417|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93334412|NCT02978417|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93334413|NCT02978417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334414|NCT02978417|Sensory System Agents|sensory system agents|mesh-ancestor
93334415|NCT02978417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334416|NCT03458559|Etidronic Acid|etidronic acid|mesh-list
93334417|NCT03458559|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93334418|NCT03458559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334419|NCT03458559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93334420|NCT03458559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334421|NCT03457467|Apatinib|apatinib|mesh-list
93334422|NCT03457467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334423|NCT03457467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334424|NCT03457467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334425|NCT03457467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334427|NCT05191875|Furazolidone|furazolidone|mesh-list
93334428|NCT05191875|Bismuth|bismuth|mesh-list
93334429|NCT05191875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93334430|NCT05191875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334431|NCT05191875|Antimalarials|antimalarials|mesh-ancestor
93334432|NCT05191875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93334433|NCT05191875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93334434|NCT05191875|Antacids|antacids|mesh-ancestor
93334435|NCT05191875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334436|NCT05191875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334437|NCT05191875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93334438|NCT05191875|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93334439|NCT05191875|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93334440|NCT05191875|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93334441|NCT05191875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334442|NCT04370145|Meropenem|meropenem|mesh-list
93334443|NCT04370145|Tinidazole|tinidazole|mesh-list
93334444|NCT04370145|Teicoplanin|teicoplanin|mesh-list
93334445|NCT04370145|Sulperazone|sulperazone|mesh-list
93334446|NCT04370145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93334447|NCT04370145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334448|NCT04370145|Alkylating Agents|alkylating agents|mesh-ancestor
93334449|NCT04370145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334450|NCT04370145|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93334451|NCT04370145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93334452|NCT04370145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93334453|NCT04370145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93334454|NCT03453723|Lidocaine|lidocaine|mesh-list
93334455|NCT03453723|Anesthetics, Local|anesthetics, local|mesh-ancestor
93334456|NCT03453723|Anesthetics|anesthetics|mesh-ancestor
93334457|NCT03453723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334458|NCT03453723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334459|NCT03453723|Sensory System Agents|sensory system agents|mesh-ancestor
93334460|NCT03453723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334461|NCT03453723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93334462|NCT03453723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93334463|NCT03453723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93334464|NCT03453723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334465|NCT03453723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334466|NCT04368429|Vaccines|vaccines|mesh-list
93334467|NCT04368429|Immunologic Factors|immunologic factors|mesh-ancestor
93334468|NCT04368429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334469|NCT04774965|Diphenhydramine|diphenhydramine|mesh-list
93334470|NCT04774965|Promethazine|promethazine|mesh-list
93334471|NCT04774965|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93334472|NCT04774965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93334473|NCT04774965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334474|NCT04774965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334475|NCT04774965|Anesthetics, Local|anesthetics, local|mesh-ancestor
93334476|NCT04774965|Anesthetics|anesthetics|mesh-ancestor
93334477|NCT04774965|Sensory System Agents|sensory system agents|mesh-ancestor
93334478|NCT04774965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334479|NCT04774965|Antiemetics|antiemetics|mesh-ancestor
93334480|NCT04774965|Autonomic Agents|autonomic agents|mesh-ancestor
93334481|NCT04774965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334482|NCT04774965|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93334483|NCT04774965|Histamine Antagonists|histamine antagonists|mesh-ancestor
93334484|NCT04774965|Histamine Agents|histamine agents|mesh-ancestor
93334485|NCT04774965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334486|NCT04774965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334487|NCT04774965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93334488|NCT04774965|Antipruritics|antipruritics|mesh-ancestor
93334489|NCT04774965|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334490|NCT03452553|Doxorubicin|doxorubicin|mesh-list
93334491|NCT03452553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93334492|NCT03452553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334493|NCT03452553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93334494|NCT03452553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93334495|NCT03452553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334496|NCT03452553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334497|NCT03452475|Lumefantrine|lumefantrine|mesh-list
93334498|NCT03452475|Artemether|artemether|mesh-list
93334499|NCT03452475|Piperaquine|piperaquine|mesh-list
93334500|NCT03452475|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93334501|NCT03452475|Mefloquine|mefloquine|mesh-list
93334502|NCT03452475|Antimalarials|antimalarials|mesh-ancestor
93334503|NCT03452475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93334504|NCT03452475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93334505|NCT03452475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334506|NCT03451227|Dexmedetomidine|dexmedetomidine|mesh-list
93334507|NCT03451227|Remifentanil|remifentanil|mesh-list
93334508|NCT03451227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93334509|NCT03451227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334510|NCT03451227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334511|NCT03451227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334512|NCT03451227|Analgesics|analgesics|mesh-ancestor
93334513|NCT03451227|Sensory System Agents|sensory system agents|mesh-ancestor
93334514|NCT03451227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334515|NCT03451227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93334516|NCT03451227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93334517|NCT03451227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334518|NCT03451227|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334519|NCT03451227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334520|NCT03451227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334521|NCT03451227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93334522|NCT03451227|Narcotics|narcotics|mesh-ancestor
93334523|NCT02529813|Cyclophosphamide|cyclophosphamide|mesh-list
93334524|NCT02529813|Fludarabine|fludarabine|mesh-list
93334525|NCT02529813|Fludarabine phosphate|fludarabine phosphate|mesh-list
93334526|NCT02529813|Tisagenlecleucel|tisagenlecleucel|mesh-list
93334527|NCT02529813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93334528|NCT02529813|Immunologic Factors|immunologic factors|mesh-ancestor
93334529|NCT02529813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334530|NCT02529813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334531|NCT02529813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93334532|NCT02529813|Alkylating Agents|alkylating agents|mesh-ancestor
93334533|NCT02529813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334534|NCT02529813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334535|NCT02529813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93334536|NCT02529813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93334537|NCT02529813|Antimetabolites|antimetabolites|mesh-ancestor
93334538|NCT02529813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334539|NCT05321511|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93334540|NCT05321511|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93334541|NCT05321511|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93334542|NCT05321511|Hormones|hormones|mesh-ancestor
93334543|NCT05321511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334544|NCT05321511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334545|NCT05321511|Luteolytic Agents|luteolytic agents|mesh-ancestor
93334546|NCT05321511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93334547|NCT05321511|Contraceptive Agents|contraceptive agents|mesh-ancestor
93334548|NCT05321511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93334549|NCT05321511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93334550|NCT05321511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93334551|NCT05321511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334552|NCT02417103|Liraglutide|liraglutide|mesh-list
93334553|NCT02417103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334554|NCT02417103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334555|NCT02417103|Incretins|incretins|mesh-ancestor
93334556|NCT02417103|Hormones|hormones|mesh-ancestor
93334557|NCT02417103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334558|NCT02097225|Trametinib|trametinib|mesh-list
93334559|NCT02097225|Dabrafenib|dabrafenib|mesh-list
93334560|NCT02097225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334561|NCT02097225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334562|NCT02097225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334563|NCT02097225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334564|NCT02958865|PF-06700841|pf-06700841|mesh-list
93334565|NCT02958865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334566|NCT02958865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334567|NCT02958865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334568|NCT02501902|Paclitaxel|paclitaxel|mesh-list
93334569|NCT02501902|Palbociclib|palbociclib|mesh-list
93334570|NCT02501902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93334571|NCT02501902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334572|NCT02501902|Tubulin Modulators|tubulin modulators|mesh-ancestor
93334573|NCT02501902|Antimitotic Agents|antimitotic agents|mesh-ancestor
93334574|NCT02501902|Mitosis Modulators|mitosis modulators|mesh-ancestor
93334575|NCT02501902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334576|NCT02501902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334577|NCT02501902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334578|NCT05320575|Zanubrutinib|zanubrutinib|mesh-list
93334579|NCT05320575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334580|NCT05320575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334581|NCT05320575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334582|NCT05320575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334583|NCT03448731|Doxycycline|doxycycline|mesh-list
93334584|NCT03448731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93334585|NCT03448731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334586|NCT03448731|Antimalarials|antimalarials|mesh-ancestor
93334587|NCT03448731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93334588|NCT03448731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93334589|NCT04452669|Epoprostenol|epoprostenol|mesh-list
93334590|NCT04452669|Tezosentan|tezosentan|mesh-list
93334591|NCT04452669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93334592|NCT04452669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93334593|NCT04452669|Vasodilator Agents|vasodilator agents|mesh-ancestor
93334594|NCT03719001|Clevidipine|clevidipine|mesh-list
93334595|NCT03719001|Phenylephrine|phenylephrine|mesh-list
93334596|NCT03719001|Oxymetazoline|oxymetazoline|mesh-list
93334597|NCT03719001|Dexmedetomidine|dexmedetomidine|mesh-list
93334598|NCT03719001|Calcium|calcium|mesh-list
93334599|NCT03719001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93334600|NCT03719001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334601|NCT03719001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93334602|NCT03719001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334603|NCT03719001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334604|NCT03719001|Analgesics|analgesics|mesh-ancestor
93334605|NCT03719001|Sensory System Agents|sensory system agents|mesh-ancestor
93334606|NCT03719001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334607|NCT03719001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93334608|NCT03719001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93334609|NCT03719001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334610|NCT03719001|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334611|NCT03719001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334612|NCT03719001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334613|NCT03719001|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93334614|NCT03719001|Mydriatics|mydriatics|mesh-ancestor
93334615|NCT03719001|Autonomic Agents|autonomic agents|mesh-ancestor
93334616|NCT03719001|Sympathomimetics|sympathomimetics|mesh-ancestor
93334617|NCT03719001|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93334618|NCT03719001|Nasal Decongestants|nasal decongestants|mesh-ancestor
93334619|NCT03719001|Respiratory System Agents|respiratory system agents|mesh-ancestor
93334620|NCT03719001|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93334621|NCT03719001|Protective Agents|protective agents|mesh-ancestor
93334622|NCT03719001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93334623|NCT03719001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334624|NCT02500732|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93334625|NCT02500732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93334626|NCT02500732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93334627|NCT02500732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334628|NCT02500732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334629|NCT02500732|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334630|NCT02500732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334631|NCT02500732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334632|NCT04965064|Capecitabine|capecitabine|mesh-list
93334633|NCT04965064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93334634|NCT04965064|Antimetabolites|antimetabolites|mesh-ancestor
93334635|NCT04965064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334636|NCT04965064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334637|NCT02499952|Pembrolizumab|pembrolizumab|mesh-list
93334638|NCT02499952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334639|NCT02499952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334640|NCT02499952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93334641|NCT02499952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334642|NCT02498392|JNJ-42165279|jnj-42165279|mesh-list
93334643|NCT02498392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334644|NCT02498392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334645|NCT03205605|Mandelic Acids|mandelic acids|mesh-list
93334646|NCT03205605|Oxybutynin|oxybutynin|mesh-list
93334647|NCT03205605|Parasympatholytics|parasympatholytics|mesh-ancestor
93334648|NCT03205605|Autonomic Agents|autonomic agents|mesh-ancestor
93006583|NCT00782405|Mirtazapine|mirtazapine|mesh-list
93334649|NCT03205605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334650|NCT03205605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334651|NCT03205605|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93334652|NCT03205605|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93334653|NCT03205605|Cholinergic Agents|cholinergic agents|mesh-ancestor
93334654|NCT03205605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334655|NCT03205605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334656|NCT03205605|Urological Agents|urological agents|mesh-ancestor
93334657|NCT03205605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93334658|NCT03205605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334660|NCT05006638|Ondansetron|ondansetron|mesh-list
93334661|NCT05006638|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
93334662|NCT05006638|Obidoxime Chloride|obidoxime chloride|mesh-list
93334663|NCT05006638|Antiemetics|antiemetics|mesh-ancestor
93334664|NCT05006638|Autonomic Agents|autonomic agents|mesh-ancestor
93334665|NCT05006638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334666|NCT05006638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334667|NCT05006638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334668|NCT05006638|Antipruritics|antipruritics|mesh-ancestor
93334669|NCT05006638|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334670|NCT05006638|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93334671|NCT05006638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93334672|NCT05006638|Serotonin Agents|serotonin agents|mesh-ancestor
93334673|NCT05006638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334674|NCT05006638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334675|NCT05006638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93334676|NCT05006638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93334677|NCT05006638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93334678|NCT05006638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93334679|NCT05006638|Respiratory System Agents|respiratory system agents|mesh-ancestor
93334680|NCT05006638|Mydriatics|mydriatics|mesh-ancestor
93334681|NCT05006638|Parasympatholytics|parasympatholytics|mesh-ancestor
93334682|NCT05006638|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93334683|NCT05006638|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93334684|NCT05006638|Cholinergic Agents|cholinergic agents|mesh-ancestor
93334685|NCT05006638|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93334686|NCT05006638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93334687|NCT05006638|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
93334688|NCT05006638|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
93334689|NCT02498236|Oxytocin|oxytocin|mesh-list
93334690|NCT02498236|Oxytocics|oxytocics|mesh-ancestor
93334691|NCT02498236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93334692|NCT02498236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334693|NCT01283997|Minocycline|minocycline|mesh-list
93334694|NCT01283997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93334695|NCT01283997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334696|NCT02496676|Magnesium Sulfate|magnesium sulfate|mesh-list
93334697|NCT02496676|Analgesics|analgesics|mesh-ancestor
93334698|NCT02496676|Sensory System Agents|sensory system agents|mesh-ancestor
93334699|NCT02496676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334700|NCT02496676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334701|NCT02496676|Anesthetics|anesthetics|mesh-ancestor
93334702|NCT02496676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334703|NCT02496676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93334704|NCT02496676|Anticonvulsants|anticonvulsants|mesh-ancestor
93334705|NCT02496676|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93334706|NCT02496676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334707|NCT02496676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334708|NCT02496676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93334709|NCT02496676|Tocolytic Agents|tocolytic agents|mesh-ancestor
93334710|NCT02496676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93334711|NCT01160211|Trastuzumab|trastuzumab|mesh-list
93334712|NCT01160211|Lapatinib|lapatinib|mesh-list
93334713|NCT01160211|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93334714|NCT01160211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334715|NCT01160211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334716|NCT01160211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334717|NCT01160211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334718|NCT01160211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334719|NCT01160211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93334720|NCT01160211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93334721|NCT01160211|Hormone Antagonists|hormone antagonists|mesh-ancestor
93334722|NCT01160211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334723|NCT01160211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334724|NCT03443271|Bupivacaine|bupivacaine|mesh-list
93334725|NCT03443271|Anesthetics, Local|anesthetics, local|mesh-ancestor
93334726|NCT03443271|Anesthetics|anesthetics|mesh-ancestor
93334727|NCT03443271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334728|NCT03443271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334729|NCT03443271|Sensory System Agents|sensory system agents|mesh-ancestor
93334730|NCT03443271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334731|NCT01064687|Metformin|metformin|mesh-list
93334732|NCT01064687|Pioglitazone|pioglitazone|mesh-list
93334733|NCT01064687|Exenatide|exenatide|mesh-list
93334734|NCT01064687|Dulaglutide|dulaglutide|mesh-list
93334735|NCT01064687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334736|NCT01064687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334737|NCT01064687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93334738|NCT01064687|Incretins|incretins|mesh-ancestor
93334739|NCT01064687|Hormones|hormones|mesh-ancestor
93334740|NCT01064687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334741|NCT03447873|Lamivudine|lamivudine|mesh-list
93334742|NCT03447873|Cobicistat|cobicistat|mesh-list
93334743|NCT03447873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93334744|NCT03447873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93334745|NCT03447873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334746|NCT03447873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334747|NCT03447873|Antiviral Agents|antiviral agents|mesh-ancestor
93334748|NCT03447873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334749|NCT03447873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93334750|NCT03447873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93334751|NCT03447873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93334752|NCT03447873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93334753|NCT02493946|Botulinum Toxins|botulinum toxins|mesh-list
93334754|NCT02493946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93334755|NCT02493946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93334756|NCT02493946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93334757|NCT02493946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334758|NCT02493946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334759|NCT02493946|Cholinergic Agents|cholinergic agents|mesh-ancestor
93334760|NCT02493946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334761|NCT02493946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334762|NCT02493946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93334763|NCT02493946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334764|NCT00740805|Cyclophosphamide|cyclophosphamide|mesh-list
93334765|NCT00740805|Doxorubicin|doxorubicin|mesh-list
93334766|NCT00740805|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93334767|NCT00740805|Veliparib|veliparib|mesh-list
93334768|NCT00740805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93334769|NCT00740805|Immunologic Factors|immunologic factors|mesh-ancestor
93334770|NCT00740805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334771|NCT00740805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334772|NCT00740805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93334773|NCT00740805|Alkylating Agents|alkylating agents|mesh-ancestor
93334774|NCT00740805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334775|NCT00740805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334776|NCT00740805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93334777|NCT00740805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93334778|NCT00740805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93334779|NCT00740805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93334780|NCT00740805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334781|NCT00740805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93334782|NCT03621995|Catalase|catalase|mesh-list
93334783|NCT03621995|Antioxidants|antioxidants|mesh-ancestor
93334784|NCT03621995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334785|NCT03621995|Protective Agents|protective agents|mesh-ancestor
93334786|NCT03621995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334787|NCT03443037|Amantadine|amantadine|mesh-list
93334788|NCT03443037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93334789|NCT03443037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93334790|NCT03443037|Antiviral Agents|antiviral agents|mesh-ancestor
93334791|NCT03443037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334792|NCT03443037|Dopamine Agents|dopamine agents|mesh-ancestor
93334793|NCT03443037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334794|NCT03443037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334795|NCT03443037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334796|NCT03443037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334797|NCT03443037|Analgesics|analgesics|mesh-ancestor
93334799|NCT03443037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334800|NCT03442491|Hemostatics|hemostatics|mesh-list
93334801|NCT03442491|Coagulants|coagulants|mesh-ancestor
93334802|NCT02918279|Liraglutide|liraglutide|mesh-list
93334803|NCT02918279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334804|NCT02918279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334805|NCT02918279|Incretins|incretins|mesh-ancestor
93334806|NCT02918279|Hormones|hormones|mesh-ancestor
93334807|NCT02918279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334808|NCT02956837|Vaccines|vaccines|mesh-list
93334809|NCT02956837|Immunologic Factors|immunologic factors|mesh-ancestor
93334810|NCT02956837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334811|NCT03447093|Methimazole|methimazole|mesh-list
93334812|NCT03447093|Propylthiouracil|propylthiouracil|mesh-list
93334813|NCT03447093|Antithyroid Agents|antithyroid agents|mesh-ancestor
93334814|NCT03447093|Hormone Antagonists|hormone antagonists|mesh-ancestor
93334815|NCT03447093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334816|NCT03447093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334817|NCT03447093|Antimetabolites|antimetabolites|mesh-ancestor
93334818|NCT03447093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334819|NCT03640351|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93334820|NCT03640351|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93334821|NCT03640351|Hyaluronic Acid|hyaluronic acid|mesh-list
93334822|NCT03640351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93334823|NCT03640351|Immunologic Factors|immunologic factors|mesh-ancestor
93334824|NCT03640351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334825|NCT03640351|Viscosupplements|viscosupplements|mesh-ancestor
93334826|NCT03640351|Protective Agents|protective agents|mesh-ancestor
93334827|NCT03640273|Loratadine|loratadine|mesh-list
93334828|NCT03640273|Antipruritics|antipruritics|mesh-ancestor
93334829|NCT03640273|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334830|NCT03640273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93334831|NCT03640273|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93334832|NCT03640273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93334833|NCT03640273|Histamine Antagonists|histamine antagonists|mesh-ancestor
93334834|NCT03640273|Histamine Agents|histamine agents|mesh-ancestor
93334835|NCT03640273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334836|NCT03640273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334837|NCT03640273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334838|NCT03442023|Chlorhexidine|chlorhexidine|mesh-list
93334839|NCT03442023|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93334840|NCT03442023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93334841|NCT03442023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334842|NCT03442023|Disinfectants|disinfectants|mesh-ancestor
93334843|NCT03442023|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334844|NCT01063283|Bevacizumab|bevacizumab|mesh-list
93334845|NCT01063283|Carboplatin|carboplatin|mesh-list
93334846|NCT01063283|Pemetrexed|pemetrexed|mesh-list
93334847|NCT01063283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334848|NCT01063283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334849|NCT01063283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93334850|NCT01063283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93334851|NCT01063283|Growth Substances|growth substances|mesh-ancestor
93334852|NCT01063283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334853|NCT01063283|Growth Inhibitors|growth inhibitors|mesh-ancestor
93334854|NCT01063283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334855|NCT01063283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334856|NCT01063283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93334857|NCT01063283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93334858|NCT01062971|Timolol|timolol|mesh-list
93334859|NCT01062971|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93334860|NCT01062971|Dorzolamide|dorzolamide|mesh-list
93334861|NCT01062971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93334862|NCT01062971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93334863|NCT01062971|Adrenergic Agents|adrenergic agents|mesh-ancestor
93334864|NCT01062971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334865|NCT01062971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334866|NCT01062971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334867|NCT01062971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93334868|NCT01062971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93006804|NCT00786383|Ramucirumab|ramucirumab|mesh-list
93334869|NCT01062971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93334870|NCT01062971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93334871|NCT01062971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93334872|NCT01062971|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93334873|NCT01062971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334874|NCT03446937|Dexamethasone|dexamethasone|mesh-list
93334875|NCT03446937|Betamethasone|betamethasone|mesh-list
93334876|NCT03446937|Betamethasone Valerate|betamethasone valerate|mesh-list
93334877|NCT03446937|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93334878|NCT03446937|Betamethasone benzoate|betamethasone benzoate|mesh-list
93334879|NCT03446937|Dexamethasone acetate|dexamethasone acetate|mesh-list
93334880|NCT03446937|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93334881|NCT03446937|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93334882|NCT03446937|BB 1101|bb 1101|mesh-list
93334883|NCT03446937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93334884|NCT03446937|Antiemetics|antiemetics|mesh-ancestor
93334885|NCT03446937|Autonomic Agents|autonomic agents|mesh-ancestor
93334886|NCT03446937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334887|NCT03446937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334888|NCT03446937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93334889|NCT03446937|Glucocorticoids|glucocorticoids|mesh-ancestor
93334890|NCT03446937|Hormones|hormones|mesh-ancestor
93334891|NCT03446937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93334892|NCT03446937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93334893|NCT03446937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334894|NCT03446937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93334895|NCT03446937|Respiratory System Agents|respiratory system agents|mesh-ancestor
93334896|NCT03446937|Protease Inhibitors|protease inhibitors|mesh-ancestor
93334897|NCT03446937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334898|NCT03446937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334899|NCT03652493|Carboplatin|carboplatin|mesh-list
93334900|NCT03652493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334901|NCT03652415|Lubricant Eye Drops|lubricant eye drops|mesh-list
93334902|NCT03652415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93334903|NCT03652415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93334904|NCT02493868|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93334905|NCT02493868|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93334906|NCT02493868|Sertraline|sertraline|mesh-list
93334907|NCT02493868|Antidepressive Agents|antidepressive agents|mesh-list
93334908|NCT02493868|Esketamine|esketamine|mesh-list
93334909|NCT02493868|Escitalopram|escitalopram|mesh-list
93334910|NCT02493868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93334911|NCT02493868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93334912|NCT02493868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334913|NCT02493868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334914|NCT02493868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334915|NCT02493868|Serotonin Agents|serotonin agents|mesh-ancestor
93334916|NCT02493868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334917|NCT02493868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334918|NCT02493868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93334919|NCT02493868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93334920|NCT02493868|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93334921|NCT02493868|Analgesics|analgesics|mesh-ancestor
93334922|NCT02493868|Sensory System Agents|sensory system agents|mesh-ancestor
93334923|NCT02493868|Dopamine Agents|dopamine agents|mesh-ancestor
93334924|NCT03619057|Anesthetics|anesthetics|mesh-list
93334925|NCT03619057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93334926|NCT03619057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334927|NCT04451655|Insulin|insulin|mesh-list
93334928|NCT04451655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93334929|NCT04451655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334930|NCT03446625|Resveratrol|resveratrol|mesh-list
93334931|NCT03446625|Antioxidants|antioxidants|mesh-ancestor
93334932|NCT03446625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334933|NCT03446625|Protective Agents|protective agents|mesh-ancestor
93334934|NCT03446625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334935|NCT03446625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334936|NCT03446625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93334937|NCT04594005|Paclitaxel|paclitaxel|mesh-list
93334938|NCT04594005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93334939|NCT04594005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334940|NCT04594005|Tubulin Modulators|tubulin modulators|mesh-ancestor
93334941|NCT04594005|Antimitotic Agents|antimitotic agents|mesh-ancestor
93334942|NCT04594005|Mitosis Modulators|mitosis modulators|mesh-ancestor
93334943|NCT04594005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334944|NCT02516410|Ivacaftor|ivacaftor|mesh-list
93334945|NCT02516410|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93006872|NCT01039948|Gefitinib|gefitinib|mesh-list
93334946|NCT02516410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334947|NCT02516410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334948|NCT02493712|Mesalamine|mesalamine|mesh-list
93334949|NCT02493712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93334950|NCT02493712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93334951|NCT02493712|Analgesics|analgesics|mesh-ancestor
93334952|NCT02493712|Sensory System Agents|sensory system agents|mesh-ancestor
93334953|NCT02493712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334954|NCT02493712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334955|NCT02493712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93334956|NCT02493712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93334957|NCT03446547|Durvalumab|durvalumab|mesh-list
93334958|NCT03446547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93334959|NCT03446547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334960|NCT02516332|Escitalopram|escitalopram|mesh-list
93334961|NCT02516332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93334962|NCT02516332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93334963|NCT02516332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93334964|NCT02516332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334965|NCT02516332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93334966|NCT02516332|Serotonin Agents|serotonin agents|mesh-ancestor
93334967|NCT02516332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334968|NCT03437655|Eugenol|eugenol|mesh-list
93334969|NCT03437655|Zinc Oxide|zinc oxide|mesh-list
93334970|NCT03437655|Dermatologic Agents|dermatologic agents|mesh-ancestor
93334971|NCT03437655|Sunscreening Agents|sunscreening agents|mesh-ancestor
93334972|NCT03437655|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93334973|NCT03437655|Protective Agents|protective agents|mesh-ancestor
93334974|NCT03437655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334975|NCT03437655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334976|NCT01062425|Temozolomide|temozolomide|mesh-list
93334977|NCT01062425|Cediranib|cediranib|mesh-list
93334978|NCT01062425|Maleic acid|maleic acid|mesh-list
93334979|NCT01062425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93334980|NCT01062425|Alkylating Agents|alkylating agents|mesh-ancestor
93334981|NCT01062425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93334982|NCT01062425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334983|NCT01062425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93334984|NCT01062425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93334985|NCT03437187|Analgesics|analgesics|mesh-list
93334986|NCT03437187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334987|NCT03437187|Sensory System Agents|sensory system agents|mesh-ancestor
93334988|NCT03437187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93334989|NCT02491684|Interferons|interferons|mesh-list
93334990|NCT02491684|Interferon-beta|interferon-beta|mesh-list
93334991|NCT02491684|Interferon beta-1a|interferon beta-1a|mesh-list
93334992|NCT02491684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93334993|NCT02491684|Antiviral Agents|antiviral agents|mesh-ancestor
93334994|NCT02491684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93334995|NCT02491684|Immunologic Factors|immunologic factors|mesh-ancestor
93334996|NCT02491684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93334997|NCT02491684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93334998|NCT03445611|Lidocaine|lidocaine|mesh-list
93334999|NCT03445611|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93335000|NCT03445611|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335001|NCT03445611|Anesthetics|anesthetics|mesh-ancestor
93335002|NCT03445611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335003|NCT03445611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335004|NCT03445611|Sensory System Agents|sensory system agents|mesh-ancestor
93335005|NCT03445611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335006|NCT03445611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93335007|NCT03445611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92628820|NCT00195078|Gefitinib|gefitinib|mesh-list
93335008|NCT03445611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93335009|NCT03445611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335010|NCT03445611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335011|NCT04360629|Tranexamic Acid|tranexamic acid|mesh-list
93335012|NCT04360629|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93335013|NCT04360629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93335014|NCT04360629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335015|NCT04360629|Hemostatics|hemostatics|mesh-ancestor
93335016|NCT04360629|Coagulants|coagulants|mesh-ancestor
93335017|NCT04727229|Bupivacaine|bupivacaine|mesh-list
93335018|NCT04727229|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335019|NCT04727229|Anesthetics|anesthetics|mesh-ancestor
93335020|NCT04727229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335021|NCT04727229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335022|NCT04727229|Sensory System Agents|sensory system agents|mesh-ancestor
93335023|NCT04727229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335024|NCT03436719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93335025|NCT03436719|Metronidazole|metronidazole|mesh-list
93335026|NCT03436719|Erythromycin|erythromycin|mesh-list
93335027|NCT03436719|Cefoperazone|cefoperazone|mesh-list
93335028|NCT03436719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93335029|NCT03436719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335030|NCT03436719|Antitubercular Agents|antitubercular agents|mesh-ancestor
93335031|NCT03436719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93335032|NCT03436719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93335033|NCT03436719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335034|NCT03436719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93335035|NCT03436719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335036|NCT03436719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335037|NCT01061333|Mometasone Furoate|mometasone furoate|mesh-list
93335038|NCT01061333|Nedocromil|nedocromil|mesh-list
93335039|NCT01061333|Montelukast|montelukast|mesh-list
93335040|NCT01061333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93335041|NCT01061333|Respiratory System Agents|respiratory system agents|mesh-ancestor
93335042|NCT01061333|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93335043|NCT01061333|Hormone Antagonists|hormone antagonists|mesh-ancestor
93335044|NCT01061333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335045|NCT01061333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335046|NCT01061333|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93335047|NCT01061333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93335048|NCT01061333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335049|NCT01061333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93335050|NCT01061333|Dermatologic Agents|dermatologic agents|mesh-ancestor
93335051|NCT01061333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93335052|NCT01061333|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
93335053|NCT01061333|Immunologic Factors|immunologic factors|mesh-ancestor
93335054|NCT02489968|Empagliflozin|empagliflozin|mesh-list
93335055|NCT02489968|Linagliptin|linagliptin|mesh-list
93335056|NCT02489968|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93335057|NCT02489968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335058|NCT02489968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93335059|NCT02489968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335060|NCT02489968|Incretins|incretins|mesh-ancestor
93335061|NCT02489968|Hormones|hormones|mesh-ancestor
93335062|NCT02489968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335063|NCT02489968|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93335064|NCT02489968|Protease Inhibitors|protease inhibitors|mesh-ancestor
93335065|NCT02489968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335066|NCT03436173|Fluoxetine|fluoxetine|mesh-list
93335067|NCT03436173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93335068|NCT03436173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93335069|NCT03436173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335070|NCT03436173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335071|NCT03436173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335072|NCT03436173|Serotonin Agents|serotonin agents|mesh-ancestor
93335073|NCT03436173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335074|NCT03436173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93335075|NCT03436173|Antidepressive Agents|antidepressive agents|mesh-ancestor
93335076|NCT03436173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335077|NCT03436173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93335078|NCT03436173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93335079|NCT03436173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335080|NCT03444831|Buspirone|buspirone|mesh-list
93335081|NCT03444831|Omeprazole|omeprazole|mesh-list
93335082|NCT03444831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93335083|NCT03444831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335084|NCT03444831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93335085|NCT03444831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335086|NCT03444831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335087|NCT03444831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93335088|NCT03444831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93335089|NCT03444831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335090|NCT03444831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335091|NCT03444831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335092|NCT03444831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93335093|NCT03444831|Serotonin Agents|serotonin agents|mesh-ancestor
93335094|NCT03444831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335095|NCT02481934|Lenalidomide|lenalidomide|mesh-list
93335097|NCT02481934|Immunologic Factors|immunologic factors|mesh-ancestor
93335098|NCT02481934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335099|NCT02481934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93335100|NCT02481934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93335101|NCT02481934|Growth Substances|growth substances|mesh-ancestor
93335102|NCT02481934|Growth Inhibitors|growth inhibitors|mesh-ancestor
93335103|NCT02481934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335104|NCT03444519|Mannitol|mannitol|mesh-list
93335105|NCT03444519|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93335106|NCT03444519|Diuretics|diuretics|mesh-ancestor
93335107|NCT03444519|Natriuretic Agents|natriuretic agents|mesh-ancestor
93335108|NCT03444519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335109|NCT03129009|Anesthetics|anesthetics|mesh-list
93335110|NCT03129009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335111|NCT03129009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335112|NCT02489500|Bortezomib|bortezomib|mesh-list
93335113|NCT02489500|Melphalan|melphalan|mesh-list
93335114|NCT02489500|Lenograstim|lenograstim|mesh-list
93335115|NCT02489500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335116|NCT02489500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93335117|NCT02489500|Alkylating Agents|alkylating agents|mesh-ancestor
93335118|NCT02489500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335119|NCT02489500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93335120|NCT02489500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335121|NCT02489500|Immunologic Factors|immunologic factors|mesh-ancestor
93335122|NCT02489500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335123|NCT02489500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93335124|NCT04053959|Insulin|insulin|mesh-list
93335125|NCT04053959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93335126|NCT04053959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93335127|NCT04053959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335128|NCT03652571|Nortriptyline|nortriptyline|mesh-list
93335129|NCT03652571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93335130|NCT03652571|Antidepressive Agents|antidepressive agents|mesh-ancestor
93335131|NCT03652571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335132|NCT03652571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93335133|NCT03652571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93335134|NCT03652571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335135|NCT03652571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335136|NCT03652571|Adrenergic Agents|adrenergic agents|mesh-ancestor
93335137|NCT03652571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335138|NCT03652571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335139|NCT03652103|Bupivacaine|bupivacaine|mesh-list
93335140|NCT03652103|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335141|NCT03652103|Anesthetics|anesthetics|mesh-ancestor
93335142|NCT03652103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335143|NCT03652103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335144|NCT03652103|Sensory System Agents|sensory system agents|mesh-ancestor
93335145|NCT03652103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335146|NCT03651947|Denosumab|denosumab|mesh-list
93335147|NCT03651947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93335148|NCT03651947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335149|NCT03651557|Salicylates|salicylates|mesh-list
93335150|NCT03651557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93335151|NCT03651557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93335152|NCT03651557|Analgesics|analgesics|mesh-ancestor
93335153|NCT03651557|Sensory System Agents|sensory system agents|mesh-ancestor
93335154|NCT03651557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335155|NCT03651557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335156|NCT03651557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93335157|NCT03651557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93335158|NCT03651557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93335159|NCT03651557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335160|NCT03651557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335161|NCT03432975|Povidone-Iodine|povidone-iodine|mesh-list
93335162|NCT03432975|Povidone|povidone|mesh-list
93335163|NCT03432975|Plasma Substitutes|plasma substitutes|mesh-ancestor
93335164|NCT03432975|Blood Substitutes|blood substitutes|mesh-ancestor
93335165|NCT03432975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93335166|NCT03432975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007100|NCT00999206|Vaccines|vaccines|mesh-list
93335167|NCT04953130|Vaccines|vaccines|mesh-list
93335168|NCT04953130|Immunologic Factors|immunologic factors|mesh-ancestor
93335169|NCT04953130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335171|NCT02488330|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93335172|NCT02488330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93335173|NCT02488330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335174|NCT02488330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93335175|NCT02488330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93335176|NCT02488330|Growth Substances|growth substances|mesh-ancestor
93335177|NCT02488330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335178|NCT02488330|Growth Inhibitors|growth inhibitors|mesh-ancestor
93335179|NCT02488330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93335180|NCT02488330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335181|NCT02488330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335182|NCT03432663|Amiodarone|amiodarone|mesh-list
93335183|NCT03432663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93335184|NCT03432663|Vasodilator Agents|vasodilator agents|mesh-ancestor
93335185|NCT03432663|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93335186|NCT03432663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335187|NCT03432663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335188|NCT03432663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93335189|NCT03432663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93335190|NCT03432663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93335191|NCT03432663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335192|NCT03432663|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93335193|NCT03432663|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93335194|NCT03432663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93335195|NCT03432273|Nicotine|nicotine|mesh-list
93335196|NCT03432273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93335197|NCT03432273|Autonomic Agents|autonomic agents|mesh-ancestor
93335198|NCT03432273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335199|NCT03432273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335200|NCT03432273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93335201|NCT03432273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93335202|NCT03432273|Cholinergic Agents|cholinergic agents|mesh-ancestor
93335203|NCT03432273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335204|NCT03432273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335205|NCT02481310|Cytarabine|cytarabine|mesh-list
93335206|NCT02481310|Prednisone|prednisone|mesh-list
93335207|NCT02481310|Hydrocortisone|hydrocortisone|mesh-list
93335208|NCT02481310|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93335209|NCT02481310|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93335210|NCT02481310|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93335211|NCT02481310|Cortisone|cortisone|mesh-list
93335212|NCT02481310|Cyclophosphamide|cyclophosphamide|mesh-list
93335213|NCT02481310|Rituximab|rituximab|mesh-list
93335214|NCT02481310|Doxorubicin|doxorubicin|mesh-list
93335215|NCT02481310|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93335216|NCT02481310|Methotrexate|methotrexate|mesh-list
93335217|NCT02481310|Etoposide|etoposide|mesh-list
93335218|NCT02481310|Vincristine|vincristine|mesh-list
93335219|NCT02481310|Etoposide phosphate|etoposide phosphate|mesh-list
93335220|NCT02481310|Ixazomib|ixazomib|mesh-list
93335221|NCT02481310|Podophyllotoxin|podophyllotoxin|mesh-list
93335222|NCT02481310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93335223|NCT02481310|Antibodies|antibodies|mesh-list
93335224|NCT02481310|Immunoglobulins|immunoglobulins|mesh-list
93335225|NCT02481310|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93335226|NCT02481310|Glycine|glycine|mesh-list
93335227|NCT02481310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335228|NCT02481310|Immunologic Factors|immunologic factors|mesh-ancestor
93335229|NCT02481310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335230|NCT02481310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93335231|NCT02481310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93335232|NCT02481310|Alkylating Agents|alkylating agents|mesh-ancestor
93335233|NCT02481310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335234|NCT02481310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335235|NCT02481310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93335236|NCT02481310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93335237|NCT02481310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93335238|NCT02481310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93335239|NCT02481310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335240|NCT02481310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93335241|NCT02481310|Glucocorticoids|glucocorticoids|mesh-ancestor
93335242|NCT02481310|Hormones|hormones|mesh-ancestor
93335243|NCT02481310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335244|NCT02481310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93335245|NCT02481310|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93335246|NCT02481310|Abortifacient Agents|abortifacient agents|mesh-ancestor
93335247|NCT02481310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93335248|NCT02481310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93335249|NCT02481310|Antimetabolites|antimetabolites|mesh-ancestor
93335250|NCT02481310|Dermatologic Agents|dermatologic agents|mesh-ancestor
93335251|NCT02481310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93335252|NCT02481310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93335253|NCT02481310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93335254|NCT02481310|Antiviral Agents|antiviral agents|mesh-ancestor
93335255|NCT02481310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335256|NCT02481310|Tubulin Modulators|tubulin modulators|mesh-ancestor
93335257|NCT02481310|Antimitotic Agents|antimitotic agents|mesh-ancestor
93335258|NCT02481310|Mitosis Modulators|mitosis modulators|mesh-ancestor
93335259|NCT02481310|Protease Inhibitors|protease inhibitors|mesh-ancestor
93335260|NCT02481310|Keratolytic Agents|keratolytic agents|mesh-ancestor
93335261|NCT02481310|Glycine Agents|glycine agents|mesh-ancestor
93335262|NCT02481310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335263|NCT03432195|Donepezil|donepezil|mesh-list
93335264|NCT03432195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93335265|NCT03432195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335266|NCT03432195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335267|NCT03432195|Cholinergic Agents|cholinergic agents|mesh-ancestor
93335268|NCT03432195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335269|NCT03432195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335270|NCT03432195|Nootropic Agents|nootropic agents|mesh-ancestor
93335271|NCT03431961|Triamcinolone|triamcinolone|mesh-list
93335272|NCT03431961|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93335273|NCT03431961|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93335274|NCT03431961|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93335275|NCT03431961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93335276|NCT03431961|Glucocorticoids|glucocorticoids|mesh-ancestor
93335277|NCT03431961|Hormones|hormones|mesh-ancestor
93335278|NCT03431961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335279|NCT03431961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335280|NCT03431961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335281|NCT03431961|Immunologic Factors|immunologic factors|mesh-ancestor
93335282|NCT03431961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335283|NCT03431961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335284|NCT02480764|Valsartan|valsartan|mesh-list
93335285|NCT02480764|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93335286|NCT02480764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93335287|NCT02480764|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93335288|NCT02480764|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93335289|NCT02480764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335290|NCT03434691|Remifentanil|remifentanil|mesh-list
93335291|NCT03434691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93335292|NCT03434691|Narcotics|narcotics|mesh-ancestor
93335293|NCT03434691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335294|NCT03434691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335295|NCT03434691|Analgesics|analgesics|mesh-ancestor
93335296|NCT03434691|Sensory System Agents|sensory system agents|mesh-ancestor
93335297|NCT03434691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335298|NCT03434613|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93335299|NCT03434613|Ezetimibe|ezetimibe|mesh-list
93335300|NCT03434613|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93335301|NCT03434613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93335302|NCT03434613|Antimetabolites|antimetabolites|mesh-ancestor
93335303|NCT03434613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335304|NCT03434613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93335305|NCT03434613|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93335306|NCT03434613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335307|NCT04953052|Imatinib Mesylate|imatinib mesylate|mesh-list
93335308|NCT04953052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335309|NCT04953052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93335310|NCT04953052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335311|NCT04953052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335312|NCT03428685|Dydrogesterone|dydrogesterone|mesh-list
93335313|NCT03428685|Progestins|progestins|mesh-ancestor
93335314|NCT03428685|Hormones|hormones|mesh-ancestor
93335315|NCT03428685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335316|NCT03428685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335317|NCT05665647|Ritonavir|ritonavir|mesh-list
93335318|NCT05665647|Itraconazole|itraconazole|mesh-list
93335319|NCT05665647|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93335320|NCT05665647|Rifampin|rifampin|mesh-list
93335321|NCT05665647|Midazolam|midazolam|mesh-list
93335322|NCT05665647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93335323|NCT05665647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93335324|NCT05665647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335325|NCT05665647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335326|NCT05665647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93335327|NCT05665647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93335328|NCT05665647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335329|NCT05665647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335330|NCT05665647|Anesthetics, General|anesthetics, general|mesh-ancestor
93335331|NCT05665647|Anesthetics|anesthetics|mesh-ancestor
93335332|NCT05665647|GABA Modulators|gaba modulators|mesh-ancestor
93335333|NCT05665647|GABA Agents|gaba agents|mesh-ancestor
93335334|NCT05665647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335335|NCT05665647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335336|NCT05665647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93335337|NCT05665647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93335338|NCT05665647|Protease Inhibitors|protease inhibitors|mesh-ancestor
93335339|NCT05665647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335340|NCT05665647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93335341|NCT05665647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93335342|NCT05665647|Antiviral Agents|antiviral agents|mesh-ancestor
92629160|NCT00177996|Sertraline|sertraline|mesh-list
93335343|NCT05665647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335344|NCT05665647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93335345|NCT05665647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93335346|NCT05665647|Antifungal Agents|antifungal agents|mesh-ancestor
93335347|NCT05665647|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93335348|NCT05665647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93335349|NCT05665647|Hormone Antagonists|hormone antagonists|mesh-ancestor
93335350|NCT05665647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335351|NCT05665647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93335352|NCT05665647|Antitubercular Agents|antitubercular agents|mesh-ancestor
93335353|NCT05665647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93335354|NCT05665647|Leprostatic Agents|leprostatic agents|mesh-ancestor
93335355|NCT05665647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93335356|NCT05665647|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93335357|NCT05665647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93335358|NCT05665647|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93335359|NCT05665647|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93335360|NCT05665647|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93335361|NCT05665647|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93335362|NCT03943173|Olaparib|olaparib|mesh-list
93335363|NCT03943173|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93335364|NCT03943173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335365|NCT03943173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335366|NCT03943173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335367|NCT04941196|Ticagrelor|ticagrelor|mesh-list
93335368|NCT04941196|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93335369|NCT04941196|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93335370|NCT04941196|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93335371|NCT04941196|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93335372|NCT04941196|Purinergic Agents|purinergic agents|mesh-ancestor
93335373|NCT04941196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335374|NCT04941196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335375|NCT04941196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335376|NCT03431805|Tranexamic Acid|tranexamic acid|mesh-list
93335377|NCT03431805|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93335378|NCT03431805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93335379|NCT03431805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335380|NCT03431805|Hemostatics|hemostatics|mesh-ancestor
93335381|NCT03431805|Coagulants|coagulants|mesh-ancestor
93335382|NCT03428607|Olaparib|olaparib|mesh-list
93335383|NCT03428607|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93335384|NCT03428607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335385|NCT03428607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335386|NCT03428607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335387|NCT02521233|Losartan|losartan|mesh-list
93335388|NCT02521233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93335389|NCT02521233|Candesartan|candesartan|mesh-list
93335390|NCT02521233|Candesartan cilexetil|candesartan cilexetil|mesh-list
93335391|NCT02521233|Chlorthalidone|chlorthalidone|mesh-list
93335392|NCT02521233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93335393|NCT02521233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93335394|NCT02521233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93335395|NCT02521233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93335396|NCT02521233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335397|NCT02521233|Diuretics|diuretics|mesh-ancestor
93335398|NCT02521233|Natriuretic Agents|natriuretic agents|mesh-ancestor
93335399|NCT02521233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335400|NCT02521233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93335401|NCT02521233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335402|NCT03428529|Fluorouracil|fluorouracil|mesh-list
93335403|NCT03428529|Capecitabine|capecitabine|mesh-list
93335404|NCT03428529|Antimetabolites|antimetabolites|mesh-ancestor
93335405|NCT03428529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335406|NCT03428529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93335407|NCT03428529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335408|NCT03428529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335409|NCT03428529|Immunologic Factors|immunologic factors|mesh-ancestor
93335410|NCT03428529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335411|NCT03431649|Sildenafil Citrate|sildenafil citrate|mesh-list
93335412|NCT03431649|Beraprost|beraprost|mesh-list
93335413|NCT03431649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335414|NCT03431649|Vasodilator Agents|vasodilator agents|mesh-ancestor
93335415|NCT03431649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93335416|NCT03431649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93335417|NCT03431649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335418|NCT03431649|Urological Agents|urological agents|mesh-ancestor
93335419|NCT03431649|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93335420|NCT04450095|Ambrisentan|ambrisentan|mesh-list
93335421|NCT04450095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93335422|NCT03101475|Durvalumab|durvalumab|mesh-list
93335423|NCT03101475|Tremelimumab|tremelimumab|mesh-list
93335424|NCT03101475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93335425|NCT03101475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335426|NCT01060007|Leucovorin|leucovorin|mesh-list
93335427|NCT01060007|Fluorouracil|fluorouracil|mesh-list
93335428|NCT01060007|Capecitabine|capecitabine|mesh-list
93335429|NCT01060007|Oxaliplatin|oxaliplatin|mesh-list
93335430|NCT01060007|Antimetabolites|antimetabolites|mesh-ancestor
93335431|NCT01060007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335432|NCT01060007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93335433|NCT01060007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335434|NCT01060007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335435|NCT01060007|Immunologic Factors|immunologic factors|mesh-ancestor
93335436|NCT01060007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335437|NCT01060007|Antidotes|antidotes|mesh-ancestor
93335438|NCT01060007|Protective Agents|protective agents|mesh-ancestor
93335439|NCT01060007|Vitamin B Complex|vitamin b complex|mesh-ancestor
93335440|NCT01060007|Vitamins|vitamins|mesh-ancestor
93335441|NCT01060007|Micronutrients|micronutrients|mesh-ancestor
93335442|NCT04175925|Famotidine|famotidine|mesh-list
93335443|NCT04175925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93335444|NCT04175925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335445|NCT04175925|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93335446|NCT04175925|Histamine Antagonists|histamine antagonists|mesh-ancestor
93335447|NCT04175925|Histamine Agents|histamine agents|mesh-ancestor
93335448|NCT04175925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335449|NCT04175925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335450|NCT04175925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335451|NCT02971007|Fluconazole|fluconazole|mesh-list
93335452|NCT02971007|Amphotericin B|amphotericin b|mesh-list
93335453|NCT02971007|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93335454|NCT02971007|Antifungal Agents|antifungal agents|mesh-ancestor
93335455|NCT02971007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335456|NCT02971007|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93335457|NCT02971007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93335458|NCT02971007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335459|NCT02971007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335460|NCT02971007|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93335461|NCT02971007|Hormone Antagonists|hormone antagonists|mesh-ancestor
93335462|NCT02971007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335463|NCT02971007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335464|NCT02971007|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93335465|NCT02971007|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93335467|NCT02971007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93335468|NCT02971007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93335469|NCT02971007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93335470|NCT03428139|Thioctic Acid|thioctic acid|mesh-list
93335471|NCT03428139|Antioxidants|antioxidants|mesh-ancestor
93335472|NCT03428139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335473|NCT03428139|Protective Agents|protective agents|mesh-ancestor
93335474|NCT03428139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335475|NCT03428139|Vitamin B Complex|vitamin b complex|mesh-ancestor
93335476|NCT03428139|Vitamins|vitamins|mesh-ancestor
93335477|NCT03428139|Micronutrients|micronutrients|mesh-ancestor
93335478|NCT03650543|Amoxicillin|amoxicillin|mesh-list
93335479|NCT03650543|Clarithromycin|clarithromycin|mesh-list
93335480|NCT03650543|Omeprazole|omeprazole|mesh-list
93335481|NCT03650543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93335482|NCT03650543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335483|NCT03650543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93335484|NCT03650543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335485|NCT03650543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93335486|NCT03650543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335487|NCT03650543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335488|NCT03650543|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93335489|NCT03650543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93335490|NCT03650543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93335491|NCT03650777|Warfarin|warfarin|mesh-list
93335492|NCT03650777|Anticoagulants|anticoagulants|mesh-ancestor
93335493|NCT02970305|Pimavanserin|pimavanserin|mesh-list
93335494|NCT02970305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93335495|NCT02970305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93335496|NCT02970305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93335497|NCT02970305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93335498|NCT02970305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335499|NCT02970305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335500|NCT02970305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335501|NCT02970305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93335502|NCT02970305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93335503|NCT02970305|Serotonin Agents|serotonin agents|mesh-ancestor
93335504|NCT02970305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335505|NCT02970305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335506|NCT03649763|Lidocaine|lidocaine|mesh-list
93335507|NCT03649763|Bupivacaine|bupivacaine|mesh-list
93335508|NCT03649763|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335509|NCT03649763|Anesthetics|anesthetics|mesh-ancestor
93335510|NCT03649763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335511|NCT03649763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335512|NCT03649763|Sensory System Agents|sensory system agents|mesh-ancestor
93335513|NCT03649763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335514|NCT03649763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93335515|NCT03649763|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93335516|NCT03649763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93335517|NCT03649763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335518|NCT03649763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335519|NCT03427437|Epinephrine|epinephrine|mesh-list
93335520|NCT03427437|Racepinephrine|racepinephrine|mesh-list
93335521|NCT03427437|Bupivacaine|bupivacaine|mesh-list
93335522|NCT03427437|Epinephryl borate|epinephryl borate|mesh-list
93335523|NCT03427437|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335524|NCT03427437|Anesthetics|anesthetics|mesh-ancestor
93335525|NCT03427437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335526|NCT03427437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335527|NCT03427437|Sensory System Agents|sensory system agents|mesh-ancestor
93335528|NCT03427437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335529|NCT03427437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93335530|NCT03427437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93335531|NCT03427437|Adrenergic Agents|adrenergic agents|mesh-ancestor
93335532|NCT03427437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335533|NCT03427437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335534|NCT03427437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93335535|NCT03427437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93335536|NCT03427437|Autonomic Agents|autonomic agents|mesh-ancestor
93335537|NCT03427437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93335538|NCT03427437|Respiratory System Agents|respiratory system agents|mesh-ancestor
93335539|NCT03427437|Mydriatics|mydriatics|mesh-ancestor
93335540|NCT03427437|Sympathomimetics|sympathomimetics|mesh-ancestor
93007486|NCT00787007|Equol|equol|mesh-list
93335541|NCT03427437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93335542|NCT03427359|Capecitabine|capecitabine|mesh-list
93335543|NCT03427359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335544|NCT03427359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93335545|NCT03427359|Antimetabolites|antimetabolites|mesh-ancestor
93335546|NCT03427359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335547|NCT05053659|Venetoclax|venetoclax|mesh-list
93335548|NCT05053659|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93335549|NCT05053659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335550|NCT05053659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93335551|NCT03423537|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93335552|NCT03423537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93335553|NCT03423537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335554|NCT03649139|Immunomodulating Agents|immunomodulating agents|mesh-list
93335555|NCT03649139|Immunologic Factors|immunologic factors|mesh-ancestor
93335556|NCT03649139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335557|NCT03648125|Salicylic Acid|salicylic acid|mesh-list
93335558|NCT03648125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335559|NCT03648125|Antifungal Agents|antifungal agents|mesh-ancestor
93335560|NCT03648125|Keratolytic Agents|keratolytic agents|mesh-ancestor
93335561|NCT03648125|Dermatologic Agents|dermatologic agents|mesh-ancestor
93335562|NCT03423225|Tacrolimus|tacrolimus|mesh-list
93335563|NCT03423225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335564|NCT03423225|Immunologic Factors|immunologic factors|mesh-ancestor
93335565|NCT03423225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335566|NCT03423225|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93335567|NCT03423225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335568|NCT03423225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335569|NCT02521077|Ascorbic Acid|ascorbic acid|mesh-list
93335570|NCT02521077|Vitamins|vitamins|mesh-ancestor
93335571|NCT02521077|Micronutrients|micronutrients|mesh-ancestor
93335572|NCT02521077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335573|NCT02521077|Antioxidants|antioxidants|mesh-ancestor
93335574|NCT02521077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335575|NCT02521077|Protective Agents|protective agents|mesh-ancestor
93335576|NCT03564093|Dexmedetomidine|dexmedetomidine|mesh-list
93335577|NCT03564093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93335578|NCT03564093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335579|NCT03564093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335580|NCT03564093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93335581|NCT03564093|Analgesics|analgesics|mesh-ancestor
93335582|NCT03564093|Sensory System Agents|sensory system agents|mesh-ancestor
93335583|NCT03564093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335584|NCT03564093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93335585|NCT03564093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93335586|NCT03564093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93335587|NCT03564093|Adrenergic Agents|adrenergic agents|mesh-ancestor
93335588|NCT03564093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335589|NCT03564093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335590|NCT03429621|Simethicone|simethicone|mesh-list
93335591|NCT03429621|Antifoaming Agents|antifoaming agents|mesh-ancestor
93335592|NCT03429621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335593|NCT03429621|Emollients|emollients|mesh-ancestor
93335594|NCT03429621|Dermatologic Agents|dermatologic agents|mesh-ancestor
93335595|NCT03426969|Mycophenolic Acid|mycophenolic acid|mesh-list
93335596|NCT03426969|Cyclophosphamide|cyclophosphamide|mesh-list
93335597|NCT03426969|Melphalan|melphalan|mesh-list
93335598|NCT03426969|Mechlorethamine|mechlorethamine|mesh-list
93335599|NCT03426969|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93335600|NCT03426969|Fludarabine|fludarabine|mesh-list
93335601|NCT03426969|Fludarabine phosphate|fludarabine phosphate|mesh-list
93335602|NCT03426969|Tacrolimus|tacrolimus|mesh-list
93335603|NCT03426969|Lenograstim|lenograstim|mesh-list
93335604|NCT03426969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335605|NCT03426969|Immunologic Factors|immunologic factors|mesh-ancestor
93335606|NCT03426969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335607|NCT03426969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93335608|NCT03426969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93335609|NCT03426969|Alkylating Agents|alkylating agents|mesh-ancestor
93335610|NCT03426969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335611|NCT03426969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335612|NCT03426969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93335613|NCT03426969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93335614|NCT03426969|Antimetabolites|antimetabolites|mesh-ancestor
93007546|NCT00385762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335615|NCT03426969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93335616|NCT03426969|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93335617|NCT03426969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335618|NCT03426969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93335619|NCT03426969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93335620|NCT03426969|Antitubercular Agents|antitubercular agents|mesh-ancestor
93335621|NCT03426969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93335622|NCT03426969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335623|NCT03422445|Temozolomide|temozolomide|mesh-list
93335624|NCT03422445|Apatinib|apatinib|mesh-list
92629433|NCT00195936|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93335625|NCT03422445|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93335626|NCT03422445|Alkylating Agents|alkylating agents|mesh-ancestor
93335627|NCT03422445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335628|NCT03422445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335629|NCT03422445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93335630|NCT03422445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335631|NCT03429309|Propofol|propofol|mesh-list
93335632|NCT03429309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93335633|NCT03429309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335634|NCT03429309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335635|NCT03429309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335636|NCT03429309|Anesthetics, General|anesthetics, general|mesh-ancestor
93335637|NCT03429309|Anesthetics|anesthetics|mesh-ancestor
93335638|NCT03429075|Psilocybin|psilocybin|mesh-list
93335639|NCT03429075|Escitalopram|escitalopram|mesh-list
93335640|NCT03429075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93335641|NCT03429075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93335642|NCT03429075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335643|NCT03429075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335644|NCT03429075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335645|NCT03429075|Serotonin Agents|serotonin agents|mesh-ancestor
93335646|NCT03429075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335647|NCT03429075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335648|NCT03429075|Hallucinogens|hallucinogens|mesh-ancestor
93335649|NCT03422289|Folic Acid|folic acid|mesh-list
93335650|NCT03422289|Vitamin B Complex|vitamin b complex|mesh-list
93335651|NCT03422289|Inositol|inositol|mesh-list
93335652|NCT03422289|Hematinics|hematinics|mesh-ancestor
93335653|NCT03422289|Vitamins|vitamins|mesh-ancestor
93335654|NCT03422289|Micronutrients|micronutrients|mesh-ancestor
93335655|NCT03422289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335656|NCT03422055|Fucoidan|fucoidan|mesh-list
93335657|NCT03422055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93335658|NCT03422055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335659|NCT03422055|Anticoagulants|anticoagulants|mesh-ancestor
93335660|NCT03422055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335661|NCT04449471|Naproxen|naproxen|mesh-list
93335662|NCT04449471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93335663|NCT04449471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93335664|NCT04449471|Analgesics|analgesics|mesh-ancestor
93335665|NCT04449471|Sensory System Agents|sensory system agents|mesh-ancestor
93335666|NCT04449471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335667|NCT04449471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335668|NCT04449471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93335669|NCT04449471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93335670|NCT04449471|Gout Suppressants|gout suppressants|mesh-ancestor
93335671|NCT04449471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93335672|NCT04449471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335673|NCT04449471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335674|NCT03127371|Nitrous Oxide|nitrous oxide|mesh-list
93335675|NCT03127371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93335676|NCT03127371|Anesthetics, General|anesthetics, general|mesh-ancestor
93335677|NCT03127371|Anesthetics|anesthetics|mesh-ancestor
93335678|NCT03127371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335679|NCT03127371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335680|NCT03127371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93335681|NCT03127371|Analgesics|analgesics|mesh-ancestor
93335682|NCT03127371|Sensory System Agents|sensory system agents|mesh-ancestor
93335683|NCT03127371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335684|NCT03421821|Ropivacaine|ropivacaine|mesh-list
93335685|NCT03421821|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335686|NCT03421821|Anesthetics|anesthetics|mesh-ancestor
93335687|NCT03421821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335688|NCT03421821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335689|NCT03421821|Sensory System Agents|sensory system agents|mesh-ancestor
93335690|NCT03421821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335691|NCT03421743|Molgramostim|molgramostim|mesh-list
93335692|NCT03421743|Sargramostim|sargramostim|mesh-list
93335693|NCT03421743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335694|NCT03421743|Immunologic Factors|immunologic factors|mesh-ancestor
93335695|NCT03421743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335696|NCT01103349|Montelukast|montelukast|mesh-list
93335697|NCT01103349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93335698|NCT01103349|Respiratory System Agents|respiratory system agents|mesh-ancestor
93335699|NCT01103349|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93335700|NCT01103349|Hormone Antagonists|hormone antagonists|mesh-ancestor
93335701|NCT01103349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335702|NCT01103349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335703|NCT01103349|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93335704|NCT01103349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93335705|NCT01103349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335706|NCT03421275|Fentanyl|fentanyl|mesh-list
93335707|NCT03421275|Esketamine|esketamine|mesh-list
93335708|NCT03421275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93335709|NCT03421275|Narcotics|narcotics|mesh-ancestor
93335710|NCT03421275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335711|NCT03421275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335712|NCT03421275|Analgesics|analgesics|mesh-ancestor
93335713|NCT03421275|Sensory System Agents|sensory system agents|mesh-ancestor
93335714|NCT03421275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335715|NCT03421275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93335716|NCT03421275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335717|NCT03421275|Anesthetics, General|anesthetics, general|mesh-ancestor
93335718|NCT03421275|Anesthetics|anesthetics|mesh-ancestor
93335719|NCT03421275|Antidepressive Agents|antidepressive agents|mesh-ancestor
93335720|NCT03421275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335721|NCT03416517|Irinotecan|irinotecan|mesh-list
93335722|NCT03416517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93335723|NCT03416517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93335724|NCT03416517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335725|NCT03416517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335726|NCT03416517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335727|NCT03421119|Insulin|insulin|mesh-list
93335728|NCT03421119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93335729|NCT03421119|Metformin|metformin|mesh-list
93335730|NCT03421119|Liraglutide|liraglutide|mesh-list
93335731|NCT03421119|Secretagogues|secretagogues|mesh-list
93335732|NCT03421119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93335733|NCT03421119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335734|NCT03421119|Incretins|incretins|mesh-ancestor
93335735|NCT03421119|Hormones|hormones|mesh-ancestor
93335736|NCT03421119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335737|NCT03426033|Warfarin|warfarin|mesh-list
93335738|NCT03426033|Anticoagulants|anticoagulants|mesh-ancestor
93335739|NCT02432547|Aflibercept|aflibercept|mesh-list
93335740|NCT02432547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93335741|NCT02432547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93335742|NCT02432547|Growth Substances|growth substances|mesh-ancestor
93335743|NCT02432547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335744|NCT02432547|Growth Inhibitors|growth inhibitors|mesh-ancestor
93335745|NCT02432547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335746|NCT02345733|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93335747|NCT02345733|Amoxicillin|amoxicillin|mesh-list
93335748|NCT02345733|Metronidazole|metronidazole|mesh-list
93335749|NCT02345733|Doxycycline|doxycycline|mesh-list
93335750|NCT02345733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335751|NCT02345733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93335752|NCT02345733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93335753|NCT02345733|Antimalarials|antimalarials|mesh-ancestor
93335754|NCT03415269|Ambroxol|ambroxol|mesh-list
93335755|NCT03415269|Expectorants|expectorants|mesh-ancestor
93335756|NCT03415269|Respiratory System Agents|respiratory system agents|mesh-ancestor
93335757|NCT03618589|Pregabalin|pregabalin|mesh-list
93335758|NCT03618589|Analgesics|analgesics|mesh-ancestor
93335759|NCT03618589|Sensory System Agents|sensory system agents|mesh-ancestor
93335760|NCT03618589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335761|NCT03618589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335762|NCT03618589|Anticonvulsants|anticonvulsants|mesh-ancestor
93335763|NCT03618589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91932299|NCT03533231|Metronidazole|metronidazole|mesh-list
93335764|NCT03618589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335765|NCT03618589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335766|NCT03618589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93335767|NCT03618589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93335768|NCT03618589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93335769|NCT03618589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335770|NCT03618589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335771|NCT03127449|Aflutinib|aflutinib|mesh-list
93335772|NCT03127449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93335773|NCT03127449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335774|NCT03127449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335775|NCT02521155|Fenbendazole|fenbendazole|mesh-list
93335776|NCT02521155|Antinematodal Agents|antinematodal agents|mesh-ancestor
93335777|NCT02521155|Anthelmintics|anthelmintics|mesh-ancestor
93335778|NCT02521155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93335779|NCT02521155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335780|NCT03415191|Ketamine|ketamine|mesh-list
93335781|NCT03415191|Analgesics|analgesics|mesh-ancestor
93335782|NCT03415191|Sensory System Agents|sensory system agents|mesh-ancestor
93335783|NCT03415191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335784|NCT03415191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335785|NCT03415191|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93335786|NCT03415191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335787|NCT03415191|Anesthetics, General|anesthetics, general|mesh-ancestor
93335788|NCT03415191|Anesthetics|anesthetics|mesh-ancestor
93335789|NCT03415191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335790|NCT03415191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93335791|NCT03415191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93335792|NCT03415191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335793|NCT03415191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335794|NCT03419949|Pregabalin|pregabalin|mesh-list
93335795|NCT03419949|Lamotrigine|lamotrigine|mesh-list
93335796|NCT03419949|Analgesics|analgesics|mesh-ancestor
93335797|NCT03419949|Sensory System Agents|sensory system agents|mesh-ancestor
93335798|NCT03419949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335799|NCT03419949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335800|NCT03419949|Anticonvulsants|anticonvulsants|mesh-ancestor
93335801|NCT03419949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93335802|NCT03419949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335803|NCT03419949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335804|NCT03419949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93335805|NCT03419949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93335806|NCT03419949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93335807|NCT03419949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335808|NCT03419949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335809|NCT03419949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93335810|NCT03419949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93335811|NCT03414879|Lidocaine|lidocaine|mesh-list
93335812|NCT03414879|Ketamine|ketamine|mesh-list
93335813|NCT03414879|Anesthetics, Local|anesthetics, local|mesh-ancestor
93335814|NCT03414879|Anesthetics|anesthetics|mesh-ancestor
93335815|NCT03414879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335816|NCT03414879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335817|NCT03414879|Sensory System Agents|sensory system agents|mesh-ancestor
93335818|NCT03414879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335819|NCT03414879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93335820|NCT03414879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93335821|NCT03414879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93335822|NCT03414879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93335823|NCT03414879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335824|NCT03414879|Analgesics|analgesics|mesh-ancestor
93335825|NCT03414879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93335826|NCT03414879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335827|NCT03414879|Anesthetics, General|anesthetics, general|mesh-ancestor
93335828|NCT03414879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93335829|NCT03414879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93335830|NCT03414879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335831|NCT03419715|Bimatoprost|bimatoprost|mesh-list
93335832|NCT03419715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93335833|NCT03618355|Sirolimus|sirolimus|mesh-list
93335834|NCT03618355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93335835|NCT03618355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335836|NCT03618355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93335837|NCT03618355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335838|NCT03618355|Antifungal Agents|antifungal agents|mesh-ancestor
93335839|NCT03618355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93335840|NCT03618355|Immunologic Factors|immunologic factors|mesh-ancestor
93335841|NCT03618355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335842|NCT04448457|Sufentanil|sufentanil|mesh-list
93335843|NCT04448457|Oxycodone|oxycodone|mesh-list
93335844|NCT04448457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93335845|NCT04448457|Narcotics|narcotics|mesh-ancestor
93335846|NCT04448457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335847|NCT04448457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335849|NCT04448457|Sensory System Agents|sensory system agents|mesh-ancestor
93335850|NCT04448457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335851|NCT04448457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93335852|NCT04448457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335853|NCT04448457|Anesthetics, General|anesthetics, general|mesh-ancestor
93335854|NCT04448457|Anesthetics|anesthetics|mesh-ancestor
93335855|NCT05384743|Rituximab|rituximab|mesh-list
93335856|NCT05384743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93335857|NCT05384743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335858|NCT05384743|Immunologic Factors|immunologic factors|mesh-ancestor
93335859|NCT05384743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335860|NCT05384743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93335861|NCT03414333|Hormones|hormones|mesh-list
93335862|NCT03414333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93335863|NCT03414333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335864|NCT03617029|Ethiodized Oil|ethiodized oil|mesh-list
93335865|NCT03617029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335866|NCT03616639|Morphine|morphine|mesh-list
93335867|NCT03616639|Oxycodone|oxycodone|mesh-list
93335868|NCT03616639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93335869|NCT03616639|Narcotics|narcotics|mesh-ancestor
93335870|NCT03616639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335871|NCT03616639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335872|NCT03616639|Analgesics|analgesics|mesh-ancestor
93335873|NCT03616639|Sensory System Agents|sensory system agents|mesh-ancestor
93335874|NCT03616639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335875|NCT03616561|Apremilast|apremilast|mesh-list
93335876|NCT03616561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93335877|NCT03616561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93335878|NCT03616561|Analgesics|analgesics|mesh-ancestor
93335879|NCT03616561|Sensory System Agents|sensory system agents|mesh-ancestor
93335880|NCT03616561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335881|NCT03616561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335882|NCT03616561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93335883|NCT03616561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93335884|NCT03616561|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93335885|NCT03616561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93335886|NCT03616561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335887|NCT03616561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335888|NCT03615313|Antibodies|antibodies|mesh-list
93335889|NCT03615313|Immunologic Factors|immunologic factors|mesh-ancestor
93335890|NCT03615313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335891|NCT03617575|Lactoferrin|lactoferrin|mesh-list
93335892|NCT03617575|Fesoterodine|fesoterodine|mesh-list
93335893|NCT03617575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335894|NCT03617575|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93335895|NCT03617575|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93335896|NCT03617575|Cholinergic Agents|cholinergic agents|mesh-ancestor
93335897|NCT03617575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335898|NCT03617575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335899|NCT03617575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335900|NCT03617575|Urological Agents|urological agents|mesh-ancestor
93335901|NCT02983617|Obinutuzumab|obinutuzumab|mesh-list
93335902|NCT02983617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93335903|NCT02983617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335904|NCT03616405|Amoxicillin|amoxicillin|mesh-list
93335905|NCT03616405|Tetracycline|tetracycline|mesh-list
93335906|NCT03616405|Furazolidone|furazolidone|mesh-list
93335907|NCT03616405|Rabeprazole|rabeprazole|mesh-list
93335908|NCT03616405|Bismuth|bismuth|mesh-list
93335909|NCT03616405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93335910|NCT03616405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93335911|NCT03616405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93335912|NCT03616405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335913|NCT03616405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93335914|NCT03616405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335915|NCT03616405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335916|NCT03616405|Antacids|antacids|mesh-ancestor
93335917|NCT03616405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93335918|NCT03616405|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93335919|NCT03616405|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93335920|NCT03616405|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93007861|NCT00801281|Prednisone|prednisone|mesh-list
93335921|NCT03616405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93335922|NCT03616405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93335923|NCT03616405|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93335924|NCT03419559|Durvalumab|durvalumab|mesh-list
93335925|NCT03419559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93335926|NCT03419559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93335927|NCT02873689|Dexlansoprazole|dexlansoprazole|mesh-list
93335928|NCT02873689|Lansoprazole|lansoprazole|mesh-list
93335929|NCT02873689|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93335930|NCT02873689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93335931|NCT02873689|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93335932|NCT02873689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335933|NCT02873689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335934|NCT02873377|Nicotine|nicotine|mesh-list
93335935|NCT02873377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93335936|NCT02873377|Autonomic Agents|autonomic agents|mesh-ancestor
93335937|NCT02873377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335938|NCT02873377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335939|NCT02873377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93335940|NCT02873377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93335941|NCT02873377|Cholinergic Agents|cholinergic agents|mesh-ancestor
93335942|NCT02873377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335943|NCT02873377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335944|NCT03647579|Midazolam|midazolam|mesh-list
93335945|NCT03647579|Dexmedetomidine|dexmedetomidine|mesh-list
93335946|NCT03647579|Ketamine|ketamine|mesh-list
93335947|NCT03647579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93335948|NCT03647579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93335949|NCT03647579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335950|NCT03647579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93335951|NCT03647579|Analgesics|analgesics|mesh-ancestor
93335952|NCT03647579|Sensory System Agents|sensory system agents|mesh-ancestor
93335953|NCT03647579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93335954|NCT03647579|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93335955|NCT03647579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93335956|NCT03647579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93335957|NCT03647579|Adrenergic Agents|adrenergic agents|mesh-ancestor
93335958|NCT03647579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335959|NCT03647579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335960|NCT03647579|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93335961|NCT03647579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93335962|NCT03647579|Anesthetics, General|anesthetics, general|mesh-ancestor
93335963|NCT03647579|Anesthetics|anesthetics|mesh-ancestor
93335964|NCT03647579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93335965|NCT03647579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93335966|NCT03647579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93335967|NCT03647579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93335968|NCT03647579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93335969|NCT03647579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93335970|NCT03647579|GABA Modulators|gaba modulators|mesh-ancestor
93335971|NCT03647579|GABA Agents|gaba agents|mesh-ancestor
93335972|NCT04046861|Ascorbic Acid|ascorbic acid|mesh-list
93335973|NCT04046861|Vitamins|vitamins|mesh-ancestor
93335974|NCT04046861|Micronutrients|micronutrients|mesh-ancestor
93335975|NCT04046861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335976|NCT04046861|Antioxidants|antioxidants|mesh-ancestor
93335977|NCT04046861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335978|NCT04046861|Protective Agents|protective agents|mesh-ancestor
93335979|NCT02236741|Pramipexole|pramipexole|mesh-list
93335980|NCT02236741|Antioxidants|antioxidants|mesh-ancestor
93335981|NCT02236741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335982|NCT02236741|Protective Agents|protective agents|mesh-ancestor
93335983|NCT02236741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335984|NCT02236741|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93335985|NCT02236741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93335986|NCT02236741|Dopamine Agonists|dopamine agonists|mesh-ancestor
93335987|NCT02236741|Dopamine Agents|dopamine agents|mesh-ancestor
93335988|NCT02236741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93335989|NCT03648671|Rasagiline|rasagiline|mesh-list
93335990|NCT03648671|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93335991|NCT03648671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93335992|NCT03648671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93335993|NCT03648671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93335994|NCT03648671|Protective Agents|protective agents|mesh-ancestor
93335995|NCT03648671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93335996|NCT03647423|Cyclophosphamide|cyclophosphamide|mesh-list
93335997|NCT03647423|Cetuximab|cetuximab|mesh-list
93335998|NCT03647423|Avelumab|avelumab|mesh-list
93335999|NCT03647423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93336000|NCT03647423|Immunologic Factors|immunologic factors|mesh-ancestor
93336001|NCT03647423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336002|NCT03647423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336003|NCT03647423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93336004|NCT03647423|Alkylating Agents|alkylating agents|mesh-ancestor
93336005|NCT03647423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336006|NCT03647423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336007|NCT03647423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93336008|NCT03647423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336009|NCT04052711|Minocycline|minocycline|mesh-list
93336010|NCT04052711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93336011|NCT04052711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336012|NCT03291847|Buprenorphine|buprenorphine|mesh-list
93336013|NCT03291847|Methadone|methadone|mesh-list
93336014|NCT03291847|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93336015|NCT03291847|Naloxone|naloxone|mesh-list
93336016|NCT03291847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93336017|NCT03291847|Narcotics|narcotics|mesh-ancestor
93336018|NCT03291847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336019|NCT03291847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336020|NCT03291847|Analgesics|analgesics|mesh-ancestor
93336021|NCT03291847|Sensory System Agents|sensory system agents|mesh-ancestor
93336022|NCT03291847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336023|NCT03291847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93336024|NCT03291847|Antitussive Agents|antitussive agents|mesh-ancestor
93336025|NCT03291847|Respiratory System Agents|respiratory system agents|mesh-ancestor
93336026|NCT03621683|Antioxidants|antioxidants|mesh-list
93336027|NCT03621683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336028|NCT03621683|Protective Agents|protective agents|mesh-ancestor
93336029|NCT03621683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336030|NCT03614065|Endostar protein|endostar protein|mesh-list
93336031|NCT03614065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93336032|NCT03614065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93336033|NCT03614065|Growth Substances|growth substances|mesh-ancestor
93336034|NCT03614065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336035|NCT03614065|Growth Inhibitors|growth inhibitors|mesh-ancestor
93336036|NCT03614065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336037|NCT03621527|Remifentanil|remifentanil|mesh-list
93336038|NCT03621527|Anesthetics|anesthetics|mesh-list
93336039|NCT03621527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336040|NCT03621527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336041|NCT03621527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93336042|NCT03621527|Narcotics|narcotics|mesh-ancestor
93336043|NCT03621527|Analgesics|analgesics|mesh-ancestor
93336044|NCT03621527|Sensory System Agents|sensory system agents|mesh-ancestor
93336045|NCT03621527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336046|NCT03646721|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93336047|NCT03646721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93336048|NCT03646721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336049|NCT03646721|Incretins|incretins|mesh-ancestor
93336050|NCT03646721|Hormones|hormones|mesh-ancestor
93336051|NCT03646721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336052|NCT03646721|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93336053|NCT03646721|Protease Inhibitors|protease inhibitors|mesh-ancestor
93336054|NCT03646721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336055|NCT03646721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336056|NCT03613753|Irinotecan|irinotecan|mesh-list
93336057|NCT03613753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93336058|NCT03613753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93336059|NCT03613753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336060|NCT03613753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336061|NCT03613753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336062|NCT04051853|Sorafenib|sorafenib|mesh-list
93336063|NCT04051853|Midazolam|midazolam|mesh-list
93336064|NCT04051853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93336065|NCT04051853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93336066|NCT04051853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336067|NCT04051853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336068|NCT04051853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93336069|NCT04051853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93336070|NCT04051853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93336071|NCT04051853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93336072|NCT04051853|Anesthetics, General|anesthetics, general|mesh-ancestor
93336073|NCT04051853|Anesthetics|anesthetics|mesh-ancestor
93336074|NCT04051853|GABA Modulators|gaba modulators|mesh-ancestor
93336075|NCT04051853|GABA Agents|gaba agents|mesh-ancestor
93336076|NCT04051853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336077|NCT04051853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336078|NCT04051853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336079|NCT04051853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336080|NCT04051853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336081|NCT03643757|Bupivacaine|bupivacaine|mesh-list
93336082|NCT03643757|Anesthetics, Local|anesthetics, local|mesh-ancestor
93336083|NCT03643757|Anesthetics|anesthetics|mesh-ancestor
93336084|NCT03643757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336085|NCT03643757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336086|NCT03643757|Sensory System Agents|sensory system agents|mesh-ancestor
93336087|NCT03643757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336088|NCT03718793|Nitric Oxide|nitric oxide|mesh-list
93336089|NCT03718793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93336090|NCT03718793|Autonomic Agents|autonomic agents|mesh-ancestor
93336091|NCT03718793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336092|NCT03718793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336093|NCT03718793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93336094|NCT03718793|Respiratory System Agents|respiratory system agents|mesh-ancestor
93336095|NCT03718793|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93336096|NCT03718793|Antioxidants|antioxidants|mesh-ancestor
93336097|NCT03718793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336098|NCT03718793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336099|NCT03718793|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93336100|NCT03718793|Vasodilator Agents|vasodilator agents|mesh-ancestor
93336101|NCT03718793|Gasotransmitters|gasotransmitters|mesh-ancestor
93336102|NCT03718793|Protective Agents|protective agents|mesh-ancestor
93336103|NCT02962739|Tenofovir|tenofovir|mesh-list
93336104|NCT02962739|Emtricitabine|emtricitabine|mesh-list
93336105|NCT02962739|Antiviral Agents|antiviral agents|mesh-ancestor
93336106|NCT02962739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336107|NCT02962739|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93336108|NCT02962739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93336109|NCT02962739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336110|NCT02962739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336111|NCT02962739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93336112|NCT02962739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93336113|NCT01344629|Telmisartan|telmisartan|mesh-list
93336114|NCT01344629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93336115|NCT01344629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93336116|NCT01344629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93336117|NCT01344629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336118|NCT03642665|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93336119|NCT03642665|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93336120|NCT03642665|Estradiol|estradiol|mesh-list
93336121|NCT03642665|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93336122|NCT03642665|Progesterone|progesterone|mesh-list
93336123|NCT03642665|Estrogens|estrogens|mesh-ancestor
93336124|NCT03642665|Hormones|hormones|mesh-ancestor
93336125|NCT03642665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336126|NCT03642665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336127|NCT03642665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93336128|NCT03642665|Contraceptive Agents|contraceptive agents|mesh-ancestor
93336129|NCT03642665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93336130|NCT03642665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93336131|NCT03642665|Progestins|progestins|mesh-ancestor
93336132|NCT03642509|Rivaroxaban|rivaroxaban|mesh-list
93336133|NCT03642509|Apixaban|apixaban|mesh-list
93336134|NCT03642509|Edoxaban|edoxaban|mesh-list
93336135|NCT03642509|Dabigatran|dabigatran|mesh-list
93336136|NCT03642509|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93336137|NCT03642509|Antithrombins|antithrombins|mesh-ancestor
93336138|NCT03642509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93336139|NCT03642509|Protease Inhibitors|protease inhibitors|mesh-ancestor
93336140|NCT03642509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336141|NCT03642509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336142|NCT03642509|Anticoagulants|anticoagulants|mesh-ancestor
93336143|NCT03642353|Listerine|listerine|mesh-list
93336144|NCT03642353|Triclosan|triclosan|mesh-list
93336145|NCT03642353|Sodium Fluoride|sodium fluoride|mesh-list
93336146|NCT03642353|Cariostatic Agents|cariostatic agents|mesh-ancestor
93336147|NCT03642353|Protective Agents|protective agents|mesh-ancestor
93336148|NCT03642353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008069|NCT03953287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93336149|NCT03642353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93336150|NCT03642353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336151|NCT03642353|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93336152|NCT03642353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93336153|NCT03642353|Antimetabolites|antimetabolites|mesh-ancestor
93336154|NCT03642353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336155|NCT03642353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93336156|NCT03424707|Eperisone|eperisone|mesh-list
93336157|NCT03424707|Anticonvulsants|anticonvulsants|mesh-ancestor
93336158|NCT03424707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93336159|NCT03424707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93336160|NCT03424707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336161|NCT03424707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93336162|NCT03424707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336163|NCT03424707|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93336164|NCT03424707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93336165|NCT03424707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336166|NCT03424707|Parasympatholytics|parasympatholytics|mesh-ancestor
93336167|NCT03424707|Autonomic Agents|autonomic agents|mesh-ancestor
93336168|NCT03424707|Vasodilator Agents|vasodilator agents|mesh-ancestor
93336169|NCT05174351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93336170|NCT05174351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93336171|NCT05174351|Adrenergic Agents|adrenergic agents|mesh-ancestor
93336172|NCT05174351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336173|NCT05174351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336174|NCT05174351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336175|NCT03418935|Niacinamide|niacinamide|mesh-list
93336176|NCT03418935|Niacin|niacin|mesh-list
93336177|NCT03418935|Nicotinic Acids|nicotinic acids|mesh-list
93336178|NCT03418935|Vitamin B Complex|vitamin b complex|mesh-ancestor
93336179|NCT03418935|Vitamins|vitamins|mesh-ancestor
93336180|NCT03418935|Micronutrients|micronutrients|mesh-ancestor
93336181|NCT03418935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336182|NCT03418935|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93336183|NCT03418935|Antimetabolites|antimetabolites|mesh-ancestor
93336184|NCT03418935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336185|NCT03418935|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93336186|NCT03418935|Vasodilator Agents|vasodilator agents|mesh-ancestor
93336187|NCT03413319|Tilavonemab|tilavonemab|mesh-list
93336188|NCT03413319|Nootropic Agents|nootropic agents|mesh-ancestor
93336189|NCT03424629|Methotrexate|methotrexate|mesh-list
93336190|NCT03424629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93336191|NCT03424629|Abortifacient Agents|abortifacient agents|mesh-ancestor
92629991|NCT02896270|Valproic Acid|valproic acid|mesh-list
93336192|NCT03424629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93336193|NCT03424629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336194|NCT03424629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93336195|NCT03424629|Antimetabolites|antimetabolites|mesh-ancestor
93336196|NCT03424629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336197|NCT03424629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336198|NCT03424629|Dermatologic Agents|dermatologic agents|mesh-ancestor
93336199|NCT03424629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336200|NCT03424629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93336201|NCT03424629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93336202|NCT03424629|Immunologic Factors|immunologic factors|mesh-ancestor
93336203|NCT03424629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336204|NCT03424629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93336205|NCT03424473|Tucatinib|tucatinib|mesh-list
93336206|NCT03424473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336207|NCT03424473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336208|NCT03424473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336209|NCT03424473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336210|NCT04448379|Osimertinib|osimertinib|mesh-list
93336211|NCT04448379|Afatinib|afatinib|mesh-list
93336212|NCT04448379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336213|NCT04448379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336214|NCT04448379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336215|NCT04448379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336216|NCT04448223|Latanoprost|latanoprost|mesh-list
93336217|NCT04448223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93336218|NCT04448223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93336219|NCT03644147|Acetaminophen|acetaminophen|mesh-list
93336220|NCT03644147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93336221|NCT03644147|Analgesics|analgesics|mesh-ancestor
93336222|NCT03644147|Sensory System Agents|sensory system agents|mesh-ancestor
93336223|NCT03644147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336224|NCT03644147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336225|NCT03644147|Antipyretics|antipyretics|mesh-ancestor
93336226|NCT02743923|Paclitaxel|paclitaxel|mesh-list
93336227|NCT02743923|Bevacizumab|bevacizumab|mesh-list
93336228|NCT02743923|Carboplatin|carboplatin|mesh-list
93336229|NCT02743923|Pemetrexed|pemetrexed|mesh-list
93336230|NCT02743923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93336231|NCT02743923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336232|NCT02743923|Tubulin Modulators|tubulin modulators|mesh-ancestor
93336233|NCT02743923|Antimitotic Agents|antimitotic agents|mesh-ancestor
93336234|NCT02743923|Mitosis Modulators|mitosis modulators|mesh-ancestor
93336235|NCT02743923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336236|NCT02743923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336237|NCT02743923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93336238|NCT02743923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93336239|NCT02743923|Growth Substances|growth substances|mesh-ancestor
93336240|NCT02743923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336241|NCT02743923|Growth Inhibitors|growth inhibitors|mesh-ancestor
93336242|NCT02743923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336243|NCT02743923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93336244|NCT02743923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93336245|NCT01065779|Alendronate|alendronate|mesh-list
93336246|NCT01065779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93336247|NCT01065779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336248|NCT02357966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93336249|NCT02357966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336250|NCT03570359|Interferons|interferons|mesh-list
93336251|NCT03570359|Interferon-beta|interferon-beta|mesh-list
93336252|NCT03570359|Interferon beta-1a|interferon beta-1a|mesh-list
93336253|NCT03570359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336254|NCT03570359|Antiviral Agents|antiviral agents|mesh-ancestor
93336255|NCT03570359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336256|NCT03570359|Immunologic Factors|immunologic factors|mesh-ancestor
93336257|NCT03570359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336258|NCT03570359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93336259|NCT02358200|Paclitaxel|paclitaxel|mesh-list
93336260|NCT02358200|Carboplatin|carboplatin|mesh-list
93336261|NCT02358200|Talazoparib|talazoparib|mesh-list
93336262|NCT02358200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93336263|NCT02358200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336264|NCT02358200|Tubulin Modulators|tubulin modulators|mesh-ancestor
93336265|NCT02358200|Antimitotic Agents|antimitotic agents|mesh-ancestor
93336266|NCT02358200|Mitosis Modulators|mitosis modulators|mesh-ancestor
93336267|NCT02358200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336268|NCT02358200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93336269|NCT02358200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336270|NCT03413007|Antigen-Antibody Complex|antigen-antibody complex|mesh-list
93336271|NCT03413007|Immunologic Factors|immunologic factors|mesh-ancestor
93336272|NCT03413007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336273|NCT03127605|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93336274|NCT03127605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336275|NCT03127605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336276|NCT03127605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93336277|NCT03127605|Immunotoxins|immunotoxins|mesh-ancestor
93336278|NCT03127605|Immunoconjugates|immunoconjugates|mesh-ancestor
93336279|NCT03127605|Immunologic Factors|immunologic factors|mesh-ancestor
93336280|NCT03127605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336281|NCT03112538|Insulin|insulin|mesh-list
93336282|NCT03112538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93336283|NCT03112538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93336284|NCT03112538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336285|NCT05283551|Famciclovir|famciclovir|mesh-list
93336286|NCT05283551|Antiviral Agents|antiviral agents|mesh-ancestor
93336287|NCT05283551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336288|NCT05283551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93336289|NCT05283551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336290|NCT05283551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336291|NCT02357732|Nivolumab|nivolumab|mesh-list
93336292|NCT02357732|Trametinib|trametinib|mesh-list
93336293|NCT02357732|Dabrafenib|dabrafenib|mesh-list
93336294|NCT02357732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336295|NCT02357732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336296|NCT02357732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93336297|NCT02357732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008224|NCT00656513|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93336298|NCT02357732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336299|NCT02357732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336300|NCT03160040|Minocycline|minocycline|mesh-list
93336301|NCT03160040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93336302|NCT03160040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336303|NCT03112148|Tofacitinib|tofacitinib|mesh-list
93336304|NCT03112148|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93336305|NCT03112148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336306|NCT03112148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336307|NCT03112148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336308|NCT03423849|Gemcitabine|gemcitabine|mesh-list
93336309|NCT03423849|Capecitabine|capecitabine|mesh-list
93336310|NCT03423849|Vinorelbine|vinorelbine|mesh-list
93336311|NCT03423849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336312|NCT03423849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93336313|NCT03423849|Antimetabolites|antimetabolites|mesh-ancestor
93336314|NCT03423849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336315|NCT03423849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93336316|NCT03423849|Tubulin Modulators|tubulin modulators|mesh-ancestor
93336317|NCT03423849|Antimitotic Agents|antimitotic agents|mesh-ancestor
93336318|NCT03423849|Mitosis Modulators|mitosis modulators|mesh-ancestor
93336319|NCT02362490|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93336320|NCT02362490|Antiviral Agents|antiviral agents|mesh-ancestor
93336321|NCT02362490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336323|NCT02362256|Naltrexone|naltrexone|mesh-list
93336324|NCT02362256|Lorazepam|lorazepam|mesh-list
93336325|NCT02362256|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93336326|NCT02362256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93336327|NCT02362256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336328|NCT02362256|Sensory System Agents|sensory system agents|mesh-ancestor
93336329|NCT02362256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336330|NCT02362256|Analgesics|analgesics|mesh-ancestor
93336331|NCT02362256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93336332|NCT02362256|Sympatholytics|sympatholytics|mesh-ancestor
93336333|NCT02362256|Autonomic Agents|autonomic agents|mesh-ancestor
93336334|NCT02362256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93336335|NCT02362256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93336336|NCT02362256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93336337|NCT02362256|Adrenergic Agents|adrenergic agents|mesh-ancestor
93336338|NCT02362256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336339|NCT02362256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336340|NCT02362256|Anticonvulsants|anticonvulsants|mesh-ancestor
93336341|NCT02362256|Antiemetics|antiemetics|mesh-ancestor
93336342|NCT02362256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336343|NCT02362256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93336344|NCT02362256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336345|NCT02362256|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93336346|NCT02362256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93336347|NCT02362256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93336348|NCT02362256|GABA Modulators|gaba modulators|mesh-ancestor
93336349|NCT02362256|GABA Agents|gaba agents|mesh-ancestor
93336350|NCT03412305|Amoxicillin|amoxicillin|mesh-list
93336351|NCT03412305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93336352|NCT03412305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336353|NCT02109081|Dexamethasone|dexamethasone|mesh-list
93336354|NCT02109081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93336355|NCT02109081|Antiemetics|antiemetics|mesh-ancestor
93336356|NCT02109081|Autonomic Agents|autonomic agents|mesh-ancestor
93336357|NCT02109081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336358|NCT02109081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336359|NCT02109081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336360|NCT02109081|Glucocorticoids|glucocorticoids|mesh-ancestor
93336361|NCT02109081|Hormones|hormones|mesh-ancestor
93336362|NCT02109081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336363|NCT02109081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93336364|NCT02109081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336365|NCT04259996|Estradiol|estradiol|mesh-list
93336366|NCT04259996|Progesterone|progesterone|mesh-list
93336367|NCT04259996|Estrogens|estrogens|mesh-ancestor
93336368|NCT04259996|Hormones|hormones|mesh-ancestor
93336369|NCT04259996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336370|NCT04259996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336371|NCT04259996|Progestins|progestins|mesh-ancestor
93336372|NCT03417453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93336373|NCT03417453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93336374|NCT04795557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93336375|NCT03397875|Zinc Oxide|zinc oxide|mesh-list
93336376|NCT03397875|Dermatologic Agents|dermatologic agents|mesh-ancestor
93336377|NCT03397875|Sunscreening Agents|sunscreening agents|mesh-ancestor
93336378|NCT03397875|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93336379|NCT03397875|Protective Agents|protective agents|mesh-ancestor
93336380|NCT03397875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336381|NCT02362022|Morphine|morphine|mesh-list
93336382|NCT02362022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93336383|NCT02362022|Narcotics|narcotics|mesh-ancestor
93336384|NCT02362022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336385|NCT02362022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336386|NCT02362022|Analgesics|analgesics|mesh-ancestor
93336387|NCT02362022|Sensory System Agents|sensory system agents|mesh-ancestor
93336388|NCT02362022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336389|NCT03412071|Metronidazole|metronidazole|mesh-list
93336390|NCT03412071|Clindamycin|clindamycin|mesh-list
93336391|NCT03412071|Clindamycin palmitate|clindamycin palmitate|mesh-list
93336392|NCT03412071|Clindamycin phosphate|clindamycin phosphate|mesh-list
93336393|NCT03412071|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93336394|NCT03412071|Tinidazole|tinidazole|mesh-list
93336395|NCT03412071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336396|NCT03412071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93336397|NCT03412071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93336398|NCT03412071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93336399|NCT03412071|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93336400|NCT03412071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336401|NCT03412071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336402|NCT03412071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93336403|NCT03412071|Alkylating Agents|alkylating agents|mesh-ancestor
93336404|NCT03412071|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93336405|NCT03397797|Rocuronium|rocuronium|mesh-list
93336406|NCT03397797|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93336407|NCT03397797|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93336408|NCT03397797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93336409|NCT03397797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336410|NCT03397797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336411|NCT05170581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93336412|NCT05170581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336413|NCT05170581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336414|NCT05170581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336415|NCT02351882|Nabilone|nabilone|mesh-list
93336416|NCT02351882|Antiemetics|antiemetics|mesh-ancestor
93336417|NCT02351882|Autonomic Agents|autonomic agents|mesh-ancestor
93336418|NCT02351882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336419|NCT02351882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336420|NCT02351882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336421|NCT02351882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93336422|NCT02351882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93336423|NCT02351882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336424|NCT02351882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93336425|NCT02356640|Levobupivacaine|levobupivacaine|mesh-list
93336426|NCT02356640|Anesthetics, Local|anesthetics, local|mesh-ancestor
93336427|NCT02356640|Anesthetics|anesthetics|mesh-ancestor
93336428|NCT02356640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336429|NCT02356640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336430|NCT02356640|Sensory System Agents|sensory system agents|mesh-ancestor
93336431|NCT02356640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336432|NCT05169801|Paclitaxel|paclitaxel|mesh-list
93336433|NCT05169801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93336434|NCT05169801|Carboplatin|carboplatin|mesh-list
93336435|NCT05169801|Bevacizumab|bevacizumab|mesh-list
93336436|NCT05169801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93336437|NCT05169801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336438|NCT05169801|Tubulin Modulators|tubulin modulators|mesh-ancestor
93336439|NCT05169801|Antimitotic Agents|antimitotic agents|mesh-ancestor
93336440|NCT05169801|Mitosis Modulators|mitosis modulators|mesh-ancestor
93336441|NCT05169801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336442|NCT05169801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336443|NCT05169801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93336444|NCT05169801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93336445|NCT05169801|Growth Substances|growth substances|mesh-ancestor
93336446|NCT05169801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336447|NCT05169801|Growth Inhibitors|growth inhibitors|mesh-ancestor
93336448|NCT04447443|Loperamide|loperamide|mesh-list
93336449|NCT04447443|Antidiarrheals|antidiarrheals|mesh-list
93336450|NCT04447443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336451|NCT02356328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93336452|NCT02356328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93336454|NCT01345253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93336455|NCT01345253|Immunologic Factors|immunologic factors|mesh-ancestor
93336456|NCT01345253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336457|NCT03397329|Mitapivat|mitapivat|mesh-list
93336458|NCT03397329|Enzyme Activators|enzyme activators|mesh-ancestor
93336459|NCT03397329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336460|NCT03150134|Cyclosporine|cyclosporine|mesh-list
93336461|NCT03150134|Cyclosporins|cyclosporins|mesh-list
93336462|NCT03150134|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93336463|NCT03150134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336464|NCT03150134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336465|NCT03150134|Immunologic Factors|immunologic factors|mesh-ancestor
93336466|NCT03150134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336467|NCT03150134|Antifungal Agents|antifungal agents|mesh-ancestor
93336468|NCT03150134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336469|NCT03150134|Dermatologic Agents|dermatologic agents|mesh-ancestor
93336470|NCT03150134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336471|NCT03150134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93336472|NCT03411369|Vitamins|vitamins|mesh-list
93336473|NCT03411369|Micronutrients|micronutrients|mesh-ancestor
93336474|NCT03411369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336475|NCT04653207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93336476|NCT02351804|Dexamethasone|dexamethasone|mesh-list
93336477|NCT02351804|Ropivacaine|ropivacaine|mesh-list
93336478|NCT02351804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93336479|NCT02351804|Antiemetics|antiemetics|mesh-ancestor
93336480|NCT02351804|Autonomic Agents|autonomic agents|mesh-ancestor
92630270|NCT00170729|Glucocorticoids|glucocorticoids|mesh-ancestor
93336481|NCT02351804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336482|NCT02351804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336483|NCT02351804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336484|NCT02351804|Glucocorticoids|glucocorticoids|mesh-ancestor
93336485|NCT02351804|Hormones|hormones|mesh-ancestor
93336486|NCT02351804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336487|NCT02351804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93336488|NCT02351804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336489|NCT02351804|Anesthetics, Local|anesthetics, local|mesh-ancestor
93336490|NCT02351804|Anesthetics|anesthetics|mesh-ancestor
93336491|NCT02351804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336492|NCT02351804|Sensory System Agents|sensory system agents|mesh-ancestor
93336493|NCT03640403|Artesunate|artesunate|mesh-list
93336494|NCT03640403|Piperaquine|piperaquine|mesh-list
93336495|NCT03640403|Amodiaquine|amodiaquine|mesh-list
93336496|NCT03640403|Artenimol|artenimol|mesh-list
93336497|NCT03640403|Antimalarials|antimalarials|mesh-ancestor
93336498|NCT03640403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93336499|NCT03640403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93336500|NCT03640403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336501|NCT03640403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336502|NCT03640403|Antiviral Agents|antiviral agents|mesh-ancestor
93336503|NCT03640403|Schistosomicides|schistosomicides|mesh-ancestor
93336504|NCT03640403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93336505|NCT03640403|Anthelmintics|anthelmintics|mesh-ancestor
93336506|NCT02355938|Vancomycin|vancomycin|mesh-list
93336507|NCT02355938|Fidaxomicin|fidaxomicin|mesh-list
93336508|NCT02355938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93336509|NCT02355938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336510|NCT03397173|Ascorbic Acid|ascorbic acid|mesh-list
93336511|NCT03397173|Azacitidine|azacitidine|mesh-list
93336512|NCT03397173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93336513|NCT03397173|Antimetabolites|antimetabolites|mesh-ancestor
93336514|NCT03397173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336515|NCT03397173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336516|NCT03397173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336517|NCT03397173|Antioxidants|antioxidants|mesh-ancestor
93336518|NCT03397173|Protective Agents|protective agents|mesh-ancestor
93336519|NCT03397173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336520|NCT03397173|Vitamins|vitamins|mesh-ancestor
93336521|NCT03397173|Micronutrients|micronutrients|mesh-ancestor
93336522|NCT03640247|Acetaminophen|acetaminophen|mesh-list
93336523|NCT03640247|Ibuprofen|ibuprofen|mesh-list
93336524|NCT03640247|Oxycodone|oxycodone|mesh-list
93336525|NCT03640247|Tramadol|tramadol|mesh-list
93336526|NCT03640247|Hydrocodone|hydrocodone|mesh-list
93336527|NCT03640247|Narcotics|narcotics|mesh-list
93008449|NCT00800423|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93336528|NCT03640247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93336529|NCT03640247|Analgesics|analgesics|mesh-ancestor
93336530|NCT03640247|Sensory System Agents|sensory system agents|mesh-ancestor
93336531|NCT03640247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336532|NCT03640247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336533|NCT03640247|Antipyretics|antipyretics|mesh-ancestor
93336534|NCT03640247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93336535|NCT03640247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93336536|NCT03640247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336537|NCT03640247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93336538|NCT03640247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336539|NCT03640247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336540|NCT03640247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93336541|NCT03640247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336542|NCT03640247|Antitussive Agents|antitussive agents|mesh-ancestor
93336543|NCT03640247|Respiratory System Agents|respiratory system agents|mesh-ancestor
93336544|NCT03394131|Insulin|insulin|mesh-list
93336545|NCT03394131|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93336546|NCT03394131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93336547|NCT03394131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336548|NCT02360618|Metformin|metformin|mesh-list
93336549|NCT02360618|Simvastatin|simvastatin|mesh-list
93336550|NCT02360618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93336551|NCT02360618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336552|NCT02360618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93336553|NCT02360618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93336554|NCT02360618|Antimetabolites|antimetabolites|mesh-ancestor
93336555|NCT02360618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336556|NCT02360618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93336557|NCT02360618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93336558|NCT02360618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336559|NCT05214183|Rituximab|rituximab|mesh-list
93336560|NCT05214183|Acalabrutinib|acalabrutinib|mesh-list
93336561|NCT05214183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336562|NCT05214183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336563|NCT05214183|Immunologic Factors|immunologic factors|mesh-ancestor
93336564|NCT05214183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336565|NCT05214183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336566|NCT01344161|Vitamin D|vitamin d|mesh-list
93336567|NCT01344161|Cholecalciferol|cholecalciferol|mesh-list
93336568|NCT01344161|Vitamins|vitamins|mesh-ancestor
93336569|NCT01344161|Micronutrients|micronutrients|mesh-ancestor
93336570|NCT01344161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336571|NCT01344161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93336572|NCT01344161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93336573|NCT02451358|Vaccines|vaccines|mesh-list
93336574|NCT02451358|Immunologic Factors|immunologic factors|mesh-ancestor
93336575|NCT02451358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336576|NCT02360384|Linaclotide|linaclotide|mesh-list
93336577|NCT02360384|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93336578|NCT02360384|Enzyme Activators|enzyme activators|mesh-ancestor
93336579|NCT02360384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336580|NCT02360384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336581|NCT03396861|Aflibercept|aflibercept|mesh-list
93336582|NCT03396861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93336583|NCT03396861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93336584|NCT03396861|Growth Substances|growth substances|mesh-ancestor
93336585|NCT03396861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336586|NCT03396861|Growth Inhibitors|growth inhibitors|mesh-ancestor
93336587|NCT03396861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336588|NCT02749721|Vortioxetine|vortioxetine|mesh-list
93336589|NCT02749721|Antidepressive Agents|antidepressive agents|mesh-ancestor
93336590|NCT02749721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93336591|NCT02749721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93336592|NCT02749721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93336593|NCT02749721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336594|NCT02749721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336595|NCT02749721|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93336596|NCT02749721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93336597|NCT02749721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93336598|NCT02749721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336599|NCT02749721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336600|NCT02749721|Serotonin Agents|serotonin agents|mesh-ancestor
93336601|NCT02749721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93336602|NCT02749721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93336603|NCT02749721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93336604|NCT02749721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93008528|NCT02552459|Sufentanil|sufentanil|mesh-list
93336606|NCT02351102|Antiviral Agents|antiviral agents|mesh-ancestor
93336607|NCT02351102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336608|NCT02351024|Naproxen|naproxen|mesh-list
93336609|NCT02351024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93336610|NCT02351024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93336611|NCT02351024|Analgesics|analgesics|mesh-ancestor
93336612|NCT02351024|Sensory System Agents|sensory system agents|mesh-ancestor
93336613|NCT02351024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336614|NCT02351024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336615|NCT02351024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93336616|NCT02351024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336617|NCT02351024|Gout Suppressants|gout suppressants|mesh-ancestor
93336618|NCT02351024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93336619|NCT02351024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336620|NCT02351024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336621|NCT02355704|Atorvastatin|atorvastatin|mesh-list
93336622|NCT02355704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93336623|NCT02355704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93336624|NCT02355704|Antimetabolites|antimetabolites|mesh-ancestor
93336625|NCT02355704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336626|NCT02355704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93336627|NCT02355704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93336628|NCT02355704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336629|NCT03396393|Artenimol|artenimol|mesh-list
93336630|NCT03396393|Antimalarials|antimalarials|mesh-ancestor
93336631|NCT03396393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93336632|NCT03396393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93336633|NCT03396393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336634|NCT03393819|Ethanol|ethanol|mesh-list
93336635|NCT03393819|Chlorhexidine|chlorhexidine|mesh-list
93336636|NCT03393819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93336637|NCT03393819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336638|NCT03393819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336639|NCT03393819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336640|NCT03393819|Disinfectants|disinfectants|mesh-ancestor
93336641|NCT03393507|Apatinib|apatinib|mesh-list
93336642|NCT03393507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336643|NCT03393507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336644|NCT03393507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336645|NCT03393507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336646|NCT01348139|AZD-3199|azd-3199|mesh-list
93336647|NCT01348139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93336648|NCT01348139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93336649|NCT01348139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93336650|NCT01348139|Adrenergic Agents|adrenergic agents|mesh-ancestor
93336651|NCT01348139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336652|NCT01348139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336653|NCT01348139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336654|NCT02355236|Celecoxib|celecoxib|mesh-list
93336655|NCT02355236|Naproxen|naproxen|mesh-list
93336656|NCT02355236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93336657|NCT02355236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93336658|NCT02355236|Analgesics|analgesics|mesh-ancestor
93336659|NCT02355236|Sensory System Agents|sensory system agents|mesh-ancestor
93336660|NCT02355236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336661|NCT02355236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336662|NCT02355236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93336663|NCT02355236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93336664|NCT02355236|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93336665|NCT02355236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93336666|NCT02355236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336667|NCT02355236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336668|NCT02355236|Gout Suppressants|gout suppressants|mesh-ancestor
93336669|NCT05169255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93336670|NCT05169255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336671|NCT02359604|Esomeprazole|esomeprazole|mesh-list
93336672|NCT02359604|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93336673|NCT02359604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336674|NCT02359604|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93336675|NCT02359604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336676|NCT02359604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336677|NCT03410511|Nicotine|nicotine|mesh-list
93336678|NCT03410511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93336679|NCT03410511|Autonomic Agents|autonomic agents|mesh-ancestor
93336680|NCT03410511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336681|NCT03410511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336682|NCT03410511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93336683|NCT03410511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93336684|NCT03410511|Cholinergic Agents|cholinergic agents|mesh-ancestor
93336685|NCT03410511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336686|NCT03410511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336687|NCT05169021|Folic Acid|folic acid|mesh-list
93336688|NCT05169021|Vitamin B Complex|vitamin b complex|mesh-list
93336689|NCT05169021|Amlodipine|amlodipine|mesh-list
93336690|NCT05169021|Antihypertensive Agents|antihypertensive agents|mesh-list
93336691|NCT05169021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93336692|NCT05169021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93336693|NCT05169021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336694|NCT05169021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93336695|NCT05169021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336696|NCT05169021|Vasodilator Agents|vasodilator agents|mesh-ancestor
93336697|NCT05169021|Hematinics|hematinics|mesh-ancestor
93336698|NCT05169021|Vitamins|vitamins|mesh-ancestor
93336699|NCT05169021|Micronutrients|micronutrients|mesh-ancestor
93336700|NCT02359292|Charcoal|charcoal|mesh-list
93336701|NCT02359292|Antidotes|antidotes|mesh-ancestor
93336702|NCT02359292|Protective Agents|protective agents|mesh-ancestor
93336703|NCT02359292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336704|NCT05168787|Valsartan|valsartan|mesh-list
93336705|NCT05168787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93336706|NCT05168787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93336707|NCT05168787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93336708|NCT05168787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93336709|NCT05168787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336710|NCT02359214|Vitamin D|vitamin d|mesh-list
93336711|NCT02359214|Cholecalciferol|cholecalciferol|mesh-list
93336712|NCT02359214|Vitamins|vitamins|mesh-ancestor
93336713|NCT02359214|Micronutrients|micronutrients|mesh-ancestor
93336714|NCT02359214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336715|NCT02359214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93336716|NCT02359214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93336717|NCT02359370|Lidocaine|lidocaine|mesh-list
93336718|NCT02359370|Magnesium Sulfate|magnesium sulfate|mesh-list
93336719|NCT02359370|Anesthetics, Local|anesthetics, local|mesh-ancestor
93336720|NCT02359370|Anesthetics|anesthetics|mesh-ancestor
93336721|NCT02359370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336722|NCT02359370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336723|NCT02359370|Sensory System Agents|sensory system agents|mesh-ancestor
93336724|NCT02359370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336725|NCT02359370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93336726|NCT02359370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93336727|NCT02359370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93336728|NCT02359370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93336729|NCT02359370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336730|NCT02359370|Analgesics|analgesics|mesh-ancestor
93336731|NCT02359370|Anticonvulsants|anticonvulsants|mesh-ancestor
93336732|NCT02359370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93336733|NCT02359370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93336734|NCT02359370|Tocolytic Agents|tocolytic agents|mesh-ancestor
93336735|NCT02359370|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93336736|NCT02359448|Melatonin|melatonin|mesh-list
93336737|NCT02359448|Antioxidants|antioxidants|mesh-ancestor
93336738|NCT02359448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336739|NCT02359448|Protective Agents|protective agents|mesh-ancestor
93336740|NCT02359448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336741|NCT02359448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336742|NCT02359526|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93336743|NCT02359526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93336744|NCT02359526|Glucocorticoids|glucocorticoids|mesh-ancestor
93336745|NCT02359526|Hormones|hormones|mesh-ancestor
93336746|NCT02359526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336747|NCT02359526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336748|NCT03618953|Atezolizumab|atezolizumab|mesh-list
93336749|NCT03618953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93336750|NCT03618953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336751|NCT03618953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336752|NCT03618953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336753|NCT02354768|Lanreotide|lanreotide|mesh-list
93336754|NCT02354768|Loperamide|loperamide|mesh-list
93336755|NCT02354768|Antidiarrheals|antidiarrheals|mesh-list
93336756|NCT02354768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336757|NCT02354768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336758|NCT00000125|Antihypertensive Agents|antihypertensive agents|mesh-list
93336759|NCT00000125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93336760|NCT00000125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93336761|NCT02354612|Bevacizumab|bevacizumab|mesh-list
93336762|NCT02354612|Capecitabine|capecitabine|mesh-list
93336763|NCT02354612|Axitinib|axitinib|mesh-list
93336764|NCT02354612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336765|NCT02354612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336766|NCT02354612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93336767|NCT02354612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93336768|NCT02354612|Growth Substances|growth substances|mesh-ancestor
93336769|NCT02354612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336770|NCT02354612|Growth Inhibitors|growth inhibitors|mesh-ancestor
93336771|NCT02354612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93336772|NCT02354612|Antimetabolites|antimetabolites|mesh-ancestor
93336773|NCT02354612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336774|NCT02354612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93336775|NCT02354612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336776|NCT02348450|Irinotecan|irinotecan|mesh-list
93336777|NCT02348450|Etoposide|etoposide|mesh-list
93336778|NCT02348450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336779|NCT02348450|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93336780|NCT02348450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93336781|NCT02348450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336782|NCT02348450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336783|NCT02348450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93336784|NCT02348450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93336785|NCT03393273|Elotuzumab|elotuzumab|mesh-list
93336786|NCT03393273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336787|NCT03613597|Etoposide|etoposide|mesh-list
93336788|NCT03613597|Etoposide phosphate|etoposide phosphate|mesh-list
93336789|NCT03613597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336790|NCT03613597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93336791|NCT03613597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93336792|NCT03613597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93336793|NCT03613597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336794|NCT03613597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336795|NCT02348372|Glycine|glycine|mesh-list
93336796|NCT02348372|Glycine Agents|glycine agents|mesh-ancestor
93336797|NCT02348372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336798|NCT02348372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336799|NCT02348372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336800|NCT02031731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93336801|NCT02031731|Immunologic Factors|immunologic factors|mesh-ancestor
93336802|NCT02031731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336803|NCT03614533|Vaccines|vaccines|mesh-list
93336804|NCT03614533|Immunologic Factors|immunologic factors|mesh-ancestor
93336805|NCT03614533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336806|NCT03147404|Avelumab|avelumab|mesh-list
93336807|NCT03147404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336808|NCT03147404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336809|NCT03614455|Itraconazole|itraconazole|mesh-list
93336810|NCT03614455|Posaconazole|posaconazole|mesh-list
93336811|NCT03614455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
93336812|NCT03614455|Antifungal Agents|antifungal agents|mesh-ancestor
93336813|NCT03614455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336814|NCT03614455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93336815|NCT03614455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93336816|NCT03614455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336817|NCT03614455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336818|NCT03614455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93336819|NCT03614455|Hormone Antagonists|hormone antagonists|mesh-ancestor
93336820|NCT03614455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336821|NCT03614455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336822|NCT03614455|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93336823|NCT03614455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93336824|NCT03614455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93336825|NCT03393117|Narcotics|narcotics|mesh-list
93336826|NCT03393117|Bupivacaine|bupivacaine|mesh-list
93336827|NCT03393117|Anesthetics, Local|anesthetics, local|mesh-ancestor
93336828|NCT03393117|Anesthetics|anesthetics|mesh-ancestor
93336829|NCT03393117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336830|NCT03393117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336831|NCT03393117|Sensory System Agents|sensory system agents|mesh-ancestor
93336832|NCT03393117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336833|NCT03393117|Analgesics|analgesics|mesh-ancestor
93336834|NCT02032303|Ticagrelor|ticagrelor|mesh-list
93336835|NCT02032303|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93336836|NCT02032303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93336837|NCT02032303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93336838|NCT02032303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93336839|NCT02032303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93336840|NCT02032303|Purinergic Agents|purinergic agents|mesh-ancestor
93336841|NCT02032303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336842|NCT02032303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336843|NCT02032303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336844|NCT04297293|Ramosetron|ramosetron|mesh-list
93336845|NCT04297293|Antiemetics|antiemetics|mesh-ancestor
93336846|NCT04297293|Autonomic Agents|autonomic agents|mesh-ancestor
93336847|NCT04297293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336848|NCT04297293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336849|NCT04297293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336850|NCT04297293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93336851|NCT04297293|Serotonin Agents|serotonin agents|mesh-ancestor
93336852|NCT04297293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336853|NCT04297293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336854|NCT03392961|Insulin|insulin|mesh-list
93336855|NCT03392961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93336856|NCT03392961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336857|NCT02350946|Oxytocin|oxytocin|mesh-list
93336858|NCT02350946|Oxytocics|oxytocics|mesh-ancestor
93336859|NCT02350946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93336860|NCT02350946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336861|NCT00000371|Cycloserine|cycloserine|mesh-list
93336862|NCT00000371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93336863|NCT00000371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93336864|NCT00000371|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93336865|NCT00000371|Antitubercular Agents|antitubercular agents|mesh-ancestor
93336866|NCT00000371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93336867|NCT00000371|Antimetabolites|antimetabolites|mesh-ancestor
93336868|NCT00000371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336869|NCT02350712|Carboplatin|carboplatin|mesh-list
93336870|NCT02350712|Cetuximab|cetuximab|mesh-list
93336871|NCT02350712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336872|NCT02350712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93336873|NCT02867995|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93336874|NCT02867995|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93336875|NCT03618797|Fenofibrate|fenofibrate|mesh-list
93336876|NCT03618797|Pitavastatin|pitavastatin|mesh-list
93336877|NCT03618797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93336878|NCT03618797|Antimetabolites|antimetabolites|mesh-ancestor
93336879|NCT03618797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336880|NCT03618797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93336881|NCT03618797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93336882|NCT03618797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93336883|NCT03618797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336884|NCT03149432|Gabapentin|gabapentin|mesh-list
93336885|NCT03149432|Analgesics|analgesics|mesh-ancestor
93336886|NCT03149432|Sensory System Agents|sensory system agents|mesh-ancestor
93336887|NCT03149432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336888|NCT03149432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336889|NCT03149432|Anticonvulsants|anticonvulsants|mesh-ancestor
93336890|NCT03149432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93336891|NCT03149432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93336892|NCT03149432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336893|NCT03149432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93336894|NCT03149432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93336895|NCT03149432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93336896|NCT03149432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336897|NCT03149432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336898|NCT03149432|Antimanic Agents|antimanic agents|mesh-ancestor
93336899|NCT05384483|Cariprazine|cariprazine|mesh-list
93336900|NCT05384483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93336901|NCT05384483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93336902|NCT05384483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008833|NCT00061945|Antioxidants|antioxidants|mesh-ancestor
93336903|NCT05384483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336904|NCT05384483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93336905|NCT05061563|Esomeprazole|esomeprazole|mesh-list
93336906|NCT05061563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93336907|NCT05061563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93336908|NCT05061563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93336909|NCT05061563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336910|NCT05061563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336911|NCT03147092|Losartan|losartan|mesh-list
93336912|NCT03147092|Atenolol|atenolol|mesh-list
93336913|NCT03147092|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93336914|NCT03147092|Clonidine|clonidine|mesh-list
93336915|NCT03147092|Captopril|captopril|mesh-list
93336916|NCT03147092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93336917|NCT03147092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93336918|NCT03147092|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93336919|NCT03147092|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93336920|NCT03147092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336921|NCT03147092|Diuretics|diuretics|mesh-ancestor
93336922|NCT03147092|Natriuretic Agents|natriuretic agents|mesh-ancestor
93336923|NCT03147092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336924|NCT03147092|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93336925|NCT03147092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93336926|NCT03147092|Analgesics|analgesics|mesh-ancestor
93336927|NCT03147092|Sensory System Agents|sensory system agents|mesh-ancestor
93336928|NCT03147092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336929|NCT03147092|Sympatholytics|sympatholytics|mesh-ancestor
93336930|NCT03147092|Autonomic Agents|autonomic agents|mesh-ancestor
93336931|NCT03147092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93336932|NCT03147092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93336933|NCT03147092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93336934|NCT03147092|Adrenergic Agents|adrenergic agents|mesh-ancestor
93336935|NCT03147092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336936|NCT03147092|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93336937|NCT03147092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93336938|NCT03147092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93336939|NCT03147092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93336940|NCT03147092|Protease Inhibitors|protease inhibitors|mesh-ancestor
93336941|NCT03147092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336942|NCT03149588|Propofol|propofol|mesh-list
93336943|NCT03149588|Sevoflurane|sevoflurane|mesh-list
93336944|NCT03149588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93336945|NCT03149588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336946|NCT03149588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336947|NCT03149588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93336948|NCT03149588|Anesthetics, General|anesthetics, general|mesh-ancestor
93336949|NCT03149588|Anesthetics|anesthetics|mesh-ancestor
93336950|NCT03149588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93336951|NCT03149588|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93336952|NCT03613207|Lidocaine|lidocaine|mesh-list
93336953|NCT03613207|Prilocaine|prilocaine|mesh-list
93336954|NCT03613207|Anesthetics, Local|anesthetics, local|mesh-ancestor
93336955|NCT03613207|Anesthetics|anesthetics|mesh-ancestor
93336956|NCT03613207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93336957|NCT03613207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336958|NCT03613207|Sensory System Agents|sensory system agents|mesh-ancestor
93336959|NCT03613207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93336960|NCT03613207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93336961|NCT03613207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93336962|NCT03613207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93336963|NCT03613207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93336964|NCT03613207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336965|NCT03612739|Azacitidine|azacitidine|mesh-list
93336966|NCT03612739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93336967|NCT03612739|Antimetabolites|antimetabolites|mesh-ancestor
92630746|NCT00197613|Nevirapine|nevirapine|mesh-list
93336968|NCT03612739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336969|NCT03612739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336970|NCT03612739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336971|NCT02350400|Irinotecan|irinotecan|mesh-list
93336972|NCT02350400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93336973|NCT02350400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93336974|NCT02350400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93336975|NCT02350400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336976|NCT02350400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336977|NCT03612817|Timolol|timolol|mesh-list
93336978|NCT03612817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93336979|NCT03612817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93336980|NCT03612817|Adrenergic Agents|adrenergic agents|mesh-ancestor
93336981|NCT03612817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93336982|NCT03612817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336983|NCT03612817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93336984|NCT03612817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93336985|NCT03612817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93336986|NCT02347904|Oxaliplatin|oxaliplatin|mesh-list
93336987|NCT02347904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93336988|NCT03612349|Menthol|menthol|mesh-list
93336989|NCT03612349|Antipruritics|antipruritics|mesh-ancestor
93336990|NCT03612349|Dermatologic Agents|dermatologic agents|mesh-ancestor
93336991|NCT03146858|Enoxaparin|enoxaparin|mesh-list
93336992|NCT03146858|Anticoagulants|anticoagulants|mesh-ancestor
93336993|NCT03146858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93336994|NCT03146858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93336995|NCT03146858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93336996|NCT03408405|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93336997|NCT03408405|Hormones|hormones|mesh-ancestor
93336998|NCT03408405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93336999|NCT03408405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337000|NCT03408093|Interferons|interferons|mesh-list
93337001|NCT03408093|Interferon-beta|interferon-beta|mesh-list
93337002|NCT03408093|Interferon beta-1b|interferon beta-1b|mesh-list
93337003|NCT03408093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337004|NCT03408093|Antiviral Agents|antiviral agents|mesh-ancestor
93337005|NCT03408093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337006|NCT03408093|Immunologic Factors|immunologic factors|mesh-ancestor
93337007|NCT03408093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337008|NCT03408093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93337009|NCT04679623|Midazolam|midazolam|mesh-list
93337010|NCT04679623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93337011|NCT04679623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93337012|NCT04679623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337013|NCT04679623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337014|NCT04679623|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93337015|NCT04679623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93337016|NCT04679623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93337017|NCT04679623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93337018|NCT04679623|Anesthetics, General|anesthetics, general|mesh-ancestor
93337019|NCT04679623|Anesthetics|anesthetics|mesh-ancestor
93337020|NCT04679623|GABA Modulators|gaba modulators|mesh-ancestor
93337021|NCT04679623|GABA Agents|gaba agents|mesh-ancestor
93337022|NCT04679623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337023|NCT04679623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337024|NCT02353988|Bicalutamide|bicalutamide|mesh-list
93337025|NCT02353988|Androgen Antagonists|androgen antagonists|mesh-ancestor
93337026|NCT02353988|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337027|NCT02353988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337028|NCT02353988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337029|NCT02353988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337030|NCT03392571|Paclitaxel|paclitaxel|mesh-list
93337031|NCT03392571|Cisplatin|cisplatin|mesh-list
93337032|NCT03392571|Gemcitabine|gemcitabine|mesh-list
93337033|NCT03392571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93337034|NCT03392571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337035|NCT03392571|Tubulin Modulators|tubulin modulators|mesh-ancestor
93337036|NCT03392571|Antimitotic Agents|antimitotic agents|mesh-ancestor
93337037|NCT03392571|Mitosis Modulators|mitosis modulators|mesh-ancestor
93337038|NCT03392571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337039|NCT03392571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93337040|NCT03392571|Antimetabolites|antimetabolites|mesh-ancestor
93337041|NCT04656067|Tranexamic Acid|tranexamic acid|mesh-list
93337042|NCT04656067|Ethamsylate|ethamsylate|mesh-list
93337043|NCT04656067|Oxytocin|oxytocin|mesh-list
93337044|NCT04656067|Oxytocics|oxytocics|mesh-ancestor
93337045|NCT04656067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93337046|NCT04656067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337047|NCT04656067|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93337048|NCT04656067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93337049|NCT04656067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337050|NCT04656067|Hemostatics|hemostatics|mesh-ancestor
93337051|NCT04656067|Coagulants|coagulants|mesh-ancestor
93337052|NCT03612037|Thioctic Acid|thioctic acid|mesh-list
93008982|NCT00059839|Methotrexate|methotrexate|mesh-list
93337053|NCT03612037|Antioxidants|antioxidants|mesh-ancestor
93337054|NCT03612037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337055|NCT03612037|Protective Agents|protective agents|mesh-ancestor
93337056|NCT03612037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337057|NCT03612037|Vitamin B Complex|vitamin b complex|mesh-ancestor
93337058|NCT03612037|Vitamins|vitamins|mesh-ancestor
93337059|NCT03612037|Micronutrients|micronutrients|mesh-ancestor
93337060|NCT04447209|Chrysarobin|chrysarobin|mesh-list
93337061|NCT04447209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93337062|NCT04447209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337063|NCT04447209|Analgesics|analgesics|mesh-ancestor
93337064|NCT04447209|Sensory System Agents|sensory system agents|mesh-ancestor
93337065|NCT04447209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337066|NCT04447209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337067|NCT04447209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337068|NCT04447209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337069|NCT04199624|Omeprazole|omeprazole|mesh-list
93337070|NCT04199624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337071|NCT04199624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93337072|NCT04199624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337073|NCT04199624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93337074|NCT04199624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337075|NCT03611491|Lidocaine|lidocaine|mesh-list
93337076|NCT03611491|Anesthetics, Local|anesthetics, local|mesh-ancestor
93337077|NCT03611491|Anesthetics|anesthetics|mesh-ancestor
93337078|NCT03611491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337079|NCT03611491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337080|NCT03611491|Sensory System Agents|sensory system agents|mesh-ancestor
93337081|NCT03611491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337082|NCT03611491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93337083|NCT03611491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93337084|NCT03611491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93337085|NCT03611491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93337086|NCT03611491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337087|NCT02748863|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93337088|NCT02748863|Immunologic Factors|immunologic factors|mesh-ancestor
93337089|NCT02748863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337090|NCT03611179|Bevacizumab|bevacizumab|mesh-list
93337091|NCT03611179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337092|NCT03611179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337093|NCT03611179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93337094|NCT03611179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93337095|NCT03611179|Growth Substances|growth substances|mesh-ancestor
93337096|NCT03611179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337097|NCT03611179|Growth Inhibitors|growth inhibitors|mesh-ancestor
93337098|NCT03126123|Acetic Acid|acetic acid|mesh-list
93337099|NCT03126123|Retinol acetate|retinol acetate|mesh-list
93337100|NCT03126123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93337101|NCT03126123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337102|NCT03126123|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93337103|NCT03126123|Immunologic Factors|immunologic factors|mesh-ancestor
93337104|NCT03126123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337105|NCT03126123|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93337106|NCT03126123|Protective Agents|protective agents|mesh-ancestor
93337107|NCT03126123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337108|NCT02353676|Bupivacaine|bupivacaine|mesh-list
93337109|NCT02353676|Anesthetics, Local|anesthetics, local|mesh-ancestor
93337110|NCT02353676|Anesthetics|anesthetics|mesh-ancestor
93337111|NCT02353676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337112|NCT02353676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337113|NCT02353676|Sensory System Agents|sensory system agents|mesh-ancestor
93337114|NCT02353676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337115|NCT03617471|Acetaminophen|acetaminophen|mesh-list
93337116|NCT03617471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337117|NCT03617471|Analgesics|analgesics|mesh-ancestor
93337118|NCT03617471|Sensory System Agents|sensory system agents|mesh-ancestor
93337119|NCT03617471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337120|NCT03617471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337121|NCT03617471|Antipyretics|antipyretics|mesh-ancestor
93337122|NCT05168007|Cariprazine|cariprazine|mesh-list
93337123|NCT05168007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93337124|NCT05168007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93337125|NCT05168007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337126|NCT05168007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337127|NCT05168007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93337128|NCT02032927|Acetaminophen|acetaminophen|mesh-list
93337129|NCT02032927|Oxycodone|oxycodone|mesh-list
93337130|NCT02032927|Codeine|codeine|mesh-list
93337131|NCT02032927|Naloxone|naloxone|mesh-list
93337132|NCT02032927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337133|NCT02032927|Analgesics|analgesics|mesh-ancestor
93337134|NCT02032927|Sensory System Agents|sensory system agents|mesh-ancestor
93337135|NCT02032927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337136|NCT02032927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337137|NCT02032927|Antipyretics|antipyretics|mesh-ancestor
93337138|NCT02032927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93337139|NCT02032927|Narcotics|narcotics|mesh-ancestor
93337140|NCT02032927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337141|NCT02032927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93337142|NCT02032927|Antitussive Agents|antitussive agents|mesh-ancestor
93337143|NCT02032927|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337144|NCT02353598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93337145|NCT02353598|Immunologic Factors|immunologic factors|mesh-ancestor
93337146|NCT02353598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337147|NCT03392103|Raltitrexed|raltitrexed|mesh-list
93337148|NCT03392103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93337149|NCT03392103|Antimetabolites|antimetabolites|mesh-ancestor
93337150|NCT03392103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337151|NCT03392103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337152|NCT03392103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93337153|NCT03392103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337154|NCT03610945|Fluconazole|fluconazole|mesh-list
93337155|NCT03610945|Quinidine|quinidine|mesh-list
93337156|NCT03610945|Antifungal Agents|antifungal agents|mesh-ancestor
93337157|NCT03610945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337158|NCT03610945|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93337159|NCT03610945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93337160|NCT03610945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337161|NCT03610945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337162|NCT03610945|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93337163|NCT03610945|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337164|NCT03610945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337165|NCT03610945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337166|NCT03610945|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93337167|NCT03610945|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93337168|NCT03610945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93337169|NCT03610945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93337170|NCT03610945|Adrenergic Agents|adrenergic agents|mesh-ancestor
93337171|NCT03610945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337172|NCT03610945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93337173|NCT03610945|Antimalarials|antimalarials|mesh-ancestor
93337174|NCT03610945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93337175|NCT03610945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93337176|NCT03610945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93337177|NCT03610945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93337178|NCT03610945|Cholinergic Agents|cholinergic agents|mesh-ancestor
93337179|NCT03610945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93337180|NCT03610945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93337181|NCT03610945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93337182|NCT03610945|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92630962|NCT02206087|Heparin|heparin|mesh-list
93337183|NCT03616769|Antihypertensive Agents|antihypertensive agents|mesh-list
93337184|NCT03616769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93337185|NCT05167851|Lazertinib|lazertinib|mesh-list
93337186|NCT05167851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93337187|NCT05167851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337188|NCT05167851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337189|NCT02236715|Ipratropium|ipratropium|mesh-list
93337190|NCT02236715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93337191|NCT02236715|Autonomic Agents|autonomic agents|mesh-ancestor
93337192|NCT02236715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337193|NCT02236715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337194|NCT02236715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93337195|NCT02236715|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337196|NCT02236715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93337197|NCT02236715|Cholinergic Agents|cholinergic agents|mesh-ancestor
93337198|NCT02236715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337199|NCT02236715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337200|NCT03823365|Blinatumomab|blinatumomab|mesh-list
93337201|NCT03823365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337202|NCT03616691|Bevacizumab|bevacizumab|mesh-list
93337203|NCT03616691|Atezolizumab|atezolizumab|mesh-list
93337204|NCT03616691|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93337205|NCT03616691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337206|NCT03616691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337207|NCT03616691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93337208|NCT03616691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93337209|NCT03616691|Growth Substances|growth substances|mesh-ancestor
93337210|NCT03616691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337211|NCT03616691|Growth Inhibitors|growth inhibitors|mesh-ancestor
93337212|NCT03616691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93337213|NCT03616691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337214|NCT03616691|Immunologic Factors|immunologic factors|mesh-ancestor
93337216|NCT03158168|Astringents|astringents|mesh-ancestor
93337217|NCT03158168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337218|NCT03158168|Dermatologic Agents|dermatologic agents|mesh-ancestor
93337219|NCT02865499|Acarbose|acarbose|mesh-list
93337220|NCT02865499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93337221|NCT02865499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337222|NCT02865499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337223|NCT02865499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93337224|NCT02865499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337225|NCT03156062|Salicylic Acid|salicylic acid|mesh-list
93337226|NCT03156062|Salicylates|salicylates|mesh-list
93337227|NCT03156062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337228|NCT03156062|Antifungal Agents|antifungal agents|mesh-ancestor
93337229|NCT03156062|Keratolytic Agents|keratolytic agents|mesh-ancestor
93337230|NCT03156062|Dermatologic Agents|dermatologic agents|mesh-ancestor
93337231|NCT03156062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93337232|NCT03156062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337233|NCT03156062|Analgesics|analgesics|mesh-ancestor
93337234|NCT03156062|Sensory System Agents|sensory system agents|mesh-ancestor
93337235|NCT03156062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337236|NCT03156062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337237|NCT03156062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337238|NCT03156062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337239|NCT03156062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93337240|NCT03156062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337241|NCT03156062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337242|NCT03404739|Ceftazidime|ceftazidime|mesh-list
93337243|NCT03404739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93337244|NCT03404739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337245|NCT02031965|Dexamethasone|dexamethasone|mesh-list
93337246|NCT02031965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337247|NCT02031965|Antiemetics|antiemetics|mesh-ancestor
93337248|NCT02031965|Autonomic Agents|autonomic agents|mesh-ancestor
93337249|NCT02031965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337250|NCT02031965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337251|NCT02031965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337252|NCT02031965|Glucocorticoids|glucocorticoids|mesh-ancestor
93337253|NCT02031965|Hormones|hormones|mesh-ancestor
93337254|NCT02031965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337255|NCT02031965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337256|NCT02031965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337257|NCT03149120|Nivolumab|nivolumab|mesh-list
93337258|NCT03149120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337259|NCT03149120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337260|NCT03149120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93337261|NCT03149120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337262|NCT04849325|Sirolimus|sirolimus|mesh-list
93337263|NCT04849325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93337264|NCT04849325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337265|NCT04849325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93337266|NCT04849325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337267|NCT04849325|Antifungal Agents|antifungal agents|mesh-ancestor
93337268|NCT04849325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337269|NCT04849325|Immunologic Factors|immunologic factors|mesh-ancestor
93337270|NCT04849325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337271|NCT03403023|Cyclosporine|cyclosporine|mesh-list
93337272|NCT03403023|Cyclosporins|cyclosporins|mesh-list
93337273|NCT03403023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337274|NCT03403023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337275|NCT03403023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337276|NCT03403023|Immunologic Factors|immunologic factors|mesh-ancestor
93337277|NCT03403023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337278|NCT03403023|Antifungal Agents|antifungal agents|mesh-ancestor
93337279|NCT03403023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337280|NCT03403023|Dermatologic Agents|dermatologic agents|mesh-ancestor
93337281|NCT03403023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337282|NCT03403023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93337283|NCT02864407|Tiotropium Bromide|tiotropium bromide|mesh-list
93337284|NCT02864407|Olodaterol|olodaterol|mesh-list
93337285|NCT02864407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93337286|NCT02864407|Autonomic Agents|autonomic agents|mesh-ancestor
93337287|NCT02864407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337288|NCT02864407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337289|NCT02864407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93337290|NCT02864407|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337291|NCT02864407|Parasympatholytics|parasympatholytics|mesh-ancestor
93337292|NCT02864407|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93337293|NCT02864407|Cholinergic Agents|cholinergic agents|mesh-ancestor
93337294|NCT02864407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337295|NCT02864407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337296|NCT03616301|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93337297|NCT03616301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93337298|NCT03616301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337299|NCT03616301|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93337300|NCT03616301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337301|NCT03616301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337302|NCT03394989|Fluticasone|fluticasone|mesh-list
93337303|NCT03394989|Xhance|xhance|mesh-list
93337304|NCT03394989|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93337305|NCT03394989|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93337306|NCT03394989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337307|NCT03394989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93337308|NCT03394989|Autonomic Agents|autonomic agents|mesh-ancestor
93337309|NCT03394989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337310|NCT03394989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337311|NCT03394989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93337312|NCT03394989|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337313|NCT03394989|Dermatologic Agents|dermatologic agents|mesh-ancestor
93337314|NCT03394989|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93337315|NCT03394989|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93337316|NCT03394989|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93337317|NCT03394989|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93337318|NCT03394989|Adrenergic Agents|adrenergic agents|mesh-ancestor
93337319|NCT03394989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337320|NCT03394989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337321|NCT03394989|Glucocorticoids|glucocorticoids|mesh-ancestor
93337322|NCT03394989|Hormones|hormones|mesh-ancestor
93337323|NCT03394989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337324|NCT03394989|Sympathomimetics|sympathomimetics|mesh-ancestor
93337325|NCT02033239|Insulin|insulin|mesh-list
93337326|NCT02033239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93337327|NCT02033239|Insulin Aspart|insulin aspart|mesh-list
93337328|NCT02033239|Insulin, Long-Acting|insulin, long-acting|mesh-list
93337329|NCT02033239|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93337330|NCT02033239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93337331|NCT02033239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337332|NCT02486302|Etanercept|etanercept|mesh-list
93337333|NCT02486302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93337334|NCT02486302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337335|NCT02486302|Analgesics|analgesics|mesh-ancestor
93337336|NCT02486302|Sensory System Agents|sensory system agents|mesh-ancestor
93337337|NCT02486302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337338|NCT02486302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337339|NCT02486302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337340|NCT02486302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337341|NCT02486302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337342|NCT02486302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337343|NCT02486302|Immunologic Factors|immunologic factors|mesh-ancestor
93337344|NCT02034097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93337345|NCT02034097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337346|NCT02034097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93337347|NCT02034097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337348|NCT02034097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337349|NCT03615833|Vitamin D|vitamin d|mesh-list
93337350|NCT03615833|Cholecalciferol|cholecalciferol|mesh-list
93337351|NCT03615833|Vitamins|vitamins|mesh-ancestor
93337352|NCT03615833|Micronutrients|micronutrients|mesh-ancestor
93337353|NCT03615833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337354|NCT03615833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93337355|NCT03615833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93337356|NCT02747875|Fentanyl|fentanyl|mesh-list
93337357|NCT02747875|Methadone|methadone|mesh-list
93337358|NCT02747875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93337359|NCT02747875|Narcotics|narcotics|mesh-ancestor
93337360|NCT02747875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337361|NCT02747875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337362|NCT02747875|Analgesics|analgesics|mesh-ancestor
93337363|NCT02747875|Sensory System Agents|sensory system agents|mesh-ancestor
93337364|NCT02747875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337365|NCT02747875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93337366|NCT02747875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93337367|NCT02747875|Anesthetics, General|anesthetics, general|mesh-ancestor
93337368|NCT02747875|Anesthetics|anesthetics|mesh-ancestor
93337369|NCT02747875|Antitussive Agents|antitussive agents|mesh-ancestor
93337370|NCT02747875|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337371|NCT03394833|Polygeline|polygeline|mesh-list
93337372|NCT03394833|Plasma Substitutes|plasma substitutes|mesh-ancestor
93337373|NCT03394833|Blood Substitutes|blood substitutes|mesh-ancestor
93337374|NCT02347358|Plasminogen|plasminogen|mesh-list
93337375|NCT02347358|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93337376|NCT02347358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93337377|NCT02347358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93337378|NCT02347358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337379|NCT03610321|Gefarnate|gefarnate|mesh-list
93337380|NCT03610321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93337381|NCT03610321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337382|NCT02236793|Becaplermin|becaplermin|mesh-list
93337383|NCT02236793|Anticoagulants|anticoagulants|mesh-ancestor
93337384|NCT02236793|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93337385|NCT02236793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93337386|NCT02236793|Growth Substances|growth substances|mesh-ancestor
93337387|NCT02236793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337388|NCT02347046|Dotinurad|dotinurad|mesh-list
93337389|NCT02347046|Uricosuric Agents|uricosuric agents|mesh-ancestor
93337390|NCT02347046|Gout Suppressants|gout suppressants|mesh-ancestor
93337391|NCT02347046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337392|NCT03391245|Vitamin D|vitamin d|mesh-list
93337393|NCT03391245|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93337394|NCT03391245|Calcifediol|calcifediol|mesh-list
93337395|NCT03391245|Vitamins|vitamins|mesh-ancestor
93337396|NCT03391245|Micronutrients|micronutrients|mesh-ancestor
93337397|NCT03391245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337398|NCT03391245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93337399|NCT03401619|Vitamin D|vitamin d|mesh-list
93337400|NCT03401619|Calcitonin|calcitonin|mesh-list
93337401|NCT03401619|Salmon calcitonin|salmon calcitonin|mesh-list
93337402|NCT03401619|Diphosphonates|diphosphonates|mesh-list
93337403|NCT03401619|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93337404|NCT03401619|Katacalcin|katacalcin|mesh-list
93337405|NCT03401619|Vitamins|vitamins|mesh-ancestor
93337406|NCT03401619|Micronutrients|micronutrients|mesh-ancestor
93337407|NCT03401619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337408|NCT03401619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93337409|NCT03401619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93337410|NCT03401619|Vasodilator Agents|vasodilator agents|mesh-ancestor
93337411|NCT03399903|Mesalamine|mesalamine|mesh-list
93337412|NCT03399903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93337413|NCT03399903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337414|NCT03399903|Analgesics|analgesics|mesh-ancestor
93337415|NCT03399903|Sensory System Agents|sensory system agents|mesh-ancestor
93337416|NCT03399903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337417|NCT03399903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337418|NCT03399903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337419|NCT03399903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337420|NCT03146468|Nivolumab|nivolumab|mesh-list
93337421|NCT03146468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337422|NCT03146468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337423|NCT03146468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93337424|NCT03146468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337425|NCT02353130|Memantine|memantine|mesh-list
93337426|NCT02353130|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93337427|NCT02353130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93337428|NCT02353130|Dopamine Agents|dopamine agents|mesh-ancestor
93337429|NCT02353130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337430|NCT02353130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337431|NCT02353130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337432|NCT02353130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93337433|NCT02353130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93337435|NCT02033551|Carboplatin|carboplatin|mesh-list
93337436|NCT02033551|Veliparib|veliparib|mesh-list
93337437|NCT02033551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93337438|NCT02033551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337439|NCT02033551|Tubulin Modulators|tubulin modulators|mesh-ancestor
93337440|NCT02033551|Antimitotic Agents|antimitotic agents|mesh-ancestor
93337441|NCT02033551|Mitosis Modulators|mitosis modulators|mesh-ancestor
93337442|NCT02033551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337443|NCT02033551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93337444|NCT02033551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337445|NCT02450578|Atovaquone|atovaquone|mesh-list
93337446|NCT02450578|Proguanil|proguanil|mesh-list
93337447|NCT02450578|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93337448|NCT02450578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337449|NCT02450578|Antimalarials|antimalarials|mesh-ancestor
93337450|NCT02450578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93337451|NCT02450578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93337452|NCT02450578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337453|NCT02450578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337454|NCT02450578|Antimetabolites|antimetabolites|mesh-ancestor
93337455|NCT02346890|Sevelamer|sevelamer|mesh-list
93337456|NCT02346890|Chelating Agents|chelating agents|mesh-ancestor
93337457|NCT02346890|Sequestering Agents|sequestering agents|mesh-ancestor
93337458|NCT02346890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337459|NCT03146390|Listerine|listerine|mesh-list
93337460|NCT03146390|Sodium Fluoride|sodium fluoride|mesh-list
93337461|NCT03146390|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93337462|NCT03146390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337463|NCT03146390|Cariostatic Agents|cariostatic agents|mesh-ancestor
93337464|NCT03146390|Protective Agents|protective agents|mesh-ancestor
93337465|NCT03146390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337466|NCT02859415|Plicamycin|plicamycin|mesh-list
93337467|NCT02859415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93337468|NCT02859415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337469|NCT02859415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93337470|NCT02859415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337471|NCT02859415|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93337472|NCT02859415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337473|NCT02859415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337474|NCT02859415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93337475|NCT02871791|Everolimus|everolimus|mesh-list
93337476|NCT02871791|Palbociclib|palbociclib|mesh-list
93337477|NCT02871791|Exemestane|exemestane|mesh-list
93337478|NCT02871791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93337479|NCT02871791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93337480|NCT02871791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337481|NCT02871791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337482|NCT02871791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337483|NCT02871791|Immunologic Factors|immunologic factors|mesh-ancestor
93337484|NCT02871791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337485|NCT02871791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337486|NCT02871791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93337487|NCT02871791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93337488|NCT02871791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93337489|NCT02871791|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337490|NCT02871791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337491|NCT02346578|Flutamide|flutamide|mesh-list
93337492|NCT02346578|Androgen Antagonists|androgen antagonists|mesh-ancestor
93337493|NCT02346578|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337494|NCT02346578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337495|NCT02346578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337496|NCT02346578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337497|NCT02346578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337498|NCT03112382|Vitamins|vitamins|mesh-list
93337499|NCT03112382|Vitamin A|vitamin a|mesh-list
93337500|NCT03112382|Retinol palmitate|retinol palmitate|mesh-list
93337501|NCT03112382|Micronutrients|micronutrients|mesh-ancestor
93337502|NCT03112382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337503|NCT03112382|Antioxidants|antioxidants|mesh-ancestor
93337504|NCT03112382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009493|NCT00461253|Copper|copper|mesh-list
93337505|NCT03112382|Protective Agents|protective agents|mesh-ancestor
93337506|NCT03112382|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93337507|NCT03112382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337508|NCT03399669|Gefitinib|gefitinib|mesh-list
93337509|NCT03399669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337510|NCT03399669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93337511|NCT03399669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337512|NCT03399669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337513|NCT03148574|Misoprostol|misoprostol|mesh-list
93337514|NCT03148574|Oxytocin|oxytocin|mesh-list
93337515|NCT03148574|Oxytocics|oxytocics|mesh-ancestor
93337516|NCT03148574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93337517|NCT03148574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337518|NCT03148574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93337519|NCT03148574|Abortifacient Agents|abortifacient agents|mesh-ancestor
93337520|NCT03148574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93337521|NCT03148574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337522|NCT02343536|Prednisone|prednisone|mesh-list
93337523|NCT02343536|Cyclophosphamide|cyclophosphamide|mesh-list
93337524|NCT02343536|Rituximab|rituximab|mesh-list
93337525|NCT02343536|Vincristine|vincristine|mesh-list
93337526|NCT02343536|Azacitidine|azacitidine|mesh-list
93337527|NCT02343536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337528|NCT02343536|Immunologic Factors|immunologic factors|mesh-ancestor
93337529|NCT02343536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337530|NCT02343536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337531|NCT02343536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93337532|NCT02343536|Alkylating Agents|alkylating agents|mesh-ancestor
93337533|NCT02343536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337534|NCT02343536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337535|NCT02343536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93337536|NCT02343536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337537|NCT02343536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337538|NCT02343536|Glucocorticoids|glucocorticoids|mesh-ancestor
93337539|NCT02343536|Hormones|hormones|mesh-ancestor
93337540|NCT02343536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337541|NCT02343536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337542|NCT02343536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93337543|NCT02343536|Tubulin Modulators|tubulin modulators|mesh-ancestor
93337544|NCT02343536|Antimitotic Agents|antimitotic agents|mesh-ancestor
93337545|NCT02343536|Mitosis Modulators|mitosis modulators|mesh-ancestor
93337546|NCT02343536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93337547|NCT02343536|Antimetabolites|antimetabolites|mesh-ancestor
93337548|NCT02343536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337549|NCT02343614|Celecoxib|celecoxib|mesh-list
93337550|NCT02343614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93337551|NCT02343614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337552|NCT02343614|Analgesics|analgesics|mesh-ancestor
93337553|NCT02343614|Sensory System Agents|sensory system agents|mesh-ancestor
93337554|NCT02343614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337555|NCT02343614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337556|NCT02343614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337557|NCT02343614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337558|NCT02343614|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93337559|NCT02343614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93337560|NCT02343614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337561|NCT02343614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337562|NCT02871635|Adalimumab|adalimumab|mesh-list
93337563|NCT02871635|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93337564|NCT02871635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337565|NCT02871635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337566|NCT03390465|Amlodipine|amlodipine|mesh-list
93337567|NCT03390465|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93337568|NCT03390465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93337569|NCT03390465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93337570|NCT03390465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93337571|NCT03390465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337572|NCT03390465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93337573|NCT03390465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337574|NCT03390465|Vasodilator Agents|vasodilator agents|mesh-ancestor
93337575|NCT03390465|Diuretics|diuretics|mesh-ancestor
93337576|NCT03390465|Natriuretic Agents|natriuretic agents|mesh-ancestor
93337577|NCT03390465|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93337578|NCT03390387|Dexamethasone|dexamethasone|mesh-list
93337579|NCT03390387|Dexamethasone acetate|dexamethasone acetate|mesh-list
93337580|NCT03390387|Methylprednisolone|methylprednisolone|mesh-list
93337582|NCT03390387|Daunorubicin|daunorubicin|mesh-list
93337583|NCT03390387|Idarubicin|idarubicin|mesh-list
93337584|NCT03390387|BB 1101|bb 1101|mesh-list
93337585|NCT03390387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337586|NCT03390387|Antiemetics|antiemetics|mesh-ancestor
93337587|NCT03390387|Autonomic Agents|autonomic agents|mesh-ancestor
93337588|NCT03390387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337589|NCT03390387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337590|NCT03390387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337591|NCT03390387|Glucocorticoids|glucocorticoids|mesh-ancestor
93337592|NCT03390387|Hormones|hormones|mesh-ancestor
93337593|NCT03390387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337594|NCT03390387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337595|NCT03390387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337596|NCT03390387|Protease Inhibitors|protease inhibitors|mesh-ancestor
93337597|NCT03390387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337598|NCT03390387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337599|NCT03390387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93337600|NCT03390387|Protective Agents|protective agents|mesh-ancestor
93337601|NCT03390387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93337602|NCT03390387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93337603|NCT03390387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93337604|NCT03146000|Meloxicam|meloxicam|mesh-list
93337605|NCT03146000|Lidocaine|lidocaine|mesh-list
93337606|NCT03146000|Prilocaine|prilocaine|mesh-list
92631380|NCT01862224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93337607|NCT03146000|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93337608|NCT03146000|Anesthetics, Local|anesthetics, local|mesh-ancestor
93337609|NCT03146000|Anesthetics|anesthetics|mesh-ancestor
93337610|NCT03146000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337611|NCT03146000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337612|NCT03146000|Sensory System Agents|sensory system agents|mesh-ancestor
93337613|NCT03146000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337614|NCT03146000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93337615|NCT03146000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93337616|NCT03146000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93337617|NCT03146000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93337618|NCT03146000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337619|NCT03146000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93337620|NCT03146000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93337621|NCT03146000|Analgesics|analgesics|mesh-ancestor
93337622|NCT03146000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337623|NCT03146000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337624|NCT03146000|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93337625|NCT03146000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93337626|NCT03146000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337627|NCT03146000|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93337628|NCT02346188|Ferrous fumarate|ferrous fumarate|mesh-list
93337629|NCT02346188|Zinc Oxide|zinc oxide|mesh-list
93337630|NCT02346188|Trace Elements|trace elements|mesh-ancestor
93337631|NCT02346188|Micronutrients|micronutrients|mesh-ancestor
93337632|NCT02346188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337633|NCT02346188|Dermatologic Agents|dermatologic agents|mesh-ancestor
93337634|NCT02346188|Sunscreening Agents|sunscreening agents|mesh-ancestor
93337635|NCT02346188|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93337636|NCT02346188|Protective Agents|protective agents|mesh-ancestor
93337637|NCT02477332|Omalizumab|omalizumab|mesh-list
93337638|NCT02477332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93337639|NCT02477332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93337640|NCT02477332|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337641|NCT02346110|Dexamethasone|dexamethasone|mesh-list
93337642|NCT02346110|Epinephrine|epinephrine|mesh-list
93337643|NCT02346110|Racepinephrine|racepinephrine|mesh-list
93337644|NCT02346110|Bupivacaine|bupivacaine|mesh-list
93337645|NCT02346110|Epinephryl borate|epinephryl borate|mesh-list
93337646|NCT02346110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337647|NCT02346110|Antiemetics|antiemetics|mesh-ancestor
93337648|NCT02346110|Autonomic Agents|autonomic agents|mesh-ancestor
93337649|NCT02346110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337650|NCT02346110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337651|NCT02346110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337652|NCT02346110|Glucocorticoids|glucocorticoids|mesh-ancestor
93337653|NCT02346110|Hormones|hormones|mesh-ancestor
93337654|NCT02346110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337655|NCT02346110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93009591|NCT02551133|Dexamethasone|dexamethasone|mesh-list
93337656|NCT02346110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337657|NCT02346110|Anesthetics, Local|anesthetics, local|mesh-ancestor
93337658|NCT02346110|Anesthetics|anesthetics|mesh-ancestor
93337659|NCT02346110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337660|NCT02346110|Sensory System Agents|sensory system agents|mesh-ancestor
93337661|NCT02346110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93337662|NCT02346110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93337663|NCT02346110|Adrenergic Agents|adrenergic agents|mesh-ancestor
93337664|NCT02346110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337665|NCT02346110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337666|NCT02346110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93337667|NCT02346110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93337668|NCT02346110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93337669|NCT02346110|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337670|NCT02346110|Mydriatics|mydriatics|mesh-ancestor
93337671|NCT02346110|Sympathomimetics|sympathomimetics|mesh-ancestor
93337672|NCT02346110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93337673|NCT02348528|Dexamethasone|dexamethasone|mesh-list
93337674|NCT02348528|Lenalidomide|lenalidomide|mesh-list
93337675|NCT02348528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337676|NCT02348528|Antiemetics|antiemetics|mesh-ancestor
93337677|NCT02348528|Autonomic Agents|autonomic agents|mesh-ancestor
93337678|NCT02348528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337679|NCT02348528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631453|NCT00555139|GABA Agents|gaba agents|mesh-ancestor
93337680|NCT02348528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337681|NCT02348528|Glucocorticoids|glucocorticoids|mesh-ancestor
93337682|NCT02348528|Hormones|hormones|mesh-ancestor
93337683|NCT02348528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337684|NCT02348528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337685|NCT02348528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337686|NCT02348528|Immunologic Factors|immunologic factors|mesh-ancestor
93337687|NCT02348528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93337688|NCT02348528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93337689|NCT02348528|Growth Substances|growth substances|mesh-ancestor
93337690|NCT02348528|Growth Inhibitors|growth inhibitors|mesh-ancestor
93337691|NCT02342600|Trametinib|trametinib|mesh-list
93337692|NCT02342600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337693|NCT02342600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93337694|NCT02342600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337695|NCT02342600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337696|NCT03147638|Warfarin|warfarin|mesh-list
93337697|NCT03147638|Anticoagulants|anticoagulants|mesh-ancestor
93337698|NCT02342366|Sodium Oxybate|sodium oxybate|mesh-list
93337699|NCT02342366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93337700|NCT02342366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93337701|NCT02342366|Anesthetics, General|anesthetics, general|mesh-ancestor
93337702|NCT02342366|Anesthetics|anesthetics|mesh-ancestor
93337703|NCT02342366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337704|NCT02342366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337705|NCT02862535|Oxaliplatin|oxaliplatin|mesh-list
93337706|NCT02862535|Nivolumab|nivolumab|mesh-list
93337707|NCT02862535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337708|NCT02862535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337709|NCT02862535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93337710|NCT02862535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337711|NCT02033707|Scopolamine|scopolamine|mesh-list
93337712|NCT02033707|Hallucinogens|hallucinogens|mesh-list
93337713|NCT02033707|Nicotine|nicotine|mesh-list
93337714|NCT02033707|Histamine Antagonists|histamine antagonists|mesh-list
93337715|NCT02033707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93337716|NCT02033707|Autonomic Agents|autonomic agents|mesh-ancestor
93337717|NCT02033707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337718|NCT02033707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337719|NCT02033707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93337720|NCT02033707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93337721|NCT02033707|Cholinergic Agents|cholinergic agents|mesh-ancestor
93337722|NCT02033707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337723|NCT02033707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337724|NCT02033707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93337725|NCT02033707|Antiemetics|antiemetics|mesh-ancestor
93337726|NCT02033707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337727|NCT02033707|Mydriatics|mydriatics|mesh-ancestor
93337728|NCT02033707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93337729|NCT02033707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93337730|NCT02033707|Histamine Agents|histamine agents|mesh-ancestor
93337731|NCT02033707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93337732|NCT02039336|Docetaxel|docetaxel|mesh-list
93337733|NCT02039336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337734|NCT02039336|Tubulin Modulators|tubulin modulators|mesh-ancestor
93337735|NCT02039336|Antimitotic Agents|antimitotic agents|mesh-ancestor
93337736|NCT02039336|Mitosis Modulators|mitosis modulators|mesh-ancestor
93337737|NCT02039336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337738|NCT04935476|Dapsone|dapsone|mesh-list
93337739|NCT04935476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337740|NCT04935476|Antimalarials|antimalarials|mesh-ancestor
93337741|NCT04935476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93337742|NCT04935476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93337743|NCT04935476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93337744|NCT04935476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337745|NCT04935476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337746|NCT04935476|Leprostatic Agents|leprostatic agents|mesh-ancestor
93337747|NCT04935476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93337748|NCT02476006|Atorvastatin|atorvastatin|mesh-list
93337749|NCT02476006|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93337750|NCT02476006|Simvastatin|simvastatin|mesh-list
93337751|NCT02476006|Ezetimibe|ezetimibe|mesh-list
93337752|NCT02476006|Alirocumab|alirocumab|mesh-list
93337753|NCT02476006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93337754|NCT02476006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93337755|NCT02476006|Antimetabolites|antimetabolites|mesh-ancestor
93337756|NCT02476006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337757|NCT02476006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93337758|NCT02476006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93337759|NCT02476006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337760|NCT02476006|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93337761|NCT02476006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93337762|NCT02476006|Protease Inhibitors|protease inhibitors|mesh-ancestor
93337763|NCT02344940|Tamoxifen|tamoxifen|mesh-list
93337764|NCT02344940|Toremifene|toremifene|mesh-list
93337765|NCT02344940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93337766|NCT02344940|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337767|NCT02344940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337768|NCT02344940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337769|NCT02344940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337770|NCT02344940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337771|NCT02344940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93337772|NCT02344940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93337773|NCT02344940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93337774|NCT03615677|Esomeprazole|esomeprazole|mesh-list
93337775|NCT03615677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93337776|NCT03615677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337777|NCT03615677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93337778|NCT03615677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337779|NCT03615677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337780|NCT02344862|Dotinurad|dotinurad|mesh-list
93337781|NCT02344862|Uricosuric Agents|uricosuric agents|mesh-ancestor
93337782|NCT02344862|Gout Suppressants|gout suppressants|mesh-ancestor
93337783|NCT02344862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93337784|NCT03614429|Chlorhexidine|chlorhexidine|mesh-list
93337785|NCT03614429|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93337786|NCT03614429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337787|NCT03614429|Disinfectants|disinfectants|mesh-ancestor
93337788|NCT03614273|Epinephrine|epinephrine|mesh-list
93337789|NCT03614273|Racepinephrine|racepinephrine|mesh-list
93337790|NCT03614273|Epinephryl borate|epinephryl borate|mesh-list
93337791|NCT03614273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93337792|NCT03614273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93337793|NCT03614273|Adrenergic Agents|adrenergic agents|mesh-ancestor
93337794|NCT03614273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337795|NCT03614273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337796|NCT03614273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337797|NCT03614273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93337798|NCT03614273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93337799|NCT03614273|Autonomic Agents|autonomic agents|mesh-ancestor
93337800|NCT03614273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337801|NCT03614273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93337802|NCT03614273|Respiratory System Agents|respiratory system agents|mesh-ancestor
93337803|NCT03614273|Mydriatics|mydriatics|mesh-ancestor
93337804|NCT03614273|Sympathomimetics|sympathomimetics|mesh-ancestor
93337805|NCT03614273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93337806|NCT02336984|Trastuzumab|trastuzumab|mesh-list
93337807|NCT02336984|Pertuzumab|pertuzumab|mesh-list
93337808|NCT02336984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93337809|NCT02336984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337810|NCT03145610|Triclosan|triclosan|mesh-list
93337811|NCT03145610|Fluorides|fluorides|mesh-list
93337812|NCT03145610|Cariostatic Agents|cariostatic agents|mesh-ancestor
93337813|NCT03145610|Protective Agents|protective agents|mesh-ancestor
93337814|NCT03145610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337815|NCT03145610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93337816|NCT03145610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337817|NCT03145610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93337818|NCT03145610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93337819|NCT03145610|Antimetabolites|antimetabolites|mesh-ancestor
93337820|NCT03145610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337821|NCT03145610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93337822|NCT02341586|Iron|iron|mesh-list
93337823|NCT02341586|Trace Elements|trace elements|mesh-ancestor
93337824|NCT02341586|Micronutrients|micronutrients|mesh-ancestor
93337825|NCT02341586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337826|NCT02336906|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93337827|NCT02336906|Laxatives|laxatives|mesh-ancestor
93337828|NCT02336906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337829|NCT03613961|Anesthetics|anesthetics|mesh-list
92631603|NCT00174239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337830|NCT03613961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337831|NCT03613961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337832|NCT02341352|Fluorides|fluorides|mesh-list
93337833|NCT02341352|Fluorides, Topical|fluorides, topical|mesh-list
93337834|NCT02341352|Immunoglobulins|immunoglobulins|mesh-list
93337835|NCT02341352|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93337836|NCT02341352|Antibodies|antibodies|mesh-list
93337837|NCT02341352|Cariostatic Agents|cariostatic agents|mesh-ancestor
93337838|NCT02341352|Protective Agents|protective agents|mesh-ancestor
93337839|NCT02341352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337840|NCT02341352|Immunologic Factors|immunologic factors|mesh-ancestor
93337841|NCT02344550|Everolimus|everolimus|mesh-list
93337842|NCT02344550|Letrozole|letrozole|mesh-list
93337843|NCT02344550|Leuprolide|leuprolide|mesh-list
93337844|NCT02344550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93337845|NCT02344550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93337846|NCT02344550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337847|NCT02344550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337848|NCT02344550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337849|NCT02344550|Immunologic Factors|immunologic factors|mesh-ancestor
93337850|NCT02344550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337851|NCT02344550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337852|NCT02344550|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93337853|NCT02344550|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93337854|NCT02344550|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93337855|NCT02344550|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337856|NCT02344550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337857|NCT02344550|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93337858|NCT02344550|Fertility Agents|fertility agents|mesh-ancestor
93337859|NCT02344550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93337860|NCT02344550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337861|NCT02419612|Dapagliflozin|dapagliflozin|mesh-list
93337862|NCT02419612|Glimepiride|glimepiride|mesh-list
93337863|NCT02419612|Saxagliptin|saxagliptin|mesh-list
93337864|NCT02419612|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93337865|NCT02419612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337866|NCT02419612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93337867|NCT02419612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337868|NCT02419612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93337869|NCT02419612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93337870|NCT02419612|Immunologic Factors|immunologic factors|mesh-ancestor
93337871|NCT02419612|Incretins|incretins|mesh-ancestor
93337872|NCT02419612|Hormones|hormones|mesh-ancestor
93337873|NCT02419612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337874|NCT02419612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93337875|NCT02419612|Protease Inhibitors|protease inhibitors|mesh-ancestor
93337876|NCT02419612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337877|NCT03612947|Magnesium Sulfate|magnesium sulfate|mesh-list
93337878|NCT03612947|Bupivacaine|bupivacaine|mesh-list
93337879|NCT03612947|Anesthetics, Local|anesthetics, local|mesh-ancestor
93337880|NCT03612947|Anesthetics|anesthetics|mesh-ancestor
93337881|NCT03612947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337882|NCT03612947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337883|NCT03612947|Sensory System Agents|sensory system agents|mesh-ancestor
93337884|NCT03612947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337885|NCT03612947|Analgesics|analgesics|mesh-ancestor
93337886|NCT03612947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93337887|NCT03612947|Anticonvulsants|anticonvulsants|mesh-ancestor
93337888|NCT03612947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93337889|NCT03612947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93337890|NCT03612947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337891|NCT03612947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93337892|NCT03612947|Tocolytic Agents|tocolytic agents|mesh-ancestor
93337893|NCT03612947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93337894|NCT02344784|Methylphenidate|methylphenidate|mesh-list
93337895|NCT02344784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93337896|NCT02344784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337897|NCT02344784|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93337898|NCT02344784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93337899|NCT02344784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92631677|NCT01718158|Ribavirin|ribavirin|mesh-list
93337900|NCT02344784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337901|NCT02344784|Dopamine Agents|dopamine agents|mesh-ancestor
93337902|NCT02344784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337903|NCT02447848|Sufentanil|sufentanil|mesh-list
93337904|NCT02447848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93337905|NCT02447848|Narcotics|narcotics|mesh-ancestor
93337906|NCT02447848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337907|NCT02447848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337908|NCT02447848|Analgesics|analgesics|mesh-ancestor
93337909|NCT02447848|Sensory System Agents|sensory system agents|mesh-ancestor
93337910|NCT02447848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337911|NCT02447848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93337912|NCT02447848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93337913|NCT02447848|Anesthetics, General|anesthetics, general|mesh-ancestor
93337914|NCT02447848|Anesthetics|anesthetics|mesh-ancestor
93337915|NCT02336516|Azithromycin|azithromycin|mesh-list
93337916|NCT02336516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93337917|NCT02336516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93337918|NCT05254652|Pregabalin|pregabalin|mesh-list
93337919|NCT05254652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93337920|NCT05254652|Analgesics|analgesics|mesh-ancestor
93337921|NCT05254652|Sensory System Agents|sensory system agents|mesh-ancestor
93337922|NCT05254652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337923|NCT05254652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337924|NCT05254652|Anticonvulsants|anticonvulsants|mesh-ancestor
93337925|NCT05254652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93337926|NCT05254652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93337927|NCT05254652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337928|NCT05254652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93337929|NCT05254652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93337930|NCT05254652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93337931|NCT05254652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337932|NCT05254652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93337933|NCT05254652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93337934|NCT05254652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93337935|NCT05254652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337936|NCT05254652|Antidepressive Agents|antidepressive agents|mesh-ancestor
93337937|NCT05254652|Dopamine Agents|dopamine agents|mesh-ancestor
93337938|NCT02343926|Metformin|metformin|mesh-list
93337939|NCT02343926|Vildagliptin|vildagliptin|mesh-list
93337940|NCT02343926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93337941|NCT02343926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337942|NCT02343926|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93337943|NCT02343926|Protease Inhibitors|protease inhibitors|mesh-ancestor
93337944|NCT02343926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93337945|NCT02343926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337946|NCT03112226|Estradiol|estradiol|mesh-list
93337947|NCT03112226|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
93337948|NCT03112226|Estrogens|estrogens|mesh-ancestor
93337949|NCT03112226|Hormones|hormones|mesh-ancestor
93337950|NCT03112226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337951|NCT03112226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337952|NCT03112226|Hormone Antagonists|hormone antagonists|mesh-ancestor
93337953|NCT02343692|Pancrelipase|pancrelipase|mesh-list
93337954|NCT02343692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337955|NCT02332616|Methylprednisolone|methylprednisolone|mesh-list
93337956|NCT02332616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93337957|NCT02332616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93009892|NCT01026597|Alirocumab|alirocumab|mesh-list
93337959|NCT02332616|Prednisolone acetate|prednisolone acetate|mesh-list
93337960|NCT02332616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93337961|NCT02332616|Prednisolone phosphate|prednisolone phosphate|mesh-list
93337962|NCT02332616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337963|NCT02332616|Antiemetics|antiemetics|mesh-ancestor
93337964|NCT02332616|Autonomic Agents|autonomic agents|mesh-ancestor
93337965|NCT02332616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337966|NCT02332616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337967|NCT02332616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337968|NCT02332616|Glucocorticoids|glucocorticoids|mesh-ancestor
93337969|NCT02332616|Hormones|hormones|mesh-ancestor
93337970|NCT02332616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93337971|NCT02332616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93337972|NCT02332616|Protective Agents|protective agents|mesh-ancestor
93337973|NCT02332616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93337974|NCT02332616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93337975|NCT03345173|Ketamine|ketamine|mesh-list
93337976|NCT03345173|Analgesics|analgesics|mesh-ancestor
93337977|NCT03345173|Sensory System Agents|sensory system agents|mesh-ancestor
93337978|NCT03345173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337979|NCT03345173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337980|NCT03345173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93337981|NCT03345173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93337982|NCT03345173|Anesthetics, General|anesthetics, general|mesh-ancestor
93337983|NCT03345173|Anesthetics|anesthetics|mesh-ancestor
93337984|NCT03345173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93337985|NCT03345173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93337986|NCT03345173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93337987|NCT03345173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93337988|NCT03345173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93337989|NCT03618173|Dexamethasone|dexamethasone|mesh-list
93337990|NCT03618173|Dexamethasone acetate|dexamethasone acetate|mesh-list
93337991|NCT03618173|BB 1101|bb 1101|mesh-list
93337992|NCT03618173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93337993|NCT03618173|Antiemetics|antiemetics|mesh-ancestor
93337994|NCT03618173|Autonomic Agents|autonomic agents|mesh-ancestor
93337995|NCT03618173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93337996|NCT03618173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93337997|NCT03618173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93337998|NCT03618173|Glucocorticoids|glucocorticoids|mesh-ancestor
93337999|NCT03618173|Hormones|hormones|mesh-ancestor
93338000|NCT03618173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338001|NCT03618173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93338002|NCT03618173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338003|NCT03618173|Protease Inhibitors|protease inhibitors|mesh-ancestor
93338004|NCT03618173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338005|NCT03618173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338006|NCT02336048|Obinutuzumab|obinutuzumab|mesh-list
93338007|NCT02336048|Chlorambucil|chlorambucil|mesh-list
93338008|NCT02336048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338009|NCT02336048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338010|NCT02336048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93338011|NCT02336048|Alkylating Agents|alkylating agents|mesh-ancestor
93338012|NCT02336048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338013|NCT03612401|Mirabegron|mirabegron|mesh-list
93338014|NCT03612401|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93338015|NCT03612401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93338016|NCT03612401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338017|NCT03612401|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338018|NCT03612401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338019|NCT03612401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338020|NCT03612401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338021|NCT03612401|Urological Agents|urological agents|mesh-ancestor
93338022|NCT03612323|Piroxicam|piroxicam|mesh-list
93338023|NCT03612323|Carticaine|carticaine|mesh-list
93338024|NCT03612323|Anesthetics, Local|anesthetics, local|mesh-ancestor
93338025|NCT03612323|Anesthetics|anesthetics|mesh-ancestor
93338026|NCT03612323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338027|NCT03612323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338028|NCT03612323|Sensory System Agents|sensory system agents|mesh-ancestor
93338029|NCT03612323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009963|NCT00458211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93338030|NCT03612323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93338031|NCT03612323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338033|NCT03612323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338034|NCT03612323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338035|NCT03612323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93338036|NCT03612323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338037|NCT03612323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338038|NCT02994719|Amantadine|amantadine|mesh-list
93338039|NCT02994719|Levodopa|levodopa|mesh-list
93338040|NCT02994719|Carbidopa|carbidopa|mesh-list
93338041|NCT02994719|Pramipexole|pramipexole|mesh-list
93338042|NCT02994719|Ropinirole|ropinirole|mesh-list
93338043|NCT02994719|Entacapone|entacapone|mesh-list
93338044|NCT02994719|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93338045|NCT02994719|Tolcapone|tolcapone|mesh-list
93338046|NCT02994719|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93338047|NCT02994719|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93338048|NCT02994719|Dopamine Agents|dopamine agents|mesh-ancestor
93338049|NCT02994719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338050|NCT02994719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338051|NCT02994719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338052|NCT02994719|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93338053|NCT02994719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338054|NCT02994719|Antioxidants|antioxidants|mesh-ancestor
93338055|NCT02994719|Protective Agents|protective agents|mesh-ancestor
93338056|NCT02994719|Dopamine Agonists|dopamine agonists|mesh-ancestor
93338057|NCT02994719|Antiviral Agents|antiviral agents|mesh-ancestor
93338058|NCT02994719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338059|NCT02994719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338060|NCT02994719|Analgesics|analgesics|mesh-ancestor
93338061|NCT02994719|Sensory System Agents|sensory system agents|mesh-ancestor
93338062|NCT02994719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338063|NCT02994719|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93338064|NCT02994719|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93338065|NCT02994719|Immunologic Factors|immunologic factors|mesh-ancestor
93338066|NCT04356638|Midazolam|midazolam|mesh-list
93338067|NCT04356638|Dexmedetomidine|dexmedetomidine|mesh-list
93338068|NCT04356638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93338069|NCT04356638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338070|NCT04356638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338071|NCT04356638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338072|NCT04356638|Analgesics|analgesics|mesh-ancestor
93338073|NCT04356638|Sensory System Agents|sensory system agents|mesh-ancestor
93338074|NCT04356638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338075|NCT04356638|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93338076|NCT04356638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93338077|NCT04356638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338078|NCT04356638|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338079|NCT04356638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338080|NCT04356638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338081|NCT04356638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93338082|NCT04356638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93338083|NCT04356638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93338084|NCT04356638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93338085|NCT04356638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93338086|NCT04356638|Anesthetics, General|anesthetics, general|mesh-ancestor
93338087|NCT04356638|Anesthetics|anesthetics|mesh-ancestor
93338088|NCT04356638|GABA Modulators|gaba modulators|mesh-ancestor
93338089|NCT04356638|GABA Agents|gaba agents|mesh-ancestor
93338090|NCT04346108|Immunoglobulins|immunoglobulins|mesh-list
93338091|NCT04346108|Antibodies|antibodies|mesh-list
93338092|NCT04346108|gamma-Globulins|gamma-globulins|mesh-list
93338093|NCT04346108|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93338094|NCT04346108|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93338095|NCT04346108|Immunoglobulin G|immunoglobulin g|mesh-list
93338096|NCT04346108|Immunologic Factors|immunologic factors|mesh-ancestor
93338097|NCT04346108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338098|NCT02335736|Cetrorelix|cetrorelix|mesh-list
93338099|NCT02335736|Hormones|hormones|mesh-list
93338100|NCT02335736|Hormone Antagonists|hormone antagonists|mesh-list
93338101|NCT02335736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338102|NCT02335736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338103|NCT02335736|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93338104|NCT02335736|Fertility Agents|fertility agents|mesh-ancestor
93338105|NCT02335736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93010041|NCT00815399|Metformin|metformin|mesh-list
93338106|NCT03613259|Alovudine|alovudine|mesh-list
93338107|NCT03613259|Antiviral Agents|antiviral agents|mesh-ancestor
92357061|NCT00262470|Modafinil|modafinil|mesh-list
93338108|NCT03613259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338109|NCT02032355|Anesthetics|anesthetics|mesh-list
93338110|NCT02032355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338111|NCT02032355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338112|NCT03095456|Tiotropium Bromide|tiotropium bromide|mesh-list
93338113|NCT03095456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93338114|NCT03095456|Autonomic Agents|autonomic agents|mesh-ancestor
93338115|NCT03095456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338116|NCT03095456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338117|NCT03095456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338118|NCT03095456|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338119|NCT03095456|Parasympatholytics|parasympatholytics|mesh-ancestor
93338120|NCT03095456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93338121|NCT03095456|Cholinergic Agents|cholinergic agents|mesh-ancestor
93338122|NCT03095456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338123|NCT03095456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338124|NCT03612557|Penicillins|penicillins|mesh-list
93338125|NCT03612557|Penicillin G|penicillin g|mesh-list
93338126|NCT03612557|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93338127|NCT03612557|Penicillin G Procaine|penicillin g procaine|mesh-list
93338128|NCT03612557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93338129|NCT03612557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338131|NCT03067844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93338132|NCT03067844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93338133|NCT03067844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93338134|NCT03067844|Antimetabolites|antimetabolites|mesh-ancestor
93338135|NCT03067844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338136|NCT03067844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93338137|NCT03067844|Protease Inhibitors|protease inhibitors|mesh-ancestor
93338138|NCT03067844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338139|NCT03067844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93338140|NCT02340182|Metronidazole|metronidazole|mesh-list
93338141|NCT02340182|Vancomycin|vancomycin|mesh-list
93338142|NCT02340182|Ciprofloxacin|ciprofloxacin|mesh-list
93338143|NCT02340182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338144|NCT02340182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93338145|NCT02340182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93338146|NCT02340182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93338147|NCT02340182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93338148|NCT02340182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93338149|NCT02340182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338150|NCT02340182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338151|NCT02340182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338152|NCT02340182|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93338153|NCT02340182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93338154|NCT02339714|Loratadine|loratadine|mesh-list
93338155|NCT02339714|Antipruritics|antipruritics|mesh-ancestor
93338156|NCT02339714|Dermatologic Agents|dermatologic agents|mesh-ancestor
93338157|NCT02339714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93338158|NCT02339714|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93338159|NCT02339714|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93338160|NCT02339714|Histamine Antagonists|histamine antagonists|mesh-ancestor
93338161|NCT02339714|Histamine Agents|histamine agents|mesh-ancestor
93338162|NCT02339714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338163|NCT02339714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338164|NCT02339714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338165|NCT02335190|Lidocaine|lidocaine|mesh-list
93338166|NCT02335190|Anesthetics, Local|anesthetics, local|mesh-ancestor
93338167|NCT02335190|Anesthetics|anesthetics|mesh-ancestor
93338168|NCT02335190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338169|NCT02335190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338170|NCT02335190|Sensory System Agents|sensory system agents|mesh-ancestor
93338171|NCT02335190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338172|NCT02335190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93338173|NCT02335190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93338174|NCT02335190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93338175|NCT02335190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93338176|NCT02335190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338177|NCT02339324|Interferons|interferons|mesh-list
93338178|NCT02339324|Interferon-alpha|interferon-alpha|mesh-list
93338179|NCT02339324|Interferon alpha-2|interferon alpha-2|mesh-list
93338180|NCT02339324|Pembrolizumab|pembrolizumab|mesh-list
93338181|NCT02339324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010118|NCT00647699|Riboflavin|riboflavin|mesh-list
93338182|NCT02339324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338183|NCT02339324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93338184|NCT02339324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338185|NCT02339324|Antiviral Agents|antiviral agents|mesh-ancestor
93338186|NCT02339324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338187|NCT02339324|Immunologic Factors|immunologic factors|mesh-ancestor
93338188|NCT02339324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338189|NCT02418754|Aflibercept|aflibercept|mesh-list
93338190|NCT02418754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93338191|NCT02418754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93338192|NCT02418754|Growth Substances|growth substances|mesh-ancestor
93338193|NCT02418754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338194|NCT02418754|Growth Inhibitors|growth inhibitors|mesh-ancestor
93338195|NCT02418754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338196|NCT02334488|Mycophenolic Acid|mycophenolic acid|mesh-list
93338197|NCT02334488|Everolimus|everolimus|mesh-list
93338198|NCT02334488|Tacrolimus|tacrolimus|mesh-list
93338199|NCT02334488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93338200|NCT02334488|Immunologic Factors|immunologic factors|mesh-ancestor
93338201|NCT02334488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338202|NCT02334488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93338203|NCT02334488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338204|NCT02334488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338205|NCT02334488|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93338206|NCT02334488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93338207|NCT02334488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338208|NCT02334488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93338209|NCT02334488|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93338210|NCT02334488|Antitubercular Agents|antitubercular agents|mesh-ancestor
93338211|NCT02334488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93338212|NCT02334488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338213|NCT02862457|Paclitaxel|paclitaxel|mesh-list
93338214|NCT02862457|Cisplatin|cisplatin|mesh-list
93338215|NCT02862457|Carboplatin|carboplatin|mesh-list
93338216|NCT02862457|Pembrolizumab|pembrolizumab|mesh-list
93338217|NCT02862457|Pemetrexed|pemetrexed|mesh-list
93338218|NCT02862457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93338219|NCT02862457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338220|NCT02862457|Tubulin Modulators|tubulin modulators|mesh-ancestor
93338221|NCT02862457|Antimitotic Agents|antimitotic agents|mesh-ancestor
93338222|NCT02862457|Mitosis Modulators|mitosis modulators|mesh-ancestor
93338223|NCT02862457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338224|NCT02862457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338225|NCT02862457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93338226|NCT02862457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338227|NCT02862457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93338228|NCT02862457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93338229|NCT02334254|Warfarin|warfarin|mesh-list
93338230|NCT02334254|Rivaroxaban|rivaroxaban|mesh-list
93338231|NCT02334254|Clopidogrel|clopidogrel|mesh-list
93338232|NCT02334254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93338233|NCT02334254|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93338234|NCT02334254|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93338235|NCT02334254|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93338236|NCT02334254|Purinergic Agents|purinergic agents|mesh-ancestor
93338237|NCT02334254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338238|NCT02334254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338239|NCT02334254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338240|NCT02334254|Anticoagulants|anticoagulants|mesh-ancestor
93338241|NCT02334254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93338242|NCT02334254|Antithrombins|antithrombins|mesh-ancestor
93338243|NCT02334254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93338244|NCT02334254|Protease Inhibitors|protease inhibitors|mesh-ancestor
93338245|NCT02334254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338246|NCT02331602|Rivaroxaban|rivaroxaban|mesh-list
93338247|NCT02331602|Dabigatran|dabigatran|mesh-list
93338248|NCT02331602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93338249|NCT02331602|Antithrombins|antithrombins|mesh-ancestor
93338250|NCT02331602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93338251|NCT02331602|Protease Inhibitors|protease inhibitors|mesh-ancestor
93338252|NCT02331602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338253|NCT02331602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338254|NCT02331602|Anticoagulants|anticoagulants|mesh-ancestor
93338255|NCT02338934|Vitamin D|vitamin d|mesh-list
93338256|NCT02338934|Cinacalcet|cinacalcet|mesh-list
93338257|NCT02338934|Vitamins|vitamins|mesh-ancestor
93338258|NCT02338934|Micronutrients|micronutrients|mesh-ancestor
93338259|NCT02338934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338260|NCT02338934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93338261|NCT02338934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93338262|NCT02338934|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93338263|NCT02338934|Hormone Antagonists|hormone antagonists|mesh-ancestor
93338264|NCT02338934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338266|NCT03861039|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93338267|NCT03861039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338268|NCT03861039|Incretins|incretins|mesh-ancestor
93338269|NCT03861039|Hormones|hormones|mesh-ancestor
93338270|NCT03861039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338271|NCT02334176|Lidocaine|lidocaine|mesh-list
93338272|NCT02334176|Epinephrine|epinephrine|mesh-list
93338273|NCT02334176|Anesthetics, Local|anesthetics, local|mesh-ancestor
93338274|NCT02334176|Anesthetics|anesthetics|mesh-ancestor
93338275|NCT02334176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338276|NCT02334176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338277|NCT02334176|Sensory System Agents|sensory system agents|mesh-ancestor
93338278|NCT02334176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338279|NCT02334176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93338280|NCT02334176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93338281|NCT02334176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93338282|NCT02334176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93338283|NCT02334176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338284|NCT02334176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93338285|NCT02334176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338286|NCT02334176|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338287|NCT02334176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338288|NCT02334176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93338289|NCT02334176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93338290|NCT02334176|Autonomic Agents|autonomic agents|mesh-ancestor
93338291|NCT02334176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338292|NCT02334176|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338293|NCT02334176|Mydriatics|mydriatics|mesh-ancestor
93338294|NCT02334176|Sympathomimetics|sympathomimetics|mesh-ancestor
93338295|NCT02334176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93338296|NCT02338856|Beta-lapachone|beta-lapachone|mesh-list
93338297|NCT02338856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338298|NCT02338856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93338299|NCT02338856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93338300|NCT02338856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338301|NCT02338856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338302|NCT02338856|Antiviral Agents|antiviral agents|mesh-ancestor
93338303|NCT03609307|Bevacizumab|bevacizumab|mesh-list
93338304|NCT03609307|Propranolol|propranolol|mesh-list
93338305|NCT03609307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338306|NCT03609307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338307|NCT03609307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93338308|NCT03609307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93338309|NCT03609307|Growth Substances|growth substances|mesh-ancestor
93338310|NCT03609307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338311|NCT03609307|Growth Inhibitors|growth inhibitors|mesh-ancestor
93338312|NCT03609307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93338313|NCT03609307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93338314|NCT03609307|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338315|NCT03609307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338316|NCT03609307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338317|NCT03609307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93338318|NCT03609307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93338319|NCT03609307|Vasodilator Agents|vasodilator agents|mesh-ancestor
93338320|NCT03399435|Epinephrine|epinephrine|mesh-list
93338321|NCT03399435|Racepinephrine|racepinephrine|mesh-list
93338322|NCT03399435|Bupivacaine|bupivacaine|mesh-list
93338323|NCT03399435|Epinephryl borate|epinephryl borate|mesh-list
93338324|NCT03399435|Neosaxitoxin|neosaxitoxin|mesh-list
93338325|NCT03399435|Anesthetics, Local|anesthetics, local|mesh-ancestor
93338326|NCT03399435|Anesthetics|anesthetics|mesh-ancestor
93338327|NCT03399435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338328|NCT03399435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338329|NCT03399435|Sensory System Agents|sensory system agents|mesh-ancestor
93338330|NCT03399435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338331|NCT03399435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93010271|NCT01022229|Vitamins|vitamins|mesh-list
93338333|NCT03399435|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338334|NCT03399435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338335|NCT03399435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338336|NCT03399435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93338337|NCT03399435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93338338|NCT03399435|Autonomic Agents|autonomic agents|mesh-ancestor
93338339|NCT03399435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338340|NCT03399435|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338341|NCT03399435|Mydriatics|mydriatics|mesh-ancestor
93338342|NCT03399435|Sympathomimetics|sympathomimetics|mesh-ancestor
93338343|NCT03399435|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93338344|NCT03399435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93338345|NCT03399435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93338346|NCT01936688|Etanercept|etanercept|mesh-list
93338347|NCT01936688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93338348|NCT01936688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338349|NCT01936688|Analgesics|analgesics|mesh-ancestor
93338350|NCT01936688|Sensory System Agents|sensory system agents|mesh-ancestor
93338351|NCT01936688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338352|NCT01936688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338353|NCT01936688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338354|NCT01936688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338355|NCT01936688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93338356|NCT01936688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93338357|NCT01936688|Immunologic Factors|immunologic factors|mesh-ancestor
93338358|NCT02338544|Adapalene|adapalene|mesh-list
93338359|NCT02338544|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93338360|NCT02338544|Dermatologic Agents|dermatologic agents|mesh-ancestor
93338361|NCT02338544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93338362|NCT02338544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338363|NCT02338544|Analgesics|analgesics|mesh-ancestor
93338364|NCT02338544|Sensory System Agents|sensory system agents|mesh-ancestor
93338365|NCT02338544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338366|NCT02338544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338367|NCT02338544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338368|NCT02338544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338369|NCT04446663|Paclitaxel|paclitaxel|mesh-list
93338370|NCT04446663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93338371|NCT04446663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93338372|NCT04446663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338373|NCT04446663|Tubulin Modulators|tubulin modulators|mesh-ancestor
93338374|NCT04446663|Antimitotic Agents|antimitotic agents|mesh-ancestor
93338375|NCT04446663|Mitosis Modulators|mitosis modulators|mesh-ancestor
93338376|NCT04446663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338377|NCT01861496|Cisplatin|cisplatin|mesh-list
93338378|NCT01861496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338379|NCT02520219|Endostar protein|endostar protein|mesh-list
93338380|NCT02520219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93338381|NCT02520219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93338382|NCT02520219|Growth Substances|growth substances|mesh-ancestor
93338383|NCT02520219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338384|NCT02520219|Growth Inhibitors|growth inhibitors|mesh-ancestor
93338385|NCT02520219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338386|NCT03394287|Apatinib|apatinib|mesh-list
93338387|NCT03394287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338388|NCT03394287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93338389|NCT03394287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338390|NCT03394287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338391|NCT02338622|Olaparib|olaparib|mesh-list
93338392|NCT02338622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93338393|NCT02338622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338394|NCT02338622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338395|NCT02338622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338396|NCT02338466|Tenecteplase|tenecteplase|mesh-list
93338397|NCT02338466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93338398|NCT02338466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93338399|NCT02338466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338400|NCT03394209|Oseltamivir|oseltamivir|mesh-list
93338401|NCT03394209|Favipiravir|favipiravir|mesh-list
93338402|NCT03394209|Antiviral Agents|antiviral agents|mesh-ancestor
93338403|NCT03394209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338404|NCT03394209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338405|NCT03394209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338406|NCT03399201|Anesthetics|anesthetics|mesh-list
93338407|NCT03399201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338408|NCT03399201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338409|NCT02520453|Durvalumab|durvalumab|mesh-list
93338410|NCT02520453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338411|NCT02520453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338412|NCT03389763|Remifentanil|remifentanil|mesh-list
93338413|NCT03389763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93338414|NCT03389763|Narcotics|narcotics|mesh-ancestor
93338415|NCT03389763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338416|NCT03389763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338417|NCT03389763|Analgesics|analgesics|mesh-ancestor
93338418|NCT03389763|Sensory System Agents|sensory system agents|mesh-ancestor
93338419|NCT03389763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338420|NCT02866175|Vitamin K|vitamin k|mesh-list
93338421|NCT02866175|Edoxaban|edoxaban|mesh-list
93338422|NCT02866175|Clopidogrel|clopidogrel|mesh-list
93338423|NCT02866175|Ticagrelor|ticagrelor|mesh-list
93338424|NCT02866175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93338425|NCT02866175|Vitamins|vitamins|mesh-ancestor
93338426|NCT02866175|Micronutrients|micronutrients|mesh-ancestor
93338427|NCT02866175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338428|NCT02866175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93338429|NCT02866175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93338430|NCT02866175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93338431|NCT02866175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93338432|NCT02866175|Purinergic Agents|purinergic agents|mesh-ancestor
93338433|NCT02866175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338434|NCT02866175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338435|NCT02866175|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93338436|NCT02866175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93338437|NCT02866175|Hemostatics|hemostatics|mesh-ancestor
93338438|NCT02866175|Coagulants|coagulants|mesh-ancestor
93338439|NCT02866175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93338440|NCT02866175|Antithrombins|antithrombins|mesh-ancestor
93338441|NCT02866175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93338442|NCT02866175|Protease Inhibitors|protease inhibitors|mesh-ancestor
93338443|NCT02866175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338444|NCT02866175|Anticoagulants|anticoagulants|mesh-ancestor
93338445|NCT02330822|Hyaluronic Acid|hyaluronic acid|mesh-list
93338446|NCT02330822|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93338447|NCT02330822|Immunologic Factors|immunologic factors|mesh-ancestor
93338448|NCT02330822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338449|NCT02330822|Viscosupplements|viscosupplements|mesh-ancestor
93338450|NCT02330822|Protective Agents|protective agents|mesh-ancestor
93338451|NCT02338310|Letrozole|letrozole|mesh-list
93338452|NCT02338310|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93338453|NCT02338310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632232|NCT00175643|Imiquimod|imiquimod|mesh-list
93338454|NCT02338310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93338455|NCT02338310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338456|NCT02338310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338457|NCT02338310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93338458|NCT02338310|Hormone Antagonists|hormone antagonists|mesh-ancestor
93338459|NCT02338310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338460|NCT02338310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338461|NCT03389607|Anesthetics|anesthetics|mesh-list
93338462|NCT03389607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338463|NCT03389607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338464|NCT02817789|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
93338465|NCT02817789|Clopidogrel|clopidogrel|mesh-list
93338466|NCT02817789|Ticagrelor|ticagrelor|mesh-list
93338467|NCT02817789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93338468|NCT02817789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93338469|NCT02817789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93338470|NCT02817789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93338471|NCT02817789|Purinergic Agents|purinergic agents|mesh-ancestor
93338472|NCT02817789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338473|NCT02817789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338474|NCT02817789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338475|NCT02817789|Analgesics|analgesics|mesh-ancestor
93338476|NCT02817789|Sensory System Agents|sensory system agents|mesh-ancestor
93338477|NCT02817789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338478|NCT02817789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93338479|NCT02817789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338480|NCT02817789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338481|NCT02817789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338482|NCT02817789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93338483|NCT02817789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338484|NCT05383625|Vaccines|vaccines|mesh-list
93338485|NCT05383625|Immunologic Factors|immunologic factors|mesh-ancestor
93338486|NCT05383625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338487|NCT02926859|Cannabidiol|cannabidiol|mesh-list
93338488|NCT02926859|Anticonvulsants|anticonvulsants|mesh-ancestor
93338489|NCT03389451|Edetic Acid|edetic acid|mesh-list
93338490|NCT03389451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93338491|NCT03389451|Chelating Agents|chelating agents|mesh-ancestor
93338492|NCT03389451|Sequestering Agents|sequestering agents|mesh-ancestor
93338493|NCT03389451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338494|NCT03389451|Anticoagulants|anticoagulants|mesh-ancestor
93338495|NCT03389451|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93338496|NCT03389451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93338497|NCT03385395|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93338498|NCT03385395|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93338499|NCT03385395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93338500|NCT03385395|Protease Inhibitors|protease inhibitors|mesh-ancestor
93338501|NCT03385395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338502|NCT03385395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338503|NCT02330120|Dexmedetomidine|dexmedetomidine|mesh-list
93338504|NCT02330120|Propofol|propofol|mesh-list
93338505|NCT02330120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93338506|NCT02330120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338507|NCT02330120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338508|NCT02330120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338509|NCT02330120|Analgesics|analgesics|mesh-ancestor
93338510|NCT02330120|Sensory System Agents|sensory system agents|mesh-ancestor
93338511|NCT02330120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338512|NCT02330120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93338513|NCT02330120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93338514|NCT02330120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338515|NCT02330120|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338516|NCT02330120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338517|NCT02330120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338518|NCT02330120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93338519|NCT02330120|Anesthetics, General|anesthetics, general|mesh-ancestor
93338520|NCT02330120|Anesthetics|anesthetics|mesh-ancestor
93338521|NCT03389295|Cisplatin|cisplatin|mesh-list
93338522|NCT03389295|Docetaxel|docetaxel|mesh-list
93338523|NCT03389295|Fluorouracil|fluorouracil|mesh-list
93338524|NCT03389295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338525|NCT03389295|Tubulin Modulators|tubulin modulators|mesh-ancestor
93338526|NCT03389295|Antimitotic Agents|antimitotic agents|mesh-ancestor
93338527|NCT03389295|Mitosis Modulators|mitosis modulators|mesh-ancestor
93338528|NCT03389295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338529|NCT03389295|Antimetabolites|antimetabolites|mesh-ancestor
93338530|NCT03389295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93338531|NCT03389295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93338532|NCT03389295|Immunologic Factors|immunologic factors|mesh-ancestor
93338533|NCT03389295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338534|NCT03727880|Pembrolizumab|pembrolizumab|mesh-list
93338535|NCT03727880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338536|NCT03727880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338537|NCT03727880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93338538|NCT03727880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338539|NCT03398811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93338540|NCT03398811|Etonogestrel|etonogestrel|mesh-list
93338541|NCT03398811|Desogestrel|desogestrel|mesh-list
93338542|NCT03398811|Medroxyprogesterone|medroxyprogesterone|mesh-list
93338543|NCT03398811|Progesterone|progesterone|mesh-list
93338544|NCT03398811|Progestins|progestins|mesh-ancestor
93338545|NCT03398811|Hormones|hormones|mesh-ancestor
93338546|NCT03398811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338547|NCT03398811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338548|NCT03398811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93338549|NCT03398811|Contraceptive Agents|contraceptive agents|mesh-ancestor
93338550|NCT03398811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93338551|NCT03398811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93338552|NCT03398811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93338553|NCT03398811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93338554|NCT03398811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93338555|NCT03398811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93338556|NCT03398811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93338557|NCT03398811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338558|NCT01300143|Chlorotrianisene|chlorotrianisene|mesh-list
93338559|NCT01300143|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93338560|NCT01300143|Estrogens|estrogens|mesh-ancestor
93338561|NCT01300143|Hormones|hormones|mesh-ancestor
93338562|NCT01300143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338563|NCT01300143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338564|NCT01300143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93338565|NCT01300143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338566|NCT01336205|Naloxegol|naloxegol|mesh-list
93338567|NCT01336205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93338568|NCT01336205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338569|NCT01336205|Sensory System Agents|sensory system agents|mesh-ancestor
93338570|NCT01336205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338571|NCT02333240|Antihypertensive Agents|antihypertensive agents|mesh-list
93338572|NCT03610685|Prednisolone|prednisolone|mesh-list
93338573|NCT03610685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338574|NCT03610685|Glucocorticoids|glucocorticoids|mesh-ancestor
93338575|NCT03610685|Hormones|hormones|mesh-ancestor
93338576|NCT03610685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338577|NCT03610685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338578|NCT03610685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93338579|NCT03610685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338580|NCT02327234|Ibuprofen|ibuprofen|mesh-list
93338581|NCT02327234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93338582|NCT02327234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338583|NCT02327234|Analgesics|analgesics|mesh-ancestor
93338584|NCT02327234|Sensory System Agents|sensory system agents|mesh-ancestor
93338585|NCT02327234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338586|NCT02327234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338587|NCT02327234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338588|NCT02327234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338589|NCT02327234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93338590|NCT02327234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338591|NCT02327234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338592|NCT01123707|Aripiprazole|aripiprazole|mesh-list
93338593|NCT01123707|Escitalopram|escitalopram|mesh-list
93338594|NCT01123707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93338595|NCT01123707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93338596|NCT01123707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93338597|NCT01123707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338598|NCT01123707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338599|NCT01123707|Serotonin Agents|serotonin agents|mesh-ancestor
93338600|NCT01123707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338601|NCT01123707|Antidepressive Agents|antidepressive agents|mesh-ancestor
93338602|NCT01123707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93338603|NCT01123707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93338604|NCT01123707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93338605|NCT01123707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338606|NCT01123707|Dopamine Agonists|dopamine agonists|mesh-ancestor
93338607|NCT01123707|Dopamine Agents|dopamine agents|mesh-ancestor
93338608|NCT01123707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93338609|NCT01123707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93338610|NCT01123707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93338611|NCT01123707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93338612|NCT01123707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93338613|NCT01123707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93338614|NCT01258803|Mometasone Furoate|mometasone furoate|mesh-list
93338615|NCT01258803|Formoterol Fumarate|formoterol fumarate|mesh-list
93338616|NCT01258803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93338617|NCT01258803|Autonomic Agents|autonomic agents|mesh-ancestor
93338618|NCT01258803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338619|NCT01258803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338620|NCT01258803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338621|NCT01258803|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338622|NCT01258803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93338623|NCT01258803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93338624|NCT01258803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338625|NCT01258803|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338626|NCT01258803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338627|NCT01258803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338628|NCT01258803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338629|NCT01258803|Dermatologic Agents|dermatologic agents|mesh-ancestor
93338630|NCT01258803|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93338631|NCT02327156|Dexmedetomidine|dexmedetomidine|mesh-list
93338632|NCT02327156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93338633|NCT02327156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338634|NCT02327156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338635|NCT02327156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338636|NCT02327156|Analgesics|analgesics|mesh-ancestor
93338637|NCT02327156|Sensory System Agents|sensory system agents|mesh-ancestor
93338638|NCT02327156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338639|NCT02327156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93338640|NCT02327156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93338641|NCT02327156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93338642|NCT02327156|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338643|NCT02327156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338644|NCT02327156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338645|NCT02039804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93338646|NCT02039804|Hyaluronic Acid|hyaluronic acid|mesh-list
93338647|NCT02039804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93338648|NCT02039804|Immunologic Factors|immunologic factors|mesh-ancestor
93338649|NCT02039804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338650|NCT02039804|Viscosupplements|viscosupplements|mesh-ancestor
93338651|NCT02039804|Protective Agents|protective agents|mesh-ancestor
93338652|NCT02039804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338653|NCT03385161|Ethanol|ethanol|mesh-list
93338654|NCT03385161|Botulinum Toxins|botulinum toxins|mesh-list
93338655|NCT03385161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93338656|NCT03385161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93338657|NCT03385161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93338658|NCT03385161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93338659|NCT03385161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338660|NCT03385161|Cholinergic Agents|cholinergic agents|mesh-ancestor
93338661|NCT03385161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338662|NCT03385161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338663|NCT03385161|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93338664|NCT03385161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338665|NCT03385161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338666|NCT03385161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93338667|NCT03385161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338668|NCT02327000|Pregabalin|pregabalin|mesh-list
93338669|NCT02327000|Analgesics|analgesics|mesh-ancestor
93338670|NCT02327000|Sensory System Agents|sensory system agents|mesh-ancestor
93338671|NCT02327000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338672|NCT02327000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338673|NCT02327000|Anticonvulsants|anticonvulsants|mesh-ancestor
93338674|NCT02327000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93338675|NCT02327000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93338676|NCT02327000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338677|NCT02327000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93338678|NCT02327000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93338679|NCT02327000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93338680|NCT02327000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338681|NCT02327000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93338682|NCT02033603|Ropivacaine|ropivacaine|mesh-list
93338683|NCT02033603|Anesthetics, Local|anesthetics, local|mesh-ancestor
93338684|NCT02033603|Anesthetics|anesthetics|mesh-ancestor
93338685|NCT02033603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338686|NCT02033603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338687|NCT02033603|Sensory System Agents|sensory system agents|mesh-ancestor
93338688|NCT02033603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338689|NCT02326922|Levonorgestrel|levonorgestrel|mesh-list
93338690|NCT02326922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93338691|NCT02326922|Contraceptive Agents|contraceptive agents|mesh-ancestor
93338692|NCT02326922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93338693|NCT02326922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338694|NCT02326922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93338695|NCT02326922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93338696|NCT02326922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93338697|NCT00862251|Atorvastatin|atorvastatin|mesh-list
93338698|NCT00862251|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93338699|NCT00862251|Simvastatin|simvastatin|mesh-list
93338700|NCT00862251|Ezetimibe|ezetimibe|mesh-list
93338701|NCT00862251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93338702|NCT00862251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93338703|NCT00862251|Antimetabolites|antimetabolites|mesh-ancestor
93338704|NCT00862251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338705|NCT00862251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93338706|NCT00862251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93338707|NCT00862251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338708|NCT00885963|Sapacitabine|sapacitabine|mesh-list
93338709|NCT00885963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338710|NCT00725127|Aspirin|aspirin|mesh-list
93338711|NCT00725127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93338712|NCT00725127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93338713|NCT00725127|Analgesics|analgesics|mesh-ancestor
93338714|NCT00725127|Sensory System Agents|sensory system agents|mesh-ancestor
93338715|NCT00725127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338716|NCT00725127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338717|NCT00725127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93338718|NCT00725127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338719|NCT00725127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93338720|NCT00725127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93338721|NCT00725127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338722|NCT00725127|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93338723|NCT00725127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93338724|NCT00725127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338725|NCT00725127|Antipyretics|antipyretics|mesh-ancestor
93338726|NCT02328950|Cytarabine|cytarabine|mesh-list
93338727|NCT02328950|Cyclophosphamide|cyclophosphamide|mesh-list
93338728|NCT02328950|Busulfan|busulfan|mesh-list
93338729|NCT02328950|Fludarabine|fludarabine|mesh-list
93338730|NCT02328950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93338731|NCT02328950|Immunologic Factors|immunologic factors|mesh-ancestor
93338732|NCT02328950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338733|NCT02328950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338734|NCT02328950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93338735|NCT02328950|Alkylating Agents|alkylating agents|mesh-ancestor
93338736|NCT02328950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338737|NCT02328950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338738|NCT02328950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93338739|NCT02328950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93338740|NCT02328950|Antimetabolites|antimetabolites|mesh-ancestor
93338741|NCT02328950|Antiviral Agents|antiviral agents|mesh-ancestor
93338742|NCT02328950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338743|NCT03398577|Dapagliflozin|dapagliflozin|mesh-list
93338744|NCT03398577|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93338745|NCT03398577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338746|NCT03398577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93338747|NCT03398577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338748|NCT03389061|Sofosbuvir|sofosbuvir|mesh-list
93338749|NCT03389061|Velpatasvir|velpatasvir|mesh-list
93338750|NCT03389061|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93338751|NCT03389061|Antiviral Agents|antiviral agents|mesh-ancestor
93338752|NCT03389061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338753|NCT05078138|Epoetin Alfa|epoetin alfa|mesh-list
93338754|NCT05078138|Hematinics|hematinics|mesh-ancestor
93338755|NCT02038868|Tamsulosin|tamsulosin|mesh-list
93338756|NCT02038868|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93338757|NCT02038868|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93338758|NCT02038868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93338759|NCT02038868|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338760|NCT02038868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338761|NCT02038868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338762|NCT02038868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338763|NCT02038868|Urological Agents|urological agents|mesh-ancestor
93338764|NCT02328794|Varenicline|varenicline|mesh-list
93338765|NCT02328794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93338766|NCT02328794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93338767|NCT02328794|Cholinergic Agents|cholinergic agents|mesh-ancestor
93338768|NCT02328794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338769|NCT02328794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338770|NCT02328794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338771|NCT03388827|Misoprostol|misoprostol|mesh-list
93338772|NCT03388827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93338773|NCT03388827|Abortifacient Agents|abortifacient agents|mesh-ancestor
93338774|NCT03388827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93338775|NCT03388827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338776|NCT03388827|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93338777|NCT03388827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93338778|NCT03388827|Oxytocics|oxytocics|mesh-ancestor
93010712|NCT00991926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93338780|NCT02328716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338781|NCT00445107|Montelukast|montelukast|mesh-list
93338782|NCT00445107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338783|NCT00445107|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338784|NCT00445107|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93338785|NCT00445107|Hormone Antagonists|hormone antagonists|mesh-ancestor
93338786|NCT00445107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338787|NCT00445107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338788|NCT00445107|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93338789|NCT00445107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93338790|NCT00445107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338791|NCT05077592|Povidone-Iodine|povidone-iodine|mesh-list
93338792|NCT05077592|Povidone|povidone|mesh-list
93338793|NCT05077592|Plasma Substitutes|plasma substitutes|mesh-ancestor
93338794|NCT05077592|Blood Substitutes|blood substitutes|mesh-ancestor
93338795|NCT05077592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93338796|NCT05077592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338797|NCT00038727|Metformin|metformin|mesh-list
93338798|NCT00038727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93338799|NCT00038727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338800|NCT02864381|Nivolumab|nivolumab|mesh-list
93338801|NCT02864381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338802|NCT02864381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338803|NCT02864381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93338804|NCT02864381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338805|NCT05230472|Simvastatin|simvastatin|mesh-list
93338806|NCT05230472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93338807|NCT05230472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93338808|NCT05230472|Antimetabolites|antimetabolites|mesh-ancestor
93338809|NCT05230472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338810|NCT05230472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93338811|NCT05230472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93338812|NCT05230472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338813|NCT03398031|Magnesium Oxide|magnesium oxide|mesh-list
93338814|NCT03398031|Antacids|antacids|mesh-ancestor
93338815|NCT03398031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338816|NCT03398031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93338817|NCT02039960|Bupropion|bupropion|mesh-list
93338818|NCT02039960|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93338819|NCT02039960|Antidepressive Agents|antidepressive agents|mesh-ancestor
93338820|NCT02039960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93338821|NCT02039960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93338822|NCT02039960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93338823|NCT02039960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93338824|NCT02039960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338825|NCT02039960|Dopamine Agents|dopamine agents|mesh-ancestor
93338826|NCT02039960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338827|NCT02039960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338828|NCT02039960|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93338829|NCT02039960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93338830|NCT02039960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338831|NCT05383313|Midazolam|midazolam|mesh-list
93338832|NCT05383313|Ketamine|ketamine|mesh-list
93338833|NCT05383313|Psilocybin|psilocybin|mesh-list
93338834|NCT05383313|Analgesics|analgesics|mesh-ancestor
93338835|NCT05383313|Sensory System Agents|sensory system agents|mesh-ancestor
93338836|NCT05383313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338837|NCT05383313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338838|NCT05383313|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93338839|NCT05383313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93338840|NCT05383313|Anesthetics, General|anesthetics, general|mesh-ancestor
93338841|NCT05383313|Anesthetics|anesthetics|mesh-ancestor
93338842|NCT05383313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338843|NCT05383313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93338844|NCT05383313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93338845|NCT05383313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338846|NCT05383313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338847|NCT05383313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93338848|NCT05383313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93338849|NCT05383313|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93338850|NCT05383313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93338851|NCT05383313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93338852|NCT05383313|GABA Modulators|gaba modulators|mesh-ancestor
93338853|NCT05383313|GABA Agents|gaba agents|mesh-ancestor
93338854|NCT05383313|Hallucinogens|hallucinogens|mesh-ancestor
93338855|NCT02033681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93338856|NCT03144128|Vitamin D|vitamin d|mesh-list
93338857|NCT03144128|Vitamins|vitamins|mesh-ancestor
93338858|NCT03144128|Micronutrients|micronutrients|mesh-ancestor
93338859|NCT03144128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338860|NCT03144128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93338861|NCT02326610|Hormones|hormones|mesh-list
93338862|NCT02326610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338863|NCT02326610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338864|NCT00409773|Atorvastatin|atorvastatin|mesh-list
93338865|NCT00409773|Simvastatin|simvastatin|mesh-list
93338866|NCT00409773|Ezetimibe|ezetimibe|mesh-list
93338867|NCT00409773|Calcium|calcium|mesh-list
93338868|NCT00409773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93338869|NCT00409773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338870|NCT00409773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93338871|NCT00409773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93338872|NCT00409773|Antimetabolites|antimetabolites|mesh-ancestor
93338873|NCT00409773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338874|NCT00409773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93338875|NCT00409773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93338876|NCT00409773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338877|NCT02326376|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93338878|NCT02326376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93338879|NCT02034422|Antioxidants|antioxidants|mesh-list
93338880|NCT02034422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338881|NCT02034422|Protective Agents|protective agents|mesh-ancestor
93338882|NCT02034422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338883|NCT02325986|Fluorouracil|fluorouracil|mesh-list
93338884|NCT02325986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338885|NCT02325986|Antimetabolites|antimetabolites|mesh-ancestor
92632674|NCT02372578|Pregabalin|pregabalin|mesh-list
93338886|NCT02325986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338887|NCT02325986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93338888|NCT02325986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93338889|NCT02325986|Immunologic Factors|immunologic factors|mesh-ancestor
93338890|NCT02325986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338891|NCT00398151|Montelukast|montelukast|mesh-list
93338892|NCT00398151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338893|NCT00398151|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338894|NCT00398151|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93338895|NCT00398151|Hormone Antagonists|hormone antagonists|mesh-ancestor
93338896|NCT00398151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338897|NCT00398151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338898|NCT00398151|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93338899|NCT00398151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93338900|NCT00398151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338901|NCT03610139|Vitamin D|vitamin d|mesh-list
93338902|NCT03610139|Cholecalciferol|cholecalciferol|mesh-list
93338903|NCT03610139|Vitamins|vitamins|mesh-ancestor
93338904|NCT03610139|Micronutrients|micronutrients|mesh-ancestor
93338905|NCT03610139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338906|NCT03610139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93338907|NCT03610139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93338908|NCT02327624|Clopidogrel|clopidogrel|mesh-list
93338909|NCT02327624|Ticagrelor|ticagrelor|mesh-list
93338910|NCT02327624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93338911|NCT02327624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93338912|NCT02327624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93338913|NCT02327624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93338914|NCT02327624|Purinergic Agents|purinergic agents|mesh-ancestor
93338915|NCT02327624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338916|NCT02327624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338917|NCT02327624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338918|NCT03388671|Bupivacaine|bupivacaine|mesh-list
93338919|NCT03388671|Anesthetics, Local|anesthetics, local|mesh-ancestor
93338920|NCT03388671|Anesthetics|anesthetics|mesh-ancestor
93338921|NCT03388671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338922|NCT03388671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338923|NCT03388671|Sensory System Agents|sensory system agents|mesh-ancestor
93338924|NCT03388671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338925|NCT02327936|Fesoterodine|fesoterodine|mesh-list
93338926|NCT02327936|Oxybutynin|oxybutynin|mesh-list
93338927|NCT02327936|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93338928|NCT02327936|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93338929|NCT02327936|Cholinergic Agents|cholinergic agents|mesh-ancestor
93338930|NCT02327936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338931|NCT02327936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338932|NCT02327936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338933|NCT02327936|Urological Agents|urological agents|mesh-ancestor
93338934|NCT02327936|Parasympatholytics|parasympatholytics|mesh-ancestor
93338935|NCT02327936|Autonomic Agents|autonomic agents|mesh-ancestor
93338936|NCT02327936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93338937|NCT03609827|Melphalan|melphalan|mesh-list
93338938|NCT03609827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93338939|NCT03609827|Alkylating Agents|alkylating agents|mesh-ancestor
93338940|NCT03609827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338941|NCT03609827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338942|NCT03609827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93338943|NCT03609827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93338944|NCT03609827|Immunologic Factors|immunologic factors|mesh-ancestor
93338945|NCT03609827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338946|NCT02858401|Vesatolimod|vesatolimod|mesh-list
93338947|NCT02858401|Antiviral Agents|antiviral agents|mesh-ancestor
93338948|NCT02858401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93338949|NCT03144596|Tamsulosin|tamsulosin|mesh-list
93338950|NCT03144596|Alfuzosin|alfuzosin|mesh-list
93338951|NCT03144596|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93338952|NCT03144596|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93338953|NCT03144596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93338954|NCT03144596|Adrenergic Agents|adrenergic agents|mesh-ancestor
93338955|NCT03144596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93338956|NCT03144596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338957|NCT03144596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338958|NCT03144596|Urological Agents|urological agents|mesh-ancestor
93338959|NCT00127647|Montelukast|montelukast|mesh-list
93338960|NCT00127647|Pranlukast|pranlukast|mesh-list
93338961|NCT00127647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93338962|NCT00127647|Respiratory System Agents|respiratory system agents|mesh-ancestor
93338963|NCT00127647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93338964|NCT00127647|Hormone Antagonists|hormone antagonists|mesh-ancestor
93338965|NCT00127647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93338966|NCT00127647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338967|NCT00127647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93338968|NCT00127647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93338969|NCT00127647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338970|NCT03111446|Anesthetics|anesthetics|mesh-list
93338971|NCT03111446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93338972|NCT03111446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93338973|NCT02034071|Diazoxide|diazoxide|mesh-list
93338974|NCT02034071|Choline|choline|mesh-list
93338975|NCT02034071|Lipotropic Agents|lipotropic agents|mesh-ancestor
93338976|NCT02034071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93338977|NCT02034071|Antimetabolites|antimetabolites|mesh-ancestor
93338978|NCT02034071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338979|NCT02034071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93338980|NCT02034071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93338981|NCT02034071|Nootropic Agents|nootropic agents|mesh-ancestor
93338982|NCT02034071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93338983|NCT02034071|Vasodilator Agents|vasodilator agents|mesh-ancestor
93338984|NCT03609359|Pembrolizumab|pembrolizumab|mesh-list
93338985|NCT03609359|Lenvatinib|lenvatinib|mesh-list
93338986|NCT03609359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93338987|NCT03609359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93338988|NCT03609359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93338989|NCT03609359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338990|NCT03609359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93338991|NCT03609359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93338992|NCT04833764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93338993|NCT04833764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93338994|NCT04833764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93338995|NCT04833764|Antimetabolites|antimetabolites|mesh-ancestor
93338996|NCT04833764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93338997|NCT04833764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93366443|NCT02796677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010938|NCT00379834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93338998|NCT04833764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93339000|NCT03388125|Ethanolamine oleate|ethanolamine oleate|mesh-list
93339001|NCT03388125|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93339002|NCT03388125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93339003|NCT04822376|Ansuvimab|ansuvimab|mesh-list
93339004|NCT04822376|Antiviral Agents|antiviral agents|mesh-ancestor
93339005|NCT04822376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339006|NCT05173545|Mitoxantrone|mitoxantrone|mesh-list
93339007|NCT05173545|Analgesics|analgesics|mesh-ancestor
93339008|NCT05173545|Sensory System Agents|sensory system agents|mesh-ancestor
93339009|NCT05173545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339010|NCT05173545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339011|NCT05173545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339012|NCT05173545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93339013|NCT05173545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93339014|NCT05173545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339015|NCT05173545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339016|NCT05383183|Choline|choline|mesh-list
93339017|NCT05383183|Lipotropic Agents|lipotropic agents|mesh-ancestor
93339018|NCT05383183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93339019|NCT05383183|Antimetabolites|antimetabolites|mesh-ancestor
93339020|NCT05383183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339021|NCT05383183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339022|NCT05383183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93339023|NCT05383183|Nootropic Agents|nootropic agents|mesh-ancestor
93339024|NCT02327702|Emtricitabine|emtricitabine|mesh-list
93339025|NCT02327702|Antiviral Agents|antiviral agents|mesh-ancestor
93339026|NCT02327702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339027|NCT02327702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93339028|NCT02327702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93339029|NCT02327702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339030|NCT02327702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339031|NCT02327702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93339032|NCT02327702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93339033|NCT03609775|Ethanol|ethanol|mesh-list
93339034|NCT03609775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93339035|NCT03609775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339036|NCT03609775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339037|NCT03609775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339038|NCT03690765|Dydrogesterone|dydrogesterone|mesh-list
93339039|NCT03690765|Progestins|progestins|mesh-ancestor
93339040|NCT03690765|Hormones|hormones|mesh-ancestor
93339041|NCT03690765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339042|NCT03690765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339043|NCT02033941|Phenol|phenol|mesh-list
93339044|NCT02033941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93339045|NCT02033941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339046|NCT02033941|Disinfectants|disinfectants|mesh-ancestor
93339047|NCT02033941|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93339048|NCT02033941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93339049|NCT03143972|Dexmedetomidine|dexmedetomidine|mesh-list
93339050|NCT03143972|Remifentanil|remifentanil|mesh-list
93339051|NCT03143972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93339052|NCT03143972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339053|NCT03143972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339054|NCT03143972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339055|NCT03143972|Analgesics|analgesics|mesh-ancestor
93339056|NCT03143972|Sensory System Agents|sensory system agents|mesh-ancestor
93339057|NCT03143972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339058|NCT03143972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93339059|NCT03143972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93339060|NCT03143972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93339061|NCT03143972|Adrenergic Agents|adrenergic agents|mesh-ancestor
93339062|NCT03143972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339063|NCT03143972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339064|NCT03143972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93339065|NCT03143972|Narcotics|narcotics|mesh-ancestor
93339066|NCT02237027|Tenofovir|tenofovir|mesh-list
93339067|NCT02237027|Emtricitabine|emtricitabine|mesh-list
93339068|NCT02237027|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93339069|NCT02237027|Antiviral Agents|antiviral agents|mesh-ancestor
93339070|NCT02237027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339071|NCT02237027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93011014|NCT00993096|Insulin|insulin|mesh-list
93339072|NCT02237027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93339073|NCT02237027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339074|NCT02237027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339075|NCT02237027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93339076|NCT02237027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93339077|NCT03609125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93339078|NCT03609125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93339079|NCT03143738|Anesthetics|anesthetics|mesh-list
93339080|NCT03143738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339081|NCT03143738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339082|NCT04393753|Avelumab|avelumab|mesh-list
93339083|NCT04393753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339084|NCT04393753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339085|NCT04647903|Amphetamine|amphetamine|mesh-list
93339086|NCT04647903|Dextroamphetamine|dextroamphetamine|mesh-list
93339087|NCT04647903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93339088|NCT04647903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339089|NCT04647903|Sympathomimetics|sympathomimetics|mesh-ancestor
93339090|NCT04647903|Autonomic Agents|autonomic agents|mesh-ancestor
93339091|NCT04647903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339092|NCT04647903|Dopamine Agents|dopamine agents|mesh-ancestor
93339093|NCT04647903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339094|NCT04647903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339095|NCT04647903|Adrenergic Agents|adrenergic agents|mesh-ancestor
93339096|NCT04647903|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93339097|NCT04647903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93339098|NCT04647903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339099|NCT04647903|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93339100|NCT03142256|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93339101|NCT03142256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93339102|NCT03142256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93339103|NCT03142256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339104|NCT03142256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339105|NCT03142256|Antiviral Agents|antiviral agents|mesh-ancestor
93339106|NCT03142256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339107|NCT03142256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93339108|NCT03142256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93339109|NCT03380403|Ciprofloxacin|ciprofloxacin|mesh-list
93339110|NCT03380403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93339111|NCT03380403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339112|NCT03380403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93339113|NCT03380403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93339114|NCT03380403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339115|NCT03380403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339116|NCT03380403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339117|NCT03380403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93339118|NCT03380403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93339119|NCT03380325|Iloprost|iloprost|mesh-list
93339120|NCT03380325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93339121|NCT03380325|Vasodilator Agents|vasodilator agents|mesh-ancestor
93339122|NCT02237053|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93339123|NCT02237053|Octreotide|octreotide|mesh-list
93339124|NCT02237053|Glucagon|glucagon|mesh-list
93339125|NCT02237053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339126|NCT02237053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339127|NCT02237053|Hormones|hormones|mesh-ancestor
93339128|NCT02237053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339129|NCT02237053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339130|NCT02237053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339131|NCT02237131|Contraceptive Agents|contraceptive agents|mesh-list
93339132|NCT02237131|Contraceptives, Oral|contraceptives, oral|mesh-list
93339133|NCT02237131|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93339134|NCT02237131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93339135|NCT02237131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339136|NCT02237131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93339137|NCT04997174|Celecoxib|celecoxib|mesh-list
93339138|NCT04997174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93339139|NCT04997174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339140|NCT04997174|Analgesics|analgesics|mesh-ancestor
93339141|NCT04997174|Sensory System Agents|sensory system agents|mesh-ancestor
93339142|NCT04997174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339143|NCT04997174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339144|NCT04997174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339145|NCT04997174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339146|NCT04997174|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93339147|NCT04997174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93339148|NCT04997174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339149|NCT04997174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339150|NCT02237209|Vaccines|vaccines|mesh-list
93339151|NCT02237209|Immunologic Factors|immunologic factors|mesh-ancestor
93339152|NCT02237209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339153|NCT03387111|Leucovorin|leucovorin|mesh-list
93339154|NCT03387111|Paclitaxel|paclitaxel|mesh-list
93339155|NCT03387111|Cyclophosphamide|cyclophosphamide|mesh-list
93339156|NCT03387111|Bevacizumab|bevacizumab|mesh-list
93339157|NCT03387111|Fluorouracil|fluorouracil|mesh-list
93339158|NCT03387111|Capecitabine|capecitabine|mesh-list
93339159|NCT03387111|Cetuximab|cetuximab|mesh-list
93339160|NCT03387111|Avelumab|avelumab|mesh-list
93339161|NCT03387111|Necitumumab|necitumumab|mesh-list
93339162|NCT03387111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93339163|NCT03387111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339164|NCT03387111|Tubulin Modulators|tubulin modulators|mesh-ancestor
93339165|NCT03387111|Antimitotic Agents|antimitotic agents|mesh-ancestor
93339166|NCT03387111|Mitosis Modulators|mitosis modulators|mesh-ancestor
93339167|NCT03387111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339168|NCT03387111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339169|NCT03387111|Immunologic Factors|immunologic factors|mesh-ancestor
93339170|NCT03387111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339171|NCT03387111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339172|NCT03387111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339173|NCT03387111|Alkylating Agents|alkylating agents|mesh-ancestor
93339174|NCT03387111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93339175|NCT03387111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339176|NCT03387111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93339177|NCT03387111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93339178|NCT03387111|Growth Substances|growth substances|mesh-ancestor
93339179|NCT03387111|Growth Inhibitors|growth inhibitors|mesh-ancestor
93339180|NCT03387111|Antimetabolites|antimetabolites|mesh-ancestor
93339181|NCT03387111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93339182|NCT03387111|Antidotes|antidotes|mesh-ancestor
93339183|NCT03387111|Protective Agents|protective agents|mesh-ancestor
93339184|NCT03387111|Vitamin B Complex|vitamin b complex|mesh-ancestor
93339185|NCT03387111|Vitamins|vitamins|mesh-ancestor
93339186|NCT03387111|Micronutrients|micronutrients|mesh-ancestor
93339187|NCT03608293|Dimercaprol|dimercaprol|mesh-list
93339188|NCT03608293|Chelating Agents|chelating agents|mesh-ancestor
93339189|NCT03608293|Sequestering Agents|sequestering agents|mesh-ancestor
93339190|NCT03608293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339191|NCT03608501|Thalidomide|thalidomide|mesh-list
93339192|NCT03608501|Dexamethasone|dexamethasone|mesh-list
93339193|NCT03608501|Ixazomib|ixazomib|mesh-list
93339194|NCT03608501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339195|NCT03608501|Antiemetics|antiemetics|mesh-ancestor
93339196|NCT03608501|Autonomic Agents|autonomic agents|mesh-ancestor
93339197|NCT03608501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339198|NCT03608501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339199|NCT03608501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339200|NCT03608501|Glucocorticoids|glucocorticoids|mesh-ancestor
93339201|NCT03608501|Hormones|hormones|mesh-ancestor
93339202|NCT03608501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339203|NCT03608501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339204|NCT03608501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339205|NCT03608501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339206|NCT03608501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339207|NCT03608501|Immunologic Factors|immunologic factors|mesh-ancestor
93339208|NCT03608501|Leprostatic Agents|leprostatic agents|mesh-ancestor
93339209|NCT03608501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93339210|NCT03608501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339211|NCT03608501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93339212|NCT03608501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93339213|NCT03608501|Growth Substances|growth substances|mesh-ancestor
93339214|NCT03608501|Growth Inhibitors|growth inhibitors|mesh-ancestor
93339215|NCT03608501|Protease Inhibitors|protease inhibitors|mesh-ancestor
93339216|NCT03608501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339217|NCT03608761|Rebamipide|rebamipide|mesh-list
93339218|NCT03608761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93339219|NCT03608761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339220|NCT03608761|Antioxidants|antioxidants|mesh-ancestor
93339221|NCT03608761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339222|NCT03608761|Protective Agents|protective agents|mesh-ancestor
93339223|NCT03608761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339224|NCT03608761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339225|NCT04554836|Cetuximab|cetuximab|mesh-list
93339226|NCT04554836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339227|NCT04554836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339228|NCT04536272|Heparin|heparin|mesh-list
93339229|NCT04536272|Calcium heparin|calcium heparin|mesh-list
93339230|NCT04536272|Enoxaparin|enoxaparin|mesh-list
93339231|NCT04536272|Nadroparin|nadroparin|mesh-list
93339232|NCT04536272|Anticoagulants|anticoagulants|mesh-ancestor
93339233|NCT04536272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93339234|NCT04536272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93339235|NCT04536272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339236|NCT02731131|Ribavirin|ribavirin|mesh-list
93339237|NCT02731131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93339238|NCT02731131|Antimetabolites|antimetabolites|mesh-ancestor
93339239|NCT02731131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339240|NCT02731131|Antiviral Agents|antiviral agents|mesh-ancestor
93339241|NCT02731131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339242|NCT04585724|Palbociclib|palbociclib|mesh-list
93339243|NCT04585724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339244|NCT04585724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93339245|NCT04585724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339246|NCT04585724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339247|NCT02237261|Prednisone|prednisone|mesh-list
93339248|NCT02237261|Bortezomib|bortezomib|mesh-list
93339249|NCT02237261|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93339250|NCT02237261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339251|NCT02237261|Glucocorticoids|glucocorticoids|mesh-ancestor
93339252|NCT02237261|Hormones|hormones|mesh-ancestor
93339253|NCT02237261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339254|NCT02237261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339255|NCT02237261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339256|NCT02237261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339257|NCT02237261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339258|NCT02237261|Alkylating Agents|alkylating agents|mesh-ancestor
93339259|NCT02237261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339260|NCT03386643|Clobetasol|clobetasol|mesh-list
93339261|NCT03386643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339262|NCT03386643|Glucocorticoids|glucocorticoids|mesh-ancestor
93339263|NCT03386643|Hormones|hormones|mesh-ancestor
93339264|NCT03386643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339265|NCT03386643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339266|NCT05171985|Dexmedetomidine|dexmedetomidine|mesh-list
93339267|NCT05171985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93339268|NCT05171985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339269|NCT05171985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339270|NCT05171985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339271|NCT05171985|Analgesics|analgesics|mesh-ancestor
93339272|NCT05171985|Sensory System Agents|sensory system agents|mesh-ancestor
93339273|NCT05171985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339274|NCT05171985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93339275|NCT05171985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93339276|NCT05171985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93339277|NCT05171985|Adrenergic Agents|adrenergic agents|mesh-ancestor
93339278|NCT05171985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339279|NCT05171985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339280|NCT02237365|Aspirin|aspirin|mesh-list
93339281|NCT02237365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93339282|NCT02237365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339283|NCT02237365|Analgesics|analgesics|mesh-ancestor
93339284|NCT02237365|Sensory System Agents|sensory system agents|mesh-ancestor
93339285|NCT02237365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339286|NCT02237365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339287|NCT02237365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339288|NCT02237365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339289|NCT02237365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93339290|NCT02237365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93339291|NCT02237365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339292|NCT02237365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93339293|NCT02237365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93339294|NCT02237365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339295|NCT02237365|Antipyretics|antipyretics|mesh-ancestor
93339296|NCT03383367|TEMPO|tempo|mesh-list
93339297|NCT03383367|Antioxidants|antioxidants|mesh-ancestor
93339298|NCT03383367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339299|NCT03383367|Protective Agents|protective agents|mesh-ancestor
93339300|NCT03383367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339301|NCT02856113|Alogliptin|alogliptin|mesh-list
93339302|NCT02856113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93339303|NCT02856113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339304|NCT02856113|Incretins|incretins|mesh-ancestor
93339305|NCT02856113|Hormones|hormones|mesh-ancestor
93339306|NCT02856113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339307|NCT02856113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93339308|NCT02856113|Protease Inhibitors|protease inhibitors|mesh-ancestor
93339309|NCT02856113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339310|NCT02856113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339311|NCT03386565|Lidocaine|lidocaine|mesh-list
93339312|NCT03386565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93339313|NCT03386565|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339314|NCT03386565|Anesthetics|anesthetics|mesh-ancestor
93339315|NCT03386565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339316|NCT03386565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339317|NCT03386565|Sensory System Agents|sensory system agents|mesh-ancestor
93339318|NCT03386565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339319|NCT03386565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93339320|NCT03386565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93339321|NCT03386565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93339322|NCT03386565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339323|NCT03386565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339324|NCT02237339|Allopurinol|allopurinol|mesh-list
93339325|NCT02237339|Antimetabolites|antimetabolites|mesh-ancestor
93339326|NCT02237339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339327|NCT02237339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339328|NCT02237339|Gout Suppressants|gout suppressants|mesh-ancestor
93339329|NCT02237339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339330|NCT02237339|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93339331|NCT02237339|Antioxidants|antioxidants|mesh-ancestor
93339332|NCT02237339|Protective Agents|protective agents|mesh-ancestor
93339333|NCT02237339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339334|NCT05171751|Octreotide|octreotide|mesh-list
93339335|NCT05171751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339336|NCT05171751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339337|NCT05171751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339338|NCT03971084|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
93339339|NCT03971084|Caseins|caseins|mesh-list
93339340|NCT03971084|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93339341|NCT03971084|Serotonin Agents|serotonin agents|mesh-ancestor
93339342|NCT03971084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339343|NCT03971084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339344|NCT03971084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339345|NCT03971084|Chelating Agents|chelating agents|mesh-ancestor
93339346|NCT03971084|Sequestering Agents|sequestering agents|mesh-ancestor
93339347|NCT03379779|Dimercaprol|dimercaprol|mesh-list
93339348|NCT03379779|Chelating Agents|chelating agents|mesh-ancestor
93339349|NCT03379779|Sequestering Agents|sequestering agents|mesh-ancestor
93339350|NCT03379779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339351|NCT04083014|Bortezomib|bortezomib|mesh-list
93339352|NCT04083014|Antibodies|antibodies|mesh-list
93339353|NCT04083014|Immunologic Factors|immunologic factors|mesh-ancestor
93339354|NCT04083014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339355|NCT04083014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339356|NCT03563066|Benralizumab|benralizumab|mesh-list
93339357|NCT03563066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93339358|NCT03563066|Respiratory System Agents|respiratory system agents|mesh-ancestor
93339359|NCT03140384|Misoprostol|misoprostol|mesh-list
93339360|NCT03140384|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93339361|NCT03140384|Abortifacient Agents|abortifacient agents|mesh-ancestor
93339362|NCT03140384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93339363|NCT03140384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339364|NCT03140384|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93339365|NCT03140384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339366|NCT03140384|Oxytocics|oxytocics|mesh-ancestor
93339367|NCT05117307|Bupivacaine|bupivacaine|mesh-list
93339368|NCT05117307|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339369|NCT05117307|Anesthetics|anesthetics|mesh-ancestor
93339370|NCT05117307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339371|NCT05117307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339372|NCT05117307|Sensory System Agents|sensory system agents|mesh-ancestor
93339373|NCT05117307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339374|NCT03739268|Sevelamer|sevelamer|mesh-list
93339375|NCT03739268|Chelating Agents|chelating agents|mesh-ancestor
93339376|NCT03739268|Sequestering Agents|sequestering agents|mesh-ancestor
93339377|NCT03739268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339378|NCT02787590|Simvastatin|simvastatin|mesh-list
93339379|NCT02787590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93339380|NCT02787590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93339381|NCT02787590|Antimetabolites|antimetabolites|mesh-ancestor
93339382|NCT02787590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339383|NCT02787590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93339384|NCT02787590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93339385|NCT02787590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339386|NCT04445571|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93339387|NCT04445571|Respiratory System Agents|respiratory system agents|mesh-ancestor
93339388|NCT03382743|Lidocaine|lidocaine|mesh-list
93339389|NCT03382743|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339390|NCT03382743|Anesthetics|anesthetics|mesh-ancestor
93339391|NCT03382743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339392|NCT03382743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339393|NCT03382743|Sensory System Agents|sensory system agents|mesh-ancestor
93339394|NCT03382743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339395|NCT03382743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93339396|NCT03382743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93339397|NCT03382743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93339398|NCT03382743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339399|NCT03382743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339400|NCT02854631|Prednisolone|prednisolone|mesh-list
93339401|NCT02854631|Selonsertib|selonsertib|mesh-list
93339402|NCT02854631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339403|NCT02854631|Glucocorticoids|glucocorticoids|mesh-ancestor
93339404|NCT02854631|Hormones|hormones|mesh-ancestor
93339405|NCT02854631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339406|NCT02854631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339407|NCT02854631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339408|NCT02854631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339409|NCT02854631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93339410|NCT02854631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339411|NCT02854631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339412|NCT03607643|Leucovorin|leucovorin|mesh-list
93339413|NCT03607643|Bevacizumab|bevacizumab|mesh-list
93339414|NCT03607643|Gemcitabine|gemcitabine|mesh-list
93339415|NCT03607643|Oxaliplatin|oxaliplatin|mesh-list
93339416|NCT03607643|Irinotecan|irinotecan|mesh-list
93339417|NCT03607643|Temozolomide|temozolomide|mesh-list
93339418|NCT03607643|Bortezomib|bortezomib|mesh-list
93339419|NCT03607643|Cannabidiol|cannabidiol|mesh-list
93339420|NCT03607643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339421|NCT03607643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339422|NCT03607643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93339423|NCT03607643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93339424|NCT03607643|Growth Substances|growth substances|mesh-ancestor
93339425|NCT03607643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339426|NCT03607643|Growth Inhibitors|growth inhibitors|mesh-ancestor
93339427|NCT03607643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93339428|NCT03607643|Antimetabolites|antimetabolites|mesh-ancestor
93339429|NCT03607643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339430|NCT03607643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93339431|NCT03607643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93339432|NCT03607643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339433|NCT03607643|Antidotes|antidotes|mesh-ancestor
93339434|NCT03607643|Protective Agents|protective agents|mesh-ancestor
93339435|NCT03607643|Vitamin B Complex|vitamin b complex|mesh-ancestor
93339436|NCT03607643|Vitamins|vitamins|mesh-ancestor
93339437|NCT03607643|Micronutrients|micronutrients|mesh-ancestor
93339438|NCT03607643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339439|NCT03607643|Alkylating Agents|alkylating agents|mesh-ancestor
93339440|NCT03607643|Anticonvulsants|anticonvulsants|mesh-ancestor
93339441|NCT02855359|Prednisone|prednisone|mesh-list
93339442|NCT02855359|Cyclophosphamide|cyclophosphamide|mesh-list
93339443|NCT02855359|Rituximab|rituximab|mesh-list
93339444|NCT02855359|Doxorubicin|doxorubicin|mesh-list
93339445|NCT02855359|Vincristine|vincristine|mesh-list
93339446|NCT02855359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339447|NCT02855359|Immunologic Factors|immunologic factors|mesh-ancestor
93011391|NCT01001364|Budesonide|budesonide|mesh-list
93339448|NCT02855359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339449|NCT02855359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339450|NCT02855359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339451|NCT02855359|Alkylating Agents|alkylating agents|mesh-ancestor
93339452|NCT02855359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339453|NCT02855359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339454|NCT02855359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93339455|NCT02855359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339456|NCT02855359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93339457|NCT02855359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93339458|NCT02855359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93339459|NCT02855359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339460|NCT02855359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339461|NCT02855359|Glucocorticoids|glucocorticoids|mesh-ancestor
93339462|NCT02855359|Hormones|hormones|mesh-ancestor
93339463|NCT02855359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339464|NCT02855359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339465|NCT02855359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93339466|NCT02855359|Tubulin Modulators|tubulin modulators|mesh-ancestor
93339467|NCT02855359|Antimitotic Agents|antimitotic agents|mesh-ancestor
93339468|NCT02855359|Mitosis Modulators|mitosis modulators|mesh-ancestor
93339469|NCT05084456|Docetaxel|docetaxel|mesh-list
93339470|NCT05084456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339471|NCT05084456|Tubulin Modulators|tubulin modulators|mesh-ancestor
93339472|NCT05084456|Antimitotic Agents|antimitotic agents|mesh-ancestor
93339473|NCT05084456|Mitosis Modulators|mitosis modulators|mesh-ancestor
93339474|NCT05084456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339475|NCT03607903|Adalimumab|adalimumab|mesh-list
93339476|NCT03607903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93339477|NCT03607903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339478|NCT03607903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339479|NCT04438850|Ivermectin|ivermectin|mesh-list
93339480|NCT04438850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93339481|NCT04438850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339482|NCT03385863|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93339483|NCT03385863|Poractant alfa|poractant alfa|mesh-list
93339484|NCT03385863|Respiratory System Agents|respiratory system agents|mesh-ancestor
93339485|NCT03939026|Cyclophosphamide|cyclophosphamide|mesh-list
93339486|NCT03939026|Fludarabine|fludarabine|mesh-list
93339487|NCT03939026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339488|NCT03939026|Immunologic Factors|immunologic factors|mesh-ancestor
93339489|NCT03939026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339490|NCT03939026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339491|NCT03939026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339492|NCT03939026|Alkylating Agents|alkylating agents|mesh-ancestor
93339493|NCT03939026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339494|NCT03939026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339495|NCT03939026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93339496|NCT03382431|PC-786|pc-786|mesh-list
93339497|NCT03382431|Antiviral Agents|antiviral agents|mesh-ancestor
93339498|NCT03382431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339499|NCT03382431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339500|NCT03382431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339501|NCT03141632|Dulaglutide|dulaglutide|mesh-list
93339502|NCT03141632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93339503|NCT03141632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339504|NCT04282239|Lidocaine|lidocaine|mesh-list
93339505|NCT04282239|Epinephrine|epinephrine|mesh-list
93339506|NCT04282239|Dexmedetomidine|dexmedetomidine|mesh-list
93339507|NCT04282239|Ropivacaine|ropivacaine|mesh-list
93339508|NCT04282239|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339509|NCT04282239|Anesthetics|anesthetics|mesh-ancestor
93339510|NCT04282239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339511|NCT04282239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339512|NCT04282239|Sensory System Agents|sensory system agents|mesh-ancestor
93339513|NCT04282239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339514|NCT04282239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93339515|NCT04282239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93339516|NCT04282239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93339517|NCT04282239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339518|NCT04282239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339519|NCT04282239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93339520|NCT04282239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339521|NCT04282239|Analgesics|analgesics|mesh-ancestor
93339522|NCT04282239|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93339523|NCT04282239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93339524|NCT04282239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93339525|NCT04282239|Adrenergic Agents|adrenergic agents|mesh-ancestor
93339526|NCT04282239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633311|NCT00206154|Hormones|hormones|mesh-ancestor
93339527|NCT04282239|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93339528|NCT04282239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93339530|NCT04282239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93339531|NCT04282239|Respiratory System Agents|respiratory system agents|mesh-ancestor
93339532|NCT04282239|Mydriatics|mydriatics|mesh-ancestor
93339533|NCT04282239|Sympathomimetics|sympathomimetics|mesh-ancestor
93339534|NCT04282239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93339535|NCT03605173|Vitamin D|vitamin d|mesh-list
93339536|NCT03605173|Ergocalciferols|ergocalciferols|mesh-list
93339537|NCT03605173|Cholecalciferol|cholecalciferol|mesh-list
93339538|NCT03605173|Vitamins|vitamins|mesh-list
93339539|NCT03605173|Micronutrients|micronutrients|mesh-ancestor
93339540|NCT03605173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339541|NCT03605173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93339542|NCT03605173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93339543|NCT03605095|Nitroglycerin|nitroglycerin|mesh-list
93339544|NCT03605095|Vasodilator Agents|vasodilator agents|mesh-ancestor
93339545|NCT03382275|Iron|iron|mesh-list
93339546|NCT03382275|Ferric maltol|ferric maltol|mesh-list
93339547|NCT03382275|Trace Elements|trace elements|mesh-ancestor
93339548|NCT03382275|Micronutrients|micronutrients|mesh-ancestor
93339549|NCT03382275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339550|NCT03382275|Hematinics|hematinics|mesh-ancestor
93339551|NCT05080478|Clopidogrel|clopidogrel|mesh-list
93339552|NCT05080478|Ticagrelor|ticagrelor|mesh-list
93339553|NCT05080478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93339554|NCT05080478|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93339555|NCT05080478|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93339556|NCT05080478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93339557|NCT05080478|Purinergic Agents|purinergic agents|mesh-ancestor
93339558|NCT05080478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339559|NCT05080478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339560|NCT05080478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339561|NCT05082974|Varenicline|varenicline|mesh-list
93339562|NCT05082974|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93339563|NCT05082974|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93339564|NCT05082974|Cholinergic Agents|cholinergic agents|mesh-ancestor
93339565|NCT05082974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339566|NCT05082974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339567|NCT05082974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339568|NCT03604471|Atorvastatin|atorvastatin|mesh-list
93339569|NCT03604471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93339570|NCT03604471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93339571|NCT03604471|Antimetabolites|antimetabolites|mesh-ancestor
93339572|NCT03604471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339573|NCT03604471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93339574|NCT03604471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93339575|NCT03604471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339576|NCT03757130|Liraglutide|liraglutide|mesh-list
93339577|NCT03757130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93339578|NCT03757130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339579|NCT03757130|Incretins|incretins|mesh-ancestor
93339580|NCT03757130|Hormones|hormones|mesh-ancestor
93339581|NCT03757130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339582|NCT02237443|Bromides|bromides|mesh-list
93339583|NCT02237443|Rocuronium|rocuronium|mesh-list
93339584|NCT02237443|Vecuronium Bromide|vecuronium bromide|mesh-list
93339585|NCT02237443|Succinylcholine|succinylcholine|mesh-list
93339586|NCT02237443|Anticonvulsants|anticonvulsants|mesh-ancestor
93339587|NCT02237443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93339588|NCT02237443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93339589|NCT02237443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93339590|NCT02237443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633383|NCT00206193|Hormone Antagonists|hormone antagonists|mesh-ancestor
93339591|NCT02237443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339592|NCT02237443|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93339593|NCT02237443|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93339594|NCT02237443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93339595|NCT02237443|Cholinergic Agents|cholinergic agents|mesh-ancestor
93339596|NCT02237443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339597|NCT02237443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339598|NCT03141398|Pancrelipase|pancrelipase|mesh-list
93339599|NCT03141398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339600|NCT03733418|Vitamin D|vitamin d|mesh-list
93339601|NCT03733418|Cholecalciferol|cholecalciferol|mesh-list
93339602|NCT03733418|Vitamins|vitamins|mesh-ancestor
93339603|NCT03733418|Micronutrients|micronutrients|mesh-ancestor
93339604|NCT03733418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339605|NCT03733418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93339606|NCT03733418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93339607|NCT03607331|Citalopram|citalopram|mesh-list
93339608|NCT03607331|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93339609|NCT03607331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93339610|NCT03607331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339611|NCT03607331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339612|NCT03607331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339613|NCT03607331|Serotonin Agents|serotonin agents|mesh-ancestor
93339614|NCT03607331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339615|NCT03607331|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93339616|NCT03607331|Antidepressive Agents|antidepressive agents|mesh-ancestor
93339617|NCT03607331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93339618|NCT05082896|Anesthetics|anesthetics|mesh-list
93339619|NCT05082896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339620|NCT05082896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339621|NCT03607955|Paclitaxel|paclitaxel|mesh-list
93339622|NCT03607955|Carboplatin|carboplatin|mesh-list
93339623|NCT03607955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93339624|NCT03607955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339625|NCT03607955|Tubulin Modulators|tubulin modulators|mesh-ancestor
93339626|NCT03607955|Antimitotic Agents|antimitotic agents|mesh-ancestor
93339627|NCT03607955|Mitosis Modulators|mitosis modulators|mesh-ancestor
93339628|NCT03607955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339629|NCT02067975|Tryptophan|tryptophan|mesh-list
93339630|NCT02067975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93339631|NCT02067975|Antidepressive Agents|antidepressive agents|mesh-ancestor
93339632|NCT02067975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93339633|NCT03143036|Thalidomide|thalidomide|mesh-list
93339634|NCT03143036|Dexamethasone|dexamethasone|mesh-list
93339635|NCT03143036|Daratumumab|daratumumab|mesh-list
93339636|NCT03143036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339637|NCT03143036|Antiemetics|antiemetics|mesh-ancestor
93339638|NCT03143036|Autonomic Agents|autonomic agents|mesh-ancestor
93339639|NCT03143036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339640|NCT03143036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339641|NCT03143036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339642|NCT03143036|Glucocorticoids|glucocorticoids|mesh-ancestor
93339643|NCT03143036|Hormones|hormones|mesh-ancestor
93339644|NCT03143036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339645|NCT03143036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339646|NCT03143036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339647|NCT03143036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339648|NCT03143036|Immunologic Factors|immunologic factors|mesh-ancestor
93339649|NCT03143036|Leprostatic Agents|leprostatic agents|mesh-ancestor
93339650|NCT03143036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93339651|NCT03143036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339652|NCT03143036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93339653|NCT03143036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93339654|NCT03143036|Growth Substances|growth substances|mesh-ancestor
93339655|NCT03143036|Growth Inhibitors|growth inhibitors|mesh-ancestor
93339656|NCT03607175|Triamcinolone|triamcinolone|mesh-list
93339657|NCT03607175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93339658|NCT03607175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339659|NCT03607175|Glucocorticoids|glucocorticoids|mesh-ancestor
93339660|NCT03607175|Hormones|hormones|mesh-ancestor
93339661|NCT03607175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339662|NCT03607175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339663|NCT03607175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339664|NCT03607175|Immunologic Factors|immunologic factors|mesh-ancestor
93339665|NCT05082662|Diclofenac|diclofenac|mesh-list
93339666|NCT05082662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93339667|NCT05082662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339668|NCT05082662|Analgesics|analgesics|mesh-ancestor
93339669|NCT05082662|Sensory System Agents|sensory system agents|mesh-ancestor
93339670|NCT05082662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339671|NCT05082662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339672|NCT05082662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339673|NCT05082662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339674|NCT05082662|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93339675|NCT05082662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339676|NCT05082662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339677|NCT05080010|Carboplatin|carboplatin|mesh-list
93339678|NCT05080010|Etoposide|etoposide|mesh-list
93339679|NCT05080010|Vincristine|vincristine|mesh-list
93339680|NCT05080010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339681|NCT05080010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93339682|NCT05080010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93339683|NCT05080010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93339684|NCT05080010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339685|NCT05080010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339686|NCT05080010|Tubulin Modulators|tubulin modulators|mesh-ancestor
93339687|NCT05080010|Antimitotic Agents|antimitotic agents|mesh-ancestor
93339688|NCT05080010|Mitosis Modulators|mitosis modulators|mesh-ancestor
93339689|NCT03385551|Estradiol|estradiol|mesh-list
93339690|NCT03385551|Estrogens|estrogens|mesh-ancestor
93339691|NCT03385551|Hormones|hormones|mesh-ancestor
93339692|NCT03385551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339693|NCT03385551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339694|NCT03606473|Amphetamine|amphetamine|mesh-list
93339695|NCT03606473|Dextroamphetamine|dextroamphetamine|mesh-list
93339696|NCT03606473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93339697|NCT03606473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339698|NCT03606473|Sympathomimetics|sympathomimetics|mesh-ancestor
93339699|NCT03606473|Autonomic Agents|autonomic agents|mesh-ancestor
93339700|NCT03606473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339701|NCT03606473|Dopamine Agents|dopamine agents|mesh-ancestor
93339702|NCT03606473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339703|NCT03606473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339704|NCT03606473|Adrenergic Agents|adrenergic agents|mesh-ancestor
93339705|NCT03606473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93339706|NCT03606473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93339707|NCT03606473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339708|NCT03606473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93339709|NCT03316274|Nivolumab|nivolumab|mesh-list
93339710|NCT03316274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339711|NCT03316274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339712|NCT03316274|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93339713|NCT03316274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339714|NCT03252626|Alprostadil|alprostadil|mesh-list
93339715|NCT03252626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93339716|NCT03252626|Vasodilator Agents|vasodilator agents|mesh-ancestor
93339717|NCT03252626|Urological Agents|urological agents|mesh-ancestor
93339718|NCT05072054|Atorvastatin|atorvastatin|mesh-list
93339719|NCT05072054|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93339720|NCT05072054|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93339721|NCT05072054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93339722|NCT05072054|Antimetabolites|antimetabolites|mesh-ancestor
93339723|NCT05072054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339724|NCT05072054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93339725|NCT05072054|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93339726|NCT05072054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339727|NCT03142880|Ropivacaine|ropivacaine|mesh-list
93339728|NCT03142880|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339729|NCT03142880|Anesthetics|anesthetics|mesh-ancestor
93339730|NCT03142880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339731|NCT03142880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339732|NCT03142880|Sensory System Agents|sensory system agents|mesh-ancestor
93339733|NCT03142880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339734|NCT03605537|Mometasone Furoate|mometasone furoate|mesh-list
93339735|NCT03605537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339736|NCT03605537|Dermatologic Agents|dermatologic agents|mesh-ancestor
93339737|NCT03605537|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93339738|NCT05379803|Aflutinib|aflutinib|mesh-list
93339739|NCT05379803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93339740|NCT05379803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339741|NCT05379803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339742|NCT03381495|Sufentanil|sufentanil|mesh-list
93339743|NCT03381495|Ropivacaine|ropivacaine|mesh-list
93339744|NCT03381495|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339745|NCT03381495|Anesthetics|anesthetics|mesh-ancestor
93339746|NCT03381495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339747|NCT03381495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339748|NCT03381495|Sensory System Agents|sensory system agents|mesh-ancestor
93339749|NCT03381495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339750|NCT03381495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93339751|NCT03381495|Narcotics|narcotics|mesh-ancestor
93339752|NCT03381495|Analgesics|analgesics|mesh-ancestor
93339753|NCT03381495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93339754|NCT03381495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93339755|NCT03381495|Anesthetics, General|anesthetics, general|mesh-ancestor
93339756|NCT03059498|Bupivacaine|bupivacaine|mesh-list
93339757|NCT03059498|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339758|NCT03059498|Anesthetics|anesthetics|mesh-ancestor
93339759|NCT03059498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339760|NCT03059498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339761|NCT03059498|Sensory System Agents|sensory system agents|mesh-ancestor
93339762|NCT03059498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339763|NCT03142646|Cyclophosphamide|cyclophosphamide|mesh-list
93339764|NCT03142646|Fludarabine|fludarabine|mesh-list
93339765|NCT03142646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339766|NCT03142646|Immunologic Factors|immunologic factors|mesh-ancestor
93339767|NCT03142646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339768|NCT03142646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339769|NCT03142646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339770|NCT03142646|Alkylating Agents|alkylating agents|mesh-ancestor
93339771|NCT03142646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339772|NCT03142646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339773|NCT03142646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93339774|NCT03541083|Blinatumomab|blinatumomab|mesh-list
93339775|NCT03541083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339776|NCT04962230|Ritonavir|ritonavir|mesh-list
93339777|NCT04962230|Nirmatrelvir|nirmatrelvir|mesh-list
93339778|NCT04962230|Carbamazepine|carbamazepine|mesh-list
93339779|NCT04962230|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93339780|NCT04962230|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93339781|NCT04962230|Protease Inhibitors|protease inhibitors|mesh-ancestor
93339782|NCT04962230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339783|NCT04962230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339784|NCT04962230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93339785|NCT04962230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93339786|NCT04962230|Antiviral Agents|antiviral agents|mesh-ancestor
93339787|NCT04962230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339788|NCT04962230|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93339789|NCT04962230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93339790|NCT04962230|Anticonvulsants|anticonvulsants|mesh-ancestor
93339791|NCT04962230|Antimanic Agents|antimanic agents|mesh-ancestor
93339792|NCT04962230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93339793|NCT04962230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339794|NCT04962230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339795|NCT04962230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93339796|NCT04962230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339797|NCT04962230|Analgesics|analgesics|mesh-ancestor
93339798|NCT04962230|Sensory System Agents|sensory system agents|mesh-ancestor
93339799|NCT04962230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339800|NCT04962230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93339801|NCT04962230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339802|NCT04962230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93339803|NCT04962230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93339804|NCT03602027|Gefitinib|gefitinib|mesh-list
93339805|NCT03602027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339806|NCT03602027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93339807|NCT03602027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633588|NCT00201396|Antidotes|antidotes|mesh-ancestor
93339808|NCT03602027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339809|NCT03141476|Cefuroxime|cefuroxime|mesh-list
93339810|NCT03141476|Cefuroxime axetil|cefuroxime axetil|mesh-list
93339811|NCT03141476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93339812|NCT03141476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339813|NCT03601871|Thalidomide|thalidomide|mesh-list
93339814|NCT03601871|Dexamethasone|dexamethasone|mesh-list
93339815|NCT03601871|Palonosetron|palonosetron|mesh-list
93339816|NCT03601871|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
93339817|NCT03601871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339818|NCT03601871|Antiemetics|antiemetics|mesh-ancestor
93339819|NCT03601871|Autonomic Agents|autonomic agents|mesh-ancestor
93339820|NCT03601871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339821|NCT03601871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339822|NCT03601871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93339823|NCT03601871|Glucocorticoids|glucocorticoids|mesh-ancestor
93339824|NCT03601871|Hormones|hormones|mesh-ancestor
93366444|NCT02796677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339825|NCT03601871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93339826|NCT03601871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93339827|NCT03601871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339828|NCT03601871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339829|NCT03601871|Immunologic Factors|immunologic factors|mesh-ancestor
93339830|NCT03601871|Leprostatic Agents|leprostatic agents|mesh-ancestor
93339831|NCT03601871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93339832|NCT03601871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339833|NCT03601871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93339834|NCT03601871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93339835|NCT03601871|Growth Substances|growth substances|mesh-ancestor
93339836|NCT03601871|Growth Inhibitors|growth inhibitors|mesh-ancestor
93339837|NCT03601871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93339838|NCT03601871|Serotonin Agents|serotonin agents|mesh-ancestor
93339839|NCT03601871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339840|NCT03601871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339841|NCT03380949|Remifentanil|remifentanil|mesh-list
93339842|NCT03380949|Analgesics, Opioid|analgesics, opioid|mesh-list
93339843|NCT03380949|Narcotics|narcotics|mesh-ancestor
93339844|NCT03380949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339845|NCT03380949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339846|NCT03380949|Analgesics|analgesics|mesh-ancestor
93339847|NCT03380949|Sensory System Agents|sensory system agents|mesh-ancestor
93339848|NCT03380949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339849|NCT03604757|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93339850|NCT03604757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93339851|NCT03604757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339852|NCT03604679|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93339853|NCT03604679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93339854|NCT03604679|Alkylating Agents|alkylating agents|mesh-ancestor
93339855|NCT03604679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339856|NCT03604679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339857|NCT05078372|Midazolam|midazolam|mesh-list
93339858|NCT05078372|Ropivacaine|ropivacaine|mesh-list
93339859|NCT05078372|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339860|NCT05078372|Anesthetics|anesthetics|mesh-ancestor
93339861|NCT05078372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339862|NCT05078372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339863|NCT05078372|Sensory System Agents|sensory system agents|mesh-ancestor
93339864|NCT05078372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339865|NCT05078372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93339866|NCT05078372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93339867|NCT05078372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93339868|NCT05078372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93339869|NCT05078372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93339870|NCT05078372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93339871|NCT05078372|Anesthetics, General|anesthetics, general|mesh-ancestor
93339872|NCT05078372|GABA Modulators|gaba modulators|mesh-ancestor
93339873|NCT05078372|GABA Agents|gaba agents|mesh-ancestor
93339874|NCT05078372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339875|NCT05078372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339876|NCT03380871|Carboplatin|carboplatin|mesh-list
93339877|NCT03380871|Pembrolizumab|pembrolizumab|mesh-list
93339878|NCT03380871|Pemetrexed|pemetrexed|mesh-list
93339879|NCT03380871|Poly ICLC|poly iclc|mesh-list
92633662|NCT00179231|Olanzapine|olanzapine|mesh-list
93339880|NCT03380871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339881|NCT03380871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339882|NCT03380871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93339883|NCT03380871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339884|NCT03380871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339885|NCT03380871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93339886|NCT03380871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93339887|NCT03380871|Interferon Inducers|interferon inducers|mesh-ancestor
93339888|NCT03380871|Immunologic Factors|immunologic factors|mesh-ancestor
93339889|NCT03380871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339890|NCT02237495|Dexmedetomidine|dexmedetomidine|mesh-list
93339891|NCT02237495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93339892|NCT02237495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339893|NCT02237495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339894|NCT02237495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339895|NCT02237495|Analgesics|analgesics|mesh-ancestor
93339896|NCT02237495|Sensory System Agents|sensory system agents|mesh-ancestor
93339897|NCT02237495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339898|NCT02237495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93339899|NCT02237495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93339900|NCT02237495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93339901|NCT02237495|Adrenergic Agents|adrenergic agents|mesh-ancestor
93339902|NCT02237495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339903|NCT02237495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339904|NCT02486666|Enoxaparin|enoxaparin|mesh-list
93339905|NCT02486666|Enoxaparin sodium|enoxaparin sodium|mesh-list
93339906|NCT02486666|Anticoagulants|anticoagulants|mesh-ancestor
93339907|NCT02486666|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93339908|NCT02486666|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93339909|NCT02486666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339910|NCT02237807|Dirithromycin|dirithromycin|mesh-list
93339911|NCT02237807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93339912|NCT02237807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339913|NCT03125187|Heparin|heparin|mesh-list
93339914|NCT03125187|Calcium heparin|calcium heparin|mesh-list
93339915|NCT03125187|Anticoagulants|anticoagulants|mesh-ancestor
93339916|NCT03125187|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93339917|NCT03125187|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93339918|NCT03125187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339919|NCT02038946|Nivolumab|nivolumab|mesh-list
93339920|NCT02038946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93339921|NCT02038946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339922|NCT02038946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93339923|NCT02038946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339924|NCT03377907|Lidocaine|lidocaine|mesh-list
93339925|NCT03377907|Ketamine|ketamine|mesh-list
93339926|NCT03377907|Anesthetics, Local|anesthetics, local|mesh-ancestor
93339927|NCT03377907|Anesthetics|anesthetics|mesh-ancestor
93339928|NCT03377907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339929|NCT03377907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339930|NCT03377907|Sensory System Agents|sensory system agents|mesh-ancestor
93339931|NCT03377907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339932|NCT03377907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93339933|NCT03377907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93339934|NCT03377907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93339935|NCT03377907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339936|NCT03377907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339937|NCT03377907|Analgesics|analgesics|mesh-ancestor
93339938|NCT03377907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93339939|NCT03377907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93339940|NCT03377907|Anesthetics, General|anesthetics, general|mesh-ancestor
93339941|NCT03377907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93339942|NCT03377907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93339943|NCT03377907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93339944|NCT03141554|Chlorhexidine|chlorhexidine|mesh-list
93339945|NCT03141554|Povidone-Iodine|povidone-iodine|mesh-list
93339946|NCT03141554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93339947|NCT03141554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339948|NCT03141554|Disinfectants|disinfectants|mesh-ancestor
93339949|NCT03369795|Methotrexate|methotrexate|mesh-list
93339950|NCT03369795|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93339951|NCT03369795|Abortifacient Agents|abortifacient agents|mesh-ancestor
93339952|NCT03369795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93339953|NCT03369795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339954|NCT03369795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93339955|NCT03369795|Antimetabolites|antimetabolites|mesh-ancestor
93339956|NCT03369795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339957|NCT03369795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93339958|NCT03369795|Dermatologic Agents|dermatologic agents|mesh-ancestor
93339959|NCT03369795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339960|NCT03369795|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93339961|NCT03369795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93339962|NCT03369795|Immunologic Factors|immunologic factors|mesh-ancestor
93339963|NCT03369795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339964|NCT03369795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93339965|NCT03374709|Oxcarbazepine|oxcarbazepine|mesh-list
93339966|NCT03374709|Anticonvulsants|anticonvulsants|mesh-ancestor
93339967|NCT03374709|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93339968|NCT03374709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93339969|NCT03374709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93339970|NCT03374709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339971|NCT03374709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93339972|NCT03374709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93339973|NCT05393414|Acetaminophen|acetaminophen|mesh-list
93339974|NCT05393414|Ketorolac|ketorolac|mesh-list
93339975|NCT05393414|Morphine|morphine|mesh-list
93339976|NCT05393414|Analgesics, Opioid|analgesics, opioid|mesh-list
93339977|NCT05393414|Narcotics|narcotics|mesh-ancestor
93339978|NCT05393414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93339979|NCT05393414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339980|NCT05393414|Analgesics|analgesics|mesh-ancestor
93339981|NCT05393414|Sensory System Agents|sensory system agents|mesh-ancestor
93339982|NCT05393414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93339983|NCT05393414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93339984|NCT05393414|Antipyretics|antipyretics|mesh-ancestor
93339985|NCT05393414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93339986|NCT05393414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93339987|NCT05393414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93339988|NCT05393414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93339989|NCT05393414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93339990|NCT05393414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93339991|NCT03369327|Sofosbuvir|sofosbuvir|mesh-list
93339992|NCT03369327|Antiviral Agents|antiviral agents|mesh-ancestor
93339993|NCT03369327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93339994|NCT02034500|Vaccines|vaccines|mesh-list
93339995|NCT02034500|Immunologic Factors|immunologic factors|mesh-ancestor
93339996|NCT02034500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93339997|NCT03377283|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93339998|NCT03377283|Thymoglobulin|thymoglobulin|mesh-list
93339999|NCT03377283|Immunologic Factors|immunologic factors|mesh-ancestor
93340000|NCT03377283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340001|NCT03377283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93340002|NCT03955640|Olaparib|olaparib|mesh-list
93340003|NCT03955640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93340004|NCT03955640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340005|NCT03955640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340006|NCT03955640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340007|NCT03369093|Amoxicillin|amoxicillin|mesh-list
93340008|NCT03369093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93340009|NCT03369093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340010|NCT03369015|Amphetamine|amphetamine|mesh-list
93340011|NCT03369015|Dextroamphetamine|dextroamphetamine|mesh-list
93340012|NCT03369015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93340013|NCT03369015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340014|NCT03369015|Sympathomimetics|sympathomimetics|mesh-ancestor
93340015|NCT03369015|Autonomic Agents|autonomic agents|mesh-ancestor
93340016|NCT03369015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340017|NCT03369015|Dopamine Agents|dopamine agents|mesh-ancestor
93340018|NCT03369015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340019|NCT03369015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340020|NCT03369015|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340021|NCT03369015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93340022|NCT03369015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93340023|NCT03369015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340024|NCT03369015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93340025|NCT03890744|Docetaxel|docetaxel|mesh-list
93340026|NCT03890744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340027|NCT03890744|Tubulin Modulators|tubulin modulators|mesh-ancestor
93340028|NCT03890744|Antimitotic Agents|antimitotic agents|mesh-ancestor
93340029|NCT03890744|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340030|NCT03890744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340031|NCT03374163|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93340032|NCT03374163|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93340033|NCT03374163|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93340034|NCT03374163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93340035|NCT03374007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93340036|NCT03374007|Antibodies|antibodies|mesh-list
93340037|NCT03374007|Immunoglobulins|immunoglobulins|mesh-list
93340038|NCT03374007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93340039|NCT03374007|Immunologic Factors|immunologic factors|mesh-ancestor
93340040|NCT03374007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340041|NCT03374007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340042|NCT04525521|Hand Sanitizers|hand sanitizers|mesh-list
93340043|NCT04525521|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93340044|NCT04525521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340045|NCT04525521|Disinfectants|disinfectants|mesh-ancestor
93340046|NCT05392166|Calcium|calcium|mesh-list
93340047|NCT05392166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93340048|NCT05392166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340050|NCT02853331|Sunitinib|sunitinib|mesh-list
93340051|NCT02853331|Axitinib|axitinib|mesh-list
93340052|NCT02853331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340053|NCT02853331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340054|NCT02853331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93340055|NCT02853331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340056|NCT02853331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93340057|NCT02853331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93340058|NCT02853331|Growth Substances|growth substances|mesh-ancestor
93340059|NCT02853331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340060|NCT02853331|Growth Inhibitors|growth inhibitors|mesh-ancestor
93340061|NCT02853331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93340062|NCT02853331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340063|NCT03136640|Docetaxel|docetaxel|mesh-list
93340064|NCT03136640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340065|NCT03136640|Tubulin Modulators|tubulin modulators|mesh-ancestor
93340066|NCT03136640|Antimitotic Agents|antimitotic agents|mesh-ancestor
93340067|NCT03136640|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340068|NCT03136640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340069|NCT02675439|Ipilimumab|ipilimumab|mesh-list
93340070|NCT02675439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340071|NCT02675439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340072|NCT02675439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93340073|NCT02675439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340074|NCT03604003|Losartan|losartan|mesh-list
93340075|NCT03604003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340076|NCT03604003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93340077|NCT03604003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93340078|NCT03604003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93340079|NCT03604003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340080|NCT03368391|Lidocaine|lidocaine|mesh-list
93340081|NCT03368391|Phenylephrine|phenylephrine|mesh-list
93340082|NCT03368391|Epinephrine|epinephrine|mesh-list
93340083|NCT03368391|Racepinephrine|racepinephrine|mesh-list
93340084|NCT03368391|Oxymetazoline|oxymetazoline|mesh-list
93340085|NCT03368391|Tetracaine|tetracaine|mesh-list
93340086|NCT03368391|Mepivacaine|mepivacaine|mesh-list
93340087|NCT03368391|Epinephryl borate|epinephryl borate|mesh-list
93340088|NCT03368391|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340089|NCT03368391|Anesthetics|anesthetics|mesh-ancestor
93340090|NCT03368391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340091|NCT03368391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340092|NCT03368391|Sensory System Agents|sensory system agents|mesh-ancestor
93340093|NCT03368391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340094|NCT03368391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340095|NCT03368391|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340096|NCT03368391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340097|NCT03368391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340098|NCT03368391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340099|NCT03368391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93340100|NCT03368391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93340101|NCT03368391|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340102|NCT03368391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340103|NCT03368391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93340104|NCT03368391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93340105|NCT03368391|Autonomic Agents|autonomic agents|mesh-ancestor
93340106|NCT03368391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93340107|NCT03368391|Respiratory System Agents|respiratory system agents|mesh-ancestor
93340108|NCT03368391|Mydriatics|mydriatics|mesh-ancestor
93340109|NCT03368391|Sympathomimetics|sympathomimetics|mesh-ancestor
93340110|NCT03368391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93340111|NCT03368391|Nasal Decongestants|nasal decongestants|mesh-ancestor
93340112|NCT03368391|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93340113|NCT03368391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93340114|NCT03368391|Protective Agents|protective agents|mesh-ancestor
93340115|NCT03373305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93340116|NCT03373305|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93340117|NCT03373305|Lenalidomide|lenalidomide|mesh-list
93340118|NCT03373305|Piperidine|piperidine|mesh-list
93340119|NCT03373305|Antibodies|antibodies|mesh-list
93340120|NCT03373305|Immunoglobulins|immunoglobulins|mesh-list
93340121|NCT03373305|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93340122|NCT03373305|Immunoconjugates|immunoconjugates|mesh-list
93340123|NCT03373305|Immunologic Factors|immunologic factors|mesh-ancestor
93012069|NCT00826553|Anesthetics|anesthetics|mesh-ancestor
93340124|NCT03373305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340125|NCT03373305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340126|NCT03373305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93340127|NCT03373305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93340128|NCT03373305|Growth Substances|growth substances|mesh-ancestor
93340129|NCT03373305|Growth Inhibitors|growth inhibitors|mesh-ancestor
93340130|NCT03373305|Immunotoxins|immunotoxins|mesh-ancestor
93340131|NCT03373305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93340132|NCT03373305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340133|NCT03373305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340134|NCT03373305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93340135|NCT03376737|Pemetrexed|pemetrexed|mesh-list
93340136|NCT03376737|Apatinib|apatinib|mesh-list
93340137|NCT03376737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340138|NCT03376737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340139|NCT03376737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340140|NCT03376737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93340141|NCT03376737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93340142|NCT03376737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93340143|NCT03373227|Tacrolimus|tacrolimus|mesh-list
93340144|NCT03373227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93340145|NCT03373227|Immunologic Factors|immunologic factors|mesh-ancestor
93340146|NCT03373227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340147|NCT03373227|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93340148|NCT03373227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340149|NCT03373227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340150|NCT02484716|Timolol|timolol|mesh-list
93340151|NCT02484716|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93340152|NCT02484716|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93340153|NCT02484716|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340154|NCT02484716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340155|NCT02484716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340156|NCT02484716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340157|NCT02484716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340158|NCT02484716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93340159|NCT03373149|Hormones|hormones|mesh-list
93340160|NCT03373149|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93340161|NCT03373149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340162|NCT03373149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340163|NCT05386784|Cholecalciferol|cholecalciferol|mesh-list
93340164|NCT05386784|Vitamin D|vitamin d|mesh-list
93340165|NCT05386784|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93340166|NCT05386784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93340167|NCT05386784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340168|NCT05386784|Vitamins|vitamins|mesh-ancestor
93340169|NCT05386784|Micronutrients|micronutrients|mesh-ancestor
93340170|NCT05386784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93340171|NCT05386784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93340172|NCT05386784|Hormone Antagonists|hormone antagonists|mesh-ancestor
93340173|NCT05386784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340174|NCT05386784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93340175|NCT05386784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93340176|NCT03602287|Lidocaine|lidocaine|mesh-list
93340177|NCT03602287|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340178|NCT03602287|Anesthetics|anesthetics|mesh-ancestor
93340179|NCT03602287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340180|NCT03602287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340181|NCT03602287|Sensory System Agents|sensory system agents|mesh-ancestor
93340182|NCT03602287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340183|NCT03602287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340184|NCT03602287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340185|NCT03602287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340186|NCT03602287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340187|NCT03602287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340188|NCT03137498|Ketorolac|ketorolac|mesh-list
93340189|NCT03137498|Lidocaine|lidocaine|mesh-list
93340190|NCT03137498|Prilocaine|prilocaine|mesh-list
93340191|NCT03137498|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340192|NCT03137498|Anesthetics|anesthetics|mesh-ancestor
93340193|NCT03137498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340194|NCT03137498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340195|NCT03137498|Sensory System Agents|sensory system agents|mesh-ancestor
93012141|NCT00830843|Propofol|propofol|mesh-list
93340197|NCT03137498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340198|NCT03137498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340199|NCT03137498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340200|NCT03137498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340201|NCT03137498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340202|NCT03137498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93340203|NCT03137498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93340204|NCT03137498|Analgesics|analgesics|mesh-ancestor
93340205|NCT03137498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340206|NCT03137498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93340207|NCT03137498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93340208|NCT03137498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340209|NCT03602209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93340210|NCT03602209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340211|NCT03367377|Insulin Glargine|insulin glargine|mesh-list
93340212|NCT03367377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93340213|NCT03367377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340214|NCT03602131|Gemcitabine|gemcitabine|mesh-list
93340215|NCT03602131|Busulfan|busulfan|mesh-list
93340216|NCT03602131|Cladribine|cladribine|mesh-list
93340217|NCT03602131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340218|NCT03602131|Antimetabolites|antimetabolites|mesh-ancestor
93340219|NCT03602131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340220|NCT03602131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340221|NCT03602131|Alkylating Agents|alkylating agents|mesh-ancestor
93340222|NCT03602131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93340223|NCT03602131|Immunologic Factors|immunologic factors|mesh-ancestor
93340224|NCT03602131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340225|NCT03602131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93340226|NCT03602131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93340227|NCT05851547|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93340228|NCT05851547|Androgens|androgens|mesh-list
93340229|NCT05851547|Hormones|hormones|mesh-ancestor
93340230|NCT05851547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340231|NCT05851547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340232|NCT05851547|Luteolytic Agents|luteolytic agents|mesh-ancestor
93340233|NCT05851547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93340234|NCT05851547|Contraceptive Agents|contraceptive agents|mesh-ancestor
93340235|NCT05851547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93340236|NCT05851547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93340237|NCT05851547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93340238|NCT05851547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340239|NCT05851508|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93340240|NCT05851508|Methylprednisolone|methylprednisolone|mesh-list
93340241|NCT05851508|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93340242|NCT05851508|Prednisolone|prednisolone|mesh-list
93340243|NCT05851508|Prednisolone acetate|prednisolone acetate|mesh-list
93340244|NCT05851508|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93340245|NCT05851508|Prednisolone phosphate|prednisolone phosphate|mesh-list
93340246|NCT05851508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340247|NCT05851508|Antiemetics|antiemetics|mesh-ancestor
93340248|NCT05851508|Autonomic Agents|autonomic agents|mesh-ancestor
93340249|NCT05851508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340250|NCT05851508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340251|NCT05851508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340252|NCT05851508|Glucocorticoids|glucocorticoids|mesh-ancestor
93340253|NCT05851508|Hormones|hormones|mesh-ancestor
93340254|NCT05851508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340255|NCT05851508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93340256|NCT05851508|Protective Agents|protective agents|mesh-ancestor
93340257|NCT05851508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93340258|NCT05851508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340259|NCT05851391|Anesthetics|anesthetics|mesh-list
93340260|NCT05851391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340261|NCT05851391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340262|NCT05851352|Antibodies|antibodies|mesh-list
93340263|NCT05851352|Immunologic Factors|immunologic factors|mesh-ancestor
93340264|NCT05851352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340265|NCT05851014|Letrozole|letrozole|mesh-list
93340266|NCT05851014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340267|NCT05851014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93340268|NCT05851014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93340269|NCT05851014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340270|NCT05851014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340271|NCT05851014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93340272|NCT05851014|Hormone Antagonists|hormone antagonists|mesh-ancestor
93340273|NCT05851014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340274|NCT05851014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340275|NCT05850936|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93340276|NCT05850936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93340277|NCT05850871|Aztreonam|aztreonam|mesh-list
93340278|NCT05850871|Avibactam|avibactam|mesh-list
93340279|NCT05850871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93340280|NCT05850871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340281|NCT05850871|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93340282|NCT05850871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340283|NCT05850871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340284|NCT05850832|Magnesium Sulfate|magnesium sulfate|mesh-list
93340285|NCT05850832|Esmolol|esmolol|mesh-list
93340286|NCT05850832|Analgesics|analgesics|mesh-ancestor
93340287|NCT05850832|Sensory System Agents|sensory system agents|mesh-ancestor
93340288|NCT05850832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340289|NCT05850832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340290|NCT05850832|Anesthetics|anesthetics|mesh-ancestor
93340291|NCT05850832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340292|NCT05850832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340293|NCT05850832|Anticonvulsants|anticonvulsants|mesh-ancestor
93340294|NCT05850832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93340295|NCT05850832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340296|NCT05850832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340297|NCT05850832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93340298|NCT05850832|Tocolytic Agents|tocolytic agents|mesh-ancestor
93340299|NCT05850832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93340300|NCT05850832|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93340301|NCT05850832|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93340302|NCT05850832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93340303|NCT05850832|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340304|NCT05850832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340305|NCT05850702|Lidocaine|lidocaine|mesh-list
93340306|NCT05850702|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340307|NCT05850702|Anesthetics|anesthetics|mesh-ancestor
93340308|NCT05850702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340309|NCT05850702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340310|NCT05850702|Sensory System Agents|sensory system agents|mesh-ancestor
93340311|NCT05850702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340312|NCT05850702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340313|NCT05850702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340314|NCT05850702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340315|NCT05850702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340316|NCT05850702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340317|NCT05850559|Mitogens|mitogens|mesh-list
93340318|NCT05850559|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340319|NCT05850559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340320|NCT05850546|Prednisone|prednisone|mesh-list
93340321|NCT05850546|Prednisolone|prednisolone|mesh-list
93340322|NCT05850546|Rituximab|rituximab|mesh-list
93340323|NCT05850546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340324|NCT05850546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340325|NCT05850546|Immunologic Factors|immunologic factors|mesh-ancestor
93340326|NCT05850546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340327|NCT05850546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93340328|NCT05850546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340329|NCT05850546|Glucocorticoids|glucocorticoids|mesh-ancestor
93340330|NCT05850546|Hormones|hormones|mesh-ancestor
93340331|NCT05850546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340332|NCT05850546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93340333|NCT05850507|Vaccines|vaccines|mesh-list
93340334|NCT05850507|Immunologic Factors|immunologic factors|mesh-ancestor
93340335|NCT05850507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340336|NCT05850468|Lidocaine|lidocaine|mesh-list
93340337|NCT05850468|Fentanyl|fentanyl|mesh-list
93340338|NCT05850468|Anesthetics|anesthetics|mesh-list
93340339|NCT05850468|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340340|NCT05850468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340341|NCT05850468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340342|NCT05850468|Sensory System Agents|sensory system agents|mesh-ancestor
93012326|NCT05888922|Minoxidil|minoxidil|mesh-list
93340343|NCT05850468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340344|NCT05850468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340345|NCT05850468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340346|NCT05850468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340347|NCT05850468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340348|NCT05850468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340349|NCT05850468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93340350|NCT05850468|Narcotics|narcotics|mesh-ancestor
93340351|NCT05850468|Analgesics|analgesics|mesh-ancestor
93340352|NCT05850468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93340353|NCT05850468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93340354|NCT05850468|Anesthetics, General|anesthetics, general|mesh-ancestor
93340355|NCT05850455|Lidocaine|lidocaine|mesh-list
93340356|NCT05850455|Dexmedetomidine|dexmedetomidine|mesh-list
93340357|NCT05850455|Bupivacaine|bupivacaine|mesh-list
93340358|NCT05850455|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340359|NCT05850455|Anesthetics|anesthetics|mesh-ancestor
93340360|NCT05850455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340361|NCT05850455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340362|NCT05850455|Sensory System Agents|sensory system agents|mesh-ancestor
93340363|NCT05850455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340364|NCT05850455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340365|NCT05850455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340366|NCT05850455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340367|NCT05850455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340368|NCT05850455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340369|NCT05850455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93340370|NCT05850455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93340371|NCT05850455|Analgesics|analgesics|mesh-ancestor
93340372|NCT05850455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93340373|NCT05850455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93340374|NCT05850455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93340375|NCT05850455|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340376|NCT05850455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340377|NCT05850377|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93340378|NCT05850377|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93340379|NCT05850377|Dermatologic Agents|dermatologic agents|mesh-ancestor
93340380|NCT05850143|Dexamethasone|dexamethasone|mesh-list
93340381|NCT05850143|Prednisolone|prednisolone|mesh-list
93340382|NCT05850143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340383|NCT05850143|Antiemetics|antiemetics|mesh-ancestor
93340384|NCT05850143|Autonomic Agents|autonomic agents|mesh-ancestor
93340385|NCT05850143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340386|NCT05850143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340387|NCT05850143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340388|NCT05850143|Glucocorticoids|glucocorticoids|mesh-ancestor
93340389|NCT05850143|Hormones|hormones|mesh-ancestor
93340390|NCT05850143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340391|NCT05850143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92634197|NCT00187083|Pegaspargase|pegaspargase|mesh-list
93340392|NCT05850143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340393|NCT05850117|Amoxicillin|amoxicillin|mesh-list
93340394|NCT05850117|Metronidazole|metronidazole|mesh-list
93340395|NCT05850117|Levofloxacin|levofloxacin|mesh-list
93340396|NCT05850117|Ofloxacin|ofloxacin|mesh-list
93340397|NCT05850117|Tetracycline|tetracycline|mesh-list
93340398|NCT05850117|Esomeprazole|esomeprazole|mesh-list
93340399|NCT05850117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93340400|NCT05850117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340401|NCT05850117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93340402|NCT05850117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93340403|NCT05850117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93340404|NCT05850117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340405|NCT05850117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93340406|NCT05850117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340407|NCT05850117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340408|NCT05850117|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93340409|NCT05850117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93340410|NCT05850117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93340411|NCT05850117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340412|NCT05850117|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93340413|NCT05850117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93340414|NCT05850117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93340415|NCT05850091|Colchicine|colchicine|mesh-list
93340416|NCT05850091|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93340417|NCT05850091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93340418|NCT05850091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93340419|NCT05850091|Antimetabolites|antimetabolites|mesh-ancestor
93340420|NCT05850091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340421|NCT05850091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93340422|NCT05850091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93340423|NCT05850091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340424|NCT05850091|Gout Suppressants|gout suppressants|mesh-ancestor
93340425|NCT05850091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93340426|NCT05850091|Tubulin Modulators|tubulin modulators|mesh-ancestor
93340427|NCT05850091|Antimitotic Agents|antimitotic agents|mesh-ancestor
93340428|NCT05850091|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340429|NCT05850091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340430|NCT05849883|Omeprazole|omeprazole|mesh-list
93340431|NCT05849883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93340432|NCT05849883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340433|NCT05849883|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93340434|NCT05849883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340435|NCT05849883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340436|NCT05849857|Dexamethasone|dexamethasone|mesh-list
93340437|NCT05849857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340438|NCT05849857|Antiemetics|antiemetics|mesh-ancestor
93340439|NCT05849857|Autonomic Agents|autonomic agents|mesh-ancestor
93340440|NCT05849857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340441|NCT05849857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340442|NCT05849857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340443|NCT05849857|Glucocorticoids|glucocorticoids|mesh-ancestor
93340444|NCT05849857|Hormones|hormones|mesh-ancestor
93340445|NCT05849857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340446|NCT05849857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93340447|NCT05849857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340448|NCT05849766|Dapagliflozin|dapagliflozin|mesh-list
93340449|NCT05849766|Carvedilol|carvedilol|mesh-list
93340450|NCT05849766|Ramipril|ramipril|mesh-list
93340451|NCT05849766|Spironolactone|spironolactone|mesh-list
93340452|NCT05849766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93340453|NCT05849766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340454|NCT05849766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93340455|NCT05849766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340456|NCT05849766|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93340457|NCT05849766|Hormone Antagonists|hormone antagonists|mesh-ancestor
93340458|NCT05849766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340459|NCT05849766|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93340460|NCT05849766|Diuretics|diuretics|mesh-ancestor
93340461|NCT05849766|Natriuretic Agents|natriuretic agents|mesh-ancestor
93340462|NCT05849766|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92634258|NCT00187122|Methotrexate|methotrexate|mesh-list
93340463|NCT05849766|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93340464|NCT05849766|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340465|NCT05849766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340466|NCT05849766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93340467|NCT05849766|Antioxidants|antioxidants|mesh-ancestor
93340468|NCT05849766|Protective Agents|protective agents|mesh-ancestor
93340469|NCT05849766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93340470|NCT05849766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340471|NCT05849766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93340472|NCT05849766|Vasodilator Agents|vasodilator agents|mesh-ancestor
93340473|NCT05849766|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93340474|NCT05849766|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93340475|NCT05849766|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93340476|NCT05849766|Protease Inhibitors|protease inhibitors|mesh-ancestor
93340477|NCT05849766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340478|NCT05849662|Cytarabine|cytarabine|mesh-list
93340479|NCT05849662|Fludarabine|fludarabine|mesh-list
93340480|NCT05849662|Azacitidine|azacitidine|mesh-list
93340481|NCT05849662|Trametinib|trametinib|mesh-list
93340482|NCT05849662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340483|NCT05849662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340484|NCT05849662|Antimetabolites|antimetabolites|mesh-ancestor
93340485|NCT05849662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340486|NCT05849662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93340487|NCT05849662|Immunologic Factors|immunologic factors|mesh-ancestor
93340488|NCT05849662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340489|NCT05849662|Antiviral Agents|antiviral agents|mesh-ancestor
93340490|NCT05849662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340491|NCT05849662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340492|NCT05849662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93340493|NCT05849597|Dexmedetomidine|dexmedetomidine|mesh-list
93340494|NCT05849597|Propofol|propofol|mesh-list
93340495|NCT05849597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93340496|NCT05849597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340497|NCT05849597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340498|NCT05849597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93340499|NCT05849597|Analgesics|analgesics|mesh-ancestor
93340500|NCT05849597|Sensory System Agents|sensory system agents|mesh-ancestor
93340501|NCT05849597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340502|NCT05849597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93340503|NCT05849597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93340504|NCT05849597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93340505|NCT05849597|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340506|NCT05849597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340507|NCT05849597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340508|NCT05849597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93340509|NCT05849597|Anesthetics, General|anesthetics, general|mesh-ancestor
93340510|NCT05849597|Anesthetics|anesthetics|mesh-ancestor
93340511|NCT05847283|Dydrogesterone|dydrogesterone|mesh-list
93340512|NCT05847283|Progestins|progestins|mesh-ancestor
93340513|NCT05847283|Hormones|hormones|mesh-ancestor
93340514|NCT05847283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340515|NCT05847283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340516|NCT05846724|Pembrolizumab|pembrolizumab|mesh-list
93340517|NCT05846724|Lenvatinib|lenvatinib|mesh-list
93340518|NCT05846724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340519|NCT05846724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340520|NCT05846724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93340521|NCT05846724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340522|NCT05846724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93340523|NCT05846724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340524|NCT05846659|Pembrolizumab|pembrolizumab|mesh-list
93340525|NCT05846659|Nivolumab|nivolumab|mesh-list
93340526|NCT05846659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93340527|NCT05846659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340528|NCT05846659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340529|NCT05846659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340530|NCT05846620|Dimercaprol|dimercaprol|mesh-list
93340531|NCT05846620|Chelating Agents|chelating agents|mesh-ancestor
93340532|NCT05846620|Sequestering Agents|sequestering agents|mesh-ancestor
93340533|NCT05846620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340534|NCT05845580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93340535|NCT05845580|Red yeast rice|red yeast rice|mesh-list
93340536|NCT05845580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93340537|NCT05845580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93340538|NCT05845580|Antimetabolites|antimetabolites|mesh-ancestor
93340539|NCT05845580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340540|NCT05845580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340541|NCT05845580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93340542|NCT05845099|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
93340543|NCT05845099|Vasodilator Agents|vasodilator agents|mesh-ancestor
93340544|NCT05845099|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93340545|NCT05845099|Protective Agents|protective agents|mesh-ancestor
93340546|NCT05845099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340547|NCT05843968|Mycophenolic Acid|mycophenolic acid|mesh-list
93340548|NCT05843968|Rituximab|rituximab|mesh-list
93340549|NCT05843968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340550|NCT05843968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340551|NCT05843968|Immunologic Factors|immunologic factors|mesh-ancestor
93340552|NCT05843968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340553|NCT05843968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93340554|NCT05843968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93340555|NCT05843968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93340556|NCT05843968|Antitubercular Agents|antitubercular agents|mesh-ancestor
93340557|NCT05843968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93340558|NCT05843968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340559|NCT05843968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340560|NCT05843968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340561|NCT05841134|Capecitabine|capecitabine|mesh-list
93340562|NCT05841134|Oxaliplatin|oxaliplatin|mesh-list
93340563|NCT05841134|Tislelizumab|tislelizumab|mesh-list
93340564|NCT05841134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340565|NCT05841134|Antimetabolites|antimetabolites|mesh-ancestor
93340566|NCT05841134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340567|NCT05841134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340568|NCT05841134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340570|NCT05837013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340571|NCT05837013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340572|NCT05831878|Disitamab vedotin|disitamab vedotin|mesh-list
93340573|NCT05831878|Immunoconjugates|immunoconjugates|mesh-ancestor
93340574|NCT05831878|Immunologic Factors|immunologic factors|mesh-ancestor
93340575|NCT05831878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340576|NCT05827705|Ephedrine|ephedrine|mesh-list
93340577|NCT05827705|Pseudoephedrine|pseudoephedrine|mesh-list
93340578|NCT05827705|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93340579|NCT05827705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340580|NCT05827705|Sympathomimetics|sympathomimetics|mesh-ancestor
93340581|NCT05827705|Autonomic Agents|autonomic agents|mesh-ancestor
93340582|NCT05827705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340583|NCT05827705|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93340584|NCT05827705|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340585|NCT05827705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340586|NCT05827705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340587|NCT05827705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93340588|NCT05827705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93340589|NCT05827705|Respiratory System Agents|respiratory system agents|mesh-ancestor
93340590|NCT05827705|Nasal Decongestants|nasal decongestants|mesh-ancestor
93340591|NCT05816746|Decitabine|decitabine|mesh-list
93340592|NCT05816746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340593|NCT05816746|Antimetabolites|antimetabolites|mesh-ancestor
93340594|NCT05816746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340595|NCT05816746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340596|NCT05816746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340597|NCT05949229|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93340598|NCT05949229|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93340599|NCT05949229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93340600|NCT05949229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340601|NCT05949229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340602|NCT05949229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340603|NCT05949229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340604|NCT05949229|Analgesics|analgesics|mesh-ancestor
93340605|NCT05949229|Sensory System Agents|sensory system agents|mesh-ancestor
93340606|NCT05949229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340607|NCT05949229|Antidepressive Agents|antidepressive agents|mesh-ancestor
93340608|NCT05949229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93340609|NCT05949229|Dopamine Agents|dopamine agents|mesh-ancestor
93340610|NCT05949203|Cabotegravir|cabotegravir|mesh-list
93340611|NCT05949203|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93340612|NCT05949203|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93340613|NCT05949203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340614|NCT05949203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340615|NCT05949203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93340616|NCT05949203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93340617|NCT05949203|Antiviral Agents|antiviral agents|mesh-ancestor
93340618|NCT05949203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340619|NCT05949190|Azithromycin|azithromycin|mesh-list
93340620|NCT05949190|Pyrimethamine|pyrimethamine|mesh-list
93340621|NCT05949190|Sulfadoxine|sulfadoxine|mesh-list
93340622|NCT05949190|Albendazole|albendazole|mesh-list
93340623|NCT05949190|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93340624|NCT05949190|Choline|choline|mesh-list
93340625|NCT05949190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93340626|NCT05949190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340627|NCT05949190|Lipotropic Agents|lipotropic agents|mesh-ancestor
93340628|NCT05949190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93340629|NCT05949190|Antimetabolites|antimetabolites|mesh-ancestor
93340630|NCT05949190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340631|NCT05949190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340632|NCT05949190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93340633|NCT05949190|Nootropic Agents|nootropic agents|mesh-ancestor
93340634|NCT05949190|Antimalarials|antimalarials|mesh-ancestor
93340635|NCT05949190|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93340636|NCT05949190|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93340637|NCT05949190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93340638|NCT05949190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340639|NCT05949190|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93340640|NCT05949190|Anthelmintics|anthelmintics|mesh-ancestor
93340641|NCT05949190|Anticestodal Agents|anticestodal agents|mesh-ancestor
93012602|NCT05696613|Hormones|hormones|mesh-ancestor
93340642|NCT05949190|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93340643|NCT05949190|Tubulin Modulators|tubulin modulators|mesh-ancestor
93340644|NCT05949190|Antimitotic Agents|antimitotic agents|mesh-ancestor
93340645|NCT05949190|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340646|NCT05949190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340647|NCT05949099|Nirogacestat|nirogacestat|mesh-list
93340648|NCT05949099|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93340649|NCT05949099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340650|NCT05949099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340651|NCT05949021|Doxorubicin|doxorubicin|mesh-list
93340652|NCT05949021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93340653|NCT05949021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634473|NCT00180908|Alkylating Agents|alkylating agents|mesh-ancestor
93340654|NCT05949021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340655|NCT05949021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93340656|NCT05949021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93340657|NCT05949021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340658|NCT05949021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340659|NCT05948891|Beclomethasone|beclomethasone|mesh-list
93340660|NCT05948891|Glycopyrrolate|glycopyrrolate|mesh-list
93340661|NCT05948891|Formoterol Fumarate|formoterol fumarate|mesh-list
93340662|NCT05948891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93340663|NCT05948891|Autonomic Agents|autonomic agents|mesh-ancestor
93340664|NCT05948891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340665|NCT05948891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340666|NCT05948891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93340667|NCT05948891|Respiratory System Agents|respiratory system agents|mesh-ancestor
93340668|NCT05948891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93340669|NCT05948891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93340670|NCT05948891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93340671|NCT05948891|Adrenergic Agents|adrenergic agents|mesh-ancestor
93340672|NCT05948891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340673|NCT05948891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340674|NCT05948891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93340675|NCT05948891|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93340676|NCT05948891|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93340677|NCT05948891|Cholinergic Agents|cholinergic agents|mesh-ancestor
93340678|NCT05948891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340679|NCT05948891|Glucocorticoids|glucocorticoids|mesh-ancestor
93340680|NCT05948891|Hormones|hormones|mesh-ancestor
93340681|NCT05948891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340682|NCT05948813|Osimertinib|osimertinib|mesh-list
93340683|NCT05948813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340684|NCT05948813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93340685|NCT05948813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340686|NCT05948813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340687|NCT05948579|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
93340688|NCT05948579|Antidepressive Agents|antidepressive agents|mesh-ancestor
93340689|NCT05948579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93340690|NCT05948579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93340691|NCT05948579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93340692|NCT05948579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340693|NCT05948579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340694|NCT05948579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340695|NCT05948579|Serotonin Agents|serotonin agents|mesh-ancestor
93340696|NCT05948579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340697|NCT05948579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93340698|NCT05948579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93340699|NCT05948553|Fluoxetine|fluoxetine|mesh-list
93340700|NCT05948553|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93340701|NCT05948553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93340702|NCT05948553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340703|NCT05948553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340704|NCT05948553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340705|NCT05948553|Serotonin Agents|serotonin agents|mesh-ancestor
93340706|NCT05948553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340707|NCT05948553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93340708|NCT05948553|Antidepressive Agents|antidepressive agents|mesh-ancestor
93340709|NCT05948553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93340710|NCT05948553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93340711|NCT05948553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93340712|NCT05948553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340713|NCT05948462|Cisplatin|cisplatin|mesh-list
93340714|NCT05948462|Carboplatin|carboplatin|mesh-list
93340715|NCT05948462|Pemetrexed|pemetrexed|mesh-list
93340716|NCT05948462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340717|NCT05948462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340718|NCT05948462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340719|NCT05948462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93340720|NCT05948462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93340721|NCT05948449|Oxaliplatin|oxaliplatin|mesh-list
93340722|NCT05948449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340723|NCT05948267|Lidocaine|lidocaine|mesh-list
93340724|NCT05948267|Fentanyl|fentanyl|mesh-list
93340725|NCT05948267|Ketamine|ketamine|mesh-list
93340726|NCT05948267|Propofol|propofol|mesh-list
93340727|NCT05948267|Anesthetics, Local|anesthetics, local|mesh-ancestor
93340728|NCT05948267|Anesthetics|anesthetics|mesh-ancestor
93340729|NCT05948267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340730|NCT05948267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340731|NCT05948267|Sensory System Agents|sensory system agents|mesh-ancestor
93340732|NCT05948267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340733|NCT05948267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340734|NCT05948267|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93340735|NCT05948267|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93340736|NCT05948267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340737|NCT05948267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340738|NCT05948267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93340739|NCT05948267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93340740|NCT05948267|Anesthetics, General|anesthetics, general|mesh-ancestor
93340741|NCT05948267|Analgesics|analgesics|mesh-ancestor
93340742|NCT05948267|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93340743|NCT05948267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93340744|NCT05948267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93340745|NCT05948267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340746|NCT05948267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93340747|NCT05948267|Narcotics|narcotics|mesh-ancestor
93340748|NCT05948267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93340749|NCT05948228|Fluorides|fluorides|mesh-list
93340750|NCT05948228|Cariostatic Agents|cariostatic agents|mesh-ancestor
93340751|NCT05948228|Protective Agents|protective agents|mesh-ancestor
93340752|NCT05948228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340753|NCT05948072|Cetuximab|cetuximab|mesh-list
93340754|NCT05948072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340755|NCT05948072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340756|NCT05947825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93340757|NCT05947825|Paclitaxel|paclitaxel|mesh-list
93340758|NCT05947825|Gemcitabine|gemcitabine|mesh-list
93340759|NCT05947825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93340760|NCT05947825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340761|NCT05947825|Tubulin Modulators|tubulin modulators|mesh-ancestor
93340762|NCT05947825|Antimitotic Agents|antimitotic agents|mesh-ancestor
93340763|NCT05947825|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340764|NCT05947825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340765|NCT05947825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340766|NCT05947825|Antimetabolites|antimetabolites|mesh-ancestor
93340767|NCT05947825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93340768|NCT05947825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340769|NCT05947825|Incretins|incretins|mesh-ancestor
93340770|NCT05947825|Hormones|hormones|mesh-ancestor
93340771|NCT05947825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340772|NCT05947825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93340773|NCT05947825|Protease Inhibitors|protease inhibitors|mesh-ancestor
93340774|NCT05947825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340775|NCT05947812|Tafenoquine|tafenoquine|mesh-list
93340776|NCT05947812|Antimalarials|antimalarials|mesh-ancestor
93340777|NCT05947812|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93340778|NCT05947812|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93340779|NCT05947812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340780|NCT05947760|Magnesium Sulfate|magnesium sulfate|mesh-list
93340781|NCT05947760|Analgesics|analgesics|mesh-ancestor
93340782|NCT05947760|Sensory System Agents|sensory system agents|mesh-ancestor
93340783|NCT05947760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340784|NCT05947760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340785|NCT05947760|Anesthetics|anesthetics|mesh-ancestor
93340786|NCT05947760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012749|NCT05304546|Pembrolizumab|pembrolizumab|mesh-list
93340787|NCT05947760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93340788|NCT05947760|Anticonvulsants|anticonvulsants|mesh-ancestor
93340789|NCT05947760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93340790|NCT05947760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93340791|NCT05947760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340792|NCT05947760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93340793|NCT05947760|Tocolytic Agents|tocolytic agents|mesh-ancestor
93340794|NCT05947760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93340795|NCT05947708|Dialysis Solutions|dialysis solutions|mesh-list
93340796|NCT05947708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93340797|NCT05947669|Methylprednisolone|methylprednisolone|mesh-list
93340798|NCT05947669|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93340799|NCT05947669|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93340800|NCT05947669|Prednisolone|prednisolone|mesh-list
93340801|NCT05947669|Prednisolone acetate|prednisolone acetate|mesh-list
93340802|NCT05947669|Infliximab|infliximab|mesh-list
93340803|NCT05947669|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93340804|NCT05947669|Prednisolone phosphate|prednisolone phosphate|mesh-list
93340805|NCT05947669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340806|NCT05947669|Antiemetics|antiemetics|mesh-ancestor
93340807|NCT05947669|Autonomic Agents|autonomic agents|mesh-ancestor
93340808|NCT05947669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340809|NCT05947669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340810|NCT05947669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93340811|NCT05947669|Glucocorticoids|glucocorticoids|mesh-ancestor
93340812|NCT05947669|Hormones|hormones|mesh-ancestor
93340813|NCT05947669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93340814|NCT05947669|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93340815|NCT05947669|Protective Agents|protective agents|mesh-ancestor
93340816|NCT05947669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93340817|NCT05947669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340818|NCT05947669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93340819|NCT05947669|Dermatologic Agents|dermatologic agents|mesh-ancestor
93340820|NCT05947669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93340821|NCT05947643|Theophylline|theophylline|mesh-list
93340822|NCT05947643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93340823|NCT05947643|Autonomic Agents|autonomic agents|mesh-ancestor
93340824|NCT05947643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340825|NCT05947643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340826|NCT05947643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93340827|NCT05947643|Respiratory System Agents|respiratory system agents|mesh-ancestor
93340828|NCT05947643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93340829|NCT05947643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340830|NCT05947643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340831|NCT05947643|Vasodilator Agents|vasodilator agents|mesh-ancestor
93340832|NCT05947643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93340833|NCT05947643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93340834|NCT05947643|Purinergic Agents|purinergic agents|mesh-ancestor
93340835|NCT05947643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340836|NCT05947604|Midazolam|midazolam|mesh-list
93340837|NCT05947604|Dextromethorphan|dextromethorphan|mesh-list
93340838|NCT05947604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93340839|NCT05947604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93340840|NCT05947604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93340841|NCT05947604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340842|NCT05947604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93340843|NCT05947604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93340844|NCT05947604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93340845|NCT05947604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93340846|NCT05947604|Anesthetics, General|anesthetics, general|mesh-ancestor
93340847|NCT05947604|Anesthetics|anesthetics|mesh-ancestor
93340848|NCT05947604|GABA Modulators|gaba modulators|mesh-ancestor
93340849|NCT05947604|GABA Agents|gaba agents|mesh-ancestor
93340850|NCT05947604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340851|NCT05947604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340852|NCT05947604|Antitussive Agents|antitussive agents|mesh-ancestor
93340853|NCT05947604|Respiratory System Agents|respiratory system agents|mesh-ancestor
93340854|NCT05947604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93340855|NCT05947604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93340856|NCT05947513|Curcumin|curcumin|mesh-list
93340857|NCT05947513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93340858|NCT05947513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93340859|NCT05947513|Analgesics|analgesics|mesh-ancestor
93340860|NCT05947513|Sensory System Agents|sensory system agents|mesh-ancestor
93340861|NCT05947513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340862|NCT05947513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340863|NCT05947513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012821|NCT05019430|Serotonin Agents|serotonin agents|mesh-ancestor
93340864|NCT05947513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634665|NCT00181571|Methylphenidate|methylphenidate|mesh-list
93340865|NCT05947513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340866|NCT05947513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340867|NCT05947513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340869|NCT05947500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93340870|NCT05947500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340871|NCT05947500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340872|NCT05947500|Immunologic Factors|immunologic factors|mesh-ancestor
93340873|NCT05947500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340874|NCT05947461|Diclofenac|diclofenac|mesh-list
93340875|NCT05947461|Indomethacin|indomethacin|mesh-list
93340876|NCT05947461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93340877|NCT05947461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93340878|NCT05947461|Analgesics|analgesics|mesh-ancestor
93340879|NCT05947461|Sensory System Agents|sensory system agents|mesh-ancestor
93340880|NCT05947461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340881|NCT05947461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340882|NCT05947461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340883|NCT05947461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93340884|NCT05947461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93340885|NCT05947461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340886|NCT05947461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340887|NCT05947461|Gout Suppressants|gout suppressants|mesh-ancestor
93340888|NCT05947461|Tocolytic Agents|tocolytic agents|mesh-ancestor
93340889|NCT05947461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93340890|NCT05947383|Psilocybin|psilocybin|mesh-list
93340891|NCT05947383|Hallucinogens|hallucinogens|mesh-ancestor
93340892|NCT05947383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340893|NCT05947383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93340894|NCT05947201|Paclitaxel|paclitaxel|mesh-list
93340895|NCT05947201|Fluorouracil|fluorouracil|mesh-list
93340896|NCT05947201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93340897|NCT05947201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340898|NCT05947201|Tubulin Modulators|tubulin modulators|mesh-ancestor
93340899|NCT05947201|Antimitotic Agents|antimitotic agents|mesh-ancestor
93340900|NCT05947201|Mitosis Modulators|mitosis modulators|mesh-ancestor
93340901|NCT05947201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340902|NCT05947201|Antimetabolites|antimetabolites|mesh-ancestor
93340903|NCT05947201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340904|NCT05947201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93340905|NCT05947201|Immunologic Factors|immunologic factors|mesh-ancestor
93340906|NCT05947201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340907|NCT05947162|Nicotine|nicotine|mesh-list
93340908|NCT05947162|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93340909|NCT05947162|Autonomic Agents|autonomic agents|mesh-ancestor
93340910|NCT05947162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340911|NCT05947162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340912|NCT05947162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93340913|NCT05947162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93340914|NCT05947162|Cholinergic Agents|cholinergic agents|mesh-ancestor
93340915|NCT05947162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340916|NCT05947162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340917|NCT05947071|Vaccines|vaccines|mesh-list
93340918|NCT05947071|Immunologic Factors|immunologic factors|mesh-ancestor
93340919|NCT05947071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340920|NCT05944445|Linezolid|linezolid|mesh-list
93340921|NCT05944445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93340922|NCT05944445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340923|NCT05944445|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93340924|NCT05944445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340925|NCT05944445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340926|NCT05944055|Vitamin D|vitamin d|mesh-list
93340927|NCT05944055|Vitamins|vitamins|mesh-ancestor
93340928|NCT05944055|Micronutrients|micronutrients|mesh-ancestor
93340929|NCT05944055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340930|NCT05944055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93340931|NCT05941858|Nicotine|nicotine|mesh-list
93340932|NCT05941858|Carbon Monoxide|carbon monoxide|mesh-list
93340933|NCT05941858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93340934|NCT05941858|Autonomic Agents|autonomic agents|mesh-ancestor
93340935|NCT05941858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93340936|NCT05941858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340937|NCT05941858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93340938|NCT05941858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93012896|NCT04736953|Sirolimus|sirolimus|mesh-list
93340939|NCT05941858|Cholinergic Agents|cholinergic agents|mesh-ancestor
93340940|NCT05941858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93340941|NCT05941858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340942|NCT05941858|Antimetabolites|antimetabolites|mesh-ancestor
93340943|NCT05941858|Gasotransmitters|gasotransmitters|mesh-ancestor
93340944|NCT05940961|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93340945|NCT05940961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340946|NCT05940961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340947|NCT05940961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93340948|NCT05940961|Immunotoxins|immunotoxins|mesh-ancestor
93340949|NCT05940961|Immunoconjugates|immunoconjugates|mesh-ancestor
93340950|NCT05940961|Immunologic Factors|immunologic factors|mesh-ancestor
93340951|NCT05940961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340953|NCT05937854|Vasodilator Agents|vasodilator agents|mesh-ancestor
93340954|NCT05937854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93340955|NCT05937854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93340956|NCT05937854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340957|NCT05937854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340958|NCT05937854|Urological Agents|urological agents|mesh-ancestor
93340959|NCT05933057|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
93340960|NCT05933057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93340961|NCT05933057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340962|NCT05933057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340963|NCT05925049|Natalizumab|natalizumab|mesh-list
93340964|NCT05925049|Immunologic Factors|immunologic factors|mesh-ancestor
93340965|NCT05925049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340966|NCT05907057|Azacitidine|azacitidine|mesh-list
93340967|NCT05907057|Ivosidenib|ivosidenib|mesh-list
93340968|NCT05907057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93340969|NCT05907057|Antimetabolites|antimetabolites|mesh-ancestor
93340970|NCT05907057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340971|NCT05907057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340972|NCT05907057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93340973|NCT05906459|Antibodies|antibodies|mesh-list
93340974|NCT05906459|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
93340975|NCT05906459|Immunologic Factors|immunologic factors|mesh-ancestor
93340976|NCT05906459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340977|NCT05904886|Bevacizumab|bevacizumab|mesh-list
93340978|NCT05904886|Atezolizumab|atezolizumab|mesh-list
93340979|NCT05904886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93340980|NCT05904886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93340981|NCT05904886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93340982|NCT05904886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93340983|NCT05904886|Growth Substances|growth substances|mesh-ancestor
93340984|NCT05904886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93340985|NCT05904886|Growth Inhibitors|growth inhibitors|mesh-ancestor
93340986|NCT05904886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93340987|NCT05904886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93340988|NCT05895747|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
93340989|NCT05895747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93340990|NCT05895747|Antidepressive Agents|antidepressive agents|mesh-ancestor
93340991|NCT05895747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93340992|NCT05878769|Astegolimab|astegolimab|mesh-list
93340993|NCT05878769|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93340994|NCT05878769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93340995|NCT05878769|Antiviral Agents|antiviral agents|mesh-ancestor
93340996|NCT05878769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93340997|NCT05862168|Paclitaxel|paclitaxel|mesh-list
93340998|NCT05862168|Fluorouracil|fluorouracil|mesh-list
93340999|NCT05862168|Tislelizumab|tislelizumab|mesh-list
93341000|NCT05862168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341001|NCT05862168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341002|NCT05862168|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341003|NCT05862168|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341004|NCT05862168|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341005|NCT05862168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341006|NCT05862168|Antimetabolites|antimetabolites|mesh-ancestor
93341007|NCT05862168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341008|NCT05862168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341009|NCT05862168|Immunologic Factors|immunologic factors|mesh-ancestor
93341010|NCT05862168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341011|NCT05862168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341012|NCT05855876|Ketamine|ketamine|mesh-list
93341013|NCT05855876|Analgesics|analgesics|mesh-ancestor
93341014|NCT05855876|Sensory System Agents|sensory system agents|mesh-ancestor
93341015|NCT05855876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341016|NCT05855876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341017|NCT05855876|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93341018|NCT05855876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93341019|NCT05855876|Anesthetics, General|anesthetics, general|mesh-ancestor
93341020|NCT05855876|Anesthetics|anesthetics|mesh-ancestor
93341021|NCT05855876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341022|NCT05855876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93341023|NCT05855876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93341024|NCT05855876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341025|NCT05855876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341026|NCT05838287|Pioglitazone|pioglitazone|mesh-list
93341027|NCT05838287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93341028|NCT05838287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341029|NCT05832047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93341030|NCT05831124|Vaccines|vaccines|mesh-list
93341031|NCT05831124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93341032|NCT05831124|Immunologic Factors|immunologic factors|mesh-ancestor
93341033|NCT05831124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341034|NCT05827978|Vaccines|vaccines|mesh-list
93341035|NCT05827978|Immunologic Factors|immunologic factors|mesh-ancestor
93341036|NCT05827978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341037|NCT05825066|Paclitaxel|paclitaxel|mesh-list
93341038|NCT05825066|Gemcitabine|gemcitabine|mesh-list
93341039|NCT05825066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341040|NCT05825066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341041|NCT05825066|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341042|NCT05825066|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341043|NCT05825066|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341044|NCT05825066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341045|NCT05825066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341046|NCT05825066|Antimetabolites|antimetabolites|mesh-ancestor
93341047|NCT05808010|Hydrotalcite|hydrotalcite|mesh-list
93341048|NCT05808010|Antacids|antacids|mesh-ancestor
93341049|NCT05808010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341050|NCT05808010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341051|NCT05799378|Hydroxychloroquine|hydroxychloroquine|mesh-list
93341052|NCT05799378|Antimalarials|antimalarials|mesh-ancestor
93341053|NCT05799378|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93341054|NCT05799378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93341055|NCT05799378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93341056|NCT05799378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341057|NCT05799378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341058|NCT05799378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341059|NCT05794958|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93341060|NCT05794958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341061|NCT05794958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341062|NCT05788016|Analgesics, Opioid|analgesics, opioid|mesh-list
93341063|NCT05788016|Narcotics|narcotics|mesh-ancestor
93341064|NCT05788016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341065|NCT05788016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341066|NCT05788016|Analgesics|analgesics|mesh-ancestor
93341067|NCT05788016|Sensory System Agents|sensory system agents|mesh-ancestor
93341068|NCT05788016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341069|NCT05776056|Methylphenidate|methylphenidate|mesh-list
93341070|NCT05776056|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93341071|NCT05776056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341072|NCT05776056|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93341073|NCT05776056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93341074|NCT05776056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93341075|NCT05776056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341076|NCT05776056|Dopamine Agents|dopamine agents|mesh-ancestor
93341077|NCT05776056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341078|NCT05775159|Bevacizumab|bevacizumab|mesh-list
93341079|NCT05775159|Gemcitabine|gemcitabine|mesh-list
93341080|NCT05775159|Lenvatinib|lenvatinib|mesh-list
93341081|NCT05775159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341082|NCT05775159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341083|NCT05775159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93341084|NCT05775159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93341085|NCT05775159|Growth Substances|growth substances|mesh-ancestor
93341086|NCT05775159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341087|NCT05775159|Growth Inhibitors|growth inhibitors|mesh-ancestor
93341088|NCT05775159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341089|NCT05775159|Antimetabolites|antimetabolites|mesh-ancestor
93341090|NCT05775159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341091|NCT05775159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341092|NCT05775159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341094|NCT05774951|Letrozole|letrozole|mesh-list
93341095|NCT05774951|Anastrozole|anastrozole|mesh-list
93341096|NCT05774951|Exemestane|exemestane|mesh-list
93341097|NCT05774951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341098|NCT05774951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93341099|NCT05774951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93341100|NCT05774951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341101|NCT05774951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341102|NCT05774951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93341103|NCT05774951|Hormone Antagonists|hormone antagonists|mesh-ancestor
93341104|NCT05774951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341105|NCT05774951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341106|NCT05774951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341107|NCT05774951|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93341108|NCT05774951|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93341109|NCT05774951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93341110|NCT05767346|Metoprolol|metoprolol|mesh-list
93341111|NCT05767346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93341112|NCT05767346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93341113|NCT05767346|Sympatholytics|sympatholytics|mesh-ancestor
93341114|NCT05767346|Autonomic Agents|autonomic agents|mesh-ancestor
93341115|NCT05767346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341116|NCT05767346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341117|NCT05767346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93341118|NCT05767346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93341119|NCT05767346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93341120|NCT05767346|Adrenergic Agents|adrenergic agents|mesh-ancestor
93341121|NCT05767346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341122|NCT05767346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341123|NCT05760313|Linaclotide|linaclotide|mesh-list
93341124|NCT05760313|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93341125|NCT05760313|Enzyme Activators|enzyme activators|mesh-ancestor
93341126|NCT05760313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341127|NCT05760313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341128|NCT05756777|Ivosidenib|ivosidenib|mesh-list
93341129|NCT05756777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341130|NCT05756777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341131|NCT05756777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341132|NCT05754203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93341133|NCT05754203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341134|NCT05754203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341135|NCT05754203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341136|NCT05748665|Etomidate|etomidate|mesh-list
93341137|NCT05748665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93341138|NCT05748665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341139|NCT05748665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341140|NCT05748665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93341141|NCT05748665|Anesthetics, General|anesthetics, general|mesh-ancestor
93341142|NCT05748665|Anesthetics|anesthetics|mesh-ancestor
93341143|NCT05724329|Dasatinib|dasatinib|mesh-list
93341144|NCT05724329|Tislelizumab|tislelizumab|mesh-list
93341145|NCT05724329|Quercetin|quercetin|mesh-list
93341146|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341147|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341148|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341149|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634942|NCT00408551|Vitamin B Complex|vitamin b complex|mesh-ancestor
93341150|NCT05724329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341151|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
93341152|NCT05724329|Protective Agents|protective agents|mesh-ancestor
93341153|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341154|NCT05718466|Bevacizumab|bevacizumab|mesh-list
93341155|NCT05718466|Carboplatin|carboplatin|mesh-list
93341156|NCT05718466|Irinotecan|irinotecan|mesh-list
93341157|NCT05718466|Etoposide|etoposide|mesh-list
93341158|NCT05718466|Temozolomide|temozolomide|mesh-list
93341159|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341160|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341161|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93341162|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93341163|NCT05718466|Growth Substances|growth substances|mesh-ancestor
93341164|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341165|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
93341166|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93341167|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341168|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341169|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341170|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341171|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341172|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93341173|NCT05718466|Alkylating Agents|alkylating agents|mesh-ancestor
93341174|NCT05715216|Nivolumab|nivolumab|mesh-list
93341175|NCT05715216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341176|NCT05715216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341177|NCT05715216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341178|NCT05715216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341179|NCT05691478|Cisplatin|cisplatin|mesh-list
93341180|NCT05691478|Doxorubicin|doxorubicin|mesh-list
93341181|NCT05691478|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93341182|NCT05691478|Methotrexate|methotrexate|mesh-list
93341183|NCT05691478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341184|NCT05691478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93341185|NCT05691478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341186|NCT05691478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341187|NCT05691478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341188|NCT05691478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341189|NCT05691478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93341190|NCT05691478|Abortifacient Agents|abortifacient agents|mesh-ancestor
93341191|NCT05691478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93341192|NCT05691478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341193|NCT05691478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341194|NCT05691478|Antimetabolites|antimetabolites|mesh-ancestor
93341195|NCT05691478|Dermatologic Agents|dermatologic agents|mesh-ancestor
93341196|NCT05691478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93341197|NCT05691478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341198|NCT05691478|Immunologic Factors|immunologic factors|mesh-ancestor
93341199|NCT05691478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341200|NCT05691478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93341201|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
93341202|NCT05688371|Morphine|morphine|mesh-list
93341203|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93341204|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341205|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341206|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93341207|NCT05688371|Analgesics|analgesics|mesh-ancestor
93341208|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
93341209|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341210|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93341211|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93341212|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93341213|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
93341214|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341215|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341216|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93341217|NCT05688371|Narcotics|narcotics|mesh-ancestor
93341218|NCT05685602|Paclitaxel|paclitaxel|mesh-list
93341219|NCT05685602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93341220|NCT05685602|Gemcitabine|gemcitabine|mesh-list
93341221|NCT05685602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341222|NCT05685602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341223|NCT05685602|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341224|NCT05685602|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341225|NCT05685602|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341226|NCT05685602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341227|NCT05685602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341228|NCT05685602|Antimetabolites|antimetabolites|mesh-ancestor
93341229|NCT05680129|Metformin|metformin|mesh-list
93341230|NCT05680129|Dulaglutide|dulaglutide|mesh-list
93341231|NCT05680129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93341232|NCT05680129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341233|NCT05656911|Zabedosertib|zabedosertib|mesh-list
93341234|NCT05656911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341235|NCT05656911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341236|NCT05656911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341237|NCT05647122|Osimertinib|osimertinib|mesh-list
93341238|NCT05647122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341239|NCT05647122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341240|NCT05647122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341241|NCT05647122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341242|NCT05643560|Factor VIII|factor viii|mesh-list
93341243|NCT05643560|Coagulants|coagulants|mesh-ancestor
93341244|NCT05640934|Melatonin|melatonin|mesh-list
93341245|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
93341246|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341247|NCT05640934|Protective Agents|protective agents|mesh-ancestor
93341248|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341249|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341250|NCT05640180|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93341251|NCT05640180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341252|NCT05640180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93341253|NCT05640180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341254|NCT05605899|Prednisone|prednisone|mesh-list
93341255|NCT05605899|Cyclophosphamide|cyclophosphamide|mesh-list
93341256|NCT05605899|Rituximab|rituximab|mesh-list
93341257|NCT05605899|Doxorubicin|doxorubicin|mesh-list
93341258|NCT05605899|Fludarabine|fludarabine|mesh-list
93341259|NCT05605899|Etoposide|etoposide|mesh-list
93341260|NCT05605899|Vincristine|vincristine|mesh-list
93341261|NCT05605899|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93341262|NCT05605899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341263|NCT05605899|Immunologic Factors|immunologic factors|mesh-ancestor
93341264|NCT05605899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341265|NCT05605899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341266|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93341267|NCT05605899|Alkylating Agents|alkylating agents|mesh-ancestor
93341268|NCT05605899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341269|NCT05605899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341270|NCT05605899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93341271|NCT05605899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341272|NCT05605899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93341273|NCT05605899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341274|NCT05605899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341275|NCT05605899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341276|NCT05605899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341277|NCT05605899|Glucocorticoids|glucocorticoids|mesh-ancestor
93341278|NCT05605899|Hormones|hormones|mesh-ancestor
93341279|NCT05605899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341280|NCT05605899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341281|NCT05605899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341282|NCT05605899|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341283|NCT05605899|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341284|NCT05605899|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341285|NCT05591118|Anticoagulants|anticoagulants|mesh-list
93341286|NCT05526157|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93341287|NCT05526157|Glucagon|glucagon|mesh-list
93341288|NCT05526157|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93341289|NCT05526157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341290|NCT05526157|Hormones|hormones|mesh-ancestor
93341291|NCT05526157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341292|NCT05526157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341293|NCT05526157|Incretins|incretins|mesh-ancestor
93341294|NCT05526157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341295|NCT05526157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93341296|NCT05520567|Azacitidine|azacitidine|mesh-list
93341297|NCT05520567|Venetoclax|venetoclax|mesh-list
93341298|NCT05520567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341299|NCT05520567|Antimetabolites|antimetabolites|mesh-ancestor
93341300|NCT05520567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341301|NCT05520567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341302|NCT05520567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341303|NCT05514054|Tamoxifen|tamoxifen|mesh-list
93341304|NCT05514054|Letrozole|letrozole|mesh-list
93341305|NCT05514054|Anastrozole|anastrozole|mesh-list
93341306|NCT05514054|Exemestane|exemestane|mesh-list
93341307|NCT05514054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341308|NCT05514054|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93341309|NCT05514054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93341310|NCT05514054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013269|NCT04026412|Durvalumab|durvalumab|mesh-list
93341311|NCT05514054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341312|NCT05514054|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93341313|NCT05514054|Hormone Antagonists|hormone antagonists|mesh-ancestor
93341314|NCT05514054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341315|NCT05514054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341316|NCT05514054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341317|NCT05514054|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93341318|NCT05514054|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93341319|NCT05514054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93341320|NCT05508009|Cyclophosphamide|cyclophosphamide|mesh-list
93341322|NCT05508009|Rituximab|rituximab|mesh-list
93341323|NCT05508009|Fludarabine|fludarabine|mesh-list
93341324|NCT05508009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341325|NCT05508009|Immunologic Factors|immunologic factors|mesh-ancestor
93341326|NCT05508009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341327|NCT05508009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341328|NCT05508009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93341329|NCT05508009|Alkylating Agents|alkylating agents|mesh-ancestor
93341330|NCT05508009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341331|NCT05508009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341332|NCT05508009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93341333|NCT05508009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341334|NCT05498272|Olaparib|olaparib|mesh-list
93341335|NCT05498272|Leuprolide|leuprolide|mesh-list
93341336|NCT05498272|Goserelin|goserelin|mesh-list
93341337|NCT05498272|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93341338|NCT05498272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93341339|NCT05498272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341340|NCT05498272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341341|NCT05498272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341342|NCT05498272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93341343|NCT05498272|Fertility Agents|fertility agents|mesh-ancestor
93341344|NCT05498272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93341345|NCT05498272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341346|NCT05498272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341347|NCT05498272|Luteolytic Agents|luteolytic agents|mesh-ancestor
93341348|NCT05498272|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93341349|NCT05498272|Contraceptive Agents|contraceptive agents|mesh-ancestor
93341350|NCT05498272|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93341351|NCT05483933|Doxorubicin|doxorubicin|mesh-list
93341352|NCT05483933|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93341353|NCT05483933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93341354|NCT05483933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341355|NCT05483933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341356|NCT05483933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341357|NCT05483933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341358|NCT05483933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341359|NCT05471830|Apixaban|apixaban|mesh-list
93341360|NCT05471830|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93341361|NCT05471830|Antithrombins|antithrombins|mesh-ancestor
93341362|NCT05471830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93341363|NCT05471830|Protease Inhibitors|protease inhibitors|mesh-ancestor
93341364|NCT05471830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341365|NCT05471830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341366|NCT05471830|Anticoagulants|anticoagulants|mesh-ancestor
93341367|NCT05459298|Vitamin D|vitamin d|mesh-list
93341368|NCT05459298|Cholecalciferol|cholecalciferol|mesh-list
93341369|NCT05459298|Vitamins|vitamins|mesh-ancestor
93341370|NCT05459298|Micronutrients|micronutrients|mesh-ancestor
93341371|NCT05459298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341372|NCT05459298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93341373|NCT05459298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93341374|NCT05407662|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
93341375|NCT05407662|Mineralocorticoids|mineralocorticoids|mesh-list
93341376|NCT05407662|Hormone Antagonists|hormone antagonists|mesh-ancestor
93341377|NCT05407662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341378|NCT05407662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341379|NCT05407662|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93341380|NCT05407662|Diuretics|diuretics|mesh-ancestor
93341381|NCT05407662|Natriuretic Agents|natriuretic agents|mesh-ancestor
93341382|NCT05407662|Hormones|hormones|mesh-ancestor
93341383|NCT05401565|Balovaptan|balovaptan|mesh-list
93013411|NCT03685773|Niacin|niacin|mesh-list
93341384|NCT05401565|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93341385|NCT05401565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341386|NCT05401565|Natriuretic Agents|natriuretic agents|mesh-ancestor
93341387|NCT05401565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341388|NCT05400577|Sotorasib|sotorasib|mesh-list
93341389|NCT05400577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341390|NCT05400577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341391|NCT05400577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341392|NCT05400577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341393|NCT05372614|Trastuzumab|trastuzumab|mesh-list
93341394|NCT05372614|Camptothecin|camptothecin|mesh-list
93341395|NCT05372614|Maleic acid|maleic acid|mesh-list
93341396|NCT05372614|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93341397|NCT05372614|Immunoconjugates|immunoconjugates|mesh-list
93341398|NCT05372614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341399|NCT05372614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341400|NCT05372614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341401|NCT05372614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341402|NCT05372614|Immunologic Factors|immunologic factors|mesh-ancestor
93341403|NCT05372614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341404|NCT05372614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341405|NCT05372614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93341406|NCT05372614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341407|NCT05345171|Prednisolone|prednisolone|mesh-list
93341408|NCT05345171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341409|NCT05345171|Glucocorticoids|glucocorticoids|mesh-ancestor
93341410|NCT05345171|Hormones|hormones|mesh-ancestor
93341411|NCT05345171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341412|NCT05345171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341413|NCT05345171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341414|NCT05345171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341415|NCT05307705|Paclitaxel|paclitaxel|mesh-list
93341416|NCT05307705|Letrozole|letrozole|mesh-list
93341417|NCT05307705|Fulvestrant|fulvestrant|mesh-list
93341418|NCT05307705|Anastrozole|anastrozole|mesh-list
93341419|NCT05307705|Exemestane|exemestane|mesh-list
93341420|NCT05307705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341421|NCT05307705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341422|NCT05307705|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341423|NCT05307705|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341424|NCT05307705|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341425|NCT05307705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341426|NCT05307705|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93341427|NCT05307705|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93341428|NCT05307705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341429|NCT05307705|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93341430|NCT05307705|Hormone Antagonists|hormone antagonists|mesh-ancestor
93341431|NCT05307705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341432|NCT05307705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341433|NCT05307705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341434|NCT05307705|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93341435|NCT05304390|Carbon Monoxide|carbon monoxide|mesh-list
93341436|NCT05304390|Antimetabolites|antimetabolites|mesh-ancestor
93341437|NCT05304390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341438|NCT05304390|Gasotransmitters|gasotransmitters|mesh-ancestor
93341439|NCT05304390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341440|NCT05304390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341441|NCT05295589|Paclitaxel|paclitaxel|mesh-list
93341442|NCT05295589|Doxorubicin|doxorubicin|mesh-list
93341443|NCT05295589|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93341444|NCT05295589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93341445|NCT05295589|Topotecan|topotecan|mesh-list
93341446|NCT05295589|Olaparib|olaparib|mesh-list
93341447|NCT05295589|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93341448|NCT05295589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341449|NCT05295589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341450|NCT05295589|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341451|NCT05295589|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341452|NCT05295589|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341453|NCT05295589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341454|NCT05295589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93341455|NCT05295589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341456|NCT05295589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341457|NCT05295589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341458|NCT05295589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93341459|NCT05288777|Capecitabine|capecitabine|mesh-list
93341460|NCT05288777|Trastuzumab|trastuzumab|mesh-list
93341461|NCT05288777|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93341462|NCT05288777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341463|NCT05288777|Antimetabolites|antimetabolites|mesh-ancestor
93341464|NCT05288777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341465|NCT05288777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341466|NCT05288777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341467|NCT05288777|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341468|NCT05288777|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341469|NCT05288777|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341470|NCT05288777|Immunotoxins|immunotoxins|mesh-ancestor
93341471|NCT05288777|Immunoconjugates|immunoconjugates|mesh-ancestor
93341472|NCT05288777|Immunologic Factors|immunologic factors|mesh-ancestor
93341473|NCT05288777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341474|NCT05269381|Cyclophosphamide|cyclophosphamide|mesh-list
93341475|NCT05269381|Pembrolizumab|pembrolizumab|mesh-list
93341476|NCT05269381|Sargramostim|sargramostim|mesh-list
93341477|NCT05269381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341478|NCT05269381|Immunologic Factors|immunologic factors|mesh-ancestor
93341479|NCT05269381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341480|NCT05269381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341481|NCT05269381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93341482|NCT05269381|Alkylating Agents|alkylating agents|mesh-ancestor
93341483|NCT05269381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341484|NCT05269381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341485|NCT05269381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93341486|NCT05269381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341487|NCT05269381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341488|NCT05261269|Niraparib|niraparib|mesh-list
93341489|NCT05261269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93341490|NCT05261269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341491|NCT05261269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341492|NCT05261269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341493|NCT05253209|Plasma-lyte 148|plasma-lyte 148|mesh-list
93341494|NCT05253209|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93341495|NCT05253209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93341496|NCT05228496|Tislelizumab|tislelizumab|mesh-list
93341497|NCT05228496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341498|NCT05228496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341499|NCT05194397|Niacinamide|niacinamide|mesh-list
93341501|NCT05194397|Nicotinic Acids|nicotinic acids|mesh-list
93341502|NCT05194397|Vitamin B Complex|vitamin b complex|mesh-ancestor
93341503|NCT05194397|Vitamins|vitamins|mesh-ancestor
93341504|NCT05194397|Micronutrients|micronutrients|mesh-ancestor
93341505|NCT05194397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635305|NCT00588913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93341506|NCT05194397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93341507|NCT05194397|Antimetabolites|antimetabolites|mesh-ancestor
93341508|NCT05194397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341509|NCT05194397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93341510|NCT05194397|Vasodilator Agents|vasodilator agents|mesh-ancestor
93341511|NCT05185947|Paclitaxel|paclitaxel|mesh-list
93341512|NCT05185947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341513|NCT05185947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341514|NCT05185947|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341515|NCT05185947|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341516|NCT05185947|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341517|NCT05185947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341518|NCT05176951|Treprostinil|treprostinil|mesh-list
93341519|NCT05176951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93341520|NCT05156281|Teriflunomide|teriflunomide|mesh-list
93341521|NCT05156281|Remibrutinib|remibrutinib|mesh-list
93341522|NCT05156281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93341523|NCT05156281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93341524|NCT05156281|Analgesics|analgesics|mesh-ancestor
93341525|NCT05156281|Sensory System Agents|sensory system agents|mesh-ancestor
93341526|NCT05156281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341527|NCT05156281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341528|NCT05156281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341529|NCT05156281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341530|NCT05156281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341531|NCT05156281|Immunologic Factors|immunologic factors|mesh-ancestor
93341532|NCT05156281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341533|NCT05156281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341534|NCT05156281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341535|NCT05153174|Sulforaphane|sulforaphane|mesh-list
93341536|NCT05153174|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93341537|NCT05153174|Protective Agents|protective agents|mesh-ancestor
93341538|NCT05153174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341539|NCT05153174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341540|NCT05147662|Factor VIII|factor viii|mesh-list
93341541|NCT05147662|Coagulants|coagulants|mesh-ancestor
93341542|NCT05143840|Niacinamide|niacinamide|mesh-list
93341543|NCT05143840|Vitamin B Complex|vitamin b complex|mesh-ancestor
93341544|NCT05143840|Vitamins|vitamins|mesh-ancestor
93341545|NCT05143840|Micronutrients|micronutrients|mesh-ancestor
93341546|NCT05143840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341547|NCT05101746|Nitric Oxide|nitric oxide|mesh-list
93341548|NCT05101746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93341549|NCT05101746|Autonomic Agents|autonomic agents|mesh-ancestor
93341550|NCT05101746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341551|NCT05101746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341552|NCT05101746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93341553|NCT05101746|Respiratory System Agents|respiratory system agents|mesh-ancestor
93341554|NCT05101746|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93341555|NCT05101746|Antioxidants|antioxidants|mesh-ancestor
93341556|NCT05101746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341557|NCT05101746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341558|NCT05101746|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93341559|NCT05101746|Vasodilator Agents|vasodilator agents|mesh-ancestor
93341560|NCT05101746|Gasotransmitters|gasotransmitters|mesh-ancestor
93341561|NCT05101746|Protective Agents|protective agents|mesh-ancestor
93341562|NCT05098210|Poly I-C|poly i-c|mesh-list
93341563|NCT05098210|Nivolumab|nivolumab|mesh-list
93341564|NCT05098210|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93341565|NCT05098210|Poly ICLC|poly iclc|mesh-list
93341566|NCT05098210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341567|NCT05098210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341568|NCT05098210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341569|NCT05098210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341570|NCT05098210|Interferon Inducers|interferon inducers|mesh-ancestor
93341571|NCT05098210|Immunologic Factors|immunologic factors|mesh-ancestor
93341572|NCT05098210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341573|NCT05098210|Laxatives|laxatives|mesh-ancestor
93341574|NCT05098210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341575|NCT05098210|Antiviral Agents|antiviral agents|mesh-ancestor
93341576|NCT05098210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635376|NCT00589732|Valsartan|valsartan|mesh-list
93341577|NCT05079230|Azacitidine|azacitidine|mesh-list
93341578|NCT05079230|Venetoclax|venetoclax|mesh-list
93341579|NCT05079230|Magrolimab|magrolimab|mesh-list
93341580|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341581|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
93341582|NCT05079230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341583|NCT05079230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341584|NCT05079230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341585|NCT05079230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341586|NCT05069597|Pancrelipase|pancrelipase|mesh-list
93341587|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341588|NCT05063565|Durvalumab|durvalumab|mesh-list
93341589|NCT05063565|Tremelimumab|tremelimumab|mesh-list
93341590|NCT05063565|Immunomodulating Agents|immunomodulating agents|mesh-list
93341591|NCT05063565|Immunologic Factors|immunologic factors|mesh-list
93341592|NCT05063565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341593|NCT05063565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341594|NCT05063565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341595|NCT05005182|Hydroxyurea|hydroxyurea|mesh-list
93341596|NCT05005182|Luspatercept|luspatercept|mesh-list
93341597|NCT05005182|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93341598|NCT05005182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341599|NCT05005182|Antisickling Agents|antisickling agents|mesh-ancestor
93341600|NCT05005182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341601|NCT05005182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341602|NCT05005182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93341603|NCT05005182|Hematinics|hematinics|mesh-ancestor
93341604|NCT05005182|Immunologic Factors|immunologic factors|mesh-ancestor
93341605|NCT05005182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341606|NCT04998279|Lenograstim|lenograstim|mesh-list
93341607|NCT04998279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93341608|NCT04998279|Immunologic Factors|immunologic factors|mesh-ancestor
93341609|NCT04998279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013578|NCT03039413|Copper|copper|mesh-list
93341610|NCT04989283|Paclitaxel|paclitaxel|mesh-list
93341611|NCT04989283|Etoposide|etoposide|mesh-list
93341612|NCT04989283|Podophyllotoxin|podophyllotoxin|mesh-list
93341613|NCT04989283|Cisplatin|cisplatin|mesh-list
93341614|NCT04989283|Carboplatin|carboplatin|mesh-list
93341615|NCT04989283|Pemetrexed|pemetrexed|mesh-list
93341616|NCT04989283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93341617|NCT04989283|Etoposide phosphate|etoposide phosphate|mesh-list
93341618|NCT04989283|Atezolizumab|atezolizumab|mesh-list
93341619|NCT04989283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93341620|NCT04989283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341621|NCT04989283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341622|NCT04989283|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341623|NCT04989283|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341624|NCT04989283|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341625|NCT04989283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341626|NCT04989283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341627|NCT04989283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341628|NCT04989283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341629|NCT04989283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93341630|NCT04989283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93341631|NCT04989283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341632|NCT04989283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341633|NCT04989283|Immunologic Factors|immunologic factors|mesh-ancestor
93341634|NCT04989283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341635|NCT04989283|Keratolytic Agents|keratolytic agents|mesh-ancestor
93341636|NCT04989283|Dermatologic Agents|dermatologic agents|mesh-ancestor
93341637|NCT04985916|Botulinum Toxins|botulinum toxins|mesh-list
93341638|NCT04985916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93341639|NCT04985916|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93341640|NCT04985916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93341641|NCT04985916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93341642|NCT04985916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341643|NCT04985916|Cholinergic Agents|cholinergic agents|mesh-ancestor
93341644|NCT04985916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341645|NCT04985916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341646|NCT04985916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93341647|NCT04985916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341648|NCT04951492|Olaparib|olaparib|mesh-list
93341649|NCT04951492|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93341650|NCT04951492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341651|NCT04951492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341652|NCT04951492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341653|NCT04938453|Nintedanib|nintedanib|mesh-list
93341654|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341655|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341656|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341657|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341658|NCT04933539|Dexamethasone|dexamethasone|mesh-list
93341659|NCT04933539|Daratumumab|daratumumab|mesh-list
93341660|NCT04933539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341661|NCT04933539|Antiemetics|antiemetics|mesh-ancestor
93341662|NCT04933539|Autonomic Agents|autonomic agents|mesh-ancestor
93341663|NCT04933539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341664|NCT04933539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341665|NCT04933539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341666|NCT04933539|Glucocorticoids|glucocorticoids|mesh-ancestor
93341667|NCT04933539|Hormones|hormones|mesh-ancestor
93341668|NCT04933539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341669|NCT04933539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341670|NCT04933539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341671|NCT04926818|Ofatumumab|ofatumumab|mesh-list
93341672|NCT04926818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93341673|NCT04926818|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93341674|NCT04926818|Siponimod|siponimod|mesh-list
93341675|NCT04926818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341676|NCT04926818|Immunologic Factors|immunologic factors|mesh-ancestor
93341677|NCT04926818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341678|NCT04926818|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93341679|NCT04926818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341680|NCT04926818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341681|NCT04887285|Anesthetics|anesthetics|mesh-list
93341682|NCT04887285|Anesthetics, Local|anesthetics, local|mesh-list
93341683|NCT04887285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341684|NCT04887285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341685|NCT04887285|Sensory System Agents|sensory system agents|mesh-ancestor
93341686|NCT04887285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341687|NCT04877821|Paclitaxel|paclitaxel|mesh-list
93341688|NCT04877821|Cyclophosphamide|cyclophosphamide|mesh-list
93341689|NCT04877821|Carboplatin|carboplatin|mesh-list
93341690|NCT04877821|Epirubicin|epirubicin|mesh-list
93341691|NCT04877821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341692|NCT04877821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341693|NCT04877821|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341694|NCT04877821|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341695|NCT04877821|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341696|NCT04877821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341697|NCT04877821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341698|NCT04877821|Immunologic Factors|immunologic factors|mesh-ancestor
93341699|NCT04877821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341700|NCT04877821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341701|NCT04877821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93341702|NCT04877821|Alkylating Agents|alkylating agents|mesh-ancestor
93341703|NCT04877821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93341704|NCT04877821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93341705|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341706|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341707|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341708|NCT04862221|Diphenhydramine|diphenhydramine|mesh-list
93341709|NCT04862221|Promethazine|promethazine|mesh-list
93341710|NCT04862221|Methylprednisolone|methylprednisolone|mesh-list
93341711|NCT04862221|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93341712|NCT04862221|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93341713|NCT04862221|Prednisolone|prednisolone|mesh-list
93341714|NCT04862221|Prednisolone acetate|prednisolone acetate|mesh-list
93341715|NCT04862221|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93341716|NCT04862221|Prednisolone phosphate|prednisolone phosphate|mesh-list
93341717|NCT04862221|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93341718|NCT04862221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341719|NCT04862221|Antiemetics|antiemetics|mesh-ancestor
93341720|NCT04862221|Autonomic Agents|autonomic agents|mesh-ancestor
93341721|NCT04862221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341722|NCT04862221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341723|NCT04862221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341724|NCT04862221|Glucocorticoids|glucocorticoids|mesh-ancestor
93341725|NCT04862221|Hormones|hormones|mesh-ancestor
93341726|NCT04862221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341727|NCT04862221|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93341728|NCT04862221|Protective Agents|protective agents|mesh-ancestor
93341729|NCT04862221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341730|NCT04862221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341731|NCT04862221|Immunologic Factors|immunologic factors|mesh-ancestor
93341732|NCT04862221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341733|NCT04862221|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93341734|NCT04862221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93341735|NCT04862221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341736|NCT04862221|Anesthetics, Local|anesthetics, local|mesh-ancestor
93341737|NCT04862221|Anesthetics|anesthetics|mesh-ancestor
93341738|NCT04862221|Sensory System Agents|sensory system agents|mesh-ancestor
93341739|NCT04862221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93341740|NCT04862221|Histamine Antagonists|histamine antagonists|mesh-ancestor
93341741|NCT04862221|Histamine Agents|histamine agents|mesh-ancestor
93341742|NCT04862221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341743|NCT04862221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341744|NCT04862221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93341745|NCT04862221|Antipruritics|antipruritics|mesh-ancestor
93341746|NCT04862221|Dermatologic Agents|dermatologic agents|mesh-ancestor
93341747|NCT04849364|Capecitabine|capecitabine|mesh-list
93341748|NCT04849364|Atezolizumab|atezolizumab|mesh-list
93341749|NCT04849364|Talazoparib|talazoparib|mesh-list
93341750|NCT04849364|Inavolisib|inavolisib|mesh-list
93341751|NCT04849364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93341752|NCT04849364|Antimetabolites|antimetabolites|mesh-ancestor
93341753|NCT04849364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341754|NCT04849364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341755|NCT04849364|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341756|NCT04849364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341757|NCT04849364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93341758|NCT04849364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013729|NCT02697448|Anesthetics, General|anesthetics, general|mesh-ancestor
93341759|NCT04849364|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93341760|NCT04840602|Rituximab|rituximab|mesh-list
93341761|NCT04840602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93341762|NCT04840602|Venetoclax|venetoclax|mesh-list
93341763|NCT04840602|Antibodies|antibodies|mesh-list
93341764|NCT04840602|Immunoglobulins|immunoglobulins|mesh-list
93341765|NCT04840602|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93341766|NCT04840602|Immunologic Factors|immunologic factors|mesh-ancestor
93341767|NCT04840602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341768|NCT04840602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341769|NCT04840602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341770|NCT04827576|Docetaxel|docetaxel|mesh-list
93341771|NCT04827576|Magrolimab|magrolimab|mesh-list
93341772|NCT04827576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341773|NCT04827576|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341774|NCT04827576|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341775|NCT04827576|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341776|NCT04827576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341777|NCT04827576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341778|NCT04809766|Cyclophosphamide|cyclophosphamide|mesh-list
93341779|NCT04809766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93341780|NCT04809766|Fludarabine|fludarabine|mesh-list
93341781|NCT04809766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93341782|NCT04809766|Immunologic Factors|immunologic factors|mesh-ancestor
93341783|NCT04809766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341784|NCT04809766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341785|NCT04809766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93341786|NCT04809766|Alkylating Agents|alkylating agents|mesh-ancestor
93341787|NCT04809766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341788|NCT04809766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341789|NCT04809766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93341790|NCT04790370|Heparin|heparin|mesh-list
93341791|NCT04790370|Calcium heparin|calcium heparin|mesh-list
93341792|NCT04790370|Anticoagulants|anticoagulants|mesh-ancestor
93341793|NCT04790370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93341794|NCT04790370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93341795|NCT04790370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341796|NCT04778982|Fulvestrant|fulvestrant|mesh-list
93341797|NCT04778982|Palbociclib|palbociclib|mesh-list
93341798|NCT04778982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93341799|NCT04778982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341800|NCT04778982|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93341801|NCT04778982|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93341802|NCT04778982|Hormone Antagonists|hormone antagonists|mesh-ancestor
93341803|NCT04778982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341804|NCT04778982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341805|NCT04778982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341806|NCT04778982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341807|NCT04778982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341808|NCT04772781|Ibuprofen|ibuprofen|mesh-list
93341809|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93341810|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93341811|NCT04772781|Analgesics|analgesics|mesh-ancestor
93341812|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
93341813|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341814|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341815|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341816|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341817|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93341818|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341819|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341820|NCT04765202|Carisoprodol|carisoprodol|mesh-list
93341821|NCT04765202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93341822|NCT04765202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341823|NCT04765202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93341824|NCT04765202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341825|NCT04756037|Relugolix|relugolix|mesh-list
93341826|NCT04756037|Androgen Antagonists|androgen antagonists|mesh-ancestor
93341827|NCT04756037|Hormone Antagonists|hormone antagonists|mesh-ancestor
93341828|NCT04756037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93341829|NCT04756037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341830|NCT04739800|Paclitaxel|paclitaxel|mesh-list
93341831|NCT04739800|Doxorubicin|doxorubicin|mesh-list
93341832|NCT04739800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93341833|NCT04739800|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93341834|NCT04739800|Durvalumab|durvalumab|mesh-list
93341835|NCT04739800|Topotecan|topotecan|mesh-list
93341836|NCT04739800|Olaparib|olaparib|mesh-list
93341837|NCT04739800|Cediranib|cediranib|mesh-list
93341838|NCT04739800|Maleic acid|maleic acid|mesh-list
93341839|NCT04739800|Immunoglobulins|immunoglobulins|mesh-list
93341840|NCT04739800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93341841|NCT04739800|Immunoglobulin G|immunoglobulin g|mesh-list
93341842|NCT04739800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93341843|NCT04739800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341844|NCT04739800|Tubulin Modulators|tubulin modulators|mesh-ancestor
93341845|NCT04739800|Antimitotic Agents|antimitotic agents|mesh-ancestor
93341846|NCT04739800|Mitosis Modulators|mitosis modulators|mesh-ancestor
93341847|NCT04739800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341848|NCT04739800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93341849|NCT04739800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93341850|NCT04739800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93341851|NCT04739800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341852|NCT04739800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341853|NCT04739800|Immunologic Factors|immunologic factors|mesh-ancestor
93341854|NCT04739800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341855|NCT04739800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93341856|NCT04739800|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93341857|NCT04739800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341858|NCT04712643|Atezolizumab|atezolizumab|mesh-list
93341859|NCT04712643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341860|NCT04712643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341861|NCT04712643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341862|NCT04712643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341863|NCT04712097|Rituximab|rituximab|mesh-list
93341864|NCT04712097|Lenalidomide|lenalidomide|mesh-list
93341865|NCT04712097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341866|NCT04712097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341867|NCT04712097|Immunologic Factors|immunologic factors|mesh-ancestor
93341868|NCT04712097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341869|NCT04712097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341870|NCT04712097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93341871|NCT04712097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93341872|NCT04712097|Growth Substances|growth substances|mesh-ancestor
93341873|NCT04712097|Growth Inhibitors|growth inhibitors|mesh-ancestor
93341874|NCT04699591|Domperidone|domperidone|mesh-list
93341875|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
93341876|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
93341877|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341878|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341879|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341880|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93341881|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
93341882|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341883|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341884|NCT04679948|Midazolam|midazolam|mesh-list
93341885|NCT04679948|Caffeine|caffeine|mesh-list
93341886|NCT04679948|Omeprazole|omeprazole|mesh-list
93341887|NCT04679948|Warfarin|warfarin|mesh-list
93341888|NCT04679948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93341889|NCT04679948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93341890|NCT04679948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341891|NCT04679948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341892|NCT04679948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93341893|NCT04679948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93341894|NCT04679948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93341895|NCT04679948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93341896|NCT04679948|Anesthetics, General|anesthetics, general|mesh-ancestor
93341897|NCT04679948|Anesthetics|anesthetics|mesh-ancestor
93341898|NCT04679948|GABA Modulators|gaba modulators|mesh-ancestor
93341899|NCT04679948|GABA Agents|gaba agents|mesh-ancestor
93341900|NCT04679948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341901|NCT04679948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341902|NCT04679948|Anticoagulants|anticoagulants|mesh-ancestor
93341903|NCT04679948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93341904|NCT04679948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93341905|NCT04679948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341906|NCT04679948|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93341907|NCT04679948|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93341908|NCT04679948|Purinergic Agents|purinergic agents|mesh-ancestor
93341909|NCT04679948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93341910|NCT04679948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93341911|NCT04679948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93341912|NCT04663308|Volixibat|volixibat|mesh-list
93341913|NCT04663308|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93341914|NCT04660344|Atezolizumab|atezolizumab|mesh-list
93341915|NCT04660344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93341916|NCT04660344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341917|NCT04660344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93341918|NCT04660344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341919|NCT04647435|Tramadol|tramadol|mesh-list
93341920|NCT04647435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93341921|NCT04647435|Narcotics|narcotics|mesh-ancestor
93341922|NCT04647435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341923|NCT04647435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341924|NCT04647435|Analgesics|analgesics|mesh-ancestor
93341925|NCT04647435|Sensory System Agents|sensory system agents|mesh-ancestor
93341926|NCT04647435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341927|NCT04637529|Ibuprofen|ibuprofen|mesh-list
93341928|NCT04637529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93341929|NCT04637529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93341930|NCT04637529|Analgesics|analgesics|mesh-ancestor
93341931|NCT04637529|Sensory System Agents|sensory system agents|mesh-ancestor
93341932|NCT04637529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341933|NCT04637529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341934|NCT04637529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93341935|NCT04637529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93341936|NCT04637529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93341937|NCT04637529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341938|NCT04637529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341939|NCT04625803|Apatinib|apatinib|mesh-list
93341940|NCT04625803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93341941|NCT04625803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93341942|NCT04625803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341943|NCT04625803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341944|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
93341945|NCT04621526|Ketamine|ketamine|mesh-list
93341946|NCT04621526|Propofol|propofol|mesh-list
93341947|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93341948|NCT04621526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341949|NCT04621526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341950|NCT04621526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93341951|NCT04621526|Analgesics|analgesics|mesh-ancestor
93341952|NCT04621526|Sensory System Agents|sensory system agents|mesh-ancestor
93341953|NCT04621526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93341954|NCT04621526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93341955|NCT04621526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93341956|NCT04621526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93341957|NCT04621526|Adrenergic Agents|adrenergic agents|mesh-ancestor
93341958|NCT04621526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341959|NCT04621526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341960|NCT04621526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93341961|NCT04621526|Anesthetics, General|anesthetics, general|mesh-ancestor
93341962|NCT04621526|Anesthetics|anesthetics|mesh-ancestor
93341963|NCT04621526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93341964|NCT04621526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93341965|NCT04621526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93341966|NCT04620759|Psilocybin|psilocybin|mesh-list
93341967|NCT04620759|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93341968|NCT04620759|Hallucinogens|hallucinogens|mesh-ancestor
93341969|NCT04620759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341970|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93341971|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93341972|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
93341973|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93341974|NCT04620759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341975|NCT04620759|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93341976|NCT04590937|Metformin|metformin|mesh-list
93341977|NCT04590937|Digoxin|digoxin|mesh-list
93341978|NCT04590937|Furosemide|furosemide|mesh-list
93341979|NCT04590937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93341980|NCT04590937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93341981|NCT04590937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93341982|NCT04590937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93341983|NCT04590937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93341984|NCT04590937|Antimetabolites|antimetabolites|mesh-ancestor
92635772|NCT00475306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93341985|NCT04590937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93341986|NCT04590937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93341987|NCT04590937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93341988|NCT04590937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93341989|NCT04590937|Diuretics|diuretics|mesh-ancestor
93341990|NCT04590937|Natriuretic Agents|natriuretic agents|mesh-ancestor
93341991|NCT04590937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93341992|NCT04590937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93341993|NCT04590937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93341994|NCT04590937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93341995|NCT04590937|Protective Agents|protective agents|mesh-ancestor
93341996|NCT04586010|Teriflunomide|teriflunomide|mesh-list
93341997|NCT04586010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93341998|NCT04586010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93341999|NCT04586010|Analgesics|analgesics|mesh-ancestor
93342000|NCT04586010|Sensory System Agents|sensory system agents|mesh-ancestor
93342001|NCT04586010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342002|NCT04586010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342003|NCT04586010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342004|NCT04586010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342005|NCT04586010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342006|NCT04586010|Immunologic Factors|immunologic factors|mesh-ancestor
93342007|NCT04579224|Paclitaxel|paclitaxel|mesh-list
93342008|NCT04579224|Docetaxel|docetaxel|mesh-list
93342009|NCT04579224|Halichondrin B|halichondrin b|mesh-list
93342010|NCT04579224|Gemcitabine|gemcitabine|mesh-list
93342011|NCT04579224|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342012|NCT04579224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342013|NCT04579224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342014|NCT04579224|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342015|NCT04579224|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342016|NCT04579224|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342017|NCT04579224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342018|NCT04579224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342019|NCT04579224|Antimetabolites|antimetabolites|mesh-ancestor
93342020|NCT04577755|Pomalidomide|pomalidomide|mesh-list
93342021|NCT04577755|Immunologic Factors|immunologic factors|mesh-ancestor
93342022|NCT04577755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342023|NCT04577755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93342024|NCT04577755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93342025|NCT04577755|Growth Substances|growth substances|mesh-ancestor
93342026|NCT04577755|Growth Inhibitors|growth inhibitors|mesh-ancestor
93342027|NCT04577755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342028|NCT04544189|Fulvestrant|fulvestrant|mesh-list
93342029|NCT04544189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342030|NCT04544189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342031|NCT04544189|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93342032|NCT04544189|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93342033|NCT04544189|Hormone Antagonists|hormone antagonists|mesh-ancestor
93342034|NCT04544189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342035|NCT04544189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342036|NCT04530565|Cytarabine|cytarabine|mesh-list
93342037|NCT04530565|Dexamethasone|dexamethasone|mesh-list
93342038|NCT04530565|Dexamethasone acetate|dexamethasone acetate|mesh-list
93342039|NCT04530565|Prednisone|prednisone|mesh-list
93342040|NCT04530565|Cortisone|cortisone|mesh-list
93342041|NCT04530565|Cyclophosphamide|cyclophosphamide|mesh-list
93342042|NCT04530565|Doxorubicin|doxorubicin|mesh-list
93342043|NCT04530565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93342044|NCT04530565|Methotrexate|methotrexate|mesh-list
93342045|NCT04530565|Vincristine|vincristine|mesh-list
93342046|NCT04530565|Dasatinib|dasatinib|mesh-list
93342047|NCT04530565|Blinatumomab|blinatumomab|mesh-list
93342048|NCT04530565|Ponatinib|ponatinib|mesh-list
93342049|NCT04530565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93342050|NCT04530565|Muromonab-CD3|muromonab-cd3|mesh-list
93342051|NCT04530565|Antibodies|antibodies|mesh-list
93342052|NCT04530565|Immunoglobulins|immunoglobulins|mesh-list
93342053|NCT04530565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342054|NCT04530565|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93342055|NCT04530565|BB 1101|bb 1101|mesh-list
93342056|NCT04530565|Mesna|mesna|mesh-list
93342057|NCT04530565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342058|NCT04530565|Immunologic Factors|immunologic factors|mesh-ancestor
93014031|NCT02550119|BB 1101|bb 1101|mesh-list
93342059|NCT04530565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342060|NCT04530565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342061|NCT04530565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93342062|NCT04530565|Alkylating Agents|alkylating agents|mesh-ancestor
93342063|NCT04530565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342064|NCT04530565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342065|NCT04530565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93342066|NCT04530565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342068|NCT04530565|Autonomic Agents|autonomic agents|mesh-ancestor
93342069|NCT04530565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342070|NCT04530565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342071|NCT04530565|Glucocorticoids|glucocorticoids|mesh-ancestor
93342072|NCT04530565|Hormones|hormones|mesh-ancestor
93342073|NCT04530565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342074|NCT04530565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342075|NCT04530565|Protease Inhibitors|protease inhibitors|mesh-ancestor
93342076|NCT04530565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342077|NCT04530565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93342078|NCT04530565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93342079|NCT04530565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342080|NCT04530565|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93342081|NCT04530565|Abortifacient Agents|abortifacient agents|mesh-ancestor
93342082|NCT04530565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93342083|NCT04530565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342084|NCT04530565|Antimetabolites|antimetabolites|mesh-ancestor
93342085|NCT04530565|Dermatologic Agents|dermatologic agents|mesh-ancestor
93342086|NCT04530565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93342087|NCT04530565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93342088|NCT04530565|Antiviral Agents|antiviral agents|mesh-ancestor
93342089|NCT04530565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342090|NCT04530565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342091|NCT04530565|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342092|NCT04530565|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342093|NCT04530565|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342094|NCT04530565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342095|NCT04530565|Protective Agents|protective agents|mesh-ancestor
93342096|NCT04491084|Antibodies|antibodies|mesh-list
93342097|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
93342098|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
93342099|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342100|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93342101|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93342102|NCT04491084|Protective Agents|protective agents|mesh-ancestor
93342103|NCT04458909|Cisplatin|cisplatin|mesh-list
93342104|NCT04458909|Carboplatin|carboplatin|mesh-list
93342105|NCT04458909|Gemcitabine|gemcitabine|mesh-list
93342106|NCT04458909|Nivolumab|nivolumab|mesh-list
93342107|NCT04458909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342108|NCT04458909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342109|NCT04458909|Antimetabolites|antimetabolites|mesh-ancestor
93342110|NCT04458909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342111|NCT04458909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342112|NCT04458909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342113|NCT04446117|Prednisone|prednisone|mesh-list
93342114|NCT04446117|Atezolizumab|atezolizumab|mesh-list
93342115|NCT04446117|Abiraterone Acetate|abiraterone acetate|mesh-list
93342116|NCT04446117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342117|NCT04446117|Glucocorticoids|glucocorticoids|mesh-ancestor
93342118|NCT04446117|Hormones|hormones|mesh-ancestor
93342119|NCT04446117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342120|NCT04446117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342121|NCT04446117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342122|NCT04446117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342123|NCT04446117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342124|NCT04446117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342125|NCT04446117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342126|NCT04446117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93342127|NCT04446117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342128|NCT04446117|Hormone Antagonists|hormone antagonists|mesh-ancestor
93342129|NCT04446117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93342130|NCT04435600|Ustekinumab|ustekinumab|mesh-list
93342131|NCT04435600|Dermatologic Agents|dermatologic agents|mesh-ancestor
93342132|NCT04431635|Rituximab|rituximab|mesh-list
93342133|NCT04431635|Nivolumab|nivolumab|mesh-list
93342134|NCT04431635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342135|NCT04431635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342136|NCT04431635|Immunologic Factors|immunologic factors|mesh-ancestor
93342137|NCT04431635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342138|NCT04431635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342139|NCT04431635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342140|NCT04431635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342142|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342143|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342144|NCT04339738|Paclitaxel|paclitaxel|mesh-list
93342145|NCT04339738|Nivolumab|nivolumab|mesh-list
93342146|NCT04339738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342147|NCT04339738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342148|NCT04339738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342149|NCT04339738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342150|NCT04339738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342151|NCT04339738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342152|NCT04339738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342153|NCT04339738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342154|NCT04339738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342155|NCT04334941|Atezolizumab|atezolizumab|mesh-list
93342156|NCT04334941|Talazoparib|talazoparib|mesh-list
93342157|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342158|NCT04334941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342159|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342160|NCT04334941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342161|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342162|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
93342163|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342164|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93342165|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342166|NCT04329065|Paclitaxel|paclitaxel|mesh-list
93342167|NCT04329065|Trastuzumab|trastuzumab|mesh-list
93342168|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342169|NCT04329065|Pertuzumab|pertuzumab|mesh-list
93342170|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93342171|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93342172|NCT04329065|Vaccines|vaccines|mesh-list
93342173|NCT04329065|Antibodies|antibodies|mesh-list
93342174|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
93342175|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342176|NCT04329065|Immunoglobulin G|immunoglobulin g|mesh-list
93342177|NCT04329065|Immunologic Factors|immunologic factors|mesh-ancestor
93342178|NCT04329065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342179|NCT04329065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342180|NCT04329065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342181|NCT04329065|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342182|NCT04329065|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342183|NCT04329065|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342184|NCT04329065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342185|NCT04326257|Nivolumab|nivolumab|mesh-list
93342186|NCT04326257|Ipilimumab|ipilimumab|mesh-list
93342187|NCT04326257|Relatlimab|relatlimab|mesh-list
93342188|NCT04326257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342189|NCT04326257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342190|NCT04326257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342191|NCT04326257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342192|NCT04249401|Warfarin|warfarin|mesh-list
93342193|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
93342194|NCT04249401|Dabigatran|dabigatran|mesh-list
93342195|NCT04249401|Apixaban|apixaban|mesh-list
93342196|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
93342197|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93342198|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
93342199|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93342200|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
93342201|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342202|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342203|NCT04222972|Paclitaxel|paclitaxel|mesh-list
93342204|NCT04222972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342205|NCT04222972|Carboplatin|carboplatin|mesh-list
93342206|NCT04222972|Gemcitabine|gemcitabine|mesh-list
93342207|NCT04222972|Pembrolizumab|pembrolizumab|mesh-list
93342208|NCT04222972|Pemetrexed|pemetrexed|mesh-list
93342209|NCT04222972|Pralsetinib|pralsetinib|mesh-list
93342210|NCT04222972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342211|NCT04222972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342212|NCT04222972|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342213|NCT04222972|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342214|NCT04222972|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342215|NCT04222972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342216|NCT04222972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342218|NCT04222972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342219|NCT04222972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342220|NCT04222972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342221|NCT04222972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93342222|NCT04222972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93342223|NCT04198766|Pembrolizumab|pembrolizumab|mesh-list
93342224|NCT04198766|Antibodies|antibodies|mesh-list
93342225|NCT04198766|Immunologic Factors|immunologic factors|mesh-ancestor
93342226|NCT04198766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342227|NCT04198766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342228|NCT04198766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342229|NCT04198766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342230|NCT04198766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342231|NCT04175912|Paclitaxel|paclitaxel|mesh-list
93342232|NCT04175912|Carboplatin|carboplatin|mesh-list
93342233|NCT04175912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342234|NCT04175912|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93342235|NCT04175912|Pevonedistat|pevonedistat|mesh-list
93342236|NCT04175912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342237|NCT04175912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342238|NCT04175912|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342239|NCT04175912|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342240|NCT04175912|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342241|NCT04175912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342242|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
93342243|NCT04147260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93342244|NCT04147260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342245|NCT04147260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93342246|NCT04147260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342247|NCT04147260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342248|NCT04147260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342249|NCT04147260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342250|NCT04147260|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93342251|NCT04147260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93342252|NCT04114136|Metformin|metformin|mesh-list
93342253|NCT04114136|Rosiglitazone|rosiglitazone|mesh-list
93342254|NCT04114136|Pembrolizumab|pembrolizumab|mesh-list
93342255|NCT04114136|Nivolumab|nivolumab|mesh-list
93342256|NCT04114136|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93342257|NCT04114136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342258|NCT04114136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342259|NCT04114136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342260|NCT04114136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342261|NCT04114136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342262|NCT04112043|Niacinamide|niacinamide|mesh-list
93342263|NCT04112043|Niacin|niacin|mesh-list
93342264|NCT04112043|Nicotinic Acids|nicotinic acids|mesh-list
93342265|NCT04112043|Vitamin B Complex|vitamin b complex|mesh-ancestor
93342266|NCT04112043|Vitamins|vitamins|mesh-ancestor
93342267|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
93342268|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342269|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93342270|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
93342271|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342272|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93342273|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
93342274|NCT04092673|Trastuzumab|trastuzumab|mesh-list
93342275|NCT04092673|Sotorasib|sotorasib|mesh-list
93342276|NCT04092673|Fulvestrant|fulvestrant|mesh-list
93342277|NCT04092673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342278|NCT04092673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342279|NCT04092673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342280|NCT04092673|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93342281|NCT04092673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93342282|NCT04092673|Hormone Antagonists|hormone antagonists|mesh-ancestor
93342283|NCT04092673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342284|NCT04092673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342285|NCT04092673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342286|NCT04092673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342287|NCT04091386|Factor VIII|factor viii|mesh-list
93342288|NCT04091386|Coagulants|coagulants|mesh-ancestor
93342289|NCT04090398|Paclitaxel|paclitaxel|mesh-list
93342290|NCT04090398|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342291|NCT04090398|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93342292|NCT04090398|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342293|NCT04090398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342294|NCT04090398|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342295|NCT04090398|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342296|NCT04090398|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342297|NCT04090398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342298|NCT04071236|Avelumab|avelumab|mesh-list
93342299|NCT04071236|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93342300|NCT04071236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342301|NCT04071236|Peposertib|peposertib|mesh-list
93342302|NCT04071236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342303|NCT04071236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342304|NCT04071236|Immunologic Factors|immunologic factors|mesh-ancestor
93342305|NCT04071236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342306|NCT04071236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342307|NCT04071236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342308|NCT04071236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342309|NCT04042740|Ribavirin|ribavirin|mesh-list
93342310|NCT04042740|Antimetabolites|antimetabolites|mesh-ancestor
93342311|NCT04042740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342312|NCT04042740|Antiviral Agents|antiviral agents|mesh-ancestor
93342313|NCT04042740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342314|NCT03997968|Rituximab|rituximab|mesh-list
93342315|NCT03997968|Gemcitabine|gemcitabine|mesh-list
93342316|NCT03997968|Capecitabine|capecitabine|mesh-list
93342317|NCT03997968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93342318|NCT03997968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342319|NCT03997968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342320|NCT03997968|Immunologic Factors|immunologic factors|mesh-ancestor
93342321|NCT03997968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342322|NCT03997968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342323|NCT03997968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342324|NCT03997968|Antimetabolites|antimetabolites|mesh-ancestor
93342325|NCT03997968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342326|NCT03997968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93342327|NCT03997968|Alkylating Agents|alkylating agents|mesh-ancestor
93342328|NCT03997786|Etanercept|etanercept|mesh-list
93342329|NCT03997786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342330|NCT03997786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93342331|NCT03997786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93342332|NCT03997786|Analgesics|analgesics|mesh-ancestor
93342333|NCT03997786|Sensory System Agents|sensory system agents|mesh-ancestor
93342334|NCT03997786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342335|NCT03997786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342336|NCT03997786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342337|NCT03997786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342338|NCT03997786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342339|NCT03997786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342340|NCT03997786|Immunologic Factors|immunologic factors|mesh-ancestor
93342341|NCT03995706|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93342342|NCT03995706|Immunoconjugates|immunoconjugates|mesh-ancestor
93342343|NCT03995706|Immunologic Factors|immunologic factors|mesh-ancestor
93342344|NCT03995706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342345|NCT03984097|Dexamethasone|dexamethasone|mesh-list
93342346|NCT03984097|Lenalidomide|lenalidomide|mesh-list
93342347|NCT03984097|Bortezomib|bortezomib|mesh-list
93342348|NCT03984097|Pomalidomide|pomalidomide|mesh-list
93342349|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342350|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
93342351|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
93342352|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342353|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342354|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342355|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
93342356|NCT03984097|Hormones|hormones|mesh-ancestor
93342357|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342358|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342359|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342360|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
93342361|NCT03984097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93342362|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93342363|NCT03984097|Growth Substances|growth substances|mesh-ancestor
93342364|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
93342365|NCT03941860|Lenalidomide|lenalidomide|mesh-list
93342366|NCT03941860|Ixazomib|ixazomib|mesh-list
93342367|NCT03941860|Glycine|glycine|mesh-list
93342368|NCT03941860|Immunologic Factors|immunologic factors|mesh-ancestor
93342369|NCT03941860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342370|NCT03941860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93342371|NCT03941860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93342372|NCT03941860|Growth Substances|growth substances|mesh-ancestor
93342373|NCT03941860|Growth Inhibitors|growth inhibitors|mesh-ancestor
93342374|NCT03941860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342375|NCT03941860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342376|NCT03941860|Protease Inhibitors|protease inhibitors|mesh-ancestor
93342377|NCT03941860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342378|NCT03941860|Glycine Agents|glycine agents|mesh-ancestor
93342379|NCT03941860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342380|NCT03887377|Botulinum Toxins|botulinum toxins|mesh-list
93342381|NCT03887377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93342382|NCT03887377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93342383|NCT03887377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93342384|NCT03887377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342385|NCT03887377|Cholinergic Agents|cholinergic agents|mesh-ancestor
93342386|NCT03887377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342387|NCT03887377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342388|NCT03876769|Tisagenlecleucel|tisagenlecleucel|mesh-list
93342389|NCT03876769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342390|NCT03876769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342391|NCT03870529|Vitamins|vitamins|mesh-list
93342392|NCT03870529|Vitamin A|vitamin a|mesh-list
93342393|NCT03870529|Anti-Infective Agents|anti-infective agents|mesh-list
93342394|NCT03870529|Retinol palmitate|retinol palmitate|mesh-list
93342395|NCT03870529|Micronutrients|micronutrients|mesh-ancestor
93342396|NCT03870529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342397|NCT03870529|Antioxidants|antioxidants|mesh-ancestor
93342398|NCT03870529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342399|NCT03870529|Protective Agents|protective agents|mesh-ancestor
93342400|NCT03870529|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93342401|NCT03870529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342402|NCT03833154|Durvalumab|durvalumab|mesh-list
93342403|NCT03833154|Osimertinib|osimertinib|mesh-list
93342404|NCT03833154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342405|NCT03833154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342406|NCT03833154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342407|NCT03833154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342408|NCT03833154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342409|NCT03789604|Antibodies|antibodies|mesh-list
93342410|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342411|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
93342412|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342413|NCT03780894|Tranexamic Acid|tranexamic acid|mesh-list
93342414|NCT03780894|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93342415|NCT03780894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92636202|NCT00218244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342416|NCT03780894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342417|NCT03780894|Hemostatics|hemostatics|mesh-ancestor
93342418|NCT03780894|Coagulants|coagulants|mesh-ancestor
93342419|NCT03741478|Insulin|insulin|mesh-list
93342420|NCT03741478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93342421|NCT03741478|Insulin Lispro|insulin lispro|mesh-list
93342422|NCT03741478|Olanzapine|olanzapine|mesh-list
93342423|NCT03741478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93342424|NCT03741478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342425|NCT03741478|Antiemetics|antiemetics|mesh-ancestor
93342426|NCT03741478|Autonomic Agents|autonomic agents|mesh-ancestor
93342427|NCT03741478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342428|NCT03741478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342429|NCT03741478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93342430|NCT03741478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93342431|NCT03741478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93342432|NCT03741478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93342433|NCT03741478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93342434|NCT03741478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93342435|NCT03741478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93342436|NCT03741478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342437|NCT03741478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342438|NCT03741478|Serotonin Agents|serotonin agents|mesh-ancestor
93342439|NCT03701282|Venetoclax|venetoclax|mesh-list
93342440|NCT03701282|Obinutuzumab|obinutuzumab|mesh-list
93342441|NCT03701282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342442|NCT03701282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342443|NCT03669367|Abatacept|abatacept|mesh-list
93342444|NCT03669367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342445|NCT03669367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342446|NCT03669367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342447|NCT03669367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342448|NCT03669367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342449|NCT03669367|Immunologic Factors|immunologic factors|mesh-ancestor
93342450|NCT03669367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342451|NCT03669367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342452|NCT03650114|Ofatumumab|ofatumumab|mesh-list
93342453|NCT03650114|Vaccines|vaccines|mesh-list
93342454|NCT03650114|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93342455|NCT03650114|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93342456|NCT03650114|Immunologic Factors|immunologic factors|mesh-ancestor
93342457|NCT03650114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342458|NCT03650114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342459|NCT03650114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93342460|NCT03630081|Ciprofloxacin|ciprofloxacin|mesh-list
93342461|NCT03630081|Meropenem|meropenem|mesh-list
93342462|NCT03630081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93342463|NCT03630081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342464|NCT03630081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93342465|NCT03630081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342466|NCT03630081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342467|NCT03630081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342468|NCT03630081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342469|NCT03630081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93342470|NCT03630081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93342471|NCT03617458|Metformin|metformin|mesh-list
93342472|NCT03617458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93342473|NCT03617458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342474|NCT03538938|Nicotine|nicotine|mesh-list
93342475|NCT03538938|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93342476|NCT03538938|Autonomic Agents|autonomic agents|mesh-ancestor
93342477|NCT03538938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342478|NCT03538938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342479|NCT03538938|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93342480|NCT03538938|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93342481|NCT03538938|Cholinergic Agents|cholinergic agents|mesh-ancestor
93342482|NCT03538938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342483|NCT03538938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342484|NCT03522688|Dexmedetomidine|dexmedetomidine|mesh-list
93342485|NCT03522688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93342486|NCT03522688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636272|NCT00185939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342487|NCT03522688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342488|NCT03522688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93342489|NCT03522688|Analgesics|analgesics|mesh-ancestor
93342490|NCT03522688|Sensory System Agents|sensory system agents|mesh-ancestor
93342491|NCT03522688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342492|NCT03522688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93342493|NCT03522688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93342494|NCT03522688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93342495|NCT03522688|Adrenergic Agents|adrenergic agents|mesh-ancestor
93342496|NCT03522688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342497|NCT03522688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342498|NCT03511118|Metformin|metformin|mesh-list
93342499|NCT03511118|Topiramate|topiramate|mesh-list
93342500|NCT03511118|Azithromycin|azithromycin|mesh-list
93342501|NCT03511118|Doxycycline|doxycycline|mesh-list
93342502|NCT03511118|Ciprofloxacin|ciprofloxacin|mesh-list
93342503|NCT03511118|Levofloxacin|levofloxacin|mesh-list
93342504|NCT03511118|Clindamycin|clindamycin|mesh-list
93342505|NCT03511118|Valganciclovir|valganciclovir|mesh-list
93342506|NCT03511118|Remdesivir|remdesivir|mesh-list
93342507|NCT03511118|Hydroxyurea|hydroxyurea|mesh-list
93342508|NCT03511118|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93342509|NCT03511118|Verapamil|verapamil|mesh-list
93342510|NCT03511118|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93342511|NCT03511118|Labetalol|labetalol|mesh-list
93342512|NCT03511118|Nifedipine|nifedipine|mesh-list
93342513|NCT03511118|Furosemide|furosemide|mesh-list
93342514|NCT03511118|Sumatriptan|sumatriptan|mesh-list
93342515|NCT03511118|Oxycodone|oxycodone|mesh-list
93342516|NCT03511118|Gabapentin|gabapentin|mesh-list
93342517|NCT03511118|Ondansetron|ondansetron|mesh-list
93342518|NCT03511118|Fluvoxamine|fluvoxamine|mesh-list
93342519|NCT03511118|Trazodone|trazodone|mesh-list
93342520|NCT03511118|Cyclobenzaprine|cyclobenzaprine|mesh-list
93342521|NCT03511118|Methylphenidate|methylphenidate|mesh-list
93342522|NCT03511118|Citalopram|citalopram|mesh-list
93342523|NCT03511118|Sertraline|sertraline|mesh-list
93342524|NCT03511118|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93342526|NCT03511118|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93342527|NCT03511118|Escitalopram|escitalopram|mesh-list
93342528|NCT03511118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93342529|NCT03511118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342530|NCT03511118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93342531|NCT03511118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93342532|NCT03511118|Antimetabolites|antimetabolites|mesh-ancestor
93342533|NCT03511118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342534|NCT03511118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93342535|NCT03511118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93342536|NCT03511118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342537|NCT03511118|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93342538|NCT03511118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93342539|NCT03511118|Hemostatics|hemostatics|mesh-ancestor
93342540|NCT03511118|Coagulants|coagulants|mesh-ancestor
93342541|NCT03511118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93342542|NCT03511118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342543|NCT03511118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93342544|NCT03511118|Narcotics|narcotics|mesh-ancestor
93342545|NCT03511118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93342546|NCT03511118|Analgesics|analgesics|mesh-ancestor
93342547|NCT03511118|Sensory System Agents|sensory system agents|mesh-ancestor
93342548|NCT03511118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342549|NCT03511118|Anticonvulsants|anticonvulsants|mesh-ancestor
93342550|NCT03511118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93342551|NCT03511118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93342552|NCT03511118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93342553|NCT03511118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93342554|NCT03511118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93342555|NCT03511118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342556|NCT03511118|Antimanic Agents|antimanic agents|mesh-ancestor
93342557|NCT03511118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93342558|NCT03511118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93342559|NCT03511118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93342560|NCT03511118|Serotonin Agents|serotonin agents|mesh-ancestor
93342561|NCT03511118|Autonomic Agents|autonomic agents|mesh-ancestor
93342562|NCT03511118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93342563|NCT03511118|Antidepressive Agents|antidepressive agents|mesh-ancestor
93342564|NCT03511118|Antiemetics|antiemetics|mesh-ancestor
93342565|NCT03511118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342566|NCT03511118|Antipruritics|antipruritics|mesh-ancestor
93342567|NCT03511118|Dermatologic Agents|dermatologic agents|mesh-ancestor
93342568|NCT03511118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93342569|NCT03511118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93342570|NCT03511118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93342571|NCT03511118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93342572|NCT03511118|Dopamine Agents|dopamine agents|mesh-ancestor
93342573|NCT03511118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93342574|NCT03511118|Diuretics|diuretics|mesh-ancestor
93342575|NCT03511118|Natriuretic Agents|natriuretic agents|mesh-ancestor
93342576|NCT03511118|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93342577|NCT03511118|Antimalarials|antimalarials|mesh-ancestor
93342578|NCT03511118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93342579|NCT03511118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93342580|NCT03511118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93342581|NCT03511118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342582|NCT03511118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342583|NCT03511118|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93342584|NCT03511118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93342585|NCT03511118|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93342586|NCT03511118|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93342587|NCT03511118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93342588|NCT03511118|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93342589|NCT03511118|Antisickling Agents|antisickling agents|mesh-ancestor
93342590|NCT03511118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93342591|NCT03511118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93342592|NCT03511118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93342593|NCT03511118|Vasodilator Agents|vasodilator agents|mesh-ancestor
93342594|NCT03511118|Tocolytic Agents|tocolytic agents|mesh-ancestor
93342595|NCT03511118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93342596|NCT03511118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342597|NCT03511118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93342598|NCT03511118|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93342599|NCT03511118|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93342600|NCT03511118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93342601|NCT03511118|Antiviral Agents|antiviral agents|mesh-ancestor
93342602|NCT03511118|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93342603|NCT03511118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93342604|NCT03511118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93342605|NCT03511118|Adrenergic Agents|adrenergic agents|mesh-ancestor
93342606|NCT03511118|Sympathomimetics|sympathomimetics|mesh-ancestor
93342607|NCT03511118|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93342608|NCT03511118|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93342609|NCT03511118|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93342610|NCT03511118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93342611|NCT03511118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93342612|NCT03493919|Vaccines|vaccines|mesh-list
93342613|NCT03493919|Immunologic Factors|immunologic factors|mesh-ancestor
93342614|NCT03493919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342615|NCT03467958|Ozanimod|ozanimod|mesh-list
93342616|NCT03467958|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93342617|NCT03467958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342618|NCT03467958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342619|NCT03467958|Immunologic Factors|immunologic factors|mesh-ancestor
93342620|NCT03467958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342621|NCT03396575|Cyclophosphamide|cyclophosphamide|mesh-list
93342622|NCT03396575|Fludarabine|fludarabine|mesh-list
93342623|NCT03396575|Vaccines|vaccines|mesh-list
93342624|NCT03396575|Immunologic Factors|immunologic factors|mesh-ancestor
93342625|NCT03396575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342626|NCT03396575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342627|NCT03396575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342628|NCT03396575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93342629|NCT03396575|Alkylating Agents|alkylating agents|mesh-ancestor
93342630|NCT03396575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342631|NCT03396575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342632|NCT03396575|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93342633|NCT03375307|Olaparib|olaparib|mesh-list
92636416|NCT00187070|Antimalarials|antimalarials|mesh-ancestor
93342634|NCT03375307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93342635|NCT03375307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342636|NCT03375307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342637|NCT03375307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342638|NCT03340506|Trametinib|trametinib|mesh-list
93342639|NCT03340506|Dabrafenib|dabrafenib|mesh-list
93342640|NCT03340506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342641|NCT03340506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342642|NCT03340506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342643|NCT03340506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342644|NCT03326128|Bupropion|bupropion|mesh-list
93342645|NCT03326128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93342646|NCT03326128|Antidepressive Agents|antidepressive agents|mesh-ancestor
93342647|NCT03326128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93342648|NCT03326128|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93342649|NCT03326128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93342650|NCT03326128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93342651|NCT03326128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342652|NCT03326128|Dopamine Agents|dopamine agents|mesh-ancestor
93342653|NCT03326128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342654|NCT03326128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342655|NCT03326128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93342656|NCT03326128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93342657|NCT03326128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342658|NCT03277924|Doxorubicin|doxorubicin|mesh-list
93342659|NCT03277924|Nivolumab|nivolumab|mesh-list
93342660|NCT03277924|Methotrexate|methotrexate|mesh-list
93342661|NCT03277924|Sunitinib|sunitinib|mesh-list
93342662|NCT03277924|Epirubicin|epirubicin|mesh-list
93342663|NCT03277924|Ifosfamide|ifosfamide|mesh-list
93342664|NCT03277924|Dacarbazine|dacarbazine|mesh-list
93342665|NCT03277924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342666|NCT03277924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93342667|NCT03277924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93342668|NCT03277924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342669|NCT03277924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342670|NCT03277924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014630|NCT00356278|Antimetabolites|antimetabolites|mesh-ancestor
93342671|NCT03277924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342672|NCT03277924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342673|NCT03277924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93342674|NCT03277924|Abortifacient Agents|abortifacient agents|mesh-ancestor
93342675|NCT03277924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93342676|NCT03277924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342677|NCT03277924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342678|NCT03277924|Antimetabolites|antimetabolites|mesh-ancestor
93342679|NCT03277924|Dermatologic Agents|dermatologic agents|mesh-ancestor
93342680|NCT03277924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93342681|NCT03277924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342682|NCT03277924|Immunologic Factors|immunologic factors|mesh-ancestor
93342683|NCT03277924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342684|NCT03277924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93342685|NCT03277924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93342686|NCT03277924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93342687|NCT03277924|Growth Substances|growth substances|mesh-ancestor
93342688|NCT03277924|Growth Inhibitors|growth inhibitors|mesh-ancestor
93342689|NCT03277924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342690|NCT03277924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93342691|NCT03277924|Alkylating Agents|alkylating agents|mesh-ancestor
93342692|NCT03244384|Pembrolizumab|pembrolizumab|mesh-list
93342693|NCT03244384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342694|NCT03244384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342695|NCT03244384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342696|NCT03244384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342697|NCT03228537|Cisplatin|cisplatin|mesh-list
93342698|NCT03228537|Pemetrexed|pemetrexed|mesh-list
93342699|NCT03228537|Atezolizumab|atezolizumab|mesh-list
93342700|NCT03228537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342701|NCT03228537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342702|NCT03228537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342703|NCT03228537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342704|NCT03228537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93342705|NCT03228537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93342706|NCT03228537|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342707|NCT03228537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342708|NCT03228537|Immunologic Factors|immunologic factors|mesh-ancestor
93342709|NCT03228537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342710|NCT03199885|Paclitaxel|paclitaxel|mesh-list
93342711|NCT03199885|Docetaxel|docetaxel|mesh-list
93342712|NCT03199885|Trastuzumab|trastuzumab|mesh-list
93342713|NCT03199885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93342714|NCT03199885|Atezolizumab|atezolizumab|mesh-list
93342715|NCT03199885|Pertuzumab|pertuzumab|mesh-list
93342716|NCT03199885|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93342717|NCT03199885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93342718|NCT03199885|Antibodies|antibodies|mesh-list
93342719|NCT03199885|Immunoglobulins|immunoglobulins|mesh-list
93342720|NCT03199885|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93342721|NCT03199885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342722|NCT03199885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342723|NCT03199885|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342724|NCT03199885|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342725|NCT03199885|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342726|NCT03199885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342727|NCT03199885|Immunologic Factors|immunologic factors|mesh-ancestor
93342728|NCT03199885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342729|NCT03199885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342730|NCT03178552|Bevacizumab|bevacizumab|mesh-list
93342731|NCT03178552|Atezolizumab|atezolizumab|mesh-list
93342732|NCT03178552|Carboplatin|carboplatin|mesh-list
93342733|NCT03178552|Gemcitabine|gemcitabine|mesh-list
93342734|NCT03178552|Docetaxel|docetaxel|mesh-list
93342735|NCT03178552|Pemetrexed|pemetrexed|mesh-list
93342736|NCT03178552|Vemurafenib|vemurafenib|mesh-list
93342737|NCT03178552|Entrectinib|entrectinib|mesh-list
93342738|NCT03178552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342739|NCT03178552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342740|NCT03178552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93342741|NCT03178552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93342742|NCT03178552|Growth Substances|growth substances|mesh-ancestor
93342743|NCT03178552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342744|NCT03178552|Growth Inhibitors|growth inhibitors|mesh-ancestor
93342745|NCT03178552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342746|NCT03178552|Antimetabolites|antimetabolites|mesh-ancestor
93342747|NCT03178552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342748|NCT03178552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342749|NCT03178552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342750|NCT03178552|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342751|NCT03178552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342752|NCT03178552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93342753|NCT03178552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93342754|NCT03178552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342755|NCT03178552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342756|NCT03176134|Tedizolid|tedizolid|mesh-list
93342757|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
93342758|NCT03176134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93342759|NCT03176134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342760|NCT03152786|Propranolol|propranolol|mesh-list
93342761|NCT03152786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93342762|NCT03152786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93342763|NCT03152786|Adrenergic Agents|adrenergic agents|mesh-ancestor
93342764|NCT03152786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342765|NCT03152786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342766|NCT03152786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342767|NCT03152786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93342768|NCT03152786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93342769|NCT03152786|Vasodilator Agents|vasodilator agents|mesh-ancestor
93342770|NCT03092674|Cytarabine|cytarabine|mesh-list
93342771|NCT03092674|Nivolumab|nivolumab|mesh-list
93342772|NCT03092674|Azacitidine|azacitidine|mesh-list
93342773|NCT03092674|Decitabine|decitabine|mesh-list
93342774|NCT03092674|Midostaurin|midostaurin|mesh-list
93342775|NCT03092674|Staurosporine|staurosporine|mesh-list
93342776|NCT03092674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342777|NCT03092674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342778|NCT03092674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342779|NCT03092674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342780|NCT03092674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342781|NCT03092674|Antimetabolites|antimetabolites|mesh-ancestor
93342782|NCT03092674|Antiviral Agents|antiviral agents|mesh-ancestor
93342783|NCT03092674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342784|NCT03092674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342785|NCT03092674|Immunologic Factors|immunologic factors|mesh-ancestor
93342786|NCT03092674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342787|NCT03092674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342788|NCT03092674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342789|NCT03065335|Ketamine|ketamine|mesh-list
93342790|NCT03065335|Analgesics|analgesics|mesh-ancestor
93342791|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
93342792|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342793|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342794|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93342795|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93342796|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
93342797|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
93342798|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93342799|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93342800|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93342801|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342802|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342803|NCT03055013|Nivolumab|nivolumab|mesh-list
93342804|NCT03055013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342805|NCT03055013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342806|NCT03055013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342807|NCT03055013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342808|NCT03004443|Infliximab|infliximab|mesh-list
93342809|NCT03004443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93342810|NCT03004443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342811|NCT03004443|Dermatologic Agents|dermatologic agents|mesh-ancestor
93342812|NCT03004443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342813|NCT03004443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342814|NCT02996773|Cyclophosphamide|cyclophosphamide|mesh-list
93342815|NCT02996773|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93342816|NCT02996773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342817|NCT02996773|Immunologic Factors|immunologic factors|mesh-ancestor
93342818|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342819|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342820|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93342821|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
93342822|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342824|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93342825|NCT02954874|Pembrolizumab|pembrolizumab|mesh-list
93342826|NCT02954874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342827|NCT02954874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342828|NCT02954874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342829|NCT02954874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342830|NCT02890355|Calcium, Dietary|calcium, dietary|mesh-list
93342831|NCT02890355|Leucovorin|leucovorin|mesh-list
93342832|NCT02890355|Folic Acid|folic acid|mesh-list
93342833|NCT02890355|Fluorouracil|fluorouracil|mesh-list
93342834|NCT02890355|Irinotecan|irinotecan|mesh-list
93342835|NCT02890355|Veliparib|veliparib|mesh-list
93342836|NCT02890355|Camptothecin|camptothecin|mesh-list
93342837|NCT02890355|Calcium|calcium|mesh-list
93342838|NCT02890355|Levoleucovorin|levoleucovorin|mesh-list
93342839|NCT02890355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93342840|NCT02890355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342841|NCT02890355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93342842|NCT02890355|Antimetabolites|antimetabolites|mesh-ancestor
93342843|NCT02890355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342844|NCT02890355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342845|NCT02890355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342846|NCT02890355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342847|NCT02890355|Immunologic Factors|immunologic factors|mesh-ancestor
93342848|NCT02890355|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93342849|NCT02890355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342850|NCT02890355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342851|NCT02890355|Antidotes|antidotes|mesh-ancestor
93342852|NCT02890355|Protective Agents|protective agents|mesh-ancestor
93342853|NCT02890355|Vitamin B Complex|vitamin b complex|mesh-ancestor
93342854|NCT02890355|Vitamins|vitamins|mesh-ancestor
93342855|NCT02890355|Micronutrients|micronutrients|mesh-ancestor
93342856|NCT02890355|Hematinics|hematinics|mesh-ancestor
93342857|NCT02890355|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93342858|NCT02890355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93342859|NCT02834013|Nivolumab|nivolumab|mesh-list
93342860|NCT02834013|Ipilimumab|ipilimumab|mesh-list
93342861|NCT02834013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342862|NCT02834013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342863|NCT02834013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342864|NCT02834013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342865|NCT02784210|Prednisone|prednisone|mesh-list
93342866|NCT02784210|Methylprednisolone|methylprednisolone|mesh-list
93342867|NCT02784210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93342868|NCT02784210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93342869|NCT02784210|Prednisolone|prednisolone|mesh-list
93342870|NCT02784210|Prednisolone acetate|prednisolone acetate|mesh-list
93342871|NCT02784210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93342872|NCT02784210|Prednisolone phosphate|prednisolone phosphate|mesh-list
93342873|NCT02784210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342874|NCT02784210|Glucocorticoids|glucocorticoids|mesh-ancestor
93342875|NCT02784210|Hormones|hormones|mesh-ancestor
93342876|NCT02784210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342877|NCT02784210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342878|NCT02784210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342879|NCT02784210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342880|NCT02784210|Antiemetics|antiemetics|mesh-ancestor
93342881|NCT02784210|Autonomic Agents|autonomic agents|mesh-ancestor
93342882|NCT02784210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342883|NCT02784210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342884|NCT02784210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93342885|NCT02784210|Protective Agents|protective agents|mesh-ancestor
93342886|NCT02748018|Insulin|insulin|mesh-list
93342887|NCT02748018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93342888|NCT02748018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342889|NCT02739035|Dexamethasone|dexamethasone|mesh-list
93342890|NCT02739035|Celecoxib|celecoxib|mesh-list
93342891|NCT02739035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93342892|NCT02739035|Antiemetics|antiemetics|mesh-ancestor
93342893|NCT02739035|Autonomic Agents|autonomic agents|mesh-ancestor
93342894|NCT02739035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342895|NCT02739035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342896|NCT02739035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93342897|NCT02739035|Glucocorticoids|glucocorticoids|mesh-ancestor
93342898|NCT02739035|Hormones|hormones|mesh-ancestor
93342899|NCT02739035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342900|NCT02739035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93342901|NCT02739035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342902|NCT02739035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93342903|NCT02739035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93342904|NCT02739035|Analgesics|analgesics|mesh-ancestor
93342905|NCT02739035|Sensory System Agents|sensory system agents|mesh-ancestor
93342906|NCT02739035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93342907|NCT02739035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93342908|NCT02739035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93342909|NCT02739035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342910|NCT02739035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342911|NCT02642042|Docetaxel|docetaxel|mesh-list
93342912|NCT02642042|Trametinib|trametinib|mesh-list
93342913|NCT02642042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342914|NCT02642042|Tubulin Modulators|tubulin modulators|mesh-ancestor
93342915|NCT02642042|Antimitotic Agents|antimitotic agents|mesh-ancestor
93342916|NCT02642042|Mitosis Modulators|mitosis modulators|mesh-ancestor
93342917|NCT02642042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342918|NCT02642042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342919|NCT02642042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342920|NCT02595944|Nivolumab|nivolumab|mesh-list
93342921|NCT02595944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342922|NCT02595944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342923|NCT02595944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342924|NCT02595944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342925|NCT02595905|Cisplatin|cisplatin|mesh-list
93342926|NCT02595905|Veliparib|veliparib|mesh-list
93342927|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342928|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93342929|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342930|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342931|NCT02543983|Ketamine|ketamine|mesh-list
93342932|NCT02543983|Analgesics|analgesics|mesh-ancestor
93342933|NCT02543983|Sensory System Agents|sensory system agents|mesh-ancestor
93342934|NCT02543983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342935|NCT02543983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342936|NCT02543983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93342937|NCT02543983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93342938|NCT02543983|Anesthetics, General|anesthetics, general|mesh-ancestor
93342939|NCT02543983|Anesthetics|anesthetics|mesh-ancestor
93342940|NCT02543983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93342941|NCT02543983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93342942|NCT02543983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93342943|NCT02543983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93342944|NCT02543983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342945|NCT02538484|Letrozole|letrozole|mesh-list
93342946|NCT02538484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342947|NCT02538484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93342948|NCT02538484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93342949|NCT02538484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342950|NCT02538484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342951|NCT02538484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93342952|NCT02538484|Hormone Antagonists|hormone antagonists|mesh-ancestor
93342953|NCT02538484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93342954|NCT02538484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342955|NCT02506153|Interferons|interferons|mesh-list
93342956|NCT02506153|Interferon-alpha|interferon-alpha|mesh-list
93342957|NCT02506153|Interferon alpha-2|interferon alpha-2|mesh-list
93342958|NCT02506153|Pembrolizumab|pembrolizumab|mesh-list
93342959|NCT02506153|Ipilimumab|ipilimumab|mesh-list
93342960|NCT02506153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93342961|NCT02506153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342962|NCT02506153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93342963|NCT02506153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342964|NCT02506153|Antiviral Agents|antiviral agents|mesh-ancestor
93342965|NCT02506153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342966|NCT02506153|Immunologic Factors|immunologic factors|mesh-ancestor
93342967|NCT02506153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342968|NCT02484391|Thioctic Acid|thioctic acid|mesh-list
93342969|NCT02484391|Cytarabine|cytarabine|mesh-list
93342970|NCT02484391|Mitoxantrone|mitoxantrone|mesh-list
93342971|NCT02484391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93342972|NCT02484391|Antimetabolites|antimetabolites|mesh-ancestor
93342973|NCT02484391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342974|NCT02484391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342975|NCT02484391|Antiviral Agents|antiviral agents|mesh-ancestor
93342976|NCT02484391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93342977|NCT02484391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93342978|NCT02484391|Immunologic Factors|immunologic factors|mesh-ancestor
93342979|NCT02484391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93342980|NCT02484391|Analgesics|analgesics|mesh-ancestor
93342981|NCT02484391|Sensory System Agents|sensory system agents|mesh-ancestor
93342982|NCT02484391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93342983|NCT02484391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93342984|NCT02484391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93342985|NCT02484391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342986|NCT02484391|Antioxidants|antioxidants|mesh-ancestor
93342987|NCT02484391|Protective Agents|protective agents|mesh-ancestor
93342988|NCT02484391|Vitamin B Complex|vitamin b complex|mesh-ancestor
93342989|NCT02484391|Vitamins|vitamins|mesh-ancestor
93342990|NCT02484391|Micronutrients|micronutrients|mesh-ancestor
93342991|NCT02478320|Ilorasertib|ilorasertib|mesh-list
93342992|NCT02478320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93342993|NCT02478320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93342994|NCT02478320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93342995|NCT02478320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93342996|NCT02465060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93342997|NCT02465060|Nivolumab|nivolumab|mesh-list
93342998|NCT02465060|Trastuzumab|trastuzumab|mesh-list
93342999|NCT02465060|Pertuzumab|pertuzumab|mesh-list
93343000|NCT02465060|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93343001|NCT02465060|Relatlimab|relatlimab|mesh-list
93343002|NCT02465060|Sunitinib|sunitinib|mesh-list
93343003|NCT02465060|Dasatinib|dasatinib|mesh-list
93343004|NCT02465060|Palbociclib|palbociclib|mesh-list
93343005|NCT02465060|Trametinib|trametinib|mesh-list
93343006|NCT02465060|Osimertinib|osimertinib|mesh-list
93343007|NCT02465060|Afatinib|afatinib|mesh-list
93343008|NCT02465060|Dabrafenib|dabrafenib|mesh-list
93343009|NCT02465060|Crizotinib|crizotinib|mesh-list
93343010|NCT02465060|Maytansine|maytansine|mesh-list
93343011|NCT02465060|Ipatasertib|ipatasertib|mesh-list
93343012|NCT02465060|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93343013|NCT02465060|GSK2636771|gsk2636771|mesh-list
93343014|NCT02465060|Antibodies|antibodies|mesh-list
93343015|NCT02465060|Immunoglobulins|immunoglobulins|mesh-list
93343016|NCT02465060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343017|NCT02465060|Immunoglobulin G|immunoglobulin g|mesh-list
93343018|NCT02465060|Adavosertib|adavosertib|mesh-list
93343019|NCT02465060|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93343020|NCT02465060|Immunoconjugates|immunoconjugates|mesh-list
93343021|NCT02465060|Immunologic Factors|immunologic factors|mesh-ancestor
93343022|NCT02465060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343023|NCT02465060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343024|NCT02465060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343025|NCT02465060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343026|NCT02465060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93343027|NCT02465060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93343028|NCT02465060|Growth Substances|growth substances|mesh-ancestor
93343029|NCT02465060|Growth Inhibitors|growth inhibitors|mesh-ancestor
93343030|NCT02465060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343031|NCT02465060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343032|NCT02465060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93343033|NCT02465060|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343034|NCT02465060|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343035|NCT02465060|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343036|NCT02465060|Immunotoxins|immunotoxins|mesh-ancestor
93343037|NCT02428985|Riociguat|riociguat|mesh-list
93343038|NCT02428985|Enzyme Activators|enzyme activators|mesh-ancestor
93343039|NCT02428985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343040|NCT02311998|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93343041|NCT02311998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343042|NCT02311998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343043|NCT02311998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93343044|NCT02311998|Immunotoxins|immunotoxins|mesh-ancestor
93343045|NCT02311998|Immunoconjugates|immunoconjugates|mesh-ancestor
93343046|NCT02311998|Immunologic Factors|immunologic factors|mesh-ancestor
93343047|NCT02311998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343048|NCT02311933|Tamoxifen|tamoxifen|mesh-list
93343049|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93343050|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
93343051|NCT02311933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343052|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343053|NCT02311933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343054|NCT02311933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343055|NCT02311933|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93343056|NCT02311933|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93343057|NCT02311933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93343058|NCT02252042|Docetaxel|docetaxel|mesh-list
93343059|NCT02252042|Pembrolizumab|pembrolizumab|mesh-list
93343060|NCT02252042|Methotrexate|methotrexate|mesh-list
93343061|NCT02252042|Cetuximab|cetuximab|mesh-list
93343062|NCT02252042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343063|NCT02252042|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343064|NCT02252042|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343065|NCT02252042|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343066|NCT02252042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343067|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343068|NCT02252042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343069|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93343070|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
93343071|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93343072|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343073|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343074|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
93343075|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
93343076|NCT02252042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343077|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93343078|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343079|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
93343080|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343081|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93343082|NCT02248597|Mycophenolic Acid|mycophenolic acid|mesh-list
93343083|NCT02248597|Cyclophosphamide|cyclophosphamide|mesh-list
93343084|NCT02248597|Busulfan|busulfan|mesh-list
93343085|NCT02248597|Fludarabine|fludarabine|mesh-list
93343086|NCT02248597|Fludarabine phosphate|fludarabine phosphate|mesh-list
93343087|NCT02248597|Tacrolimus|tacrolimus|mesh-list
93343088|NCT02248597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343089|NCT02248597|Immunologic Factors|immunologic factors|mesh-ancestor
93343090|NCT02248597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343091|NCT02248597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343092|NCT02248597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93343093|NCT02248597|Alkylating Agents|alkylating agents|mesh-ancestor
93343094|NCT02248597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343095|NCT02248597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343096|NCT02248597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93343097|NCT02248597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343098|NCT02248597|Antimetabolites|antimetabolites|mesh-ancestor
93343099|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93343100|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343101|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93343102|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93343103|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
93343104|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93343105|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343106|NCT02232152|Thioctic Acid|thioctic acid|mesh-list
93343107|NCT02232152|Fluorouracil|fluorouracil|mesh-list
93343108|NCT02232152|Antimetabolites|antimetabolites|mesh-ancestor
93343109|NCT02232152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343110|NCT02232152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343111|NCT02232152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343112|NCT02232152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343113|NCT02232152|Immunologic Factors|immunologic factors|mesh-ancestor
93343114|NCT02232152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343115|NCT02232152|Antioxidants|antioxidants|mesh-ancestor
93343116|NCT02232152|Protective Agents|protective agents|mesh-ancestor
93343117|NCT02232152|Vitamin B Complex|vitamin b complex|mesh-ancestor
93343118|NCT02232152|Vitamins|vitamins|mesh-ancestor
93343119|NCT02232152|Micronutrients|micronutrients|mesh-ancestor
93343120|NCT02224781|Nivolumab|nivolumab|mesh-list
93343121|NCT02224781|Ipilimumab|ipilimumab|mesh-list
93343122|NCT02224781|Trametinib|trametinib|mesh-list
93343123|NCT02224781|Dabrafenib|dabrafenib|mesh-list
93343124|NCT02224781|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93343125|NCT02224781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343126|NCT02224781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343127|NCT02224781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343128|NCT02224781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015078|NCT00841841|Dipyrone|dipyrone|mesh-list
93343129|NCT02224781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343130|NCT02224781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343131|NCT02224781|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93343132|NCT02224781|Protective Agents|protective agents|mesh-ancestor
93343133|NCT02224781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343134|NCT02224781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93343135|NCT02224781|Antioxidants|antioxidants|mesh-ancestor
93343136|NCT02196181|Trametinib|trametinib|mesh-list
93343137|NCT02196181|Dabrafenib|dabrafenib|mesh-list
93343138|NCT02196181|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93343139|NCT02196181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343140|NCT02196181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343141|NCT02196181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343142|NCT02196181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343143|NCT02196181|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93343144|NCT02196181|Protective Agents|protective agents|mesh-ancestor
93343145|NCT02196181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343146|NCT02196181|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93343147|NCT02196181|Antioxidants|antioxidants|mesh-ancestor
93343148|NCT02193282|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93343149|NCT02193282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343150|NCT02193282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343151|NCT02193282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343152|NCT02193282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343153|NCT02157324|Acalabrutinib|acalabrutinib|mesh-list
93343154|NCT02157324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343155|NCT02099058|Nivolumab|nivolumab|mesh-list
93343156|NCT02099058|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93343157|NCT02099058|Osimertinib|osimertinib|mesh-list
93343158|NCT02099058|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343159|NCT02099058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343160|NCT02099058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343161|NCT02099058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343162|NCT02099058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343163|NCT02099058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343164|NCT02099058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343165|NCT02099058|Immunologic Factors|immunologic factors|mesh-ancestor
93343166|NCT02099058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343167|NCT02003222|Cytarabine|cytarabine|mesh-list
93343168|NCT02003222|Dexamethasone|dexamethasone|mesh-list
93343169|NCT02003222|Dexamethasone acetate|dexamethasone acetate|mesh-list
93343170|NCT02003222|Prednisone|prednisone|mesh-list
93343171|NCT02003222|Cortisone|cortisone|mesh-list
93343172|NCT02003222|Cyclophosphamide|cyclophosphamide|mesh-list
93343173|NCT02003222|Rituximab|rituximab|mesh-list
93343174|NCT02003222|Methotrexate|methotrexate|mesh-list
93343175|NCT02003222|Etoposide|etoposide|mesh-list
93343176|NCT02003222|Vincristine|vincristine|mesh-list
93343177|NCT02003222|Etoposide phosphate|etoposide phosphate|mesh-list
93343178|NCT02003222|Daunorubicin|daunorubicin|mesh-list
93343179|NCT02003222|Asparaginase|asparaginase|mesh-list
93343180|NCT02003222|Mercaptopurine|mercaptopurine|mesh-list
93343181|NCT02003222|Podophyllotoxin|podophyllotoxin|mesh-list
93343182|NCT02003222|Pegaspargase|pegaspargase|mesh-list
93343183|NCT02003222|Blinatumomab|blinatumomab|mesh-list
93343184|NCT02003222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93343185|NCT02003222|Muromonab-CD3|muromonab-cd3|mesh-list
93343186|NCT02003222|Antibodies|antibodies|mesh-list
93343187|NCT02003222|Immunoglobulins|immunoglobulins|mesh-list
93343188|NCT02003222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343189|NCT02003222|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93343190|NCT02003222|BB 1101|bb 1101|mesh-list
93343191|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343192|NCT02003222|Immunologic Factors|immunologic factors|mesh-ancestor
93343193|NCT02003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343194|NCT02003222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343195|NCT02003222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93343196|NCT02003222|Alkylating Agents|alkylating agents|mesh-ancestor
93343197|NCT02003222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343198|NCT02003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343199|NCT02003222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93343200|NCT02003222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343201|NCT02003222|Antiemetics|antiemetics|mesh-ancestor
93343202|NCT02003222|Autonomic Agents|autonomic agents|mesh-ancestor
93343203|NCT02003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343204|NCT02003222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93343205|NCT02003222|Glucocorticoids|glucocorticoids|mesh-ancestor
93015148|NCT00620555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343206|NCT02003222|Hormones|hormones|mesh-ancestor
93366445|NCT02796677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93343207|NCT02003222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343208|NCT02003222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343209|NCT02003222|Protease Inhibitors|protease inhibitors|mesh-ancestor
93343210|NCT02003222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343211|NCT02003222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93343212|NCT02003222|Abortifacient Agents|abortifacient agents|mesh-ancestor
93343213|NCT02003222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93343214|NCT02003222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343215|NCT02003222|Antimetabolites|antimetabolites|mesh-ancestor
93343216|NCT02003222|Dermatologic Agents|dermatologic agents|mesh-ancestor
93343217|NCT02003222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93343218|NCT02003222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93343219|NCT02003222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93343220|NCT02003222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93343221|NCT02003222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93343222|NCT02003222|Antiviral Agents|antiviral agents|mesh-ancestor
93343223|NCT02003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343224|NCT02003222|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343225|NCT02003222|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343226|NCT02003222|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343227|NCT02003222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93343228|NCT02003222|Keratolytic Agents|keratolytic agents|mesh-ancestor
93343229|NCT01950390|Bevacizumab|bevacizumab|mesh-list
93343230|NCT01950390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93343231|NCT01950390|Ipilimumab|ipilimumab|mesh-list
93343232|NCT01950390|Endothelial Growth Factors|endothelial growth factors|mesh-list
93343233|NCT01950390|Antibodies|antibodies|mesh-list
93343234|NCT01950390|Immunoglobulins|immunoglobulins|mesh-list
93343235|NCT01950390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343236|NCT01950390|Immunoglobulin G|immunoglobulin g|mesh-list
93343237|NCT01950390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343238|NCT01950390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93343239|NCT01950390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93343240|NCT01950390|Growth Substances|growth substances|mesh-ancestor
93343241|NCT01950390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343242|NCT01950390|Growth Inhibitors|growth inhibitors|mesh-ancestor
93343243|NCT01950390|Immunologic Factors|immunologic factors|mesh-ancestor
93343244|NCT01950390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343245|NCT01950390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343246|NCT01900847|Ketamine|ketamine|mesh-list
93343247|NCT01900847|Morphine|morphine|mesh-list
93343248|NCT01900847|Analgesics|analgesics|mesh-ancestor
93343249|NCT01900847|Sensory System Agents|sensory system agents|mesh-ancestor
93343250|NCT01900847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343251|NCT01900847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343252|NCT01900847|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93343253|NCT01900847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93343254|NCT01900847|Anesthetics, General|anesthetics, general|mesh-ancestor
93343255|NCT01900847|Anesthetics|anesthetics|mesh-ancestor
93343256|NCT01900847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343257|NCT01900847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93343258|NCT01900847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93343259|NCT01900847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343260|NCT01900847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343261|NCT01900847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93343262|NCT01900847|Narcotics|narcotics|mesh-ancestor
93343263|NCT01886872|Rituximab|rituximab|mesh-list
93343264|NCT01886872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93343265|NCT01886872|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93343266|NCT01886872|Antibodies|antibodies|mesh-list
93343267|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
93343268|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343269|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
93343270|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343271|NCT01886872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343272|NCT01886872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343273|NCT01886872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93343274|NCT01886872|Alkylating Agents|alkylating agents|mesh-ancestor
93343275|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343276|NCT01710007|Atorvastatin|atorvastatin|mesh-list
93343277|NCT01710007|Pitavastatin|pitavastatin|mesh-list
93343278|NCT01710007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93343279|NCT01710007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93343280|NCT01710007|Antimetabolites|antimetabolites|mesh-ancestor
93343281|NCT01710007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343282|NCT01710007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93343283|NCT01710007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93343284|NCT01710007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343285|NCT01708954|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93343286|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343287|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343288|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343289|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343290|NCT01708941|Interferons|interferons|mesh-list
93343291|NCT01708941|Interferon-alpha|interferon-alpha|mesh-list
93343292|NCT01708941|Interferon alpha-2|interferon alpha-2|mesh-list
93343293|NCT01708941|Ipilimumab|ipilimumab|mesh-list
93343294|NCT01708941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343295|NCT01708941|Antiviral Agents|antiviral agents|mesh-ancestor
93343296|NCT01708941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343297|NCT01708941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343298|NCT01708941|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343299|NCT01708941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343300|NCT01708941|Immunologic Factors|immunologic factors|mesh-ancestor
93343301|NCT01708941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343302|NCT01357772|Tamoxifen|tamoxifen|mesh-list
93343303|NCT01357772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93343304|NCT01357772|Hormone Antagonists|hormone antagonists|mesh-ancestor
93343305|NCT01357772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343306|NCT01357772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343307|NCT01357772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343308|NCT01357772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343309|NCT01357772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93343310|NCT01357772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93343311|NCT01357772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93343312|NCT01274338|Interferons|interferons|mesh-list
93343313|NCT01274338|Interferon-alpha|interferon-alpha|mesh-list
93343314|NCT01274338|Interferon alpha-2|interferon alpha-2|mesh-list
93343315|NCT01274338|Ipilimumab|ipilimumab|mesh-list
93343316|NCT01274338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343317|NCT01274338|Antiviral Agents|antiviral agents|mesh-ancestor
93343318|NCT01274338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343319|NCT01274338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343320|NCT01274338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343321|NCT01274338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343322|NCT01274338|Immunologic Factors|immunologic factors|mesh-ancestor
93343323|NCT01274338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343324|NCT01196390|Paclitaxel|paclitaxel|mesh-list
93343325|NCT01196390|Carboplatin|carboplatin|mesh-list
93343326|NCT01196390|Trastuzumab|trastuzumab|mesh-list
93343327|NCT01196390|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93343328|NCT01196390|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93343329|NCT01196390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93343330|NCT01196390|Antibodies|antibodies|mesh-list
93343331|NCT01196390|Immunoglobulins|immunoglobulins|mesh-list
93343332|NCT01196390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343333|NCT01196390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93343334|NCT01196390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343335|NCT01196390|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343336|NCT01196390|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343337|NCT01196390|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343338|NCT01196390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343339|NCT01196390|Immunologic Factors|immunologic factors|mesh-ancestor
93343340|NCT01196390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343341|NCT01065454|Riociguat|riociguat|mesh-list
93343342|NCT01065454|Enzyme Activators|enzyme activators|mesh-ancestor
93343343|NCT01065454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343344|NCT01013649|Gemcitabine|gemcitabine|mesh-list
93343345|NCT01013649|Fluorouracil|fluorouracil|mesh-list
93343346|NCT01013649|Capecitabine|capecitabine|mesh-list
93343347|NCT01013649|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93343348|NCT01013649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343349|NCT01013649|Antimetabolites|antimetabolites|mesh-ancestor
93343350|NCT01013649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343351|NCT01013649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343352|NCT01013649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343353|NCT01013649|Immunologic Factors|immunologic factors|mesh-ancestor
93343354|NCT01013649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343355|NCT01013649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343356|NCT01013649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343357|NCT00977977|Cyclosporine|cyclosporine|mesh-list
93343358|NCT00977977|Rituximab|rituximab|mesh-list
93343359|NCT00977977|Cyclosporins|cyclosporins|mesh-list
93343360|NCT00977977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343361|NCT00977977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343362|NCT00977977|Immunologic Factors|immunologic factors|mesh-ancestor
93343363|NCT00977977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343364|NCT00977977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343365|NCT00977977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343366|NCT00977977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343367|NCT00977977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343368|NCT00977977|Antifungal Agents|antifungal agents|mesh-ancestor
93343369|NCT00977977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343370|NCT00977977|Dermatologic Agents|dermatologic agents|mesh-ancestor
93343371|NCT00977977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93343372|NCT00769379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93343373|NCT00769379|Trastuzumab|trastuzumab|mesh-list
93343374|NCT00769379|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93343375|NCT00769379|Antibodies|antibodies|mesh-list
93343376|NCT00769379|Immunoglobulins|immunoglobulins|mesh-list
93343377|NCT00769379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343378|NCT00769379|Immunologic Factors|immunologic factors|mesh-ancestor
93343379|NCT00769379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343380|NCT00769379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343381|NCT00588770|Bevacizumab|bevacizumab|mesh-list
93343382|NCT00588770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93343383|NCT00588770|Cisplatin|cisplatin|mesh-list
93343384|NCT00588770|Carboplatin|carboplatin|mesh-list
93343385|NCT00588770|Docetaxel|docetaxel|mesh-list
93343386|NCT00588770|Fluorouracil|fluorouracil|mesh-list
93343387|NCT00588770|Endothelial Growth Factors|endothelial growth factors|mesh-list
93343388|NCT00588770|Antibodies|antibodies|mesh-list
93343389|NCT00588770|Immunoglobulins|immunoglobulins|mesh-list
93343390|NCT00588770|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93343391|NCT00588770|Immunoglobulin G|immunoglobulin g|mesh-list
93343392|NCT00588770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343393|NCT00588770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93343394|NCT00588770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93343395|NCT00588770|Growth Substances|growth substances|mesh-ancestor
93343396|NCT00588770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343397|NCT00588770|Growth Inhibitors|growth inhibitors|mesh-ancestor
93343398|NCT00588770|Immunologic Factors|immunologic factors|mesh-ancestor
93343399|NCT00588770|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343400|NCT00588770|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343401|NCT00588770|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343402|NCT00588770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343403|NCT00588770|Antimetabolites|antimetabolites|mesh-ancestor
93343404|NCT00588770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343405|NCT00588770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343406|NCT00378482|Tremelimumab|tremelimumab|mesh-list
93343407|NCT00378482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343408|NCT00018057|Fluoxetine|fluoxetine|mesh-list
93343409|NCT00018057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93343410|NCT00018057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93343411|NCT00018057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93343412|NCT00018057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343413|NCT00018057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343414|NCT00018057|Serotonin Agents|serotonin agents|mesh-ancestor
93343415|NCT00018057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343416|NCT00018057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93343417|NCT00018057|Antidepressive Agents|antidepressive agents|mesh-ancestor
93343418|NCT00018057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93343419|NCT00018057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93343420|NCT00018057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93343421|NCT00018057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343422|NCT05813860|Infliximab|infliximab|mesh-list
93343423|NCT05813860|Azathioprine|azathioprine|mesh-list
93343424|NCT05813860|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93343425|NCT05813860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343426|NCT05813860|Dermatologic Agents|dermatologic agents|mesh-ancestor
93343427|NCT05813860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93343428|NCT05813860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343429|NCT05813860|Antimetabolites|antimetabolites|mesh-ancestor
93343430|NCT05813860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343431|NCT05813860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343432|NCT05813860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343433|NCT05813860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343434|NCT05813860|Immunologic Factors|immunologic factors|mesh-ancestor
93343435|NCT05813860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343436|NCT05798793|Cisplatin|cisplatin|mesh-list
93343437|NCT05798793|Docetaxel|docetaxel|mesh-list
93343438|NCT05798793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343439|NCT05798793|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343440|NCT05798793|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343441|NCT05798793|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343442|NCT05798793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343443|NCT05795517|Ezetimibe|ezetimibe|mesh-list
93343444|NCT05795517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93343445|NCT05795517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93343446|NCT05795517|Antimetabolites|antimetabolites|mesh-ancestor
93343447|NCT05795517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343448|NCT05795517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93343449|NCT05788276|Dapagliflozin|dapagliflozin|mesh-list
93343450|NCT05788276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93343451|NCT05788276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343452|NCT05788276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93343453|NCT05788276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343454|NCT05782270|Warfarin|warfarin|mesh-list
93343455|NCT05782270|Anticoagulants|anticoagulants|mesh-ancestor
93343456|NCT05759754|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93343457|NCT05759754|Protease Inhibitors|protease inhibitors|mesh-ancestor
93343458|NCT05759754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343459|NCT05759754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343460|NCT05759572|Apatinib|apatinib|mesh-list
93343461|NCT05759572|Fulvestrant|fulvestrant|mesh-list
93343462|NCT05759572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343463|NCT05759572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343464|NCT05759572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343465|NCT05759572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343466|NCT05759572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343467|NCT05759572|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93343468|NCT05759572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93343469|NCT05759572|Hormone Antagonists|hormone antagonists|mesh-ancestor
93343470|NCT05759572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343471|NCT05759572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343472|NCT05738694|Axitinib|axitinib|mesh-list
93343473|NCT05738694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343474|NCT05738694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343475|NCT05738694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343476|NCT05738694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343477|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
93343478|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343479|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343480|NCT05737199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343481|NCT05737199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343482|NCT05731986|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
93343483|NCT05731986|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93343484|NCT05731986|Immunologic Factors|immunologic factors|mesh-ancestor
92637252|NCT00190931|Adrenergic Agents|adrenergic agents|mesh-ancestor
93343485|NCT05731986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343486|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
93343487|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93343488|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
93343489|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343490|NCT05708521|Hydromorphone|hydromorphone|mesh-list
93343491|NCT05708521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93343492|NCT05708521|Narcotics|narcotics|mesh-ancestor
93343493|NCT05708521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343494|NCT05708521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343495|NCT05708521|Analgesics|analgesics|mesh-ancestor
93343496|NCT05708521|Sensory System Agents|sensory system agents|mesh-ancestor
93343497|NCT05708521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343498|NCT05707234|Midazolam|midazolam|mesh-list
93343499|NCT05707234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93343500|NCT05707234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93343501|NCT05707234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343502|NCT05707234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343503|NCT05707234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93343504|NCT05707234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93343505|NCT05707234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93343506|NCT05707234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93343507|NCT05707234|Anesthetics, General|anesthetics, general|mesh-ancestor
93343508|NCT05707234|Anesthetics|anesthetics|mesh-ancestor
93343509|NCT05707234|GABA Modulators|gaba modulators|mesh-ancestor
93343510|NCT05707234|GABA Agents|gaba agents|mesh-ancestor
93343511|NCT05707234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343512|NCT05707234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343513|NCT05703672|Varenicline|varenicline|mesh-list
93343514|NCT05703672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93343515|NCT05703672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93343516|NCT05703672|Cholinergic Agents|cholinergic agents|mesh-ancestor
93343517|NCT05703672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343518|NCT05703672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343519|NCT05703672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343520|NCT05702359|Vitamin D|vitamin d|mesh-list
93343521|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
93343522|NCT05702359|Cholecalciferol|cholecalciferol|mesh-list
93343523|NCT05702359|Vitamins|vitamins|mesh-list
93343524|NCT05702359|Micronutrients|micronutrients|mesh-ancestor
93343525|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343526|NCT05702359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93343527|NCT05702359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93343528|NCT05702073|Insulin Glargine|insulin glargine|mesh-list
93343529|NCT05702073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93343530|NCT05702073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343531|NCT05690282|Acetaminophen|acetaminophen|mesh-list
93343532|NCT05690282|Ibuprofen|ibuprofen|mesh-list
93343533|NCT05690282|Gabapentin|gabapentin|mesh-list
93343534|NCT05690282|Bupivacaine|bupivacaine|mesh-list
93343535|NCT05690282|Anesthetics, Local|anesthetics, local|mesh-ancestor
93343536|NCT05690282|Anesthetics|anesthetics|mesh-ancestor
93343537|NCT05690282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343538|NCT05690282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343539|NCT05690282|Sensory System Agents|sensory system agents|mesh-ancestor
93343540|NCT05690282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343541|NCT05690282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93343542|NCT05690282|Analgesics|analgesics|mesh-ancestor
93343543|NCT05690282|Antipyretics|antipyretics|mesh-ancestor
93343544|NCT05690282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93343545|NCT05690282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343546|NCT05690282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343547|NCT05690282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93343548|NCT05690282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343549|NCT05690282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343550|NCT05690282|Anticonvulsants|anticonvulsants|mesh-ancestor
93343551|NCT05690282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93343552|NCT05690282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93343553|NCT05690282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93343554|NCT05690282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93343555|NCT05690282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93343556|NCT05690282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343557|NCT05690282|Antimanic Agents|antimanic agents|mesh-ancestor
93343558|NCT05677334|Insulin|insulin|mesh-list
93343559|NCT05677334|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93343560|NCT05677334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93343561|NCT05677334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343562|NCT05676645|Lumefantrine|lumefantrine|mesh-list
93343563|NCT05676645|Artemether|artemether|mesh-list
93343564|NCT05676645|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93343565|NCT05676645|Antimalarials|antimalarials|mesh-ancestor
93343566|NCT05676645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93343567|NCT05676645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93343568|NCT05676645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343569|NCT05591651|Hyaluronic Acid|hyaluronic acid|mesh-list
93343570|NCT05591651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93343571|NCT05591651|Immunologic Factors|immunologic factors|mesh-ancestor
93343572|NCT05591651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343573|NCT05591651|Viscosupplements|viscosupplements|mesh-ancestor
93343574|NCT05591651|Protective Agents|protective agents|mesh-ancestor
93343575|NCT05574504|Avelumab|avelumab|mesh-list
93343576|NCT05574504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93343577|NCT05574504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343578|NCT05574504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343579|NCT05574504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343580|NCT05570409|Mycophenolic Acid|mycophenolic acid|mesh-list
93343581|NCT05570409|Prednisolone|prednisolone|mesh-list
93343582|NCT05570409|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93343584|NCT05570409|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93343585|NCT05570409|Prednisolone acetate|prednisolone acetate|mesh-list
93343586|NCT05570409|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93343587|NCT05570409|Prednisolone phosphate|prednisolone phosphate|mesh-list
93343588|NCT05570409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93343589|NCT05570409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343590|NCT05570409|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93343591|NCT05570409|Antitubercular Agents|antitubercular agents|mesh-ancestor
93343592|NCT05570409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93343593|NCT05570409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343594|NCT05570409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343595|NCT05570409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343596|NCT05570409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343597|NCT05570409|Glucocorticoids|glucocorticoids|mesh-ancestor
93343598|NCT05570409|Hormones|hormones|mesh-ancestor
93343599|NCT05570409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343600|NCT05570409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343601|NCT05570409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343602|NCT05570409|Antiemetics|antiemetics|mesh-ancestor
93343603|NCT05570409|Autonomic Agents|autonomic agents|mesh-ancestor
93343604|NCT05570409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343605|NCT05570409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93343606|NCT05570409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93343607|NCT05570409|Protective Agents|protective agents|mesh-ancestor
93343608|NCT05555732|Carboplatin|carboplatin|mesh-list
93343609|NCT05555732|Pembrolizumab|pembrolizumab|mesh-list
93343610|NCT05555732|Pemetrexed|pemetrexed|mesh-list
93343611|NCT05555732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343612|NCT05555732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343613|NCT05555732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343614|NCT05555732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343615|NCT05555732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343616|NCT05555732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93343617|NCT05555732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93343618|NCT05545670|Allopurinol|allopurinol|mesh-list
93343619|NCT05545670|Antimetabolites|antimetabolites|mesh-ancestor
93343620|NCT05545670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343621|NCT05545670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343622|NCT05545670|Gout Suppressants|gout suppressants|mesh-ancestor
93343623|NCT05545670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343624|NCT05545670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93343625|NCT05545670|Antioxidants|antioxidants|mesh-ancestor
93343626|NCT05545670|Protective Agents|protective agents|mesh-ancestor
93343627|NCT05545670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343628|NCT05514106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93343629|NCT05514106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343630|NCT05514106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637385|NCT00191399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343631|NCT05514106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343632|NCT05514106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93343633|NCT05487794|Methyltestosterone|methyltestosterone|mesh-list
93343634|NCT05487794|Testosterone|testosterone|mesh-list
93343635|NCT05487794|Testosterone undecanoate|testosterone undecanoate|mesh-list
93343636|NCT05487794|Testosterone enanthate|testosterone enanthate|mesh-list
93343637|NCT05487794|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93343638|NCT05487794|Androgens|androgens|mesh-ancestor
93343639|NCT05487794|Hormones|hormones|mesh-ancestor
93343640|NCT05487794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343641|NCT05487794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343642|NCT05487794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343643|NCT05487794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343644|NCT05487794|Anabolic Agents|anabolic agents|mesh-ancestor
93343645|NCT05481684|Progesterone|progesterone|mesh-list
93343646|NCT05481684|Progestins|progestins|mesh-ancestor
93343647|NCT05481684|Hormones|hormones|mesh-ancestor
93343648|NCT05481684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343649|NCT05481684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343650|NCT05481528|Moxifloxacin|moxifloxacin|mesh-list
93343651|NCT05481528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93343652|NCT05481528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343653|NCT05481528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93343654|NCT05481528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93343655|NCT05481528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343656|NCT05481528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343657|NCT05481528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343658|NCT05461131|Azithromycin|azithromycin|mesh-list
93343659|NCT05461131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93343660|NCT05461131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343661|NCT05458674|Trastuzumab|trastuzumab|mesh-list
93343662|NCT05458674|Tucatinib|tucatinib|mesh-list
93343663|NCT05458674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343664|NCT05458674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343665|NCT05458674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93343666|NCT05458674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343667|NCT05458674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343668|NCT05458453|Esketamine|esketamine|mesh-list
93343669|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
93343670|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93343671|NCT05429489|Morphine|morphine|mesh-list
93343672|NCT05429489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93343673|NCT05429489|Narcotics|narcotics|mesh-ancestor
93343674|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343675|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343676|NCT05429489|Analgesics|analgesics|mesh-ancestor
93343677|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
93343678|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343679|NCT05413863|Insulin|insulin|mesh-list
93343680|NCT05413863|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93343681|NCT05413863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93343682|NCT05413863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343683|NCT05412914|Propofol|propofol|mesh-list
93343684|NCT05412914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93343685|NCT05412914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343686|NCT05412914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343687|NCT05412914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93343688|NCT05412914|Anesthetics, General|anesthetics, general|mesh-ancestor
93343689|NCT05412914|Anesthetics|anesthetics|mesh-ancestor
93343690|NCT05374499|Epinephrine|epinephrine|mesh-list
93343691|NCT05374499|Bupivacaine|bupivacaine|mesh-list
93343692|NCT05374499|Anesthetics, Local|anesthetics, local|mesh-ancestor
93343693|NCT05374499|Anesthetics|anesthetics|mesh-ancestor
93343694|NCT05374499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343695|NCT05374499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343696|NCT05374499|Sensory System Agents|sensory system agents|mesh-ancestor
93343697|NCT05374499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343698|NCT05374499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93343699|NCT05374499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93343700|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
93343701|NCT05374499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343702|NCT05374499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343703|NCT05374499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93343704|NCT05374499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93343705|NCT05374499|Autonomic Agents|autonomic agents|mesh-ancestor
93343706|NCT05374499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93343707|NCT05374499|Respiratory System Agents|respiratory system agents|mesh-ancestor
93343708|NCT05374499|Mydriatics|mydriatics|mesh-ancestor
93343709|NCT05374499|Sympathomimetics|sympathomimetics|mesh-ancestor
93343710|NCT05374499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93343711|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93343712|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93343713|NCT05373264|Diuretics|diuretics|mesh-ancestor
93343714|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
93343715|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343716|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93343717|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93343718|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343719|NCT05367492|Varenicline|varenicline|mesh-list
93343720|NCT05367492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93343721|NCT05367492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93343722|NCT05367492|Cholinergic Agents|cholinergic agents|mesh-ancestor
93343723|NCT05367492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343724|NCT05367492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343725|NCT05367492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343726|NCT05358704|Leucovorin|leucovorin|mesh-list
93343727|NCT05358704|Fluorouracil|fluorouracil|mesh-list
93343728|NCT05358704|Capecitabine|capecitabine|mesh-list
93343729|NCT05358704|Oxaliplatin|oxaliplatin|mesh-list
93343730|NCT05358704|Irinotecan|irinotecan|mesh-list
93343731|NCT05358704|Antimetabolites|antimetabolites|mesh-ancestor
93343732|NCT05358704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015676|NCT00857753|Analgesics|analgesics|mesh-ancestor
93343733|NCT05358704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343734|NCT05358704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343735|NCT05358704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343736|NCT05358704|Immunologic Factors|immunologic factors|mesh-ancestor
93343737|NCT05358704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343738|NCT05358704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93343739|NCT05358704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93343740|NCT05358704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343741|NCT05358704|Antidotes|antidotes|mesh-ancestor
93343742|NCT05358704|Protective Agents|protective agents|mesh-ancestor
93343743|NCT05358704|Vitamin B Complex|vitamin b complex|mesh-ancestor
93343744|NCT05358704|Vitamins|vitamins|mesh-ancestor
93343745|NCT05358704|Micronutrients|micronutrients|mesh-ancestor
93343746|NCT05358691|Durvalumab|durvalumab|mesh-list
93343747|NCT05358691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343748|NCT05358691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343749|NCT05357690|Bupivacaine|bupivacaine|mesh-list
93343750|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
93343751|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
93343752|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343753|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343754|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
93343755|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343756|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
93343757|NCT05341154|Ketamine|ketamine|mesh-list
93343758|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93343759|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343760|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343761|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93343762|NCT05341154|Analgesics|analgesics|mesh-ancestor
93343763|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
93343764|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343765|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93343766|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93343767|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93343768|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
93343769|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343770|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343771|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93343772|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93343773|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
93343774|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
93343775|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93343776|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93343777|NCT05330858|Rabeprazole|rabeprazole|mesh-list
93343778|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93343779|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93343780|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93343781|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343782|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343783|NCT05328102|Lenalidomide|lenalidomide|mesh-list
93343784|NCT05328102|Immunologic Factors|immunologic factors|mesh-ancestor
93343785|NCT05328102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343786|NCT05328102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93343787|NCT05328102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93343788|NCT05328102|Growth Substances|growth substances|mesh-ancestor
93343789|NCT05328102|Growth Inhibitors|growth inhibitors|mesh-ancestor
93343790|NCT05328102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343791|NCT05317676|Palmidrol|palmidrol|mesh-list
93343792|NCT05317676|Analgesics|analgesics|mesh-ancestor
93343793|NCT05317676|Sensory System Agents|sensory system agents|mesh-ancestor
93343794|NCT05317676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343795|NCT05317676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343796|NCT05317676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93343797|NCT05317676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93343798|NCT05317676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343799|NCT05317676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343800|NCT05317676|Antiviral Agents|antiviral agents|mesh-ancestor
93343801|NCT05317676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343802|NCT05317676|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93343803|NCT05317676|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93343804|NCT05317676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343805|NCT05317676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343806|NCT05317676|Hormones|hormones|mesh-ancestor
93366446|NCT02796677|Respiratory System Agents|respiratory system agents|mesh-ancestor
93343807|NCT05317676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343809|NCT05312268|Gout Suppressants|gout suppressants|mesh-ancestor
93343810|NCT05312268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343811|NCT05295927|Prednisone|prednisone|mesh-list
93343812|NCT05295927|Prednisolone|prednisolone|mesh-list
93343813|NCT05295927|Abiraterone Acetate|abiraterone acetate|mesh-list
93343814|NCT05295927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343815|NCT05295927|Glucocorticoids|glucocorticoids|mesh-ancestor
93343816|NCT05295927|Hormones|hormones|mesh-ancestor
93343817|NCT05295927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343818|NCT05295927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343819|NCT05295927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343820|NCT05295927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343821|NCT05295927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93343822|NCT05295927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343823|NCT05295927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343824|NCT05295927|Hormone Antagonists|hormone antagonists|mesh-ancestor
93343825|NCT05295927|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93343826|NCT05288673|Ravulizumab|ravulizumab|mesh-list
93343827|NCT05288673|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93343828|NCT05288673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343829|NCT05288673|Immunologic Factors|immunologic factors|mesh-ancestor
93343830|NCT05288673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343831|NCT05288660|Ravulizumab|ravulizumab|mesh-list
93343832|NCT05288660|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93343833|NCT05288660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343834|NCT05288660|Immunologic Factors|immunologic factors|mesh-ancestor
93343835|NCT05288660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343836|NCT05284812|Vaccines|vaccines|mesh-list
93343837|NCT05284812|Immunologic Factors|immunologic factors|mesh-ancestor
93343838|NCT05284812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343839|NCT05283226|Paclitaxel|paclitaxel|mesh-list
93343840|NCT05283226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93343841|NCT05283226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343842|NCT05283226|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343843|NCT05283226|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343844|NCT05283226|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343845|NCT05283226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343846|NCT05257460|Insulin|insulin|mesh-list
93343847|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93343848|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
93343849|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93343850|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343851|NCT05254626|Pioglitazone|pioglitazone|mesh-list
93343852|NCT05254626|Dapagliflozin|dapagliflozin|mesh-list
93343853|NCT05254626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93343854|NCT05254626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343855|NCT05254626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93343856|NCT05254626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343857|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
93343858|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343859|NCT05243550|Mitomycins|mitomycins|mesh-list
93343860|NCT05243550|Mitomycin|mitomycin|mesh-list
93343861|NCT05243550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93343862|NCT05243550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343863|NCT05243550|Alkylating Agents|alkylating agents|mesh-ancestor
93343864|NCT05243550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343865|NCT05243550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93343866|NCT05243550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343867|NCT05223335|Clopidogrel|clopidogrel|mesh-list
93343868|NCT05223335|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93343869|NCT05223335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93343870|NCT05223335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93343871|NCT05223335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93343872|NCT05223335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93343873|NCT05223335|Purinergic Agents|purinergic agents|mesh-ancestor
93343874|NCT05223335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343875|NCT05223335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343876|NCT05223335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343877|NCT05216653|Capecitabine|capecitabine|mesh-list
93343878|NCT05216653|Oxaliplatin|oxaliplatin|mesh-list
93343879|NCT05216653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93343880|NCT05216653|Antimetabolites|antimetabolites|mesh-ancestor
93343881|NCT05216653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343882|NCT05216653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343884|NCT05211791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343885|NCT05211791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343886|NCT05166811|Magnesium Sulfate|magnesium sulfate|mesh-list
93343887|NCT05166811|Analgesics|analgesics|mesh-ancestor
93343888|NCT05166811|Sensory System Agents|sensory system agents|mesh-ancestor
93343889|NCT05166811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343890|NCT05166811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343891|NCT05166811|Anesthetics|anesthetics|mesh-ancestor
93343892|NCT05166811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343893|NCT05166811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93343894|NCT05166811|Anticonvulsants|anticonvulsants|mesh-ancestor
93343895|NCT05166811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93343896|NCT05166811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93343897|NCT05166811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343898|NCT05166811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93343899|NCT05166811|Tocolytic Agents|tocolytic agents|mesh-ancestor
93343900|NCT05166811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93343901|NCT05165225|Cyclophosphamide|cyclophosphamide|mesh-list
93343902|NCT05165225|Docetaxel|docetaxel|mesh-list
93343903|NCT05165225|Epirubicin|epirubicin|mesh-list
93343904|NCT05165225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93343905|NCT05165225|Immunologic Factors|immunologic factors|mesh-ancestor
93343906|NCT05165225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343907|NCT05165225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93343908|NCT05165225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93343909|NCT05165225|Alkylating Agents|alkylating agents|mesh-ancestor
93343910|NCT05165225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343911|NCT05165225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343912|NCT05165225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93343913|NCT05165225|Tubulin Modulators|tubulin modulators|mesh-ancestor
93343914|NCT05165225|Antimitotic Agents|antimitotic agents|mesh-ancestor
93343915|NCT05165225|Mitosis Modulators|mitosis modulators|mesh-ancestor
93343916|NCT05165225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93343917|NCT05165225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93343918|NCT05165225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93343919|NCT05165225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343920|NCT05150587|Rifaximin|rifaximin|mesh-list
93343921|NCT05150587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93343922|NCT05150587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93343923|NCT05150587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93343924|NCT05143229|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93343925|NCT05143229|Immunoconjugates|immunoconjugates|mesh-ancestor
93343926|NCT05143229|Immunologic Factors|immunologic factors|mesh-ancestor
93343927|NCT05143229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343928|NCT05120596|Pembrolizumab|pembrolizumab|mesh-list
93343929|NCT05120596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93343930|NCT05120596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343931|NCT05120596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93343932|NCT05120596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343933|NCT05116293|Acetaminophen|acetaminophen|mesh-list
93343934|NCT05116293|Digoxin|digoxin|mesh-list
93343935|NCT05116293|Midazolam|midazolam|mesh-list
93343936|NCT05116293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93343937|NCT05116293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93343938|NCT05116293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343939|NCT05116293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343940|NCT05116293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93343941|NCT05116293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93343942|NCT05116293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93343943|NCT05116293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93343944|NCT05116293|Anesthetics, General|anesthetics, general|mesh-ancestor
93343945|NCT05116293|Anesthetics|anesthetics|mesh-ancestor
93343946|NCT05116293|GABA Modulators|gaba modulators|mesh-ancestor
93343947|NCT05116293|GABA Agents|gaba agents|mesh-ancestor
93343948|NCT05116293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93343949|NCT05116293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343950|NCT05116293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93343951|NCT05116293|Analgesics|analgesics|mesh-ancestor
93343952|NCT05116293|Sensory System Agents|sensory system agents|mesh-ancestor
93343953|NCT05116293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343954|NCT05116293|Antipyretics|antipyretics|mesh-ancestor
93343955|NCT05116293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93343956|NCT05116293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93343957|NCT05116293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93343958|NCT05116293|Protective Agents|protective agents|mesh-ancestor
93343959|NCT05099055|Dexmedetomidine|dexmedetomidine|mesh-list
93343960|NCT05099055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93343961|NCT05099055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343962|NCT05099055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343963|NCT05099055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93343964|NCT05099055|Analgesics|analgesics|mesh-ancestor
93343965|NCT05099055|Sensory System Agents|sensory system agents|mesh-ancestor
93343966|NCT05099055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343967|NCT05099055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93343968|NCT05099055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93343969|NCT05099055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93343970|NCT05099055|Adrenergic Agents|adrenergic agents|mesh-ancestor
93343971|NCT05099055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637731|NCT00474994|Sunitinib|sunitinib|mesh-list
93343972|NCT05099055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93343973|NCT05024344|Dexamethasone|dexamethasone|mesh-list
93343974|NCT05024344|Ropivacaine|ropivacaine|mesh-list
93343975|NCT05024344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93343976|NCT05024344|Antiemetics|antiemetics|mesh-ancestor
93343977|NCT05024344|Autonomic Agents|autonomic agents|mesh-ancestor
93343978|NCT05024344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343979|NCT05024344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343980|NCT05024344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93343981|NCT05024344|Glucocorticoids|glucocorticoids|mesh-ancestor
93343982|NCT05024344|Hormones|hormones|mesh-ancestor
93343983|NCT05024344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93343984|NCT05024344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93343985|NCT05024344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93343986|NCT05024344|Anesthetics, Local|anesthetics, local|mesh-ancestor
93343987|NCT05024344|Anesthetics|anesthetics|mesh-ancestor
93343988|NCT05024344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93343989|NCT05024344|Sensory System Agents|sensory system agents|mesh-ancestor
93343990|NCT04997304|Albuterol|albuterol|mesh-list
93343991|NCT04997304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93343992|NCT04997304|Autonomic Agents|autonomic agents|mesh-ancestor
93343993|NCT04997304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93343994|NCT04997304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93343995|NCT04997304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93343996|NCT04997304|Respiratory System Agents|respiratory system agents|mesh-ancestor
93343997|NCT04997304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93343998|NCT04997304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93343999|NCT04997304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93344000|NCT04997304|Adrenergic Agents|adrenergic agents|mesh-ancestor
93344001|NCT04997304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344002|NCT04997304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344003|NCT04997304|Tocolytic Agents|tocolytic agents|mesh-ancestor
93344004|NCT04997304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93344005|NCT04993027|Vancomycin|vancomycin|mesh-list
93344006|NCT04993027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93344007|NCT04993027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344008|NCT04991324|Vitamin D|vitamin d|mesh-list
93344009|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
93344010|NCT04991324|Vitamins|vitamins|mesh-ancestor
93344011|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
93344012|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344013|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93344014|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93344015|NCT04984616|Atorvastatin|atorvastatin|mesh-list
93344016|NCT04984616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93344017|NCT04984616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93344018|NCT04984616|Antimetabolites|antimetabolites|mesh-ancestor
93344019|NCT04984616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344020|NCT04984616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93344021|NCT04984616|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93344022|NCT04984616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344023|NCT04966481|Cetuximab|cetuximab|mesh-list
93344024|NCT04966481|Palbociclib|palbociclib|mesh-list
93344025|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344026|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344027|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344028|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344029|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344030|NCT04957329|Latanoprost|latanoprost|mesh-list
93344031|NCT04957329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93344032|NCT04957329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93344033|NCT04937881|Tenofovir|tenofovir|mesh-list
93344034|NCT04937881|Antiviral Agents|antiviral agents|mesh-ancestor
92637794|NCT00474058|Rotigotine|rotigotine|mesh-list
93344035|NCT04937881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344036|NCT04937881|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93344037|NCT04937881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93344038|NCT04937881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344039|NCT04937881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344040|NCT04937881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93344041|NCT04937881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93344042|NCT04910568|Dexamethasone|dexamethasone|mesh-list
93344043|NCT04910568|Daratumumab|daratumumab|mesh-list
93344044|NCT04910568|Pomalidomide|pomalidomide|mesh-list
93344045|NCT04910568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344046|NCT04910568|Antiemetics|antiemetics|mesh-ancestor
93344047|NCT04910568|Autonomic Agents|autonomic agents|mesh-ancestor
93344048|NCT04910568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344049|NCT04910568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344050|NCT04910568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344051|NCT04910568|Glucocorticoids|glucocorticoids|mesh-ancestor
93344052|NCT04910568|Hormones|hormones|mesh-ancestor
93344053|NCT04910568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344054|NCT04910568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93344055|NCT04910568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344056|NCT04910568|Immunologic Factors|immunologic factors|mesh-ancestor
93344057|NCT04910568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93344058|NCT04910568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93344059|NCT04910568|Growth Substances|growth substances|mesh-ancestor
93344060|NCT04910568|Growth Inhibitors|growth inhibitors|mesh-ancestor
93344061|NCT04907721|Glucagon|glucagon|mesh-list
93344062|NCT04907721|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93344063|NCT04907721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344064|NCT04907721|Hormones|hormones|mesh-ancestor
93344065|NCT04907721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344066|NCT04907721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344067|NCT04907721|Incretins|incretins|mesh-ancestor
93344068|NCT04905810|Azacitidine|azacitidine|mesh-list
93344069|NCT04905810|Decitabine|decitabine|mesh-list
93344070|NCT04905810|Venetoclax|venetoclax|mesh-list
93344071|NCT04905810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344072|NCT04905810|Antimetabolites|antimetabolites|mesh-ancestor
93344073|NCT04905810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344074|NCT04905810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344075|NCT04905810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344076|NCT04871412|Vitamin D|vitamin d|mesh-list
93344077|NCT04871412|Ergocalciferols|ergocalciferols|mesh-list
93344078|NCT04871412|Cholecalciferol|cholecalciferol|mesh-list
93344079|NCT04871412|Vitamins|vitamins|mesh-list
93344080|NCT04871412|Curcumin|curcumin|mesh-list
93344081|NCT04871412|Micronutrients|micronutrients|mesh-ancestor
93344082|NCT04871412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344083|NCT04871412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93344084|NCT04871412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93344085|NCT04871412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93344086|NCT04871412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93344087|NCT04871412|Analgesics|analgesics|mesh-ancestor
93344088|NCT04871412|Sensory System Agents|sensory system agents|mesh-ancestor
93344089|NCT04871412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344090|NCT04871412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344091|NCT04871412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344092|NCT04871412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344093|NCT04871412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344094|NCT04871412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344095|NCT04868877|Osimertinib|osimertinib|mesh-list
93344096|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344097|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344098|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344099|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344100|NCT04818086|Buprenorphine|buprenorphine|mesh-list
93344101|NCT04818086|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93344102|NCT04818086|Lemborexant|lemborexant|mesh-list
93344103|NCT04818086|Naloxone|naloxone|mesh-list
93344104|NCT04818086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93344105|NCT04818086|Narcotics|narcotics|mesh-ancestor
93344106|NCT04818086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016052|NCT01009476|Nicergoline|nicergoline|mesh-list
93344107|NCT04818086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344108|NCT04818086|Analgesics|analgesics|mesh-ancestor
93344109|NCT04818086|Sensory System Agents|sensory system agents|mesh-ancestor
93344110|NCT04818086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344111|NCT04818086|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93344112|NCT04818086|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93344113|NCT04818086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344114|NCT04818086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344115|NCT04818086|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93344116|NCT04818086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93344117|NCT04799431|Poly I-C|poly i-c|mesh-list
93344118|NCT04799431|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93344119|NCT04799431|Poly ICLC|poly iclc|mesh-list
93344120|NCT04799431|Interferon Inducers|interferon inducers|mesh-ancestor
93344121|NCT04799431|Immunologic Factors|immunologic factors|mesh-ancestor
93344122|NCT04799431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344123|NCT04799431|Laxatives|laxatives|mesh-ancestor
93344124|NCT04799431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344125|NCT04799431|Antiviral Agents|antiviral agents|mesh-ancestor
93344126|NCT04799431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344127|NCT04745832|Prednisone|prednisone|mesh-list
93344128|NCT04745832|Cyclophosphamide|cyclophosphamide|mesh-list
93344129|NCT04745832|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93344130|NCT04745832|Rituximab|rituximab|mesh-list
93344131|NCT04745832|Vincristine|vincristine|mesh-list
93344132|NCT04745832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344133|NCT04745832|Immunologic Factors|immunologic factors|mesh-ancestor
93344134|NCT04745832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344135|NCT04745832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344136|NCT04745832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344137|NCT04745832|Alkylating Agents|alkylating agents|mesh-ancestor
93344138|NCT04745832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344139|NCT04745832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344140|NCT04745832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93344141|NCT04745832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344142|NCT04745832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344143|NCT04745832|Glucocorticoids|glucocorticoids|mesh-ancestor
93344144|NCT04745832|Hormones|hormones|mesh-ancestor
93344145|NCT04745832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344146|NCT04745832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93344147|NCT04745832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344148|NCT04745832|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344149|NCT04745832|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344150|NCT04745832|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344151|NCT04724668|Melatonin|melatonin|mesh-list
93344152|NCT04724668|Antioxidants|antioxidants|mesh-ancestor
93344153|NCT04724668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344154|NCT04724668|Protective Agents|protective agents|mesh-ancestor
93344155|NCT04724668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344156|NCT04724668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344157|NCT04685772|Methylprednisolone|methylprednisolone|mesh-list
93344158|NCT04685772|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93344159|NCT04685772|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93344160|NCT04685772|Prednisolone|prednisolone|mesh-list
93344161|NCT04685772|Prednisolone acetate|prednisolone acetate|mesh-list
93344162|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93344163|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
93344164|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344165|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
93344166|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
93344167|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344168|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344169|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344170|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
93344171|NCT04685772|Hormones|hormones|mesh-ancestor
93344172|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344173|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93344174|NCT04685772|Protective Agents|protective agents|mesh-ancestor
93344175|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93344176|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344177|NCT04629209|TIC10 compound|tic10 compound|mesh-list
93344178|NCT04629209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344179|NCT04609189|Vitamin D|vitamin d|mesh-list
93344180|NCT04609189|Cholecalciferol|cholecalciferol|mesh-list
93344181|NCT04609189|Calcium Carbonate|calcium carbonate|mesh-list
93344182|NCT04609189|Calcium|calcium|mesh-list
93344183|NCT04609189|Vitamins|vitamins|mesh-ancestor
93344185|NCT04609189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344186|NCT04609189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93344187|NCT04609189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93344188|NCT04609189|Antacids|antacids|mesh-ancestor
93344189|NCT04609189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344190|NCT04609189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344191|NCT04604795|Itraconazole|itraconazole|mesh-list
93344192|NCT04604795|Antifungal Agents|antifungal agents|mesh-ancestor
93344193|NCT04604795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344194|NCT04604795|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93344195|NCT04604795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93344196|NCT04604795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344197|NCT04604795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344198|NCT04604795|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93344199|NCT04604795|Hormone Antagonists|hormone antagonists|mesh-ancestor
93344200|NCT04604795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344201|NCT04604795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344202|NCT04604795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93344203|NCT04588233|Melatonin|melatonin|mesh-list
93344204|NCT04588233|Antioxidants|antioxidants|mesh-ancestor
93344205|NCT04588233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344206|NCT04588233|Protective Agents|protective agents|mesh-ancestor
93344207|NCT04588233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344208|NCT04588233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344209|NCT04587128|Irinotecan|irinotecan|mesh-list
93344210|NCT04587128|Cetuximab|cetuximab|mesh-list
93344211|NCT04587128|Panitumumab|panitumumab|mesh-list
93344212|NCT04587128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93344213|NCT04587128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93344214|NCT04587128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344215|NCT04587128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344216|NCT04587128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344217|NCT04587128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344218|NCT04570150|Neostigmine|neostigmine|mesh-list
93344219|NCT04570150|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93344220|NCT04570150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344221|NCT04570150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344222|NCT04570150|Cholinergic Agents|cholinergic agents|mesh-ancestor
93344223|NCT04570150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344224|NCT04570150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344225|NCT04570150|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93344226|NCT04570150|Autonomic Agents|autonomic agents|mesh-ancestor
92637991|NCT00192725|Tryptophan|tryptophan|mesh-list
93344227|NCT04570150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344228|NCT04563273|Vaccines|vaccines|mesh-list
93344229|NCT04563273|BCG Vaccine|bcg vaccine|mesh-list
93344230|NCT04563273|Immunologic Factors|immunologic factors|mesh-ancestor
93344231|NCT04563273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344232|NCT04563273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93344233|NCT04552782|Ethanol|ethanol|mesh-list
93344234|NCT04552782|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93344235|NCT04552782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344236|NCT04552782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344237|NCT04552782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344238|NCT04545762|Cyclophosphamide|cyclophosphamide|mesh-list
93344239|NCT04545762|Fludarabine|fludarabine|mesh-list
93344240|NCT04545762|Fludarabine phosphate|fludarabine phosphate|mesh-list
93344241|NCT04545762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344242|NCT04545762|Immunologic Factors|immunologic factors|mesh-ancestor
93344243|NCT04545762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344244|NCT04545762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344245|NCT04545762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344246|NCT04545762|Alkylating Agents|alkylating agents|mesh-ancestor
93344247|NCT04545762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344248|NCT04545762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344249|NCT04545762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93344250|NCT04545762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344251|NCT04545762|Antimetabolites|antimetabolites|mesh-ancestor
93344252|NCT04539977|Carboplatin|carboplatin|mesh-list
93344253|NCT04539977|Etoposide|etoposide|mesh-list
93344254|NCT04539977|Etoposide phosphate|etoposide phosphate|mesh-list
93344255|NCT04539977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344256|NCT04539977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344257|NCT04539977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93344258|NCT04539977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93344259|NCT04539977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344260|NCT04539977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344261|NCT04535141|Olanzapine|olanzapine|mesh-list
93344262|NCT04535141|Antiemetics|antiemetics|mesh-ancestor
93344263|NCT04535141|Autonomic Agents|autonomic agents|mesh-ancestor
93344264|NCT04535141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344265|NCT04535141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344266|NCT04535141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344267|NCT04535141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93344268|NCT04535141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93344269|NCT04535141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344270|NCT04535141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93344271|NCT04535141|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93344272|NCT04535141|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93344273|NCT04535141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93344274|NCT04535141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344275|NCT04535141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344276|NCT04535141|Serotonin Agents|serotonin agents|mesh-ancestor
93344277|NCT04534023|Idebenone|idebenone|mesh-list
93344278|NCT04534023|Antioxidants|antioxidants|mesh-ancestor
93344279|NCT04534023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344280|NCT04534023|Protective Agents|protective agents|mesh-ancestor
93344281|NCT04534023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344282|NCT04527393|Morphine|morphine|mesh-list
93344283|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93344284|NCT04527393|Narcotics|narcotics|mesh-ancestor
93344285|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344286|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344287|NCT04527393|Analgesics|analgesics|mesh-ancestor
93344288|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
93344289|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344290|NCT04510506|Pancrelipase|pancrelipase|mesh-list
93344291|NCT04510506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344292|NCT04480918|Ketamine|ketamine|mesh-list
93344293|NCT04480918|Esketamine|esketamine|mesh-list
93344294|NCT04480918|Analgesics|analgesics|mesh-ancestor
93344295|NCT04480918|Sensory System Agents|sensory system agents|mesh-ancestor
93344296|NCT04480918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344297|NCT04480918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344298|NCT04480918|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93344299|NCT04480918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93344300|NCT04480918|Anesthetics, General|anesthetics, general|mesh-ancestor
93344301|NCT04480918|Anesthetics|anesthetics|mesh-ancestor
93344302|NCT04480918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344303|NCT04480918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93344304|NCT04480918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93344305|NCT04480918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344306|NCT04480918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344307|NCT04480918|Antidepressive Agents|antidepressive agents|mesh-ancestor
93344308|NCT04480918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93344309|NCT04465487|Cemiplimab|cemiplimab|mesh-list
93344310|NCT04465487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344311|NCT04465487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344312|NCT04419909|Tisagenlecleucel|tisagenlecleucel|mesh-list
93344313|NCT04419909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344314|NCT04419909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344315|NCT04410796|Carboplatin|carboplatin|mesh-list
93344316|NCT04410796|Pemetrexed|pemetrexed|mesh-list
93344317|NCT04410796|Osimertinib|osimertinib|mesh-list
93344318|NCT04410796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344319|NCT04410796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344320|NCT04410796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344321|NCT04410796|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93344322|NCT04410796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93344323|NCT04410796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344324|NCT04374500|Verapamil|verapamil|mesh-list
93344325|NCT04374500|Nitroprusside|nitroprusside|mesh-list
93344326|NCT04374500|Acetylcholine|acetylcholine|mesh-list
93344327|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
93344328|NCT04374500|Bradykinin|bradykinin|mesh-list
93344329|NCT04374500|Substance P|substance p|mesh-list
93344330|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93344331|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93344332|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93344333|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344334|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93344335|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344336|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93344337|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93344338|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93344339|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
93344340|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344341|NCT04340947|Nicotine|nicotine|mesh-list
93344342|NCT04340947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93344343|NCT04340947|Autonomic Agents|autonomic agents|mesh-ancestor
93344344|NCT04340947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344345|NCT04340947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344346|NCT04340947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93344347|NCT04340947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93344348|NCT04340947|Cholinergic Agents|cholinergic agents|mesh-ancestor
93344349|NCT04340947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344350|NCT04340947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344351|NCT04326283|Trametinib|trametinib|mesh-list
93344352|NCT04326283|Riluzole|riluzole|mesh-list
93344353|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344354|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344355|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344356|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344357|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
93344358|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93344359|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93344360|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344361|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344362|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93344363|NCT04326283|Protective Agents|protective agents|mesh-ancestor
93344364|NCT04287062|Suvorexant|suvorexant|mesh-list
93344365|NCT04287062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93344366|NCT04287062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93344367|NCT04287062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344368|NCT04287062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344369|NCT04287062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93344370|NCT04287062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344371|NCT04287062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344372|NCT04280965|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93344373|NCT04280965|Antidepressive Agents|antidepressive agents|mesh-ancestor
93344374|NCT04280965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93344375|NCT04280965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93344376|NCT04280965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93344377|NCT04280965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344378|NCT04280965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344379|NCT04266353|Resveratrol|resveratrol|mesh-list
93344380|NCT04266353|Antioxidants|antioxidants|mesh-ancestor
93344381|NCT04266353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344382|NCT04266353|Protective Agents|protective agents|mesh-ancestor
93344383|NCT04266353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344384|NCT04266353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344385|NCT04266353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93344386|NCT04249427|Erenumab|erenumab|mesh-list
93344387|NCT04249427|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93344388|NCT04249427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344389|NCT04249427|Analgesics|analgesics|mesh-ancestor
93344390|NCT04249427|Sensory System Agents|sensory system agents|mesh-ancestor
93344391|NCT04249427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344392|NCT04249427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344393|NCT04231643|Dronabinol|dronabinol|mesh-list
93344394|NCT04231643|Cannabidiol|cannabidiol|mesh-list
93344395|NCT04231643|Hallucinogens|hallucinogens|mesh-ancestor
93344396|NCT04231643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344397|NCT04231643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93344398|NCT04231643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93344399|NCT04231643|Analgesics|analgesics|mesh-ancestor
93344400|NCT04231643|Sensory System Agents|sensory system agents|mesh-ancestor
93344401|NCT04231643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344402|NCT04231643|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93344403|NCT04231643|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93344404|NCT04231643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344405|NCT04231643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344406|NCT04231643|Hormones|hormones|mesh-ancestor
93344407|NCT04231643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344408|NCT04231643|Anticonvulsants|anticonvulsants|mesh-ancestor
93344409|NCT04207190|Talazoparib|talazoparib|mesh-list
93344410|NCT04207190|Gemtuzumab|gemtuzumab|mesh-list
93344411|NCT04207190|Calicheamicins|calicheamicins|mesh-list
93344412|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93344413|NCT04207190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344414|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344415|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344416|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344417|NCT04207190|Immunotoxins|immunotoxins|mesh-ancestor
93344418|NCT04207190|Immunoconjugates|immunoconjugates|mesh-ancestor
93344419|NCT04207190|Immunologic Factors|immunologic factors|mesh-ancestor
93344420|NCT04207190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344421|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93344422|NCT04174196|Lenalidomide|lenalidomide|mesh-list
93344423|NCT04174196|Cc-486|cc-486|mesh-list
93344424|NCT04174196|Immunologic Factors|immunologic factors|mesh-ancestor
93344425|NCT04174196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344426|NCT04174196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93344427|NCT04174196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93344428|NCT04174196|Growth Substances|growth substances|mesh-ancestor
93344429|NCT04174196|Growth Inhibitors|growth inhibitors|mesh-ancestor
93344430|NCT04174196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344431|NCT04171167|Fluticasone|fluticasone|mesh-list
93344432|NCT04171167|Xhance|xhance|mesh-list
93344433|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344434|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93344435|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
93344436|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344437|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344438|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93344439|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
93344440|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93344441|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93344442|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
93344443|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93344444|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344445|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344446|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344447|NCT04119284|Terephthalic acid|terephthalic acid|mesh-list
93344448|NCT04119284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93344449|NCT04119284|Antioxidants|antioxidants|mesh-ancestor
93344450|NCT04119284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344451|NCT04119284|Protective Agents|protective agents|mesh-ancestor
93344452|NCT04119284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344453|NCT04117763|Empagliflozin|empagliflozin|mesh-list
93344454|NCT04117763|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93344455|NCT04117763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344456|NCT04117763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93344457|NCT04117763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344458|NCT04078880|Ascorbic Acid|ascorbic acid|mesh-list
93344459|NCT04078880|Antioxidants|antioxidants|mesh-ancestor
93344460|NCT04078880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344461|NCT04078880|Protective Agents|protective agents|mesh-ancestor
93344462|NCT04078880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344463|NCT04078880|Vitamins|vitamins|mesh-ancestor
93344464|NCT04078880|Micronutrients|micronutrients|mesh-ancestor
93344465|NCT04077437|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93344466|NCT04077437|Hallucinogens|hallucinogens|mesh-ancestor
93344467|NCT04077437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344468|NCT04077437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93344469|NCT04077437|Serotonin Agents|serotonin agents|mesh-ancestor
93344470|NCT04077437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344471|NCT04077437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344472|NCT04077437|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93344473|NCT04077437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93344474|NCT04077437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93344475|NCT04077437|Adrenergic Agents|adrenergic agents|mesh-ancestor
93344476|NCT04071574|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93344477|NCT04071574|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93344478|NCT04071574|Cetrorelix|cetrorelix|mesh-list
93344479|NCT04071574|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93344480|NCT04071574|Hormones|hormones|mesh-ancestor
93344481|NCT04071574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344482|NCT04071574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344483|NCT04071574|Luteolytic Agents|luteolytic agents|mesh-ancestor
93344484|NCT04071574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93344485|NCT04071574|Contraceptive Agents|contraceptive agents|mesh-ancestor
93344486|NCT04071574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93344487|NCT04071574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93344488|NCT04071574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93344489|NCT04071574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344490|NCT04071574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93344491|NCT04071574|Fertility Agents|fertility agents|mesh-ancestor
93344492|NCT04071574|Hormone Antagonists|hormone antagonists|mesh-ancestor
93344493|NCT04046107|Cemiplimab|cemiplimab|mesh-list
93344494|NCT04046107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344495|NCT04046107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344496|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
93344497|NCT04023669|Gemcitabine|gemcitabine|mesh-list
93344498|NCT04023669|Lenograstim|lenograstim|mesh-list
93344499|NCT04023669|Prexasertib|prexasertib|mesh-list
93344500|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344501|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
93344502|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344503|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344504|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344505|NCT04023669|Alkylating Agents|alkylating agents|mesh-ancestor
93344506|NCT04023669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344507|NCT04023669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344508|NCT04023669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93344509|NCT04023669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344510|NCT04023669|Antimetabolites|antimetabolites|mesh-ancestor
93344511|NCT04023669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93344512|NCT04023669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344513|NCT04023669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344514|NCT04002362|Triamcinolone|triamcinolone|mesh-list
93344515|NCT04002362|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93344516|NCT04002362|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93344517|NCT04002362|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93344518|NCT04002362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344519|NCT04002362|Glucocorticoids|glucocorticoids|mesh-ancestor
93344520|NCT04002362|Hormones|hormones|mesh-ancestor
93344521|NCT04002362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344522|NCT04002362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344523|NCT04002362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344524|NCT04002362|Immunologic Factors|immunologic factors|mesh-ancestor
93344525|NCT04002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344526|NCT04002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344527|NCT03992196|Rotigotine|rotigotine|mesh-list
93344528|NCT03992196|Dopamine Agonists|dopamine agonists|mesh-ancestor
93344529|NCT03992196|Dopamine Agents|dopamine agents|mesh-ancestor
93344530|NCT03992196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344531|NCT03992196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344532|NCT03992196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344533|NCT03982381|Metformin|metformin|mesh-list
93344534|NCT03982381|Dapagliflozin|dapagliflozin|mesh-list
93344535|NCT03982381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93344536|NCT03982381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344537|NCT03982381|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93344538|NCT03982381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344539|NCT03982186|JNJ-56136379|jnj-56136379|mesh-list
93344540|NCT03982186|Antiviral Agents|antiviral agents|mesh-ancestor
93344541|NCT03982186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344542|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
93344543|NCT03970252|Leucovorin|leucovorin|mesh-list
93344544|NCT03970252|Folic Acid|folic acid|mesh-list
93344545|NCT03970252|Fluorouracil|fluorouracil|mesh-list
93344546|NCT03970252|Oxaliplatin|oxaliplatin|mesh-list
93344547|NCT03970252|Nivolumab|nivolumab|mesh-list
93344548|NCT03970252|Irinotecan|irinotecan|mesh-list
93344549|NCT03970252|Camptothecin|camptothecin|mesh-list
93344550|NCT03970252|Calcium|calcium|mesh-list
93344551|NCT03970252|Levoleucovorin|levoleucovorin|mesh-list
93344552|NCT03970252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93344553|NCT03970252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344554|NCT03970252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93344555|NCT03970252|Antimetabolites|antimetabolites|mesh-ancestor
93344556|NCT03970252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344557|NCT03970252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344558|NCT03970252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344559|NCT03970252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344560|NCT03970252|Immunologic Factors|immunologic factors|mesh-ancestor
93344561|NCT03970252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344562|NCT03970252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344563|NCT03970252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93344564|NCT03970252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93344565|NCT03970252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344566|NCT03970252|Antidotes|antidotes|mesh-ancestor
93344567|NCT03970252|Protective Agents|protective agents|mesh-ancestor
93344568|NCT03970252|Vitamin B Complex|vitamin b complex|mesh-ancestor
93344569|NCT03970252|Vitamins|vitamins|mesh-ancestor
93344570|NCT03970252|Micronutrients|micronutrients|mesh-ancestor
93344571|NCT03970252|Hematinics|hematinics|mesh-ancestor
93344572|NCT03970252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344573|NCT03969004|Cemiplimab|cemiplimab|mesh-list
93344574|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344575|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344576|NCT03932409|Paclitaxel|paclitaxel|mesh-list
93344577|NCT03932409|Carboplatin|carboplatin|mesh-list
93344578|NCT03932409|Pembrolizumab|pembrolizumab|mesh-list
93344579|NCT03932409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344580|NCT03932409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344581|NCT03932409|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344582|NCT03932409|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344583|NCT03932409|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344584|NCT03932409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344585|NCT03932409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344586|NCT03932409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344587|NCT03915613|Insulin|insulin|mesh-list
93344588|NCT03915613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93344589|NCT03915613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92638338|NCT00216177|Adalimumab|adalimumab|mesh-list
93344590|NCT03915613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344591|NCT03907852|Cyclophosphamide|cyclophosphamide|mesh-list
93344592|NCT03907852|Nivolumab|nivolumab|mesh-list
93344593|NCT03907852|Fludarabine|fludarabine|mesh-list
93344594|NCT03907852|Ipilimumab|ipilimumab|mesh-list
93344595|NCT03907852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344596|NCT03907852|Immunologic Factors|immunologic factors|mesh-ancestor
93344597|NCT03907852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344598|NCT03907852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344599|NCT03907852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344600|NCT03907852|Alkylating Agents|alkylating agents|mesh-ancestor
93344601|NCT03907852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344602|NCT03907852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344603|NCT03907852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93344604|NCT03907852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344605|NCT03907852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344606|NCT03904251|Cytarabine|cytarabine|mesh-list
93344607|NCT03904251|Daunorubicin|daunorubicin|mesh-list
93344608|NCT03904251|Gemtuzumab|gemtuzumab|mesh-list
93344609|NCT03904251|Calicheamicins|calicheamicins|mesh-list
93344610|NCT03904251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344611|NCT03904251|Antimetabolites|antimetabolites|mesh-ancestor
93344612|NCT03904251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344613|NCT03904251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344614|NCT03904251|Antiviral Agents|antiviral agents|mesh-ancestor
93344615|NCT03904251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344616|NCT03904251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344617|NCT03904251|Immunologic Factors|immunologic factors|mesh-ancestor
93344618|NCT03904251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344619|NCT03904251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93344620|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93344621|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93344622|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344623|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344624|NCT03904251|Immunotoxins|immunotoxins|mesh-ancestor
93344625|NCT03904251|Immunoconjugates|immunoconjugates|mesh-ancestor
93344626|NCT03896633|Brinzolamide|brinzolamide|mesh-list
93344627|NCT03896633|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93344628|NCT03896633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344629|NCT03896633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344630|NCT03890731|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93016590|NCT00420927|Adalimumab|adalimumab|mesh-list
93344631|NCT03890731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344632|NCT03890731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344633|NCT03890731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344634|NCT03872180|Venetoclax|venetoclax|mesh-list
93344635|NCT03872180|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93344636|NCT03872180|Obinutuzumab|obinutuzumab|mesh-list
93344637|NCT03872180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344638|NCT03872180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344639|NCT03872180|Alkylating Agents|alkylating agents|mesh-ancestor
93344640|NCT03872180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344641|NCT03872180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344642|NCT03847649|Prednisone|prednisone|mesh-list
93344643|NCT03847649|Durvalumab|durvalumab|mesh-list
93344644|NCT03847649|Tremelimumab|tremelimumab|mesh-list
93344645|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344646|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
93344647|NCT03847649|Hormones|hormones|mesh-ancestor
93344648|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93344649|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638408|NCT00473590|Bevacizumab|bevacizumab|mesh-list
93344650|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93344651|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344652|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344653|NCT03847311|Sulfasalazine|sulfasalazine|mesh-list
93344654|NCT03847311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344655|NCT03847311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93344656|NCT03847311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93344657|NCT03847311|Analgesics|analgesics|mesh-ancestor
93344658|NCT03847311|Sensory System Agents|sensory system agents|mesh-ancestor
93344659|NCT03847311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344660|NCT03847311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344661|NCT03847311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344662|NCT03847311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344663|NCT03847311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344664|NCT03845543|Paclitaxel|paclitaxel|mesh-list
93344665|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344666|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344667|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344668|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344669|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344670|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344671|NCT03827889|Fluorides|fluorides|mesh-list
93344672|NCT03827889|Fluorides, Topical|fluorides, topical|mesh-list
93344673|NCT03827889|Cariostatic Agents|cariostatic agents|mesh-ancestor
93344674|NCT03827889|Protective Agents|protective agents|mesh-ancestor
93344675|NCT03827889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344676|NCT03826563|Melatonin|melatonin|mesh-list
93344677|NCT03826563|Antioxidants|antioxidants|mesh-ancestor
93344678|NCT03826563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344679|NCT03826563|Protective Agents|protective agents|mesh-ancestor
93344680|NCT03826563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344681|NCT03826563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93344682|NCT03825796|Cytarabine|cytarabine|mesh-list
93344683|NCT03825796|Daunorubicin|daunorubicin|mesh-list
93344684|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344685|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
93344686|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344687|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344688|NCT03825796|Antiviral Agents|antiviral agents|mesh-ancestor
93344689|NCT03825796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344690|NCT03825796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344691|NCT03825796|Immunologic Factors|immunologic factors|mesh-ancestor
93344692|NCT03825796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344693|NCT03825796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93344694|NCT03825796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93344695|NCT03825796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93344696|NCT03825796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344697|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
93344698|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344699|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344700|NCT03823131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344701|NCT03823131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344702|NCT03822091|Terlipressin|terlipressin|mesh-list
93344703|NCT03822091|Norepinephrine|norepinephrine|mesh-list
93344704|NCT03822091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93344705|NCT03822091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93344706|NCT03822091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93344707|NCT03822091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93344709|NCT03822091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344710|NCT03822091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344711|NCT03822091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344712|NCT03822091|Sympathomimetics|sympathomimetics|mesh-ancestor
93344713|NCT03822091|Autonomic Agents|autonomic agents|mesh-ancestor
93344714|NCT03822091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344715|NCT03767348|Nivolumab|nivolumab|mesh-list
93344716|NCT03767348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344717|NCT03767348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344718|NCT03767348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344719|NCT03767348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344720|NCT03739619|Gemcitabine|gemcitabine|mesh-list
93344721|NCT03739619|Nivolumab|nivolumab|mesh-list
93344722|NCT03739619|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92638470|NCT00206310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344723|NCT03739619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344724|NCT03739619|Antimetabolites|antimetabolites|mesh-ancestor
93344725|NCT03739619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344726|NCT03739619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344727|NCT03739619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344728|NCT03739619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344729|NCT03739619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344730|NCT03739619|Alkylating Agents|alkylating agents|mesh-ancestor
93344731|NCT03728933|Rotigotine|rotigotine|mesh-list
93344732|NCT03728933|Dopamine Agonists|dopamine agonists|mesh-ancestor
93344733|NCT03728933|Dopamine Agents|dopamine agents|mesh-ancestor
93344734|NCT03728933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344735|NCT03728933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344736|NCT03728933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344737|NCT03664544|Edaravone|edaravone|mesh-list
93344738|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93344739|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
93344740|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344741|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93344742|NCT03664544|Protective Agents|protective agents|mesh-ancestor
93344743|NCT03664544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344744|NCT03645928|Pembrolizumab|pembrolizumab|mesh-list
93344745|NCT03645928|Nivolumab|nivolumab|mesh-list
93344746|NCT03645928|Ipilimumab|ipilimumab|mesh-list
93344747|NCT03645928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344748|NCT03645928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344749|NCT03645928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344750|NCT03645928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344751|NCT03537495|Linezolid|linezolid|mesh-list
93344752|NCT03537495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93344753|NCT03537495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344754|NCT03537495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93344755|NCT03537495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344756|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344757|NCT03535259|Sorafenib|sorafenib|mesh-list
93344758|NCT03535259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344759|NCT03535259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344760|NCT03535259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344761|NCT03535259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344762|NCT03521570|Nivolumab|nivolumab|mesh-list
93344763|NCT03521570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344764|NCT03521570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344765|NCT03521570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344766|NCT03521570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344767|NCT03484299|Gemcitabine|gemcitabine|mesh-list
93344768|NCT03484299|Folfirinox|folfirinox|mesh-list
93344769|NCT03484299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344770|NCT03484299|Antimetabolites|antimetabolites|mesh-ancestor
93344771|NCT03484299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344772|NCT03484299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344773|NCT03468218|Pembrolizumab|pembrolizumab|mesh-list
93344774|NCT03468218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344775|NCT03468218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344776|NCT03468218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344777|NCT03468218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344778|NCT03408574|Mecamylamine|mecamylamine|mesh-list
93344779|NCT03408574|Nicotine|nicotine|mesh-list
93016728|NCT04040465|Antipyretics|antipyretics|mesh-ancestor
93344781|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
93344782|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344783|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344784|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93344785|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93344786|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
93344787|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344788|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344789|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93344790|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
93344791|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93344792|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93344793|NCT03341520|Obinutuzumab|obinutuzumab|mesh-list
93344794|NCT03341520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344795|NCT03341520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344796|NCT03222570|Serotonin|serotonin|mesh-list
93344797|NCT03222570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93344798|NCT03222570|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93344799|NCT03222570|Serotonin Agents|serotonin agents|mesh-ancestor
93344800|NCT03222570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344801|NCT03222570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344802|NCT03222570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344803|NCT03222570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93344804|NCT03222570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93344805|NCT03193853|Paclitaxel|paclitaxel|mesh-list
93344806|NCT03193853|Serabelisib|serabelisib|mesh-list
93344807|NCT03193853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344808|NCT03193853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344809|NCT03193853|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344810|NCT03193853|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344811|NCT03193853|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344812|NCT03193853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344813|NCT03193853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344814|NCT03136328|Edotreotide|edotreotide|mesh-list
93344815|NCT03136328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93344816|NCT03136328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344817|NCT03072771|Cytarabine|cytarabine|mesh-list
93344818|NCT03072771|Etoposide|etoposide|mesh-list
93344819|NCT03072771|Melphalan|melphalan|mesh-list
93344820|NCT03072771|Carmustine|carmustine|mesh-list
93344821|NCT03072771|Blinatumomab|blinatumomab|mesh-list
93344822|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344823|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344824|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93344825|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93344826|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344827|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344828|NCT03072771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344829|NCT03072771|Antimetabolites|antimetabolites|mesh-ancestor
93344830|NCT03072771|Antiviral Agents|antiviral agents|mesh-ancestor
93344831|NCT03072771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344832|NCT03072771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344833|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
93344834|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344835|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344836|NCT03072771|Alkylating Agents|alkylating agents|mesh-ancestor
93344837|NCT03072771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93344838|NCT03067272|Contraceptive Agents|contraceptive agents|mesh-list
93344839|NCT03067272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93344840|NCT03067272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344841|NCT02966782|Azacitidine|azacitidine|mesh-list
93344842|NCT02966782|Venetoclax|venetoclax|mesh-list
93344843|NCT02966782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344844|NCT02966782|Antimetabolites|antimetabolites|mesh-ancestor
93344845|NCT02966782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344846|NCT02966782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344847|NCT02966782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344848|NCT02925650|Phenserine|phenserine|mesh-list
93344849|NCT02925650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93344850|NCT02925650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344851|NCT02925650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344852|NCT02925650|Cholinergic Agents|cholinergic agents|mesh-ancestor
93344853|NCT02925650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344854|NCT02925650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344856|NCT02914938|Zanubrutinib|zanubrutinib|mesh-list
93344857|NCT02914938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344858|NCT02914938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344859|NCT02914938|Immunologic Factors|immunologic factors|mesh-ancestor
93344860|NCT02914938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344861|NCT02914938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344862|NCT02914938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344863|NCT02914938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344864|NCT02914938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344865|NCT02849457|Vigabatrin|vigabatrin|mesh-list
93344866|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
93344867|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344868|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344869|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
93344870|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344871|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344872|NCT02802631|Minocycline|minocycline|mesh-list
93344873|NCT02802631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93344874|NCT02802631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344875|NCT02757898|Biotin|biotin|mesh-list
93344876|NCT02757898|Vitamin B Complex|vitamin b complex|mesh-ancestor
93344877|NCT02757898|Vitamins|vitamins|mesh-ancestor
93344878|NCT02757898|Micronutrients|micronutrients|mesh-ancestor
93344879|NCT02757898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344880|NCT02730546|Calcium, Dietary|calcium, dietary|mesh-list
93344881|NCT02730546|Leucovorin|leucovorin|mesh-list
93344882|NCT02730546|Folic Acid|folic acid|mesh-list
93344883|NCT02730546|Paclitaxel|paclitaxel|mesh-list
93344884|NCT02730546|Carboplatin|carboplatin|mesh-list
93344885|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
93344886|NCT02730546|Fluorouracil|fluorouracil|mesh-list
93344887|NCT02730546|Oxaliplatin|oxaliplatin|mesh-list
93344888|NCT02730546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93344889|NCT02730546|Calcium|calcium|mesh-list
93344890|NCT02730546|Levoleucovorin|levoleucovorin|mesh-list
93344891|NCT02730546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344892|NCT02730546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344893|NCT02730546|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344894|NCT02730546|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344895|NCT02730546|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344896|NCT02730546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344897|NCT02730546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344898|NCT02730546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344899|NCT02730546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93344900|NCT02730546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344901|NCT02730546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93344902|NCT02730546|Antimetabolites|antimetabolites|mesh-ancestor
93344903|NCT02730546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93344904|NCT02730546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344905|NCT02730546|Immunologic Factors|immunologic factors|mesh-ancestor
93344906|NCT02730546|Antidotes|antidotes|mesh-ancestor
93344907|NCT02730546|Protective Agents|protective agents|mesh-ancestor
93344908|NCT02730546|Vitamin B Complex|vitamin b complex|mesh-ancestor
93344909|NCT02730546|Vitamins|vitamins|mesh-ancestor
93344910|NCT02730546|Micronutrients|micronutrients|mesh-ancestor
93344911|NCT02730546|Hematinics|hematinics|mesh-ancestor
93344912|NCT02672098|Carboplatin|carboplatin|mesh-list
93344913|NCT02672098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344914|NCT02649335|Propranolol|propranolol|mesh-list
93344915|NCT02649335|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93344916|NCT02649335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93344917|NCT02649335|Adrenergic Agents|adrenergic agents|mesh-ancestor
93344918|NCT02649335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344919|NCT02649335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344920|NCT02649335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344921|NCT02649335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93344922|NCT02649335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93344923|NCT02649335|Vasodilator Agents|vasodilator agents|mesh-ancestor
93344924|NCT02609386|Zinc|zinc|mesh-list
93344925|NCT02609386|Indomethacin|indomethacin|mesh-list
93344926|NCT02609386|Cyclophosphamide|cyclophosphamide|mesh-list
93344927|NCT02609386|Omeprazole|omeprazole|mesh-list
93016868|NCT00878345|Pentobarbital|pentobarbital|mesh-list
93344928|NCT02609386|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93344929|NCT02609386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93344930|NCT02609386|Immunologic Factors|immunologic factors|mesh-ancestor
93344931|NCT02609386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344932|NCT02609386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93344933|NCT02609386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93344934|NCT02609386|Alkylating Agents|alkylating agents|mesh-ancestor
93344935|NCT02609386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344936|NCT02609386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344937|NCT02609386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93344938|NCT02609386|Micronutrients|micronutrients|mesh-ancestor
93344939|NCT02609386|Trace Elements|trace elements|mesh-ancestor
93344940|NCT02609386|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93344941|NCT02609386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93344942|NCT02609386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344943|NCT02609386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93344944|NCT02609386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93344945|NCT02609386|Analgesics|analgesics|mesh-ancestor
93344946|NCT02609386|Sensory System Agents|sensory system agents|mesh-ancestor
93344947|NCT02609386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93344948|NCT02609386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93344949|NCT02609386|Gout Suppressants|gout suppressants|mesh-ancestor
93344950|NCT02609386|Tocolytic Agents|tocolytic agents|mesh-ancestor
93344951|NCT02609386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93344952|NCT02609386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93344953|NCT02589496|Pembrolizumab|pembrolizumab|mesh-list
93344954|NCT02589496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93344955|NCT02589496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344956|NCT02589496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93344957|NCT02589496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344958|NCT02213575|Minocycline|minocycline|mesh-list
93344959|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93344960|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344961|NCT02148796|Broncho-Vaxom|broncho-vaxom|mesh-list
93344962|NCT02148796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93344963|NCT02148796|Immunologic Factors|immunologic factors|mesh-ancestor
93344964|NCT02148796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344965|NCT02133872|Minocycline|minocycline|mesh-list
93344966|NCT02133872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93344967|NCT02133872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93344968|NCT01958593|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93344969|NCT01958593|Hallucinogens|hallucinogens|mesh-ancestor
93344970|NCT01958593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93344971|NCT01958593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93344972|NCT01958593|Serotonin Agents|serotonin agents|mesh-ancestor
93344973|NCT01958593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93344974|NCT01958593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344975|NCT01958593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93344976|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93344977|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93344978|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
93344979|NCT01820858|Paclitaxel|paclitaxel|mesh-list
93344980|NCT01820858|Carboplatin|carboplatin|mesh-list
93344981|NCT01820858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344982|NCT01820858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344983|NCT01820858|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344984|NCT01820858|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344985|NCT01820858|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344986|NCT01820858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344987|NCT01802632|Osimertinib|osimertinib|mesh-list
93344988|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344989|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93344990|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93344991|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93344992|NCT01755897|Paclitaxel|paclitaxel|mesh-list
93344993|NCT01755897|Cisplatin|cisplatin|mesh-list
93344994|NCT01755897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93344995|NCT01755897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93344996|NCT01755897|Tubulin Modulators|tubulin modulators|mesh-ancestor
93344997|NCT01755897|Antimitotic Agents|antimitotic agents|mesh-ancestor
93344998|NCT01755897|Mitosis Modulators|mitosis modulators|mesh-ancestor
93344999|NCT01755897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345000|NCT01738607|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93345001|NCT01738607|Psyllium|psyllium|mesh-list
93345002|NCT01738607|Laxatives|laxatives|mesh-ancestor
93345003|NCT01738607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345004|NCT01738607|Cathartics|cathartics|mesh-ancestor
93345005|NCT01728259|Dexamethasone|dexamethasone|mesh-list
93345006|NCT01728259|Bortezomib|bortezomib|mesh-list
93345007|NCT01728259|Pomalidomide|pomalidomide|mesh-list
93345008|NCT01728259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345009|NCT01728259|Antiemetics|antiemetics|mesh-ancestor
93345010|NCT01728259|Autonomic Agents|autonomic agents|mesh-ancestor
93345011|NCT01728259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345012|NCT01728259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345013|NCT01728259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345014|NCT01728259|Glucocorticoids|glucocorticoids|mesh-ancestor
93345015|NCT01728259|Hormones|hormones|mesh-ancestor
93345016|NCT01728259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345017|NCT01728259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345018|NCT01728259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345019|NCT01728259|Immunologic Factors|immunologic factors|mesh-ancestor
93345020|NCT01728259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93345021|NCT01728259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93345022|NCT01728259|Growth Substances|growth substances|mesh-ancestor
93345023|NCT01728259|Growth Inhibitors|growth inhibitors|mesh-ancestor
93345024|NCT01722604|Brinzolamide|brinzolamide|mesh-list
93345025|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93345026|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345027|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345028|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93345029|NCT01689740|Hallucinogens|hallucinogens|mesh-ancestor
93345030|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345031|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345032|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
93345033|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345034|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345035|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93345036|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93345037|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93345038|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345039|NCT01567800|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93345040|NCT01567800|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93345041|NCT01567800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345042|NCT01305499|Azacitidine|azacitidine|mesh-list
93345043|NCT01305499|Entinostat|entinostat|mesh-list
93345044|NCT01305499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345045|NCT01305499|Antimetabolites|antimetabolites|mesh-ancestor
93345046|NCT01305499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345047|NCT01305499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345048|NCT01305499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345049|NCT01305499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93345050|NCT01202994|Flutemetamol|flutemetamol|mesh-list
93345051|NCT01202994|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93345052|NCT01202994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345053|NCT00930943|Oxymorphone|oxymorphone|mesh-list
93345054|NCT00930943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93345055|NCT00930943|Narcotics|narcotics|mesh-ancestor
93345056|NCT00930943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345057|NCT00930943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345058|NCT00930943|Analgesics|analgesics|mesh-ancestor
93345059|NCT00930943|Sensory System Agents|sensory system agents|mesh-ancestor
93345060|NCT00930943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345061|NCT00930943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345062|NCT00670670|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
93345063|NCT00670670|Caseins|caseins|mesh-list
93345064|NCT00670670|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92638809|NCT00473083|Hormones|hormones|mesh-ancestor
93345065|NCT00670670|Serotonin Agents|serotonin agents|mesh-ancestor
93345066|NCT00670670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345067|NCT00670670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345068|NCT00670670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345069|NCT00670670|Chelating Agents|chelating agents|mesh-ancestor
93345070|NCT00670670|Sequestering Agents|sequestering agents|mesh-ancestor
93345071|NCT00670618|Fluorides|fluorides|mesh-list
93345072|NCT00670618|Cariostatic Agents|cariostatic agents|mesh-ancestor
93345073|NCT00670618|Protective Agents|protective agents|mesh-ancestor
93345074|NCT00670618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345075|NCT00620425|Sumatriptan|sumatriptan|mesh-list
93345076|NCT00620425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93345077|NCT00620425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93345078|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93345079|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
93345080|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017014|NCT00531284|Autonomic Agents|autonomic agents|mesh-ancestor
93345081|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345082|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345083|NCT00515281|Nitric Oxide|nitric oxide|mesh-list
93345084|NCT00515281|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93345085|NCT00515281|Autonomic Agents|autonomic agents|mesh-ancestor
93345086|NCT00515281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345087|NCT00515281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345088|NCT00515281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93345089|NCT00515281|Respiratory System Agents|respiratory system agents|mesh-ancestor
93345090|NCT00515281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93345091|NCT00515281|Antioxidants|antioxidants|mesh-ancestor
93345092|NCT00515281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345093|NCT00515281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345094|NCT00515281|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93345095|NCT00515281|Vasodilator Agents|vasodilator agents|mesh-ancestor
93345096|NCT00515281|Gasotransmitters|gasotransmitters|mesh-ancestor
93345097|NCT00515281|Protective Agents|protective agents|mesh-ancestor
93345098|NCT00504582|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93345099|NCT00504582|Hemostatics|hemostatics|mesh-ancestor
93345100|NCT00504582|Coagulants|coagulants|mesh-ancestor
93345101|NCT00436254|Molgramostim|molgramostim|mesh-list
93345102|NCT00436254|Sargramostim|sargramostim|mesh-list
93345103|NCT00436254|Immunologic Factors|immunologic factors|mesh-ancestor
93345104|NCT00436254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345105|NCT00436254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345106|NCT00353938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93345107|NCT00353938|Hallucinogens|hallucinogens|mesh-ancestor
93345108|NCT00353938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345109|NCT00353938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345110|NCT00353938|Serotonin Agents|serotonin agents|mesh-ancestor
93345111|NCT00353938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345112|NCT00353938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345113|NCT00353938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93345114|NCT00353938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93345115|NCT00353938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93345116|NCT00353938|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345117|NCT00335114|Cyclosporine|cyclosporine|mesh-list
93345118|NCT00335114|Cyclosporins|cyclosporins|mesh-list
93345119|NCT00335114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345120|NCT00335114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345121|NCT00335114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345122|NCT00335114|Immunologic Factors|immunologic factors|mesh-ancestor
93345123|NCT00335114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345124|NCT00335114|Antifungal Agents|antifungal agents|mesh-ancestor
93345125|NCT00335114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345126|NCT00335114|Dermatologic Agents|dermatologic agents|mesh-ancestor
93345127|NCT00335114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93345128|NCT00335114|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93345129|NCT03606577|Dexamethasone|dexamethasone|mesh-list
93345130|NCT03606577|Lenalidomide|lenalidomide|mesh-list
93345131|NCT03606577|Daratumumab|daratumumab|mesh-list
93345132|NCT03606577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345133|NCT03606577|Antiemetics|antiemetics|mesh-ancestor
93345134|NCT03606577|Autonomic Agents|autonomic agents|mesh-ancestor
93345135|NCT03606577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345136|NCT03606577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345137|NCT03606577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345138|NCT03606577|Glucocorticoids|glucocorticoids|mesh-ancestor
93345139|NCT03606577|Hormones|hormones|mesh-ancestor
93345140|NCT03606577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345141|NCT03606577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345142|NCT03606577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345143|NCT03606577|Immunologic Factors|immunologic factors|mesh-ancestor
93345144|NCT03606577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93345145|NCT03606577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93345146|NCT03606577|Growth Substances|growth substances|mesh-ancestor
93345147|NCT03606577|Growth Inhibitors|growth inhibitors|mesh-ancestor
93345148|NCT03601975|Gemcitabine|gemcitabine|mesh-list
93345149|NCT03601975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345150|NCT03601975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345151|NCT03601975|Antimetabolites|antimetabolites|mesh-ancestor
93345152|NCT03601975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345153|NCT03602911|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93345154|NCT03602911|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93345155|NCT03602911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345156|NCT03137186|Metformin|metformin|mesh-list
93345157|NCT03137186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93345158|NCT03137186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345159|NCT03601897|Paclitaxel|paclitaxel|mesh-list
93345160|NCT03601897|Rebastinib|rebastinib|mesh-list
93345161|NCT03601897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93345162|NCT03601897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345163|NCT03601897|Tubulin Modulators|tubulin modulators|mesh-ancestor
93345164|NCT03601897|Antimitotic Agents|antimitotic agents|mesh-ancestor
93345165|NCT03601897|Mitosis Modulators|mitosis modulators|mesh-ancestor
93345166|NCT03601897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345167|NCT03601897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93345168|NCT03601897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345169|NCT03137030|Acetaminophen|acetaminophen|mesh-list
93345170|NCT03137030|Hydrocodone|hydrocodone|mesh-list
93345171|NCT03137030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345172|NCT03137030|Analgesics|analgesics|mesh-ancestor
93345173|NCT03137030|Sensory System Agents|sensory system agents|mesh-ancestor
93345174|NCT03137030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345175|NCT03137030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345176|NCT03137030|Antipyretics|antipyretics|mesh-ancestor
93345177|NCT03137030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93345178|NCT03137030|Narcotics|narcotics|mesh-ancestor
93345179|NCT03137030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345180|NCT03137030|Antitussive Agents|antitussive agents|mesh-ancestor
93345181|NCT03137030|Respiratory System Agents|respiratory system agents|mesh-ancestor
93345182|NCT03596749|Sevelamer|sevelamer|mesh-list
93345183|NCT03596749|Chelating Agents|chelating agents|mesh-ancestor
93345184|NCT03596749|Sequestering Agents|sequestering agents|mesh-ancestor
93345185|NCT03596749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345186|NCT01595061|Cisplatin|cisplatin|mesh-list
93345187|NCT01595061|Gemcitabine|gemcitabine|mesh-list
93345188|NCT01595061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345189|NCT01595061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345190|NCT01595061|Antimetabolites|antimetabolites|mesh-ancestor
93345191|NCT01595061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345192|NCT03367143|Carboplatin|carboplatin|mesh-list
93345193|NCT03367143|Etoposide|etoposide|mesh-list
93345194|NCT03367143|Lenalidomide|lenalidomide|mesh-list
93345195|NCT03367143|Ifosfamide|ifosfamide|mesh-list
93345196|NCT03367143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345197|NCT03367143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93345198|NCT03367143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93345199|NCT03367143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93345200|NCT03367143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345201|NCT03367143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345202|NCT03367143|Immunologic Factors|immunologic factors|mesh-ancestor
93345203|NCT03367143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345204|NCT03367143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93345205|NCT03367143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93345206|NCT03367143|Growth Substances|growth substances|mesh-ancestor
93345207|NCT03367143|Growth Inhibitors|growth inhibitors|mesh-ancestor
93345208|NCT03367143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93345209|NCT03367143|Alkylating Agents|alkylating agents|mesh-ancestor
93345210|NCT03372681|Antidiarrheals|antidiarrheals|mesh-list
93345211|NCT03372681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345212|NCT04762316|Pyridoxal|pyridoxal|mesh-list
93345213|NCT04762316|Pyridoxine|pyridoxine|mesh-list
93345214|NCT04762316|Vitamin B 6|vitamin b 6|mesh-list
93345215|NCT04762316|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
93345216|NCT04762316|Vitamin B Complex|vitamin b complex|mesh-ancestor
93345217|NCT04762316|Vitamins|vitamins|mesh-ancestor
93345218|NCT04762316|Micronutrients|micronutrients|mesh-ancestor
93345219|NCT04762316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345220|NCT03372447|Thiamine|thiamine|mesh-list
93345221|NCT03372447|Pyridoxine|pyridoxine|mesh-list
93345222|NCT03372447|Hydroxocobalamin|hydroxocobalamin|mesh-list
93345223|NCT03372447|Vitamin B 12|vitamin b 12|mesh-list
93345224|NCT03372447|Vitamin B Complex|vitamin b complex|mesh-ancestor
93345225|NCT03372447|Vitamins|vitamins|mesh-ancestor
93345226|NCT03372447|Micronutrients|micronutrients|mesh-ancestor
93345227|NCT03372447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345228|NCT03372447|Hematinics|hematinics|mesh-ancestor
93345229|NCT04651166|Tranexamic Acid|tranexamic acid|mesh-list
93345230|NCT04651166|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93345231|NCT04651166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93345232|NCT04651166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345233|NCT04651166|Hemostatics|hemostatics|mesh-ancestor
93345234|NCT04651166|Coagulants|coagulants|mesh-ancestor
93345235|NCT03376191|Apatinib|apatinib|mesh-list
93345236|NCT03376191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345237|NCT03376191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93345238|NCT03376191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345239|NCT03376191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345240|NCT03366597|Sevoflurane|sevoflurane|mesh-list
93345241|NCT03366597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93345242|NCT03366597|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93345243|NCT03366597|Anesthetics, General|anesthetics, general|mesh-ancestor
93345244|NCT03366597|Anesthetics|anesthetics|mesh-ancestor
93345245|NCT03366597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345246|NCT03366597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345247|NCT03110120|Levobupivacaine|levobupivacaine|mesh-list
93345248|NCT03110120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93345249|NCT03110120|Anesthetics, Local|anesthetics, local|mesh-ancestor
93345250|NCT03110120|Anesthetics|anesthetics|mesh-ancestor
93345251|NCT03110120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345252|NCT03110120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345253|NCT03110120|Sensory System Agents|sensory system agents|mesh-ancestor
93345254|NCT03110120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345255|NCT03109886|Maleic acid|maleic acid|mesh-list
93345256|NCT03109886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345257|NCT03109886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345258|NCT03110198|Hydrocortisone|hydrocortisone|mesh-list
93345259|NCT03110198|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93345260|NCT03110198|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93345261|NCT03110198|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93345262|NCT03110198|Mesalamine|mesalamine|mesh-list
93345263|NCT03110198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345264|NCT03110198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93345265|NCT03110198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345266|NCT03110198|Analgesics|analgesics|mesh-ancestor
93345267|NCT03110198|Sensory System Agents|sensory system agents|mesh-ancestor
93345268|NCT03110198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345269|NCT03110198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345270|NCT03110198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93345271|NCT04460781|Vaccines|vaccines|mesh-list
93345272|NCT04460781|Immunologic Factors|immunologic factors|mesh-ancestor
93345273|NCT04460781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345274|NCT03371589|Dexamethasone|dexamethasone|mesh-list
93345275|NCT03371589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345276|NCT03371589|Antiemetics|antiemetics|mesh-ancestor
93345277|NCT03371589|Autonomic Agents|autonomic agents|mesh-ancestor
93345278|NCT03371589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345279|NCT03371589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345280|NCT03371589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345281|NCT03371589|Glucocorticoids|glucocorticoids|mesh-ancestor
93345282|NCT03371589|Hormones|hormones|mesh-ancestor
93345283|NCT03371589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345284|NCT03371589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345285|NCT03371589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345286|NCT03365817|Fentanyl|fentanyl|mesh-list
93345287|NCT03365817|Morphine|morphine|mesh-list
93345288|NCT03365817|Oxycodone|oxycodone|mesh-list
93345289|NCT03365817|Analgesics, Opioid|analgesics, opioid|mesh-list
93345290|NCT03365817|Tramadol|tramadol|mesh-list
93345291|NCT03365817|Methadone|methadone|mesh-list
93345292|NCT03365817|Narcotics|narcotics|mesh-ancestor
93345293|NCT03365817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345294|NCT03365817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345295|NCT03365817|Analgesics|analgesics|mesh-ancestor
93345296|NCT03365817|Sensory System Agents|sensory system agents|mesh-ancestor
93345297|NCT03365817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345298|NCT03365817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345299|NCT03365817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345300|NCT03365817|Anesthetics, General|anesthetics, general|mesh-ancestor
93345301|NCT03365817|Anesthetics|anesthetics|mesh-ancestor
93345302|NCT03365817|Antitussive Agents|antitussive agents|mesh-ancestor
93345303|NCT03365817|Respiratory System Agents|respiratory system agents|mesh-ancestor
93345304|NCT02852005|Vaccines|vaccines|mesh-list
93345305|NCT02852005|Immunologic Factors|immunologic factors|mesh-ancestor
93345306|NCT02852005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345307|NCT03601741|Anti-Infective Agents|anti-infective agents|mesh-list
93345308|NCT03601741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93345309|NCT03365115|Fentanyl|fentanyl|mesh-list
93345310|NCT03365115|Morphine|morphine|mesh-list
93345311|NCT03365115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93345312|NCT03365115|Narcotics|narcotics|mesh-ancestor
93345313|NCT03365115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345314|NCT03365115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345315|NCT03365115|Analgesics|analgesics|mesh-ancestor
93345316|NCT03365115|Sensory System Agents|sensory system agents|mesh-ancestor
93345317|NCT03365115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345318|NCT03365115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345319|NCT03365115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345320|NCT03365115|Anesthetics, General|anesthetics, general|mesh-ancestor
93345321|NCT03365115|Anesthetics|anesthetics|mesh-ancestor
93345322|NCT02237755|Citric Acid|citric acid|mesh-list
93345323|NCT02237755|Sodium Citrate|sodium citrate|mesh-list
93345324|NCT02237755|Clomiphene|clomiphene|mesh-list
93345325|NCT02237755|Enclomiphene|enclomiphene|mesh-list
93345326|NCT02237755|Zuclomiphene|zuclomiphene|mesh-list
93345327|NCT02237755|Anticoagulants|anticoagulants|mesh-ancestor
93345328|NCT02237755|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93345329|NCT02237755|Chelating Agents|chelating agents|mesh-ancestor
93345330|NCT02237755|Sequestering Agents|sequestering agents|mesh-ancestor
93345331|NCT02237755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345332|NCT02237755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93345333|NCT02237755|Hormone Antagonists|hormone antagonists|mesh-ancestor
93345334|NCT02237755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345335|NCT02237755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345336|NCT02237755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93345337|NCT02237755|Fertility Agents|fertility agents|mesh-ancestor
93345338|NCT02237755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93345339|NCT02237755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93345340|NCT02237755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93345341|NCT04524897|Triamcinolone|triamcinolone|mesh-list
93345342|NCT04524897|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93345343|NCT04524897|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93345344|NCT04524897|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93345345|NCT04524897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345346|NCT04524897|Glucocorticoids|glucocorticoids|mesh-ancestor
93345347|NCT04524897|Hormones|hormones|mesh-ancestor
93345348|NCT04524897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345349|NCT04524897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345350|NCT04524897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345351|NCT04524897|Immunologic Factors|immunologic factors|mesh-ancestor
93345352|NCT04524897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345353|NCT04524897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345354|NCT03364569|Tranexamic Acid|tranexamic acid|mesh-list
93345355|NCT03364569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93345356|NCT03364569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93345357|NCT03364569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345358|NCT03364569|Hemostatics|hemostatics|mesh-ancestor
93345359|NCT03364569|Coagulants|coagulants|mesh-ancestor
93345360|NCT03363477|Enoxaparin|enoxaparin|mesh-list
93345361|NCT03363477|Enoxaparin sodium|enoxaparin sodium|mesh-list
92639102|NCT00409760|Amlodipine|amlodipine|mesh-list
93345362|NCT03363477|Anticoagulants|anticoagulants|mesh-ancestor
93345363|NCT03363477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93345364|NCT03363477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93345365|NCT03363477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345366|NCT02879318|Paclitaxel|paclitaxel|mesh-list
93345367|NCT02879318|Gemcitabine|gemcitabine|mesh-list
93345368|NCT02879318|Durvalumab|durvalumab|mesh-list
93345369|NCT02879318|Tremelimumab|tremelimumab|mesh-list
93345370|NCT02879318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93345371|NCT02879318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345372|NCT02879318|Tubulin Modulators|tubulin modulators|mesh-ancestor
93345373|NCT02879318|Antimitotic Agents|antimitotic agents|mesh-ancestor
93345374|NCT02879318|Mitosis Modulators|mitosis modulators|mesh-ancestor
93345375|NCT02879318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345376|NCT02879318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345377|NCT02879318|Antimetabolites|antimetabolites|mesh-ancestor
93345378|NCT02879318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93345379|NCT03593707|Metformin|metformin|mesh-list
93345380|NCT03593707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93345381|NCT03593707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345382|NCT03592537|Fentanyl|fentanyl|mesh-list
93345383|NCT03592537|Midazolam|midazolam|mesh-list
93345384|NCT03592537|Bupivacaine|bupivacaine|mesh-list
93345385|NCT03592537|Anesthetics, Local|anesthetics, local|mesh-ancestor
93345386|NCT03592537|Anesthetics|anesthetics|mesh-ancestor
93345387|NCT03592537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345388|NCT03592537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345389|NCT03592537|Sensory System Agents|sensory system agents|mesh-ancestor
93345390|NCT03592537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345391|NCT03592537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93345392|NCT03592537|Narcotics|narcotics|mesh-ancestor
93345393|NCT03592537|Analgesics|analgesics|mesh-ancestor
93345394|NCT03592537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345395|NCT03592537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345396|NCT03592537|Anesthetics, General|anesthetics, general|mesh-ancestor
93345397|NCT03592537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93345398|NCT03592537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93345399|NCT03592537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93345400|NCT03592537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345401|NCT03592537|GABA Modulators|gaba modulators|mesh-ancestor
93345402|NCT03592537|GABA Agents|gaba agents|mesh-ancestor
93345403|NCT03592537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345404|NCT03592537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345405|NCT03362853|Moxifloxacin|moxifloxacin|mesh-list
93345406|NCT03362853|Nemonoxacin|nemonoxacin|mesh-list
93345407|NCT03362853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93345408|NCT03362853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345409|NCT03362853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93345410|NCT03362853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93345411|NCT03362853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345412|NCT03362853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345413|NCT03362853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345414|NCT02849743|Oxytocin|oxytocin|mesh-list
93345415|NCT02849743|Oxytocics|oxytocics|mesh-ancestor
93345416|NCT02849743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93345417|NCT02849743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345418|NCT05063006|Methamphetamine|methamphetamine|mesh-list
93345419|NCT05063006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93345420|NCT05063006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345421|NCT05063006|Sympathomimetics|sympathomimetics|mesh-ancestor
93345422|NCT05063006|Autonomic Agents|autonomic agents|mesh-ancestor
93345423|NCT05063006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345424|NCT05063006|Dopamine Agents|dopamine agents|mesh-ancestor
93345425|NCT05063006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345426|NCT05063006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345427|NCT05063006|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345428|NCT05063006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93345429|NCT05063006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93345430|NCT05063006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93345431|NCT05063006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93345432|NCT03587077|Isosorbide|isosorbide|mesh-list
93345433|NCT03587077|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93345434|NCT03587077|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93345435|NCT03587077|Misoprostol|misoprostol|mesh-list
93345436|NCT03587077|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93345437|NCT03587077|Abortifacient Agents|abortifacient agents|mesh-ancestor
93345438|NCT03587077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93345439|NCT03587077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345440|NCT03587077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93345441|NCT03587077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345442|NCT03587077|Oxytocics|oxytocics|mesh-ancestor
93345443|NCT03587077|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93345444|NCT03587077|Diuretics|diuretics|mesh-ancestor
93345445|NCT03587077|Natriuretic Agents|natriuretic agents|mesh-ancestor
93345446|NCT03587077|Vasodilator Agents|vasodilator agents|mesh-ancestor
93345447|NCT03587077|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93345448|NCT03587077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345449|NCT02238457|Losartan|losartan|mesh-list
93345450|NCT02238457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93345451|NCT02238457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93345452|NCT02238457|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93345453|NCT02238457|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93345454|NCT02238457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345455|NCT02238535|Iloprost|iloprost|mesh-list
93345456|NCT02238535|Warfarin|warfarin|mesh-list
93345457|NCT02238535|Anticoagulants|anticoagulants|mesh-ancestor
93345458|NCT02238535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93345459|NCT02238535|Vasodilator Agents|vasodilator agents|mesh-ancestor
93345460|NCT03362697|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93345461|NCT03362697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345462|NCT03909074|Vaccines|vaccines|mesh-list
93345463|NCT03909074|Immunologic Factors|immunologic factors|mesh-ancestor
93345464|NCT03909074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345465|NCT03138668|Ropivacaine|ropivacaine|mesh-list
93345466|NCT03138668|Anesthetics, Local|anesthetics, local|mesh-ancestor
93345467|NCT03138668|Anesthetics|anesthetics|mesh-ancestor
93345468|NCT03138668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345469|NCT03138668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345470|NCT03138668|Sensory System Agents|sensory system agents|mesh-ancestor
93345471|NCT03138668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345472|NCT03371043|Analgesics|analgesics|mesh-list
93345473|NCT03371043|Sensory System Agents|sensory system agents|mesh-ancestor
93345474|NCT03371043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345475|NCT03371043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345476|NCT03600961|Sirolimus|sirolimus|mesh-list
93345477|NCT03600961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93345478|NCT03600961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345479|NCT03600961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93345480|NCT03600961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345481|NCT03600961|Antifungal Agents|antifungal agents|mesh-ancestor
93345482|NCT03600961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345483|NCT03600961|Immunologic Factors|immunologic factors|mesh-ancestor
93345484|NCT03600961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345485|NCT05013242|Goserelin|goserelin|mesh-list
93345486|NCT05013242|Dienogest|dienogest|mesh-list
93345487|NCT05013242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345488|NCT05013242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345489|NCT05013242|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93345490|NCT05013242|Contraceptive Agents|contraceptive agents|mesh-ancestor
93345491|NCT05013242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93345492|NCT05013242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345493|NCT05013242|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93345494|NCT05013242|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93345495|NCT05013242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93345496|NCT05013242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93345497|NCT05013242|Hormone Antagonists|hormone antagonists|mesh-ancestor
93345498|NCT05013242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345499|NCT05089604|Tacrolimus|tacrolimus|mesh-list
93345500|NCT05089604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345501|NCT05089604|Immunologic Factors|immunologic factors|mesh-ancestor
93345502|NCT05089604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345503|NCT05089604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93345504|NCT05089604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345505|NCT05089604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345506|NCT03590275|Folfirinox|folfirinox|mesh-list
93345507|NCT03590275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345508|NCT05089448|Amlodipine|amlodipine|mesh-list
93345509|NCT05089448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93345510|NCT05089448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93345511|NCT05089448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93345512|NCT05089448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345513|NCT05089448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93345514|NCT05089448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345515|NCT05089448|Vasodilator Agents|vasodilator agents|mesh-ancestor
93345516|NCT00601003|Nifurtimox|nifurtimox|mesh-list
93345517|NCT00601003|Cyclophosphamide|cyclophosphamide|mesh-list
93345518|NCT00601003|Topotecan|topotecan|mesh-list
93345519|NCT00601003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345520|NCT00601003|Immunologic Factors|immunologic factors|mesh-ancestor
93345521|NCT00601003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345522|NCT00601003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93345523|NCT00601003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93345524|NCT00601003|Alkylating Agents|alkylating agents|mesh-ancestor
93345525|NCT00601003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345526|NCT00601003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345527|NCT00601003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93345528|NCT00601003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93345529|NCT00601003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93345530|NCT00601003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345531|NCT00601003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93345532|NCT00601003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93345533|NCT00601003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93345534|NCT00601003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345535|NCT02849509|Vitamin K|vitamin k|mesh-list
93345536|NCT02849509|Dabigatran|dabigatran|mesh-list
93345537|NCT02849509|Vitamins|vitamins|mesh-ancestor
93345538|NCT02849509|Micronutrients|micronutrients|mesh-ancestor
93345539|NCT02849509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345540|NCT02849509|Antithrombins|antithrombins|mesh-ancestor
93345541|NCT02849509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93345542|NCT02849509|Protease Inhibitors|protease inhibitors|mesh-ancestor
93345543|NCT02849509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345544|NCT02849509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345545|NCT02849509|Anticoagulants|anticoagulants|mesh-ancestor
93345546|NCT02849509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93345547|NCT02849509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93345548|NCT02849509|Hemostatics|hemostatics|mesh-ancestor
93345549|NCT02849509|Coagulants|coagulants|mesh-ancestor
93345551|NCT00151424|Asenapine|asenapine|mesh-list
93345552|NCT00151424|Antiemetics|antiemetics|mesh-ancestor
93345553|NCT00151424|Autonomic Agents|autonomic agents|mesh-ancestor
93345554|NCT00151424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345555|NCT00151424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345556|NCT00151424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345557|NCT00151424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93345558|NCT00151424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93345559|NCT00151424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345560|NCT00151424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345561|NCT00151424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93345562|NCT00151424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93345563|NCT00151424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93345564|NCT00151424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345565|NCT00151424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345566|NCT00151424|Serotonin Agents|serotonin agents|mesh-ancestor
93345567|NCT03600727|Dexmedetomidine|dexmedetomidine|mesh-list
93345568|NCT03600727|Propofol|propofol|mesh-list
93345569|NCT03600727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93345570|NCT03600727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345571|NCT03600727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345572|NCT03600727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345573|NCT03600727|Analgesics|analgesics|mesh-ancestor
93345574|NCT03600727|Sensory System Agents|sensory system agents|mesh-ancestor
93345575|NCT03600727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345576|NCT03600727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93345577|NCT03600727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93345578|NCT03600727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93345579|NCT03600727|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345580|NCT03600727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345581|NCT03600727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345582|NCT03600727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345583|NCT03600727|Anesthetics, General|anesthetics, general|mesh-ancestor
93345584|NCT03600727|Anesthetics|anesthetics|mesh-ancestor
93345585|NCT02733133|Testosterone|testosterone|mesh-list
93345586|NCT02733133|Androgens|androgens|mesh-ancestor
93345587|NCT02733133|Hormones|hormones|mesh-ancestor
93345588|NCT02733133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345589|NCT02733133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345590|NCT03584893|Dehydrocholesterols|dehydrocholesterols|mesh-list
93345591|NCT03584893|Provitamins|provitamins|mesh-ancestor
93345592|NCT03584893|Vitamins|vitamins|mesh-ancestor
93345593|NCT03584893|Micronutrients|micronutrients|mesh-ancestor
93345594|NCT03584893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345595|NCT03362073|Ketamine|ketamine|mesh-list
93345596|NCT03362073|Analgesics|analgesics|mesh-ancestor
93345597|NCT03362073|Sensory System Agents|sensory system agents|mesh-ancestor
93345598|NCT03362073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345599|NCT03362073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345600|NCT03362073|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93345601|NCT03362073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345602|NCT03362073|Anesthetics, General|anesthetics, general|mesh-ancestor
93345603|NCT03362073|Anesthetics|anesthetics|mesh-ancestor
93345604|NCT03362073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345605|NCT03362073|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93345606|NCT03362073|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93345607|NCT03362073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345608|NCT03362073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345609|NCT03582865|Tamoxifen|tamoxifen|mesh-list
93345610|NCT03582865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93345611|NCT03582865|Hormone Antagonists|hormone antagonists|mesh-ancestor
93345612|NCT03582865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345613|NCT03582865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345614|NCT03582865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345615|NCT03582865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345616|NCT03582865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93345617|NCT03582865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93345618|NCT03582865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93345620|NCT03136406|Paclitaxel|paclitaxel|mesh-list
93345621|NCT03136406|Cyclophosphamide|cyclophosphamide|mesh-list
93345622|NCT03136406|Bevacizumab|bevacizumab|mesh-list
93345623|NCT03136406|Fluorouracil|fluorouracil|mesh-list
93345624|NCT03136406|Capecitabine|capecitabine|mesh-list
93345625|NCT03136406|Oxaliplatin|oxaliplatin|mesh-list
93345626|NCT03136406|Avelumab|avelumab|mesh-list
93345627|NCT03136406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93345628|NCT03136406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345629|NCT03136406|Tubulin Modulators|tubulin modulators|mesh-ancestor
93345630|NCT03136406|Antimitotic Agents|antimitotic agents|mesh-ancestor
93345631|NCT03136406|Mitosis Modulators|mitosis modulators|mesh-ancestor
93345632|NCT03136406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345633|NCT03136406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345634|NCT03136406|Immunologic Factors|immunologic factors|mesh-ancestor
93345635|NCT03136406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345636|NCT03136406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93345637|NCT03136406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93345638|NCT03136406|Alkylating Agents|alkylating agents|mesh-ancestor
93345639|NCT03136406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93345640|NCT03136406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93345641|NCT03136406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93345642|NCT03136406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93345643|NCT03136406|Growth Substances|growth substances|mesh-ancestor
93345644|NCT03136406|Growth Inhibitors|growth inhibitors|mesh-ancestor
93345645|NCT03136406|Antimetabolites|antimetabolites|mesh-ancestor
93345646|NCT03136406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345647|NCT03136406|Antidotes|antidotes|mesh-ancestor
93345648|NCT03136406|Protective Agents|protective agents|mesh-ancestor
93345649|NCT03136406|Vitamin B Complex|vitamin b complex|mesh-ancestor
93345650|NCT03136406|Vitamins|vitamins|mesh-ancestor
93345651|NCT03136406|Micronutrients|micronutrients|mesh-ancestor
93345652|NCT03590197|Melatonin|melatonin|mesh-list
93345653|NCT03590197|Antioxidants|antioxidants|mesh-ancestor
93345654|NCT03590197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345655|NCT03590197|Protective Agents|protective agents|mesh-ancestor
93345656|NCT03590197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345657|NCT03590197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345658|NCT03357315|Immunomodulating Agents|immunomodulating agents|mesh-list
93345659|NCT03357315|Immunologic Factors|immunologic factors|mesh-ancestor
93345660|NCT03357315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345661|NCT05057468|Cyclosporine|cyclosporine|mesh-list
93345662|NCT05057468|Rituximab|rituximab|mesh-list
93345663|NCT05057468|Cyclosporins|cyclosporins|mesh-list
93345664|NCT05057468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93345665|NCT05057468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345666|NCT05057468|Immunologic Factors|immunologic factors|mesh-ancestor
93345667|NCT05057468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345668|NCT05057468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93345669|NCT05057468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345670|NCT05057468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345671|NCT05057468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345672|NCT05057468|Antifungal Agents|antifungal agents|mesh-ancestor
93345673|NCT05057468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345674|NCT05057468|Dermatologic Agents|dermatologic agents|mesh-ancestor
93345675|NCT05057468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93345676|NCT02518503|Atorvastatin|atorvastatin|mesh-list
93345677|NCT02518503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93345678|NCT02518503|Simvastatin|simvastatin|mesh-list
93345679|NCT02518503|Pravastatin|pravastatin|mesh-list
93345680|NCT02518503|Lovastatin|lovastatin|mesh-list
93345681|NCT02518503|L 647318|l 647318|mesh-list
93345682|NCT02518503|Dihydromevinolin|dihydromevinolin|mesh-list
93345683|NCT02518503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93345684|NCT02518503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93345685|NCT02518503|Antimetabolites|antimetabolites|mesh-ancestor
93345686|NCT02518503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345687|NCT02518503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93345688|NCT02518503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93345689|NCT02518503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345690|NCT03600493|Lidocaine|lidocaine|mesh-list
93345691|NCT03600493|Dexmedetomidine|dexmedetomidine|mesh-list
93345692|NCT03600493|Anesthetics, Local|anesthetics, local|mesh-ancestor
93345693|NCT03600493|Anesthetics|anesthetics|mesh-ancestor
93345694|NCT03600493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345695|NCT03600493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345696|NCT03600493|Sensory System Agents|sensory system agents|mesh-ancestor
93345697|NCT03600493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345698|NCT03600493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93345699|NCT03600493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93345700|NCT03600493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93345701|NCT03600493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93345702|NCT03600493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345703|NCT03600493|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93345704|NCT03600493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345705|NCT03600493|Analgesics|analgesics|mesh-ancestor
93345706|NCT03600493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93345707|NCT03600493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93345708|NCT03600493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93345709|NCT03600493|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345710|NCT03600493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345711|NCT03138356|Metformin|metformin|mesh-list
93345712|NCT03138356|Dapagliflozin|dapagliflozin|mesh-list
93345713|NCT03138356|Saxagliptin|saxagliptin|mesh-list
93345714|NCT03138356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93345715|NCT03138356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345716|NCT03138356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93345717|NCT03138356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345718|NCT03138356|Incretins|incretins|mesh-ancestor
93345719|NCT03138356|Hormones|hormones|mesh-ancestor
93345720|NCT03138356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345721|NCT03138356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93345722|NCT03138356|Protease Inhibitors|protease inhibitors|mesh-ancestor
93345723|NCT03138356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345724|NCT03137966|Deferoxamine|deferoxamine|mesh-list
93345725|NCT03137966|Siderophores|siderophores|mesh-ancestor
93345726|NCT03137966|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93345727|NCT03137966|Chelating Agents|chelating agents|mesh-ancestor
93345728|NCT03137966|Sequestering Agents|sequestering agents|mesh-ancestor
93345729|NCT03137966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345730|NCT02853305|Carboplatin|carboplatin|mesh-list
93345731|NCT02853305|Gemcitabine|gemcitabine|mesh-list
93345732|NCT02853305|Pembrolizumab|pembrolizumab|mesh-list
93345733|NCT02853305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345734|NCT02853305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345735|NCT02853305|Antimetabolites|antimetabolites|mesh-ancestor
93345736|NCT02853305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345737|NCT02853305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93345738|NCT02853305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93345739|NCT04521387|Hyaluronic Acid|hyaluronic acid|mesh-list
93345740|NCT04521387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93345741|NCT04521387|Immunologic Factors|immunologic factors|mesh-ancestor
93345742|NCT04521387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345743|NCT04521387|Viscosupplements|viscosupplements|mesh-ancestor
93345744|NCT04521387|Protective Agents|protective agents|mesh-ancestor
93345745|NCT03579979|Methylene Blue|methylene blue|mesh-list
93345746|NCT03579979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345747|NCT03579979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345748|NCT04509219|Methylprednisolone|methylprednisolone|mesh-list
93345749|NCT04509219|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93345750|NCT04509219|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93345751|NCT04509219|Prednisolone|prednisolone|mesh-list
93345752|NCT04509219|Prednisolone acetate|prednisolone acetate|mesh-list
93345753|NCT04509219|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93345754|NCT04509219|Prednisolone phosphate|prednisolone phosphate|mesh-list
93345755|NCT04509219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345756|NCT04509219|Antiemetics|antiemetics|mesh-ancestor
93345757|NCT04509219|Autonomic Agents|autonomic agents|mesh-ancestor
93345758|NCT04509219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345759|NCT04509219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345760|NCT04509219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345761|NCT04509219|Glucocorticoids|glucocorticoids|mesh-ancestor
93345762|NCT04509219|Hormones|hormones|mesh-ancestor
93345763|NCT04509219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345764|NCT04509219|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93345765|NCT04509219|Protective Agents|protective agents|mesh-ancestor
93345766|NCT04509219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345767|NCT04509219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345768|NCT04444635|Fentanyl|fentanyl|mesh-list
93345769|NCT04444635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93345771|NCT04444635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345772|NCT04444635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345773|NCT04444635|Analgesics|analgesics|mesh-ancestor
93345774|NCT04444635|Sensory System Agents|sensory system agents|mesh-ancestor
93345775|NCT04444635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345776|NCT04444635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345777|NCT04444635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345778|NCT04444635|Anesthetics, General|anesthetics, general|mesh-ancestor
93345779|NCT04444635|Anesthetics|anesthetics|mesh-ancestor
93345780|NCT03033446|Nivolumab|nivolumab|mesh-list
93345781|NCT03033446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93345782|NCT03033446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345783|NCT03033446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93345784|NCT03033446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345785|NCT03579823|Adalimumab|adalimumab|mesh-list
93345786|NCT03579823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93345787|NCT03579823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345788|NCT03579823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93345789|NCT04444011|Amoxicillin|amoxicillin|mesh-list
93345790|NCT04444011|Clarithromycin|clarithromycin|mesh-list
93345791|NCT04444011|Bismuth|bismuth|mesh-list
93345792|NCT04444011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93345793|NCT04444011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93345794|NCT04444011|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93345795|NCT04444011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345796|NCT04444011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345797|NCT04444011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93345798|NCT04444011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93345799|NCT04444011|Antacids|antacids|mesh-ancestor
93345800|NCT04444011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345801|NCT04443387|Vitamin D|vitamin d|mesh-list
93345802|NCT04443387|Vitamins|vitamins|mesh-ancestor
93345803|NCT04443387|Micronutrients|micronutrients|mesh-ancestor
93345804|NCT04443387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345805|NCT04443387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93345806|NCT02316236|Dexmedetomidine|dexmedetomidine|mesh-list
93345807|NCT02316236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93345808|NCT02316236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345809|NCT02316236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345810|NCT02316236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345811|NCT02316236|Analgesics|analgesics|mesh-ancestor
93345812|NCT02316236|Sensory System Agents|sensory system agents|mesh-ancestor
93345813|NCT02316236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345814|NCT02316236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93345815|NCT02316236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93345816|NCT02316236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93345817|NCT02316236|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345818|NCT02316236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345819|NCT02316236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345820|NCT04521075|Nivolumab|nivolumab|mesh-list
93345821|NCT04521075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93345822|NCT04521075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345823|NCT04521075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93345824|NCT04521075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345825|NCT03577249|Dialysis Solutions|dialysis solutions|mesh-list
93345826|NCT03577249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93345827|NCT03601091|Midazolam|midazolam|mesh-list
93345828|NCT03601091|Dexmedetomidine|dexmedetomidine|mesh-list
93345829|NCT03601091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93345830|NCT03601091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345831|NCT03601091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345832|NCT03601091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345833|NCT03601091|Analgesics|analgesics|mesh-ancestor
93345834|NCT03601091|Sensory System Agents|sensory system agents|mesh-ancestor
93345835|NCT03601091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345836|NCT03601091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93345837|NCT03601091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93345838|NCT03601091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93345839|NCT03601091|Adrenergic Agents|adrenergic agents|mesh-ancestor
93345840|NCT03601091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345841|NCT03601091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345842|NCT03601091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345843|NCT03601091|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93345845|NCT03601091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345846|NCT03601091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345847|NCT03601091|Anesthetics, General|anesthetics, general|mesh-ancestor
93345848|NCT03601091|Anesthetics|anesthetics|mesh-ancestor
93345849|NCT03601091|GABA Modulators|gaba modulators|mesh-ancestor
93345850|NCT03601091|GABA Agents|gaba agents|mesh-ancestor
93345851|NCT04508829|Antibodies|antibodies|mesh-list
93345852|NCT04508829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93345853|NCT04508829|Immunologic Factors|immunologic factors|mesh-ancestor
93345854|NCT04508829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345855|NCT04521309|Antibodies|antibodies|mesh-list
93345856|NCT04521309|Immunologic Factors|immunologic factors|mesh-ancestor
93345857|NCT04521309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345858|NCT02267252|Antibodies|antibodies|mesh-list
93345859|NCT02267252|Immunologic Factors|immunologic factors|mesh-ancestor
93345860|NCT02267252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345861|NCT04521153|Apatinib|apatinib|mesh-list
93345862|NCT04521153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345863|NCT04521153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93345864|NCT04521153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345865|NCT04521153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345866|NCT04362566|Bupivacaine|bupivacaine|mesh-list
93345867|NCT04362566|Anesthetics, Local|anesthetics, local|mesh-ancestor
93345868|NCT04362566|Anesthetics|anesthetics|mesh-ancestor
93345869|NCT04362566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345870|NCT04362566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345871|NCT04362566|Sensory System Agents|sensory system agents|mesh-ancestor
93345872|NCT04362566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345873|NCT03579589|Neostigmine|neostigmine|mesh-list
93345874|NCT03579589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93345875|NCT03579589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345876|NCT03579589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345877|NCT03579589|Cholinergic Agents|cholinergic agents|mesh-ancestor
93345878|NCT03579589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345879|NCT03579589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345880|NCT03579589|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93345881|NCT03579589|Autonomic Agents|autonomic agents|mesh-ancestor
93345882|NCT03579589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345883|NCT03600857|Misoprostol|misoprostol|mesh-list
93345884|NCT03600857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93345885|NCT03600857|Abortifacient Agents|abortifacient agents|mesh-ancestor
93345886|NCT03600857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93345887|NCT03600857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345888|NCT03600857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93345889|NCT03600857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345890|NCT03600857|Oxytocics|oxytocics|mesh-ancestor
93345891|NCT02229968|Aminocaproic Acid|aminocaproic acid|mesh-list
93345892|NCT02229968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93345893|NCT02229968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93345894|NCT02229968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345895|NCT02229968|Hemostatics|hemostatics|mesh-ancestor
93345896|NCT02229968|Coagulants|coagulants|mesh-ancestor
93345897|NCT03600623|Paclitaxel|paclitaxel|mesh-list
93345898|NCT03600623|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93345899|NCT03600623|Gemcitabine|gemcitabine|mesh-list
93345900|NCT03600623|Fluorouracil|fluorouracil|mesh-list
93345901|NCT03600623|Oxaliplatin|oxaliplatin|mesh-list
93345902|NCT03600623|Irinotecan|irinotecan|mesh-list
93345903|NCT03600623|Folfirinox|folfirinox|mesh-list
93345904|NCT03600623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93345905|NCT03600623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345906|NCT03600623|Tubulin Modulators|tubulin modulators|mesh-ancestor
93345907|NCT03600623|Antimitotic Agents|antimitotic agents|mesh-ancestor
93345908|NCT03600623|Mitosis Modulators|mitosis modulators|mesh-ancestor
93345909|NCT03600623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345910|NCT03600623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93345911|NCT03600623|Antimetabolites|antimetabolites|mesh-ancestor
93345912|NCT03600623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93345913|NCT03600623|Immunologic Factors|immunologic factors|mesh-ancestor
93345914|NCT03600623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345915|NCT03600623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93345916|NCT03600623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93345917|NCT03600623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345918|NCT02848729|Acetaminophen|acetaminophen|mesh-list
93345919|NCT02848729|Morphine|morphine|mesh-list
93345920|NCT02848729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93345921|NCT02848729|Narcotics|narcotics|mesh-ancestor
93345922|NCT02848729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345923|NCT02848729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345925|NCT02848729|Sensory System Agents|sensory system agents|mesh-ancestor
93345926|NCT02848729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345927|NCT02848729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345928|NCT02848729|Antipyretics|antipyretics|mesh-ancestor
93345929|NCT03600467|Seviteronel|seviteronel|mesh-list
93345930|NCT03600467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345931|NCT03600467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93345932|NCT03600467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93345933|NCT03600467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345934|NCT05737784|Pramoxine|pramoxine|mesh-list
93345935|NCT05737784|Anesthetics, Local|anesthetics, local|mesh-ancestor
93345936|NCT05737784|Anesthetics|anesthetics|mesh-ancestor
93345937|NCT05737784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345938|NCT05737784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345939|NCT05737784|Sensory System Agents|sensory system agents|mesh-ancestor
93345940|NCT05737784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345941|NCT04520919|Anesthetics|anesthetics|mesh-list
93345942|NCT04520919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345943|NCT04520919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345944|NCT03600311|Vitamin D|vitamin d|mesh-list
93345945|NCT03600311|Calcium|calcium|mesh-list
93345946|NCT03600311|Vitamins|vitamins|mesh-ancestor
93345947|NCT03600311|Micronutrients|micronutrients|mesh-ancestor
93345948|NCT03600311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345949|NCT03600311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93345950|NCT03600311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93345951|NCT04562324|Antipsychotic Agents|antipsychotic agents|mesh-list
93345952|NCT04562324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93345953|NCT04562324|Antidepressive Agents|antidepressive agents|mesh-list
93345954|NCT04562324|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
93345955|NCT04562324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345956|NCT04562324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93345957|NCT04562324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345958|NCT04562324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345959|NCT03603119|Dexamethasone|dexamethasone|mesh-list
93345960|NCT03603119|Midazolam|midazolam|mesh-list
93345961|NCT03603119|Ondansetron|ondansetron|mesh-list
93345962|NCT03603119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93345963|NCT03603119|Antiemetics|antiemetics|mesh-ancestor
93345964|NCT03603119|Autonomic Agents|autonomic agents|mesh-ancestor
93345965|NCT03603119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345966|NCT03603119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345967|NCT03603119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93345968|NCT03603119|Glucocorticoids|glucocorticoids|mesh-ancestor
93345969|NCT03603119|Hormones|hormones|mesh-ancestor
93345970|NCT03603119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93345971|NCT03603119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93345972|NCT03603119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93345973|NCT03603119|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93345974|NCT03603119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93345975|NCT03603119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93345976|NCT03603119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93345977|NCT03603119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93345978|NCT03603119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93345979|NCT03603119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93345980|NCT03603119|Anesthetics, General|anesthetics, general|mesh-ancestor
93345981|NCT03603119|Anesthetics|anesthetics|mesh-ancestor
93345982|NCT03603119|GABA Modulators|gaba modulators|mesh-ancestor
93345983|NCT03603119|GABA Agents|gaba agents|mesh-ancestor
93345984|NCT03603119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93345985|NCT03603119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93345986|NCT03603119|Antipruritics|antipruritics|mesh-ancestor
93345987|NCT03603119|Dermatologic Agents|dermatologic agents|mesh-ancestor
93345988|NCT03603119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93345989|NCT03603119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93345990|NCT03603119|Serotonin Agents|serotonin agents|mesh-ancestor
93345991|NCT03356769|Aspirin|aspirin|mesh-list
93345992|NCT03356769|Anticonvulsants|anticonvulsants|mesh-list
93345993|NCT03356769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93345994|NCT03356769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93345995|NCT03356769|Analgesics|analgesics|mesh-ancestor
93017980|NCT05727371|Hylan|hylan|mesh-list
93345996|NCT03356769|Sensory System Agents|sensory system agents|mesh-ancestor
93345997|NCT03356769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93345998|NCT03356769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93345999|NCT03356769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346000|NCT03356769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346001|NCT03356769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93346002|NCT03356769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93346003|NCT03356769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346004|NCT03356769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93346005|NCT03356769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93346006|NCT03356769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346007|NCT03356769|Antipyretics|antipyretics|mesh-ancestor
93346008|NCT04508439|Heparin|heparin|mesh-list
93346009|NCT04508439|Enoxaparin|enoxaparin|mesh-list
93346010|NCT04508439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93346011|NCT04508439|Tinzaparin|tinzaparin|mesh-list
93346012|NCT04508439|Dalteparin|dalteparin|mesh-list
93346013|NCT04508439|Anticoagulants|anticoagulants|mesh-ancestor
93346014|NCT04508439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93346015|NCT04508439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93346016|NCT04508439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346017|NCT02237651|Anesthetics|anesthetics|mesh-list
93346018|NCT02237651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346019|NCT02237651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346020|NCT02237729|Adalimumab|adalimumab|mesh-list
93346021|NCT02237729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93346022|NCT02237729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346023|NCT02237729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346024|NCT02238119|Formoterol Fumarate|formoterol fumarate|mesh-list
93346025|NCT02238119|Tiotropium Bromide|tiotropium bromide|mesh-list
93346026|NCT02238119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93346027|NCT02238119|Autonomic Agents|autonomic agents|mesh-ancestor
93346028|NCT02238119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346029|NCT02238119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346030|NCT02238119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93346031|NCT02238119|Respiratory System Agents|respiratory system agents|mesh-ancestor
93346032|NCT02238119|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93346033|NCT02238119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93346034|NCT02238119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93346035|NCT02238119|Adrenergic Agents|adrenergic agents|mesh-ancestor
93346036|NCT02238119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346037|NCT02238119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346038|NCT02238119|Parasympatholytics|parasympatholytics|mesh-ancestor
93346039|NCT02238119|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93346040|NCT02238119|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346041|NCT03354117|Meloxicam|meloxicam|mesh-list
93346042|NCT03354117|Ulipristal acetate|ulipristal acetate|mesh-list
93346043|NCT03354117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93346044|NCT03354117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93346045|NCT03354117|Analgesics|analgesics|mesh-ancestor
93346046|NCT03354117|Sensory System Agents|sensory system agents|mesh-ancestor
93346047|NCT03354117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346048|NCT03354117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346049|NCT03354117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346050|NCT03354117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346051|NCT03354117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93346052|NCT03354117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93346053|NCT03354117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346054|NCT03354117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346055|NCT03354117|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93346056|NCT03354117|Contraceptive Agents|contraceptive agents|mesh-ancestor
93346057|NCT03354117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346058|NCT03354117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93346059|NCT03360981|Incretins|incretins|mesh-list
93346060|NCT03360981|Hormones|hormones|mesh-ancestor
93346061|NCT03360981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346062|NCT03360981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346063|NCT03597815|Aflibercept|aflibercept|mesh-list
93346064|NCT03597815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93346065|NCT03597815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93346066|NCT03597815|Growth Substances|growth substances|mesh-ancestor
93346067|NCT03597815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346068|NCT03597815|Growth Inhibitors|growth inhibitors|mesh-ancestor
93346069|NCT03597815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346070|NCT03595085|Streptokinase|streptokinase|mesh-list
93346071|NCT03595085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93346072|NCT03595085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93346073|NCT03595085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346074|NCT00158756|Vaccines|vaccines|mesh-list
93346075|NCT00158756|Immunologic Factors|immunologic factors|mesh-ancestor
93346076|NCT00158756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346077|NCT03353883|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93346078|NCT03353883|Luteolytic Agents|luteolytic agents|mesh-ancestor
93346079|NCT03353883|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93346080|NCT03353883|Contraceptive Agents|contraceptive agents|mesh-ancestor
93346081|NCT03353883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346082|NCT03353883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346083|NCT03353883|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93346084|NCT03353883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93346085|NCT03353883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346086|NCT03885713|Adalimumab|adalimumab|mesh-list
93346087|NCT03885713|Infliximab|infliximab|mesh-list
93346088|NCT03885713|Golimumab|golimumab|mesh-list
93346089|NCT03885713|Ustekinumab|ustekinumab|mesh-list
93346090|NCT03885713|Vedolizumab|vedolizumab|mesh-list
93346091|NCT03885713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93346092|NCT03885713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346093|NCT03885713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346094|NCT03885713|Dermatologic Agents|dermatologic agents|mesh-ancestor
93346095|NCT03885713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346096|NCT03885713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93346097|NCT03885713|Immunologic Factors|immunologic factors|mesh-ancestor
93346098|NCT03885713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346099|NCT04519125|Tenofovir|tenofovir|mesh-list
93346100|NCT04519125|Emtricitabine|emtricitabine|mesh-list
93346101|NCT04519125|Antiviral Agents|antiviral agents|mesh-ancestor
93346102|NCT04519125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346103|NCT04519125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93346104|NCT04519125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93346105|NCT04519125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346106|NCT04519125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346107|NCT04519125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93346108|NCT04519125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92639846|NCT00208299|Adenosine|adenosine|mesh-list
93346109|NCT02730195|Pioglitazone|pioglitazone|mesh-list
93346110|NCT02730195|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93346111|NCT02730195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346112|NCT02730195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346113|NCT02730195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93346114|NCT02730195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346115|NCT02730195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346116|NCT03360279|Paclitaxel|paclitaxel|mesh-list
93346117|NCT03360279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93346118|NCT03360279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346119|NCT03360279|Tubulin Modulators|tubulin modulators|mesh-ancestor
93346120|NCT03360279|Antimitotic Agents|antimitotic agents|mesh-ancestor
93346121|NCT03360279|Mitosis Modulators|mitosis modulators|mesh-ancestor
93346122|NCT03360279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346123|NCT03353103|Listerine|listerine|mesh-list
93346124|NCT03353103|Fluorides|fluorides|mesh-list
93346125|NCT03353103|Sodium Fluoride|sodium fluoride|mesh-list
93346126|NCT03353103|Cariostatic Agents|cariostatic agents|mesh-ancestor
93346127|NCT03353103|Protective Agents|protective agents|mesh-ancestor
93346128|NCT03353103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346129|NCT03353103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93346130|NCT03353103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346131|NCT03360123|Midazolam|midazolam|mesh-list
93346132|NCT03360123|Triazolam|triazolam|mesh-list
93346133|NCT03360123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93346134|NCT03360123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93346135|NCT03360123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346136|NCT03360123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346137|NCT03360123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93346138|NCT03360123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93346139|NCT03360123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93346140|NCT03360123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93346141|NCT03360123|Anesthetics, General|anesthetics, general|mesh-ancestor
93346142|NCT03360123|Anesthetics|anesthetics|mesh-ancestor
93346143|NCT03360123|GABA Modulators|gaba modulators|mesh-ancestor
93346144|NCT03360123|GABA Agents|gaba agents|mesh-ancestor
93346145|NCT03360123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346146|NCT03360123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346147|NCT03360045|Tranexamic Acid|tranexamic acid|mesh-list
93346148|NCT03360045|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
93346149|NCT03360045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93346150|NCT03360045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93346151|NCT03360045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346152|NCT03360045|Hemostatics|hemostatics|mesh-ancestor
93346153|NCT03360045|Coagulants|coagulants|mesh-ancestor
93346154|NCT03353025|Dopamine|dopamine|mesh-list
93346155|NCT03353025|Dopamine Agonists|dopamine agonists|mesh-list
93346156|NCT03353025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93346157|NCT03353025|Sympathomimetics|sympathomimetics|mesh-ancestor
93346158|NCT03353025|Autonomic Agents|autonomic agents|mesh-ancestor
93346159|NCT03353025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346160|NCT03353025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346161|NCT03353025|Dopamine Agents|dopamine agents|mesh-ancestor
93346162|NCT03353025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346163|NCT03353025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346164|NCT03353025|Protective Agents|protective agents|mesh-ancestor
93346165|NCT03359967|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93346166|NCT03359967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93346167|NCT03359967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346168|NCT04506957|Chrysarobin|chrysarobin|mesh-list
93346169|NCT04506957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93346170|NCT04506957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93346171|NCT04506957|Analgesics|analgesics|mesh-ancestor
93346172|NCT04506957|Sensory System Agents|sensory system agents|mesh-ancestor
93346173|NCT04506957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346174|NCT04506957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346175|NCT04506957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346176|NCT04506957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346177|NCT04516395|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93346178|NCT04516395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93346179|NCT04516395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346180|NCT04516395|Antitubercular Agents|antitubercular agents|mesh-ancestor
93346181|NCT03352947|Trametinib|trametinib|mesh-list
93346182|NCT03352947|Dabrafenib|dabrafenib|mesh-list
93346183|NCT03352947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346184|NCT03352947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93346185|NCT03352947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346186|NCT03352947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346187|NCT02730351|Fluticasone|fluticasone|mesh-list
93346188|NCT02730351|Xhance|xhance|mesh-list
93346189|NCT02730351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346190|NCT02730351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93346191|NCT02730351|Autonomic Agents|autonomic agents|mesh-ancestor
93346192|NCT02730351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346193|NCT02730351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346194|NCT02730351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93346195|NCT02730351|Respiratory System Agents|respiratory system agents|mesh-ancestor
93346196|NCT02730351|Dermatologic Agents|dermatologic agents|mesh-ancestor
93346197|NCT02730351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93346198|NCT03359655|Scopolamine|scopolamine|mesh-list
93346199|NCT03359655|Bromides|bromides|mesh-list
93346200|NCT03359655|Misoprostol|misoprostol|mesh-list
93346201|NCT03359655|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93346202|NCT03359655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93346203|NCT03359655|Abortifacient Agents|abortifacient agents|mesh-ancestor
93346204|NCT03359655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346205|NCT03359655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346206|NCT03359655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93346207|NCT03359655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346208|NCT03359655|Oxytocics|oxytocics|mesh-ancestor
93346209|NCT03359655|Anticonvulsants|anticonvulsants|mesh-ancestor
93346210|NCT03359655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93346211|NCT03359655|Antiemetics|antiemetics|mesh-ancestor
93346212|NCT03359655|Autonomic Agents|autonomic agents|mesh-ancestor
93346213|NCT03359655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346214|NCT03359655|Mydriatics|mydriatics|mesh-ancestor
93346215|NCT03359655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93346216|NCT03359655|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346217|NCT03359655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346218|NCT03359655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346219|NCT03359655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93346220|NCT03359655|Parasympatholytics|parasympatholytics|mesh-ancestor
93346221|NCT03352869|Metformin|metformin|mesh-list
93018142|NCT05616923|Trametinib|trametinib|mesh-list
93346222|NCT03352869|Exenatide|exenatide|mesh-list
93346223|NCT03352869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346224|NCT03352869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346225|NCT03352869|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93346226|NCT03352869|Incretins|incretins|mesh-ancestor
93346227|NCT03352869|Hormones|hormones|mesh-ancestor
93346228|NCT03352869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346229|NCT03359499|Trimebutine|trimebutine|mesh-list
93346230|NCT03359499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346231|NCT03359499|Parasympatholytics|parasympatholytics|mesh-ancestor
93346232|NCT03359499|Autonomic Agents|autonomic agents|mesh-ancestor
93346233|NCT03359499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346234|NCT03359499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346235|NCT03352479|Analgesics, Opioid|analgesics, opioid|mesh-list
93346236|NCT03352479|Narcotics|narcotics|mesh-ancestor
93346237|NCT03352479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346238|NCT03352479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346239|NCT03352479|Analgesics|analgesics|mesh-ancestor
93346240|NCT03352479|Sensory System Agents|sensory system agents|mesh-ancestor
93346241|NCT03352479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346242|NCT03355053|Dexmedetomidine|dexmedetomidine|mesh-list
93346243|NCT03355053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93346244|NCT03355053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346245|NCT03355053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346246|NCT03355053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93346247|NCT03355053|Analgesics|analgesics|mesh-ancestor
93346248|NCT03355053|Sensory System Agents|sensory system agents|mesh-ancestor
93346249|NCT03355053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346250|NCT03355053|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93346251|NCT03355053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93346252|NCT03355053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93346253|NCT03355053|Adrenergic Agents|adrenergic agents|mesh-ancestor
93346254|NCT03355053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346255|NCT03355053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346256|NCT03354897|Torsemide|torsemide|mesh-list
93346257|NCT03354897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93346258|NCT03354897|Diuretics|diuretics|mesh-ancestor
93346259|NCT03354897|Natriuretic Agents|natriuretic agents|mesh-ancestor
93346260|NCT03354897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346261|NCT03354897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93346262|NCT03354897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346263|NCT03354897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346264|NCT04506567|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93346265|NCT04506567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93346266|NCT04506567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346267|NCT03358953|Nicotine|nicotine|mesh-list
93346268|NCT03358953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93346269|NCT03358953|Autonomic Agents|autonomic agents|mesh-ancestor
93346270|NCT03358953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346271|NCT03358953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346272|NCT03358953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93346273|NCT03358953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93346274|NCT03358953|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346275|NCT03358953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346276|NCT03358953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346277|NCT04509999|Bicalutamide|bicalutamide|mesh-list
93346278|NCT04509999|Androgen Antagonists|androgen antagonists|mesh-ancestor
93346279|NCT04509999|Hormone Antagonists|hormone antagonists|mesh-ancestor
93346280|NCT04509999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346281|NCT04509999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346282|NCT04509999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346283|NCT04505943|Isoniazid|isoniazid|mesh-list
93346284|NCT04505943|Misoprostol|misoprostol|mesh-list
93346285|NCT04505943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93346286|NCT04505943|Abortifacient Agents|abortifacient agents|mesh-ancestor
93346287|NCT04505943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346288|NCT04505943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346289|NCT04505943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93346290|NCT04505943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346291|NCT04505943|Oxytocics|oxytocics|mesh-ancestor
93346292|NCT04505943|Antitubercular Agents|antitubercular agents|mesh-ancestor
93346293|NCT04505943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93346294|NCT04505943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346295|NCT04505943|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93346296|NCT04505943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93346297|NCT04505943|Antimetabolites|antimetabolites|mesh-ancestor
93366447|NCT02796677|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93346298|NCT04505943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346299|NCT04505943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93346300|NCT03358719|Poly I-C|poly i-c|mesh-list
93346301|NCT03358719|Nivolumab|nivolumab|mesh-list
93346302|NCT03358719|Decitabine|decitabine|mesh-list
93346303|NCT03358719|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93346304|NCT03358719|Poly ICLC|poly iclc|mesh-list
93346305|NCT03358719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346306|NCT03358719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346307|NCT03358719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93346308|NCT03358719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346309|NCT03358719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93346310|NCT03358719|Antimetabolites|antimetabolites|mesh-ancestor
93346311|NCT03358719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346312|NCT03358719|Interferon Inducers|interferon inducers|mesh-ancestor
93346313|NCT03358719|Immunologic Factors|immunologic factors|mesh-ancestor
93346314|NCT03358719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346315|NCT03358719|Laxatives|laxatives|mesh-ancestor
93346316|NCT03358719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346317|NCT03358719|Antiviral Agents|antiviral agents|mesh-ancestor
93346318|NCT03358719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346319|NCT04505475|Hemostatics|hemostatics|mesh-list
93346320|NCT04505475|Coagulants|coagulants|mesh-ancestor
93346321|NCT01376349|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93346322|NCT01376349|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93346323|NCT01376349|Immunologic Factors|immunologic factors|mesh-ancestor
93346324|NCT01376349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346325|NCT03350373|Dotinurad|dotinurad|mesh-list
93346326|NCT03350373|Uricosuric Agents|uricosuric agents|mesh-ancestor
93346327|NCT03350373|Gout Suppressants|gout suppressants|mesh-ancestor
93346328|NCT03350373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346329|NCT03350295|Nifurtimox|nifurtimox|mesh-list
93346330|NCT03350295|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93346331|NCT03350295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93346332|NCT03350295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93346333|NCT03350295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346334|NCT03349983|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93346335|NCT03349983|Antiviral Agents|antiviral agents|mesh-ancestor
93346336|NCT03349983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346337|NCT03349827|Apatinib|apatinib|mesh-list
93346338|NCT03349827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346339|NCT03349827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93346340|NCT03349827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346341|NCT03349827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346342|NCT04503915|Estrogens|estrogens|mesh-list
93346343|NCT04503915|Hormones|hormones|mesh-ancestor
93346344|NCT04503915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346345|NCT04503915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346346|NCT04504851|Rifampin|rifampin|mesh-list
93346347|NCT04504851|Isoniazid|isoniazid|mesh-list
93346348|NCT04504851|Pyrazinamide|pyrazinamide|mesh-list
93346349|NCT04504851|Ethambutol|ethambutol|mesh-list
93346350|NCT04504851|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93346351|NCT04504851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93346352|NCT04504851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93346353|NCT04504851|Antimetabolites|antimetabolites|mesh-ancestor
93346354|NCT04504851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346355|NCT04504851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93346356|NCT04504851|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93346357|NCT04504851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346358|NCT04504851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93346359|NCT04504851|Antitubercular Agents|antitubercular agents|mesh-ancestor
93346360|NCT04504851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93346361|NCT04504851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346362|NCT04504851|Leprostatic Agents|leprostatic agents|mesh-ancestor
93346363|NCT04504851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93346364|NCT04504851|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93346365|NCT04504851|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93346366|NCT04504851|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93346367|NCT04504851|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93346368|NCT04504851|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93346369|NCT04504851|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93346370|NCT04504851|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93346371|NCT05509257|Naltrexone|naltrexone|mesh-list
93018289|NCT05440201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93346372|NCT05509257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93346373|NCT05509257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93346374|NCT05509257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346375|NCT05509257|Sensory System Agents|sensory system agents|mesh-ancestor
93346376|NCT05509257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346377|NCT03349359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93346379|NCT03349359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346380|NCT03030261|Dexamethasone|dexamethasone|mesh-list
93346381|NCT03030261|Pomalidomide|pomalidomide|mesh-list
93346382|NCT03030261|Elotuzumab|elotuzumab|mesh-list
93346383|NCT03030261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346384|NCT03030261|Antiemetics|antiemetics|mesh-ancestor
93346385|NCT03030261|Autonomic Agents|autonomic agents|mesh-ancestor
93346386|NCT03030261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346387|NCT03030261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346388|NCT03030261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346389|NCT03030261|Glucocorticoids|glucocorticoids|mesh-ancestor
93346390|NCT03030261|Hormones|hormones|mesh-ancestor
93346391|NCT03030261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346392|NCT03030261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93346393|NCT03030261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346394|NCT03030261|Immunologic Factors|immunologic factors|mesh-ancestor
93346395|NCT03030261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93346396|NCT03030261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93346397|NCT03030261|Growth Substances|growth substances|mesh-ancestor
93346398|NCT03030261|Growth Inhibitors|growth inhibitors|mesh-ancestor
93346399|NCT02176161|Metformin|metformin|mesh-list
93346400|NCT02176161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346401|NCT02176161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346402|NCT03348735|Lidocaine|lidocaine|mesh-list
93346403|NCT03348735|Pregabalin|pregabalin|mesh-list
93346404|NCT03348735|Capsaicin|capsaicin|mesh-list
93346405|NCT03348735|Anesthetics, Local|anesthetics, local|mesh-ancestor
93346406|NCT03348735|Anesthetics|anesthetics|mesh-ancestor
93346407|NCT03348735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346408|NCT03348735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346409|NCT03348735|Sensory System Agents|sensory system agents|mesh-ancestor
93346410|NCT03348735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346411|NCT03348735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93346412|NCT03348735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93346413|NCT03348735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93346414|NCT03348735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346415|NCT03348735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346416|NCT03348735|Analgesics|analgesics|mesh-ancestor
93346417|NCT03348735|Anticonvulsants|anticonvulsants|mesh-ancestor
93346418|NCT03348735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93346419|NCT03348735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93346420|NCT03348735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93346421|NCT03348735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93346422|NCT03348735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93346423|NCT03348735|Antipruritics|antipruritics|mesh-ancestor
93346424|NCT03348735|Dermatologic Agents|dermatologic agents|mesh-ancestor
93346425|NCT01700673|Azacitidine|azacitidine|mesh-list
93346426|NCT01700673|Sargramostim|sargramostim|mesh-list
93346427|NCT01700673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93346428|NCT01700673|Antimetabolites|antimetabolites|mesh-ancestor
93346429|NCT01700673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346430|NCT01700673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346431|NCT01700673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346432|NCT01700673|Immunologic Factors|immunologic factors|mesh-ancestor
93346433|NCT01700673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346434|NCT03898154|Dexamethasone|dexamethasone|mesh-list
93346435|NCT03898154|Methylprednisolone|methylprednisolone|mesh-list
93346436|NCT03898154|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93346437|NCT03898154|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93346438|NCT03898154|Prednisolone|prednisolone|mesh-list
93346439|NCT03898154|Prednisolone acetate|prednisolone acetate|mesh-list
93346440|NCT03898154|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93346441|NCT03898154|Prednisolone phosphate|prednisolone phosphate|mesh-list
93346442|NCT03898154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346443|NCT03898154|Antiemetics|antiemetics|mesh-ancestor
93346444|NCT03898154|Autonomic Agents|autonomic agents|mesh-ancestor
93346445|NCT03898154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346446|NCT03898154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346447|NCT03898154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346448|NCT03898154|Glucocorticoids|glucocorticoids|mesh-ancestor
93346449|NCT03898154|Hormones|hormones|mesh-ancestor
93346450|NCT03898154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346451|NCT03898154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93346452|NCT03898154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346453|NCT03898154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93346454|NCT03898154|Protective Agents|protective agents|mesh-ancestor
93346455|NCT02517957|Loperamide|loperamide|mesh-list
93346456|NCT02517957|Antidiarrheals|antidiarrheals|mesh-list
93346457|NCT02517957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346458|NCT03348267|Caseins|caseins|mesh-list
93346459|NCT03348267|Chelating Agents|chelating agents|mesh-ancestor
93346460|NCT03348267|Sequestering Agents|sequestering agents|mesh-ancestor
93346461|NCT03348267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346462|NCT03136796|Meropenem|meropenem|mesh-list
93346463|NCT03136796|Piperacillin|piperacillin|mesh-list
93346464|NCT03136796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93346465|NCT03136796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346466|NCT05243745|Fluorides|fluorides|mesh-list
93346467|NCT05243745|Cariostatic Agents|cariostatic agents|mesh-ancestor
93346468|NCT05243745|Protective Agents|protective agents|mesh-ancestor
93346469|NCT05243745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346470|NCT04500717|Carboplatin|carboplatin|mesh-list
93346471|NCT04500717|Pemetrexed|pemetrexed|mesh-list
93346472|NCT04500717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346473|NCT04500717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346474|NCT04500717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346475|NCT04500717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93346476|NCT04500717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93346477|NCT01680458|Fluconazole|fluconazole|mesh-list
93346478|NCT01680458|Antifungal Agents|antifungal agents|mesh-ancestor
93346479|NCT01680458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346480|NCT01680458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93346481|NCT01680458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93346482|NCT01680458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346483|NCT01680458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346484|NCT01680458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93346485|NCT01680458|Hormone Antagonists|hormone antagonists|mesh-ancestor
93346486|NCT01680458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346487|NCT01680458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346488|NCT01680458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93346489|NCT01680458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93346490|NCT03346317|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93346491|NCT03346317|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93346492|NCT03346317|Estradiol|estradiol|mesh-list
93346493|NCT03346317|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93346494|NCT03346317|Dydrogesterone|dydrogesterone|mesh-list
93346495|NCT03346317|Estrogens|estrogens|mesh-ancestor
93346496|NCT03346317|Hormones|hormones|mesh-ancestor
93346497|NCT03346317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346498|NCT03346317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346499|NCT03346317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93346500|NCT03346317|Contraceptive Agents|contraceptive agents|mesh-ancestor
93346501|NCT03346317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346502|NCT03346317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93346503|NCT03346317|Progestins|progestins|mesh-ancestor
93346504|NCT01550432|Acetylcysteine|acetylcysteine|mesh-list
93346505|NCT01550432|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93346506|NCT01550432|Antiviral Agents|antiviral agents|mesh-ancestor
93346507|NCT01550432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346508|NCT01550432|Expectorants|expectorants|mesh-ancestor
93346509|NCT01550432|Respiratory System Agents|respiratory system agents|mesh-ancestor
93346510|NCT01550432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93346511|NCT01550432|Antioxidants|antioxidants|mesh-ancestor
93346512|NCT01550432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346513|NCT01550432|Protective Agents|protective agents|mesh-ancestor
93346514|NCT01550432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346515|NCT01550432|Antidotes|antidotes|mesh-ancestor
93346516|NCT04502277|Fluconazole|fluconazole|mesh-list
93346517|NCT04502277|Antifungal Agents|antifungal agents|mesh-ancestor
93346518|NCT04502277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346519|NCT04502277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93346520|NCT04502277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93346521|NCT04502277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346522|NCT04502277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346523|NCT04502277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93018443|NCT05264883|Decitabine|decitabine|mesh-list
93346524|NCT04502277|Hormone Antagonists|hormone antagonists|mesh-ancestor
93346525|NCT04502277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346526|NCT04502277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346527|NCT04502277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93346528|NCT04502277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93346529|NCT05730608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93346530|NCT05730608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93346531|NCT05730608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346532|NCT02517489|Hydrocortisone|hydrocortisone|mesh-list
93346533|NCT02517489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346535|NCT04850144|Tiotropium Bromide|tiotropium bromide|mesh-list
93346536|NCT04850144|Charcoal|charcoal|mesh-list
93346537|NCT04850144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93346538|NCT04850144|Autonomic Agents|autonomic agents|mesh-ancestor
93346539|NCT04850144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346540|NCT04850144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346541|NCT04850144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93346542|NCT04850144|Respiratory System Agents|respiratory system agents|mesh-ancestor
93346543|NCT04850144|Parasympatholytics|parasympatholytics|mesh-ancestor
93346544|NCT04850144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93346545|NCT04850144|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346546|NCT04850144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346547|NCT04850144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346548|NCT04850144|Anticonvulsants|anticonvulsants|mesh-ancestor
93346549|NCT04850144|Antidotes|antidotes|mesh-ancestor
93346550|NCT04850144|Protective Agents|protective agents|mesh-ancestor
93346551|NCT04590794|Plasminogen|plasminogen|mesh-list
93346552|NCT04590794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93346553|NCT04590794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93346554|NCT04590794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346555|NCT00709761|Paclitaxel|paclitaxel|mesh-list
93346556|NCT00709761|Lapatinib|lapatinib|mesh-list
93346557|NCT00709761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93346558|NCT00709761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346559|NCT00709761|Tubulin Modulators|tubulin modulators|mesh-ancestor
93346560|NCT00709761|Antimitotic Agents|antimitotic agents|mesh-ancestor
93346561|NCT00709761|Mitosis Modulators|mitosis modulators|mesh-ancestor
93346562|NCT00709761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346563|NCT00709761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93346564|NCT00709761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346565|NCT03346083|Betrixaban|betrixaban|mesh-list
93346566|NCT03346083|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93346567|NCT03346083|Antithrombins|antithrombins|mesh-ancestor
93346568|NCT03346083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93346569|NCT03346083|Protease Inhibitors|protease inhibitors|mesh-ancestor
93346570|NCT03346083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346571|NCT03346083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346572|NCT03346083|Anticoagulants|anticoagulants|mesh-ancestor
93346573|NCT05584683|Amoxicillin|amoxicillin|mesh-list
93346574|NCT05584683|Clavulanic Acid|clavulanic acid|mesh-list
93346575|NCT05584683|Clavulanic Acids|clavulanic acids|mesh-list
93346576|NCT05584683|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93346577|NCT05584683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93346578|NCT05584683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346579|NCT05584683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93346580|NCT05584683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346581|NCT05584683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346582|NCT02358031|Carboplatin|carboplatin|mesh-list
93346583|NCT02358031|Pembrolizumab|pembrolizumab|mesh-list
93346584|NCT02358031|Cetuximab|cetuximab|mesh-list
92640336|NCT00204191|Tacrolimus|tacrolimus|mesh-list
93346585|NCT02358031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346586|NCT02358031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346587|NCT02358031|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93346588|NCT02358031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346589|NCT02516631|Misoprostol|misoprostol|mesh-list
93346590|NCT02516631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93346591|NCT02516631|Abortifacient Agents|abortifacient agents|mesh-ancestor
93346592|NCT02516631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346593|NCT02516631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346594|NCT02516631|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93346595|NCT02516631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346596|NCT02516631|Oxytocics|oxytocics|mesh-ancestor
93346597|NCT02516475|Zinc Sulfate|zinc sulfate|mesh-list
93346598|NCT02516475|Astringents|astringents|mesh-ancestor
93346599|NCT02516475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346600|NCT02516475|Dermatologic Agents|dermatologic agents|mesh-ancestor
93346601|NCT05083286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93346602|NCT05083286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93346603|NCT05083286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93346604|NCT05083286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346605|NCT05083286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346606|NCT05083286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93346607|NCT05083286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346608|NCT05083286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346609|NCT05083286|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346610|NCT05083286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346611|NCT03423680|Aripiprazole|aripiprazole|mesh-list
93346612|NCT03423680|Antidepressive Agents|antidepressive agents|mesh-ancestor
93346613|NCT03423680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93346614|NCT03423680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93346615|NCT03423680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93346616|NCT03423680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346617|NCT03423680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346618|NCT03423680|Dopamine Agonists|dopamine agonists|mesh-ancestor
93346619|NCT03423680|Dopamine Agents|dopamine agents|mesh-ancestor
93346620|NCT03423680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346621|NCT03423680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346622|NCT03423680|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93346623|NCT03423680|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93346624|NCT03423680|Serotonin Agents|serotonin agents|mesh-ancestor
93346625|NCT03423680|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93346626|NCT03423680|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93346627|NCT03423680|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93346628|NCT03423680|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93346629|NCT04443543|Fluorouracil|fluorouracil|mesh-list
93346630|NCT04443543|Capecitabine|capecitabine|mesh-list
93346631|NCT04443543|Oxaliplatin|oxaliplatin|mesh-list
93346632|NCT04443543|Irinotecan|irinotecan|mesh-list
93346633|NCT04443543|Tislelizumab|tislelizumab|mesh-list
93346634|NCT04443543|Antimetabolites|antimetabolites|mesh-ancestor
93346635|NCT04443543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346636|NCT04443543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93346637|NCT04443543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346638|NCT04443543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93346639|NCT04443543|Immunologic Factors|immunologic factors|mesh-ancestor
93346640|NCT04443543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346641|NCT04443543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93346642|NCT04443543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93346643|NCT04443543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346644|NCT04443543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346645|NCT02516085|Metformin|metformin|mesh-list
93346646|NCT02516085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346647|NCT02516085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346648|NCT02515929|Proanthocyanidin|proanthocyanidin|mesh-list
93346649|NCT02515929|Procyanidin|procyanidin|mesh-list
93346650|NCT02515929|Antioxidants|antioxidants|mesh-ancestor
93346651|NCT02515929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346652|NCT02515929|Protective Agents|protective agents|mesh-ancestor
93346653|NCT02515929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346654|NCT02515929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93346655|NCT02515929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93346656|NCT02515929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346657|NCT03347721|Lidocaine|lidocaine|mesh-list
93346658|NCT03347721|Anesthetics, Local|anesthetics, local|mesh-ancestor
93346659|NCT03347721|Anesthetics|anesthetics|mesh-ancestor
93346660|NCT03347721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346661|NCT03347721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346662|NCT03347721|Sensory System Agents|sensory system agents|mesh-ancestor
93346663|NCT03347721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346664|NCT03347721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93346665|NCT03347721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93346666|NCT03347721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93346667|NCT03347721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346668|NCT03347721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346669|NCT02848651|Atezolizumab|atezolizumab|mesh-list
93346670|NCT02848651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93346671|NCT02848651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018589|NCT04998786|Autonomic Agents|autonomic agents|mesh-ancestor
93346672|NCT02848651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346673|NCT02848651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346674|NCT00709059|Ribavirin|ribavirin|mesh-list
93346675|NCT00709059|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93346676|NCT00709059|Interferon-alpha|interferon-alpha|mesh-list
93346677|NCT00709059|Antimetabolites|antimetabolites|mesh-ancestor
93346678|NCT00709059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346679|NCT00709059|Antiviral Agents|antiviral agents|mesh-ancestor
93346680|NCT00709059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346681|NCT00709059|Immunologic Factors|immunologic factors|mesh-ancestor
93346682|NCT00709059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346683|NCT04500561|Gemcitabine|gemcitabine|mesh-list
93346684|NCT04500561|Oxaliplatin|oxaliplatin|mesh-list
93346685|NCT04500561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93346686|NCT04500561|Antimetabolites|antimetabolites|mesh-ancestor
93346687|NCT04500561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346688|NCT04500561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346689|NCT04507256|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93346690|NCT04507256|Antiviral Agents|antiviral agents|mesh-ancestor
93346691|NCT04507256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346692|NCT04968015|Cytarabine|cytarabine|mesh-list
93346693|NCT04968015|Venetoclax|venetoclax|mesh-list
93346694|NCT04968015|Idarubicin|idarubicin|mesh-list
93346695|NCT04968015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93346696|NCT04968015|Antimetabolites|antimetabolites|mesh-ancestor
93346697|NCT04968015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346698|NCT04968015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346699|NCT04968015|Antiviral Agents|antiviral agents|mesh-ancestor
93346700|NCT04968015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346701|NCT04968015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93346702|NCT04968015|Immunologic Factors|immunologic factors|mesh-ancestor
93346703|NCT04968015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346704|NCT04968015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93346705|NCT04968015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93346706|NCT04968015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93346707|NCT04968015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346708|NCT05094596|Montelukast|montelukast|mesh-list
93346709|NCT05094596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93346710|NCT05094596|Respiratory System Agents|respiratory system agents|mesh-ancestor
93346711|NCT05094596|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93346712|NCT05094596|Hormone Antagonists|hormone antagonists|mesh-ancestor
93346713|NCT05094596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346714|NCT05094596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346715|NCT05094596|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93346716|NCT05094596|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93346717|NCT05094596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346718|NCT01678820|Metformin|metformin|mesh-list
93346719|NCT01678820|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93346720|NCT01678820|Glimepiride|glimepiride|mesh-list
93346721|NCT01678820|Simvastatin|simvastatin|mesh-list
93346722|NCT01678820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346723|NCT01678820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346724|NCT01678820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93346725|NCT01678820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93346726|NCT01678820|Antimetabolites|antimetabolites|mesh-ancestor
93346727|NCT01678820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346728|NCT01678820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93346729|NCT01678820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93346730|NCT01678820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346731|NCT01678820|Incretins|incretins|mesh-ancestor
93346732|NCT01678820|Hormones|hormones|mesh-ancestor
93346733|NCT01678820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346734|NCT01678820|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93346735|NCT01678820|Protease Inhibitors|protease inhibitors|mesh-ancestor
93346736|NCT01678820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93346737|NCT01678820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93346738|NCT01678820|Immunologic Factors|immunologic factors|mesh-ancestor
93346739|NCT02515695|Interferons|interferons|mesh-list
93346740|NCT02515695|Interferon-beta|interferon-beta|mesh-list
93346741|NCT02515695|Interferon beta-1a|interferon beta-1a|mesh-list
93346742|NCT02515695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346743|NCT02515695|Antiviral Agents|antiviral agents|mesh-ancestor
93346744|NCT02515695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346745|NCT02515695|Immunologic Factors|immunologic factors|mesh-ancestor
93018665|NCT04931355|Cetrorelix|cetrorelix|mesh-list
93346746|NCT02515695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346747|NCT02515695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93346749|NCT03346629|Mifepristone|mifepristone|mesh-list
93346750|NCT03346629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93346751|NCT03346629|Abortifacient Agents|abortifacient agents|mesh-ancestor
93346752|NCT03346629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346753|NCT03346629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346754|NCT03346629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93346755|NCT03346629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346756|NCT03346629|Oxytocics|oxytocics|mesh-ancestor
93346757|NCT03346629|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93346758|NCT03346629|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93346759|NCT03346629|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93346760|NCT03346629|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93346761|NCT03346629|Contraceptive Agents|contraceptive agents|mesh-ancestor
93346762|NCT03346629|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93346763|NCT03346629|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93346764|NCT03346629|Hormone Antagonists|hormone antagonists|mesh-ancestor
93346765|NCT03346629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346766|NCT03346629|Luteolytic Agents|luteolytic agents|mesh-ancestor
93346767|NCT03346629|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93346768|NCT03346629|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93346769|NCT04501965|Azithromycin|azithromycin|mesh-list
93346770|NCT04501965|Hydroxychloroquine|hydroxychloroquine|mesh-list
93346771|NCT04501965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93346772|NCT04501965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346773|NCT04501965|Antimalarials|antimalarials|mesh-ancestor
93346774|NCT04501965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93346775|NCT04501965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93346776|NCT04501965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346777|NCT04501965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346778|NCT04501965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346779|NCT04437836|Rifampin|rifampin|mesh-list
93346780|NCT04437836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93346781|NCT04437836|Antitubercular Agents|antitubercular agents|mesh-ancestor
93346782|NCT04437836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93346783|NCT04437836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346784|NCT04437836|Leprostatic Agents|leprostatic agents|mesh-ancestor
93346785|NCT04437836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93346786|NCT04437836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346787|NCT04437836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346788|NCT04437836|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93346789|NCT04437836|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93346790|NCT04437836|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93346791|NCT04437836|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93346792|NCT04437836|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93346793|NCT04437836|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93346794|NCT03122067|Oxytocin|oxytocin|mesh-list
93346795|NCT03122067|Oxytocics|oxytocics|mesh-ancestor
93346796|NCT03122067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93346797|NCT03122067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346798|NCT04536194|Dopamine|dopamine|mesh-list
93346799|NCT04536194|Norepinephrine|norepinephrine|mesh-list
93346800|NCT04536194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93346801|NCT04536194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93346802|NCT04536194|Adrenergic Agents|adrenergic agents|mesh-ancestor
93346803|NCT04536194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346804|NCT04536194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346805|NCT04536194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346806|NCT04536194|Sympathomimetics|sympathomimetics|mesh-ancestor
93346807|NCT04536194|Autonomic Agents|autonomic agents|mesh-ancestor
93346808|NCT04536194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346809|NCT04536194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93346810|NCT04536194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93346811|NCT04536194|Dopamine Agents|dopamine agents|mesh-ancestor
93346812|NCT04536194|Protective Agents|protective agents|mesh-ancestor
93346813|NCT03122769|Metformin|metformin|mesh-list
93346814|NCT03122769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346815|NCT03122769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346816|NCT03121833|Endostar protein|endostar protein|mesh-list
93346817|NCT03121833|Endostatins|endostatins|mesh-list
93346818|NCT03121833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93346819|NCT03121833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93346820|NCT03121833|Growth Substances|growth substances|mesh-ancestor
93346821|NCT03121833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346822|NCT03121833|Growth Inhibitors|growth inhibitors|mesh-ancestor
93346823|NCT03121833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346824|NCT03121521|Melatonin|melatonin|mesh-list
93346825|NCT03121521|Antioxidants|antioxidants|mesh-ancestor
93346826|NCT03121521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346827|NCT03121521|Protective Agents|protective agents|mesh-ancestor
93346828|NCT03121521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346829|NCT03121521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346830|NCT03046862|Gemcitabine|gemcitabine|mesh-list
93346831|NCT03046862|Durvalumab|durvalumab|mesh-list
93346832|NCT03046862|Tremelimumab|tremelimumab|mesh-list
93346833|NCT03046862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346834|NCT03046862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93346835|NCT03046862|Antimetabolites|antimetabolites|mesh-ancestor
93346836|NCT03046862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346837|NCT03046862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346838|NCT05590923|Dexamethasone|dexamethasone|mesh-list
93346839|NCT05590923|Olanzapine|olanzapine|mesh-list
93346840|NCT05590923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346841|NCT05590923|Antiemetics|antiemetics|mesh-ancestor
93346842|NCT05590923|Autonomic Agents|autonomic agents|mesh-ancestor
93346843|NCT05590923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346844|NCT05590923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346845|NCT05590923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93346846|NCT05590923|Glucocorticoids|glucocorticoids|mesh-ancestor
93346847|NCT05590923|Hormones|hormones|mesh-ancestor
93346848|NCT05590923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93346849|NCT05590923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93346850|NCT05590923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346851|NCT05590923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93346852|NCT05590923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93346853|NCT05590923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346854|NCT05590923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93346855|NCT05590923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93346856|NCT05590923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93346857|NCT05590923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346858|NCT05590923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346859|NCT05590923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346860|NCT05590923|Serotonin Agents|serotonin agents|mesh-ancestor
93346861|NCT02643056|Panitumumab|panitumumab|mesh-list
93346862|NCT02643056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346863|NCT02643056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346864|NCT02515617|Silver Sulfadiazine|silver sulfadiazine|mesh-list
93346865|NCT02515617|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93346866|NCT02515617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93346867|NCT04578639|Rituximab|rituximab|mesh-list
93346868|NCT04578639|Ocrelizumab|ocrelizumab|mesh-list
93346869|NCT04578639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346870|NCT04578639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346871|NCT04578639|Immunologic Factors|immunologic factors|mesh-ancestor
93346872|NCT04578639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346873|NCT04578639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346874|NCT04413422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93346875|NCT04413422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346876|NCT04413422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346877|NCT02238145|Ipratropium|ipratropium|mesh-list
93346878|NCT02238145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93346879|NCT02238145|Autonomic Agents|autonomic agents|mesh-ancestor
93346880|NCT02238145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346881|NCT02238145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346882|NCT02238145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93346883|NCT02238145|Respiratory System Agents|respiratory system agents|mesh-ancestor
93346884|NCT02238145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93346885|NCT02238145|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346886|NCT02238145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346887|NCT02238145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346888|NCT04550637|Apixaban|apixaban|mesh-list
93346889|NCT04550637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93346890|NCT04550637|Antithrombins|antithrombins|mesh-ancestor
93346891|NCT04550637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93018811|NCT04677972|Ebselen|ebselen|mesh-list
93346892|NCT04550637|Protease Inhibitors|protease inhibitors|mesh-ancestor
93346893|NCT04550637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346894|NCT04550637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346895|NCT04550637|Anticoagulants|anticoagulants|mesh-ancestor
93346896|NCT03345303|Bortezomib|bortezomib|mesh-list
93346897|NCT03345303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346898|NCT03574909|Aspirin|aspirin|mesh-list
93346899|NCT03574909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93346900|NCT03574909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93346901|NCT03574909|Analgesics|analgesics|mesh-ancestor
93346902|NCT03574909|Sensory System Agents|sensory system agents|mesh-ancestor
93346903|NCT03574909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346904|NCT03574909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346905|NCT03574909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93346906|NCT03574909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93346907|NCT03574909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93346908|NCT03574909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93346909|NCT03574909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346910|NCT03574909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93346911|NCT03574909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93346912|NCT03574909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346913|NCT03574909|Antipyretics|antipyretics|mesh-ancestor
93346914|NCT02515227|Pembrolizumab|pembrolizumab|mesh-list
93346915|NCT02515227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93346916|NCT02515227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346917|NCT02515227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93346918|NCT02515227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346919|NCT03579043|Cocaine|cocaine|mesh-list
93346920|NCT03579043|Anesthetics, Local|anesthetics, local|mesh-ancestor
93346921|NCT03579043|Anesthetics|anesthetics|mesh-ancestor
93346922|NCT03579043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346923|NCT03579043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346924|NCT03579043|Sensory System Agents|sensory system agents|mesh-ancestor
93346925|NCT03579043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346926|NCT03579043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93346927|NCT03579043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93346928|NCT03579043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93346929|NCT03579043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346930|NCT03579043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346931|NCT03579043|Dopamine Agents|dopamine agents|mesh-ancestor
93346932|NCT03579043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346933|NCT02187991|Paclitaxel|paclitaxel|mesh-list
93346934|NCT02187991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93346935|NCT02187991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346936|NCT02187991|Tubulin Modulators|tubulin modulators|mesh-ancestor
93346937|NCT02187991|Antimitotic Agents|antimitotic agents|mesh-ancestor
93346938|NCT02187991|Mitosis Modulators|mitosis modulators|mesh-ancestor
93346939|NCT02187991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346940|NCT02660138|Hemagglutinins|hemagglutinins|mesh-list
93346941|NCT02660138|Botulinum Toxins|botulinum toxins|mesh-list
93346942|NCT02660138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93346943|NCT02660138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93346944|NCT02660138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93346945|NCT02660138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346946|NCT02660138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346947|NCT02660138|Cholinergic Agents|cholinergic agents|mesh-ancestor
93346948|NCT02660138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93346949|NCT02660138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346950|NCT02660138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93346951|NCT02660138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346952|NCT02660138|Agglutinins|agglutinins|mesh-ancestor
93346953|NCT02660138|Immunologic Factors|immunologic factors|mesh-ancestor
93346954|NCT02660138|Coagulants|coagulants|mesh-ancestor
93346955|NCT03576469|Complement C1s|complement c1s|mesh-list
93346956|NCT03576469|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93346957|NCT03576469|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
93346958|NCT03576469|Immunologic Factors|immunologic factors|mesh-ancestor
93346959|NCT03576469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346960|NCT03576469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93346961|NCT03576469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93346962|NCT05036876|Insulin Glargine|insulin glargine|mesh-list
93346963|NCT05036876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93346964|NCT05036876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346965|NCT05097950|Acetaminophen|acetaminophen|mesh-list
93346966|NCT05097950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93346967|NCT05097950|Analgesics|analgesics|mesh-ancestor
93346968|NCT05097950|Sensory System Agents|sensory system agents|mesh-ancestor
93346969|NCT05097950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346970|NCT05097950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346972|NCT05097248|Doxorubicin|doxorubicin|mesh-list
93346973|NCT05097248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93346974|NCT05097248|Losartan|losartan|mesh-list
93346975|NCT05097248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93346976|NCT05097248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93346977|NCT05097248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93346978|NCT05097248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93346979|NCT05097248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93346980|NCT05097248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346981|NCT05097248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93346982|NCT05097248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93346983|NCT05097248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93346984|NCT05097248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93346985|NCT01603394|Pregabalin|pregabalin|mesh-list
93346986|NCT01603394|Analgesics|analgesics|mesh-ancestor
93346987|NCT01603394|Sensory System Agents|sensory system agents|mesh-ancestor
93346988|NCT01603394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93346989|NCT01603394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93346990|NCT01603394|Anticonvulsants|anticonvulsants|mesh-ancestor
93346991|NCT01603394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93346992|NCT01603394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93346993|NCT01603394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93346994|NCT01603394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93346995|NCT01603394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93346996|NCT01603394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93346997|NCT01603394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93346998|NCT01603394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93346999|NCT04682522|Metronidazole|metronidazole|mesh-list
93347000|NCT04682522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347001|NCT04682522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347002|NCT04682522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93347003|NCT04682522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93347004|NCT02837432|Hydrocortisone|hydrocortisone|mesh-list
93347005|NCT02837432|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93347006|NCT02837432|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93347007|NCT02837432|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93347008|NCT02837432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347009|NCT02729025|Evolocumab|evolocumab|mesh-list
93347010|NCT02729025|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93347011|NCT02729025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93347012|NCT02729025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93347013|NCT02729025|Antimetabolites|antimetabolites|mesh-ancestor
93347014|NCT02729025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347015|NCT02729025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93347016|NCT02729025|Protease Inhibitors|protease inhibitors|mesh-ancestor
93347017|NCT02729025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347018|NCT02729025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93347019|NCT05599971|Fluorouracil|fluorouracil|mesh-list
93347020|NCT05599971|Digoxin|digoxin|mesh-list
93347021|NCT05599971|Furosemide|furosemide|mesh-list
93347022|NCT05599971|Antimetabolites|antimetabolites|mesh-ancestor
93347023|NCT05599971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347024|NCT05599971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347025|NCT05599971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347026|NCT05599971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93347027|NCT05599971|Immunologic Factors|immunologic factors|mesh-ancestor
93347028|NCT05599971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347029|NCT05599971|Diuretics|diuretics|mesh-ancestor
93347030|NCT05599971|Natriuretic Agents|natriuretic agents|mesh-ancestor
93347031|NCT05599971|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93347032|NCT05599971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93347033|NCT05599971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347034|NCT05599971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93347035|NCT05599971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347036|NCT05599971|Protective Agents|protective agents|mesh-ancestor
93347037|NCT02511873|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
93347038|NCT02511873|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93347039|NCT02511873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347040|NCT02511873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018956|NCT04546009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93347041|NCT02511873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347043|NCT02511795|Adavosertib|adavosertib|mesh-list
93347044|NCT02511795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93347045|NCT02511795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347046|NCT02511795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347047|NCT02511795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347048|NCT04796636|Ascorbic Acid|ascorbic acid|mesh-list
93347049|NCT04796636|Antioxidants|antioxidants|mesh-ancestor
93347050|NCT04796636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347051|NCT04796636|Protective Agents|protective agents|mesh-ancestor
93347052|NCT04796636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347053|NCT04796636|Vitamins|vitamins|mesh-ancestor
93347054|NCT04796636|Micronutrients|micronutrients|mesh-ancestor
93347055|NCT04501809|Misoprostol|misoprostol|mesh-list
93347056|NCT04501809|Oxytocin|oxytocin|mesh-list
93347057|NCT04501809|Oxytocics|oxytocics|mesh-ancestor
93347058|NCT04501809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347059|NCT04501809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347060|NCT04501809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93347061|NCT04501809|Abortifacient Agents|abortifacient agents|mesh-ancestor
93347062|NCT04501809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93347063|NCT04501809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347064|NCT04718636|Moxifloxacin|moxifloxacin|mesh-list
93347065|NCT04718636|Contraceptive Agents|contraceptive agents|mesh-list
93347066|NCT04718636|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93347067|NCT04718636|Contraceptives, Oral|contraceptives, oral|mesh-list
93347068|NCT04718636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347069|NCT04718636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347070|NCT04718636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93347071|NCT04718636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93347072|NCT04718636|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93347073|NCT04718636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347074|NCT04718636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347075|NCT04718636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93347076|NCT04718636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93347077|NCT04718636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347078|NCT04718636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347079|NCT04718636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347080|NCT02514681|Paclitaxel|paclitaxel|mesh-list
93347081|NCT02514681|Vinorelbine|vinorelbine|mesh-list
93347082|NCT02514681|Docetaxel|docetaxel|mesh-list
93347083|NCT02514681|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93347084|NCT02514681|Gemcitabine|gemcitabine|mesh-list
93347085|NCT02514681|Capecitabine|capecitabine|mesh-list
93347086|NCT02514681|Trastuzumab|trastuzumab|mesh-list
93347087|NCT02514681|Pertuzumab|pertuzumab|mesh-list
93347088|NCT02514681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93347089|NCT02514681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347090|NCT02514681|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347091|NCT02514681|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347092|NCT02514681|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347093|NCT02514681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347094|NCT02514681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347095|NCT02514681|Antimetabolites|antimetabolites|mesh-ancestor
93347096|NCT02514681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347097|NCT02511639|Everolimus|everolimus|mesh-list
93347098|NCT02511639|Letrozole|letrozole|mesh-list
93347099|NCT02511639|Anastrozole|anastrozole|mesh-list
93347100|NCT02511639|Exemestane|exemestane|mesh-list
93347101|NCT02511639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93347102|NCT02511639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93347103|NCT02511639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93347104|NCT02511639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347105|NCT02511639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347106|NCT02511639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93347107|NCT02511639|Immunologic Factors|immunologic factors|mesh-ancestor
93347108|NCT02511639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347109|NCT02511639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347110|NCT02511639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93347111|NCT02511639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93347112|NCT02511639|Hormone Antagonists|hormone antagonists|mesh-ancestor
93347113|NCT02511639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019047|NCT04471428|Docetaxel|docetaxel|mesh-list
93347114|NCT02511639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93347115|NCT02514603|Prexasertib|prexasertib|mesh-list
93347116|NCT02514603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93347117|NCT02514603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347118|NCT02514603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347119|NCT02511483|Propranolol|propranolol|mesh-list
93347120|NCT02511483|Morphine|morphine|mesh-list
93347121|NCT02511483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93347122|NCT02511483|Narcotics|narcotics|mesh-ancestor
93347123|NCT02511483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347124|NCT02511483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347125|NCT02511483|Analgesics|analgesics|mesh-ancestor
93347126|NCT02511483|Sensory System Agents|sensory system agents|mesh-ancestor
93347127|NCT02511483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347128|NCT02511483|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93347129|NCT02511483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93347130|NCT02511483|Adrenergic Agents|adrenergic agents|mesh-ancestor
93347131|NCT02511483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347132|NCT02511483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347133|NCT02511483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347134|NCT02511483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93347135|NCT02511483|Vasodilator Agents|vasodilator agents|mesh-ancestor
93347136|NCT04429802|Prucalopride|prucalopride|mesh-list
93347137|NCT04429802|Laxatives|laxatives|mesh-ancestor
93347138|NCT04429802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347139|NCT04429802|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93347140|NCT04429802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93347141|NCT04429802|Serotonin Agents|serotonin agents|mesh-ancestor
93347142|NCT04429802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347143|NCT04429802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347144|NCT04429802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347145|NCT02511405|Bevacizumab|bevacizumab|mesh-list
93347146|NCT02511405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347147|NCT02511405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347148|NCT02511405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93347149|NCT02511405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93347150|NCT02511405|Growth Substances|growth substances|mesh-ancestor
93347151|NCT02511405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347152|NCT02511405|Growth Inhibitors|growth inhibitors|mesh-ancestor
93347153|NCT04387760|Hydroxychloroquine|hydroxychloroquine|mesh-list
93347154|NCT04387760|Favipiravir|favipiravir|mesh-list
93347155|NCT04387760|Antimalarials|antimalarials|mesh-ancestor
93347156|NCT04387760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93347157|NCT04387760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93347158|NCT04387760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347159|NCT04387760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347160|NCT04387760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347161|NCT04387760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347162|NCT04387760|Antiviral Agents|antiviral agents|mesh-ancestor
93347163|NCT05091086|Zoledronic Acid|zoledronic acid|mesh-list
93347164|NCT05091086|Denosumab|denosumab|mesh-list
93347165|NCT05091086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93347166|NCT05091086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347167|NCT05091008|Sofosbuvir|sofosbuvir|mesh-list
93347168|NCT05091008|Ledipasvir|ledipasvir|mesh-list
93347169|NCT05091008|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93347170|NCT05091008|Antiviral Agents|antiviral agents|mesh-ancestor
93347171|NCT05091008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347172|NCT02918084|Letrozole|letrozole|mesh-list
93347173|NCT02918084|Anastrozole|anastrozole|mesh-list
93347174|NCT02918084|Exemestane|exemestane|mesh-list
93347175|NCT02918084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347176|NCT02918084|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93347177|NCT02918084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93347178|NCT02918084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347179|NCT02918084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347180|NCT02918084|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93347181|NCT02918084|Hormone Antagonists|hormone antagonists|mesh-ancestor
93347182|NCT02918084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93347183|NCT02918084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347184|NCT02918084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93347185|NCT01603082|Clopidogrel|clopidogrel|mesh-list
93347186|NCT01603082|Ticagrelor|ticagrelor|mesh-list
93347187|NCT01603082|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93347188|NCT01603082|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93347189|NCT01603082|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93347190|NCT01603082|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93347191|NCT01603082|Purinergic Agents|purinergic agents|mesh-ancestor
93347192|NCT01603082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347193|NCT01603082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347194|NCT01603082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347195|NCT04499313|Dexamethasone|dexamethasone|mesh-list
93347196|NCT04499313|Methylprednisolone|methylprednisolone|mesh-list
92640948|NCT00205166|Caffeine|caffeine|mesh-list
93347197|NCT04499313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93347198|NCT04499313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93347199|NCT04499313|Prednisolone|prednisolone|mesh-list
93347200|NCT04499313|Prednisolone acetate|prednisolone acetate|mesh-list
93347201|NCT04499313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93347202|NCT04499313|Prednisolone phosphate|prednisolone phosphate|mesh-list
93347203|NCT04499313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347204|NCT04499313|Antiemetics|antiemetics|mesh-ancestor
93347205|NCT04499313|Autonomic Agents|autonomic agents|mesh-ancestor
93347206|NCT04499313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347207|NCT04499313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347208|NCT04499313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347209|NCT04499313|Glucocorticoids|glucocorticoids|mesh-ancestor
93347210|NCT04499313|Hormones|hormones|mesh-ancestor
93347211|NCT04499313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93347212|NCT04499313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93347213|NCT04499313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347214|NCT04499313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93347215|NCT04499313|Protective Agents|protective agents|mesh-ancestor
93347216|NCT04331756|Anesthetics|anesthetics|mesh-list
93347217|NCT04331756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347218|NCT04331756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347219|NCT02499835|Pembrolizumab|pembrolizumab|mesh-list
93347220|NCT02499835|Immunoglobulins|immunoglobulins|mesh-list
93347221|NCT02499835|Immunoglobulin G|immunoglobulin g|mesh-list
93347222|NCT02499835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347223|NCT02499835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347224|NCT02499835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93347225|NCT02499835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347226|NCT02499835|Immunologic Factors|immunologic factors|mesh-ancestor
93347227|NCT02499835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347228|NCT02510781|Carboplatin|carboplatin|mesh-list
93347229|NCT02510781|Docetaxel|docetaxel|mesh-list
93347230|NCT02510781|Trastuzumab|trastuzumab|mesh-list
93347231|NCT02510781|Epirubicin|epirubicin|mesh-list
93347232|NCT02510781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347233|NCT02510781|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347234|NCT02510781|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347235|NCT02510781|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347236|NCT02510781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347237|NCT02510781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347238|NCT02510781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93347239|NCT02510781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93347240|NCT02510781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93347241|NCT02510781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347242|NCT03121599|Alovudine|alovudine|mesh-list
93347243|NCT03121599|Antiviral Agents|antiviral agents|mesh-ancestor
93347244|NCT03121599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347245|NCT03576079|Salicylic Acid|salicylic acid|mesh-list
93347246|NCT03576079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347247|NCT03576079|Antifungal Agents|antifungal agents|mesh-ancestor
93347248|NCT03576079|Keratolytic Agents|keratolytic agents|mesh-ancestor
93347249|NCT03576079|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347250|NCT04181606|Esmolol|esmolol|mesh-list
93347251|NCT04181606|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93347252|NCT04181606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93347253|NCT04181606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93347254|NCT04181606|Adrenergic Agents|adrenergic agents|mesh-ancestor
93347255|NCT04181606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347256|NCT04181606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347257|NCT04181606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347258|NCT04499235|Mometasone Furoate|mometasone furoate|mesh-list
93347259|NCT04499235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347260|NCT04499235|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347261|NCT04499235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93347262|NCT02510469|Apatinib|apatinib|mesh-list
93347263|NCT02510469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347264|NCT02510469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93347265|NCT02510469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347266|NCT02510469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347267|NCT05375630|Vitamin K|vitamin k|mesh-list
93347268|NCT05375630|Vitamin K 2|vitamin k 2|mesh-list
93347269|NCT05375630|Vitamins|vitamins|mesh-ancestor
93347270|NCT05375630|Micronutrients|micronutrients|mesh-ancestor
92641005|NCT00205322|Leucovorin|leucovorin|mesh-list
93347271|NCT05375630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347272|NCT05375630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93347273|NCT05375630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93347274|NCT05375630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347275|NCT05375630|Hemostatics|hemostatics|mesh-ancestor
93347276|NCT05375630|Coagulants|coagulants|mesh-ancestor
93347277|NCT02510235|Hyaluronic Acid|hyaluronic acid|mesh-list
93347278|NCT02510235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93347279|NCT02510235|Immunologic Factors|immunologic factors|mesh-ancestor
93347280|NCT02510235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347281|NCT02510235|Viscosupplements|viscosupplements|mesh-ancestor
93347282|NCT02510235|Protective Agents|protective agents|mesh-ancestor
93347283|NCT05081336|Alirocumab|alirocumab|mesh-list
93347284|NCT05081336|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93347285|NCT05081336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93347286|NCT05081336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93347287|NCT05081336|Antimetabolites|antimetabolites|mesh-ancestor
93347288|NCT05081336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347289|NCT05081336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93347290|NCT05081336|Protease Inhibitors|protease inhibitors|mesh-ancestor
93347291|NCT05081336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347292|NCT05081336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93347293|NCT03578497|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93347294|NCT03578497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347295|NCT03710876|Celecoxib|celecoxib|mesh-list
93347296|NCT03710876|Gemcitabine|gemcitabine|mesh-list
93347297|NCT03710876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347298|NCT03710876|Antimetabolites|antimetabolites|mesh-ancestor
93347299|NCT03710876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347300|NCT03710876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347301|NCT03710876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93347302|NCT03710876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93347303|NCT03710876|Analgesics|analgesics|mesh-ancestor
93347304|NCT03710876|Sensory System Agents|sensory system agents|mesh-ancestor
93347305|NCT03710876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347306|NCT03710876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347307|NCT03710876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347308|NCT03710876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347309|NCT03710876|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93347310|NCT03710876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93347311|NCT03710876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347312|NCT02513433|Bupivacaine|bupivacaine|mesh-list
93347313|NCT02513433|Ropivacaine|ropivacaine|mesh-list
93347314|NCT02513433|Levobupivacaine|levobupivacaine|mesh-list
93347315|NCT02513433|Anesthetics, Local|anesthetics, local|mesh-ancestor
93347316|NCT02513433|Anesthetics|anesthetics|mesh-ancestor
93347317|NCT02513433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347318|NCT02513433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347319|NCT02513433|Sensory System Agents|sensory system agents|mesh-ancestor
93347320|NCT02513433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347321|NCT02510157|Dexamethasone|dexamethasone|mesh-list
93347322|NCT02510157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347323|NCT02510157|Antiemetics|antiemetics|mesh-ancestor
93347324|NCT02510157|Autonomic Agents|autonomic agents|mesh-ancestor
93347325|NCT02510157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347326|NCT02510157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347327|NCT02510157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347328|NCT02510157|Glucocorticoids|glucocorticoids|mesh-ancestor
93347329|NCT02510157|Hormones|hormones|mesh-ancestor
93347330|NCT02510157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93347331|NCT02510157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93347332|NCT02510157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347333|NCT03345147|Vitamins|vitamins|mesh-list
93347334|NCT03345147|Vitamin A|vitamin a|mesh-list
93347335|NCT03345147|Retinol palmitate|retinol palmitate|mesh-list
93347336|NCT03345147|Micronutrients|micronutrients|mesh-ancestor
93347337|NCT03345147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347338|NCT03345147|Antioxidants|antioxidants|mesh-ancestor
93347339|NCT03345147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347340|NCT03345147|Protective Agents|protective agents|mesh-ancestor
93347341|NCT03345147|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93347342|NCT03345147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347343|NCT03662919|Adalimumab|adalimumab|mesh-list
93347344|NCT03662919|Infliximab|infliximab|mesh-list
93347345|NCT03662919|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93347346|NCT03662919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347347|NCT03662919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347348|NCT03662919|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347349|NCT03662919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347350|NCT05375240|Ceftriaxone|ceftriaxone|mesh-list
93347351|NCT05375240|Propranolol|propranolol|mesh-list
93347352|NCT05375240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93347353|NCT05375240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93347354|NCT05375240|Adrenergic Agents|adrenergic agents|mesh-ancestor
93347355|NCT05375240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347356|NCT05375240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347357|NCT05375240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347358|NCT05375240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347359|NCT05375240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93347360|NCT05375240|Vasodilator Agents|vasodilator agents|mesh-ancestor
93347361|NCT05375240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347362|NCT05375240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347363|NCT00406393|Sirolimus|sirolimus|mesh-list
93347364|NCT00406393|Methotrexate|methotrexate|mesh-list
93347365|NCT00406393|Tacrolimus|tacrolimus|mesh-list
93347366|NCT00406393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93347367|NCT00406393|Abortifacient Agents|abortifacient agents|mesh-ancestor
93347368|NCT00406393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347369|NCT00406393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347370|NCT00406393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347371|NCT00406393|Antimetabolites|antimetabolites|mesh-ancestor
93347372|NCT00406393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347373|NCT00406393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347374|NCT00406393|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347375|NCT00406393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347376|NCT00406393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93347377|NCT00406393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93347378|NCT00406393|Immunologic Factors|immunologic factors|mesh-ancestor
93347379|NCT00406393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347380|NCT00406393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93347381|NCT00406393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93347382|NCT00406393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347383|NCT00406393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347384|NCT00406393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93347385|NCT00406393|Antifungal Agents|antifungal agents|mesh-ancestor
93347386|NCT02513355|Cisplatin|cisplatin|mesh-list
93347387|NCT02513355|Endostar protein|endostar protein|mesh-list
93347388|NCT02513355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347389|NCT02513355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93347390|NCT02513355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93347391|NCT02513355|Growth Substances|growth substances|mesh-ancestor
93347392|NCT02513355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347393|NCT02513355|Growth Inhibitors|growth inhibitors|mesh-ancestor
93347394|NCT03329378|Paclitaxel|paclitaxel|mesh-list
93347395|NCT03329378|Docetaxel|docetaxel|mesh-list
93347396|NCT03329378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93347397|NCT03329378|Cyclophosphamide|cyclophosphamide|mesh-list
93347398|NCT03329378|Carboplatin|carboplatin|mesh-list
93347399|NCT03329378|Doxorubicin|doxorubicin|mesh-list
93347400|NCT03329378|Trastuzumab|trastuzumab|mesh-list
93347401|NCT03329378|Pertuzumab|pertuzumab|mesh-list
93347402|NCT03329378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93347403|NCT03329378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347404|NCT03329378|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347405|NCT03329378|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347406|NCT03329378|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347407|NCT03329378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347408|NCT03329378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93347409|NCT03329378|Immunologic Factors|immunologic factors|mesh-ancestor
93347410|NCT03329378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347411|NCT03329378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347412|NCT03329378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93347413|NCT03329378|Alkylating Agents|alkylating agents|mesh-ancestor
93347414|NCT03329378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93347415|NCT03329378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93347416|NCT03329378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93347417|NCT03329378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93347418|NCT03329378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347419|NCT03329378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347420|NCT03574285|Sarpogrelate|sarpogrelate|mesh-list
93347421|NCT03574285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93347422|NCT03574285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93347423|NCT03574285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347424|NCT03574285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93347425|NCT03574285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93347427|NCT03574285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347428|NCT03574285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347429|NCT02509923|Rabeprazole|rabeprazole|mesh-list
93347430|NCT02509923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93347431|NCT02509923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347432|NCT02509923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93347433|NCT02509923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347434|NCT02509923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347435|NCT03578263|Oxytocin|oxytocin|mesh-list
93347436|NCT03578263|Carbetocin|carbetocin|mesh-list
93347437|NCT03578263|Ergonovine|ergonovine|mesh-list
93347438|NCT03578263|Oxytocics|oxytocics|mesh-ancestor
93347439|NCT03578263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347440|NCT03578263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347441|NCT03572257|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93347442|NCT03572257|Antidepressive Agents|antidepressive agents|mesh-ancestor
93347443|NCT03572257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93347444|NCT03572257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93347445|NCT03572257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93347446|NCT03572257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347447|NCT03572257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347448|NCT02845375|Neostigmine|neostigmine|mesh-list
93347449|NCT02845375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93347450|NCT02845375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347451|NCT02845375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347452|NCT02845375|Cholinergic Agents|cholinergic agents|mesh-ancestor
93347453|NCT02845375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347454|NCT02845375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347455|NCT02845375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93347456|NCT02845375|Autonomic Agents|autonomic agents|mesh-ancestor
93347457|NCT02845375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347458|NCT02979860|Oxymetazoline|oxymetazoline|mesh-list
93347459|NCT02979860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93347460|NCT02979860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93347461|NCT02979860|Adrenergic Agents|adrenergic agents|mesh-ancestor
93347462|NCT02979860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347463|NCT02979860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347464|NCT02979860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347465|NCT02979860|Sympathomimetics|sympathomimetics|mesh-ancestor
93347466|NCT02979860|Autonomic Agents|autonomic agents|mesh-ancestor
93347467|NCT02979860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347468|NCT02979860|Nasal Decongestants|nasal decongestants|mesh-ancestor
93347469|NCT02979860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93347470|NCT02979860|Respiratory System Agents|respiratory system agents|mesh-ancestor
93347471|NCT03344679|Magnesium Sulfate|magnesium sulfate|mesh-list
93347472|NCT03344679|Adenosine|adenosine|mesh-list
93347473|NCT03344679|Bupivacaine|bupivacaine|mesh-list
93347474|NCT03344679|Anesthetics, Local|anesthetics, local|mesh-ancestor
93347475|NCT03344679|Anesthetics|anesthetics|mesh-ancestor
93347476|NCT03344679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347477|NCT03344679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347478|NCT03344679|Sensory System Agents|sensory system agents|mesh-ancestor
93347479|NCT03344679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347480|NCT03344679|Analgesics|analgesics|mesh-ancestor
93347481|NCT03344679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347482|NCT03344679|Anticonvulsants|anticonvulsants|mesh-ancestor
93347483|NCT03344679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93347484|NCT03344679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93347485|NCT03344679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347486|NCT03344679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93347487|NCT03344679|Tocolytic Agents|tocolytic agents|mesh-ancestor
92641227|NCT00411281|Cytarabine|cytarabine|mesh-list
93347488|NCT03344679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347489|NCT03344679|Vasodilator Agents|vasodilator agents|mesh-ancestor
93347490|NCT03344679|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93347491|NCT03344679|Purinergic Agonists|purinergic agonists|mesh-ancestor
93347492|NCT03344679|Purinergic Agents|purinergic agents|mesh-ancestor
93347493|NCT03344679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347494|NCT02259829|Amlodipine|amlodipine|mesh-list
93347495|NCT02259829|Telmisartan|telmisartan|mesh-list
93347496|NCT02259829|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93347497|NCT02259829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93347498|NCT02259829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93347499|NCT02259829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93347500|NCT02259829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347501|NCT02259829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93347502|NCT02259829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347503|NCT02259829|Vasodilator Agents|vasodilator agents|mesh-ancestor
93347504|NCT02259829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93347505|NCT02259829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93347506|NCT03344523|Iron protein succinylate|iron protein succinylate|mesh-list
93347507|NCT03344523|Hematinics|hematinics|mesh-ancestor
93347508|NCT02658734|Trastuzumab|trastuzumab|mesh-list
93347509|NCT02658734|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93347510|NCT02658734|Maytansine|maytansine|mesh-list
93347511|NCT02658734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347512|NCT02658734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347513|NCT02658734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93347514|NCT02658734|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347515|NCT02658734|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347516|NCT02658734|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347517|NCT02658734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347518|NCT02658734|Immunotoxins|immunotoxins|mesh-ancestor
93347519|NCT02658734|Immunoconjugates|immunoconjugates|mesh-ancestor
93347520|NCT02658734|Immunologic Factors|immunologic factors|mesh-ancestor
93347521|NCT02658734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347522|NCT03344445|Anesthetics|anesthetics|mesh-list
93347523|NCT03344445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347524|NCT03344445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347525|NCT04501107|Insulin|insulin|mesh-list
93347526|NCT04501107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93347527|NCT04501107|Insulin Lispro|insulin lispro|mesh-list
93347528|NCT04501107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93347529|NCT04501107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347530|NCT03143985|Pomalidomide|pomalidomide|mesh-list
93347531|NCT03143985|Vactosertib|vactosertib|mesh-list
93347532|NCT03143985|Immunologic Factors|immunologic factors|mesh-ancestor
93347533|NCT03143985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347534|NCT03143985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93347535|NCT03143985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93347536|NCT03143985|Growth Substances|growth substances|mesh-ancestor
93347537|NCT03143985|Growth Inhibitors|growth inhibitors|mesh-ancestor
93347538|NCT03143985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347539|NCT03143985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93347540|NCT03143985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347541|NCT03143985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347542|NCT02605148|Vitamin D|vitamin d|mesh-list
93347543|NCT02605148|Vitamins|vitamins|mesh-ancestor
93347544|NCT02605148|Micronutrients|micronutrients|mesh-ancestor
93347545|NCT02605148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347546|NCT02605148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93347547|NCT02395640|Capecitabine|capecitabine|mesh-list
93347548|NCT02395640|Oxaliplatin|oxaliplatin|mesh-list
93347549|NCT02395640|Epirubicin|epirubicin|mesh-list
93347550|NCT02395640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347551|NCT02395640|Antimetabolites|antimetabolites|mesh-ancestor
92641288|NCT01056159|Albuterol|albuterol|mesh-list
93347552|NCT02395640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347553|NCT02395640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347554|NCT02395640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93347555|NCT02395640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93347556|NCT02395640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93347557|NCT02395640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347558|NCT02509143|Ramosetron|ramosetron|mesh-list
93347559|NCT02509143|Antiemetics|antiemetics|mesh-list
93347560|NCT02509143|Autonomic Agents|autonomic agents|mesh-ancestor
93347561|NCT02509143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347562|NCT02509143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347563|NCT02509143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347564|NCT02509143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93347565|NCT02509143|Serotonin Agents|serotonin agents|mesh-ancestor
93347566|NCT02509143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347567|NCT02509143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347568|NCT05100446|Amoxicillin|amoxicillin|mesh-list
93347569|NCT05100446|Esomeprazole|esomeprazole|mesh-list
93347570|NCT05100446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347571|NCT05100446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347572|NCT05100446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93347573|NCT05100446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347574|NCT05100446|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93347575|NCT05100446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347576|NCT05100446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347577|NCT02506803|Paclitaxel|paclitaxel|mesh-list
93347578|NCT02506803|Gemcitabine|gemcitabine|mesh-list
93347579|NCT02506803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93347580|NCT02506803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347581|NCT02506803|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347582|NCT02506803|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347583|NCT02506803|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347584|NCT02506803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347585|NCT02506803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347586|NCT02506803|Antimetabolites|antimetabolites|mesh-ancestor
93347587|NCT02844439|XL647|xl647|mesh-list
93347588|NCT02844439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347589|NCT02844439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93347590|NCT02844439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347591|NCT02844439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347592|NCT04531592|Valproic Acid|valproic acid|mesh-list
93347593|NCT04531592|Anticonvulsants|anticonvulsants|mesh-ancestor
93347594|NCT04531592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347595|NCT04531592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347596|NCT04531592|GABA Agents|gaba agents|mesh-ancestor
93347597|NCT04531592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347598|NCT04531592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347599|NCT04531592|Antimanic Agents|antimanic agents|mesh-ancestor
93347600|NCT04531592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93347601|NCT04531592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347602|NCT04531592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93347603|NCT03571711|Meropenem|meropenem|mesh-list
93347604|NCT03571711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347605|NCT03571711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347606|NCT03570541|Acetaminophen|acetaminophen|mesh-list
93347607|NCT03570541|Morphine|morphine|mesh-list
93347608|NCT03570541|Ropivacaine|ropivacaine|mesh-list
93347609|NCT03570541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93347610|NCT03570541|Narcotics|narcotics|mesh-ancestor
93347611|NCT03570541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347612|NCT03570541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347613|NCT03570541|Analgesics|analgesics|mesh-ancestor
93347614|NCT03570541|Sensory System Agents|sensory system agents|mesh-ancestor
93347615|NCT03570541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347616|NCT03570541|Anesthetics, Local|anesthetics, local|mesh-ancestor
93347617|NCT03570541|Anesthetics|anesthetics|mesh-ancestor
93347618|NCT03570541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93347619|NCT03570541|Antipyretics|antipyretics|mesh-ancestor
93347620|NCT00708435|Protein C|protein c|mesh-list
93347621|NCT00708435|Protein S|protein s|mesh-list
93347622|NCT00708435|Anticoagulants|anticoagulants|mesh-ancestor
93347623|NCT00708435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93347624|NCT00708435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93347625|NCT00708435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347626|NCT02508753|Moxifloxacin|moxifloxacin|mesh-list
93347627|NCT02508753|Tazobactam|tazobactam|mesh-list
93347628|NCT02508753|Ceftolozane|ceftolozane|mesh-list
93347629|NCT02508753|Cephalosporins|cephalosporins|mesh-list
93347630|NCT02508753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347631|NCT02508753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347632|NCT02508753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93347633|NCT02508753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93347634|NCT02508753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347635|NCT02508753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347636|NCT02508753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347637|NCT02508753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93347638|NCT02506647|Insulin|insulin|mesh-list
93347639|NCT02506647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93347640|NCT02506647|Insulin Glargine|insulin glargine|mesh-list
93347641|NCT02506647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93347642|NCT02506647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347643|NCT02571530|Trastuzumab|trastuzumab|mesh-list
93347644|NCT02571530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347645|NCT02571530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347646|NCT04379024|Bazedoxifene|bazedoxifene|mesh-list
93347647|NCT04379024|Estrogens|estrogens|mesh-list
93347648|NCT04379024|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93347649|NCT04379024|Hormones|hormones|mesh-ancestor
93019567|NCT03306446|Adalimumab|adalimumab|mesh-list
93366448|NCT02796677|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93347650|NCT04379024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93347651|NCT04379024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347652|NCT04379024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93347653|NCT04379024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93347654|NCT04379024|Hormone Antagonists|hormone antagonists|mesh-ancestor
93347655|NCT04379024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93347656|NCT04497831|Morphine|morphine|mesh-list
93347657|NCT04497831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93347658|NCT04497831|Narcotics|narcotics|mesh-ancestor
93347659|NCT04497831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347660|NCT04497831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347661|NCT04497831|Analgesics|analgesics|mesh-ancestor
93347662|NCT04497831|Sensory System Agents|sensory system agents|mesh-ancestor
93347663|NCT04497831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347664|NCT04498689|Paclitaxel|paclitaxel|mesh-list
93347665|NCT04498689|Gemcitabine|gemcitabine|mesh-list
93347666|NCT04498689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93347667|NCT04498689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347668|NCT04498689|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347669|NCT04498689|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347670|NCT04498689|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347671|NCT04498689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347672|NCT04498689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347673|NCT04498689|Antimetabolites|antimetabolites|mesh-ancestor
93347674|NCT05103098|Misoprostol|misoprostol|mesh-list
93347675|NCT05103098|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93347676|NCT05103098|Abortifacient Agents|abortifacient agents|mesh-ancestor
93347677|NCT05103098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347678|NCT05103098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347679|NCT05103098|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93347680|NCT05103098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347681|NCT05103098|Oxytocics|oxytocics|mesh-ancestor
93347682|NCT04272008|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93347683|NCT04272008|Estradiol|estradiol|mesh-list
93347684|NCT04272008|Estrogens|estrogens|mesh-ancestor
93347685|NCT04272008|Hormones|hormones|mesh-ancestor
93347686|NCT04272008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93347687|NCT04272008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347688|NCT04272008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93347689|NCT04272008|Contraceptive Agents|contraceptive agents|mesh-ancestor
93347690|NCT04272008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347691|NCT04272008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93347692|NCT04272008|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93347693|NCT04272008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93347694|NCT05103020|Bevacizumab|bevacizumab|mesh-list
93347695|NCT05103020|Cetuximab|cetuximab|mesh-list
93347696|NCT05103020|Oxaliplatin|oxaliplatin|mesh-list
93347697|NCT05103020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347698|NCT05103020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347699|NCT05103020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93347700|NCT05103020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93347701|NCT05103020|Growth Substances|growth substances|mesh-ancestor
93347702|NCT05103020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347703|NCT05103020|Growth Inhibitors|growth inhibitors|mesh-ancestor
93347704|NCT02501109|Aripiprazole|aripiprazole|mesh-list
93347705|NCT02501109|Antidepressive Agents|antidepressive agents|mesh-ancestor
93347706|NCT02501109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93347707|NCT02501109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93347708|NCT02501109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93347709|NCT02501109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347710|NCT02501109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347711|NCT02501109|Dopamine Agonists|dopamine agonists|mesh-ancestor
93347712|NCT02501109|Dopamine Agents|dopamine agents|mesh-ancestor
93347713|NCT02501109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347714|NCT02501109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347715|NCT02501109|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93347716|NCT02501109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93347717|NCT02501109|Serotonin Agents|serotonin agents|mesh-ancestor
93347718|NCT02501109|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93347719|NCT02501109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93347720|NCT02501109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93347721|NCT02501109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93347722|NCT05060666|Ivermectin|ivermectin|mesh-list
93347723|NCT05060666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93347724|NCT05060666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347725|NCT02506335|Cholic Acids|cholic acids|mesh-list
93347726|NCT02506335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93347728|NCT04725032|Sevoflurane|sevoflurane|mesh-list
93347729|NCT04725032|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93347730|NCT04725032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347731|NCT04725032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347732|NCT04725032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93347733|NCT04725032|Anesthetics, General|anesthetics, general|mesh-ancestor
93347734|NCT04725032|Anesthetics|anesthetics|mesh-ancestor
93347735|NCT04725032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93347736|NCT04725032|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93347737|NCT01353859|Methotrexate|methotrexate|mesh-list
93347738|NCT01353859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93347739|NCT01353859|Abortifacient Agents|abortifacient agents|mesh-ancestor
93347740|NCT01353859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93347741|NCT01353859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347742|NCT01353859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93347743|NCT01353859|Antimetabolites|antimetabolites|mesh-ancestor
93347744|NCT01353859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347745|NCT01353859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347746|NCT01353859|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347747|NCT01353859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347748|NCT01353859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93347749|NCT01353859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93347750|NCT01353859|Immunologic Factors|immunologic factors|mesh-ancestor
93347751|NCT01353859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347752|NCT01353859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93347753|NCT02238197|Ipratropium|ipratropium|mesh-list
93347754|NCT02238197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93347755|NCT02238197|Autonomic Agents|autonomic agents|mesh-ancestor
93347756|NCT02238197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347757|NCT02238197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347758|NCT02238197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93347759|NCT02238197|Respiratory System Agents|respiratory system agents|mesh-ancestor
93347760|NCT02238197|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93347761|NCT02238197|Cholinergic Agents|cholinergic agents|mesh-ancestor
93347762|NCT02238197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347763|NCT02238197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347764|NCT03592199|Sunitinib|sunitinib|mesh-list
93347765|NCT03592199|Axitinib|axitinib|mesh-list
93347766|NCT03592199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347767|NCT03592199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93347768|NCT03592199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93347769|NCT03592199|Growth Substances|growth substances|mesh-ancestor
93347770|NCT03592199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347771|NCT03592199|Growth Inhibitors|growth inhibitors|mesh-ancestor
93347772|NCT03592199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93347773|NCT03592199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347774|NCT03592199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347775|NCT02245867|Antibodies|antibodies|mesh-list
93347776|NCT02245867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93347777|NCT02245867|Immunologic Factors|immunologic factors|mesh-ancestor
93347778|NCT02245867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347779|NCT03139916|Temozolomide|temozolomide|mesh-list
93347780|NCT03139916|Bavituximab|bavituximab|mesh-list
93347781|NCT03139916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93347782|NCT03139916|Alkylating Agents|alkylating agents|mesh-ancestor
93347783|NCT03139916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347784|NCT03139916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347785|NCT03139916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93347786|NCT02507583|Insulin|insulin|mesh-list
93347787|NCT02507583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93347788|NCT02507583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347789|NCT02506023|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93347790|NCT02506023|Hemostatics|hemostatics|mesh-ancestor
93347791|NCT02506023|Coagulants|coagulants|mesh-ancestor
93347792|NCT02506023|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93347793|NCT02506023|Natriuretic Agents|natriuretic agents|mesh-ancestor
93347794|NCT02506023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347795|NCT02246179|Lidocaine|lidocaine|mesh-list
93347796|NCT02246179|Epinephrine|epinephrine|mesh-list
93347797|NCT02246179|Prilocaine|prilocaine|mesh-list
93347798|NCT02246179|Carticaine|carticaine|mesh-list
93347799|NCT02246179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93347800|NCT02246179|Anesthetics, Local|anesthetics, local|mesh-ancestor
93347801|NCT02246179|Anesthetics|anesthetics|mesh-ancestor
93347802|NCT02246179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347803|NCT02246179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347804|NCT02246179|Sensory System Agents|sensory system agents|mesh-ancestor
93347805|NCT02246179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347806|NCT02246179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347807|NCT02246179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93347808|NCT02246179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93347809|NCT02246179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93347810|NCT02246179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347811|NCT02246179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93347812|NCT02246179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93347813|NCT02246179|Adrenergic Agents|adrenergic agents|mesh-ancestor
93347814|NCT02246179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347815|NCT02246179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93347816|NCT02246179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93347817|NCT02246179|Autonomic Agents|autonomic agents|mesh-ancestor
93347818|NCT02246179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93347819|NCT02246179|Respiratory System Agents|respiratory system agents|mesh-ancestor
93347820|NCT02246179|Mydriatics|mydriatics|mesh-ancestor
93347821|NCT02246179|Sympathomimetics|sympathomimetics|mesh-ancestor
93347822|NCT02246179|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93347823|NCT02246179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93347824|NCT02238275|Telmisartan|telmisartan|mesh-list
93347825|NCT02238275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93347826|NCT02238275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93347827|NCT02238275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93347828|NCT02238275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347829|NCT04495101|Protease Inhibitors|protease inhibitors|mesh-list
93347830|NCT04495101|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93347831|NCT04495101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347832|NCT04495101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347833|NCT04495101|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93347834|NCT04495101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93347835|NCT04394117|Losartan|losartan|mesh-list
93347836|NCT04394117|Valsartan|valsartan|mesh-list
93347837|NCT04394117|Telmisartan|telmisartan|mesh-list
93347838|NCT04394117|Candesartan|candesartan|mesh-list
93347839|NCT04394117|Olmesartan|olmesartan|mesh-list
93347840|NCT04394117|Irbesartan|irbesartan|mesh-list
93347841|NCT04394117|Eprosartan|eprosartan|mesh-list
93347842|NCT04394117|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93347843|NCT04394117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93347844|NCT04394117|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92641566|NCT00424580|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93347845|NCT04394117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347846|NCT04394117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347847|NCT04394117|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
93347848|NCT02500563|Caseins|caseins|mesh-list
93347849|NCT02500563|Chelating Agents|chelating agents|mesh-ancestor
93347850|NCT02500563|Sequestering Agents|sequestering agents|mesh-ancestor
93347851|NCT02500563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347852|NCT02500329|Acarbose|acarbose|mesh-list
93347853|NCT02500329|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93347854|NCT02500329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347855|NCT02500329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347856|NCT02500329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93347857|NCT02500329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347858|NCT02243137|Aspirin|aspirin|mesh-list
93347859|NCT02243137|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
93347860|NCT02243137|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93347861|NCT02243137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93347862|NCT02243137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93347863|NCT02243137|Analgesics|analgesics|mesh-ancestor
93347864|NCT02243137|Sensory System Agents|sensory system agents|mesh-ancestor
93347865|NCT02243137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347866|NCT02243137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347867|NCT02243137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347868|NCT02243137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347869|NCT02243137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93347870|NCT02243137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93347871|NCT02243137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347872|NCT02243137|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93347873|NCT02243137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93019786|NCT02813135|Adavosertib|adavosertib|mesh-list
93347874|NCT02243137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347875|NCT02243137|Antipyretics|antipyretics|mesh-ancestor
93347876|NCT03343977|Docetaxel|docetaxel|mesh-list
93347877|NCT03343977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93347878|NCT03343977|Tubulin Modulators|tubulin modulators|mesh-ancestor
93347879|NCT03343977|Antimitotic Agents|antimitotic agents|mesh-ancestor
93347880|NCT03343977|Mitosis Modulators|mitosis modulators|mesh-ancestor
93347881|NCT03343977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347882|NCT02850965|Adalimumab|adalimumab|mesh-list
93347883|NCT02850965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93347884|NCT02850965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347885|NCT02850965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93347886|NCT03571087|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93347887|NCT03571087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93347888|NCT03571087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93347889|NCT03571087|Antimetabolites|antimetabolites|mesh-ancestor
93347890|NCT03571087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347891|NCT03571087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93347892|NCT03571087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93347893|NCT03571087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347894|NCT04557644|Dermatologic Agents|dermatologic agents|mesh-list
93347895|NCT01375959|Resveratrol|resveratrol|mesh-list
93347896|NCT01375959|Antioxidants|antioxidants|mesh-ancestor
93347897|NCT01375959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347898|NCT01375959|Protective Agents|protective agents|mesh-ancestor
93347899|NCT01375959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347900|NCT01375959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347901|NCT01375959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93347902|NCT02238353|Fluticasone|fluticasone|mesh-list
93347903|NCT02238353|Azelastine|azelastine|mesh-list
93347904|NCT02238353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93347905|NCT02238353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93347906|NCT02238353|Autonomic Agents|autonomic agents|mesh-ancestor
93347907|NCT02238353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347908|NCT02238353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347909|NCT02238353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93347910|NCT02238353|Respiratory System Agents|respiratory system agents|mesh-ancestor
93347911|NCT02238353|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347912|NCT02238353|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93347913|NCT02238353|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93347914|NCT02238353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932301|NCT03533231|Propolis|propolis|mesh-list
93347915|NCT02238353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347916|NCT02238353|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93347917|NCT02238353|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93347918|NCT02238353|Histamine Antagonists|histamine antagonists|mesh-ancestor
93347919|NCT02238353|Histamine Agents|histamine agents|mesh-ancestor
93347920|NCT02238353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347921|NCT04482686|Vitamin D|vitamin d|mesh-list
93347922|NCT04482686|Cholecalciferol|cholecalciferol|mesh-list
93347923|NCT04482686|Vitamins|vitamins|mesh-list
93347924|NCT04482686|Ascorbic Acid|ascorbic acid|mesh-list
93347925|NCT04482686|Zinc|zinc|mesh-list
93347926|NCT04482686|Doxycycline|doxycycline|mesh-list
93347927|NCT04482686|Ivermectin|ivermectin|mesh-list
93347928|NCT04482686|Zinc Sulfate|zinc sulfate|mesh-list
93347929|NCT04482686|Micronutrients|micronutrients|mesh-ancestor
93347930|NCT04482686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347931|NCT04482686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93347932|NCT04482686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93347933|NCT04482686|Trace Elements|trace elements|mesh-ancestor
93347934|NCT04482686|Antioxidants|antioxidants|mesh-ancestor
93347935|NCT04482686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347936|NCT04482686|Protective Agents|protective agents|mesh-ancestor
93347937|NCT04482686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93347938|NCT04482686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93347939|NCT04482686|Antimalarials|antimalarials|mesh-ancestor
93347940|NCT04482686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93347941|NCT04482686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93347942|NCT04482686|Astringents|astringents|mesh-ancestor
93347943|NCT04482686|Dermatologic Agents|dermatologic agents|mesh-ancestor
93347944|NCT03580889|Atropine|atropine|mesh-list
93347945|NCT03580889|Glycopyrrolate|glycopyrrolate|mesh-list
93347946|NCT03580889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93347947|NCT03580889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347948|NCT03580889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93347949|NCT03580889|Autonomic Agents|autonomic agents|mesh-ancestor
93347950|NCT03580889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019862|NCT02425852|Glucocorticoids|glucocorticoids|mesh-ancestor
93347951|NCT03580889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347952|NCT03580889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93347953|NCT03580889|Respiratory System Agents|respiratory system agents|mesh-ancestor
93347954|NCT03580889|Mydriatics|mydriatics|mesh-ancestor
93347955|NCT03580889|Parasympatholytics|parasympatholytics|mesh-ancestor
93347956|NCT03580889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93347957|NCT03580889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93347958|NCT03580889|Cholinergic Agents|cholinergic agents|mesh-ancestor
93347959|NCT03580889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347960|NCT03580889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347961|NCT02500017|Melatonin|melatonin|mesh-list
93347962|NCT02500017|Antioxidants|antioxidants|mesh-ancestor
93347963|NCT02500017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347964|NCT02500017|Protective Agents|protective agents|mesh-ancestor
93347965|NCT02500017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347966|NCT02500017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347967|NCT02505633|Lidocaine|lidocaine|mesh-list
93347968|NCT02505633|Epinephrine|epinephrine|mesh-list
93347969|NCT02505633|Racepinephrine|racepinephrine|mesh-list
93347970|NCT02505633|Epinephryl borate|epinephryl borate|mesh-list
93347971|NCT02505633|Anesthetics, Local|anesthetics, local|mesh-ancestor
93347972|NCT02505633|Anesthetics|anesthetics|mesh-ancestor
93347973|NCT02505633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93347974|NCT02505633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93347975|NCT02505633|Sensory System Agents|sensory system agents|mesh-ancestor
93347976|NCT02505633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93347977|NCT02505633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93347978|NCT02505633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93347979|NCT02505633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93347980|NCT02505633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93347981|NCT02505633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347982|NCT02505633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93347983|NCT02505633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93347984|NCT02505633|Adrenergic Agents|adrenergic agents|mesh-ancestor
93347985|NCT02505633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93347986|NCT02505633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93347987|NCT02505633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93347988|NCT02505633|Autonomic Agents|autonomic agents|mesh-ancestor
93347989|NCT02505633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93347990|NCT02505633|Respiratory System Agents|respiratory system agents|mesh-ancestor
93347991|NCT02505633|Mydriatics|mydriatics|mesh-ancestor
93347992|NCT02505633|Sympathomimetics|sympathomimetics|mesh-ancestor
93347993|NCT02505633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93347994|NCT03587441|Neostigmine|neostigmine|mesh-list
93347995|NCT03587441|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93347996|NCT03587441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93347997|NCT03587441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93347998|NCT03587441|Cholinergic Agents|cholinergic agents|mesh-ancestor
93347999|NCT03587441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348000|NCT03587441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348001|NCT03587441|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93348002|NCT03587441|Autonomic Agents|autonomic agents|mesh-ancestor
93348003|NCT03587441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348004|NCT05102396|Mandelic Acids|mandelic acids|mesh-list
93348005|NCT05102396|Oxybutynin|oxybutynin|mesh-list
93348006|NCT05102396|Parasympatholytics|parasympatholytics|mesh-ancestor
93348007|NCT05102396|Autonomic Agents|autonomic agents|mesh-ancestor
93348008|NCT05102396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348009|NCT05102396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348010|NCT05102396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93348011|NCT05102396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93348012|NCT05102396|Cholinergic Agents|cholinergic agents|mesh-ancestor
93348013|NCT05102396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348014|NCT05102396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348015|NCT05102396|Urological Agents|urological agents|mesh-ancestor
93348016|NCT05102396|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93348017|NCT05102396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348018|NCT01165645|Ritonavir|ritonavir|mesh-list
93348019|NCT01165645|Lopinavir|lopinavir|mesh-list
93348020|NCT01165645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93348021|NCT01165645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93348022|NCT01165645|Protease Inhibitors|protease inhibitors|mesh-ancestor
93348023|NCT01165645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348024|NCT01165645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019939|NCT02166463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348025|NCT01165645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93348026|NCT01165645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93348027|NCT01165645|Antiviral Agents|antiviral agents|mesh-ancestor
93348028|NCT01165645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348029|NCT01165645|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93348030|NCT01165645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93348031|NCT03579875|Methylprednisolone|methylprednisolone|mesh-list
93348032|NCT03579875|Cyclophosphamide|cyclophosphamide|mesh-list
93348033|NCT03579875|Busulfan|busulfan|mesh-list
93348034|NCT03579875|Rituximab|rituximab|mesh-list
93348035|NCT03579875|Fludarabine|fludarabine|mesh-list
93348036|NCT03579875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348037|NCT03579875|Immunologic Factors|immunologic factors|mesh-ancestor
93348038|NCT03579875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348039|NCT03579875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348040|NCT03579875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93348041|NCT03579875|Alkylating Agents|alkylating agents|mesh-ancestor
93348042|NCT03579875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348043|NCT03579875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348044|NCT03579875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93348045|NCT03579875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348046|NCT03579875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348047|NCT03579875|Antiemetics|antiemetics|mesh-ancestor
93348048|NCT03579875|Autonomic Agents|autonomic agents|mesh-ancestor
93348049|NCT03579875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348050|NCT03579875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93348051|NCT03579875|Glucocorticoids|glucocorticoids|mesh-ancestor
93348052|NCT03579875|Hormones|hormones|mesh-ancestor
93348053|NCT03579875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348054|NCT03579875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93348055|NCT03579875|Protective Agents|protective agents|mesh-ancestor
93348056|NCT03569995|Cytarabine|cytarabine|mesh-list
93348057|NCT03569995|Rituximab|rituximab|mesh-list
93348058|NCT03569995|Methotrexate|methotrexate|mesh-list
93348059|NCT03569995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348060|NCT03569995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348061|NCT03569995|Immunologic Factors|immunologic factors|mesh-ancestor
93348062|NCT03569995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348063|NCT03569995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348064|NCT03569995|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93348065|NCT03569995|Abortifacient Agents|abortifacient agents|mesh-ancestor
93348066|NCT03569995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348067|NCT03569995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93348068|NCT03569995|Antimetabolites|antimetabolites|mesh-ancestor
93348069|NCT03569995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348070|NCT03569995|Dermatologic Agents|dermatologic agents|mesh-ancestor
93348071|NCT03569995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348072|NCT03569995|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93348073|NCT03569995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348074|NCT03569995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93348075|NCT03569995|Antiviral Agents|antiviral agents|mesh-ancestor
93348076|NCT03569995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348077|NCT02238431|Leuprolide|leuprolide|mesh-list
93348078|NCT02238431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93348079|NCT02238431|Fertility Agents|fertility agents|mesh-ancestor
93348080|NCT02238431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348081|NCT02238431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348082|NCT02238431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93348083|NCT02238431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348084|NCT05122598|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
93348085|NCT05122598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348086|NCT02238509|Trastuzumab|trastuzumab|mesh-list
93348087|NCT02238509|Lapatinib|lapatinib|mesh-list
93348088|NCT02238509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348089|NCT02238509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348090|NCT02238509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93348091|NCT02238509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348092|NCT02238509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348093|NCT03579914|Metoprolol|metoprolol|mesh-list
93348094|NCT03579914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93348095|NCT03579914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93348096|NCT03579914|Sympatholytics|sympatholytics|mesh-ancestor
93348097|NCT03579914|Autonomic Agents|autonomic agents|mesh-ancestor
93348098|NCT03579914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348099|NCT03579914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020018|NCT01806571|Cytarabine|cytarabine|mesh-list
93348100|NCT03579914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93348101|NCT03579914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93348102|NCT03579914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93348103|NCT03579914|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348104|NCT03579914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348105|NCT03579914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348106|NCT03573037|Anticoagulants|anticoagulants|mesh-list
93348107|NCT05354635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93348108|NCT05354635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348109|NCT03585413|Micronutrients|micronutrients|mesh-list
93348110|NCT03585413|Trace Elements|trace elements|mesh-list
93348111|NCT03585413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348112|NCT03569683|Hyaluronic Acid|hyaluronic acid|mesh-list
93348113|NCT03569683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93348114|NCT03569683|Immunologic Factors|immunologic factors|mesh-ancestor
93348115|NCT03569683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348116|NCT03569683|Viscosupplements|viscosupplements|mesh-ancestor
93348117|NCT03569683|Protective Agents|protective agents|mesh-ancestor
93348118|NCT00708201|Alvimopan|alvimopan|mesh-list
93348119|NCT00708201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93348120|NCT03572959|Triamcinolone|triamcinolone|mesh-list
93348121|NCT03572959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93348122|NCT03572959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93348123|NCT03572959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93348124|NCT03572959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348125|NCT03572959|Glucocorticoids|glucocorticoids|mesh-ancestor
93348126|NCT03572959|Hormones|hormones|mesh-ancestor
93348127|NCT03572959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348128|NCT03572959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348129|NCT03572959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348130|NCT03572959|Immunologic Factors|immunologic factors|mesh-ancestor
93348131|NCT03572959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348132|NCT03572959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348133|NCT02500251|Rituximab|rituximab|mesh-list
93348134|NCT02500251|Bortezomib|bortezomib|mesh-list
93348135|NCT02500251|Belimumab|belimumab|mesh-list
93348136|NCT02500251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348137|NCT02500251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348138|NCT02500251|Immunologic Factors|immunologic factors|mesh-ancestor
93348139|NCT02500251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348140|NCT02500251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348141|NCT02500251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348142|NCT03568513|Curcumin|curcumin|mesh-list
93348143|NCT03568513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93348144|NCT03568513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348145|NCT03568513|Analgesics|analgesics|mesh-ancestor
93348146|NCT03568513|Sensory System Agents|sensory system agents|mesh-ancestor
93348147|NCT03568513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348148|NCT03568513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348149|NCT03568513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348150|NCT03568513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348151|NCT03568513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348152|NCT03568513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348153|NCT03568513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348154|NCT02982668|Metoclopramide|metoclopramide|mesh-list
93348155|NCT02982668|Mosapride|mosapride|mesh-list
93348156|NCT02982668|Antiemetics|antiemetics|mesh-ancestor
93348157|NCT02982668|Autonomic Agents|autonomic agents|mesh-ancestor
93348158|NCT02982668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348159|NCT02982668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348160|NCT02982668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93348161|NCT02982668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93348162|NCT02982668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93348163|NCT02982668|Dopamine Agents|dopamine agents|mesh-ancestor
93348164|NCT02982668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348165|NCT02982668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348166|NCT02982668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93348167|NCT02982668|Serotonin Agents|serotonin agents|mesh-ancestor
93348168|NCT02398526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93348169|NCT02398526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348170|NCT05354479|Acetaminophen|acetaminophen|mesh-list
93348171|NCT05354479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348172|NCT05354479|Analgesics|analgesics|mesh-ancestor
93348173|NCT05354479|Sensory System Agents|sensory system agents|mesh-ancestor
93348174|NCT05354479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348175|NCT05354479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348176|NCT05354479|Antipyretics|antipyretics|mesh-ancestor
93348177|NCT02505399|Clopidogrel|clopidogrel|mesh-list
93348178|NCT02505399|Ticagrelor|ticagrelor|mesh-list
93348179|NCT02505399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93348180|NCT02505399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93348181|NCT02505399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93348182|NCT02505399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93348183|NCT02505399|Purinergic Agents|purinergic agents|mesh-ancestor
93348184|NCT02505399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348185|NCT02505399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348186|NCT02505399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348187|NCT02728089|Tazobactam|tazobactam|mesh-list
93348188|NCT02728089|Ceftolozane|ceftolozane|mesh-list
93348189|NCT02728089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348190|NCT02728089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348191|NCT02728089|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93348192|NCT02728089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348193|NCT02728089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348194|NCT05110118|Bevacizumab|bevacizumab|mesh-list
93348195|NCT05110118|Endothelial Growth Factors|endothelial growth factors|mesh-list
93348196|NCT05110118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348197|NCT05110118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348198|NCT05110118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93348199|NCT05110118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93348200|NCT05110118|Growth Substances|growth substances|mesh-ancestor
93348201|NCT05110118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348202|NCT05110118|Growth Inhibitors|growth inhibitors|mesh-ancestor
93348203|NCT03572647|Epoetin Alfa|epoetin alfa|mesh-list
93348204|NCT03572647|Hematinics|hematinics|mesh-ancestor
93348205|NCT02495181|Aflibercept|aflibercept|mesh-list
93348206|NCT02495181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93348207|NCT02495181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93348208|NCT02495181|Growth Substances|growth substances|mesh-ancestor
93348209|NCT02495181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348210|NCT02495181|Growth Inhibitors|growth inhibitors|mesh-ancestor
93348211|NCT02495181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348212|NCT02499861|Decitabine|decitabine|mesh-list
93348213|NCT02499861|Genistein|genistein|mesh-list
93348214|NCT02499861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93348215|NCT02499861|Antimetabolites|antimetabolites|mesh-ancestor
93348216|NCT02499861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348217|NCT02499861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348218|NCT02499861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348219|NCT02499861|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93348220|NCT02499861|Protective Agents|protective agents|mesh-ancestor
93348221|NCT02499861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348222|NCT02499861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93348223|NCT02499861|Phytoestrogens|phytoestrogens|mesh-ancestor
93348224|NCT02499861|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93348225|NCT02499861|Estrogens|estrogens|mesh-ancestor
93348226|NCT02499861|Hormones|hormones|mesh-ancestor
93348227|NCT02499861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348228|NCT05505435|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93348229|NCT05505435|Medroxyprogesterone|medroxyprogesterone|mesh-list
93348230|NCT05505435|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93348231|NCT05505435|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93348232|NCT05505435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93348233|NCT05505435|Contraceptive Agents|contraceptive agents|mesh-ancestor
93348234|NCT05505435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348235|NCT05505435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348236|NCT05505435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93348237|NCT05505435|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93348238|NCT05505435|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93348239|NCT05505435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93348240|NCT05505435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348241|NCT02840461|Ivermectin|ivermectin|mesh-list
93348242|NCT02840461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348243|NCT02840461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348244|NCT05108714|Lidocaine|lidocaine|mesh-list
93348245|NCT05108714|Anesthetics, Local|anesthetics, local|mesh-ancestor
93348246|NCT05108714|Anesthetics|anesthetics|mesh-ancestor
93348247|NCT05108714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348248|NCT05108714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348249|NCT05108714|Sensory System Agents|sensory system agents|mesh-ancestor
93348250|NCT05108714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348251|NCT05108714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93348252|NCT05108714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93348253|NCT05108714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93348254|NCT05108714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93348255|NCT05108714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348256|NCT02495415|Fenretinide|fenretinide|mesh-list
93348257|NCT02495415|Retinamide|retinamide|mesh-list
93348258|NCT02495415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348259|NCT02495415|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93348260|NCT02495415|Protective Agents|protective agents|mesh-ancestor
93348261|NCT02495415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348262|NCT02505009|Tenofovir|tenofovir|mesh-list
93348263|NCT02505009|Entecavir|entecavir|mesh-list
93348264|NCT02505009|Antiviral Agents|antiviral agents|mesh-ancestor
93348265|NCT02505009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348266|NCT02505009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93348267|NCT02505009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93348268|NCT02505009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348269|NCT02505009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348270|NCT02505009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93348271|NCT02505009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93348272|NCT05353543|Antidepressive Agents|antidepressive agents|mesh-list
93348273|NCT05353543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93348274|NCT02499627|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93348275|NCT02499627|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92641997|NCT00209495|Autonomic Agents|autonomic agents|mesh-ancestor
93348276|NCT02499627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93348277|NCT02499627|Alkylating Agents|alkylating agents|mesh-ancestor
93348278|NCT02499627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348279|NCT02499627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348280|NCT02499627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348281|NCT02499627|Immunotoxins|immunotoxins|mesh-ancestor
93348282|NCT02499627|Immunoconjugates|immunoconjugates|mesh-ancestor
93348283|NCT02499627|Immunologic Factors|immunologic factors|mesh-ancestor
93348284|NCT02499627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348285|NCT03567655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93348286|NCT03567655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93348287|NCT03567655|Contraceptive Agents|contraceptive agents|mesh-ancestor
93348288|NCT03567655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348289|NCT03567655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348290|NCT03567655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93348291|NCT03567655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93348292|NCT03567655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93348293|NCT03567655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348294|NCT02505087|Acetylcysteine|acetylcysteine|mesh-list
93348295|NCT02505087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93348296|NCT02505087|Antiviral Agents|antiviral agents|mesh-ancestor
93348297|NCT02505087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348298|NCT02505087|Expectorants|expectorants|mesh-ancestor
93348299|NCT02505087|Respiratory System Agents|respiratory system agents|mesh-ancestor
93348300|NCT02505087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93348301|NCT02505087|Antioxidants|antioxidants|mesh-ancestor
93348302|NCT02505087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348303|NCT02505087|Protective Agents|protective agents|mesh-ancestor
93348304|NCT02505087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348305|NCT02505087|Antidotes|antidotes|mesh-ancestor
93348306|NCT02839681|Maytansine|maytansine|mesh-list
93348307|NCT02839681|Anetumab ravtansine|anetumab ravtansine|mesh-list
93348308|NCT02839681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93348309|NCT02839681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348310|NCT02839681|Tubulin Modulators|tubulin modulators|mesh-ancestor
93348311|NCT02839681|Antimitotic Agents|antimitotic agents|mesh-ancestor
93348312|NCT02839681|Mitosis Modulators|mitosis modulators|mesh-ancestor
93348313|NCT02839681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348314|NCT02839681|Immunoconjugates|immunoconjugates|mesh-ancestor
93348315|NCT02839681|Immunologic Factors|immunologic factors|mesh-ancestor
93348316|NCT02839681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348317|NCT02504463|Naltrexone|naltrexone|mesh-list
93348318|NCT02504463|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93348319|NCT02504463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93348320|NCT02504463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348321|NCT02504463|Sensory System Agents|sensory system agents|mesh-ancestor
93348322|NCT02504463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348323|NCT03566329|Lidocaine|lidocaine|mesh-list
93348324|NCT03566329|Magnesium Sulfate|magnesium sulfate|mesh-list
93348325|NCT03566329|Anesthetics, Local|anesthetics, local|mesh-ancestor
93348326|NCT03566329|Anesthetics|anesthetics|mesh-ancestor
93348327|NCT03566329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348328|NCT03566329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348329|NCT03566329|Sensory System Agents|sensory system agents|mesh-ancestor
93348330|NCT03566329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348331|NCT03566329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93348332|NCT03566329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93348333|NCT03566329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93348334|NCT03566329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93348335|NCT03566329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348336|NCT03566329|Analgesics|analgesics|mesh-ancestor
93348337|NCT03566329|Anticonvulsants|anticonvulsants|mesh-ancestor
93348338|NCT03566329|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93348339|NCT03566329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93348340|NCT03566329|Tocolytic Agents|tocolytic agents|mesh-ancestor
93348341|NCT03566329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348342|NCT02499237|Zoledronic Acid|zoledronic acid|mesh-list
93348343|NCT02499237|Denosumab|denosumab|mesh-list
93348344|NCT02499237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93348345|NCT02499237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348346|NCT02499393|Magnesium Sulfate|magnesium sulfate|mesh-list
93348347|NCT02499393|Analgesics|analgesics|mesh-ancestor
93348348|NCT02499393|Sensory System Agents|sensory system agents|mesh-ancestor
93348349|NCT02499393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348350|NCT02499393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348351|NCT02499393|Anesthetics|anesthetics|mesh-ancestor
93348352|NCT02499393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348353|NCT02499393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93348354|NCT02499393|Anticonvulsants|anticonvulsants|mesh-ancestor
93348355|NCT02499393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93348356|NCT02499393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93348357|NCT02499393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348358|NCT02499393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93348359|NCT02499393|Tocolytic Agents|tocolytic agents|mesh-ancestor
93348360|NCT02499393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348361|NCT02504307|Sirolimus|sirolimus|mesh-list
93348362|NCT02504307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348363|NCT02504307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348364|NCT02504307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93348365|NCT02504307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348366|NCT02504307|Antifungal Agents|antifungal agents|mesh-ancestor
93348367|NCT02504307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348368|NCT02504307|Immunologic Factors|immunologic factors|mesh-ancestor
93348369|NCT02504307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348370|NCT02504229|Oxaliplatin|oxaliplatin|mesh-list
93348371|NCT02504229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348372|NCT03567343|Melatonin|melatonin|mesh-list
93348373|NCT03567343|Antioxidants|antioxidants|mesh-ancestor
93348374|NCT03567343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348375|NCT03567343|Protective Agents|protective agents|mesh-ancestor
93348376|NCT03567343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348377|NCT03567343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348378|NCT04595864|Leucovorin|leucovorin|mesh-list
93348379|NCT04595864|Oxaliplatin|oxaliplatin|mesh-list
93348380|NCT04595864|Calcium|calcium|mesh-list
93348381|NCT04595864|Levoleucovorin|levoleucovorin|mesh-list
93348382|NCT04595864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93348383|NCT04595864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348384|NCT04595864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348385|NCT04595864|Antidotes|antidotes|mesh-ancestor
93348386|NCT04595864|Protective Agents|protective agents|mesh-ancestor
93348387|NCT04595864|Vitamin B Complex|vitamin b complex|mesh-ancestor
93348388|NCT04595864|Vitamins|vitamins|mesh-ancestor
93348389|NCT04595864|Micronutrients|micronutrients|mesh-ancestor
93348390|NCT04583462|Metformin|metformin|mesh-list
93348391|NCT04583462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348392|NCT04583462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348393|NCT04456322|Cisplatin|cisplatin|mesh-list
93348394|NCT04456322|Nimotuzumab|nimotuzumab|mesh-list
93348395|NCT04456322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348396|NCT04456322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348397|NCT02503761|Meropenem|meropenem|mesh-list
93348398|NCT02503761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348399|NCT02503761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348400|NCT04305548|Trabectedin|trabectedin|mesh-list
93348401|NCT04305548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93348402|NCT04305548|Alkylating Agents|alkylating agents|mesh-ancestor
93348403|NCT04305548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348404|NCT04305548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348405|NCT04097912|Aspirin|aspirin|mesh-list
93348406|NCT04097912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93348407|NCT04097912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348408|NCT04097912|Analgesics|analgesics|mesh-ancestor
93348409|NCT04097912|Sensory System Agents|sensory system agents|mesh-ancestor
93348410|NCT04097912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348411|NCT04097912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348412|NCT04097912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348413|NCT04097912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348414|NCT04097912|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93348415|NCT04097912|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93348416|NCT04097912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348417|NCT04097912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93348418|NCT04097912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93348419|NCT04097912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348420|NCT04097912|Antipyretics|antipyretics|mesh-ancestor
93348421|NCT04966676|Nivolumab|nivolumab|mesh-list
93348422|NCT04966676|Ipilimumab|ipilimumab|mesh-list
93348423|NCT04966676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348424|NCT04966676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348425|NCT04966676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93348426|NCT04966676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348427|NCT03340779|Dobutamine|dobutamine|mesh-list
93348428|NCT03340779|Norepinephrine|norepinephrine|mesh-list
93348429|NCT03340779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93348430|NCT03340779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348431|NCT03340779|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348432|NCT03340779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348433|NCT03340779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348434|NCT03340779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348435|NCT03340779|Sympathomimetics|sympathomimetics|mesh-ancestor
93348436|NCT03340779|Autonomic Agents|autonomic agents|mesh-ancestor
93348437|NCT03340779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348438|NCT03340779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93348439|NCT03340779|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93348440|NCT03340779|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93348441|NCT03340779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93348442|NCT03340779|Protective Agents|protective agents|mesh-ancestor
93348443|NCT04040738|Anesthetics|anesthetics|mesh-list
93348444|NCT04040738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348445|NCT04040738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348446|NCT05104424|Insulin Aspart|insulin aspart|mesh-list
93348447|NCT05104424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348448|NCT05104424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348449|NCT05087732|Lidocaine|lidocaine|mesh-list
93348450|NCT05087732|Anesthetics, Local|anesthetics, local|mesh-ancestor
93348451|NCT05087732|Anesthetics|anesthetics|mesh-ancestor
93348452|NCT05087732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348453|NCT05087732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348454|NCT05087732|Sensory System Agents|sensory system agents|mesh-ancestor
93348455|NCT05087732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348456|NCT05087732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93348457|NCT05087732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93348458|NCT05087732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93348459|NCT05087732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93348460|NCT05087732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348461|NCT03340701|Progesterone|progesterone|mesh-list
93348462|NCT03340701|Progestins|progestins|mesh-ancestor
93348463|NCT03340701|Hormones|hormones|mesh-ancestor
93348464|NCT03340701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348465|NCT03340701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348466|NCT02498535|Nitric Oxide|nitric oxide|mesh-list
93348467|NCT02498535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93348468|NCT02498535|Autonomic Agents|autonomic agents|mesh-ancestor
93348469|NCT02498535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348470|NCT02498535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348471|NCT02498535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93348472|NCT02498535|Respiratory System Agents|respiratory system agents|mesh-ancestor
93348473|NCT02498535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93348474|NCT02498535|Antioxidants|antioxidants|mesh-ancestor
93366449|NCT02796677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348475|NCT02498535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348476|NCT02498535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348477|NCT02498535|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93348478|NCT02498535|Vasodilator Agents|vasodilator agents|mesh-ancestor
93348479|NCT02498535|Gasotransmitters|gasotransmitters|mesh-ancestor
93348480|NCT02498535|Protective Agents|protective agents|mesh-ancestor
93348481|NCT04727138|Midazolam|midazolam|mesh-list
93348482|NCT04727138|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93348483|NCT04727138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93348484|NCT04727138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348485|NCT04727138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348486|NCT04727138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93348487|NCT04727138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93348488|NCT04727138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93348489|NCT04727138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93348490|NCT04727138|Anesthetics, General|anesthetics, general|mesh-ancestor
93348491|NCT04727138|Anesthetics|anesthetics|mesh-ancestor
93348492|NCT04727138|GABA Modulators|gaba modulators|mesh-ancestor
93348493|NCT04727138|GABA Agents|gaba agents|mesh-ancestor
93348494|NCT04727138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348495|NCT04727138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348496|NCT02498457|Calcium|calcium|mesh-list
93348497|NCT02498457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93348498|NCT02498457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348499|NCT02498301|Rifaximin|rifaximin|mesh-list
93348500|NCT02498301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348501|NCT02498301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348502|NCT02498301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93348503|NCT03343665|Nivolumab|nivolumab|mesh-list
93348504|NCT03343665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348505|NCT03343665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348506|NCT03343665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93348507|NCT03343665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348508|NCT02733614|SRX246|srx246|mesh-list
93348509|NCT02733614|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93348510|NCT02733614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348511|NCT02733614|Natriuretic Agents|natriuretic agents|mesh-ancestor
93348512|NCT02733614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348513|NCT04674254|Bevacizumab|bevacizumab|mesh-list
93348514|NCT04674254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348515|NCT04674254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348516|NCT04674254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93348517|NCT04674254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93348518|NCT04674254|Growth Substances|growth substances|mesh-ancestor
93348519|NCT04674254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348520|NCT04674254|Growth Inhibitors|growth inhibitors|mesh-ancestor
93348521|NCT03342807|Insulin|insulin|mesh-list
93348522|NCT03342807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348523|NCT03342807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348524|NCT02570672|Metformin|metformin|mesh-list
93348525|NCT02570672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348526|NCT02570672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348527|NCT03339921|Botulinum Toxins|botulinum toxins|mesh-list
93348528|NCT03339921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93348529|NCT03339921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93348530|NCT03339921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348531|NCT03339921|Cholinergic Agents|cholinergic agents|mesh-ancestor
93348532|NCT03339921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348533|NCT03339921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348534|NCT04593914|Protective Agents|protective agents|mesh-list
93348535|NCT04593914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348536|NCT04523090|Nitazoxanide|nitazoxanide|mesh-list
93348537|NCT04523090|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348538|NCT04523090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348539|NCT03342651|Vitamin D|vitamin d|mesh-list
93348540|NCT03342651|Vitamins|vitamins|mesh-ancestor
93348541|NCT03342651|Micronutrients|micronutrients|mesh-ancestor
93348542|NCT03342651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348543|NCT03342651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93348544|NCT04819568|Terlipressin|terlipressin|mesh-list
93348545|NCT04819568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93348546|NCT04819568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93348547|NCT02502981|Chlorthalidone|chlorthalidone|mesh-list
93348548|NCT02502981|Spironolactone|spironolactone|mesh-list
93348549|NCT02502981|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
93348550|NCT02502981|Diuretics|diuretics|mesh-list
93348551|NCT02502981|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
93348552|NCT02502981|Mineralocorticoids|mineralocorticoids|mesh-list
93348553|NCT02502981|Hormone Antagonists|hormone antagonists|mesh-ancestor
93348554|NCT02502981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348555|NCT02502981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348556|NCT02502981|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93348557|NCT02502981|Natriuretic Agents|natriuretic agents|mesh-ancestor
93348558|NCT02502981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93348559|NCT02502981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93348560|NCT02502981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348561|NCT02502981|Hormones|hormones|mesh-ancestor
93348562|NCT04230746|Trimethoprim|trimethoprim|mesh-list
93348563|NCT04230746|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93348564|NCT04230746|Sulfamethoxazole|sulfamethoxazole|mesh-list
93348565|NCT04230746|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93348566|NCT04230746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348567|NCT04230746|Antimalarials|antimalarials|mesh-ancestor
93348568|NCT04230746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93348569|NCT04230746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348570|NCT04230746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93348571|NCT04230746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348572|NCT04230746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348573|NCT04230746|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93348574|NCT04230746|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93348575|NCT04230746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93348576|NCT04230746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348577|NCT04633772|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93348578|NCT04633772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93348579|NCT04633772|Vasodilator Agents|vasodilator agents|mesh-ancestor
93348580|NCT05111444|Paclitaxel|paclitaxel|mesh-list
93348581|NCT05111444|Capecitabine|capecitabine|mesh-list
93348582|NCT05111444|Oxaliplatin|oxaliplatin|mesh-list
93348583|NCT05111444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93348584|NCT05111444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348585|NCT05111444|Tubulin Modulators|tubulin modulators|mesh-ancestor
93348586|NCT05111444|Antimitotic Agents|antimitotic agents|mesh-ancestor
93348587|NCT05111444|Mitosis Modulators|mitosis modulators|mesh-ancestor
93348588|NCT05111444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348589|NCT05111444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93348590|NCT05111444|Antimetabolites|antimetabolites|mesh-ancestor
93348591|NCT03769688|Metronidazole|metronidazole|mesh-list
93348592|NCT03769688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348593|NCT03769688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348594|NCT03769688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93348595|NCT03769688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348596|NCT02502825|Methacholine Chloride|methacholine chloride|mesh-list
93348597|NCT02502825|Miotics|miotics|mesh-ancestor
93348598|NCT02502825|Autonomic Agents|autonomic agents|mesh-ancestor
93348599|NCT02502825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348600|NCT02502825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348601|NCT02502825|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93348602|NCT02502825|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93348603|NCT02502825|Respiratory System Agents|respiratory system agents|mesh-ancestor
93348604|NCT02502825|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93348605|NCT02502825|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93348606|NCT02502825|Cholinergic Agents|cholinergic agents|mesh-ancestor
93348607|NCT02502825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348608|NCT02502825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348609|NCT02498145|Nicotine|nicotine|mesh-list
93348610|NCT02498145|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93348611|NCT02498145|Autonomic Agents|autonomic agents|mesh-ancestor
93348612|NCT02498145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348613|NCT02498145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348614|NCT02498145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93348615|NCT02498145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93348616|NCT02498145|Cholinergic Agents|cholinergic agents|mesh-ancestor
93348617|NCT02498145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348618|NCT02498145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348619|NCT02497911|Bupivacaine|bupivacaine|mesh-list
93348620|NCT02497911|Anesthetics, Local|anesthetics, local|mesh-ancestor
93348621|NCT02497911|Anesthetics|anesthetics|mesh-ancestor
93348622|NCT02497911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348623|NCT02497911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366450|NCT02796677|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348624|NCT02497911|Sensory System Agents|sensory system agents|mesh-ancestor
93348625|NCT02497911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348627|NCT02497833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348628|NCT02497833|Keratolytic Agents|keratolytic agents|mesh-ancestor
93348629|NCT02497833|Dermatologic Agents|dermatologic agents|mesh-ancestor
93348630|NCT02493933|Acetylcysteine|acetylcysteine|mesh-list
93348631|NCT02493933|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93348632|NCT02493933|Phytoestrogens|phytoestrogens|mesh-list
93348633|NCT02493933|Antiviral Agents|antiviral agents|mesh-ancestor
93348634|NCT02493933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348635|NCT02493933|Expectorants|expectorants|mesh-ancestor
93348636|NCT02493933|Respiratory System Agents|respiratory system agents|mesh-ancestor
93348637|NCT02493933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93348638|NCT02493933|Antioxidants|antioxidants|mesh-ancestor
93348639|NCT02493933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348640|NCT02493933|Protective Agents|protective agents|mesh-ancestor
93348641|NCT02493933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348642|NCT02493933|Antidotes|antidotes|mesh-ancestor
93348643|NCT02493933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93348644|NCT02493933|Estrogens|estrogens|mesh-ancestor
93348645|NCT02493933|Hormones|hormones|mesh-ancestor
93348646|NCT02493933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348647|NCT04153604|Doxycycline|doxycycline|mesh-list
93348648|NCT04153604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348649|NCT04153604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348650|NCT04153604|Antimalarials|antimalarials|mesh-ancestor
93348651|NCT04153604|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93348652|NCT04153604|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348653|NCT03338205|Ketamine|ketamine|mesh-list
93348654|NCT03338205|Analgesics|analgesics|mesh-ancestor
93348655|NCT03338205|Sensory System Agents|sensory system agents|mesh-ancestor
93348656|NCT03338205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348657|NCT03338205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348658|NCT03338205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93348659|NCT03338205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93348660|NCT03338205|Anesthetics, General|anesthetics, general|mesh-ancestor
93348661|NCT03338205|Anesthetics|anesthetics|mesh-ancestor
93348662|NCT03338205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348663|NCT03338205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93348664|NCT03338205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93348665|NCT03338205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348666|NCT03338205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348667|NCT04314050|Dexmedetomidine|dexmedetomidine|mesh-list
93348668|NCT04314050|Tramadol|tramadol|mesh-list
93348669|NCT04314050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93348670|NCT04314050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348671|NCT04314050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348672|NCT04314050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348673|NCT04314050|Analgesics|analgesics|mesh-ancestor
93348674|NCT04314050|Sensory System Agents|sensory system agents|mesh-ancestor
93348675|NCT04314050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348676|NCT04314050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93348677|NCT04314050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93348678|NCT04314050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348679|NCT04314050|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348680|NCT04314050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348681|NCT04314050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348682|NCT04314050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93348683|NCT04314050|Narcotics|narcotics|mesh-ancestor
93348684|NCT03343509|Metronidazole|metronidazole|mesh-list
93348685|NCT03343509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348686|NCT03343509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348687|NCT03343509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93348688|NCT03343509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348689|NCT04516148|Clindamycin|clindamycin|mesh-list
93348690|NCT04516148|Clindamycin palmitate|clindamycin palmitate|mesh-list
93348691|NCT04516148|Clindamycin phosphate|clindamycin phosphate|mesh-list
93348692|NCT04516148|Cefazolin|cefazolin|mesh-list
93348693|NCT04516148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348694|NCT04516148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348695|NCT04516148|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93348696|NCT04516148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348697|NCT04516148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348698|NCT02497365|Cefazolin|cefazolin|mesh-list
93348699|NCT02497365|Tobramycin|tobramycin|mesh-list
93348700|NCT02497365|Besifloxacin|besifloxacin|mesh-list
93348701|NCT02497365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348702|NCT02497365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348703|NCT02497365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93348704|NCT02497365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93348705|NCT02497365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348706|NCT02497365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348707|NCT02497365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348708|NCT02497053|Pemetrexed|pemetrexed|mesh-list
93348709|NCT02497053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348710|NCT02497053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348711|NCT02497053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348712|NCT02497053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93348713|NCT02497053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93348714|NCT03120975|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93348715|NCT03120975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348716|NCT03337581|Dexmedetomidine|dexmedetomidine|mesh-list
93348717|NCT03337581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93348718|NCT03337581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348719|NCT03337581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348720|NCT03337581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348721|NCT03337581|Analgesics|analgesics|mesh-ancestor
93348722|NCT03337581|Sensory System Agents|sensory system agents|mesh-ancestor
93348723|NCT03337581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348724|NCT03337581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93348725|NCT03337581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93348726|NCT03337581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348727|NCT03337581|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348728|NCT03337581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348729|NCT03337581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348730|NCT02496975|Cyclosporine|cyclosporine|mesh-list
93348731|NCT02496975|Cyclosporins|cyclosporins|mesh-list
93348732|NCT02496975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348733|NCT02496975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348734|NCT02496975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348735|NCT02496975|Immunologic Factors|immunologic factors|mesh-ancestor
93348736|NCT02496975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348737|NCT02496975|Antifungal Agents|antifungal agents|mesh-ancestor
93348738|NCT02496975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348739|NCT02496975|Dermatologic Agents|dermatologic agents|mesh-ancestor
93348740|NCT02496975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348741|NCT02496975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93348742|NCT03337503|Dronabinol|dronabinol|mesh-list
93348743|NCT03337503|Hallucinogens|hallucinogens|mesh-ancestor
93348744|NCT03337503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348745|NCT03337503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93348746|NCT03337503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348747|NCT03337503|Analgesics|analgesics|mesh-ancestor
93348748|NCT03337503|Sensory System Agents|sensory system agents|mesh-ancestor
93348749|NCT03337503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348750|NCT03337503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93348751|NCT03337503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93348752|NCT03337503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348753|NCT03337503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348754|NCT03337503|Hormones|hormones|mesh-ancestor
93348755|NCT03337503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348756|NCT01675622|Morphine|morphine|mesh-list
93348757|NCT01675622|Oxycodone|oxycodone|mesh-list
93348758|NCT01675622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93348759|NCT01675622|Narcotics|narcotics|mesh-ancestor
93348760|NCT01675622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348761|NCT01675622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348762|NCT01675622|Analgesics|analgesics|mesh-ancestor
93348763|NCT01675622|Sensory System Agents|sensory system agents|mesh-ancestor
93348764|NCT01675622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348765|NCT02496741|Metformin|metformin|mesh-list
93348766|NCT02496741|Chloroquine|chloroquine|mesh-list
93348767|NCT02496741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348768|NCT02496741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348769|NCT02496741|Amebicides|amebicides|mesh-ancestor
93348770|NCT02496741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93348771|NCT02496741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93348772|NCT02496741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348773|NCT02496741|Antimalarials|antimalarials|mesh-ancestor
93348774|NCT02496741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020695|NCT02543099|Policosanol|policosanol|mesh-list
93348775|NCT04496037|Rituximab|rituximab|mesh-list
93348776|NCT04496037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348777|NCT04496037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348778|NCT04496037|Immunologic Factors|immunologic factors|mesh-ancestor
93348779|NCT04496037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348780|NCT04496037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348781|NCT04169828|Leucovorin|leucovorin|mesh-list
93348782|NCT04169828|Folic Acid|folic acid|mesh-list
93348783|NCT04169828|Methotrexate|methotrexate|mesh-list
93348784|NCT04169828|Ondansetron|ondansetron|mesh-list
93348785|NCT04169828|Levoleucovorin|levoleucovorin|mesh-list
93348786|NCT04169828|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93348787|NCT04169828|Abortifacient Agents|abortifacient agents|mesh-ancestor
93348788|NCT04169828|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348789|NCT04169828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348790|NCT04169828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93348791|NCT04169828|Antimetabolites|antimetabolites|mesh-ancestor
93348792|NCT04169828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348793|NCT04169828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348794|NCT04169828|Dermatologic Agents|dermatologic agents|mesh-ancestor
93348795|NCT04169828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348796|NCT04169828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93348797|NCT04169828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348798|NCT04169828|Immunologic Factors|immunologic factors|mesh-ancestor
93348799|NCT04169828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348800|NCT04169828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93348801|NCT04169828|Antidotes|antidotes|mesh-ancestor
93348802|NCT04169828|Protective Agents|protective agents|mesh-ancestor
93348803|NCT04169828|Vitamin B Complex|vitamin b complex|mesh-ancestor
93348804|NCT04169828|Vitamins|vitamins|mesh-ancestor
93348805|NCT04169828|Micronutrients|micronutrients|mesh-ancestor
93348806|NCT04169828|Antiemetics|antiemetics|mesh-ancestor
93348807|NCT04169828|Autonomic Agents|autonomic agents|mesh-ancestor
93348808|NCT04169828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348809|NCT04169828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93348810|NCT04169828|Antipruritics|antipruritics|mesh-ancestor
93348811|NCT04169828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93348812|NCT04169828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93348813|NCT04169828|Serotonin Agents|serotonin agents|mesh-ancestor
93348814|NCT04169828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348815|NCT04169828|Hematinics|hematinics|mesh-ancestor
93348816|NCT04495881|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93348817|NCT04495881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348818|NCT04495881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348819|NCT04495881|Incretins|incretins|mesh-ancestor
93348820|NCT04495881|Hormones|hormones|mesh-ancestor
93348821|NCT04495881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348822|NCT04495881|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93348823|NCT04495881|Protease Inhibitors|protease inhibitors|mesh-ancestor
93348824|NCT04495881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348825|NCT04495881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348826|NCT02493465|Everolimus|everolimus|mesh-list
93348827|NCT02493465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93348828|NCT02493465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93348829|NCT02493465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348830|NCT02493465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348831|NCT02493465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93348832|NCT02493465|Immunologic Factors|immunologic factors|mesh-ancestor
93348833|NCT02493465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348834|NCT02493465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348835|NCT03342261|Antiviral Agents|antiviral agents|mesh-list
93348836|NCT03342261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348837|NCT04495569|Antibodies|antibodies|mesh-list
93348838|NCT04495569|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93348839|NCT04495569|Immunologic Factors|immunologic factors|mesh-ancestor
93348840|NCT04495569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348841|NCT03337191|Morphine|morphine|mesh-list
93348842|NCT03337191|Levobupivacaine|levobupivacaine|mesh-list
93348843|NCT03337191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93348844|NCT03337191|Narcotics|narcotics|mesh-ancestor
93348845|NCT03337191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348846|NCT03337191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348847|NCT03337191|Analgesics|analgesics|mesh-ancestor
93348848|NCT03337191|Sensory System Agents|sensory system agents|mesh-ancestor
93348849|NCT03337191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348850|NCT03337191|Anesthetics, Local|anesthetics, local|mesh-ancestor
93348851|NCT03337191|Anesthetics|anesthetics|mesh-ancestor
93348852|NCT04494243|Rabeprazole|rabeprazole|mesh-list
93348853|NCT04494243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93348854|NCT04494243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93348855|NCT04494243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93348856|NCT04494243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348857|NCT04494243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348859|NCT03337035|Oxytocics|oxytocics|mesh-ancestor
93348860|NCT03337035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93348861|NCT03337035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348862|NCT03330717|Anesthetics|anesthetics|mesh-list
93348863|NCT03330717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348864|NCT03330717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348865|NCT02655224|Relugolix|relugolix|mesh-list
93348866|NCT02655224|Androgen Antagonists|androgen antagonists|mesh-ancestor
93348867|NCT02655224|Hormone Antagonists|hormone antagonists|mesh-ancestor
93348868|NCT02655224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348869|NCT02655224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348870|NCT04494321|Budesonide|budesonide|mesh-list
93348871|NCT04494321|Formoterol Fumarate|formoterol fumarate|mesh-list
93348872|NCT04494321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348873|NCT04494321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93348874|NCT04494321|Autonomic Agents|autonomic agents|mesh-ancestor
93348875|NCT04494321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348876|NCT04494321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348877|NCT04494321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93348878|NCT04494321|Respiratory System Agents|respiratory system agents|mesh-ancestor
93348879|NCT04494321|Glucocorticoids|glucocorticoids|mesh-ancestor
93348880|NCT04494321|Hormones|hormones|mesh-ancestor
93348881|NCT04494321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348882|NCT04494321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93348883|NCT04494321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93348884|NCT04494321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348885|NCT04494321|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348886|NCT04494321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348887|NCT04494321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348888|NCT03330171|Vaccines|vaccines|mesh-list
93348889|NCT03330171|Immunologic Factors|immunologic factors|mesh-ancestor
93348890|NCT03330171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348891|NCT05118542|Methimazole|methimazole|mesh-list
93348892|NCT05118542|Propylthiouracil|propylthiouracil|mesh-list
93348893|NCT05118542|Antithyroid Agents|antithyroid agents|mesh-ancestor
93348894|NCT05118542|Hormone Antagonists|hormone antagonists|mesh-ancestor
93348895|NCT05118542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348896|NCT05118542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348897|NCT05118542|Antimetabolites|antimetabolites|mesh-ancestor
93348898|NCT05118542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348899|NCT03336801|Propofol|propofol|mesh-list
93348900|NCT03336801|Sevoflurane|sevoflurane|mesh-list
93348901|NCT03336801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93348902|NCT03336801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348903|NCT03336801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348904|NCT03336801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93348905|NCT03336801|Anesthetics, General|anesthetics, general|mesh-ancestor
93348906|NCT03336801|Anesthetics|anesthetics|mesh-ancestor
93348907|NCT03336801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93348908|NCT03336801|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93348909|NCT05115578|Midazolam|midazolam|mesh-list
93348910|NCT05115578|Remifentanil|remifentanil|mesh-list
93348911|NCT05115578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93348912|NCT05115578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93348913|NCT05115578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93348914|NCT05115578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348915|NCT05115578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93348916|NCT05115578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642642|NCT04569214|PAZ320|paz320|mesh-list
93348917|NCT05115578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93348918|NCT05115578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93348919|NCT05115578|Anesthetics, General|anesthetics, general|mesh-ancestor
93348920|NCT05115578|Anesthetics|anesthetics|mesh-ancestor
93348921|NCT05115578|GABA Modulators|gaba modulators|mesh-ancestor
93348922|NCT05115578|GABA Agents|gaba agents|mesh-ancestor
93348923|NCT05115578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348924|NCT05115578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348925|NCT05115578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93348926|NCT05115578|Narcotics|narcotics|mesh-ancestor
93348927|NCT05115578|Analgesics|analgesics|mesh-ancestor
93348928|NCT05115578|Sensory System Agents|sensory system agents|mesh-ancestor
93348929|NCT05115578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348930|NCT02636036|Nivolumab|nivolumab|mesh-list
93348931|NCT02636036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93348932|NCT02636036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348933|NCT02636036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93348934|NCT02636036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348935|NCT03329781|Curcumin|curcumin|mesh-list
93348936|NCT03329781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93348937|NCT03329781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93348938|NCT03329781|Analgesics|analgesics|mesh-ancestor
93348939|NCT03329781|Sensory System Agents|sensory system agents|mesh-ancestor
93348940|NCT03329781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348941|NCT03329781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348942|NCT03329781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348943|NCT03329781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93348944|NCT03329781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348945|NCT03329781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93348946|NCT03329781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348947|NCT02437604|Fluticasone|fluticasone|mesh-list
93348948|NCT02437604|Xhance|xhance|mesh-list
93348949|NCT02437604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93348950|NCT02437604|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93348951|NCT02437604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93348952|NCT02437604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93348953|NCT02437604|Autonomic Agents|autonomic agents|mesh-ancestor
93348954|NCT02437604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348955|NCT02437604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348956|NCT02437604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93348957|NCT02437604|Respiratory System Agents|respiratory system agents|mesh-ancestor
93348958|NCT02437604|Dermatologic Agents|dermatologic agents|mesh-ancestor
93348959|NCT02437604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93348960|NCT02437604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93348961|NCT02437604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93348962|NCT02437604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348963|NCT02437604|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348964|NCT02437604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93348965|NCT02437604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93348966|NCT02437604|Glucocorticoids|glucocorticoids|mesh-ancestor
93348967|NCT02437604|Hormones|hormones|mesh-ancestor
93348968|NCT02437604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93348969|NCT02437604|Sympathomimetics|sympathomimetics|mesh-ancestor
93348970|NCT03329547|Cefixime|cefixime|mesh-list
93348971|NCT03329547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93348972|NCT03329547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348973|NCT05463627|Metformin|metformin|mesh-list
93348974|NCT05463627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348975|NCT05463627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348976|NCT01975298|Interferons|interferons|mesh-list
93348977|NCT01975298|Interferon beta-1a|interferon beta-1a|mesh-list
93348978|NCT01975298|Interferon-beta|interferon-beta|mesh-list
93348979|NCT01975298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93348980|NCT01975298|Antiviral Agents|antiviral agents|mesh-ancestor
93348981|NCT01975298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93348982|NCT01975298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93348983|NCT01975298|Immunologic Factors|immunologic factors|mesh-ancestor
93348984|NCT01975298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348985|NCT03324867|Insulin|insulin|mesh-list
93348986|NCT03324867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93348987|NCT03324867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93348988|NCT03324867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348989|NCT05084534|Midodrine|midodrine|mesh-list
93348990|NCT05084534|Sympathomimetics|sympathomimetics|mesh-ancestor
93348991|NCT05084534|Autonomic Agents|autonomic agents|mesh-ancestor
93348992|NCT05084534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93348993|NCT05084534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93348994|NCT05084534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93348995|NCT05084534|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93348996|NCT05084534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93348997|NCT05084534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93348998|NCT05084534|Adrenergic Agents|adrenergic agents|mesh-ancestor
93348999|NCT05084534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349000|NCT05084534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349001|NCT04645316|Propofol|propofol|mesh-list
93349002|NCT04645316|Sevoflurane|sevoflurane|mesh-list
93020947|NCT00521144|Topotecan|topotecan|mesh-list
93349003|NCT04645316|Desflurane|desflurane|mesh-list
93349004|NCT04645316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93349005|NCT04645316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349006|NCT04645316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349007|NCT04645316|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93349008|NCT04645316|Anesthetics, General|anesthetics, general|mesh-ancestor
93349009|NCT04645316|Anesthetics|anesthetics|mesh-ancestor
93349010|NCT04645316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93349011|NCT04645316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93349012|NCT00659126|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93349013|NCT00659126|Hematinics|hematinics|mesh-ancestor
93349014|NCT00659126|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93349015|NCT00659126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93349016|NCT04594382|Analgesics, Opioid|analgesics, opioid|mesh-list
93349017|NCT04594382|Narcotics|narcotics|mesh-ancestor
93349018|NCT04594382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349019|NCT04594382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349020|NCT04594382|Analgesics|analgesics|mesh-ancestor
93349021|NCT04594382|Sensory System Agents|sensory system agents|mesh-ancestor
93349022|NCT04594382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349023|NCT02491515|Denosumab|denosumab|mesh-list
93349024|NCT02491515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93349025|NCT02491515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349026|NCT05113628|Methylene Blue|methylene blue|mesh-list
93349027|NCT05113628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349028|NCT05113628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349029|NCT04247750|Sirolimus|sirolimus|mesh-list
93349030|NCT04247750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349031|NCT04247750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349032|NCT04247750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93349033|NCT04247750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349034|NCT04247750|Antifungal Agents|antifungal agents|mesh-ancestor
93349035|NCT04247750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349036|NCT04247750|Immunologic Factors|immunologic factors|mesh-ancestor
93349037|NCT04247750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349038|NCT04513808|Anesthetics|anesthetics|mesh-list
93349039|NCT04513808|Propofol|propofol|mesh-list
93349040|NCT04513808|Sevoflurane|sevoflurane|mesh-list
93349041|NCT04513808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349042|NCT04513808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349043|NCT04513808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93349044|NCT04513808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93349045|NCT04513808|Anesthetics, General|anesthetics, general|mesh-ancestor
93349046|NCT04513808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93349047|NCT04513808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93349048|NCT02493231|Ketamine|ketamine|mesh-list
93349049|NCT02493231|Nefopam|nefopam|mesh-list
93349050|NCT02493231|Analgesics|analgesics|mesh-ancestor
93349051|NCT02493231|Sensory System Agents|sensory system agents|mesh-ancestor
93349052|NCT02493231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349053|NCT02493231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349054|NCT02493231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93349055|NCT02493231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93349056|NCT02493231|Anesthetics, General|anesthetics, general|mesh-ancestor
93349057|NCT02493231|Anesthetics|anesthetics|mesh-ancestor
93349058|NCT02493231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349059|NCT02493231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93349060|NCT02493231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93349061|NCT02493231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349062|NCT02493231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349063|NCT02493231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93349064|NCT05112692|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93349065|NCT05112692|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93349066|NCT05112692|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93349067|NCT05112692|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93349068|NCT05112692|Cetrorelix|cetrorelix|mesh-list
93349069|NCT05112692|Menotropins|menotropins|mesh-list
93349070|NCT05112692|Estradiol|estradiol|mesh-list
93349071|NCT05112692|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93349072|NCT05112692|Progesterone|progesterone|mesh-list
93349073|NCT05112692|Dydrogesterone|dydrogesterone|mesh-list
93349074|NCT05112692|Estrogens|estrogens|mesh-ancestor
93349075|NCT05112692|Hormones|hormones|mesh-ancestor
93349076|NCT05112692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349077|NCT05112692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349078|NCT05112692|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93349079|NCT05112692|Contraceptive Agents|contraceptive agents|mesh-ancestor
93349080|NCT05112692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349081|NCT05112692|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93349082|NCT05112692|Progestins|progestins|mesh-ancestor
93349083|NCT05112692|Luteolytic Agents|luteolytic agents|mesh-ancestor
93349084|NCT05112692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93349085|NCT05112692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349086|NCT05112692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93349087|NCT05112692|Fertility Agents|fertility agents|mesh-ancestor
93349088|NCT05112692|Hormone Antagonists|hormone antagonists|mesh-ancestor
93349089|NCT03328533|Phenylephrine|phenylephrine|mesh-list
93349090|NCT03328533|Oxymetazoline|oxymetazoline|mesh-list
93349091|NCT03328533|Norepinephrine|norepinephrine|mesh-list
93349092|NCT03328533|Bupivacaine|bupivacaine|mesh-list
93349093|NCT03328533|Anesthetics, Local|anesthetics, local|mesh-ancestor
93349094|NCT03328533|Anesthetics|anesthetics|mesh-ancestor
93349095|NCT03328533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349096|NCT03328533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349097|NCT03328533|Sensory System Agents|sensory system agents|mesh-ancestor
93349098|NCT03328533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349099|NCT03328533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93349100|NCT03328533|Mydriatics|mydriatics|mesh-ancestor
93349101|NCT03328533|Autonomic Agents|autonomic agents|mesh-ancestor
93349102|NCT03328533|Sympathomimetics|sympathomimetics|mesh-ancestor
93349103|NCT03328533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93349104|NCT03328533|Nasal Decongestants|nasal decongestants|mesh-ancestor
93349105|NCT03328533|Respiratory System Agents|respiratory system agents|mesh-ancestor
93349106|NCT03328533|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93349107|NCT03328533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93349108|NCT03328533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93349109|NCT03328533|Adrenergic Agents|adrenergic agents|mesh-ancestor
93349110|NCT03328533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349111|NCT03328533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349112|NCT03328533|Protective Agents|protective agents|mesh-ancestor
93349113|NCT05117372|Immunomodulating Agents|immunomodulating agents|mesh-list
93349114|NCT05117372|Immunologic Factors|immunologic factors|mesh-ancestor
93349115|NCT05117372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349116|NCT03324243|Cytarabine|cytarabine|mesh-list
93349117|NCT03324243|Fludarabine|fludarabine|mesh-list
93349118|NCT03324243|Crenolanib|crenolanib|mesh-list
93349119|NCT03324243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349120|NCT03324243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93349121|NCT03324243|Antimetabolites|antimetabolites|mesh-ancestor
93349122|NCT03324243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349123|NCT03324243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349124|NCT03324243|Immunologic Factors|immunologic factors|mesh-ancestor
93349125|NCT03324243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349126|NCT03324243|Antiviral Agents|antiviral agents|mesh-ancestor
93349127|NCT03324243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349128|NCT03328299|Dexmedetomidine|dexmedetomidine|mesh-list
93349129|NCT03328299|Bupivacaine|bupivacaine|mesh-list
93349130|NCT03328299|Anesthetics, Local|anesthetics, local|mesh-ancestor
93349131|NCT03328299|Anesthetics|anesthetics|mesh-ancestor
93349132|NCT03328299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349133|NCT03328299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349134|NCT03328299|Sensory System Agents|sensory system agents|mesh-ancestor
93349135|NCT03328299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349136|NCT03328299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93349137|NCT03328299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93349138|NCT03328299|Analgesics|analgesics|mesh-ancestor
93349139|NCT03328299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93349140|NCT03328299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93349141|NCT03328299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93349142|NCT03328299|Adrenergic Agents|adrenergic agents|mesh-ancestor
93349143|NCT03328299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349144|NCT03328299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349145|NCT03564301|Metronidazole|metronidazole|mesh-list
93349146|NCT03564301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349147|NCT03564301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349148|NCT03564301|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93349149|NCT03564301|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93349150|NCT05079854|Moxifloxacin|moxifloxacin|mesh-list
93349151|NCT05079854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349152|NCT05079854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349153|NCT05079854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93349154|NCT05079854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93349155|NCT05079854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366451|NCT02796677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349156|NCT05079854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349157|NCT05079854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349159|NCT03327987|Immunologic Factors|immunologic factors|mesh-ancestor
93349160|NCT03327987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349161|NCT03335241|Doxorubicin|doxorubicin|mesh-list
93349162|NCT03335241|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93349163|NCT03335241|Fludarabine|fludarabine|mesh-list
93349164|NCT03335241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93349165|NCT03335241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349166|NCT03335241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93349167|NCT03335241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93349168|NCT03335241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349169|NCT03335241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349170|NCT03327831|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93349171|NCT03327831|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93349172|NCT03327831|Dermatologic Agents|dermatologic agents|mesh-ancestor
93349173|NCT03120663|Amoxicillin|amoxicillin|mesh-list
93349174|NCT03120663|Clindamycin|clindamycin|mesh-list
93349175|NCT03120663|Meropenem|meropenem|mesh-list
93349176|NCT03120663|Tazobactam|tazobactam|mesh-list
93349177|NCT03120663|Piperacillin|piperacillin|mesh-list
93349178|NCT03120663|Clavulanic Acids|clavulanic acids|mesh-list
93349179|NCT03120663|Clavulanic Acid|clavulanic acid|mesh-list
93349180|NCT03120663|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93349181|NCT03120663|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93349182|NCT03120663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349183|NCT03120663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349184|NCT03120663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93349185|NCT03120663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349186|NCT03120663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349187|NCT03120663|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93349188|NCT02578394|Methylprednisolone|methylprednisolone|mesh-list
93349189|NCT02578394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93349190|NCT02578394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93349191|NCT02578394|Prednisolone|prednisolone|mesh-list
93349192|NCT02578394|Prednisolone acetate|prednisolone acetate|mesh-list
93349193|NCT02578394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93349194|NCT02578394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93349195|NCT02578394|Prednisolone phosphate|prednisolone phosphate|mesh-list
93349196|NCT02578394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349197|NCT02578394|Antiemetics|antiemetics|mesh-ancestor
93349198|NCT02578394|Autonomic Agents|autonomic agents|mesh-ancestor
93349199|NCT02578394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349200|NCT02578394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349201|NCT02578394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349202|NCT02578394|Glucocorticoids|glucocorticoids|mesh-ancestor
93349203|NCT02578394|Hormones|hormones|mesh-ancestor
93349204|NCT02578394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349205|NCT02578394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93349206|NCT02578394|Protective Agents|protective agents|mesh-ancestor
93349207|NCT02578394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93349208|NCT02578394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349209|NCT02578394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349210|NCT04493229|Oxytocin|oxytocin|mesh-list
93349211|NCT04493229|Oxytocics|oxytocics|mesh-ancestor
93349212|NCT04493229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349213|NCT04493229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349214|NCT03120273|Lansoprazole|lansoprazole|mesh-list
93349215|NCT03120273|Dexlansoprazole|dexlansoprazole|mesh-list
93349216|NCT03120273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93349217|NCT03120273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349218|NCT03120273|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93349219|NCT03120273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349220|NCT03120273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349221|NCT02122718|Allopurinol|allopurinol|mesh-list
93349222|NCT02122718|Antimetabolites|antimetabolites|mesh-ancestor
93349223|NCT02122718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349224|NCT02122718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349225|NCT02122718|Gout Suppressants|gout suppressants|mesh-ancestor
93349226|NCT02122718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349227|NCT02122718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93349228|NCT02122718|Antioxidants|antioxidants|mesh-ancestor
93349229|NCT02122718|Protective Agents|protective agents|mesh-ancestor
93349230|NCT02122718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349231|NCT04513652|Carticaine|carticaine|mesh-list
93349232|NCT04513652|Anesthetics, Local|anesthetics, local|mesh-ancestor
93349233|NCT04513652|Anesthetics|anesthetics|mesh-ancestor
93349234|NCT04513652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349235|NCT04513652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349236|NCT04513652|Sensory System Agents|sensory system agents|mesh-ancestor
93349237|NCT04513652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349238|NCT00706797|Etanercept|etanercept|mesh-list
93349239|NCT00706797|Methotrexate|methotrexate|mesh-list
93349240|NCT00706797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93349241|NCT00706797|Abortifacient Agents|abortifacient agents|mesh-ancestor
93349242|NCT00706797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349243|NCT00706797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349244|NCT00706797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93349245|NCT00706797|Antimetabolites|antimetabolites|mesh-ancestor
93349246|NCT00706797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349247|NCT00706797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349248|NCT00706797|Dermatologic Agents|dermatologic agents|mesh-ancestor
93349249|NCT00706797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349250|NCT00706797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93349251|NCT00706797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349252|NCT00706797|Immunologic Factors|immunologic factors|mesh-ancestor
93349253|NCT00706797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349254|NCT00706797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93349255|NCT00706797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93349256|NCT00706797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93349257|NCT00706797|Analgesics|analgesics|mesh-ancestor
93349258|NCT00706797|Sensory System Agents|sensory system agents|mesh-ancestor
93349259|NCT00706797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349260|NCT00706797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349261|NCT00706797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349262|NCT03323697|Escitalopram|escitalopram|mesh-list
93349263|NCT03323697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93349264|NCT03323697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93349265|NCT03323697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93349266|NCT03323697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349267|NCT03323697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349268|NCT03323697|Serotonin Agents|serotonin agents|mesh-ancestor
93349269|NCT03323697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349270|NCT00706641|Dasatinib|dasatinib|mesh-list
93349271|NCT00706641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349272|NCT00706641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93349273|NCT00706641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349274|NCT00706641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349275|NCT03335085|Oxytocin|oxytocin|mesh-list
93349276|NCT03335085|Oxytocics|oxytocics|mesh-ancestor
93349277|NCT03335085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349278|NCT03335085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349279|NCT03323619|Anesthetics|anesthetics|mesh-list
93349280|NCT03323619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349281|NCT03323619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349282|NCT03323541|Lenograstim|lenograstim|mesh-list
93349283|NCT03323541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93349284|NCT03323541|Immunologic Factors|immunologic factors|mesh-ancestor
93349285|NCT03323541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349286|NCT03335007|Aceclofenac|aceclofenac|mesh-list
93349287|NCT03335007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93349288|NCT03335007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93349289|NCT03335007|Analgesics|analgesics|mesh-ancestor
93349290|NCT03335007|Sensory System Agents|sensory system agents|mesh-ancestor
93349291|NCT03335007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349292|NCT03335007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349293|NCT03335007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349294|NCT03335007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349295|NCT01362530|Ondansetron|ondansetron|mesh-list
93349296|NCT01362530|Aprepitant|aprepitant|mesh-list
93349297|NCT01362530|Fosaprepitant|fosaprepitant|mesh-list
93349298|NCT01362530|Antiemetics|antiemetics|mesh-ancestor
93349299|NCT01362530|Autonomic Agents|autonomic agents|mesh-ancestor
93349300|NCT01362530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349301|NCT01362530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349302|NCT01362530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349303|NCT01362530|Antipruritics|antipruritics|mesh-ancestor
93349304|NCT01362530|Dermatologic Agents|dermatologic agents|mesh-ancestor
93349305|NCT01362530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93021226|NCT00518882|Exenatide|exenatide|mesh-list
93349306|NCT01362530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93349307|NCT01362530|Serotonin Agents|serotonin agents|mesh-ancestor
93349308|NCT01362530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349309|NCT01362530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349310|NCT01362530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93349312|NCT04494399|Ribavirin|ribavirin|mesh-list
93349313|NCT04494399|Interferon-beta|interferon-beta|mesh-list
93349314|NCT04494399|Interferon beta-1b|interferon beta-1b|mesh-list
93349315|NCT04494399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349316|NCT04494399|Antiviral Agents|antiviral agents|mesh-ancestor
93349317|NCT04494399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349318|NCT04494399|Antimetabolites|antimetabolites|mesh-ancestor
93349319|NCT04494399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349320|NCT04494399|Immunologic Factors|immunologic factors|mesh-ancestor
93349321|NCT04494399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349322|NCT04494399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93349323|NCT01758614|Aspirin|aspirin|mesh-list
93349324|NCT01758614|Clopidogrel|clopidogrel|mesh-list
93349325|NCT01758614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93349326|NCT01758614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93349327|NCT01758614|Analgesics|analgesics|mesh-ancestor
93349328|NCT01758614|Sensory System Agents|sensory system agents|mesh-ancestor
93349329|NCT01758614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349330|NCT01758614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349331|NCT01758614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349332|NCT01758614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349333|NCT01758614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93349334|NCT01758614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93349335|NCT01758614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349336|NCT01758614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93349337|NCT01758614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93349338|NCT01758614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349339|NCT01758614|Antipyretics|antipyretics|mesh-ancestor
93349340|NCT01758614|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93349341|NCT01758614|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93349342|NCT01758614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93349343|NCT01758614|Purinergic Agents|purinergic agents|mesh-ancestor
93349344|NCT01758614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349345|NCT02490657|Iloprost|iloprost|mesh-list
93349346|NCT02490657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93349347|NCT02490657|Vasodilator Agents|vasodilator agents|mesh-ancestor
93349348|NCT04323566|Rituximab|rituximab|mesh-list
93349349|NCT04323566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93349350|NCT04323566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349351|NCT04323566|Immunologic Factors|immunologic factors|mesh-ancestor
93349352|NCT04323566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349353|NCT04323566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349354|NCT03109119|Propofol|propofol|mesh-list
93349355|NCT03109119|Sevoflurane|sevoflurane|mesh-list
93349356|NCT03109119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93349357|NCT03109119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349358|NCT03109119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349359|NCT03109119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93349360|NCT03109119|Anesthetics, General|anesthetics, general|mesh-ancestor
93349361|NCT03109119|Anesthetics|anesthetics|mesh-ancestor
93349362|NCT03109119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93349363|NCT03109119|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93349364|NCT05070104|Bevacizumab|bevacizumab|mesh-list
93349365|NCT05070104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93349366|NCT05070104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349367|NCT05070104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93349368|NCT05070104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93349369|NCT05070104|Growth Substances|growth substances|mesh-ancestor
93349370|NCT05070104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349371|NCT05070104|Growth Inhibitors|growth inhibitors|mesh-ancestor
93349372|NCT03326661|Clindamycin|clindamycin|mesh-list
93349373|NCT03326661|Clindamycin palmitate|clindamycin palmitate|mesh-list
93349374|NCT03326661|Clindamycin phosphate|clindamycin phosphate|mesh-list
93349375|NCT03326661|Penicillins|penicillins|mesh-list
93349376|NCT03326661|Penicillin V|penicillin v|mesh-list
93349377|NCT03326661|Metronidazole|metronidazole|mesh-list
93349378|NCT03326661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349379|NCT03326661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349380|NCT03326661|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93021299|NCT04501406|Pioglitazone|pioglitazone|mesh-list
93349382|NCT03326661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349383|NCT03326661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93349384|NCT03326661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93349385|NCT05119712|Terbinafine|terbinafine|mesh-list
93349386|NCT05119712|Antifungal Agents|antifungal agents|mesh-ancestor
93349387|NCT05119712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349388|NCT05119712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349389|NCT05119712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349390|NCT03333915|Pamiparib|pamiparib|mesh-list
93349391|NCT03333915|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93349392|NCT03333915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349393|NCT03333915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349394|NCT03333915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349395|NCT04261478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93349396|NCT02654054|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93349397|NCT02654054|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93349398|NCT02654054|Norethindrone|norethindrone|mesh-list
93349399|NCT02654054|Norethindrone Acetate|norethindrone acetate|mesh-list
93349400|NCT02654054|Estradiol|estradiol|mesh-list
93349401|NCT02654054|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93349402|NCT02654054|Estrogens|estrogens|mesh-ancestor
93349403|NCT02654054|Hormones|hormones|mesh-ancestor
93349404|NCT02654054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349405|NCT02654054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349406|NCT02654054|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93349407|NCT02654054|Contraceptive Agents|contraceptive agents|mesh-ancestor
93349408|NCT02654054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349409|NCT02654054|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93349410|NCT02654054|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93349411|NCT02654054|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93349412|NCT02654054|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93349413|NCT03186404|Atorvastatin|atorvastatin|mesh-list
93349414|NCT03186404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93349415|NCT03186404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93349416|NCT03186404|Antimetabolites|antimetabolites|mesh-ancestor
93349417|NCT03186404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349418|NCT03186404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93349419|NCT03186404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93349420|NCT03186404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349421|NCT02492373|Clobetasol|clobetasol|mesh-list
93349422|NCT02492373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349423|NCT02492373|Glucocorticoids|glucocorticoids|mesh-ancestor
93349424|NCT02492373|Hormones|hormones|mesh-ancestor
93349425|NCT02492373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349426|NCT02492373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349427|NCT03073070|Biotin|biotin|mesh-list
93349428|NCT03073070|Vitamin B Complex|vitamin b complex|mesh-ancestor
93349429|NCT03073070|Vitamins|vitamins|mesh-ancestor
93349430|NCT03073070|Micronutrients|micronutrients|mesh-ancestor
93349431|NCT03073070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349432|NCT02905214|Sirolimus|sirolimus|mesh-list
93349433|NCT02905214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349434|NCT02905214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349435|NCT02905214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93349436|NCT02905214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349437|NCT02905214|Antifungal Agents|antifungal agents|mesh-ancestor
93349438|NCT02905214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349439|NCT02905214|Immunologic Factors|immunologic factors|mesh-ancestor
93349440|NCT02905214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349441|NCT03333603|Esomeprazole|esomeprazole|mesh-list
93349442|NCT03333603|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93349443|NCT03333603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349444|NCT03333603|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93349445|NCT03333603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349446|NCT03333603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349447|NCT03333525|Insulin|insulin|mesh-list
93349448|NCT03333525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93349449|NCT03333525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349450|NCT03333369|Levodopa|levodopa|mesh-list
93349451|NCT03333369|Benserazide|benserazide|mesh-list
93349452|NCT03333369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93349453|NCT03333369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93349454|NCT03333369|Dopamine Agents|dopamine agents|mesh-ancestor
93349455|NCT03333369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349456|NCT03333369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349457|NCT03333369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349458|NCT03333369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349459|NCT03325803|Lidocaine|lidocaine|mesh-list
93349460|NCT03325803|Prilocaine|prilocaine|mesh-list
93349461|NCT03325803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93349462|NCT03325803|Anesthetics, Local|anesthetics, local|mesh-ancestor
93349463|NCT03325803|Anesthetics|anesthetics|mesh-ancestor
93349464|NCT03325803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349465|NCT03325803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349466|NCT03325803|Sensory System Agents|sensory system agents|mesh-ancestor
93349467|NCT03325803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349468|NCT03325803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93349469|NCT03325803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93349470|NCT03325803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93349471|NCT03325803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93349472|NCT03325803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349473|NCT03325803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93349474|NCT05465343|Aflutinib|aflutinib|mesh-list
93349475|NCT05465343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93349476|NCT05465343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349477|NCT05465343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349478|NCT03325491|Acipimox|acipimox|mesh-list
93349479|NCT03325491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93349480|NCT03325491|Antimetabolites|antimetabolites|mesh-ancestor
93349481|NCT03325491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349482|NCT03325491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93349483|NCT04150562|Avelumab|avelumab|mesh-list
93349484|NCT04150562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93349485|NCT04150562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349486|NCT03325413|Anesthetics|anesthetics|mesh-list
93349487|NCT03325413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349488|NCT03325413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349489|NCT03325335|Midazolam|midazolam|mesh-list
93349490|NCT03325335|Remifentanil|remifentanil|mesh-list
93349491|NCT03325335|Propofol|propofol|mesh-list
93349492|NCT03325335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93349493|NCT03325335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349494|NCT03325335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349495|NCT03325335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93349496|NCT03325335|Anesthetics, General|anesthetics, general|mesh-ancestor
93349497|NCT03325335|Anesthetics|anesthetics|mesh-ancestor
93349498|NCT03325335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93349499|NCT03325335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93349500|NCT03325335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93349501|NCT03325335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93349502|NCT03325335|GABA Modulators|gaba modulators|mesh-ancestor
93349503|NCT03325335|GABA Agents|gaba agents|mesh-ancestor
93349504|NCT03325335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349505|NCT03325335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643252|NCT00211952|Celecoxib|celecoxib|mesh-list
93349506|NCT03325335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93349507|NCT03325335|Narcotics|narcotics|mesh-ancestor
93349508|NCT03325335|Analgesics|analgesics|mesh-ancestor
93349509|NCT03325335|Sensory System Agents|sensory system agents|mesh-ancestor
93349510|NCT03325335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349511|NCT05114720|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93349512|NCT05114720|Moxifloxacin|moxifloxacin|mesh-list
93349513|NCT05114720|Cyclophosphamide|cyclophosphamide|mesh-list
93349514|NCT05114720|Docetaxel|docetaxel|mesh-list
93349515|NCT05114720|Doxorubicin|doxorubicin|mesh-list
93349516|NCT05114720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93349517|NCT05114720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93349518|NCT05114720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349519|NCT05114720|Immunologic Factors|immunologic factors|mesh-ancestor
93349520|NCT05114720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349521|NCT05114720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349522|NCT05114720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93349523|NCT05114720|Alkylating Agents|alkylating agents|mesh-ancestor
93349524|NCT05114720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349525|NCT05114720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349526|NCT05114720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93349527|NCT05114720|Tubulin Modulators|tubulin modulators|mesh-ancestor
93349528|NCT05114720|Antimitotic Agents|antimitotic agents|mesh-ancestor
93349529|NCT05114720|Mitosis Modulators|mitosis modulators|mesh-ancestor
93349530|NCT05114720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93349531|NCT05114720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93349532|NCT05114720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93349533|NCT05114720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349534|NCT05114720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349535|NCT05114720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93349536|NCT05114720|Contraceptive Agents|contraceptive agents|mesh-ancestor
93349537|NCT05114720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349538|NCT05114720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93349539|NCT05114720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93349540|NCT05114720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93349541|NCT04493463|Methylprednisolone|methylprednisolone|mesh-list
93349542|NCT04493463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93349543|NCT04493463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93349544|NCT04493463|Prednisolone|prednisolone|mesh-list
93349545|NCT04493463|Prednisolone acetate|prednisolone acetate|mesh-list
93349546|NCT04493463|Ropivacaine|ropivacaine|mesh-list
93349547|NCT04493463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93349548|NCT04493463|Prednisolone phosphate|prednisolone phosphate|mesh-list
93349549|NCT04493463|Anesthetics, Local|anesthetics, local|mesh-ancestor
93349550|NCT04493463|Anesthetics|anesthetics|mesh-ancestor
93349551|NCT04493463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349552|NCT04493463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349553|NCT04493463|Sensory System Agents|sensory system agents|mesh-ancestor
93349554|NCT04493463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349555|NCT04493463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349556|NCT04493463|Antiemetics|antiemetics|mesh-ancestor
93349557|NCT04493463|Autonomic Agents|autonomic agents|mesh-ancestor
93349558|NCT04493463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349559|NCT04493463|Glucocorticoids|glucocorticoids|mesh-ancestor
93349560|NCT04493463|Hormones|hormones|mesh-ancestor
93349561|NCT04493463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349562|NCT04493463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93349563|NCT04493463|Protective Agents|protective agents|mesh-ancestor
93349564|NCT04493463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93349565|NCT04493463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349566|NCT04493073|Mitomycins|mitomycins|mesh-list
93349567|NCT04493073|Mitomycin|mitomycin|mesh-list
93349568|NCT04493073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93349569|NCT04493073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349570|NCT04493073|Alkylating Agents|alkylating agents|mesh-ancestor
93349571|NCT04493073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349572|NCT04493073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93349573|NCT04493073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349574|NCT00748904|Rifaximin|rifaximin|mesh-list
93349575|NCT00748904|Lactulose|lactulose|mesh-list
93349576|NCT00748904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349577|NCT00748904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349578|NCT00748904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349579|NCT03321903|Charcoal|charcoal|mesh-list
93349580|NCT03321903|Antidotes|antidotes|mesh-ancestor
93349581|NCT03321903|Protective Agents|protective agents|mesh-ancestor
93349582|NCT03321903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349583|NCT04411550|Pertuzumab|pertuzumab|mesh-list
93349584|NCT04411550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93349585|NCT04411550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349586|NCT03321825|Lidocaine|lidocaine|mesh-list
93349587|NCT03321825|Hyaluronic Acid|hyaluronic acid|mesh-list
93349588|NCT03321825|Anesthetics, Local|anesthetics, local|mesh-ancestor
93349589|NCT03321825|Anesthetics|anesthetics|mesh-ancestor
93349590|NCT03321825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349591|NCT03321825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349592|NCT03321825|Sensory System Agents|sensory system agents|mesh-ancestor
93349593|NCT03321825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349594|NCT03321825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93349595|NCT03321825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93349596|NCT03321825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93349597|NCT03321825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93349598|NCT03321825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349599|NCT03321825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93349600|NCT03321825|Immunologic Factors|immunologic factors|mesh-ancestor
93349601|NCT03321825|Viscosupplements|viscosupplements|mesh-ancestor
93349602|NCT03321825|Protective Agents|protective agents|mesh-ancestor
93349603|NCT02492217|Adalimumab|adalimumab|mesh-list
93349604|NCT02492217|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93349605|NCT02492217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349606|NCT02492217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349607|NCT05229536|Vaccines|vaccines|mesh-list
93349609|NCT05229536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349610|NCT04810910|Molgramostim|molgramostim|mesh-list
93349611|NCT04810910|Sargramostim|sargramostim|mesh-list
93349612|NCT04810910|Immunologic Factors|immunologic factors|mesh-ancestor
93349613|NCT04810910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349614|NCT04810910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349615|NCT04562558|Leucovorin|leucovorin|mesh-list
93349616|NCT04562558|Dactinomycin|dactinomycin|mesh-list
93349617|NCT04562558|Methotrexate|methotrexate|mesh-list
93349618|NCT04562558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349619|NCT04562558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93349620|NCT04562558|Abortifacient Agents|abortifacient agents|mesh-ancestor
93349621|NCT04562558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349622|NCT04562558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93349623|NCT04562558|Antimetabolites|antimetabolites|mesh-ancestor
93349624|NCT04562558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349625|NCT04562558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349626|NCT04562558|Dermatologic Agents|dermatologic agents|mesh-ancestor
93349627|NCT04562558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349628|NCT04562558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93349629|NCT04562558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349630|NCT04562558|Immunologic Factors|immunologic factors|mesh-ancestor
93349631|NCT04562558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349632|NCT04562558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93349633|NCT04562558|Antidotes|antidotes|mesh-ancestor
93349634|NCT04562558|Protective Agents|protective agents|mesh-ancestor
93349635|NCT04562558|Vitamin B Complex|vitamin b complex|mesh-ancestor
93349636|NCT04562558|Vitamins|vitamins|mesh-ancestor
93349637|NCT04562558|Micronutrients|micronutrients|mesh-ancestor
93349638|NCT04562558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349639|NCT04562558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349640|NCT04562558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93349641|NCT04562558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93349642|NCT03320187|Nitroglycerin|nitroglycerin|mesh-list
93349643|NCT03320187|Dinoprostone|dinoprostone|mesh-list
93349644|NCT03320187|Vasodilator Agents|vasodilator agents|mesh-ancestor
93349645|NCT03320187|Oxytocics|oxytocics|mesh-ancestor
93349646|NCT03320187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349647|NCT03320187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349648|NCT03320109|Vitamin D|vitamin d|mesh-list
93349649|NCT03320109|Ergocalciferols|ergocalciferols|mesh-list
93349650|NCT03320109|Cholecalciferol|cholecalciferol|mesh-list
93349651|NCT03320109|Vitamins|vitamins|mesh-list
93349652|NCT03320109|Micronutrients|micronutrients|mesh-ancestor
93349653|NCT03320109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349654|NCT03320109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93349655|NCT03320109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93349656|NCT04529876|Abatacept|abatacept|mesh-list
93349657|NCT04529876|Tofacitinib|tofacitinib|mesh-list
93349658|NCT04529876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93349659|NCT04529876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349660|NCT04529876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93349661|NCT04529876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349662|NCT04529876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349663|NCT04529876|Immunologic Factors|immunologic factors|mesh-ancestor
93349664|NCT04529876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349665|NCT04529876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349666|NCT04529876|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93349667|NCT04529876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93349668|NCT04529876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349669|NCT03320031|Insulin Lispro|insulin lispro|mesh-list
93349670|NCT03320031|Linagliptin|linagliptin|mesh-list
93349671|NCT03320031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93349672|NCT03320031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349673|NCT03320031|Incretins|incretins|mesh-ancestor
93349674|NCT03320031|Hormones|hormones|mesh-ancestor
93349675|NCT03320031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349676|NCT03320031|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93349677|NCT03320031|Protease Inhibitors|protease inhibitors|mesh-ancestor
93349678|NCT03320031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349679|NCT03320031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349680|NCT04510922|Droxidopa|droxidopa|mesh-list
93349681|NCT04510922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93349682|NCT04510922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93021637|NCT01057498|RNS60|rns60|mesh-list
93349683|NCT05465031|Valsartan|valsartan|mesh-list
93349684|NCT05465031|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93349685|NCT05465031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93349686|NCT05465031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93349687|NCT05465031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93349688|NCT05465031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349689|NCT04510844|Evolocumab|evolocumab|mesh-list
93349690|NCT04510844|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93349691|NCT04510844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93349692|NCT04510844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93349693|NCT04510844|Antimetabolites|antimetabolites|mesh-ancestor
93349694|NCT04510844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349695|NCT04510844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93349696|NCT04510844|Protease Inhibitors|protease inhibitors|mesh-ancestor
93349697|NCT04510844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349698|NCT04510844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93349699|NCT05464953|Triamcinolone|triamcinolone|mesh-list
93349700|NCT05464953|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93349701|NCT05464953|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93349702|NCT05464953|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93349703|NCT05464953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93349704|NCT05464953|Glucocorticoids|glucocorticoids|mesh-ancestor
93349705|NCT05464953|Hormones|hormones|mesh-ancestor
93349706|NCT05464953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349707|NCT05464953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349708|NCT05464953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93349709|NCT05464953|Immunologic Factors|immunologic factors|mesh-ancestor
93349710|NCT05464953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643433|NCT00239499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349711|NCT05464953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349712|NCT02491749|Anesthetics|anesthetics|mesh-list
93349713|NCT02491749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349714|NCT02491749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349715|NCT04408898|Pembrolizumab|pembrolizumab|mesh-list
93349716|NCT04408898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93349717|NCT04408898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349718|NCT04408898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93349719|NCT04408898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349720|NCT02490345|Gabapentin|gabapentin|mesh-list
93349721|NCT02490345|Analgesics|analgesics|mesh-ancestor
93349722|NCT02490345|Sensory System Agents|sensory system agents|mesh-ancestor
93349723|NCT02490345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349724|NCT02490345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349725|NCT02490345|Anticonvulsants|anticonvulsants|mesh-ancestor
93349726|NCT02490345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93349727|NCT02490345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93349728|NCT02490345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349729|NCT02490345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93349730|NCT02490345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93349731|NCT02490345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93349732|NCT02490345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349733|NCT02490345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349734|NCT02490345|Antimanic Agents|antimanic agents|mesh-ancestor
93349735|NCT03331263|Chlorhexidine|chlorhexidine|mesh-list
93349736|NCT03331263|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93349737|NCT03331263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93349738|NCT03331263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349739|NCT03331263|Disinfectants|disinfectants|mesh-ancestor
93349740|NCT03331263|Dermatologic Agents|dermatologic agents|mesh-ancestor
93349741|NCT03319563|Epinephrine|epinephrine|mesh-list
93349742|NCT03319563|Anesthetics|anesthetics|mesh-list
93349743|NCT03319563|Anesthetics, Local|anesthetics, local|mesh-list
93349744|NCT03319563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349745|NCT03319563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349746|NCT03319563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93349747|NCT03319563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93349748|NCT03319563|Adrenergic Agents|adrenergic agents|mesh-ancestor
93349749|NCT03319563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349750|NCT03319563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349751|NCT03319563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93349752|NCT03319563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93349753|NCT03319563|Autonomic Agents|autonomic agents|mesh-ancestor
93349754|NCT03319563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349755|NCT03319563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93021682|NCT00354172|Cyclosporine|cyclosporine|mesh-list
93349756|NCT03319563|Respiratory System Agents|respiratory system agents|mesh-ancestor
93349757|NCT03319563|Mydriatics|mydriatics|mesh-ancestor
93349758|NCT03319563|Sympathomimetics|sympathomimetics|mesh-ancestor
93349759|NCT03319563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93349760|NCT03319563|Sensory System Agents|sensory system agents|mesh-ancestor
93349761|NCT02485119|Anetumab ravtansine|anetumab ravtansine|mesh-list
93349762|NCT02485119|Immunoconjugates|immunoconjugates|mesh-ancestor
93349763|NCT02485119|Immunologic Factors|immunologic factors|mesh-ancestor
93349764|NCT02485119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349765|NCT02484573|Propranolol|propranolol|mesh-list
93349766|NCT02484573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93349767|NCT02484573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93349768|NCT02484573|Adrenergic Agents|adrenergic agents|mesh-ancestor
93349769|NCT02484573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349770|NCT02484573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349771|NCT02484573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349772|NCT02484573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93349773|NCT02484573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93349774|NCT02484573|Vasodilator Agents|vasodilator agents|mesh-ancestor
93349776|NCT02489955|Amikacin|amikacin|mesh-list
93349777|NCT02489955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93349778|NCT02489955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349779|NCT03734744|Vitamin D|vitamin d|mesh-list
93349780|NCT03734744|Cholecalciferol|cholecalciferol|mesh-list
93349781|NCT03734744|Vitamins|vitamins|mesh-ancestor
93349782|NCT03734744|Micronutrients|micronutrients|mesh-ancestor
92643497|NCT00213122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93349783|NCT03734744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349784|NCT03734744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93349785|NCT03734744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93349786|NCT03576716|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93349787|NCT03576716|Calcifediol|calcifediol|mesh-list
93349788|NCT03576716|Vitamins|vitamins|mesh-ancestor
93349789|NCT03576716|Micronutrients|micronutrients|mesh-ancestor
93349790|NCT03576716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349791|NCT03576716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93349792|NCT02487381|Dronabinol|dronabinol|mesh-list
93349793|NCT02487381|Cannabidiol|cannabidiol|mesh-list
93349794|NCT02487381|Anticonvulsants|anticonvulsants|mesh-ancestor
93349795|NCT02487381|Hallucinogens|hallucinogens|mesh-ancestor
93349796|NCT02487381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349797|NCT02487381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93349798|NCT02487381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93349799|NCT02487381|Analgesics|analgesics|mesh-ancestor
93349800|NCT02487381|Sensory System Agents|sensory system agents|mesh-ancestor
93349801|NCT02487381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349802|NCT02487381|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93349803|NCT02487381|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93349804|NCT02487381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349805|NCT02487381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349806|NCT02487381|Hormones|hormones|mesh-ancestor
93349807|NCT02487381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93349808|NCT02487849|Carboplatin|carboplatin|mesh-list
93349809|NCT02487849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349810|NCT02484339|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93349811|NCT02484339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349812|NCT04021550|Thioctic Acid|thioctic acid|mesh-list
93349813|NCT04021550|Telmisartan|telmisartan|mesh-list
93349814|NCT04021550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93349815|NCT04021550|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93349816|NCT04021550|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93349817|NCT04021550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349818|NCT04021550|Antioxidants|antioxidants|mesh-ancestor
93349819|NCT04021550|Protective Agents|protective agents|mesh-ancestor
93349820|NCT04021550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349821|NCT04021550|Vitamin B Complex|vitamin b complex|mesh-ancestor
93349822|NCT04021550|Vitamins|vitamins|mesh-ancestor
93349823|NCT04021550|Micronutrients|micronutrients|mesh-ancestor
93349824|NCT02489487|Ritonavir|ritonavir|mesh-list
93349825|NCT02489487|Darunavir|darunavir|mesh-list
93349826|NCT02489487|Raltegravir Potassium|raltegravir potassium|mesh-list
93349827|NCT02489487|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93349828|NCT02489487|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93349829|NCT02489487|Protease Inhibitors|protease inhibitors|mesh-ancestor
93349830|NCT02489487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349831|NCT02489487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349832|NCT02489487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93349833|NCT02489487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93349834|NCT02489487|Antiviral Agents|antiviral agents|mesh-ancestor
93349835|NCT02489487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349836|NCT02489487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93349837|NCT02489487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93349838|NCT02489487|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93349839|NCT02489487|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93349840|NCT02096354|Irinotecan|irinotecan|mesh-list
93349841|NCT02096354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349842|NCT02096354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93349843|NCT02096354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93349844|NCT02096354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349845|NCT02096354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349846|NCT03177746|Tadalafil|tadalafil|mesh-list
93349847|NCT03177746|Vasodilator Agents|vasodilator agents|mesh-ancestor
93349848|NCT03177746|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93349849|NCT03177746|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93349850|NCT03177746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643566|NCT00213590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93349851|NCT03177746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349852|NCT03177746|Urological Agents|urological agents|mesh-ancestor
93349853|NCT02484027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93349854|NCT02484027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93349855|NCT02484027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93349856|NCT02484027|Antimetabolites|antimetabolites|mesh-ancestor
93349857|NCT02484027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349858|NCT02484027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93349859|NCT02484027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93349860|NCT02484027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349861|NCT02483715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93349862|NCT02483715|Amoxicillin|amoxicillin|mesh-list
93349863|NCT02483715|Metronidazole|metronidazole|mesh-list
93349864|NCT02483715|Tetracycline|tetracycline|mesh-list
93349865|NCT02483715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93349866|NCT02483715|Rabeprazole|rabeprazole|mesh-list
93349867|NCT02483715|Bismuth|bismuth|mesh-list
93349868|NCT02483715|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93349869|NCT02483715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93349870|NCT02483715|Antitubercular Agents|antitubercular agents|mesh-ancestor
93349871|NCT02483715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93349872|NCT02483715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93349873|NCT02483715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93349874|NCT02483715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93349875|NCT02483715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349876|NCT02483715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349877|NCT02483715|Antacids|antacids|mesh-ancestor
93349878|NCT02483715|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93349879|NCT02483793|Tamsulosin|tamsulosin|mesh-list
93349880|NCT02483793|Oxybutynin|oxybutynin|mesh-list
93349881|NCT02483793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93349882|NCT02483793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93349883|NCT02483793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93349884|NCT02483793|Adrenergic Agents|adrenergic agents|mesh-ancestor
93349885|NCT02483793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349886|NCT02483793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349887|NCT02483793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349888|NCT02483793|Urological Agents|urological agents|mesh-ancestor
93349889|NCT02483793|Parasympatholytics|parasympatholytics|mesh-ancestor
93349890|NCT02483793|Autonomic Agents|autonomic agents|mesh-ancestor
93349891|NCT02483793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349892|NCT02483793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93349893|NCT02483793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93349894|NCT02483793|Cholinergic Agents|cholinergic agents|mesh-ancestor
93349895|NCT03200288|Hyaluronic Acid|hyaluronic acid|mesh-list
93349896|NCT03200288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93349897|NCT03200288|Immunologic Factors|immunologic factors|mesh-ancestor
93349898|NCT03200288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349899|NCT03200288|Viscosupplements|viscosupplements|mesh-ancestor
93349900|NCT03200288|Protective Agents|protective agents|mesh-ancestor
93349901|NCT03318471|Magnesium Sulfate|magnesium sulfate|mesh-list
93349902|NCT03318471|Analgesics|analgesics|mesh-ancestor
93349903|NCT03318471|Sensory System Agents|sensory system agents|mesh-ancestor
93349904|NCT03318471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349905|NCT03318471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349906|NCT03318471|Anesthetics|anesthetics|mesh-ancestor
93349907|NCT03318471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349908|NCT03318471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93349909|NCT03318471|Anticonvulsants|anticonvulsants|mesh-ancestor
93349910|NCT03318471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93349911|NCT03318471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93349912|NCT03318471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349913|NCT03318471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93349914|NCT03318471|Tocolytic Agents|tocolytic agents|mesh-ancestor
92643637|NCT00243750|Antimetabolites|antimetabolites|mesh-ancestor
93349915|NCT03318471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93349916|NCT04234022|Pomalidomide|pomalidomide|mesh-list
93349917|NCT04234022|Immunologic Factors|immunologic factors|mesh-ancestor
93349918|NCT04234022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349919|NCT04234022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93349920|NCT04234022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93349921|NCT04234022|Growth Substances|growth substances|mesh-ancestor
93349922|NCT04234022|Growth Inhibitors|growth inhibitors|mesh-ancestor
93349923|NCT04234022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349924|NCT02489409|Gemcitabine|gemcitabine|mesh-list
93349925|NCT02489409|Vinorelbine|vinorelbine|mesh-list
93349926|NCT02489409|Endostatins|endostatins|mesh-list
93349927|NCT02489409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93349928|NCT02489409|Antimetabolites|antimetabolites|mesh-ancestor
93349929|NCT02489409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349930|NCT02489409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93349931|NCT02489409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93349932|NCT02489409|Tubulin Modulators|tubulin modulators|mesh-ancestor
93349933|NCT02489409|Antimitotic Agents|antimitotic agents|mesh-ancestor
93349934|NCT02489409|Mitosis Modulators|mitosis modulators|mesh-ancestor
93349935|NCT02489409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93349936|NCT02489409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93349937|NCT02489409|Growth Substances|growth substances|mesh-ancestor
93349938|NCT02489409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349939|NCT02489409|Growth Inhibitors|growth inhibitors|mesh-ancestor
93349940|NCT03930602|Fluvoxamine|fluvoxamine|mesh-list
93349941|NCT03930602|Deucravacitinib|deucravacitinib|mesh-list
93349942|NCT03930602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93349943|NCT03930602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93349944|NCT03930602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349945|NCT03930602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349946|NCT03930602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93349947|NCT03930602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93349948|NCT03930602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93349949|NCT03930602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93349950|NCT03930602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349951|NCT03930602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349952|NCT03930602|Serotonin Agents|serotonin agents|mesh-ancestor
93349953|NCT03930602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93349954|NCT03930602|Antidepressive Agents|antidepressive agents|mesh-ancestor
93349955|NCT03930602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93349956|NCT03930602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93349957|NCT03930602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349958|NCT03930602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93349959|NCT03930602|Dermatologic Agents|dermatologic agents|mesh-ancestor
93349960|NCT03930602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93349961|NCT02483871|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93349962|NCT02483871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93349963|NCT02483871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93349964|NCT02483871|Antimetabolites|antimetabolites|mesh-ancestor
93349965|NCT02483871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349966|NCT02483871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93349967|NCT02483871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93349968|NCT02483871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93349969|NCT02489019|Fentanyl|fentanyl|mesh-list
93349970|NCT02489019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93349971|NCT02489019|Narcotics|narcotics|mesh-ancestor
93349972|NCT02489019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349973|NCT02489019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349974|NCT02489019|Analgesics|analgesics|mesh-ancestor
93349975|NCT02489019|Sensory System Agents|sensory system agents|mesh-ancestor
93349976|NCT02489019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349977|NCT02489019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93349978|NCT02489019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93349979|NCT02489019|Anesthetics, General|anesthetics, general|mesh-ancestor
93349980|NCT02489019|Anesthetics|anesthetics|mesh-ancestor
93021907|NCT00515216|Leucovorin|leucovorin|mesh-list
93349981|NCT02604446|Oxycodone|oxycodone|mesh-list
93349982|NCT02604446|Tapentadol|tapentadol|mesh-list
93349983|NCT02604446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93349984|NCT02604446|Narcotics|narcotics|mesh-ancestor
93349985|NCT02604446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93349986|NCT02604446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93349987|NCT02604446|Analgesics|analgesics|mesh-ancestor
93349988|NCT02604446|Sensory System Agents|sensory system agents|mesh-ancestor
93349989|NCT02604446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93349990|NCT02604446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93349991|NCT02604446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93349992|NCT02604446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93349993|NCT02604446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93349994|NCT02604446|Adrenergic Agents|adrenergic agents|mesh-ancestor
93349995|NCT02604446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93349996|NCT02847637|Factor VIII|factor viii|mesh-list
93349997|NCT02847637|Coagulants|coagulants|mesh-ancestor
93349998|NCT02652260|Tenofovir|tenofovir|mesh-list
93349999|NCT02652260|Lamivudine|lamivudine|mesh-list
93350000|NCT02652260|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93350001|NCT02652260|Antiviral Agents|antiviral agents|mesh-ancestor
93350002|NCT02652260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350003|NCT02652260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93350004|NCT02652260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93350005|NCT02652260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350006|NCT02652260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350007|NCT02652260|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93350008|NCT02652260|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93350009|NCT01710176|Gemcitabine|gemcitabine|mesh-list
93350010|NCT01710176|Docetaxel|docetaxel|mesh-list
93350011|NCT01710176|Etoposide|etoposide|mesh-list
93350012|NCT01710176|Epirubicin|epirubicin|mesh-list
93350013|NCT01710176|Ifosfamide|ifosfamide|mesh-list
93350014|NCT01710176|Isophosphamide mustard|isophosphamide mustard|mesh-list
93350015|NCT01710176|Dacarbazine|dacarbazine|mesh-list
93350016|NCT01710176|Trabectedin|trabectedin|mesh-list
93350017|NCT01710176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93350018|NCT01710176|Antimetabolites|antimetabolites|mesh-ancestor
93350019|NCT01710176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350020|NCT01710176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350021|NCT01710176|Tubulin Modulators|tubulin modulators|mesh-ancestor
93350022|NCT01710176|Antimitotic Agents|antimitotic agents|mesh-ancestor
93350023|NCT01710176|Mitosis Modulators|mitosis modulators|mesh-ancestor
93350024|NCT01710176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93350025|NCT01710176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93350026|NCT01710176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93350027|NCT01710176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350028|NCT01710176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93350029|NCT01710176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93350030|NCT01710176|Alkylating Agents|alkylating agents|mesh-ancestor
93350031|NCT00584246|Pregabalin|pregabalin|mesh-list
93350032|NCT00584246|Analgesics|analgesics|mesh-ancestor
93350033|NCT00584246|Sensory System Agents|sensory system agents|mesh-ancestor
93350034|NCT00584246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350035|NCT00584246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350036|NCT00584246|Anticonvulsants|anticonvulsants|mesh-ancestor
93350037|NCT00584246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93350038|NCT00584246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93350039|NCT00584246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350040|NCT00584246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93350041|NCT00584246|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93350042|NCT00584246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93350043|NCT00584246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350044|NCT00584246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93350045|NCT05124314|Misoprostol|misoprostol|mesh-list
93350046|NCT05124314|Mifepristone|mifepristone|mesh-list
93350047|NCT05124314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93350048|NCT05124314|Abortifacient Agents|abortifacient agents|mesh-ancestor
93350049|NCT05124314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93350050|NCT05124314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350051|NCT05124314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93350052|NCT05124314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350053|NCT05124314|Oxytocics|oxytocics|mesh-ancestor
93350054|NCT05124314|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93350055|NCT05124314|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93350056|NCT05124314|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93350057|NCT05124314|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93350058|NCT05124314|Contraceptive Agents|contraceptive agents|mesh-ancestor
93350059|NCT05124314|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93350060|NCT05124314|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93350061|NCT05124314|Hormone Antagonists|hormone antagonists|mesh-ancestor
93350062|NCT05124314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350063|NCT05124314|Luteolytic Agents|luteolytic agents|mesh-ancestor
93350064|NCT05124314|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93350065|NCT05124314|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93350066|NCT03320967|Arginine Vasopressin|arginine vasopressin|mesh-list
93350067|NCT03320967|Hemostatics|hemostatics|mesh-ancestor
93350068|NCT03320967|Coagulants|coagulants|mesh-ancestor
93350069|NCT03320967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93350070|NCT03320967|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93350071|NCT03320967|Natriuretic Agents|natriuretic agents|mesh-ancestor
93350072|NCT03320967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350073|NCT02483325|Fludarabine|fludarabine|mesh-list
93350074|NCT02483325|Busulfan|busulfan|mesh-list
93350075|NCT02483325|Thymoglobulin|thymoglobulin|mesh-list
93350076|NCT02483325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350077|NCT02483325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350078|NCT02483325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93350079|NCT02483325|Immunologic Factors|immunologic factors|mesh-ancestor
93350080|NCT02483325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350081|NCT02483325|Alkylating Agents|alkylating agents|mesh-ancestor
93350082|NCT02483325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93350083|NCT02483325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93350084|NCT04211090|Carboplatin|carboplatin|mesh-list
93350085|NCT04211090|Pemetrexed|pemetrexed|mesh-list
93350086|NCT04211090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350087|NCT04211090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350088|NCT04211090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350089|NCT04211090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93350090|NCT04211090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93350091|NCT02486445|Rivaroxaban|rivaroxaban|mesh-list
93350092|NCT02486445|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93350093|NCT02486445|Antithrombins|antithrombins|mesh-ancestor
93350094|NCT02486445|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93350095|NCT02486445|Protease Inhibitors|protease inhibitors|mesh-ancestor
93350096|NCT02486445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350097|NCT02486445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350098|NCT02486445|Anticoagulants|anticoagulants|mesh-ancestor
93350099|NCT02836873|Bexagliflozin|bexagliflozin|mesh-list
93350100|NCT02836873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93350101|NCT02836873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350102|NCT04538534|Nicardipine|nicardipine|mesh-list
93350103|NCT04538534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93350104|NCT04538534|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93350105|NCT04538534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93350106|NCT04538534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350107|NCT04538534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93350108|NCT04538534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350109|NCT04538534|Vasodilator Agents|vasodilator agents|mesh-ancestor
93350110|NCT03318159|Posaconazole|posaconazole|mesh-list
93350111|NCT03318159|Antifungal Agents|antifungal agents|mesh-ancestor
93350112|NCT03318159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350113|NCT03318159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93350114|NCT03318159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93350115|NCT03318159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93350116|NCT03318159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93350117|NCT03318159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93350118|NCT03318159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350119|NCT03318159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350120|NCT03318159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93350121|NCT03318159|Hormone Antagonists|hormone antagonists|mesh-ancestor
93350122|NCT03318159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350123|NCT03318159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350124|NCT03315507|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
93350125|NCT03315507|Vasodilator Agents|vasodilator agents|mesh-ancestor
93350126|NCT02724410|Amoxicillin|amoxicillin|mesh-list
93350127|NCT02724410|Clavulanic Acid|clavulanic acid|mesh-list
93350128|NCT02724410|Clavulanic Acids|clavulanic acids|mesh-list
93350129|NCT02724410|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93350130|NCT02724410|Ertapenem|ertapenem|mesh-list
93350131|NCT02724410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350132|NCT02724410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350133|NCT02724410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93350134|NCT02724410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350135|NCT02724410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350136|NCT02486601|Paclitaxel|paclitaxel|mesh-list
93350137|NCT02486601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93350138|NCT02486601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350139|NCT02486601|Tubulin Modulators|tubulin modulators|mesh-ancestor
93350140|NCT02486601|Antimitotic Agents|antimitotic agents|mesh-ancestor
93350141|NCT02486601|Mitosis Modulators|mitosis modulators|mesh-ancestor
93350142|NCT02486601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350143|NCT02487069|Cyclosporine|cyclosporine|mesh-list
93350144|NCT02487069|Mycophenolic Acid|mycophenolic acid|mesh-list
93350145|NCT02487069|Methotrexate|methotrexate|mesh-list
93350146|NCT02487069|Cyclosporins|cyclosporins|mesh-list
93350147|NCT02487069|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93350148|NCT02487069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93350149|NCT02487069|Abortifacient Agents|abortifacient agents|mesh-ancestor
93350150|NCT02487069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93350151|NCT02487069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350152|NCT02487069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93350153|NCT02487069|Antimetabolites|antimetabolites|mesh-ancestor
93350154|NCT02487069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350155|NCT02487069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350156|NCT02487069|Dermatologic Agents|dermatologic agents|mesh-ancestor
93350157|NCT02487069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350158|NCT02487069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93350159|NCT02487069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93350160|NCT02487069|Immunologic Factors|immunologic factors|mesh-ancestor
93350161|NCT02487069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350162|NCT02487069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93350163|NCT02487069|Antifungal Agents|antifungal agents|mesh-ancestor
93350164|NCT02487069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350165|NCT02487069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93350166|NCT02487069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93350167|NCT02487069|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93350168|NCT02487069|Antitubercular Agents|antitubercular agents|mesh-ancestor
93350169|NCT02487069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350170|NCT03564379|JNJ-42165279|jnj-42165279|mesh-list
93350171|NCT03564379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350172|NCT03564379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350173|NCT03317847|Dexamethasone|dexamethasone|mesh-list
93350174|NCT03317847|Bromfenac|bromfenac|mesh-list
93350175|NCT03317847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93350176|NCT03317847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350177|NCT03317847|Antiemetics|antiemetics|mesh-ancestor
93350178|NCT03317847|Autonomic Agents|autonomic agents|mesh-ancestor
93350179|NCT03317847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350180|NCT03317847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350181|NCT03317847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350182|NCT03317847|Glucocorticoids|glucocorticoids|mesh-ancestor
93350183|NCT03317847|Hormones|hormones|mesh-ancestor
93350184|NCT03317847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350185|NCT03317847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93350186|NCT03317847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350187|NCT03317847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93350188|NCT03317847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93350189|NCT03317847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350190|NCT03317847|Analgesics|analgesics|mesh-ancestor
93350191|NCT03317847|Sensory System Agents|sensory system agents|mesh-ancestor
93350192|NCT03317847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350193|NCT01342081|Timolol|timolol|mesh-list
93350194|NCT01342081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93350195|NCT01342081|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93350196|NCT01342081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93350197|NCT01342081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93350198|NCT01342081|Adrenergic Agents|adrenergic agents|mesh-ancestor
93350199|NCT01342081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350200|NCT01342081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350201|NCT01342081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350202|NCT01342081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92643916|NCT00215345|Celecoxib|celecoxib|mesh-list
93350203|NCT01342081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93350204|NCT03563833|Anesthetics|anesthetics|mesh-list
93022129|NCT00404547|Hormones|hormones|mesh-ancestor
93350205|NCT03563833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350206|NCT03563833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350208|NCT02483169|Cilostazol|cilostazol|mesh-list
93350209|NCT02483169|Probucol|probucol|mesh-list
93350210|NCT02483169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93350211|NCT02483169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350212|NCT02483169|Analgesics|analgesics|mesh-ancestor
93350213|NCT02483169|Sensory System Agents|sensory system agents|mesh-ancestor
93350214|NCT02483169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350215|NCT02483169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350216|NCT02483169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350217|NCT02483169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350218|NCT02483169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93350219|NCT02483169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93350220|NCT02483169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350221|NCT02483169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93350222|NCT02483169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93350223|NCT02483169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350224|NCT02483169|Antipyretics|antipyretics|mesh-ancestor
93350225|NCT02483169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93350226|NCT02483169|Autonomic Agents|autonomic agents|mesh-ancestor
93350227|NCT02483169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93350228|NCT02483169|Respiratory System Agents|respiratory system agents|mesh-ancestor
93350229|NCT02483169|Vasodilator Agents|vasodilator agents|mesh-ancestor
93350230|NCT02483169|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93350231|NCT02483169|Protective Agents|protective agents|mesh-ancestor
93350232|NCT02483169|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93350233|NCT02483169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93350234|NCT02483169|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93350235|NCT02483169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350236|NCT02483169|Antimetabolites|antimetabolites|mesh-ancestor
93350237|NCT02483169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350238|NCT02483169|Antioxidants|antioxidants|mesh-ancestor
93350239|NCT02489097|Nitrous Oxide|nitrous oxide|mesh-list
93350240|NCT02489097|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93350241|NCT02489097|Anesthetics, General|anesthetics, general|mesh-ancestor
93350242|NCT02489097|Anesthetics|anesthetics|mesh-ancestor
93350243|NCT02489097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350244|NCT02489097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350245|NCT02489097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350246|NCT02489097|Analgesics|analgesics|mesh-ancestor
93350247|NCT02489097|Sensory System Agents|sensory system agents|mesh-ancestor
93350248|NCT02489097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350249|NCT02203682|Doxycycline|doxycycline|mesh-list
93350250|NCT02203682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350251|NCT02203682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350252|NCT02203682|Antimalarials|antimalarials|mesh-ancestor
93350253|NCT02203682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93350254|NCT02203682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93350255|NCT02256800|Leucovorin|leucovorin|mesh-list
93350256|NCT02256800|Bevacizumab|bevacizumab|mesh-list
93350257|NCT02256800|Irinotecan|irinotecan|mesh-list
93350258|NCT02256800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93350259|NCT02256800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350260|NCT02256800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93350261|NCT02256800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93350262|NCT02256800|Growth Substances|growth substances|mesh-ancestor
93350263|NCT02256800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350264|NCT02256800|Growth Inhibitors|growth inhibitors|mesh-ancestor
93350265|NCT02256800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93350266|NCT02256800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93350267|NCT02256800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643987|NCT00215501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350268|NCT02256800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350269|NCT02256800|Antidotes|antidotes|mesh-ancestor
93350270|NCT02256800|Protective Agents|protective agents|mesh-ancestor
93350271|NCT02256800|Vitamin B Complex|vitamin b complex|mesh-ancestor
93350272|NCT02256800|Vitamins|vitamins|mesh-ancestor
93350273|NCT02256800|Micronutrients|micronutrients|mesh-ancestor
93350274|NCT01341457|Gemcitabine|gemcitabine|mesh-list
93350275|NCT01341457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93350276|NCT01341457|Antimetabolites|antimetabolites|mesh-ancestor
93350277|NCT01341457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350278|NCT01341457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350279|NCT02488473|Dexmedetomidine|dexmedetomidine|mesh-list
93350280|NCT02488473|Ropivacaine|ropivacaine|mesh-list
93350281|NCT02488473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93350282|NCT02488473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350283|NCT02488473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350284|NCT02488473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350285|NCT02488473|Analgesics|analgesics|mesh-ancestor
93350286|NCT02488473|Sensory System Agents|sensory system agents|mesh-ancestor
93350287|NCT02488473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350288|NCT02488473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93350289|NCT02488473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93350290|NCT02488473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93350291|NCT02488473|Adrenergic Agents|adrenergic agents|mesh-ancestor
93350292|NCT02488473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350293|NCT02488473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350294|NCT02488473|Anesthetics, Local|anesthetics, local|mesh-ancestor
93350295|NCT02488473|Anesthetics|anesthetics|mesh-ancestor
93350296|NCT05128292|Selenium|selenium|mesh-list
93350297|NCT05128292|Antioxidants|antioxidants|mesh-ancestor
93350298|NCT05128292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350299|NCT05128292|Protective Agents|protective agents|mesh-ancestor
93350300|NCT05128292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350301|NCT05128292|Trace Elements|trace elements|mesh-ancestor
93350302|NCT05128292|Micronutrients|micronutrients|mesh-ancestor
93350303|NCT05127980|Antibodies|antibodies|mesh-list
93350304|NCT05127980|Autoantibodies|autoantibodies|mesh-list
93350305|NCT05127980|Immunologic Factors|immunologic factors|mesh-ancestor
93350306|NCT05127980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350307|NCT03971708|Lidocaine|lidocaine|mesh-list
93350308|NCT03971708|Ropivacaine|ropivacaine|mesh-list
93350309|NCT03971708|Anesthetics, Local|anesthetics, local|mesh-ancestor
93350310|NCT03971708|Anesthetics|anesthetics|mesh-ancestor
93350311|NCT03971708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350312|NCT03971708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350313|NCT03971708|Sensory System Agents|sensory system agents|mesh-ancestor
93350314|NCT03971708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350315|NCT03971708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93350316|NCT03971708|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93350317|NCT03971708|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93350318|NCT03971708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93350319|NCT03971708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350320|NCT02832037|BI 425809|bi 425809|mesh-list
93350321|NCT02832037|Nootropic Agents|nootropic agents|mesh-ancestor
93350322|NCT03966014|Amoxicillin|amoxicillin|mesh-list
93350323|NCT03966014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350324|NCT03966014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350325|NCT02482857|Aspirin|aspirin|mesh-list
93350326|NCT02482857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93350327|NCT02482857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350328|NCT02482857|Analgesics|analgesics|mesh-ancestor
93350329|NCT02482857|Sensory System Agents|sensory system agents|mesh-ancestor
93350330|NCT02482857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350331|NCT02482857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350332|NCT02482857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350333|NCT02482857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350334|NCT02482857|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93350335|NCT02482857|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93350336|NCT02482857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350337|NCT02482857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93350338|NCT02482857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93350339|NCT02482857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350340|NCT02482857|Antipyretics|antipyretics|mesh-ancestor
93350341|NCT02480049|Montelukast|montelukast|mesh-list
93350342|NCT02480049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93350343|NCT02480049|Respiratory System Agents|respiratory system agents|mesh-ancestor
93350344|NCT02480049|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93350345|NCT02480049|Hormone Antagonists|hormone antagonists|mesh-ancestor
93350346|NCT02480049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350347|NCT02480049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350348|NCT02480049|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93350349|NCT02480049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93350350|NCT02480049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350351|NCT02479971|Clindamycin|clindamycin|mesh-list
93350352|NCT02479971|Clindamycin palmitate|clindamycin palmitate|mesh-list
93350353|NCT02479971|Clindamycin phosphate|clindamycin phosphate|mesh-list
93350354|NCT02479971|Gentamicins|gentamicins|mesh-list
93350355|NCT02479971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93022286|NCT00893477|Rituximab|rituximab|mesh-list
93350356|NCT02479971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350357|NCT02479971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93350358|NCT02479971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350359|NCT02479971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350360|NCT02486133|Ritonavir|ritonavir|mesh-list
93350361|NCT02486133|Darunavir|darunavir|mesh-list
93350362|NCT02486133|Tenofovir|tenofovir|mesh-list
93350363|NCT02486133|Lamivudine|lamivudine|mesh-list
93350364|NCT02486133|Emtricitabine|emtricitabine|mesh-list
93350365|NCT02486133|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93350366|NCT02486133|Dolutegravir|dolutegravir|mesh-list
93350367|NCT02486133|Abacavir|abacavir|mesh-list
93350368|NCT02486133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93350369|NCT02486133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93350370|NCT02486133|Protease Inhibitors|protease inhibitors|mesh-ancestor
93350371|NCT02486133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350372|NCT02486133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350373|NCT02486133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93350374|NCT02486133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93350375|NCT02486133|Antiviral Agents|antiviral agents|mesh-ancestor
93350376|NCT02486133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350377|NCT02486133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93350378|NCT02486133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93350379|NCT02486133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93350380|NCT02486133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93350381|NCT02486133|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93350382|NCT02486133|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93350383|NCT02486055|Coenzyme Q10|coenzyme q10|mesh-list
93350384|NCT02486055|Micronutrients|micronutrients|mesh-ancestor
93350385|NCT02486055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350386|NCT02486055|Vitamins|vitamins|mesh-ancestor
93350387|NCT02486289|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
93350388|NCT02486289|Chelating Agents|chelating agents|mesh-ancestor
93350389|NCT02486289|Sequestering Agents|sequestering agents|mesh-ancestor
93350390|NCT02486289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350391|NCT02485821|Misoprostol|misoprostol|mesh-list
93350392|NCT02485821|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93350393|NCT02485821|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93350394|NCT02485821|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93350395|NCT02485821|Estradiol|estradiol|mesh-list
93350396|NCT02485821|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93350397|NCT02485821|Estrogens|estrogens|mesh-ancestor
93350398|NCT02485821|Hormones|hormones|mesh-ancestor
93350399|NCT02485821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350400|NCT02485821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350401|NCT02485821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93350402|NCT02485821|Contraceptive Agents|contraceptive agents|mesh-ancestor
93350403|NCT02485821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93350404|NCT02485821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93350405|NCT02485821|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93350406|NCT02485821|Abortifacient Agents|abortifacient agents|mesh-ancestor
93350407|NCT02485821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93350408|NCT02485821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350409|NCT02485821|Oxytocics|oxytocics|mesh-ancestor
93350410|NCT02485821|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93350411|NCT02485821|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93350412|NCT02479815|Micronutrients|micronutrients|mesh-list
93350413|NCT02479815|Trace Elements|trace elements|mesh-list
93350414|NCT02479815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350415|NCT04119830|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
93350416|NCT04119830|Pembrolizumab|pembrolizumab|mesh-list
93350417|NCT04119830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93350418|NCT04119830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350419|NCT04119830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93350420|NCT04119830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350421|NCT04119830|Antiviral Agents|antiviral agents|mesh-ancestor
93350422|NCT04119830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350423|NCT04049786|Metoprolol|metoprolol|mesh-list
93350424|NCT04049786|Carvedilol|carvedilol|mesh-list
93350425|NCT04049786|Midazolam|midazolam|mesh-list
93350426|NCT04049786|Simvastatin|simvastatin|mesh-list
93350427|NCT04049786|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93350428|NCT04049786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93022361|NCT01058902|Aspirin|aspirin|mesh-list
93350429|NCT04049786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350430|NCT04049786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350431|NCT04049786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93350432|NCT04049786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93350433|NCT04049786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93350434|NCT04049786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93350435|NCT04049786|Anesthetics, General|anesthetics, general|mesh-ancestor
93350437|NCT04049786|GABA Modulators|gaba modulators|mesh-ancestor
93350438|NCT04049786|GABA Agents|gaba agents|mesh-ancestor
93350439|NCT04049786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350440|NCT04049786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350441|NCT04049786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93350442|NCT04049786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350443|NCT04049786|Antimetabolites|antimetabolites|mesh-ancestor
93350444|NCT04049786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350445|NCT04049786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93350446|NCT04049786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350447|NCT04049786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93350448|NCT04049786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93350449|NCT04049786|Sympatholytics|sympatholytics|mesh-ancestor
93350450|NCT04049786|Autonomic Agents|autonomic agents|mesh-ancestor
93350451|NCT04049786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350452|NCT04049786|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93350453|NCT04049786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93350454|NCT04049786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93350455|NCT04049786|Adrenergic Agents|adrenergic agents|mesh-ancestor
93350456|NCT04049786|Antioxidants|antioxidants|mesh-ancestor
93350457|NCT04049786|Protective Agents|protective agents|mesh-ancestor
93350458|NCT04049786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93350459|NCT04049786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93350460|NCT04049786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93350461|NCT04049786|Vasodilator Agents|vasodilator agents|mesh-ancestor
93350462|NCT04049786|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93350463|NCT04049786|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93350464|NCT02482077|Sofosbuvir|sofosbuvir|mesh-list
93350465|NCT02482077|Antiviral Agents|antiviral agents|mesh-ancestor
93350466|NCT02482077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350467|NCT03316599|Paclitaxel|paclitaxel|mesh-list
93350468|NCT03316599|Gemcitabine|gemcitabine|mesh-list
93350469|NCT03316599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93350470|NCT03316599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350471|NCT03316599|Tubulin Modulators|tubulin modulators|mesh-ancestor
93350472|NCT03316599|Antimitotic Agents|antimitotic agents|mesh-ancestor
93350473|NCT03316599|Mitosis Modulators|mitosis modulators|mesh-ancestor
93350474|NCT03316599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350475|NCT03316599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93350476|NCT03316599|Antimetabolites|antimetabolites|mesh-ancestor
93350477|NCT02482155|Ibuprofen|ibuprofen|mesh-list
93350478|NCT02482155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93350479|NCT02482155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350480|NCT02482155|Analgesics|analgesics|mesh-ancestor
93350481|NCT02482155|Sensory System Agents|sensory system agents|mesh-ancestor
93350482|NCT02482155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350483|NCT02482155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350484|NCT02482155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350485|NCT02482155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350486|NCT02482155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93350487|NCT02482155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350488|NCT02482155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350489|NCT01675154|Orlistat|orlistat|mesh-list
93350490|NCT01675154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350491|NCT01675154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350492|NCT01675154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93350493|NCT01675154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350494|NCT02485431|Deflazacort|deflazacort|mesh-list
93350495|NCT02485431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350496|NCT02485431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93350497|NCT02485431|Immunologic Factors|immunologic factors|mesh-ancestor
93350498|NCT02485431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350499|NCT02744755|Adalimumab|adalimumab|mesh-list
93350500|NCT02744755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93350501|NCT02744755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350502|NCT02744755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350503|NCT03314493|Spironolactone|spironolactone|mesh-list
93350504|NCT03314493|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93350505|NCT03314493|Hormone Antagonists|hormone antagonists|mesh-ancestor
93022432|NCT00891605|Paclitaxel|paclitaxel|mesh-list
93350506|NCT03314493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350507|NCT03314493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350508|NCT03314493|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93350510|NCT03314493|Natriuretic Agents|natriuretic agents|mesh-ancestor
93350511|NCT03912350|Balovaptan|balovaptan|mesh-list
93350512|NCT03912350|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93350513|NCT03912350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350514|NCT03912350|Natriuretic Agents|natriuretic agents|mesh-ancestor
93350515|NCT03912350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350516|NCT03829514|Fenofibrate|fenofibrate|mesh-list
93350517|NCT03829514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350518|NCT03829514|Antimetabolites|antimetabolites|mesh-ancestor
93350519|NCT03829514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350520|NCT03829514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350521|NCT03801200|Apatinib|apatinib|mesh-list
93350522|NCT03801200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350523|NCT03801200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93350524|NCT03801200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350525|NCT03801200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350526|NCT02485041|Mirodenafil|mirodenafil|mesh-list
93350527|NCT02485041|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93350528|NCT02485041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93350529|NCT02485041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350530|NCT02485041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350531|NCT02484963|Zolpidem|zolpidem|mesh-list
93350532|NCT02484963|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93350533|NCT02484963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93350534|NCT02484963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350535|NCT02484963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350536|NCT02484963|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93350537|NCT02484963|GABA Agonists|gaba agonists|mesh-ancestor
93350538|NCT02484963|GABA Agents|gaba agents|mesh-ancestor
93350539|NCT02484963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350540|NCT02484963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350541|NCT05713773|Caffeine|caffeine|mesh-list
93350542|NCT05713773|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93350543|NCT05713773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350544|NCT05713773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93350545|NCT05713773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350546|NCT05713773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350547|NCT05713773|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93350548|NCT05713773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93350549|NCT05713773|Purinergic Agents|purinergic agents|mesh-ancestor
93350550|NCT05713773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350551|NCT05708053|Metformin|metformin|mesh-list
93350552|NCT05708053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93350553|NCT05708053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350554|NCT02829775|Interferons|interferons|mesh-list
93350555|NCT02829775|Interferon-alpha|interferon-alpha|mesh-list
93350556|NCT02829775|Interferon alpha-2|interferon alpha-2|mesh-list
93350557|NCT02829775|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93350558|NCT02829775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350559|NCT02829775|Antiviral Agents|antiviral agents|mesh-ancestor
93350560|NCT02829775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350561|NCT02829775|Immunologic Factors|immunologic factors|mesh-ancestor
93350562|NCT02829775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350563|NCT02476773|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93350564|NCT02476773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93350565|NCT02476773|Immunologic Factors|immunologic factors|mesh-ancestor
93350566|NCT02476773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350567|NCT02476773|Antacids|antacids|mesh-ancestor
93350568|NCT02476773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350569|NCT02476773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350570|NCT04500860|Tadalafil|tadalafil|mesh-list
93350571|NCT04500860|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93350572|NCT04500860|Vasodilator Agents|vasodilator agents|mesh-ancestor
93350573|NCT04500860|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93350574|NCT04500860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93350575|NCT04500860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350576|NCT04500860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350577|NCT04500860|Urological Agents|urological agents|mesh-ancestor
93350578|NCT04500860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93350579|NCT04500860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93350580|NCT04500860|Cholinergic Agents|cholinergic agents|mesh-ancestor
93350581|NCT04500860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350582|NCT04500860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350583|NCT02479503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93350584|NCT02479503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350586|NCT02479581|Dexamethasone|dexamethasone|mesh-list
93350587|NCT02479581|Methylprednisolone|methylprednisolone|mesh-list
93350588|NCT02479581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93350589|NCT02479581|Scopolamine|scopolamine|mesh-list
93350590|NCT02479581|Morphine|morphine|mesh-list
93350591|NCT02479581|Anesthetics|anesthetics|mesh-list
93350592|NCT02479581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350593|NCT02479581|Antiemetics|antiemetics|mesh-ancestor
93350594|NCT02479581|Autonomic Agents|autonomic agents|mesh-ancestor
93350595|NCT02479581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350596|NCT02479581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350597|NCT02479581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350598|NCT02479581|Glucocorticoids|glucocorticoids|mesh-ancestor
93350599|NCT02479581|Hormones|hormones|mesh-ancestor
93350600|NCT02479581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350601|NCT02479581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93350602|NCT02479581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350603|NCT02479581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350604|NCT02479581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350605|NCT02479581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93350606|NCT02479581|Narcotics|narcotics|mesh-ancestor
93350607|NCT02479581|Analgesics|analgesics|mesh-ancestor
93350608|NCT02479581|Sensory System Agents|sensory system agents|mesh-ancestor
93350609|NCT02479581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93350610|NCT02479581|Protective Agents|protective agents|mesh-ancestor
93350611|NCT02479581|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93350612|NCT02479581|Mydriatics|mydriatics|mesh-ancestor
93350613|NCT02479581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93350614|NCT02479581|Cholinergic Agents|cholinergic agents|mesh-ancestor
93350615|NCT02479581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350616|NCT02479581|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93350617|NCT02479581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350618|NCT02479581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350619|NCT02479347|Chlorhexidine|chlorhexidine|mesh-list
93350620|NCT02479347|Povidone-Iodine|povidone-iodine|mesh-list
93350621|NCT02479347|Povidone|povidone|mesh-list
93350622|NCT02479347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93350623|NCT02479347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350624|NCT02479347|Disinfectants|disinfectants|mesh-ancestor
93350625|NCT02479347|Plasma Substitutes|plasma substitutes|mesh-ancestor
93350626|NCT02479347|Blood Substitutes|blood substitutes|mesh-ancestor
93350627|NCT05125718|Anti-Infective Agents|anti-infective agents|mesh-list
93350628|NCT05125718|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93350629|NCT02481609|Acetylcysteine|acetylcysteine|mesh-list
93350630|NCT02481609|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93350631|NCT02481609|Antiviral Agents|antiviral agents|mesh-ancestor
93350632|NCT02481609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350633|NCT02481609|Expectorants|expectorants|mesh-ancestor
93350634|NCT02481609|Respiratory System Agents|respiratory system agents|mesh-ancestor
93350635|NCT02481609|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93350636|NCT02481609|Antioxidants|antioxidants|mesh-ancestor
93350637|NCT02481609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350638|NCT02481609|Protective Agents|protective agents|mesh-ancestor
93350639|NCT02481609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350640|NCT02481609|Antidotes|antidotes|mesh-ancestor
93350641|NCT05373225|Acetic Acid|acetic acid|mesh-list
93350642|NCT05373225|Retinol acetate|retinol acetate|mesh-list
93350643|NCT05373225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350644|NCT05373225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350645|NCT05373225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93350646|NCT05373225|Immunologic Factors|immunologic factors|mesh-ancestor
93350647|NCT05373225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350648|NCT05373225|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93350649|NCT05373225|Protective Agents|protective agents|mesh-ancestor
93350650|NCT05373225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350651|NCT01355575|Rifaximin|rifaximin|mesh-list
93350652|NCT01355575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350653|NCT01355575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350654|NCT01355575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350655|NCT05125640|Progesterone|progesterone|mesh-list
93350656|NCT05125640|Progestins|progestins|mesh-ancestor
93350657|NCT05125640|Hormones|hormones|mesh-ancestor
93350658|NCT05125640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350659|NCT05125640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350660|NCT03314259|Tamsulosin|tamsulosin|mesh-list
93350661|NCT03314259|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93350662|NCT03314259|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93350663|NCT03314259|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93350664|NCT03314259|Adrenergic Agents|adrenergic agents|mesh-ancestor
93350665|NCT03314259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350666|NCT03314259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350667|NCT03314259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350668|NCT03314259|Urological Agents|urological agents|mesh-ancestor
93350669|NCT05125328|Remifentanil|remifentanil|mesh-list
93350670|NCT05125328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93350671|NCT05125328|Narcotics|narcotics|mesh-ancestor
93350672|NCT05125328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350673|NCT05125328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350674|NCT05125328|Analgesics|analgesics|mesh-ancestor
93350675|NCT05125328|Sensory System Agents|sensory system agents|mesh-ancestor
93350676|NCT05125328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350677|NCT02481453|Sirolimus|sirolimus|mesh-list
93350678|NCT02481453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93350679|NCT02481453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350680|NCT02481453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93350681|NCT02481453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350682|NCT02481453|Antifungal Agents|antifungal agents|mesh-ancestor
93350683|NCT02481453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93350684|NCT02481453|Immunologic Factors|immunologic factors|mesh-ancestor
93350685|NCT02481453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350686|NCT02825251|Insulin|insulin|mesh-list
93350687|NCT02825251|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93350688|NCT02825251|Insulin Aspart|insulin aspart|mesh-list
93350689|NCT02825251|Insulin, Long-Acting|insulin, long-acting|mesh-list
93350690|NCT02825251|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93350691|NCT02825251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93350692|NCT02825251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350693|NCT03563365|Adapalene|adapalene|mesh-list
93350694|NCT03563365|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93350695|NCT03563365|Resveratrol|resveratrol|mesh-list
93350696|NCT03563365|Antioxidants|antioxidants|mesh-ancestor
93350697|NCT03563365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350698|NCT03563365|Protective Agents|protective agents|mesh-ancestor
93350699|NCT03563365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350700|NCT03563365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350701|NCT03563365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93350702|NCT03563365|Dermatologic Agents|dermatologic agents|mesh-ancestor
93350703|NCT03563365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93350704|NCT03563365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93350705|NCT03563365|Analgesics|analgesics|mesh-ancestor
93350706|NCT03563365|Sensory System Agents|sensory system agents|mesh-ancestor
93350707|NCT03563365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350708|NCT03563365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350709|NCT03563365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350710|NCT02475915|Tenofovir|tenofovir|mesh-list
93350711|NCT02475915|Emtricitabine|emtricitabine|mesh-list
93350712|NCT02475915|Efavirenz|efavirenz|mesh-list
93350713|NCT02475915|Maraviroc|maraviroc|mesh-list
93350714|NCT02475915|Darunavir|darunavir|mesh-list
93350715|NCT02475915|Hydroxychloroquine|hydroxychloroquine|mesh-list
93350716|NCT02475915|Vorinostat|vorinostat|mesh-list
93350717|NCT02475915|Antiviral Agents|antiviral agents|mesh-ancestor
93350718|NCT02475915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350719|NCT02475915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93350720|NCT02475915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93350721|NCT02475915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350722|NCT02475915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350723|NCT02475915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93350724|NCT02475915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93350725|NCT02475915|Antimalarials|antimalarials|mesh-ancestor
93350726|NCT02475915|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93350727|NCT02475915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93350728|NCT02475915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350729|NCT02475915|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93350730|NCT02475915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93350731|NCT02475915|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93350732|NCT02475915|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93350733|NCT02475915|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93350734|NCT02475915|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93350735|NCT02475915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350736|NCT02475915|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93350737|NCT02475915|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93350738|NCT02475915|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93350739|NCT02475915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93350740|NCT02475915|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93350741|NCT02475915|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93350742|NCT02475915|Protease Inhibitors|protease inhibitors|mesh-ancestor
93350743|NCT05124457|Insulin|insulin|mesh-list
93350744|NCT05124457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93350745|NCT05124457|Insulin Detemir|insulin detemir|mesh-list
93350746|NCT05124457|Isophane Insulin, Human|isophane insulin, human|mesh-list
93350747|NCT05124457|Insulin, Isophane|insulin, isophane|mesh-list
93350748|NCT05124457|Isophane insulin, beef|isophane insulin, beef|mesh-list
93350749|NCT05124457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93350750|NCT05124457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350751|NCT03833323|Treprostinil|treprostinil|mesh-list
93350752|NCT03833323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93350753|NCT03110575|Cyclobenzaprine|cyclobenzaprine|mesh-list
93350754|NCT03110575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93350755|NCT03110575|Antidepressive Agents|antidepressive agents|mesh-ancestor
93350756|NCT03110575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93350757|NCT03110575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93350758|NCT03110575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350759|NCT03110575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93350760|NCT03110575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350761|NCT03110575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93350762|NCT03110575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350763|NCT02824627|Oxytocin|oxytocin|mesh-list
93350764|NCT02824627|Oxytocics|oxytocics|mesh-ancestor
93350765|NCT02824627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93350766|NCT02824627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350767|NCT05384847|Hormones|hormones|mesh-list
93350768|NCT05384847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350769|NCT05384847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350770|NCT02478879|Teriparatide|teriparatide|mesh-list
93350771|NCT02478879|Parathyroid Hormone|parathyroid hormone|mesh-list
93350772|NCT02478879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350773|NCT02478879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93350774|NCT02478879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93350775|NCT02478645|Ramosetron|ramosetron|mesh-list
93350776|NCT02478645|Antiemetics|antiemetics|mesh-ancestor
93350777|NCT02478645|Autonomic Agents|autonomic agents|mesh-ancestor
93350778|NCT02478645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350779|NCT02478645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350780|NCT02478645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350781|NCT02478645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93350782|NCT02478645|Serotonin Agents|serotonin agents|mesh-ancestor
93350783|NCT02478645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350784|NCT02478645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350785|NCT05871957|Vitamin D|vitamin d|mesh-list
93350786|NCT05871957|Ergocalciferols|ergocalciferols|mesh-list
93350787|NCT05871957|Cholecalciferol|cholecalciferol|mesh-list
93350788|NCT05871957|Vitamins|vitamins|mesh-list
93350789|NCT05871957|Micronutrients|micronutrients|mesh-ancestor
93350790|NCT05871957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350791|NCT05871957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93350792|NCT05871957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93350793|NCT05871684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93350794|NCT05871684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350795|NCT05871684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93350796|NCT05871684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350797|NCT05871073|Dexamethasone|dexamethasone|mesh-list
93350798|NCT05871073|Ropivacaine|ropivacaine|mesh-list
93350799|NCT05871073|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93350800|NCT05871073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350801|NCT05871073|Antiemetics|antiemetics|mesh-ancestor
93350802|NCT05871073|Autonomic Agents|autonomic agents|mesh-ancestor
93350803|NCT05871073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350804|NCT05871073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350805|NCT05871073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350806|NCT05871073|Glucocorticoids|glucocorticoids|mesh-ancestor
93350807|NCT05871073|Hormones|hormones|mesh-ancestor
93350808|NCT05871073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350809|NCT05871073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93350810|NCT05871073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350811|NCT05871073|Anesthetics, Local|anesthetics, local|mesh-ancestor
93350812|NCT05871073|Anesthetics|anesthetics|mesh-ancestor
93350813|NCT05871073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350814|NCT05871073|Sensory System Agents|sensory system agents|mesh-ancestor
93350815|NCT05871021|Bevacizumab|bevacizumab|mesh-list
93350816|NCT05871021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93350817|NCT05871021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350818|NCT05871021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93350819|NCT05871021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93350820|NCT05871021|Growth Substances|growth substances|mesh-ancestor
93350821|NCT05871021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350822|NCT05871021|Growth Inhibitors|growth inhibitors|mesh-ancestor
93350823|NCT05870969|Liver Extracts|liver extracts|mesh-list
93350824|NCT05870969|Hematinics|hematinics|mesh-ancestor
93350825|NCT05870917|Dexamethasone|dexamethasone|mesh-list
93350826|NCT05870917|Lenalidomide|lenalidomide|mesh-list
93350827|NCT05870917|Bortezomib|bortezomib|mesh-list
93350828|NCT05870917|Venetoclax|venetoclax|mesh-list
93350829|NCT05870917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350830|NCT05870917|Antiemetics|antiemetics|mesh-ancestor
93350831|NCT05870917|Autonomic Agents|autonomic agents|mesh-ancestor
93350832|NCT05870917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350833|NCT05870917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350834|NCT05870917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350835|NCT05870917|Glucocorticoids|glucocorticoids|mesh-ancestor
93350836|NCT05870917|Hormones|hormones|mesh-ancestor
93350837|NCT05870917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350838|NCT05870917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93350839|NCT05870917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350840|NCT05870917|Immunologic Factors|immunologic factors|mesh-ancestor
93350841|NCT05870917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93350842|NCT05870917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93350843|NCT05870917|Growth Substances|growth substances|mesh-ancestor
93350844|NCT05870917|Growth Inhibitors|growth inhibitors|mesh-ancestor
93350845|NCT05870761|Niraparib|niraparib|mesh-list
93350846|NCT05870761|Dostarlimab|dostarlimab|mesh-list
93350847|NCT05870761|Immunoglobulins|immunoglobulins|mesh-list
93350848|NCT05870761|Immunoglobulin G|immunoglobulin g|mesh-list
93350849|NCT05870761|Immunologic Factors|immunologic factors|mesh-ancestor
93350850|NCT05870761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350851|NCT05870761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93350852|NCT05870761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644557|NCT04660786|Vitamins|vitamins|mesh-ancestor
93350853|NCT05870761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350854|NCT05870761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350855|NCT05870553|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93350856|NCT05870553|Laxatives|laxatives|mesh-ancestor
93350857|NCT05870553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350858|NCT05870501|Midazolam|midazolam|mesh-list
93350859|NCT05870501|Ketamine|ketamine|mesh-list
93350860|NCT05870501|Analgesics|analgesics|mesh-ancestor
93350861|NCT05870501|Sensory System Agents|sensory system agents|mesh-ancestor
93350862|NCT05870501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350863|NCT05870501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350864|NCT05870501|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93350865|NCT05870501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93350866|NCT05870501|Anesthetics, General|anesthetics, general|mesh-ancestor
93350867|NCT05870501|Anesthetics|anesthetics|mesh-ancestor
93350868|NCT05870501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350869|NCT05870501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93350870|NCT05870501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93350871|NCT05870501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350872|NCT05870501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350873|NCT05870501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93350874|NCT05870501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93350875|NCT05870501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93350876|NCT05870501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93350877|NCT05870501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93350878|NCT05870501|GABA Modulators|gaba modulators|mesh-ancestor
93350879|NCT05870501|GABA Agents|gaba agents|mesh-ancestor
93350880|NCT05870475|Interferons|interferons|mesh-list
93350881|NCT05870475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350882|NCT05870475|Antiviral Agents|antiviral agents|mesh-ancestor
93350883|NCT05870475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350884|NCT05870436|Choline|choline|mesh-list
93350885|NCT05870436|Methacholine Chloride|methacholine chloride|mesh-list
93350886|NCT05870436|Lipotropic Agents|lipotropic agents|mesh-ancestor
93350887|NCT05870436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350888|NCT05870436|Antimetabolites|antimetabolites|mesh-ancestor
93350889|NCT05870436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350890|NCT05870436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350891|NCT05870436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350892|NCT05870436|Nootropic Agents|nootropic agents|mesh-ancestor
93350894|NCT05870436|Autonomic Agents|autonomic agents|mesh-ancestor
93350895|NCT05870436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350896|NCT05870436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350897|NCT05870436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93350898|NCT05870436|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93350899|NCT05870436|Respiratory System Agents|respiratory system agents|mesh-ancestor
93350900|NCT05870436|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93350901|NCT05870436|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93350902|NCT05870436|Cholinergic Agents|cholinergic agents|mesh-ancestor
93350903|NCT05870436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93350904|NCT05870423|Olaparib|olaparib|mesh-list
93350905|NCT05870423|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93350906|NCT05870423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350907|NCT05870423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350908|NCT05870423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350909|NCT05870358|Melatonin|melatonin|mesh-list
93350910|NCT05870358|Antioxidants|antioxidants|mesh-ancestor
93350911|NCT05870358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350912|NCT05870358|Protective Agents|protective agents|mesh-ancestor
93350913|NCT05870358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350914|NCT05870358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350915|NCT05870111|Choline|choline|mesh-list
93350916|NCT05870111|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93350917|NCT05870111|Lipotropic Agents|lipotropic agents|mesh-ancestor
93350918|NCT05870111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350919|NCT05870111|Antimetabolites|antimetabolites|mesh-ancestor
93350920|NCT05870111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350921|NCT05870111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350922|NCT05870111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350923|NCT05870111|Nootropic Agents|nootropic agents|mesh-ancestor
93350924|NCT05870059|Chlorhexidine|chlorhexidine|mesh-list
93350925|NCT05870059|Propolis|propolis|mesh-list
93350926|NCT05870059|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93350927|NCT05870059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93350928|NCT05870059|Disinfectants|disinfectants|mesh-ancestor
93350929|NCT05870007|Atorvastatin|atorvastatin|mesh-list
93350930|NCT05870007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93350931|NCT05870007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350932|NCT05870007|Antimetabolites|antimetabolites|mesh-ancestor
93350933|NCT05870007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350934|NCT05870007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350935|NCT05870007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93350936|NCT05870007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93350937|NCT05869955|Cyclophosphamide|cyclophosphamide|mesh-list
93350938|NCT05869955|Fludarabine|fludarabine|mesh-list
93350939|NCT05869955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93350940|NCT05869955|Immunologic Factors|immunologic factors|mesh-ancestor
93350941|NCT05869955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350942|NCT05869955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93350943|NCT05869955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93350944|NCT05869955|Alkylating Agents|alkylating agents|mesh-ancestor
93350945|NCT05869955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350946|NCT05869955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350947|NCT05869955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93350948|NCT05868226|Trastuzumab|trastuzumab|mesh-list
93350949|NCT05868226|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93350950|NCT05868226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93350951|NCT05868226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350952|NCT05868226|Immunoconjugates|immunoconjugates|mesh-ancestor
93350953|NCT05868226|Immunologic Factors|immunologic factors|mesh-ancestor
93350954|NCT05868226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350955|NCT05866653|Lidocaine|lidocaine|mesh-list
93350956|NCT05866653|Anesthetics, Local|anesthetics, local|mesh-ancestor
93350957|NCT05866653|Anesthetics|anesthetics|mesh-ancestor
93350958|NCT05866653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93350959|NCT05866653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350960|NCT05866653|Sensory System Agents|sensory system agents|mesh-ancestor
93350961|NCT05866653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350962|NCT05866653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93350963|NCT05866653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93350964|NCT05866653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93350965|NCT05866653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93350966|NCT05866653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350967|NCT05790577|Niacinamide|niacinamide|mesh-list
93350969|NCT05790577|Nicotinic Acids|nicotinic acids|mesh-list
93350970|NCT05790577|Metformin|metformin|mesh-list
93350971|NCT05790577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93350972|NCT05790577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350973|NCT05790577|Vitamin B Complex|vitamin b complex|mesh-ancestor
93350974|NCT05790577|Vitamins|vitamins|mesh-ancestor
93350975|NCT05790577|Micronutrients|micronutrients|mesh-ancestor
93350976|NCT05790577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93350977|NCT05790577|Antimetabolites|antimetabolites|mesh-ancestor
93350978|NCT05790577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93350979|NCT05790577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93350980|NCT05790577|Vasodilator Agents|vasodilator agents|mesh-ancestor
93350981|NCT05789589|Dexamethasone|dexamethasone|mesh-list
93350982|NCT05789589|Methylprednisolone|methylprednisolone|mesh-list
93350983|NCT05789589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93350984|NCT05789589|Antiemetics|antiemetics|mesh-ancestor
93350985|NCT05789589|Autonomic Agents|autonomic agents|mesh-ancestor
93350986|NCT05789589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93350987|NCT05789589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93350988|NCT05789589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93350989|NCT05789589|Glucocorticoids|glucocorticoids|mesh-ancestor
93350990|NCT05789589|Hormones|hormones|mesh-ancestor
93350991|NCT05789589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93350992|NCT05789589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93350993|NCT05789589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93350994|NCT05789589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93350995|NCT05789589|Protective Agents|protective agents|mesh-ancestor
93350996|NCT05778838|Midodrine|midodrine|mesh-list
93350997|NCT05778838|Sympathomimetics|sympathomimetics|mesh-ancestor
93350998|NCT05778838|Autonomic Agents|autonomic agents|mesh-ancestor
93350999|NCT05778838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644705|NCT00217373|Immunologic Factors|immunologic factors|mesh-ancestor
93351000|NCT05778838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351001|NCT05778838|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93351002|NCT05778838|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93351003|NCT05778838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93351004|NCT05778838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93351005|NCT05778838|Adrenergic Agents|adrenergic agents|mesh-ancestor
93351006|NCT05778838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351007|NCT05778838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351008|NCT05760248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93351009|NCT05757544|Ganaxolone|ganaxolone|mesh-list
93351010|NCT05757544|Neurosteroids|neurosteroids|mesh-ancestor
93351011|NCT05757544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351012|NCT05757544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351013|NCT05757544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351014|NCT05757544|GABA Modulators|gaba modulators|mesh-ancestor
93351015|NCT05757544|GABA Agents|gaba agents|mesh-ancestor
93351016|NCT05746559|Ravulizumab|ravulizumab|mesh-list
93351017|NCT05746559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93351018|NCT05746559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351019|NCT05746559|Immunologic Factors|immunologic factors|mesh-ancestor
93351020|NCT05746559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351021|NCT05688943|Anesthetics|anesthetics|mesh-list
93351022|NCT05688943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351023|NCT05688943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351024|NCT05666310|Zoledronic Acid|zoledronic acid|mesh-list
93351025|NCT05666310|Denosumab|denosumab|mesh-list
93351026|NCT05666310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93351027|NCT05666310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351028|NCT05638919|Antiviral Agents|antiviral agents|mesh-list
93351029|NCT05638919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351030|NCT05631405|Dexamethasone|dexamethasone|mesh-list
93351031|NCT05631405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351032|NCT05631405|Antiemetics|antiemetics|mesh-ancestor
93351033|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
93351034|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351035|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022957|NCT00605813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93351036|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351038|NCT05631405|Hormones|hormones|mesh-ancestor
93351039|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351040|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351041|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351042|NCT05621655|Vaccines|vaccines|mesh-list
93351043|NCT05621655|Immunologic Factors|immunologic factors|mesh-ancestor
93351044|NCT05621655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351045|NCT05620407|Deucravacitinib|deucravacitinib|mesh-list
93351046|NCT05620407|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351047|NCT05620407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351048|NCT05620407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351049|NCT05620407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351050|NCT05619653|Prednisolone|prednisolone|mesh-list
93351051|NCT05619653|Losartan|losartan|mesh-list
93351052|NCT05619653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351053|NCT05619653|Glucocorticoids|glucocorticoids|mesh-ancestor
93351054|NCT05619653|Hormones|hormones|mesh-ancestor
93351055|NCT05619653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351056|NCT05619653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351057|NCT05619653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351058|NCT05619653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351059|NCT05619653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93351060|NCT05619653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93351061|NCT05619653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93351062|NCT05619653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93351063|NCT05619653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351064|NCT05602519|Fentanyl|fentanyl|mesh-list
93351065|NCT05602519|Propofol|propofol|mesh-list
93351066|NCT05602519|Rocuronium|rocuronium|mesh-list
93351067|NCT05602519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93351068|NCT05602519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351069|NCT05602519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351070|NCT05602519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92644789|NCT00217568|Docetaxel|docetaxel|mesh-list
93351071|NCT05602519|Anesthetics, General|anesthetics, general|mesh-ancestor
93351072|NCT05602519|Anesthetics|anesthetics|mesh-ancestor
93351073|NCT05602519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93351074|NCT05602519|Narcotics|narcotics|mesh-ancestor
93351075|NCT05602519|Analgesics|analgesics|mesh-ancestor
93351076|NCT05602519|Sensory System Agents|sensory system agents|mesh-ancestor
93351077|NCT05602519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351078|NCT05602519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93351079|NCT05602519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93351080|NCT05602519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93351081|NCT05602519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93351082|NCT05586971|Allopurinol|allopurinol|mesh-list
93351083|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
93351084|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351085|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351086|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
93351087|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351088|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93351089|NCT05586971|Antioxidants|antioxidants|mesh-ancestor
93351090|NCT05586971|Protective Agents|protective agents|mesh-ancestor
93351091|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351092|NCT05576207|Micronutrients|micronutrients|mesh-list
93351093|NCT05576207|Trace Elements|trace elements|mesh-list
93351094|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351095|NCT05553522|Capecitabine|capecitabine|mesh-list
93351096|NCT05553522|Trastuzumab|trastuzumab|mesh-list
93351097|NCT05553522|Tucatinib|tucatinib|mesh-list
93351098|NCT05553522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93351099|NCT05553522|Antimetabolites|antimetabolites|mesh-ancestor
93351100|NCT05553522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351101|NCT05553522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351102|NCT05553522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351103|NCT05553522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351104|NCT05553522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351105|NCT05586724|Norethindrone|norethindrone|mesh-list
93351106|NCT05586724|Norethindrone Acetate|norethindrone acetate|mesh-list
93351107|NCT05586724|Progesterone|progesterone|mesh-list
93351108|NCT05586724|Estrogens|estrogens|mesh-list
93351109|NCT05586724|Progestins|progestins|mesh-ancestor
93351110|NCT05586724|Hormones|hormones|mesh-ancestor
93023033|NCT00605657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93351111|NCT05586724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351112|NCT05586724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351113|NCT05586724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93351114|NCT05586724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93351115|NCT05586724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93351116|NCT05586724|Contraceptive Agents|contraceptive agents|mesh-ancestor
93351117|NCT05586724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93351118|NCT05586724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93351119|NCT05586724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93351120|NCT05508152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93351121|NCT05508152|Amoxicillin|amoxicillin|mesh-list
93351122|NCT05508152|Clavulanic Acid|clavulanic acid|mesh-list
93351123|NCT05508152|Clavulanic Acids|clavulanic acids|mesh-list
93351124|NCT05508152|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93351125|NCT05508152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93351126|NCT05508152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351127|NCT05508152|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93351128|NCT05508152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351129|NCT05508152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351130|NCT05485558|Acetylcysteine|acetylcysteine|mesh-list
93351131|NCT05485558|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93351132|NCT05485558|Antiviral Agents|antiviral agents|mesh-ancestor
93351133|NCT05485558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351134|NCT05485558|Expectorants|expectorants|mesh-ancestor
93351135|NCT05485558|Respiratory System Agents|respiratory system agents|mesh-ancestor
93351136|NCT05485558|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93351137|NCT05485558|Antioxidants|antioxidants|mesh-ancestor
93351138|NCT05485558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351139|NCT05485558|Protective Agents|protective agents|mesh-ancestor
93351140|NCT05485558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351141|NCT05485558|Antidotes|antidotes|mesh-ancestor
93351142|NCT05485155|Protease Inhibitors|protease inhibitors|mesh-list
93351143|NCT05485155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351144|NCT05485155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351145|NCT05478174|Propofol|propofol|mesh-list
93351146|NCT05478174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93351147|NCT05478174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351148|NCT05478174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351149|NCT05478174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93351150|NCT05478174|Anesthetics, General|anesthetics, general|mesh-ancestor
93351151|NCT05478174|Anesthetics|anesthetics|mesh-ancestor
93351152|NCT05457556|Mycophenolic Acid|mycophenolic acid|mesh-list
93351153|NCT05457556|Cyclophosphamide|cyclophosphamide|mesh-list
93351154|NCT05457556|Melphalan|melphalan|mesh-list
93351155|NCT05457556|Busulfan|busulfan|mesh-list
93351156|NCT05457556|Mechlorethamine|mechlorethamine|mesh-list
93351157|NCT05457556|Thiotepa|thiotepa|mesh-list
93351158|NCT05457556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93351159|NCT05457556|Rituximab|rituximab|mesh-list
93351160|NCT05457556|Methotrexate|methotrexate|mesh-list
93351161|NCT05457556|Fludarabine|fludarabine|mesh-list
93351162|NCT05457556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93351163|NCT05457556|Tacrolimus|tacrolimus|mesh-list
93351164|NCT05457556|Thymoglobulin|thymoglobulin|mesh-list
93351165|NCT05457556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93351166|NCT05457556|Antibodies|antibodies|mesh-list
93351167|NCT05457556|Immunoglobulins|immunoglobulins|mesh-list
93351168|NCT05457556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93351169|NCT05457556|gamma-Globulins|gamma-globulins|mesh-list
93351170|NCT05457556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93351171|NCT05457556|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93351172|NCT05457556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351173|NCT05457556|Immunologic Factors|immunologic factors|mesh-ancestor
93351174|NCT05457556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351175|NCT05457556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351176|NCT05457556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351177|NCT05457556|Alkylating Agents|alkylating agents|mesh-ancestor
93351178|NCT05457556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351179|NCT05457556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351180|NCT05457556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351181|NCT05457556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93351182|NCT05457556|Abortifacient Agents|abortifacient agents|mesh-ancestor
93351183|NCT05457556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93351184|NCT05457556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93351185|NCT05457556|Antimetabolites|antimetabolites|mesh-ancestor
93023108|NCT00904397|Celecoxib|celecoxib|mesh-list
93351186|NCT05457556|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351187|NCT05457556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351188|NCT05457556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93351189|NCT05457556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93351190|NCT05457556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93351191|NCT05457556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93351192|NCT05457556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93351193|NCT05457556|Antitubercular Agents|antitubercular agents|mesh-ancestor
93351194|NCT05457556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351195|NCT05457556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351196|NCT05456295|Carbon Fiber|carbon fiber|mesh-list
93351197|NCT05456295|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93351198|NCT05456295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351199|NCT05447286|Oxycodone|oxycodone|mesh-list
93351200|NCT05447286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93351201|NCT05447286|Narcotics|narcotics|mesh-ancestor
93351202|NCT05447286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351203|NCT05447286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351204|NCT05447286|Analgesics|analgesics|mesh-ancestor
93351205|NCT05447286|Sensory System Agents|sensory system agents|mesh-ancestor
93351206|NCT05447286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351207|NCT05411237|Paclitaxel|paclitaxel|mesh-list
93351208|NCT05411237|Doxorubicin|doxorubicin|mesh-list
93351209|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93351210|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351211|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351212|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351213|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351214|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351215|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351216|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93351217|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93351218|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93351219|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351220|NCT05389462|Gemcitabine|gemcitabine|mesh-list
93351221|NCT05389462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93351222|NCT05389462|Antimetabolites|antimetabolites|mesh-ancestor
93351223|NCT05389462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351224|NCT05389462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351225|NCT05383196|Paclitaxel|paclitaxel|mesh-list
93351226|NCT05383196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93351227|NCT05383196|Onvansertib|onvansertib|mesh-list
93351228|NCT05383196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351229|NCT05383196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351230|NCT05383196|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351231|NCT05383196|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351232|NCT05383196|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351233|NCT05383196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351234|NCT05383196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351235|NCT05383196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351236|NCT05382338|Sodium thiosulfate|sodium thiosulfate|mesh-list
93351237|NCT05382338|Cyclophosphamide|cyclophosphamide|mesh-list
93351238|NCT05382338|Lomustine|lomustine|mesh-list
93351239|NCT05382338|Cisplatin|cisplatin|mesh-list
93351240|NCT05382338|Vincristine|vincristine|mesh-list
93351241|NCT05382338|Mesna|mesna|mesh-list
93351242|NCT05382338|Antidotes|antidotes|mesh-list
93351243|NCT05382338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351244|NCT05382338|Immunologic Factors|immunologic factors|mesh-ancestor
93351245|NCT05382338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351246|NCT05382338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351247|NCT05382338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351248|NCT05382338|Alkylating Agents|alkylating agents|mesh-ancestor
93351249|NCT05382338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351250|NCT05382338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351251|NCT05382338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351252|NCT05382338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351253|NCT05382338|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351254|NCT05382338|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351255|NCT05382338|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351256|NCT05382338|Protective Agents|protective agents|mesh-ancestor
93351257|NCT05382338|Antioxidants|antioxidants|mesh-ancestor
93351258|NCT05382338|Antitubercular Agents|antitubercular agents|mesh-ancestor
93351259|NCT05382338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351260|NCT05382338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351261|NCT05382338|Chelating Agents|chelating agents|mesh-ancestor
93023204|NCT01057966|Vitamins|vitamins|mesh-list
93351262|NCT05382338|Sequestering Agents|sequestering agents|mesh-ancestor
93351263|NCT05347238|Dopamine|dopamine|mesh-list
93351264|NCT05347238|Norepinephrine|norepinephrine|mesh-list
93351265|NCT05347238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93351266|NCT05347238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93351267|NCT05347238|Adrenergic Agents|adrenergic agents|mesh-ancestor
93351268|NCT05347238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351269|NCT05347238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351270|NCT05347238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351271|NCT05347238|Sympathomimetics|sympathomimetics|mesh-ancestor
93351272|NCT05347238|Autonomic Agents|autonomic agents|mesh-ancestor
93351273|NCT05347238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351274|NCT05347238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93351275|NCT05347238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93351276|NCT05347238|Dopamine Agents|dopamine agents|mesh-ancestor
93351277|NCT05347238|Protective Agents|protective agents|mesh-ancestor
93351278|NCT05340582|Acetaminophen|acetaminophen|mesh-list
93351279|NCT05340582|Ibuprofen|ibuprofen|mesh-list
93351280|NCT05340582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93351281|NCT05340582|Analgesics|analgesics|mesh-ancestor
93351282|NCT05340582|Sensory System Agents|sensory system agents|mesh-ancestor
92644994|NCT00218309|Analgesics|analgesics|mesh-ancestor
93351283|NCT05340582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351284|NCT05340582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351285|NCT05340582|Antipyretics|antipyretics|mesh-ancestor
93351286|NCT05340582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93351287|NCT05340582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351288|NCT05340582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351289|NCT05340582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93351290|NCT05340582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351291|NCT05340582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351292|NCT05324501|Lomustine|lomustine|mesh-list
93351293|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351294|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
93351295|NCT05324501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351296|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351297|NCT05304585|Dactinomycin|dactinomycin|mesh-list
93351298|NCT05304585|Cactinomycin|cactinomycin|mesh-list
93351299|NCT05304585|Cyclophosphamide|cyclophosphamide|mesh-list
93351300|NCT05304585|Vincristine|vincristine|mesh-list
93351301|NCT05304585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351302|NCT05304585|Immunologic Factors|immunologic factors|mesh-ancestor
93351303|NCT05304585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351304|NCT05304585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351305|NCT05304585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351306|NCT05304585|Alkylating Agents|alkylating agents|mesh-ancestor
93351307|NCT05304585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351308|NCT05304585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351309|NCT05304585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351310|NCT05304585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351311|NCT05304585|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351312|NCT05304585|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351313|NCT05304585|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351314|NCT05304585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351315|NCT05304585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351316|NCT05304585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93351317|NCT05304585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93351318|NCT05304585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351319|NCT05304585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93351320|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
93351321|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93351322|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
93351323|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93351324|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351325|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93351326|NCT05245474|Tislelizumab|tislelizumab|mesh-list
93351327|NCT05245474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93351328|NCT05245474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351329|NCT05245474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351330|NCT05245474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351331|NCT05179733|Rituximab|rituximab|mesh-list
93351332|NCT05179733|Lenalidomide|lenalidomide|mesh-list
93351333|NCT05179733|Zanubrutinib|zanubrutinib|mesh-list
93351334|NCT05179733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351335|NCT05179733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351336|NCT05179733|Immunologic Factors|immunologic factors|mesh-ancestor
93351337|NCT05179733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023253|NCT00909311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93351338|NCT05179733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351339|NCT05179733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93351340|NCT05179733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93351341|NCT05179733|Growth Substances|growth substances|mesh-ancestor
93351342|NCT05179733|Growth Inhibitors|growth inhibitors|mesh-ancestor
93351343|NCT05179733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351344|NCT05179733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351345|NCT05179733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351347|NCT05170334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351348|NCT05170334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93351349|NCT05170334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351350|NCT05170334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351351|NCT05083247|Paclitaxel|paclitaxel|mesh-list
93351352|NCT05083247|Gemcitabine|gemcitabine|mesh-list
92645058|NCT00559429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351353|NCT05083247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351354|NCT05083247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351355|NCT05083247|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351356|NCT05083247|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351357|NCT05083247|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351358|NCT05083247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351359|NCT05083247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93351360|NCT05083247|Antimetabolites|antimetabolites|mesh-ancestor
93351361|NCT05076110|Acetaminophen|acetaminophen|mesh-list
93351362|NCT05076110|Ibuprofen|ibuprofen|mesh-list
93351363|NCT05076110|Oxycodone|oxycodone|mesh-list
93351364|NCT05076110|Gabapentin|gabapentin|mesh-list
93351365|NCT05076110|Methocarbamol|methocarbamol|mesh-list
93351366|NCT05076110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93351367|NCT05076110|Analgesics|analgesics|mesh-ancestor
93351368|NCT05076110|Sensory System Agents|sensory system agents|mesh-ancestor
93351369|NCT05076110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351370|NCT05076110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351371|NCT05076110|Antipyretics|antipyretics|mesh-ancestor
93351372|NCT05076110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93351373|NCT05076110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351374|NCT05076110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351375|NCT05076110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93351376|NCT05076110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351377|NCT05076110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351378|NCT05076110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93351379|NCT05076110|Narcotics|narcotics|mesh-ancestor
93351380|NCT05076110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351381|NCT05076110|Anticonvulsants|anticonvulsants|mesh-ancestor
93351382|NCT05076110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93351383|NCT05076110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93351384|NCT05076110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93351385|NCT05076110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93351386|NCT05076110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93351387|NCT05076110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351388|NCT05076110|Antimanic Agents|antimanic agents|mesh-ancestor
93351389|NCT05076110|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93351390|NCT05076110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93351391|NCT05063838|Anesthetics|anesthetics|mesh-list
93351392|NCT05063838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351393|NCT05063838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351394|NCT05046795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93351395|NCT05174650|Atezolizumab|atezolizumab|mesh-list
93351396|NCT05174650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93351397|NCT05174650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351398|NCT05174650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351399|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351400|NCT05014828|Lenvatinib|lenvatinib|mesh-list
93351401|NCT05014828|Tislelizumab|tislelizumab|mesh-list
93351402|NCT05014828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351403|NCT05014828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351404|NCT05014828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351405|NCT05014828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351406|NCT05014828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351407|NCT05014282|Nicotine|nicotine|mesh-list
93351408|NCT05014282|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93351409|NCT05014282|Autonomic Agents|autonomic agents|mesh-ancestor
93351410|NCT05014282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351411|NCT05014282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351412|NCT05014282|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93351413|NCT05014282|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93351414|NCT05014282|Cholinergic Agents|cholinergic agents|mesh-ancestor
93351415|NCT05014282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351416|NCT05014282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351417|NCT05007821|Linezolid|linezolid|mesh-list
93351418|NCT05007821|Bedaquiline|bedaquiline|mesh-list
93351419|NCT05007821|Diarylquinolines|diarylquinolines|mesh-list
93351420|NCT05007821|Clofazimine|clofazimine|mesh-list
93351421|NCT05007821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351422|NCT05007821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351423|NCT05007821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93351424|NCT05007821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351425|NCT05007821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351426|NCT05007821|Antitubercular Agents|antitubercular agents|mesh-ancestor
93351427|NCT05007821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351428|NCT05007821|Leprostatic Agents|leprostatic agents|mesh-ancestor
93351429|NCT04994132|Dactinomycin|dactinomycin|mesh-list
93351430|NCT04994132|Cactinomycin|cactinomycin|mesh-list
93351431|NCT04994132|Cyclophosphamide|cyclophosphamide|mesh-list
93351432|NCT04994132|Vincristine|vincristine|mesh-list
93351433|NCT04994132|Vinorelbine|vinorelbine|mesh-list
93351434|NCT04994132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351435|NCT04994132|Immunologic Factors|immunologic factors|mesh-ancestor
93351436|NCT04994132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351437|NCT04994132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351438|NCT04994132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351439|NCT04994132|Alkylating Agents|alkylating agents|mesh-ancestor
93351440|NCT04994132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351441|NCT04994132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351442|NCT04994132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351443|NCT04994132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351444|NCT04994132|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351445|NCT04994132|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351446|NCT04994132|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351447|NCT04994132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351448|NCT04994132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351449|NCT04994132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93351450|NCT04994132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93351451|NCT04994132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351452|NCT04994132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93351453|NCT04986579|Trastuzumab|trastuzumab|mesh-list
93351454|NCT04986579|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93351455|NCT04986579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93351456|NCT04986579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351457|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351458|NCT04986579|Immunoconjugates|immunoconjugates|mesh-ancestor
93351459|NCT04986579|Immunologic Factors|immunologic factors|mesh-ancestor
93351460|NCT04986579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351461|NCT04940065|Ofatumumab|ofatumumab|mesh-list
93351462|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351463|NCT04939441|Tenofovir|tenofovir|mesh-list
93351464|NCT04939441|Antiviral Agents|antiviral agents|mesh-ancestor
93351465|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351466|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93351467|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93351468|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351469|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351470|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93351471|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93351472|NCT04937738|Leucovorin|leucovorin|mesh-list
93351473|NCT04937738|Docetaxel|docetaxel|mesh-list
93351474|NCT04937738|Fluorouracil|fluorouracil|mesh-list
93351475|NCT04937738|Capecitabine|capecitabine|mesh-list
93351476|NCT04937738|Oxaliplatin|oxaliplatin|mesh-list
93351477|NCT04937738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351478|NCT04937738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351479|NCT04937738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351480|NCT04937738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351481|NCT04937738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351482|NCT04937738|Antimetabolites|antimetabolites|mesh-ancestor
93351483|NCT04937738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93351484|NCT04937738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351485|NCT04937738|Immunologic Factors|immunologic factors|mesh-ancestor
93351486|NCT04937738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351487|NCT04937738|Antidotes|antidotes|mesh-ancestor
93351488|NCT04937738|Protective Agents|protective agents|mesh-ancestor
93351489|NCT04937738|Vitamin B Complex|vitamin b complex|mesh-ancestor
93351490|NCT04937738|Vitamins|vitamins|mesh-ancestor
93351491|NCT04937738|Micronutrients|micronutrients|mesh-ancestor
93351492|NCT04933617|Prednisone|prednisone|mesh-list
93351493|NCT04933617|Cyclophosphamide|cyclophosphamide|mesh-list
93351494|NCT04933617|Rituximab|rituximab|mesh-list
93351495|NCT04933617|Doxorubicin|doxorubicin|mesh-list
93351496|NCT04933617|Etoposide|etoposide|mesh-list
93351497|NCT04933617|Vincristine|vincristine|mesh-list
93351498|NCT04933617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351499|NCT04933617|Immunologic Factors|immunologic factors|mesh-ancestor
93351500|NCT04933617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351501|NCT04933617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351502|NCT04933617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351503|NCT04933617|Alkylating Agents|alkylating agents|mesh-ancestor
93351504|NCT04933617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351505|NCT04933617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351506|NCT04933617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351507|NCT04933617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351508|NCT04933617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93351509|NCT04933617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93351510|NCT04933617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93351511|NCT04933617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351512|NCT04933617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351513|NCT04933617|Glucocorticoids|glucocorticoids|mesh-ancestor
93351514|NCT04933617|Hormones|hormones|mesh-ancestor
93351515|NCT04933617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351516|NCT04933617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351517|NCT04933617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351518|NCT04933617|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351519|NCT04933617|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351520|NCT04933617|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351521|NCT04908189|Apremilast|apremilast|mesh-list
93351522|NCT04908189|Deucravacitinib|deucravacitinib|mesh-list
93351523|NCT04908189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93351524|NCT04908189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93351525|NCT04908189|Analgesics|analgesics|mesh-ancestor
93351526|NCT04908189|Sensory System Agents|sensory system agents|mesh-ancestor
93351527|NCT04908189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351528|NCT04908189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351529|NCT04908189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351530|NCT04908189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351531|NCT04908189|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93351532|NCT04908189|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93351533|NCT04908189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351534|NCT04908189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351535|NCT04908189|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351536|NCT04908189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351537|NCT04875975|Rozanolixizumab|rozanolixizumab|mesh-list
93351538|NCT04875975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351539|NCT04875975|Immunologic Factors|immunologic factors|mesh-ancestor
93351540|NCT04875975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351541|NCT04860505|Doxycycline|doxycycline|mesh-list
93351542|NCT04860505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351543|NCT04860505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351544|NCT04860505|Antimalarials|antimalarials|mesh-ancestor
93351545|NCT04860505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93351546|NCT04860505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93351547|NCT04857034|Deucravacitinib|deucravacitinib|mesh-list
93351548|NCT04857034|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351549|NCT04857034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351550|NCT04857034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351551|NCT04857034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351552|NCT04816643|Vaccines|vaccines|mesh-list
93351553|NCT04816643|Immunologic Factors|immunologic factors|mesh-ancestor
93351554|NCT04816643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351555|NCT04810559|Antibodies|antibodies|mesh-list
93351556|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
93351557|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351558|NCT04799288|Teriflunomide|teriflunomide|mesh-list
93351559|NCT04799288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93351560|NCT04799288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93351561|NCT04799288|Analgesics|analgesics|mesh-ancestor
93351562|NCT04799288|Sensory System Agents|sensory system agents|mesh-ancestor
92645270|NCT00242346|Candesartan|candesartan|mesh-list
93351563|NCT04799288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351564|NCT04799288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351565|NCT04799288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351566|NCT04799288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351567|NCT04799288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351568|NCT04799288|Immunologic Factors|immunologic factors|mesh-ancestor
93351570|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351571|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351572|NCT04799054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93351573|NCT04799054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351574|NCT04777357|Cariprazine|cariprazine|mesh-list
93351575|NCT04777357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93351576|NCT04777357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93351577|NCT04777357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351578|NCT04777357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351579|NCT04777357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93351580|NCT04724018|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93351581|NCT04724018|Immunoconjugates|immunoconjugates|mesh-ancestor
93351582|NCT04724018|Immunologic Factors|immunologic factors|mesh-ancestor
93351583|NCT04724018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351584|NCT04713592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93351585|NCT04713592|Immunologic Factors|immunologic factors|mesh-ancestor
93351586|NCT04713592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351587|NCT04687176|Arsenic Trioxide|arsenic trioxide|mesh-list
93351588|NCT04687176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351589|NCT04684368|Carboplatin|carboplatin|mesh-list
93351590|NCT04684368|Etoposide|etoposide|mesh-list
93351591|NCT04684368|Etoposide phosphate|etoposide phosphate|mesh-list
93351592|NCT04684368|Ifosfamide|ifosfamide|mesh-list
93351593|NCT04684368|Isophosphamide mustard|isophosphamide mustard|mesh-list
93351594|NCT04684368|Thiotepa|thiotepa|mesh-list
93351595|NCT04684368|Podophyllotoxin|podophyllotoxin|mesh-list
93351596|NCT04684368|Lenograstim|lenograstim|mesh-list
93351597|NCT04684368|Mesna|mesna|mesh-list
93351598|NCT04684368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351599|NCT04684368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351600|NCT04684368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93351601|NCT04684368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93351602|NCT04684368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351603|NCT04684368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351604|NCT04684368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93351605|NCT04684368|Immunologic Factors|immunologic factors|mesh-ancestor
93351606|NCT04684368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351607|NCT04684368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351608|NCT04684368|Alkylating Agents|alkylating agents|mesh-ancestor
93351609|NCT04684368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351610|NCT04684368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351611|NCT04684368|Protective Agents|protective agents|mesh-ancestor
93351612|NCT04684368|Keratolytic Agents|keratolytic agents|mesh-ancestor
93351613|NCT04684368|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351614|NCT04684368|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351615|NCT04684368|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351616|NCT04684368|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351617|NCT04653831|Pirfenidone|pirfenidone|mesh-list
93351618|NCT04653831|Analgesics|analgesics|mesh-ancestor
93351619|NCT04653831|Sensory System Agents|sensory system agents|mesh-ancestor
93351620|NCT04653831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351621|NCT04653831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351622|NCT04653831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93351623|NCT04653831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93351624|NCT04653831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351625|NCT04653831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351626|NCT04653831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351627|NCT04570956|Tamoxifen|tamoxifen|mesh-list
93351628|NCT04570956|Afimoxifene|afimoxifene|mesh-list
93351629|NCT04570956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93351630|NCT04570956|Hormone Antagonists|hormone antagonists|mesh-ancestor
93351631|NCT04570956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351632|NCT04570956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351633|NCT04570956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351634|NCT04570956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351635|NCT04570956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93351636|NCT04570956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93351637|NCT04570956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93351638|NCT04512638|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93351639|NCT04512638|Amoxicillin|amoxicillin|mesh-list
93351640|NCT04512638|Chlorhexidine|chlorhexidine|mesh-list
93351641|NCT04512638|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93351642|NCT04512638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351643|NCT04512638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93351644|NCT04512638|Disinfectants|disinfectants|mesh-ancestor
93351645|NCT04512638|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351646|NCT04510428|Immunoglobulins|immunoglobulins|mesh-list
93351647|NCT04510428|Antibodies|antibodies|mesh-list
93351648|NCT04510428|gamma-Globulins|gamma-globulins|mesh-list
93351649|NCT04510428|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93351650|NCT04510428|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93351651|NCT04510428|Immunologic Factors|immunologic factors|mesh-ancestor
93351652|NCT04510428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351653|NCT04504825|Dexamethasone|dexamethasone|mesh-list
93351654|NCT04504825|Cyclophosphamide|cyclophosphamide|mesh-list
93351655|NCT04504825|Bortezomib|bortezomib|mesh-list
93351656|NCT04504825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351657|NCT04504825|Immunologic Factors|immunologic factors|mesh-ancestor
93351658|NCT04504825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351659|NCT04504825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351660|NCT04504825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351661|NCT04504825|Alkylating Agents|alkylating agents|mesh-ancestor
93351662|NCT04504825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351663|NCT04504825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351664|NCT04504825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351665|NCT04504825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351666|NCT04504825|Antiemetics|antiemetics|mesh-ancestor
93351667|NCT04504825|Autonomic Agents|autonomic agents|mesh-ancestor
93351668|NCT04504825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351669|NCT04504825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351670|NCT04504825|Glucocorticoids|glucocorticoids|mesh-ancestor
93351671|NCT04504825|Hormones|hormones|mesh-ancestor
93351672|NCT04504825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351673|NCT04504825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351674|NCT04437303|Anticoagulants|anticoagulants|mesh-list
93351675|NCT04436107|Lenalidomide|lenalidomide|mesh-list
93351676|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
93351677|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
93351678|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351679|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93351680|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93351681|NCT04436107|Growth Substances|growth substances|mesh-ancestor
93351682|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
93351683|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351684|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351685|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351686|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351687|NCT04411693|Dexamethasone|dexamethasone|mesh-list
93351688|NCT04411693|Aflibercept|aflibercept|mesh-list
93351689|NCT04411693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351690|NCT04411693|Antiemetics|antiemetics|mesh-ancestor
93351691|NCT04411693|Autonomic Agents|autonomic agents|mesh-ancestor
93351692|NCT04411693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351693|NCT04411693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351694|NCT04411693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351695|NCT04411693|Glucocorticoids|glucocorticoids|mesh-ancestor
93351696|NCT04411693|Hormones|hormones|mesh-ancestor
93351697|NCT04411693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351698|NCT04411693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351699|NCT04411693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351700|NCT04411693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93351701|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93351702|NCT04411693|Growth Substances|growth substances|mesh-ancestor
93351703|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
93351704|NCT04385277|Vitamin A|vitamin a|mesh-list
93351705|NCT04385277|Irinotecan|irinotecan|mesh-list
93351706|NCT04385277|Temozolomide|temozolomide|mesh-list
93351707|NCT04385277|Tretinoin|tretinoin|mesh-list
93351708|NCT04385277|Dinutuximab|dinutuximab|mesh-list
93351709|NCT04385277|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93351710|NCT04385277|Isotretinoin|isotretinoin|mesh-list
93351711|NCT04385277|Sargramostim|sargramostim|mesh-list
93351712|NCT04385277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93351713|NCT04385277|Vitamins|vitamins|mesh-ancestor
93351714|NCT04385277|Micronutrients|micronutrients|mesh-ancestor
93351715|NCT04385277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351716|NCT04385277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93351717|NCT04385277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93351718|NCT04385277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351719|NCT04385277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351720|NCT04385277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351721|NCT04385277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351722|NCT04385277|Alkylating Agents|alkylating agents|mesh-ancestor
93351723|NCT04385277|Immunologic Factors|immunologic factors|mesh-ancestor
93351724|NCT04385277|Keratolytic Agents|keratolytic agents|mesh-ancestor
93351725|NCT04385277|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351726|NCT04385277|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93351727|NCT04380740|Abatacept|abatacept|mesh-list
93351728|NCT04380740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93351729|NCT04380740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351730|NCT04380740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93351731|NCT04380740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351732|NCT04380740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351733|NCT04380740|Immunologic Factors|immunologic factors|mesh-ancestor
93351734|NCT04380740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351735|NCT04380740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351736|NCT04322318|Cyclophosphamide|cyclophosphamide|mesh-list
93351737|NCT04322318|Ifosfamide|ifosfamide|mesh-list
93351738|NCT04322318|Isophosphamide mustard|isophosphamide mustard|mesh-list
93351739|NCT04322318|Carboplatin|carboplatin|mesh-list
93351740|NCT04322318|Doxorubicin|doxorubicin|mesh-list
93351741|NCT04322318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93351742|NCT04322318|Irinotecan|irinotecan|mesh-list
93351743|NCT04322318|Etoposide|etoposide|mesh-list
93351744|NCT04322318|Vincristine|vincristine|mesh-list
93351745|NCT04322318|Etoposide phosphate|etoposide phosphate|mesh-list
93351746|NCT04322318|Daunorubicin|daunorubicin|mesh-list
93351747|NCT04322318|Topotecan|topotecan|mesh-list
93351748|NCT04322318|Podophyllotoxin|podophyllotoxin|mesh-list
93351749|NCT04322318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351750|NCT04322318|Immunologic Factors|immunologic factors|mesh-ancestor
93351751|NCT04322318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351752|NCT04322318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351753|NCT04322318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351754|NCT04322318|Alkylating Agents|alkylating agents|mesh-ancestor
93351755|NCT04322318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351756|NCT04322318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351757|NCT04322318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351758|NCT04322318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93351759|NCT04322318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93351760|NCT04322318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93351761|NCT04322318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351762|NCT04322318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93351763|NCT04322318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93351764|NCT04322318|Tubulin Modulators|tubulin modulators|mesh-ancestor
93351765|NCT04322318|Antimitotic Agents|antimitotic agents|mesh-ancestor
93351766|NCT04322318|Mitosis Modulators|mitosis modulators|mesh-ancestor
93351767|NCT04322318|Keratolytic Agents|keratolytic agents|mesh-ancestor
93351768|NCT04322318|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351769|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
93351770|NCT04274335|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93351771|NCT04274335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93351772|NCT04274335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351773|NCT04274335|Hemostatics|hemostatics|mesh-ancestor
93351774|NCT04274335|Coagulants|coagulants|mesh-ancestor
93351775|NCT04267887|Ascorbic Acid|ascorbic acid|mesh-list
93351776|NCT04267887|Prednisone|prednisone|mesh-list
93351777|NCT04267887|Cortisone|cortisone|mesh-list
93351778|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
93351779|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
93351780|NCT04267887|Hormones|hormones|mesh-list
93351781|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93351782|NCT04267887|Androgens|androgens|mesh-list
93351783|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
93351784|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351785|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
93351786|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351787|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351788|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351789|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351790|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93351791|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351792|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351793|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
93351794|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93351795|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
93351796|NCT04267887|Protective Agents|protective agents|mesh-ancestor
93351797|NCT04267887|Vitamins|vitamins|mesh-ancestor
93351798|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
93351799|NCT04267887|Estrogens|estrogens|mesh-ancestor
93351800|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
93351801|NCT04238819|Irinotecan|irinotecan|mesh-list
93351802|NCT04238819|Temozolomide|temozolomide|mesh-list
93351803|NCT04238819|Dinutuximab|dinutuximab|mesh-list
93351804|NCT04238819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93351805|NCT04238819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93351806|NCT04238819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351807|NCT04238819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351808|NCT04238819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351809|NCT04238819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351810|NCT04238819|Alkylating Agents|alkylating agents|mesh-ancestor
93351811|NCT04238767|Dolutegravir|dolutegravir|mesh-list
93351812|NCT04238767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93351813|NCT04238767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93351814|NCT04238767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351815|NCT04238767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351816|NCT04238767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93351817|NCT04238767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93351818|NCT04238767|Antiviral Agents|antiviral agents|mesh-ancestor
93351819|NCT04238767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351820|NCT04232553|Mirikizumab|mirikizumab|mesh-list
93351821|NCT04232553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93351822|NCT04232553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93351823|NCT04232553|Analgesics|analgesics|mesh-ancestor
93351824|NCT04232553|Sensory System Agents|sensory system agents|mesh-ancestor
93351825|NCT04232553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351826|NCT04232553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351827|NCT04232553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351828|NCT04232553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351829|NCT04232553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93351830|NCT04232553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351831|NCT04195399|Imidazole|imidazole|mesh-list
93351832|NCT04195399|Nirogacestat|nirogacestat|mesh-list
93351833|NCT04195399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351834|NCT04195399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351835|NCT04195399|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93351836|NCT04177355|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93351837|NCT04177355|1018 oligonucleotide|1018 oligonucleotide|mesh-list
93351838|NCT04177355|MEDI9197|medi9197|mesh-list
93351839|NCT04177355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93351840|NCT04177355|Immunologic Factors|immunologic factors|mesh-ancestor
93351841|NCT04177355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351842|NCT04177355|Antacids|antacids|mesh-ancestor
93351843|NCT04177355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351844|NCT04177355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351845|NCT04166110|Oxymetazoline|oxymetazoline|mesh-list
93351846|NCT04166110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93351847|NCT04166110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93351848|NCT04166110|Adrenergic Agents|adrenergic agents|mesh-ancestor
93351849|NCT04166110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351850|NCT04166110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351851|NCT04166110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351852|NCT04166110|Sympathomimetics|sympathomimetics|mesh-ancestor
93351853|NCT04166110|Autonomic Agents|autonomic agents|mesh-ancestor
93351854|NCT04166110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351855|NCT04166110|Nasal Decongestants|nasal decongestants|mesh-ancestor
93351856|NCT04166110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93351857|NCT04166110|Respiratory System Agents|respiratory system agents|mesh-ancestor
93351858|NCT04126200|Dexamethasone|dexamethasone|mesh-list
93351859|NCT04126200|Lenalidomide|lenalidomide|mesh-list
93351860|NCT04126200|Pomalidomide|pomalidomide|mesh-list
93351861|NCT04126200|Dostarlimab|dostarlimab|mesh-list
93351862|NCT04126200|Nirogacestat|nirogacestat|mesh-list
93351863|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351864|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
93351865|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
93351866|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351867|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351868|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351869|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
93351870|NCT04126200|Hormones|hormones|mesh-ancestor
93351871|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351872|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93351873|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645600|NCT01580683|Vitamins|vitamins|mesh-ancestor
93351874|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
93351875|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93351876|NCT04126200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93351877|NCT04126200|Growth Substances|growth substances|mesh-ancestor
93351879|NCT04126200|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93351880|NCT04126200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351881|NCT04126200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351882|NCT04063865|Everolimus|everolimus|mesh-list
93351883|NCT04063865|Tacrolimus|tacrolimus|mesh-list
93351884|NCT04063865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351885|NCT04063865|Immunologic Factors|immunologic factors|mesh-ancestor
93351886|NCT04063865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351887|NCT04063865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93351888|NCT04063865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351889|NCT04063865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351890|NCT04063865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93351891|NCT04063865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93351892|NCT04063865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351893|NCT04045665|Anticoagulants|anticoagulants|mesh-list
93351894|NCT04015700|Coal Tar|coal tar|mesh-list
93351895|NCT04015700|Vaccines|vaccines|mesh-list
93351896|NCT04015700|Immunologic Factors|immunologic factors|mesh-ancestor
93351897|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351898|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
93351899|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
93351900|NCT04004416|Lorazepam|lorazepam|mesh-list
93351901|NCT04004416|Anticonvulsants|anticonvulsants|mesh-ancestor
93351902|NCT04004416|Antiemetics|antiemetics|mesh-ancestor
93351903|NCT04004416|Autonomic Agents|autonomic agents|mesh-ancestor
93351904|NCT04004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93351905|NCT04004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351906|NCT04004416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93351907|NCT04004416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93351908|NCT04004416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93351909|NCT04004416|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93351910|NCT04004416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93351911|NCT04004416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93351912|NCT04004416|GABA Modulators|gaba modulators|mesh-ancestor
93351913|NCT04004416|GABA Agents|gaba agents|mesh-ancestor
93351914|NCT04004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351915|NCT04004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351916|NCT03996265|Bupropion|bupropion|mesh-list
93351917|NCT03996265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93351918|NCT03996265|Antidepressive Agents|antidepressive agents|mesh-ancestor
93351919|NCT03996265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93351920|NCT03996265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93351921|NCT03996265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93351922|NCT03996265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93351923|NCT03996265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351924|NCT03996265|Dopamine Agents|dopamine agents|mesh-ancestor
93351925|NCT03996265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93351926|NCT03996265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351927|NCT03996265|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93351928|NCT03996265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93351929|NCT03996265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351930|NCT03994211|Itraconazole|itraconazole|mesh-list
93351931|NCT03994211|Rifampin|rifampin|mesh-list
93351932|NCT03994211|Pamiparib|pamiparib|mesh-list
93351933|NCT03994211|Antifungal Agents|antifungal agents|mesh-ancestor
93351934|NCT03994211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93351935|NCT03994211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93351936|NCT03994211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93351937|NCT03994211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93351938|NCT03994211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351939|NCT03994211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93351940|NCT03994211|Hormone Antagonists|hormone antagonists|mesh-ancestor
93351941|NCT03994211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93351942|NCT03994211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351943|NCT03994211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93351944|NCT03994211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93351945|NCT03994211|Antitubercular Agents|antitubercular agents|mesh-ancestor
93351946|NCT03994211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93351947|NCT03994211|Leprostatic Agents|leprostatic agents|mesh-ancestor
93351948|NCT03994211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93351949|NCT03994211|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93351950|NCT03994211|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93351951|NCT03994211|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93351952|NCT03994211|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93351953|NCT03994211|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93351954|NCT03994211|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93351955|NCT03994211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93351956|NCT03994211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351957|NCT03959085|Calcium, Dietary|calcium, dietary|mesh-list
93351958|NCT03959085|Leucovorin|leucovorin|mesh-list
93351959|NCT03959085|Folic Acid|folic acid|mesh-list
93351960|NCT03959085|Cytarabine|cytarabine|mesh-list
93351961|NCT03959085|Dexamethasone|dexamethasone|mesh-list
93351962|NCT03959085|Dexamethasone acetate|dexamethasone acetate|mesh-list
93351963|NCT03959085|Prednisolone|prednisolone|mesh-list
93351964|NCT03959085|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93351965|NCT03959085|Methylprednisolone|methylprednisolone|mesh-list
93351966|NCT03959085|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93351967|NCT03959085|Prednisolone acetate|prednisolone acetate|mesh-list
93351968|NCT03959085|Hydrocortisone|hydrocortisone|mesh-list
93351969|NCT03959085|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93351970|NCT03959085|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93351971|NCT03959085|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93351972|NCT03959085|Cyclophosphamide|cyclophosphamide|mesh-list
93351973|NCT03959085|Doxorubicin|doxorubicin|mesh-list
93351974|NCT03959085|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93351975|NCT03959085|Methotrexate|methotrexate|mesh-list
93351976|NCT03959085|Vincristine|vincristine|mesh-list
93351977|NCT03959085|Daunorubicin|daunorubicin|mesh-list
93351978|NCT03959085|Asparaginase|asparaginase|mesh-list
93351979|NCT03959085|Mercaptopurine|mercaptopurine|mesh-list
93351980|NCT03959085|Pegaspargase|pegaspargase|mesh-list
93351981|NCT03959085|Thioguanine|thioguanine|mesh-list
93351982|NCT03959085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93351983|NCT03959085|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93351984|NCT03959085|Prednisolone phosphate|prednisolone phosphate|mesh-list
93351985|NCT03959085|BB 1101|bb 1101|mesh-list
93351986|NCT03959085|Calcium|calcium|mesh-list
93351987|NCT03959085|2-Aminopurine|2-aminopurine|mesh-list
93351988|NCT03959085|Levoleucovorin|levoleucovorin|mesh-list
93351989|NCT03959085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93351990|NCT03959085|Immunologic Factors|immunologic factors|mesh-ancestor
93351991|NCT03959085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93351992|NCT03959085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93351993|NCT03959085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93351994|NCT03959085|Alkylating Agents|alkylating agents|mesh-ancestor
93351995|NCT03959085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93351996|NCT03959085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93351997|NCT03959085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93351998|NCT03959085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93351999|NCT03959085|Antiemetics|antiemetics|mesh-ancestor
93352000|NCT03959085|Autonomic Agents|autonomic agents|mesh-ancestor
93352001|NCT03959085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352002|NCT03959085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352003|NCT03959085|Glucocorticoids|glucocorticoids|mesh-ancestor
93352004|NCT03959085|Hormones|hormones|mesh-ancestor
93352005|NCT03959085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352006|NCT03959085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352007|NCT03959085|Protease Inhibitors|protease inhibitors|mesh-ancestor
93352008|NCT03959085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352009|NCT03959085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352010|NCT03959085|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352011|NCT03959085|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352012|NCT03959085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93352013|NCT03959085|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93352014|NCT03959085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93352015|NCT03959085|Abortifacient Agents|abortifacient agents|mesh-ancestor
93352016|NCT03959085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93352017|NCT03959085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352018|NCT03959085|Antimetabolites|antimetabolites|mesh-ancestor
93352019|NCT03959085|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352020|NCT03959085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93352021|NCT03959085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93352022|NCT03959085|Antiviral Agents|antiviral agents|mesh-ancestor
93352023|NCT03959085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352024|NCT03959085|Antidotes|antidotes|mesh-ancestor
93352025|NCT03959085|Protective Agents|protective agents|mesh-ancestor
93352026|NCT03959085|Vitamin B Complex|vitamin b complex|mesh-ancestor
93023919|NCT01015482|GABA Agents|gaba agents|mesh-ancestor
93352027|NCT03959085|Vitamins|vitamins|mesh-ancestor
93352028|NCT03959085|Micronutrients|micronutrients|mesh-ancestor
93352029|NCT03959085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352030|NCT03959085|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352031|NCT03959085|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352032|NCT03959085|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352033|NCT03959085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93352034|NCT03959085|Hematinics|hematinics|mesh-ancestor
93352035|NCT03959085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352036|NCT03959085|Immunotoxins|immunotoxins|mesh-ancestor
93352037|NCT03959085|Immunoconjugates|immunoconjugates|mesh-ancestor
93352038|NCT03952637|Sirolimus|sirolimus|mesh-list
93352039|NCT03952637|Prednisone|prednisone|mesh-list
93352040|NCT03952637|Methylprednisolone|methylprednisolone|mesh-list
93352041|NCT03952637|Rituximab|rituximab|mesh-list
93352042|NCT03952637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352043|NCT03952637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352044|NCT03952637|Immunologic Factors|immunologic factors|mesh-ancestor
93352045|NCT03952637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352046|NCT03952637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352047|NCT03952637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352048|NCT03952637|Glucocorticoids|glucocorticoids|mesh-ancestor
93352049|NCT03952637|Hormones|hormones|mesh-ancestor
93352050|NCT03952637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352051|NCT03952637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352052|NCT03952637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93352053|NCT03952637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352054|NCT03952637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352055|NCT03952637|Antifungal Agents|antifungal agents|mesh-ancestor
93352056|NCT03952637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352057|NCT03952637|Antiemetics|antiemetics|mesh-ancestor
93352058|NCT03952637|Autonomic Agents|autonomic agents|mesh-ancestor
93352059|NCT03952637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352060|NCT03952637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352061|NCT03952637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93352062|NCT03952637|Protective Agents|protective agents|mesh-ancestor
93352063|NCT03950609|Everolimus|everolimus|mesh-list
93352064|NCT03950609|Lenvatinib|lenvatinib|mesh-list
93352065|NCT03950609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93352066|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352067|NCT03950609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352068|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352069|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352070|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
93352071|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352072|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352073|NCT03930732|Cholinergic Agents|cholinergic agents|mesh-list
93352074|NCT03930732|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93352075|NCT03930732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93352076|NCT03930732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352077|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352078|NCT03930732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93352079|NCT03910660|Pembrolizumab|pembrolizumab|mesh-list
93352080|NCT03910660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352081|NCT03910660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352082|NCT03910660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352083|NCT03910660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352084|NCT03875378|Estrogens|estrogens|mesh-list
93352085|NCT03875378|Hormones|hormones|mesh-ancestor
93352086|NCT03875378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352087|NCT03875378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352088|NCT03823768|Tacrolimus|tacrolimus|mesh-list
93352089|NCT03823768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352090|NCT03823768|Immunologic Factors|immunologic factors|mesh-ancestor
93352091|NCT03823768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352092|NCT03823768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93352093|NCT03823768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645780|NCT00220454|Hydrocortisone|hydrocortisone|mesh-list
93352094|NCT03823768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352095|NCT03818607|Eculizumab|eculizumab|mesh-list
93352096|NCT03818607|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93352097|NCT03818607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352098|NCT03818607|Immunologic Factors|immunologic factors|mesh-ancestor
93352099|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352100|NCT03817398|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93352101|NCT03817398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352102|NCT03817398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352103|NCT03817398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352104|NCT03796156|Aspirin|aspirin|mesh-list
93352105|NCT03796156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93352106|NCT03796156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93352107|NCT03796156|Analgesics|analgesics|mesh-ancestor
93352108|NCT03796156|Sensory System Agents|sensory system agents|mesh-ancestor
93352109|NCT03796156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352110|NCT03796156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352111|NCT03796156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352112|NCT03796156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352113|NCT03796156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93352114|NCT03796156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93352115|NCT03796156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352116|NCT03796156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93352117|NCT03796156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93352118|NCT03796156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352119|NCT03796156|Antipyretics|antipyretics|mesh-ancestor
93352120|NCT03794349|Eflornithine|eflornithine|mesh-list
93352121|NCT03794349|Irinotecan|irinotecan|mesh-list
93352122|NCT03794349|Camptothecin|camptothecin|mesh-list
93352123|NCT03794349|Temozolomide|temozolomide|mesh-list
93352124|NCT03794349|Dinutuximab|dinutuximab|mesh-list
93352125|NCT03794349|Sargramostim|sargramostim|mesh-list
93352126|NCT03794349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352127|NCT03794349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93352128|NCT03794349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352129|NCT03794349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352130|NCT03794349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352131|NCT03794349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352132|NCT03794349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352133|NCT03794349|Alkylating Agents|alkylating agents|mesh-ancestor
93352134|NCT03794349|Immunologic Factors|immunologic factors|mesh-ancestor
93352135|NCT03794349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352136|NCT03794349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352137|NCT03794349|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93352138|NCT03794349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93352139|NCT03794349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93352140|NCT03794349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352141|NCT03794349|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93352142|NCT03737292|Bupivacaine|bupivacaine|mesh-list
93352143|NCT03737292|Anesthetics, Local|anesthetics, local|mesh-ancestor
93352144|NCT03737292|Anesthetics|anesthetics|mesh-ancestor
93352145|NCT03737292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93352146|NCT03737292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352147|NCT03737292|Sensory System Agents|sensory system agents|mesh-ancestor
93352148|NCT03737292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352149|NCT03710460|Metformin|metformin|mesh-list
93352150|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
93352151|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93352152|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352153|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93352154|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352155|NCT03650894|Nivolumab|nivolumab|mesh-list
93352156|NCT03650894|Ipilimumab|ipilimumab|mesh-list
93352157|NCT03650894|Bicalutamide|bicalutamide|mesh-list
93352158|NCT03650894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352159|NCT03650894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352160|NCT03650894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352161|NCT03650894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352162|NCT03650894|Androgen Antagonists|androgen antagonists|mesh-ancestor
92645861|NCT00220649|Vitamins|vitamins|mesh-ancestor
93352163|NCT03650894|Hormone Antagonists|hormone antagonists|mesh-ancestor
93352164|NCT03650894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352165|NCT03650894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352166|NCT03606694|Metformin|metformin|mesh-list
93352167|NCT03606694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93352168|NCT03606694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352169|NCT03599622|Deucravacitinib|deucravacitinib|mesh-list
93352170|NCT03599622|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352171|NCT03599622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352172|NCT03599622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352173|NCT03599622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352174|NCT03544281|Dexamethasone|dexamethasone|mesh-list
93352175|NCT03544281|Lenalidomide|lenalidomide|mesh-list
93024079|NCT00930839|Antipyretics|antipyretics|mesh-ancestor
93352176|NCT03544281|Bortezomib|bortezomib|mesh-list
93352177|NCT03544281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352178|NCT03544281|Antiemetics|antiemetics|mesh-ancestor
93352179|NCT03544281|Autonomic Agents|autonomic agents|mesh-ancestor
93352180|NCT03544281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352181|NCT03544281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352182|NCT03544281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352183|NCT03544281|Glucocorticoids|glucocorticoids|mesh-ancestor
93352184|NCT03544281|Hormones|hormones|mesh-ancestor
93352185|NCT03544281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352186|NCT03544281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352187|NCT03544281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352188|NCT03544281|Immunologic Factors|immunologic factors|mesh-ancestor
93352189|NCT03544281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93352190|NCT03544281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93352191|NCT03544281|Growth Substances|growth substances|mesh-ancestor
93352192|NCT03544281|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352193|NCT03533582|Cisplatin|cisplatin|mesh-list
93352194|NCT03533582|Carboplatin|carboplatin|mesh-list
93352195|NCT03533582|Gemcitabine|gemcitabine|mesh-list
93352196|NCT03533582|Doxorubicin|doxorubicin|mesh-list
93352197|NCT03533582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93352198|NCT03533582|Fluorouracil|fluorouracil|mesh-list
93352199|NCT03533582|Oxaliplatin|oxaliplatin|mesh-list
93352200|NCT03533582|Irinotecan|irinotecan|mesh-list
93352201|NCT03533582|Etoposide|etoposide|mesh-list
93352202|NCT03533582|Vincristine|vincristine|mesh-list
93352203|NCT03533582|Etoposide phosphate|etoposide phosphate|mesh-list
93352204|NCT03533582|Sorafenib|sorafenib|mesh-list
93352205|NCT03533582|Daunorubicin|daunorubicin|mesh-list
93352206|NCT03533582|Podophyllotoxin|podophyllotoxin|mesh-list
93352207|NCT03533582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352208|NCT03533582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352209|NCT03533582|Antimetabolites|antimetabolites|mesh-ancestor
93352210|NCT03533582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352211|NCT03533582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352212|NCT03533582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352213|NCT03533582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352214|NCT03533582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352215|NCT03533582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352216|NCT03533582|Immunologic Factors|immunologic factors|mesh-ancestor
93352217|NCT03533582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352218|NCT03533582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93352219|NCT03533582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352220|NCT03533582|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352221|NCT03533582|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352222|NCT03533582|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352223|NCT03533582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352224|NCT03533582|Keratolytic Agents|keratolytic agents|mesh-ancestor
93352225|NCT03533582|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352226|NCT03519945|Mirikizumab|mirikizumab|mesh-list
93352227|NCT03519945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93352228|NCT03519945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93352229|NCT03519945|Analgesics|analgesics|mesh-ancestor
93352230|NCT03519945|Sensory System Agents|sensory system agents|mesh-ancestor
93352231|NCT03519945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352232|NCT03519945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352233|NCT03519945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352234|NCT03519945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352235|NCT03519945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93352236|NCT03519945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352237|NCT03432741|Deoxyglucose|deoxyglucose|mesh-list
93352238|NCT03432741|Rituximab|rituximab|mesh-list
93352239|NCT03432741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93352240|NCT03432741|Pembrolizumab|pembrolizumab|mesh-list
93352241|NCT03432741|Nivolumab|nivolumab|mesh-list
93352242|NCT03432741|Trastuzumab|trastuzumab|mesh-list
93352243|NCT03432741|Obinutuzumab|obinutuzumab|mesh-list
93352244|NCT03432741|Gemcitabine|gemcitabine|mesh-list
93352245|NCT03432741|Daratumumab|daratumumab|mesh-list
93352246|NCT03432741|Romidepsin|romidepsin|mesh-list
93352247|NCT03432741|Belinostat|belinostat|mesh-list
93352248|NCT03432741|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93352249|NCT03432741|Antibodies|antibodies|mesh-list
93352250|NCT03432741|Immunoglobulins|immunoglobulins|mesh-list
93024151|NCT00936689|Doxorubicin|doxorubicin|mesh-list
93352251|NCT03432741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352252|NCT03432741|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93352253|NCT03432741|Immunologic Factors|immunologic factors|mesh-ancestor
93352254|NCT03432741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352255|NCT03432741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352256|NCT03432741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352257|NCT03432741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352258|NCT03432741|Antimetabolites|antimetabolites|mesh-ancestor
93352259|NCT03432741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352260|NCT03432741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352261|NCT03432741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352262|NCT03432741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93352263|NCT03432741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352264|NCT03432741|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93352265|NCT03432741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352266|NCT03432741|Antiviral Agents|antiviral agents|mesh-ancestor
93352267|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93352268|NCT03387579|SMOFlipid|smoflipid|mesh-list
93352269|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93352270|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93352271|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93352272|NCT03366272|Rituximab|rituximab|mesh-list
93352273|NCT03366272|Nivolumab|nivolumab|mesh-list
93352274|NCT03366272|Gemcitabine|gemcitabine|mesh-list
93352275|NCT03366272|Oxaliplatin|oxaliplatin|mesh-list
93352276|NCT03366272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352277|NCT03366272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352278|NCT03366272|Immunologic Factors|immunologic factors|mesh-ancestor
93352279|NCT03366272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352280|NCT03366272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352281|NCT03366272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352282|NCT03366272|Antimetabolites|antimetabolites|mesh-ancestor
93352283|NCT03366272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352284|NCT03366272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352285|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
93352286|NCT03339635|Testosterone|testosterone|mesh-list
93352287|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
93352288|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
93352289|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93352290|NCT03339635|Androgens|androgens|mesh-ancestor
93352291|NCT03339635|Hormones|hormones|mesh-ancestor
93352292|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352293|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352294|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352295|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352296|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
93352297|NCT03322215|Capecitabine|capecitabine|mesh-list
93352298|NCT03322215|Fulvestrant|fulvestrant|mesh-list
93352299|NCT03322215|Palbociclib|palbociclib|mesh-list
93352300|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352301|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
93352302|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352303|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352304|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352305|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93352306|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93352307|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
93352308|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352309|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352310|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352311|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352312|NCT03300817|Poly ICLC|poly iclc|mesh-list
93352313|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
93352314|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
93352315|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352316|NCT03282916|Valacyclovir|valacyclovir|mesh-list
93352317|NCT03282916|Antiviral Agents|antiviral agents|mesh-ancestor
93352318|NCT03282916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352319|NCT03271372|Avelumab|avelumab|mesh-list
93352320|NCT03271372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352321|NCT03271372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352322|NCT03271372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352323|NCT03271372|Immunologic Factors|immunologic factors|mesh-ancestor
93352324|NCT03271372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352325|NCT03246750|Cisplatin|cisplatin|mesh-list
93352326|NCT03246750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352327|NCT03173950|Nivolumab|nivolumab|mesh-list
93352328|NCT03173950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352329|NCT03173950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352330|NCT03173950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352331|NCT03173950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352332|NCT03126916|Vitamin A|vitamin a|mesh-list
93352333|NCT03126916|Cyclophosphamide|cyclophosphamide|mesh-list
93352334|NCT03126916|Melphalan|melphalan|mesh-list
93352335|NCT03126916|Busulfan|busulfan|mesh-list
93352336|NCT03126916|Thiotepa|thiotepa|mesh-list
93352337|NCT03126916|Cisplatin|cisplatin|mesh-list
93352338|NCT03126916|Carboplatin|carboplatin|mesh-list
93352339|NCT03126916|Doxorubicin|doxorubicin|mesh-list
93352340|NCT03126916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93352341|NCT03126916|Etoposide|etoposide|mesh-list
93352342|NCT03126916|Vincristine|vincristine|mesh-list
93352343|NCT03126916|Topotecan|topotecan|mesh-list
93352344|NCT03126916|Tretinoin|tretinoin|mesh-list
93352345|NCT03126916|Etoposide phosphate|etoposide phosphate|mesh-list
93352346|NCT03126916|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93352347|NCT03126916|Dinutuximab|dinutuximab|mesh-list
93352348|NCT03126916|Dexrazoxane|dexrazoxane|mesh-list
93352349|NCT03126916|Razoxane|razoxane|mesh-list
93352350|NCT03126916|Isotretinoin|isotretinoin|mesh-list
93352351|NCT03126916|Sargramostim|sargramostim|mesh-list
93352352|NCT03126916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352353|NCT03126916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352354|NCT03126916|Immunologic Factors|immunologic factors|mesh-ancestor
93352355|NCT03126916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352356|NCT03126916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352357|NCT03126916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352358|NCT03126916|Alkylating Agents|alkylating agents|mesh-ancestor
93352359|NCT03126916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352360|NCT03126916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352361|NCT03126916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352362|NCT03126916|Vitamins|vitamins|mesh-ancestor
93352363|NCT03126916|Micronutrients|micronutrients|mesh-ancestor
93352364|NCT03126916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352365|NCT03126916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352366|NCT03126916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352367|NCT03126916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352368|NCT03126916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352369|NCT03126916|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352370|NCT03126916|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352371|NCT03126916|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352372|NCT03126916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93352373|NCT03126916|Keratolytic Agents|keratolytic agents|mesh-ancestor
93352374|NCT03126916|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352375|NCT03126916|Protective Agents|protective agents|mesh-ancestor
93352376|NCT03126916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93352377|NCT03126916|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93352378|NCT03094884|Paclitaxel|paclitaxel|mesh-list
93352379|NCT03094884|Carboplatin|carboplatin|mesh-list
93352380|NCT03094884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352381|NCT03094884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352382|NCT03094884|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352383|NCT03094884|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352384|NCT03094884|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352385|NCT03094884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352386|NCT03092518|Sodium thiosulfate|sodium thiosulfate|mesh-list
93352387|NCT03092518|Mitomycins|mitomycins|mesh-list
93352388|NCT03092518|Mitomycin|mitomycin|mesh-list
93352389|NCT03092518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352390|NCT03092518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352391|NCT03092518|Alkylating Agents|alkylating agents|mesh-ancestor
93352392|NCT03092518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352393|NCT03092518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93352394|NCT03092518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352395|NCT03092518|Antidotes|antidotes|mesh-ancestor
93352396|NCT03092518|Protective Agents|protective agents|mesh-ancestor
93352397|NCT03092518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352398|NCT03092518|Antioxidants|antioxidants|mesh-ancestor
93352399|NCT03092518|Antitubercular Agents|antitubercular agents|mesh-ancestor
93352400|NCT03092518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93352401|NCT03092518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352402|NCT03092518|Chelating Agents|chelating agents|mesh-ancestor
93352403|NCT03092518|Sequestering Agents|sequestering agents|mesh-ancestor
93352404|NCT03074513|Bevacizumab|bevacizumab|mesh-list
93352405|NCT03074513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93352406|NCT03074513|Atezolizumab|atezolizumab|mesh-list
93352407|NCT03074513|Endothelial Growth Factors|endothelial growth factors|mesh-list
93352408|NCT03074513|Antibodies|antibodies|mesh-list
93352409|NCT03074513|Immunoglobulins|immunoglobulins|mesh-list
93352410|NCT03074513|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352411|NCT03074513|Immunoglobulin G|immunoglobulin g|mesh-list
93352412|NCT03074513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352413|NCT03074513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93352414|NCT03074513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93352415|NCT03074513|Growth Substances|growth substances|mesh-ancestor
93352416|NCT03074513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352417|NCT03074513|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352418|NCT03074513|Immunologic Factors|immunologic factors|mesh-ancestor
93352419|NCT03074513|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352420|NCT03074513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352421|NCT03067181|Cisplatin|cisplatin|mesh-list
93352422|NCT03067181|Carboplatin|carboplatin|mesh-list
93352423|NCT03067181|Etoposide|etoposide|mesh-list
93352424|NCT03067181|Etoposide phosphate|etoposide phosphate|mesh-list
93352425|NCT03067181|Bleomycin|bleomycin|mesh-list
93352426|NCT03067181|Podophyllotoxin|podophyllotoxin|mesh-list
93352427|NCT03067181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352428|NCT03067181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352429|NCT03067181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352430|NCT03067181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352431|NCT03067181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352432|NCT03067181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352433|NCT03067181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352434|NCT03067181|Keratolytic Agents|keratolytic agents|mesh-ancestor
93352435|NCT03067181|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352436|NCT03067181|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352437|NCT03067181|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352438|NCT03067181|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352439|NCT03029390|Metformin|metformin|mesh-list
93352440|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93352441|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352442|NCT03007147|Calcium, Dietary|calcium, dietary|mesh-list
93352443|NCT03007147|Leucovorin|leucovorin|mesh-list
93352444|NCT03007147|Folic Acid|folic acid|mesh-list
93352445|NCT03007147|Cytarabine|cytarabine|mesh-list
93352446|NCT03007147|Dexamethasone|dexamethasone|mesh-list
93352447|NCT03007147|Dexamethasone acetate|dexamethasone acetate|mesh-list
93352448|NCT03007147|Methylprednisolone|methylprednisolone|mesh-list
93352449|NCT03007147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93352450|NCT03007147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93352451|NCT03007147|Prednisolone|prednisolone|mesh-list
93352452|NCT03007147|Prednisolone acetate|prednisolone acetate|mesh-list
93352453|NCT03007147|Hydrocortisone|hydrocortisone|mesh-list
93352454|NCT03007147|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93352455|NCT03007147|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93352456|NCT03007147|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93352457|NCT03007147|Cyclophosphamide|cyclophosphamide|mesh-list
93352458|NCT03007147|Ifosfamide|ifosfamide|mesh-list
93352459|NCT03007147|Isophosphamide mustard|isophosphamide mustard|mesh-list
93352460|NCT03007147|Doxorubicin|doxorubicin|mesh-list
93352461|NCT03007147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93352462|NCT03007147|Methotrexate|methotrexate|mesh-list
93352463|NCT03007147|Etoposide|etoposide|mesh-list
93352464|NCT03007147|Vincristine|vincristine|mesh-list
93352465|NCT03007147|Etoposide phosphate|etoposide phosphate|mesh-list
93352466|NCT03007147|Imatinib Mesylate|imatinib mesylate|mesh-list
93352467|NCT03007147|Daunorubicin|daunorubicin|mesh-list
93352468|NCT03007147|Asparaginase|asparaginase|mesh-list
93352469|NCT03007147|Mercaptopurine|mercaptopurine|mesh-list
93352470|NCT03007147|Podophyllotoxin|podophyllotoxin|mesh-list
93352471|NCT03007147|Pegaspargase|pegaspargase|mesh-list
93352472|NCT03007147|Thioguanine|thioguanine|mesh-list
93352473|NCT03007147|Dexrazoxane|dexrazoxane|mesh-list
93352474|NCT03007147|Razoxane|razoxane|mesh-list
93352475|NCT03007147|Azathioprine|azathioprine|mesh-list
93352476|NCT03007147|Lenograstim|lenograstim|mesh-list
93352477|NCT03007147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93352478|NCT03007147|Prednisolone phosphate|prednisolone phosphate|mesh-list
93352479|NCT03007147|BB 1101|bb 1101|mesh-list
93352480|NCT03007147|Calcium|calcium|mesh-list
93352481|NCT03007147|2-Aminopurine|2-aminopurine|mesh-list
93352482|NCT03007147|Levoleucovorin|levoleucovorin|mesh-list
93352483|NCT03007147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352484|NCT03007147|Immunologic Factors|immunologic factors|mesh-ancestor
93352485|NCT03007147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352486|NCT03007147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352487|NCT03007147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352488|NCT03007147|Alkylating Agents|alkylating agents|mesh-ancestor
93352489|NCT03007147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352490|NCT03007147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352491|NCT03007147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352492|NCT03007147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352493|NCT03007147|Antiemetics|antiemetics|mesh-ancestor
93352494|NCT03007147|Autonomic Agents|autonomic agents|mesh-ancestor
93352495|NCT03007147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352496|NCT03007147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352497|NCT03007147|Glucocorticoids|glucocorticoids|mesh-ancestor
93352498|NCT03007147|Hormones|hormones|mesh-ancestor
93352499|NCT03007147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352500|NCT03007147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352501|NCT03007147|Protease Inhibitors|protease inhibitors|mesh-ancestor
93352502|NCT03007147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352503|NCT03007147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352504|NCT03007147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352505|NCT03007147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352506|NCT03007147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93352507|NCT03007147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93352508|NCT03007147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93352509|NCT03007147|Abortifacient Agents|abortifacient agents|mesh-ancestor
93352510|NCT03007147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93352511|NCT03007147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352512|NCT03007147|Antimetabolites|antimetabolites|mesh-ancestor
93352513|NCT03007147|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352514|NCT03007147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93352515|NCT03007147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93352516|NCT03007147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352517|NCT03007147|Antiviral Agents|antiviral agents|mesh-ancestor
93352518|NCT03007147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352519|NCT03007147|Antidotes|antidotes|mesh-ancestor
93352520|NCT03007147|Protective Agents|protective agents|mesh-ancestor
93352521|NCT03007147|Vitamin B Complex|vitamin b complex|mesh-ancestor
93352522|NCT03007147|Vitamins|vitamins|mesh-ancestor
93352523|NCT03007147|Micronutrients|micronutrients|mesh-ancestor
93352524|NCT03007147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93352525|NCT03007147|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352526|NCT03007147|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352527|NCT03007147|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352528|NCT03007147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93352529|NCT03007147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352530|NCT03007147|Hematinics|hematinics|mesh-ancestor
93352531|NCT03007147|Keratolytic Agents|keratolytic agents|mesh-ancestor
93352532|NCT03007147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93352533|NCT02981628|Calcium, Dietary|calcium, dietary|mesh-list
93352534|NCT02981628|Leucovorin|leucovorin|mesh-list
93352535|NCT02981628|Folic Acid|folic acid|mesh-list
93352536|NCT02981628|Cytarabine|cytarabine|mesh-list
93352537|NCT02981628|Cyclophosphamide|cyclophosphamide|mesh-list
93352538|NCT02981628|Methotrexate|methotrexate|mesh-list
93352539|NCT02981628|Vincristine|vincristine|mesh-list
93352540|NCT02981628|Asparaginase|asparaginase|mesh-list
93352541|NCT02981628|Pegaspargase|pegaspargase|mesh-list
93352542|NCT02981628|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93352543|NCT02981628|Calcium|calcium|mesh-list
93352544|NCT02981628|Levoleucovorin|levoleucovorin|mesh-list
93352545|NCT02981628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352546|NCT02981628|Immunologic Factors|immunologic factors|mesh-ancestor
93352547|NCT02981628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352548|NCT02981628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352549|NCT02981628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352550|NCT02981628|Alkylating Agents|alkylating agents|mesh-ancestor
93352551|NCT02981628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352552|NCT02981628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352553|NCT02981628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352554|NCT02981628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93352555|NCT02981628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93352556|NCT02981628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93352557|NCT02981628|Abortifacient Agents|abortifacient agents|mesh-ancestor
93352558|NCT02981628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93352559|NCT02981628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352560|NCT02981628|Antimetabolites|antimetabolites|mesh-ancestor
93352561|NCT02981628|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352562|NCT02981628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352563|NCT02981628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93352564|NCT02981628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93352565|NCT02981628|Antiviral Agents|antiviral agents|mesh-ancestor
93352566|NCT02981628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352567|NCT02981628|Antidotes|antidotes|mesh-ancestor
93352568|NCT02981628|Protective Agents|protective agents|mesh-ancestor
93352569|NCT02981628|Vitamin B Complex|vitamin b complex|mesh-ancestor
93352570|NCT02981628|Vitamins|vitamins|mesh-ancestor
93352571|NCT02981628|Micronutrients|micronutrients|mesh-ancestor
93024440|NCT00940667|Amlodipine|amlodipine|mesh-list
93352572|NCT02981628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352573|NCT02981628|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352574|NCT02981628|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352575|NCT02981628|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352576|NCT02981628|Hematinics|hematinics|mesh-ancestor
93352577|NCT02981628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352578|NCT02981628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352579|NCT02981628|Immunotoxins|immunotoxins|mesh-ancestor
93352580|NCT02981628|Immunoconjugates|immunoconjugates|mesh-ancestor
93352581|NCT02873962|Bevacizumab|bevacizumab|mesh-list
93352582|NCT02873962|Nivolumab|nivolumab|mesh-list
93352583|NCT02873962|Rucaparib|rucaparib|mesh-list
93352584|NCT02873962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352585|NCT02873962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352586|NCT02873962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93352587|NCT02873962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93352588|NCT02873962|Growth Substances|growth substances|mesh-ancestor
93352589|NCT02873962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352590|NCT02873962|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352591|NCT02873962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352592|NCT02873962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352593|NCT02873962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93352594|NCT02873962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352595|NCT02822144|Lidocaine|lidocaine|mesh-list
93352596|NCT02822144|Remifentanil|remifentanil|mesh-list
93352597|NCT02822144|Propofol|propofol|mesh-list
93352598|NCT02822144|Etomidate|etomidate|mesh-list
93352599|NCT02822144|Succinylcholine|succinylcholine|mesh-list
93352600|NCT02822144|Anesthetics, Local|anesthetics, local|mesh-ancestor
93352601|NCT02822144|Anesthetics|anesthetics|mesh-ancestor
93352602|NCT02822144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93352603|NCT02822144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352604|NCT02822144|Sensory System Agents|sensory system agents|mesh-ancestor
93352605|NCT02822144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352606|NCT02822144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93352607|NCT02822144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93352608|NCT02822144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93352609|NCT02822144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93352610|NCT02822144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352611|NCT02822144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93352612|NCT02822144|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93352613|NCT02822144|Anesthetics, General|anesthetics, general|mesh-ancestor
93352614|NCT02822144|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93352615|NCT02822144|Narcotics|narcotics|mesh-ancestor
93352616|NCT02822144|Analgesics|analgesics|mesh-ancestor
93352617|NCT02822144|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93352618|NCT02822144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93352619|NCT02822144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93352620|NCT02725060|Phenylephrine|phenylephrine|mesh-list
93352621|NCT02725060|Isoproterenol|isoproterenol|mesh-list
93352622|NCT02725060|Oxymetazoline|oxymetazoline|mesh-list
93352623|NCT02725060|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93352624|NCT02725060|Mydriatics|mydriatics|mesh-ancestor
93352625|NCT02725060|Autonomic Agents|autonomic agents|mesh-ancestor
93352626|NCT02725060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352627|NCT02725060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352628|NCT02725060|Sympathomimetics|sympathomimetics|mesh-ancestor
93352629|NCT02725060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93352630|NCT02725060|Nasal Decongestants|nasal decongestants|mesh-ancestor
93352631|NCT02725060|Respiratory System Agents|respiratory system agents|mesh-ancestor
93352632|NCT02725060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93352633|NCT02725060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93352634|NCT02725060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93352635|NCT02725060|Adrenergic Agents|adrenergic agents|mesh-ancestor
93352636|NCT02725060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93352637|NCT02725060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352638|NCT02725060|Protective Agents|protective agents|mesh-ancestor
93352639|NCT02725060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93352640|NCT02725060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93352641|NCT02725060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93352642|NCT02724579|Cyclophosphamide|cyclophosphamide|mesh-list
93352643|NCT02724579|Lomustine|lomustine|mesh-list
93352644|NCT02724579|Cisplatin|cisplatin|mesh-list
93352645|NCT02724579|Vincristine|vincristine|mesh-list
93352646|NCT02724579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352647|NCT02724579|Immunologic Factors|immunologic factors|mesh-ancestor
93352648|NCT02724579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352649|NCT02724579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352650|NCT02724579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352651|NCT02724579|Alkylating Agents|alkylating agents|mesh-ancestor
93352652|NCT02724579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352653|NCT02724579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352654|NCT02724579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352655|NCT02724579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352656|NCT02724579|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352657|NCT02724579|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352658|NCT02724579|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352659|NCT02565680|Prednisone|prednisone|mesh-list
93352660|NCT02565680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352661|NCT02565680|Glucocorticoids|glucocorticoids|mesh-ancestor
93352662|NCT02565680|Hormones|hormones|mesh-ancestor
93352663|NCT02565680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352664|NCT02565680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352665|NCT02565680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352666|NCT02565680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352667|NCT02521285|Aspirin|aspirin|mesh-list
93352668|NCT02521285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93352669|NCT02521285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93352670|NCT02521285|Analgesics|analgesics|mesh-ancestor
93352671|NCT02521285|Sensory System Agents|sensory system agents|mesh-ancestor
93352672|NCT02521285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352673|NCT02521285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352674|NCT02521285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352675|NCT02521285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352676|NCT02521285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93352677|NCT02521285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93352678|NCT02521285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352679|NCT02521285|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93352680|NCT02521285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93352681|NCT02521285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352682|NCT02521285|Antipyretics|antipyretics|mesh-ancestor
93352683|NCT02422615|Fulvestrant|fulvestrant|mesh-list
93352684|NCT02422615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352685|NCT02422615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352686|NCT02422615|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93352687|NCT02422615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93352688|NCT02422615|Hormone Antagonists|hormone antagonists|mesh-ancestor
93352689|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352690|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352691|NCT02382406|Paclitaxel|paclitaxel|mesh-list
93352692|NCT02382406|Carboplatin|carboplatin|mesh-list
93352693|NCT02382406|Pembrolizumab|pembrolizumab|mesh-list
93352694|NCT02382406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352695|NCT02382406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352696|NCT02382406|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352697|NCT02382406|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352698|NCT02382406|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352699|NCT02382406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352700|NCT02382406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352701|NCT02382406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93352702|NCT02176967|Cyclophosphamide|cyclophosphamide|mesh-list
93352703|NCT02176967|Carboplatin|carboplatin|mesh-list
93352704|NCT02176967|Doxorubicin|doxorubicin|mesh-list
93352705|NCT02176967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93352706|NCT02176967|Etoposide|etoposide|mesh-list
93352707|NCT02176967|Etoposide phosphate|etoposide phosphate|mesh-list
93352708|NCT02176967|Podophyllotoxin|podophyllotoxin|mesh-list
93352709|NCT02176967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352710|NCT02176967|Immunologic Factors|immunologic factors|mesh-ancestor
93352711|NCT02176967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352712|NCT02176967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352713|NCT02176967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352714|NCT02176967|Alkylating Agents|alkylating agents|mesh-ancestor
93352715|NCT02176967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352716|NCT02176967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352717|NCT02176967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352718|NCT02176967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352719|NCT02176967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352720|NCT02176967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352721|NCT02176967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352722|NCT02176967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352723|NCT02176967|Keratolytic Agents|keratolytic agents|mesh-ancestor
93352724|NCT02176967|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352726|NCT02176967|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352727|NCT02176967|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352728|NCT02134327|Midazolam|midazolam|mesh-list
93352729|NCT02134327|Dexmedetomidine|dexmedetomidine|mesh-list
93352730|NCT02134327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93352731|NCT02134327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93352732|NCT02134327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352733|NCT02134327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93352734|NCT02134327|Analgesics|analgesics|mesh-ancestor
93352735|NCT02134327|Sensory System Agents|sensory system agents|mesh-ancestor
93352736|NCT02134327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352737|NCT02134327|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93352738|NCT02134327|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93352739|NCT02134327|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93352740|NCT02134327|Adrenergic Agents|adrenergic agents|mesh-ancestor
93352741|NCT02134327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93352742|NCT02134327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352743|NCT02134327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93352744|NCT02134327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93352745|NCT02134327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93352746|NCT02134327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93352747|NCT02134327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93352748|NCT02134327|Anesthetics, General|anesthetics, general|mesh-ancestor
93352749|NCT02134327|Anesthetics|anesthetics|mesh-ancestor
93352750|NCT02134327|GABA Modulators|gaba modulators|mesh-ancestor
93352751|NCT02134327|GABA Agents|gaba agents|mesh-ancestor
93352752|NCT02112916|Calcium, Dietary|calcium, dietary|mesh-list
93352753|NCT02112916|Leucovorin|leucovorin|mesh-list
93352754|NCT02112916|Folic Acid|folic acid|mesh-list
93352755|NCT02112916|Cytarabine|cytarabine|mesh-list
93352756|NCT02112916|Dexamethasone|dexamethasone|mesh-list
93352757|NCT02112916|Dexamethasone acetate|dexamethasone acetate|mesh-list
93352758|NCT02112916|Hydrocortisone|hydrocortisone|mesh-list
93352759|NCT02112916|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93352760|NCT02112916|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93352761|NCT02112916|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93352762|NCT02112916|Cyclophosphamide|cyclophosphamide|mesh-list
93352763|NCT02112916|Ifosfamide|ifosfamide|mesh-list
93352764|NCT02112916|Isophosphamide mustard|isophosphamide mustard|mesh-list
93352765|NCT02112916|Doxorubicin|doxorubicin|mesh-list
93352766|NCT02112916|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93352767|NCT02112916|Methotrexate|methotrexate|mesh-list
93352768|NCT02112916|Etoposide|etoposide|mesh-list
93352769|NCT02112916|Vincristine|vincristine|mesh-list
93352770|NCT02112916|Etoposide phosphate|etoposide phosphate|mesh-list
93352771|NCT02112916|Bortezomib|bortezomib|mesh-list
93352772|NCT02112916|Daunorubicin|daunorubicin|mesh-list
93352773|NCT02112916|Asparaginase|asparaginase|mesh-list
93352774|NCT02112916|Mercaptopurine|mercaptopurine|mesh-list
93352775|NCT02112916|Podophyllotoxin|podophyllotoxin|mesh-list
93352776|NCT02112916|Pegaspargase|pegaspargase|mesh-list
93352777|NCT02112916|Thioguanine|thioguanine|mesh-list
93352778|NCT02112916|BB 1101|bb 1101|mesh-list
93352779|NCT02112916|Calcium|calcium|mesh-list
93352780|NCT02112916|2-Aminopurine|2-aminopurine|mesh-list
93352781|NCT02112916|Levoleucovorin|levoleucovorin|mesh-list
93352782|NCT02112916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352783|NCT02112916|Immunologic Factors|immunologic factors|mesh-ancestor
93352784|NCT02112916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352785|NCT02112916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352786|NCT02112916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352787|NCT02112916|Alkylating Agents|alkylating agents|mesh-ancestor
93352788|NCT02112916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352789|NCT02112916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352790|NCT02112916|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352791|NCT02112916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352792|NCT02112916|Antiemetics|antiemetics|mesh-ancestor
93352793|NCT02112916|Autonomic Agents|autonomic agents|mesh-ancestor
93352794|NCT02112916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352795|NCT02112916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352796|NCT02112916|Glucocorticoids|glucocorticoids|mesh-ancestor
93352797|NCT02112916|Hormones|hormones|mesh-ancestor
93352798|NCT02112916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352799|NCT02112916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352800|NCT02112916|Protease Inhibitors|protease inhibitors|mesh-ancestor
93352801|NCT02112916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352802|NCT02112916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352803|NCT02112916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352804|NCT02112916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352805|NCT02112916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93352806|NCT02112916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93352807|NCT02112916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93352809|NCT02112916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93352810|NCT02112916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352811|NCT02112916|Antimetabolites|antimetabolites|mesh-ancestor
93352812|NCT02112916|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352813|NCT02112916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93352814|NCT02112916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93352815|NCT02112916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352816|NCT02112916|Antiviral Agents|antiviral agents|mesh-ancestor
93352817|NCT02112916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352818|NCT02112916|Antidotes|antidotes|mesh-ancestor
93352819|NCT02112916|Protective Agents|protective agents|mesh-ancestor
93352820|NCT02112916|Vitamin B Complex|vitamin b complex|mesh-ancestor
93352821|NCT02112916|Vitamins|vitamins|mesh-ancestor
93352822|NCT02112916|Micronutrients|micronutrients|mesh-ancestor
93352823|NCT02112916|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352824|NCT02112916|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352825|NCT02112916|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352826|NCT02112916|Hematinics|hematinics|mesh-ancestor
93352827|NCT02112916|Keratolytic Agents|keratolytic agents|mesh-ancestor
93352828|NCT02101268|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
93352829|NCT02101268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352830|NCT02101268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352831|NCT02101268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352832|NCT01880515|Tetracycline|tetracycline|mesh-list
93352833|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93352834|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352835|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93352836|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352837|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352838|NCT01780883|Melatonin|melatonin|mesh-list
93352839|NCT01780883|Antioxidants|antioxidants|mesh-ancestor
93352840|NCT01780883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352841|NCT01780883|Protective Agents|protective agents|mesh-ancestor
93352842|NCT01780883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352843|NCT01780883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93352844|NCT01668719|Dexamethasone|dexamethasone|mesh-list
93352845|NCT01668719|Dexamethasone acetate|dexamethasone acetate|mesh-list
93352846|NCT01668719|Lenalidomide|lenalidomide|mesh-list
93352847|NCT01668719|Bortezomib|bortezomib|mesh-list
93352848|NCT01668719|Elotuzumab|elotuzumab|mesh-list
93352849|NCT01668719|Ichthammol|ichthammol|mesh-list
93352850|NCT01668719|BB 1101|bb 1101|mesh-list
93352851|NCT01668719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93352852|NCT01668719|Antiemetics|antiemetics|mesh-ancestor
93352853|NCT01668719|Autonomic Agents|autonomic agents|mesh-ancestor
93352854|NCT01668719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352855|NCT01668719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352856|NCT01668719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93352857|NCT01668719|Glucocorticoids|glucocorticoids|mesh-ancestor
93352858|NCT01668719|Hormones|hormones|mesh-ancestor
93352859|NCT01668719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93352860|NCT01668719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93352861|NCT01668719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352862|NCT01668719|Immunologic Factors|immunologic factors|mesh-ancestor
93352863|NCT01668719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93352864|NCT01668719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93352865|NCT01668719|Growth Substances|growth substances|mesh-ancestor
93352866|NCT01668719|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352867|NCT01668719|Protease Inhibitors|protease inhibitors|mesh-ancestor
93352868|NCT01668719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352869|NCT01668719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352870|NCT01668719|Dermatologic Agents|dermatologic agents|mesh-ancestor
93352871|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
93352872|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93352873|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352874|NCT01488045|Fentanyl|fentanyl|mesh-list
93352875|NCT01488045|Midazolam|midazolam|mesh-list
93352876|NCT01488045|Propofol|propofol|mesh-list
93352877|NCT01488045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93352878|NCT01488045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93352879|NCT01488045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352880|NCT01488045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93352881|NCT01488045|Anesthetics, General|anesthetics, general|mesh-ancestor
93352882|NCT01488045|Anesthetics|anesthetics|mesh-ancestor
93352883|NCT01488045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93352884|NCT01488045|Narcotics|narcotics|mesh-ancestor
93352885|NCT01488045|Analgesics|analgesics|mesh-ancestor
93352886|NCT01488045|Sensory System Agents|sensory system agents|mesh-ancestor
93352887|NCT01488045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352888|NCT01488045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93352889|NCT01488045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93352890|NCT01488045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93352891|NCT01488045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93352892|NCT01488045|GABA Modulators|gaba modulators|mesh-ancestor
93352893|NCT01488045|GABA Agents|gaba agents|mesh-ancestor
93352894|NCT01488045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93352895|NCT01488045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352896|NCT01404754|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93352897|NCT01404754|Hallucinogens|hallucinogens|mesh-ancestor
93352898|NCT01404754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352899|NCT01404754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93352900|NCT01404754|Serotonin Agents|serotonin agents|mesh-ancestor
93352901|NCT01404754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93352902|NCT01404754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352903|NCT01404754|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93352904|NCT01404754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93352905|NCT01404754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93352906|NCT01404754|Adrenergic Agents|adrenergic agents|mesh-ancestor
93352907|NCT01090479|Chlorhexidine|chlorhexidine|mesh-list
93352908|NCT01090479|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93352909|NCT01090479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93352910|NCT01090479|Disinfectants|disinfectants|mesh-ancestor
93352911|NCT00946712|Paclitaxel|paclitaxel|mesh-list
93352912|NCT00946712|Bevacizumab|bevacizumab|mesh-list
93352913|NCT00946712|Carboplatin|carboplatin|mesh-list
93352914|NCT00946712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93352915|NCT00946712|Cetuximab|cetuximab|mesh-list
93352916|NCT00946712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93352917|NCT00946712|Endothelial Growth Factors|endothelial growth factors|mesh-list
93352918|NCT00946712|Antibodies|antibodies|mesh-list
93352919|NCT00946712|Immunoglobulins|immunoglobulins|mesh-list
93352920|NCT00946712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352921|NCT00946712|Immunoglobulin G|immunoglobulin g|mesh-list
93352922|NCT00946712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352923|NCT00946712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352924|NCT00946712|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352925|NCT00946712|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352926|NCT00946712|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352927|NCT00946712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352928|NCT00946712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93352929|NCT00946712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93352930|NCT00946712|Growth Substances|growth substances|mesh-ancestor
93352931|NCT00946712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352932|NCT00946712|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352933|NCT00946712|Immunologic Factors|immunologic factors|mesh-ancestor
93352934|NCT00656669|Paclitaxel|paclitaxel|mesh-list
93352935|NCT00656669|Cyclophosphamide|cyclophosphamide|mesh-list
93352936|NCT00656669|Doxorubicin|doxorubicin|mesh-list
93352937|NCT00656669|Sunitinib|sunitinib|mesh-list
93352938|NCT00656669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93352939|NCT00656669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352940|NCT00656669|Tubulin Modulators|tubulin modulators|mesh-ancestor
93352941|NCT00656669|Antimitotic Agents|antimitotic agents|mesh-ancestor
93352942|NCT00656669|Mitosis Modulators|mitosis modulators|mesh-ancestor
93352943|NCT00656669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352944|NCT00656669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352945|NCT00656669|Immunologic Factors|immunologic factors|mesh-ancestor
93352946|NCT00656669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352947|NCT00656669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352948|NCT00656669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93352949|NCT00656669|Alkylating Agents|alkylating agents|mesh-ancestor
93352950|NCT00656669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93352951|NCT00656669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93352952|NCT00656669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93352953|NCT00656669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93352954|NCT00656669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352955|NCT00656669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93352956|NCT00656669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93352957|NCT00656669|Growth Substances|growth substances|mesh-ancestor
93352958|NCT00656669|Growth Inhibitors|growth inhibitors|mesh-ancestor
93352959|NCT00656669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352960|NCT00494728|Nicotine|nicotine|mesh-list
93352961|NCT00494728|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93352962|NCT00494728|Autonomic Agents|autonomic agents|mesh-ancestor
93352963|NCT00494728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93352964|NCT00494728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352965|NCT00494728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93352966|NCT00494728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93352967|NCT00494728|Cholinergic Agents|cholinergic agents|mesh-ancestor
93352968|NCT00494728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93352969|NCT00494728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352970|NCT00470704|Trastuzumab|trastuzumab|mesh-list
93352971|NCT00470704|Lapatinib|lapatinib|mesh-list
93352972|NCT00470704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93352973|NCT00470704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352974|NCT00470704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93352975|NCT00470704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93352976|NCT00470704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352977|NCT00412594|Rituximab|rituximab|mesh-list
93352978|NCT00412594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93352979|NCT00412594|Cladribine|cladribine|mesh-list
93352980|NCT00412594|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93352981|NCT00412594|Antibodies|antibodies|mesh-list
93352982|NCT00412594|Immunoglobulins|immunoglobulins|mesh-list
93352983|NCT00412594|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93352984|NCT00412594|Immunologic Factors|immunologic factors|mesh-ancestor
93352985|NCT00412594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93352986|NCT00412594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93352987|NCT00412594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93352988|NCT00412594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93352989|NCT00412594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93352990|NCT00412594|Antimetabolites|antimetabolites|mesh-ancestor
93352991|NCT00412594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93352992|NCT03829579|Esketamine|esketamine|mesh-list
93352993|NCT03829579|Antidepressive Agents|antidepressive agents|mesh-ancestor
93352994|NCT03829579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93352995|NCT04759339|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93352996|NCT04759339|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93352997|NCT01362296|Docetaxel|docetaxel|mesh-list
93352998|NCT01362296|Trametinib|trametinib|mesh-list
93352999|NCT01362296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353000|NCT01362296|Tubulin Modulators|tubulin modulators|mesh-ancestor
93353001|NCT01362296|Antimitotic Agents|antimitotic agents|mesh-ancestor
93353002|NCT01362296|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353003|NCT01362296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353004|NCT01362296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93353005|NCT01362296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353006|NCT01338415|Bosentan|bosentan|mesh-list
93353007|NCT01338415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93353008|NCT01338415|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93353009|NCT01338415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353010|NCT04353128|Melatonin|melatonin|mesh-list
93353011|NCT04353128|Antioxidants|antioxidants|mesh-ancestor
93353012|NCT04353128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353013|NCT04353128|Protective Agents|protective agents|mesh-ancestor
93353014|NCT04353128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353015|NCT04353128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353016|NCT04263350|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93353017|NCT04263350|Cobicistat|cobicistat|mesh-list
93353018|NCT04263350|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93353019|NCT04263350|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93353020|NCT04263350|Protease Inhibitors|protease inhibitors|mesh-ancestor
93353021|NCT04263350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353022|NCT04263350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353023|NCT04263350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93353024|NCT04263350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93353025|NCT04263350|Antiviral Agents|antiviral agents|mesh-ancestor
93353026|NCT04263350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353027|NCT04263350|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93353028|NCT04263350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93024897|NCT04334330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93353029|NCT03562585|Antibodies|antibodies|mesh-list
93353030|NCT03562585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93353031|NCT03562585|Immunologic Factors|immunologic factors|mesh-ancestor
93353032|NCT03562585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353033|NCT04578535|Immunoglobulins|immunoglobulins|mesh-list
93353034|NCT04578535|Immunologic Factors|immunologic factors|mesh-ancestor
93353035|NCT04578535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353036|NCT05124938|Hormones|hormones|mesh-list
93353037|NCT05124938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353038|NCT05124938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353039|NCT02259985|Itasetron|itasetron|mesh-list
93353040|NCT02259985|Antiemetics|antiemetics|mesh-ancestor
93353041|NCT02259985|Autonomic Agents|autonomic agents|mesh-ancestor
92646711|NCT04607629|Omalizumab|omalizumab|mesh-list
93353042|NCT02259985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353043|NCT02259985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353044|NCT02259985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353045|NCT02259985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93353046|NCT02259985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93353047|NCT02259985|Serotonin Agents|serotonin agents|mesh-ancestor
93353048|NCT02259985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353049|NCT02259985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353050|NCT01371643|Octreotide|octreotide|mesh-list
93353051|NCT01371643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353052|NCT01371643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93353053|NCT01371643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353054|NCT03023462|Droperidol|droperidol|mesh-list
93353055|NCT03023462|Oxycodone|oxycodone|mesh-list
93353056|NCT03023462|Ondansetron|ondansetron|mesh-list
93353057|NCT03023462|Ropivacaine|ropivacaine|mesh-list
93353058|NCT03023462|Anesthetics, Local|anesthetics, local|mesh-ancestor
93353059|NCT03023462|Anesthetics|anesthetics|mesh-ancestor
93353060|NCT03023462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353061|NCT03023462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353062|NCT03023462|Sensory System Agents|sensory system agents|mesh-ancestor
93353063|NCT03023462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353064|NCT03023462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93353065|NCT03023462|Narcotics|narcotics|mesh-ancestor
93353066|NCT03023462|Analgesics|analgesics|mesh-ancestor
93353067|NCT03023462|Antiemetics|antiemetics|mesh-ancestor
93353068|NCT03023462|Autonomic Agents|autonomic agents|mesh-ancestor
93353069|NCT03023462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353070|NCT03023462|Antipruritics|antipruritics|mesh-ancestor
93353071|NCT03023462|Dermatologic Agents|dermatologic agents|mesh-ancestor
93353072|NCT03023462|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93353073|NCT03023462|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93353074|NCT03023462|Serotonin Agents|serotonin agents|mesh-ancestor
93353075|NCT03023462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353076|NCT03023462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353077|NCT03023462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93353078|NCT03023462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93353079|NCT03023462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93353080|NCT03023462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93353081|NCT03023462|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93353082|NCT03023462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93353083|NCT03023462|Dopamine Agents|dopamine agents|mesh-ancestor
93353084|NCT02824952|Osimertinib|osimertinib|mesh-list
93353085|NCT02824952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353086|NCT02824952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93353087|NCT02824952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353088|NCT02824952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353089|NCT01371565|Mifepristone|mifepristone|mesh-list
93353090|NCT01371565|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93353091|NCT01371565|Abortifacient Agents|abortifacient agents|mesh-ancestor
93353092|NCT01371565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93353093|NCT01371565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353094|NCT01371565|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93353095|NCT01371565|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93353096|NCT01371565|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93353097|NCT01371565|Contraceptive Agents|contraceptive agents|mesh-ancestor
93353098|NCT01371565|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93353099|NCT01371565|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93353100|NCT01371565|Hormone Antagonists|hormone antagonists|mesh-ancestor
93353101|NCT01371565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353102|NCT01371565|Luteolytic Agents|luteolytic agents|mesh-ancestor
93353103|NCT01371565|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93353104|NCT01371565|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93353105|NCT02821819|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93353106|NCT02821819|Hormones|hormones|mesh-ancestor
93353107|NCT02821819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353109|NCT04500548|Nivolumab|nivolumab|mesh-list
93353110|NCT04500548|Ipilimumab|ipilimumab|mesh-list
93353111|NCT04500548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353112|NCT04500548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353113|NCT04500548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353114|NCT04500548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353115|NCT05707819|Antibodies|antibodies|mesh-list
93353116|NCT05707819|Immunologic Factors|immunologic factors|mesh-ancestor
93353117|NCT05707819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353118|NCT03034538|Zonisamide|zonisamide|mesh-list
93353119|NCT03034538|Anticonvulsants|anticonvulsants|mesh-ancestor
93353120|NCT03034538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93353121|NCT03034538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353122|NCT03034538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353123|NCT03034538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93353124|NCT03034538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353125|NCT02468180|Polidocanol|polidocanol|mesh-list
93353126|NCT02468180|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93353127|NCT02468180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93353128|NCT01836068|Enfuvirtide|enfuvirtide|mesh-list
93353129|NCT01836068|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93353130|NCT01836068|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93353131|NCT01836068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353132|NCT01836068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93353133|NCT01836068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93353134|NCT01836068|Antiviral Agents|antiviral agents|mesh-ancestor
93353135|NCT01836068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353136|NCT05053880|Pembrolizumab|pembrolizumab|mesh-list
93353137|NCT05053880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353138|NCT05053880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353139|NCT05053880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353140|NCT05053880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353141|NCT00094016|Beclomethasone|beclomethasone|mesh-list
93353142|NCT00094016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353143|NCT00094016|Glucocorticoids|glucocorticoids|mesh-ancestor
93353144|NCT00094016|Hormones|hormones|mesh-ancestor
93353145|NCT00094016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353146|NCT00094016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353147|NCT00094016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93353148|NCT00094016|Respiratory System Agents|respiratory system agents|mesh-ancestor
93353149|NCT05134298|Meropenem|meropenem|mesh-list
93353150|NCT05134298|Tazobactam|tazobactam|mesh-list
93353151|NCT05134298|Piperacillin|piperacillin|mesh-list
93353152|NCT05134298|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93353153|NCT05134298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93353154|NCT05134298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353155|NCT05134298|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93353156|NCT05134298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353157|NCT05134298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353158|NCT05134220|Calcium|calcium|mesh-list
93353159|NCT05134220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93353160|NCT05134220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353161|NCT03562507|Nivolumab|nivolumab|mesh-list
93353162|NCT03562507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353163|NCT03562507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353164|NCT03562507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353165|NCT03562507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353166|NCT03954379|Dexamethasone|dexamethasone|mesh-list
93353167|NCT03954379|Dexamethasone acetate|dexamethasone acetate|mesh-list
93353168|NCT03954379|Analgesics|analgesics|mesh-list
93353169|NCT03954379|Anesthetics|anesthetics|mesh-list
93353170|NCT03954379|Anesthetics, Local|anesthetics, local|mesh-list
93353171|NCT03954379|BB 1101|bb 1101|mesh-list
93353172|NCT03954379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353173|NCT03954379|Antiemetics|antiemetics|mesh-ancestor
93353174|NCT03954379|Autonomic Agents|autonomic agents|mesh-ancestor
93353175|NCT03954379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353176|NCT03954379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353177|NCT03954379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353178|NCT03954379|Glucocorticoids|glucocorticoids|mesh-ancestor
93353179|NCT03954379|Hormones|hormones|mesh-ancestor
93025044|NCT00321646|Docetaxel|docetaxel|mesh-list
93353180|NCT03954379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353181|NCT03954379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93353182|NCT03954379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353183|NCT03954379|Protease Inhibitors|protease inhibitors|mesh-ancestor
93353184|NCT03954379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353185|NCT03954379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353186|NCT03954379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353187|NCT03954379|Sensory System Agents|sensory system agents|mesh-ancestor
93353188|NCT02036125|Methylprednisolone|methylprednisolone|mesh-list
93353189|NCT02036125|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93353190|NCT02036125|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93353191|NCT02036125|Prednisolone|prednisolone|mesh-list
93353192|NCT02036125|Prednisolone acetate|prednisolone acetate|mesh-list
93353193|NCT02036125|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93353194|NCT02036125|Prednisolone phosphate|prednisolone phosphate|mesh-list
93353195|NCT02036125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353196|NCT02036125|Antiemetics|antiemetics|mesh-ancestor
93353197|NCT02036125|Autonomic Agents|autonomic agents|mesh-ancestor
93353198|NCT02036125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353199|NCT02036125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353200|NCT02036125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353201|NCT02036125|Glucocorticoids|glucocorticoids|mesh-ancestor
93353202|NCT02036125|Hormones|hormones|mesh-ancestor
93353203|NCT02036125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353204|NCT02036125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93353205|NCT02036125|Protective Agents|protective agents|mesh-ancestor
93353206|NCT02036125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93353207|NCT02036125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353208|NCT05133752|Nemonoxacin|nemonoxacin|mesh-list
93353209|NCT05133752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93353210|NCT05133752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353211|NCT02818777|Cannabidiol|cannabidiol|mesh-list
93353212|NCT02818777|Anticonvulsants|anticonvulsants|mesh-ancestor
93353213|NCT05128916|Terbinafine|terbinafine|mesh-list
93353214|NCT05128916|Antifungal Agents|antifungal agents|mesh-ancestor
93353215|NCT05128916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353216|NCT05128916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353217|NCT05128916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353218|NCT05133050|Ramipril|ramipril|mesh-list
93353219|NCT05133050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93353220|NCT05133050|Protease Inhibitors|protease inhibitors|mesh-ancestor
93353221|NCT05133050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353222|NCT05133050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353223|NCT05133050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93353224|NCT02817841|Drospirenone|drospirenone|mesh-list
93353225|NCT02817841|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93353226|NCT02817841|Hormone Antagonists|hormone antagonists|mesh-ancestor
93353227|NCT02817841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353228|NCT02817841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353229|NCT02817841|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93353230|NCT02817841|Diuretics|diuretics|mesh-ancestor
93353231|NCT02817841|Natriuretic Agents|natriuretic agents|mesh-ancestor
93353232|NCT05132270|Thalidomide|thalidomide|mesh-list
93353233|NCT05132270|Hydroxyurea|hydroxyurea|mesh-list
93353234|NCT05132270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93353235|NCT05132270|Immunologic Factors|immunologic factors|mesh-ancestor
93353236|NCT05132270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353237|NCT05132270|Leprostatic Agents|leprostatic agents|mesh-ancestor
93353238|NCT05132270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93353239|NCT05132270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353240|NCT05132270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93353241|NCT05132270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93353242|NCT05132270|Growth Substances|growth substances|mesh-ancestor
93353243|NCT05132270|Growth Inhibitors|growth inhibitors|mesh-ancestor
93353244|NCT05132270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353245|NCT05132270|Antisickling Agents|antisickling agents|mesh-ancestor
93353246|NCT05132270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353247|NCT05132270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353248|NCT05132270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93353249|NCT02814565|Cyclobenzaprine|cyclobenzaprine|mesh-list
93353250|NCT02814565|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93353251|NCT02814565|Antidepressive Agents|antidepressive agents|mesh-ancestor
93353252|NCT02814565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025123|NCT01009970|Hormones|hormones|mesh-ancestor
93353253|NCT02814565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93353254|NCT02814565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353255|NCT02814565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93353256|NCT02814565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353257|NCT02814565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93353258|NCT02814565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353259|NCT05121038|Leucovorin|leucovorin|mesh-list
93353260|NCT05121038|Fluorouracil|fluorouracil|mesh-list
93353261|NCT05121038|Oxaliplatin|oxaliplatin|mesh-list
93353262|NCT05121038|Irinotecan|irinotecan|mesh-list
93353263|NCT05121038|Panitumumab|panitumumab|mesh-list
93353264|NCT05121038|Folfirinox|folfirinox|mesh-list
93353265|NCT05121038|Antimetabolites|antimetabolites|mesh-ancestor
93353266|NCT05121038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353267|NCT05121038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93353268|NCT05121038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353269|NCT05121038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93353270|NCT05121038|Immunologic Factors|immunologic factors|mesh-ancestor
93353271|NCT05121038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353272|NCT05121038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93353273|NCT05121038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93353274|NCT05121038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353275|NCT05121038|Antidotes|antidotes|mesh-ancestor
93353276|NCT05121038|Protective Agents|protective agents|mesh-ancestor
93353277|NCT05121038|Vitamin B Complex|vitamin b complex|mesh-ancestor
93353278|NCT05121038|Vitamins|vitamins|mesh-ancestor
93353279|NCT05121038|Micronutrients|micronutrients|mesh-ancestor
93353280|NCT05121038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353281|NCT05097794|Indapamide|indapamide|mesh-list
93353282|NCT05097794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93353283|NCT05097794|Diuretics|diuretics|mesh-ancestor
93353284|NCT05097794|Natriuretic Agents|natriuretic agents|mesh-ancestor
93353285|NCT05097794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353286|NCT05097794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93353287|NCT05097794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353288|NCT05097794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353289|NCT02036281|Substance P|substance p|mesh-list
93353290|NCT02036281|Neurokinin A|neurokinin a|mesh-list
93353291|NCT02036281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353292|NCT02036281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353293|NCT02036281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353294|NCT02036359|Docetaxel|docetaxel|mesh-list
93353295|NCT02036359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93353296|NCT02036359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353297|NCT02036359|Tubulin Modulators|tubulin modulators|mesh-ancestor
93353298|NCT02036359|Antimitotic Agents|antimitotic agents|mesh-ancestor
93353299|NCT02036359|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353300|NCT02036359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353301|NCT02036359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93353302|NCT02036359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353303|NCT02036437|Misoprostol|misoprostol|mesh-list
93353304|NCT02036437|Dinoprostone|dinoprostone|mesh-list
93353305|NCT02036437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93353306|NCT02036437|Abortifacient Agents|abortifacient agents|mesh-ancestor
93353307|NCT02036437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93353308|NCT02036437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353309|NCT02036437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93353310|NCT02036437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353311|NCT02036437|Oxytocics|oxytocics|mesh-ancestor
93353312|NCT05027360|Nitroprusside|nitroprusside|mesh-list
93353313|NCT05027360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93353314|NCT05027360|Vasodilator Agents|vasodilator agents|mesh-ancestor
93353315|NCT05027360|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93353316|NCT05027360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353317|NCT02036983|Anesthetics|anesthetics|mesh-list
93353318|NCT02036983|Anesthetics, Local|anesthetics, local|mesh-list
93353319|NCT02036983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353320|NCT02036983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353321|NCT02036983|Sensory System Agents|sensory system agents|mesh-ancestor
93353322|NCT02036983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353323|NCT05020652|Hydroxyurea|hydroxyurea|mesh-list
93353324|NCT05020652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353325|NCT05020652|Antisickling Agents|antisickling agents|mesh-ancestor
93353326|NCT05020652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353327|NCT05020652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353328|NCT05020652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93353329|NCT05689177|Vaccines|vaccines|mesh-list
93353330|NCT05689177|Immunologic Factors|immunologic factors|mesh-ancestor
93353331|NCT05689177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353332|NCT04818320|Favipiravir|favipiravir|mesh-list
93353333|NCT04818320|Antiviral Agents|antiviral agents|mesh-ancestor
93353334|NCT04818320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353335|NCT02475135|Tenofovir|tenofovir|mesh-list
93353336|NCT02475135|Emtricitabine|emtricitabine|mesh-list
93353337|NCT02475135|Darunavir|darunavir|mesh-list
93353338|NCT02475135|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93353339|NCT02475135|Cobicistat|cobicistat|mesh-list
93353340|NCT02475135|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93353341|NCT02475135|Elvitegravir|elvitegravir|mesh-list
93353342|NCT02475135|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
93353343|NCT02475135|Antiviral Agents|antiviral agents|mesh-ancestor
93353344|NCT02475135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353345|NCT02475135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93353346|NCT02475135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93353347|NCT02475135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353348|NCT02475135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353349|NCT02475135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93353350|NCT02475135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93353351|NCT02475135|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93353352|NCT02475135|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93353353|NCT02475135|Protease Inhibitors|protease inhibitors|mesh-ancestor
93353354|NCT02475135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93353355|NCT02475135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93353356|NCT02475135|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93353357|NCT05161754|Hemostatics|hemostatics|mesh-list
93353358|NCT05161754|Coagulants|coagulants|mesh-ancestor
93353359|NCT05118620|Bupivacaine|bupivacaine|mesh-list
93353360|NCT05118620|Anesthetics, Local|anesthetics, local|mesh-ancestor
93353361|NCT05118620|Anesthetics|anesthetics|mesh-ancestor
93353362|NCT05118620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353363|NCT05118620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353364|NCT05118620|Sensory System Agents|sensory system agents|mesh-ancestor
93353365|NCT05118620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353366|NCT02814643|Benralizumab|benralizumab|mesh-list
93353367|NCT02814643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93353368|NCT02814643|Respiratory System Agents|respiratory system agents|mesh-ancestor
93353369|NCT05080790|Zoledronic Acid|zoledronic acid|mesh-list
93353370|NCT05080790|Interleukin-2|interleukin-2|mesh-list
93353371|NCT05080790|Dinutuximab|dinutuximab|mesh-list
93353372|NCT05080790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353373|NCT05080790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93353374|NCT05080790|Analgesics|analgesics|mesh-ancestor
93353375|NCT05080790|Sensory System Agents|sensory system agents|mesh-ancestor
93353376|NCT05080790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353377|NCT05080790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353378|NCT05080790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93353379|NCT02036827|Bromides|bromides|mesh-list
93353380|NCT02036827|Rocuronium|rocuronium|mesh-list
93353381|NCT02036827|Anticonvulsants|anticonvulsants|mesh-ancestor
93353382|NCT02036827|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93353383|NCT02036827|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93353384|NCT02036827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93353385|NCT02036827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353386|NCT02036827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353387|NCT02475213|Pembrolizumab|pembrolizumab|mesh-list
93353388|NCT02475213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353389|NCT02475213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353390|NCT02475213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353391|NCT02475213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353392|NCT05328440|Fulvestrant|fulvestrant|mesh-list
93353393|NCT05328440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93353394|NCT05328440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353395|NCT05328440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93353396|NCT05328440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93353397|NCT05328440|Hormone Antagonists|hormone antagonists|mesh-ancestor
93353398|NCT05328440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353399|NCT05328440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353400|NCT05256056|Bupivacaine|bupivacaine|mesh-list
93353401|NCT05256056|Anesthetics, Local|anesthetics, local|mesh-ancestor
93353402|NCT05256056|Anesthetics|anesthetics|mesh-ancestor
93353403|NCT05256056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025278|NCT00503984|Glucocorticoids|glucocorticoids|mesh-ancestor
93353404|NCT05256056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353405|NCT05256056|Sensory System Agents|sensory system agents|mesh-ancestor
93353406|NCT05256056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353407|NCT05360511|Epoetin Alfa|epoetin alfa|mesh-list
93353408|NCT05360511|Hematinics|hematinics|mesh-ancestor
93353409|NCT02724111|Rocuronium|rocuronium|mesh-list
93353410|NCT02724111|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93353411|NCT02724111|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93353412|NCT02724111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93353413|NCT02724111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353414|NCT02724111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353415|NCT02480751|Beraprost|beraprost|mesh-list
93353416|NCT02480751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93353417|NCT02480751|Vasodilator Agents|vasodilator agents|mesh-ancestor
93353418|NCT04227314|Apremilast|apremilast|mesh-list
93353419|NCT04227314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93353420|NCT04227314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93353421|NCT04227314|Analgesics|analgesics|mesh-ancestor
93353422|NCT04227314|Sensory System Agents|sensory system agents|mesh-ancestor
93353423|NCT04227314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353424|NCT04227314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353425|NCT04227314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353426|NCT04227314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93353427|NCT04227314|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93353428|NCT04227314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93353429|NCT04227314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353430|NCT04227314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353431|NCT04223648|Nivolumab|nivolumab|mesh-list
93353432|NCT04223648|Ipilimumab|ipilimumab|mesh-list
93353433|NCT04223648|Durvalumab|durvalumab|mesh-list
93353434|NCT04223648|Tremelimumab|tremelimumab|mesh-list
93353435|NCT04223648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353436|NCT04223648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353437|NCT04223648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353438|NCT04223648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353439|NCT02814175|Adalimumab|adalimumab|mesh-list
93353440|NCT02814175|Methotrexate|methotrexate|mesh-list
93353441|NCT02814175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93353442|NCT02814175|Abortifacient Agents|abortifacient agents|mesh-ancestor
93353443|NCT02814175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93353444|NCT02814175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353445|NCT02814175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93353446|NCT02814175|Antimetabolites|antimetabolites|mesh-ancestor
93353447|NCT02814175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353448|NCT02814175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353449|NCT02814175|Dermatologic Agents|dermatologic agents|mesh-ancestor
93353450|NCT02814175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353451|NCT02814175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93353452|NCT02814175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93353453|NCT02814175|Immunologic Factors|immunologic factors|mesh-ancestor
93353454|NCT02814175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93353455|NCT02814175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93353456|NCT02814175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93353457|NCT02814175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353458|NCT02475057|Hormones|hormones|mesh-list
93353459|NCT02475057|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93353460|NCT02475057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353461|NCT02475057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353462|NCT02474667|Mitogens|mitogens|mesh-list
93353463|NCT02474667|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353464|NCT02474667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353465|NCT03096080|XL647|xl647|mesh-list
93353466|NCT03096080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353467|NCT03096080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93353468|NCT03096080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353469|NCT03096080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353470|NCT01335997|Niacin|niacin|mesh-list
93353471|NCT01335997|Niacinamide|niacinamide|mesh-list
93353472|NCT01335997|Nicotinic Acids|nicotinic acids|mesh-list
93353473|NCT01335997|Simvastatin|simvastatin|mesh-list
93353474|NCT01335997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93353475|NCT01335997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93353476|NCT01335997|Antimetabolites|antimetabolites|mesh-ancestor
93353477|NCT01335997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353478|NCT01335997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93353479|NCT01335997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93353480|NCT01335997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353481|NCT01335997|Vasodilator Agents|vasodilator agents|mesh-ancestor
93353482|NCT01335997|Vitamin B Complex|vitamin b complex|mesh-ancestor
93353484|NCT01335997|Micronutrients|micronutrients|mesh-ancestor
93353485|NCT01335997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353486|NCT02048215|Ephedrine|ephedrine|mesh-list
93353487|NCT02048215|Caffeine|caffeine|mesh-list
93353488|NCT02048215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93353489|NCT02048215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353490|NCT02048215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93353491|NCT02048215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353492|NCT02048215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353493|NCT02048215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93353494|NCT02048215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93353495|NCT02048215|Purinergic Agents|purinergic agents|mesh-ancestor
93353496|NCT02048215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353497|NCT02048215|Sympathomimetics|sympathomimetics|mesh-ancestor
93353498|NCT02048215|Autonomic Agents|autonomic agents|mesh-ancestor
93353499|NCT02048215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353500|NCT02048215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93353501|NCT02048215|Adrenergic Agents|adrenergic agents|mesh-ancestor
93353502|NCT04849832|Fesoterodine|fesoterodine|mesh-list
93353503|NCT04849832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93353504|NCT04849832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93353505|NCT04849832|Cholinergic Agents|cholinergic agents|mesh-ancestor
93353506|NCT04849832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353507|NCT04849832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353508|NCT04849832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353509|NCT04849832|Urological Agents|urological agents|mesh-ancestor
93353510|NCT02048293|Remifentanil|remifentanil|mesh-list
93353511|NCT02048293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93353512|NCT02048293|Narcotics|narcotics|mesh-ancestor
93353513|NCT02048293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353514|NCT02048293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353515|NCT02048293|Analgesics|analgesics|mesh-ancestor
93353516|NCT02048293|Sensory System Agents|sensory system agents|mesh-ancestor
93353517|NCT02048293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353518|NCT02050009|Metformin|metformin|mesh-list
93353519|NCT02050009|Paclitaxel|paclitaxel|mesh-list
93353520|NCT02050009|Carboplatin|carboplatin|mesh-list
93353521|NCT02050009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93353522|NCT02050009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353523|NCT02050009|Tubulin Modulators|tubulin modulators|mesh-ancestor
93353524|NCT02050009|Antimitotic Agents|antimitotic agents|mesh-ancestor
93353525|NCT02050009|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353526|NCT02050009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353527|NCT02050009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353528|NCT02050009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353529|NCT04495088|Leucovorin|leucovorin|mesh-list
93353530|NCT04495088|Folic Acid|folic acid|mesh-list
93353531|NCT04495088|Capecitabine|capecitabine|mesh-list
93353532|NCT04495088|Fluorouracil|fluorouracil|mesh-list
93353533|NCT04495088|Oxaliplatin|oxaliplatin|mesh-list
93353534|NCT04495088|Levoleucovorin|levoleucovorin|mesh-list
93353535|NCT04495088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93353536|NCT04495088|Antimetabolites|antimetabolites|mesh-ancestor
93353537|NCT04495088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353538|NCT04495088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353539|NCT04495088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93353540|NCT04495088|Immunologic Factors|immunologic factors|mesh-ancestor
93353541|NCT04495088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353542|NCT04495088|Antidotes|antidotes|mesh-ancestor
93353543|NCT04495088|Protective Agents|protective agents|mesh-ancestor
93353544|NCT04495088|Vitamin B Complex|vitamin b complex|mesh-ancestor
93353545|NCT04495088|Vitamins|vitamins|mesh-ancestor
93353546|NCT04495088|Micronutrients|micronutrients|mesh-ancestor
93353547|NCT04495088|Hematinics|hematinics|mesh-ancestor
93353548|NCT04717154|Nivolumab|nivolumab|mesh-list
93353549|NCT04717154|Ipilimumab|ipilimumab|mesh-list
93353550|NCT04717154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353551|NCT04717154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353552|NCT04717154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353553|NCT04717154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353554|NCT02474511|Anesthetics|anesthetics|mesh-list
93353555|NCT02474511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353556|NCT02474511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353557|NCT03108963|Metformin|metformin|mesh-list
93353558|NCT03108963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353559|NCT03108963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353560|NCT04697654|Hydroxychloroquine|hydroxychloroquine|mesh-list
93353561|NCT04697654|Antimalarials|antimalarials|mesh-ancestor
93353562|NCT04697654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93353563|NCT04697654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93353564|NCT04697654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353565|NCT04697654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353566|NCT04697654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353567|NCT04697654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93353568|NCT02474433|Misoprostol|misoprostol|mesh-list
93353569|NCT02474433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93353570|NCT02474433|Abortifacient Agents|abortifacient agents|mesh-ancestor
93353571|NCT02474433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93353572|NCT02474433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353573|NCT02474433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93353574|NCT02474433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353575|NCT02474433|Oxytocics|oxytocics|mesh-ancestor
93353576|NCT04812002|Bevacizumab|bevacizumab|mesh-list
93353577|NCT04812002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93353578|NCT04812002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353579|NCT04812002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353580|NCT04812002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93353581|NCT04812002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93353582|NCT04812002|Growth Substances|growth substances|mesh-ancestor
93353583|NCT04812002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353584|NCT04812002|Growth Inhibitors|growth inhibitors|mesh-ancestor
93353585|NCT04812002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353586|NCT03424460|Hemostatics|hemostatics|mesh-list
93353587|NCT03424460|Coagulants|coagulants|mesh-ancestor
93353588|NCT05712837|Salicylic Acid|salicylic acid|mesh-list
93353589|NCT05712837|Salicylates|salicylates|mesh-list
93353590|NCT05712837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353591|NCT05712837|Antifungal Agents|antifungal agents|mesh-ancestor
93353592|NCT05712837|Keratolytic Agents|keratolytic agents|mesh-ancestor
93353593|NCT05712837|Dermatologic Agents|dermatologic agents|mesh-ancestor
93353594|NCT05712837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93353595|NCT05712837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93353596|NCT05712837|Analgesics|analgesics|mesh-ancestor
93353597|NCT05712837|Sensory System Agents|sensory system agents|mesh-ancestor
93353598|NCT05712837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353599|NCT05712837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353600|NCT05712837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353601|NCT05712837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93353602|NCT05712837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93353603|NCT05712837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353604|NCT05712837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353605|NCT02472249|Norepinephrine|norepinephrine|mesh-list
93353606|NCT02472249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93353607|NCT02472249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93353608|NCT02472249|Adrenergic Agents|adrenergic agents|mesh-ancestor
93353609|NCT02472249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353610|NCT02472249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353611|NCT02472249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353612|NCT02472249|Sympathomimetics|sympathomimetics|mesh-ancestor
93353613|NCT02472249|Autonomic Agents|autonomic agents|mesh-ancestor
93353614|NCT02472249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353615|NCT02472249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93353616|NCT02313194|Buspirone|buspirone|mesh-list
93353617|NCT02313194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93353618|NCT02313194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93353619|NCT02313194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353620|NCT02313194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353621|NCT02313194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93353622|NCT02313194|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93353623|NCT02313194|Serotonin Agents|serotonin agents|mesh-ancestor
93353624|NCT02313194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353625|NCT02313194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353626|NCT04821141|Bazedoxifene|bazedoxifene|mesh-list
93353627|NCT04821141|Estrogens|estrogens|mesh-list
93353628|NCT04821141|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93353629|NCT04821141|Hormones|hormones|mesh-ancestor
93353630|NCT04821141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353631|NCT04821141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647294|NCT00249171|Risperidone|risperidone|mesh-list
93353632|NCT04821141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93353633|NCT04821141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93353635|NCT04821141|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93353636|NCT04435652|Paclitaxel|paclitaxel|mesh-list
93353637|NCT04435652|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93353638|NCT04435652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93353639|NCT04435652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353640|NCT04435652|Tubulin Modulators|tubulin modulators|mesh-ancestor
93353641|NCT04435652|Antimitotic Agents|antimitotic agents|mesh-ancestor
93353642|NCT04435652|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353643|NCT04435652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353644|NCT02473887|Ondansetron|ondansetron|mesh-list
93353645|NCT02473887|Antiemetics|antiemetics|mesh-ancestor
93353646|NCT02473887|Autonomic Agents|autonomic agents|mesh-ancestor
93353647|NCT02473887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353648|NCT02473887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353649|NCT02473887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353650|NCT02473887|Antipruritics|antipruritics|mesh-ancestor
93353651|NCT02473887|Dermatologic Agents|dermatologic agents|mesh-ancestor
93353652|NCT02473887|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93353653|NCT02473887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93353654|NCT02473887|Serotonin Agents|serotonin agents|mesh-ancestor
93353655|NCT02473887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353656|NCT02473887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353657|NCT02478021|Hydrocortisone|hydrocortisone|mesh-list
93353658|NCT02478021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353659|NCT00071552|Fluticasone|fluticasone|mesh-list
93353660|NCT00071552|Xhance|xhance|mesh-list
93353661|NCT00071552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353662|NCT00071552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93353663|NCT00071552|Autonomic Agents|autonomic agents|mesh-ancestor
93353664|NCT00071552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353665|NCT00071552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353666|NCT00071552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93353667|NCT00071552|Respiratory System Agents|respiratory system agents|mesh-ancestor
93353668|NCT00071552|Dermatologic Agents|dermatologic agents|mesh-ancestor
93353669|NCT00071552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93353670|NCT05164263|Empagliflozin|empagliflozin|mesh-list
93353671|NCT05164263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93353672|NCT05164263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353673|NCT05164263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353674|NCT05164263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353675|NCT04767711|Prednisolone|prednisolone|mesh-list
93353676|NCT04767711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353677|NCT04767711|Glucocorticoids|glucocorticoids|mesh-ancestor
93353678|NCT04767711|Hormones|hormones|mesh-ancestor
93353679|NCT04767711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353680|NCT04767711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353681|NCT04767711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93353682|NCT04767711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353683|NCT02473809|Liraglutide|liraglutide|mesh-list
93353684|NCT02473809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353685|NCT02473809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353686|NCT02473809|Incretins|incretins|mesh-ancestor
93353687|NCT02473809|Hormones|hormones|mesh-ancestor
93353688|NCT02473809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353689|NCT03976934|Tamsulosin|tamsulosin|mesh-list
93353690|NCT03976934|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93353691|NCT03976934|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93353692|NCT03976934|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93353693|NCT03976934|Adrenergic Agents|adrenergic agents|mesh-ancestor
93353694|NCT03976934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353695|NCT03976934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353696|NCT03976934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353697|NCT03976934|Urological Agents|urological agents|mesh-ancestor
93353698|NCT02416180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93353699|NCT02416180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93353700|NCT02416180|Autonomic Agents|autonomic agents|mesh-ancestor
93353701|NCT02416180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353702|NCT02416180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353703|NCT02416180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92647359|NCT04597762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353704|NCT02416180|Respiratory System Agents|respiratory system agents|mesh-ancestor
93353705|NCT02416180|Glucocorticoids|glucocorticoids|mesh-ancestor
93353706|NCT02416180|Hormones|hormones|mesh-ancestor
93353707|NCT02416180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353708|NCT02416180|Sympathomimetics|sympathomimetics|mesh-ancestor
93353709|NCT02473575|Caffeine|caffeine|mesh-list
93353710|NCT02473575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93353711|NCT02473575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353712|NCT02473575|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93353713|NCT02473575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353714|NCT02473575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353715|NCT02473575|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93353716|NCT02473575|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93353717|NCT02473575|Purinergic Agents|purinergic agents|mesh-ancestor
93353718|NCT02473575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353719|NCT03770546|Betamethasone|betamethasone|mesh-list
93353720|NCT03770546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353721|NCT03770546|Glucocorticoids|glucocorticoids|mesh-ancestor
93353722|NCT03770546|Hormones|hormones|mesh-ancestor
93353723|NCT03770546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353724|NCT03770546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353725|NCT03770546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93353726|NCT03770546|Respiratory System Agents|respiratory system agents|mesh-ancestor
93353727|NCT05341323|Ketamine|ketamine|mesh-list
93353728|NCT05341323|Bupivacaine|bupivacaine|mesh-list
93353729|NCT05341323|Anesthetics, Local|anesthetics, local|mesh-ancestor
93353730|NCT05341323|Anesthetics|anesthetics|mesh-ancestor
93353731|NCT05341323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353732|NCT05341323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353733|NCT05341323|Sensory System Agents|sensory system agents|mesh-ancestor
93353734|NCT05341323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353735|NCT05341323|Analgesics|analgesics|mesh-ancestor
93353736|NCT05341323|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93353737|NCT05341323|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93353738|NCT05341323|Anesthetics, General|anesthetics, general|mesh-ancestor
93353739|NCT05341323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93353740|NCT05341323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93353741|NCT05341323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353742|NCT05341323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353743|NCT04622865|Quercetin|quercetin|mesh-list
93353744|NCT04622865|Antioxidants|antioxidants|mesh-ancestor
93353745|NCT04622865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353746|NCT04622865|Protective Agents|protective agents|mesh-ancestor
93353747|NCT04622865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353748|NCT02473185|Methylphenidate|methylphenidate|mesh-list
93353749|NCT02473185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93353750|NCT02473185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353751|NCT02473185|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93353752|NCT02473185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93353753|NCT02473185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353754|NCT02473185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353755|NCT02473185|Dopamine Agents|dopamine agents|mesh-ancestor
93353756|NCT02473185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353757|NCT02445586|Docetaxel|docetaxel|mesh-list
93353758|NCT02445586|Trastuzumab|trastuzumab|mesh-list
93353759|NCT02445586|Pertuzumab|pertuzumab|mesh-list
93353760|NCT02445586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353761|NCT02445586|Tubulin Modulators|tubulin modulators|mesh-ancestor
93353762|NCT02445586|Antimitotic Agents|antimitotic agents|mesh-ancestor
93353763|NCT02445586|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353764|NCT02445586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353765|NCT02445586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353766|NCT02471547|Mitomycins|mitomycins|mesh-list
93353767|NCT02471547|Mitomycin|mitomycin|mesh-list
93353768|NCT02471547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93353769|NCT02471547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353770|NCT02471547|Alkylating Agents|alkylating agents|mesh-ancestor
93353771|NCT02471547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353772|NCT02471547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93353773|NCT02471547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353774|NCT02477631|Deferiprone|deferiprone|mesh-list
93353775|NCT02477631|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93353776|NCT02477631|Chelating Agents|chelating agents|mesh-ancestor
93025653|NCT00488514|Analgesics|analgesics|mesh-ancestor
93353777|NCT02477631|Sequestering Agents|sequestering agents|mesh-ancestor
93353778|NCT02477631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353779|NCT01674062|Trastuzumab|trastuzumab|mesh-list
93353780|NCT01674062|Pertuzumab|pertuzumab|mesh-list
93353781|NCT01674062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353782|NCT01674062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353783|NCT02472873|Ethanol|ethanol|mesh-list
93353784|NCT02472873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93353785|NCT02472873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353786|NCT02472873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353787|NCT02472873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353788|NCT02472886|Sofosbuvir|sofosbuvir|mesh-list
93353789|NCT02472886|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93353790|NCT02472886|Ledipasvir|ledipasvir|mesh-list
93353791|NCT02472886|Antiviral Agents|antiviral agents|mesh-ancestor
93353792|NCT02472886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353793|NCT04570839|Nivolumab|nivolumab|mesh-list
93353794|NCT04570839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353795|NCT04570839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353796|NCT04570839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93353797|NCT04570839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353798|NCT05283356|Ticagrelor|ticagrelor|mesh-list
93353799|NCT05283356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93353800|NCT05283356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93353801|NCT05283356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93353802|NCT05283356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93353803|NCT05283356|Purinergic Agents|purinergic agents|mesh-ancestor
93353804|NCT05283356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353805|NCT05283356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353806|NCT05283356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353807|NCT02472652|Aripiprazole|aripiprazole|mesh-list
93353808|NCT02472652|Antidepressive Agents|antidepressive agents|mesh-ancestor
93353809|NCT02472652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93353810|NCT02472652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93353811|NCT02472652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93353812|NCT02472652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353813|NCT02472652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353814|NCT02472652|Dopamine Agonists|dopamine agonists|mesh-ancestor
93353815|NCT02472652|Dopamine Agents|dopamine agents|mesh-ancestor
93353816|NCT02472652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353817|NCT02472652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353818|NCT02472652|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93353819|NCT02472652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93353820|NCT02472652|Serotonin Agents|serotonin agents|mesh-ancestor
93353821|NCT02472652|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93353822|NCT02472652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93353823|NCT02472652|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93353824|NCT02472652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93353825|NCT05243186|Methylphenidate|methylphenidate|mesh-list
93353826|NCT05243186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93353827|NCT05243186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353828|NCT05243186|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93353829|NCT05243186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93353830|NCT05243186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353831|NCT05243186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353832|NCT05243186|Dopamine Agents|dopamine agents|mesh-ancestor
93353833|NCT05243186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353834|NCT02808182|Niacin|niacin|mesh-list
93353835|NCT02808182|Nicotinic Acids|nicotinic acids|mesh-list
93353836|NCT02808182|Niacinamide|niacinamide|mesh-list
93353837|NCT02808182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93353838|NCT02808182|Antimetabolites|antimetabolites|mesh-ancestor
93353839|NCT02808182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353840|NCT02808182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93353841|NCT02808182|Vasodilator Agents|vasodilator agents|mesh-ancestor
93353842|NCT02808182|Vitamin B Complex|vitamin b complex|mesh-ancestor
93353843|NCT02808182|Vitamins|vitamins|mesh-ancestor
93353844|NCT02808182|Micronutrients|micronutrients|mesh-ancestor
93353845|NCT02808182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353846|NCT04695704|Montelukast|montelukast|mesh-list
92647546|NCT00566761|Hormones|hormones|mesh-ancestor
93353847|NCT04695704|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93353848|NCT04695704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93353849|NCT04695704|Respiratory System Agents|respiratory system agents|mesh-ancestor
93353850|NCT04695704|Hormone Antagonists|hormone antagonists|mesh-ancestor
93353851|NCT04695704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353852|NCT04695704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353853|NCT04695704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93353854|NCT04695704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93353855|NCT04695704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353856|NCT02051569|Tryptophan|tryptophan|mesh-list
93353857|NCT02051569|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93353858|NCT02051569|Antidepressive Agents|antidepressive agents|mesh-ancestor
93353859|NCT02051569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93353860|NCT02591420|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93353861|NCT02591420|Antiviral Agents|antiviral agents|mesh-ancestor
93353862|NCT02591420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93353863|NCT05217758|Mifepristone|mifepristone|mesh-list
93353864|NCT05217758|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93353865|NCT05217758|Abortifacient Agents|abortifacient agents|mesh-ancestor
93353866|NCT05217758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93353867|NCT05217758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353868|NCT05217758|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93353869|NCT05217758|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93353870|NCT05217758|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93353871|NCT05217758|Contraceptive Agents|contraceptive agents|mesh-ancestor
93353872|NCT05217758|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93353873|NCT05217758|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93353874|NCT05217758|Hormone Antagonists|hormone antagonists|mesh-ancestor
93353875|NCT05217758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353876|NCT05217758|Luteolytic Agents|luteolytic agents|mesh-ancestor
93353877|NCT05217758|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93353878|NCT05217758|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93353879|NCT02051023|Fluorometholone|fluorometholone|mesh-list
93353880|NCT02051023|Lubricant Eye Drops|lubricant eye drops|mesh-list
93353881|NCT02051023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93353882|NCT02051023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93353883|NCT02051023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353884|NCT02051023|Glucocorticoids|glucocorticoids|mesh-ancestor
93353885|NCT02051023|Hormones|hormones|mesh-ancestor
93353886|NCT02051023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353887|NCT02051023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353888|NCT02051023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93353889|NCT02415556|Insulin|insulin|mesh-list
93353890|NCT02415556|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93353891|NCT02415556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353892|NCT02415556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353893|NCT05192798|Paclitaxel|paclitaxel|mesh-list
93353894|NCT05192798|Bevacizumab|bevacizumab|mesh-list
93353895|NCT05192798|Apatinib|apatinib|mesh-list
93353896|NCT05192798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93353897|NCT05192798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93353898|NCT05192798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353899|NCT05192798|Tubulin Modulators|tubulin modulators|mesh-ancestor
93353900|NCT05192798|Antimitotic Agents|antimitotic agents|mesh-ancestor
93353901|NCT05192798|Mitosis Modulators|mitosis modulators|mesh-ancestor
93353902|NCT05192798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353903|NCT05192798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93353904|NCT05192798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93353905|NCT05192798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93353906|NCT05192798|Growth Substances|growth substances|mesh-ancestor
93353907|NCT05192798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353908|NCT05192798|Growth Inhibitors|growth inhibitors|mesh-ancestor
93353909|NCT05192798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93353910|NCT05192798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353911|NCT02048683|Sevoflurane|sevoflurane|mesh-list
93353912|NCT02048683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93353913|NCT02048683|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93353914|NCT02048683|Anesthetics, General|anesthetics, general|mesh-ancestor
93353915|NCT02048683|Anesthetics|anesthetics|mesh-ancestor
93353916|NCT02048683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93353917|NCT02048683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353918|NCT03108807|Fibrin fragment D|fibrin fragment d|mesh-list
93353919|NCT03108807|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93353920|NCT03108807|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93353921|NCT03108807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353922|NCT03108807|Hemostatics|hemostatics|mesh-ancestor
93353923|NCT03108807|Coagulants|coagulants|mesh-ancestor
93353924|NCT02048761|Metformin|metformin|mesh-list
93353925|NCT02048761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353926|NCT02048761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353927|NCT03108729|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
93353928|NCT03108729|Anticonvulsants|anticonvulsants|mesh-ancestor
93353929|NCT03108729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93353930|NCT03108729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93353931|NCT03108729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353932|NCT03108729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353933|NCT02048917|Bupropion|bupropion|mesh-list
93353934|NCT02048917|Varenicline|varenicline|mesh-list
93353935|NCT02048917|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93353936|NCT02048917|Antidepressive Agents|antidepressive agents|mesh-ancestor
93353937|NCT02048917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93353938|NCT02048917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93353939|NCT02048917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93353940|NCT02048917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353941|NCT02048917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353942|NCT02048917|Dopamine Agents|dopamine agents|mesh-ancestor
93353943|NCT02048917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353944|NCT02048917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353945|NCT02048917|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93353946|NCT02048917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93353947|NCT02048917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353948|NCT02048917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93353949|NCT02048917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93353950|NCT02048917|Cholinergic Agents|cholinergic agents|mesh-ancestor
93353951|NCT02472717|Liraglutide|liraglutide|mesh-list
93353952|NCT02472717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93353953|NCT02472717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353954|NCT02472717|Incretins|incretins|mesh-ancestor
93353955|NCT02472717|Hormones|hormones|mesh-ancestor
93353956|NCT02472717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353957|NCT02049073|Methylprednisolone|methylprednisolone|mesh-list
93353958|NCT02049073|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93353959|NCT02049073|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93353960|NCT02049073|Prednisolone|prednisolone|mesh-list
93353961|NCT02049073|Prednisolone acetate|prednisolone acetate|mesh-list
93353962|NCT02049073|Zonisamide|zonisamide|mesh-list
93353963|NCT02049073|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93353964|NCT02049073|Prednisolone phosphate|prednisolone phosphate|mesh-list
93353965|NCT02049073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93353966|NCT02049073|Antiemetics|antiemetics|mesh-ancestor
93353967|NCT02049073|Autonomic Agents|autonomic agents|mesh-ancestor
93353968|NCT02049073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93353969|NCT02049073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353970|NCT02049073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93353971|NCT02049073|Glucocorticoids|glucocorticoids|mesh-ancestor
93353972|NCT02049073|Hormones|hormones|mesh-ancestor
93353973|NCT02049073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93353974|NCT02049073|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93353975|NCT02049073|Protective Agents|protective agents|mesh-ancestor
93353976|NCT02049073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93353977|NCT02049073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353978|NCT02049073|Anticonvulsants|anticonvulsants|mesh-ancestor
92647657|NCT04484363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353979|NCT02049073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93353980|NCT02049073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93353981|NCT02049073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353982|NCT02049073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93353983|NCT04518345|Azacitidine|azacitidine|mesh-list
93353984|NCT04518345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93353985|NCT04518345|Antimetabolites|antimetabolites|mesh-ancestor
93353986|NCT04518345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353987|NCT04518345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93353988|NCT04518345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93353989|NCT02260063|Epinastine|epinastine|mesh-list
93353990|NCT02260063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93353991|NCT02260063|Histamine Antagonists|histamine antagonists|mesh-ancestor
93353992|NCT02260063|Histamine Agents|histamine agents|mesh-ancestor
93353993|NCT02260063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93353994|NCT02260063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93353995|NCT02260063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93353996|NCT04398914|Paclitaxel|paclitaxel|mesh-list
93353997|NCT04398914|Trastuzumab|trastuzumab|mesh-list
93353998|NCT04398914|Pertuzumab|pertuzumab|mesh-list
93353999|NCT04398914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93354000|NCT04398914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354001|NCT04398914|Tubulin Modulators|tubulin modulators|mesh-ancestor
93354002|NCT04398914|Antimitotic Agents|antimitotic agents|mesh-ancestor
93354003|NCT04398914|Mitosis Modulators|mitosis modulators|mesh-ancestor
93354004|NCT04398914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354005|NCT04398914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354006|NCT03561649|Adalimumab|adalimumab|mesh-list
93354007|NCT03561649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93354008|NCT03561649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354009|NCT03561649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354010|NCT02807623|Ibuprofen|ibuprofen|mesh-list
93354011|NCT02807623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93354012|NCT02807623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354013|NCT02807623|Analgesics|analgesics|mesh-ancestor
93354014|NCT02807623|Sensory System Agents|sensory system agents|mesh-ancestor
93354015|NCT02807623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354016|NCT02807623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354017|NCT02807623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354018|NCT02807623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354019|NCT02807623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93354020|NCT02807623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354021|NCT02807623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354022|NCT05137964|Vitamin D|vitamin d|mesh-list
93354023|NCT05137964|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93354024|NCT05137964|Vitamins|vitamins|mesh-ancestor
93354025|NCT05137964|Micronutrients|micronutrients|mesh-ancestor
93354026|NCT05137964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354027|NCT05137964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93354028|NCT04374578|Dulaglutide|dulaglutide|mesh-list
93354029|NCT04374578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93354030|NCT04374578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354031|NCT02470923|Nicotine|nicotine|mesh-list
93354032|NCT02470923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93354033|NCT02470923|Autonomic Agents|autonomic agents|mesh-ancestor
93354034|NCT02470923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354035|NCT02470923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354036|NCT02470923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93354037|NCT02470923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93354038|NCT02470923|Cholinergic Agents|cholinergic agents|mesh-ancestor
93354039|NCT02470923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354040|NCT02470923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354041|NCT02049229|Everolimus|everolimus|mesh-list
93354042|NCT02049229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93354043|NCT02049229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93354044|NCT02049229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354045|NCT02049229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354046|NCT02049229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93354047|NCT02049229|Immunologic Factors|immunologic factors|mesh-ancestor
93354048|NCT02049229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354049|NCT02049229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354050|NCT02805907|Calcifediol|calcifediol|mesh-list
93354051|NCT02805907|Vitamins|vitamins|mesh-ancestor
93354052|NCT02805907|Micronutrients|micronutrients|mesh-ancestor
93354053|NCT02805907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354054|NCT02805907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93354055|NCT02477397|Fluticasone|fluticasone|mesh-list
93354057|NCT02477397|Budesonide|budesonide|mesh-list
93354058|NCT02477397|Formoterol Fumarate|formoterol fumarate|mesh-list
93354059|NCT02477397|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93354060|NCT02477397|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93354061|NCT02477397|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93354062|NCT02477397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354063|NCT02477397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93354064|NCT02477397|Autonomic Agents|autonomic agents|mesh-ancestor
93354065|NCT02477397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354066|NCT02477397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354067|NCT02477397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93354068|NCT02477397|Respiratory System Agents|respiratory system agents|mesh-ancestor
93354069|NCT02477397|Dermatologic Agents|dermatologic agents|mesh-ancestor
93354070|NCT02477397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93354071|NCT02477397|Glucocorticoids|glucocorticoids|mesh-ancestor
93354072|NCT02477397|Hormones|hormones|mesh-ancestor
93354073|NCT02477397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354074|NCT02477397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93354076|NCT02477397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93354077|NCT02477397|Adrenergic Agents|adrenergic agents|mesh-ancestor
93354078|NCT02477397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354079|NCT02477397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354080|NCT02477397|Sympathomimetics|sympathomimetics|mesh-ancestor
93354081|NCT02051413|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93354082|NCT02051413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93354083|NCT02051413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93354084|NCT02051413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354085|NCT02051413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354086|NCT02051413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354087|NCT02051413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354088|NCT02051413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93354089|NCT02051413|Antidepressive Agents|antidepressive agents|mesh-ancestor
93354090|NCT02051413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93354091|NCT02470767|Anticoagulants|anticoagulants|mesh-list
93354092|NCT02049541|Rituximab|rituximab|mesh-list
93354093|NCT02049541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354094|NCT02049541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354095|NCT02049541|Immunologic Factors|immunologic factors|mesh-ancestor
93354096|NCT02049541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354097|NCT02049541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354098|NCT02470611|Alendronate|alendronate|mesh-list
93354099|NCT02470611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93354100|NCT02470611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354101|NCT05305898|Metformin|metformin|mesh-list
93354102|NCT05305898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93354103|NCT05305898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354104|NCT05580861|Sulfasalazine|sulfasalazine|mesh-list
93354105|NCT05580861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354106|NCT05580861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93354107|NCT05580861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354108|NCT05580861|Analgesics|analgesics|mesh-ancestor
93354109|NCT05580861|Sensory System Agents|sensory system agents|mesh-ancestor
93354110|NCT05580861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354111|NCT05580861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354112|NCT05580861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354113|NCT05580861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354114|NCT05580861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354115|NCT02469831|Rocuronium|rocuronium|mesh-list
93354116|NCT02469831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93354117|NCT02469831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93354118|NCT02469831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93354119|NCT02469831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354120|NCT02469831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354121|NCT02995005|Tenofovir|tenofovir|mesh-list
93354122|NCT02995005|Antiviral Agents|antiviral agents|mesh-ancestor
93354123|NCT02995005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354124|NCT02995005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93354125|NCT02995005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93354126|NCT02995005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354127|NCT02995005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354128|NCT02995005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93354129|NCT02995005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93354130|NCT03561415|Posaconazole|posaconazole|mesh-list
93354131|NCT03561415|Antifungal Agents|antifungal agents|mesh-ancestor
93354132|NCT03561415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354133|NCT03561415|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93354134|NCT03561415|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93354135|NCT03561415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93354136|NCT03561415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93354137|NCT03561415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93354138|NCT03561415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354139|NCT03561415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354140|NCT03561415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93354141|NCT03561415|Hormone Antagonists|hormone antagonists|mesh-ancestor
93354142|NCT03561415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354143|NCT03561415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354144|NCT02477007|Acetaminophen|acetaminophen|mesh-list
93354145|NCT02477007|Ibuprofen|ibuprofen|mesh-list
93354146|NCT02477007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93354148|NCT02477007|Analgesics|analgesics|mesh-ancestor
93354149|NCT02477007|Sensory System Agents|sensory system agents|mesh-ancestor
93354150|NCT02477007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354151|NCT02477007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354152|NCT02477007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354153|NCT02477007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354154|NCT02477007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93354155|NCT02477007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354156|NCT02477007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354157|NCT02477007|Antipyretics|antipyretics|mesh-ancestor
93354158|NCT02052973|Propolis|propolis|mesh-list
93354159|NCT02052973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354160|NCT04347434|Atorvastatin|atorvastatin|mesh-list
93354161|NCT04347434|Ezetimibe|ezetimibe|mesh-list
93354162|NCT04347434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93354163|NCT04347434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93354164|NCT04347434|Antimetabolites|antimetabolites|mesh-ancestor
93354165|NCT04347434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354166|NCT04347434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93354167|NCT04347434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93354168|NCT04347434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354169|NCT02053519|Vitamin D|vitamin d|mesh-list
93354170|NCT02053519|Cholecalciferol|cholecalciferol|mesh-list
93354171|NCT02053519|Vitamins|vitamins|mesh-ancestor
93354172|NCT02053519|Micronutrients|micronutrients|mesh-ancestor
93354173|NCT02053519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354174|NCT02053519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93354175|NCT02053519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93354176|NCT02053597|Paclitaxel|paclitaxel|mesh-list
93354177|NCT02053597|Doxorubicin|doxorubicin|mesh-list
93354178|NCT02053597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93354179|NCT02053597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354180|NCT02053597|Tubulin Modulators|tubulin modulators|mesh-ancestor
93354181|NCT02053597|Antimitotic Agents|antimitotic agents|mesh-ancestor
93354182|NCT02053597|Mitosis Modulators|mitosis modulators|mesh-ancestor
93354183|NCT02053597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354184|NCT02053597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93354185|NCT02053597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93354186|NCT02053597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93354187|NCT02053597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354188|NCT02801617|Latanoprost|latanoprost|mesh-list
93354189|NCT02801617|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93354190|NCT02801617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93354191|NCT02056249|Norepinephrine|norepinephrine|mesh-list
93354192|NCT02056249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93354193|NCT02056249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93354194|NCT02056249|Adrenergic Agents|adrenergic agents|mesh-ancestor
93354195|NCT02056249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354196|NCT02056249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354197|NCT02056249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354198|NCT02056249|Sympathomimetics|sympathomimetics|mesh-ancestor
93354199|NCT02056249|Autonomic Agents|autonomic agents|mesh-ancestor
93354200|NCT02056249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354201|NCT02056249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93354202|NCT04140968|Progesterone|progesterone|mesh-list
93354203|NCT04140968|Progestins|progestins|mesh-ancestor
93354204|NCT04140968|Hormones|hormones|mesh-ancestor
93354205|NCT04140968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354206|NCT04140968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354207|NCT04383938|Pembrolizumab|pembrolizumab|mesh-list
93354208|NCT04383938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354209|NCT04383938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354210|NCT04383938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93354211|NCT04383938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354212|NCT01334515|Isotretinoin|isotretinoin|mesh-list
93354213|NCT01334515|Sargramostim|sargramostim|mesh-list
93354214|NCT01334515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354215|NCT01334515|Immunologic Factors|immunologic factors|mesh-ancestor
93354216|NCT01334515|Dermatologic Agents|dermatologic agents|mesh-ancestor
93354217|NCT02415400|Aspirin|aspirin|mesh-list
93354218|NCT02415400|Vitamin K|vitamin k|mesh-list
93354219|NCT02415400|Apixaban|apixaban|mesh-list
93354220|NCT02415400|Vitamins|vitamins|mesh-ancestor
93354221|NCT02415400|Micronutrients|micronutrients|mesh-ancestor
93354222|NCT02415400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354223|NCT02415400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93354224|NCT02415400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354226|NCT02415400|Sensory System Agents|sensory system agents|mesh-ancestor
93354227|NCT02415400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354228|NCT02415400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354229|NCT02415400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354230|NCT02415400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93354231|NCT02415400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93354232|NCT02415400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354233|NCT02415400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93354234|NCT02415400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93354235|NCT02415400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354236|NCT02415400|Antipyretics|antipyretics|mesh-ancestor
93354237|NCT02415400|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93354238|NCT02415400|Antithrombins|antithrombins|mesh-ancestor
93354239|NCT02415400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93354240|NCT02415400|Protease Inhibitors|protease inhibitors|mesh-ancestor
93354241|NCT02415400|Anticoagulants|anticoagulants|mesh-ancestor
93354242|NCT02415400|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93354243|NCT02415400|Hemostatics|hemostatics|mesh-ancestor
93354244|NCT02415400|Coagulants|coagulants|mesh-ancestor
93354245|NCT02053675|Vasopressins|vasopressins|mesh-list
93354246|NCT02053675|Arginine Vasopressin|arginine vasopressin|mesh-list
93354247|NCT02053675|Hemostatics|hemostatics|mesh-ancestor
93354248|NCT02053675|Coagulants|coagulants|mesh-ancestor
93354249|NCT02053675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93354250|NCT02053675|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93354251|NCT02053675|Natriuretic Agents|natriuretic agents|mesh-ancestor
93354252|NCT02053675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354253|NCT02037997|Docetaxel|docetaxel|mesh-list
93354254|NCT02037997|Pemetrexed|pemetrexed|mesh-list
93354255|NCT02037997|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93354256|NCT02037997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354257|NCT02037997|Tubulin Modulators|tubulin modulators|mesh-ancestor
93354258|NCT02037997|Antimitotic Agents|antimitotic agents|mesh-ancestor
93354259|NCT02037997|Mitosis Modulators|mitosis modulators|mesh-ancestor
93354260|NCT02037997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354261|NCT02037997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354262|NCT02037997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93354263|NCT02037997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93354264|NCT02037997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93354265|NCT02056405|Mosapride|mosapride|mesh-list
93354266|NCT02056405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354267|NCT02056405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93354268|NCT02056405|Serotonin Agents|serotonin agents|mesh-ancestor
93354269|NCT02056405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354270|NCT02056405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354271|NCT02056405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354272|NCT02056717|Dexamethasone|dexamethasone|mesh-list
93354273|NCT02056717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354274|NCT02056717|Antiemetics|antiemetics|mesh-ancestor
93354275|NCT02056717|Autonomic Agents|autonomic agents|mesh-ancestor
93354276|NCT02056717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354277|NCT02056717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354278|NCT02056717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354279|NCT02056717|Glucocorticoids|glucocorticoids|mesh-ancestor
93354280|NCT02056717|Hormones|hormones|mesh-ancestor
93354281|NCT02056717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354282|NCT02056717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93354283|NCT02056717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354284|NCT04194801|Fisogatinib|fisogatinib|mesh-list
93354285|NCT04194801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354286|NCT02802865|Letrozole|letrozole|mesh-list
93354287|NCT02802865|Clomiphene|clomiphene|mesh-list
93354288|NCT02802865|Enclomiphene|enclomiphene|mesh-list
93354289|NCT02802865|Zuclomiphene|zuclomiphene|mesh-list
93354290|NCT02802865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354291|NCT02802865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354292|NCT02802865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93354293|NCT02802865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93354294|NCT02802865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354295|NCT02802865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93354296|NCT02802865|Hormone Antagonists|hormone antagonists|mesh-ancestor
93354297|NCT02802865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354298|NCT02802865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354299|NCT02802865|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93354300|NCT02802865|Fertility Agents|fertility agents|mesh-ancestor
93354301|NCT02802865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93354302|NCT02802865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93354303|NCT02802865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93354304|NCT02414932|Midazolam|midazolam|mesh-list
93354305|NCT02414932|Ketamine|ketamine|mesh-list
93354306|NCT02414932|Analgesics|analgesics|mesh-ancestor
93354307|NCT02414932|Sensory System Agents|sensory system agents|mesh-ancestor
93354308|NCT02414932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354309|NCT02414932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354310|NCT02414932|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93354311|NCT02414932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93354312|NCT02414932|Anesthetics, General|anesthetics, general|mesh-ancestor
93354313|NCT02414932|Anesthetics|anesthetics|mesh-ancestor
93354314|NCT02414932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354315|NCT02414932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93354316|NCT02414932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93354317|NCT02414932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354318|NCT02414932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354319|NCT02414932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93354320|NCT02414932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93354321|NCT02414932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93354322|NCT02414932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93354323|NCT02414932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93354324|NCT02414932|GABA Modulators|gaba modulators|mesh-ancestor
93354325|NCT02414932|GABA Agents|gaba agents|mesh-ancestor
93354326|NCT02476929|Nitrous Oxide|nitrous oxide|mesh-list
93354327|NCT02476929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93354328|NCT02476929|Anesthetics, General|anesthetics, general|mesh-ancestor
93354329|NCT02476929|Anesthetics|anesthetics|mesh-ancestor
93354330|NCT02476929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354331|NCT02476929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354332|NCT02476929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354333|NCT02476929|Analgesics|analgesics|mesh-ancestor
93354334|NCT02476929|Sensory System Agents|sensory system agents|mesh-ancestor
93354335|NCT02476929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354336|NCT02726997|Paclitaxel|paclitaxel|mesh-list
93354337|NCT02726997|Carboplatin|carboplatin|mesh-list
93354338|NCT02726997|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93354339|NCT02726997|Durvalumab|durvalumab|mesh-list
93354340|NCT02726997|Immunoglobulins|immunoglobulins|mesh-list
93354341|NCT02726997|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93354342|NCT02726997|Immunoglobulin G|immunoglobulin g|mesh-list
93354343|NCT02726997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93354344|NCT02726997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354345|NCT02726997|Tubulin Modulators|tubulin modulators|mesh-ancestor
93354346|NCT02726997|Antimitotic Agents|antimitotic agents|mesh-ancestor
93354347|NCT02726997|Mitosis Modulators|mitosis modulators|mesh-ancestor
93354348|NCT02726997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354349|NCT02726997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354350|NCT02726997|Immunologic Factors|immunologic factors|mesh-ancestor
93354351|NCT02726997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354352|NCT02054143|Sevoflurane|sevoflurane|mesh-list
93354353|NCT02054143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93354354|NCT02054143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93354355|NCT02054143|Anesthetics, General|anesthetics, general|mesh-ancestor
93354356|NCT02054143|Anesthetics|anesthetics|mesh-ancestor
93354357|NCT02054143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354358|NCT02054143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354359|NCT02058667|Paclitaxel|paclitaxel|mesh-list
93354360|NCT02058667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93354361|NCT02058667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354362|NCT02058667|Tubulin Modulators|tubulin modulators|mesh-ancestor
93354363|NCT02058667|Antimitotic Agents|antimitotic agents|mesh-ancestor
93354364|NCT02058667|Mitosis Modulators|mitosis modulators|mesh-ancestor
93354365|NCT02058667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354366|NCT02470455|Atorvastatin|atorvastatin|mesh-list
93354367|NCT02470455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93354368|NCT02470455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93354369|NCT02470455|Antimetabolites|antimetabolites|mesh-ancestor
93354370|NCT02470455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354371|NCT02470455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93354372|NCT02470455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93354373|NCT02470455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354374|NCT02057263|Alendronate|alendronate|mesh-list
93354375|NCT02057263|Diphosphonates|diphosphonates|mesh-list
93354376|NCT02057263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93354377|NCT02057263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354378|NCT05550909|Artesunate|artesunate|mesh-list
93354379|NCT05550909|Lumefantrine|lumefantrine|mesh-list
93354380|NCT05550909|Artemether|artemether|mesh-list
93354381|NCT05550909|Primaquine|primaquine|mesh-list
93354382|NCT05550909|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93354383|NCT05550909|Amodiaquine|amodiaquine|mesh-list
93354384|NCT05550909|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
93354385|NCT05550909|Antimalarials|antimalarials|mesh-ancestor
93354386|NCT05550909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93354387|NCT05550909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93354388|NCT05550909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354389|NCT05550909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354390|NCT05550909|Antiviral Agents|antiviral agents|mesh-ancestor
93354391|NCT05550909|Schistosomicides|schistosomicides|mesh-ancestor
93354392|NCT05550909|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93354393|NCT05550909|Anthelmintics|anthelmintics|mesh-ancestor
93354394|NCT02054299|Thiamine|thiamine|mesh-list
93354395|NCT02054299|Proguanil|proguanil|mesh-list
93354396|NCT02054299|Sumatriptan|sumatriptan|mesh-list
93354397|NCT02054299|Amitriptyline|amitriptyline|mesh-list
93354398|NCT02054299|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93354399|NCT02054299|Fenoterol|fenoterol|mesh-list
93354400|NCT02054299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93354401|NCT02054299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93354402|NCT02054299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93354403|NCT02054299|Serotonin Agents|serotonin agents|mesh-ancestor
93354404|NCT02054299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354405|NCT02054299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354406|NCT02054299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354407|NCT02054299|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93354408|NCT02054299|Antidepressive Agents|antidepressive agents|mesh-ancestor
93354409|NCT02054299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93354410|NCT02054299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354411|NCT02054299|Analgesics|analgesics|mesh-ancestor
93354412|NCT02054299|Sensory System Agents|sensory system agents|mesh-ancestor
93354413|NCT02054299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354414|NCT02054299|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93354415|NCT02054299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93354416|NCT02054299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354417|NCT02054299|Adrenergic Agents|adrenergic agents|mesh-ancestor
93354418|NCT02054299|Vitamin B Complex|vitamin b complex|mesh-ancestor
93354419|NCT02054299|Vitamins|vitamins|mesh-ancestor
93354420|NCT02054299|Micronutrients|micronutrients|mesh-ancestor
93354421|NCT02054299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93354422|NCT02054299|Antimalarials|antimalarials|mesh-ancestor
93354423|NCT02054299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93354424|NCT02054299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93354425|NCT02054299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354426|NCT02054299|Antimetabolites|antimetabolites|mesh-ancestor
93354427|NCT02054299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93354428|NCT02054299|Autonomic Agents|autonomic agents|mesh-ancestor
93354429|NCT02054299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93354430|NCT02054299|Respiratory System Agents|respiratory system agents|mesh-ancestor
93354431|NCT02054299|Sympathomimetics|sympathomimetics|mesh-ancestor
93354432|NCT02054299|Tocolytic Agents|tocolytic agents|mesh-ancestor
93354433|NCT02054299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93354434|NCT02054299|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93354435|NCT02054299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93354436|NCT02054299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93354437|NCT02058823|Amlodipine|amlodipine|mesh-list
93354438|NCT02058823|Valsartan|valsartan|mesh-list
93354439|NCT02058823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93354440|NCT02058823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93354441|NCT02058823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354442|NCT02058823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354443|NCT02058823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93354444|NCT02058823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354445|NCT02058823|Vasodilator Agents|vasodilator agents|mesh-ancestor
93354446|NCT02058823|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93354447|NCT02058823|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93354448|NCT00704535|Ezetimibe|ezetimibe|mesh-list
93354449|NCT00704535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93354450|NCT00704535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93354451|NCT00704535|Antimetabolites|antimetabolites|mesh-ancestor
93354452|NCT00704535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354453|NCT00704535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93354454|NCT02058901|Sunitinib|sunitinib|mesh-list
93354455|NCT02058901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354456|NCT02058901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93354457|NCT02058901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93354458|NCT02058901|Growth Substances|growth substances|mesh-ancestor
93354459|NCT02058901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354460|NCT02058901|Growth Inhibitors|growth inhibitors|mesh-ancestor
93354461|NCT02058901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93354462|NCT02058901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354463|NCT02058901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354464|NCT01955499|Lenalidomide|lenalidomide|mesh-list
93354465|NCT01955499|Immunologic Factors|immunologic factors|mesh-ancestor
93354466|NCT01955499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354467|NCT01955499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93354468|NCT01955499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93354469|NCT01955499|Growth Substances|growth substances|mesh-ancestor
93354470|NCT01955499|Growth Inhibitors|growth inhibitors|mesh-ancestor
93354471|NCT01955499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354472|NCT02058979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93354473|NCT02058979|Cefazolin|cefazolin|mesh-list
93354474|NCT02058979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354475|NCT02057887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93354476|NCT02057887|Antiviral Agents|antiviral agents|mesh-ancestor
93354477|NCT02057887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354478|NCT03893955|Paclitaxel|paclitaxel|mesh-list
93354479|NCT03893955|Carboplatin|carboplatin|mesh-list
93354480|NCT03893955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93354481|NCT03893955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354482|NCT03893955|Tubulin Modulators|tubulin modulators|mesh-ancestor
93354483|NCT03893955|Antimitotic Agents|antimitotic agents|mesh-ancestor
93354484|NCT03893955|Mitosis Modulators|mitosis modulators|mesh-ancestor
93354485|NCT03893955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354486|NCT02648204|Dulaglutide|dulaglutide|mesh-list
93354487|NCT02648204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93354488|NCT02648204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354489|NCT03310749|Metformin|metformin|mesh-list
93354490|NCT03310749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93354491|NCT03310749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354492|NCT01217931|Bevacizumab|bevacizumab|mesh-list
93354493|NCT01217931|Everolimus|everolimus|mesh-list
93354494|NCT01217931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354495|NCT01217931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354496|NCT01217931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93354497|NCT01217931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93354498|NCT01217931|Growth Substances|growth substances|mesh-ancestor
93354499|NCT01217931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354500|NCT01217931|Growth Inhibitors|growth inhibitors|mesh-ancestor
93354501|NCT01217931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93354502|NCT01217931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93354503|NCT01217931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354504|NCT01217931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354505|NCT01217931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93354506|NCT01217931|Immunologic Factors|immunologic factors|mesh-ancestor
93354507|NCT05291325|Linaclotide|linaclotide|mesh-list
93354508|NCT05291325|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93354509|NCT05291325|Enzyme Activators|enzyme activators|mesh-ancestor
93354510|NCT05291325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354511|NCT05291325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354512|NCT03310593|Cannabidiol|cannabidiol|mesh-list
93354513|NCT03310593|Anticonvulsants|anticonvulsants|mesh-ancestor
93354514|NCT05304338|Chlorhexidine|chlorhexidine|mesh-list
93354515|NCT05304338|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93354516|NCT05304338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354517|NCT05304338|Disinfectants|disinfectants|mesh-ancestor
93354518|NCT02058199|Rivaroxaban|rivaroxaban|mesh-list
93354519|NCT02058199|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93354520|NCT02058199|Antithrombins|antithrombins|mesh-ancestor
93354521|NCT02058199|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93354522|NCT02058199|Protease Inhibitors|protease inhibitors|mesh-ancestor
93354523|NCT02058199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354524|NCT02058199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354525|NCT02058199|Anticoagulants|anticoagulants|mesh-ancestor
93354526|NCT02058277|Aprepitant|aprepitant|mesh-list
93354527|NCT02058277|Antiemetics|antiemetics|mesh-ancestor
93354528|NCT02058277|Autonomic Agents|autonomic agents|mesh-ancestor
93354529|NCT02058277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354530|NCT02058277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354531|NCT02058277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354532|NCT02058277|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93354533|NCT02058277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354534|NCT02058277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354535|NCT04813562|Vaccines|vaccines|mesh-list
93354536|NCT04813562|Immunologic Factors|immunologic factors|mesh-ancestor
93354537|NCT04813562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354538|NCT03314025|Tamsulosin|tamsulosin|mesh-list
93354539|NCT03314025|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93354540|NCT03314025|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93354541|NCT03314025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93354542|NCT03314025|Adrenergic Agents|adrenergic agents|mesh-ancestor
93354543|NCT03314025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354544|NCT03314025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354545|NCT03314025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354546|NCT03314025|Urological Agents|urological agents|mesh-ancestor
93354547|NCT02055079|Sirolimus|sirolimus|mesh-list
93354548|NCT02055079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93354549|NCT02055079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354550|NCT02055079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93354551|NCT02055079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354552|NCT02055079|Antifungal Agents|antifungal agents|mesh-ancestor
93354553|NCT02055079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93354554|NCT02055079|Immunologic Factors|immunologic factors|mesh-ancestor
93354555|NCT02055079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354556|NCT02470065|Afatinib|afatinib|mesh-list
93354557|NCT02470065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354558|NCT02470065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93354559|NCT02470065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354560|NCT02470065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354561|NCT03313869|Vitamin E|vitamin e|mesh-list
93354562|NCT03313869|Selenium|selenium|mesh-list
93354563|NCT03313869|Vitamins|vitamins|mesh-ancestor
93354564|NCT03313869|Micronutrients|micronutrients|mesh-ancestor
93354565|NCT03313869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354566|NCT03313869|Antioxidants|antioxidants|mesh-ancestor
93354567|NCT03313869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354568|NCT03313869|Protective Agents|protective agents|mesh-ancestor
93354569|NCT03313869|Trace Elements|trace elements|mesh-ancestor
93354570|NCT00705159|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93354571|NCT00705159|Tobramycin|tobramycin|mesh-list
93354572|NCT00705159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93354573|NCT00705159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354574|NCT00705159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93354575|NCT01673984|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93354576|NCT01673984|Goserelin|goserelin|mesh-list
93354577|NCT01673984|Luteolytic Agents|luteolytic agents|mesh-ancestor
93354578|NCT01673984|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93354579|NCT01673984|Contraceptive Agents|contraceptive agents|mesh-ancestor
93354580|NCT01673984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93354581|NCT01673984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354582|NCT01673984|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93354583|NCT01673984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93354584|NCT01673984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354585|NCT03313791|Caseins|caseins|mesh-list
93354586|NCT03313791|Chelating Agents|chelating agents|mesh-ancestor
93354587|NCT03313791|Sequestering Agents|sequestering agents|mesh-ancestor
93354588|NCT03313791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354589|NCT03310047|Lidocaine|lidocaine|mesh-list
93354590|NCT03310047|Anesthetics, Local|anesthetics, local|mesh-ancestor
93354591|NCT03310047|Anesthetics|anesthetics|mesh-ancestor
93354592|NCT03310047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354593|NCT03310047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354594|NCT03310047|Sensory System Agents|sensory system agents|mesh-ancestor
93354595|NCT03310047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354596|NCT03310047|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93354597|NCT03310047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93354598|NCT03310047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93354599|NCT03310047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354600|NCT03310047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354601|NCT03313557|Adavosertib|adavosertib|mesh-list
93354602|NCT03313557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354603|NCT03313557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354604|NCT04103216|Nitazoxanide|nitazoxanide|mesh-list
93354605|NCT04103216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93354606|NCT04103216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354607|NCT03313479|Dexmedetomidine|dexmedetomidine|mesh-list
93354608|NCT03313479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93354609|NCT03313479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354610|NCT03313479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354611|NCT03313479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354612|NCT03313479|Analgesics|analgesics|mesh-ancestor
93354613|NCT03313479|Sensory System Agents|sensory system agents|mesh-ancestor
93354614|NCT03313479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354615|NCT03313479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93354616|NCT03313479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93354617|NCT03313479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93354618|NCT03313479|Adrenergic Agents|adrenergic agents|mesh-ancestor
93354619|NCT03313479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354620|NCT03313479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354621|NCT04079738|Ixazomib|ixazomib|mesh-list
93354622|NCT04079738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354623|NCT04079738|Protease Inhibitors|protease inhibitors|mesh-ancestor
93354624|NCT04079738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354625|NCT04079738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354626|NCT03313401|Aflibercept|aflibercept|mesh-list
93354627|NCT03313401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93354628|NCT03313401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93354629|NCT03313401|Growth Substances|growth substances|mesh-ancestor
93354630|NCT03313401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354631|NCT03313401|Growth Inhibitors|growth inhibitors|mesh-ancestor
93354632|NCT03313401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354633|NCT05278065|Nicotine|nicotine|mesh-list
93354634|NCT05278065|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93354635|NCT05278065|Autonomic Agents|autonomic agents|mesh-ancestor
93354636|NCT05278065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354637|NCT05278065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354638|NCT05278065|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93354639|NCT05278065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93354640|NCT05278065|Cholinergic Agents|cholinergic agents|mesh-ancestor
93354641|NCT05278065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354642|NCT05278065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354643|NCT03313323|Ipilimumab|ipilimumab|mesh-list
93354644|NCT03313323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354645|NCT03313323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354646|NCT03313323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93354647|NCT03313323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354648|NCT05302232|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93354649|NCT05302232|Methylprednisolone|methylprednisolone|mesh-list
93354650|NCT05302232|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93354651|NCT05302232|Prednisolone|prednisolone|mesh-list
93354652|NCT05302232|Prednisolone acetate|prednisolone acetate|mesh-list
93354653|NCT05302232|Lidocaine|lidocaine|mesh-list
93354654|NCT05302232|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93354655|NCT05302232|Prednisolone phosphate|prednisolone phosphate|mesh-list
93354656|NCT05302232|Anesthetics, Local|anesthetics, local|mesh-ancestor
93354657|NCT05302232|Anesthetics|anesthetics|mesh-ancestor
93354658|NCT05302232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354659|NCT05302232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354660|NCT05302232|Sensory System Agents|sensory system agents|mesh-ancestor
93354661|NCT05302232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354662|NCT05302232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93354663|NCT05302232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93354664|NCT05302232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93354665|NCT05302232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354666|NCT05302232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354667|NCT05302232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354668|NCT05302232|Antiemetics|antiemetics|mesh-ancestor
93354669|NCT05302232|Autonomic Agents|autonomic agents|mesh-ancestor
93354670|NCT05302232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354671|NCT05302232|Glucocorticoids|glucocorticoids|mesh-ancestor
93354672|NCT05302232|Hormones|hormones|mesh-ancestor
93354673|NCT05302232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354674|NCT05302232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93026554|NCT01041729|Antimetabolites|antimetabolites|mesh-ancestor
93354676|NCT05302232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93354677|NCT05302232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354678|NCT02468661|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93354679|NCT02468661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354680|NCT02468661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93354681|NCT02468661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354682|NCT02468661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354683|NCT03304431|Lidocaine|lidocaine|mesh-list
93354684|NCT03304431|Anesthetics, Local|anesthetics, local|mesh-ancestor
93354685|NCT03304431|Anesthetics|anesthetics|mesh-ancestor
93354686|NCT03304431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354687|NCT03304431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354688|NCT03304431|Sensory System Agents|sensory system agents|mesh-ancestor
93354689|NCT03304431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354690|NCT03304431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93354691|NCT03304431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93354692|NCT03304431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93354693|NCT03304431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354694|NCT03304431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354695|NCT04741334|Anticoagulants|anticoagulants|mesh-list
93354696|NCT04741334|Dicumarol|dicumarol|mesh-list
93354697|NCT04741334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93354698|NCT04741334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354699|NCT04741334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354700|NCT04741334|Uncoupling Agents|uncoupling agents|mesh-ancestor
93354701|NCT03309735|Progesterone|progesterone|mesh-list
93354702|NCT03309735|Dydrogesterone|dydrogesterone|mesh-list
93354703|NCT03309735|Progestins|progestins|mesh-ancestor
93354704|NCT03309735|Hormones|hormones|mesh-ancestor
93354705|NCT03309735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354706|NCT03309735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354707|NCT04266938|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93354708|NCT04266938|Antiviral Agents|antiviral agents|mesh-ancestor
93354709|NCT04266938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354710|NCT02926586|Cytarabine|cytarabine|mesh-list
93354711|NCT02926586|Fludarabine|fludarabine|mesh-list
93354712|NCT02926586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354713|NCT02926586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93354714|NCT02926586|Antimetabolites|antimetabolites|mesh-ancestor
93354715|NCT02926586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354716|NCT02926586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93354717|NCT02926586|Immunologic Factors|immunologic factors|mesh-ancestor
93354718|NCT02926586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354719|NCT02926586|Antiviral Agents|antiviral agents|mesh-ancestor
93354720|NCT02926586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354721|NCT04490967|Salicylic Acid|salicylic acid|mesh-list
93354722|NCT04490967|Salicylates|salicylates|mesh-list
93354723|NCT04490967|Silybin|silybin|mesh-list
93354724|NCT04490967|Silymarin|silymarin|mesh-list
93354725|NCT04490967|Antioxidants|antioxidants|mesh-ancestor
93354726|NCT04490967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354727|NCT04490967|Protective Agents|protective agents|mesh-ancestor
93354728|NCT04490967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354729|NCT04490967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354730|NCT04490967|Antifungal Agents|antifungal agents|mesh-ancestor
93354731|NCT04490967|Keratolytic Agents|keratolytic agents|mesh-ancestor
93354732|NCT04490967|Dermatologic Agents|dermatologic agents|mesh-ancestor
93354733|NCT04490967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93354734|NCT04490967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93354735|NCT04490967|Analgesics|analgesics|mesh-ancestor
93354736|NCT04490967|Sensory System Agents|sensory system agents|mesh-ancestor
93354737|NCT04490967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354738|NCT04490967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93354739|NCT04490967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354740|NCT04490967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93354741|NCT04490967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354742|NCT04490967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93354743|NCT04490967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354744|NCT03312855|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93354745|NCT03312855|Immunologic Factors|immunologic factors|mesh-ancestor
93354746|NCT03312855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354747|NCT03312777|Tramadol|tramadol|mesh-list
93354748|NCT03312777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93354749|NCT03312777|Narcotics|narcotics|mesh-ancestor
93354750|NCT03312777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354751|NCT03312777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354753|NCT03312777|Sensory System Agents|sensory system agents|mesh-ancestor
93354754|NCT03312777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354755|NCT02332928|Melatonin|melatonin|mesh-list
93354756|NCT02332928|Antioxidants|antioxidants|mesh-ancestor
93354757|NCT02332928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354758|NCT02332928|Protective Agents|protective agents|mesh-ancestor
93354759|NCT02332928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354760|NCT02332928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354761|NCT03738878|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93354762|NCT03738878|Valsartan|valsartan|mesh-list
93354763|NCT03738878|Bradykinin|bradykinin|mesh-list
93354764|NCT03738878|Kininogens|kininogens|mesh-list
93354765|NCT03738878|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93354766|NCT03738878|Substance P|substance p|mesh-list
93354767|NCT03738878|Neurokinin A|neurokinin a|mesh-list
93354768|NCT03738878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93354769|NCT03738878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354770|NCT03738878|Incretins|incretins|mesh-ancestor
93354771|NCT03738878|Hormones|hormones|mesh-ancestor
91933009|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
93354772|NCT03738878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354773|NCT03738878|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93354774|NCT03738878|Protease Inhibitors|protease inhibitors|mesh-ancestor
93354775|NCT03738878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354776|NCT03738878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354777|NCT03738878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93354778|NCT03738878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93354779|NCT03738878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93354780|NCT03738878|Vasodilator Agents|vasodilator agents|mesh-ancestor
93354781|NCT03738878|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93354782|NCT03738878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354783|NCT04682834|Probenecid|probenecid|mesh-list
93354784|NCT04682834|Uricosuric Agents|uricosuric agents|mesh-ancestor
93354785|NCT04682834|Gout Suppressants|gout suppressants|mesh-ancestor
93354786|NCT04682834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354787|NCT00703677|Lithium Carbonate|lithium carbonate|mesh-list
93354788|NCT00703677|Antidepressive Agents|antidepressive agents|mesh-ancestor
93354789|NCT00703677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93354790|NCT00703677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354791|NCT00703677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354792|NCT00703677|Antimanic Agents|antimanic agents|mesh-ancestor
93354793|NCT00703677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93354794|NCT00703677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354795|NCT00703677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354796|NCT05426252|Sirolimus|sirolimus|mesh-list
93354797|NCT05426252|Abatacept|abatacept|mesh-list
93354798|NCT05426252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93354799|NCT05426252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354800|NCT05426252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93354801|NCT05426252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354802|NCT05426252|Antifungal Agents|antifungal agents|mesh-ancestor
93354803|NCT05426252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93354804|NCT05426252|Immunologic Factors|immunologic factors|mesh-ancestor
93354805|NCT05426252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354806|NCT05426252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354807|NCT05426252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93354808|NCT05426252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354809|NCT05426252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93354810|NCT01506986|Metronidazole|metronidazole|mesh-list
93354811|NCT01506986|Clarithromycin|clarithromycin|mesh-list
93354812|NCT01506986|Lansoprazole|lansoprazole|mesh-list
93354813|NCT01506986|Dexlansoprazole|dexlansoprazole|mesh-list
93354814|NCT01506986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354815|NCT01506986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93354816|NCT01506986|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93354817|NCT01506986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93354818|NCT01506986|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93354819|NCT01506986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354820|NCT01506986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354821|NCT01506986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93354822|NCT01506986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93354823|NCT01506986|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93354824|NCT01506986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93354825|NCT01506986|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93354826|NCT02714894|Clozapine|clozapine|mesh-list
93354827|NCT02714894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93354828|NCT02714894|Serotonin Agents|serotonin agents|mesh-ancestor
93354829|NCT02714894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354830|NCT02714894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354831|NCT02714894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354832|NCT02714894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93354833|NCT02714894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93354834|NCT02714894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354835|NCT02714894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93354836|NCT02714894|GABA Antagonists|gaba antagonists|mesh-ancestor
93354837|NCT02714894|GABA Agents|gaba agents|mesh-ancestor
93354838|NCT03303651|Analgesics, Opioid|analgesics, opioid|mesh-list
93354839|NCT03303651|Narcotics|narcotics|mesh-ancestor
93354840|NCT03303651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354841|NCT03303651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354842|NCT03303651|Analgesics|analgesics|mesh-ancestor
93354843|NCT03303651|Sensory System Agents|sensory system agents|mesh-ancestor
93354844|NCT03303651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354845|NCT03312153|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93354847|NCT03312153|Disinfectants|disinfectants|mesh-ancestor
93354848|NCT03312153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354849|NCT03303573|Epoetin Alfa|epoetin alfa|mesh-list
93354850|NCT03303573|Hematinics|hematinics|mesh-ancestor
93354851|NCT03303495|Leucovorin|leucovorin|mesh-list
93354852|NCT03303495|Bevacizumab|bevacizumab|mesh-list
93354853|NCT03303495|Fluorouracil|fluorouracil|mesh-list
93354854|NCT03303495|Irinotecan|irinotecan|mesh-list
93354855|NCT03303495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93354856|NCT03303495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93354857|NCT03303495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93354858|NCT03303495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93354859|NCT03303495|Growth Substances|growth substances|mesh-ancestor
93354860|NCT03303495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354861|NCT03303495|Growth Inhibitors|growth inhibitors|mesh-ancestor
93354862|NCT03303495|Antimetabolites|antimetabolites|mesh-ancestor
93354863|NCT03303495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354864|NCT03303495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93354865|NCT03303495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93354866|NCT03303495|Immunologic Factors|immunologic factors|mesh-ancestor
93354867|NCT03303495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93354868|NCT03303495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93354869|NCT03303495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354870|NCT03303495|Antidotes|antidotes|mesh-ancestor
93354871|NCT03303495|Protective Agents|protective agents|mesh-ancestor
93354872|NCT03303495|Vitamin B Complex|vitamin b complex|mesh-ancestor
93354873|NCT03303495|Vitamins|vitamins|mesh-ancestor
93354874|NCT03303495|Micronutrients|micronutrients|mesh-ancestor
93354875|NCT03308955|Tramadol|tramadol|mesh-list
93354876|NCT03308955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93354877|NCT03308955|Narcotics|narcotics|mesh-ancestor
93354878|NCT03308955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354879|NCT03308955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354880|NCT03308955|Analgesics|analgesics|mesh-ancestor
93354881|NCT03308955|Sensory System Agents|sensory system agents|mesh-ancestor
93354882|NCT03308955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354883|NCT03311607|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93354884|NCT03311607|Antifungal Agents|antifungal agents|mesh-ancestor
93354885|NCT03311607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354886|NCT03311607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93354887|NCT03311607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93354888|NCT03308643|Oxytocin|oxytocin|mesh-list
93354889|NCT03308643|Oxytocics|oxytocics|mesh-ancestor
93354890|NCT03308643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93354891|NCT03308643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354892|NCT03302871|Botulinum Toxins|botulinum toxins|mesh-list
93354893|NCT03302871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93026776|NCT03926754|Mirabegron|mirabegron|mesh-list
93354894|NCT03302871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93354895|NCT03302871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93354896|NCT03302871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354897|NCT03302871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354898|NCT03302871|Cholinergic Agents|cholinergic agents|mesh-ancestor
93354899|NCT03302871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354900|NCT03302871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354901|NCT03302871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93354902|NCT03302871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354903|NCT03311139|Fibrinolytic Agents|fibrinolytic agents|mesh-list
93354904|NCT03311139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93354905|NCT03311139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354906|NCT03308487|Vitamin D|vitamin d|mesh-list
93354907|NCT03308487|Ergocalciferols|ergocalciferols|mesh-list
93354908|NCT03308487|Cholecalciferol|cholecalciferol|mesh-list
93354909|NCT03308487|Vitamins|vitamins|mesh-list
93354910|NCT03308487|Micronutrients|micronutrients|mesh-ancestor
93354911|NCT03308487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354912|NCT03308487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93354913|NCT03308487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93354914|NCT03308331|Nicotine|nicotine|mesh-list
93354915|NCT03308331|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93354916|NCT03308331|Autonomic Agents|autonomic agents|mesh-ancestor
93354917|NCT03308331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354918|NCT03308331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354919|NCT03308331|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93354920|NCT03308331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93354921|NCT03308331|Cholinergic Agents|cholinergic agents|mesh-ancestor
93354922|NCT03308331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354923|NCT03308331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354924|NCT02414854|Albuterol|albuterol|mesh-list
93354925|NCT02414854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93354926|NCT02414854|Autonomic Agents|autonomic agents|mesh-ancestor
93354927|NCT02414854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354928|NCT02414854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354929|NCT02414854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93354930|NCT02414854|Respiratory System Agents|respiratory system agents|mesh-ancestor
93354931|NCT02414854|Tocolytic Agents|tocolytic agents|mesh-ancestor
93354932|NCT02414854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93354933|NCT02414854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93354934|NCT02414854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93354935|NCT02414854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93354936|NCT02414854|Adrenergic Agents|adrenergic agents|mesh-ancestor
93354937|NCT02414854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354938|NCT02414854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354939|NCT03308253|Vancomycin|vancomycin|mesh-list
93354940|NCT03308253|Tobramycin|tobramycin|mesh-list
93354941|NCT03308253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93354942|NCT03308253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354943|NCT02467023|Lidocaine|lidocaine|mesh-list
93354944|NCT02467023|Fentanyl|fentanyl|mesh-list
93354945|NCT02467023|Midazolam|midazolam|mesh-list
93354946|NCT02467023|Anesthetics, Local|anesthetics, local|mesh-ancestor
93354947|NCT02467023|Anesthetics|anesthetics|mesh-ancestor
93354948|NCT02467023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93354949|NCT02467023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354950|NCT02467023|Sensory System Agents|sensory system agents|mesh-ancestor
93354951|NCT02467023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93354952|NCT02467023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93354953|NCT02467023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93354954|NCT02467023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93354955|NCT02467023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93354956|NCT02467023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354957|NCT02467023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93354958|NCT02467023|Narcotics|narcotics|mesh-ancestor
93354959|NCT02467023|Analgesics|analgesics|mesh-ancestor
93354960|NCT02467023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93354961|NCT02467023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93354962|NCT02467023|Anesthetics, General|anesthetics, general|mesh-ancestor
93354963|NCT02467023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93354964|NCT02467023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93354965|NCT02467023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93354966|NCT02467023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93354967|NCT02467023|GABA Modulators|gaba modulators|mesh-ancestor
93354968|NCT02467023|GABA Agents|gaba agents|mesh-ancestor
93354969|NCT02467023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354970|NCT02055703|Itraconazole|itraconazole|mesh-list
93354971|NCT02055703|Rifampin|rifampin|mesh-list
93354972|NCT02055703|Digoxin|digoxin|mesh-list
93354973|NCT02055703|Donepezil|donepezil|mesh-list
93354974|NCT02055703|Antifungal Agents|antifungal agents|mesh-ancestor
93354975|NCT02055703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93354976|NCT02055703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93354977|NCT02055703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93354978|NCT02055703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93354979|NCT02055703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93354980|NCT02055703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93354981|NCT02055703|Hormone Antagonists|hormone antagonists|mesh-ancestor
93354982|NCT02055703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93354983|NCT02055703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93354984|NCT02055703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93354985|NCT02055703|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93354986|NCT02055703|Cholinergic Agents|cholinergic agents|mesh-ancestor
93354987|NCT02055703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93354988|NCT02055703|Nootropic Agents|nootropic agents|mesh-ancestor
93354989|NCT02055703|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93354990|NCT02055703|Antitubercular Agents|antitubercular agents|mesh-ancestor
93354991|NCT02055703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93354992|NCT02055703|Leprostatic Agents|leprostatic agents|mesh-ancestor
93354993|NCT02055703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93354994|NCT02055703|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93354995|NCT02055703|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93354996|NCT02055703|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93354997|NCT02055703|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93354998|NCT02055703|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93354999|NCT02055703|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93355000|NCT02055703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93355001|NCT02055703|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93355002|NCT02055703|Protective Agents|protective agents|mesh-ancestor
93355003|NCT02058433|Paclitaxel|paclitaxel|mesh-list
93355004|NCT02058433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93355005|NCT02058433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93355006|NCT02058433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355007|NCT02058433|Tubulin Modulators|tubulin modulators|mesh-ancestor
93355008|NCT02058433|Antimitotic Agents|antimitotic agents|mesh-ancestor
93355009|NCT02058433|Mitosis Modulators|mitosis modulators|mesh-ancestor
93355010|NCT02058433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355011|NCT03561181|Vaccines|vaccines|mesh-list
93355012|NCT03561181|Immunologic Factors|immunologic factors|mesh-ancestor
93355013|NCT03561181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355014|NCT02060149|Minocycline|minocycline|mesh-list
93355015|NCT02060149|Sulbactam|sulbactam|mesh-list
93355016|NCT02060149|Cefoperazone|cefoperazone|mesh-list
93355017|NCT02060149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93355018|NCT02060149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93355019|NCT02060149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355020|NCT02060149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93355021|NCT02060149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355022|NCT02060149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355023|NCT03302403|Cyclophosphamide|cyclophosphamide|mesh-list
93355024|NCT03302403|Fludarabine|fludarabine|mesh-list
93355025|NCT03302403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355026|NCT03302403|Immunologic Factors|immunologic factors|mesh-ancestor
93355027|NCT03302403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355028|NCT03302403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355029|NCT03302403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93355030|NCT03302403|Alkylating Agents|alkylating agents|mesh-ancestor
93355031|NCT03302403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355032|NCT03302403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355033|NCT03302403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93355034|NCT02038621|Paclitaxel|paclitaxel|mesh-list
93355035|NCT02038621|Capecitabine|capecitabine|mesh-list
93355036|NCT02038621|Oxaliplatin|oxaliplatin|mesh-list
93355037|NCT02038621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93355038|NCT02038621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355039|NCT02038621|Tubulin Modulators|tubulin modulators|mesh-ancestor
93355040|NCT02038621|Antimitotic Agents|antimitotic agents|mesh-ancestor
93355041|NCT02038621|Mitosis Modulators|mitosis modulators|mesh-ancestor
93355042|NCT02038621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355043|NCT02038621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355044|NCT02038621|Antimetabolites|antimetabolites|mesh-ancestor
93355045|NCT03332498|Pembrolizumab|pembrolizumab|mesh-list
93355046|NCT03332498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355047|NCT03332498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355048|NCT03332498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93355049|NCT03332498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355050|NCT05727969|Dexmedetomidine|dexmedetomidine|mesh-list
93355051|NCT05727969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93355052|NCT05727969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355053|NCT05727969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355054|NCT05727969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355055|NCT05727969|Analgesics|analgesics|mesh-ancestor
93355056|NCT05727969|Sensory System Agents|sensory system agents|mesh-ancestor
93355057|NCT05727969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355058|NCT05727969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93355059|NCT05727969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93355060|NCT05727969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93355061|NCT05727969|Adrenergic Agents|adrenergic agents|mesh-ancestor
93355062|NCT05727969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355063|NCT05727969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355064|NCT01334125|Metformin|metformin|mesh-list
93355065|NCT01334125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355066|NCT01334125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355067|NCT02414152|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93355068|NCT02414152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355069|NCT01333501|Interferons|interferons|mesh-list
93355070|NCT01333501|Interferon-beta|interferon-beta|mesh-list
93355071|NCT01333501|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93355072|NCT01333501|Interferon beta-1b|interferon beta-1b|mesh-list
93355073|NCT01333501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355074|NCT01333501|Antiviral Agents|antiviral agents|mesh-ancestor
93355075|NCT01333501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355076|NCT01333501|Immunologic Factors|immunologic factors|mesh-ancestor
93355077|NCT01333501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355078|NCT01333501|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93355079|NCT01333501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355080|NCT01333501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355081|NCT01333501|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93355082|NCT01362140|Darbepoetin alfa|darbepoetin alfa|mesh-list
93355083|NCT01362140|Hematinics|hematinics|mesh-ancestor
93355084|NCT03307941|Fluorouracil|fluorouracil|mesh-list
93355085|NCT03307941|Oxaliplatin|oxaliplatin|mesh-list
93355086|NCT03307941|Antimetabolites|antimetabolites|mesh-ancestor
93355087|NCT03307941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355088|NCT03307941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355089|NCT03307941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355090|NCT03307941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355091|NCT03307941|Immunologic Factors|immunologic factors|mesh-ancestor
93355092|NCT03307941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355093|NCT03307863|Topiramate|topiramate|mesh-list
93355094|NCT03307863|Carbamazepine|carbamazepine|mesh-list
93355095|NCT03307863|Anticonvulsants|anticonvulsants|mesh-ancestor
93355096|NCT03307863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355097|NCT03307863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355098|NCT03307863|Antimanic Agents|antimanic agents|mesh-ancestor
93355099|NCT03307863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93355100|NCT03307863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355101|NCT03307863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93355102|NCT03307863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355103|NCT03307863|Analgesics|analgesics|mesh-ancestor
93355104|NCT03307863|Sensory System Agents|sensory system agents|mesh-ancestor
93355105|NCT03307863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355106|NCT03307863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93355107|NCT03307863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93355108|NCT03307863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355109|NCT03307863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93355110|NCT03307863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93355111|NCT04656470|Dexmedetomidine|dexmedetomidine|mesh-list
93355112|NCT04656470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93355113|NCT04656470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355114|NCT04656470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355115|NCT04656470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355116|NCT04656470|Analgesics|analgesics|mesh-ancestor
93355117|NCT04656470|Sensory System Agents|sensory system agents|mesh-ancestor
93355118|NCT04656470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355119|NCT04656470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93355120|NCT04656470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93355121|NCT04656470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93355122|NCT04656470|Adrenergic Agents|adrenergic agents|mesh-ancestor
93355123|NCT04656470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026999|NCT00944957|Efavirenz|efavirenz|mesh-list
93355124|NCT04656470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355125|NCT05391074|Vitamins|vitamins|mesh-list
93355126|NCT05391074|Micronutrients|micronutrients|mesh-ancestor
93355127|NCT05391074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355128|NCT05373212|Insulin Lispro|insulin lispro|mesh-list
93355129|NCT05373212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355130|NCT05373212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355131|NCT02467647|Thalidomide|thalidomide|mesh-list
93355132|NCT02467647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355133|NCT02467647|Immunologic Factors|immunologic factors|mesh-ancestor
93355134|NCT02467647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355135|NCT02467647|Leprostatic Agents|leprostatic agents|mesh-ancestor
93355136|NCT02467647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93355137|NCT02467647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355138|NCT02467647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93355139|NCT02467647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93355140|NCT02467647|Growth Substances|growth substances|mesh-ancestor
93355141|NCT02467647|Growth Inhibitors|growth inhibitors|mesh-ancestor
93355142|NCT02467647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355143|NCT03263936|Cytarabine|cytarabine|mesh-list
93355144|NCT03263936|Fludarabine|fludarabine|mesh-list
93355145|NCT03263936|Decitabine|decitabine|mesh-list
93355146|NCT03263936|Vorinostat|vorinostat|mesh-list
93355147|NCT03263936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355148|NCT03263936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355149|NCT03263936|Antimetabolites|antimetabolites|mesh-ancestor
93355150|NCT03263936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355151|NCT03263936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355152|NCT03263936|Immunologic Factors|immunologic factors|mesh-ancestor
93355153|NCT03263936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355154|NCT03263936|Antiviral Agents|antiviral agents|mesh-ancestor
93355155|NCT03263936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355156|NCT03263936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355157|NCT03263936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93355158|NCT03307551|Propofol|propofol|mesh-list
93355159|NCT03307551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93355160|NCT03307551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355161|NCT03307551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355162|NCT03307551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93355163|NCT03307551|Anesthetics, General|anesthetics, general|mesh-ancestor
93355164|NCT03307551|Anesthetics|anesthetics|mesh-ancestor
93355165|NCT02060305|Bevacizumab|bevacizumab|mesh-list
93355166|NCT02060305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355167|NCT02060305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355168|NCT02060305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93355169|NCT02060305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93355170|NCT02060305|Growth Substances|growth substances|mesh-ancestor
93355171|NCT02060305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355172|NCT02060305|Growth Inhibitors|growth inhibitors|mesh-ancestor
93355173|NCT03561025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93355174|NCT03561025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93355175|NCT03561025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355176|NCT02059759|Aldesleukin|aldesleukin|mesh-list
93355177|NCT02059759|Interleukin-2|interleukin-2|mesh-list
93355178|NCT02059759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355179|NCT02059759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355180|NCT02059759|Analgesics|analgesics|mesh-ancestor
93355181|NCT02059759|Sensory System Agents|sensory system agents|mesh-ancestor
93355182|NCT02059759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355183|NCT02059759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355184|NCT02059759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93355185|NCT02059759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93355186|NCT02059759|Antiviral Agents|antiviral agents|mesh-ancestor
93355187|NCT02059759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355188|NCT03103022|Acetaminophen|acetaminophen|mesh-list
93355189|NCT03103022|Ibuprofen|ibuprofen|mesh-list
93355190|NCT03103022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355191|NCT03103022|Analgesics|analgesics|mesh-ancestor
93355192|NCT03103022|Sensory System Agents|sensory system agents|mesh-ancestor
93355193|NCT03103022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355194|NCT03103022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355195|NCT03103022|Antipyretics|antipyretics|mesh-ancestor
93355196|NCT03103022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93355197|NCT03103022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355198|NCT03103022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355199|NCT03103022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93355200|NCT03103022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355201|NCT03103022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355202|NCT00702507|Miconazole|miconazole|mesh-list
93355203|NCT00702507|Clotrimazole|clotrimazole|mesh-list
93355204|NCT00702507|Antifungal Agents|antifungal agents|mesh-ancestor
93355205|NCT00702507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355206|NCT00702507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93355207|NCT00702507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93355208|NCT00702507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355209|NCT00702507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355210|NCT00702507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93355211|NCT00702507|Hormone Antagonists|hormone antagonists|mesh-ancestor
93355212|NCT00702507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355213|NCT00702507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355214|NCT00702507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93355215|NCT00702507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93355216|NCT00702507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93355217|NCT03324932|Denosumab|denosumab|mesh-list
93355218|NCT03324932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93355219|NCT03324932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355220|NCT03301233|Sildenafil Citrate|sildenafil citrate|mesh-list
93355221|NCT03301233|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93355222|NCT03301233|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93355223|NCT03301233|Estradiol|estradiol|mesh-list
93355224|NCT03301233|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93355225|NCT03301233|Estrogens|estrogens|mesh-ancestor
93355226|NCT03301233|Hormones|hormones|mesh-ancestor
93355227|NCT03301233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355228|NCT03301233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355229|NCT03301233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93355230|NCT03301233|Contraceptive Agents|contraceptive agents|mesh-ancestor
93355231|NCT03301233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93355232|NCT03301233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93355233|NCT03301233|Vasodilator Agents|vasodilator agents|mesh-ancestor
93355234|NCT03301233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93355235|NCT03301233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93355236|NCT03301233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355237|NCT03301233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355238|NCT03301233|Urological Agents|urological agents|mesh-ancestor
93355239|NCT02581748|Trastuzumab|trastuzumab|mesh-list
93355240|NCT02581748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355241|NCT02581748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355242|NCT01003028|Remifentanil|remifentanil|mesh-list
93355243|NCT01003028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93355244|NCT01003028|Narcotics|narcotics|mesh-ancestor
93355245|NCT01003028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355246|NCT01003028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355247|NCT01003028|Analgesics|analgesics|mesh-ancestor
93355248|NCT01003028|Sensory System Agents|sensory system agents|mesh-ancestor
93355249|NCT01003028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355250|NCT03113942|Thalidomide|thalidomide|mesh-list
93355251|NCT03113942|Pomalidomide|pomalidomide|mesh-list
93355252|NCT03113942|Immunologic Factors|immunologic factors|mesh-ancestor
93355253|NCT03113942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355254|NCT03113942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93355255|NCT03113942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93355256|NCT03113942|Growth Substances|growth substances|mesh-ancestor
93355257|NCT03113942|Growth Inhibitors|growth inhibitors|mesh-ancestor
93355258|NCT03113942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355259|NCT03113942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355260|NCT03113942|Leprostatic Agents|leprostatic agents|mesh-ancestor
93355261|NCT03113942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93355262|NCT03113942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355263|NCT04786340|Pirenzepine|pirenzepine|mesh-list
93355264|NCT04786340|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93355265|NCT04786340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93355266|NCT04786340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93355267|NCT04786340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93355268|NCT04786340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355269|NCT04786340|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355270|NCT04786340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355271|NCT04786340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355272|NCT04786340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355273|NCT03104270|Dexamethasone|dexamethasone|mesh-list
93027151|NCT00300274|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93355275|NCT03104270|Elotuzumab|elotuzumab|mesh-list
93355276|NCT03104270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355277|NCT03104270|Antiemetics|antiemetics|mesh-ancestor
93355278|NCT03104270|Autonomic Agents|autonomic agents|mesh-ancestor
93355279|NCT03104270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355280|NCT03104270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355281|NCT03104270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93355282|NCT03104270|Glucocorticoids|glucocorticoids|mesh-ancestor
93355283|NCT03104270|Hormones|hormones|mesh-ancestor
93355284|NCT03104270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355285|NCT03104270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93355286|NCT03104270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355287|NCT03104270|Immunologic Factors|immunologic factors|mesh-ancestor
93355288|NCT03104270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93355289|NCT03104270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93355290|NCT03104270|Growth Substances|growth substances|mesh-ancestor
93355291|NCT03104270|Growth Inhibitors|growth inhibitors|mesh-ancestor
93355292|NCT03300765|Apatinib|apatinib|mesh-list
93355293|NCT03300765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355294|NCT03300765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93355295|NCT03300765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355296|NCT03300765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355297|NCT04064918|Timolol|timolol|mesh-list
93355298|NCT04064918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355299|NCT04064918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93355300|NCT04064918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93355301|NCT04064918|Adrenergic Agents|adrenergic agents|mesh-ancestor
93355302|NCT04064918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355303|NCT04064918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355304|NCT04064918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93355305|NCT04064918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93355306|NCT02467946|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93355307|NCT02467946|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93355308|NCT02467946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93355309|NCT02467946|Alkylating Agents|alkylating agents|mesh-ancestor
93355310|NCT02467946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355311|NCT02467946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355312|NCT02467946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355313|NCT02467946|Immunotoxins|immunotoxins|mesh-ancestor
93355314|NCT02467946|Immunoconjugates|immunoconjugates|mesh-ancestor
93355315|NCT02467946|Immunologic Factors|immunologic factors|mesh-ancestor
93355316|NCT02467946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355317|NCT04688294|Valsartan|valsartan|mesh-list
93355318|NCT04688294|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93355319|NCT04688294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93355320|NCT04688294|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93355321|NCT04688294|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93355322|NCT04688294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355323|NCT03300609|Calcium, Dietary|calcium, dietary|mesh-list
93355324|NCT03300609|Leucovorin|leucovorin|mesh-list
93355325|NCT03300609|Folic Acid|folic acid|mesh-list
93355326|NCT03300609|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
93355327|NCT03300609|Tetrahydrofolates|tetrahydrofolates|mesh-list
93355328|NCT03300609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93355329|NCT03300609|Panitumumab|panitumumab|mesh-list
93355330|NCT03300609|Fluorouracil|fluorouracil|mesh-list
93355331|NCT03300609|Capecitabine|capecitabine|mesh-list
93355332|NCT03300609|Oxaliplatin|oxaliplatin|mesh-list
93355333|NCT03300609|Antibodies|antibodies|mesh-list
93355334|NCT03300609|Immunoglobulins|immunoglobulins|mesh-list
93355335|NCT03300609|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93355336|NCT03300609|Calcium|calcium|mesh-list
93355337|NCT03300609|Levoleucovorin|levoleucovorin|mesh-list
93355338|NCT03300609|Immunologic Factors|immunologic factors|mesh-ancestor
93355339|NCT03300609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355340|NCT03300609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355341|NCT03300609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93355342|NCT03300609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93355343|NCT03300609|Antimetabolites|antimetabolites|mesh-ancestor
93355344|NCT03300609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355345|NCT03300609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355346|NCT03300609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355347|NCT03300609|Antidotes|antidotes|mesh-ancestor
93355348|NCT03300609|Protective Agents|protective agents|mesh-ancestor
93355349|NCT03300609|Vitamin B Complex|vitamin b complex|mesh-ancestor
93355350|NCT03300609|Vitamins|vitamins|mesh-ancestor
93355351|NCT03300609|Micronutrients|micronutrients|mesh-ancestor
93355352|NCT03300609|Hematinics|hematinics|mesh-ancestor
93355353|NCT00583778|Ipratropium|ipratropium|mesh-list
93355354|NCT00583778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93355355|NCT00583778|Autonomic Agents|autonomic agents|mesh-ancestor
93355356|NCT00583778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355357|NCT00583778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355358|NCT00583778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93355359|NCT00583778|Respiratory System Agents|respiratory system agents|mesh-ancestor
93355360|NCT00583778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355361|NCT00583778|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355362|NCT00583778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355363|NCT00583778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355364|NCT03300531|Betamethasone|betamethasone|mesh-list
93355365|NCT03300531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355366|NCT03300531|Glucocorticoids|glucocorticoids|mesh-ancestor
93355367|NCT03300531|Hormones|hormones|mesh-ancestor
93355368|NCT03300531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355369|NCT03300531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355370|NCT03300531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93355371|NCT03300531|Respiratory System Agents|respiratory system agents|mesh-ancestor
93355372|NCT02467335|Fostemsavir|fostemsavir|mesh-list
93355373|NCT02467335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93355374|NCT02467335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93355375|NCT02467335|Antiviral Agents|antiviral agents|mesh-ancestor
93355376|NCT02467335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355377|NCT02467335|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93355378|NCT02467335|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93355379|NCT02467335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355380|NCT02809820|Metoprolol|metoprolol|mesh-list
93355381|NCT02809820|Carvedilol|carvedilol|mesh-list
93355382|NCT02809820|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93355383|NCT02809820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93355384|NCT02809820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93355385|NCT02809820|Sympatholytics|sympatholytics|mesh-ancestor
93355386|NCT02809820|Autonomic Agents|autonomic agents|mesh-ancestor
93355387|NCT02809820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355388|NCT02809820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355389|NCT02809820|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93355390|NCT02809820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93355391|NCT02809820|Adrenergic Agents|adrenergic agents|mesh-ancestor
93355392|NCT02809820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355393|NCT02809820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355394|NCT02809820|Antioxidants|antioxidants|mesh-ancestor
93355395|NCT02809820|Protective Agents|protective agents|mesh-ancestor
93355396|NCT02809820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93355397|NCT02809820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93355398|NCT02809820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93355399|NCT02809820|Vasodilator Agents|vasodilator agents|mesh-ancestor
93355400|NCT02809820|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93355401|NCT02809820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93355402|NCT04491357|Calcium, Dietary|calcium, dietary|mesh-list
93355403|NCT04491357|Calcium|calcium|mesh-list
93355404|NCT04491357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93355405|NCT04491357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355406|NCT04491357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93355407|NCT01673594|Naltrexone|naltrexone|mesh-list
93355408|NCT01673594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93355409|NCT01673594|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93355410|NCT01673594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355411|NCT01673594|Sensory System Agents|sensory system agents|mesh-ancestor
93355412|NCT01673594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355413|NCT03249207|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93355414|NCT03249207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355415|NCT02786498|Vitamin D|vitamin d|mesh-list
93355416|NCT02786498|Cholecalciferol|cholecalciferol|mesh-list
93355417|NCT02786498|Vitamins|vitamins|mesh-ancestor
93355418|NCT02786498|Micronutrients|micronutrients|mesh-ancestor
93355419|NCT02786498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355420|NCT02786498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93355421|NCT02786498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93355422|NCT03891914|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93355423|NCT03891914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93355424|NCT03891914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355425|NCT02597660|Hormones|hormones|mesh-list
93355426|NCT02597660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355427|NCT02597660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355428|NCT02419664|Edotreotide|edotreotide|mesh-list
93355429|NCT02419664|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92649095|NCT00235014|Verapamil|verapamil|mesh-list
93355430|NCT02419664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355431|NCT03102476|Insulin Lispro|insulin lispro|mesh-list
93355432|NCT03102476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355433|NCT03102476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355434|NCT04435574|Lactoferrin|lactoferrin|mesh-list
93355435|NCT04435574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355436|NCT03104426|Darbepoetin alfa|darbepoetin alfa|mesh-list
93355437|NCT03104426|Hematinics|hematinics|mesh-ancestor
93355438|NCT02163356|Ketoconazole|ketoconazole|mesh-list
93355439|NCT02163356|Vincristine|vincristine|mesh-list
93355440|NCT02163356|Fenretinide|fenretinide|mesh-list
93355441|NCT02163356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93355442|NCT02163356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355443|NCT02163356|Tubulin Modulators|tubulin modulators|mesh-ancestor
93355444|NCT02163356|Antimitotic Agents|antimitotic agents|mesh-ancestor
93355445|NCT02163356|Mitosis Modulators|mitosis modulators|mesh-ancestor
93355446|NCT02163356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355447|NCT02163356|Antifungal Agents|antifungal agents|mesh-ancestor
93355448|NCT02163356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355449|NCT02163356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93355450|NCT02163356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93355451|NCT02163356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355452|NCT02163356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93355453|NCT02163356|Hormone Antagonists|hormone antagonists|mesh-ancestor
93355454|NCT02163356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355455|NCT02163356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355456|NCT02163356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93355457|NCT02163356|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93355458|NCT02163356|Protective Agents|protective agents|mesh-ancestor
93355459|NCT02021006|Amoxicillin|amoxicillin|mesh-list
93355460|NCT02021006|Clavulanic Acid|clavulanic acid|mesh-list
93355461|NCT02021006|Clavulanic Acids|clavulanic acids|mesh-list
93355462|NCT02021006|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93355463|NCT02021006|Nitrofurantoin|nitrofurantoin|mesh-list
93355464|NCT02021006|Cefixime|cefixime|mesh-list
93355465|NCT02021006|Trimethoprim|trimethoprim|mesh-list
93355466|NCT02021006|Sulfamethoxazole|sulfamethoxazole|mesh-list
93355467|NCT02021006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93355468|NCT02021006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355469|NCT02021006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93355470|NCT02021006|Antimalarials|antimalarials|mesh-ancestor
93355471|NCT02021006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93355472|NCT02021006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93355473|NCT02021006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93355474|NCT02021006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355475|NCT02021006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355476|NCT02021006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93355477|NCT02021006|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93355478|NCT02021006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93355479|NCT02021006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93355480|NCT04412642|Methoxyflurane|methoxyflurane|mesh-list
93355481|NCT04412642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93355482|NCT04412642|Anesthetics, General|anesthetics, general|mesh-ancestor
93355483|NCT04412642|Anesthetics|anesthetics|mesh-ancestor
93355484|NCT04412642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355485|NCT04412642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355486|NCT03867110|Atorvastatin|atorvastatin|mesh-list
93355487|NCT03867110|Ezetimibe|ezetimibe|mesh-list
93355488|NCT03867110|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93355489|NCT03867110|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93355490|NCT03867110|Antimetabolites|antimetabolites|mesh-ancestor
93355491|NCT03867110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355492|NCT03867110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93355493|NCT03867110|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93355494|NCT03867110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355495|NCT03865082|Nivolumab|nivolumab|mesh-list
93355496|NCT03865082|Ipilimumab|ipilimumab|mesh-list
93355497|NCT03865082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355498|NCT03865082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355499|NCT03865082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93355500|NCT03865082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649168|NCT00235053|Fluticasone|fluticasone|mesh-list
93355501|NCT03102398|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93355502|NCT03102398|Vasodilator Agents|vasodilator agents|mesh-ancestor
93355503|NCT03102398|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93355504|NCT03102398|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93355505|NCT03102398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355506|NCT03102398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355507|NCT03102398|Urological Agents|urological agents|mesh-ancestor
93355508|NCT01187810|Cytarabine|cytarabine|mesh-list
93355509|NCT01187810|Methotrexate|methotrexate|mesh-list
93355510|NCT01187810|Fenretinide|fenretinide|mesh-list
93355511|NCT01187810|Retinamide|retinamide|mesh-list
93355512|NCT01187810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93355513|NCT01187810|Abortifacient Agents|abortifacient agents|mesh-ancestor
93355514|NCT01187810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93355515|NCT01187810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355516|NCT01187810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355517|NCT01187810|Antimetabolites|antimetabolites|mesh-ancestor
93355518|NCT01187810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355519|NCT01187810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355520|NCT01187810|Dermatologic Agents|dermatologic agents|mesh-ancestor
93355521|NCT01187810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355522|NCT01187810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93355523|NCT01187810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355524|NCT01187810|Immunologic Factors|immunologic factors|mesh-ancestor
93355525|NCT01187810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355526|NCT01187810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93355527|NCT01187810|Antiviral Agents|antiviral agents|mesh-ancestor
93355528|NCT01187810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355529|NCT01187810|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93355530|NCT01187810|Protective Agents|protective agents|mesh-ancestor
93355531|NCT03104036|Mesalamine|mesalamine|mesh-list
93355532|NCT03104036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93355533|NCT03104036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355534|NCT03104036|Analgesics|analgesics|mesh-ancestor
93355535|NCT03104036|Sensory System Agents|sensory system agents|mesh-ancestor
93355536|NCT03104036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355537|NCT03104036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355538|NCT03104036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355539|NCT03104036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355540|NCT03449888|Calcium, Dietary|calcium, dietary|mesh-list
93355541|NCT03449888|Calcium|calcium|mesh-list
93355542|NCT03449888|Regadenoson|regadenoson|mesh-list
93355543|NCT03449888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93355544|NCT03449888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355545|NCT03449888|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93355546|NCT03449888|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93355547|NCT03449888|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93355548|NCT03449888|Purinergic Agonists|purinergic agonists|mesh-ancestor
93355549|NCT03449888|Purinergic Agents|purinergic agents|mesh-ancestor
93355550|NCT03449888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355551|NCT03449888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355552|NCT03308396|Durvalumab|durvalumab|mesh-list
93355553|NCT03308396|Guadecitabine|guadecitabine|mesh-list
93355554|NCT03308396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355555|NCT03308396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649250|NCT00574483|Quinacrine|quinacrine|mesh-list
93355556|NCT02720523|Upadacitinib|upadacitinib|mesh-list
93355557|NCT02720523|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93355558|NCT02720523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93355559|NCT02720523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355560|NCT02720523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355561|NCT02720523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355562|NCT02646332|Amoxicillin|amoxicillin|mesh-list
93355563|NCT02646332|Metronidazole|metronidazole|mesh-list
93355564|NCT02646332|Clarithromycin|clarithromycin|mesh-list
93355565|NCT02646332|Dexlansoprazole|dexlansoprazole|mesh-list
93355566|NCT02646332|Lansoprazole|lansoprazole|mesh-list
93355567|NCT02646332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93355568|NCT02646332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355569|NCT02646332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93355570|NCT02646332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93355571|NCT02646332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93355572|NCT02646332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355573|NCT02646332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355574|NCT02646332|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93355575|NCT02646332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93355576|NCT02646332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93355577|NCT02646332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93355578|NCT02646332|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93355579|NCT00015002|Betamethasone|betamethasone|mesh-list
93355580|NCT00015002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355581|NCT00015002|Glucocorticoids|glucocorticoids|mesh-ancestor
93355582|NCT00015002|Hormones|hormones|mesh-ancestor
93355583|NCT00015002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355584|NCT00015002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355585|NCT00015002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93355586|NCT00015002|Respiratory System Agents|respiratory system agents|mesh-ancestor
93355587|NCT03103412|Tofacitinib|tofacitinib|mesh-list
93355588|NCT03103412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93355589|NCT03103412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93355590|NCT03103412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355591|NCT03103412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355592|NCT02061007|Misonidazole|misonidazole|mesh-list
93355593|NCT02061007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355594|NCT02061007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93355595|NCT02061007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93355596|NCT02061007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355597|NCT02086604|Lenalidomide|lenalidomide|mesh-list
93355598|NCT02086604|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93355599|NCT02086604|Immunologic Factors|immunologic factors|mesh-ancestor
93355600|NCT02086604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355601|NCT02086604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93355602|NCT02086604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93355603|NCT02086604|Growth Substances|growth substances|mesh-ancestor
93355604|NCT02086604|Growth Inhibitors|growth inhibitors|mesh-ancestor
93355605|NCT02086604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355606|NCT02086604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355607|NCT02086604|Immunotoxins|immunotoxins|mesh-ancestor
93355608|NCT02086604|Immunoconjugates|immunoconjugates|mesh-ancestor
93355609|NCT03103568|Tolbutamide|tolbutamide|mesh-list
93355610|NCT03103568|Metoprolol|metoprolol|mesh-list
93355611|NCT03103568|Furosemide|furosemide|mesh-list
93355612|NCT03103568|Chlorzoxazone|chlorzoxazone|mesh-list
93355613|NCT03103568|Nitisinone|nitisinone|mesh-list
93355614|NCT03103568|Diuretics|diuretics|mesh-ancestor
93355615|NCT03103568|Natriuretic Agents|natriuretic agents|mesh-ancestor
93355616|NCT03103568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355617|NCT03103568|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93355618|NCT03103568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93355619|NCT03103568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355620|NCT03103568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93355621|NCT03103568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93355622|NCT03103568|Sympatholytics|sympatholytics|mesh-ancestor
93355623|NCT03103568|Autonomic Agents|autonomic agents|mesh-ancestor
93355624|NCT03103568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355625|NCT03103568|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93355626|NCT03103568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93355627|NCT03103568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93355628|NCT03103568|Adrenergic Agents|adrenergic agents|mesh-ancestor
93355629|NCT03103568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355630|NCT03103568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355631|NCT03103568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355632|NCT03103568|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93355633|NCT03103568|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93355634|NCT05654467|Vaccines|vaccines|mesh-list
93355635|NCT05654467|Immunologic Factors|immunologic factors|mesh-ancestor
93355636|NCT05654467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355637|NCT03101072|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93355638|NCT03101072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93355639|NCT03101072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355640|NCT03101072|Antitubercular Agents|antitubercular agents|mesh-ancestor
93355641|NCT02925195|Vitamin D|vitamin d|mesh-list
93355642|NCT02925195|Cholecalciferol|cholecalciferol|mesh-list
93355643|NCT02925195|Vitamins|vitamins|mesh-ancestor
93355644|NCT02925195|Micronutrients|micronutrients|mesh-ancestor
93355645|NCT02925195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355646|NCT02925195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93355647|NCT02925195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93355648|NCT03103646|Itraconazole|itraconazole|mesh-list
93027519|NCT00490022|Androgens|androgens|mesh-ancestor
93355649|NCT03103646|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93355650|NCT03103646|Antifungal Agents|antifungal agents|mesh-ancestor
93355651|NCT03103646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355652|NCT03103646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93355653|NCT03103646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93355654|NCT03103646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355655|NCT03103646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355656|NCT03103646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93355657|NCT03103646|Hormone Antagonists|hormone antagonists|mesh-ancestor
93355658|NCT03103646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355659|NCT03103646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355660|NCT03103646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93355661|NCT01554410|Gemcitabine|gemcitabine|mesh-list
93355662|NCT01554410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355663|NCT01554410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355664|NCT01554410|Antimetabolites|antimetabolites|mesh-ancestor
93355665|NCT01554410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355666|NCT01499888|Sirolimus|sirolimus|mesh-list
93355667|NCT01499888|Alemtuzumab|alemtuzumab|mesh-list
93355668|NCT01499888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93355669|NCT01499888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93355670|NCT01499888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93355671|NCT01499888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355672|NCT01499888|Antifungal Agents|antifungal agents|mesh-ancestor
93355673|NCT01499888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355674|NCT01499888|Immunologic Factors|immunologic factors|mesh-ancestor
93355675|NCT01499888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355676|NCT01499888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355677|NCT03299829|Trientine|trientine|mesh-list
93355678|NCT03299829|Chelating Agents|chelating agents|mesh-ancestor
93355679|NCT03299829|Sequestering Agents|sequestering agents|mesh-ancestor
93355680|NCT03299829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355681|NCT04968158|Acetaminophen|acetaminophen|mesh-list
93355682|NCT04968158|Etoricoxib|etoricoxib|mesh-list
93355683|NCT04968158|Tramadol|tramadol|mesh-list
93355684|NCT04968158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355685|NCT04968158|Analgesics|analgesics|mesh-ancestor
93355686|NCT04968158|Sensory System Agents|sensory system agents|mesh-ancestor
93355687|NCT04968158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355688|NCT04968158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355689|NCT04968158|Antipyretics|antipyretics|mesh-ancestor
93355690|NCT04968158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93355691|NCT04968158|Narcotics|narcotics|mesh-ancestor
93355692|NCT04968158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355693|NCT04968158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93355694|NCT04968158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355695|NCT04968158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355696|NCT04968158|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93355697|NCT04968158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93355698|NCT04968158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355699|NCT04968158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355700|NCT02059915|Oxycodone|oxycodone|mesh-list
93355701|NCT02059915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93355702|NCT02059915|Narcotics|narcotics|mesh-ancestor
93355703|NCT02059915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355704|NCT02059915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355705|NCT02059915|Analgesics|analgesics|mesh-ancestor
93355706|NCT02059915|Sensory System Agents|sensory system agents|mesh-ancestor
93355707|NCT02059915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355708|NCT02471404|Dapagliflozin|dapagliflozin|mesh-list
93355709|NCT02471404|Glimepiride|glimepiride|mesh-list
93355710|NCT02471404|Saxagliptin|saxagliptin|mesh-list
93355711|NCT02471404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93355712|NCT02471404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355713|NCT02471404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355714|NCT02471404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355715|NCT02471404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93355716|NCT02471404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355717|NCT02471404|Immunologic Factors|immunologic factors|mesh-ancestor
93355718|NCT02471404|Incretins|incretins|mesh-ancestor
93355719|NCT02471404|Hormones|hormones|mesh-ancestor
93355720|NCT02471404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93355721|NCT02471404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93355722|NCT02471404|Protease Inhibitors|protease inhibitors|mesh-ancestor
93027591|NCT00560417|Coagulants|coagulants|mesh-ancestor
93355724|NCT00835094|Mometasone Furoate|mometasone furoate|mesh-list
93355725|NCT00835094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355726|NCT00835094|Dermatologic Agents|dermatologic agents|mesh-ancestor
93355727|NCT00835094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93355728|NCT02061475|Lidocaine|lidocaine|mesh-list
93355729|NCT02061475|Anesthetics, Local|anesthetics, local|mesh-ancestor
93355730|NCT02061475|Anesthetics|anesthetics|mesh-ancestor
93355731|NCT02061475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355732|NCT02061475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355733|NCT02061475|Sensory System Agents|sensory system agents|mesh-ancestor
93355734|NCT02061475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355735|NCT02061475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93355736|NCT02061475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93355737|NCT02061475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93355738|NCT02061475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93355739|NCT02061475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355740|NCT03100994|Bupivacaine|bupivacaine|mesh-list
93355741|NCT03100994|Anesthetics, Local|anesthetics, local|mesh-ancestor
93355742|NCT03100994|Anesthetics|anesthetics|mesh-ancestor
93355743|NCT03100994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355744|NCT03100994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355745|NCT03100994|Sensory System Agents|sensory system agents|mesh-ancestor
93355746|NCT03100994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355747|NCT04160936|Bupivacaine|bupivacaine|mesh-list
93355748|NCT04160936|Anesthetics, Local|anesthetics, local|mesh-ancestor
93355749|NCT04160936|Anesthetics|anesthetics|mesh-ancestor
93355750|NCT04160936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355751|NCT04160936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355752|NCT04160936|Sensory System Agents|sensory system agents|mesh-ancestor
93355753|NCT04160936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355754|NCT03103334|Methotrexate|methotrexate|mesh-list
93355755|NCT03103334|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93355756|NCT03103334|Abortifacient Agents|abortifacient agents|mesh-ancestor
93355757|NCT03103334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93355758|NCT03103334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355759|NCT03103334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355760|NCT03103334|Antimetabolites|antimetabolites|mesh-ancestor
93355761|NCT03103334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355762|NCT03103334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355763|NCT03103334|Dermatologic Agents|dermatologic agents|mesh-ancestor
93355764|NCT03103334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355765|NCT03103334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93355766|NCT03103334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355767|NCT03103334|Immunologic Factors|immunologic factors|mesh-ancestor
93355768|NCT03103334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355769|NCT03103334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93355770|NCT02471014|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93355771|NCT02471014|Immunologic Factors|immunologic factors|mesh-ancestor
93355772|NCT02471014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355773|NCT00795158|Desloratadine|desloratadine|mesh-list
93355774|NCT00795158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355775|NCT00795158|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355776|NCT00795158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355777|NCT00795158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355778|NCT00795158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355779|NCT00795158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93355780|NCT00795158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93355781|NCT00795158|Histamine Antagonists|histamine antagonists|mesh-ancestor
93355782|NCT00795158|Histamine Agents|histamine agents|mesh-ancestor
93355783|NCT02063269|Rivastigmine|rivastigmine|mesh-list
93355784|NCT02063269|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93355785|NCT02063269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355786|NCT02063269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355787|NCT02063269|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355788|NCT02063269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355789|NCT02063269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355790|NCT02063269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93355791|NCT02063269|Protective Agents|protective agents|mesh-ancestor
93355792|NCT00794846|Cetirizine|cetirizine|mesh-list
93355793|NCT00794846|Desloratadine|desloratadine|mesh-list
93355794|NCT00794846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93355795|NCT00794846|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93355796|NCT00794846|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93355797|NCT00794846|Histamine Antagonists|histamine antagonists|mesh-ancestor
93355798|NCT00794846|Histamine Agents|histamine agents|mesh-ancestor
93355799|NCT00794846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355800|NCT00794846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355801|NCT00794846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355802|NCT00794846|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355803|NCT00794846|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355804|NCT00794768|Fexofenadine|fexofenadine|mesh-list
93355805|NCT00794768|Desloratadine|desloratadine|mesh-list
93355806|NCT00794768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355807|NCT00794768|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355808|NCT00794768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355809|NCT00794768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355810|NCT00794768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355811|NCT00794768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93355812|NCT00794768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93355813|NCT00794768|Histamine Antagonists|histamine antagonists|mesh-ancestor
93355814|NCT00794768|Histamine Agents|histamine agents|mesh-ancestor
93355815|NCT00794768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93355817|NCT02060851|Trace Elements|trace elements|mesh-ancestor
93355818|NCT02060851|Micronutrients|micronutrients|mesh-ancestor
93355819|NCT02060851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355820|NCT00779636|Desloratadine|desloratadine|mesh-list
93355821|NCT00779636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355822|NCT00779636|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355823|NCT00779636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355824|NCT00779636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355825|NCT00779636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355826|NCT00779636|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93355827|NCT00779636|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93355828|NCT00779636|Histamine Antagonists|histamine antagonists|mesh-ancestor
93355829|NCT00779636|Histamine Agents|histamine agents|mesh-ancestor
93355830|NCT02060929|Esketamine|esketamine|mesh-list
93355831|NCT02060929|Antidepressive Agents|antidepressive agents|mesh-ancestor
93355832|NCT02060929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93355833|NCT00757562|Desloratadine|desloratadine|mesh-list
93355834|NCT00757562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93355835|NCT00757562|Cholinergic Agents|cholinergic agents|mesh-ancestor
93355836|NCT00757562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355837|NCT00757562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355838|NCT00757562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355839|NCT00757562|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93355840|NCT00757562|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93355841|NCT00757562|Histamine Antagonists|histamine antagonists|mesh-ancestor
93355842|NCT00757562|Histamine Agents|histamine agents|mesh-ancestor
93355843|NCT03299517|Lidocaine|lidocaine|mesh-list
93355844|NCT03299517|Amiodarone|amiodarone|mesh-list
93355845|NCT03299517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93355846|NCT03299517|Anesthetics, Local|anesthetics, local|mesh-ancestor
93355847|NCT03299517|Anesthetics|anesthetics|mesh-ancestor
93355848|NCT03299517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355849|NCT03299517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355850|NCT03299517|Sensory System Agents|sensory system agents|mesh-ancestor
93355851|NCT03299517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355852|NCT03299517|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93355853|NCT03299517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93355854|NCT03299517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93355855|NCT03299517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355856|NCT03299517|Vasodilator Agents|vasodilator agents|mesh-ancestor
93355857|NCT03299517|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93355858|NCT03299517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93355859|NCT03299517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93355860|NCT03299517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355861|NCT03299517|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93355862|NCT03299517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93355863|NCT03299517|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93355864|NCT00651404|Ezetimibe|ezetimibe|mesh-list
93355865|NCT00651404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93355866|NCT00651404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93355867|NCT00651404|Antimetabolites|antimetabolites|mesh-ancestor
93355868|NCT00651404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355869|NCT00651404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93355870|NCT00651014|Ezetimibe|ezetimibe|mesh-list
93355871|NCT00651014|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93355872|NCT00651014|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93355873|NCT00651014|Antimetabolites|antimetabolites|mesh-ancestor
93355874|NCT00651014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355875|NCT00651014|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93355876|NCT04435418|Apixaban|apixaban|mesh-list
93355877|NCT04435418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93355878|NCT04435418|Antithrombins|antithrombins|mesh-ancestor
93355879|NCT04435418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93355880|NCT04435418|Protease Inhibitors|protease inhibitors|mesh-ancestor
93355881|NCT04435418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355882|NCT04435418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355883|NCT04435418|Anticoagulants|anticoagulants|mesh-ancestor
93355884|NCT02062255|Aspirin|aspirin|mesh-list
93355885|NCT02062255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93355886|NCT02062255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93355887|NCT02062255|Analgesics|analgesics|mesh-ancestor
93355888|NCT02062255|Sensory System Agents|sensory system agents|mesh-ancestor
93355889|NCT02062255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93355890|NCT02062255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355891|NCT02062255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93355892|NCT02062255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93355893|NCT02062255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93355894|NCT02062255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93355895|NCT02062255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355896|NCT02062255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93355897|NCT02062255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93355898|NCT02062255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355899|NCT02062255|Antipyretics|antipyretics|mesh-ancestor
93355900|NCT02739542|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93355901|NCT02739542|Dermatologic Agents|dermatologic agents|mesh-ancestor
93355902|NCT02739542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93355903|NCT02739542|Immunologic Factors|immunologic factors|mesh-ancestor
93355904|NCT02739542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355905|NCT02466477|Psychotropic Drugs|psychotropic drugs|mesh-list
93355906|NCT05547243|Vaccines|vaccines|mesh-list
93355907|NCT05547243|Immunologic Factors|immunologic factors|mesh-ancestor
93355908|NCT05547243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355909|NCT03100604|Sevoflurane|sevoflurane|mesh-list
93355910|NCT03100604|Desflurane|desflurane|mesh-list
93355911|NCT03100604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93355912|NCT03100604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93355913|NCT03100604|Anesthetics, General|anesthetics, general|mesh-ancestor
93355914|NCT03100604|Anesthetics|anesthetics|mesh-ancestor
93355915|NCT03100604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93355916|NCT03100604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355917|NCT00398294|Simvastatin|simvastatin|mesh-list
93355918|NCT00398294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93355919|NCT00398294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93355920|NCT00398294|Antimetabolites|antimetabolites|mesh-ancestor
93355921|NCT00398294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355922|NCT00398294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93355923|NCT00398294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93355924|NCT00398294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355925|NCT04823403|Nivolumab|nivolumab|mesh-list
93355926|NCT04823403|Ipilimumab|ipilimumab|mesh-list
93355927|NCT04823403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355928|NCT04823403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355929|NCT04823403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93355930|NCT04823403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355931|NCT03493646|Azacitidine|azacitidine|mesh-list
93355932|NCT03493646|Cc-486|cc-486|mesh-list
93355933|NCT03493646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355934|NCT03493646|Antimetabolites|antimetabolites|mesh-ancestor
93355935|NCT03493646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355936|NCT03493646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355937|NCT03493646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355938|NCT05519865|Tislelizumab|tislelizumab|mesh-list
93355939|NCT05519865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355940|NCT05519865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355941|NCT05500443|Vitamin K|vitamin k|mesh-list
93355942|NCT05500443|Vitamin K 2|vitamin k 2|mesh-list
93355943|NCT05500443|Menaquinone 7|menaquinone 7|mesh-list
93355944|NCT05500443|Vitamins|vitamins|mesh-ancestor
93355945|NCT05500443|Micronutrients|micronutrients|mesh-ancestor
93355946|NCT05500443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355947|NCT05500443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93355948|NCT05500443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93355949|NCT05500443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355950|NCT05500443|Hemostatics|hemostatics|mesh-ancestor
93355951|NCT05500443|Coagulants|coagulants|mesh-ancestor
93355952|NCT05244200|Insulin|insulin|mesh-list
93355953|NCT05244200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355954|NCT05244200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355955|NCT03451370|Bevacizumab|bevacizumab|mesh-list
93355956|NCT03451370|Capecitabine|capecitabine|mesh-list
93355957|NCT03451370|Oxaliplatin|oxaliplatin|mesh-list
93355958|NCT03451370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355959|NCT03451370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355960|NCT03451370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93355961|NCT03451370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93355962|NCT03451370|Growth Substances|growth substances|mesh-ancestor
93355963|NCT03451370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355964|NCT03451370|Growth Inhibitors|growth inhibitors|mesh-ancestor
93355965|NCT03451370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93355966|NCT03451370|Antimetabolites|antimetabolites|mesh-ancestor
93355967|NCT03451370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355968|NCT03991832|Durvalumab|durvalumab|mesh-list
93355969|NCT03991832|Olaparib|olaparib|mesh-list
93355970|NCT03991832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93355971|NCT03991832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93355972|NCT03991832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93355973|NCT03991832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93355974|NCT03991832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355975|NCT01361594|Insulin|insulin|mesh-list
93355976|NCT01361594|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93355977|NCT01361594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93355978|NCT01361594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355979|NCT04435028|Ketotifen|ketotifen|mesh-list
93355980|NCT04435028|Antipruritics|antipruritics|mesh-ancestor
93355981|NCT04435028|Dermatologic Agents|dermatologic agents|mesh-ancestor
93355982|NCT04435028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93355983|NCT04435028|Histamine Antagonists|histamine antagonists|mesh-ancestor
93355984|NCT04435028|Histamine Agents|histamine agents|mesh-ancestor
93355985|NCT04435028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93355986|NCT04435028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93355987|NCT04435028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355988|NCT04435028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93355989|NCT03945812|Lenograstim|lenograstim|mesh-list
93355990|NCT03945812|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93355991|NCT03945812|Immunologic Factors|immunologic factors|mesh-ancestor
93355992|NCT03945812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93355993|NCT05060198|Lumefantrine|lumefantrine|mesh-list
93355994|NCT05060198|Artemether|artemether|mesh-list
93355995|NCT05060198|Piperaquine|piperaquine|mesh-list
93355996|NCT05060198|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93355997|NCT05060198|Artenimol|artenimol|mesh-list
93355998|NCT05060198|Antimalarials|antimalarials|mesh-ancestor
93355999|NCT05060198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93356000|NCT05060198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93356001|NCT05060198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356002|NCT04478084|Vaccines|vaccines|mesh-list
93356003|NCT04478084|Immunoglobulins|immunoglobulins|mesh-list
93356004|NCT04478084|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93356005|NCT04478084|Antibodies|antibodies|mesh-list
93356006|NCT04478084|Immunologic Factors|immunologic factors|mesh-ancestor
93356007|NCT04478084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356008|NCT03098888|Dimercaprol|dimercaprol|mesh-list
93356009|NCT03098888|Chelating Agents|chelating agents|mesh-ancestor
93356010|NCT03098888|Sequestering Agents|sequestering agents|mesh-ancestor
93356011|NCT03098888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356012|NCT03098810|Zinc Sulfate|zinc sulfate|mesh-list
93356013|NCT03098810|Astringents|astringents|mesh-ancestor
93356014|NCT03098810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356015|NCT03098810|Dermatologic Agents|dermatologic agents|mesh-ancestor
93356016|NCT02464761|Verteporfin|verteporfin|mesh-list
93356017|NCT02464761|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93356018|NCT02464761|Dermatologic Agents|dermatologic agents|mesh-ancestor
93356019|NCT02462889|Aflibercept|aflibercept|mesh-list
93356020|NCT02462889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93356021|NCT02462889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93356022|NCT02462889|Growth Substances|growth substances|mesh-ancestor
93356023|NCT02462889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356024|NCT02462889|Growth Inhibitors|growth inhibitors|mesh-ancestor
93356025|NCT02462889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356026|NCT02462577|Morphine|morphine|mesh-list
93356027|NCT02462577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93356028|NCT02462577|Narcotics|narcotics|mesh-ancestor
93356029|NCT02462577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356030|NCT02462577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356031|NCT02462577|Analgesics|analgesics|mesh-ancestor
93356032|NCT02462577|Sensory System Agents|sensory system agents|mesh-ancestor
93356033|NCT02462577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356034|NCT02462499|Eplerenone|eplerenone|mesh-list
93356035|NCT02462499|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93356036|NCT02462499|Hormone Antagonists|hormone antagonists|mesh-ancestor
93356037|NCT02462499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356038|NCT02462499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356039|NCT02462499|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93356040|NCT02462499|Diuretics|diuretics|mesh-ancestor
93356041|NCT02462499|Natriuretic Agents|natriuretic agents|mesh-ancestor
93356042|NCT02462499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93356043|NCT02464683|Vitamin D|vitamin d|mesh-list
93356044|NCT02464683|Vitamins|vitamins|mesh-ancestor
93356045|NCT02464683|Micronutrients|micronutrients|mesh-ancestor
93356046|NCT02464683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356047|NCT02464683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93356048|NCT02061631|Dexamethasone|dexamethasone|mesh-list
93356049|NCT02061631|Dexamethasone acetate|dexamethasone acetate|mesh-list
93356050|NCT02061631|Docetaxel|docetaxel|mesh-list
93356051|NCT02061631|BB 1101|bb 1101|mesh-list
93356052|NCT02061631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356053|NCT02061631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356054|NCT02061631|Antiemetics|antiemetics|mesh-ancestor
93356055|NCT02061631|Autonomic Agents|autonomic agents|mesh-ancestor
93356056|NCT02061631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356057|NCT02061631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356058|NCT02061631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93356059|NCT02061631|Glucocorticoids|glucocorticoids|mesh-ancestor
93356060|NCT02061631|Hormones|hormones|mesh-ancestor
93356061|NCT02061631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356062|NCT02061631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93356063|NCT02061631|Protease Inhibitors|protease inhibitors|mesh-ancestor
93356064|NCT02061631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356065|NCT02061631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356066|NCT02061631|Tubulin Modulators|tubulin modulators|mesh-ancestor
93356067|NCT02061631|Antimitotic Agents|antimitotic agents|mesh-ancestor
93356068|NCT02061631|Mitosis Modulators|mitosis modulators|mesh-ancestor
93356069|NCT03098342|Amorolfine|amorolfine|mesh-list
93356070|NCT03098342|Methylene Blue|methylene blue|mesh-list
93356071|NCT03098342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356072|NCT03098342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356073|NCT03098342|Antifungal Agents|antifungal agents|mesh-ancestor
93356074|NCT03098342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356075|NCT05059418|Clonazepam|clonazepam|mesh-list
93356076|NCT05059418|Capsaicin|capsaicin|mesh-list
93356077|NCT05059418|Antipruritics|antipruritics|mesh-ancestor
93356078|NCT05059418|Dermatologic Agents|dermatologic agents|mesh-ancestor
93356079|NCT05059418|Sensory System Agents|sensory system agents|mesh-ancestor
93356080|NCT05059418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356081|NCT05059418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356082|NCT05059418|Anticonvulsants|anticonvulsants|mesh-ancestor
93356083|NCT05059418|GABA Modulators|gaba modulators|mesh-ancestor
93356084|NCT05059418|GABA Agents|gaba agents|mesh-ancestor
93356085|NCT05059418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356086|NCT05059418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356087|NCT02062333|Dexmedetomidine|dexmedetomidine|mesh-list
93356088|NCT02062333|Esmolol|esmolol|mesh-list
93356089|NCT02062333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93356090|NCT02062333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356091|NCT02062333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356092|NCT02062333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93356093|NCT02062333|Analgesics|analgesics|mesh-ancestor
93356094|NCT02062333|Sensory System Agents|sensory system agents|mesh-ancestor
93356095|NCT02062333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356096|NCT02062333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93356097|NCT02062333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93356098|NCT02062333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93356099|NCT02062333|Adrenergic Agents|adrenergic agents|mesh-ancestor
93356100|NCT02062333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356101|NCT02062333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356102|NCT02062333|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93356103|NCT02062333|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93356104|NCT02062333|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93356105|NCT05014724|Rozanolixizumab|rozanolixizumab|mesh-list
93356106|NCT05014724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93356107|NCT05014724|Immunologic Factors|immunologic factors|mesh-ancestor
93356108|NCT05014724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356109|NCT05010668|Lenvatinib|lenvatinib|mesh-list
93356110|NCT05010668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356111|NCT05010668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93356112|NCT05010668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356113|NCT05010668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356114|NCT02063425|Fluoxetine|fluoxetine|mesh-list
93356115|NCT02063425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93356116|NCT02063425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93356117|NCT02063425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356118|NCT02063425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356119|NCT02063425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356120|NCT02063425|Serotonin Agents|serotonin agents|mesh-ancestor
93356121|NCT02063425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356122|NCT02063425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93356123|NCT02063425|Antidepressive Agents|antidepressive agents|mesh-ancestor
93356124|NCT02063425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356125|NCT02063425|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93356126|NCT02063425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93356127|NCT02063425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356128|NCT05071118|Pregabalin|pregabalin|mesh-list
93356129|NCT05071118|Analgesics|analgesics|mesh-ancestor
93356130|NCT05071118|Sensory System Agents|sensory system agents|mesh-ancestor
93356131|NCT05071118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356132|NCT05071118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356133|NCT05071118|Anticonvulsants|anticonvulsants|mesh-ancestor
93356134|NCT05071118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93356135|NCT05071118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356136|NCT05071118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356137|NCT05071118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356138|NCT05071118|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93356139|NCT05071118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356140|NCT05071118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356141|NCT05071118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356142|NCT03559400|Gentamicins|gentamicins|mesh-list
93356143|NCT03559400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93356144|NCT03559400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356145|NCT03559400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93356146|NCT03559400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356147|NCT03559400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356148|NCT03464019|Etripamil|etripamil|mesh-list
93356149|NCT03464019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93356150|NCT03464019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356151|NCT03464019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356152|NCT03464019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356153|NCT03464019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356154|NCT05070416|Lithium Carbonate|lithium carbonate|mesh-list
93356155|NCT05070416|Antidepressive Agents|antidepressive agents|mesh-ancestor
93356156|NCT05070416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356157|NCT05070416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356158|NCT05070416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356159|NCT05070416|Antimanic Agents|antimanic agents|mesh-ancestor
93356160|NCT05070416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356161|NCT05070416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356162|NCT05070416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356163|NCT05069870|Itraconazole|itraconazole|mesh-list
93356164|NCT05069870|Rifampin|rifampin|mesh-list
93356165|NCT05069870|Gemfibrozil|gemfibrozil|mesh-list
93356166|NCT05069870|Antifungal Agents|antifungal agents|mesh-ancestor
93356167|NCT05069870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356168|NCT05069870|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93356169|NCT05069870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93356170|NCT05069870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356171|NCT05069870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356172|NCT05069870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93356173|NCT05069870|Hormone Antagonists|hormone antagonists|mesh-ancestor
93356174|NCT05069870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356175|NCT05069870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356176|NCT05069870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93356177|NCT05069870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93356178|NCT05069870|Antitubercular Agents|antitubercular agents|mesh-ancestor
93356179|NCT05069870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93356180|NCT05069870|Leprostatic Agents|leprostatic agents|mesh-ancestor
93356181|NCT05069870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93356182|NCT05069870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93356183|NCT05069870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93356184|NCT05069870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93356185|NCT05069870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93356186|NCT05069870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93356187|NCT05069870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93356188|NCT05069870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93356189|NCT05069870|Antimetabolites|antimetabolites|mesh-ancestor
93356190|NCT05069870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93356191|NCT05069870|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93356193|NCT05275491|Parathyroid Hormone|parathyroid hormone|mesh-list
93356194|NCT05275491|Hormones|hormones|mesh-list
93356195|NCT05275491|Mitogens|mitogens|mesh-list
93356196|NCT05275491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356197|NCT05275491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356198|NCT05275491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356199|NCT05275491|Mitosis Modulators|mitosis modulators|mesh-ancestor
93356200|NCT05275491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356201|NCT04584255|Niraparib|niraparib|mesh-list
93356202|NCT04584255|Dostarlimab|dostarlimab|mesh-list
93356203|NCT04584255|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93356204|NCT04584255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356205|NCT04584255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356206|NCT04584255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356207|NCT02976753|Factor VIII|factor viii|mesh-list
93356208|NCT02976753|Coagulants|coagulants|mesh-ancestor
93356209|NCT04559529|Levetiracetam|levetiracetam|mesh-list
93356210|NCT04559529|Anticonvulsants|anticonvulsants|mesh-ancestor
93356211|NCT04559529|Nootropic Agents|nootropic agents|mesh-ancestor
93356212|NCT04490421|Etoposide|etoposide|mesh-list
93356213|NCT04490421|Apatinib|apatinib|mesh-list
93356214|NCT04490421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356215|NCT04490421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93356216|NCT04490421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93356217|NCT04490421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93356218|NCT04490421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356219|NCT04490421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356220|NCT04490421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93356221|NCT04542291|Dapagliflozin|dapagliflozin|mesh-list
93356222|NCT04542291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93356223|NCT04542291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356224|NCT04542291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93356225|NCT04542291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356226|NCT02462109|Lorazepam|lorazepam|mesh-list
93356227|NCT02462109|Anticonvulsants|anticonvulsants|mesh-ancestor
93356228|NCT02462109|Antiemetics|antiemetics|mesh-ancestor
93356229|NCT02462109|Autonomic Agents|autonomic agents|mesh-ancestor
93356230|NCT02462109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356231|NCT02462109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356232|NCT02462109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93356233|NCT02462109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93356234|NCT02462109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356235|NCT02462109|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93356236|NCT02462109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356237|NCT02462109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356238|NCT02462109|GABA Modulators|gaba modulators|mesh-ancestor
93356239|NCT02462109|GABA Agents|gaba agents|mesh-ancestor
93356240|NCT02462109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356241|NCT02462109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356242|NCT02063581|Ipatasertib|ipatasertib|mesh-list
93356243|NCT02063581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356244|NCT02063581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93356245|NCT02063581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356246|NCT02063581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356247|NCT02056899|Gabapentin|gabapentin|mesh-list
93356248|NCT02056899|Analgesics|analgesics|mesh-ancestor
93356249|NCT02056899|Sensory System Agents|sensory system agents|mesh-ancestor
93356250|NCT02056899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356251|NCT02056899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356252|NCT02056899|Anticonvulsants|anticonvulsants|mesh-ancestor
93356253|NCT02056899|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93356254|NCT02056899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356255|NCT02056899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356256|NCT02056899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356257|NCT02056899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93356258|NCT02056899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93356259|NCT02056899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356260|NCT02056899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356261|NCT02056899|Antimanic Agents|antimanic agents|mesh-ancestor
93356262|NCT02462265|Mitoxantrone|mitoxantrone|mesh-list
93356263|NCT02462265|Antineoplastic Agents|antineoplastic agents|mesh-list
93356264|NCT02462265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356265|NCT02462265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356266|NCT02462265|Analgesics|analgesics|mesh-ancestor
93356267|NCT02462265|Sensory System Agents|sensory system agents|mesh-ancestor
93356268|NCT02462265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356269|NCT02462265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93356270|NCT02462265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93356271|NCT02462265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356272|NCT02461875|Cabergoline|cabergoline|mesh-list
93356273|NCT02461875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93356274|NCT02461875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93356275|NCT02461875|Dopamine Agonists|dopamine agonists|mesh-ancestor
93356276|NCT02461875|Dopamine Agents|dopamine agents|mesh-ancestor
93356277|NCT02461875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356278|NCT02461875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356279|NCT02461875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356280|NCT02461719|Cyclosporine|cyclosporine|mesh-list
93356281|NCT02461719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93356282|NCT02461719|Cyclosporins|cyclosporins|mesh-list
93356283|NCT02461719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356284|NCT02461719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356285|NCT02461719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93356286|NCT02461719|Immunologic Factors|immunologic factors|mesh-ancestor
93356287|NCT02461719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356288|NCT02461719|Antifungal Agents|antifungal agents|mesh-ancestor
93356289|NCT02461719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356290|NCT02461719|Dermatologic Agents|dermatologic agents|mesh-ancestor
93356291|NCT02461719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93356292|NCT02461719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93356293|NCT02461719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93356294|NCT04322643|Pembrolizumab|pembrolizumab|mesh-list
93356295|NCT04322643|Nivolumab|nivolumab|mesh-list
93356296|NCT04322643|Atezolizumab|atezolizumab|mesh-list
93356297|NCT04322643|Durvalumab|durvalumab|mesh-list
93356298|NCT04322643|Avelumab|avelumab|mesh-list
93356299|NCT04322643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93356300|NCT04322643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356301|NCT04322643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93356302|NCT04322643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356303|NCT02796391|Nicotine|nicotine|mesh-list
93356304|NCT02796391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93356305|NCT02796391|Autonomic Agents|autonomic agents|mesh-ancestor
93356306|NCT02796391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356307|NCT02796391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356308|NCT02796391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93356309|NCT02796391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93356310|NCT02796391|Cholinergic Agents|cholinergic agents|mesh-ancestor
93356311|NCT02796391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356312|NCT02796391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356313|NCT02064049|Sofosbuvir|sofosbuvir|mesh-list
93356314|NCT02064049|Velpatasvir|velpatasvir|mesh-list
93356315|NCT02064049|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93356316|NCT02064049|Antiviral Agents|antiviral agents|mesh-ancestor
93356317|NCT02064049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356318|NCT02064829|Paclitaxel|paclitaxel|mesh-list
93356319|NCT02064829|genexol-PM|genexol-pm|mesh-list
93356320|NCT02064829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93356321|NCT02064829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93356322|NCT02064829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356323|NCT02064829|Tubulin Modulators|tubulin modulators|mesh-ancestor
93356324|NCT02064829|Antimitotic Agents|antimitotic agents|mesh-ancestor
93356325|NCT02064829|Mitosis Modulators|mitosis modulators|mesh-ancestor
93356326|NCT02064829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356327|NCT02064517|Calcium|calcium|mesh-list
93356328|NCT02064517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356329|NCT02064517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356330|NCT02067949|Simvastatin|simvastatin|mesh-list
93356331|NCT02067949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93356332|NCT02067949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93356333|NCT02067949|Antimetabolites|antimetabolites|mesh-ancestor
93356334|NCT02067949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356335|NCT02067949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93356336|NCT02067949|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93356337|NCT02067949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356338|NCT02068339|Oltipraz|oltipraz|mesh-list
93356339|NCT02068339|Antiviral Agents|antiviral agents|mesh-ancestor
93356340|NCT02068339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356341|NCT02068339|Schistosomicides|schistosomicides|mesh-ancestor
93356342|NCT02068339|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93356343|NCT02068339|Anthelmintics|anthelmintics|mesh-ancestor
93356344|NCT02068339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93356345|NCT02068339|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93356346|NCT02068339|Protective Agents|protective agents|mesh-ancestor
93356347|NCT02068339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356348|NCT02068339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356349|NCT02068339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93356350|NCT02068339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93356351|NCT02068339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356352|NCT02068339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356353|NCT02065843|Midazolam|midazolam|mesh-list
93356354|NCT02065843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93356355|NCT02065843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93356356|NCT02065843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356357|NCT02065843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356358|NCT02065843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93356359|NCT02065843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356360|NCT02065843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356361|NCT02065843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93356362|NCT02065843|Anesthetics, General|anesthetics, general|mesh-ancestor
93356363|NCT02065843|Anesthetics|anesthetics|mesh-ancestor
93356364|NCT02065843|GABA Modulators|gaba modulators|mesh-ancestor
93356365|NCT02065843|GABA Agents|gaba agents|mesh-ancestor
93356366|NCT02065843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356367|NCT02065843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356368|NCT02066077|Propofol|propofol|mesh-list
93356369|NCT02066077|Etomidate|etomidate|mesh-list
93356370|NCT02066077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93356371|NCT02066077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356372|NCT02066077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356373|NCT02066077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93356374|NCT02066077|Anesthetics, General|anesthetics, general|mesh-ancestor
93356375|NCT02066077|Anesthetics|anesthetics|mesh-ancestor
93356376|NCT03350815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93356377|NCT03350815|Immunologic Factors|immunologic factors|mesh-ancestor
93356378|NCT03350815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356379|NCT02065063|Palbociclib|palbociclib|mesh-list
93356380|NCT02065063|Trametinib|trametinib|mesh-list
93356381|NCT02065063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356382|NCT02065063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93356383|NCT02065063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356384|NCT02065063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356385|NCT02069197|Orlistat|orlistat|mesh-list
93356386|NCT02069197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356387|NCT02069197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356388|NCT02069197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93356389|NCT02069197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93356390|NCT02069431|Oxytocin|oxytocin|mesh-list
93356391|NCT02069431|Oxytocics|oxytocics|mesh-ancestor
93356392|NCT02069431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93356393|NCT02069431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356394|NCT01652872|Darbepoetin alfa|darbepoetin alfa|mesh-list
93356395|NCT01652872|Hematinics|hematinics|mesh-ancestor
93356396|NCT02065219|Bupivacaine|bupivacaine|mesh-list
93356397|NCT02065219|Anesthetics, Local|anesthetics, local|mesh-ancestor
93356398|NCT02065219|Anesthetics|anesthetics|mesh-ancestor
93356399|NCT02065219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356400|NCT02065219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356401|NCT02065219|Sensory System Agents|sensory system agents|mesh-ancestor
93356402|NCT02065219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356403|NCT03560011|Immunoglobulins|immunoglobulins|mesh-list
93356404|NCT03560011|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93356405|NCT03560011|Antibodies|antibodies|mesh-list
93356406|NCT03560011|Immunologic Factors|immunologic factors|mesh-ancestor
93356407|NCT03560011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356408|NCT02069665|Ribavirin|ribavirin|mesh-list
93356409|NCT02069665|Ibuprofen|ibuprofen|mesh-list
93356410|NCT02069665|Phenylpropanolamine|phenylpropanolamine|mesh-list
93356411|NCT02069665|Albuterol|albuterol|mesh-list
93356412|NCT02069665|Guaifenesin|guaifenesin|mesh-list
93356413|NCT02069665|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93356414|NCT02069665|Antimetabolites|antimetabolites|mesh-ancestor
93356415|NCT02069665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356416|NCT02069665|Antiviral Agents|antiviral agents|mesh-ancestor
93356417|NCT02069665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356418|NCT02069665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93356419|NCT02069665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93356420|NCT02069665|Analgesics|analgesics|mesh-ancestor
93356421|NCT02069665|Sensory System Agents|sensory system agents|mesh-ancestor
93356422|NCT02069665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356423|NCT02069665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356424|NCT02069665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356425|NCT02069665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93356426|NCT02069665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93356427|NCT02069665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356428|NCT02069665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93356429|NCT02069665|Autonomic Agents|autonomic agents|mesh-ancestor
93356430|NCT02069665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93356431|NCT02069665|Respiratory System Agents|respiratory system agents|mesh-ancestor
93356432|NCT02069665|Tocolytic Agents|tocolytic agents|mesh-ancestor
93356433|NCT02069665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93356434|NCT02069665|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93356435|NCT02069665|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93356436|NCT02069665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93356437|NCT02069665|Adrenergic Agents|adrenergic agents|mesh-ancestor
93356438|NCT02069665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356439|NCT02069665|Expectorants|expectorants|mesh-ancestor
93356440|NCT02069665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93356441|NCT02069665|Appetite Depressants|appetite depressants|mesh-ancestor
93356442|NCT02069665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93356443|NCT02069665|Sympathomimetics|sympathomimetics|mesh-ancestor
93356444|NCT02069665|Nasal Decongestants|nasal decongestants|mesh-ancestor
93356445|NCT02069665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93356446|NCT04938856|Lamotrigine|lamotrigine|mesh-list
93356447|NCT04938856|Anticonvulsants|anticonvulsants|mesh-ancestor
93356448|NCT04938856|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93356449|NCT04938856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356450|NCT04938856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356451|NCT04938856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356452|NCT04938856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356453|NCT04938856|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93356454|NCT04938856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356455|NCT04938856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356456|NCT04938856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356457|NCT04938856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93356458|NCT02461329|Polygeline|polygeline|mesh-list
93356459|NCT02461329|Plasma Substitutes|plasma substitutes|mesh-ancestor
93356460|NCT02461329|Blood Substitutes|blood substitutes|mesh-ancestor
93356461|NCT02463825|Pimozide|pimozide|mesh-list
92650125|NCT00228605|Fentanyl|fentanyl|mesh-list
93356462|NCT02463825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93356463|NCT02463825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356464|NCT02463825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356465|NCT02463825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356466|NCT02463825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356467|NCT02463825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93356468|NCT02463825|Dopamine Agents|dopamine agents|mesh-ancestor
93356469|NCT02463825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356470|NCT02463825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356471|NCT02463825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93028350|NCT00953537|Capecitabine|capecitabine|mesh-list
93356472|NCT02069977|Aripiprazole|aripiprazole|mesh-list
93356473|NCT02069977|Antidepressive Agents|antidepressive agents|mesh-ancestor
93356474|NCT02069977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356475|NCT02069977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93356476|NCT02069977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356477|NCT02069977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356478|NCT02069977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356479|NCT02069977|Dopamine Agonists|dopamine agonists|mesh-ancestor
93356480|NCT02069977|Dopamine Agents|dopamine agents|mesh-ancestor
93356481|NCT02069977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356482|NCT02069977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356483|NCT02069977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93356484|NCT02069977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93356485|NCT02069977|Serotonin Agents|serotonin agents|mesh-ancestor
93356486|NCT02069977|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93356487|NCT02069977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93356488|NCT02069977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93356489|NCT02069977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93356490|NCT04490031|Ketamine|ketamine|mesh-list
93356491|NCT04490031|Analgesics|analgesics|mesh-ancestor
93356492|NCT04490031|Sensory System Agents|sensory system agents|mesh-ancestor
93356493|NCT04490031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356494|NCT04490031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356495|NCT04490031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93356496|NCT04490031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93356497|NCT04490031|Anesthetics, General|anesthetics, general|mesh-ancestor
93356498|NCT04490031|Anesthetics|anesthetics|mesh-ancestor
93356499|NCT04490031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356500|NCT04490031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93356501|NCT04490031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93356502|NCT04490031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356503|NCT04490031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356504|NCT02443402|Insulin|insulin|mesh-list
93356505|NCT02443402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93356506|NCT02443402|Insulin Glargine|insulin glargine|mesh-list
93356507|NCT02443402|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93356508|NCT02443402|Insulin Aspart|insulin aspart|mesh-list
93356509|NCT02443402|Insulin Lispro|insulin lispro|mesh-list
93356510|NCT02443402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93356511|NCT02443402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356512|NCT02443402|Incretins|incretins|mesh-ancestor
93356513|NCT02443402|Hormones|hormones|mesh-ancestor
93356514|NCT02443402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356515|NCT02443402|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93356516|NCT02443402|Protease Inhibitors|protease inhibitors|mesh-ancestor
93356517|NCT02443402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356518|NCT02443402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356519|NCT02067013|Ranibizumab|ranibizumab|mesh-list
93356520|NCT02067013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93356521|NCT02067013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93356522|NCT02067013|Growth Substances|growth substances|mesh-ancestor
93356523|NCT02067013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356524|NCT02067013|Growth Inhibitors|growth inhibitors|mesh-ancestor
93356525|NCT02067013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356526|NCT03298581|Clobetasol|clobetasol|mesh-list
93356527|NCT03298581|Halobetasol|halobetasol|mesh-list
93356528|NCT03298581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93356529|NCT03298581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356530|NCT03298581|Glucocorticoids|glucocorticoids|mesh-ancestor
93356531|NCT03298581|Hormones|hormones|mesh-ancestor
92650196|NCT00414024|Tegaserod|tegaserod|mesh-list
93356532|NCT03298581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356533|NCT03298581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356534|NCT01370005|Empagliflozin|empagliflozin|mesh-list
93356535|NCT01370005|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93356536|NCT01370005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356537|NCT01370005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93356538|NCT01370005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356539|NCT02070133|Simvastatin|simvastatin|mesh-list
93356540|NCT02070133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93356541|NCT02070133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93356542|NCT02070133|Antimetabolites|antimetabolites|mesh-ancestor
93356543|NCT02070133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356544|NCT02070133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93028417|NCT01027494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93356545|NCT02070133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93356546|NCT02070133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356547|NCT02070289|PF-06372865|pf-06372865|mesh-list
93356548|NCT02070289|GABA Modulators|gaba modulators|mesh-ancestor
93356549|NCT02070289|GABA Agents|gaba agents|mesh-ancestor
93356550|NCT02070289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356551|NCT02070289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356552|NCT02070289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356553|NCT02071927|Azacitidine|azacitidine|mesh-list
93356554|NCT02071927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93356555|NCT02071927|Antimetabolites|antimetabolites|mesh-ancestor
93356556|NCT02071927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356557|NCT02071927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356558|NCT02071927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356559|NCT02072083|Dexmedetomidine|dexmedetomidine|mesh-list
93356560|NCT02072083|Ketamine|ketamine|mesh-list
93356561|NCT02072083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93356562|NCT02072083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356563|NCT02072083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356564|NCT02072083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93356565|NCT02072083|Analgesics|analgesics|mesh-ancestor
93356566|NCT02072083|Sensory System Agents|sensory system agents|mesh-ancestor
93356567|NCT02072083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356568|NCT02072083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93356569|NCT02072083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93356570|NCT02072083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93356571|NCT02072083|Adrenergic Agents|adrenergic agents|mesh-ancestor
93356572|NCT02072083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356573|NCT02072083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356574|NCT02072083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93356575|NCT02072083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93356576|NCT02072083|Anesthetics, General|anesthetics, general|mesh-ancestor
93356577|NCT02072083|Anesthetics|anesthetics|mesh-ancestor
93356578|NCT02072083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93356579|NCT02072083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93356580|NCT02070679|Vitamin E|vitamin e|mesh-list
93356581|NCT02070679|Tocopherols|tocopherols|mesh-list
93356582|NCT02070679|alpha-Tocopherol|alpha-tocopherol|mesh-list
93356583|NCT02070679|Vitamins|vitamins|mesh-ancestor
93356584|NCT02070679|Micronutrients|micronutrients|mesh-ancestor
93356585|NCT02070679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356586|NCT02070679|Antioxidants|antioxidants|mesh-ancestor
93356587|NCT02070679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356588|NCT02070679|Protective Agents|protective agents|mesh-ancestor
93356589|NCT02412436|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93356590|NCT02412436|Medroxyprogesterone|medroxyprogesterone|mesh-list
93356591|NCT02412436|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93356592|NCT02412436|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93356593|NCT02412436|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93356594|NCT02412436|Contraceptive Agents|contraceptive agents|mesh-ancestor
93356595|NCT02412436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93356596|NCT02412436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356597|NCT02412436|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93356598|NCT02412436|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93356599|NCT02412436|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92650271|NCT00191152|Tubulin Modulators|tubulin modulators|mesh-ancestor
93356600|NCT02412436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93356601|NCT02412436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356602|NCT02067715|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93356603|NCT02067715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93356604|NCT02067715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356605|NCT02072317|Raltitrexed|raltitrexed|mesh-list
93356606|NCT02072317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93356607|NCT02072317|Antimetabolites|antimetabolites|mesh-ancestor
93356608|NCT02072317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356609|NCT02072317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356610|NCT02072317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93356611|NCT02072317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356612|NCT01651000|Calcifediol|calcifediol|mesh-list
93356613|NCT01651000|Vitamins|vitamins|mesh-ancestor
93356614|NCT01651000|Micronutrients|micronutrients|mesh-ancestor
93356615|NCT01651000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356616|NCT01651000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93356617|NCT02469610|Bupivacaine|bupivacaine|mesh-list
93356618|NCT02469610|Anesthetics, Local|anesthetics, local|mesh-ancestor
93356619|NCT02469610|Anesthetics|anesthetics|mesh-ancestor
93356620|NCT02469610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356621|NCT02469610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356622|NCT02469610|Sensory System Agents|sensory system agents|mesh-ancestor
93356623|NCT02469610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356625|NCT02071069|Irinotecan|irinotecan|mesh-list
93356626|NCT02071069|Cetuximab|cetuximab|mesh-list
93356627|NCT02071069|Antimetabolites|antimetabolites|mesh-ancestor
93356628|NCT02071069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356629|NCT02071069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93356630|NCT02071069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356631|NCT02071069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93356632|NCT02071069|Immunologic Factors|immunologic factors|mesh-ancestor
93356633|NCT02071069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356634|NCT02071069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93356635|NCT02071069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93356636|NCT02071069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356637|NCT02071069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93356638|NCT02076373|Epoetin Alfa|epoetin alfa|mesh-list
93356639|NCT02076373|Hematinics|hematinics|mesh-ancestor
93356640|NCT02072785|Vincristine|vincristine|mesh-list
93356641|NCT02072785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93356642|NCT02072785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356643|NCT02072785|Tubulin Modulators|tubulin modulators|mesh-ancestor
93356644|NCT02072785|Antimitotic Agents|antimitotic agents|mesh-ancestor
93356645|NCT02072785|Mitosis Modulators|mitosis modulators|mesh-ancestor
93356646|NCT02072785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356647|NCT02469298|Oseltamivir|oseltamivir|mesh-list
93356648|NCT02469298|Antiviral Agents|antiviral agents|mesh-ancestor
93356649|NCT02469298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356650|NCT02469298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356651|NCT02469298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356652|NCT02076451|DS-8273a|ds-8273a|mesh-list
93356653|NCT02076451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93356654|NCT02076451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356655|NCT02071303|Celecoxib|celecoxib|mesh-list
93356656|NCT02071303|Tramadol|tramadol|mesh-list
93356657|NCT02071303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93356658|NCT02071303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93356659|NCT02071303|Analgesics|analgesics|mesh-ancestor
93356660|NCT02071303|Sensory System Agents|sensory system agents|mesh-ancestor
93356661|NCT02071303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356662|NCT02071303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356663|NCT02071303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356664|NCT02071303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93356665|NCT02071303|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93356666|NCT02071303|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93356667|NCT02071303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356668|NCT02071303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356669|NCT02071303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93356670|NCT02071303|Narcotics|narcotics|mesh-ancestor
93356671|NCT02071303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356672|NCT02076529|Ramosetron|ramosetron|mesh-list
93356673|NCT02076529|Antiemetics|antiemetics|mesh-ancestor
93356674|NCT02076529|Autonomic Agents|autonomic agents|mesh-ancestor
92650386|NCT00199277|Iron|iron|mesh-list
93356675|NCT02076529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356676|NCT02076529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356677|NCT02076529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93356678|NCT02076529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93356679|NCT02076529|Serotonin Agents|serotonin agents|mesh-ancestor
93356680|NCT02076529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356681|NCT02076529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356682|NCT02411578|Glucagon|glucagon|mesh-list
93356683|NCT02411578|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93356684|NCT02411578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93356685|NCT02411578|Hormones|hormones|mesh-ancestor
93356686|NCT02411578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356687|NCT02411578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356688|NCT02411578|Incretins|incretins|mesh-ancestor
93356689|NCT02076685|Isoniazid|isoniazid|mesh-list
93356690|NCT02076685|Antitubercular Agents|antitubercular agents|mesh-ancestor
93356691|NCT02076685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028574|NCT01026558|Ceftobiprole|ceftobiprole|mesh-list
93356692|NCT02076685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356693|NCT02076685|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93356694|NCT02076685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93356695|NCT02076685|Antimetabolites|antimetabolites|mesh-ancestor
93356696|NCT02076685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356697|NCT02076685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93356698|NCT05077917|Cromolyn Sodium|cromolyn sodium|mesh-list
93356699|NCT05077917|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
93356700|NCT05077917|Immunologic Factors|immunologic factors|mesh-ancestor
93356701|NCT05077917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356702|NCT05077917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93356703|NCT05077917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356704|NCT05077917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93356705|NCT05077917|Respiratory System Agents|respiratory system agents|mesh-ancestor
93356706|NCT02071459|Droxidopa|droxidopa|mesh-list
93356707|NCT02071459|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93356708|NCT02071459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93356709|NCT02463747|Vancomycin|vancomycin|mesh-list
93356710|NCT02463747|Meropenem|meropenem|mesh-list
93356711|NCT02463747|Tazobactam|tazobactam|mesh-list
93356712|NCT02463747|Piperacillin|piperacillin|mesh-list
93356713|NCT02463747|Ceftazidime|ceftazidime|mesh-list
93356714|NCT02463747|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93356715|NCT02463747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93356716|NCT02463747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356717|NCT02463747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93356718|NCT02463747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356719|NCT02463747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356720|NCT02071537|Chloroquine|chloroquine|mesh-list
93356721|NCT02071537|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93356722|NCT02071537|Carboplatin|carboplatin|mesh-list
93356723|NCT02071537|Gemcitabine|gemcitabine|mesh-list
93356724|NCT02071537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356725|NCT02071537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93356726|NCT02071537|Antimetabolites|antimetabolites|mesh-ancestor
93356727|NCT02071537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356728|NCT02071537|Amebicides|amebicides|mesh-ancestor
93356729|NCT02071537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93356730|NCT02071537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93356731|NCT02071537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356732|NCT02071537|Antimalarials|antimalarials|mesh-ancestor
93356733|NCT02071537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93356734|NCT02071537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93356735|NCT02071537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93356736|NCT02071537|Analgesics|analgesics|mesh-ancestor
93356737|NCT02071537|Sensory System Agents|sensory system agents|mesh-ancestor
93356738|NCT02071537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356739|NCT02071537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356740|NCT02071537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356741|NCT02071537|Filaricides|filaricides|mesh-ancestor
93356742|NCT02071537|Antinematodal Agents|antinematodal agents|mesh-ancestor
93356743|NCT02071537|Anthelmintics|anthelmintics|mesh-ancestor
93356744|NCT02076841|Interferons|interferons|mesh-list
93356745|NCT02076841|Interferon-beta|interferon-beta|mesh-list
93356746|NCT02076841|Interferon beta-1a|interferon beta-1a|mesh-list
93356747|NCT02076841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356748|NCT02076841|Antiviral Agents|antiviral agents|mesh-ancestor
93356749|NCT02076841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356750|NCT02076841|Immunologic Factors|immunologic factors|mesh-ancestor
93356751|NCT02076841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356752|NCT02076841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93356753|NCT02442310|Deferiprone|deferiprone|mesh-list
93356754|NCT02442310|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93356755|NCT02442310|Chelating Agents|chelating agents|mesh-ancestor
93356756|NCT02442310|Sequestering Agents|sequestering agents|mesh-ancestor
93356757|NCT02442310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356758|NCT02071615|Caffeine|caffeine|mesh-list
93356759|NCT02071615|Methylphenidate|methylphenidate|mesh-list
93356760|NCT02071615|Modafinil|modafinil|mesh-list
93356761|NCT02071615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93356762|NCT02071615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356763|NCT02071615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93356764|NCT02071615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356765|NCT02071615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356766|NCT02071615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93356767|NCT02071615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93356768|NCT02071615|Purinergic Agents|purinergic agents|mesh-ancestor
93356769|NCT02071615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356770|NCT02071615|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93356771|NCT02071615|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93356772|NCT02071615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356773|NCT02071615|Dopamine Agents|dopamine agents|mesh-ancestor
93356774|NCT02071615|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93356775|NCT02071615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93356776|NCT02071615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93356777|NCT02077231|Vitamins|vitamins|mesh-list
93356778|NCT02077231|Vitamin A|vitamin a|mesh-list
93356779|NCT02077231|Retinol palmitate|retinol palmitate|mesh-list
93356780|NCT02077231|Micronutrients|micronutrients|mesh-ancestor
93356781|NCT02077231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356782|NCT02077231|Antioxidants|antioxidants|mesh-ancestor
93356783|NCT02077231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356784|NCT02077231|Protective Agents|protective agents|mesh-ancestor
93356785|NCT02077231|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93356786|NCT02077231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356787|NCT02077309|Linagliptin|linagliptin|mesh-list
93356788|NCT02077309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93356789|NCT02077309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356790|NCT02077309|Incretins|incretins|mesh-ancestor
93356791|NCT02077309|Hormones|hormones|mesh-ancestor
93356792|NCT02077309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356793|NCT02077309|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93356794|NCT02077309|Protease Inhibitors|protease inhibitors|mesh-ancestor
93356795|NCT02077309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356796|NCT02077309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356797|NCT01369849|Rituximab|rituximab|mesh-list
93356798|NCT01369849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93356799|NCT01369849|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93356800|NCT01369849|Antibodies|antibodies|mesh-list
93356801|NCT01369849|Immunoglobulins|immunoglobulins|mesh-list
93356802|NCT01369849|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93356803|NCT01369849|Immunologic Factors|immunologic factors|mesh-ancestor
93356804|NCT01369849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356805|NCT01369849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356806|NCT01369849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93356807|NCT01369849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93356808|NCT01369849|Alkylating Agents|alkylating agents|mesh-ancestor
93356809|NCT01369849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356810|NCT02716779|Interferons|interferons|mesh-list
93356811|NCT02716779|Ribavirin|ribavirin|mesh-list
93356812|NCT02716779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356813|NCT02716779|Antiviral Agents|antiviral agents|mesh-ancestor
93356814|NCT02716779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356815|NCT02716779|Antimetabolites|antimetabolites|mesh-ancestor
93356816|NCT02716779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356817|NCT02074189|Gemcitabine|gemcitabine|mesh-list
93356818|NCT02074189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356819|NCT02074189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93356820|NCT02074189|Antimetabolites|antimetabolites|mesh-ancestor
93356821|NCT02074189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356822|NCT02463591|Thrombin|thrombin|mesh-list
93356823|NCT02463591|Hemostatics|hemostatics|mesh-ancestor
93356824|NCT02463591|Coagulants|coagulants|mesh-ancestor
93356825|NCT02079961|Micronutrients|micronutrients|mesh-list
93356826|NCT02079961|Trace Elements|trace elements|mesh-list
93356827|NCT02079961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356828|NCT03298347|Caffeine|caffeine|mesh-list
93356829|NCT03298347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93356830|NCT03298347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356831|NCT03298347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93356832|NCT03298347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356833|NCT03298347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356834|NCT03298347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93356835|NCT03298347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93356836|NCT03298347|Purinergic Agents|purinergic agents|mesh-ancestor
93356837|NCT03298347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356838|NCT02074267|Gabapentin|gabapentin|mesh-list
93356839|NCT02074267|Analgesics|analgesics|mesh-ancestor
93356840|NCT02074267|Sensory System Agents|sensory system agents|mesh-ancestor
93356841|NCT02074267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356842|NCT02074267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356843|NCT02074267|Anticonvulsants|anticonvulsants|mesh-ancestor
93356844|NCT02074267|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93356845|NCT02074267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356846|NCT02074267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356847|NCT02074267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356848|NCT02074267|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93356849|NCT02074267|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93356850|NCT02074267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356851|NCT02074267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356852|NCT02074267|Antimanic Agents|antimanic agents|mesh-ancestor
93356853|NCT02077777|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93356855|NCT02077777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93356856|NCT02077777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93356857|NCT02077777|Analgesics|analgesics|mesh-ancestor
93356858|NCT02077777|Sensory System Agents|sensory system agents|mesh-ancestor
93356859|NCT02077777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356860|NCT02077777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356861|NCT02077777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356862|NCT02077777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93356863|NCT02077777|Antitubercular Agents|antitubercular agents|mesh-ancestor
93356864|NCT02077777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93356865|NCT02077777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356866|NCT05036421|Empagliflozin|empagliflozin|mesh-list
93356867|NCT05036421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93356868|NCT05036421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356869|NCT05036421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93356870|NCT05036421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356871|NCT03298191|Magnesium Sulfate|magnesium sulfate|mesh-list
93356872|NCT03298191|Calcium Channel Blockers|calcium channel blockers|mesh-list
93356873|NCT03298191|Ritodrine|ritodrine|mesh-list
93356874|NCT03298191|Calcium|calcium|mesh-list
93356875|NCT03298191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356876|NCT03298191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356877|NCT03298191|Analgesics|analgesics|mesh-ancestor
93356878|NCT03298191|Sensory System Agents|sensory system agents|mesh-ancestor
93356879|NCT03298191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356880|NCT03298191|Anesthetics|anesthetics|mesh-ancestor
93356881|NCT03298191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356882|NCT03298191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93356883|NCT03298191|Anticonvulsants|anticonvulsants|mesh-ancestor
93356884|NCT03298191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356885|NCT03298191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356886|NCT03298191|Tocolytic Agents|tocolytic agents|mesh-ancestor
93356887|NCT03298191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93356888|NCT03298191|Sympathomimetics|sympathomimetics|mesh-ancestor
93356889|NCT03298191|Autonomic Agents|autonomic agents|mesh-ancestor
93356890|NCT03298191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93356891|NCT03298191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93356892|NCT03298191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93356893|NCT03298191|Adrenergic Agents|adrenergic agents|mesh-ancestor
93356894|NCT03298191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356895|NCT01369615|Oxycodone|oxycodone|mesh-list
93356896|NCT01369615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93356897|NCT01369615|Narcotics|narcotics|mesh-ancestor
93356898|NCT01369615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356899|NCT01369615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356900|NCT01369615|Analgesics|analgesics|mesh-ancestor
93356901|NCT01369615|Sensory System Agents|sensory system agents|mesh-ancestor
93356902|NCT01369615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356903|NCT02077933|Everolimus|everolimus|mesh-list
93356904|NCT02077933|Exemestane|exemestane|mesh-list
93356905|NCT02077933|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93356906|NCT02077933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93356907|NCT02077933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356908|NCT02077933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356909|NCT02077933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93356910|NCT02077933|Immunologic Factors|immunologic factors|mesh-ancestor
93356911|NCT02077933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356912|NCT02077933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93356913|NCT02077933|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93356914|NCT02077933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93356915|NCT02077933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93356916|NCT02077933|Hormone Antagonists|hormone antagonists|mesh-ancestor
93356917|NCT02077933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356918|NCT02078089|Oxcarbazepine|oxcarbazepine|mesh-list
93356919|NCT02078089|Morphine|morphine|mesh-list
93356920|NCT02078089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93356921|NCT02078089|Narcotics|narcotics|mesh-ancestor
93356922|NCT02078089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356923|NCT02078089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356924|NCT02078089|Analgesics|analgesics|mesh-ancestor
93356925|NCT02078089|Sensory System Agents|sensory system agents|mesh-ancestor
93356926|NCT02078089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356927|NCT02078089|Anticonvulsants|anticonvulsants|mesh-ancestor
93356928|NCT02078089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93356929|NCT02078089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93356930|NCT02078089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356931|NCT02078089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356932|NCT02078089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93356933|NCT02078089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93356934|NCT02074891|Tenofovir|tenofovir|mesh-list
93356935|NCT02074891|Antiviral Agents|antiviral agents|mesh-ancestor
93356936|NCT02074891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93356937|NCT02074891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93356938|NCT02074891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93356939|NCT02074891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356940|NCT02074891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356941|NCT02074891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93356942|NCT02074891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93356943|NCT02078167|Policosanol|policosanol|mesh-list
93356944|NCT02078167|Red yeast rice|red yeast rice|mesh-list
93356945|NCT02078167|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93356946|NCT02078167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93356947|NCT02078167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93356948|NCT02078167|Antimetabolites|antimetabolites|mesh-ancestor
93356949|NCT02078167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356950|NCT02078167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650626|NCT00199979|Antiviral Agents|antiviral agents|mesh-ancestor
93356951|NCT02078167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93356952|NCT02078167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93356953|NCT02078323|Linaclotide|linaclotide|mesh-list
93356954|NCT02078323|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93356955|NCT02078323|Enzyme Activators|enzyme activators|mesh-ancestor
93356956|NCT02078323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356957|NCT02078323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93356958|NCT02075749|Triamcinolone|triamcinolone|mesh-list
93356959|NCT02075749|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93356960|NCT02075749|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93356961|NCT02075749|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93356962|NCT02075749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93356963|NCT02075749|Glucocorticoids|glucocorticoids|mesh-ancestor
93356964|NCT02075749|Hormones|hormones|mesh-ancestor
93356965|NCT02075749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93356966|NCT02075749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356967|NCT02075749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93356968|NCT02075749|Immunologic Factors|immunologic factors|mesh-ancestor
93356969|NCT02075749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93356970|NCT02075749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356971|NCT02081287|Inositol|inositol|mesh-list
93356972|NCT02081287|Lamotrigine|lamotrigine|mesh-list
93356973|NCT02081287|Anticonvulsants|anticonvulsants|mesh-ancestor
93356974|NCT02081287|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93356975|NCT02081287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93356976|NCT02081287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356977|NCT02081287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93356978|NCT02081287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356979|NCT02081287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93356980|NCT02081287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93356981|NCT02081287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93356982|NCT02081287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93356983|NCT02081287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93356984|NCT02081287|Vitamin B Complex|vitamin b complex|mesh-ancestor
93356985|NCT02081287|Vitamins|vitamins|mesh-ancestor
93356986|NCT02081287|Micronutrients|micronutrients|mesh-ancestor
93356987|NCT02078791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93356988|NCT02078791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93356989|NCT02078791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93356990|NCT02078791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93356991|NCT02078791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93356992|NCT02078791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93356993|NCT02078791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028862|NCT00953771|Danazol|danazol|mesh-list
93356994|NCT02078791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93356995|NCT02078791|Cholinergic Agents|cholinergic agents|mesh-ancestor
93356996|NCT02078791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93356998|NCT04918069|Antipruritics|antipruritics|mesh-ancestor
93356999|NCT04918069|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357000|NCT04918069|Sensory System Agents|sensory system agents|mesh-ancestor
93357001|NCT04918069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357002|NCT04918069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357003|NCT02083315|Morphine|morphine|mesh-list
93357004|NCT02083315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93357005|NCT02083315|Narcotics|narcotics|mesh-ancestor
93357006|NCT02083315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357007|NCT02083315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357008|NCT02083315|Analgesics|analgesics|mesh-ancestor
93357009|NCT02083315|Sensory System Agents|sensory system agents|mesh-ancestor
93357010|NCT02083315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357011|NCT03559387|Lenograstim|lenograstim|mesh-list
93357012|NCT03559387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93357013|NCT03559387|Immunologic Factors|immunologic factors|mesh-ancestor
93357014|NCT03559387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357015|NCT05519059|Paclitaxel|paclitaxel|mesh-list
93357016|NCT05519059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93357017|NCT05519059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357018|NCT05519059|Tubulin Modulators|tubulin modulators|mesh-ancestor
93357019|NCT05519059|Antimitotic Agents|antimitotic agents|mesh-ancestor
93357020|NCT05519059|Mitosis Modulators|mitosis modulators|mesh-ancestor
93357021|NCT05519059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357022|NCT02079337|Rocuronium|rocuronium|mesh-list
92650689|NCT00257751|Protease Inhibitors|protease inhibitors|mesh-ancestor
93357023|NCT02079337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93357024|NCT02079337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93357025|NCT02079337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93357026|NCT02079337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357027|NCT02079337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357028|NCT02083627|Fidaxomicin|fidaxomicin|mesh-list
93357029|NCT02083627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93357030|NCT02083627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357031|NCT02083627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357032|NCT02083627|Antimetabolites|antimetabolites|mesh-ancestor
93357033|NCT02083627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357034|NCT02083627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357035|NCT02083627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93357036|NCT02083627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357037|NCT02083627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357038|NCT02083627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357039|NCT02079727|Celecoxib|celecoxib|mesh-list
93357040|NCT02079727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93357041|NCT02079727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357042|NCT02079727|Analgesics|analgesics|mesh-ancestor
93357043|NCT02079727|Sensory System Agents|sensory system agents|mesh-ancestor
93357044|NCT02079727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357045|NCT02079727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357046|NCT02079727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357047|NCT02079727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357048|NCT02079727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93357049|NCT02079727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93357050|NCT02079727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357051|NCT02079727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357052|NCT02082067|Ketorolac|ketorolac|mesh-list
93357053|NCT02082067|Morphine|morphine|mesh-list
93357054|NCT02082067|Anesthetics|anesthetics|mesh-list
93357055|NCT02082067|Ropivacaine|ropivacaine|mesh-list
93357056|NCT02082067|Levobupivacaine|levobupivacaine|mesh-list
93357057|NCT02082067|Anesthetics, Local|anesthetics, local|mesh-list
93357058|NCT02082067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357059|NCT02082067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357060|NCT02082067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93357061|NCT02082067|Narcotics|narcotics|mesh-ancestor
93357062|NCT02082067|Analgesics|analgesics|mesh-ancestor
93357063|NCT02082067|Sensory System Agents|sensory system agents|mesh-ancestor
93357064|NCT02082067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357065|NCT02082067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93357066|NCT02082067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357067|NCT02082067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357068|NCT02082067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357069|NCT02082067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93357070|NCT02082067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357071|NCT02082067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357072|NCT02084563|Cytarabine|cytarabine|mesh-list
93357073|NCT02084563|Decitabine|decitabine|mesh-list
93357074|NCT02084563|Daunorubicin|daunorubicin|mesh-list
93357075|NCT02084563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93357076|NCT02084563|Antimetabolites|antimetabolites|mesh-ancestor
93357077|NCT02084563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357078|NCT02084563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357079|NCT02084563|Antiviral Agents|antiviral agents|mesh-ancestor
93357080|NCT02084563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357081|NCT02084563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357082|NCT02084563|Immunologic Factors|immunologic factors|mesh-ancestor
93357083|NCT02084563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357084|NCT02084563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93357085|NCT02084563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93357086|NCT02084563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93357087|NCT02084563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357088|NCT02084719|Antibodies|antibodies|mesh-list
93357089|NCT02084719|Immunologic Factors|immunologic factors|mesh-ancestor
93357090|NCT02084719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357091|NCT02084875|Tofacitinib|tofacitinib|mesh-list
93357092|NCT02084875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93357093|NCT02084875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93357094|NCT02084875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357095|NCT02084875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357096|NCT02689453|Alemtuzumab|alemtuzumab|mesh-list
93357097|NCT02689453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93357098|NCT02689453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357099|NCT02084953|Moxifloxacin|moxifloxacin|mesh-list
93357100|NCT02084953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357101|NCT02084953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357102|NCT02084953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93357103|NCT02084953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93357104|NCT02084953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357105|NCT02084953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357106|NCT02084953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357107|NCT02082613|Polidocanol|polidocanol|mesh-list
93357108|NCT02082613|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93357109|NCT02082613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93357110|NCT02085109|Theobromine|theobromine|mesh-list
93357111|NCT02085109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93357112|NCT02085109|Autonomic Agents|autonomic agents|mesh-ancestor
93357113|NCT02085109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357114|NCT02085109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357115|NCT02085109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93357116|NCT02085109|Respiratory System Agents|respiratory system agents|mesh-ancestor
93357117|NCT02085109|Vasodilator Agents|vasodilator agents|mesh-ancestor
93357118|NCT03557983|Fenofibrate|fenofibrate|mesh-list
93357119|NCT03557983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357120|NCT03557983|Antimetabolites|antimetabolites|mesh-ancestor
93357121|NCT03557983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357122|NCT03557983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357123|NCT03558919|Solifenacin Succinate|solifenacin succinate|mesh-list
93357124|NCT03558919|Mirabegron|mirabegron|mesh-list
93357125|NCT03558919|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93357126|NCT03558919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93357127|NCT03558919|Cholinergic Agents|cholinergic agents|mesh-ancestor
93357128|NCT03558919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357129|NCT03558919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357130|NCT03558919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357131|NCT03558919|Urological Agents|urological agents|mesh-ancestor
93357132|NCT03558919|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93357133|NCT03558919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93357134|NCT03558919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93357135|NCT03558919|Adrenergic Agents|adrenergic agents|mesh-ancestor
93357136|NCT02085577|Acetaminophen|acetaminophen|mesh-list
93357137|NCT02085577|Sufentanil|sufentanil|mesh-list
93357138|NCT02085577|Ketamine|ketamine|mesh-list
93357139|NCT02085577|Morphine|morphine|mesh-list
93357140|NCT02085577|Dsuvia|dsuvia|mesh-list
93357141|NCT02085577|Ondansetron|ondansetron|mesh-list
93357142|NCT02085577|Analgesics|analgesics|mesh-ancestor
93357143|NCT02085577|Sensory System Agents|sensory system agents|mesh-ancestor
93357144|NCT02085577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357145|NCT02085577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357146|NCT02085577|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93357147|NCT02085577|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93357148|NCT02085577|Anesthetics, General|anesthetics, general|mesh-ancestor
93357149|NCT02085577|Anesthetics|anesthetics|mesh-ancestor
93357150|NCT02085577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357151|NCT02085577|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93357152|NCT02085577|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93357153|NCT02085577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357154|NCT02085577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357155|NCT02085577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93357156|NCT02085577|Narcotics|narcotics|mesh-ancestor
93357157|NCT02085577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357158|NCT02085577|Antipyretics|antipyretics|mesh-ancestor
93357159|NCT02085577|Antiemetics|antiemetics|mesh-ancestor
93357160|NCT02085577|Autonomic Agents|autonomic agents|mesh-ancestor
93357161|NCT02085577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357162|NCT02085577|Antipruritics|antipruritics|mesh-ancestor
93357163|NCT02085577|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357164|NCT02085577|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93357165|NCT02085577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93357166|NCT02085577|Serotonin Agents|serotonin agents|mesh-ancestor
93357167|NCT02085577|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93357168|NCT02085655|Thalidomide|thalidomide|mesh-list
93357169|NCT02085655|Dexamethasone|dexamethasone|mesh-list
93357170|NCT02085655|Gemcitabine|gemcitabine|mesh-list
93357171|NCT02085655|Oxaliplatin|oxaliplatin|mesh-list
93357172|NCT02085655|Methotrexate|methotrexate|mesh-list
93357173|NCT02085655|Pegaspargase|pegaspargase|mesh-list
93357174|NCT02085655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357175|NCT02085655|Antiemetics|antiemetics|mesh-ancestor
93357176|NCT02085655|Autonomic Agents|autonomic agents|mesh-ancestor
93357177|NCT02085655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357178|NCT02085655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357179|NCT02085655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357180|NCT02085655|Glucocorticoids|glucocorticoids|mesh-ancestor
93357182|NCT02085655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357183|NCT02085655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93357184|NCT02085655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357185|NCT02085655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93357186|NCT02085655|Antimetabolites|antimetabolites|mesh-ancestor
93357187|NCT02085655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357188|NCT02085655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93357189|NCT02085655|Abortifacient Agents|abortifacient agents|mesh-ancestor
93357190|NCT02085655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93357191|NCT02085655|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357192|NCT02085655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357193|NCT02085655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93357194|NCT02085655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357195|NCT02085655|Immunologic Factors|immunologic factors|mesh-ancestor
93357196|NCT02085655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357197|NCT02085655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93357198|NCT02085655|Leprostatic Agents|leprostatic agents|mesh-ancestor
93357199|NCT02085655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357200|NCT02085655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357201|NCT02085655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93357202|NCT02085655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93357203|NCT02085655|Growth Substances|growth substances|mesh-ancestor
93357204|NCT02085655|Growth Inhibitors|growth inhibitors|mesh-ancestor
93357205|NCT02085967|Itraconazole|itraconazole|mesh-list
93357206|NCT02085967|Rifampin|rifampin|mesh-list
93357207|NCT02085967|Midazolam|midazolam|mesh-list
93357208|NCT02085967|Bupropion|bupropion|mesh-list
93357209|NCT02085967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93357210|NCT02085967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93357211|NCT02085967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357212|NCT02085967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357213|NCT02085967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93357214|NCT02085967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93357215|NCT02085967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93357216|NCT02085967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93357217|NCT02085967|Anesthetics, General|anesthetics, general|mesh-ancestor
93357218|NCT02085967|Anesthetics|anesthetics|mesh-ancestor
93357219|NCT02085967|GABA Modulators|gaba modulators|mesh-ancestor
93357220|NCT02085967|GABA Agents|gaba agents|mesh-ancestor
93357221|NCT02085967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357222|NCT02085967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357223|NCT02085967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93357224|NCT02085967|Antidepressive Agents|antidepressive agents|mesh-ancestor
93357225|NCT02085967|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93357226|NCT02085967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93357227|NCT02085967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93357229|NCT02085967|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93357230|NCT02085967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93357231|NCT02085967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357232|NCT02085967|Antifungal Agents|antifungal agents|mesh-ancestor
93357233|NCT02085967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357234|NCT02085967|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93357235|NCT02085967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93357236|NCT02085967|Hormone Antagonists|hormone antagonists|mesh-ancestor
93357237|NCT02085967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357238|NCT02085967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92650908|NCT00172042|Zoledronic Acid|zoledronic acid|mesh-list
93357239|NCT02085967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93357240|NCT02085967|Antitubercular Agents|antitubercular agents|mesh-ancestor
93357241|NCT02085967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357242|NCT02085967|Leprostatic Agents|leprostatic agents|mesh-ancestor
93357243|NCT02085967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93357244|NCT02085967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93357245|NCT02085967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93357246|NCT02085967|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93357247|NCT02085967|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93357248|NCT02085967|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93357249|NCT02085967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93357250|NCT02091505|Ranibizumab|ranibizumab|mesh-list
93357251|NCT02091505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93357252|NCT02091505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93357253|NCT02091505|Growth Substances|growth substances|mesh-ancestor
93357254|NCT02091505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357255|NCT02091505|Growth Inhibitors|growth inhibitors|mesh-ancestor
93357256|NCT02091505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357257|NCT02091817|Oxytocin|oxytocin|mesh-list
93357258|NCT02091817|Oxytocics|oxytocics|mesh-ancestor
93357259|NCT02091817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93357260|NCT02091817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357261|NCT02086279|Hormones|hormones|mesh-list
93357262|NCT02086279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357263|NCT02086279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357264|NCT02091973|Everolimus|everolimus|mesh-list
93357265|NCT02091973|Tacrolimus|tacrolimus|mesh-list
93357266|NCT02091973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357267|NCT02091973|Immunologic Factors|immunologic factors|mesh-ancestor
93357268|NCT02091973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357269|NCT02091973|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93357270|NCT02091973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357271|NCT02091973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357272|NCT02091973|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93357273|NCT02091973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93357274|NCT02091973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357275|NCT03558295|Anticoagulants|anticoagulants|mesh-list
93357276|NCT02089399|Olmesartan|olmesartan|mesh-list
93357277|NCT02089399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93357278|NCT02089399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357279|NCT02089399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357280|NCT02089399|Antimetabolites|antimetabolites|mesh-ancestor
93357281|NCT02089399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357282|NCT02089399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357283|NCT02089399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93357284|NCT02089399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357285|NCT02089399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93357286|NCT02089399|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93357287|NCT02089399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93357288|NCT03557437|Amoxicillin|amoxicillin|mesh-list
93357289|NCT03557437|Metronidazole|metronidazole|mesh-list
93357290|NCT03557437|Potassium Citrate|potassium citrate|mesh-list
93357291|NCT03557437|Esomeprazole|esomeprazole|mesh-list
93357292|NCT03557437|Bismuth|bismuth|mesh-list
93357293|NCT03557437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357294|NCT03557437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357295|NCT03557437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357297|NCT03557437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93357298|NCT03557437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93357299|NCT03557437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357300|NCT03557437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93357301|NCT03557437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357302|NCT03557437|Antacids|antacids|mesh-ancestor
93357303|NCT03557437|Diuretics|diuretics|mesh-ancestor
93357304|NCT03557437|Natriuretic Agents|natriuretic agents|mesh-ancestor
93357305|NCT03557437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357306|NCT03557437|Expectorants|expectorants|mesh-ancestor
93357307|NCT03557437|Respiratory System Agents|respiratory system agents|mesh-ancestor
93357308|NCT02089633|BCT-100|bct-100|mesh-list
93357309|NCT02089633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357310|NCT02086747|Acetaminophen|acetaminophen|mesh-list
93357311|NCT02086747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357312|NCT02086747|Analgesics|analgesics|mesh-ancestor
92650981|NCT00201422|Omeprazole|omeprazole|mesh-list
93357313|NCT02086747|Sensory System Agents|sensory system agents|mesh-ancestor
93357314|NCT02086747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357315|NCT02086747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357316|NCT02086747|Antipyretics|antipyretics|mesh-ancestor
93357317|NCT02086825|Rifaximin|rifaximin|mesh-list
93357318|NCT02086825|Lactulose|lactulose|mesh-list
93357319|NCT02086825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357320|NCT02086825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357321|NCT02086825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357322|NCT02086903|Clopidogrel|clopidogrel|mesh-list
93357323|NCT02086903|Ticagrelor|ticagrelor|mesh-list
93357324|NCT02086903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93357325|NCT02086903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93357326|NCT02086903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93357327|NCT02086903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93357328|NCT02086903|Purinergic Agents|purinergic agents|mesh-ancestor
93357329|NCT02086903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357330|NCT02086903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357331|NCT02086903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357332|NCT02087215|Boron|boron|mesh-list
93357333|NCT02087215|Trace Elements|trace elements|mesh-ancestor
93357334|NCT02087215|Micronutrients|micronutrients|mesh-ancestor
93357335|NCT02087215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357336|NCT02087527|Dexamethasone|dexamethasone|mesh-list
93357337|NCT02087527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357338|NCT02087527|Antiemetics|antiemetics|mesh-ancestor
93357339|NCT02087527|Autonomic Agents|autonomic agents|mesh-ancestor
93357340|NCT02087527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357341|NCT02087527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357342|NCT02087527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357343|NCT02087527|Glucocorticoids|glucocorticoids|mesh-ancestor
93357344|NCT02087527|Hormones|hormones|mesh-ancestor
93357345|NCT02087527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357346|NCT02087527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93357347|NCT02087527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357348|NCT02087683|Vitamin D|vitamin d|mesh-list
93357349|NCT02087683|Vitamins|vitamins|mesh-ancestor
93357350|NCT02087683|Micronutrients|micronutrients|mesh-ancestor
93357351|NCT02087683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357352|NCT02087683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93357353|NCT02092363|Paclitaxel|paclitaxel|mesh-list
93357354|NCT02092363|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93357355|NCT02092363|Carboplatin|carboplatin|mesh-list
93357356|NCT02092363|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93357357|NCT02092363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93357358|NCT02092363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357359|NCT02092363|Tubulin Modulators|tubulin modulators|mesh-ancestor
93357360|NCT02092363|Antimitotic Agents|antimitotic agents|mesh-ancestor
93357361|NCT02092363|Mitosis Modulators|mitosis modulators|mesh-ancestor
93357362|NCT02092363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357363|NCT02092363|Immunologic Factors|immunologic factors|mesh-ancestor
93357364|NCT02092363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357365|NCT03558139|Avelumab|avelumab|mesh-list
93357366|NCT03558139|Magrolimab|magrolimab|mesh-list
93357367|NCT03558139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93357368|NCT03558139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357369|NCT02089867|Ezetimibe|ezetimibe|mesh-list
93357370|NCT02089867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357371|NCT02089867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357372|NCT02089867|Antimetabolites|antimetabolites|mesh-ancestor
93357373|NCT02089867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357374|NCT02089867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357376|NCT02092597|Linagliptin|linagliptin|mesh-list
93357377|NCT02092597|Gliclazide|gliclazide|mesh-list
93357378|NCT02092597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93357379|NCT02092597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357380|NCT02092597|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93357381|NCT02092597|Incretins|incretins|mesh-ancestor
93357382|NCT02092597|Hormones|hormones|mesh-ancestor
93357383|NCT02092597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357384|NCT02092597|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93357385|NCT02092597|Protease Inhibitors|protease inhibitors|mesh-ancestor
93357386|NCT02092597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357387|NCT02092597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357388|NCT02090101|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93357389|NCT02090101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357390|NCT02093143|Remifentanil|remifentanil|mesh-list
93357391|NCT02093143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93357392|NCT02093143|Narcotics|narcotics|mesh-ancestor
93357393|NCT02093143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357394|NCT02093143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357395|NCT02093143|Analgesics|analgesics|mesh-ancestor
93357396|NCT02093143|Sensory System Agents|sensory system agents|mesh-ancestor
93357397|NCT02093143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357398|NCT02093299|Clopidogrel|clopidogrel|mesh-list
93357399|NCT02093299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93357400|NCT02093299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93357401|NCT02093299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93357402|NCT02093299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93357403|NCT02093299|Purinergic Agents|purinergic agents|mesh-ancestor
93357404|NCT02093299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357405|NCT02093299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357406|NCT02093299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357407|NCT00454753|Dasatinib|dasatinib|mesh-list
93357408|NCT00454753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357409|NCT00454753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93357410|NCT00454753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357411|NCT00454753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357412|NCT02093533|Eculizumab|eculizumab|mesh-list
93357413|NCT02093533|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93357414|NCT02093533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357415|NCT02093533|Immunologic Factors|immunologic factors|mesh-ancestor
93357416|NCT02093533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357417|NCT03297879|Metformin|metformin|mesh-list
93357418|NCT03297879|Exenatide|exenatide|mesh-list
93357419|NCT03297879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93357420|NCT03297879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357421|NCT03297879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93357422|NCT03297879|Incretins|incretins|mesh-ancestor
93357423|NCT03297879|Hormones|hormones|mesh-ancestor
93357424|NCT03297879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357425|NCT02093845|Everolimus|everolimus|mesh-list
93357426|NCT02093845|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93357427|NCT02093845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93357428|NCT02093845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357429|NCT02093845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357430|NCT02093845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357431|NCT02093845|Immunologic Factors|immunologic factors|mesh-ancestor
93357432|NCT02093845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357433|NCT02093845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357434|NCT04489797|Acalabrutinib|acalabrutinib|mesh-list
93357435|NCT04489797|Rabeprazole|rabeprazole|mesh-list
93357436|NCT04489797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93357437|NCT04489797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357438|NCT04489797|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93357439|NCT04489797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357440|NCT04489797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357441|NCT04489797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357442|NCT02094001|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93357443|NCT02094001|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93357444|NCT02094001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357445|NCT02096419|Clopidogrel|clopidogrel|mesh-list
93357446|NCT02096419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93357447|NCT02096419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93357448|NCT02096419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93357449|NCT02096419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93357451|NCT02096419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357452|NCT02096419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357453|NCT02096419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357454|NCT02094157|Heparin|heparin|mesh-list
93357455|NCT02094157|Calcium heparin|calcium heparin|mesh-list
93357456|NCT02094157|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93357457|NCT02094157|Tinzaparin|tinzaparin|mesh-list
93357458|NCT02094157|Dalteparin|dalteparin|mesh-list
93357459|NCT02094157|Warfarin|warfarin|mesh-list
93357460|NCT02094157|Anticoagulants|anticoagulants|mesh-ancestor
93357461|NCT02094157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93357462|NCT02094157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93357463|NCT02094157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357464|NCT02094313|Atorvastatin|atorvastatin|mesh-list
93357465|NCT02094313|Anticholesteremic Agents|anticholesteremic agents|mesh-list
93357466|NCT02094313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357467|NCT02094313|Antimetabolites|antimetabolites|mesh-ancestor
93357468|NCT02094313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357469|NCT02094313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357470|NCT02094313|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93357471|NCT02094313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357472|NCT02094391|Ipilimumab|ipilimumab|mesh-list
93357473|NCT02094391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93357474|NCT02094391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357475|NCT02094391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93357476|NCT02094391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357477|NCT02094469|Cilostazol|cilostazol|mesh-list
93357478|NCT02094469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93357479|NCT02094469|Autonomic Agents|autonomic agents|mesh-ancestor
93357480|NCT02094469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357481|NCT02094469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357482|NCT02094469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93357483|NCT02094469|Respiratory System Agents|respiratory system agents|mesh-ancestor
93357484|NCT02094469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93357485|NCT02094469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93357486|NCT02094469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357487|NCT02094469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93357488|NCT02094469|Vasodilator Agents|vasodilator agents|mesh-ancestor
93357489|NCT02094469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93357490|NCT02094469|Protective Agents|protective agents|mesh-ancestor
93357491|NCT02094469|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93357492|NCT02094469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93357493|NCT02094469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357494|NCT02094703|Levofloxacin|levofloxacin|mesh-list
93357495|NCT02094703|Solifenacin Succinate|solifenacin succinate|mesh-list
93357496|NCT02094703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93357497|NCT02094703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357498|NCT02094703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357499|NCT02094703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93357500|NCT02094703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93357501|NCT02094703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357502|NCT02094703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357503|NCT02094703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357504|NCT02094703|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93357505|NCT02094703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93357506|NCT02094703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93357507|NCT02094703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93357508|NCT02094703|Cholinergic Agents|cholinergic agents|mesh-ancestor
93357509|NCT02094703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357510|NCT02094703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357511|NCT02094703|Urological Agents|urological agents|mesh-ancestor
93357512|NCT02098837|Dolutegravir|dolutegravir|mesh-list
93357513|NCT02098837|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93357514|NCT02098837|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93357515|NCT02098837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357516|NCT02098837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357517|NCT02098837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93357518|NCT02098837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93357519|NCT02098837|Antiviral Agents|antiviral agents|mesh-ancestor
93357520|NCT02098837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357521|NCT02098915|Metoclopramide|metoclopramide|mesh-list
93357522|NCT02098915|Antiemetics|antiemetics|mesh-ancestor
93357523|NCT02098915|Autonomic Agents|autonomic agents|mesh-ancestor
93357524|NCT02098915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357525|NCT02098915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357526|NCT02098915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357527|NCT02098915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93357528|NCT02098915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93357529|NCT02098915|Dopamine Agents|dopamine agents|mesh-ancestor
93357530|NCT02098915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357531|NCT02098915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651203|NCT00266058|Artemether|artemether|mesh-list
93357532|NCT03556033|Dapagliflozin|dapagliflozin|mesh-list
93357533|NCT03556033|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93357534|NCT03556033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357535|NCT03556033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93357536|NCT03556033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357537|NCT05046860|Dalbavancin|dalbavancin|mesh-list
93357538|NCT05046860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357539|NCT05046860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357540|NCT02095405|Caffeine|caffeine|mesh-list
93357541|NCT02095405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93357542|NCT02095405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357543|NCT02095405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93357544|NCT02095405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357545|NCT02095405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357546|NCT02095405|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93357547|NCT02095405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93357548|NCT02095405|Purinergic Agents|purinergic agents|mesh-ancestor
93357549|NCT02095405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357550|NCT04434482|Temozolomide|temozolomide|mesh-list
93357551|NCT04434482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93357552|NCT04434482|Alkylating Agents|alkylating agents|mesh-ancestor
93357553|NCT04434482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357554|NCT04434482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357555|NCT02096965|Tolvaptan|tolvaptan|mesh-list
93357556|NCT02096965|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93357557|NCT02096965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357558|NCT02096965|Natriuretic Agents|natriuretic agents|mesh-ancestor
93357559|NCT02096965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357560|NCT02097043|Tedizolid phosphate|tedizolid phosphate|mesh-list
93357561|NCT02097043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93357562|NCT02097043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357563|NCT05069246|Chlorhexidine|chlorhexidine|mesh-list
93357564|NCT05069246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93357565|NCT05069246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357566|NCT05069246|Disinfectants|disinfectants|mesh-ancestor
93357567|NCT02095717|Curcumin|curcumin|mesh-list
93357568|NCT02095717|Docetaxel|docetaxel|mesh-list
93357569|NCT02095717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357570|NCT02095717|Tubulin Modulators|tubulin modulators|mesh-ancestor
93357571|NCT02095717|Antimitotic Agents|antimitotic agents|mesh-ancestor
93357572|NCT02095717|Mitosis Modulators|mitosis modulators|mesh-ancestor
93357573|NCT02095717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357574|NCT02095717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93357575|NCT02095717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357576|NCT02095717|Analgesics|analgesics|mesh-ancestor
93357577|NCT02095717|Sensory System Agents|sensory system agents|mesh-ancestor
93357578|NCT02095717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357579|NCT02095717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357580|NCT02095717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357581|NCT02095717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357582|NCT02095717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357583|NCT03099824|Avasopasem manganese|avasopasem manganese|mesh-list
93357584|NCT03099824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93357585|NCT03099824|Antioxidants|antioxidants|mesh-ancestor
93357586|NCT03099824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357587|NCT03099824|Protective Agents|protective agents|mesh-ancestor
93357588|NCT03099824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357589|NCT02718417|Paclitaxel|paclitaxel|mesh-list
93357590|NCT02718417|Carboplatin|carboplatin|mesh-list
93357591|NCT02718417|Avelumab|avelumab|mesh-list
93357592|NCT02718417|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93357593|NCT02718417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93357594|NCT02718417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357595|NCT02718417|Tubulin Modulators|tubulin modulators|mesh-ancestor
93357596|NCT02718417|Antimitotic Agents|antimitotic agents|mesh-ancestor
93357597|NCT02718417|Mitosis Modulators|mitosis modulators|mesh-ancestor
93357598|NCT02718417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357599|NCT02718417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93357600|NCT02718417|Immunologic Factors|immunologic factors|mesh-ancestor
93357601|NCT02718417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357602|NCT05067530|Paclitaxel|paclitaxel|mesh-list
93357603|NCT05067530|Carboplatin|carboplatin|mesh-list
93357604|NCT05067530|Palbociclib|palbociclib|mesh-list
93357605|NCT05067530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93357606|NCT05067530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357607|NCT05067530|Tubulin Modulators|tubulin modulators|mesh-ancestor
93357608|NCT05067530|Antimitotic Agents|antimitotic agents|mesh-ancestor
93357609|NCT05067530|Mitosis Modulators|mitosis modulators|mesh-ancestor
93357610|NCT05067530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357611|NCT05067530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93357612|NCT05067530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357613|NCT02640404|Vaccines|vaccines|mesh-list
93357614|NCT02640404|Immunologic Factors|immunologic factors|mesh-ancestor
93357615|NCT02640404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357616|NCT03097406|Imidacloprid|imidacloprid|mesh-list
93357617|NCT03097406|Cholinergic Agents|cholinergic agents|mesh-ancestor
93357618|NCT03097406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357619|NCT03097406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357620|NCT03097406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357621|NCT03099590|Puerarin|puerarin|mesh-list
93357622|NCT03099590|Vasodilator Agents|vasodilator agents|mesh-ancestor
93357623|NCT04999761|Futibatinib|futibatinib|mesh-list
93357624|NCT04999761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357625|NCT05054426|Methotrexate|methotrexate|mesh-list
93357626|NCT05054426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93357627|NCT05054426|Abortifacient Agents|abortifacient agents|mesh-ancestor
93357628|NCT05054426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93357629|NCT05054426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357630|NCT05054426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93357631|NCT05054426|Antimetabolites|antimetabolites|mesh-ancestor
93357632|NCT05054426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357633|NCT05054426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357634|NCT05054426|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357635|NCT05054426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357636|NCT05054426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93357637|NCT05054426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357638|NCT05054426|Immunologic Factors|immunologic factors|mesh-ancestor
93357639|NCT05054426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357640|NCT05054426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93357641|NCT00701727|Ezetimibe|ezetimibe|mesh-list
93357642|NCT00701727|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357643|NCT00701727|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357644|NCT00701727|Antimetabolites|antimetabolites|mesh-ancestor
93357645|NCT00701727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357646|NCT00701727|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357647|NCT02463513|Vitamins|vitamins|mesh-list
93357648|NCT02463513|Riboflavin|riboflavin|mesh-list
93357649|NCT02463513|Vitamin B Complex|vitamin b complex|mesh-list
93357650|NCT02463513|Micronutrients|micronutrients|mesh-ancestor
93357651|NCT02463513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357652|NCT02463513|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93357653|NCT02463513|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357654|NCT04990323|Vidarabine|vidarabine|mesh-list
93357655|NCT04990323|Cyclophosphamide|cyclophosphamide|mesh-list
93357656|NCT04990323|Busulfan|busulfan|mesh-list
93357657|NCT04990323|Thiotepa|thiotepa|mesh-list
93357658|NCT04990323|Fludarabine|fludarabine|mesh-list
93357659|NCT04990323|Fludarabine phosphate|fludarabine phosphate|mesh-list
93357660|NCT04990323|Clofarabine|clofarabine|mesh-list
93357661|NCT04990323|Tacrolimus|tacrolimus|mesh-list
93357662|NCT04990323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357663|NCT04990323|Immunologic Factors|immunologic factors|mesh-ancestor
93357664|NCT04990323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357665|NCT04990323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93357666|NCT04990323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93357667|NCT04990323|Alkylating Agents|alkylating agents|mesh-ancestor
93357668|NCT04990323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357669|NCT04990323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357670|NCT04990323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93357671|NCT04990323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93357672|NCT04990323|Antimetabolites|antimetabolites|mesh-ancestor
93357673|NCT04990323|Antiviral Agents|antiviral agents|mesh-ancestor
93357674|NCT04990323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357675|NCT04990323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93357676|NCT04990323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357677|NCT04155008|Dexamethasone|dexamethasone|mesh-list
93357679|NCT04155008|Mirtazapine|mirtazapine|mesh-list
93357680|NCT04155008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357681|NCT04155008|Antiemetics|antiemetics|mesh-ancestor
93357682|NCT04155008|Autonomic Agents|autonomic agents|mesh-ancestor
93357683|NCT04155008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357684|NCT04155008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357685|NCT04155008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357686|NCT04155008|Glucocorticoids|glucocorticoids|mesh-ancestor
93357687|NCT04155008|Hormones|hormones|mesh-ancestor
93357688|NCT04155008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357689|NCT04155008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93357690|NCT04155008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357691|NCT04155008|Antidepressive Agents|antidepressive agents|mesh-ancestor
93357692|NCT04155008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93357693|NCT04155008|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93357694|NCT04155008|Histamine Antagonists|histamine antagonists|mesh-ancestor
93357695|NCT04155008|Histamine Agents|histamine agents|mesh-ancestor
93357696|NCT04155008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651399|NCT00230984|Methyltestosterone|methyltestosterone|mesh-list
93357697|NCT04155008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357698|NCT04155008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93357699|NCT04155008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93357700|NCT04155008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357701|NCT04155008|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93357702|NCT04155008|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93357703|NCT04155008|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93357704|NCT04155008|Adrenergic Agents|adrenergic agents|mesh-ancestor
93357705|NCT04155008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93357706|NCT04155008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93357707|NCT04155008|Serotonin Agents|serotonin agents|mesh-ancestor
93357708|NCT04155008|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93357709|NCT04155008|Hallucinogens|hallucinogens|mesh-ancestor
93357710|NCT04155008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357711|NCT04155008|Analgesics|analgesics|mesh-ancestor
93357712|NCT04155008|Sensory System Agents|sensory system agents|mesh-ancestor
93357713|NCT04155008|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93357714|NCT04155008|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93357715|NCT05044364|Clevidipine|clevidipine|mesh-list
93357716|NCT05044364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93357717|NCT05044364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93357718|NCT05044364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357719|NCT05044364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93357720|NCT05044364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357721|NCT03993717|Vaccines|vaccines|mesh-list
93357722|NCT03993717|Immunologic Factors|immunologic factors|mesh-ancestor
93357723|NCT03993717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357724|NCT04150640|Pembrolizumab|pembrolizumab|mesh-list
93357725|NCT04150640|Nivolumab|nivolumab|mesh-list
93357726|NCT04150640|Trastuzumab|trastuzumab|mesh-list
93357727|NCT04150640|Fluorouracil|fluorouracil|mesh-list
93357728|NCT04150640|Oxaliplatin|oxaliplatin|mesh-list
93357729|NCT04150640|Irinotecan|irinotecan|mesh-list
93357730|NCT04150640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93357731|NCT04150640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357732|NCT04150640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93357733|NCT04150640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357734|NCT04150640|Antimetabolites|antimetabolites|mesh-ancestor
93357735|NCT04150640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93357736|NCT04150640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93357737|NCT04150640|Immunologic Factors|immunologic factors|mesh-ancestor
93357738|NCT04150640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357739|NCT04150640|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93357740|NCT04150640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93357741|NCT04150640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357742|NCT05054114|Interferons|interferons|mesh-list
93357743|NCT05054114|Interferon-gamma|interferon-gamma|mesh-list
93029606|NCT00964535|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93357744|NCT05054114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357745|NCT05054114|Antiviral Agents|antiviral agents|mesh-ancestor
93357746|NCT05054114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357747|NCT04665531|Ropivacaine|ropivacaine|mesh-list
93357748|NCT04665531|Anesthetics, Local|anesthetics, local|mesh-ancestor
93357749|NCT04665531|Anesthetics|anesthetics|mesh-ancestor
93357750|NCT04665531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357751|NCT04665531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357752|NCT04665531|Sensory System Agents|sensory system agents|mesh-ancestor
93357753|NCT04665531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357754|NCT01369069|Insulin|insulin|mesh-list
93357755|NCT01369069|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93357756|NCT01369069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93357757|NCT01369069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357758|NCT02097511|Metoprolol|metoprolol|mesh-list
93357759|NCT02097511|Sarpogrelate|sarpogrelate|mesh-list
93357760|NCT02097511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93357761|NCT02097511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93357762|NCT02097511|Sympatholytics|sympatholytics|mesh-ancestor
93357763|NCT02097511|Autonomic Agents|autonomic agents|mesh-ancestor
93357764|NCT02097511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357765|NCT02097511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357766|NCT02097511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93357767|NCT02097511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93357768|NCT02097511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93357769|NCT02097511|Adrenergic Agents|adrenergic agents|mesh-ancestor
93357770|NCT02097511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357771|NCT02097511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357772|NCT02097511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93357773|NCT02097511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93357774|NCT02097511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93357775|NCT02097511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93357776|NCT02097511|Serotonin Agents|serotonin agents|mesh-ancestor
93357777|NCT03957681|Brodalumab|brodalumab|mesh-list
93357778|NCT03957681|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357779|NCT05043740|Evolocumab|evolocumab|mesh-list
93357780|NCT05043740|Alirocumab|alirocumab|mesh-list
93357781|NCT05043740|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93357782|NCT05043740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357783|NCT05043740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357784|NCT05043740|Antimetabolites|antimetabolites|mesh-ancestor
93357785|NCT05043740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357786|NCT05043740|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93357787|NCT05043740|Protease Inhibitors|protease inhibitors|mesh-ancestor
93357788|NCT05043740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357789|NCT05043740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357790|NCT03928275|Aldesleukin|aldesleukin|mesh-list
93357791|NCT03928275|Interleukin-2|interleukin-2|mesh-list
93357792|NCT03928275|BCG Vaccine|bcg vaccine|mesh-list
93357793|NCT03928275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357794|NCT03928275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93357795|NCT03928275|Analgesics|analgesics|mesh-ancestor
93357796|NCT03928275|Sensory System Agents|sensory system agents|mesh-ancestor
93357797|NCT03928275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357798|NCT03928275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357799|NCT03928275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93357800|NCT03928275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93357801|NCT03928275|Antiviral Agents|antiviral agents|mesh-ancestor
93357802|NCT03928275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357803|NCT03928275|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93357804|NCT03928275|Immunologic Factors|immunologic factors|mesh-ancestor
93357805|NCT05043896|Tadalafil|tadalafil|mesh-list
93357806|NCT05043896|Vasodilator Agents|vasodilator agents|mesh-ancestor
93357807|NCT05043896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93357808|NCT05043896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93357809|NCT05043896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357810|NCT05043896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357811|NCT05043896|Urological Agents|urological agents|mesh-ancestor
93357812|NCT02099617|Oxymetazoline|oxymetazoline|mesh-list
93357813|NCT02099617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93357814|NCT02099617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93357815|NCT02099617|Adrenergic Agents|adrenergic agents|mesh-ancestor
93357816|NCT02099617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357817|NCT02099617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357818|NCT02099617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357819|NCT02099617|Sympathomimetics|sympathomimetics|mesh-ancestor
93357820|NCT02099617|Autonomic Agents|autonomic agents|mesh-ancestor
93357821|NCT02099617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357822|NCT02099617|Nasal Decongestants|nasal decongestants|mesh-ancestor
93357823|NCT02099617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93357824|NCT02099617|Respiratory System Agents|respiratory system agents|mesh-ancestor
93357825|NCT03096704|Vitamin D|vitamin d|mesh-list
93357826|NCT03096704|Vitamins|vitamins|mesh-ancestor
93357827|NCT03096704|Micronutrients|micronutrients|mesh-ancestor
93357828|NCT03096704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357829|NCT03096704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93357830|NCT02099695|Oxybutynin|oxybutynin|mesh-list
93357831|NCT02099695|Parasympatholytics|parasympatholytics|mesh-ancestor
93357832|NCT02099695|Autonomic Agents|autonomic agents|mesh-ancestor
93357833|NCT02099695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357834|NCT02099695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357835|NCT02099695|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93357836|NCT02099695|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93357837|NCT02099695|Cholinergic Agents|cholinergic agents|mesh-ancestor
93357838|NCT02099695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651508|NCT00231569|Mipomersen|mipomersen|mesh-list
93357839|NCT02099695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357840|NCT02099695|Urological Agents|urological agents|mesh-ancestor
93357841|NCT05066516|Dapagliflozin|dapagliflozin|mesh-list
93357842|NCT05066516|Linagliptin|linagliptin|mesh-list
93357843|NCT05066516|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93357844|NCT05066516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357845|NCT05066516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93357846|NCT05066516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357847|NCT05066516|Incretins|incretins|mesh-ancestor
93357848|NCT05066516|Hormones|hormones|mesh-ancestor
93357849|NCT05066516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357850|NCT05066516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93357851|NCT05066516|Protease Inhibitors|protease inhibitors|mesh-ancestor
93357852|NCT05066516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357853|NCT02097589|Atorvastatin|atorvastatin|mesh-list
93357854|NCT02097589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93357855|NCT02097589|Immunologic Factors|immunologic factors|mesh-ancestor
93357856|NCT02097589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357857|NCT02097589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357858|NCT02097589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357859|NCT02097589|Antimetabolites|antimetabolites|mesh-ancestor
93357860|NCT02097589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357861|NCT02097589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357862|NCT02097589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93357863|NCT02097589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357864|NCT03836001|Serlopitant|serlopitant|mesh-list
93357865|NCT03836001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93357866|NCT03836001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357867|NCT03836001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357868|NCT03836001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357869|NCT02465866|Promethazine|promethazine|mesh-list
93357870|NCT02465866|Antipruritics|antipruritics|mesh-ancestor
93357871|NCT02465866|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357872|NCT02465866|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93357873|NCT02465866|Histamine Antagonists|histamine antagonists|mesh-ancestor
93357874|NCT02465866|Histamine Agents|histamine agents|mesh-ancestor
93357875|NCT02465866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357876|NCT02465866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357877|NCT02465866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357878|NCT02465866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93357879|NCT05052008|Erenumab|erenumab|mesh-list
93357880|NCT05052008|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93357881|NCT05052008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357882|NCT05052008|Analgesics|analgesics|mesh-ancestor
93357883|NCT05052008|Sensory System Agents|sensory system agents|mesh-ancestor
93357884|NCT05052008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357885|NCT05052008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357886|NCT04727307|Bevacizumab|bevacizumab|mesh-list
93357887|NCT04727307|Atezolizumab|atezolizumab|mesh-list
93357888|NCT04727307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93357889|NCT04727307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93357890|NCT04727307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357891|NCT04727307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93357892|NCT04727307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93357893|NCT04727307|Growth Substances|growth substances|mesh-ancestor
93357894|NCT04727307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357895|NCT04727307|Growth Inhibitors|growth inhibitors|mesh-ancestor
93357896|NCT04727307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93357897|NCT04727307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357898|NCT04727307|Immunologic Factors|immunologic factors|mesh-ancestor
93357899|NCT05066360|Hormones|hormones|mesh-list
93357900|NCT05066360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357901|NCT05066360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357902|NCT02439970|Valganciclovir|valganciclovir|mesh-list
93357903|NCT02439970|Brincidofovir|brincidofovir|mesh-list
93357904|NCT02439970|Antiviral Agents|antiviral agents|mesh-ancestor
93357905|NCT02439970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357906|NCT03290859|Propofol|propofol|mesh-list
93357907|NCT03290859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93357908|NCT03290859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93357909|NCT03290859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357910|NCT03290859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93357911|NCT03290859|Anesthetics, General|anesthetics, general|mesh-ancestor
93357912|NCT03290859|Anesthetics|anesthetics|mesh-ancestor
93357913|NCT05065658|Posaconazole|posaconazole|mesh-list
93357914|NCT05065658|Antifungal Agents|antifungal agents|mesh-ancestor
93357915|NCT05065658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357916|NCT05065658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93357917|NCT05065658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93357918|NCT05065658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93357919|NCT05065658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93357920|NCT05065658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93357921|NCT05065658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357922|NCT05065658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357923|NCT05065658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93357924|NCT05065658|Hormone Antagonists|hormone antagonists|mesh-ancestor
93357925|NCT05065658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357926|NCT05065658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357927|NCT02102815|Dexamethasone|dexamethasone|mesh-list
93357928|NCT02102815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93357929|NCT02102815|Antiemetics|antiemetics|mesh-ancestor
93357930|NCT02102815|Autonomic Agents|autonomic agents|mesh-ancestor
93357931|NCT02102815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93357932|NCT02102815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357933|NCT02102815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357934|NCT02102815|Glucocorticoids|glucocorticoids|mesh-ancestor
93357935|NCT02102815|Hormones|hormones|mesh-ancestor
93357936|NCT02102815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93357937|NCT02102815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93357938|NCT02102815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93357939|NCT04935112|Pantoprazole|pantoprazole|mesh-list
93357940|NCT04935112|Famotidine|famotidine|mesh-list
93357941|NCT04935112|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93357942|NCT04935112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357943|NCT04935112|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93357944|NCT04935112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93357945|NCT04935112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357946|NCT04935112|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93357947|NCT04935112|Histamine Antagonists|histamine antagonists|mesh-ancestor
93357948|NCT04935112|Histamine Agents|histamine agents|mesh-ancestor
93357949|NCT04935112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357950|NCT04935112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357951|NCT02102971|Liver Extracts|liver extracts|mesh-list
93357952|NCT02102971|Hematinics|hematinics|mesh-ancestor
93357953|NCT05043350|Loratadine|loratadine|mesh-list
93357954|NCT05043350|Famotidine|famotidine|mesh-list
93357955|NCT05043350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93357956|NCT05043350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357957|NCT05043350|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93357958|NCT05043350|Histamine Antagonists|histamine antagonists|mesh-ancestor
93357959|NCT05043350|Histamine Agents|histamine agents|mesh-ancestor
93357960|NCT05043350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93357961|NCT05043350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357962|NCT05043350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357963|NCT05043350|Antipruritics|antipruritics|mesh-ancestor
93357964|NCT05043350|Dermatologic Agents|dermatologic agents|mesh-ancestor
93357965|NCT05043350|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93357966|NCT05043350|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93357967|NCT05043350|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93357968|NCT03555487|Choline|choline|mesh-list
93357969|NCT03555487|Lipotropic Agents|lipotropic agents|mesh-ancestor
93357970|NCT03555487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357971|NCT03555487|Antimetabolites|antimetabolites|mesh-ancestor
93357972|NCT03555487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357973|NCT03555487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357974|NCT03555487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357975|NCT03555487|Nootropic Agents|nootropic agents|mesh-ancestor
93357976|NCT05043194|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93357977|NCT05043194|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93357978|NCT05043194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93357980|NCT02103049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357981|NCT02103049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357982|NCT02103049|Antimetabolites|antimetabolites|mesh-ancestor
93357983|NCT02103049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357984|NCT02103049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357985|NCT03099278|Ezetimibe|ezetimibe|mesh-list
93357986|NCT03099278|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93357987|NCT03099278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93357988|NCT03099278|Antimetabolites|antimetabolites|mesh-ancestor
93357989|NCT03099278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93357990|NCT03099278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93357991|NCT02103205|Iron|iron|mesh-list
93357992|NCT02103205|Lactoferrin|lactoferrin|mesh-list
93357993|NCT02103205|Trace Elements|trace elements|mesh-ancestor
93357994|NCT02103205|Micronutrients|micronutrients|mesh-ancestor
93357995|NCT02103205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93357996|NCT02103205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93357997|NCT03290703|Rabeprazole|rabeprazole|mesh-list
93357998|NCT03290703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93357999|NCT03290703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358000|NCT03290703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93358001|NCT03290703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358002|NCT03290703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358003|NCT02408068|Dexamethasone|dexamethasone|mesh-list
93358004|NCT02408068|Hydrocortisone|hydrocortisone|mesh-list
93358005|NCT02408068|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93358006|NCT02408068|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93358007|NCT02408068|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93358008|NCT02408068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358009|NCT02408068|Antiemetics|antiemetics|mesh-ancestor
93358010|NCT02408068|Autonomic Agents|autonomic agents|mesh-ancestor
93358011|NCT02408068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358012|NCT02408068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358013|NCT02408068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358014|NCT02408068|Glucocorticoids|glucocorticoids|mesh-ancestor
93358015|NCT02408068|Hormones|hormones|mesh-ancestor
93358016|NCT02408068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358017|NCT02408068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93358018|NCT02408068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358019|NCT02465853|Hyaluronic Acid|hyaluronic acid|mesh-list
93358020|NCT02465853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93358021|NCT02465853|Immunologic Factors|immunologic factors|mesh-ancestor
93358022|NCT02465853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358023|NCT02465853|Viscosupplements|viscosupplements|mesh-ancestor
93358024|NCT02465853|Protective Agents|protective agents|mesh-ancestor
93358025|NCT02465385|Linaclotide|linaclotide|mesh-list
93358026|NCT02465385|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93358027|NCT02465385|Enzyme Activators|enzyme activators|mesh-ancestor
93358028|NCT02465385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358029|NCT02465385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358030|NCT05050604|Choline|choline|mesh-list
93358031|NCT05050604|Lipotropic Agents|lipotropic agents|mesh-ancestor
93358032|NCT05050604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93358033|NCT05050604|Antimetabolites|antimetabolites|mesh-ancestor
93358034|NCT05050604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358035|NCT05050604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358036|NCT05050604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93358037|NCT05050604|Nootropic Agents|nootropic agents|mesh-ancestor
93358038|NCT03290625|Dexmedetomidine|dexmedetomidine|mesh-list
93358039|NCT03290625|Ketamine|ketamine|mesh-list
93358040|NCT03290625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93358041|NCT03290625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358042|NCT03290625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358043|NCT03290625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93358044|NCT03290625|Analgesics|analgesics|mesh-ancestor
93358045|NCT03290625|Sensory System Agents|sensory system agents|mesh-ancestor
93358046|NCT03290625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358047|NCT03290625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93358048|NCT03290625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93358049|NCT03290625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93358050|NCT03290625|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358051|NCT03290625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358052|NCT03290625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358053|NCT03290625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93358054|NCT03290625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93358055|NCT03290625|Anesthetics, General|anesthetics, general|mesh-ancestor
93358056|NCT03290625|Anesthetics|anesthetics|mesh-ancestor
93358057|NCT03290625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93358058|NCT03290625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93358059|NCT02250781|TIC10 compound|tic10 compound|mesh-list
93358060|NCT02250781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358061|NCT03099122|Mycophenolic Acid|mycophenolic acid|mesh-list
93358062|NCT03099122|Prednisone|prednisone|mesh-list
93358063|NCT03099122|Methylprednisolone|methylprednisolone|mesh-list
93358064|NCT03099122|Tacrolimus|tacrolimus|mesh-list
93358065|NCT03099122|Thymoglobulin|thymoglobulin|mesh-list
93358066|NCT03099122|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93358067|NCT03099122|Immunoglobulins|immunoglobulins|mesh-list
93358068|NCT03099122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358069|NCT03099122|Glucocorticoids|glucocorticoids|mesh-ancestor
93358070|NCT03099122|Hormones|hormones|mesh-ancestor
93358071|NCT03099122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358072|NCT03099122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358073|NCT03099122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93358074|NCT03099122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358075|NCT03099122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358076|NCT03099122|Immunologic Factors|immunologic factors|mesh-ancestor
93358077|NCT03099122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93358078|NCT03099122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358079|NCT03099122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358080|NCT03099122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93358081|NCT03099122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93358082|NCT03099122|Antitubercular Agents|antitubercular agents|mesh-ancestor
93358083|NCT03099122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93358084|NCT03099122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358085|NCT03099122|Antiemetics|antiemetics|mesh-ancestor
93358086|NCT03099122|Autonomic Agents|autonomic agents|mesh-ancestor
93358087|NCT03099122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358088|NCT03099122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358089|NCT03099122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93358090|NCT03099122|Protective Agents|protective agents|mesh-ancestor
93358091|NCT04335201|Defibrotide|defibrotide|mesh-list
93358092|NCT04335201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93358093|NCT04335201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93358094|NCT04335201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358095|NCT04335201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93358096|NCT03295851|Iron|iron|mesh-list
93358097|NCT03295851|Ferrous fumarate|ferrous fumarate|mesh-list
93358098|NCT03295851|Trace Elements|trace elements|mesh-ancestor
93358099|NCT03295851|Micronutrients|micronutrients|mesh-ancestor
93358100|NCT03295851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358101|NCT03096470|Anesthetics|anesthetics|mesh-list
93358102|NCT03096470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358103|NCT03096470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358104|NCT02100553|Itraconazole|itraconazole|mesh-list
93358105|NCT02100553|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93358106|NCT02100553|Antifungal Agents|antifungal agents|mesh-ancestor
93358107|NCT02100553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358108|NCT02100553|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93358109|NCT02100553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93358110|NCT02100553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358111|NCT02100553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358112|NCT02100553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93358113|NCT02100553|Hormone Antagonists|hormone antagonists|mesh-ancestor
93358114|NCT02100553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358115|NCT02100553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358116|NCT02100553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93358117|NCT02100787|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93358118|NCT02100787|Laxatives|laxatives|mesh-ancestor
93358119|NCT02100787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93029978|NCT03978286|Sertraline|sertraline|mesh-list
93358120|NCT03295695|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93358121|NCT03295695|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93358122|NCT03295695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358123|NCT04718805|Darunavir|darunavir|mesh-list
93358124|NCT04718805|Cobicistat|cobicistat|mesh-list
93358125|NCT04718805|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
93358126|NCT04718805|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93358127|NCT04718805|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93358128|NCT04718805|Protease Inhibitors|protease inhibitors|mesh-ancestor
93358129|NCT04718805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358130|NCT04718805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358131|NCT04718805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93358132|NCT04718805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93358133|NCT04718805|Antiviral Agents|antiviral agents|mesh-ancestor
93358134|NCT04718805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358135|NCT04718805|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93358136|NCT04718805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93358137|NCT05042336|Lenvatinib|lenvatinib|mesh-list
93358138|NCT05042336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358139|NCT05042336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93358140|NCT05042336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358141|NCT05042336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358142|NCT03096392|Insulin|insulin|mesh-list
93358143|NCT03096392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93358144|NCT03096392|Insulin Lispro|insulin lispro|mesh-list
93358145|NCT03096392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93358146|NCT03096392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358147|NCT05042024|N-Methylaspartate|n-methylaspartate|mesh-list
93358148|NCT05042024|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93358149|NCT05042024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93358150|NCT05042024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358151|NCT05042024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358152|NCT05042024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358153|NCT02460393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93358154|NCT02460393|Antibodies|antibodies|mesh-list
93358155|NCT02460393|Immunoglobulins|immunoglobulins|mesh-list
93358156|NCT02460393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93358157|NCT02460393|Immunologic Factors|immunologic factors|mesh-ancestor
93358158|NCT02460393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358159|NCT02460393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358160|NCT02250859|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93358161|NCT02250859|Minocycline|minocycline|mesh-list
93358162|NCT02250859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358163|NCT03295461|Chlorhexidine|chlorhexidine|mesh-list
93358164|NCT03295461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93358165|NCT03295461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358166|NCT03295461|Disinfectants|disinfectants|mesh-ancestor
93358167|NCT03295383|Cyclophosphamide|cyclophosphamide|mesh-list
93358168|NCT03295383|Rituximab|rituximab|mesh-list
93358169|NCT03295383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358170|NCT03295383|Immunologic Factors|immunologic factors|mesh-ancestor
93358171|NCT03295383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358172|NCT03295383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93358173|NCT03295383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93358174|NCT03295383|Alkylating Agents|alkylating agents|mesh-ancestor
93358175|NCT03295383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358176|NCT03295383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358177|NCT03295383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93358178|NCT03295383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93358179|NCT02101255|Fluorides|fluorides|mesh-list
93358180|NCT02101255|Cariostatic Agents|cariostatic agents|mesh-ancestor
93358181|NCT02101255|Protective Agents|protective agents|mesh-ancestor
93358182|NCT02101255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358183|NCT05063318|Itraconazole|itraconazole|mesh-list
93358184|NCT05063318|Antifungal Agents|antifungal agents|mesh-ancestor
93358185|NCT05063318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358186|NCT05063318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93358187|NCT05063318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93358188|NCT05063318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358189|NCT05063318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358190|NCT05063318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93358191|NCT05063318|Hormone Antagonists|hormone antagonists|mesh-ancestor
93358192|NCT05063318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358193|NCT05063318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030057|NCT00972803|Chlorhexidine|chlorhexidine|mesh-list
93358194|NCT05063318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93358195|NCT02104297|Remifentanil|remifentanil|mesh-list
93358196|NCT02104297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93358197|NCT02104297|Narcotics|narcotics|mesh-ancestor
93358198|NCT02104297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358199|NCT02104297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358200|NCT02104297|Analgesics|analgesics|mesh-ancestor
93358201|NCT02104297|Sensory System Agents|sensory system agents|mesh-ancestor
93358202|NCT02104297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358203|NCT02106481|Ropivacaine|ropivacaine|mesh-list
93358204|NCT02106481|Anesthetics, Local|anesthetics, local|mesh-ancestor
93358205|NCT02106481|Anesthetics|anesthetics|mesh-ancestor
93358206|NCT02106481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358207|NCT02106481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358208|NCT02106481|Sensory System Agents|sensory system agents|mesh-ancestor
93358209|NCT02106481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358210|NCT02106559|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
93358211|NCT02106559|Trioxsalen|trioxsalen|mesh-list
93358212|NCT02106559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358213|NCT02106559|Dermatologic Agents|dermatologic agents|mesh-ancestor
93358214|NCT02106559|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93358215|NCT05047874|Methylprednisolone|methylprednisolone|mesh-list
93358216|NCT05047874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93358217|NCT05047874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93358218|NCT05047874|Prednisolone|prednisolone|mesh-list
93358219|NCT05047874|Prednisolone acetate|prednisolone acetate|mesh-list
93358220|NCT05047874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93358221|NCT05047874|Prednisolone phosphate|prednisolone phosphate|mesh-list
93358222|NCT05047874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358223|NCT05047874|Antiemetics|antiemetics|mesh-ancestor
93358224|NCT05047874|Autonomic Agents|autonomic agents|mesh-ancestor
93358225|NCT05047874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358226|NCT05047874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358227|NCT05047874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358228|NCT05047874|Glucocorticoids|glucocorticoids|mesh-ancestor
93358229|NCT05047874|Hormones|hormones|mesh-ancestor
93358230|NCT05047874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358231|NCT05047874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93358232|NCT05047874|Protective Agents|protective agents|mesh-ancestor
93358233|NCT05047874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651920|NCT00267267|Atorvastatin|atorvastatin|mesh-list
93358234|NCT05047874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358235|NCT04488705|Albuterol|albuterol|mesh-list
93358236|NCT04488705|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93358237|NCT04488705|Autonomic Agents|autonomic agents|mesh-ancestor
93358238|NCT04488705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358239|NCT04488705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358240|NCT04488705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93358241|NCT04488705|Respiratory System Agents|respiratory system agents|mesh-ancestor
93358242|NCT04488705|Tocolytic Agents|tocolytic agents|mesh-ancestor
93358243|NCT04488705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358244|NCT04488705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93358245|NCT04488705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93358246|NCT04488705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93358247|NCT04488705|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358248|NCT04488705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358249|NCT04488705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358250|NCT02106637|Varenicline|varenicline|mesh-list
93358251|NCT02106637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93358252|NCT02106637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93358253|NCT02106637|Cholinergic Agents|cholinergic agents|mesh-ancestor
93358254|NCT02106637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358255|NCT02106637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358256|NCT02106637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358257|NCT05047328|Inolimomab|inolimomab|mesh-list
93358258|NCT05047328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358259|NCT05047328|Immunologic Factors|immunologic factors|mesh-ancestor
93358260|NCT05047328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358261|NCT02104609|Levonorgestrel|levonorgestrel|mesh-list
93358262|NCT02104609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93358263|NCT02104609|Contraceptive Agents|contraceptive agents|mesh-ancestor
93358264|NCT02104609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358265|NCT02104609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358266|NCT02104609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93358267|NCT02104609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93358268|NCT02104609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93358269|NCT02106793|Mitomycins|mitomycins|mesh-list
93358271|NCT02106793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93358272|NCT02106793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358273|NCT02106793|Alkylating Agents|alkylating agents|mesh-ancestor
93358274|NCT02106793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358275|NCT02106793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93358276|NCT02106793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358277|NCT02104843|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93358278|NCT02104843|Asunaprevir|asunaprevir|mesh-list
93358279|NCT02104843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93358280|NCT02104843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93358281|NCT02104843|Antimetabolites|antimetabolites|mesh-ancestor
93358282|NCT02104843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358283|NCT02104843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93358284|NCT02104843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93358285|NCT02104843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358286|NCT02104843|Protease Inhibitors|protease inhibitors|mesh-ancestor
93358287|NCT05041790|Choline|choline|mesh-list
93358288|NCT05041790|Lipotropic Agents|lipotropic agents|mesh-ancestor
93358289|NCT05041790|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93358290|NCT05041790|Antimetabolites|antimetabolites|mesh-ancestor
93358291|NCT05041790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358292|NCT05041790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358293|NCT05041790|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93358294|NCT05041790|Nootropic Agents|nootropic agents|mesh-ancestor
93358295|NCT02105077|Anesthetics|anesthetics|mesh-list
93358297|NCT02105077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358298|NCT02105077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358299|NCT02105077|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93358300|NCT02105077|Anesthetics, General|anesthetics, general|mesh-ancestor
93358301|NCT02101567|Oxytocin|oxytocin|mesh-list
93358302|NCT02101567|Carbetocin|carbetocin|mesh-list
93358303|NCT02101567|Oxytocics|oxytocics|mesh-ancestor
93358304|NCT02101567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358305|NCT02101567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358306|NCT02106871|Sildenafil Citrate|sildenafil citrate|mesh-list
93358307|NCT02106871|Vasodilator Agents|vasodilator agents|mesh-ancestor
93358308|NCT02106871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93358309|NCT02106871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93358310|NCT02106871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358311|NCT02106871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358312|NCT02106871|Urological Agents|urological agents|mesh-ancestor
93358313|NCT02251015|Salicylic Acid|salicylic acid|mesh-list
93358314|NCT02251015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358315|NCT02251015|Antifungal Agents|antifungal agents|mesh-ancestor
93358316|NCT02251015|Keratolytic Agents|keratolytic agents|mesh-ancestor
93358317|NCT02251015|Dermatologic Agents|dermatologic agents|mesh-ancestor
93358318|NCT03288597|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93358319|NCT03288597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93358320|NCT03288597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358321|NCT02407990|Tislelizumab|tislelizumab|mesh-list
93358322|NCT02407990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93358323|NCT02407990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358324|NCT02105155|Tacrolimus|tacrolimus|mesh-list
93358325|NCT02105155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358326|NCT02105155|Immunologic Factors|immunologic factors|mesh-ancestor
93358327|NCT02105155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358328|NCT02105155|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93358329|NCT02105155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358330|NCT02105155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358331|NCT03294525|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93358332|NCT03294525|Mirtazapine|mirtazapine|mesh-list
93358333|NCT03294525|Antidepressive Agents|antidepressive agents|mesh-list
93358334|NCT03294525|Escitalopram|escitalopram|mesh-list
93358335|NCT03294525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93358336|NCT03294525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93358337|NCT03294525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358338|NCT03294525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358339|NCT03294525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358340|NCT03294525|Serotonin Agents|serotonin agents|mesh-ancestor
93358341|NCT03294525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358342|NCT03294525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358343|NCT03294525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93358344|NCT03294525|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93358345|NCT03294525|Analgesics|analgesics|mesh-ancestor
93358346|NCT03294525|Sensory System Agents|sensory system agents|mesh-ancestor
93358347|NCT03294525|Dopamine Agents|dopamine agents|mesh-ancestor
93358348|NCT03294525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93358349|NCT03294525|Histamine Antagonists|histamine antagonists|mesh-ancestor
93358350|NCT03294525|Histamine Agents|histamine agents|mesh-ancestor
93358351|NCT03294525|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93358352|NCT03294525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93358353|NCT03294525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358354|NCT03294525|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93358355|NCT03294525|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93358356|NCT03294525|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93358357|NCT03294525|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358358|NCT03294525|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93358359|NCT03294525|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93358360|NCT03294525|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93358361|NCT05036174|Diphenhydramine|diphenhydramine|mesh-list
93358362|NCT05036174|Promethazine|promethazine|mesh-list
93358363|NCT05036174|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93358364|NCT05036174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93358365|NCT05036174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358366|NCT05036174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358367|NCT05036174|Anesthetics, Local|anesthetics, local|mesh-ancestor
93358368|NCT05036174|Anesthetics|anesthetics|mesh-ancestor
93358369|NCT05036174|Sensory System Agents|sensory system agents|mesh-ancestor
93358370|NCT05036174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358371|NCT05036174|Antiemetics|antiemetics|mesh-ancestor
93358372|NCT05036174|Autonomic Agents|autonomic agents|mesh-ancestor
93358373|NCT05036174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358374|NCT05036174|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93358375|NCT05036174|Histamine Antagonists|histamine antagonists|mesh-ancestor
93358376|NCT05036174|Histamine Agents|histamine agents|mesh-ancestor
93358377|NCT05036174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358378|NCT05036174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358379|NCT05036174|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93358380|NCT05036174|Antipruritics|antipruritics|mesh-ancestor
93358381|NCT05036174|Dermatologic Agents|dermatologic agents|mesh-ancestor
93358382|NCT03283059|Donepezil|donepezil|mesh-list
93358383|NCT03283059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93358384|NCT03283059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358385|NCT03283059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358386|NCT03283059|Cholinergic Agents|cholinergic agents|mesh-ancestor
93358387|NCT03283059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358388|NCT03283059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358389|NCT03283059|Nootropic Agents|nootropic agents|mesh-ancestor
93358390|NCT05060588|Valsartan|valsartan|mesh-list
93358391|NCT05060588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93358392|NCT05060588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93358393|NCT05060588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93358394|NCT05060588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93358395|NCT05060588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358396|NCT02105311|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93358397|NCT02105311|Travoprost|travoprost|mesh-list
93358398|NCT02105311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93358399|NCT02105311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93358400|NCT02105311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358401|NCT03554395|Antibodies|antibodies|mesh-list
93358402|NCT03554395|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93358403|NCT03554395|Immunologic Factors|immunologic factors|mesh-ancestor
93358404|NCT03554395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358405|NCT03282825|Paclitaxel|paclitaxel|mesh-list
93358406|NCT03282825|Decitabine|decitabine|mesh-list
93358407|NCT03282825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93358408|NCT03282825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358409|NCT03282825|Tubulin Modulators|tubulin modulators|mesh-ancestor
93358410|NCT03282825|Antimitotic Agents|antimitotic agents|mesh-ancestor
93358411|NCT03282825|Mitosis Modulators|mitosis modulators|mesh-ancestor
93358412|NCT03282825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358413|NCT03282825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93358414|NCT03282825|Antimetabolites|antimetabolites|mesh-ancestor
93358415|NCT03282825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358416|NCT02105623|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93358417|NCT02105623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93358418|NCT02105623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93358419|NCT02105623|Antimetabolites|antimetabolites|mesh-ancestor
93358420|NCT02105623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358421|NCT02105623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93358422|NCT02105623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93358423|NCT02105623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358424|NCT05039606|Nedaplatin|nedaplatin|mesh-list
93358425|NCT05039606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358426|NCT03288051|Dobutamine|dobutamine|mesh-list
93358427|NCT03288051|Norepinephrine|norepinephrine|mesh-list
93358428|NCT03288051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93358429|NCT03288051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93358430|NCT03288051|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358431|NCT03288051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358432|NCT03288051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358433|NCT03288051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358434|NCT03288051|Sympathomimetics|sympathomimetics|mesh-ancestor
93358435|NCT03288051|Autonomic Agents|autonomic agents|mesh-ancestor
93358436|NCT03288051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358437|NCT03288051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93358438|NCT03288051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93358439|NCT03288051|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93358440|NCT03288051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93358441|NCT03288051|Protective Agents|protective agents|mesh-ancestor
93358442|NCT05035472|Phenylephrine|phenylephrine|mesh-list
93358443|NCT05035472|Oxymetazoline|oxymetazoline|mesh-list
93358444|NCT05035472|Norepinephrine|norepinephrine|mesh-list
93358445|NCT05035472|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93358446|NCT05035472|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93358447|NCT05035472|Mydriatics|mydriatics|mesh-ancestor
93358448|NCT05035472|Autonomic Agents|autonomic agents|mesh-ancestor
93358449|NCT05035472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358450|NCT05035472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358451|NCT05035472|Sympathomimetics|sympathomimetics|mesh-ancestor
93358452|NCT05035472|Nasal Decongestants|nasal decongestants|mesh-ancestor
93358453|NCT05035472|Respiratory System Agents|respiratory system agents|mesh-ancestor
93358454|NCT05035472|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93358455|NCT05035472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93358456|NCT05035472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93358457|NCT05035472|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358458|NCT05035472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358459|NCT05035472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358460|NCT05035472|Protective Agents|protective agents|mesh-ancestor
93358461|NCT02460627|Lidocaine|lidocaine|mesh-list
93358462|NCT02460627|Anesthetics, Local|anesthetics, local|mesh-ancestor
93358463|NCT02460627|Anesthetics|anesthetics|mesh-ancestor
93358464|NCT02460627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358465|NCT02460627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358466|NCT02460627|Sensory System Agents|sensory system agents|mesh-ancestor
93358467|NCT02460627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358468|NCT02460627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93358469|NCT02460627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93358470|NCT02460627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93358471|NCT02460627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358472|NCT02460627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358473|NCT02107729|Lidocaine|lidocaine|mesh-list
93358474|NCT02107729|Anesthetics, Local|anesthetics, local|mesh-ancestor
93358475|NCT02107729|Anesthetics|anesthetics|mesh-ancestor
93358476|NCT02107729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358477|NCT02107729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358478|NCT02107729|Sensory System Agents|sensory system agents|mesh-ancestor
93358479|NCT02107729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358480|NCT02107729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93358481|NCT02107729|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93358482|NCT02107729|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93358483|NCT02107729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358484|NCT02107729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358485|NCT03282513|Ivosidenib|ivosidenib|mesh-list
93358486|NCT03282513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358487|NCT03282513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358488|NCT03282513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358489|NCT02107807|Lactitol|lactitol|mesh-list
93358490|NCT02107807|Vaccines|vaccines|mesh-list
93358491|NCT02107807|Immunologic Factors|immunologic factors|mesh-ancestor
93358492|NCT02107807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358493|NCT02107807|Cathartics|cathartics|mesh-ancestor
93358494|NCT02107807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358495|NCT01673282|Lacosamide|lacosamide|mesh-list
93358496|NCT01673282|Anticonvulsants|anticonvulsants|mesh-ancestor
93358497|NCT01673282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93358498|NCT01673282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93358499|NCT01673282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358500|NCT01673282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358501|NCT02113735|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93358502|NCT02113735|Hormones|hormones|mesh-ancestor
93358503|NCT02113735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358504|NCT02113735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358505|NCT02113813|Naquotinib|naquotinib|mesh-list
93358506|NCT02113813|Midazolam|midazolam|mesh-list
93358507|NCT02113813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93358508|NCT02113813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93358509|NCT02113813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358510|NCT02113813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358511|NCT02113813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93358512|NCT02113813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93358513|NCT02113813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93358514|NCT02113813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93358515|NCT02113813|Anesthetics, General|anesthetics, general|mesh-ancestor
93358516|NCT02113813|Anesthetics|anesthetics|mesh-ancestor
93358517|NCT02113813|GABA Modulators|gaba modulators|mesh-ancestor
93358518|NCT02113813|GABA Agents|gaba agents|mesh-ancestor
93358519|NCT02113813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358520|NCT02113813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358521|NCT02113813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358522|NCT02113813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93358523|NCT02113813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358524|NCT03095144|Anesthetics|anesthetics|mesh-list
93358525|NCT03095144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358526|NCT03095144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358527|NCT03095222|Ketamine|ketamine|mesh-list
93358528|NCT03095222|Analgesics|analgesics|mesh-ancestor
93358529|NCT03095222|Sensory System Agents|sensory system agents|mesh-ancestor
93358530|NCT03095222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358531|NCT03095222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358532|NCT03095222|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93358533|NCT03095222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93358534|NCT03095222|Anesthetics, General|anesthetics, general|mesh-ancestor
93358535|NCT03095222|Anesthetics|anesthetics|mesh-ancestor
93358536|NCT03095222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358537|NCT03095222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93358538|NCT03095222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93358539|NCT03095222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358540|NCT03095222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358541|NCT02113891|Eculizumab|eculizumab|mesh-list
93358542|NCT02113891|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93358543|NCT02113891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358544|NCT02113891|Immunologic Factors|immunologic factors|mesh-ancestor
93358545|NCT02113891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358546|NCT03095378|Anti-Infective Agents|anti-infective agents|mesh-list
93358547|NCT03095378|Tetracycline|tetracycline|mesh-list
93358548|NCT03095378|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93358549|NCT03095378|Citric Acid|citric acid|mesh-list
93358550|NCT03095378|Sodium Citrate|sodium citrate|mesh-list
93358551|NCT03095378|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93358552|NCT03095378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358553|NCT03095378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358554|NCT03095378|Anticoagulants|anticoagulants|mesh-ancestor
93358555|NCT03095378|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93358556|NCT03095378|Chelating Agents|chelating agents|mesh-ancestor
93358557|NCT03095378|Sequestering Agents|sequestering agents|mesh-ancestor
93358558|NCT05025098|Azacitidine|azacitidine|mesh-list
93358559|NCT05025098|Venetoclax|venetoclax|mesh-list
93358560|NCT05025098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93358561|NCT05025098|Antimetabolites|antimetabolites|mesh-ancestor
93358562|NCT05025098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358563|NCT05025098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358564|NCT05025098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358565|NCT05038202|Mometasone Furoate|mometasone furoate|mesh-list
93358566|NCT05038202|Bromides|bromides|mesh-list
93358567|NCT05038202|Anticonvulsants|anticonvulsants|mesh-ancestor
93358568|NCT05038202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358569|NCT05038202|Dermatologic Agents|dermatologic agents|mesh-ancestor
93358570|NCT05038202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93358571|NCT02114359|Cisplatin|cisplatin|mesh-list
93358572|NCT02114359|Fluorouracil|fluorouracil|mesh-list
93358573|NCT02114359|Capecitabine|capecitabine|mesh-list
93358574|NCT02114359|Oxaliplatin|oxaliplatin|mesh-list
93358575|NCT02114359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358576|NCT02114359|Antimetabolites|antimetabolites|mesh-ancestor
93358577|NCT02114359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358578|NCT02114359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93358579|NCT02114359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358580|NCT02114359|Immunologic Factors|immunologic factors|mesh-ancestor
93358581|NCT02114359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358582|NCT02110303|Ticagrelor|ticagrelor|mesh-list
93358583|NCT02110303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93358584|NCT02110303|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93358585|NCT02110303|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93358586|NCT02110303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93358587|NCT02110303|Purinergic Agents|purinergic agents|mesh-ancestor
93358588|NCT02110303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358589|NCT02110303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358590|NCT02110303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358591|NCT03093740|Sofosbuvir|sofosbuvir|mesh-list
93358592|NCT03093740|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93358593|NCT03093740|Antiviral Agents|antiviral agents|mesh-ancestor
93358594|NCT03093740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358595|NCT02108353|Melatonin|melatonin|mesh-list
93358596|NCT02108353|Antioxidants|antioxidants|mesh-ancestor
93358597|NCT02108353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358598|NCT02108353|Protective Agents|protective agents|mesh-ancestor
93358599|NCT02108353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358600|NCT02108353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358601|NCT04157751|Empagliflozin|empagliflozin|mesh-list
93358602|NCT04157751|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93358603|NCT04157751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358604|NCT04157751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93358605|NCT04157751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358606|NCT02114671|Ciprofloxacin|ciprofloxacin|mesh-list
93358607|NCT02114671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93358608|NCT02114671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358609|NCT02114671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93358610|NCT02114671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93358611|NCT02114671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358612|NCT02114671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358613|NCT02114671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358614|NCT02114671|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93358615|NCT02114671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93358616|NCT02110459|Murepavadin|murepavadin|mesh-list
93358617|NCT02110459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93358618|NCT02110459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358619|NCT03287505|Aripiprazole|aripiprazole|mesh-list
93358620|NCT03287505|Antidepressive Agents|antidepressive agents|mesh-ancestor
93358621|NCT03287505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93358622|NCT03287505|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93358623|NCT03287505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93358624|NCT03287505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358625|NCT03287505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358626|NCT03287505|Dopamine Agonists|dopamine agonists|mesh-ancestor
93358627|NCT03287505|Dopamine Agents|dopamine agents|mesh-ancestor
93358628|NCT03287505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358629|NCT03287505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358630|NCT03287505|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93358631|NCT03287505|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93358632|NCT03287505|Serotonin Agents|serotonin agents|mesh-ancestor
93358633|NCT03287505|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93358634|NCT03287505|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93358635|NCT03287505|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93358636|NCT03287505|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93358637|NCT03090698|Triamcinolone|triamcinolone|mesh-list
93358638|NCT03090698|Hylan|hylan|mesh-list
93358639|NCT03090698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358640|NCT03090698|Glucocorticoids|glucocorticoids|mesh-ancestor
93358641|NCT03090698|Hormones|hormones|mesh-ancestor
93358642|NCT03090698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358643|NCT03090698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358644|NCT03090698|Viscosupplements|viscosupplements|mesh-ancestor
93358645|NCT03090698|Protective Agents|protective agents|mesh-ancestor
93358647|NCT03293511|Oxytocics|oxytocics|mesh-ancestor
93358648|NCT03293511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358649|NCT03293511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358650|NCT02251171|Ritonavir|ritonavir|mesh-list
93358651|NCT02251171|Tipranavir|tipranavir|mesh-list
93358652|NCT02251171|Rifabutin|rifabutin|mesh-list
93358653|NCT02251171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93358654|NCT02251171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93358655|NCT02251171|Protease Inhibitors|protease inhibitors|mesh-ancestor
93358656|NCT02251171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358657|NCT02251171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358658|NCT02251171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93358659|NCT02251171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93358660|NCT02251171|Antiviral Agents|antiviral agents|mesh-ancestor
93358661|NCT02251171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358662|NCT02251171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93358663|NCT02251171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93358664|NCT02251171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93358665|NCT02251171|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93358666|NCT02251171|Antitubercular Agents|antitubercular agents|mesh-ancestor
93358667|NCT02110537|Flecainide|flecainide|mesh-list
93358668|NCT02110537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93358669|NCT02110537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93358670|NCT02110537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93358671|NCT02110537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358672|NCT02110537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358673|NCT03293277|Dexmedetomidine|dexmedetomidine|mesh-list
93358674|NCT03293277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93358675|NCT03293277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358676|NCT03293277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358677|NCT03293277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93358678|NCT03293277|Analgesics|analgesics|mesh-ancestor
93358679|NCT03293277|Sensory System Agents|sensory system agents|mesh-ancestor
93358680|NCT03293277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358681|NCT03293277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93358682|NCT03293277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93358683|NCT03293277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93358684|NCT03293277|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358685|NCT03293277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358686|NCT03293277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358687|NCT02108743|Albuterol|albuterol|mesh-list
93358688|NCT02108743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93358689|NCT02108743|Autonomic Agents|autonomic agents|mesh-ancestor
93358690|NCT02108743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358691|NCT02108743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358692|NCT02108743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93358693|NCT02108743|Respiratory System Agents|respiratory system agents|mesh-ancestor
93358694|NCT02108743|Tocolytic Agents|tocolytic agents|mesh-ancestor
93358695|NCT02108743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358696|NCT02108743|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93358697|NCT02108743|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93358698|NCT02108743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93358699|NCT02108743|Adrenergic Agents|adrenergic agents|mesh-ancestor
93358700|NCT02108743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358701|NCT02108743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358702|NCT03292965|Neostigmine|neostigmine|mesh-list
93358703|NCT03292965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93358704|NCT03292965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652385|NCT00556387|Ketamine|ketamine|mesh-list
93358705|NCT03292965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358706|NCT03292965|Cholinergic Agents|cholinergic agents|mesh-ancestor
93358707|NCT03292965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358708|NCT03292965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358709|NCT03292965|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93358710|NCT03292965|Autonomic Agents|autonomic agents|mesh-ancestor
93358711|NCT03292965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358712|NCT05024084|Anesthetics|anesthetics|mesh-list
93358713|NCT05024084|Sevoflurane|sevoflurane|mesh-list
93358714|NCT05024084|Desflurane|desflurane|mesh-list
93358715|NCT05024084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358716|NCT05024084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358717|NCT05024084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93358718|NCT05024084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93358719|NCT05024084|Anesthetics, General|anesthetics, general|mesh-ancestor
93358720|NCT02109289|Etanercept|etanercept|mesh-list
93358721|NCT02109289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93358722|NCT02109289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93358723|NCT02109289|Analgesics|analgesics|mesh-ancestor
93358724|NCT02109289|Sensory System Agents|sensory system agents|mesh-ancestor
93358725|NCT02109289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358726|NCT02109289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358727|NCT02109289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358728|NCT02109289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93358729|NCT02109289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358730|NCT02109289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358731|NCT02109289|Immunologic Factors|immunologic factors|mesh-ancestor
93358732|NCT03292731|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93358733|NCT03292731|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93358734|NCT03292731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93358735|NCT03292731|Hormone Antagonists|hormone antagonists|mesh-ancestor
93358736|NCT03292731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358737|NCT03292731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358738|NCT03292731|Progestins|progestins|mesh-ancestor
93358739|NCT03292731|Hormones|hormones|mesh-ancestor
93358740|NCT03553303|Valsartan|valsartan|mesh-list
93358741|NCT03553303|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93358742|NCT03553303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93358743|NCT03553303|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93358744|NCT03553303|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93358745|NCT03553303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358746|NCT03286959|Calcium|calcium|mesh-list
93358747|NCT03286959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93358748|NCT03286959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358749|NCT03292575|Anticoagulants|anticoagulants|mesh-list
93358750|NCT02115529|Nabilone|nabilone|mesh-list
93358751|NCT02115529|Antiemetics|antiemetics|mesh-ancestor
93358752|NCT02115529|Autonomic Agents|autonomic agents|mesh-ancestor
93358753|NCT02115529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358754|NCT02115529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358755|NCT02115529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93358756|NCT02115529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93358757|NCT02115529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93358758|NCT02115529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358759|NCT02115529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93358760|NCT01652716|Exenatide|exenatide|mesh-list
93358761|NCT01652716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93358762|NCT01652716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358763|NCT01652716|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93358764|NCT01652716|Incretins|incretins|mesh-ancestor
93358765|NCT01652716|Hormones|hormones|mesh-ancestor
93358766|NCT01652716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358767|NCT02459613|Annexin A5|annexin a5|mesh-list
93358768|NCT02459613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358769|NCT02459613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358770|NCT02251249|Acetaminophen|acetaminophen|mesh-list
93358771|NCT02251249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93358772|NCT02251249|Analgesics|analgesics|mesh-ancestor
93358773|NCT02251249|Sensory System Agents|sensory system agents|mesh-ancestor
93358774|NCT02251249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358775|NCT02251249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358776|NCT02251249|Antipyretics|antipyretics|mesh-ancestor
93358777|NCT05017766|Anti-Infective Agents|anti-infective agents|mesh-list
93358778|NCT05017766|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93358779|NCT03292263|Nivolumab|nivolumab|mesh-list
93358780|NCT03292263|Melphalan|melphalan|mesh-list
93358781|NCT03292263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93358782|NCT03292263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358783|NCT03292263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93358784|NCT03292263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358785|NCT03292263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93358786|NCT03292263|Alkylating Agents|alkylating agents|mesh-ancestor
93358787|NCT03292263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93358788|NCT03292263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358789|NCT03292263|Immunologic Factors|immunologic factors|mesh-ancestor
93358790|NCT03292263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358791|NCT02115763|Caffeine|caffeine|mesh-list
93358793|NCT02115763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358794|NCT02115763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93358795|NCT02115763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358796|NCT02115763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358797|NCT02115763|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93358798|NCT02115763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93358799|NCT02115763|Purinergic Agents|purinergic agents|mesh-ancestor
93358800|NCT02115763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358801|NCT03286803|Vaccines|vaccines|mesh-list
93358802|NCT03286803|Immunologic Factors|immunologic factors|mesh-ancestor
93358803|NCT03286803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358804|NCT03292185|Insulin|insulin|mesh-list
93358805|NCT03292185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93358806|NCT03292185|Liraglutide|liraglutide|mesh-list
93358807|NCT03292185|Insulin, Long-Acting|insulin, long-acting|mesh-list
93358808|NCT03292185|Xultophy|xultophy|mesh-list
93358809|NCT03292185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93358810|NCT03292185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358811|NCT03292185|Incretins|incretins|mesh-ancestor
93358812|NCT03292185|Hormones|hormones|mesh-ancestor
93358813|NCT03292185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358814|NCT04239339|Escitalopram|escitalopram|mesh-list
93358815|NCT04239339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93358816|NCT04239339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93358817|NCT04239339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358818|NCT04239339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358819|NCT04239339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358820|NCT04239339|Serotonin Agents|serotonin agents|mesh-ancestor
93358821|NCT04239339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358822|NCT02109679|Metformin|metformin|mesh-list
93358823|NCT02109679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93358824|NCT02109679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358825|NCT05023304|Prednisolone|prednisolone|mesh-list
93358826|NCT05023304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358827|NCT05023304|Glucocorticoids|glucocorticoids|mesh-ancestor
93358828|NCT05023304|Hormones|hormones|mesh-ancestor
93358829|NCT05023304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358830|NCT05023304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358831|NCT05023304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93358832|NCT05023304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358833|NCT02109913|Everolimus|everolimus|mesh-list
93358834|NCT02109913|Exemestane|exemestane|mesh-list
93358835|NCT02109913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93358836|NCT02109913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93358837|NCT02109913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358838|NCT02109913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358839|NCT02109913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358840|NCT02109913|Immunologic Factors|immunologic factors|mesh-ancestor
93358841|NCT02109913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358842|NCT02109913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358843|NCT02109913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93358844|NCT02109913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93358845|NCT02109913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93358846|NCT02109913|Hormone Antagonists|hormone antagonists|mesh-ancestor
93358847|NCT02109913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358848|NCT02116231|Cisplatin|cisplatin|mesh-list
93358849|NCT02116231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358850|NCT02111161|Immunoglobulins|immunoglobulins|mesh-list
93358851|NCT02111161|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93358852|NCT02111161|Immunoglobulin G|immunoglobulin g|mesh-list
93358853|NCT02111161|gamma-Globulins|gamma-globulins|mesh-list
93358854|NCT02111161|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93358855|NCT02111161|Immunologic Factors|immunologic factors|mesh-ancestor
93358856|NCT02111161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358857|NCT02116465|Levodopa|levodopa|mesh-list
93358858|NCT02116465|Carbidopa|carbidopa|mesh-list
93358859|NCT02116465|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93358860|NCT02116465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93358861|NCT02116465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93358862|NCT02116465|Dopamine Agents|dopamine agents|mesh-ancestor
93358863|NCT02116465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358864|NCT02116465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358865|NCT02116465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358866|NCT02116465|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93358867|NCT02116465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358868|NCT02116465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93358869|NCT02116465|Immunologic Factors|immunologic factors|mesh-ancestor
93358870|NCT02116465|Dopamine Agonists|dopamine agonists|mesh-ancestor
93358871|NCT02119039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93358872|NCT02119039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93358873|NCT02119117|Coenzyme Q10|coenzyme q10|mesh-list
93358874|NCT02119117|Vitamins|vitamins|mesh-ancestor
93358875|NCT02119117|Micronutrients|micronutrients|mesh-ancestor
93358876|NCT02119117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358877|NCT05016128|Ketamine|ketamine|mesh-list
93358878|NCT05016128|Esketamine|esketamine|mesh-list
93358879|NCT05016128|Analgesics|analgesics|mesh-ancestor
93358880|NCT05016128|Sensory System Agents|sensory system agents|mesh-ancestor
93358881|NCT05016128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358882|NCT05016128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358883|NCT05016128|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93358884|NCT05016128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93358885|NCT05016128|Anesthetics, General|anesthetics, general|mesh-ancestor
93358886|NCT05016128|Anesthetics|anesthetics|mesh-ancestor
93358887|NCT05016128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93358888|NCT05016128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93358889|NCT05016128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93358890|NCT05016128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358891|NCT05016128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358892|NCT05016128|Antidepressive Agents|antidepressive agents|mesh-ancestor
93358893|NCT05016128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93358894|NCT02111317|Verapamil|verapamil|mesh-list
93358895|NCT02111317|Peficitinib|peficitinib|mesh-list
93358896|NCT02111317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93358897|NCT02111317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93358898|NCT02111317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93358899|NCT02111317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358900|NCT02111317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93358901|NCT02111317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358902|NCT02111317|Vasodilator Agents|vasodilator agents|mesh-ancestor
93358903|NCT02111317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358904|NCT02111317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93358905|NCT02111317|Immunologic Factors|immunologic factors|mesh-ancestor
93358906|NCT03553615|Ivermectin|ivermectin|mesh-list
93358907|NCT03553615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93358908|NCT03553615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358909|NCT05016206|Moxifloxacin|moxifloxacin|mesh-list
92652593|NCT00234845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358910|NCT05016206|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93358911|NCT05016206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93358912|NCT05016206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358913|NCT05016206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93358914|NCT05016206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93358915|NCT05016206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358916|NCT05016206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358917|NCT05016206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358918|NCT05016206|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93358919|NCT05016206|Contraceptive Agents|contraceptive agents|mesh-ancestor
93358920|NCT05016206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358921|NCT05016206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358922|NCT05016206|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93358923|NCT05016206|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93358924|NCT05016206|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93358925|NCT02111473|Testosterone|testosterone|mesh-list
93358926|NCT02111473|Androgens|androgens|mesh-ancestor
93358927|NCT02111473|Hormones|hormones|mesh-ancestor
93358928|NCT02111473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358929|NCT02111473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358930|NCT02111551|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
93358931|NCT02111551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93358932|NCT02111551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93358933|NCT02111551|Cholinergic Agents|cholinergic agents|mesh-ancestor
93358934|NCT02111551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358935|NCT02111551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358936|NCT02111551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358937|NCT02119273|Prednisone|prednisone|mesh-list
93358938|NCT02119273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358939|NCT02119273|Glucocorticoids|glucocorticoids|mesh-ancestor
93030800|NCT03975166|Xhance|xhance|mesh-list
93358940|NCT02119273|Hormones|hormones|mesh-ancestor
93358941|NCT02119273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358942|NCT02119273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358943|NCT02119273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93358944|NCT02119273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93358945|NCT05029076|Liraglutide|liraglutide|mesh-list
93358946|NCT05029076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93358947|NCT05029076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358948|NCT05029076|Incretins|incretins|mesh-ancestor
93358949|NCT05029076|Hormones|hormones|mesh-ancestor
93358950|NCT05029076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358951|NCT05016440|Lisinopril|lisinopril|mesh-list
93358952|NCT05016440|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93358953|NCT05016440|Protease Inhibitors|protease inhibitors|mesh-ancestor
93358954|NCT05016440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358955|NCT05016440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358956|NCT05016440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93358957|NCT05016440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93358958|NCT05016440|Protective Agents|protective agents|mesh-ancestor
93358959|NCT05016440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358960|NCT02111629|Fluconazole|fluconazole|mesh-list
93358961|NCT02111629|Secnidazole|secnidazole|mesh-list
93358962|NCT02111629|Antifungal Agents|antifungal agents|mesh-ancestor
93358963|NCT02111629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93358964|NCT02111629|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93358965|NCT02111629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93358966|NCT02111629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358967|NCT02111629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358968|NCT02111629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93358969|NCT02111629|Hormone Antagonists|hormone antagonists|mesh-ancestor
93358970|NCT02111629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93358971|NCT02111629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358972|NCT02111629|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92652660|NCT04551703|Autonomic Agents|autonomic agents|mesh-ancestor
93358973|NCT02111629|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93358974|NCT02111629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93358975|NCT02111629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93358976|NCT02111707|Indomethacin|indomethacin|mesh-list
93358977|NCT02111707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93358978|NCT02111707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93358979|NCT02111707|Analgesics|analgesics|mesh-ancestor
93358980|NCT02111707|Sensory System Agents|sensory system agents|mesh-ancestor
93358981|NCT02111707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358982|NCT02111707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358983|NCT02111707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93358984|NCT02111707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93358985|NCT02111707|Gout Suppressants|gout suppressants|mesh-ancestor
93358986|NCT02111707|Tocolytic Agents|tocolytic agents|mesh-ancestor
93358987|NCT02111707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93358988|NCT02111707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93358989|NCT02111707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93358990|NCT02111707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93358991|NCT03552601|Methamphetamine|methamphetamine|mesh-list
93358992|NCT03552601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93358993|NCT03552601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93358994|NCT03552601|Sympathomimetics|sympathomimetics|mesh-ancestor
93358995|NCT03552601|Autonomic Agents|autonomic agents|mesh-ancestor
93358996|NCT03552601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93358997|NCT03552601|Dopamine Agents|dopamine agents|mesh-ancestor
93358998|NCT03552601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93358999|NCT03552601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359000|NCT03552601|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359001|NCT03552601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93359002|NCT03552601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93359003|NCT03552601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93359004|NCT03552601|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93359005|NCT05021588|Anticoagulants|anticoagulants|mesh-list
93359006|NCT03087890|Trimethoprim|trimethoprim|mesh-list
93359007|NCT03087890|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93359008|NCT03087890|Sulfamethoxazole|sulfamethoxazole|mesh-list
93359009|NCT03087890|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93359010|NCT03087890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359011|NCT03087890|Antimalarials|antimalarials|mesh-ancestor
93359012|NCT03087890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93359013|NCT03087890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93359014|NCT03087890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93359015|NCT03087890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359016|NCT03087890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359017|NCT03087890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93359018|NCT03087890|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93359019|NCT03087890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93359020|NCT03087890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93359021|NCT02112019|Hydrocortisone|hydrocortisone|mesh-list
93359022|NCT02112019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359023|NCT02117401|Midazolam|midazolam|mesh-list
93359024|NCT02117401|Ketamine|ketamine|mesh-list
93359025|NCT02117401|Remifentanil|remifentanil|mesh-list
93359026|NCT02117401|Propofol|propofol|mesh-list
93359027|NCT02117401|Mivacurium|mivacurium|mesh-list
93359028|NCT02117401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93359029|NCT02117401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359030|NCT02117401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359031|NCT02117401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93359032|NCT02117401|Anesthetics, General|anesthetics, general|mesh-ancestor
93359033|NCT02117401|Anesthetics|anesthetics|mesh-ancestor
93359034|NCT02117401|Analgesics|analgesics|mesh-ancestor
93359035|NCT02117401|Sensory System Agents|sensory system agents|mesh-ancestor
93359036|NCT02117401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359037|NCT02117401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93359038|NCT02117401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93359039|NCT02117401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93359040|NCT02117401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359041|NCT02117401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359042|NCT02117401|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93359043|NCT02117401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93359044|NCT02117401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93359045|NCT02117401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93359046|NCT02117401|GABA Modulators|gaba modulators|mesh-ancestor
93359047|NCT02117401|GABA Agents|gaba agents|mesh-ancestor
93359048|NCT02117401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93359049|NCT02117401|Narcotics|narcotics|mesh-ancestor
93359050|NCT02117401|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93359051|NCT02117401|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93359052|NCT02117401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93359053|NCT04434404|Silymarin|silymarin|mesh-list
93359054|NCT04434404|Antioxidants|antioxidants|mesh-ancestor
93359055|NCT04434404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359056|NCT04434404|Protective Agents|protective agents|mesh-ancestor
93359057|NCT04434404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359058|NCT02251483|Immunoglobulins|immunoglobulins|mesh-list
93359059|NCT02251483|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93359060|NCT02251483|Antibodies|antibodies|mesh-list
93359061|NCT02251483|Immunologic Factors|immunologic factors|mesh-ancestor
93359062|NCT02251483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359063|NCT02117869|Furocoumarins|furocoumarins|mesh-list
93359064|NCT02117869|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359065|NCT02117869|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93359066|NCT02120599|Folic Acid|folic acid|mesh-list
93359067|NCT02120599|Hematinics|hematinics|mesh-ancestor
93359068|NCT02120599|Vitamin B Complex|vitamin b complex|mesh-ancestor
93359069|NCT02120599|Vitamins|vitamins|mesh-ancestor
93359070|NCT02120599|Micronutrients|micronutrients|mesh-ancestor
93359071|NCT02120599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359072|NCT02112097|Etanercept|etanercept|mesh-list
93359073|NCT02112097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359074|NCT02112097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359075|NCT02112097|Analgesics|analgesics|mesh-ancestor
93359076|NCT02112097|Sensory System Agents|sensory system agents|mesh-ancestor
93359077|NCT02112097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359078|NCT02112097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359079|NCT02112097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359080|NCT02112097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359081|NCT02112097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93359082|NCT02112097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93359083|NCT02112097|Immunologic Factors|immunologic factors|mesh-ancestor
93359084|NCT02112175|Lenalidomide|lenalidomide|mesh-list
93359085|NCT02112175|Immunologic Factors|immunologic factors|mesh-ancestor
93359086|NCT02112175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359087|NCT02112175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93359088|NCT02112175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93359089|NCT02112175|Growth Substances|growth substances|mesh-ancestor
93359090|NCT02112175|Growth Inhibitors|growth inhibitors|mesh-ancestor
93359091|NCT02112175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359093|NCT03553537|Cyclophosphamide|cyclophosphamide|mesh-list
93359094|NCT03553537|Doxorubicin|doxorubicin|mesh-list
93359095|NCT03553537|Vincristine|vincristine|mesh-list
93359096|NCT03553537|Decitabine|decitabine|mesh-list
93359097|NCT03553537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93359098|NCT03553537|Immunologic Factors|immunologic factors|mesh-ancestor
93359099|NCT03553537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359100|NCT03553537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359101|NCT03553537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93359102|NCT03553537|Alkylating Agents|alkylating agents|mesh-ancestor
93359103|NCT03553537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359104|NCT03553537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359105|NCT03553537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93359106|NCT03553537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93359107|NCT03553537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93359108|NCT03553537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93359109|NCT03553537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359110|NCT03553537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359111|NCT03553537|Glucocorticoids|glucocorticoids|mesh-ancestor
93359112|NCT03553537|Hormones|hormones|mesh-ancestor
93359113|NCT03553537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359114|NCT03553537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93359115|NCT03553537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93359116|NCT03553537|Tubulin Modulators|tubulin modulators|mesh-ancestor
93359117|NCT03553537|Antimitotic Agents|antimitotic agents|mesh-ancestor
93359118|NCT03553537|Mitosis Modulators|mitosis modulators|mesh-ancestor
93359119|NCT03553537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93359120|NCT03553537|Antimetabolites|antimetabolites|mesh-ancestor
93359121|NCT04434170|Valsartan|valsartan|mesh-list
93359122|NCT04434170|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93359123|NCT04434170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93359124|NCT04434170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93359125|NCT04434170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93359126|NCT04434170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359127|NCT03086174|Antibodies|antibodies|mesh-list
93359128|NCT03086174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93359129|NCT03086174|Immunologic Factors|immunologic factors|mesh-ancestor
93359130|NCT03086174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359131|NCT03085784|Aflibercept|aflibercept|mesh-list
93359132|NCT03085784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93359133|NCT03085784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93359134|NCT03085784|Growth Substances|growth substances|mesh-ancestor
93359135|NCT03085784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359136|NCT03085784|Growth Inhibitors|growth inhibitors|mesh-ancestor
93359137|NCT03085784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359138|NCT05021276|Basiliximab|basiliximab|mesh-list
93359139|NCT05021276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93359140|NCT05021276|Immunologic Factors|immunologic factors|mesh-ancestor
93359141|NCT05021276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359142|NCT05014490|Etoricoxib|etoricoxib|mesh-list
93359143|NCT05014490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359144|NCT05014490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359145|NCT05014490|Analgesics|analgesics|mesh-ancestor
93359146|NCT05014490|Sensory System Agents|sensory system agents|mesh-ancestor
93359147|NCT05014490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359148|NCT05014490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359149|NCT05014490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359150|NCT05014490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359151|NCT05014490|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93359152|NCT05014490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93359153|NCT05014490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359154|NCT05014490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359155|NCT05020964|Trastuzumab|trastuzumab|mesh-list
93359156|NCT05020964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93359157|NCT05020964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359158|NCT05014100|Lenalidomide|lenalidomide|mesh-list
93359159|NCT05014100|Immunologic Factors|immunologic factors|mesh-ancestor
93359160|NCT05014100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359161|NCT05014100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93359162|NCT05014100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93359163|NCT05014100|Growth Substances|growth substances|mesh-ancestor
93359164|NCT05014100|Growth Inhibitors|growth inhibitors|mesh-ancestor
93359165|NCT05014100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359166|NCT05027126|Folic Acid|folic acid|mesh-list
93359167|NCT05027126|Vitamin B Complex|vitamin b complex|mesh-list
93359168|NCT05027126|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93359169|NCT05027126|Vitamins|vitamins|mesh-ancestor
93359170|NCT05027126|Micronutrients|micronutrients|mesh-ancestor
93359171|NCT05027126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359172|NCT05027126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359173|NCT05027126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359174|NCT05027126|Analgesics|analgesics|mesh-ancestor
93359175|NCT05027126|Sensory System Agents|sensory system agents|mesh-ancestor
93359176|NCT05027126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359177|NCT05027126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359178|NCT05027126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359179|NCT05027126|Hematinics|hematinics|mesh-ancestor
93359180|NCT02120677|Itraconazole|itraconazole|mesh-list
93359181|NCT02120677|Antifungal Agents|antifungal agents|mesh-ancestor
93359182|NCT02120677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359183|NCT02120677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93359184|NCT02120677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93359185|NCT02120677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359186|NCT02120677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359187|NCT02120677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93359188|NCT02120677|Hormone Antagonists|hormone antagonists|mesh-ancestor
93359189|NCT02120677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359190|NCT02120677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359191|NCT02120677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93359192|NCT02120911|Trastuzumab|trastuzumab|mesh-list
93359193|NCT02120911|Pertuzumab|pertuzumab|mesh-list
93359194|NCT02120911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93359195|NCT02120911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359196|NCT02112487|Macitentan|macitentan|mesh-list
93359197|NCT02112487|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93359198|NCT02112487|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93359199|NCT02112487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359200|NCT02112487|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93359201|NCT03094442|Dexamethasone|dexamethasone|mesh-list
93359202|NCT03094442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359203|NCT03094442|Antiemetics|antiemetics|mesh-ancestor
93359204|NCT03094442|Autonomic Agents|autonomic agents|mesh-ancestor
93359205|NCT03094442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359206|NCT03094442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359207|NCT03094442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93359208|NCT03094442|Glucocorticoids|glucocorticoids|mesh-ancestor
93359209|NCT03094442|Hormones|hormones|mesh-ancestor
93359210|NCT03094442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359211|NCT03094442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93359212|NCT03094442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359213|NCT02406742|Obinutuzumab|obinutuzumab|mesh-list
93359214|NCT02406742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93359215|NCT02406742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359216|NCT02112643|Selenium|selenium|mesh-list
93359217|NCT02112643|Selenic Acid|selenic acid|mesh-list
93359218|NCT02112643|Antioxidants|antioxidants|mesh-ancestor
93359219|NCT02112643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359220|NCT02112643|Protective Agents|protective agents|mesh-ancestor
93359221|NCT02112643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359222|NCT02112643|Trace Elements|trace elements|mesh-ancestor
93359223|NCT02112643|Micronutrients|micronutrients|mesh-ancestor
93359224|NCT02112721|Vitamin D|vitamin d|mesh-list
93359225|NCT02112721|Vitamins|vitamins|mesh-ancestor
93359226|NCT02112721|Micronutrients|micronutrients|mesh-ancestor
93359227|NCT02112721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359228|NCT02112721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93359229|NCT02112799|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93359230|NCT02112799|Antiviral Agents|antiviral agents|mesh-ancestor
93359231|NCT02112799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359232|NCT02122939|Escitalopram|escitalopram|mesh-list
93359233|NCT02122939|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93359234|NCT02122939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93359235|NCT02122939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93359236|NCT02122939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359237|NCT02122939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359238|NCT02122939|Serotonin Agents|serotonin agents|mesh-ancestor
93359239|NCT02122939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359240|NCT04434248|Ritonavir|ritonavir|mesh-list
93359241|NCT04434248|Lopinavir|lopinavir|mesh-list
93359242|NCT04434248|Hydroxychloroquine|hydroxychloroquine|mesh-list
93359243|NCT04434248|Chloroquine|chloroquine|mesh-list
93359244|NCT04434248|Favipiravir|favipiravir|mesh-list
93359245|NCT04434248|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93359246|NCT04434248|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93359247|NCT04434248|Protease Inhibitors|protease inhibitors|mesh-ancestor
93359248|NCT04434248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359249|NCT04434248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359250|NCT04434248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93359251|NCT04434248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93359252|NCT04434248|Antiviral Agents|antiviral agents|mesh-ancestor
93359253|NCT04434248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359254|NCT04434248|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93359255|NCT04434248|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93359256|NCT04434248|Antimalarials|antimalarials|mesh-ancestor
93359257|NCT04434248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93359258|NCT04434248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93359259|NCT04434248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359260|NCT04434248|Amebicides|amebicides|mesh-ancestor
93359261|NCT02121457|Selenium|selenium|mesh-list
93359262|NCT02121457|Antioxidants|antioxidants|mesh-ancestor
92652944|NCT00268593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359263|NCT02121457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359264|NCT02121457|Protective Agents|protective agents|mesh-ancestor
93359265|NCT02121457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359266|NCT02121457|Trace Elements|trace elements|mesh-ancestor
93359267|NCT02121457|Micronutrients|micronutrients|mesh-ancestor
93359268|NCT02251795|Aspirin|aspirin|mesh-list
93359269|NCT02251795|Ritonavir|ritonavir|mesh-list
93359270|NCT02251795|Darunavir|darunavir|mesh-list
93359271|NCT02251795|Tipranavir|tipranavir|mesh-list
93359272|NCT02251795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359273|NCT02251795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359274|NCT02251795|Analgesics|analgesics|mesh-ancestor
93359275|NCT02251795|Sensory System Agents|sensory system agents|mesh-ancestor
93359276|NCT02251795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359277|NCT02251795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359278|NCT02251795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359279|NCT02251795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359280|NCT02251795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93359281|NCT02251795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93359282|NCT02251795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359283|NCT02251795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93359284|NCT02251795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93359285|NCT02251795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359286|NCT02251795|Antipyretics|antipyretics|mesh-ancestor
93359287|NCT02251795|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93359288|NCT02251795|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93359289|NCT02251795|Protease Inhibitors|protease inhibitors|mesh-ancestor
93359290|NCT02251795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93359291|NCT02251795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93359292|NCT02251795|Antiviral Agents|antiviral agents|mesh-ancestor
93359293|NCT02251795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359294|NCT02251795|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93359295|NCT02251795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93359296|NCT05013164|Leucovorin|leucovorin|mesh-list
93359297|NCT05013164|Folic Acid|folic acid|mesh-list
93359298|NCT05013164|Levoleucovorin|levoleucovorin|mesh-list
93359299|NCT05013164|Antidotes|antidotes|mesh-ancestor
93359300|NCT05013164|Protective Agents|protective agents|mesh-ancestor
93359301|NCT05013164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359302|NCT05013164|Vitamin B Complex|vitamin b complex|mesh-ancestor
93359303|NCT05013164|Vitamins|vitamins|mesh-ancestor
93359304|NCT05013164|Micronutrients|micronutrients|mesh-ancestor
93359305|NCT05013164|Hematinics|hematinics|mesh-ancestor
93359306|NCT02251951|Paclitaxel|paclitaxel|mesh-list
93359307|NCT02251951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93359308|NCT02251951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359309|NCT02251951|Tubulin Modulators|tubulin modulators|mesh-ancestor
93359310|NCT02251951|Antimitotic Agents|antimitotic agents|mesh-ancestor
93359311|NCT02251951|Mitosis Modulators|mitosis modulators|mesh-ancestor
93359312|NCT02251951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359313|NCT03091868|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93359314|NCT03091868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93031214|NCT00286234|Niacin|niacin|mesh-list
93359315|NCT03091868|Immunologic Factors|immunologic factors|mesh-ancestor
93359316|NCT03091868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359317|NCT03091868|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93359318|NCT03091868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93359319|NCT03091868|Dopamine Agonists|dopamine agonists|mesh-ancestor
93359320|NCT03091868|Dopamine Agents|dopamine agents|mesh-ancestor
93359321|NCT03091868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359322|NCT03091868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359323|NCT02121613|Tamsulosin|tamsulosin|mesh-list
93359324|NCT02121613|Saw palmetto extract|saw palmetto extract|mesh-list
93359325|NCT02121613|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93359326|NCT02121613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93359327|NCT02121613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93359328|NCT02121613|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359329|NCT02121613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359330|NCT02121613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359331|NCT02121613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359332|NCT02121613|Urological Agents|urological agents|mesh-ancestor
93359333|NCT03091712|Insulin|insulin|mesh-list
93359334|NCT03091712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93359335|NCT03091712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359336|NCT03552211|Biotin|biotin|mesh-list
93359337|NCT03552211|Vitamin B Complex|vitamin b complex|mesh-ancestor
93359338|NCT03552211|Vitamins|vitamins|mesh-ancestor
93359339|NCT03552211|Micronutrients|micronutrients|mesh-ancestor
93359340|NCT03552211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359341|NCT02113267|Mometasone Furoate|mometasone furoate|mesh-list
93359342|NCT02113267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359343|NCT02113267|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359344|NCT02113267|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93359345|NCT03281187|Methyltestosterone|methyltestosterone|mesh-list
93359346|NCT03281187|Testosterone|testosterone|mesh-list
93359347|NCT03281187|Testosterone undecanoate|testosterone undecanoate|mesh-list
93359348|NCT03281187|Testosterone enanthate|testosterone enanthate|mesh-list
93359349|NCT03281187|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93359350|NCT03281187|Androgens|androgens|mesh-ancestor
93359351|NCT03281187|Hormones|hormones|mesh-ancestor
93359352|NCT03281187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359353|NCT03281187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359354|NCT03281187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93359355|NCT03281187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359356|NCT03281187|Anabolic Agents|anabolic agents|mesh-ancestor
93359357|NCT03291249|Omeprazole|omeprazole|mesh-list
93359358|NCT03291249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93359359|NCT03291249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93359360|NCT03291249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93359361|NCT03291249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359362|NCT03291249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359363|NCT05013320|Glycopyrrolate|glycopyrrolate|mesh-list
93359364|NCT05013320|Dexmedetomidine|dexmedetomidine|mesh-list
93359365|NCT05013320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93359366|NCT05013320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359367|NCT05013320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359368|NCT05013320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359369|NCT05013320|Analgesics|analgesics|mesh-ancestor
93359370|NCT05013320|Sensory System Agents|sensory system agents|mesh-ancestor
93359371|NCT05013320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359372|NCT05013320|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93359373|NCT05013320|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93359374|NCT05013320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93359375|NCT05013320|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359376|NCT05013320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359377|NCT05013320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359378|NCT05013320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93359379|NCT05013320|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93359380|NCT05013320|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93359381|NCT05013320|Cholinergic Agents|cholinergic agents|mesh-ancestor
93359382|NCT02437162|Golimumab|golimumab|mesh-list
93359383|NCT02437162|Ustekinumab|ustekinumab|mesh-list
93359384|NCT02437162|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359385|NCT02437162|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93359386|NCT02437162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359387|NCT02437162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93359388|NCT02437162|Immunologic Factors|immunologic factors|mesh-ancestor
93359389|NCT02437162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359390|NCT03291093|Flutemetamol|flutemetamol|mesh-list
93359391|NCT03291093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93359392|NCT03291093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359393|NCT02123563|Listerine|listerine|mesh-list
93359394|NCT02123563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93359395|NCT02123563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359396|NCT02122003|Sorafenib|sorafenib|mesh-list
93359397|NCT02122003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359398|NCT02122003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93359399|NCT02122003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359400|NCT02122003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359401|NCT03079388|Azithromycin|azithromycin|mesh-list
93359402|NCT03079388|Pyrimethamine|pyrimethamine|mesh-list
93359403|NCT03079388|Sulfadoxine|sulfadoxine|mesh-list
93359404|NCT03079388|Albendazole|albendazole|mesh-list
93359405|NCT03079388|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93359406|NCT03079388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93359407|NCT03079388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359408|NCT03079388|Antimalarials|antimalarials|mesh-ancestor
93359409|NCT03079388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93359410|NCT03079388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93359411|NCT03079388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93359412|NCT03079388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653088|NCT00235859|Adalimumab|adalimumab|mesh-list
93359413|NCT03079388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359414|NCT03079388|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93359415|NCT03079388|Anthelmintics|anthelmintics|mesh-ancestor
93359416|NCT03079388|Anticestodal Agents|anticestodal agents|mesh-ancestor
93359417|NCT03079388|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93359418|NCT03079388|Tubulin Modulators|tubulin modulators|mesh-ancestor
93359419|NCT03079388|Antimitotic Agents|antimitotic agents|mesh-ancestor
93359420|NCT03079388|Mitosis Modulators|mitosis modulators|mesh-ancestor
93359421|NCT03079388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359422|NCT03079544|Asparaginase|asparaginase|mesh-list
93359423|NCT03079544|Pegaspargase|pegaspargase|mesh-list
93359424|NCT03079544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359425|NCT03286101|Ivermectin|ivermectin|mesh-list
93359426|NCT03286101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93359427|NCT03286101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359428|NCT02437084|Atorvastatin|atorvastatin|mesh-list
93359429|NCT02437084|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93359430|NCT02437084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93359431|NCT02437084|Antimetabolites|antimetabolites|mesh-ancestor
93359432|NCT02437084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359433|NCT02437084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93359434|NCT02437084|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93359435|NCT02437084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359436|NCT05009498|Vitamin D|vitamin d|mesh-list
93359437|NCT05009498|Cholecalciferol|cholecalciferol|mesh-list
93359438|NCT05009498|Vitamins|vitamins|mesh-ancestor
93359439|NCT05009498|Micronutrients|micronutrients|mesh-ancestor
93359440|NCT05009498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359441|NCT05009498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93359442|NCT05009498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93359443|NCT02406586|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
93359444|NCT02406586|Carvedilol|carvedilol|mesh-list
93359445|NCT02406586|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93359446|NCT02406586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93359447|NCT02406586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93359448|NCT02406586|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359449|NCT02406586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359450|NCT02406586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359451|NCT02406586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359452|NCT02406586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93359453|NCT02406586|Antioxidants|antioxidants|mesh-ancestor
93359454|NCT02406586|Protective Agents|protective agents|mesh-ancestor
93359455|NCT02406586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93359456|NCT02406586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93359457|NCT02406586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93359458|NCT02406586|Vasodilator Agents|vasodilator agents|mesh-ancestor
93359459|NCT02406586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93359460|NCT02406586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93359461|NCT02406586|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93359462|NCT02406586|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93359463|NCT02406586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93359464|NCT02406586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359465|NCT02406586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359466|NCT02406586|Analgesics|analgesics|mesh-ancestor
93359467|NCT02406586|Sensory System Agents|sensory system agents|mesh-ancestor
93031338|NCT00377403|Expectorants|expectorants|mesh-ancestor
93359468|NCT02406586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359469|NCT02406586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359470|NCT02406586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359471|NCT03091166|Dexmedetomidine|dexmedetomidine|mesh-list
93359472|NCT03091166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93359473|NCT03091166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359474|NCT03091166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359475|NCT03091166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359476|NCT03091166|Analgesics|analgesics|mesh-ancestor
93359477|NCT03091166|Sensory System Agents|sensory system agents|mesh-ancestor
93359478|NCT03091166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359479|NCT03091166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93359480|NCT03091166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93359481|NCT03091166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93359482|NCT03091166|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359483|NCT03091166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359484|NCT03091166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359485|NCT02122393|Sertraline|sertraline|mesh-list
93359486|NCT02122393|Antidepressive Agents|antidepressive agents|mesh-ancestor
93359487|NCT02122393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93359488|NCT02122393|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93359489|NCT02122393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93359490|NCT02122393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93359491|NCT02122393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359492|NCT02122393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359493|NCT02122393|Serotonin Agents|serotonin agents|mesh-ancestor
93359494|NCT02122393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359495|NCT03821883|Aspirin|aspirin|mesh-list
93359496|NCT03821883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359497|NCT03821883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359498|NCT03821883|Analgesics|analgesics|mesh-ancestor
93359499|NCT03821883|Sensory System Agents|sensory system agents|mesh-ancestor
93359500|NCT03821883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359501|NCT03821883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359502|NCT03821883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359503|NCT03821883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359504|NCT03821883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93359505|NCT03821883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93359506|NCT03821883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359507|NCT03821883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93359508|NCT03821883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93359509|NCT03821883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359510|NCT03821883|Antipyretics|antipyretics|mesh-ancestor
93359511|NCT03080480|Pioglitazone|pioglitazone|mesh-list
93359512|NCT03080480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93359513|NCT03080480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359514|NCT02126761|Vaccines|vaccines|mesh-list
93359515|NCT02126761|Immunologic Factors|immunologic factors|mesh-ancestor
93359516|NCT02126761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359517|NCT02788357|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93359518|NCT02788357|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93359519|NCT02788357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93359520|NCT02788357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93359521|NCT02788357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359522|NCT02788357|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359523|NCT02788357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359524|NCT02788357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359525|NCT03280641|Warfarin|warfarin|mesh-list
93359526|NCT03280641|Dabigatran|dabigatran|mesh-list
93359527|NCT03280641|Anticoagulants|anticoagulants|mesh-ancestor
93359528|NCT03280641|Antithrombins|antithrombins|mesh-ancestor
93359529|NCT03280641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93359530|NCT03280641|Protease Inhibitors|protease inhibitors|mesh-ancestor
93359531|NCT03280641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359532|NCT03280641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359533|NCT03285165|Propofol|propofol|mesh-list
93359534|NCT03285165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93359535|NCT03285165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359536|NCT03285165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359537|NCT03285165|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93359538|NCT03285165|Anesthetics, General|anesthetics, general|mesh-ancestor
93359539|NCT03285165|Anesthetics|anesthetics|mesh-ancestor
93359540|NCT03285087|Dexmedetomidine|dexmedetomidine|mesh-list
93359541|NCT03285087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93359542|NCT03285087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359543|NCT03285087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359544|NCT03285087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359545|NCT03285087|Analgesics|analgesics|mesh-ancestor
93359546|NCT03285087|Sensory System Agents|sensory system agents|mesh-ancestor
93359547|NCT03285087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359548|NCT03285087|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93359549|NCT03285087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93359550|NCT03285087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93359551|NCT03285087|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359552|NCT03285087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359553|NCT03285087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359554|NCT02122627|Vitamin D|vitamin d|mesh-list
93359555|NCT02122627|Ergocalciferols|ergocalciferols|mesh-list
93359556|NCT02122627|Cholecalciferol|cholecalciferol|mesh-list
93359557|NCT02122627|Vitamins|vitamins|mesh-list
93359558|NCT02122627|Micronutrients|micronutrients|mesh-ancestor
93359559|NCT02122627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359560|NCT02122627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93359561|NCT02122627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93359562|NCT02122705|Remifentanil|remifentanil|mesh-list
93359563|NCT02122705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93359564|NCT02122705|Narcotics|narcotics|mesh-ancestor
93359565|NCT02122705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359566|NCT02122705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359567|NCT02122705|Analgesics|analgesics|mesh-ancestor
93359568|NCT02122705|Sensory System Agents|sensory system agents|mesh-ancestor
93359569|NCT02122705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359570|NCT05011916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93359571|NCT05011916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93359572|NCT03384225|Cytarabine|cytarabine|mesh-list
93359573|NCT03384225|Fludarabine|fludarabine|mesh-list
93359574|NCT03384225|Busulfan|busulfan|mesh-list
93359575|NCT03384225|Cladribine|cladribine|mesh-list
93359576|NCT03384225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359577|NCT03384225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93359578|NCT03384225|Antimetabolites|antimetabolites|mesh-ancestor
93359579|NCT03384225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359580|NCT03384225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93359581|NCT03384225|Immunologic Factors|immunologic factors|mesh-ancestor
93359582|NCT03384225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359583|NCT03384225|Antiviral Agents|antiviral agents|mesh-ancestor
93359584|NCT03384225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359585|NCT03384225|Alkylating Agents|alkylating agents|mesh-ancestor
93359586|NCT03384225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93359587|NCT03384225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93359588|NCT05019326|Andrographolide|andrographolide|mesh-list
93359589|NCT05019326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359590|NCT05019326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359591|NCT05019326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359592|NCT05019326|Analgesics|analgesics|mesh-ancestor
93359593|NCT05019326|Sensory System Agents|sensory system agents|mesh-ancestor
93359594|NCT05019326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359595|NCT05019326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359596|NCT05019326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359597|NCT05019326|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93359598|NCT05019326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93359599|NCT05019326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359600|NCT05019326|Antiviral Agents|antiviral agents|mesh-ancestor
93359601|NCT05019326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93359602|NCT05008250|Metoprolol|metoprolol|mesh-list
93359603|NCT05008250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93359604|NCT05008250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93359605|NCT05008250|Sympatholytics|sympatholytics|mesh-ancestor
93359606|NCT05008250|Autonomic Agents|autonomic agents|mesh-ancestor
93359607|NCT05008250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359608|NCT05008250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359609|NCT05008250|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93359610|NCT05008250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93359611|NCT05008250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93359612|NCT05008250|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359613|NCT05008250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359614|NCT05008250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359615|NCT03079076|Bupivacaine|bupivacaine|mesh-list
93359616|NCT03079076|Anesthetics, Local|anesthetics, local|mesh-ancestor
93359617|NCT03079076|Anesthetics|anesthetics|mesh-ancestor
93359618|NCT03079076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359619|NCT03079076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359620|NCT03079076|Sensory System Agents|sensory system agents|mesh-ancestor
93359621|NCT03079076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359622|NCT03271749|Anesthetics|anesthetics|mesh-list
93359623|NCT03271749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359624|NCT03271749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359625|NCT03280407|Leucovorin|leucovorin|mesh-list
93359626|NCT03280407|Capecitabine|capecitabine|mesh-list
93359627|NCT03280407|Oxaliplatin|oxaliplatin|mesh-list
93359628|NCT03280407|Levoleucovorin|levoleucovorin|mesh-list
93359629|NCT03280407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93359630|NCT03280407|Antimetabolites|antimetabolites|mesh-ancestor
93359631|NCT03280407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359632|NCT03280407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359633|NCT03280407|Antidotes|antidotes|mesh-ancestor
93359634|NCT03280407|Protective Agents|protective agents|mesh-ancestor
93359635|NCT03280407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359636|NCT03280407|Vitamin B Complex|vitamin b complex|mesh-ancestor
93359637|NCT03280407|Vitamins|vitamins|mesh-ancestor
93359638|NCT03280407|Micronutrients|micronutrients|mesh-ancestor
93359639|NCT03078842|Zinc|zinc|mesh-list
93359640|NCT03078842|Trace Elements|trace elements|mesh-ancestor
93359641|NCT03078842|Micronutrients|micronutrients|mesh-ancestor
93359642|NCT03078842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359643|NCT05007860|Vaccines|vaccines|mesh-list
93359644|NCT05007860|Immunologic Factors|immunologic factors|mesh-ancestor
93359645|NCT05007860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359646|NCT03270033|Dexamethasone|dexamethasone|mesh-list
93359647|NCT03270033|Dexamethasone acetate|dexamethasone acetate|mesh-list
93359648|NCT03270033|Dexmedetomidine|dexmedetomidine|mesh-list
93359649|NCT03270033|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93359650|NCT03270033|BB 1101|bb 1101|mesh-list
93359651|NCT03270033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359652|NCT03270033|Antiemetics|antiemetics|mesh-ancestor
93359653|NCT03270033|Autonomic Agents|autonomic agents|mesh-ancestor
93359654|NCT03270033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359655|NCT03270033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359656|NCT03270033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93359657|NCT03270033|Glucocorticoids|glucocorticoids|mesh-ancestor
93359658|NCT03270033|Hormones|hormones|mesh-ancestor
93359659|NCT03270033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359660|NCT03270033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93359661|NCT03270033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359662|NCT03270033|Protease Inhibitors|protease inhibitors|mesh-ancestor
93359663|NCT03270033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359664|NCT03270033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359665|NCT03270033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93359666|NCT03270033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359667|NCT03270033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359668|NCT03270033|Analgesics|analgesics|mesh-ancestor
93359669|NCT03270033|Sensory System Agents|sensory system agents|mesh-ancestor
93359670|NCT03270033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93359671|NCT03270033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93359672|NCT03270033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93359673|NCT03270033|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359674|NCT03270033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359675|NCT04959812|Sufentanil|sufentanil|mesh-list
93359676|NCT04959812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93359677|NCT04959812|Narcotics|narcotics|mesh-ancestor
93359678|NCT04959812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359679|NCT04959812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359680|NCT04959812|Analgesics|analgesics|mesh-ancestor
93359681|NCT04959812|Sensory System Agents|sensory system agents|mesh-ancestor
93359682|NCT04959812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359683|NCT04959812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93359684|NCT04959812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93359685|NCT04959812|Anesthetics, General|anesthetics, general|mesh-ancestor
93359686|NCT04959812|Anesthetics|anesthetics|mesh-ancestor
93359687|NCT03280095|Acetaminophen|acetaminophen|mesh-list
93359688|NCT03280095|Codeine|codeine|mesh-list
92653374|NCT00236327|Analgesics|analgesics|mesh-ancestor
93359689|NCT03280095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359690|NCT03280095|Analgesics|analgesics|mesh-ancestor
93359691|NCT03280095|Sensory System Agents|sensory system agents|mesh-ancestor
93359692|NCT03280095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359693|NCT03280095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359694|NCT03280095|Antipyretics|antipyretics|mesh-ancestor
93359695|NCT03280095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93359696|NCT03280095|Narcotics|narcotics|mesh-ancestor
93359697|NCT03280095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359698|NCT03280095|Antitussive Agents|antitussive agents|mesh-ancestor
93359699|NCT03280095|Respiratory System Agents|respiratory system agents|mesh-ancestor
93359700|NCT04463030|Vitamins|vitamins|mesh-list
93359701|NCT04463030|Ascorbic Acid|ascorbic acid|mesh-list
93359702|NCT04463030|Micronutrients|micronutrients|mesh-ancestor
93359703|NCT04463030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359704|NCT04463030|Antioxidants|antioxidants|mesh-ancestor
93359705|NCT04463030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359706|NCT04463030|Protective Agents|protective agents|mesh-ancestor
93359707|NCT03269721|Carbon Monoxide|carbon monoxide|mesh-list
93359708|NCT03269721|Antimetabolites|antimetabolites|mesh-ancestor
93359709|NCT03269721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359710|NCT03269721|Gasotransmitters|gasotransmitters|mesh-ancestor
93359711|NCT03269721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359712|NCT03269721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359713|NCT05010434|Bevacizumab|bevacizumab|mesh-list
93359714|NCT05010434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93359715|NCT05010434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359716|NCT05010434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93359717|NCT05010434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93359718|NCT05010434|Growth Substances|growth substances|mesh-ancestor
93359719|NCT05010434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359720|NCT05010434|Growth Inhibitors|growth inhibitors|mesh-ancestor
93359721|NCT05010356|Insulin|insulin|mesh-list
93359722|NCT05010356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93359723|NCT05010356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359724|NCT03269955|Thrombin|thrombin|mesh-list
93359725|NCT03269955|Hemostatics|hemostatics|mesh-ancestor
93359726|NCT03269955|Coagulants|coagulants|mesh-ancestor
93359727|NCT05006846|Analgesics, Opioid|analgesics, opioid|mesh-list
93359728|NCT05006846|Narcotics|narcotics|mesh-ancestor
93359729|NCT05006846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359730|NCT05006846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359731|NCT05006846|Analgesics|analgesics|mesh-ancestor
93359732|NCT05006846|Sensory System Agents|sensory system agents|mesh-ancestor
93359733|NCT05006846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359734|NCT02457520|Isotretinoin|isotretinoin|mesh-list
93359735|NCT02457520|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359736|NCT02457585|Infliximab|infliximab|mesh-list
93359737|NCT02457585|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93359738|NCT02457585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359739|NCT02457585|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359740|NCT02457585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93359741|NCT02457585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359742|NCT02457507|Vitamin B 12|vitamin b 12|mesh-list
93359743|NCT02457507|Hydroxocobalamin|hydroxocobalamin|mesh-list
93359744|NCT02457507|Vitamins|vitamins|mesh-ancestor
93359745|NCT02457507|Micronutrients|micronutrients|mesh-ancestor
93359746|NCT02457507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359747|NCT02457507|Vitamin B Complex|vitamin b complex|mesh-ancestor
93359748|NCT02457507|Hematinics|hematinics|mesh-ancestor
93359749|NCT03265197|Lidocaine|lidocaine|mesh-list
93359750|NCT03265197|Anesthetics, Local|anesthetics, local|mesh-ancestor
93359751|NCT03265197|Anesthetics|anesthetics|mesh-ancestor
93359752|NCT03265197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359753|NCT03265197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359754|NCT03265197|Sensory System Agents|sensory system agents|mesh-ancestor
93359755|NCT03265197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359756|NCT03265197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93359757|NCT03265197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93359758|NCT03265197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93359759|NCT03265197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93359760|NCT03265197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359761|NCT03078374|Warfarin|warfarin|mesh-list
93359762|NCT03078374|Anticoagulants|anticoagulants|mesh-ancestor
93359763|NCT04944836|Clomiphene|clomiphene|mesh-list
93359764|NCT04944836|Enclomiphene|enclomiphene|mesh-list
93359765|NCT04944836|Zuclomiphene|zuclomiphene|mesh-list
93359766|NCT04944836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93359767|NCT04944836|Hormone Antagonists|hormone antagonists|mesh-ancestor
93359768|NCT04944836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031631|NCT00445692|Immunologic Factors|immunologic factors|mesh-ancestor
93359769|NCT04944836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359770|NCT04944836|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93359771|NCT04944836|Fertility Agents|fertility agents|mesh-ancestor
93359772|NCT04944836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93359773|NCT04944836|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93359774|NCT04944836|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93359776|NCT02788279|Antibodies|antibodies|mesh-list
93359777|NCT02788279|Immunologic Factors|immunologic factors|mesh-ancestor
93359778|NCT02788279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359779|NCT02788279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93359780|NCT02788279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359781|NCT02788279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93359782|NCT02788279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359783|NCT03268863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93359784|NCT03264651|Anastrozole|anastrozole|mesh-list
93359785|NCT03264651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93359786|NCT03264651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359787|NCT03264651|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93359788|NCT03264651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93359789|NCT03264651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359790|NCT03264651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359791|NCT03264651|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93359792|NCT03264651|Hormone Antagonists|hormone antagonists|mesh-ancestor
93359793|NCT03264651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359794|NCT03264651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359795|NCT03078062|Dexamethasone|dexamethasone|mesh-list
93359796|NCT03078062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359797|NCT03078062|Antiemetics|antiemetics|mesh-ancestor
93359798|NCT03078062|Autonomic Agents|autonomic agents|mesh-ancestor
93359799|NCT03078062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359800|NCT03078062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359801|NCT03078062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93359802|NCT03078062|Glucocorticoids|glucocorticoids|mesh-ancestor
93359803|NCT03078062|Hormones|hormones|mesh-ancestor
93359804|NCT03078062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359805|NCT03078062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93359806|NCT03078062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359807|NCT02435992|Ozanimod|ozanimod|mesh-list
93359808|NCT02435992|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93359809|NCT02435992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359810|NCT02435992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93359811|NCT02435992|Immunologic Factors|immunologic factors|mesh-ancestor
93359812|NCT02435992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359813|NCT02457351|Itraconazole|itraconazole|mesh-list
93359814|NCT02457351|Antifungal Agents|antifungal agents|mesh-ancestor
93359815|NCT02457351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359816|NCT02457351|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93359817|NCT02457351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93359818|NCT02457351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359819|NCT02457351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359820|NCT02457351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93359821|NCT02457351|Hormone Antagonists|hormone antagonists|mesh-ancestor
93359822|NCT02457351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359823|NCT02457351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359824|NCT02457351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93359825|NCT02788513|BI 425809|bi 425809|mesh-list
93359826|NCT02788513|Nootropic Agents|nootropic agents|mesh-ancestor
93359827|NCT03077828|Carboplatin|carboplatin|mesh-list
93359828|NCT03077828|Pembrolizumab|pembrolizumab|mesh-list
93359829|NCT03077828|Etoposide|etoposide|mesh-list
93359830|NCT03077828|Etoposide phosphate|etoposide phosphate|mesh-list
93359831|NCT03077828|Ifosfamide|ifosfamide|mesh-list
93359832|NCT03077828|Isophosphamide mustard|isophosphamide mustard|mesh-list
93359833|NCT03077828|Podophyllotoxin|podophyllotoxin|mesh-list
93359834|NCT03077828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359835|NCT03077828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93359836|NCT03077828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93359837|NCT03077828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359838|NCT03077828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93359839|NCT03077828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93359840|NCT03077828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93359841|NCT03077828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359842|NCT03077828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93359843|NCT03077828|Alkylating Agents|alkylating agents|mesh-ancestor
93359844|NCT03077828|Keratolytic Agents|keratolytic agents|mesh-ancestor
93359845|NCT03077828|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359846|NCT03077828|Tubulin Modulators|tubulin modulators|mesh-ancestor
93359847|NCT03077828|Antimitotic Agents|antimitotic agents|mesh-ancestor
93359848|NCT03077828|Mitosis Modulators|mitosis modulators|mesh-ancestor
93359849|NCT02126995|Metadoxine|metadoxine|mesh-list
93359850|NCT02126995|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93359851|NCT04459052|Acetylcysteine|acetylcysteine|mesh-list
93359852|NCT04459052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93359853|NCT04459052|Antiviral Agents|antiviral agents|mesh-ancestor
93359854|NCT04459052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359855|NCT04459052|Expectorants|expectorants|mesh-ancestor
93359856|NCT04459052|Respiratory System Agents|respiratory system agents|mesh-ancestor
93359857|NCT04459052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93359858|NCT04459052|Antioxidants|antioxidants|mesh-ancestor
93359859|NCT04459052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359860|NCT04459052|Protective Agents|protective agents|mesh-ancestor
93359861|NCT04459052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359862|NCT04459052|Antidotes|antidotes|mesh-ancestor
93359863|NCT05257291|Melatonin|melatonin|mesh-list
93359864|NCT05257291|Antioxidants|antioxidants|mesh-ancestor
93359865|NCT05257291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359866|NCT05257291|Protective Agents|protective agents|mesh-ancestor
93359867|NCT05257291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359868|NCT05257291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359869|NCT04930900|Epinephrine|epinephrine|mesh-list
93359870|NCT04930900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93359871|NCT04930900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93359872|NCT04930900|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359873|NCT04930900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359874|NCT04930900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359875|NCT04930900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359876|NCT04930900|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93359877|NCT04930900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93359878|NCT04930900|Autonomic Agents|autonomic agents|mesh-ancestor
93359879|NCT04930900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359880|NCT04930900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93359881|NCT04930900|Respiratory System Agents|respiratory system agents|mesh-ancestor
93359882|NCT04930900|Mydriatics|mydriatics|mesh-ancestor
93359883|NCT04930900|Sympathomimetics|sympathomimetics|mesh-ancestor
93359884|NCT04930900|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93359885|NCT02458209|Bococizumab|bococizumab|mesh-list
93359886|NCT02458209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93359887|NCT02458209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93359888|NCT02458209|Antimetabolites|antimetabolites|mesh-ancestor
93359889|NCT02458209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359890|NCT02458209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93359891|NCT02127151|Talazoparib|talazoparib|mesh-list
93359892|NCT02127151|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93359893|NCT02127151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359894|NCT02127151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359895|NCT02127151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359896|NCT03077516|Meloxicam|meloxicam|mesh-list
93359897|NCT03077516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359898|NCT03077516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359899|NCT03077516|Analgesics|analgesics|mesh-ancestor
93359900|NCT03077516|Sensory System Agents|sensory system agents|mesh-ancestor
93359901|NCT03077516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359902|NCT03077516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359903|NCT03077516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359904|NCT03077516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359905|NCT03077516|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93359906|NCT03077516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93359907|NCT03077516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359908|NCT03077516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359909|NCT02435914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93359910|NCT02435914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93359911|NCT04993040|Paclitaxel|paclitaxel|mesh-list
93359912|NCT04993040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93359913|NCT04993040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359914|NCT04993040|Tubulin Modulators|tubulin modulators|mesh-ancestor
93359915|NCT04993040|Antimitotic Agents|antimitotic agents|mesh-ancestor
93359916|NCT04993040|Mitosis Modulators|mitosis modulators|mesh-ancestor
93359917|NCT04993040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359918|NCT05300035|Antibodies|antibodies|mesh-list
93359919|NCT05300035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93031783|NCT00988949|Diuretics|diuretics|mesh-ancestor
93359920|NCT05300035|Immunologic Factors|immunologic factors|mesh-ancestor
93359921|NCT05300035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359923|NCT03072992|Paclitaxel|paclitaxel|mesh-list
93359924|NCT03072992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93359925|NCT03072992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93359926|NCT03072992|Tubulin Modulators|tubulin modulators|mesh-ancestor
93359927|NCT03072992|Antimitotic Agents|antimitotic agents|mesh-ancestor
93359928|NCT03072992|Mitosis Modulators|mitosis modulators|mesh-ancestor
93359929|NCT03072992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359930|NCT03072992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93359931|NCT03072992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93359932|NCT03072992|Analgesics|analgesics|mesh-ancestor
93359933|NCT03072992|Sensory System Agents|sensory system agents|mesh-ancestor
93359934|NCT03072992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359935|NCT03072992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359936|NCT03072992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359937|NCT03072992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93359938|NCT03072992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93359939|NCT03267771|Progesterone|progesterone|mesh-list
93359940|NCT03267771|Dydrogesterone|dydrogesterone|mesh-list
93359941|NCT03267771|Progestins|progestins|mesh-ancestor
93359942|NCT03267771|Hormones|hormones|mesh-ancestor
93359943|NCT03267771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359944|NCT03267771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359945|NCT03073304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93359946|NCT03550651|Chlorhexidine|chlorhexidine|mesh-list
93359947|NCT03550651|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93359948|NCT03550651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93359949|NCT03550651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93359950|NCT03550651|Disinfectants|disinfectants|mesh-ancestor
93359951|NCT03550651|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359952|NCT02456961|Riboflavin|riboflavin|mesh-list
93359953|NCT02456961|Vitamin B Complex|vitamin b complex|mesh-ancestor
93359954|NCT02456961|Vitamins|vitamins|mesh-ancestor
93359955|NCT02456961|Micronutrients|micronutrients|mesh-ancestor
93359956|NCT02456961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359957|NCT02456961|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93359958|NCT02456961|Dermatologic Agents|dermatologic agents|mesh-ancestor
93359959|NCT03551197|Budesonide|budesonide|mesh-list
93359960|NCT03551197|Formoterol Fumarate|formoterol fumarate|mesh-list
93359961|NCT03551197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93359962|NCT03551197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93359963|NCT03551197|Autonomic Agents|autonomic agents|mesh-ancestor
93359964|NCT03551197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93359965|NCT03551197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359966|NCT03551197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93359967|NCT03551197|Respiratory System Agents|respiratory system agents|mesh-ancestor
93359968|NCT03551197|Glucocorticoids|glucocorticoids|mesh-ancestor
93359969|NCT03551197|Hormones|hormones|mesh-ancestor
92653649|NCT02215447|Paclitaxel|paclitaxel|mesh-list
93359970|NCT03551197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93359971|NCT03551197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93359972|NCT03551197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93359973|NCT03551197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93359974|NCT03551197|Adrenergic Agents|adrenergic agents|mesh-ancestor
93359975|NCT03551197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359976|NCT03551197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359977|NCT02435836|Aripiprazole|aripiprazole|mesh-list
93359978|NCT02435836|Antidepressive Agents|antidepressive agents|mesh-ancestor
93359979|NCT02435836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93359980|NCT02435836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93359981|NCT02435836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93359982|NCT02435836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93359983|NCT02435836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93359984|NCT02435836|Dopamine Agonists|dopamine agonists|mesh-ancestor
93359985|NCT02435836|Dopamine Agents|dopamine agents|mesh-ancestor
93359986|NCT02435836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93359987|NCT02435836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93359988|NCT02435836|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93359989|NCT02435836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93359990|NCT02435836|Serotonin Agents|serotonin agents|mesh-ancestor
93359991|NCT02435836|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93359992|NCT02435836|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93359993|NCT02435836|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93359994|NCT02435836|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93359995|NCT02127463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93359996|NCT02127463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93359997|NCT05075265|Methadone|methadone|mesh-list
93359998|NCT05075265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93359999|NCT05075265|Narcotics|narcotics|mesh-ancestor
93360000|NCT05075265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360001|NCT05075265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360002|NCT05075265|Analgesics|analgesics|mesh-ancestor
93360003|NCT05075265|Sensory System Agents|sensory system agents|mesh-ancestor
93360004|NCT05075265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360005|NCT05075265|Antitussive Agents|antitussive agents|mesh-ancestor
93360006|NCT05075265|Respiratory System Agents|respiratory system agents|mesh-ancestor
93360007|NCT02127541|Exenatide|exenatide|mesh-list
93360008|NCT02127541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93360009|NCT02127541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360010|NCT02127541|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93360011|NCT02127541|Incretins|incretins|mesh-ancestor
93360012|NCT02127541|Hormones|hormones|mesh-ancestor
93360013|NCT02127541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360014|NCT03263871|Micronutrients|micronutrients|mesh-list
93360015|NCT03263871|Trace Elements|trace elements|mesh-list
93360016|NCT03263871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360017|NCT04992182|Vaccines|vaccines|mesh-list
93360018|NCT04992182|Immunologic Factors|immunologic factors|mesh-ancestor
93360019|NCT04992182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360020|NCT02124655|Chlorhexidine|chlorhexidine|mesh-list
93360021|NCT02124655|Listerine|listerine|mesh-list
93360022|NCT02124655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93360023|NCT02124655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360024|NCT02124655|Disinfectants|disinfectants|mesh-ancestor
93360025|NCT03263715|Glucocorticoids|glucocorticoids|mesh-list
93360026|NCT03263715|Hormones|hormones|mesh-ancestor
93360027|NCT03263715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360028|NCT03263715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360029|NCT02457039|Cyclophosphamide|cyclophosphamide|mesh-list
93360030|NCT02457039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360031|NCT02457039|Immunologic Factors|immunologic factors|mesh-ancestor
93360032|NCT02457039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360033|NCT02457039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360034|NCT02457039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93360035|NCT02457039|Alkylating Agents|alkylating agents|mesh-ancestor
93360036|NCT02457039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360037|NCT02457039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360038|NCT02457039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93360039|NCT03266991|Isoniazid|isoniazid|mesh-list
93360040|NCT03266991|Rifapentine|rifapentine|mesh-list
93360041|NCT03266991|Antitubercular Agents|antitubercular agents|mesh-ancestor
93360042|NCT03266991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93360043|NCT03266991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360044|NCT03266991|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93360045|NCT03266991|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93360046|NCT03266991|Antimetabolites|antimetabolites|mesh-ancestor
93360047|NCT03266991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360048|NCT03266991|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93360049|NCT03266991|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93360050|NCT03266991|Leprostatic Agents|leprostatic agents|mesh-ancestor
93360051|NCT02456740|Erenumab|erenumab|mesh-list
93360052|NCT02456740|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93360053|NCT02456740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360054|NCT02456740|Analgesics|analgesics|mesh-ancestor
93360055|NCT02456740|Sensory System Agents|sensory system agents|mesh-ancestor
93360056|NCT02456740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360057|NCT02456740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360058|NCT03768115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93360059|NCT03768115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93360060|NCT03266601|Interferons|interferons|mesh-list
93360061|NCT03266601|Ribavirin|ribavirin|mesh-list
93360062|NCT03266601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360063|NCT03266601|Antiviral Agents|antiviral agents|mesh-ancestor
93360064|NCT03266601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360065|NCT03266601|Antimetabolites|antimetabolites|mesh-ancestor
93360066|NCT03266601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360067|NCT02124733|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93360068|NCT02124733|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93360069|NCT02124733|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031936|NCT05712707|Sensory System Agents|sensory system agents|mesh-ancestor
93360071|NCT02458755|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93360072|NCT02458755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93360073|NCT02458755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93360074|NCT02458755|Antimetabolites|antimetabolites|mesh-ancestor
93360075|NCT02458755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360076|NCT02458755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93360077|NCT02458755|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93360078|NCT02458755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360079|NCT04462406|Pembrolizumab|pembrolizumab|mesh-list
93360080|NCT04462406|Nivolumab|nivolumab|mesh-list
93360081|NCT04462406|Ipilimumab|ipilimumab|mesh-list
93360082|NCT04462406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93360083|NCT04462406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360084|NCT04462406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93360085|NCT04462406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360086|NCT02400580|Acetaminophen|acetaminophen|mesh-list
93360087|NCT02400580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93360088|NCT02400580|Analgesics|analgesics|mesh-ancestor
93360089|NCT02400580|Sensory System Agents|sensory system agents|mesh-ancestor
93360090|NCT02400580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360091|NCT02400580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360092|NCT02400580|Antipyretics|antipyretics|mesh-ancestor
93360093|NCT03262857|Lidocaine|lidocaine|mesh-list
93360094|NCT03262857|Magnesium Sulfate|magnesium sulfate|mesh-list
93360095|NCT03262857|Anesthetics, Local|anesthetics, local|mesh-ancestor
93360096|NCT03262857|Anesthetics|anesthetics|mesh-ancestor
93360097|NCT03262857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360098|NCT03262857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360099|NCT03262857|Sensory System Agents|sensory system agents|mesh-ancestor
93360100|NCT03262857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360101|NCT03262857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93360102|NCT03262857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93360103|NCT03262857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93360104|NCT03262857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93360105|NCT03262857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360106|NCT03262857|Analgesics|analgesics|mesh-ancestor
93360107|NCT03262857|Anticonvulsants|anticonvulsants|mesh-ancestor
93360108|NCT03262857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93360109|NCT03262857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93360110|NCT03262857|Tocolytic Agents|tocolytic agents|mesh-ancestor
93360111|NCT03262857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93360112|NCT02127697|Glycopyrrolate|glycopyrrolate|mesh-list
93360113|NCT02127697|Albuterol|albuterol|mesh-list
93360114|NCT02127697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93360115|NCT02127697|Autonomic Agents|autonomic agents|mesh-ancestor
93360116|NCT02127697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360117|NCT02127697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360118|NCT02127697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93360119|NCT02127697|Respiratory System Agents|respiratory system agents|mesh-ancestor
93360120|NCT02127697|Tocolytic Agents|tocolytic agents|mesh-ancestor
93360121|NCT02127697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93360122|NCT02127697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93360123|NCT02127697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93360124|NCT02127697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93360125|NCT02127697|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360126|NCT02127697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360127|NCT02127697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360128|NCT02127697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93360129|NCT02127697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93360130|NCT02127697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93360131|NCT02127697|Cholinergic Agents|cholinergic agents|mesh-ancestor
93360132|NCT02127775|Lesinurad|lesinurad|mesh-list
93360133|NCT02127775|Gout Suppressants|gout suppressants|mesh-ancestor
93360134|NCT02127775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360135|NCT02127775|Uricosuric Agents|uricosuric agents|mesh-ancestor
93360136|NCT02252341|Acetylcysteine|acetylcysteine|mesh-list
93360137|NCT02252341|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93360138|NCT02252341|Antiviral Agents|antiviral agents|mesh-ancestor
93360139|NCT02252341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360140|NCT02252341|Expectorants|expectorants|mesh-ancestor
93360141|NCT02252341|Respiratory System Agents|respiratory system agents|mesh-ancestor
93032011|NCT00481676|Respiratory System Agents|respiratory system agents|mesh-ancestor
93360142|NCT02252341|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93360143|NCT02252341|Antioxidants|antioxidants|mesh-ancestor
93360144|NCT02252341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360145|NCT02252341|Protective Agents|protective agents|mesh-ancestor
93360146|NCT02252341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360147|NCT02252341|Antidotes|antidotes|mesh-ancestor
93360148|NCT02127853|Gabapentin|gabapentin|mesh-list
93360149|NCT02127853|Analgesics|analgesics|mesh-ancestor
93360150|NCT02127853|Sensory System Agents|sensory system agents|mesh-ancestor
93360151|NCT02127853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360152|NCT02127853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360153|NCT02127853|Anticonvulsants|anticonvulsants|mesh-ancestor
93360154|NCT02127853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93360155|NCT02127853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93360156|NCT02127853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360157|NCT02127853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93360158|NCT02127853|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93360159|NCT02127853|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93360160|NCT02127853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360161|NCT02127853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360162|NCT02127853|Antimanic Agents|antimanic agents|mesh-ancestor
93360163|NCT03266445|Buprenorphine|buprenorphine|mesh-list
93360164|NCT03266445|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93360165|NCT03266445|Naloxone|naloxone|mesh-list
93360166|NCT03266445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360167|NCT03266445|Narcotics|narcotics|mesh-ancestor
93360168|NCT03266445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360169|NCT03266445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360170|NCT03266445|Analgesics|analgesics|mesh-ancestor
93360171|NCT03266445|Sensory System Agents|sensory system agents|mesh-ancestor
93360172|NCT03266445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360173|NCT03266445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93360174|NCT01367119|Ketamine|ketamine|mesh-list
93360175|NCT01367119|Methohexital|methohexital|mesh-list
93360176|NCT01367119|Analgesics|analgesics|mesh-ancestor
93360177|NCT01367119|Sensory System Agents|sensory system agents|mesh-ancestor
93360178|NCT01367119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360179|NCT01367119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360180|NCT01367119|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93360181|NCT01367119|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93360182|NCT01367119|Anesthetics, General|anesthetics, general|mesh-ancestor
93360183|NCT01367119|Anesthetics|anesthetics|mesh-ancestor
93360184|NCT01367119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360185|NCT01367119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93360186|NCT01367119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93360187|NCT01367119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360188|NCT01367119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360189|NCT02252107|Decitabine|decitabine|mesh-list
93360190|NCT02252107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93360191|NCT02252107|Antimetabolites|antimetabolites|mesh-ancestor
93360192|NCT02252107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360193|NCT02252107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360194|NCT02252107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360195|NCT03262545|Apatinib|apatinib|mesh-list
93360196|NCT03262545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360197|NCT03262545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93360198|NCT03262545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360199|NCT03262545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360200|NCT03262077|Methylene Blue|methylene blue|mesh-list
93360201|NCT03262077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360202|NCT03262077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360203|NCT03265899|Lactitol|lactitol|mesh-list
93360204|NCT03265899|Oxytocin|oxytocin|mesh-list
93360205|NCT03265899|Oxytocics|oxytocics|mesh-ancestor
93360206|NCT03265899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93360207|NCT03265899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360208|NCT03265899|Cathartics|cathartics|mesh-ancestor
93360209|NCT03265899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360210|NCT04459988|Ocrelizumab|ocrelizumab|mesh-list
93360211|NCT04459988|Immunologic Factors|immunologic factors|mesh-ancestor
93360212|NCT04459988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360213|NCT03934905|Sulforaphane|sulforaphane|mesh-list
93360214|NCT03934905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93360215|NCT03934905|Protective Agents|protective agents|mesh-ancestor
93360216|NCT03934905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360217|NCT03934905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360218|NCT02125201|Fentanyl|fentanyl|mesh-list
93360219|NCT02125201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360220|NCT02125201|Narcotics|narcotics|mesh-ancestor
93360221|NCT02125201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360222|NCT02125201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360223|NCT02125201|Analgesics|analgesics|mesh-ancestor
93360224|NCT02125201|Sensory System Agents|sensory system agents|mesh-ancestor
93360225|NCT02125201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360226|NCT02125201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93360227|NCT02125201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93360228|NCT02125201|Anesthetics, General|anesthetics, general|mesh-ancestor
93360229|NCT02125201|Anesthetics|anesthetics|mesh-ancestor
93360230|NCT02125357|Abiraterone Acetate|abiraterone acetate|mesh-list
93360231|NCT02125357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360232|NCT02125357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93360233|NCT02125357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360234|NCT02125357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360235|NCT02125357|Hormone Antagonists|hormone antagonists|mesh-ancestor
93360236|NCT02125357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360237|NCT02125357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360238|NCT02125357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93360239|NCT03074942|Reslizumab|reslizumab|mesh-list
93360240|NCT03074942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93360241|NCT03074942|Respiratory System Agents|respiratory system agents|mesh-ancestor
93360242|NCT02125435|ASP2408|asp2408|mesh-list
93360243|NCT02125435|Immunoconjugates|immunoconjugates|mesh-ancestor
93360244|NCT02125435|Immunologic Factors|immunologic factors|mesh-ancestor
93360245|NCT02125435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360246|NCT02458911|Paclitaxel|paclitaxel|mesh-list
93360247|NCT02458911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93360248|NCT02458911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360249|NCT02458911|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360250|NCT02458911|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360251|NCT02458911|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360252|NCT02458911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360253|NCT03075020|Carbon Monoxide|carbon monoxide|mesh-list
93360254|NCT03075020|Antimetabolites|antimetabolites|mesh-ancestor
93360255|NCT03075020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360256|NCT03075020|Gasotransmitters|gasotransmitters|mesh-ancestor
93360257|NCT03075020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360258|NCT03075020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360259|NCT04998344|Vaccines|vaccines|mesh-list
93360260|NCT04998344|Immunologic Factors|immunologic factors|mesh-ancestor
93360261|NCT04998344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360262|NCT02128243|Leucovorin|leucovorin|mesh-list
93360263|NCT02128243|Cisplatin|cisplatin|mesh-list
93360264|NCT02128243|Docetaxel|docetaxel|mesh-list
93360265|NCT02128243|Fluorouracil|fluorouracil|mesh-list
93360266|NCT02128243|Capecitabine|capecitabine|mesh-list
93360267|NCT02128243|Oxaliplatin|oxaliplatin|mesh-list
93360268|NCT02128243|Epirubicin|epirubicin|mesh-list
93360269|NCT02128243|Levoleucovorin|levoleucovorin|mesh-list
93360270|NCT02128243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360271|NCT02128243|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360272|NCT02128243|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360273|NCT02128243|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360274|NCT02128243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360275|NCT02128243|Antimetabolites|antimetabolites|mesh-ancestor
93360276|NCT02128243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93360277|NCT02128243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360278|NCT02128243|Immunologic Factors|immunologic factors|mesh-ancestor
93360279|NCT02128243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360280|NCT02128243|Antidotes|antidotes|mesh-ancestor
93360281|NCT02128243|Protective Agents|protective agents|mesh-ancestor
93360282|NCT02128243|Vitamin B Complex|vitamin b complex|mesh-ancestor
93360283|NCT02128243|Vitamins|vitamins|mesh-ancestor
93360284|NCT02128243|Micronutrients|micronutrients|mesh-ancestor
93360285|NCT02128243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93360286|NCT02128243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93360287|NCT02128243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93360288|NCT02128243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360289|NCT03072290|Triamcinolone|triamcinolone|mesh-list
93360290|NCT03072290|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93360291|NCT03072290|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93360292|NCT03072290|Lidocaine|lidocaine|mesh-list
93360293|NCT03072290|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93360294|NCT03072290|Anesthetics, Local|anesthetics, local|mesh-ancestor
93032170|NCT00264550|Golimumab|golimumab|mesh-list
93360295|NCT03072290|Anesthetics|anesthetics|mesh-ancestor
93360296|NCT03072290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360297|NCT03072290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360298|NCT03072290|Sensory System Agents|sensory system agents|mesh-ancestor
93360299|NCT03072290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360300|NCT03072290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93360301|NCT03072290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93360302|NCT03072290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93360303|NCT03072290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93360304|NCT03072290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360305|NCT03072290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360306|NCT03072290|Glucocorticoids|glucocorticoids|mesh-ancestor
93360307|NCT03072290|Hormones|hormones|mesh-ancestor
93360308|NCT03072290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360309|NCT03072290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360310|NCT03072290|Immunologic Factors|immunologic factors|mesh-ancestor
93360311|NCT03072290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360312|NCT02132689|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93360313|NCT02132689|Fibrinolytic Agents|fibrinolytic agents|mesh-list
93360314|NCT02132689|Heparin|heparin|mesh-list
93360315|NCT02132689|Calcium heparin|calcium heparin|mesh-list
93360316|NCT02132689|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93360317|NCT02132689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360318|NCT02132689|Anticoagulants|anticoagulants|mesh-ancestor
93360319|NCT02128321|Repaglinide|repaglinide|mesh-list
93360320|NCT02128321|Isavuconazole|isavuconazole|mesh-list
93360321|NCT02128321|Caffeine|caffeine|mesh-list
93360322|NCT02128321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93360323|NCT02128321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360324|NCT02128321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93360325|NCT02128321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360326|NCT02128321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360327|NCT02128321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93360328|NCT02128321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93360329|NCT02128321|Purinergic Agents|purinergic agents|mesh-ancestor
93360330|NCT02128321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360331|NCT02128321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93360332|NCT02128321|Antifungal Agents|antifungal agents|mesh-ancestor
93360333|NCT02128321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360334|NCT02457975|Ranibizumab|ranibizumab|mesh-list
93360335|NCT02457975|Aflibercept|aflibercept|mesh-list
93360336|NCT02457975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360337|NCT02457975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93360338|NCT02457975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93360339|NCT02457975|Growth Substances|growth substances|mesh-ancestor
93360340|NCT02457975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360341|NCT02457975|Growth Inhibitors|growth inhibitors|mesh-ancestor
93360342|NCT03074864|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93360343|NCT03074864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360344|NCT03074864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93360345|NCT03074864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360346|NCT03074864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360347|NCT02125903|Ropivacaine|ropivacaine|mesh-list
93360348|NCT02125903|Anesthetics, Local|anesthetics, local|mesh-ancestor
93360349|NCT02125903|Anesthetics|anesthetics|mesh-ancestor
93360350|NCT02125903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360351|NCT02125903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360352|NCT02125903|Sensory System Agents|sensory system agents|mesh-ancestor
93360353|NCT02125903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360354|NCT04997564|Tenofovir|tenofovir|mesh-list
93360355|NCT04997564|Sofosbuvir|sofosbuvir|mesh-list
93360356|NCT04997564|Velpatasvir|velpatasvir|mesh-list
93360357|NCT04997564|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93360358|NCT04997564|Antiviral Agents|antiviral agents|mesh-ancestor
93360359|NCT04997564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360360|NCT04997564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93360361|NCT04997564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93360362|NCT04997564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360363|NCT04997564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360364|NCT04997564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93360365|NCT04997564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93360366|NCT03842943|Pembrolizumab|pembrolizumab|mesh-list
93360367|NCT03842943|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93360368|NCT03842943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93360369|NCT03842943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360370|NCT03842943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93360371|NCT03842943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360372|NCT02126137|Ezetimibe|ezetimibe|mesh-list
93360373|NCT02126137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93360374|NCT02126137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93360375|NCT02126137|Antimetabolites|antimetabolites|mesh-ancestor
93360376|NCT02126137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360377|NCT02126137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93360379|NCT02126293|Trace Elements|trace elements|mesh-ancestor
93360380|NCT02126293|Micronutrients|micronutrients|mesh-ancestor
93360381|NCT02126293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360382|NCT03261921|Dexamethasone|dexamethasone|mesh-list
93360383|NCT03261921|Dexmedetomidine|dexmedetomidine|mesh-list
93360384|NCT03261921|Bupivacaine|bupivacaine|mesh-list
93360385|NCT03261921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360386|NCT03261921|Antiemetics|antiemetics|mesh-ancestor
93360387|NCT03261921|Autonomic Agents|autonomic agents|mesh-ancestor
93360388|NCT03261921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360389|NCT03261921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360390|NCT03261921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360391|NCT03261921|Glucocorticoids|glucocorticoids|mesh-ancestor
93360392|NCT03261921|Hormones|hormones|mesh-ancestor
93360393|NCT03261921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360394|NCT03261921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93360395|NCT03261921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360396|NCT03261921|Anesthetics, Local|anesthetics, local|mesh-ancestor
93360397|NCT03261921|Anesthetics|anesthetics|mesh-ancestor
93360398|NCT03261921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360399|NCT03261921|Sensory System Agents|sensory system agents|mesh-ancestor
93360400|NCT03261921|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93360401|NCT03261921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93360402|NCT03261921|Analgesics|analgesics|mesh-ancestor
93360403|NCT03261921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93360404|NCT03261921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93360405|NCT03261921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93360406|NCT03261921|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360407|NCT03261921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360408|NCT03261921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360409|NCT02635724|Peramivir|peramivir|mesh-list
93360410|NCT02635724|Antiviral Agents|antiviral agents|mesh-ancestor
93360411|NCT02635724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360412|NCT02635724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360413|NCT02635724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360414|NCT02133469|Vaccines|vaccines|mesh-list
93360415|NCT02133469|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93360416|NCT02133469|Immunologic Factors|immunologic factors|mesh-ancestor
93360417|NCT02133469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360418|NCT03905265|Moxidectin|moxidectin|mesh-list
93360419|NCT03905265|Anthelmintics|anthelmintics|mesh-ancestor
93360420|NCT03905265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93360421|NCT03905265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360422|NCT03905265|Antinematodal Agents|antinematodal agents|mesh-ancestor
93360423|NCT05001854|Fludrocortisone|fludrocortisone|mesh-list
93360424|NCT05001854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360425|NCT02126527|Sirolimus|sirolimus|mesh-list
93360426|NCT02126527|Auranofin|auranofin|mesh-list
93360427|NCT02126527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93360428|NCT02126527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360429|NCT02126527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93360430|NCT02126527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360431|NCT02126527|Antifungal Agents|antifungal agents|mesh-ancestor
93360432|NCT02126527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360433|NCT02126527|Immunologic Factors|immunologic factors|mesh-ancestor
93360434|NCT02126527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360435|NCT02126527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360436|NCT02133625|Pioglitazone|pioglitazone|mesh-list
93360437|NCT02133625|Carboplatin|carboplatin|mesh-list
93360438|NCT02133625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360439|NCT02133625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93360440|NCT02133625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360441|NCT02260687|Aflibercept|aflibercept|mesh-list
93360442|NCT02260687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93360443|NCT02260687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93360444|NCT02260687|Growth Substances|growth substances|mesh-ancestor
93360445|NCT02260687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360446|NCT02260687|Growth Inhibitors|growth inhibitors|mesh-ancestor
93360447|NCT02260687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360448|NCT03071822|Dexamethasone|dexamethasone|mesh-list
93360449|NCT03071822|Gemcitabine|gemcitabine|mesh-list
93360450|NCT03071822|Etoposide|etoposide|mesh-list
93360451|NCT03071822|Asparaginase|asparaginase|mesh-list
93360452|NCT03071822|Ifosfamide|ifosfamide|mesh-list
93360453|NCT03071822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360454|NCT03071822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360455|NCT03071822|Antiemetics|antiemetics|mesh-ancestor
93360456|NCT03071822|Autonomic Agents|autonomic agents|mesh-ancestor
93360457|NCT03071822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360458|NCT03071822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360459|NCT03071822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360460|NCT03071822|Glucocorticoids|glucocorticoids|mesh-ancestor
93360461|NCT03071822|Hormones|hormones|mesh-ancestor
93360462|NCT03071822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360463|NCT03071822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93360464|NCT03071822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93360465|NCT03071822|Antimetabolites|antimetabolites|mesh-ancestor
93360466|NCT03071822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360467|NCT03071822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93360468|NCT03071822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93360469|NCT03071822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93360470|NCT03071822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360471|NCT03071822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93360472|NCT03071822|Alkylating Agents|alkylating agents|mesh-ancestor
93360473|NCT04991012|Triamcinolone|triamcinolone|mesh-list
93360474|NCT04991012|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93360475|NCT04991012|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93360476|NCT04991012|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93360477|NCT04991012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360478|NCT04991012|Glucocorticoids|glucocorticoids|mesh-ancestor
93360479|NCT04991012|Hormones|hormones|mesh-ancestor
93360480|NCT04991012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360481|NCT04991012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360482|NCT04991012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360483|NCT04991012|Immunologic Factors|immunologic factors|mesh-ancestor
93360484|NCT04991012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360485|NCT04991012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360486|NCT02252731|Warfarin|warfarin|mesh-list
93360487|NCT02252731|Anticoagulants|anticoagulants|mesh-ancestor
93360488|NCT02128633|Listerine|listerine|mesh-list
93360489|NCT02128633|Fluorides|fluorides|mesh-list
93360490|NCT02128633|Sodium Fluoride|sodium fluoride|mesh-list
93360491|NCT02128633|Cariostatic Agents|cariostatic agents|mesh-ancestor
93360492|NCT02128633|Protective Agents|protective agents|mesh-ancestor
93360493|NCT02128633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360494|NCT02128633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93360495|NCT02128633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360496|NCT02126683|Hydroxychloroquine|hydroxychloroquine|mesh-list
93360497|NCT02126683|Antimalarials|antimalarials|mesh-ancestor
93360498|NCT02126683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93360499|NCT02126683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93360500|NCT02126683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360501|NCT02126683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360502|NCT02126683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360503|NCT02126683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360504|NCT03252561|Anesthetics|anesthetics|mesh-list
93360505|NCT03252561|Anesthetics, Local|anesthetics, local|mesh-list
93360506|NCT03252561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360507|NCT03252561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360508|NCT03252561|Sensory System Agents|sensory system agents|mesh-ancestor
93360509|NCT03252561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360510|NCT02252263|Elotuzumab|elotuzumab|mesh-list
93360511|NCT02252263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360512|NCT04996550|Metoprolol|metoprolol|mesh-list
93360513|NCT04996550|Carvedilol|carvedilol|mesh-list
93360514|NCT04996550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93360515|NCT04996550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93360516|NCT04996550|Sympatholytics|sympatholytics|mesh-ancestor
93360517|NCT04996550|Autonomic Agents|autonomic agents|mesh-ancestor
93360518|NCT04996550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360519|NCT04996550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360520|NCT04996550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93360521|NCT04996550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93032382|NCT04005365|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360522|NCT04996550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93360523|NCT04996550|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360524|NCT04996550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360525|NCT04996550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360526|NCT04996550|Antioxidants|antioxidants|mesh-ancestor
93360527|NCT04996550|Protective Agents|protective agents|mesh-ancestor
93360528|NCT04996550|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93360529|NCT04996550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93360530|NCT04996550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93360531|NCT04996550|Vasodilator Agents|vasodilator agents|mesh-ancestor
93360532|NCT04996550|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93360533|NCT04996550|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93360534|NCT03252171|Immunomodulating Agents|immunomodulating agents|mesh-list
93360535|NCT03252171|Immunologic Factors|immunologic factors|mesh-ancestor
93360536|NCT03252171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360537|NCT02133937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93360538|NCT02133937|Immunologic Factors|immunologic factors|mesh-ancestor
93360539|NCT02133937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360540|NCT02135965|Caffeine|caffeine|mesh-list
93360541|NCT02135965|Albuterol|albuterol|mesh-list
93360542|NCT02135965|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93360543|NCT02135965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360544|NCT02135965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93360545|NCT02135965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360546|NCT02135965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360547|NCT02135965|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93360548|NCT02135965|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93360549|NCT02135965|Purinergic Agents|purinergic agents|mesh-ancestor
93360550|NCT02135965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360551|NCT02135965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93360552|NCT02135965|Autonomic Agents|autonomic agents|mesh-ancestor
93360553|NCT02135965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360554|NCT02135965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93360555|NCT02135965|Respiratory System Agents|respiratory system agents|mesh-ancestor
93360556|NCT02135965|Tocolytic Agents|tocolytic agents|mesh-ancestor
93360557|NCT02135965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93360558|NCT02135965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93360559|NCT02135965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93360560|NCT02135965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93360561|NCT02135965|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360562|NCT02455401|Remifentanil|remifentanil|mesh-list
93360563|NCT02455401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360564|NCT02455401|Narcotics|narcotics|mesh-ancestor
93360565|NCT02455401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360566|NCT02455401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360567|NCT02455401|Analgesics|analgesics|mesh-ancestor
93360568|NCT02455401|Sensory System Agents|sensory system agents|mesh-ancestor
93360569|NCT02455401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360570|NCT03260829|Ascorbic Acid|ascorbic acid|mesh-list
93360571|NCT03260829|Vitamins|vitamins|mesh-ancestor
93360572|NCT03260829|Micronutrients|micronutrients|mesh-ancestor
93360573|NCT03260829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360574|NCT03260829|Antioxidants|antioxidants|mesh-ancestor
93360575|NCT03260829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360576|NCT03260829|Protective Agents|protective agents|mesh-ancestor
93360577|NCT02134093|Midazolam|midazolam|mesh-list
93360578|NCT02134093|Sufentanil|sufentanil|mesh-list
93360579|NCT02134093|Dexmedetomidine|dexmedetomidine|mesh-list
93360580|NCT02134093|Remifentanil|remifentanil|mesh-list
93360581|NCT02134093|Anesthetics|anesthetics|mesh-list
93360582|NCT02134093|Propofol|propofol|mesh-list
93360583|NCT02134093|Etomidate|etomidate|mesh-list
93360584|NCT02134093|Vecuronium Bromide|vecuronium bromide|mesh-list
93360585|NCT02134093|Rocuronium|rocuronium|mesh-list
93360586|NCT02134093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360587|NCT02134093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360588|NCT02134093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93360589|NCT02134093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93360590|NCT02134093|Analgesics|analgesics|mesh-ancestor
93360591|NCT02134093|Sensory System Agents|sensory system agents|mesh-ancestor
93360592|NCT02134093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360593|NCT02134093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93360594|NCT02134093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93360595|NCT02134093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93360596|NCT02134093|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360597|NCT02134093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032472|NCT01070680|Analgesics|analgesics|mesh-ancestor
93360598|NCT02134093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360599|NCT02134093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93360600|NCT02134093|Anesthetics, General|anesthetics, general|mesh-ancestor
93360601|NCT02134093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93360602|NCT02134093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93360603|NCT02134093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93360604|NCT02134093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93360605|NCT02134093|GABA Modulators|gaba modulators|mesh-ancestor
93360606|NCT02134093|GABA Agents|gaba agents|mesh-ancestor
93360607|NCT02134093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360608|NCT02134093|Narcotics|narcotics|mesh-ancestor
93360609|NCT02134093|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93360610|NCT02134093|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93360611|NCT02134093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93360612|NCT02134093|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93360613|NCT02134093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93360614|NCT02134093|Cholinergic Agents|cholinergic agents|mesh-ancestor
93360615|NCT03074786|Tenofovir|tenofovir|mesh-list
93360616|NCT03074786|Emtricitabine|emtricitabine|mesh-list
93360617|NCT03074786|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93360618|NCT03074786|Dapivirine|dapivirine|mesh-list
93360619|NCT03074786|Antiviral Agents|antiviral agents|mesh-ancestor
93360620|NCT03074786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360621|NCT03074786|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93360622|NCT03074786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93360623|NCT03074786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360624|NCT03074786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360625|NCT03074786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93360626|NCT03074786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93360627|NCT03070028|Phenol|phenol|mesh-list
93360628|NCT03070028|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93360629|NCT03070028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360630|NCT03070028|Disinfectants|disinfectants|mesh-ancestor
93360631|NCT03070028|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93360632|NCT03070028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93360633|NCT03260439|Tramadol|tramadol|mesh-list
93360634|NCT03260439|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360635|NCT03260439|Narcotics|narcotics|mesh-ancestor
93360636|NCT03260439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360637|NCT03260439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360638|NCT03260439|Analgesics|analgesics|mesh-ancestor
93360639|NCT03260439|Sensory System Agents|sensory system agents|mesh-ancestor
93360640|NCT03260439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360641|NCT02634788|Buprenorphine|buprenorphine|mesh-list
93360642|NCT02634788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360643|NCT02634788|Narcotics|narcotics|mesh-ancestor
93360644|NCT02634788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360645|NCT02634788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360646|NCT02634788|Analgesics|analgesics|mesh-ancestor
93360647|NCT02634788|Sensory System Agents|sensory system agents|mesh-ancestor
93360648|NCT02634788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360649|NCT02634788|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93360650|NCT03260283|Fentanyl|fentanyl|mesh-list
93360651|NCT03260283|Meperidine|meperidine|mesh-list
93360652|NCT03260283|Ropivacaine|ropivacaine|mesh-list
93360653|NCT03260283|Anesthetics, Local|anesthetics, local|mesh-ancestor
93360654|NCT03260283|Anesthetics|anesthetics|mesh-ancestor
93360655|NCT03260283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360656|NCT03260283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360657|NCT03260283|Sensory System Agents|sensory system agents|mesh-ancestor
93360658|NCT03260283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360659|NCT03260283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93360660|NCT03260283|Narcotics|narcotics|mesh-ancestor
93360661|NCT03260283|Analgesics|analgesics|mesh-ancestor
93360662|NCT03260283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93360663|NCT03260283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93360664|NCT03260283|Anesthetics, General|anesthetics, general|mesh-ancestor
93360665|NCT03251469|Tranexamic Acid|tranexamic acid|mesh-list
93360666|NCT03251469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93360667|NCT03251469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93360668|NCT03251469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360669|NCT03251469|Hemostatics|hemostatics|mesh-ancestor
93360670|NCT03251469|Coagulants|coagulants|mesh-ancestor
93360671|NCT04986644|Hyaluronic Acid|hyaluronic acid|mesh-list
93360672|NCT04986644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93360673|NCT04986644|Immunologic Factors|immunologic factors|mesh-ancestor
93360674|NCT04986644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360675|NCT04986644|Viscosupplements|viscosupplements|mesh-ancestor
93360676|NCT04986644|Protective Agents|protective agents|mesh-ancestor
93360677|NCT02785939|Docetaxel|docetaxel|mesh-list
93360678|NCT02785939|Palbociclib|palbociclib|mesh-list
93360679|NCT02785939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360680|NCT02785939|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360681|NCT02785939|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360682|NCT02785939|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360683|NCT02785939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360684|NCT02785939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93360685|NCT02785939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360686|NCT03583229|Aspirin|aspirin|mesh-list
93360687|NCT03583229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93360688|NCT03583229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93360689|NCT03583229|Analgesics|analgesics|mesh-ancestor
93360690|NCT03583229|Sensory System Agents|sensory system agents|mesh-ancestor
93360691|NCT03583229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360692|NCT03583229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360693|NCT03583229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360694|NCT03583229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360695|NCT03583229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93360696|NCT03583229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93360697|NCT03583229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360698|NCT03583229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93360699|NCT03583229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93360700|NCT03583229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360701|NCT03583229|Antipyretics|antipyretics|mesh-ancestor
93360702|NCT02259803|Amlodipine|amlodipine|mesh-list
93360703|NCT02259803|Telmisartan|telmisartan|mesh-list
93360704|NCT02259803|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93360705|NCT02259803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93360706|NCT02259803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93360707|NCT02259803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93360708|NCT02259803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360709|NCT02259803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93360710|NCT02259803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360711|NCT02259803|Vasodilator Agents|vasodilator agents|mesh-ancestor
93360712|NCT02259803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93360713|NCT02259803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93360714|NCT03260049|Antiviral Agents|antiviral agents|mesh-list
93360715|NCT03260049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360716|NCT03069950|Leucovorin|leucovorin|mesh-list
93360717|NCT03069950|Dexamethasone|dexamethasone|mesh-list
93360718|NCT03069950|Fluorouracil|fluorouracil|mesh-list
93360719|NCT03069950|Irinotecan|irinotecan|mesh-list
93360720|NCT03069950|Panitumumab|panitumumab|mesh-list
93360721|NCT03069950|Floxuridine|floxuridine|mesh-list
93360722|NCT03069950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360723|NCT03069950|Antiemetics|antiemetics|mesh-ancestor
93360724|NCT03069950|Autonomic Agents|autonomic agents|mesh-ancestor
93360725|NCT03069950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360726|NCT03069950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360727|NCT03069950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360728|NCT03069950|Glucocorticoids|glucocorticoids|mesh-ancestor
93360729|NCT03069950|Hormones|hormones|mesh-ancestor
93360730|NCT03069950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360731|NCT03069950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93360732|NCT03069950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360733|NCT03069950|Antimetabolites|antimetabolites|mesh-ancestor
93360734|NCT03069950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360735|NCT03069950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93360736|NCT03069950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360737|NCT03069950|Immunologic Factors|immunologic factors|mesh-ancestor
93360738|NCT03069950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93360739|NCT03069950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93360740|NCT03069950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360741|NCT03069950|Antidotes|antidotes|mesh-ancestor
93360742|NCT03069950|Protective Agents|protective agents|mesh-ancestor
93360743|NCT03069950|Vitamin B Complex|vitamin b complex|mesh-ancestor
93360744|NCT03069950|Vitamins|vitamins|mesh-ancestor
93360745|NCT03069950|Micronutrients|micronutrients|mesh-ancestor
93360746|NCT03069950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93360747|NCT04913870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93360748|NCT04913870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360749|NCT03577457|Oxytocin|oxytocin|mesh-list
93360750|NCT03577457|Oxytocics|oxytocics|mesh-ancestor
93360751|NCT03577457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92654421|NCT04534465|Mannitol|mannitol|mesh-list
93360752|NCT03577457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360753|NCT02455245|Carboplatin|carboplatin|mesh-list
93360754|NCT02455245|Vincristine|vincristine|mesh-list
93360755|NCT02455245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360756|NCT02455245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93360757|NCT02455245|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360758|NCT02455245|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360759|NCT02455245|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360760|NCT02455245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360761|NCT03537599|Daratumumab|daratumumab|mesh-list
93360762|NCT03537599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360763|NCT04986254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93360764|NCT04986254|Meropenem|meropenem|mesh-list
93360765|NCT04986254|Ceftriaxone|ceftriaxone|mesh-list
93360766|NCT04986254|Tazobactam|tazobactam|mesh-list
93360767|NCT04986254|Piperacillin|piperacillin|mesh-list
93360768|NCT04986254|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93360769|NCT04986254|Penicillin G|penicillin g|mesh-list
93360770|NCT04986254|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93360771|NCT04986254|Penicillin G Procaine|penicillin g procaine|mesh-list
93360772|NCT04986254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360773|NCT04986254|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93360774|NCT04986254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360775|NCT04986254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360776|NCT03257943|Ivermectin|ivermectin|mesh-list
93360777|NCT03257943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93360778|NCT03257943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360779|NCT04996160|Dexamethasone|dexamethasone|mesh-list
93360780|NCT04996160|Dexamethasone acetate|dexamethasone acetate|mesh-list
93360781|NCT04996160|Doxorubicin|doxorubicin|mesh-list
93360782|NCT04996160|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93360783|NCT04996160|Bortezomib|bortezomib|mesh-list
93360784|NCT04996160|Palbociclib|palbociclib|mesh-list
93360785|NCT04996160|BB 1101|bb 1101|mesh-list
93360786|NCT04996160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360787|NCT04996160|Antiemetics|antiemetics|mesh-ancestor
93360788|NCT04996160|Autonomic Agents|autonomic agents|mesh-ancestor
93360789|NCT04996160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360790|NCT04996160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360791|NCT04996160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360792|NCT04996160|Glucocorticoids|glucocorticoids|mesh-ancestor
93360793|NCT04996160|Hormones|hormones|mesh-ancestor
93360794|NCT04996160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360795|NCT04996160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93360796|NCT04996160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360797|NCT04996160|Protease Inhibitors|protease inhibitors|mesh-ancestor
93360798|NCT04996160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360799|NCT04996160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360800|NCT04996160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93360801|NCT04996160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93360802|NCT04996160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93360803|NCT04996160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93360804|NCT04986098|Paclitaxel|paclitaxel|mesh-list
93360805|NCT04986098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93360806|NCT04986098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360807|NCT04986098|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360808|NCT04986098|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360809|NCT04986098|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360810|NCT04986098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360811|NCT02239445|Dexmedetomidine|dexmedetomidine|mesh-list
93360812|NCT02239445|Chloral Hydrate|chloral hydrate|mesh-list
93360813|NCT02239445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93360814|NCT02239445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360815|NCT02239445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360816|NCT02239445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93360817|NCT02239445|Analgesics|analgesics|mesh-ancestor
93360818|NCT02239445|Sensory System Agents|sensory system agents|mesh-ancestor
93360819|NCT02239445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360820|NCT02239445|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93360821|NCT02239445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93360822|NCT02239445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93360823|NCT02239445|Adrenergic Agents|adrenergic agents|mesh-ancestor
93360824|NCT02239445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360825|NCT02239445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360826|NCT03071042|Docetaxel|docetaxel|mesh-list
93360827|NCT03071042|Apatinib|apatinib|mesh-list
93360828|NCT03071042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360829|NCT03071042|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360830|NCT03071042|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360831|NCT03071042|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360832|NCT03071042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360833|NCT03071042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93360834|NCT03071042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360836|NCT03582605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93360837|NCT03582605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360838|NCT04433546|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
93360839|NCT04433546|Vasodilator Agents|vasodilator agents|mesh-ancestor
93360840|NCT04989140|Dexamethasone|dexamethasone|mesh-list
93360841|NCT04989140|Pomalidomide|pomalidomide|mesh-list
93360842|NCT04989140|Ixazomib|ixazomib|mesh-list
93360843|NCT04989140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360844|NCT04989140|Antiemetics|antiemetics|mesh-ancestor
93360845|NCT04989140|Autonomic Agents|autonomic agents|mesh-ancestor
93360846|NCT04989140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360847|NCT04989140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360848|NCT04989140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360849|NCT04989140|Glucocorticoids|glucocorticoids|mesh-ancestor
93360850|NCT04989140|Hormones|hormones|mesh-ancestor
93360851|NCT04989140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93360852|NCT04989140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93360853|NCT04989140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360854|NCT04989140|Immunologic Factors|immunologic factors|mesh-ancestor
93360855|NCT04989140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93360856|NCT04989140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93360857|NCT04989140|Growth Substances|growth substances|mesh-ancestor
93360858|NCT04989140|Growth Inhibitors|growth inhibitors|mesh-ancestor
93360859|NCT04989140|Protease Inhibitors|protease inhibitors|mesh-ancestor
93360860|NCT04989140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360861|NCT04989140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360862|NCT03246009|Lenograstim|lenograstim|mesh-list
93360863|NCT03246009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93360864|NCT03246009|Immunologic Factors|immunologic factors|mesh-ancestor
93360865|NCT03246009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360866|NCT03246399|Lorecivivint|lorecivivint|mesh-list
93360867|NCT03246399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360868|NCT02134249|Cabergoline|cabergoline|mesh-list
93360869|NCT02134249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93360870|NCT02134249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93360871|NCT02134249|Dopamine Agonists|dopamine agonists|mesh-ancestor
93360872|NCT02134249|Dopamine Agents|dopamine agents|mesh-ancestor
93360873|NCT02134249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360874|NCT02134249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360875|NCT02134249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360876|NCT03245853|Riboflavin|riboflavin|mesh-list
93360877|NCT03245853|Flavin Mononucleotide|flavin mononucleotide|mesh-list
93360878|NCT03245853|Vitamin B Complex|vitamin b complex|mesh-ancestor
93360879|NCT03245853|Vitamins|vitamins|mesh-ancestor
93360880|NCT03245853|Micronutrients|micronutrients|mesh-ancestor
93360881|NCT03245853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360882|NCT03245853|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93360883|NCT03245853|Dermatologic Agents|dermatologic agents|mesh-ancestor
93360884|NCT03574649|Paclitaxel|paclitaxel|mesh-list
93360885|NCT03574649|Docetaxel|docetaxel|mesh-list
93360886|NCT03574649|Cyclophosphamide|cyclophosphamide|mesh-list
93360887|NCT03574649|Carboplatin|carboplatin|mesh-list
93360888|NCT03574649|Fluorouracil|fluorouracil|mesh-list
93360889|NCT03574649|Avelumab|avelumab|mesh-list
93360890|NCT03574649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93360891|NCT03574649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360892|NCT03574649|Tubulin Modulators|tubulin modulators|mesh-ancestor
93360893|NCT03574649|Antimitotic Agents|antimitotic agents|mesh-ancestor
93360894|NCT03574649|Mitosis Modulators|mitosis modulators|mesh-ancestor
93360895|NCT03574649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360896|NCT03574649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360897|NCT03574649|Immunologic Factors|immunologic factors|mesh-ancestor
93360898|NCT03574649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360899|NCT03574649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360900|NCT03574649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93360901|NCT03574649|Alkylating Agents|alkylating agents|mesh-ancestor
93360902|NCT03574649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93360903|NCT03574649|Antimetabolites|antimetabolites|mesh-ancestor
93360904|NCT03574649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93360905|NCT03574649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93360906|NCT02128945|Fludarabine|fludarabine|mesh-list
93360907|NCT02128945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360908|NCT02136277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93360909|NCT03073928|Ropivacaine|ropivacaine|mesh-list
93360910|NCT03073928|Anesthetics, Local|anesthetics, local|mesh-ancestor
93360911|NCT03073928|Anesthetics|anesthetics|mesh-ancestor
93360912|NCT03073928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93360913|NCT03073928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360914|NCT03073928|Sensory System Agents|sensory system agents|mesh-ancestor
93360915|NCT03073928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360916|NCT02134405|Esomeprazole|esomeprazole|mesh-list
93360917|NCT02134405|Rebamipide|rebamipide|mesh-list
93360918|NCT02134405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93360919|NCT02134405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360920|NCT02134405|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93360921|NCT02134405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360922|NCT02134405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360923|NCT02134405|Antioxidants|antioxidants|mesh-ancestor
93360924|NCT02134405|Protective Agents|protective agents|mesh-ancestor
93360925|NCT02134405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360926|NCT03574415|Fexuprazan|fexuprazan|mesh-list
93360927|NCT03574415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93360928|NCT02456025|Tacrolimus|tacrolimus|mesh-list
93360929|NCT02456025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93360930|NCT02456025|Immunologic Factors|immunologic factors|mesh-ancestor
93360931|NCT02456025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360932|NCT02456025|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93360933|NCT02456025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360934|NCT02456025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360935|NCT02134483|Parathyroid Hormone|parathyroid hormone|mesh-list
93360936|NCT02134483|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93360937|NCT02134483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360938|NCT02136511|Rituximab|rituximab|mesh-list
93360939|NCT02136511|Idelalisib|idelalisib|mesh-list
93360940|NCT02136511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93360941|NCT02136511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360942|NCT02136511|Immunologic Factors|immunologic factors|mesh-ancestor
93360943|NCT02136511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360944|NCT02136511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360945|NCT02136511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360946|NCT02136511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360947|NCT02136589|Diclofenac|diclofenac|mesh-list
93360948|NCT02136589|Travoprost|travoprost|mesh-list
93360949|NCT02136589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93360950|NCT02136589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93360951|NCT02136589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93360952|NCT02136589|Analgesics|analgesics|mesh-ancestor
93360953|NCT02136589|Sensory System Agents|sensory system agents|mesh-ancestor
93360954|NCT02136589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93360955|NCT02136589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360956|NCT02136589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93360957|NCT02136589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93360958|NCT02136589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93360959|NCT02136589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360960|NCT02136589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360961|NCT02134639|Edotreotide|edotreotide|mesh-list
93360962|NCT02134639|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93360963|NCT02134639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360964|NCT02129101|Azacitidine|azacitidine|mesh-list
93360965|NCT02129101|Decitabine|decitabine|mesh-list
93360966|NCT02129101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93360967|NCT02129101|Antimetabolites|antimetabolites|mesh-ancestor
93360968|NCT02129101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360969|NCT02129101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93360970|NCT02129101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93360971|NCT02134717|Maraviroc|maraviroc|mesh-list
93360972|NCT02134717|Dimercaprol|dimercaprol|mesh-list
93360973|NCT02134717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93360974|NCT02134717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93360975|NCT02134717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360976|NCT02134717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93360977|NCT02134717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93360978|NCT02134717|Antiviral Agents|antiviral agents|mesh-ancestor
93360979|NCT02134717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93360980|NCT02134717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93360981|NCT02134717|Chelating Agents|chelating agents|mesh-ancestor
93032855|NCT01051167|Cetuximab|cetuximab|mesh-list
93360982|NCT02134717|Sequestering Agents|sequestering agents|mesh-ancestor
93360983|NCT03245385|Halobetasol|halobetasol|mesh-list
93360984|NCT03245385|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93360985|NCT02136823|Isradipine|isradipine|mesh-list
93360986|NCT02136823|Riluzole|riluzole|mesh-list
93360987|NCT02136823|Memantine|memantine|mesh-list
93360988|NCT02136823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93360989|NCT02136823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93360990|NCT02136823|Dopamine Agents|dopamine agents|mesh-ancestor
93360991|NCT02136823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93360992|NCT02136823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93360993|NCT02136823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93360994|NCT02136823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93360995|NCT02136823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93360996|NCT02136823|Anticonvulsants|anticonvulsants|mesh-ancestor
93360997|NCT02136823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93360998|NCT02136823|Protective Agents|protective agents|mesh-ancestor
93360999|NCT02136823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93361000|NCT02136823|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93361001|NCT02136823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361002|NCT02136823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93361003|NCT02136823|Vasodilator Agents|vasodilator agents|mesh-ancestor
93361004|NCT03250143|Cyclosporine|cyclosporine|mesh-list
93361005|NCT03250143|Azathioprine|azathioprine|mesh-list
93361006|NCT03250143|Cyclosporins|cyclosporins|mesh-list
93361007|NCT03250143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361008|NCT03250143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361009|NCT03250143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361010|NCT03250143|Immunologic Factors|immunologic factors|mesh-ancestor
93361011|NCT03250143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361012|NCT03250143|Antifungal Agents|antifungal agents|mesh-ancestor
93361013|NCT03250143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361014|NCT03250143|Dermatologic Agents|dermatologic agents|mesh-ancestor
93361015|NCT03250143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361016|NCT03250143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93361017|NCT03250143|Antimetabolites|antimetabolites|mesh-ancestor
93361018|NCT03250143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361019|NCT03250143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361020|NCT03073850|Anticoagulants|anticoagulants|mesh-list
93361021|NCT03073850|Edoxaban|edoxaban|mesh-list
93361022|NCT03073850|Clopidogrel|clopidogrel|mesh-list
93361023|NCT03073850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361024|NCT03073850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361025|NCT03073850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93361026|NCT03073850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361027|NCT03073850|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93361028|NCT03073850|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93361029|NCT03073850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93361030|NCT03073850|Purinergic Agents|purinergic agents|mesh-ancestor
93361031|NCT03073850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361032|NCT03073850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93361033|NCT03073850|Antithrombins|antithrombins|mesh-ancestor
93361034|NCT03073850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93361035|NCT03073850|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361036|NCT03257319|Morphine|morphine|mesh-list
93361037|NCT03257319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93361038|NCT03257319|Narcotics|narcotics|mesh-ancestor
93361039|NCT03257319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361040|NCT03257319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361041|NCT03257319|Analgesics|analgesics|mesh-ancestor
93361042|NCT03257319|Sensory System Agents|sensory system agents|mesh-ancestor
93361043|NCT03257319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361044|NCT03070574|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93361045|NCT03070574|Mesalamine|mesalamine|mesh-list
92654709|NCT05896683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361046|NCT03070574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93361047|NCT03070574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361048|NCT03070574|Analgesics|analgesics|mesh-ancestor
93361049|NCT03070574|Sensory System Agents|sensory system agents|mesh-ancestor
93361050|NCT03070574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361051|NCT03070574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361052|NCT03070574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361053|NCT03070574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361054|NCT03070574|Antitubercular Agents|antitubercular agents|mesh-ancestor
93361055|NCT03070574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93361056|NCT03070574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361057|NCT03257241|Cytarabine|cytarabine|mesh-list
93361058|NCT03257241|Fludarabine|fludarabine|mesh-list
93361059|NCT03257241|Daunorubicin|daunorubicin|mesh-list
93361060|NCT03257241|Mitoxantrone|mitoxantrone|mesh-list
93361061|NCT03257241|Idarubicin|idarubicin|mesh-list
93361062|NCT03257241|Cladribine|cladribine|mesh-list
93361063|NCT03257241|Lenograstim|lenograstim|mesh-list
93361064|NCT03257241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361065|NCT03257241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361066|NCT03257241|Antimetabolites|antimetabolites|mesh-ancestor
93361067|NCT03257241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361068|NCT03257241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361069|NCT03257241|Immunologic Factors|immunologic factors|mesh-ancestor
93361070|NCT03257241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361071|NCT03257241|Antiviral Agents|antiviral agents|mesh-ancestor
93361072|NCT03257241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361073|NCT03257241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93361074|NCT03257241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93361075|NCT03257241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93361076|NCT03257241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93361077|NCT03257241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361078|NCT03257241|Analgesics|analgesics|mesh-ancestor
93361079|NCT03257241|Sensory System Agents|sensory system agents|mesh-ancestor
93361080|NCT03257241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361081|NCT02129179|Glucagon|glucagon|mesh-list
93361082|NCT02129179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93361083|NCT02129179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361084|NCT02129179|Hormones|hormones|mesh-ancestor
93361085|NCT02129179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361086|NCT02129179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361087|NCT02129179|Incretins|incretins|mesh-ancestor
93361088|NCT02129257|Leucovorin|leucovorin|mesh-list
93361089|NCT02129257|Folic Acid|folic acid|mesh-list
93361090|NCT02129257|Fluorouracil|fluorouracil|mesh-list
93361091|NCT02129257|Irinotecan|irinotecan|mesh-list
93361092|NCT02129257|Aflibercept|aflibercept|mesh-list
93361093|NCT02129257|Levoleucovorin|levoleucovorin|mesh-list
93361094|NCT02129257|Antimetabolites|antimetabolites|mesh-ancestor
93361095|NCT02129257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361096|NCT02129257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361097|NCT02129257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361098|NCT02129257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361099|NCT02129257|Immunologic Factors|immunologic factors|mesh-ancestor
93361100|NCT02129257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361101|NCT02129257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93361102|NCT02129257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93361103|NCT02129257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361104|NCT02129257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93361105|NCT02129257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93361106|NCT02129257|Growth Substances|growth substances|mesh-ancestor
93361107|NCT02129257|Growth Inhibitors|growth inhibitors|mesh-ancestor
93361108|NCT02129257|Antidotes|antidotes|mesh-ancestor
93361109|NCT02129257|Protective Agents|protective agents|mesh-ancestor
93361110|NCT02129257|Vitamin B Complex|vitamin b complex|mesh-ancestor
93361111|NCT02129257|Vitamins|vitamins|mesh-ancestor
93361112|NCT02129257|Micronutrients|micronutrients|mesh-ancestor
93361113|NCT02129257|Hematinics|hematinics|mesh-ancestor
93361114|NCT03245307|Apatinib|apatinib|mesh-list
93361115|NCT03245307|Nifedipine|nifedipine|mesh-list
93361116|NCT03245307|Warfarin|warfarin|mesh-list
93361117|NCT03245307|Anticoagulants|anticoagulants|mesh-ancestor
93361118|NCT03245307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361119|NCT03245307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93361120|NCT03245307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361121|NCT03245307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361122|NCT03245307|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93361123|NCT03245307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361124|NCT03245307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93361125|NCT03245307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361126|NCT03245307|Vasodilator Agents|vasodilator agents|mesh-ancestor
93361127|NCT03245307|Tocolytic Agents|tocolytic agents|mesh-ancestor
93361128|NCT03245307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93361129|NCT02136979|Propofol|propofol|mesh-list
93361130|NCT02136979|Sevoflurane|sevoflurane|mesh-list
93361131|NCT02136979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93361132|NCT02136979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361133|NCT02136979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361134|NCT02136979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93361135|NCT02136979|Anesthetics, General|anesthetics, general|mesh-ancestor
93361136|NCT02136979|Anesthetics|anesthetics|mesh-ancestor
93361137|NCT02136979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93361138|NCT02136979|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93361139|NCT02455011|Volagidemab|volagidemab|mesh-list
93361140|NCT02455011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93361141|NCT02455011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361142|NCT03249285|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93361143|NCT03249285|Perindopril|perindopril|mesh-list
93361144|NCT03249285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93361145|NCT03249285|Diuretics|diuretics|mesh-ancestor
93361146|NCT03249285|Natriuretic Agents|natriuretic agents|mesh-ancestor
93361147|NCT03249285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361148|NCT03249285|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93361149|NCT03249285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361150|NCT03249285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361151|NCT03249285|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93361152|NCT03249285|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361153|NCT03249285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361154|NCT03249519|Cisplatin|cisplatin|mesh-list
93361155|NCT03249519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361156|NCT04983524|Propolis|propolis|mesh-list
93361157|NCT04983524|Calcium|calcium|mesh-list
93361158|NCT04983524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93361159|NCT04983524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361160|NCT04983524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361161|NCT03576911|Ubiquinone|ubiquinone|mesh-list
93361162|NCT03576911|Coenzyme Q10|coenzyme q10|mesh-list
93361163|NCT03576911|Micronutrients|micronutrients|mesh-ancestor
93361164|NCT03576911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361165|NCT03576911|Vitamins|vitamins|mesh-ancestor
93361166|NCT02634320|Aripiprazole|aripiprazole|mesh-list
93361167|NCT02634320|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
93361168|NCT02634320|Antidepressive Agents|antidepressive agents|mesh-ancestor
93361169|NCT02634320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93361170|NCT02634320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93361171|NCT02634320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93361172|NCT02634320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361173|NCT02634320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361174|NCT02634320|Dopamine Agonists|dopamine agonists|mesh-ancestor
93361175|NCT02634320|Dopamine Agents|dopamine agents|mesh-ancestor
93361176|NCT02634320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361177|NCT02634320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361178|NCT02634320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93361179|NCT02634320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93361180|NCT02634320|Serotonin Agents|serotonin agents|mesh-ancestor
93361181|NCT02634320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93361182|NCT02634320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93361183|NCT02634320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93361184|NCT02634320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93361185|NCT02435680|Carboplatin|carboplatin|mesh-list
93361186|NCT02435680|Gemcitabine|gemcitabine|mesh-list
93361187|NCT02435680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361188|NCT02435680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361189|NCT02435680|Antimetabolites|antimetabolites|mesh-ancestor
93361190|NCT02435680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361191|NCT04988048|Vaccines|vaccines|mesh-list
93361192|NCT04988048|Immunologic Factors|immunologic factors|mesh-ancestor
93361193|NCT04988048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361194|NCT04982900|Aflutinib|aflutinib|mesh-list
93361195|NCT04982900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93361196|NCT04982900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361197|NCT04982900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361198|NCT03256071|Decitabine|decitabine|mesh-list
93361199|NCT03256071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361200|NCT03256071|Antimetabolites|antimetabolites|mesh-ancestor
93361201|NCT03256071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361202|NCT03256071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361203|NCT03256071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361204|NCT04912856|Ezogabine|ezogabine|mesh-list
93361205|NCT04912856|Anticonvulsants|anticonvulsants|mesh-ancestor
93361206|NCT04912856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361207|NCT04912856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361208|NCT03248817|Phenylephrine|phenylephrine|mesh-list
93361209|NCT03248817|Oxymetazoline|oxymetazoline|mesh-list
93361210|NCT03248817|Bupivacaine|bupivacaine|mesh-list
93361211|NCT03248817|Anesthetics, Local|anesthetics, local|mesh-ancestor
93361212|NCT03248817|Anesthetics|anesthetics|mesh-ancestor
93361213|NCT03248817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361214|NCT03248817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361215|NCT03248817|Sensory System Agents|sensory system agents|mesh-ancestor
93361216|NCT03248817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361217|NCT03248817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93361218|NCT03248817|Mydriatics|mydriatics|mesh-ancestor
93361219|NCT03248817|Autonomic Agents|autonomic agents|mesh-ancestor
93361220|NCT03248817|Sympathomimetics|sympathomimetics|mesh-ancestor
93361221|NCT03248817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93361222|NCT03248817|Nasal Decongestants|nasal decongestants|mesh-ancestor
93361223|NCT03248817|Respiratory System Agents|respiratory system agents|mesh-ancestor
93361224|NCT03248817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93361225|NCT03248817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93361226|NCT03248817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93361227|NCT03248817|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361228|NCT03248817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361229|NCT03248817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361230|NCT03248817|Protective Agents|protective agents|mesh-ancestor
93361231|NCT03647774|Naltrexone|naltrexone|mesh-list
93361232|NCT03647774|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93361233|NCT03647774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93361234|NCT03647774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361235|NCT03647774|Sensory System Agents|sensory system agents|mesh-ancestor
93361236|NCT03647774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361237|NCT03248973|Ampicillin|ampicillin|mesh-list
93361238|NCT03248973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93361239|NCT03248973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361240|NCT02832531|Aspirin|aspirin|mesh-list
93361241|NCT02832531|Rivaroxaban|rivaroxaban|mesh-list
93361242|NCT02832531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93361243|NCT02832531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361244|NCT02832531|Analgesics|analgesics|mesh-ancestor
93361245|NCT02832531|Sensory System Agents|sensory system agents|mesh-ancestor
93361246|NCT02832531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361247|NCT02832531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361248|NCT02832531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361249|NCT02832531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361250|NCT02832531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93361251|NCT02832531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93361252|NCT02832531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361253|NCT02832531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93361254|NCT02832531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93361255|NCT02832531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361256|NCT02832531|Antipyretics|antipyretics|mesh-ancestor
93361257|NCT02832531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93361258|NCT02832531|Antithrombins|antithrombins|mesh-ancestor
93361259|NCT02832531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93361260|NCT02832531|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361261|NCT02832531|Anticoagulants|anticoagulants|mesh-ancestor
93361262|NCT03248427|Paclitaxel|paclitaxel|mesh-list
93361263|NCT03248427|Cyclophosphamide|cyclophosphamide|mesh-list
93361264|NCT03248427|Doxorubicin|doxorubicin|mesh-list
93361265|NCT03248427|Letrozole|letrozole|mesh-list
93361266|NCT03248427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93361267|NCT03248427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361268|NCT03248427|Tubulin Modulators|tubulin modulators|mesh-ancestor
93361269|NCT03248427|Antimitotic Agents|antimitotic agents|mesh-ancestor
93361270|NCT03248427|Mitosis Modulators|mitosis modulators|mesh-ancestor
93361271|NCT03248427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361272|NCT03248427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361273|NCT03248427|Immunologic Factors|immunologic factors|mesh-ancestor
93361274|NCT03248427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361275|NCT03248427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361276|NCT03248427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93361277|NCT03248427|Alkylating Agents|alkylating agents|mesh-ancestor
93361278|NCT03248427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93361279|NCT03248427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93361280|NCT03248427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93361281|NCT03248427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93361282|NCT03248427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361283|NCT03248427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93361284|NCT03248427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93361285|NCT03248427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93361286|NCT03248427|Hormone Antagonists|hormone antagonists|mesh-ancestor
93361287|NCT03248427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033153|NCT01564199|Xhance|xhance|mesh-list
93361288|NCT03248349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93361289|NCT03248349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361290|NCT03243903|Insulin|insulin|mesh-list
93361291|NCT03243903|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93361292|NCT03243903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93361293|NCT03243903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361294|NCT03576677|Simendan|simendan|mesh-list
93361295|NCT03576677|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93361296|NCT03576677|Vasodilator Agents|vasodilator agents|mesh-ancestor
93361297|NCT03576677|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93361298|NCT03576677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93361299|NCT03576677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361300|NCT03576677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361301|NCT03576677|Protective Agents|protective agents|mesh-ancestor
93361302|NCT03576677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361303|NCT03247257|Lidocaine|lidocaine|mesh-list
93361304|NCT03247257|Anesthetics|anesthetics|mesh-list
93361305|NCT03247257|Propofol|propofol|mesh-list
93361306|NCT03247257|Anesthetics, Local|anesthetics, local|mesh-ancestor
93361307|NCT03247257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361308|NCT03247257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361309|NCT03247257|Sensory System Agents|sensory system agents|mesh-ancestor
93361310|NCT03247257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361311|NCT03247257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93361312|NCT03247257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93361313|NCT03247257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93361314|NCT03247257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361315|NCT03247257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361316|NCT03247257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93361317|NCT03247257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93361318|NCT03247257|Anesthetics, General|anesthetics, general|mesh-ancestor
93361319|NCT03576599|Zoledronic Acid|zoledronic acid|mesh-list
93361320|NCT03576599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93361321|NCT03576599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361322|NCT02239835|Ritonavir|ritonavir|mesh-list
93361323|NCT02239835|Saquinavir|saquinavir|mesh-list
93361324|NCT02239835|Tipranavir|tipranavir|mesh-list
93361325|NCT02239835|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93361326|NCT02239835|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93361327|NCT02239835|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361328|NCT02239835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361329|NCT02239835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361330|NCT02239835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93361331|NCT02239835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93361332|NCT02239835|Antiviral Agents|antiviral agents|mesh-ancestor
93361333|NCT02239835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361334|NCT02239835|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93361335|NCT02239835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93361336|NCT02239913|Topiramate|topiramate|mesh-list
93361337|NCT02239913|Phentermine|phentermine|mesh-list
93361338|NCT02239913|Cocaine|cocaine|mesh-list
93361339|NCT02239913|Anticonvulsants|anticonvulsants|mesh-ancestor
93361340|NCT02239913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93361341|NCT02239913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361342|NCT02239913|Anesthetics, Local|anesthetics, local|mesh-ancestor
93361343|NCT02239913|Anesthetics|anesthetics|mesh-ancestor
93361344|NCT02239913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361345|NCT02239913|Sensory System Agents|sensory system agents|mesh-ancestor
93361346|NCT02239913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361347|NCT02239913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93361348|NCT02239913|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93361349|NCT02239913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93361350|NCT02239913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361351|NCT02239913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361352|NCT02239913|Dopamine Agents|dopamine agents|mesh-ancestor
93361353|NCT02239913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361354|NCT02239913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93361355|NCT02239913|Appetite Depressants|appetite depressants|mesh-ancestor
93361356|NCT02239913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93361357|NCT02239913|Sympathomimetics|sympathomimetics|mesh-ancestor
93361358|NCT02239913|Autonomic Agents|autonomic agents|mesh-ancestor
93361359|NCT02239913|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361360|NCT03576287|Apremilast|apremilast|mesh-list
93361361|NCT03576287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93361362|NCT03576287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361363|NCT03576287|Analgesics|analgesics|mesh-ancestor
93361364|NCT03576287|Sensory System Agents|sensory system agents|mesh-ancestor
93361365|NCT03576287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361366|NCT03576287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361367|NCT03576287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361368|NCT03576287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361369|NCT03576287|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93361370|NCT03576287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93361371|NCT03576287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361372|NCT03576287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361373|NCT02455869|Alendronate|alendronate|mesh-list
93361374|NCT02455869|Atorvastatin|atorvastatin|mesh-list
93361375|NCT02455869|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93361376|NCT02455869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93361377|NCT02455869|Antimetabolites|antimetabolites|mesh-ancestor
93361378|NCT02455869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361379|NCT02455869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93361380|NCT02455869|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93361381|NCT02455869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361382|NCT02455869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93361383|NCT02455869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361384|NCT03246555|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93361385|NCT03246555|Perindopril|perindopril|mesh-list
93361386|NCT03246555|Indapamide|indapamide|mesh-list
93361387|NCT03246555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93361388|NCT03246555|Diuretics|diuretics|mesh-ancestor
93361389|NCT03246555|Natriuretic Agents|natriuretic agents|mesh-ancestor
93361390|NCT03246555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361391|NCT03246555|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93361392|NCT03246555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361393|NCT03246555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361394|NCT03246555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93361395|NCT03246555|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361396|NCT03246555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361397|NCT03576053|Lidocaine|lidocaine|mesh-list
93361398|NCT03576053|Serotonin|serotonin|mesh-list
93361399|NCT03576053|Histamine|histamine|mesh-list
93361400|NCT03576053|Anesthetics, Local|anesthetics, local|mesh-ancestor
93361401|NCT03576053|Anesthetics|anesthetics|mesh-ancestor
93361402|NCT03576053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361403|NCT03576053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361404|NCT03576053|Sensory System Agents|sensory system agents|mesh-ancestor
93361405|NCT03576053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361406|NCT03576053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93361407|NCT03576053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93361408|NCT03576053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93361409|NCT03576053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361410|NCT03576053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361411|NCT03576053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93361412|NCT03576053|Serotonin Agents|serotonin agents|mesh-ancestor
93361413|NCT03576053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361414|NCT03576053|Histamine Agonists|histamine agonists|mesh-ancestor
93361415|NCT03576053|Histamine Agents|histamine agents|mesh-ancestor
93361416|NCT03242967|Darbepoetin alfa|darbepoetin alfa|mesh-list
93361417|NCT03242967|Hematinics|hematinics|mesh-ancestor
93361418|NCT03239457|Mitogens|mitogens|mesh-list
93361419|NCT03239457|Mitosis Modulators|mitosis modulators|mesh-ancestor
93361420|NCT03239457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361421|NCT00075803|Fluconazole|fluconazole|mesh-list
93361422|NCT00075803|Voriconazole|voriconazole|mesh-list
93361423|NCT00075803|Antifungal Agents|antifungal agents|mesh-ancestor
93361424|NCT00075803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361425|NCT00075803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93361426|NCT00075803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93361427|NCT00075803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361428|NCT00075803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361429|NCT00075803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93361430|NCT00075803|Hormone Antagonists|hormone antagonists|mesh-ancestor
93361431|NCT00075803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361432|NCT00075803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361433|NCT00075803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93361434|NCT00075803|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93361435|NCT00075803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93361436|NCT03242499|Lovastatin|lovastatin|mesh-list
93361437|NCT03242499|L 647318|l 647318|mesh-list
93361439|NCT03242499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93361440|NCT03242499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93361441|NCT03242499|Antimetabolites|antimetabolites|mesh-ancestor
93361442|NCT03242499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361443|NCT03242499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93361444|NCT03242499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93361445|NCT03242499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361446|NCT02523911|Magnesium Sulfate|magnesium sulfate|mesh-list
93361447|NCT02523911|Simethicone|simethicone|mesh-list
93361448|NCT02523911|Sodium sulfate|sodium sulfate|mesh-list
93361449|NCT02523911|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93361450|NCT02523911|Analgesics|analgesics|mesh-ancestor
93361451|NCT02523911|Sensory System Agents|sensory system agents|mesh-ancestor
93361452|NCT02523911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361453|NCT02523911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361454|NCT02523911|Anesthetics|anesthetics|mesh-ancestor
93361455|NCT02523911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361456|NCT02523911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93361457|NCT02523911|Anticonvulsants|anticonvulsants|mesh-ancestor
93361458|NCT02523911|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93361459|NCT02523911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361460|NCT02523911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361461|NCT02523911|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93361462|NCT02523911|Tocolytic Agents|tocolytic agents|mesh-ancestor
93361463|NCT02523911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93361464|NCT02523911|Antifoaming Agents|antifoaming agents|mesh-ancestor
93361465|NCT02523911|Emollients|emollients|mesh-ancestor
93361466|NCT02523911|Dermatologic Agents|dermatologic agents|mesh-ancestor
93361467|NCT02523911|Cathartics|cathartics|mesh-ancestor
93361468|NCT02523911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361469|NCT03572231|Solifenacin Succinate|solifenacin succinate|mesh-list
93361470|NCT03572231|Mirabegron|mirabegron|mesh-list
93361471|NCT03572231|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93361472|NCT03572231|Fesoterodine|fesoterodine|mesh-list
93361473|NCT03572231|Oxybutynin|oxybutynin|mesh-list
93361474|NCT03572231|Darifenacin|darifenacin|mesh-list
93361475|NCT03572231|Propiverine|propiverine|mesh-list
93361476|NCT03572231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93361477|NCT03572231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93361478|NCT03572231|Cholinergic Agents|cholinergic agents|mesh-ancestor
93361479|NCT03572231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361480|NCT03572231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361481|NCT03572231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361482|NCT03572231|Urological Agents|urological agents|mesh-ancestor
93361483|NCT03572231|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93361484|NCT03572231|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93361485|NCT03572231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93361486|NCT03572231|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361487|NCT03572231|Parasympatholytics|parasympatholytics|mesh-ancestor
93361488|NCT03572231|Autonomic Agents|autonomic agents|mesh-ancestor
93361489|NCT03572231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361490|NCT02135029|Atorvastatin|atorvastatin|mesh-list
93361491|NCT02135029|Bococizumab|bococizumab|mesh-list
93361492|NCT02135029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93361493|NCT02135029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93361494|NCT02135029|Antimetabolites|antimetabolites|mesh-ancestor
93361495|NCT02135029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361496|NCT02135029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93361497|NCT02135029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93361498|NCT02135029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361499|NCT03573245|Tranexamic Acid|tranexamic acid|mesh-list
93361500|NCT03573245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93361501|NCT03573245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93361502|NCT03573245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361503|NCT03573245|Hemostatics|hemostatics|mesh-ancestor
93361504|NCT03573245|Coagulants|coagulants|mesh-ancestor
93361505|NCT02241161|Bacteriocins|bacteriocins|mesh-list
93361506|NCT02241161|Antioxidants|antioxidants|mesh-list
93361507|NCT02241161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361508|NCT02241161|Protective Agents|protective agents|mesh-ancestor
93361509|NCT02241161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361510|NCT02241161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93361511|NCT02241161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361512|NCT02135263|Enalapril|enalapril|mesh-list
93361513|NCT02135263|Methylphenidate|methylphenidate|mesh-list
93361514|NCT02135263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93361515|NCT02135263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361516|NCT02135263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93361517|NCT02135263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93361518|NCT02135263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361519|NCT02135263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361520|NCT02135263|Dopamine Agents|dopamine agents|mesh-ancestor
93361521|NCT02135263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361522|NCT02135263|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93361523|NCT02135263|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361524|NCT02135263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361525|NCT02135263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93361526|NCT02135341|Botulinum Toxins|botulinum toxins|mesh-list
93361527|NCT02135341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93361528|NCT02135341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93361529|NCT02135341|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93361530|NCT02135341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93361531|NCT02135341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361532|NCT02135341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361533|NCT02135341|Cholinergic Agents|cholinergic agents|mesh-ancestor
93361534|NCT02135341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361535|NCT02135341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361536|NCT02135341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93361537|NCT02135341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361538|NCT02239523|Denosumab|denosumab|mesh-list
93361539|NCT02239523|Teriparatide|teriparatide|mesh-list
93361540|NCT02239523|Diphosphonates|diphosphonates|mesh-list
93361541|NCT02239523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93361542|NCT02239523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361543|NCT02239523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93361544|NCT02137213|Naloxone|naloxone|mesh-list
93361545|NCT02137213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93361546|NCT02137213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361547|NCT02137213|Sensory System Agents|sensory system agents|mesh-ancestor
93361548|NCT02137213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361549|NCT03571919|Lidocaine|lidocaine|mesh-list
93361550|NCT03571919|Anesthetics, Local|anesthetics, local|mesh-ancestor
93361551|NCT03571919|Anesthetics|anesthetics|mesh-ancestor
93361552|NCT03571919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361553|NCT03571919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361554|NCT03571919|Sensory System Agents|sensory system agents|mesh-ancestor
93361555|NCT03571919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361556|NCT03571919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93361557|NCT03571919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93361558|NCT03571919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93361559|NCT03571919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361560|NCT03571919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361561|NCT02252809|Methylprednisolone|methylprednisolone|mesh-list
93361562|NCT02252809|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93361563|NCT02252809|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93361564|NCT02252809|Prednisolone|prednisolone|mesh-list
93361565|NCT02252809|Prednisolone acetate|prednisolone acetate|mesh-list
93361566|NCT02252809|Adalimumab|adalimumab|mesh-list
93361567|NCT02252809|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93361568|NCT02252809|Prednisolone phosphate|prednisolone phosphate|mesh-list
93361569|NCT02252809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361570|NCT02252809|Antiemetics|antiemetics|mesh-ancestor
93361571|NCT02252809|Autonomic Agents|autonomic agents|mesh-ancestor
93361572|NCT02252809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361573|NCT02252809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361574|NCT02252809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361575|NCT02252809|Glucocorticoids|glucocorticoids|mesh-ancestor
93361576|NCT02252809|Hormones|hormones|mesh-ancestor
93361577|NCT02252809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361578|NCT02252809|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93361579|NCT02252809|Protective Agents|protective agents|mesh-ancestor
93361580|NCT02252809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93361581|NCT02252809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361582|NCT02252809|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93361583|NCT02252809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361584|NCT02137525|Fentanyl|fentanyl|mesh-list
93361585|NCT02137525|Morphine|morphine|mesh-list
93361586|NCT02137525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93361587|NCT02137525|Narcotics|narcotics|mesh-ancestor
93361588|NCT02137525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361589|NCT02137525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361590|NCT02137525|Analgesics|analgesics|mesh-ancestor
93361591|NCT02137525|Sensory System Agents|sensory system agents|mesh-ancestor
93361592|NCT02137525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361593|NCT02137525|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93361594|NCT02137525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93361595|NCT02137525|Anesthetics, General|anesthetics, general|mesh-ancestor
93361596|NCT02137525|Anesthetics|anesthetics|mesh-ancestor
93361598|NCT02137681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93361599|NCT02137681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361600|NCT02137681|Immunologic Factors|immunologic factors|mesh-ancestor
93361601|NCT02137681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361602|NCT02137681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361603|NCT02842073|Naltrexone|naltrexone|mesh-list
93361604|NCT02842073|Bupropion|bupropion|mesh-list
93361605|NCT02842073|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93361606|NCT02842073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93361607|NCT02842073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361608|NCT02842073|Sensory System Agents|sensory system agents|mesh-ancestor
93361609|NCT02842073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361610|NCT02842073|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93361611|NCT02842073|Antidepressive Agents|antidepressive agents|mesh-ancestor
93361612|NCT02842073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93361613|NCT02842073|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93361614|NCT02842073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93361615|NCT02842073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361616|NCT02842073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361617|NCT02842073|Dopamine Agents|dopamine agents|mesh-ancestor
93361618|NCT02842073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361619|NCT02842073|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93361620|NCT02842073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93361621|NCT02842073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361622|NCT02135887|Leucovorin|leucovorin|mesh-list
93361623|NCT02135887|Folic Acid|folic acid|mesh-list
93361624|NCT02135887|Fluorouracil|fluorouracil|mesh-list
93361625|NCT02135887|Oxaliplatin|oxaliplatin|mesh-list
93361626|NCT02135887|Levoleucovorin|levoleucovorin|mesh-list
93361627|NCT02135887|Antimetabolites|antimetabolites|mesh-ancestor
93361628|NCT02135887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361629|NCT02135887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361630|NCT02135887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361631|NCT02135887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361632|NCT02135887|Immunologic Factors|immunologic factors|mesh-ancestor
93361633|NCT02135887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361634|NCT02135887|Antidotes|antidotes|mesh-ancestor
93361635|NCT02135887|Protective Agents|protective agents|mesh-ancestor
93361636|NCT02135887|Vitamin B Complex|vitamin b complex|mesh-ancestor
93361637|NCT02135887|Vitamins|vitamins|mesh-ancestor
93361638|NCT02135887|Micronutrients|micronutrients|mesh-ancestor
93361639|NCT02135887|Hematinics|hematinics|mesh-ancestor
93361640|NCT02137993|Olanzapine|olanzapine|mesh-list
93361641|NCT02137993|Antiemetics|antiemetics|mesh-ancestor
93361642|NCT02137993|Autonomic Agents|autonomic agents|mesh-ancestor
93361643|NCT02137993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361644|NCT02137993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361645|NCT02137993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361646|NCT02137993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93361647|NCT02137993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93361648|NCT02137993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361649|NCT02137993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93361650|NCT02137993|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93361651|NCT02137993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93361652|NCT02137993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361653|NCT02137993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361654|NCT02137993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361655|NCT02137993|Serotonin Agents|serotonin agents|mesh-ancestor
93361656|NCT05579119|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93361657|NCT05579119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93361658|NCT05579119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361659|NCT05579119|Incretins|incretins|mesh-ancestor
93361660|NCT05579119|Hormones|hormones|mesh-ancestor
93361661|NCT05579119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361662|NCT05579119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93361663|NCT05579119|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361664|NCT05579119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361665|NCT05579119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361666|NCT02245841|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93361667|NCT02245841|Hormones|hormones|mesh-ancestor
93361668|NCT02245841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361669|NCT02245841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361670|NCT05709041|Anesthetics|anesthetics|mesh-list
93361671|NCT05709041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361672|NCT05709041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361673|NCT02784535|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93361674|NCT02784535|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93361675|NCT02784535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93361676|NCT02784535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93361677|NCT02784535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361678|NCT02784535|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361679|NCT02784535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361680|NCT02784535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361681|NCT03570281|Enoxaparin|enoxaparin|mesh-list
93361682|NCT03570281|Edoxaban|edoxaban|mesh-list
93361683|NCT03570281|Anticoagulants|anticoagulants|mesh-ancestor
93361684|NCT03570281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93361685|NCT03570281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93361686|NCT03570281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361687|NCT03570281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93361688|NCT03570281|Antithrombins|antithrombins|mesh-ancestor
93361689|NCT03570281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93361690|NCT03570281|Protease Inhibitors|protease inhibitors|mesh-ancestor
93361691|NCT03570281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361692|NCT02242799|Artesunate|artesunate|mesh-list
93361693|NCT02242799|Lumefantrine|lumefantrine|mesh-list
93361694|NCT02242799|Artemether|artemether|mesh-list
93361695|NCT02242799|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93361696|NCT02242799|Amodiaquine|amodiaquine|mesh-list
93361697|NCT02242799|Dolutegravir|dolutegravir|mesh-list
93361698|NCT02242799|Antimalarials|antimalarials|mesh-ancestor
93361699|NCT02242799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93361700|NCT02242799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93361701|NCT02242799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361702|NCT02242799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361703|NCT02242799|Antiviral Agents|antiviral agents|mesh-ancestor
93361704|NCT02242799|Schistosomicides|schistosomicides|mesh-ancestor
93361705|NCT02242799|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93361706|NCT02242799|Anthelmintics|anthelmintics|mesh-ancestor
93361707|NCT02242799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93361708|NCT02242799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93361709|NCT02242799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361710|NCT02242799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361711|NCT02242799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93361712|NCT02242799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93361713|NCT02138383|Paclitaxel|paclitaxel|mesh-list
93361714|NCT02138383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93361715|NCT02138383|Gemcitabine|gemcitabine|mesh-list
93361716|NCT02138383|Androgens|androgens|mesh-list
93361717|NCT02138383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93361718|NCT02138383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361719|NCT02138383|Tubulin Modulators|tubulin modulators|mesh-ancestor
93361720|NCT02138383|Antimitotic Agents|antimitotic agents|mesh-ancestor
93361721|NCT02138383|Mitosis Modulators|mitosis modulators|mesh-ancestor
93361722|NCT02138383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361723|NCT02138383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93361724|NCT02138383|Antimetabolites|antimetabolites|mesh-ancestor
93361725|NCT02138383|Hormones|hormones|mesh-ancestor
93361726|NCT02138383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361727|NCT02138383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361728|NCT02243735|Ferrous fumarate|ferrous fumarate|mesh-list
93361729|NCT02243735|Trace Elements|trace elements|mesh-ancestor
93361730|NCT02243735|Micronutrients|micronutrients|mesh-ancestor
93361731|NCT02243735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361732|NCT02138539|Hydroquinone|hydroquinone|mesh-list
93361733|NCT02138539|Antioxidants|antioxidants|mesh-ancestor
93361734|NCT02138539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361735|NCT02138539|Protective Agents|protective agents|mesh-ancestor
93361736|NCT02138539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361737|NCT02138539|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93361738|NCT02252419|Acetaminophen|acetaminophen|mesh-list
93361739|NCT02252419|Dexamethasone|dexamethasone|mesh-list
93361740|NCT02252419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361741|NCT02252419|Antiemetics|antiemetics|mesh-ancestor
93361742|NCT02252419|Autonomic Agents|autonomic agents|mesh-ancestor
93361743|NCT02252419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361744|NCT02252419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361745|NCT02252419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361746|NCT02252419|Glucocorticoids|glucocorticoids|mesh-ancestor
93361747|NCT02252419|Hormones|hormones|mesh-ancestor
93361748|NCT02252419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361749|NCT02252419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93361750|NCT02252419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361751|NCT02252419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361752|NCT02252419|Analgesics|analgesics|mesh-ancestor
93361753|NCT02252419|Sensory System Agents|sensory system agents|mesh-ancestor
93361754|NCT02252419|Antipyretics|antipyretics|mesh-ancestor
93361755|NCT02252497|Tranexamic Acid|tranexamic acid|mesh-list
93361756|NCT02252497|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93361757|NCT02252497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93361758|NCT02252497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361759|NCT02252497|Hemostatics|hemostatics|mesh-ancestor
93361760|NCT02252497|Coagulants|coagulants|mesh-ancestor
93361761|NCT02138773|Tamsulosin|tamsulosin|mesh-list
93361762|NCT02138773|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93361763|NCT02138773|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93361764|NCT02138773|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93361765|NCT02138773|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361766|NCT02138773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361767|NCT02138773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361768|NCT02138773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361769|NCT02138773|Urological Agents|urological agents|mesh-ancestor
93361770|NCT01367275|Irinotecan|irinotecan|mesh-list
93361771|NCT01367275|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93361772|NCT01367275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93361773|NCT01367275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361774|NCT01367275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361775|NCT01367275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361776|NCT02138929|Everolimus|everolimus|mesh-list
93361777|NCT02138929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93361778|NCT02138929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93361779|NCT02138929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361780|NCT02138929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361781|NCT02138929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361782|NCT02138929|Immunologic Factors|immunologic factors|mesh-ancestor
93361783|NCT02138929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361784|NCT02138929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361785|NCT02253199|Dexmedetomidine|dexmedetomidine|mesh-list
93361786|NCT02253199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93361787|NCT02253199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361788|NCT02253199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361789|NCT02253199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361790|NCT02253199|Analgesics|analgesics|mesh-ancestor
93361791|NCT02253199|Sensory System Agents|sensory system agents|mesh-ancestor
93361792|NCT02253199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361793|NCT02253199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93361794|NCT02253199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93361795|NCT02253199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93361796|NCT02253199|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361797|NCT02253199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361798|NCT02253199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361799|NCT02842853|Vaccines|vaccines|mesh-list
93361800|NCT02842853|Immunologic Factors|immunologic factors|mesh-ancestor
93361801|NCT02842853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361802|NCT02139241|Ramosetron|ramosetron|mesh-list
93361803|NCT02139241|Antiemetics|antiemetics|mesh-ancestor
93361804|NCT02139241|Autonomic Agents|autonomic agents|mesh-ancestor
93361805|NCT02139241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361806|NCT02139241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361807|NCT02139241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361808|NCT02139241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93361809|NCT02139241|Serotonin Agents|serotonin agents|mesh-ancestor
93361810|NCT02139241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361811|NCT02139241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361812|NCT03569579|Memantine|memantine|mesh-list
93033666|NCT04139525|Heparin|heparin|mesh-list
93361813|NCT03569579|Donepezil|donepezil|mesh-list
93361814|NCT03569579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93361815|NCT03569579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361816|NCT03569579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361817|NCT03569579|Cholinergic Agents|cholinergic agents|mesh-ancestor
93361818|NCT03569579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361819|NCT03569579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361820|NCT03569579|Nootropic Agents|nootropic agents|mesh-ancestor
93361821|NCT03569579|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93361822|NCT03569579|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93361823|NCT03569579|Dopamine Agents|dopamine agents|mesh-ancestor
93361824|NCT03569579|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93361825|NCT03569579|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93361826|NCT02130661|Itraconazole|itraconazole|mesh-list
93361827|NCT02130661|Antifungal Agents|antifungal agents|mesh-ancestor
93361828|NCT02130661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361829|NCT02130661|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93361830|NCT02130661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93361831|NCT02130661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361832|NCT02130661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361833|NCT02130661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93361834|NCT02130661|Hormone Antagonists|hormone antagonists|mesh-ancestor
93361835|NCT02130661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361836|NCT02130661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361837|NCT02130661|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93361838|NCT02130739|Fentanyl|fentanyl|mesh-list
93361839|NCT02130739|Propofol|propofol|mesh-list
93361840|NCT02130739|Ropivacaine|ropivacaine|mesh-list
93361841|NCT02130739|Anesthetics|anesthetics|mesh-ancestor
93361842|NCT02130739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361843|NCT02130739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361844|NCT02130739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93361845|NCT02130739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93361846|NCT02130739|Anesthetics, General|anesthetics, general|mesh-ancestor
93361847|NCT02130739|Anesthetics, Local|anesthetics, local|mesh-ancestor
93361848|NCT02130739|Sensory System Agents|sensory system agents|mesh-ancestor
93361849|NCT02130739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361850|NCT02130739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93361851|NCT02130739|Narcotics|narcotics|mesh-ancestor
93361852|NCT02130739|Analgesics|analgesics|mesh-ancestor
93361853|NCT02130739|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93361854|NCT02248493|Acetaminophen|acetaminophen|mesh-list
93361855|NCT02248493|Ketoprofen|ketoprofen|mesh-list
93361856|NCT02248493|Morphine|morphine|mesh-list
93361857|NCT02248493|Tramadol|tramadol|mesh-list
93361858|NCT02248493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93361859|NCT02248493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93361860|NCT02248493|Narcotics|narcotics|mesh-ancestor
93361861|NCT02248493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361862|NCT02248493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361863|NCT02248493|Analgesics|analgesics|mesh-ancestor
93361864|NCT02248493|Sensory System Agents|sensory system agents|mesh-ancestor
93361865|NCT02248493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361866|NCT02248493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361867|NCT02248493|Antipyretics|antipyretics|mesh-ancestor
93361868|NCT02248493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93361869|NCT02248493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361870|NCT02248493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361871|NCT02248493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93361872|NCT02248493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361873|NCT02248493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361874|NCT05577871|Dexmedetomidine|dexmedetomidine|mesh-list
93361875|NCT05577871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93361876|NCT05577871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93361877|NCT05577871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361878|NCT05577871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361879|NCT05577871|Analgesics|analgesics|mesh-ancestor
93361880|NCT05577871|Sensory System Agents|sensory system agents|mesh-ancestor
93361881|NCT05577871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361882|NCT05577871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93361883|NCT05577871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93361884|NCT05577871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93361885|NCT05577871|Adrenergic Agents|adrenergic agents|mesh-ancestor
93361886|NCT05577871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361887|NCT05577871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361889|NCT03140423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93361890|NCT03140423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361891|NCT03140423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93361892|NCT03140423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361893|NCT03140423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361894|NCT02130817|Mycophenolic Acid|mycophenolic acid|mesh-list
93361895|NCT02130817|Dexamethasone|dexamethasone|mesh-list
93361896|NCT02130817|Prednisone|prednisone|mesh-list
93361897|NCT02130817|Abatacept|abatacept|mesh-list
93361898|NCT02130817|Tacrolimus|tacrolimus|mesh-list
93361899|NCT02130817|Thymoglobulin|thymoglobulin|mesh-list
93361900|NCT02130817|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93361901|NCT02130817|Immunoglobulins|immunoglobulins|mesh-list
93361902|NCT02130817|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93361903|NCT02130817|Immunoglobulin G|immunoglobulin g|mesh-list
93361904|NCT02130817|gamma-Globulins|gamma-globulins|mesh-list
93361905|NCT02130817|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93361906|NCT02130817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361907|NCT02130817|Antiemetics|antiemetics|mesh-ancestor
93361908|NCT02130817|Autonomic Agents|autonomic agents|mesh-ancestor
93361909|NCT02130817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361910|NCT02130817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361911|NCT02130817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361912|NCT02130817|Glucocorticoids|glucocorticoids|mesh-ancestor
93361913|NCT02130817|Hormones|hormones|mesh-ancestor
93361914|NCT02130817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93361915|NCT02130817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93361916|NCT02130817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93361917|NCT02130817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361918|NCT02130817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361919|NCT02130817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93361920|NCT02130817|Immunologic Factors|immunologic factors|mesh-ancestor
93361921|NCT02130817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93361922|NCT02130817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93361923|NCT02130817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93361924|NCT02130817|Antitubercular Agents|antitubercular agents|mesh-ancestor
93361925|NCT02130817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93361926|NCT02130817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93361927|NCT02130817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93361928|NCT02130817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93361929|NCT02130817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361930|NCT02400346|Brexpiprazole|brexpiprazole|mesh-list
93361931|NCT02400346|Serotonin Agents|serotonin agents|mesh-ancestor
93361932|NCT02400346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361933|NCT02400346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361934|NCT02400346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361935|NCT02400346|Dopamine Agonists|dopamine agonists|mesh-ancestor
93361936|NCT02400346|Dopamine Agents|dopamine agents|mesh-ancestor
93361937|NCT02130973|Denosumab|denosumab|mesh-list
93361938|NCT02130973|Teriparatide|teriparatide|mesh-list
93361939|NCT02130973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93361940|NCT02130973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361941|NCT02130973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93361942|NCT02456662|Ondansetron|ondansetron|mesh-list
93361943|NCT02456662|Antiemetics|antiemetics|mesh-ancestor
93361944|NCT02456662|Autonomic Agents|autonomic agents|mesh-ancestor
93361945|NCT02456662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361946|NCT02456662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361947|NCT02456662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93361948|NCT02456662|Antipruritics|antipruritics|mesh-ancestor
93361949|NCT02456662|Dermatologic Agents|dermatologic agents|mesh-ancestor
93361950|NCT02456662|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93361951|NCT02456662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93361952|NCT02456662|Serotonin Agents|serotonin agents|mesh-ancestor
93361953|NCT02456662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93361954|NCT02456662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361955|NCT03548311|Vitamin B 12|vitamin b 12|mesh-list
93361956|NCT03548311|Vitamin B Complex|vitamin b complex|mesh-ancestor
93361957|NCT03548311|Vitamins|vitamins|mesh-ancestor
93361958|NCT03548311|Micronutrients|micronutrients|mesh-ancestor
93361959|NCT03548311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361960|NCT01653262|Brivaracetam|brivaracetam|mesh-list
93361961|NCT01653262|Anticonvulsants|anticonvulsants|mesh-ancestor
93361962|NCT02455336|Fenofibrate|fenofibrate|mesh-list
93361963|NCT02455336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93361964|NCT02455336|Antimetabolites|antimetabolites|mesh-ancestor
93361965|NCT02455336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361966|NCT02455336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93361967|NCT02253121|Insulin|insulin|mesh-list
93361968|NCT02253121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93361969|NCT02253121|Dapagliflozin|dapagliflozin|mesh-list
93361970|NCT02253121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93361971|NCT02253121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361972|NCT02253121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93361973|NCT02253121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361974|NCT03548233|BCG Vaccine|bcg vaccine|mesh-list
93361975|NCT03548233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93361976|NCT03548233|Immunologic Factors|immunologic factors|mesh-ancestor
93361977|NCT03548233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361978|NCT03568721|Acetaminophen|acetaminophen|mesh-list
93361979|NCT03568721|Ibuprofen|ibuprofen|mesh-list
93361980|NCT03568721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93361981|NCT03568721|Analgesics|analgesics|mesh-ancestor
93361982|NCT03568721|Sensory System Agents|sensory system agents|mesh-ancestor
93361983|NCT03568721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93361984|NCT03568721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361985|NCT03568721|Antipyretics|antipyretics|mesh-ancestor
93361986|NCT03568721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93361987|NCT03568721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93361988|NCT03568721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93361989|NCT03568721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93361990|NCT03568721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93361991|NCT03568721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93361992|NCT05354375|Immunomodulating Agents|immunomodulating agents|mesh-list
93361993|NCT05354375|Immunologic Factors|immunologic factors|mesh-ancestor
93361994|NCT05354375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93361995|NCT03566303|Vitamin K|vitamin k|mesh-list
93361996|NCT03566303|Warfarin|warfarin|mesh-list
93361997|NCT03566303|Rivaroxaban|rivaroxaban|mesh-list
93361998|NCT03566303|Vitamins|vitamins|mesh-ancestor
93361999|NCT03566303|Micronutrients|micronutrients|mesh-ancestor
93362000|NCT03566303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362001|NCT03566303|Anticoagulants|anticoagulants|mesh-ancestor
93362002|NCT03566303|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93362003|NCT03566303|Antithrombins|antithrombins|mesh-ancestor
93362004|NCT03566303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93362005|NCT03566303|Protease Inhibitors|protease inhibitors|mesh-ancestor
93362006|NCT03566303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362007|NCT03566303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362008|NCT03566303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93362009|NCT03566303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93362010|NCT03566303|Hemostatics|hemostatics|mesh-ancestor
93362011|NCT03566303|Coagulants|coagulants|mesh-ancestor
93362012|NCT02140333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93362013|NCT02140333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362014|NCT02140333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362015|NCT02140333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362016|NCT02140333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362017|NCT05936528|Lactoferrin|lactoferrin|mesh-list
93362018|NCT05936528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362019|NCT05936216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
93362020|NCT05936216|Immunologic Factors|immunologic factors|mesh-ancestor
93362021|NCT05936216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362022|NCT05936190|Lidocaine|lidocaine|mesh-list
93362023|NCT05936190|Anesthetics, Local|anesthetics, local|mesh-ancestor
93362024|NCT05936190|Anesthetics|anesthetics|mesh-ancestor
93362025|NCT05936190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362026|NCT05936190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362027|NCT05936190|Sensory System Agents|sensory system agents|mesh-ancestor
93362028|NCT05936190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362029|NCT05936190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93362030|NCT05936190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93362031|NCT05936190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93362032|NCT05936190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93362033|NCT05936190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362034|NCT05936060|Plasma-lyte 148|plasma-lyte 148|mesh-list
93362035|NCT05936060|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93362036|NCT05936060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93362037|NCT05936021|Darbepoetin alfa|darbepoetin alfa|mesh-list
93362038|NCT05936021|Hematinics|hematinics|mesh-ancestor
93362039|NCT05935930|Propofol|propofol|mesh-list
93362040|NCT05935930|Sevoflurane|sevoflurane|mesh-list
93362041|NCT05935930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93362042|NCT05935930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362043|NCT05935930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362044|NCT05935930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93362045|NCT05935930|Anesthetics, General|anesthetics, general|mesh-ancestor
93362046|NCT05935930|Anesthetics|anesthetics|mesh-ancestor
93362047|NCT05935930|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93362048|NCT05935930|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93362049|NCT05935917|Brincidofovir|brincidofovir|mesh-list
93362050|NCT05935917|Antiviral Agents|antiviral agents|mesh-ancestor
93362051|NCT05935917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362052|NCT05935774|Atezolizumab|atezolizumab|mesh-list
93362053|NCT05935774|Trabedersen|trabedersen|mesh-list
93362054|NCT05935774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362055|NCT05935774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362056|NCT05935774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362057|NCT05935774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362058|NCT05935748|Palbociclib|palbociclib|mesh-list
93362059|NCT05935748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362060|NCT05935748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362061|NCT05935748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362062|NCT05935748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362063|NCT05935631|Folic Acid|folic acid|mesh-list
93362064|NCT05935631|Hematinics|hematinics|mesh-ancestor
93362065|NCT05935631|Vitamin B Complex|vitamin b complex|mesh-ancestor
93362066|NCT05935631|Vitamins|vitamins|mesh-ancestor
93362067|NCT05935631|Micronutrients|micronutrients|mesh-ancestor
93362068|NCT05935631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362069|NCT05935579|Durvalumab|durvalumab|mesh-list
93362070|NCT05935579|Lenvatinib|lenvatinib|mesh-list
93362071|NCT05935579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362072|NCT05935579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362073|NCT05935579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362074|NCT05935579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362075|NCT05935579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362076|NCT05935553|Baclofen|baclofen|mesh-list
93362077|NCT05935553|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93362078|NCT05935553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362079|NCT05935553|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93362080|NCT05935553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362081|NCT05935553|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93362082|NCT05935553|GABA Agonists|gaba agonists|mesh-ancestor
93362083|NCT05935553|GABA Agents|gaba agents|mesh-ancestor
93362084|NCT05935553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362085|NCT05935553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362086|NCT05935449|Lidocaine|lidocaine|mesh-list
93362087|NCT05935449|Anesthetics, Local|anesthetics, local|mesh-ancestor
93362088|NCT05935449|Anesthetics|anesthetics|mesh-ancestor
93362089|NCT05935449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362090|NCT05935449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362091|NCT05935449|Sensory System Agents|sensory system agents|mesh-ancestor
93362092|NCT05935449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362093|NCT05935449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93362094|NCT05935449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93362095|NCT05935449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93362096|NCT05935449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93362097|NCT05935449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362098|NCT05935306|Ibuprofen|ibuprofen|mesh-list
93362099|NCT05935306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93362100|NCT05935306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362101|NCT05935306|Analgesics|analgesics|mesh-ancestor
93362102|NCT05935306|Sensory System Agents|sensory system agents|mesh-ancestor
93362103|NCT05935306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362104|NCT05935306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362105|NCT05935306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362106|NCT05935306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362107|NCT05935306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93362108|NCT05935306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362109|NCT05935306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362110|NCT05935293|Dexmedetomidine|dexmedetomidine|mesh-list
93362111|NCT05935293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92655773|NCT02740712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362112|NCT05935293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362113|NCT05935293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362114|NCT05935293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362115|NCT05935293|Analgesics|analgesics|mesh-ancestor
93362116|NCT05935293|Sensory System Agents|sensory system agents|mesh-ancestor
93362117|NCT05935293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362118|NCT05935293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93362119|NCT05935293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93362120|NCT05935293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93362121|NCT05935293|Adrenergic Agents|adrenergic agents|mesh-ancestor
93362122|NCT05935293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362123|NCT05935293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362124|NCT05935280|Lidocaine|lidocaine|mesh-list
93362125|NCT05935280|Sodium Channel Blockers|sodium channel blockers|mesh-list
93362126|NCT05935280|Anesthetics, Local|anesthetics, local|mesh-ancestor
93362127|NCT05935280|Anesthetics|anesthetics|mesh-ancestor
93362128|NCT05935280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362129|NCT05935280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362130|NCT05935280|Sensory System Agents|sensory system agents|mesh-ancestor
93362131|NCT05935280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362132|NCT05935280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93362133|NCT05935280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93362134|NCT05935280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93362135|NCT05935280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362136|NCT05935098|Tislelizumab|tislelizumab|mesh-list
93362137|NCT05935098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362138|NCT05935098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362139|NCT05934812|Oxytocin|oxytocin|mesh-list
93362140|NCT05934812|Oxytocics|oxytocics|mesh-ancestor
93362141|NCT05934812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93362142|NCT05934812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362143|NCT05934799|Clopidogrel|clopidogrel|mesh-list
93362144|NCT05934799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93362145|NCT05934799|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93362146|NCT05934799|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93362147|NCT05934799|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93362148|NCT05934799|Purinergic Agents|purinergic agents|mesh-ancestor
93362149|NCT05934799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362150|NCT05934799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362151|NCT05934799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362152|NCT05934669|Midazolam|midazolam|mesh-list
93362153|NCT05934669|Dexmedetomidine|dexmedetomidine|mesh-list
93362154|NCT05934669|Ketamine|ketamine|mesh-list
93362155|NCT05934669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93362156|NCT05934669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362157|NCT05934669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362158|NCT05934669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362159|NCT05934669|Analgesics|analgesics|mesh-ancestor
93362160|NCT05934669|Sensory System Agents|sensory system agents|mesh-ancestor
93362161|NCT05934669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362162|NCT05934669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93362163|NCT05934669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93362164|NCT05934669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93362165|NCT05934669|Adrenergic Agents|adrenergic agents|mesh-ancestor
93362166|NCT05934669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362167|NCT05934669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362168|NCT05934669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93362169|NCT05934669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93362170|NCT05934669|Anesthetics, General|anesthetics, general|mesh-ancestor
93362171|NCT05934669|Anesthetics|anesthetics|mesh-ancestor
93362172|NCT05934669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93362173|NCT05934669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93362174|NCT05934669|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93362175|NCT05934669|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93362176|NCT05934669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93362177|NCT05934669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362178|NCT05934669|GABA Modulators|gaba modulators|mesh-ancestor
93362179|NCT05934669|GABA Agents|gaba agents|mesh-ancestor
93362180|NCT05934552|Lactulose|lactulose|mesh-list
93362181|NCT05934552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93362182|NCT05934500|Cannabidiol|cannabidiol|mesh-list
93362183|NCT05934500|Anticonvulsants|anticonvulsants|mesh-ancestor
93362184|NCT05934448|Cyclophosphamide|cyclophosphamide|mesh-list
93362185|NCT05934448|Pembrolizumab|pembrolizumab|mesh-list
93362186|NCT05934448|Fludarabine|fludarabine|mesh-list
93362187|NCT05934448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93362188|NCT05934448|Immunologic Factors|immunologic factors|mesh-ancestor
93362189|NCT05934448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362190|NCT05934448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362191|NCT05934448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93362192|NCT05934448|Alkylating Agents|alkylating agents|mesh-ancestor
93362193|NCT05934448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362194|NCT05934448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362195|NCT05934448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93362196|NCT05934448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362197|NCT05934448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362199|NCT05934409|Nicotinic Acids|nicotinic acids|mesh-list
93362200|NCT05934409|Niacinamide|niacinamide|mesh-list
93362201|NCT05934409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93362202|NCT05934409|Antimetabolites|antimetabolites|mesh-ancestor
93362203|NCT05934409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362204|NCT05934409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93362205|NCT05934409|Vasodilator Agents|vasodilator agents|mesh-ancestor
93362206|NCT05934409|Vitamin B Complex|vitamin b complex|mesh-ancestor
93362207|NCT05934409|Vitamins|vitamins|mesh-ancestor
93362208|NCT05934409|Micronutrients|micronutrients|mesh-ancestor
93362209|NCT05934409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362210|NCT05933538|Cariprazine|cariprazine|mesh-list
93362211|NCT05933538|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93362212|NCT05933538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93362213|NCT05933538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362214|NCT05933538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362215|NCT05933538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362216|NCT05932238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93362217|NCT05932199|Carboplatin|carboplatin|mesh-list
93362218|NCT05932199|Pemetrexed|pemetrexed|mesh-list
93362219|NCT05932199|Durvalumab|durvalumab|mesh-list
93362220|NCT05932199|Tremelimumab|tremelimumab|mesh-list
93362221|NCT05932199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93362222|NCT05932199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362223|NCT05932199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362224|NCT05932199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362225|NCT05932199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93362226|NCT05932199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93362227|NCT05932199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362228|NCT05932199|Immunologic Factors|immunologic factors|mesh-ancestor
93362229|NCT05932199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362230|NCT05924776|Immunomodulating Agents|immunomodulating agents|mesh-list
93362231|NCT05924776|Immunologic Factors|immunologic factors|mesh-ancestor
93362232|NCT05924776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362233|NCT05922124|Meropenem|meropenem|mesh-list
93362234|NCT05922124|Colistin|colistin|mesh-list
93362235|NCT05922124|Ampicillin|ampicillin|mesh-list
93362236|NCT05922124|Sulbactam|sulbactam|mesh-list
93362237|NCT05922124|Sultamicillin|sultamicillin|mesh-list
93362238|NCT05922124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93362239|NCT05922124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362240|NCT05922124|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93362241|NCT05922124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362242|NCT05922124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362243|NCT05919888|Povidone-Iodine|povidone-iodine|mesh-list
93362244|NCT05919888|Povidone|povidone|mesh-list
93362245|NCT05919888|Plasma Substitutes|plasma substitutes|mesh-ancestor
93362246|NCT05919888|Blood Substitutes|blood substitutes|mesh-ancestor
93362247|NCT05919888|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93362248|NCT05919888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362249|NCT05916053|Vitamin D|vitamin d|mesh-list
93362250|NCT05916053|Vitamins|vitamins|mesh-ancestor
93362251|NCT05916053|Micronutrients|micronutrients|mesh-ancestor
93362252|NCT05916053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362253|NCT05916053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93362254|NCT05909644|Efavirenz|efavirenz|mesh-list
93362255|NCT05909644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93362256|NCT05909644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93362257|NCT05909644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362258|NCT05909644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362259|NCT05909644|Antiviral Agents|antiviral agents|mesh-ancestor
93362260|NCT05909644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362261|NCT05909644|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93362262|NCT05909644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93362263|NCT05909644|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93362264|NCT05909644|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93362265|NCT05909644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93362266|NCT05909644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93362267|NCT05901519|Prednisone|prednisone|mesh-list
93362268|NCT05901519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362269|NCT05901519|Glucocorticoids|glucocorticoids|mesh-ancestor
93362270|NCT05901519|Hormones|hormones|mesh-ancestor
93362271|NCT05901519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93362272|NCT05901519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362273|NCT05901519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93362274|NCT05901519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362275|NCT05896163|Obinutuzumab|obinutuzumab|mesh-list
93362276|NCT05896163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362277|NCT05896163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362278|NCT05892393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93362279|NCT05892393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93362280|NCT05892393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362281|NCT05887843|Mometasone Furoate|mometasone furoate|mesh-list
93362282|NCT05887843|Azelastine|azelastine|mesh-list
93362283|NCT05887843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362284|NCT05887843|Dermatologic Agents|dermatologic agents|mesh-ancestor
93362285|NCT05887843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93362286|NCT05887843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93362287|NCT05887843|Autonomic Agents|autonomic agents|mesh-ancestor
93362288|NCT05887843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362289|NCT05887843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362290|NCT05887843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93362291|NCT05887843|Respiratory System Agents|respiratory system agents|mesh-ancestor
93362292|NCT05887843|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93362293|NCT05887843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362294|NCT05887843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362295|NCT05887843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93362296|NCT05887843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93362297|NCT05887843|Histamine Antagonists|histamine antagonists|mesh-ancestor
93362298|NCT05887843|Histamine Agents|histamine agents|mesh-ancestor
93362299|NCT05887843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362300|NCT05880849|Choline|choline|mesh-list
93362301|NCT05880849|Lipotropic Agents|lipotropic agents|mesh-ancestor
93362302|NCT05880849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93362303|NCT05880849|Antimetabolites|antimetabolites|mesh-ancestor
93362304|NCT05880849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362305|NCT05880849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93362306|NCT05880849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93362307|NCT05880849|Nootropic Agents|nootropic agents|mesh-ancestor
93362308|NCT05879419|Benzocaine|benzocaine|mesh-list
93362309|NCT05879419|Anesthetics, Local|anesthetics, local|mesh-ancestor
93362310|NCT05879419|Anesthetics|anesthetics|mesh-ancestor
93362311|NCT05879419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362312|NCT05879419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362313|NCT05879419|Sensory System Agents|sensory system agents|mesh-ancestor
93362314|NCT05879419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362315|NCT05878691|Pembrolizumab|pembrolizumab|mesh-list
93362316|NCT05878691|Atezolizumab|atezolizumab|mesh-list
93362317|NCT05878691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362318|NCT05878691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362319|NCT05878691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362320|NCT05878691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362321|NCT05876572|Naloxone|naloxone|mesh-list
93362322|NCT05876572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93362323|NCT05876572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362324|NCT05876572|Sensory System Agents|sensory system agents|mesh-ancestor
93362325|NCT05876572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362326|NCT05867121|Paclitaxel|paclitaxel|mesh-list
93362327|NCT05867121|Gemcitabine|gemcitabine|mesh-list
93362328|NCT05867121|Capecitabine|capecitabine|mesh-list
93362329|NCT05867121|Oxaliplatin|oxaliplatin|mesh-list
93362330|NCT05867121|Nivolumab|nivolumab|mesh-list
93362331|NCT05867121|Atezolizumab|atezolizumab|mesh-list
93362332|NCT05867121|Tegafur|tegafur|mesh-list
93362333|NCT05867121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362334|NCT05867121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362335|NCT05867121|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362336|NCT05867121|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362337|NCT05867121|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362338|NCT05867121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362339|NCT05867121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93362340|NCT05867121|Antimetabolites|antimetabolites|mesh-ancestor
93362341|NCT05867121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362342|NCT05867121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362343|NCT05853458|Hydroxyurea|hydroxyurea|mesh-list
93362344|NCT05853458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362345|NCT05853458|Antisickling Agents|antisickling agents|mesh-ancestor
93362346|NCT05853458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362347|NCT05853458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362348|NCT05853458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93362349|NCT05825781|Pertuzumab|pertuzumab|mesh-list
93362350|NCT05825781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362351|NCT05825781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362352|NCT05825391|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93362353|NCT05820594|BCG Vaccine|bcg vaccine|mesh-list
93362354|NCT05820594|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93362355|NCT05820594|Immunologic Factors|immunologic factors|mesh-ancestor
93362356|NCT05820594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362357|NCT05814640|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93362358|NCT05814640|Olanzapine|olanzapine|mesh-list
93362359|NCT05814640|Aripiprazole|aripiprazole|mesh-list
93362360|NCT05814640|Lithium Carbonate|lithium carbonate|mesh-list
93362361|NCT05814640|Vortioxetine|vortioxetine|mesh-list
93362362|NCT05814640|Sertraline|sertraline|mesh-list
93362363|NCT05814640|Fluoxetine|fluoxetine|mesh-list
93362364|NCT05814640|Antiemetics|antiemetics|mesh-ancestor
93362365|NCT05814640|Autonomic Agents|autonomic agents|mesh-ancestor
93362366|NCT05814640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362367|NCT05814640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362368|NCT05814640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93362369|NCT05814640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93362370|NCT05814640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93362371|NCT05814640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362372|NCT05814640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362373|NCT05814640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93362374|NCT05814640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93362375|NCT05814640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93362376|NCT05814640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362377|NCT05814640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362378|NCT05814640|Serotonin Agents|serotonin agents|mesh-ancestor
93362379|NCT05814640|Antidepressive Agents|antidepressive agents|mesh-ancestor
93362380|NCT05814640|Dopamine Agonists|dopamine agonists|mesh-ancestor
93362381|NCT05814640|Dopamine Agents|dopamine agents|mesh-ancestor
93362382|NCT05814640|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93362383|NCT05814640|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93362384|NCT05814640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93362385|NCT05814640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93362386|NCT05814640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93362387|NCT05814640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93362388|NCT05814640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93362389|NCT05814640|Analgesics|analgesics|mesh-ancestor
93362390|NCT05814640|Sensory System Agents|sensory system agents|mesh-ancestor
93362391|NCT05814640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93362392|NCT05814640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93362393|NCT05814640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93362394|NCT05814640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362395|NCT05814640|Antimanic Agents|antimanic agents|mesh-ancestor
93362396|NCT05814640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93362397|NCT05814640|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93362398|NCT05807932|Mycophenolic Acid|mycophenolic acid|mesh-list
93362399|NCT05807932|Venetoclax|venetoclax|mesh-list
93362400|NCT05807932|Amsacrine|amsacrine|mesh-list
93362401|NCT05807932|Tacrolimus|tacrolimus|mesh-list
93362402|NCT05807932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93362403|NCT05807932|Immunologic Factors|immunologic factors|mesh-ancestor
93362404|NCT05807932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362405|NCT05807932|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93362406|NCT05807932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362407|NCT05807932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362408|NCT05807932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93362409|NCT05807932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362410|NCT05807932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93362411|NCT05807932|Antitubercular Agents|antitubercular agents|mesh-ancestor
93362412|NCT05807932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93362413|NCT05807932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362414|NCT05793060|Dexamethasone|dexamethasone|mesh-list
93362415|NCT05793060|Dexamethasone acetate|dexamethasone acetate|mesh-list
93362416|NCT05793060|Dexmedetomidine|dexmedetomidine|mesh-list
93362417|NCT05793060|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93362418|NCT05793060|BB 1101|bb 1101|mesh-list
93362419|NCT05793060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362420|NCT05793060|Antiemetics|antiemetics|mesh-ancestor
93362421|NCT05793060|Autonomic Agents|autonomic agents|mesh-ancestor
93362422|NCT05793060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362423|NCT05793060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362424|NCT05793060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93362425|NCT05793060|Glucocorticoids|glucocorticoids|mesh-ancestor
93362426|NCT05793060|Hormones|hormones|mesh-ancestor
93362427|NCT05793060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93362428|NCT05793060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93362429|NCT05793060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362430|NCT05793060|Protease Inhibitors|protease inhibitors|mesh-ancestor
93362431|NCT05793060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362432|NCT05793060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362433|NCT05793060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93362434|NCT05793060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362435|NCT05793060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362436|NCT05793060|Analgesics|analgesics|mesh-ancestor
93362437|NCT05793060|Sensory System Agents|sensory system agents|mesh-ancestor
93362438|NCT05793060|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93362439|NCT05793060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93362440|NCT05793060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93362441|NCT05793060|Adrenergic Agents|adrenergic agents|mesh-ancestor
93362442|NCT05793060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362443|NCT05790499|Atorvastatin|atorvastatin|mesh-list
93362444|NCT05790499|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93362445|NCT05790499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93362446|NCT05790499|Antimetabolites|antimetabolites|mesh-ancestor
93362447|NCT05790499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362448|NCT05790499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93362449|NCT05790499|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93362450|NCT05790499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362451|NCT05785065|Mycophenolic Acid|mycophenolic acid|mesh-list
93362452|NCT05785065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93362453|NCT05785065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362454|NCT05785065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93362455|NCT05785065|Antitubercular Agents|antitubercular agents|mesh-ancestor
93362456|NCT05785065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93362457|NCT05785065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362458|NCT05785065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362459|NCT05785065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362460|NCT05775380|Pioglitazone|pioglitazone|mesh-list
93362461|NCT05775380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93362462|NCT05775380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362463|NCT05772169|Mifepristone|mifepristone|mesh-list
93362464|NCT05772169|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93362465|NCT05772169|Abortifacient Agents|abortifacient agents|mesh-ancestor
93362466|NCT05772169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93362467|NCT05772169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362468|NCT05772169|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93362469|NCT05772169|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93362470|NCT05772169|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93362471|NCT05772169|Contraceptive Agents|contraceptive agents|mesh-ancestor
93362472|NCT05772169|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93362473|NCT05772169|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93362474|NCT05772169|Hormone Antagonists|hormone antagonists|mesh-ancestor
93362475|NCT05772169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93362476|NCT05772169|Luteolytic Agents|luteolytic agents|mesh-ancestor
93362477|NCT05772169|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93362478|NCT05772169|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93362479|NCT05763875|Ezetimibe|ezetimibe|mesh-list
93362480|NCT05763875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93362481|NCT05763875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93362482|NCT05763875|Antimetabolites|antimetabolites|mesh-ancestor
93362483|NCT05763875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362484|NCT05763875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93362485|NCT05714007|Ferrous succinate|ferrous succinate|mesh-list
93362486|NCT05714007|Hematinics|hematinics|mesh-ancestor
93362487|NCT05704543|Buprenorphine|buprenorphine|mesh-list
93362488|NCT05704543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93362489|NCT05704543|Narcotics|narcotics|mesh-ancestor
93362490|NCT05704543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362491|NCT05704543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362492|NCT05704543|Analgesics|analgesics|mesh-ancestor
93362493|NCT05704543|Sensory System Agents|sensory system agents|mesh-ancestor
93362494|NCT05704543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362495|NCT05704543|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93362496|NCT05681481|Prednisone|prednisone|mesh-list
93362497|NCT05681481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362498|NCT05681481|Glucocorticoids|glucocorticoids|mesh-ancestor
93362499|NCT05681481|Hormones|hormones|mesh-ancestor
93362500|NCT05681481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93362501|NCT05681481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362502|NCT05681481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93362503|NCT05681481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362504|NCT05672524|Trastuzumab|trastuzumab|mesh-list
93362505|NCT05672524|Tucatinib|tucatinib|mesh-list
93362506|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362507|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362508|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362509|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362510|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362511|NCT05663710|Nivolumab|nivolumab|mesh-list
93362512|NCT05663710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362513|NCT05663710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362514|NCT05663710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362515|NCT05663710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362516|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93362517|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93362518|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
93362519|NCT05643170|Xanomeline|xanomeline|mesh-list
93362520|NCT05643170|Trospium chloride|trospium chloride|mesh-list
93362521|NCT05643170|Parasympatholytics|parasympatholytics|mesh-ancestor
93362522|NCT05643170|Autonomic Agents|autonomic agents|mesh-ancestor
93362523|NCT05643170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362524|NCT05643170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362525|NCT05643170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93362526|NCT05643170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93362527|NCT05643170|Cholinergic Agents|cholinergic agents|mesh-ancestor
93362528|NCT05643170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362529|NCT05643170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362530|NCT05643170|Urological Agents|urological agents|mesh-ancestor
93362531|NCT05643170|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93362532|NCT05643170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362533|NCT05643170|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93362534|NCT05643170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93362535|NCT05635916|Bupivacaine|bupivacaine|mesh-list
93362536|NCT05635916|Anesthetics, Local|anesthetics, local|mesh-ancestor
93362537|NCT05635916|Anesthetics|anesthetics|mesh-ancestor
93362538|NCT05635916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362539|NCT05635916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362540|NCT05635916|Sensory System Agents|sensory system agents|mesh-ancestor
93362541|NCT05635916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362542|NCT05633771|Adalimumab|adalimumab|mesh-list
93362543|NCT05633771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93362544|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362545|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362546|NCT05633381|Temozolomide|temozolomide|mesh-list
93362547|NCT05633381|Trabectedin|trabectedin|mesh-list
93362548|NCT05633381|Olaparib|olaparib|mesh-list
93362549|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93362550|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
93362551|NCT05633381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362552|NCT05633381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362553|NCT05633381|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93362554|NCT05633381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362555|NCT05629585|Pembrolizumab|pembrolizumab|mesh-list
93362556|NCT05629585|Durvalumab|durvalumab|mesh-list
93362557|NCT05629585|Capecitabine|capecitabine|mesh-list
93362558|NCT05629585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362559|NCT05629585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362560|NCT05629585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362561|NCT05629585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362562|NCT05629585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93362563|NCT05629585|Antimetabolites|antimetabolites|mesh-ancestor
93362564|NCT05613062|Oren gedoku to|oren gedoku to|mesh-list
93034417|NCT00436566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362565|NCT05613062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93362566|NCT05613062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362567|NCT05613062|Analgesics|analgesics|mesh-ancestor
93362568|NCT05613062|Sensory System Agents|sensory system agents|mesh-ancestor
93362569|NCT05613062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362570|NCT05613062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362571|NCT05613062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362572|NCT05613062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362573|NCT05605535|Paclitaxel|paclitaxel|mesh-list
93362574|NCT05605535|Carboplatin|carboplatin|mesh-list
93362575|NCT05605535|Oregovomab|oregovomab|mesh-list
93362576|NCT05605535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362577|NCT05605535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362578|NCT05605535|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362579|NCT05605535|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362580|NCT05605535|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362581|NCT05605535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362582|NCT05605535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362583|NCT05604560|Tislelizumab|tislelizumab|mesh-list
93362584|NCT05604560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362585|NCT05604560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362586|NCT05600322|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93362587|NCT05600322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93362588|NCT05600322|Dermatologic Agents|dermatologic agents|mesh-ancestor
93362589|NCT05583227|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93362590|NCT05583227|Immunologic Factors|immunologic factors|mesh-ancestor
93362591|NCT05583227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362592|NCT05576350|Ethanol|ethanol|mesh-list
93362593|NCT05576350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93362594|NCT05576350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362595|NCT05576350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362596|NCT05576350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362597|NCT05555615|Pimavanserin|pimavanserin|mesh-list
93362598|NCT05555615|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93362599|NCT05555615|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93362600|NCT05555615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93362601|NCT05555615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93362602|NCT05555615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362603|NCT05555615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362604|NCT05555615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362605|NCT05555615|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93362606|NCT05555615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93362607|NCT05555615|Serotonin Agents|serotonin agents|mesh-ancestor
93362608|NCT05555615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362609|NCT05555615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362610|NCT05552508|Benralizumab|benralizumab|mesh-list
93362611|NCT05552508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93362612|NCT05552508|Respiratory System Agents|respiratory system agents|mesh-ancestor
93362613|NCT05523895|Pimavanserin|pimavanserin|mesh-list
93362614|NCT05523895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93362615|NCT05523895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93362616|NCT05523895|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93362617|NCT05523895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93362618|NCT05523895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362619|NCT05523895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362620|NCT05523895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362621|NCT05523895|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92656280|NCT01644253|Rituximab|rituximab|mesh-list
93362622|NCT05523895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93362623|NCT05523895|Serotonin Agents|serotonin agents|mesh-ancestor
93362624|NCT05523895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362625|NCT05523895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362626|NCT05514444|Pembrolizumab|pembrolizumab|mesh-list
93362627|NCT05514444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362628|NCT05514444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362629|NCT05514444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362630|NCT05514444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362631|NCT05513586|Immunoglobulins|immunoglobulins|mesh-list
93362632|NCT05513586|Immunologic Factors|immunologic factors|mesh-ancestor
93362633|NCT05513586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362634|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
93362635|NCT05511415|Oxytocin|oxytocin|mesh-list
93362636|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93362637|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362638|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362639|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362640|NCT05511415|Analgesics|analgesics|mesh-ancestor
93362641|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
93362642|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362643|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93362644|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93362645|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93362646|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
93362647|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362648|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362649|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
93362650|NCT05511415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93362651|NCT05505825|Chiauranib|chiauranib|mesh-list
93362652|NCT05505825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362653|NCT05505825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362654|NCT05505825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362655|NCT05505825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362656|NCT05490381|Ethiodized Oil|ethiodized oil|mesh-list
93362657|NCT05490381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362658|NCT05485805|Naproxen|naproxen|mesh-list
93362659|NCT05485805|Caffeine|caffeine|mesh-list
93362660|NCT05485805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93362661|NCT05485805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362662|NCT05485805|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93362663|NCT05485805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362664|NCT05485805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362665|NCT05485805|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93362666|NCT05485805|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93362667|NCT05485805|Purinergic Agents|purinergic agents|mesh-ancestor
93362668|NCT05485805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362669|NCT05485805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93362670|NCT05485805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362671|NCT05485805|Analgesics|analgesics|mesh-ancestor
93362672|NCT05485805|Sensory System Agents|sensory system agents|mesh-ancestor
93362673|NCT05485805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362674|NCT05485805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362675|NCT05485805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362676|NCT05485805|Gout Suppressants|gout suppressants|mesh-ancestor
93362677|NCT05485805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93362678|NCT05485012|Analgesics, Opioid|analgesics, opioid|mesh-list
93362679|NCT05485012|Narcotics|narcotics|mesh-ancestor
93362680|NCT05485012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362681|NCT05485012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362682|NCT05485012|Analgesics|analgesics|mesh-ancestor
93362683|NCT05485012|Sensory System Agents|sensory system agents|mesh-ancestor
93362684|NCT05485012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362685|NCT05457959|Poly I-C|poly i-c|mesh-list
93362686|NCT05457959|Nivolumab|nivolumab|mesh-list
93362687|NCT05457959|Ipilimumab|ipilimumab|mesh-list
93362688|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93362689|NCT05457959|Vaccines|vaccines|mesh-list
93362690|NCT05457959|Poly ICLC|poly iclc|mesh-list
93362691|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
93362692|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362693|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362694|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362695|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362696|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362697|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
93362698|NCT05457959|Laxatives|laxatives|mesh-ancestor
93362699|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93362700|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
93362701|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362702|NCT05432388|Remibrutinib|remibrutinib|mesh-list
93362703|NCT05432388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362704|NCT05432388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362705|NCT05432388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362706|NCT05422612|Fluoxetine|fluoxetine|mesh-list
93362707|NCT05422612|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
93362708|NCT05422612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93362709|NCT05422612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93362710|NCT05422612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93362711|NCT05422612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362712|NCT05422612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362713|NCT05422612|Serotonin Agents|serotonin agents|mesh-ancestor
93362714|NCT05422612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362715|NCT05422612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93362716|NCT05422612|Antidepressive Agents|antidepressive agents|mesh-ancestor
93362717|NCT05422612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93362718|NCT05422612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93362719|NCT05422612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93362720|NCT05422612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362721|NCT05422612|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93362722|NCT05422612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93362724|NCT05403385|Pemetrexed|pemetrexed|mesh-list
93362725|NCT05403385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362726|NCT05403385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362727|NCT05403385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362728|NCT05403385|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93362729|NCT05403385|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93362730|NCT05400369|Moxifloxacin|moxifloxacin|mesh-list
93362731|NCT05400369|Sitafloxacin|sitafloxacin|mesh-list
93362732|NCT05400369|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93362733|NCT05400369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93362734|NCT05400369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362735|NCT05400369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93362736|NCT05400369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93362737|NCT05400369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362738|NCT05400369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362739|NCT05400369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362740|NCT05400369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93362741|NCT05400369|Contraceptive Agents|contraceptive agents|mesh-ancestor
93362742|NCT05400369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93362743|NCT05400369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362744|NCT05400369|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93362745|NCT05400369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93362746|NCT05400369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93362747|NCT05382325|Pembrolizumab|pembrolizumab|mesh-list
93362748|NCT05382325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362749|NCT05382325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362750|NCT05382325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362751|NCT05382325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362752|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93362753|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93362754|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93362755|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93362756|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362757|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
93362758|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362759|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362760|NCT05326776|Oxytocin|oxytocin|mesh-list
93362761|NCT05326776|Oxytocics|oxytocics|mesh-ancestor
93362762|NCT05326776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93362763|NCT05326776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362764|NCT05319730|Paclitaxel|paclitaxel|mesh-list
93362765|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
93362766|NCT05319730|Irinotecan|irinotecan|mesh-list
93362767|NCT05319730|Lenvatinib|lenvatinib|mesh-list
93362768|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
93362769|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362770|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362771|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362772|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362773|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362774|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362775|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362776|NCT05319730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362777|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93362778|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93362779|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362780|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
93362781|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362782|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362783|NCT05258747|Olaparib|olaparib|mesh-list
93362784|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93362785|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362786|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362787|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362788|NCT05222906|Venglustat|venglustat|mesh-list
93362789|NCT05222906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362790|NCT05222906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362791|NCT05169684|Docetaxel|docetaxel|mesh-list
93362792|NCT05169684|Nivolumab|nivolumab|mesh-list
93362793|NCT05169684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362794|NCT05169684|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362795|NCT05169684|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362796|NCT05169684|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362797|NCT05169684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362798|NCT05169684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362799|NCT05169684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362800|NCT05161533|Cisplatin|cisplatin|mesh-list
93362801|NCT05161533|Carboplatin|carboplatin|mesh-list
93362802|NCT05161533|Etoposide|etoposide|mesh-list
93362803|NCT05161533|Etoposide phosphate|etoposide phosphate|mesh-list
93362804|NCT05161533|Durvalumab|durvalumab|mesh-list
93362805|NCT05161533|Podophyllotoxin|podophyllotoxin|mesh-list
93362806|NCT05161533|Immunoglobulins|immunoglobulins|mesh-list
93362807|NCT05161533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93362808|NCT05161533|Immunoglobulin G|immunoglobulin g|mesh-list
93362809|NCT05161533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362810|NCT05161533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362811|NCT05161533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93362812|NCT05161533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93362813|NCT05161533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362814|NCT05161533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362815|NCT05161533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362816|NCT05161533|Immunologic Factors|immunologic factors|mesh-ancestor
93362817|NCT05161533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362818|NCT05161533|Keratolytic Agents|keratolytic agents|mesh-ancestor
93362819|NCT05161533|Dermatologic Agents|dermatologic agents|mesh-ancestor
93362820|NCT05161533|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362821|NCT05161533|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362822|NCT05161533|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362823|NCT05139017|Rituximab|rituximab|mesh-list
93362824|NCT05139017|Gemcitabine|gemcitabine|mesh-list
93362825|NCT05139017|Oxaliplatin|oxaliplatin|mesh-list
93362826|NCT05139017|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93362827|NCT05139017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362828|NCT05139017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362829|NCT05139017|Immunologic Factors|immunologic factors|mesh-ancestor
93362830|NCT05139017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362831|NCT05139017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362832|NCT05139017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93362833|NCT05139017|Antimetabolites|antimetabolites|mesh-ancestor
93362834|NCT05139017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362835|NCT05139017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93362836|NCT05139017|Alkylating Agents|alkylating agents|mesh-ancestor
93362837|NCT05127395|Acyclovir|acyclovir|mesh-list
93362838|NCT05127395|Antiviral Agents|antiviral agents|mesh-ancestor
93362839|NCT05127395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362840|NCT05109234|Brivaracetam|brivaracetam|mesh-list
93362841|NCT05109234|Anticonvulsants|anticonvulsants|mesh-ancestor
93362842|NCT05094336|Docetaxel|docetaxel|mesh-list
93362843|NCT05094336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362844|NCT05094336|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362845|NCT05094336|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362846|NCT05094336|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362847|NCT05094336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362848|NCT05084053|Immunoglobulins|immunoglobulins|mesh-list
93362849|NCT05084053|Immunologic Factors|immunologic factors|mesh-ancestor
93362850|NCT05084053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362851|NCT05071053|Ramucirumab|ramucirumab|mesh-list
93362852|NCT05071053|Maytansine|maytansine|mesh-list
93362853|NCT05071053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362854|NCT05071053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362855|NCT05071053|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362856|NCT05071053|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362857|NCT05071053|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362858|NCT05071053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362859|NCT05070650|Acetaminophen|acetaminophen|mesh-list
93034711|NCT01005797|Sorafenib|sorafenib|mesh-list
93362860|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
93362861|NCT05070650|Phenylephrine|phenylephrine|mesh-list
93362862|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
93362863|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93362864|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93362865|NCT05070650|Analgesics|analgesics|mesh-ancestor
93362866|NCT05070650|Sensory System Agents|sensory system agents|mesh-ancestor
93362867|NCT05070650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362868|NCT05070650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362869|NCT05070650|Antipyretics|antipyretics|mesh-ancestor
93362870|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
93362871|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93362872|NCT05070650|Expectorants|expectorants|mesh-ancestor
93362873|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
93362874|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93362875|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
93362876|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362877|NCT05070650|Protective Agents|protective agents|mesh-ancestor
93362878|NCT05070650|Antidotes|antidotes|mesh-ancestor
93362879|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93362880|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
93362881|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
93362882|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
93362883|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93362884|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
93362885|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93362886|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93362887|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93362888|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
93362889|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93362890|NCT05061134|Durvalumab|durvalumab|mesh-list
93362891|NCT05061134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362892|NCT05061134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362893|NCT05041062|Nivolumab|nivolumab|mesh-list
93362894|NCT05041062|Ipilimumab|ipilimumab|mesh-list
93362895|NCT05041062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362896|NCT05041062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362897|NCT05041062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362898|NCT05041062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362899|NCT05022342|Fulvestrant|fulvestrant|mesh-list
93362900|NCT05022342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93362901|NCT05022342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362902|NCT05022342|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93362903|NCT05022342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93362904|NCT05022342|Hormone Antagonists|hormone antagonists|mesh-ancestor
93362905|NCT05022342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93362906|NCT05022342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362907|NCT05019716|Cisplatin|cisplatin|mesh-list
93362908|NCT05019716|Etoposide|etoposide|mesh-list
93362909|NCT05019716|Etoposide phosphate|etoposide phosphate|mesh-list
93362910|NCT05019716|Podophyllotoxin|podophyllotoxin|mesh-list
93362911|NCT05019716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362912|NCT05019716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362913|NCT05019716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93362914|NCT05019716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93362915|NCT05019716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362916|NCT05019716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362917|NCT05019716|Keratolytic Agents|keratolytic agents|mesh-ancestor
93362918|NCT05019716|Dermatologic Agents|dermatologic agents|mesh-ancestor
93362919|NCT05019716|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362920|NCT05019716|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362921|NCT05019716|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362922|NCT05008224|Prednisone|prednisone|mesh-list
93362923|NCT05008224|Cyclophosphamide|cyclophosphamide|mesh-list
93362924|NCT05008224|Dacarbazine|dacarbazine|mesh-list
93362925|NCT05008224|Doxorubicin|doxorubicin|mesh-list
93362926|NCT05008224|Pembrolizumab|pembrolizumab|mesh-list
93362927|NCT05008224|Etoposide|etoposide|mesh-list
93362928|NCT05008224|Etoposide phosphate|etoposide phosphate|mesh-list
93362929|NCT05008224|Vincristine|vincristine|mesh-list
93362930|NCT05008224|Bleomycin|bleomycin|mesh-list
93362931|NCT05008224|Vinblastine|vinblastine|mesh-list
93362932|NCT05008224|Procarbazine|procarbazine|mesh-list
93362933|NCT05008224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93362934|NCT05008224|Immunologic Factors|immunologic factors|mesh-ancestor
93362935|NCT05008224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362936|NCT05008224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93362937|NCT05008224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93362938|NCT05008224|Alkylating Agents|alkylating agents|mesh-ancestor
93362939|NCT05008224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362940|NCT05008224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362941|NCT05008224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93362942|NCT05008224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93362943|NCT05008224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93362944|NCT05008224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93362945|NCT05008224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362946|NCT05008224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362947|NCT05008224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362948|NCT05008224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93362949|NCT05008224|Glucocorticoids|glucocorticoids|mesh-ancestor
93362950|NCT05008224|Hormones|hormones|mesh-ancestor
93362951|NCT05008224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93362952|NCT05008224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93362953|NCT05008224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93362954|NCT05008224|Tubulin Modulators|tubulin modulators|mesh-ancestor
93362955|NCT05008224|Antimitotic Agents|antimitotic agents|mesh-ancestor
93362956|NCT05008224|Mitosis Modulators|mitosis modulators|mesh-ancestor
93362957|NCT04995029|Buprenorphine|buprenorphine|mesh-list
93362958|NCT04995029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93362959|NCT04995029|Narcotics|narcotics|mesh-ancestor
93362960|NCT04995029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93362961|NCT04995029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362962|NCT04995029|Analgesics|analgesics|mesh-ancestor
93362963|NCT04995029|Sensory System Agents|sensory system agents|mesh-ancestor
93362964|NCT04995029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93362965|NCT04995029|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93362966|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93362967|NCT04971226|Imatinib Mesylate|imatinib mesylate|mesh-list
93362968|NCT04971226|Dasatinib|dasatinib|mesh-list
93362969|NCT04971226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362970|NCT04971226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93362971|NCT04971226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93362972|NCT04971226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362973|NCT04967196|Nivolumab|nivolumab|mesh-list
93362974|NCT04967196|Ipilimumab|ipilimumab|mesh-list
93362975|NCT04967196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362976|NCT04967196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362977|NCT04967196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93362978|NCT04967196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93362979|NCT04964466|Becaplermin|becaplermin|mesh-list
93362980|NCT04964466|Anticoagulants|anticoagulants|mesh-ancestor
93362981|NCT04964466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93362982|NCT04964466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93362983|NCT04964466|Growth Substances|growth substances|mesh-ancestor
93362984|NCT04964466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362985|NCT04950270|Arginine Vasopressin|arginine vasopressin|mesh-list
93362986|NCT04950270|Hemostatics|hemostatics|mesh-ancestor
93362987|NCT04950270|Coagulants|coagulants|mesh-ancestor
93362988|NCT04950270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93362989|NCT04950270|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93362990|NCT04950270|Natriuretic Agents|natriuretic agents|mesh-ancestor
93362991|NCT04950270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93362992|NCT04855136|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93362993|NCT04855136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93362994|NCT04855136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93362995|NCT04820309|Xanomeline|xanomeline|mesh-list
93362996|NCT04820309|Trospium chloride|trospium chloride|mesh-list
93362997|NCT04820309|Parasympatholytics|parasympatholytics|mesh-ancestor
93362998|NCT04820309|Autonomic Agents|autonomic agents|mesh-ancestor
93362999|NCT04820309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363000|NCT04820309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363001|NCT04820309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93363002|NCT04820309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93363003|NCT04820309|Cholinergic Agents|cholinergic agents|mesh-ancestor
93363004|NCT04820309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93363005|NCT04820309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363006|NCT04820309|Urological Agents|urological agents|mesh-ancestor
93363007|NCT04820309|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93363008|NCT04820309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93363009|NCT04820309|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93363010|NCT04820309|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93363011|NCT04820179|Atezolizumab|atezolizumab|mesh-list
93363012|NCT04820179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363013|NCT04820179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363014|NCT04820179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363015|NCT04820179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363016|NCT04804553|Apremilast|apremilast|mesh-list
93363017|NCT04804553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93363018|NCT04804553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93363019|NCT04804553|Analgesics|analgesics|mesh-ancestor
93363020|NCT04804553|Sensory System Agents|sensory system agents|mesh-ancestor
93363021|NCT04804553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363022|NCT04804553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363023|NCT04804553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363024|NCT04804553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363025|NCT04804553|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93363026|NCT04804553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93363027|NCT04804553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363028|NCT04804553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363029|NCT04802876|Tislelizumab|tislelizumab|mesh-list
93363030|NCT04802876|Spartalizumab|spartalizumab|mesh-list
93363031|NCT04802876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363032|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363033|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363034|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363035|NCT04789928|Gentamicins|gentamicins|mesh-list
93363036|NCT04789928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363037|NCT04789928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363038|NCT04789928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93363039|NCT04789928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363040|NCT04789928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363041|NCT04762992|Enoxaparin|enoxaparin|mesh-list
93363042|NCT04762992|Anticoagulants|anticoagulants|mesh-ancestor
93363043|NCT04762992|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93363044|NCT04762992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93363045|NCT04762992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363046|NCT04738942|Vedolizumab|vedolizumab|mesh-list
93363047|NCT04738942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363048|NCT04738123|Xanomeline|xanomeline|mesh-list
93363049|NCT04738123|Trospium chloride|trospium chloride|mesh-list
93363050|NCT04738123|Parasympatholytics|parasympatholytics|mesh-ancestor
93363051|NCT04738123|Autonomic Agents|autonomic agents|mesh-ancestor
93363052|NCT04738123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363053|NCT04738123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363054|NCT04738123|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93363055|NCT04738123|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93363056|NCT04738123|Cholinergic Agents|cholinergic agents|mesh-ancestor
93363057|NCT04738123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93363058|NCT04738123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363059|NCT04738123|Urological Agents|urological agents|mesh-ancestor
93363060|NCT04738123|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93363061|NCT04738123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93363062|NCT04738123|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93363063|NCT04738123|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93363064|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
93363065|NCT04715191|Fludarabine|fludarabine|mesh-list
93363066|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
93363067|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363068|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
93363069|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363070|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363071|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363072|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
93363073|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363074|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363075|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363076|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363077|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
93363078|NCT04704453|Amitriptyline|amitriptyline|mesh-list
93363079|NCT04704453|Capsaicin|capsaicin|mesh-list
93363080|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
93363081|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
93363082|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
93363083|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363084|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363085|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93363086|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
93363087|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93363088|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034938|NCT00531011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363089|NCT04704453|Analgesics|analgesics|mesh-ancestor
93363090|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93363091|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93363092|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93363093|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363094|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
93363095|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93363097|NCT04700124|Gemcitabine|gemcitabine|mesh-list
93363098|NCT04700124|Pembrolizumab|pembrolizumab|mesh-list
93363099|NCT04700124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363100|NCT04700124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363101|NCT04700124|Antimetabolites|antimetabolites|mesh-ancestor
93363102|NCT04700124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363103|NCT04700124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363104|NCT04700124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363105|NCT04695847|Antibodies|antibodies|mesh-list
93363106|NCT04695847|Immunoglobulins|immunoglobulins|mesh-list
93363107|NCT04695847|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93363108|NCT04695847|Immunoconjugates|immunoconjugates|mesh-list
93363109|NCT04695847|Immunologic Factors|immunologic factors|mesh-ancestor
93363110|NCT04695847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363111|NCT04682353|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93363112|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
93363113|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93363114|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
93363115|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93363116|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363117|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93363118|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93363119|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363120|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363121|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93363122|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93363123|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93363124|NCT04675333|Carboplatin|carboplatin|mesh-list
93363125|NCT04675333|Pembrolizumab|pembrolizumab|mesh-list
93363126|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363127|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363128|NCT04675333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363129|NCT04675333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363130|NCT04674813|Cyclophosphamide|cyclophosphamide|mesh-list
93363131|NCT04674813|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93363132|NCT04674813|Fludarabine|fludarabine|mesh-list
93363133|NCT04674813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363134|NCT04674813|Immunologic Factors|immunologic factors|mesh-ancestor
93363135|NCT04674813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363136|NCT04674813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363137|NCT04674813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363138|NCT04674813|Alkylating Agents|alkylating agents|mesh-ancestor
93363139|NCT04674813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363140|NCT04674813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363141|NCT04674813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363142|NCT04665050|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93363143|NCT04665050|Immunologic Factors|immunologic factors|mesh-ancestor
93363144|NCT04665050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363145|NCT04586231|Lenvatinib|lenvatinib|mesh-list
93363146|NCT04586231|Belzutifan|belzutifan|mesh-list
93363147|NCT04586231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363148|NCT04586231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363149|NCT04586231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363150|NCT04586231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363151|NCT04581395|Rocuronium|rocuronium|mesh-list
93363152|NCT04581395|Succinylcholine|succinylcholine|mesh-list
93363153|NCT04581395|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93363154|NCT04581395|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93363155|NCT04581395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93363156|NCT04581395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363157|NCT04581395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363158|NCT04581395|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93363159|NCT04572100|Paclitaxel|paclitaxel|mesh-list
93363160|NCT04572100|Carboplatin|carboplatin|mesh-list
93363161|NCT04572100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363162|NCT04572100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363163|NCT04572100|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363164|NCT04572100|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363165|NCT04572100|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363166|NCT04572100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363167|NCT04564625|Vitamin D|vitamin d|mesh-list
93363168|NCT04564625|Vitamins|vitamins|mesh-ancestor
93363169|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
93363170|NCT04564625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363171|NCT04564625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93363172|NCT04560322|Venetoclax|venetoclax|mesh-list
93363173|NCT04560322|Obinutuzumab|obinutuzumab|mesh-list
93363174|NCT04560322|Acalabrutinib|acalabrutinib|mesh-list
93363175|NCT04560322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363176|NCT04560322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363177|NCT04538352|Insulin|insulin|mesh-list
93363178|NCT04538352|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93363179|NCT04538352|Insulin Aspart|insulin aspart|mesh-list
93363180|NCT04538352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93363181|NCT04538352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363182|NCT04504734|Bucillamine|bucillamine|mesh-list
93363183|NCT04504734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93363184|NCT04504734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93363185|NCT04504734|Analgesics|analgesics|mesh-ancestor
93363186|NCT04504734|Sensory System Agents|sensory system agents|mesh-ancestor
93363187|NCT04504734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363188|NCT04504734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363189|NCT04504734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363190|NCT04504734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363191|NCT04504734|Antioxidants|antioxidants|mesh-ancestor
93363192|NCT04504734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363193|NCT04504734|Protective Agents|protective agents|mesh-ancestor
93363194|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
93363195|NCT04469842|Prednisone|prednisone|mesh-list
93363196|NCT04469842|Azathioprine|azathioprine|mesh-list
93363197|NCT04469842|Tacrolimus|tacrolimus|mesh-list
93363198|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363199|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
93363200|NCT04469842|Hormones|hormones|mesh-ancestor
93363201|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363202|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363203|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363204|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363205|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363206|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
93363207|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93363208|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363209|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363210|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93363211|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93363212|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
93363213|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363214|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363215|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
93363216|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363217|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363218|NCT04439227|Adavosertib|adavosertib|mesh-list
93363219|NCT04439227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363220|NCT04439227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363221|NCT04434092|Eculizumab|eculizumab|mesh-list
93363222|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93363223|NCT04434092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363224|NCT04434092|Immunologic Factors|immunologic factors|mesh-ancestor
93363225|NCT04434092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363226|NCT04432584|Eculizumab|eculizumab|mesh-list
93363227|NCT04432584|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93363228|NCT04432584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363229|NCT04432584|Immunologic Factors|immunologic factors|mesh-ancestor
93363230|NCT04432584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363231|NCT04416633|Durvalumab|durvalumab|mesh-list
93363232|NCT04416633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363233|NCT04416633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363234|NCT04396873|11C-PS13|11c-ps13|mesh-list
93363235|NCT04396873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93363236|NCT04396873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363237|NCT04388774|Ketamine|ketamine|mesh-list
93363238|NCT04388774|Analgesics|analgesics|mesh-ancestor
93363239|NCT04388774|Sensory System Agents|sensory system agents|mesh-ancestor
93363240|NCT04388774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363241|NCT04388774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363242|NCT04388774|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93363243|NCT04388774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93363244|NCT04388774|Anesthetics, General|anesthetics, general|mesh-ancestor
93363245|NCT04388774|Anesthetics|anesthetics|mesh-ancestor
93363246|NCT04388774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93363247|NCT04388774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93363248|NCT04388774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93363249|NCT04388774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93363250|NCT04388774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363251|NCT04305054|Pembrolizumab|pembrolizumab|mesh-list
93363252|NCT04305054|Lenvatinib|lenvatinib|mesh-list
93363253|NCT04305054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363254|NCT04305054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363255|NCT04305054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363256|NCT04305054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363257|NCT04305054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363258|NCT04305054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363259|NCT04305041|Pembrolizumab|pembrolizumab|mesh-list
93363260|NCT04305041|Lenvatinib|lenvatinib|mesh-list
93363261|NCT04305041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363262|NCT04305041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363263|NCT04305041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363264|NCT04305041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363265|NCT04305041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363266|NCT04305041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363267|NCT04303169|Pembrolizumab|pembrolizumab|mesh-list
93363268|NCT04303169|Tretinoin|tretinoin|mesh-list
93363269|NCT04303169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363270|NCT04303169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363271|NCT04303169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363272|NCT04303169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363273|NCT04303169|Keratolytic Agents|keratolytic agents|mesh-ancestor
93363274|NCT04303169|Dermatologic Agents|dermatologic agents|mesh-ancestor
93363275|NCT04274426|Paclitaxel|paclitaxel|mesh-list
93363276|NCT04274426|Maytansine|maytansine|mesh-list
93363277|NCT04274426|Carboplatin|carboplatin|mesh-list
93363278|NCT04274426|Gemcitabine|gemcitabine|mesh-list
93363279|NCT04274426|Doxorubicin|doxorubicin|mesh-list
93363280|NCT04274426|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93363281|NCT04274426|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
93363282|NCT04274426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363283|NCT04274426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363284|NCT04274426|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363285|NCT04274426|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363286|NCT04274426|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363287|NCT04274426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363288|NCT04274426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363289|NCT04274426|Antimetabolites|antimetabolites|mesh-ancestor
93363290|NCT04274426|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93363291|NCT04274426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93363292|NCT04274426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363293|NCT04274426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363294|NCT04274426|Immunoconjugates|immunoconjugates|mesh-ancestor
93363295|NCT04274426|Immunologic Factors|immunologic factors|mesh-ancestor
93363296|NCT04274426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363297|NCT04267614|Etanercept|etanercept|mesh-list
93363298|NCT04267614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93363299|NCT04267614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93363300|NCT04267614|Analgesics|analgesics|mesh-ancestor
93363301|NCT04267614|Sensory System Agents|sensory system agents|mesh-ancestor
93363302|NCT04267614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363303|NCT04267614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363304|NCT04267614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363305|NCT04267614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363306|NCT04267614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363307|NCT04267614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363308|NCT04267614|Immunologic Factors|immunologic factors|mesh-ancestor
93363309|NCT04185883|Docetaxel|docetaxel|mesh-list
93363310|NCT04185883|Bevacizumab|bevacizumab|mesh-list
93363311|NCT04185883|Carboplatin|carboplatin|mesh-list
93363312|NCT04185883|Pembrolizumab|pembrolizumab|mesh-list
93363313|NCT04185883|Pemetrexed|pemetrexed|mesh-list
93363314|NCT04185883|Everolimus|everolimus|mesh-list
93035161|NCT00463346|Acamprosate|acamprosate|mesh-list
93363315|NCT04185883|Atezolizumab|atezolizumab|mesh-list
93363316|NCT04185883|Palbociclib|palbociclib|mesh-list
93363317|NCT04185883|Panitumumab|panitumumab|mesh-list
93363318|NCT04185883|Trametinib|trametinib|mesh-list
93363319|NCT04185883|Afatinib|afatinib|mesh-list
93363320|NCT04185883|Sotorasib|sotorasib|mesh-list
93363321|NCT04185883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363322|NCT04185883|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363323|NCT04185883|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363324|NCT04185883|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363325|NCT04185883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363326|NCT04185883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363327|NCT04185883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93363328|NCT04185883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93363329|NCT04185883|Growth Substances|growth substances|mesh-ancestor
93363330|NCT04185883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363331|NCT04185883|Growth Inhibitors|growth inhibitors|mesh-ancestor
93363332|NCT04185883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363333|NCT04185883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363334|NCT04185883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93363335|NCT04185883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93363336|NCT04185883|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93363337|NCT04185883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363338|NCT04185883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363339|NCT04185883|Immunologic Factors|immunologic factors|mesh-ancestor
93363340|NCT04175431|Prednisone|prednisone|mesh-list
93363341|NCT04175431|Abiraterone Acetate|abiraterone acetate|mesh-list
93363342|NCT04175431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363343|NCT04175431|Glucocorticoids|glucocorticoids|mesh-ancestor
93363344|NCT04175431|Hormones|hormones|mesh-ancestor
93363345|NCT04175431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363346|NCT04175431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363347|NCT04175431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363348|NCT04175431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363349|NCT04175431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93363350|NCT04175431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363351|NCT04175431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363352|NCT04175431|Hormone Antagonists|hormone antagonists|mesh-ancestor
93363353|NCT04175431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93363354|NCT04170309|Ceftobiprole|ceftobiprole|mesh-list
93363355|NCT04170309|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93363356|NCT04170309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363357|NCT04170309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363358|NCT04164212|Vaccines|vaccines|mesh-list
93363359|NCT04164212|Immunologic Factors|immunologic factors|mesh-ancestor
93363360|NCT04164212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363361|NCT04113018|Dexamethasone|dexamethasone|mesh-list
93363362|NCT04113018|Lenalidomide|lenalidomide|mesh-list
93363363|NCT04113018|Daratumumab|daratumumab|mesh-list
93363364|NCT04113018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363365|NCT04113018|Antiemetics|antiemetics|mesh-ancestor
93363366|NCT04113018|Autonomic Agents|autonomic agents|mesh-ancestor
93363367|NCT04113018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363368|NCT04113018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363369|NCT04113018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363370|NCT04113018|Glucocorticoids|glucocorticoids|mesh-ancestor
93363371|NCT04113018|Hormones|hormones|mesh-ancestor
93363372|NCT04113018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363373|NCT04113018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363374|NCT04113018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363375|NCT04113018|Immunologic Factors|immunologic factors|mesh-ancestor
93363376|NCT04113018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93363377|NCT04113018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93363378|NCT04113018|Growth Substances|growth substances|mesh-ancestor
93363379|NCT04113018|Growth Inhibitors|growth inhibitors|mesh-ancestor
93363380|NCT04112199|Terlipressin|terlipressin|mesh-list
93363381|NCT04112199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93363382|NCT04112199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93363383|NCT04109066|Paclitaxel|paclitaxel|mesh-list
93363384|NCT04109066|Cyclophosphamide|cyclophosphamide|mesh-list
93363385|NCT04109066|Nivolumab|nivolumab|mesh-list
93363386|NCT04109066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363387|NCT04109066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363388|NCT04109066|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363389|NCT04109066|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363390|NCT04109066|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363391|NCT04109066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363392|NCT04109066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363393|NCT04109066|Immunologic Factors|immunologic factors|mesh-ancestor
93363394|NCT04109066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363395|NCT04109066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363396|NCT04109066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363397|NCT04109066|Alkylating Agents|alkylating agents|mesh-ancestor
93363398|NCT04109066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363399|NCT04109066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363400|NCT04109066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363401|NCT04102020|Azacitidine|azacitidine|mesh-list
93363402|NCT04102020|Venetoclax|venetoclax|mesh-list
93363403|NCT04102020|Cc-486|cc-486|mesh-list
93363404|NCT04102020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363405|NCT04102020|Antimetabolites|antimetabolites|mesh-ancestor
93363406|NCT04102020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363407|NCT04102020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363408|NCT04102020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363409|NCT04089904|Pembrolizumab|pembrolizumab|mesh-list
93363410|NCT04089904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363411|NCT04089904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363412|NCT04089904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363413|NCT04089904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363414|NCT04068831|Avelumab|avelumab|mesh-list
93363415|NCT04068831|Talazoparib|talazoparib|mesh-list
93363416|NCT04068831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363417|NCT04068831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363418|NCT04068831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93363419|NCT04068831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363420|NCT04068831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363421|NCT04055428|Valsartan|valsartan|mesh-list
93363422|NCT04055428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93363423|NCT04055428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93363424|NCT04055428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93363425|NCT04055428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93363426|NCT04055428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363427|NCT04038255|Nicotine|nicotine|mesh-list
93363428|NCT04038255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93363429|NCT04038255|Autonomic Agents|autonomic agents|mesh-ancestor
93363430|NCT04038255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363431|NCT04038255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363432|NCT04038255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93363433|NCT04038255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93363434|NCT04038255|Cholinergic Agents|cholinergic agents|mesh-ancestor
93363435|NCT04038255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93363436|NCT04038255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363437|NCT03998488|Psyllium|psyllium|mesh-list
93363438|NCT03998488|Calcium polycarbophil|calcium polycarbophil|mesh-list
93363439|NCT03998488|Cathartics|cathartics|mesh-ancestor
93363440|NCT03998488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363441|NCT03998488|Antidiarrheals|antidiarrheals|mesh-ancestor
93363442|NCT03994601|Nivolumab|nivolumab|mesh-list
93363443|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363444|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363445|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363446|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363447|NCT03990961|Pembrolizumab|pembrolizumab|mesh-list
93363448|NCT03990961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363449|NCT03990961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363450|NCT03990961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363451|NCT03990961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363452|NCT03986034|Venetoclax|venetoclax|mesh-list
93363453|NCT03986034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363454|NCT03963960|Dialysis Solutions|dialysis solutions|mesh-list
93363455|NCT03963960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93363456|NCT03923374|Buprenorphine|buprenorphine|mesh-list
93363457|NCT03923374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93363458|NCT03923374|Narcotics|narcotics|mesh-ancestor
93363459|NCT03923374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93363460|NCT03923374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363461|NCT03923374|Analgesics|analgesics|mesh-ancestor
93363462|NCT03923374|Sensory System Agents|sensory system agents|mesh-ancestor
93363463|NCT03923374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363464|NCT03923374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93363465|NCT03912428|Celecoxib|celecoxib|mesh-list
93363466|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93363467|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93363469|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
93363470|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363471|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363472|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363473|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363474|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93363475|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93363476|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363477|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363478|NCT03911973|Talazoparib|talazoparib|mesh-list
93363479|NCT03911973|Gedatolisib|gedatolisib|mesh-list
93363480|NCT03911973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93363481|NCT03911973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363482|NCT03911973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363483|NCT03911973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363484|NCT03911973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363485|NCT03910972|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93363486|NCT03910972|Vaccines|vaccines|mesh-list
93363487|NCT03910972|Immunologic Factors|immunologic factors|mesh-ancestor
93363488|NCT03910972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363489|NCT03910972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93363490|NCT03910972|Antacids|antacids|mesh-ancestor
93363491|NCT03910972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363492|NCT03910972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363493|NCT03861702|Irinotecan|irinotecan|mesh-list
93363494|NCT03861702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93363495|NCT03861702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363496|NCT03861702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363497|NCT03861702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363498|NCT03861702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363499|NCT03845517|PF-06700841|pf-06700841|mesh-list
93363500|NCT03845517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363501|NCT03845517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363502|NCT03845517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363503|NCT03829462|Irinotecan|irinotecan|mesh-list
93363504|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93363505|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363506|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363507|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363508|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363509|NCT03781128|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93363510|NCT03781128|Hallucinogens|hallucinogens|mesh-ancestor
93363511|NCT03781128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363512|NCT03781128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93363513|NCT03781128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93363514|NCT03781128|Serotonin Agents|serotonin agents|mesh-ancestor
93363515|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657164|NCT02219893|Immunologic Factors|immunologic factors|mesh-ancestor
93363516|NCT03781128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363517|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93363518|NCT03774641|Lamotrigine|lamotrigine|mesh-list
93363519|NCT03774641|Anticonvulsants|anticonvulsants|mesh-ancestor
93363520|NCT03774641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93363521|NCT03774641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93363522|NCT03774641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363523|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93363524|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363525|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93363526|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93363527|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93363528|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93363529|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93363530|NCT03747939|Thalidomide|thalidomide|mesh-list
93363531|NCT03747939|Apremilast|apremilast|mesh-list
93363532|NCT03747939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93363533|NCT03747939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93363534|NCT03747939|Analgesics|analgesics|mesh-ancestor
93363535|NCT03747939|Sensory System Agents|sensory system agents|mesh-ancestor
93363536|NCT03747939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363537|NCT03747939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363538|NCT03747939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363539|NCT03747939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363540|NCT03747939|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93363541|NCT03747939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93363542|NCT03747939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363543|NCT03747939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363544|NCT03747939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363545|NCT03747939|Immunologic Factors|immunologic factors|mesh-ancestor
93363546|NCT03747939|Leprostatic Agents|leprostatic agents|mesh-ancestor
93363547|NCT03747939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363548|NCT03747939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363549|NCT03747939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93363550|NCT03747939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93363551|NCT03747939|Growth Substances|growth substances|mesh-ancestor
93363552|NCT03747939|Growth Inhibitors|growth inhibitors|mesh-ancestor
93363553|NCT03747939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363554|NCT03739931|Durvalumab|durvalumab|mesh-list
93363555|NCT03739931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363556|NCT03739931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363557|NCT03716349|Anesthetics|anesthetics|mesh-list
93363558|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
93363559|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93363560|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363561|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
93363562|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363563|NCT03682536|Epoetin Alfa|epoetin alfa|mesh-list
93363564|NCT03682536|Luspatercept|luspatercept|mesh-list
93363565|NCT03682536|Hematinics|hematinics|mesh-ancestor
93363566|NCT03653338|Rituximab|rituximab|mesh-list
93363567|NCT03653338|Alemtuzumab|alemtuzumab|mesh-list
93363568|NCT03653338|Fludarabine|fludarabine|mesh-list
93363569|NCT03653338|Thiotepa|thiotepa|mesh-list
93363570|NCT03653338|Hydroxyurea|hydroxyurea|mesh-list
93363571|NCT03653338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363572|NCT03653338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363573|NCT03653338|Immunologic Factors|immunologic factors|mesh-ancestor
93363574|NCT03653338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363575|NCT03653338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363576|NCT03653338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363577|NCT03653338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363578|NCT03653338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363579|NCT03653338|Alkylating Agents|alkylating agents|mesh-ancestor
93363580|NCT03653338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363581|NCT03653338|Antisickling Agents|antisickling agents|mesh-ancestor
93363582|NCT03653338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363583|NCT03653338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93363584|NCT03610724|Tisagenlecleucel|tisagenlecleucel|mesh-list
93363585|NCT03610724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363586|NCT03610724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363587|NCT03576755|Spironolactone|spironolactone|mesh-list
93363588|NCT03576755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93363589|NCT03576755|Hormone Antagonists|hormone antagonists|mesh-ancestor
93363590|NCT03576755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363591|NCT03576755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363592|NCT03576755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93363593|NCT03576755|Diuretics|diuretics|mesh-ancestor
93363594|NCT03576755|Natriuretic Agents|natriuretic agents|mesh-ancestor
93363595|NCT03572049|Itraconazole|itraconazole|mesh-list
93363596|NCT03572049|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93363597|NCT03572049|Antifungal Agents|antifungal agents|mesh-ancestor
93363598|NCT03572049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363599|NCT03572049|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93363600|NCT03572049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93363601|NCT03572049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363602|NCT03572049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363603|NCT03572049|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93363604|NCT03572049|Hormone Antagonists|hormone antagonists|mesh-ancestor
93363605|NCT03572049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363606|NCT03572049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363607|NCT03572049|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93363608|NCT03556332|Dexamethasone|dexamethasone|mesh-list
93363609|NCT03556332|Lenalidomide|lenalidomide|mesh-list
93363610|NCT03556332|Daratumumab|daratumumab|mesh-list
93363611|NCT03556332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93363612|NCT03556332|Antiemetics|antiemetics|mesh-ancestor
93035461|NCT00433836|Protease Inhibitors|protease inhibitors|mesh-ancestor
93363613|NCT03556332|Autonomic Agents|autonomic agents|mesh-ancestor
93363614|NCT03556332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93363615|NCT03556332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363616|NCT03556332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363618|NCT03556332|Hormones|hormones|mesh-ancestor
93363619|NCT03556332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363620|NCT03556332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363621|NCT03556332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363622|NCT03556332|Immunologic Factors|immunologic factors|mesh-ancestor
93363623|NCT03556332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93363624|NCT03556332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93363625|NCT03556332|Growth Substances|growth substances|mesh-ancestor
93363626|NCT03556332|Growth Inhibitors|growth inhibitors|mesh-ancestor
93363627|NCT03555877|Letrozole|letrozole|mesh-list
93363628|NCT03555877|Fulvestrant|fulvestrant|mesh-list
93363629|NCT03555877|Anastrozole|anastrozole|mesh-list
93363630|NCT03555877|Exemestane|exemestane|mesh-list
93363631|NCT03555877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363632|NCT03555877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93363633|NCT03555877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93363634|NCT03555877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363635|NCT03555877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363636|NCT03555877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93363637|NCT03555877|Hormone Antagonists|hormone antagonists|mesh-ancestor
93363638|NCT03555877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363639|NCT03555877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363640|NCT03555877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363641|NCT03555877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93363642|NCT03481972|Doxycycline|doxycycline|mesh-list
93363643|NCT03481972|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
93363644|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363645|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363646|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
93363647|NCT03481972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93363648|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93363649|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
93363650|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93363651|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93363652|NCT03472560|Avelumab|avelumab|mesh-list
93363653|NCT03472560|Axitinib|axitinib|mesh-list
93363654|NCT03472560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363655|NCT03472560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363656|NCT03472560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363657|NCT03472560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657308|NCT00242411|Formoterol Fumarate|formoterol fumarate|mesh-list
93363658|NCT03472560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363659|NCT03397004|Doxycycline|doxycycline|mesh-list
93363660|NCT03397004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363661|NCT03397004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363662|NCT03397004|Antimalarials|antimalarials|mesh-ancestor
93363663|NCT03397004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93363664|NCT03397004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93363665|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93363666|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
93363667|NCT03389412|Coagulants|coagulants|mesh-ancestor
93363668|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93363669|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
93363670|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363671|NCT03340675|Ifetroban|ifetroban|mesh-list
93363672|NCT03340675|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93363673|NCT03336216|Leucovorin|leucovorin|mesh-list
93363674|NCT03336216|Paclitaxel|paclitaxel|mesh-list
93363675|NCT03336216|Gemcitabine|gemcitabine|mesh-list
93363676|NCT03336216|Fluorouracil|fluorouracil|mesh-list
93363677|NCT03336216|Oxaliplatin|oxaliplatin|mesh-list
93363678|NCT03336216|Nivolumab|nivolumab|mesh-list
93363679|NCT03336216|Irinotecan|irinotecan|mesh-list
93363680|NCT03336216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363681|NCT03336216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363682|NCT03336216|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363683|NCT03336216|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363684|NCT03336216|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363685|NCT03336216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363686|NCT03336216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363687|NCT03336216|Antimetabolites|antimetabolites|mesh-ancestor
93363688|NCT03336216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363689|NCT03336216|Immunologic Factors|immunologic factors|mesh-ancestor
93363690|NCT03336216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363691|NCT03336216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363693|NCT03336216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93363694|NCT03336216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363695|NCT03336216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363696|NCT03336216|Antidotes|antidotes|mesh-ancestor
93363697|NCT03336216|Protective Agents|protective agents|mesh-ancestor
93363698|NCT03336216|Vitamin B Complex|vitamin b complex|mesh-ancestor
93363699|NCT03336216|Vitamins|vitamins|mesh-ancestor
93363700|NCT03336216|Micronutrients|micronutrients|mesh-ancestor
93363701|NCT03319940|Pembrolizumab|pembrolizumab|mesh-list
93363702|NCT03319940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363703|NCT03319940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363704|NCT03319940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363705|NCT03319940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363706|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93363707|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93363708|NCT03283878|Cefazolin|cefazolin|mesh-list
93363709|NCT03283878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363710|NCT03283878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363711|NCT03269994|Tazobactam|tazobactam|mesh-list
93363712|NCT03269994|Piperacillin|piperacillin|mesh-list
93363713|NCT03269994|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93363714|NCT03269994|Cefoxitin|cefoxitin|mesh-list
93363715|NCT03269994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363716|NCT03269994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363717|NCT03269994|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93363718|NCT03269994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363719|NCT03269994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363720|NCT03165734|Hydroxyurea|hydroxyurea|mesh-list
93363721|NCT03165734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363722|NCT03165734|Antisickling Agents|antisickling agents|mesh-ancestor
93363723|NCT03165734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363724|NCT03165734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363725|NCT03165734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93363726|NCT03148327|Durvalumab|durvalumab|mesh-list
93363727|NCT03148327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363728|NCT03148327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363729|NCT03065387|Everolimus|everolimus|mesh-list
93363730|NCT03065387|Palbociclib|palbociclib|mesh-list
93363731|NCT03065387|Trametinib|trametinib|mesh-list
93363732|NCT03065387|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93363733|NCT03065387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363734|NCT03065387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363735|NCT03065387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363736|NCT03065387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363737|NCT03065387|Immunologic Factors|immunologic factors|mesh-ancestor
93363738|NCT03065387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363739|NCT03065387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363740|NCT03063606|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
93363741|NCT03063606|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93363742|NCT03062358|Pembrolizumab|pembrolizumab|mesh-list
93363743|NCT03062358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363744|NCT03062358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363745|NCT03062358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363746|NCT03062358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363747|NCT02903537|Vitamin D|vitamin d|mesh-list
93363748|NCT02903537|Cholecalciferol|cholecalciferol|mesh-list
93363749|NCT02903537|Interferons|interferons|mesh-list
93363750|NCT02903537|Interferon-beta|interferon-beta|mesh-list
93363751|NCT02903537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363752|NCT02903537|Antiviral Agents|antiviral agents|mesh-ancestor
93363753|NCT02903537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363754|NCT02903537|Immunologic Factors|immunologic factors|mesh-ancestor
93363755|NCT02903537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363756|NCT02903537|Vitamins|vitamins|mesh-ancestor
93363757|NCT02903537|Micronutrients|micronutrients|mesh-ancestor
93363758|NCT02903537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93363759|NCT02903537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93363760|NCT02706873|Methotrexate|methotrexate|mesh-list
93363761|NCT02706873|Upadacitinib|upadacitinib|mesh-list
93363762|NCT02706873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93363763|NCT02706873|Abortifacient Agents|abortifacient agents|mesh-ancestor
93363764|NCT02706873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93363765|NCT02706873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363766|NCT02706873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363768|NCT02706873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363769|NCT02706873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363770|NCT02706873|Dermatologic Agents|dermatologic agents|mesh-ancestor
93363771|NCT02706873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363772|NCT02706873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93363773|NCT02706873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363774|NCT02706873|Immunologic Factors|immunologic factors|mesh-ancestor
93363775|NCT02706873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363776|NCT02706873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93363777|NCT02706873|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93363778|NCT02706873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363779|NCT02677038|Olaparib|olaparib|mesh-list
93363780|NCT02677038|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93363781|NCT02677038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363782|NCT02677038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363783|NCT02677038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363784|NCT02668666|Tamoxifen|tamoxifen|mesh-list
93363785|NCT02668666|Palbociclib|palbociclib|mesh-list
93363786|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93363787|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
93363788|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363789|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363790|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363791|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363792|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93363793|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93363794|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93363795|NCT02668666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363796|NCT02668666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363797|NCT02668666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363798|NCT02625961|Pembrolizumab|pembrolizumab|mesh-list
93363799|NCT02625961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363800|NCT02625961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363801|NCT02625961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93363802|NCT02625961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363803|NCT02584634|Avelumab|avelumab|mesh-list
93363804|NCT02584634|Crizotinib|crizotinib|mesh-list
93363805|NCT02584634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363806|NCT02584634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363807|NCT02584634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363808|NCT02584634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363809|NCT02584634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363810|NCT02570542|Cytarabine|cytarabine|mesh-list
93363811|NCT02570542|Plerixafor|plerixafor|mesh-list
93363812|NCT02570542|Etoposide|etoposide|mesh-list
93363813|NCT02570542|Melphalan|melphalan|mesh-list
93363814|NCT02570542|Carmustine|carmustine|mesh-list
93363815|NCT02570542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363816|NCT02570542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363817|NCT02570542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93363818|NCT02570542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363819|NCT02570542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363820|NCT02570542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363821|NCT02570542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363822|NCT02570542|Antimetabolites|antimetabolites|mesh-ancestor
93363823|NCT02570542|Antiviral Agents|antiviral agents|mesh-ancestor
93363824|NCT02570542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363825|NCT02570542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363826|NCT02570542|Immunologic Factors|immunologic factors|mesh-ancestor
93363827|NCT02570542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363828|NCT02570542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363829|NCT02570542|Alkylating Agents|alkylating agents|mesh-ancestor
93363830|NCT02570542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363831|NCT02570542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93363832|NCT02570542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93363833|NCT02513563|Paclitaxel|paclitaxel|mesh-list
93363834|NCT02513563|Carboplatin|carboplatin|mesh-list
93363835|NCT02513563|Adavosertib|adavosertib|mesh-list
93363836|NCT02513563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363837|NCT02513563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363838|NCT02513563|Tubulin Modulators|tubulin modulators|mesh-ancestor
93035682|NCT01064115|Cetirizine|cetirizine|mesh-list
93363839|NCT02513563|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363840|NCT02513563|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363841|NCT02513563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363842|NCT02513563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363843|NCT02386826|Bevacizumab|bevacizumab|mesh-list
93363844|NCT02386826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363845|NCT02386826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363846|NCT02386826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93363847|NCT02386826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93363848|NCT02386826|Growth Substances|growth substances|mesh-ancestor
93363849|NCT02386826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363850|NCT02386826|Growth Inhibitors|growth inhibitors|mesh-ancestor
93363851|NCT02365441|Imatinib Mesylate|imatinib mesylate|mesh-list
93363852|NCT02365441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363853|NCT02365441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363854|NCT02365441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363855|NCT02365441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363856|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
93363857|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93363858|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
93363859|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363860|NCT02124941|Expectorants|expectorants|mesh-ancestor
93363861|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
93363862|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93363863|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
93363864|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363865|NCT02124941|Protective Agents|protective agents|mesh-ancestor
93363866|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363867|NCT02124941|Antidotes|antidotes|mesh-ancestor
93363868|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
93363869|NCT02114229|Carboplatin|carboplatin|mesh-list
93363870|NCT02114229|Methotrexate|methotrexate|mesh-list
93363871|NCT02114229|Etoposide|etoposide|mesh-list
93363872|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
93363873|NCT02114229|Vincristine|vincristine|mesh-list
93363874|NCT02114229|Topotecan|topotecan|mesh-list
93363875|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363876|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
93363877|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363878|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363879|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363880|NCT02114229|Alkylating Agents|alkylating agents|mesh-ancestor
93363881|NCT02114229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363882|NCT02114229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363883|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363884|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93363885|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
93363886|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93363887|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93363888|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
93363889|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
93363890|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363891|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93363892|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93363893|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363894|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93363895|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363896|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363897|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363898|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363899|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93363900|NCT02091960|Trastuzumab|trastuzumab|mesh-list
93363901|NCT02091960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363902|NCT02091960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363903|NCT02000622|Olaparib|olaparib|mesh-list
93363904|NCT02000622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93363905|NCT02000622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363906|NCT02000622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363907|NCT02000622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363908|NCT01871766|Dactinomycin|dactinomycin|mesh-list
93363909|NCT01871766|Cyclophosphamide|cyclophosphamide|mesh-list
93363910|NCT01871766|Ifosfamide|ifosfamide|mesh-list
93363911|NCT01871766|Bevacizumab|bevacizumab|mesh-list
93363912|NCT01871766|Doxorubicin|doxorubicin|mesh-list
93363913|NCT01871766|Irinotecan|irinotecan|mesh-list
93035755|NCT01038648|Protease Inhibitors|protease inhibitors|mesh-ancestor
93363914|NCT01871766|Etoposide|etoposide|mesh-list
93363915|NCT01871766|Etoposide phosphate|etoposide phosphate|mesh-list
93363916|NCT01871766|Vincristine|vincristine|mesh-list
93363917|NCT01871766|Sorafenib|sorafenib|mesh-list
93363918|NCT01871766|Dexrazoxane|dexrazoxane|mesh-list
93363919|NCT01871766|Razoxane|razoxane|mesh-list
93363920|NCT01871766|Mitogens|mitogens|mesh-list
93363921|NCT01871766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93363922|NCT01871766|Immunologic Factors|immunologic factors|mesh-ancestor
93363923|NCT01871766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363924|NCT01871766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93363925|NCT01871766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363926|NCT01871766|Alkylating Agents|alkylating agents|mesh-ancestor
93363927|NCT01871766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363928|NCT01871766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363929|NCT01871766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93363930|NCT01871766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363931|NCT01871766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93363932|NCT01871766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93363933|NCT01871766|Growth Substances|growth substances|mesh-ancestor
93363934|NCT01871766|Growth Inhibitors|growth inhibitors|mesh-ancestor
93363935|NCT01871766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93363936|NCT01871766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93363937|NCT01871766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363938|NCT01871766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363939|NCT01871766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93363940|NCT01871766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363941|NCT01871766|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363942|NCT01871766|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363943|NCT01871766|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363944|NCT01871766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93363945|NCT01871766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93363946|NCT01871766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363947|NCT01871766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93363948|NCT01871766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93363949|NCT01871766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93363950|NCT01871766|Protective Agents|protective agents|mesh-ancestor
93363951|NCT01868451|Doxorubicin|doxorubicin|mesh-list
93363952|NCT01868451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93363953|NCT01868451|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93363954|NCT01868451|Dacarbazine|dacarbazine|mesh-list
93363955|NCT01868451|Vinblastine|vinblastine|mesh-list
93363956|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93363957|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363958|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93363959|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93363960|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93363961|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363962|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93363963|NCT01868451|Immunotoxins|immunotoxins|mesh-ancestor
93363964|NCT01868451|Immunoconjugates|immunoconjugates|mesh-ancestor
93363965|NCT01868451|Immunologic Factors|immunologic factors|mesh-ancestor
93363966|NCT01868451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363967|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93363968|NCT01868451|Alkylating Agents|alkylating agents|mesh-ancestor
93363969|NCT01868451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93363970|NCT01868451|Tubulin Modulators|tubulin modulators|mesh-ancestor
93363971|NCT01868451|Antimitotic Agents|antimitotic agents|mesh-ancestor
93363972|NCT01868451|Mitosis Modulators|mitosis modulators|mesh-ancestor
93363973|NCT01767675|Carboplatin|carboplatin|mesh-list
93363974|NCT01767675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363975|NCT01597388|Fulvestrant|fulvestrant|mesh-list
93363976|NCT01597388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93363977|NCT01597388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363978|NCT01597388|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93363979|NCT01597388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93363980|NCT01597388|Hormone Antagonists|hormone antagonists|mesh-ancestor
93363981|NCT01597388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93363982|NCT01597388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363983|NCT01275729|Furosemide|furosemide|mesh-list
93363984|NCT01275729|Diuretics|diuretics|mesh-ancestor
93363985|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
93363986|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363987|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93363988|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93363989|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93363990|NCT01125228|Interferons|interferons|mesh-list
93363991|NCT01125228|Interferon-alpha|interferon-alpha|mesh-list
93363992|NCT01125228|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93363993|NCT01125228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93363994|NCT01125228|Antiviral Agents|antiviral agents|mesh-ancestor
93363995|NCT01125228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93363996|NCT01125228|Immunologic Factors|immunologic factors|mesh-ancestor
93363997|NCT01125228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93363998|NCT01107626|Paclitaxel|paclitaxel|mesh-list
93363999|NCT01107626|Bevacizumab|bevacizumab|mesh-list
93364000|NCT01107626|Carboplatin|carboplatin|mesh-list
93364001|NCT01107626|Pemetrexed|pemetrexed|mesh-list
93364002|NCT01107626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93364003|NCT01107626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364004|NCT01107626|Tubulin Modulators|tubulin modulators|mesh-ancestor
93364005|NCT01107626|Antimitotic Agents|antimitotic agents|mesh-ancestor
93364006|NCT01107626|Mitosis Modulators|mitosis modulators|mesh-ancestor
93364007|NCT01107626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364008|NCT01107626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364009|NCT01107626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93364010|NCT01107626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93364011|NCT01107626|Growth Substances|growth substances|mesh-ancestor
93364012|NCT01107626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364013|NCT01107626|Growth Inhibitors|growth inhibitors|mesh-ancestor
93364014|NCT01107626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364015|NCT01107626|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93364016|NCT01107626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93364017|NCT01082224|Motexafin gadolinium|motexafin gadolinium|mesh-list
93364018|NCT01082224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364019|NCT01082224|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93364020|NCT01082224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364021|NCT00828009|Paclitaxel|paclitaxel|mesh-list
93364022|NCT00828009|Cyclophosphamide|cyclophosphamide|mesh-list
93364023|NCT00828009|Bevacizumab|bevacizumab|mesh-list
93364024|NCT00828009|Carboplatin|carboplatin|mesh-list
93364025|NCT00828009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93364026|NCT00828009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364027|NCT00828009|Tubulin Modulators|tubulin modulators|mesh-ancestor
93364028|NCT00828009|Antimitotic Agents|antimitotic agents|mesh-ancestor
93364029|NCT00828009|Mitosis Modulators|mitosis modulators|mesh-ancestor
93364030|NCT00828009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364031|NCT00828009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364032|NCT00828009|Immunologic Factors|immunologic factors|mesh-ancestor
93364033|NCT00828009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364034|NCT00828009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364035|NCT00828009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93364036|NCT00828009|Alkylating Agents|alkylating agents|mesh-ancestor
93364037|NCT00828009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93364038|NCT00828009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364039|NCT00828009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93364040|NCT00828009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93364041|NCT00828009|Growth Substances|growth substances|mesh-ancestor
93364042|NCT00828009|Growth Inhibitors|growth inhibitors|mesh-ancestor
93364043|NCT00578721|Aspirin|aspirin|mesh-list
93364044|NCT00578721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93364045|NCT00578721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93364046|NCT00578721|Analgesics|analgesics|mesh-ancestor
93364047|NCT00578721|Sensory System Agents|sensory system agents|mesh-ancestor
93364048|NCT00578721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364049|NCT00578721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364050|NCT00578721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93364051|NCT00578721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364052|NCT00578721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93364053|NCT00578721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93364054|NCT00578721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364055|NCT00578721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93364056|NCT00578721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93364057|NCT00578721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364058|NCT00578721|Antipyretics|antipyretics|mesh-ancestor
93364059|NCT00539591|Interferons|interferons|mesh-list
93364060|NCT00539591|Interferon-alpha|interferon-alpha|mesh-list
93364061|NCT00539591|Interferon alpha-2|interferon alpha-2|mesh-list
93364062|NCT00539591|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93364063|NCT00539591|Temozolomide|temozolomide|mesh-list
93364064|NCT00539591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035901|NCT00443456|Vasodilator Agents|vasodilator agents|mesh-ancestor
93364065|NCT00539591|Antiviral Agents|antiviral agents|mesh-ancestor
93364066|NCT00539591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364067|NCT00539591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93364068|NCT00539591|Alkylating Agents|alkylating agents|mesh-ancestor
93364069|NCT00539591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364070|NCT00539591|Immunologic Factors|immunologic factors|mesh-ancestor
93364071|NCT00539591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364072|NCT00357890|Insulin|insulin|mesh-list
93364073|NCT00357890|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93364074|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
93364075|NCT00357890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93364076|NCT00357890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364077|NCT00068393|Gemcitabine|gemcitabine|mesh-list
93364078|NCT00068393|Doxorubicin|doxorubicin|mesh-list
93364079|NCT00068393|Lenograstim|lenograstim|mesh-list
93364080|NCT00068393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364081|NCT00068393|Antimetabolites|antimetabolites|mesh-ancestor
93364082|NCT00068393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364083|NCT00068393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364084|NCT00068393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93364085|NCT00068393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93364086|NCT00068393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93364087|NCT00068393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364088|NCT00068393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93364089|NCT00068393|Immunologic Factors|immunologic factors|mesh-ancestor
93364090|NCT00068393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364091|NCT00062010|Interferons|interferons|mesh-list
93364092|NCT00062010|Interferon-alpha|interferon-alpha|mesh-list
93364093|NCT00062010|Interferon alpha-2|interferon alpha-2|mesh-list
93364094|NCT00062010|Paclitaxel|paclitaxel|mesh-list
93364095|NCT00062010|Tretinoin|tretinoin|mesh-list
93364096|NCT00062010|Isotretinoin|isotretinoin|mesh-list
93364097|NCT00062010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93364098|NCT00062010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657744|NCT00244517|Analgesics|analgesics|mesh-ancestor
93364099|NCT00062010|Tubulin Modulators|tubulin modulators|mesh-ancestor
93364100|NCT00062010|Antimitotic Agents|antimitotic agents|mesh-ancestor
93364101|NCT00062010|Mitosis Modulators|mitosis modulators|mesh-ancestor
93364102|NCT00062010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364103|NCT00062010|Antiviral Agents|antiviral agents|mesh-ancestor
93364104|NCT00062010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364105|NCT00062010|Immunologic Factors|immunologic factors|mesh-ancestor
93364106|NCT00062010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364107|NCT00062010|Keratolytic Agents|keratolytic agents|mesh-ancestor
93364108|NCT00062010|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364109|NCT00061568|Sirolimus|sirolimus|mesh-list
93364110|NCT00061568|Alemtuzumab|alemtuzumab|mesh-list
93364111|NCT00061568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93364112|NCT00061568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364113|NCT00061568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93364114|NCT00061568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364115|NCT00061568|Antifungal Agents|antifungal agents|mesh-ancestor
93364116|NCT00061568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364117|NCT00061568|Immunologic Factors|immunologic factors|mesh-ancestor
93364118|NCT00061568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364119|NCT00061568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364120|NCT00047008|Cisplatin|cisplatin|mesh-list
93364121|NCT00047008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364122|NCT03567941|Acetaminophen|acetaminophen|mesh-list
93364123|NCT03567941|Hydrocodone|hydrocodone|mesh-list
93364124|NCT03567941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93364125|NCT03567941|Analgesics|analgesics|mesh-ancestor
93364126|NCT03567941|Sensory System Agents|sensory system agents|mesh-ancestor
93364127|NCT03567941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364128|NCT03567941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364129|NCT03567941|Antipyretics|antipyretics|mesh-ancestor
93364130|NCT03567941|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93364131|NCT03567941|Narcotics|narcotics|mesh-ancestor
93364132|NCT03567941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364133|NCT03567941|Antitussive Agents|antitussive agents|mesh-ancestor
93364134|NCT03567941|Respiratory System Agents|respiratory system agents|mesh-ancestor
93364135|NCT02140489|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93364136|NCT02140489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93364137|NCT02140489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93364138|NCT02140489|Antimetabolites|antimetabolites|mesh-ancestor
93364139|NCT02140489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364140|NCT02140489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93035976|NCT00316173|Carboplatin|carboplatin|mesh-list
93364141|NCT02140489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93364142|NCT02140489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364143|NCT03566225|Metformin|metformin|mesh-list
93364144|NCT03566225|Pioglitazone|pioglitazone|mesh-list
93364145|NCT03566225|Clomiphene|clomiphene|mesh-list
93364146|NCT03566225|Enclomiphene|enclomiphene|mesh-list
93364147|NCT03566225|Zuclomiphene|zuclomiphene|mesh-list
93364148|NCT03566225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93364149|NCT03566225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364150|NCT03566225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93364151|NCT03566225|Hormone Antagonists|hormone antagonists|mesh-ancestor
93364152|NCT03566225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364153|NCT03566225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93364154|NCT03566225|Fertility Agents|fertility agents|mesh-ancestor
93364155|NCT03566225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364156|NCT03566225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93364157|NCT03566225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93364158|NCT02397694|Dolutegravir|dolutegravir|mesh-list
93364159|NCT02397694|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93364160|NCT02397694|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93364161|NCT02397694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364162|NCT02397694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364163|NCT02397694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93364164|NCT02397694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93364165|NCT02397694|Antiviral Agents|antiviral agents|mesh-ancestor
93364166|NCT02397694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364167|NCT03566069|Oxytocin|oxytocin|mesh-list
93364168|NCT03566069|Oxytocics|oxytocics|mesh-ancestor
93364169|NCT03566069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364170|NCT03566069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364171|NCT03567629|Calcium, Dietary|calcium, dietary|mesh-list
93364172|NCT03567629|Leucovorin|leucovorin|mesh-list
93364173|NCT03567629|Bevacizumab|bevacizumab|mesh-list
93364174|NCT03567629|Cetuximab|cetuximab|mesh-list
93364175|NCT03567629|Fluorouracil|fluorouracil|mesh-list
93364176|NCT03567629|Capecitabine|capecitabine|mesh-list
93364177|NCT03567629|Oxaliplatin|oxaliplatin|mesh-list
93364178|NCT03567629|Irinotecan|irinotecan|mesh-list
93364179|NCT03567629|Calcium|calcium|mesh-list
93364180|NCT03567629|Levoleucovorin|levoleucovorin|mesh-list
93364181|NCT03567629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364182|NCT03567629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364183|NCT03567629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93364184|NCT03567629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93364185|NCT03567629|Growth Substances|growth substances|mesh-ancestor
93364186|NCT03567629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364187|NCT03567629|Growth Inhibitors|growth inhibitors|mesh-ancestor
93364188|NCT03567629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93364189|NCT03567629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93364190|NCT03567629|Antimetabolites|antimetabolites|mesh-ancestor
93364191|NCT03567629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364192|NCT03567629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364193|NCT03567629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364194|NCT03567629|Immunologic Factors|immunologic factors|mesh-ancestor
93364195|NCT03567629|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93364196|NCT03567629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93364197|NCT03567629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364198|NCT03567629|Antidotes|antidotes|mesh-ancestor
93364199|NCT03567629|Protective Agents|protective agents|mesh-ancestor
93364200|NCT03567629|Vitamin B Complex|vitamin b complex|mesh-ancestor
93364201|NCT03567629|Vitamins|vitamins|mesh-ancestor
93364202|NCT03567629|Micronutrients|micronutrients|mesh-ancestor
93364203|NCT02783599|Doxorubicin|doxorubicin|mesh-list
93364204|NCT02783599|Olaratumab|olaratumab|mesh-list
93364205|NCT02783599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93364206|NCT02783599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364207|NCT02783599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93364208|NCT02783599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93364209|NCT02783599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364210|NCT02783599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364211|NCT03567395|Melatonin|melatonin|mesh-list
93364212|NCT03567395|Antioxidants|antioxidants|mesh-ancestor
93364213|NCT03567395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364214|NCT03567395|Protective Agents|protective agents|mesh-ancestor
93364215|NCT03567395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364216|NCT03567395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036052|NCT01026584|Serotonin Agents|serotonin agents|mesh-ancestor
93364217|NCT03565133|Quinine|quinine|mesh-list
93364218|NCT03565133|Antimalarials|antimalarials|mesh-ancestor
93364219|NCT03565133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93364221|NCT03565133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364222|NCT03565133|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93364223|NCT03565133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364224|NCT03565133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93364225|NCT03565133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364226|NCT03565133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93364227|NCT03565133|Analgesics|analgesics|mesh-ancestor
93364228|NCT03565133|Sensory System Agents|sensory system agents|mesh-ancestor
93364229|NCT05353673|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93364230|NCT05353673|Danazol|danazol|mesh-list
93364231|NCT05353673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93364232|NCT05353673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364233|NCT05353673|Incretins|incretins|mesh-ancestor
93364234|NCT05353673|Hormones|hormones|mesh-ancestor
93364235|NCT05353673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364236|NCT05353673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93364237|NCT05353673|Protease Inhibitors|protease inhibitors|mesh-ancestor
93364238|NCT05353673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364239|NCT05353673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364240|NCT05353673|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93364241|NCT05353673|Hormone Antagonists|hormone antagonists|mesh-ancestor
93364242|NCT05353205|Flumatinib|flumatinib|mesh-list
93364243|NCT05353205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93364244|NCT05353205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364245|NCT05353205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364246|NCT03564509|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92383183|NCT00564876|Dasatinib|dasatinib|mesh-list
93364247|NCT03564509|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93364248|NCT03564509|Hormones|hormones|mesh-ancestor
93364249|NCT03564509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364250|NCT03564509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364251|NCT03564509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364252|NCT03068234|Pirfenidone|pirfenidone|mesh-list
93364253|NCT03068234|Analgesics|analgesics|mesh-ancestor
93364254|NCT03068234|Sensory System Agents|sensory system agents|mesh-ancestor
93364255|NCT03068234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364256|NCT03068234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364257|NCT03068234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93364258|NCT03068234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93364259|NCT03068234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93364260|NCT03068234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364261|NCT03068234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364262|NCT05339399|Oxytocin|oxytocin|mesh-list
93364263|NCT05339399|Oxytocics|oxytocics|mesh-ancestor
93364264|NCT05339399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364265|NCT05339399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364266|NCT05634824|Immunoglobulins|immunoglobulins|mesh-list
93364267|NCT05634824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93364268|NCT05634824|Antibodies|antibodies|mesh-list
93364269|NCT05634824|gamma-Globulins|gamma-globulins|mesh-list
93364270|NCT05634824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93364271|NCT05634824|Immunologic Factors|immunologic factors|mesh-ancestor
93364272|NCT05634824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364273|NCT02454478|Everolimus|everolimus|mesh-list
93364274|NCT02454478|Lenvatinib|lenvatinib|mesh-list
93364275|NCT02454478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93364276|NCT02454478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93364277|NCT02454478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364278|NCT02454478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364279|NCT02454478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364280|NCT02454478|Immunologic Factors|immunologic factors|mesh-ancestor
93364281|NCT02454478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364282|NCT02454478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364283|NCT02359097|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93364284|NCT02359097|Hematinics|hematinics|mesh-ancestor
93364285|NCT02359097|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93364286|NCT02359097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93364287|NCT05284214|Ipilimumab|ipilimumab|mesh-list
93364288|NCT05284214|Sargramostim|sargramostim|mesh-list
93364289|NCT05284214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364290|NCT05284214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364291|NCT05284214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93364292|NCT05284214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364293|NCT05284214|Immunologic Factors|immunologic factors|mesh-ancestor
93036129|NCT01028924|Teduglutide|teduglutide|mesh-list
93364294|NCT05284214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364296|NCT03563963|Ropivacaine|ropivacaine|mesh-list
93364297|NCT03563963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93364298|NCT03563963|Anesthetics, Local|anesthetics, local|mesh-ancestor
93364299|NCT03563963|Anesthetics|anesthetics|mesh-ancestor
93364300|NCT03563963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364301|NCT03563963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364302|NCT03563963|Sensory System Agents|sensory system agents|mesh-ancestor
93364303|NCT03563963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364304|NCT03563963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93364305|NCT03563963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93364306|NCT03563963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93364307|NCT03563963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93364308|NCT03563963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364309|NCT03066518|Melatonin|melatonin|mesh-list
93364310|NCT03066518|Antioxidants|antioxidants|mesh-ancestor
93364311|NCT03066518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364312|NCT03066518|Protective Agents|protective agents|mesh-ancestor
93364313|NCT03066518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364314|NCT03066518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364315|NCT03069248|Interferons|interferons|mesh-list
93364316|NCT03069248|Interferon-alpha|interferon-alpha|mesh-list
93364317|NCT03069248|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93364318|NCT03069248|Rituximab|rituximab|mesh-list
93364319|NCT03069248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364320|NCT03069248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364321|NCT03069248|Immunologic Factors|immunologic factors|mesh-ancestor
93364322|NCT03069248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364323|NCT03069248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364324|NCT03069248|Antiviral Agents|antiviral agents|mesh-ancestor
93364325|NCT03069248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364326|NCT05730062|Oxycodone|oxycodone|mesh-list
93364327|NCT05730062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93364328|NCT05730062|Narcotics|narcotics|mesh-ancestor
93364329|NCT05730062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364330|NCT05730062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364331|NCT05730062|Analgesics|analgesics|mesh-ancestor
93364332|NCT05730062|Sensory System Agents|sensory system agents|mesh-ancestor
93364333|NCT05730062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364334|NCT03068936|Cisplatin|cisplatin|mesh-list
93364335|NCT03068936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364336|NCT05017610|Lomustine|lomustine|mesh-list
93364337|NCT05017610|Methimazole|methimazole|mesh-list
93364338|NCT05017610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93364339|NCT05017610|Alkylating Agents|alkylating agents|mesh-ancestor
93364340|NCT05017610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364341|NCT05017610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364342|NCT05017610|Antithyroid Agents|antithyroid agents|mesh-ancestor
93364343|NCT05017610|Hormone Antagonists|hormone antagonists|mesh-ancestor
93364344|NCT05017610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364345|NCT05017610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364346|NCT02431468|Bryostatin 1|bryostatin 1|mesh-list
93364347|NCT02431468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93364348|NCT02431468|Immunologic Factors|immunologic factors|mesh-ancestor
93364349|NCT02431468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364350|NCT02431468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364351|NCT04454528|Pembrolizumab|pembrolizumab|mesh-list
93364352|NCT04454528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364353|NCT04454528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364354|NCT04454528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93364355|NCT04454528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364356|NCT05004116|Irinotecan|irinotecan|mesh-list
93364357|NCT05004116|Temozolomide|temozolomide|mesh-list
93364358|NCT05004116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93364359|NCT05004116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93364360|NCT05004116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364361|NCT05004116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364362|NCT05004116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364363|NCT05004116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93364364|NCT05004116|Alkylating Agents|alkylating agents|mesh-ancestor
93364365|NCT02452762|Vitamin D|vitamin d|mesh-list
93364366|NCT02452762|Cholecalciferol|cholecalciferol|mesh-list
93364367|NCT02452762|Vitamins|vitamins|mesh-ancestor
93364368|NCT02452762|Micronutrients|micronutrients|mesh-ancestor
93364369|NCT02452762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364370|NCT02452762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93364371|NCT02452762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93364373|NCT04886414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93364374|NCT04886414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364375|NCT04886414|Disinfectants|disinfectants|mesh-ancestor
93364376|NCT05633420|Artesunate|artesunate|mesh-list
93364377|NCT05633420|Pyronaridine|pyronaridine|mesh-list
93364378|NCT05633420|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93364379|NCT05633420|Antimalarials|antimalarials|mesh-ancestor
93364380|NCT05633420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93364381|NCT05633420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93364382|NCT05633420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364383|NCT05633420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364384|NCT05633420|Antiviral Agents|antiviral agents|mesh-ancestor
93364385|NCT05633420|Schistosomicides|schistosomicides|mesh-ancestor
93364386|NCT05633420|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93364387|NCT05633420|Anthelmintics|anthelmintics|mesh-ancestor
93364388|NCT05729594|Bimatoprost|bimatoprost|mesh-list
93364389|NCT05729594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93364390|NCT02631746|Nivolumab|nivolumab|mesh-list
93364391|NCT02631746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364392|NCT02631746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364393|NCT02631746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93364394|NCT02631746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364395|NCT04699058|Antibodies|antibodies|mesh-list
93364396|NCT04699058|Immunologic Factors|immunologic factors|mesh-ancestor
93364397|NCT04699058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364398|NCT04626128|Aflibercept|aflibercept|mesh-list
93364399|NCT04626128|Axitinib|axitinib|mesh-list
93364400|NCT04626128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93364401|NCT04626128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93364402|NCT04626128|Growth Substances|growth substances|mesh-ancestor
93364403|NCT04626128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364404|NCT04626128|Growth Inhibitors|growth inhibitors|mesh-ancestor
93364405|NCT04626128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364406|NCT04626128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93364407|NCT04626128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364408|NCT04626128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364409|NCT05487092|Letrozole|letrozole|mesh-list
93364410|NCT05487092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364411|NCT05487092|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93364412|NCT05487092|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93364413|NCT05487092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364414|NCT05487092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364415|NCT05487092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93364416|NCT05487092|Hormone Antagonists|hormone antagonists|mesh-ancestor
93364417|NCT05487092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364418|NCT05487092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364419|NCT05728892|Melatonin|melatonin|mesh-list
93364420|NCT05728892|Antioxidants|antioxidants|mesh-ancestor
93364421|NCT05728892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364422|NCT05728892|Protective Agents|protective agents|mesh-ancestor
93364423|NCT05728892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364424|NCT05728892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364425|NCT03067688|Amlodipine|amlodipine|mesh-list
93364426|NCT03067688|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
93364427|NCT03067688|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93364428|NCT03067688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93364429|NCT03067688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93364430|NCT03067688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93364431|NCT03067688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364432|NCT03067688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93364433|NCT03067688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364434|NCT03067688|Vasodilator Agents|vasodilator agents|mesh-ancestor
93364435|NCT03067688|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93364436|NCT03067688|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93364437|NCT03067688|Antimetabolites|antimetabolites|mesh-ancestor
93364438|NCT03067688|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93364439|NCT03067688|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93364440|NCT03067688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036278|NCT01039194|BMS 708163|bms 708163|mesh-list
93364441|NCT03067688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93364442|NCT03067688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93364444|NCT02396758|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93364445|NCT02396758|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93364446|NCT02396758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93364447|NCT02396758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364448|NCT05728424|Amoxicillin|amoxicillin|mesh-list
93364449|NCT05728424|Levofloxacin|levofloxacin|mesh-list
93364450|NCT05728424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93364451|NCT05728424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364452|NCT05728424|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93364453|NCT05728424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93364454|NCT05728424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93364455|NCT05728424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364456|NCT05728424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364457|NCT05728424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364458|NCT05728424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93364459|NCT05728424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93364460|NCT05728346|Hyaluronic Acid|hyaluronic acid|mesh-list
93364461|NCT05728346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93364462|NCT05728346|Immunologic Factors|immunologic factors|mesh-ancestor
93364463|NCT05728346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364464|NCT05728346|Viscosupplements|viscosupplements|mesh-ancestor
93364465|NCT05728346|Protective Agents|protective agents|mesh-ancestor
93364466|NCT05515796|Trastuzumab|trastuzumab|mesh-list
93364467|NCT05515796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364468|NCT05515796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364469|NCT05728268|Paclitaxel|paclitaxel|mesh-list
93364470|NCT05728268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93364471|NCT05728268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364472|NCT05728268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93364473|NCT05728268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93364474|NCT05728268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93364475|NCT05728268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364476|NCT04882358|Dapagliflozin|dapagliflozin|mesh-list
93364477|NCT04882358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93364478|NCT04882358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364479|NCT04882358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93364480|NCT04882358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364481|NCT04926844|Midazolam|midazolam|mesh-list
93364482|NCT04926844|Levetiracetam|levetiracetam|mesh-list
93364483|NCT04926844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93364484|NCT04926844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93364485|NCT04926844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364486|NCT04926844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364487|NCT04926844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93364488|NCT04926844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93364489|NCT04926844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93364490|NCT04926844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93364491|NCT04926844|Anesthetics, General|anesthetics, general|mesh-ancestor
93364492|NCT04926844|Anesthetics|anesthetics|mesh-ancestor
93364493|NCT04926844|GABA Modulators|gaba modulators|mesh-ancestor
93364494|NCT04926844|GABA Agents|gaba agents|mesh-ancestor
93364495|NCT04926844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364496|NCT04926844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364497|NCT04926844|Anticonvulsants|anticonvulsants|mesh-ancestor
93364498|NCT04926844|Nootropic Agents|nootropic agents|mesh-ancestor
93364499|NCT05482256|Listerine|listerine|mesh-list
93364500|NCT05482256|Sodium Fluoride|sodium fluoride|mesh-list
93364501|NCT05482256|Cariostatic Agents|cariostatic agents|mesh-ancestor
93364502|NCT05482256|Protective Agents|protective agents|mesh-ancestor
93364503|NCT05482256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364504|NCT05482256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93364505|NCT05482256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364506|NCT01651936|Methotrexate|methotrexate|mesh-list
93364507|NCT01651936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93364508|NCT01651936|Abortifacient Agents|abortifacient agents|mesh-ancestor
93364509|NCT01651936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364510|NCT01651936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364511|NCT01651936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364512|NCT01651936|Antimetabolites|antimetabolites|mesh-ancestor
93364513|NCT01651936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036356|NCT00448760|Vitamins|vitamins|mesh-ancestor
93364514|NCT01651936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364515|NCT01651936|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364516|NCT01651936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364517|NCT01651936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93364518|NCT01651936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364519|NCT01651936|Immunologic Factors|immunologic factors|mesh-ancestor
93364520|NCT01651936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364521|NCT01651936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93364522|NCT04075916|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93364523|NCT04075916|Antiviral Agents|antiviral agents|mesh-ancestor
93364524|NCT04075916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364525|NCT03065504|Turmeric extract|turmeric extract|mesh-list
93364526|NCT03065504|Antioxidants|antioxidants|mesh-ancestor
93364527|NCT03065504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364528|NCT03065504|Protective Agents|protective agents|mesh-ancestor
93364529|NCT03065504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364530|NCT02630966|Vedolizumab|vedolizumab|mesh-list
93364531|NCT02630966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364532|NCT05724212|Interferons|interferons|mesh-list
93364533|NCT05724212|Interferon-gamma|interferon-gamma|mesh-list
93364534|NCT05724212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364535|NCT05724212|Antiviral Agents|antiviral agents|mesh-ancestor
93364536|NCT05724212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364537|NCT05723588|Nicotine|nicotine|mesh-list
93364538|NCT05723588|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93364539|NCT05723588|Autonomic Agents|autonomic agents|mesh-ancestor
93364540|NCT05723588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364541|NCT05723588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364542|NCT05723588|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93364543|NCT05723588|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93364544|NCT05723588|Cholinergic Agents|cholinergic agents|mesh-ancestor
93364545|NCT05723588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364546|NCT05723588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364547|NCT01651780|Heparin|heparin|mesh-list
93364548|NCT01651780|Calcium heparin|calcium heparin|mesh-list
93364549|NCT01651780|Bivalirudin|bivalirudin|mesh-list
93364550|NCT01651780|Anticoagulants|anticoagulants|mesh-ancestor
93364551|NCT01651780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93364552|NCT01651780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93364553|NCT01651780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364554|NCT01651780|Antithrombins|antithrombins|mesh-ancestor
93364555|NCT01651780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93364556|NCT01651780|Protease Inhibitors|protease inhibitors|mesh-ancestor
93364557|NCT01651780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364558|NCT02394730|Vorapaxar|vorapaxar|mesh-list
93364559|NCT02394730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93364560|NCT05376878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93364561|NCT05376878|Trastuzumab|trastuzumab|mesh-list
93364562|NCT05376878|Camptothecin|camptothecin|mesh-list
93364563|NCT05376878|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93364564|NCT05376878|Antibodies|antibodies|mesh-list
93364565|NCT05376878|Immunoglobulins|immunoglobulins|mesh-list
93364566|NCT05376878|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93364567|NCT05376878|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93364568|NCT05376878|Immunoconjugates|immunoconjugates|mesh-list
93364569|NCT05376878|Immunologic Factors|immunologic factors|mesh-ancestor
93364570|NCT05376878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364571|NCT05376878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364572|NCT05376878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364573|NCT05376878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93364574|NCT05376878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93364575|NCT05376878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93364576|NCT05376878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364577|NCT02430532|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93364578|NCT02430532|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364579|NCT02430532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364580|NCT02430532|Immunologic Factors|immunologic factors|mesh-ancestor
93364581|NCT02430532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364582|NCT05357612|Pimavanserin|pimavanserin|mesh-list
93364583|NCT05357612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93364584|NCT05357612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93364585|NCT05357612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93364586|NCT05357612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93364587|NCT05357612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364588|NCT05357612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364589|NCT05357612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93364590|NCT05357612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93364591|NCT05357612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93364593|NCT05357612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364594|NCT05357612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364595|NCT02394340|Luliconazole|luliconazole|mesh-list
93364596|NCT02394340|Omeprazole|omeprazole|mesh-list
93364597|NCT02394340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93364598|NCT02394340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364599|NCT02394340|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93364600|NCT02394340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364601|NCT02394340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364602|NCT02394340|Antifungal Agents|antifungal agents|mesh-ancestor
93364603|NCT02394340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364604|NCT01672736|Dexamethasone|dexamethasone|mesh-list
93364605|NCT01672736|Dexamethasone acetate|dexamethasone acetate|mesh-list
93364606|NCT01672736|Bortezomib|bortezomib|mesh-list
93364607|NCT01672736|BB 1101|bb 1101|mesh-list
93364608|NCT01672736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93364609|NCT01672736|Antiemetics|antiemetics|mesh-ancestor
93364610|NCT01672736|Autonomic Agents|autonomic agents|mesh-ancestor
93364611|NCT01672736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364612|NCT01672736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364613|NCT01672736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364614|NCT01672736|Glucocorticoids|glucocorticoids|mesh-ancestor
93364615|NCT01672736|Hormones|hormones|mesh-ancestor
93364616|NCT01672736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364617|NCT01672736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93364618|NCT01672736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364619|NCT01672736|Protease Inhibitors|protease inhibitors|mesh-ancestor
93364620|NCT01672736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364621|NCT01672736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364622|NCT03065660|Mifepristone|mifepristone|mesh-list
93364623|NCT03065660|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93364624|NCT03065660|Abortifacient Agents|abortifacient agents|mesh-ancestor
93364625|NCT03065660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364626|NCT03065660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364627|NCT03065660|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93364628|NCT03065660|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93364629|NCT03065660|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93364630|NCT03065660|Contraceptive Agents|contraceptive agents|mesh-ancestor
93364631|NCT03065660|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93364632|NCT03065660|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93364633|NCT03065660|Hormone Antagonists|hormone antagonists|mesh-ancestor
93364634|NCT03065660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364635|NCT03065660|Luteolytic Agents|luteolytic agents|mesh-ancestor
93364636|NCT03065660|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93364637|NCT03065660|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93364638|NCT03893630|Aspirin|aspirin|mesh-list
93364639|NCT03893630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93364640|NCT03893630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93364641|NCT03893630|Analgesics|analgesics|mesh-ancestor
93364642|NCT03893630|Sensory System Agents|sensory system agents|mesh-ancestor
93364643|NCT03893630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364644|NCT03893630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364645|NCT03893630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93364646|NCT03893630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364647|NCT03893630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93364648|NCT03893630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93364649|NCT03893630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364650|NCT03893630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93364651|NCT03893630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93364652|NCT03893630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364653|NCT03893630|Antipyretics|antipyretics|mesh-ancestor
93364654|NCT03065816|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
93364655|NCT03065816|Antacids|antacids|mesh-ancestor
93364656|NCT03065816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364657|NCT03065816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364658|NCT05619848|Midazolam|midazolam|mesh-list
93364659|NCT05619848|Remifentanil|remifentanil|mesh-list
93364660|NCT05619848|Bromides|bromides|mesh-list
93364661|NCT05619848|Propofol|propofol|mesh-list
93364662|NCT05619848|Etomidate|etomidate|mesh-list
93364663|NCT05619848|Rocuronium|rocuronium|mesh-list
93364664|NCT05619848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93364665|NCT05619848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364666|NCT05619848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364667|NCT05619848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93364668|NCT05619848|Anesthetics, General|anesthetics, general|mesh-ancestor
93364669|NCT05619848|Anesthetics|anesthetics|mesh-ancestor
93364670|NCT05619848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93364671|NCT05619848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93364672|NCT05619848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93364673|NCT05619848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93364674|NCT05619848|GABA Modulators|gaba modulators|mesh-ancestor
93364675|NCT05619848|GABA Agents|gaba agents|mesh-ancestor
93364676|NCT05619848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364677|NCT05619848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364678|NCT05619848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93364679|NCT05619848|Narcotics|narcotics|mesh-ancestor
93364680|NCT05619848|Analgesics|analgesics|mesh-ancestor
93364681|NCT05619848|Sensory System Agents|sensory system agents|mesh-ancestor
93364682|NCT05619848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364683|NCT05619848|Anticonvulsants|anticonvulsants|mesh-ancestor
93364684|NCT05619848|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93364685|NCT05619848|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93364686|NCT05619848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93364687|NCT01560637|Treprostinil|treprostinil|mesh-list
93364688|NCT01560637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93364689|NCT04447352|Leucovorin|leucovorin|mesh-list
93364690|NCT04447352|Docetaxel|docetaxel|mesh-list
93364691|NCT04447352|Fluorouracil|fluorouracil|mesh-list
93364692|NCT04447352|Oxaliplatin|oxaliplatin|mesh-list
93364693|NCT04447352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364694|NCT04447352|Tubulin Modulators|tubulin modulators|mesh-ancestor
93364695|NCT04447352|Antimitotic Agents|antimitotic agents|mesh-ancestor
93364696|NCT04447352|Mitosis Modulators|mitosis modulators|mesh-ancestor
93364697|NCT04447352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364698|NCT04447352|Antimetabolites|antimetabolites|mesh-ancestor
93364699|NCT04447352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364700|NCT04447352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364701|NCT04447352|Immunologic Factors|immunologic factors|mesh-ancestor
93364702|NCT04447352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364703|NCT04447352|Antidotes|antidotes|mesh-ancestor
93364704|NCT04447352|Protective Agents|protective agents|mesh-ancestor
93364705|NCT04447352|Vitamin B Complex|vitamin b complex|mesh-ancestor
93364706|NCT04447352|Vitamins|vitamins|mesh-ancestor
93364707|NCT04447352|Micronutrients|micronutrients|mesh-ancestor
93364708|NCT04157036|Ibuprofen|ibuprofen|mesh-list
93364709|NCT04157036|Methylprednisolone|methylprednisolone|mesh-list
93364710|NCT04157036|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93364711|NCT04157036|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93364712|NCT04157036|Prednisolone|prednisolone|mesh-list
93364713|NCT04157036|Prednisolone acetate|prednisolone acetate|mesh-list
93364714|NCT04157036|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93364715|NCT04157036|Prednisolone phosphate|prednisolone phosphate|mesh-list
93364716|NCT04157036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93364717|NCT04157036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93364718|NCT04157036|Analgesics|analgesics|mesh-ancestor
93364719|NCT04157036|Sensory System Agents|sensory system agents|mesh-ancestor
93364720|NCT04157036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364721|NCT04157036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364722|NCT04157036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93364723|NCT04157036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364724|NCT04157036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93364725|NCT04157036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364726|NCT04157036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364727|NCT04157036|Antiemetics|antiemetics|mesh-ancestor
93364728|NCT04157036|Autonomic Agents|autonomic agents|mesh-ancestor
93364729|NCT04157036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364730|NCT04157036|Glucocorticoids|glucocorticoids|mesh-ancestor
93364731|NCT04157036|Hormones|hormones|mesh-ancestor
93364732|NCT04157036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93364733|NCT04157036|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93364734|NCT04157036|Protective Agents|protective agents|mesh-ancestor
93364735|NCT04157036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93364736|NCT04157036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364737|NCT03547375|Apatinib|apatinib|mesh-list
93364738|NCT03547375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364739|NCT03547375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93364740|NCT03547375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364741|NCT03547375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364742|NCT01353911|Interferons|interferons|mesh-list
93364743|NCT01353911|Ribavirin|ribavirin|mesh-list
93364744|NCT01353911|Interferon-alpha|interferon-alpha|mesh-list
93364745|NCT01353911|Interferon alpha-2|interferon alpha-2|mesh-list
93364746|NCT01353911|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93364747|NCT01353911|Grazoprevir|grazoprevir|mesh-list
93364748|NCT01353911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364749|NCT01353911|Antiviral Agents|antiviral agents|mesh-ancestor
93364750|NCT01353911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364751|NCT01353911|Antimetabolites|antimetabolites|mesh-ancestor
93364752|NCT01353911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364753|NCT01353911|Immunologic Factors|immunologic factors|mesh-ancestor
93364754|NCT01353911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364755|NCT05575297|Rifampin|rifampin|mesh-list
93364756|NCT05575297|Methotrexate|methotrexate|mesh-list
93364757|NCT05575297|Febuxostat|febuxostat|mesh-list
93364758|NCT05575297|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93364759|NCT05575297|Abortifacient Agents|abortifacient agents|mesh-ancestor
93364760|NCT05575297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364761|NCT05575297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364762|NCT05575297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364763|NCT05575297|Antimetabolites|antimetabolites|mesh-ancestor
93364764|NCT05575297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364765|NCT05575297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364766|NCT05575297|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364767|NCT05575297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364768|NCT05575297|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93364769|NCT05575297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364770|NCT05575297|Immunologic Factors|immunologic factors|mesh-ancestor
93364771|NCT05575297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364772|NCT05575297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93364773|NCT05575297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93364774|NCT05575297|Antitubercular Agents|antitubercular agents|mesh-ancestor
93364775|NCT05575297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93364776|NCT05575297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364777|NCT05575297|Leprostatic Agents|leprostatic agents|mesh-ancestor
93364778|NCT05575297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93364779|NCT05575297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93364780|NCT05575297|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93364781|NCT05575297|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93364782|NCT05575297|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93364783|NCT05575297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93364784|NCT05575297|Gout Suppressants|gout suppressants|mesh-ancestor
93364785|NCT01671488|Mitomycins|mitomycins|mesh-list
93364786|NCT01671488|Mitomycin|mitomycin|mesh-list
93364787|NCT01671488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93364788|NCT01671488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364789|NCT01671488|Alkylating Agents|alkylating agents|mesh-ancestor
93364790|NCT01671488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364791|NCT01671488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93364792|NCT01671488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364793|NCT05400889|Tofacitinib|tofacitinib|mesh-list
93364794|NCT05400889|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93364795|NCT05400889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93364796|NCT05400889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364797|NCT05400889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364798|NCT05395117|Digoxin|digoxin|mesh-list
93364799|NCT05395117|Midazolam|midazolam|mesh-list
93364800|NCT05395117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93364801|NCT05395117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93364802|NCT05395117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93364803|NCT05395117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364804|NCT05395117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364805|NCT05395117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93364806|NCT05395117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93364807|NCT05395117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93364808|NCT05395117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93364809|NCT05395117|Anesthetics, General|anesthetics, general|mesh-ancestor
93364810|NCT05395117|Anesthetics|anesthetics|mesh-ancestor
93364811|NCT05395117|GABA Modulators|gaba modulators|mesh-ancestor
93364812|NCT05395117|GABA Agents|gaba agents|mesh-ancestor
93364813|NCT05395117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364814|NCT05395117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364815|NCT05395117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93364816|NCT05395117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93364817|NCT05395117|Antimetabolites|antimetabolites|mesh-ancestor
93364818|NCT05395117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93364819|NCT05395117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93364821|NCT05395117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93364822|NCT05395117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93364823|NCT05395117|Protective Agents|protective agents|mesh-ancestor
93364824|NCT05325229|Bevacizumab|bevacizumab|mesh-list
93364825|NCT05325229|Docetaxel|docetaxel|mesh-list
93364826|NCT05325229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364827|NCT05325229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364828|NCT05325229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93364829|NCT05325229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93364830|NCT05325229|Growth Substances|growth substances|mesh-ancestor
93364831|NCT05325229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364832|NCT05325229|Growth Inhibitors|growth inhibitors|mesh-ancestor
93364833|NCT05325229|Tubulin Modulators|tubulin modulators|mesh-ancestor
93364834|NCT05325229|Antimitotic Agents|antimitotic agents|mesh-ancestor
93364835|NCT05325229|Mitosis Modulators|mitosis modulators|mesh-ancestor
93364836|NCT05325229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364837|NCT05573581|Botulinum Toxins|botulinum toxins|mesh-list
93364838|NCT05573581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93364839|NCT05573581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93364840|NCT05573581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93364841|NCT05573581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93364842|NCT05573581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364843|NCT05573581|Cholinergic Agents|cholinergic agents|mesh-ancestor
93364844|NCT05573581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364845|NCT05573581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364846|NCT05573581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93364847|NCT05573581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364848|NCT01358357|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93364849|NCT01358357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93364850|NCT01358357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93364851|NCT01358357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93364852|NCT01358357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364853|NCT01358357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93364854|NCT01358357|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93364855|NCT01358357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93364856|NCT01358357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93364857|NCT01358357|Adrenergic Agents|adrenergic agents|mesh-ancestor
93364858|NCT01358357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364859|NCT01358357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364860|NCT01358357|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93364861|NCT01358357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93364862|NCT01358357|Serotonin Agents|serotonin agents|mesh-ancestor
93364863|NCT01358357|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93364864|NCT01358357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93364865|NCT01358357|Dopamine Agents|dopamine agents|mesh-ancestor
93364866|NCT05573425|Tazarotene|tazarotene|mesh-list
93364867|NCT05573425|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364868|NCT05573425|Keratolytic Agents|keratolytic agents|mesh-ancestor
93364869|NCT02253901|Ritonavir|ritonavir|mesh-list
93364870|NCT02253901|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93364871|NCT02253901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93364872|NCT02253901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93364873|NCT02253901|Protease Inhibitors|protease inhibitors|mesh-ancestor
93364874|NCT02253901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364875|NCT02253901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364876|NCT02253901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93364877|NCT02253901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93364878|NCT02253901|Antiviral Agents|antiviral agents|mesh-ancestor
93364879|NCT02253901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93364880|NCT02253901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93364881|NCT02253901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93364882|NCT02253901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93364883|NCT02253901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93364884|NCT03546283|Cardiac Glycosides|cardiac glycosides|mesh-list
93364885|NCT03546283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93364886|NCT03546283|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93364887|NCT03546283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364888|NCT03546283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364889|NCT03546283|Protective Agents|protective agents|mesh-ancestor
93364891|NCT02831387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93364892|NCT02831387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93364893|NCT04940546|Bevacizumab|bevacizumab|mesh-list
93364894|NCT04940546|Capecitabine|capecitabine|mesh-list
93364895|NCT04940546|Oxaliplatin|oxaliplatin|mesh-list
93364896|NCT04940546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93364897|NCT04940546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364898|NCT04940546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93364899|NCT04940546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93364900|NCT04940546|Growth Substances|growth substances|mesh-ancestor
93364901|NCT04940546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364902|NCT04940546|Growth Inhibitors|growth inhibitors|mesh-ancestor
93364903|NCT04940546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364904|NCT04940546|Antimetabolites|antimetabolites|mesh-ancestor
93364905|NCT04940546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364906|NCT03547219|Escitalopram|escitalopram|mesh-list
93364907|NCT03547219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93364908|NCT03547219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93364909|NCT03547219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93364910|NCT03547219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364911|NCT03547219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364912|NCT03547219|Serotonin Agents|serotonin agents|mesh-ancestor
93364913|NCT03547219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364914|NCT04116320|Poly ICLC|poly iclc|mesh-list
93364915|NCT04116320|Interferon Inducers|interferon inducers|mesh-ancestor
93364916|NCT04116320|Immunologic Factors|immunologic factors|mesh-ancestor
93364917|NCT04116320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364918|NCT04069819|Cilostazol|cilostazol|mesh-list
93364919|NCT04069819|Escitalopram|escitalopram|mesh-list
93364920|NCT04069819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93364921|NCT04069819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93364922|NCT04069819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93364923|NCT04069819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364924|NCT04069819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93364925|NCT04069819|Serotonin Agents|serotonin agents|mesh-ancestor
93364926|NCT04069819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364927|NCT04069819|Autonomic Agents|autonomic agents|mesh-ancestor
93364928|NCT04069819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364929|NCT04069819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93364930|NCT04069819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93364931|NCT04069819|Respiratory System Agents|respiratory system agents|mesh-ancestor
93364932|NCT04069819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93364933|NCT04069819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93364934|NCT04069819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93364935|NCT04069819|Vasodilator Agents|vasodilator agents|mesh-ancestor
93364936|NCT04069819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93364937|NCT04069819|Protective Agents|protective agents|mesh-ancestor
93364938|NCT04069819|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93364939|NCT04069819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93364940|NCT04069819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364941|NCT04084496|Folfirinox|folfirinox|mesh-list
93364942|NCT04084496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364943|NCT02831855|Methotrexate|methotrexate|mesh-list
93364944|NCT02831855|Tofacitinib|tofacitinib|mesh-list
93364945|NCT02831855|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93364946|NCT02831855|Abortifacient Agents|abortifacient agents|mesh-ancestor
93364947|NCT02831855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93364948|NCT02831855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364949|NCT02831855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93364950|NCT02831855|Antimetabolites|antimetabolites|mesh-ancestor
93364951|NCT02831855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364952|NCT02831855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364953|NCT02831855|Dermatologic Agents|dermatologic agents|mesh-ancestor
93364954|NCT02831855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93364955|NCT02831855|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93364956|NCT02831855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364957|NCT02831855|Immunologic Factors|immunologic factors|mesh-ancestor
93364958|NCT02831855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364959|NCT02831855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93364960|NCT02831855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93364961|NCT02831855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93364962|NCT04071626|Ertugliflozin|ertugliflozin|mesh-list
93364963|NCT04071626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93364964|NCT04071626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364965|NCT04071626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93364966|NCT04071626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364967|NCT01356407|Picosulfate sodium|picosulfate sodium|mesh-list
93364968|NCT01356407|Cathartics|cathartics|mesh-ancestor
93364969|NCT01356407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364970|NCT00109837|Leucovorin|leucovorin|mesh-list
93364971|NCT00109837|Cytarabine|cytarabine|mesh-list
93364972|NCT00109837|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93364973|NCT00109837|Dexamethasone|dexamethasone|mesh-list
93364974|NCT00109837|Prednisone|prednisone|mesh-list
93364975|NCT00109837|Cyclophosphamide|cyclophosphamide|mesh-list
93364976|NCT00109837|Doxorubicin|doxorubicin|mesh-list
93364977|NCT00109837|Methotrexate|methotrexate|mesh-list
93364978|NCT00109837|Vincristine|vincristine|mesh-list
93364979|NCT00109837|Daunorubicin|daunorubicin|mesh-list
93364980|NCT00109837|Asparaginase|asparaginase|mesh-list
93364981|NCT00109837|Mitoxantrone|mitoxantrone|mesh-list
93364982|NCT00109837|Mercaptopurine|mercaptopurine|mesh-list
93364983|NCT00109837|Thioguanine|thioguanine|mesh-list
93364984|NCT00109837|Allopurinol|allopurinol|mesh-list
93364985|NCT00109837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93364986|NCT00109837|Immunologic Factors|immunologic factors|mesh-ancestor
93364987|NCT00109837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93364988|NCT00109837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93364989|NCT00109837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93364990|NCT00109837|Alkylating Agents|alkylating agents|mesh-ancestor
93364991|NCT00109837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93364992|NCT00109837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93364993|NCT00109837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93364994|NCT00109837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93364995|NCT00109837|Antiemetics|antiemetics|mesh-ancestor
93364996|NCT00109837|Autonomic Agents|autonomic agents|mesh-ancestor
93364997|NCT00109837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93364998|NCT00109837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93364999|NCT00109837|Glucocorticoids|glucocorticoids|mesh-ancestor
93365000|NCT00109837|Hormones|hormones|mesh-ancestor
93365001|NCT00109837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365002|NCT00109837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365003|NCT00109837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93365004|NCT00109837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93365005|NCT00109837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365006|NCT00109837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365007|NCT00109837|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93365008|NCT00109837|Abortifacient Agents|abortifacient agents|mesh-ancestor
93365009|NCT00109837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93365010|NCT00109837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365011|NCT00109837|Antimetabolites|antimetabolites|mesh-ancestor
93365012|NCT00109837|Dermatologic Agents|dermatologic agents|mesh-ancestor
93365013|NCT00109837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93365014|NCT00109837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93365015|NCT00109837|Antiviral Agents|antiviral agents|mesh-ancestor
93365016|NCT00109837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365017|NCT00109837|Antidotes|antidotes|mesh-ancestor
93365018|NCT00109837|Protective Agents|protective agents|mesh-ancestor
93365019|NCT00109837|Vitamin B Complex|vitamin b complex|mesh-ancestor
93365020|NCT00109837|Vitamins|vitamins|mesh-ancestor
93365021|NCT00109837|Micronutrients|micronutrients|mesh-ancestor
93365022|NCT00109837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365023|NCT00109837|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365024|NCT00109837|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365025|NCT00109837|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365026|NCT00109837|Analgesics|analgesics|mesh-ancestor
93365027|NCT00109837|Sensory System Agents|sensory system agents|mesh-ancestor
93365028|NCT00109837|Gout Suppressants|gout suppressants|mesh-ancestor
93365029|NCT00109837|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93365030|NCT00109837|Antioxidants|antioxidants|mesh-ancestor
93365031|NCT00109837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93365032|NCT00109837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93365033|NCT00109837|Antimalarials|antimalarials|mesh-ancestor
93365034|NCT00109837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93365035|NCT00109837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93365036|NCT05229445|Insulin|insulin|mesh-list
93365037|NCT05229445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92658670|NCT00249158|Risperidone|risperidone|mesh-list
93365038|NCT05229445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365039|NCT01671332|Suramin|suramin|mesh-list
93365040|NCT01671332|Docetaxel|docetaxel|mesh-list
93365041|NCT01671332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365042|NCT01671332|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365043|NCT01671332|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365044|NCT01671332|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365045|NCT01671332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365046|NCT01671332|Antinematodal Agents|antinematodal agents|mesh-ancestor
93365047|NCT01671332|Anthelmintics|anthelmintics|mesh-ancestor
93365048|NCT01671332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93365049|NCT01671332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365050|NCT01671332|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93365051|NCT01671332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93365052|NCT03063242|Sargramostim|sargramostim|mesh-list
93365053|NCT03063242|Immunologic Factors|immunologic factors|mesh-ancestor
93365054|NCT03063242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365056|NCT03897062|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93365057|NCT03897062|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93365058|NCT03897062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365059|NCT03897062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365060|NCT03897062|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93365061|NCT03897062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365062|NCT03897062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365063|NCT00100802|Temozolomide|temozolomide|mesh-list
93365064|NCT00100802|Lomustine|lomustine|mesh-list
93365065|NCT00100802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93365066|NCT00100802|Alkylating Agents|alkylating agents|mesh-ancestor
93365067|NCT00100802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365068|NCT00100802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365069|NCT01355159|Folic Acid|folic acid|mesh-list
93365070|NCT01355159|Hematinics|hematinics|mesh-ancestor
93365071|NCT01355159|Vitamin B Complex|vitamin b complex|mesh-ancestor
93365072|NCT01355159|Vitamins|vitamins|mesh-ancestor
93365073|NCT01355159|Micronutrients|micronutrients|mesh-ancestor
93365074|NCT01355159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365075|NCT04661852|Cyclophosphamide|cyclophosphamide|mesh-list
93365076|NCT04661852|Topotecan|topotecan|mesh-list
93365077|NCT04661852|Mitogens|mitogens|mesh-list
93365078|NCT04661852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365079|NCT04661852|Immunologic Factors|immunologic factors|mesh-ancestor
93365080|NCT04661852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365081|NCT04661852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365082|NCT04661852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93365083|NCT04661852|Alkylating Agents|alkylating agents|mesh-ancestor
93365084|NCT04661852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365085|NCT04661852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365086|NCT04661852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93365087|NCT04661852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93365088|NCT04661852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365089|NCT04661852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365090|NCT04661852|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365091|NCT02630186|Atezolizumab|atezolizumab|mesh-list
93365092|NCT02630186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365093|NCT02630186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365094|NCT02630186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365095|NCT02630186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365096|NCT00002462|Cobalt|cobalt|mesh-list
93365097|NCT00002462|Prednisone|prednisone|mesh-list
93365098|NCT00002462|Doxorubicin|doxorubicin|mesh-list
93365099|NCT00002462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93365100|NCT00002462|Bleomycin|bleomycin|mesh-list
93365101|NCT00002462|Vincristine|vincristine|mesh-list
93365102|NCT00002462|Vinblastine|vinblastine|mesh-list
93365103|NCT00002462|Procarbazine|procarbazine|mesh-list
93365104|NCT00002462|Mechlorethamine|mechlorethamine|mesh-list
93365105|NCT00002462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93365106|NCT00002462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365107|NCT00002462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93365108|NCT00002462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365109|NCT00002462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365110|NCT00002462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365111|NCT00002462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93365112|NCT00002462|Glucocorticoids|glucocorticoids|mesh-ancestor
93365113|NCT00002462|Hormones|hormones|mesh-ancestor
93365114|NCT00002462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365115|NCT00002462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365116|NCT00002462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365117|NCT00002462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365118|NCT00002462|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365119|NCT00002462|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365120|NCT00002462|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365121|NCT00002462|Trace Elements|trace elements|mesh-ancestor
93365122|NCT00002462|Micronutrients|micronutrients|mesh-ancestor
93365123|NCT00002462|Alkylating Agents|alkylating agents|mesh-ancestor
93365124|NCT00002462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93365125|NCT01669928|Antihypertensive Agents|antihypertensive agents|mesh-list
93365126|NCT01669928|Calcium Channel Blockers|calcium channel blockers|mesh-list
93365127|NCT01669928|Angiotensin II|angiotensin ii|mesh-list
93365128|NCT01669928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93365129|NCT01669928|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93365130|NCT01669928|Renin Inhibitors|renin inhibitors|mesh-list
93365131|NCT01669928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93365132|NCT01669928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365133|NCT01669928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365134|NCT01669928|Protease Inhibitors|protease inhibitors|mesh-ancestor
93365135|NCT01669928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365136|NCT01669928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93365137|NCT01669928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365138|NCT01995578|Azacitidine|azacitidine|mesh-list
93365139|NCT01995578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365140|NCT01995578|Antimetabolites|antimetabolites|mesh-ancestor
93365141|NCT01995578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365142|NCT01995578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365143|NCT01995578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365144|NCT04440176|Vaccines|vaccines|mesh-list
93365145|NCT04440176|Immunologic Factors|immunologic factors|mesh-ancestor
93365146|NCT04440176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365147|NCT03595592|Paclitaxel|paclitaxel|mesh-list
93365148|NCT03595592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93365149|NCT03595592|Cyclophosphamide|cyclophosphamide|mesh-list
93365150|NCT03595592|Carboplatin|carboplatin|mesh-list
93365151|NCT03595592|Doxorubicin|doxorubicin|mesh-list
93365152|NCT03595592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93365153|NCT03595592|Trastuzumab|trastuzumab|mesh-list
93365154|NCT03595592|Atezolizumab|atezolizumab|mesh-list
93365155|NCT03595592|Pertuzumab|pertuzumab|mesh-list
93365156|NCT03595592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365157|NCT03595592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365158|NCT03595592|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365159|NCT03595592|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365160|NCT03595592|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365161|NCT03595592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365162|NCT03595592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365163|NCT03595592|Immunologic Factors|immunologic factors|mesh-ancestor
93365164|NCT03595592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365165|NCT03595592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365166|NCT03595592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93365167|NCT03595592|Alkylating Agents|alkylating agents|mesh-ancestor
93365168|NCT03595592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93365169|NCT03595592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93365170|NCT03595592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93365171|NCT03595592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365172|NCT03595592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365173|NCT03595592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365174|NCT03595592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365175|NCT01355081|Vortioxetine|vortioxetine|mesh-list
93365176|NCT01355081|Antidepressive Agents|antidepressive agents|mesh-ancestor
93365177|NCT01355081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93365178|NCT01355081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93365179|NCT01355081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93365180|NCT01355081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365181|NCT01355081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365182|NCT01355081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93365183|NCT01355081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93365184|NCT01355081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658811|NCT00249704|Vitamins|vitamins|mesh-list
93365185|NCT01355081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365186|NCT01355081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365187|NCT01355081|Serotonin Agents|serotonin agents|mesh-ancestor
93365188|NCT01355081|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93365189|NCT01355081|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93365190|NCT01355081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93365191|NCT01355081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93365192|NCT02259959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93365193|NCT02259959|Tiotropium Bromide|tiotropium bromide|mesh-list
93365194|NCT02259959|Olodaterol|olodaterol|mesh-list
93365195|NCT02259959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93365196|NCT02259959|Autonomic Agents|autonomic agents|mesh-ancestor
93365197|NCT02259959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365198|NCT02259959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365199|NCT02259959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93365200|NCT02259959|Respiratory System Agents|respiratory system agents|mesh-ancestor
93365201|NCT02259959|Parasympatholytics|parasympatholytics|mesh-ancestor
93365202|NCT02259959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93365203|NCT02259959|Cholinergic Agents|cholinergic agents|mesh-ancestor
93365204|NCT02259959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365205|NCT02259959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365206|NCT03062462|Clopidogrel|clopidogrel|mesh-list
93365207|NCT03062462|Ticagrelor|ticagrelor|mesh-list
93365208|NCT03062462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93365209|NCT03062462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93365210|NCT03062462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93365211|NCT03062462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93365212|NCT03062462|Purinergic Agents|purinergic agents|mesh-ancestor
93365213|NCT03062462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365214|NCT03062462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365215|NCT03062462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365216|NCT04433078|Doxycycline|doxycycline|mesh-list
93365217|NCT04433078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93365218|NCT04433078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365219|NCT04433078|Antimalarials|antimalarials|mesh-ancestor
93365220|NCT04433078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93365221|NCT04433078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93365222|NCT04458311|Abiraterone Acetate|abiraterone acetate|mesh-list
93365223|NCT04458311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365224|NCT04458311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93365225|NCT04458311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365226|NCT04458311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365227|NCT04458311|Hormone Antagonists|hormone antagonists|mesh-ancestor
93365228|NCT04458311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365229|NCT04458311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365230|NCT04458311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93365231|NCT05212571|Ketamine|ketamine|mesh-list
93365232|NCT05212571|Esketamine|esketamine|mesh-list
93365233|NCT05212571|Analgesics|analgesics|mesh-ancestor
93365234|NCT05212571|Sensory System Agents|sensory system agents|mesh-ancestor
93365235|NCT05212571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365236|NCT05212571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365237|NCT05212571|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93365238|NCT05212571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93365239|NCT05212571|Anesthetics, General|anesthetics, general|mesh-ancestor
93365240|NCT05212571|Anesthetics|anesthetics|mesh-ancestor
93365241|NCT05212571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365242|NCT05212571|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93365243|NCT05212571|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93365244|NCT05212571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365245|NCT05212571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365246|NCT05212571|Antidepressive Agents|antidepressive agents|mesh-ancestor
93365247|NCT05212571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93365248|NCT04368533|Fluorides|fluorides|mesh-list
93365249|NCT04368533|Cariostatic Agents|cariostatic agents|mesh-ancestor
93365250|NCT04368533|Protective Agents|protective agents|mesh-ancestor
93365251|NCT04368533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365252|NCT02627144|Interferons|interferons|mesh-list
93365253|NCT02627144|Interferon-alpha|interferon-alpha|mesh-list
92658886|NCT02961608|Tacrolimus|tacrolimus|mesh-list
93365254|NCT02627144|Interferon alpha-2|interferon alpha-2|mesh-list
93365255|NCT02627144|Bevacizumab|bevacizumab|mesh-list
93365256|NCT02627144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365257|NCT02627144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365258|NCT02627144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93365259|NCT02627144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93365260|NCT02627144|Growth Substances|growth substances|mesh-ancestor
93365261|NCT02627144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365262|NCT02627144|Growth Inhibitors|growth inhibitors|mesh-ancestor
93365263|NCT02627144|Antiviral Agents|antiviral agents|mesh-ancestor
93365264|NCT02627144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365265|NCT02627144|Immunologic Factors|immunologic factors|mesh-ancestor
93365266|NCT04586335|Olaparib|olaparib|mesh-list
93365267|NCT04586335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93365268|NCT04586335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365269|NCT04586335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365270|NCT04586335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365272|NCT04981886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93365273|NCT03873727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93365274|NCT03873727|Immunologic Factors|immunologic factors|mesh-ancestor
93365275|NCT03873727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365276|NCT05107453|Levobupivacaine|levobupivacaine|mesh-list
93365277|NCT05107453|Anesthetics, Local|anesthetics, local|mesh-ancestor
93365278|NCT05107453|Anesthetics|anesthetics|mesh-ancestor
93365279|NCT05107453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365280|NCT05107453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365281|NCT05107453|Sensory System Agents|sensory system agents|mesh-ancestor
93365282|NCT05107453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365283|NCT03493178|Acetylcysteine|acetylcysteine|mesh-list
93365284|NCT03493178|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93365285|NCT03493178|Glycine|glycine|mesh-list
93365286|NCT03493178|Antiviral Agents|antiviral agents|mesh-ancestor
93365287|NCT03493178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365288|NCT03493178|Expectorants|expectorants|mesh-ancestor
93365289|NCT03493178|Respiratory System Agents|respiratory system agents|mesh-ancestor
93365290|NCT03493178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93365291|NCT03493178|Antioxidants|antioxidants|mesh-ancestor
93365292|NCT03493178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365293|NCT03493178|Protective Agents|protective agents|mesh-ancestor
93365294|NCT03493178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365295|NCT03493178|Antidotes|antidotes|mesh-ancestor
93365296|NCT03493178|Glycine Agents|glycine agents|mesh-ancestor
93365297|NCT03493178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365298|NCT04548440|Paclitaxel|paclitaxel|mesh-list
93365299|NCT04548440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93365300|NCT04548440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365301|NCT04548440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365302|NCT04548440|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365303|NCT04548440|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365304|NCT04548440|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365305|NCT04548440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365306|NCT03742921|Romidepsin|romidepsin|mesh-list
93365307|NCT03742921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93365308|NCT03742921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365309|NCT03742921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93365310|NCT03742921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365311|NCT03742921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365312|NCT02626520|Paclitaxel|paclitaxel|mesh-list
93365313|NCT02626520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93365314|NCT02626520|Gemcitabine|gemcitabine|mesh-list
93365315|NCT02626520|Fluorouracil|fluorouracil|mesh-list
93365316|NCT02626520|Irinotecan|irinotecan|mesh-list
93365317|NCT02626520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365318|NCT02626520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365319|NCT02626520|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365320|NCT02626520|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365321|NCT02626520|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365322|NCT02626520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365323|NCT02626520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365324|NCT02626520|Antimetabolites|antimetabolites|mesh-ancestor
93365325|NCT02626520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365326|NCT02626520|Immunologic Factors|immunologic factors|mesh-ancestor
93365327|NCT02626520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365328|NCT02626520|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93365329|NCT02626520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365330|NCT02626520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365331|NCT03063710|Olaparib|olaparib|mesh-list
93365332|NCT03063710|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93365333|NCT03063710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365334|NCT03063710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365335|NCT03063710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365336|NCT05084521|Famotidine|famotidine|mesh-list
93365337|NCT05084521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93365338|NCT05084521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365339|NCT05084521|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93037182|NCT00409188|Alkylating Agents|alkylating agents|mesh-ancestor
93365340|NCT05084521|Histamine Antagonists|histamine antagonists|mesh-ancestor
93365341|NCT05084521|Histamine Agents|histamine agents|mesh-ancestor
93365342|NCT05084521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365343|NCT05084521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365344|NCT05084521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365345|NCT05069857|Apatinib|apatinib|mesh-list
93365346|NCT05069857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93365347|NCT05069857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365348|NCT05069857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93365349|NCT05069857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365350|NCT05069857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365351|NCT05069857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365352|NCT02971891|Furosemide|furosemide|mesh-list
93365353|NCT02971891|Diuretics|diuretics|mesh-ancestor
93365354|NCT02971891|Natriuretic Agents|natriuretic agents|mesh-ancestor
93365355|NCT02971891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365356|NCT02971891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93365357|NCT02971891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365358|NCT02971891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365359|NCT05063851|Memantine|memantine|mesh-list
93365360|NCT05063851|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93365361|NCT05063851|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93365362|NCT05063851|Dopamine Agents|dopamine agents|mesh-ancestor
93365363|NCT05063851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365364|NCT05063851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365365|NCT05063851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365366|NCT05063851|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93365367|NCT05063851|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93365368|NCT04392037|Dexamethasone|dexamethasone|mesh-list
93365369|NCT04392037|Cyclophosphamide|cyclophosphamide|mesh-list
93365370|NCT04392037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365371|NCT04392037|Immunologic Factors|immunologic factors|mesh-ancestor
93365372|NCT04392037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365373|NCT04392037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365374|NCT04392037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93365375|NCT04392037|Alkylating Agents|alkylating agents|mesh-ancestor
93365376|NCT04392037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365377|NCT04392037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365378|NCT04392037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93365379|NCT04392037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93365380|NCT04392037|Antiemetics|antiemetics|mesh-ancestor
93365381|NCT04392037|Autonomic Agents|autonomic agents|mesh-ancestor
93365382|NCT04392037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365383|NCT04392037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365384|NCT04392037|Glucocorticoids|glucocorticoids|mesh-ancestor
93365385|NCT04392037|Hormones|hormones|mesh-ancestor
93365386|NCT04392037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365387|NCT04392037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365388|NCT03359161|Furosemide|furosemide|mesh-list
93365389|NCT03359161|Diuretics|diuretics|mesh-ancestor
93365390|NCT03359161|Natriuretic Agents|natriuretic agents|mesh-ancestor
93365391|NCT03359161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365392|NCT03359161|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93365393|NCT03359161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365394|NCT03359161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365395|NCT05030623|Tadalafil|tadalafil|mesh-list
93365396|NCT05030623|Vasodilator Agents|vasodilator agents|mesh-ancestor
93365397|NCT05030623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93365398|NCT05030623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93365399|NCT05030623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365400|NCT05030623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365401|NCT05030623|Urological Agents|urological agents|mesh-ancestor
93365402|NCT04986631|Topiramate|topiramate|mesh-list
93365403|NCT04986631|Anticonvulsants|anticonvulsants|mesh-ancestor
93365404|NCT04986631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93365405|NCT04986631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365406|NCT03277339|Paroxetine|paroxetine|mesh-list
93365407|NCT03277339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93365408|NCT03277339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93365409|NCT03277339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365410|NCT03277339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365411|NCT03277339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365412|NCT03277339|Serotonin Agents|serotonin agents|mesh-ancestor
93365413|NCT03277339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365414|NCT03277339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93365415|NCT03277339|Antidepressive Agents|antidepressive agents|mesh-ancestor
93365416|NCT03277339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93365417|NCT03277339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93365418|NCT03277339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93365419|NCT03277339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365420|NCT03145675|Enoxaparin|enoxaparin|mesh-list
93365421|NCT03145675|Enoxaparin sodium|enoxaparin sodium|mesh-list
93365422|NCT03145675|Anticoagulants|anticoagulants|mesh-ancestor
93365423|NCT03145675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93365424|NCT03145675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93365425|NCT03145675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365426|NCT04251715|Leucovorin|leucovorin|mesh-list
93365427|NCT04251715|Dexamethasone|dexamethasone|mesh-list
93365428|NCT04251715|Dexamethasone acetate|dexamethasone acetate|mesh-list
93365429|NCT04251715|Fluorouracil|fluorouracil|mesh-list
93365430|NCT04251715|Oxaliplatin|oxaliplatin|mesh-list
93365431|NCT04251715|Irinotecan|irinotecan|mesh-list
93365432|NCT04251715|Floxuridine|floxuridine|mesh-list
93365433|NCT04251715|BB 1101|bb 1101|mesh-list
93365434|NCT04251715|Deoxyuridine|deoxyuridine|mesh-list
93365435|NCT04251715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93365436|NCT04251715|Antiemetics|antiemetics|mesh-ancestor
93365437|NCT04251715|Autonomic Agents|autonomic agents|mesh-ancestor
93365438|NCT04251715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365439|NCT04251715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365440|NCT04251715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365441|NCT04251715|Glucocorticoids|glucocorticoids|mesh-ancestor
93365442|NCT04251715|Hormones|hormones|mesh-ancestor
93365443|NCT04251715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365444|NCT04251715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365445|NCT04251715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365446|NCT04251715|Protease Inhibitors|protease inhibitors|mesh-ancestor
93365447|NCT04251715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365448|NCT04251715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365449|NCT04251715|Antimetabolites|antimetabolites|mesh-ancestor
93365450|NCT04251715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365451|NCT04251715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365452|NCT04251715|Immunologic Factors|immunologic factors|mesh-ancestor
93365453|NCT04251715|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93365454|NCT04251715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365455|NCT04251715|Antidotes|antidotes|mesh-ancestor
93365456|NCT04251715|Protective Agents|protective agents|mesh-ancestor
93365457|NCT04251715|Vitamin B Complex|vitamin b complex|mesh-ancestor
93365458|NCT04251715|Vitamins|vitamins|mesh-ancestor
93365459|NCT04251715|Micronutrients|micronutrients|mesh-ancestor
93365460|NCT04042727|Dexmedetomidine|dexmedetomidine|mesh-list
93365461|NCT04042727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93365462|NCT04042727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365463|NCT04042727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365464|NCT04042727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93365465|NCT04042727|Analgesics|analgesics|mesh-ancestor
93365466|NCT04042727|Sensory System Agents|sensory system agents|mesh-ancestor
93365467|NCT04042727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365468|NCT04042727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93365469|NCT04042727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93365470|NCT04042727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93365471|NCT04042727|Adrenergic Agents|adrenergic agents|mesh-ancestor
93365472|NCT04042727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365473|NCT04042727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365474|NCT02035943|Insulin|insulin|mesh-list
93365475|NCT02035943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93365476|NCT02035943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93365477|NCT02035943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365478|NCT03819413|Antibodies|antibodies|mesh-list
93365479|NCT03819413|Immunoglobulins|immunoglobulins|mesh-list
93365480|NCT03819413|Immunologic Factors|immunologic factors|mesh-ancestor
93365481|NCT03819413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365482|NCT04099901|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93365483|NCT04099901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365484|NCT02394028|Etrolizumab|etrolizumab|mesh-list
93365485|NCT02394028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037332|NCT00414908|Pancrelipase|pancrelipase|mesh-list
93365486|NCT02394028|Immunologic Factors|immunologic factors|mesh-ancestor
93365487|NCT02394028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365488|NCT04079621|Primaquine|primaquine|mesh-list
93365489|NCT04079621|Antimalarials|antimalarials|mesh-ancestor
93365490|NCT04079621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93365491|NCT04079621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93365492|NCT04079621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365493|NCT02819297|Laxatives|laxatives|mesh-list
93365494|NCT02819297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365495|NCT05134441|Calcium, Dietary|calcium, dietary|mesh-list
93365496|NCT05134441|Calcium|calcium|mesh-list
93365497|NCT05134441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93365498|NCT05134441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365499|NCT05134441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93365500|NCT04925557|Ocrelizumab|ocrelizumab|mesh-list
93365501|NCT04925557|Siponimod|siponimod|mesh-list
93365502|NCT04925557|Immunologic Factors|immunologic factors|mesh-ancestor
93365503|NCT04925557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365504|NCT04925557|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93365505|NCT04925557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365506|NCT04925557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365507|NCT03063788|Copper|copper|mesh-list
93365508|NCT03063788|Trace Elements|trace elements|mesh-ancestor
93365509|NCT03063788|Micronutrients|micronutrients|mesh-ancestor
93365510|NCT03063788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365511|NCT02821715|Flecainide|flecainide|mesh-list
93365512|NCT02821715|Modafinil|modafinil|mesh-list
93365513|NCT02821715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93365514|NCT02821715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365515|NCT02821715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93365516|NCT02821715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93365517|NCT02821715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93365518|NCT02821715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365519|NCT02821715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93365520|NCT02821715|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93365521|NCT02821715|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93365522|NCT02821715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365523|NCT03545347|Nandrolone Decanoate|nandrolone decanoate|mesh-list
93365524|NCT03545347|Nandrolone|nandrolone|mesh-list
93365525|NCT03545347|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
93365526|NCT03545347|Androgens|androgens|mesh-ancestor
93365527|NCT03545347|Hormones|hormones|mesh-ancestor
93365528|NCT03545347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365529|NCT03545347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365530|NCT03545347|Anabolic Agents|anabolic agents|mesh-ancestor
93365531|NCT03545347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93365532|NCT02815397|Metformin|metformin|mesh-list
93365533|NCT02815397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93365534|NCT02815397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365535|NCT04980404|Decitabine|decitabine|mesh-list
93365536|NCT04980404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365537|NCT04980404|Antimetabolites|antimetabolites|mesh-ancestor
93365538|NCT04980404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365539|NCT04980404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365540|NCT04980404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365541|NCT02427958|Leuprolide|leuprolide|mesh-list
93365542|NCT02427958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93365543|NCT02427958|Fertility Agents|fertility agents|mesh-ancestor
93365544|NCT02427958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92659179|NCT01641406|Bevacizumab|bevacizumab|mesh-list
93365545|NCT02427958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365546|NCT02427958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365547|NCT02427958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365548|NCT03715127|Psilocybin|psilocybin|mesh-list
93365549|NCT03715127|Hallucinogens|hallucinogens|mesh-ancestor
93365550|NCT03715127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365551|NCT03715127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93365552|NCT02260037|Epinastine|epinastine|mesh-list
93365553|NCT02260037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93365554|NCT02260037|Histamine Antagonists|histamine antagonists|mesh-ancestor
93365555|NCT02260037|Histamine Agents|histamine agents|mesh-ancestor
93365556|NCT02260037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365557|NCT02260037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365558|NCT02260037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365559|NCT02036489|Prednisone|prednisone|mesh-list
93365560|NCT02036489|Vincristine|vincristine|mesh-list
93365561|NCT02036489|Daunorubicin|daunorubicin|mesh-list
93365562|NCT02036489|Asparaginase|asparaginase|mesh-list
93365563|NCT02036489|Mercaptopurine|mercaptopurine|mesh-list
93365564|NCT02036489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93365565|NCT02036489|Glucocorticoids|glucocorticoids|mesh-ancestor
93365566|NCT02036489|Hormones|hormones|mesh-ancestor
93365567|NCT02036489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365568|NCT02036489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365569|NCT02036489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365570|NCT02036489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365571|NCT02036489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365572|NCT02036489|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365573|NCT02036489|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365574|NCT02036489|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365575|NCT02036489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365576|NCT02036489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93365577|NCT02036489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93365578|NCT02036489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365579|NCT02036489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365580|NCT02036489|Antimetabolites|antimetabolites|mesh-ancestor
93365581|NCT02036489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365582|NCT02036489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365583|NCT02036489|Immunologic Factors|immunologic factors|mesh-ancestor
93365584|NCT02036489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93365585|NCT02392624|Omalizumab|omalizumab|mesh-list
93365586|NCT02392624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93365587|NCT02392624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93365588|NCT02392624|Respiratory System Agents|respiratory system agents|mesh-ancestor
93365589|NCT02047565|Edoxaban|edoxaban|mesh-list
93365590|NCT02047565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93365591|NCT02047565|Antithrombins|antithrombins|mesh-ancestor
93365592|NCT02047565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93365593|NCT02047565|Protease Inhibitors|protease inhibitors|mesh-ancestor
93365594|NCT02047565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365595|NCT02047565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365596|NCT02047565|Anticoagulants|anticoagulants|mesh-ancestor
93365597|NCT03063866|Fentanyl|fentanyl|mesh-list
93365598|NCT03063866|Midazolam|midazolam|mesh-list
93365599|NCT03063866|Propofol|propofol|mesh-list
93365600|NCT03063866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93365601|NCT03063866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365602|NCT03063866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365603|NCT03063866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93365604|NCT03063866|Anesthetics, General|anesthetics, general|mesh-ancestor
93365605|NCT03063866|Anesthetics|anesthetics|mesh-ancestor
93365606|NCT03063866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93365607|NCT03063866|Narcotics|narcotics|mesh-ancestor
93365608|NCT03063866|Analgesics|analgesics|mesh-ancestor
93365609|NCT03063866|Sensory System Agents|sensory system agents|mesh-ancestor
93365610|NCT03063866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365611|NCT03063866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93365612|NCT03063866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93365613|NCT03063866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93365614|NCT03063866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93365615|NCT03063866|GABA Modulators|gaba modulators|mesh-ancestor
93365616|NCT03063866|GABA Agents|gaba agents|mesh-ancestor
93365617|NCT03063866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365618|NCT03063866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365619|NCT02037191|Methotrexate|methotrexate|mesh-list
93365620|NCT02037191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93365621|NCT02037191|Abortifacient Agents|abortifacient agents|mesh-ancestor
93365622|NCT02037191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93365623|NCT02037191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365624|NCT02037191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365625|NCT02037191|Antimetabolites|antimetabolites|mesh-ancestor
93365626|NCT02037191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365627|NCT02037191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365628|NCT02037191|Dermatologic Agents|dermatologic agents|mesh-ancestor
93365629|NCT02037191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365630|NCT02037191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93365631|NCT02037191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365632|NCT02037191|Immunologic Factors|immunologic factors|mesh-ancestor
93365633|NCT02037191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365634|NCT02037191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93365635|NCT04980170|Amoxicillin|amoxicillin|mesh-list
93365636|NCT04980170|Clindamycin|clindamycin|mesh-list
93365637|NCT04980170|Clindamycin palmitate|clindamycin palmitate|mesh-list
93365638|NCT04980170|Clindamycin phosphate|clindamycin phosphate|mesh-list
93365639|NCT04980170|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93365640|NCT04980170|Clavulanic Acids|clavulanic acids|mesh-list
93365641|NCT04980170|Clavulanic Acid|clavulanic acid|mesh-list
93365642|NCT04980170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93365643|NCT04980170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365644|NCT04980170|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93365645|NCT04980170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365646|NCT04980170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365647|NCT04980170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93365648|NCT02387164|Vitamin D|vitamin d|mesh-list
93365649|NCT02387164|Cholecalciferol|cholecalciferol|mesh-list
93365650|NCT02387164|Vitamins|vitamins|mesh-ancestor
93365651|NCT02387164|Micronutrients|micronutrients|mesh-ancestor
93365652|NCT02387164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365653|NCT02387164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93365654|NCT02387164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93365655|NCT02047799|Calcitriol|calcitriol|mesh-list
93365656|NCT02047799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93365657|NCT02047799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365658|NCT02047799|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93365659|NCT02047799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365660|NCT02047799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365661|NCT02047799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93365662|NCT02047799|Vitamins|vitamins|mesh-ancestor
93365663|NCT02047799|Micronutrients|micronutrients|mesh-ancestor
93365664|NCT02047799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93365665|NCT02048189|Insulin Detemir|insulin detemir|mesh-list
93365666|NCT02048189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93365667|NCT02048189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365668|NCT02392234|Ivacaftor|ivacaftor|mesh-list
93365669|NCT02392234|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93365670|NCT02392234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365671|NCT02392234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365672|NCT02036723|Bevacizumab|bevacizumab|mesh-list
93365673|NCT02036723|Ranibizumab|ranibizumab|mesh-list
93365674|NCT02036723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365675|NCT02036723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365676|NCT02036723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93365677|NCT02036723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93365678|NCT02036723|Growth Substances|growth substances|mesh-ancestor
93365679|NCT02036723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365680|NCT02036723|Growth Inhibitors|growth inhibitors|mesh-ancestor
93365681|NCT02036879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93365682|NCT02036879|Norethindrone|norethindrone|mesh-list
93365683|NCT02036879|Norethindrone Acetate|norethindrone acetate|mesh-list
92659338|NCT04455139|Melphalan|melphalan|mesh-list
93365684|NCT02036879|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
93365685|NCT02036879|Estradiol|estradiol|mesh-list
93365686|NCT02036879|Estrogens|estrogens|mesh-ancestor
93365687|NCT02036879|Hormones|hormones|mesh-ancestor
93365688|NCT02036879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365689|NCT02036879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365690|NCT02036879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93365691|NCT02036879|Contraceptive Agents|contraceptive agents|mesh-ancestor
93365692|NCT02036879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93365693|NCT02036879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93365694|NCT02036879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93365695|NCT02036879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93365696|NCT02036879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93365697|NCT02036879|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93365698|NCT02036879|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
93365699|NCT02048345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93365700|NCT02963090|Pembrolizumab|pembrolizumab|mesh-list
93365701|NCT02963090|Topotecan|topotecan|mesh-list
93365702|NCT02963090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365703|NCT02963090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365704|NCT02963090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365705|NCT02963090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365706|NCT02963090|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93365707|NCT02963090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93365708|NCT02963090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365709|NCT02048423|Ketamine|ketamine|mesh-list
93365710|NCT02048423|Analgesics|analgesics|mesh-ancestor
93365711|NCT02048423|Sensory System Agents|sensory system agents|mesh-ancestor
93365712|NCT02048423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365713|NCT02048423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365714|NCT02048423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93365715|NCT02048423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93365717|NCT02048423|Anesthetics|anesthetics|mesh-ancestor
93365718|NCT02048423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365719|NCT02048423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93365720|NCT02048423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93365721|NCT02048423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365722|NCT02048423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365723|NCT02037035|Ketamine|ketamine|mesh-list
93365724|NCT02037035|Analgesics|analgesics|mesh-ancestor
93365725|NCT02037035|Sensory System Agents|sensory system agents|mesh-ancestor
93365726|NCT02037035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365727|NCT02037035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365728|NCT02037035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93365729|NCT02037035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93365730|NCT02037035|Anesthetics, General|anesthetics, general|mesh-ancestor
93365731|NCT02037035|Anesthetics|anesthetics|mesh-ancestor
93365732|NCT02037035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365733|NCT02037035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93365734|NCT02037035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93365735|NCT02037035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365736|NCT02037035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365737|NCT04979468|Lamivudine|lamivudine|mesh-list
93365738|NCT04979468|Dolutegravir|dolutegravir|mesh-list
93365739|NCT04979468|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93365740|NCT04979468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93365741|NCT04979468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365742|NCT04979468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365743|NCT04979468|Antiviral Agents|antiviral agents|mesh-ancestor
93365744|NCT04979468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365745|NCT04979468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93365746|NCT04979468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93365747|NCT04979468|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93365748|NCT04979468|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93365749|NCT03562169|Thalidomide|thalidomide|mesh-list
93365750|NCT03562169|Dexamethasone|dexamethasone|mesh-list
93365751|NCT03562169|Ixazomib|ixazomib|mesh-list
93365752|NCT03562169|Glycine|glycine|mesh-list
93365753|NCT03562169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93365754|NCT03562169|Antiemetics|antiemetics|mesh-ancestor
93365755|NCT03562169|Autonomic Agents|autonomic agents|mesh-ancestor
93365756|NCT03562169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365757|NCT03562169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365758|NCT03562169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365759|NCT03562169|Glucocorticoids|glucocorticoids|mesh-ancestor
93365760|NCT03562169|Hormones|hormones|mesh-ancestor
93365761|NCT03562169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365762|NCT03562169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365763|NCT03562169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365764|NCT03562169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365765|NCT03562169|Immunologic Factors|immunologic factors|mesh-ancestor
93365766|NCT03562169|Leprostatic Agents|leprostatic agents|mesh-ancestor
93365767|NCT03562169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93365768|NCT03562169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365769|NCT03562169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93365770|NCT03562169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93365771|NCT03562169|Growth Substances|growth substances|mesh-ancestor
93365772|NCT03562169|Growth Inhibitors|growth inhibitors|mesh-ancestor
93365773|NCT03562169|Protease Inhibitors|protease inhibitors|mesh-ancestor
93365774|NCT03562169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365775|NCT03562169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365776|NCT03562169|Glycine Agents|glycine agents|mesh-ancestor
93365777|NCT03562169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365778|NCT02427802|Gentamicins|gentamicins|mesh-list
93365779|NCT02427802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93365780|NCT02427802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365781|NCT02427802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93365782|NCT02427802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365783|NCT02427802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365784|NCT02050529|Labetalol|labetalol|mesh-list
93365785|NCT02050529|Hydralazine|hydralazine|mesh-list
93365786|NCT02050529|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93365787|NCT02050529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93365788|NCT02050529|Adrenergic Agents|adrenergic agents|mesh-ancestor
93365789|NCT02050529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037647|NCT00234052|Pemetrexed|pemetrexed|mesh-list
93365790|NCT02050529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365791|NCT02050529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365792|NCT02050529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93365793|NCT02050529|Sympathomimetics|sympathomimetics|mesh-ancestor
93365794|NCT02050529|Autonomic Agents|autonomic agents|mesh-ancestor
93365795|NCT02050529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365796|NCT02050529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93365797|NCT02050529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93365798|NCT02050529|Vasodilator Agents|vasodilator agents|mesh-ancestor
93365799|NCT02427646|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93365800|NCT02427646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93365801|NCT02427646|Botulinum Toxins|botulinum toxins|mesh-list
93365802|NCT02427646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93365803|NCT02427646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93365804|NCT02427646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365805|NCT02427646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365806|NCT02427646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93365807|NCT02427646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365808|NCT02427646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365809|NCT02427646|Cholinergic Agents|cholinergic agents|mesh-ancestor
93365810|NCT02427646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365811|NCT02048969|Flumazenil|flumazenil|mesh-list
93365812|NCT02048969|Antidotes|antidotes|mesh-ancestor
93365813|NCT02048969|Protective Agents|protective agents|mesh-ancestor
93365814|NCT02048969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365815|NCT02048969|GABA Modulators|gaba modulators|mesh-ancestor
93365816|NCT02048969|GABA Agents|gaba agents|mesh-ancestor
93365817|NCT02048969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365818|NCT02048969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365819|NCT03561935|Propafenone|propafenone|mesh-list
93365820|NCT03561935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93365821|NCT03561935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93365822|NCT03561935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92659467|NCT00280644|Leflunomide|leflunomide|mesh-list
93365823|NCT03561935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365824|NCT03561935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365825|NCT02808143|Pembrolizumab|pembrolizumab|mesh-list
93365826|NCT02808143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93365827|NCT02808143|BCG Vaccine|bcg vaccine|mesh-list
93365828|NCT02808143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365829|NCT02808143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365830|NCT02808143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365831|NCT02808143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365832|NCT02808143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93365833|NCT02808143|Immunologic Factors|immunologic factors|mesh-ancestor
93365834|NCT02808143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365835|NCT02620280|Paclitaxel|paclitaxel|mesh-list
93365836|NCT02620280|Carboplatin|carboplatin|mesh-list
93365837|NCT02620280|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93365838|NCT02620280|Atezolizumab|atezolizumab|mesh-list
93365839|NCT02620280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93365840|NCT02620280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365841|NCT02620280|Tubulin Modulators|tubulin modulators|mesh-ancestor
93365842|NCT02620280|Antimitotic Agents|antimitotic agents|mesh-ancestor
93365843|NCT02620280|Mitosis Modulators|mitosis modulators|mesh-ancestor
93365844|NCT02620280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365845|NCT02620280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365846|NCT02620280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365847|NCT02806973|Glucagon|glucagon|mesh-list
93365848|NCT02806973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365849|NCT02806973|Hormones|hormones|mesh-ancestor
93365850|NCT02806973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365851|NCT02806973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365852|NCT02049203|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
93365853|NCT02049203|Enzyme Activators|enzyme activators|mesh-ancestor
93365854|NCT02049203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365855|NCT02037737|Abatacept|abatacept|mesh-list
93365856|NCT02037737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365857|NCT02037737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365858|NCT02037737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365859|NCT02037737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037700|NCT03973840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365860|NCT02037737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365861|NCT02037737|Immunologic Factors|immunologic factors|mesh-ancestor
93365862|NCT02037737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365863|NCT02037737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365864|NCT02037503|Ketamine|ketamine|mesh-list
93365865|NCT02037503|Analgesics|analgesics|mesh-ancestor
93365866|NCT02037503|Sensory System Agents|sensory system agents|mesh-ancestor
93365867|NCT02037503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365868|NCT02037503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365869|NCT02037503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93365870|NCT02037503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93365871|NCT02037503|Anesthetics, General|anesthetics, general|mesh-ancestor
93365872|NCT02037503|Anesthetics|anesthetics|mesh-ancestor
93365873|NCT02037503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365874|NCT02037503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93365875|NCT02037503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93365876|NCT02037503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365877|NCT02037503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365878|NCT02049671|Hormones|hormones|mesh-list
93365879|NCT02049671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93365880|NCT02049671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365881|NCT02037815|Mannitol|mannitol|mesh-list
93365882|NCT02037815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93365883|NCT02037815|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93365884|NCT02037815|Diuretics|diuretics|mesh-ancestor
93365885|NCT02037815|Natriuretic Agents|natriuretic agents|mesh-ancestor
93365886|NCT02037815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365887|NCT02051621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93365888|NCT02806505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93365889|NCT02806505|Antiviral Agents|antiviral agents|mesh-ancestor
93365890|NCT02806505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365891|NCT02053727|Abatacept|abatacept|mesh-list
93365892|NCT02053727|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93365893|NCT02053727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365894|NCT02053727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93365895|NCT02053727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365896|NCT02053727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365897|NCT02053727|Immunologic Factors|immunologic factors|mesh-ancestor
93365898|NCT02053727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365899|NCT02053727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365900|NCT02051153|Modafinil|modafinil|mesh-list
93365901|NCT02051153|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93365902|NCT02051153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365903|NCT02051153|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93365904|NCT02051153|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93365905|NCT02051153|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93365906|NCT02051153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365907|NCT02807363|Leuprolide|leuprolide|mesh-list
93365908|NCT02807363|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93365909|NCT02807363|Fertility Agents|fertility agents|mesh-ancestor
93365910|NCT02807363|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93365911|NCT02807363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365912|NCT02807363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93365913|NCT02807363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365914|NCT02051231|Oxytocin|oxytocin|mesh-list
93365915|NCT02051231|Oxytocics|oxytocics|mesh-ancestor
93365916|NCT02051231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93365917|NCT02051231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365918|NCT02051387|Cannabidiol|cannabidiol|mesh-list
93365919|NCT02051387|Olanzapine|olanzapine|mesh-list
93365920|NCT02051387|Risperidone|risperidone|mesh-list
93365921|NCT02051387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93365922|NCT02051387|Amisulpride|amisulpride|mesh-list
93365923|NCT02051387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93365924|NCT02051387|Serotonin Agents|serotonin agents|mesh-ancestor
93365925|NCT02051387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93365926|NCT02051387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365927|NCT02051387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365928|NCT02051387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93365929|NCT02051387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93365930|NCT02051387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93365931|NCT02051387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93365932|NCT02051387|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93365933|NCT02051387|Dopamine Agents|dopamine agents|mesh-ancestor
93037778|NCT00209092|Docetaxel|docetaxel|mesh-list
93365934|NCT02051387|Antiemetics|antiemetics|mesh-ancestor
93365935|NCT02051387|Autonomic Agents|autonomic agents|mesh-ancestor
93365936|NCT02051387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365937|NCT02051387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93365938|NCT02051387|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93365939|NCT02051387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93365940|NCT02051387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93365941|NCT02051387|Antidepressive Agents|antidepressive agents|mesh-ancestor
93365942|NCT02051387|Anticonvulsants|anticonvulsants|mesh-ancestor
93365943|NCT02051387|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93365944|NCT02052167|Methotrexate|methotrexate|mesh-list
93365945|NCT02052167|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93365946|NCT02052167|Abortifacient Agents|abortifacient agents|mesh-ancestor
93365947|NCT02052167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93365948|NCT02052167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365949|NCT02052167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93365950|NCT02052167|Antimetabolites|antimetabolites|mesh-ancestor
93365951|NCT02052167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365952|NCT02052167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365953|NCT02052167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93365954|NCT02052167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365955|NCT02052167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93365956|NCT02052167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93365957|NCT02052167|Immunologic Factors|immunologic factors|mesh-ancestor
93365958|NCT02052167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365959|NCT02052167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93365960|NCT03524417|Immunoglobulins|immunoglobulins|mesh-list
93365961|NCT03524417|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93365962|NCT03524417|Antibodies|antibodies|mesh-list
93365963|NCT03524417|Immunologic Factors|immunologic factors|mesh-ancestor
93365964|NCT03524417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365965|NCT02054429|Insulin|insulin|mesh-list
93365966|NCT02054429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93365967|NCT02054429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93365968|NCT02054429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365969|NCT03806543|Vancomycin|vancomycin|mesh-list
93365970|NCT03806543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93365971|NCT03806543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365972|NCT02052323|Artesunate|artesunate|mesh-list
93365973|NCT02052323|Mefloquine|mefloquine|mesh-list
93365974|NCT02052323|Antimalarials|antimalarials|mesh-ancestor
93365975|NCT02052323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93365976|NCT02052323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93365977|NCT02052323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93365978|NCT02052323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93365979|NCT02052323|Antiviral Agents|antiviral agents|mesh-ancestor
93365980|NCT02052323|Schistosomicides|schistosomicides|mesh-ancestor
93365981|NCT02052323|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93365982|NCT02052323|Anthelmintics|anthelmintics|mesh-ancestor
93365983|NCT02056223|Acetaminophen|acetaminophen|mesh-list
93365984|NCT02056223|Ibuprofen|ibuprofen|mesh-list
93365985|NCT02056223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93365986|NCT02056223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93365987|NCT02056223|Analgesics|analgesics|mesh-ancestor
93365988|NCT02056223|Sensory System Agents|sensory system agents|mesh-ancestor
93365989|NCT02056223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93365990|NCT02056223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93365991|NCT02056223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93365992|NCT02056223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93365993|NCT02056223|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93365994|NCT02056223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93365995|NCT02056223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93365996|NCT02056223|Antipyretics|antipyretics|mesh-ancestor
93365997|NCT02056379|Dexamethasone|dexamethasone|mesh-list
93365998|NCT02056379|Budesonide|budesonide|mesh-list
93365999|NCT02056379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366000|NCT02056379|Antiemetics|antiemetics|mesh-ancestor
93366001|NCT02056379|Autonomic Agents|autonomic agents|mesh-ancestor
93366002|NCT02056379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366003|NCT02056379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366004|NCT02056379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93366005|NCT02056379|Glucocorticoids|glucocorticoids|mesh-ancestor
93366006|NCT02056379|Hormones|hormones|mesh-ancestor
93366007|NCT02056379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366008|NCT02056379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93366009|NCT02056379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037852|NCT00315705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366010|NCT02056379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93366011|NCT02056379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93366012|NCT02056379|Respiratory System Agents|respiratory system agents|mesh-ancestor
93366013|NCT02383966|Carboplatin|carboplatin|mesh-list
93366014|NCT02383966|Fluorouracil|fluorouracil|mesh-list
93366015|NCT02383966|Cetuximab|cetuximab|mesh-list
93366016|NCT02383966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366017|NCT02383966|Antimetabolites|antimetabolites|mesh-ancestor
93366018|NCT02383966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366019|NCT02383966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366020|NCT02383966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366021|NCT02383966|Immunologic Factors|immunologic factors|mesh-ancestor
93366022|NCT02383966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366023|NCT02383966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93366024|NCT02054663|Clopidogrel|clopidogrel|mesh-list
93366025|NCT02054663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93366026|NCT02054663|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93366027|NCT02054663|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93366028|NCT02054663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93366029|NCT02054663|Purinergic Agents|purinergic agents|mesh-ancestor
93366030|NCT02054663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366031|NCT02054663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366032|NCT02054663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366033|NCT02054975|Vitamin D|vitamin d|mesh-list
93366034|NCT02054975|Ergocalciferols|ergocalciferols|mesh-list
93366035|NCT02054975|Cholecalciferol|cholecalciferol|mesh-list
93366036|NCT02054975|Vitamins|vitamins|mesh-list
93366037|NCT02054975|Micronutrients|micronutrients|mesh-ancestor
93366038|NCT02054975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366039|NCT02054975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93366040|NCT02054975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93366041|NCT02055131|Aspirin|aspirin|mesh-list
93366042|NCT02055131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93366043|NCT02055131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366044|NCT02055131|Analgesics|analgesics|mesh-ancestor
93366045|NCT02055131|Sensory System Agents|sensory system agents|mesh-ancestor
93366046|NCT02055131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366047|NCT02055131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366048|NCT02055131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366049|NCT02055131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366050|NCT02055131|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93366051|NCT02055131|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93366052|NCT02055131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366053|NCT02055131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93366054|NCT02055131|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93366055|NCT02055131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366056|NCT02055131|Antipyretics|antipyretics|mesh-ancestor
93366057|NCT02056847|Calcium, Dietary|calcium, dietary|mesh-list
93366058|NCT02056847|Pitavastatin|pitavastatin|mesh-list
93366059|NCT02056847|Calcium|calcium|mesh-list
93366060|NCT02056847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93366061|NCT02056847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366062|NCT02056847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93366063|NCT02056847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93366064|NCT02056847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93366065|NCT02056847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93366066|NCT02056847|Antimetabolites|antimetabolites|mesh-ancestor
93366067|NCT02056847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366068|NCT02056847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366069|NCT02056847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93366070|NCT02052713|Tamsulosin|tamsulosin|mesh-list
93366071|NCT02052713|Dutasteride|dutasteride|mesh-list
93366072|NCT02052713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93366073|NCT02052713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93366074|NCT02052713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93366075|NCT02052713|Adrenergic Agents|adrenergic agents|mesh-ancestor
93366076|NCT02052713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366077|NCT02052713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366078|NCT02052713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366079|NCT02052713|Urological Agents|urological agents|mesh-ancestor
93366080|NCT02052713|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93366081|NCT02052713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93366082|NCT02052713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366083|NCT02052713|Hormone Antagonists|hormone antagonists|mesh-ancestor
93366084|NCT02052713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366085|NCT02057003|Sofosbuvir|sofosbuvir|mesh-list
93366086|NCT02057003|Grazoprevir|grazoprevir|mesh-list
93366087|NCT02057003|Ledipasvir|ledipasvir|mesh-list
93366088|NCT02057003|Velpatasvir|velpatasvir|mesh-list
93366089|NCT02057003|Simeprevir|simeprevir|mesh-list
93366090|NCT02057003|Antiviral Agents|antiviral agents|mesh-ancestor
93366091|NCT02057003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366092|NCT02057003|Protease Inhibitors|protease inhibitors|mesh-ancestor
93366093|NCT02057003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366094|NCT02057003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366095|NCT02426086|Niacinamide|niacinamide|mesh-list
93366096|NCT02426086|Imetelstat|imetelstat|mesh-list
93366097|NCT02426086|Motesanib diphosphate|motesanib diphosphate|mesh-list
93366098|NCT02426086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366099|NCT02426086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366100|NCT02426086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93366101|NCT02426086|Vitamin B Complex|vitamin b complex|mesh-ancestor
93366102|NCT02426086|Vitamins|vitamins|mesh-ancestor
93366103|NCT02426086|Micronutrients|micronutrients|mesh-ancestor
93366104|NCT02426086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366105|NCT02055911|Ranibizumab|ranibizumab|mesh-list
93366106|NCT02055911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93366107|NCT02055911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93366108|NCT02055911|Growth Substances|growth substances|mesh-ancestor
93366109|NCT02055911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366110|NCT02055911|Growth Inhibitors|growth inhibitors|mesh-ancestor
93366111|NCT02055911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366112|NCT02422264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93366113|NCT02422264|Immunologic Factors|immunologic factors|mesh-ancestor
93366114|NCT02422264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366115|NCT02390362|Rituximab|rituximab|mesh-list
93366116|NCT02390362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93366117|NCT02390362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366118|NCT02390362|Immunologic Factors|immunologic factors|mesh-ancestor
93366119|NCT02390362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366120|NCT02390362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366121|NCT02389816|Vortioxetine|vortioxetine|mesh-list
93366122|NCT02389816|Antidepressive Agents|antidepressive agents|mesh-ancestor
93366123|NCT02389816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93366124|NCT02389816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93366125|NCT02389816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93366126|NCT02389816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366127|NCT02389816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366128|NCT02389816|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93366129|NCT02389816|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93366130|NCT02389816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366131|NCT02389816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366132|NCT02389816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366133|NCT02389816|Serotonin Agents|serotonin agents|mesh-ancestor
93366134|NCT02389816|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93366135|NCT02389816|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93366136|NCT02389816|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93366137|NCT02389816|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93366138|NCT02388724|Lansoprazole|lansoprazole|mesh-list
93366139|NCT02388724|Dexlansoprazole|dexlansoprazole|mesh-list
93366140|NCT02388724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93366141|NCT02388724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93366142|NCT02388724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93366143|NCT02388724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366144|NCT02388724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366145|NCT02382640|Febuxostat|febuxostat|mesh-list
93366146|NCT02382640|Gout Suppressants|gout suppressants|mesh-ancestor
93366147|NCT02382640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366148|NCT02801669|Edoxaban|edoxaban|mesh-list
93366149|NCT02801669|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93366150|NCT02801669|Antithrombins|antithrombins|mesh-ancestor
93366151|NCT02801669|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93366152|NCT02801669|Protease Inhibitors|protease inhibitors|mesh-ancestor
93366153|NCT02801669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366154|NCT02801669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366155|NCT02801669|Anticoagulants|anticoagulants|mesh-ancestor
93366156|NCT02804399|Rifampin|rifampin|mesh-list
93366157|NCT02804399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93038011|NCT02532777|Hormones|hormones|mesh-ancestor
93366158|NCT02804399|Antitubercular Agents|antitubercular agents|mesh-ancestor
93366159|NCT02804399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93366160|NCT02804399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366161|NCT02804399|Leprostatic Agents|leprostatic agents|mesh-ancestor
93366162|NCT02804399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93366163|NCT02804399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366164|NCT02804399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366165|NCT02804399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93366166|NCT02804399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93366167|NCT02804399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93366168|NCT02804399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93366169|NCT02804399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93366170|NCT02804399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93366171|NCT05614037|Felodipine|felodipine|mesh-list
93366172|NCT05614037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93366173|NCT05614037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92659824|NCT00252863|Glucocorticoids|glucocorticoids|mesh-ancestor
93366174|NCT05614037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93366175|NCT05614037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366176|NCT05614037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366177|NCT05614037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93366178|NCT05614037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366179|NCT05614037|Vasodilator Agents|vasodilator agents|mesh-ancestor
93366180|NCT02058875|Cyclosporine|cyclosporine|mesh-list
93366181|NCT02058875|Mycophenolic Acid|mycophenolic acid|mesh-list
93366182|NCT02058875|Prednisone|prednisone|mesh-list
93366183|NCT02058875|Cyclosporins|cyclosporins|mesh-list
93366184|NCT02058875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366185|NCT02058875|Glucocorticoids|glucocorticoids|mesh-ancestor
93366186|NCT02058875|Hormones|hormones|mesh-ancestor
93366187|NCT02058875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366188|NCT02058875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366189|NCT02058875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93366190|NCT02058875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366191|NCT02058875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366192|NCT02058875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366193|NCT02058875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366194|NCT02058875|Immunologic Factors|immunologic factors|mesh-ancestor
93366195|NCT02058875|Antifungal Agents|antifungal agents|mesh-ancestor
93366196|NCT02058875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366197|NCT02058875|Dermatologic Agents|dermatologic agents|mesh-ancestor
93366198|NCT02058875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366199|NCT02058875|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93366200|NCT02058875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93366201|NCT02058875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93366202|NCT02058875|Antitubercular Agents|antitubercular agents|mesh-ancestor
93366203|NCT02058875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93366204|NCT02059031|Cabotegravir|cabotegravir|mesh-list
93366205|NCT02059031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93366206|NCT02059031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93366207|NCT02059031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366208|NCT02059031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366209|NCT02059031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93366210|NCT02059031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93366211|NCT02059031|Antiviral Agents|antiviral agents|mesh-ancestor
93366212|NCT02059031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366213|NCT01333865|Memantine|memantine|mesh-list
93366214|NCT01333865|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93366215|NCT01333865|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93366216|NCT01333865|Dopamine Agents|dopamine agents|mesh-ancestor
93366217|NCT01333865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366218|NCT01333865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366219|NCT01333865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366220|NCT01333865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93366221|NCT01333865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93366222|NCT04978688|Relugolix|relugolix|mesh-list
93366223|NCT04978688|Androgen Antagonists|androgen antagonists|mesh-ancestor
93366224|NCT04978688|Hormone Antagonists|hormone antagonists|mesh-ancestor
93366225|NCT04978688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366226|NCT04978688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366227|NCT03062072|Antineoplastic Agents|antineoplastic agents|mesh-list
93366228|NCT04434326|Vorolanib|vorolanib|mesh-list
93366229|NCT04434326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93366230|NCT04434326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366231|NCT04434326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366232|NCT01333397|Botulinum Toxins|botulinum toxins|mesh-list
93366233|NCT01333397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93366234|NCT01333397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93366235|NCT01333397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93366236|NCT01333397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366237|NCT01333397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366238|NCT01333397|Cholinergic Agents|cholinergic agents|mesh-ancestor
93366239|NCT01333397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366240|NCT01333397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366241|NCT01333397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93366242|NCT01333397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366243|NCT02172872|Decitabine|decitabine|mesh-list
93366244|NCT02172872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366245|NCT02172872|Antimetabolites|antimetabolites|mesh-ancestor
93366246|NCT02172872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366247|NCT02172872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366248|NCT02172872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366249|NCT02059655|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93366250|NCT02059655|Bimatoprost|bimatoprost|mesh-list
93366251|NCT02059655|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93366252|NCT02059655|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93366253|NCT02059655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93366254|NCT02059655|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93366255|NCT02059655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366452|NCT02796677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366453|NCT02796677|Parasympatholytics|parasympatholytics|mesh-ancestor
93366454|NCT02796677|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93366455|NCT02796677|Cholinergic Agents|cholinergic agents|mesh-ancestor
93366456|NCT02796677|Anticonvulsants|anticonvulsants|mesh-ancestor
93366457|NCT04973462|Oseltamivir|oseltamivir|mesh-list
93366458|NCT04973462|Antiviral Agents|antiviral agents|mesh-ancestor
93366459|NCT04973462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366460|NCT04973462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366461|NCT04973462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366462|NCT02378506|Etanercept|etanercept|mesh-list
93366463|NCT02378506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93366464|NCT02378506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366465|NCT02378506|Analgesics|analgesics|mesh-ancestor
93366466|NCT02378506|Sensory System Agents|sensory system agents|mesh-ancestor
93366467|NCT02378506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366468|NCT02378506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366469|NCT02378506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366470|NCT02378506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366471|NCT02378506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93366472|NCT02378506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366473|NCT02378506|Immunologic Factors|immunologic factors|mesh-ancestor
93366474|NCT02794883|Durvalumab|durvalumab|mesh-list
93366475|NCT02794883|Ipilimumab|ipilimumab|mesh-list
93366476|NCT02794883|Tremelimumab|tremelimumab|mesh-list
93366477|NCT02794883|Immunoglobulins|immunoglobulins|mesh-list
93366478|NCT02794883|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93366479|NCT02794883|Immunoglobulin G|immunoglobulin g|mesh-list
93366480|NCT02794883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93366481|NCT02794883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366482|NCT02794883|Immunologic Factors|immunologic factors|mesh-ancestor
93366483|NCT02794883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366484|NCT02794883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93366485|NCT02794883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366486|NCT02063789|Immunoglobulins|immunoglobulins|mesh-list
93366487|NCT02063789|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93366488|NCT02063789|Antibodies|antibodies|mesh-list
93366489|NCT02063789|Immunologic Factors|immunologic factors|mesh-ancestor
93366490|NCT02063789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366491|NCT02063945|Risperidone|risperidone|mesh-list
93366492|NCT02063945|Methylphenidate|methylphenidate|mesh-list
93366493|NCT02063945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93366494|NCT02063945|Serotonin Agents|serotonin agents|mesh-ancestor
93366495|NCT02063945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366496|NCT02063945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366497|NCT02063945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366498|NCT02063945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93366499|NCT02063945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93366500|NCT02063945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366501|NCT02063945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038150|NCT01067235|Modafinil|modafinil|mesh-list
93366502|NCT02063945|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93366504|NCT02063945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93366505|NCT02063945|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93366506|NCT02063945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93366507|NCT02063945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366508|NCT02064023|Insulin|insulin|mesh-list
93366509|NCT02064023|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93366510|NCT02064023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93366511|NCT02064023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366512|NCT02064725|10-carboxymethyl-9-acridanone|10-carboxymethyl-9-acridanone|mesh-list
93366513|NCT02064725|Interferon Inducers|interferon inducers|mesh-ancestor
93366514|NCT02064725|Immunologic Factors|immunologic factors|mesh-ancestor
93366515|NCT02064725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366516|NCT01370603|Atorvastatin|atorvastatin|mesh-list
93366517|NCT01370603|Ezetimibe|ezetimibe|mesh-list
93366518|NCT01370603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93366519|NCT01370603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93366520|NCT01370603|Antimetabolites|antimetabolites|mesh-ancestor
93366521|NCT01370603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366522|NCT01370603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93366523|NCT01370603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93366524|NCT01370603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366525|NCT02659397|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93366526|NCT02659397|Atorvastatin|atorvastatin|mesh-list
93366527|NCT02659397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93366528|NCT02659397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93366529|NCT02659397|Antimetabolites|antimetabolites|mesh-ancestor
93366530|NCT02659397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366531|NCT02659397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93366532|NCT02659397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93366533|NCT02659397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366534|NCT02659397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93366535|NCT02659397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366536|NCT02347072|Glycopyrrolate|glycopyrrolate|mesh-list
93366537|NCT02347072|Bromides|bromides|mesh-list
93366538|NCT02347072|Formoterol Fumarate|formoterol fumarate|mesh-list
93366539|NCT02347072|Tiotropium Bromide|tiotropium bromide|mesh-list
93366540|NCT02347072|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93366541|NCT02347072|Autonomic Agents|autonomic agents|mesh-ancestor
93366542|NCT02347072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366543|NCT02347072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366544|NCT02347072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93366545|NCT02347072|Respiratory System Agents|respiratory system agents|mesh-ancestor
93366546|NCT02347072|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93366547|NCT02347072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93366548|NCT02347072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93366549|NCT02347072|Adrenergic Agents|adrenergic agents|mesh-ancestor
93366550|NCT02347072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366551|NCT02347072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366552|NCT02347072|Parasympatholytics|parasympatholytics|mesh-ancestor
93366553|NCT02347072|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93366554|NCT02347072|Cholinergic Agents|cholinergic agents|mesh-ancestor
93366555|NCT02347072|Anticonvulsants|anticonvulsants|mesh-ancestor
93366556|NCT02347072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93366557|NCT02347072|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93366558|NCT02064491|Paclitaxel|paclitaxel|mesh-list
93366559|NCT02064491|Docetaxel|docetaxel|mesh-list
93366560|NCT02064491|Cisplatin|cisplatin|mesh-list
93366561|NCT02064491|Carboplatin|carboplatin|mesh-list
93366562|NCT02064491|Pemetrexed|pemetrexed|mesh-list
93366563|NCT02064491|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93366564|NCT02064491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93366565|NCT02064491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366566|NCT02064491|Tubulin Modulators|tubulin modulators|mesh-ancestor
93366567|NCT02064491|Antimitotic Agents|antimitotic agents|mesh-ancestor
93366568|NCT02064491|Mitosis Modulators|mitosis modulators|mesh-ancestor
93366569|NCT02064491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366570|NCT02064491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366571|NCT02064491|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93366572|NCT02064491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93366573|NCT02064491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93366574|NCT02064881|Metformin|metformin|mesh-list
93366575|NCT02064881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93366576|NCT02064881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366577|NCT02346370|Docetaxel|docetaxel|mesh-list
93366578|NCT02346370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366579|NCT02346370|Tubulin Modulators|tubulin modulators|mesh-ancestor
93366580|NCT02346370|Antimitotic Agents|antimitotic agents|mesh-ancestor
93366581|NCT02346370|Mitosis Modulators|mitosis modulators|mesh-ancestor
93366582|NCT02346370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366583|NCT02065739|Itraconazole|itraconazole|mesh-list
93366584|NCT02065739|JNJ-42165279|jnj-42165279|mesh-list
93366585|NCT02065739|Antifungal Agents|antifungal agents|mesh-ancestor
93366586|NCT02065739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366587|NCT02065739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93366588|NCT02065739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93366589|NCT02065739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366590|NCT02065739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366591|NCT02065739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93366592|NCT02065739|Hormone Antagonists|hormone antagonists|mesh-ancestor
93366593|NCT02065739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366594|NCT02065739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366595|NCT02065739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93366596|NCT02068079|Vemurafenib|vemurafenib|mesh-list
93366597|NCT02068079|Trientine|trientine|mesh-list
93366598|NCT02068079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366599|NCT02068079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93366600|NCT02068079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366601|NCT02068079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366602|NCT02068079|Chelating Agents|chelating agents|mesh-ancestor
93366603|NCT02068079|Sequestering Agents|sequestering agents|mesh-ancestor
93366604|NCT02793947|Epinephrine|epinephrine|mesh-list
93366605|NCT02793947|Morphine|morphine|mesh-list
93366606|NCT02793947|Ropivacaine|ropivacaine|mesh-list
93366607|NCT02793947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93366608|NCT02793947|Narcotics|narcotics|mesh-ancestor
93366609|NCT02793947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366610|NCT02793947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366611|NCT02793947|Analgesics|analgesics|mesh-ancestor
93366612|NCT02793947|Sensory System Agents|sensory system agents|mesh-ancestor
93366613|NCT02793947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366614|NCT02793947|Anesthetics, Local|anesthetics, local|mesh-ancestor
93366615|NCT02793947|Anesthetics|anesthetics|mesh-ancestor
93366616|NCT02793947|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93366617|NCT02793947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93366618|NCT02793947|Adrenergic Agents|adrenergic agents|mesh-ancestor
93366619|NCT02793947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366620|NCT02793947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366621|NCT02793947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93366622|NCT02793947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93366623|NCT02793947|Autonomic Agents|autonomic agents|mesh-ancestor
93366624|NCT02793947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93366625|NCT02793947|Respiratory System Agents|respiratory system agents|mesh-ancestor
93366626|NCT02793947|Mydriatics|mydriatics|mesh-ancestor
93366627|NCT02793947|Sympathomimetics|sympathomimetics|mesh-ancestor
93366628|NCT02793947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93366629|NCT02068235|Ponesimod|ponesimod|mesh-list
93366630|NCT02068235|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93366631|NCT02068235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366632|NCT02068235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366633|NCT02068235|Immunologic Factors|immunologic factors|mesh-ancestor
93366634|NCT02068235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366635|NCT01370213|Interleukin-2|interleukin-2|mesh-list
93366636|NCT01370213|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93366637|NCT01370213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366638|NCT01370213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366639|NCT01370213|Analgesics|analgesics|mesh-ancestor
93366640|NCT01370213|Sensory System Agents|sensory system agents|mesh-ancestor
93366641|NCT01370213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366642|NCT01370213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366643|NCT01370213|Immunologic Factors|immunologic factors|mesh-ancestor
93366644|NCT01370213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366645|NCT02066207|Atorvastatin|atorvastatin|mesh-list
93366646|NCT02066207|Fenofibrate|fenofibrate|mesh-list
93366647|NCT02066207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93366648|NCT02066207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93366649|NCT02066207|Antimetabolites|antimetabolites|mesh-ancestor
93366650|NCT02066207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366651|NCT02066207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93366652|NCT02066207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93366653|NCT02066207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366654|NCT01370525|Esomeprazole|esomeprazole|mesh-list
93366655|NCT01370525|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93366656|NCT01370525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93366657|NCT01370525|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93366658|NCT01370525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366659|NCT01370525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366660|NCT02065349|ASP8477|asp8477|mesh-list
93366661|NCT02065349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366662|NCT02065349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366663|NCT02068625|Rasagiline|rasagiline|mesh-list
93366664|NCT02068625|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93366665|NCT02068625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366666|NCT02068625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366667|NCT02068625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93366668|NCT02068625|Protective Agents|protective agents|mesh-ancestor
93366669|NCT02068625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366670|NCT02068859|Diclofenac|diclofenac|mesh-list
93366671|NCT02068859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93366672|NCT02068859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366673|NCT02068859|Analgesics|analgesics|mesh-ancestor
93366674|NCT02068859|Sensory System Agents|sensory system agents|mesh-ancestor
93366675|NCT02068859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366676|NCT02068859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366677|NCT02068859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366678|NCT02068859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366679|NCT02068859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93366680|NCT02068859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366681|NCT02068859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366682|NCT02068937|Furosemide|furosemide|mesh-list
93366683|NCT02068937|Diuretics|diuretics|mesh-ancestor
93366684|NCT02068937|Natriuretic Agents|natriuretic agents|mesh-ancestor
93366685|NCT02068937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366686|NCT02068937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93366687|NCT02068937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366688|NCT02068937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366689|NCT02066675|Trabectedin|trabectedin|mesh-list
93366690|NCT02066675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93366691|NCT02066675|Alkylating Agents|alkylating agents|mesh-ancestor
93366692|NCT02066675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366693|NCT02066675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366694|NCT02072135|Bupivacaine|bupivacaine|mesh-list
93366695|NCT02072135|Anesthetics, Local|anesthetics, local|mesh-ancestor
93366696|NCT02072135|Anesthetics|anesthetics|mesh-ancestor
93366697|NCT02072135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366698|NCT02072135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366699|NCT02072135|Sensory System Agents|sensory system agents|mesh-ancestor
93366700|NCT02072135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366701|NCT02067065|Propofol|propofol|mesh-list
93366702|NCT02067065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93366703|NCT02067065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366704|NCT02067065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366705|NCT02067065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93366706|NCT02067065|Anesthetics, General|anesthetics, general|mesh-ancestor
93366707|NCT02067065|Anesthetics|anesthetics|mesh-ancestor
93366708|NCT02067143|Cytarabine|cytarabine|mesh-list
93366709|NCT02067143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366710|NCT02067143|Antimetabolites|antimetabolites|mesh-ancestor
93366711|NCT02067143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366712|NCT02067143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366713|NCT02067143|Antiviral Agents|antiviral agents|mesh-ancestor
93366714|NCT02067143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366715|NCT02067143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366716|NCT02067143|Immunologic Factors|immunologic factors|mesh-ancestor
93366717|NCT02067143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366718|NCT02072213|Tamsulosin|tamsulosin|mesh-list
93366719|NCT02072213|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93366720|NCT02072213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93366721|NCT02072213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93366722|NCT02072213|Adrenergic Agents|adrenergic agents|mesh-ancestor
93366723|NCT02072213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366724|NCT02072213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366725|NCT02072213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366727|NCT02072291|Nifedipine|nifedipine|mesh-list
93366728|NCT02072291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93366729|NCT02072291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366730|NCT02072291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366731|NCT02072291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93366732|NCT02072291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366733|NCT02072291|Vasodilator Agents|vasodilator agents|mesh-ancestor
93366734|NCT02072291|Tocolytic Agents|tocolytic agents|mesh-ancestor
93366735|NCT02072291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93366736|NCT02072525|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93366737|NCT02072525|Immunologic Factors|immunologic factors|mesh-ancestor
93366738|NCT02072525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366739|NCT03059888|Abatacept|abatacept|mesh-list
93366740|NCT03059888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93366741|NCT03059888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366742|NCT03059888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93366743|NCT03059888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366744|NCT03059888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366745|NCT03059888|Immunologic Factors|immunologic factors|mesh-ancestor
93366746|NCT03059888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366747|NCT03059888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366748|NCT04976816|Triamcinolone|triamcinolone|mesh-list
93366749|NCT04976816|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93366750|NCT04976816|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93366751|NCT04976816|Betamethasone|betamethasone|mesh-list
93366752|NCT04976816|Betamethasone Valerate|betamethasone valerate|mesh-list
93366753|NCT04976816|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93366754|NCT04976816|Betamethasone benzoate|betamethasone benzoate|mesh-list
93366755|NCT04976816|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93366756|NCT04976816|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93366757|NCT04976816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366758|NCT04976816|Glucocorticoids|glucocorticoids|mesh-ancestor
93366759|NCT04976816|Hormones|hormones|mesh-ancestor
93366760|NCT04976816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366761|NCT04976816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366762|NCT04976816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366763|NCT04976816|Immunologic Factors|immunologic factors|mesh-ancestor
93366764|NCT04976816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366765|NCT04976816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366766|NCT04976816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93366767|NCT04976816|Respiratory System Agents|respiratory system agents|mesh-ancestor
93366768|NCT03061838|Rituximab|rituximab|mesh-list
93366769|NCT03061838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93366770|NCT03061838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366771|NCT03061838|Immunologic Factors|immunologic factors|mesh-ancestor
93366772|NCT03061838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366773|NCT03061838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366774|NCT04964180|Indomethacin|indomethacin|mesh-list
93366775|NCT04964180|Lidocaine|lidocaine|mesh-list
93366776|NCT04964180|Anesthetics, Local|anesthetics, local|mesh-ancestor
93366777|NCT04964180|Anesthetics|anesthetics|mesh-ancestor
93366778|NCT04964180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366779|NCT04964180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366780|NCT04964180|Sensory System Agents|sensory system agents|mesh-ancestor
93366781|NCT04964180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366782|NCT04964180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93366783|NCT04964180|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93366784|NCT04964180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93366785|NCT04964180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366786|NCT04964180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366787|NCT04964180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93366788|NCT04964180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366789|NCT04964180|Analgesics|analgesics|mesh-ancestor
93366790|NCT04964180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366791|NCT04964180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366792|NCT04964180|Gout Suppressants|gout suppressants|mesh-ancestor
93366793|NCT04964180|Tocolytic Agents|tocolytic agents|mesh-ancestor
93366794|NCT04964180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93366795|NCT04964180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93366796|NCT04964180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366797|NCT02067377|Immunoglobulins|immunoglobulins|mesh-list
93038446|NCT00400764|Rituximab|rituximab|mesh-list
93366798|NCT02067377|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93366799|NCT02067377|Antibodies|antibodies|mesh-list
93366800|NCT02067377|Immunologic Factors|immunologic factors|mesh-ancestor
93366801|NCT02067377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366802|NCT02073149|Iron|iron|mesh-list
93366803|NCT02073149|Fe(III)-EDTA|fe(iii)-edta|mesh-list
93366804|NCT02073149|Trace Elements|trace elements|mesh-ancestor
93366805|NCT02073149|Micronutrients|micronutrients|mesh-ancestor
93366806|NCT02073149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366807|NCT02073149|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93366808|NCT02073149|Chelating Agents|chelating agents|mesh-ancestor
93366809|NCT02073149|Sequestering Agents|sequestering agents|mesh-ancestor
93366810|NCT02073149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366811|NCT02625974|Nifurtimox|nifurtimox|mesh-list
93366812|NCT02625974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93366813|NCT02625974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93366814|NCT02625974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93366815|NCT02625974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366816|NCT02067767|Lamivudine|lamivudine|mesh-list
93366817|NCT02067767|Abacavir|abacavir|mesh-list
93366818|NCT02067767|Dolutegravir|dolutegravir|mesh-list
93366819|NCT02067767|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93366820|NCT02067767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93366821|NCT02067767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366822|NCT02067767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366823|NCT02067767|Antiviral Agents|antiviral agents|mesh-ancestor
93366824|NCT02067767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366825|NCT02067767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93366826|NCT02067767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93366827|NCT02067767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93366828|NCT02067767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93366829|NCT02073227|Metformin|metformin|mesh-list
93366830|NCT02073227|Canagliflozin|canagliflozin|mesh-list
93366831|NCT02073227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93366832|NCT02073227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366833|NCT02073227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93366834|NCT02073227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366835|NCT03060044|Fluticasone|fluticasone|mesh-list
93366836|NCT03060044|Xhance|xhance|mesh-list
93366837|NCT03060044|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93366838|NCT03060044|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93366839|NCT03060044|Charcoal|charcoal|mesh-list
93366840|NCT03060044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366841|NCT03060044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93366842|NCT03060044|Autonomic Agents|autonomic agents|mesh-ancestor
93366843|NCT03060044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366844|NCT03060044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366845|NCT03060044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93366846|NCT03060044|Respiratory System Agents|respiratory system agents|mesh-ancestor
93366847|NCT03060044|Dermatologic Agents|dermatologic agents|mesh-ancestor
93366848|NCT03060044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93366849|NCT03060044|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93366850|NCT03060044|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93366851|NCT03060044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93366852|NCT03060044|Adrenergic Agents|adrenergic agents|mesh-ancestor
93366853|NCT03060044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366854|NCT03060044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366855|NCT03060044|Glucocorticoids|glucocorticoids|mesh-ancestor
93366856|NCT03060044|Hormones|hormones|mesh-ancestor
93366857|NCT03060044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93366858|NCT03060044|Sympathomimetics|sympathomimetics|mesh-ancestor
93366859|NCT03060044|Antidotes|antidotes|mesh-ancestor
93366860|NCT03060044|Protective Agents|protective agents|mesh-ancestor
93366861|NCT02070653|Ticagrelor|ticagrelor|mesh-list
93366862|NCT02070653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93366863|NCT02070653|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93366864|NCT02070653|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93366865|NCT02070653|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93366866|NCT02070653|Purinergic Agents|purinergic agents|mesh-ancestor
93366867|NCT02070653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366868|NCT02070653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366869|NCT02070653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366870|NCT04831892|Isosorbide|isosorbide|mesh-list
93366871|NCT04831892|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93038521|NCT01068327|Protective Agents|protective agents|mesh-ancestor
93366872|NCT04831892|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93366873|NCT04831892|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93366874|NCT04831892|Diuretics|diuretics|mesh-ancestor
93366875|NCT04831892|Natriuretic Agents|natriuretic agents|mesh-ancestor
93366876|NCT04831892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366877|NCT04831892|Vasodilator Agents|vasodilator agents|mesh-ancestor
93366878|NCT04831892|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93366879|NCT04831892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366880|NCT02073773|Levodopa|levodopa|mesh-list
93366881|NCT02073773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93366882|NCT02073773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93366883|NCT02073773|Dopamine Agents|dopamine agents|mesh-ancestor
93366884|NCT02073773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366885|NCT02073773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366886|NCT02073773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366887|NCT03062150|Cycloserine|cycloserine|mesh-list
93366888|NCT03062150|Fludrocortisone|fludrocortisone|mesh-list
93366889|NCT03062150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93366890|NCT03062150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366891|NCT03062150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93366892|NCT03062150|Antitubercular Agents|antitubercular agents|mesh-ancestor
93366893|NCT03062150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93366894|NCT03062150|Antimetabolites|antimetabolites|mesh-ancestor
93366895|NCT03062150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366896|NCT03062150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366897|NCT03061916|Chlorhexidine|chlorhexidine|mesh-list
93366898|NCT03061916|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93366899|NCT03061916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93366900|NCT03061916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93366901|NCT03061916|Disinfectants|disinfectants|mesh-ancestor
93366902|NCT03061916|Dermatologic Agents|dermatologic agents|mesh-ancestor
93366903|NCT02076659|Methotrexate|methotrexate|mesh-list
93366904|NCT02076659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93366905|NCT02076659|Abortifacient Agents|abortifacient agents|mesh-ancestor
93366906|NCT02076659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93366907|NCT02076659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366908|NCT02076659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366909|NCT02076659|Antimetabolites|antimetabolites|mesh-ancestor
93366910|NCT02076659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366911|NCT02076659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366912|NCT02076659|Dermatologic Agents|dermatologic agents|mesh-ancestor
93366913|NCT02076659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366914|NCT02076659|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93366915|NCT02076659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366916|NCT02076659|Immunologic Factors|immunologic factors|mesh-ancestor
93366917|NCT02076659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366918|NCT02076659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93366919|NCT04975724|Citalopram|citalopram|mesh-list
93366920|NCT04975724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93366921|NCT04975724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93366922|NCT04975724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366923|NCT04975724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366924|NCT04975724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366925|NCT04975724|Serotonin Agents|serotonin agents|mesh-ancestor
93366926|NCT04975724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366927|NCT04975724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93366928|NCT04975724|Antidepressive Agents|antidepressive agents|mesh-ancestor
93366929|NCT04975724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93366930|NCT02076815|Anagrelide|anagrelide|mesh-list
93366931|NCT02076815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93366932|NCT02076815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93366933|NCT02076815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366934|NCT02076815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93366935|NCT02071043|Capecitabine|capecitabine|mesh-list
93366936|NCT02071043|Oxaliplatin|oxaliplatin|mesh-list
92660397|NCT01687582|Exenatide|exenatide|mesh-list
93366937|NCT02071043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366938|NCT02071043|Antimetabolites|antimetabolites|mesh-ancestor
93366939|NCT02071043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366940|NCT02071043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366941|NCT02076893|Ibuprofen|ibuprofen|mesh-list
93366942|NCT02076893|Gabapentin|gabapentin|mesh-list
93366943|NCT02076893|Tramadol|tramadol|mesh-list
93366944|NCT02076893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93366945|NCT02076893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93366946|NCT02076893|Analgesics|analgesics|mesh-ancestor
93366947|NCT02076893|Sensory System Agents|sensory system agents|mesh-ancestor
93366948|NCT02076893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366949|NCT02076893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366950|NCT02076893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93366951|NCT02076893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366952|NCT02076893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93366953|NCT02076893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366954|NCT02076893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366955|NCT02076893|Anticonvulsants|anticonvulsants|mesh-ancestor
93366956|NCT02076893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93366957|NCT02076893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93366958|NCT02076893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93366959|NCT02076893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93366960|NCT02076893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93366961|NCT02076893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93366962|NCT02076893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366963|NCT02076893|Antimanic Agents|antimanic agents|mesh-ancestor
93366964|NCT02076893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93366965|NCT02076893|Narcotics|narcotics|mesh-ancestor
93366966|NCT02074163|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93366967|NCT02074163|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93366968|NCT02074163|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93366969|NCT02074163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93366970|NCT02074163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366971|NCT02074163|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93366972|NCT02074163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93366973|NCT02074163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366974|NCT02074163|Cholinergic Agents|cholinergic agents|mesh-ancestor
93366975|NCT02074163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93366976|NCT04963088|Capecitabine|capecitabine|mesh-list
93366977|NCT04963088|Oxaliplatin|oxaliplatin|mesh-list
93366978|NCT04963088|Tislelizumab|tislelizumab|mesh-list
93366979|NCT04963088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366980|NCT04963088|Antimetabolites|antimetabolites|mesh-ancestor
93366981|NCT04963088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366982|NCT04963088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366983|NCT04963088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93366984|NCT02074319|Methotrexate|methotrexate|mesh-list
93366985|NCT02074319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93366986|NCT02074319|Abortifacient Agents|abortifacient agents|mesh-ancestor
93366987|NCT02074319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93366988|NCT02074319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93366989|NCT02074319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93366990|NCT02074319|Antimetabolites|antimetabolites|mesh-ancestor
93366991|NCT02074319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93366992|NCT02074319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93366993|NCT02074319|Dermatologic Agents|dermatologic agents|mesh-ancestor
93366994|NCT02074319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93366995|NCT02074319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93366996|NCT02074319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93366997|NCT02074319|Immunologic Factors|immunologic factors|mesh-ancestor
93366998|NCT02074319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93366999|NCT02074319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93367000|NCT04975022|Insulin|insulin|mesh-list
93367001|NCT04975022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93367002|NCT04975022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367003|NCT03061604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93367004|NCT03061604|Ceftriaxone|ceftriaxone|mesh-list
93367005|NCT03061604|Octreotide|octreotide|mesh-list
93367006|NCT03061604|Hemostatics|hemostatics|mesh-list
93367007|NCT03061604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367008|NCT03061604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367009|NCT03061604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93367010|NCT03061604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367011|NCT03061604|Coagulants|coagulants|mesh-ancestor
93367012|NCT04974944|Paclitaxel|paclitaxel|mesh-list
93367013|NCT04974944|Bevacizumab|bevacizumab|mesh-list
93367014|NCT04974944|Carboplatin|carboplatin|mesh-list
93367015|NCT04974944|Apatinib|apatinib|mesh-list
93367016|NCT04974944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93367017|NCT04974944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367018|NCT04974944|Tubulin Modulators|tubulin modulators|mesh-ancestor
93367019|NCT04974944|Antimitotic Agents|antimitotic agents|mesh-ancestor
93367020|NCT04974944|Mitosis Modulators|mitosis modulators|mesh-ancestor
93367021|NCT04974944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367022|NCT04974944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367023|NCT04974944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93367024|NCT04974944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93367025|NCT04974944|Growth Substances|growth substances|mesh-ancestor
93367026|NCT04974944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367027|NCT04974944|Growth Inhibitors|growth inhibitors|mesh-ancestor
93367028|NCT04974944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367029|NCT04974944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367030|NCT04962386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93367031|NCT04962386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93367032|NCT04962386|Hormones|hormones|mesh-list
93367033|NCT04962386|Estradiol|estradiol|mesh-list
93367034|NCT04962386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93367035|NCT04962386|Progesterone|progesterone|mesh-list
93367036|NCT04962386|Estrogens|estrogens|mesh-list
93367037|NCT04962386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367038|NCT04962386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367039|NCT04962386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93367040|NCT04962386|Contraceptive Agents|contraceptive agents|mesh-ancestor
93367041|NCT04962386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93367042|NCT04962386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93367043|NCT04962386|Progestins|progestins|mesh-ancestor
93367044|NCT02071355|Simeprevir|simeprevir|mesh-list
93367045|NCT02071355|Antiviral Agents|antiviral agents|mesh-ancestor
93367046|NCT02071355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367047|NCT02071355|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367048|NCT02071355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367049|NCT02071355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367050|NCT02071433|Iodine|iodine|mesh-list
93367051|NCT02071433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93367052|NCT02071433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367053|NCT02071433|Trace Elements|trace elements|mesh-ancestor
93367054|NCT02071433|Micronutrients|micronutrients|mesh-ancestor
93367055|NCT02071433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367056|NCT04962308|Vaccines|vaccines|mesh-list
93367057|NCT04962308|Immunologic Factors|immunologic factors|mesh-ancestor
93367058|NCT04962308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367059|NCT02071589|Nifedipine|nifedipine|mesh-list
93367060|NCT02071589|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93367061|NCT02071589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367062|NCT02071589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367063|NCT02071589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93367064|NCT02071589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367065|NCT02071589|Vasodilator Agents|vasodilator agents|mesh-ancestor
93367066|NCT02071589|Tocolytic Agents|tocolytic agents|mesh-ancestor
93367067|NCT02071589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93367068|NCT02077751|Biotin|biotin|mesh-list
93367069|NCT02077751|Vitamin B Complex|vitamin b complex|mesh-ancestor
93367070|NCT02077751|Vitamins|vitamins|mesh-ancestor
93367071|NCT02077751|Micronutrients|micronutrients|mesh-ancestor
93367072|NCT02077751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367073|NCT04961684|Amorolfine|amorolfine|mesh-list
93367074|NCT04961684|Antifungal Agents|antifungal agents|mesh-ancestor
93367075|NCT04961684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367076|NCT03061058|Docetaxel|docetaxel|mesh-list
93367077|NCT03061058|Oxaliplatin|oxaliplatin|mesh-list
93367078|NCT03061058|Irinotecan|irinotecan|mesh-list
93367079|NCT03061058|Pemetrexed|pemetrexed|mesh-list
93367080|NCT03061058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367081|NCT03061058|Tubulin Modulators|tubulin modulators|mesh-ancestor
93367082|NCT03061058|Antimitotic Agents|antimitotic agents|mesh-ancestor
93367083|NCT03061058|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660545|NCT00415064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367084|NCT03061058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367085|NCT03061058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93367086|NCT03061058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93367087|NCT03061058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367088|NCT03061058|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93367089|NCT03061058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93367090|NCT04961918|Durvalumab|durvalumab|mesh-list
93367091|NCT04961918|Lenvatinib|lenvatinib|mesh-list
93367092|NCT04961918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367093|NCT04961918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367094|NCT04961918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367095|NCT04961918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367096|NCT04961918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367097|NCT04954040|Azithromycin|azithromycin|mesh-list
93367098|NCT04954040|Hydroxychloroquine|hydroxychloroquine|mesh-list
93367099|NCT04954040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93367100|NCT04954040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367101|NCT04954040|Antimalarials|antimalarials|mesh-ancestor
93367102|NCT04954040|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93367103|NCT04954040|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93367104|NCT04954040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367105|NCT04954040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367106|NCT04954040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367107|NCT04424654|Methyltestosterone|methyltestosterone|mesh-list
93367108|NCT04424654|Testosterone|testosterone|mesh-list
93367109|NCT04424654|Testosterone undecanoate|testosterone undecanoate|mesh-list
93367110|NCT04424654|Testosterone enanthate|testosterone enanthate|mesh-list
93367111|NCT04424654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93367112|NCT04424654|Androgens|androgens|mesh-ancestor
93367113|NCT04424654|Hormones|hormones|mesh-ancestor
93367114|NCT04424654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367115|NCT04424654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367116|NCT04424654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93367117|NCT04424654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367118|NCT04424654|Anabolic Agents|anabolic agents|mesh-ancestor
93367119|NCT04968392|Dexmedetomidine|dexmedetomidine|mesh-list
93367120|NCT04968392|Levobupivacaine|levobupivacaine|mesh-list
93367121|NCT04968392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93367122|NCT04968392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367123|NCT04968392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367124|NCT04968392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367125|NCT04968392|Analgesics|analgesics|mesh-ancestor
93367126|NCT04968392|Sensory System Agents|sensory system agents|mesh-ancestor
93367127|NCT04968392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367128|NCT04968392|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93367129|NCT04968392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93367130|NCT04968392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93367131|NCT04968392|Adrenergic Agents|adrenergic agents|mesh-ancestor
93367132|NCT04968392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367133|NCT04968392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367134|NCT04968392|Anesthetics, Local|anesthetics, local|mesh-ancestor
93367135|NCT04968392|Anesthetics|anesthetics|mesh-ancestor
93367136|NCT02792699|Rituximab|rituximab|mesh-list
93367137|NCT02792699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367138|NCT02792699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367139|NCT02792699|Immunologic Factors|immunologic factors|mesh-ancestor
93367140|NCT02792699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367141|NCT02792699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367142|NCT04968002|Apatinib|apatinib|mesh-list
93367143|NCT04968002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367144|NCT04968002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367145|NCT04968002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367146|NCT04968002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367147|NCT04961138|Lenvatinib|lenvatinib|mesh-list
93367148|NCT04961138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367149|NCT04961138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367150|NCT04961138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367151|NCT04961138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367152|NCT03061136|Clonazepam|clonazepam|mesh-list
93367153|NCT03061136|Anticonvulsants|anticonvulsants|mesh-ancestor
93367154|NCT03061136|GABA Modulators|gaba modulators|mesh-ancestor
93367155|NCT03061136|GABA Agents|gaba agents|mesh-ancestor
93367156|NCT03061136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367157|NCT03061136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367158|NCT03061136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367159|NCT04952792|Apixaban|apixaban|mesh-list
93367160|NCT04952792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93367161|NCT04952792|Antithrombins|antithrombins|mesh-ancestor
93367162|NCT04952792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93367163|NCT04952792|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367164|NCT04952792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367165|NCT04952792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367166|NCT04952792|Anticoagulants|anticoagulants|mesh-ancestor
93367167|NCT02075333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93367168|NCT02080169|Fentanyl|fentanyl|mesh-list
93367169|NCT02080169|Midazolam|midazolam|mesh-list
93367170|NCT02080169|Dexmedetomidine|dexmedetomidine|mesh-list
93367171|NCT02080169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93367172|NCT02080169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367173|NCT02080169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367174|NCT02080169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93038819|NCT00428792|Dopamine Agents|dopamine agents|mesh-ancestor
93367175|NCT02080169|Analgesics|analgesics|mesh-ancestor
93367176|NCT02080169|Sensory System Agents|sensory system agents|mesh-ancestor
93367177|NCT02080169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367178|NCT02080169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93367179|NCT02080169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93367180|NCT02080169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93367181|NCT02080169|Adrenergic Agents|adrenergic agents|mesh-ancestor
93367182|NCT02080169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367183|NCT02080169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367184|NCT02080169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93367185|NCT02080169|Narcotics|narcotics|mesh-ancestor
93367186|NCT02080169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93367187|NCT02080169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93367188|NCT02080169|Anesthetics, General|anesthetics, general|mesh-ancestor
93367189|NCT02080169|Anesthetics|anesthetics|mesh-ancestor
93367190|NCT02080169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93367191|NCT02080169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93367192|NCT02080169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93367193|NCT02080169|GABA Modulators|gaba modulators|mesh-ancestor
93367194|NCT02080169|GABA Agents|gaba agents|mesh-ancestor
93367195|NCT02078063|Mepivacaine|mepivacaine|mesh-list
93367196|NCT02078063|Anesthetics, Local|anesthetics, local|mesh-ancestor
93367197|NCT02078063|Anesthetics|anesthetics|mesh-ancestor
93367198|NCT02078063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367199|NCT02078063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367200|NCT02078063|Sensory System Agents|sensory system agents|mesh-ancestor
93367201|NCT02078063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367202|NCT04951856|Evolocumab|evolocumab|mesh-list
93367203|NCT04951856|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93367204|NCT04951856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93367205|NCT04951856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93367206|NCT04951856|Antimetabolites|antimetabolites|mesh-ancestor
93367207|NCT04951856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367208|NCT04951856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93367209|NCT04951856|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367210|NCT04951856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367211|NCT04951856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93367212|NCT04951232|Cinepazide|cinepazide|mesh-list
93367213|NCT04951232|Vasodilator Agents|vasodilator agents|mesh-ancestor
93367214|NCT04959578|Epoetin Alfa|epoetin alfa|mesh-list
93367215|NCT04959578|Darbepoetin alfa|darbepoetin alfa|mesh-list
93367216|NCT04959578|Hematinics|hematinics|mesh-ancestor
93367217|NCT04959500|Temozolomide|temozolomide|mesh-list
93367218|NCT04959500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93367219|NCT04959500|Alkylating Agents|alkylating agents|mesh-ancestor
93367220|NCT04959500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367221|NCT04959500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367222|NCT02076191|Decitabine|decitabine|mesh-list
93367223|NCT02076191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367224|NCT02076191|Antimetabolites|antimetabolites|mesh-ancestor
93367225|NCT02076191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367226|NCT02076191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367227|NCT02076191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367228|NCT02080715|Tolcapone|tolcapone|mesh-list
93367229|NCT02080715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93367230|NCT02080715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93367231|NCT02080715|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93367232|NCT02080715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367233|NCT02080715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367234|NCT04965662|Tenofovir|tenofovir|mesh-list
93367235|NCT04965662|Emtricitabine|emtricitabine|mesh-list
93367236|NCT04965662|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93367237|NCT04965662|Maraviroc|maraviroc|mesh-list
93367238|NCT04965662|Antiviral Agents|antiviral agents|mesh-ancestor
93367239|NCT04965662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367240|NCT04965662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93367241|NCT04965662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93367242|NCT04965662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367243|NCT04965662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367244|NCT04965662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93367245|NCT04965662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93367246|NCT04965662|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93367247|NCT04965662|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93038891|NCT01325571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367248|NCT04965662|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93367249|NCT02078609|Midostaurin|midostaurin|mesh-list
93367250|NCT02078609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367251|NCT02078609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367252|NCT02078609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367253|NCT02078609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367254|NCT04957940|SMOFlipid|smoflipid|mesh-list
93367255|NCT04957940|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93367256|NCT04957940|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93367257|NCT04957940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93367258|NCT03060278|Nicotine|nicotine|mesh-list
93367259|NCT03060278|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93367260|NCT03060278|Autonomic Agents|autonomic agents|mesh-ancestor
93367261|NCT03060278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367262|NCT03060278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367263|NCT03060278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93367264|NCT03060278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93367265|NCT03060278|Cholinergic Agents|cholinergic agents|mesh-ancestor
93367266|NCT03060278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367267|NCT03060278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367268|NCT02083991|Prednisolone|prednisolone|mesh-list
93367269|NCT02083991|Thymoglobulin|thymoglobulin|mesh-list
93367270|NCT02083991|Basiliximab|basiliximab|mesh-list
93367271|NCT02083991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367272|NCT02083991|Glucocorticoids|glucocorticoids|mesh-ancestor
93367273|NCT02083991|Hormones|hormones|mesh-ancestor
93367274|NCT02083991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367275|NCT02083991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367276|NCT02083991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93367277|NCT02083991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367278|NCT02083991|Immunologic Factors|immunologic factors|mesh-ancestor
93367279|NCT02083991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93367280|NCT02081027|Riluzole|riluzole|mesh-list
93367281|NCT02081027|Anticonvulsants|anticonvulsants|mesh-ancestor
93367282|NCT02081027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93367283|NCT02081027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93367284|NCT02081027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367285|NCT02081027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367286|NCT02081027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367287|NCT02081027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93367288|NCT02081027|Protective Agents|protective agents|mesh-ancestor
93367289|NCT04948034|Tislelizumab|tislelizumab|mesh-list
93367290|NCT04948034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367291|NCT04948034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367292|NCT04947956|Apatinib|apatinib|mesh-list
93367293|NCT04947956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367294|NCT04947956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367295|NCT04947956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367296|NCT04947956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367297|NCT03254511|Enoxaparin|enoxaparin|mesh-list
93367298|NCT03254511|Enoxaparin sodium|enoxaparin sodium|mesh-list
93367299|NCT03254511|Anticoagulants|anticoagulants|mesh-ancestor
93367300|NCT03254511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93367301|NCT03254511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93367302|NCT03254511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367303|NCT04947566|Ibuprofen|ibuprofen|mesh-list
93367304|NCT04947566|Naproxen|naproxen|mesh-list
93367305|NCT04947566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93367306|NCT04947566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367307|NCT04947566|Analgesics|analgesics|mesh-ancestor
93367308|NCT04947566|Sensory System Agents|sensory system agents|mesh-ancestor
93367309|NCT04947566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367310|NCT04947566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367311|NCT04947566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367312|NCT04947566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367313|NCT04947566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93367314|NCT04947566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367315|NCT04947566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367316|NCT04947566|Gout Suppressants|gout suppressants|mesh-ancestor
93367317|NCT03241875|Pregabalin|pregabalin|mesh-list
93367318|NCT03241875|Gabapentin|gabapentin|mesh-list
93367319|NCT03241875|Analgesics|analgesics|mesh-ancestor
93367320|NCT03241875|Sensory System Agents|sensory system agents|mesh-ancestor
93367321|NCT03241875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367322|NCT03241875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367323|NCT03241875|Anticonvulsants|anticonvulsants|mesh-ancestor
93367324|NCT03241875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93367325|NCT03241875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367326|NCT03241875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367327|NCT03241875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93367329|NCT03241875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93367330|NCT03241875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367331|NCT03241875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93367332|NCT03241875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93367333|NCT03241875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93367334|NCT03241875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367335|NCT03241875|Antimanic Agents|antimanic agents|mesh-ancestor
93367336|NCT03058094|Pemetrexed|pemetrexed|mesh-list
93367337|NCT03058094|Abivertinib|abivertinib|mesh-list
93367338|NCT03058094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367339|NCT03058094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367340|NCT03058094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367341|NCT03058094|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93367342|NCT03058094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93367343|NCT03058094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367344|NCT04413266|Curcumin|curcumin|mesh-list
93367345|NCT04413266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93367346|NCT04413266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367347|NCT04413266|Analgesics|analgesics|mesh-ancestor
93367348|NCT04413266|Sensory System Agents|sensory system agents|mesh-ancestor
93367349|NCT04413266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367350|NCT04413266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367351|NCT04413266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367352|NCT04413266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367353|NCT04413266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367354|NCT04413266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367355|NCT04413266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367356|NCT04944524|Methotrexate|methotrexate|mesh-list
93367357|NCT04944524|Tofacitinib|tofacitinib|mesh-list
93367358|NCT04944524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93367359|NCT04944524|Abortifacient Agents|abortifacient agents|mesh-ancestor
93367360|NCT04944524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93367361|NCT04944524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367362|NCT04944524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367363|NCT04944524|Antimetabolites|antimetabolites|mesh-ancestor
93367364|NCT04944524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367365|NCT04944524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367366|NCT04944524|Dermatologic Agents|dermatologic agents|mesh-ancestor
93367367|NCT04944524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367368|NCT04944524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93367369|NCT04944524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93367370|NCT04944524|Immunologic Factors|immunologic factors|mesh-ancestor
93367371|NCT04944524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367372|NCT04944524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93367373|NCT04944524|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93367374|NCT04944524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367375|NCT04412876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93367376|NCT04412876|Imipramine|imipramine|mesh-list
93367377|NCT04412876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93367378|NCT04412876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93367379|NCT04412876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367380|NCT04412876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367381|NCT04412876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367382|NCT04412876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367383|NCT04412876|Analgesics|analgesics|mesh-ancestor
93367384|NCT04412876|Sensory System Agents|sensory system agents|mesh-ancestor
93367385|NCT04412876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367386|NCT04412876|Antidepressive Agents|antidepressive agents|mesh-ancestor
93367387|NCT04412876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93367388|NCT04412876|Dopamine Agents|dopamine agents|mesh-ancestor
93367389|NCT04412876|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93367390|NCT04412876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93367391|NCT04412876|Adrenergic Agents|adrenergic agents|mesh-ancestor
93367392|NCT03241563|Triamcinolone|triamcinolone|mesh-list
93367393|NCT03241563|Deoxycholic Acid|deoxycholic acid|mesh-list
93367394|NCT03241563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367395|NCT03241563|Glucocorticoids|glucocorticoids|mesh-ancestor
93367396|NCT03241563|Hormones|hormones|mesh-ancestor
93367397|NCT03241563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367398|NCT03241563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367399|NCT03241563|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93367400|NCT03241563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367402|NCT03241641|Antiviral Agents|antiviral agents|mesh-ancestor
93367403|NCT03241641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367404|NCT03241641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93367405|NCT03241641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93367406|NCT03241641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367407|NCT03241641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367408|NCT03241641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93367409|NCT03241641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93367410|NCT04486521|Siltuximab|siltuximab|mesh-list
93367411|NCT04486521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367412|NCT04955834|Insulin|insulin|mesh-list
93367413|NCT04955834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93367414|NCT04955834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367415|NCT03241407|Triclosan|triclosan|mesh-list
93367416|NCT03241407|Fluorides|fluorides|mesh-list
93367417|NCT03241407|Cariostatic Agents|cariostatic agents|mesh-ancestor
93367418|NCT03241407|Protective Agents|protective agents|mesh-ancestor
93367419|NCT03241407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367420|NCT03241407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93367421|NCT03241407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367422|NCT03241407|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93367423|NCT03241407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93367424|NCT03241407|Antimetabolites|antimetabolites|mesh-ancestor
93367425|NCT03241407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367426|NCT03241407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93367427|NCT03238131|Ivermectin|ivermectin|mesh-list
93367428|NCT03238131|Albendazole|albendazole|mesh-list
93367429|NCT03238131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93367430|NCT03238131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367431|NCT03238131|Anthelmintics|anthelmintics|mesh-ancestor
93367432|NCT03238131|Anticestodal Agents|anticestodal agents|mesh-ancestor
93367433|NCT03238131|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93367434|NCT03238131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93367435|NCT03238131|Tubulin Modulators|tubulin modulators|mesh-ancestor
93367436|NCT03238131|Antimitotic Agents|antimitotic agents|mesh-ancestor
93367437|NCT03238131|Mitosis Modulators|mitosis modulators|mesh-ancestor
93367438|NCT03238131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367439|NCT03238131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367440|NCT01369433|Sirolimus|sirolimus|mesh-list
93367441|NCT01369433|Paclitaxel|paclitaxel|mesh-list
93367442|NCT01369433|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93367443|NCT01369433|Capecitabine|capecitabine|mesh-list
93367444|NCT01369433|Temsirolimus|temsirolimus|mesh-list
93367445|NCT01369433|MTOR Inhibitors|mtor inhibitors|mesh-list
93367446|NCT01369433|Tivozanib|tivozanib|mesh-list
93367447|NCT01369433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93367448|NCT01369433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367449|NCT01369433|Tubulin Modulators|tubulin modulators|mesh-ancestor
93367450|NCT01369433|Antimitotic Agents|antimitotic agents|mesh-ancestor
93367451|NCT01369433|Mitosis Modulators|mitosis modulators|mesh-ancestor
93367452|NCT01369433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367453|NCT01369433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367454|NCT01369433|Antimetabolites|antimetabolites|mesh-ancestor
93367455|NCT01369433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367456|NCT01369433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367457|NCT01369433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93367458|NCT01369433|Immunologic Factors|immunologic factors|mesh-ancestor
93367459|NCT01369433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367460|NCT01369433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93367461|NCT01369433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367462|NCT01369433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93367463|NCT01369433|Antifungal Agents|antifungal agents|mesh-ancestor
93367464|NCT04946162|Tadalafil|tadalafil|mesh-list
93367465|NCT04946162|Vasodilator Agents|vasodilator agents|mesh-ancestor
93367466|NCT04946162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93367467|NCT04946162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93367468|NCT04946162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367469|NCT04946162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367470|NCT04946162|Urological Agents|urological agents|mesh-ancestor
93367471|NCT02084225|Lidocaine|lidocaine|mesh-list
93367472|NCT02084225|Anesthetics, Local|anesthetics, local|mesh-ancestor
93367473|NCT02084225|Anesthetics|anesthetics|mesh-ancestor
93367474|NCT02084225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367475|NCT02084225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367476|NCT02084225|Sensory System Agents|sensory system agents|mesh-ancestor
93367477|NCT02084225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367478|NCT02084225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93367479|NCT02084225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93367480|NCT02084225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93367481|NCT02084225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367482|NCT02084225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367483|NCT04945694|Fentanyl|fentanyl|mesh-list
93367484|NCT04945694|Propofol|propofol|mesh-list
93367485|NCT04945694|Sevoflurane|sevoflurane|mesh-list
93367486|NCT04945694|Atracurium|atracurium|mesh-list
93367487|NCT04945694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93367488|NCT04945694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367489|NCT04945694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367490|NCT04945694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93367491|NCT04945694|Anesthetics, General|anesthetics, general|mesh-ancestor
93367492|NCT04945694|Anesthetics|anesthetics|mesh-ancestor
93367493|NCT04945694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93367494|NCT04945694|Narcotics|narcotics|mesh-ancestor
93367495|NCT04945694|Analgesics|analgesics|mesh-ancestor
93367496|NCT04945694|Sensory System Agents|sensory system agents|mesh-ancestor
93367497|NCT04945694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367498|NCT04945694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93367499|NCT04945694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93367500|NCT04945694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93367501|NCT04945694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93367502|NCT04945694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93367503|NCT04945694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93367504|NCT04945694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93367505|NCT04945694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93367506|NCT04945694|Cholinergic Agents|cholinergic agents|mesh-ancestor
93367507|NCT04945694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367508|NCT04945694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367509|NCT02084303|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93367510|NCT02084303|Hematinics|hematinics|mesh-ancestor
93367511|NCT02084303|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93367512|NCT02084303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93367513|NCT02420847|Gemcitabine|gemcitabine|mesh-list
93367514|NCT02420847|Doxorubicin|doxorubicin|mesh-list
93367515|NCT02420847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93367516|NCT02420847|Ixazomib|ixazomib|mesh-list
93367517|NCT02420847|Glycine|glycine|mesh-list
93367518|NCT02420847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367519|NCT02420847|Antimetabolites|antimetabolites|mesh-ancestor
93367520|NCT02420847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367521|NCT02420847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367522|NCT02420847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93367523|NCT02420847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93367524|NCT02420847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93367525|NCT02420847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367526|NCT02420847|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367527|NCT02420847|Glycine Agents|glycine agents|mesh-ancestor
93367528|NCT02420847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367529|NCT02420847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367530|NCT03253887|Ethanol|ethanol|mesh-list
93367531|NCT03253887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93367532|NCT03253887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367533|NCT03253887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367534|NCT03253887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367535|NCT02453607|Infliximab|infliximab|mesh-list
93367536|NCT02453607|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93367537|NCT02453607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367538|NCT02453607|Dermatologic Agents|dermatologic agents|mesh-ancestor
93367539|NCT02453607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367540|NCT02453607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367541|NCT02453529|Nafithromycin|nafithromycin|mesh-list
93367542|NCT02453529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93367543|NCT02453529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367544|NCT02453529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93367545|NCT02453529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367546|NCT02453529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367547|NCT03241017|Durvalumab|durvalumab|mesh-list
93367548|NCT03241017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367549|NCT03241017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367550|NCT03237741|Rabeprazole|rabeprazole|mesh-list
93367551|NCT03237741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93367552|NCT03237741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367553|NCT03237741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93367554|NCT03237741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367555|NCT03237741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367556|NCT03240939|Tadalafil|tadalafil|mesh-list
93367557|NCT03240939|Dutasteride|dutasteride|mesh-list
93367558|NCT03240939|Vasodilator Agents|vasodilator agents|mesh-ancestor
92661014|NCT00289419|Analgesics|analgesics|mesh-ancestor
93367559|NCT03240939|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93367560|NCT03240939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93367561|NCT03240939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367562|NCT03240939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367563|NCT03240939|Urological Agents|urological agents|mesh-ancestor
93367564|NCT03240939|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93367565|NCT03240939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93367566|NCT03240939|Hormone Antagonists|hormone antagonists|mesh-ancestor
93367567|NCT03240939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367568|NCT03240939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367569|NCT02624492|Rituximab|rituximab|mesh-list
93367570|NCT02624492|BI 836826|bi 836826|mesh-list
93367571|NCT02624492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367572|NCT02624492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367573|NCT02624492|Immunologic Factors|immunologic factors|mesh-ancestor
93367574|NCT02624492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367575|NCT02624492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367576|NCT03240783|Dexamethasone|dexamethasone|mesh-list
93367577|NCT03240783|Dexamethasone acetate|dexamethasone acetate|mesh-list
93367578|NCT03240783|Betamethasone|betamethasone|mesh-list
93367579|NCT03240783|BB 1101|bb 1101|mesh-list
93367580|NCT03240783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367581|NCT03240783|Antiemetics|antiemetics|mesh-ancestor
93367582|NCT03240783|Autonomic Agents|autonomic agents|mesh-ancestor
93367583|NCT03240783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367584|NCT03240783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367585|NCT03240783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367586|NCT03240783|Glucocorticoids|glucocorticoids|mesh-ancestor
93367587|NCT03240783|Hormones|hormones|mesh-ancestor
93367588|NCT03240783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367589|NCT03240783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93367590|NCT03240783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367591|NCT03240783|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367592|NCT03240783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367593|NCT03240783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367594|NCT03240783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93367595|NCT03240783|Respiratory System Agents|respiratory system agents|mesh-ancestor
93367596|NCT03237507|Paclitaxel|paclitaxel|mesh-list
93367597|NCT03237507|Oxaliplatin|oxaliplatin|mesh-list
93367598|NCT03237507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93367599|NCT03237507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367600|NCT03237507|Tubulin Modulators|tubulin modulators|mesh-ancestor
93367601|NCT03237507|Antimitotic Agents|antimitotic agents|mesh-ancestor
93367602|NCT03237507|Mitosis Modulators|mitosis modulators|mesh-ancestor
93367603|NCT03237507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367604|NCT04945226|Finasteride|finasteride|mesh-list
93367605|NCT04945226|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93367606|NCT04945226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93367607|NCT04945226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367608|NCT04945226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367609|NCT04945226|Hormone Antagonists|hormone antagonists|mesh-ancestor
93367610|NCT04945226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367611|NCT04945226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367612|NCT04945226|Urological Agents|urological agents|mesh-ancestor
93367613|NCT01975831|Durvalumab|durvalumab|mesh-list
93367614|NCT01975831|Tremelimumab|tremelimumab|mesh-list
93367615|NCT01975831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367616|NCT01975831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367617|NCT04945070|Insulin|insulin|mesh-list
93367618|NCT04945070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93367619|NCT04945070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367620|NCT03240471|Calpastatin|calpastatin|mesh-list
93367621|NCT03240471|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93367622|NCT03240471|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367623|NCT03240471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367624|NCT03240471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367625|NCT04942652|Itraconazole|itraconazole|mesh-list
93367626|NCT04942652|Esomeprazole|esomeprazole|mesh-list
93367627|NCT04942652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93367628|NCT04942652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367629|NCT04942652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93367630|NCT04942652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661086|NCT00270426|Protease Inhibitors|protease inhibitors|mesh-ancestor
93367631|NCT04942652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367632|NCT04942652|Antifungal Agents|antifungal agents|mesh-ancestor
93367633|NCT04942652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367634|NCT04942652|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93367635|NCT04942652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93367636|NCT04942652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93367637|NCT04942652|Hormone Antagonists|hormone antagonists|mesh-ancestor
93367638|NCT04942652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367639|NCT04942652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367640|NCT04942652|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93367641|NCT03240549|Bevacizumab|bevacizumab|mesh-list
93367642|NCT03240549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367643|NCT03240549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367644|NCT03240549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93367645|NCT03240549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93367646|NCT03240549|Growth Substances|growth substances|mesh-ancestor
93367647|NCT03240549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367648|NCT03240549|Growth Inhibitors|growth inhibitors|mesh-ancestor
93367649|NCT04933292|Mycophenolic Acid|mycophenolic acid|mesh-list
93367650|NCT04933292|Methylprednisolone|methylprednisolone|mesh-list
93367651|NCT04933292|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93367652|NCT04933292|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93367653|NCT04933292|Prednisolone|prednisolone|mesh-list
93367654|NCT04933292|Prednisolone acetate|prednisolone acetate|mesh-list
93367655|NCT04933292|Azathioprine|azathioprine|mesh-list
93367656|NCT04933292|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93367657|NCT04933292|Prednisolone phosphate|prednisolone phosphate|mesh-list
93367658|NCT04933292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93367659|NCT04933292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367660|NCT04933292|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93367661|NCT04933292|Antitubercular Agents|antitubercular agents|mesh-ancestor
93367662|NCT04933292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93367663|NCT04933292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367664|NCT04933292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367665|NCT04933292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367666|NCT04933292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367667|NCT04933292|Antiemetics|antiemetics|mesh-ancestor
93367668|NCT04933292|Autonomic Agents|autonomic agents|mesh-ancestor
93367669|NCT04933292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367670|NCT04933292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367671|NCT04933292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367672|NCT04933292|Glucocorticoids|glucocorticoids|mesh-ancestor
93367673|NCT04933292|Hormones|hormones|mesh-ancestor
93367674|NCT04933292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367675|NCT04933292|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93367676|NCT04933292|Protective Agents|protective agents|mesh-ancestor
93367677|NCT04933292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93367678|NCT04933292|Antimetabolites|antimetabolites|mesh-ancestor
93367679|NCT04933292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367680|NCT04933292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93367681|NCT04933292|Immunologic Factors|immunologic factors|mesh-ancestor
93367682|NCT04933292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367683|NCT04942496|Chlorhexidine|chlorhexidine|mesh-list
93367684|NCT04942496|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93367685|NCT04942496|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93367686|NCT04942496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367687|NCT04942496|Disinfectants|disinfectants|mesh-ancestor
93367688|NCT04942496|Dermatologic Agents|dermatologic agents|mesh-ancestor
93367689|NCT04941872|FAPI-46|fapi-46|mesh-list
93367690|NCT04941872|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93367691|NCT04941872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367692|NCT03237117|Hormones|hormones|mesh-list
93367693|NCT03237117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93367694|NCT03237117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367695|NCT03239691|ACT-709478|act-709478|mesh-list
93367696|NCT03239691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93367697|NCT03239691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039335|NCT00206518|Mitosis Modulators|mitosis modulators|mesh-ancestor
93367698|NCT03239691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367699|NCT03239691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93367700|NCT03239691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367701|NCT04944602|Omalizumab|omalizumab|mesh-list
93367702|NCT04944602|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93367703|NCT04944602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93367704|NCT04944602|Respiratory System Agents|respiratory system agents|mesh-ancestor
93367705|NCT03253107|Trastuzumab|trastuzumab|mesh-list
93367706|NCT03253107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367707|NCT03253107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367708|NCT03236883|Gemcitabine|gemcitabine|mesh-list
93367709|NCT03236883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367710|NCT03236883|Antimetabolites|antimetabolites|mesh-ancestor
93367711|NCT03236883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367712|NCT03236883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367713|NCT03236961|Moxifloxacin|moxifloxacin|mesh-list
93367714|NCT03236961|Metronidazole|metronidazole|mesh-list
93367715|NCT03236961|Levofloxacin|levofloxacin|mesh-list
93367716|NCT03236961|Ertapenem|ertapenem|mesh-list
93367717|NCT03236961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93367718|NCT03236961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367719|NCT03236961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93367720|NCT03236961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93367721|NCT03236961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367722|NCT03236961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367723|NCT03236961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367724|NCT03236961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93367725|NCT03236961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93367726|NCT03236961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93367727|NCT03236961|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93367728|NCT03236961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93367729|NCT05234619|Ketorolac|ketorolac|mesh-list
93367730|NCT05234619|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93367731|NCT05234619|Lidocaine|lidocaine|mesh-list
93367732|NCT05234619|Anesthetics, Local|anesthetics, local|mesh-ancestor
93367733|NCT05234619|Anesthetics|anesthetics|mesh-ancestor
93367734|NCT05234619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367735|NCT05234619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367736|NCT05234619|Sensory System Agents|sensory system agents|mesh-ancestor
93367737|NCT05234619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367738|NCT05234619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93367739|NCT05234619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93367740|NCT05234619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93367741|NCT05234619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367742|NCT05234619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367743|NCT05234619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93367744|NCT05234619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367745|NCT05234619|Analgesics|analgesics|mesh-ancestor
93367746|NCT05234619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367747|NCT05234619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367748|NCT05234619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93367749|NCT05234619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367750|NCT04921904|Ramucirumab|ramucirumab|mesh-list
93367751|NCT04921904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367752|NCT02622386|Riboflavin|riboflavin|mesh-list
93367753|NCT02622386|Vitamins|vitamins|mesh-ancestor
93367754|NCT02622386|Micronutrients|micronutrients|mesh-ancestor
93367755|NCT02622386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367756|NCT02622386|Vitamin B Complex|vitamin b complex|mesh-ancestor
93367757|NCT02622386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93367758|NCT02622386|Dermatologic Agents|dermatologic agents|mesh-ancestor
93367759|NCT04427618|Tranexamic Acid|tranexamic acid|mesh-list
93367760|NCT04427618|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93367761|NCT04427618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93367762|NCT04427618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367763|NCT04427618|Hemostatics|hemostatics|mesh-ancestor
93367764|NCT04427618|Coagulants|coagulants|mesh-ancestor
93367765|NCT03236727|Dexmedetomidine|dexmedetomidine|mesh-list
93367766|NCT03236727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93367767|NCT03236727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367768|NCT03236727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367769|NCT03236727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367770|NCT03236727|Analgesics|analgesics|mesh-ancestor
93367771|NCT03236727|Sensory System Agents|sensory system agents|mesh-ancestor
93367772|NCT03236727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367773|NCT03236727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93367774|NCT03236727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93367775|NCT03236727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93367776|NCT03236727|Adrenergic Agents|adrenergic agents|mesh-ancestor
93367777|NCT03236727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367778|NCT03236727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367779|NCT03236493|PF-06700841|pf-06700841|mesh-list
93367780|NCT03236493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367781|NCT03236493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367782|NCT03236493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367783|NCT04921124|Teriparatide|teriparatide|mesh-list
93367784|NCT04921124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93367785|NCT04921124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367786|NCT04921124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93367787|NCT04921046|Lidocaine|lidocaine|mesh-list
93367788|NCT04921046|Midazolam|midazolam|mesh-list
93367789|NCT04921046|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93367790|NCT04921046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93367791|NCT04921046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367792|NCT04921046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367793|NCT04921046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93367794|NCT04921046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93367795|NCT04921046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93367796|NCT04921046|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93367797|NCT04921046|Anesthetics, General|anesthetics, general|mesh-ancestor
93367798|NCT04921046|Anesthetics|anesthetics|mesh-ancestor
93367799|NCT04921046|GABA Modulators|gaba modulators|mesh-ancestor
93367800|NCT04921046|GABA Agents|gaba agents|mesh-ancestor
93367801|NCT04921046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367802|NCT04921046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367803|NCT04921046|Anesthetics, Local|anesthetics, local|mesh-ancestor
93367804|NCT04921046|Sensory System Agents|sensory system agents|mesh-ancestor
93367805|NCT04921046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367806|NCT04921046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93367807|NCT04921046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93367808|NCT04921046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93367809|NCT04921046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367810|NCT02792231|Teriflunomide|teriflunomide|mesh-list
93367811|NCT02792231|Ofatumumab|ofatumumab|mesh-list
93367812|NCT02792231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93367813|NCT02792231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367814|NCT02792231|Immunologic Factors|immunologic factors|mesh-ancestor
93367815|NCT02792231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367816|NCT02792231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93367817|NCT02792231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367818|NCT02792231|Analgesics|analgesics|mesh-ancestor
93367819|NCT02792231|Sensory System Agents|sensory system agents|mesh-ancestor
93367820|NCT02792231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367821|NCT02792231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367822|NCT02792231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367823|NCT02792231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93367824|NCT04930952|Ethanol|ethanol|mesh-list
93367825|NCT04930952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93367826|NCT04930952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367827|NCT04930952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367828|NCT04930952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367829|NCT04920968|Rituximab|rituximab|mesh-list
93367830|NCT04920968|Obinutuzumab|obinutuzumab|mesh-list
93367831|NCT04920968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93367832|NCT04920968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367833|NCT04920968|Immunologic Factors|immunologic factors|mesh-ancestor
93367834|NCT04920968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367835|NCT04920968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367836|NCT00700401|Ribavirin|ribavirin|mesh-list
93367837|NCT00700401|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93367838|NCT00700401|Antimetabolites|antimetabolites|mesh-ancestor
93367839|NCT00700401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367840|NCT00700401|Antiviral Agents|antiviral agents|mesh-ancestor
93367841|NCT00700401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367842|NCT04931108|Atenolol|atenolol|mesh-list
93367843|NCT04931108|Nitrendipine|nitrendipine|mesh-list
93367844|NCT04931108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93367845|NCT04931108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93367846|NCT04931108|Sympatholytics|sympatholytics|mesh-ancestor
93367847|NCT04931108|Autonomic Agents|autonomic agents|mesh-ancestor
93367848|NCT04931108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367849|NCT04931108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367850|NCT04931108|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93367851|NCT04931108|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93367852|NCT04931108|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93367853|NCT04931108|Adrenergic Agents|adrenergic agents|mesh-ancestor
93367854|NCT04931108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367855|NCT04931108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367856|NCT04931108|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93367857|NCT04931108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367858|NCT04931108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93367859|NCT04931108|Vasodilator Agents|vasodilator agents|mesh-ancestor
93367860|NCT04920500|Cytarabine|cytarabine|mesh-list
93367861|NCT04920500|Daunorubicin|daunorubicin|mesh-list
93367862|NCT04920500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93367863|NCT04920500|Antimetabolites|antimetabolites|mesh-ancestor
93367864|NCT04920500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367865|NCT04920500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367866|NCT04920500|Antiviral Agents|antiviral agents|mesh-ancestor
93367867|NCT04920500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367868|NCT04920500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93367869|NCT04920500|Immunologic Factors|immunologic factors|mesh-ancestor
93367870|NCT04920500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367871|NCT04920500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93367872|NCT04920500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93367873|NCT04920500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93367874|NCT04920500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367875|NCT02084615|Aspirin|aspirin|mesh-list
93367876|NCT02084615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93367877|NCT02084615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93367878|NCT02084615|Analgesics|analgesics|mesh-ancestor
93367879|NCT02084615|Sensory System Agents|sensory system agents|mesh-ancestor
93367880|NCT02084615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367881|NCT02084615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367882|NCT02084615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93367883|NCT02084615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93367884|NCT02084615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93367885|NCT02084615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93367886|NCT02084615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367887|NCT02084615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93367888|NCT02084615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93367889|NCT02084615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367890|NCT02084615|Antipyretics|antipyretics|mesh-ancestor
93367891|NCT03559751|Nicotine|nicotine|mesh-list
93367892|NCT03559751|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93367893|NCT03559751|Autonomic Agents|autonomic agents|mesh-ancestor
93367894|NCT03559751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93367895|NCT03559751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367896|NCT03559751|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93367897|NCT03559751|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93367898|NCT03559751|Cholinergic Agents|cholinergic agents|mesh-ancestor
93367899|NCT03559751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367900|NCT03559751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367901|NCT03234699|Midazolam|midazolam|mesh-list
93367902|NCT03234699|Cenobamate|cenobamate|mesh-list
93367903|NCT03234699|Bupropion|bupropion|mesh-list
93367904|NCT03234699|Omeprazole|omeprazole|mesh-list
93367905|NCT03234699|Warfarin|warfarin|mesh-list
93367906|NCT03234699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93367907|NCT03234699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93367908|NCT03234699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93367909|NCT03234699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367910|NCT03234699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93367911|NCT03234699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93367912|NCT03234699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93367913|NCT03234699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93367914|NCT03234699|Anesthetics, General|anesthetics, general|mesh-ancestor
93367915|NCT03234699|Anesthetics|anesthetics|mesh-ancestor
93367916|NCT03234699|GABA Modulators|gaba modulators|mesh-ancestor
93367917|NCT03234699|GABA Agents|gaba agents|mesh-ancestor
93367918|NCT03234699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367919|NCT03234699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367920|NCT03234699|Anticoagulants|anticoagulants|mesh-ancestor
93039566|NCT01041170|Rimonabant|rimonabant|mesh-list
93367921|NCT03234699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93367922|NCT03234699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93367923|NCT03234699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93367924|NCT03234699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367925|NCT03234699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93367926|NCT03234699|Antidepressive Agents|antidepressive agents|mesh-ancestor
93367927|NCT03234699|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93367928|NCT03234699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93367929|NCT03234699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367930|NCT03234699|Dopamine Agents|dopamine agents|mesh-ancestor
93367931|NCT03234699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93367932|NCT03234699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93367933|NCT03234699|Anticonvulsants|anticonvulsants|mesh-ancestor
93367934|NCT03228771|Atorvastatin|atorvastatin|mesh-list
93367935|NCT03228771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93367936|NCT03228771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93367937|NCT03228771|Antimetabolites|antimetabolites|mesh-ancestor
93367938|NCT03228771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367939|NCT03228771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93367940|NCT03228771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93367941|NCT03228771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367942|NCT02081339|Ranibizumab|ranibizumab|mesh-list
93367943|NCT02081339|Aflibercept|aflibercept|mesh-list
93367944|NCT02081339|Verteporfin|verteporfin|mesh-list
93367945|NCT02081339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93367946|NCT02081339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93367947|NCT02081339|Growth Substances|growth substances|mesh-ancestor
93367948|NCT02081339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367949|NCT02081339|Growth Inhibitors|growth inhibitors|mesh-ancestor
93367950|NCT02081339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367951|NCT02081339|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93367952|NCT02081339|Dermatologic Agents|dermatologic agents|mesh-ancestor
93367953|NCT04939766|Insulin|insulin|mesh-list
93367954|NCT04939766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93367955|NCT04939766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367956|NCT02079545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93367957|NCT02079545|Immunologic Factors|immunologic factors|mesh-ancestor
93367958|NCT02079545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367959|NCT03559673|Lacosamide|lacosamide|mesh-list
93367960|NCT03559673|Anticonvulsants|anticonvulsants|mesh-ancestor
92661433|NCT00271050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367961|NCT03559673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93367962|NCT03559673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93367963|NCT03559673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93367964|NCT03559673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367965|NCT03234387|Acetylcholine|acetylcholine|mesh-list
93367966|NCT03234387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367967|NCT03234387|Vasodilator Agents|vasodilator agents|mesh-ancestor
93367968|NCT03234387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93367969|NCT03234387|Cholinergic Agents|cholinergic agents|mesh-ancestor
93367970|NCT03234387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93367971|NCT03234387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367972|NCT03235947|Trimethoprim|trimethoprim|mesh-list
93367973|NCT03235947|Sulfamethoxazole|sulfamethoxazole|mesh-list
93367974|NCT03235947|Fosfomycin|fosfomycin|mesh-list
93367975|NCT03235947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93367976|NCT03235947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367977|NCT03235947|Antimalarials|antimalarials|mesh-ancestor
93367978|NCT03235947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93367979|NCT03235947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93367980|NCT03235947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93367981|NCT03235947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367982|NCT03235947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367983|NCT03235947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93367984|NCT03235947|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93367985|NCT03235947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93367986|NCT03235947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93367987|NCT03057470|Insulin|insulin|mesh-list
93367988|NCT03057470|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93367989|NCT03057470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93367990|NCT03057470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93367991|NCT02871401|Valganciclovir|valganciclovir|mesh-list
93367992|NCT02871401|Antiviral Agents|antiviral agents|mesh-ancestor
93367993|NCT02871401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93367994|NCT03228303|Imatinib Mesylate|imatinib mesylate|mesh-list
93367995|NCT03228303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93367996|NCT03228303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93367997|NCT03228303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93367998|NCT03228303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93367999|NCT02085005|Capecitabine|capecitabine|mesh-list
93368000|NCT02085005|Oxaliplatin|oxaliplatin|mesh-list
93368001|NCT02085005|Aflibercept|aflibercept|mesh-list
93368002|NCT02085005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93368003|NCT02085005|Antimetabolites|antimetabolites|mesh-ancestor
93368004|NCT02085005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368005|NCT02085005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368006|NCT02085005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93368007|NCT02085005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93368008|NCT02085005|Growth Substances|growth substances|mesh-ancestor
93368009|NCT02085005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368010|NCT02085005|Growth Inhibitors|growth inhibitors|mesh-ancestor
93368011|NCT03235869|Durvalumab|durvalumab|mesh-list
93368012|NCT03235869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368013|NCT03235869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368014|NCT02079701|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93368015|NCT02079701|Immunologic Factors|immunologic factors|mesh-ancestor
93368016|NCT02079701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368017|NCT03057314|Calcium Carbonate|calcium carbonate|mesh-list
93368018|NCT03057314|Calcium|calcium|mesh-list
93368019|NCT03057314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93368020|NCT03057314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368021|NCT03057314|Antacids|antacids|mesh-ancestor
93368022|NCT03057314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368023|NCT03057314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368024|NCT02081495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93368025|NCT02081495|Doxorubicin|doxorubicin|mesh-list
93368026|NCT02081495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93368027|NCT02081495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368028|NCT02081495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93368029|NCT02081495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93368030|NCT02081495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368031|NCT02081495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368032|NCT03056846|Sulfalene|sulfalene|mesh-list
92661501|NCT00257114|Bortezomib|bortezomib|mesh-list
93368033|NCT03056846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368034|NCT03056846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93368035|NCT03056846|Antimalarials|antimalarials|mesh-ancestor
93368036|NCT03056846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93368037|NCT03056846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93368038|NCT03227679|Bupropion|bupropion|mesh-list
93368039|NCT03227679|Nicotine|nicotine|mesh-list
93368040|NCT03227679|Varenicline|varenicline|mesh-list
93368041|NCT03227679|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93368042|NCT03227679|Autonomic Agents|autonomic agents|mesh-ancestor
93368043|NCT03227679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368044|NCT03227679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368045|NCT03227679|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93368046|NCT03227679|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93368047|NCT03227679|Cholinergic Agents|cholinergic agents|mesh-ancestor
93368048|NCT03227679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368049|NCT03227679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368050|NCT03227679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93368051|NCT03227679|Antidepressive Agents|antidepressive agents|mesh-ancestor
93368052|NCT03227679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368053|NCT03227679|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93368054|NCT03227679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93368055|NCT03227679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368056|NCT03227679|Dopamine Agents|dopamine agents|mesh-ancestor
93368057|NCT03227679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93368058|NCT03227679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93368059|NCT03227679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368060|NCT04886167|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93368061|NCT04886167|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93368062|NCT04886167|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93368063|NCT04886167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368064|NCT04886167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368065|NCT04886167|Cholinergic Agents|cholinergic agents|mesh-ancestor
93368066|NCT04886167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368067|NCT04886167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368068|NCT04886167|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93368069|NCT04886167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368070|NCT04937894|Tigecycline|tigecycline|mesh-list
93368071|NCT04937894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93368072|NCT04937894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368073|NCT04937894|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93368074|NCT04937894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368075|NCT04937894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368076|NCT04919252|Vedolizumab|vedolizumab|mesh-list
93368077|NCT04919252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368078|NCT04919174|Dexmedetomidine|dexmedetomidine|mesh-list
93368079|NCT04919174|Remifentanil|remifentanil|mesh-list
93368080|NCT04919174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93368081|NCT04919174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368082|NCT04919174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368083|NCT04919174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93368084|NCT04919174|Analgesics|analgesics|mesh-ancestor
93368085|NCT04919174|Sensory System Agents|sensory system agents|mesh-ancestor
93368086|NCT04919174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368087|NCT04919174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93368088|NCT04919174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93368089|NCT04919174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93368090|NCT04919174|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368091|NCT04919174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368092|NCT04919174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368093|NCT04919174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93368094|NCT04919174|Narcotics|narcotics|mesh-ancestor
93368095|NCT02085239|Lidocaine|lidocaine|mesh-list
93368096|NCT02085239|Ropivacaine|ropivacaine|mesh-list
93368097|NCT02085239|Anesthetics, Local|anesthetics, local|mesh-ancestor
93368098|NCT02085239|Anesthetics|anesthetics|mesh-ancestor
93368099|NCT02085239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368100|NCT02085239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368101|NCT02085239|Sensory System Agents|sensory system agents|mesh-ancestor
93368102|NCT02085239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368103|NCT02085239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93368104|NCT02085239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93368105|NCT02085239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93368106|NCT02085239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368107|NCT02085239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368108|NCT05143489|Lidocaine|lidocaine|mesh-list
93368109|NCT05143489|Anesthetics, Local|anesthetics, local|mesh-ancestor
93368110|NCT05143489|Anesthetics|anesthetics|mesh-ancestor
93368111|NCT05143489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368112|NCT05143489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368113|NCT05143489|Sensory System Agents|sensory system agents|mesh-ancestor
93368114|NCT05143489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368115|NCT05143489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93368116|NCT05143489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93368117|NCT05143489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93368118|NCT05143489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368119|NCT05143489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368120|NCT02085317|Nitroprusside|nitroprusside|mesh-list
93368121|NCT02085317|Acetylcholine|acetylcholine|mesh-list
93368122|NCT02085317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93368123|NCT02085317|Vasodilator Agents|vasodilator agents|mesh-ancestor
93368124|NCT02085317|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93368125|NCT02085317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368126|NCT02085317|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93368127|NCT02085317|Cholinergic Agents|cholinergic agents|mesh-ancestor
93368128|NCT02085317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368129|NCT02085317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368130|NCT03234153|Durvalumab|durvalumab|mesh-list
93368131|NCT03234153|Tremelimumab|tremelimumab|mesh-list
93368132|NCT03234153|Immunomodulating Agents|immunomodulating agents|mesh-list
93368133|NCT03234153|Immunologic Factors|immunologic factors|mesh-list
93368134|NCT03234153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368135|NCT03234153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368136|NCT03234153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368137|NCT03056924|Vaccines|vaccines|mesh-list
93368138|NCT03056924|Immunologic Factors|immunologic factors|mesh-ancestor
93368139|NCT03056924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368140|NCT05523401|Psilocybin|psilocybin|mesh-list
93368141|NCT05523401|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93368142|NCT05523401|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|2-(4-bromo-2,5-dimethoxyphenyl)ethylamine|mesh-list
93368143|NCT05523401|Hallucinogens|hallucinogens|mesh-ancestor
93368144|NCT05523401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368145|NCT05523401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368146|NCT05523401|Serotonin Agents|serotonin agents|mesh-ancestor
93368147|NCT05523401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368148|NCT05523401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368149|NCT05523401|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93368150|NCT05523401|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93368151|NCT05523401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368152|NCT05523401|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368153|NCT05523401|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93368154|NCT05523401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93368155|NCT05523401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93368156|NCT05523401|Serotonin 5-HT2 Receptor Agonists|serotonin 5-ht2 receptor agonists|mesh-ancestor
93368157|NCT05523401|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93368158|NCT04918862|Granisetron|granisetron|mesh-list
93368159|NCT04918862|Antiemetics|antiemetics|mesh-ancestor
93368160|NCT04918862|Autonomic Agents|autonomic agents|mesh-ancestor
93368161|NCT04918862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368162|NCT04918862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368163|NCT04918862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368164|NCT04918862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93368165|NCT04918862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93368166|NCT04918862|Serotonin Agents|serotonin agents|mesh-ancestor
93368167|NCT04918862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368168|NCT04918862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368169|NCT02452905|Nitazoxanide|nitazoxanide|mesh-list
93368170|NCT02452905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93368171|NCT02452905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368173|NCT02081885|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93368174|NCT02081885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93368175|NCT02081885|Antimetabolites|antimetabolites|mesh-ancestor
93368176|NCT02081885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368177|NCT02081885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93368178|NCT02081885|Chelating Agents|chelating agents|mesh-ancestor
93368179|NCT02081885|Sequestering Agents|sequestering agents|mesh-ancestor
93368180|NCT02081885|Hemostatics|hemostatics|mesh-ancestor
93368181|NCT02081885|Coagulants|coagulants|mesh-ancestor
93368182|NCT03235245|Nivolumab|nivolumab|mesh-list
93368183|NCT03235245|Ipilimumab|ipilimumab|mesh-list
93368184|NCT03235245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368185|NCT03235245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368186|NCT03235245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93368187|NCT03235245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368188|NCT02452281|Ipilimumab|ipilimumab|mesh-list
93368189|NCT02452281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368190|NCT02452281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368191|NCT02452281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93368192|NCT02452281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368193|NCT02452125|Nicotine|nicotine|mesh-list
93368194|NCT02452125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93368195|NCT02452125|Autonomic Agents|autonomic agents|mesh-ancestor
93368196|NCT02452125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368197|NCT02452125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368198|NCT02452125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93368199|NCT02452125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93368200|NCT02452125|Cholinergic Agents|cholinergic agents|mesh-ancestor
93368201|NCT02452125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368202|NCT02452125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368203|NCT02619812|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93368204|NCT02619812|Immunoglobulins|immunoglobulins|mesh-list
93368205|NCT02619812|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93368206|NCT02619812|Antibodies|antibodies|mesh-list
93368207|NCT02619812|Immunologic Factors|immunologic factors|mesh-ancestor
93368208|NCT02619812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368209|NCT02619812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93368210|NCT02619812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93368211|NCT02619812|Antimetabolites|antimetabolites|mesh-ancestor
93368212|NCT02619812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368213|NCT02619812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93368214|NCT04928066|Prednisone|prednisone|mesh-list
93368215|NCT04928066|Tofacitinib|tofacitinib|mesh-list
93368216|NCT04928066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368217|NCT04928066|Glucocorticoids|glucocorticoids|mesh-ancestor
93368218|NCT04928066|Hormones|hormones|mesh-ancestor
93368219|NCT04928066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93368220|NCT04928066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368221|NCT04928066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93368222|NCT04928066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368223|NCT04928066|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93368224|NCT04928066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93368225|NCT04928066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368226|NCT04928066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368228|NCT03222765|Linagliptin|linagliptin|mesh-list
93368229|NCT03222765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368230|NCT03222765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368231|NCT03222765|Incretins|incretins|mesh-ancestor
93368232|NCT03222765|Hormones|hormones|mesh-ancestor
93368233|NCT03222765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93368234|NCT03222765|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93368235|NCT03222765|Protease Inhibitors|protease inhibitors|mesh-ancestor
93368236|NCT03222765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368237|NCT03222765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368238|NCT04485585|Tamsulosin|tamsulosin|mesh-list
93368239|NCT04485585|Mirabegron|mirabegron|mesh-list
92661722|NCT00290628|Autonomic Agents|autonomic agents|mesh-ancestor
93368240|NCT04485585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93368241|NCT04485585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93368242|NCT04485585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93368243|NCT04485585|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368244|NCT04485585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368245|NCT04485585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368246|NCT04485585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368247|NCT04485585|Urological Agents|urological agents|mesh-ancestor
93368248|NCT04485585|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93368249|NCT04485585|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93368250|NCT04485585|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93368251|NCT03222687|Prednisone|prednisone|mesh-list
93368252|NCT03222687|Tacrolimus|tacrolimus|mesh-list
93368253|NCT03222687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368254|NCT03222687|Glucocorticoids|glucocorticoids|mesh-ancestor
93368255|NCT03222687|Hormones|hormones|mesh-ancestor
93368256|NCT03222687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93368257|NCT03222687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368258|NCT03222687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93368259|NCT03222687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368260|NCT03222687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93368261|NCT03222687|Immunologic Factors|immunologic factors|mesh-ancestor
93368262|NCT03222687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93368263|NCT03222687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368264|NCT03222687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368265|NCT03055442|Inositol|inositol|mesh-list
93368266|NCT03055442|Vitamin B Complex|vitamin b complex|mesh-ancestor
93368267|NCT03055442|Vitamins|vitamins|mesh-ancestor
93368268|NCT03055442|Micronutrients|micronutrients|mesh-ancestor
93368269|NCT03055442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368270|NCT03226431|Ascorbic Acid|ascorbic acid|mesh-list
93368271|NCT03226431|Antioxidants|antioxidants|mesh-ancestor
93368272|NCT03226431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368273|NCT03226431|Protective Agents|protective agents|mesh-ancestor
93368274|NCT03226431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368275|NCT03226431|Vitamins|vitamins|mesh-ancestor
93368276|NCT03226431|Micronutrients|micronutrients|mesh-ancestor
93368277|NCT02451579|Cetirizine|cetirizine|mesh-list
93368278|NCT02451579|Histamine Antagonists|histamine antagonists|mesh-list
93368279|NCT02451579|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93368280|NCT02451579|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93368281|NCT02451579|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93368282|NCT02451579|Histamine Agents|histamine agents|mesh-ancestor
93368283|NCT02451579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368284|NCT02451579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368285|NCT02451579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368286|NCT04935788|Caseins|caseins|mesh-list
93368287|NCT04935788|Chelating Agents|chelating agents|mesh-ancestor
93368288|NCT04935788|Sequestering Agents|sequestering agents|mesh-ancestor
93368289|NCT04935788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368290|NCT03233295|Vitamin D|vitamin d|mesh-list
93368291|NCT03233295|Cholecalciferol|cholecalciferol|mesh-list
93368292|NCT03233295|Vitamins|vitamins|mesh-ancestor
93368293|NCT03233295|Micronutrients|micronutrients|mesh-ancestor
93368294|NCT03233295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368295|NCT03233295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93368296|NCT03233295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93368298|NCT04917458|Cholecalciferol|cholecalciferol|mesh-list
93368299|NCT04917458|Vitamins|vitamins|mesh-ancestor
93368300|NCT04917458|Micronutrients|micronutrients|mesh-ancestor
93368301|NCT04917458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368302|NCT04917458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93368303|NCT04917458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93368304|NCT03225963|Temozolomide|temozolomide|mesh-list
93368305|NCT03225963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93368306|NCT03225963|Alkylating Agents|alkylating agents|mesh-ancestor
93368307|NCT03225963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368308|NCT03225963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368309|NCT03221907|Pregabalin|pregabalin|mesh-list
93368310|NCT03221907|Analgesics|analgesics|mesh-ancestor
93368311|NCT03221907|Sensory System Agents|sensory system agents|mesh-ancestor
93368312|NCT03221907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368313|NCT03221907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387101|NCT00003462|Busulfan|busulfan|mesh-list
93368314|NCT03221907|Anticonvulsants|anticonvulsants|mesh-ancestor
93368315|NCT03221907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93368316|NCT03221907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368317|NCT03221907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368318|NCT03221907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93368319|NCT03221907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93368320|NCT03221907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93368321|NCT03221907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368322|NCT03221907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368323|NCT04934930|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93368324|NCT04934930|Obinutuzumab|obinutuzumab|mesh-list
93368325|NCT04934930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93368326|NCT04934930|Alkylating Agents|alkylating agents|mesh-ancestor
93368327|NCT04934930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368328|NCT04934930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368329|NCT04934930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368330|NCT03107481|Acetaminophen|acetaminophen|mesh-list
93368331|NCT03107481|Hydromorphone|hydromorphone|mesh-list
93368332|NCT03107481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93368333|NCT03107481|Analgesics|analgesics|mesh-ancestor
93368334|NCT03107481|Sensory System Agents|sensory system agents|mesh-ancestor
93368335|NCT03107481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368336|NCT03107481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368337|NCT03107481|Antipyretics|antipyretics|mesh-ancestor
93368338|NCT03107481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93368339|NCT03107481|Narcotics|narcotics|mesh-ancestor
93368340|NCT03107481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368341|NCT04934852|Ephedrine|ephedrine|mesh-list
93368342|NCT04934852|Pseudoephedrine|pseudoephedrine|mesh-list
93368343|NCT04934852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93368344|NCT04934852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368345|NCT04934852|Sympathomimetics|sympathomimetics|mesh-ancestor
93368346|NCT04934852|Autonomic Agents|autonomic agents|mesh-ancestor
93368347|NCT04934852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368348|NCT04934852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93368349|NCT04934852|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368350|NCT04934852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368351|NCT04934852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368352|NCT04934852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93368353|NCT04934852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93368354|NCT04934852|Respiratory System Agents|respiratory system agents|mesh-ancestor
93368355|NCT04934852|Nasal Decongestants|nasal decongestants|mesh-ancestor
93368356|NCT04934618|Irinotecan|irinotecan|mesh-list
93368357|NCT04934618|Apatinib|apatinib|mesh-list
93368358|NCT04934618|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93368359|NCT04934618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93368360|NCT04934618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368361|NCT04934618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368362|NCT04934618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368363|NCT04934618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93368364|NCT03107325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93368365|NCT03107325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93368366|NCT03107325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368367|NCT04916522|Colchicine|colchicine|mesh-list
93368368|NCT04916522|Gout Suppressants|gout suppressants|mesh-ancestor
93368369|NCT04916522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93368370|NCT04916522|Tubulin Modulators|tubulin modulators|mesh-ancestor
93368371|NCT04916522|Antimitotic Agents|antimitotic agents|mesh-ancestor
93368372|NCT04916522|Mitosis Modulators|mitosis modulators|mesh-ancestor
93368373|NCT04916522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368374|NCT04916522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368375|NCT04407650|Metformin|metformin|mesh-list
93368376|NCT04407650|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93368377|NCT04407650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368378|NCT04407650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368379|NCT04407650|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93368380|NCT04407650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368381|NCT00105157|Raltegravir Potassium|raltegravir potassium|mesh-list
93368382|NCT00105157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93368383|NCT00105157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93368384|NCT00105157|Antiviral Agents|antiviral agents|mesh-ancestor
93368385|NCT00105157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368386|NCT00105157|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93368387|NCT00105157|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93368388|NCT00105157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368389|NCT00105157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368390|NCT03220815|Methamphetamine|methamphetamine|mesh-list
93368391|NCT03220815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93368392|NCT03220815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368393|NCT03220815|Sympathomimetics|sympathomimetics|mesh-ancestor
93368394|NCT03220815|Autonomic Agents|autonomic agents|mesh-ancestor
93368395|NCT03220815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368396|NCT03220815|Dopamine Agents|dopamine agents|mesh-ancestor
93368397|NCT03220815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368398|NCT03220815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368399|NCT03220815|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368400|NCT03220815|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93368401|NCT03220815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93368402|NCT03220815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368403|NCT03220815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93368404|NCT04913402|Sufentanil|sufentanil|mesh-list
93368405|NCT04913402|Dsuvia|dsuvia|mesh-list
93368406|NCT04913402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93368407|NCT04913402|Narcotics|narcotics|mesh-ancestor
93368408|NCT04913402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368409|NCT04913402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368410|NCT04913402|Analgesics|analgesics|mesh-ancestor
93368411|NCT04913402|Sensory System Agents|sensory system agents|mesh-ancestor
93368412|NCT04913402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368413|NCT04913402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93368414|NCT04913402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93368415|NCT04913402|Anesthetics, General|anesthetics, general|mesh-ancestor
93368416|NCT04913402|Anesthetics|anesthetics|mesh-ancestor
93368417|NCT04912934|Insulin|insulin|mesh-list
93368418|NCT04912934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368419|NCT04912934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368420|NCT04915586|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93368421|NCT04915586|Plasminogen|plasminogen|mesh-list
93368422|NCT04915586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93368423|NCT04915586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93368424|NCT04915586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368425|NCT03232125|Ramosetron|ramosetron|mesh-list
93368426|NCT03232125|Antiemetics|antiemetics|mesh-ancestor
93368427|NCT03232125|Autonomic Agents|autonomic agents|mesh-ancestor
93368428|NCT03232125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368429|NCT03232125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368430|NCT03232125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368431|NCT03232125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93368432|NCT03232125|Serotonin Agents|serotonin agents|mesh-ancestor
93368433|NCT03232125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368434|NCT03232125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368435|NCT03224637|Acetaminophen|acetaminophen|mesh-list
93368436|NCT03224637|Ketorolac|ketorolac|mesh-list
93368437|NCT03224637|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93368438|NCT03224637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93368439|NCT03224637|Analgesics|analgesics|mesh-ancestor
93368440|NCT03224637|Sensory System Agents|sensory system agents|mesh-ancestor
93368441|NCT03224637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368442|NCT03224637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368443|NCT03224637|Antipyretics|antipyretics|mesh-ancestor
93368444|NCT03224637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93368445|NCT03224637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368446|NCT03224637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93368447|NCT03224637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93368448|NCT03224637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368449|NCT03224637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368450|NCT04912700|Vaccines|vaccines|mesh-list
93368451|NCT04912700|Immunologic Factors|immunologic factors|mesh-ancestor
93368452|NCT04912700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368453|NCT03224871|Aldesleukin|aldesleukin|mesh-list
93368454|NCT03224871|Pembrolizumab|pembrolizumab|mesh-list
93368455|NCT03224871|Nivolumab|nivolumab|mesh-list
93368456|NCT03224871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368457|NCT03224871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368458|NCT03224871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93368459|NCT03224871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368460|NCT03224871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93368461|NCT03224871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93368462|NCT03224871|Antiviral Agents|antiviral agents|mesh-ancestor
93368463|NCT03224871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368464|NCT03220425|Insulin|insulin|mesh-list
93368465|NCT03220425|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93368466|NCT03220425|Insulin Detemir|insulin detemir|mesh-list
93368467|NCT03220425|Insulin, Isophane|insulin, isophane|mesh-list
93368468|NCT03220425|Isophane Insulin, Human|isophane insulin, human|mesh-list
93368469|NCT03220425|Isophane insulin, beef|isophane insulin, beef|mesh-list
93368470|NCT03220425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368471|NCT03220425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368472|NCT04924868|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93368473|NCT04924868|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93368474|NCT04924868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368475|NCT04402346|Pancrelipase|pancrelipase|mesh-list
93368476|NCT04402346|Pancreatin|pancreatin|mesh-list
93368477|NCT04402346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368478|NCT03220191|Palbociclib|palbociclib|mesh-list
93368479|NCT03220191|Rabeprazole|rabeprazole|mesh-list
93368480|NCT03220191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368481|NCT03220191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93368482|NCT03220191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368483|NCT03220191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368484|NCT03220191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93368485|NCT03220191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368486|NCT03220191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93368487|NCT03220113|Thiamine|thiamine|mesh-list
93368488|NCT03220113|Dexamethasone|dexamethasone|mesh-list
93368489|NCT03220113|Lidocaine|lidocaine|mesh-list
93368490|NCT03220113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368491|NCT03220113|Antiemetics|antiemetics|mesh-ancestor
93368492|NCT03220113|Autonomic Agents|autonomic agents|mesh-ancestor
93368493|NCT03220113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368494|NCT03220113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368495|NCT03220113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368496|NCT03220113|Glucocorticoids|glucocorticoids|mesh-ancestor
93368497|NCT03220113|Hormones|hormones|mesh-ancestor
93368498|NCT03220113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93368499|NCT03220113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93368500|NCT03220113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368501|NCT03220113|Anesthetics, Local|anesthetics, local|mesh-ancestor
93368502|NCT03220113|Anesthetics|anesthetics|mesh-ancestor
93368503|NCT03220113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368504|NCT03220113|Sensory System Agents|sensory system agents|mesh-ancestor
93368505|NCT03220113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93368506|NCT03220113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93368507|NCT03220113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93368508|NCT03220113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368509|NCT03220113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368510|NCT03220113|Vitamin B Complex|vitamin b complex|mesh-ancestor
93368511|NCT03220113|Vitamins|vitamins|mesh-ancestor
93368512|NCT03220113|Micronutrients|micronutrients|mesh-ancestor
93368513|NCT02254525|Ibuprofen|ibuprofen|mesh-list
93368514|NCT02254525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93368515|NCT02254525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93368516|NCT02254525|Analgesics|analgesics|mesh-ancestor
93368517|NCT02254525|Sensory System Agents|sensory system agents|mesh-ancestor
93368518|NCT02254525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368519|NCT02254525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368520|NCT02254525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368521|NCT02254525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93368522|NCT02254525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93368523|NCT02254525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368524|NCT02254525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368525|NCT03231813|Emollients|emollients|mesh-list
93368526|NCT03231813|Dermatologic Agents|dermatologic agents|mesh-ancestor
93368527|NCT04914962|Lithium Carbonate|lithium carbonate|mesh-list
93368528|NCT04914962|Antidepressive Agents|antidepressive agents|mesh-ancestor
93368529|NCT04914962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368530|NCT04914962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368531|NCT04914962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368532|NCT04914962|Antimanic Agents|antimanic agents|mesh-ancestor
93368533|NCT04914962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93368534|NCT04914962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368535|NCT04914962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368536|NCT02143531|Haloperidol|haloperidol|mesh-list
93368537|NCT02143531|Ondansetron|ondansetron|mesh-list
93368538|NCT02143531|Haloperidol decanoate|haloperidol decanoate|mesh-list
93368539|NCT02143531|Antiemetics|antiemetics|mesh-ancestor
93368540|NCT02143531|Autonomic Agents|autonomic agents|mesh-ancestor
93368541|NCT02143531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368542|NCT02143531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368543|NCT02143531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368544|NCT02143531|Antipruritics|antipruritics|mesh-ancestor
93368545|NCT02143531|Dermatologic Agents|dermatologic agents|mesh-ancestor
93368546|NCT02143531|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93368547|NCT02143531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93368548|NCT02143531|Serotonin Agents|serotonin agents|mesh-ancestor
93368549|NCT02143531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368550|NCT02143531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368551|NCT02143531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93368552|NCT02143531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93368553|NCT02143531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368554|NCT02143531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368555|NCT02143531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93368556|NCT02143531|Dopamine Agents|dopamine agents|mesh-ancestor
93368557|NCT02143531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93368558|NCT04485117|Anesthetics|anesthetics|mesh-list
93368559|NCT04485117|Propofol|propofol|mesh-list
93368560|NCT04485117|Sevoflurane|sevoflurane|mesh-list
93368561|NCT04485117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368562|NCT04485117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368563|NCT04485117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93368564|NCT04485117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93368565|NCT04485117|Anesthetics, General|anesthetics, general|mesh-ancestor
93368566|NCT04485117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368567|NCT04485117|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93368568|NCT00803569|Sargramostim|sargramostim|mesh-list
93368569|NCT00803569|Immunologic Factors|immunologic factors|mesh-ancestor
93368570|NCT00803569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368571|NCT02143687|Sevoflurane|sevoflurane|mesh-list
93368572|NCT02143687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368573|NCT02143687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93368574|NCT02143687|Anesthetics, General|anesthetics, general|mesh-ancestor
93368575|NCT02143687|Anesthetics|anesthetics|mesh-ancestor
93368576|NCT02143687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368577|NCT02143687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368578|NCT02143765|Acarbose|acarbose|mesh-list
93368579|NCT02143765|Mitiglinide|mitiglinide|mesh-list
93368580|NCT02143765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93368581|NCT02143765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368582|NCT02143765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368583|NCT02143765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368584|NCT02143765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368585|NCT02148367|Epoetin Alfa|epoetin alfa|mesh-list
93368586|NCT02148367|Hematinics|hematinics|mesh-ancestor
93368587|NCT00482833|Methotrexate|methotrexate|mesh-list
93368588|NCT00482833|Mercaptopurine|mercaptopurine|mesh-list
93368589|NCT00482833|Idarubicin|idarubicin|mesh-list
93368590|NCT00482833|Tretinoin|tretinoin|mesh-list
93368591|NCT00482833|Arsenic Trioxide|arsenic trioxide|mesh-list
93368592|NCT00482833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93368593|NCT00482833|Abortifacient Agents|abortifacient agents|mesh-ancestor
93368594|NCT00482833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93368595|NCT00482833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368596|NCT00482833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93368597|NCT00482833|Antimetabolites|antimetabolites|mesh-ancestor
93368598|NCT00482833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368599|NCT00482833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368600|NCT00482833|Dermatologic Agents|dermatologic agents|mesh-ancestor
93368601|NCT00482833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368602|NCT00482833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93368603|NCT00482833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93368604|NCT00482833|Immunologic Factors|immunologic factors|mesh-ancestor
93368605|NCT00482833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93368606|NCT00482833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93368607|NCT00482833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93368608|NCT00482833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93368609|NCT00482833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93368610|NCT00482833|Keratolytic Agents|keratolytic agents|mesh-ancestor
93368611|NCT02451033|Hormones|hormones|mesh-list
93368612|NCT02451033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93368613|NCT02451033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368614|NCT04485429|Methylprednisolone|methylprednisolone|mesh-list
93368615|NCT04485429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93368616|NCT04485429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93368617|NCT04485429|Prednisolone|prednisolone|mesh-list
93368618|NCT04485429|Prednisolone acetate|prednisolone acetate|mesh-list
93368619|NCT04485429|Heparin|heparin|mesh-list
93368620|NCT04485429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93368621|NCT04485429|Prednisolone phosphate|prednisolone phosphate|mesh-list
93368622|NCT04485429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368623|NCT04485429|Antiemetics|antiemetics|mesh-ancestor
93368624|NCT04485429|Autonomic Agents|autonomic agents|mesh-ancestor
93368625|NCT04485429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368626|NCT04485429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368627|NCT04485429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368628|NCT04485429|Glucocorticoids|glucocorticoids|mesh-ancestor
93368629|NCT04485429|Hormones|hormones|mesh-ancestor
93368630|NCT04485429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93368631|NCT04485429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93368632|NCT04485429|Protective Agents|protective agents|mesh-ancestor
93368633|NCT04485429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93368634|NCT04485429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368635|NCT04485429|Anticoagulants|anticoagulants|mesh-ancestor
93368636|NCT04485429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93368637|NCT04485429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93368638|NCT04485429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368639|NCT00112957|Vaccines|vaccines|mesh-list
93368640|NCT00112957|Immunologic Factors|immunologic factors|mesh-ancestor
93368641|NCT00112957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368642|NCT02140801|Clopidogrel|clopidogrel|mesh-list
93368643|NCT02140801|Ticagrelor|ticagrelor|mesh-list
93368644|NCT02140801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368645|NCT02140801|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93368646|NCT02140801|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93368647|NCT02140801|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93368648|NCT02140801|Purinergic Agents|purinergic agents|mesh-ancestor
93368649|NCT02140801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368650|NCT02140801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368651|NCT02140801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368652|NCT02148601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93368653|NCT02148601|Vancomycin|vancomycin|mesh-list
93368654|NCT02148601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368655|NCT02141035|Acetylcarnitine|acetylcarnitine|mesh-list
93368656|NCT02141035|Vitamin B Complex|vitamin b complex|mesh-ancestor
93368657|NCT02141035|Vitamins|vitamins|mesh-ancestor
93368658|NCT02141035|Micronutrients|micronutrients|mesh-ancestor
93368659|NCT02141035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368660|NCT02141035|Nootropic Agents|nootropic agents|mesh-ancestor
93368661|NCT03214653|Propofol|propofol|mesh-list
93368662|NCT03214653|Sevoflurane|sevoflurane|mesh-list
93368663|NCT03214653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93368664|NCT03214653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368665|NCT03214653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368666|NCT03214653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93368667|NCT03214653|Anesthetics, General|anesthetics, general|mesh-ancestor
93368668|NCT03214653|Anesthetics|anesthetics|mesh-ancestor
93368669|NCT03214653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368670|NCT03214653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93368671|NCT02450877|Azacitidine|azacitidine|mesh-list
93368672|NCT02450877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93368673|NCT02450877|Antimetabolites|antimetabolites|mesh-ancestor
93368674|NCT02450877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368675|NCT02450877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368676|NCT02450877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368677|NCT02141113|Guanfacine|guanfacine|mesh-list
93368678|NCT02141113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93368679|NCT02141113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93368680|NCT02141113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93368681|NCT02141113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93368682|NCT02141113|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368683|NCT02141113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368684|NCT02141113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368685|NCT02141113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368686|NCT03213639|Esomeprazole|esomeprazole|mesh-list
93368687|NCT03213639|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93368688|NCT03213639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368689|NCT03213639|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93368690|NCT03213639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368691|NCT03213639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368692|NCT03231033|Pioglitazone|pioglitazone|mesh-list
93368693|NCT03231033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368694|NCT03231033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368695|NCT02141347|Durvalumab|durvalumab|mesh-list
93368696|NCT02141347|Tremelimumab|tremelimumab|mesh-list
93368697|NCT02141347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368698|NCT02141347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368699|NCT02254759|Midazolam|midazolam|mesh-list
93368700|NCT02254759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93368701|NCT02254759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93368702|NCT02254759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368703|NCT02254759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368704|NCT02254759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93368705|NCT02254759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93368706|NCT02254759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368707|NCT02254759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93368708|NCT02254759|Anesthetics, General|anesthetics, general|mesh-ancestor
93368709|NCT02254759|Anesthetics|anesthetics|mesh-ancestor
93368710|NCT02254759|GABA Modulators|gaba modulators|mesh-ancestor
93368711|NCT02254759|GABA Agents|gaba agents|mesh-ancestor
93368712|NCT02254759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368713|NCT02254759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368714|NCT03208257|Esmolol|esmolol|mesh-list
93368715|NCT03208257|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93368716|NCT03208257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93368717|NCT03208257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93368718|NCT03208257|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368719|NCT03208257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368720|NCT03208257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368721|NCT03208257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368722|NCT02141425|Peficitinib|peficitinib|mesh-list
93368723|NCT02141425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368724|NCT02141425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368725|NCT02141425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93368726|NCT02141425|Immunologic Factors|immunologic factors|mesh-ancestor
93368727|NCT02141425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368728|NCT02148913|Melphalan|melphalan|mesh-list
93368729|NCT02148913|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92662204|NCT00258557|Darunavir|darunavir|mesh-list
93368730|NCT02148913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93368731|NCT02148913|Alkylating Agents|alkylating agents|mesh-ancestor
93368732|NCT02148913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368733|NCT02148913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368734|NCT02148913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93368735|NCT02148913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93368736|NCT02148913|Immunologic Factors|immunologic factors|mesh-ancestor
93368737|NCT02148913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368738|NCT03208101|Vaccines|vaccines|mesh-list
93368739|NCT03208101|Immunologic Factors|immunologic factors|mesh-ancestor
93368740|NCT03208101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368741|NCT02149225|Poly I-C|poly i-c|mesh-list
93368742|NCT02149225|Molgramostim|molgramostim|mesh-list
93368743|NCT02149225|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93368744|NCT02149225|Vaccines|vaccines|mesh-list
93368745|NCT02149225|Sargramostim|sargramostim|mesh-list
93368746|NCT02149225|Poly ICLC|poly iclc|mesh-list
93368747|NCT02149225|Immunologic Factors|immunologic factors|mesh-ancestor
93368748|NCT02149225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368749|NCT02149225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040383|NCT00406640|Escitalopram|escitalopram|mesh-list
93368750|NCT02149225|Interferon Inducers|interferon inducers|mesh-ancestor
93368751|NCT02149225|Laxatives|laxatives|mesh-ancestor
93368752|NCT02149225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368753|NCT02149225|Antiviral Agents|antiviral agents|mesh-ancestor
93368754|NCT02149225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368755|NCT03208335|Endostatins|endostatins|mesh-list
93368756|NCT03208335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368757|NCT03208335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93368758|NCT03208335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93368759|NCT03208335|Growth Substances|growth substances|mesh-ancestor
93368760|NCT03208335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368761|NCT03208335|Growth Inhibitors|growth inhibitors|mesh-ancestor
93368762|NCT03211065|Immunoglobulins|immunoglobulins|mesh-list
93368763|NCT03211065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93368764|NCT03211065|Antibodies|antibodies|mesh-list
93368765|NCT03211065|Immunologic Factors|immunologic factors|mesh-ancestor
93368766|NCT03211065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368767|NCT02149459|Metformin|metformin|mesh-list
93368768|NCT02149459|Biguanides|biguanides|mesh-list
93368769|NCT02149459|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93368770|NCT02149459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368771|NCT02376790|Etanercept|etanercept|mesh-list
93368772|NCT02376790|Methotrexate|methotrexate|mesh-list
93368773|NCT02376790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93368774|NCT02376790|Abortifacient Agents|abortifacient agents|mesh-ancestor
93368775|NCT02376790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93368776|NCT02376790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368777|NCT02376790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93368778|NCT02376790|Antimetabolites|antimetabolites|mesh-ancestor
93368779|NCT02376790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368780|NCT02376790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368781|NCT02376790|Dermatologic Agents|dermatologic agents|mesh-ancestor
93368782|NCT02376790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368783|NCT02376790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93368784|NCT02376790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93368785|NCT02376790|Immunologic Factors|immunologic factors|mesh-ancestor
93368786|NCT02376790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93368787|NCT02376790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93368788|NCT02376790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93368789|NCT02376790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93368790|NCT02376790|Analgesics|analgesics|mesh-ancestor
93368791|NCT02376790|Sensory System Agents|sensory system agents|mesh-ancestor
93368792|NCT02376790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368793|NCT02376790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93368794|NCT02376790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93368795|NCT02141737|Lidocaine|lidocaine|mesh-list
93368796|NCT02141737|Fentanyl|fentanyl|mesh-list
93368797|NCT02141737|Midazolam|midazolam|mesh-list
93368798|NCT02141737|Etomidate|etomidate|mesh-list
93368799|NCT02141737|Rocuronium|rocuronium|mesh-list
93368800|NCT02141737|Anesthetics, Local|anesthetics, local|mesh-ancestor
93368801|NCT02141737|Anesthetics|anesthetics|mesh-ancestor
93368802|NCT02141737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368803|NCT02141737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368804|NCT02141737|Sensory System Agents|sensory system agents|mesh-ancestor
93368805|NCT02141737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368806|NCT02141737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93368807|NCT02141737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93368808|NCT02141737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93368809|NCT02141737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93368810|NCT02141737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368811|NCT02141737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93368812|NCT02141737|Narcotics|narcotics|mesh-ancestor
93368813|NCT02141737|Analgesics|analgesics|mesh-ancestor
93368814|NCT02141737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93368815|NCT02141737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93368816|NCT02141737|Anesthetics, General|anesthetics, general|mesh-ancestor
93368817|NCT02141737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93368818|NCT02141737|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93368819|NCT02141737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93368820|NCT02141737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368821|NCT02141737|GABA Modulators|gaba modulators|mesh-ancestor
93368822|NCT02141737|GABA Agents|gaba agents|mesh-ancestor
93368823|NCT02141737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368824|NCT02141737|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93368825|NCT02141737|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93368826|NCT02141737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93368827|NCT02254447|Candesartan|candesartan|mesh-list
93368828|NCT02254447|Candesartan cilexetil|candesartan cilexetil|mesh-list
93368829|NCT02254447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93368830|NCT02254447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93368831|NCT02254447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93368832|NCT02254447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368833|NCT02376166|Metformin|metformin|mesh-list
93368834|NCT02376166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93368835|NCT02376166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368836|NCT03207165|Dobutamine|dobutamine|mesh-list
93368837|NCT03207165|Milrinone|milrinone|mesh-list
93368838|NCT03207165|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-list
93368839|NCT03207165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93368840|NCT03207165|Sympathomimetics|sympathomimetics|mesh-ancestor
93368841|NCT03207165|Autonomic Agents|autonomic agents|mesh-ancestor
93368842|NCT03207165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368843|NCT03207165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368844|NCT03207165|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93368845|NCT03207165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93368846|NCT03207165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93368847|NCT03207165|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368848|NCT03207165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368849|NCT03207165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368850|NCT03207165|Protective Agents|protective agents|mesh-ancestor
93368851|NCT03207165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368852|NCT03207165|Vasodilator Agents|vasodilator agents|mesh-ancestor
93368853|NCT03207165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93368854|NCT03207165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368855|NCT02142205|Natalizumab|natalizumab|mesh-list
93368856|NCT02142205|Immunologic Factors|immunologic factors|mesh-ancestor
93368857|NCT02142205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368858|NCT03209427|Morphine|morphine|mesh-list
93368859|NCT03209427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93368860|NCT03209427|Narcotics|narcotics|mesh-ancestor
93368861|NCT03209427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368862|NCT03209427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368863|NCT03209427|Analgesics|analgesics|mesh-ancestor
93368864|NCT03209427|Sensory System Agents|sensory system agents|mesh-ancestor
93368865|NCT03209427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368866|NCT03544723|Pembrolizumab|pembrolizumab|mesh-list
93368867|NCT03544723|Nivolumab|nivolumab|mesh-list
93368868|NCT03544723|Atezolizumab|atezolizumab|mesh-list
93368869|NCT03544723|Durvalumab|durvalumab|mesh-list
93368870|NCT03544723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368871|NCT03544723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368872|NCT03544723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93368873|NCT03544723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368874|NCT03209661|Menthol|menthol|mesh-list
93368875|NCT03209661|Nicotine|nicotine|mesh-list
93368876|NCT03209661|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93368877|NCT03209661|Autonomic Agents|autonomic agents|mesh-ancestor
93368878|NCT03209661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368879|NCT03209661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368880|NCT03209661|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93368881|NCT03209661|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93368882|NCT03209661|Cholinergic Agents|cholinergic agents|mesh-ancestor
93368883|NCT03209661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368884|NCT03209661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368885|NCT03209661|Antipruritics|antipruritics|mesh-ancestor
93368886|NCT03209661|Dermatologic Agents|dermatologic agents|mesh-ancestor
93368887|NCT03209037|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93368888|NCT03209037|Antiviral Agents|antiviral agents|mesh-ancestor
93368889|NCT03209037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368890|NCT03209115|Calcium, Dietary|calcium, dietary|mesh-list
93368891|NCT03209115|Chlorhexidine|chlorhexidine|mesh-list
93368892|NCT03209115|Calcium|calcium|mesh-list
93368893|NCT03209115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93368894|NCT03209115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368895|NCT03209115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93368896|NCT03209115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93368897|NCT03209115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368898|NCT03209115|Disinfectants|disinfectants|mesh-ancestor
93368899|NCT03209193|Sevoflurane|sevoflurane|mesh-list
93368900|NCT03209193|Desflurane|desflurane|mesh-list
93368901|NCT03209193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368902|NCT03209193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93368903|NCT03209193|Anesthetics, General|anesthetics, general|mesh-ancestor
93368904|NCT03209193|Anesthetics|anesthetics|mesh-ancestor
93368905|NCT03209193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368906|NCT03209193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368907|NCT02142595|Midazolam|midazolam|mesh-list
93368908|NCT02142595|Dexmedetomidine|dexmedetomidine|mesh-list
93368909|NCT02142595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93368910|NCT02142595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368911|NCT02142595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368912|NCT02142595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93368913|NCT02142595|Analgesics|analgesics|mesh-ancestor
93368914|NCT02142595|Sensory System Agents|sensory system agents|mesh-ancestor
93368915|NCT02142595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368916|NCT02142595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93368917|NCT02142595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93368918|NCT02142595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93368919|NCT02142595|Adrenergic Agents|adrenergic agents|mesh-ancestor
93368920|NCT02142595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93368921|NCT02142595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368922|NCT02142595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93368923|NCT02142595|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93368924|NCT02142595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93368925|NCT02142595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93368926|NCT02142595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93368927|NCT02142595|Anesthetics, General|anesthetics, general|mesh-ancestor
93368928|NCT02142595|Anesthetics|anesthetics|mesh-ancestor
93368929|NCT02142595|GABA Modulators|gaba modulators|mesh-ancestor
93368930|NCT02142595|GABA Agents|gaba agents|mesh-ancestor
93368931|NCT04898374|Cisplatin|cisplatin|mesh-list
93368932|NCT04898374|Gemcitabine|gemcitabine|mesh-list
93368933|NCT04898374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368934|NCT04898374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93368935|NCT04898374|Antimetabolites|antimetabolites|mesh-ancestor
93368936|NCT04898374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368937|NCT03207477|Mydriatics|mydriatics|mesh-list
93368938|NCT03207477|Autonomic Agents|autonomic agents|mesh-ancestor
93368939|NCT03207477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368940|NCT03207477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368941|NCT02452515|Fulacimstat|fulacimstat|mesh-list
93368942|NCT02452515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368943|NCT02452515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368944|NCT03206931|Selitrectinib|selitrectinib|mesh-list
93368945|NCT03206931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93368946|NCT03206931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368947|NCT02344342|Diuretics|diuretics|mesh-list
93368948|NCT02344342|Natriuretic Agents|natriuretic agents|mesh-ancestor
93368949|NCT02344342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368950|NCT02452437|Oxycodone|oxycodone|mesh-list
93368951|NCT02452437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93368952|NCT02452437|Narcotics|narcotics|mesh-ancestor
93368953|NCT02452437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368954|NCT02452437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368955|NCT02452437|Analgesics|analgesics|mesh-ancestor
93368956|NCT02452437|Sensory System Agents|sensory system agents|mesh-ancestor
93368957|NCT02452437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93368958|NCT03208413|Thalidomide|thalidomide|mesh-list
93368959|NCT03208413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93368960|NCT03208413|Immunologic Factors|immunologic factors|mesh-ancestor
93368961|NCT03208413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368962|NCT03208413|Leprostatic Agents|leprostatic agents|mesh-ancestor
93368963|NCT03208413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93368964|NCT03208413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368965|NCT03208413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93368966|NCT03208413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93368967|NCT03208413|Growth Substances|growth substances|mesh-ancestor
93368968|NCT03208413|Growth Inhibitors|growth inhibitors|mesh-ancestor
93368969|NCT03208413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368970|NCT03201159|Pentamidine|pentamidine|mesh-list
93368971|NCT03201159|Antifungal Agents|antifungal agents|mesh-ancestor
93368972|NCT03201159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368973|NCT03201159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93368974|NCT03201159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93368975|NCT03201159|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93368976|NCT02149927|Sevoflurane|sevoflurane|mesh-list
93368977|NCT02149927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93368978|NCT02149927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93368979|NCT02149927|Anesthetics, General|anesthetics, general|mesh-ancestor
93368980|NCT02149927|Anesthetics|anesthetics|mesh-ancestor
93040603|NCT01074346|Immunologic Factors|immunologic factors|mesh-ancestor
93368981|NCT02149927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368983|NCT02142751|Meropenem|meropenem|mesh-list
93368984|NCT02142751|Ceftriaxone|ceftriaxone|mesh-list
93368985|NCT02142751|Fosfomycin|fosfomycin|mesh-list
93368986|NCT02142751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93368987|NCT02142751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93368988|NCT02142751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93368989|NCT02343952|Pembrolizumab|pembrolizumab|mesh-list
93368990|NCT02343952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93368991|NCT02343952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93368992|NCT02343952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93368993|NCT02343952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93368994|NCT02142829|Bupivacaine|bupivacaine|mesh-list
93368995|NCT02142829|Anesthetics, Local|anesthetics, local|mesh-ancestor
93368996|NCT02142829|Anesthetics|anesthetics|mesh-ancestor
93368997|NCT02142829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93368998|NCT02142829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93368999|NCT02142829|Sensory System Agents|sensory system agents|mesh-ancestor
93369000|NCT02142829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369001|NCT03200691|Antibodies|antibodies|mesh-list
93369002|NCT03200691|Immunologic Factors|immunologic factors|mesh-ancestor
93369003|NCT03200691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369004|NCT02150161|Lidocaine|lidocaine|mesh-list
93369005|NCT02150161|Fentanyl|fentanyl|mesh-list
93369006|NCT02150161|Ketamine|ketamine|mesh-list
93369007|NCT02150161|Anesthetics, Local|anesthetics, local|mesh-ancestor
93369008|NCT02150161|Anesthetics|anesthetics|mesh-ancestor
93369009|NCT02150161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369010|NCT02150161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369011|NCT02150161|Sensory System Agents|sensory system agents|mesh-ancestor
92662480|NCT00415376|Levetiracetam|levetiracetam|mesh-list
93369012|NCT02150161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369013|NCT02150161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93369014|NCT02150161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93369015|NCT02150161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93369016|NCT02150161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93369017|NCT02150161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369018|NCT02150161|Analgesics|analgesics|mesh-ancestor
93369019|NCT02150161|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93369020|NCT02150161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93369021|NCT02150161|Anesthetics, General|anesthetics, general|mesh-ancestor
93369022|NCT02150161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93369023|NCT02150161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93369024|NCT02150161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369025|NCT02150161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93369026|NCT02150161|Narcotics|narcotics|mesh-ancestor
93369027|NCT02150161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93369028|NCT03200613|Heparin|heparin|mesh-list
93369029|NCT03200613|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93369030|NCT03200613|Tinzaparin|tinzaparin|mesh-list
93369031|NCT03200613|Dalteparin|dalteparin|mesh-list
93369032|NCT03200613|Apixaban|apixaban|mesh-list
93369033|NCT03200613|Anticoagulants|anticoagulants|mesh-ancestor
93369034|NCT03200613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93369035|NCT03200613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93369036|NCT03200613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369037|NCT03200613|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93369038|NCT03200613|Antithrombins|antithrombins|mesh-ancestor
93369039|NCT03200613|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93369040|NCT03200613|Protease Inhibitors|protease inhibitors|mesh-ancestor
93369041|NCT03200613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369042|NCT02150317|Sorafenib|sorafenib|mesh-list
93369043|NCT02150317|Chlorotrianisene|chlorotrianisene|mesh-list
93369044|NCT02150317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369045|NCT02150317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369046|NCT02150317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369047|NCT02150317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369048|NCT02150317|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93369049|NCT02150317|Estrogens|estrogens|mesh-ancestor
93369050|NCT02150317|Hormones|hormones|mesh-ancestor
93369051|NCT02150317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369052|NCT02150317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369053|NCT02150317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93369054|NCT02310568|PF-06372865|pf-06372865|mesh-list
93369055|NCT02310568|GABA Modulators|gaba modulators|mesh-ancestor
93369056|NCT02310568|GABA Agents|gaba agents|mesh-ancestor
93369057|NCT02310568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369058|NCT02310568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369059|NCT02310568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369060|NCT02448069|Argatroban|argatroban|mesh-list
93369061|NCT02448069|Antithrombins|antithrombins|mesh-ancestor
93369062|NCT02448069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93369063|NCT02448069|Protease Inhibitors|protease inhibitors|mesh-ancestor
93369064|NCT02448069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369065|NCT02448069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369066|NCT02448069|Anticoagulants|anticoagulants|mesh-ancestor
93369067|NCT02448069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93369068|NCT02449941|Rabeprazole|rabeprazole|mesh-list
93369069|NCT02449941|Pantoprazole|pantoprazole|mesh-list
93369070|NCT02449941|Lansoprazole|lansoprazole|mesh-list
93369071|NCT02449941|Dexlansoprazole|dexlansoprazole|mesh-list
93369072|NCT02449941|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93369073|NCT02449941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93369074|NCT02449941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93369075|NCT02449941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369076|NCT02449941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369077|NCT04484493|Mometasone Furoate|mometasone furoate|mesh-list
93369078|NCT04484493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369079|NCT04484493|Dermatologic Agents|dermatologic agents|mesh-ancestor
93369080|NCT04484493|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93369081|NCT03199989|Capecitabine|capecitabine|mesh-list
93369082|NCT03199989|Oxaliplatin|oxaliplatin|mesh-list
93369083|NCT03199989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93369084|NCT03199989|Antimetabolites|antimetabolites|mesh-ancestor
93369085|NCT03199989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369086|NCT03199989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369087|NCT03195933|Hydrocortisone|hydrocortisone|mesh-list
93369088|NCT03195933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369089|NCT03195543|Thrombin|thrombin|mesh-list
93369090|NCT03195543|Hemostatics|hemostatics|mesh-ancestor
93369091|NCT03195543|Coagulants|coagulants|mesh-ancestor
93369092|NCT03204669|Trace Elements|trace elements|mesh-list
93369093|NCT03204669|Micronutrients|micronutrients|mesh-list
93369094|NCT03204669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369095|NCT03199677|Apatinib|apatinib|mesh-list
93369096|NCT03199677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369097|NCT03199677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369098|NCT03199677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369099|NCT03199677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369100|NCT02780167|Abrocitinib|abrocitinib|mesh-list
93369101|NCT02780167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369102|NCT02780167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369103|NCT02780167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369104|NCT02447757|Remifentanil|remifentanil|mesh-list
93369105|NCT02447757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93369106|NCT02447757|Narcotics|narcotics|mesh-ancestor
93369107|NCT02447757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369108|NCT02447757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369109|NCT02447757|Analgesics|analgesics|mesh-ancestor
93369110|NCT02447757|Sensory System Agents|sensory system agents|mesh-ancestor
93369111|NCT02447757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369112|NCT02447835|Olanzapine|olanzapine|mesh-list
93369113|NCT02447835|Antiemetics|antiemetics|mesh-ancestor
93369114|NCT02447835|Autonomic Agents|autonomic agents|mesh-ancestor
93369115|NCT02447835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369116|NCT02447835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369117|NCT02447835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93369118|NCT02447835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93369119|NCT02447835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93369120|NCT02447835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369121|NCT02447835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369122|NCT02447835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93369123|NCT02447835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93369124|NCT02447835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93369125|NCT02447835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369126|NCT02447835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369127|NCT02447835|Serotonin Agents|serotonin agents|mesh-ancestor
93369128|NCT02447679|Tegafur|tegafur|mesh-list
93369129|NCT02447679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93369130|NCT02447679|Antimetabolites|antimetabolites|mesh-ancestor
93369131|NCT02447679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369132|NCT02447679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369133|NCT03203967|Morphine|morphine|mesh-list
93369134|NCT03203967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93369135|NCT03203967|Narcotics|narcotics|mesh-ancestor
93369136|NCT03203967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369137|NCT03203967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369138|NCT03203967|Analgesics|analgesics|mesh-ancestor
93369139|NCT03203967|Sensory System Agents|sensory system agents|mesh-ancestor
93369140|NCT03203967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369141|NCT03204045|Fentanyl|fentanyl|mesh-list
93369142|NCT03204045|Oxycodone|oxycodone|mesh-list
93369143|NCT03204045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93369144|NCT03204045|Narcotics|narcotics|mesh-ancestor
93369145|NCT03204045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369146|NCT03204045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369147|NCT03204045|Analgesics|analgesics|mesh-ancestor
93369148|NCT03204045|Sensory System Agents|sensory system agents|mesh-ancestor
93369149|NCT03204045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369150|NCT03204045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93369151|NCT03204045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93369152|NCT03204045|Anesthetics, General|anesthetics, general|mesh-ancestor
93369153|NCT03204045|Anesthetics|anesthetics|mesh-ancestor
93369154|NCT03199521|Thrombin|thrombin|mesh-list
93369155|NCT03199521|Hemostatics|hemostatics|mesh-ancestor
93369156|NCT03199521|Coagulants|coagulants|mesh-ancestor
93369157|NCT03195153|Allopurinol|allopurinol|mesh-list
93369158|NCT03195153|Atorvastatin|atorvastatin|mesh-list
93369159|NCT03195153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93369160|NCT03195153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93369161|NCT03195153|Antimetabolites|antimetabolites|mesh-ancestor
93369162|NCT03195153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369163|NCT03195153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93369164|NCT03195153|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93369165|NCT03195153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369166|NCT03195153|Gout Suppressants|gout suppressants|mesh-ancestor
93369167|NCT03195153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369168|NCT03195153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93369169|NCT03195153|Antioxidants|antioxidants|mesh-ancestor
93369170|NCT03195153|Protective Agents|protective agents|mesh-ancestor
93369171|NCT03195153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369172|NCT03195309|Fentanyl|fentanyl|mesh-list
93369173|NCT03195309|Ropivacaine|ropivacaine|mesh-list
93369174|NCT03195309|Anesthetics, Local|anesthetics, local|mesh-ancestor
93369175|NCT03195309|Anesthetics|anesthetics|mesh-ancestor
93369176|NCT03195309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369177|NCT03195309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369178|NCT03195309|Sensory System Agents|sensory system agents|mesh-ancestor
93369179|NCT03195309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369180|NCT03195309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93369181|NCT03195309|Narcotics|narcotics|mesh-ancestor
93369182|NCT03195309|Analgesics|analgesics|mesh-ancestor
93369183|NCT03195309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93369184|NCT03195309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93369185|NCT03195309|Anesthetics, General|anesthetics, general|mesh-ancestor
93369186|NCT03198819|Cefotaxime|cefotaxime|mesh-list
93369187|NCT03198819|Cefoxitin|cefoxitin|mesh-list
93369188|NCT03198819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93369189|NCT03198819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369190|NCT02447601|Simvastatin|simvastatin|mesh-list
93369191|NCT02447601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93369192|NCT02447601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93369193|NCT02447601|Antimetabolites|antimetabolites|mesh-ancestor
93369194|NCT02447601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369195|NCT02447601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93369196|NCT02447601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93369197|NCT02447601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369198|NCT03118713|Metformin|metformin|mesh-list
93369199|NCT03118713|Glimepiride|glimepiride|mesh-list
93369200|NCT03118713|Ipragliflozin|ipragliflozin|mesh-list
93369201|NCT03118713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93369202|NCT03118713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369203|NCT03118713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93369204|NCT03118713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369205|NCT03118713|Immunologic Factors|immunologic factors|mesh-ancestor
93369206|NCT03118713|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93040830|NCT00254566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369207|NCT03118713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369208|NCT03198585|Empagliflozin|empagliflozin|mesh-list
93369209|NCT03198585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93369210|NCT03198585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369211|NCT03198585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93369212|NCT03198585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369213|NCT02447289|Midazolam|midazolam|mesh-list
93369214|NCT02447289|Ketamine|ketamine|mesh-list
93369215|NCT02447289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93369216|NCT02447289|Analgesics|analgesics|mesh-ancestor
93369217|NCT02447289|Sensory System Agents|sensory system agents|mesh-ancestor
93369218|NCT02447289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369219|NCT02447289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369220|NCT02447289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93369221|NCT02447289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93369222|NCT02447289|Anesthetics, General|anesthetics, general|mesh-ancestor
93369223|NCT02447289|Anesthetics|anesthetics|mesh-ancestor
93369224|NCT02447289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369225|NCT02447289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93369226|NCT02447289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93369227|NCT02447289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369228|NCT02447289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369229|NCT02447289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93369230|NCT02447289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93369231|NCT02447289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93369232|NCT02447289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93369233|NCT02447289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369234|NCT02447289|GABA Modulators|gaba modulators|mesh-ancestor
93369235|NCT02447289|GABA Agents|gaba agents|mesh-ancestor
93369236|NCT02447211|Doxepin|doxepin|mesh-list
93369237|NCT02447211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93369238|NCT02447211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93369239|NCT02447211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369240|NCT02447211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369241|NCT02447211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93369242|NCT02447211|Antidepressive Agents|antidepressive agents|mesh-ancestor
93369243|NCT02447211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369244|NCT02447211|Histamine Antagonists|histamine antagonists|mesh-ancestor
93369245|NCT02447211|Histamine Agents|histamine agents|mesh-ancestor
93369246|NCT02447211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369247|NCT02447211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369248|NCT03198195|Cyclophosphamide|cyclophosphamide|mesh-list
93369249|NCT03198195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369250|NCT03198195|Immunologic Factors|immunologic factors|mesh-ancestor
93369251|NCT03198195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369252|NCT03198195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369253|NCT03198195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369254|NCT03198195|Alkylating Agents|alkylating agents|mesh-ancestor
93369255|NCT03198195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369256|NCT03198195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369257|NCT03198195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93369258|NCT03203421|Heparin Cofactor II|heparin cofactor ii|mesh-list
93369259|NCT03203421|Antithrombins|antithrombins|mesh-ancestor
93369260|NCT03203421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93369261|NCT03203421|Protease Inhibitors|protease inhibitors|mesh-ancestor
93369262|NCT03203421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369263|NCT03203421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369264|NCT03203421|Anticoagulants|anticoagulants|mesh-ancestor
93369265|NCT03203031|Anesthetics|anesthetics|mesh-list
93369266|NCT03203031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369267|NCT03203031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369268|NCT03118479|Anastrozole|anastrozole|mesh-list
93369269|NCT03118479|Testosterone|testosterone|mesh-list
93369270|NCT03118479|Androgens|androgens|mesh-ancestor
93369271|NCT03118479|Hormones|hormones|mesh-ancestor
93369272|NCT03118479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369273|NCT03118479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369274|NCT03118479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93369275|NCT03118479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369276|NCT03118479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93369277|NCT03118479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93369278|NCT03118479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369279|NCT03118479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369280|NCT03118479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93369281|NCT03118479|Hormone Antagonists|hormone antagonists|mesh-ancestor
93369282|NCT03197961|Tenofovir|tenofovir|mesh-list
93369283|NCT03197961|Emtricitabine|emtricitabine|mesh-list
93040904|NCT00369486|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93369284|NCT03197961|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93369285|NCT03197961|Medroxyprogesterone|medroxyprogesterone|mesh-list
93369286|NCT03197961|Antiviral Agents|antiviral agents|mesh-ancestor
93369287|NCT03197961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369288|NCT03197961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93369289|NCT03197961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93369290|NCT03197961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369291|NCT03197961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369292|NCT03197961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93369293|NCT03197961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93369294|NCT03197961|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93369295|NCT03197961|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93369296|NCT03197961|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93369297|NCT03197961|Contraceptive Agents|contraceptive agents|mesh-ancestor
93369298|NCT03197961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93369299|NCT03197961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369300|NCT03197961|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93369301|NCT03197961|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93369302|NCT03197961|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93369303|NCT03197961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93369304|NCT03197961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369305|NCT03202875|Insulin|insulin|mesh-list
93369306|NCT03202875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93369307|NCT03202875|Insulin Aspart|insulin aspart|mesh-list
93369308|NCT03202875|Insulin, Long-Acting|insulin, long-acting|mesh-list
93369309|NCT03202875|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93369310|NCT03202875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93369311|NCT03202875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369312|NCT03197571|Leucovorin|leucovorin|mesh-list
93369313|NCT03197571|Paclitaxel|paclitaxel|mesh-list
93369314|NCT03197571|Cyclophosphamide|cyclophosphamide|mesh-list
93369315|NCT03197571|Bevacizumab|bevacizumab|mesh-list
93369316|NCT03197571|Fluorouracil|fluorouracil|mesh-list
93369317|NCT03197571|Capecitabine|capecitabine|mesh-list
93369318|NCT03197571|Fulvestrant|fulvestrant|mesh-list
93369319|NCT03197571|Avelumab|avelumab|mesh-list
93369320|NCT03197571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93369321|NCT03197571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369322|NCT03197571|Tubulin Modulators|tubulin modulators|mesh-ancestor
93369323|NCT03197571|Antimitotic Agents|antimitotic agents|mesh-ancestor
93369324|NCT03197571|Mitosis Modulators|mitosis modulators|mesh-ancestor
93369325|NCT03197571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369326|NCT03197571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369327|NCT03197571|Immunologic Factors|immunologic factors|mesh-ancestor
93369328|NCT03197571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369329|NCT03197571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369330|NCT03197571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369331|NCT03197571|Alkylating Agents|alkylating agents|mesh-ancestor
93369332|NCT03197571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93369333|NCT03197571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93369334|NCT03197571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93369335|NCT03197571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93369336|NCT03197571|Growth Substances|growth substances|mesh-ancestor
93369337|NCT03197571|Growth Inhibitors|growth inhibitors|mesh-ancestor
93369338|NCT03197571|Antimetabolites|antimetabolites|mesh-ancestor
93369339|NCT03197571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93369340|NCT03197571|Antidotes|antidotes|mesh-ancestor
93369341|NCT03197571|Protective Agents|protective agents|mesh-ancestor
93369342|NCT03197571|Vitamin B Complex|vitamin b complex|mesh-ancestor
93369343|NCT03197571|Vitamins|vitamins|mesh-ancestor
93369344|NCT03197571|Micronutrients|micronutrients|mesh-ancestor
93369345|NCT03197571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93369346|NCT03197571|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93369347|NCT03197571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93369348|NCT03197571|Hormone Antagonists|hormone antagonists|mesh-ancestor
93369349|NCT03197571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369350|NCT02446977|Riboflavin|riboflavin|mesh-list
93369351|NCT02446977|Vitamins|vitamins|mesh-ancestor
93369352|NCT02446977|Micronutrients|micronutrients|mesh-ancestor
93369353|NCT02446977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369354|NCT02446977|Vitamin B Complex|vitamin b complex|mesh-ancestor
93369355|NCT02446977|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93369356|NCT02446977|Dermatologic Agents|dermatologic agents|mesh-ancestor
93369357|NCT02447055|Mycophenolic Acid|mycophenolic acid|mesh-list
93369358|NCT02447055|Cyclophosphamide|cyclophosphamide|mesh-list
93040979|NCT00221104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93369359|NCT02447055|Melphalan|melphalan|mesh-list
93369360|NCT02447055|Fludarabine|fludarabine|mesh-list
93369361|NCT02447055|Fludarabine phosphate|fludarabine phosphate|mesh-list
93369363|NCT02447055|Lenograstim|lenograstim|mesh-list
93369364|NCT02447055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369365|NCT02447055|Immunologic Factors|immunologic factors|mesh-ancestor
93369366|NCT02447055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369367|NCT02447055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369368|NCT02447055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369369|NCT02447055|Alkylating Agents|alkylating agents|mesh-ancestor
93369370|NCT02447055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369371|NCT02447055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369372|NCT02447055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93369373|NCT02447055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93369374|NCT02447055|Antimetabolites|antimetabolites|mesh-ancestor
93369375|NCT02447055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93369376|NCT02447055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93369377|NCT02447055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369378|NCT02447055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93369379|NCT02447055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93369380|NCT02447055|Antitubercular Agents|antitubercular agents|mesh-ancestor
93369381|NCT02447055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93369382|NCT02447055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369383|NCT03202563|Metformin|metformin|mesh-list
93369384|NCT03202563|Dapagliflozin|dapagliflozin|mesh-list
93369385|NCT03202563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93369386|NCT03202563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369387|NCT03202563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93369388|NCT03202563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369389|NCT03197493|Levodopa|levodopa|mesh-list
93369390|NCT03197493|Carbidopa|carbidopa|mesh-list
93369391|NCT03197493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93369392|NCT03197493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93369393|NCT03197493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93369394|NCT03197493|Dopamine Agents|dopamine agents|mesh-ancestor
93369395|NCT03197493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369396|NCT03197493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369397|NCT03197493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369398|NCT03197493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93369399|NCT03197493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369400|NCT03197493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93369401|NCT03197493|Immunologic Factors|immunologic factors|mesh-ancestor
93369402|NCT03197493|Dopamine Agonists|dopamine agonists|mesh-ancestor
93369403|NCT02450175|Everolimus|everolimus|mesh-list
93369404|NCT02450175|Letrozole|letrozole|mesh-list
93369405|NCT02450175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93369406|NCT02450175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369407|NCT02450175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369408|NCT02450175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369409|NCT02450175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369410|NCT02450175|Immunologic Factors|immunologic factors|mesh-ancestor
93369411|NCT02450175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369412|NCT02450175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369413|NCT02450175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93369414|NCT02450175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93369415|NCT02450175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93369416|NCT02450175|Hormone Antagonists|hormone antagonists|mesh-ancestor
92662877|NCT00261170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369417|NCT02450175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369418|NCT03202719|Vaccines|vaccines|mesh-list
93369419|NCT03202719|Immunologic Factors|immunologic factors|mesh-ancestor
93369420|NCT03202719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369421|NCT03202407|Calcium|calcium|mesh-list
93369422|NCT03202407|Sevelamer|sevelamer|mesh-list
93369423|NCT03202407|Calcium acetate|calcium acetate|mesh-list
93369424|NCT03202407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93369425|NCT03202407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369426|NCT03202407|Chelating Agents|chelating agents|mesh-ancestor
93369427|NCT03202407|Sequestering Agents|sequestering agents|mesh-ancestor
93369428|NCT03202407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369429|NCT02261077|Scopolamine|scopolamine|mesh-list
93369430|NCT02261077|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93369431|NCT02261077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93369432|NCT02261077|Antiemetics|antiemetics|mesh-ancestor
93369433|NCT02261077|Autonomic Agents|autonomic agents|mesh-ancestor
93369434|NCT02261077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041062|NCT00357552|Ritonavir|ritonavir|mesh-list
93369435|NCT02261077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369436|NCT02261077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93369437|NCT02261077|Mydriatics|mydriatics|mesh-ancestor
93369438|NCT02261077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93369439|NCT02261077|Cholinergic Agents|cholinergic agents|mesh-ancestor
93369440|NCT02261077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369441|NCT02261077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369442|NCT02261077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93369443|NCT02261077|Parasympatholytics|parasympatholytics|mesh-ancestor
93369444|NCT03196869|Cisplatin|cisplatin|mesh-list
93369445|NCT03196869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369446|NCT02150473|Adalimumab|adalimumab|mesh-list
93369447|NCT02150473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93369448|NCT02150473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369449|NCT02150473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369450|NCT02446431|Sirolimus|sirolimus|mesh-list
93369451|NCT02446431|Cyclophosphamide|cyclophosphamide|mesh-list
93369452|NCT02446431|Bevacizumab|bevacizumab|mesh-list
93369453|NCT02446431|Temsirolimus|temsirolimus|mesh-list
93369454|NCT02446431|MTOR Inhibitors|mtor inhibitors|mesh-list
93369455|NCT02446431|Valproic Acid|valproic acid|mesh-list
93369456|NCT02446431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369457|NCT02446431|Immunologic Factors|immunologic factors|mesh-ancestor
93369458|NCT02446431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369459|NCT02446431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369460|NCT02446431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369461|NCT02446431|Alkylating Agents|alkylating agents|mesh-ancestor
93369462|NCT02446431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369463|NCT02446431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369464|NCT02446431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93369465|NCT02446431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93369466|NCT02446431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93369467|NCT02446431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93369468|NCT02446431|Growth Substances|growth substances|mesh-ancestor
93369469|NCT02446431|Growth Inhibitors|growth inhibitors|mesh-ancestor
93369470|NCT02446431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369471|NCT02446431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369472|NCT02446431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93369473|NCT02446431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369474|NCT02446431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93369475|NCT02446431|Antifungal Agents|antifungal agents|mesh-ancestor
93369476|NCT02446431|Anticonvulsants|anticonvulsants|mesh-ancestor
93369477|NCT02446431|GABA Agents|gaba agents|mesh-ancestor
93369478|NCT02446431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369479|NCT02446431|Antimanic Agents|antimanic agents|mesh-ancestor
93369480|NCT02446431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93369481|NCT02446431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369482|NCT02446431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369483|NCT02446353|Megestrol Acetate|megestrol acetate|mesh-list
93369484|NCT02446353|Megestrol|megestrol|mesh-list
93369485|NCT02446353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93369486|NCT02446353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369487|NCT02446353|Appetite Stimulants|appetite stimulants|mesh-ancestor
93369488|NCT02446353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93369489|NCT02446353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369490|NCT02446353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93369491|NCT02446353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93369492|NCT02446353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93369493|NCT02446353|Contraceptive Agents|contraceptive agents|mesh-ancestor
93369494|NCT02446353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93369495|NCT02446353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93369496|NCT02446353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93369497|NCT02144389|Praziquantel|praziquantel|mesh-list
93369498|NCT02144389|Anthelmintics|anthelmintics|mesh-ancestor
93369499|NCT02144389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93369500|NCT02144389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369501|NCT03197103|Acetylcysteine|acetylcysteine|mesh-list
93369502|NCT03197103|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93369503|NCT03197103|Antiviral Agents|antiviral agents|mesh-ancestor
93369504|NCT03197103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369505|NCT03197103|Expectorants|expectorants|mesh-ancestor
93369506|NCT03197103|Respiratory System Agents|respiratory system agents|mesh-ancestor
93369507|NCT03197103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93369508|NCT03197103|Antioxidants|antioxidants|mesh-ancestor
93369509|NCT03197103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041156|NCT00186628|Hormones|hormones|mesh-ancestor
93369510|NCT03197103|Protective Agents|protective agents|mesh-ancestor
93369511|NCT03197103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369513|NCT02144623|Valproic Acid|valproic acid|mesh-list
93369514|NCT02144623|Anticonvulsants|anticonvulsants|mesh-ancestor
93369515|NCT02144623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369516|NCT02144623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369517|NCT02144623|GABA Agents|gaba agents|mesh-ancestor
93369518|NCT02144623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369519|NCT02144623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369520|NCT02144623|Antimanic Agents|antimanic agents|mesh-ancestor
93369521|NCT02144623|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93369522|NCT02144623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369523|NCT02144623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369524|NCT03201861|Paclitaxel|paclitaxel|mesh-list
93369525|NCT03201861|Docetaxel|docetaxel|mesh-list
93369526|NCT03201861|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93369527|NCT03201861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93369528|NCT03201861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369529|NCT03201861|Tubulin Modulators|tubulin modulators|mesh-ancestor
93369530|NCT03201861|Antimitotic Agents|antimitotic agents|mesh-ancestor
93369531|NCT03201861|Mitosis Modulators|mitosis modulators|mesh-ancestor
93369532|NCT03201861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369533|NCT03194685|FF-10101|ff-10101|mesh-list
93369534|NCT03194685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369535|NCT03194685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369536|NCT03194685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369537|NCT00105079|Ritonavir|ritonavir|mesh-list
93369538|NCT00105079|Lopinavir|lopinavir|mesh-list
93369539|NCT00105079|Saquinavir|saquinavir|mesh-list
93369540|NCT00105079|Tenofovir|tenofovir|mesh-list
93369541|NCT00105079|Emtricitabine|emtricitabine|mesh-list
93369542|NCT00105079|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93369543|NCT00105079|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93369544|NCT00105079|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93369545|NCT00105079|Protease Inhibitors|protease inhibitors|mesh-ancestor
93369546|NCT00105079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369547|NCT00105079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369548|NCT00105079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93369549|NCT00105079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93369550|NCT00105079|Antiviral Agents|antiviral agents|mesh-ancestor
93369551|NCT00105079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369552|NCT00105079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93369553|NCT00105079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93369554|NCT00105079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93369555|NCT00105079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93369556|NCT03196401|Durvalumab|durvalumab|mesh-list
93369557|NCT03196401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93369558|NCT03196401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369559|NCT02150707|Liraglutide|liraglutide|mesh-list
93369560|NCT02150707|Exenatide|exenatide|mesh-list
93369561|NCT02150707|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93369562|NCT02150707|Glucagon|glucagon|mesh-list
93369563|NCT02150707|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93369564|NCT02150707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93369565|NCT02150707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369566|NCT02150707|Incretins|incretins|mesh-ancestor
93369567|NCT02150707|Hormones|hormones|mesh-ancestor
93369568|NCT02150707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369569|NCT02150707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93369570|NCT02150707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93369571|NCT02150707|Protease Inhibitors|protease inhibitors|mesh-ancestor
93369572|NCT02150707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369573|NCT02150707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369574|NCT03196479|Ketamine|ketamine|mesh-list
93369575|NCT03196479|Propofol|propofol|mesh-list
93369576|NCT03196479|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93369577|NCT03196479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369578|NCT03196479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369579|NCT03196479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93369580|NCT03196479|Anesthetics, General|anesthetics, general|mesh-ancestor
93369581|NCT03196479|Anesthetics|anesthetics|mesh-ancestor
93369582|NCT03196479|Analgesics|analgesics|mesh-ancestor
93369583|NCT03196479|Sensory System Agents|sensory system agents|mesh-ancestor
93369584|NCT03196479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369585|NCT03196479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93041206|NCT01050114|Oxybutynin|oxybutynin|mesh-list
93369586|NCT03196479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93369587|NCT03196479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93369588|NCT03196479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369589|NCT03196479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369590|NCT03201627|Lithium Carbonate|lithium carbonate|mesh-list
93369591|NCT03201627|Antidepressive Agents|antidepressive agents|mesh-ancestor
93369592|NCT03201627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369593|NCT03201627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369594|NCT03201627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369595|NCT03201627|Antimanic Agents|antimanic agents|mesh-ancestor
93369596|NCT03201627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93369597|NCT03201627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369598|NCT03201627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369599|NCT02151721|Gefitinib|gefitinib|mesh-list
93369600|NCT02151721|Vorinostat|vorinostat|mesh-list
93369601|NCT02151721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369602|NCT02151721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369603|NCT02151721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369604|NCT02151721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369605|NCT02151721|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93369606|NCT03201393|Acetaminophen|acetaminophen|mesh-list
93369607|NCT03201393|Naltrexone|naltrexone|mesh-list
93369608|NCT03201393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93369609|NCT03201393|Analgesics|analgesics|mesh-ancestor
93369610|NCT03201393|Sensory System Agents|sensory system agents|mesh-ancestor
93369611|NCT03201393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369612|NCT03201393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369613|NCT03201393|Antipyretics|antipyretics|mesh-ancestor
93369614|NCT03201393|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93369615|NCT03201393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93369616|NCT03192969|Abatacept|abatacept|mesh-list
93369617|NCT03192969|Glucocorticoids|glucocorticoids|mesh-list
93369618|NCT03192969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93369619|NCT03192969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369620|NCT03192969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93369621|NCT03192969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369622|NCT03192969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369623|NCT03192969|Immunologic Factors|immunologic factors|mesh-ancestor
93369624|NCT03192969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369625|NCT03192969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369626|NCT03192969|Hormones|hormones|mesh-ancestor
93369627|NCT03192969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369628|NCT03194139|Avasopasem manganese|avasopasem manganese|mesh-list
93369629|NCT03194139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93369630|NCT03194139|Antioxidants|antioxidants|mesh-ancestor
93369631|NCT03194139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369632|NCT03194139|Protective Agents|protective agents|mesh-ancestor
93369633|NCT03194139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369634|NCT03118167|Antioxidants|antioxidants|mesh-list
93369635|NCT03118167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369636|NCT03118167|Protective Agents|protective agents|mesh-ancestor
93369637|NCT03118167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369638|NCT00189267|Imiquimod|imiquimod|mesh-list
93369639|NCT00189267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93369640|NCT00189267|Immunologic Factors|immunologic factors|mesh-ancestor
93369641|NCT00189267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369642|NCT00189267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369643|NCT00189267|Interferon Inducers|interferon inducers|mesh-ancestor
93369644|NCT02444949|Cisplatin|cisplatin|mesh-list
93369645|NCT02444949|Endostar protein|endostar protein|mesh-list
93369646|NCT02444949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369647|NCT02444949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93369648|NCT02444949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93369649|NCT02444949|Growth Substances|growth substances|mesh-ancestor
93369650|NCT02444949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369651|NCT02444949|Growth Inhibitors|growth inhibitors|mesh-ancestor
93369652|NCT03192579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93369653|NCT03192579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93369654|NCT03192579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93369655|NCT03192579|Antimetabolites|antimetabolites|mesh-ancestor
93369656|NCT03192579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369657|NCT03192579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93369658|NCT03192579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93369659|NCT03192579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369660|NCT03192657|Basiliximab|basiliximab|mesh-list
93369661|NCT03192657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93369662|NCT03192657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369663|NCT03192657|Immunologic Factors|immunologic factors|mesh-ancestor
93369664|NCT03192657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369665|NCT03192657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369666|NCT03192657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369667|NCT02444169|Hyaluronic Acid|hyaluronic acid|mesh-list
93369668|NCT02444169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93369669|NCT02444169|Immunologic Factors|immunologic factors|mesh-ancestor
93369670|NCT02444169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369671|NCT02444169|Viscosupplements|viscosupplements|mesh-ancestor
93369672|NCT02444169|Protective Agents|protective agents|mesh-ancestor
93369673|NCT03194061|Cisplatin|cisplatin|mesh-list
93369674|NCT03194061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369675|NCT02343406|Temozolomide|temozolomide|mesh-list
93369676|NCT02343406|Lomustine|lomustine|mesh-list
93369677|NCT02343406|ABT-414|abt-414|mesh-list
93369678|NCT02343406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369679|NCT02343406|Alkylating Agents|alkylating agents|mesh-ancestor
93369680|NCT02343406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369681|NCT02343406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369682|NCT02343406|Immunoconjugates|immunoconjugates|mesh-ancestor
93369683|NCT02343406|Immunologic Factors|immunologic factors|mesh-ancestor
93369684|NCT02343406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369685|NCT02444091|Cyclophosphamide|cyclophosphamide|mesh-list
93369686|NCT02444091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369687|NCT02444091|Immunologic Factors|immunologic factors|mesh-ancestor
93369688|NCT02444091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369689|NCT02444091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369690|NCT02444091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369691|NCT02444091|Alkylating Agents|alkylating agents|mesh-ancestor
93369692|NCT02444091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369693|NCT02444091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369694|NCT02444091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93369695|NCT02443935|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
93369696|NCT02443935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93369697|NCT02443935|Immunologic Factors|immunologic factors|mesh-ancestor
93369698|NCT02443935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369699|NCT03193749|Amiodarone|amiodarone|mesh-list
93369700|NCT03193749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93369701|NCT03193749|Vasodilator Agents|vasodilator agents|mesh-ancestor
93369702|NCT03193749|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93369703|NCT03193749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93369704|NCT03193749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369705|NCT03193749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93369706|NCT03193749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93369707|NCT03193749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93369708|NCT03193749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369709|NCT03193749|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93369710|NCT03193749|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93369711|NCT03193749|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93369712|NCT02444013|Folic Acid|folic acid|mesh-list
93369713|NCT02444013|Uric Acid|uric acid|mesh-list
93369714|NCT02444013|Hematinics|hematinics|mesh-ancestor
93369715|NCT02444013|Vitamin B Complex|vitamin b complex|mesh-ancestor
93369716|NCT02444013|Vitamins|vitamins|mesh-ancestor
93369717|NCT02444013|Micronutrients|micronutrients|mesh-ancestor
93369718|NCT02444013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369719|NCT02444013|Antioxidants|antioxidants|mesh-ancestor
93369720|NCT02444013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369721|NCT02444013|Protective Agents|protective agents|mesh-ancestor
93369722|NCT02444637|Rivastigmine|rivastigmine|mesh-list
93369723|NCT02444637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93369724|NCT02444637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369725|NCT02444637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369726|NCT02444637|Cholinergic Agents|cholinergic agents|mesh-ancestor
93369727|NCT02444637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369728|NCT02444637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369729|NCT02444637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93369730|NCT02444637|Protective Agents|protective agents|mesh-ancestor
93369731|NCT05172999|Levonorgestrel|levonorgestrel|mesh-list
93369732|NCT05172999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93369733|NCT05172999|Contraceptive Agents|contraceptive agents|mesh-ancestor
93369734|NCT05172999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93369735|NCT05172999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369736|NCT05172999|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93369737|NCT05172999|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93369738|NCT05172999|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93369739|NCT02710071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93369741|NCT02710071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93369742|NCT02710071|Diuretics|diuretics|mesh-ancestor
93369743|NCT02710071|Natriuretic Agents|natriuretic agents|mesh-ancestor
93369744|NCT02710071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369745|NCT02710071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93369746|NCT02710071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93369747|NCT02710071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369748|NCT02710071|Vasodilator Agents|vasodilator agents|mesh-ancestor
93369749|NCT02710071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93369750|NCT02710071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93369751|NCT02710071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93369752|NCT02710071|Adrenergic Agents|adrenergic agents|mesh-ancestor
93369753|NCT02710071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369754|NCT02443545|Deferiprone|deferiprone|mesh-list
93369755|NCT02443545|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93369756|NCT02443545|Chelating Agents|chelating agents|mesh-ancestor
93369757|NCT02443545|Sequestering Agents|sequestering agents|mesh-ancestor
93369758|NCT02443545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369759|NCT02439489|Carboplatin|carboplatin|mesh-list
93369760|NCT02439489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369761|NCT02444481|Polymyxins|polymyxins|mesh-list
93369762|NCT02444481|Neomycin|neomycin|mesh-list
93369763|NCT02444481|Nystatin|nystatin|mesh-list
93369764|NCT02444481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93369765|NCT02444481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369766|NCT02444481|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93369767|NCT02444481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369768|NCT02444481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369769|NCT02444481|Antifungal Agents|antifungal agents|mesh-ancestor
93369770|NCT02444481|Ionophores|ionophores|mesh-ancestor
93369771|NCT02444481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93369772|NCT02444559|Clonidine|clonidine|mesh-list
93369773|NCT02444559|Ropivacaine|ropivacaine|mesh-list
92663242|NCT00262808|Vitamins|vitamins|mesh-ancestor
93369774|NCT02444559|Anesthetics, Local|anesthetics, local|mesh-ancestor
93369775|NCT02444559|Anesthetics|anesthetics|mesh-ancestor
93369776|NCT02444559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369777|NCT02444559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369778|NCT02444559|Sensory System Agents|sensory system agents|mesh-ancestor
93369779|NCT02444559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369780|NCT02444559|Analgesics|analgesics|mesh-ancestor
93369781|NCT02444559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93369782|NCT02444559|Sympatholytics|sympatholytics|mesh-ancestor
93369783|NCT02444559|Autonomic Agents|autonomic agents|mesh-ancestor
93369784|NCT02444559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93369785|NCT02444559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93369786|NCT02444559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93369787|NCT02444559|Adrenergic Agents|adrenergic agents|mesh-ancestor
93369788|NCT02444559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369789|NCT02444559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369790|NCT03190239|Pemetrexed|pemetrexed|mesh-list
93369791|NCT03190239|Apatinib|apatinib|mesh-list
93369792|NCT03190239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369793|NCT03190239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369794|NCT03190239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369795|NCT03190239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93369796|NCT03190239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93369797|NCT03190239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369798|NCT02439411|Trametinib|trametinib|mesh-list
93369799|NCT02439411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369800|NCT02439411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93369801|NCT02439411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369802|NCT02439411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369803|NCT03192735|Oxaliplatin|oxaliplatin|mesh-list
93369804|NCT03192735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369805|NCT02443311|Betamethasone|betamethasone|mesh-list
93041427|NCT01582672|Sunitinib|sunitinib|mesh-list
93369806|NCT02443311|Betamethasone Valerate|betamethasone valerate|mesh-list
93369807|NCT02443311|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93369808|NCT02443311|Betamethasone benzoate|betamethasone benzoate|mesh-list
93369809|NCT02443311|Pimecrolimus|pimecrolimus|mesh-list
93369810|NCT02443311|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93369811|NCT02443311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369812|NCT02443311|Glucocorticoids|glucocorticoids|mesh-ancestor
93369813|NCT02443311|Hormones|hormones|mesh-ancestor
93369814|NCT02443311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93369815|NCT02443311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369816|NCT02443311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93369817|NCT02443311|Respiratory System Agents|respiratory system agents|mesh-ancestor
93369818|NCT02443311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93369819|NCT02443311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93369820|NCT02443311|Analgesics|analgesics|mesh-ancestor
93369821|NCT02443311|Sensory System Agents|sensory system agents|mesh-ancestor
93369822|NCT02443311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369823|NCT02443311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369824|NCT02443311|Dermatologic Agents|dermatologic agents|mesh-ancestor
93369825|NCT02443311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369826|NCT02443311|Immunologic Factors|immunologic factors|mesh-ancestor
93369827|NCT02443311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93369828|NCT02443311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369829|NCT02443311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663317|NCT00263276|Metformin|metformin|mesh-list
93369830|NCT02373202|Sulfasalazine|sulfasalazine|mesh-list
93369831|NCT02373202|Mizoribine|mizoribine|mesh-list
93369832|NCT02373202|Bucillamine|bucillamine|mesh-list
93369833|NCT02373202|Tacrolimus|tacrolimus|mesh-list
93369834|NCT02373202|Leflunomide|leflunomide|mesh-list
93369835|NCT02373202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369836|NCT02373202|Immunologic Factors|immunologic factors|mesh-ancestor
93369837|NCT02373202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369838|NCT02373202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93369839|NCT02373202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369840|NCT02373202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369841|NCT02373202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369842|NCT02373202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93369843|NCT02373202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93369844|NCT02373202|Analgesics|analgesics|mesh-ancestor
93369845|NCT02373202|Sensory System Agents|sensory system agents|mesh-ancestor
93369846|NCT02373202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369847|NCT02373202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369848|NCT02373202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369849|NCT02373202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93369850|NCT02373202|Antioxidants|antioxidants|mesh-ancestor
93369851|NCT02373202|Protective Agents|protective agents|mesh-ancestor
93369852|NCT02373202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93369853|NCT02373202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93369854|NCT02373202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369855|NCT02373202|Antimalarials|antimalarials|mesh-ancestor
93369856|NCT02373202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93369857|NCT02373202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93369858|NCT03192111|Entinostat|entinostat|mesh-list
93369859|NCT03192111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369860|NCT03192111|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93369861|NCT03192111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369862|NCT03192111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369863|NCT02622074|Paclitaxel|paclitaxel|mesh-list
93369864|NCT02622074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93369865|NCT02622074|Cyclophosphamide|cyclophosphamide|mesh-list
93369866|NCT02622074|Carboplatin|carboplatin|mesh-list
93369867|NCT02622074|Doxorubicin|doxorubicin|mesh-list
93369868|NCT02622074|Pembrolizumab|pembrolizumab|mesh-list
93369869|NCT02622074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93369870|NCT02622074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369871|NCT02622074|Tubulin Modulators|tubulin modulators|mesh-ancestor
93369872|NCT02622074|Antimitotic Agents|antimitotic agents|mesh-ancestor
93369873|NCT02622074|Mitosis Modulators|mitosis modulators|mesh-ancestor
93369874|NCT02622074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369875|NCT02622074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369876|NCT02622074|Immunologic Factors|immunologic factors|mesh-ancestor
93369877|NCT02622074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369878|NCT02622074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369879|NCT02622074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93369880|NCT02622074|Alkylating Agents|alkylating agents|mesh-ancestor
93369881|NCT02622074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93369882|NCT02622074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93369883|NCT02622074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93369884|NCT02622074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93369885|NCT02622074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369886|NCT02622074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93369887|NCT02622074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93369888|NCT02438709|Etoricoxib|etoricoxib|mesh-list
93369889|NCT02438709|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
93369890|NCT02438709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93369891|NCT02438709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93369892|NCT02438709|Analgesics|analgesics|mesh-ancestor
93369893|NCT02438709|Sensory System Agents|sensory system agents|mesh-ancestor
93369894|NCT02438709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369895|NCT02438709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369896|NCT02438709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369897|NCT02438709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369898|NCT02438709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93369899|NCT02438709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369900|NCT02438709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369901|NCT05438758|Ketamine|ketamine|mesh-list
93369902|NCT05438758|Esketamine|esketamine|mesh-list
93369903|NCT05438758|Analgesics|analgesics|mesh-ancestor
93369904|NCT05438758|Sensory System Agents|sensory system agents|mesh-ancestor
93369905|NCT05438758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369906|NCT05438758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369907|NCT05438758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93369908|NCT05438758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93369909|NCT05438758|Anesthetics, General|anesthetics, general|mesh-ancestor
93369910|NCT05438758|Anesthetics|anesthetics|mesh-ancestor
93369911|NCT05438758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93369912|NCT05438758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93369913|NCT05438758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93369914|NCT05438758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369915|NCT05438758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369916|NCT05438758|Antidepressive Agents|antidepressive agents|mesh-ancestor
93369917|NCT05438758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93369918|NCT02442921|Colchicine|colchicine|mesh-list
93369919|NCT02442921|Gout Suppressants|gout suppressants|mesh-ancestor
93369920|NCT02442921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369921|NCT02442921|Tubulin Modulators|tubulin modulators|mesh-ancestor
93369922|NCT02442921|Antimitotic Agents|antimitotic agents|mesh-ancestor
93369923|NCT02442921|Mitosis Modulators|mitosis modulators|mesh-ancestor
93369924|NCT02442921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369925|NCT02442921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369926|NCT02438865|Epirubicin|epirubicin|mesh-list
93369927|NCT02438865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93369928|NCT02438865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369929|NCT02438865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93369930|NCT02438865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93369931|NCT02438865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369932|NCT02438865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369933|NCT04924946|Antihypertensive Agents|antihypertensive agents|mesh-list
93369934|NCT03189771|Salicylic Acid|salicylic acid|mesh-list
93369935|NCT03189771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93369936|NCT03189771|Antifungal Agents|antifungal agents|mesh-ancestor
93369937|NCT03189771|Keratolytic Agents|keratolytic agents|mesh-ancestor
93369938|NCT03189771|Dermatologic Agents|dermatologic agents|mesh-ancestor
93369939|NCT02342704|Natalizumab|natalizumab|mesh-list
93369940|NCT02342704|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93369941|NCT02342704|Immunologic Factors|immunologic factors|mesh-ancestor
93369942|NCT02342704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369943|NCT02342704|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93369944|NCT02342704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369945|NCT02342704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369946|NCT02442453|Turmeric extract|turmeric extract|mesh-list
93369947|NCT02442453|Antioxidants|antioxidants|mesh-ancestor
93369948|NCT02442453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369949|NCT02442453|Protective Agents|protective agents|mesh-ancestor
93369950|NCT02442453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369951|NCT02438397|Insulin|insulin|mesh-list
93369952|NCT02438397|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93369953|NCT02438397|Metformin|metformin|mesh-list
93369954|NCT02438397|Acarbose|acarbose|mesh-list
93369955|NCT02438397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93369956|NCT02438397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369957|NCT02438397|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93369958|NCT02438397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93369959|NCT02438397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369960|NCT03193359|Botulinum Toxins|botulinum toxins|mesh-list
93369961|NCT03193359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93369962|NCT03193359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93369963|NCT03193359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93369964|NCT03193359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93369965|NCT03193359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369966|NCT03193359|Cholinergic Agents|cholinergic agents|mesh-ancestor
93369967|NCT03193359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93369968|NCT03193359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369969|NCT03193359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93369970|NCT03193359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369971|NCT02442531|Docetaxel|docetaxel|mesh-list
93369972|NCT02442531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369973|NCT02442531|Tubulin Modulators|tubulin modulators|mesh-ancestor
93369974|NCT02442531|Antimitotic Agents|antimitotic agents|mesh-ancestor
93369975|NCT02442531|Mitosis Modulators|mitosis modulators|mesh-ancestor
93369976|NCT02442531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369977|NCT03193203|Etanercept|etanercept|mesh-list
93369978|NCT03193203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93369979|NCT03193203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93369980|NCT03193203|Analgesics|analgesics|mesh-ancestor
93369981|NCT03193203|Sensory System Agents|sensory system agents|mesh-ancestor
93369982|NCT03193203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93369983|NCT03193203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93369984|NCT03193203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93369985|NCT03193203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93369986|NCT03193203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93369987|NCT03193203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93369988|NCT03193203|Immunologic Factors|immunologic factors|mesh-ancestor
93369989|NCT02442063|Paclitaxel|paclitaxel|mesh-list
93369990|NCT02442063|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93369991|NCT02442063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93369992|NCT02442063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93369993|NCT02442063|Tubulin Modulators|tubulin modulators|mesh-ancestor
93369994|NCT02442063|Antimitotic Agents|antimitotic agents|mesh-ancestor
93369995|NCT02442063|Mitosis Modulators|mitosis modulators|mesh-ancestor
93369996|NCT02442063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93369997|NCT04923152|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93369998|NCT04923152|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93369999|NCT04923152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93370000|NCT04923152|Antimetabolites|antimetabolites|mesh-ancestor
93370001|NCT04923152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370002|NCT04923152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370003|NCT04923152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93370004|NCT03369717|Clavulanic Acid|clavulanic acid|mesh-list
93370005|NCT03369717|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93370006|NCT03369717|Clavulanic Acids|clavulanic acids|mesh-list
93370007|NCT03369717|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93370008|NCT03369717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370009|NCT03369717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370010|NCT03369717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93370011|NCT03369717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370012|NCT03054662|Hemostatics|hemostatics|mesh-list
93370013|NCT03054662|Coagulants|coagulants|mesh-ancestor
93370014|NCT04922996|Calcium Dobesilate|calcium dobesilate|mesh-list
93370015|NCT04922996|Calcium|calcium|mesh-list
93370016|NCT04922996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93370017|NCT04922996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370018|NCT04922996|Hemostatics|hemostatics|mesh-ancestor
93370019|NCT04922996|Coagulants|coagulants|mesh-ancestor
93370020|NCT04913480|Durvalumab|durvalumab|mesh-list
93370021|NCT04913480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93370022|NCT04913480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370023|NCT02441907|Aflibercept|aflibercept|mesh-list
93370024|NCT02441907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93370025|NCT02441907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93370026|NCT02441907|Growth Substances|growth substances|mesh-ancestor
93370027|NCT02441907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370028|NCT02441907|Growth Inhibitors|growth inhibitors|mesh-ancestor
93370029|NCT02441907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370030|NCT02437461|Triamcinolone|triamcinolone|mesh-list
93370031|NCT02437461|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93370032|NCT02437461|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93370033|NCT02437461|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93041648|NCT00348816|Hormones|hormones|mesh-ancestor
93370034|NCT02437461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93370035|NCT02437461|Glucocorticoids|glucocorticoids|mesh-ancestor
93370036|NCT02437461|Hormones|hormones|mesh-ancestor
93370037|NCT02437461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93370038|NCT02437461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370039|NCT02437461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93370040|NCT02437461|Immunologic Factors|immunologic factors|mesh-ancestor
93370041|NCT02437461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370042|NCT02437461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370043|NCT04910594|Epoetin Alfa|epoetin alfa|mesh-list
93370044|NCT04910594|Hematinics|hematinics|mesh-ancestor
93370045|NCT02441673|Ephedrine|ephedrine|mesh-list
93370046|NCT02441673|Meperidine|meperidine|mesh-list
93370047|NCT02441673|Tramadol|tramadol|mesh-list
93370048|NCT02441673|Nefopam|nefopam|mesh-list
93370049|NCT02441673|Metoclopramide|metoclopramide|mesh-list
93370050|NCT02441673|Ranitidine|ranitidine|mesh-list
93370051|NCT02441673|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93370052|NCT02441673|Oxytocin|oxytocin|mesh-list
93370053|NCT02441673|Oxytocics|oxytocics|mesh-ancestor
93370054|NCT02441673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93370055|NCT02441673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370056|NCT02441673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93370057|NCT02441673|Narcotics|narcotics|mesh-ancestor
93370058|NCT02441673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93370059|NCT02441673|Analgesics|analgesics|mesh-ancestor
93370060|NCT02441673|Sensory System Agents|sensory system agents|mesh-ancestor
93370061|NCT02441673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370062|NCT02441673|Antiemetics|antiemetics|mesh-ancestor
93370063|NCT02441673|Autonomic Agents|autonomic agents|mesh-ancestor
93370064|NCT02441673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93370065|NCT02441673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93370066|NCT02441673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93370067|NCT02441673|Dopamine Agents|dopamine agents|mesh-ancestor
93370068|NCT02441673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370069|NCT02441673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370070|NCT02441673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93370071|NCT02441673|Sympathomimetics|sympathomimetics|mesh-ancestor
93370072|NCT02441673|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93370073|NCT02441673|Adrenergic Agents|adrenergic agents|mesh-ancestor
93370074|NCT02441673|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93370075|NCT02441673|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93370076|NCT02441673|Histamine Antagonists|histamine antagonists|mesh-ancestor
93370077|NCT02441673|Histamine Agents|histamine agents|mesh-ancestor
93370078|NCT02441673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93370079|NCT02441673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370080|NCT04910126|Doxorubicin|doxorubicin|mesh-list
93370081|NCT04910126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93370082|NCT04910126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93370083|NCT04910126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370084|NCT04910126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93370085|NCT04910126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93370086|NCT04910126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370087|NCT04910126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370088|NCT04922450|Paclitaxel|paclitaxel|mesh-list
93370089|NCT04922450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93370090|NCT04922450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93370091|NCT04922450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370092|NCT04922450|Tubulin Modulators|tubulin modulators|mesh-ancestor
93370093|NCT04922450|Antimitotic Agents|antimitotic agents|mesh-ancestor
93370094|NCT04922450|Mitosis Modulators|mitosis modulators|mesh-ancestor
93370095|NCT04922450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370096|NCT04922450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93370097|NCT04903808|Allyl sulfide|allyl sulfide|mesh-list
93370098|NCT04903808|Antioxidants|antioxidants|mesh-ancestor
93370099|NCT04903808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370100|NCT04903808|Protective Agents|protective agents|mesh-ancestor
93370101|NCT04903808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370102|NCT04903808|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93370103|NCT04903808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370104|NCT04903808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93370105|NCT04903808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370106|NCT03189537|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
93370107|NCT03189537|Antiviral Agents|antiviral agents|mesh-ancestor
93370108|NCT03189537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370109|NCT04893980|Aldesleukin|aldesleukin|mesh-list
93370110|NCT04893980|Interleukin-2|interleukin-2|mesh-list
93370111|NCT04893980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370112|NCT04893980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370113|NCT04893980|Analgesics|analgesics|mesh-ancestor
93370114|NCT04893980|Sensory System Agents|sensory system agents|mesh-ancestor
93370115|NCT04893980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370116|NCT04893980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370117|NCT04893980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93370118|NCT04893980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93370119|NCT04893980|Antiviral Agents|antiviral agents|mesh-ancestor
93370120|NCT04893980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370121|NCT04149470|Omeprazole|omeprazole|mesh-list
93370122|NCT04149470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93370123|NCT04149470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93370124|NCT04149470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93370125|NCT04149470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370126|NCT04149470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370127|NCT04902638|Dexamethasone|dexamethasone|mesh-list
93370128|NCT04902638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93370129|NCT04902638|Antiemetics|antiemetics|mesh-ancestor
93370130|NCT04902638|Autonomic Agents|autonomic agents|mesh-ancestor
93370131|NCT04902638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370132|NCT04902638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370133|NCT04902638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93370134|NCT04902638|Glucocorticoids|glucocorticoids|mesh-ancestor
93370135|NCT04902638|Hormones|hormones|mesh-ancestor
93370136|NCT04902638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93370137|NCT04902638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93370138|NCT04902638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370139|NCT02617628|Naltrexone|naltrexone|mesh-list
93370140|NCT02617628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93370141|NCT02617628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93370142|NCT02617628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370143|NCT02617628|Sensory System Agents|sensory system agents|mesh-ancestor
93370144|NCT02617628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370145|NCT03053414|Vitamin D|vitamin d|mesh-list
93370146|NCT03053414|Cholecalciferol|cholecalciferol|mesh-list
93370147|NCT03053414|Ergocalciferols|ergocalciferols|mesh-list
93370148|NCT03053414|Vitamins|vitamins|mesh-ancestor
93370149|NCT03053414|Micronutrients|micronutrients|mesh-ancestor
93370150|NCT03053414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370151|NCT03053414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93370152|NCT03053414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93370153|NCT02308540|Vaccines|vaccines|mesh-list
93370154|NCT02308540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93370155|NCT02308540|Immunologic Factors|immunologic factors|mesh-ancestor
93370156|NCT02308540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370157|NCT02308228|Metformin|metformin|mesh-list
93370158|NCT02308228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93370159|NCT02308228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370160|NCT03051932|Acetaminophen|acetaminophen|mesh-list
93370161|NCT03051932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370162|NCT03051932|Analgesics|analgesics|mesh-ancestor
93370163|NCT03051932|Sensory System Agents|sensory system agents|mesh-ancestor
93370164|NCT03051932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370165|NCT03051932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370166|NCT03051932|Antipyretics|antipyretics|mesh-ancestor
93370167|NCT04900766|Mitoxantrone|mitoxantrone|mesh-list
93370168|NCT04900766|Analgesics|analgesics|mesh-ancestor
93370169|NCT04900766|Sensory System Agents|sensory system agents|mesh-ancestor
93370170|NCT04900766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370171|NCT04900766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370172|NCT04900766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370173|NCT04900766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93370174|NCT04900766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93370175|NCT04900766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370176|NCT04900766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370177|NCT04908566|Folfirinox|folfirinox|mesh-list
93370178|NCT04908566|Antibodies|antibodies|mesh-list
93370179|NCT04908566|Immunoglobulins|immunoglobulins|mesh-list
93370180|NCT04908566|Immunologic Factors|immunologic factors|mesh-ancestor
93370181|NCT04908566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370182|NCT04908566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370183|NCT04892654|Dolutegravir|dolutegravir|mesh-list
93370184|NCT04892654|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93370185|NCT04892654|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93370186|NCT04892654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370187|NCT04892654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370188|NCT04892654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93370189|NCT04892654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93370190|NCT04892654|Antiviral Agents|antiviral agents|mesh-ancestor
93370191|NCT04892654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370192|NCT04899674|Bupropion|bupropion|mesh-list
93370193|NCT04899674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93370194|NCT04899674|Antidepressive Agents|antidepressive agents|mesh-ancestor
93370195|NCT04899674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93370196|NCT04899674|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93370197|NCT04899674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93370198|NCT04899674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93370199|NCT04899674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370200|NCT04899674|Dopamine Agents|dopamine agents|mesh-ancestor
93370201|NCT04899674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370202|NCT04899674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370203|NCT04899674|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93370204|NCT04899674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93370205|NCT04899674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370206|NCT04907708|Metformin|metformin|mesh-list
93370207|NCT04907708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93370208|NCT04907708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370209|NCT04890626|Tenofovir|tenofovir|mesh-list
93370210|NCT04890626|Emtricitabine|emtricitabine|mesh-list
93370211|NCT04890626|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93370212|NCT04890626|Dexamethasone|dexamethasone|mesh-list
93370213|NCT04890626|Dexamethasone acetate|dexamethasone acetate|mesh-list
93370214|NCT04890626|BB 1101|bb 1101|mesh-list
93370215|NCT04890626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93370216|NCT04890626|Antiemetics|antiemetics|mesh-ancestor
93370217|NCT04890626|Autonomic Agents|autonomic agents|mesh-ancestor
93370218|NCT04890626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370219|NCT04890626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370220|NCT04890626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93370221|NCT04890626|Glucocorticoids|glucocorticoids|mesh-ancestor
93370222|NCT04890626|Hormones|hormones|mesh-ancestor
93370223|NCT04890626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93370224|NCT04890626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93370225|NCT04890626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370226|NCT04890626|Protease Inhibitors|protease inhibitors|mesh-ancestor
93370227|NCT04890626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370228|NCT04890626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370229|NCT04890626|Antiviral Agents|antiviral agents|mesh-ancestor
93370230|NCT04890626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370231|NCT04890626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93370232|NCT04890626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93370233|NCT04890626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93370234|NCT04890626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93370235|NCT04907864|Ibuprofen|ibuprofen|mesh-list
93370236|NCT04907864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93370237|NCT04907864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370238|NCT04907864|Analgesics|analgesics|mesh-ancestor
93370239|NCT04907864|Sensory System Agents|sensory system agents|mesh-ancestor
93370240|NCT04907864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370241|NCT04907864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370242|NCT04907864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93370243|NCT04907864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93370244|NCT04907864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93370245|NCT04907864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370246|NCT04907864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370247|NCT03051542|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93370248|NCT03051542|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93370249|NCT03051542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370250|NCT04907474|Phenylephrine|phenylephrine|mesh-list
93370251|NCT04907474|Oxymetazoline|oxymetazoline|mesh-list
93370252|NCT04907474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93370253|NCT04907474|Tropicamide|tropicamide|mesh-list
93370254|NCT04907474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93370255|NCT04907474|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93370256|NCT04907474|Mydriatics|mydriatics|mesh-ancestor
93370257|NCT04907474|Autonomic Agents|autonomic agents|mesh-ancestor
93370258|NCT04907474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370259|NCT04907474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370260|NCT04907474|Sympathomimetics|sympathomimetics|mesh-ancestor
93370261|NCT04907474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93370262|NCT04907474|Nasal Decongestants|nasal decongestants|mesh-ancestor
93370263|NCT04907474|Respiratory System Agents|respiratory system agents|mesh-ancestor
93370264|NCT04907474|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93370265|NCT04907474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93370266|NCT04907474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93370267|NCT04907474|Adrenergic Agents|adrenergic agents|mesh-ancestor
93370268|NCT04907474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370269|NCT04907474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370270|NCT04907474|Protective Agents|protective agents|mesh-ancestor
93370271|NCT04907474|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93370272|NCT04907474|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93370273|NCT04907474|Cholinergic Agents|cholinergic agents|mesh-ancestor
93370274|NCT04898738|Hand Sanitizers|hand sanitizers|mesh-list
93370275|NCT04898738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93370276|NCT04898738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370277|NCT04898738|Disinfectants|disinfectants|mesh-ancestor
93370278|NCT04890392|Oxaliplatin|oxaliplatin|mesh-list
93370279|NCT04890392|Tislelizumab|tislelizumab|mesh-list
93370280|NCT04890392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93370281|NCT04890392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370282|NCT04890392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93370283|NCT04890392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370284|NCT04900532|Tocotrienols|tocotrienols|mesh-list
93370285|NCT04900532|Vitamin E|vitamin e|mesh-list
93370286|NCT04900532|Tocopherols|tocopherols|mesh-list
93370287|NCT04900532|Antioxidants|antioxidants|mesh-ancestor
93370288|NCT04900532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370289|NCT04900532|Protective Agents|protective agents|mesh-ancestor
93370290|NCT04900532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370291|NCT04900532|Vitamins|vitamins|mesh-ancestor
93370292|NCT04900532|Micronutrients|micronutrients|mesh-ancestor
93370293|NCT02616614|Clindamycin|clindamycin|mesh-list
93370294|NCT02616614|Clindamycin palmitate|clindamycin palmitate|mesh-list
93370295|NCT02616614|Clindamycin phosphate|clindamycin phosphate|mesh-list
93370296|NCT02616614|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93370297|NCT02616614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93370298|NCT02616614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370299|NCT02616614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93370300|NCT02616614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370301|NCT02616614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370302|NCT02616614|Dermatologic Agents|dermatologic agents|mesh-ancestor
93370303|NCT04906772|Dexmedetomidine|dexmedetomidine|mesh-list
93370304|NCT04906772|Ketamine|ketamine|mesh-list
93370305|NCT04906772|Propofol|propofol|mesh-list
93370306|NCT04906772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93370307|NCT04906772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93370308|NCT04906772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370309|NCT04906772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370310|NCT04906772|Analgesics|analgesics|mesh-ancestor
93370311|NCT04906772|Sensory System Agents|sensory system agents|mesh-ancestor
93370312|NCT04906772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370313|NCT04906772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93370314|NCT04906772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93370315|NCT04906772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93370316|NCT04906772|Adrenergic Agents|adrenergic agents|mesh-ancestor
93370317|NCT04906772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370318|NCT04906772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370319|NCT04906772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93370320|NCT04906772|Anesthetics, General|anesthetics, general|mesh-ancestor
93370321|NCT04906772|Anesthetics|anesthetics|mesh-ancestor
93370322|NCT04906772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93370323|NCT04906772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93370324|NCT04906772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93370325|NCT04404140|Docetaxel|docetaxel|mesh-list
93370326|NCT04404140|Atezolizumab|atezolizumab|mesh-list
93370327|NCT04404140|Ipatasertib|ipatasertib|mesh-list
93370328|NCT04404140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370329|NCT04404140|Tubulin Modulators|tubulin modulators|mesh-ancestor
93370330|NCT04404140|Antimitotic Agents|antimitotic agents|mesh-ancestor
93370331|NCT04404140|Mitosis Modulators|mitosis modulators|mesh-ancestor
93370332|NCT04404140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370333|NCT04404140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93370334|NCT04404140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93370335|NCT04404140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93370336|NCT04404140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370337|NCT04898504|Floxuridine|floxuridine|mesh-list
93370338|NCT04898504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93370339|NCT04898504|Antimetabolites|antimetabolites|mesh-ancestor
93370340|NCT04898504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370341|NCT04898504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370342|NCT04890470|Vasopressins|vasopressins|mesh-list
93370343|NCT04890470|Arginine Vasopressin|arginine vasopressin|mesh-list
93370344|NCT04890470|Oxytocin|oxytocin|mesh-list
93370345|NCT04890470|Oxytocics|oxytocics|mesh-ancestor
93370346|NCT04890470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93370347|NCT04890470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370348|NCT04890470|Hemostatics|hemostatics|mesh-ancestor
93370349|NCT04890470|Coagulants|coagulants|mesh-ancestor
93370350|NCT04890470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93370351|NCT04890470|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93370352|NCT04890470|Natriuretic Agents|natriuretic agents|mesh-ancestor
93370353|NCT04889768|Antibodies|antibodies|mesh-list
93370354|NCT04889768|Immunologic Factors|immunologic factors|mesh-ancestor
93370355|NCT04889768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370356|NCT04898270|Antipsychotic Agents|antipsychotic agents|mesh-list
93370357|NCT04898270|Flupenthixol|flupenthixol|mesh-list
93370358|NCT04898270|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
93370359|NCT04898270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93370360|NCT04898270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93370361|NCT04898270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370362|NCT04898270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93370363|NCT04898270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93370364|NCT04898270|Dopamine Agents|dopamine agents|mesh-ancestor
93370365|NCT04898270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370366|NCT04898270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370367|NCT04906304|Mycophenolic Acid|mycophenolic acid|mesh-list
93370368|NCT04906304|Cyclosporine|cyclosporine|mesh-list
93370369|NCT04906304|Everolimus|everolimus|mesh-list
93370370|NCT04906304|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93370371|NCT04906304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93370372|NCT04906304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370373|NCT04906304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370374|NCT04906304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93370375|NCT04906304|Immunologic Factors|immunologic factors|mesh-ancestor
93370376|NCT04906304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370377|NCT04906304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370378|NCT04906304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93370379|NCT04906304|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93370380|NCT04906304|Antitubercular Agents|antitubercular agents|mesh-ancestor
93370381|NCT04906304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93370382|NCT04906304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370383|NCT04906304|Antifungal Agents|antifungal agents|mesh-ancestor
93370384|NCT04906304|Dermatologic Agents|dermatologic agents|mesh-ancestor
93370385|NCT04906304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93370386|NCT04906304|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93370387|NCT03051698|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93370388|NCT03051698|Metronidazole|metronidazole|mesh-list
93370389|NCT03051698|Vancomycin|vancomycin|mesh-list
93370390|NCT03051698|Ciprofloxacin|ciprofloxacin|mesh-list
93370391|NCT03051698|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93370392|NCT03051698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370393|NCT03051698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93370394|NCT03051698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93370395|NCT03051698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93370396|NCT03051698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93370397|NCT03051698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370398|NCT03051698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370399|NCT03051698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370400|NCT03051698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93370401|NCT03051698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93370402|NCT03051698|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92663873|NCT00266123|Sirolimus|sirolimus|mesh-list
93370403|NCT03051698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93370404|NCT03051698|Immunologic Factors|immunologic factors|mesh-ancestor
93370405|NCT03051698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370406|NCT04896164|Curcumin|curcumin|mesh-list
93370407|NCT04896164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93370408|NCT04896164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370409|NCT04896164|Analgesics|analgesics|mesh-ancestor
93370410|NCT04896164|Sensory System Agents|sensory system agents|mesh-ancestor
93370411|NCT04896164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370412|NCT04896164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042048|NCT03490292|Paclitaxel|paclitaxel|mesh-list
93370413|NCT04896164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93370414|NCT04896164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93370415|NCT04896164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370416|NCT04896164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370417|NCT04896164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370418|NCT04887818|Lidocaine|lidocaine|mesh-list
93370419|NCT04887818|Diltiazem|diltiazem|mesh-list
93370420|NCT04887818|Nifedipine|nifedipine|mesh-list
93370421|NCT04887818|Anesthetics, Local|anesthetics, local|mesh-ancestor
93370422|NCT04887818|Anesthetics|anesthetics|mesh-ancestor
93370423|NCT04887818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93370424|NCT04887818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370425|NCT04887818|Sensory System Agents|sensory system agents|mesh-ancestor
93370426|NCT04887818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370427|NCT04887818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93370428|NCT04887818|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93370429|NCT04887818|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93370430|NCT04887818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93370431|NCT04887818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370432|NCT04887818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93370433|NCT04887818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93370434|NCT04887818|Vasodilator Agents|vasodilator agents|mesh-ancestor
93370435|NCT04887818|Tocolytic Agents|tocolytic agents|mesh-ancestor
93370436|NCT04887818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93370437|NCT04887818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93370438|NCT04883996|Pilocarpine|pilocarpine|mesh-list
93370439|NCT04883996|Miotics|miotics|mesh-ancestor
93370440|NCT04883996|Autonomic Agents|autonomic agents|mesh-ancestor
93370441|NCT04883996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370442|NCT04883996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370443|NCT04883996|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93370444|NCT04883996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93370445|NCT04883996|Cholinergic Agents|cholinergic agents|mesh-ancestor
93370446|NCT04883996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370447|NCT04883996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370448|NCT04884464|Chlorhexidine|chlorhexidine|mesh-list
93370449|NCT04884464|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93370450|NCT04884464|Hyaluronic Acid|hyaluronic acid|mesh-list
93370451|NCT04884464|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93370452|NCT04884464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370453|NCT04884464|Disinfectants|disinfectants|mesh-ancestor
93370454|NCT04884464|Dermatologic Agents|dermatologic agents|mesh-ancestor
93370455|NCT04884464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93370456|NCT04884464|Immunologic Factors|immunologic factors|mesh-ancestor
93370457|NCT04884464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370458|NCT04884464|Viscosupplements|viscosupplements|mesh-ancestor
93370459|NCT04884464|Protective Agents|protective agents|mesh-ancestor
93370460|NCT05028608|Carbamazepine|carbamazepine|mesh-list
93370461|NCT05028608|Midazolam|midazolam|mesh-list
93370462|NCT05028608|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93370463|NCT05028608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93370464|NCT05028608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93370465|NCT05028608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370466|NCT05028608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93370467|NCT05028608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93370468|NCT05028608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93370469|NCT05028608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93370470|NCT05028608|Anesthetics, General|anesthetics, general|mesh-ancestor
93370471|NCT05028608|Anesthetics|anesthetics|mesh-ancestor
93370472|NCT05028608|GABA Modulators|gaba modulators|mesh-ancestor
93370473|NCT05028608|GABA Agents|gaba agents|mesh-ancestor
93370474|NCT05028608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93370475|NCT05028608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370476|NCT05028608|Anticonvulsants|anticonvulsants|mesh-ancestor
93370477|NCT05028608|Antimanic Agents|antimanic agents|mesh-ancestor
93370478|NCT05028608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93370479|NCT05028608|Analgesics|analgesics|mesh-ancestor
93370480|NCT05028608|Sensory System Agents|sensory system agents|mesh-ancestor
93370481|NCT05028608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93370482|NCT05028608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93370483|NCT05028608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93370484|NCT05028608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93370485|NCT05028608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93370486|NCT04882826|Sildenafil Citrate|sildenafil citrate|mesh-list
93370487|NCT04882826|Vasodilator Agents|vasodilator agents|mesh-ancestor
93370488|NCT04882826|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93370489|NCT04882826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93370490|NCT04882826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370491|NCT04882826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370492|NCT04882826|Urological Agents|urological agents|mesh-ancestor
93370493|NCT04309916|Esomeprazole|esomeprazole|mesh-list
93370494|NCT04309916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93370495|NCT04309916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93370496|NCT04309916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93370497|NCT04309916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370498|NCT04309916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370499|NCT01596062|Cyclosporine|cyclosporine|mesh-list
93370500|NCT01596062|Mycophenolic Acid|mycophenolic acid|mesh-list
93370501|NCT01596062|Everolimus|everolimus|mesh-list
93370502|NCT01596062|Cyclosporins|cyclosporins|mesh-list
93370503|NCT01596062|Basiliximab|basiliximab|mesh-list
93370504|NCT01596062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93370505|NCT01596062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93370506|NCT01596062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93370507|NCT01596062|Immunologic Factors|immunologic factors|mesh-ancestor
93370508|NCT01596062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93370509|NCT01596062|Antifungal Agents|antifungal agents|mesh-ancestor
93370510|NCT01596062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93370511|NCT01596062|Dermatologic Agents|dermatologic agents|mesh-ancestor
93370512|NCT01596062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93370513|NCT01596062|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93370514|NCT01596062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93370515|NCT01596062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93370516|NCT01596062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93370517|NCT01596062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93370518|NCT01596062|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93370519|NCT01596062|Antitubercular Agents|antitubercular agents|mesh-ancestor
93370520|NCT01596062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93370521|NCT02614898|Eculizumab|eculizumab|mesh-list
93370522|NCT02614898|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93370523|NCT02614898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93370524|NCT02614898|Immunologic Factors|immunologic factors|mesh-ancestor
93370525|NCT02614898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042634|NCT01048190|Vaccines|vaccines|mesh-list
93043073|NCT00127192|Hormones|hormones|mesh-ancestor
93043151|NCT00126490|Analgesics|analgesics|mesh-ancestor
93043454|NCT03988452|Ritonavir|ritonavir|mesh-list
93043981|NCT01061112|Ketoprofen|ketoprofen|mesh-list
93044130|NCT03968835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045193|NCT00506129|Melphalan|melphalan|mesh-list
93045250|NCT01010243|Hormones|hormones|mesh-ancestor
93045397|NCT00357500|Etoposide|etoposide|mesh-list
93046014|NCT01015547|Analgesics|analgesics|mesh-ancestor
93046226|NCT01054118|Incretins|incretins|mesh-ancestor
93046448|NCT00321828|Leucovorin|leucovorin|mesh-list
93046746|NCT00359762|Glimepiride|glimepiride|mesh-list
93047380|NCT00314808|Hormones|hormones|mesh-ancestor
93047822|NCT01064232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93047901|NCT00329108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93048049|NCT00326612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048653|NCT02532270|Phenylephrine|phenylephrine|mesh-list
93048947|NCT01067898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049993|NCT01082146|Dopamine Agents|dopamine agents|mesh-ancestor
93050151|NCT01085032|Nicotine|nicotine|mesh-list
93050222|NCT01073748|Acetaminophen|acetaminophen|mesh-list
93050340|NCT00116272|Etanercept|etanercept|mesh-list
93050826|NCT01072890|Antifungal Agents|antifungal agents|mesh-ancestor
93073715|NCT05934071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93073716|NCT05934071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073717|NCT05934071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93073718|NCT05934071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073719|NCT05933863|Antibodies|antibodies|mesh-list
93073720|NCT05933863|Immunologic Factors|immunologic factors|mesh-ancestor
93073721|NCT05933863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073722|NCT05933759|Insulin|insulin|mesh-list
93073723|NCT05933759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93073724|NCT05933759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073725|NCT05933603|Oxybutynin|oxybutynin|mesh-list
93073726|NCT05933603|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93073727|NCT05933603|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93073728|NCT05933603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93073729|NCT05933603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073730|NCT05933603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073731|NCT05933603|Adrenergic Agents|adrenergic agents|mesh-ancestor
93073732|NCT05933603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073733|NCT05933603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073734|NCT05933603|Parasympatholytics|parasympatholytics|mesh-ancestor
93073735|NCT05933603|Autonomic Agents|autonomic agents|mesh-ancestor
93073736|NCT05933603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073737|NCT05933603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93073738|NCT05933603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93073739|NCT05933603|Cholinergic Agents|cholinergic agents|mesh-ancestor
93073740|NCT05933603|Urological Agents|urological agents|mesh-ancestor
93073741|NCT05933486|Pregabalin|pregabalin|mesh-list
93073742|NCT05933486|Analgesics|analgesics|mesh-ancestor
93073743|NCT05933486|Sensory System Agents|sensory system agents|mesh-ancestor
93073744|NCT05933486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073745|NCT05933486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073746|NCT05933486|Anticonvulsants|anticonvulsants|mesh-ancestor
93073747|NCT05933486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93073748|NCT05933486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073749|NCT05933486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073750|NCT05933486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93073751|NCT05933486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93073752|NCT05933486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93073753|NCT05933486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073754|NCT05933486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073755|NCT05933447|Moxifloxacin|moxifloxacin|mesh-list
93073756|NCT05933447|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93073757|NCT05933447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93073758|NCT05933447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073759|NCT05933447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93073760|NCT05933447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93073761|NCT05933447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073762|NCT05933447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073763|NCT05933447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073764|NCT05933447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93073765|NCT05933447|Contraceptive Agents|contraceptive agents|mesh-ancestor
93073766|NCT05933447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93073767|NCT05933447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073768|NCT05933447|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93073769|NCT05933447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93073770|NCT05933447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93073771|NCT05933395|Everolimus|everolimus|mesh-list
93073772|NCT05933395|Fulvestrant|fulvestrant|mesh-list
93073773|NCT05933395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93073774|NCT05933395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93073775|NCT05933395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073776|NCT05933395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073777|NCT05933395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073778|NCT05933395|Immunologic Factors|immunologic factors|mesh-ancestor
93073779|NCT05933395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073780|NCT05933395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073781|NCT05933395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073782|NCT05933395|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93073783|NCT05933395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93073784|NCT05933395|Hormone Antagonists|hormone antagonists|mesh-ancestor
93073785|NCT05933395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073786|NCT05933213|Mescaline|mescaline|mesh-list
93050897|NCT00312494|Ziprasidone|ziprasidone|mesh-list
93073788|NCT05933213|Hormones|hormones|mesh-ancestor
93073789|NCT05933213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073790|NCT05933213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073791|NCT05933213|Hallucinogens|hallucinogens|mesh-ancestor
93073792|NCT05933213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073793|NCT05933213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93073794|NCT05933213|Serotonin Agents|serotonin agents|mesh-ancestor
93073795|NCT05933213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073796|NCT05933213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073797|NCT05933044|Durvalumab|durvalumab|mesh-list
93073798|NCT05933044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073799|NCT05933044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073800|NCT05933031|Lansoprazole|lansoprazole|mesh-list
93073801|NCT05933031|Dexlansoprazole|dexlansoprazole|mesh-list
93073802|NCT05933031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93073803|NCT05933031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93073804|NCT05933031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93073805|NCT05933031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073806|NCT05933031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073807|NCT05932966|Insulin|insulin|mesh-list
93073808|NCT05932966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93073809|NCT05932966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073810|NCT05932849|Benralizumab|benralizumab|mesh-list
93073811|NCT05932849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93073812|NCT05932849|Respiratory System Agents|respiratory system agents|mesh-ancestor
93073813|NCT05932693|Menthol|menthol|mesh-list
93073814|NCT05932693|Antipruritics|antipruritics|mesh-ancestor
93073815|NCT05932693|Dermatologic Agents|dermatologic agents|mesh-ancestor
93073816|NCT05932667|Fulvestrant|fulvestrant|mesh-list
93073817|NCT05932667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073818|NCT05932667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073819|NCT05932667|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93073820|NCT05932667|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93073821|NCT05932667|Hormone Antagonists|hormone antagonists|mesh-ancestor
93073822|NCT05932667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073823|NCT05932667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073824|NCT05932550|Maraviroc|maraviroc|mesh-list
93073825|NCT05932550|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93073826|NCT05932550|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93073827|NCT05932550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073828|NCT05932550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93073829|NCT05932550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93073830|NCT05932550|Antiviral Agents|antiviral agents|mesh-ancestor
93073831|NCT05932550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073832|NCT05932550|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93073833|NCT05932524|Dexamethasone|dexamethasone|mesh-list
93073834|NCT05932524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073835|NCT05932524|Antiemetics|antiemetics|mesh-ancestor
93073836|NCT05932524|Autonomic Agents|autonomic agents|mesh-ancestor
93073837|NCT05932524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073838|NCT05932524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073839|NCT05932524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93073840|NCT05932524|Glucocorticoids|glucocorticoids|mesh-ancestor
93073841|NCT05932524|Hormones|hormones|mesh-ancestor
93073842|NCT05932524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073843|NCT05932524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073844|NCT05932524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073845|NCT05932511|Ascorbic Acid|ascorbic acid|mesh-list
93073846|NCT05932511|Antioxidants|antioxidants|mesh-ancestor
93073847|NCT05932511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073848|NCT05932511|Protective Agents|protective agents|mesh-ancestor
93073849|NCT05932511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073850|NCT05932511|Vitamins|vitamins|mesh-ancestor
93073851|NCT05932511|Micronutrients|micronutrients|mesh-ancestor
93073852|NCT05932472|Aspirin|aspirin|mesh-list
93073853|NCT05932472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93073854|NCT05932472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93073855|NCT05932472|Analgesics|analgesics|mesh-ancestor
93073856|NCT05932472|Sensory System Agents|sensory system agents|mesh-ancestor
93073857|NCT05932472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073858|NCT05932472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073859|NCT05932472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073860|NCT05932472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050970|NCT00290498|Mitosis Modulators|mitosis modulators|mesh-ancestor
93073861|NCT05932472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93073862|NCT05932472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93073863|NCT05932472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073864|NCT05932472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93073865|NCT05932472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93073866|NCT05932472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073867|NCT05932472|Antipyretics|antipyretics|mesh-ancestor
93073868|NCT05932407|Vortioxetine|vortioxetine|mesh-list
93073869|NCT05932407|Antidepressive Agents|antidepressive agents|mesh-ancestor
93073870|NCT05932407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073871|NCT05932407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93073872|NCT05932407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93073873|NCT05932407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073874|NCT05932407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073875|NCT05932407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93073876|NCT05932407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93073877|NCT05932407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073878|NCT05932407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073879|NCT05932407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073880|NCT05932407|Serotonin Agents|serotonin agents|mesh-ancestor
93073881|NCT05932407|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93073882|NCT05932407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93073883|NCT05932407|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93073884|NCT05932407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93073885|NCT05932316|Albuterol|albuterol|mesh-list
93073886|NCT05932316|Bronchodilator Agents|bronchodilator agents|mesh-list
93073887|NCT05932316|Autonomic Agents|autonomic agents|mesh-ancestor
93073888|NCT05932316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073889|NCT05932316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073890|NCT05932316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93073891|NCT05932316|Respiratory System Agents|respiratory system agents|mesh-ancestor
93073892|NCT05932316|Tocolytic Agents|tocolytic agents|mesh-ancestor
93073893|NCT05932316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93073894|NCT05932316|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93073895|NCT05932316|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93073896|NCT05932316|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93073897|NCT05932316|Adrenergic Agents|adrenergic agents|mesh-ancestor
93073898|NCT05932316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073899|NCT05932316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073900|NCT05932303|Itraconazole|itraconazole|mesh-list
93073901|NCT05932303|Carbamazepine|carbamazepine|mesh-list
93073902|NCT05932303|Gemfibrozil|gemfibrozil|mesh-list
93073903|NCT05932303|Antifungal Agents|antifungal agents|mesh-ancestor
93073904|NCT05932303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073905|NCT05932303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93073906|NCT05932303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93073907|NCT05932303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073908|NCT05932303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073909|NCT05932303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93073910|NCT05932303|Hormone Antagonists|hormone antagonists|mesh-ancestor
93073911|NCT05932303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073912|NCT05932303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073913|NCT05932303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93073914|NCT05932303|Anticonvulsants|anticonvulsants|mesh-ancestor
93073915|NCT05932303|Antimanic Agents|antimanic agents|mesh-ancestor
93073916|NCT05932303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93073917|NCT05932303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073918|NCT05932303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073919|NCT05932303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93073920|NCT05932303|Analgesics|analgesics|mesh-ancestor
93073921|NCT05932303|Sensory System Agents|sensory system agents|mesh-ancestor
93073922|NCT05932303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073923|NCT05932303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93073924|NCT05932303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073925|NCT05932303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93073926|NCT05932303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93073927|NCT05932303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93073928|NCT05932303|Antimetabolites|antimetabolites|mesh-ancestor
93073929|NCT05932303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93073930|NCT05932303|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93073931|NCT05932277|Fexofenadine|fexofenadine|mesh-list
93073932|NCT05932277|Flurbiprofen|flurbiprofen|mesh-list
93051058|NCT01062776|Furosemide|furosemide|mesh-list
93073933|NCT05932277|Midazolam|midazolam|mesh-list
93073934|NCT05932277|Caffeine|caffeine|mesh-list
93073935|NCT05932277|Bupropion|bupropion|mesh-list
93073936|NCT05932277|Omeprazole|omeprazole|mesh-list
93073937|NCT05932277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93073938|NCT05932277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93073939|NCT05932277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073940|NCT05932277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073941|NCT05932277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93073942|NCT05932277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93073943|NCT05932277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073944|NCT05932277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93073945|NCT05932277|Anesthetics, General|anesthetics, general|mesh-ancestor
93073946|NCT05932277|Anesthetics|anesthetics|mesh-ancestor
93073947|NCT05932277|GABA Modulators|gaba modulators|mesh-ancestor
93073948|NCT05932277|GABA Agents|gaba agents|mesh-ancestor
93073949|NCT05932277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073950|NCT05932277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073951|NCT05932277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93073952|NCT05932277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93073953|NCT05932277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073954|NCT05932277|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93073955|NCT05932277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93073956|NCT05932277|Purinergic Agents|purinergic agents|mesh-ancestor
93073957|NCT05932277|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93073958|NCT05932277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93073959|NCT05932277|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93073960|NCT05932277|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93073961|NCT05932277|Antidepressive Agents|antidepressive agents|mesh-ancestor
93073962|NCT05932277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93073963|NCT05932277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93073964|NCT05932277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073965|NCT05932277|Dopamine Agents|dopamine agents|mesh-ancestor
93073966|NCT05932277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93073967|NCT05932277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93073968|NCT05932277|Analgesics|analgesics|mesh-ancestor
93073969|NCT05932277|Sensory System Agents|sensory system agents|mesh-ancestor
93073970|NCT05932277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073971|NCT05932277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93073972|NCT05932277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93073973|NCT05932277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073974|NCT05932277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93073975|NCT05932277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93073976|NCT05932277|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93073977|NCT05932277|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93073978|NCT05932277|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93073979|NCT05932277|Histamine Antagonists|histamine antagonists|mesh-ancestor
93073980|NCT05932277|Histamine Agents|histamine agents|mesh-ancestor
93073981|NCT05932264|Apatinib|apatinib|mesh-list
93073982|NCT05932264|Fluzoparib|fluzoparib|mesh-list
93073983|NCT05932264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073984|NCT05932264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93073985|NCT05932264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073986|NCT05932264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073987|NCT05932264|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93073988|NCT05932186|Anesthetics|anesthetics|mesh-list
93073989|NCT05932186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073990|NCT05932186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073991|NCT05931965|Vitamin B 12|vitamin b 12|mesh-list
93073992|NCT05931965|Hydroxocobalamin|hydroxocobalamin|mesh-list
93073993|NCT05931965|Vitamins|vitamins|mesh-ancestor
93073994|NCT05931965|Micronutrients|micronutrients|mesh-ancestor
93073995|NCT05931965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073996|NCT05931965|Vitamin B Complex|vitamin b complex|mesh-ancestor
93073997|NCT05931965|Hematinics|hematinics|mesh-ancestor
93073998|NCT05931822|Fluorides|fluorides|mesh-list
93073999|NCT05931822|Fluorides, Topical|fluorides, topical|mesh-list
93074000|NCT05931822|Cariostatic Agents|cariostatic agents|mesh-ancestor
93074001|NCT05931822|Protective Agents|protective agents|mesh-ancestor
93074002|NCT05931822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074003|NCT05931757|Blinatumomab|blinatumomab|mesh-list
93074004|NCT05931757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074005|NCT05931744|Prednisone|prednisone|mesh-list
93074006|NCT05931744|Budesonide|budesonide|mesh-list
93074007|NCT05931744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074008|NCT05931744|Glucocorticoids|glucocorticoids|mesh-ancestor
93074009|NCT05931744|Hormones|hormones|mesh-ancestor
93074010|NCT05931744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074011|NCT05931744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074012|NCT05931744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074013|NCT05931744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074014|NCT05931744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93074015|NCT05931744|Autonomic Agents|autonomic agents|mesh-ancestor
93074016|NCT05931744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074017|NCT05931744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93074018|NCT05931744|Respiratory System Agents|respiratory system agents|mesh-ancestor
93074019|NCT05931718|Epoetin Alfa|epoetin alfa|mesh-list
93074020|NCT05931718|Luspatercept|luspatercept|mesh-list
93074021|NCT05931718|Hematinics|hematinics|mesh-ancestor
93074022|NCT05931601|Norepinephrine|norepinephrine|mesh-list
93074023|NCT05931601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93074024|NCT05931601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93074025|NCT05931601|Adrenergic Agents|adrenergic agents|mesh-ancestor
93074026|NCT05931601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074027|NCT05931601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074028|NCT05931601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074029|NCT05931601|Sympathomimetics|sympathomimetics|mesh-ancestor
93074030|NCT05931601|Autonomic Agents|autonomic agents|mesh-ancestor
93074031|NCT05931601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074032|NCT05931601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93074033|NCT05931575|Quinine|quinine|mesh-list
93074034|NCT05931575|Fasudil|fasudil|mesh-list
93074035|NCT05931575|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
93074036|NCT05931575|Antimalarials|antimalarials|mesh-ancestor
93074037|NCT05931575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93074038|NCT05931575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93074039|NCT05931575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074040|NCT05931575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93074041|NCT05931575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074042|NCT05931575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93074043|NCT05931575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074044|NCT05931575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074045|NCT05931575|Analgesics|analgesics|mesh-ancestor
93074046|NCT05931575|Sensory System Agents|sensory system agents|mesh-ancestor
93074047|NCT05931575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93074048|NCT05931575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93074049|NCT05931575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074050|NCT05931575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93074051|NCT05931575|Vasodilator Agents|vasodilator agents|mesh-ancestor
93074052|NCT05931575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93074053|NCT05931575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074054|NCT05931484|Gemfibrozil|gemfibrozil|mesh-list
93074055|NCT05931484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93074056|NCT05931484|Antimetabolites|antimetabolites|mesh-ancestor
93074057|NCT05931484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074058|NCT05931484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93074059|NCT05931484|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93074060|NCT05931484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93074061|NCT05931484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074062|NCT05931458|Infliximab|infliximab|mesh-list
93074063|NCT05931458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93074064|NCT05931458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074065|NCT05931458|Dermatologic Agents|dermatologic agents|mesh-ancestor
93074066|NCT05931458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074067|NCT05931458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074068|NCT05931393|Nivolumab|nivolumab|mesh-list
93074069|NCT05931393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074070|NCT05931393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074071|NCT05931393|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074072|NCT05931393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074073|NCT05931328|Pomalidomide|pomalidomide|mesh-list
93074074|NCT05931328|Thiotepa|thiotepa|mesh-list
93074075|NCT05931328|Immunologic Factors|immunologic factors|mesh-ancestor
93074076|NCT05931328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074077|NCT05931328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93074078|NCT05931328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93074079|NCT05931328|Growth Substances|growth substances|mesh-ancestor
93074080|NCT05931328|Growth Inhibitors|growth inhibitors|mesh-ancestor
93074081|NCT05931328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074082|NCT05931328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93074083|NCT05931328|Alkylating Agents|alkylating agents|mesh-ancestor
93074084|NCT05931328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074085|NCT05931328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93074086|NCT05931328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93074087|NCT05931302|FAPI-46|fapi-46|mesh-list
93074088|NCT05931302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93074089|NCT05931302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074090|NCT05931276|Metoprolol|metoprolol|mesh-list
93074091|NCT05931276|Carvedilol|carvedilol|mesh-list
93074092|NCT05931276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93074093|NCT05931276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93074094|NCT05931276|Sympatholytics|sympatholytics|mesh-ancestor
93074095|NCT05931276|Autonomic Agents|autonomic agents|mesh-ancestor
93074096|NCT05931276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074097|NCT05931276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074098|NCT05931276|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93074099|NCT05931276|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93074100|NCT05931276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93074101|NCT05931276|Adrenergic Agents|adrenergic agents|mesh-ancestor
93074102|NCT05931276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074103|NCT05931276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074104|NCT05931276|Antioxidants|antioxidants|mesh-ancestor
93074105|NCT05931276|Protective Agents|protective agents|mesh-ancestor
93074106|NCT05931276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93074107|NCT05931276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93074108|NCT05931276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93074109|NCT05931276|Vasodilator Agents|vasodilator agents|mesh-ancestor
93074110|NCT05931276|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93074111|NCT05931276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93074112|NCT05931263|Cytarabine|cytarabine|mesh-list
93074113|NCT05931263|Carmustine|carmustine|mesh-list
93074114|NCT05931263|Melphalan|melphalan|mesh-list
93074115|NCT05931263|Etoposide|etoposide|mesh-list
93074116|NCT05931263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93074117|NCT05931263|Alkylating Agents|alkylating agents|mesh-ancestor
93074118|NCT05931263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074119|NCT05931263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074120|NCT05931263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93074121|NCT05931263|Antimetabolites|antimetabolites|mesh-ancestor
93074122|NCT05931263|Antiviral Agents|antiviral agents|mesh-ancestor
93074123|NCT05931263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074124|NCT05931263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93074125|NCT05931263|Immunologic Factors|immunologic factors|mesh-ancestor
93074126|NCT05931263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074127|NCT05931263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93074128|NCT05931263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93074129|NCT05931263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93074130|NCT05931263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074131|NCT05931263|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93074132|NCT05931224|Antihypertensive Agents|antihypertensive agents|mesh-list
93074133|NCT05931042|Trastuzumab|trastuzumab|mesh-list
93074134|NCT05931042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074135|NCT05931042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074136|NCT05931029|Ubiquinone|ubiquinone|mesh-list
93074137|NCT05931029|Idebenone|idebenone|mesh-list
93074138|NCT05931029|Antioxidants|antioxidants|mesh-ancestor
93074139|NCT05931029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074140|NCT05931029|Protective Agents|protective agents|mesh-ancestor
93074141|NCT05931029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074142|NCT05931029|Micronutrients|micronutrients|mesh-ancestor
93074143|NCT05930938|Cetuximab|cetuximab|mesh-list
93074144|NCT05930938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074145|NCT05930938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074146|NCT05930912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93074147|NCT05930912|Sertraline|sertraline|mesh-list
93074148|NCT05930912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93074149|NCT05930912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93074150|NCT05930912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93074151|NCT05930912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074152|NCT05930912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074153|NCT05930912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074154|NCT05930912|Analgesics|analgesics|mesh-ancestor
93074155|NCT05930912|Sensory System Agents|sensory system agents|mesh-ancestor
93074156|NCT05930912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074157|NCT05930912|Antidepressive Agents|antidepressive agents|mesh-ancestor
93074158|NCT05930912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93074159|NCT05930912|Dopamine Agents|dopamine agents|mesh-ancestor
93074160|NCT05930912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93074161|NCT05930912|Serotonin Agents|serotonin agents|mesh-ancestor
93074162|NCT05930808|Bisoprolol|bisoprolol|mesh-list
93074163|NCT05930808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93074164|NCT05930808|Sympatholytics|sympatholytics|mesh-ancestor
93074165|NCT05930808|Autonomic Agents|autonomic agents|mesh-ancestor
93074166|NCT05930808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074167|NCT05930808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074168|NCT05930808|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93074169|NCT05930808|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93074170|NCT05930808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93074171|NCT05930808|Adrenergic Agents|adrenergic agents|mesh-ancestor
93074172|NCT05930808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074173|NCT05930808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074174|NCT05930782|Piperaquine|piperaquine|mesh-list
93074175|NCT05930782|Antimalarials|antimalarials|mesh-ancestor
93074176|NCT05930782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93074177|NCT05930782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93074178|NCT05930782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074179|NCT05930665|Bevacizumab|bevacizumab|mesh-list
93074180|NCT05930665|Carboplatin|carboplatin|mesh-list
93074181|NCT05930665|Pemetrexed|pemetrexed|mesh-list
93074182|NCT05930665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074183|NCT05930665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074184|NCT05930665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93074185|NCT05930665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93074186|NCT05930665|Growth Substances|growth substances|mesh-ancestor
93074187|NCT05930665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074188|NCT05930665|Growth Inhibitors|growth inhibitors|mesh-ancestor
93074189|NCT05930665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074190|NCT05930665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074191|NCT05930665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93074192|NCT05930665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93074193|NCT05930613|Certolizumab Pegol|certolizumab pegol|mesh-list
93074194|NCT05930613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93074195|NCT05930613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074196|NCT05930613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93074197|NCT05930613|Immunologic Factors|immunologic factors|mesh-ancestor
93074198|NCT05930613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074199|NCT05930613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074200|NCT05930561|Aflibercept|aflibercept|mesh-list
93074201|NCT05930561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93074202|NCT05930561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93074203|NCT05930561|Growth Substances|growth substances|mesh-ancestor
93074204|NCT05930561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074205|NCT05930561|Growth Inhibitors|growth inhibitors|mesh-ancestor
93074206|NCT05930561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074207|NCT05930405|Sufentanil|sufentanil|mesh-list
93074208|NCT05930405|Ropivacaine|ropivacaine|mesh-list
93074209|NCT05930405|Anesthetics, Local|anesthetics, local|mesh-ancestor
93074210|NCT05930405|Anesthetics|anesthetics|mesh-ancestor
93074211|NCT05930405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074212|NCT05930405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074213|NCT05930405|Sensory System Agents|sensory system agents|mesh-ancestor
93074214|NCT05930405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074215|NCT05930405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93074216|NCT05930405|Narcotics|narcotics|mesh-ancestor
93074217|NCT05930405|Analgesics|analgesics|mesh-ancestor
93074218|NCT05930405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93074219|NCT05930405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074220|NCT05930405|Anesthetics, General|anesthetics, general|mesh-ancestor
93074221|NCT05930236|Methylprednisolone|methylprednisolone|mesh-list
93074222|NCT05930236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93074223|NCT05930236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93074224|NCT05930236|Prednisolone|prednisolone|mesh-list
93074225|NCT05930236|Prednisolone acetate|prednisolone acetate|mesh-list
93074226|NCT05930236|Lidocaine|lidocaine|mesh-list
93074227|NCT05930236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93074228|NCT05930236|Prednisolone phosphate|prednisolone phosphate|mesh-list
93074229|NCT05930236|Anesthetics, Local|anesthetics, local|mesh-ancestor
93074230|NCT05930236|Anesthetics|anesthetics|mesh-ancestor
93074231|NCT05930236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074232|NCT05930236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074233|NCT05930236|Sensory System Agents|sensory system agents|mesh-ancestor
93074234|NCT05930236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074235|NCT05930236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93074236|NCT05930236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93074237|NCT05930236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93074238|NCT05930236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93074239|NCT05930236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074240|NCT05930236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074241|NCT05930236|Antiemetics|antiemetics|mesh-ancestor
93074242|NCT05930236|Autonomic Agents|autonomic agents|mesh-ancestor
93074243|NCT05930236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074244|NCT05930236|Glucocorticoids|glucocorticoids|mesh-ancestor
93074245|NCT05930236|Hormones|hormones|mesh-ancestor
93074246|NCT05930236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074247|NCT05930236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93074248|NCT05930236|Protective Agents|protective agents|mesh-ancestor
93074249|NCT05930236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074250|NCT05930236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074251|NCT05930171|Acetaminophen|acetaminophen|mesh-list
93074252|NCT05930171|Bupivacaine|bupivacaine|mesh-list
93074253|NCT05930171|Anesthetics, Local|anesthetics, local|mesh-ancestor
93074254|NCT05930171|Anesthetics|anesthetics|mesh-ancestor
93074255|NCT05930171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074256|NCT05930171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074257|NCT05930171|Sensory System Agents|sensory system agents|mesh-ancestor
93074258|NCT05930171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074259|NCT05930171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074260|NCT05930171|Analgesics|analgesics|mesh-ancestor
93074261|NCT05930171|Antipyretics|antipyretics|mesh-ancestor
93074262|NCT05930119|Rabeprazole|rabeprazole|mesh-list
93074263|NCT05930119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93074264|NCT05930119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074265|NCT05930119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93074266|NCT05930119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074267|NCT05930119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074268|NCT05930080|Celecoxib|celecoxib|mesh-list
93074269|NCT05930080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93074270|NCT05930080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074271|NCT05930080|Analgesics|analgesics|mesh-ancestor
93074272|NCT05930080|Sensory System Agents|sensory system agents|mesh-ancestor
93074273|NCT05930080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074274|NCT05930080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074275|NCT05930080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074276|NCT05930080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074277|NCT05930080|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93074278|NCT05930080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93074279|NCT05930080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074280|NCT05930080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074281|NCT05930002|Ivermectin|ivermectin|mesh-list
93074282|NCT05930002|Colchicine|colchicine|mesh-list
93074283|NCT05930002|Gout Suppressants|gout suppressants|mesh-ancestor
93074284|NCT05930002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074285|NCT05930002|Tubulin Modulators|tubulin modulators|mesh-ancestor
93074286|NCT05930002|Antimitotic Agents|antimitotic agents|mesh-ancestor
93074287|NCT05930002|Mitosis Modulators|mitosis modulators|mesh-ancestor
93074288|NCT05930002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074289|NCT05930002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074290|NCT05930002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93074291|NCT05930002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074292|NCT05929092|Cyclophosphamide|cyclophosphamide|mesh-list
93074293|NCT05929092|Busulfan|busulfan|mesh-list
93074294|NCT05929092|Fludarabine|fludarabine|mesh-list
93074295|NCT05929092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93074296|NCT05929092|Immunologic Factors|immunologic factors|mesh-ancestor
93074297|NCT05929092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074298|NCT05929092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074299|NCT05929092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93074300|NCT05929092|Alkylating Agents|alkylating agents|mesh-ancestor
93074301|NCT05929092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074302|NCT05929092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074303|NCT05929092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93074304|NCT05928897|Disitamab vedotin|disitamab vedotin|mesh-list
93074305|NCT05928897|Immunoconjugates|immunoconjugates|mesh-ancestor
93074306|NCT05928897|Immunologic Factors|immunologic factors|mesh-ancestor
93074307|NCT05928897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074308|NCT05926505|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93074309|NCT05926505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074310|NCT05926336|Anesthetics|anesthetics|mesh-list
93074311|NCT05926336|Propofol|propofol|mesh-list
93074312|NCT05926336|Sevoflurane|sevoflurane|mesh-list
93074313|NCT05926336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074314|NCT05926336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074315|NCT05926336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93074316|NCT05926336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074317|NCT05926336|Anesthetics, General|anesthetics, general|mesh-ancestor
93074318|NCT05926336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93074319|NCT05926336|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93074320|NCT05925894|Anesthetics|anesthetics|mesh-list
93074321|NCT05925894|Mydriatics|mydriatics|mesh-list
93074322|NCT05925894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074323|NCT05925894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074324|NCT05925894|Autonomic Agents|autonomic agents|mesh-ancestor
93074325|NCT05925894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074326|NCT05925127|Vaccines|vaccines|mesh-list
93074327|NCT05925127|Immunologic Factors|immunologic factors|mesh-ancestor
93074328|NCT05925127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074329|NCT05923086|Lidocaine|lidocaine|mesh-list
93074330|NCT05923086|Anesthetics, Local|anesthetics, local|mesh-ancestor
93074331|NCT05923086|Anesthetics|anesthetics|mesh-ancestor
93074332|NCT05923086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074333|NCT05923086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074334|NCT05923086|Sensory System Agents|sensory system agents|mesh-ancestor
93074335|NCT05923086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074336|NCT05923086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93074337|NCT05923086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93074338|NCT05923086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93074339|NCT05923086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93074340|NCT05923086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074341|NCT05909618|Nivolumab|nivolumab|mesh-list
93074342|NCT05909618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93074343|NCT05909618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074344|NCT05909618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074345|NCT05909618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074346|NCT05909618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074347|NCT05902117|Arginine Vasopressin|arginine vasopressin|mesh-list
93074348|NCT05902117|Hemostatics|hemostatics|mesh-ancestor
93074349|NCT05902117|Coagulants|coagulants|mesh-ancestor
93074350|NCT05902117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93074351|NCT05902117|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93074352|NCT05902117|Natriuretic Agents|natriuretic agents|mesh-ancestor
93074353|NCT05902117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074354|NCT05900284|Metformin|metformin|mesh-list
93074355|NCT05900284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93074356|NCT05900284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074357|NCT05899010|Progesterone|progesterone|mesh-list
93074358|NCT05899010|Progestins|progestins|mesh-ancestor
93074359|NCT05899010|Hormones|hormones|mesh-ancestor
93074360|NCT05899010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074361|NCT05899010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074362|NCT05895955|Vaccines|vaccines|mesh-list
93074363|NCT05895955|Immunologic Factors|immunologic factors|mesh-ancestor
93074364|NCT05895955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074365|NCT05894577|Montelukast|montelukast|mesh-list
93074366|NCT05894577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93074367|NCT05894577|Respiratory System Agents|respiratory system agents|mesh-ancestor
93074368|NCT05894577|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93074369|NCT05894577|Hormone Antagonists|hormone antagonists|mesh-ancestor
93074370|NCT05894577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074371|NCT05894577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074372|NCT05894577|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93074373|NCT05894577|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93074374|NCT05894577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074375|NCT05894564|Fluvoxamine|fluvoxamine|mesh-list
93074376|NCT05894564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074377|NCT05894564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074378|NCT05894564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93074379|NCT05894564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93074380|NCT05894564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074381|NCT05894564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074382|NCT05894564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93074383|NCT05894564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93074384|NCT05894564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93074385|NCT05894564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93074386|NCT05894564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074387|NCT05894564|Serotonin Agents|serotonin agents|mesh-ancestor
93074388|NCT05894564|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93074389|NCT05894564|Antidepressive Agents|antidepressive agents|mesh-ancestor
93074390|NCT05894564|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93074391|NCT05894564|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93074392|NCT05894564|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93074394|NCT05894538|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93074395|NCT05894538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074396|NCT05886036|Deoxyglucose|deoxyglucose|mesh-list
93074397|NCT05886036|Rituximab|rituximab|mesh-list
93074398|NCT05886036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93074399|NCT05886036|Antibodies|antibodies|mesh-list
93074400|NCT05886036|Immunoglobulins|immunoglobulins|mesh-list
93074401|NCT05886036|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93074402|NCT05886036|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93074403|NCT05886036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93074404|NCT05886036|Immunologic Factors|immunologic factors|mesh-ancestor
93074405|NCT05886036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074406|NCT05886036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074407|NCT05886036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074408|NCT05886036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93074409|NCT05886036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074410|NCT05886036|Antimetabolites|antimetabolites|mesh-ancestor
93074411|NCT05886036|Antiviral Agents|antiviral agents|mesh-ancestor
93074412|NCT05886036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074413|NCT05877573|Capecitabine|capecitabine|mesh-list
93074414|NCT05877573|Oxaliplatin|oxaliplatin|mesh-list
93074415|NCT05877573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93074416|NCT05877573|Antimetabolites|antimetabolites|mesh-ancestor
93074417|NCT05877573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074418|NCT05877573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074419|NCT05872542|Listerine|listerine|mesh-list
93074420|NCT05872542|Fluorides|fluorides|mesh-list
93074421|NCT05872542|Sodium Fluoride|sodium fluoride|mesh-list
93074422|NCT05872542|Fluorides, Topical|fluorides, topical|mesh-list
93074423|NCT05872542|Cariostatic Agents|cariostatic agents|mesh-ancestor
93074424|NCT05872542|Protective Agents|protective agents|mesh-ancestor
93074425|NCT05872542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074426|NCT05872542|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93074427|NCT05872542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074428|NCT05872425|Drospirenone|drospirenone|mesh-list
93074429|NCT05872425|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93074430|NCT05872425|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93074431|NCT05872425|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93074432|NCT05872425|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93074433|NCT05872425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93074434|NCT05872425|Contraceptive Agents|contraceptive agents|mesh-ancestor
93074435|NCT05872425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93074436|NCT05872425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074437|NCT05872425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93074438|NCT05872425|Estrogens|estrogens|mesh-ancestor
93074439|NCT05872425|Hormones|hormones|mesh-ancestor
93074440|NCT05872425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074441|NCT05872425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93074442|NCT05872425|Hormone Antagonists|hormone antagonists|mesh-ancestor
93074443|NCT05872425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93074444|NCT05872425|Diuretics|diuretics|mesh-ancestor
93074445|NCT05872425|Natriuretic Agents|natriuretic agents|mesh-ancestor
93074446|NCT05871424|Buprenorphine|buprenorphine|mesh-list
93074447|NCT05871424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93074448|NCT05871424|Narcotics|narcotics|mesh-ancestor
93074449|NCT05871424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074450|NCT05871424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074451|NCT05871424|Analgesics|analgesics|mesh-ancestor
93074452|NCT05871424|Sensory System Agents|sensory system agents|mesh-ancestor
93074453|NCT05871424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074454|NCT05871424|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93074455|NCT05870709|Valsartan|valsartan|mesh-list
93074456|NCT05870709|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93074457|NCT05870709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93074458|NCT05870709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93074459|NCT05870709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93074460|NCT05870709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074461|NCT05870514|Propofol|propofol|mesh-list
93074462|NCT05870514|Fospropofol|fospropofol|mesh-list
93074463|NCT05870514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93074464|NCT05870514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074465|NCT05870514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074466|NCT05870514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074467|NCT05870514|Anesthetics, General|anesthetics, general|mesh-ancestor
93074468|NCT05870514|Anesthetics|anesthetics|mesh-ancestor
93074469|NCT05851560|Hyaluronic Acid|hyaluronic acid|mesh-list
93074470|NCT05851560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93074471|NCT05851560|Immunologic Factors|immunologic factors|mesh-ancestor
93074472|NCT05851560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074473|NCT05851560|Viscosupplements|viscosupplements|mesh-ancestor
93074474|NCT05851560|Protective Agents|protective agents|mesh-ancestor
93074475|NCT05849298|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93074476|NCT05849298|177Lu-PSMA-617|177lu-psma-617|mesh-list
93074477|NCT05849298|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93074478|NCT05849298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074479|NCT05829356|Vaccines|vaccines|mesh-list
93074480|NCT05829356|Immunologic Factors|immunologic factors|mesh-ancestor
93074481|NCT05829356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074482|NCT05817240|Nintedanib|nintedanib|mesh-list
93074483|NCT05817240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074484|NCT05817240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93074485|NCT05817240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074486|NCT05817240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074487|NCT05810363|Propofol|propofol|mesh-list
93074488|NCT05810363|Etomidate|etomidate|mesh-list
93074489|NCT05810363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93074490|NCT05810363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074491|NCT05810363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074492|NCT05810363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074493|NCT05810363|Anesthetics, General|anesthetics, general|mesh-ancestor
93074494|NCT05810363|Anesthetics|anesthetics|mesh-ancestor
93074495|NCT05807126|Olaparib|olaparib|mesh-list
93074496|NCT05807126|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93074497|NCT05807126|Magrolimab|magrolimab|mesh-list
93074498|NCT05807126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074499|NCT05807126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074500|NCT05807126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074501|NCT05807126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074502|NCT05804123|Acetylcysteine|acetylcysteine|mesh-list
93074503|NCT05804123|Ciprofloxacin|ciprofloxacin|mesh-list
93074504|NCT05804123|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93074505|NCT05804123|Cefotaxime|cefotaxime|mesh-list
93074506|NCT05804123|Cefoxitin|cefoxitin|mesh-list
93074507|NCT05804123|Xylometazoline|xylometazoline|mesh-list
93074508|NCT05804123|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93074509|NCT05804123|Antiviral Agents|antiviral agents|mesh-ancestor
93074510|NCT05804123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074511|NCT05804123|Expectorants|expectorants|mesh-ancestor
93074512|NCT05804123|Respiratory System Agents|respiratory system agents|mesh-ancestor
93074513|NCT05804123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93074514|NCT05804123|Antioxidants|antioxidants|mesh-ancestor
93074515|NCT05804123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074516|NCT05804123|Protective Agents|protective agents|mesh-ancestor
93074517|NCT05804123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074518|NCT05804123|Antidotes|antidotes|mesh-ancestor
93074519|NCT05804123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93074520|NCT05804123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93074521|NCT05804123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93074522|NCT05804123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074523|NCT05804123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074524|NCT05804123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93074525|NCT05804123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93074526|NCT05804123|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93074527|NCT05804123|Nasal Decongestants|nasal decongestants|mesh-ancestor
93074528|NCT05804123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93074529|NCT05803148|Midodrine|midodrine|mesh-list
93074530|NCT05803148|Sympathomimetics|sympathomimetics|mesh-ancestor
93074531|NCT05803148|Autonomic Agents|autonomic agents|mesh-ancestor
93074532|NCT05803148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074533|NCT05803148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051652|NCT01092520|Antimanic Agents|antimanic agents|mesh-ancestor
93074534|NCT05803148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93074535|NCT05803148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93074536|NCT05803148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93074537|NCT05803148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93074538|NCT05803148|Adrenergic Agents|adrenergic agents|mesh-ancestor
93074539|NCT05803148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074540|NCT05803148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074541|NCT05802849|Acetazolamide|acetazolamide|mesh-list
93074542|NCT05802849|Anticonvulsants|anticonvulsants|mesh-ancestor
93074543|NCT05802849|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93074544|NCT05802849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074545|NCT05802849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074546|NCT05802849|Diuretics|diuretics|mesh-ancestor
93074547|NCT05802849|Natriuretic Agents|natriuretic agents|mesh-ancestor
93074548|NCT05802849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074549|NCT05799521|Glycine|glycine|mesh-list
93074550|NCT05799521|Glycine Agents|glycine agents|mesh-ancestor
93074551|NCT05799521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074552|NCT05799521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074553|NCT05799521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074554|NCT05785832|Insulin|insulin|mesh-list
93074555|NCT05785832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93074556|NCT05785832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074557|NCT05776953|Ketorolac|ketorolac|mesh-list
93074558|NCT05776953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93074559|NCT05776953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074560|NCT05776953|Analgesics|analgesics|mesh-ancestor
93074561|NCT05776953|Sensory System Agents|sensory system agents|mesh-ancestor
93074562|NCT05776953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074563|NCT05776953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074564|NCT05776953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074565|NCT05776953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074566|NCT05776953|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93074567|NCT05776953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074568|NCT05776953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074569|NCT05773664|Dexamethasone|dexamethasone|mesh-list
93074570|NCT05773664|Dexamethasone acetate|dexamethasone acetate|mesh-list
93074571|NCT05773664|Ichthammol|ichthammol|mesh-list
93074572|NCT05773664|BB 1101|bb 1101|mesh-list
93074573|NCT05773664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074574|NCT05773664|Antiemetics|antiemetics|mesh-ancestor
93074575|NCT05773664|Autonomic Agents|autonomic agents|mesh-ancestor
93074576|NCT05773664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074577|NCT05773664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074578|NCT05773664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074579|NCT05773664|Glucocorticoids|glucocorticoids|mesh-ancestor
93074580|NCT05773664|Hormones|hormones|mesh-ancestor
93074581|NCT05773664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074582|NCT05773664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074583|NCT05773664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074584|NCT05773664|Protease Inhibitors|protease inhibitors|mesh-ancestor
93074585|NCT05773664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074586|NCT05773664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074587|NCT05773664|Dermatologic Agents|dermatologic agents|mesh-ancestor
93074588|NCT05769309|Fentanyl|fentanyl|mesh-list
93074589|NCT05769309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93074590|NCT05769309|Narcotics|narcotics|mesh-ancestor
93074591|NCT05769309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074592|NCT05769309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074593|NCT05769309|Analgesics|analgesics|mesh-ancestor
93074594|NCT05769309|Sensory System Agents|sensory system agents|mesh-ancestor
93074595|NCT05769309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074596|NCT05769309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93074597|NCT05769309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074598|NCT05769309|Anesthetics, General|anesthetics, general|mesh-ancestor
93074599|NCT05769309|Anesthetics|anesthetics|mesh-ancestor
93074600|NCT05748366|Analgesics|analgesics|mesh-list
93074601|NCT05748366|Sensory System Agents|sensory system agents|mesh-ancestor
93074602|NCT05748366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074603|NCT05748366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074604|NCT05738161|Cisplatin|cisplatin|mesh-list
93074605|NCT05738161|Gemcitabine|gemcitabine|mesh-list
93074606|NCT05738161|Magrolimab|magrolimab|mesh-list
93074607|NCT05738161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074608|NCT05738161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93074609|NCT05738161|Antimetabolites|antimetabolites|mesh-ancestor
93074610|NCT05738161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074611|NCT05738161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074612|NCT05732701|Oxymetazoline|oxymetazoline|mesh-list
93074613|NCT05732701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93074614|NCT05732701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93074615|NCT05732701|Adrenergic Agents|adrenergic agents|mesh-ancestor
93074616|NCT05732701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074617|NCT05732701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074618|NCT05732701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074619|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
93074620|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
93074621|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074622|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
93074623|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93074624|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
93074625|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93074626|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93074627|NCT05729568|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93074628|NCT05729568|Antiviral Agents|antiviral agents|mesh-ancestor
93074629|NCT05729568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074630|NCT05726383|Viscum album peptide|viscum album peptide|mesh-list
93074631|NCT05726383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074632|NCT05726383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93074633|NCT05726383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93074634|NCT05726383|Antiviral Agents|antiviral agents|mesh-ancestor
93074635|NCT05726383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074636|NCT05723055|Nivolumab|nivolumab|mesh-list
93074637|NCT05723055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074638|NCT05723055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074639|NCT05723055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074640|NCT05723055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074641|NCT05715229|Paclitaxel|paclitaxel|mesh-list
93074642|NCT05715229|Carboplatin|carboplatin|mesh-list
93074643|NCT05715229|Nivolumab|nivolumab|mesh-list
93074644|NCT05715229|Pemetrexed|pemetrexed|mesh-list
93074645|NCT05715229|Ipilimumab|ipilimumab|mesh-list
93074646|NCT05715229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93074647|NCT05715229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074648|NCT05715229|Tubulin Modulators|tubulin modulators|mesh-ancestor
93074649|NCT05715229|Antimitotic Agents|antimitotic agents|mesh-ancestor
93074650|NCT05715229|Mitosis Modulators|mitosis modulators|mesh-ancestor
93074651|NCT05715229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664939|NCT00271271|Gemcitabine|gemcitabine|mesh-list
93074652|NCT05715229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074653|NCT05715229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074654|NCT05715229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074655|NCT05715229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93074656|NCT05715229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93074657|NCT05709977|Histamine Antagonists|histamine antagonists|mesh-list
93074658|NCT05709977|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93074659|NCT05709977|Histamine Agents|histamine agents|mesh-ancestor
93074660|NCT05709977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074661|NCT05709977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074662|NCT05709977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074663|NCT05709821|Pembrolizumab|pembrolizumab|mesh-list
93074664|NCT05709821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074665|NCT05709821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074666|NCT05709821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074667|NCT05709821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074668|NCT05708638|Anesthetics|anesthetics|mesh-list
93074669|NCT05708638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074670|NCT05708638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074671|NCT05705804|Atorvastatin|atorvastatin|mesh-list
93074672|NCT05705804|Pitavastatin|pitavastatin|mesh-list
93074673|NCT05705804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93074674|NCT05705804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93074675|NCT05705804|Antimetabolites|antimetabolites|mesh-ancestor
93074676|NCT05705804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074677|NCT05705804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93074678|NCT05705804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93074679|NCT05705804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074680|NCT05703659|Sulfalene|sulfalene|mesh-list
93074681|NCT05703659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074682|NCT05703659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93074683|NCT05703659|Antimalarials|antimalarials|mesh-ancestor
93074684|NCT05703659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93074685|NCT05703659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93074687|NCT05701189|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93074688|NCT05701189|Antibodies|antibodies|mesh-list
93074689|NCT05701189|gamma-Globulins|gamma-globulins|mesh-list
93074690|NCT05701189|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93074691|NCT05701189|Immunologic Factors|immunologic factors|mesh-ancestor
93074692|NCT05701189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074693|NCT05691491|Temozolomide|temozolomide|mesh-list
93074694|NCT05691491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93074695|NCT05691491|Alkylating Agents|alkylating agents|mesh-ancestor
93074696|NCT05691491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074697|NCT05691491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074698|NCT05688475|Dexamethasone|dexamethasone|mesh-list
93074699|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074700|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
93074701|NCT05688475|Autonomic Agents|autonomic agents|mesh-ancestor
93074702|NCT05688475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074703|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074704|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074705|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
93074706|NCT05688475|Hormones|hormones|mesh-ancestor
93074707|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074708|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074709|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074710|NCT05686863|Remifentanil|remifentanil|mesh-list
93074711|NCT05686863|Propofol|propofol|mesh-list
93074712|NCT05686863|Esketamine|esketamine|mesh-list
93074713|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93074714|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074715|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074716|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074717|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
93074718|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
93074719|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93074720|NCT05686863|Narcotics|narcotics|mesh-ancestor
93074721|NCT05686863|Analgesics|analgesics|mesh-ancestor
93074722|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
93074723|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074724|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
93074725|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93074726|NCT05661669|Ketamine|ketamine|mesh-list
93074727|NCT05661669|Analgesics|analgesics|mesh-ancestor
93074728|NCT05661669|Sensory System Agents|sensory system agents|mesh-ancestor
93074729|NCT05661669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074730|NCT05661669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074731|NCT05661669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93074732|NCT05661669|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074733|NCT05661669|Anesthetics, General|anesthetics, general|mesh-ancestor
93074734|NCT05661669|Anesthetics|anesthetics|mesh-ancestor
93074735|NCT05661669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074736|NCT05661669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93074737|NCT05661669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93074738|NCT05661669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074739|NCT05661669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074740|NCT05654454|Paclitaxel|paclitaxel|mesh-list
93074741|NCT05654454|Bevacizumab|bevacizumab|mesh-list
93074742|NCT05654454|Carboplatin|carboplatin|mesh-list
93074743|NCT05654454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93074744|NCT05654454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074745|NCT05654454|Tubulin Modulators|tubulin modulators|mesh-ancestor
93074746|NCT05654454|Antimitotic Agents|antimitotic agents|mesh-ancestor
93074747|NCT05654454|Mitosis Modulators|mitosis modulators|mesh-ancestor
93074748|NCT05654454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074749|NCT05654454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074750|NCT05654454|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93074751|NCT05654454|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93074752|NCT05654454|Growth Substances|growth substances|mesh-ancestor
93074753|NCT05654454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074754|NCT05654454|Growth Inhibitors|growth inhibitors|mesh-ancestor
93074755|NCT05649722|Treprostinil|treprostinil|mesh-list
93074756|NCT05649722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93074757|NCT05640102|Zanubrutinib|zanubrutinib|mesh-list
93074758|NCT05640102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074759|NCT05640102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93074760|NCT05640102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074761|NCT05640102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074762|NCT05636787|Melphalan|melphalan|mesh-list
93074763|NCT05636787|Treosulfan|treosulfan|mesh-list
93074764|NCT05636787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93074765|NCT05636787|Alkylating Agents|alkylating agents|mesh-ancestor
93074766|NCT05636787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074767|NCT05636787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074768|NCT05636787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93074769|NCT05636787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93074770|NCT05636787|Immunologic Factors|immunologic factors|mesh-ancestor
93074771|NCT05636787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074772|NCT05635162|Rituximab|rituximab|mesh-list
93074773|NCT05635162|Zanubrutinib|zanubrutinib|mesh-list
93074774|NCT05635162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074775|NCT05635162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074776|NCT05635162|Immunologic Factors|immunologic factors|mesh-ancestor
93074777|NCT05635162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074778|NCT05635162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074779|NCT05635162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93074780|NCT05635162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074781|NCT05635162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074782|NCT05631912|Cyclophosphamide|cyclophosphamide|mesh-list
93074783|NCT05631912|Fludarabine|fludarabine|mesh-list
93074784|NCT05631912|Fludarabine phosphate|fludarabine phosphate|mesh-list
93074785|NCT05631912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93074786|NCT05631912|Immunologic Factors|immunologic factors|mesh-ancestor
93074787|NCT05631912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074788|NCT05631912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074789|NCT05631912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93074790|NCT05631912|Alkylating Agents|alkylating agents|mesh-ancestor
93074791|NCT05631912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074792|NCT05631912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074793|NCT05631912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93074794|NCT05631912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93074795|NCT05631912|Antimetabolites|antimetabolites|mesh-ancestor
93074796|NCT05631795|Fulvestrant|fulvestrant|mesh-list
93074797|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074798|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074799|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93074800|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93074801|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
93074802|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074803|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074804|NCT05627557|Acetaminophen|acetaminophen|mesh-list
93074805|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
93074806|NCT05627557|Promethazine|promethazine|mesh-list
93074807|NCT05627557|Prednisone|prednisone|mesh-list
93074808|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
93074809|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
93074810|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074811|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
93074812|NCT05627557|Hormones|hormones|mesh-ancestor
93074813|NCT05627557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074814|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074815|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074816|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074817|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074818|NCT05627557|Analgesics|analgesics|mesh-ancestor
93074819|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
93074820|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074821|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
93074822|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
93074823|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
93074824|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074825|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93074826|NCT05627557|Protective Agents|protective agents|mesh-ancestor
93074827|NCT05627557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074828|NCT05627557|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93074829|NCT05627557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93074830|NCT05627557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074831|NCT05627557|Anesthetics, Local|anesthetics, local|mesh-ancestor
93074832|NCT05627557|Anesthetics|anesthetics|mesh-ancestor
93074833|NCT05627557|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93074834|NCT05627557|Histamine Antagonists|histamine antagonists|mesh-ancestor
93074835|NCT05627557|Histamine Agents|histamine agents|mesh-ancestor
93074836|NCT05627557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074837|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074838|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93074839|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
93074840|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
93074841|NCT05623059|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93074842|NCT05623059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93074843|NCT05623059|Immunologic Factors|immunologic factors|mesh-ancestor
93074844|NCT05623059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074845|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
93074846|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
93074847|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93074848|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074849|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074850|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
93074851|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93074852|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074853|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074854|NCT05615948|Ketamine|ketamine|mesh-list
93074855|NCT05615948|Analgesics|analgesics|mesh-ancestor
93074856|NCT05615948|Sensory System Agents|sensory system agents|mesh-ancestor
93074857|NCT05615948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074858|NCT05615948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074859|NCT05615948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074860|NCT05615948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93074861|NCT05615948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93074862|NCT05615948|Anesthetics, General|anesthetics, general|mesh-ancestor
93074863|NCT05615948|Anesthetics|anesthetics|mesh-ancestor
93074864|NCT05615948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074865|NCT05615948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93074866|NCT05615948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93074867|NCT05615948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074868|NCT05614349|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
93074869|NCT05614349|Antiviral Agents|antiviral agents|mesh-ancestor
93074870|NCT05614349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93074871|NCT05609630|Upadacitinib|upadacitinib|mesh-list
93074872|NCT05609630|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93074873|NCT05609630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93074874|NCT05609630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074875|NCT05609630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074876|NCT05609630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074877|NCT05605964|Leuprolide|leuprolide|mesh-list
93074878|NCT05605964|Relugolix|relugolix|mesh-list
93074879|NCT05605964|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93074880|NCT05605964|Fertility Agents|fertility agents|mesh-ancestor
93074881|NCT05605964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93074882|NCT05605964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074883|NCT05605964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93074884|NCT05605964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074885|NCT05605964|Androgen Antagonists|androgen antagonists|mesh-ancestor
93074886|NCT05605964|Hormone Antagonists|hormone antagonists|mesh-ancestor
93074887|NCT05605964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93074888|NCT05595460|Carboplatin|carboplatin|mesh-list
93074889|NCT05595460|Etoposide|etoposide|mesh-list
93074890|NCT05595460|Atezolizumab|atezolizumab|mesh-list
93074891|NCT05595460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074892|NCT05595460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93074893|NCT05595460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93074894|NCT05595460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93074895|NCT05595460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074896|NCT05595460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074897|NCT05595460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074898|NCT05595460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074899|NCT05594667|Psilocybin|psilocybin|mesh-list
93074900|NCT05594667|Hallucinogens|hallucinogens|mesh-ancestor
93074901|NCT05594667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074902|NCT05594667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93074903|NCT05590377|Daratumumab|daratumumab|mesh-list
93074904|NCT05590377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074905|NCT05589818|Pembrolizumab|pembrolizumab|mesh-list
93074906|NCT05589818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074907|NCT05589818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074908|NCT05589818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074909|NCT05589818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074910|NCT05586360|Simvastatin|simvastatin|mesh-list
93074911|NCT05586360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93074912|NCT05586360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93074913|NCT05586360|Antimetabolites|antimetabolites|mesh-ancestor
93074914|NCT05586360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074915|NCT05586360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93074916|NCT05586360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93074917|NCT05586360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93074918|NCT05583474|Carteolol|carteolol|mesh-list
93074919|NCT05583474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93074920|NCT05583474|Latanoprost|latanoprost|mesh-list
93074921|NCT05583474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93074922|NCT05583474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93074923|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93074924|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
93074925|NCT05583474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074926|NCT05583474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074927|NCT05583474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074928|NCT05583474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93074929|NCT05583474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93074930|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
93074931|NCT05583474|Autonomic Agents|autonomic agents|mesh-ancestor
93074932|NCT05583474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074933|NCT05581004|Atezolizumab|atezolizumab|mesh-list
93074934|NCT05581004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93074935|NCT05581004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074936|NCT05581004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074937|NCT05581004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074938|NCT05573360|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93074939|NCT05573360|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93074940|NCT05571319|Metformin|metformin|mesh-list
93074941|NCT05571319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93074942|NCT05571319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074943|NCT05557695|Acalabrutinib|acalabrutinib|mesh-list
93074944|NCT05557695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074945|NCT05553691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93074946|NCT05553691|Hallucinogens|hallucinogens|mesh-ancestor
93074947|NCT05553691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074948|NCT05553691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93074949|NCT05553691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93074950|NCT05553691|Serotonin Agents|serotonin agents|mesh-ancestor
93074951|NCT05553691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93074952|NCT05553691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93074953|NCT05553691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93074954|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93074955|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
93074956|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074957|NCT05544929|Tislelizumab|tislelizumab|mesh-list
93074958|NCT05544929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93074959|NCT05544929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074960|NCT05542615|Pirfenidone|pirfenidone|mesh-list
93074961|NCT05542615|Analgesics|analgesics|mesh-ancestor
93074962|NCT05542615|Sensory System Agents|sensory system agents|mesh-ancestor
93074963|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074964|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074965|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93074966|NCT05542615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074967|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074968|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93074969|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93074970|NCT05532163|Natalizumab|natalizumab|mesh-list
93074971|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
93074972|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074973|NCT05526690|Metformin|metformin|mesh-list
93074974|NCT05526690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93074975|NCT05526690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074976|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
93074977|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93074978|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
93074979|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
93074980|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93074981|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074982|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93074983|NCT05510141|Analgesics|analgesics|mesh-ancestor
93074984|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
93074985|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074986|NCT05509634|Dexamethasone|dexamethasone|mesh-list
93074987|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
93074988|NCT05509634|Palonosetron|palonosetron|mesh-list
93074989|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
93074990|NCT05509634|Aprepitant|aprepitant|mesh-list
93074991|NCT05509634|BB 1101|bb 1101|mesh-list
93074992|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93074993|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
93074994|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
93074995|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93074996|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93074997|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93074998|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
93074999|NCT05509634|Hormones|hormones|mesh-ancestor
93075000|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075001|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075002|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075003|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
93075004|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075005|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075006|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93075007|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93075008|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
93075009|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075010|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93075011|NCT05502315|Nivolumab|nivolumab|mesh-list
93075012|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075013|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075014|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075015|NCT05502315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075016|NCT05501600|Lidocaine|lidocaine|mesh-list
93075017|NCT05501600|Anesthetics, Local|anesthetics, local|mesh-ancestor
93075018|NCT05501600|Anesthetics|anesthetics|mesh-ancestor
93075019|NCT05501600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075020|NCT05501600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075021|NCT05501600|Sensory System Agents|sensory system agents|mesh-ancestor
93075022|NCT05501600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075023|NCT05501600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93075024|NCT05501600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93075025|NCT05501600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93075026|NCT05501600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075027|NCT05501600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075028|NCT05501548|Ascorbic Acid|ascorbic acid|mesh-list
93075029|NCT05501548|Olaparib|olaparib|mesh-list
93075030|NCT05501548|Vitamins|vitamins|mesh-ancestor
93075031|NCT05501548|Micronutrients|micronutrients|mesh-ancestor
93075032|NCT05501548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075033|NCT05501548|Antioxidants|antioxidants|mesh-ancestor
93075034|NCT05501548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075035|NCT05501548|Protective Agents|protective agents|mesh-ancestor
93075036|NCT05501548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93075037|NCT05501548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075038|NCT05501548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075039|NCT05498155|Durvalumab|durvalumab|mesh-list
93075040|NCT05498155|Olaparib|olaparib|mesh-list
93075041|NCT05498155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075042|NCT05498155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075043|NCT05498155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93075044|NCT05498155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075045|NCT05498155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075046|NCT05488405|Mesalamine|mesalamine|mesh-list
93075047|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93075048|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93075049|NCT05488405|Analgesics|analgesics|mesh-ancestor
93075050|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
93075051|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075052|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075053|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075054|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075055|NCT05477576|Everolimus|everolimus|mesh-list
93075056|NCT05477576|Sunitinib|sunitinib|mesh-list
93075057|NCT05477576|Octreotide|octreotide|mesh-list
93075058|NCT05477576|Lanreotide|lanreotide|mesh-list
93075059|NCT05477576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93075060|NCT05477576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075061|NCT05477576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075062|NCT05477576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075063|NCT05477576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075064|NCT05477576|Immunologic Factors|immunologic factors|mesh-ancestor
93075065|NCT05477576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075066|NCT05477576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075067|NCT05477576|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93075068|NCT05477576|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93075069|NCT05477576|Growth Substances|growth substances|mesh-ancestor
93075070|NCT05477576|Growth Inhibitors|growth inhibitors|mesh-ancestor
93075071|NCT05477576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075072|NCT05477576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075073|NCT05467176|Relugolix|relugolix|mesh-list
93075074|NCT05467176|Androgen Antagonists|androgen antagonists|mesh-ancestor
93075075|NCT05467176|Hormone Antagonists|hormone antagonists|mesh-ancestor
93075076|NCT05467176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075077|NCT05467176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075078|NCT05457933|Dapagliflozin|dapagliflozin|mesh-list
93075079|NCT05457933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93075080|NCT05457933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075081|NCT05457933|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93075082|NCT05457933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075083|NCT05455424|Niraparib|niraparib|mesh-list
93075084|NCT05455424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93075085|NCT05455424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075086|NCT05455424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075087|NCT05455424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075088|NCT05444543|Fluticasone|fluticasone|mesh-list
93075089|NCT05444543|Xhance|xhance|mesh-list
93075090|NCT05444543|Budesonide|budesonide|mesh-list
93075091|NCT05444543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075092|NCT05444543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93075093|NCT05444543|Autonomic Agents|autonomic agents|mesh-ancestor
93075094|NCT05444543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075095|NCT05444543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075096|NCT05444543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93075097|NCT05444543|Respiratory System Agents|respiratory system agents|mesh-ancestor
93075098|NCT05444543|Dermatologic Agents|dermatologic agents|mesh-ancestor
93075099|NCT05444543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93075100|NCT05444543|Glucocorticoids|glucocorticoids|mesh-ancestor
93075101|NCT05444543|Hormones|hormones|mesh-ancestor
93075102|NCT05444543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075103|NCT05443971|Durvalumab|durvalumab|mesh-list
93075104|NCT05443971|Immunoglobulins|immunoglobulins|mesh-list
93075105|NCT05443971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93075106|NCT05443971|Immunoglobulin G|immunoglobulin g|mesh-list
93075107|NCT05443971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075108|NCT05443971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075109|NCT05443971|Immunologic Factors|immunologic factors|mesh-ancestor
93075110|NCT05443971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075111|NCT05439616|Cariprazine|cariprazine|mesh-list
93075112|NCT05439616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93075113|NCT05439616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075114|NCT05439616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075115|NCT05439616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075116|NCT05439616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075117|NCT05437575|Fentanyl|fentanyl|mesh-list
93075118|NCT05437575|Ketamine|ketamine|mesh-list
93075119|NCT05437575|Analgesics|analgesics|mesh-ancestor
93075120|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
93075121|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075122|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075123|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93075124|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93075125|NCT05437575|Anesthetics, General|anesthetics, general|mesh-ancestor
93075126|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
93075127|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075128|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93075129|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93075130|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075131|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075132|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93075133|NCT05437575|Narcotics|narcotics|mesh-ancestor
93052242|NCT03976544|Estradiol|estradiol|mesh-list
93075134|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93075135|NCT05431270|Antibodies|antibodies|mesh-list
93075136|NCT05431270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93075137|NCT05431270|Immunologic Factors|immunologic factors|mesh-ancestor
93075138|NCT05431270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075139|NCT05429268|Lenalidomide|lenalidomide|mesh-list
93075140|NCT05429268|Immunologic Factors|immunologic factors|mesh-ancestor
93075141|NCT05429268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075142|NCT05429268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93075143|NCT05429268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93075144|NCT05429268|Growth Substances|growth substances|mesh-ancestor
93075145|NCT05429268|Growth Inhibitors|growth inhibitors|mesh-ancestor
93075146|NCT05429268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075147|NCT05421741|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93075148|NCT05421741|Vancomycin|vancomycin|mesh-list
93075149|NCT05421741|Gentamicins|gentamicins|mesh-list
93075150|NCT05421741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075151|NCT05421741|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93075152|NCT05421741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075153|NCT05421741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075154|NCT05416658|Antipsychotic Agents|antipsychotic agents|mesh-list
93075155|NCT05416658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075156|NCT05416658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075157|NCT05416658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075158|NCT05416658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075159|NCT05416021|Dapivirine|dapivirine|mesh-list
93075160|NCT05416021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93075161|NCT05416021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93075162|NCT05416021|Antiviral Agents|antiviral agents|mesh-ancestor
93075163|NCT05416021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075164|NCT05403580|Olanzapine|olanzapine|mesh-list
93075165|NCT05403580|Antiemetics|antiemetics|mesh-ancestor
93075166|NCT05403580|Autonomic Agents|autonomic agents|mesh-ancestor
93075167|NCT05403580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075168|NCT05403580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075169|NCT05403580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075170|NCT05403580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93075171|NCT05403580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075172|NCT05403580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075173|NCT05403580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075174|NCT05403580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93075175|NCT05403580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93075176|NCT05403580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075177|NCT05403580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075178|NCT05403580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075179|NCT05403580|Serotonin Agents|serotonin agents|mesh-ancestor
93075180|NCT05399550|Balovaptan|balovaptan|mesh-list
93075181|NCT05399550|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93075182|NCT05399550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075183|NCT05399550|Natriuretic Agents|natriuretic agents|mesh-ancestor
93075184|NCT05399550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075185|NCT05393271|Midazolam|midazolam|mesh-list
93075186|NCT05393271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93075187|NCT05393271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93075188|NCT05393271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075189|NCT05393271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075190|NCT05393271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93075191|NCT05393271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075192|NCT05393271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075193|NCT05393271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93075194|NCT05393271|Anesthetics, General|anesthetics, general|mesh-ancestor
93075195|NCT05393271|Anesthetics|anesthetics|mesh-ancestor
93075196|NCT05393271|GABA Modulators|gaba modulators|mesh-ancestor
93075197|NCT05393271|GABA Agents|gaba agents|mesh-ancestor
93075198|NCT05393271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075199|NCT05393271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075200|NCT05388487|Complement Factor H|complement factor h|mesh-list
93075201|NCT05388487|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93075202|NCT05388487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075203|NCT05388487|Immunologic Factors|immunologic factors|mesh-ancestor
93075204|NCT05388487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075205|NCT05388058|Cannabidiol|cannabidiol|mesh-list
93075206|NCT05388058|Anticonvulsants|anticonvulsants|mesh-ancestor
93075207|NCT05374525|Cabotegravir|cabotegravir|mesh-list
93075208|NCT05374525|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93075209|NCT05374525|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93075210|NCT05374525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075211|NCT05374525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075212|NCT05374525|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93075213|NCT05374525|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93075214|NCT05374525|Antiviral Agents|antiviral agents|mesh-ancestor
93075215|NCT05374525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075216|NCT05372367|Itraconazole|itraconazole|mesh-list
93075217|NCT05372367|Rifampin|rifampin|mesh-list
93075218|NCT05372367|Antifungal Agents|antifungal agents|mesh-ancestor
93075219|NCT05372367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075220|NCT05372367|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93075221|NCT05372367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93075222|NCT05372367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075223|NCT05372367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075224|NCT05372367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93075225|NCT05372367|Hormone Antagonists|hormone antagonists|mesh-ancestor
93075226|NCT05372367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075227|NCT05372367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075228|NCT05372367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93075229|NCT05372367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93075230|NCT05372367|Antitubercular Agents|antitubercular agents|mesh-ancestor
93075231|NCT05372367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93075232|NCT05372367|Leprostatic Agents|leprostatic agents|mesh-ancestor
93075233|NCT05372367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93075234|NCT05372367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93075235|NCT05372367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93075236|NCT05372367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93075237|NCT05372367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93075238|NCT05372367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93075239|NCT05372367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93075240|NCT05363553|Caseins|caseins|mesh-list
93075241|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
93075242|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
93075243|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075244|NCT05360966|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93075245|NCT05360966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93075246|NCT05335993|Niraparib|niraparib|mesh-list
93075247|NCT05335993|Oregovomab|oregovomab|mesh-list
93075248|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93075249|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075250|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075251|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075252|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075253|NCT05332561|Trastuzumab|trastuzumab|mesh-list
93075254|NCT05332561|Atezolizumab|atezolizumab|mesh-list
93075255|NCT05332561|Pertuzumab|pertuzumab|mesh-list
93075256|NCT05332561|Olaparib|olaparib|mesh-list
93075257|NCT05332561|Ipatasertib|ipatasertib|mesh-list
93075258|NCT05332561|Inavolisib|inavolisib|mesh-list
93075259|NCT05332561|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93075260|NCT05332561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075261|NCT05332561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075262|NCT05332561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075263|NCT05332561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075264|NCT05332561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93075265|NCT05332561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075266|NCT05332561|Immunoconjugates|immunoconjugates|mesh-ancestor
93075267|NCT05332561|Immunologic Factors|immunologic factors|mesh-ancestor
93075268|NCT05332561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075269|NCT05332561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075270|NCT05332561|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93075271|NCT05327023|Mycophenolic Acid|mycophenolic acid|mesh-list
93075272|NCT05327023|Sirolimus|sirolimus|mesh-list
93075273|NCT05327023|Cyclophosphamide|cyclophosphamide|mesh-list
93075274|NCT05327023|Busulfan|busulfan|mesh-list
93075275|NCT05327023|Fludarabine|fludarabine|mesh-list
93075276|NCT05327023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075277|NCT05327023|Immunologic Factors|immunologic factors|mesh-ancestor
93075278|NCT05327023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075279|NCT05327023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075280|NCT05327023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075281|NCT05327023|Alkylating Agents|alkylating agents|mesh-ancestor
93075282|NCT05327023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075283|NCT05327023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075284|NCT05327023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93075285|NCT05327023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93075286|NCT05327023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93075287|NCT05327023|Antitubercular Agents|antitubercular agents|mesh-ancestor
92665576|NCT00274040|Cholinergic Agents|cholinergic agents|mesh-ancestor
93075288|NCT05327023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93075289|NCT05327023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075290|NCT05327023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075291|NCT05327023|Antifungal Agents|antifungal agents|mesh-ancestor
93075292|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93075293|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
93075294|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075295|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93075296|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075297|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075298|NCT05303935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075299|NCT05298449|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93075300|NCT05298449|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93075301|NCT05298449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93075302|NCT05298449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075303|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075304|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93075305|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075306|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075307|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
93075308|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075309|NCT05296837|Doxycycline|doxycycline|mesh-list
93075310|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93075311|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075312|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
93075313|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93075314|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93075315|NCT05291130|Vitamin E|vitamin e|mesh-list
93075316|NCT05291130|Vitamins|vitamins|mesh-ancestor
93075317|NCT05291130|Micronutrients|micronutrients|mesh-ancestor
93075318|NCT05291130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075319|NCT05291130|Antioxidants|antioxidants|mesh-ancestor
93075320|NCT05291130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075321|NCT05291130|Protective Agents|protective agents|mesh-ancestor
93075322|NCT05286814|Leucovorin|leucovorin|mesh-list
93075323|NCT05286814|Dexamethasone|dexamethasone|mesh-list
93075324|NCT05286814|Gemcitabine|gemcitabine|mesh-list
93075325|NCT05286814|Fluorouracil|fluorouracil|mesh-list
93075326|NCT05286814|Oxaliplatin|oxaliplatin|mesh-list
93075327|NCT05286814|Irinotecan|irinotecan|mesh-list
93075328|NCT05286814|Floxuridine|floxuridine|mesh-list
93075329|NCT05286814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075330|NCT05286814|Antiemetics|antiemetics|mesh-ancestor
93075331|NCT05286814|Autonomic Agents|autonomic agents|mesh-ancestor
93075332|NCT05286814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075333|NCT05286814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075334|NCT05286814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075335|NCT05286814|Glucocorticoids|glucocorticoids|mesh-ancestor
93075336|NCT05286814|Hormones|hormones|mesh-ancestor
93075337|NCT05286814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075338|NCT05286814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075339|NCT05286814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075340|NCT05286814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93075341|NCT05286814|Antimetabolites|antimetabolites|mesh-ancestor
93075342|NCT05286814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075343|NCT05286814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075344|NCT05286814|Immunologic Factors|immunologic factors|mesh-ancestor
93075345|NCT05286814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93075346|NCT05286814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93075347|NCT05286814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075348|NCT05286814|Antidotes|antidotes|mesh-ancestor
93075349|NCT05286814|Protective Agents|protective agents|mesh-ancestor
93075350|NCT05286814|Vitamin B Complex|vitamin b complex|mesh-ancestor
93075351|NCT05286814|Vitamins|vitamins|mesh-ancestor
93075352|NCT05286814|Micronutrients|micronutrients|mesh-ancestor
93075353|NCT05283720|Prednisone|prednisone|mesh-list
93075354|NCT05283720|Cyclophosphamide|cyclophosphamide|mesh-list
93075355|NCT05283720|Rituximab|rituximab|mesh-list
93075356|NCT05283720|Doxorubicin|doxorubicin|mesh-list
93075357|NCT05283720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93075358|NCT05283720|Lenalidomide|lenalidomide|mesh-list
93075359|NCT05283720|Venetoclax|venetoclax|mesh-list
93075360|NCT05283720|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93075361|NCT05283720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075362|NCT05283720|Immunologic Factors|immunologic factors|mesh-ancestor
93075363|NCT05283720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075364|NCT05283720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075365|NCT05283720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075366|NCT05283720|Alkylating Agents|alkylating agents|mesh-ancestor
93075367|NCT05283720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075368|NCT05283720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075369|NCT05283720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93075370|NCT05283720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075371|NCT05283720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93075372|NCT05283720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93075373|NCT05283720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93075374|NCT05283720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075375|NCT05283720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075376|NCT05283720|Glucocorticoids|glucocorticoids|mesh-ancestor
93075377|NCT05283720|Hormones|hormones|mesh-ancestor
93075378|NCT05283720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075379|NCT05283720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075380|NCT05283720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93075381|NCT05283720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93075382|NCT05283720|Growth Substances|growth substances|mesh-ancestor
93075383|NCT05283720|Growth Inhibitors|growth inhibitors|mesh-ancestor
93075384|NCT05283720|Immunoconjugates|immunoconjugates|mesh-ancestor
93075385|NCT05280769|Lobeline|lobeline|mesh-list
93075386|NCT05280769|Nicotine|nicotine|mesh-list
93075387|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93075388|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
93075389|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075390|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075391|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93075392|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93075393|NCT05280769|Cholinergic Agents|cholinergic agents|mesh-ancestor
93075394|NCT05280769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075395|NCT05280769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075396|NCT05280769|Respiratory System Agents|respiratory system agents|mesh-ancestor
93075397|NCT05259722|Alitretinoin|alitretinoin|mesh-list
93075398|NCT05259722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075399|NCT05259722|Dermatologic Agents|dermatologic agents|mesh-ancestor
93075400|NCT05256745|Paclitaxel|paclitaxel|mesh-list
93075401|NCT05256745|Docetaxel|docetaxel|mesh-list
93075402|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
93075403|NCT05256745|Carboplatin|carboplatin|mesh-list
93075404|NCT05256745|Doxorubicin|doxorubicin|mesh-list
93075405|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93075406|NCT05256745|Trastuzumab|trastuzumab|mesh-list
93075407|NCT05256745|Pertuzumab|pertuzumab|mesh-list
93075408|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93075409|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075410|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
93075411|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
93075412|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
93075413|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075414|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075415|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
93075416|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075417|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075418|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075419|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
93075420|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93075421|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93075422|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93075423|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93075424|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075425|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075426|NCT05254002|Empagliflozin|empagliflozin|mesh-list
93075427|NCT05254002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93075428|NCT05254002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075429|NCT05254002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93075430|NCT05254002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075431|NCT05252390|Olaparib|olaparib|mesh-list
93075432|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93075433|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075434|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075435|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075436|NCT05243797|Lenalidomide|lenalidomide|mesh-list
93075437|NCT05243797|Immunologic Factors|immunologic factors|mesh-ancestor
93075438|NCT05243797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075439|NCT05243797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93075440|NCT05243797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93075441|NCT05243797|Growth Substances|growth substances|mesh-ancestor
93075442|NCT05243797|Growth Inhibitors|growth inhibitors|mesh-ancestor
93075443|NCT05243797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075444|NCT05243342|Daratumumab|daratumumab|mesh-list
93075445|NCT05243342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075446|NCT05236673|Empagliflozin|empagliflozin|mesh-list
93075447|NCT05236673|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93075448|NCT05236673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075449|NCT05236673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93075450|NCT05236673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075451|NCT05219513|Obinutuzumab|obinutuzumab|mesh-list
93075452|NCT05219513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075453|NCT05219513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075454|NCT05206266|Turmeric extract|turmeric extract|mesh-list
93075455|NCT05206266|Antioxidants|antioxidants|mesh-ancestor
93075456|NCT05206266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075457|NCT05206266|Protective Agents|protective agents|mesh-ancestor
93075458|NCT05206266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075459|NCT05202262|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93075460|NCT05202262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93075461|NCT05202262|Respiratory System Agents|respiratory system agents|mesh-ancestor
93075462|NCT05188898|Hyaluronic Acid|hyaluronic acid|mesh-list
93075463|NCT05188898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93075464|NCT05188898|Immunologic Factors|immunologic factors|mesh-ancestor
93075465|NCT05188898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075466|NCT05188898|Viscosupplements|viscosupplements|mesh-ancestor
93075467|NCT05188898|Protective Agents|protective agents|mesh-ancestor
93075468|NCT05172258|Pembrolizumab|pembrolizumab|mesh-list
93075469|NCT05172258|Ipatasertib|ipatasertib|mesh-list
93075470|NCT05172258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075471|NCT05172258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075472|NCT05172258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075473|NCT05172258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075474|NCT05172258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075475|NCT05172258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075476|NCT05169268|Aripiprazole|aripiprazole|mesh-list
93075477|NCT05169268|Brexpiprazole|brexpiprazole|mesh-list
93075478|NCT05169268|Antidepressive Agents|antidepressive agents|mesh-ancestor
93075479|NCT05169268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075480|NCT05169268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93075481|NCT05169268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075482|NCT05169268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075483|NCT05169268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075484|NCT05169268|Dopamine Agonists|dopamine agonists|mesh-ancestor
93075485|NCT05169268|Dopamine Agents|dopamine agents|mesh-ancestor
93075486|NCT05169268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075487|NCT05169268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075488|NCT05169268|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93075489|NCT05169268|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93075490|NCT05169268|Serotonin Agents|serotonin agents|mesh-ancestor
93075491|NCT05169268|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93075492|NCT05169268|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92665777|NCT00274820|Thalidomide|thalidomide|mesh-list
93075493|NCT05169268|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93075494|NCT05169268|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93075495|NCT05166746|Clindamycin|clindamycin|mesh-list
93075496|NCT05166746|Clindamycin palmitate|clindamycin palmitate|mesh-list
93075497|NCT05166746|Clindamycin phosphate|clindamycin phosphate|mesh-list
93075498|NCT05166746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93075499|NCT05166746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075500|NCT05166746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93075501|NCT05166746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075502|NCT05166746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075503|NCT05160298|Ropivacaine|ropivacaine|mesh-list
93075504|NCT05160298|Anesthetics, Local|anesthetics, local|mesh-ancestor
93075505|NCT05160298|Anesthetics|anesthetics|mesh-ancestor
93075506|NCT05160298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075507|NCT05160298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075508|NCT05160298|Sensory System Agents|sensory system agents|mesh-ancestor
93075509|NCT05160298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075510|NCT05155709|Azacitidine|azacitidine|mesh-list
93075511|NCT05155709|Venetoclax|venetoclax|mesh-list
93075512|NCT05155709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93075513|NCT05155709|Antimetabolites|antimetabolites|mesh-ancestor
93075514|NCT05155709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075515|NCT05155709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075516|NCT05155709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075517|NCT05155579|Vaccines|vaccines|mesh-list
93075518|NCT05155579|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93075519|NCT05155579|Immunologic Factors|immunologic factors|mesh-ancestor
93075520|NCT05155579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075521|NCT05155254|Pembrolizumab|pembrolizumab|mesh-list
93075522|NCT05155254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075523|NCT05155254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075524|NCT05155254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075525|NCT05155254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075526|NCT05145400|Dexamethasone|dexamethasone|mesh-list
93075527|NCT05145400|Lenalidomide|lenalidomide|mesh-list
93075528|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075529|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
93075530|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
93075531|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075532|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075533|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075534|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
93075535|NCT05145400|Hormones|hormones|mesh-ancestor
93075536|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075537|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075538|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075539|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
93075540|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93075541|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93075542|NCT05145400|Growth Substances|growth substances|mesh-ancestor
93075543|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
93075544|NCT05143281|Dexamethasone|dexamethasone|mesh-list
93075545|NCT05143281|Dexamethasone acetate|dexamethasone acetate|mesh-list
93075546|NCT05143281|BB 1101|bb 1101|mesh-list
93075547|NCT05143281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075548|NCT05143281|Antiemetics|antiemetics|mesh-ancestor
93075549|NCT05143281|Autonomic Agents|autonomic agents|mesh-ancestor
93075550|NCT05143281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075551|NCT05143281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075552|NCT05143281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075553|NCT05143281|Glucocorticoids|glucocorticoids|mesh-ancestor
93075554|NCT05143281|Hormones|hormones|mesh-ancestor
93075555|NCT05143281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075556|NCT05143281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075557|NCT05143281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075558|NCT05143281|Protease Inhibitors|protease inhibitors|mesh-ancestor
93075559|NCT05143281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075560|NCT05143281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075561|NCT05133297|Tofacitinib|tofacitinib|mesh-list
93075562|NCT05133297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93075563|NCT05133297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075564|NCT05133297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075565|NCT05133297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075566|NCT05130060|Trifluridine|trifluridine|mesh-list
93075567|NCT05130060|Vaccines|vaccines|mesh-list
93075568|NCT05130060|Immunologic Factors|immunologic factors|mesh-ancestor
93075569|NCT05130060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075570|NCT05130060|Antimetabolites|antimetabolites|mesh-ancestor
93075571|NCT05130060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075572|NCT05130060|Antiviral Agents|antiviral agents|mesh-ancestor
93075573|NCT05130060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075574|NCT05117710|Ebselen|ebselen|mesh-list
93075575|NCT05117710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93075576|NCT05117710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93075577|NCT05117710|Analgesics|analgesics|mesh-ancestor
93075578|NCT05117710|Sensory System Agents|sensory system agents|mesh-ancestor
93075579|NCT05117710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075580|NCT05117710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075581|NCT05117710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075582|NCT05117710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075583|NCT05117710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93075584|NCT05117710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075585|NCT05117710|Antioxidants|antioxidants|mesh-ancestor
93075586|NCT05117710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075588|NCT05117710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93075589|NCT05117710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075590|NCT05117710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93075591|NCT05117242|Pembrolizumab|pembrolizumab|mesh-list
93075592|NCT05117242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075593|NCT05117242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075594|NCT05117242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075595|NCT05117242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075596|NCT05115110|Risdiplam|risdiplam|mesh-list
93075597|NCT05115110|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93075598|NCT05115110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075599|NCT05115110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075600|NCT05114746|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93075601|NCT05114746|177Lu-PSMA-617|177lu-psma-617|mesh-list
93075602|NCT05114746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93075603|NCT05114746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075604|NCT05106192|Triamcinolone|triamcinolone|mesh-list
93075605|NCT05106192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93075606|NCT05106192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93075607|NCT05106192|Mechlorethamine|mechlorethamine|mesh-list
93075608|NCT05106192|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93075609|NCT05106192|Bexarotene|bexarotene|mesh-list
93075610|NCT05106192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93075611|NCT05106192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075612|NCT05106192|Glucocorticoids|glucocorticoids|mesh-ancestor
93075613|NCT05106192|Hormones|hormones|mesh-ancestor
93075614|NCT05106192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075615|NCT05106192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075616|NCT05106192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075617|NCT05106192|Immunologic Factors|immunologic factors|mesh-ancestor
93075618|NCT05106192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075619|NCT05106192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075620|NCT05106192|Alkylating Agents|alkylating agents|mesh-ancestor
93075621|NCT05106192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075622|NCT05106192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075623|NCT05105022|Propofol|propofol|mesh-list
93075624|NCT05105022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93075625|NCT05105022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075626|NCT05105022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075627|NCT05105022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93075628|NCT05105022|Anesthetics, General|anesthetics, general|mesh-ancestor
93075629|NCT05105022|Anesthetics|anesthetics|mesh-ancestor
93075630|NCT05103605|Osimertinib|osimertinib|mesh-list
93075631|NCT05103605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075632|NCT05103605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075633|NCT05103605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075634|NCT05103605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075635|NCT05099718|Hyaluronic Acid|hyaluronic acid|mesh-list
93075636|NCT05099718|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93075637|NCT05099718|Immunologic Factors|immunologic factors|mesh-ancestor
93075638|NCT05099718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075639|NCT05099718|Viscosupplements|viscosupplements|mesh-ancestor
93075640|NCT05099718|Protective Agents|protective agents|mesh-ancestor
93075641|NCT05096468|Pregabalin|pregabalin|mesh-list
93075642|NCT05096468|Ketamine|ketamine|mesh-list
93075643|NCT05096468|Esketamine|esketamine|mesh-list
93075644|NCT05096468|Analgesics|analgesics|mesh-ancestor
93075645|NCT05096468|Sensory System Agents|sensory system agents|mesh-ancestor
93075646|NCT05096468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075647|NCT05096468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075648|NCT05096468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93075649|NCT05096468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93075650|NCT05096468|Anesthetics, General|anesthetics, general|mesh-ancestor
93075651|NCT05096468|Anesthetics|anesthetics|mesh-ancestor
93075652|NCT05096468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075653|NCT05096468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93075654|NCT05096468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93075655|NCT05096468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075656|NCT05096468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075657|NCT05096468|Anticonvulsants|anticonvulsants|mesh-ancestor
93075658|NCT05096468|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93075659|NCT05096468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075660|NCT05096468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93075661|NCT05096468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93075662|NCT05096468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93075663|NCT05096468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075664|NCT05096468|Antidepressive Agents|antidepressive agents|mesh-ancestor
93075665|NCT05085028|Pembrolizumab|pembrolizumab|mesh-list
93075666|NCT05085028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075667|NCT05085028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075668|NCT05085028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075669|NCT05085028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075670|NCT05084365|Sulforaphane|sulforaphane|mesh-list
93075671|NCT05084365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93075672|NCT05084365|Protective Agents|protective agents|mesh-ancestor
93075673|NCT05084365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075674|NCT05084365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075675|NCT05081180|Lenvatinib|lenvatinib|mesh-list
93075676|NCT05081180|Avelumab|avelumab|mesh-list
93075677|NCT05081180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075678|NCT05081180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075679|NCT05081180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075680|NCT05081180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075681|NCT05081180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075682|NCT05079789|Amiloride|amiloride|mesh-list
93075683|NCT05079789|Furosemide|furosemide|mesh-list
93075684|NCT05079789|Diuretics|diuretics|mesh-ancestor
93075685|NCT05079789|Natriuretic Agents|natriuretic agents|mesh-ancestor
93075686|NCT05079789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075687|NCT05079789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93075688|NCT05079789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075689|NCT05079789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075690|NCT05079789|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93075691|NCT05079789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93075692|NCT05079789|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93075693|NCT05079789|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93075694|NCT05074810|Sotorasib|sotorasib|mesh-list
93075695|NCT05074810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075696|NCT05074810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075697|NCT05074810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075698|NCT05074810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075699|NCT05062083|11C-PS13|11c-ps13|mesh-list
93075700|NCT05062083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93075701|NCT05062083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075702|NCT05056727|Valsartan|valsartan|mesh-list
93075703|NCT05056727|Lisinopril|lisinopril|mesh-list
93075704|NCT05056727|Irbesartan|irbesartan|mesh-list
93075705|NCT05056727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93075706|NCT05056727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93075707|NCT05056727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93075708|NCT05056727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075709|NCT05056727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93075710|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
93075711|NCT05056727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075712|NCT05056727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93075713|NCT05056727|Protective Agents|protective agents|mesh-ancestor
93075714|NCT05056727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075715|NCT05053503|Lofexidine|lofexidine|mesh-list
93075716|NCT05053503|Naltrexone|naltrexone|mesh-list
93075717|NCT05053503|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93075718|NCT05053503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93075719|NCT05053503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075720|NCT05053503|Sensory System Agents|sensory system agents|mesh-ancestor
93075721|NCT05053503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075722|NCT05053503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93075723|NCT05053503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93075724|NCT05053503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93075725|NCT05053503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93075726|NCT05053503|Adrenergic Agents|adrenergic agents|mesh-ancestor
93075727|NCT05053503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075728|NCT05053503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075729|NCT05050136|Volixibat|volixibat|mesh-list
93075730|NCT05050136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93075731|NCT05035407|Aldesleukin|aldesleukin|mesh-list
93075732|NCT05035407|Cyclophosphamide|cyclophosphamide|mesh-list
93075733|NCT05035407|Fludarabine|fludarabine|mesh-list
93075734|NCT05035407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075735|NCT05035407|Immunologic Factors|immunologic factors|mesh-ancestor
93075736|NCT05035407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075737|NCT05035407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075738|NCT05035407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075739|NCT05035407|Alkylating Agents|alkylating agents|mesh-ancestor
93075740|NCT05035407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075741|NCT05035407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075742|NCT05035407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93075743|NCT05035407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93075744|NCT05035407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93075745|NCT05035407|Antiviral Agents|antiviral agents|mesh-ancestor
93075746|NCT05035407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075747|NCT05028569|Botulinum Toxins|botulinum toxins|mesh-list
93075748|NCT05028569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93075749|NCT05028569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93075750|NCT05028569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93075751|NCT05028569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075752|NCT05028569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075753|NCT05028569|Cholinergic Agents|cholinergic agents|mesh-ancestor
93075754|NCT05028569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075755|NCT05028569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075756|NCT05028569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93075757|NCT05028569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075758|NCT05025423|Venetoclax|venetoclax|mesh-list
93075759|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93075760|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075761|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075762|NCT05025423|Alkylating Agents|alkylating agents|mesh-ancestor
93075763|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075764|NCT05023993|Niacinamide|niacinamide|mesh-list
93075766|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
93075767|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
93075768|NCT05023993|Vitamins|vitamins|mesh-ancestor
93075769|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
93075770|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075771|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93075772|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
93075773|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075774|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93075775|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
93075776|NCT05021926|Lidocaine|lidocaine|mesh-list
93075777|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
93075778|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
93075779|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
93075780|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075781|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075782|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
93075783|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075784|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93075785|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93075786|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93075787|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075788|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075789|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93075790|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
93075791|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
93075792|NCT05021926|Protective Agents|protective agents|mesh-ancestor
93075793|NCT05021913|Lidocaine|lidocaine|mesh-list
93075794|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
93075795|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
93075796|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
93075797|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075798|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075799|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
93075800|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075801|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93075802|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93075803|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93075804|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075805|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075806|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93052932|NCT00205712|Ketamine|ketamine|mesh-list
93075807|NCT05021913|Immunologic Factors|immunologic factors|mesh-ancestor
93075808|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
93075809|NCT05021913|Protective Agents|protective agents|mesh-ancestor
93075810|NCT04999241|Infliximab|infliximab|mesh-list
93075811|NCT04999241|Mesalamine|mesalamine|mesh-list
93075812|NCT04999241|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93075813|NCT04999241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075814|NCT04999241|Dermatologic Agents|dermatologic agents|mesh-ancestor
93075815|NCT04999241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075816|NCT04999241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075817|NCT04999241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93075818|NCT04999241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93075819|NCT04999241|Analgesics|analgesics|mesh-ancestor
93075820|NCT04999241|Sensory System Agents|sensory system agents|mesh-ancestor
93075821|NCT04999241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075822|NCT04999241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075823|NCT04997993|Leflunomide|leflunomide|mesh-list
93075824|NCT04997993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075825|NCT04997993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075826|NCT04997993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075827|NCT04997993|Immunologic Factors|immunologic factors|mesh-ancestor
93075828|NCT04997993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075829|NCT04994808|Fludarabine|fludarabine|mesh-list
93075830|NCT04994808|Clofarabine|clofarabine|mesh-list
93075831|NCT04994808|Treosulfan|treosulfan|mesh-list
93075832|NCT04994808|Busulfan|busulfan|mesh-list
93075833|NCT04994808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075834|NCT04994808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93075835|NCT04994808|Antimetabolites|antimetabolites|mesh-ancestor
93075836|NCT04994808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075837|NCT04994808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93075838|NCT04994808|Immunologic Factors|immunologic factors|mesh-ancestor
93075839|NCT04994808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075840|NCT04994808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93075841|NCT04994808|Alkylating Agents|alkylating agents|mesh-ancestor
93075842|NCT04994808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93075843|NCT04992065|Evolocumab|evolocumab|mesh-list
93075844|NCT04992065|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93075845|NCT04992065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93075846|NCT04992065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93075847|NCT04992065|Antimetabolites|antimetabolites|mesh-ancestor
93075848|NCT04992065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075849|NCT04992065|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93075850|NCT04992065|Protease Inhibitors|protease inhibitors|mesh-ancestor
93075851|NCT04992065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075852|NCT04992065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93075853|NCT04965090|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
93075854|NCT04965090|Lazertinib|lazertinib|mesh-list
93075855|NCT04965090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93075856|NCT04965090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075857|NCT04965090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075858|NCT04965090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075859|NCT04965090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075860|NCT04941287|Atezolizumab|atezolizumab|mesh-list
93075861|NCT04941287|Immunoglobulins|immunoglobulins|mesh-list
93075862|NCT04941287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93075863|NCT04941287|Immunoglobulin G|immunoglobulin g|mesh-list
93075864|NCT04941287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075865|NCT04941287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075866|NCT04941287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075867|NCT04941287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075868|NCT04941287|Immunologic Factors|immunologic factors|mesh-ancestor
93075869|NCT04941287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075870|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
93075871|NCT04939701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075872|NCT04939701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075873|NCT04939701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075874|NCT04939701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075875|NCT04925752|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93075876|NCT04925752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93075877|NCT04925752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93075878|NCT04925752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075879|NCT04925752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075880|NCT04925752|Antiviral Agents|antiviral agents|mesh-ancestor
93075881|NCT04925752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075882|NCT04925752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93075883|NCT04925752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93075884|NCT04916548|Ketamine|ketamine|mesh-list
93075885|NCT04916548|Analgesics|analgesics|mesh-ancestor
93075886|NCT04916548|Sensory System Agents|sensory system agents|mesh-ancestor
93075887|NCT04916548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075888|NCT04916548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075889|NCT04916548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93075890|NCT04916548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93075891|NCT04916548|Anesthetics, General|anesthetics, general|mesh-ancestor
93075892|NCT04916548|Anesthetics|anesthetics|mesh-ancestor
93075893|NCT04916548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075894|NCT04916548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93075895|NCT04916548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93075896|NCT04916548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075897|NCT04916548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075898|NCT04906902|Acalabrutinib|acalabrutinib|mesh-list
93075899|NCT04906902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075900|NCT04906096|GDC-0084|gdc-0084|mesh-list
93075901|NCT04906096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075902|NCT04906096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075903|NCT04901494|Serotonin|serotonin|mesh-list
93075904|NCT04901494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93075905|NCT04901494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93075906|NCT04901494|Serotonin Agents|serotonin agents|mesh-ancestor
93075907|NCT04901494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93075908|NCT04901494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075909|NCT04901494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666206|NCT00316212|INS 50589|ins 50589|mesh-list
93075910|NCT04901494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93075911|NCT04901494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075912|NCT04898114|Magnesium Sulfate|magnesium sulfate|mesh-list
93075913|NCT04898114|Sildenafil Citrate|sildenafil citrate|mesh-list
93075914|NCT04898114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075915|NCT04898114|Vasodilator Agents|vasodilator agents|mesh-ancestor
93075916|NCT04898114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93075917|NCT04898114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93075918|NCT04898114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075919|NCT04898114|Urological Agents|urological agents|mesh-ancestor
93075920|NCT04898114|Analgesics|analgesics|mesh-ancestor
93075921|NCT04898114|Sensory System Agents|sensory system agents|mesh-ancestor
93075922|NCT04898114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075923|NCT04898114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075924|NCT04898114|Anesthetics|anesthetics|mesh-ancestor
93075925|NCT04898114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93075926|NCT04898114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93075927|NCT04898114|Anticonvulsants|anticonvulsants|mesh-ancestor
93075928|NCT04898114|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93075929|NCT04898114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93075930|NCT04898114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93075931|NCT04898114|Tocolytic Agents|tocolytic agents|mesh-ancestor
93075932|NCT04898114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93075933|NCT04897217|Megestrol|megestrol|mesh-list
93075934|NCT04897217|Megestrol Acetate|megestrol acetate|mesh-list
93075935|NCT04897217|Levonorgestrel|levonorgestrel|mesh-list
93075936|NCT04897217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93075937|NCT04897217|Contraceptive Agents|contraceptive agents|mesh-ancestor
93075938|NCT04897217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93075939|NCT04897217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075940|NCT04897217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93075941|NCT04897217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93075942|NCT04897217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93075943|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93075944|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075945|NCT04897217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075946|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
93075947|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93075948|NCT04897022|Pembrolizumab|pembrolizumab|mesh-list
93075949|NCT04897022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93075950|NCT04897022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075951|NCT04897022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93075952|NCT04897022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053085|NCT00039130|Vitamins|vitamins|mesh-ancestor
93075953|NCT04873583|Methylprednisolone|methylprednisolone|mesh-list
93075954|NCT04873583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93075955|NCT04873583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93075956|NCT04873583|Prednisolone|prednisolone|mesh-list
93075957|NCT04873583|Prednisolone acetate|prednisolone acetate|mesh-list
93075958|NCT04873583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93075959|NCT04873583|Prednisolone phosphate|prednisolone phosphate|mesh-list
93075960|NCT04873583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075961|NCT04873583|Antiemetics|antiemetics|mesh-ancestor
93075962|NCT04873583|Autonomic Agents|autonomic agents|mesh-ancestor
93075963|NCT04873583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93075964|NCT04873583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075965|NCT04873583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93075966|NCT04873583|Glucocorticoids|glucocorticoids|mesh-ancestor
93075967|NCT04873583|Hormones|hormones|mesh-ancestor
93075968|NCT04873583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075969|NCT04873583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93075970|NCT04873583|Protective Agents|protective agents|mesh-ancestor
93075971|NCT04873583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93075972|NCT04873583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93075973|NCT04870203|Adalimumab|adalimumab|mesh-list
93075974|NCT04870203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93075975|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93075976|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93075977|NCT04867707|Zanamivir|zanamivir|mesh-list
93075978|NCT04867707|Antiviral Agents|antiviral agents|mesh-ancestor
93075979|NCT04867707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075980|NCT04867707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666277|NCT00279539|Growth Substances|growth substances|mesh-ancestor
93075981|NCT04867707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075982|NCT04865419|Voriconazole|voriconazole|mesh-list
93075983|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
93075984|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93075985|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93075986|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93075987|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93075988|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93075989|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93075990|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
93075991|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93075992|NCT04865419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93075993|NCT04865419|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93075994|NCT04860661|Esketamine|esketamine|mesh-list
93075995|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
93075996|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93075997|NCT04853199|Quercetin|quercetin|mesh-list
93075998|NCT04853199|Antioxidants|antioxidants|mesh-ancestor
93075999|NCT04853199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076000|NCT04853199|Protective Agents|protective agents|mesh-ancestor
93076001|NCT04853199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076002|NCT04852887|Tamoxifen|tamoxifen|mesh-list
93076003|NCT04852887|Letrozole|letrozole|mesh-list
93076004|NCT04852887|Exemestane|exemestane|mesh-list
93076005|NCT04852887|Anastrozole|anastrozole|mesh-list
93076006|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076007|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93076008|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93076009|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076010|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076011|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93076012|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
93076013|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076014|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076015|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076016|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93076017|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93076018|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93076019|NCT04835805|Nivolumab|nivolumab|mesh-list
93076020|NCT04835805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076021|NCT04835805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076022|NCT04835805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076023|NCT04835805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076024|NCT04813926|Riociguat|riociguat|mesh-list
93076025|NCT04813926|Enzyme Activators|enzyme activators|mesh-ancestor
93076026|NCT04813926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076027|NCT04804722|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93076028|NCT04804722|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93076029|NCT04804722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076030|NCT04801485|Inositol|inositol|mesh-list
93076031|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
93076032|NCT04801485|Vitamins|vitamins|mesh-ancestor
93076033|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
93076034|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076035|NCT04777201|Faricimab|faricimab|mesh-list
93076036|NCT04777201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076037|NCT04777201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076038|NCT04777201|Growth Substances|growth substances|mesh-ancestor
93076039|NCT04777201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076040|NCT04777201|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076041|NCT04777201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076042|NCT04753970|Cilostazol|cilostazol|mesh-list
93076043|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93076044|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
93076045|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076046|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076047|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93076048|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
93076049|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93076050|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93076051|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076052|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93076053|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
93076054|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93076055|NCT04753970|Protective Agents|protective agents|mesh-ancestor
93076056|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93076057|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93076058|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076059|NCT04744831|Camptothecin|camptothecin|mesh-list
93076060|NCT04744831|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93076061|NCT04744831|Immunoconjugates|immunoconjugates|mesh-list
93076062|NCT04744831|Immunologic Factors|immunologic factors|mesh-ancestor
93076063|NCT04744831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076064|NCT04744831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076065|NCT04744831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076066|NCT04744831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93076067|NCT04744831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076068|NCT04744831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076069|NCT04744831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076070|NCT04741204|Metformin|metformin|mesh-list
93076071|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93076072|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076073|NCT04727723|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93076074|NCT04727723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93076075|NCT04727723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076076|NCT04725188|Docetaxel|docetaxel|mesh-list
93076077|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
93076078|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076079|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076080|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076081|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076082|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076083|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076084|NCT04725188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076085|NCT04723394|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93076086|NCT04723394|Antiviral Agents|antiviral agents|mesh-ancestor
93076087|NCT04723394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076088|NCT04722523|Carboplatin|carboplatin|mesh-list
93076089|NCT04722523|Docetaxel|docetaxel|mesh-list
93076090|NCT04722523|Cetuximab|cetuximab|mesh-list
93076091|NCT04722523|Cemiplimab|cemiplimab|mesh-list
93076092|NCT04722523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076093|NCT04722523|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666424|NCT00310206|Vaccines|vaccines|mesh-list
93076094|NCT04722523|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076095|NCT04722523|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076096|NCT04722523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076097|NCT04722523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076098|NCT04718792|Psilocybin|psilocybin|mesh-list
93076099|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
93076100|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076101|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93053222|NCT01323257|Ritonavir|ritonavir|mesh-list
93076103|NCT04707196|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93076104|NCT04707196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076105|NCT04707196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076106|NCT04707196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93076107|NCT04707196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93076108|NCT04707196|Hormone Antagonists|hormone antagonists|mesh-ancestor
93076109|NCT04707196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076110|NCT04707196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076111|NCT04707196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93076112|NCT04707196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076113|NCT04707196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076114|NCT04700527|Butyric Acid|butyric acid|mesh-list
93076115|NCT04700527|Histamine Antagonists|histamine antagonists|mesh-ancestor
93076116|NCT04700527|Histamine Agents|histamine agents|mesh-ancestor
93076117|NCT04700527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93076118|NCT04700527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076119|NCT04700527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076120|NCT04696055|Pembrolizumab|pembrolizumab|mesh-list
93076121|NCT04696055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076122|NCT04696055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076123|NCT04696055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076124|NCT04696055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076125|NCT04681144|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93076126|NCT04681144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076127|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93076128|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93076129|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076130|NCT04663750|Aflibercept|aflibercept|mesh-list
93076131|NCT04663750|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93076132|NCT04663750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076133|NCT04663750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076134|NCT04663750|Growth Substances|growth substances|mesh-ancestor
93076135|NCT04663750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076136|NCT04663750|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076137|NCT04663750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076138|NCT04663750|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93076139|NCT04663750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93076140|NCT04663750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076141|NCT04656652|Docetaxel|docetaxel|mesh-list
93076142|NCT04656652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076143|NCT04656652|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076144|NCT04656652|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076145|NCT04656652|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076146|NCT04656652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076147|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
93076148|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93076149|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93076150|NCT04656145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076151|NCT04656145|Disinfectants|disinfectants|mesh-ancestor
93076152|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
93076153|NCT04641975|Mirabegron|mirabegron|mesh-list
93076154|NCT04641975|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93076155|NCT04641975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93076156|NCT04641975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93076157|NCT04641975|Adrenergic Agents|adrenergic agents|mesh-ancestor
93076158|NCT04641975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93076159|NCT04641975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076160|NCT04641975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076161|NCT04641975|Urological Agents|urological agents|mesh-ancestor
93076162|NCT04622319|Trastuzumab|trastuzumab|mesh-list
93076163|NCT04622319|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93076164|NCT04622319|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92666471|NCT00280358|Xhance|xhance|mesh-list
93076165|NCT04622319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076166|NCT04622319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076167|NCT04622319|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076168|NCT04622319|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076169|NCT04622319|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076170|NCT04622319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076171|NCT04622319|Immunotoxins|immunotoxins|mesh-ancestor
93076172|NCT04622319|Immunoconjugates|immunoconjugates|mesh-ancestor
93076173|NCT04622319|Immunologic Factors|immunologic factors|mesh-ancestor
93053333|NCT01028261|CKD732|ckd732|mesh-list
93076174|NCT04622319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076175|NCT04613206|Vaccines|vaccines|mesh-list
93076176|NCT04613206|Immunologic Factors|immunologic factors|mesh-ancestor
93076177|NCT04613206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076178|NCT04590508|Xanthohumol|xanthohumol|mesh-list
93076179|NCT04590508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076180|NCT04590508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076181|NCT04590508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076182|NCT04590508|Growth Substances|growth substances|mesh-ancestor
93076183|NCT04590508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076184|NCT04590508|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076185|NCT04585958|Trastuzumab|trastuzumab|mesh-list
93076186|NCT04585958|Olaparib|olaparib|mesh-list
93076187|NCT04585958|Camptothecin|camptothecin|mesh-list
93076188|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93076189|NCT04585958|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93076190|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
93076191|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076192|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076193|NCT04585958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076194|NCT04585958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076195|NCT04585958|Immunologic Factors|immunologic factors|mesh-ancestor
93076196|NCT04585958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076197|NCT04585958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076198|NCT04585958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93076199|NCT04585958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076200|NCT04572295|Fulvestrant|fulvestrant|mesh-list
93076201|NCT04572295|Exemestane|exemestane|mesh-list
93076202|NCT04572295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076203|NCT04572295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076204|NCT04572295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93076205|NCT04572295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93076206|NCT04572295|Hormone Antagonists|hormone antagonists|mesh-ancestor
93076207|NCT04572295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076208|NCT04572295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076209|NCT04572295|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93076210|NCT04572295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93076211|NCT04572295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076212|NCT04572295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076213|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
93076214|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93076215|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
93076216|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076217|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
93076218|NCT04557527|Protective Agents|protective agents|mesh-ancestor
93076219|NCT04543383|Thrombin|thrombin|mesh-list
93076220|NCT04543383|Hemostatics|hemostatics|mesh-ancestor
93076221|NCT04543383|Coagulants|coagulants|mesh-ancestor
93076222|NCT04539366|Cyclophosphamide|cyclophosphamide|mesh-list
93076223|NCT04539366|Fludarabine|fludarabine|mesh-list
93076224|NCT04539366|Fludarabine phosphate|fludarabine phosphate|mesh-list
93076225|NCT04539366|Immunologic Factors|immunologic factors|mesh-ancestor
92666542|NCT00419172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076226|NCT04539366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076227|NCT04539366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076228|NCT04539366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076229|NCT04539366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93076230|NCT04539366|Alkylating Agents|alkylating agents|mesh-ancestor
93076231|NCT04539366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076232|NCT04539366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076233|NCT04539366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93076234|NCT04539366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076235|NCT04539366|Antimetabolites|antimetabolites|mesh-ancestor
93076236|NCT04533880|Calcium|calcium|mesh-list
93076237|NCT04533880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93076238|NCT04533880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076239|NCT04532606|Anesthetics|anesthetics|mesh-list
93076240|NCT04532606|Propofol|propofol|mesh-list
93076241|NCT04532606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93076242|NCT04532606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076243|NCT04532606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93076244|NCT04532606|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93076245|NCT04532606|Anesthetics, General|anesthetics, general|mesh-ancestor
93076246|NCT04513145|Ropivacaine|ropivacaine|mesh-list
93076247|NCT04513145|Anesthetics, Local|anesthetics, local|mesh-ancestor
93076248|NCT04513145|Anesthetics|anesthetics|mesh-ancestor
93076249|NCT04513145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93076250|NCT04513145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076251|NCT04513145|Sensory System Agents|sensory system agents|mesh-ancestor
93076252|NCT04513145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076253|NCT04497961|Lenalidomide|lenalidomide|mesh-list
93076254|NCT04497961|Daratumumab|daratumumab|mesh-list
93076255|NCT04497961|Immunologic Factors|immunologic factors|mesh-ancestor
93076256|NCT04497961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076257|NCT04497961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076258|NCT04497961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076259|NCT04497961|Growth Substances|growth substances|mesh-ancestor
93076260|NCT04497961|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076261|NCT04497961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076262|NCT04478266|Letrozole|letrozole|mesh-list
93076263|NCT04478266|Palbociclib|palbociclib|mesh-list
93076264|NCT04478266|Goserelin|goserelin|mesh-list
93076265|NCT04478266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076266|NCT04478266|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93076267|NCT04478266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93076268|NCT04478266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076269|NCT04478266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076270|NCT04478266|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93076271|NCT04478266|Hormone Antagonists|hormone antagonists|mesh-ancestor
93076272|NCT04478266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076273|NCT04478266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076274|NCT04478266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076275|NCT04478266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076276|NCT04466475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93076277|NCT04466475|Melphalan|melphalan|mesh-list
93076278|NCT04466475|Mechlorethamine|mechlorethamine|mesh-list
93076279|NCT04466475|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93076280|NCT04466475|Daratumumab|daratumumab|mesh-list
93076281|NCT04466475|Antibodies|antibodies|mesh-list
93076282|NCT04466475|Immunoglobulins|immunoglobulins|mesh-list
93076283|NCT04466475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93076284|NCT04466475|Immunologic Factors|immunologic factors|mesh-ancestor
93076285|NCT04466475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076286|NCT04466475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076287|NCT04466475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93076288|NCT04466475|Alkylating Agents|alkylating agents|mesh-ancestor
93076289|NCT04466475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076290|NCT04466475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93076291|NCT04466475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076292|NCT04460885|Insulin|insulin|mesh-list
93076293|NCT04460885|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93076294|NCT04460885|Insulin Glargine|insulin glargine|mesh-list
93076295|NCT04460885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93076296|NCT04460885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076297|NCT04459715|Cisplatin|cisplatin|mesh-list
93076298|NCT04459715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076299|NCT04421963|Olaparib|olaparib|mesh-list
93076300|NCT04421963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93076301|NCT04421963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076302|NCT04421963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076303|NCT04421963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076304|NCT04418154|Paclitaxel|paclitaxel|mesh-list
93076305|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
93076306|NCT04418154|Epirubicin|epirubicin|mesh-list
93076307|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93076308|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076309|NCT04418154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076310|NCT04418154|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076311|NCT04418154|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076312|NCT04418154|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076313|NCT04418154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076314|NCT04418154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076315|NCT04418154|Immunologic Factors|immunologic factors|mesh-ancestor
93076316|NCT04418154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076317|NCT04418154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076318|NCT04418154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93076319|NCT04418154|Alkylating Agents|alkylating agents|mesh-ancestor
93076320|NCT04418154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93076321|NCT04418154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93076322|NCT04418154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053446|NCT00441545|Sequestering Agents|sequestering agents|mesh-ancestor
93076323|NCT04418154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076324|NCT04418154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076325|NCT04417192|Pembrolizumab|pembrolizumab|mesh-list
93076326|NCT04417192|Olaparib|olaparib|mesh-list
93076327|NCT04417192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076328|NCT04417192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076329|NCT04417192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076330|NCT04417192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076331|NCT04417192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93076332|NCT04417192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076333|NCT04409002|Niraparib|niraparib|mesh-list
93076334|NCT04409002|Dostarlimab|dostarlimab|mesh-list
93076335|NCT04409002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93076336|NCT04409002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076337|NCT04409002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076338|NCT04409002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076339|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
93076340|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076341|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076342|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076343|NCT04343885|Docetaxel|docetaxel|mesh-list
93076344|NCT04343885|177Lu-PSMA-617|177lu-psma-617|mesh-list
93076345|NCT04343885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076346|NCT04343885|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076347|NCT04343885|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076348|NCT04343885|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076349|NCT04343885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076350|NCT04343885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93076351|NCT04338061|Teriflunomide|teriflunomide|mesh-list
93076352|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93076353|NCT04338061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93076354|NCT04338061|Analgesics|analgesics|mesh-ancestor
93076355|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
93076356|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076357|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076358|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076359|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076360|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076361|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
93076362|NCT04338022|Teriflunomide|teriflunomide|mesh-list
93076363|NCT04338022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93076364|NCT04338022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93076365|NCT04338022|Analgesics|analgesics|mesh-ancestor
93076366|NCT04338022|Sensory System Agents|sensory system agents|mesh-ancestor
93076367|NCT04338022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076368|NCT04338022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076369|NCT04338022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076370|NCT04338022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076371|NCT04338022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076372|NCT04338022|Immunologic Factors|immunologic factors|mesh-ancestor
93076373|NCT04329325|Dexamethasone|dexamethasone|mesh-list
93076374|NCT04329325|Methotrexate|methotrexate|mesh-list
93076375|NCT04329325|Dasatinib|dasatinib|mesh-list
93076376|NCT04329325|Blinatumomab|blinatumomab|mesh-list
93076377|NCT04329325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076378|NCT04329325|Antiemetics|antiemetics|mesh-ancestor
93076379|NCT04329325|Autonomic Agents|autonomic agents|mesh-ancestor
93076380|NCT04329325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076381|NCT04329325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076382|NCT04329325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93076383|NCT04329325|Glucocorticoids|glucocorticoids|mesh-ancestor
93076384|NCT04329325|Hormones|hormones|mesh-ancestor
93076385|NCT04329325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076386|NCT04329325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076387|NCT04329325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076388|NCT04329325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93076389|NCT04329325|Abortifacient Agents|abortifacient agents|mesh-ancestor
93076390|NCT04329325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93076391|NCT04329325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076392|NCT04329325|Antimetabolites|antimetabolites|mesh-ancestor
93076393|NCT04329325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076394|NCT04329325|Dermatologic Agents|dermatologic agents|mesh-ancestor
93076395|NCT04329325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076396|NCT04329325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93076397|NCT04329325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076398|NCT04329325|Immunologic Factors|immunologic factors|mesh-ancestor
93053521|NCT01097902|Analgesics|analgesics|mesh-ancestor
93076399|NCT04329325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076400|NCT04329325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93076401|NCT04329325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076402|NCT04311502|Pyridoxine|pyridoxine|mesh-list
93076403|NCT04311502|Pyridoxal|pyridoxal|mesh-list
93076404|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
93076405|NCT04311502|Rifampin|rifampin|mesh-list
93076406|NCT04311502|Rifapentine|rifapentine|mesh-list
93076407|NCT04311502|Clofazimine|clofazimine|mesh-list
93076408|NCT04311502|Isoniazid|isoniazid|mesh-list
93076409|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
93076410|NCT04311502|Ethambutol|ethambutol|mesh-list
93076411|NCT04311502|Vitamins|vitamins|mesh-ancestor
93076412|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
93076413|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076414|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
93076415|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93076416|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
93076417|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93076418|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076419|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
93076420|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93076421|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076422|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076423|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93076424|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93076425|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93076426|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93076427|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93076428|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93076429|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93076430|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93076431|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
93076432|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93076433|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076434|NCT04310995|Nicorandil|nicorandil|mesh-list
93076435|NCT04310995|Diltiazem|diltiazem|mesh-list
93076436|NCT04310995|Isosorbide|isosorbide|mesh-list
93076437|NCT04310995|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93076438|NCT04310995|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93076439|NCT04310995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93076440|NCT04310995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93076441|NCT04310995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93076442|NCT04310995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076443|NCT04310995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93076444|NCT04310995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076445|NCT04310995|Vasodilator Agents|vasodilator agents|mesh-ancestor
93076446|NCT04310995|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93076447|NCT04310995|Diuretics|diuretics|mesh-ancestor
93076448|NCT04310995|Natriuretic Agents|natriuretic agents|mesh-ancestor
93076449|NCT04310995|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93076450|NCT04310995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93076451|NCT04310995|Vitamin B Complex|vitamin b complex|mesh-ancestor
93076452|NCT04310995|Vitamins|vitamins|mesh-ancestor
93076453|NCT04310995|Micronutrients|micronutrients|mesh-ancestor
93076454|NCT04302324|Clarithromycin|clarithromycin|mesh-list
93076455|NCT04302324|Dexamethasone|dexamethasone|mesh-list
93076456|NCT04302324|Daratumumab|daratumumab|mesh-list
93076457|NCT04302324|Pomalidomide|pomalidomide|mesh-list
93076458|NCT04302324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076459|NCT04302324|Antiemetics|antiemetics|mesh-ancestor
93076460|NCT04302324|Autonomic Agents|autonomic agents|mesh-ancestor
93076461|NCT04302324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076462|NCT04302324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076463|NCT04302324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93076464|NCT04302324|Glucocorticoids|glucocorticoids|mesh-ancestor
93076465|NCT04302324|Hormones|hormones|mesh-ancestor
93076466|NCT04302324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076467|NCT04302324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076468|NCT04302324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076469|NCT04302324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93076470|NCT04302324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076471|NCT04302324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93076472|NCT04302324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076473|NCT04302324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076474|NCT04302324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93076475|NCT04302324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93076476|NCT04302324|Immunologic Factors|immunologic factors|mesh-ancestor
93076477|NCT04302324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076478|NCT04302324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076479|NCT04302324|Growth Substances|growth substances|mesh-ancestor
93076480|NCT04302324|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076481|NCT04292743|Leucovorin|leucovorin|mesh-list
93076482|NCT04292743|Fluorouracil|fluorouracil|mesh-list
93076483|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
93076484|NCT04292743|Irinotecan|irinotecan|mesh-list
93076485|NCT04292743|Folfirinox|folfirinox|mesh-list
93076486|NCT04292743|Eryaspase|eryaspase|mesh-list
93076487|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
93076488|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076489|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076490|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076491|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076492|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
93076493|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076494|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93076495|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076496|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076497|NCT04292743|Antidotes|antidotes|mesh-ancestor
93076498|NCT04292743|Protective Agents|protective agents|mesh-ancestor
93076499|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
93076500|NCT04292743|Vitamins|vitamins|mesh-ancestor
93076501|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
93076502|NCT04270409|Dexamethasone|dexamethasone|mesh-list
93076503|NCT04270409|Lenalidomide|lenalidomide|mesh-list
93076504|NCT04270409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076505|NCT04270409|Antiemetics|antiemetics|mesh-ancestor
93076506|NCT04270409|Autonomic Agents|autonomic agents|mesh-ancestor
93076507|NCT04270409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076508|NCT04270409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076509|NCT04270409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93076510|NCT04270409|Glucocorticoids|glucocorticoids|mesh-ancestor
93076511|NCT04270409|Hormones|hormones|mesh-ancestor
93076512|NCT04270409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076513|NCT04270409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076514|NCT04270409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076515|NCT04270409|Immunologic Factors|immunologic factors|mesh-ancestor
93076516|NCT04270409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076517|NCT04270409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076518|NCT04270409|Growth Substances|growth substances|mesh-ancestor
93076519|NCT04270409|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076520|NCT04270175|Dexamethasone|dexamethasone|mesh-list
93076521|NCT04270175|Daratumumab|daratumumab|mesh-list
93076522|NCT04270175|Pomalidomide|pomalidomide|mesh-list
93076523|NCT04270175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076524|NCT04270175|Antiemetics|antiemetics|mesh-ancestor
93076525|NCT04270175|Autonomic Agents|autonomic agents|mesh-ancestor
93076526|NCT04270175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076527|NCT04270175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076528|NCT04270175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93076529|NCT04270175|Glucocorticoids|glucocorticoids|mesh-ancestor
93076530|NCT04270175|Hormones|hormones|mesh-ancestor
93076531|NCT04270175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076532|NCT04270175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076533|NCT04270175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076534|NCT04270175|Immunologic Factors|immunologic factors|mesh-ancestor
93076535|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076536|NCT04270175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076537|NCT04270175|Growth Substances|growth substances|mesh-ancestor
93076538|NCT04270175|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076539|NCT04267939|Niraparib|niraparib|mesh-list
93076540|NCT04267939|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93076541|NCT04267939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076542|NCT04267939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076543|NCT04267939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076544|NCT04267549|Paclitaxel|paclitaxel|mesh-list
93076545|NCT04267549|Apatinib|apatinib|mesh-list
93076546|NCT04267549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076547|NCT04267549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076548|NCT04267549|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076549|NCT04267549|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076550|NCT04267549|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076551|NCT04267549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076552|NCT04267549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076553|NCT04267549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076554|NCT04262336|Sodium thiosulfate|sodium thiosulfate|mesh-list
93076555|NCT04262336|Hyaluronic Acid|hyaluronic acid|mesh-list
93076556|NCT04262336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93076557|NCT04262336|Immunologic Factors|immunologic factors|mesh-ancestor
93076558|NCT04262336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076559|NCT04262336|Viscosupplements|viscosupplements|mesh-ancestor
93076560|NCT04262336|Protective Agents|protective agents|mesh-ancestor
93076561|NCT04262336|Antidotes|antidotes|mesh-ancestor
93076562|NCT04262336|Antioxidants|antioxidants|mesh-ancestor
93076563|NCT04262336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076564|NCT04262336|Antitubercular Agents|antitubercular agents|mesh-ancestor
93076565|NCT04262336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93076566|NCT04262336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076567|NCT04262336|Chelating Agents|chelating agents|mesh-ancestor
93076568|NCT04262336|Sequestering Agents|sequestering agents|mesh-ancestor
93076569|NCT04262154|Prednisone|prednisone|mesh-list
93076570|NCT04262154|Atezolizumab|atezolizumab|mesh-list
93076571|NCT04262154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076572|NCT04262154|Glucocorticoids|glucocorticoids|mesh-ancestor
93076573|NCT04262154|Hormones|hormones|mesh-ancestor
93076574|NCT04262154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076575|NCT04262154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076576|NCT04262154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076577|NCT04262154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076578|NCT04262154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076579|NCT04262154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076580|NCT04262154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076581|NCT04250155|Atezolizumab|atezolizumab|mesh-list
93076582|NCT04250155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076583|NCT04250155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076584|NCT04250155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076585|NCT04250155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076586|NCT04242238|Avelumab|avelumab|mesh-list
93076587|NCT04242238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076588|NCT04242238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076589|NCT04235959|Tirzepatide|tirzepatide|mesh-list
93076590|NCT04235959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93076591|NCT04235959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076592|NCT04235959|Incretins|incretins|mesh-ancestor
93076593|NCT04235959|Hormones|hormones|mesh-ancestor
92666896|NCT00317967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93076594|NCT04235959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076595|NCT04235101|Trastuzumab|trastuzumab|mesh-list
93076596|NCT04235101|Niraparib|niraparib|mesh-list
93076597|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076598|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076599|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93076600|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076601|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076602|NCT04200534|Nicotine|nicotine|mesh-list
93076603|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93076604|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
93076605|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076606|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076607|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93076608|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93076609|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
93076610|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93076611|NCT04200534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076612|NCT04182360|Carbetocin|carbetocin|mesh-list
93076613|NCT04182360|Oxytocics|oxytocics|mesh-ancestor
93076614|NCT04182360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93076615|NCT04182360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076616|NCT04176705|Triamcinolone|triamcinolone|mesh-list
93076617|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93076618|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93076619|NCT04176705|Lidocaine|lidocaine|mesh-list
93076620|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93076621|NCT04176705|Anesthetics, Local|anesthetics, local|mesh-ancestor
93076622|NCT04176705|Anesthetics|anesthetics|mesh-ancestor
93076623|NCT04176705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93076624|NCT04176705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076625|NCT04176705|Sensory System Agents|sensory system agents|mesh-ancestor
93076626|NCT04176705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076627|NCT04176705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93076628|NCT04176705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93076629|NCT04176705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93076630|NCT04176705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93076631|NCT04176705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076632|NCT04176705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076634|NCT04176705|Hormones|hormones|mesh-ancestor
93076635|NCT04176705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076636|NCT04176705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076637|NCT04176705|Immunologic Factors|immunologic factors|mesh-ancestor
93076638|NCT04176705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076639|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
93076640|NCT04147533|Dasatinib|dasatinib|mesh-list
93076641|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076642|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076643|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076644|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076645|NCT04115384|Insulin|insulin|mesh-list
93076646|NCT04115384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93076647|NCT04115384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93076648|NCT04115384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076649|NCT04112368|Estradiol|estradiol|mesh-list
93076650|NCT04112368|Progesterone|progesterone|mesh-list
93076651|NCT04112368|Estrogens|estrogens|mesh-ancestor
93076652|NCT04112368|Hormones|hormones|mesh-ancestor
93076653|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076654|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076655|NCT04112368|Progestins|progestins|mesh-ancestor
93076656|NCT04088188|Cisplatin|cisplatin|mesh-list
93076657|NCT04088188|Gemcitabine|gemcitabine|mesh-list
93076658|NCT04088188|Ivosidenib|ivosidenib|mesh-list
93076659|NCT04088188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076660|NCT04088188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076661|NCT04088188|Antimetabolites|antimetabolites|mesh-ancestor
93076662|NCT04088188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076663|NCT04088188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076664|NCT04083599|Paclitaxel|paclitaxel|mesh-list
93076665|NCT04083599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93076666|NCT04083599|Carboplatin|carboplatin|mesh-list
93076667|NCT04083599|Gemcitabine|gemcitabine|mesh-list
93076668|NCT04083599|Pembrolizumab|pembrolizumab|mesh-list
93076669|NCT04083599|Pemetrexed|pemetrexed|mesh-list
93076670|NCT04083599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076671|NCT04083599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076672|NCT04083599|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076673|NCT04083599|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076674|NCT04083599|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076675|NCT04083599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076676|NCT04083599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076677|NCT04083599|Antimetabolites|antimetabolites|mesh-ancestor
93076678|NCT04083599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076679|NCT04083599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076680|NCT04083599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076681|NCT04083599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93076682|NCT04083599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93076683|NCT04080804|Nivolumab|nivolumab|mesh-list
93076684|NCT04080804|Ipilimumab|ipilimumab|mesh-list
93076685|NCT04080804|Relatlimab|relatlimab|mesh-list
93076686|NCT04080804|Antibodies|antibodies|mesh-list
93076687|NCT04080804|Immunoglobulins|immunoglobulins|mesh-list
93076688|NCT04080804|Immunologic Factors|immunologic factors|mesh-ancestor
93076689|NCT04080804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076690|NCT04080804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076691|NCT04080804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076692|NCT04080804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076693|NCT04080804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076694|NCT04075747|Venetoclax|venetoclax|mesh-list
93076695|NCT04075747|Midostaurin|midostaurin|mesh-list
93076696|NCT04075747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076697|NCT04075747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076698|NCT04075747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076699|NCT04075747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076700|NCT04069273|Paclitaxel|paclitaxel|mesh-list
93076701|NCT04069273|Pembrolizumab|pembrolizumab|mesh-list
93076702|NCT04069273|Ramucirumab|ramucirumab|mesh-list
93076703|NCT04069273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076704|NCT04069273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076705|NCT04069273|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076706|NCT04069273|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076707|NCT04069273|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076708|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076709|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076710|NCT04069273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076711|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
93076712|NCT04068103|Leucovorin|leucovorin|mesh-list
93076713|NCT04068103|Folic Acid|folic acid|mesh-list
93076714|NCT04068103|Fluorouracil|fluorouracil|mesh-list
93076715|NCT04068103|Capecitabine|capecitabine|mesh-list
93076716|NCT04068103|Oxaliplatin|oxaliplatin|mesh-list
93076717|NCT04068103|Calcium|calcium|mesh-list
93076718|NCT04068103|Levoleucovorin|levoleucovorin|mesh-list
93076719|NCT04068103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93076720|NCT04068103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076721|NCT04068103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93076722|NCT04068103|Antimetabolites|antimetabolites|mesh-ancestor
93076723|NCT04068103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076724|NCT04068103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076725|NCT04068103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076726|NCT04068103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076727|NCT04068103|Immunologic Factors|immunologic factors|mesh-ancestor
93076728|NCT04068103|Antidotes|antidotes|mesh-ancestor
93076729|NCT04068103|Protective Agents|protective agents|mesh-ancestor
93076730|NCT04068103|Vitamin B Complex|vitamin b complex|mesh-ancestor
93076731|NCT04068103|Vitamins|vitamins|mesh-ancestor
93076732|NCT04068103|Micronutrients|micronutrients|mesh-ancestor
93076733|NCT04068103|Hematinics|hematinics|mesh-ancestor
93076734|NCT04067115|Alovudine|alovudine|mesh-list
93076735|NCT04067115|Irinotecan|irinotecan|mesh-list
93076736|NCT04067115|Trabectedin|trabectedin|mesh-list
93076737|NCT04067115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93076738|NCT04067115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076739|NCT04067115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076740|NCT04067115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076741|NCT04067115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076742|NCT04067115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93076743|NCT04067115|Alkylating Agents|alkylating agents|mesh-ancestor
93076744|NCT04067115|Antiviral Agents|antiviral agents|mesh-ancestor
93076745|NCT04067115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076746|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
93076747|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
93076748|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93076749|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076750|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076751|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
93076752|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
93076753|NCT04062123|Fentanyl|fentanyl|mesh-list
93076754|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
93076755|NCT04062123|Propofol|propofol|mesh-list
93076756|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93076757|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93076758|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076759|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93076760|NCT04062123|Analgesics|analgesics|mesh-ancestor
93076761|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
93076762|NCT04062123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076763|NCT04062123|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93076764|NCT04062123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93076765|NCT04062123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93076766|NCT04062123|Adrenergic Agents|adrenergic agents|mesh-ancestor
93076767|NCT04062123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93076768|NCT04062123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076769|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93076770|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
93076771|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
93076772|NCT04062123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93076773|NCT04062123|Narcotics|narcotics|mesh-ancestor
93076774|NCT04062123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93076775|NCT04059562|Irinotecan|irinotecan|mesh-list
93076776|NCT04059562|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93076777|NCT04059562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076778|NCT04059562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076779|NCT04059562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076780|NCT04059562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076781|NCT04040088|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
93076782|NCT04040088|Chelating Agents|chelating agents|mesh-ancestor
93076783|NCT04040088|Sequestering Agents|sequestering agents|mesh-ancestor
93076784|NCT04040088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076785|NCT04024436|Fulvestrant|fulvestrant|mesh-list
93076786|NCT04024436|Futibatinib|futibatinib|mesh-list
93076787|NCT04024436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076788|NCT04024436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076789|NCT04024436|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93076790|NCT04024436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93076791|NCT04024436|Hormone Antagonists|hormone antagonists|mesh-ancestor
93076792|NCT04024436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076793|NCT04024436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076794|NCT04009681|Antibodies|antibodies|mesh-list
93076795|NCT04009681|Immunologic Factors|immunologic factors|mesh-ancestor
93076796|NCT04009681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076797|NCT03992261|Halobetasol|halobetasol|mesh-list
93076798|NCT03992261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93076799|NCT03991884|Prednisone|prednisone|mesh-list
93076800|NCT03991884|Cortisone|cortisone|mesh-list
93076801|NCT03991884|Cyclophosphamide|cyclophosphamide|mesh-list
93076802|NCT03991884|Doxorubicin|doxorubicin|mesh-list
93076803|NCT03991884|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93076804|NCT03991884|Etoposide|etoposide|mesh-list
93076805|NCT03991884|Vincristine|vincristine|mesh-list
93076806|NCT03991884|Etoposide phosphate|etoposide phosphate|mesh-list
93076807|NCT03991884|Daunorubicin|daunorubicin|mesh-list
93076808|NCT03991884|Podophyllotoxin|podophyllotoxin|mesh-list
93076809|NCT03991884|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93076810|NCT03991884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076811|NCT03991884|Immunologic Factors|immunologic factors|mesh-ancestor
93076812|NCT03991884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076813|NCT03991884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076814|NCT03991884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93076815|NCT03991884|Alkylating Agents|alkylating agents|mesh-ancestor
93076816|NCT03991884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076817|NCT03991884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076818|NCT03991884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93076819|NCT03991884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93076820|NCT03991884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93076821|NCT03991884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93076822|NCT03991884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076823|NCT03991884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076824|NCT03991884|Glucocorticoids|glucocorticoids|mesh-ancestor
93076825|NCT03991884|Hormones|hormones|mesh-ancestor
93076826|NCT03991884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93076827|NCT03991884|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93076828|NCT03991884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076829|NCT03991884|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076830|NCT03991884|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076831|NCT03991884|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076832|NCT03991884|Keratolytic Agents|keratolytic agents|mesh-ancestor
93076833|NCT03991884|Dermatologic Agents|dermatologic agents|mesh-ancestor
93076834|NCT03991884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076835|NCT03991884|Immunotoxins|immunotoxins|mesh-ancestor
93076836|NCT03991884|Immunoconjugates|immunoconjugates|mesh-ancestor
93076837|NCT03984565|Cannabidiol|cannabidiol|mesh-list
93076838|NCT03984565|Anticonvulsants|anticonvulsants|mesh-ancestor
93076839|NCT03980509|Curcumin|curcumin|mesh-list
93076840|NCT03980509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93076841|NCT03980509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93076842|NCT03980509|Analgesics|analgesics|mesh-ancestor
93076843|NCT03980509|Sensory System Agents|sensory system agents|mesh-ancestor
93076844|NCT03980509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076845|NCT03980509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076846|NCT03980509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076847|NCT03980509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076848|NCT03980509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076849|NCT03980509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076850|NCT03980509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076851|NCT03978039|Immunomodulating Agents|immunomodulating agents|mesh-list
93076852|NCT03978039|Immunologic Factors|immunologic factors|mesh-ancestor
93076853|NCT03978039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076854|NCT03961971|Spartalizumab|spartalizumab|mesh-list
93076855|NCT03961971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076856|NCT03961971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076857|NCT03961971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076858|NCT03961971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076860|NCT03961334|Dabigatran|dabigatran|mesh-list
93076861|NCT03961334|Apixaban|apixaban|mesh-list
93076862|NCT03961334|Edoxaban|edoxaban|mesh-list
93076863|NCT03961334|Clopidogrel|clopidogrel|mesh-list
93076864|NCT03961334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93076865|NCT03961334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93076866|NCT03961334|Analgesics|analgesics|mesh-ancestor
93076867|NCT03961334|Sensory System Agents|sensory system agents|mesh-ancestor
93076868|NCT03961334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076869|NCT03961334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076870|NCT03961334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93076871|NCT03961334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076872|NCT03961334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93076873|NCT03961334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93076874|NCT03961334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076875|NCT03961334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93076876|NCT03961334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93076877|NCT03961334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076878|NCT03961334|Antipyretics|antipyretics|mesh-ancestor
93076879|NCT03961334|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93076880|NCT03961334|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93076881|NCT03961334|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93076882|NCT03961334|Purinergic Agents|purinergic agents|mesh-ancestor
93076883|NCT03961334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93076884|NCT03961334|Antithrombins|antithrombins|mesh-ancestor
93076885|NCT03961334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93076886|NCT03961334|Protease Inhibitors|protease inhibitors|mesh-ancestor
93076887|NCT03961334|Anticoagulants|anticoagulants|mesh-ancestor
93076888|NCT03961334|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93076889|NCT03953300|Benralizumab|benralizumab|mesh-list
93076890|NCT03953300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93076891|NCT03953300|Respiratory System Agents|respiratory system agents|mesh-ancestor
93076892|NCT03947385|Crizotinib|crizotinib|mesh-list
93076893|NCT03947385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076894|NCT03947385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076895|NCT03947385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076896|NCT03947385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076897|NCT03918798|Chloroprocaine|chloroprocaine|mesh-list
93076898|NCT03918798|Procaine|procaine|mesh-list
93076899|NCT03918798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93076900|NCT03918798|Anesthetics, Local|anesthetics, local|mesh-ancestor
93076901|NCT03918798|Anesthetics|anesthetics|mesh-ancestor
93076902|NCT03918798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93076903|NCT03918798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076904|NCT03918798|Sensory System Agents|sensory system agents|mesh-ancestor
93076905|NCT03918798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93076906|NCT03917381|Docetaxel|docetaxel|mesh-list
93076907|NCT03917381|Pembrolizumab|pembrolizumab|mesh-list
93076908|NCT03917381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076909|NCT03917381|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076910|NCT03917381|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076911|NCT03917381|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076912|NCT03917381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076913|NCT03917381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076914|NCT03917381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076915|NCT03890289|Obinutuzumab|obinutuzumab|mesh-list
93076916|NCT03890289|Idelalisib|idelalisib|mesh-list
93076917|NCT03890289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076918|NCT03890289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076919|NCT03890289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076920|NCT03890289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076921|NCT03858322|Paclitaxel|paclitaxel|mesh-list
93076922|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
93076923|NCT03858322|Carboplatin|carboplatin|mesh-list
93076924|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93076925|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076926|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
93076927|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
93076928|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
93076929|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076930|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93076931|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
93076932|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076933|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054053|NCT00143403|Micronutrients|micronutrients|mesh-ancestor
93076934|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93076935|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
93076936|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93076937|NCT03828799|Folfirinox|folfirinox|mesh-list
93076938|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076939|NCT03825289|Hydroxychloroquine|hydroxychloroquine|mesh-list
93076940|NCT03825289|Trametinib|trametinib|mesh-list
93076941|NCT03825289|Antimalarials|antimalarials|mesh-ancestor
93076942|NCT03825289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93076943|NCT03825289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93076944|NCT03825289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93076945|NCT03825289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076946|NCT03825289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076947|NCT03825289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076948|NCT03825289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076949|NCT03825289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076950|NCT03824483|Venetoclax|venetoclax|mesh-list
93076951|NCT03824483|Obinutuzumab|obinutuzumab|mesh-list
93076952|NCT03824483|Zanubrutinib|zanubrutinib|mesh-list
93076953|NCT03824483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076954|NCT03824483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076955|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93076956|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93076957|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076958|NCT03802591|Capecitabine|capecitabine|mesh-list
93076959|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
93076960|NCT03802591|Antibodies|antibodies|mesh-list
93076961|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93076962|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
93076963|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076964|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93076965|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
93076966|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076967|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076968|NCT03800602|Metformin|metformin|mesh-list
93076969|NCT03800602|Nivolumab|nivolumab|mesh-list
93076970|NCT03800602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93076971|NCT03800602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076972|NCT03800602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076973|NCT03800602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076974|NCT03800602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076975|NCT03800602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076976|NCT03799003|Pembrolizumab|pembrolizumab|mesh-list
93076977|NCT03799003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076978|NCT03799003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076979|NCT03799003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93076980|NCT03799003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93076981|NCT03783403|Rituximab|rituximab|mesh-list
93076982|NCT03783403|Cetuximab|cetuximab|mesh-list
93076983|NCT03783403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076984|NCT03783403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076985|NCT03783403|Immunologic Factors|immunologic factors|mesh-ancestor
93076986|NCT03783403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076987|NCT03783403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93076988|NCT03779191|Bevacizumab|bevacizumab|mesh-list
93076989|NCT03779191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93076990|NCT03779191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93076991|NCT03779191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93076992|NCT03779191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93076993|NCT03779191|Growth Substances|growth substances|mesh-ancestor
93076994|NCT03779191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93076995|NCT03779191|Growth Inhibitors|growth inhibitors|mesh-ancestor
93076996|NCT03775902|Nicorandil|nicorandil|mesh-list
93076997|NCT03775902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93076998|NCT03775902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93076999|NCT03775902|Vasodilator Agents|vasodilator agents|mesh-ancestor
93077000|NCT03775902|Vitamin B Complex|vitamin b complex|mesh-ancestor
93077001|NCT03775902|Vitamins|vitamins|mesh-ancestor
93077002|NCT03775902|Micronutrients|micronutrients|mesh-ancestor
93077003|NCT03775902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077004|NCT03772925|Belinostat|belinostat|mesh-list
93077005|NCT03772925|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93077006|NCT03772925|Pevonedistat|pevonedistat|mesh-list
93077007|NCT03772925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077008|NCT03772925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077009|NCT03772925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93077010|NCT03753074|Tenofovir|tenofovir|mesh-list
93077011|NCT03753074|Antiviral Agents|antiviral agents|mesh-ancestor
93077012|NCT03753074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077013|NCT03753074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93077014|NCT03753074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92667306|NCT00285389|Chlorambucil|chlorambucil|mesh-list
93077015|NCT03753074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077016|NCT03753074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077017|NCT03753074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93077018|NCT03753074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93077019|NCT03743662|Bevacizumab|bevacizumab|mesh-list
93077020|NCT03743662|Nivolumab|nivolumab|mesh-list
93077021|NCT03743662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077022|NCT03743662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077023|NCT03743662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077024|NCT03743662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077025|NCT03743662|Growth Substances|growth substances|mesh-ancestor
93077026|NCT03743662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077027|NCT03743662|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077028|NCT03743662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077029|NCT03743662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077030|NCT03742102|Paclitaxel|paclitaxel|mesh-list
93077031|NCT03742102|Trastuzumab|trastuzumab|mesh-list
93077032|NCT03742102|Durvalumab|durvalumab|mesh-list
93077033|NCT03742102|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93077034|NCT03742102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077035|NCT03742102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077036|NCT03742102|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077037|NCT03742102|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077038|NCT03742102|Mitosis Modulators|mitosis modulators|mesh-ancestor
93077039|NCT03742102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077040|NCT03742102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077041|NCT03742102|Immunoconjugates|immunoconjugates|mesh-ancestor
93077042|NCT03742102|Immunologic Factors|immunologic factors|mesh-ancestor
93077043|NCT03742102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077044|NCT03735121|Atezolizumab|atezolizumab|mesh-list
93077045|NCT03735121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077046|NCT03735121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077047|NCT03735121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077048|NCT03735121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077049|NCT03715946|Nivolumab|nivolumab|mesh-list
93077050|NCT03715946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077051|NCT03715946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077052|NCT03715946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077053|NCT03715946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077054|NCT03712878|Mycophenolic Acid|mycophenolic acid|mesh-list
93077055|NCT03712878|Cyclophosphamide|cyclophosphamide|mesh-list
93077056|NCT03712878|Tacrolimus|tacrolimus|mesh-list
93077057|NCT03712878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077058|NCT03712878|Immunologic Factors|immunologic factors|mesh-ancestor
93077059|NCT03712878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077060|NCT03712878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077061|NCT03712878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077062|NCT03712878|Alkylating Agents|alkylating agents|mesh-ancestor
93077063|NCT03712878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077064|NCT03712878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077065|NCT03712878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077066|NCT03712878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93077067|NCT03712878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077068|NCT03712878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93077069|NCT03712878|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93077070|NCT03712878|Antitubercular Agents|antitubercular agents|mesh-ancestor
93077071|NCT03712878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93077072|NCT03712878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077073|NCT03703167|Rituximab|rituximab|mesh-list
93077074|NCT03703167|Lenalidomide|lenalidomide|mesh-list
93077075|NCT03703167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077076|NCT03703167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077077|NCT03703167|Immunologic Factors|immunologic factors|mesh-ancestor
93077078|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077079|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077080|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077081|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077082|NCT03703167|Growth Substances|growth substances|mesh-ancestor
93077083|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054206|NCT01101646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93077085|NCT03683251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077086|NCT03683251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077087|NCT03683251|Growth Substances|growth substances|mesh-ancestor
93077088|NCT03683251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077089|NCT03683251|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077090|NCT03683251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077091|NCT03655002|Cyclophosphamide|cyclophosphamide|mesh-list
93077092|NCT03655002|Nivolumab|nivolumab|mesh-list
93077093|NCT03655002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077094|NCT03655002|Immunologic Factors|immunologic factors|mesh-ancestor
93077095|NCT03655002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077096|NCT03655002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077097|NCT03655002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077098|NCT03655002|Alkylating Agents|alkylating agents|mesh-ancestor
93077099|NCT03655002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077100|NCT03655002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077101|NCT03655002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077102|NCT03655002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077103|NCT03655002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077104|NCT03653507|Capecitabine|capecitabine|mesh-list
93077105|NCT03653507|Oxaliplatin|oxaliplatin|mesh-list
93077106|NCT03653507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077107|NCT03653507|Antimetabolites|antimetabolites|mesh-ancestor
93077108|NCT03653507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077109|NCT03653507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077110|NCT03651206|Niraparib|niraparib|mesh-list
93077111|NCT03651206|Dostarlimab|dostarlimab|mesh-list
93077112|NCT03651206|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93077113|NCT03651206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077114|NCT03651206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077115|NCT03651206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077116|NCT03643510|Fulvestrant|fulvestrant|mesh-list
93077117|NCT03643510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077118|NCT03643510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077119|NCT03643510|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93077120|NCT03643510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93077121|NCT03643510|Hormone Antagonists|hormone antagonists|mesh-ancestor
93077122|NCT03643510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077123|NCT03643510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077124|NCT03641313|Irinotecan|irinotecan|mesh-list
93077125|NCT03641313|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93077126|NCT03641313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077127|NCT03641313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077128|NCT03641313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077129|NCT03641313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077130|NCT03618537|Dexamethasone|dexamethasone|mesh-list
93077131|NCT03618537|Ixazomib|ixazomib|mesh-list
93077132|NCT03618537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077133|NCT03618537|Antiemetics|antiemetics|mesh-ancestor
93077134|NCT03618537|Autonomic Agents|autonomic agents|mesh-ancestor
93077135|NCT03618537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077136|NCT03618537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077137|NCT03618537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93077138|NCT03618537|Glucocorticoids|glucocorticoids|mesh-ancestor
93077139|NCT03618537|Hormones|hormones|mesh-ancestor
93077140|NCT03618537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077141|NCT03618537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077142|NCT03618537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077143|NCT03618537|Protease Inhibitors|protease inhibitors|mesh-ancestor
93077144|NCT03618537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077145|NCT03618537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077146|NCT03587844|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93077147|NCT03587844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077148|NCT03587844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077149|NCT03587844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077150|NCT03587844|Immunotoxins|immunotoxins|mesh-ancestor
93077151|NCT03587844|Immunoconjugates|immunoconjugates|mesh-ancestor
93077152|NCT03587844|Immunologic Factors|immunologic factors|mesh-ancestor
93077153|NCT03587844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077154|NCT03552692|Venetoclax|venetoclax|mesh-list
93077155|NCT03552692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077156|NCT03542175|Rucaparib|rucaparib|mesh-list
93054283|NCT00002842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077157|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93077158|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077159|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077160|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077161|NCT03502733|Nivolumab|nivolumab|mesh-list
93077162|NCT03502733|Ipilimumab|ipilimumab|mesh-list
93077163|NCT03502733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077164|NCT03502733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077165|NCT03502733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077166|NCT03502733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077167|NCT03485417|Aripiprazole|aripiprazole|mesh-list
93077168|NCT03485417|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93077169|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
93077170|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93077171|NCT03485417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93077172|NCT03485417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93077173|NCT03485417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93077174|NCT03485417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077175|NCT03485417|Dopamine Agonists|dopamine agonists|mesh-ancestor
93077176|NCT03485417|Dopamine Agents|dopamine agents|mesh-ancestor
93077177|NCT03485417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077178|NCT03485417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077179|NCT03485417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93077180|NCT03485417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93077181|NCT03485417|Serotonin Agents|serotonin agents|mesh-ancestor
93077182|NCT03485417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93077183|NCT03485417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93077184|NCT03485417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93077185|NCT03485417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93077186|NCT03485274|Vortioxetine|vortioxetine|mesh-list
93077187|NCT03485274|Antidepressive Agents|antidepressive agents|mesh-ancestor
93077188|NCT03485274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93077189|NCT03485274|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93077190|NCT03485274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93077191|NCT03485274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93077192|NCT03485274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077193|NCT03485274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93077194|NCT03485274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93077195|NCT03485274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93077196|NCT03485274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077197|NCT03485274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077198|NCT03485274|Serotonin Agents|serotonin agents|mesh-ancestor
93077199|NCT03485274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93077200|NCT03485274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93077201|NCT03485274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93077202|NCT03485274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93077203|NCT03484819|Nivolumab|nivolumab|mesh-list
93077204|NCT03484819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077205|NCT03484819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077206|NCT03484819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077207|NCT03484819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077208|NCT03473756|Atezolizumab|atezolizumab|mesh-list
93077209|NCT03473756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92667515|NCT00319878|Sirolimus|sirolimus|mesh-list
93077210|NCT03473756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077211|NCT03473756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077212|NCT03473756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077213|NCT03434028|Norepinephrine|norepinephrine|mesh-list
93077214|NCT03434028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93077215|NCT03434028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93077216|NCT03434028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93077217|NCT03434028|Adrenergic Agents|adrenergic agents|mesh-ancestor
93077218|NCT03434028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077219|NCT03434028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077220|NCT03434028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077221|NCT03434028|Sympathomimetics|sympathomimetics|mesh-ancestor
93077222|NCT03434028|Autonomic Agents|autonomic agents|mesh-ancestor
93077223|NCT03434028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077224|NCT03412773|Sorafenib|sorafenib|mesh-list
93077225|NCT03412773|Tislelizumab|tislelizumab|mesh-list
93077226|NCT03412773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077227|NCT03412773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054361|NCT01100164|Eszopiclone|eszopiclone|mesh-list
93077228|NCT03412773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077229|NCT03412773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077230|NCT03412773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077231|NCT03404960|Nivolumab|nivolumab|mesh-list
93077232|NCT03404960|Ipilimumab|ipilimumab|mesh-list
93077233|NCT03404960|Niraparib|niraparib|mesh-list
93077234|NCT03404960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077235|NCT03404960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077236|NCT03404960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077237|NCT03404960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077238|NCT03404960|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93077239|NCT03404960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077240|NCT03400332|Nivolumab|nivolumab|mesh-list
93077241|NCT03400332|Ipilimumab|ipilimumab|mesh-list
93077242|NCT03400332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077243|NCT03400332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077244|NCT03400332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077245|NCT03400332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077246|NCT03393845|Pembrolizumab|pembrolizumab|mesh-list
93077247|NCT03393845|Fulvestrant|fulvestrant|mesh-list
93077248|NCT03393845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077249|NCT03393845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077250|NCT03393845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077251|NCT03393845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077252|NCT03393845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077253|NCT03393845|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93077254|NCT03393845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93077255|NCT03393845|Hormone Antagonists|hormone antagonists|mesh-ancestor
93077256|NCT03393845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077257|NCT03393845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077258|NCT03391466|Cyclophosphamide|cyclophosphamide|mesh-list
93077259|NCT03391466|Fludarabine|fludarabine|mesh-list
93077260|NCT03391466|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
93077261|NCT03391466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077262|NCT03391466|Immunologic Factors|immunologic factors|mesh-ancestor
93077263|NCT03391466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077264|NCT03391466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077265|NCT03391466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077266|NCT03391466|Alkylating Agents|alkylating agents|mesh-ancestor
93077267|NCT03391466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077268|NCT03391466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077269|NCT03391466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077270|NCT03391466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077271|NCT03391427|Lidocaine|lidocaine|mesh-list
93077272|NCT03391427|Ketamine|ketamine|mesh-list
93077273|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
93077274|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
93077275|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93077276|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077277|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
93077278|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077279|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93077280|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93077281|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93077282|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93077283|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077284|NCT03391427|Analgesics|analgesics|mesh-ancestor
93077285|NCT03391427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93077286|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93077287|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
93077288|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93077289|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93077290|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077291|NCT03382834|Tamoxifen|tamoxifen|mesh-list
93077292|NCT03382834|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93077293|NCT03382834|Vorinostat|vorinostat|mesh-list
93077294|NCT03382834|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93077295|NCT03382834|Hormone Antagonists|hormone antagonists|mesh-ancestor
93077296|NCT03382834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077297|NCT03382834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077298|NCT03382834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077299|NCT03382834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077300|NCT03382834|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93077301|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93077302|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93077303|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93077304|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077305|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077306|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
93077307|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077308|NCT03381274|Osimertinib|osimertinib|mesh-list
93077309|NCT03381274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077310|NCT03381274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077311|NCT03381274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077312|NCT03381274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077313|NCT03366155|Oxaliplatin|oxaliplatin|mesh-list
93077314|NCT03366155|Irinotecan|irinotecan|mesh-list
93077315|NCT03366155|Cetuximab|cetuximab|mesh-list
93077316|NCT03366155|Panitumumab|panitumumab|mesh-list
93077317|NCT03366155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077318|NCT03366155|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93077319|NCT03366155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077320|NCT03366155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077321|NCT03366155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077322|NCT03366155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077323|NCT03290950|Dexamethasone|dexamethasone|mesh-list
93077324|NCT03290950|Dexamethasone acetate|dexamethasone acetate|mesh-list
93077325|NCT03290950|Lenalidomide|lenalidomide|mesh-list
93077326|NCT03290950|Daratumumab|daratumumab|mesh-list
93077327|NCT03290950|BB 1101|bb 1101|mesh-list
93077328|NCT03290950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077329|NCT03290950|Antiemetics|antiemetics|mesh-ancestor
93077330|NCT03290950|Autonomic Agents|autonomic agents|mesh-ancestor
93077331|NCT03290950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077332|NCT03290950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077333|NCT03290950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93077334|NCT03290950|Glucocorticoids|glucocorticoids|mesh-ancestor
93077335|NCT03290950|Hormones|hormones|mesh-ancestor
93077336|NCT03290950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077337|NCT03290950|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077338|NCT03290950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077339|NCT03290950|Protease Inhibitors|protease inhibitors|mesh-ancestor
93077340|NCT03290950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077341|NCT03290950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077342|NCT03290950|Immunologic Factors|immunologic factors|mesh-ancestor
93077343|NCT03290950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077344|NCT03290950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077345|NCT03290950|Growth Substances|growth substances|mesh-ancestor
93077346|NCT03290950|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077347|NCT03277638|Pembrolizumab|pembrolizumab|mesh-list
93077348|NCT03277638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077349|NCT03277638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077350|NCT03277638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077351|NCT03277638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077352|NCT03264404|Pembrolizumab|pembrolizumab|mesh-list
93077353|NCT03264404|Azacitidine|azacitidine|mesh-list
93077354|NCT03264404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077355|NCT03264404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077356|NCT03264404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077357|NCT03264404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077358|NCT03264404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077359|NCT03264404|Antimetabolites|antimetabolites|mesh-ancestor
93077360|NCT03264404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077361|NCT03241745|Nivolumab|nivolumab|mesh-list
93077362|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077363|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077364|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077365|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077366|NCT03198351|Teriflunomide|teriflunomide|mesh-list
93077367|NCT03198351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93077368|NCT03198351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93077369|NCT03198351|Analgesics|analgesics|mesh-ancestor
93077370|NCT03198351|Sensory System Agents|sensory system agents|mesh-ancestor
93077371|NCT03198351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077372|NCT03198351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077373|NCT03198351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077374|NCT03198351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077375|NCT03198351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077376|NCT03198351|Immunologic Factors|immunologic factors|mesh-ancestor
93077377|NCT03188432|Carboplatin|carboplatin|mesh-list
93077378|NCT03188432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077379|NCT03132532|Paclitaxel|paclitaxel|mesh-list
93077380|NCT03132532|Etoposide|etoposide|mesh-list
93077381|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
93077382|NCT03132532|Cisplatin|cisplatin|mesh-list
93077383|NCT03132532|Carboplatin|carboplatin|mesh-list
93077384|NCT03132532|Pemetrexed|pemetrexed|mesh-list
93077385|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93077386|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
93077387|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077388|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077389|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077390|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077391|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
93077392|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077393|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93077394|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077395|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077396|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93077397|NCT03132532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93077398|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
93077399|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
93077400|NCT03129555|Rivaroxaban|rivaroxaban|mesh-list
93077401|NCT03129555|Apixaban|apixaban|mesh-list
93077402|NCT03129555|Edoxaban|edoxaban|mesh-list
93077403|NCT03129555|Dabigatran|dabigatran|mesh-list
93077404|NCT03129555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93077405|NCT03129555|Antithrombins|antithrombins|mesh-ancestor
93077406|NCT03129555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93077407|NCT03129555|Protease Inhibitors|protease inhibitors|mesh-ancestor
93077408|NCT03129555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077409|NCT03129555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077410|NCT03129555|Anticoagulants|anticoagulants|mesh-ancestor
93077411|NCT03129490|Rivaroxaban|rivaroxaban|mesh-list
93077412|NCT03129490|Apixaban|apixaban|mesh-list
93077413|NCT03129490|Edoxaban|edoxaban|mesh-list
93077414|NCT03129490|Dabigatran|dabigatran|mesh-list
93077415|NCT03129490|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93077416|NCT03129490|Antithrombins|antithrombins|mesh-ancestor
93077417|NCT03129490|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93077418|NCT03129490|Protease Inhibitors|protease inhibitors|mesh-ancestor
93077419|NCT03129490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077420|NCT03129490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077421|NCT03129490|Anticoagulants|anticoagulants|mesh-ancestor
93077422|NCT03121014|Methotrexate|methotrexate|mesh-list
93077423|NCT03121014|Fludarabine|fludarabine|mesh-list
93077424|NCT03121014|Busulfan|busulfan|mesh-list
93077425|NCT03121014|Tacrolimus|tacrolimus|mesh-list
93077426|NCT03121014|Thymoglobulin|thymoglobulin|mesh-list
93077427|NCT03121014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93077428|NCT03121014|Abortifacient Agents|abortifacient agents|mesh-ancestor
93077429|NCT03121014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93077430|NCT03121014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077431|NCT03121014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077432|NCT03121014|Antimetabolites|antimetabolites|mesh-ancestor
93077433|NCT03121014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077434|NCT03121014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077435|NCT03121014|Dermatologic Agents|dermatologic agents|mesh-ancestor
93077436|NCT03121014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077437|NCT03121014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93077438|NCT03121014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077439|NCT03121014|Immunologic Factors|immunologic factors|mesh-ancestor
93077440|NCT03121014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077441|NCT03121014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93077442|NCT03121014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93077443|NCT03121014|Alkylating Agents|alkylating agents|mesh-ancestor
93077444|NCT03121014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077445|NCT03121014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077446|NCT03118570|Vitamin D|vitamin d|mesh-list
93077447|NCT03118570|Zoledronic Acid|zoledronic acid|mesh-list
93077448|NCT03118570|Calcium|calcium|mesh-list
93077449|NCT03118570|Vitamins|vitamins|mesh-ancestor
93054578|NCT01582646|Terbutaline|terbutaline|mesh-list
93077450|NCT03118570|Micronutrients|micronutrients|mesh-ancestor
93077451|NCT03118570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077452|NCT03118570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93077453|NCT03118570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93077454|NCT03114319|Nazartinib|nazartinib|mesh-list
93077455|NCT03114319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077456|NCT03076320|Adapalene|adapalene|mesh-list
93077457|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93077458|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
93077459|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93077460|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93077461|NCT03076320|Analgesics|analgesics|mesh-ancestor
93077462|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
93077463|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077464|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077465|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077466|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077467|NCT03069937|Docetaxel|docetaxel|mesh-list
93077468|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077469|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077470|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077471|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667804|NCT00320697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077472|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077473|NCT03066739|Remifentanil|remifentanil|mesh-list
93077474|NCT03066739|Naloxone|naloxone|mesh-list
93077475|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93077476|NCT03066739|Narcotics|narcotics|mesh-ancestor
93077477|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93077478|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077479|NCT03066739|Analgesics|analgesics|mesh-ancestor
93077480|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
93077481|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077482|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93077483|NCT03054896|Venetoclax|venetoclax|mesh-list
93077484|NCT03054896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077485|NCT03038672|Nivolumab|nivolumab|mesh-list
93077486|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
93077487|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
93077488|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077489|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077490|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077491|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077492|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077493|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
93077494|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077495|NCT03033303|Isotretinoin|isotretinoin|mesh-list
93077496|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
93077497|NCT03030378|Pembrolizumab|pembrolizumab|mesh-list
93077498|NCT03030378|Interleukin-12|interleukin-12|mesh-list
93077499|NCT03030378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077500|NCT03030378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077501|NCT03030378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077502|NCT03030378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077503|NCT03030378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93077504|NCT03030378|Immunologic Factors|immunologic factors|mesh-ancestor
93077505|NCT03030378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077506|NCT03030378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077507|NCT03030378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077508|NCT03030378|Growth Substances|growth substances|mesh-ancestor
93077509|NCT03030378|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077510|NCT03009981|Prednisone|prednisone|mesh-list
93077511|NCT03009981|Leuprolide|leuprolide|mesh-list
93077512|NCT03009981|Abiraterone Acetate|abiraterone acetate|mesh-list
93077513|NCT03009981|Bicalutamide|bicalutamide|mesh-list
93077514|NCT03009981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077515|NCT03009981|Glucocorticoids|glucocorticoids|mesh-ancestor
93077516|NCT03009981|Hormones|hormones|mesh-ancestor
93077517|NCT03009981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077518|NCT03009981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077519|NCT03009981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077520|NCT03009981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077521|NCT03009981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93077522|NCT03009981|Fertility Agents|fertility agents|mesh-ancestor
93077523|NCT03009981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93077524|NCT03009981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93077525|NCT03009981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077526|NCT03009981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077527|NCT03009981|Hormone Antagonists|hormone antagonists|mesh-ancestor
93077528|NCT03009981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93077529|NCT03009981|Androgen Antagonists|androgen antagonists|mesh-ancestor
93077530|NCT03009240|Decitabine|decitabine|mesh-list
93077531|NCT03009240|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93077532|NCT03009240|Pevonedistat|pevonedistat|mesh-list
93077533|NCT03009240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077534|NCT03009240|Antimetabolites|antimetabolites|mesh-ancestor
93077535|NCT03009240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077536|NCT03009240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077537|NCT03006705|Capecitabine|capecitabine|mesh-list
93077538|NCT03006705|Tegafur|tegafur|mesh-list
93077539|NCT03006705|Oxaliplatin|oxaliplatin|mesh-list
93077540|NCT03006705|Nivolumab|nivolumab|mesh-list
93077541|NCT03006705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077542|NCT03006705|Antimetabolites|antimetabolites|mesh-ancestor
93077543|NCT03006705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077544|NCT03006705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077545|NCT03006705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077546|NCT03006705|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077547|NCT03006172|Metformin|metformin|mesh-list
93077548|NCT03006172|Trastuzumab|trastuzumab|mesh-list
93077549|NCT03006172|Pertuzumab|pertuzumab|mesh-list
93077550|NCT03006172|Letrozole|letrozole|mesh-list
93077551|NCT03006172|Fulvestrant|fulvestrant|mesh-list
93077552|NCT03006172|Palbociclib|palbociclib|mesh-list
93077553|NCT03006172|Inavolisib|inavolisib|mesh-list
93077554|NCT03006172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93077555|NCT03006172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077556|NCT03006172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077557|NCT03006172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077558|NCT03006172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93077559|NCT03006172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93077560|NCT03006172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077561|NCT03006172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077562|NCT03006172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93077563|NCT03006172|Hormone Antagonists|hormone antagonists|mesh-ancestor
93077564|NCT03006172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077565|NCT03006172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077566|NCT03006172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93077567|NCT03006172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077568|NCT03006172|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93077569|NCT03006068|Upadacitinib|upadacitinib|mesh-list
93077570|NCT03006068|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93077571|NCT03006068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077572|NCT03006068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077573|NCT03006068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077574|NCT03006068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077575|NCT02971683|Abatacept|abatacept|mesh-list
93077576|NCT02971683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077577|NCT02971683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077578|NCT02971683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077579|NCT02971683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077580|NCT02971683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077581|NCT02971683|Immunologic Factors|immunologic factors|mesh-ancestor
93077582|NCT02971683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077583|NCT02971683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077584|NCT02971501|Bevacizumab|bevacizumab|mesh-list
93077585|NCT02971501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93077586|NCT02971501|Osimertinib|osimertinib|mesh-list
93077587|NCT02971501|Endothelial Growth Factors|endothelial growth factors|mesh-list
93077588|NCT02971501|Antibodies|antibodies|mesh-list
93077589|NCT02971501|Immunoglobulins|immunoglobulins|mesh-list
93077590|NCT02971501|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077591|NCT02971501|Immunoglobulin G|immunoglobulin g|mesh-list
93077592|NCT02971501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077593|NCT02971501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077594|NCT02971501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077595|NCT02971501|Growth Substances|growth substances|mesh-ancestor
93077596|NCT02971501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077597|NCT02971501|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077598|NCT02971501|Immunologic Factors|immunologic factors|mesh-ancestor
93077599|NCT02971501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077600|NCT02971501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077601|NCT02971501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077602|NCT02950051|Cyclophosphamide|cyclophosphamide|mesh-list
93077603|NCT02950051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93077604|NCT02950051|Rituximab|rituximab|mesh-list
93077606|NCT02950051|Venetoclax|venetoclax|mesh-list
93077607|NCT02950051|Obinutuzumab|obinutuzumab|mesh-list
93077608|NCT02950051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077609|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
93077610|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077611|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077612|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077613|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
93077614|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077615|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077616|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077617|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077618|NCT02949219|Pembrolizumab|pembrolizumab|mesh-list
93077619|NCT02949219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077620|NCT02949219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077621|NCT02949219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077622|NCT02949219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077623|NCT02921022|Paclitaxel|paclitaxel|mesh-list
93077624|NCT02921022|Gemcitabine|gemcitabine|mesh-list
93077625|NCT02921022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077626|NCT02921022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077627|NCT02921022|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077628|NCT02921022|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077629|NCT02921022|Mitosis Modulators|mitosis modulators|mesh-ancestor
93077630|NCT02921022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077631|NCT02921022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077632|NCT02921022|Antimetabolites|antimetabolites|mesh-ancestor
93077633|NCT02918162|Pembrolizumab|pembrolizumab|mesh-list
93077634|NCT02918162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077635|NCT02918162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077636|NCT02918162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077637|NCT02918162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077638|NCT02899299|Carboplatin|carboplatin|mesh-list
93077639|NCT02899299|Nivolumab|nivolumab|mesh-list
93077640|NCT02899299|Pemetrexed|pemetrexed|mesh-list
93077641|NCT02899299|Ipilimumab|ipilimumab|mesh-list
93077642|NCT02899299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077643|NCT02899299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077644|NCT02899299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077645|NCT02899299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077646|NCT02899299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077647|NCT02899299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93077648|NCT02899299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93077649|NCT02899195|Durvalumab|durvalumab|mesh-list
93077650|NCT02899195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077651|NCT02899195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077652|NCT02890329|Ipilimumab|ipilimumab|mesh-list
93077653|NCT02890329|Decitabine|decitabine|mesh-list
93077654|NCT02890329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077655|NCT02890329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077656|NCT02890329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077657|NCT02890329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077658|NCT02890329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077659|NCT02890329|Antimetabolites|antimetabolites|mesh-ancestor
93077660|NCT02890329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077661|NCT02839707|Bevacizumab|bevacizumab|mesh-list
93077662|NCT02839707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93077663|NCT02839707|Atezolizumab|atezolizumab|mesh-list
93077664|NCT02839707|Doxorubicin|doxorubicin|mesh-list
93077665|NCT02839707|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93077666|NCT02839707|Endothelial Growth Factors|endothelial growth factors|mesh-list
93077667|NCT02839707|Antibodies|antibodies|mesh-list
93077668|NCT02839707|Immunoglobulins|immunoglobulins|mesh-list
93077669|NCT02839707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077670|NCT02839707|Immunoglobulin G|immunoglobulin g|mesh-list
93077671|NCT02839707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077672|NCT02839707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077673|NCT02839707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077674|NCT02839707|Growth Substances|growth substances|mesh-ancestor
93077675|NCT02839707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077676|NCT02839707|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077677|NCT02839707|Immunologic Factors|immunologic factors|mesh-ancestor
93077678|NCT02839707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93077679|NCT02839707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93077680|NCT02839707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077681|NCT02839707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077682|NCT02839707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077683|NCT02839707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077684|NCT02833233|Nivolumab|nivolumab|mesh-list
93077685|NCT02833233|Ipilimumab|ipilimumab|mesh-list
93077686|NCT02833233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077687|NCT02833233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077688|NCT02833233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077689|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077690|NCT02814916|Dalbavancin|dalbavancin|mesh-list
93077691|NCT02814916|Teicoplanin|teicoplanin|mesh-list
93077692|NCT02814916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93077693|NCT02814916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077694|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
93077695|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93077696|NCT02804594|Antiviral Agents|antiviral agents|mesh-ancestor
93077697|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077698|NCT02804594|Expectorants|expectorants|mesh-ancestor
93077699|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
93077700|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93077701|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
93077702|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077703|NCT02804594|Protective Agents|protective agents|mesh-ancestor
93077704|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077705|NCT02804594|Antidotes|antidotes|mesh-ancestor
93077706|NCT02803437|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93077707|NCT02803437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077708|NCT02728050|Cytarabine|cytarabine|mesh-list
93077709|NCT02728050|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93077710|NCT02728050|Sorafenib|sorafenib|mesh-list
93077711|NCT02728050|Mitoxantrone|mitoxantrone|mesh-list
93077712|NCT02728050|Cladribine|cladribine|mesh-list
93077713|NCT02728050|Lenograstim|lenograstim|mesh-list
93077714|NCT02728050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077715|NCT02728050|Antimetabolites|antimetabolites|mesh-ancestor
93077716|NCT02728050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077717|NCT02728050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077718|NCT02728050|Antiviral Agents|antiviral agents|mesh-ancestor
93077719|NCT02728050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077720|NCT02728050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077721|NCT02728050|Immunologic Factors|immunologic factors|mesh-ancestor
93077722|NCT02728050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077723|NCT02728050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93077724|NCT02728050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077725|NCT02728050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077726|NCT02728050|Analgesics|analgesics|mesh-ancestor
93077727|NCT02728050|Sensory System Agents|sensory system agents|mesh-ancestor
93077728|NCT02728050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077729|NCT02728050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93077730|NCT02728050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077731|NCT02704858|Perillyl alcohol|perillyl alcohol|mesh-list
93077732|NCT02704858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077733|NCT02704858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077734|NCT02704858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077735|NCT02698254|Bevacizumab|bevacizumab|mesh-list
93077736|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93077737|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
93077738|NCT02698254|Antibodies|antibodies|mesh-list
93077739|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
93077740|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077741|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
93077742|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077743|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077744|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077745|NCT02698254|Growth Substances|growth substances|mesh-ancestor
93077746|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077747|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077748|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
93077749|NCT02659930|Doxorubicin|doxorubicin|mesh-list
93077750|NCT02659930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93077751|NCT02659930|Pomalidomide|pomalidomide|mesh-list
93077752|NCT02659930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93077753|NCT02659930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077754|NCT02659930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93054876|NCT00232596|Ezogabine|ezogabine|mesh-list
93077755|NCT02659930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077756|NCT02659930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077757|NCT02659930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077758|NCT02659930|Immunologic Factors|immunologic factors|mesh-ancestor
93077759|NCT02659930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077760|NCT02659930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077761|NCT02659930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077762|NCT02659930|Growth Substances|growth substances|mesh-ancestor
93077763|NCT02659930|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077764|NCT02633059|Dexamethasone|dexamethasone|mesh-list
93077765|NCT02633059|Dexamethasone acetate|dexamethasone acetate|mesh-list
93077766|NCT02633059|Ixazomib|ixazomib|mesh-list
93077767|NCT02633059|Ichthammol|ichthammol|mesh-list
93077768|NCT02633059|BB 1101|bb 1101|mesh-list
93077769|NCT02633059|Glycine|glycine|mesh-list
93077770|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077771|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
93077772|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
93077773|NCT02633059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077774|NCT02633059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077775|NCT02633059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93077776|NCT02633059|Glucocorticoids|glucocorticoids|mesh-ancestor
93077777|NCT02633059|Hormones|hormones|mesh-ancestor
93077778|NCT02633059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077779|NCT02633059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077780|NCT02633059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077781|NCT02633059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077782|NCT02633059|Protease Inhibitors|protease inhibitors|mesh-ancestor
93077783|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077784|NCT02633059|Dermatologic Agents|dermatologic agents|mesh-ancestor
93077785|NCT02633059|Glycine Agents|glycine agents|mesh-ancestor
93077786|NCT02633059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077787|NCT02631733|Irinotecan|irinotecan|mesh-list
93077788|NCT02631733|Veliparib|veliparib|mesh-list
93077789|NCT02631733|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93077790|NCT02631733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93077791|NCT02631733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077792|NCT02631733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077793|NCT02631733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077794|NCT02631733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077795|NCT02631733|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93077796|NCT02631733|Hematinics|hematinics|mesh-ancestor
93077797|NCT02631733|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93077798|NCT02631733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93077799|NCT02598349|Capecitabine|capecitabine|mesh-list
93077800|NCT02598349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93077801|NCT02598349|Antimetabolites|antimetabolites|mesh-ancestor
93077802|NCT02598349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077803|NCT02598349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077804|NCT02581943|Paclitaxel|paclitaxel|mesh-list
93077805|NCT02581943|Carboplatin|carboplatin|mesh-list
93077806|NCT02581943|Pembrolizumab|pembrolizumab|mesh-list
93077807|NCT02581943|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93077808|NCT02581943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077809|NCT02581943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077810|NCT02581943|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077811|NCT02581943|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077812|NCT02581943|Mitosis Modulators|mitosis modulators|mesh-ancestor
93077813|NCT02581943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077814|NCT02581943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077815|NCT02581943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077816|NCT02568553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93077817|NCT02568553|Lenalidomide|lenalidomide|mesh-list
93077818|NCT02568553|Blinatumomab|blinatumomab|mesh-list
93077819|NCT02568553|Antibodies|antibodies|mesh-list
93077820|NCT02568553|Immunoglobulins|immunoglobulins|mesh-list
93077821|NCT02568553|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077822|NCT02568553|Muromonab-CD3|muromonab-cd3|mesh-list
93077823|NCT02568553|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93077824|NCT02568553|Immunologic Factors|immunologic factors|mesh-ancestor
93077825|NCT02568553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077826|NCT02568553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077827|NCT02568553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077828|NCT02568553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077829|NCT02568553|Growth Substances|growth substances|mesh-ancestor
93077830|NCT02568553|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077831|NCT02568553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077832|NCT02567435|Sirolimus|sirolimus|mesh-list
93077833|NCT02567435|Dactinomycin|dactinomycin|mesh-list
93077835|NCT02567435|Irinotecan|irinotecan|mesh-list
93077836|NCT02567435|Vincristine|vincristine|mesh-list
93077837|NCT02567435|Temsirolimus|temsirolimus|mesh-list
93077838|NCT02567435|Vinorelbine|vinorelbine|mesh-list
93077839|NCT02567435|Camptothecin|camptothecin|mesh-list
93077840|NCT02567435|MTOR Inhibitors|mtor inhibitors|mesh-list
93077841|NCT02567435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077842|NCT02567435|Immunologic Factors|immunologic factors|mesh-ancestor
93077843|NCT02567435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077844|NCT02567435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077845|NCT02567435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077846|NCT02567435|Alkylating Agents|alkylating agents|mesh-ancestor
93077847|NCT02567435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077848|NCT02567435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077849|NCT02567435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077850|NCT02567435|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93077851|NCT02567435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077852|NCT02567435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077853|NCT02567435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077854|NCT02567435|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077855|NCT02567435|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077856|NCT02567435|Mitosis Modulators|mitosis modulators|mesh-ancestor
93077857|NCT02567435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93077858|NCT02567435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93077859|NCT02567435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93077860|NCT02567435|Antifungal Agents|antifungal agents|mesh-ancestor
93077861|NCT02567435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077862|NCT02567435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93077863|NCT02567435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93077864|NCT02562235|Riociguat|riociguat|mesh-list
93077865|NCT02562235|Enzyme Activators|enzyme activators|mesh-ancestor
93077866|NCT02562235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077867|NCT02527200|Liraglutide|liraglutide|mesh-list
93077868|NCT02527200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93077869|NCT02527200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077870|NCT02527200|Incretins|incretins|mesh-ancestor
93077871|NCT02527200|Hormones|hormones|mesh-ancestor
93077872|NCT02527200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077873|NCT02520791|Antibodies|antibodies|mesh-list
93077874|NCT02520791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077875|NCT02520791|Immunologic Factors|immunologic factors|mesh-ancestor
93077876|NCT02520791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077877|NCT02510040|Botulinum Toxins|botulinum toxins|mesh-list
93077878|NCT02510040|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93077879|NCT02510040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93077880|NCT02510040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077881|NCT02510040|Cholinergic Agents|cholinergic agents|mesh-ancestor
93077882|NCT02510040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93077883|NCT02510040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077884|NCT02502266|Paclitaxel|paclitaxel|mesh-list
93077885|NCT02502266|Doxorubicin|doxorubicin|mesh-list
93077886|NCT02502266|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93077887|NCT02502266|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93077888|NCT02502266|Topotecan|topotecan|mesh-list
93077889|NCT02502266|Olaparib|olaparib|mesh-list
93077890|NCT02502266|Cediranib|cediranib|mesh-list
93077891|NCT02502266|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93077892|NCT02502266|Maleic acid|maleic acid|mesh-list
93077893|NCT02502266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077894|NCT02502266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077895|NCT02502266|Tubulin Modulators|tubulin modulators|mesh-ancestor
93077896|NCT02502266|Antimitotic Agents|antimitotic agents|mesh-ancestor
93077897|NCT02502266|Mitosis Modulators|mitosis modulators|mesh-ancestor
93077898|NCT02502266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077899|NCT02502266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93077900|NCT02502266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93077901|NCT02502266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077902|NCT02502266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077903|NCT02502266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93077904|NCT02502266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077905|NCT02414269|Cyclophosphamide|cyclophosphamide|mesh-list
93077906|NCT02414269|Pembrolizumab|pembrolizumab|mesh-list
93077907|NCT02414269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077908|NCT02414269|Immunologic Factors|immunologic factors|mesh-ancestor
93077909|NCT02414269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077911|NCT02414269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077912|NCT02414269|Alkylating Agents|alkylating agents|mesh-ancestor
93077913|NCT02414269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077914|NCT02414269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077915|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077916|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077917|NCT02414269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077918|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
93077919|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077920|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077921|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077922|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077923|NCT02400216|Cholic Acids|cholic acids|mesh-list
93077924|NCT02400216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93077925|NCT02341989|Carboplatin|carboplatin|mesh-list
93077926|NCT02341989|Etoposide|etoposide|mesh-list
93077927|NCT02341989|Bleomycin|bleomycin|mesh-list
93077928|NCT02341989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077929|NCT02341989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93077930|NCT02341989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93077931|NCT02341989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93077932|NCT02341989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077933|NCT02341989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077934|NCT02341989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93077935|NCT02296125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93077936|NCT02296125|Gefitinib|gefitinib|mesh-list
93077937|NCT02296125|Osimertinib|osimertinib|mesh-list
93077938|NCT02296125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077939|NCT02296125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93077940|NCT02296125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077941|NCT02296125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077942|NCT02285192|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93077943|NCT02285192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93077944|NCT02285192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077945|NCT02267603|Pembrolizumab|pembrolizumab|mesh-list
93077946|NCT02267603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077947|NCT02267603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077948|NCT02267603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93077949|NCT02267603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077950|NCT02264678|Carboplatin|carboplatin|mesh-list
93077951|NCT02264678|Durvalumab|durvalumab|mesh-list
93077952|NCT02264678|Olaparib|olaparib|mesh-list
93077953|NCT02264678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93077954|NCT02264678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077955|NCT02264678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077956|NCT02264678|Immunologic Factors|immunologic factors|mesh-ancestor
93077957|NCT02264678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077958|NCT02264678|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93077959|NCT02264678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93077960|NCT02264678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077961|NCT02244125|Dexamethasone|dexamethasone|mesh-list
93077962|NCT02244125|Cyclophosphamide|cyclophosphamide|mesh-list
93077963|NCT02244125|Pomalidomide|pomalidomide|mesh-list
93077964|NCT02244125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93077965|NCT02244125|Immunologic Factors|immunologic factors|mesh-ancestor
93077966|NCT02244125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077967|NCT02244125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93077968|NCT02244125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93077969|NCT02244125|Alkylating Agents|alkylating agents|mesh-ancestor
93077970|NCT02244125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93077971|NCT02244125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077972|NCT02244125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93077973|NCT02244125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93077974|NCT02244125|Antiemetics|antiemetics|mesh-ancestor
93077975|NCT02244125|Autonomic Agents|autonomic agents|mesh-ancestor
93077976|NCT02244125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93077977|NCT02244125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93077978|NCT02244125|Glucocorticoids|glucocorticoids|mesh-ancestor
93077979|NCT02244125|Hormones|hormones|mesh-ancestor
93077980|NCT02244125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93077981|NCT02244125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93077982|NCT02244125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077983|NCT02244125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077984|NCT02244125|Growth Substances|growth substances|mesh-ancestor
93077985|NCT02244125|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077986|NCT02243878|Ranibizumab|ranibizumab|mesh-list
93077987|NCT02243878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93077988|NCT02243878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93077989|NCT02243878|Growth Substances|growth substances|mesh-ancestor
93077990|NCT02243878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93077991|NCT02243878|Growth Inhibitors|growth inhibitors|mesh-ancestor
93077992|NCT02243878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077993|NCT02203526|Cytarabine|cytarabine|mesh-list
93077994|NCT02203526|Isavuconazole|isavuconazole|mesh-list
93077995|NCT02203526|Rituximab|rituximab|mesh-list
93077996|NCT02203526|Methotrexate|methotrexate|mesh-list
93077997|NCT02203526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93077998|NCT02203526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93077999|NCT02203526|Immunologic Factors|immunologic factors|mesh-ancestor
93078000|NCT02203526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078001|NCT02203526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078002|NCT02203526|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93078003|NCT02203526|Abortifacient Agents|abortifacient agents|mesh-ancestor
93078004|NCT02203526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93078005|NCT02203526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078006|NCT02203526|Antimetabolites|antimetabolites|mesh-ancestor
93078007|NCT02203526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078008|NCT02203526|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078009|NCT02203526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078010|NCT02203526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93078011|NCT02203526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078012|NCT02203526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93078013|NCT02203526|Antiviral Agents|antiviral agents|mesh-ancestor
93078014|NCT02203526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078015|NCT02203526|Antifungal Agents|antifungal agents|mesh-ancestor
93078016|NCT02199236|Capecitabine|capecitabine|mesh-list
93078017|NCT02199236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078018|NCT02199236|Antimetabolites|antimetabolites|mesh-ancestor
93078019|NCT02199236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078020|NCT02199236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078021|NCT02176148|Fluocinonide|fluocinonide|mesh-list
93078022|NCT02176148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078023|NCT02176148|Glucocorticoids|glucocorticoids|mesh-ancestor
93078024|NCT02176148|Hormones|hormones|mesh-ancestor
93078025|NCT02176148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078026|NCT02176148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078027|NCT02176148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93078028|NCT02157051|Vaccines|vaccines|mesh-list
93078029|NCT02157051|Immunologic Factors|immunologic factors|mesh-ancestor
93078030|NCT02157051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078031|NCT02140255|Ritonavir|ritonavir|mesh-list
93078032|NCT02140255|Lopinavir|lopinavir|mesh-list
93078033|NCT02140255|Raltegravir Potassium|raltegravir potassium|mesh-list
93078034|NCT02140255|Nevirapine|nevirapine|mesh-list
93078035|NCT02140255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93078036|NCT02140255|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93078037|NCT02140255|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93078038|NCT02140255|Protease Inhibitors|protease inhibitors|mesh-ancestor
93078039|NCT02140255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078040|NCT02140255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078041|NCT02140255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93078042|NCT02140255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93078043|NCT02140255|Antiviral Agents|antiviral agents|mesh-ancestor
93078044|NCT02140255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078045|NCT02140255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93078046|NCT02140255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93078047|NCT02140255|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93078048|NCT02140255|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93078049|NCT02140255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93078050|NCT02140255|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93078051|NCT02140255|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93078052|NCT02111941|Vaccines|vaccines|mesh-list
93078053|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
93078054|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078055|NCT02043678|Prednisone|prednisone|mesh-list
93078056|NCT02043678|Prednisolone|prednisolone|mesh-list
93078057|NCT02043678|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93078058|NCT02043678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078059|NCT02043678|Glucocorticoids|glucocorticoids|mesh-ancestor
93078060|NCT02043678|Hormones|hormones|mesh-ancestor
93078061|NCT02043678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078062|NCT02043678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078063|NCT02043678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078064|NCT02043678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078065|NCT02037048|Leucovorin|leucovorin|mesh-list
93078066|NCT02037048|Paclitaxel|paclitaxel|mesh-list
93078067|NCT02037048|Carboplatin|carboplatin|mesh-list
93078068|NCT02037048|Fluorouracil|fluorouracil|mesh-list
93078069|NCT02037048|Oxaliplatin|oxaliplatin|mesh-list
93078070|NCT02037048|Calcium|calcium|mesh-list
93078071|NCT02037048|Levoleucovorin|levoleucovorin|mesh-list
93078072|NCT02037048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078073|NCT02037048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078074|NCT02037048|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078075|NCT02037048|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078076|NCT02037048|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078077|NCT02037048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078078|NCT02037048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93078079|NCT02037048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078080|NCT02037048|Antimetabolites|antimetabolites|mesh-ancestor
93078081|NCT02037048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078082|NCT02037048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078083|NCT02037048|Immunologic Factors|immunologic factors|mesh-ancestor
93078084|NCT02037048|Antidotes|antidotes|mesh-ancestor
93078085|NCT02037048|Protective Agents|protective agents|mesh-ancestor
93078086|NCT02037048|Vitamin B Complex|vitamin b complex|mesh-ancestor
93078087|NCT02037048|Vitamins|vitamins|mesh-ancestor
93078088|NCT02037048|Micronutrients|micronutrients|mesh-ancestor
93078089|NCT01935089|Interferons|interferons|mesh-list
93078090|NCT01935089|Interferon-alpha|interferon-alpha|mesh-list
93078091|NCT01935089|Interferon alpha-2|interferon alpha-2|mesh-list
93078092|NCT01935089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93078093|NCT01935089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078094|NCT01935089|Antiviral Agents|antiviral agents|mesh-ancestor
93078095|NCT01935089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078096|NCT01935089|Immunologic Factors|immunologic factors|mesh-ancestor
93078097|NCT01935089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078098|NCT01889992|Sirolimus|sirolimus|mesh-list
93078099|NCT01889992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078100|NCT01889992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078101|NCT01889992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078102|NCT01889992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078103|NCT01889992|Antifungal Agents|antifungal agents|mesh-ancestor
93078104|NCT01889992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078105|NCT01889992|Immunologic Factors|immunologic factors|mesh-ancestor
93078106|NCT01889992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078107|NCT01803152|Gemcitabine|gemcitabine|mesh-list
93078108|NCT01803152|Imiquimod|imiquimod|mesh-list
93078109|NCT01803152|Vaccines|vaccines|mesh-list
93078110|NCT01803152|Immunologic Factors|immunologic factors|mesh-ancestor
93078111|NCT01803152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078112|NCT01803152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078113|NCT01803152|Antimetabolites|antimetabolites|mesh-ancestor
93078114|NCT01803152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078115|NCT01803152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078116|NCT01803152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93078117|NCT01803152|Interferon Inducers|interferon inducers|mesh-ancestor
93078118|NCT01787409|Vitamin D|vitamin d|mesh-list
93078119|NCT01787409|Cholecalciferol|cholecalciferol|mesh-list
93078120|NCT01787409|Vitamins|vitamins|mesh-ancestor
93078121|NCT01787409|Micronutrients|micronutrients|mesh-ancestor
93078122|NCT01787409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078123|NCT01787409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93078124|NCT01787409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93078125|NCT01773707|Abatacept|abatacept|mesh-list
93078126|NCT01773707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078127|NCT01773707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078128|NCT01773707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078129|NCT01773707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078130|NCT01773707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078131|NCT01773707|Immunologic Factors|immunologic factors|mesh-ancestor
93078132|NCT01773707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078133|NCT01773707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078134|NCT01628640|Interferons|interferons|mesh-list
93078135|NCT01628640|Interferon-beta|interferon-beta|mesh-list
93078136|NCT01628640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078137|NCT01628640|Antiviral Agents|antiviral agents|mesh-ancestor
93078138|NCT01628640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078139|NCT01628640|Immunologic Factors|immunologic factors|mesh-ancestor
93078140|NCT01628640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078141|NCT01628029|Melatonin|melatonin|mesh-list
93078142|NCT01628029|Methylphenidate|methylphenidate|mesh-list
93078143|NCT01628029|Antioxidants|antioxidants|mesh-ancestor
93078144|NCT01628029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078145|NCT01628029|Protective Agents|protective agents|mesh-ancestor
93078146|NCT01628029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078147|NCT01628029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93078148|NCT01628029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93078149|NCT01628029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93078150|NCT01628029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93078151|NCT01628029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93078152|NCT01628029|Dopamine Agents|dopamine agents|mesh-ancestor
93078153|NCT01628029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93078154|NCT01504815|Cisplatin|cisplatin|mesh-list
93078155|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078156|NCT01494662|Capecitabine|capecitabine|mesh-list
93078157|NCT01494662|Trastuzumab|trastuzumab|mesh-list
93078158|NCT01494662|Maytansine|maytansine|mesh-list
93078159|NCT01494662|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93078160|NCT01494662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078161|NCT01494662|Antimetabolites|antimetabolites|mesh-ancestor
93078162|NCT01494662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078163|NCT01494662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078164|NCT01494662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078165|NCT01494662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078166|NCT01494662|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078167|NCT01494662|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078168|NCT01494662|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078169|NCT01494662|Immunotoxins|immunotoxins|mesh-ancestor
93078170|NCT01494662|Immunoconjugates|immunoconjugates|mesh-ancestor
93078171|NCT01494662|Immunologic Factors|immunologic factors|mesh-ancestor
93078172|NCT01494662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078173|NCT01413100|Mycophenolic Acid|mycophenolic acid|mesh-list
93078174|NCT01413100|Plerixafor|plerixafor|mesh-list
93078175|NCT01413100|Cyclophosphamide|cyclophosphamide|mesh-list
93078176|NCT01413100|Thymoglobulin|thymoglobulin|mesh-list
93078177|NCT01413100|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93078178|NCT01413100|Lenograstim|lenograstim|mesh-list
93078179|NCT01413100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078180|NCT01413100|Immunologic Factors|immunologic factors|mesh-ancestor
93078181|NCT01413100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078182|NCT01413100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078183|NCT01413100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078184|NCT01413100|Alkylating Agents|alkylating agents|mesh-ancestor
93078185|NCT01413100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078186|NCT01413100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078187|NCT01413100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078188|NCT01413100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93078189|NCT01413100|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078190|NCT01413100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93078191|NCT01413100|Antitubercular Agents|antitubercular agents|mesh-ancestor
93078192|NCT01413100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078193|NCT01413100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078194|NCT01413100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078195|NCT01413100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93078196|NCT01413100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93078197|NCT01413100|Antiviral Agents|antiviral agents|mesh-ancestor
93078198|NCT01334944|Ibuprofen|ibuprofen|mesh-list
93078199|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93078200|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93078201|NCT01334944|Analgesics|analgesics|mesh-ancestor
93078202|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
93078203|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93078204|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078205|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078206|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078207|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93078208|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078209|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078210|NCT01174121|Aldesleukin|aldesleukin|mesh-list
93078211|NCT01174121|Cyclophosphamide|cyclophosphamide|mesh-list
93078212|NCT01174121|Pembrolizumab|pembrolizumab|mesh-list
93078213|NCT01174121|Fludarabine|fludarabine|mesh-list
93078214|NCT01174121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078215|NCT01174121|Immunologic Factors|immunologic factors|mesh-ancestor
93078216|NCT01174121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078217|NCT01174121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078218|NCT01174121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078219|NCT01174121|Alkylating Agents|alkylating agents|mesh-ancestor
93078220|NCT01174121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078221|NCT01174121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078222|NCT01174121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078223|NCT01174121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078224|NCT01174121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078225|NCT01174121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93078226|NCT01174121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93078227|NCT01174121|Antiviral Agents|antiviral agents|mesh-ancestor
93078228|NCT01174121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078229|NCT01169337|Lenalidomide|lenalidomide|mesh-list
93078230|NCT01169337|Immunologic Factors|immunologic factors|mesh-ancestor
93078231|NCT01169337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078232|NCT01169337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93078233|NCT01169337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92668545|NCT00324363|Exenatide|exenatide|mesh-list
93078234|NCT01169337|Growth Substances|growth substances|mesh-ancestor
93078235|NCT01169337|Growth Inhibitors|growth inhibitors|mesh-ancestor
93078236|NCT01169337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078237|NCT01140373|Cyclophosphamide|cyclophosphamide|mesh-list
93078238|NCT01140373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078239|NCT01140373|Immunologic Factors|immunologic factors|mesh-ancestor
93078240|NCT01140373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078241|NCT01140373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078242|NCT01140373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078243|NCT01140373|Alkylating Agents|alkylating agents|mesh-ancestor
93078244|NCT01140373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078245|NCT01140373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078246|NCT01140373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078247|NCT00810732|Nifedipine|nifedipine|mesh-list
93078248|NCT00810732|Sitaxsentan|sitaxsentan|mesh-list
93078249|NCT00810732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93078250|NCT00810732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93078251|NCT00810732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078252|NCT00810732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93078253|NCT00810732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078254|NCT00810732|Vasodilator Agents|vasodilator agents|mesh-ancestor
93078255|NCT00810732|Tocolytic Agents|tocolytic agents|mesh-ancestor
93078256|NCT00810732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93078257|NCT00810732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93078258|NCT00770809|Paclitaxel|paclitaxel|mesh-list
93078259|NCT00770809|Trastuzumab|trastuzumab|mesh-list
93078260|NCT00770809|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93078261|NCT00770809|Lapatinib|lapatinib|mesh-list
93078262|NCT00770809|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
93078263|NCT00770809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93078264|NCT00770809|Antibodies|antibodies|mesh-list
93078265|NCT00770809|Immunoglobulins|immunoglobulins|mesh-list
93078266|NCT00770809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93078267|NCT00770809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078268|NCT00770809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078269|NCT00770809|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078270|NCT00770809|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078271|NCT00770809|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078272|NCT00770809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078273|NCT00770809|Immunologic Factors|immunologic factors|mesh-ancestor
93078274|NCT00770809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078275|NCT00770809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93078276|NCT00770809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078277|NCT00719888|Cyclosporine|cyclosporine|mesh-list
93078278|NCT00719888|Mycophenolic Acid|mycophenolic acid|mesh-list
93078279|NCT00719888|Cyclophosphamide|cyclophosphamide|mesh-list
93078280|NCT00719888|Thiotepa|thiotepa|mesh-list
93078281|NCT00719888|Fludarabine|fludarabine|mesh-list
93078282|NCT00719888|Cyclosporins|cyclosporins|mesh-list
93078283|NCT00719888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078284|NCT00719888|Immunologic Factors|immunologic factors|mesh-ancestor
93078285|NCT00719888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078286|NCT00719888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078287|NCT00719888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078288|NCT00719888|Alkylating Agents|alkylating agents|mesh-ancestor
93078289|NCT00719888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078290|NCT00719888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078291|NCT00719888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078292|NCT00719888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078293|NCT00719888|Antifungal Agents|antifungal agents|mesh-ancestor
93078294|NCT00719888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078295|NCT00719888|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078296|NCT00719888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93078297|NCT00719888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078298|NCT00719888|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93078299|NCT00719888|Antitubercular Agents|antitubercular agents|mesh-ancestor
93078300|NCT00719888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078301|NCT00716066|Cytarabine|cytarabine|mesh-list
93078302|NCT00716066|Prednisone|prednisone|mesh-list
93078303|NCT00716066|Cortisone|cortisone|mesh-list
93078304|NCT00716066|Etoposide|etoposide|mesh-list
93078305|NCT00716066|Etoposide phosphate|etoposide phosphate|mesh-list
93078306|NCT00716066|Melphalan|melphalan|mesh-list
93078307|NCT00716066|Mechlorethamine|mechlorethamine|mesh-list
93078308|NCT00716066|Carmustine|carmustine|mesh-list
93078309|NCT00716066|Podophyllotoxin|podophyllotoxin|mesh-list
93078310|NCT00716066|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93078311|NCT00716066|Thymoglobulin|thymoglobulin|mesh-list
93078312|NCT00716066|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93078313|NCT00716066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078314|NCT00716066|Glucocorticoids|glucocorticoids|mesh-ancestor
93078315|NCT00716066|Hormones|hormones|mesh-ancestor
93078316|NCT00716066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078317|NCT00716066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078318|NCT00716066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078319|NCT00716066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078320|NCT00716066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078321|NCT00716066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078322|NCT00716066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078323|NCT00716066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078324|NCT00716066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078325|NCT00716066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078326|NCT00716066|Antimetabolites|antimetabolites|mesh-ancestor
93078327|NCT00716066|Antiviral Agents|antiviral agents|mesh-ancestor
93078328|NCT00716066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078329|NCT00716066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078330|NCT00716066|Immunologic Factors|immunologic factors|mesh-ancestor
93078331|NCT00716066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078332|NCT00716066|Alkylating Agents|alkylating agents|mesh-ancestor
93078333|NCT00716066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078334|NCT00716066|Keratolytic Agents|keratolytic agents|mesh-ancestor
93078335|NCT00716066|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078336|NCT00716066|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078337|NCT00716066|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078338|NCT00716066|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078339|NCT00571727|Mecasermin|mecasermin|mesh-list
93078340|NCT00571727|Growth Substances|growth substances|mesh-ancestor
93078341|NCT00571727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078342|NCT00489307|Dexamethasone|dexamethasone|mesh-list
93078343|NCT00489307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078344|NCT00489307|Antiemetics|antiemetics|mesh-ancestor
93078345|NCT00489307|Autonomic Agents|autonomic agents|mesh-ancestor
93078346|NCT00489307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93078347|NCT00489307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078348|NCT00489307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93078349|NCT00489307|Glucocorticoids|glucocorticoids|mesh-ancestor
93078350|NCT00489307|Hormones|hormones|mesh-ancestor
93078351|NCT00489307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078352|NCT00489307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078353|NCT00489307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078354|NCT00427349|Octreotide|octreotide|mesh-list
93078355|NCT00427349|Motesanib diphosphate|motesanib diphosphate|mesh-list
93078356|NCT00427349|Imetelstat|imetelstat|mesh-list
93078357|NCT00427349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93078358|NCT00427349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078359|NCT00427349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078360|NCT00427349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93078361|NCT00427349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078362|NCT00427349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078363|NCT00309985|Docetaxel|docetaxel|mesh-list
93078364|NCT00309985|Androgens|androgens|mesh-list
93078365|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078366|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078367|NCT00309985|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078368|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078369|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078370|NCT00309985|Hormones|hormones|mesh-ancestor
93078371|NCT00309985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078372|NCT00309985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078373|NCT00295893|Paclitaxel|paclitaxel|mesh-list
93078374|NCT00295893|Docetaxel|docetaxel|mesh-list
93078375|NCT00295893|Cyclophosphamide|cyclophosphamide|mesh-list
93078376|NCT00295893|Carboplatin|carboplatin|mesh-list
93078377|NCT00295893|Doxorubicin|doxorubicin|mesh-list
93078378|NCT00295893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93078379|NCT00295893|Trastuzumab|trastuzumab|mesh-list
93078380|NCT00295893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078381|NCT00295893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078382|NCT00295893|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078383|NCT00295893|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078384|NCT00295893|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078385|NCT00295893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078386|NCT00295893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078387|NCT00295893|Immunologic Factors|immunologic factors|mesh-ancestor
93078388|NCT00295893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078389|NCT00295893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078390|NCT00295893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078391|NCT00295893|Alkylating Agents|alkylating agents|mesh-ancestor
93078392|NCT00295893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078393|NCT00295893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078394|NCT00295893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078395|NCT00295893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078396|NCT00295893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078397|NCT00295893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078398|NCT00200174|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93078399|NCT00200174|Exemestane|exemestane|mesh-list
93078400|NCT00200174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078401|NCT00200174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93078402|NCT00200174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93078403|NCT00200174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078404|NCT00200174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078405|NCT00200174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93078406|NCT00200174|Hormone Antagonists|hormone antagonists|mesh-ancestor
93078407|NCT00200174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078408|NCT00200174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078409|NCT00200174|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93078410|NCT00200174|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93078411|NCT00200174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93078412|NCT00195091|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
93078413|NCT00195091|Chelating Agents|chelating agents|mesh-ancestor
93078414|NCT00195091|Sequestering Agents|sequestering agents|mesh-ancestor
93078415|NCT00195091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078416|NCT00195091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078417|NCT00195091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93078418|NCT00195091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93078419|NCT00195091|Growth Substances|growth substances|mesh-ancestor
93078420|NCT00195091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078421|NCT00195091|Growth Inhibitors|growth inhibitors|mesh-ancestor
93078422|NCT00195091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078423|NCT00114101|Lenalidomide|lenalidomide|mesh-list
93078424|NCT00114101|Melphalan|melphalan|mesh-list
93078425|NCT00114101|Mechlorethamine|mechlorethamine|mesh-list
93078426|NCT00114101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93078427|NCT00114101|Immunologic Factors|immunologic factors|mesh-ancestor
93078428|NCT00114101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078429|NCT00114101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93078430|NCT00114101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93078431|NCT00114101|Growth Substances|growth substances|mesh-ancestor
93078432|NCT00114101|Growth Inhibitors|growth inhibitors|mesh-ancestor
93078433|NCT00114101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078434|NCT00114101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078435|NCT00114101|Alkylating Agents|alkylating agents|mesh-ancestor
93078436|NCT00114101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078437|NCT00114101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078438|NCT00114101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078439|NCT00098787|Leucovorin|leucovorin|mesh-list
93078440|NCT00098787|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
93078441|NCT00098787|Tetrahydrofolates|tetrahydrofolates|mesh-list
93078442|NCT00098787|Bevacizumab|bevacizumab|mesh-list
93078443|NCT00098787|Fluorouracil|fluorouracil|mesh-list
93078444|NCT00098787|Oxaliplatin|oxaliplatin|mesh-list
93078445|NCT00098787|Irinotecan|irinotecan|mesh-list
93078446|NCT00098787|Camptothecin|camptothecin|mesh-list
93078447|NCT00098787|Levoleucovorin|levoleucovorin|mesh-list
93078448|NCT00098787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078449|NCT00098787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078450|NCT00098787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93078451|NCT00098787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93078452|NCT00098787|Growth Substances|growth substances|mesh-ancestor
93078453|NCT00098787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078454|NCT00098787|Growth Inhibitors|growth inhibitors|mesh-ancestor
93078455|NCT00098787|Antimetabolites|antimetabolites|mesh-ancestor
93078456|NCT00098787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078457|NCT00098787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078458|NCT00098787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078459|NCT00098787|Immunologic Factors|immunologic factors|mesh-ancestor
93078460|NCT00098787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93078461|NCT00098787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078462|NCT00098787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078463|NCT00098787|Antidotes|antidotes|mesh-ancestor
93078464|NCT00098787|Protective Agents|protective agents|mesh-ancestor
93078465|NCT00098787|Vitamin B Complex|vitamin b complex|mesh-ancestor
93078466|NCT00098787|Vitamins|vitamins|mesh-ancestor
93078467|NCT00098787|Micronutrients|micronutrients|mesh-ancestor
93078468|NCT00098787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078469|NCT00098475|Thalidomide|thalidomide|mesh-list
93078470|NCT00098475|Dexamethasone|dexamethasone|mesh-list
93078471|NCT00098475|Dexamethasone acetate|dexamethasone acetate|mesh-list
93078472|NCT00098475|Lenalidomide|lenalidomide|mesh-list
93078473|NCT00098475|Ichthammol|ichthammol|mesh-list
93078474|NCT00098475|BB 1101|bb 1101|mesh-list
93078475|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078476|NCT00098475|Antiemetics|antiemetics|mesh-ancestor
93078477|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
93078478|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93078479|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078480|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93078481|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
93078482|NCT00098475|Hormones|hormones|mesh-ancestor
93078483|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078484|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078485|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078486|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
93078487|NCT00098475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078488|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078489|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
93078490|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93078491|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93078492|NCT00098475|Growth Substances|growth substances|mesh-ancestor
93078493|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
93078494|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078495|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
93078496|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078497|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078498|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078499|NCT00075946|Rituximab|rituximab|mesh-list
93078500|NCT00075946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078501|NCT00075946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078502|NCT00075946|Immunologic Factors|immunologic factors|mesh-ancestor
93078503|NCT00075946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078504|NCT00075946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078505|NCT00074165|Cytarabine|cytarabine|mesh-list
93078506|NCT00074165|Sodium thiosulfate|sodium thiosulfate|mesh-list
93078507|NCT00074165|Cyclophosphamide|cyclophosphamide|mesh-list
93078508|NCT00074165|Rituximab|rituximab|mesh-list
93078509|NCT00074165|Carboplatin|carboplatin|mesh-list
93078510|NCT00074165|Etoposide|etoposide|mesh-list
93078511|NCT00074165|Etoposide phosphate|etoposide phosphate|mesh-list
93078512|NCT00074165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078513|NCT00074165|Immunologic Factors|immunologic factors|mesh-ancestor
93078514|NCT00074165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078515|NCT00074165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078516|NCT00074165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078517|NCT00074165|Alkylating Agents|alkylating agents|mesh-ancestor
93078518|NCT00074165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078519|NCT00074165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078520|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078521|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078522|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078523|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078524|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078525|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078526|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078527|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
93078528|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
93078529|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078530|NCT00074165|Antidotes|antidotes|mesh-ancestor
93078531|NCT00074165|Protective Agents|protective agents|mesh-ancestor
93078532|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
93078533|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
93078534|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078535|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
93078536|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
93078537|NCT00059930|Leucovorin|leucovorin|mesh-list
93078538|NCT00059930|Dexamethasone|dexamethasone|mesh-list
93078539|NCT00059930|Fluorouracil|fluorouracil|mesh-list
93078540|NCT00059930|Oxaliplatin|oxaliplatin|mesh-list
93078541|NCT00059930|Floxuridine|floxuridine|mesh-list
93078542|NCT00059930|Calcium|calcium|mesh-list
93078543|NCT00059930|Levoleucovorin|levoleucovorin|mesh-list
93078544|NCT00059930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078545|NCT00059930|Antiemetics|antiemetics|mesh-ancestor
93078546|NCT00059930|Autonomic Agents|autonomic agents|mesh-ancestor
93078547|NCT00059930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93078548|NCT00059930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078549|NCT00059930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93078550|NCT00059930|Glucocorticoids|glucocorticoids|mesh-ancestor
93078551|NCT00059930|Hormones|hormones|mesh-ancestor
93078552|NCT00059930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078553|NCT00059930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078554|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078555|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93078556|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
93078557|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078558|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078559|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078560|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
93078561|NCT00059930|Antidotes|antidotes|mesh-ancestor
93078562|NCT00059930|Protective Agents|protective agents|mesh-ancestor
93078563|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
93078564|NCT00059930|Vitamins|vitamins|mesh-ancestor
93078565|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
93078566|NCT00057876|Gemcitabine|gemcitabine|mesh-list
93078567|NCT00057876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078568|NCT00057876|Antimetabolites|antimetabolites|mesh-ancestor
93078569|NCT00057876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078570|NCT00057876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078571|NCT00057837|Cisplatin|cisplatin|mesh-list
93078572|NCT00057837|Irinotecan|irinotecan|mesh-list
93078573|NCT00057837|Etoposide|etoposide|mesh-list
93078574|NCT00057837|Etoposide phosphate|etoposide phosphate|mesh-list
93078575|NCT00057837|Topotecan|topotecan|mesh-list
93078576|NCT00057837|Podophyllotoxin|podophyllotoxin|mesh-list
93078577|NCT00057837|Camptothecin|camptothecin|mesh-list
93078578|NCT00057837|Lenograstim|lenograstim|mesh-list
93078579|NCT00057837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078580|NCT00057837|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93078581|NCT00057837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078582|NCT00057837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078583|NCT00057837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078584|NCT00057837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078585|NCT00057837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078586|NCT00057837|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93078587|NCT00057837|Immunologic Factors|immunologic factors|mesh-ancestor
93078588|NCT00057837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078589|NCT00057837|Keratolytic Agents|keratolytic agents|mesh-ancestor
93078590|NCT00057837|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078591|NCT00057837|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078592|NCT00057837|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078593|NCT00057837|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078594|NCT00046930|Cytarabine|cytarabine|mesh-list
93055690|NCT01115842|Vitamin D|vitamin d|mesh-list
93078595|NCT00046930|Daunorubicin|daunorubicin|mesh-list
93078596|NCT00046930|Molgramostim|molgramostim|mesh-list
93078597|NCT00046930|Lenograstim|lenograstim|mesh-list
93078598|NCT00046930|Sargramostim|sargramostim|mesh-list
93078599|NCT00046930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078601|NCT00046930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078602|NCT00046930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078603|NCT00046930|Antiviral Agents|antiviral agents|mesh-ancestor
93078604|NCT00046930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078605|NCT00046930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078606|NCT00046930|Immunologic Factors|immunologic factors|mesh-ancestor
93078607|NCT00046930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078608|NCT00046930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93078609|NCT00046930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078610|NCT00046930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078611|NCT00046930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078612|NCT00046930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078613|NCT00042939|Docetaxel|docetaxel|mesh-list
93078614|NCT00042939|Irinotecan|irinotecan|mesh-list
93078615|NCT00042939|Cetuximab|cetuximab|mesh-list
93078616|NCT00042939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078617|NCT00042939|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078618|NCT00042939|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078619|NCT00042939|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078620|NCT00042939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078621|NCT00042939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93078622|NCT00042939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078623|NCT00042939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078624|NCT00042939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078625|NCT00008385|Selenium|selenium|mesh-list
93078626|NCT00008385|Antioxidants|antioxidants|mesh-ancestor
93078627|NCT00008385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078628|NCT00008385|Protective Agents|protective agents|mesh-ancestor
93078629|NCT00008385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078630|NCT00008385|Trace Elements|trace elements|mesh-ancestor
93078631|NCT00008385|Micronutrients|micronutrients|mesh-ancestor
93078632|NCT00003927|Paclitaxel|paclitaxel|mesh-list
93078633|NCT00003927|Cyclophosphamide|cyclophosphamide|mesh-list
93078634|NCT00003927|Doxorubicin|doxorubicin|mesh-list
93078635|NCT00003927|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93078636|NCT00003927|Amifostine|amifostine|mesh-list
93078637|NCT00003927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078638|NCT00003927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078639|NCT00003927|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078640|NCT00003927|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078641|NCT00003927|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078642|NCT00003927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078643|NCT00003927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078644|NCT00003927|Immunologic Factors|immunologic factors|mesh-ancestor
93078645|NCT00003927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078646|NCT00003927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078647|NCT00003927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078648|NCT00003927|Alkylating Agents|alkylating agents|mesh-ancestor
93078649|NCT00003927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078650|NCT00003927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078651|NCT00003927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078652|NCT00003927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078653|NCT00003927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078654|NCT00003927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93078655|NCT00003927|Protective Agents|protective agents|mesh-ancestor
93078656|NCT00003910|Prednisone|prednisone|mesh-list
93078657|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
93078658|NCT00003910|Methotrexate|methotrexate|mesh-list
93078659|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078660|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
93078661|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078662|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078663|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078664|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
93078665|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078666|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078667|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078668|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078669|NCT00003910|Glucocorticoids|glucocorticoids|mesh-ancestor
93078670|NCT00003910|Hormones|hormones|mesh-ancestor
93078671|NCT00003910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078672|NCT00003910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078673|NCT00003910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93078675|NCT00003910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93078676|NCT00003910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078677|NCT00003910|Antimetabolites|antimetabolites|mesh-ancestor
93078678|NCT00003910|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078679|NCT00003910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078680|NCT00003910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93078681|NCT00003910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93078682|NCT00003907|Cisplatin|cisplatin|mesh-list
93078683|NCT00003907|Doxorubicin|doxorubicin|mesh-list
93078684|NCT00003907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93078685|NCT00003907|Mitomycins|mitomycins|mesh-list
93078686|NCT00003907|Mitomycin|mitomycin|mesh-list
93078687|NCT00003907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078688|NCT00003907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93078689|NCT00003907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93078690|NCT00003907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93078691|NCT00003907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078692|NCT00003907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078693|NCT00003907|Alkylating Agents|alkylating agents|mesh-ancestor
93078694|NCT00003907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93078695|NCT00001337|Rituximab|rituximab|mesh-list
93078696|NCT00001337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078697|NCT00001337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078698|NCT00001337|Immunologic Factors|immunologic factors|mesh-ancestor
93078699|NCT00001337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078700|NCT00001337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078701|NCT04331067|Paclitaxel|paclitaxel|mesh-list
93078702|NCT04331067|Carboplatin|carboplatin|mesh-list
93078703|NCT04331067|Nivolumab|nivolumab|mesh-list
93078704|NCT04331067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078705|NCT04331067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078706|NCT04331067|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078707|NCT04331067|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078708|NCT04331067|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078709|NCT04331067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078710|NCT04331067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078711|NCT04331067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078712|NCT04329221|Calcitriol|calcitriol|mesh-list
93078713|NCT04329221|Fluorouracil|fluorouracil|mesh-list
93078714|NCT04329221|Calcipotriene|calcipotriene|mesh-list
93078715|NCT04329221|Petrolatum|petrolatum|mesh-list
93078716|NCT04329221|Antimetabolites|antimetabolites|mesh-ancestor
93078717|NCT04329221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078718|NCT04329221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078719|NCT04329221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078720|NCT04329221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078721|NCT04329221|Immunologic Factors|immunologic factors|mesh-ancestor
93078722|NCT04329221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078723|NCT04329221|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078724|NCT04329221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93078725|NCT04329221|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93078726|NCT04329221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93078727|NCT04329221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93078728|NCT04329221|Vitamins|vitamins|mesh-ancestor
93078729|NCT04329221|Micronutrients|micronutrients|mesh-ancestor
93078730|NCT04329221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93078731|NCT04329221|Emollients|emollients|mesh-ancestor
93078732|NCT04324840|Temozolomide|temozolomide|mesh-list
93078733|NCT04324840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078734|NCT04324840|Alkylating Agents|alkylating agents|mesh-ancestor
93078735|NCT04324840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078736|NCT04324840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078737|NCT04316013|Lidocaine|lidocaine|mesh-list
93078738|NCT04316013|Propofol|propofol|mesh-list
93078739|NCT04316013|Sevoflurane|sevoflurane|mesh-list
93078740|NCT04316013|Anesthetics, Local|anesthetics, local|mesh-ancestor
93078741|NCT04316013|Anesthetics|anesthetics|mesh-ancestor
93078742|NCT04316013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93078743|NCT04316013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078744|NCT04316013|Sensory System Agents|sensory system agents|mesh-ancestor
93078745|NCT04316013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055831|NCT02529514|GABA Agents|gaba agents|mesh-ancestor
93078746|NCT04316013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93078747|NCT04316013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93078748|NCT04316013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93078749|NCT04316013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93078750|NCT04316013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078751|NCT04316013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93078752|NCT04316013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93078753|NCT04316013|Anesthetics, General|anesthetics, general|mesh-ancestor
93078754|NCT04316013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93078755|NCT04316013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93078756|NCT04312594|Acetylcysteine|acetylcysteine|mesh-list
93078757|NCT04312594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93078758|NCT04312594|Antiviral Agents|antiviral agents|mesh-ancestor
93078759|NCT04312594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078760|NCT04312594|Expectorants|expectorants|mesh-ancestor
93078761|NCT04312594|Respiratory System Agents|respiratory system agents|mesh-ancestor
93078762|NCT04312594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93078763|NCT04312594|Antioxidants|antioxidants|mesh-ancestor
93078764|NCT04312594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078765|NCT04312594|Protective Agents|protective agents|mesh-ancestor
93078766|NCT04312594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078767|NCT04312594|Antidotes|antidotes|mesh-ancestor
93078768|NCT04270474|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93078769|NCT04270474|Cholinergic Agents|cholinergic agents|mesh-ancestor
93078770|NCT04270474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93078771|NCT04270474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078772|NCT04270474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078773|NCT04264897|Metformin|metformin|mesh-list
93078774|NCT04264897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93078775|NCT04264897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078776|NCT04225026|Manganese|manganese|mesh-list
93078777|NCT04225026|Avasopasem manganese|avasopasem manganese|mesh-list
93078778|NCT04225026|Trace Elements|trace elements|mesh-ancestor
93078779|NCT04225026|Micronutrients|micronutrients|mesh-ancestor
93078780|NCT04225026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078781|NCT04225026|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93078782|NCT04225026|Antioxidants|antioxidants|mesh-ancestor
93078783|NCT04225026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078784|NCT04225026|Protective Agents|protective agents|mesh-ancestor
93078785|NCT04177108|Paclitaxel|paclitaxel|mesh-list
93078786|NCT04177108|Atezolizumab|atezolizumab|mesh-list
93078787|NCT04177108|Ipatasertib|ipatasertib|mesh-list
93078788|NCT04177108|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93078789|NCT04177108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93078790|NCT04177108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078791|NCT04177108|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078792|NCT04177108|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078793|NCT04177108|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078794|NCT04177108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669086|NCT00325689|Risperidone|risperidone|mesh-list
93078795|NCT04177108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078796|NCT04177108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078797|NCT04177108|Immunologic Factors|immunologic factors|mesh-ancestor
93078798|NCT04177108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078799|NCT04177108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93078800|NCT04177108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078801|NCT04140513|Deoxyglucose|deoxyglucose|mesh-list
93078802|NCT04140513|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93078803|NCT04140513|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93078804|NCT04140513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078805|NCT04140513|Antimetabolites|antimetabolites|mesh-ancestor
93078806|NCT04140513|Antiviral Agents|antiviral agents|mesh-ancestor
93078807|NCT04140513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078808|NCT04111627|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93078809|NCT04111627|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93078810|NCT04111627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93078811|NCT04111627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93078812|NCT04111627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078813|NCT04111627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93078814|NCT04111627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078815|NCT04111627|Analgesics|analgesics|mesh-ancestor
93078816|NCT04111627|Sensory System Agents|sensory system agents|mesh-ancestor
93078817|NCT04111627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93078818|NCT04111627|Antidepressive Agents|antidepressive agents|mesh-ancestor
93078819|NCT04111627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93078820|NCT04111627|Dopamine Agents|dopamine agents|mesh-ancestor
93078821|NCT04090710|Nivolumab|nivolumab|mesh-list
93078822|NCT04090710|Ipilimumab|ipilimumab|mesh-list
93078823|NCT04090710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078824|NCT04090710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078825|NCT04090710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078826|NCT04090710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078828|NCT04069312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078829|NCT04069312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078830|NCT04032080|Prexasertib|prexasertib|mesh-list
93078831|NCT04032080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93078832|NCT04032080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078833|NCT04032080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078834|NCT03983954|Durvalumab|durvalumab|mesh-list
93078835|NCT03983954|Obinutuzumab|obinutuzumab|mesh-list
93078836|NCT03983954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93078837|NCT03983954|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
93078838|NCT03983954|Immunoconjugates|immunoconjugates|mesh-list
93078839|NCT03983954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078840|NCT03983954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078841|NCT03983954|Immunologic Factors|immunologic factors|mesh-ancestor
93078842|NCT03983954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078843|NCT03982277|Rifampin|rifampin|mesh-list
93078844|NCT03982277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93078845|NCT03982277|Antitubercular Agents|antitubercular agents|mesh-ancestor
93078846|NCT03982277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93078847|NCT03982277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078848|NCT03982277|Leprostatic Agents|leprostatic agents|mesh-ancestor
93078849|NCT03982277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93078850|NCT03982277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078851|NCT03982277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078852|NCT03982277|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93078853|NCT03982277|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93078854|NCT03982277|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93078855|NCT03982277|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93078856|NCT03982277|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93078857|NCT03982277|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93078858|NCT03955978|Dostarlimab|dostarlimab|mesh-list
93078859|NCT03955978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078860|NCT03940352|Venetoclax|venetoclax|mesh-list
93078861|NCT03940352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078862|NCT03918499|Cyclophosphamide|cyclophosphamide|mesh-list
93078863|NCT03918499|Pembrolizumab|pembrolizumab|mesh-list
93078864|NCT03918499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078865|NCT03918499|Immunologic Factors|immunologic factors|mesh-ancestor
93078866|NCT03918499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078867|NCT03918499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93078868|NCT03918499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93078869|NCT03918499|Alkylating Agents|alkylating agents|mesh-ancestor
93078870|NCT03918499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078871|NCT03918499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078872|NCT03918499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93078873|NCT03918499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078874|NCT03918499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078875|NCT03914443|Cisplatin|cisplatin|mesh-list
93078876|NCT03914443|Docetaxel|docetaxel|mesh-list
93078877|NCT03914443|Fluorouracil|fluorouracil|mesh-list
93078878|NCT03914443|Nivolumab|nivolumab|mesh-list
93078879|NCT03914443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078880|NCT03914443|Tubulin Modulators|tubulin modulators|mesh-ancestor
93078881|NCT03914443|Antimitotic Agents|antimitotic agents|mesh-ancestor
93078882|NCT03914443|Mitosis Modulators|mitosis modulators|mesh-ancestor
93078883|NCT03914443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078884|NCT03914443|Antimetabolites|antimetabolites|mesh-ancestor
93078885|NCT03914443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078886|NCT03914443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93078887|NCT03914443|Immunologic Factors|immunologic factors|mesh-ancestor
93078888|NCT03914443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078889|NCT03914443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078890|NCT03914443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078891|NCT03815890|Nivolumab|nivolumab|mesh-list
93078892|NCT03815890|Ipilimumab|ipilimumab|mesh-list
93078893|NCT03815890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078894|NCT03815890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078895|NCT03815890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078896|NCT03815890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078897|NCT03794583|Treprostinil|treprostinil|mesh-list
93078898|NCT03794583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93078899|NCT03777657|Capecitabine|capecitabine|mesh-list
93078900|NCT03777657|Oxaliplatin|oxaliplatin|mesh-list
93078901|NCT03777657|Tislelizumab|tislelizumab|mesh-list
93078902|NCT03777657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078903|NCT03777657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078904|NCT03777657|Antimetabolites|antimetabolites|mesh-ancestor
93078905|NCT03777657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078906|NCT03777657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078907|NCT03711474|Dexamethasone|dexamethasone|mesh-list
93078908|NCT03711474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93078909|NCT03711474|Antiemetics|antiemetics|mesh-ancestor
93078910|NCT03711474|Autonomic Agents|autonomic agents|mesh-ancestor
93078911|NCT03711474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93078912|NCT03711474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078913|NCT03711474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93078914|NCT03711474|Glucocorticoids|glucocorticoids|mesh-ancestor
93078915|NCT03711474|Hormones|hormones|mesh-ancestor
93078916|NCT03711474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078917|NCT03711474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078918|NCT03711474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078919|NCT03482024|Tirzepatide|tirzepatide|mesh-list
93078920|NCT03482024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93078921|NCT03482024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078922|NCT03482024|Incretins|incretins|mesh-ancestor
93078923|NCT03482024|Hormones|hormones|mesh-ancestor
93078924|NCT03482024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078925|NCT03423199|Tamoxifen|tamoxifen|mesh-list
93078926|NCT03423199|Goserelin|goserelin|mesh-list
93078927|NCT03423199|Palbociclib|palbociclib|mesh-list
93078928|NCT03423199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93078929|NCT03423199|Hormone Antagonists|hormone antagonists|mesh-ancestor
93078930|NCT03423199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078931|NCT03423199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078932|NCT03423199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93078933|NCT03423199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078934|NCT03423199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93078935|NCT03423199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93078936|NCT03423199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93078937|NCT03423199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93078938|NCT03423199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669226|NCT00325845|Hylan|hylan|mesh-list
93078939|NCT03423199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078940|NCT03423147|Chlorhexidine|chlorhexidine|mesh-list
93078941|NCT03423147|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93078942|NCT03423147|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93078943|NCT03423147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93078944|NCT03423147|Disinfectants|disinfectants|mesh-ancestor
93078945|NCT03423147|Dermatologic Agents|dermatologic agents|mesh-ancestor
93078946|NCT03418532|Osimertinib|osimertinib|mesh-list
93078947|NCT03418532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078948|NCT03418532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93078949|NCT03418532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93078950|NCT03418532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078951|NCT03417401|Plasminogen|plasminogen|mesh-list
93078952|NCT03417401|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93078953|NCT03417401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93078954|NCT03417401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93078955|NCT03417401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078956|NCT03322631|Tirzepatide|tirzepatide|mesh-list
93078957|NCT03322631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93078958|NCT03322631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078959|NCT03322631|Incretins|incretins|mesh-ancestor
93078960|NCT03322631|Hormones|hormones|mesh-ancestor
93078961|NCT03322631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93078962|NCT03290612|Ascorbic Acid|ascorbic acid|mesh-list
93078963|NCT03290612|Vitamins|vitamins|mesh-ancestor
93078964|NCT03290612|Micronutrients|micronutrients|mesh-ancestor
93078965|NCT03290612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078966|NCT03290612|Antioxidants|antioxidants|mesh-ancestor
93078967|NCT03290612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078968|NCT03290612|Protective Agents|protective agents|mesh-ancestor
93078969|NCT03086642|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93078970|NCT03086642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93078971|NCT03086642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056064|NCT01119196|Icodextrin|icodextrin|mesh-list
93078972|NCT03057795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93078973|NCT03057795|Nivolumab|nivolumab|mesh-list
93078974|NCT03057795|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93078975|NCT03057795|Antibodies|antibodies|mesh-list
93078976|NCT03057795|Immunoglobulins|immunoglobulins|mesh-list
93078977|NCT03057795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93078978|NCT03057795|Immunoconjugates|immunoconjugates|mesh-list
93078979|NCT03057795|Immunologic Factors|immunologic factors|mesh-ancestor
93078980|NCT03057795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078981|NCT03057795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078982|NCT03057795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93078983|NCT03057795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078984|NCT03057795|Immunotoxins|immunotoxins|mesh-ancestor
93078985|NCT03018704|Topiramate|topiramate|mesh-list
93078986|NCT03018704|Anticonvulsants|anticonvulsants|mesh-ancestor
93078987|NCT03018704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93078988|NCT03018704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078989|NCT02978612|Capecitabine|capecitabine|mesh-list
93078990|NCT02978612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93078991|NCT02978612|Antimetabolites|antimetabolites|mesh-ancestor
93078992|NCT02978612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93078993|NCT02978612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93078994|NCT02970500|Methylphenidate|methylphenidate|mesh-list
93078995|NCT02970500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93078996|NCT02970500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93078997|NCT02970500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93078998|NCT02970500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93078999|NCT02970500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93079000|NCT02970500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079001|NCT02970500|Dopamine Agents|dopamine agents|mesh-ancestor
93079002|NCT02970500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079003|NCT02951130|Milrinone|milrinone|mesh-list
93079004|NCT02951130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93079005|NCT02951130|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93079006|NCT02951130|Vasodilator Agents|vasodilator agents|mesh-ancestor
93079007|NCT02951130|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93079008|NCT02951130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93079009|NCT02951130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079010|NCT02951130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079011|NCT02951130|Protective Agents|protective agents|mesh-ancestor
93079012|NCT02951130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079013|NCT02810743|Olaparib|olaparib|mesh-list
93079014|NCT02810743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93079015|NCT02810743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079016|NCT02810743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079017|NCT02810743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079018|NCT02617407|Listerine|listerine|mesh-list
93079019|NCT02617407|Sodium Fluoride|sodium fluoride|mesh-list
93079020|NCT02617407|Cariostatic Agents|cariostatic agents|mesh-ancestor
93079021|NCT02617407|Protective Agents|protective agents|mesh-ancestor
93079022|NCT02617407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079023|NCT02617407|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93079024|NCT02617407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079025|NCT02537509|Cholecalciferol|cholecalciferol|mesh-list
93079026|NCT02537509|Vitamin D|vitamin d|mesh-list
93079027|NCT02537509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93079028|NCT02537509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079029|NCT02537509|Vitamins|vitamins|mesh-ancestor
93079030|NCT02537509|Micronutrients|micronutrients|mesh-ancestor
93079031|NCT02537509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93079032|NCT02490878|Bevacizumab|bevacizumab|mesh-list
93079033|NCT02490878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079034|NCT02490878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079035|NCT02490878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93079036|NCT02490878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93079037|NCT02490878|Growth Substances|growth substances|mesh-ancestor
93079038|NCT02490878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079039|NCT02490878|Growth Inhibitors|growth inhibitors|mesh-ancestor
93079040|NCT02332850|Dexamethasone|dexamethasone|mesh-list
93079041|NCT02332850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079042|NCT02332850|Antiemetics|antiemetics|mesh-ancestor
93079043|NCT02332850|Autonomic Agents|autonomic agents|mesh-ancestor
93079044|NCT02332850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079045|NCT02332850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079046|NCT02332850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079048|NCT02332850|Hormones|hormones|mesh-ancestor
93079049|NCT02332850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079050|NCT02332850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079051|NCT02332850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079052|NCT02262325|Etoposide|etoposide|mesh-list
93079053|NCT02262325|Etoposide phosphate|etoposide phosphate|mesh-list
93079054|NCT02262325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079055|NCT02262325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079056|NCT02262325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93079057|NCT02262325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93079058|NCT02262325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079059|NCT02262325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079060|NCT02205762|Cytarabine|cytarabine|mesh-list
93079061|NCT02205762|Prednisone|prednisone|mesh-list
93079062|NCT02205762|Indomethacin|indomethacin|mesh-list
93079063|NCT02205762|Methotrexate|methotrexate|mesh-list
93079064|NCT02205762|Mercaptopurine|mercaptopurine|mesh-list
93079065|NCT02205762|Vinblastine|vinblastine|mesh-list
93079066|NCT02205762|Cladribine|cladribine|mesh-list
93079067|NCT02205762|Immunoglobulins|immunoglobulins|mesh-list
93079068|NCT02205762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93079069|NCT02205762|gamma-Globulins|gamma-globulins|mesh-list
93079070|NCT02205762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93079071|NCT02205762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079072|NCT02205762|Glucocorticoids|glucocorticoids|mesh-ancestor
93079073|NCT02205762|Hormones|hormones|mesh-ancestor
93079074|NCT02205762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079075|NCT02205762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079076|NCT02205762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079077|NCT02205762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079078|NCT02205762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93079079|NCT02205762|Abortifacient Agents|abortifacient agents|mesh-ancestor
93079080|NCT02205762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93079081|NCT02205762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079082|NCT02205762|Antimetabolites|antimetabolites|mesh-ancestor
93079083|NCT02205762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079084|NCT02205762|Dermatologic Agents|dermatologic agents|mesh-ancestor
93079085|NCT02205762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079086|NCT02205762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93079087|NCT02205762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079088|NCT02205762|Immunologic Factors|immunologic factors|mesh-ancestor
93079089|NCT02205762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079090|NCT02205762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93079091|NCT02205762|Antiviral Agents|antiviral agents|mesh-ancestor
93079092|NCT02205762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079093|NCT02205762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079094|NCT02205762|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079095|NCT02205762|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079096|NCT02205762|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079097|NCT02205762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93079098|NCT02205762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93079099|NCT02205762|Analgesics|analgesics|mesh-ancestor
93079100|NCT02205762|Sensory System Agents|sensory system agents|mesh-ancestor
93079101|NCT02205762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079102|NCT02205762|Gout Suppressants|gout suppressants|mesh-ancestor
93079103|NCT02205762|Tocolytic Agents|tocolytic agents|mesh-ancestor
93079104|NCT02205762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93079105|NCT01996267|Paclitaxel|paclitaxel|mesh-list
93079106|NCT01996267|Cyclophosphamide|cyclophosphamide|mesh-list
93079107|NCT01996267|Carboplatin|carboplatin|mesh-list
93079108|NCT01996267|Fluorouracil|fluorouracil|mesh-list
93079109|NCT01996267|Trastuzumab|trastuzumab|mesh-list
93079110|NCT01996267|Pertuzumab|pertuzumab|mesh-list
93079111|NCT01996267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079112|NCT01996267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079113|NCT01996267|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079114|NCT01996267|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079115|NCT01996267|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079116|NCT01996267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079117|NCT01996267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079118|NCT01996267|Immunologic Factors|immunologic factors|mesh-ancestor
93079119|NCT01996267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079120|NCT01996267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079121|NCT01996267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079122|NCT01996267|Alkylating Agents|alkylating agents|mesh-ancestor
93079123|NCT01996267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93079125|NCT01996267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079126|NCT01996267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079127|NCT01934218|Hyaluronic Acid|hyaluronic acid|mesh-list
93079128|NCT01934218|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93079129|NCT01934218|Immunologic Factors|immunologic factors|mesh-ancestor
93079130|NCT01934218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079131|NCT01934218|Viscosupplements|viscosupplements|mesh-ancestor
93079132|NCT01934218|Protective Agents|protective agents|mesh-ancestor
93079133|NCT01898117|Paclitaxel|paclitaxel|mesh-list
93079134|NCT01898117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93079135|NCT01898117|Cyclophosphamide|cyclophosphamide|mesh-list
93079136|NCT01898117|Carboplatin|carboplatin|mesh-list
93079137|NCT01898117|Atezolizumab|atezolizumab|mesh-list
93079138|NCT01898117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93079139|NCT01898117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079140|NCT01898117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079141|NCT01898117|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079142|NCT01898117|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079143|NCT01898117|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079144|NCT01898117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079145|NCT01898117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079146|NCT01898117|Immunologic Factors|immunologic factors|mesh-ancestor
93079147|NCT01898117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079148|NCT01898117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079149|NCT01898117|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079150|NCT01898117|Alkylating Agents|alkylating agents|mesh-ancestor
93079151|NCT01898117|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93079152|NCT01898117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93079153|NCT01898117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079154|NCT01623167|Cyclosporine|cyclosporine|mesh-list
93079155|NCT01623167|Cyclosporins|cyclosporins|mesh-list
93079156|NCT01623167|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93079157|NCT01623167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079158|NCT01623167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079159|NCT01623167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079160|NCT01623167|Immunologic Factors|immunologic factors|mesh-ancestor
93079161|NCT01623167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079162|NCT01623167|Antifungal Agents|antifungal agents|mesh-ancestor
93079163|NCT01623167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079164|NCT01623167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93079165|NCT01623167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079166|NCT01623167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93079167|NCT01233635|Losartan|losartan|mesh-list
93079168|NCT01233635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93079169|NCT01233635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93079170|NCT01233635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93079171|NCT01233635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93079172|NCT01233635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079173|NCT00385606|Rofecoxib|rofecoxib|mesh-list
93079174|NCT00385606|Gemcitabine|gemcitabine|mesh-list
93079175|NCT00385606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079176|NCT00385606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079177|NCT00385606|Antimetabolites|antimetabolites|mesh-ancestor
93079178|NCT00385606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079179|NCT00385606|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93079180|NCT00385606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93079181|NCT00385606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079182|NCT00385606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93079183|NCT00385606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93079184|NCT00385606|Analgesics|analgesics|mesh-ancestor
93079185|NCT00385606|Sensory System Agents|sensory system agents|mesh-ancestor
93079186|NCT00385606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079187|NCT00385606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079188|NCT00385606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079189|NCT00385606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079190|NCT03721744|Paclitaxel|paclitaxel|mesh-list
93079191|NCT03721744|Gemcitabine|gemcitabine|mesh-list
93079192|NCT03721744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079193|NCT03721744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079194|NCT03721744|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079195|NCT03721744|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079196|NCT03721744|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056275|NCT01215214|Midazolam|midazolam|mesh-list
93079197|NCT03721744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079198|NCT03721744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079199|NCT03721744|Antimetabolites|antimetabolites|mesh-ancestor
93079200|NCT01589354|Ropivacaine|ropivacaine|mesh-list
93079201|NCT01589354|Anesthetics, Local|anesthetics, local|mesh-ancestor
93079202|NCT01589354|Anesthetics|anesthetics|mesh-ancestor
93079203|NCT01589354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079204|NCT01589354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079205|NCT01589354|Sensory System Agents|sensory system agents|mesh-ancestor
93079206|NCT01589354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079207|NCT01583660|Acetaminophen|acetaminophen|mesh-list
93079208|NCT01583660|Celecoxib|celecoxib|mesh-list
93079209|NCT01583660|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93079210|NCT01583660|Oxycodone|oxycodone|mesh-list
93079211|NCT01583660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93079212|NCT01583660|Analgesics|analgesics|mesh-ancestor
93079213|NCT01583660|Sensory System Agents|sensory system agents|mesh-ancestor
93079214|NCT01583660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079215|NCT01583660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079216|NCT01583660|Antipyretics|antipyretics|mesh-ancestor
93079217|NCT01583660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93079218|NCT01583660|Narcotics|narcotics|mesh-ancestor
93079219|NCT01583660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079220|NCT01583660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93079221|NCT01583660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079222|NCT01583660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079223|NCT01583660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93079224|NCT01583660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93079225|NCT01583660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079226|NCT01583660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079227|NCT03960866|Phentolamine|phentolamine|mesh-list
93079228|NCT03960866|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93079229|NCT03960866|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93079230|NCT03960866|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93079231|NCT03960866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93079232|NCT03960866|Adrenergic Agents|adrenergic agents|mesh-ancestor
93079233|NCT03960866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079234|NCT03960866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079235|NCT03960866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079236|NCT03960866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93079237|NCT01089218|Amoxicillin|amoxicillin|mesh-list
93079238|NCT01089218|Clavulanic Acid|clavulanic acid|mesh-list
93079239|NCT01089218|Clavulanic Acids|clavulanic acids|mesh-list
93079240|NCT01089218|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93079241|NCT01089218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079242|NCT01089218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079243|NCT01089218|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93079244|NCT01089218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079245|NCT01089218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079246|NCT03957668|Lactulose|lactulose|mesh-list
93079247|NCT03957668|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93079248|NCT03957668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079249|NCT03957668|Laxatives|laxatives|mesh-ancestor
93079250|NCT01089452|Amlodipine|amlodipine|mesh-list
93079251|NCT01089452|Olmesartan|olmesartan|mesh-list
93079252|NCT01089452|Perindopril|perindopril|mesh-list
93079253|NCT01089452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93079254|NCT01089452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93079255|NCT01089452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93079256|NCT01089452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079257|NCT01089452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93079258|NCT01089452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079259|NCT01089452|Vasodilator Agents|vasodilator agents|mesh-ancestor
93079260|NCT01089452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93079261|NCT01089452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93079262|NCT01089452|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93079263|NCT01089452|Protease Inhibitors|protease inhibitors|mesh-ancestor
93079264|NCT01089452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079265|NCT04880980|Itraconazole|itraconazole|mesh-list
93079266|NCT04880980|Terbinafine|terbinafine|mesh-list
93079267|NCT04880980|Antifungal Agents|antifungal agents|mesh-ancestor
93079268|NCT04880980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079269|NCT04880980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93079270|NCT04880980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93079271|NCT04880980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079272|NCT04880980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079273|NCT04880980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93079274|NCT04880980|Hormone Antagonists|hormone antagonists|mesh-ancestor
93079275|NCT04880980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079276|NCT04880980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079277|NCT04880980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93079279|NCT01583504|Anesthetics, Local|anesthetics, local|mesh-list
93079280|NCT01583504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079281|NCT01583504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079282|NCT01583504|Sensory System Agents|sensory system agents|mesh-ancestor
93079283|NCT01583504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079284|NCT01583036|Digoxin|digoxin|mesh-list
93079285|NCT01583036|Ezogabine|ezogabine|mesh-list
93079286|NCT01583036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93079287|NCT01583036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93079288|NCT01583036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079289|NCT01583036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079290|NCT01583036|Protective Agents|protective agents|mesh-ancestor
93079291|NCT01583036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079292|NCT01583036|Anticonvulsants|anticonvulsants|mesh-ancestor
93079293|NCT01583036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93079294|NCT01091792|Bevacizumab|bevacizumab|mesh-list
93079295|NCT01091792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079296|NCT01091792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079297|NCT01091792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93079298|NCT01091792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93079299|NCT01091792|Growth Substances|growth substances|mesh-ancestor
93079300|NCT01091792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079301|NCT01091792|Growth Inhibitors|growth inhibitors|mesh-ancestor
93079302|NCT03510910|Acetaminophen|acetaminophen|mesh-list
93079303|NCT03510910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93079304|NCT03510910|Analgesics|analgesics|mesh-ancestor
93079305|NCT03510910|Sensory System Agents|sensory system agents|mesh-ancestor
93079306|NCT03510910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079307|NCT03510910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079308|NCT03510910|Antipyretics|antipyretics|mesh-ancestor
93079309|NCT01091870|Sildenafil Citrate|sildenafil citrate|mesh-list
93079310|NCT01091870|Citric Acid|citric acid|mesh-list
93079311|NCT01091870|Sodium Citrate|sodium citrate|mesh-list
93079312|NCT01091870|Anticoagulants|anticoagulants|mesh-ancestor
93079313|NCT01091870|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93079314|NCT01091870|Chelating Agents|chelating agents|mesh-ancestor
93079315|NCT01091870|Sequestering Agents|sequestering agents|mesh-ancestor
93079316|NCT01091870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079317|NCT01091870|Vasodilator Agents|vasodilator agents|mesh-ancestor
93079318|NCT01091870|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93079319|NCT01091870|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93079320|NCT01091870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079321|NCT01091870|Urological Agents|urological agents|mesh-ancestor
93079322|NCT03509350|Vitamins|vitamins|mesh-list
93079323|NCT03509350|Ascorbic Acid|ascorbic acid|mesh-list
93079324|NCT03509350|Thiamine|thiamine|mesh-list
93079325|NCT03509350|Hydrocortisone|hydrocortisone|mesh-list
93079326|NCT03509350|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93079327|NCT03509350|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93079328|NCT03509350|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93079329|NCT03509350|Micronutrients|micronutrients|mesh-ancestor
93079330|NCT03509350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079331|NCT03509350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079332|NCT03509350|Antioxidants|antioxidants|mesh-ancestor
93079333|NCT03509350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079334|NCT03509350|Protective Agents|protective agents|mesh-ancestor
93079335|NCT03509350|Vitamin B Complex|vitamin b complex|mesh-ancestor
93079336|NCT00072410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93079337|NCT00072410|Antibodies|antibodies|mesh-list
93079338|NCT00072410|Immunoglobulins|immunoglobulins|mesh-list
93079339|NCT00072410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93079340|NCT00072410|Immunologic Factors|immunologic factors|mesh-ancestor
93079341|NCT00072410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079342|NCT00072410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079343|NCT03478696|Budesonide|budesonide|mesh-list
93079344|NCT03478696|Albuterol|albuterol|mesh-list
93079345|NCT03478696|Formoterol Fumarate|formoterol fumarate|mesh-list
93079346|NCT03478696|Tiotropium Bromide|tiotropium bromide|mesh-list
93079347|NCT03478696|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93079348|NCT03478696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079349|NCT03478696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93079350|NCT03478696|Autonomic Agents|autonomic agents|mesh-ancestor
93079351|NCT03478696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079352|NCT03478696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079353|NCT03478696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93079354|NCT03478696|Respiratory System Agents|respiratory system agents|mesh-ancestor
93079355|NCT03478696|Glucocorticoids|glucocorticoids|mesh-ancestor
93079356|NCT03478696|Hormones|hormones|mesh-ancestor
93079357|NCT03478696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079358|NCT03478696|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93079359|NCT03478696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93079360|NCT03478696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93079361|NCT03478696|Adrenergic Agents|adrenergic agents|mesh-ancestor
93079362|NCT03478696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079363|NCT03478696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079364|NCT03478696|Parasympatholytics|parasympatholytics|mesh-ancestor
93079365|NCT03478696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93079366|NCT03478696|Cholinergic Agents|cholinergic agents|mesh-ancestor
93079367|NCT03478696|Tocolytic Agents|tocolytic agents|mesh-ancestor
93079368|NCT03478696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93079369|NCT00072176|Sirolimus|sirolimus|mesh-list
93079370|NCT00072176|Temsirolimus|temsirolimus|mesh-list
93079371|NCT00072176|MTOR Inhibitors|mtor inhibitors|mesh-list
93079372|NCT00072176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079373|NCT00072176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079374|NCT00072176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079375|NCT00072176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079376|NCT00072176|Immunologic Factors|immunologic factors|mesh-ancestor
93079377|NCT00072176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079378|NCT00072176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079379|NCT00072176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079380|NCT00072176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079381|NCT00072176|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93079382|NCT00072176|Antifungal Agents|antifungal agents|mesh-ancestor
93079383|NCT00071396|Rituximab|rituximab|mesh-list
93079384|NCT00071396|Alemtuzumab|alemtuzumab|mesh-list
93079385|NCT00071396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079386|NCT00071396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079387|NCT00071396|Immunologic Factors|immunologic factors|mesh-ancestor
93079388|NCT00071396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079389|NCT00071396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079390|NCT03472534|Diacerein|diacerein|mesh-list
93079391|NCT03472534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079392|NCT03725020|Fluorides|fluorides|mesh-list
93079393|NCT03725020|Fluorides, Topical|fluorides, topical|mesh-list
93079394|NCT03725020|Cariostatic Agents|cariostatic agents|mesh-ancestor
93079395|NCT03725020|Protective Agents|protective agents|mesh-ancestor
93079396|NCT03725020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079397|NCT03721432|Pregabalin|pregabalin|mesh-list
93079398|NCT03721432|Analgesics|analgesics|mesh-ancestor
93079399|NCT03721432|Sensory System Agents|sensory system agents|mesh-ancestor
93079400|NCT03721432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079401|NCT03721432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079402|NCT03721432|Anticonvulsants|anticonvulsants|mesh-ancestor
93079403|NCT03721432|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93079404|NCT03721432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93079405|NCT03721432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079406|NCT03721432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93079407|NCT03721432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93079408|NCT03721432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93079409|NCT03721432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079410|NCT03721432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93079411|NCT03469336|Betamethasone|betamethasone|mesh-list
93079412|NCT03469336|Calcipotriene|calcipotriene|mesh-list
93079413|NCT03469336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079414|NCT03469336|Glucocorticoids|glucocorticoids|mesh-ancestor
93079415|NCT03469336|Hormones|hormones|mesh-ancestor
93079416|NCT03469336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079417|NCT03469336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079418|NCT03469336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93079419|NCT03469336|Respiratory System Agents|respiratory system agents|mesh-ancestor
93079420|NCT03469336|Dermatologic Agents|dermatologic agents|mesh-ancestor
93079421|NCT03719560|Cytarabine|cytarabine|mesh-list
93079422|NCT03719560|Methotrexate|methotrexate|mesh-list
93079423|NCT03719560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93079424|NCT03719560|Abortifacient Agents|abortifacient agents|mesh-ancestor
93079425|NCT03719560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93079426|NCT03719560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079427|NCT03719560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079428|NCT03719560|Antimetabolites|antimetabolites|mesh-ancestor
93079429|NCT03719560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079430|NCT03719560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079431|NCT03719560|Dermatologic Agents|dermatologic agents|mesh-ancestor
93079432|NCT03719560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079433|NCT03719560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93079434|NCT03719560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079435|NCT03719560|Immunologic Factors|immunologic factors|mesh-ancestor
93079436|NCT03719560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079437|NCT03719560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93079438|NCT03719560|Antiviral Agents|antiviral agents|mesh-ancestor
93079439|NCT03719560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079440|NCT03469258|Pancrelipase|pancrelipase|mesh-list
93079441|NCT03469258|Pancreatin|pancreatin|mesh-list
93079442|NCT03469258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079443|NCT00066170|Sodium Oxybate|sodium oxybate|mesh-list
93079444|NCT00066170|Modafinil|modafinil|mesh-list
91933010|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
93079445|NCT00066170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93079446|NCT00066170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079447|NCT00066170|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93079448|NCT00066170|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93079449|NCT00066170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93079450|NCT00066170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079451|NCT00066170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93079452|NCT00066170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93079453|NCT00066170|Anesthetics, General|anesthetics, general|mesh-ancestor
93079454|NCT00066170|Anesthetics|anesthetics|mesh-ancestor
93079455|NCT00066170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079456|NCT00065468|Interferons|interferons|mesh-list
93079457|NCT00065468|Interferon-alpha|interferon-alpha|mesh-list
93079458|NCT00065468|Sirolimus|sirolimus|mesh-list
93079459|NCT00065468|Temsirolimus|temsirolimus|mesh-list
93079460|NCT00065468|MTOR Inhibitors|mtor inhibitors|mesh-list
93079461|NCT00065468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079462|NCT00065468|Antiviral Agents|antiviral agents|mesh-ancestor
93079463|NCT00065468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079464|NCT00065468|Immunologic Factors|immunologic factors|mesh-ancestor
93079465|NCT00065468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079466|NCT00065468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079467|NCT00065468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079468|NCT00065468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079469|NCT00065468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079470|NCT00065468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079471|NCT00065468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93079472|NCT00065468|Antifungal Agents|antifungal agents|mesh-ancestor
93079473|NCT00071006|Axitinib|axitinib|mesh-list
93079474|NCT00071006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079475|NCT00071006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079476|NCT00071006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079477|NCT00071006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079478|NCT01089998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93079479|NCT01089998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93079480|NCT01089998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079481|NCT00094107|Axitinib|axitinib|mesh-list
93079482|NCT00094107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079483|NCT00094107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079484|NCT00094107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079485|NCT00094107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079486|NCT00102063|Aripiprazole|aripiprazole|mesh-list
93079487|NCT00102063|Antidepressive Agents|antidepressive agents|mesh-ancestor
93079488|NCT00102063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93079489|NCT00102063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93079490|NCT00102063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93079491|NCT00102063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079492|NCT00102063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079493|NCT00102063|Dopamine Agonists|dopamine agonists|mesh-ancestor
93079494|NCT00102063|Dopamine Agents|dopamine agents|mesh-ancestor
93079495|NCT00102063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079496|NCT00102063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079497|NCT00102063|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93079498|NCT00102063|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93079499|NCT00102063|Serotonin Agents|serotonin agents|mesh-ancestor
93079500|NCT00102063|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93079501|NCT00102063|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93079502|NCT00102063|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93079503|NCT00102063|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93079504|NCT00065156|Lenalidomide|lenalidomide|mesh-list
93079505|NCT00065156|Immunologic Factors|immunologic factors|mesh-ancestor
93079506|NCT00065156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079507|NCT00065156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93079508|NCT00065156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93079509|NCT00065156|Growth Substances|growth substances|mesh-ancestor
93079510|NCT00065156|Growth Inhibitors|growth inhibitors|mesh-ancestor
93079511|NCT00065156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079512|NCT01094210|Fluorides|fluorides|mesh-list
93079513|NCT01094210|Fluorides, Topical|fluorides, topical|mesh-list
93079514|NCT01094210|Cariostatic Agents|cariostatic agents|mesh-ancestor
93079515|NCT01094210|Protective Agents|protective agents|mesh-ancestor
92669798|NCT05458089|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93079516|NCT01094210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079517|NCT01094444|Vitamin K|vitamin k|mesh-list
93079518|NCT01094444|Vitamin K 3|vitamin k 3|mesh-list
93079519|NCT01094444|Vitamins|vitamins|mesh-ancestor
93079520|NCT01094444|Micronutrients|micronutrients|mesh-ancestor
93079521|NCT01094444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079522|NCT01094444|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93079523|NCT01094444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93079524|NCT01094444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079525|NCT01094444|Hemostatics|hemostatics|mesh-ancestor
93079526|NCT01094444|Coagulants|coagulants|mesh-ancestor
93079527|NCT00078819|Etanercept|etanercept|mesh-list
93079528|NCT00078819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93079529|NCT00078819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93079530|NCT00078819|Analgesics|analgesics|mesh-ancestor
93079531|NCT00078819|Sensory System Agents|sensory system agents|mesh-ancestor
93079532|NCT00078819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079533|NCT00078819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079534|NCT00078819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079535|NCT00078819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079536|NCT00078819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079537|NCT00078819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079538|NCT00078819|Immunologic Factors|immunologic factors|mesh-ancestor
93079539|NCT01088607|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93079540|NCT01088607|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93079541|NCT01088607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079542|NCT00098865|Thalidomide|thalidomide|mesh-list
93079543|NCT00098865|Temozolomide|temozolomide|mesh-list
93079544|NCT00098865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079545|NCT00098865|Alkylating Agents|alkylating agents|mesh-ancestor
93079546|NCT00098865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079547|NCT00098865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079548|NCT00098865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079549|NCT00098865|Immunologic Factors|immunologic factors|mesh-ancestor
93079550|NCT00098865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079551|NCT00098865|Leprostatic Agents|leprostatic agents|mesh-ancestor
93079552|NCT00098865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079553|NCT00098865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079554|NCT00098865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93079555|NCT00098865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93079556|NCT00098865|Growth Substances|growth substances|mesh-ancestor
93079557|NCT00098865|Growth Inhibitors|growth inhibitors|mesh-ancestor
93079558|NCT01084863|Paclitaxel|paclitaxel|mesh-list
93079559|NCT01084863|Trastuzumab|trastuzumab|mesh-list
93079560|NCT01084863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079561|NCT01084863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079562|NCT01084863|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079563|NCT01084863|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079564|NCT01084863|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079565|NCT01084863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079566|NCT01084863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079567|NCT03719404|Chlorhexidine|chlorhexidine|mesh-list
93079568|NCT03719404|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93079569|NCT03719404|Eusol|eusol|mesh-list
93079570|NCT03719404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93079571|NCT03719404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079572|NCT03719404|Disinfectants|disinfectants|mesh-ancestor
93079573|NCT03720886|Teriparatide|teriparatide|mesh-list
93079574|NCT03720886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93079575|NCT03720886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079576|NCT03720886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93079577|NCT00077649|Ribavirin|ribavirin|mesh-list
93079578|NCT00077649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93079579|NCT00077649|Interferon-alpha|interferon-alpha|mesh-list
93079580|NCT00077649|Interferon alpha-2|interferon alpha-2|mesh-list
93079581|NCT00077649|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93079582|NCT00077649|Antimetabolites|antimetabolites|mesh-ancestor
93079583|NCT00077649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079584|NCT00077649|Antiviral Agents|antiviral agents|mesh-ancestor
93079585|NCT00077649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079586|NCT00077649|Immunologic Factors|immunologic factors|mesh-ancestor
93079587|NCT00077649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079588|NCT00077649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079589|NCT00038948|Cyclosporine|cyclosporine|mesh-list
93079590|NCT00038948|Sirolimus|sirolimus|mesh-list
93079591|NCT00038948|Tacrolimus|tacrolimus|mesh-list
93079592|NCT00038948|Cyclosporins|cyclosporins|mesh-list
93079593|NCT00038948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079594|NCT00038948|Immunologic Factors|immunologic factors|mesh-ancestor
93079595|NCT00038948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079596|NCT00038948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93079597|NCT00038948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079598|NCT00038948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079599|NCT00038948|Antifungal Agents|antifungal agents|mesh-ancestor
93079600|NCT00038948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079601|NCT00038948|Dermatologic Agents|dermatologic agents|mesh-ancestor
93079602|NCT00038948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079603|NCT00038948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079604|NCT00038948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93079605|NCT00038948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079606|NCT01096940|Simvastatin|simvastatin|mesh-list
93079607|NCT01096940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93079608|NCT01096940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93079609|NCT01096940|Antimetabolites|antimetabolites|mesh-ancestor
93079610|NCT01096940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079611|NCT01096940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93079612|NCT01096940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93079613|NCT01096940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079614|NCT02530424|Trastuzumab|trastuzumab|mesh-list
93079615|NCT02530424|Pertuzumab|pertuzumab|mesh-list
93079616|NCT02530424|Fulvestrant|fulvestrant|mesh-list
93079617|NCT02530424|Palbociclib|palbociclib|mesh-list
93079618|NCT02530424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079619|NCT02530424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079620|NCT02530424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079621|NCT02530424|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93079622|NCT02530424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93079623|NCT02530424|Hormone Antagonists|hormone antagonists|mesh-ancestor
93079624|NCT02530424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079625|NCT02530424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079626|NCT02530424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079627|NCT02530424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079628|NCT02530424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079629|NCT01088763|Dexamethasone|dexamethasone|mesh-list
93079630|NCT01088763|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93079631|NCT01088763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079632|NCT01088763|Antiemetics|antiemetics|mesh-ancestor
93079633|NCT01088763|Autonomic Agents|autonomic agents|mesh-ancestor
93079634|NCT01088763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079635|NCT01088763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079636|NCT01088763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079637|NCT01088763|Glucocorticoids|glucocorticoids|mesh-ancestor
93079638|NCT01088763|Hormones|hormones|mesh-ancestor
93079639|NCT01088763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079640|NCT01088763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079641|NCT01088763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079642|NCT01088763|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93079643|NCT01088763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079644|NCT01088763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079645|NCT01094600|Secretin|secretin|mesh-list
93056731|NCT03932578|Antiemetics|antiemetics|mesh-ancestor
93079646|NCT01094600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079647|NCT01094600|Hormones|hormones|mesh-ancestor
93079648|NCT01094600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079649|NCT01094600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079650|NCT01097252|Cisplatin|cisplatin|mesh-list
93079651|NCT01097252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079652|NCT02530502|Pembrolizumab|pembrolizumab|mesh-list
93079653|NCT02530502|Temozolomide|temozolomide|mesh-list
93079654|NCT02530502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93079655|NCT02530502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079656|NCT02530502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93079657|NCT02530502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079658|NCT02530502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079659|NCT02530502|Alkylating Agents|alkylating agents|mesh-ancestor
93079660|NCT00054704|Riluzole|riluzole|mesh-list
92669947|NCT00300014|Hormones|hormones|mesh-ancestor
93079661|NCT00054704|Anticonvulsants|anticonvulsants|mesh-ancestor
93079662|NCT00054704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93079663|NCT00054704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93079664|NCT00054704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079665|NCT00054704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079666|NCT00054704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079667|NCT00054704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93079668|NCT00054704|Protective Agents|protective agents|mesh-ancestor
93079669|NCT01092572|Simvastatin|simvastatin|mesh-list
93079670|NCT01092572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93079671|NCT01092572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93079672|NCT01092572|Antimetabolites|antimetabolites|mesh-ancestor
93079673|NCT01092572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079674|NCT01092572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93079675|NCT01092572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93079676|NCT01092572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079677|NCT03956966|Dexamethasone|dexamethasone|mesh-list
93079678|NCT03956966|Bupivacaine|bupivacaine|mesh-list
93079679|NCT03956966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079680|NCT03956966|Antiemetics|antiemetics|mesh-ancestor
93079681|NCT03956966|Autonomic Agents|autonomic agents|mesh-ancestor
93079682|NCT03956966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079683|NCT03956966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079684|NCT03956966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079685|NCT03956966|Glucocorticoids|glucocorticoids|mesh-ancestor
93079686|NCT03956966|Hormones|hormones|mesh-ancestor
93079687|NCT03956966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079688|NCT03956966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079689|NCT03956966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079690|NCT03956966|Anesthetics, Local|anesthetics, local|mesh-ancestor
93079691|NCT03956966|Anesthetics|anesthetics|mesh-ancestor
93079692|NCT03956966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079693|NCT03956966|Sensory System Agents|sensory system agents|mesh-ancestor
93079694|NCT00031694|Paclitaxel|paclitaxel|mesh-list
93079695|NCT00031694|Bryostatin 1|bryostatin 1|mesh-list
93079696|NCT00031694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079697|NCT00031694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079698|NCT00031694|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079699|NCT00031694|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079700|NCT00031694|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079701|NCT00031694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079702|NCT00031694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93079703|NCT00031694|Immunologic Factors|immunologic factors|mesh-ancestor
93079704|NCT00031694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079705|NCT03953066|Melatonin|melatonin|mesh-list
93079706|NCT03953066|Antioxidants|antioxidants|mesh-ancestor
93079707|NCT03953066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079708|NCT03953066|Protective Agents|protective agents|mesh-ancestor
93079709|NCT03953066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079710|NCT03953066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079711|NCT00093795|Paclitaxel|paclitaxel|mesh-list
93079712|NCT00093795|Docetaxel|docetaxel|mesh-list
93079713|NCT00093795|Cyclophosphamide|cyclophosphamide|mesh-list
93079714|NCT00093795|Gemcitabine|gemcitabine|mesh-list
93079715|NCT00093795|Doxorubicin|doxorubicin|mesh-list
93079716|NCT00093795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056805|NCT01224652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079717|NCT00093795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079718|NCT00093795|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079719|NCT00093795|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079720|NCT00093795|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079721|NCT00093795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079722|NCT00093795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079723|NCT00093795|Immunologic Factors|immunologic factors|mesh-ancestor
93079724|NCT00093795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079725|NCT00093795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079726|NCT00093795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079727|NCT00093795|Alkylating Agents|alkylating agents|mesh-ancestor
93079728|NCT00093795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93079729|NCT00093795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079730|NCT00093795|Antimetabolites|antimetabolites|mesh-ancestor
93079731|NCT00093795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93079732|NCT00093795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93079733|NCT00093795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93079734|NCT00093795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079735|NCT01092806|Tacrolimus|tacrolimus|mesh-list
93079736|NCT01092806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079737|NCT01092806|Immunologic Factors|immunologic factors|mesh-ancestor
93079738|NCT01092806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079739|NCT01092806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93079740|NCT01092806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079741|NCT01092806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079742|NCT01094912|Analgesics, Opioid|analgesics, opioid|mesh-list
93079743|NCT01094912|Narcotics|narcotics|mesh-ancestor
93079744|NCT01094912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079745|NCT01094912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079746|NCT01094912|Analgesics|analgesics|mesh-ancestor
93079747|NCT01094912|Sensory System Agents|sensory system agents|mesh-ancestor
93079748|NCT01094912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079749|NCT01092962|Mycophenolic Acid|mycophenolic acid|mesh-list
93079750|NCT01092962|Cyclophosphamide|cyclophosphamide|mesh-list
93079751|NCT01092962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079752|NCT01092962|Immunologic Factors|immunologic factors|mesh-ancestor
93079753|NCT01092962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079754|NCT01092962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079755|NCT01092962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079756|NCT01092962|Alkylating Agents|alkylating agents|mesh-ancestor
93079757|NCT01092962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079758|NCT01092962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079759|NCT01092962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93079760|NCT01092962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93079761|NCT01092962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93079762|NCT01092962|Antitubercular Agents|antitubercular agents|mesh-ancestor
93079763|NCT01092962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079764|NCT01092962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079765|NCT01092962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079766|NCT03802994|Vaccines|vaccines|mesh-list
93079767|NCT03802994|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93079768|NCT03802994|Immunologic Factors|immunologic factors|mesh-ancestor
93079769|NCT03802994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079770|NCT01088919|Pioglitazone|pioglitazone|mesh-list
93079771|NCT01088919|Ipragliflozin|ipragliflozin|mesh-list
93079772|NCT01088919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93079773|NCT01088919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079774|NCT01088919|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93079775|NCT01088919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079776|NCT03802916|Deferiprone|deferiprone|mesh-list
93079777|NCT03802916|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93079778|NCT03802916|Chelating Agents|chelating agents|mesh-ancestor
93079779|NCT03802916|Sequestering Agents|sequestering agents|mesh-ancestor
93079780|NCT03802916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079781|NCT03720340|Oprelvekin|oprelvekin|mesh-list
93079782|NCT03720340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079783|NCT01094990|Dexamethasone|dexamethasone|mesh-list
93079784|NCT01094990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079785|NCT01094990|Antiemetics|antiemetics|mesh-ancestor
93079786|NCT01094990|Autonomic Agents|autonomic agents|mesh-ancestor
93079787|NCT01094990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079788|NCT01094990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079789|NCT01094990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079790|NCT01094990|Glucocorticoids|glucocorticoids|mesh-ancestor
93079791|NCT01094990|Hormones|hormones|mesh-ancestor
93079792|NCT01094990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079793|NCT01094990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079794|NCT01094990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079795|NCT01584050|Folic Acid|folic acid|mesh-list
93079796|NCT01584050|Hematinics|hematinics|mesh-ancestor
93079797|NCT01584050|Vitamin B Complex|vitamin b complex|mesh-ancestor
93079798|NCT01584050|Vitamins|vitamins|mesh-ancestor
93079799|NCT01584050|Micronutrients|micronutrients|mesh-ancestor
93079800|NCT01584050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079801|NCT03952832|Leflunomide|leflunomide|mesh-list
93079802|NCT03952832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079803|NCT03952832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079804|NCT03952832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079805|NCT03952832|Immunologic Factors|immunologic factors|mesh-ancestor
93079806|NCT03952832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079807|NCT01311076|Insulin|insulin|mesh-list
93079808|NCT01311076|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93079809|NCT01311076|Insulin Lispro|insulin lispro|mesh-list
93079810|NCT01311076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93079811|NCT01311076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079812|NCT01098344|Gemcitabine|gemcitabine|mesh-list
93079813|NCT01098344|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
93079814|NCT01098344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93079815|NCT01098344|Antimetabolites|antimetabolites|mesh-ancestor
93079816|NCT01098344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079817|NCT01098344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079818|NCT01098344|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93079819|NCT01098344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079820|NCT01098656|Lenalidomide|lenalidomide|mesh-list
93079821|NCT01098656|Immunologic Factors|immunologic factors|mesh-ancestor
93079822|NCT01098656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079823|NCT01098656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93079824|NCT01098656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93079825|NCT01098656|Growth Substances|growth substances|mesh-ancestor
93079826|NCT01098656|Growth Inhibitors|growth inhibitors|mesh-ancestor
93079827|NCT01098656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079828|NCT00076011|Mitogens|mitogens|mesh-list
93079829|NCT00076011|Endothelial Growth Factors|endothelial growth factors|mesh-list
93079830|NCT00076011|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079831|NCT00076011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079832|NCT00076011|Growth Substances|growth substances|mesh-ancestor
93079833|NCT00076011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079834|NCT03465436|Moxifloxacin|moxifloxacin|mesh-list
93079835|NCT03465436|Lasmiditan|lasmiditan|mesh-list
93079836|NCT03465436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079837|NCT03465436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079838|NCT03465436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93079839|NCT03465436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93079840|NCT03465436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079841|NCT03465436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079842|NCT03465436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079843|NCT03465436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079844|NCT03465436|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93079845|NCT03465436|Serotonin Agents|serotonin agents|mesh-ancestor
93079846|NCT03465436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079847|NCT01098890|Plasminogen|plasminogen|mesh-list
93079848|NCT01098890|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93079849|NCT01098890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93079850|NCT01098890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93079851|NCT01098890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079852|NCT00053846|Buspirone|buspirone|mesh-list
93079853|NCT00053846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93079854|NCT00053846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93079855|NCT00053846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079856|NCT00053846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079857|NCT00053846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93079858|NCT00053846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93079859|NCT00053846|Serotonin Agents|serotonin agents|mesh-ancestor
93079860|NCT00053846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079861|NCT00053846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079862|NCT01089075|Hydrocortisone|hydrocortisone|mesh-list
93079863|NCT01089075|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93079864|NCT01089075|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93079865|NCT01089075|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93079866|NCT01089075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079867|NCT00090987|Imatinib Mesylate|imatinib mesylate|mesh-list
93056951|NCT03927118|Antiemetics|antiemetics|mesh-ancestor
93079868|NCT00090987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079869|NCT00090987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079870|NCT00090987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079871|NCT00090987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079872|NCT03489304|Zaleplon|zaleplon|mesh-list
93079873|NCT03489304|Anticonvulsants|anticonvulsants|mesh-ancestor
93079874|NCT03489304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93079875|NCT03489304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93079876|NCT03489304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079877|NCT03489304|GABA Modulators|gaba modulators|mesh-ancestor
93079878|NCT03489304|GABA Agents|gaba agents|mesh-ancestor
93079879|NCT03489304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079880|NCT03489304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079881|NCT03718624|Paclitaxel|paclitaxel|mesh-list
93079882|NCT03718624|Apatinib|apatinib|mesh-list
93079883|NCT03718624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93079884|NCT03718624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079885|NCT03718624|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079886|NCT03718624|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079887|NCT03718624|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079888|NCT03718624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079889|NCT03718624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93079890|NCT03718624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079891|NCT03543358|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
93079892|NCT03543358|Immunoconjugates|immunoconjugates|mesh-list
93079893|NCT03543358|Immunologic Factors|immunologic factors|mesh-ancestor
93079894|NCT03543358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079895|NCT03485950|Meropenem|meropenem|mesh-list
93079896|NCT03485950|Tazobactam|tazobactam|mesh-list
93079897|NCT03485950|Piperacillin|piperacillin|mesh-list
93079898|NCT03485950|Cefepime|cefepime|mesh-list
93079899|NCT03485950|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93079900|NCT03485950|Ceftolozane|ceftolozane|mesh-list
93079901|NCT03485950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079902|NCT03485950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079903|NCT03485950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93079904|NCT03485950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079905|NCT03485950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079906|NCT00060944|Dexamethasone|dexamethasone|mesh-list
93079907|NCT00060944|Dexamethasone acetate|dexamethasone acetate|mesh-list
93079908|NCT00060944|Trabectedin|trabectedin|mesh-list
93079909|NCT00060944|BB 1101|bb 1101|mesh-list
93079910|NCT00060944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079911|NCT00060944|Antiemetics|antiemetics|mesh-ancestor
93079912|NCT00060944|Autonomic Agents|autonomic agents|mesh-ancestor
93079913|NCT00060944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079914|NCT00060944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079915|NCT00060944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079916|NCT00060944|Glucocorticoids|glucocorticoids|mesh-ancestor
93079917|NCT00060944|Hormones|hormones|mesh-ancestor
93079918|NCT00060944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93079919|NCT00060944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93079920|NCT00060944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079921|NCT00060944|Protease Inhibitors|protease inhibitors|mesh-ancestor
93079922|NCT00060944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079923|NCT00060944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079924|NCT00060944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079925|NCT00060944|Alkylating Agents|alkylating agents|mesh-ancestor
93079926|NCT03956732|Vitamin D|vitamin d|mesh-list
93079927|NCT03956732|Caseins|caseins|mesh-list
93079928|NCT03956732|Vitamins|vitamins|mesh-ancestor
93079929|NCT03956732|Micronutrients|micronutrients|mesh-ancestor
93079930|NCT03956732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079931|NCT03956732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93079932|NCT03956732|Chelating Agents|chelating agents|mesh-ancestor
93079933|NCT03956732|Sequestering Agents|sequestering agents|mesh-ancestor
93079934|NCT03956732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079935|NCT01093274|Picosulfate sodium|picosulfate sodium|mesh-list
93079936|NCT01093274|Cathartics|cathartics|mesh-ancestor
93079937|NCT01093274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93079938|NCT01584206|Ezetimibe|ezetimibe|mesh-list
93079939|NCT01584206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93079940|NCT01584206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93079941|NCT01584206|Antimetabolites|antimetabolites|mesh-ancestor
93079942|NCT01584206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079943|NCT01584206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93079944|NCT03541252|Cisplatin|cisplatin|mesh-list
93079945|NCT03541252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079946|NCT00031460|Acyclovir|acyclovir|mesh-list
93079947|NCT00031460|Antiviral Agents|antiviral agents|mesh-ancestor
92670237|NCT05238831|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079948|NCT00031460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079949|NCT03540160|Serlopitant|serlopitant|mesh-list
93079950|NCT03540160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93079951|NCT03540160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93079952|NCT03540160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079953|NCT03540160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079954|NCT01095302|Docetaxel|docetaxel|mesh-list
93079955|NCT01095302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079956|NCT01095302|Tubulin Modulators|tubulin modulators|mesh-ancestor
93079957|NCT01095302|Antimitotic Agents|antimitotic agents|mesh-ancestor
93079958|NCT01095302|Mitosis Modulators|mitosis modulators|mesh-ancestor
93079959|NCT01095302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079960|NCT03459040|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93079961|NCT03459040|Protein C Inhibitor|protein c inhibitor|mesh-list
93079962|NCT03459040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93079963|NCT03459040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93079964|NCT03459040|Protease Inhibitors|protease inhibitors|mesh-ancestor
93079965|NCT03459040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93079966|NCT03459040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079967|NCT03457636|Doxycycline|doxycycline|mesh-list
93079968|NCT03457636|Adapalene|adapalene|mesh-list
93079969|NCT03457636|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
93079970|NCT03457636|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93079971|NCT03457636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93079972|NCT03457636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93079973|NCT03457636|Antimalarials|antimalarials|mesh-ancestor
93079974|NCT03457636|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93079975|NCT03457636|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93079976|NCT03457636|Dermatologic Agents|dermatologic agents|mesh-ancestor
93079977|NCT03457636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93079978|NCT03457636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93079979|NCT03457636|Analgesics|analgesics|mesh-ancestor
93079980|NCT03457636|Sensory System Agents|sensory system agents|mesh-ancestor
93079981|NCT03457636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93079982|NCT03457636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079983|NCT03457636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93079984|NCT03457636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079985|NCT01099436|Zoledronic Acid|zoledronic acid|mesh-list
93079986|NCT01099436|Cyclophosphamide|cyclophosphamide|mesh-list
93079987|NCT01099436|Docetaxel|docetaxel|mesh-list
93079988|NCT01099436|Doxorubicin|doxorubicin|mesh-list
93079989|NCT01099436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93079990|NCT01099436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93079991|NCT01099436|Immunologic Factors|immunologic factors|mesh-ancestor
93079992|NCT01099436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93079993|NCT01099436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93079994|NCT01099436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93079995|NCT01099436|Alkylating Agents|alkylating agents|mesh-ancestor
93079996|NCT01099436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93079997|NCT01099436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93079998|NCT01099436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93079999|NCT01099436|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080000|NCT01099436|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080001|NCT01099436|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080002|NCT01099436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080003|NCT01099436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080004|NCT01099436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080005|NCT01099436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080006|NCT01099436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93080007|NCT01099592|Citalopram|citalopram|mesh-list
93080008|NCT01099592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93080009|NCT01099592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93080010|NCT01099592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93080011|NCT01099592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080012|NCT01099592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080013|NCT01099592|Serotonin Agents|serotonin agents|mesh-ancestor
93080014|NCT01099592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080015|NCT01099592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93080016|NCT01099592|Antidepressive Agents|antidepressive agents|mesh-ancestor
93080017|NCT01099592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080018|NCT01099748|Methadone|methadone|mesh-list
93057102|NCT03926182|Aflutinib|aflutinib|mesh-list
93080019|NCT01099748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93080020|NCT01099748|Narcotics|narcotics|mesh-ancestor
93080021|NCT01099748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93080022|NCT01099748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080023|NCT01099748|Analgesics|analgesics|mesh-ancestor
93080024|NCT01099748|Sensory System Agents|sensory system agents|mesh-ancestor
93080025|NCT01099748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080026|NCT01099748|Antitussive Agents|antitussive agents|mesh-ancestor
93080027|NCT01099748|Respiratory System Agents|respiratory system agents|mesh-ancestor
93080028|NCT03481816|Vaccines|vaccines|mesh-list
93080029|NCT03481816|Immunologic Factors|immunologic factors|mesh-ancestor
93080030|NCT03481816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080031|NCT03956888|Acetylcysteine|acetylcysteine|mesh-list
93080032|NCT03956888|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93080033|NCT03956888|Antiviral Agents|antiviral agents|mesh-ancestor
93080034|NCT03956888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080035|NCT03956888|Expectorants|expectorants|mesh-ancestor
93080036|NCT03956888|Respiratory System Agents|respiratory system agents|mesh-ancestor
93080037|NCT03956888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93080038|NCT03956888|Antioxidants|antioxidants|mesh-ancestor
93080039|NCT03956888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080040|NCT03956888|Protective Agents|protective agents|mesh-ancestor
93080041|NCT03956888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080042|NCT03956888|Antidotes|antidotes|mesh-ancestor
93080043|NCT03955406|Anesthetics|anesthetics|mesh-list
93080044|NCT03955406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93080045|NCT03955406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080046|NCT03538054|Dextromethorphan|dextromethorphan|mesh-list
93080047|NCT03538054|Antitussive Agents|antitussive agents|mesh-ancestor
93080048|NCT03538054|Respiratory System Agents|respiratory system agents|mesh-ancestor
93080049|NCT03538054|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93080050|NCT03538054|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93080051|NCT03538054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080052|NCT03538054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080053|NCT03538054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080054|NCT03480802|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93080055|NCT03480802|Immunologic Factors|immunologic factors|mesh-ancestor
93080056|NCT03480802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080057|NCT00050960|Paclitaxel|paclitaxel|mesh-list
93080058|NCT00050960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93080059|NCT00050960|Carboplatin|carboplatin|mesh-list
93080060|NCT00050960|Bexarotene|bexarotene|mesh-list
93080061|NCT00050960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93080062|NCT00050960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080063|NCT00050960|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080064|NCT00050960|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080065|NCT00050960|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080066|NCT00050960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080067|NCT00097773|Ciprofloxacin|ciprofloxacin|mesh-list
93080068|NCT00097773|Tobramycin|tobramycin|mesh-list
93080069|NCT00097773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93080070|NCT00097773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080071|NCT00097773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080072|NCT00097773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080073|NCT00097773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080074|NCT00097773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080075|NCT00097773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080076|NCT00097773|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93080077|NCT00097773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93080078|NCT03480022|Liraglutide|liraglutide|mesh-list
93080079|NCT03480022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93080080|NCT03480022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080081|NCT03480022|Incretins|incretins|mesh-ancestor
93080082|NCT03480022|Hormones|hormones|mesh-ancestor
93080083|NCT03480022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080084|NCT01093820|Epoetin Alfa|epoetin alfa|mesh-list
93080085|NCT01093820|Hematinics|hematinics|mesh-ancestor
93080086|NCT00049322|Bevacizumab|bevacizumab|mesh-list
93080087|NCT00049322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080088|NCT00049322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080089|NCT00049322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080090|NCT00049322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080091|NCT00049322|Growth Substances|growth substances|mesh-ancestor
93080092|NCT00049322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080093|NCT00049322|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080094|NCT00008138|Paclitaxel|paclitaxel|mesh-list
93080095|NCT00008138|Carboplatin|carboplatin|mesh-list
93080096|NCT00008138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93080097|NCT00008138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080098|NCT00008138|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080099|NCT00008138|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080100|NCT00008138|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080101|NCT00008138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080102|NCT03436732|LMB-100|lmb-100|mesh-list
93080103|NCT03436732|Immunoconjugates|immunoconjugates|mesh-ancestor
93080104|NCT03436732|Immunologic Factors|immunologic factors|mesh-ancestor
93080105|NCT03436732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080106|NCT01100060|Azithromycin|azithromycin|mesh-list
93080107|NCT01100060|Chloroquine|chloroquine|mesh-list
93080108|NCT01100060|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93080109|NCT01100060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93080110|NCT01100060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080111|NCT01100060|Amebicides|amebicides|mesh-ancestor
93080112|NCT01100060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93080113|NCT01100060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93080114|NCT01100060|Antimalarials|antimalarials|mesh-ancestor
93080115|NCT01100060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080116|NCT01100060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93080117|NCT01100060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93080118|NCT01100060|Analgesics|analgesics|mesh-ancestor
93080119|NCT01100060|Sensory System Agents|sensory system agents|mesh-ancestor
93080120|NCT01100060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080121|NCT01100060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080122|NCT01100060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080123|NCT01100060|Filaricides|filaricides|mesh-ancestor
93080124|NCT01100060|Antinematodal Agents|antinematodal agents|mesh-ancestor
93080125|NCT01100060|Anthelmintics|anthelmintics|mesh-ancestor
93080126|NCT01100216|Nicotine|nicotine|mesh-list
93080127|NCT01100216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93080128|NCT01100216|Autonomic Agents|autonomic agents|mesh-ancestor
93080129|NCT01100216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080130|NCT01100216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080131|NCT01100216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93080132|NCT01100216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93080133|NCT01100216|Cholinergic Agents|cholinergic agents|mesh-ancestor
93080134|NCT01100216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080135|NCT01100216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080136|NCT01100294|Vaccines|vaccines|mesh-list
93080137|NCT01100294|Immunologic Factors|immunologic factors|mesh-ancestor
93080138|NCT01100294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080139|NCT03436420|Calcium|calcium|mesh-list
93080140|NCT03436420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93080141|NCT03436420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080142|NCT01100372|Gemcitabine|gemcitabine|mesh-list
93080143|NCT01100372|Doxorubicin|doxorubicin|mesh-list
93080144|NCT01100372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93080145|NCT01100372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93080146|NCT01100372|Antimetabolites|antimetabolites|mesh-ancestor
93080147|NCT01100372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080148|NCT01100372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080149|NCT01100372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080150|NCT01100372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080151|NCT01100372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080152|NCT01100372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080153|NCT00027560|Cyclosporine|cyclosporine|mesh-list
93080154|NCT00027560|Fludarabine|fludarabine|mesh-list
93080155|NCT00027560|Fludarabine phosphate|fludarabine phosphate|mesh-list
93080156|NCT00027560|Melphalan|melphalan|mesh-list
93080157|NCT00027560|Alemtuzumab|alemtuzumab|mesh-list
93080158|NCT00027560|Cyclosporins|cyclosporins|mesh-list
93080159|NCT00027560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080160|NCT00027560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93080161|NCT00027560|Antimetabolites|antimetabolites|mesh-ancestor
93080162|NCT00027560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080163|NCT00027560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080164|NCT00027560|Immunologic Factors|immunologic factors|mesh-ancestor
93080165|NCT00027560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080166|NCT00027560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080167|NCT00027560|Antifungal Agents|antifungal agents|mesh-ancestor
93080168|NCT00027560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080169|NCT00027560|Dermatologic Agents|dermatologic agents|mesh-ancestor
93080170|NCT00027560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080171|NCT00027560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93080172|NCT00027560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93080173|NCT00027560|Alkylating Agents|alkylating agents|mesh-ancestor
93080174|NCT00027560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93080175|NCT00027560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080176|NCT02529878|Paclitaxel|paclitaxel|mesh-list
93080177|NCT02529878|Apatinib|apatinib|mesh-list
93080178|NCT02529878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93080179|NCT02529878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080180|NCT02529878|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080181|NCT02529878|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080182|NCT02529878|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080183|NCT02529878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080184|NCT02529878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93080185|NCT02529878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080186|NCT03451006|Metformin|metformin|mesh-list
93080187|NCT03451006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93080188|NCT03451006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080189|NCT05625854|Cocaine|cocaine|mesh-list
93080190|NCT05625854|Anesthetics, Local|anesthetics, local|mesh-ancestor
93080191|NCT05625854|Anesthetics|anesthetics|mesh-ancestor
93080192|NCT05625854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93080193|NCT05625854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080194|NCT05625854|Sensory System Agents|sensory system agents|mesh-ancestor
93080195|NCT05625854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080196|NCT05625854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93080197|NCT05625854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93080198|NCT05625854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93080199|NCT05625854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93080200|NCT05625854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080201|NCT05625854|Dopamine Agents|dopamine agents|mesh-ancestor
93080202|NCT05625854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080203|NCT01327118|Dinoprost|dinoprost|mesh-list
93080204|NCT01327118|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
93080205|NCT01327118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93080206|NCT01327118|Abortifacient Agents|abortifacient agents|mesh-ancestor
93080207|NCT01327118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93080208|NCT01327118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080209|NCT01327118|Oxytocics|oxytocics|mesh-ancestor
93080210|NCT03449758|Hydroxychloroquine|hydroxychloroquine|mesh-list
93080211|NCT03449758|Chloroquine|chloroquine|mesh-list
93080212|NCT03449758|Sulfasalazine|sulfasalazine|mesh-list
93080213|NCT03449758|Methotrexate|methotrexate|mesh-list
93080214|NCT03449758|Azathioprine|azathioprine|mesh-list
93080215|NCT03449758|Leflunomide|leflunomide|mesh-list
93080216|NCT03449758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93080217|NCT03449758|Abortifacient Agents|abortifacient agents|mesh-ancestor
92670506|NCT00419796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080218|NCT03449758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93080219|NCT03449758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080220|NCT03449758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93080221|NCT03449758|Antimetabolites|antimetabolites|mesh-ancestor
93080222|NCT03449758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080223|NCT03449758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080224|NCT03449758|Dermatologic Agents|dermatologic agents|mesh-ancestor
93080225|NCT03449758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080226|NCT03449758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93080227|NCT03449758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080228|NCT03449758|Immunologic Factors|immunologic factors|mesh-ancestor
93080229|NCT03449758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080230|NCT03449758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93080231|NCT03449758|Antimalarials|antimalarials|mesh-ancestor
93080232|NCT03449758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93080233|NCT03449758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93080234|NCT03449758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080235|NCT03449758|Amebicides|amebicides|mesh-ancestor
93080236|NCT03449758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93080237|NCT03449758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93080238|NCT03449758|Analgesics|analgesics|mesh-ancestor
93080239|NCT03449758|Sensory System Agents|sensory system agents|mesh-ancestor
93080240|NCT03449758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080241|NCT03449758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080242|NCT03449758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080243|NCT03449446|Firsocostat|firsocostat|mesh-list
93080244|NCT03449446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080245|NCT03449446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080246|NCT03716596|Antibodies|antibodies|mesh-list
93080247|NCT03716596|Immunologic Factors|immunologic factors|mesh-ancestor
93080248|NCT03716596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080249|NCT05650840|Calcium Carbonate|calcium carbonate|mesh-list
93080250|NCT05650840|Calcium|calcium|mesh-list
93080251|NCT05650840|Charcoal|charcoal|mesh-list
93080252|NCT05650840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93080253|NCT05650840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080254|NCT05650840|Antacids|antacids|mesh-ancestor
93080255|NCT05650840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080256|NCT05650840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080257|NCT05650840|Antidotes|antidotes|mesh-ancestor
93080258|NCT05650840|Protective Agents|protective agents|mesh-ancestor
93080259|NCT03722914|Benzonatate|benzonatate|mesh-list
93080260|NCT03722914|Antitussive Agents|antitussive agents|mesh-ancestor
93080261|NCT03722914|Respiratory System Agents|respiratory system agents|mesh-ancestor
93080262|NCT03429556|Botulinum Toxins|botulinum toxins|mesh-list
93080263|NCT03429556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93080264|NCT03429556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93080265|NCT03429556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080266|NCT03429556|Cholinergic Agents|cholinergic agents|mesh-ancestor
93080267|NCT03429556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080268|NCT03429556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080269|NCT03444766|Nivolumab|nivolumab|mesh-list
93080270|NCT03444766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080271|NCT03444766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080272|NCT03444766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93080273|NCT03444766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080274|NCT03526432|Bevacizumab|bevacizumab|mesh-list
93080275|NCT03526432|Atezolizumab|atezolizumab|mesh-list
93080276|NCT03526432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080277|NCT03526432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080278|NCT03526432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080279|NCT03526432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080280|NCT03526432|Growth Substances|growth substances|mesh-ancestor
93080281|NCT03526432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080282|NCT03526432|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080283|NCT03526432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93080284|NCT03526432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080285|NCT01310842|Nicotine|nicotine|mesh-list
93080286|NCT01310842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93080287|NCT01310842|Autonomic Agents|autonomic agents|mesh-ancestor
92670578|NCT00303836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93080288|NCT01310842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080289|NCT01310842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080290|NCT01310842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93080291|NCT01310842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93080292|NCT01310842|Cholinergic Agents|cholinergic agents|mesh-ancestor
93080293|NCT01310842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080294|NCT01310842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080295|NCT03722290|Metformin|metformin|mesh-list
93080296|NCT03722290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93080297|NCT03722290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080298|NCT03717688|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93080299|NCT03717688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93080300|NCT03717688|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93080301|NCT03717688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93080302|NCT03717688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080303|NCT03717688|Incretins|incretins|mesh-ancestor
93080304|NCT03717688|Hormones|hormones|mesh-ancestor
93080305|NCT03717688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080306|NCT03717688|Protease Inhibitors|protease inhibitors|mesh-ancestor
93080307|NCT03717688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080308|NCT03717688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080309|NCT03717688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93080310|NCT02953678|Prednisone|prednisone|mesh-list
93080311|NCT02953678|Methylprednisolone|methylprednisolone|mesh-list
93080312|NCT02953678|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93080313|NCT02953678|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93080314|NCT02953678|Prednisolone|prednisolone|mesh-list
93080315|NCT02953678|Prednisolone acetate|prednisolone acetate|mesh-list
93080316|NCT02953678|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93080317|NCT02953678|Prednisolone phosphate|prednisolone phosphate|mesh-list
93080318|NCT02953678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080319|NCT02953678|Glucocorticoids|glucocorticoids|mesh-ancestor
93080320|NCT02953678|Hormones|hormones|mesh-ancestor
93080321|NCT02953678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080322|NCT02953678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080323|NCT02953678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080324|NCT02953678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080325|NCT02953678|Antiemetics|antiemetics|mesh-ancestor
93080326|NCT02953678|Autonomic Agents|autonomic agents|mesh-ancestor
93080327|NCT02953678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080328|NCT02953678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080329|NCT02953678|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93080330|NCT02953678|Protective Agents|protective agents|mesh-ancestor
93080331|NCT00090753|Epoetin Alfa|epoetin alfa|mesh-list
93080332|NCT00090753|Darbepoetin alfa|darbepoetin alfa|mesh-list
93080333|NCT00090753|Hematinics|hematinics|mesh-ancestor
93080334|NCT00048932|Abatacept|abatacept|mesh-list
93080335|NCT00048932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93080336|NCT00048932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080337|NCT00048932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080338|NCT00048932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080339|NCT00048932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080340|NCT00048932|Immunologic Factors|immunologic factors|mesh-ancestor
93080341|NCT00048932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080342|NCT00048932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080343|NCT00073983|Gemcitabine|gemcitabine|mesh-list
93080344|NCT00073983|Docetaxel|docetaxel|mesh-list
93080345|NCT00073983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93080346|NCT00073983|Antimetabolites|antimetabolites|mesh-ancestor
93080347|NCT00073983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080348|NCT00073983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080349|NCT00073983|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080350|NCT00073983|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080351|NCT00073983|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080352|NCT02952820|Lemborexant|lemborexant|mesh-list
93080353|NCT02952820|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93080354|NCT02952820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080355|NCT02952820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080356|NCT02952820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93080357|NCT02952820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93080358|NCT02952820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93080359|NCT02952820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080360|NCT01583361|Oxaliplatin|oxaliplatin|mesh-list
93080361|NCT01583361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080362|NCT01085487|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
93080363|NCT01085487|Levonorgestrel|levonorgestrel|mesh-list
93080364|NCT01085487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93080365|NCT01085487|Contraceptive Agents|contraceptive agents|mesh-ancestor
93080366|NCT01085487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93080367|NCT01085487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080368|NCT01085487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93080369|NCT01085487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93080370|NCT01085487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93080371|NCT01085487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93080372|NCT01085487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080373|NCT01085487|Hemostatics|hemostatics|mesh-ancestor
93080374|NCT01085487|Coagulants|coagulants|mesh-ancestor
93080375|NCT01089309|Spironolactone|spironolactone|mesh-list
93080376|NCT01089309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93080377|NCT01089309|Hormone Antagonists|hormone antagonists|mesh-ancestor
93080378|NCT01089309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080379|NCT01089309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080380|NCT01089309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93080381|NCT01089309|Diuretics|diuretics|mesh-ancestor
93080382|NCT01089309|Natriuretic Agents|natriuretic agents|mesh-ancestor
93080383|NCT01085721|Chlorpheniramine|chlorpheniramine|mesh-list
93080384|NCT01085721|Phenylpropanolamine|phenylpropanolamine|mesh-list
93080385|NCT01085721|Pseudoephedrine|pseudoephedrine|mesh-list
93080386|NCT01085721|Ephedrine|ephedrine|mesh-list
93080387|NCT01085721|Guaifenesin|guaifenesin|mesh-list
93080388|NCT01085721|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93080389|NCT01085721|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93080390|NCT01085721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93080391|NCT01085721|Autonomic Agents|autonomic agents|mesh-ancestor
93080392|NCT01085721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080393|NCT01085721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080394|NCT01085721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93080395|NCT01085721|Respiratory System Agents|respiratory system agents|mesh-ancestor
93080396|NCT01085721|Nasal Decongestants|nasal decongestants|mesh-ancestor
93080397|NCT01085721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93080398|NCT01085721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93080400|NCT01085721|Adrenergic Agents|adrenergic agents|mesh-ancestor
93080401|NCT01085721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080402|NCT01085721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080403|NCT01085721|Expectorants|expectorants|mesh-ancestor
93080404|NCT01085721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93080405|NCT01085721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93080406|NCT01085721|Appetite Depressants|appetite depressants|mesh-ancestor
93080407|NCT01085721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93080408|NCT01085721|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93080409|NCT01085721|Histamine Antagonists|histamine antagonists|mesh-ancestor
93080410|NCT01085721|Histamine Agents|histamine agents|mesh-ancestor
93080411|NCT01085721|Antipruritics|antipruritics|mesh-ancestor
93080412|NCT01085721|Dermatologic Agents|dermatologic agents|mesh-ancestor
93080413|NCT01085721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93080414|NCT01089465|Dermatologic Agents|dermatologic agents|mesh-list
93080415|NCT00006392|Vitamins|vitamins|mesh-list
93080416|NCT00006392|Vitamin E|vitamin e|mesh-list
93080417|NCT00006392|Tocopherols|tocopherols|mesh-list
93080418|NCT00006392|Tocotrienols|tocotrienols|mesh-list
93080419|NCT00006392|alpha-Tocopherol|alpha-tocopherol|mesh-list
93080420|NCT00006392|Selenium|selenium|mesh-list
93080421|NCT00006392|Micronutrients|micronutrients|mesh-ancestor
93080422|NCT00006392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080423|NCT00006392|Antioxidants|antioxidants|mesh-ancestor
93080424|NCT00006392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080425|NCT00006392|Protective Agents|protective agents|mesh-ancestor
93080426|NCT00006392|Trace Elements|trace elements|mesh-ancestor
93080427|NCT01089621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93080428|NCT01089621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93080429|NCT01089621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93080430|NCT01089621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93080431|NCT01089621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670718|NCT00304655|Aripiprazole|aripiprazole|mesh-list
93080432|NCT01089621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080433|NCT01089621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080434|NCT01089621|Analgesics|analgesics|mesh-ancestor
93080435|NCT01089621|Sensory System Agents|sensory system agents|mesh-ancestor
93080436|NCT01089621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080437|NCT01089621|Antidepressive Agents|antidepressive agents|mesh-ancestor
93080438|NCT01089621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080439|NCT01089621|Dopamine Agents|dopamine agents|mesh-ancestor
93080440|NCT01101152|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93080441|NCT01101152|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93080442|NCT01101152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93080443|NCT01101152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93080444|NCT01101152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080445|NCT01101152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080446|NCT01101152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080447|NCT01101152|Antidepressive Agents|antidepressive agents|mesh-ancestor
93080448|NCT01101152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080449|NCT00379769|Metformin|metformin|mesh-list
93080450|NCT00379769|Rosiglitazone|rosiglitazone|mesh-list
93080451|NCT00379769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93080452|NCT00379769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080453|NCT00006164|Ribavirin|ribavirin|mesh-list
93080454|NCT00006164|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93080455|NCT00006164|Interferon-alpha|interferon-alpha|mesh-list
93080456|NCT00006164|Antimetabolites|antimetabolites|mesh-ancestor
93080457|NCT00006164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080458|NCT00006164|Antiviral Agents|antiviral agents|mesh-ancestor
93080459|NCT00006164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080460|NCT00006164|Immunologic Factors|immunologic factors|mesh-ancestor
93080461|NCT00006164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080462|NCT00378599|Interferons|interferons|mesh-list
93080463|NCT00378599|Interferon-alpha|interferon-alpha|mesh-list
93080464|NCT00378599|Interferon alpha-2|interferon alpha-2|mesh-list
93080465|NCT00378599|Ribavirin|ribavirin|mesh-list
93080466|NCT00378599|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93080467|NCT00378599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080468|NCT00378599|Antiviral Agents|antiviral agents|mesh-ancestor
93080469|NCT00378599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080470|NCT00378599|Immunologic Factors|immunologic factors|mesh-ancestor
93080471|NCT00378599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080472|NCT00378599|Antimetabolites|antimetabolites|mesh-ancestor
93080473|NCT00378599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080474|NCT01046981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93080475|NCT01046981|Metronidazole|metronidazole|mesh-list
93080476|NCT01046981|Cefazolin|cefazolin|mesh-list
93080477|NCT01046981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93080478|NCT01046981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080479|NCT01046981|Antitubercular Agents|antitubercular agents|mesh-ancestor
93080480|NCT01046981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93080481|NCT01046981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93080482|NCT00378209|Dexamethasone|dexamethasone|mesh-list
93080483|NCT00378209|Lenalidomide|lenalidomide|mesh-list
93080484|NCT00378209|Bortezomib|bortezomib|mesh-list
93080485|NCT00378209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080486|NCT00378209|Antiemetics|antiemetics|mesh-ancestor
93080487|NCT00378209|Autonomic Agents|autonomic agents|mesh-ancestor
93080488|NCT00378209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080489|NCT00378209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080490|NCT00378209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080491|NCT00378209|Glucocorticoids|glucocorticoids|mesh-ancestor
93080492|NCT00378209|Hormones|hormones|mesh-ancestor
93080493|NCT00378209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080494|NCT00378209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080495|NCT00378209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080496|NCT00378209|Immunologic Factors|immunologic factors|mesh-ancestor
93080497|NCT00378209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080498|NCT00378209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080499|NCT00378209|Growth Substances|growth substances|mesh-ancestor
93080500|NCT00378209|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080501|NCT01047059|Bevacizumab|bevacizumab|mesh-list
93080502|NCT01047059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93080503|NCT01047059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080504|NCT01047059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080505|NCT01047059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080506|NCT01047059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080507|NCT01047059|Growth Substances|growth substances|mesh-ancestor
93080508|NCT01047059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080509|NCT01047059|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080510|NCT01047059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93080511|NCT01047059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080512|NCT01047059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080513|NCT00377819|Denosumab|denosumab|mesh-list
93080514|NCT00377819|Alendronate|alendronate|mesh-list
93080515|NCT00377819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93080516|NCT00377819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080517|NCT00377429|Catumaxomab|catumaxomab|mesh-list
93080518|NCT00377429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080519|NCT01047215|Aripiprazole|aripiprazole|mesh-list
93080520|NCT01047215|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93080521|NCT01047215|Antidepressive Agents|antidepressive agents|mesh-ancestor
93080522|NCT01047215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080523|NCT01047215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93080524|NCT01047215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93080525|NCT01047215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93080526|NCT01047215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080527|NCT01047215|Dopamine Agonists|dopamine agonists|mesh-ancestor
93080528|NCT01047215|Dopamine Agents|dopamine agents|mesh-ancestor
93080529|NCT01047215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080530|NCT01047215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080531|NCT01047215|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93080532|NCT01047215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93080533|NCT01047215|Serotonin Agents|serotonin agents|mesh-ancestor
93080534|NCT01047215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93080535|NCT01047215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93080536|NCT01047215|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93080537|NCT01047215|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93080538|NCT03715582|Trimetazidine|trimetazidine|mesh-list
93080539|NCT03715582|Vasodilator Agents|vasodilator agents|mesh-ancestor
93080540|NCT00376961|Prednisone|prednisone|mesh-list
93080541|NCT00376961|Cyclophosphamide|cyclophosphamide|mesh-list
93080542|NCT00376961|Rituximab|rituximab|mesh-list
93080543|NCT00376961|Doxorubicin|doxorubicin|mesh-list
93080544|NCT00376961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93080545|NCT00376961|Vincristine|vincristine|mesh-list
93080546|NCT00376961|Bortezomib|bortezomib|mesh-list
93080547|NCT00376961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080548|NCT00376961|Immunologic Factors|immunologic factors|mesh-ancestor
93080549|NCT00376961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080550|NCT00376961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080551|NCT00376961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93080552|NCT00376961|Alkylating Agents|alkylating agents|mesh-ancestor
93080553|NCT00376961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080554|NCT00376961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080555|NCT00376961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93080556|NCT00376961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080557|NCT00376961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080558|NCT00376961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080559|NCT00376961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080560|NCT00376961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080561|NCT00376961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080562|NCT00376961|Glucocorticoids|glucocorticoids|mesh-ancestor
93080563|NCT00376961|Hormones|hormones|mesh-ancestor
93080564|NCT00376961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080565|NCT00376961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080566|NCT00376961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93080567|NCT00376961|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080568|NCT00376961|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080569|NCT00376961|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080570|NCT00376259|Adefovir|adefovir|mesh-list
93080571|NCT00376259|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93080572|NCT00376259|Telbivudine|telbivudine|mesh-list
93080573|NCT00376259|Antiviral Agents|antiviral agents|mesh-ancestor
93080574|NCT00376259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080575|NCT00376259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93080576|NCT00376259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93080577|NCT00376259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080578|NCT00376259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080579|NCT03715348|Thrombin|thrombin|mesh-list
93080580|NCT03715348|Hemostatics|hemostatics|mesh-ancestor
93080581|NCT03715348|Coagulants|coagulants|mesh-ancestor
93080582|NCT01041755|N-Methylaspartate|n-methylaspartate|mesh-list
93080583|NCT01041755|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93080584|NCT01041755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93080585|NCT01041755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080586|NCT01041755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080587|NCT01041755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080588|NCT00365105|Vitamin D|vitamin d|mesh-list
93080589|NCT00365105|Zoledronic Acid|zoledronic acid|mesh-list
93080590|NCT00365105|Calcium|calcium|mesh-list
93080591|NCT00365105|Vitamins|vitamins|mesh-ancestor
93080592|NCT00365105|Micronutrients|micronutrients|mesh-ancestor
93080593|NCT00365105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080594|NCT00365105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93080595|NCT00365105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93080596|NCT01049633|Aspirin|aspirin|mesh-list
93080597|NCT01049633|Sirolimus|sirolimus|mesh-list
93080598|NCT01049633|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93080599|NCT01049633|Antifungal Agents|antifungal agents|mesh-list
93080600|NCT01049633|Clotrimazole|clotrimazole|mesh-list
93080601|NCT01049633|Miconazole|miconazole|mesh-list
93080602|NCT01049633|Trimethoprim|trimethoprim|mesh-list
93080603|NCT01049633|Sulfamethoxazole|sulfamethoxazole|mesh-list
93080604|NCT01049633|Valganciclovir|valganciclovir|mesh-list
93080605|NCT01049633|Antiviral Agents|antiviral agents|mesh-list
93080606|NCT01049633|Heparin|heparin|mesh-list
93080607|NCT01049633|Enoxaparin|enoxaparin|mesh-list
93080608|NCT01049633|Pentoxifylline|pentoxifylline|mesh-list
93080609|NCT01049633|Tacrolimus|tacrolimus|mesh-list
93080610|NCT01049633|Basiliximab|basiliximab|mesh-list
93080611|NCT01049633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93080612|NCT01049633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93080613|NCT01049633|Analgesics|analgesics|mesh-ancestor
93080614|NCT01049633|Sensory System Agents|sensory system agents|mesh-ancestor
93080615|NCT01049633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080616|NCT01049633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080617|NCT01049633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080618|NCT01049633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080619|NCT01049633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93080620|NCT01049633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93080621|NCT01049633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080622|NCT01049633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93080623|NCT01049633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93080624|NCT01049633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080625|NCT01049633|Antipyretics|antipyretics|mesh-ancestor
93080626|NCT01049633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080627|NCT01049633|Immunologic Factors|immunologic factors|mesh-ancestor
93080628|NCT01049633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93080629|NCT01049633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080630|NCT01049633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080631|NCT01049633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080632|NCT01049633|Anticoagulants|anticoagulants|mesh-ancestor
93080633|NCT01049633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93080634|NCT01049633|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93080635|NCT01049633|Protective Agents|protective agents|mesh-ancestor
93080636|NCT01049633|Vasodilator Agents|vasodilator agents|mesh-ancestor
93080637|NCT01049633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93080638|NCT01049633|Antioxidants|antioxidants|mesh-ancestor
93080639|NCT01049633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93080640|NCT01049633|Antimalarials|antimalarials|mesh-ancestor
93080641|NCT01049633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93080642|NCT01049633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93080643|NCT01049633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93080644|NCT01049633|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93080645|NCT01049633|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93080646|NCT01049633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93080647|NCT01049633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93080648|NCT01049633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93080649|NCT01049633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93080650|NCT01049633|Hormone Antagonists|hormone antagonists|mesh-ancestor
93080651|NCT01049633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080652|NCT01049633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92670941|NCT00305513|Caffeine|caffeine|mesh-list
93080653|NCT01049633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93080654|NCT00399893|Octreotide|octreotide|mesh-list
93080655|NCT00399893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080656|NCT00399893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080657|NCT00399893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080658|NCT01049711|Epoetin Alfa|epoetin alfa|mesh-list
93080659|NCT01049711|Hematinics|hematinics|mesh-ancestor
93080660|NCT00048542|Adalimumab|adalimumab|mesh-list
93080661|NCT00048542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93080662|NCT00048542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080663|NCT00048542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080664|NCT03814590|Vaccines|vaccines|mesh-list
93080665|NCT03814590|Immunologic Factors|immunologic factors|mesh-ancestor
93080666|NCT03814590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080667|NCT01583244|Abatacept|abatacept|mesh-list
93080668|NCT01583244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93080669|NCT01583244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080670|NCT01583244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080671|NCT01583244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080672|NCT01583244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080673|NCT01583244|Immunologic Factors|immunologic factors|mesh-ancestor
93080674|NCT01583244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080675|NCT01583244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080676|NCT01085526|Immunomodulating Agents|immunomodulating agents|mesh-list
93080677|NCT01085526|Immunologic Factors|immunologic factors|mesh-list
93080678|NCT01085526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080679|NCT00048074|Ibandronic Acid|ibandronic acid|mesh-list
93080680|NCT00048074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93080681|NCT00048074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080682|NCT01102946|Ranibizumab|ranibizumab|mesh-list
93080683|NCT01102946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080684|NCT01102946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080685|NCT01102946|Growth Substances|growth substances|mesh-ancestor
93080686|NCT01102946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080687|NCT01102946|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080688|NCT01102946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080689|NCT01103024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93080690|NCT01103024|Immunologic Factors|immunologic factors|mesh-ancestor
93080691|NCT01103024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080692|NCT01101386|Voriconazole|voriconazole|mesh-list
93080693|NCT01101386|Antifungal Agents|antifungal agents|mesh-ancestor
93080694|NCT01101386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080695|NCT01101386|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93080696|NCT01101386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93080697|NCT01101386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080698|NCT01101386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080699|NCT01101386|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93080700|NCT01101386|Hormone Antagonists|hormone antagonists|mesh-ancestor
93080701|NCT01101386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080702|NCT01101386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080703|NCT01101386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93080704|NCT00005906|Octreotide|octreotide|mesh-list
93080705|NCT00005906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080706|NCT00005906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080707|NCT00005906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080708|NCT01103336|Nicorandil|nicorandil|mesh-list
93080709|NCT01103336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93080710|NCT01103336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93080711|NCT01103336|Vasodilator Agents|vasodilator agents|mesh-ancestor
93080712|NCT01103336|Vitamin B Complex|vitamin b complex|mesh-ancestor
93080713|NCT01103336|Vitamins|vitamins|mesh-ancestor
93080714|NCT01103336|Micronutrients|micronutrients|mesh-ancestor
93080715|NCT01103336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080716|NCT03950960|Itraconazole|itraconazole|mesh-list
93080717|NCT03950960|Antifungal Agents|antifungal agents|mesh-ancestor
93080718|NCT03950960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080719|NCT03950960|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93080720|NCT03950960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93080721|NCT03950960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080722|NCT03950960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080723|NCT03950960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93080724|NCT03950960|Hormone Antagonists|hormone antagonists|mesh-ancestor
93080725|NCT03950960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080726|NCT03950960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080727|NCT03950960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93080728|NCT03954860|Tranexamic Acid|tranexamic acid|mesh-list
93080729|NCT03954860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93080730|NCT03954860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93080731|NCT03954860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080732|NCT03954860|Hemostatics|hemostatics|mesh-ancestor
93080733|NCT03954860|Coagulants|coagulants|mesh-ancestor
93080734|NCT00066690|Tamoxifen|tamoxifen|mesh-list
93080735|NCT00066690|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93080736|NCT00066690|Exemestane|exemestane|mesh-list
93080737|NCT00066690|Tryptophan|tryptophan|mesh-list
93080738|NCT00066690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080739|NCT00066690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080740|NCT00066690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080741|NCT00066690|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93080742|NCT00066690|Hormone Antagonists|hormone antagonists|mesh-ancestor
93080743|NCT00066690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080744|NCT00066690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080745|NCT00066690|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93080746|NCT00066690|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93080747|NCT00066690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93080748|NCT00066690|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93080749|NCT00066690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93080750|NCT00066690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080751|NCT00066690|Luteolytic Agents|luteolytic agents|mesh-ancestor
93080752|NCT00066690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93080753|NCT00066690|Contraceptive Agents|contraceptive agents|mesh-ancestor
93080754|NCT00066690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93080755|NCT00066690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93080756|NCT00066690|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93080757|NCT00066690|Antidepressive Agents|antidepressive agents|mesh-ancestor
93080758|NCT00066690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080759|NCT03409276|Vaccines|vaccines|mesh-list
93080760|NCT03409276|Immunologic Factors|immunologic factors|mesh-ancestor
93080761|NCT03409276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080762|NCT00004562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93080763|NCT00004562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93080764|NCT00004562|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93080765|NCT00004562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93080766|NCT00004562|Adrenergic Agents|adrenergic agents|mesh-list
93080767|NCT00004562|Adrenergic Antagonists|adrenergic antagonists|mesh-list
93080768|NCT00004562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080769|NCT00004562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080770|NCT00004562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080771|NCT00004562|Protease Inhibitors|protease inhibitors|mesh-ancestor
93080772|NCT00004412|Arginine butyrate|arginine butyrate|mesh-list
93080774|NCT00004088|Pamidronate|pamidronate|mesh-list
93080775|NCT00004088|Interferons|interferons|mesh-list
93080776|NCT00004088|Interferon-alpha|interferon-alpha|mesh-list
93080777|NCT00004088|Thalidomide|thalidomide|mesh-list
93080778|NCT00004088|Cyclophosphamide|cyclophosphamide|mesh-list
93080779|NCT00004088|Melphalan|melphalan|mesh-list
93080780|NCT00004088|Busulfan|busulfan|mesh-list
93080781|NCT00004088|Lenograstim|lenograstim|mesh-list
93080782|NCT00004088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080783|NCT00004088|Immunologic Factors|immunologic factors|mesh-ancestor
93080784|NCT00004088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080785|NCT00004088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080786|NCT00004088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93080787|NCT00004088|Alkylating Agents|alkylating agents|mesh-ancestor
93080788|NCT00004088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080789|NCT00004088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080790|NCT00004088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93080791|NCT00004088|Antiviral Agents|antiviral agents|mesh-ancestor
93080792|NCT00004088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080793|NCT00004088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93080794|NCT00004088|Leprostatic Agents|leprostatic agents|mesh-ancestor
93080795|NCT00004088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93080796|NCT00004088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080797|NCT00004088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080798|NCT00004088|Growth Substances|growth substances|mesh-ancestor
93080799|NCT00004088|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080800|NCT00004088|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93080801|NCT03439072|Glucagon|glucagon|mesh-list
93080802|NCT03439072|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93080803|NCT03439072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080804|NCT03439072|Hormones|hormones|mesh-ancestor
93080805|NCT03439072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080806|NCT03439072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080807|NCT03439072|Incretins|incretins|mesh-ancestor
93080808|NCT00078312|Modafinil|modafinil|mesh-list
93080809|NCT00078312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93080810|NCT00078312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080811|NCT00078312|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93080812|NCT00078312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93080813|NCT00078312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93080814|NCT00078312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080815|NCT01085838|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93080816|NCT01085838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080817|NCT01085838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93080818|NCT01085838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080819|NCT01085838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080820|NCT00003896|Paclitaxel|paclitaxel|mesh-list
93080821|NCT00003896|Doxorubicin|doxorubicin|mesh-list
93080822|NCT00003896|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93080823|NCT00003896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93080824|NCT00003896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080825|NCT00003896|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080826|NCT00003896|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080827|NCT00003896|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080828|NCT00003896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080829|NCT00003896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080830|NCT00003896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080831|NCT00003896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080832|NCT00003896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080833|NCT01091766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93080834|NCT03712540|Rifampin|rifampin|mesh-list
93080835|NCT03712540|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93080836|NCT03712540|Antitubercular Agents|antitubercular agents|mesh-ancestor
93080837|NCT03712540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93080838|NCT03712540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080839|NCT03712540|Leprostatic Agents|leprostatic agents|mesh-ancestor
93080840|NCT03712540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93080841|NCT03712540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080842|NCT03712540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080843|NCT03712540|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93080844|NCT03712540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93080845|NCT03712540|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93057935|NCT01078779|Analgesics|analgesics|mesh-ancestor
93080846|NCT03712540|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93080847|NCT03712540|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93080848|NCT03712540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93080849|NCT05472220|Carboplatin|carboplatin|mesh-list
93080850|NCT05472220|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
93080851|NCT05472220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080852|NCT05472220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080853|NCT05472220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080854|NCT00003782|Cyclophosphamide|cyclophosphamide|mesh-list
93080855|NCT00003782|Docetaxel|docetaxel|mesh-list
93080856|NCT00003782|Doxorubicin|doxorubicin|mesh-list
93080857|NCT00003782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93080858|NCT00003782|Immunologic Factors|immunologic factors|mesh-ancestor
93080859|NCT00003782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080860|NCT00003782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080861|NCT00003782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93080862|NCT00003782|Alkylating Agents|alkylating agents|mesh-ancestor
93080863|NCT00003782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080864|NCT00003782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080865|NCT00003782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93080866|NCT00003782|Tubulin Modulators|tubulin modulators|mesh-ancestor
93080867|NCT00003782|Antimitotic Agents|antimitotic agents|mesh-ancestor
93080868|NCT00003782|Mitosis Modulators|mitosis modulators|mesh-ancestor
93080869|NCT00003782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080870|NCT00003782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080871|NCT00003782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080872|NCT00003782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080873|NCT03389308|Diacerein|diacerein|mesh-list
93080874|NCT03389308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080875|NCT03714490|Capecitabine|capecitabine|mesh-list
93080876|NCT03714490|Oxaliplatin|oxaliplatin|mesh-list
93080877|NCT03714490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93080878|NCT03714490|Antimetabolites|antimetabolites|mesh-ancestor
93080879|NCT03714490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080880|NCT03714490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080881|NCT03407170|Pembrolizumab|pembrolizumab|mesh-list
93080882|NCT03407170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080883|NCT03407170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080884|NCT03407170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93080885|NCT03407170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080886|NCT01103648|Simvastatin|simvastatin|mesh-list
93080887|NCT01103648|Ezetimibe|ezetimibe|mesh-list
93080888|NCT01103648|Hypolipidemic Agents|hypolipidemic agents|mesh-list
93080889|NCT01103648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93080890|NCT01103648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93080891|NCT01103648|Antimetabolites|antimetabolites|mesh-ancestor
93080892|NCT01103648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080893|NCT01103648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93080894|NCT01103648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080895|NCT03406858|Pembrolizumab|pembrolizumab|mesh-list
93080896|NCT03406858|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93080897|NCT03406858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93080898|NCT03406858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080899|NCT03406858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93080900|NCT03406858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080901|NCT03406858|Immunologic Factors|immunologic factors|mesh-ancestor
93080902|NCT03406858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080903|NCT01095848|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93080904|NCT01095848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93080905|NCT01095848|Immunologic Factors|immunologic factors|mesh-ancestor
93080906|NCT01095848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080907|NCT01095926|Doxorubicin|doxorubicin|mesh-list
93080908|NCT01095926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93080909|NCT01095926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080910|NCT01095926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93080911|NCT01095926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93080912|NCT01095926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080913|NCT01095926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080914|NCT00003656|Interferons|interferons|mesh-list
93080915|NCT00003656|Interferon-alpha|interferon-alpha|mesh-list
93080916|NCT00003656|Tretinoin|tretinoin|mesh-list
93080917|NCT00003656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058020|NCT00113373|Lapatinib|lapatinib|mesh-list
93080918|NCT00003656|Antiviral Agents|antiviral agents|mesh-ancestor
93080919|NCT00003656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080920|NCT00003656|Immunologic Factors|immunologic factors|mesh-ancestor
93080921|NCT00003656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080922|NCT00003656|Keratolytic Agents|keratolytic agents|mesh-ancestor
93080923|NCT00003656|Dermatologic Agents|dermatologic agents|mesh-ancestor
93080924|NCT00003590|Hydroxyurea|hydroxyurea|mesh-list
93080925|NCT00003590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080926|NCT00003590|Antisickling Agents|antisickling agents|mesh-ancestor
93080927|NCT00003590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080928|NCT00003590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080929|NCT00003590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93080930|NCT03948620|Penicillins|penicillins|mesh-list
93080931|NCT03948620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93080932|NCT03948620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93080933|NCT03416374|Dexamethasone|dexamethasone|mesh-list
93080934|NCT03416374|Lenalidomide|lenalidomide|mesh-list
93080935|NCT03416374|Bortezomib|bortezomib|mesh-list
93080936|NCT03416374|Ixazomib|ixazomib|mesh-list
93080937|NCT03416374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080938|NCT03416374|Antiemetics|antiemetics|mesh-ancestor
93080939|NCT03416374|Autonomic Agents|autonomic agents|mesh-ancestor
93080940|NCT03416374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080941|NCT03416374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080942|NCT03416374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93080943|NCT03416374|Glucocorticoids|glucocorticoids|mesh-ancestor
93080944|NCT03416374|Hormones|hormones|mesh-ancestor
93080945|NCT03416374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93080946|NCT03416374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93080947|NCT03416374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93080948|NCT03416374|Immunologic Factors|immunologic factors|mesh-ancestor
93080949|NCT03416374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93080950|NCT03416374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93080951|NCT03416374|Growth Substances|growth substances|mesh-ancestor
93080952|NCT03416374|Growth Inhibitors|growth inhibitors|mesh-ancestor
93080953|NCT03416374|Protease Inhibitors|protease inhibitors|mesh-ancestor
93080954|NCT03416374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080955|NCT03416374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080956|NCT00077766|Darbepoetin alfa|darbepoetin alfa|mesh-list
93080957|NCT00077766|Hematinics|hematinics|mesh-ancestor
93080958|NCT01096082|Lithium Carbonate|lithium carbonate|mesh-list
93080959|NCT01096082|Antidepressive Agents|antidepressive agents|mesh-ancestor
93080960|NCT01096082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93080961|NCT01096082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080962|NCT01096082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080963|NCT01096082|Antimanic Agents|antimanic agents|mesh-ancestor
93080964|NCT01096082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93080965|NCT01096082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93080966|NCT01096082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080967|NCT03388138|Ketotifen|ketotifen|mesh-list
93080968|NCT03388138|Antipruritics|antipruritics|mesh-ancestor
93080969|NCT03388138|Dermatologic Agents|dermatologic agents|mesh-ancestor
93080970|NCT03388138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93080971|NCT03388138|Histamine Antagonists|histamine antagonists|mesh-ancestor
93080972|NCT03388138|Histamine Agents|histamine agents|mesh-ancestor
93080973|NCT03388138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93080974|NCT03388138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080975|NCT03388138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080976|NCT03388138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93080977|NCT01101620|Simendan|simendan|mesh-list
93080978|NCT01101620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93080979|NCT01101620|Vasodilator Agents|vasodilator agents|mesh-ancestor
93080980|NCT01101620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93080981|NCT01101620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93080982|NCT01101620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080983|NCT01101620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080984|NCT01101620|Protective Agents|protective agents|mesh-ancestor
93080985|NCT01101620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080986|NCT02952898|Diclofenac|diclofenac|mesh-list
93080987|NCT02952898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93080988|NCT02952898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93080989|NCT02952898|Analgesics|analgesics|mesh-ancestor
93080990|NCT02952898|Sensory System Agents|sensory system agents|mesh-ancestor
93080991|NCT02952898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93080992|NCT02952898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93080993|NCT02952898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93080994|NCT02952898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93080995|NCT02952898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93080996|NCT02952898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93080997|NCT02952898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93080998|NCT01101698|Vitamin D|vitamin d|mesh-list
93080999|NCT01101698|Cholecalciferol|cholecalciferol|mesh-list
93081000|NCT01101698|Vitamins|vitamins|mesh-list
93081001|NCT01101698|Vitamin K|vitamin k|mesh-list
93081002|NCT01101698|Vitamin K 2|vitamin k 2|mesh-list
93081003|NCT01101698|Micronutrients|micronutrients|mesh-ancestor
93081004|NCT01101698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081005|NCT01101698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93081006|NCT01101698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93081007|NCT01101698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93081008|NCT01101698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93081009|NCT01101698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081010|NCT01101698|Hemostatics|hemostatics|mesh-ancestor
93081011|NCT01101698|Coagulants|coagulants|mesh-ancestor
93081012|NCT00045734|Imatinib Mesylate|imatinib mesylate|mesh-list
93081013|NCT00045734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081014|NCT00045734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93081015|NCT00045734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081016|NCT00045734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081017|NCT05513768|Protein C|protein c|mesh-list
93081018|NCT05513768|Anticoagulants|anticoagulants|mesh-ancestor
93081019|NCT05513768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93081020|NCT05513768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93081021|NCT05513768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081022|NCT03387046|Methylprednisolone|methylprednisolone|mesh-list
93081023|NCT03387046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93081024|NCT03387046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93081025|NCT03387046|Prednisolone|prednisolone|mesh-list
93081026|NCT03387046|Prednisolone acetate|prednisolone acetate|mesh-list
93081027|NCT03387046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93081028|NCT03387046|Prednisolone phosphate|prednisolone phosphate|mesh-list
93081029|NCT03387046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081030|NCT03387046|Antiemetics|antiemetics|mesh-ancestor
93081031|NCT03387046|Autonomic Agents|autonomic agents|mesh-ancestor
93081032|NCT03387046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081033|NCT03387046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081034|NCT03387046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081035|NCT03387046|Glucocorticoids|glucocorticoids|mesh-ancestor
93081036|NCT03387046|Hormones|hormones|mesh-ancestor
93081037|NCT03387046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93081038|NCT03387046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93081039|NCT03387046|Protective Agents|protective agents|mesh-ancestor
93081040|NCT03387046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93081041|NCT03387046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081042|NCT01101776|Interferons|interferons|mesh-list
93081043|NCT01101776|Interferon-beta|interferon-beta|mesh-list
93081044|NCT01101776|Interferon beta-1a|interferon beta-1a|mesh-list
93081045|NCT01101776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081046|NCT01101776|Antiviral Agents|antiviral agents|mesh-ancestor
93081047|NCT01101776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081048|NCT01101776|Immunologic Factors|immunologic factors|mesh-ancestor
93081049|NCT01101776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081050|NCT01101776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93081051|NCT00045110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93081052|NCT00045110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081053|NCT00045110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93081054|NCT00045110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081055|NCT00045110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081056|NCT03353740|Edetic Acid|edetic acid|mesh-list
93081057|NCT03353740|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93081058|NCT03353740|Chelating Agents|chelating agents|mesh-ancestor
93081059|NCT03353740|Sequestering Agents|sequestering agents|mesh-ancestor
93081060|NCT03353740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081061|NCT03353740|Anticoagulants|anticoagulants|mesh-ancestor
93081062|NCT03353740|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93081063|NCT03353740|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93081064|NCT04814602|Proglumide|proglumide|mesh-list
93081065|NCT04814602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93081066|NCT04814602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081067|NCT01104038|Chlorhexidine|chlorhexidine|mesh-list
93081068|NCT01104038|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93081069|NCT01104038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93058154|NCT01238146|Immunologic Factors|immunologic factors|mesh-ancestor
93081070|NCT01104038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081071|NCT01104038|Disinfectants|disinfectants|mesh-ancestor
93081072|NCT01104038|Dermatologic Agents|dermatologic agents|mesh-ancestor
93081073|NCT03386344|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93081074|NCT03386344|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93081075|NCT03386344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081076|NCT03386344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93081077|NCT03386344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081079|NCT00399035|Fluorouracil|fluorouracil|mesh-list
93081080|NCT00399035|Capecitabine|capecitabine|mesh-list
93081081|NCT00399035|Oxaliplatin|oxaliplatin|mesh-list
93081082|NCT00399035|Cediranib|cediranib|mesh-list
93081083|NCT00399035|Levoleucovorin|levoleucovorin|mesh-list
93081084|NCT00399035|Antimetabolites|antimetabolites|mesh-ancestor
93081085|NCT00399035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081086|NCT00399035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081087|NCT00399035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081088|NCT00399035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93081089|NCT00399035|Immunologic Factors|immunologic factors|mesh-ancestor
93081090|NCT00399035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081091|NCT00399035|Antidotes|antidotes|mesh-ancestor
93081092|NCT00399035|Protective Agents|protective agents|mesh-ancestor
93081093|NCT00399035|Vitamin B Complex|vitamin b complex|mesh-ancestor
93081094|NCT00399035|Vitamins|vitamins|mesh-ancestor
93081095|NCT00399035|Micronutrients|micronutrients|mesh-ancestor
93081096|NCT00399035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93081097|NCT00399035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081098|NCT00073749|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93081099|NCT00073749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081100|NCT00073749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081101|NCT00073749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93081102|NCT00073749|Immunotoxins|immunotoxins|mesh-ancestor
93081103|NCT00073749|Immunoconjugates|immunoconjugates|mesh-ancestor
93081104|NCT00073749|Immunologic Factors|immunologic factors|mesh-ancestor
93081105|NCT00073749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081106|NCT03960801|Remifentanil|remifentanil|mesh-list
93081107|NCT03960801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93081108|NCT03960801|Narcotics|narcotics|mesh-ancestor
93081109|NCT03960801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081110|NCT03960801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081111|NCT03960801|Analgesics|analgesics|mesh-ancestor
93081112|NCT03960801|Sensory System Agents|sensory system agents|mesh-ancestor
93081113|NCT03960801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081114|NCT01583439|Ritonavir|ritonavir|mesh-list
93081115|NCT01583439|Lopinavir|lopinavir|mesh-list
93081116|NCT01583439|Tenofovir|tenofovir|mesh-list
93081117|NCT01583439|Lamivudine|lamivudine|mesh-list
93081118|NCT01583439|Emtricitabine|emtricitabine|mesh-list
93081119|NCT01583439|Zidovudine|zidovudine|mesh-list
93081120|NCT01583439|Efavirenz|efavirenz|mesh-list
93081121|NCT01583439|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93081122|NCT01583439|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93081123|NCT01583439|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93081124|NCT01583439|Protease Inhibitors|protease inhibitors|mesh-ancestor
93081125|NCT01583439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081126|NCT01583439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081127|NCT01583439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93081128|NCT01583439|Antiviral Agents|antiviral agents|mesh-ancestor
93081129|NCT01583439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081130|NCT01583439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93081131|NCT01583439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93081132|NCT01583439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93081133|NCT01583439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93081134|NCT01583439|Antimetabolites|antimetabolites|mesh-ancestor
93081135|NCT01583439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93081136|NCT01583439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93081137|NCT01583439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93081138|NCT01583439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93081139|NCT01583439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93081140|NCT02530827|Hypolipidemic Agents|hypolipidemic agents|mesh-list
93081141|NCT02530827|Antimetabolites|antimetabolites|mesh-ancestor
93081142|NCT02530827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081143|NCT02530827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93081144|NCT00398567|Trastuzumab|trastuzumab|mesh-list
93081145|NCT00398567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081146|NCT00398567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081147|NCT01082289|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93081148|NCT01082289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93081149|NCT01082289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93081150|NCT01082289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081151|NCT01082289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081152|NCT01082289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081153|NCT01082289|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93081154|NCT01082289|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93081155|NCT01082289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93081156|NCT01082289|Adrenergic Agents|adrenergic agents|mesh-ancestor
93081157|NCT01082289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081158|NCT01082289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081159|NCT01082289|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93081160|NCT01082289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93081161|NCT01082289|Serotonin Agents|serotonin agents|mesh-ancestor
93081162|NCT01082289|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93081163|NCT01082289|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93081164|NCT01082289|Dopamine Agents|dopamine agents|mesh-ancestor
93081165|NCT05842213|Golimumab|golimumab|mesh-list
93081166|NCT05842213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081167|NCT05842213|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93081168|NCT05842213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081169|NCT05842213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93081170|NCT05842213|Immunologic Factors|immunologic factors|mesh-ancestor
93081171|NCT05842213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081172|NCT05842174|Hydroxychloroquine|hydroxychloroquine|mesh-list
93081173|NCT05842174|Ethiodized Oil|ethiodized oil|mesh-list
93081174|NCT05842174|Antimalarials|antimalarials|mesh-ancestor
93081175|NCT05842174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93081176|NCT05842174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93081177|NCT05842174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081178|NCT05842174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081179|NCT05842174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081180|NCT05842174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081181|NCT05842174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081182|NCT05842096|Antibodies|antibodies|mesh-list
93081183|NCT05842096|Immunologic Factors|immunologic factors|mesh-ancestor
93081184|NCT05842096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081185|NCT05841992|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93081186|NCT05841992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93081187|NCT05841992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081188|NCT05841849|Aprepitant|aprepitant|mesh-list
93081189|NCT05841849|Fosaprepitant|fosaprepitant|mesh-list
93081190|NCT05841849|Palonosetron|palonosetron|mesh-list
93081191|NCT05841849|Antiemetics|antiemetics|mesh-ancestor
93081192|NCT05841849|Autonomic Agents|autonomic agents|mesh-ancestor
93081193|NCT05841849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081194|NCT05841849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081195|NCT05841849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081196|NCT05841849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93081197|NCT05841849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081198|NCT05841849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081199|NCT05841849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93081200|NCT05841849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93081201|NCT05841849|Serotonin Agents|serotonin agents|mesh-ancestor
93081202|NCT05841771|Azacitidine|azacitidine|mesh-list
93081203|NCT05841771|Decitabine|decitabine|mesh-list
93081204|NCT05841771|Venetoclax|venetoclax|mesh-list
93081205|NCT05841771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081206|NCT05841771|Antimetabolites|antimetabolites|mesh-ancestor
93081207|NCT05841771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081208|NCT05841771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081209|NCT05841771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081210|NCT05841758|Hydroxychloroquine|hydroxychloroquine|mesh-list
93081211|NCT05841758|Antimalarials|antimalarials|mesh-ancestor
93081212|NCT05841758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93081213|NCT05841758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93081214|NCT05841758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081215|NCT05841758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081216|NCT05841758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081217|NCT05841758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081218|NCT05841654|Antihypertensive Agents|antihypertensive agents|mesh-list
93081219|NCT05841654|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
91933011|NCT02225093|Caffeine|caffeine|mesh-list
93081220|NCT05841654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93081221|NCT05841654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93081222|NCT05841654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081223|NCT05841641|Hemostatics|hemostatics|mesh-list
93081224|NCT05841641|Coagulants|coagulants|mesh-ancestor
93081225|NCT05841589|Chlorhexidine|chlorhexidine|mesh-list
93081226|NCT05841589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93081227|NCT05841589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081228|NCT05841589|Disinfectants|disinfectants|mesh-ancestor
93081229|NCT05841472|Carboplatin|carboplatin|mesh-list
93081230|NCT05841472|Pemetrexed|pemetrexed|mesh-list
93081231|NCT05841472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081232|NCT05841472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081233|NCT05841472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081234|NCT05841472|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93081235|NCT05841472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93081236|NCT05841446|Apixaban|apixaban|mesh-list
93081237|NCT05841446|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93081238|NCT05841446|Antithrombins|antithrombins|mesh-ancestor
93081239|NCT05841446|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93081240|NCT05841446|Protease Inhibitors|protease inhibitors|mesh-ancestor
93081241|NCT05841446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081242|NCT05841446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081243|NCT05841446|Anticoagulants|anticoagulants|mesh-ancestor
93081244|NCT05841394|Esomeprazole|esomeprazole|mesh-list
93081245|NCT05841394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93081246|NCT05841394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081247|NCT05841394|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93081248|NCT05841394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081249|NCT05841394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081250|NCT05841381|Paclitaxel|paclitaxel|mesh-list
93081251|NCT05841381|Trastuzumab|trastuzumab|mesh-list
93081252|NCT05841381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081253|NCT05841381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081254|NCT05841381|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081255|NCT05841381|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081256|NCT05841381|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081257|NCT05841381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081258|NCT05841381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081259|NCT05841303|Ascorbic Acid|ascorbic acid|mesh-list
93081260|NCT05841303|Antioxidants|antioxidants|mesh-ancestor
93081261|NCT05841303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081262|NCT05841303|Protective Agents|protective agents|mesh-ancestor
93081263|NCT05841303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081264|NCT05841303|Vitamins|vitamins|mesh-ancestor
93081265|NCT05841303|Micronutrients|micronutrients|mesh-ancestor
93081266|NCT05841290|Anesthetics|anesthetics|mesh-list
93081267|NCT05841290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081268|NCT05841290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081269|NCT05841251|Phenylephrine|phenylephrine|mesh-list
93081270|NCT05841251|Oxymetazoline|oxymetazoline|mesh-list
93081271|NCT05841251|Tranexamic Acid|tranexamic acid|mesh-list
93081272|NCT05841251|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93081273|NCT05841251|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93081274|NCT05841251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081275|NCT05841251|Hemostatics|hemostatics|mesh-ancestor
93081276|NCT05841251|Coagulants|coagulants|mesh-ancestor
93081277|NCT05841251|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93081278|NCT05841251|Mydriatics|mydriatics|mesh-ancestor
93081279|NCT05841251|Autonomic Agents|autonomic agents|mesh-ancestor
93081280|NCT05841251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081281|NCT05841251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081282|NCT05841251|Sympathomimetics|sympathomimetics|mesh-ancestor
93081283|NCT05841251|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93081284|NCT05841251|Nasal Decongestants|nasal decongestants|mesh-ancestor
93081285|NCT05841251|Respiratory System Agents|respiratory system agents|mesh-ancestor
93081286|NCT05841251|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93081287|NCT05841251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93081288|NCT05841251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93081289|NCT05841251|Adrenergic Agents|adrenergic agents|mesh-ancestor
93081290|NCT05841251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081291|NCT05841251|Protective Agents|protective agents|mesh-ancestor
93081292|NCT05841147|Tirofiban|tirofiban|mesh-list
93081293|NCT05841147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93081294|NCT05841147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93081295|NCT05841147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081296|NCT05841147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93058378|NCT01145950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081297|NCT05841121|Dexamethasone|dexamethasone|mesh-list
93081298|NCT05841121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081299|NCT05841121|Antiemetics|antiemetics|mesh-ancestor
93081300|NCT05841121|Autonomic Agents|autonomic agents|mesh-ancestor
93081301|NCT05841121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081302|NCT05841121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081303|NCT05841121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081304|NCT05841121|Glucocorticoids|glucocorticoids|mesh-ancestor
93081305|NCT05841121|Hormones|hormones|mesh-ancestor
93081306|NCT05841121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93081307|NCT05841121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93081308|NCT05841121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081309|NCT05841056|Amiodarone|amiodarone|mesh-list
93081310|NCT05841056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93081311|NCT05841056|Vasodilator Agents|vasodilator agents|mesh-ancestor
93081312|NCT05841056|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93081313|NCT05841056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081314|NCT05841056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081315|NCT05841056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93081316|NCT05841056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93081317|NCT05841056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93081318|NCT05841056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081319|NCT05841056|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93081320|NCT05841056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93081321|NCT05841056|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93081322|NCT05841043|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93081323|NCT05841043|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93081324|NCT05840952|Itraconazole|itraconazole|mesh-list
93081325|NCT05840952|Carbamazepine|carbamazepine|mesh-list
93081326|NCT05840952|Midazolam|midazolam|mesh-list
93081327|NCT05840952|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93081328|NCT05840952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93081329|NCT05840952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081330|NCT05840952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081331|NCT05840952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93081332|NCT05840952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93081333|NCT05840952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081334|NCT05840952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93081335|NCT05840952|Anesthetics, General|anesthetics, general|mesh-ancestor
93081336|NCT05840952|Anesthetics|anesthetics|mesh-ancestor
93081337|NCT05840952|GABA Modulators|gaba modulators|mesh-ancestor
93081338|NCT05840952|GABA Agents|gaba agents|mesh-ancestor
93081339|NCT05840952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081340|NCT05840952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081341|NCT05840952|Antifungal Agents|antifungal agents|mesh-ancestor
93081342|NCT05840952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081343|NCT05840952|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93081344|NCT05840952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93081345|NCT05840952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081346|NCT05840952|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93081347|NCT05840952|Hormone Antagonists|hormone antagonists|mesh-ancestor
93081348|NCT05840952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93081349|NCT05840952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93081350|NCT05840952|Anticonvulsants|anticonvulsants|mesh-ancestor
93081351|NCT05840952|Antimanic Agents|antimanic agents|mesh-ancestor
93081352|NCT05840952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93081353|NCT05840952|Analgesics|analgesics|mesh-ancestor
93081354|NCT05840952|Sensory System Agents|sensory system agents|mesh-ancestor
93081355|NCT05840952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081356|NCT05840952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93081357|NCT05840952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081358|NCT05840952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93081359|NCT05840952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93081360|NCT05840913|Epinephrine|epinephrine|mesh-list
93081361|NCT05840913|Carticaine|carticaine|mesh-list
93081362|NCT05840913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93081363|NCT05840913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93081364|NCT05840913|Adrenergic Agents|adrenergic agents|mesh-ancestor
93081365|NCT05840913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081366|NCT05840913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081367|NCT05840913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081368|NCT05840913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93081369|NCT05840913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93058458|NCT00422513|Epoetin Alfa|epoetin alfa|mesh-list
93081370|NCT05840913|Autonomic Agents|autonomic agents|mesh-ancestor
93081371|NCT05840913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081372|NCT05840913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93081373|NCT05840913|Respiratory System Agents|respiratory system agents|mesh-ancestor
93081374|NCT05840913|Mydriatics|mydriatics|mesh-ancestor
93081375|NCT05840913|Sympathomimetics|sympathomimetics|mesh-ancestor
93081376|NCT05840913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93081377|NCT05840913|Anesthetics, Local|anesthetics, local|mesh-ancestor
93081378|NCT05840913|Anesthetics|anesthetics|mesh-ancestor
93081379|NCT05840913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081380|NCT05840913|Sensory System Agents|sensory system agents|mesh-ancestor
93081381|NCT05840861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93081382|NCT05840861|Vortioxetine|vortioxetine|mesh-list
93081383|NCT05840861|Antidepressive Agents|antidepressive agents|mesh-ancestor
93081384|NCT05840861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081385|NCT05840861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93081386|NCT05840861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93081387|NCT05840861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081388|NCT05840861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081389|NCT05840861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93081390|NCT05840861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93081391|NCT05840861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93081392|NCT05840861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081393|NCT05840861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081394|NCT05840861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081395|NCT05840861|Serotonin Agents|serotonin agents|mesh-ancestor
93081396|NCT05840861|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93081397|NCT05840861|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93081398|NCT05840861|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93081399|NCT05840861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93081400|NCT05840822|Cannabidiol|cannabidiol|mesh-list
93081401|NCT05840822|Anticonvulsants|anticonvulsants|mesh-ancestor
93081402|NCT05840796|Caseins|caseins|mesh-list
93081403|NCT05840796|Chelating Agents|chelating agents|mesh-ancestor
93081404|NCT05840796|Sequestering Agents|sequestering agents|mesh-ancestor
93081405|NCT05840796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081406|NCT05840770|Cemiplimab|cemiplimab|mesh-list
93081407|NCT05840770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081408|NCT05840770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081409|NCT05840068|Metformin|metformin|mesh-list
93081410|NCT05840068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93081411|NCT05840068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081412|NCT05834569|Acetaminophen|acetaminophen|mesh-list
93081413|NCT05834569|Ibuprofen|ibuprofen|mesh-list
93081414|NCT05834569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93081415|NCT05834569|Analgesics|analgesics|mesh-ancestor
93081416|NCT05834569|Sensory System Agents|sensory system agents|mesh-ancestor
93081417|NCT05834569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081418|NCT05834569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081419|NCT05834569|Antipyretics|antipyretics|mesh-ancestor
93081420|NCT05834569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93081421|NCT05834569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081422|NCT05834569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081423|NCT05834569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93081424|NCT05834569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081425|NCT05834569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081426|NCT05834023|Lidocaine|lidocaine|mesh-list
93081427|NCT05834023|Bupivacaine|bupivacaine|mesh-list
93081428|NCT05834023|Anesthetics, Local|anesthetics, local|mesh-ancestor
93081429|NCT05834023|Anesthetics|anesthetics|mesh-ancestor
93081430|NCT05834023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081431|NCT05834023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081432|NCT05834023|Sensory System Agents|sensory system agents|mesh-ancestor
93081433|NCT05834023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081434|NCT05834023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93081435|NCT05834023|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93081436|NCT05834023|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93081437|NCT05834023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081438|NCT05834023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081439|NCT05804708|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
93081440|NCT05804708|Hallucinogens|hallucinogens|mesh-ancestor
93081441|NCT05804708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081442|NCT05804708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081443|NCT05804708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93058529|NCT01146028|Autonomic Agents|autonomic agents|mesh-ancestor
93081444|NCT05804708|Serotonin Agents|serotonin agents|mesh-ancestor
93081445|NCT05804708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081446|NCT05804708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081447|NCT05804708|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93081449|NCT05787600|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93081450|NCT05787600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93081451|NCT05787600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081452|NCT05787600|Disinfectants|disinfectants|mesh-ancestor
93081453|NCT05787600|Dermatologic Agents|dermatologic agents|mesh-ancestor
93081454|NCT05782972|Dapagliflozin|dapagliflozin|mesh-list
93081455|NCT05782972|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93081456|NCT05782972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081457|NCT05782972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93081458|NCT05782972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081459|NCT05782816|Oxytocin|oxytocin|mesh-list
93081460|NCT05782816|Oxytocics|oxytocics|mesh-ancestor
93081461|NCT05782816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93081462|NCT05782816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081463|NCT05768932|Paclitaxel|paclitaxel|mesh-list
93081464|NCT05768932|Carboplatin|carboplatin|mesh-list
93081465|NCT05768932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081466|NCT05768932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081467|NCT05768932|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081468|NCT05768932|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081469|NCT05768932|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081470|NCT05768932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081471|NCT05726318|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93081472|NCT05726318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081473|NCT05707754|Bupivacaine|bupivacaine|mesh-list
93081474|NCT05707754|Anesthetics, Local|anesthetics, local|mesh-ancestor
93081475|NCT05707754|Anesthetics|anesthetics|mesh-ancestor
93081476|NCT05707754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081477|NCT05707754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081478|NCT05707754|Sensory System Agents|sensory system agents|mesh-ancestor
93081479|NCT05707754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081480|NCT05653882|Pembrolizumab|pembrolizumab|mesh-list
93081481|NCT05653882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081482|NCT05653882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081483|NCT05653882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081484|NCT05653882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081485|NCT05637398|Colchicine|colchicine|mesh-list
93081486|NCT05637398|Gout Suppressants|gout suppressants|mesh-ancestor
93081487|NCT05637398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081488|NCT05637398|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081489|NCT05637398|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081490|NCT05637398|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081491|NCT05637398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081492|NCT05637398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081493|NCT05633602|Pembrolizumab|pembrolizumab|mesh-list
93081494|NCT05633602|Ramucirumab|ramucirumab|mesh-list
93081495|NCT05633602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081496|NCT05633602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081497|NCT05633602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081498|NCT05633602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081499|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
93081500|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93081501|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93081502|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93081503|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081504|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081505|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
93081506|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081507|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081508|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93081509|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081510|NCT05583071|Rituximab|rituximab|mesh-list
93081511|NCT05583071|Methotrexate|methotrexate|mesh-list
93081512|NCT05583071|Lenalidomide|lenalidomide|mesh-list
93081513|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081514|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081515|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
93081516|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081517|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081518|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93081519|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
93081520|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93081521|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081522|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
93081523|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081524|NCT05583071|Dermatologic Agents|dermatologic agents|mesh-ancestor
93081525|NCT05583071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081526|NCT05583071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93081527|NCT05583071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93081528|NCT05583071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93081529|NCT05583071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93081530|NCT05583071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93081531|NCT05583071|Growth Substances|growth substances|mesh-ancestor
93081532|NCT05583071|Growth Inhibitors|growth inhibitors|mesh-ancestor
93081533|NCT05515575|Niraparib|niraparib|mesh-list
93081534|NCT05515575|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93081535|NCT05515575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081536|NCT05515575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081537|NCT05515575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081538|NCT05417113|Bupivacaine|bupivacaine|mesh-list
93081539|NCT05417113|Anesthetics, Local|anesthetics, local|mesh-ancestor
93081540|NCT05417113|Anesthetics|anesthetics|mesh-ancestor
93081541|NCT05417113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081542|NCT05417113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081543|NCT05417113|Sensory System Agents|sensory system agents|mesh-ancestor
93081544|NCT05417113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081545|NCT05405166|Dexamethasone|dexamethasone|mesh-list
93081546|NCT05405166|Pomalidomide|pomalidomide|mesh-list
93081547|NCT05405166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081548|NCT05405166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081549|NCT05405166|Antiemetics|antiemetics|mesh-ancestor
93081550|NCT05405166|Autonomic Agents|autonomic agents|mesh-ancestor
93081551|NCT05405166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081552|NCT05405166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081553|NCT05405166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081554|NCT05405166|Glucocorticoids|glucocorticoids|mesh-ancestor
93081555|NCT05405166|Hormones|hormones|mesh-ancestor
93081556|NCT05405166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93081557|NCT05405166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93081558|NCT05405166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081559|NCT05405166|Immunologic Factors|immunologic factors|mesh-ancestor
93081560|NCT05405166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93081561|NCT05405166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93081562|NCT05405166|Growth Substances|growth substances|mesh-ancestor
93081563|NCT05405166|Growth Inhibitors|growth inhibitors|mesh-ancestor
93081564|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93081565|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93081566|NCT05394298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081567|NCT05394298|Antitubercular Agents|antitubercular agents|mesh-ancestor
93081568|NCT05390359|Oxymetazoline|oxymetazoline|mesh-list
93081569|NCT05390359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93081570|NCT05390359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93081571|NCT05390359|Adrenergic Agents|adrenergic agents|mesh-ancestor
93081572|NCT05390359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081573|NCT05390359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081574|NCT05390359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081575|NCT05390359|Sympathomimetics|sympathomimetics|mesh-ancestor
93081576|NCT05390359|Autonomic Agents|autonomic agents|mesh-ancestor
93081577|NCT05390359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081578|NCT05390359|Nasal Decongestants|nasal decongestants|mesh-ancestor
93081579|NCT05390359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93081580|NCT05390359|Respiratory System Agents|respiratory system agents|mesh-ancestor
93081581|NCT05330078|Botulinum Toxins|botulinum toxins|mesh-list
93081582|NCT05330078|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93081583|NCT05330078|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93081584|NCT05330078|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93081585|NCT05330078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081586|NCT05330078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081587|NCT05330078|Cholinergic Agents|cholinergic agents|mesh-ancestor
93081588|NCT05330078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081589|NCT05330078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081590|NCT05330078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93081591|NCT05330078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081593|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93081594|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93081595|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93081596|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93081597|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081598|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
93081599|NCT05309564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081600|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081601|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93081602|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081603|NCT05249569|Avelumab|avelumab|mesh-list
93081604|NCT05249569|Bavituximab|bavituximab|mesh-list
93081605|NCT05249569|Axitinib|axitinib|mesh-list
93081606|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081607|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081608|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93081609|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081610|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081611|NCT05245071|Maytansine|maytansine|mesh-list
93081612|NCT05245071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081613|NCT05245071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081614|NCT05245071|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081615|NCT05245071|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081616|NCT05245071|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081617|NCT05245071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081618|NCT05212662|Cysteamine|cysteamine|mesh-list
93081619|NCT05212662|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
93081620|NCT05212662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081621|NCT05198830|Cisplatin|cisplatin|mesh-list
93081622|NCT05198830|Pemetrexed|pemetrexed|mesh-list
93081623|NCT05198830|Durvalumab|durvalumab|mesh-list
93081624|NCT05198830|Immunoglobulins|immunoglobulins|mesh-list
93081625|NCT05198830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081626|NCT05198830|Immunoglobulin G|immunoglobulin g|mesh-list
93081627|NCT05198830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081628|NCT05198830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081629|NCT05198830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081630|NCT05198830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93081631|NCT05198830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93081632|NCT05198830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081633|NCT05198830|Immunologic Factors|immunologic factors|mesh-ancestor
93081634|NCT05198830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081635|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
93081636|NCT05182073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93081637|NCT05182073|Fludarabine|fludarabine|mesh-list
93081638|NCT05182073|Daratumumab|daratumumab|mesh-list
93081639|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081640|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93081641|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
93081642|NCT05182073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081643|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081644|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93081645|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
93081646|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081647|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081648|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93081649|NCT05180318|Ketamine|ketamine|mesh-list
93081650|NCT05180318|Esketamine|esketamine|mesh-list
93081651|NCT05180318|Analgesics|analgesics|mesh-ancestor
93081652|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
93081653|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081654|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081655|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93081656|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93081657|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
93081658|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
93081659|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081660|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93081661|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93081662|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081663|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081664|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
93081665|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081666|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93081667|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081668|NCT05096663|Vitamins|vitamins|mesh-list
93081669|NCT05096663|Folic Acid|folic acid|mesh-list
93081670|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
93081671|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
93081672|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
93081673|NCT05096663|Dexamethasone|dexamethasone|mesh-list
93081674|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
93081675|NCT05096663|Gemcitabine|gemcitabine|mesh-list
93081676|NCT05096663|Docetaxel|docetaxel|mesh-list
93081677|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
93081678|NCT05096663|Pemetrexed|pemetrexed|mesh-list
93081679|NCT05096663|Ramucirumab|ramucirumab|mesh-list
93081680|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93081681|NCT05096663|Antibodies|antibodies|mesh-list
93081682|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
93081683|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081684|NCT05096663|Lexatumumab|lexatumumab|mesh-list
93081685|NCT05096663|BB 1101|bb 1101|mesh-list
93081686|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
93081687|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081688|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
93081689|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081690|NCT05096663|Antiemetics|antiemetics|mesh-ancestor
93081691|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
93081692|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081693|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081694|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
93081695|NCT05096663|Hormones|hormones|mesh-ancestor
93081696|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93081697|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93081698|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081699|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
93081700|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081701|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081702|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081703|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
93081704|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081705|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081706|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081707|NCT05096663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081708|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93081709|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93081710|NCT05096663|Hematinics|hematinics|mesh-ancestor
93081711|NCT05061420|Pembrolizumab|pembrolizumab|mesh-list
93081712|NCT05061420|Cetuximab|cetuximab|mesh-list
93081713|NCT05061420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081714|NCT05061420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081715|NCT05061420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081716|NCT05061420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081717|NCT05040360|Capecitabine|capecitabine|mesh-list
93081718|NCT05040360|Temozolomide|temozolomide|mesh-list
93081719|NCT05040360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081720|NCT05040360|Antimetabolites|antimetabolites|mesh-ancestor
93081721|NCT05040360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081722|NCT05040360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672008|NCT00306878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081723|NCT05040360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93081724|NCT05040360|Alkylating Agents|alkylating agents|mesh-ancestor
93081725|NCT05009082|Paclitaxel|paclitaxel|mesh-list
93081726|NCT05009082|Bevacizumab|bevacizumab|mesh-list
93081727|NCT05009082|Carboplatin|carboplatin|mesh-list
93081728|NCT05009082|Niraparib|niraparib|mesh-list
93081729|NCT05009082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081730|NCT05009082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081731|NCT05009082|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081732|NCT05009082|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081733|NCT05009082|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081734|NCT05009082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081735|NCT05009082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081736|NCT05009082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93081737|NCT05009082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93058828|NCT01251328|Anesthetics|anesthetics|mesh-list
93081738|NCT05009082|Growth Substances|growth substances|mesh-ancestor
93081739|NCT05009082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081740|NCT05009082|Growth Inhibitors|growth inhibitors|mesh-ancestor
93081741|NCT05009082|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93081742|NCT05009082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081743|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93081744|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081745|NCT04982796|Psilocybin|psilocybin|mesh-list
93081746|NCT04982796|Hallucinogens|hallucinogens|mesh-ancestor
93081747|NCT04982796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081748|NCT04982796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081749|NCT04970576|Warfarin|warfarin|mesh-list
93081750|NCT04970576|Rivaroxaban|rivaroxaban|mesh-list
93081751|NCT04970576|Anticoagulants|anticoagulants|mesh-ancestor
93081752|NCT04970576|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93081753|NCT04970576|Antithrombins|antithrombins|mesh-ancestor
93081754|NCT04970576|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93081755|NCT04970576|Protease Inhibitors|protease inhibitors|mesh-ancestor
93081756|NCT04970576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081757|NCT04970576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081758|NCT04941911|Octreotide|octreotide|mesh-list
93081759|NCT04941911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081760|NCT04941911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93081761|NCT04941911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081762|NCT04936230|Atezolizumab|atezolizumab|mesh-list
93081763|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081764|NCT04936230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081765|NCT04936230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081766|NCT04936230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081767|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081768|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
93081769|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081770|NCT04871529|Carboplatin|carboplatin|mesh-list
93081771|NCT04871529|Gemcitabine|gemcitabine|mesh-list
93081772|NCT04871529|Avelumab|avelumab|mesh-list
93081773|NCT04871529|Immunoglobulins|immunoglobulins|mesh-list
93081774|NCT04871529|Immunoglobulin G|immunoglobulin g|mesh-list
93081775|NCT04871529|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081776|NCT04871529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081777|NCT04871529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081778|NCT04871529|Antimetabolites|antimetabolites|mesh-ancestor
93081779|NCT04871529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081780|NCT04871529|Immunologic Factors|immunologic factors|mesh-ancestor
93081781|NCT04871529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081782|NCT04871529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081783|NCT04858490|Diazepam|diazepam|mesh-list
93081784|NCT04858490|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93081785|NCT04858490|Anticonvulsants|anticonvulsants|mesh-ancestor
93081786|NCT04858490|Antiemetics|antiemetics|mesh-ancestor
93081787|NCT04858490|Autonomic Agents|autonomic agents|mesh-ancestor
93081788|NCT04858490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081789|NCT04858490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081790|NCT04858490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081791|NCT04858490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93081792|NCT04858490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081793|NCT04858490|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93081794|NCT04858490|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93081795|NCT04858490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93081796|NCT04858490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93081797|NCT04858490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93081798|NCT04858490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93081799|NCT04858490|Anesthetics, General|anesthetics, general|mesh-ancestor
93081800|NCT04858490|Anesthetics|anesthetics|mesh-ancestor
93081801|NCT04858490|GABA Modulators|gaba modulators|mesh-ancestor
93081802|NCT04858490|GABA Agents|gaba agents|mesh-ancestor
93081803|NCT04858490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081804|NCT04858490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081805|NCT04790032|Cangrelor|cangrelor|mesh-list
93081806|NCT04790032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93081807|NCT04790032|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93081808|NCT04790032|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93081809|NCT04790032|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93081810|NCT04790032|Purinergic Agents|purinergic agents|mesh-ancestor
93081811|NCT04790032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081812|NCT04790032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081813|NCT04790032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081814|NCT04779879|Sotrovimab|sotrovimab|mesh-list
93081815|NCT04779879|Antiviral Agents|antiviral agents|mesh-ancestor
93081816|NCT04779879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081817|NCT04768101|Corticosterone|corticosterone|mesh-list
93081818|NCT04768101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081819|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
93081820|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
93081821|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
93081822|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
93081823|NCT04681729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93081824|NCT04681729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081825|NCT04681729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081826|NCT04643002|Dexamethasone|dexamethasone|mesh-list
93081827|NCT04643002|Pomalidomide|pomalidomide|mesh-list
93081828|NCT04643002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081829|NCT04643002|Antiemetics|antiemetics|mesh-ancestor
93081830|NCT04643002|Autonomic Agents|autonomic agents|mesh-ancestor
93081831|NCT04643002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081832|NCT04643002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081833|NCT04643002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93081834|NCT04643002|Glucocorticoids|glucocorticoids|mesh-ancestor
93081835|NCT04643002|Hormones|hormones|mesh-ancestor
93081836|NCT04643002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93081837|NCT04643002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93081838|NCT04643002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081839|NCT04643002|Immunologic Factors|immunologic factors|mesh-ancestor
93081840|NCT04643002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93081841|NCT04643002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93081842|NCT04643002|Growth Substances|growth substances|mesh-ancestor
93081843|NCT04643002|Growth Inhibitors|growth inhibitors|mesh-ancestor
93081844|NCT04629729|Cyclophosphamide|cyclophosphamide|mesh-list
93081845|NCT04629729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93081846|NCT04629729|Fludarabine|fludarabine|mesh-list
93081847|NCT04629729|Interleukin-2|interleukin-2|mesh-list
93081848|NCT04629729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93081849|NCT04629729|Immunologic Factors|immunologic factors|mesh-ancestor
93081850|NCT04629729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081851|NCT04629729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081852|NCT04629729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93081853|NCT04629729|Alkylating Agents|alkylating agents|mesh-ancestor
93081854|NCT04629729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081855|NCT04629729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081856|NCT04629729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93081857|NCT04629729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93081858|NCT04629729|Analgesics|analgesics|mesh-ancestor
93081859|NCT04629729|Sensory System Agents|sensory system agents|mesh-ancestor
93081860|NCT04629729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081861|NCT04599075|Insulin|insulin|mesh-list
93081862|NCT04599075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93081863|NCT04599075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93081864|NCT04599075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081865|NCT04574583|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93081866|NCT04574583|Antiviral Agents|antiviral agents|mesh-ancestor
93081867|NCT04574583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081868|NCT04544202|Trametinib|trametinib|mesh-list
93081869|NCT04544202|Dabrafenib|dabrafenib|mesh-list
93081870|NCT04544202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081871|NCT04544202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93081872|NCT04544202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081873|NCT04544202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081874|NCT04523363|Metformin|metformin|mesh-list
93081875|NCT04523363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93081876|NCT04523363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081877|NCT04516447|Paclitaxel|paclitaxel|mesh-list
93081878|NCT04516447|Carboplatin|carboplatin|mesh-list
93081879|NCT04516447|Gemcitabine|gemcitabine|mesh-list
93081880|NCT04516447|Doxorubicin|doxorubicin|mesh-list
93081881|NCT04516447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93081882|NCT04516447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081883|NCT04516447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081884|NCT04516447|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081885|NCT04516447|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081886|NCT04516447|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081887|NCT04516447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081888|NCT04516447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081889|NCT04516447|Antimetabolites|antimetabolites|mesh-ancestor
93081890|NCT04516447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93081891|NCT04516447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93081892|NCT04516447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93081893|NCT04516447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081894|NCT04511013|Nivolumab|nivolumab|mesh-list
93058972|NCT00227370|Valganciclovir|valganciclovir|mesh-list
93081896|NCT04511013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081897|NCT04511013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081898|NCT04511013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081899|NCT04511013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081900|NCT04495894|Ketorolac|ketorolac|mesh-list
93081901|NCT04495894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93081902|NCT04495894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93081903|NCT04495894|Analgesics|analgesics|mesh-ancestor
93081904|NCT04495894|Sensory System Agents|sensory system agents|mesh-ancestor
93081905|NCT04495894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081906|NCT04495894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081907|NCT04495894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93081908|NCT04495894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93081909|NCT04495894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93081910|NCT04495894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081911|NCT04495894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081912|NCT04489433|Trametinib|trametinib|mesh-list
93081913|NCT04489433|Dabrafenib|dabrafenib|mesh-list
93081914|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081915|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93081916|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081917|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081918|NCT04478721|Meropenem|meropenem|mesh-list
93081919|NCT04478721|Temocillin|temocillin|mesh-list
93081920|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93081921|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081922|NCT04370054|Factor VIII|factor viii|mesh-list
93081923|NCT04370054|Coagulants|coagulants|mesh-ancestor
93081924|NCT04348747|Pembrolizumab|pembrolizumab|mesh-list
93081925|NCT04348747|Vaccines|vaccines|mesh-list
93081926|NCT04348747|Immunologic Factors|immunologic factors|mesh-ancestor
93081927|NCT04348747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672222|NCT00308360|Dopamine Agents|dopamine agents|mesh-ancestor
93081928|NCT04348747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93081929|NCT04348747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081930|NCT04348747|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93081931|NCT04348747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081932|NCT04283500|Buprenorphine|buprenorphine|mesh-list
93081933|NCT04283500|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93081934|NCT04283500|Naloxone|naloxone|mesh-list
93081935|NCT04283500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93081936|NCT04283500|Narcotics|narcotics|mesh-ancestor
93081937|NCT04283500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93081938|NCT04283500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081939|NCT04283500|Analgesics|analgesics|mesh-ancestor
93081940|NCT04283500|Sensory System Agents|sensory system agents|mesh-ancestor
93081941|NCT04283500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93081942|NCT04283500|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93081943|NCT04223791|Islatravir|islatravir|mesh-list
93081944|NCT04223791|Antiviral Agents|antiviral agents|mesh-ancestor
93081945|NCT04223791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93081946|NCT04223791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081947|NCT04223791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081948|NCT04223791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93081949|NCT04223791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93081950|NCT04223791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93081951|NCT04205968|Calcium, Dietary|calcium, dietary|mesh-list
93081952|NCT04205968|Leucovorin|leucovorin|mesh-list
93081953|NCT04205968|Folic Acid|folic acid|mesh-list
93081954|NCT04205968|Paclitaxel|paclitaxel|mesh-list
93081955|NCT04205968|Camptothecin|camptothecin|mesh-list
93081956|NCT04205968|Fluorouracil|fluorouracil|mesh-list
93081957|NCT04205968|Irinotecan|irinotecan|mesh-list
93081958|NCT04205968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93081959|NCT04205968|Ramucirumab|ramucirumab|mesh-list
93081960|NCT04205968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93081961|NCT04205968|Antibodies|antibodies|mesh-list
93081962|NCT04205968|Immunoglobulins|immunoglobulins|mesh-list
93081963|NCT04205968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93081964|NCT04205968|Lexatumumab|lexatumumab|mesh-list
93081965|NCT04205968|Calcium|calcium|mesh-list
93081966|NCT04205968|Levoleucovorin|levoleucovorin|mesh-list
93081967|NCT04205968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081968|NCT04205968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081969|NCT04205968|Tubulin Modulators|tubulin modulators|mesh-ancestor
93059048|NCT01149304|Antioxidants|antioxidants|mesh-ancestor
93081970|NCT04205968|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081971|NCT04205968|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081972|NCT04205968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081974|NCT04205968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93081975|NCT04205968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93081976|NCT04205968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93081977|NCT04205968|Antimetabolites|antimetabolites|mesh-ancestor
93081978|NCT04205968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93081979|NCT04205968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93081980|NCT04205968|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93081981|NCT04205968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93081982|NCT04205968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93081983|NCT04205968|Antidotes|antidotes|mesh-ancestor
93081984|NCT04205968|Protective Agents|protective agents|mesh-ancestor
93081985|NCT04205968|Vitamin B Complex|vitamin b complex|mesh-ancestor
93081986|NCT04205968|Vitamins|vitamins|mesh-ancestor
93081987|NCT04205968|Micronutrients|micronutrients|mesh-ancestor
93081988|NCT04205968|Hematinics|hematinics|mesh-ancestor
93081989|NCT04205812|Paclitaxel|paclitaxel|mesh-list
93081990|NCT04205812|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93081991|NCT04205812|Carboplatin|carboplatin|mesh-list
93081992|NCT04205812|Pemetrexed|pemetrexed|mesh-list
93081993|NCT04205812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93081994|NCT04205812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93081995|NCT04205812|Tubulin Modulators|tubulin modulators|mesh-ancestor
93081996|NCT04205812|Antimitotic Agents|antimitotic agents|mesh-ancestor
93081997|NCT04205812|Mitosis Modulators|mitosis modulators|mesh-ancestor
93081998|NCT04205812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93081999|NCT04205812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082000|NCT04205812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93082001|NCT04205812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93082002|NCT04191421|Spartalizumab|spartalizumab|mesh-list
93082003|NCT04191421|Siltuximab|siltuximab|mesh-list
93082004|NCT04191421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082005|NCT04191421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082006|NCT04191421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082007|NCT04191421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082008|NCT04071457|Lenalidomide|lenalidomide|mesh-list
93082009|NCT04071457|Daratumumab|daratumumab|mesh-list
93082010|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
93082011|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082012|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93082013|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93082014|NCT04071457|Growth Substances|growth substances|mesh-ancestor
93082015|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
93082016|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082017|NCT04031846|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93082018|NCT04031846|Immunologic Factors|immunologic factors|mesh-ancestor
93082019|NCT04031846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082020|NCT03982030|Dalbavancin|dalbavancin|mesh-list
93082021|NCT03982030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93082022|NCT03982030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082023|NCT03918850|Buprenorphine|buprenorphine|mesh-list
93082024|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93082025|NCT03918850|Narcotics|narcotics|mesh-ancestor
93082026|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082027|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082028|NCT03918850|Analgesics|analgesics|mesh-ancestor
93082029|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
93082030|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082031|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93082032|NCT03917914|Bisoprolol|bisoprolol|mesh-list
93082033|NCT03917914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93082034|NCT03917914|Sympatholytics|sympatholytics|mesh-ancestor
93082035|NCT03917914|Autonomic Agents|autonomic agents|mesh-ancestor
93082036|NCT03917914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082037|NCT03917914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082038|NCT03917914|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93082039|NCT03917914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93082040|NCT03917914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93082041|NCT03917914|Adrenergic Agents|adrenergic agents|mesh-ancestor
93082042|NCT03917914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082043|NCT03917914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082044|NCT03915067|Botulinum Toxins|botulinum toxins|mesh-list
93082045|NCT03915067|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93082046|NCT03915067|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93082047|NCT03915067|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93082048|NCT03915067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93082049|NCT03915067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082050|NCT03915067|Cholinergic Agents|cholinergic agents|mesh-ancestor
93082051|NCT03915067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082052|NCT03915067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082053|NCT03915067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93082054|NCT03915067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082056|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93082057|NCT03911466|Narcotics|narcotics|mesh-ancestor
93082058|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082059|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082060|NCT03911466|Analgesics|analgesics|mesh-ancestor
93082061|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
93082062|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082063|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93082064|NCT03903133|Vitamin E|vitamin e|mesh-list
93082065|NCT03903133|Antioxidants|antioxidants|mesh-list
93082066|NCT03903133|Vitamins|vitamins|mesh-ancestor
93082067|NCT03903133|Micronutrients|micronutrients|mesh-ancestor
93082068|NCT03903133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082069|NCT03903133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082070|NCT03903133|Protective Agents|protective agents|mesh-ancestor
93082071|NCT03859024|Acetaminophen|acetaminophen|mesh-list
93082072|NCT03859024|Dexamethasone|dexamethasone|mesh-list
93082073|NCT03859024|Ibuprofen|ibuprofen|mesh-list
93082074|NCT03859024|Celecoxib|celecoxib|mesh-list
93082075|NCT03859024|Oxycodone|oxycodone|mesh-list
93082076|NCT03859024|Gabapentin|gabapentin|mesh-list
93082077|NCT03859024|Bupivacaine|bupivacaine|mesh-list
93082078|NCT03859024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082079|NCT03859024|Antiemetics|antiemetics|mesh-ancestor
93082080|NCT03859024|Autonomic Agents|autonomic agents|mesh-ancestor
93082081|NCT03859024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082082|NCT03859024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082083|NCT03859024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93082084|NCT03859024|Glucocorticoids|glucocorticoids|mesh-ancestor
93082085|NCT03859024|Hormones|hormones|mesh-ancestor
93082086|NCT03859024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082087|NCT03859024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93082088|NCT03859024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082089|NCT03859024|Anesthetics, Local|anesthetics, local|mesh-ancestor
93082090|NCT03859024|Anesthetics|anesthetics|mesh-ancestor
93082091|NCT03859024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082092|NCT03859024|Sensory System Agents|sensory system agents|mesh-ancestor
93082093|NCT03859024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93082094|NCT03859024|Analgesics|analgesics|mesh-ancestor
93082095|NCT03859024|Antipyretics|antipyretics|mesh-ancestor
93082096|NCT03859024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93082097|NCT03859024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082098|NCT03859024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93082099|NCT03859024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082100|NCT03859024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082101|NCT03859024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93082102|NCT03859024|Narcotics|narcotics|mesh-ancestor
93082103|NCT03859024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93082104|NCT03859024|Anticonvulsants|anticonvulsants|mesh-ancestor
93082105|NCT03859024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93082106|NCT03859024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93082107|NCT03859024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93082108|NCT03859024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93082109|NCT03859024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93082110|NCT03859024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082111|NCT03859024|Antimanic Agents|antimanic agents|mesh-ancestor
93082112|NCT03841305|Liver Extracts|liver extracts|mesh-list
93082113|NCT03841305|Hematinics|hematinics|mesh-ancestor
93082114|NCT03798626|Leucovorin|leucovorin|mesh-list
93082115|NCT03798626|Paclitaxel|paclitaxel|mesh-list
93082116|NCT03798626|Bevacizumab|bevacizumab|mesh-list
93082117|NCT03798626|Fluorouracil|fluorouracil|mesh-list
93082118|NCT03798626|Oxaliplatin|oxaliplatin|mesh-list
93082119|NCT03798626|Irinotecan|irinotecan|mesh-list
93082120|NCT03798626|Ramucirumab|ramucirumab|mesh-list
93082121|NCT03798626|Levoleucovorin|levoleucovorin|mesh-list
93082122|NCT03798626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082123|NCT03798626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082124|NCT03798626|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082125|NCT03798626|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082126|NCT03798626|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082127|NCT03798626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082128|NCT03798626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082129|NCT03798626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93082130|NCT03798626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93082131|NCT03798626|Growth Substances|growth substances|mesh-ancestor
93082132|NCT03798626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082133|NCT03798626|Growth Inhibitors|growth inhibitors|mesh-ancestor
93082135|NCT03798626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082136|NCT03798626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082137|NCT03798626|Immunologic Factors|immunologic factors|mesh-ancestor
93082138|NCT03798626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93082139|NCT03798626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082140|NCT03798626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082141|NCT03798626|Antidotes|antidotes|mesh-ancestor
93082142|NCT03798626|Protective Agents|protective agents|mesh-ancestor
93082143|NCT03798626|Vitamin B Complex|vitamin b complex|mesh-ancestor
93082144|NCT03798626|Vitamins|vitamins|mesh-ancestor
93082145|NCT03798626|Micronutrients|micronutrients|mesh-ancestor
93082146|NCT03768414|Paclitaxel|paclitaxel|mesh-list
93082147|NCT03768414|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93082148|NCT03768414|Cisplatin|cisplatin|mesh-list
93082149|NCT03768414|Gemcitabine|gemcitabine|mesh-list
93082150|NCT03768414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082151|NCT03768414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082152|NCT03768414|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082153|NCT03768414|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082154|NCT03768414|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082155|NCT03768414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082156|NCT03768414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082157|NCT03768414|Antimetabolites|antimetabolites|mesh-ancestor
93082158|NCT03743766|Nivolumab|nivolumab|mesh-list
93082159|NCT03743766|Relatlimab|relatlimab|mesh-list
93082160|NCT03743766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082161|NCT03743766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082162|NCT03743766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082163|NCT03743766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082164|NCT03727633|Idarubicin|idarubicin|mesh-list
93082165|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
93082166|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082167|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082168|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93082169|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082170|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082171|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082172|NCT03698019|Pembrolizumab|pembrolizumab|mesh-list
93082173|NCT03698019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082174|NCT03698019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082175|NCT03698019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082176|NCT03698019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082177|NCT03694002|Paclitaxel|paclitaxel|mesh-list
93082178|NCT03694002|Carboplatin|carboplatin|mesh-list
93082179|NCT03694002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93082180|NCT03694002|Ramucirumab|ramucirumab|mesh-list
93082181|NCT03694002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93082182|NCT03694002|Antibodies|antibodies|mesh-list
93082183|NCT03694002|Immunoglobulins|immunoglobulins|mesh-list
93082184|NCT03694002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93082185|NCT03694002|Lexatumumab|lexatumumab|mesh-list
93082186|NCT03694002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082187|NCT03694002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082188|NCT03694002|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082189|NCT03694002|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082190|NCT03694002|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082191|NCT03694002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082192|NCT03694002|Immunologic Factors|immunologic factors|mesh-ancestor
93082193|NCT03694002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082194|NCT03678025|Prednisone|prednisone|mesh-list
93082195|NCT03678025|Cortisone|cortisone|mesh-list
93082196|NCT03678025|Docetaxel|docetaxel|mesh-list
93082197|NCT03678025|Leuprolide|leuprolide|mesh-list
93082198|NCT03678025|Goserelin|goserelin|mesh-list
93082199|NCT03678025|Bicalutamide|bicalutamide|mesh-list
93082200|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93082201|NCT03678025|Flutamide|flutamide|mesh-list
93082202|NCT03678025|Nilutamide|nilutamide|mesh-list
93082203|NCT03678025|Tryptophan|tryptophan|mesh-list
93082204|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082205|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082206|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082207|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082208|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082209|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082210|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
93082211|NCT03678025|Hormones|hormones|mesh-ancestor
93082212|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082213|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082214|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93082215|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93082216|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
93082217|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93082218|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
93082219|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
93082220|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
93082221|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93082222|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
93082223|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93082224|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93082225|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
93082226|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93082227|NCT03623321|Pimavanserin|pimavanserin|mesh-list
93082228|NCT03623321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93082229|NCT03623321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93082230|NCT03623321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93082231|NCT03623321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93082232|NCT03623321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082233|NCT03623321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082234|NCT03623321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93082235|NCT03623321|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93082236|NCT03623321|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93082237|NCT03623321|Serotonin Agents|serotonin agents|mesh-ancestor
93082238|NCT03623321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082239|NCT03623321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082240|NCT03602586|Pembrolizumab|pembrolizumab|mesh-list
93082241|NCT03602586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082242|NCT03602586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082243|NCT03602586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082244|NCT03602586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082245|NCT03528642|Temozolomide|temozolomide|mesh-list
93082246|NCT03528642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082247|NCT03528642|Alkylating Agents|alkylating agents|mesh-ancestor
93082248|NCT03528642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082249|NCT03528642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082250|NCT03447314|Pembrolizumab|pembrolizumab|mesh-list
93082251|NCT03447314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082252|NCT03447314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082253|NCT03447314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082254|NCT03447314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082255|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
93082256|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
93082257|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082258|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93082259|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93082260|NCT03365882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93082261|NCT03365882|Trastuzumab|trastuzumab|mesh-list
93082262|NCT03365882|Cetuximab|cetuximab|mesh-list
93082263|NCT03365882|Pertuzumab|pertuzumab|mesh-list
93082264|NCT03365882|Irinotecan|irinotecan|mesh-list
93082265|NCT03365882|Camptothecin|camptothecin|mesh-list
93082266|NCT03365882|Antibodies|antibodies|mesh-list
93082267|NCT03365882|Immunoglobulins|immunoglobulins|mesh-list
93082268|NCT03365882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93082269|NCT03365882|Immunologic Factors|immunologic factors|mesh-ancestor
93082270|NCT03365882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082271|NCT03365882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082272|NCT03365882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93082273|NCT03365882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082274|NCT03365882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082275|NCT03365882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082276|NCT03365882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082277|NCT03364530|Gemcitabine|gemcitabine|mesh-list
93082278|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
93082279|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082280|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
93082281|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082282|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082283|NCT03289910|Carboplatin|carboplatin|mesh-list
93082284|NCT03289910|Topotecan|topotecan|mesh-list
93082285|NCT03289910|Veliparib|veliparib|mesh-list
93082286|NCT03289910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082287|NCT03289910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93082288|NCT03289910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082289|NCT03289910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082290|NCT03289910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082291|NCT03289910|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93082292|NCT03253133|Oxaliplatin|oxaliplatin|mesh-list
93082293|NCT03253133|Oxycodone|oxycodone|mesh-list
93082294|NCT03253133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082295|NCT03253133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93082296|NCT03253133|Narcotics|narcotics|mesh-ancestor
93082297|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082298|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082299|NCT03253133|Analgesics|analgesics|mesh-ancestor
93082300|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
93082301|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082302|NCT03252756|Cannabidiol|cannabidiol|mesh-list
93082303|NCT03252756|Anticonvulsants|anticonvulsants|mesh-ancestor
93082304|NCT03225417|Sirolimus|sirolimus|mesh-list
93082305|NCT03225417|Cyclophosphamide|cyclophosphamide|mesh-list
93082306|NCT03225417|Ixazomib|ixazomib|mesh-list
93082307|NCT03225417|Tacrolimus|tacrolimus|mesh-list
93082308|NCT03225417|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93082309|NCT03225417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082310|NCT03225417|Immunologic Factors|immunologic factors|mesh-ancestor
93082311|NCT03225417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082312|NCT03225417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082313|NCT03225417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082314|NCT03225417|Alkylating Agents|alkylating agents|mesh-ancestor
93082315|NCT03225417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082316|NCT03225417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082317|NCT03225417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082318|NCT03225417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93082319|NCT03225417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082320|NCT03225417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93082321|NCT03225417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082322|NCT03225417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082323|NCT03225417|Antifungal Agents|antifungal agents|mesh-ancestor
93082324|NCT03225417|Protease Inhibitors|protease inhibitors|mesh-ancestor
93082325|NCT03218826|Docetaxel|docetaxel|mesh-list
93082326|NCT03218826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082327|NCT03218826|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082328|NCT03218826|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082329|NCT03218826|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082330|NCT03218826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082331|NCT03091660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93082332|NCT03091660|Vaccines|vaccines|mesh-list
93082333|NCT03091660|BCG Vaccine|bcg vaccine|mesh-list
93082334|NCT03091660|Immunologic Factors|immunologic factors|mesh-ancestor
93082335|NCT03091660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082336|NCT03091660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93082337|NCT03091595|Drospirenone|drospirenone|mesh-list
93082338|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93082339|NCT03091595|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93082340|NCT03091595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93082341|NCT03091595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93082342|NCT03091595|Contraceptive Agents|contraceptive agents|mesh-ancestor
93082343|NCT03091595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93082344|NCT03091595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082345|NCT03091595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93082346|NCT03091595|Estrogens|estrogens|mesh-ancestor
93082347|NCT03091595|Hormones|hormones|mesh-ancestor
93082348|NCT03091595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672624|NCT00310934|Buprenorphine|buprenorphine|mesh-list
93082349|NCT03091595|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93082350|NCT03091595|Hormone Antagonists|hormone antagonists|mesh-ancestor
93082351|NCT03091595|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93082352|NCT03091595|Diuretics|diuretics|mesh-ancestor
93082353|NCT03091595|Natriuretic Agents|natriuretic agents|mesh-ancestor
93082354|NCT02844816|Atezolizumab|atezolizumab|mesh-list
93082355|NCT02844816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93082356|NCT02844816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082357|NCT02844816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082358|NCT02844816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082359|NCT02844816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082360|NCT02844816|Immunologic Factors|immunologic factors|mesh-ancestor
93082361|NCT02844816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082362|NCT02822378|Vitamin D|vitamin d|mesh-list
93082363|NCT02822378|Calcium|calcium|mesh-list
93082364|NCT02822378|Vitamins|vitamins|mesh-ancestor
93082365|NCT02822378|Micronutrients|micronutrients|mesh-ancestor
93082366|NCT02822378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082367|NCT02822378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93082368|NCT02822378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93082369|NCT02595931|Irinotecan|irinotecan|mesh-list
93082370|NCT02595931|Camptothecin|camptothecin|mesh-list
93082371|NCT02595931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93082372|NCT02595931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082373|NCT02595931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082374|NCT02595931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082375|NCT02595931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082376|NCT02595931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082377|NCT02577406|Cytarabine|cytarabine|mesh-list
93082378|NCT02577406|Azacitidine|azacitidine|mesh-list
93082379|NCT02577406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082380|NCT02577406|Antimetabolites|antimetabolites|mesh-ancestor
93082381|NCT02577406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082382|NCT02577406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082383|NCT02577406|Antiviral Agents|antiviral agents|mesh-ancestor
93082384|NCT02577406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082385|NCT02577406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082386|NCT02577406|Immunologic Factors|immunologic factors|mesh-ancestor
93082387|NCT02577406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082388|NCT02577406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082389|NCT02567422|Cisplatin|cisplatin|mesh-list
93082390|NCT02567422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082391|NCT02498600|Nivolumab|nivolumab|mesh-list
93082392|NCT02498600|Ipilimumab|ipilimumab|mesh-list
93082393|NCT02498600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082394|NCT02498600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082395|NCT02498600|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082396|NCT02498600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082397|NCT02193191|Plerixafor|plerixafor|mesh-list
93082398|NCT02193191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93082399|NCT02193191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93082400|NCT02193191|Antiviral Agents|antiviral agents|mesh-ancestor
93082401|NCT02193191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082402|NCT02073994|Ivosidenib|ivosidenib|mesh-list
93082403|NCT02073994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082404|NCT02073994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082405|NCT02073994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082406|NCT02059265|Dasatinib|dasatinib|mesh-list
93082407|NCT02059265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082408|NCT02059265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93082409|NCT02059265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082410|NCT02059265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082411|NCT01925131|Prednisone|prednisone|mesh-list
93082412|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
93082413|NCT01925131|Vincristine|vincristine|mesh-list
93082414|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93082415|NCT01925131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082416|NCT01925131|Immunologic Factors|immunologic factors|mesh-ancestor
93082417|NCT01925131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082418|NCT01925131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082419|NCT01925131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082420|NCT01925131|Alkylating Agents|alkylating agents|mesh-ancestor
93082421|NCT01925131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082422|NCT01925131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082423|NCT01925131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082424|NCT01925131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082425|NCT01925131|Glucocorticoids|glucocorticoids|mesh-ancestor
93082426|NCT01925131|Hormones|hormones|mesh-ancestor
93082427|NCT01925131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082428|NCT01925131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93082429|NCT01925131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082430|NCT01925131|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082431|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082432|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082433|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082434|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082435|NCT01925131|Immunotoxins|immunotoxins|mesh-ancestor
93082436|NCT01925131|Immunoconjugates|immunoconjugates|mesh-ancestor
93082437|NCT01809691|Bicalutamide|bicalutamide|mesh-list
93082438|NCT01809691|Androgen Antagonists|androgen antagonists|mesh-ancestor
93082439|NCT01809691|Hormone Antagonists|hormone antagonists|mesh-ancestor
93082440|NCT01809691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082441|NCT01809691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082442|NCT01809691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082443|NCT01698918|Dexamethasone|dexamethasone|mesh-list
93082444|NCT01698918|Everolimus|everolimus|mesh-list
93082445|NCT01698918|Letrozole|letrozole|mesh-list
93082446|NCT01698918|Exemestane|exemestane|mesh-list
93082447|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082448|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
93082449|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
93082450|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082451|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082452|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93082453|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
93082454|NCT01698918|Hormones|hormones|mesh-ancestor
93082455|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082456|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93082457|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082458|NCT01698918|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93082459|NCT01698918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93082460|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082461|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082462|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082463|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
93082464|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93082465|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93082466|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93082467|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
93082468|NCT01674140|Tamoxifen|tamoxifen|mesh-list
93082469|NCT01674140|Everolimus|everolimus|mesh-list
93082470|NCT01674140|Letrozole|letrozole|mesh-list
93082471|NCT01674140|Anastrozole|anastrozole|mesh-list
93082472|NCT01674140|Leuprolide|leuprolide|mesh-list
93082473|NCT01674140|Exemestane|exemestane|mesh-list
93082474|NCT01674140|Goserelin|goserelin|mesh-list
93082475|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082476|NCT01674140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93082477|NCT01674140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93082478|NCT01674140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082479|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082480|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
93082481|NCT01674140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082482|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082483|NCT01674140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93082484|NCT01674140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93082485|NCT01674140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93082486|NCT01674140|Hormone Antagonists|hormone antagonists|mesh-ancestor
93082487|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082488|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93082489|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93082490|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93082491|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93082492|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93082493|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
93082494|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93082495|NCT01574274|Pegaspargase|pegaspargase|mesh-list
93082496|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082497|NCT01495403|Hydroxychloroquine|hydroxychloroquine|mesh-list
93082498|NCT01495403|Antimalarials|antimalarials|mesh-ancestor
93082499|NCT01495403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93082500|NCT01495403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93082501|NCT01495403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082502|NCT01495403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082503|NCT01495403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082504|NCT01495403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082505|NCT00840177|Cytarabine|cytarabine|mesh-list
93059571|NCT01326078|Propofol|propofol|mesh-list
93082506|NCT00840177|Idarubicin|idarubicin|mesh-list
93082507|NCT00840177|Pravastatin|pravastatin|mesh-list
93082508|NCT00840177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082509|NCT00840177|Antimetabolites|antimetabolites|mesh-ancestor
93082510|NCT00840177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082511|NCT00840177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082512|NCT00840177|Antiviral Agents|antiviral agents|mesh-ancestor
93082513|NCT00840177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082514|NCT00840177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082515|NCT00840177|Immunologic Factors|immunologic factors|mesh-ancestor
93082516|NCT00840177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082517|NCT00840177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082518|NCT00840177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93082519|NCT00840177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082520|NCT00840177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082521|NCT00840177|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93082522|NCT00840177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93082523|NCT00840177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93082524|NCT00840177|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93082525|NCT00588991|Carboplatin|carboplatin|mesh-list
93082526|NCT00588991|Topotecan|topotecan|mesh-list
93082527|NCT00588991|Veliparib|veliparib|mesh-list
93082528|NCT00588991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082529|NCT00588991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93082530|NCT00588991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082531|NCT00588991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082532|NCT00588991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082533|NCT00588991|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93082534|NCT01347580|Ticagrelor|ticagrelor|mesh-list
93082535|NCT01347580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93082536|NCT01347580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93082537|NCT01347580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93082538|NCT01347580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93082539|NCT01347580|Purinergic Agents|purinergic agents|mesh-ancestor
93082540|NCT01347580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082541|NCT01347580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082542|NCT01347580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082543|NCT00398411|Moxifloxacin|moxifloxacin|mesh-list
93082544|NCT00398411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93082545|NCT00398411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082546|NCT00398411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93082547|NCT00398411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082548|NCT00398411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082549|NCT00398411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082550|NCT00398411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082551|NCT03352414|Alvimopan|alvimopan|mesh-list
93082552|NCT03352414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93082553|NCT00364793|Emtricitabine|emtricitabine|mesh-list
93082554|NCT00364793|Efavirenz|efavirenz|mesh-list
93082555|NCT00364793|Didanosine|didanosine|mesh-list
93082556|NCT00364793|Antiviral Agents|antiviral agents|mesh-ancestor
93082557|NCT00364793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082558|NCT00364793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93082559|NCT00364793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93082560|NCT00364793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672832|NCT00312182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93082561|NCT00364793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082562|NCT00364793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93082563|NCT00364793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93082564|NCT00364793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93082565|NCT00364793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93082566|NCT00364793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93082567|NCT00364793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93082568|NCT00364793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93082569|NCT00364793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93082570|NCT00364793|Antimetabolites|antimetabolites|mesh-ancestor
93082571|NCT03351478|Empagliflozin|empagliflozin|mesh-list
93082572|NCT03351478|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
93082573|NCT03351478|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93082574|NCT03351478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082575|NCT03351478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93082576|NCT03351478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082577|NCT00363545|Vaccines|vaccines|mesh-list
93082578|NCT00363545|Immunologic Factors|immunologic factors|mesh-ancestor
93082579|NCT00363545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082580|NCT03351244|BI 409306|bi 409306|mesh-list
93082581|NCT03351244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93082582|NCT03351244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082583|NCT03351244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082584|NCT03386032|Desonide|desonide|mesh-list
93082585|NCT03386032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082586|NCT00077610|Epoetin Alfa|epoetin alfa|mesh-list
93082587|NCT00077610|Hematinics|hematinics|mesh-ancestor
93082588|NCT00066222|Etoposide|etoposide|mesh-list
93082589|NCT00066222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082590|NCT00066222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082591|NCT00066222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93082592|NCT00066222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082593|NCT00066222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082594|NCT00066222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082595|NCT00397943|Vaccines|vaccines|mesh-list
93082596|NCT00397943|Immunologic Factors|immunologic factors|mesh-ancestor
93082597|NCT00397943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082598|NCT00066066|Amoxicillin|amoxicillin|mesh-list
93082599|NCT00066066|Metronidazole|metronidazole|mesh-list
93082600|NCT00066066|Doxycycline|doxycycline|mesh-list
93082601|NCT00066066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93082602|NCT00066066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082603|NCT00066066|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93082604|NCT00066066|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93082605|NCT00066066|Antimalarials|antimalarials|mesh-ancestor
93082606|NCT00363467|Busulfan|busulfan|mesh-list
93082607|NCT00363467|Alkylating Agents|alkylating agents|mesh-ancestor
93082608|NCT00363467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082609|NCT00363467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082610|NCT00363467|Immunologic Factors|immunologic factors|mesh-ancestor
93082611|NCT00363467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082612|NCT00363467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082613|NCT00363467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082614|NCT00363467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082615|NCT00397631|Pioglitazone|pioglitazone|mesh-list
93082616|NCT00397631|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93082617|NCT00397631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93082618|NCT00397631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082619|NCT00397631|Incretins|incretins|mesh-ancestor
93082620|NCT00397631|Hormones|hormones|mesh-ancestor
93082621|NCT00397631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082622|NCT00397631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93082623|NCT00397631|Protease Inhibitors|protease inhibitors|mesh-ancestor
93082624|NCT00397631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082625|NCT00397631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082626|NCT00077376|Carboplatin|carboplatin|mesh-list
93082627|NCT00077376|Trastuzumab|trastuzumab|mesh-list
93082628|NCT00077376|Epothilone B|epothilone b|mesh-list
93082629|NCT00077376|Epothilones|epothilones|mesh-list
93082630|NCT00077376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082631|NCT00077376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082632|NCT00077376|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082633|NCT00077376|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082634|NCT00077376|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082635|NCT00077376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082636|NCT01088724|Cyclophosphamide|cyclophosphamide|mesh-list
93082637|NCT01088724|Rituximab|rituximab|mesh-list
93082638|NCT01088724|Doxorubicin|doxorubicin|mesh-list
93082639|NCT01088724|Fludarabine|fludarabine|mesh-list
93082640|NCT01088724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082641|NCT01088724|Immunologic Factors|immunologic factors|mesh-ancestor
93082642|NCT01088724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082643|NCT01088724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082644|NCT01088724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082645|NCT01088724|Alkylating Agents|alkylating agents|mesh-ancestor
93082646|NCT01088724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082647|NCT01088724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082648|NCT01088724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082649|NCT01088724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082650|NCT01088724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082651|NCT01088724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93082652|NCT01088724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93059723|NCT01260610|Tenofovir|tenofovir|mesh-list
93082653|NCT01088724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082654|NCT03957174|Rivastigmine|rivastigmine|mesh-list
93082655|NCT03957174|Reboxetine|reboxetine|mesh-list
93082656|NCT03957174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93082657|NCT03957174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082658|NCT03957174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082659|NCT03957174|Cholinergic Agents|cholinergic agents|mesh-ancestor
93082660|NCT03957174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082661|NCT03957174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082662|NCT03957174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93082663|NCT03957174|Protective Agents|protective agents|mesh-ancestor
93082664|NCT03957174|Antidepressive Agents|antidepressive agents|mesh-ancestor
93082665|NCT03957174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93082666|NCT03957174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93082667|NCT03957174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93082668|NCT03957174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93082669|NCT03957174|Adrenergic Agents|adrenergic agents|mesh-ancestor
93082670|NCT03406156|Venetoclax|venetoclax|mesh-list
93082671|NCT03406156|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93082672|NCT03406156|Obinutuzumab|obinutuzumab|mesh-list
93082673|NCT03406156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082674|NCT03406156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082675|NCT03406156|Alkylating Agents|alkylating agents|mesh-ancestor
93082676|NCT03406156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082677|NCT03406156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082678|NCT00363311|Dutasteride|dutasteride|mesh-list
93082679|NCT00363311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93082680|NCT00363311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93082681|NCT00363311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082682|NCT00363311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082683|NCT00363311|Hormone Antagonists|hormone antagonists|mesh-ancestor
93082684|NCT00363311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082685|NCT00363311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082686|NCT00362609|Pantoprazole|pantoprazole|mesh-list
93082687|NCT00362609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93082688|NCT00362609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93082689|NCT00362609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93082690|NCT00362609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082691|NCT00362609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082692|NCT02534753|Ascorbic Acid|ascorbic acid|mesh-list
93082693|NCT02534753|Antioxidants|antioxidants|mesh-ancestor
93082694|NCT02534753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082695|NCT02534753|Protective Agents|protective agents|mesh-ancestor
93082696|NCT02534753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082697|NCT02534753|Vitamins|vitamins|mesh-ancestor
93082698|NCT02534753|Micronutrients|micronutrients|mesh-ancestor
93082699|NCT01042457|Mycophenolic Acid|mycophenolic acid|mesh-list
93082700|NCT01042457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082701|NCT01042457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082702|NCT01042457|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93082703|NCT01042457|Antitubercular Agents|antitubercular agents|mesh-ancestor
93082704|NCT01042457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93082705|NCT01042457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082706|NCT01042457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082707|NCT01042457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082708|NCT00362297|Valacyclovir|valacyclovir|mesh-list
93082709|NCT00362297|Acyclovir|acyclovir|mesh-list
93082710|NCT00362297|Antiviral Agents|antiviral agents|mesh-ancestor
93082711|NCT00362297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082712|NCT01042691|Oxaliplatin|oxaliplatin|mesh-list
93082713|NCT01042691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082714|NCT00090402|Thioctic Acid|thioctic acid|mesh-list
93082715|NCT00090402|Antioxidants|antioxidants|mesh-ancestor
93082716|NCT00090402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082717|NCT00090402|Protective Agents|protective agents|mesh-ancestor
93082718|NCT00090402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082719|NCT00090402|Vitamin B Complex|vitamin b complex|mesh-ancestor
93082720|NCT00090402|Vitamins|vitamins|mesh-ancestor
93082721|NCT00090402|Micronutrients|micronutrients|mesh-ancestor
93082722|NCT00361283|Atorvastatin|atorvastatin|mesh-list
93082723|NCT00361283|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93082724|NCT00361283|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93082725|NCT00361283|Antimetabolites|antimetabolites|mesh-ancestor
93082726|NCT00361283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082727|NCT00361283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93059801|NCT03891472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082728|NCT00361283|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93082729|NCT00361283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082730|NCT00077064|Captopril|captopril|mesh-list
93082731|NCT00077064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93082732|NCT00077064|Protease Inhibitors|protease inhibitors|mesh-ancestor
93082733|NCT00077064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082734|NCT00077064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082735|NCT00077064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93082736|NCT00396383|Plerixafor|plerixafor|mesh-list
93082737|NCT00396383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93082738|NCT00396383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93082739|NCT00396383|Antiviral Agents|antiviral agents|mesh-ancestor
93082740|NCT00396383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082741|NCT02534363|Aripiprazole|aripiprazole|mesh-list
93082742|NCT02534363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93082743|NCT02534363|Ziprasidone|ziprasidone|mesh-list
93082744|NCT02534363|Antidepressive Agents|antidepressive agents|mesh-ancestor
93082745|NCT02534363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93082746|NCT02534363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93082747|NCT02534363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93082748|NCT02534363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082749|NCT02534363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082750|NCT02534363|Dopamine Agonists|dopamine agonists|mesh-ancestor
93082751|NCT02534363|Dopamine Agents|dopamine agents|mesh-ancestor
93082752|NCT02534363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082753|NCT02534363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082754|NCT02534363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93082755|NCT02534363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93082756|NCT02534363|Serotonin Agents|serotonin agents|mesh-ancestor
93082757|NCT02534363|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93082758|NCT02534363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93082759|NCT02534363|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93082760|NCT02534363|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93082761|NCT01050491|Sitaxsentan|sitaxsentan|mesh-list
93082762|NCT01050491|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93082763|NCT01050491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082764|NCT01088958|Micronutrients|micronutrients|mesh-list
93082765|NCT01088958|Trace Elements|trace elements|mesh-list
93082766|NCT01088958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082767|NCT03404518|Acetaminophen|acetaminophen|mesh-list
93082768|NCT03404518|Ibuprofen|ibuprofen|mesh-list
93082769|NCT03404518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93082770|NCT03404518|Hydrocodone|hydrocodone|mesh-list
93082771|NCT03404518|Narcotics|narcotics|mesh-list
93082772|NCT03404518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93082773|NCT03404518|Analgesics|analgesics|mesh-ancestor
93082774|NCT03404518|Sensory System Agents|sensory system agents|mesh-ancestor
93082775|NCT03404518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082776|NCT03404518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082777|NCT03404518|Antipyretics|antipyretics|mesh-ancestor
93082778|NCT03404518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93082779|NCT03404518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082780|NCT03404518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082781|NCT03404518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93082782|NCT03404518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082783|NCT03404518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082784|NCT03404518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93082785|NCT03404518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082786|NCT03404518|Antitussive Agents|antitussive agents|mesh-ancestor
93082787|NCT03404518|Respiratory System Agents|respiratory system agents|mesh-ancestor
93082788|NCT03404206|Ibuprofen|ibuprofen|mesh-list
93082789|NCT03404206|Naproxen|naproxen|mesh-list
93082790|NCT03404206|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93082791|NCT03404206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93082792|NCT03404206|Analgesics|analgesics|mesh-ancestor
93082793|NCT03404206|Sensory System Agents|sensory system agents|mesh-ancestor
93082794|NCT03404206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082795|NCT03404206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082796|NCT03404206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082797|NCT03404206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082798|NCT03404206|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93082799|NCT03404206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082800|NCT03404206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082801|NCT03404206|Gout Suppressants|gout suppressants|mesh-ancestor
93082802|NCT00394901|Pregabalin|pregabalin|mesh-list
93082803|NCT00394901|Analgesics|analgesics|mesh-ancestor
93082804|NCT00394901|Sensory System Agents|sensory system agents|mesh-ancestor
93082805|NCT00394901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082806|NCT00394901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082807|NCT00394901|Anticonvulsants|anticonvulsants|mesh-ancestor
93082808|NCT00394901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93082809|NCT00394901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93082810|NCT00394901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082811|NCT00394901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93082812|NCT00394901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93082813|NCT00394901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93082814|NCT00394901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082815|NCT00394901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93082816|NCT03349060|Abrocitinib|abrocitinib|mesh-list
93082817|NCT03349060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93082818|NCT03349060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082819|NCT03349060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082820|NCT03348904|Paclitaxel|paclitaxel|mesh-list
93082821|NCT03348904|Carboplatin|carboplatin|mesh-list
93082822|NCT03348904|Gemcitabine|gemcitabine|mesh-list
93082823|NCT03348904|Nivolumab|nivolumab|mesh-list
93082824|NCT03348904|Pemetrexed|pemetrexed|mesh-list
93082825|NCT03348904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082826|NCT03348904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082827|NCT03348904|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082828|NCT03348904|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082829|NCT03348904|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082830|NCT03348904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082831|NCT03348904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082832|NCT03348904|Antimetabolites|antimetabolites|mesh-ancestor
93082833|NCT03348904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082834|NCT03348904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93082835|NCT03348904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082836|NCT03348904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93082837|NCT03348904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93082838|NCT00359021|Etravirine|etravirine|mesh-list
93082839|NCT00359021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93082840|NCT00359021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93082841|NCT00359021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082842|NCT00359021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082843|NCT00359021|Antiviral Agents|antiviral agents|mesh-ancestor
93082844|NCT00359021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082845|NCT00360269|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93082846|NCT00360269|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93082847|NCT00360269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93082848|NCT00360269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93082849|NCT00360269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082850|NCT00360269|Adrenergic Agents|adrenergic agents|mesh-ancestor
93082851|NCT00360269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082852|NCT00360269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082853|NCT01052597|Curcumin|curcumin|mesh-list
93082854|NCT01052597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93082855|NCT01052597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93082856|NCT01052597|Analgesics|analgesics|mesh-ancestor
93082857|NCT01052597|Sensory System Agents|sensory system agents|mesh-ancestor
93082858|NCT01052597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082859|NCT01052597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082860|NCT01052597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082861|NCT01052597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082862|NCT01052597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082863|NCT01052597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082864|NCT01052597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082865|NCT01051115|Dasatinib|dasatinib|mesh-list
93082866|NCT01051115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082867|NCT01051115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93082868|NCT01051115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082869|NCT01051115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082870|NCT00076752|Diphenhydramine|diphenhydramine|mesh-list
93082871|NCT00076752|Promethazine|promethazine|mesh-list
93082872|NCT00076752|Methylprednisolone|methylprednisolone|mesh-list
93082873|NCT00076752|Cyclophosphamide|cyclophosphamide|mesh-list
93082874|NCT00076752|Rituximab|rituximab|mesh-list
93082875|NCT00076752|Fludarabine|fludarabine|mesh-list
93082876|NCT00076752|Fludarabine phosphate|fludarabine phosphate|mesh-list
93082877|NCT00076752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082878|NCT00076752|Immunologic Factors|immunologic factors|mesh-ancestor
93082879|NCT00076752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082880|NCT00076752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082881|NCT00076752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082882|NCT00076752|Alkylating Agents|alkylating agents|mesh-ancestor
93082883|NCT00076752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082884|NCT00076752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082885|NCT00076752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082886|NCT00076752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082887|NCT00076752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082888|NCT00076752|Antimetabolites|antimetabolites|mesh-ancestor
93082889|NCT00076752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082890|NCT00076752|Antiemetics|antiemetics|mesh-ancestor
93082891|NCT00076752|Autonomic Agents|autonomic agents|mesh-ancestor
93082892|NCT00076752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93082893|NCT00076752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93082894|NCT00076752|Glucocorticoids|glucocorticoids|mesh-ancestor
93082895|NCT00076752|Hormones|hormones|mesh-ancestor
93082896|NCT00076752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082897|NCT00076752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93082898|NCT00076752|Protective Agents|protective agents|mesh-ancestor
93082899|NCT00076752|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93082900|NCT00076752|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93082901|NCT00076752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082902|NCT00076752|Anesthetics, Local|anesthetics, local|mesh-ancestor
93082903|NCT00076752|Anesthetics|anesthetics|mesh-ancestor
93082904|NCT00076752|Sensory System Agents|sensory system agents|mesh-ancestor
93082905|NCT00076752|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93082906|NCT00076752|Histamine Antagonists|histamine antagonists|mesh-ancestor
93082907|NCT00076752|Histamine Agents|histamine agents|mesh-ancestor
93082908|NCT00076752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93082909|NCT00076752|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93082910|NCT00076752|Antipruritics|antipruritics|mesh-ancestor
93082911|NCT00076752|Dermatologic Agents|dermatologic agents|mesh-ancestor
93082912|NCT03384940|Trastuzumab|trastuzumab|mesh-list
93082913|NCT03384940|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93082914|NCT03384940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082915|NCT03384940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082916|NCT03384940|Immunoconjugates|immunoconjugates|mesh-ancestor
93082917|NCT03384940|Immunologic Factors|immunologic factors|mesh-ancestor
93082918|NCT03384940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082919|NCT00075582|Dactinomycin|dactinomycin|mesh-list
93082920|NCT00075582|Cactinomycin|cactinomycin|mesh-list
93082921|NCT00075582|Cyclophosphamide|cyclophosphamide|mesh-list
93082922|NCT00075582|Vincristine|vincristine|mesh-list
93082923|NCT00075582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082924|NCT00075582|Immunologic Factors|immunologic factors|mesh-ancestor
93082925|NCT00075582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082926|NCT00075582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082927|NCT00075582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082928|NCT00075582|Alkylating Agents|alkylating agents|mesh-ancestor
93082929|NCT00075582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082930|NCT00075582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082931|NCT00075582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082932|NCT00075582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082933|NCT00075582|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082934|NCT00075582|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082935|NCT00075582|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082936|NCT00075582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93082937|NCT00075582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93082938|NCT00075582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93082939|NCT00075582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93082940|NCT00075582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082941|NCT00075582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93082942|NCT00063258|Paclitaxel|paclitaxel|mesh-list
93082943|NCT00063258|Carboplatin|carboplatin|mesh-list
93082944|NCT00063258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93082945|NCT00063258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082946|NCT00063258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082947|NCT00063258|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082948|NCT00063258|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082949|NCT00063258|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082950|NCT00063258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060020|NCT03883204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93082951|NCT00063258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93082952|NCT00063258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082953|NCT00088530|Prednisone|prednisone|mesh-list
93082954|NCT00088530|Cyclophosphamide|cyclophosphamide|mesh-list
93082955|NCT00088530|Rituximab|rituximab|mesh-list
93082956|NCT00088530|Gemcitabine|gemcitabine|mesh-list
93082957|NCT00088530|Etoposide|etoposide|mesh-list
93082958|NCT00088530|Vincristine|vincristine|mesh-list
93082959|NCT00088530|Vinorelbine|vinorelbine|mesh-list
93082960|NCT00088530|Pixantrone|pixantrone|mesh-list
93082961|NCT00088530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93082962|NCT00088530|Immunologic Factors|immunologic factors|mesh-ancestor
93082963|NCT00088530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082964|NCT00088530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93082965|NCT00088530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93082966|NCT00088530|Alkylating Agents|alkylating agents|mesh-ancestor
93082967|NCT00088530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082968|NCT00088530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93082969|NCT00088530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93082970|NCT00088530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93082971|NCT00088530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93082972|NCT00088530|Antimetabolites|antimetabolites|mesh-ancestor
93082973|NCT00088530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93082974|NCT00088530|Glucocorticoids|glucocorticoids|mesh-ancestor
93082975|NCT00088530|Hormones|hormones|mesh-ancestor
93082976|NCT00088530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93082977|NCT00088530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93082978|NCT00088530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93082979|NCT00088530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93082980|NCT00088530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93082981|NCT00088530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93082982|NCT00088530|Tubulin Modulators|tubulin modulators|mesh-ancestor
93082983|NCT00088530|Antimitotic Agents|antimitotic agents|mesh-ancestor
93082984|NCT00088530|Mitosis Modulators|mitosis modulators|mesh-ancestor
93082985|NCT00359801|Insulin|insulin|mesh-list
93082986|NCT00359801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93082987|NCT00359801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93082988|NCT00359801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082989|NCT03990701|Metomidate|metomidate|mesh-list
93082990|NCT03990701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93082991|NCT03990701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93082992|NCT03990701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93082993|NCT01051193|Oxcarbazepine|oxcarbazepine|mesh-list
93082994|NCT01051193|Anticonvulsants|anticonvulsants|mesh-ancestor
93082995|NCT01051193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93082996|NCT01051193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93082997|NCT01051193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93082998|NCT01051193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93082999|NCT01051193|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93083000|NCT01051193|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93083001|NCT01051271|Midazolam|midazolam|mesh-list
93083002|NCT01051271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93083003|NCT01051271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93083004|NCT01051271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083005|NCT01051271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083006|NCT01051271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93083007|NCT01051271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93083008|NCT01051271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93083009|NCT01051271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93083010|NCT01051271|Anesthetics, General|anesthetics, general|mesh-ancestor
93083011|NCT01051271|Anesthetics|anesthetics|mesh-ancestor
93083012|NCT01051271|GABA Modulators|gaba modulators|mesh-ancestor
93083013|NCT01051271|GABA Agents|gaba agents|mesh-ancestor
93083014|NCT01051271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083015|NCT01051271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083016|NCT01051427|Hemostatics|hemostatics|mesh-list
93083017|NCT01051427|Surgiflo|surgiflo|mesh-list
93083018|NCT01051427|Coagulants|coagulants|mesh-ancestor
93083019|NCT01052909|Glimepiride|glimepiride|mesh-list
93083020|NCT01052909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93083021|NCT01052909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083022|NCT01052909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673324|NCT00344526|Dexamethasone|dexamethasone|mesh-list
93083023|NCT01052909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083024|NCT01052909|Immunologic Factors|immunologic factors|mesh-ancestor
93083025|NCT00045032|Trastuzumab|trastuzumab|mesh-list
93083026|NCT00045032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083027|NCT00045032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083028|NCT01052987|Tranilast|tranilast|mesh-list
93083029|NCT01052987|Allopurinol|allopurinol|mesh-list
93083030|NCT01052987|Antimetabolites|antimetabolites|mesh-ancestor
93083031|NCT01052987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083032|NCT01052987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083033|NCT01052987|Gout Suppressants|gout suppressants|mesh-ancestor
93083034|NCT01052987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083035|NCT01052987|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93083036|NCT01052987|Antioxidants|antioxidants|mesh-ancestor
93083037|NCT01052987|Protective Agents|protective agents|mesh-ancestor
93083038|NCT01052987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083039|NCT01052987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93083040|NCT01052987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93083041|NCT01052987|Analgesics|analgesics|mesh-ancestor
93083042|NCT01052987|Sensory System Agents|sensory system agents|mesh-ancestor
93083043|NCT01052987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083044|NCT01052987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083045|NCT01052987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93083046|NCT01052987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93083047|NCT01052987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93083048|NCT01052987|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93083049|NCT01052987|Histamine Antagonists|histamine antagonists|mesh-ancestor
93083050|NCT01052987|Histamine Agents|histamine agents|mesh-ancestor
93083051|NCT01052987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083052|NCT01052987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93083053|NCT01052987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93083054|NCT02533973|Calcipotriene|calcipotriene|mesh-list
93083055|NCT02533973|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083056|NCT01053065|Atorvastatin|atorvastatin|mesh-list
93083057|NCT01053065|Cholestyramine Resin|cholestyramine resin|mesh-list
93083058|NCT01053065|Gamma-sitosterol|gamma-sitosterol|mesh-list
93083059|NCT01053065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93083060|NCT01053065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93083061|NCT01053065|Antimetabolites|antimetabolites|mesh-ancestor
93083062|NCT01053065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083063|NCT01053065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93083064|NCT01053065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93083065|NCT01053065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083066|NCT01051583|Bevacizumab|bevacizumab|mesh-list
93083067|NCT01051583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083068|NCT01051583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083069|NCT01051583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93083070|NCT01051583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93083071|NCT01051583|Growth Substances|growth substances|mesh-ancestor
93083072|NCT01051583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083073|NCT01051583|Growth Inhibitors|growth inhibitors|mesh-ancestor
93083074|NCT05386706|Metformin|metformin|mesh-list
93083075|NCT05386706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083076|NCT05386706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083077|NCT03950804|Eculizumab|eculizumab|mesh-list
93083078|NCT03950804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93083079|NCT03950804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083080|NCT03950804|Immunologic Factors|immunologic factors|mesh-ancestor
93083081|NCT03950804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083082|NCT00356915|Itraconazole|itraconazole|mesh-list
93083083|NCT00356915|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93083084|NCT00356915|Antifungal Agents|antifungal agents|mesh-ancestor
93083085|NCT00356915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083086|NCT00356915|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93083087|NCT00356915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93083088|NCT00356915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083089|NCT00356915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083090|NCT00356915|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93083091|NCT00356915|Hormone Antagonists|hormone antagonists|mesh-ancestor
93083092|NCT00356915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083093|NCT00356915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083094|NCT00356915|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93083095|NCT00356759|Warfarin|warfarin|mesh-list
93083096|NCT00356759|Anticoagulants|anticoagulants|mesh-ancestor
93083097|NCT00356603|Sumatriptan|sumatriptan|mesh-list
93083098|NCT00356603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93083099|NCT00356603|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93083100|NCT00356603|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93083101|NCT00356603|Serotonin Agents|serotonin agents|mesh-ancestor
93060180|NCT00224484|Vaccines|vaccines|mesh-list
93083102|NCT00356603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083103|NCT00356603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083104|NCT00356603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083105|NCT01052051|Vitamin D|vitamin d|mesh-list
93083106|NCT01052051|Cholecalciferol|cholecalciferol|mesh-list
93083107|NCT01052051|Calcium Carbonate|calcium carbonate|mesh-list
93083108|NCT01052051|Calcium|calcium|mesh-list
93083109|NCT01052051|Vitamins|vitamins|mesh-ancestor
93083110|NCT01052051|Micronutrients|micronutrients|mesh-ancestor
93083111|NCT01052051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083112|NCT01052051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93083113|NCT01052051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93083114|NCT01052051|Antacids|antacids|mesh-ancestor
93083115|NCT01052051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083116|NCT01052051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93083117|NCT00002558|Paclitaxel|paclitaxel|mesh-list
93083118|NCT00002558|Etoposide|etoposide|mesh-list
93083119|NCT00002558|Carboplatin|carboplatin|mesh-list
93083120|NCT00002558|Ifosfamide|ifosfamide|mesh-list
93083121|NCT00002558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93083122|NCT00002558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083123|NCT00002558|Tubulin Modulators|tubulin modulators|mesh-ancestor
93083124|NCT00002558|Antimitotic Agents|antimitotic agents|mesh-ancestor
93083125|NCT00002558|Mitosis Modulators|mitosis modulators|mesh-ancestor
93083126|NCT00002558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083127|NCT00002558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93083128|NCT00002558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93083129|NCT00002558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083130|NCT00002558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93083131|NCT00002558|Alkylating Agents|alkylating agents|mesh-ancestor
93083132|NCT00001880|Cyclosporine|cyclosporine|mesh-list
93083133|NCT00001880|Methotrexate|methotrexate|mesh-list
93083134|NCT00001880|Cyclosporins|cyclosporins|mesh-list
93083135|NCT00001880|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93083136|NCT00001880|Abortifacient Agents|abortifacient agents|mesh-ancestor
93083137|NCT00001880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93083138|NCT00001880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083139|NCT00001880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93083140|NCT00001880|Antimetabolites|antimetabolites|mesh-ancestor
93083141|NCT00001880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083142|NCT00001880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083143|NCT00001880|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083144|NCT00001880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083145|NCT00001880|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93083146|NCT00001880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083147|NCT00001880|Immunologic Factors|immunologic factors|mesh-ancestor
93083148|NCT00001880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083149|NCT00001880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93083150|NCT00001880|Antifungal Agents|antifungal agents|mesh-ancestor
93083151|NCT00001880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083152|NCT00001880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93083153|NCT01096472|Octenidine|octenidine|mesh-list
93083154|NCT01096472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083155|NCT01096472|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93083156|NCT05627648|Mitogens|mitogens|mesh-list
93083157|NCT05627648|Mitosis Modulators|mitosis modulators|mesh-ancestor
93083158|NCT05627648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083159|NCT05296772|Pembrolizumab|pembrolizumab|mesh-list
93083160|NCT05296772|Antibodies|antibodies|mesh-list
93083161|NCT05296772|Immunoglobulins|immunoglobulins|mesh-list
93083162|NCT05296772|Immunologic Factors|immunologic factors|mesh-ancestor
93083163|NCT05296772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083164|NCT05296772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083165|NCT05296772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083166|NCT05296772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93083167|NCT05296772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083168|NCT03947528|Sarpogrelate|sarpogrelate|mesh-list
93083169|NCT03947528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93083170|NCT03947528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93083171|NCT03947528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083172|NCT03947528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93083173|NCT03947528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93083174|NCT03947528|Serotonin Agents|serotonin agents|mesh-ancestor
93083175|NCT03947528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083176|NCT03947528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083177|NCT01104896|Nicotine|nicotine|mesh-list
93083178|NCT01104896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93083179|NCT01104896|Autonomic Agents|autonomic agents|mesh-ancestor
93083180|NCT01104896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083181|NCT01104896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083182|NCT01104896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93083183|NCT01104896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93083184|NCT01104896|Cholinergic Agents|cholinergic agents|mesh-ancestor
93083185|NCT01104896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083186|NCT01104896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083187|NCT00043550|Sertraline|sertraline|mesh-list
93083188|NCT00043550|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93083189|NCT00043550|Antidepressive Agents|antidepressive agents|mesh-ancestor
93083190|NCT00043550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93083191|NCT00043550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93083192|NCT00043550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93083193|NCT00043550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93083194|NCT00043550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083195|NCT00043550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083196|NCT00043550|Serotonin Agents|serotonin agents|mesh-ancestor
93083197|NCT00043550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083198|NCT00043550|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93083199|NCT00043550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93083200|NCT01102244|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93083201|NCT01102244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083202|NCT01102244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083203|NCT01102244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083204|NCT01102244|Glucocorticoids|glucocorticoids|mesh-ancestor
93083205|NCT01102244|Hormones|hormones|mesh-ancestor
93083206|NCT01102244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083207|NCT01102244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083208|NCT01102244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93083209|NCT01102244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93083210|NCT01105208|Cephalexin|cephalexin|mesh-list
93083211|NCT01105208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083212|NCT01105208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083213|NCT01105286|Vitamin D|vitamin d|mesh-list
93083214|NCT01105286|Calcipotriene|calcipotriene|mesh-list
93083215|NCT01105286|Vitamins|vitamins|mesh-ancestor
93083216|NCT01105286|Micronutrients|micronutrients|mesh-ancestor
93083217|NCT01105286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083218|NCT01105286|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93083219|NCT01105286|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083220|NCT00041132|Leucovorin|leucovorin|mesh-list
93083221|NCT00041132|Cytarabine|cytarabine|mesh-list
93083222|NCT00041132|Dexamethasone|dexamethasone|mesh-list
93083223|NCT00041132|Cyclophosphamide|cyclophosphamide|mesh-list
93083224|NCT00041132|Rituximab|rituximab|mesh-list
93083225|NCT00041132|Doxorubicin|doxorubicin|mesh-list
93083226|NCT00041132|Methotrexate|methotrexate|mesh-list
93083227|NCT00041132|Vincristine|vincristine|mesh-list
93083228|NCT00041132|Levoleucovorin|levoleucovorin|mesh-list
93083229|NCT00041132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083230|NCT00041132|Immunologic Factors|immunologic factors|mesh-ancestor
93083231|NCT00041132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083232|NCT00041132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083233|NCT00041132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93083234|NCT00041132|Alkylating Agents|alkylating agents|mesh-ancestor
93083235|NCT00041132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083236|NCT00041132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083237|NCT00041132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93083238|NCT00041132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083239|NCT00041132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083240|NCT00041132|Antiemetics|antiemetics|mesh-ancestor
93083241|NCT00041132|Autonomic Agents|autonomic agents|mesh-ancestor
93083242|NCT00041132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083243|NCT00041132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93083244|NCT00041132|Glucocorticoids|glucocorticoids|mesh-ancestor
93083245|NCT00041132|Hormones|hormones|mesh-ancestor
93083246|NCT00041132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083247|NCT00041132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93083248|NCT00041132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93060320|NCT01264354|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93083249|NCT00041132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93083250|NCT00041132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93083251|NCT00041132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083252|NCT00041132|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93083253|NCT00041132|Abortifacient Agents|abortifacient agents|mesh-ancestor
93083254|NCT00041132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93083255|NCT00041132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93083256|NCT00041132|Antimetabolites|antimetabolites|mesh-ancestor
93083257|NCT00041132|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083258|NCT00041132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93083259|NCT00041132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93083260|NCT00041132|Antiviral Agents|antiviral agents|mesh-ancestor
93083261|NCT00041132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083262|NCT00041132|Antidotes|antidotes|mesh-ancestor
93083263|NCT00041132|Protective Agents|protective agents|mesh-ancestor
93083264|NCT00041132|Vitamin B Complex|vitamin b complex|mesh-ancestor
93083265|NCT00041132|Vitamins|vitamins|mesh-ancestor
93083266|NCT00041132|Micronutrients|micronutrients|mesh-ancestor
93083267|NCT00041132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93083268|NCT00041132|Tubulin Modulators|tubulin modulators|mesh-ancestor
93083269|NCT00041132|Antimitotic Agents|antimitotic agents|mesh-ancestor
93083270|NCT00041132|Mitosis Modulators|mitosis modulators|mesh-ancestor
93083271|NCT00040664|Ritonavir|ritonavir|mesh-list
93083272|NCT00040664|Fosamprenavir|fosamprenavir|mesh-list
93083273|NCT00040664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93083274|NCT00040664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93083275|NCT00040664|Protease Inhibitors|protease inhibitors|mesh-ancestor
93083276|NCT00040664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083277|NCT00040664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083278|NCT00040664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93083279|NCT00040664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93083280|NCT00040664|Antiviral Agents|antiviral agents|mesh-ancestor
93083281|NCT00040664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083282|NCT00040664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93083283|NCT00040664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93083284|NCT02952586|Avelumab|avelumab|mesh-list
93083285|NCT02952586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083286|NCT02952586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083287|NCT05098574|Drospirenone|drospirenone|mesh-list
93083288|NCT05098574|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93083289|NCT05098574|Estradiol|estradiol|mesh-list
93083290|NCT05098574|Estrogens|estrogens|mesh-ancestor
93083291|NCT05098574|Hormones|hormones|mesh-ancestor
93083292|NCT05098574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083293|NCT05098574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083294|NCT05098574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93083295|NCT05098574|Contraceptive Agents|contraceptive agents|mesh-ancestor
93083296|NCT05098574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93083297|NCT05098574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93083298|NCT05098574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93083299|NCT05098574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93083300|NCT05098574|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93083301|NCT05098574|Hormone Antagonists|hormone antagonists|mesh-ancestor
93083302|NCT05098574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93083303|NCT05098574|Diuretics|diuretics|mesh-ancestor
93083304|NCT05098574|Natriuretic Agents|natriuretic agents|mesh-ancestor
93083305|NCT01096706|Aspirin|aspirin|mesh-list
93083306|NCT01096706|Fluconazole|fluconazole|mesh-list
93083307|NCT01096706|Substance P|substance p|mesh-list
93083308|NCT01096706|Neurokinin A|neurokinin a|mesh-list
93083309|NCT01096706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93083310|NCT01096706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93083311|NCT01096706|Analgesics|analgesics|mesh-ancestor
93083312|NCT01096706|Sensory System Agents|sensory system agents|mesh-ancestor
93083313|NCT01096706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083314|NCT01096706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083315|NCT01096706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083316|NCT01096706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083317|NCT01096706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93083318|NCT01096706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93083319|NCT01096706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083320|NCT01096706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93083321|NCT01096706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93083322|NCT01096706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083323|NCT01096706|Antipyretics|antipyretics|mesh-ancestor
93083324|NCT01096706|Antifungal Agents|antifungal agents|mesh-ancestor
93060394|NCT01267084|Ketoconazole|ketoconazole|mesh-list
93083325|NCT01096706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083326|NCT01096706|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93083327|NCT01096706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93083328|NCT01096706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93083329|NCT01096706|Hormone Antagonists|hormone antagonists|mesh-ancestor
93083330|NCT01096706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083331|NCT01096706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93083332|NCT01096706|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93083333|NCT01096706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083334|NCT01102478|Losartan|losartan|mesh-list
93083335|NCT01102478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93083336|NCT01102478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93083337|NCT01102478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93083338|NCT01102478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93083339|NCT01102478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93083340|NCT01102478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083341|NCT01102478|Diuretics|diuretics|mesh-ancestor
93083342|NCT01102478|Natriuretic Agents|natriuretic agents|mesh-ancestor
93083343|NCT01102478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083344|NCT01102478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93083345|NCT01102478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93083346|NCT01105598|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93083347|NCT01105598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93083348|NCT01105598|Antimetabolites|antimetabolites|mesh-ancestor
93083349|NCT01105598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083350|NCT01105598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93083351|NCT01105598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083352|NCT01105598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083353|NCT01105598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083354|NCT03384316|Vaccines|vaccines|mesh-list
93083355|NCT03384316|Immunologic Factors|immunologic factors|mesh-ancestor
93083356|NCT03384316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083357|NCT03994172|Calcium, Dietary|calcium, dietary|mesh-list
93083358|NCT03994172|Vitamin D|vitamin d|mesh-list
93083359|NCT03994172|Cholecalciferol|cholecalciferol|mesh-list
93083360|NCT03994172|Teriparatide|teriparatide|mesh-list
93083361|NCT03994172|Citric Acid|citric acid|mesh-list
93083362|NCT03994172|Sodium Citrate|sodium citrate|mesh-list
93083363|NCT03994172|Calcium|calcium|mesh-list
93083364|NCT03994172|Parathyroid Hormone|parathyroid hormone|mesh-list
93083365|NCT03994172|Cinacalcet|cinacalcet|mesh-list
93083366|NCT03994172|Hormones|hormones|mesh-list
93083367|NCT03994172|Vitamins|vitamins|mesh-ancestor
93083368|NCT03994172|Micronutrients|micronutrients|mesh-ancestor
93083369|NCT03994172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083370|NCT03994172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93083371|NCT03994172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93083372|NCT03994172|Anticoagulants|anticoagulants|mesh-ancestor
93083373|NCT03994172|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93083374|NCT03994172|Chelating Agents|chelating agents|mesh-ancestor
93083375|NCT03994172|Sequestering Agents|sequestering agents|mesh-ancestor
93083376|NCT03994172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083377|NCT03994172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083378|NCT03994172|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93083379|NCT03994172|Hormone Antagonists|hormone antagonists|mesh-ancestor
93083380|NCT01105832|Teriparatide|teriparatide|mesh-list
93083381|NCT01105832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93083382|NCT01105832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083383|NCT01105832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93083384|NCT01105910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93083385|NCT01105910|Lubricant Eye Drops|lubricant eye drops|mesh-list
93083386|NCT01105910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93083387|NCT00356525|Carboplatin|carboplatin|mesh-list
93083388|NCT00356525|Gemcitabine|gemcitabine|mesh-list
93083389|NCT00356525|Pemetrexed|pemetrexed|mesh-list
93083390|NCT00356525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083391|NCT00356525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93083392|NCT00356525|Antimetabolites|antimetabolites|mesh-ancestor
93083393|NCT00356525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083394|NCT00356525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083395|NCT00356525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93083396|NCT00356525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93083397|NCT01106066|Oxaliplatin|oxaliplatin|mesh-list
93083398|NCT01106066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083399|NCT01052129|Naproxen|naproxen|mesh-list
93060478|NCT01161316|Cetuximab|cetuximab|mesh-list
93083400|NCT01052129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93083401|NCT01052129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93083403|NCT01052129|Sensory System Agents|sensory system agents|mesh-ancestor
93083404|NCT01052129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083405|NCT01052129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083406|NCT01052129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083407|NCT01052129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083408|NCT01052129|Gout Suppressants|gout suppressants|mesh-ancestor
93083409|NCT01052129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93083410|NCT01052129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083411|NCT01052129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083412|NCT01053377|Oseltamivir|oseltamivir|mesh-list
93083413|NCT01053377|Antiviral Agents|antiviral agents|mesh-ancestor
93083414|NCT01053377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083415|NCT01053377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083416|NCT01053377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083417|NCT03991559|Manganese|manganese|mesh-list
93083418|NCT03991559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93083419|NCT03991559|Antibodies|antibodies|mesh-list
93083420|NCT03991559|Immunoglobulins|immunoglobulins|mesh-list
93083421|NCT03991559|Immunologic Factors|immunologic factors|mesh-ancestor
93083422|NCT03991559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083423|NCT03991559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083424|NCT03991559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083425|NCT03991559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083426|NCT03991559|Trace Elements|trace elements|mesh-ancestor
93083427|NCT03991559|Micronutrients|micronutrients|mesh-ancestor
93083428|NCT03949634|Paclitaxel|paclitaxel|mesh-list
93083429|NCT03949634|Docetaxel|docetaxel|mesh-list
93083430|NCT03949634|Doxorubicin|doxorubicin|mesh-list
93083431|NCT03949634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93083432|NCT03949634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083433|NCT03949634|Tubulin Modulators|tubulin modulators|mesh-ancestor
93083434|NCT03949634|Antimitotic Agents|antimitotic agents|mesh-ancestor
93083435|NCT03949634|Mitosis Modulators|mitosis modulators|mesh-ancestor
93083436|NCT03949634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083437|NCT03949634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93083438|NCT03949634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92673736|NCT00316940|Analgesics|analgesics|mesh-ancestor
93083439|NCT03949634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93083440|NCT03949634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083441|NCT01108874|Metaraminol|metaraminol|mesh-list
93083442|NCT01108874|Sympathomimetics|sympathomimetics|mesh-ancestor
93083443|NCT01108874|Autonomic Agents|autonomic agents|mesh-ancestor
93083444|NCT01108874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083445|NCT01108874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083446|NCT01108874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93083447|NCT01108874|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93083448|NCT01108874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93083449|NCT01108874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93083450|NCT01108874|Adrenergic Agents|adrenergic agents|mesh-ancestor
93083451|NCT01108874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083452|NCT01108874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083453|NCT03383614|Emodepside|emodepside|mesh-list
93083454|NCT03383614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93083455|NCT03383614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083456|NCT03403036|Brodalumab|brodalumab|mesh-list
93083457|NCT03403036|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083458|NCT00356135|Clopidogrel|clopidogrel|mesh-list
93083459|NCT00356135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93083460|NCT00356135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93083461|NCT00356135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93083462|NCT00356135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93083463|NCT00356135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93083464|NCT00356135|Purinergic Agents|purinergic agents|mesh-ancestor
93083465|NCT00356135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083466|NCT00356135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083467|NCT00356135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083468|NCT01052363|Bevacizumab|bevacizumab|mesh-list
93083469|NCT01052363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083470|NCT01052363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083471|NCT01052363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93083472|NCT01052363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93083473|NCT01052363|Growth Substances|growth substances|mesh-ancestor
93083474|NCT01052363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083475|NCT01052363|Growth Inhibitors|growth inhibitors|mesh-ancestor
93083476|NCT01053611|Remifentanil|remifentanil|mesh-list
93083477|NCT01053611|Propofol|propofol|mesh-list
93083478|NCT01053611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93083479|NCT01053611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083480|NCT01053611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083481|NCT01053611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93083482|NCT01053611|Anesthetics, General|anesthetics, general|mesh-ancestor
93083483|NCT01053611|Anesthetics|anesthetics|mesh-ancestor
93083484|NCT01053611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93083485|NCT01053611|Narcotics|narcotics|mesh-ancestor
93083486|NCT01053611|Analgesics|analgesics|mesh-ancestor
93083487|NCT01053611|Sensory System Agents|sensory system agents|mesh-ancestor
93083488|NCT01053611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083489|NCT00350519|Epoetin Alfa|epoetin alfa|mesh-list
93083490|NCT00350519|Hematinics|hematinics|mesh-ancestor
93083491|NCT01053689|Glimepiride|glimepiride|mesh-list
93083492|NCT01053689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93083493|NCT01053689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083494|NCT01053689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083495|NCT01053689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083496|NCT01053689|Immunologic Factors|immunologic factors|mesh-ancestor
93083497|NCT01111448|Sirolimus|sirolimus|mesh-list
93083498|NCT01111448|Temsirolimus|temsirolimus|mesh-list
93083499|NCT01111448|MTOR Inhibitors|mtor inhibitors|mesh-list
93083500|NCT01111448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93083501|NCT01111448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083502|NCT01111448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083503|NCT01111448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083504|NCT01111448|Immunologic Factors|immunologic factors|mesh-ancestor
93083505|NCT01111448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083506|NCT01111448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083507|NCT01111448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083508|NCT01111448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083509|NCT01111448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93083510|NCT01111448|Antifungal Agents|antifungal agents|mesh-ancestor
93083511|NCT03382912|Nivolumab|nivolumab|mesh-list
93083512|NCT03382912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083513|NCT03382912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083514|NCT03382912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93083515|NCT03382912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083516|NCT03942926|Sirolimus|sirolimus|mesh-list
93083517|NCT03942926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083518|NCT03942926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083519|NCT03942926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93083520|NCT03942926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083521|NCT03942926|Antifungal Agents|antifungal agents|mesh-ancestor
93083522|NCT03942926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083523|NCT03942926|Immunologic Factors|immunologic factors|mesh-ancestor
93083524|NCT03942926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083525|NCT00350207|Bromides|bromides|mesh-list
93083526|NCT00350207|Tiotropium Bromide|tiotropium bromide|mesh-list
93083527|NCT00350207|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93083528|NCT00350207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93083529|NCT00350207|Autonomic Agents|autonomic agents|mesh-ancestor
93083530|NCT00350207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083531|NCT00350207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083532|NCT00350207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93083533|NCT00350207|Respiratory System Agents|respiratory system agents|mesh-ancestor
93083534|NCT00350207|Parasympatholytics|parasympatholytics|mesh-ancestor
93083535|NCT00350207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93083536|NCT00350207|Cholinergic Agents|cholinergic agents|mesh-ancestor
93083537|NCT00350207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083538|NCT00350207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083539|NCT00350207|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93083540|NCT00350207|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93083541|NCT00350207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93083542|NCT00350207|Adrenergic Agents|adrenergic agents|mesh-ancestor
93083543|NCT00350207|Anticonvulsants|anticonvulsants|mesh-ancestor
93083544|NCT03946826|Halometasone|halometasone|mesh-list
93083545|NCT03946826|Petrolatum|petrolatum|mesh-list
93083546|NCT03946826|Emollients|emollients|mesh-ancestor
93083547|NCT03946826|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083548|NCT03946826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060624|NCT01280734|Melatonin|melatonin|mesh-list
93083549|NCT03946826|Glucocorticoids|glucocorticoids|mesh-ancestor
93083550|NCT03946826|Hormones|hormones|mesh-ancestor
93083551|NCT03946826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083552|NCT03946826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083553|NCT01311622|Warfarin|warfarin|mesh-list
93083554|NCT01311622|Anticoagulants|anticoagulants|mesh-ancestor
93083555|NCT00349973|Dipyridamole|dipyridamole|mesh-list
93083556|NCT00349973|Olanzapine|olanzapine|mesh-list
93083557|NCT00349973|Antiemetics|antiemetics|mesh-ancestor
93083558|NCT00349973|Autonomic Agents|autonomic agents|mesh-ancestor
93083559|NCT00349973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083560|NCT00349973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083561|NCT00349973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93083562|NCT00349973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93083563|NCT00349973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93083564|NCT00349973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083565|NCT00349973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93083566|NCT00349973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93083567|NCT00349973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93083568|NCT00349973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93083569|NCT00349973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083570|NCT00349973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083571|NCT00349973|Serotonin Agents|serotonin agents|mesh-ancestor
93083572|NCT00349973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93083573|NCT00349973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083574|NCT00349973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93083575|NCT00349973|Vasodilator Agents|vasodilator agents|mesh-ancestor
93083576|NCT01111682|Mannitol|mannitol|mesh-list
93083577|NCT01111682|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93083578|NCT01111682|Diuretics|diuretics|mesh-ancestor
93083579|NCT01111682|Natriuretic Agents|natriuretic agents|mesh-ancestor
93083580|NCT01111682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083581|NCT04464122|Somatostatin|somatostatin|mesh-list
93083582|NCT04464122|Hormones|hormones|mesh-ancestor
93083583|NCT04464122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083584|NCT04464122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083585|NCT01111994|Clindamycin|clindamycin|mesh-list
93083586|NCT01111994|Clindamycin palmitate|clindamycin palmitate|mesh-list
93083587|NCT01111994|Clindamycin phosphate|clindamycin phosphate|mesh-list
93083588|NCT01111994|Tretinoin|tretinoin|mesh-list
93083589|NCT01111994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083590|NCT01111994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083591|NCT01111994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93083592|NCT01111994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083593|NCT01111994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083594|NCT01111994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083595|NCT01111994|Keratolytic Agents|keratolytic agents|mesh-ancestor
93083596|NCT01111994|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083597|NCT03187262|Daratumumab|daratumumab|mesh-list
93083598|NCT03187262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083599|NCT03944252|Cetuximab|cetuximab|mesh-list
93083600|NCT03944252|Avelumab|avelumab|mesh-list
93083601|NCT03944252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083602|NCT03944252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083603|NCT01209026|Fluticasone|fluticasone|mesh-list
93083604|NCT01209026|Xhance|xhance|mesh-list
93083605|NCT01209026|Moxifloxacin|moxifloxacin|mesh-list
93083606|NCT01209026|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93083607|NCT01209026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083608|NCT01209026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93083609|NCT01209026|Autonomic Agents|autonomic agents|mesh-ancestor
93083610|NCT01209026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083611|NCT01209026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083612|NCT01209026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93083613|NCT01209026|Respiratory System Agents|respiratory system agents|mesh-ancestor
93083614|NCT01209026|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083615|NCT01209026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93083616|NCT01209026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083617|NCT01209026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083618|NCT01209026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93083619|NCT01209026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93083620|NCT01209026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083621|NCT01209026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083622|NCT01209026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755891|NCT01260467|Memantine|memantine|mesh-list
93083623|NCT01209026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93083624|NCT01209026|Contraceptive Agents|contraceptive agents|mesh-ancestor
93083625|NCT01209026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93083626|NCT01209026|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93083627|NCT01209026|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93083628|NCT01209026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93083629|NCT01107470|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93083630|NCT01107470|Hormones|hormones|mesh-ancestor
93083631|NCT01107470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083632|NCT01107470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083633|NCT01109264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93083634|NCT01109264|Chlorambucil|chlorambucil|mesh-list
93083635|NCT01109264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93083636|NCT01109264|Alkylating Agents|alkylating agents|mesh-ancestor
93083637|NCT01109264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083638|NCT01109264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083639|NCT01311700|Metoprolol|metoprolol|mesh-list
93083640|NCT01311700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93083641|NCT01311700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93083642|NCT01311700|Sympatholytics|sympatholytics|mesh-ancestor
93083643|NCT01311700|Autonomic Agents|autonomic agents|mesh-ancestor
93083644|NCT01311700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083645|NCT01311700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083646|NCT01311700|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93083647|NCT01311700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93083648|NCT01311700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93083649|NCT01311700|Adrenergic Agents|adrenergic agents|mesh-ancestor
93083650|NCT01311700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083651|NCT01311700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083652|NCT01107782|Sildenafil Citrate|sildenafil citrate|mesh-list
93083653|NCT01107782|Vasodilator Agents|vasodilator agents|mesh-ancestor
93083654|NCT01107782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93083655|NCT01107782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93083656|NCT01107782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083657|NCT01107782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083658|NCT01107782|Urological Agents|urological agents|mesh-ancestor
93083659|NCT01107938|Esomeprazole|esomeprazole|mesh-list
93083660|NCT01107938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93083661|NCT01107938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93083662|NCT01107938|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93083663|NCT01107938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083664|NCT01107938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083665|NCT02950558|Ropivacaine|ropivacaine|mesh-list
93083666|NCT02950558|Anesthetics, Local|anesthetics, local|mesh-ancestor
93083667|NCT02950558|Anesthetics|anesthetics|mesh-ancestor
93083668|NCT02950558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083669|NCT02950558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083670|NCT02950558|Sensory System Agents|sensory system agents|mesh-ancestor
93083671|NCT02950558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083672|NCT02791334|Ramucirumab|ramucirumab|mesh-list
93083673|NCT02791334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083674|NCT03945344|Tiotropium Bromide|tiotropium bromide|mesh-list
93083675|NCT03945344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93083676|NCT03945344|Autonomic Agents|autonomic agents|mesh-ancestor
93083677|NCT03945344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083678|NCT03945344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083679|NCT03945344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93083680|NCT03945344|Respiratory System Agents|respiratory system agents|mesh-ancestor
93083681|NCT03945344|Parasympatholytics|parasympatholytics|mesh-ancestor
93083682|NCT03945344|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93083683|NCT03945344|Cholinergic Agents|cholinergic agents|mesh-ancestor
93083684|NCT03945344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083685|NCT03945344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083686|NCT05497726|Bevacizumab|bevacizumab|mesh-list
93083687|NCT05497726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083688|NCT05497726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083689|NCT05497726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93083690|NCT05497726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93083691|NCT05497726|Growth Substances|growth substances|mesh-ancestor
93083692|NCT05497726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083693|NCT05497726|Growth Inhibitors|growth inhibitors|mesh-ancestor
93083694|NCT01209416|Acipimox|acipimox|mesh-list
93083695|NCT01209416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93083696|NCT01209416|Antimetabolites|antimetabolites|mesh-ancestor
93083697|NCT01209416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083698|NCT01209416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93083699|NCT00349349|Ofatumumab|ofatumumab|mesh-list
93083700|NCT00349349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083701|NCT01112462|Acetaminophen|acetaminophen|mesh-list
93083702|NCT01112462|Phenylephrine|phenylephrine|mesh-list
93083703|NCT01112462|Oxymetazoline|oxymetazoline|mesh-list
93083704|NCT01112462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93083705|NCT01112462|Analgesics|analgesics|mesh-ancestor
93083706|NCT01112462|Sensory System Agents|sensory system agents|mesh-ancestor
93083707|NCT01112462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083708|NCT01112462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083709|NCT01112462|Antipyretics|antipyretics|mesh-ancestor
93083710|NCT01112462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93083711|NCT01112462|Mydriatics|mydriatics|mesh-ancestor
93083712|NCT01112462|Autonomic Agents|autonomic agents|mesh-ancestor
93083713|NCT01112462|Sympathomimetics|sympathomimetics|mesh-ancestor
93083714|NCT01112462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93083715|NCT01112462|Nasal Decongestants|nasal decongestants|mesh-ancestor
93083716|NCT01112462|Respiratory System Agents|respiratory system agents|mesh-ancestor
93083717|NCT01112462|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93083718|NCT01112462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93083719|NCT01112462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93083720|NCT01112462|Adrenergic Agents|adrenergic agents|mesh-ancestor
93083721|NCT01112462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083722|NCT01112462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083723|NCT01112462|Protective Agents|protective agents|mesh-ancestor
93083724|NCT02950480|Zafirlukast|zafirlukast|mesh-list
93083725|NCT02950480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93083726|NCT02950480|Respiratory System Agents|respiratory system agents|mesh-ancestor
93083727|NCT02950480|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93083728|NCT02950480|Hormone Antagonists|hormone antagonists|mesh-ancestor
93083729|NCT02950480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083730|NCT02950480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083731|NCT01109030|Pioglitazone|pioglitazone|mesh-list
93083732|NCT01109030|Chlordiazepoxide|chlordiazepoxide|mesh-list
93083733|NCT01109030|Dexetimide|dexetimide|mesh-list
93083734|NCT01109030|Citalopram|citalopram|mesh-list
93083735|NCT01109030|Escitalopram|escitalopram|mesh-list
93083736|NCT01109030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083737|NCT01109030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083738|NCT01109030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93083739|NCT01109030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93083740|NCT01109030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93083741|NCT01109030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083742|NCT01109030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083743|NCT01109030|Serotonin Agents|serotonin agents|mesh-ancestor
93083744|NCT01109030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93083745|NCT01109030|Antidepressive Agents|antidepressive agents|mesh-ancestor
93083746|NCT01109030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93083747|NCT01109030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93083748|NCT01109030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93083749|NCT01109030|Parasympatholytics|parasympatholytics|mesh-ancestor
93083750|NCT01109030|Autonomic Agents|autonomic agents|mesh-ancestor
93083751|NCT01109030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083752|NCT01109030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93083753|NCT01109030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93083754|NCT01109030|Cholinergic Agents|cholinergic agents|mesh-ancestor
93083755|NCT01109030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93083756|NCT01109030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93083757|NCT01109030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083758|NCT01109030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93083759|NCT01109030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93083760|NCT01109030|GABA Modulators|gaba modulators|mesh-ancestor
93083761|NCT01109030|GABA Agents|gaba agents|mesh-ancestor
93083762|NCT05494528|Entecavir|entecavir|mesh-list
93083763|NCT05494528|Antiviral Agents|antiviral agents|mesh-ancestor
93083764|NCT05494528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083765|NCT03987815|Nivolumab|nivolumab|mesh-list
93083766|NCT03987815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083767|NCT03987815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083768|NCT03987815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93083769|NCT03987815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756040|NCT01258595|Vaccines|vaccines|mesh-list
93083770|NCT00348881|Vaccines|vaccines|mesh-list
93083771|NCT00348881|Immunologic Factors|immunologic factors|mesh-ancestor
93083772|NCT00348881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083773|NCT02257580|Aminocaproic Acid|aminocaproic acid|mesh-list
93083774|NCT02257580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93083775|NCT02257580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93083776|NCT02257580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083777|NCT02257580|Hemostatics|hemostatics|mesh-ancestor
93083778|NCT02257580|Coagulants|coagulants|mesh-ancestor
93083779|NCT01055795|Bevacizumab|bevacizumab|mesh-list
93083780|NCT01055795|Everolimus|everolimus|mesh-list
93083781|NCT01055795|Panobinostat|panobinostat|mesh-list
93083782|NCT01055795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083783|NCT01055795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083784|NCT01055795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93083785|NCT01055795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93083786|NCT01055795|Growth Substances|growth substances|mesh-ancestor
93083787|NCT01055795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083788|NCT01055795|Growth Inhibitors|growth inhibitors|mesh-ancestor
93083789|NCT01055795|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93083790|NCT01055795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93083791|NCT01055795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083792|NCT01055795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083793|NCT01055795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083794|NCT01055795|Immunologic Factors|immunologic factors|mesh-ancestor
93083795|NCT01055795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93083796|NCT03943784|Propranolol|propranolol|mesh-list
93083797|NCT03943784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93083798|NCT03943784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93083799|NCT03943784|Adrenergic Agents|adrenergic agents|mesh-ancestor
93083800|NCT03943784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93083801|NCT03943784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083802|NCT03943784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083803|NCT03943784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93083804|NCT03943784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93083805|NCT03943784|Vasodilator Agents|vasodilator agents|mesh-ancestor
93083806|NCT00347009|Adefovir|adefovir|mesh-list
93083807|NCT00347009|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93083808|NCT00347009|Antiviral Agents|antiviral agents|mesh-ancestor
93083809|NCT00347009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083810|NCT00347009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93083811|NCT00347009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93083812|NCT00347009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083813|NCT00347009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083814|NCT01209650|Afatinib|afatinib|mesh-list
93083815|NCT01209650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083816|NCT01209650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93083817|NCT01209650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083818|NCT01209650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083819|NCT01947140|Romidepsin|romidepsin|mesh-list
93083820|NCT01947140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93083821|NCT01947140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083822|NCT01947140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93083823|NCT01947140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083824|NCT01947140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083825|NCT00346775|Beclomethasone|beclomethasone|mesh-list
93083826|NCT00346775|Flunisolide|flunisolide|mesh-list
93083827|NCT00346775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083828|NCT00346775|Glucocorticoids|glucocorticoids|mesh-ancestor
93083829|NCT00346775|Hormones|hormones|mesh-ancestor
93083830|NCT00346775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083831|NCT00346775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083832|NCT00346775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93083833|NCT00346775|Respiratory System Agents|respiratory system agents|mesh-ancestor
93083834|NCT01108562|Lidocaine|lidocaine|mesh-list
93083835|NCT01108562|Anesthetics, Local|anesthetics, local|mesh-ancestor
93083836|NCT01108562|Anesthetics|anesthetics|mesh-ancestor
93083837|NCT01108562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083838|NCT01108562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083839|NCT01108562|Sensory System Agents|sensory system agents|mesh-ancestor
93083840|NCT01108562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083841|NCT01108562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93083842|NCT01108562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93083843|NCT01108562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93083844|NCT01108562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93083845|NCT01108562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083846|NCT01112540|Morphine|morphine|mesh-list
93083847|NCT01112540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93083848|NCT01112540|Narcotics|narcotics|mesh-ancestor
93083849|NCT01112540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083850|NCT01112540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083852|NCT01112540|Sensory System Agents|sensory system agents|mesh-ancestor
93083853|NCT01112540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083854|NCT03400852|Cosyntropin|cosyntropin|mesh-list
93083855|NCT03400852|Hormones|hormones|mesh-ancestor
93083856|NCT03400852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083857|NCT03400852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083858|NCT01056419|Propylthiouracil|propylthiouracil|mesh-list
93083859|NCT01056419|Antimetabolites|antimetabolites|mesh-ancestor
93083860|NCT01056419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083861|NCT01056419|Antithyroid Agents|antithyroid agents|mesh-ancestor
93083862|NCT01056419|Hormone Antagonists|hormone antagonists|mesh-ancestor
93083863|NCT01056419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083864|NCT01056419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083865|NCT01056497|Thioctic Acid|thioctic acid|mesh-list
93083866|NCT01056497|Antioxidants|antioxidants|mesh-ancestor
93083867|NCT01056497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083868|NCT01056497|Protective Agents|protective agents|mesh-ancestor
93083869|NCT01056497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083870|NCT01056497|Vitamin B Complex|vitamin b complex|mesh-ancestor
93083871|NCT01056497|Vitamins|vitamins|mesh-ancestor
93083872|NCT01056497|Micronutrients|micronutrients|mesh-ancestor
93083873|NCT03398356|Metformin|metformin|mesh-list
93083874|NCT03398356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083875|NCT03398356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083876|NCT00346151|Sirolimus|sirolimus|mesh-list
93083877|NCT00346151|Methylprednisolone|methylprednisolone|mesh-list
93083878|NCT00346151|Abatacept|abatacept|mesh-list
93083879|NCT00346151|Thymoglobulin|thymoglobulin|mesh-list
93083880|NCT00346151|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93083881|NCT00346151|Immunoglobulins|immunoglobulins|mesh-list
93083882|NCT00346151|Glucocorticoids|glucocorticoids|mesh-list
93083883|NCT00346151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083884|NCT00346151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083885|NCT00346151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93083886|NCT00346151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083887|NCT00346151|Antifungal Agents|antifungal agents|mesh-ancestor
93083888|NCT00346151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083889|NCT00346151|Immunologic Factors|immunologic factors|mesh-ancestor
93083890|NCT00346151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083891|NCT00346151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083892|NCT00346151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93083893|NCT00346151|Antiemetics|antiemetics|mesh-ancestor
93083894|NCT00346151|Autonomic Agents|autonomic agents|mesh-ancestor
93083895|NCT00346151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083896|NCT00346151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93083897|NCT00346151|Hormones|hormones|mesh-ancestor
93083898|NCT00346151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93083899|NCT00346151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93083900|NCT00346151|Protective Agents|protective agents|mesh-ancestor
93083901|NCT00346151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93083902|NCT00346151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083903|NCT00346151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083904|NCT03940976|Afatinib|afatinib|mesh-list
93083905|NCT03940976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083906|NCT03940976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93083907|NCT03940976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083908|NCT03940976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083909|NCT01109498|Cyclosporine|cyclosporine|mesh-list
93083910|NCT01109498|Mycophenolic Acid|mycophenolic acid|mesh-list
93083911|NCT01109498|Cyclosporins|cyclosporins|mesh-list
93083912|NCT01109498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083913|NCT01109498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083914|NCT01109498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083915|NCT01109498|Immunologic Factors|immunologic factors|mesh-ancestor
93083916|NCT01109498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083917|NCT01109498|Antifungal Agents|antifungal agents|mesh-ancestor
93083918|NCT01109498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083919|NCT01109498|Dermatologic Agents|dermatologic agents|mesh-ancestor
93083920|NCT01109498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083921|NCT01109498|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93083922|NCT01109498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93083923|NCT01109498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083924|NCT01109498|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93083925|NCT01109498|Antitubercular Agents|antitubercular agents|mesh-ancestor
93083926|NCT01109498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93083927|NCT00130286|Rosiglitazone|rosiglitazone|mesh-list
93083928|NCT00130286|Hormones|hormones|mesh-list
93083929|NCT00130286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674222|NCT00346359|Abortifacient Agents|abortifacient agents|mesh-ancestor
93083930|NCT00130286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083931|NCT00130286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93083932|NCT03940664|Formaldehyde|formaldehyde|mesh-list
93083933|NCT03940664|Disinfectants|disinfectants|mesh-ancestor
93083934|NCT03940664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083935|NCT01211834|Antirheumatic Agents|antirheumatic agents|mesh-list
93083936|NCT03941990|Nitrous Oxide|nitrous oxide|mesh-list
93083937|NCT03941990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93083938|NCT03941990|Anesthetics, General|anesthetics, general|mesh-ancestor
93083939|NCT03941990|Anesthetics|anesthetics|mesh-ancestor
93083940|NCT03941990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083941|NCT03941990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083942|NCT03941990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93083943|NCT03941990|Analgesics|analgesics|mesh-ancestor
93083944|NCT03941990|Sensory System Agents|sensory system agents|mesh-ancestor
93083945|NCT03941990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083946|NCT03374488|Pembrolizumab|pembrolizumab|mesh-list
93083947|NCT03374488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083948|NCT03374488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083949|NCT03374488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93083950|NCT03374488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083951|NCT01209728|Ethanol|ethanol|mesh-list
93083952|NCT01209728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93083953|NCT01209728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93083954|NCT01209728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93083955|NCT01209728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083956|NCT00076310|Cisplatin|cisplatin|mesh-list
93083957|NCT00076310|Docetaxel|docetaxel|mesh-list
93083958|NCT00076310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93083959|NCT00076310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083960|NCT00076310|Tubulin Modulators|tubulin modulators|mesh-ancestor
93083961|NCT00076310|Antimitotic Agents|antimitotic agents|mesh-ancestor
93083962|NCT00076310|Mitosis Modulators|mitosis modulators|mesh-ancestor
93083963|NCT00076310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083964|NCT00076310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93083965|NCT00076310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93083966|NCT00345683|Vaccines|vaccines|mesh-list
93083967|NCT00345683|Immunologic Factors|immunologic factors|mesh-ancestor
93083968|NCT00345683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083969|NCT01211912|Acetaminophen|acetaminophen|mesh-list
93083970|NCT01211912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93083971|NCT01211912|Analgesics|analgesics|mesh-ancestor
93083972|NCT01211912|Sensory System Agents|sensory system agents|mesh-ancestor
93083973|NCT01211912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93083974|NCT01211912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083975|NCT01211912|Antipyretics|antipyretics|mesh-ancestor
93083976|NCT03943472|Cyclophosphamide|cyclophosphamide|mesh-list
93083977|NCT03943472|Fludarabine|fludarabine|mesh-list
93083978|NCT03943472|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93083979|NCT03943472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93083980|NCT03943472|Immunologic Factors|immunologic factors|mesh-ancestor
93083981|NCT03943472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93083982|NCT03943472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93083983|NCT03943472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93083984|NCT03943472|Alkylating Agents|alkylating agents|mesh-ancestor
93083985|NCT03943472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083986|NCT03943472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93083987|NCT03943472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93083988|NCT03943472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93083989|NCT01114490|Anacetrapib|anacetrapib|mesh-list
93083990|NCT01114490|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93083991|NCT01114490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93083992|NCT01114490|Antimetabolites|antimetabolites|mesh-ancestor
93083993|NCT01114490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93083994|NCT01114490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93083995|NCT01209806|Simethicone|simethicone|mesh-list
93083996|NCT01209806|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
92756263|NCT01123395|Colchicine|colchicine|mesh-list
93083997|NCT01209806|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93083998|NCT01209806|Magnesium Hydroxide|magnesium hydroxide|mesh-list
93083999|NCT01209806|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
93084001|NCT01209806|Antifoaming Agents|antifoaming agents|mesh-ancestor
93084002|NCT01209806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084003|NCT01209806|Emollients|emollients|mesh-ancestor
93084004|NCT01209806|Dermatologic Agents|dermatologic agents|mesh-ancestor
93084005|NCT01209806|Antacids|antacids|mesh-ancestor
93084006|NCT01209806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084007|NCT01209806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93084008|NCT01209806|Immunologic Factors|immunologic factors|mesh-ancestor
93084009|NCT01209806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084010|NCT01209806|Antioxidants|antioxidants|mesh-ancestor
93084011|NCT01209806|Protective Agents|protective agents|mesh-ancestor
93084012|NCT01114568|Ertugliflozin|ertugliflozin|mesh-list
93084013|NCT01114568|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93084014|NCT01114568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084015|NCT01114568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93084016|NCT01114568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084017|NCT01109654|Cetrorelix|cetrorelix|mesh-list
93084018|NCT01109654|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93084019|NCT01109654|Hormones|hormones|mesh-ancestor
93084020|NCT01109654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084021|NCT01109654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084022|NCT01109654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93084023|NCT01109654|Fertility Agents|fertility agents|mesh-ancestor
93084024|NCT01109654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93084025|NCT01109654|Hormone Antagonists|hormone antagonists|mesh-ancestor
93084026|NCT01054001|Sildenafil Citrate|sildenafil citrate|mesh-list
93084027|NCT01054001|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084028|NCT01054001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93084029|NCT01054001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93084030|NCT01054001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084031|NCT01054001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084032|NCT01054001|Urological Agents|urological agents|mesh-ancestor
93084033|NCT01057355|Ethanol|ethanol|mesh-list
93084034|NCT01057355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93084035|NCT01057355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084036|NCT01057355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084037|NCT01057355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084038|NCT01057511|Progesterone|progesterone|mesh-list
93084039|NCT01057511|Progestins|progestins|mesh-ancestor
93084040|NCT01057511|Hormones|hormones|mesh-ancestor
93084041|NCT01057511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084042|NCT01057511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084043|NCT00345605|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93084044|NCT00345605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084045|NCT01210040|Folic Acid|folic acid|mesh-list
93084046|NCT01210040|Vitamin B Complex|vitamin b complex|mesh-list
93084047|NCT01210040|Hematinics|hematinics|mesh-ancestor
93084048|NCT01210040|Vitamins|vitamins|mesh-ancestor
93084049|NCT01210040|Micronutrients|micronutrients|mesh-ancestor
93084050|NCT01210040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084051|NCT01054313|Sirolimus|sirolimus|mesh-list
93084052|NCT01054313|Prednisone|prednisone|mesh-list
93084053|NCT01054313|Docetaxel|docetaxel|mesh-list
93084054|NCT01054313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084055|NCT01054313|Tubulin Modulators|tubulin modulators|mesh-ancestor
93084056|NCT01054313|Antimitotic Agents|antimitotic agents|mesh-ancestor
93084057|NCT01054313|Mitosis Modulators|mitosis modulators|mesh-ancestor
93084058|NCT01054313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084059|NCT01054313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084060|NCT01054313|Glucocorticoids|glucocorticoids|mesh-ancestor
93084061|NCT01054313|Hormones|hormones|mesh-ancestor
93084062|NCT01054313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084063|NCT01054313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084064|NCT01054313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93084065|NCT01054313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93084066|NCT01054313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084067|NCT01054313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93084068|NCT01054313|Antifungal Agents|antifungal agents|mesh-ancestor
93084069|NCT01054313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084070|NCT01054313|Immunologic Factors|immunologic factors|mesh-ancestor
93084071|NCT01114958|Cisplatin|cisplatin|mesh-list
93084072|NCT01114958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084073|NCT03742115|Dexamethasone|dexamethasone|mesh-list
93084074|NCT03742115|Etoposide|etoposide|mesh-list
93084075|NCT03742115|Etoposide phosphate|etoposide phosphate|mesh-list
93084076|NCT03742115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084077|NCT03742115|Antiemetics|antiemetics|mesh-ancestor
93084078|NCT03742115|Autonomic Agents|autonomic agents|mesh-ancestor
93084079|NCT03742115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084080|NCT03742115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084081|NCT03742115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084082|NCT03742115|Glucocorticoids|glucocorticoids|mesh-ancestor
93084083|NCT03742115|Hormones|hormones|mesh-ancestor
93084084|NCT03742115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084085|NCT03742115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93084086|NCT03742115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084087|NCT03742115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93084088|NCT03742115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93084089|NCT03742115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93084090|NCT03742115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084091|NCT03742115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084092|NCT01115036|Panobinostat|panobinostat|mesh-list
93084093|NCT01115036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084094|NCT01115036|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93084095|NCT01115036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084096|NCT01115036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084097|NCT01207622|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93084098|NCT01207622|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93084099|NCT01207622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93084100|NCT01207622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084101|NCT01207622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084102|NCT01207622|Adrenergic Agents|adrenergic agents|mesh-ancestor
93084103|NCT01207622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084104|NCT01207622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084105|NCT03942068|Paclitaxel|paclitaxel|mesh-list
93084106|NCT03942068|Apatinib|apatinib|mesh-list
93084107|NCT03942068|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93084108|NCT03942068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93084109|NCT03942068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084110|NCT03942068|Tubulin Modulators|tubulin modulators|mesh-ancestor
93084111|NCT03942068|Antimitotic Agents|antimitotic agents|mesh-ancestor
93084112|NCT03942068|Mitosis Modulators|mitosis modulators|mesh-ancestor
93084113|NCT03942068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084114|NCT03942068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93084115|NCT03942068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084116|NCT01112852|Terlipressin|terlipressin|mesh-list
93084117|NCT01112852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93084118|NCT01112852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93084119|NCT01112852|Somatostatin|somatostatin|mesh-list
93084120|NCT01112852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93084121|NCT01112852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084122|NCT01112852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084123|NCT01112852|Hormones|hormones|mesh-ancestor
93084124|NCT01112852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084125|NCT01112852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084126|NCT01054469|Ropivacaine|ropivacaine|mesh-list
93084127|NCT01054469|Anesthetics, Local|anesthetics, local|mesh-ancestor
93084128|NCT01054469|Anesthetics|anesthetics|mesh-ancestor
93084129|NCT01054469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084130|NCT01054469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084131|NCT01054469|Sensory System Agents|sensory system agents|mesh-ancestor
93084132|NCT01054469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084133|NCT03940430|Lactoferrin|lactoferrin|mesh-list
93084134|NCT03940430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084135|NCT00355121|Vaccines|vaccines|mesh-list
93084136|NCT00355121|Immunologic Factors|immunologic factors|mesh-ancestor
93084137|NCT00355121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084138|NCT02533349|Pantoprazole|pantoprazole|mesh-list
93084139|NCT02533349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93084140|NCT02533349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084141|NCT02533349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93084142|NCT02533349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084143|NCT02533349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084144|NCT01115426|Losartan|losartan|mesh-list
93084145|NCT01115426|Ramipril|ramipril|mesh-list
93084146|NCT01115426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93084147|NCT01115426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93084148|NCT01115426|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93084149|NCT01115426|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93084150|NCT01115426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084151|NCT01115426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93084152|NCT01115426|Protease Inhibitors|protease inhibitors|mesh-ancestor
93084153|NCT01115426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084155|NCT03942458|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93084156|NCT03942458|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93084157|NCT03942458|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93084158|NCT03942458|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93084159|NCT03942458|Purinergic Agents|purinergic agents|mesh-ancestor
93084160|NCT03942458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084161|NCT03942458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084162|NCT03942458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084163|NCT01115504|Thiamine|thiamine|mesh-list
93084164|NCT01115504|Vitamin B Complex|vitamin b complex|mesh-ancestor
93084165|NCT01115504|Vitamins|vitamins|mesh-ancestor
93084166|NCT01115504|Micronutrients|micronutrients|mesh-ancestor
93084167|NCT01115504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084168|NCT00343889|Vaccines|vaccines|mesh-list
93084169|NCT00343889|Immunologic Factors|immunologic factors|mesh-ancestor
93084170|NCT00343889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084171|NCT03939884|Diclofenac|diclofenac|mesh-list
93084172|NCT03939884|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93084173|NCT03939884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93084174|NCT03939884|Analgesics|analgesics|mesh-ancestor
93084175|NCT03939884|Sensory System Agents|sensory system agents|mesh-ancestor
93084176|NCT03939884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084177|NCT03939884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084178|NCT03939884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084179|NCT03939884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084180|NCT03939884|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93084181|NCT03939884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084182|NCT03939884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084183|NCT01054547|Anesthetics|anesthetics|mesh-list
93084184|NCT01054547|Ropivacaine|ropivacaine|mesh-list
93084185|NCT01054547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084186|NCT01054547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084187|NCT01054547|Anesthetics, Local|anesthetics, local|mesh-ancestor
93084188|NCT01054547|Sensory System Agents|sensory system agents|mesh-ancestor
93084189|NCT01054547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084190|NCT01115894|Naltrexone|naltrexone|mesh-list
93084191|NCT01115894|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93084192|NCT01115894|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93084193|NCT01115894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084194|NCT01115894|Sensory System Agents|sensory system agents|mesh-ancestor
93084195|NCT01115894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084196|NCT01115972|Valsartan|valsartan|mesh-list
93084197|NCT01115972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93084198|NCT01115972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93084199|NCT01115972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93084200|NCT01115972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084201|NCT01116050|Misoprostol|misoprostol|mesh-list
93084202|NCT01116050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93084203|NCT01116050|Abortifacient Agents|abortifacient agents|mesh-ancestor
93084204|NCT01116050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93084205|NCT01116050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084206|NCT01116050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93084207|NCT01116050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084208|NCT01116050|Oxytocics|oxytocics|mesh-ancestor
93084209|NCT01054781|Rituximab|rituximab|mesh-list
93084210|NCT01054781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93084211|NCT01054781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084212|NCT01054781|Immunologic Factors|immunologic factors|mesh-ancestor
93084213|NCT01054781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084214|NCT01054781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084215|NCT05282290|Antihypertensive Agents|antihypertensive agents|mesh-list
93084216|NCT01311778|Fentanyl|fentanyl|mesh-list
93084217|NCT01311778|Cannabidiol|cannabidiol|mesh-list
93084218|NCT01311778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93084219|NCT01311778|Narcotics|narcotics|mesh-ancestor
93084220|NCT01311778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084221|NCT01311778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084222|NCT01311778|Analgesics|analgesics|mesh-ancestor
93084223|NCT01311778|Sensory System Agents|sensory system agents|mesh-ancestor
93084224|NCT01311778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084225|NCT01311778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93084226|NCT01311778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93084227|NCT01311778|Anesthetics, General|anesthetics, general|mesh-ancestor
93084228|NCT01311778|Anesthetics|anesthetics|mesh-ancestor
93084229|NCT01311778|Anticonvulsants|anticonvulsants|mesh-ancestor
93084230|NCT00354341|Epoetin Alfa|epoetin alfa|mesh-list
93084231|NCT00354341|Hematinics|hematinics|mesh-ancestor
93084232|NCT03708718|Prednisolone|prednisolone|mesh-list
93084233|NCT03708718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084234|NCT03708718|Glucocorticoids|glucocorticoids|mesh-ancestor
93084235|NCT03708718|Hormones|hormones|mesh-ancestor
93084236|NCT03708718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084237|NCT03708718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084238|NCT03708718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93084239|NCT03708718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084240|NCT00354107|Cytarabine|cytarabine|mesh-list
93084241|NCT00354107|Hydrocortisone|hydrocortisone|mesh-list
93084242|NCT00354107|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93084243|NCT00354107|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93084244|NCT00354107|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93084245|NCT00354107|Carboplatin|carboplatin|mesh-list
93084246|NCT00354107|Methotrexate|methotrexate|mesh-list
93084247|NCT00354107|Etoposide|etoposide|mesh-list
93084248|NCT00354107|Etoposide phosphate|etoposide phosphate|mesh-list
93084249|NCT00354107|Ifosfamide|ifosfamide|mesh-list
93084250|NCT00354107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93084251|NCT00354107|Antibodies|antibodies|mesh-list
93084252|NCT00354107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93084253|NCT00354107|Immunologic Factors|immunologic factors|mesh-ancestor
93084254|NCT00354107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084255|NCT00354107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084256|NCT00354107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93084257|NCT00354107|Abortifacient Agents|abortifacient agents|mesh-ancestor
93084258|NCT00354107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93084259|NCT00354107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93084260|NCT00354107|Antimetabolites|antimetabolites|mesh-ancestor
93084261|NCT00354107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084262|NCT00354107|Dermatologic Agents|dermatologic agents|mesh-ancestor
93084263|NCT00354107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084264|NCT00354107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93084265|NCT00354107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084266|NCT00354107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084267|NCT00354107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93084268|NCT00354107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93084269|NCT00354107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93084270|NCT00354107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93084271|NCT00354107|Antiviral Agents|antiviral agents|mesh-ancestor
93084272|NCT00354107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084273|NCT00354107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084274|NCT00354107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93084275|NCT00354107|Alkylating Agents|alkylating agents|mesh-ancestor
93084276|NCT00354107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93084277|NCT00354107|Immunotoxins|immunotoxins|mesh-ancestor
93084278|NCT00354107|Immunoconjugates|immunoconjugates|mesh-ancestor
93084279|NCT00354029|Ketamine|ketamine|mesh-list
93084280|NCT00354029|Analgesics|analgesics|mesh-ancestor
93084281|NCT00354029|Sensory System Agents|sensory system agents|mesh-ancestor
93084282|NCT00354029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084283|NCT00354029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084284|NCT00354029|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93084285|NCT00354029|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93084286|NCT00354029|Anesthetics, General|anesthetics, general|mesh-ancestor
93084287|NCT00354029|Anesthetics|anesthetics|mesh-ancestor
93084288|NCT00354029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084289|NCT00354029|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93084290|NCT00354029|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93084291|NCT00354029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084292|NCT00354029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084293|NCT00353873|Fluticasone|fluticasone|mesh-list
93084294|NCT00353873|Xhance|xhance|mesh-list
93084295|NCT00353873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93084296|NCT00353873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084297|NCT00353873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93084298|NCT00353873|Autonomic Agents|autonomic agents|mesh-ancestor
93084299|NCT00353873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084300|NCT00353873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084301|NCT00353873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93084302|NCT00353873|Respiratory System Agents|respiratory system agents|mesh-ancestor
93084303|NCT00353873|Dermatologic Agents|dermatologic agents|mesh-ancestor
93084304|NCT00353873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93084305|NCT00353873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93084306|NCT00353873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93084307|NCT00353873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93084308|NCT00353873|Adrenergic Agents|adrenergic agents|mesh-ancestor
93084309|NCT00353873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084310|NCT00353873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084311|NCT01058057|Atorvastatin|atorvastatin|mesh-list
93084312|NCT01058057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93084313|NCT01058057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93084314|NCT01058057|Antimetabolites|antimetabolites|mesh-ancestor
93084315|NCT01058057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084316|NCT01058057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93084317|NCT01058057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93084318|NCT01058057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084319|NCT03796676|Abrocitinib|abrocitinib|mesh-list
93084320|NCT03796676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93084321|NCT03796676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084322|NCT03796676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084323|NCT00339833|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
93084324|NCT00339833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93084325|NCT00339833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93084326|NCT00339833|Analgesics|analgesics|mesh-ancestor
93084327|NCT00339833|Sensory System Agents|sensory system agents|mesh-ancestor
93084328|NCT00339833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084329|NCT00339833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084330|NCT00339833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084331|NCT00339833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084332|NCT01058291|Apomorphine|apomorphine|mesh-list
93084333|NCT01058291|Emetics|emetics|mesh-ancestor
93084334|NCT01058291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084335|NCT01058291|Autonomic Agents|autonomic agents|mesh-ancestor
93084336|NCT01058291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084337|NCT01058291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084338|NCT01058291|Dopamine Agonists|dopamine agonists|mesh-ancestor
93084339|NCT01058291|Dopamine Agents|dopamine agents|mesh-ancestor
93084340|NCT01058291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084341|NCT01058291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084342|NCT01055249|Ibuprofen|ibuprofen|mesh-list
93084343|NCT01055249|Hydrocortisone|hydrocortisone|mesh-list
93084344|NCT01055249|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93084345|NCT01055249|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93084346|NCT01055249|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93084347|NCT01055249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93084348|NCT01055249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93084349|NCT01055249|Analgesics|analgesics|mesh-ancestor
93084350|NCT01055249|Sensory System Agents|sensory system agents|mesh-ancestor
93084351|NCT01055249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084352|NCT01055249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084353|NCT01055249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084354|NCT01055249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084355|NCT01055249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93084356|NCT01055249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084357|NCT01055249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084358|NCT01055327|Lamotrigine|lamotrigine|mesh-list
93084359|NCT01055327|Anticonvulsants|anticonvulsants|mesh-list
93084360|NCT01055327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93084361|NCT01055327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084362|NCT01055327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084363|NCT01055327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93084364|NCT01055327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084365|NCT01055327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93084366|NCT01055327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93084367|NCT01055327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084368|NCT01055327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084369|NCT01055327|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93084370|NCT03793556|Omeprazole|omeprazole|mesh-list
93084371|NCT03793556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93084372|NCT03793556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084373|NCT03793556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93084374|NCT03793556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084375|NCT03793556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084376|NCT01113164|Ondansetron|ondansetron|mesh-list
93084377|NCT01113164|Sertraline|sertraline|mesh-list
93084378|NCT01113164|Antiemetics|antiemetics|mesh-ancestor
93084379|NCT01113164|Autonomic Agents|autonomic agents|mesh-ancestor
93084380|NCT01113164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084381|NCT01113164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084382|NCT01113164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084383|NCT01113164|Antipruritics|antipruritics|mesh-ancestor
93084384|NCT01113164|Dermatologic Agents|dermatologic agents|mesh-ancestor
93084385|NCT01113164|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93084386|NCT01113164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93084387|NCT01113164|Serotonin Agents|serotonin agents|mesh-ancestor
93084388|NCT01113164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674684|NCT00331305|Serotonin Agents|serotonin agents|mesh-ancestor
93084389|NCT01113164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084390|NCT01113164|Antidepressive Agents|antidepressive agents|mesh-ancestor
93084391|NCT01113164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084392|NCT01113164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93084393|NCT01113164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93084394|NCT01113164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084395|NCT01210430|Vitamins|vitamins|mesh-list
93084396|NCT01210430|Ascorbic Acid|ascorbic acid|mesh-list
93084397|NCT01210430|Losartan|losartan|mesh-list
93084398|NCT01210430|Micronutrients|micronutrients|mesh-ancestor
93084399|NCT01210430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084400|NCT01210430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93084401|NCT01210430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93084402|NCT01210430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93084403|NCT01210430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93084404|NCT01210430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084405|NCT01210430|Antioxidants|antioxidants|mesh-ancestor
93084406|NCT01210430|Protective Agents|protective agents|mesh-ancestor
93084407|NCT01210742|Hylan|hylan|mesh-list
93084408|NCT01210742|Viscosupplements|viscosupplements|mesh-ancestor
93084409|NCT01210742|Protective Agents|protective agents|mesh-ancestor
93084410|NCT01210742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084411|NCT01116128|Prednisone|prednisone|mesh-list
93084412|NCT01116128|Melphalan|melphalan|mesh-list
93084413|NCT01116128|Dasatinib|dasatinib|mesh-list
93084414|NCT01116128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084415|NCT01116128|Glucocorticoids|glucocorticoids|mesh-ancestor
93084416|NCT01116128|Hormones|hormones|mesh-ancestor
93084417|NCT01116128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084418|NCT01116128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084419|NCT01116128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93084420|NCT01116128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084421|NCT01116128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93084422|NCT01116128|Alkylating Agents|alkylating agents|mesh-ancestor
93084423|NCT01116128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084424|NCT01116128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93084425|NCT01116128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084426|NCT01116128|Immunologic Factors|immunologic factors|mesh-ancestor
93084427|NCT01116128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93084428|NCT01116128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084429|NCT03390166|Vaccines|vaccines|mesh-list
93084430|NCT03390166|Immunologic Factors|immunologic factors|mesh-ancestor
93084431|NCT03390166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084432|NCT01116206|Prucalopride|prucalopride|mesh-list
93084433|NCT01116206|Laxatives|laxatives|mesh-ancestor
93084434|NCT01116206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084435|NCT01116206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93084436|NCT01116206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93084437|NCT01116206|Serotonin Agents|serotonin agents|mesh-ancestor
93084438|NCT01116206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084439|NCT01116206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084440|NCT01116206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084441|NCT01210976|Simendan|simendan|mesh-list
93084442|NCT01210976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93084443|NCT01210976|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084444|NCT01210976|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93084445|NCT01210976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93084446|NCT01210976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084447|NCT01210976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084448|NCT01210976|Protective Agents|protective agents|mesh-ancestor
93084449|NCT01210976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084450|NCT03828539|Topiramate|topiramate|mesh-list
93084451|NCT03828539|Erenumab|erenumab|mesh-list
93084452|NCT03828539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93084453|NCT03828539|Anticonvulsants|anticonvulsants|mesh-ancestor
93084454|NCT03828539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93084455|NCT03828539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084456|NCT03828539|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93084457|NCT03828539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084458|NCT03828539|Analgesics|analgesics|mesh-ancestor
93084459|NCT03828539|Sensory System Agents|sensory system agents|mesh-ancestor
93084460|NCT03828539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084461|NCT03828539|Immunologic Factors|immunologic factors|mesh-ancestor
93084462|NCT01109888|Cetrorelix|cetrorelix|mesh-list
93084463|NCT01109888|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93084464|NCT01109888|Fertility Agents|fertility agents|mesh-ancestor
93084465|NCT01109888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93084466|NCT01109888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084467|NCT01109888|Hormone Antagonists|hormone antagonists|mesh-ancestor
93084468|NCT01109888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084469|NCT03336502|Posaconazole|posaconazole|mesh-list
93084470|NCT03336502|Antifungal Agents|antifungal agents|mesh-ancestor
93084471|NCT03336502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084472|NCT03336502|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93084473|NCT03336502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93084474|NCT03336502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93084475|NCT03336502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93084476|NCT03336502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93084477|NCT03336502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084478|NCT03336502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084479|NCT03336502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93084480|NCT03336502|Hormone Antagonists|hormone antagonists|mesh-ancestor
93084481|NCT03336502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084482|NCT03336502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084483|NCT01325051|Raltegravir Potassium|raltegravir potassium|mesh-list
93084484|NCT01325051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93084485|NCT01325051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93084486|NCT01325051|Antiviral Agents|antiviral agents|mesh-ancestor
93084487|NCT01325051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084488|NCT01325051|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93084489|NCT01325051|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93084490|NCT01325051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084491|NCT01325051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084492|NCT01055405|Sildenafil Citrate|sildenafil citrate|mesh-list
93084493|NCT01055405|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084494|NCT01055405|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93084495|NCT01055405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93084496|NCT01055405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084497|NCT01055405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084498|NCT01055405|Urological Agents|urological agents|mesh-ancestor
93084499|NCT01055483|Panobinostat|panobinostat|mesh-list
93084500|NCT01055483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084501|NCT01055483|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93084502|NCT01055483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084503|NCT01055483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084504|NCT03370510|Oxytocin|oxytocin|mesh-list
93084505|NCT03370510|Oxytocics|oxytocics|mesh-ancestor
93084506|NCT03370510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93084507|NCT03370510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084508|NCT03985865|Quinine|quinine|mesh-list
93084509|NCT03985865|Denatonium|denatonium|mesh-list
93084510|NCT03985865|Antimalarials|antimalarials|mesh-ancestor
93084511|NCT03985865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93084512|NCT03985865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93084513|NCT03985865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084514|NCT03985865|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93084515|NCT03985865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084516|NCT03985865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93084517|NCT03985865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084518|NCT03985865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93084519|NCT03985865|Analgesics|analgesics|mesh-ancestor
93084520|NCT03985865|Sensory System Agents|sensory system agents|mesh-ancestor
93084521|NCT03985865|Aversive Agents|aversive agents|mesh-ancestor
93084522|NCT03985865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084523|NCT03985865|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
93084524|NCT01116596|Acetaminophen|acetaminophen|mesh-list
93084525|NCT01116596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93084526|NCT01116596|Analgesics|analgesics|mesh-ancestor
93084527|NCT01116596|Sensory System Agents|sensory system agents|mesh-ancestor
93084528|NCT01116596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084529|NCT01116596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084530|NCT01116596|Antipyretics|antipyretics|mesh-ancestor
93084531|NCT00351611|Pregabalin|pregabalin|mesh-list
93084532|NCT00351611|Analgesics|analgesics|mesh-ancestor
93084533|NCT00351611|Sensory System Agents|sensory system agents|mesh-ancestor
93084534|NCT00351611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084535|NCT00351611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084536|NCT00351611|Anticonvulsants|anticonvulsants|mesh-ancestor
93084537|NCT00351611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93084538|NCT00351611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084539|NCT00351611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084540|NCT00351611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93084541|NCT00351611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93084542|NCT00351611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93084543|NCT00351611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084544|NCT00351611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084545|NCT01211210|Fluorouracil|fluorouracil|mesh-list
93084546|NCT01211210|Oxaliplatin|oxaliplatin|mesh-list
93084547|NCT01211210|Antimetabolites|antimetabolites|mesh-ancestor
93084548|NCT01211210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084549|NCT01211210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93084550|NCT01211210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084551|NCT01211210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084552|NCT01211210|Immunologic Factors|immunologic factors|mesh-ancestor
93084553|NCT01211210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084554|NCT01116830|Antipsychotic Agents|antipsychotic agents|mesh-list
93084555|NCT01116830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93084556|NCT01116830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084557|NCT01116830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084558|NCT01116830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084559|NCT01208012|Liraglutide|liraglutide|mesh-list
93084560|NCT01208012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93084561|NCT01208012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084562|NCT01208012|Incretins|incretins|mesh-ancestor
93084563|NCT01208012|Hormones|hormones|mesh-ancestor
93084564|NCT01208012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084565|NCT03939806|Oxytocin|oxytocin|mesh-list
93084566|NCT03939806|Carbetocin|carbetocin|mesh-list
93084567|NCT03939806|Oxytocics|oxytocics|mesh-ancestor
93084568|NCT03939806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93084569|NCT03939806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084570|NCT00351377|Mycophenolic Acid|mycophenolic acid|mesh-list
93084571|NCT00351377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93084572|NCT00351377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084573|NCT00351377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93084574|NCT00351377|Antitubercular Agents|antitubercular agents|mesh-ancestor
93084575|NCT00351377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93084576|NCT00351377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084577|NCT00351377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084578|NCT00351377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084579|NCT00337727|Dexamethasone|dexamethasone|mesh-list
93084580|NCT00337727|Dexamethasone acetate|dexamethasone acetate|mesh-list
93084581|NCT00337727|Ondansetron|ondansetron|mesh-list
93084582|NCT00337727|Aprepitant|aprepitant|mesh-list
93084583|NCT00337727|Fosaprepitant|fosaprepitant|mesh-list
93084584|NCT00337727|BB 1101|bb 1101|mesh-list
93084585|NCT00337727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084586|NCT00337727|Antiemetics|antiemetics|mesh-ancestor
93084587|NCT00337727|Autonomic Agents|autonomic agents|mesh-ancestor
93084588|NCT00337727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084589|NCT00337727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084590|NCT00337727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084591|NCT00337727|Glucocorticoids|glucocorticoids|mesh-ancestor
93084592|NCT00337727|Hormones|hormones|mesh-ancestor
93084593|NCT00337727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93084594|NCT00337727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93084595|NCT00337727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084596|NCT00337727|Protease Inhibitors|protease inhibitors|mesh-ancestor
92756866|NCT02888990|Dasatinib|dasatinib|mesh-list
93084597|NCT00337727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084598|NCT00337727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084599|NCT00337727|Antipruritics|antipruritics|mesh-ancestor
93084600|NCT00337727|Dermatologic Agents|dermatologic agents|mesh-ancestor
93084601|NCT00337727|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93084602|NCT00337727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93084603|NCT00337727|Serotonin Agents|serotonin agents|mesh-ancestor
93084604|NCT00337727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084605|NCT00337727|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93084606|NCT03987893|Lactulose|lactulose|mesh-list
93084607|NCT03987893|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93084608|NCT03987893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084609|NCT03987893|Laxatives|laxatives|mesh-ancestor
93084610|NCT01208480|Carboplatin|carboplatin|mesh-list
93084611|NCT01208480|Docetaxel|docetaxel|mesh-list
93084612|NCT01208480|Bevacizumab|bevacizumab|mesh-list
93084613|NCT01208480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084614|NCT01208480|Tubulin Modulators|tubulin modulators|mesh-ancestor
93084615|NCT01208480|Antimitotic Agents|antimitotic agents|mesh-ancestor
93084616|NCT01208480|Mitosis Modulators|mitosis modulators|mesh-ancestor
93084617|NCT01208480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084618|NCT01208480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93084619|NCT01208480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93084620|NCT01208480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93084621|NCT01208480|Growth Substances|growth substances|mesh-ancestor
93084622|NCT01208480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084623|NCT01208480|Growth Inhibitors|growth inhibitors|mesh-ancestor
93084624|NCT04774120|Propofol|propofol|mesh-list
93084625|NCT04774120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93084626|NCT04774120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084627|NCT04774120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084628|NCT04774120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93084629|NCT04774120|Anesthetics, General|anesthetics, general|mesh-ancestor
93084630|NCT04774120|Anesthetics|anesthetics|mesh-ancestor
93084631|NCT01117220|Ziprasidone|ziprasidone|mesh-list
93084632|NCT01117220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93084633|NCT01117220|Serotonin Agents|serotonin agents|mesh-ancestor
93084634|NCT01117220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084635|NCT01117220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084636|NCT01117220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084637|NCT01117220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93084638|NCT01117220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93084639|NCT01117220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084640|NCT01117220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084641|NCT01117220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93084642|NCT01117220|Dopamine Agents|dopamine agents|mesh-ancestor
93084643|NCT05236972|Capecitabine|capecitabine|mesh-list
93084644|NCT05236972|Oxaliplatin|oxaliplatin|mesh-list
93084645|NCT05236972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93084646|NCT05236972|Antimetabolites|antimetabolites|mesh-ancestor
93084647|NCT05236972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084648|NCT05236972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084649|NCT01114100|Sertraline|sertraline|mesh-list
93084650|NCT01114100|Antidepressive Agents|antidepressive agents|mesh-ancestor
93084651|NCT01114100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084652|NCT01114100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93084653|NCT01114100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93084654|NCT01114100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084655|NCT01114100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084656|NCT01114100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084657|NCT01114100|Serotonin Agents|serotonin agents|mesh-ancestor
93084658|NCT01114100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084659|NCT01110590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93084660|NCT01110590|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084661|NCT01110590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93084662|NCT01110590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93084663|NCT01110590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084664|NCT01110590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084665|NCT01110590|Urological Agents|urological agents|mesh-ancestor
93084666|NCT01117298|Tadalafil|tadalafil|mesh-list
93084667|NCT01117298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92756951|NCT02867020|Prednisone|prednisone|mesh-list
93084668|NCT01117298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93084669|NCT01117298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93084670|NCT01117298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084671|NCT01117298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084672|NCT01117298|Urological Agents|urological agents|mesh-ancestor
93084673|NCT01117376|Erythromycin|erythromycin|mesh-list
93084674|NCT01117376|Erythromycin Estolate|erythromycin estolate|mesh-list
93084675|NCT01117376|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92674993|NCT00332085|Chromium|chromium|mesh-list
93084676|NCT01117376|Erythromycin stearate|erythromycin stearate|mesh-list
93084677|NCT01117376|Methylnaltrexone|methylnaltrexone|mesh-list
93084678|NCT01117376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93084679|NCT01117376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084680|NCT01117376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084681|NCT01117376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93084682|NCT01117376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084683|NCT01117376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084684|NCT01117376|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93084685|NCT01117376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084686|NCT01117376|Sensory System Agents|sensory system agents|mesh-ancestor
93084687|NCT01117376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084688|NCT01213238|Bevacizumab|bevacizumab|mesh-list
93084689|NCT01213238|Capecitabine|capecitabine|mesh-list
93084690|NCT01213238|Oxaliplatin|oxaliplatin|mesh-list
93084691|NCT01213238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93084692|NCT01213238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084693|NCT01213238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93084694|NCT01213238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93084695|NCT01213238|Growth Substances|growth substances|mesh-ancestor
93084696|NCT01213238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084697|NCT01213238|Growth Inhibitors|growth inhibitors|mesh-ancestor
93084698|NCT01213238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93084699|NCT01213238|Antimetabolites|antimetabolites|mesh-ancestor
93084700|NCT01213238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084701|NCT01110824|Carvedilol|carvedilol|mesh-list
93084702|NCT01110824|Enalapril|enalapril|mesh-list
93084703|NCT01110824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93084704|NCT01110824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93084705|NCT01110824|Adrenergic Agents|adrenergic agents|mesh-ancestor
93084706|NCT01110824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084707|NCT01110824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084708|NCT01110824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084709|NCT01110824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93084710|NCT01110824|Antioxidants|antioxidants|mesh-ancestor
93084711|NCT01110824|Protective Agents|protective agents|mesh-ancestor
93084712|NCT01110824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93084713|NCT01110824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084714|NCT01110824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93084715|NCT01110824|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084716|NCT01110824|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93084717|NCT01110824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93084718|NCT01110824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93084719|NCT01110824|Protease Inhibitors|protease inhibitors|mesh-ancestor
93084720|NCT01110824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084721|NCT03936140|Iloprost|iloprost|mesh-list
93084722|NCT03936140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93084723|NCT03936140|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084724|NCT01117610|Ropivacaine|ropivacaine|mesh-list
93084725|NCT01117610|Anesthetics, Local|anesthetics, local|mesh-ancestor
93084726|NCT01117610|Anesthetics|anesthetics|mesh-ancestor
93084727|NCT01117610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084728|NCT01117610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084729|NCT01117610|Sensory System Agents|sensory system agents|mesh-ancestor
93084730|NCT01117610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084731|NCT01215890|Risedronic Acid|risedronic acid|mesh-list
93084732|NCT01215890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93084733|NCT01215890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084734|NCT01215890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084735|NCT01215890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93084736|NCT01215890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084737|NCT01215890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93084738|NCT01213394|Mycophenolic Acid|mycophenolic acid|mesh-list
93084739|NCT01213394|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93084740|NCT01213394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084741|NCT01213394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93084742|NCT01213394|Antitubercular Agents|antitubercular agents|mesh-ancestor
93084743|NCT01213394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93084744|NCT01213394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084745|NCT01213394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084746|NCT01213394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084747|NCT03368170|Mesdopetam|mesdopetam|mesh-list
93084748|NCT03368170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93084749|NCT03368170|Dopamine Agents|dopamine agents|mesh-ancestor
93084750|NCT03368170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084751|NCT03368170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084752|NCT03368170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084753|NCT01121744|Sirolimus|sirolimus|mesh-list
93084754|NCT01121744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93084755|NCT01121744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084756|NCT01121744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93084757|NCT01121744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084758|NCT01121744|Antifungal Agents|antifungal agents|mesh-ancestor
93084759|NCT01121744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084760|NCT01121744|Immunologic Factors|immunologic factors|mesh-ancestor
93084761|NCT01121744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084762|NCT01121822|Vaccines|vaccines|mesh-list
93084763|NCT01121822|Immunologic Factors|immunologic factors|mesh-ancestor
93084764|NCT01121822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084765|NCT01213550|Chlorhexidine|chlorhexidine|mesh-list
93084766|NCT01213550|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93084767|NCT01213550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93084768|NCT01213550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084769|NCT01213550|Disinfectants|disinfectants|mesh-ancestor
93084770|NCT01213550|Dermatologic Agents|dermatologic agents|mesh-ancestor
93084771|NCT01213784|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93084772|NCT01213784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084773|NCT01216046|Ivacaftor|ivacaftor|mesh-list
93084774|NCT01216046|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93084775|NCT01216046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084776|NCT01216046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084777|NCT01216124|Docetaxel|docetaxel|mesh-list
93084778|NCT01216124|Oxaliplatin|oxaliplatin|mesh-list
93084779|NCT01216124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084780|NCT01216124|Tubulin Modulators|tubulin modulators|mesh-ancestor
93084781|NCT01216124|Antimitotic Agents|antimitotic agents|mesh-ancestor
93084782|NCT01216124|Mitosis Modulators|mitosis modulators|mesh-ancestor
93084783|NCT01216124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084784|NCT01219010|Siltuximab|siltuximab|mesh-list
93084785|NCT01219010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084786|NCT01118234|Rituximab|rituximab|mesh-list
93084787|NCT01118234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93084788|NCT01118234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084789|NCT01118234|Immunologic Factors|immunologic factors|mesh-ancestor
93084790|NCT01118234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084791|NCT01118234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084792|NCT00324155|Ipilimumab|ipilimumab|mesh-list
93084793|NCT00324155|Dacarbazine|dacarbazine|mesh-list
93084794|NCT00324155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93084795|NCT00324155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084796|NCT00324155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93084797|NCT00324155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084798|NCT00324155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93084799|NCT00324155|Alkylating Agents|alkylating agents|mesh-ancestor
93084800|NCT03937544|Cyclophosphamide|cyclophosphamide|mesh-list
93084801|NCT03937544|Fludarabine|fludarabine|mesh-list
93084802|NCT03937544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084803|NCT03937544|Immunologic Factors|immunologic factors|mesh-ancestor
93084804|NCT03937544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084805|NCT03937544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084806|NCT03937544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93084807|NCT03937544|Alkylating Agents|alkylating agents|mesh-ancestor
93084808|NCT03937544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084809|NCT03937544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084810|NCT03937544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93084811|NCT01122056|Interferons|interferons|mesh-list
93084812|NCT01122056|Interferon beta-1b|interferon beta-1b|mesh-list
93084813|NCT01122056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084814|NCT01122056|Antiviral Agents|antiviral agents|mesh-ancestor
93084815|NCT01122056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084816|NCT01122056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93084817|NCT01122056|Immunologic Factors|immunologic factors|mesh-ancestor
93084818|NCT01122056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084819|NCT01219088|Morphine|morphine|mesh-list
92675121|NCT00325286|Carbamazepine|carbamazepine|mesh-list
93084821|NCT01219088|Anesthetics, Local|anesthetics, local|mesh-ancestor
93084822|NCT01219088|Anesthetics|anesthetics|mesh-ancestor
93084823|NCT01219088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084824|NCT01219088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084825|NCT01219088|Sensory System Agents|sensory system agents|mesh-ancestor
93084826|NCT01219088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084827|NCT01219088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93084828|NCT01219088|Narcotics|narcotics|mesh-ancestor
93084829|NCT01219088|Analgesics|analgesics|mesh-ancestor
93084830|NCT01122134|Artesunate|artesunate|mesh-list
93084831|NCT01122134|Antimalarials|antimalarials|mesh-ancestor
93084832|NCT01122134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93084833|NCT01122134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93084834|NCT01122134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084835|NCT01122134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084836|NCT01122134|Antiviral Agents|antiviral agents|mesh-ancestor
93084837|NCT01122134|Schistosomicides|schistosomicides|mesh-ancestor
93084838|NCT01122134|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93084839|NCT01122134|Anthelmintics|anthelmintics|mesh-ancestor
93084840|NCT01118702|Methylphenidate|methylphenidate|mesh-list
93084841|NCT01118702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93084842|NCT01118702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084843|NCT01118702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93084844|NCT01118702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93084845|NCT01118702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084846|NCT01118702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084847|NCT01118702|Dopamine Agents|dopamine agents|mesh-ancestor
93084848|NCT01118702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084849|NCT01118936|Magnesium Hydroxide|magnesium hydroxide|mesh-list
93084850|NCT01118936|Antacids|antacids|mesh-ancestor
93084851|NCT01118936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084852|NCT01118936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084853|NCT01119014|Aripiprazole|aripiprazole|mesh-list
93084854|NCT01119014|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93084855|NCT01119014|Antidepressive Agents|antidepressive agents|mesh-ancestor
93084856|NCT01119014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084857|NCT01119014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93084858|NCT01119014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93084859|NCT01119014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084860|NCT01119014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084861|NCT01119014|Dopamine Agonists|dopamine agonists|mesh-ancestor
93084862|NCT01119014|Dopamine Agents|dopamine agents|mesh-ancestor
93084863|NCT01119014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084864|NCT01119014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084865|NCT01119014|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93084866|NCT01119014|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93084867|NCT01119014|Serotonin Agents|serotonin agents|mesh-ancestor
93084868|NCT01119014|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93084869|NCT01119014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93084870|NCT01119014|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93084871|NCT01119014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93084872|NCT01219244|Resveratrol|resveratrol|mesh-list
93084873|NCT01219244|Antioxidants|antioxidants|mesh-ancestor
93084874|NCT01219244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084875|NCT01219244|Protective Agents|protective agents|mesh-ancestor
93084876|NCT01219244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084877|NCT01219244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084878|NCT01219244|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93084879|NCT01119482|Vaccines|vaccines|mesh-list
93084880|NCT01119482|Immunologic Factors|immunologic factors|mesh-ancestor
92675200|NCT00354198|Hormones|hormones|mesh-ancestor
93084881|NCT01119482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084882|NCT01119638|Risperidone|risperidone|mesh-list
93084883|NCT01119638|Escitalopram|escitalopram|mesh-list
93084884|NCT01119638|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93084885|NCT01119638|Serotonin Agents|serotonin agents|mesh-ancestor
93084886|NCT01119638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93084887|NCT01119638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084888|NCT01119638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084889|NCT01119638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93084890|NCT01119638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93084891|NCT01119638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93084892|NCT01119638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93084893|NCT01119638|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93084894|NCT01119638|Dopamine Agents|dopamine agents|mesh-ancestor
93084895|NCT01119638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93084896|NCT01119638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93084897|NCT01119638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93084898|NCT03338998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93084899|NCT03338998|Siponimod|siponimod|mesh-list
93084900|NCT03338998|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93084901|NCT03338998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084902|NCT03338998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084903|NCT03338998|Immunologic Factors|immunologic factors|mesh-ancestor
93084904|NCT03338998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084905|NCT03935984|Calcitonin|calcitonin|mesh-list
93084906|NCT03935984|Salmon calcitonin|salmon calcitonin|mesh-list
93084907|NCT03935984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93084908|NCT03935984|Katacalcin|katacalcin|mesh-list
93084909|NCT03935984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93084910|NCT03935984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084911|NCT03935984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93084912|NCT03935984|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084913|NCT01219400|Vildagliptin|vildagliptin|mesh-list
93084914|NCT01219400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93084915|NCT01219400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084916|NCT01219400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93084917|NCT01219400|Protease Inhibitors|protease inhibitors|mesh-ancestor
93084918|NCT01219400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084919|NCT01219400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084920|NCT01124630|Leucovorin|leucovorin|mesh-list
93084921|NCT01124630|Fluorouracil|fluorouracil|mesh-list
93084922|NCT01124630|Irinotecan|irinotecan|mesh-list
93084923|NCT01124630|Antimetabolites|antimetabolites|mesh-ancestor
93084924|NCT01124630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084925|NCT01124630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93084926|NCT01124630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084927|NCT01124630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084928|NCT01124630|Immunologic Factors|immunologic factors|mesh-ancestor
93084929|NCT01124630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084930|NCT01124630|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93084931|NCT01124630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93084932|NCT01124630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084933|NCT01124630|Antidotes|antidotes|mesh-ancestor
93084934|NCT01124630|Protective Agents|protective agents|mesh-ancestor
93084935|NCT01124630|Vitamin B Complex|vitamin b complex|mesh-ancestor
93084936|NCT01124630|Vitamins|vitamins|mesh-ancestor
93084937|NCT01124630|Micronutrients|micronutrients|mesh-ancestor
93084938|NCT05683054|Adalimumab|adalimumab|mesh-list
93084939|NCT05683054|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93084940|NCT05683054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084941|NCT05683054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084942|NCT01120106|Simendan|simendan|mesh-list
93084943|NCT01120106|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93084944|NCT01120106|Vasodilator Agents|vasodilator agents|mesh-ancestor
93084945|NCT01120106|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93084946|NCT01120106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93084947|NCT01120106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084948|NCT01120106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084949|NCT01120106|Protective Agents|protective agents|mesh-ancestor
93084950|NCT01120106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084951|NCT01122368|Micafungin|micafungin|mesh-list
93084952|NCT01122368|Antifungal Agents|antifungal agents|mesh-ancestor
93084953|NCT01122368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084954|NCT03338062|Iminodiacetic acid|iminodiacetic acid|mesh-list
93084955|NCT03338062|Chelating Agents|chelating agents|mesh-ancestor
93084956|NCT03338062|Sequestering Agents|sequestering agents|mesh-ancestor
93084957|NCT03338062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084958|NCT01216826|Everolimus|everolimus|mesh-list
93084959|NCT01216826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93084960|NCT01216826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93084961|NCT01216826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084962|NCT01216826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084963|NCT01216826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93084964|NCT01216826|Immunologic Factors|immunologic factors|mesh-ancestor
93084965|NCT01216826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084966|NCT01216826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93084967|NCT01120340|Mesalamine|mesalamine|mesh-list
93084968|NCT01120340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92757227|NCT01111851|Ondansetron|ondansetron|mesh-list
93084969|NCT01120340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93084970|NCT01120340|Analgesics|analgesics|mesh-ancestor
93084971|NCT01120340|Sensory System Agents|sensory system agents|mesh-ancestor
93084972|NCT01120340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084973|NCT01120340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084974|NCT01120340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93084975|NCT01120340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93084976|NCT01214408|Pantoprazole|pantoprazole|mesh-list
93084977|NCT01214408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93084978|NCT01214408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93084979|NCT01214408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93084980|NCT01214408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084981|NCT01214408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084982|NCT01214486|Raltegravir Potassium|raltegravir potassium|mesh-list
93084983|NCT01214486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93084984|NCT01214486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93084985|NCT01214486|Antiviral Agents|antiviral agents|mesh-ancestor
93084986|NCT01214486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93084987|NCT01214486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93084988|NCT01214486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93084989|NCT01214486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93084990|NCT01214486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93084991|NCT01216904|Nicotine|nicotine|mesh-list
93084992|NCT01216904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93084993|NCT01216904|Autonomic Agents|autonomic agents|mesh-ancestor
93084994|NCT01216904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93084995|NCT01216904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93084996|NCT01216904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93084997|NCT01216904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93084998|NCT01216904|Cholinergic Agents|cholinergic agents|mesh-ancestor
93084999|NCT01216904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085000|NCT01216904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085001|NCT01125020|Gemcitabine|gemcitabine|mesh-list
93085002|NCT01125020|Doxorubicin|doxorubicin|mesh-list
93085003|NCT01125020|Oxaliplatin|oxaliplatin|mesh-list
93085004|NCT01125020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085005|NCT01125020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085006|NCT01125020|Antimetabolites|antimetabolites|mesh-ancestor
93085007|NCT01125020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085008|NCT01125020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93085009|NCT01125020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93085010|NCT01125020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085011|NCT01125020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085012|NCT01312012|Antiviral Agents|antiviral agents|mesh-list
93085013|NCT01312012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085014|NCT01125254|Amlodipine|amlodipine|mesh-list
93085015|NCT01125254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93085016|NCT01125254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93085017|NCT01125254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93085018|NCT01125254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085019|NCT01125254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93085020|NCT01125254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085021|NCT01125254|Vasodilator Agents|vasodilator agents|mesh-ancestor
93085022|NCT03710434|Lansoprazole|lansoprazole|mesh-list
93085023|NCT03710434|Dexlansoprazole|dexlansoprazole|mesh-list
93085024|NCT03710434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93085025|NCT03710434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085026|NCT03710434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93085027|NCT03710434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085028|NCT03710434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085029|NCT03706924|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93085030|NCT03706924|Elsulfavirine|elsulfavirine|mesh-list
93085031|NCT03706924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93085032|NCT03706924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93085033|NCT03706924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085034|NCT03706924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085035|NCT03706924|Antiviral Agents|antiviral agents|mesh-ancestor
93085036|NCT03706924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085037|NCT03706924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93085038|NCT03706924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93085039|NCT05682586|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
93085040|NCT05682586|Antiviral Agents|antiviral agents|mesh-ancestor
92757319|NCT01203072|Edoxaban|edoxaban|mesh-list
93085041|NCT05682586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085042|NCT01217138|Epinephrine|epinephrine|mesh-list
93085043|NCT01217138|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93085044|NCT01217138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93085045|NCT01217138|Adrenergic Agents|adrenergic agents|mesh-ancestor
93085046|NCT01217138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085047|NCT01217138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085048|NCT01217138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085049|NCT01217138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93085050|NCT01217138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93085051|NCT01217138|Autonomic Agents|autonomic agents|mesh-ancestor
93085052|NCT01217138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085053|NCT01217138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93085054|NCT01217138|Respiratory System Agents|respiratory system agents|mesh-ancestor
93085055|NCT01217138|Mydriatics|mydriatics|mesh-ancestor
93085056|NCT01217138|Sympathomimetics|sympathomimetics|mesh-ancestor
93085057|NCT01217138|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93085059|NCT03710356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93085060|NCT03710356|Hormone Antagonists|hormone antagonists|mesh-ancestor
93085061|NCT03710356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085062|NCT03710356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085063|NCT01217294|Morphine|morphine|mesh-list
93085064|NCT01217294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93085065|NCT01217294|Narcotics|narcotics|mesh-ancestor
93085066|NCT01217294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085067|NCT01217294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085068|NCT01217294|Analgesics|analgesics|mesh-ancestor
93085069|NCT01217294|Sensory System Agents|sensory system agents|mesh-ancestor
93085070|NCT01217294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085071|NCT03361228|Pembrolizumab|pembrolizumab|mesh-list
93085072|NCT03361228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93085073|NCT03361228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085074|NCT03361228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93085075|NCT03361228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085076|NCT01121042|Ondansetron|ondansetron|mesh-list
93085077|NCT01121042|Antiemetics|antiemetics|mesh-ancestor
93085078|NCT01121042|Autonomic Agents|autonomic agents|mesh-ancestor
93085079|NCT01121042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085080|NCT01121042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085081|NCT01121042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085082|NCT01121042|Antipruritics|antipruritics|mesh-ancestor
92675392|NCT00326807|Naltrexone|naltrexone|mesh-list
93085083|NCT01121042|Dermatologic Agents|dermatologic agents|mesh-ancestor
93085084|NCT01121042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93085085|NCT01121042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93085086|NCT01121042|Serotonin Agents|serotonin agents|mesh-ancestor
93085087|NCT01121042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085088|NCT01121042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085089|NCT01121120|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93085090|NCT01121120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93085091|NCT01121120|Vasodilator Agents|vasodilator agents|mesh-ancestor
93085092|NCT01217450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93085093|NCT01217450|Cetuximab|cetuximab|mesh-list
93085094|NCT01217450|Antibodies|antibodies|mesh-list
93085095|NCT01217450|Immunoglobulins|immunoglobulins|mesh-list
93085096|NCT01217450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93085097|NCT01217450|Immunologic Factors|immunologic factors|mesh-ancestor
93085098|NCT01217450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085099|NCT01217450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085100|NCT01219556|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93085101|NCT01219556|Olmesartan|olmesartan|mesh-list
93085102|NCT01219556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93085103|NCT01219556|Diuretics|diuretics|mesh-ancestor
93085104|NCT01219556|Natriuretic Agents|natriuretic agents|mesh-ancestor
93085105|NCT01219556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085106|NCT01219556|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93085107|NCT01219556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93085108|NCT01219556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085109|NCT01219556|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93085110|NCT01219556|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93085111|NCT01121198|Ipragliflozin|ipragliflozin|mesh-list
93085112|NCT01121198|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93085113|NCT01121198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085114|NCT01121198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92757377|NCT02880033|Deferiprone|deferiprone|mesh-list
93085115|NCT01121198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085116|NCT01121276|Insulin|insulin|mesh-list
93085117|NCT01121276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93085118|NCT01121276|Insulin Aspart|insulin aspart|mesh-list
93085119|NCT01121276|Insulin, Long-Acting|insulin, long-acting|mesh-list
93085120|NCT01121276|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93085121|NCT01121276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085122|NCT01121276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085123|NCT05175508|Azacitidine|azacitidine|mesh-list
93085124|NCT05175508|Tretinoin|tretinoin|mesh-list
93085125|NCT05175508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085126|NCT05175508|Antimetabolites|antimetabolites|mesh-ancestor
93085127|NCT05175508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085128|NCT05175508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085129|NCT05175508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085130|NCT05175508|Keratolytic Agents|keratolytic agents|mesh-ancestor
93085131|NCT05175508|Dermatologic Agents|dermatologic agents|mesh-ancestor
93085132|NCT01125410|Clindamycin|clindamycin|mesh-list
93085133|NCT01125410|Clindamycin palmitate|clindamycin palmitate|mesh-list
93085134|NCT01125410|Clindamycin phosphate|clindamycin phosphate|mesh-list
93085135|NCT01125410|Dequalinium|dequalinium|mesh-list
93085136|NCT01125410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085137|NCT01125410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085138|NCT01125410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93085139|NCT01125410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085140|NCT01125410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085141|NCT01125410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93085142|NCT01328834|Tacrolimus|tacrolimus|mesh-list
93085143|NCT01328834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085144|NCT01328834|Immunologic Factors|immunologic factors|mesh-ancestor
93085145|NCT01328834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085146|NCT01328834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93085147|NCT01328834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675450|NCT00327080|Acetylcholine|acetylcholine|mesh-list
93085148|NCT01328834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085149|NCT01121354|Cefazolin|cefazolin|mesh-list
93085150|NCT01121354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085151|NCT01121354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085152|NCT01122602|Aspirin|aspirin|mesh-list
93085153|NCT01122602|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085154|NCT01122602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085155|NCT01122602|Analgesics|analgesics|mesh-ancestor
93085156|NCT01122602|Sensory System Agents|sensory system agents|mesh-ancestor
93085157|NCT01122602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085158|NCT01122602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085159|NCT01122602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085160|NCT01122602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085161|NCT01122602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93085162|NCT01122602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93085163|NCT01122602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085164|NCT01122602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93085165|NCT01122602|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93085166|NCT01122602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085167|NCT01122602|Antipyretics|antipyretics|mesh-ancestor
93085168|NCT03359590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93085169|NCT03359590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085170|NCT03359590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085171|NCT03359590|Incretins|incretins|mesh-ancestor
93085172|NCT03359590|Hormones|hormones|mesh-ancestor
93085173|NCT03359590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085174|NCT03359590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93085175|NCT03359590|Protease Inhibitors|protease inhibitors|mesh-ancestor
93085176|NCT03359590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085177|NCT03359590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085178|NCT01219712|Simendan|simendan|mesh-list
93085179|NCT01219712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93085180|NCT01219712|Vasodilator Agents|vasodilator agents|mesh-ancestor
93085181|NCT01219712|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93085182|NCT01219712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93085183|NCT01219712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085184|NCT01219712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085185|NCT01219712|Protective Agents|protective agents|mesh-ancestor
93085186|NCT01219712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085187|NCT01215266|Sorafenib|sorafenib|mesh-list
93085188|NCT01215266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085189|NCT01215266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085190|NCT01215266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085191|NCT01215266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085192|NCT05682196|Rituximab|rituximab|mesh-list
93085193|NCT05682196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93085194|NCT05682196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085195|NCT05682196|Immunologic Factors|immunologic factors|mesh-ancestor
93085196|NCT05682196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085197|NCT05682196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085198|NCT03936374|Omeprazole|omeprazole|mesh-list
93085199|NCT03936374|Linrodostat|linrodostat|mesh-list
93085200|NCT03936374|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93085201|NCT03936374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085202|NCT03936374|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93085203|NCT03936374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085204|NCT03936374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085205|NCT01125488|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93085206|NCT01125488|Luteolytic Agents|luteolytic agents|mesh-ancestor
93085207|NCT01125488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93085208|NCT01125488|Contraceptive Agents|contraceptive agents|mesh-ancestor
93085209|NCT01125488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93085210|NCT01125488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085211|NCT01125488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93085212|NCT01125488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93085213|NCT01125488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085214|NCT01215578|Sunitinib|sunitinib|mesh-list
93085215|NCT01215578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085216|NCT01215578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93085217|NCT01215578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93085218|NCT01215578|Growth Substances|growth substances|mesh-ancestor
93085219|NCT01215578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085220|NCT01215578|Growth Inhibitors|growth inhibitors|mesh-ancestor
93085221|NCT01215578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085222|NCT01215578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085223|NCT01215578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085224|NCT01120418|Besifloxacin|besifloxacin|mesh-list
93085225|NCT01120418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085226|NCT01120418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085227|NCT01120418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93085228|NCT01120418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085229|NCT01120418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085230|NCT01120418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085231|NCT01120418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085232|NCT05577988|Aspirin|aspirin|mesh-list
93085233|NCT05577988|Clopidogrel|clopidogrel|mesh-list
93085234|NCT05577988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085235|NCT05577988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085236|NCT05577988|Analgesics|analgesics|mesh-ancestor
93085237|NCT05577988|Sensory System Agents|sensory system agents|mesh-ancestor
93085238|NCT05577988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085239|NCT05577988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085240|NCT05577988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085241|NCT05577988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085242|NCT05577988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93085243|NCT05577988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93085244|NCT05577988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085245|NCT05577988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93085246|NCT05577988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93085247|NCT05577988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085248|NCT05577988|Antipyretics|antipyretics|mesh-ancestor
93085249|NCT05577988|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93085250|NCT05577988|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93085251|NCT05577988|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93085252|NCT05577988|Purinergic Agents|purinergic agents|mesh-ancestor
93085253|NCT05577988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085254|NCT01222052|Cyclophosphamide|cyclophosphamide|mesh-list
93085255|NCT01222052|Docetaxel|docetaxel|mesh-list
93085256|NCT01222052|Fluorouracil|fluorouracil|mesh-list
93085257|NCT01222052|Epirubicin|epirubicin|mesh-list
93085258|NCT01222052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085259|NCT01222052|Immunologic Factors|immunologic factors|mesh-ancestor
93085260|NCT01222052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085261|NCT01222052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757521|NCT05506982|Psilocybin|psilocybin|mesh-list
93085262|NCT01222052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93085263|NCT01222052|Alkylating Agents|alkylating agents|mesh-ancestor
93085264|NCT01222052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085265|NCT01222052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085266|NCT01222052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93085267|NCT01222052|Tubulin Modulators|tubulin modulators|mesh-ancestor
93085268|NCT01222052|Antimitotic Agents|antimitotic agents|mesh-ancestor
93085269|NCT01222052|Mitosis Modulators|mitosis modulators|mesh-ancestor
93085270|NCT01222052|Antimetabolites|antimetabolites|mesh-ancestor
93085271|NCT01222052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085272|NCT01222052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93085273|NCT01222052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93085274|NCT01222052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085275|NCT01222052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085276|NCT03710044|Cyclosporine|cyclosporine|mesh-list
93085277|NCT03710044|Cyclosporins|cyclosporins|mesh-list
93085278|NCT03710044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085279|NCT03710044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085280|NCT03710044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085281|NCT03710044|Immunologic Factors|immunologic factors|mesh-ancestor
93085282|NCT03710044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085283|NCT03710044|Antifungal Agents|antifungal agents|mesh-ancestor
93085284|NCT03710044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085285|NCT03710044|Dermatologic Agents|dermatologic agents|mesh-ancestor
93085286|NCT03710044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085287|NCT03710044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93085288|NCT03706300|Phenylpropanolamine|phenylpropanolamine|mesh-list
93085289|NCT03706300|Pseudoephedrine|pseudoephedrine|mesh-list
93085290|NCT03706300|Ephedrine|ephedrine|mesh-list
93085291|NCT03706300|Guaifenesin|guaifenesin|mesh-list
93085292|NCT03706300|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93085293|NCT03706300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93085294|NCT03706300|Autonomic Agents|autonomic agents|mesh-ancestor
93085295|NCT03706300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085296|NCT03706300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085297|NCT03706300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93085298|NCT03706300|Respiratory System Agents|respiratory system agents|mesh-ancestor
93085299|NCT03706300|Nasal Decongestants|nasal decongestants|mesh-ancestor
93085300|NCT03706300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93085301|NCT03706300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93085302|NCT03706300|Sympathomimetics|sympathomimetics|mesh-ancestor
93085303|NCT03706300|Adrenergic Agents|adrenergic agents|mesh-ancestor
93085304|NCT03706300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085305|NCT03706300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085306|NCT03706300|Expectorants|expectorants|mesh-ancestor
93085307|NCT03706300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93085308|NCT03706300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93085309|NCT03706300|Appetite Depressants|appetite depressants|mesh-ancestor
93085310|NCT03706300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93085311|NCT05155540|Plasminogen|plasminogen|mesh-list
93085312|NCT05155540|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93085313|NCT05155540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93085314|NCT05155540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93085315|NCT05155540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085316|NCT01122914|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93085317|NCT01122914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085318|NCT01222442|Moxifloxacin|moxifloxacin|mesh-list
93085319|NCT01222442|AZD-3199|azd-3199|mesh-list
93085320|NCT01222442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085321|NCT01222442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085322|NCT01222442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93085323|NCT01222442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085324|NCT01222442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085325|NCT01222442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085326|NCT01222442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085327|NCT01222442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085328|NCT01222442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93085329|NCT01222442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93085330|NCT01222442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93085331|NCT01222442|Adrenergic Agents|adrenergic agents|mesh-ancestor
93085332|NCT01222442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085333|NCT03706222|Grazoprevir|grazoprevir|mesh-list
93085334|NCT03706222|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93085335|NCT03706222|Antiviral Agents|antiviral agents|mesh-ancestor
93085336|NCT03706222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085337|NCT01222676|Gemcitabine|gemcitabine|mesh-list
93085338|NCT01222676|Sorafenib|sorafenib|mesh-list
93085339|NCT01222676|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93085340|NCT01222676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085341|NCT01222676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085342|NCT01222676|Antimetabolites|antimetabolites|mesh-ancestor
93085343|NCT01222676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085344|NCT01222676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085345|NCT01222676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085346|NCT01222676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93085347|NCT05681728|Paclitaxel|paclitaxel|mesh-list
93085348|NCT05681728|Cyclophosphamide|cyclophosphamide|mesh-list
93085349|NCT05681728|Pembrolizumab|pembrolizumab|mesh-list
93085350|NCT05681728|Epirubicin|epirubicin|mesh-list
93085351|NCT05681728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93085352|NCT05681728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085353|NCT05681728|Tubulin Modulators|tubulin modulators|mesh-ancestor
93085354|NCT05681728|Antimitotic Agents|antimitotic agents|mesh-ancestor
93085355|NCT05681728|Mitosis Modulators|mitosis modulators|mesh-ancestor
93085356|NCT05681728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085357|NCT05681728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085358|NCT05681728|Immunologic Factors|immunologic factors|mesh-ancestor
93085359|NCT05681728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085360|NCT05681728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085361|NCT05681728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93085362|NCT05681728|Alkylating Agents|alkylating agents|mesh-ancestor
93085363|NCT05681728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93085364|NCT05681728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93085365|NCT05681728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93085366|NCT05681728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93085367|NCT05681728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93085368|NCT05681728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085369|NCT05681728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085370|NCT03931928|Tamoxifen|tamoxifen|mesh-list
93085371|NCT03931928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93085372|NCT03931928|Hormone Antagonists|hormone antagonists|mesh-ancestor
93085373|NCT03931928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085374|NCT03931928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085375|NCT03931928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93085376|NCT03931928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085377|NCT03931928|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93085378|NCT03931928|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93085379|NCT03931928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93085380|NCT01220102|Adapalene|adapalene|mesh-list
93085381|NCT01220102|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93085382|NCT01220102|Dermatologic Agents|dermatologic agents|mesh-ancestor
93085383|NCT01220102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085384|NCT01220102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085385|NCT01220102|Analgesics|analgesics|mesh-ancestor
93085386|NCT01220102|Sensory System Agents|sensory system agents|mesh-ancestor
93085387|NCT01220102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085388|NCT01220102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085389|NCT01220102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085390|NCT01220102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085391|NCT05133310|Simvastatin|simvastatin|mesh-list
93085392|NCT05133310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93085393|NCT05133310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93085394|NCT05133310|Antimetabolites|antimetabolites|mesh-ancestor
93085395|NCT05133310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085396|NCT05133310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93085397|NCT05133310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93085398|NCT05133310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085399|NCT04576000|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
93085400|NCT04576000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085401|NCT04576000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085402|NCT04576000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085403|NCT01222910|Valacyclovir|valacyclovir|mesh-list
93085404|NCT01222910|Antiviral Agents|antiviral agents|mesh-ancestor
93085405|NCT01222910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085406|NCT04533568|Ibuprofen|ibuprofen|mesh-list
93085407|NCT04533568|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93085408|NCT04533568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085409|NCT04533568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085410|NCT04533568|Analgesics|analgesics|mesh-ancestor
93085411|NCT04533568|Sensory System Agents|sensory system agents|mesh-ancestor
92757670|NCT02881125|Adrenergic Agents|adrenergic agents|mesh-ancestor
93085412|NCT04533568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085413|NCT04533568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085414|NCT04533568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085415|NCT04533568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085416|NCT04533568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93085417|NCT04533568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085418|NCT04533568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085419|NCT03932864|Plerixafor|plerixafor|mesh-list
93085420|NCT03932864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93085421|NCT03932864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93085422|NCT03932864|Antiviral Agents|antiviral agents|mesh-ancestor
93085423|NCT03932864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085424|NCT05268562|Ketamine|ketamine|mesh-list
93085425|NCT05268562|Propofol|propofol|mesh-list
93085426|NCT05268562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93085427|NCT05268562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085428|NCT05268562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085429|NCT05268562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93085430|NCT05268562|Anesthetics, General|anesthetics, general|mesh-ancestor
93085431|NCT05268562|Anesthetics|anesthetics|mesh-ancestor
93085432|NCT05268562|Analgesics|analgesics|mesh-ancestor
93085433|NCT05268562|Sensory System Agents|sensory system agents|mesh-ancestor
93085434|NCT05268562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085435|NCT05268562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93085436|NCT05268562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93085437|NCT05268562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93085438|NCT05268562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085439|NCT05268562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085440|NCT05245552|Vaccines|vaccines|mesh-list
93085441|NCT05245552|Immunologic Factors|immunologic factors|mesh-ancestor
93085442|NCT05245552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085443|NCT01312324|Docetaxel|docetaxel|mesh-list
93085444|NCT01312324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085445|NCT01312324|Tubulin Modulators|tubulin modulators|mesh-ancestor
93085446|NCT01312324|Antimitotic Agents|antimitotic agents|mesh-ancestor
93085447|NCT01312324|Mitosis Modulators|mitosis modulators|mesh-ancestor
93085448|NCT01312324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085449|NCT05482516|Bevacizumab|bevacizumab|mesh-list
93085450|NCT05482516|Atezolizumab|atezolizumab|mesh-list
93085451|NCT05482516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93085452|NCT05482516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085453|NCT05482516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93085454|NCT05482516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93085455|NCT05482516|Growth Substances|growth substances|mesh-ancestor
93085456|NCT05482516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085457|NCT05482516|Growth Inhibitors|growth inhibitors|mesh-ancestor
93085458|NCT05482516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93085459|NCT05482516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085460|NCT01127594|Temozolomide|temozolomide|mesh-list
93085461|NCT01127594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93085462|NCT01127594|Alkylating Agents|alkylating agents|mesh-ancestor
93085463|NCT01127594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085464|NCT01127594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085465|NCT01127672|Betamethasone|betamethasone|mesh-list
93085466|NCT01127672|Lidocaine|lidocaine|mesh-list
93085467|NCT01127672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085468|NCT01127672|Glucocorticoids|glucocorticoids|mesh-ancestor
93085469|NCT01127672|Hormones|hormones|mesh-ancestor
93085470|NCT01127672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085471|NCT01127672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085472|NCT01127672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93085473|NCT01127672|Respiratory System Agents|respiratory system agents|mesh-ancestor
93085474|NCT01127672|Anesthetics, Local|anesthetics, local|mesh-ancestor
93085475|NCT01127672|Anesthetics|anesthetics|mesh-ancestor
93085476|NCT01127672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085477|NCT01127672|Sensory System Agents|sensory system agents|mesh-ancestor
93085478|NCT01127672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085479|NCT01127672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93085480|NCT01127672|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93085481|NCT01127672|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93085482|NCT01127672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93085483|NCT01127672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085484|NCT01220258|Azithromycin|azithromycin|mesh-list
92757744|NCT01251146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93085485|NCT01220258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93085486|NCT01220258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93085487|NCT01220258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085488|NCT01220258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085489|NCT01223534|Isoniazid|isoniazid|mesh-list
93085490|NCT01223534|Antitubercular Agents|antitubercular agents|mesh-ancestor
93085491|NCT01223534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085492|NCT01223534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085493|NCT01223534|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93085494|NCT01223534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93085495|NCT01223534|Antimetabolites|antimetabolites|mesh-ancestor
93085496|NCT01223534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085497|NCT01223534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93085498|NCT01223612|Ranibizumab|ranibizumab|mesh-list
93085499|NCT01223612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93085500|NCT01223612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93085501|NCT01223612|Growth Substances|growth substances|mesh-ancestor
93085502|NCT01223612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085503|NCT01223612|Growth Inhibitors|growth inhibitors|mesh-ancestor
93085504|NCT01223612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085505|NCT01127750|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93085506|NCT01127750|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93085507|NCT01127750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085508|NCT01127750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085509|NCT01127750|Immunologic Factors|immunologic factors|mesh-ancestor
93085510|NCT01127750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085511|NCT02946580|Naloxegol|naloxegol|mesh-list
93085512|NCT02946580|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93085513|NCT02946580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085514|NCT02946580|Sensory System Agents|sensory system agents|mesh-ancestor
93085515|NCT02946580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085516|NCT01223690|Clarithromycin|clarithromycin|mesh-list
93085517|NCT01223690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085518|NCT01223690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085519|NCT01223690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93085520|NCT01223690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085521|NCT01223690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085522|NCT01223690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93085523|NCT01223690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93085524|NCT05381350|Vaccines|vaccines|mesh-list
93085525|NCT05381350|Immunologic Factors|immunologic factors|mesh-ancestor
93085526|NCT05381350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085527|NCT01223768|Acetylcarnitine|acetylcarnitine|mesh-list
93085528|NCT01223768|Vitamin B Complex|vitamin b complex|mesh-ancestor
93085529|NCT01223768|Vitamins|vitamins|mesh-ancestor
93085530|NCT01223768|Micronutrients|micronutrients|mesh-ancestor
93085531|NCT01223768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085532|NCT01223768|Nootropic Agents|nootropic agents|mesh-ancestor
93085533|NCT01126112|Panitumumab|panitumumab|mesh-list
93085534|NCT01126112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93085535|NCT01126112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085536|NCT05024032|Tirzepatide|tirzepatide|mesh-list
93085537|NCT05024032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085538|NCT05024032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085539|NCT05024032|Incretins|incretins|mesh-ancestor
93085540|NCT05024032|Hormones|hormones|mesh-ancestor
93085541|NCT05024032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085542|NCT01123538|Chlormadinone Acetate|chlormadinone acetate|mesh-list
93085543|NCT01123538|Progesterone|progesterone|mesh-list
93085544|NCT01123538|Progestins|progestins|mesh-ancestor
93085545|NCT01123538|Hormones|hormones|mesh-ancestor
93085546|NCT01123538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085547|NCT01123538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085548|NCT01123538|Androgen Antagonists|androgen antagonists|mesh-ancestor
93085549|NCT01123538|Hormone Antagonists|hormone antagonists|mesh-ancestor
93085550|NCT01123538|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93085551|NCT01123538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93085552|NCT01123538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93085553|NCT01123538|Contraceptive Agents|contraceptive agents|mesh-ancestor
93085554|NCT01123538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93085555|NCT01123538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93085556|NCT01123538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93085557|NCT03930992|Zoledronic Acid|zoledronic acid|mesh-list
93085558|NCT03930992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93085559|NCT03930992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085561|NCT01220570|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93085562|NCT01220570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085563|NCT01220570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085564|NCT01220570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93085565|NCT01220570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085566|NCT01220570|Antifungal Agents|antifungal agents|mesh-ancestor
93085567|NCT01220570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085568|NCT01220570|Immunologic Factors|immunologic factors|mesh-ancestor
93085569|NCT01220570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085570|NCT04682860|Scopolamine|scopolamine|mesh-list
93085571|NCT04682860|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93085572|NCT04682860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93085573|NCT04682860|Antiemetics|antiemetics|mesh-ancestor
93085574|NCT04682860|Autonomic Agents|autonomic agents|mesh-ancestor
93085575|NCT04682860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085576|NCT04682860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085577|NCT04682860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085578|NCT04682860|Mydriatics|mydriatics|mesh-ancestor
93085579|NCT04682860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93085580|NCT04682860|Cholinergic Agents|cholinergic agents|mesh-ancestor
93085581|NCT04682860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085582|NCT04682860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085583|NCT04682860|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93085584|NCT04682860|Parasympatholytics|parasympatholytics|mesh-ancestor
93085585|NCT01127906|Oxycodone|oxycodone|mesh-list
93085586|NCT01127906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93085587|NCT01127906|Narcotics|narcotics|mesh-ancestor
93085588|NCT01127906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085589|NCT01127906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085590|NCT01127906|Analgesics|analgesics|mesh-ancestor
93085591|NCT01127906|Sensory System Agents|sensory system agents|mesh-ancestor
93085592|NCT01127906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085593|NCT01127984|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93085594|NCT01127984|Hemostatics|hemostatics|mesh-ancestor
93085595|NCT01127984|Coagulants|coagulants|mesh-ancestor
93085596|NCT01220648|Interferons|interferons|mesh-list
93085597|NCT01220648|Interferon-alpha|interferon-alpha|mesh-list
93085598|NCT01220648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085599|NCT01220648|Antiviral Agents|antiviral agents|mesh-ancestor
93085600|NCT01220648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085601|NCT01220648|Immunologic Factors|immunologic factors|mesh-ancestor
93085602|NCT01220648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085603|NCT01218386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93085604|NCT01218386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93085605|NCT01218386|Estradiol|estradiol|mesh-list
93085606|NCT01218386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93085607|NCT01218386|Estrogens|estrogens|mesh-ancestor
93085608|NCT01218386|Hormones|hormones|mesh-ancestor
93085609|NCT01218386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085610|NCT01218386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085611|NCT01218386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93085612|NCT01218386|Contraceptive Agents|contraceptive agents|mesh-ancestor
93085613|NCT01218386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93085614|NCT01218386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93085615|NCT03933098|Vaccines|vaccines|mesh-list
93085616|NCT03933098|Immunologic Factors|immunologic factors|mesh-ancestor
93085617|NCT03933098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085618|NCT05111314|Edetic Acid|edetic acid|mesh-list
93085619|NCT05111314|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93085620|NCT05111314|Chelating Agents|chelating agents|mesh-ancestor
93085621|NCT05111314|Sequestering Agents|sequestering agents|mesh-ancestor
93085622|NCT05111314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085623|NCT05111314|Anticoagulants|anticoagulants|mesh-ancestor
93085624|NCT05111314|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93085625|NCT05111314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93085626|NCT01224314|Dialysis Solutions|dialysis solutions|mesh-list
93085627|NCT01224314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93085628|NCT01224392|Capecitabine|capecitabine|mesh-list
93085629|NCT01224392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085630|NCT01224392|Antimetabolites|antimetabolites|mesh-ancestor
93085631|NCT01224392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757893|NCT01078389|Febuxostat|febuxostat|mesh-list
93085632|NCT01224392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085633|NCT01224470|Dexmedetomidine|dexmedetomidine|mesh-list
93085634|NCT01224470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93085635|NCT01224470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085636|NCT01224470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085637|NCT01224470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085638|NCT01224470|Analgesics|analgesics|mesh-ancestor
93085639|NCT01224470|Sensory System Agents|sensory system agents|mesh-ancestor
93085640|NCT01224470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085641|NCT01224470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93085642|NCT01224470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93085643|NCT01224470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93085644|NCT01224470|Adrenergic Agents|adrenergic agents|mesh-ancestor
93085645|NCT01224470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085646|NCT01224470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085647|NCT01128218|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93085648|NCT01128218|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93085649|NCT01128218|Dermatologic Agents|dermatologic agents|mesh-ancestor
93085650|NCT03740516|Apremilast|apremilast|mesh-list
93085651|NCT03740516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085652|NCT03740516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085653|NCT03740516|Analgesics|analgesics|mesh-ancestor
93085654|NCT03740516|Sensory System Agents|sensory system agents|mesh-ancestor
93085655|NCT03740516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085656|NCT03740516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085657|NCT03740516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085658|NCT03740516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085659|NCT03740516|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93085660|NCT03740516|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93085661|NCT03740516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085662|NCT03740516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085663|NCT03933956|Empagliflozin|empagliflozin|mesh-list
93085664|NCT03933956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93085665|NCT03933956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085666|NCT03933956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085667|NCT03933956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085668|NCT01218620|Tolbutamide|tolbutamide|mesh-list
93085669|NCT01218620|Rifampin|rifampin|mesh-list
93085670|NCT01218620|Ketoconazole|ketoconazole|mesh-list
93085671|NCT01218620|Midazolam|midazolam|mesh-list
93085672|NCT01218620|Dextromethorphan|dextromethorphan|mesh-list
93085673|NCT01218620|Omeprazole|omeprazole|mesh-list
93085674|NCT01218620|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93085675|NCT01218620|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93085676|NCT01218620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93085677|NCT01218620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93085678|NCT01218620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085679|NCT01218620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085680|NCT01218620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93085681|NCT01218620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93085682|NCT01218620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93085683|NCT01218620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93085684|NCT01218620|Anesthetics, General|anesthetics, general|mesh-ancestor
93085685|NCT01218620|Anesthetics|anesthetics|mesh-ancestor
93085686|NCT01218620|GABA Modulators|gaba modulators|mesh-ancestor
93085687|NCT01218620|GABA Agents|gaba agents|mesh-ancestor
93085688|NCT01218620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085689|NCT01218620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085690|NCT01218620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93085691|NCT01218620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085692|NCT01218620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93085693|NCT01218620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085694|NCT01218620|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93085695|NCT01218620|Antitubercular Agents|antitubercular agents|mesh-ancestor
93085696|NCT01218620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93085697|NCT01218620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085698|NCT01218620|Leprostatic Agents|leprostatic agents|mesh-ancestor
93085699|NCT01218620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93085700|NCT01218620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93085701|NCT01218620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93085702|NCT01218620|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93085703|NCT01218620|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93085704|NCT01218620|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93085705|NCT01218620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93085706|NCT01218620|Antifungal Agents|antifungal agents|mesh-ancestor
93085707|NCT01218620|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93085708|NCT01218620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93085709|NCT01218620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93085710|NCT01218620|Hormone Antagonists|hormone antagonists|mesh-ancestor
93085711|NCT01218620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085712|NCT01218620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93085713|NCT01218620|Antitussive Agents|antitussive agents|mesh-ancestor
93085714|NCT01218620|Respiratory System Agents|respiratory system agents|mesh-ancestor
93085715|NCT01218620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93085716|NCT01218620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93085717|NCT01218620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085718|NCT00323297|Bosentan|bosentan|mesh-list
93085719|NCT00323297|Sildenafil Citrate|sildenafil citrate|mesh-list
93085720|NCT00323297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085721|NCT00323297|Vasodilator Agents|vasodilator agents|mesh-ancestor
93085722|NCT00323297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93085723|NCT00323297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93085724|NCT00323297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085725|NCT00323297|Urological Agents|urological agents|mesh-ancestor
93085726|NCT00323297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93085727|NCT00323297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93085728|NCT01218698|Losartan|losartan|mesh-list
93085729|NCT01218698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93085730|NCT01218698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93085731|NCT01218698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93085732|NCT01218698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93085733|NCT01218698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085734|NCT01224860|Losartan|losartan|mesh-list
93085735|NCT01224860|Telmisartan|telmisartan|mesh-list
93085736|NCT01224860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93085737|NCT01224860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93085738|NCT01224860|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93085739|NCT01224860|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93085740|NCT01224860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085741|NCT00323063|Gemcitabine|gemcitabine|mesh-list
93085742|NCT00323063|Imatinib Mesylate|imatinib mesylate|mesh-list
93085743|NCT00323063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085744|NCT00323063|Antimetabolites|antimetabolites|mesh-ancestor
93085745|NCT00323063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085746|NCT00323063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085747|NCT00323063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085748|NCT00323063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085749|NCT01328990|Pyrimethamine|pyrimethamine|mesh-list
93085750|NCT01328990|Sulfadoxine|sulfadoxine|mesh-list
93085751|NCT01328990|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93085752|NCT01328990|Amodiaquine|amodiaquine|mesh-list
93085753|NCT01328990|Antimalarials|antimalarials|mesh-ancestor
93085754|NCT01328990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93085755|NCT01328990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93085756|NCT01328990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085757|NCT01328990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93085758|NCT01328990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085759|NCT01328990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085760|NCT01328990|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93085761|NCT01225094|Curcumin|curcumin|mesh-list
93085762|NCT01225094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085763|NCT01225094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085764|NCT01225094|Analgesics|analgesics|mesh-ancestor
93085765|NCT01225094|Sensory System Agents|sensory system agents|mesh-ancestor
93085766|NCT01225094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085767|NCT01225094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085768|NCT01225094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085769|NCT01225094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085770|NCT01225094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085771|NCT01225094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085772|NCT01225094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085773|NCT00322049|Vaccines|vaccines|mesh-list
93085774|NCT00322049|Immunologic Factors|immunologic factors|mesh-ancestor
93085775|NCT00322049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085776|NCT01124240|Temozolomide|temozolomide|mesh-list
93085777|NCT01124240|Procarbazine|procarbazine|mesh-list
93085778|NCT01124240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93085779|NCT01124240|Alkylating Agents|alkylating agents|mesh-ancestor
93085780|NCT01124240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085781|NCT01124240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085783|NCT01124318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085784|NCT01221116|Simendan|simendan|mesh-list
93085785|NCT01221116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93085786|NCT01221116|Vasodilator Agents|vasodilator agents|mesh-ancestor
93085787|NCT01221116|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93085788|NCT01221116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93085789|NCT01221116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085790|NCT01221116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085791|NCT01221116|Protective Agents|protective agents|mesh-ancestor
93085792|NCT01221116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085793|NCT03929744|Midazolam|midazolam|mesh-list
93085794|NCT03929744|Atorvastatin|atorvastatin|mesh-list
93085795|NCT03929744|Simvastatin|simvastatin|mesh-list
93085796|NCT03929744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93085797|NCT03929744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93085798|NCT03929744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085799|NCT03929744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085800|NCT03929744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93085801|NCT03929744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93085802|NCT03929744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93085803|NCT03929744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93085804|NCT03929744|Anesthetics, General|anesthetics, general|mesh-ancestor
93085805|NCT03929744|Anesthetics|anesthetics|mesh-ancestor
93085806|NCT03929744|GABA Modulators|gaba modulators|mesh-ancestor
93085807|NCT03929744|GABA Agents|gaba agents|mesh-ancestor
93085808|NCT03929744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085809|NCT03929744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085810|NCT03929744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93085811|NCT03929744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93085812|NCT03929744|Antimetabolites|antimetabolites|mesh-ancestor
93085813|NCT03929744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93085814|NCT03929744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93085815|NCT03929744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085816|NCT01225406|Tenofovir|tenofovir|mesh-list
93085817|NCT01225406|Antiviral Agents|antiviral agents|mesh-ancestor
93085818|NCT01225406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085819|NCT01225406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93085820|NCT01225406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93085821|NCT01225406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085822|NCT01225406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085823|NCT01225406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93085824|NCT01225406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93085825|NCT01126814|Imatinib Mesylate|imatinib mesylate|mesh-list
93085826|NCT01126814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085827|NCT01126814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085828|NCT01126814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085829|NCT01126814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085830|NCT01225484|Ropivacaine|ropivacaine|mesh-list
93085831|NCT01225484|Anesthetics, Local|anesthetics, local|mesh-ancestor
93085832|NCT01225484|Anesthetics|anesthetics|mesh-ancestor
93085833|NCT01225484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085834|NCT01225484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085835|NCT01225484|Sensory System Agents|sensory system agents|mesh-ancestor
93085836|NCT01225484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085837|NCT03928496|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93085838|NCT03928496|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93085839|NCT03928496|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93085840|NCT03928496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93085841|NCT03928496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085842|NCT03928496|Cholinergic Agents|cholinergic agents|mesh-ancestor
93085843|NCT03928496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085844|NCT03928496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085845|NCT03928496|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93085846|NCT03928496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085847|NCT01128998|Sorafenib|sorafenib|mesh-list
93085848|NCT01128998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085849|NCT01128998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085850|NCT01128998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085851|NCT01128998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085852|NCT00321893|Budesonide|budesonide|mesh-list
93085853|NCT00321893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085854|NCT00321893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93085855|NCT00321893|Autonomic Agents|autonomic agents|mesh-ancestor
93085856|NCT00321893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085857|NCT00321893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085858|NCT00321893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93085859|NCT00321893|Respiratory System Agents|respiratory system agents|mesh-ancestor
93085860|NCT00321893|Glucocorticoids|glucocorticoids|mesh-ancestor
93085861|NCT00321893|Hormones|hormones|mesh-ancestor
93085862|NCT00321893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085863|NCT01225874|Cytarabine|cytarabine|mesh-list
93085864|NCT01225874|Dexamethasone|dexamethasone|mesh-list
93085865|NCT01225874|Prednisone|prednisone|mesh-list
93085866|NCT01225874|Methotrexate|methotrexate|mesh-list
93085867|NCT01225874|Vincristine|vincristine|mesh-list
93085868|NCT01225874|Daunorubicin|daunorubicin|mesh-list
93085869|NCT01225874|Asparaginase|asparaginase|mesh-list
93085870|NCT01225874|Pegaspargase|pegaspargase|mesh-list
93085871|NCT01225874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085872|NCT01225874|Antiemetics|antiemetics|mesh-ancestor
93085873|NCT01225874|Autonomic Agents|autonomic agents|mesh-ancestor
93085874|NCT01225874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085875|NCT01225874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085876|NCT01225874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085877|NCT01225874|Glucocorticoids|glucocorticoids|mesh-ancestor
93085878|NCT01225874|Hormones|hormones|mesh-ancestor
93085879|NCT01225874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93085880|NCT01225874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93085881|NCT01225874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085882|NCT01225874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93085883|NCT01225874|Abortifacient Agents|abortifacient agents|mesh-ancestor
93085884|NCT01225874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93085885|NCT01225874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085886|NCT01225874|Antimetabolites|antimetabolites|mesh-ancestor
93085887|NCT01225874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085888|NCT01225874|Dermatologic Agents|dermatologic agents|mesh-ancestor
93085889|NCT01225874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085890|NCT01225874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93085891|NCT01225874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93085892|NCT01225874|Immunologic Factors|immunologic factors|mesh-ancestor
93085893|NCT01225874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085894|NCT01225874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93085895|NCT01225874|Antiviral Agents|antiviral agents|mesh-ancestor
93085896|NCT01225874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085897|NCT01225874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93085898|NCT01225874|Tubulin Modulators|tubulin modulators|mesh-ancestor
93085899|NCT01225874|Antimitotic Agents|antimitotic agents|mesh-ancestor
93085900|NCT01225874|Mitosis Modulators|mitosis modulators|mesh-ancestor
93085901|NCT01225874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93085902|NCT01225874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93085903|NCT01225874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085904|NCT03928340|Metformin|metformin|mesh-list
93085905|NCT03928340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93085906|NCT03928340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085907|NCT00371345|Dasatinib|dasatinib|mesh-list
93085908|NCT00371345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085909|NCT00371345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93085910|NCT00371345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085911|NCT00371345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085912|NCT01226186|Morphine|morphine|mesh-list
93085913|NCT01226186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93085914|NCT01226186|Narcotics|narcotics|mesh-ancestor
93085915|NCT01226186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93085916|NCT01226186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085917|NCT01226186|Analgesics|analgesics|mesh-ancestor
93085918|NCT01226186|Sensory System Agents|sensory system agents|mesh-ancestor
93085919|NCT01226186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085920|NCT01228214|Aspirin|aspirin|mesh-list
93085921|NCT01228214|Amiloride|amiloride|mesh-list
93085922|NCT01228214|Clopidogrel|clopidogrel|mesh-list
93085923|NCT01228214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085924|NCT01228214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085925|NCT01228214|Analgesics|analgesics|mesh-ancestor
93085926|NCT01228214|Sensory System Agents|sensory system agents|mesh-ancestor
93085927|NCT01228214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758189|NCT02866396|Pregabalin|pregabalin|mesh-list
93085928|NCT01228214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085929|NCT01228214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085930|NCT01228214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085931|NCT01228214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93085932|NCT01228214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93085933|NCT01228214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085934|NCT01228214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93085935|NCT01228214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93085936|NCT01228214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085937|NCT01228214|Antipyretics|antipyretics|mesh-ancestor
93085938|NCT01228214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93085939|NCT01228214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93085940|NCT01228214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93085941|NCT01228214|Purinergic Agents|purinergic agents|mesh-ancestor
93085942|NCT01228214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93085943|NCT01228214|Diuretics|diuretics|mesh-ancestor
93085944|NCT01228214|Natriuretic Agents|natriuretic agents|mesh-ancestor
93085945|NCT01228214|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93085946|NCT01228214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93085947|NCT01228214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93085948|NCT01228214|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93085949|NCT01228214|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93085950|NCT00321737|Dexlansoprazole|dexlansoprazole|mesh-list
93085951|NCT00321737|Lansoprazole|lansoprazole|mesh-list
93085952|NCT00321737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93085953|NCT00321737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93085954|NCT00321737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93085955|NCT00321737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085956|NCT00321737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085957|NCT03928262|Benralizumab|benralizumab|mesh-list
93085958|NCT03928262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93085959|NCT03928262|Respiratory System Agents|respiratory system agents|mesh-ancestor
93085960|NCT03740438|Chrysarobin|chrysarobin|mesh-list
93085961|NCT03740438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93085962|NCT03740438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93085963|NCT03740438|Analgesics|analgesics|mesh-ancestor
93085964|NCT03740438|Sensory System Agents|sensory system agents|mesh-ancestor
93085965|NCT03740438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93085966|NCT03740438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93085967|NCT03740438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93085968|NCT03740438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93085969|NCT01129154|Panitumumab|panitumumab|mesh-list
93085970|NCT01129154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93085971|NCT01129154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085972|NCT01047995|Ritonavir|ritonavir|mesh-list
93085973|NCT01047995|Darunavir|darunavir|mesh-list
93085974|NCT01047995|Raltegravir Potassium|raltegravir potassium|mesh-list
93085975|NCT01047995|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93085976|NCT01047995|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93085977|NCT01047995|Protease Inhibitors|protease inhibitors|mesh-ancestor
93085978|NCT01047995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085979|NCT01047995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085980|NCT01047995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93085981|NCT01047995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93085982|NCT01047995|Antiviral Agents|antiviral agents|mesh-ancestor
93085983|NCT01047995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93085984|NCT01047995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93085985|NCT01047995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93085986|NCT01047995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93085987|NCT01047995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93085988|NCT01129310|Capecitabine|capecitabine|mesh-list
93085989|NCT01129310|Oxaliplatin|oxaliplatin|mesh-list
93085990|NCT01129310|Irinotecan|irinotecan|mesh-list
93085991|NCT01129310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93085992|NCT01129310|Antimetabolites|antimetabolites|mesh-ancestor
93085993|NCT01129310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93085994|NCT01129310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93085995|NCT01129310|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93085996|NCT01129310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93085997|NCT01129310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93085998|NCT01129388|Omeprazole|omeprazole|mesh-list
93085999|NCT01129388|Clopidogrel|clopidogrel|mesh-list
93086000|NCT01129388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93086001|NCT01129388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93086002|NCT01129388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93086003|NCT01129388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93086004|NCT01129388|Purinergic Agents|purinergic agents|mesh-ancestor
93086005|NCT01129388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086006|NCT01129388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086007|NCT01129388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086008|NCT01129388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93086009|NCT01129388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086010|NCT01129388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93086011|NCT01129388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086012|NCT01228292|Heparin|heparin|mesh-list
93086013|NCT01228292|Calcium heparin|calcium heparin|mesh-list
93086014|NCT01228292|Anticoagulants|anticoagulants|mesh-ancestor
93086015|NCT01228292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93086016|NCT01228292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93086017|NCT01228292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086018|NCT03924596|Boswellic acid|boswellic acid|mesh-list
93086019|NCT03924596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93086020|NCT03924596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93086021|NCT03924596|Analgesics|analgesics|mesh-ancestor
93086022|NCT03924596|Sensory System Agents|sensory system agents|mesh-ancestor
93086023|NCT03924596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086024|NCT03924596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086025|NCT03924596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086026|NCT03924596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086027|NCT00320801|Buprenorphine|buprenorphine|mesh-list
93086028|NCT00320801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93086029|NCT00320801|Narcotics|narcotics|mesh-ancestor
93086030|NCT00320801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086031|NCT00320801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086032|NCT00320801|Analgesics|analgesics|mesh-ancestor
93086033|NCT00320801|Sensory System Agents|sensory system agents|mesh-ancestor
93086034|NCT00320801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086035|NCT00320801|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93086036|NCT01127204|Lamivudine|lamivudine|mesh-list
93086037|NCT01127204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93086038|NCT01127204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93086039|NCT01127204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086040|NCT01127204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086041|NCT01127204|Antiviral Agents|antiviral agents|mesh-ancestor
93086042|NCT01127204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086043|NCT01127204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93086044|NCT01127204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93086045|NCT01228370|Silodosin|silodosin|mesh-list
93086046|NCT01228370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93086047|NCT01228370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93086048|NCT01228370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93086049|NCT01228370|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086050|NCT01228370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086051|NCT01228370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086052|NCT01228370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086053|NCT01228370|Urological Agents|urological agents|mesh-ancestor
93086054|NCT01221740|Milnacipran|milnacipran|mesh-list
93086055|NCT01221740|Levomilnacipran|levomilnacipran|mesh-list
93086056|NCT01221740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93086057|NCT01221740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93086058|NCT01221740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93086059|NCT01221740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086060|NCT01221740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086061|NCT01221740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086062|NCT01221740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93086063|NCT01221740|Analgesics|analgesics|mesh-ancestor
93086064|NCT01221740|Sensory System Agents|sensory system agents|mesh-ancestor
93086065|NCT01221740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086066|NCT01221740|Antidepressive Agents|antidepressive agents|mesh-ancestor
93086067|NCT01221740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93086068|NCT00320489|Olanzapine|olanzapine|mesh-list
93086069|NCT00320489|Antiemetics|antiemetics|mesh-ancestor
93086070|NCT00320489|Autonomic Agents|autonomic agents|mesh-ancestor
93086071|NCT00320489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086072|NCT00320489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086073|NCT00320489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086074|NCT00320489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93086075|NCT00320489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93086076|NCT00320489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086077|NCT00320489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758344|NCT00976456|Bevacizumab|bevacizumab|mesh-list
93086078|NCT00320489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93086079|NCT00320489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93086080|NCT00320489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93086081|NCT00320489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086082|NCT00320489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086083|NCT00320489|Serotonin Agents|serotonin agents|mesh-ancestor
93086084|NCT01127282|Vitamins|vitamins|mesh-list
93086085|NCT01127282|Vitamin A|vitamin a|mesh-list
93086086|NCT01127282|Micronutrients|micronutrients|mesh-ancestor
93086087|NCT01127282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086088|NCT01127360|Bevacizumab|bevacizumab|mesh-list
93086089|NCT01127360|Ranibizumab|ranibizumab|mesh-list
93086090|NCT01127360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086091|NCT01127360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086092|NCT01127360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93086093|NCT01127360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93086094|NCT01127360|Growth Substances|growth substances|mesh-ancestor
93086095|NCT01127360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086096|NCT01127360|Growth Inhibitors|growth inhibitors|mesh-ancestor
93086097|NCT01228604|Methylphenidate|methylphenidate|mesh-list
93086098|NCT01228604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93086099|NCT01228604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086100|NCT01228604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93086101|NCT01228604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93086102|NCT01228604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93086103|NCT01228604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086104|NCT01228604|Dopamine Agents|dopamine agents|mesh-ancestor
93086105|NCT01228604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086106|NCT01228682|Tolvaptan|tolvaptan|mesh-list
93086107|NCT01228682|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93086108|NCT01228682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086109|NCT01228682|Natriuretic Agents|natriuretic agents|mesh-ancestor
93086110|NCT01228682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086111|NCT01221896|Choline|choline|mesh-list
93086112|NCT01221896|Lipotropic Agents|lipotropic agents|mesh-ancestor
93086113|NCT01221896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93086114|NCT01221896|Antimetabolites|antimetabolites|mesh-ancestor
93086115|NCT01221896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086116|NCT01221896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086117|NCT01221896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93086118|NCT01221896|Nootropic Agents|nootropic agents|mesh-ancestor
93086119|NCT03923114|Exenatide|exenatide|mesh-list
93086120|NCT03923114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086121|NCT03923114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086122|NCT03923114|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92676427|NCT00329498|Vitamins|vitamins|mesh-ancestor
93086123|NCT03923114|Incretins|incretins|mesh-ancestor
93086124|NCT03923114|Hormones|hormones|mesh-ancestor
93086125|NCT03923114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086126|NCT00320411|Lapatinib|lapatinib|mesh-list
93086127|NCT00320411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086128|NCT00320411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086129|NCT00320411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086130|NCT00320411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086131|NCT01132040|Primidone|primidone|mesh-list
93086132|NCT01132040|Anticonvulsants|anticonvulsants|mesh-ancestor
93086133|NCT01132040|GABA Modulators|gaba modulators|mesh-ancestor
93086134|NCT01132040|GABA Agents|gaba agents|mesh-ancestor
93086135|NCT01132040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086136|NCT01132040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086137|NCT01132040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086138|NCT01226966|Liraglutide|liraglutide|mesh-list
93086139|NCT01226966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086140|NCT01226966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086141|NCT01226966|Incretins|incretins|mesh-ancestor
93086142|NCT01226966|Hormones|hormones|mesh-ancestor
93086143|NCT01226966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086144|NCT03923036|Cetuximab|cetuximab|mesh-list
93086145|NCT03923036|Panitumumab|panitumumab|mesh-list
93086146|NCT03923036|Aflibercept|aflibercept|mesh-list
93086147|NCT03923036|Capecitabine|capecitabine|mesh-list
93086148|NCT03923036|Irinotecan|irinotecan|mesh-list
93086149|NCT03923036|Antineoplastic Agents|antineoplastic agents|mesh-list
93086150|NCT03923036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086151|NCT03923036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93086152|NCT03923036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93086153|NCT03923036|Growth Substances|growth substances|mesh-ancestor
93086154|NCT03923036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086155|NCT03923036|Growth Inhibitors|growth inhibitors|mesh-ancestor
93086156|NCT03923036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93086157|NCT03923036|Antimetabolites|antimetabolites|mesh-ancestor
93086158|NCT03923036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086159|NCT03923036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93086160|NCT03923036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086161|NCT03923036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086162|NCT01129856|Dexamethasone|dexamethasone|mesh-list
93086163|NCT01129856|Citric Acid|citric acid|mesh-list
93086164|NCT01129856|Sodium Citrate|sodium citrate|mesh-list
93086165|NCT01129856|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93086166|NCT01129856|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93086167|NCT01129856|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93086168|NCT01129856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086169|NCT01129856|Antiemetics|antiemetics|mesh-ancestor
93086170|NCT01129856|Autonomic Agents|autonomic agents|mesh-ancestor
93086171|NCT01129856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086172|NCT01129856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086173|NCT01129856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086174|NCT01129856|Glucocorticoids|glucocorticoids|mesh-ancestor
93086176|NCT01129856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086177|NCT01129856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93086178|NCT01129856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086179|NCT01129856|Anticoagulants|anticoagulants|mesh-ancestor
93086180|NCT01129856|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93086181|NCT01129856|Chelating Agents|chelating agents|mesh-ancestor
93086182|NCT01129856|Sequestering Agents|sequestering agents|mesh-ancestor
93086183|NCT01129856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086184|NCT01129934|Promethazine|promethazine|mesh-list
93086185|NCT01129934|Diphenhydramine|diphenhydramine|mesh-list
93086186|NCT01129934|Morphine|morphine|mesh-list
93086187|NCT01129934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93086188|NCT01129934|Narcotics|narcotics|mesh-ancestor
93086189|NCT01129934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086190|NCT01129934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086191|NCT01129934|Analgesics|analgesics|mesh-ancestor
93086192|NCT01129934|Sensory System Agents|sensory system agents|mesh-ancestor
93086193|NCT01129934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086194|NCT01129934|Antipruritics|antipruritics|mesh-ancestor
93086195|NCT01129934|Dermatologic Agents|dermatologic agents|mesh-ancestor
93086196|NCT01129934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93086197|NCT01129934|Histamine Antagonists|histamine antagonists|mesh-ancestor
93086198|NCT01129934|Histamine Agents|histamine agents|mesh-ancestor
93086199|NCT01129934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086200|NCT01129934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086201|NCT01129934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93086202|NCT01129934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93086203|NCT01129934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93086204|NCT01129934|Anesthetics, Local|anesthetics, local|mesh-ancestor
93086205|NCT01129934|Anesthetics|anesthetics|mesh-ancestor
93086206|NCT01129934|Antiemetics|antiemetics|mesh-ancestor
93086207|NCT01129934|Autonomic Agents|autonomic agents|mesh-ancestor
93086208|NCT01129934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086209|NCT01131572|Acetylcysteine|acetylcysteine|mesh-list
93086210|NCT01131572|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93086211|NCT01131572|Antiviral Agents|antiviral agents|mesh-ancestor
93086212|NCT01131572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086213|NCT01131572|Expectorants|expectorants|mesh-ancestor
93086214|NCT01131572|Respiratory System Agents|respiratory system agents|mesh-ancestor
93086215|NCT01131572|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93086216|NCT01131572|Antioxidants|antioxidants|mesh-ancestor
93086217|NCT01131572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086218|NCT01131572|Protective Agents|protective agents|mesh-ancestor
93086219|NCT01131572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086220|NCT01131572|Antidotes|antidotes|mesh-ancestor
93086221|NCT01132196|Valproic Acid|valproic acid|mesh-list
93086222|NCT01132196|Anticonvulsants|anticonvulsants|mesh-ancestor
93086223|NCT01132196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086224|NCT01132196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086225|NCT01132196|GABA Agents|gaba agents|mesh-ancestor
93086226|NCT01132196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086227|NCT01132196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086228|NCT01132196|Antimanic Agents|antimanic agents|mesh-ancestor
93086229|NCT01132196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93086230|NCT01132196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086231|NCT01132196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93086233|NCT01228994|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93086234|NCT01228994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086235|NCT01228994|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93086236|NCT01228994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086237|NCT01228994|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93086238|NCT01228994|GABA Agonists|gaba agonists|mesh-ancestor
93086239|NCT01228994|GABA Agents|gaba agents|mesh-ancestor
93086240|NCT01228994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086241|NCT01228994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086242|NCT03927170|Metformin|metformin|mesh-list
93086243|NCT03927170|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93086244|NCT03927170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086245|NCT03927170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086246|NCT03927170|Incretins|incretins|mesh-ancestor
93086247|NCT03927170|Hormones|hormones|mesh-ancestor
93086248|NCT03927170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086249|NCT03927170|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93086250|NCT03927170|Protease Inhibitors|protease inhibitors|mesh-ancestor
93086251|NCT03927170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086252|NCT03927170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086253|NCT01227200|Tramadol|tramadol|mesh-list
93086254|NCT01227200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93086255|NCT01227200|Narcotics|narcotics|mesh-ancestor
93086256|NCT01227200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086257|NCT01227200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086258|NCT01227200|Analgesics|analgesics|mesh-ancestor
93086259|NCT01227200|Sensory System Agents|sensory system agents|mesh-ancestor
93086260|NCT01227200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086261|NCT01227356|Interferons|interferons|mesh-list
93086262|NCT01227356|Imatinib Mesylate|imatinib mesylate|mesh-list
93086263|NCT01227356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086264|NCT01227356|Antiviral Agents|antiviral agents|mesh-ancestor
93086265|NCT01227356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086266|NCT01227356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086267|NCT01227356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086268|NCT01227356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086269|NCT01132352|Levetiracetam|levetiracetam|mesh-list
93086270|NCT01132352|Anticonvulsants|anticonvulsants|mesh-ancestor
93086271|NCT01132352|Nootropic Agents|nootropic agents|mesh-ancestor
93086272|NCT01131728|Naproxen|naproxen|mesh-list
93086273|NCT01131728|Pseudoephedrine|pseudoephedrine|mesh-list
93086274|NCT01131728|Ephedrine|ephedrine|mesh-list
93086275|NCT01131728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93086276|NCT01131728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93086277|NCT01131728|Analgesics|analgesics|mesh-ancestor
93086278|NCT01131728|Sensory System Agents|sensory system agents|mesh-ancestor
93086279|NCT01131728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086280|NCT01131728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086281|NCT01131728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086282|NCT01131728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086283|NCT01131728|Gout Suppressants|gout suppressants|mesh-ancestor
93086284|NCT01131728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93086285|NCT01131728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086286|NCT01131728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086287|NCT01131728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93086288|NCT01131728|Autonomic Agents|autonomic agents|mesh-ancestor
93086289|NCT01131728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93086290|NCT01131728|Respiratory System Agents|respiratory system agents|mesh-ancestor
93086291|NCT01131728|Nasal Decongestants|nasal decongestants|mesh-ancestor
93086292|NCT01131728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93086293|NCT01131728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93086294|NCT01131728|Sympathomimetics|sympathomimetics|mesh-ancestor
93086295|NCT01131728|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086296|NCT01131728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086297|NCT01132586|Cytarabine|cytarabine|mesh-list
93086298|NCT01132586|Lenalidomide|lenalidomide|mesh-list
93086299|NCT01132586|Idarubicin|idarubicin|mesh-list
93086300|NCT01132586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93086301|NCT01132586|Antimetabolites|antimetabolites|mesh-ancestor
93086302|NCT01132586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086303|NCT01132586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086304|NCT01132586|Antiviral Agents|antiviral agents|mesh-ancestor
93086305|NCT01132586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086307|NCT01132586|Immunologic Factors|immunologic factors|mesh-ancestor
93086308|NCT01132586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086309|NCT01132586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93086310|NCT01132586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93086311|NCT01132586|Growth Substances|growth substances|mesh-ancestor
93086312|NCT01132586|Growth Inhibitors|growth inhibitors|mesh-ancestor
93086313|NCT01132586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93086314|NCT01132586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93086315|NCT01132586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086316|NCT01132586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086317|NCT01130246|Varespladib methyl|varespladib methyl|mesh-list
93086318|NCT01130246|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93086319|NCT01130246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086320|NCT01130246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086321|NCT03921086|Antihypertensive Agents|antihypertensive agents|mesh-list
93086322|NCT01227590|Ritonavir|ritonavir|mesh-list
93086323|NCT01227590|Lopinavir|lopinavir|mesh-list
93086324|NCT01227590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93086325|NCT01227590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93086326|NCT01227590|Protease Inhibitors|protease inhibitors|mesh-ancestor
93086327|NCT01227590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086328|NCT01227590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086329|NCT01227590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93086330|NCT01227590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93086331|NCT01227590|Antiviral Agents|antiviral agents|mesh-ancestor
93086332|NCT01227590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086333|NCT01227590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93086334|NCT01227590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93086335|NCT03927248|Nivolumab|nivolumab|mesh-list
93086336|NCT03927248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086337|NCT03927248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086338|NCT03927248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93086339|NCT03927248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086340|NCT03926780|Warfarin|warfarin|mesh-list
93086341|NCT03926780|Rivaroxaban|rivaroxaban|mesh-list
93086342|NCT03926780|Anticoagulants|anticoagulants|mesh-ancestor
93086343|NCT03926780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93086344|NCT03926780|Antithrombins|antithrombins|mesh-ancestor
93086345|NCT03926780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93086346|NCT03926780|Protease Inhibitors|protease inhibitors|mesh-ancestor
93086347|NCT03926780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086348|NCT03926780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086349|NCT03926936|Fulvestrant|fulvestrant|mesh-list
93086350|NCT03926936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93086351|NCT03926936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086352|NCT03926936|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93086353|NCT03926936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93086354|NCT03926936|Hormone Antagonists|hormone antagonists|mesh-ancestor
93086355|NCT03926936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086356|NCT03926936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086357|NCT03920618|Tenofovir|tenofovir|mesh-list
93086358|NCT03920618|Entecavir|entecavir|mesh-list
93086359|NCT03920618|Antiviral Agents|antiviral agents|mesh-ancestor
93086360|NCT03920618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086361|NCT03920618|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93086362|NCT03920618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93086363|NCT03920618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086364|NCT03920618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086365|NCT03920618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93086366|NCT03920618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93086367|NCT01131806|Fluticasone|fluticasone|mesh-list
93086368|NCT01131806|Xhance|xhance|mesh-list
93086369|NCT01131806|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93086370|NCT01131806|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93086371|NCT01131806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086372|NCT01131806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93086373|NCT01131806|Autonomic Agents|autonomic agents|mesh-ancestor
93086374|NCT01131806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086375|NCT01131806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086376|NCT01131806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93086377|NCT01131806|Respiratory System Agents|respiratory system agents|mesh-ancestor
93086378|NCT01131806|Dermatologic Agents|dermatologic agents|mesh-ancestor
93086379|NCT01131806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93086380|NCT01131806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93086381|NCT01131806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93086382|NCT01131806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93086383|NCT01131806|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086384|NCT01131806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086385|NCT01131806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086386|NCT01131806|Glucocorticoids|glucocorticoids|mesh-ancestor
93086387|NCT01131806|Hormones|hormones|mesh-ancestor
93086388|NCT01131806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086389|NCT01131806|Sympathomimetics|sympathomimetics|mesh-ancestor
93086390|NCT01229930|Paclitaxel|paclitaxel|mesh-list
93086391|NCT01229930|Carboplatin|carboplatin|mesh-list
93086392|NCT01229930|Cediranib|cediranib|mesh-list
93086393|NCT01229930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93086394|NCT01229930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086395|NCT01229930|Tubulin Modulators|tubulin modulators|mesh-ancestor
93086396|NCT01229930|Antimitotic Agents|antimitotic agents|mesh-ancestor
93086397|NCT01229930|Mitosis Modulators|mitosis modulators|mesh-ancestor
93086398|NCT01229930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086399|NCT01229930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086400|NCT01229930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086401|NCT03805100|Ranibizumab|ranibizumab|mesh-list
93086402|NCT03805100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93086403|NCT03805100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93086404|NCT03805100|Growth Substances|growth substances|mesh-ancestor
93086405|NCT03805100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086406|NCT03805100|Growth Inhibitors|growth inhibitors|mesh-ancestor
93086407|NCT03805100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086408|NCT03920150|Vitamin D|vitamin d|mesh-list
93086409|NCT03920150|Ergocalciferols|ergocalciferols|mesh-list
93086410|NCT03920150|Cholecalciferol|cholecalciferol|mesh-list
93086411|NCT03920150|Vitamins|vitamins|mesh-list
93086412|NCT03920150|Micronutrients|micronutrients|mesh-ancestor
93086413|NCT03920150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086414|NCT03920150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93086415|NCT03920150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93086416|NCT01131962|Sclerosing Solutions|sclerosing solutions|mesh-list
93086417|NCT01131962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93086418|NCT01130324|Telavancin|telavancin|mesh-list
93086419|NCT01130324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93086420|NCT01130324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086421|NCT01229774|Diclofenac|diclofenac|mesh-list
93086422|NCT01229774|Etoricoxib|etoricoxib|mesh-list
93086423|NCT01229774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93086424|NCT01229774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93086425|NCT01229774|Analgesics|analgesics|mesh-ancestor
93086426|NCT01229774|Sensory System Agents|sensory system agents|mesh-ancestor
93086427|NCT01229774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086428|NCT01229774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086429|NCT01229774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086430|NCT01229774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086431|NCT01229774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93086432|NCT01229774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086433|NCT01229774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086434|NCT01229774|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93086435|NCT03918590|Nepafenac|nepafenac|mesh-list
93086436|NCT03918590|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93086437|NCT03918590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93086438|NCT03918590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93086439|NCT03918590|Analgesics|analgesics|mesh-ancestor
93086440|NCT03918590|Sensory System Agents|sensory system agents|mesh-ancestor
93086441|NCT03918590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086442|NCT03918590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086443|NCT03918590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086444|NCT03918590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086445|NCT03918590|Laxatives|laxatives|mesh-ancestor
93086446|NCT03918590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086447|NCT00320255|Apixaban|apixaban|mesh-list
93086448|NCT00320255|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93086449|NCT00320255|Antithrombins|antithrombins|mesh-ancestor
93086450|NCT00320255|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93086451|NCT00320255|Protease Inhibitors|protease inhibitors|mesh-ancestor
93086452|NCT00320255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086453|NCT00320255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758724|NCT01868269|Antiemetics|antiemetics|mesh-ancestor
93086454|NCT00320255|Anticoagulants|anticoagulants|mesh-ancestor
93086455|NCT01231802|Leucovorin|leucovorin|mesh-list
93086456|NCT01231802|Fluorouracil|fluorouracil|mesh-list
93086457|NCT01231802|Capecitabine|capecitabine|mesh-list
93086458|NCT01231802|Eniluracil|eniluracil|mesh-list
93086459|NCT01231802|Antimetabolites|antimetabolites|mesh-ancestor
93086460|NCT01231802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086461|NCT01231802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93086462|NCT01231802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086463|NCT01231802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93086464|NCT01231802|Immunologic Factors|immunologic factors|mesh-ancestor
93086465|NCT01231802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086466|NCT01231802|Antidotes|antidotes|mesh-ancestor
93086467|NCT01231802|Protective Agents|protective agents|mesh-ancestor
93086468|NCT01231802|Vitamin B Complex|vitamin b complex|mesh-ancestor
93086469|NCT01231802|Vitamins|vitamins|mesh-ancestor
93086470|NCT01231802|Micronutrients|micronutrients|mesh-ancestor
93086471|NCT01231802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086472|NCT01329614|Nicotine|nicotine|mesh-list
93086473|NCT01329614|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93086474|NCT01329614|Autonomic Agents|autonomic agents|mesh-ancestor
93086475|NCT01329614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086476|NCT01329614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086477|NCT01329614|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93086478|NCT01329614|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93086479|NCT01329614|Cholinergic Agents|cholinergic agents|mesh-ancestor
93086480|NCT01329614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086481|NCT01329614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086482|NCT01231880|Piperaquine|piperaquine|mesh-list
93086483|NCT01231880|Artenimol|artenimol|mesh-list
93086484|NCT01231880|Antimalarials|antimalarials|mesh-ancestor
93086485|NCT01231880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93086486|NCT01231880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93086487|NCT01231880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086488|NCT01232036|Metformin|metformin|mesh-list
93086489|NCT01232036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086490|NCT01232036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086491|NCT01130636|Oseltamivir|oseltamivir|mesh-list
93086492|NCT01130636|Antiviral Agents|antiviral agents|mesh-ancestor
93086493|NCT01130636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086494|NCT01130636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086495|NCT01130636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086496|NCT03926156|Warfarin|warfarin|mesh-list
93086497|NCT03926156|Rivaroxaban|rivaroxaban|mesh-list
93086498|NCT03926156|Anticoagulants|anticoagulants|mesh-ancestor
93086499|NCT03926156|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93086500|NCT03926156|Antithrombins|antithrombins|mesh-ancestor
93086501|NCT03926156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93086502|NCT03926156|Protease Inhibitors|protease inhibitors|mesh-ancestor
93086503|NCT03926156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086504|NCT03926156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086505|NCT01134536|Tapentadol|tapentadol|mesh-list
93086506|NCT01134536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93086507|NCT01134536|Narcotics|narcotics|mesh-ancestor
93086508|NCT01134536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086509|NCT01134536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086510|NCT01134536|Analgesics|analgesics|mesh-ancestor
93086511|NCT01134536|Sensory System Agents|sensory system agents|mesh-ancestor
93086512|NCT01134536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086513|NCT01134536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93086514|NCT01134536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93086515|NCT01134536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93086516|NCT01134536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086517|NCT01134536|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086518|NCT01134536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086519|NCT01134692|Norfloxacin|norfloxacin|mesh-list
93086520|NCT01134692|Propranolol|propranolol|mesh-list
93086521|NCT01134692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93086522|NCT01134692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93086523|NCT01134692|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086524|NCT01134692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086525|NCT01134692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086526|NCT01134692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086527|NCT01134692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93086528|NCT01134692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93086529|NCT01134692|Vasodilator Agents|vasodilator agents|mesh-ancestor
93086530|NCT01134692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93086531|NCT01134692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086532|NCT01134692|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93086533|NCT01134692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086534|NCT01134692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086535|NCT01134692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086536|NCT01134692|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93086537|NCT01134692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93086538|NCT01134848|Morphine|morphine|mesh-list
93086539|NCT01134848|Secretin|secretin|mesh-list
93086540|NCT01134848|Neostigmine|neostigmine|mesh-list
93086541|NCT01134848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93086542|NCT01134848|Narcotics|narcotics|mesh-ancestor
93086543|NCT01134848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086544|NCT01134848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086545|NCT01134848|Analgesics|analgesics|mesh-ancestor
93086546|NCT01134848|Sensory System Agents|sensory system agents|mesh-ancestor
93086547|NCT01134848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086548|NCT01134848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93086549|NCT01134848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086550|NCT01134848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086551|NCT01134848|Cholinergic Agents|cholinergic agents|mesh-ancestor
93086552|NCT01134848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086553|NCT01134848|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93086554|NCT01134848|Autonomic Agents|autonomic agents|mesh-ancestor
93086555|NCT01134848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086556|NCT01134848|Hormones|hormones|mesh-ancestor
93086557|NCT01134848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086558|NCT03926000|Pregabalin|pregabalin|mesh-list
93086559|NCT03926000|Analgesics|analgesics|mesh-ancestor
93086560|NCT03926000|Sensory System Agents|sensory system agents|mesh-ancestor
93086561|NCT03926000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086562|NCT03926000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086563|NCT03926000|Anticonvulsants|anticonvulsants|mesh-ancestor
93086564|NCT03926000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93086565|NCT03926000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93086566|NCT03926000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086567|NCT03926000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93086568|NCT03926000|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93086569|NCT03926000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93086570|NCT03926000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086571|NCT03926000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93086572|NCT01134926|Misoprostol|misoprostol|mesh-list
93086573|NCT01134926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93086574|NCT01134926|Abortifacient Agents|abortifacient agents|mesh-ancestor
93086575|NCT01134926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93086576|NCT01134926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086577|NCT01134926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93086578|NCT01134926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086579|NCT01134926|Oxytocics|oxytocics|mesh-ancestor
93086580|NCT01228136|Tranexamic Acid|tranexamic acid|mesh-list
93086581|NCT01228136|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93086582|NCT01228136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93086583|NCT01228136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086584|NCT01228136|Hemostatics|hemostatics|mesh-ancestor
93086585|NCT01228136|Coagulants|coagulants|mesh-ancestor
93086586|NCT03140176|Sunitinib|sunitinib|mesh-list
93086587|NCT03140176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086588|NCT03140176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93086589|NCT03140176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93086590|NCT03140176|Growth Substances|growth substances|mesh-ancestor
93086591|NCT03140176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086592|NCT03140176|Growth Inhibitors|growth inhibitors|mesh-ancestor
93086593|NCT03140176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086594|NCT03140176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086595|NCT03140176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086596|NCT04259164|Mometasone Furoate|mometasone furoate|mesh-list
93086597|NCT04259164|Glycopyrrolate|glycopyrrolate|mesh-list
93086598|NCT04259164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086599|NCT04259164|Dermatologic Agents|dermatologic agents|mesh-ancestor
93086600|NCT04259164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93086601|NCT04259164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93086602|NCT04259164|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93086603|NCT04259164|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93086604|NCT04259164|Cholinergic Agents|cholinergic agents|mesh-ancestor
93086605|NCT04259164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758863|NCT04304157|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086606|NCT04259164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086607|NCT04259164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086608|NCT01230476|Cetuximab|cetuximab|mesh-list
93086609|NCT01230476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086610|NCT01230476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086611|NCT01135472|Esomeprazole|esomeprazole|mesh-list
93086612|NCT01135472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93086613|NCT01135472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086614|NCT01135472|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93086615|NCT01135472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086616|NCT01135472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086617|NCT01133210|Maraviroc|maraviroc|mesh-list
93086618|NCT01133210|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93086619|NCT01133210|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93086620|NCT01133210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086621|NCT01133210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93086622|NCT01133210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93086623|NCT01133210|Antiviral Agents|antiviral agents|mesh-ancestor
93086624|NCT01133210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086625|NCT01133210|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93086626|NCT01135550|Dexamethasone|dexamethasone|mesh-list
93086627|NCT01135550|Dexamethasone acetate|dexamethasone acetate|mesh-list
93086628|NCT01135550|BB 1101|bb 1101|mesh-list
93086629|NCT01135550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086630|NCT01135550|Antiemetics|antiemetics|mesh-ancestor
93086631|NCT01135550|Autonomic Agents|autonomic agents|mesh-ancestor
93086632|NCT01135550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086633|NCT01135550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086634|NCT01135550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086635|NCT01135550|Glucocorticoids|glucocorticoids|mesh-ancestor
93086636|NCT01135550|Hormones|hormones|mesh-ancestor
93086637|NCT01135550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086638|NCT01135550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93086639|NCT01135550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086640|NCT01135550|Protease Inhibitors|protease inhibitors|mesh-ancestor
93086641|NCT01135550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086642|NCT01135550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086643|NCT05401370|Methylene Blue|methylene blue|mesh-list
93086644|NCT05401370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086645|NCT05401370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086646|NCT01131026|Amoxicillin|amoxicillin|mesh-list
93086647|NCT01131026|Levofloxacin|levofloxacin|mesh-list
93086648|NCT01131026|Lansoprazole|lansoprazole|mesh-list
93086649|NCT01131026|Dexlansoprazole|dexlansoprazole|mesh-list
93086650|NCT01131026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93086651|NCT01131026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086652|NCT01131026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93086653|NCT01131026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93086654|NCT01131026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086655|NCT01131026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086656|NCT01131026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086657|NCT01131026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086658|NCT01131026|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93086659|NCT01131026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93086660|NCT01131026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93086661|NCT01131026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086662|NCT01131026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93086663|NCT05401292|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93086664|NCT05401292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93086665|NCT05401292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086666|NCT05401292|Dermatologic Agents|dermatologic agents|mesh-ancestor
93086667|NCT01135628|Nitazoxanide|nitazoxanide|mesh-list
93086668|NCT01135628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93086669|NCT01135628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086670|NCT01133366|Warfarin|warfarin|mesh-list
93086671|NCT01133366|Mipomersen|mipomersen|mesh-list
93086672|NCT01133366|Anticoagulants|anticoagulants|mesh-ancestor
93086673|NCT01133366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93086674|NCT01133366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93086675|NCT01133366|Antimetabolites|antimetabolites|mesh-ancestor
93086676|NCT01133366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086677|NCT01133366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93086678|NCT01232270|Propofol|propofol|mesh-list
92758943|NCT02962063|Paclitaxel|paclitaxel|mesh-list
93086679|NCT01232270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93086680|NCT01232270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086681|NCT01232270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086682|NCT01232270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93086683|NCT01232270|Anesthetics, General|anesthetics, general|mesh-ancestor
93086684|NCT01232270|Anesthetics|anesthetics|mesh-ancestor
93086685|NCT05400902|Apatinib|apatinib|mesh-list
93086686|NCT05400902|Tislelizumab|tislelizumab|mesh-list
93086687|NCT05400902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086688|NCT05400902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086689|NCT05400902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086690|NCT05400902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086691|NCT05400902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086692|NCT01233206|Metformin|metformin|mesh-list
93086693|NCT01233206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086694|NCT01233206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086695|NCT00369941|Tenofovir|tenofovir|mesh-list
93086696|NCT00369941|Emtricitabine|emtricitabine|mesh-list
93086697|NCT00369941|Efavirenz|efavirenz|mesh-list
93086698|NCT00369941|Raltegravir Potassium|raltegravir potassium|mesh-list
93086699|NCT00369941|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93086700|NCT00369941|Antiviral Agents|antiviral agents|mesh-ancestor
93086701|NCT00369941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086702|NCT00369941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93086703|NCT00369941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93086704|NCT00369941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086705|NCT00369941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086706|NCT00369941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93086707|NCT00369941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93086708|NCT00369941|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93086709|NCT00369941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93086710|NCT00369941|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93086711|NCT00369941|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93086712|NCT00369941|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93086713|NCT00369941|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93086714|NCT00369941|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93086715|NCT00369941|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93086716|NCT01133444|Finasteride|finasteride|mesh-list
93086717|NCT01133444|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93086718|NCT01133444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93086719|NCT01133444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086720|NCT01133444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086721|NCT01133444|Hormone Antagonists|hormone antagonists|mesh-ancestor
93086722|NCT01133444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086723|NCT01133444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086724|NCT01133444|Urological Agents|urological agents|mesh-ancestor
93086725|NCT01137656|Acetylcholine|acetylcholine|mesh-list
93086726|NCT01137656|Vasodilator Agents|vasodilator agents|mesh-ancestor
93086727|NCT01137656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93086728|NCT01137656|Cholinergic Agents|cholinergic agents|mesh-ancestor
93086729|NCT01137656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086730|NCT01137656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086731|NCT01137656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086732|NCT00369785|Donepezil|donepezil|mesh-list
93086733|NCT00369785|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93086734|NCT00369785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086735|NCT00369785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086736|NCT00369785|Cholinergic Agents|cholinergic agents|mesh-ancestor
93086737|NCT00369785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086738|NCT00369785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086739|NCT00369785|Nootropic Agents|nootropic agents|mesh-ancestor
93086740|NCT05476562|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93086741|NCT05476562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086742|NCT05476562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086743|NCT05476562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086744|NCT01136252|Adalimumab|adalimumab|mesh-list
93086745|NCT01136252|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93086746|NCT01136252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086747|NCT01136252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086748|NCT05597462|Minocycline|minocycline|mesh-list
93086749|NCT05597462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93086750|NCT05597462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086751|NCT00369707|Rituximab|rituximab|mesh-list
93086752|NCT00369707|Bortezomib|bortezomib|mesh-list
92759010|NCT00626769|Estrogens|estrogens|mesh-ancestor
93086753|NCT00369707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086754|NCT00369707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086755|NCT00369707|Immunologic Factors|immunologic factors|mesh-ancestor
93086756|NCT00369707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086757|NCT00369707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086758|NCT01232660|Hydroxychloroquine|hydroxychloroquine|mesh-list
93086759|NCT01232660|Antimalarials|antimalarials|mesh-ancestor
93086760|NCT01232660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93086761|NCT01232660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93086762|NCT01232660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086763|NCT01232660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086764|NCT01232660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086765|NCT01232660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086766|NCT01233362|Vaccines|vaccines|mesh-list
93086767|NCT01233362|Immunologic Factors|immunologic factors|mesh-ancestor
93086768|NCT01233362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086769|NCT01136642|Nicotine|nicotine|mesh-list
93086770|NCT01136642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93086771|NCT01136642|Autonomic Agents|autonomic agents|mesh-ancestor
93086772|NCT01136642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086773|NCT01136642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086774|NCT01136642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93086775|NCT01136642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93086776|NCT01136642|Cholinergic Agents|cholinergic agents|mesh-ancestor
93086777|NCT01136642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086778|NCT01136642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086779|NCT00369629|Gemcitabine|gemcitabine|mesh-list
93086780|NCT00369629|Pemetrexed|pemetrexed|mesh-list
92677079|NCT00435747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086781|NCT00369629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93086782|NCT00369629|Antimetabolites|antimetabolites|mesh-ancestor
93086783|NCT00369629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086784|NCT00369629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086785|NCT00369629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086786|NCT00369629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93086787|NCT00369629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93086788|NCT01133600|Vancomycin|vancomycin|mesh-list
93086789|NCT01133600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93086790|NCT01133600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086791|NCT01133912|Paclitaxel|paclitaxel|mesh-list
93086792|NCT01133912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93086793|NCT01133912|Gemcitabine|gemcitabine|mesh-list
93086794|NCT01133912|Lapatinib|lapatinib|mesh-list
93086795|NCT01133912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93086796|NCT01133912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086797|NCT01133912|Tubulin Modulators|tubulin modulators|mesh-ancestor
93086798|NCT01133912|Antimitotic Agents|antimitotic agents|mesh-ancestor
93086799|NCT01133912|Mitosis Modulators|mitosis modulators|mesh-ancestor
93086800|NCT01133912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086801|NCT01133912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93086802|NCT01133912|Antimetabolites|antimetabolites|mesh-ancestor
93086803|NCT01133912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086804|NCT01133912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086805|NCT05320094|Sorbitol|sorbitol|mesh-list
93086806|NCT05320094|Charcoal|charcoal|mesh-list
93086807|NCT05320094|Antidotes|antidotes|mesh-ancestor
93086808|NCT05320094|Protective Agents|protective agents|mesh-ancestor
93086809|NCT05320094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086810|NCT05320094|Cathartics|cathartics|mesh-ancestor
93086811|NCT05320094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086812|NCT01233752|Morphine|morphine|mesh-list
93086813|NCT01233752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93086814|NCT01233752|Narcotics|narcotics|mesh-ancestor
93086815|NCT01233752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086816|NCT01233752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086817|NCT01233752|Analgesics|analgesics|mesh-ancestor
93086818|NCT01233752|Sensory System Agents|sensory system agents|mesh-ancestor
93086819|NCT01233752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086820|NCT01140620|Ketamine|ketamine|mesh-list
93086821|NCT01140620|Risperidone|risperidone|mesh-list
93086822|NCT01140620|Analgesics|analgesics|mesh-ancestor
93086823|NCT01140620|Sensory System Agents|sensory system agents|mesh-ancestor
93086824|NCT01140620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086825|NCT01140620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086826|NCT01140620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93086827|NCT01140620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93086828|NCT01140620|Anesthetics, General|anesthetics, general|mesh-ancestor
93086829|NCT01140620|Anesthetics|anesthetics|mesh-ancestor
93086830|NCT01140620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759094|NCT00975130|Golimumab|golimumab|mesh-list
93086831|NCT01140620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93086832|NCT01140620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93086833|NCT01140620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086834|NCT01140620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086835|NCT01140620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93086836|NCT01140620|Serotonin Agents|serotonin agents|mesh-ancestor
93086837|NCT01140620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93086838|NCT01140620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93086839|NCT01140620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93086840|NCT01140620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93086841|NCT01140620|Dopamine Agents|dopamine agents|mesh-ancestor
93086842|NCT03917186|Sevoflurane|sevoflurane|mesh-list
93086843|NCT03917186|Desflurane|desflurane|mesh-list
93086844|NCT03917186|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93086845|NCT03917186|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93086846|NCT03917186|Anesthetics, General|anesthetics, general|mesh-ancestor
93086847|NCT03917186|Anesthetics|anesthetics|mesh-ancestor
93086848|NCT03917186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93086849|NCT03917186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086850|NCT04713098|Coal Tar|coal tar|mesh-list
93086851|NCT04713098|Keratolytic Agents|keratolytic agents|mesh-ancestor
93086852|NCT04713098|Dermatologic Agents|dermatologic agents|mesh-ancestor
93086853|NCT04630730|Gemcitabine|gemcitabine|mesh-list
93086854|NCT04630730|Atezolizumab|atezolizumab|mesh-list
93086855|NCT04630730|BCG Vaccine|bcg vaccine|mesh-list
93086856|NCT04630730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086857|NCT04630730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93086858|NCT04630730|Antimetabolites|antimetabolites|mesh-ancestor
93086859|NCT04630730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086860|NCT04630730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93086861|NCT04630730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086862|NCT04630730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93086863|NCT04630730|Immunologic Factors|immunologic factors|mesh-ancestor
93086864|NCT04630730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086865|NCT01140932|Prednisolone|prednisolone|mesh-list
93086866|NCT01140932|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93086867|NCT01140932|Methylprednisolone|methylprednisolone|mesh-list
93086868|NCT01140932|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93086869|NCT01140932|Prednisolone acetate|prednisolone acetate|mesh-list
93086870|NCT01140932|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93086871|NCT01140932|Prednisolone phosphate|prednisolone phosphate|mesh-list
93086872|NCT01140932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086873|NCT01140932|Glucocorticoids|glucocorticoids|mesh-ancestor
93086874|NCT01140932|Hormones|hormones|mesh-ancestor
93086875|NCT01140932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93086876|NCT01140932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086877|NCT01140932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93086878|NCT01140932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086879|NCT01140932|Antiemetics|antiemetics|mesh-ancestor
93086880|NCT01140932|Autonomic Agents|autonomic agents|mesh-ancestor
93086881|NCT01140932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086882|NCT01140932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086883|NCT01140932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93086884|NCT01140932|Protective Agents|protective agents|mesh-ancestor
93086885|NCT01138904|Oxaliplatin|oxaliplatin|mesh-list
93086886|NCT01138904|Irinotecan|irinotecan|mesh-list
93086887|NCT01138904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086888|NCT01138904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93086889|NCT01138904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086890|NCT01138904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086891|NCT01138904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086892|NCT04582448|Insulin|insulin|mesh-list
93086893|NCT04582448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086894|NCT04582448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086895|NCT05280314|Pembrolizumab|pembrolizumab|mesh-list
93086896|NCT05280314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086897|NCT05280314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086898|NCT05280314|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93086899|NCT05280314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086900|NCT01139138|Irinotecan|irinotecan|mesh-list
93086901|NCT01139138|Everolimus|everolimus|mesh-list
93086902|NCT01139138|Panitumumab|panitumumab|mesh-list
93086903|NCT01139138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93086904|NCT01139138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92759157|NCT02848183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086905|NCT01139138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086906|NCT01139138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086907|NCT01139138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086908|NCT01139138|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93086909|NCT01139138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086910|NCT01139138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93086911|NCT01139138|Immunologic Factors|immunologic factors|mesh-ancestor
93086912|NCT01139138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086913|NCT01139138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93086914|NCT01134224|Insulin|insulin|mesh-list
93086915|NCT01134224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93086916|NCT01134224|Insulin Aspart|insulin aspart|mesh-list
93086917|NCT01134224|Insulin, Long-Acting|insulin, long-acting|mesh-list
93086918|NCT01134224|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93086919|NCT01134224|Biphasic Insulins|biphasic insulins|mesh-list
93086920|NCT01134224|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93086921|NCT01134224|Insulin, Isophane|insulin, isophane|mesh-list
93086922|NCT01134224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086923|NCT01134224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086924|NCT05308888|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93086925|NCT05308888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92677221|NCT00420524|Epothilone B|epothilone b|mesh-list
93086926|NCT05308888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086927|NCT01231490|Naproxen|naproxen|mesh-list
93086928|NCT01231490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93086929|NCT01231490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93086930|NCT01231490|Analgesics|analgesics|mesh-ancestor
93086931|NCT01231490|Sensory System Agents|sensory system agents|mesh-ancestor
93086932|NCT01231490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086933|NCT01231490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086934|NCT01231490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93086935|NCT01231490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93086936|NCT01231490|Gout Suppressants|gout suppressants|mesh-ancestor
93086937|NCT01231490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93086938|NCT01231490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086939|NCT01231490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086940|NCT01141244|Sirolimus|sirolimus|mesh-list
93086941|NCT01141244|Irinotecan|irinotecan|mesh-list
93086942|NCT01141244|Temozolomide|temozolomide|mesh-list
93086943|NCT01141244|Temsirolimus|temsirolimus|mesh-list
93086944|NCT01141244|MTOR Inhibitors|mtor inhibitors|mesh-list
93086945|NCT01141244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93086946|NCT01141244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93086947|NCT01141244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93086948|NCT01141244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086949|NCT01141244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93086950|NCT01141244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93086951|NCT01141244|Alkylating Agents|alkylating agents|mesh-ancestor
93086952|NCT01141244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93086953|NCT01141244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93086954|NCT01141244|Immunologic Factors|immunologic factors|mesh-ancestor
93086955|NCT01141244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086956|NCT01141244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93086957|NCT01141244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93086958|NCT01141244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93086959|NCT01141244|Antifungal Agents|antifungal agents|mesh-ancestor
93086960|NCT01141322|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93086961|NCT01141322|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93086962|NCT01141322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93086963|NCT01141556|Selenium|selenium|mesh-list
93086964|NCT01141556|Antioxidants|antioxidants|mesh-ancestor
93086965|NCT01141556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086966|NCT01141556|Protective Agents|protective agents|mesh-ancestor
93086967|NCT01141556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086968|NCT01141556|Trace Elements|trace elements|mesh-ancestor
93086969|NCT01141556|Micronutrients|micronutrients|mesh-ancestor
93086970|NCT01139372|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93086971|NCT01139372|Lubricant Eye Drops|lubricant eye drops|mesh-list
93086972|NCT01139372|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93086973|NCT03638440|Naloxegol|naloxegol|mesh-list
93086974|NCT03638440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93086975|NCT03638440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086976|NCT03638440|Sensory System Agents|sensory system agents|mesh-ancestor
93086977|NCT03638440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086978|NCT01719640|Insulin|insulin|mesh-list
93086979|NCT01719640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93086980|NCT01719640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086981|NCT02439658|Sotalol|sotalol|mesh-list
93086982|NCT02439658|Dofetilide|dofetilide|mesh-list
93086983|NCT02439658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93086984|NCT02439658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93086985|NCT02439658|Adrenergic Agents|adrenergic agents|mesh-ancestor
93086986|NCT02439658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93086987|NCT02439658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93086988|NCT02439658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086989|NCT02439658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93086990|NCT02439658|Sympatholytics|sympatholytics|mesh-ancestor
93086991|NCT02439658|Autonomic Agents|autonomic agents|mesh-ancestor
93086992|NCT02439658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93086993|NCT02439658|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93086994|NCT02439658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93086995|NCT05191394|Antibodies|antibodies|mesh-list
93086996|NCT05191394|Immunologic Factors|immunologic factors|mesh-ancestor
93086997|NCT05191394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93086998|NCT04895098|Ezetimibe|ezetimibe|mesh-list
93086999|NCT04895098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93087000|NCT04895098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93087001|NCT04895098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93087002|NCT04895098|Antimetabolites|antimetabolites|mesh-ancestor
93087003|NCT04895098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087004|NCT04895098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93087005|NCT04895098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087006|NCT00318461|Metformin|metformin|mesh-list
93087007|NCT00318461|Liraglutide|liraglutide|mesh-list
93087008|NCT00318461|Glimepiride|glimepiride|mesh-list
93087009|NCT00318461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087010|NCT00318461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087011|NCT00318461|Incretins|incretins|mesh-ancestor
93087012|NCT00318461|Hormones|hormones|mesh-ancestor
93087013|NCT00318461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93087014|NCT00318461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93087015|NCT00318461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087016|NCT00318461|Immunologic Factors|immunologic factors|mesh-ancestor
93087017|NCT01142258|Trazodone|trazodone|mesh-list
93087018|NCT01142258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93087019|NCT01142258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93087020|NCT01142258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087021|NCT01142258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087022|NCT01142258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087023|NCT01142258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93087024|NCT01142258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087025|NCT01142258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087026|NCT01142258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087027|NCT01142258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087028|NCT01142258|Serotonin Agents|serotonin agents|mesh-ancestor
93087029|NCT01142258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93087030|NCT01142258|Antidepressive Agents|antidepressive agents|mesh-ancestor
93087031|NCT05152940|Ertugliflozin|ertugliflozin|mesh-list
93087032|NCT05152940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93087033|NCT05152940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087034|NCT05152940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087035|NCT05152940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087036|NCT01139840|Vitamin D|vitamin d|mesh-list
93087037|NCT01139840|Ergocalciferols|ergocalciferols|mesh-list
93087038|NCT01139840|Cholecalciferol|cholecalciferol|mesh-list
93087039|NCT01139840|Vitamins|vitamins|mesh-list
93087040|NCT01139840|Micronutrients|micronutrients|mesh-ancestor
93087041|NCT01139840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087042|NCT01139840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087043|NCT01139840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087044|NCT02945410|Vitamin D|vitamin d|mesh-list
93087045|NCT02945410|Calcium|calcium|mesh-list
93087046|NCT02945410|Vitamins|vitamins|mesh-ancestor
93087047|NCT02945410|Micronutrients|micronutrients|mesh-ancestor
93087048|NCT02945410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087049|NCT02945410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087050|NCT02945410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087051|NCT03727724|Cetuximab|cetuximab|mesh-list
93087052|NCT03727724|Afatinib|afatinib|mesh-list
93087053|NCT03727724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087054|NCT03727724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087055|NCT03727724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087056|NCT03727724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759308|NCT04672525|Leprostatic Agents|leprostatic agents|mesh-ancestor
93087057|NCT03727724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087059|NCT05032508|Anesthetics, Local|anesthetics, local|mesh-ancestor
93087060|NCT05032508|Anesthetics|anesthetics|mesh-ancestor
93087061|NCT05032508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087062|NCT05032508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087063|NCT05032508|Sensory System Agents|sensory system agents|mesh-ancestor
93087064|NCT05032508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087065|NCT05032508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93087066|NCT05032508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93087067|NCT05032508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93087068|NCT05032508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087069|NCT05032508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087070|NCT01140074|Zinc Sulfate|zinc sulfate|mesh-list
93087071|NCT01140074|Astringents|astringents|mesh-ancestor
93087072|NCT01140074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087073|NCT01140074|Dermatologic Agents|dermatologic agents|mesh-ancestor
93087074|NCT03913442|Colchicine|colchicine|mesh-list
93087075|NCT03913442|Gout Suppressants|gout suppressants|mesh-ancestor
93087076|NCT03913442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93087077|NCT03913442|Tubulin Modulators|tubulin modulators|mesh-ancestor
93087078|NCT03913442|Antimitotic Agents|antimitotic agents|mesh-ancestor
93087079|NCT03913442|Mitosis Modulators|mitosis modulators|mesh-ancestor
93087080|NCT03913442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087081|NCT03913442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087082|NCT01142414|Fluorouracil|fluorouracil|mesh-list
93087083|NCT01142414|Panitumumab|panitumumab|mesh-list
93087084|NCT01142414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087085|NCT01142414|Antimetabolites|antimetabolites|mesh-ancestor
93087086|NCT01142414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087087|NCT01142414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087088|NCT01142414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087089|NCT01142414|Immunologic Factors|immunologic factors|mesh-ancestor
93087090|NCT01142414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087091|NCT01142414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087092|NCT01236482|Oxytocin|oxytocin|mesh-list
93087093|NCT01236482|Ergonovine|ergonovine|mesh-list
93087094|NCT01236482|Oxytocics|oxytocics|mesh-ancestor
93087095|NCT01236482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93087096|NCT01236482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087097|NCT01142492|Interferons|interferons|mesh-list
93087098|NCT01142492|Interferon-beta|interferon-beta|mesh-list
93087099|NCT01142492|Interferon beta-1a|interferon beta-1a|mesh-list
93087100|NCT01142492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087101|NCT01142492|Antiviral Agents|antiviral agents|mesh-ancestor
93087102|NCT01142492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087103|NCT01142492|Immunologic Factors|immunologic factors|mesh-ancestor
93087104|NCT01142492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087105|NCT01142492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93087106|NCT03958474|Remifentanil|remifentanil|mesh-list
93087107|NCT03958474|Oxycodone|oxycodone|mesh-list
93087108|NCT03958474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93087109|NCT03958474|Narcotics|narcotics|mesh-ancestor
93087110|NCT03958474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087111|NCT03958474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087112|NCT03958474|Analgesics|analgesics|mesh-ancestor
93087113|NCT03958474|Sensory System Agents|sensory system agents|mesh-ancestor
93087114|NCT03958474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087115|NCT04956692|Paclitaxel|paclitaxel|mesh-list
93087116|NCT04956692|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93087117|NCT04956692|Carboplatin|carboplatin|mesh-list
93087118|NCT04956692|Pembrolizumab|pembrolizumab|mesh-list
93087119|NCT04956692|Pemetrexed|pemetrexed|mesh-list
93087120|NCT04956692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93087121|NCT04956692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087122|NCT04956692|Tubulin Modulators|tubulin modulators|mesh-ancestor
93087123|NCT04956692|Antimitotic Agents|antimitotic agents|mesh-ancestor
93087124|NCT04956692|Mitosis Modulators|mitosis modulators|mesh-ancestor
93087125|NCT04956692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087126|NCT04956692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087127|NCT04956692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93087128|NCT04956692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087129|NCT04956692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93087130|NCT04956692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93087131|NCT01234142|Varenicline|varenicline|mesh-list
93087132|NCT01234142|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93087133|NCT01234142|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93087134|NCT01234142|Cholinergic Agents|cholinergic agents|mesh-ancestor
93087135|NCT01234142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087136|NCT01234142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087137|NCT01234142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087138|NCT01140308|Ubiquinone|ubiquinone|mesh-list
93087139|NCT01140308|Coenzyme Q10|coenzyme q10|mesh-list
93087140|NCT01140308|Micronutrients|micronutrients|mesh-ancestor
93087141|NCT01140308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087142|NCT01140308|Vitamins|vitamins|mesh-ancestor
93087143|NCT01142648|Glycopyrrolate|glycopyrrolate|mesh-list
93087144|NCT01142648|Neostigmine|neostigmine|mesh-list
93087145|NCT01142648|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93087146|NCT01142648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087147|NCT01142648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087148|NCT01142648|Cholinergic Agents|cholinergic agents|mesh-ancestor
93087149|NCT01142648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087150|NCT01142648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087151|NCT01142648|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93087152|NCT01142648|Autonomic Agents|autonomic agents|mesh-ancestor
93087153|NCT01142648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087154|NCT01142648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93087155|NCT01142648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93087156|NCT01142648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93087157|NCT02143726|Everolimus|everolimus|mesh-list
93087158|NCT02143726|Sorafenib|sorafenib|mesh-list
93087159|NCT02143726|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93087160|NCT02143726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087161|NCT02143726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087162|NCT02143726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087163|NCT02143726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087164|NCT02143726|Immunologic Factors|immunologic factors|mesh-ancestor
93087165|NCT02143726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087166|NCT02143726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087167|NCT03503864|Arsenic Trioxide|arsenic trioxide|mesh-list
93087168|NCT03503864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087169|NCT02088112|Durvalumab|durvalumab|mesh-list
93087170|NCT02088112|Gefitinib|gefitinib|mesh-list
93087171|NCT02088112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087172|NCT02088112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087173|NCT02088112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087174|NCT02088112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087175|NCT02088112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087176|NCT01144910|Methacholine Chloride|methacholine chloride|mesh-list
93087177|NCT01144910|Miotics|miotics|mesh-ancestor
93087178|NCT01144910|Autonomic Agents|autonomic agents|mesh-ancestor
93087179|NCT01144910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087180|NCT01144910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087181|NCT01144910|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93087182|NCT01144910|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93087183|NCT01144910|Respiratory System Agents|respiratory system agents|mesh-ancestor
93087184|NCT01144910|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93087185|NCT01144910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93087186|NCT01144910|Cholinergic Agents|cholinergic agents|mesh-ancestor
93087187|NCT01144910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087188|NCT01144910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087189|NCT01234298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93087190|NCT01234298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93087191|NCT01234298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087192|NCT01234298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93087193|NCT01234298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087194|NCT01234298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087195|NCT01234298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087196|NCT01234298|Dopamine Agents|dopamine agents|mesh-ancestor
93087197|NCT01234298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087198|NCT05308342|Hormones|hormones|mesh-list
93087199|NCT05308342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93087200|NCT05308342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087201|NCT03332212|Empagliflozin|empagliflozin|mesh-list
93087202|NCT03332212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93087203|NCT03332212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087204|NCT03332212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087205|NCT03332212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759458|NCT00900757|Palonosetron|palonosetron|mesh-list
93087206|NCT01144988|Bevacizumab|bevacizumab|mesh-list
93087207|NCT01144988|Irinotecan|irinotecan|mesh-list
93087208|NCT01144988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087209|NCT01144988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087210|NCT01144988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93087211|NCT01144988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93087212|NCT01144988|Growth Substances|growth substances|mesh-ancestor
93087213|NCT01144988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087214|NCT01144988|Growth Inhibitors|growth inhibitors|mesh-ancestor
93087215|NCT01144988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93087216|NCT01144988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93087217|NCT01144988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087218|NCT01144988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087219|NCT03331666|Evolocumab|evolocumab|mesh-list
93087220|NCT03331666|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93087221|NCT03331666|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93087222|NCT03331666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93087223|NCT03331666|Antimetabolites|antimetabolites|mesh-ancestor
93087224|NCT03331666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087225|NCT03331666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93087226|NCT03331666|Protease Inhibitors|protease inhibitors|mesh-ancestor
93087227|NCT03331666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087228|NCT03331666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93087229|NCT04828538|Vitamin D|vitamin d|mesh-list
93087230|NCT04828538|Vitamins|vitamins|mesh-list
93087231|NCT04828538|Folic Acid|folic acid|mesh-list
93087232|NCT04828538|Vitamin B Complex|vitamin b complex|mesh-list
93087233|NCT04828538|Micronutrients|micronutrients|mesh-ancestor
93087234|NCT04828538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087235|NCT04828538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087236|NCT04828538|Hematinics|hematinics|mesh-ancestor
93087237|NCT01145144|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93087238|NCT01145144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93087239|NCT01145144|Immunologic Factors|immunologic factors|mesh-ancestor
93087240|NCT01145144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087241|NCT03638206|Immunomodulating Agents|immunomodulating agents|mesh-list
93087242|NCT03638206|Immunologic Factors|immunologic factors|mesh-ancestor
93087243|NCT03638206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087244|NCT00566488|Parathyroid Hormone|parathyroid hormone|mesh-list
93087245|NCT00566488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087246|NCT00566488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087247|NCT04943302|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93087248|NCT04943302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93087249|NCT04943302|Alkylating Agents|alkylating agents|mesh-ancestor
93087250|NCT04943302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087251|NCT04943302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087252|NCT01234454|Olanzapine|olanzapine|mesh-list
93087253|NCT01234454|Risperidone|risperidone|mesh-list
93087254|NCT01234454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93087255|NCT01234454|Serotonin Agents|serotonin agents|mesh-ancestor
93087256|NCT01234454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087257|NCT01234454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087258|NCT01234454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087259|NCT01234454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93087260|NCT01234454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93087261|NCT01234454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087262|NCT01234454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087263|NCT01234454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93087264|NCT01234454|Dopamine Agents|dopamine agents|mesh-ancestor
93087265|NCT01234454|Antiemetics|antiemetics|mesh-ancestor
93087266|NCT01234454|Autonomic Agents|autonomic agents|mesh-ancestor
93087267|NCT01234454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087268|NCT01234454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93087269|NCT01234454|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93087270|NCT01234454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087271|NCT01234454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087272|NCT01145456|Gemcitabine|gemcitabine|mesh-list
93087273|NCT01145456|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93087274|NCT01145456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087275|NCT01145456|Antimetabolites|antimetabolites|mesh-ancestor
93087276|NCT01145456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087277|NCT01145456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087278|NCT01145456|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93087280|NCT04939636|Vitamin D|vitamin d|mesh-list
93087281|NCT04939636|Ergocalciferols|ergocalciferols|mesh-list
93087282|NCT04939636|Cholecalciferol|cholecalciferol|mesh-list
93087283|NCT04939636|Vitamins|vitamins|mesh-list
93087284|NCT04939636|Micronutrients|micronutrients|mesh-ancestor
93087285|NCT04939636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087286|NCT04939636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087287|NCT04939636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087288|NCT01238276|Cefazolin|cefazolin|mesh-list
93087289|NCT01238276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93087290|NCT01238276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087291|NCT01145534|Glyburide|glyburide|mesh-list
93087292|NCT01145534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087293|NCT01145534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087294|NCT01145612|Losartan|losartan|mesh-list
93087295|NCT01145612|Atenolol|atenolol|mesh-list
93087296|NCT01145612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93087297|NCT01145612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93087298|NCT01145612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93087299|NCT01145612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93087300|NCT01145612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087301|NCT01145612|Sympatholytics|sympatholytics|mesh-ancestor
93087302|NCT01145612|Autonomic Agents|autonomic agents|mesh-ancestor
93087303|NCT01145612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087304|NCT01145612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087305|NCT01145612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93087306|NCT01145612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93087307|NCT01145612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93087308|NCT01145612|Adrenergic Agents|adrenergic agents|mesh-ancestor
93087309|NCT01145612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087310|NCT05293366|Dermatologic Agents|dermatologic agents|mesh-list
93087311|NCT03621670|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93087312|NCT03621670|Immunologic Factors|immunologic factors|mesh-ancestor
93087313|NCT03621670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087314|NCT01143584|Dopamine|dopamine|mesh-list
93087315|NCT01143584|Cabergoline|cabergoline|mesh-list
93087316|NCT01143584|Dopamine Agonists|dopamine agonists|mesh-list
93087317|NCT01143584|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93087318|NCT01143584|Sympathomimetics|sympathomimetics|mesh-ancestor
93087319|NCT01143584|Autonomic Agents|autonomic agents|mesh-ancestor
93087320|NCT01143584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087321|NCT01143584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087322|NCT01143584|Dopamine Agents|dopamine agents|mesh-ancestor
93087323|NCT01143584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087324|NCT01143584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087325|NCT01143584|Protective Agents|protective agents|mesh-ancestor
93087326|NCT01143584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93087327|NCT01143584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93087328|NCT01145846|Cytarabine|cytarabine|mesh-list
93087329|NCT01145846|Daunorubicin|daunorubicin|mesh-list
93087330|NCT01145846|Idarubicin|idarubicin|mesh-list
93087331|NCT01145846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087332|NCT01145846|Antimetabolites|antimetabolites|mesh-ancestor
93087333|NCT01145846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087334|NCT01145846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087335|NCT01145846|Antiviral Agents|antiviral agents|mesh-ancestor
93087336|NCT01145846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087337|NCT01145846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087338|NCT01145846|Immunologic Factors|immunologic factors|mesh-ancestor
93087339|NCT01145846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087340|NCT01145846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93087341|NCT01145846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93087342|NCT01145846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93087343|NCT01145846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087344|NCT03134456|Pembrolizumab|pembrolizumab|mesh-list
93087345|NCT03134456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087346|NCT03134456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087347|NCT03134456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93087348|NCT03134456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087349|NCT01143662|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93087350|NCT01143662|Antiviral Agents|antiviral agents|mesh-ancestor
93087351|NCT01143662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087352|NCT05173688|Propofol|propofol|mesh-list
93087353|NCT05173688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92759611|NCT00968968|Lapatinib|lapatinib|mesh-list
93087354|NCT05173688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087355|NCT05173688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087356|NCT05173688|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087357|NCT05173688|Anesthetics, General|anesthetics, general|mesh-ancestor
93087358|NCT05173688|Anesthetics|anesthetics|mesh-ancestor
93087359|NCT01146548|Fluoxetine|fluoxetine|mesh-list
93087360|NCT01146548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93087361|NCT01146548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087362|NCT01146548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087363|NCT01146548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087364|NCT01146548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087365|NCT01146548|Serotonin Agents|serotonin agents|mesh-ancestor
93087366|NCT01146548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087367|NCT01146548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93087368|NCT01146548|Antidepressive Agents|antidepressive agents|mesh-ancestor
93087369|NCT01146548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087370|NCT01146548|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93087371|NCT01146548|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93087372|NCT01146548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087373|NCT03478930|Omalizumab|omalizumab|mesh-list
93087374|NCT03478930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93087375|NCT03478930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93087376|NCT03478930|Respiratory System Agents|respiratory system agents|mesh-ancestor
93087377|NCT01312714|Vitamin D|vitamin d|mesh-list
93087378|NCT01312714|Cholecalciferol|cholecalciferol|mesh-list
93087379|NCT01312714|Vitamins|vitamins|mesh-ancestor
93087380|NCT01312714|Micronutrients|micronutrients|mesh-ancestor
93087381|NCT01312714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087382|NCT01312714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087383|NCT01312714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087384|NCT04188028|Dextromethorphan|dextromethorphan|mesh-list
93087385|NCT04188028|Paroxetine|paroxetine|mesh-list
93087386|NCT04188028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93087387|NCT04188028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087388|NCT04188028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087389|NCT04188028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087390|NCT04188028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087391|NCT04188028|Serotonin Agents|serotonin agents|mesh-ancestor
93087392|NCT04188028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087393|NCT04188028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93087394|NCT04188028|Antidepressive Agents|antidepressive agents|mesh-ancestor
93087395|NCT04188028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087396|NCT04188028|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93087397|NCT04188028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93087398|NCT04188028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087399|NCT04188028|Antitussive Agents|antitussive agents|mesh-ancestor
93087400|NCT04188028|Respiratory System Agents|respiratory system agents|mesh-ancestor
93087401|NCT04188028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93087402|NCT04188028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93087403|NCT01312792|Ampicillin|ampicillin|mesh-list
93087404|NCT01312792|Cephradine|cephradine|mesh-list
93087405|NCT01312792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93087406|NCT01312792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087407|NCT03523000|Fentanyl|fentanyl|mesh-list
93087408|NCT03523000|Bupivacaine|bupivacaine|mesh-list
93087409|NCT03523000|Anesthetics, Local|anesthetics, local|mesh-ancestor
93087410|NCT03523000|Anesthetics|anesthetics|mesh-ancestor
93087411|NCT03523000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087412|NCT03523000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087413|NCT03523000|Sensory System Agents|sensory system agents|mesh-ancestor
93087414|NCT03523000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087415|NCT03523000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93087416|NCT03523000|Narcotics|narcotics|mesh-ancestor
93087417|NCT03523000|Analgesics|analgesics|mesh-ancestor
93087418|NCT03523000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93087419|NCT03523000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087420|NCT03523000|Anesthetics, General|anesthetics, general|mesh-ancestor
93087421|NCT04705480|Pregabalin|pregabalin|mesh-list
93087422|NCT04705480|Gabapentin|gabapentin|mesh-list
93087423|NCT04705480|Analgesics|analgesics|mesh-ancestor
93087424|NCT04705480|Sensory System Agents|sensory system agents|mesh-ancestor
93087425|NCT04705480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087426|NCT04705480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759676|NCT02842567|Antioxidants|antioxidants|mesh-ancestor
93087427|NCT04705480|Anticonvulsants|anticonvulsants|mesh-ancestor
93087428|NCT04705480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93087429|NCT04705480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087430|NCT04705480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087431|NCT04705480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087432|NCT04705480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93087433|NCT04705480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93087434|NCT04705480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087435|NCT04705480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087436|NCT04705480|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93087437|NCT04705480|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93087438|NCT04705480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087439|NCT04705480|Antimanic Agents|antimanic agents|mesh-ancestor
93087440|NCT01238978|Vildagliptin|vildagliptin|mesh-list
93087441|NCT01238978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087442|NCT01238978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087443|NCT01238978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93087444|NCT01238978|Protease Inhibitors|protease inhibitors|mesh-ancestor
93087445|NCT01238978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087446|NCT01238978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087447|NCT00318149|Vaccines|vaccines|mesh-list
93087448|NCT00318149|Immunologic Factors|immunologic factors|mesh-ancestor
93087449|NCT00318149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087450|NCT04648696|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93087451|NCT04648696|Vancomycin|vancomycin|mesh-list
93087452|NCT04648696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93087453|NCT04648696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087454|NCT04648696|Antitubercular Agents|antitubercular agents|mesh-ancestor
93087455|NCT01236716|Paclitaxel|paclitaxel|mesh-list
93087456|NCT01236716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93087457|NCT01236716|Carboplatin|carboplatin|mesh-list
93087458|NCT01236716|Gemcitabine|gemcitabine|mesh-list
93087459|NCT01236716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93087460|NCT01236716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087461|NCT01236716|Tubulin Modulators|tubulin modulators|mesh-ancestor
93087462|NCT01236716|Antimitotic Agents|antimitotic agents|mesh-ancestor
93087463|NCT01236716|Mitosis Modulators|mitosis modulators|mesh-ancestor
93087464|NCT01236716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087465|NCT01236716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087466|NCT01236716|Antimetabolites|antimetabolites|mesh-ancestor
93087467|NCT04154800|Itraconazole|itraconazole|mesh-list
93087468|NCT04154800|Diltiazem|diltiazem|mesh-list
93087469|NCT04154800|Antifungal Agents|antifungal agents|mesh-ancestor
93087470|NCT04154800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087471|NCT04154800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93087472|NCT04154800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93087473|NCT04154800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087474|NCT04154800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087475|NCT04154800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93087476|NCT04154800|Hormone Antagonists|hormone antagonists|mesh-ancestor
93087477|NCT04154800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677775|NCT00335699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93087478|NCT04154800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087479|NCT04154800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93087480|NCT04154800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93087481|NCT04154800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93087482|NCT04154800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087483|NCT04154800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087484|NCT04154800|Vasodilator Agents|vasodilator agents|mesh-ancestor
93087485|NCT01048229|Pramipexole|pramipexole|mesh-list
93087486|NCT01048229|Rasagiline|rasagiline|mesh-list
93087487|NCT01048229|Antioxidants|antioxidants|mesh-ancestor
93087488|NCT01048229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087489|NCT01048229|Protective Agents|protective agents|mesh-ancestor
93087490|NCT01048229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087491|NCT01048229|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93087492|NCT01048229|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93087493|NCT01048229|Dopamine Agonists|dopamine agonists|mesh-ancestor
93087494|NCT01048229|Dopamine Agents|dopamine agents|mesh-ancestor
93087495|NCT01048229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087496|NCT01048229|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93087497|NCT01048229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087498|NCT01048229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93087499|NCT01048307|Polihexanide|polihexanide|mesh-list
93087500|NCT01048307|Betaine|betaine|mesh-list
93087501|NCT01048307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93087502|NCT01048307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93087503|NCT01048307|Lipotropic Agents|lipotropic agents|mesh-ancestor
93087504|NCT01048307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93087505|NCT01048307|Antimetabolites|antimetabolites|mesh-ancestor
93087506|NCT01048307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087507|NCT01048307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93087508|NCT01048307|Disinfectants|disinfectants|mesh-ancestor
93087509|NCT01048307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087510|NCT04017832|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93087511|NCT04017832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087512|NCT04017832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087513|NCT04017832|Incretins|incretins|mesh-ancestor
93087514|NCT04017832|Hormones|hormones|mesh-ancestor
93087515|NCT04017832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93087516|NCT04017832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93087517|NCT04017832|Protease Inhibitors|protease inhibitors|mesh-ancestor
93087518|NCT04017832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087519|NCT04017832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087520|NCT02049905|Gemcitabine|gemcitabine|mesh-list
93087521|NCT02049905|Docetaxel|docetaxel|mesh-list
93087522|NCT02049905|Doxorubicin|doxorubicin|mesh-list
93087523|NCT02049905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93087524|NCT02049905|Ifosfamide|ifosfamide|mesh-list
93087525|NCT02049905|Isophosphamide mustard|isophosphamide mustard|mesh-list
93087526|NCT02049905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087527|NCT02049905|Antimetabolites|antimetabolites|mesh-ancestor
93087528|NCT02049905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087529|NCT02049905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087530|NCT02049905|Tubulin Modulators|tubulin modulators|mesh-ancestor
93087531|NCT02049905|Antimitotic Agents|antimitotic agents|mesh-ancestor
93087532|NCT02049905|Mitosis Modulators|mitosis modulators|mesh-ancestor
93087533|NCT02049905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93087534|NCT02049905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93087535|NCT02049905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93087536|NCT02049905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087537|NCT02049905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93087538|NCT02049905|Alkylating Agents|alkylating agents|mesh-ancestor
93087539|NCT01062191|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93087540|NCT01062191|Laxatives|laxatives|mesh-ancestor
93087541|NCT01062191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93087542|NCT01058759|Enoxaparin|enoxaparin|mesh-list
93087543|NCT01058759|Enoxaparin sodium|enoxaparin sodium|mesh-list
93087544|NCT01058759|Anticoagulants|anticoagulants|mesh-ancestor
93087545|NCT01058759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93087546|NCT01058759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93087547|NCT01058759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087548|NCT01239368|Sirolimus|sirolimus|mesh-list
93087549|NCT01239368|Immunologic Factors|immunologic factors|mesh-ancestor
93087550|NCT01239368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087551|NCT01239368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93087552|NCT01239368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087553|NCT01239368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93087554|NCT01239368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087555|NCT01239368|Antifungal Agents|antifungal agents|mesh-ancestor
93087556|NCT01239368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087557|NCT01146002|Guanfacine|guanfacine|mesh-list
93087558|NCT01146002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93087559|NCT01146002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93087560|NCT01146002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93087561|NCT01146002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93087562|NCT01146002|Adrenergic Agents|adrenergic agents|mesh-ancestor
93087563|NCT01146002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087564|NCT01146002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087565|NCT01146002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087566|NCT01146626|Vitamin D|vitamin d|mesh-list
93087567|NCT01146626|Ribavirin|ribavirin|mesh-list
93087568|NCT01146626|Vitamins|vitamins|mesh-ancestor
93087569|NCT01146626|Micronutrients|micronutrients|mesh-ancestor
93087570|NCT01146626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087571|NCT01146626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087572|NCT01146626|Antimetabolites|antimetabolites|mesh-ancestor
93087573|NCT01146626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087574|NCT01146626|Antiviral Agents|antiviral agents|mesh-ancestor
93087575|NCT01146626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087576|NCT02924324|Propofol|propofol|mesh-list
93087577|NCT02924324|Ropivacaine|ropivacaine|mesh-list
93087578|NCT02924324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93087579|NCT02924324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087580|NCT02924324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087581|NCT02924324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087582|NCT02924324|Anesthetics, General|anesthetics, general|mesh-ancestor
93087583|NCT02924324|Anesthetics|anesthetics|mesh-ancestor
93087584|NCT02924324|Anesthetics, Local|anesthetics, local|mesh-ancestor
93087585|NCT02924324|Sensory System Agents|sensory system agents|mesh-ancestor
93087586|NCT02924324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087587|NCT03518606|Durvalumab|durvalumab|mesh-list
93087588|NCT03518606|Vinorelbine|vinorelbine|mesh-list
93087589|NCT03518606|Tremelimumab|tremelimumab|mesh-list
93087590|NCT03518606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087591|NCT03518606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087592|NCT03518606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93087593|NCT03518606|Tubulin Modulators|tubulin modulators|mesh-ancestor
93087594|NCT03518606|Antimitotic Agents|antimitotic agents|mesh-ancestor
93087595|NCT03518606|Mitosis Modulators|mitosis modulators|mesh-ancestor
93087596|NCT03518606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087597|NCT05137574|Ketamine|ketamine|mesh-list
93087598|NCT05137574|Propofol|propofol|mesh-list
93087599|NCT05137574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93087600|NCT05137574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087601|NCT05137574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087602|NCT05137574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087603|NCT05137574|Anesthetics, General|anesthetics, general|mesh-ancestor
93087604|NCT05137574|Anesthetics|anesthetics|mesh-ancestor
93087605|NCT05137574|Analgesics|analgesics|mesh-ancestor
93087606|NCT05137574|Sensory System Agents|sensory system agents|mesh-ancestor
93087607|NCT05137574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087608|NCT05137574|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93087609|NCT05137574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93087610|NCT05137574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93087611|NCT05137574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087612|NCT05137574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087613|NCT02842424|Ramipril|ramipril|mesh-list
93087614|NCT02842424|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93087615|NCT02842424|Protease Inhibitors|protease inhibitors|mesh-ancestor
93087616|NCT02842424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087617|NCT02842424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087618|NCT02842424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93087619|NCT01236950|Listerine|listerine|mesh-list
93087620|NCT01236950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93087621|NCT01236950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087622|NCT04971746|Pirfenidone|pirfenidone|mesh-list
93087623|NCT04971746|Nintedanib|nintedanib|mesh-list
92403400|NCT04203472|Hormones|hormones|mesh-ancestor
93087624|NCT04971746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087625|NCT04971746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087626|NCT04971746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087627|NCT04971746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087628|NCT04971746|Analgesics|analgesics|mesh-ancestor
93087629|NCT04971746|Sensory System Agents|sensory system agents|mesh-ancestor
93087630|NCT04971746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087631|NCT04971746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087632|NCT04971746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93087633|NCT04971746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93087634|NCT04971746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93087635|NCT04971746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93087636|NCT00369161|Everolimus|everolimus|mesh-list
93087637|NCT00369161|Tacrolimus|tacrolimus|mesh-list
93087638|NCT00369161|Basiliximab|basiliximab|mesh-list
93087639|NCT00369161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087640|NCT00369161|Immunologic Factors|immunologic factors|mesh-ancestor
93087641|NCT00369161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087642|NCT00369161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93087643|NCT00369161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087644|NCT00369161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087645|NCT00369161|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93087646|NCT00369161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087647|NCT00369161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087648|NCT01143974|Pemetrexed|pemetrexed|mesh-list
93087649|NCT01143974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087650|NCT01143974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087651|NCT01143974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087652|NCT01143974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93087653|NCT01143974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93087654|NCT00337571|Aripiprazole|aripiprazole|mesh-list
93087655|NCT00337571|Antidepressive Agents|antidepressive agents|mesh-ancestor
93087656|NCT00337571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087657|NCT00337571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93087658|NCT00337571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93087659|NCT00337571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087660|NCT00337571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087661|NCT00337571|Dopamine Agonists|dopamine agonists|mesh-ancestor
93087662|NCT00337571|Dopamine Agents|dopamine agents|mesh-ancestor
93087663|NCT00337571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087664|NCT00337571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087665|NCT00337571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93087666|NCT00337571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93087667|NCT00337571|Serotonin Agents|serotonin agents|mesh-ancestor
93087668|NCT00337571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93087669|NCT00337571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93087670|NCT00337571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93087671|NCT00337571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93087672|NCT01247870|Metformin|metformin|mesh-list
93087673|NCT01247870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087674|NCT01247870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087675|NCT02528396|Insulin Lispro|insulin lispro|mesh-list
93087676|NCT02528396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087677|NCT02528396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087678|NCT03985319|Esomeprazole|esomeprazole|mesh-list
93087679|NCT03985319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93087680|NCT03985319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93087681|NCT03985319|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93087682|NCT03985319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087683|NCT03985319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087684|NCT01237028|Calcitriol|calcitriol|mesh-list
93087685|NCT01237028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93087686|NCT01237028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087687|NCT01237028|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93087688|NCT01237028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087689|NCT01237028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087690|NCT01237028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93087691|NCT01237028|Vitamins|vitamins|mesh-ancestor
93087692|NCT01237028|Micronutrients|micronutrients|mesh-ancestor
93087693|NCT01237028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087694|NCT01240850|Prednisone|prednisone|mesh-list
93087695|NCT01240850|Methotrexate|methotrexate|mesh-list
93087696|NCT01240850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93087697|NCT01240850|Glucocorticoids|glucocorticoids|mesh-ancestor
93087698|NCT01240850|Hormones|hormones|mesh-ancestor
93087699|NCT01240850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93087700|NCT01240850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087701|NCT01240850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93087702|NCT01240850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087703|NCT01240850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93087704|NCT01240850|Abortifacient Agents|abortifacient agents|mesh-ancestor
93087705|NCT01240850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93087706|NCT01240850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087707|NCT01240850|Antimetabolites|antimetabolites|mesh-ancestor
93087708|NCT01240850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087709|NCT01240850|Dermatologic Agents|dermatologic agents|mesh-ancestor
93087710|NCT01240850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087711|NCT01240850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93087712|NCT01240850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087713|NCT01240850|Immunologic Factors|immunologic factors|mesh-ancestor
93087714|NCT01240850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93087715|NCT01240850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93087716|NCT04813016|Dexmedetomidine|dexmedetomidine|mesh-list
93087717|NCT04813016|Tramadol|tramadol|mesh-list
93087718|NCT04813016|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93087719|NCT04813016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087720|NCT04813016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087721|NCT04813016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93087722|NCT04813016|Analgesics|analgesics|mesh-ancestor
93087723|NCT04813016|Sensory System Agents|sensory system agents|mesh-ancestor
93087724|NCT04813016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087725|NCT04813016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92759981|NCT05333731|Oxytocics|oxytocics|mesh-ancestor
93087726|NCT04813016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93087727|NCT04813016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93087728|NCT04813016|Adrenergic Agents|adrenergic agents|mesh-ancestor
93087729|NCT04813016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087730|NCT04813016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087731|NCT04813016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93087732|NCT04813016|Narcotics|narcotics|mesh-ancestor
93087734|NCT00368927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93087735|NCT00368927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93087736|NCT00368927|Analgesics|analgesics|mesh-ancestor
93087737|NCT00368927|Sensory System Agents|sensory system agents|mesh-ancestor
93087738|NCT00368927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087739|NCT00368927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087740|NCT00368927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93087741|NCT00368927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93087742|NCT00368927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087743|NCT00368927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93087744|NCT00368927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087745|NCT00368927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087746|NCT01242410|Silicon|silicon|mesh-list
93087747|NCT01242410|Trace Elements|trace elements|mesh-ancestor
93087748|NCT01242410|Micronutrients|micronutrients|mesh-ancestor
93087749|NCT01242410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087750|NCT02655692|Ketamine|ketamine|mesh-list
93087751|NCT02655692|Analgesics|analgesics|mesh-ancestor
93087752|NCT02655692|Sensory System Agents|sensory system agents|mesh-ancestor
93087753|NCT02655692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087754|NCT02655692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087755|NCT02655692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93087756|NCT02655692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087757|NCT02655692|Anesthetics, General|anesthetics, general|mesh-ancestor
93087758|NCT02655692|Anesthetics|anesthetics|mesh-ancestor
93087759|NCT02655692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087760|NCT02655692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93087761|NCT02655692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93087762|NCT02655692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087763|NCT02655692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087764|NCT01237262|Adalimumab|adalimumab|mesh-list
93087765|NCT01237262|Infliximab|infliximab|mesh-list
93087766|NCT01237262|Etanercept|etanercept|mesh-list
93087767|NCT01237262|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93087768|NCT01237262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93087769|NCT01237262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93087770|NCT01237262|Dermatologic Agents|dermatologic agents|mesh-ancestor
93087771|NCT01237262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93087772|NCT01237262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93087773|NCT01237262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93087774|NCT01237262|Analgesics|analgesics|mesh-ancestor
93087775|NCT01237262|Sensory System Agents|sensory system agents|mesh-ancestor
93087776|NCT01237262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087777|NCT01237262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087778|NCT01237262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087779|NCT01237262|Immunologic Factors|immunologic factors|mesh-ancestor
93087780|NCT01329770|Vitamins|vitamins|mesh-list
93087781|NCT01329770|Ascorbic Acid|ascorbic acid|mesh-list
93087782|NCT01329770|Vitamin E|vitamin e|mesh-list
93087783|NCT01329770|Tocopherols|tocopherols|mesh-list
93087784|NCT01329770|alpha-Tocopherol|alpha-tocopherol|mesh-list
93087785|NCT01329770|Micronutrients|micronutrients|mesh-ancestor
93087786|NCT01329770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087787|NCT01329770|Antioxidants|antioxidants|mesh-ancestor
93087788|NCT01329770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087789|NCT01329770|Protective Agents|protective agents|mesh-ancestor
93087790|NCT00316589|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93087791|NCT00316589|Antiviral Agents|antiviral agents|mesh-ancestor
93087792|NCT00316589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087793|NCT01048385|Ubiquinone|ubiquinone|mesh-list
93087794|NCT01048385|Coenzyme Q10|coenzyme q10|mesh-list
93087795|NCT01048385|Micronutrients|micronutrients|mesh-ancestor
93087796|NCT01048385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087797|NCT01048385|Vitamins|vitamins|mesh-ancestor
93087798|NCT03916640|Insulin Lispro|insulin lispro|mesh-list
93087799|NCT03916640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93087800|NCT03916640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087801|NCT03916250|Petrolatum|petrolatum|mesh-list
93087802|NCT03916250|PF-06700841|pf-06700841|mesh-list
93087803|NCT03916250|Emollients|emollients|mesh-ancestor
93087804|NCT03916250|Dermatologic Agents|dermatologic agents|mesh-ancestor
93087805|NCT03916250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087806|NCT03916250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087807|NCT03916250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087808|NCT01062503|Zoledronic Acid|zoledronic acid|mesh-list
93087809|NCT01062503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93087810|NCT01062503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087811|NCT03916406|Midazolam|midazolam|mesh-list
93087812|NCT03916406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93087813|NCT03916406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93087814|NCT03916406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087815|NCT03916406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087816|NCT03916406|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93087817|NCT03916406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93087818|NCT03916406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93087819|NCT03916406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087820|NCT03916406|Anesthetics, General|anesthetics, general|mesh-ancestor
93087821|NCT03916406|Anesthetics|anesthetics|mesh-ancestor
93087822|NCT03916406|GABA Modulators|gaba modulators|mesh-ancestor
93087823|NCT03916406|GABA Agents|gaba agents|mesh-ancestor
93087824|NCT03916406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087825|NCT03916406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087826|NCT00316277|Opiate Alkaloids|opiate alkaloids|mesh-list
93087827|NCT00316277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93087828|NCT00316277|Narcotics|narcotics|mesh-ancestor
93087829|NCT00316277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087830|NCT00316277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087831|NCT00316277|Analgesics|analgesics|mesh-ancestor
93087832|NCT00316277|Sensory System Agents|sensory system agents|mesh-ancestor
93087833|NCT00316277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087834|NCT01249352|Fluorouracil|fluorouracil|mesh-list
93087835|NCT01249352|Nimotuzumab|nimotuzumab|mesh-list
93087836|NCT01249352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087837|NCT01249352|Antimetabolites|antimetabolites|mesh-ancestor
93087838|NCT01249352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087839|NCT01249352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087840|NCT01249352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087841|NCT01249352|Immunologic Factors|immunologic factors|mesh-ancestor
93087842|NCT01249352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087843|NCT01249352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087844|NCT03912974|Escitalopram|escitalopram|mesh-list
93087845|NCT03912974|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93087846|NCT03912974|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087847|NCT03912974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087848|NCT03912974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087849|NCT03912974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087850|NCT03912974|Serotonin Agents|serotonin agents|mesh-ancestor
93087851|NCT03912974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087852|NCT00368849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93087853|NCT00368849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93087854|NCT00368849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93087855|NCT00368849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087856|NCT00368849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087857|NCT00368849|Adrenergic Agents|adrenergic agents|mesh-ancestor
93087858|NCT00368849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087859|NCT00368849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087860|NCT01144676|Dapivirine|dapivirine|mesh-list
93087861|NCT01144676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93087862|NCT01144676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93087863|NCT01144676|Antiviral Agents|antiviral agents|mesh-ancestor
93087864|NCT01144676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087865|NCT00316199|Paclitaxel|paclitaxel|mesh-list
93087866|NCT00316199|Gemcitabine|gemcitabine|mesh-list
93087867|NCT00316199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93087868|NCT00316199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087869|NCT00316199|Tubulin Modulators|tubulin modulators|mesh-ancestor
93087870|NCT00316199|Antimitotic Agents|antimitotic agents|mesh-ancestor
93087871|NCT00316199|Mitosis Modulators|mitosis modulators|mesh-ancestor
93087872|NCT00316199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087873|NCT00316199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93087874|NCT00316199|Antimetabolites|antimetabolites|mesh-ancestor
93087875|NCT01147718|Digoxin|digoxin|mesh-list
93087876|NCT01147718|rGLP-1 protein|rglp-1 protein|mesh-list
93087877|NCT01147718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93087878|NCT01147718|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93087879|NCT01147718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087880|NCT01147718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087881|NCT01147718|Protective Agents|protective agents|mesh-ancestor
93087882|NCT01147718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087883|NCT01147718|Incretins|incretins|mesh-ancestor
93087884|NCT01147718|Hormones|hormones|mesh-ancestor
93087885|NCT01147718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93087886|NCT03913052|Viscosupplements|viscosupplements|mesh-list
93087887|NCT03913052|Protective Agents|protective agents|mesh-ancestor
93087888|NCT03913052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087889|NCT03915938|Ketamine|ketamine|mesh-list
93087890|NCT03915938|Analgesics|analgesics|mesh-ancestor
93087891|NCT03915938|Sensory System Agents|sensory system agents|mesh-ancestor
93087892|NCT03915938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087893|NCT03915938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087894|NCT03915938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93087895|NCT03915938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93087896|NCT03915938|Anesthetics, General|anesthetics, general|mesh-ancestor
93087897|NCT03915938|Anesthetics|anesthetics|mesh-ancestor
93087898|NCT03915938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087899|NCT03915938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93087900|NCT03915938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93087901|NCT03915938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087902|NCT03915938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087903|NCT01237496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93087904|NCT01237496|Antiviral Agents|antiviral agents|mesh-ancestor
93087905|NCT01237496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087906|NCT01251458|Temsirolimus|temsirolimus|mesh-list
93087907|NCT01251458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93087908|NCT01251458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93087909|NCT01251458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087910|NCT01251458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087911|NCT01251458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93087912|NCT01251458|Immunologic Factors|immunologic factors|mesh-ancestor
93087913|NCT01251458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087914|NCT01251458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087915|NCT03912740|Dexmedetomidine|dexmedetomidine|mesh-list
93087916|NCT03912740|Remifentanil|remifentanil|mesh-list
93087917|NCT03912740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93087918|NCT03912740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087919|NCT03912740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087920|NCT03912740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93087921|NCT03912740|Analgesics|analgesics|mesh-ancestor
93087922|NCT03912740|Sensory System Agents|sensory system agents|mesh-ancestor
93087923|NCT03912740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087924|NCT03912740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93087925|NCT03912740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93087926|NCT03912740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93087927|NCT03912740|Adrenergic Agents|adrenergic agents|mesh-ancestor
93087928|NCT03912740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087929|NCT03912740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087930|NCT03912740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93087931|NCT03912740|Narcotics|narcotics|mesh-ancestor
93087932|NCT01058915|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93087933|NCT01058915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93087934|NCT01058915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93087935|NCT01058915|Antimetabolites|antimetabolites|mesh-ancestor
93087936|NCT01058915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087937|NCT01058915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93087938|NCT01058915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93087939|NCT01058915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087940|NCT01144754|Rituximab|rituximab|mesh-list
93087941|NCT01144754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087942|NCT01144754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087943|NCT01144754|Immunologic Factors|immunologic factors|mesh-ancestor
93087944|NCT01144754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087945|NCT01144754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93087946|NCT01144832|Ebastine|ebastine|mesh-list
93087947|NCT01144832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93087948|NCT01144832|Histamine Antagonists|histamine antagonists|mesh-ancestor
93087949|NCT01144832|Histamine Agents|histamine agents|mesh-ancestor
93087950|NCT01144832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93087951|NCT01144832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087952|NCT01144832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087953|NCT01251848|Ritonavir|ritonavir|mesh-list
93087954|NCT01251848|Sitaxsentan|sitaxsentan|mesh-list
93087955|NCT01251848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93087956|NCT01251848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93087957|NCT01251848|Protease Inhibitors|protease inhibitors|mesh-ancestor
93087958|NCT01251848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93087959|NCT01251848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087960|NCT01251848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93087961|NCT01251848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93087962|NCT01251848|Antiviral Agents|antiviral agents|mesh-ancestor
93087963|NCT01251848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087964|NCT01251848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93087965|NCT01251848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93087966|NCT01251848|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93087967|NCT01251926|Bevacizumab|bevacizumab|mesh-list
93087968|NCT01251926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93087969|NCT01251926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93087970|NCT01251926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93087971|NCT01251926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93087972|NCT01251926|Growth Substances|growth substances|mesh-ancestor
93087973|NCT01251926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087974|NCT01251926|Growth Inhibitors|growth inhibitors|mesh-ancestor
93087975|NCT03911648|Lidocaine|lidocaine|mesh-list
93087976|NCT03911648|Bupivacaine|bupivacaine|mesh-list
93087977|NCT03911648|Anesthetics, Local|anesthetics, local|mesh-ancestor
93087978|NCT03911648|Anesthetics|anesthetics|mesh-ancestor
93087979|NCT03911648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93087980|NCT03911648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93087981|NCT03911648|Sensory System Agents|sensory system agents|mesh-ancestor
93087982|NCT03911648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087983|NCT03911648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93087984|NCT03911648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93087985|NCT03911648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93087986|NCT03911648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93087987|NCT03911648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93087988|NCT01237730|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93087989|NCT01237730|Cefuroxime|cefuroxime|mesh-list
93087990|NCT01237730|Cefuroxime axetil|cefuroxime axetil|mesh-list
93087991|NCT01237730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087992|NCT01148030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93087993|NCT01148030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93087994|NCT01252160|Capsaicin|capsaicin|mesh-list
93087995|NCT01252160|Antipruritics|antipruritics|mesh-ancestor
93087996|NCT01252160|Dermatologic Agents|dermatologic agents|mesh-ancestor
93087997|NCT01252160|Sensory System Agents|sensory system agents|mesh-ancestor
93087998|NCT01252160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93087999|NCT01252160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088000|NCT00337103|Capecitabine|capecitabine|mesh-list
93088001|NCT00337103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088002|NCT00337103|Antimetabolites|antimetabolites|mesh-ancestor
93088003|NCT00337103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088004|NCT00337103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088005|NCT03911570|Acetaminophen|acetaminophen|mesh-list
93088006|NCT03911570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93088007|NCT03911570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93088008|NCT03911570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088009|NCT03911570|Analgesics|analgesics|mesh-ancestor
93088010|NCT03911570|Sensory System Agents|sensory system agents|mesh-ancestor
93088011|NCT03911570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088012|NCT03911570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088013|NCT03911570|Antipyretics|antipyretics|mesh-ancestor
93088014|NCT03911570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088015|NCT01250366|Ribavirin|ribavirin|mesh-list
93088016|NCT01250366|Antimetabolites|antimetabolites|mesh-ancestor
93088017|NCT01250366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088018|NCT01250366|Antiviral Agents|antiviral agents|mesh-ancestor
93088019|NCT01250366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088020|NCT00075504|Gemcitabine|gemcitabine|mesh-list
93088021|NCT00075504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088022|NCT00075504|Antimetabolites|antimetabolites|mesh-ancestor
93088023|NCT00075504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088024|NCT00075504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088025|NCT01092624|Solifenacin Succinate|solifenacin succinate|mesh-list
93088026|NCT01092624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93088027|NCT01092624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93088028|NCT01092624|Cholinergic Agents|cholinergic agents|mesh-ancestor
93088029|NCT01092624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088030|NCT01092624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088031|NCT01092624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088032|NCT01092624|Urological Agents|urological agents|mesh-ancestor
93088033|NCT00321464|Zoledronic Acid|zoledronic acid|mesh-list
93088034|NCT00321464|Denosumab|denosumab|mesh-list
93088035|NCT00321464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93088036|NCT00321464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088037|NCT02889796|Adalimumab|adalimumab|mesh-list
93088038|NCT02889796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93088039|NCT02889796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088040|NCT02889796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088041|NCT01237808|Cytarabine|cytarabine|mesh-list
93088042|NCT01237808|Etoposide|etoposide|mesh-list
93088043|NCT01237808|Tretinoin|tretinoin|mesh-list
93088044|NCT01237808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93088045|NCT01237808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088046|NCT01237808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93088047|NCT01237808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93088048|NCT01237808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088049|NCT01237808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088050|NCT01237808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088051|NCT01237808|Antimetabolites|antimetabolites|mesh-ancestor
93088052|NCT01237808|Antiviral Agents|antiviral agents|mesh-ancestor
93088053|NCT01237808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088054|NCT01237808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088055|NCT01237808|Immunologic Factors|immunologic factors|mesh-ancestor
93088056|NCT01237808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088057|NCT01237808|Keratolytic Agents|keratolytic agents|mesh-ancestor
93088058|NCT01237808|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088059|NCT03910634|Carboplatin|carboplatin|mesh-list
93088060|NCT03910634|Fluorouracil|fluorouracil|mesh-list
93088061|NCT03910634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088062|NCT03910634|Antimetabolites|antimetabolites|mesh-ancestor
93088063|NCT03910634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088064|NCT03910634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088065|NCT03910634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088066|NCT03910634|Immunologic Factors|immunologic factors|mesh-ancestor
93088067|NCT03910634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088068|NCT03910712|Trastuzumab|trastuzumab|mesh-list
93088069|NCT03910712|Letrozole|letrozole|mesh-list
93088070|NCT03910712|Anastrozole|anastrozole|mesh-list
93088071|NCT03910712|Exemestane|exemestane|mesh-list
93088072|NCT03910712|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93088073|NCT03910712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088074|NCT03910712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088075|NCT03910712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93088076|NCT03910712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088077|NCT03910712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088078|NCT03910712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93088079|NCT03910712|Hormone Antagonists|hormone antagonists|mesh-ancestor
93088080|NCT03910712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088081|NCT03910712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088082|NCT03910712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93088083|NCT03910556|Propofol|propofol|mesh-list
93088084|NCT03910556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93088085|NCT03910556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088086|NCT03910556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088087|NCT03910556|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93088088|NCT03910556|Anesthetics, General|anesthetics, general|mesh-ancestor
93088089|NCT03910556|Anesthetics|anesthetics|mesh-ancestor
93088090|NCT03659578|Thymalfasin|thymalfasin|mesh-list
93088091|NCT03659578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93088092|NCT03659578|Immunologic Factors|immunologic factors|mesh-ancestor
93088093|NCT03659578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088094|NCT02889562|Warfarin|warfarin|mesh-list
93088095|NCT02889562|Apixaban|apixaban|mesh-list
93088096|NCT02889562|Anticoagulants|anticoagulants|mesh-ancestor
93088097|NCT02889562|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93088098|NCT02889562|Antithrombins|antithrombins|mesh-ancestor
93088099|NCT02889562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93088100|NCT02889562|Protease Inhibitors|protease inhibitors|mesh-ancestor
93088101|NCT02889562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760355|NCT00629824|Interferons|interferons|mesh-list
93088102|NCT02889562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088103|NCT03323164|Timolol|timolol|mesh-list
93088104|NCT03323164|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93088105|NCT03323164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088106|NCT03323164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93088107|NCT03323164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93088108|NCT03323164|Adrenergic Agents|adrenergic agents|mesh-ancestor
93088109|NCT03323164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088110|NCT03323164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088111|NCT03323164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93088112|NCT03323164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93088113|NCT03323164|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93088114|NCT03323164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93088115|NCT03323164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93088116|NCT03914690|Epoetin Alfa|epoetin alfa|mesh-list
93088117|NCT03914690|Hematinics|hematinics|mesh-ancestor
93088118|NCT03914534|Valproic Acid|valproic acid|mesh-list
93088119|NCT03914534|Anticonvulsants|anticonvulsants|mesh-ancestor
93088120|NCT03914534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088121|NCT03914534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088122|NCT03914534|GABA Agents|gaba agents|mesh-ancestor
93088123|NCT03914534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088124|NCT03914534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088125|NCT03914534|Antimanic Agents|antimanic agents|mesh-ancestor
93088126|NCT03914534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088127|NCT03914534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088128|NCT03914534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088129|NCT03910088|Acetaminophen|acetaminophen|mesh-list
93088130|NCT03910088|Hydrocortisone|hydrocortisone|mesh-list
93088131|NCT03910088|Diclofenac|diclofenac|mesh-list
93088132|NCT03910088|Pregabalin|pregabalin|mesh-list
93088133|NCT03910088|Caffeine|caffeine|mesh-list
93088134|NCT03910088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088135|NCT03910088|Analgesics|analgesics|mesh-ancestor
93088136|NCT03910088|Sensory System Agents|sensory system agents|mesh-ancestor
93088137|NCT03910088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088138|NCT03910088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088139|NCT03910088|Antipyretics|antipyretics|mesh-ancestor
93088140|NCT03910088|Anticonvulsants|anticonvulsants|mesh-ancestor
93088141|NCT03910088|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93088142|NCT03910088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088143|NCT03910088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088144|NCT03910088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93088145|NCT03910088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93088146|NCT03910088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088147|NCT03910088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088148|NCT03910088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088149|NCT03910088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088150|NCT03910088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93088151|NCT03910088|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93088152|NCT03910088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088153|NCT03910088|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93088154|NCT03910088|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93088155|NCT03910088|Purinergic Agents|purinergic agents|mesh-ancestor
93088156|NCT03910088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088157|NCT03910088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93088158|NCT03910088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088159|NCT03910088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93088160|NCT03610438|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93088161|NCT03610438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088162|NCT03610438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088163|NCT03610438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93088164|NCT03610438|Immunotoxins|immunotoxins|mesh-ancestor
93088165|NCT03610438|Immunoconjugates|immunoconjugates|mesh-ancestor
93088166|NCT03610438|Immunologic Factors|immunologic factors|mesh-ancestor
93088167|NCT03610438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088168|NCT03908372|Docetaxel|docetaxel|mesh-list
93088169|NCT03908372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088170|NCT03908372|Tubulin Modulators|tubulin modulators|mesh-ancestor
93088171|NCT03908372|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088172|NCT03908372|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088173|NCT03908372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088174|NCT05617664|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93088175|NCT05617664|Mirabegron|mirabegron|mesh-list
93088176|NCT05617664|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93088177|NCT05617664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93088178|NCT05617664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93088179|NCT05617664|Adrenergic Agents|adrenergic agents|mesh-ancestor
93088180|NCT05617664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088181|NCT05617664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088182|NCT05617664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088183|NCT05617664|Urological Agents|urological agents|mesh-ancestor
93088184|NCT05617664|Hemostatics|hemostatics|mesh-ancestor
93088185|NCT05617664|Coagulants|coagulants|mesh-ancestor
93088186|NCT05617664|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93088187|NCT05617664|Natriuretic Agents|natriuretic agents|mesh-ancestor
93088188|NCT03909776|Cisplatin|cisplatin|mesh-list
93088189|NCT03909776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088190|NCT01148264|Olanzapine|olanzapine|mesh-list
93088191|NCT01148264|Metoclopramide|metoclopramide|mesh-list
93088192|NCT01148264|Antiemetics|antiemetics|mesh-ancestor
93088193|NCT01148264|Autonomic Agents|autonomic agents|mesh-ancestor
93088194|NCT01148264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088195|NCT01148264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088196|NCT01148264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93088197|NCT01148264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93088198|NCT01148264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088199|NCT01148264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088200|NCT01148264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088201|NCT01148264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93088202|NCT01148264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93088203|NCT01148264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088204|NCT01148264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088205|NCT01148264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088206|NCT01148264|Serotonin Agents|serotonin agents|mesh-ancestor
93088207|NCT01148264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93088208|NCT01148264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93088209|NCT01148264|Dopamine Agents|dopamine agents|mesh-ancestor
93088210|NCT01253252|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93088211|NCT01253252|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93088212|NCT01253252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088213|NCT00086580|Vidarabine|vidarabine|mesh-list
93088214|NCT00086580|Fludarabine|fludarabine|mesh-list
93088215|NCT00086580|Fludarabine phosphate|fludarabine phosphate|mesh-list
93088216|NCT00086580|Alemtuzumab|alemtuzumab|mesh-list
93088217|NCT00086580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088218|NCT00086580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088219|NCT00086580|Antimetabolites|antimetabolites|mesh-ancestor
93088220|NCT00086580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088221|NCT00086580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088222|NCT00086580|Immunologic Factors|immunologic factors|mesh-ancestor
93088223|NCT00086580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088224|NCT00086580|Antiviral Agents|antiviral agents|mesh-ancestor
93088225|NCT00086580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088226|NCT00086580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088227|NCT03908528|Thioctic Acid|thioctic acid|mesh-list
93088228|NCT03908528|Cyclophosphamide|cyclophosphamide|mesh-list
93088229|NCT03908528|Doxorubicin|doxorubicin|mesh-list
93088230|NCT03908528|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93088231|NCT03908528|Paclitaxel|paclitaxel|mesh-list
93088232|NCT03908528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93088233|NCT03908528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088234|NCT03908528|Immunologic Factors|immunologic factors|mesh-ancestor
93088235|NCT03908528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088236|NCT03908528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088237|NCT03908528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93088238|NCT03908528|Alkylating Agents|alkylating agents|mesh-ancestor
93088239|NCT03908528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088240|NCT03908528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088241|NCT03908528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93088242|NCT03908528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93088243|NCT03908528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93088244|NCT03908528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93088245|NCT03908528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088246|NCT03908528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93088247|NCT03908528|Tubulin Modulators|tubulin modulators|mesh-ancestor
93088248|NCT03908528|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088249|NCT03908528|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088250|NCT03908528|Antioxidants|antioxidants|mesh-ancestor
93088251|NCT03908528|Protective Agents|protective agents|mesh-ancestor
93088252|NCT03908528|Vitamin B Complex|vitamin b complex|mesh-ancestor
93088253|NCT03908528|Vitamins|vitamins|mesh-ancestor
93088254|NCT03908528|Micronutrients|micronutrients|mesh-ancestor
93088255|NCT03903458|Nivolumab|nivolumab|mesh-list
93088256|NCT03903458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088257|NCT03903458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088258|NCT03903458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93088259|NCT03903458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088260|NCT00086502|Metformin|metformin|mesh-list
93088261|NCT00086502|Pioglitazone|pioglitazone|mesh-list
93088262|NCT00086502|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93088263|NCT00086502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93088264|NCT00086502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088265|NCT00086502|Incretins|incretins|mesh-ancestor
93088266|NCT00086502|Hormones|hormones|mesh-ancestor
93088267|NCT00086502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088268|NCT00086502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93088269|NCT00086502|Protease Inhibitors|protease inhibitors|mesh-ancestor
93088270|NCT00086502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088271|NCT00086502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088272|NCT03903302|Valproic Acid|valproic acid|mesh-list
93088273|NCT03903302|Anticonvulsants|anticonvulsants|mesh-ancestor
93088274|NCT03903302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088275|NCT03903302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088276|NCT03903302|GABA Agents|gaba agents|mesh-ancestor
93088277|NCT03903302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088278|NCT03903302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088279|NCT03903302|Antimanic Agents|antimanic agents|mesh-ancestor
93088280|NCT03903302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088281|NCT03903302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088282|NCT03903302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088283|NCT03636542|Bupivacaine|bupivacaine|mesh-list
93088284|NCT03636542|Anesthetics, Local|anesthetics, local|mesh-ancestor
93088285|NCT03636542|Anesthetics|anesthetics|mesh-ancestor
93088286|NCT03636542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088287|NCT03636542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088288|NCT03636542|Sensory System Agents|sensory system agents|mesh-ancestor
93088289|NCT03636542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088290|NCT00086190|Paroxetine|paroxetine|mesh-list
93088291|NCT00086190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93088292|NCT00086190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93088293|NCT00086190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93088294|NCT00086190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088295|NCT00086190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088296|NCT00086190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088297|NCT00086190|Serotonin Agents|serotonin agents|mesh-ancestor
93088298|NCT00086190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088299|NCT00086190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93088300|NCT00086190|Antidepressive Agents|antidepressive agents|mesh-ancestor
93088301|NCT00086190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088302|NCT00086190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93088303|NCT00086190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93088304|NCT00086190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088305|NCT00086190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93088306|NCT03275350|Naltrexone|naltrexone|mesh-list
93088307|NCT03275350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93088308|NCT03275350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93088309|NCT03275350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088310|NCT03275350|Sensory System Agents|sensory system agents|mesh-ancestor
93088311|NCT03275350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088312|NCT01148342|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93088313|NCT01148342|Hallucinogens|hallucinogens|mesh-ancestor
93088314|NCT01148342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088315|NCT01148342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088316|NCT01148342|Serotonin Agents|serotonin agents|mesh-ancestor
93088317|NCT01148342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088318|NCT01148342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088319|NCT01148342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93088320|NCT01148342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93088321|NCT01148342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088322|NCT01148342|Adrenergic Agents|adrenergic agents|mesh-ancestor
93088323|NCT03557242|Aspirin|aspirin|mesh-list
93088324|NCT03557242|Warfarin|warfarin|mesh-list
93088325|NCT03557242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93088326|NCT03557242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088327|NCT03557242|Analgesics|analgesics|mesh-ancestor
93088328|NCT03557242|Sensory System Agents|sensory system agents|mesh-ancestor
93088329|NCT03557242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088330|NCT03557242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088331|NCT03557242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088332|NCT03557242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088333|NCT03557242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93088334|NCT03557242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93088335|NCT03557242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088336|NCT03557242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93088337|NCT03557242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93088338|NCT03557242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088339|NCT03557242|Antipyretics|antipyretics|mesh-ancestor
93088340|NCT03557242|Anticoagulants|anticoagulants|mesh-ancestor
93088341|NCT04774666|Antibodies|antibodies|mesh-list
93088342|NCT04774666|Immunologic Factors|immunologic factors|mesh-ancestor
93088343|NCT04774666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088344|NCT01150448|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93088345|NCT01150448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93088346|NCT01150448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088347|NCT01150448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088348|NCT01150448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088349|NCT01150448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088350|NCT01150448|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93088351|NCT01150448|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93088352|NCT01150448|Serotonin Agents|serotonin agents|mesh-ancestor
93088353|NCT01150448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088354|NCT01150448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088355|NCT01150448|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93088356|NCT01150448|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93088357|NCT01150448|Dopamine Agents|dopamine agents|mesh-ancestor
93088358|NCT03898466|Fluticasone|fluticasone|mesh-list
93088359|NCT03898466|Xhance|xhance|mesh-list
93088360|NCT03898466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088361|NCT03898466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93088362|NCT03898466|Autonomic Agents|autonomic agents|mesh-ancestor
93088363|NCT03898466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088364|NCT03898466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088365|NCT03898466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93088366|NCT03898466|Respiratory System Agents|respiratory system agents|mesh-ancestor
93088367|NCT03898466|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088368|NCT03898466|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93088369|NCT03907124|Psychotropic Drugs|psychotropic drugs|mesh-list
93088370|NCT02527772|Leucovorin|leucovorin|mesh-list
93088371|NCT02527772|Gemcitabine|gemcitabine|mesh-list
93088372|NCT02527772|Fluorouracil|fluorouracil|mesh-list
93088373|NCT02527772|Doxorubicin|doxorubicin|mesh-list
93088374|NCT02527772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93088375|NCT02527772|Oxaliplatin|oxaliplatin|mesh-list
93088376|NCT02527772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088377|NCT02527772|Antimetabolites|antimetabolites|mesh-ancestor
93088378|NCT02527772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088379|NCT02527772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088380|NCT02527772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93088381|NCT02527772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93088382|NCT02527772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93088383|NCT02527772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088384|NCT02527772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088385|NCT02527772|Immunologic Factors|immunologic factors|mesh-ancestor
93088386|NCT02527772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088387|NCT02527772|Antidotes|antidotes|mesh-ancestor
93088388|NCT02527772|Protective Agents|protective agents|mesh-ancestor
93088389|NCT02527772|Vitamin B Complex|vitamin b complex|mesh-ancestor
93088390|NCT02527772|Vitamins|vitamins|mesh-ancestor
93088391|NCT02527772|Micronutrients|micronutrients|mesh-ancestor
93088392|NCT03273946|Fluticasone|fluticasone|mesh-list
93088393|NCT03273946|Xhance|xhance|mesh-list
93088394|NCT03273946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088395|NCT03273946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93088396|NCT03273946|Autonomic Agents|autonomic agents|mesh-ancestor
93088397|NCT03273946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088398|NCT03273946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088399|NCT03273946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93088400|NCT03273946|Respiratory System Agents|respiratory system agents|mesh-ancestor
93088401|NCT03273946|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088402|NCT03273946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93088403|NCT00660218|Paclitaxel|paclitaxel|mesh-list
93088405|NCT00660218|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
93088406|NCT00660218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93088407|NCT00660218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088408|NCT00660218|Tubulin Modulators|tubulin modulators|mesh-ancestor
93088409|NCT00660218|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088410|NCT00660218|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088411|NCT00660218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088412|NCT00660218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088413|NCT00314951|Vancomycin|vancomycin|mesh-list
93088414|NCT00314951|Fidaxomicin|fidaxomicin|mesh-list
93088415|NCT00314951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93088416|NCT00314951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088417|NCT00085644|Adalimumab|adalimumab|mesh-list
93088418|NCT00085644|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93088419|NCT00085644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088420|NCT00085644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088421|NCT01257074|Acyclovir|acyclovir|mesh-list
93088422|NCT01257074|Penciclovir|penciclovir|mesh-list
93088423|NCT01257074|Antiviral Agents|antiviral agents|mesh-ancestor
93088424|NCT01257074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088425|NCT04597918|Faricimab|faricimab|mesh-list
93088426|NCT04597918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93088427|NCT04597918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93088428|NCT04597918|Growth Substances|growth substances|mesh-ancestor
93088429|NCT04597918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088430|NCT04597918|Growth Inhibitors|growth inhibitors|mesh-ancestor
93088431|NCT04597918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088432|NCT01149278|Benzocaine|benzocaine|mesh-list
93088433|NCT01149278|Anesthetics, Local|anesthetics, local|mesh-ancestor
93088434|NCT01149278|Anesthetics|anesthetics|mesh-ancestor
93088435|NCT01149278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088436|NCT01149278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088437|NCT01149278|Sensory System Agents|sensory system agents|mesh-ancestor
93088438|NCT01149278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088439|NCT01086774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93088440|NCT01086774|Lubricant Eye Drops|lubricant eye drops|mesh-list
93088441|NCT01086774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93088442|NCT03902522|Leronlimab|leronlimab|mesh-list
93088443|NCT03902522|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93088444|NCT03902522|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93088445|NCT03902522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088446|NCT03902522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93088447|NCT03902522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93088448|NCT03902522|Antiviral Agents|antiviral agents|mesh-ancestor
93088449|NCT03902522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088450|NCT01092858|Methyltestosterone|methyltestosterone|mesh-list
93088451|NCT01092858|Testosterone|testosterone|mesh-list
93088452|NCT01092858|Testosterone undecanoate|testosterone undecanoate|mesh-list
93088453|NCT01092858|Testosterone enanthate|testosterone enanthate|mesh-list
93088454|NCT01092858|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93088455|NCT01092858|Androgens|androgens|mesh-ancestor
93088456|NCT01092858|Hormones|hormones|mesh-ancestor
93088457|NCT01092858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088458|NCT01092858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088459|NCT01092858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93088460|NCT01092858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088461|NCT01092858|Anabolic Agents|anabolic agents|mesh-ancestor
93088462|NCT00314327|Risperidone|risperidone|mesh-list
93088463|NCT00314327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93088464|NCT00314327|Serotonin Agents|serotonin agents|mesh-ancestor
93088465|NCT00314327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088466|NCT00314327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088467|NCT00314327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088468|NCT00314327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93088469|NCT00314327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088470|NCT00314327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088471|NCT00314327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088472|NCT00314327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93088473|NCT00314327|Dopamine Agents|dopamine agents|mesh-ancestor
93088474|NCT03897452|Fentanyl|fentanyl|mesh-list
93088475|NCT03897452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93088476|NCT03897452|Narcotics|narcotics|mesh-ancestor
93088477|NCT03897452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088478|NCT03897452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088479|NCT03897452|Analgesics|analgesics|mesh-ancestor
93088480|NCT03897452|Sensory System Agents|sensory system agents|mesh-ancestor
93088481|NCT03897452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088482|NCT03897452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93088483|NCT03897452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93088484|NCT03897452|Anesthetics, General|anesthetics, general|mesh-ancestor
93088486|NCT01151072|Insulin|insulin|mesh-list
93088487|NCT01151072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93088488|NCT01151072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088489|NCT01257386|Mesalamine|mesalamine|mesh-list
93088490|NCT01257386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93088491|NCT01257386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088492|NCT01257386|Analgesics|analgesics|mesh-ancestor
93088493|NCT01257386|Sensory System Agents|sensory system agents|mesh-ancestor
93088494|NCT01257386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088495|NCT01257386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088496|NCT01257386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088497|NCT01257386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088498|NCT01257464|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93088499|NCT01257464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93088500|NCT01257464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93088501|NCT01257464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088502|NCT01257464|Incretins|incretins|mesh-ancestor
93088503|NCT01257464|Hormones|hormones|mesh-ancestor
93088504|NCT01257464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088505|NCT01257464|Protease Inhibitors|protease inhibitors|mesh-ancestor
93088506|NCT01257464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088507|NCT01257464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088508|NCT01255046|Donepezil|donepezil|mesh-list
93088509|NCT01255046|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93088510|NCT01255046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088511|NCT01255046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088512|NCT01255046|Cholinergic Agents|cholinergic agents|mesh-ancestor
93088513|NCT01255046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088514|NCT01255046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088515|NCT01255046|Nootropic Agents|nootropic agents|mesh-ancestor
93088516|NCT01149356|Exemestane|exemestane|mesh-list
93088517|NCT01149356|Goserelin|goserelin|mesh-list
93088518|NCT01149356|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93088519|NCT01149356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93088520|NCT01149356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088521|NCT01149356|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93088522|NCT01149356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93088523|NCT01149356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088524|NCT01149356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088525|NCT01149356|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93088526|NCT01149356|Hormone Antagonists|hormone antagonists|mesh-ancestor
93088527|NCT01149356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088528|NCT01149356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088529|NCT01149356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93088530|NCT01148576|Vitamin E|vitamin e|mesh-list
93088531|NCT01148576|Entecavir|entecavir|mesh-list
93088532|NCT01148576|Essential 303 forte|essential 303 forte|mesh-list
93088533|NCT01148576|Vitamins|vitamins|mesh-ancestor
93088534|NCT01148576|Micronutrients|micronutrients|mesh-ancestor
93088535|NCT01148576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088536|NCT01148576|Antioxidants|antioxidants|mesh-ancestor
93088537|NCT01148576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088538|NCT01148576|Protective Agents|protective agents|mesh-ancestor
93088539|NCT01148576|Antiviral Agents|antiviral agents|mesh-ancestor
93088540|NCT01148576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088541|NCT01148576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93088542|NCT01148576|Immunologic Factors|immunologic factors|mesh-ancestor
93088543|NCT01148576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93088544|NCT01148576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93088545|NCT01148576|Antimetabolites|antimetabolites|mesh-ancestor
93088546|NCT01148576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93088547|NCT01148576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93088548|NCT01148576|Antitubercular Agents|antitubercular agents|mesh-ancestor
93088549|NCT01148576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93088550|NCT01148576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93088551|NCT03905486|Pregabalin|pregabalin|mesh-list
93088552|NCT03905486|Analgesics|analgesics|mesh-ancestor
93088553|NCT03905486|Sensory System Agents|sensory system agents|mesh-ancestor
92760809|NCT01243424|Linagliptin|linagliptin|mesh-list
93088554|NCT03905486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088555|NCT03905486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088556|NCT03905486|Anticonvulsants|anticonvulsants|mesh-ancestor
93088557|NCT03905486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93088558|NCT03905486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678847|NCT00344669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93088559|NCT03905486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088560|NCT03905486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93088561|NCT03905486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93088562|NCT03905486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93088563|NCT03905486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088564|NCT03905486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088565|NCT03901118|Paclitaxel|paclitaxel|mesh-list
93088566|NCT03901118|Etoposide|etoposide|mesh-list
93088567|NCT03901118|Chiauranib|chiauranib|mesh-list
93088568|NCT03901118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93088569|NCT03901118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088570|NCT03901118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93088571|NCT03901118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088572|NCT03901118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088573|NCT03901118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088574|NCT03901118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93088575|NCT03901118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93088576|NCT03901118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088577|NCT03901118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93088578|NCT03895892|Caffeine|caffeine|mesh-list
93088579|NCT03895892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93088580|NCT03895892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088581|NCT03895892|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93088582|NCT03895892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088583|NCT03895892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088584|NCT03895892|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93088585|NCT03895892|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93088586|NCT03895892|Purinergic Agents|purinergic agents|mesh-ancestor
93088587|NCT03895892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088588|NCT01151306|Simvastatin|simvastatin|mesh-list
93088589|NCT01151306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93088590|NCT01151306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93088591|NCT01151306|Antimetabolites|antimetabolites|mesh-ancestor
93088592|NCT01151306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088593|NCT01151306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93088594|NCT01151306|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93088595|NCT01151306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088596|NCT05570786|Gestrinone|gestrinone|mesh-list
93088597|NCT05570786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93088598|NCT05570786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93088599|NCT05570786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93088600|NCT05570786|Contraceptive Agents|contraceptive agents|mesh-ancestor
93088601|NCT05570786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93088602|NCT05570786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088603|NCT05570786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93088604|NCT05570786|Progestins|progestins|mesh-ancestor
93088605|NCT05570786|Hormones|hormones|mesh-ancestor
93088606|NCT05570786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088607|NCT03895970|Pembrolizumab|pembrolizumab|mesh-list
93088608|NCT03895970|Lenvatinib|lenvatinib|mesh-list
93088609|NCT03895970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088610|NCT03895970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088611|NCT03895970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93088612|NCT03895970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088613|NCT03895970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93088614|NCT03895970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088615|NCT00336479|Interferons|interferons|mesh-list
93088616|NCT00336479|Ribavirin|ribavirin|mesh-list
93088617|NCT00336479|Interferon-alpha|interferon-alpha|mesh-list
93088618|NCT00336479|Interferon alpha-2|interferon alpha-2|mesh-list
93088619|NCT00336479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93088620|NCT00336479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088621|NCT00336479|Antiviral Agents|antiviral agents|mesh-ancestor
93088622|NCT00336479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088623|NCT00336479|Antimetabolites|antimetabolites|mesh-ancestor
93088624|NCT00336479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088625|NCT00336479|Immunologic Factors|immunologic factors|mesh-ancestor
93088626|NCT00336479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088627|NCT03905564|Pyridoxine|pyridoxine|mesh-list
93088628|NCT03905564|Vitamin B 6|vitamin b 6|mesh-list
93088629|NCT03905564|Doxylamine|doxylamine|mesh-list
92678920|NCT00344942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088630|NCT03905564|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
93088631|NCT03905564|Doxylamine succinate|doxylamine succinate|mesh-list
93088632|NCT03905564|Vitamin B Complex|vitamin b complex|mesh-ancestor
93088633|NCT03905564|Vitamins|vitamins|mesh-ancestor
93088634|NCT03905564|Micronutrients|micronutrients|mesh-ancestor
93088635|NCT03905564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088636|NCT03905564|Antiemetics|antiemetics|mesh-ancestor
93088637|NCT03905564|Autonomic Agents|autonomic agents|mesh-ancestor
93088638|NCT03905564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088639|NCT03905564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93088640|NCT03905564|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93088641|NCT03905564|Histamine Antagonists|histamine antagonists|mesh-ancestor
93088642|NCT03905564|Histamine Agents|histamine agents|mesh-ancestor
93088643|NCT03905564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088644|NCT03905564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088645|NCT01151384|Docetaxel|docetaxel|mesh-list
93088646|NCT01151384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088647|NCT01151384|Tubulin Modulators|tubulin modulators|mesh-ancestor
93088648|NCT01151384|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088649|NCT01151384|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088650|NCT01151384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088651|NCT01258010|Tranexamic Acid|tranexamic acid|mesh-list
93088652|NCT01258010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93088653|NCT01258010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93088654|NCT01258010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088655|NCT01258010|Hemostatics|hemostatics|mesh-ancestor
93088656|NCT01258010|Coagulants|coagulants|mesh-ancestor
93088657|NCT00314249|Milnacipran|milnacipran|mesh-list
93088658|NCT00314249|Levomilnacipran|levomilnacipran|mesh-list
93088659|NCT00314249|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93088660|NCT00314249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93088661|NCT00314249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088662|NCT00314249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088663|NCT00314249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088664|NCT00314249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088665|NCT00314249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088666|NCT00314249|Analgesics|analgesics|mesh-ancestor
93088667|NCT00314249|Sensory System Agents|sensory system agents|mesh-ancestor
93088668|NCT00314249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088669|NCT00314249|Antidepressive Agents|antidepressive agents|mesh-ancestor
93088670|NCT00314249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088671|NCT03905018|Tadalafil|tadalafil|mesh-list
93088672|NCT03905018|Vasodilator Agents|vasodilator agents|mesh-ancestor
93088673|NCT03905018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93088674|NCT03905018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93088675|NCT03905018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088676|NCT03905018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088677|NCT03905018|Urological Agents|urological agents|mesh-ancestor
93088678|NCT03894722|Povidone-Iodine|povidone-iodine|mesh-list
93088679|NCT03894722|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93088680|NCT03894722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088681|NCT03894800|Fentanyl|fentanyl|mesh-list
93088682|NCT03894800|Methoxyflurane|methoxyflurane|mesh-list
93088683|NCT03894800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93088684|NCT03894800|Narcotics|narcotics|mesh-ancestor
93088685|NCT03894800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088686|NCT03894800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088687|NCT03894800|Analgesics|analgesics|mesh-ancestor
93088688|NCT03894800|Sensory System Agents|sensory system agents|mesh-ancestor
93088689|NCT03894800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088690|NCT03894800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93088691|NCT03894800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93088692|NCT03894800|Anesthetics, General|anesthetics, general|mesh-ancestor
93088693|NCT03894800|Anesthetics|anesthetics|mesh-ancestor
93088694|NCT03894800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93088695|NCT03900026|Evolocumab|evolocumab|mesh-list
93088696|NCT03900026|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93088697|NCT03900026|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93088698|NCT03900026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93088699|NCT03900026|Antimetabolites|antimetabolites|mesh-ancestor
93088700|NCT03900026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088701|NCT03900026|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93088702|NCT03900026|Protease Inhibitors|protease inhibitors|mesh-ancestor
93088703|NCT03900026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088704|NCT03900026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93088706|NCT01149668|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93088707|NCT01149668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088708|NCT01149668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088709|NCT01149746|Tamsulosin|tamsulosin|mesh-list
93088710|NCT01149746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93088711|NCT01149746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93088712|NCT01149746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93088713|NCT01149746|Adrenergic Agents|adrenergic agents|mesh-ancestor
93088714|NCT01149746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088715|NCT01149746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088716|NCT01149746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088717|NCT01149746|Urological Agents|urological agents|mesh-ancestor
93088718|NCT01149824|Salvinorin A|salvinorin a|mesh-list
93088719|NCT01149824|Hallucinogens|hallucinogens|mesh-ancestor
93088720|NCT01149824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088721|NCT01149824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088722|NCT01149902|Cyclophosphamide|cyclophosphamide|mesh-list
93088723|NCT01149902|Docetaxel|docetaxel|mesh-list
93088724|NCT01149902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088725|NCT01149902|Immunologic Factors|immunologic factors|mesh-ancestor
93088726|NCT01149902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088727|NCT01149902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088728|NCT01149902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93088729|NCT01149902|Alkylating Agents|alkylating agents|mesh-ancestor
93088730|NCT01149902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088731|NCT01149902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088732|NCT01149902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93088733|NCT01149902|Tubulin Modulators|tubulin modulators|mesh-ancestor
93088734|NCT01149902|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088735|NCT01149902|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088736|NCT01151696|Hydroxyzine|hydroxyzine|mesh-list
93088737|NCT01151696|Antipruritics|antipruritics|mesh-ancestor
93088738|NCT01151696|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088739|NCT01151696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93088740|NCT01151696|Histamine Antagonists|histamine antagonists|mesh-ancestor
93088741|NCT01151696|Histamine Agents|histamine agents|mesh-ancestor
93088742|NCT01151696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088743|NCT01151696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088744|NCT01151696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088745|NCT01149980|Dexetimide|dexetimide|mesh-list
93088746|NCT01149980|Citalopram|citalopram|mesh-list
93088747|NCT01149980|Escitalopram|escitalopram|mesh-list
93088748|NCT01149980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93088749|NCT01149980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93088750|NCT01149980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088751|NCT01149980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088752|NCT01149980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088753|NCT01149980|Serotonin Agents|serotonin agents|mesh-ancestor
93088754|NCT01149980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088755|NCT01149980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93088756|NCT01149980|Antidepressive Agents|antidepressive agents|mesh-ancestor
93088757|NCT01149980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93088758|NCT01149980|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93088759|NCT01149980|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93088760|NCT01149980|Parasympatholytics|parasympatholytics|mesh-ancestor
93088761|NCT01149980|Autonomic Agents|autonomic agents|mesh-ancestor
93088762|NCT01149980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088763|NCT01149980|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93088764|NCT01149980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93088765|NCT01149980|Cholinergic Agents|cholinergic agents|mesh-ancestor
93088766|NCT01258322|Pioglitazone|pioglitazone|mesh-list
93088767|NCT01258322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93088768|NCT01258322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088769|NCT01255358|Dexamethasone|dexamethasone|mesh-list
93088770|NCT01255358|Dexamethasone acetate|dexamethasone acetate|mesh-list
93088771|NCT01255358|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93088772|NCT01255358|BB 1101|bb 1101|mesh-list
93088773|NCT01255358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088774|NCT01255358|Antiemetics|antiemetics|mesh-ancestor
93088775|NCT01255358|Autonomic Agents|autonomic agents|mesh-ancestor
93088776|NCT01255358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088777|NCT01255358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088778|NCT01255358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93088779|NCT01255358|Glucocorticoids|glucocorticoids|mesh-ancestor
93088780|NCT01255358|Hormones|hormones|mesh-ancestor
93088781|NCT01255358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088782|NCT01255358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93088783|NCT01255358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088784|NCT01255358|Protease Inhibitors|protease inhibitors|mesh-ancestor
93088785|NCT01255358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088786|NCT01255358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088787|NCT03899246|Capsaicin|capsaicin|mesh-list
93088788|NCT03899246|Antipruritics|antipruritics|mesh-ancestor
93088789|NCT03899246|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088790|NCT03899246|Sensory System Agents|sensory system agents|mesh-ancestor
93088791|NCT03899246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088792|NCT03899246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088793|NCT03893864|Ubiquinone|ubiquinone|mesh-list
93088794|NCT03893864|Coenzyme Q10|coenzyme q10|mesh-list
93088795|NCT03893864|Antioxidants|antioxidants|mesh-list
93088796|NCT03893864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088797|NCT03893864|Protective Agents|protective agents|mesh-ancestor
93088798|NCT03893864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088799|NCT03893864|Micronutrients|micronutrients|mesh-ancestor
93088800|NCT03893864|Vitamins|vitamins|mesh-ancestor
93088801|NCT03899324|Bumetanide|bumetanide|mesh-list
93088802|NCT03899324|Diuretics|diuretics|mesh-ancestor
93088803|NCT03899324|Natriuretic Agents|natriuretic agents|mesh-ancestor
93088804|NCT03899324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088805|NCT03899324|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93088806|NCT03899324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088807|NCT03899324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088808|NCT01148966|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93088809|NCT01148966|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93088810|NCT01148966|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088811|NCT01258634|Leucovorin|leucovorin|mesh-list
93088812|NCT01258634|Doxorubicin|doxorubicin|mesh-list
93088813|NCT01258634|Etoposide|etoposide|mesh-list
93088814|NCT01258634|Ifosfamide|ifosfamide|mesh-list
93088815|NCT01258634|Dexrazoxane|dexrazoxane|mesh-list
93088816|NCT01258634|Razoxane|razoxane|mesh-list
93088817|NCT01258634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088818|NCT01258634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93088819|NCT01258634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93088820|NCT01258634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93088821|NCT01258634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088822|NCT01258634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088823|NCT01258634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93088824|NCT01258634|Antidotes|antidotes|mesh-ancestor
93088825|NCT01258634|Protective Agents|protective agents|mesh-ancestor
93088826|NCT01258634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088827|NCT01258634|Vitamin B Complex|vitamin b complex|mesh-ancestor
93088828|NCT01258634|Vitamins|vitamins|mesh-ancestor
93088829|NCT01258634|Micronutrients|micronutrients|mesh-ancestor
93088830|NCT01258634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93088831|NCT01258634|Alkylating Agents|alkylating agents|mesh-ancestor
93088832|NCT01258634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93088833|NCT01258634|Antimitotic Agents|antimitotic agents|mesh-ancestor
93088834|NCT01258634|Mitosis Modulators|mitosis modulators|mesh-ancestor
93088835|NCT01258712|Methotrexate|methotrexate|mesh-list
93088836|NCT01258712|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93088837|NCT01258712|Abortifacient Agents|abortifacient agents|mesh-ancestor
93088838|NCT01258712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93088839|NCT01258712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088840|NCT01258712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088841|NCT01258712|Antimetabolites|antimetabolites|mesh-ancestor
93088842|NCT01258712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088843|NCT01258712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088844|NCT01258712|Dermatologic Agents|dermatologic agents|mesh-ancestor
93088845|NCT01258712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088846|NCT01258712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93088847|NCT01258712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93088848|NCT01258712|Immunologic Factors|immunologic factors|mesh-ancestor
93088849|NCT01258712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088850|NCT01258712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93088851|NCT01258868|Celecoxib|celecoxib|mesh-list
93088852|NCT01258868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93088853|NCT01258868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088854|NCT01258868|Analgesics|analgesics|mesh-ancestor
93088855|NCT01258868|Sensory System Agents|sensory system agents|mesh-ancestor
93088856|NCT01258868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088857|NCT01258868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088858|NCT01258868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93088859|NCT01258868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93088860|NCT01258868|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93088861|NCT01258868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93088862|NCT01258868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088863|NCT01258868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088864|NCT01254578|Lenalidomide|lenalidomide|mesh-list
93088865|NCT01254578|Immunologic Factors|immunologic factors|mesh-ancestor
93088866|NCT01254578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088867|NCT01254578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93088868|NCT01254578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93088869|NCT01254578|Growth Substances|growth substances|mesh-ancestor
93088870|NCT01254578|Growth Inhibitors|growth inhibitors|mesh-ancestor
93088871|NCT01254578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088872|NCT03892928|Dexmedetomidine|dexmedetomidine|mesh-list
93088873|NCT03892928|Propofol|propofol|mesh-list
93088874|NCT03892928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93088875|NCT03892928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088876|NCT03892928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088877|NCT03892928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93088878|NCT03892928|Analgesics|analgesics|mesh-ancestor
93088879|NCT03892928|Sensory System Agents|sensory system agents|mesh-ancestor
93088880|NCT03892928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088881|NCT03892928|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93088882|NCT03892928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93088883|NCT03892928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93088884|NCT03892928|Adrenergic Agents|adrenergic agents|mesh-ancestor
93088885|NCT03892928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088886|NCT03892928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088887|NCT03892928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93088888|NCT03892928|Anesthetics, General|anesthetics, general|mesh-ancestor
93088889|NCT03892928|Anesthetics|anesthetics|mesh-ancestor
93088890|NCT01152242|Insulin Glargine|insulin glargine|mesh-list
93088891|NCT01152242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93088892|NCT01152242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088893|NCT03341806|Avelumab|avelumab|mesh-list
93088894|NCT03341806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088895|NCT03341806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088896|NCT03904004|Botulinum Toxins|botulinum toxins|mesh-list
93088897|NCT03904004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93088898|NCT03904004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088899|NCT03904004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088900|NCT03904004|Cholinergic Agents|cholinergic agents|mesh-ancestor
93088901|NCT03904004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93088902|NCT03904004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088903|NCT01149122|Gemcitabine|gemcitabine|mesh-list
93088904|NCT01149122|Oxaliplatin|oxaliplatin|mesh-list
93088905|NCT01149122|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93088906|NCT01149122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088907|NCT01149122|Antimetabolites|antimetabolites|mesh-ancestor
93088908|NCT01149122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088909|NCT01149122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088910|NCT01149122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93088911|NCT01149122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088912|NCT01152398|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93088913|NCT01152398|Antiviral Agents|antiviral agents|mesh-ancestor
93088914|NCT01152398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088915|NCT03892148|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93088916|NCT03892148|Furosemide|furosemide|mesh-list
93088917|NCT03892148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93088918|NCT03892148|Diuretics|diuretics|mesh-ancestor
93088919|NCT03892148|Natriuretic Agents|natriuretic agents|mesh-ancestor
93088920|NCT03892148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088921|NCT03892148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93088922|NCT03892148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088923|NCT03892148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088924|NCT03892148|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93088925|NCT01152476|Remifentanil|remifentanil|mesh-list
92761185|NCT02821897|Anesthetics|anesthetics|mesh-list
93088926|NCT01152476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93088928|NCT01152476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088929|NCT01152476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088930|NCT01152476|Analgesics|analgesics|mesh-ancestor
93088931|NCT01152476|Sensory System Agents|sensory system agents|mesh-ancestor
93088932|NCT01152476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088933|NCT03892070|Mannitol|mannitol|mesh-list
93088934|NCT03892070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93088935|NCT03892070|Diuretics|diuretics|mesh-ancestor
93088936|NCT03892070|Natriuretic Agents|natriuretic agents|mesh-ancestor
93088937|NCT03892070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088938|NCT01155440|Lidocaine|lidocaine|mesh-list
93088939|NCT01155440|Anesthetics, Local|anesthetics, local|mesh-ancestor
93088940|NCT01155440|Anesthetics|anesthetics|mesh-ancestor
93088941|NCT01155440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088942|NCT01155440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088943|NCT01155440|Sensory System Agents|sensory system agents|mesh-ancestor
93088944|NCT01155440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93088945|NCT01155440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93088946|NCT01155440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93088947|NCT01155440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93088948|NCT01155440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088949|NCT01155440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088950|NCT01259336|Itraconazole|itraconazole|mesh-list
93088951|NCT01259336|Antifungal Agents|antifungal agents|mesh-ancestor
93088952|NCT01259336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93088953|NCT01259336|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93088954|NCT01259336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93088955|NCT01259336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93088956|NCT01259336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088957|NCT01259336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93088958|NCT01259336|Hormone Antagonists|hormone antagonists|mesh-ancestor
93088959|NCT01259336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93088960|NCT01259336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088961|NCT01259336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93088962|NCT01259414|Ethiodized Oil|ethiodized oil|mesh-list
93088963|NCT01259414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088964|NCT03314662|Vaccines|vaccines|mesh-list
93088965|NCT03314662|MF59 oil emulsion|mf59 oil emulsion|mesh-list
93088966|NCT03314662|Immunologic Factors|immunologic factors|mesh-ancestor
93088967|NCT03314662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088968|NCT03314662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93088969|NCT01152710|Capecitabine|capecitabine|mesh-list
93088970|NCT01152710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088971|NCT01152710|Antimetabolites|antimetabolites|mesh-ancestor
93088972|NCT01152710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088973|NCT01152710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088974|NCT03271528|Lacosamide|lacosamide|mesh-list
93088975|NCT03271528|Anticonvulsants|anticonvulsants|mesh-ancestor
93088976|NCT03271528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93088977|NCT03271528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93088978|NCT03271528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93088979|NCT03271528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088980|NCT04480372|Gemcitabine|gemcitabine|mesh-list
93088981|NCT04480372|Atezolizumab|atezolizumab|mesh-list
93088982|NCT04480372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93088983|NCT04480372|Antimetabolites|antimetabolites|mesh-ancestor
93088984|NCT04480372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088985|NCT04480372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088986|NCT04480372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93088987|NCT04480372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088988|NCT04462276|Atezolizumab|atezolizumab|mesh-list
93088989|NCT04462276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93088990|NCT04462276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93088991|NCT04462276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93088992|NCT04462276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93088993|NCT03890510|Anesthetics|anesthetics|mesh-list
93088994|NCT03890510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93088995|NCT03890510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088996|NCT01152866|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93088997|NCT01152866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93088998|NCT01152866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93088999|NCT01153568|Vitamin D|vitamin d|mesh-list
93089000|NCT01153568|Cholecalciferol|cholecalciferol|mesh-list
93089001|NCT01153568|Vitamins|vitamins|mesh-ancestor
93089002|NCT01153568|Micronutrients|micronutrients|mesh-ancestor
93089003|NCT01153568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089004|NCT01153568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93089005|NCT01153568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089006|NCT03889808|Antitoxins|antitoxins|mesh-list
93089007|NCT03889808|Immunologic Factors|immunologic factors|mesh-ancestor
93089008|NCT03889808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089009|NCT03890042|Dienogest|dienogest|mesh-list
93089010|NCT03890042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93089011|NCT03890042|Gestodene|gestodene|mesh-list
93089012|NCT03890042|Femovan|femovan|mesh-list
93089013|NCT03890042|Estradiol|estradiol|mesh-list
93089014|NCT03890042|Estrogens|estrogens|mesh-ancestor
93089015|NCT03890042|Hormones|hormones|mesh-ancestor
93089016|NCT03890042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93089017|NCT03890042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089018|NCT03890042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93089019|NCT03890042|Contraceptive Agents|contraceptive agents|mesh-ancestor
93089020|NCT03890042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089021|NCT03890042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93089022|NCT03890042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93089023|NCT03890042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93089024|NCT03890042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93089025|NCT03890042|Hormone Antagonists|hormone antagonists|mesh-ancestor
93089026|NCT03890042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93089027|NCT03890042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089028|NCT03890042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93089029|NCT03890042|Progestins|progestins|mesh-ancestor
93089030|NCT03890042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93089031|NCT01153802|Dopamine|dopamine|mesh-list
93089032|NCT01153802|Norepinephrine|norepinephrine|mesh-list
93089033|NCT01153802|Serotonin|serotonin|mesh-list
93089034|NCT01153802|Neurotransmitter Agents|neurotransmitter agents|mesh-list
93089035|NCT01153802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93089036|NCT01153802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93089037|NCT01153802|Adrenergic Agents|adrenergic agents|mesh-ancestor
92679325|NCT00347555|Antacids|antacids|mesh-ancestor
93089038|NCT01153802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089039|NCT01153802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089040|NCT01153802|Sympathomimetics|sympathomimetics|mesh-ancestor
93089041|NCT01153802|Autonomic Agents|autonomic agents|mesh-ancestor
93089042|NCT01153802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089043|NCT01153802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93089044|NCT01153802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93089045|NCT01153802|Dopamine Agents|dopamine agents|mesh-ancestor
93089046|NCT01153802|Protective Agents|protective agents|mesh-ancestor
93089047|NCT01153802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93089048|NCT01153802|Serotonin Agents|serotonin agents|mesh-ancestor
93089049|NCT01153100|Insulin Glargine|insulin glargine|mesh-list
93089050|NCT01153100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93089051|NCT01153100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089052|NCT01153256|Magnesium Sulfate|magnesium sulfate|mesh-list
93089053|NCT01153256|Analgesics|analgesics|mesh-ancestor
93089054|NCT01153256|Sensory System Agents|sensory system agents|mesh-ancestor
93089055|NCT01153256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089056|NCT01153256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089057|NCT01153256|Anesthetics|anesthetics|mesh-ancestor
93089058|NCT01153256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089059|NCT01153256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089060|NCT01153256|Anticonvulsants|anticonvulsants|mesh-ancestor
93089061|NCT01153256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93089062|NCT01153256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089063|NCT01153256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089064|NCT01153256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089065|NCT01153256|Tocolytic Agents|tocolytic agents|mesh-ancestor
93089066|NCT01153256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089067|NCT01153334|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93089068|NCT01153334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93089069|NCT01153334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93089070|NCT01153334|Antimetabolites|antimetabolites|mesh-ancestor
92761329|NCT04748523|Mirtazapine|mirtazapine|mesh-list
93089071|NCT01153334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089072|NCT01153334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93089073|NCT01153334|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93089074|NCT01153334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089075|NCT01259804|Immunomodulating Agents|immunomodulating agents|mesh-list
93089076|NCT01259804|Immunologic Factors|immunologic factors|mesh-ancestor
93089077|NCT01259804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089078|NCT01153880|Mupirocin|mupirocin|mesh-list
93089079|NCT01153880|Retapamulin|retapamulin|mesh-list
93089080|NCT01153880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93089081|NCT01153880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089082|NCT01153880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93089083|NCT01153880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089084|NCT01153880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089085|NCT01260506|Bevacizumab|bevacizumab|mesh-list
93089086|NCT01260506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93089087|NCT01260506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089088|NCT01260506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93089089|NCT01260506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93089090|NCT01260506|Growth Substances|growth substances|mesh-ancestor
93089091|NCT01260506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089092|NCT01260506|Growth Inhibitors|growth inhibitors|mesh-ancestor
93089093|NCT03884972|Venetoclax|venetoclax|mesh-list
93089094|NCT03884972|Trabectedin|trabectedin|mesh-list
93089095|NCT03884972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089096|NCT03884972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93089097|NCT03884972|Alkylating Agents|alkylating agents|mesh-ancestor
93089098|NCT03884972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089099|NCT01154114|Darapladib|darapladib|mesh-list
93089100|NCT01154114|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93089101|NCT01154114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089102|NCT01154114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089103|NCT01157312|Citric Acid|citric acid|mesh-list
93089104|NCT01157312|Sodium Citrate|sodium citrate|mesh-list
93089105|NCT01157312|Clomiphene|clomiphene|mesh-list
93089106|NCT01157312|Enclomiphene|enclomiphene|mesh-list
93089107|NCT01157312|Zuclomiphene|zuclomiphene|mesh-list
93089108|NCT01157312|Anticoagulants|anticoagulants|mesh-ancestor
92679397|NCT00348023|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089109|NCT01157312|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93089110|NCT01157312|Chelating Agents|chelating agents|mesh-ancestor
93089111|NCT01157312|Sequestering Agents|sequestering agents|mesh-ancestor
93089112|NCT01157312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089113|NCT01157312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93089114|NCT01157312|Hormone Antagonists|hormone antagonists|mesh-ancestor
93089115|NCT01157312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93089116|NCT01157312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089117|NCT01157312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93089118|NCT01157312|Fertility Agents|fertility agents|mesh-ancestor
93089119|NCT01157312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089120|NCT01157312|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93089121|NCT01157312|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93089122|NCT01157546|Lidocaine|lidocaine|mesh-list
93089123|NCT01157546|Anesthetics, Local|anesthetics, local|mesh-ancestor
93089124|NCT01157546|Anesthetics|anesthetics|mesh-ancestor
93089125|NCT01157546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089126|NCT01157546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089127|NCT01157546|Sensory System Agents|sensory system agents|mesh-ancestor
93089128|NCT01157546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089129|NCT01157546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089130|NCT01157546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93089131|NCT01157546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93089132|NCT01157546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089133|NCT01157546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089134|NCT02527460|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93089135|NCT02527460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089136|NCT01263860|Ribavirin|ribavirin|mesh-list
93089137|NCT01263860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93089138|NCT01263860|Interferon-alpha|interferon-alpha|mesh-list
93089139|NCT01263860|Antimetabolites|antimetabolites|mesh-ancestor
93089140|NCT01263860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089141|NCT01263860|Antiviral Agents|antiviral agents|mesh-ancestor
93089142|NCT01263860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089143|NCT01263860|Immunologic Factors|immunologic factors|mesh-ancestor
93089144|NCT01263860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089145|NCT03881306|Oxaliplatin|oxaliplatin|mesh-list
93089146|NCT03881306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089147|NCT01154348|Metformin|metformin|mesh-list
93089148|NCT01154348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93089149|NCT01154348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089150|NCT00075270|Paclitaxel|paclitaxel|mesh-list
93089151|NCT00075270|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93089152|NCT00075270|Lapatinib|lapatinib|mesh-list
93089153|NCT00075270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93089154|NCT00075270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089155|NCT00075270|Tubulin Modulators|tubulin modulators|mesh-ancestor
93089156|NCT00075270|Antimitotic Agents|antimitotic agents|mesh-ancestor
93089157|NCT00075270|Mitosis Modulators|mitosis modulators|mesh-ancestor
93089158|NCT00075270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089159|NCT00075270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089160|NCT00075270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089161|NCT01264094|Clevudine|clevudine|mesh-list
93089162|NCT01264094|Antiviral Agents|antiviral agents|mesh-ancestor
93089163|NCT01264094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089164|NCT03884348|Amoxicillin|amoxicillin|mesh-list
93089165|NCT03884348|Metronidazole|metronidazole|mesh-list
93089166|NCT03884348|Clarithromycin|clarithromycin|mesh-list
93089167|NCT03884348|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93089168|NCT03884348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93089169|NCT03884348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089170|NCT03884348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93089171|NCT03884348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93089172|NCT03884348|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93089173|NCT03884348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089174|NCT03884348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089175|NCT03884348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93089176|NCT03884348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93089177|NCT01154426|Gemcitabine|gemcitabine|mesh-list
93089178|NCT01154426|Veliparib|veliparib|mesh-list
93089179|NCT01154426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93089180|NCT01154426|Antimetabolites|antimetabolites|mesh-ancestor
93089181|NCT01154426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089182|NCT01154426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089183|NCT01154426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93089184|NCT01154426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089185|NCT01589744|Hemostatics|hemostatics|mesh-list
93089186|NCT01589744|Coagulants|coagulants|mesh-ancestor
93089187|NCT01154504|Adrenomedullin|adrenomedullin|mesh-list
93089188|NCT01154504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93089189|NCT01154504|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93089190|NCT01154504|Autonomic Agents|autonomic agents|mesh-ancestor
93089191|NCT01154504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089192|NCT01154504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089193|NCT01154504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93089194|NCT01154504|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089195|NCT01154504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93089196|NCT01154504|Vasodilator Agents|vasodilator agents|mesh-ancestor
93089197|NCT01154504|Protective Agents|protective agents|mesh-ancestor
93089198|NCT03880916|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93089199|NCT03880916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93089200|NCT03880916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93089201|NCT03880916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089202|NCT03880916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089203|NCT03880916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089204|NCT03880916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089205|NCT03880916|Analgesics|analgesics|mesh-ancestor
93089206|NCT03880916|Sensory System Agents|sensory system agents|mesh-ancestor
93089207|NCT03880916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089208|NCT03880916|Antidepressive Agents|antidepressive agents|mesh-ancestor
93089209|NCT03880916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93089210|NCT03880916|Dopamine Agents|dopamine agents|mesh-ancestor
93089211|NCT01155908|Amlodipine|amlodipine|mesh-list
93089212|NCT01155908|Benazepril|benazepril|mesh-list
93089213|NCT01155908|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93089214|NCT01155908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93089215|NCT01155908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089216|NCT01155908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089217|NCT01155908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089218|NCT01155908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089219|NCT01155908|Vasodilator Agents|vasodilator agents|mesh-ancestor
93089220|NCT01155908|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93089221|NCT01155908|Protease Inhibitors|protease inhibitors|mesh-ancestor
93089222|NCT01155908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089223|NCT03880448|Metronidazole|metronidazole|mesh-list
93089224|NCT03880448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089225|NCT03880448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93089226|NCT03880448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93089227|NCT03880448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93089228|NCT03298984|Cytarabine|cytarabine|mesh-list
93089229|NCT03298984|Daunorubicin|daunorubicin|mesh-list
93089230|NCT03298984|Alvocidib|alvocidib|mesh-list
93089231|NCT03298984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93089232|NCT03298984|Antimetabolites|antimetabolites|mesh-ancestor
93089233|NCT03298984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089234|NCT03298984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089235|NCT03298984|Antiviral Agents|antiviral agents|mesh-ancestor
93089236|NCT03298984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089237|NCT03298984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93089238|NCT03298984|Immunologic Factors|immunologic factors|mesh-ancestor
93089239|NCT03298984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089240|NCT03298984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93089241|NCT03298984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93089242|NCT03298984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93089243|NCT03298984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089244|NCT03298984|Growth Inhibitors|growth inhibitors|mesh-ancestor
93089245|NCT03298984|Growth Substances|growth substances|mesh-ancestor
93089246|NCT03298984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089247|NCT03887858|Tamsulosin|tamsulosin|mesh-list
93089248|NCT03887858|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93089249|NCT03887858|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93089250|NCT03887858|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93089251|NCT03887858|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089252|NCT03887858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089253|NCT03887858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089254|NCT03887858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089255|NCT03887858|Urological Agents|urological agents|mesh-ancestor
93089256|NCT02940574|Oxytocin|oxytocin|mesh-list
93089257|NCT02940574|Oxytocics|oxytocics|mesh-ancestor
93089258|NCT02940574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089259|NCT02940574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089260|NCT01264328|Paclitaxel|paclitaxel|mesh-list
93089261|NCT01264328|Panitumumab|panitumumab|mesh-list
93089262|NCT01264328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93089263|NCT01264328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089264|NCT01264328|Tubulin Modulators|tubulin modulators|mesh-ancestor
93089265|NCT01264328|Antimitotic Agents|antimitotic agents|mesh-ancestor
93089266|NCT01264328|Mitosis Modulators|mitosis modulators|mesh-ancestor
93089267|NCT01264328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089268|NCT01264328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93089269|NCT01157858|Everolimus|everolimus|mesh-list
93089270|NCT01157858|Octreotide|octreotide|mesh-list
93089271|NCT01157858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93089272|NCT01157858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089273|NCT01157858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089274|NCT01157858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089275|NCT01157858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93089276|NCT01157858|Immunologic Factors|immunologic factors|mesh-ancestor
93089277|NCT01157858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089278|NCT01157858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089279|NCT01157858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089280|NCT01157858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93089281|NCT01157936|Allopurinol|allopurinol|mesh-list
93089282|NCT01157936|Antimetabolites|antimetabolites|mesh-ancestor
93089283|NCT01157936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089284|NCT01157936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089285|NCT01157936|Gout Suppressants|gout suppressants|mesh-ancestor
93089286|NCT01157936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089287|NCT01157936|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93089288|NCT01157936|Antioxidants|antioxidants|mesh-ancestor
93089289|NCT01157936|Protective Agents|protective agents|mesh-ancestor
93089290|NCT01157936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089291|NCT01264484|Imidacloprid|imidacloprid|mesh-list
93089292|NCT01264484|Cholinergic Agents|cholinergic agents|mesh-ancestor
93089293|NCT01264484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089294|NCT01264484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089295|NCT01264484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089296|NCT01260818|Tranexamic Acid|tranexamic acid|mesh-list
92761566|NCT04551547|Vaccines|vaccines|mesh-list
93089297|NCT01260818|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93089298|NCT01260818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93089299|NCT01260818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089300|NCT01260818|Hemostatics|hemostatics|mesh-ancestor
93089301|NCT01260818|Coagulants|coagulants|mesh-ancestor
93089302|NCT01262612|Cediranib|cediranib|mesh-list
93089303|NCT01262612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089304|NCT01262612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089305|NCT01262612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089306|NCT01262612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089307|NCT01158014|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93089308|NCT01158014|Hemostatics|hemostatics|mesh-ancestor
93089309|NCT01158014|Coagulants|coagulants|mesh-ancestor
93089310|NCT03884036|Vitamin D|vitamin d|mesh-list
93089311|NCT03884036|Vitamins|vitamins|mesh-ancestor
93089312|NCT03884036|Micronutrients|micronutrients|mesh-ancestor
93089313|NCT03884036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089314|NCT03884036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93089315|NCT01158170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93089316|NCT01158170|Gefitinib|gefitinib|mesh-list
93089317|NCT01158170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089318|NCT01158170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089319|NCT01158170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089320|NCT01158170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089321|NCT01260974|Caspofungin|caspofungin|mesh-list
93089322|NCT01260974|Antifungal Agents|antifungal agents|mesh-ancestor
93089323|NCT01260974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089324|NCT01260974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089325|NCT01260974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089326|NCT01264640|Aspirin|aspirin|mesh-list
93089327|NCT01264640|Clopidogrel|clopidogrel|mesh-list
93089328|NCT01264640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93089329|NCT01264640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93089330|NCT01264640|Analgesics|analgesics|mesh-ancestor
93089331|NCT01264640|Sensory System Agents|sensory system agents|mesh-ancestor
93089332|NCT01264640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089333|NCT01264640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089334|NCT01264640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93089335|NCT01264640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089336|NCT01264640|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93089337|NCT01264640|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93089338|NCT01264640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089339|NCT01264640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93089340|NCT01264640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93089341|NCT01264640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089342|NCT01264640|Antipyretics|antipyretics|mesh-ancestor
93089343|NCT01264640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93089344|NCT01264640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93089345|NCT01264640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93089346|NCT01264640|Purinergic Agents|purinergic agents|mesh-ancestor
93089347|NCT01264640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089348|NCT01155986|Lidocaine|lidocaine|mesh-list
93089349|NCT01155986|Anesthetics, Local|anesthetics, local|mesh-ancestor
93089350|NCT01155986|Anesthetics|anesthetics|mesh-ancestor
93089351|NCT01155986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089352|NCT01155986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089353|NCT01155986|Sensory System Agents|sensory system agents|mesh-ancestor
93089354|NCT01155986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089355|NCT01155986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089356|NCT01155986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93089357|NCT01155986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93089358|NCT01155986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089359|NCT01155986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089360|NCT01261130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93089361|NCT01261130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93089362|NCT01261130|Immunologic Factors|immunologic factors|mesh-ancestor
93089363|NCT01261130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089364|NCT01261130|Antacids|antacids|mesh-ancestor
93089365|NCT01261130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089366|NCT01261130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089367|NCT01158248|Panitumumab|panitumumab|mesh-list
93089368|NCT01158248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089369|NCT01158248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93089370|NCT01264874|Vitamin D|vitamin d|mesh-list
93089371|NCT01264874|Cholecalciferol|cholecalciferol|mesh-list
93089373|NCT01264874|Micronutrients|micronutrients|mesh-ancestor
93089374|NCT01264874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089375|NCT01264874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93089376|NCT01264874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089377|NCT01262924|Vaccines|vaccines|mesh-list
93089378|NCT01262924|Immunologic Factors|immunologic factors|mesh-ancestor
93089379|NCT01262924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089380|NCT01158560|Vitamin D|vitamin d|mesh-list
93089381|NCT01158560|Cholecalciferol|cholecalciferol|mesh-list
93089382|NCT01158560|Vitamins|vitamins|mesh-ancestor
93089383|NCT01158560|Micronutrients|micronutrients|mesh-ancestor
93089384|NCT01158560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089385|NCT01158560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93089386|NCT01158560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089387|NCT03879746|Paroxetine|paroxetine|mesh-list
93089388|NCT03879746|Tamsulosin|tamsulosin|mesh-list
93089389|NCT03879746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93089390|NCT03879746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93089391|NCT03879746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089392|NCT03879746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089393|NCT03879746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089394|NCT03879746|Serotonin Agents|serotonin agents|mesh-ancestor
93089395|NCT03879746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089396|NCT03879746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93089397|NCT03879746|Antidepressive Agents|antidepressive agents|mesh-ancestor
93089398|NCT03879746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93089399|NCT03879746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93089400|NCT03879746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93089401|NCT03879746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089402|NCT03879746|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93089403|NCT03879746|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93089404|NCT03879746|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93089405|NCT03879746|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089406|NCT03879746|Urological Agents|urological agents|mesh-ancestor
93089407|NCT03879590|Budesonide|budesonide|mesh-list
93089408|NCT03879590|Doxofylline|doxofylline|mesh-list
93089409|NCT03879590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93089410|NCT03879590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93089411|NCT03879590|Autonomic Agents|autonomic agents|mesh-ancestor
93089412|NCT03879590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089413|NCT03879590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089414|NCT03879590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93089415|NCT03879590|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089416|NCT03879590|Glucocorticoids|glucocorticoids|mesh-ancestor
93089417|NCT03879590|Hormones|hormones|mesh-ancestor
93089418|NCT03879590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93089419|NCT03879590|Antitussive Agents|antitussive agents|mesh-ancestor
93089420|NCT03879590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93089421|NCT03879590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089422|NCT03879590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089423|NCT01265108|Iron|iron|mesh-list
93089424|NCT01265108|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93089425|NCT01265108|Trace Elements|trace elements|mesh-ancestor
93089426|NCT01265108|Micronutrients|micronutrients|mesh-ancestor
93089427|NCT01265108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089428|NCT01265108|Hematinics|hematinics|mesh-ancestor
93089429|NCT01154738|Lidocaine|lidocaine|mesh-list
93089430|NCT01154738|Anesthetics, Local|anesthetics, local|mesh-ancestor
93089431|NCT01154738|Anesthetics|anesthetics|mesh-ancestor
93089432|NCT01154738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089433|NCT01154738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089434|NCT01154738|Sensory System Agents|sensory system agents|mesh-ancestor
93089435|NCT01154738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089436|NCT01154738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089437|NCT01154738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93089438|NCT01154738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93089439|NCT01154738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089440|NCT01154738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089441|NCT01263002|Adefovir|adefovir|mesh-list
93089442|NCT01263002|Clevudine|clevudine|mesh-list
93089443|NCT01263002|Antiviral Agents|antiviral agents|mesh-ancestor
93089444|NCT01263002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089445|NCT01263002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93089446|NCT01263002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93089447|NCT01263002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089448|NCT01263002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089449|NCT01261286|Verapamil|verapamil|mesh-list
93089450|NCT01261286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089451|NCT01261286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93089452|NCT01261286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089453|NCT01261286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089454|NCT01261286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089455|NCT01261286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089456|NCT01261286|Vasodilator Agents|vasodilator agents|mesh-ancestor
93089457|NCT01263080|Folic Acid|folic acid|mesh-list
93089458|NCT01263080|Vitamin B Complex|vitamin b complex|mesh-list
93089459|NCT01263080|Mirtazapine|mirtazapine|mesh-list
93089460|NCT01263080|Vitamins|vitamins|mesh-ancestor
93089461|NCT01263080|Micronutrients|micronutrients|mesh-ancestor
93089462|NCT01263080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089463|NCT01263080|Hematinics|hematinics|mesh-ancestor
93089464|NCT01263080|Antidepressive Agents|antidepressive agents|mesh-ancestor
93089465|NCT01263080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93089466|NCT01263080|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93089467|NCT01263080|Histamine Antagonists|histamine antagonists|mesh-ancestor
93089468|NCT01263080|Histamine Agents|histamine agents|mesh-ancestor
93089469|NCT01263080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679757|NCT00349739|Growth Substances|growth substances|mesh-ancestor
93089470|NCT01263080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089471|NCT01263080|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93089472|NCT01263080|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93089473|NCT01263080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089474|NCT01263080|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93089475|NCT01263080|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93089476|NCT01263080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93089477|NCT01263080|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089478|NCT01263080|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93089479|NCT01263080|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93089480|NCT01263080|Serotonin Agents|serotonin agents|mesh-ancestor
93089481|NCT01263080|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93089482|NCT01263158|Oxytocin|oxytocin|mesh-list
93089483|NCT01263158|Oxytocics|oxytocics|mesh-ancestor
93089484|NCT01263158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089485|NCT01263158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089486|NCT03879356|Acetylcysteine|acetylcysteine|mesh-list
93089487|NCT03879356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93089488|NCT03879356|Antiviral Agents|antiviral agents|mesh-ancestor
93089489|NCT03879356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089490|NCT03879356|Expectorants|expectorants|mesh-ancestor
93089491|NCT03879356|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089492|NCT03879356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93089493|NCT03879356|Antioxidants|antioxidants|mesh-ancestor
93089494|NCT03879356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089495|NCT03879356|Protective Agents|protective agents|mesh-ancestor
93089496|NCT03879356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089497|NCT03879356|Antidotes|antidotes|mesh-ancestor
93089498|NCT01159418|Paclitaxel|paclitaxel|mesh-list
93089499|NCT01159418|Carboplatin|carboplatin|mesh-list
93089500|NCT01159418|Panobinostat|panobinostat|mesh-list
93089501|NCT01159418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93089502|NCT01159418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089503|NCT01159418|Tubulin Modulators|tubulin modulators|mesh-ancestor
93089504|NCT01159418|Antimitotic Agents|antimitotic agents|mesh-ancestor
93089505|NCT01159418|Mitosis Modulators|mitosis modulators|mesh-ancestor
93089506|NCT01159418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089507|NCT01159418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93089508|NCT01159418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089509|NCT03886766|Efavirenz|efavirenz|mesh-list
93089510|NCT03886766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93089511|NCT03886766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93089512|NCT03886766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089513|NCT03886766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089514|NCT03886766|Antiviral Agents|antiviral agents|mesh-ancestor
93089515|NCT03886766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089516|NCT03886766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93089517|NCT03886766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93089518|NCT03886766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93089519|NCT03886766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93089520|NCT03886766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93089521|NCT03886766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93089522|NCT01265342|Beclomethasone|beclomethasone|mesh-list
93089523|NCT01265342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93089524|NCT01265342|Glucocorticoids|glucocorticoids|mesh-ancestor
93089525|NCT01265342|Hormones|hormones|mesh-ancestor
93089526|NCT01265342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93089527|NCT01265342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089528|NCT01265342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93089529|NCT01265342|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089530|NCT03883334|Inosine Pranobex|inosine pranobex|mesh-list
93089531|NCT03883334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93089532|NCT03883334|Immunologic Factors|immunologic factors|mesh-ancestor
93089533|NCT03883334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089534|NCT03883334|Antiviral Agents|antiviral agents|mesh-ancestor
93089535|NCT03883334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089536|NCT01265576|Etodolac|etodolac|mesh-list
93089537|NCT01265576|Sorafenib|sorafenib|mesh-list
93089538|NCT01265576|Propranolol|propranolol|mesh-list
93089539|NCT01265576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089540|NCT01265576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089541|NCT01265576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089542|NCT01265576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089543|NCT01265576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93089544|NCT01265576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93089545|NCT01265576|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089546|NCT01265576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089547|NCT01265576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089548|NCT01265576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089549|NCT01265576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93089550|NCT01265576|Vasodilator Agents|vasodilator agents|mesh-ancestor
93089551|NCT01265576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93089552|NCT01265576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93089553|NCT01265576|Analgesics|analgesics|mesh-ancestor
93089554|NCT01265576|Sensory System Agents|sensory system agents|mesh-ancestor
93089555|NCT01265576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089556|NCT01265576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93089557|NCT01265576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089558|NCT01265576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93089559|NCT01265576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93089560|NCT03883022|Vancomycin|vancomycin|mesh-list
93089561|NCT03883022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93089562|NCT03883022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089563|NCT01159652|Zaleplon|zaleplon|mesh-list
93089564|NCT01159652|Zolpidem|zolpidem|mesh-list
93089565|NCT01159652|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93089566|NCT01159652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93089567|NCT01159652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089568|NCT01159652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089569|NCT01159652|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93089570|NCT01159652|GABA Agonists|gaba agonists|mesh-ancestor
93089571|NCT01159652|GABA Agents|gaba agents|mesh-ancestor
93089572|NCT01159652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089573|NCT01159652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089574|NCT01159652|Anticonvulsants|anticonvulsants|mesh-ancestor
93089575|NCT01159652|GABA Modulators|gaba modulators|mesh-ancestor
93089576|NCT01261832|Cilostazol|cilostazol|mesh-list
93089577|NCT01261832|Clopidogrel|clopidogrel|mesh-list
93089578|NCT01261832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93089579|NCT01261832|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93089580|NCT01261832|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93089581|NCT01261832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93089582|NCT01261832|Purinergic Agents|purinergic agents|mesh-ancestor
93089583|NCT01261832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089584|NCT01261832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089585|NCT01261832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089586|NCT01261832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93089587|NCT01261832|Autonomic Agents|autonomic agents|mesh-ancestor
93089588|NCT01261832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089589|NCT01261832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93089590|NCT01261832|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089591|NCT01261832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93089592|NCT01261832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93089593|NCT01261832|Vasodilator Agents|vasodilator agents|mesh-ancestor
93089594|NCT01261832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93089595|NCT01261832|Protective Agents|protective agents|mesh-ancestor
93089596|NCT01261832|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93089597|NCT01261832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93089598|NCT01261832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089600|NCT01265810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93089601|NCT01265810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089602|NCT01265888|Nitric Oxide|nitric oxide|mesh-list
93089603|NCT01265888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93089604|NCT01265888|Autonomic Agents|autonomic agents|mesh-ancestor
93089605|NCT01265888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089606|NCT01265888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679899|NCT00351026|Methadone|methadone|mesh-list
93089607|NCT01265888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93089608|NCT01265888|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089609|NCT01265888|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93089610|NCT01265888|Antioxidants|antioxidants|mesh-ancestor
93089611|NCT01265888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089612|NCT01265888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089613|NCT01265888|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93089614|NCT01265888|Vasodilator Agents|vasodilator agents|mesh-ancestor
93089615|NCT01265888|Gasotransmitters|gasotransmitters|mesh-ancestor
93089616|NCT01265888|Protective Agents|protective agents|mesh-ancestor
93089617|NCT01155206|Glucagon|glucagon|mesh-list
93089618|NCT01155206|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93089619|NCT01155206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089620|NCT01155206|Hormones|hormones|mesh-ancestor
93089621|NCT01155206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93089622|NCT01155206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089623|NCT01155206|Incretins|incretins|mesh-ancestor
93089624|NCT03879278|Immunoglobulins|immunoglobulins|mesh-list
93089625|NCT03879278|Immunoglobulin G|immunoglobulin g|mesh-list
93089626|NCT03879278|Immunologic Factors|immunologic factors|mesh-ancestor
93089627|NCT03879278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089628|NCT03878888|Bupivacaine|bupivacaine|mesh-list
93089629|NCT03878888|Anesthetics, Local|anesthetics, local|mesh-ancestor
93089630|NCT03878888|Anesthetics|anesthetics|mesh-ancestor
93089631|NCT03878888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089632|NCT03878888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089633|NCT03878888|Sensory System Agents|sensory system agents|mesh-ancestor
93089634|NCT03878888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089635|NCT03882710|Metoprolol|metoprolol|mesh-list
93089636|NCT03882710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089637|NCT03882710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93089638|NCT03882710|Sympatholytics|sympatholytics|mesh-ancestor
93089639|NCT03882710|Autonomic Agents|autonomic agents|mesh-ancestor
93089640|NCT03882710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089641|NCT03882710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089642|NCT03882710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93089643|NCT03882710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93089644|NCT03882710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93089645|NCT03882710|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089646|NCT03882710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089647|NCT03882710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089648|NCT01161836|Iniparib|iniparib|mesh-list
93089649|NCT01161836|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93089650|NCT01161836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089651|NCT01161836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089652|NCT01161836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089653|NCT01266434|Simvastatin|simvastatin|mesh-list
93089654|NCT01266434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93089655|NCT01266434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93089656|NCT01266434|Antimetabolites|antimetabolites|mesh-ancestor
93089657|NCT01266434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089658|NCT01266434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93089659|NCT01266434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93089660|NCT01266434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089661|NCT01266512|Docetaxel|docetaxel|mesh-list
93089662|NCT01266512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089663|NCT01266512|Tubulin Modulators|tubulin modulators|mesh-ancestor
93089664|NCT01266512|Antimitotic Agents|antimitotic agents|mesh-ancestor
93089665|NCT01266512|Mitosis Modulators|mitosis modulators|mesh-ancestor
93089666|NCT01266512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089667|NCT01160042|Metformin|metformin|mesh-list
93089668|NCT01160042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93089669|NCT01160042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089670|NCT03882788|Fentanyl|fentanyl|mesh-list
93089671|NCT03882788|Isoflurane|isoflurane|mesh-list
93089672|NCT03882788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93089673|NCT03882788|Narcotics|narcotics|mesh-ancestor
93089674|NCT03882788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089675|NCT03882788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089676|NCT03882788|Analgesics|analgesics|mesh-ancestor
93089677|NCT03882788|Sensory System Agents|sensory system agents|mesh-ancestor
93089678|NCT03882788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089679|NCT03882788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93089680|NCT03882788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93089681|NCT03882788|Anesthetics, General|anesthetics, general|mesh-ancestor
93089682|NCT03882788|Anesthetics|anesthetics|mesh-ancestor
93089683|NCT03882788|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93089684|NCT01156688|Misoprostol|misoprostol|mesh-list
93089685|NCT01156688|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93089686|NCT01156688|Abortifacient Agents|abortifacient agents|mesh-ancestor
93089687|NCT01156688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089688|NCT01156688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089689|NCT01156688|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93089690|NCT01156688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089691|NCT01156688|Oxytocics|oxytocics|mesh-ancestor
93089692|NCT03876704|Vitamins|vitamins|mesh-list
93089693|NCT03876704|Micronutrients|micronutrients|mesh-ancestor
93089694|NCT03876704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089695|NCT03878654|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
93089696|NCT03878654|Antiviral Agents|antiviral agents|mesh-ancestor
93089697|NCT03878654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089698|NCT03878654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93089699|NCT03878654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089700|NCT03878264|Cortisone|cortisone|mesh-list
93089701|NCT03878264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93089702|NCT03882164|Tacrolimus|tacrolimus|mesh-list
93089703|NCT03882164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93089704|NCT03882164|Immunologic Factors|immunologic factors|mesh-ancestor
93089705|NCT03882164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089706|NCT03882164|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93089707|NCT03882164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089708|NCT03882164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089709|NCT01160276|Cyclosporine|cyclosporine|mesh-list
93089710|NCT01160276|Colchicine|colchicine|mesh-list
93089711|NCT01160276|Tacrolimus|tacrolimus|mesh-list
93089712|NCT01160276|Cyclosporins|cyclosporins|mesh-list
93089713|NCT01160276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93089714|NCT01160276|Immunologic Factors|immunologic factors|mesh-ancestor
93089715|NCT01160276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089716|NCT01160276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93089717|NCT01160276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089718|NCT01160276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089719|NCT01160276|Antifungal Agents|antifungal agents|mesh-ancestor
93089720|NCT01160276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089721|NCT01160276|Dermatologic Agents|dermatologic agents|mesh-ancestor
93089722|NCT01160276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089723|NCT01160276|Gout Suppressants|gout suppressants|mesh-ancestor
93089724|NCT01160276|Tubulin Modulators|tubulin modulators|mesh-ancestor
93089725|NCT01160276|Antimitotic Agents|antimitotic agents|mesh-ancestor
93089726|NCT01160276|Mitosis Modulators|mitosis modulators|mesh-ancestor
93089727|NCT01160276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089728|NCT01263548|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93089729|NCT01263548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93089730|NCT01263548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089731|NCT01263548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93089732|NCT01263548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93089733|NCT01263548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089734|NCT01263548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089735|NCT01263548|Dopamine Agents|dopamine agents|mesh-ancestor
93089736|NCT01263548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089737|NCT01160432|Methadone|methadone|mesh-list
93089738|NCT01160432|Naloxone|naloxone|mesh-list
93089739|NCT01160432|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93089740|NCT01160432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089741|NCT01160432|Sensory System Agents|sensory system agents|mesh-ancestor
93089742|NCT01160432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089743|NCT01160432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93089744|NCT01160432|Narcotics|narcotics|mesh-ancestor
93089745|NCT01160432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089746|NCT01160432|Analgesics|analgesics|mesh-ancestor
93089747|NCT01160432|Antitussive Agents|antitussive agents|mesh-ancestor
93089748|NCT01160432|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089749|NCT03877718|Promethazine|promethazine|mesh-list
93089750|NCT03877718|Diphenhydramine|diphenhydramine|mesh-list
93089751|NCT03877718|Sumatriptan|sumatriptan|mesh-list
93089752|NCT03877718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93089753|NCT03877718|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93089754|NCT03877718|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93089755|NCT03877718|Serotonin Agents|serotonin agents|mesh-ancestor
93089756|NCT03877718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089757|NCT03877718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089758|NCT03877718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089759|NCT03877718|Antipruritics|antipruritics|mesh-ancestor
93089760|NCT03877718|Dermatologic Agents|dermatologic agents|mesh-ancestor
93089761|NCT03877718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93089762|NCT03877718|Histamine Antagonists|histamine antagonists|mesh-ancestor
93089763|NCT03877718|Histamine Agents|histamine agents|mesh-ancestor
93089764|NCT03877718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93089765|NCT03877718|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93089766|NCT03877718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93089767|NCT03877718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089768|NCT03877718|Anesthetics, Local|anesthetics, local|mesh-ancestor
93089769|NCT03877718|Anesthetics|anesthetics|mesh-ancestor
93089770|NCT03877718|Sensory System Agents|sensory system agents|mesh-ancestor
93089771|NCT03877718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089772|NCT03877718|Antiemetics|antiemetics|mesh-ancestor
93089773|NCT03877718|Autonomic Agents|autonomic agents|mesh-ancestor
93089774|NCT03877718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089775|NCT01267058|Vaccines|vaccines|mesh-list
93089776|NCT01267058|Immunologic Factors|immunologic factors|mesh-ancestor
93089777|NCT01267058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089778|NCT02526914|Vasopressins|vasopressins|mesh-list
93089779|NCT02526914|Arginine Vasopressin|arginine vasopressin|mesh-list
93089780|NCT02526914|Oxytocin|oxytocin|mesh-list
93089781|NCT02526914|Oxytocics|oxytocics|mesh-ancestor
93089782|NCT02526914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089783|NCT02526914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089784|NCT02526914|Hemostatics|hemostatics|mesh-ancestor
93089785|NCT02526914|Coagulants|coagulants|mesh-ancestor
93089786|NCT02526914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93089787|NCT02526914|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93089788|NCT02526914|Natriuretic Agents|natriuretic agents|mesh-ancestor
93089789|NCT03876938|Olanzapine|olanzapine|mesh-list
93089790|NCT03876938|Aprepitant|aprepitant|mesh-list
93089791|NCT03876938|Antiemetics|antiemetics|mesh-ancestor
93089792|NCT03876938|Autonomic Agents|autonomic agents|mesh-ancestor
93089793|NCT03876938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089794|NCT03876938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089795|NCT03876938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089796|NCT03876938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93089797|NCT03876938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93089798|NCT03876938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089799|NCT03876938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93089800|NCT03876938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93089801|NCT03876938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93089802|NCT03876938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089803|NCT03876938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089804|NCT03876938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089805|NCT03876938|Serotonin Agents|serotonin agents|mesh-ancestor
93089806|NCT03876938|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93089807|NCT01162460|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
93089808|NCT01162460|Anticonvulsants|anticonvulsants|mesh-ancestor
93089809|NCT01162460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93089810|NCT01162460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93089811|NCT01162460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089812|NCT01162460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089813|NCT03882008|Abatacept|abatacept|mesh-list
93089814|NCT03882008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93089815|NCT03882008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089816|NCT03882008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93089817|NCT03882008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089818|NCT03882008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93089819|NCT03882008|Immunologic Factors|immunologic factors|mesh-ancestor
93089820|NCT03882008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089821|NCT03882008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089822|NCT01267214|Hyaluronic Acid|hyaluronic acid|mesh-list
93089823|NCT01267214|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93089824|NCT01267214|Immunologic Factors|immunologic factors|mesh-ancestor
93089825|NCT01267214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089826|NCT01267214|Viscosupplements|viscosupplements|mesh-ancestor
93089827|NCT01267214|Protective Agents|protective agents|mesh-ancestor
93089828|NCT01156922|Rituximab|rituximab|mesh-list
93089829|NCT01156922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93089830|NCT01156922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089831|NCT01156922|Immunologic Factors|immunologic factors|mesh-ancestor
93089832|NCT01156922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089833|NCT01156922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089834|NCT03877874|Terbutaline|terbutaline|mesh-list
93089835|NCT03877874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93089836|NCT03877874|Autonomic Agents|autonomic agents|mesh-ancestor
93089837|NCT03877874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089838|NCT03877874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089839|NCT03877874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93089840|NCT03877874|Respiratory System Agents|respiratory system agents|mesh-ancestor
93089841|NCT03877874|Sympathomimetics|sympathomimetics|mesh-ancestor
93089842|NCT03877874|Tocolytic Agents|tocolytic agents|mesh-ancestor
93089843|NCT03877874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93089844|NCT03877874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93089845|NCT03877874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93089846|NCT03877874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93089847|NCT03877874|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089848|NCT03877874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089849|NCT03877874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089850|NCT01160588|Sertraline|sertraline|mesh-list
93089851|NCT01160588|Antidepressive Agents|antidepressive agents|mesh-ancestor
93089852|NCT01160588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93089853|NCT01160588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93089854|NCT01160588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93089855|NCT01160588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089856|NCT01160588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089857|NCT01160588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089858|NCT01160588|Serotonin Agents|serotonin agents|mesh-ancestor
93089859|NCT01160588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089860|NCT03877562|Olanzapine|olanzapine|mesh-list
93089861|NCT03877562|Antiemetics|antiemetics|mesh-ancestor
93089862|NCT03877562|Autonomic Agents|autonomic agents|mesh-ancestor
93089863|NCT03877562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089864|NCT03877562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089865|NCT03877562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93089866|NCT03877562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93089867|NCT03877562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93089868|NCT03877562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089869|NCT03877562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93089870|NCT03877562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93089871|NCT03877562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93089872|NCT03877562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089873|NCT03877562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089874|NCT03877562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089875|NCT03877562|Serotonin Agents|serotonin agents|mesh-ancestor
93089876|NCT01160666|Belimumab|belimumab|mesh-list
93089877|NCT01160666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93089878|NCT01160666|Immunologic Factors|immunologic factors|mesh-ancestor
93089879|NCT01160666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089880|NCT03876548|Iodine|iodine|mesh-list
93089881|NCT03876548|Cadexomer iodine|cadexomer iodine|mesh-list
93089882|NCT03876548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93089883|NCT03876548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089884|NCT03876548|Trace Elements|trace elements|mesh-ancestor
93089885|NCT03876548|Micronutrients|micronutrients|mesh-ancestor
93089886|NCT03876548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089887|NCT03760250|Imiquimod|imiquimod|mesh-list
93089888|NCT03760250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93089889|NCT03760250|Immunologic Factors|immunologic factors|mesh-ancestor
93089890|NCT03760250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089891|NCT03760250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089892|NCT03760250|Interferon Inducers|interferon inducers|mesh-ancestor
93089893|NCT01157000|Canagliflozin|canagliflozin|mesh-list
93089894|NCT01157000|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93089895|NCT01157000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089896|NCT01157000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93089897|NCT01157000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089898|NCT01160900|Bivalirudin|bivalirudin|mesh-list
93089899|NCT01160900|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93089900|NCT01160900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93089901|NCT01160900|Antithrombins|antithrombins|mesh-ancestor
93089902|NCT01160900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93089903|NCT01160900|Protease Inhibitors|protease inhibitors|mesh-ancestor
93089904|NCT01160900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089905|NCT01160900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089906|NCT01160900|Anticoagulants|anticoagulants|mesh-ancestor
93089907|NCT01160978|Simvastatin|simvastatin|mesh-list
93089908|NCT01160978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93089909|NCT01160978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93089910|NCT01160978|Antimetabolites|antimetabolites|mesh-ancestor
93089911|NCT01160978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089912|NCT01160978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93089913|NCT01160978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93089914|NCT01160978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089915|NCT01161134|Meloxicam|meloxicam|mesh-list
93089916|NCT01161134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93089917|NCT01161134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93089918|NCT01161134|Analgesics|analgesics|mesh-ancestor
93089919|NCT01161134|Sensory System Agents|sensory system agents|mesh-ancestor
93089920|NCT01161134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089921|NCT01161134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089922|NCT01161134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93089923|NCT01161134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93089924|NCT01161134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93089925|NCT01161134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93089926|NCT01161134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089927|NCT01161134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089928|NCT01268384|Gemcitabine|gemcitabine|mesh-list
93089929|NCT01268384|Capecitabine|capecitabine|mesh-list
93089930|NCT01268384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93089931|NCT01268384|Antimetabolites|antimetabolites|mesh-ancestor
93089932|NCT01268384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089933|NCT01268384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089934|NCT01269476|Fluorides|fluorides|mesh-list
93089935|NCT01269476|Methanesulfonyl fluoride|methanesulfonyl fluoride|mesh-list
93089936|NCT01269476|Cariostatic Agents|cariostatic agents|mesh-ancestor
93089937|NCT01269476|Protective Agents|protective agents|mesh-ancestor
93089938|NCT01269476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089939|NCT01269476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93089940|NCT01269476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089941|NCT01269476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089942|NCT01269476|Cholinergic Agents|cholinergic agents|mesh-ancestor
93089943|NCT01269476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089944|NCT01161368|Vinorelbine|vinorelbine|mesh-list
93089945|NCT01161368|Lapatinib|lapatinib|mesh-list
93089946|NCT01161368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93089947|NCT01161368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089948|NCT01161368|Tubulin Modulators|tubulin modulators|mesh-ancestor
93089949|NCT01161368|Antimitotic Agents|antimitotic agents|mesh-ancestor
93089950|NCT01161368|Mitosis Modulators|mitosis modulators|mesh-ancestor
93089951|NCT01161368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089952|NCT01161368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93089953|NCT01161368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93089954|NCT01267760|Dialysis Solutions|dialysis solutions|mesh-list
93089955|NCT01267760|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93089956|NCT01280162|Piperaquine|piperaquine|mesh-list
93089957|NCT01280162|Artenimol|artenimol|mesh-list
93089958|NCT01280162|Antimalarials|antimalarials|mesh-ancestor
93089959|NCT01280162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93089960|NCT01280162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93089961|NCT01280162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93089962|NCT01167062|Tamsulosin|tamsulosin|mesh-list
93089963|NCT01167062|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93089964|NCT01167062|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93089965|NCT01167062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93089966|NCT01167062|Adrenergic Agents|adrenergic agents|mesh-ancestor
93089967|NCT01167062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93089968|NCT01167062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089969|NCT01167062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089970|NCT01167062|Urological Agents|urological agents|mesh-ancestor
93089971|NCT01280240|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93089973|NCT01165268|Dapagliflozin|dapagliflozin|mesh-list
93089974|NCT01165268|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93089975|NCT01165268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089976|NCT01165268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93089977|NCT01165268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089978|NCT03874364|Lidocaine|lidocaine|mesh-list
93089979|NCT03874364|Anesthetics, Local|anesthetics, local|mesh-ancestor
93089980|NCT03874364|Anesthetics|anesthetics|mesh-ancestor
93089981|NCT03874364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93089982|NCT03874364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93089983|NCT03874364|Sensory System Agents|sensory system agents|mesh-ancestor
93089984|NCT03874364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93089985|NCT03874364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93089986|NCT03874364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93089987|NCT03874364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93089988|NCT03874364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93089989|NCT03874364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93089990|NCT01163396|Leucovorin|leucovorin|mesh-list
93089991|NCT01163396|Bevacizumab|bevacizumab|mesh-list
93089992|NCT01163396|Fluorouracil|fluorouracil|mesh-list
93089993|NCT01163396|Oxaliplatin|oxaliplatin|mesh-list
93089994|NCT01163396|Irinotecan|irinotecan|mesh-list
93089995|NCT01163396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93089996|NCT01163396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93089997|NCT01163396|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93089998|NCT01163396|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93089999|NCT01163396|Growth Substances|growth substances|mesh-ancestor
93090000|NCT01163396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090001|NCT01163396|Growth Inhibitors|growth inhibitors|mesh-ancestor
93090002|NCT01163396|Antimetabolites|antimetabolites|mesh-ancestor
93090003|NCT01163396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090004|NCT01163396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93090005|NCT01163396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93090006|NCT01163396|Immunologic Factors|immunologic factors|mesh-ancestor
93090007|NCT01163396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93090008|NCT01163396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93090009|NCT01163396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090010|NCT01163396|Antidotes|antidotes|mesh-ancestor
93090011|NCT01163396|Protective Agents|protective agents|mesh-ancestor
93090012|NCT01163396|Vitamin B Complex|vitamin b complex|mesh-ancestor
93090013|NCT01163396|Vitamins|vitamins|mesh-ancestor
93090014|NCT01163396|Micronutrients|micronutrients|mesh-ancestor
93090015|NCT01269788|Fluoxetine|fluoxetine|mesh-list
93090016|NCT01269788|Omeprazole|omeprazole|mesh-list
93090017|NCT01269788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090018|NCT01269788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090019|NCT01269788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93090020|NCT01269788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090021|NCT01269788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090022|NCT01269788|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93090023|NCT01269788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93090024|NCT01269788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090025|NCT01269788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090026|NCT01269788|Serotonin Agents|serotonin agents|mesh-ancestor
93090027|NCT01269788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090028|NCT01269788|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93090029|NCT01269788|Antidepressive Agents|antidepressive agents|mesh-ancestor
93090030|NCT01269788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93090031|NCT01269788|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93090032|NCT01269788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090033|NCT01163630|Esomeprazole|esomeprazole|mesh-list
93090034|NCT01163630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090035|NCT01163630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090036|NCT01163630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93090037|NCT01163630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090038|NCT01163630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090039|NCT03874130|Scopolamine|scopolamine|mesh-list
93090040|NCT03874130|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93090041|NCT03874130|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93090042|NCT03874130|Antiemetics|antiemetics|mesh-ancestor
93090043|NCT03874130|Autonomic Agents|autonomic agents|mesh-ancestor
93090044|NCT03874130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090045|NCT03874130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090046|NCT03874130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090047|NCT03874130|Mydriatics|mydriatics|mesh-ancestor
93090048|NCT03874130|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93090049|NCT03874130|Cholinergic Agents|cholinergic agents|mesh-ancestor
93090050|NCT03874130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090051|NCT03874130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090052|NCT03874130|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93090053|NCT03874130|Parasympatholytics|parasympatholytics|mesh-ancestor
93090054|NCT01269866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93090055|NCT01269866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93090056|NCT01269866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93090057|NCT01269866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090058|NCT01269866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090059|NCT01269866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090060|NCT01269866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090061|NCT01269866|Analgesics|analgesics|mesh-ancestor
93090062|NCT01269866|Sensory System Agents|sensory system agents|mesh-ancestor
93090063|NCT01269866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090064|NCT01269866|Antidepressive Agents|antidepressive agents|mesh-ancestor
93090065|NCT01269866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93090066|NCT01269866|Dopamine Agents|dopamine agents|mesh-ancestor
93090067|NCT05387642|Pramoxine|pramoxine|mesh-list
93090068|NCT05387642|Anesthetics, Local|anesthetics, local|mesh-ancestor
93090069|NCT05387642|Anesthetics|anesthetics|mesh-ancestor
93090070|NCT05387642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090071|NCT05387642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090072|NCT05387642|Sensory System Agents|sensory system agents|mesh-ancestor
93090073|NCT05387642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090074|NCT03871322|Vitamin D|vitamin d|mesh-list
93090075|NCT03871322|Ergocalciferols|ergocalciferols|mesh-list
93090076|NCT03871322|Cholecalciferol|cholecalciferol|mesh-list
93090077|NCT03871322|Vitamins|vitamins|mesh-list
93090078|NCT03871322|Micronutrients|micronutrients|mesh-ancestor
93090079|NCT03871322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090080|NCT03871322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93090081|NCT03871322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93090082|NCT00313781|Prednisone|prednisone|mesh-list
93090083|NCT00313781|Docetaxel|docetaxel|mesh-list
93090084|NCT00313781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090085|NCT00313781|Tubulin Modulators|tubulin modulators|mesh-ancestor
93090086|NCT00313781|Antimitotic Agents|antimitotic agents|mesh-ancestor
93090087|NCT00313781|Mitosis Modulators|mitosis modulators|mesh-ancestor
93090088|NCT00313781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090089|NCT00313781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090090|NCT00313781|Glucocorticoids|glucocorticoids|mesh-ancestor
93090091|NCT00313781|Hormones|hormones|mesh-ancestor
93090092|NCT00313781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090093|NCT00313781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090094|NCT00313781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93090095|NCT03871478|Lidocaine|lidocaine|mesh-list
93090096|NCT03871478|Bupivacaine|bupivacaine|mesh-list
93090097|NCT03871478|Anesthetics, Local|anesthetics, local|mesh-ancestor
93090098|NCT03871478|Anesthetics|anesthetics|mesh-ancestor
93090099|NCT03871478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090100|NCT03871478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090101|NCT03871478|Sensory System Agents|sensory system agents|mesh-ancestor
93090102|NCT03871478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090103|NCT03871478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93090104|NCT03871478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93090105|NCT03871478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93090106|NCT03871478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090107|NCT03871478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090108|NCT01281566|Cisapride|cisapride|mesh-list
93090109|NCT01281566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090110|NCT01281566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090111|NCT01281566|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93090112|NCT01281566|Serotonin Agents|serotonin agents|mesh-ancestor
93090113|NCT01281566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090114|NCT01281566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090115|NCT01281566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090116|NCT00368537|Ampicillin|ampicillin|mesh-list
93090117|NCT00368537|Tigecycline|tigecycline|mesh-list
93090118|NCT00368537|Sulbactam|sulbactam|mesh-list
93090119|NCT00368537|Sultamicillin|sultamicillin|mesh-list
92762391|NCT00943852|Losartan|losartan|mesh-list
93090120|NCT00368537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93090121|NCT00368537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090122|NCT00368537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93090123|NCT00368537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090124|NCT00368537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090125|NCT00368537|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93090126|NCT01165580|Valganciclovir|valganciclovir|mesh-list
93090127|NCT01165580|Antiviral Agents|antiviral agents|mesh-ancestor
93090128|NCT01165580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090129|NCT01048619|ON 01910|on 01910|mesh-list
93090130|NCT01048619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090131|NCT01048619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93090132|NCT01048619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090133|NCT01048619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090134|NCT01281800|Gemcitabine|gemcitabine|mesh-list
93090135|NCT01281800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93090136|NCT01281800|Antimetabolites|antimetabolites|mesh-ancestor
93090137|NCT01281800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090138|NCT01281800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090139|NCT03982121|Nivolumab|nivolumab|mesh-list
93090140|NCT03982121|Ipilimumab|ipilimumab|mesh-list
93090141|NCT03982121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090142|NCT03982121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090143|NCT03982121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93090144|NCT03982121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090145|NCT01167530|Everolimus|everolimus|mesh-list
93090146|NCT01167530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93090147|NCT01167530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93090148|NCT01167530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090149|NCT01167530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090150|NCT01167530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93090151|NCT01167530|Immunologic Factors|immunologic factors|mesh-ancestor
93090152|NCT01167530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090153|NCT01167530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090154|NCT01167764|Tranexamic Acid|tranexamic acid|mesh-list
93090155|NCT01167764|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93090156|NCT01167764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93090157|NCT01167764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090158|NCT01167764|Hemostatics|hemostatics|mesh-ancestor
93090159|NCT01167764|Coagulants|coagulants|mesh-ancestor
93090160|NCT01164176|Everolimus|everolimus|mesh-list
93090161|NCT01164176|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93090162|NCT01164176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93090163|NCT01164176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090164|NCT01164176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090165|NCT01164176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93090166|NCT01164176|Immunologic Factors|immunologic factors|mesh-ancestor
93090167|NCT01164176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090168|NCT01164176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090169|NCT00313313|Metformin|metformin|mesh-list
93090170|NCT00313313|Saxagliptin|saxagliptin|mesh-list
93090171|NCT00313313|Glyburide|glyburide|mesh-list
93090172|NCT00313313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93090173|NCT00313313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090174|NCT00313313|Incretins|incretins|mesh-ancestor
93090175|NCT00313313|Hormones|hormones|mesh-ancestor
93090176|NCT00313313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090177|NCT00313313|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93090178|NCT00313313|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090179|NCT00313313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090180|NCT00313313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090181|NCT01167920|Calcium Channel Blockers|calcium channel blockers|mesh-list
93090182|NCT01167920|Angiotensin II|angiotensin ii|mesh-list
93090183|NCT01167920|Diuretics|diuretics|mesh-list
93090184|NCT01167920|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93090185|NCT01167920|Renin Inhibitors|renin inhibitors|mesh-list
93090186|NCT01167920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93090187|NCT01167920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090188|NCT01167920|Natriuretic Agents|natriuretic agents|mesh-ancestor
93090189|NCT01167920|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090190|NCT01167920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680483|NCT00426101|Immunologic Factors|immunologic factors|mesh-ancestor
93090191|NCT01167920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090192|NCT01167920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93090193|NCT01167920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090194|NCT03873974|Immunoglobulin G|immunoglobulin g|mesh-list
93090195|NCT03873974|Immunoglobulin M|immunoglobulin m|mesh-list
93090196|NCT03873974|Immunologic Factors|immunologic factors|mesh-ancestor
93090197|NCT03873974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090198|NCT01268930|Hemostatics|hemostatics|mesh-list
93090199|NCT01268930|Coagulants|coagulants|mesh-ancestor
93090200|NCT02526758|Budesonide|budesonide|mesh-list
93090201|NCT02526758|Beclomethasone|beclomethasone|mesh-list
93090202|NCT02526758|Formoterol Fumarate|formoterol fumarate|mesh-list
93090203|NCT02526758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090204|NCT02526758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93090205|NCT02526758|Autonomic Agents|autonomic agents|mesh-ancestor
93090206|NCT02526758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090207|NCT02526758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090208|NCT02526758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93090209|NCT02526758|Respiratory System Agents|respiratory system agents|mesh-ancestor
93090210|NCT02526758|Glucocorticoids|glucocorticoids|mesh-ancestor
93090211|NCT02526758|Hormones|hormones|mesh-ancestor
93090212|NCT02526758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090213|NCT02526758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93090214|NCT02526758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93090215|NCT02526758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93090216|NCT02526758|Adrenergic Agents|adrenergic agents|mesh-ancestor
93090217|NCT02526758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090218|NCT02526758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090219|NCT01281878|Vitamin B 6|vitamin b 6|mesh-list
93090220|NCT01281878|Pyridoxal|pyridoxal|mesh-list
93090221|NCT01281878|Pyridoxine|pyridoxine|mesh-list
93090222|NCT01281878|Vitamins|vitamins|mesh-ancestor
93090223|NCT01281878|Micronutrients|micronutrients|mesh-ancestor
93090224|NCT01281878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090225|NCT01281878|Vitamin B Complex|vitamin b complex|mesh-ancestor
93090226|NCT01164488|Ritonavir|ritonavir|mesh-list
93090227|NCT01164488|Ketoconazole|ketoconazole|mesh-list
93090228|NCT01164488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93090229|NCT01164488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93090230|NCT01164488|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090231|NCT01164488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090232|NCT01164488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090233|NCT01164488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93090234|NCT01164488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93090235|NCT01164488|Antiviral Agents|antiviral agents|mesh-ancestor
93090236|NCT01164488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090237|NCT01164488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93090238|NCT01164488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090239|NCT01164488|Antifungal Agents|antifungal agents|mesh-ancestor
93090240|NCT01164488|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93090241|NCT01164488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93090242|NCT01164488|Hormone Antagonists|hormone antagonists|mesh-ancestor
93090243|NCT01164488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090244|NCT01164488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090245|NCT00312845|Rituximab|rituximab|mesh-list
93090246|NCT00312845|Bortezomib|bortezomib|mesh-list
93090247|NCT00312845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090248|NCT00312845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090249|NCT00312845|Immunologic Factors|immunologic factors|mesh-ancestor
93090250|NCT00312845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090251|NCT00312845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93090252|NCT01168544|Vitamin D|vitamin d|mesh-list
93090253|NCT01168544|Ergocalciferols|ergocalciferols|mesh-list
93090254|NCT01168544|Cholecalciferol|cholecalciferol|mesh-list
93090255|NCT01168544|Vitamins|vitamins|mesh-list
93090256|NCT01168544|Micronutrients|micronutrients|mesh-ancestor
93090257|NCT01168544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090258|NCT01168544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93090259|NCT01168544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93090260|NCT00368069|Levetiracetam|levetiracetam|mesh-list
93090261|NCT00368069|Anticonvulsants|anticonvulsants|mesh-ancestor
93090262|NCT00368069|Nootropic Agents|nootropic agents|mesh-ancestor
93090263|NCT01165814|Naproxen|naproxen|mesh-list
93090264|NCT01165814|Tramadol|tramadol|mesh-list
92680567|NCT03271905|Bromides|bromides|mesh-list
93090265|NCT01165814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93090266|NCT01165814|Narcotics|narcotics|mesh-ancestor
93090267|NCT01165814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090268|NCT01165814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090269|NCT01165814|Analgesics|analgesics|mesh-ancestor
93090270|NCT01165814|Sensory System Agents|sensory system agents|mesh-ancestor
93090271|NCT01165814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090272|NCT01165814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93090273|NCT01165814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93090274|NCT01165814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090275|NCT01165814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93090276|NCT01165814|Gout Suppressants|gout suppressants|mesh-ancestor
93090277|NCT01165814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93090278|NCT01165814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090279|NCT01165814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090280|NCT00367991|Epoetin Alfa|epoetin alfa|mesh-list
93090281|NCT00367991|Hematinics|hematinics|mesh-ancestor
93090282|NCT00367835|Guanfacine|guanfacine|mesh-list
93090283|NCT00367835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93090284|NCT00367835|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93090285|NCT00367835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93090286|NCT00367835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93090287|NCT00367835|Adrenergic Agents|adrenergic agents|mesh-ancestor
93090288|NCT00367835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090289|NCT00367835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090290|NCT00367835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090291|NCT03874832|Dihydroergotamine|dihydroergotamine|mesh-list
93090292|NCT03874832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93090293|NCT03874832|Dopamine Agonists|dopamine agonists|mesh-ancestor
93090294|NCT03874832|Dopamine Agents|dopamine agents|mesh-ancestor
93090295|NCT03874832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090296|NCT03874832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090297|NCT03874832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090298|NCT03874832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93090299|NCT03874832|Analgesics|analgesics|mesh-ancestor
93090300|NCT03874832|Sensory System Agents|sensory system agents|mesh-ancestor
93090301|NCT03874832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090302|NCT01164800|Trandolapril|trandolapril|mesh-list
93090303|NCT01164800|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93090304|NCT01164800|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090305|NCT01164800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090306|NCT01164800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090307|NCT01164800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93090308|NCT01169012|Clofarabine|clofarabine|mesh-list
93090309|NCT01169012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93090310|NCT01169012|Antimetabolites|antimetabolites|mesh-ancestor
93090311|NCT01169012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090312|NCT01169012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090313|NCT01169090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93090314|NCT01169090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93090315|NCT01169090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090316|NCT01169090|Incretins|incretins|mesh-ancestor
93090317|NCT01169090|Hormones|hormones|mesh-ancestor
93090318|NCT01169090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090319|NCT01169090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93090320|NCT01169090|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090321|NCT01169090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090322|NCT01169090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090323|NCT01282502|Midostaurin|midostaurin|mesh-list
93090324|NCT01282502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090325|NCT01282502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93090326|NCT01282502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090327|NCT01282502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090328|NCT01269242|Bindarit|bindarit|mesh-list
93090329|NCT01269242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090330|NCT01269242|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93090331|NCT01269242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090332|NCT01269242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090333|NCT01169792|Tamoxifen|tamoxifen|mesh-list
93090334|NCT01169792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93090335|NCT01169792|Hormone Antagonists|hormone antagonists|mesh-ancestor
93090336|NCT01169792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090337|NCT01169792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090338|NCT01169792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93090339|NCT01169792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090340|NCT01169792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93090341|NCT01169792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93090342|NCT01169792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93090343|NCT01169402|Fluconazole|fluconazole|mesh-list
93090344|NCT01169402|Antifungal Agents|antifungal agents|mesh-ancestor
93090345|NCT01169402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090346|NCT01169402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93090347|NCT01169402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090348|NCT01169402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090349|NCT01169402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090350|NCT01169402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93090351|NCT01169402|Hormone Antagonists|hormone antagonists|mesh-ancestor
93090352|NCT01169402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090353|NCT01169402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090354|NCT01169402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93090355|NCT01169402|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93090356|NCT01274780|Ritonavir|ritonavir|mesh-list
93090357|NCT01274780|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93090358|NCT01274780|Darunavir|darunavir|mesh-list
93090359|NCT01274780|Tenofovir|tenofovir|mesh-list
93090360|NCT01274780|Emtricitabine|emtricitabine|mesh-list
93090361|NCT01274780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93090362|NCT01274780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93090363|NCT01274780|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090364|NCT01274780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090365|NCT01274780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090366|NCT01274780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93090367|NCT01274780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93090368|NCT01274780|Antiviral Agents|antiviral agents|mesh-ancestor
93090369|NCT01274780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090370|NCT01274780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93090371|NCT01274780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090372|NCT01274780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93090373|NCT01274780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93090374|NCT01169870|Paclitaxel|paclitaxel|mesh-list
93090375|NCT01169870|genexol-PM|genexol-pm|mesh-list
93090376|NCT01169870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93090377|NCT01169870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090378|NCT01169870|Tubulin Modulators|tubulin modulators|mesh-ancestor
93090379|NCT01169870|Antimitotic Agents|antimitotic agents|mesh-ancestor
93090380|NCT01169870|Mitosis Modulators|mitosis modulators|mesh-ancestor
93090381|NCT01169870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090382|NCT01165970|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93090383|NCT01165970|Laxatives|laxatives|mesh-ancestor
93090384|NCT01165970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090385|NCT01166048|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93090386|NCT01166048|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93090387|NCT01166048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93090388|NCT01166048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090389|NCT01166048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090390|NCT01166048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090391|NCT01166048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090392|NCT01166048|Analgesics|analgesics|mesh-ancestor
93090393|NCT01166048|Sensory System Agents|sensory system agents|mesh-ancestor
93090394|NCT01166048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090395|NCT01166048|Antidepressive Agents|antidepressive agents|mesh-ancestor
93090396|NCT01166048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93090397|NCT01166048|Dopamine Agents|dopamine agents|mesh-ancestor
93090398|NCT03869762|Denosumab|denosumab|mesh-list
93090399|NCT03869762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93090400|NCT03869762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090401|NCT01283126|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93090402|NCT01283126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090403|NCT01283048|Bevacizumab|bevacizumab|mesh-list
93090404|NCT01283048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090405|NCT01283048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090406|NCT01283048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93090407|NCT01283048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93090408|NCT01283048|Growth Substances|growth substances|mesh-ancestor
93090409|NCT01283048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090410|NCT01283048|Growth Inhibitors|growth inhibitors|mesh-ancestor
93090411|NCT03873740|Vaccines|vaccines|mesh-list
93090412|NCT03873740|Immunologic Factors|immunologic factors|mesh-ancestor
93090413|NCT03873740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090414|NCT01172756|Riociguat|riociguat|mesh-list
93090415|NCT01172756|Enzyme Activators|enzyme activators|mesh-ancestor
93090416|NCT01172756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090417|NCT02525822|Tazarotene|tazarotene|mesh-list
93090418|NCT02525822|Dermatologic Agents|dermatologic agents|mesh-ancestor
93090419|NCT02525822|Keratolytic Agents|keratolytic agents|mesh-ancestor
93090420|NCT01172912|Dexamethasone|dexamethasone|mesh-list
93090421|NCT01172912|Carboplatin|carboplatin|mesh-list
93090422|NCT01172912|Etoposide|etoposide|mesh-list
93090423|NCT01172912|Ifosfamide|ifosfamide|mesh-list
93090424|NCT01172912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090425|NCT01172912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090426|NCT01172912|Antiemetics|antiemetics|mesh-ancestor
93090427|NCT01172912|Autonomic Agents|autonomic agents|mesh-ancestor
93090428|NCT01172912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090429|NCT01172912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090430|NCT01172912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090431|NCT01172912|Glucocorticoids|glucocorticoids|mesh-ancestor
93090432|NCT01172912|Hormones|hormones|mesh-ancestor
93090433|NCT01172912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090434|NCT01172912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93090435|NCT01172912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93090436|NCT01172912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93090437|NCT01172912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93090438|NCT01172912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090439|NCT01172912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090440|NCT01172912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93090441|NCT01172912|Alkylating Agents|alkylating agents|mesh-ancestor
93090442|NCT01283204|Leucovorin|leucovorin|mesh-list
93090443|NCT01283204|Paclitaxel|paclitaxel|mesh-list
93090444|NCT01283204|Docetaxel|docetaxel|mesh-list
93090445|NCT01283204|Cisplatin|cisplatin|mesh-list
93090446|NCT01283204|Oxaliplatin|oxaliplatin|mesh-list
93090447|NCT01283204|Levoleucovorin|levoleucovorin|mesh-list
93090448|NCT01283204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93090449|NCT01283204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090450|NCT01283204|Tubulin Modulators|tubulin modulators|mesh-ancestor
93090451|NCT01283204|Antimitotic Agents|antimitotic agents|mesh-ancestor
93090452|NCT01283204|Mitosis Modulators|mitosis modulators|mesh-ancestor
93090453|NCT01283204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090454|NCT01283204|Antidotes|antidotes|mesh-ancestor
93090455|NCT01283204|Protective Agents|protective agents|mesh-ancestor
93090456|NCT01283204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090457|NCT01283204|Vitamin B Complex|vitamin b complex|mesh-ancestor
93090458|NCT01283204|Vitamins|vitamins|mesh-ancestor
93090459|NCT01283204|Micronutrients|micronutrients|mesh-ancestor
93090460|NCT03869528|Lidocaine|lidocaine|mesh-list
93090461|NCT03869528|Anesthetics, Local|anesthetics, local|mesh-ancestor
93090462|NCT03869528|Anesthetics|anesthetics|mesh-ancestor
93090463|NCT03869528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090464|NCT03869528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090465|NCT03869528|Sensory System Agents|sensory system agents|mesh-ancestor
93090466|NCT03869528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090467|NCT03869528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93090468|NCT03869528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93090469|NCT03869528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93090470|NCT03869528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090471|NCT03869528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090472|NCT01283360|Tenofovir|tenofovir|mesh-list
93090473|NCT01283360|Antiviral Agents|antiviral agents|mesh-ancestor
93090474|NCT01283360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090475|NCT01283360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93090476|NCT01283360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93090477|NCT01283360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090478|NCT01283360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090479|NCT01283360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93090480|NCT01283360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93090481|NCT01173068|Ertapenem|ertapenem|mesh-list
93090482|NCT01173068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93090483|NCT01173068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090484|NCT03267940|Atezolizumab|atezolizumab|mesh-list
93090485|NCT03267940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93090486|NCT03267940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090487|NCT03267940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090488|NCT03267940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090489|NCT01284452|Hydrocortisone|hydrocortisone|mesh-list
93090490|NCT01284452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090491|NCT01170104|Sorafenib|sorafenib|mesh-list
93090492|NCT01170104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090493|NCT01170104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93090494|NCT01170104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090495|NCT01170104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090496|NCT01284764|Mosapride|mosapride|mesh-list
93090497|NCT01284764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090498|NCT01284764|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93090499|NCT01284764|Serotonin Agents|serotonin agents|mesh-ancestor
93090500|NCT01284764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090501|NCT01284764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090502|NCT01284764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090503|NCT01170182|Omeprazole|omeprazole|mesh-list
93090504|NCT01170182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090505|NCT01170182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090506|NCT01170182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93090507|NCT01170182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090508|NCT01170182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090509|NCT01170260|Ethanol|ethanol|mesh-list
93090510|NCT01170260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93090511|NCT01170260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090512|NCT01170260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090513|NCT01170260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090514|NCT00312377|Docetaxel|docetaxel|mesh-list
93090515|NCT00312377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090516|NCT00312377|Tubulin Modulators|tubulin modulators|mesh-ancestor
93090517|NCT00312377|Antimitotic Agents|antimitotic agents|mesh-ancestor
93090518|NCT00312377|Mitosis Modulators|mitosis modulators|mesh-ancestor
93090519|NCT00312377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090520|NCT01173536|Moxifloxacin|moxifloxacin|mesh-list
93090521|NCT01173536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93090522|NCT01173536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090523|NCT01173536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93090524|NCT01173536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93090525|NCT01173536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090526|NCT01173536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090527|NCT01173536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090528|NCT01580891|Naftifine|naftifine|mesh-list
93090529|NCT01580891|Antifungal Agents|antifungal agents|mesh-ancestor
93090530|NCT01580891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090531|NCT01059383|Esomeprazole|esomeprazole|mesh-list
93090532|NCT01059383|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090533|NCT01059383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090534|NCT01059383|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93090535|NCT01059383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090536|NCT01059383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090537|NCT01285232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93090538|NCT01285232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93090539|NCT01166594|Bevacizumab|bevacizumab|mesh-list
93090540|NCT01166594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090541|NCT01166594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090542|NCT01166594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93090543|NCT01166594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93090544|NCT01166594|Growth Substances|growth substances|mesh-ancestor
93090545|NCT01166594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090546|NCT01166594|Growth Inhibitors|growth inhibitors|mesh-ancestor
93090547|NCT01170338|Varenicline|varenicline|mesh-list
93090548|NCT01170338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93090549|NCT01170338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93090550|NCT01170338|Cholinergic Agents|cholinergic agents|mesh-ancestor
93090551|NCT01170338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090552|NCT01170338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090553|NCT01170338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090554|NCT00312221|Oxycodone|oxycodone|mesh-list
93090555|NCT00312221|Buprenorphine|buprenorphine|mesh-list
93090556|NCT00312221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93090557|NCT00312221|Narcotics|narcotics|mesh-ancestor
93090558|NCT00312221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090559|NCT00312221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090560|NCT00312221|Analgesics|analgesics|mesh-ancestor
93090561|NCT00312221|Sensory System Agents|sensory system agents|mesh-ancestor
93090562|NCT00312221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090563|NCT00312221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93090564|NCT03872570|Phenylephrine|phenylephrine|mesh-list
93090565|NCT03872570|Oxymetazoline|oxymetazoline|mesh-list
93090566|NCT03872570|Norepinephrine|norepinephrine|mesh-list
93090567|NCT03872570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93090568|NCT03872570|Mydriatics|mydriatics|mesh-ancestor
93090569|NCT03872570|Autonomic Agents|autonomic agents|mesh-ancestor
93090570|NCT03872570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090571|NCT03872570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090572|NCT03872570|Sympathomimetics|sympathomimetics|mesh-ancestor
93090573|NCT03872570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93090574|NCT03872570|Nasal Decongestants|nasal decongestants|mesh-ancestor
93090575|NCT03872570|Respiratory System Agents|respiratory system agents|mesh-ancestor
93090576|NCT03872570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93090577|NCT03872570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93090578|NCT03872570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93090579|NCT03872570|Adrenergic Agents|adrenergic agents|mesh-ancestor
93090580|NCT03872570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090581|NCT03872570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090582|NCT03872570|Protective Agents|protective agents|mesh-ancestor
93090583|NCT01173926|Insulin|insulin|mesh-list
93090584|NCT01173926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93090585|NCT01173926|Insulin Aspart|insulin aspart|mesh-list
93090586|NCT01173926|Insulin, Long-Acting|insulin, long-acting|mesh-list
93090587|NCT01173926|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93090588|NCT01173926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93090589|NCT01173926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090591|NCT03349268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93090592|NCT03349268|Anesthetics, General|anesthetics, general|mesh-ancestor
93090593|NCT03349268|Anesthetics|anesthetics|mesh-ancestor
93090594|NCT03349268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090595|NCT03349268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090596|NCT01170494|Cholecalciferol|cholecalciferol|mesh-list
93090597|NCT01170494|Vitamin D|vitamin d|mesh-list
93090598|NCT01170494|Ergocalciferols|ergocalciferols|mesh-list
93090599|NCT01170494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93090600|NCT01170494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090601|NCT01170494|Vitamins|vitamins|mesh-ancestor
93090602|NCT01170494|Micronutrients|micronutrients|mesh-ancestor
93090603|NCT01170494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93090604|NCT01587326|Escitalopram|escitalopram|mesh-list
93090605|NCT01587326|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93090606|NCT01587326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93090607|NCT01587326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090608|NCT01587326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090609|NCT01587326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090610|NCT01587326|Serotonin Agents|serotonin agents|mesh-ancestor
93090611|NCT01587326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090612|NCT03294538|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93090613|NCT03294538|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93090614|NCT03294538|Estradiol|estradiol|mesh-list
93090615|NCT03294538|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93090616|NCT03294538|Estrogens|estrogens|mesh-ancestor
93090617|NCT03294538|Hormones|hormones|mesh-ancestor
93090618|NCT03294538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090619|NCT03294538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090620|NCT03294538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93090621|NCT03294538|Contraceptive Agents|contraceptive agents|mesh-ancestor
93090622|NCT03294538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93090623|NCT03294538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93090624|NCT03872336|Labetalol|labetalol|mesh-list
93090625|NCT03872336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93090626|NCT03872336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93090627|NCT03872336|Adrenergic Agents|adrenergic agents|mesh-ancestor
93090628|NCT03872336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090629|NCT03872336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090630|NCT03872336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090631|NCT03872336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93090632|NCT03872336|Sympathomimetics|sympathomimetics|mesh-ancestor
93090633|NCT03872336|Autonomic Agents|autonomic agents|mesh-ancestor
93090634|NCT03872336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090635|NCT03872336|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93090636|NCT03872336|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93090637|NCT02987530|Tenofovir|tenofovir|mesh-list
93090638|NCT02987530|Emtricitabine|emtricitabine|mesh-list
93090639|NCT02987530|Dolutegravir|dolutegravir|mesh-list
93090640|NCT02987530|Darunavir|darunavir|mesh-list
93090641|NCT02987530|Cobicistat|cobicistat|mesh-list
93090642|NCT02987530|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
93090643|NCT02987530|Antiviral Agents|antiviral agents|mesh-ancestor
93090644|NCT02987530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090645|NCT02987530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93090646|NCT02987530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93090647|NCT02987530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090648|NCT02987530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090649|NCT02987530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93090650|NCT02987530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93090651|NCT02987530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93090652|NCT02987530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93090653|NCT02987530|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93090654|NCT02987530|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93090655|NCT02987530|Protease Inhibitors|protease inhibitors|mesh-ancestor
93090656|NCT02987530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93090657|NCT02987530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090658|NCT03865550|Ketamine|ketamine|mesh-list
93090659|NCT03865550|Analgesics|analgesics|mesh-ancestor
93090660|NCT03865550|Sensory System Agents|sensory system agents|mesh-ancestor
93090661|NCT03865550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090662|NCT03865550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090663|NCT03865550|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93090664|NCT03865550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93090665|NCT03865550|Anesthetics, General|anesthetics, general|mesh-ancestor
93090666|NCT03865550|Anesthetics|anesthetics|mesh-ancestor
93090667|NCT03865550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090668|NCT03865550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93090669|NCT03865550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93090670|NCT03865550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090671|NCT03865550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090672|NCT02965690|Cimetidine|cimetidine|mesh-list
93090673|NCT02965690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090674|NCT02965690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090675|NCT02965690|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93090676|NCT02965690|Histamine Antagonists|histamine antagonists|mesh-ancestor
93090677|NCT02965690|Histamine Agents|histamine agents|mesh-ancestor
93090678|NCT02965690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090679|NCT02965690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090680|NCT02965690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090681|NCT02965690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93090682|NCT02965690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090683|NCT02965690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090684|NCT01285388|Beta-lapachone|beta-lapachone|mesh-list
93090685|NCT01285388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090686|NCT01285388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93090687|NCT01285388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93090688|NCT01285388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090689|NCT01285388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090690|NCT01285388|Antiviral Agents|antiviral agents|mesh-ancestor
93090691|NCT01285466|Paclitaxel|paclitaxel|mesh-list
93090692|NCT01285466|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93090693|NCT01285466|Trastuzumab|trastuzumab|mesh-list
93090694|NCT01285466|Dactolisib|dactolisib|mesh-list
93090695|NCT01285466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93090696|NCT01285466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090697|NCT01285466|Tubulin Modulators|tubulin modulators|mesh-ancestor
93090698|NCT01285466|Antimitotic Agents|antimitotic agents|mesh-ancestor
93090699|NCT01285466|Mitosis Modulators|mitosis modulators|mesh-ancestor
93090700|NCT01285466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090701|NCT01285466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090702|NCT01285544|Atorvastatin|atorvastatin|mesh-list
93090703|NCT01285544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93090704|NCT01285544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93090705|NCT01285544|Antimetabolites|antimetabolites|mesh-ancestor
93090706|NCT01285544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090707|NCT01285544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93090708|NCT01285544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93090709|NCT01285544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090710|NCT01174394|Fluoxetine|fluoxetine|mesh-list
93090711|NCT01174394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93090712|NCT01174394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93090713|NCT01174394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090714|NCT01174394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090715|NCT01174394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090716|NCT01174394|Serotonin Agents|serotonin agents|mesh-ancestor
93090717|NCT01174394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090718|NCT01174394|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93090719|NCT01174394|Antidepressive Agents|antidepressive agents|mesh-ancestor
93090720|NCT01174394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93090721|NCT01174394|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93090722|NCT01174394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090723|NCT01174394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090725|NCT01174472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93090726|NCT01174472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090727|NCT01174472|Tubulin Modulators|tubulin modulators|mesh-ancestor
93090728|NCT01174472|Antimitotic Agents|antimitotic agents|mesh-ancestor
93090729|NCT01174472|Mitosis Modulators|mitosis modulators|mesh-ancestor
93090730|NCT01174472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090731|NCT00335153|Levodopa|levodopa|mesh-list
93090732|NCT00335153|Carbidopa|carbidopa|mesh-list
93090733|NCT00335153|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93090734|NCT00335153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93090735|NCT00335153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93090736|NCT00335153|Dopamine Agents|dopamine agents|mesh-ancestor
93090737|NCT00335153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090738|NCT00335153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090739|NCT00335153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090740|NCT00335153|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93090741|NCT00335153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090742|NCT00335153|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93090743|NCT00335153|Immunologic Factors|immunologic factors|mesh-ancestor
93090744|NCT00335153|Dopamine Agonists|dopamine agonists|mesh-ancestor
93090745|NCT01170806|Orlistat|orlistat|mesh-list
93090746|NCT01170806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090747|NCT01170806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090748|NCT01170806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93090749|NCT01170806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93090750|NCT03868436|Methoxyflurane|methoxyflurane|mesh-list
93090751|NCT03868436|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93090752|NCT03868436|Anesthetics, General|anesthetics, general|mesh-ancestor
93090753|NCT03868436|Anesthetics|anesthetics|mesh-ancestor
93090754|NCT03868436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090755|NCT03868436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090756|NCT01280006|Celecoxib|celecoxib|mesh-list
93090757|NCT01280006|Indomethacin|indomethacin|mesh-list
93090758|NCT01280006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93090759|NCT01280006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93090760|NCT01280006|Analgesics|analgesics|mesh-ancestor
93090761|NCT01280006|Sensory System Agents|sensory system agents|mesh-ancestor
93090762|NCT01280006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090763|NCT01280006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090764|NCT01280006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090765|NCT01280006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93090766|NCT01280006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93090767|NCT01280006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93090768|NCT01280006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090769|NCT01280006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090770|NCT01280006|Gout Suppressants|gout suppressants|mesh-ancestor
93090771|NCT01280006|Tocolytic Agents|tocolytic agents|mesh-ancestor
93090772|NCT01280006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93090773|NCT03265132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93090774|NCT03265132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93090775|NCT03865160|Atropine|atropine|mesh-list
93090776|NCT03865160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93090777|NCT03865160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93090778|NCT03865160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93090779|NCT03865160|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93090780|NCT03865160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93090781|NCT03865160|Autonomic Agents|autonomic agents|mesh-ancestor
93090782|NCT03865160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090783|NCT03865160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090784|NCT03865160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93090785|NCT03865160|Respiratory System Agents|respiratory system agents|mesh-ancestor
93090786|NCT03865160|Mydriatics|mydriatics|mesh-ancestor
93090787|NCT03865160|Parasympatholytics|parasympatholytics|mesh-ancestor
93090788|NCT03865160|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93090789|NCT03865160|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93090790|NCT03865160|Cholinergic Agents|cholinergic agents|mesh-ancestor
93090791|NCT03865160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090792|NCT03865160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090793|NCT01059461|Cerebrolysin|cerebrolysin|mesh-list
93090794|NCT01059461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93090795|NCT01059461|Protective Agents|protective agents|mesh-ancestor
93090796|NCT01059461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090797|NCT01059461|Nootropic Agents|nootropic agents|mesh-ancestor
93090798|NCT01324739|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93090799|NCT01324739|Natriuretic Agents|natriuretic agents|mesh-ancestor
93090800|NCT01324739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090801|NCT01286246|Progesterone|progesterone|mesh-list
93090802|NCT01286246|Progestins|progestins|mesh-ancestor
93090803|NCT01286246|Hormones|hormones|mesh-ancestor
93090804|NCT01286246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090805|NCT01286246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090806|NCT03981887|Nafithromycin|nafithromycin|mesh-list
93090807|NCT03981887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93090808|NCT03981887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090809|NCT03981887|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93090810|NCT03981887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090811|NCT03981887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090812|NCT01063127|Insulin|insulin|mesh-list
93090813|NCT01063127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93090814|NCT01063127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090815|NCT03865004|Acetaminophen|acetaminophen|mesh-list
93090816|NCT03865004|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
93090817|NCT03865004|Morphine|morphine|mesh-list
93090818|NCT03865004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93090819|NCT03865004|Narcotics|narcotics|mesh-ancestor
93090820|NCT03865004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090821|NCT03865004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090822|NCT03865004|Analgesics|analgesics|mesh-ancestor
93090823|NCT03865004|Sensory System Agents|sensory system agents|mesh-ancestor
93090824|NCT03865004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090825|NCT03865004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93090826|NCT03865004|Antipyretics|antipyretics|mesh-ancestor
93090827|NCT03865004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93090828|NCT03865004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93090829|NCT03865004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93090830|NCT00334295|Fulvestrant|fulvestrant|mesh-list
93090831|NCT00334295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93090832|NCT00334295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090833|NCT00334295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93090834|NCT00334295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93090835|NCT00334295|Hormone Antagonists|hormone antagonists|mesh-ancestor
93090836|NCT00334295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090837|NCT00334295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090838|NCT01285778|Panitumumab|panitumumab|mesh-list
93090839|NCT01285778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090840|NCT01285778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090841|NCT01063205|Acetylcysteine|acetylcysteine|mesh-list
93090842|NCT01063205|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93090843|NCT01063205|Antiviral Agents|antiviral agents|mesh-ancestor
93090844|NCT01063205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090845|NCT01063205|Expectorants|expectorants|mesh-ancestor
93090846|NCT01063205|Respiratory System Agents|respiratory system agents|mesh-ancestor
93090847|NCT01063205|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93090848|NCT01063205|Antioxidants|antioxidants|mesh-ancestor
93090849|NCT01063205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090850|NCT01063205|Protective Agents|protective agents|mesh-ancestor
93090851|NCT01063205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090852|NCT01063205|Antidotes|antidotes|mesh-ancestor
93090853|NCT01175096|Everolimus|everolimus|mesh-list
93090854|NCT01175096|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93090855|NCT01175096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93090856|NCT01175096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090857|NCT01175096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090858|NCT01175096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93090859|NCT01175096|Immunologic Factors|immunologic factors|mesh-ancestor
93090860|NCT01175096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090861|NCT01175096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090862|NCT01285934|Insulin|insulin|mesh-list
93090863|NCT01285934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93090864|NCT01285934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090865|NCT01060163|Tranexamic Acid|tranexamic acid|mesh-list
93090866|NCT01060163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93090867|NCT01060163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93090868|NCT01060163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090869|NCT01060163|Hemostatics|hemostatics|mesh-ancestor
93090870|NCT01060163|Coagulants|coagulants|mesh-ancestor
93090871|NCT01063439|Cytarabine|cytarabine|mesh-list
93090872|NCT01063439|Etoposide|etoposide|mesh-list
93090873|NCT01063439|Melphalan|melphalan|mesh-list
93090874|NCT01063439|Busulfan|busulfan|mesh-list
93090875|NCT01063439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93090876|NCT01063439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090877|NCT01063439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93090878|NCT01063439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93090879|NCT01063439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090880|NCT01063439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090881|NCT01063439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93090882|NCT01063439|Antimetabolites|antimetabolites|mesh-ancestor
93090883|NCT01063439|Antiviral Agents|antiviral agents|mesh-ancestor
93090884|NCT01063439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93090885|NCT01063439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93090886|NCT01063439|Immunologic Factors|immunologic factors|mesh-ancestor
93090887|NCT01063439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090888|NCT01063439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93090889|NCT01063439|Alkylating Agents|alkylating agents|mesh-ancestor
93090890|NCT01063439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93090891|NCT05275270|Oxytocin|oxytocin|mesh-list
93090892|NCT05275270|Oxytocics|oxytocics|mesh-ancestor
93090893|NCT05275270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93090894|NCT05275270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090895|NCT02884648|Bevacizumab|bevacizumab|mesh-list
93090896|NCT02884648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93090897|NCT02884648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93090898|NCT02884648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93090899|NCT02884648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93090900|NCT02884648|Growth Substances|growth substances|mesh-ancestor
93090901|NCT02884648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090902|NCT02884648|Growth Inhibitors|growth inhibitors|mesh-ancestor
93090903|NCT03868202|Estradiol|estradiol|mesh-list
93090904|NCT03868202|Progesterone|progesterone|mesh-list
93090905|NCT03868202|Estrogens|estrogens|mesh-ancestor
93090906|NCT03868202|Hormones|hormones|mesh-ancestor
93090907|NCT03868202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090908|NCT03868202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090909|NCT03868202|Progestins|progestins|mesh-ancestor
93090910|NCT00311363|Gabapentin|gabapentin|mesh-list
93090911|NCT00311363|Analgesics|analgesics|mesh-ancestor
93090912|NCT00311363|Sensory System Agents|sensory system agents|mesh-ancestor
93090913|NCT00311363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93090914|NCT00311363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090915|NCT00311363|Anticonvulsants|anticonvulsants|mesh-ancestor
93090916|NCT00311363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93090917|NCT00311363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93090918|NCT00311363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090919|NCT00311363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93090920|NCT00311363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93090921|NCT00311363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93090922|NCT00311363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090923|NCT00311363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090924|NCT00311363|Antimanic Agents|antimanic agents|mesh-ancestor
93090925|NCT01175330|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93090926|NCT01175330|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93090927|NCT01175330|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93090928|NCT01175330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93090929|NCT03262012|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93090930|NCT03262012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93090931|NCT03262012|Respiratory System Agents|respiratory system agents|mesh-ancestor
93090932|NCT01286090|Cisapride|cisapride|mesh-list
93090933|NCT01286090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93090934|NCT01286090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090935|NCT01286090|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93090936|NCT01286090|Serotonin Agents|serotonin agents|mesh-ancestor
93090937|NCT01286090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090938|NCT01286090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090939|NCT01286090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090940|NCT00310817|Vaccines|vaccines|mesh-list
92763209|NCT05331859|Insulin|insulin|mesh-list
93090941|NCT00310817|Immunologic Factors|immunologic factors|mesh-ancestor
93090942|NCT00310817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090943|NCT03783286|Ivacaftor|ivacaftor|mesh-list
93090944|NCT03783286|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93090945|NCT03783286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090946|NCT03783286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090947|NCT03863366|Prucalopride|prucalopride|mesh-list
93090948|NCT03863366|Laxatives|laxatives|mesh-ancestor
93090949|NCT03863366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93090950|NCT03863366|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93090951|NCT03863366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93090952|NCT03863366|Serotonin Agents|serotonin agents|mesh-ancestor
93090953|NCT03863366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090954|NCT03863366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090955|NCT03863366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090956|NCT01175486|Pioglitazone|pioglitazone|mesh-list
93090957|NCT01175486|Acarbose|acarbose|mesh-list
93090958|NCT01175486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93090959|NCT01175486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090960|NCT01175486|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93090961|NCT01175486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090962|NCT01175486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090963|NCT01177904|Progesterone|progesterone|mesh-list
93090964|NCT01177904|Progestins|progestins|mesh-ancestor
93090965|NCT01177904|Hormones|hormones|mesh-ancestor
93090966|NCT01177904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93090967|NCT01177904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090968|NCT02940886|Iron|iron|mesh-list
93090969|NCT02940886|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93090970|NCT02940886|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93090971|NCT02940886|Trace Elements|trace elements|mesh-ancestor
93090972|NCT02940886|Micronutrients|micronutrients|mesh-ancestor
93090973|NCT02940886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090974|NCT02940886|Hematinics|hematinics|mesh-ancestor
93090975|NCT05216614|Fluvoxamine|fluvoxamine|mesh-list
93090976|NCT05216614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93090977|NCT05216614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93090978|NCT05216614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93090979|NCT05216614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93090980|NCT05216614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93090981|NCT05216614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93090982|NCT05216614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93090983|NCT05216614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93090984|NCT05216614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93090985|NCT05216614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93090986|NCT05216614|Serotonin Agents|serotonin agents|mesh-ancestor
93090987|NCT05216614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93090988|NCT05216614|Antidepressive Agents|antidepressive agents|mesh-ancestor
93090989|NCT05216614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93090990|NCT05216614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93090991|NCT05216614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93090992|NCT05216614|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93090993|NCT03860636|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93090994|NCT03860636|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93090995|NCT03860636|Estradiol|estradiol|mesh-list
93090996|NCT03860636|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93090997|NCT03860636|Progesterone|progesterone|mesh-list
93090998|NCT03860636|Estrogens|estrogens|mesh-ancestor
93090999|NCT03860636|Hormones|hormones|mesh-ancestor
93091000|NCT03860636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091001|NCT03860636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091002|NCT03860636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93091003|NCT03860636|Contraceptive Agents|contraceptive agents|mesh-ancestor
93091004|NCT03860636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93091005|NCT03860636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93091006|NCT03860636|Progestins|progestins|mesh-ancestor
93091007|NCT03860480|Bupivacaine|bupivacaine|mesh-list
93091008|NCT03860480|Anesthetics, Local|anesthetics, local|mesh-ancestor
93091009|NCT03860480|Anesthetics|anesthetics|mesh-ancestor
93091010|NCT03860480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091011|NCT03860480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091012|NCT03860480|Sensory System Agents|sensory system agents|mesh-ancestor
93091013|NCT03860480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091014|NCT03285646|Fasinumab|fasinumab|mesh-list
93091015|NCT03285646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091016|NCT03285646|Analgesics|analgesics|mesh-ancestor
93091017|NCT03285646|Sensory System Agents|sensory system agents|mesh-ancestor
93091018|NCT03285646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091019|NCT03285646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091020|NCT03860012|Folic Acid|folic acid|mesh-list
93091021|NCT03860012|Hematinics|hematinics|mesh-ancestor
93091022|NCT03860012|Vitamin B Complex|vitamin b complex|mesh-ancestor
93091023|NCT03860012|Vitamins|vitamins|mesh-ancestor
93091024|NCT03860012|Micronutrients|micronutrients|mesh-ancestor
93091025|NCT03860012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091026|NCT03859934|Melatonin|melatonin|mesh-list
93091027|NCT03859934|Antioxidants|antioxidants|mesh-ancestor
93091028|NCT03859934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091029|NCT03859934|Protective Agents|protective agents|mesh-ancestor
93091030|NCT03859934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091031|NCT03859934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091032|NCT01178372|Lactulose|lactulose|mesh-list
93091033|NCT01178372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091034|NCT01178450|Cinacalcet|cinacalcet|mesh-list
93091035|NCT01178450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93091036|NCT01178450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091037|NCT01178450|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93091038|NCT01178450|Hormone Antagonists|hormone antagonists|mesh-ancestor
93091039|NCT01178450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091040|NCT00074490|Prednisone|prednisone|mesh-list
93091041|NCT00074490|Cyclophosphamide|cyclophosphamide|mesh-list
93091042|NCT00074490|Rituximab|rituximab|mesh-list
93091043|NCT00074490|Doxorubicin|doxorubicin|mesh-list
93091044|NCT00074490|Fludarabine|fludarabine|mesh-list
93091045|NCT00074490|Etoposide|etoposide|mesh-list
93091046|NCT00074490|Vincristine|vincristine|mesh-list
93091047|NCT00074490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091048|NCT00074490|Immunologic Factors|immunologic factors|mesh-ancestor
93091049|NCT00074490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091050|NCT00074490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091051|NCT00074490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93091052|NCT00074490|Alkylating Agents|alkylating agents|mesh-ancestor
93091053|NCT00074490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091054|NCT00074490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091055|NCT00074490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93091056|NCT00074490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93091057|NCT00074490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93091058|NCT00074490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93091059|NCT00074490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93091060|NCT00074490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091061|NCT00074490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091062|NCT00074490|Glucocorticoids|glucocorticoids|mesh-ancestor
93091063|NCT00074490|Hormones|hormones|mesh-ancestor
93091064|NCT00074490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091065|NCT00074490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93091066|NCT00074490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93091067|NCT00074490|Tubulin Modulators|tubulin modulators|mesh-ancestor
93091068|NCT00074490|Antimitotic Agents|antimitotic agents|mesh-ancestor
93091069|NCT00074490|Mitosis Modulators|mitosis modulators|mesh-ancestor
93091070|NCT03859856|Hormones|hormones|mesh-list
93091071|NCT03859856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091072|NCT03859856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091073|NCT01094028|Oxytocin|oxytocin|mesh-list
93091074|NCT01094028|Oxytocics|oxytocics|mesh-ancestor
93091075|NCT01094028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93091076|NCT01094028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091077|NCT01288508|Psyllium|psyllium|mesh-list
93091078|NCT01288508|Cathartics|cathartics|mesh-ancestor
93091079|NCT01288508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091080|NCT01175954|Lacosamide|lacosamide|mesh-list
93091081|NCT01175954|Anticonvulsants|anticonvulsants|mesh-ancestor
93091082|NCT01175954|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93091083|NCT01175954|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93091084|NCT01175954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091085|NCT01175954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091086|NCT01288664|Tacrolimus|tacrolimus|mesh-list
93091087|NCT01288664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091088|NCT01288664|Immunologic Factors|immunologic factors|mesh-ancestor
93091089|NCT01288664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091090|NCT01288664|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93091091|NCT01288664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091092|NCT01288664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091093|NCT03285490|Tirbanibulin|tirbanibulin|mesh-list
93091094|NCT03285490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091095|NCT03285490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091096|NCT02525276|Hormones|hormones|mesh-list
93091097|NCT02525276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091098|NCT02525276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091099|NCT01172444|Mesalamine|mesalamine|mesh-list
93091100|NCT01172444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93091101|NCT01172444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091102|NCT01172444|Analgesics|analgesics|mesh-ancestor
93091103|NCT01172444|Sensory System Agents|sensory system agents|mesh-ancestor
93091104|NCT01172444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091105|NCT01172444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091106|NCT01172444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091107|NCT01172444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091108|NCT01288742|Simeprevir|simeprevir|mesh-list
93091109|NCT01288742|Digoxin|digoxin|mesh-list
93091110|NCT01288742|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93091111|NCT01288742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93091112|NCT01288742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93091113|NCT01288742|Antimetabolites|antimetabolites|mesh-ancestor
93091114|NCT01288742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091115|NCT01288742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93091116|NCT01288742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93091117|NCT01288742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091118|NCT01288742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93091119|NCT01288742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93091120|NCT01288742|Protective Agents|protective agents|mesh-ancestor
93091121|NCT01288742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091122|NCT01288742|Antiviral Agents|antiviral agents|mesh-ancestor
93091123|NCT01288742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091124|NCT01288742|Protease Inhibitors|protease inhibitors|mesh-ancestor
93091125|NCT01178996|Ribavirin|ribavirin|mesh-list
93091126|NCT01178996|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93091127|NCT01178996|Thymalfasin|thymalfasin|mesh-list
93091128|NCT01178996|Antimetabolites|antimetabolites|mesh-ancestor
93091129|NCT01178996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091130|NCT01178996|Antiviral Agents|antiviral agents|mesh-ancestor
93091131|NCT01178996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091132|NCT01178996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93091133|NCT01178996|Immunologic Factors|immunologic factors|mesh-ancestor
93091134|NCT01178996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091135|NCT03862586|Acetylcysteine|acetylcysteine|mesh-list
93091136|NCT03862586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93091137|NCT03862586|Antiviral Agents|antiviral agents|mesh-ancestor
93091138|NCT03862586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091139|NCT03862586|Expectorants|expectorants|mesh-ancestor
93091140|NCT03862586|Respiratory System Agents|respiratory system agents|mesh-ancestor
93091141|NCT03862586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93091142|NCT03862586|Antioxidants|antioxidants|mesh-ancestor
93091143|NCT03862586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091144|NCT03862586|Protective Agents|protective agents|mesh-ancestor
93091145|NCT03862586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091146|NCT03862586|Antidotes|antidotes|mesh-ancestor
93091147|NCT01180946|Vitamin D|vitamin d|mesh-list
93091148|NCT01180946|Ergocalciferols|ergocalciferols|mesh-list
93091149|NCT01180946|Vitamins|vitamins|mesh-ancestor
93091150|NCT01180946|Micronutrients|micronutrients|mesh-ancestor
93091151|NCT01180946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091152|NCT01180946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93091153|NCT01180946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93091154|NCT01179152|Budesonide|budesonide|mesh-list
93091155|NCT01179152|Formoterol Fumarate|formoterol fumarate|mesh-list
93091156|NCT01179152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091157|NCT01179152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93091158|NCT01179152|Autonomic Agents|autonomic agents|mesh-ancestor
93091159|NCT01179152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091160|NCT01179152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091161|NCT01179152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93091162|NCT01179152|Respiratory System Agents|respiratory system agents|mesh-ancestor
93091163|NCT01179152|Glucocorticoids|glucocorticoids|mesh-ancestor
93091164|NCT01179152|Hormones|hormones|mesh-ancestor
93091165|NCT01179152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763430|NCT02775877|Letrozole|letrozole|mesh-list
93091166|NCT01179152|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93091167|NCT01179152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93091168|NCT01179152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93091169|NCT01179152|Adrenergic Agents|adrenergic agents|mesh-ancestor
93091170|NCT01179152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091171|NCT01179152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091172|NCT01179230|Dipyridamole|dipyridamole|mesh-list
93091173|NCT01179230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93091174|NCT01179230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091175|NCT01179230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091176|NCT01179230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93091177|NCT01179230|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091178|NCT01286948|Levonorgestrel|levonorgestrel|mesh-list
93091179|NCT01286948|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93091180|NCT01286948|Contraceptive Agents|contraceptive agents|mesh-ancestor
93091181|NCT01286948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93091182|NCT01286948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091183|NCT01286948|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93091184|NCT01286948|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93091185|NCT01286948|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93091186|NCT01179308|Anesthetics|anesthetics|mesh-list
93091187|NCT01179308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091188|NCT01179308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091189|NCT03088826|Acetaminophen|acetaminophen|mesh-list
93091190|NCT03088826|Morphine|morphine|mesh-list
93091191|NCT03088826|Oxycodone|oxycodone|mesh-list
93091192|NCT03088826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93091193|NCT03088826|Narcotics|narcotics|mesh-ancestor
93091194|NCT03088826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091195|NCT03088826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091196|NCT03088826|Analgesics|analgesics|mesh-ancestor
93091197|NCT03088826|Sensory System Agents|sensory system agents|mesh-ancestor
93091198|NCT03088826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091199|NCT03088826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091200|NCT03088826|Antipyretics|antipyretics|mesh-ancestor
93091201|NCT00367133|Triamcinolone|triamcinolone|mesh-list
93091202|NCT00367133|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93091203|NCT00367133|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93091204|NCT00367133|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93091205|NCT00367133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091206|NCT00367133|Glucocorticoids|glucocorticoids|mesh-ancestor
93091207|NCT00367133|Hormones|hormones|mesh-ancestor
93091208|NCT00367133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091209|NCT00367133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091210|NCT00367133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091211|NCT00367133|Immunologic Factors|immunologic factors|mesh-ancestor
93091212|NCT00367133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091213|NCT00367133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091214|NCT01179464|Simvastatin|simvastatin|mesh-list
93091215|NCT01179464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93091216|NCT01179464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93091217|NCT01179464|Antimetabolites|antimetabolites|mesh-ancestor
93091218|NCT01179464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091219|NCT01179464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93091220|NCT01179464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93091221|NCT01179464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091222|NCT01179620|Certoparin|certoparin|mesh-list
93091223|NCT01179620|Anticoagulants|anticoagulants|mesh-ancestor
93091224|NCT01288820|Artesunate|artesunate|mesh-list
93091225|NCT01288820|Primaquine|primaquine|mesh-list
93091226|NCT01288820|Piperaquine|piperaquine|mesh-list
93091227|NCT01288820|Amodiaquine|amodiaquine|mesh-list
93091228|NCT01288820|Artenimol|artenimol|mesh-list
93091229|NCT01288820|Antimalarials|antimalarials|mesh-ancestor
93091230|NCT01288820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93091231|NCT01288820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93091232|NCT01288820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091233|NCT01288820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091234|NCT01288820|Antiviral Agents|antiviral agents|mesh-ancestor
93091235|NCT01288820|Schistosomicides|schistosomicides|mesh-ancestor
93091236|NCT01288820|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93091237|NCT01288820|Anthelmintics|anthelmintics|mesh-ancestor
93091238|NCT00367055|Metformin|metformin|mesh-list
93091239|NCT00367055|Rosiglitazone|rosiglitazone|mesh-list
93091240|NCT00367055|Gliclazide|gliclazide|mesh-list
93091241|NCT00367055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091242|NCT00367055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091243|NCT00057330|polysaccharide-K|polysaccharide-k|mesh-list
93091244|NCT00057330|Vaccines|vaccines|mesh-list
93091245|NCT00057330|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
93091246|NCT00057330|Immunologic Factors|immunologic factors|mesh-ancestor
93091247|NCT00057330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091248|NCT00057330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92681539|NCT00431795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091249|NCT00057330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93091250|NCT00057330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091251|NCT00057330|Antiviral Agents|antiviral agents|mesh-ancestor
93091252|NCT00057330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091253|NCT00057330|Interferon Inducers|interferon inducers|mesh-ancestor
93091254|NCT00057330|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93091255|NCT00057330|Protective Agents|protective agents|mesh-ancestor
93091256|NCT03857672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93091257|NCT03857672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091258|NCT03857672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091259|NCT03283696|Doxorubicin|doxorubicin|mesh-list
93091260|NCT03283696|Ifosfamide|ifosfamide|mesh-list
93091261|NCT03283696|Olaratumab|olaratumab|mesh-list
93091262|NCT03283696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93091263|NCT03283696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091264|NCT03283696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93091265|NCT03283696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93091266|NCT03283696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091267|NCT03283696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091268|NCT03283696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93091269|NCT03283696|Alkylating Agents|alkylating agents|mesh-ancestor
93091270|NCT01176344|Vitamin D|vitamin d|mesh-list
93091271|NCT01176344|Vitamins|vitamins|mesh-ancestor
93091272|NCT01176344|Micronutrients|micronutrients|mesh-ancestor
93091273|NCT01176344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091274|NCT01176344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93091275|NCT02530788|Selenium|selenium|mesh-list
93091276|NCT02530788|Selenious Acid|selenious acid|mesh-list
93091277|NCT02530788|Sodium Selenite|sodium selenite|mesh-list
93091278|NCT02530788|Antioxidants|antioxidants|mesh-ancestor
93091279|NCT02530788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091280|NCT02530788|Protective Agents|protective agents|mesh-ancestor
93091281|NCT02530788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091282|NCT02530788|Trace Elements|trace elements|mesh-ancestor
93091283|NCT02530788|Micronutrients|micronutrients|mesh-ancestor
93091284|NCT01288898|Ipragliflozin|ipragliflozin|mesh-list
93091285|NCT01288898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93091286|NCT01288898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091287|NCT01288898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091288|NCT01288898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091289|NCT01089192|Metformin|metformin|mesh-list
93091290|NCT01089192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091291|NCT01089192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091292|NCT02564380|Pembrolizumab|pembrolizumab|mesh-list
93091293|NCT02564380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93091294|NCT02564380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091295|NCT02564380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93091296|NCT02564380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091297|NCT01093092|Calcitriol|calcitriol|mesh-list
93091298|NCT01093092|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93091299|NCT01093092|Gemcitabine|gemcitabine|mesh-list
93091300|NCT01093092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091301|NCT01093092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93091302|NCT01093092|Antimetabolites|antimetabolites|mesh-ancestor
93091303|NCT01093092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091304|NCT01093092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93091305|NCT01093092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091306|NCT01093092|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93091307|NCT01093092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091308|NCT01093092|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93091309|NCT01093092|Vitamins|vitamins|mesh-ancestor
93091310|NCT01093092|Micronutrients|micronutrients|mesh-ancestor
93091311|NCT01093092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93091312|NCT01289054|Imatinib Mesylate|imatinib mesylate|mesh-list
93091313|NCT01289054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091314|NCT01289054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091315|NCT01289054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091316|NCT01289054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091317|NCT01179776|Iloprost|iloprost|mesh-list
93091318|NCT01179776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93091319|NCT01179776|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091320|NCT01181414|Amiodarone|amiodarone|mesh-list
93091321|NCT01181414|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93091322|NCT01181414|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93091323|NCT01181414|Adrenergic Agents|adrenergic agents|mesh-ancestor
93091324|NCT01181414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091325|NCT01181414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091326|NCT01181414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091327|NCT01181414|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93091328|NCT01181414|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091329|NCT01181414|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93091330|NCT01181414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091331|NCT01181414|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93091332|NCT01181414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93091333|NCT01181414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93091334|NCT01181414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091335|NCT01181414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93091336|NCT01181414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93091337|NCT01181414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93091338|NCT01094340|Thalidomide|thalidomide|mesh-list
93091339|NCT01094340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091340|NCT01094340|Immunologic Factors|immunologic factors|mesh-ancestor
93091341|NCT01094340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091342|NCT01094340|Leprostatic Agents|leprostatic agents|mesh-ancestor
93091343|NCT01094340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93091344|NCT01094340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091345|NCT01094340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93091346|NCT01094340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93091347|NCT01094340|Growth Substances|growth substances|mesh-ancestor
93091348|NCT01094340|Growth Inhibitors|growth inhibitors|mesh-ancestor
93091349|NCT01094340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091350|NCT00056862|Ribavirin|ribavirin|mesh-list
93091351|NCT00056862|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93091352|NCT00056862|Interferon-alpha|interferon-alpha|mesh-list
93091353|NCT00056862|Antimetabolites|antimetabolites|mesh-ancestor
93091354|NCT00056862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091355|NCT00056862|Antiviral Agents|antiviral agents|mesh-ancestor
93091356|NCT00056862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091357|NCT00056862|Immunologic Factors|immunologic factors|mesh-ancestor
93091358|NCT00056862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091359|NCT01289132|Candesartan|candesartan|mesh-list
93091360|NCT01289132|Candesartan cilexetil|candesartan cilexetil|mesh-list
93091361|NCT01289132|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93091362|NCT01289132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93091363|NCT01289132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93091364|NCT01289132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93091365|NCT01289132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091366|NCT01287260|Nifedipine|nifedipine|mesh-list
93091367|NCT01287260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93091368|NCT01287260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091369|NCT01287260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091370|NCT01287260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93091371|NCT01287260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091372|NCT01287260|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091373|NCT01287260|Tocolytic Agents|tocolytic agents|mesh-ancestor
93091374|NCT01287260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93091375|NCT01181570|Adalimumab|adalimumab|mesh-list
93091376|NCT01181570|Mannitol|mannitol|mesh-list
93091377|NCT01181570|Citric Acid|citric acid|mesh-list
93091378|NCT01181570|Sodium Citrate|sodium citrate|mesh-list
93091379|NCT01181570|Anticoagulants|anticoagulants|mesh-ancestor
93091380|NCT01181570|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93091381|NCT01181570|Chelating Agents|chelating agents|mesh-ancestor
93091382|NCT01181570|Sequestering Agents|sequestering agents|mesh-ancestor
93091383|NCT01181570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091384|NCT01181570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93091385|NCT01181570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091386|NCT01181570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091387|NCT01181570|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93091388|NCT01181570|Diuretics|diuretics|mesh-ancestor
93091389|NCT01181570|Natriuretic Agents|natriuretic agents|mesh-ancestor
93091390|NCT01181570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091391|NCT05200312|Prednisone|prednisone|mesh-list
93091392|NCT05200312|Cyclophosphamide|cyclophosphamide|mesh-list
93091393|NCT05200312|Rituximab|rituximab|mesh-list
93091394|NCT05200312|Doxorubicin|doxorubicin|mesh-list
93091395|NCT05200312|Vincristine|vincristine|mesh-list
93091396|NCT05200312|Lenalidomide|lenalidomide|mesh-list
93091397|NCT05200312|Zanubrutinib|zanubrutinib|mesh-list
93091398|NCT05200312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091399|NCT05200312|Immunologic Factors|immunologic factors|mesh-ancestor
93091400|NCT05200312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091401|NCT05200312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091402|NCT05200312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93091403|NCT05200312|Alkylating Agents|alkylating agents|mesh-ancestor
93091404|NCT05200312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091405|NCT05200312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091406|NCT05200312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93091407|NCT05200312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93091408|NCT05200312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93091409|NCT05200312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93091410|NCT05200312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93091411|NCT05200312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091412|NCT05200312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091413|NCT05200312|Glucocorticoids|glucocorticoids|mesh-ancestor
93091415|NCT05200312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091416|NCT05200312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93091417|NCT05200312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93091418|NCT05200312|Tubulin Modulators|tubulin modulators|mesh-ancestor
93091419|NCT05200312|Antimitotic Agents|antimitotic agents|mesh-ancestor
93091420|NCT05200312|Mitosis Modulators|mitosis modulators|mesh-ancestor
93091421|NCT05200312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93091422|NCT05200312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93091423|NCT05200312|Growth Substances|growth substances|mesh-ancestor
93091424|NCT05200312|Growth Inhibitors|growth inhibitors|mesh-ancestor
93091425|NCT05200312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091426|NCT01180166|Nimotuzumab|nimotuzumab|mesh-list
93091427|NCT01180166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93091428|NCT01180166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091429|NCT02940730|Dalbavancin|dalbavancin|mesh-list
93091430|NCT02940730|Teicoplanin|teicoplanin|mesh-list
93091431|NCT02940730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93091432|NCT02940730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091433|NCT01587638|Metoprolol|metoprolol|mesh-list
93091434|NCT01587638|Atenolol|atenolol|mesh-list
93091435|NCT01587638|Carvedilol|carvedilol|mesh-list
93091436|NCT01587638|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
93091437|NCT01587638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93091438|NCT01587638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93091439|NCT01587638|Sympatholytics|sympatholytics|mesh-ancestor
93091440|NCT01587638|Autonomic Agents|autonomic agents|mesh-ancestor
93091441|NCT01587638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091442|NCT01587638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091443|NCT01587638|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93091444|NCT01587638|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93091445|NCT01587638|Adrenergic Agents|adrenergic agents|mesh-ancestor
93091446|NCT01587638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091447|NCT01587638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091448|NCT01587638|Antioxidants|antioxidants|mesh-ancestor
93091449|NCT01587638|Protective Agents|protective agents|mesh-ancestor
93091450|NCT01587638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93091451|NCT01587638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091452|NCT01587638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93091453|NCT01587638|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091454|NCT01587638|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93091455|NCT01587638|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93091456|NCT01287338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93091457|NCT01287338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93091458|NCT01287338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091459|NCT01287338|Analgesics|analgesics|mesh-ancestor
93091460|NCT01287338|Sensory System Agents|sensory system agents|mesh-ancestor
93091461|NCT01287338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091462|NCT01287338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091463|NCT01287338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091464|NCT01287338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091465|NCT01287338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93091466|NCT01287338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93091467|NCT01287338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93091468|NCT01287338|Histamine Antagonists|histamine antagonists|mesh-ancestor
93091469|NCT01287338|Histamine Agents|histamine agents|mesh-ancestor
93091470|NCT01287338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091471|NCT01287338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091472|NCT01180322|Cytarabine|cytarabine|mesh-list
93091473|NCT01180322|Etoposide|etoposide|mesh-list
93091474|NCT01180322|Idarubicin|idarubicin|mesh-list
93091475|NCT01180322|Azacitidine|azacitidine|mesh-list
93091476|NCT01180322|Lenograstim|lenograstim|mesh-list
93091477|NCT01180322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93091478|NCT01180322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091479|NCT01180322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93091480|NCT01180322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93091481|NCT01180322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091482|NCT01180322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091483|NCT01180322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93091484|NCT01180322|Antimetabolites|antimetabolites|mesh-ancestor
93091485|NCT01180322|Antiviral Agents|antiviral agents|mesh-ancestor
93091486|NCT01180322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091487|NCT01180322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091488|NCT01180322|Immunologic Factors|immunologic factors|mesh-ancestor
93091489|NCT01180322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091490|NCT01180322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93091491|NCT01180322|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93091492|NCT01287494|Sertraline|sertraline|mesh-list
93091493|NCT01287494|Antidepressive Agents|antidepressive agents|mesh-ancestor
93091494|NCT01287494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93091495|NCT01287494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93091496|NCT01287494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93091497|NCT01287494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091498|NCT01287494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091499|NCT01287494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091500|NCT01287494|Serotonin Agents|serotonin agents|mesh-ancestor
93091501|NCT01287494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091502|NCT02524964|Tanshinone|tanshinone|mesh-list
93091503|NCT02524964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091504|NCT02524964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93091505|NCT02524964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091506|NCT02524964|Analgesics|analgesics|mesh-ancestor
93091507|NCT02524964|Sensory System Agents|sensory system agents|mesh-ancestor
93091508|NCT02524964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091509|NCT02524964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091510|NCT02524964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091511|NCT02524964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091512|NCT02524964|Anticoagulants|anticoagulants|mesh-ancestor
93091513|NCT02524964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93091514|NCT02524964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091515|NCT02524964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091516|NCT02524964|Immunologic Factors|immunologic factors|mesh-ancestor
93091517|NCT02639702|Clozapine|clozapine|mesh-list
93091518|NCT02639702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93091519|NCT02639702|Serotonin Agents|serotonin agents|mesh-ancestor
93091520|NCT02639702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091521|NCT02639702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091522|NCT02639702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091523|NCT02639702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93091524|NCT02639702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93091525|NCT02639702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091526|NCT02639702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93091527|NCT02639702|GABA Antagonists|gaba antagonists|mesh-ancestor
93091528|NCT02639702|GABA Agents|gaba agents|mesh-ancestor
93091529|NCT01289756|Clarithromycin|clarithromycin|mesh-list
93091530|NCT01289756|Paroxetine|paroxetine|mesh-list
93091531|NCT01289756|Clomiphene|clomiphene|mesh-list
93091532|NCT01289756|Enclomiphene|enclomiphene|mesh-list
93091533|NCT01289756|Zuclomiphene|zuclomiphene|mesh-list
93091534|NCT01289756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93091535|NCT01289756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091536|NCT01289756|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93091537|NCT01289756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091538|NCT01289756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091539|NCT01289756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93091540|NCT01289756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93091541|NCT01289756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93091542|NCT01289756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93091543|NCT01289756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091544|NCT01289756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091545|NCT01289756|Serotonin Agents|serotonin agents|mesh-ancestor
93091546|NCT01289756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091547|NCT01289756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93091548|NCT01289756|Antidepressive Agents|antidepressive agents|mesh-ancestor
93091549|NCT01289756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93091550|NCT01289756|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93091551|NCT01289756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93091552|NCT01289756|Hormone Antagonists|hormone antagonists|mesh-ancestor
93091553|NCT01289756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091554|NCT01289756|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93091555|NCT01289756|Fertility Agents|fertility agents|mesh-ancestor
93091556|NCT01289756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93091557|NCT01289756|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93091558|NCT01289756|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93091559|NCT01181882|Aspirin|aspirin|mesh-list
93091560|NCT01181882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93091561|NCT01181882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091562|NCT01181882|Analgesics|analgesics|mesh-ancestor
93091563|NCT01181882|Sensory System Agents|sensory system agents|mesh-ancestor
93091564|NCT01181882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091565|NCT01181882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091566|NCT01181882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091567|NCT01181882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091568|NCT01181882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93091569|NCT01181882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93091570|NCT01181882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091571|NCT01181882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93091572|NCT01181882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93091573|NCT01181882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091574|NCT01181882|Antipyretics|antipyretics|mesh-ancestor
93091575|NCT01181960|Risperidone|risperidone|mesh-list
93091576|NCT01181960|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93091577|NCT01181960|Antipsychotic Agents|antipsychotic agents|mesh-list
93091578|NCT01181960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93091579|NCT01181960|Serotonin Agents|serotonin agents|mesh-ancestor
93091580|NCT01181960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091581|NCT01181960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091582|NCT01181960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091583|NCT01181960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93091584|NCT01181960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091585|NCT01181960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93091586|NCT01181960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93091587|NCT01181960|Dopamine Agents|dopamine agents|mesh-ancestor
93091588|NCT01181960|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93091589|NCT01181960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93091590|NCT03858062|Insulin|insulin|mesh-list
93091591|NCT03858062|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93091592|NCT03858062|Pancrelipase|pancrelipase|mesh-list
93091593|NCT03858062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091594|NCT03858062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091595|NCT03858062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091596|NCT03307252|Metformin|metformin|mesh-list
93091597|NCT03307252|Rifampin|rifampin|mesh-list
93091598|NCT03307252|Probenecid|probenecid|mesh-list
93091599|NCT03307252|Digoxin|digoxin|mesh-list
93091600|NCT03307252|Verapamil|verapamil|mesh-list
93091601|NCT03307252|Furosemide|furosemide|mesh-list
93091602|NCT03307252|Cimetidine|cimetidine|mesh-list
93091603|NCT03307252|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93091604|NCT03307252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091605|NCT03307252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091606|NCT03307252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93091607|NCT03307252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93091608|NCT03307252|Antimetabolites|antimetabolites|mesh-ancestor
93091609|NCT03307252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091610|NCT03307252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93091611|NCT03307252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93091612|NCT03307252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091613|NCT03307252|Diuretics|diuretics|mesh-ancestor
93091614|NCT03307252|Natriuretic Agents|natriuretic agents|mesh-ancestor
93091615|NCT03307252|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93091616|NCT03307252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091617|NCT03307252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93091618|NCT03307252|Antitubercular Agents|antitubercular agents|mesh-ancestor
93091619|NCT03307252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93091620|NCT03307252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091621|NCT03307252|Leprostatic Agents|leprostatic agents|mesh-ancestor
93091622|NCT03307252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93091623|NCT03307252|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93091624|NCT03307252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93091625|NCT03307252|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93091626|NCT03307252|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93091627|NCT03307252|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93091628|NCT03307252|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93091629|NCT03307252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93091630|NCT03307252|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93091631|NCT03307252|Protective Agents|protective agents|mesh-ancestor
93091632|NCT03307252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93091633|NCT03307252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93091634|NCT03307252|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091635|NCT03307252|Uricosuric Agents|uricosuric agents|mesh-ancestor
93091636|NCT03307252|Gout Suppressants|gout suppressants|mesh-ancestor
93091637|NCT03307252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091638|NCT03307252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93091639|NCT03307252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091640|NCT03307252|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93091641|NCT03307252|Histamine Antagonists|histamine antagonists|mesh-ancestor
93091642|NCT03307252|Histamine Agents|histamine agents|mesh-ancestor
93091643|NCT03307252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091644|NCT03307252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93091645|NCT03307252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93091646|NCT03307174|Fentanyl|fentanyl|mesh-list
93091647|NCT03307174|Bupivacaine|bupivacaine|mesh-list
93091648|NCT03307174|Anesthetics, Local|anesthetics, local|mesh-ancestor
93091649|NCT03307174|Anesthetics|anesthetics|mesh-ancestor
93091650|NCT03307174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091651|NCT03307174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091652|NCT03307174|Sensory System Agents|sensory system agents|mesh-ancestor
93091653|NCT03307174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091654|NCT03307174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93091655|NCT03307174|Narcotics|narcotics|mesh-ancestor
93091656|NCT03307174|Analgesics|analgesics|mesh-ancestor
93091657|NCT03307174|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93091658|NCT03307174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93091659|NCT03307174|Anesthetics, General|anesthetics, general|mesh-ancestor
93091660|NCT03448978|Cyclophosphamide|cyclophosphamide|mesh-list
93091661|NCT03448978|Fludarabine|fludarabine|mesh-list
93091662|NCT03448978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091663|NCT03448978|Immunologic Factors|immunologic factors|mesh-ancestor
93091664|NCT03448978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091665|NCT03448978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681973|NCT00472329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091666|NCT03448978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93091667|NCT03448978|Alkylating Agents|alkylating agents|mesh-ancestor
93091668|NCT03448978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091669|NCT03448978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091670|NCT03448978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93091671|NCT01290926|Sorafenib|sorafenib|mesh-list
93091672|NCT01290926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091673|NCT01290926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091674|NCT01290926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091675|NCT01290926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091676|NCT01185158|Gefitinib|gefitinib|mesh-list
93091677|NCT01185158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091678|NCT01185158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091679|NCT01185158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091680|NCT01185158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091681|NCT01185236|Atorvastatin|atorvastatin|mesh-list
93091682|NCT01185236|Simvastatin|simvastatin|mesh-list
93091683|NCT01185236|Ezetimibe|ezetimibe|mesh-list
93091684|NCT01185236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93091685|NCT01185236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93091686|NCT01185236|Antimetabolites|antimetabolites|mesh-ancestor
93091687|NCT01185236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091688|NCT01185236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93091689|NCT01185236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93091690|NCT01185236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091691|NCT02524652|Ropivacaine|ropivacaine|mesh-list
93091692|NCT02524652|Anesthetics, Local|anesthetics, local|mesh-ancestor
93091693|NCT02524652|Anesthetics|anesthetics|mesh-ancestor
93091694|NCT02524652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091695|NCT02524652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091696|NCT02524652|Sensory System Agents|sensory system agents|mesh-ancestor
93091697|NCT02524652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091698|NCT01182272|Sorafenib|sorafenib|mesh-list
93091699|NCT01182272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091700|NCT01182272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091701|NCT01182272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091702|NCT01182272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091703|NCT03861416|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93091704|NCT01185470|Morphine|morphine|mesh-list
93091705|NCT01185470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93091706|NCT01185470|Narcotics|narcotics|mesh-ancestor
93091707|NCT01185470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091708|NCT01185470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091709|NCT01185470|Analgesics|analgesics|mesh-ancestor
93091710|NCT01185470|Sensory System Agents|sensory system agents|mesh-ancestor
93091711|NCT01185470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091712|NCT00056160|Dexamethasone|dexamethasone|mesh-list
93091713|NCT00056160|Lenalidomide|lenalidomide|mesh-list
93091714|NCT00056160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091715|NCT00056160|Antiemetics|antiemetics|mesh-ancestor
93091716|NCT00056160|Autonomic Agents|autonomic agents|mesh-ancestor
93091717|NCT00056160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091718|NCT00056160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091719|NCT00056160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091720|NCT00056160|Glucocorticoids|glucocorticoids|mesh-ancestor
93091721|NCT00056160|Hormones|hormones|mesh-ancestor
93091722|NCT00056160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091723|NCT00056160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93091724|NCT00056160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091725|NCT00056160|Immunologic Factors|immunologic factors|mesh-ancestor
93091726|NCT00056160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93091727|NCT00056160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93091728|NCT00056160|Growth Substances|growth substances|mesh-ancestor
93091729|NCT00056160|Growth Inhibitors|growth inhibitors|mesh-ancestor
93091730|NCT01290146|Simendan|simendan|mesh-list
93091731|NCT01290146|Diuretics|diuretics|mesh-list
93091732|NCT01290146|Natriuretic Agents|natriuretic agents|mesh-ancestor
93091733|NCT01290146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091734|NCT01290146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93091735|NCT01290146|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091736|NCT01290146|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93091737|NCT01290146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93091738|NCT01290146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682041|NCT00472368|Panobinostat|panobinostat|mesh-list
93091739|NCT01290146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091740|NCT01290146|Protective Agents|protective agents|mesh-ancestor
93091741|NCT00061932|Irinotecan|irinotecan|mesh-list
93091742|NCT00061932|Bortezomib|bortezomib|mesh-list
93091743|NCT00061932|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93091744|NCT00061932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93091745|NCT00061932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091746|NCT00061932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091747|NCT00061932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091748|NCT03856970|Glyburide|glyburide|mesh-list
93091749|NCT03856970|Digoxin|digoxin|mesh-list
93091750|NCT03856970|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93091751|NCT03856970|Norethindrone|norethindrone|mesh-list
93091752|NCT03856970|Estradiol|estradiol|mesh-list
93091753|NCT03856970|Estrogens|estrogens|mesh-ancestor
93091754|NCT03856970|Hormones|hormones|mesh-ancestor
93091755|NCT03856970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091756|NCT03856970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091757|NCT03856970|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93091758|NCT03856970|Contraceptive Agents|contraceptive agents|mesh-ancestor
93091759|NCT03856970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93091760|NCT03856970|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93091761|NCT03856970|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93091762|NCT03856970|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93091763|NCT03856970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93091764|NCT03856970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93091765|NCT03856970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091766|NCT03856970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091767|NCT03856970|Protective Agents|protective agents|mesh-ancestor
93091768|NCT03856970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091769|NCT03856970|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93091770|NCT01089348|Metronidazole|metronidazole|mesh-list
93091771|NCT01089348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091772|NCT01089348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93091773|NCT01089348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93091774|NCT01089348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93091775|NCT01291316|Clonazepam|clonazepam|mesh-list
93091776|NCT01291316|Clobazam|clobazam|mesh-list
93091777|NCT01291316|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93091778|NCT01291316|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93091779|NCT01291316|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93091780|NCT01291316|Cholinergic Agents|cholinergic agents|mesh-ancestor
93091781|NCT01291316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091782|NCT01291316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091783|NCT01291316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091784|NCT01291316|Urological Agents|urological agents|mesh-ancestor
93091785|NCT01291316|Anticonvulsants|anticonvulsants|mesh-ancestor
93091786|NCT01291316|GABA Modulators|gaba modulators|mesh-ancestor
93091787|NCT01291316|GABA Agents|gaba agents|mesh-ancestor
93091788|NCT01291316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93091789|NCT01291316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93091790|NCT01291316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091791|NCT01291316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93091792|NCT01291316|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93091793|NCT01291316|GABA Agonists|gaba agonists|mesh-ancestor
93091794|NCT00060840|Nitric Oxide|nitric oxide|mesh-list
93091795|NCT00060840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93091796|NCT00060840|Autonomic Agents|autonomic agents|mesh-ancestor
93091797|NCT00060840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091798|NCT00060840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682104|NCT00434096|Hormones|hormones|mesh-ancestor
93091799|NCT00060840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93091800|NCT00060840|Respiratory System Agents|respiratory system agents|mesh-ancestor
93091801|NCT00060840|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93091802|NCT00060840|Antioxidants|antioxidants|mesh-ancestor
93091803|NCT00060840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091804|NCT00060840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091805|NCT00060840|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93091806|NCT00060840|Vasodilator Agents|vasodilator agents|mesh-ancestor
93091807|NCT00060840|Gasotransmitters|gasotransmitters|mesh-ancestor
93091808|NCT00060840|Protective Agents|protective agents|mesh-ancestor
93091809|NCT01185860|Ritonavir|ritonavir|mesh-list
93091810|NCT01185860|Ribavirin|ribavirin|mesh-list
93091811|NCT01185860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93091812|NCT01185860|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93091813|NCT01185860|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93091814|NCT01185860|Protease Inhibitors|protease inhibitors|mesh-ancestor
93091815|NCT01185860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091816|NCT01185860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091817|NCT01185860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93091818|NCT01185860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93091819|NCT01185860|Antiviral Agents|antiviral agents|mesh-ancestor
93091820|NCT01185860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091821|NCT01185860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93091822|NCT01185860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93091823|NCT01185860|Antimetabolites|antimetabolites|mesh-ancestor
93091824|NCT01290302|Azacitidine|azacitidine|mesh-list
93091825|NCT01290302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93091826|NCT01290302|Antimetabolites|antimetabolites|mesh-ancestor
93091827|NCT01290302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091828|NCT01290302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091829|NCT01290302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091830|NCT01089660|Vaccines|vaccines|mesh-list
93091831|NCT01089660|Immunologic Factors|immunologic factors|mesh-ancestor
93091832|NCT01089660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091833|NCT01182662|Cyclosporine|cyclosporine|mesh-list
93091834|NCT01182662|Cyclosporins|cyclosporins|mesh-list
93091835|NCT01182662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091836|NCT01182662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091837|NCT01182662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091838|NCT01182662|Immunologic Factors|immunologic factors|mesh-ancestor
93091839|NCT01182662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091840|NCT01182662|Antifungal Agents|antifungal agents|mesh-ancestor
93091841|NCT01182662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091842|NCT01182662|Dermatologic Agents|dermatologic agents|mesh-ancestor
93091843|NCT01182662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93091844|NCT01182662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93091845|NCT01185938|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93091846|NCT01185938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93091847|NCT01185938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93091848|NCT01185938|Antimetabolites|antimetabolites|mesh-ancestor
93091849|NCT01185938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091850|NCT01185938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93091851|NCT01185938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93091852|NCT01185938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091853|NCT00059202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93091854|NCT00059202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93091855|NCT00059202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091856|NCT01177358|Botulinum Toxins|botulinum toxins|mesh-list
93091857|NCT01177358|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93091858|NCT01177358|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93091859|NCT01177358|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93091860|NCT01177358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091861|NCT01177358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091862|NCT01177358|Cholinergic Agents|cholinergic agents|mesh-ancestor
93091863|NCT01177358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091864|NCT01177358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091865|NCT01177358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93091866|NCT01177358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091867|NCT03854942|Naltrexone|naltrexone|mesh-list
93091868|NCT03854942|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93091869|NCT03854942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93091870|NCT03854942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091871|NCT03854942|Sensory System Agents|sensory system agents|mesh-ancestor
93091872|NCT03854942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091873|NCT03278626|Paclitaxel|paclitaxel|mesh-list
93091874|NCT03278626|Carboplatin|carboplatin|mesh-list
93091875|NCT03278626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93091876|NCT03278626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091877|NCT03278626|Tubulin Modulators|tubulin modulators|mesh-ancestor
93091878|NCT03278626|Antimitotic Agents|antimitotic agents|mesh-ancestor
93091879|NCT03278626|Mitosis Modulators|mitosis modulators|mesh-ancestor
93091880|NCT03278626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091881|NCT01186094|Sirolimus|sirolimus|mesh-list
93091882|NCT01186094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93091883|NCT01186094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091884|NCT01186094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93091885|NCT01186094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091886|NCT01186094|Antifungal Agents|antifungal agents|mesh-ancestor
93091887|NCT01186094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091888|NCT01186094|Immunologic Factors|immunologic factors|mesh-ancestor
93091889|NCT01186094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091890|NCT01287806|Urinastatin|urinastatin|mesh-list
93091891|NCT01287806|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93091892|NCT01287806|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93091893|NCT01287806|Protease Inhibitors|protease inhibitors|mesh-ancestor
93091894|NCT01287806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091895|NCT01287806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091896|NCT01186172|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93091897|NCT01186172|Ethanol|ethanol|mesh-list
93091898|NCT01186172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93091899|NCT01186172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93091900|NCT01186172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091901|NCT01186172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091902|NCT03854708|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
93091903|NCT03854708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091904|NCT03854708|Hormones|hormones|mesh-ancestor
93091905|NCT03854708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091906|NCT03854708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091907|NCT03860870|Clenbuterol|clenbuterol|mesh-list
93091908|NCT03860870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93091909|NCT03860870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93091910|NCT03860870|Adrenergic Agents|adrenergic agents|mesh-ancestor
93091911|NCT03860870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091912|NCT03860870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091913|NCT03860870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091914|NCT03860870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93091915|NCT03860870|Autonomic Agents|autonomic agents|mesh-ancestor
93091916|NCT03860870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091917|NCT03860870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93091918|NCT03860870|Respiratory System Agents|respiratory system agents|mesh-ancestor
93091919|NCT03860870|Sympathomimetics|sympathomimetics|mesh-ancestor
92764190|NCT02757391|Analgesics|analgesics|mesh-ancestor
93091920|NCT01177514|Gabapentin|gabapentin|mesh-list
93091921|NCT01177514|Analgesics|analgesics|mesh-ancestor
93091922|NCT01177514|Sensory System Agents|sensory system agents|mesh-ancestor
93091923|NCT01177514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091924|NCT01177514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091925|NCT01177514|Anticonvulsants|anticonvulsants|mesh-ancestor
93091926|NCT01177514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93091927|NCT01177514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93091928|NCT01177514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091929|NCT01177514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93091930|NCT01177514|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93091931|NCT01177514|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93091932|NCT01177514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091933|NCT01177514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091934|NCT01177514|Antimanic Agents|antimanic agents|mesh-ancestor
93091935|NCT00073008|Lapatinib|lapatinib|mesh-list
93091936|NCT00073008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091937|NCT00073008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091938|NCT00073008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091939|NCT00073008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091940|NCT01182974|Acetaminophen|acetaminophen|mesh-list
93091941|NCT01182974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93091942|NCT01182974|Analgesics|analgesics|mesh-ancestor
93091943|NCT01182974|Sensory System Agents|sensory system agents|mesh-ancestor
93091944|NCT01182974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091945|NCT01182974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091946|NCT01182974|Antipyretics|antipyretics|mesh-ancestor
93091947|NCT03856502|Dexamethasone|dexamethasone|mesh-list
93091948|NCT03856502|Dexamethasone acetate|dexamethasone acetate|mesh-list
93091949|NCT03856502|Levobupivacaine|levobupivacaine|mesh-list
93091950|NCT03856502|BB 1101|bb 1101|mesh-list
93091951|NCT03856502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93091952|NCT03856502|Antiemetics|antiemetics|mesh-ancestor
93091953|NCT03856502|Autonomic Agents|autonomic agents|mesh-ancestor
93091954|NCT03856502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091955|NCT03856502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091956|NCT03856502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93091957|NCT03856502|Glucocorticoids|glucocorticoids|mesh-ancestor
93091958|NCT03856502|Hormones|hormones|mesh-ancestor
93091959|NCT03856502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93091960|NCT03856502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93091961|NCT03856502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091962|NCT03856502|Protease Inhibitors|protease inhibitors|mesh-ancestor
93091963|NCT03856502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091964|NCT03856502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091965|NCT03856502|Anesthetics, Local|anesthetics, local|mesh-ancestor
93091966|NCT03856502|Anesthetics|anesthetics|mesh-ancestor
93091967|NCT03856502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93091968|NCT03856502|Sensory System Agents|sensory system agents|mesh-ancestor
93091969|NCT01583478|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93091970|NCT01583478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93091971|NCT01583478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93091972|NCT01583478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091973|NCT01583478|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93091974|NCT01583478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93091975|NCT01583478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091976|NCT01583478|Cholinergic Agents|cholinergic agents|mesh-ancestor
93091977|NCT01583478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93091978|NCT03854396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93091979|NCT03854396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93091980|NCT03854396|Immunologic Factors|immunologic factors|mesh-ancestor
93091981|NCT03854396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091982|NCT01093638|Insulin|insulin|mesh-list
93091983|NCT01093638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93091984|NCT01093638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93091985|NCT01287962|Apatinib|apatinib|mesh-list
93091986|NCT01287962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93091987|NCT01287962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93091988|NCT01287962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93091989|NCT01287962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93091990|NCT00058422|Prednisone|prednisone|mesh-list
93091991|NCT00058422|Cyclophosphamide|cyclophosphamide|mesh-list
93091992|NCT00058422|Rituximab|rituximab|mesh-list
93091993|NCT00058422|Doxorubicin|doxorubicin|mesh-list
93091994|NCT00058422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93091995|NCT00058422|Vincristine|vincristine|mesh-list
93091996|NCT00058422|Darbepoetin alfa|darbepoetin alfa|mesh-list
93091997|NCT00058422|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93091998|NCT00058422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93091999|NCT00058422|Immunologic Factors|immunologic factors|mesh-ancestor
93092000|NCT00058422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092001|NCT00058422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092002|NCT00058422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93092003|NCT00058422|Alkylating Agents|alkylating agents|mesh-ancestor
92682287|NCT00465036|Cathartics|cathartics|mesh-ancestor
93092004|NCT00058422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092005|NCT00058422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092006|NCT00058422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93092007|NCT00058422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93092008|NCT00058422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092009|NCT00058422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092010|NCT00058422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092011|NCT00058422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092012|NCT00058422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092013|NCT00058422|Glucocorticoids|glucocorticoids|mesh-ancestor
93092014|NCT00058422|Hormones|hormones|mesh-ancestor
93092015|NCT00058422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092016|NCT00058422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092017|NCT00058422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092018|NCT00058422|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092019|NCT00058422|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092020|NCT00058422|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092021|NCT00058422|Hematinics|hematinics|mesh-ancestor
93092022|NCT01094964|Interferons|interferons|mesh-list
93092023|NCT01094964|Interferon-alpha|interferon-alpha|mesh-list
93092024|NCT01094964|Epirubicin|epirubicin|mesh-list
93092025|NCT01094964|Mitomycins|mitomycins|mesh-list
93092026|NCT01094964|Mitomycin|mitomycin|mesh-list
93092027|NCT01094964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092028|NCT01094964|Antiviral Agents|antiviral agents|mesh-ancestor
93092029|NCT01094964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092030|NCT01094964|Immunologic Factors|immunologic factors|mesh-ancestor
93092031|NCT01094964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092032|NCT01094964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092033|NCT01094964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092034|NCT01094964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092035|NCT01094964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092036|NCT01094964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092037|NCT01094964|Alkylating Agents|alkylating agents|mesh-ancestor
93092038|NCT01094964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93092039|NCT01291472|Ketorolac|ketorolac|mesh-list
93092040|NCT01291472|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93092041|NCT01291472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93092042|NCT01291472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93092043|NCT01291472|Analgesics|analgesics|mesh-ancestor
93092044|NCT01291472|Sensory System Agents|sensory system agents|mesh-ancestor
93092045|NCT01291472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092046|NCT01291472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092047|NCT01291472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092048|NCT01291472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092049|NCT01291472|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93092050|NCT01291472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092051|NCT01291472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092052|NCT02530632|Propofol|propofol|mesh-list
93092053|NCT02530632|Sevoflurane|sevoflurane|mesh-list
93092054|NCT02530632|Anesthetics|anesthetics|mesh-ancestor
93092055|NCT02530632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092056|NCT02530632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092057|NCT02530632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93092058|NCT02530632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93092059|NCT02530632|Anesthetics, General|anesthetics, general|mesh-ancestor
93092060|NCT02530632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93092061|NCT02530632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93092062|NCT01183364|Docetaxel|docetaxel|mesh-list
93092063|NCT01183364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092064|NCT01183364|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092065|NCT01183364|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092066|NCT01183364|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682359|NCT00473460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092067|NCT01183364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092068|NCT00072384|Carboplatin|carboplatin|mesh-list
93092069|NCT00072384|Etoposide|etoposide|mesh-list
93092070|NCT00072384|Vincristine|vincristine|mesh-list
93092071|NCT00072384|Etoposide phosphate|etoposide phosphate|mesh-list
93092072|NCT00072384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092073|NCT00072384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092074|NCT00072384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092075|NCT00072384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092076|NCT00072384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092077|NCT00072384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092078|NCT00072384|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092079|NCT00072384|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092080|NCT00072384|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092081|NCT01183442|Vitamin D|vitamin d|mesh-list
93092082|NCT01183442|Ergocalciferols|ergocalciferols|mesh-list
93092083|NCT01183442|Cholecalciferol|cholecalciferol|mesh-list
93092084|NCT01183442|Vitamins|vitamins|mesh-list
93092085|NCT01183442|Micronutrients|micronutrients|mesh-ancestor
93092086|NCT01183442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092087|NCT01183442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93092088|NCT01183442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93092089|NCT01187108|Acetylcysteine|acetylcysteine|mesh-list
93092090|NCT01187108|Acetazolamide|acetazolamide|mesh-list
93092091|NCT01187108|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93092092|NCT01187108|Antiviral Agents|antiviral agents|mesh-ancestor
93092093|NCT01187108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092094|NCT01187108|Expectorants|expectorants|mesh-ancestor
93092095|NCT01187108|Respiratory System Agents|respiratory system agents|mesh-ancestor
93092096|NCT01187108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93092097|NCT01187108|Antioxidants|antioxidants|mesh-ancestor
93092098|NCT01187108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092099|NCT01187108|Protective Agents|protective agents|mesh-ancestor
93092100|NCT01187108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092101|NCT01187108|Antidotes|antidotes|mesh-ancestor
93092102|NCT01187108|Anticonvulsants|anticonvulsants|mesh-ancestor
93092103|NCT01187108|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93092104|NCT01187108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092105|NCT01187108|Diuretics|diuretics|mesh-ancestor
93092106|NCT01187108|Natriuretic Agents|natriuretic agents|mesh-ancestor
93092107|NCT01187888|Rasagiline|rasagiline|mesh-list
93092108|NCT01187888|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93092109|NCT01187888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092110|NCT01187888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092111|NCT01187888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93092112|NCT01187888|Protective Agents|protective agents|mesh-ancestor
93092113|NCT01187888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092114|NCT01187186|Ipragliflozin|ipragliflozin|mesh-list
93092115|NCT01187186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93092116|NCT01187186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092117|NCT01187186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092118|NCT01187186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092119|NCT00054132|Bevacizumab|bevacizumab|mesh-list
93092120|NCT00054132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92682420|NCT02957474|Omeprazole|omeprazole|mesh-list
93092121|NCT00054132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93092122|NCT00054132|Endothelial Growth Factors|endothelial growth factors|mesh-list
93092123|NCT00054132|Antibodies|antibodies|mesh-list
93092124|NCT00054132|Immunoglobulins|immunoglobulins|mesh-list
93092125|NCT00054132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93092126|NCT00054132|Immunoglobulin G|immunoglobulin g|mesh-list
93092127|NCT00054132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092128|NCT00054132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93092129|NCT00054132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93092130|NCT00054132|Growth Substances|growth substances|mesh-ancestor
93092131|NCT00054132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092132|NCT00054132|Growth Inhibitors|growth inhibitors|mesh-ancestor
93092133|NCT00054132|Immunologic Factors|immunologic factors|mesh-ancestor
93092134|NCT00054132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93092135|NCT00054132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092136|NCT00054132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092137|NCT01187264|Methotrexate|methotrexate|mesh-list
93092138|NCT01187264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93092139|NCT01187264|Abortifacient Agents|abortifacient agents|mesh-ancestor
93092140|NCT01187264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93092141|NCT01187264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092142|NCT01187264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93092143|NCT01187264|Antimetabolites|antimetabolites|mesh-ancestor
93092144|NCT01187264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092145|NCT01187264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092146|NCT01187264|Dermatologic Agents|dermatologic agents|mesh-ancestor
93092147|NCT01187264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092148|NCT01187264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93092149|NCT01187264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092150|NCT01187264|Immunologic Factors|immunologic factors|mesh-ancestor
93092151|NCT01187264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092152|NCT01187264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93092154|NCT01183676|Anticonvulsants|anticonvulsants|mesh-ancestor
93092155|NCT01183676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092156|NCT01183676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092157|NCT01183676|GABA Agents|gaba agents|mesh-ancestor
93092158|NCT01183676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092159|NCT01183676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092160|NCT01183676|Antimanic Agents|antimanic agents|mesh-ancestor
93092161|NCT01183676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93092162|NCT01183676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092163|NCT01183676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93092164|NCT03856112|Dexamethasone|dexamethasone|mesh-list
93092165|NCT03856112|Dexamethasone acetate|dexamethasone acetate|mesh-list
93092166|NCT03856112|Venetoclax|venetoclax|mesh-list
93092167|NCT03856112|Ixazomib|ixazomib|mesh-list
93092168|NCT03856112|Ichthammol|ichthammol|mesh-list
93092169|NCT03856112|BB 1101|bb 1101|mesh-list
93092170|NCT03856112|Glycine|glycine|mesh-list
93092171|NCT03856112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092172|NCT03856112|Antiemetics|antiemetics|mesh-ancestor
93092173|NCT03856112|Autonomic Agents|autonomic agents|mesh-ancestor
93092174|NCT03856112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092175|NCT03856112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092176|NCT03856112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092177|NCT03856112|Glucocorticoids|glucocorticoids|mesh-ancestor
93092178|NCT03856112|Hormones|hormones|mesh-ancestor
93092179|NCT03856112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092180|NCT03856112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092181|NCT03856112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092182|NCT03856112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092183|NCT03856112|Protease Inhibitors|protease inhibitors|mesh-ancestor
93092184|NCT03856112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092185|NCT03856112|Glycine Agents|glycine agents|mesh-ancestor
93092186|NCT03856112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092187|NCT03856112|Dermatologic Agents|dermatologic agents|mesh-ancestor
93092188|NCT01290380|Vadimezan|vadimezan|mesh-list
93092189|NCT01290380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092190|NCT00071760|Ritonavir|ritonavir|mesh-list
93092191|NCT00071760|Fosamprenavir|fosamprenavir|mesh-list
93092192|NCT00071760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93092193|NCT00071760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93092194|NCT00071760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93092195|NCT00071760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682476|NCT00481572|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93092196|NCT00071760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092197|NCT00071760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93092198|NCT00071760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93092199|NCT00071760|Antiviral Agents|antiviral agents|mesh-ancestor
93092200|NCT00071760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092201|NCT00071760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93092202|NCT00071760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93092203|NCT01183910|Calcium Carbonate|calcium carbonate|mesh-list
93092204|NCT01183910|Calcium|calcium|mesh-list
93092205|NCT01183910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93092206|NCT01183910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092207|NCT01183910|Antacids|antacids|mesh-ancestor
93092208|NCT01183910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092209|NCT01183910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092210|NCT03852914|Hyaluronic Acid|hyaluronic acid|mesh-list
93092211|NCT03852914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93092212|NCT03852914|Immunologic Factors|immunologic factors|mesh-ancestor
93092213|NCT03852914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092214|NCT03852914|Viscosupplements|viscosupplements|mesh-ancestor
93092215|NCT03852914|Protective Agents|protective agents|mesh-ancestor
93092216|NCT05234684|Prednisone|prednisone|mesh-list
93092217|NCT05234684|Cyclophosphamide|cyclophosphamide|mesh-list
93092218|NCT05234684|Vincristine|vincristine|mesh-list
93092219|NCT05234684|Rituximab|rituximab|mesh-list
93092220|NCT05234684|Doxorubicin|doxorubicin|mesh-list
93092221|NCT05234684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092222|NCT05234684|Immunologic Factors|immunologic factors|mesh-ancestor
93092223|NCT05234684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092224|NCT05234684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092225|NCT05234684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93092226|NCT05234684|Alkylating Agents|alkylating agents|mesh-ancestor
93092227|NCT05234684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092228|NCT05234684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092229|NCT05234684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93092230|NCT05234684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092231|NCT05234684|Glucocorticoids|glucocorticoids|mesh-ancestor
93092232|NCT05234684|Hormones|hormones|mesh-ancestor
93092233|NCT05234684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092234|NCT05234684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092235|NCT05234684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092236|NCT05234684|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092237|NCT05234684|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092238|NCT05234684|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092239|NCT05234684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93092240|NCT05234684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092241|NCT05234684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092242|NCT05234684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092243|NCT05234684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092244|NCT03853538|Petrolatum|petrolatum|mesh-list
93092245|NCT03853538|Emollients|emollients|mesh-ancestor
93092246|NCT03853538|Dermatologic Agents|dermatologic agents|mesh-ancestor
93092247|NCT03853304|Folic Acid|folic acid|mesh-list
93092248|NCT03853304|Vitamin B 12|vitamin b 12|mesh-list
93092249|NCT03853304|Hydroxocobalamin|hydroxocobalamin|mesh-list
93092250|NCT03853304|Vitamins|vitamins|mesh-ancestor
93092251|NCT03853304|Micronutrients|micronutrients|mesh-ancestor
93092252|NCT03853304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092253|NCT03853304|Hematinics|hematinics|mesh-ancestor
93092254|NCT03853304|Vitamin B Complex|vitamin b complex|mesh-ancestor
93092255|NCT01290458|Vitamins|vitamins|mesh-list
93092256|NCT01290458|Ascorbic Acid|ascorbic acid|mesh-list
93092257|NCT01290458|Vitamin E|vitamin e|mesh-list
93092258|NCT01290458|Tocopherols|tocopherols|mesh-list
93092259|NCT01290458|alpha-Tocopherol|alpha-tocopherol|mesh-list
93092260|NCT01290458|Antioxidants|antioxidants|mesh-list
93092261|NCT01290458|Micronutrients|micronutrients|mesh-ancestor
93092262|NCT01290458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092263|NCT01290458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092264|NCT01290458|Protective Agents|protective agents|mesh-ancestor
93092265|NCT01184144|Pioglitazone|pioglitazone|mesh-list
93092266|NCT01184144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092267|NCT01184144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092268|NCT01291628|Copper|copper|mesh-list
93092269|NCT01291628|Trace Elements|trace elements|mesh-ancestor
93092270|NCT01291628|Micronutrients|micronutrients|mesh-ancestor
93092271|NCT01291628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092272|NCT00053898|Tamoxifen|tamoxifen|mesh-list
93092273|NCT00053898|Anastrozole|anastrozole|mesh-list
92682548|NCT00436787|PENTA|penta|mesh-list
93092274|NCT00053898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092275|NCT00053898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93092276|NCT00053898|Hormone Antagonists|hormone antagonists|mesh-ancestor
93092277|NCT00053898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092278|NCT00053898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092279|NCT00053898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092280|NCT00053898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092281|NCT00053898|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93092282|NCT00053898|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93092283|NCT00053898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93092284|NCT00053898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93092285|NCT00053898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93092286|NCT00053898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092287|NCT01293734|Budesonide|budesonide|mesh-list
93092288|NCT01293734|Theophylline|theophylline|mesh-list
93092289|NCT01293734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092290|NCT01293734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93092291|NCT01293734|Autonomic Agents|autonomic agents|mesh-ancestor
93092292|NCT01293734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092293|NCT01293734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092294|NCT01293734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93092295|NCT01293734|Respiratory System Agents|respiratory system agents|mesh-ancestor
93092296|NCT01293734|Glucocorticoids|glucocorticoids|mesh-ancestor
93092297|NCT01293734|Hormones|hormones|mesh-ancestor
93092298|NCT01293734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764561|NCT01184118|Fluticasone|fluticasone|mesh-list
93092299|NCT01293734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93092300|NCT01293734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092301|NCT01293734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092302|NCT01293734|Vasodilator Agents|vasodilator agents|mesh-ancestor
93092303|NCT01293734|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93092304|NCT01293734|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93092305|NCT01293734|Purinergic Agents|purinergic agents|mesh-ancestor
93092306|NCT01293734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092307|NCT01184300|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93092308|NCT01184300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93092309|NCT01188278|Imatinib Mesylate|imatinib mesylate|mesh-list
93092310|NCT01188278|Dasatinib|dasatinib|mesh-list
93092311|NCT01188278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092312|NCT01188278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93092313|NCT01188278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092314|NCT01188278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092315|NCT01184378|Caseins|caseins|mesh-list
93092316|NCT01184378|Chelating Agents|chelating agents|mesh-ancestor
93092317|NCT01184378|Sequestering Agents|sequestering agents|mesh-ancestor
93092318|NCT01184378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092319|NCT03852602|Analgesics|analgesics|mesh-list
93092320|NCT03852602|Sensory System Agents|sensory system agents|mesh-ancestor
93092321|NCT03852602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092322|NCT03852602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092323|NCT02459392|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93092324|NCT02459392|Methylprednisolone|methylprednisolone|mesh-list
93092325|NCT02459392|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93092326|NCT02459392|Prednisolone|prednisolone|mesh-list
93092327|NCT02459392|Prednisolone acetate|prednisolone acetate|mesh-list
93092328|NCT02459392|Hyaluronic Acid|hyaluronic acid|mesh-list
93092329|NCT02459392|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93092330|NCT02459392|Prednisolone phosphate|prednisolone phosphate|mesh-list
93092331|NCT02459392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93092332|NCT02459392|Immunologic Factors|immunologic factors|mesh-ancestor
93092333|NCT02459392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092334|NCT02459392|Viscosupplements|viscosupplements|mesh-ancestor
93092335|NCT02459392|Protective Agents|protective agents|mesh-ancestor
93092336|NCT02459392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092337|NCT02459392|Antiemetics|antiemetics|mesh-ancestor
93092338|NCT02459392|Autonomic Agents|autonomic agents|mesh-ancestor
93092339|NCT02459392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092340|NCT02459392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092341|NCT02459392|Glucocorticoids|glucocorticoids|mesh-ancestor
93092342|NCT02459392|Hormones|hormones|mesh-ancestor
93092343|NCT02459392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092344|NCT02459392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93092345|NCT02459392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092346|NCT02459392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092347|NCT03256552|Glycopyrrolate|glycopyrrolate|mesh-list
93092348|NCT03256552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93092349|NCT03256552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93092350|NCT03256552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93092351|NCT03256552|Cholinergic Agents|cholinergic agents|mesh-ancestor
93092352|NCT03256552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092353|NCT03256552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092354|NCT03256552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092355|NCT03852446|Tryptophan|tryptophan|mesh-list
93092356|NCT03852446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93092357|NCT03852446|Antidepressive Agents|antidepressive agents|mesh-ancestor
93092358|NCT03852446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93092359|NCT03637582|Lidocaine|lidocaine|mesh-list
93092360|NCT03637582|Anesthetics, Local|anesthetics, local|mesh-ancestor
93092361|NCT03637582|Anesthetics|anesthetics|mesh-ancestor
93092362|NCT03637582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092363|NCT03637582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092364|NCT03637582|Sensory System Agents|sensory system agents|mesh-ancestor
93092365|NCT03637582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092366|NCT03637582|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93092367|NCT03637582|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93092368|NCT03637582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93092369|NCT03637582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93092370|NCT03637582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092371|NCT00053352|Etoposide|etoposide|mesh-list
93092372|NCT00053352|Etoposide phosphate|etoposide phosphate|mesh-list
93092373|NCT00053352|Bleomycin|bleomycin|mesh-list
93092374|NCT00053352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092375|NCT00053352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092376|NCT00053352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092377|NCT00053352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092378|NCT00053352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092379|NCT00053352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092380|NCT00053352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092381|NCT01193816|Loxapine|loxapine|mesh-list
93092382|NCT01193816|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93092383|NCT01193816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93092384|NCT01193816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092385|NCT01193816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092386|NCT01193816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93092387|NCT01193816|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93092388|NCT01193816|Dopamine Agents|dopamine agents|mesh-ancestor
93092389|NCT01193816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092390|NCT01193816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092391|NCT05571202|Anesthetics|anesthetics|mesh-list
93092392|NCT05571202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092393|NCT05571202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092394|NCT03245398|Mebendazole|mebendazole|mesh-list
93092395|NCT03245398|Piperazine|piperazine|mesh-list
93092396|NCT03245398|Piperazine citrate|piperazine citrate|mesh-list
93092397|NCT03245398|DMP 777|dmp 777|mesh-list
93092398|NCT03245398|Antinematodal Agents|antinematodal agents|mesh-ancestor
93092399|NCT03245398|Anthelmintics|anthelmintics|mesh-ancestor
93092400|NCT03245398|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93092401|NCT03245398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092402|NCT03245398|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092403|NCT03245398|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092404|NCT03245398|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092405|NCT03245398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092406|NCT03245398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092407|NCT03245398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092408|NCT01291940|Petrolatum|petrolatum|mesh-list
93092409|NCT01291940|Emollients|emollients|mesh-ancestor
93092410|NCT01291940|Dermatologic Agents|dermatologic agents|mesh-ancestor
93092411|NCT03244618|Fluorides|fluorides|mesh-list
93092412|NCT03244618|Cariostatic Agents|cariostatic agents|mesh-ancestor
93092413|NCT03244618|Protective Agents|protective agents|mesh-ancestor
93092414|NCT03244618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092415|NCT05571046|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
93092416|NCT05571046|Glucocorticoids|glucocorticoids|mesh-list
93092417|NCT05571046|Hormones|hormones|mesh-ancestor
93092418|NCT05571046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092419|NCT05571046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092470|NCT01191554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092471|NCT01191554|Hemostatics|hemostatics|mesh-ancestor
93092472|NCT01191554|Coagulants|coagulants|mesh-ancestor
93092473|NCT01296464|Carbidopa|carbidopa|mesh-list
93092474|NCT01296464|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93092475|NCT01296464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93092476|NCT01296464|Dopamine Agents|dopamine agents|mesh-ancestor
93092477|NCT01296464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092478|NCT01296464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092479|NCT01296464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092480|NCT01296464|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93092481|NCT01296464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092482|NCT00038142|Cyclophosphamide|cyclophosphamide|mesh-list
93092483|NCT00038142|Doxorubicin|doxorubicin|mesh-list
93092484|NCT00038142|Vincristine|vincristine|mesh-list
93092485|NCT00038142|Dexrazoxane|dexrazoxane|mesh-list
93092486|NCT00038142|Razoxane|razoxane|mesh-list
93092487|NCT00038142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092488|NCT00038142|Immunologic Factors|immunologic factors|mesh-ancestor
93092489|NCT00038142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092490|NCT00038142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092491|NCT00038142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93092492|NCT00038142|Alkylating Agents|alkylating agents|mesh-ancestor
93092493|NCT00038142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092494|NCT00038142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092495|NCT00038142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93092496|NCT00038142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092497|NCT00038142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092498|NCT00038142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092499|NCT00038142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092500|NCT00038142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092501|NCT00038142|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092502|NCT00038142|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092503|NCT00038142|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092504|NCT00038142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93092505|NCT00038142|Protective Agents|protective agents|mesh-ancestor
93092506|NCT00366899|Vaccines|vaccines|mesh-list
93092507|NCT00366899|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93092508|NCT00366899|Immunologic Factors|immunologic factors|mesh-ancestor
93092509|NCT00366899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092510|NCT03847376|Rilpivirine|rilpivirine|mesh-list
93092511|NCT03847376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93092512|NCT03847376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93092513|NCT03847376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092514|NCT03847376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092515|NCT03847376|Antiviral Agents|antiviral agents|mesh-ancestor
93092516|NCT03847376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092517|NCT03847376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93092518|NCT03847376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93092519|NCT01090128|Paclitaxel|paclitaxel|mesh-list
93092520|NCT01090128|Cyclophosphamide|cyclophosphamide|mesh-list
93092521|NCT01090128|Doxorubicin|doxorubicin|mesh-list
93092522|NCT01090128|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93092523|NCT01090128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092524|NCT01090128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092525|NCT01090128|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092526|NCT01090128|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092527|NCT01090128|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092528|NCT01090128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092529|NCT01090128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092530|NCT01090128|Immunologic Factors|immunologic factors|mesh-ancestor
93092531|NCT01090128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092532|NCT01090128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092533|NCT01090128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93092534|NCT01090128|Alkylating Agents|alkylating agents|mesh-ancestor
93092535|NCT01090128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93092536|NCT01090128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092537|NCT01090128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93092538|NCT01090128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93092539|NCT01090128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092540|NCT01292174|Ibalizumab|ibalizumab|mesh-list
93092541|NCT01292174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93092542|NCT01292174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93092543|NCT01292174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93092544|NCT01292174|Antiviral Agents|antiviral agents|mesh-ancestor
93092545|NCT01292174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092546|NCT01292174|Immunologic Factors|immunologic factors|mesh-ancestor
93092547|NCT01292174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092548|NCT01090206|Vitamin D|vitamin d|mesh-list
93092549|NCT01090206|Calcium|calcium|mesh-list
93092550|NCT01090206|Vitamins|vitamins|mesh-ancestor
93092551|NCT01090206|Micronutrients|micronutrients|mesh-ancestor
93092552|NCT01090206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092553|NCT01090206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93092554|NCT01090206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93092555|NCT04728646|Dexamethasone|dexamethasone|mesh-list
93092556|NCT04728646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092557|NCT04728646|Antiemetics|antiemetics|mesh-ancestor
93092558|NCT04728646|Autonomic Agents|autonomic agents|mesh-ancestor
93092559|NCT04728646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092560|NCT04728646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092561|NCT04728646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092562|NCT04728646|Glucocorticoids|glucocorticoids|mesh-ancestor
93092563|NCT04728646|Hormones|hormones|mesh-ancestor
93092564|NCT04728646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092565|NCT04728646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092566|NCT04728646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092567|NCT04674826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93092568|NCT04674826|Immunologic Factors|immunologic factors|mesh-ancestor
93092569|NCT04674826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092570|NCT01295138|Lactulose|lactulose|mesh-list
93092571|NCT01295138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092572|NCT01188824|Cilostazol|cilostazol|mesh-list
93092573|NCT01188824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93092574|NCT01188824|Autonomic Agents|autonomic agents|mesh-ancestor
93092575|NCT01188824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092576|NCT01188824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092577|NCT01188824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93092578|NCT01188824|Respiratory System Agents|respiratory system agents|mesh-ancestor
93092579|NCT01188824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93092580|NCT01188824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93092581|NCT01188824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092582|NCT01188824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93092583|NCT01188824|Vasodilator Agents|vasodilator agents|mesh-ancestor
93092584|NCT01188824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93092585|NCT01188824|Protective Agents|protective agents|mesh-ancestor
93092586|NCT01188824|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93092587|NCT01188824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93092588|NCT01188824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092589|NCT01060475|Tacrolimus|tacrolimus|mesh-list
93092590|NCT01060475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092591|NCT01060475|Immunologic Factors|immunologic factors|mesh-ancestor
93092592|NCT01060475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092593|NCT01060475|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93092594|NCT01060475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092595|NCT01060475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092596|NCT01060631|Propofol|propofol|mesh-list
93092597|NCT01060631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93092598|NCT01060631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092599|NCT01060631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092600|NCT01060631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93092601|NCT01060631|Anesthetics, General|anesthetics, general|mesh-ancestor
93092602|NCT01060631|Anesthetics|anesthetics|mesh-ancestor
92764859|NCT01183104|Hormones|hormones|mesh-ancestor
93092604|NCT03254134|Dabigatran|dabigatran|mesh-list
93092605|NCT03254134|Anticoagulants|anticoagulants|mesh-ancestor
93092606|NCT03254134|Antithrombins|antithrombins|mesh-ancestor
93092607|NCT03254134|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93092608|NCT03254134|Protease Inhibitors|protease inhibitors|mesh-ancestor
93092609|NCT03254134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092610|NCT03254134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092611|NCT03953196|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93092612|NCT03953196|Antiviral Agents|antiviral agents|mesh-ancestor
93092613|NCT03953196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092614|NCT01295294|Mefenamic Acid|mefenamic acid|mesh-list
93092615|NCT01295294|Tranexamic Acid|tranexamic acid|mesh-list
93092616|NCT01295294|Levonorgestrel|levonorgestrel|mesh-list
93092617|NCT01295294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93092618|NCT01295294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93092619|NCT01295294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092620|NCT01295294|Hemostatics|hemostatics|mesh-ancestor
93092621|NCT01295294|Coagulants|coagulants|mesh-ancestor
93092622|NCT01295294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93092623|NCT01295294|Contraceptive Agents|contraceptive agents|mesh-ancestor
93092624|NCT01295294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93092625|NCT01295294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092626|NCT01295294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93092627|NCT01295294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93092628|NCT01295294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93092629|NCT01295294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93092630|NCT01295294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93092631|NCT01295294|Analgesics|analgesics|mesh-ancestor
93092632|NCT01295294|Sensory System Agents|sensory system agents|mesh-ancestor
93092633|NCT01295294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092634|NCT01295294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092635|NCT01295294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092636|NCT01295294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93092637|NCT01295294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092638|NCT01191710|Progesterone|progesterone|mesh-list
93092639|NCT01191710|Progestins|progestins|mesh-ancestor
93092640|NCT01191710|Hormones|hormones|mesh-ancestor
93092641|NCT01191710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092642|NCT01191710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092643|NCT04367740|Antibodies|antibodies|mesh-list
93092644|NCT04367740|Immunoglobulin G|immunoglobulin g|mesh-list
93092645|NCT04367740|Immunologic Factors|immunologic factors|mesh-ancestor
93092646|NCT04367740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092647|NCT03852056|Fluorides|fluorides|mesh-list
93092648|NCT03852056|Tin Fluorides|tin fluorides|mesh-list
93092649|NCT03852056|Cariostatic Agents|cariostatic agents|mesh-ancestor
93092650|NCT03852056|Protective Agents|protective agents|mesh-ancestor
93092651|NCT03852056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092652|NCT03242434|Mannitol|mannitol|mesh-list
93092653|NCT03242434|Lactulose|lactulose|mesh-list
93092654|NCT03242434|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93092655|NCT03242434|Diuretics|diuretics|mesh-ancestor
93092656|NCT03242434|Natriuretic Agents|natriuretic agents|mesh-ancestor
93092657|NCT03242434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092658|NCT03242434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092659|NCT04222426|Atezolizumab|atezolizumab|mesh-list
93092660|NCT04222426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93092661|NCT04222426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092662|NCT04222426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93092663|NCT04222426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092664|NCT01292408|Hydroxychloroquine|hydroxychloroquine|mesh-list
93092665|NCT01292408|Antimalarials|antimalarials|mesh-ancestor
93092666|NCT01292408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93092667|NCT01292408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93092668|NCT01292408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092669|NCT01292408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092670|NCT01292408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092671|NCT01292408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092672|NCT01295372|Risperidone|risperidone|mesh-list
93092673|NCT01295372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93092674|NCT01295372|Serotonin Agents|serotonin agents|mesh-ancestor
93092675|NCT01295372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092676|NCT01295372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764948|NCT01227512|Tolvaptan|tolvaptan|mesh-list
93092677|NCT01295372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092678|NCT01295372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93092679|NCT01295372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93092680|NCT01295372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092681|NCT01295372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93092682|NCT01295372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93092683|NCT01295372|Dopamine Agents|dopamine agents|mesh-ancestor
93092684|NCT05283278|Lactoferrin|lactoferrin|mesh-list
93092685|NCT05283278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092686|NCT05179018|Autoantibodies|autoantibodies|mesh-list
93092687|NCT05179018|Immunologic Factors|immunologic factors|mesh-ancestor
93092688|NCT05179018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092689|NCT01295450|Vitamins|vitamins|mesh-list
93092690|NCT01295450|Micronutrients|micronutrients|mesh-ancestor
93092691|NCT01295450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092692|NCT01297010|Dexamethasone|dexamethasone|mesh-list
93092693|NCT01297010|Dexamethasone acetate|dexamethasone acetate|mesh-list
93092694|NCT01297010|BB 1101|bb 1101|mesh-list
93092695|NCT01297010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092696|NCT01297010|Antiemetics|antiemetics|mesh-ancestor
93092697|NCT01297010|Autonomic Agents|autonomic agents|mesh-ancestor
93092698|NCT01297010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092699|NCT01297010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092700|NCT01297010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092701|NCT01297010|Glucocorticoids|glucocorticoids|mesh-ancestor
93092702|NCT01297010|Hormones|hormones|mesh-ancestor
93092703|NCT01297010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092704|NCT01297010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092705|NCT01297010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092706|NCT01297010|Protease Inhibitors|protease inhibitors|mesh-ancestor
93092707|NCT01297010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092708|NCT01297010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092709|NCT03851432|Metformin|metformin|mesh-list
93092710|NCT03851432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092711|NCT03851432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092712|NCT01192490|Lidocaine|lidocaine|mesh-list
93092713|NCT01192490|Anesthetics, Local|anesthetics, local|mesh-ancestor
93092714|NCT01192490|Anesthetics|anesthetics|mesh-ancestor
93092715|NCT01192490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092716|NCT01192490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092717|NCT01192490|Sensory System Agents|sensory system agents|mesh-ancestor
93092718|NCT01192490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092719|NCT01192490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93092720|NCT01192490|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93092721|NCT01192490|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93092722|NCT01192490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93092723|NCT01192490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092724|NCT01295606|Cefazolin|cefazolin|mesh-list
93092725|NCT01295606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93092726|NCT01295606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092727|NCT01192724|Aspirin|aspirin|mesh-list
93092728|NCT01192724|Cilostazol|cilostazol|mesh-list
93092729|NCT01192724|Clopidogrel|clopidogrel|mesh-list
93092730|NCT01192724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93092731|NCT01192724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93092732|NCT01192724|Analgesics|analgesics|mesh-ancestor
93092733|NCT01192724|Sensory System Agents|sensory system agents|mesh-ancestor
93092734|NCT01192724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092735|NCT01192724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092736|NCT01192724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092737|NCT01192724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93092738|NCT01192724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93092739|NCT01192724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93092740|NCT01192724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092741|NCT01192724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93092742|NCT01192724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93092743|NCT01192724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092744|NCT01192724|Antipyretics|antipyretics|mesh-ancestor
93092745|NCT01192724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93092746|NCT01192724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93092747|NCT01192724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93092748|NCT01192724|Purinergic Agents|purinergic agents|mesh-ancestor
93092749|NCT01192724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092750|NCT01192724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93092751|NCT01192724|Autonomic Agents|autonomic agents|mesh-ancestor
93092752|NCT01192724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93092753|NCT01192724|Respiratory System Agents|respiratory system agents|mesh-ancestor
93092754|NCT01192724|Vasodilator Agents|vasodilator agents|mesh-ancestor
93092755|NCT01192724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93092756|NCT01192724|Protective Agents|protective agents|mesh-ancestor
93092757|NCT01192724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93092758|NCT01192724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93092760|NCT01192802|Anthelmintics|anthelmintics|mesh-ancestor
93092761|NCT01192802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93092762|NCT01192802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092763|NCT01192802|Anticestodal Agents|anticestodal agents|mesh-ancestor
93092764|NCT01192802|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93092765|NCT01192802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93092766|NCT01192802|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092767|NCT01192802|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092768|NCT01192802|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092769|NCT01192802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092770|NCT01192802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092771|NCT01292720|Vitamin D|vitamin d|mesh-list
93092772|NCT01292720|Cholecalciferol|cholecalciferol|mesh-list
93092773|NCT01292720|Vitamins|vitamins|mesh-ancestor
93092774|NCT01292720|Micronutrients|micronutrients|mesh-ancestor
93092775|NCT01292720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092776|NCT01292720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93092777|NCT01292720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93092778|NCT02939014|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93092779|NCT02939014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93092780|NCT02939014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092781|NCT02939014|Immunotoxins|immunotoxins|mesh-ancestor
93092782|NCT02939014|Immunoconjugates|immunoconjugates|mesh-ancestor
93092783|NCT02939014|Immunologic Factors|immunologic factors|mesh-ancestor
93092784|NCT02939014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092785|NCT05177926|Tenofovir|tenofovir|mesh-list
93092786|NCT05177926|Antiviral Agents|antiviral agents|mesh-list
93092787|NCT05177926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092788|NCT05177926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93092789|NCT05177926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93092790|NCT05177926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092791|NCT05177926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092792|NCT05177926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93092793|NCT05177926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93092794|NCT01193192|Vitamins|vitamins|mesh-list
93092795|NCT01193192|Micronutrients|micronutrients|mesh-ancestor
93092796|NCT01193192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092797|NCT01193270|Vitamin E|vitamin e|mesh-list
93092798|NCT01193270|Vitamins|vitamins|mesh-ancestor
93092799|NCT01193270|Micronutrients|micronutrients|mesh-ancestor
93092800|NCT01193270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092801|NCT01193270|Antioxidants|antioxidants|mesh-ancestor
93092802|NCT01193270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092803|NCT01193270|Protective Agents|protective agents|mesh-ancestor
93092804|NCT01189214|Memantine|memantine|mesh-list
93092805|NCT01189214|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93092806|NCT01189214|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93092807|NCT01189214|Dopamine Agents|dopamine agents|mesh-ancestor
93092808|NCT01189214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93092809|NCT01189214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092810|NCT01189214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092811|NCT01189214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93092812|NCT01189214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93092813|NCT01193504|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93092814|NCT01193504|Prednisolone acetate|prednisolone acetate|mesh-list
93092815|NCT01193504|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93092816|NCT01193504|Methylprednisolone|methylprednisolone|mesh-list
93092817|NCT01193504|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93092818|NCT01193504|Prednisolone|prednisolone|mesh-list
93092819|NCT01193504|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93092820|NCT01193504|Prednisolone phosphate|prednisolone phosphate|mesh-list
93092821|NCT01193504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092822|NCT01193504|Antiemetics|antiemetics|mesh-ancestor
93092823|NCT01193504|Autonomic Agents|autonomic agents|mesh-ancestor
93092824|NCT01193504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93092825|NCT01193504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092826|NCT01193504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93092827|NCT01193504|Glucocorticoids|glucocorticoids|mesh-ancestor
93092828|NCT01193504|Hormones|hormones|mesh-ancestor
93092829|NCT01193504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092830|NCT01193504|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93092831|NCT01193504|Protective Agents|protective agents|mesh-ancestor
93092832|NCT01193504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092833|NCT01193504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092834|NCT01193504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93092836|NCT03848780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93092837|NCT03848780|Anesthetics, General|anesthetics, general|mesh-ancestor
93092838|NCT03848780|Anesthetics|anesthetics|mesh-ancestor
93092839|NCT03848780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93092840|NCT03848780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092841|NCT05599802|Vaccines|vaccines|mesh-list
93092842|NCT05599802|Immunologic Factors|immunologic factors|mesh-ancestor
93092843|NCT05599802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092844|NCT00051558|Alendronate|alendronate|mesh-list
93092845|NCT00051558|Teriparatide|teriparatide|mesh-list
93092846|NCT00051558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93092847|NCT00051558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092848|NCT00051558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93092849|NCT03848234|Estradiol|estradiol|mesh-list
93092850|NCT03848234|Estrogens|estrogens|mesh-ancestor
93092851|NCT03848234|Hormones|hormones|mesh-ancestor
93092852|NCT03848234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092853|NCT03848234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092854|NCT01295918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93092855|NCT01295918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092856|NCT01195298|Bevacizumab|bevacizumab|mesh-list
93092857|NCT01195298|Capecitabine|capecitabine|mesh-list
93092858|NCT01195298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93092859|NCT01195298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092860|NCT01195298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93092861|NCT01195298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93092862|NCT01195298|Growth Substances|growth substances|mesh-ancestor
93092863|NCT01195298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092864|NCT01195298|Growth Inhibitors|growth inhibitors|mesh-ancestor
93092865|NCT01195298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93092866|NCT01195298|Antimetabolites|antimetabolites|mesh-ancestor
93092867|NCT01195298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092868|NCT01296074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93092869|NCT01296074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93092870|NCT01296074|Glucocorticoids|glucocorticoids|mesh-ancestor
93092871|NCT01296074|Hormones|hormones|mesh-ancestor
93092872|NCT01296074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092873|NCT01296074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092874|NCT01296074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93092875|NCT01296074|Protective Agents|protective agents|mesh-ancestor
93092876|NCT01296074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092877|NCT01296074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092878|NCT01189448|Pyrimethamine|pyrimethamine|mesh-list
93092879|NCT01189448|Sulfadiazine|sulfadiazine|mesh-list
93092880|NCT01189448|Spiramycin|spiramycin|mesh-list
93092881|NCT01189448|Antimalarials|antimalarials|mesh-ancestor
93092882|NCT01189448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93092883|NCT01189448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93092884|NCT01189448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092885|NCT01189448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93092886|NCT01189448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092887|NCT01189448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092888|NCT01189448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93092889|NCT01189448|Coccidiostats|coccidiostats|mesh-ancestor
93092890|NCT01195376|Dactolisib|dactolisib|mesh-list
93092891|NCT01195376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092892|NCT01189526|Ranibizumab|ranibizumab|mesh-list
93092893|NCT01189526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93092894|NCT01189526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93092895|NCT01189526|Growth Substances|growth substances|mesh-ancestor
93092896|NCT01189526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092897|NCT01189526|Growth Inhibitors|growth inhibitors|mesh-ancestor
93092898|NCT01189526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092899|NCT01296230|Hormones|hormones|mesh-list
93092900|NCT01296230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092901|NCT01296230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092902|NCT01580696|Molgramostim|molgramostim|mesh-list
93092903|NCT01580696|Vaccines|vaccines|mesh-list
93092904|NCT01580696|Sargramostim|sargramostim|mesh-list
93092905|NCT01580696|Immunologic Factors|immunologic factors|mesh-ancestor
93092906|NCT01580696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092907|NCT01580696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092908|NCT01197014|Losartan|losartan|mesh-list
93092909|NCT01197014|Amlodipine|amlodipine|mesh-list
93092910|NCT01197014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93092911|NCT01197014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93092912|NCT01197014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93092913|NCT01197014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092914|NCT01197014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93092915|NCT01197014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092916|NCT01197014|Vasodilator Agents|vasodilator agents|mesh-ancestor
93092917|NCT01197014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93092918|NCT01197014|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93092919|NCT01197014|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93092920|NCT01195454|Insulin|insulin|mesh-list
93092921|NCT01195454|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93092922|NCT01195454|Insulin Glargine|insulin glargine|mesh-list
93092923|NCT01195454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092924|NCT01195454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092925|NCT01197170|Bevacizumab|bevacizumab|mesh-list
93092926|NCT01197170|Everolimus|everolimus|mesh-list
93092927|NCT01197170|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93092928|NCT01197170|Sorafenib|sorafenib|mesh-list
93092929|NCT01197170|Anastrozole|anastrozole|mesh-list
93092930|NCT01197170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93092931|NCT01197170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092932|NCT01197170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93092933|NCT01197170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93092934|NCT01197170|Growth Substances|growth substances|mesh-ancestor
93092935|NCT01197170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092936|NCT01197170|Growth Inhibitors|growth inhibitors|mesh-ancestor
93092937|NCT01197170|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93092938|NCT01197170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93092939|NCT01197170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092940|NCT01197170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092941|NCT01197170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092942|NCT01197170|Immunologic Factors|immunologic factors|mesh-ancestor
93092943|NCT01197170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93092944|NCT01197170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93092945|NCT01197170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93092946|NCT01197170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93092947|NCT01197170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93092948|NCT01197170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93092949|NCT05516966|Dulaglutide|dulaglutide|mesh-list
93092950|NCT05516966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93092951|NCT05516966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092952|NCT01195766|Ofatumumab|ofatumumab|mesh-list
93092953|NCT01195766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092954|NCT03850886|Niacinamide|niacinamide|mesh-list
93092955|NCT03850886|Niacin|niacin|mesh-list
93092956|NCT03850886|Nicotinic Acids|nicotinic acids|mesh-list
93092957|NCT03850886|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93092958|NCT03850886|Vitamins|vitamins|mesh-ancestor
93092959|NCT03850886|Micronutrients|micronutrients|mesh-ancestor
93092960|NCT03850886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092961|NCT03850886|Vitamin B Complex|vitamin b complex|mesh-ancestor
93092962|NCT03850886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93092963|NCT03850886|Antimetabolites|antimetabolites|mesh-ancestor
93092964|NCT03850886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092965|NCT03850886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93092966|NCT03850886|Vasodilator Agents|vasodilator agents|mesh-ancestor
93092967|NCT03251482|Apixaban|apixaban|mesh-list
93092968|NCT03251482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93092969|NCT03251482|Antithrombins|antithrombins|mesh-ancestor
93092970|NCT03251482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93092971|NCT03251482|Protease Inhibitors|protease inhibitors|mesh-ancestor
93092972|NCT03251482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092973|NCT03251482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092974|NCT03251482|Anticoagulants|anticoagulants|mesh-ancestor
93092975|NCT03732248|Sirolimus|sirolimus|mesh-list
93092976|NCT03732248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93092977|NCT03732248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93092978|NCT03732248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93092979|NCT03732248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092980|NCT03732248|Antifungal Agents|antifungal agents|mesh-ancestor
93092981|NCT03732248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93092982|NCT03732248|Immunologic Factors|immunologic factors|mesh-ancestor
93092983|NCT03732248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93092984|NCT00310037|Bortezomib|bortezomib|mesh-list
93092985|NCT00310037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092986|NCT01196234|Paclitaxel|paclitaxel|mesh-list
93092987|NCT01196234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93092988|NCT01196234|Carboplatin|carboplatin|mesh-list
93092989|NCT01196234|Gefitinib|gefitinib|mesh-list
93092990|NCT01196234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93092991|NCT01196234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93092992|NCT01196234|Tubulin Modulators|tubulin modulators|mesh-ancestor
93092993|NCT01196234|Antimitotic Agents|antimitotic agents|mesh-ancestor
93092994|NCT01196234|Mitosis Modulators|mitosis modulators|mesh-ancestor
93092995|NCT01196234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93092996|NCT01196234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93092997|NCT01196234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93092998|NCT05292404|Alirocumab|alirocumab|mesh-list
93092999|NCT05292404|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93093000|NCT05292404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93093001|NCT05292404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93093002|NCT05292404|Antimetabolites|antimetabolites|mesh-ancestor
93093003|NCT05292404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093004|NCT05292404|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93093005|NCT05292404|Protease Inhibitors|protease inhibitors|mesh-ancestor
93093006|NCT05292404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093007|NCT05292404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93093008|NCT00309959|Paclitaxel|paclitaxel|mesh-list
93093009|NCT00309959|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92683289|NCT00438321|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93093010|NCT00309959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93093011|NCT00309959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093012|NCT00309959|Tubulin Modulators|tubulin modulators|mesh-ancestor
93093013|NCT00309959|Antimitotic Agents|antimitotic agents|mesh-ancestor
93093014|NCT00309959|Mitosis Modulators|mitosis modulators|mesh-ancestor
93093015|NCT00309959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093016|NCT03238924|Oxytocin|oxytocin|mesh-list
93093017|NCT03238924|Oxytocics|oxytocics|mesh-ancestor
93093018|NCT03238924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93093019|NCT03238924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093020|NCT01190384|Grape Seed Extract|grape seed extract|mesh-list
93093021|NCT01190384|Antioxidants|antioxidants|mesh-list
93093022|NCT01190384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093023|NCT01190384|Protective Agents|protective agents|mesh-ancestor
93093024|NCT01190384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093025|NCT01190384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93093026|NCT01190384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093027|NCT02532413|Entecavir|entecavir|mesh-list
93093028|NCT02532413|Poly I-C|poly i-c|mesh-list
93093029|NCT02532413|Antiviral Agents|antiviral agents|mesh-ancestor
93093030|NCT02532413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093031|NCT02532413|Interferon Inducers|interferon inducers|mesh-ancestor
93093032|NCT02532413|Immunologic Factors|immunologic factors|mesh-ancestor
93093033|NCT02532413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093034|NCT01190462|Cetuximab|cetuximab|mesh-list
93093035|NCT01190462|Simvastatin|simvastatin|mesh-list
93093036|NCT01190462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093037|NCT01190462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093038|NCT01190462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93093039|NCT01190462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93093040|NCT01190462|Antimetabolites|antimetabolites|mesh-ancestor
93093041|NCT01190462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093042|NCT01190462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93093043|NCT01190462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93093044|NCT01190462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093045|NCT01198106|Cinnarizine|cinnarizine|mesh-list
93093046|NCT01198106|Scopolamine|scopolamine|mesh-list
93093047|NCT01198106|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93093048|NCT01198106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93093049|NCT01198106|Antiemetics|antiemetics|mesh-ancestor
93093050|NCT01198106|Autonomic Agents|autonomic agents|mesh-ancestor
93093051|NCT01198106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093052|NCT01198106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093053|NCT01198106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093054|NCT01198106|Mydriatics|mydriatics|mesh-ancestor
93093055|NCT01198106|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93093056|NCT01198106|Cholinergic Agents|cholinergic agents|mesh-ancestor
92765311|NCT02753647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093057|NCT01198106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093058|NCT01198106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093059|NCT01198106|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93093060|NCT01198106|Parasympatholytics|parasympatholytics|mesh-ancestor
93093061|NCT01198106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93093062|NCT01198106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093063|NCT01198106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093064|NCT01198106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93093065|NCT01198106|Histamine Antagonists|histamine antagonists|mesh-ancestor
93093066|NCT01198106|Histamine Agents|histamine agents|mesh-ancestor
93093067|NCT02918500|Nicotine|nicotine|mesh-list
93093068|NCT02918500|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93093069|NCT02918500|Autonomic Agents|autonomic agents|mesh-ancestor
93093070|NCT02918500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093071|NCT02918500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093072|NCT02918500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93093073|NCT02918500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93093074|NCT02918500|Cholinergic Agents|cholinergic agents|mesh-ancestor
93093075|NCT02918500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093076|NCT02918500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093077|NCT03850652|Iron|iron|mesh-list
93093078|NCT03850652|Trace Elements|trace elements|mesh-ancestor
93093079|NCT03850652|Micronutrients|micronutrients|mesh-ancestor
93093080|NCT03850652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093081|NCT01198184|Sirolimus|sirolimus|mesh-list
93093082|NCT01198184|Temsirolimus|temsirolimus|mesh-list
93093083|NCT01198184|MTOR Inhibitors|mtor inhibitors|mesh-list
93093084|NCT01198184|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93093085|NCT01198184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93093086|NCT01198184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093087|NCT01198184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093088|NCT01198184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093089|NCT01198184|Immunologic Factors|immunologic factors|mesh-ancestor
93093090|NCT01198184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093091|NCT01198184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093092|NCT01198184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093093|NCT01198184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093094|NCT01198184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93093095|NCT01198184|Antifungal Agents|antifungal agents|mesh-ancestor
93093096|NCT01198184|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93093097|NCT00333359|Gabapentin|gabapentin|mesh-list
93093098|NCT00333359|Analgesics|analgesics|mesh-ancestor
93093099|NCT00333359|Sensory System Agents|sensory system agents|mesh-ancestor
93093100|NCT00333359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093101|NCT00333359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093102|NCT00333359|Anticonvulsants|anticonvulsants|mesh-ancestor
93093103|NCT00333359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93093104|NCT00333359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93093105|NCT00333359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093106|NCT00333359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93093107|NCT00333359|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93093108|NCT00333359|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93093109|NCT00333359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093110|NCT00333359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093111|NCT00333359|Antimanic Agents|antimanic agents|mesh-ancestor
93093112|NCT03246724|Midazolam|midazolam|mesh-list
93093113|NCT03246724|Triazolam|triazolam|mesh-list
93093114|NCT03246724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93093115|NCT03246724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93093116|NCT03246724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093117|NCT03246724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093118|NCT03246724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93093119|NCT03246724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93093120|NCT03246724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93093121|NCT03246724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93093122|NCT03246724|Anesthetics, General|anesthetics, general|mesh-ancestor
93093123|NCT03246724|Anesthetics|anesthetics|mesh-ancestor
93093124|NCT03246724|GABA Modulators|gaba modulators|mesh-ancestor
93093125|NCT03246724|GABA Agents|gaba agents|mesh-ancestor
93093126|NCT03246724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093127|NCT03246724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093128|NCT01196546|Metformin|metformin|mesh-list
93093129|NCT01196546|Vildagliptin|vildagliptin|mesh-list
93093130|NCT01196546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093131|NCT01196546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093132|NCT01196546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92765388|NCT02750995|Azacitidine|azacitidine|mesh-list
93093133|NCT01196546|Protease Inhibitors|protease inhibitors|mesh-ancestor
93093134|NCT01196546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093135|NCT01196546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093136|NCT01293266|Propofol|propofol|mesh-list
93093137|NCT01293266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93093138|NCT01293266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093139|NCT01293266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093140|NCT01293266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93093141|NCT01293266|Anesthetics, General|anesthetics, general|mesh-ancestor
93093142|NCT01293266|Anesthetics|anesthetics|mesh-ancestor
93093143|NCT03948646|Bromides|bromides|mesh-list
93093144|NCT03948646|Anticonvulsants|anticonvulsants|mesh-ancestor
93093145|NCT01198340|Ropivacaine|ropivacaine|mesh-list
93093146|NCT01198340|Anesthetics, Local|anesthetics, local|mesh-list
93093147|NCT01198340|Anesthetics|anesthetics|mesh-list
93093148|NCT01198340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093149|NCT01198340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093150|NCT01198340|Sensory System Agents|sensory system agents|mesh-ancestor
93093151|NCT01198340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093152|NCT01347112|Varenicline|varenicline|mesh-list
93093153|NCT01347112|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93093154|NCT01347112|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93093155|NCT01347112|Cholinergic Agents|cholinergic agents|mesh-ancestor
93093156|NCT01347112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093157|NCT01347112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093158|NCT01347112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093159|NCT00308711|Misoprostol|misoprostol|mesh-list
93093160|NCT00308711|Dinoprostone|dinoprostone|mesh-list
93093161|NCT00308711|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93093162|NCT00308711|Abortifacient Agents|abortifacient agents|mesh-ancestor
93093163|NCT00308711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93093164|NCT00308711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093165|NCT00308711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93093166|NCT00308711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093167|NCT00308711|Oxytocics|oxytocics|mesh-ancestor
93093168|NCT04057456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93093169|NCT04057456|Nabilone|nabilone|mesh-list
93093170|NCT04057456|Antiemetics|antiemetics|mesh-ancestor
93093171|NCT04057456|Autonomic Agents|autonomic agents|mesh-ancestor
93093172|NCT04057456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093173|NCT04057456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093174|NCT04057456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093175|NCT04057456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93093176|NCT04057456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93093177|NCT04057456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093178|NCT04057456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93093179|NCT01198496|Losartan|losartan|mesh-list
93093180|NCT01198496|Amlodipine|amlodipine|mesh-list
93093181|NCT01198496|Valsartan|valsartan|mesh-list
93093182|NCT01198496|Telmisartan|telmisartan|mesh-list
93093183|NCT01198496|Candesartan|candesartan|mesh-list
93093184|NCT01198496|Candesartan cilexetil|candesartan cilexetil|mesh-list
93093185|NCT01198496|Olmesartan|olmesartan|mesh-list
93093186|NCT01198496|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93093187|NCT01198496|Spironolactone|spironolactone|mesh-list
93093188|NCT01198496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93093189|NCT01198496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93093190|NCT01198496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093191|NCT01198496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093192|NCT01198496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093193|NCT01198496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093194|NCT01198496|Vasodilator Agents|vasodilator agents|mesh-ancestor
93093195|NCT01198496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93093196|NCT01198496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93093197|NCT01198496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93093198|NCT01198496|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93093199|NCT01198496|Hormone Antagonists|hormone antagonists|mesh-ancestor
93093200|NCT01198496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093201|NCT01198496|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93093202|NCT01198496|Diuretics|diuretics|mesh-ancestor
93093203|NCT01198496|Natriuretic Agents|natriuretic agents|mesh-ancestor
93093204|NCT01066013|Anti-Infective Agents|anti-infective agents|mesh-list
93093205|NCT01066013|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93093206|NCT01066091|Palmitic Acid|palmitic acid|mesh-list
93093207|NCT01066091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093208|NCT01066091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093210|NCT03719326|Doxorubicin|doxorubicin|mesh-list
93093211|NCT03719326|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93093212|NCT03719326|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93093213|NCT03719326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93093214|NCT03719326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093215|NCT03719326|Tubulin Modulators|tubulin modulators|mesh-ancestor
93093216|NCT03719326|Antimitotic Agents|antimitotic agents|mesh-ancestor
93093217|NCT03719326|Mitosis Modulators|mitosis modulators|mesh-ancestor
93093218|NCT03719326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093219|NCT03719326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93093220|NCT03719326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93093221|NCT03719326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93093222|NCT03719326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093223|NCT03846284|Magnesium Sulfate|magnesium sulfate|mesh-list
93093224|NCT03846284|Bupivacaine|bupivacaine|mesh-list
93093225|NCT03846284|Anesthetics, Local|anesthetics, local|mesh-list
93093226|NCT03846284|Anesthetics|anesthetics|mesh-list
93093227|NCT03846284|N-Methylaspartate|n-methylaspartate|mesh-list
93093228|NCT03846284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093229|NCT03846284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093230|NCT03846284|Sensory System Agents|sensory system agents|mesh-ancestor
93093231|NCT03846284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093232|NCT03846284|Analgesics|analgesics|mesh-ancestor
93093233|NCT03846284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93093234|NCT03846284|Anticonvulsants|anticonvulsants|mesh-ancestor
93093235|NCT03846284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93093236|NCT03846284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093237|NCT03846284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093238|NCT03846284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093239|NCT03846284|Tocolytic Agents|tocolytic agents|mesh-ancestor
93093240|NCT03846284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93093241|NCT03846284|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93093242|NCT03846284|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93093243|NCT03846284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093244|NCT01066169|Lactitol|lactitol|mesh-list
93093245|NCT01066169|Cathartics|cathartics|mesh-ancestor
93093246|NCT01066169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093247|NCT05572060|Metformin|metformin|mesh-list
93093248|NCT05572060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093249|NCT05572060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093250|NCT05431244|Antiviral Agents|antiviral agents|mesh-list
93093251|NCT05431244|Gemcitabine|gemcitabine|mesh-list
93093252|NCT05431244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93093253|NCT05431244|Antimetabolites|antimetabolites|mesh-ancestor
93093254|NCT05431244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093255|NCT05431244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093256|NCT05431244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093257|NCT01199432|Cyclophosphamide|cyclophosphamide|mesh-list
93093258|NCT01199432|Fluorouracil|fluorouracil|mesh-list
93093259|NCT01199432|Epirubicin|epirubicin|mesh-list
93093260|NCT01199432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093261|NCT01199432|Immunologic Factors|immunologic factors|mesh-ancestor
93093262|NCT01199432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093263|NCT01199432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93093264|NCT01199432|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93093265|NCT01199432|Alkylating Agents|alkylating agents|mesh-ancestor
93093266|NCT01199432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093267|NCT01199432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093268|NCT01199432|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93093269|NCT01199432|Antimetabolites|antimetabolites|mesh-ancestor
93093270|NCT01199432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93093271|NCT01199432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93093272|NCT01199432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93093273|NCT01199432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93093274|NCT01199432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093275|NCT05064020|Tenofovir|tenofovir|mesh-list
93093276|NCT05064020|Emtricitabine|emtricitabine|mesh-list
93093277|NCT05064020|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93093278|NCT05064020|Antiviral Agents|antiviral agents|mesh-ancestor
93093279|NCT05064020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093280|NCT05064020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93093281|NCT05064020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93093282|NCT05064020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093283|NCT05064020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093284|NCT05064020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93093285|NCT05064020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93093286|NCT05058560|Tislelizumab|tislelizumab|mesh-list
93093287|NCT05058560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093288|NCT05058560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093289|NCT01293422|Rifampin|rifampin|mesh-list
93093290|NCT01293422|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93093291|NCT01293422|Antitubercular Agents|antitubercular agents|mesh-ancestor
93093292|NCT01293422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093293|NCT01293422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093294|NCT01293422|Leprostatic Agents|leprostatic agents|mesh-ancestor
93093295|NCT01293422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93093296|NCT01293422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093297|NCT01293422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093298|NCT01293422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93093299|NCT01293422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93093300|NCT01293422|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93093301|NCT01293422|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93093302|NCT01293422|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93093303|NCT01293422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93093304|NCT01566656|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93093305|NCT01566656|Immunologic Factors|immunologic factors|mesh-ancestor
93093306|NCT01566656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093307|NCT01566656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093308|NCT01566734|Cefazolin|cefazolin|mesh-list
93093309|NCT01566734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093310|NCT01566734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093311|NCT00050778|Interferons|interferons|mesh-list
93093312|NCT00050778|Interferon-beta|interferon-beta|mesh-list
93093313|NCT00050778|Interferon beta-1a|interferon beta-1a|mesh-list
93093314|NCT00050778|Alemtuzumab|alemtuzumab|mesh-list
93093315|NCT00050778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093316|NCT00050778|Antiviral Agents|antiviral agents|mesh-ancestor
93093317|NCT00050778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093318|NCT00050778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093319|NCT00050778|Immunologic Factors|immunologic factors|mesh-ancestor
93093320|NCT00050778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093321|NCT00050778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93093322|NCT01199510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93093323|NCT01199510|Lubricant Eye Drops|lubricant eye drops|mesh-list
93093324|NCT01199510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93093325|NCT04153682|Anti-Infective Agents|anti-infective agents|mesh-list
93093326|NCT04153682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93093327|NCT00050622|Methylphenidate|methylphenidate|mesh-list
93093328|NCT00050622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93093329|NCT00050622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093330|NCT00050622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93093331|NCT00050622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93093332|NCT00050622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093333|NCT00050622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093334|NCT00050622|Dopamine Agents|dopamine agents|mesh-ancestor
93093335|NCT00050622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093336|NCT00308087|Rituximab|rituximab|mesh-list
93093337|NCT00308087|Molgramostim|molgramostim|mesh-list
93093338|NCT00308087|Sargramostim|sargramostim|mesh-list
93093339|NCT00308087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093340|NCT00308087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093341|NCT00308087|Immunologic Factors|immunologic factors|mesh-ancestor
93093342|NCT00308087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093343|NCT00308087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93093344|NCT04942184|Complement Factor H|complement factor h|mesh-list
93093345|NCT04942184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93093346|NCT04942184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093347|NCT04942184|Immunologic Factors|immunologic factors|mesh-ancestor
93093348|NCT04942184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093349|NCT00307931|Certolizumab Pegol|certolizumab pegol|mesh-list
93093350|NCT00307931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93093351|NCT00307931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093352|NCT00307931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093353|NCT00307931|Immunologic Factors|immunologic factors|mesh-ancestor
93093354|NCT00307931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093355|NCT00307931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93093356|NCT01097148|Atracurium|atracurium|mesh-list
93093357|NCT01097148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93093358|NCT01097148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93093359|NCT01097148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93093360|NCT01097148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093361|NCT01097148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093362|NCT01097148|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93093363|NCT01097148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93093364|NCT01097148|Cholinergic Agents|cholinergic agents|mesh-ancestor
93093365|NCT01097148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093366|NCT01097148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093367|NCT01199276|Sevoflurane|sevoflurane|mesh-list
93093368|NCT01199276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93093369|NCT01199276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93093370|NCT01199276|Anesthetics, General|anesthetics, general|mesh-ancestor
93093371|NCT01199276|Anesthetics|anesthetics|mesh-ancestor
93093372|NCT01199276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093373|NCT01199276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093374|NCT01202084|Fluticasone|fluticasone|mesh-list
93093376|NCT01202084|Formoterol Fumarate|formoterol fumarate|mesh-list
93093377|NCT01202084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093378|NCT01202084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93093379|NCT01202084|Autonomic Agents|autonomic agents|mesh-ancestor
93093380|NCT01202084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093381|NCT01202084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093382|NCT01202084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93093383|NCT01202084|Respiratory System Agents|respiratory system agents|mesh-ancestor
93093384|NCT01202084|Dermatologic Agents|dermatologic agents|mesh-ancestor
93093385|NCT01202084|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93093386|NCT01202084|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93093387|NCT01202084|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93093388|NCT01202084|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93093389|NCT01202084|Adrenergic Agents|adrenergic agents|mesh-ancestor
93093390|NCT01202084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093391|NCT01202084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093392|NCT04133792|Simvastatin|simvastatin|mesh-list
93093393|NCT04133792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93093394|NCT04133792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93093395|NCT04133792|Antimetabolites|antimetabolites|mesh-ancestor
93093396|NCT04133792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093397|NCT04133792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93093398|NCT04133792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93093399|NCT04133792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093400|NCT01202240|Ketoconazole|ketoconazole|mesh-list
93093401|NCT01202240|Tofacitinib|tofacitinib|mesh-list
93093402|NCT01202240|Antifungal Agents|antifungal agents|mesh-ancestor
93093403|NCT01202240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093404|NCT01202240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93093405|NCT01202240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93093406|NCT01202240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093407|NCT01202240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093408|NCT01202240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93093409|NCT01202240|Hormone Antagonists|hormone antagonists|mesh-ancestor
93093410|NCT01202240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093411|NCT01202240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093412|NCT01202240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93093413|NCT01202240|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93093414|NCT01202240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93093415|NCT01204112|Rifampin|rifampin|mesh-list
93093416|NCT01204112|Tofacitinib|tofacitinib|mesh-list
93093417|NCT01204112|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93093418|NCT01204112|Antitubercular Agents|antitubercular agents|mesh-ancestor
93093419|NCT01204112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093420|NCT01204112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093421|NCT01204112|Leprostatic Agents|leprostatic agents|mesh-ancestor
93093422|NCT01204112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93093423|NCT01204112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093424|NCT01204112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093425|NCT01204112|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93093426|NCT01204112|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93093427|NCT01204112|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93093428|NCT01204112|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93093429|NCT01204112|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92765697|NCT02735239|Vitamins|vitamins|mesh-ancestor
93093430|NCT01204112|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93093431|NCT01204112|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93093432|NCT01204112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93093433|NCT01204190|Gestodene|gestodene|mesh-list
93093434|NCT01204190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93093435|NCT01204190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93093436|NCT01204190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93093437|NCT01204190|Contraceptive Agents|contraceptive agents|mesh-ancestor
93093438|NCT01204190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93093439|NCT01204190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093440|NCT01204190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93093441|NCT01204190|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93093442|NCT01204190|Progestins|progestins|mesh-ancestor
93093443|NCT01204190|Hormones|hormones|mesh-ancestor
93093444|NCT01204190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093445|NCT01204268|Sevoflurane|sevoflurane|mesh-list
93093446|NCT01204268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93093447|NCT01204268|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93093448|NCT01204268|Anesthetics, General|anesthetics, general|mesh-ancestor
93093449|NCT01204268|Anesthetics|anesthetics|mesh-ancestor
93093450|NCT01204268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093451|NCT01204268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093452|NCT02965898|Vitamin D|vitamin d|mesh-list
93093453|NCT02965898|Ergocalciferols|ergocalciferols|mesh-list
93093454|NCT02965898|Cholecalciferol|cholecalciferol|mesh-list
93093455|NCT02965898|Vitamins|vitamins|mesh-list
93093456|NCT02965898|Micronutrients|micronutrients|mesh-ancestor
93093457|NCT02965898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093458|NCT02965898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93093459|NCT02965898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093460|NCT01204346|Psychotropic Drugs|psychotropic drugs|mesh-list
93093461|NCT02796170|Dapagliflozin|dapagliflozin|mesh-list
93093462|NCT02796170|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93093463|NCT02796170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093464|NCT02796170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093465|NCT02796170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093466|NCT03844178|Tetracaine|tetracaine|mesh-list
93093467|NCT03844178|Anesthetics, Local|anesthetics, local|mesh-ancestor
93093468|NCT03844178|Anesthetics|anesthetics|mesh-ancestor
93093469|NCT03844178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093470|NCT03844178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093471|NCT03844178|Sensory System Agents|sensory system agents|mesh-ancestor
93093472|NCT03844178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093473|NCT00049842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93093474|NCT00049842|Antiviral Agents|antiviral agents|mesh-ancestor
93093475|NCT00049842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093476|NCT00307151|Ritonavir|ritonavir|mesh-list
93093477|NCT00307151|Lopinavir|lopinavir|mesh-list
93093478|NCT00307151|Lamivudine|lamivudine|mesh-list
93093479|NCT00307151|Zidovudine|zidovudine|mesh-list
93093480|NCT00307151|Nevirapine|nevirapine|mesh-list
93093481|NCT00307151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93093482|NCT00307151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93093483|NCT00307151|Protease Inhibitors|protease inhibitors|mesh-ancestor
93093484|NCT00307151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093485|NCT00307151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093486|NCT00307151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93093487|NCT00307151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93093488|NCT00307151|Antiviral Agents|antiviral agents|mesh-ancestor
93093489|NCT00307151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093490|NCT00307151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93093491|NCT00307151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93093492|NCT00307151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93093493|NCT00307151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93093494|NCT00307151|Antimetabolites|antimetabolites|mesh-ancestor
93093495|NCT00307151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93093496|NCT00307151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93093497|NCT03981029|Folic Acid|folic acid|mesh-list
93093498|NCT03981029|Hematinics|hematinics|mesh-ancestor
93093499|NCT03981029|Vitamin B Complex|vitamin b complex|mesh-ancestor
93093500|NCT03981029|Vitamins|vitamins|mesh-ancestor
93093501|NCT03981029|Micronutrients|micronutrients|mesh-ancestor
93093502|NCT03981029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093503|NCT02654132|Dexamethasone|dexamethasone|mesh-list
93093504|NCT02654132|Dexamethasone acetate|dexamethasone acetate|mesh-list
93093505|NCT02654132|Pomalidomide|pomalidomide|mesh-list
93093506|NCT02654132|Elotuzumab|elotuzumab|mesh-list
93093507|NCT02654132|BB 1101|bb 1101|mesh-list
93093508|NCT02654132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093509|NCT02654132|Antiemetics|antiemetics|mesh-ancestor
93093510|NCT02654132|Autonomic Agents|autonomic agents|mesh-ancestor
93093511|NCT02654132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093512|NCT02654132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093513|NCT02654132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093514|NCT02654132|Glucocorticoids|glucocorticoids|mesh-ancestor
93093515|NCT02654132|Hormones|hormones|mesh-ancestor
93093516|NCT02654132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093517|NCT02654132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93093518|NCT02654132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093519|NCT02654132|Protease Inhibitors|protease inhibitors|mesh-ancestor
93093520|NCT02654132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093521|NCT02654132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093522|NCT02654132|Immunologic Factors|immunologic factors|mesh-ancestor
93093523|NCT02654132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93093524|NCT02654132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93093525|NCT02654132|Growth Substances|growth substances|mesh-ancestor
93093526|NCT02654132|Growth Inhibitors|growth inhibitors|mesh-ancestor
93093527|NCT01064141|Vaccines|vaccines|mesh-list
93093528|NCT01064141|Immunologic Factors|immunologic factors|mesh-ancestor
93093529|NCT01064141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093530|NCT03837470|Furosemide|furosemide|mesh-list
93093531|NCT03837470|Diuretics|diuretics|mesh-ancestor
93093532|NCT03837470|Natriuretic Agents|natriuretic agents|mesh-ancestor
93093533|NCT03837470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093534|NCT03837470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93093535|NCT03837470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093536|NCT03837470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093537|NCT05307874|Aldesleukin|aldesleukin|mesh-list
93093538|NCT05307874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093539|NCT05307874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93093540|NCT05307874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93093541|NCT05307874|Antiviral Agents|antiviral agents|mesh-ancestor
93093542|NCT05307874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093543|NCT01199900|Prednisone|prednisone|mesh-list
93093544|NCT01199900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093545|NCT01199900|Glucocorticoids|glucocorticoids|mesh-ancestor
93093546|NCT01199900|Hormones|hormones|mesh-ancestor
93093547|NCT01199900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093548|NCT01199900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093549|NCT01199900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93093550|NCT01199900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093551|NCT01200056|Atorvastatin|atorvastatin|mesh-list
93093552|NCT01200056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93093553|NCT01200056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93093554|NCT01200056|Antimetabolites|antimetabolites|mesh-ancestor
93093555|NCT01200056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093556|NCT01200056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93093557|NCT01200056|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93093558|NCT01200056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093559|NCT03841526|Glucagon|glucagon|mesh-list
93093560|NCT03841526|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93093561|NCT03841526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093562|NCT03841526|Hormones|hormones|mesh-ancestor
93093563|NCT03841526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093564|NCT03841526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093565|NCT03841526|Incretins|incretins|mesh-ancestor
93093566|NCT01200212|Bevacizumab|bevacizumab|mesh-list
93093567|NCT01200212|Taxane|taxane|mesh-list
93093568|NCT01200212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093569|NCT01200212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093570|NCT01200212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93093571|NCT01200212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93093572|NCT01200212|Growth Substances|growth substances|mesh-ancestor
93093573|NCT01200212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093574|NCT01200212|Growth Inhibitors|growth inhibitors|mesh-ancestor
93093575|NCT03978845|Lidocaine|lidocaine|mesh-list
93093576|NCT03978845|Anesthetics, Local|anesthetics, local|mesh-list
93093577|NCT03978845|Anesthetics|anesthetics|mesh-list
93093578|NCT03978845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093579|NCT03978845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093580|NCT03978845|Sensory System Agents|sensory system agents|mesh-ancestor
93093581|NCT03978845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093582|NCT03978845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93093583|NCT03978845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93093584|NCT03978845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93093585|NCT03978845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683865|NCT00478764|Triamcinolone|triamcinolone|mesh-list
93093586|NCT03978845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093587|NCT02387996|Nivolumab|nivolumab|mesh-list
93093588|NCT02387996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093589|NCT02387996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093590|NCT02387996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93093591|NCT02387996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093592|NCT01204580|Metformin|metformin|mesh-list
93093593|NCT01204580|Glimepiride|glimepiride|mesh-list
93093594|NCT01204580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093595|NCT01204580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093596|NCT01204580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93093597|NCT01204580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093598|NCT01204580|Immunologic Factors|immunologic factors|mesh-ancestor
93093599|NCT03850366|Cyclophosphamide|cyclophosphamide|mesh-list
93093600|NCT03850366|Bortezomib|bortezomib|mesh-list
93093601|NCT03850366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093602|NCT03850366|Immunologic Factors|immunologic factors|mesh-ancestor
93093603|NCT03850366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093604|NCT03850366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93093605|NCT03850366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93093606|NCT03850366|Alkylating Agents|alkylating agents|mesh-ancestor
93093607|NCT03850366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093608|NCT03850366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093609|NCT03850366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93093610|NCT05181592|Luspatercept|luspatercept|mesh-list
93093611|NCT05181592|Hematinics|hematinics|mesh-ancestor
93093612|NCT05181514|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93093613|NCT05181514|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93093614|NCT05181514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93093615|NCT05181514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93093616|NCT03229486|Glycopyrrolate|glycopyrrolate|mesh-list
93093617|NCT03229486|Neostigmine|neostigmine|mesh-list
93093618|NCT03229486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93093619|NCT03229486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093620|NCT03229486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093621|NCT03229486|Cholinergic Agents|cholinergic agents|mesh-ancestor
93093622|NCT03229486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093623|NCT03229486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093624|NCT03229486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93093625|NCT03229486|Autonomic Agents|autonomic agents|mesh-ancestor
93093626|NCT03229486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093627|NCT03229486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93093628|NCT03229486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93093629|NCT03229486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93093630|NCT05153668|Everolimus|everolimus|mesh-list
93093631|NCT05153668|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93093632|NCT05153668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93093633|NCT05153668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093634|NCT05153668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093635|NCT05153668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093636|NCT05153668|Immunologic Factors|immunologic factors|mesh-ancestor
93093637|NCT05153668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093638|NCT05153668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093639|NCT03833570|Melatonin|melatonin|mesh-list
93093640|NCT03833570|Antioxidants|antioxidants|mesh-ancestor
93093641|NCT03833570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093642|NCT03833570|Protective Agents|protective agents|mesh-ancestor
93093643|NCT03833570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093644|NCT03833570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093645|NCT01779050|Paclitaxel|paclitaxel|mesh-list
93093646|NCT01779050|Docetaxel|docetaxel|mesh-list
93093647|NCT01779050|Cyclophosphamide|cyclophosphamide|mesh-list
93093648|NCT01779050|Carboplatin|carboplatin|mesh-list
93093649|NCT01779050|Doxorubicin|doxorubicin|mesh-list
93093650|NCT01779050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93093651|NCT01779050|Fluorouracil|fluorouracil|mesh-list
93093652|NCT01779050|Trastuzumab|trastuzumab|mesh-list
93093653|NCT01779050|Epirubicin|epirubicin|mesh-list
93093654|NCT01779050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93093655|NCT01779050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093656|NCT01779050|Tubulin Modulators|tubulin modulators|mesh-ancestor
93093657|NCT01779050|Antimitotic Agents|antimitotic agents|mesh-ancestor
93093658|NCT01779050|Mitosis Modulators|mitosis modulators|mesh-ancestor
93093659|NCT01779050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093660|NCT01779050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93093661|NCT01779050|Immunologic Factors|immunologic factors|mesh-ancestor
93093662|NCT01779050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093663|NCT01779050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93093664|NCT01779050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93093665|NCT01779050|Alkylating Agents|alkylating agents|mesh-ancestor
93093666|NCT01779050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93093667|NCT01779050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93093668|NCT01779050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93093669|NCT01779050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93093670|NCT01779050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093671|NCT01779050|Antimetabolites|antimetabolites|mesh-ancestor
93093672|NCT01779050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93093673|NCT01779050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093674|NCT03841136|Etoposide|etoposide|mesh-list
93093675|NCT03841136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93093676|NCT03841136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093677|NCT03841136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93093678|NCT03841136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93093679|NCT03841136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093680|NCT03841136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093681|NCT05669768|Tamoxifen|tamoxifen|mesh-list
93093682|NCT05669768|Pamiparib|pamiparib|mesh-list
93093683|NCT05669768|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93093684|NCT05669768|Hormone Antagonists|hormone antagonists|mesh-ancestor
93093685|NCT05669768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093686|NCT05669768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093687|NCT05669768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93093688|NCT05669768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093689|NCT05669768|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93093690|NCT05669768|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93093691|NCT05669768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93093692|NCT05669768|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93093693|NCT05669768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093694|NCT05669768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093695|NCT00306527|Vaccines|vaccines|mesh-list
93093696|NCT00306527|Immunologic Factors|immunologic factors|mesh-ancestor
93093697|NCT00306527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093698|NCT01066247|Midazolam|midazolam|mesh-list
93093699|NCT01066247|Morphine|morphine|mesh-list
93093700|NCT01066247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93093701|NCT01066247|Narcotics|narcotics|mesh-ancestor
93093702|NCT01066247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093703|NCT01066247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093704|NCT01066247|Analgesics|analgesics|mesh-ancestor
93093705|NCT01066247|Sensory System Agents|sensory system agents|mesh-ancestor
93093706|NCT01066247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093707|NCT01066247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93093708|NCT01066247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93093709|NCT01066247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93093710|NCT01066247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93093711|NCT01066247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93093712|NCT01066247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93093713|NCT01066247|Anesthetics, General|anesthetics, general|mesh-ancestor
93093714|NCT01066247|Anesthetics|anesthetics|mesh-ancestor
93093715|NCT01066247|GABA Modulators|gaba modulators|mesh-ancestor
93093716|NCT01066247|GABA Agents|gaba agents|mesh-ancestor
93093717|NCT01066247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093718|NCT01066247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093719|NCT00306293|Valacyclovir|valacyclovir|mesh-list
93093720|NCT00306293|Antiviral Agents|antiviral agents|mesh-ancestor
93093721|NCT00306293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093722|NCT03980951|Analgesics, Opioid|analgesics, opioid|mesh-list
93093723|NCT03980951|Narcotics|narcotics|mesh-ancestor
93093724|NCT03980951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093725|NCT03980951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093726|NCT03980951|Analgesics|analgesics|mesh-ancestor
93093727|NCT03980951|Sensory System Agents|sensory system agents|mesh-ancestor
93093728|NCT03980951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093729|NCT02532491|Risperidone|risperidone|mesh-list
93093730|NCT02532491|Aripiprazole|aripiprazole|mesh-list
93093731|NCT02532491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93093732|NCT02532491|Serotonin Agents|serotonin agents|mesh-ancestor
93093733|NCT02532491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093734|NCT02532491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093735|NCT02532491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093736|NCT02532491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93093737|NCT02532491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93093738|NCT02532491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093739|NCT02532491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93093740|NCT02532491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93093741|NCT02532491|Dopamine Agents|dopamine agents|mesh-ancestor
93093742|NCT02532491|Antidepressive Agents|antidepressive agents|mesh-ancestor
93093743|NCT02532491|Dopamine Agonists|dopamine agonists|mesh-ancestor
93093744|NCT02532491|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93093745|NCT02532491|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93093746|NCT02532491|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93093747|NCT02532491|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93093748|NCT01066403|Pergolide|pergolide|mesh-list
93093749|NCT01066403|Dopamine Agonists|dopamine agonists|mesh-ancestor
93093750|NCT01066403|Dopamine Agents|dopamine agents|mesh-ancestor
93093751|NCT01066403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093752|NCT01066403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093753|NCT01066403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093754|NCT01064219|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93093755|NCT01064219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93093756|NCT01064219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093757|NCT00294671|Diflunisal|diflunisal|mesh-list
93093758|NCT00294671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93093759|NCT00294671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93093760|NCT00294671|Analgesics|analgesics|mesh-ancestor
93093761|NCT00294671|Sensory System Agents|sensory system agents|mesh-ancestor
93093762|NCT00294671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093763|NCT00294671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093764|NCT00294671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093765|NCT00294671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93093766|NCT00294671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93093767|NCT00294671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093768|NCT00294671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093769|NCT01064453|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93093770|NCT01064453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93093771|NCT01064453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093772|NCT03980249|Carvedilol|carvedilol|mesh-list
93093773|NCT03980249|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93093774|NCT03980249|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93093775|NCT03980249|Adrenergic Agents|adrenergic agents|mesh-ancestor
93093776|NCT03980249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093777|NCT03980249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093778|NCT03980249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093779|NCT03980249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93093780|NCT03980249|Antioxidants|antioxidants|mesh-ancestor
93093781|NCT03980249|Protective Agents|protective agents|mesh-ancestor
93093782|NCT03980249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93093783|NCT03980249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093784|NCT03980249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093785|NCT03980249|Vasodilator Agents|vasodilator agents|mesh-ancestor
93093786|NCT03980249|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93093787|NCT03980249|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93093788|NCT01495598|Pomalidomide|pomalidomide|mesh-list
93093789|NCT01495598|Immunologic Factors|immunologic factors|mesh-ancestor
93093790|NCT01495598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093791|NCT01495598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93093792|NCT01495598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93093793|NCT01495598|Growth Substances|growth substances|mesh-ancestor
93093794|NCT01495598|Growth Inhibitors|growth inhibitors|mesh-ancestor
93093795|NCT01495598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093796|NCT01297166|Calcitriol|calcitriol|mesh-list
93093797|NCT01297166|Calcipotriene|calcipotriene|mesh-list
93093798|NCT01297166|Dermatologic Agents|dermatologic agents|mesh-ancestor
93093799|NCT01297166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093800|NCT01297166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093801|NCT01297166|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93093802|NCT01297166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093803|NCT01297166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766061|NCT02743663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093804|NCT01297166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93093805|NCT01297166|Vitamins|vitamins|mesh-ancestor
93093806|NCT01297166|Micronutrients|micronutrients|mesh-ancestor
93093807|NCT01297166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93093808|NCT01202474|Insulin|insulin|mesh-list
93093809|NCT01202474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93093810|NCT01202474|Insulin Glargine|insulin glargine|mesh-list
93093811|NCT01202474|Insulin glulisine|insulin glulisine|mesh-list
93093812|NCT01202474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093813|NCT01202474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093814|NCT05667818|Norfloxacin|norfloxacin|mesh-list
93093815|NCT05667818|Amlodipine|amlodipine|mesh-list
93093816|NCT05667818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93093817|NCT05667818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93093818|NCT05667818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093819|NCT05667818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093820|NCT05667818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93093821|NCT05667818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093822|NCT05667818|Vasodilator Agents|vasodilator agents|mesh-ancestor
93093823|NCT05667818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093824|NCT05667818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093825|NCT05667818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93093826|NCT05667818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93093827|NCT05667818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093828|NCT05667818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093829|NCT05667818|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93093830|NCT05667818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93093831|NCT01205204|Clonidine|clonidine|mesh-list
93093832|NCT01205204|Fentanyl|fentanyl|mesh-list
93093833|NCT01205204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93093834|NCT01205204|Narcotics|narcotics|mesh-ancestor
93093835|NCT01205204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093836|NCT01205204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093837|NCT01205204|Analgesics|analgesics|mesh-ancestor
93093838|NCT01205204|Sensory System Agents|sensory system agents|mesh-ancestor
93093839|NCT01205204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093840|NCT01205204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93093841|NCT01205204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93093842|NCT01205204|Anesthetics, General|anesthetics, general|mesh-ancestor
93093843|NCT01205204|Anesthetics|anesthetics|mesh-ancestor
93093844|NCT01205204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93093845|NCT01205204|Sympatholytics|sympatholytics|mesh-ancestor
93093846|NCT01205204|Autonomic Agents|autonomic agents|mesh-ancestor
93093847|NCT01205204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93093848|NCT01205204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93093849|NCT01205204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93093850|NCT01205204|Adrenergic Agents|adrenergic agents|mesh-ancestor
93093851|NCT01205204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093852|NCT01205204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093853|NCT01205282|Pioglitazone|pioglitazone|mesh-list
93093854|NCT01205282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093855|NCT01205282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093856|NCT03902912|Prednisolone|prednisolone|mesh-list
93093857|NCT03902912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093858|NCT03902912|Glucocorticoids|glucocorticoids|mesh-ancestor
93093859|NCT03902912|Hormones|hormones|mesh-ancestor
93093860|NCT03902912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093861|NCT03902912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093862|NCT03902912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93093863|NCT03902912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093864|NCT01205360|Fentanyl|fentanyl|mesh-list
93093865|NCT01205360|Bupivacaine|bupivacaine|mesh-list
93093866|NCT01205360|Anesthetics, Local|anesthetics, local|mesh-ancestor
93093867|NCT01205360|Anesthetics|anesthetics|mesh-ancestor
93093868|NCT01205360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093869|NCT01205360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093870|NCT01205360|Sensory System Agents|sensory system agents|mesh-ancestor
93093871|NCT01205360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093872|NCT01205360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93093873|NCT01205360|Narcotics|narcotics|mesh-ancestor
93093874|NCT01205360|Analgesics|analgesics|mesh-ancestor
93093875|NCT01205360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93093876|NCT01205360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92766137|NCT02730091|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93093877|NCT01205360|Anesthetics, General|anesthetics, general|mesh-ancestor
93093878|NCT01200914|Heparin|heparin|mesh-list
93093879|NCT01200914|Anticoagulants|anticoagulants|mesh-ancestor
93093880|NCT01200914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93093881|NCT01200914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93093882|NCT01200914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093884|NCT01205516|Methadone|methadone|mesh-list
93093885|NCT01205516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93093886|NCT01205516|Narcotics|narcotics|mesh-ancestor
93093887|NCT01205516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93093888|NCT01205516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093889|NCT01205516|Analgesics|analgesics|mesh-ancestor
93093890|NCT01205516|Sensory System Agents|sensory system agents|mesh-ancestor
93093891|NCT01205516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093892|NCT01205516|Antitussive Agents|antitussive agents|mesh-ancestor
93093893|NCT01205516|Respiratory System Agents|respiratory system agents|mesh-ancestor
93093894|NCT01297634|Botulinum Toxins|botulinum toxins|mesh-list
93093895|NCT01297634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93093896|NCT01297634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93093897|NCT01297634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93093898|NCT01297634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93093899|NCT01297634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093900|NCT01297634|Cholinergic Agents|cholinergic agents|mesh-ancestor
93093901|NCT01297634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093902|NCT01297634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093903|NCT01297634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93093904|NCT01297634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093905|NCT01201070|Antithrombins|antithrombins|mesh-list
93093906|NCT01201070|Antithrombin III|antithrombin iii|mesh-list
93093907|NCT01201070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93093908|NCT01201070|Protease Inhibitors|protease inhibitors|mesh-ancestor
93093909|NCT01201070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093910|NCT01201070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093911|NCT01201070|Anticoagulants|anticoagulants|mesh-ancestor
93093912|NCT01205672|Metformin|metformin|mesh-list
93093913|NCT01205672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093914|NCT01205672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093915|NCT03817970|Ondansetron|ondansetron|mesh-list
93093916|NCT03817970|Palonosetron|palonosetron|mesh-list
93093917|NCT03817970|Granisetron|granisetron|mesh-list
93093918|NCT03817970|Antiemetics|antiemetics|mesh-ancestor
93093919|NCT03817970|Autonomic Agents|autonomic agents|mesh-ancestor
93093920|NCT03817970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093921|NCT03817970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093922|NCT03817970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093923|NCT03817970|Antipruritics|antipruritics|mesh-ancestor
93093924|NCT03817970|Dermatologic Agents|dermatologic agents|mesh-ancestor
93093925|NCT03817970|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93093926|NCT03817970|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93093927|NCT03817970|Serotonin Agents|serotonin agents|mesh-ancestor
93093928|NCT03817970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93093929|NCT03817970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093930|NCT03457948|Pembrolizumab|pembrolizumab|mesh-list
93093931|NCT03457948|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
93093932|NCT03457948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93093933|NCT03457948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093934|NCT03457948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93093935|NCT03457948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093936|NCT03457948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93093937|NCT01205750|Insulin|insulin|mesh-list
93093938|NCT01205750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93093939|NCT01205750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093940|NCT01205750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093941|NCT03012386|Sildenafil Citrate|sildenafil citrate|mesh-list
93093942|NCT03012386|Citric Acid|citric acid|mesh-list
93093943|NCT03012386|Sodium Citrate|sodium citrate|mesh-list
93093944|NCT03012386|Anticoagulants|anticoagulants|mesh-ancestor
93093945|NCT03012386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93093946|NCT03012386|Chelating Agents|chelating agents|mesh-ancestor
93093947|NCT03012386|Sequestering Agents|sequestering agents|mesh-ancestor
93093948|NCT03012386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093949|NCT03012386|Vasodilator Agents|vasodilator agents|mesh-ancestor
93093950|NCT03012386|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93093951|NCT03012386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93093952|NCT03012386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093953|NCT03012386|Urological Agents|urological agents|mesh-ancestor
93093954|NCT01202552|Vaccines|vaccines|mesh-list
93093955|NCT01202552|Immunologic Factors|immunologic factors|mesh-ancestor
93093956|NCT01202552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093957|NCT01205984|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93093958|NCT01205984|Methylprednisolone|methylprednisolone|mesh-list
93093959|NCT01205984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93093960|NCT01205984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93093961|NCT01205984|Prednisolone|prednisolone|mesh-list
93093962|NCT01205984|Prednisolone acetate|prednisolone acetate|mesh-list
93093963|NCT01205984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93093964|NCT01205984|Prednisolone phosphate|prednisolone phosphate|mesh-list
93093965|NCT01205984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93093966|NCT01205984|Antiemetics|antiemetics|mesh-ancestor
93093967|NCT01205984|Autonomic Agents|autonomic agents|mesh-ancestor
93093968|NCT01205984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93093969|NCT01205984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093970|NCT01205984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93093971|NCT01205984|Glucocorticoids|glucocorticoids|mesh-ancestor
93093972|NCT01205984|Hormones|hormones|mesh-ancestor
93093973|NCT01205984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093974|NCT01205984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93093975|NCT01205984|Protective Agents|protective agents|mesh-ancestor
93093976|NCT01205984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93093977|NCT01205984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93093978|NCT01205984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093979|NCT01205984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93093980|NCT01205984|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93093981|NCT01205984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93093982|NCT01205984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93093983|NCT01297946|Hormones|hormones|mesh-list
93093984|NCT01297946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026432|NCT00493038|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93093985|NCT01297946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093986|NCT03211858|Insulin|insulin|mesh-list
93093987|NCT03211858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93093988|NCT03211858|Insulin Glargine|insulin glargine|mesh-list
93093989|NCT03211858|Insulin Aspart|insulin aspart|mesh-list
93093990|NCT03211858|Insulin, Long-Acting|insulin, long-acting|mesh-list
93093991|NCT03211858|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93093992|NCT03211858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93093993|NCT03211858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093994|NCT01298180|Hormones|hormones|mesh-list
93093995|NCT01298180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93093996|NCT01298180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93093997|NCT03211156|Amoxicillin|amoxicillin|mesh-list
93093998|NCT03211156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93093999|NCT03211156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094000|NCT01298336|Moxifloxacin|moxifloxacin|mesh-list
93094001|NCT01298336|Clarithromycin|clarithromycin|mesh-list
93094002|NCT01298336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93094003|NCT01298336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094004|NCT01298336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93094005|NCT01298336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93094006|NCT01298336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094007|NCT01298336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094008|NCT01298336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094009|NCT01298336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93094010|NCT01298336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93094011|NCT01298336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93094012|NCT04472494|Abatacept|abatacept|mesh-list
93094013|NCT04472494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93094014|NCT04472494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094015|NCT04472494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094016|NCT04472494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094017|NCT04472494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094018|NCT04472494|Immunologic Factors|immunologic factors|mesh-ancestor
93094019|NCT04472494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094020|NCT04472494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094021|NCT04568200|Paclitaxel|paclitaxel|mesh-list
93094022|NCT04568200|Carboplatin|carboplatin|mesh-list
93094023|NCT04568200|Durvalumab|durvalumab|mesh-list
93094024|NCT04568200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93094025|NCT04568200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094026|NCT04568200|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094027|NCT04568200|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094028|NCT04568200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92766289|NCT02728687|Mannitol|mannitol|mesh-list
93094029|NCT04568200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094030|NCT04568200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094031|NCT03236506|Sofosbuvir|sofosbuvir|mesh-list
93094032|NCT03236506|Grazoprevir|grazoprevir|mesh-list
93094033|NCT03236506|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93094034|NCT03236506|Antiviral Agents|antiviral agents|mesh-ancestor
93094035|NCT03236506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094036|NCT01298882|Diacerein|diacerein|mesh-list
93094037|NCT01298882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094038|NCT01206530|Leucovorin|leucovorin|mesh-list
93094039|NCT01206530|Hydroxychloroquine|hydroxychloroquine|mesh-list
93094040|NCT01206530|Bevacizumab|bevacizumab|mesh-list
93094041|NCT01206530|Fluorouracil|fluorouracil|mesh-list
93094042|NCT01206530|Oxaliplatin|oxaliplatin|mesh-list
93094043|NCT01206530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094044|NCT01206530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094045|NCT01206530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93094046|NCT01206530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93094047|NCT01206530|Growth Substances|growth substances|mesh-ancestor
93094048|NCT01206530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094049|NCT01206530|Growth Inhibitors|growth inhibitors|mesh-ancestor
93094050|NCT01206530|Antimetabolites|antimetabolites|mesh-ancestor
93094051|NCT01206530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094052|NCT01206530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094053|NCT01206530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094054|NCT01206530|Immunologic Factors|immunologic factors|mesh-ancestor
93094055|NCT01206530|Antidotes|antidotes|mesh-ancestor
93094056|NCT01206530|Protective Agents|protective agents|mesh-ancestor
93094057|NCT01206530|Vitamin B Complex|vitamin b complex|mesh-ancestor
93094058|NCT01206530|Vitamins|vitamins|mesh-ancestor
93094059|NCT01206530|Micronutrients|micronutrients|mesh-ancestor
93094060|NCT01206530|Antimalarials|antimalarials|mesh-ancestor
93094061|NCT01206530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93094062|NCT01206530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93094063|NCT01206530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094064|NCT01206530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094065|NCT01206530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094066|NCT03209518|Leuprolide|leuprolide|mesh-list
93094067|NCT03209518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93094068|NCT03209518|Fertility Agents|fertility agents|mesh-ancestor
93094069|NCT03209518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93094070|NCT03209518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094071|NCT03209518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93094072|NCT03209518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094073|NCT05282420|Ranibizumab|ranibizumab|mesh-list
93094074|NCT05282420|Aflibercept|aflibercept|mesh-list
93094075|NCT05282420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93094076|NCT05282420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93094077|NCT05282420|Growth Substances|growth substances|mesh-ancestor
93094078|NCT05282420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094079|NCT05282420|Growth Inhibitors|growth inhibitors|mesh-ancestor
93094080|NCT05282420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094081|NCT00304031|Temozolomide|temozolomide|mesh-list
93094082|NCT00304031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094083|NCT00304031|Alkylating Agents|alkylating agents|mesh-ancestor
93094084|NCT00304031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094085|NCT00304031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094086|NCT01567124|Moxonidine|moxonidine|mesh-list
93094087|NCT01567124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93094088|NCT03617666|Avelumab|avelumab|mesh-list
93094089|NCT03617666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094090|NCT03617666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094091|NCT01299194|Atorvastatin|atorvastatin|mesh-list
93094092|NCT01299194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93094093|NCT01299194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93094094|NCT01299194|Antimetabolites|antimetabolites|mesh-ancestor
93094095|NCT01299194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094096|NCT01299194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93094097|NCT01299194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93094098|NCT01299194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094099|NCT03827408|Midazolam|midazolam|mesh-list
93094100|NCT03827408|Dexmedetomidine|dexmedetomidine|mesh-list
93094101|NCT03827408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094102|NCT03827408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094103|NCT03827408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094104|NCT03827408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094105|NCT03827408|Analgesics|analgesics|mesh-ancestor
93094106|NCT03827408|Sensory System Agents|sensory system agents|mesh-ancestor
93094107|NCT03827408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094108|NCT03827408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93094109|NCT03827408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93094110|NCT03827408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93094111|NCT03827408|Adrenergic Agents|adrenergic agents|mesh-ancestor
93094112|NCT03827408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094113|NCT03827408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094114|NCT03827408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93094115|NCT03827408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93094116|NCT03827408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93094117|NCT03827408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93094118|NCT03827408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93094119|NCT03827408|Anesthetics, General|anesthetics, general|mesh-ancestor
93094120|NCT03827408|Anesthetics|anesthetics|mesh-ancestor
93094121|NCT03827408|GABA Modulators|gaba modulators|mesh-ancestor
93094122|NCT03827408|GABA Agents|gaba agents|mesh-ancestor
93094123|NCT03556904|Docetaxel|docetaxel|mesh-list
93094124|NCT03556904|Hormones|hormones|mesh-list
93094125|NCT03556904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094126|NCT03556904|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094127|NCT03556904|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094128|NCT03556904|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094129|NCT03556904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094130|NCT03556904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094131|NCT03556904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094132|NCT00332189|Verapamil|verapamil|mesh-list
93094133|NCT00332189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93094134|NCT00332189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93094135|NCT00332189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93094136|NCT00332189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094137|NCT00332189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93094138|NCT00332189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094139|NCT00332189|Vasodilator Agents|vasodilator agents|mesh-ancestor
93094140|NCT01206998|Progesterone|progesterone|mesh-list
93094141|NCT01206998|Progestins|progestins|mesh-ancestor
93094142|NCT01206998|Hormones|hormones|mesh-ancestor
93094143|NCT01206998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094144|NCT01206998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094145|NCT00331799|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93094146|NCT00331799|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93094147|NCT00331799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93094148|NCT00331799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93094149|NCT00331799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094150|NCT00331799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094151|NCT00331799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094152|NCT00331799|Analgesics|analgesics|mesh-ancestor
93094153|NCT00331799|Sensory System Agents|sensory system agents|mesh-ancestor
93094154|NCT00331799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094155|NCT00331799|Antidepressive Agents|antidepressive agents|mesh-ancestor
93094156|NCT00331799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93094157|NCT00331799|Dopamine Agents|dopamine agents|mesh-ancestor
93094158|NCT03826940|Lovastatin|lovastatin|mesh-list
93094159|NCT03826940|L 647318|l 647318|mesh-list
93094160|NCT03826940|Dihydromevinolin|dihydromevinolin|mesh-list
93094161|NCT03826940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93094162|NCT03826940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93094163|NCT03826940|Antimetabolites|antimetabolites|mesh-ancestor
93094164|NCT03826940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094165|NCT03826940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93094166|NCT03826940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93094167|NCT03826940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094168|NCT01201694|Curcumin|curcumin|mesh-list
93094169|NCT01201694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93094170|NCT01201694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094171|NCT01201694|Analgesics|analgesics|mesh-ancestor
93094172|NCT01201694|Sensory System Agents|sensory system agents|mesh-ancestor
93094173|NCT01201694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094174|NCT01201694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094175|NCT01201694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094176|NCT01201694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094177|NCT01201694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766430|NCT01224431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93094178|NCT01201694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094179|NCT01201694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094180|NCT01201928|Insulin|insulin|mesh-list
93094181|NCT01201928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93094182|NCT01201928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094183|NCT00303719|Cyclosporine|cyclosporine|mesh-list
93094184|NCT00303719|Mycophenolic Acid|mycophenolic acid|mesh-list
93094185|NCT00303719|Cyclophosphamide|cyclophosphamide|mesh-list
93094186|NCT00303719|Fludarabine|fludarabine|mesh-list
93094187|NCT00303719|Cyclosporins|cyclosporins|mesh-list
93094188|NCT00303719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93094189|NCT00303719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094190|NCT00303719|Immunologic Factors|immunologic factors|mesh-ancestor
93094191|NCT00303719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094192|NCT00303719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094193|NCT00303719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094194|NCT00303719|Alkylating Agents|alkylating agents|mesh-ancestor
93094195|NCT00303719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094196|NCT00303719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094197|NCT00303719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93094198|NCT00303719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094199|NCT00303719|Antifungal Agents|antifungal agents|mesh-ancestor
93094200|NCT00303719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094201|NCT00303719|Dermatologic Agents|dermatologic agents|mesh-ancestor
93094202|NCT00303719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93094203|NCT00303719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93094204|NCT00303719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93094205|NCT00303719|Antitubercular Agents|antitubercular agents|mesh-ancestor
93094206|NCT00303719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93094207|NCT01207310|Nicotine|nicotine|mesh-list
93094208|NCT01207310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93094209|NCT01207310|Autonomic Agents|autonomic agents|mesh-ancestor
93094210|NCT01207310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094211|NCT01207310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094212|NCT01207310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93094213|NCT01207310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93094214|NCT01207310|Cholinergic Agents|cholinergic agents|mesh-ancestor
93094215|NCT01207310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094216|NCT01207310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094217|NCT00331409|Everolimus|everolimus|mesh-list
93094218|NCT00331409|Imatinib Mesylate|imatinib mesylate|mesh-list
93094219|NCT00331409|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93094220|NCT00331409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93094221|NCT00331409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094222|NCT00331409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094223|NCT00331409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094224|NCT00331409|Immunologic Factors|immunologic factors|mesh-ancestor
93094225|NCT00331409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094226|NCT00331409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094227|NCT01203254|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93094228|NCT01203254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93094229|NCT01203254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93094230|NCT01203254|Antimetabolites|antimetabolites|mesh-ancestor
93094231|NCT01203254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094232|NCT01203254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93094233|NCT01064921|Vorinostat|vorinostat|mesh-list
93094234|NCT01064921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094235|NCT01064921|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93094236|NCT01064921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094237|NCT01064921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094238|NCT01299662|Poly ICLC|poly iclc|mesh-list
93094239|NCT01299662|Interferon Inducers|interferon inducers|mesh-ancestor
93094240|NCT01299662|Immunologic Factors|immunologic factors|mesh-ancestor
93094241|NCT01299662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094242|NCT00303485|Vitamin D|vitamin d|mesh-list
93094243|NCT00303485|Ibandronic Acid|ibandronic acid|mesh-list
93094244|NCT00303485|Calcium|calcium|mesh-list
93094245|NCT00303485|Vitamins|vitamins|mesh-ancestor
93094246|NCT00303485|Micronutrients|micronutrients|mesh-ancestor
93094247|NCT00303485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094248|NCT00303485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93094249|NCT00303485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93094250|NCT03983915|Dexmedetomidine|dexmedetomidine|mesh-list
93094251|NCT03983915|Remifentanil|remifentanil|mesh-list
93094252|NCT03983915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094253|NCT03983915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094254|NCT03983915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094255|NCT03983915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094256|NCT03983915|Analgesics|analgesics|mesh-ancestor
93094257|NCT03983915|Sensory System Agents|sensory system agents|mesh-ancestor
93094258|NCT03983915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094259|NCT03983915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93094260|NCT03983915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93094261|NCT03983915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93094262|NCT03983915|Adrenergic Agents|adrenergic agents|mesh-ancestor
93094263|NCT03983915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094264|NCT03983915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094265|NCT03983915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93094266|NCT03983915|Narcotics|narcotics|mesh-ancestor
93094267|NCT01300754|Lidocaine|lidocaine|mesh-list
93094268|NCT01300754|Anesthetics, Local|anesthetics, local|mesh-ancestor
93094269|NCT01300754|Anesthetics|anesthetics|mesh-ancestor
93094270|NCT01300754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094271|NCT01300754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094272|NCT01300754|Sensory System Agents|sensory system agents|mesh-ancestor
93094273|NCT01300754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094274|NCT01300754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93094275|NCT01300754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93094276|NCT01300754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93094277|NCT01300754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93094278|NCT01300754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094279|NCT00303953|Belinostat|belinostat|mesh-list
93094280|NCT00303953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094281|NCT00303953|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93094282|NCT00303953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094283|NCT00303953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094284|NCT03840122|Anesthetics|anesthetics|mesh-list
93094285|NCT03840122|Anesthetics, Local|anesthetics, local|mesh-list
93094286|NCT03840122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094287|NCT03840122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094288|NCT03840122|Sensory System Agents|sensory system agents|mesh-ancestor
93094289|NCT03840122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094290|NCT03723590|Hyaluronic Acid|hyaluronic acid|mesh-list
93094291|NCT03723590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93094292|NCT03723590|Immunologic Factors|immunologic factors|mesh-ancestor
93094293|NCT03723590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094294|NCT03723590|Viscosupplements|viscosupplements|mesh-ancestor
93094295|NCT03723590|Protective Agents|protective agents|mesh-ancestor
93094296|NCT04343872|Metformin|metformin|mesh-list
93094297|NCT04343872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93094298|NCT04343872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094299|NCT01314274|Bevacizumab|bevacizumab|mesh-list
93094300|NCT01314274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094301|NCT01314274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094302|NCT01314274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684595|NCT00480675|Autonomic Agents|autonomic agents|mesh-ancestor
93094303|NCT01314274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93094304|NCT01314274|Growth Substances|growth substances|mesh-ancestor
93094305|NCT01314274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094306|NCT01314274|Growth Inhibitors|growth inhibitors|mesh-ancestor
93094307|NCT02935894|Ibuprofen|ibuprofen|mesh-list
93094308|NCT02935894|Pilocarpine|pilocarpine|mesh-list
93094309|NCT02935894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93094310|NCT02935894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094311|NCT02935894|Analgesics|analgesics|mesh-ancestor
93094312|NCT02935894|Sensory System Agents|sensory system agents|mesh-ancestor
93094313|NCT02935894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094314|NCT02935894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094315|NCT02935894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094316|NCT02935894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094317|NCT02935894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93094318|NCT02935894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094319|NCT02935894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094320|NCT02935894|Miotics|miotics|mesh-ancestor
93094321|NCT02935894|Autonomic Agents|autonomic agents|mesh-ancestor
93094322|NCT02935894|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93094323|NCT02935894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93094324|NCT02935894|Cholinergic Agents|cholinergic agents|mesh-ancestor
93094325|NCT02935894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094326|NCT03224182|Apaziquone|apaziquone|mesh-list
93094327|NCT03224182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094328|NCT03821480|Fluconazole|fluconazole|mesh-list
93094329|NCT03821480|Antifungal Agents|antifungal agents|mesh-ancestor
93094330|NCT03821480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094331|NCT03821480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93094332|NCT03821480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93094333|NCT03821480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094334|NCT03821480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094335|NCT03821480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93094336|NCT03821480|Hormone Antagonists|hormone antagonists|mesh-ancestor
93094337|NCT03821480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094338|NCT03821480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094339|NCT03821480|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93094340|NCT03821480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93094341|NCT01203488|Vitamin A|vitamin a|mesh-list
93094342|NCT01203488|Vitamins|vitamins|mesh-ancestor
93094343|NCT01203488|Micronutrients|micronutrients|mesh-ancestor
93094344|NCT01203488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094345|NCT03697720|Naproxen|naproxen|mesh-list
93094346|NCT03697720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93094347|NCT03697720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094348|NCT03697720|Analgesics|analgesics|mesh-ancestor
93094349|NCT03697720|Sensory System Agents|sensory system agents|mesh-ancestor
93094350|NCT03697720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094351|NCT03697720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094352|NCT03697720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094353|NCT03697720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094354|NCT03697720|Gout Suppressants|gout suppressants|mesh-ancestor
93094355|NCT03697720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93094356|NCT03697720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094357|NCT03697720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094358|NCT01314352|Desloratadine|desloratadine|mesh-list
93094359|NCT01314352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93094360|NCT01314352|Cholinergic Agents|cholinergic agents|mesh-ancestor
93094361|NCT01314352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094362|NCT01314352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094363|NCT01314352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094364|NCT01314352|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93094365|NCT01314352|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93094366|NCT01314352|Histamine Antagonists|histamine antagonists|mesh-ancestor
93094367|NCT01314352|Histamine Agents|histamine agents|mesh-ancestor
93094368|NCT03818282|Paclitaxel|paclitaxel|mesh-list
93094369|NCT03818282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93094370|NCT03818282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094371|NCT03818282|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094372|NCT03818282|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094373|NCT03818282|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094374|NCT03818282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094375|NCT01300364|Citalopram|citalopram|mesh-list
93094376|NCT01300364|Reboxetine|reboxetine|mesh-list
93094377|NCT01300364|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93094378|NCT01300364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93094379|NCT01300364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93094380|NCT01300364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094381|NCT01300364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094382|NCT01300364|Serotonin Agents|serotonin agents|mesh-ancestor
93094383|NCT01300364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094384|NCT01300364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93094385|NCT01300364|Antidepressive Agents|antidepressive agents|mesh-ancestor
93094386|NCT01300364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93094387|NCT01300364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93094388|NCT01300364|Adrenergic Agents|adrenergic agents|mesh-ancestor
93094389|NCT03221842|Complement C1s|complement c1s|mesh-list
93094390|NCT03221842|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93094391|NCT03221842|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
93094392|NCT03221842|Immunologic Factors|immunologic factors|mesh-ancestor
93094393|NCT03221842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094394|NCT03221842|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93094395|NCT03221842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094396|NCT05622890|Maytansine|maytansine|mesh-list
93094397|NCT05622890|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
93094398|NCT05622890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93094399|NCT05622890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094400|NCT05622890|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094401|NCT05622890|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094402|NCT05622890|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094403|NCT05622890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094404|NCT05622890|Immunoconjugates|immunoconjugates|mesh-ancestor
93094405|NCT05622890|Immunologic Factors|immunologic factors|mesh-ancestor
93094406|NCT05622890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094407|NCT00303329|Deferasirox|deferasirox|mesh-list
93094408|NCT00303329|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93094409|NCT00303329|Chelating Agents|chelating agents|mesh-ancestor
93094410|NCT00303329|Sequestering Agents|sequestering agents|mesh-ancestor
93094411|NCT00303329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094412|NCT01300988|Aprepitant|aprepitant|mesh-list
93094413|NCT01300988|Fosaprepitant|fosaprepitant|mesh-list
93094414|NCT01300988|Antiemetics|antiemetics|mesh-ancestor
93094415|NCT01300988|Autonomic Agents|autonomic agents|mesh-ancestor
93094416|NCT01300988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094417|NCT01300988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094418|NCT01300988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094419|NCT01300988|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93094420|NCT01300988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094421|NCT01300988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094422|NCT01064999|Capecitabine|capecitabine|mesh-list
93094423|NCT01064999|Oxaliplatin|oxaliplatin|mesh-list
93094424|NCT01064999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094425|NCT01064999|Antimetabolites|antimetabolites|mesh-ancestor
93094426|NCT01064999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094427|NCT01064999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094428|NCT03818048|Propofol|propofol|mesh-list
93094429|NCT03818048|Sevoflurane|sevoflurane|mesh-list
93094430|NCT03818048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094431|NCT03818048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094432|NCT03818048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094433|NCT03818048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93094434|NCT03818048|Anesthetics, General|anesthetics, general|mesh-ancestor
93094435|NCT03818048|Anesthetics|anesthetics|mesh-ancestor
93094436|NCT03818048|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93094437|NCT03818048|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93094438|NCT01301924|Meglumine Antimoniate|meglumine antimoniate|mesh-list
93094439|NCT01301924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93094440|NCT01301924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93094441|NCT01301924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094442|NCT00329849|Vaccines|vaccines|mesh-list
93094443|NCT00329849|Immunologic Factors|immunologic factors|mesh-ancestor
93094444|NCT00329849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094445|NCT05655806|Aminophylline|aminophylline|mesh-list
93094446|NCT05655806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93094447|NCT05655806|Autonomic Agents|autonomic agents|mesh-ancestor
93094448|NCT05655806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094449|NCT05655806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094450|NCT05655806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93094451|NCT05655806|Respiratory System Agents|respiratory system agents|mesh-ancestor
93094452|NCT05655806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93094453|NCT05655806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93094454|NCT05655806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094455|NCT05655806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094456|NCT05655806|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93094457|NCT05655806|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93094458|NCT05655806|Purinergic Agents|purinergic agents|mesh-ancestor
93094459|NCT05655806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094460|NCT05655806|Protective Agents|protective agents|mesh-ancestor
93094461|NCT01300676|Estradiol|estradiol|mesh-list
93094462|NCT01300676|Dydrogesterone|dydrogesterone|mesh-list
93094463|NCT01300676|Estrogens|estrogens|mesh-ancestor
93094464|NCT01300676|Hormones|hormones|mesh-ancestor
93094465|NCT01300676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094466|NCT01300676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094467|NCT01300676|Progestins|progestins|mesh-ancestor
93094468|NCT03113968|Ketamine|ketamine|mesh-list
93094469|NCT03113968|Analgesics|analgesics|mesh-ancestor
93094470|NCT03113968|Sensory System Agents|sensory system agents|mesh-ancestor
93094471|NCT03113968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094472|NCT03113968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094473|NCT03113968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93094474|NCT03113968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93094475|NCT03113968|Anesthetics, General|anesthetics, general|mesh-ancestor
93094476|NCT03113968|Anesthetics|anesthetics|mesh-ancestor
93094477|NCT03113968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094478|NCT03113968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93094479|NCT03113968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93094480|NCT03113968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094481|NCT03113968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094482|NCT00329303|Certolizumab Pegol|certolizumab pegol|mesh-list
93094483|NCT00329303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93094484|NCT00329303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094485|NCT00329303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094486|NCT00329303|Immunologic Factors|immunologic factors|mesh-ancestor
93094487|NCT00329303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094488|NCT00329303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094489|NCT03806816|Melatonin|melatonin|mesh-list
93094490|NCT03806816|Antioxidants|antioxidants|mesh-ancestor
93094491|NCT03806816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094492|NCT03806816|Protective Agents|protective agents|mesh-ancestor
93094493|NCT03806816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094494|NCT03806816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094495|NCT01301222|Octreotide|octreotide|mesh-list
93094496|NCT01301222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094497|NCT01301222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93094498|NCT01301222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094499|NCT02532569|Vaccines|vaccines|mesh-list
93094500|NCT02532569|Immunologic Factors|immunologic factors|mesh-ancestor
93094501|NCT02532569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094502|NCT01302002|Metformin|metformin|mesh-list
93094503|NCT01302002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93094504|NCT01302002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094505|NCT01303250|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93094506|NCT01303250|Plasma Substitutes|plasma substitutes|mesh-ancestor
93094507|NCT01303250|Blood Substitutes|blood substitutes|mesh-ancestor
93094508|NCT03814616|Artesunate|artesunate|mesh-list
93094509|NCT03814616|Pyronaridine|pyronaridine|mesh-list
93094510|NCT03814616|Antimalarials|antimalarials|mesh-ancestor
93094511|NCT03814616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93094512|NCT03814616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93094513|NCT03814616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094514|NCT03814616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094515|NCT03814616|Antiviral Agents|antiviral agents|mesh-ancestor
93094516|NCT03814616|Schistosomicides|schistosomicides|mesh-ancestor
93094517|NCT03814616|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93094518|NCT03814616|Anthelmintics|anthelmintics|mesh-ancestor
93094519|NCT00302159|Temozolomide|temozolomide|mesh-list
93094520|NCT00302159|Valproic Acid|valproic acid|mesh-list
93094521|NCT00302159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094522|NCT00302159|Alkylating Agents|alkylating agents|mesh-ancestor
93094523|NCT00302159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094524|NCT00302159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094525|NCT00302159|Anticonvulsants|anticonvulsants|mesh-ancestor
93094526|NCT00302159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094527|NCT00302159|GABA Agents|gaba agents|mesh-ancestor
93094528|NCT00302159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094529|NCT00302159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094530|NCT00302159|Antimanic Agents|antimanic agents|mesh-ancestor
93094531|NCT00302159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93094532|NCT00302159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094533|NCT00302159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93094534|NCT03814226|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
93094535|NCT03814226|Growth Substances|growth substances|mesh-ancestor
93094536|NCT03814226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094537|NCT03814226|Vasodilator Agents|vasodilator agents|mesh-ancestor
93094538|NCT03814226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094539|NCT03814226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094540|NCT00302081|Ribavirin|ribavirin|mesh-list
93094541|NCT00302081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93094542|NCT00302081|Interferon-alpha|interferon-alpha|mesh-list
93094543|NCT00302081|Antimetabolites|antimetabolites|mesh-ancestor
93094544|NCT00302081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094545|NCT00302081|Antiviral Agents|antiviral agents|mesh-ancestor
93094546|NCT00302081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094547|NCT00302081|Immunologic Factors|immunologic factors|mesh-ancestor
93094548|NCT00302081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094549|NCT00302003|Cytarabine|cytarabine|mesh-list
93094550|NCT00302003|Dexamethasone|dexamethasone|mesh-list
93094551|NCT00302003|Prednisone|prednisone|mesh-list
93094552|NCT00302003|Cyclophosphamide|cyclophosphamide|mesh-list
93094553|NCT00302003|Ifosfamide|ifosfamide|mesh-list
93094554|NCT00302003|Doxorubicin|doxorubicin|mesh-list
93094555|NCT00302003|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93094556|NCT00302003|Etoposide|etoposide|mesh-list
93094557|NCT00302003|Vincristine|vincristine|mesh-list
93094558|NCT00302003|Vinorelbine|vinorelbine|mesh-list
93094559|NCT00302003|Etoposide phosphate|etoposide phosphate|mesh-list
93094560|NCT00302003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094561|NCT00302003|Immunologic Factors|immunologic factors|mesh-ancestor
93094562|NCT00302003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094563|NCT00302003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094564|NCT00302003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094565|NCT00302003|Alkylating Agents|alkylating agents|mesh-ancestor
93094566|NCT00302003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094567|NCT00302003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094568|NCT00302003|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93094569|NCT00302003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094570|NCT00302003|Antiemetics|antiemetics|mesh-ancestor
93094571|NCT00302003|Autonomic Agents|autonomic agents|mesh-ancestor
93094572|NCT00302003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094573|NCT00302003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094574|NCT00302003|Glucocorticoids|glucocorticoids|mesh-ancestor
93094575|NCT00302003|Hormones|hormones|mesh-ancestor
93094576|NCT00302003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094577|NCT00302003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93094578|NCT00302003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92684865|NCT00458510|Narcotics|narcotics|mesh-ancestor
93094579|NCT00302003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93094580|NCT00302003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93094581|NCT00302003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094582|NCT00302003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93094583|NCT00302003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094584|NCT00302003|Antimetabolites|antimetabolites|mesh-ancestor
93094585|NCT00302003|Antiviral Agents|antiviral agents|mesh-ancestor
93094586|NCT00302003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094587|NCT00302003|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094588|NCT00302003|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094589|NCT00302003|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094590|NCT00036270|Tamoxifen|tamoxifen|mesh-list
93094591|NCT00036270|Exemestane|exemestane|mesh-list
93094592|NCT00036270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93094593|NCT00036270|Hormone Antagonists|hormone antagonists|mesh-ancestor
93094594|NCT00036270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094595|NCT00036270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094596|NCT00036270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93094597|NCT00036270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094598|NCT00036270|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93094599|NCT00036270|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93094600|NCT00036270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93094601|NCT00036270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93094602|NCT00036270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93094603|NCT00036270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094604|NCT00036270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094605|NCT01097382|Zolpidem|zolpidem|mesh-list
93094606|NCT01097382|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93094607|NCT01097382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094608|NCT01097382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094609|NCT01097382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094610|NCT01097382|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93094611|NCT01097382|GABA Agonists|gaba agonists|mesh-ancestor
93094612|NCT01097382|GABA Agents|gaba agents|mesh-ancestor
93094613|NCT01097382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094614|NCT01097382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094615|NCT00301067|Calcitriol|calcitriol|mesh-list
93094616|NCT00301067|Temozolomide|temozolomide|mesh-list
93094617|NCT00301067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094618|NCT00301067|Alkylating Agents|alkylating agents|mesh-ancestor
93094619|NCT00301067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094620|NCT00301067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094621|NCT00301067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93094622|NCT00301067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094623|NCT00301067|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93094624|NCT00301067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93094625|NCT00301067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93094626|NCT00301067|Vitamins|vitamins|mesh-ancestor
92766892|NCT03820531|Pancrelipase|pancrelipase|mesh-list
93094628|NCT00301067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93094629|NCT03979859|Nafithromycin|nafithromycin|mesh-list
93094630|NCT03979859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93094631|NCT03979859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094632|NCT03979859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93094633|NCT03979859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094634|NCT03979859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094635|NCT03955458|Bupivacaine|bupivacaine|mesh-list
93094636|NCT03955458|Ropivacaine|ropivacaine|mesh-list
93094637|NCT03955458|Anesthetics, Local|anesthetics, local|mesh-ancestor
93094638|NCT03955458|Anesthetics|anesthetics|mesh-ancestor
93094639|NCT03955458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094640|NCT03955458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094641|NCT03955458|Sensory System Agents|sensory system agents|mesh-ancestor
93094642|NCT03955458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094643|NCT00007020|Cholic Acids|cholic acids|mesh-list
93094644|NCT00007020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094645|NCT00300755|Pantoprazole|pantoprazole|mesh-list
93094646|NCT00300755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93094647|NCT00300755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094648|NCT00300755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93094649|NCT00300755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094650|NCT00300755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094651|NCT00033540|Gemcitabine|gemcitabine|mesh-list
93094652|NCT00033540|Capecitabine|capecitabine|mesh-list
93094653|NCT00033540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094654|NCT00033540|Antimetabolites|antimetabolites|mesh-ancestor
93094655|NCT00033540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094656|NCT00033540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094657|NCT00300365|Aspirin|aspirin|mesh-list
93094658|NCT00300365|Niacin|niacin|mesh-list
93094659|NCT00300365|Pioglitazone|pioglitazone|mesh-list
93094660|NCT00300365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93094661|NCT00300365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094662|NCT00300365|Analgesics|analgesics|mesh-ancestor
93094663|NCT00300365|Sensory System Agents|sensory system agents|mesh-ancestor
93094664|NCT00300365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094665|NCT00300365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094666|NCT00300365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094667|NCT00300365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094668|NCT00300365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93094669|NCT00300365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93094670|NCT00300365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094671|NCT00300365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93094672|NCT00300365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93094673|NCT00300365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094674|NCT00300365|Antipyretics|antipyretics|mesh-ancestor
93094675|NCT00300365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93094676|NCT00300365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93094677|NCT00300365|Antimetabolites|antimetabolites|mesh-ancestor
93094678|NCT00300365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93094679|NCT00300365|Vasodilator Agents|vasodilator agents|mesh-ancestor
93094680|NCT00300365|Vitamin B Complex|vitamin b complex|mesh-ancestor
93094681|NCT00300365|Vitamins|vitamins|mesh-ancestor
93094682|NCT00300365|Micronutrients|micronutrients|mesh-ancestor
93094683|NCT03980015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93094684|NCT03980015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094685|NCT00048048|Epoetin Alfa|epoetin alfa|mesh-list
93094686|NCT00048048|Hematinics|hematinics|mesh-ancestor
93094687|NCT03953118|Azithromycin|azithromycin|mesh-list
93094688|NCT03953118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93094689|NCT03953118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094690|NCT01101204|Metformin|metformin|mesh-list
93094691|NCT01101204|Simvastatin|simvastatin|mesh-list
93094692|NCT01101204|Fenofibrate|fenofibrate|mesh-list
93094693|NCT01101204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93094694|NCT01101204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094695|NCT01101204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93094696|NCT01101204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93094697|NCT01101204|Antimetabolites|antimetabolites|mesh-ancestor
93094698|NCT01101204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094699|NCT01101204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93094700|NCT01101204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93094701|NCT01101204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094702|NCT01095822|Valsartan|valsartan|mesh-list
93094703|NCT01095822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93094704|NCT01095822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93094705|NCT01095822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93094706|NCT01095822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094707|NCT01095900|Botulinum Toxins|botulinum toxins|mesh-list
93094708|NCT01095900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93094709|NCT01095900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93094710|NCT01095900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094711|NCT01095900|Cholinergic Agents|cholinergic agents|mesh-ancestor
93094712|NCT01095900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094713|NCT01095900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094714|NCT00300053|Lenograstim|lenograstim|mesh-list
93094715|NCT00300053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93094716|NCT00300053|Immunologic Factors|immunologic factors|mesh-ancestor
93094717|NCT00300053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094718|NCT01098084|Decitabine|decitabine|mesh-list
93094719|NCT01098084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094720|NCT01098084|Antimetabolites|antimetabolites|mesh-ancestor
93094721|NCT01098084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094722|NCT01098084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094723|NCT01098084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094724|NCT03952572|Prednisone|prednisone|mesh-list
93094725|NCT03952572|Cyclophosphamide|cyclophosphamide|mesh-list
93094726|NCT03952572|Doxorubicin|doxorubicin|mesh-list
93094727|NCT03952572|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93094728|NCT03952572|Vincristine|vincristine|mesh-list
93094729|NCT03952572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094730|NCT03952572|Immunologic Factors|immunologic factors|mesh-ancestor
93094731|NCT03952572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094732|NCT03952572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094733|NCT03952572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094734|NCT03952572|Alkylating Agents|alkylating agents|mesh-ancestor
93094735|NCT03952572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094736|NCT03952572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094737|NCT03952572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93094738|NCT03952572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93094739|NCT03952572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93094740|NCT03952572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93094741|NCT03952572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094742|NCT03952572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094743|NCT03952572|Glucocorticoids|glucocorticoids|mesh-ancestor
93094744|NCT03952572|Hormones|hormones|mesh-ancestor
93094745|NCT03952572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094746|NCT03952572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93094747|NCT03952572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93094748|NCT03952572|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094749|NCT03952572|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094750|NCT03952572|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094751|NCT03954756|Apatinib|apatinib|mesh-list
93094752|NCT03954756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094753|NCT03954756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93094754|NCT03954756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094755|NCT03954756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094756|NCT00326963|Enfuvirtide|enfuvirtide|mesh-list
93094757|NCT00326963|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93094758|NCT00326963|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93094759|NCT00326963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094760|NCT00326963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93094761|NCT00326963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93094762|NCT00326963|Antiviral Agents|antiviral agents|mesh-ancestor
93094763|NCT00326963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094764|NCT00326885|Catumaxomab|catumaxomab|mesh-list
93094765|NCT00326885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094766|NCT00326495|Cetuximab|cetuximab|mesh-list
93094767|NCT00326495|Sorafenib|sorafenib|mesh-list
93094768|NCT00326495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094769|NCT00326495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094770|NCT00326495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93094771|NCT00326495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094772|NCT00326495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094773|NCT00326417|Cyclophosphamide|cyclophosphamide|mesh-list
93094774|NCT00326417|Fludarabine|fludarabine|mesh-list
93094775|NCT00326417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094776|NCT00326417|Immunologic Factors|immunologic factors|mesh-ancestor
93094777|NCT00326417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094778|NCT00326417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094779|NCT00326417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094780|NCT00326417|Alkylating Agents|alkylating agents|mesh-ancestor
93094781|NCT00326417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094782|NCT00326417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094783|NCT00326417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93094784|NCT01060787|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93094785|NCT01060787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93094786|NCT01060787|Glucocorticoids|glucocorticoids|mesh-ancestor
93094788|NCT01060787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094789|NCT01060787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094790|NCT01065467|Panobinostat|panobinostat|mesh-list
93094791|NCT01065467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094792|NCT01065467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93094793|NCT01065467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094794|NCT01065467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094795|NCT01065545|Clofarabine|clofarabine|mesh-list
93094796|NCT01065545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094797|NCT01065545|Antimetabolites|antimetabolites|mesh-ancestor
93094798|NCT01065545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094799|NCT01065545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094800|NCT03979469|Fentanyl|fentanyl|mesh-list
93094801|NCT03979469|Dexmedetomidine|dexmedetomidine|mesh-list
93094802|NCT03979469|Ketamine|ketamine|mesh-list
93094803|NCT03979469|Remifentanil|remifentanil|mesh-list
93094804|NCT03979469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094805|NCT03979469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094806|NCT03979469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094807|NCT03979469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094808|NCT03979469|Analgesics|analgesics|mesh-ancestor
93094809|NCT03979469|Sensory System Agents|sensory system agents|mesh-ancestor
93094810|NCT03979469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094811|NCT03979469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93094812|NCT03979469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93094813|NCT03979469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93094814|NCT03979469|Adrenergic Agents|adrenergic agents|mesh-ancestor
93094815|NCT03979469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094816|NCT03979469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094817|NCT03979469|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93094818|NCT03979469|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93094819|NCT03979469|Anesthetics, General|anesthetics, general|mesh-ancestor
93094820|NCT03979469|Anesthetics|anesthetics|mesh-ancestor
93094821|NCT03979469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93094822|NCT03979469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93094823|NCT03979469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93094824|NCT03979469|Narcotics|narcotics|mesh-ancestor
93094825|NCT03979469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93094826|NCT01065701|Dexmedetomidine|dexmedetomidine|mesh-list
93094827|NCT01065701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094828|NCT01065701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094829|NCT01065701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094830|NCT01065701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094831|NCT01065701|Analgesics|analgesics|mesh-ancestor
93094832|NCT01065701|Sensory System Agents|sensory system agents|mesh-ancestor
93094833|NCT01065701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094834|NCT01065701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93094835|NCT01065701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93094836|NCT01065701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93094837|NCT01065701|Adrenergic Agents|adrenergic agents|mesh-ancestor
93094838|NCT01065701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094839|NCT01065701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094840|NCT03825341|Hydroxyurea|hydroxyurea|mesh-list
93094841|NCT03825341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094842|NCT03825341|Antisickling Agents|antisickling agents|mesh-ancestor
93094843|NCT03825341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094844|NCT03825341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094845|NCT03825341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93094846|NCT01065857|Picosulfate sodium|picosulfate sodium|mesh-list
93094847|NCT01065857|Sodium sulfate|sodium sulfate|mesh-list
93094848|NCT01065857|Magnesium Oxide|magnesium oxide|mesh-list
93094849|NCT01065857|Citric Acid|citric acid|mesh-list
93094850|NCT01065857|Sodium Citrate|sodium citrate|mesh-list
93094851|NCT01065857|Cathartics|cathartics|mesh-ancestor
93094852|NCT01065857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094853|NCT01065857|Anticoagulants|anticoagulants|mesh-ancestor
93094854|NCT01065857|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93094855|NCT01065857|Chelating Agents|chelating agents|mesh-ancestor
93094856|NCT01065857|Sequestering Agents|sequestering agents|mesh-ancestor
93094857|NCT01065857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094858|NCT01065857|Antacids|antacids|mesh-ancestor
93094859|NCT00297479|Nicotine|nicotine|mesh-list
93094860|NCT00297479|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93094861|NCT00297479|Autonomic Agents|autonomic agents|mesh-ancestor
93094862|NCT00297479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094863|NCT00297479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094864|NCT00297479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93094865|NCT00297479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93094866|NCT00297479|Cholinergic Agents|cholinergic agents|mesh-ancestor
93094867|NCT00297479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094868|NCT00297479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094869|NCT00688870|Vaccines|vaccines|mesh-list
93094870|NCT00688870|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93094871|NCT00688870|Immunologic Factors|immunologic factors|mesh-ancestor
93094872|NCT00688870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094873|NCT02532335|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
93094874|NCT02532335|Cathartics|cathartics|mesh-ancestor
93094875|NCT02532335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094876|NCT03216226|Glucagon|glucagon|mesh-list
93094877|NCT03216226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93094878|NCT03216226|Hormones|hormones|mesh-ancestor
93094879|NCT03216226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094880|NCT03216226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094881|NCT00290771|Imatinib Mesylate|imatinib mesylate|mesh-list
93094882|NCT00290771|Hydroxyurea|hydroxyurea|mesh-list
93094883|NCT00290771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094884|NCT00290771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93094885|NCT00290771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094886|NCT00290771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094887|NCT00290771|Antisickling Agents|antisickling agents|mesh-ancestor
93094888|NCT00290771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93094889|NCT00290693|Docetaxel|docetaxel|mesh-list
93094890|NCT00290693|Capecitabine|capecitabine|mesh-list
93094891|NCT00290693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094892|NCT00290693|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094893|NCT00290693|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094894|NCT00290693|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094895|NCT00290693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094896|NCT00290693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93094897|NCT00290693|Antimetabolites|antimetabolites|mesh-ancestor
93094898|NCT00274469|Fulvestrant|fulvestrant|mesh-list
93094899|NCT00274469|Anastrozole|anastrozole|mesh-list
93094900|NCT00274469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93094901|NCT00274469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094902|NCT00274469|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93094903|NCT00274469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93094904|NCT00274469|Hormone Antagonists|hormone antagonists|mesh-ancestor
93094905|NCT00274469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93094906|NCT00274469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094907|NCT00274469|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93094908|NCT00274469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93094909|NCT00274469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094910|NCT00274469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094911|NCT01556776|Lenalidomide|lenalidomide|mesh-list
93094912|NCT01556776|Immunologic Factors|immunologic factors|mesh-ancestor
93094913|NCT01556776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094914|NCT01556776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93094915|NCT01556776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93094916|NCT01556776|Growth Substances|growth substances|mesh-ancestor
93094917|NCT01556776|Growth Inhibitors|growth inhibitors|mesh-ancestor
93094918|NCT01556776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094919|NCT05180422|Sotorasib|sotorasib|mesh-list
93094920|NCT05180422|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93094921|NCT05180422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094922|NCT05180422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094923|NCT05180422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094924|NCT02422498|Cisplatin|cisplatin|mesh-list
93094925|NCT02422498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094926|NCT01314976|Metronidazole|metronidazole|mesh-list
93094927|NCT01314976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094928|NCT01314976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93094929|NCT01314976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93094930|NCT01314976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93094931|NCT02379520|Cyclophosphamide|cyclophosphamide|mesh-list
93094932|NCT02379520|Nivolumab|nivolumab|mesh-list
93094933|NCT02379520|Fludarabine|fludarabine|mesh-list
93094934|NCT02379520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93094935|NCT02379520|Immunologic Factors|immunologic factors|mesh-ancestor
93094936|NCT02379520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094937|NCT02379520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93094938|NCT02379520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93094939|NCT02379520|Alkylating Agents|alkylating agents|mesh-ancestor
93094940|NCT02379520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094941|NCT02379520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094942|NCT02379520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93094943|NCT02379520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094944|NCT02379520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93094945|NCT01973452|Dexmedetomidine|dexmedetomidine|mesh-list
93094946|NCT01973452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93094947|NCT01973452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93094948|NCT01973452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094949|NCT01973452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93094950|NCT01973452|Analgesics|analgesics|mesh-ancestor
93094951|NCT01973452|Sensory System Agents|sensory system agents|mesh-ancestor
93094952|NCT01973452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93094953|NCT01973452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93094954|NCT01973452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93094955|NCT01973452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93094956|NCT01973452|Adrenergic Agents|adrenergic agents|mesh-ancestor
93094957|NCT01973452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93094958|NCT01973452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094959|NCT04504942|Leronlimab|leronlimab|mesh-list
93094960|NCT04504942|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93094961|NCT04504942|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93094962|NCT04504942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094963|NCT04504942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93094964|NCT04504942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93094965|NCT04504942|Antiviral Agents|antiviral agents|mesh-ancestor
93094966|NCT04504942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93094967|NCT01882816|Doxorubicin|doxorubicin|mesh-list
93094968|NCT01882816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93094969|NCT01882816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094970|NCT01882816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93094971|NCT01882816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93094972|NCT01882816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094973|NCT01882816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094974|NCT00272987|Paclitaxel|paclitaxel|mesh-list
93094975|NCT00272987|Trastuzumab|trastuzumab|mesh-list
93094976|NCT00272987|Lapatinib|lapatinib|mesh-list
93094977|NCT00272987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93094978|NCT00272987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094979|NCT00272987|Tubulin Modulators|tubulin modulators|mesh-ancestor
93094980|NCT00272987|Antimitotic Agents|antimitotic agents|mesh-ancestor
93094981|NCT00272987|Mitosis Modulators|mitosis modulators|mesh-ancestor
93094982|NCT00272987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094983|NCT00272987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93094984|NCT00272987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93094985|NCT00272987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094986|NCT01069757|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93094987|NCT01069757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93094988|NCT01069757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93094989|NCT01069757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094990|NCT01069757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094991|NCT01070927|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93094992|NCT01070927|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93094993|NCT01070927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93094994|NCT01070927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93094995|NCT03976271|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93094996|NCT03976271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93094997|NCT01069913|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92767267|NCT05379478|Antibodies|antibodies|mesh-list
93094998|NCT01069913|Dermatologic Agents|dermatologic agents|mesh-ancestor
93094999|NCT01069913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095000|NCT01069913|Immunologic Factors|immunologic factors|mesh-ancestor
93095001|NCT01069913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095002|NCT01730950|Bevacizumab|bevacizumab|mesh-list
93095003|NCT01730950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93095004|NCT01730950|Antibodies|antibodies|mesh-list
93095005|NCT01730950|Immunoglobulins|immunoglobulins|mesh-list
93095006|NCT01730950|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93095007|NCT01730950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095008|NCT01730950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095009|NCT01730950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095010|NCT01730950|Growth Substances|growth substances|mesh-ancestor
93095011|NCT01730950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095012|NCT01730950|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095013|NCT01730950|Immunologic Factors|immunologic factors|mesh-ancestor
93095014|NCT00271505|Bevacizumab|bevacizumab|mesh-list
93095015|NCT00271505|Carboplatin|carboplatin|mesh-list
93095016|NCT00271505|Docetaxel|docetaxel|mesh-list
93095017|NCT00271505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095018|NCT00271505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095019|NCT00271505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095020|NCT00271505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095021|NCT00271505|Growth Substances|growth substances|mesh-ancestor
93095022|NCT00271505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095023|NCT00271505|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095024|NCT00271505|Tubulin Modulators|tubulin modulators|mesh-ancestor
93095025|NCT00271505|Antimitotic Agents|antimitotic agents|mesh-ancestor
93095026|NCT00271505|Mitosis Modulators|mitosis modulators|mesh-ancestor
93095027|NCT00271505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095028|NCT01642186|Everolimus|everolimus|mesh-list
93095029|NCT01642186|Letrozole|letrozole|mesh-list
93095030|NCT01642186|Leuprolide|leuprolide|mesh-list
93095031|NCT01642186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93095032|NCT01642186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095033|NCT01642186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095034|NCT01642186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095035|NCT01642186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095036|NCT01642186|Immunologic Factors|immunologic factors|mesh-ancestor
93095037|NCT01642186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095038|NCT01642186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095039|NCT01642186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93095040|NCT01642186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93095041|NCT01642186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93095042|NCT01642186|Hormone Antagonists|hormone antagonists|mesh-ancestor
93095043|NCT01642186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095044|NCT01642186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93095045|NCT01642186|Fertility Agents|fertility agents|mesh-ancestor
93095046|NCT01642186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93095047|NCT01642186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93095048|NCT00423514|Mycophenolic Acid|mycophenolic acid|mesh-list
93095049|NCT00423514|Melphalan|melphalan|mesh-list
93095050|NCT00423514|Thiotepa|thiotepa|mesh-list
93095051|NCT00423514|Clofarabine|clofarabine|mesh-list
93095052|NCT00423514|Tacrolimus|tacrolimus|mesh-list
93095053|NCT00423514|Immunologic Factors|immunologic factors|mesh-ancestor
93095054|NCT00423514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095055|NCT00423514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095056|NCT00423514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93095057|NCT00423514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095058|NCT00423514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095059|NCT00423514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93095060|NCT00423514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095061|NCT00423514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93095062|NCT00423514|Antitubercular Agents|antitubercular agents|mesh-ancestor
93095063|NCT00423514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93095064|NCT00423514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095065|NCT00423514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93095066|NCT00423514|Alkylating Agents|alkylating agents|mesh-ancestor
93095067|NCT00423514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93095068|NCT00423514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095069|NCT00423514|Antimetabolites|antimetabolites|mesh-ancestor
93095070|NCT00120952|Cobalt|cobalt|mesh-list
93095071|NCT00120952|Chromium|chromium|mesh-list
93095072|NCT00120952|Trace Elements|trace elements|mesh-ancestor
93095073|NCT00120952|Micronutrients|micronutrients|mesh-ancestor
93095074|NCT00120952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095075|NCT00289991|Itraconazole|itraconazole|mesh-list
93095076|NCT00289991|Voriconazole|voriconazole|mesh-list
93095077|NCT00289991|Antifungal Agents|antifungal agents|mesh-ancestor
93095078|NCT00289991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095079|NCT00289991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93095080|NCT00289991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93095081|NCT00289991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095082|NCT00289991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095083|NCT00289991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93095084|NCT00289991|Hormone Antagonists|hormone antagonists|mesh-ancestor
93095085|NCT00289991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095086|NCT00289991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095087|NCT00289991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93095089|NCT00270413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095090|NCT00270413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095091|NCT00270413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095092|NCT00270413|Growth Substances|growth substances|mesh-ancestor
93095093|NCT00270413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095094|NCT00270413|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095095|NCT00270413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095096|NCT00270413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095097|NCT00270413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095098|NCT00270257|Buprenorphine|buprenorphine|mesh-list
93095099|NCT00270257|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93095100|NCT00270257|Naloxone|naloxone|mesh-list
92685384|NCT00591916|Hyaluronic Acid|hyaluronic acid|mesh-list
93095101|NCT00270257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93095102|NCT00270257|Narcotics|narcotics|mesh-ancestor
93095103|NCT00270257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095104|NCT00270257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095105|NCT00270257|Analgesics|analgesics|mesh-ancestor
93095106|NCT00270257|Sensory System Agents|sensory system agents|mesh-ancestor
93095107|NCT00270257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095108|NCT00270257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93095109|NCT00269399|Vancomycin|vancomycin|mesh-list
93095110|NCT00269399|Rifaximin|rifaximin|mesh-list
93095111|NCT00269399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93095112|NCT00269399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095113|NCT00269399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095114|NCT00269087|Fluticasone|fluticasone|mesh-list
93095115|NCT00269087|Xhance|xhance|mesh-list
93095116|NCT00269087|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93095117|NCT00269087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095118|NCT00269087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93095119|NCT00269087|Autonomic Agents|autonomic agents|mesh-ancestor
93095120|NCT00269087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095121|NCT00269087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095122|NCT00269087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93095123|NCT00269087|Respiratory System Agents|respiratory system agents|mesh-ancestor
93095124|NCT00269087|Dermatologic Agents|dermatologic agents|mesh-ancestor
93095125|NCT00269087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93095126|NCT00269087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93095127|NCT00269087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93095128|NCT00269087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93095129|NCT00269087|Adrenergic Agents|adrenergic agents|mesh-ancestor
93095130|NCT00269087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095131|NCT00269087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095132|NCT00288587|Diuretics|diuretics|mesh-list
93095133|NCT00288587|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
93095134|NCT00288587|Natriuretic Agents|natriuretic agents|mesh-ancestor
93095135|NCT00288587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095136|NCT00288587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095137|NCT00288587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095138|NCT00268463|Capecitabine|capecitabine|mesh-list
93095139|NCT00268463|Floxuridine|floxuridine|mesh-list
93095140|NCT00268463|Oxaliplatin|oxaliplatin|mesh-list
93095141|NCT00268463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095142|NCT00268463|Antimetabolites|antimetabolites|mesh-ancestor
93095143|NCT00268463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095144|NCT00268463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095145|NCT00288509|Botulinum Toxins|botulinum toxins|mesh-list
93095146|NCT00288509|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93095147|NCT00288509|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93095148|NCT00288509|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93095149|NCT00288509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095150|NCT00288509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095151|NCT00288509|Cholinergic Agents|cholinergic agents|mesh-ancestor
93095152|NCT00288509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095153|NCT00288509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095154|NCT00288509|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93095155|NCT00288509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095156|NCT01071005|Leuprolide|leuprolide|mesh-list
93095157|NCT01071005|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93095158|NCT01071005|Fertility Agents|fertility agents|mesh-ancestor
93095159|NCT01071005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93095160|NCT01071005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095161|NCT01071005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93095162|NCT01071005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095163|NCT03976037|Misoprostol|misoprostol|mesh-list
93095164|NCT03976037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93095165|NCT03976037|Abortifacient Agents|abortifacient agents|mesh-ancestor
93095166|NCT03976037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93095167|NCT03976037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095168|NCT03976037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93095169|NCT03976037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095170|NCT03976037|Oxytocics|oxytocics|mesh-ancestor
93095171|NCT00265889|Cyclophosphamide|cyclophosphamide|mesh-list
93095172|NCT00265889|Melphalan|melphalan|mesh-list
93095173|NCT00265889|Busulfan|busulfan|mesh-list
93095174|NCT00265889|Etoposide|etoposide|mesh-list
93095175|NCT00265889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095176|NCT00265889|Immunologic Factors|immunologic factors|mesh-ancestor
93095177|NCT00265889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095178|NCT00265889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095179|NCT00265889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93095180|NCT00265889|Alkylating Agents|alkylating agents|mesh-ancestor
93095181|NCT00265889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095182|NCT00265889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095183|NCT00265889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93095184|NCT00265889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93095185|NCT00265889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93095186|NCT00265889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93095187|NCT00265889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095188|NCT02795182|Tislelizumab|tislelizumab|mesh-list
93095189|NCT02795182|Zanubrutinib|zanubrutinib|mesh-list
93095190|NCT02795182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095191|NCT02795182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095192|NCT02795182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095193|NCT02795182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095194|NCT02795182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095195|NCT01333696|Pemetrexed|pemetrexed|mesh-list
93095196|NCT01333696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095197|NCT01333696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095198|NCT01333696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095199|NCT01333696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93095200|NCT01333696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93095201|NCT01333774|Acarbose|acarbose|mesh-list
93095202|NCT01333774|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93095203|NCT01333774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095204|NCT01333774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095205|NCT01333774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095206|NCT01333774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095207|NCT01333852|Metformin|metformin|mesh-list
93095208|NCT01333852|Paclitaxel|paclitaxel|mesh-list
93095209|NCT01333852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93095210|NCT01333852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095211|NCT01333852|Tubulin Modulators|tubulin modulators|mesh-ancestor
93095212|NCT01333852|Antimitotic Agents|antimitotic agents|mesh-ancestor
93095213|NCT01333852|Mitosis Modulators|mitosis modulators|mesh-ancestor
93095214|NCT01333852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095215|NCT01333852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095216|NCT01333852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095217|NCT03365362|Varenicline|varenicline|mesh-list
93095218|NCT03365362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93095219|NCT03365362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93095220|NCT03365362|Cholinergic Agents|cholinergic agents|mesh-ancestor
92767494|NCT00613093|Temozolomide|temozolomide|mesh-list
93095221|NCT03365362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095222|NCT03365362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095223|NCT03365362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095225|NCT03206788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93095226|NCT03206788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095227|NCT03206788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93095228|NCT03206788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93095229|NCT03206788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095230|NCT03205150|Licogliflozin|licogliflozin|mesh-list
93095231|NCT03205150|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93095232|NCT03205150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095233|NCT03205150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095234|NCT03205150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095235|NCT04936984|Abaloparatide|abaloparatide|mesh-list
93095236|NCT04936984|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
93095237|NCT04936984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93095238|NCT04936984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095239|NCT04936984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095240|NCT02931838|Deucravacitinib|deucravacitinib|mesh-list
93095241|NCT02931838|Dermatologic Agents|dermatologic agents|mesh-ancestor
93095242|NCT02931838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095243|NCT02931838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095244|NCT02931838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095245|NCT03201562|Tropicamide|tropicamide|mesh-list
93095246|NCT03201562|Aceclidine|aceclidine|mesh-list
93095247|NCT03201562|Mydriatics|mydriatics|mesh-ancestor
93095248|NCT03201562|Autonomic Agents|autonomic agents|mesh-ancestor
93095249|NCT03201562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095250|NCT03201562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095251|NCT03201562|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93095252|NCT03201562|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93095253|NCT03201562|Cholinergic Agents|cholinergic agents|mesh-ancestor
93095254|NCT03201562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095255|NCT03201562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095256|NCT03201562|Miotics|miotics|mesh-ancestor
93095257|NCT03201562|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93095258|NCT03200860|Empagliflozin|empagliflozin|mesh-list
93095259|NCT03200860|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93095260|NCT03200860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095261|NCT03200860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095262|NCT03200860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095263|NCT01314508|Mecasermin|mecasermin|mesh-list
93095264|NCT01314508|Growth Substances|growth substances|mesh-ancestor
93095265|NCT01314508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095266|NCT03268954|Azacitidine|azacitidine|mesh-list
93095267|NCT03268954|Pevonedistat|pevonedistat|mesh-list
93095268|NCT03268954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095269|NCT03268954|Antimetabolites|antimetabolites|mesh-ancestor
93095270|NCT03268954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095271|NCT03268954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095272|NCT03268954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095273|NCT01314586|Secoisolariciresinol|secoisolariciresinol|mesh-list
93095274|NCT01314586|Phytoestrogens|phytoestrogens|mesh-ancestor
93095275|NCT01314586|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93095276|NCT01314586|Estrogens|estrogens|mesh-ancestor
93095277|NCT01314586|Hormones|hormones|mesh-ancestor
93095278|NCT01314586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095279|NCT01314586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095280|NCT03187756|Cyclophosphamide|cyclophosphamide|mesh-list
93095281|NCT03187756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095282|NCT03187756|Immunologic Factors|immunologic factors|mesh-ancestor
93095283|NCT03187756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095284|NCT03187756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095285|NCT03187756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93095286|NCT03187756|Alkylating Agents|alkylating agents|mesh-ancestor
93095287|NCT03187756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095288|NCT03187756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095289|NCT03187756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93095290|NCT03184558|Pembrolizumab|pembrolizumab|mesh-list
93095291|NCT03184558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095292|NCT03184558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095293|NCT03184558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93095294|NCT03184558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095295|NCT03180736|Dexamethasone|dexamethasone|mesh-list
93095296|NCT03180736|Daratumumab|daratumumab|mesh-list
93095297|NCT03180736|Pomalidomide|pomalidomide|mesh-list
93095298|NCT03180736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095299|NCT03180736|Antiemetics|antiemetics|mesh-ancestor
93095300|NCT03180736|Autonomic Agents|autonomic agents|mesh-ancestor
93095301|NCT03180736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095302|NCT03180736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095303|NCT03180736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095304|NCT03180736|Glucocorticoids|glucocorticoids|mesh-ancestor
93095305|NCT03180736|Hormones|hormones|mesh-ancestor
93095306|NCT03180736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095307|NCT03180736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93095308|NCT03180736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095309|NCT03180736|Immunologic Factors|immunologic factors|mesh-ancestor
93095310|NCT03180736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095311|NCT03180736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095312|NCT03180736|Growth Substances|growth substances|mesh-ancestor
93095313|NCT03180736|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095314|NCT03178942|Permethrin|permethrin|mesh-list
93095315|NCT03178942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095316|NCT03178942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095317|NCT03093922|Gemcitabine|gemcitabine|mesh-list
93095318|NCT03093922|Atezolizumab|atezolizumab|mesh-list
93095319|NCT03093922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095320|NCT03093922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095321|NCT03093922|Antimetabolites|antimetabolites|mesh-ancestor
93095322|NCT03093922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095323|NCT03093922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93095324|NCT03093922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095325|NCT03175198|Dabigatran|dabigatran|mesh-list
93095326|NCT03175198|Antithrombins|antithrombins|mesh-ancestor
93095327|NCT03175198|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93095328|NCT03175198|Protease Inhibitors|protease inhibitors|mesh-ancestor
93095329|NCT03175198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095330|NCT03175198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095331|NCT03175198|Anticoagulants|anticoagulants|mesh-ancestor
93095332|NCT03087448|Trametinib|trametinib|mesh-list
93095333|NCT03087448|Ceritinib|ceritinib|mesh-list
93095334|NCT03087448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095335|NCT03087448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095336|NCT03087448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095337|NCT03087448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095338|NCT03175120|Insulin|insulin|mesh-list
93095339|NCT03175120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93095340|NCT03175120|Liraglutide|liraglutide|mesh-list
93095341|NCT03175120|Insulin, Long-Acting|insulin, long-acting|mesh-list
93095342|NCT03175120|Xultophy|xultophy|mesh-list
93095343|NCT03175120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095344|NCT03175120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095345|NCT03175120|Incretins|incretins|mesh-ancestor
93095346|NCT03175120|Hormones|hormones|mesh-ancestor
93095347|NCT03175120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095348|NCT03054766|Ranibizumab|ranibizumab|mesh-list
93095349|NCT03054766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095350|NCT03054766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095351|NCT03054766|Growth Substances|growth substances|mesh-ancestor
93095352|NCT03054766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095353|NCT03054766|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095354|NCT03054766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095355|NCT05118724|Atezolizumab|atezolizumab|mesh-list
93095356|NCT05118724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93095357|NCT05118724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095358|NCT05118724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095359|NCT05118724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095360|NCT03036748|Amiloride|amiloride|mesh-list
93095361|NCT03036748|Diuretics|diuretics|mesh-ancestor
93095362|NCT03036748|Natriuretic Agents|natriuretic agents|mesh-ancestor
93095363|NCT03036748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095364|NCT03036748|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93095365|NCT03036748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93095366|NCT03036748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095367|NCT03036748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095368|NCT03036748|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93095369|NCT03036748|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93095370|NCT03167242|Lumefantrine|lumefantrine|mesh-list
93095371|NCT03167242|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93095372|NCT03167242|Antimalarials|antimalarials|mesh-ancestor
93095373|NCT03167242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93095374|NCT03167242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93095375|NCT03167242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095376|NCT03636178|Daminozide|daminozide|mesh-list
93095377|NCT03636178|Plant Growth Regulators|plant growth regulators|mesh-ancestor
93095378|NCT03636178|Growth Substances|growth substances|mesh-ancestor
93095379|NCT03636178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095380|NCT01330654|Metoprolol|metoprolol|mesh-list
93095381|NCT01330654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93095382|NCT01330654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095383|NCT01330654|Sympatholytics|sympatholytics|mesh-ancestor
93095384|NCT01330654|Autonomic Agents|autonomic agents|mesh-ancestor
93095385|NCT01330654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095386|NCT01330654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095387|NCT01330654|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93095388|NCT01330654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92685696|NCT00466388|Cevimeline|cevimeline|mesh-list
93095389|NCT01330654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93095390|NCT01330654|Adrenergic Agents|adrenergic agents|mesh-ancestor
93095391|NCT01330654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095392|NCT01330654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095393|NCT01330810|Curcumin|curcumin|mesh-list
93095394|NCT01330810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93095395|NCT01330810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93095396|NCT01330810|Analgesics|analgesics|mesh-ancestor
93095397|NCT01330810|Sensory System Agents|sensory system agents|mesh-ancestor
93095398|NCT01330810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095399|NCT01330810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095400|NCT01330810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095401|NCT01330810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095402|NCT01330810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095403|NCT01330810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095404|NCT01330810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095405|NCT01331122|Droxidopa|droxidopa|mesh-list
93095406|NCT01331122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93095407|NCT01331122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93095408|NCT01320280|Afatinib|afatinib|mesh-list
93095409|NCT01320280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095410|NCT01320280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095411|NCT01320280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095412|NCT01320280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095413|NCT01331434|Exemestane|exemestane|mesh-list
93095414|NCT01331434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095415|NCT01331434|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93095416|NCT01331434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93095417|NCT01331434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095418|NCT01331434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095419|NCT01331434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93095420|NCT01331434|Hormone Antagonists|hormone antagonists|mesh-ancestor
93095421|NCT01331434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095422|NCT01331434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095423|NCT01331590|Dexamethasone|dexamethasone|mesh-list
93095424|NCT01331590|Etoposide|etoposide|mesh-list
93095425|NCT01331590|Ifosfamide|ifosfamide|mesh-list
93095426|NCT01331590|Lenograstim|lenograstim|mesh-list
93095427|NCT01331590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095428|NCT01331590|Antiemetics|antiemetics|mesh-ancestor
93095429|NCT01331590|Autonomic Agents|autonomic agents|mesh-ancestor
93095430|NCT01331590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095431|NCT01331590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095432|NCT01331590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095433|NCT01331590|Glucocorticoids|glucocorticoids|mesh-ancestor
93095434|NCT01331590|Hormones|hormones|mesh-ancestor
93095435|NCT01331590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095436|NCT01331590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93095437|NCT01331590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095438|NCT01331590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93095439|NCT01331590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93095440|NCT01331590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93095441|NCT01331590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095442|NCT01331590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767777|NCT00613717|Iron|iron|mesh-list
93095443|NCT01331590|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93095444|NCT01331590|Immunologic Factors|immunologic factors|mesh-ancestor
93095445|NCT01331590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93095446|NCT01331590|Alkylating Agents|alkylating agents|mesh-ancestor
93095447|NCT01331902|Nicorandil|nicorandil|mesh-list
93095448|NCT01331902|Adenosine|adenosine|mesh-list
93095449|NCT01331902|Analgesics|analgesics|mesh-ancestor
92685747|NCT00464165|Rimonabant|rimonabant|mesh-list
93095450|NCT01331902|Sensory System Agents|sensory system agents|mesh-ancestor
93095451|NCT01331902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095452|NCT01331902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095453|NCT01331902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93095454|NCT01331902|Vasodilator Agents|vasodilator agents|mesh-ancestor
93095455|NCT01331902|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93095456|NCT01331902|Purinergic Agonists|purinergic agonists|mesh-ancestor
93095457|NCT01331902|Purinergic Agents|purinergic agents|mesh-ancestor
93095458|NCT01331902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095459|NCT01331902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095460|NCT01331902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095461|NCT01331902|Vitamin B Complex|vitamin b complex|mesh-ancestor
93095462|NCT01331902|Vitamins|vitamins|mesh-ancestor
93095463|NCT01331902|Micronutrients|micronutrients|mesh-ancestor
93095464|NCT04245748|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93095465|NCT04245748|Escitalopram|escitalopram|mesh-list
93095466|NCT04245748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93095467|NCT04245748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93095468|NCT04245748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095469|NCT04245748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095470|NCT04245748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095471|NCT04245748|Serotonin Agents|serotonin agents|mesh-ancestor
93095472|NCT04245748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095473|NCT04245748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095474|NCT04245748|Antidepressive Agents|antidepressive agents|mesh-ancestor
93095475|NCT04245748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93095476|NCT04245748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93095477|NCT04245748|Analgesics|analgesics|mesh-ancestor
93095478|NCT04245748|Sensory System Agents|sensory system agents|mesh-ancestor
93095479|NCT04245748|Dopamine Agents|dopamine agents|mesh-ancestor
93095480|NCT04245436|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93095481|NCT04245436|Escitalopram|escitalopram|mesh-list
93095482|NCT04245436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93095483|NCT04245436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93095484|NCT04245436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095485|NCT04245436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095486|NCT04245436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095487|NCT04245436|Serotonin Agents|serotonin agents|mesh-ancestor
93095488|NCT04245436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095489|NCT04245436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095490|NCT04245436|Antidepressive Agents|antidepressive agents|mesh-ancestor
93095491|NCT04245436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93095492|NCT04245436|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93095493|NCT04245436|Analgesics|analgesics|mesh-ancestor
93095494|NCT04245436|Sensory System Agents|sensory system agents|mesh-ancestor
93095495|NCT04245436|Dopamine Agents|dopamine agents|mesh-ancestor
93095496|NCT01332370|Metformin|metformin|mesh-list
93095497|NCT01332370|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93095498|NCT01332370|Rosiglitazone|rosiglitazone|mesh-list
93095499|NCT01332370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095500|NCT01332370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095501|NCT01332370|Incretins|incretins|mesh-ancestor
93095502|NCT01332370|Hormones|hormones|mesh-ancestor
93095503|NCT01332370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095504|NCT01332370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93095505|NCT01332370|Protease Inhibitors|protease inhibitors|mesh-ancestor
93095506|NCT01332370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095507|NCT01332370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095508|NCT01332448|Orlistat|orlistat|mesh-list
93095509|NCT01332448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095510|NCT01332448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095511|NCT01332448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93095512|NCT01332448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93095513|NCT04484428|Menthol|menthol|mesh-list
93095514|NCT04484428|Antipruritics|antipruritics|mesh-ancestor
93095515|NCT04484428|Dermatologic Agents|dermatologic agents|mesh-ancestor
92767795|NCT03369301|Immunoglobulins|immunoglobulins|mesh-list
93095516|NCT01332604|Bevacizumab|bevacizumab|mesh-list
93095517|NCT01332604|Capecitabine|capecitabine|mesh-list
93095518|NCT01332604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095519|NCT01332604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095520|NCT01332604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095521|NCT01332604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095522|NCT01332604|Growth Substances|growth substances|mesh-ancestor
93095523|NCT01332604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095524|NCT01332604|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095525|NCT01332604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095526|NCT01332604|Antimetabolites|antimetabolites|mesh-ancestor
93095527|NCT01332604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095528|NCT03445858|Pembrolizumab|pembrolizumab|mesh-list
93095529|NCT03445858|Decitabine|decitabine|mesh-list
93095530|NCT03445858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095531|NCT03445858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095532|NCT03445858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93095533|NCT03445858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095534|NCT03445858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095535|NCT03445858|Antimetabolites|antimetabolites|mesh-ancestor
93095536|NCT03445858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095537|NCT01333150|Propranolol|propranolol|mesh-list
93095538|NCT01333150|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93095539|NCT01333150|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93095540|NCT01333150|Adrenergic Agents|adrenergic agents|mesh-ancestor
93095541|NCT01333150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095542|NCT01333150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095543|NCT01333150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095544|NCT01333150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93095545|NCT01333150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095546|NCT01333150|Vasodilator Agents|vasodilator agents|mesh-ancestor
93095547|NCT02913664|Losartan|losartan|mesh-list
93095548|NCT02913664|Amlodipine|amlodipine|mesh-list
93095549|NCT02913664|Calcium Channel Blockers|calcium channel blockers|mesh-list
93095550|NCT02913664|Angiotensin II|angiotensin ii|mesh-list
93095551|NCT02913664|Giapreza|giapreza|mesh-list
93095552|NCT02913664|Calcium|calcium|mesh-list
93095553|NCT02913664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93095554|NCT02913664|Angiotensinogen|angiotensinogen|mesh-list
93095555|NCT02913664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095556|NCT02913664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095557|NCT02913664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095558|NCT02913664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095559|NCT02913664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095560|NCT02913664|Vasodilator Agents|vasodilator agents|mesh-ancestor
93095561|NCT02913664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93095562|NCT02913664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93095563|NCT02913664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93095564|NCT02913664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93095565|NCT02913664|Protease Inhibitors|protease inhibitors|mesh-ancestor
93095566|NCT02913664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095567|NCT02818582|Remdesivir|remdesivir|mesh-list
93095568|NCT02818582|Antimetabolites|antimetabolites|mesh-ancestor
93095569|NCT02818582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095570|NCT02818582|Antiviral Agents|antiviral agents|mesh-ancestor
93095571|NCT02818582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095572|NCT01337440|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93095573|NCT01337440|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93095574|NCT01337440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095575|NCT01337440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095576|NCT01337440|Incretins|incretins|mesh-ancestor
93095577|NCT01337440|Hormones|hormones|mesh-ancestor
93095578|NCT01337440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095579|NCT01337440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93095580|NCT01337440|Protease Inhibitors|protease inhibitors|mesh-ancestor
93095581|NCT01337440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095582|NCT01337440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095583|NCT01337440|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93095584|NCT01337440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095585|NCT01337518|Androgens|androgens|mesh-list
93095586|NCT01337518|Hormones|hormones|mesh-ancestor
93095587|NCT01337518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095588|NCT01337518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095589|NCT05186194|Vitamin D|vitamin d|mesh-list
93095590|NCT05186194|Calcium|calcium|mesh-list
93095592|NCT05186194|Micronutrients|micronutrients|mesh-ancestor
93095593|NCT05186194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095594|NCT05186194|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095595|NCT05186194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93095596|NCT01338454|Tranexamic Acid|tranexamic acid|mesh-list
93095597|NCT01338454|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93095598|NCT01338454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93095599|NCT01338454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095600|NCT01338454|Hemostatics|hemostatics|mesh-ancestor
93095601|NCT01338454|Coagulants|coagulants|mesh-ancestor
93095602|NCT02882152|Morphine|morphine|mesh-list
93095603|NCT02882152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93095604|NCT02882152|Narcotics|narcotics|mesh-ancestor
93095605|NCT02882152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095606|NCT02882152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095607|NCT02882152|Analgesics|analgesics|mesh-ancestor
93095608|NCT02882152|Sensory System Agents|sensory system agents|mesh-ancestor
93095609|NCT02882152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095610|NCT05185804|Enoxaparin|enoxaparin|mesh-list
93095611|NCT05185804|Enoxaparin sodium|enoxaparin sodium|mesh-list
93095612|NCT05185804|Anticoagulants|anticoagulants|mesh-ancestor
93095613|NCT05185804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93095614|NCT05185804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93095615|NCT05185804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095616|NCT01338844|Inositol|inositol|mesh-list
93095617|NCT01338844|Vitamin B Complex|vitamin b complex|mesh-ancestor
93095618|NCT01338844|Vitamins|vitamins|mesh-ancestor
93095619|NCT01338844|Micronutrients|micronutrients|mesh-ancestor
93095620|NCT01338844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095621|NCT01338922|Insulin|insulin|mesh-list
93095622|NCT01338922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095623|NCT01338922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095624|NCT01339312|Vaccines|vaccines|mesh-list
93095625|NCT01339312|Immunologic Factors|immunologic factors|mesh-ancestor
93095626|NCT01339312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095627|NCT01339468|Tacrolimus|tacrolimus|mesh-list
93095628|NCT01339468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095629|NCT01339468|Immunologic Factors|immunologic factors|mesh-ancestor
93095630|NCT01339468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095631|NCT01339468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93095632|NCT01339468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095633|NCT01339468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095634|NCT01339624|Ketorolac|ketorolac|mesh-list
93095635|NCT01339624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93095636|NCT01339624|Fentanyl|fentanyl|mesh-list
93095637|NCT01339624|Morphine|morphine|mesh-list
93095638|NCT01339624|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93095639|NCT01339624|Narcotics|narcotics|mesh-ancestor
93095640|NCT01339624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095641|NCT01339624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095642|NCT01339624|Analgesics|analgesics|mesh-ancestor
93095643|NCT01339624|Sensory System Agents|sensory system agents|mesh-ancestor
93095644|NCT01339624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095645|NCT01339624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93095646|NCT01339624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93095647|NCT01339624|Anesthetics, General|anesthetics, general|mesh-ancestor
93095648|NCT01339624|Anesthetics|anesthetics|mesh-ancestor
92685948|NCT02893384|Anesthetics|anesthetics|mesh-list
93095649|NCT01339624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93095650|NCT01339624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93095651|NCT01339624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095652|NCT01339624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095653|NCT01339624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93095654|NCT01339624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095655|NCT01339624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095656|NCT01340248|Carvedilol|carvedilol|mesh-list
93095657|NCT01340248|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93095658|NCT01340248|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93095659|NCT01340248|Adrenergic Agents|adrenergic agents|mesh-ancestor
93095660|NCT01340248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767958|NCT00614809|Gefitinib|gefitinib|mesh-list
93095661|NCT01340248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095662|NCT01340248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095663|NCT01340248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095664|NCT01340248|Antioxidants|antioxidants|mesh-ancestor
93095665|NCT01340248|Protective Agents|protective agents|mesh-ancestor
93095666|NCT01340248|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93095667|NCT01340248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095668|NCT01340248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095669|NCT01340248|Vasodilator Agents|vasodilator agents|mesh-ancestor
93095670|NCT01340248|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93095671|NCT01340248|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93095672|NCT01340326|Valsartan|valsartan|mesh-list
93095673|NCT01340326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095674|NCT01340326|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93095675|NCT01340326|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93095676|NCT01340326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095677|NCT00286091|Denosumab|denosumab|mesh-list
93095678|NCT00286091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93095679|NCT00286091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095680|NCT01340950|Tenofovir|tenofovir|mesh-list
93095681|NCT01340950|Lamivudine|lamivudine|mesh-list
93095682|NCT01340950|Zidovudine|zidovudine|mesh-list
93095683|NCT01340950|Efavirenz|efavirenz|mesh-list
93095684|NCT01340950|Nevirapine|nevirapine|mesh-list
93095685|NCT01340950|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93095686|NCT01340950|Antiviral Agents|antiviral agents|mesh-ancestor
93095687|NCT01340950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095688|NCT01340950|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93095689|NCT01340950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93095690|NCT01340950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095691|NCT01340950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095692|NCT01340950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93095693|NCT01340950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93095694|NCT01340950|Antimetabolites|antimetabolites|mesh-ancestor
93095695|NCT01340950|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93095696|NCT01340950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93095697|NCT01340950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93095698|NCT01340950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93095699|NCT01340950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93095700|NCT01340950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93095701|NCT01341106|Entecavir|entecavir|mesh-list
93095702|NCT01341106|Antiviral Agents|antiviral agents|mesh-ancestor
93095703|NCT01341106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095704|NCT01341184|Rifampin|rifampin|mesh-list
93095705|NCT01341184|Rifabutin|rifabutin|mesh-list
93095706|NCT01341184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93095707|NCT01341184|Antitubercular Agents|antitubercular agents|mesh-ancestor
93095708|NCT01341184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93095709|NCT01341184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095710|NCT01341184|Leprostatic Agents|leprostatic agents|mesh-ancestor
93095711|NCT01341184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93095712|NCT01341184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095713|NCT01341184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095714|NCT01341184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92686007|NCT00467012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095715|NCT01341184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93095716|NCT01341184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93095717|NCT01341184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93095718|NCT01341184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93095719|NCT01341184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93095720|NCT00285857|Lovastatin|lovastatin|mesh-list
93095721|NCT00285857|L 647318|l 647318|mesh-list
93095722|NCT00285857|Dihydromevinolin|dihydromevinolin|mesh-list
93095723|NCT00285857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93095724|NCT00285857|Antimetabolites|antimetabolites|mesh-ancestor
93095725|NCT00285857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095726|NCT00285857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93095727|NCT00285857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93095728|NCT00285857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93095729|NCT00285857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095730|NCT01341262|Zoledronic Acid|zoledronic acid|mesh-list
93095731|NCT01341262|Thalidomide|thalidomide|mesh-list
93095732|NCT01341262|Dexamethasone|dexamethasone|mesh-list
93095733|NCT01341262|Cyclophosphamide|cyclophosphamide|mesh-list
93095734|NCT01341262|Melphalan|melphalan|mesh-list
93095735|NCT01341262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095736|NCT01341262|Immunologic Factors|immunologic factors|mesh-ancestor
93095737|NCT01341262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095738|NCT01341262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095739|NCT01341262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93095740|NCT01341262|Alkylating Agents|alkylating agents|mesh-ancestor
93095741|NCT01341262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095743|NCT01341262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93095744|NCT01341262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095745|NCT01341262|Antiemetics|antiemetics|mesh-ancestor
93095746|NCT01341262|Autonomic Agents|autonomic agents|mesh-ancestor
93095747|NCT01341262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095748|NCT01341262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095749|NCT01341262|Glucocorticoids|glucocorticoids|mesh-ancestor
93095750|NCT01341262|Hormones|hormones|mesh-ancestor
93095751|NCT01341262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095752|NCT01341262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93095753|NCT01341262|Leprostatic Agents|leprostatic agents|mesh-ancestor
93095754|NCT01341262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93095755|NCT01341262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095756|NCT01341262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095757|NCT01341262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095758|NCT01341262|Growth Substances|growth substances|mesh-ancestor
93095759|NCT01341262|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095760|NCT01341262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93095761|NCT01341340|Everolimus|everolimus|mesh-list
93095762|NCT01341340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93095763|NCT01341340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095764|NCT01341340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095765|NCT01341340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095766|NCT01341340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095767|NCT01341340|Immunologic Factors|immunologic factors|mesh-ancestor
93095768|NCT01341340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095769|NCT01341340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095770|NCT01341496|Celecoxib|celecoxib|mesh-list
93095771|NCT01341496|Cyclophosphamide|cyclophosphamide|mesh-list
93095772|NCT01341496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93095773|NCT01341496|Immunologic Factors|immunologic factors|mesh-ancestor
93095774|NCT01341496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095775|NCT01341496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095776|NCT01341496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93095777|NCT01341496|Alkylating Agents|alkylating agents|mesh-ancestor
93095778|NCT01341496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095779|NCT01341496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095780|NCT01341496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93095781|NCT01341496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93095782|NCT01341496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93095783|NCT01341496|Analgesics|analgesics|mesh-ancestor
93095784|NCT01341496|Sensory System Agents|sensory system agents|mesh-ancestor
93095785|NCT01341496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095786|NCT01341496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095787|NCT01341496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93095788|NCT01341496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93095789|NCT01341496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095790|NCT00284141|Aflibercept|aflibercept|mesh-list
93095791|NCT00284141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93095792|NCT00284141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93095793|NCT00284141|Growth Substances|growth substances|mesh-ancestor
93095794|NCT00284141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095795|NCT00284141|Growth Inhibitors|growth inhibitors|mesh-ancestor
93095796|NCT00284141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095797|NCT05182138|Zinc|zinc|mesh-list
93095798|NCT05182138|Trace Elements|trace elements|mesh-ancestor
93095799|NCT05182138|Micronutrients|micronutrients|mesh-ancestor
93095800|NCT05182138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095801|NCT01315990|Cetuximab|cetuximab|mesh-list
93095802|NCT01315990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095803|NCT01315990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095804|NCT00265343|Olanzapine|olanzapine|mesh-list
93095805|NCT00265343|Asenapine|asenapine|mesh-list
93095806|NCT00265343|Antiemetics|antiemetics|mesh-ancestor
93095807|NCT00265343|Autonomic Agents|autonomic agents|mesh-ancestor
93095808|NCT00265343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095809|NCT00265343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095810|NCT00265343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095811|NCT00265343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93095812|NCT00265343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93095813|NCT00265343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095814|NCT00265343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92768099|NCT00848731|Nitric Oxide|nitric oxide|mesh-list
93095815|NCT00265343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93095816|NCT00265343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93095817|NCT00265343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095818|NCT00265343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095820|NCT00265343|Serotonin Agents|serotonin agents|mesh-ancestor
93095821|NCT01341886|Metformin|metformin|mesh-list
93095822|NCT01341886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095823|NCT01341886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095824|NCT00283595|Hormones|hormones|mesh-list
93095825|NCT00283595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93095826|NCT00283595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095827|NCT00265109|Levetiracetam|levetiracetam|mesh-list
93095828|NCT00265109|Anticonvulsants|anticonvulsants|mesh-ancestor
93095829|NCT00265109|Nootropic Agents|nootropic agents|mesh-ancestor
93095830|NCT01342198|Erythromycin|erythromycin|mesh-list
93095831|NCT01342198|Erythromycin Estolate|erythromycin estolate|mesh-list
93095832|NCT01342198|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93095833|NCT01342198|Erythromycin stearate|erythromycin stearate|mesh-list
93095834|NCT01342198|Pregabalin|pregabalin|mesh-list
93095835|NCT01342198|Analgesics|analgesics|mesh-ancestor
93095836|NCT01342198|Sensory System Agents|sensory system agents|mesh-ancestor
93095837|NCT01342198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095838|NCT01342198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095839|NCT01342198|Anticonvulsants|anticonvulsants|mesh-ancestor
93095840|NCT01342198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93095841|NCT01342198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095842|NCT01342198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095843|NCT01342198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095844|NCT01342198|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93095845|NCT01342198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93095846|NCT01342198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095847|NCT01342198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93095848|NCT01342198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93095849|NCT01342198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93095850|NCT01342198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93095851|NCT01342198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93095852|NCT01342198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095853|NCT01342744|Metformin|metformin|mesh-list
93095854|NCT01342744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095855|NCT01342744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095856|NCT05150782|Ascorbic Acid|ascorbic acid|mesh-list
93095857|NCT05150782|Curcumin|curcumin|mesh-list
93095858|NCT05150782|Antioxidants|antioxidants|mesh-ancestor
93095859|NCT05150782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095860|NCT05150782|Protective Agents|protective agents|mesh-ancestor
93095861|NCT05150782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095862|NCT05150782|Vitamins|vitamins|mesh-ancestor
93095863|NCT05150782|Micronutrients|micronutrients|mesh-ancestor
93095864|NCT05150782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93095865|NCT05150782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93095866|NCT05150782|Analgesics|analgesics|mesh-ancestor
93095867|NCT05150782|Sensory System Agents|sensory system agents|mesh-ancestor
93095868|NCT05150782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095869|NCT05150782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93095870|NCT05150782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93095871|NCT05150782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095872|NCT05150782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095873|NCT01316068|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
93095874|NCT01316068|Anticoagulants|anticoagulants|mesh-ancestor
93095875|NCT01316068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93095876|NCT01316068|Antimetabolites|antimetabolites|mesh-ancestor
93095877|NCT01316068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095878|NCT01316068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93095879|NCT01316068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93095880|NCT01316068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93095881|NCT01316068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095882|NCT01316068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095883|NCT03233308|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93095884|NCT03233308|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93095885|NCT00283049|Insulin|insulin|mesh-list
93095886|NCT00283049|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93095887|NCT00283049|Insulin Glargine|insulin glargine|mesh-list
93095888|NCT00283049|Insulin glulisine|insulin glulisine|mesh-list
93095889|NCT00283049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93095890|NCT00283049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095891|NCT00264875|Pregabalin|pregabalin|mesh-list
93095892|NCT00264875|Analgesics|analgesics|mesh-ancestor
93095893|NCT00264875|Sensory System Agents|sensory system agents|mesh-ancestor
93095894|NCT00264875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095895|NCT00264875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095896|NCT00264875|Anticonvulsants|anticonvulsants|mesh-ancestor
93095897|NCT00264875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93095898|NCT00264875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095899|NCT00264875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095900|NCT00264875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095901|NCT00264875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93095902|NCT00264875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92686211|NCT02892916|Anesthetics|anesthetics|mesh-ancestor
93095903|NCT00264875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095904|NCT00264875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93095905|NCT03635398|Midazolam|midazolam|mesh-list
93095906|NCT03635398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93095907|NCT03635398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93095908|NCT03635398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095909|NCT03635398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095910|NCT03635398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93095911|NCT03635398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93095912|NCT03635398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93095913|NCT03635398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93095914|NCT03635398|Anesthetics, General|anesthetics, general|mesh-ancestor
93095915|NCT03635398|Anesthetics|anesthetics|mesh-ancestor
93095916|NCT03635398|GABA Modulators|gaba modulators|mesh-ancestor
93095917|NCT03635398|GABA Agents|gaba agents|mesh-ancestor
93095918|NCT03635398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93095919|NCT03635398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095920|NCT03151408|Azacitidine|azacitidine|mesh-list
93095921|NCT03151408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095922|NCT03151408|Antimetabolites|antimetabolites|mesh-ancestor
93095923|NCT03151408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095924|NCT03151408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095925|NCT03151408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095926|NCT05226442|Heparin|heparin|mesh-list
93095927|NCT05226442|Calcium heparin|calcium heparin|mesh-list
93095928|NCT05226442|Argatroban|argatroban|mesh-list
93095929|NCT05226442|Anticoagulants|anticoagulants|mesh-ancestor
93095930|NCT05226442|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93095931|NCT05226442|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93095932|NCT05226442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095933|NCT05226442|Antithrombins|antithrombins|mesh-ancestor
93095934|NCT05226442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93095935|NCT05226442|Protease Inhibitors|protease inhibitors|mesh-ancestor
93095936|NCT05226442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095937|NCT05226442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93095938|NCT01316458|Imatinib Mesylate|imatinib mesylate|mesh-list
93095939|NCT01316458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095940|NCT01316458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095941|NCT01316458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095942|NCT01316458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095943|NCT05198128|Calcium|calcium|mesh-list
93095944|NCT05198128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93095945|NCT05198128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095946|NCT01316848|Tivozanib|tivozanib|mesh-list
93095947|NCT01316848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095948|NCT01316848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095949|NCT01316848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095950|NCT02121184|Oxytocin|oxytocin|mesh-list
93095951|NCT02121184|Oxytocics|oxytocics|mesh-ancestor
93095952|NCT02121184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93095953|NCT02121184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095954|NCT01485874|Doxorubicin|doxorubicin|mesh-list
93095955|NCT01485874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93095956|NCT01485874|Nintedanib|nintedanib|mesh-list
93095957|NCT01485874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93095958|NCT01485874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095959|NCT01485874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93095960|NCT01485874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93095961|NCT01485874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93095962|NCT01485874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768241|NCT01012713|Hormones|hormones|mesh-ancestor
93095963|NCT01485874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93095964|NCT05000710|Durvalumab|durvalumab|mesh-list
93095965|NCT05000710|Tremelimumab|tremelimumab|mesh-list
93095966|NCT05000710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93095967|NCT05000710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095968|NCT04786756|Bupivacaine|bupivacaine|mesh-list
93095969|NCT04786756|Anesthetics, Local|anesthetics, local|mesh-ancestor
93095970|NCT04786756|Anesthetics|anesthetics|mesh-ancestor
93095971|NCT04786756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095972|NCT04786756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095973|NCT04786756|Sensory System Agents|sensory system agents|mesh-ancestor
93095974|NCT04786756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93095975|NCT00546754|Losartan|losartan|mesh-list
93095976|NCT00546754|Valsartan|valsartan|mesh-list
93095977|NCT00546754|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93095978|NCT00546754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93095979|NCT00546754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93095980|NCT00546754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93095981|NCT00546754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095982|NCT00546754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93095983|NCT00546754|Diuretics|diuretics|mesh-ancestor
93095984|NCT00546754|Natriuretic Agents|natriuretic agents|mesh-ancestor
93095985|NCT00546754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095986|NCT00546754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93095987|NCT00546754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93095988|NCT04768426|Capecitabine|capecitabine|mesh-list
93095989|NCT04768426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93095990|NCT04768426|Antimetabolites|antimetabolites|mesh-ancestor
93095991|NCT04768426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93095992|NCT04768426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93095993|NCT04473508|Ropivacaine|ropivacaine|mesh-list
93095994|NCT04473508|Anesthetics, Local|anesthetics, local|mesh-ancestor
93095995|NCT04473508|Anesthetics|anesthetics|mesh-ancestor
93095996|NCT04473508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93095997|NCT04473508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93095998|NCT04473508|Sensory System Agents|sensory system agents|mesh-ancestor
93095999|NCT04473508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096000|NCT04471402|Dexmedetomidine|dexmedetomidine|mesh-list
93096001|NCT04471402|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93096002|NCT04471402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096003|NCT04471402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096004|NCT04471402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096005|NCT04471402|Analgesics|analgesics|mesh-ancestor
93096006|NCT04471402|Sensory System Agents|sensory system agents|mesh-ancestor
93096007|NCT04471402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096008|NCT04471402|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93096009|NCT04471402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93096010|NCT04471402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93096011|NCT04471402|Adrenergic Agents|adrenergic agents|mesh-ancestor
93096012|NCT04471402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096013|NCT04471402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096014|NCT00282347|Acetaminophen|acetaminophen|mesh-list
93096015|NCT00282347|Diphenhydramine|diphenhydramine|mesh-list
93096016|NCT00282347|Promethazine|promethazine|mesh-list
93096017|NCT00282347|Mycophenolic Acid|mycophenolic acid|mesh-list
93096018|NCT00282347|Prednisone|prednisone|mesh-list
93096019|NCT00282347|Methylprednisolone|methylprednisolone|mesh-list
93096020|NCT00282347|Rituximab|rituximab|mesh-list
93096021|NCT00282347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096022|NCT00282347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096023|NCT00282347|Immunologic Factors|immunologic factors|mesh-ancestor
93096024|NCT00282347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096025|NCT00282347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096026|NCT00282347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096027|NCT00282347|Glucocorticoids|glucocorticoids|mesh-ancestor
93096028|NCT00282347|Hormones|hormones|mesh-ancestor
93096029|NCT00282347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096030|NCT00282347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096031|NCT00282347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096032|NCT00282347|Analgesics|analgesics|mesh-ancestor
93096033|NCT00282347|Sensory System Agents|sensory system agents|mesh-ancestor
93096034|NCT00282347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096035|NCT00282347|Antipyretics|antipyretics|mesh-ancestor
93096036|NCT00282347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93096037|NCT00282347|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93096038|NCT00282347|Antitubercular Agents|antitubercular agents|mesh-ancestor
93096039|NCT00282347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096040|NCT00282347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096041|NCT00282347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096042|NCT00282347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096043|NCT00282347|Antiemetics|antiemetics|mesh-ancestor
93096044|NCT00282347|Autonomic Agents|autonomic agents|mesh-ancestor
93096045|NCT00282347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096046|NCT00282347|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93096047|NCT00282347|Protective Agents|protective agents|mesh-ancestor
93096048|NCT00282347|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93096049|NCT00282347|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93096050|NCT00282347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096051|NCT00282347|Anesthetics, Local|anesthetics, local|mesh-ancestor
93096052|NCT00282347|Anesthetics|anesthetics|mesh-ancestor
93096053|NCT00282347|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93096054|NCT00282347|Histamine Antagonists|histamine antagonists|mesh-ancestor
93096055|NCT00282347|Histamine Agents|histamine agents|mesh-ancestor
93096056|NCT00282347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096057|NCT00282347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93096058|NCT00282347|Antipruritics|antipruritics|mesh-ancestor
93096059|NCT00282347|Dermatologic Agents|dermatologic agents|mesh-ancestor
93096061|NCT01334632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93096062|NCT01334632|Narcotics|narcotics|mesh-ancestor
93096063|NCT01334632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096064|NCT01334632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096065|NCT01334632|Analgesics|analgesics|mesh-ancestor
93096066|NCT01334632|Sensory System Agents|sensory system agents|mesh-ancestor
93096067|NCT01334632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096068|NCT00405964|Desloratadine|desloratadine|mesh-list
93096069|NCT00405964|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93096070|NCT00405964|Cholinergic Agents|cholinergic agents|mesh-ancestor
93096071|NCT00405964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096072|NCT00405964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096073|NCT00405964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096074|NCT00405964|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93096075|NCT00405964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92686370|NCT00622843|Vaccines|vaccines|mesh-list
93096076|NCT00405964|Histamine Antagonists|histamine antagonists|mesh-ancestor
93096077|NCT00405964|Histamine Agents|histamine agents|mesh-ancestor
93096078|NCT00264797|Methylphenidate|methylphenidate|mesh-list
93096079|NCT00264797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93096080|NCT00264797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096081|NCT00264797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93096082|NCT00264797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93096083|NCT00264797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93096084|NCT00264797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096085|NCT00264797|Dopamine Agents|dopamine agents|mesh-ancestor
93096086|NCT00264797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096087|NCT03148756|Dalbavancin|dalbavancin|mesh-list
93096088|NCT03148756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096089|NCT03148756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096090|NCT01343680|Heparin|heparin|mesh-list
93096091|NCT01343680|Anticoagulants|anticoagulants|mesh-ancestor
93096092|NCT01343680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93096093|NCT01343680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93096094|NCT01343680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096095|NCT00281957|Sirolimus|sirolimus|mesh-list
93096096|NCT00281957|Sorafenib|sorafenib|mesh-list
93096097|NCT00281957|Temsirolimus|temsirolimus|mesh-list
93096098|NCT00281957|Tipifarnib|tipifarnib|mesh-list
93096099|NCT00281957|MTOR Inhibitors|mtor inhibitors|mesh-list
93096100|NCT00281957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096101|NCT00281957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096102|NCT00281957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096103|NCT00281957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096104|NCT00281957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096105|NCT00281957|Immunologic Factors|immunologic factors|mesh-ancestor
93096106|NCT00281957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096107|NCT00281957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096108|NCT00281957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096109|NCT00281957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93096110|NCT00281957|Antifungal Agents|antifungal agents|mesh-ancestor
93096111|NCT01071161|Azithromycin|azithromycin|mesh-list
93096112|NCT01071161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096113|NCT01071161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096114|NCT01070225|Hydrocortisone|hydrocortisone|mesh-list
93096115|NCT01070225|Propranolol|propranolol|mesh-list
93096117|NCT01070225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93096118|NCT01070225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93096119|NCT01070225|Adrenergic Agents|adrenergic agents|mesh-ancestor
93096120|NCT01070225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096121|NCT01070225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096122|NCT01070225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096123|NCT01070225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93096124|NCT01070225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93096125|NCT01070225|Vasodilator Agents|vasodilator agents|mesh-ancestor
93096126|NCT01070615|Prucalopride|prucalopride|mesh-list
93096127|NCT01070615|Laxatives|laxatives|mesh-ancestor
93096128|NCT01070615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096129|NCT01070615|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93096130|NCT01070615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93096131|NCT01070615|Serotonin Agents|serotonin agents|mesh-ancestor
93096132|NCT01070615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096133|NCT01070615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096134|NCT01070615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096135|NCT00262925|Leucovorin|leucovorin|mesh-list
93096136|NCT00262925|Dexamethasone|dexamethasone|mesh-list
93096137|NCT00262925|Methotrexate|methotrexate|mesh-list
93096138|NCT00262925|Vincristine|vincristine|mesh-list
93096139|NCT00262925|Asparaginase|asparaginase|mesh-list
93096140|NCT00262925|Mercaptopurine|mercaptopurine|mesh-list
93096141|NCT00262925|Alemtuzumab|alemtuzumab|mesh-list
93096142|NCT00262925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93096143|NCT00262925|Antibodies|antibodies|mesh-list
93096144|NCT00262925|Immunoglobulins|immunoglobulins|mesh-list
93096145|NCT00262925|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93096146|NCT00262925|Levoleucovorin|levoleucovorin|mesh-list
93096147|NCT00262925|Immunologic Factors|immunologic factors|mesh-ancestor
93096148|NCT00262925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096149|NCT00262925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096150|NCT00262925|Antiemetics|antiemetics|mesh-ancestor
93096151|NCT00262925|Autonomic Agents|autonomic agents|mesh-ancestor
93096152|NCT00262925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096153|NCT00262925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096154|NCT00262925|Glucocorticoids|glucocorticoids|mesh-ancestor
93096155|NCT00262925|Hormones|hormones|mesh-ancestor
93096156|NCT00262925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096157|NCT00262925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096158|NCT00262925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096159|NCT00262925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93096160|NCT00262925|Abortifacient Agents|abortifacient agents|mesh-ancestor
93096161|NCT00262925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93096162|NCT00262925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93096163|NCT00262925|Antimetabolites|antimetabolites|mesh-ancestor
93096164|NCT00262925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096165|NCT00262925|Dermatologic Agents|dermatologic agents|mesh-ancestor
93096166|NCT00262925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096167|NCT00262925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93096168|NCT00262925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096169|NCT00262925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096170|NCT00262925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93096171|NCT00262925|Antidotes|antidotes|mesh-ancestor
93096172|NCT00262925|Protective Agents|protective agents|mesh-ancestor
93096173|NCT00262925|Vitamin B Complex|vitamin b complex|mesh-ancestor
93096174|NCT00262925|Vitamins|vitamins|mesh-ancestor
93096175|NCT00262925|Micronutrients|micronutrients|mesh-ancestor
93096176|NCT00262925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096177|NCT00262925|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096178|NCT00262925|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096179|NCT00262925|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096180|NCT01581515|Everolimus|everolimus|mesh-list
93096181|NCT01581515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93096182|NCT01581515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096183|NCT01581515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096184|NCT01581515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096185|NCT01581515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096186|NCT01581515|Immunologic Factors|immunologic factors|mesh-ancestor
93096187|NCT01581515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096188|NCT01581515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096189|NCT03720470|Abrocitinib|abrocitinib|mesh-list
93096190|NCT03720470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096191|NCT03720470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096192|NCT03720470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096194|NCT00262847|Bevacizumab|bevacizumab|mesh-list
93096195|NCT00262847|Carboplatin|carboplatin|mesh-list
93096196|NCT00262847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92686506|NCT01379521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096197|NCT00262847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93096198|NCT00262847|Endothelial Growth Factors|endothelial growth factors|mesh-list
93096199|NCT00262847|Antibodies|antibodies|mesh-list
93096200|NCT00262847|Immunoglobulins|immunoglobulins|mesh-list
93096201|NCT00262847|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93096202|NCT00262847|Immunoglobulin G|immunoglobulin g|mesh-list
93096203|NCT00262847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096204|NCT00262847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096205|NCT00262847|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096206|NCT00262847|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096207|NCT00262847|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096208|NCT00262847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096209|NCT00262847|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93096210|NCT00262847|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93096211|NCT00262847|Growth Substances|growth substances|mesh-ancestor
93096212|NCT00262847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096213|NCT00262847|Growth Inhibitors|growth inhibitors|mesh-ancestor
93096214|NCT00262847|Immunologic Factors|immunologic factors|mesh-ancestor
93096215|NCT05329532|Pembrolizumab|pembrolizumab|mesh-list
93096216|NCT05329532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096217|NCT05329532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096218|NCT05329532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93096219|NCT05329532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096220|NCT01303640|Everolimus|everolimus|mesh-list
93096221|NCT01303640|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93096222|NCT01303640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096223|NCT01303640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096224|NCT01303640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096225|NCT01303640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096226|NCT01303640|Immunologic Factors|immunologic factors|mesh-ancestor
93096227|NCT01303640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096228|NCT01303640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096229|NCT03817268|Capecitabine|capecitabine|mesh-list
93096230|NCT03817268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93096231|NCT03817268|Antimetabolites|antimetabolites|mesh-ancestor
93096232|NCT03817268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096233|NCT03817268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096234|NCT00280397|Lenvatinib|lenvatinib|mesh-list
93096235|NCT00280397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096236|NCT00280397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096237|NCT00280397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096238|NCT00280397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096239|NCT03817112|Dexmedetomidine|dexmedetomidine|mesh-list
93096240|NCT03817112|Propofol|propofol|mesh-list
93096241|NCT03817112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93096242|NCT03817112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096243|NCT03817112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096244|NCT03817112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92686559|NCT00492687|Tamoxifen|tamoxifen|mesh-list
93096245|NCT03817112|Analgesics|analgesics|mesh-ancestor
93096246|NCT03817112|Sensory System Agents|sensory system agents|mesh-ancestor
93096247|NCT03817112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096248|NCT03817112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93096249|NCT03817112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93096250|NCT03817112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93096251|NCT03817112|Adrenergic Agents|adrenergic agents|mesh-ancestor
93096252|NCT03817112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096253|NCT03817112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096254|NCT03817112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93096255|NCT03817112|Anesthetics, General|anesthetics, general|mesh-ancestor
93096256|NCT03817112|Anesthetics|anesthetics|mesh-ancestor
93096257|NCT00262301|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93096258|NCT00262301|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93096259|NCT00262301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096260|NCT00262301|Immunologic Factors|immunologic factors|mesh-ancestor
93096261|NCT00262301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096262|NCT03814148|Indapamide|indapamide|mesh-list
93096263|NCT03814148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93096264|NCT03814148|Diuretics|diuretics|mesh-ancestor
93096265|NCT03814148|Natriuretic Agents|natriuretic agents|mesh-ancestor
93096266|NCT03814148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096267|NCT03814148|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93096268|NCT03814148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93096269|NCT03814148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096270|NCT00279305|Rituximab|rituximab|mesh-list
93096271|NCT00279305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096272|NCT00279305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096273|NCT00279305|Immunologic Factors|immunologic factors|mesh-ancestor
93096274|NCT00279305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096275|NCT00279305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096276|NCT04224272|Fulvestrant|fulvestrant|mesh-list
93096277|NCT04224272|Palbociclib|palbociclib|mesh-list
93096278|NCT04224272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096279|NCT04224272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096280|NCT04224272|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93096281|NCT04224272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93096282|NCT04224272|Hormone Antagonists|hormone antagonists|mesh-ancestor
93096283|NCT04224272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096284|NCT04224272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096285|NCT04224272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096286|NCT04224272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096287|NCT04224272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096288|NCT03800810|Hyaluronic Acid|hyaluronic acid|mesh-list
93096289|NCT03800810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93096290|NCT03800810|Immunologic Factors|immunologic factors|mesh-ancestor
93096291|NCT03800810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096292|NCT03800810|Viscosupplements|viscosupplements|mesh-ancestor
93096293|NCT03800810|Protective Agents|protective agents|mesh-ancestor
93096294|NCT03974867|Prednisone|prednisone|mesh-list
93096295|NCT03974867|Methylprednisolone|methylprednisolone|mesh-list
93096296|NCT03974867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93096297|NCT03974867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93096298|NCT03974867|Prednisolone|prednisolone|mesh-list
93096299|NCT03974867|Prednisolone acetate|prednisolone acetate|mesh-list
93096300|NCT03974867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93096301|NCT03974867|Prednisolone phosphate|prednisolone phosphate|mesh-list
93096302|NCT03974867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096303|NCT03974867|Glucocorticoids|glucocorticoids|mesh-ancestor
93096304|NCT03974867|Hormones|hormones|mesh-ancestor
93096305|NCT03974867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096306|NCT03974867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096307|NCT03974867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096308|NCT03974867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096309|NCT03974867|Antiemetics|antiemetics|mesh-ancestor
93096310|NCT03974867|Autonomic Agents|autonomic agents|mesh-ancestor
93096311|NCT03974867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096312|NCT03974867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096313|NCT03974867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93096314|NCT03974867|Protective Agents|protective agents|mesh-ancestor
93096315|NCT03799406|Vitamin D|vitamin d|mesh-list
93096316|NCT03799406|Cholecalciferol|cholecalciferol|mesh-list
93096317|NCT03799406|Vitamins|vitamins|mesh-ancestor
93096318|NCT03799406|Micronutrients|micronutrients|mesh-ancestor
93096319|NCT03799406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096320|NCT03799406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93096321|NCT03799406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93096322|NCT03799172|Echinocandins|echinocandins|mesh-list
93096323|NCT03799172|Antifungal Agents|antifungal agents|mesh-ancestor
93096324|NCT03799172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096325|NCT03799094|Ascorbic Acid|ascorbic acid|mesh-list
93096326|NCT03799094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93096327|NCT03799094|Vitamins|vitamins|mesh-ancestor
93096328|NCT03799094|Micronutrients|micronutrients|mesh-ancestor
93096329|NCT03799094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096330|NCT03799094|Antioxidants|antioxidants|mesh-ancestor
93096331|NCT03799094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096332|NCT03799094|Protective Agents|protective agents|mesh-ancestor
93096333|NCT03799094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096334|NCT03799094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096335|NCT00277355|Minocycline|minocycline|mesh-list
93096336|NCT00277355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096337|NCT00277355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096338|NCT05593094|Trastuzumab|trastuzumab|mesh-list
93096339|NCT05593094|Pertuzumab|pertuzumab|mesh-list
93096340|NCT05593094|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93096341|NCT05593094|Maytansine|maytansine|mesh-list
93096342|NCT05593094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096343|NCT05593094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096344|NCT05593094|Immunotoxins|immunotoxins|mesh-ancestor
93096345|NCT05593094|Immunoconjugates|immunoconjugates|mesh-ancestor
93096346|NCT05593094|Immunologic Factors|immunologic factors|mesh-ancestor
93096347|NCT05593094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096348|NCT05593094|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096349|NCT05593094|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096350|NCT05593094|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096351|NCT05593094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096352|NCT05593094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096353|NCT00262223|Sertraline|sertraline|mesh-list
93096354|NCT00262223|Antidepressive Agents|antidepressive agents|mesh-ancestor
93096355|NCT00262223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93096356|NCT00262223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93096357|NCT00262223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93096358|NCT00262223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93096359|NCT00262223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096360|NCT00262223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096361|NCT00262223|Serotonin Agents|serotonin agents|mesh-ancestor
93096362|NCT00262223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096363|NCT05575700|Ibuprofen|ibuprofen|mesh-list
93096364|NCT05575700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93096365|NCT05575700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096366|NCT05575700|Analgesics|analgesics|mesh-ancestor
93096367|NCT05575700|Sensory System Agents|sensory system agents|mesh-ancestor
93096368|NCT05575700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096369|NCT05575700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096370|NCT05575700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096371|NCT05575700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096372|NCT05575700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93096373|NCT05575700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096374|NCT05575700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096375|NCT00276419|Diclofenac|diclofenac|mesh-list
93096376|NCT00276419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93096377|NCT00276419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096378|NCT00276419|Analgesics|analgesics|mesh-ancestor
93096379|NCT00276419|Sensory System Agents|sensory system agents|mesh-ancestor
93096380|NCT00276419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096381|NCT00276419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096382|NCT00276419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096383|NCT00276419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096384|NCT00276419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93096385|NCT00276419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096386|NCT00276419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096387|NCT03798392|Anesthetics|anesthetics|mesh-list
93096388|NCT03798392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096389|NCT03798392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096390|NCT03816020|Niacinamide|niacinamide|mesh-list
93096391|NCT03816020|Niacin|niacin|mesh-list
93096392|NCT03816020|Nicotinic Acids|nicotinic acids|mesh-list
93096393|NCT03816020|Vitamin B Complex|vitamin b complex|mesh-ancestor
93096394|NCT03816020|Vitamins|vitamins|mesh-ancestor
93096395|NCT03816020|Micronutrients|micronutrients|mesh-ancestor
93096396|NCT03816020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096397|NCT03816020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93096398|NCT03816020|Antimetabolites|antimetabolites|mesh-ancestor
93096399|NCT03816020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096400|NCT03816020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93096401|NCT03816020|Vasodilator Agents|vasodilator agents|mesh-ancestor
93096402|NCT03815864|Antibodies|antibodies|mesh-list
93096403|NCT03815864|Immunoglobulins|immunoglobulins|mesh-list
93096404|NCT03815864|Immunologic Factors|immunologic factors|mesh-ancestor
93096405|NCT03815864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096406|NCT04151342|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93096407|NCT04151342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096408|NCT04151342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096409|NCT04151342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096410|NCT03815942|Nivolumab|nivolumab|mesh-list
93096411|NCT03815942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096412|NCT03815942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096413|NCT03815942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93096414|NCT03815942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096415|NCT01303874|Etanercept|etanercept|mesh-list
93096416|NCT01303874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93096417|NCT01303874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096418|NCT01303874|Analgesics|analgesics|mesh-ancestor
93096419|NCT01303874|Sensory System Agents|sensory system agents|mesh-ancestor
93096420|NCT01303874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096421|NCT01303874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096422|NCT01303874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096423|NCT01303874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096424|NCT01303874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686707|NCT00493077|Antiviral Agents|antiviral agents|mesh-ancestor
93096425|NCT01303874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096426|NCT01303874|Immunologic Factors|immunologic factors|mesh-ancestor
93096427|NCT03813056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93096428|NCT03813056|Lubricant Eye Drops|lubricant eye drops|mesh-list
93096429|NCT03813056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93096430|NCT04140266|Tenofovir|tenofovir|mesh-list
93096431|NCT04140266|Emtricitabine|emtricitabine|mesh-list
93096432|NCT04140266|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93096433|NCT04140266|Dapivirine|dapivirine|mesh-list
93096434|NCT04140266|Antiviral Agents|antiviral agents|mesh-ancestor
93096435|NCT04140266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096436|NCT04140266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93096437|NCT04140266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93096438|NCT04140266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096439|NCT04140266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096440|NCT04140266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93096441|NCT04140266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93096442|NCT04109924|Trifluridine|trifluridine|mesh-list
93096443|NCT04109924|Bevacizumab|bevacizumab|mesh-list
93096444|NCT04109924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93096445|NCT04109924|Irinotecan|irinotecan|mesh-list
93096446|NCT04109924|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
93096447|NCT04109924|Antibodies|antibodies|mesh-list
93096448|NCT04109924|Immunoglobulins|immunoglobulins|mesh-list
93096449|NCT04109924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93096450|NCT04109924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096451|NCT04109924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93096452|NCT04109924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93096453|NCT04109924|Growth Substances|growth substances|mesh-ancestor
93096454|NCT04109924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096455|NCT04109924|Growth Inhibitors|growth inhibitors|mesh-ancestor
93096456|NCT04109924|Immunologic Factors|immunologic factors|mesh-ancestor
93096457|NCT04109924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93096458|NCT04109924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93096459|NCT04109924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096460|NCT04109924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096461|NCT04109924|Antimetabolites|antimetabolites|mesh-ancestor
93096462|NCT04109924|Antiviral Agents|antiviral agents|mesh-ancestor
93096463|NCT04109924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096464|NCT04109924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096465|NCT04070768|Venetoclax|venetoclax|mesh-list
93096466|NCT04070768|Gemtuzumab|gemtuzumab|mesh-list
93096467|NCT04070768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096468|NCT04070768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096469|NCT04070768|Immunotoxins|immunotoxins|mesh-ancestor
93096470|NCT04070768|Immunoconjugates|immunoconjugates|mesh-ancestor
93096471|NCT04070768|Immunologic Factors|immunologic factors|mesh-ancestor
93096472|NCT04070768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096473|NCT01301612|Cisplatin|cisplatin|mesh-list
93096474|NCT01301612|Nimotuzumab|nimotuzumab|mesh-list
93096475|NCT01301612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096476|NCT01301612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096477|NCT01303952|Eculizumab|eculizumab|mesh-list
93096478|NCT01303952|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93096479|NCT01303952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096480|NCT01303952|Immunologic Factors|immunologic factors|mesh-ancestor
93096481|NCT01303952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096482|NCT03970616|Durvalumab|durvalumab|mesh-list
93096483|NCT03970616|Tivozanib|tivozanib|mesh-list
93096484|NCT03970616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096485|NCT03970616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096486|NCT03970616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096487|NCT03970616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096488|NCT03970616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096489|NCT03815474|Epirubicin|epirubicin|mesh-list
93096490|NCT03815474|Ifosfamide|ifosfamide|mesh-list
93096491|NCT03815474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93096492|NCT03815474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096493|NCT03815474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93096494|NCT03815474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93096495|NCT03815474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096496|NCT03815474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096497|NCT03815474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93096498|NCT03815474|Alkylating Agents|alkylating agents|mesh-ancestor
93096500|NCT01302158|Ipragliflozin|ipragliflozin|mesh-list
93096501|NCT01302158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93096502|NCT01302158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93096503|NCT01302158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096504|NCT01302158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096505|NCT01302158|Immunologic Factors|immunologic factors|mesh-ancestor
93096506|NCT01302158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93096507|NCT01302158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096508|NCT01302236|Eplerenone|eplerenone|mesh-list
93096509|NCT01302236|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93096510|NCT01302236|Hormone Antagonists|hormone antagonists|mesh-ancestor
93096511|NCT01302236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096512|NCT01302236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096513|NCT01302236|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93096514|NCT01302236|Diuretics|diuretics|mesh-ancestor
93096515|NCT01302236|Natriuretic Agents|natriuretic agents|mesh-ancestor
93096516|NCT01302236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93096517|NCT01304264|Maleic acid|maleic acid|mesh-list
93096518|NCT01304264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096519|NCT01304264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096520|NCT01304342|Fentanyl|fentanyl|mesh-list
93096521|NCT01304342|Remifentanil|remifentanil|mesh-list
93096522|NCT01304342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93096523|NCT01304342|Narcotics|narcotics|mesh-ancestor
93096524|NCT01304342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096525|NCT01304342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096526|NCT01304342|Analgesics|analgesics|mesh-ancestor
93096527|NCT01304342|Sensory System Agents|sensory system agents|mesh-ancestor
93096528|NCT01304342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096529|NCT01304342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93096530|NCT01304342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93096531|NCT01304342|Anesthetics, General|anesthetics, general|mesh-ancestor
93096532|NCT01304342|Anesthetics|anesthetics|mesh-ancestor
93096533|NCT03653546|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93096534|NCT03653546|Gefitinib|gefitinib|mesh-list
93096535|NCT03653546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096536|NCT03653546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096537|NCT03653546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096538|NCT03653546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096539|NCT03812354|Nicotine|nicotine|mesh-list
93096540|NCT03812354|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93096541|NCT03812354|Autonomic Agents|autonomic agents|mesh-ancestor
93096542|NCT03812354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096543|NCT03812354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096544|NCT03812354|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93096545|NCT03812354|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93096546|NCT03812354|Cholinergic Agents|cholinergic agents|mesh-ancestor
93096547|NCT03812354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096548|NCT03812354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096549|NCT03812120|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93096550|NCT03812120|Hemostatics|hemostatics|mesh-ancestor
93096551|NCT03812120|Coagulants|coagulants|mesh-ancestor
93096552|NCT03796364|Endostar protein|endostar protein|mesh-list
93096553|NCT03796364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93096554|NCT03796364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93096555|NCT03796364|Growth Substances|growth substances|mesh-ancestor
93096556|NCT03796364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096557|NCT03796364|Growth Inhibitors|growth inhibitors|mesh-ancestor
93096558|NCT03796364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096559|NCT03795584|Hemostatics|hemostatics|mesh-list
93096560|NCT03795584|Coagulants|coagulants|mesh-ancestor
93096561|NCT03792776|Lidocaine|lidocaine|mesh-list
93096562|NCT03792776|Anesthetics|anesthetics|mesh-list
93096563|NCT03792776|Anesthetics, Local|anesthetics, local|mesh-ancestor
93096564|NCT03792776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096565|NCT03792776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096566|NCT03792776|Sensory System Agents|sensory system agents|mesh-ancestor
92686857|NCT00493233|Antidepressive Agents|antidepressive agents|mesh-ancestor
93096567|NCT03792776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096568|NCT03792776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93096569|NCT03792776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93096570|NCT03792776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93096571|NCT03792776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93096572|NCT03792776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096573|NCT03795272|Rucaparib|rucaparib|mesh-list
93096574|NCT03795272|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93096575|NCT03795272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096576|NCT03795272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096577|NCT03795272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096578|NCT00980954|Paclitaxel|paclitaxel|mesh-list
93096579|NCT00980954|Carboplatin|carboplatin|mesh-list
93096580|NCT00980954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096581|NCT00980954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096582|NCT00980954|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096583|NCT00980954|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096584|NCT00980954|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096585|NCT00980954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096586|NCT00956930|Doxorubicin|doxorubicin|mesh-list
93096587|NCT00956930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93096588|NCT00956930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93096589|NCT00956930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096590|NCT00956930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93096591|NCT00956930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93096592|NCT00956930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096593|NCT00956930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096594|NCT00080756|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93096595|NCT00080756|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93096596|NCT00080756|Estradiol|estradiol|mesh-list
93096597|NCT00080756|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93096598|NCT00080756|Testosterone|testosterone|mesh-list
93096599|NCT00080756|Deslorelin|deslorelin|mesh-list
93096600|NCT00080756|Estrogens|estrogens|mesh-ancestor
93096601|NCT00080756|Hormones|hormones|mesh-ancestor
93096602|NCT00080756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096603|NCT00080756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096604|NCT00080756|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93096605|NCT00080756|Contraceptive Agents|contraceptive agents|mesh-ancestor
93096606|NCT00080756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93096607|NCT00080756|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93096608|NCT00080756|Androgens|androgens|mesh-ancestor
93096609|NCT00080756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096610|NCT00080756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096611|NCT03792620|Daratumumab|daratumumab|mesh-list
93096612|NCT03792620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096613|NCT05027594|Dexamethasone|dexamethasone|mesh-list
93096614|NCT05027594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096615|NCT05027594|Antiemetics|antiemetics|mesh-ancestor
93096616|NCT05027594|Autonomic Agents|autonomic agents|mesh-ancestor
93096617|NCT05027594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096618|NCT05027594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096619|NCT05027594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096620|NCT05027594|Glucocorticoids|glucocorticoids|mesh-ancestor
93096621|NCT05027594|Hormones|hormones|mesh-ancestor
93096622|NCT05027594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096623|NCT05027594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096624|NCT05027594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096625|NCT03811418|Docetaxel|docetaxel|mesh-list
93096626|NCT03811418|Trastuzumab|trastuzumab|mesh-list
93096627|NCT03811418|Vinorelbine|vinorelbine|mesh-list
93096628|NCT03811418|Pertuzumab|pertuzumab|mesh-list
93096629|NCT03811418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096630|NCT03811418|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096631|NCT03811418|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096632|NCT03811418|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096633|NCT03811418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096634|NCT03811418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096635|NCT03811418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096636|NCT03794492|Mycophenolic Acid|mycophenolic acid|mesh-list
93096637|NCT03794492|Methylprednisolone|methylprednisolone|mesh-list
93096638|NCT03794492|Prednisolone|prednisolone|mesh-list
93096639|NCT03794492|Tacrolimus|tacrolimus|mesh-list
93096640|NCT03794492|Basiliximab|basiliximab|mesh-list
93096641|NCT03794492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096642|NCT03794492|Immunologic Factors|immunologic factors|mesh-ancestor
93096643|NCT03794492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096644|NCT03794492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93096645|NCT03794492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096646|NCT03794492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096647|NCT03794492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93096648|NCT03794492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096649|NCT03794492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93096650|NCT03794492|Antitubercular Agents|antitubercular agents|mesh-ancestor
93096651|NCT03794492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096652|NCT03794492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096653|NCT03794492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096654|NCT03794492|Antiemetics|antiemetics|mesh-ancestor
93096655|NCT03794492|Autonomic Agents|autonomic agents|mesh-ancestor
93096656|NCT03794492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096657|NCT03794492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096658|NCT03794492|Glucocorticoids|glucocorticoids|mesh-ancestor
93096659|NCT03794492|Hormones|hormones|mesh-ancestor
93096660|NCT03794492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096661|NCT03794492|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93096662|NCT03794492|Protective Agents|protective agents|mesh-ancestor
93096663|NCT03794492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096664|NCT03792152|Warfarin|warfarin|mesh-list
93096665|NCT03792152|Rivaroxaban|rivaroxaban|mesh-list
93096666|NCT03792152|Anticoagulants|anticoagulants|mesh-ancestor
93096667|NCT03792152|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93096668|NCT03792152|Antithrombins|antithrombins|mesh-ancestor
93096669|NCT03792152|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93096670|NCT03792152|Protease Inhibitors|protease inhibitors|mesh-ancestor
93096671|NCT03792152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096672|NCT03792152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096673|NCT00262067|Bevacizumab|bevacizumab|mesh-list
93096674|NCT00262067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096675|NCT00262067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096676|NCT00262067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93096677|NCT00262067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93096678|NCT00262067|Growth Substances|growth substances|mesh-ancestor
93096679|NCT00262067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096680|NCT00262067|Growth Inhibitors|growth inhibitors|mesh-ancestor
93096681|NCT00275561|Fluticasone|fluticasone|mesh-list
93096682|NCT00275561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096683|NCT00275561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93096684|NCT00275561|Autonomic Agents|autonomic agents|mesh-ancestor
93096685|NCT00275561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096686|NCT00275561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096687|NCT00275561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93096688|NCT00275561|Respiratory System Agents|respiratory system agents|mesh-ancestor
93096689|NCT00275561|Dermatologic Agents|dermatologic agents|mesh-ancestor
93096690|NCT00275561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93096691|NCT03810872|Paclitaxel|paclitaxel|mesh-list
93096692|NCT03810872|Afatinib|afatinib|mesh-list
93096693|NCT03810872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096694|NCT03810872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096695|NCT03810872|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096696|NCT03810872|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096697|NCT03810872|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096698|NCT03810872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096699|NCT03810872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096700|NCT03810872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096701|NCT05569148|Faricimab|faricimab|mesh-list
93096702|NCT05569148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93096703|NCT05569148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93096704|NCT05569148|Growth Substances|growth substances|mesh-ancestor
93096705|NCT05569148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096706|NCT05569148|Growth Inhibitors|growth inhibitors|mesh-ancestor
93096707|NCT05569148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096708|NCT03794180|Plonmarlimab|plonmarlimab|mesh-list
93096709|NCT03794180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096710|NCT03794180|Antiviral Agents|antiviral agents|mesh-ancestor
93096711|NCT03794180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096712|NCT00274937|Cisplatin|cisplatin|mesh-list
93096713|NCT00274937|Fluorouracil|fluorouracil|mesh-list
93096714|NCT00274937|Amifostine|amifostine|mesh-list
93096715|NCT00274937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096716|NCT00274937|Antimetabolites|antimetabolites|mesh-ancestor
93096717|NCT00274937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096718|NCT00274937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93096719|NCT00274937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93096721|NCT00274937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096722|NCT00274937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93096723|NCT00274937|Protective Agents|protective agents|mesh-ancestor
93096724|NCT03792074|Paclitaxel|paclitaxel|mesh-list
93096725|NCT03792074|Bevacizumab|bevacizumab|mesh-list
93096726|NCT03792074|Carboplatin|carboplatin|mesh-list
93096727|NCT03792074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096728|NCT03792074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096729|NCT03792074|Tubulin Modulators|tubulin modulators|mesh-ancestor
93096730|NCT03792074|Antimitotic Agents|antimitotic agents|mesh-ancestor
93096731|NCT03792074|Mitosis Modulators|mitosis modulators|mesh-ancestor
93096732|NCT03792074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096733|NCT03792074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93096734|NCT03792074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93096735|NCT03792074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93096736|NCT03792074|Growth Substances|growth substances|mesh-ancestor
93096737|NCT03792074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096738|NCT03792074|Growth Inhibitors|growth inhibitors|mesh-ancestor
93096739|NCT00251693|Lansoprazole|lansoprazole|mesh-list
93096740|NCT00251693|Dexlansoprazole|dexlansoprazole|mesh-list
93096741|NCT00251693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93096742|NCT00251693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096743|NCT00251693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93096744|NCT00251693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096745|NCT00251693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096746|NCT03791918|Lenvatinib|lenvatinib|mesh-list
93096747|NCT03791918|Chlorotrianisene|chlorotrianisene|mesh-list
93096748|NCT03791918|Antibodies|antibodies|mesh-list
93096749|NCT03791918|Immunoglobulins|immunoglobulins|mesh-list
93096750|NCT03791918|Immunologic Factors|immunologic factors|mesh-ancestor
93096751|NCT03791918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096752|NCT03791918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096753|NCT03791918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096754|NCT03791918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096755|NCT03791918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096756|NCT03791918|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93096757|NCT03791918|Estrogens|estrogens|mesh-ancestor
93096758|NCT03791918|Hormones|hormones|mesh-ancestor
93096759|NCT03791918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096760|NCT03791918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93096761|NCT00250835|Celecoxib|celecoxib|mesh-list
93096762|NCT00250835|Capecitabine|capecitabine|mesh-list
93096763|NCT00250835|Oxaliplatin|oxaliplatin|mesh-list
93096764|NCT00250835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93096765|NCT00250835|Antimetabolites|antimetabolites|mesh-ancestor
93096766|NCT00250835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096767|NCT00250835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096768|NCT00250835|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93096769|NCT00250835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096770|NCT00250835|Analgesics|analgesics|mesh-ancestor
93096771|NCT00250835|Sensory System Agents|sensory system agents|mesh-ancestor
93096772|NCT00250835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096773|NCT00250835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096774|NCT00250835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096775|NCT00250835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096776|NCT00250835|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93096777|NCT00250835|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93096778|NCT00250835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096779|NCT01303094|Trabectedin|trabectedin|mesh-list
93096780|NCT01303094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93096781|NCT01303094|Alkylating Agents|alkylating agents|mesh-ancestor
93096782|NCT01303094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096783|NCT01303094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096784|NCT04785326|Ustekinumab|ustekinumab|mesh-list
93096785|NCT04785326|Dermatologic Agents|dermatologic agents|mesh-ancestor
93096786|NCT03791762|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
93096787|NCT03791762|Vasodilator Agents|vasodilator agents|mesh-ancestor
93096788|NCT03791762|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93096789|NCT03791762|Protective Agents|protective agents|mesh-ancestor
93096790|NCT03791762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769057|NCT05228041|Benralizumab|benralizumab|mesh-list
93096791|NCT04663568|Levonorgestrel|levonorgestrel|mesh-list
93096792|NCT04663568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93096793|NCT04663568|Contraceptive Agents|contraceptive agents|mesh-ancestor
93096794|NCT04663568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93096795|NCT04663568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096796|NCT04663568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93096797|NCT04663568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93096798|NCT04663568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93096799|NCT03789032|Rabeprazole|rabeprazole|mesh-list
93096800|NCT03789032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93096801|NCT03789032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096802|NCT03789032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93096803|NCT03789032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096804|NCT03789032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096805|NCT01306370|Tranexamic Acid|tranexamic acid|mesh-list
93096806|NCT01306370|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93096807|NCT01306370|Hemostatics|hemostatics|mesh-list
93096808|NCT01306370|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93096809|NCT01306370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93096810|NCT01306370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096811|NCT01306370|Coagulants|coagulants|mesh-ancestor
93096812|NCT03716024|Linezolid|linezolid|mesh-list
93096813|NCT03716024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096814|NCT03716024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096815|NCT03716024|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93096816|NCT03716024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096817|NCT03716024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096818|NCT00250679|Formoterol Fumarate|formoterol fumarate|mesh-list
93096819|NCT00250679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93096820|NCT00250679|Autonomic Agents|autonomic agents|mesh-ancestor
93096821|NCT00250679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096822|NCT00250679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096823|NCT00250679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93096824|NCT00250679|Respiratory System Agents|respiratory system agents|mesh-ancestor
93096825|NCT00250679|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93096826|NCT00250679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93096827|NCT00250679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93096828|NCT00250679|Adrenergic Agents|adrenergic agents|mesh-ancestor
93096829|NCT00250679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096830|NCT00250679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096831|NCT03791294|Titanium dioxide|titanium dioxide|mesh-list
93096832|NCT03791294|Hyaluronic Acid|hyaluronic acid|mesh-list
93096833|NCT03791294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93096834|NCT03791294|Immunologic Factors|immunologic factors|mesh-ancestor
93096835|NCT03791294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096836|NCT03791294|Viscosupplements|viscosupplements|mesh-ancestor
93096837|NCT03791294|Protective Agents|protective agents|mesh-ancestor
93096838|NCT03791294|Sunscreening Agents|sunscreening agents|mesh-ancestor
93096839|NCT03791294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93096840|NCT03791294|Dermatologic Agents|dermatologic agents|mesh-ancestor
93096841|NCT03791294|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93096842|NCT01567358|Infliximab|infliximab|mesh-list
93096843|NCT01567358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93096844|NCT01567358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096845|NCT01567358|Dermatologic Agents|dermatologic agents|mesh-ancestor
93096846|NCT01567358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93096847|NCT01567358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096848|NCT00261833|Protease Inhibitors|protease inhibitors|mesh-list
93096849|NCT00261833|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93096850|NCT00261833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096851|NCT00261833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096852|NCT00261833|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93096853|NCT00261833|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93096854|NCT01308242|Sevelamer|sevelamer|mesh-list
93096855|NCT01308242|Chelating Agents|chelating agents|mesh-ancestor
93096856|NCT01308242|Sequestering Agents|sequestering agents|mesh-ancestor
93096857|NCT01308242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096858|NCT01308320|Fentanyl|fentanyl|mesh-list
93096859|NCT01308320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93096860|NCT01308320|Narcotics|narcotics|mesh-ancestor
93096861|NCT01308320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096862|NCT01308320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096863|NCT01308320|Analgesics|analgesics|mesh-ancestor
93096864|NCT01308320|Sensory System Agents|sensory system agents|mesh-ancestor
93096865|NCT01308320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096866|NCT01308320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93096867|NCT01308320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93096868|NCT01308320|Anesthetics, General|anesthetics, general|mesh-ancestor
93096869|NCT01308320|Anesthetics|anesthetics|mesh-ancestor
93096870|NCT01306760|Ketamine|ketamine|mesh-list
93096871|NCT01306760|Propofol|propofol|mesh-list
93096872|NCT01306760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93096873|NCT01306760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096874|NCT01306760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096875|NCT01306760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93096876|NCT01306760|Anesthetics, General|anesthetics, general|mesh-ancestor
93096877|NCT01306760|Anesthetics|anesthetics|mesh-ancestor
93096878|NCT01306760|Analgesics|analgesics|mesh-ancestor
93096879|NCT01306760|Sensory System Agents|sensory system agents|mesh-ancestor
93096880|NCT01306760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096881|NCT01306760|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93096882|NCT01306760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93096883|NCT01306760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93096884|NCT01306760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096885|NCT01306760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096886|NCT03787940|Isoniazid|isoniazid|mesh-list
93096887|NCT03787940|Antitubercular Agents|antitubercular agents|mesh-ancestor
93096888|NCT03787940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93096889|NCT03787940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096890|NCT03787940|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93096891|NCT03787940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93096892|NCT03787940|Antimetabolites|antimetabolites|mesh-ancestor
93096893|NCT03787940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096894|NCT03787940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93096895|NCT03788018|Lidocaine|lidocaine|mesh-list
93096896|NCT03788018|Dexmedetomidine|dexmedetomidine|mesh-list
93096897|NCT03788018|Anesthetics, Local|anesthetics, local|mesh-ancestor
93096898|NCT03788018|Anesthetics|anesthetics|mesh-ancestor
93096899|NCT03788018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096900|NCT03788018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096901|NCT03788018|Sensory System Agents|sensory system agents|mesh-ancestor
93096902|NCT03788018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096903|NCT03788018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93096904|NCT03788018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93096905|NCT03788018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93096906|NCT03788018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93096907|NCT03788018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096908|NCT03788018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93096909|NCT03788018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096910|NCT03788018|Analgesics|analgesics|mesh-ancestor
93096911|NCT03788018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93096912|NCT03788018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93096913|NCT03788018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93096914|NCT03788018|Adrenergic Agents|adrenergic agents|mesh-ancestor
93096915|NCT03788018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096916|NCT03785756|Ibuprofen|ibuprofen|mesh-list
93096917|NCT03785756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93096918|NCT03785756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93096919|NCT03785756|Analgesics|analgesics|mesh-ancestor
93096920|NCT03785756|Sensory System Agents|sensory system agents|mesh-ancestor
93096921|NCT03785756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096922|NCT03785756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096923|NCT03785756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93096924|NCT03785756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93096925|NCT03785756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93096926|NCT03785756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096927|NCT03785756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096928|NCT03788174|Apatinib|apatinib|mesh-list
93096929|NCT03788174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096930|NCT03788174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93096931|NCT03788174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096932|NCT03788174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096933|NCT03787550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93096934|NCT03787550|Analgesics|analgesics|mesh-list
93096935|NCT03787550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93096936|NCT03787550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096937|NCT03787550|Sensory System Agents|sensory system agents|mesh-ancestor
93096938|NCT03787550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096939|NCT03787550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096940|NCT03787550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096941|NCT03790358|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92769206|NCT04223661|Antiemetics|antiemetics|mesh-ancestor
93096942|NCT03790358|Hallucinogens|hallucinogens|mesh-ancestor
92687254|NCT04326166|Metformin|metformin|mesh-list
93096943|NCT03790358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096944|NCT03790358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93096945|NCT03790358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93096946|NCT03790358|Serotonin Agents|serotonin agents|mesh-ancestor
93096947|NCT03790358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93096948|NCT03790358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096949|NCT03790358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93096951|NCT03789890|Antifungal Agents|antifungal agents|mesh-ancestor
93096952|NCT03789890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93096953|NCT03789890|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93096954|NCT03789890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93096955|NCT03789890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096956|NCT03789890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096957|NCT03789890|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93096958|NCT03789890|Hormone Antagonists|hormone antagonists|mesh-ancestor
93096959|NCT03789890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93096960|NCT03789890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096961|NCT03789890|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93096962|NCT01308554|Bupivacaine|bupivacaine|mesh-list
93096963|NCT01308554|Anesthetics, Local|anesthetics, local|mesh-ancestor
93096964|NCT01308554|Anesthetics|anesthetics|mesh-ancestor
93096965|NCT01308554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096966|NCT01308554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096967|NCT01308554|Sensory System Agents|sensory system agents|mesh-ancestor
93096968|NCT01308554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096969|NCT05693402|Analgesics, Opioid|analgesics, opioid|mesh-list
93096970|NCT05693402|Anesthetics|anesthetics|mesh-list
93096971|NCT05693402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93096972|NCT05693402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096973|NCT05693402|Narcotics|narcotics|mesh-ancestor
93096974|NCT05693402|Analgesics|analgesics|mesh-ancestor
93096975|NCT05693402|Sensory System Agents|sensory system agents|mesh-ancestor
93096976|NCT05693402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93096977|NCT05694728|Vaccines|vaccines|mesh-list
93096978|NCT05694728|Immunologic Factors|immunologic factors|mesh-ancestor
93096979|NCT05694728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096980|NCT01308632|Irinotecan|irinotecan|mesh-list
93096981|NCT01308632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93096982|NCT01308632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93096983|NCT01308632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096984|NCT01308632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096985|NCT01308632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096986|NCT03713684|Efpeglenatide|efpeglenatide|mesh-list
93096987|NCT03713684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93096988|NCT03713684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096989|NCT03785522|Insulin|insulin|mesh-list
93096990|NCT03785522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93096991|NCT03785522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93096992|NCT05694416|Etoposide|etoposide|mesh-list
93096993|NCT05694416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93096994|NCT05694416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93096995|NCT05694416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93096996|NCT05694416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93096997|NCT05694416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93096998|NCT05694416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93096999|NCT03789422|Cetirizine|cetirizine|mesh-list
93097000|NCT03789422|Tranexamic Acid|tranexamic acid|mesh-list
93097001|NCT03789422|Levocetirizine|levocetirizine|mesh-list
93097002|NCT03789422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93097003|NCT03789422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93097004|NCT03789422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097005|NCT03789422|Hemostatics|hemostatics|mesh-ancestor
93097006|NCT03789422|Coagulants|coagulants|mesh-ancestor
93097007|NCT03789422|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93097008|NCT03789422|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93097009|NCT03789422|Histamine Antagonists|histamine antagonists|mesh-ancestor
93097010|NCT03789422|Histamine Agents|histamine agents|mesh-ancestor
93097011|NCT03789422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097012|NCT03789422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097013|NCT03789422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93097014|NCT04751084|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92769284|NCT04208581|Fluticasone|fluticasone|mesh-list
93097015|NCT04751084|Parasympatholytics|parasympatholytics|mesh-ancestor
93097016|NCT04751084|Autonomic Agents|autonomic agents|mesh-ancestor
93097017|NCT04751084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097018|NCT04751084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097019|NCT04751084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93097020|NCT04751084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93097021|NCT04751084|Cholinergic Agents|cholinergic agents|mesh-ancestor
93097022|NCT04751084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097023|NCT04751084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097024|NCT05690048|Vancomycin|vancomycin|mesh-list
93097025|NCT05690048|Bevacizumab|bevacizumab|mesh-list
93097026|NCT05690048|Atezolizumab|atezolizumab|mesh-list
93097027|NCT05690048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097028|NCT05690048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097029|NCT05690048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93097030|NCT05690048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93097031|NCT05690048|Growth Substances|growth substances|mesh-ancestor
93097032|NCT05690048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097033|NCT05690048|Growth Inhibitors|growth inhibitors|mesh-ancestor
93097034|NCT05690048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097035|NCT05690048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097036|NCT05690048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097037|NCT05690048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097038|NCT01308086|Leucovorin|leucovorin|mesh-list
93097039|NCT01308086|Fluorouracil|fluorouracil|mesh-list
93097040|NCT01308086|Capecitabine|capecitabine|mesh-list
93097041|NCT01308086|Oxaliplatin|oxaliplatin|mesh-list
93097042|NCT01308086|Levoleucovorin|levoleucovorin|mesh-list
93097043|NCT01308086|Antimetabolites|antimetabolites|mesh-ancestor
93097044|NCT01308086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097045|NCT01308086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93097046|NCT01308086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097047|NCT01308086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93097048|NCT01308086|Immunologic Factors|immunologic factors|mesh-ancestor
93097049|NCT01308086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097050|NCT01308086|Antidotes|antidotes|mesh-ancestor
93097051|NCT01308086|Protective Agents|protective agents|mesh-ancestor
93097052|NCT01308086|Vitamin B Complex|vitamin b complex|mesh-ancestor
93097053|NCT01308086|Vitamins|vitamins|mesh-ancestor
93097054|NCT01308086|Micronutrients|micronutrients|mesh-ancestor
93097055|NCT05443802|Insulin|insulin|mesh-list
93097056|NCT05443802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93097057|NCT05443802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93097058|NCT05443802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097059|NCT01308944|Propranolol|propranolol|mesh-list
93097060|NCT01308944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93097061|NCT01308944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93097062|NCT01308944|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097063|NCT01308944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097064|NCT01308944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097065|NCT01308944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097066|NCT01308944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097067|NCT01308944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097068|NCT01308944|Vasodilator Agents|vasodilator agents|mesh-ancestor
93097069|NCT03777488|Tranexamic Acid|tranexamic acid|mesh-list
93097070|NCT03777488|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93097071|NCT03777488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93097072|NCT03777488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097073|NCT03777488|Hemostatics|hemostatics|mesh-ancestor
93097074|NCT03777488|Coagulants|coagulants|mesh-ancestor
93097075|NCT03777254|RC28-E protein|rc28-e protein|mesh-list
93097076|NCT03777254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93097077|NCT03777254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93097078|NCT03777254|Growth Substances|growth substances|mesh-ancestor
93097079|NCT03777254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097080|NCT03777254|Growth Inhibitors|growth inhibitors|mesh-ancestor
93097081|NCT03777254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097082|NCT01312298|Bupivacaine|bupivacaine|mesh-list
93097083|NCT01312298|Anesthetics|anesthetics|mesh-list
93097084|NCT01312298|Propofol|propofol|mesh-list
93097085|NCT01312298|Succinylcholine|succinylcholine|mesh-list
93097086|NCT01312298|Anesthetics, Local|anesthetics, local|mesh-ancestor
93097087|NCT01312298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097088|NCT01312298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097089|NCT01312298|Sensory System Agents|sensory system agents|mesh-ancestor
93097090|NCT01312298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097091|NCT01312298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097092|NCT01312298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097093|NCT01312298|Anesthetics, General|anesthetics, general|mesh-ancestor
93097094|NCT01312298|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93097095|NCT01312298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93097096|NCT01312298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93097097|NCT01309022|Mycophenolic Acid|mycophenolic acid|mesh-list
93097098|NCT01309022|Sirolimus|sirolimus|mesh-list
93097099|NCT01309022|Tacrolimus|tacrolimus|mesh-list
93097100|NCT01309022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93097101|NCT01309022|Immunologic Factors|immunologic factors|mesh-ancestor
93097102|NCT01309022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097103|NCT01309022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93097104|NCT01309022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097105|NCT01309022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097106|NCT01309022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93097107|NCT01309022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097108|NCT01309022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93097109|NCT01309022|Antitubercular Agents|antitubercular agents|mesh-ancestor
93097110|NCT01309022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097111|NCT01309022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097112|NCT01309022|Antifungal Agents|antifungal agents|mesh-ancestor
93097113|NCT01560962|Azithromycin|azithromycin|mesh-list
93097114|NCT01560962|Tobramycin|tobramycin|mesh-list
93097115|NCT01560962|Povidone-Iodine|povidone-iodine|mesh-list
93097116|NCT01560962|Povidone|povidone|mesh-list
93097117|NCT01560962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097118|NCT01560962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097119|NCT01560962|Plasma Substitutes|plasma substitutes|mesh-ancestor
93097120|NCT01560962|Blood Substitutes|blood substitutes|mesh-ancestor
93097121|NCT01560962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93097122|NCT05401058|Droperidol|droperidol|mesh-list
93097123|NCT05401058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93097124|NCT05401058|Antiemetics|antiemetics|mesh-ancestor
93097125|NCT05401058|Autonomic Agents|autonomic agents|mesh-ancestor
93097126|NCT05401058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097127|NCT05401058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097128|NCT05401058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097129|NCT05401058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93097130|NCT05401058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93097131|NCT05401058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097132|NCT05401058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93097133|NCT05401058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93097134|NCT05401058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93097135|NCT05401058|Dopamine Agents|dopamine agents|mesh-ancestor
93097136|NCT05401058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097137|NCT05401058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097138|NCT03781466|Progesterone|progesterone|mesh-list
93097139|NCT03781466|Progestins|progestins|mesh-ancestor
93097140|NCT03781466|Hormones|hormones|mesh-ancestor
93097141|NCT03781466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097142|NCT03781466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097143|NCT03150862|Pamiparib|pamiparib|mesh-list
93097144|NCT03150862|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93097145|NCT03150862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097146|NCT03150862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097147|NCT03150862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097148|NCT01318928|Metronidazole|metronidazole|mesh-list
93097149|NCT01318928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097150|NCT01318928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097151|NCT01318928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93097152|NCT01318928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93097153|NCT01309178|Mannitol|mannitol|mesh-list
93097154|NCT01309178|Amitriptyline|amitriptyline|mesh-list
93097155|NCT01309178|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93097156|NCT01309178|Antidepressive Agents|antidepressive agents|mesh-ancestor
93097157|NCT01309178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93097158|NCT01309178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93097159|NCT01309178|Analgesics|analgesics|mesh-ancestor
93097160|NCT01309178|Sensory System Agents|sensory system agents|mesh-ancestor
93097161|NCT01309178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097162|NCT01309178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097163|NCT01309178|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93097164|NCT01309178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93097165|NCT01309178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097166|NCT01309178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097167|NCT01309178|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097168|NCT01309178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097169|NCT01309178|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93097170|NCT01309178|Diuretics|diuretics|mesh-ancestor
93097171|NCT01309178|Natriuretic Agents|natriuretic agents|mesh-ancestor
93097172|NCT01335334|Metronidazole|metronidazole|mesh-list
93097173|NCT01335334|Tetracycline|tetracycline|mesh-list
93097174|NCT01335334|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
93097175|NCT01335334|Omeprazole|omeprazole|mesh-list
93097176|NCT01335334|Bismuth|bismuth|mesh-list
93097177|NCT01335334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097178|NCT01335334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097179|NCT01335334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93097180|NCT01335334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93097181|NCT01335334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93097182|NCT01335334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097183|NCT01335334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93097184|NCT01335334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097185|NCT01335334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097186|NCT01335334|Antacids|antacids|mesh-ancestor
93097187|NCT01335334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93097188|NCT01344304|Aprepitant|aprepitant|mesh-list
93097189|NCT01344304|Fosaprepitant|fosaprepitant|mesh-list
93097190|NCT01344304|Antiemetics|antiemetics|mesh-ancestor
93097191|NCT01344304|Autonomic Agents|autonomic agents|mesh-ancestor
93097192|NCT01344304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097193|NCT01344304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097194|NCT01344304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097195|NCT01344304|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93097196|NCT01344304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097197|NCT01344304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097198|NCT01320020|Catumaxomab|catumaxomab|mesh-list
93097199|NCT01320020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097200|NCT05312762|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93097201|NCT05312762|Chitosan|chitosan|mesh-list
93097202|NCT05312762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097203|NCT05312762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097204|NCT05312762|Antimetabolites|antimetabolites|mesh-ancestor
93097205|NCT05312762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097206|NCT05312762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097207|NCT05312762|Chelating Agents|chelating agents|mesh-ancestor
93097208|NCT05312762|Sequestering Agents|sequestering agents|mesh-ancestor
93097209|NCT05312762|Hemostatics|hemostatics|mesh-ancestor
93097210|NCT05312762|Coagulants|coagulants|mesh-ancestor
93097211|NCT05312762|Laxatives|laxatives|mesh-ancestor
93097212|NCT05312762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097213|NCT00379288|Fluticasone|fluticasone|mesh-list
93097214|NCT00379288|Xhance|xhance|mesh-list
93097215|NCT00379288|Mometasone Furoate|mometasone furoate|mesh-list
93097216|NCT00379288|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93097217|NCT00379288|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93097218|NCT00379288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93097219|NCT00379288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93097220|NCT00379288|Autonomic Agents|autonomic agents|mesh-ancestor
93097221|NCT00379288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097222|NCT00379288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097223|NCT00379288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93097224|NCT00379288|Respiratory System Agents|respiratory system agents|mesh-ancestor
93097225|NCT00379288|Dermatologic Agents|dermatologic agents|mesh-ancestor
93097226|NCT00379288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93097227|NCT00379288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93097228|NCT00379288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93097229|NCT00379288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93097230|NCT00379288|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097231|NCT00379288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097232|NCT00379288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097233|NCT00379288|Glucocorticoids|glucocorticoids|mesh-ancestor
93097234|NCT00379288|Hormones|hormones|mesh-ancestor
93097235|NCT00379288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097236|NCT00379288|Sympathomimetics|sympathomimetics|mesh-ancestor
93097237|NCT03784040|Nivolumab|nivolumab|mesh-list
93097238|NCT03784040|Ipilimumab|ipilimumab|mesh-list
93097239|NCT03784040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097240|NCT03784040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097241|NCT03784040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097242|NCT03784040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097243|NCT00243503|Trastuzumab|trastuzumab|mesh-list
93097244|NCT00243503|Sunitinib|sunitinib|mesh-list
93097245|NCT00243503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097246|NCT00243503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097247|NCT00243503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93097248|NCT00243503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93097249|NCT00243503|Growth Substances|growth substances|mesh-ancestor
93097250|NCT00243503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097251|NCT00243503|Growth Inhibitors|growth inhibitors|mesh-ancestor
93097252|NCT00243503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93097253|NCT00243503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097254|NCT00243503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097255|NCT03780686|Dopamine|dopamine|mesh-list
93097256|NCT03780686|Norepinephrine|norepinephrine|mesh-list
93097257|NCT03780686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93097258|NCT03780686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93097259|NCT03780686|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097260|NCT03780686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097261|NCT03780686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097262|NCT03780686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097263|NCT03780686|Sympathomimetics|sympathomimetics|mesh-ancestor
93097264|NCT03780686|Autonomic Agents|autonomic agents|mesh-ancestor
93097265|NCT03780686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097266|NCT03780686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93097267|NCT03780686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93097268|NCT03780686|Dopamine Agents|dopamine agents|mesh-ancestor
93097269|NCT03780686|Protective Agents|protective agents|mesh-ancestor
93097270|NCT00338260|Atenolol|atenolol|mesh-list
93097271|NCT00338260|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097272|NCT00338260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097273|NCT00338260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097274|NCT00338260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097275|NCT00338260|Autonomic Agents|autonomic agents|mesh-ancestor
93097276|NCT00338260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097277|NCT00338260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097278|NCT00338260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097279|NCT00338260|Sympatholytics|sympatholytics|mesh-ancestor
93097280|NCT00338260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93097281|NCT00338260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93097282|NCT00338260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93097283|NCT03775928|Capecitabine|capecitabine|mesh-list
93097284|NCT03775928|Apatinib|apatinib|mesh-list
93097285|NCT03775928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93097286|NCT03775928|Antimetabolites|antimetabolites|mesh-ancestor
93097287|NCT03775928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097288|NCT03775928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097289|NCT03775928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93097290|NCT03775928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097291|NCT03775538|Dopamine|dopamine|mesh-list
93097292|NCT03775538|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93097293|NCT03775538|Sympathomimetics|sympathomimetics|mesh-ancestor
93097294|NCT03775538|Autonomic Agents|autonomic agents|mesh-ancestor
93097295|NCT03775538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097296|NCT03775538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097297|NCT03775538|Dopamine Agents|dopamine agents|mesh-ancestor
93097298|NCT03775538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097299|NCT03775538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097300|NCT03775538|Protective Agents|protective agents|mesh-ancestor
93097301|NCT00259649|Eletriptan|eletriptan|mesh-list
93097302|NCT00259649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93097303|NCT00259649|Serotonin Agents|serotonin agents|mesh-ancestor
93097304|NCT00259649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097305|NCT00259649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097306|NCT00259649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097307|NCT05668988|Carboplatin|carboplatin|mesh-list
93097308|NCT05668988|Pemetrexed|pemetrexed|mesh-list
93097309|NCT05668988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097310|NCT05668988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097311|NCT05668988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097312|NCT05668988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93097313|NCT05668988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93097314|NCT01320176|Vaccines|vaccines|mesh-list
93097315|NCT01320176|Immunologic Factors|immunologic factors|mesh-ancestor
93097316|NCT01320176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097317|NCT01335646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93097318|NCT01335646|Analgesics|analgesics|mesh-list
93097319|NCT01335646|Sensory System Agents|sensory system agents|mesh-ancestor
93097320|NCT01335646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097321|NCT01335646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097322|NCT01309412|Siltuximab|siltuximab|mesh-list
93097323|NCT01309412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097324|NCT00307060|Losartan|losartan|mesh-list
93097325|NCT00307060|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93097326|NCT00307060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097327|NCT00307060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097328|NCT00307060|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93097329|NCT00307060|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93097330|NCT00307060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097331|NCT00307060|Diuretics|diuretics|mesh-ancestor
93097332|NCT00307060|Natriuretic Agents|natriuretic agents|mesh-ancestor
93097333|NCT00307060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097334|NCT00307060|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93097335|NCT00307060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097336|NCT01320254|Cisplatin|cisplatin|mesh-list
93097337|NCT01320254|Gemcitabine|gemcitabine|mesh-list
93097338|NCT01320254|Panitumumab|panitumumab|mesh-list
93097339|NCT01320254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93097340|NCT01320254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097341|NCT01320254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93097342|NCT01320254|Antimetabolites|antimetabolites|mesh-ancestor
93097343|NCT01320254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097344|NCT01320254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097345|NCT00092638|Ezetimibe|ezetimibe|mesh-list
93097346|NCT00092638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097347|NCT00092638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097348|NCT00092638|Antimetabolites|antimetabolites|mesh-ancestor
93097349|NCT00092638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097350|NCT00092638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097351|NCT03783728|Pyridoxine|pyridoxine|mesh-list
93097352|NCT03783728|Vitamin B 6|vitamin b 6|mesh-list
93097353|NCT03783728|Isoniazid|isoniazid|mesh-list
93097354|NCT03783728|Rifapentine|rifapentine|mesh-list
93097355|NCT03783728|Vitamins|vitamins|mesh-ancestor
93097356|NCT03783728|Micronutrients|micronutrients|mesh-ancestor
93097357|NCT03783728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097358|NCT03783728|Vitamin B Complex|vitamin b complex|mesh-ancestor
93097359|NCT03783728|Antitubercular Agents|antitubercular agents|mesh-ancestor
93097360|NCT03783728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097361|NCT03783728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097362|NCT03783728|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93097363|NCT03783728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097364|NCT03783728|Antimetabolites|antimetabolites|mesh-ancestor
93097365|NCT03783728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097366|NCT03783728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097367|NCT03783728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93097368|NCT03783728|Leprostatic Agents|leprostatic agents|mesh-ancestor
93097369|NCT03620422|Mannitol|mannitol|mesh-list
93097370|NCT03620422|Albuterol|albuterol|mesh-list
93097371|NCT03620422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93097372|NCT03620422|Autonomic Agents|autonomic agents|mesh-ancestor
93097373|NCT03620422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097374|NCT03620422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097375|NCT03620422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93097376|NCT03620422|Respiratory System Agents|respiratory system agents|mesh-ancestor
93097377|NCT03620422|Tocolytic Agents|tocolytic agents|mesh-ancestor
93097378|NCT03620422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93097379|NCT03620422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93097380|NCT03620422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93097381|NCT03620422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93097382|NCT03620422|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097383|NCT03620422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097384|NCT03620422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097385|NCT03620422|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93097386|NCT03620422|Diuretics|diuretics|mesh-ancestor
93097387|NCT03620422|Natriuretic Agents|natriuretic agents|mesh-ancestor
93097388|NCT01309490|Ribavirin|ribavirin|mesh-list
93097389|NCT01309490|Antimetabolites|antimetabolites|mesh-ancestor
93097390|NCT01309490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097391|NCT01309490|Antiviral Agents|antiviral agents|mesh-ancestor
93097392|NCT01309490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097393|NCT04883840|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93097394|NCT04883840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097395|NCT04883840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097396|NCT04883840|Antimetabolites|antimetabolites|mesh-ancestor
92769660|NCT02687269|Ranolazine|ranolazine|mesh-list
93097397|NCT04883840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097398|NCT04883840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097399|NCT04883840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93097400|NCT04883840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097401|NCT01345084|Nimotuzumab|nimotuzumab|mesh-list
93097402|NCT01345084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097403|NCT01345084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097404|NCT03783494|Propofol|propofol|mesh-list
93097405|NCT03783494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097406|NCT03783494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687681|NCT00601978|Levodopa|levodopa|mesh-list
93097407|NCT03783494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097408|NCT03783494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097409|NCT03783494|Anesthetics, General|anesthetics, general|mesh-ancestor
93097410|NCT03783494|Anesthetics|anesthetics|mesh-ancestor
93097411|NCT03774836|Morphine|morphine|mesh-list
93097412|NCT03774836|Tramadol|tramadol|mesh-list
93097413|NCT03774836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93097414|NCT03774836|Narcotics|narcotics|mesh-ancestor
93097415|NCT03774836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097416|NCT03774836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097417|NCT03774836|Analgesics|analgesics|mesh-ancestor
93097418|NCT03774836|Sensory System Agents|sensory system agents|mesh-ancestor
93097419|NCT03774836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097420|NCT03774680|Cetuximab|cetuximab|mesh-list
93097421|NCT03774680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097422|NCT03774680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097423|NCT03783338|Vitamin D|vitamin d|mesh-list
93097424|NCT03783338|Vitamins|vitamins|mesh-ancestor
93097425|NCT03783338|Micronutrients|micronutrients|mesh-ancestor
93097426|NCT03783338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097427|NCT03783338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93097428|NCT03774524|Misoprostol|misoprostol|mesh-list
93097429|NCT03774524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93097430|NCT03774524|Abortifacient Agents|abortifacient agents|mesh-ancestor
93097431|NCT03774524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93097432|NCT03774524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097433|NCT03774524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93097434|NCT03774524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097435|NCT03774524|Oxytocics|oxytocics|mesh-ancestor
93097436|NCT03773744|Cyclophosphamide|cyclophosphamide|mesh-list
93097437|NCT03773744|Pembrolizumab|pembrolizumab|mesh-list
93097438|NCT03773744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93097439|NCT03773744|Immunologic Factors|immunologic factors|mesh-ancestor
93097440|NCT03773744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097441|NCT03773744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93097442|NCT03773744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93097443|NCT03773744|Alkylating Agents|alkylating agents|mesh-ancestor
93097444|NCT03773744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097445|NCT03773744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097446|NCT03773744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93097447|NCT03773744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097448|NCT03773744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097449|NCT03779516|Lidocaine|lidocaine|mesh-list
93097450|NCT03779516|Anesthetics, Local|anesthetics, local|mesh-ancestor
93097451|NCT03779516|Anesthetics|anesthetics|mesh-ancestor
93097452|NCT03779516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097453|NCT03779516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097454|NCT03779516|Sensory System Agents|sensory system agents|mesh-ancestor
93097455|NCT03779516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097456|NCT03779516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097457|NCT03779516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93097458|NCT03779516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93097459|NCT03779516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097460|NCT03779516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097461|NCT03779594|Acetazolamide|acetazolamide|mesh-list
93097462|NCT03779594|Anticonvulsants|anticonvulsants|mesh-ancestor
93097463|NCT03779594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93097464|NCT03779594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097465|NCT03779594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097466|NCT03779594|Diuretics|diuretics|mesh-ancestor
93097467|NCT03779594|Natriuretic Agents|natriuretic agents|mesh-ancestor
93097468|NCT03779594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097469|NCT03779672|Memantine|memantine|mesh-list
93097470|NCT03779672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93097471|NCT03779672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93097472|NCT03779672|Dopamine Agents|dopamine agents|mesh-ancestor
93097473|NCT03779672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097474|NCT03779672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097475|NCT03779672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097476|NCT03779672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93097477|NCT03779672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93097478|NCT03779282|Dexmedetomidine|dexmedetomidine|mesh-list
93097479|NCT03779282|Ketamine|ketamine|mesh-list
93097480|NCT03779282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097481|NCT03779282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097482|NCT03779282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097483|NCT03779282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93097484|NCT03779282|Analgesics|analgesics|mesh-ancestor
93097485|NCT03779282|Sensory System Agents|sensory system agents|mesh-ancestor
93097486|NCT03779282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097487|NCT03779282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93097488|NCT03779282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93097489|NCT03779282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93097490|NCT03779282|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097491|NCT03779282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097492|NCT03779282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097493|NCT03779282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93097494|NCT03779282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097495|NCT03779282|Anesthetics, General|anesthetics, general|mesh-ancestor
93097496|NCT03779282|Anesthetics|anesthetics|mesh-ancestor
93097497|NCT03779282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93097498|NCT03779282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93097499|NCT03773588|Propofol|propofol|mesh-list
93097500|NCT03773588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097501|NCT03773588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097502|NCT03773588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097503|NCT03773588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097504|NCT03773588|Anesthetics, General|anesthetics, general|mesh-ancestor
93097505|NCT03773588|Anesthetics|anesthetics|mesh-ancestor
93097506|NCT03773510|Trabectedin|trabectedin|mesh-list
93097507|NCT03773510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93097508|NCT03773510|Alkylating Agents|alkylating agents|mesh-ancestor
93097509|NCT03773510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097510|NCT03773510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097511|NCT03779360|Clindamycin|clindamycin|mesh-list
93097512|NCT03779360|Clindamycin palmitate|clindamycin palmitate|mesh-list
93097513|NCT03779360|Clindamycin phosphate|clindamycin phosphate|mesh-list
93097514|NCT03779360|Erythromycin|erythromycin|mesh-list
93097515|NCT03779360|Erythromycin Estolate|erythromycin estolate|mesh-list
93097516|NCT03779360|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93097517|NCT03779360|Erythromycin stearate|erythromycin stearate|mesh-list
93097518|NCT03779360|Prednisolone|prednisolone|mesh-list
93097519|NCT03779360|Clobetasol|clobetasol|mesh-list
93097520|NCT03779360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93097521|NCT03779360|Glucocorticoids|glucocorticoids|mesh-ancestor
93097522|NCT03779360|Hormones|hormones|mesh-ancestor
93097523|NCT03779360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097524|NCT03779360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097525|NCT03779360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93097526|NCT03779360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097527|NCT03779360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097528|NCT03779360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097529|NCT03779360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097530|NCT03779360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93097531|NCT03779360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097532|NCT03779360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097533|NCT01320878|Iloprost|iloprost|mesh-list
93097534|NCT01320878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93097535|NCT01320878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93097536|NCT01320878|Vasodilator Agents|vasodilator agents|mesh-ancestor
93097537|NCT01321034|Niacin|niacin|mesh-list
93097538|NCT01321034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097539|NCT01321034|Antimetabolites|antimetabolites|mesh-ancestor
93097540|NCT01321034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097541|NCT01321034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097542|NCT01321034|Vasodilator Agents|vasodilator agents|mesh-ancestor
93097543|NCT01321034|Vitamin B Complex|vitamin b complex|mesh-ancestor
93097544|NCT01321034|Vitamins|vitamins|mesh-ancestor
93097545|NCT01321034|Micronutrients|micronutrients|mesh-ancestor
93097546|NCT01321034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097547|NCT05254184|Nivolumab|nivolumab|mesh-list
93097548|NCT05254184|Ipilimumab|ipilimumab|mesh-list
93097549|NCT05254184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097550|NCT05254184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097551|NCT05254184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097552|NCT05254184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097553|NCT03773042|Propofol|propofol|mesh-list
93097554|NCT03773042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097555|NCT03773042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097556|NCT03773042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097557|NCT03773042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097558|NCT03773042|Anesthetics, General|anesthetics, general|mesh-ancestor
93097559|NCT03773042|Anesthetics|anesthetics|mesh-ancestor
93097560|NCT03782480|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93097561|NCT03782480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93097562|NCT03782480|Immunologic Factors|immunologic factors|mesh-ancestor
93097563|NCT03782480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097564|NCT03712280|Rifaximin|rifaximin|mesh-list
93097565|NCT03712280|Phenylacetic acid|phenylacetic acid|mesh-list
93097566|NCT03712280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097567|NCT03712280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097568|NCT03712280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097569|NCT03712280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93097570|NCT03712280|Antimetabolites|antimetabolites|mesh-ancestor
93097571|NCT03712280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097572|NCT03712280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097573|NCT01561508|Butyric Acid|butyric acid|mesh-list
93097574|NCT01561508|Histamine Antagonists|histamine antagonists|mesh-ancestor
93097575|NCT01561508|Histamine Agents|histamine agents|mesh-ancestor
93097576|NCT01561508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097577|NCT01561508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097578|NCT01561508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097579|NCT04673942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93097580|NCT04673942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097581|NCT04673942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097582|NCT04673942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097583|NCT03772262|Metformin|metformin|mesh-list
93097584|NCT03772262|Furosemide|furosemide|mesh-list
93097585|NCT03772262|Midazolam|midazolam|mesh-list
93097586|NCT03772262|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93097587|NCT03772262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93097588|NCT03772262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097589|NCT03772262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93097590|NCT03772262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097591|NCT03772262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097592|NCT03772262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93097593|NCT03772262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93097594|NCT03772262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93097595|NCT03772262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097596|NCT03772262|Anesthetics, General|anesthetics, general|mesh-ancestor
93097597|NCT03772262|Anesthetics|anesthetics|mesh-ancestor
93097598|NCT03772262|GABA Modulators|gaba modulators|mesh-ancestor
93097599|NCT03772262|GABA Agents|gaba agents|mesh-ancestor
93097600|NCT03772262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097601|NCT03772262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097602|NCT03772262|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097603|NCT03772262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097604|NCT03772262|Antimetabolites|antimetabolites|mesh-ancestor
93097605|NCT03772262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097606|NCT03772262|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93097607|NCT03772262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097608|NCT03772262|Diuretics|diuretics|mesh-ancestor
93097609|NCT03772262|Natriuretic Agents|natriuretic agents|mesh-ancestor
93097610|NCT03772262|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93097611|NCT03772262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097612|NCT03772106|Propofol|propofol|mesh-list
93097613|NCT03772106|Sevoflurane|sevoflurane|mesh-list
93097614|NCT03772106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097615|NCT03772106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097616|NCT03772106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097617|NCT03772106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097618|NCT03772106|Anesthetics, General|anesthetics, general|mesh-ancestor
93097619|NCT03772106|Anesthetics|anesthetics|mesh-ancestor
93097620|NCT03772106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93097621|NCT03772106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93097622|NCT01345240|Vaccines|vaccines|mesh-list
93097623|NCT01345240|Immunologic Factors|immunologic factors|mesh-ancestor
93097624|NCT01345240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097626|NCT03771638|Emtricitabine|emtricitabine|mesh-list
93097627|NCT03771638|Antiviral Agents|antiviral agents|mesh-ancestor
93097628|NCT03771638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097629|NCT03771638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93097630|NCT03771638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93097631|NCT03771638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097632|NCT03771638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097633|NCT03771638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93097634|NCT03771638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93097635|NCT00092560|Ezetimibe|ezetimibe|mesh-list
93097636|NCT00092560|Fenofibrate|fenofibrate|mesh-list
93097637|NCT00092560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097638|NCT00092560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097639|NCT00092560|Antimetabolites|antimetabolites|mesh-ancestor
93097640|NCT00092560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097641|NCT00092560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097642|NCT03769064|Methylphenidate|methylphenidate|mesh-list
93097643|NCT03769064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93097644|NCT03769064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097645|NCT03769064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93097646|NCT03769064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93097647|NCT03769064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097648|NCT03769064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097649|NCT03769064|Dopamine Agents|dopamine agents|mesh-ancestor
93097650|NCT03769064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097651|NCT00090298|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93097652|NCT00090298|Simvastatin|simvastatin|mesh-list
93097653|NCT00090298|Ezetimibe|ezetimibe|mesh-list
93097654|NCT00090298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097655|NCT00090298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097656|NCT00090298|Antimetabolites|antimetabolites|mesh-ancestor
93097657|NCT00090298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097658|NCT00090298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097659|NCT00090298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93097660|NCT00090298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097661|NCT03771092|Ferric gluconate|ferric gluconate|mesh-list
93097662|NCT03771092|Hematinics|hematinics|mesh-ancestor
93097663|NCT03768908|Artesunate|artesunate|mesh-list
93097664|NCT03768908|Lumefantrine|lumefantrine|mesh-list
93097665|NCT03768908|Artemether|artemether|mesh-list
93097666|NCT03768908|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93097667|NCT03768908|Amodiaquine|amodiaquine|mesh-list
93097668|NCT03768908|Antimalarials|antimalarials|mesh-ancestor
93097669|NCT03768908|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93097670|NCT03768908|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93097671|NCT03768908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097672|NCT03768908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097673|NCT03768908|Antiviral Agents|antiviral agents|mesh-ancestor
93097674|NCT03768908|Schistosomicides|schistosomicides|mesh-ancestor
93097675|NCT03768908|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93097676|NCT03768908|Anthelmintics|anthelmintics|mesh-ancestor
93097677|NCT03777878|Oxytocin|oxytocin|mesh-list
93097678|NCT03777878|Carbetocin|carbetocin|mesh-list
93097679|NCT03777878|Oxytocics|oxytocics|mesh-ancestor
93097680|NCT03777878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93097681|NCT03777878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097682|NCT03246958|Nivolumab|nivolumab|mesh-list
93097683|NCT03246958|Ipilimumab|ipilimumab|mesh-list
93097684|NCT03246958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097685|NCT03246958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097686|NCT03246958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097687|NCT03246958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097688|NCT01321268|Beta Carotene|beta carotene|mesh-list
93097689|NCT01321268|Lycopene|lycopene|mesh-list
93097690|NCT01321268|Resveratrol|resveratrol|mesh-list
93097691|NCT01321268|Carotenoids|carotenoids|mesh-list
93097692|NCT01321268|Antioxidants|antioxidants|mesh-ancestor
93097693|NCT01321268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097694|NCT01321268|Protective Agents|protective agents|mesh-ancestor
93097695|NCT01321268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097696|NCT01321268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097697|NCT01321268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93097698|NCT01321268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93097699|NCT01321268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93097700|NCT01321268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93097701|NCT01321268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097702|NCT01321268|Provitamins|provitamins|mesh-ancestor
93097703|NCT01321268|Vitamins|vitamins|mesh-ancestor
93097704|NCT01321268|Micronutrients|micronutrients|mesh-ancestor
93097705|NCT01335958|DMUC5754A|dmuc5754a|mesh-list
93097706|NCT01335958|Immunoconjugates|immunoconjugates|mesh-ancestor
93097707|NCT01335958|Immunologic Factors|immunologic factors|mesh-ancestor
93097708|NCT01335958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097709|NCT01561274|Bupivacaine|bupivacaine|mesh-list
93097710|NCT01561274|Anesthetics, Local|anesthetics, local|mesh-ancestor
93097711|NCT01561274|Anesthetics|anesthetics|mesh-ancestor
93097712|NCT01561274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097713|NCT01561274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097714|NCT01561274|Sensory System Agents|sensory system agents|mesh-ancestor
93097715|NCT01561274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097716|NCT02882854|Guanfacine|guanfacine|mesh-list
93097717|NCT02882854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097718|NCT02882854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93097719|NCT02882854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93097720|NCT02882854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93097721|NCT02882854|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097722|NCT02882854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097723|NCT02882854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097724|NCT02882854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097725|NCT03770936|Candesartan|candesartan|mesh-list
93097726|NCT03770936|Candesartan cilexetil|candesartan cilexetil|mesh-list
93097727|NCT03770936|Ramipril|ramipril|mesh-list
93097728|NCT03770936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097729|NCT03770936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93097730|NCT03770936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93097731|NCT03770936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097732|NCT03770936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93097733|NCT03770936|Protease Inhibitors|protease inhibitors|mesh-ancestor
93097734|NCT03770936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097735|NCT03150082|Ciprofloxacin|ciprofloxacin|mesh-list
93097736|NCT03150082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097737|NCT03150082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097738|NCT03150082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93097739|NCT03150082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93097740|NCT03150082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097741|NCT03150082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097742|NCT03150082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097743|NCT03150082|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93097744|NCT03150082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93097745|NCT01321346|Cytarabine|cytarabine|mesh-list
93097746|NCT01321346|Panobinostat|panobinostat|mesh-list
93097747|NCT01321346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93097748|NCT01321346|Antimetabolites|antimetabolites|mesh-ancestor
93097749|NCT01321346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097750|NCT01321346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097751|NCT01321346|Antiviral Agents|antiviral agents|mesh-ancestor
93097752|NCT01321346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097753|NCT01321346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93097754|NCT01321346|Immunologic Factors|immunologic factors|mesh-ancestor
93097755|NCT01321346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097756|NCT01321346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93097757|NCT01321346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097758|NCT04058366|Ivacaftor|ivacaftor|mesh-list
93097759|NCT04058366|Elexacaftor|elexacaftor|mesh-list
93097760|NCT04058366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93097761|NCT04058366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097762|NCT04058366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097763|NCT02118610|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
93097764|NCT02118610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097765|NCT02118610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097766|NCT02118610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93097767|NCT02118610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097768|NCT02118610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097769|NCT02118610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93097770|NCT02118610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097771|NCT02118610|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93097772|NCT02118610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93097773|NCT02118610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097774|NCT02118610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93097775|NCT02118610|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93097777|NCT02118610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097778|NCT02118610|Adrenergic Agents|adrenergic agents|mesh-ancestor
93097779|NCT02118610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93097780|NCT02118610|Analgesics|analgesics|mesh-ancestor
93097781|NCT02118610|Sensory System Agents|sensory system agents|mesh-ancestor
93097782|NCT02118610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097783|NCT01561742|Minocycline|minocycline|mesh-list
93097784|NCT01561742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097785|NCT01561742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097786|NCT03770702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93097787|NCT03770702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097788|NCT01345708|Prednisone|prednisone|mesh-list
93097789|NCT01345708|Rituximab|rituximab|mesh-list
93097790|NCT01345708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097791|NCT01345708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097792|NCT01345708|Immunologic Factors|immunologic factors|mesh-ancestor
93097793|NCT01345708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097794|NCT01345708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93097795|NCT01345708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93097796|NCT01345708|Glucocorticoids|glucocorticoids|mesh-ancestor
93097797|NCT01345708|Hormones|hormones|mesh-ancestor
93097798|NCT01345708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097799|NCT01345708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93097800|NCT01345864|Scopolamine|scopolamine|mesh-list
93097801|NCT01345864|Donepezil|donepezil|mesh-list
93097802|NCT01345864|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93097803|NCT01345864|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93097804|NCT01345864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097805|NCT01345864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097806|NCT01345864|Cholinergic Agents|cholinergic agents|mesh-ancestor
93097807|NCT01345864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097808|NCT01345864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097809|NCT01345864|Nootropic Agents|nootropic agents|mesh-ancestor
93097810|NCT01345864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93097811|NCT01345864|Antiemetics|antiemetics|mesh-ancestor
93097812|NCT01345864|Autonomic Agents|autonomic agents|mesh-ancestor
93097813|NCT01345864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097814|NCT01345864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93097815|NCT01345864|Mydriatics|mydriatics|mesh-ancestor
93097816|NCT01345864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93097817|NCT01345864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93097818|NCT01345864|Parasympatholytics|parasympatholytics|mesh-ancestor
93097819|NCT04320602|Eculizumab|eculizumab|mesh-list
93097820|NCT04320602|Ravulizumab|ravulizumab|mesh-list
93097821|NCT04320602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93097822|NCT04320602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93097823|NCT04320602|Immunologic Factors|immunologic factors|mesh-ancestor
93097824|NCT04320602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097825|NCT03948022|Progesterone|progesterone|mesh-list
93097826|NCT03948022|Dydrogesterone|dydrogesterone|mesh-list
93097827|NCT03948022|Progestins|progestins|mesh-ancestor
93097828|NCT03948022|Hormones|hormones|mesh-ancestor
93097829|NCT03948022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097830|NCT03948022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097831|NCT03777644|Morphine|morphine|mesh-list
93097832|NCT03777644|Ropivacaine|ropivacaine|mesh-list
93097833|NCT03777644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93097834|NCT03777644|Narcotics|narcotics|mesh-ancestor
93097835|NCT03777644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097836|NCT03777644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097837|NCT03777644|Analgesics|analgesics|mesh-ancestor
93097838|NCT03777644|Sensory System Agents|sensory system agents|mesh-ancestor
93097839|NCT03777644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097840|NCT03777644|Anesthetics, Local|anesthetics, local|mesh-ancestor
93097841|NCT03777644|Anesthetics|anesthetics|mesh-ancestor
93097842|NCT04345666|Methyltestosterone|methyltestosterone|mesh-list
93097843|NCT04345666|Testosterone|testosterone|mesh-list
93097844|NCT04345666|Testosterone undecanoate|testosterone undecanoate|mesh-list
93097845|NCT04345666|Testosterone enanthate|testosterone enanthate|mesh-list
93097846|NCT04345666|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93097847|NCT04345666|Androgens|androgens|mesh-ancestor
93097848|NCT04345666|Hormones|hormones|mesh-ancestor
93097849|NCT04345666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097850|NCT04345666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097851|NCT04345666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93097852|NCT04345666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097853|NCT04345666|Anabolic Agents|anabolic agents|mesh-ancestor
93097854|NCT01336192|Gemcitabine|gemcitabine|mesh-list
93097855|NCT01336192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93097856|NCT01336192|Antimetabolites|antimetabolites|mesh-ancestor
93097857|NCT01336192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097858|NCT01336192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097859|NCT04459234|Ketamine|ketamine|mesh-list
93097860|NCT04459234|Analgesics|analgesics|mesh-ancestor
93097861|NCT04459234|Sensory System Agents|sensory system agents|mesh-ancestor
93097862|NCT04459234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097863|NCT04459234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097864|NCT04459234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93097865|NCT04459234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93097866|NCT04459234|Anesthetics, General|anesthetics, general|mesh-ancestor
93097867|NCT04459234|Anesthetics|anesthetics|mesh-ancestor
93097868|NCT04459234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097869|NCT04459234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93097870|NCT04459234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93097871|NCT04459234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097872|NCT04459234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097873|NCT01336348|Tirofiban|tirofiban|mesh-list
93097874|NCT01336348|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93097875|NCT01336348|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93097876|NCT01336348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93097877|NCT01336348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93097878|NCT01336348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097879|NCT01346254|Pioglitazone|pioglitazone|mesh-list
93097880|NCT01346254|Vildagliptin|vildagliptin|mesh-list
93097881|NCT01346254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93097882|NCT01346254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097883|NCT01346254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93097884|NCT01346254|Protease Inhibitors|protease inhibitors|mesh-ancestor
93097885|NCT01346254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097886|NCT01346254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097887|NCT04592536|Alprazolam|alprazolam|mesh-list
93097888|NCT04592536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93097889|NCT04592536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097890|NCT04592536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097891|NCT04592536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93097892|NCT04592536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93097893|NCT04592536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93097894|NCT04592536|GABA Modulators|gaba modulators|mesh-ancestor
93097895|NCT04592536|GABA Agents|gaba agents|mesh-ancestor
93097896|NCT04592536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93097897|NCT04592536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097898|NCT01336582|Docetaxel|docetaxel|mesh-list
93097899|NCT01336582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097900|NCT01336582|Tubulin Modulators|tubulin modulators|mesh-ancestor
93097901|NCT01336582|Antimitotic Agents|antimitotic agents|mesh-ancestor
93097902|NCT01336582|Mitosis Modulators|mitosis modulators|mesh-ancestor
93097903|NCT01336582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097904|NCT03149848|Rifabutin|rifabutin|mesh-list
93097905|NCT03149848|Cabotegravir|cabotegravir|mesh-list
93097906|NCT03149848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93097907|NCT03149848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097908|NCT03149848|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93097909|NCT03149848|Antitubercular Agents|antitubercular agents|mesh-ancestor
93097910|NCT03149848|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93097911|NCT03149848|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93097912|NCT03149848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097913|NCT03149848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097914|NCT03149848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93097915|NCT03149848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93097916|NCT03149848|Antiviral Agents|antiviral agents|mesh-ancestor
93097917|NCT01346800|Ritonavir|ritonavir|mesh-list
93097918|NCT01346800|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93097919|NCT01346800|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93097920|NCT01346800|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93097921|NCT01346800|Protease Inhibitors|protease inhibitors|mesh-ancestor
93097922|NCT01346800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097923|NCT01346800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097924|NCT01346800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93097925|NCT01346800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93097926|NCT01346800|Antiviral Agents|antiviral agents|mesh-ancestor
93097927|NCT01346800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097928|NCT01346800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93097929|NCT01346800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92688208|NCT00477035|Alkylating Agents|alkylating agents|mesh-ancestor
93097930|NCT01346800|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93097932|NCT03902314|Anesthetics, Local|anesthetics, local|mesh-ancestor
93097933|NCT03902314|Anesthetics|anesthetics|mesh-ancestor
93097934|NCT03902314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097935|NCT03902314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097936|NCT03902314|Sensory System Agents|sensory system agents|mesh-ancestor
93097937|NCT03902314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097938|NCT03902314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097939|NCT03902314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93097940|NCT03902314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93097941|NCT03902314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93097942|NCT03902314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097943|NCT01336660|Antivenins|antivenins|mesh-list
93097944|NCT01336660|Immunologic Factors|immunologic factors|mesh-ancestor
93097945|NCT01336660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097946|NCT03768518|Exenatide|exenatide|mesh-list
93097947|NCT03768518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93097948|NCT03768518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097949|NCT03768518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93097950|NCT03768518|Incretins|incretins|mesh-ancestor
93097951|NCT03768518|Hormones|hormones|mesh-ancestor
93097952|NCT03768518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93097953|NCT04276376|Atezolizumab|atezolizumab|mesh-list
93097954|NCT04276376|Rucaparib|rucaparib|mesh-list
93097955|NCT04276376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097956|NCT04276376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097957|NCT04276376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097958|NCT04276376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097959|NCT04276376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93097960|NCT04276376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097961|NCT04254692|Bupivacaine|bupivacaine|mesh-list
93097962|NCT04254692|Anesthetics, Local|anesthetics, local|mesh-ancestor
93097963|NCT04254692|Anesthetics|anesthetics|mesh-ancestor
93097964|NCT04254692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93097965|NCT04254692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93097966|NCT04254692|Sensory System Agents|sensory system agents|mesh-ancestor
93097967|NCT04254692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93097968|NCT03770000|Romidepsin|romidepsin|mesh-list
93097969|NCT03770000|Tenalisib|tenalisib|mesh-list
93097970|NCT03770000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93097971|NCT03770000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097972|NCT03770000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93097973|NCT03770000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097974|NCT03770000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097975|NCT03770000|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
93097976|NCT03770312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93097977|NCT03770312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93097978|NCT03770312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93097979|NCT03770312|Antimetabolites|antimetabolites|mesh-ancestor
93097980|NCT03770312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097981|NCT03770312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097982|NCT03770312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93097983|NCT03158272|Nivolumab|nivolumab|mesh-list
93097984|NCT03158272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93097985|NCT03158272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93097986|NCT03158272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93097987|NCT03158272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097988|NCT01431508|Losartan|losartan|mesh-list
93097989|NCT01431508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93097990|NCT01431508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93097991|NCT01431508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93097992|NCT01431508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93097993|NCT01431508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93097994|NCT01321502|Famciclovir|famciclovir|mesh-list
93097995|NCT01321502|Antiviral Agents|antiviral agents|mesh-ancestor
93097996|NCT01321502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93097997|NCT01321502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93097998|NCT01321502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93097999|NCT01321502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098000|NCT01347268|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93098001|NCT01347268|Hormones|hormones|mesh-ancestor
93098002|NCT01347268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93098003|NCT01347268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098004|NCT01347424|Paclitaxel|paclitaxel|mesh-list
93098005|NCT01347424|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93098006|NCT01347424|Carboplatin|carboplatin|mesh-list
93098007|NCT01347424|Endostatins|endostatins|mesh-list
93098008|NCT01347424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93098009|NCT01347424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098010|NCT01347424|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098011|NCT01347424|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098012|NCT01347424|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098013|NCT01347424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098014|NCT01347424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93098015|NCT01347424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93098016|NCT01347424|Growth Substances|growth substances|mesh-ancestor
93098017|NCT01347424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098018|NCT01347424|Growth Inhibitors|growth inhibitors|mesh-ancestor
93098019|NCT01322438|Rifampin|rifampin|mesh-list
93098020|NCT01322438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93098021|NCT01322438|Antitubercular Agents|antitubercular agents|mesh-ancestor
93098022|NCT01322438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098023|NCT01322438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098024|NCT01322438|Leprostatic Agents|leprostatic agents|mesh-ancestor
93098025|NCT01322438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098026|NCT01322438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098027|NCT01322438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098028|NCT01322438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93098029|NCT01322438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93098030|NCT01322438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93098031|NCT01322438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93098032|NCT01322438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93098033|NCT01322438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93098034|NCT00654628|Simvastatin|simvastatin|mesh-list
93098035|NCT00654628|Ezetimibe|ezetimibe|mesh-list
93098036|NCT00654628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93098037|NCT00654628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93098038|NCT00654628|Antimetabolites|antimetabolites|mesh-ancestor
93098039|NCT00654628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098040|NCT00654628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93098041|NCT00654628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93098042|NCT00654628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098043|NCT00536380|Loratadine|loratadine|mesh-list
93098044|NCT00536380|Desloratadine|desloratadine|mesh-list
93098045|NCT00536380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93098046|NCT00536380|Cholinergic Agents|cholinergic agents|mesh-ancestor
93098047|NCT00536380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098048|NCT00536380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098049|NCT00536380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098050|NCT00536380|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93098051|NCT00536380|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93098052|NCT00536380|Histamine Antagonists|histamine antagonists|mesh-ancestor
93098053|NCT00536380|Histamine Agents|histamine agents|mesh-ancestor
93098054|NCT00536380|Antipruritics|antipruritics|mesh-ancestor
93098055|NCT00536380|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098056|NCT00536380|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93098057|NCT01337362|Insulin|insulin|mesh-list
93098058|NCT01337362|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93098059|NCT01337362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098060|NCT01337362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098061|NCT03762824|Vaccines|vaccines|mesh-list
93098062|NCT03762824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93098063|NCT03762824|Immunologic Factors|immunologic factors|mesh-ancestor
93098064|NCT03762824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098065|NCT00496834|Losartan|losartan|mesh-list
93098066|NCT00496834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93098067|NCT00496834|Carvedilol|carvedilol|mesh-list
92770338|NCT00641095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098068|NCT00496834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93098069|NCT00496834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93098070|NCT00496834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93098071|NCT00496834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93098072|NCT00496834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098073|NCT00496834|Diuretics|diuretics|mesh-ancestor
93098074|NCT00496834|Natriuretic Agents|natriuretic agents|mesh-ancestor
93098075|NCT00496834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098076|NCT00496834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93098077|NCT00496834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93098078|NCT00496834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93098079|NCT00496834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93098080|NCT00496834|Adrenergic Agents|adrenergic agents|mesh-ancestor
93098081|NCT00496834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098082|NCT00496834|Antioxidants|antioxidants|mesh-ancestor
93098083|NCT00496834|Protective Agents|protective agents|mesh-ancestor
93098084|NCT00496834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93098085|NCT00496834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93098086|NCT00496834|Vasodilator Agents|vasodilator agents|mesh-ancestor
93098087|NCT00496834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93098088|NCT00496834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93098089|NCT00189280|Imiquimod|imiquimod|mesh-list
93098090|NCT00189280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93098091|NCT00189280|Immunologic Factors|immunologic factors|mesh-ancestor
93098092|NCT00189280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098093|NCT00189280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098094|NCT00189280|Interferon Inducers|interferon inducers|mesh-ancestor
93098095|NCT01352494|Gemcitabine|gemcitabine|mesh-list
93098096|NCT01352494|Docetaxel|docetaxel|mesh-list
93098097|NCT01352494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098098|NCT01352494|Antimetabolites|antimetabolites|mesh-ancestor
93098099|NCT01352494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098100|NCT01352494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098101|NCT01352494|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098102|NCT01352494|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098103|NCT01352494|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098104|NCT01347814|Domperidone|domperidone|mesh-list
93098105|NCT01347814|Antiemetics|antiemetics|mesh-ancestor
93098106|NCT01347814|Autonomic Agents|autonomic agents|mesh-ancestor
93098107|NCT01347814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098108|NCT01347814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098109|NCT01347814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098110|NCT01347814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93098111|NCT01347814|Dopamine Agents|dopamine agents|mesh-ancestor
93098112|NCT01347814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098113|NCT01347814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098114|NCT01348126|Docetaxel|docetaxel|mesh-list
93098115|NCT01348126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098116|NCT01348126|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098117|NCT01348126|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098118|NCT01348126|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098119|NCT01348126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098120|NCT01348204|Quercetin|quercetin|mesh-list
93098121|NCT01348204|Antioxidants|antioxidants|mesh-ancestor
93098122|NCT01348204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098123|NCT01348204|Protective Agents|protective agents|mesh-ancestor
93098124|NCT01348204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098125|NCT00166504|Atorvastatin|atorvastatin|mesh-list
93098126|NCT00166504|Simvastatin|simvastatin|mesh-list
93098127|NCT00166504|Ezetimibe|ezetimibe|mesh-list
93098128|NCT00166504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93098129|NCT00166504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93098130|NCT00166504|Antimetabolites|antimetabolites|mesh-ancestor
93098131|NCT00166504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098132|NCT00166504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93098133|NCT00166504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93098134|NCT00166504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098135|NCT01348282|Rivastigmine|rivastigmine|mesh-list
93098136|NCT01348282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098137|NCT01348282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098138|NCT01348282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098139|NCT01348282|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93098140|NCT01348282|Cholinergic Agents|cholinergic agents|mesh-ancestor
93098141|NCT01348282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098142|NCT01348282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93098143|NCT01348282|Protective Agents|protective agents|mesh-ancestor
93098144|NCT03137992|Bromides|bromides|mesh-list
93098145|NCT03137992|Tiotropium Bromide|tiotropium bromide|mesh-list
93098146|NCT03137992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93098147|NCT03137992|Autonomic Agents|autonomic agents|mesh-ancestor
93098148|NCT03137992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098149|NCT03137992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098150|NCT03137992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93098151|NCT03137992|Respiratory System Agents|respiratory system agents|mesh-ancestor
93098152|NCT03137992|Parasympatholytics|parasympatholytics|mesh-ancestor
93098153|NCT03137992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93098154|NCT03137992|Cholinergic Agents|cholinergic agents|mesh-ancestor
93098155|NCT03137992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098156|NCT03137992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098157|NCT03137992|Anticonvulsants|anticonvulsants|mesh-ancestor
93098159|NCT04470778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93098160|NCT04470778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098161|NCT04470778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93098162|NCT04470778|Histamine Antagonists|histamine antagonists|mesh-ancestor
93098163|NCT04470778|Histamine Agents|histamine agents|mesh-ancestor
93098164|NCT04470778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098165|NCT04470778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098166|NCT04470778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098167|NCT01352572|Milnacipran|milnacipran|mesh-list
93098168|NCT01352572|Mirtazapine|mirtazapine|mesh-list
93098169|NCT01352572|Sertraline|sertraline|mesh-list
93098170|NCT01352572|Fluoxetine|fluoxetine|mesh-list
93098171|NCT01352572|Paroxetine|paroxetine|mesh-list
93098172|NCT01352572|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93098173|NCT01352572|Antidepressive Agents|antidepressive agents|mesh-list
93098174|NCT01352572|Levomilnacipran|levomilnacipran|mesh-list
93098175|NCT01352572|Nortriptyline|nortriptyline|mesh-list
93098176|NCT01352572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93098177|NCT01352572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93098178|NCT01352572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93098179|NCT01352572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93098180|NCT01352572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098181|NCT01352572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098182|NCT01352572|Serotonin Agents|serotonin agents|mesh-ancestor
93098183|NCT01352572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098184|NCT01352572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93098185|NCT01352572|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93098186|NCT01352572|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93098187|NCT01352572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098188|NCT01352572|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93098189|NCT01352572|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93098190|NCT01352572|Histamine Antagonists|histamine antagonists|mesh-ancestor
93098191|NCT01352572|Histamine Agents|histamine agents|mesh-ancestor
93098192|NCT01352572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93098193|NCT01352572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93098194|NCT01352572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098195|NCT01352572|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93098196|NCT01352572|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93098197|NCT01352572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93098198|NCT01352572|Adrenergic Agents|adrenergic agents|mesh-ancestor
93098199|NCT01352572|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93098200|NCT01352572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93098201|NCT01352572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93098202|NCT01352572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098203|NCT01352572|Analgesics|analgesics|mesh-ancestor
93098204|NCT01352572|Sensory System Agents|sensory system agents|mesh-ancestor
93098205|NCT01352572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098206|NCT01352572|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93098207|NCT01352572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93098208|NCT01352650|Plerixafor|plerixafor|mesh-list
93098209|NCT01352650|Decitabine|decitabine|mesh-list
93098210|NCT01352650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098211|NCT01352650|Antimetabolites|antimetabolites|mesh-ancestor
93098212|NCT01352650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098213|NCT01352650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098214|NCT01352650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098215|NCT01352650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93098216|NCT01352650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93098217|NCT01352650|Antiviral Agents|antiviral agents|mesh-ancestor
93098218|NCT01352650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098219|NCT01352728|Axitinib|axitinib|mesh-list
93098221|NCT01352728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098222|NCT01352728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098223|NCT01352728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098224|NCT03997448|Pembrolizumab|pembrolizumab|mesh-list
93098225|NCT03997448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93098226|NCT03997448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098227|NCT03997448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93098228|NCT03997448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098229|NCT03767660|Sirolimus|sirolimus|mesh-list
93098230|NCT03767660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098231|NCT03767660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098232|NCT03767660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93098233|NCT03767660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098234|NCT03767660|Antifungal Agents|antifungal agents|mesh-ancestor
93098235|NCT03767660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098236|NCT03767660|Immunologic Factors|immunologic factors|mesh-ancestor
93098237|NCT03767660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098238|NCT03767504|Thymol|thymol|mesh-list
93098239|NCT03767504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098240|NCT03767504|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93098241|NCT03767504|Antifungal Agents|antifungal agents|mesh-ancestor
93098242|NCT01343290|Canagliflozin|canagliflozin|mesh-list
93098243|NCT01343290|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93098244|NCT01343290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098245|NCT01343290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098246|NCT01343290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098247|NCT03761264|Amoxicillin|amoxicillin|mesh-list
93098248|NCT03761264|Zinc Oxide|zinc oxide|mesh-list
93098249|NCT03761264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098250|NCT03761264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098251|NCT03761264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098252|NCT03761264|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098253|NCT03761264|Sunscreening Agents|sunscreening agents|mesh-ancestor
93098254|NCT03761264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93098255|NCT03761264|Protective Agents|protective agents|mesh-ancestor
93098256|NCT05096312|Zinc|zinc|mesh-list
93098257|NCT05096312|Adapalene|adapalene|mesh-list
93098258|NCT05096312|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
93098259|NCT05096312|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93098260|NCT05096312|Trace Elements|trace elements|mesh-ancestor
93098261|NCT05096312|Micronutrients|micronutrients|mesh-ancestor
93098262|NCT05096312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098263|NCT05096312|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098264|NCT05096312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93098265|NCT05096312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098266|NCT05096312|Analgesics|analgesics|mesh-ancestor
93098267|NCT05096312|Sensory System Agents|sensory system agents|mesh-ancestor
93098268|NCT05096312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098269|NCT05096312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098270|NCT05096312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098271|NCT03767036|Ketorolac|ketorolac|mesh-list
93098272|NCT03767036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93098273|NCT03767036|Tramadol|tramadol|mesh-list
93098274|NCT03767036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93098275|NCT03767036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098276|NCT03767036|Analgesics|analgesics|mesh-ancestor
93098277|NCT03767036|Sensory System Agents|sensory system agents|mesh-ancestor
93098278|NCT03767036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098279|NCT03767036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098280|NCT03767036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098281|NCT03767036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098282|NCT03767036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93098283|NCT03767036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098284|NCT03767036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098285|NCT03767036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93098286|NCT03767036|Narcotics|narcotics|mesh-ancestor
93098287|NCT03767036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098288|NCT03758144|Rifaximin|rifaximin|mesh-list
93098289|NCT03758144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098290|NCT03758144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098291|NCT03758144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098292|NCT03766724|Dapagliflozin|dapagliflozin|mesh-list
93098293|NCT03766724|Empagliflozin|empagliflozin|mesh-list
93098294|NCT03766724|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93098295|NCT03766724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098296|NCT03766724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098297|NCT03766724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098298|NCT04860518|Dexamethasone|dexamethasone|mesh-list
93098299|NCT04860518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098300|NCT04860518|Antiemetics|antiemetics|mesh-ancestor
93098301|NCT04860518|Autonomic Agents|autonomic agents|mesh-ancestor
93098302|NCT04860518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098303|NCT04860518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098304|NCT04860518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098305|NCT04860518|Glucocorticoids|glucocorticoids|mesh-ancestor
93098306|NCT04860518|Hormones|hormones|mesh-ancestor
93098307|NCT04860518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93098308|NCT04860518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93098309|NCT04860518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098310|NCT03110380|Dolutegravir|dolutegravir|mesh-list
93098311|NCT03110380|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93098312|NCT03110380|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93098313|NCT03110380|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93098314|NCT03110380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098315|NCT03110380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098316|NCT03110380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93098317|NCT03110380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93098318|NCT03110380|Antiviral Agents|antiviral agents|mesh-ancestor
93098319|NCT03110380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098320|NCT03110380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93098321|NCT03110380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098322|NCT03757910|Corticosterone|corticosterone|mesh-list
93098323|NCT03757910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098324|NCT01322204|Codeine|codeine|mesh-list
93098325|NCT01322204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93098326|NCT01322204|Narcotics|narcotics|mesh-ancestor
93098327|NCT01322204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098328|NCT01322204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098329|NCT01322204|Analgesics|analgesics|mesh-ancestor
93098330|NCT01322204|Sensory System Agents|sensory system agents|mesh-ancestor
93098331|NCT01322204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098332|NCT01322204|Antitussive Agents|antitussive agents|mesh-ancestor
93098333|NCT01322204|Respiratory System Agents|respiratory system agents|mesh-ancestor
93098334|NCT03766490|Gefitinib|gefitinib|mesh-list
93098335|NCT03766490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098336|NCT03766490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098337|NCT03766490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098338|NCT03766490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098339|NCT01348984|Fentanyl|fentanyl|mesh-list
93098340|NCT01348984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93098341|NCT01348984|Narcotics|narcotics|mesh-ancestor
93098342|NCT01348984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098343|NCT01348984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098344|NCT01348984|Analgesics|analgesics|mesh-ancestor
93098345|NCT01348984|Sensory System Agents|sensory system agents|mesh-ancestor
92688625|NCT01248078|Cephalexin|cephalexin|mesh-list
93098346|NCT01348984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098347|NCT01348984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93098348|NCT01348984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93098349|NCT01348984|Anesthetics, General|anesthetics, general|mesh-ancestor
93098350|NCT01348984|Anesthetics|anesthetics|mesh-ancestor
93098351|NCT01567670|Naloxone|naloxone|mesh-list
93098352|NCT01567670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93098353|NCT01567670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098354|NCT01567670|Sensory System Agents|sensory system agents|mesh-ancestor
93098355|NCT01567670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098356|NCT01349062|Immunomodulating Agents|immunomodulating agents|mesh-list
93098357|NCT01349062|Immunologic Factors|immunologic factors|mesh-ancestor
93098358|NCT01349062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098359|NCT04848662|Budesonide|budesonide|mesh-list
93098360|NCT04848662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098361|NCT04848662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93098362|NCT04848662|Autonomic Agents|autonomic agents|mesh-ancestor
93098363|NCT04848662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098364|NCT04848662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098365|NCT04848662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93098366|NCT04848662|Respiratory System Agents|respiratory system agents|mesh-ancestor
93098367|NCT04848662|Glucocorticoids|glucocorticoids|mesh-ancestor
93098368|NCT04848662|Hormones|hormones|mesh-ancestor
92770639|NCT01192295|Analgesics|analgesics|mesh-ancestor
93098369|NCT04848662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93098371|NCT04351256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93098372|NCT04351256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098373|NCT03700892|Cinnamaldehyde|cinnamaldehyde|mesh-list
93098374|NCT03700892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93098375|NCT03700892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098376|NCT03700892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93098377|NCT03700892|Protective Agents|protective agents|mesh-ancestor
93098378|NCT03700892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098379|NCT01322282|Cetirizine|cetirizine|mesh-list
93098380|NCT01322282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93098381|NCT01322282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93098382|NCT01322282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93098383|NCT01322282|Histamine Antagonists|histamine antagonists|mesh-ancestor
93098384|NCT01322282|Histamine Agents|histamine agents|mesh-ancestor
93098385|NCT01322282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098386|NCT01322282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098387|NCT01322282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098388|NCT03757364|Methotrexate|methotrexate|mesh-list
93098389|NCT03757364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93098390|NCT03757364|Abortifacient Agents|abortifacient agents|mesh-ancestor
93098391|NCT03757364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93098392|NCT03757364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098393|NCT03757364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098394|NCT03757364|Antimetabolites|antimetabolites|mesh-ancestor
93098395|NCT03757364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098396|NCT03757364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098397|NCT03757364|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098398|NCT03757364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098399|NCT03757364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93098400|NCT03757364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098401|NCT03757364|Immunologic Factors|immunologic factors|mesh-ancestor
93098402|NCT03757364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098403|NCT03757364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098404|NCT03766178|Nimotuzumab|nimotuzumab|mesh-list
93098405|NCT03766178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93098406|NCT03766178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098407|NCT04737278|Nicotinic Acids|nicotinic acids|mesh-list
93098408|NCT04737278|Niacin|niacin|mesh-list
93098409|NCT04737278|Vitamin B Complex|vitamin b complex|mesh-ancestor
93098410|NCT04737278|Vitamins|vitamins|mesh-ancestor
93098411|NCT04737278|Micronutrients|micronutrients|mesh-ancestor
93098412|NCT04737278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098413|NCT04737278|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93098414|NCT04737278|Antimetabolites|antimetabolites|mesh-ancestor
93098415|NCT04737278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098416|NCT04737278|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93098417|NCT04737278|Vasodilator Agents|vasodilator agents|mesh-ancestor
93098418|NCT03759860|Ranibizumab|ranibizumab|mesh-list
93098419|NCT03759860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93098420|NCT03759860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93098421|NCT03759860|Growth Substances|growth substances|mesh-ancestor
93098422|NCT03759860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098423|NCT03759860|Growth Inhibitors|growth inhibitors|mesh-ancestor
93098424|NCT03759860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098425|NCT03759782|Tenofovir|tenofovir|mesh-list
93098426|NCT03759782|Ribavirin|ribavirin|mesh-list
93098427|NCT03759782|Antiviral Agents|antiviral agents|mesh-ancestor
93098428|NCT03759782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098429|NCT03759782|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93098430|NCT03759782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098431|NCT03759782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098432|NCT03759782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098433|NCT03759782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93098434|NCT03759782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93098435|NCT03759782|Antimetabolites|antimetabolites|mesh-ancestor
93098436|NCT03757052|Amoxicillin|amoxicillin|mesh-list
93098437|NCT03757052|Penicillins|penicillins|mesh-list
93098438|NCT03757052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098439|NCT03757052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098440|NCT03765944|Sirolimus|sirolimus|mesh-list
93098441|NCT03765944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098442|NCT03765944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770714|NCT01181609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098443|NCT03765944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93098444|NCT03765944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098445|NCT03765944|Antifungal Agents|antifungal agents|mesh-ancestor
93098446|NCT03765944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098447|NCT03765944|Immunologic Factors|immunologic factors|mesh-ancestor
93098448|NCT03765944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098449|NCT04684394|Aflibercept|aflibercept|mesh-list
93098450|NCT04684394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93098451|NCT04684394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93098452|NCT04684394|Growth Substances|growth substances|mesh-ancestor
93098453|NCT04684394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098454|NCT04684394|Growth Inhibitors|growth inhibitors|mesh-ancestor
93098455|NCT04684394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098456|NCT03765554|PF-06700841|pf-06700841|mesh-list
93098457|NCT03765554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098458|NCT03765554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098459|NCT03765554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098460|NCT04668950|Fluvoxamine|fluvoxamine|mesh-list
93098461|NCT04668950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93098462|NCT04668950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93098463|NCT04668950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098464|NCT04668950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098465|NCT04668950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93098466|NCT04668950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93098467|NCT04668950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93098468|NCT04668950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93098469|NCT04668950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098470|NCT04668950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098471|NCT04668950|Serotonin Agents|serotonin agents|mesh-ancestor
93098472|NCT04668950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93098473|NCT04668950|Antidepressive Agents|antidepressive agents|mesh-ancestor
93098474|NCT04668950|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93098475|NCT04668950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93098476|NCT04668950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098477|NCT04668950|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93098478|NCT03078478|Insulin|insulin|mesh-list
93098479|NCT03078478|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93098480|NCT03078478|Insulin Glargine|insulin glargine|mesh-list
93098481|NCT03078478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098482|NCT03078478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098483|NCT01349296|Everolimus|everolimus|mesh-list
93098484|NCT01349296|Nintedanib|nintedanib|mesh-list
93098485|NCT01349296|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93098486|NCT01349296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098487|NCT01349296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098488|NCT01349296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098489|NCT01349296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098490|NCT01349296|Immunologic Factors|immunologic factors|mesh-ancestor
93098491|NCT01349296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098492|NCT01349296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098493|NCT03522844|Escitalopram|escitalopram|mesh-list
93098494|NCT03522844|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93098495|NCT03522844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93098496|NCT03522844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93098497|NCT03522844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098498|NCT03522844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098499|NCT03522844|Serotonin Agents|serotonin agents|mesh-ancestor
93098500|NCT03522844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098501|NCT00045942|Itraconazole|itraconazole|mesh-list
93098502|NCT00045942|Midostaurin|midostaurin|mesh-list
93098503|NCT00045942|Antifungal Agents|antifungal agents|mesh-ancestor
93098504|NCT00045942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098505|NCT00045942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93098506|NCT00045942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93098507|NCT00045942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098508|NCT00045942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098509|NCT00045942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93098510|NCT00045942|Hormone Antagonists|hormone antagonists|mesh-ancestor
93098511|NCT00045942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93098512|NCT00045942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098513|NCT00045942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93098514|NCT00045942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098515|NCT00045942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098516|NCT04386616|Astegolimab|astegolimab|mesh-list
93098517|NCT04386616|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93098518|NCT04386616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098519|NCT04386616|Antiviral Agents|antiviral agents|mesh-ancestor
93098520|NCT04386616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098521|NCT00045708|Epothilones|epothilones|mesh-list
93098522|NCT00045708|Epothilone B|epothilone b|mesh-list
93098523|NCT00045708|Anticonvulsants|anticonvulsants|mesh-list
93098524|NCT00045708|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098525|NCT00045708|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098526|NCT00045708|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098527|NCT00045708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098528|NCT00045708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098529|NCT01349452|Ganciclovir|ganciclovir|mesh-list
93098530|NCT01349452|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93098531|NCT01349452|Lubricant Eye Drops|lubricant eye drops|mesh-list
93098532|NCT01349452|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93098533|NCT01349452|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93098534|NCT01349452|Antiviral Agents|antiviral agents|mesh-ancestor
93098535|NCT01349452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098536|NCT01349452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098537|NCT01349452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098538|NCT01349452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098540|NCT00045630|Carboplatin|carboplatin|mesh-list
93098541|NCT00045630|Gemcitabine|gemcitabine|mesh-list
93098542|NCT00045630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93098543|NCT00045630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098544|NCT00045630|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098545|NCT00045630|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098546|NCT00045630|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098547|NCT00045630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098548|NCT00045630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098549|NCT00045630|Antimetabolites|antimetabolites|mesh-ancestor
93098550|NCT01357252|Vildagliptin|vildagliptin|mesh-list
93098551|NCT01357252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098552|NCT01357252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098553|NCT01357252|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93098554|NCT01357252|Protease Inhibitors|protease inhibitors|mesh-ancestor
93098555|NCT01357252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098556|NCT01357252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098557|NCT03465280|Interferons|interferons|mesh-list
93098558|NCT03465280|Acyclovir|acyclovir|mesh-list
93098559|NCT03465280|Cidofovir|cidofovir|mesh-list
93098560|NCT03465280|Interferon-alpha|interferon-alpha|mesh-list
93098561|NCT03465280|Artemisinins|artemisinins|mesh-list
93098562|NCT03465280|Artemisinin|artemisinin|mesh-list
93098563|NCT03465280|Celecoxib|celecoxib|mesh-list
93098564|NCT03465280|Methotrexate|methotrexate|mesh-list
93098565|NCT03465280|Indole-3-carbinol|indole-3-carbinol|mesh-list
93098566|NCT03465280|Isotretinoin|isotretinoin|mesh-list
93098567|NCT03465280|Cimetidine|cimetidine|mesh-list
93098568|NCT03465280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098569|NCT03465280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098570|NCT03465280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93098571|NCT03465280|Abortifacient Agents|abortifacient agents|mesh-ancestor
93098572|NCT03465280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93098573|NCT03465280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098574|NCT03465280|Antimetabolites|antimetabolites|mesh-ancestor
93098575|NCT03465280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098576|NCT03465280|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098577|NCT03465280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098578|NCT03465280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93098579|NCT03465280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098580|NCT03465280|Immunologic Factors|immunologic factors|mesh-ancestor
93098581|NCT03465280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098582|NCT03465280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098583|NCT03465280|Antiviral Agents|antiviral agents|mesh-ancestor
93098584|NCT03465280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098585|NCT03465280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93098586|NCT03465280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098587|NCT03465280|Analgesics|analgesics|mesh-ancestor
93098588|NCT03465280|Sensory System Agents|sensory system agents|mesh-ancestor
93098589|NCT03465280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098590|NCT03465280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098591|NCT03465280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93098592|NCT03465280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93098593|NCT03465280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93098594|NCT03465280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098595|NCT03465280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93098596|NCT03465280|Histamine Antagonists|histamine antagonists|mesh-ancestor
93098597|NCT03465280|Histamine Agents|histamine agents|mesh-ancestor
93098598|NCT03465280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098599|NCT03465280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93098600|NCT03465280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93098601|NCT03465280|Antimalarials|antimalarials|mesh-ancestor
93098602|NCT03465280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93098603|NCT03465280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93098604|NCT03465280|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93098605|NCT03465280|Protective Agents|protective agents|mesh-ancestor
93098606|NCT01349764|Vitamin D|vitamin d|mesh-list
93098607|NCT01349764|Cholecalciferol|cholecalciferol|mesh-list
93098608|NCT01349764|Vitamins|vitamins|mesh-ancestor
93098609|NCT01349764|Micronutrients|micronutrients|mesh-ancestor
93098610|NCT01349764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098611|NCT01349764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93098612|NCT01349764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93098613|NCT02924272|Ixazomib|ixazomib|mesh-list
93098614|NCT02924272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098615|NCT02924272|Protease Inhibitors|protease inhibitors|mesh-ancestor
93098616|NCT02924272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098617|NCT02924272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098618|NCT01353742|Lamivudine|lamivudine|mesh-list
93098619|NCT01353742|Adefovir|adefovir|mesh-list
93098620|NCT01353742|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93098621|NCT01353742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93098622|NCT01353742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098623|NCT01353742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098624|NCT01353742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098625|NCT01353742|Antiviral Agents|antiviral agents|mesh-ancestor
93098626|NCT01353742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098627|NCT01353742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93098628|NCT01353742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93098629|NCT00003702|Dactinomycin|dactinomycin|mesh-list
93098630|NCT00003702|Cactinomycin|cactinomycin|mesh-list
93098631|NCT00003702|Methotrexate|methotrexate|mesh-list
93098632|NCT00003702|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93098633|NCT00003702|Abortifacient Agents|abortifacient agents|mesh-ancestor
93098634|NCT00003702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93098635|NCT00003702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098636|NCT00003702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098637|NCT00003702|Antimetabolites|antimetabolites|mesh-ancestor
93098638|NCT00003702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098639|NCT00003702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098640|NCT00003702|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098641|NCT00003702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098642|NCT00003702|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93098643|NCT00003702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098644|NCT00003702|Immunologic Factors|immunologic factors|mesh-ancestor
93098645|NCT00003702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098646|NCT00003702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098647|NCT00003702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93098648|NCT00003702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098649|NCT00003702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93098650|NCT00003702|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93098651|NCT01350154|Sildenafil Citrate|sildenafil citrate|mesh-list
93098652|NCT01350154|Vasodilator Agents|vasodilator agents|mesh-ancestor
93098653|NCT01350154|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93098654|NCT01350154|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93098655|NCT01350154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098656|NCT01350154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098657|NCT01350154|Urological Agents|urological agents|mesh-ancestor
93098658|NCT00031590|Cyclophosphamide|cyclophosphamide|mesh-list
93098659|NCT00031590|Lomustine|lomustine|mesh-list
93098660|NCT00031590|Etoposide|etoposide|mesh-list
93098661|NCT00031590|Vincristine|vincristine|mesh-list
93098662|NCT00031590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098663|NCT00031590|Immunologic Factors|immunologic factors|mesh-ancestor
93098664|NCT00031590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098665|NCT00031590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098666|NCT00031590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93098667|NCT00031590|Alkylating Agents|alkylating agents|mesh-ancestor
93098668|NCT00031590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098669|NCT00031590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098670|NCT00031590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93098671|NCT00031590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93098672|NCT00031590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93098673|NCT00031590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93098674|NCT00031590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098675|NCT00031590|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098676|NCT00031590|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098677|NCT00031590|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098678|NCT01318096|Tenofovir|tenofovir|mesh-list
93098679|NCT01318096|Lamivudine|lamivudine|mesh-list
93098680|NCT01318096|Efavirenz|efavirenz|mesh-list
93098681|NCT01318096|Raltegravir Potassium|raltegravir potassium|mesh-list
93098682|NCT01318096|Antiviral Agents|antiviral agents|mesh-ancestor
93098683|NCT01318096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098684|NCT01318096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93098685|NCT01318096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93098686|NCT01318096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098687|NCT01318096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098688|NCT01318096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93098689|NCT01318096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93098690|NCT01318096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93098691|NCT01318096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93098692|NCT01318096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93098693|NCT01318096|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93098694|NCT01318096|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93098695|NCT01318096|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93098696|NCT01318096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93098697|NCT01318096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93098698|NCT02530320|Palbociclib|palbociclib|mesh-list
93098699|NCT02530320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098700|NCT02530320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098701|NCT02530320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098702|NCT02530320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098703|NCT00239681|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93098704|NCT00239681|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93098705|NCT00239681|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93098706|NCT00239681|Antimetabolites|antimetabolites|mesh-ancestor
93098707|NCT00239681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098708|NCT00239681|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93098709|NCT00239681|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93098710|NCT00239681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098711|NCT00238433|Melphalan|melphalan|mesh-list
93098712|NCT00238433|Busulfan|busulfan|mesh-list
93098713|NCT00238433|Thiotepa|thiotepa|mesh-list
93098714|NCT00238433|Immunologic Factors|immunologic factors|mesh-ancestor
93098715|NCT00238433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098716|NCT00238433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93098717|NCT00238433|Alkylating Agents|alkylating agents|mesh-ancestor
93098718|NCT00238433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098719|NCT00238433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098720|NCT00238433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93098721|NCT00238433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098722|NCT02532023|Curcumin|curcumin|mesh-list
93098723|NCT02532023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93098724|NCT02532023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098725|NCT02532023|Analgesics|analgesics|mesh-ancestor
93098726|NCT02532023|Sensory System Agents|sensory system agents|mesh-ancestor
93098727|NCT02532023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098728|NCT02532023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098729|NCT02532023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098730|NCT02532023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098731|NCT02532023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098732|NCT02532023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098733|NCT02532023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098734|NCT01354522|Cyclophosphamide|cyclophosphamide|mesh-list
93098735|NCT01354522|Docetaxel|docetaxel|mesh-list
93098736|NCT01354522|Doxorubicin|doxorubicin|mesh-list
93098737|NCT01354522|Capecitabine|capecitabine|mesh-list
93098738|NCT01354522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098739|NCT01354522|Immunologic Factors|immunologic factors|mesh-ancestor
93098740|NCT01354522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098741|NCT01354522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098742|NCT01354522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93098743|NCT01354522|Alkylating Agents|alkylating agents|mesh-ancestor
93098744|NCT01354522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098745|NCT01354522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098746|NCT01354522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93098747|NCT01354522|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098748|NCT01354522|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098749|NCT01354522|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098750|NCT01354522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93098751|NCT01354522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93098752|NCT01354522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93098753|NCT01354522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098754|NCT01354522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93098755|NCT01354522|Antimetabolites|antimetabolites|mesh-ancestor
93098756|NCT00045162|Irinotecan|irinotecan|mesh-list
93098757|NCT00045162|Etoposide|etoposide|mesh-list
93098758|NCT00045162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098759|NCT00045162|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93098760|NCT00045162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93098761|NCT00045162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098762|NCT00045162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098763|NCT00045162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93098764|NCT00045162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93098765|NCT02748616|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93098766|NCT02748616|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93098767|NCT02748616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098768|NCT00238121|Sorafenib|sorafenib|mesh-list
93098769|NCT00238121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098770|NCT00238121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098771|NCT00238121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098772|NCT00238121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098773|NCT01350622|Diclofenac|diclofenac|mesh-list
93098774|NCT01350622|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
93098775|NCT01350622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93098776|NCT01350622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098777|NCT01350622|Analgesics|analgesics|mesh-ancestor
93098778|NCT01350622|Sensory System Agents|sensory system agents|mesh-ancestor
93098779|NCT01350622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098780|NCT01350622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098781|NCT01350622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098782|NCT01350622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098783|NCT01350622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93098784|NCT01350622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098785|NCT01350622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098786|NCT01096212|Sevoflurane|sevoflurane|mesh-list
93098787|NCT01096212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93098788|NCT01096212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93098789|NCT01096212|Anesthetics, General|anesthetics, general|mesh-ancestor
93098790|NCT01096212|Anesthetics|anesthetics|mesh-ancestor
93098791|NCT01096212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098792|NCT01096212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098793|NCT03139240|Oxycodone|oxycodone|mesh-list
93098794|NCT03139240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93098795|NCT03139240|Narcotics|narcotics|mesh-ancestor
93098796|NCT03139240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098797|NCT03139240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098798|NCT03139240|Analgesics|analgesics|mesh-ancestor
93098799|NCT03139240|Sensory System Agents|sensory system agents|mesh-ancestor
93098800|NCT03139240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098801|NCT01350856|Artesunate|artesunate|mesh-list
93098802|NCT01350856|Antimalarials|antimalarials|mesh-ancestor
93098803|NCT01350856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93098804|NCT01350856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93098805|NCT01350856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098806|NCT01350856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098807|NCT01350856|Antiviral Agents|antiviral agents|mesh-ancestor
93098808|NCT01350856|Schistosomicides|schistosomicides|mesh-ancestor
93098809|NCT01350856|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93098810|NCT01350856|Anthelmintics|anthelmintics|mesh-ancestor
93098811|NCT03973775|Permethrin|permethrin|mesh-list
93098812|NCT03973775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098813|NCT03973775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098814|NCT01351168|Levodopa|levodopa|mesh-list
93098815|NCT01351168|Zolpidem|zolpidem|mesh-list
93098816|NCT01351168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93098817|NCT01351168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93098818|NCT01351168|Dopamine Agents|dopamine agents|mesh-ancestor
93098819|NCT01351168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098820|NCT01351168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098821|NCT01351168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098822|NCT01351168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93098823|NCT01351168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93098824|NCT01351168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098825|NCT01351168|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93098826|NCT01351168|GABA Agonists|gaba agonists|mesh-ancestor
93098827|NCT01351168|GABA Agents|gaba agents|mesh-ancestor
93098828|NCT01351636|Arotinolol|arotinolol|mesh-list
93098829|NCT01351636|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93098830|NCT01351636|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93098831|NCT01351636|Adrenergic Agents|adrenergic agents|mesh-ancestor
93098832|NCT01351636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098833|NCT01351636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098834|NCT01351636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098835|NCT01351636|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93098836|NCT01351792|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93098837|NCT01351792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93098838|NCT01351792|Respiratory System Agents|respiratory system agents|mesh-ancestor
93098839|NCT03952260|Anesthetics|anesthetics|mesh-list
93098840|NCT03952260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098841|NCT03952260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098842|NCT01351948|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93098843|NCT01351948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93098844|NCT01351948|Immunologic Factors|immunologic factors|mesh-ancestor
93098845|NCT01351948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098846|NCT01351948|Antacids|antacids|mesh-ancestor
93098847|NCT01351948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098848|NCT01351948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098849|NCT01352026|Metformin|metformin|mesh-list
93098850|NCT01352026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098851|NCT01352026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098852|NCT03136198|Vasodilator Agents|vasodilator agents|mesh-list
93098853|NCT03136198|Diuretics|diuretics|mesh-list
93098854|NCT03136198|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
93098855|NCT03136198|Natriuretic Agents|natriuretic agents|mesh-ancestor
93098856|NCT03136198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098857|NCT03136198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93098858|NCT03136198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098859|NCT01357486|Sorafenib|sorafenib|mesh-list
93098860|NCT01357486|Pravastatin|pravastatin|mesh-list
93098861|NCT01357486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098862|NCT01357486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098863|NCT01357486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098864|NCT01357486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098865|NCT01357486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93098866|NCT01357486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93098867|NCT01357486|Antimetabolites|antimetabolites|mesh-ancestor
93098868|NCT01357486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93098869|NCT01357486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93098870|NCT01318564|Metformin|metformin|mesh-list
93098871|NCT01318564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098872|NCT01318564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098873|NCT00042432|Cinacalcet|cinacalcet|mesh-list
93098874|NCT00042432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93098875|NCT00042432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098876|NCT00042432|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93098877|NCT00042432|Hormone Antagonists|hormone antagonists|mesh-ancestor
93098878|NCT00042432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93098879|NCT01352338|Prednisone|prednisone|mesh-list
93098880|NCT01352338|Cyclophosphamide|cyclophosphamide|mesh-list
93098881|NCT01352338|Lenalidomide|lenalidomide|mesh-list
93098882|NCT01352338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098883|NCT01352338|Immunologic Factors|immunologic factors|mesh-ancestor
93098884|NCT01352338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098885|NCT01352338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098886|NCT01352338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93098887|NCT01352338|Alkylating Agents|alkylating agents|mesh-ancestor
93098888|NCT01352338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098889|NCT01352338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098890|NCT01352338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93098891|NCT01352338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098892|NCT01352338|Glucocorticoids|glucocorticoids|mesh-ancestor
93098893|NCT01352338|Hormones|hormones|mesh-ancestor
93098894|NCT01352338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93098895|NCT01352338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93098896|NCT01352338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93098897|NCT01352338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93098898|NCT01352338|Growth Substances|growth substances|mesh-ancestor
93098899|NCT01352338|Growth Inhibitors|growth inhibitors|mesh-ancestor
93098900|NCT01542736|Carboplatin|carboplatin|mesh-list
93098901|NCT01542736|Vincristine|vincristine|mesh-list
93098902|NCT01542736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098903|NCT01542736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93098904|NCT01542736|Tubulin Modulators|tubulin modulators|mesh-ancestor
93098905|NCT01542736|Antimitotic Agents|antimitotic agents|mesh-ancestor
93098906|NCT01542736|Mitosis Modulators|mitosis modulators|mesh-ancestor
93098907|NCT01542736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098908|NCT01099566|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93098909|NCT01099566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93098910|NCT01099722|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93098911|NCT01099722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93098912|NCT01099722|Respiratory System Agents|respiratory system agents|mesh-ancestor
93098913|NCT01361542|Infliximab|infliximab|mesh-list
93098914|NCT01361542|Etanercept|etanercept|mesh-list
93098915|NCT01361542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93098916|NCT01361542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93098917|NCT01361542|Dermatologic Agents|dermatologic agents|mesh-ancestor
93098918|NCT01361542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93098919|NCT01361542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93098920|NCT01361542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93098921|NCT01361542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098922|NCT01361542|Analgesics|analgesics|mesh-ancestor
93098923|NCT01361542|Sensory System Agents|sensory system agents|mesh-ancestor
93098924|NCT01361542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098925|NCT01361542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098926|NCT01361542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098927|NCT01361542|Immunologic Factors|immunologic factors|mesh-ancestor
93098928|NCT03950700|Epinephrine|epinephrine|mesh-list
93098929|NCT03950700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93098930|NCT03950700|Bupivacaine|bupivacaine|mesh-list
93098931|NCT03950700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93098932|NCT03950700|Anesthetics, Local|anesthetics, local|mesh-ancestor
93098933|NCT03950700|Anesthetics|anesthetics|mesh-ancestor
93098934|NCT03950700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93098935|NCT03950700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098936|NCT03950700|Sensory System Agents|sensory system agents|mesh-ancestor
93098937|NCT03950700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098938|NCT03950700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93098939|NCT03950700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93098940|NCT03950700|Adrenergic Agents|adrenergic agents|mesh-ancestor
93098941|NCT03950700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098942|NCT03950700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098943|NCT03950700|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93098944|NCT03950700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93098945|NCT03950700|Autonomic Agents|autonomic agents|mesh-ancestor
93098946|NCT03950700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93098947|NCT03950700|Respiratory System Agents|respiratory system agents|mesh-ancestor
93098948|NCT03950700|Mydriatics|mydriatics|mesh-ancestor
93098949|NCT03950700|Sympathomimetics|sympathomimetics|mesh-ancestor
93098950|NCT00237185|Imatinib Mesylate|imatinib mesylate|mesh-list
93098951|NCT00237185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098952|NCT00237185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93098953|NCT00237185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098954|NCT00237185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098955|NCT01357798|Botulinum Toxins|botulinum toxins|mesh-list
93098956|NCT01357798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93098957|NCT01357798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93098958|NCT01357798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93098959|NCT01357798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93098960|NCT01357798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098961|NCT01357798|Cholinergic Agents|cholinergic agents|mesh-ancestor
93098962|NCT01357798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93098963|NCT01357798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098964|NCT01357798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93098965|NCT01357798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098966|NCT00003222|Aldesleukin|aldesleukin|mesh-list
93098967|NCT00003222|Interleukin-2|interleukin-2|mesh-list
93098968|NCT00003222|Sargramostim|sargramostim|mesh-list
93098969|NCT00003222|Freund's Adjuvant|freund's adjuvant|mesh-list
93098970|NCT00003222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098971|NCT00003222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93098972|NCT00003222|Analgesics|analgesics|mesh-ancestor
93098973|NCT00003222|Sensory System Agents|sensory system agents|mesh-ancestor
93098974|NCT00003222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93098975|NCT00003222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098976|NCT00003222|Immunologic Factors|immunologic factors|mesh-ancestor
93098977|NCT00003222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93098978|NCT00003222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93098979|NCT00003222|Antiviral Agents|antiviral agents|mesh-ancestor
93098980|NCT00003222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93098981|NCT00003222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93098982|NCT01357876|Metformin|metformin|mesh-list
93098983|NCT01357876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93098984|NCT01357876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098985|NCT02877082|Bortezomib|bortezomib|mesh-list
93098986|NCT02877082|Tacrolimus|tacrolimus|mesh-list
93098987|NCT02877082|Thymoglobulin|thymoglobulin|mesh-list
93098988|NCT02877082|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93098989|NCT02877082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93098990|NCT02877082|Immunologic Factors|immunologic factors|mesh-ancestor
93098991|NCT02877082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93098992|NCT02877082|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93098993|NCT02877082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93098994|NCT02877082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93098995|NCT02877082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93098996|NCT03951558|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93098997|NCT03951558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93098998|NCT03951558|Diuretics|diuretics|mesh-ancestor
93098999|NCT03951558|Natriuretic Agents|natriuretic agents|mesh-ancestor
93099000|NCT03951558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099001|NCT03951558|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93099002|NCT03951558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099003|NCT03951558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099004|NCT01362010|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93099005|NCT01362010|Minocycline|minocycline|mesh-list
93099006|NCT01362010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099007|NCT02875366|Ivacaftor|ivacaftor|mesh-list
93099008|NCT02875366|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93099009|NCT02875366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099010|NCT02875366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099011|NCT01362400|Docetaxel|docetaxel|mesh-list
93099012|NCT01362400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099013|NCT01362400|Tubulin Modulators|tubulin modulators|mesh-ancestor
93099014|NCT01362400|Antimitotic Agents|antimitotic agents|mesh-ancestor
93099015|NCT01362400|Mitosis Modulators|mitosis modulators|mesh-ancestor
93099016|NCT01362400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099017|NCT00003102|Antibodies|antibodies|mesh-list
93099018|NCT00003102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93099019|NCT00003102|Immunologic Factors|immunologic factors|mesh-ancestor
93099020|NCT00003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099021|NCT00002850|Ciprofloxacin|ciprofloxacin|mesh-list
93099022|NCT00002850|Ofloxacin|ofloxacin|mesh-list
93099023|NCT00002850|Trimethoprim|trimethoprim|mesh-list
93099024|NCT00002850|Sulfamethoxazole|sulfamethoxazole|mesh-list
93099025|NCT00002850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099026|NCT00002850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099027|NCT00002850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099028|NCT00002850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099029|NCT00002850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099030|NCT00002850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099031|NCT00002850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099032|NCT00002850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93099033|NCT00002850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93099034|NCT00002850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93099035|NCT00002850|Antimalarials|antimalarials|mesh-ancestor
93099036|NCT00002850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93099037|NCT00002850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93099038|NCT00002850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93099039|NCT00002850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93099040|NCT00002850|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93099041|NCT04234906|Magnesium Sulfate|magnesium sulfate|mesh-list
93099042|NCT04234906|Amiodarone|amiodarone|mesh-list
93099043|NCT04234906|Procainamide|procainamide|mesh-list
93099044|NCT04234906|Dexmedetomidine|dexmedetomidine|mesh-list
93099045|NCT04234906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93099046|NCT04234906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099047|NCT04234906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099048|NCT04234906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93099049|NCT04234906|Analgesics|analgesics|mesh-ancestor
93099050|NCT04234906|Sensory System Agents|sensory system agents|mesh-ancestor
93099051|NCT04234906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099052|NCT04234906|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93099053|NCT04234906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93099054|NCT04234906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93099055|NCT04234906|Adrenergic Agents|adrenergic agents|mesh-ancestor
93099056|NCT04234906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099057|NCT04234906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099058|NCT04234906|Anesthetics|anesthetics|mesh-ancestor
93099059|NCT04234906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93099060|NCT04234906|Anticonvulsants|anticonvulsants|mesh-ancestor
93099061|NCT04234906|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93099062|NCT04234906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099063|NCT04234906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93099064|NCT04234906|Tocolytic Agents|tocolytic agents|mesh-ancestor
93099065|NCT04234906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92689360|NCT00482573|Autonomic Agents|autonomic agents|mesh-ancestor
93099066|NCT04234906|Vasodilator Agents|vasodilator agents|mesh-ancestor
93099067|NCT04234906|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93099068|NCT04234906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93099069|NCT04234906|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93099070|NCT04234906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93099071|NCT04234906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099072|NCT04234906|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93099073|NCT04234906|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93099074|NCT04234906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93099075|NCT04234906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93099076|NCT00002766|Cytarabine|cytarabine|mesh-list
93099077|NCT00002766|Dactinomycin|dactinomycin|mesh-list
93099078|NCT00002766|Prednisone|prednisone|mesh-list
93099079|NCT00002766|Cyclophosphamide|cyclophosphamide|mesh-list
93099080|NCT00002766|Carmustine|carmustine|mesh-list
93099081|NCT00002766|Doxorubicin|doxorubicin|mesh-list
93099082|NCT00002766|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93099083|NCT00002766|Methotrexate|methotrexate|mesh-list
93099084|NCT00002766|Etoposide|etoposide|mesh-list
93099085|NCT00002766|Vincristine|vincristine|mesh-list
93099086|NCT00002766|Daunorubicin|daunorubicin|mesh-list
93099087|NCT00002766|Mitoxantrone|mitoxantrone|mesh-list
93099088|NCT00002766|Mercaptopurine|mercaptopurine|mesh-list
93099089|NCT00002766|Pegaspargase|pegaspargase|mesh-list
93099090|NCT00002766|Sargramostim|sargramostim|mesh-list
93099091|NCT00002766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099092|NCT00002766|Immunologic Factors|immunologic factors|mesh-ancestor
93099093|NCT00002766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099094|NCT00002766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099095|NCT00002766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93099096|NCT00002766|Alkylating Agents|alkylating agents|mesh-ancestor
93099097|NCT00002766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099098|NCT00002766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099099|NCT00002766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93099100|NCT00002766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93099101|NCT00002766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099102|NCT00002766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099103|NCT00002766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099104|NCT00002766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099105|NCT00002766|Glucocorticoids|glucocorticoids|mesh-ancestor
93099106|NCT00002766|Hormones|hormones|mesh-ancestor
93099107|NCT00002766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099108|NCT00002766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93099109|NCT00002766|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93099110|NCT00002766|Abortifacient Agents|abortifacient agents|mesh-ancestor
93099111|NCT00002766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93099112|NCT00002766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93099113|NCT00002766|Antimetabolites|antimetabolites|mesh-ancestor
93099114|NCT00002766|Dermatologic Agents|dermatologic agents|mesh-ancestor
93099115|NCT00002766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92771389|NCT05663125|Temozolomide|temozolomide|mesh-list
93099116|NCT00002766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93099117|NCT00002766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93099118|NCT00002766|Antiviral Agents|antiviral agents|mesh-ancestor
93099119|NCT00002766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099120|NCT00002766|Tubulin Modulators|tubulin modulators|mesh-ancestor
93099121|NCT00002766|Antimitotic Agents|antimitotic agents|mesh-ancestor
93099122|NCT00002766|Mitosis Modulators|mitosis modulators|mesh-ancestor
93099123|NCT00002766|Analgesics|analgesics|mesh-ancestor
93099124|NCT00002766|Sensory System Agents|sensory system agents|mesh-ancestor
93099125|NCT00002766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099126|NCT00002766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099127|NCT00002766|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93099128|NCT01355380|Iloprost|iloprost|mesh-list
93099129|NCT01355380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93099130|NCT01355380|Vasodilator Agents|vasodilator agents|mesh-ancestor
93099131|NCT01355614|Infliximab|infliximab|mesh-list
93099132|NCT01355614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93099133|NCT01355614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099134|NCT01355614|Dermatologic Agents|dermatologic agents|mesh-ancestor
93099135|NCT01355614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93099136|NCT01355614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099137|NCT01584492|Beclomethasone|beclomethasone|mesh-list
93099138|NCT01584492|Albuterol|albuterol|mesh-list
93099139|NCT01584492|Formoterol Fumarate|formoterol fumarate|mesh-list
93099140|NCT01584492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93099141|NCT01584492|Autonomic Agents|autonomic agents|mesh-ancestor
93099142|NCT01584492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099143|NCT01584492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099144|NCT01584492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93099145|NCT01584492|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099146|NCT01584492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93099147|NCT01584492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93099148|NCT01584492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93099149|NCT01584492|Adrenergic Agents|adrenergic agents|mesh-ancestor
93099150|NCT01584492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099151|NCT01584492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099152|NCT01584492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099153|NCT01584492|Glucocorticoids|glucocorticoids|mesh-ancestor
93099154|NCT01584492|Hormones|hormones|mesh-ancestor
93099155|NCT01584492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099156|NCT01584492|Tocolytic Agents|tocolytic agents|mesh-ancestor
93099157|NCT01584492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93099158|NCT00001962|Daclizumab|daclizumab|mesh-list
93099159|NCT00001962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099160|NCT00001962|Immunologic Factors|immunologic factors|mesh-ancestor
93099161|NCT00001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099162|NCT01101984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93099163|NCT01101984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93099164|NCT01101984|Hyaluronic Acid|hyaluronic acid|mesh-list
93099165|NCT01101984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93099166|NCT01101984|Immunologic Factors|immunologic factors|mesh-ancestor
93099167|NCT01101984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099168|NCT01101984|Viscosupplements|viscosupplements|mesh-ancestor
93099169|NCT01101984|Protective Agents|protective agents|mesh-ancestor
93099170|NCT01103154|Nadolol|nadolol|mesh-list
93099171|NCT01103154|Carvedilol|carvedilol|mesh-list
93099172|NCT01103154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93099173|NCT01103154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93099174|NCT01103154|Adrenergic Agents|adrenergic agents|mesh-ancestor
93099175|NCT01103154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099176|NCT01103154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099177|NCT01103154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099178|NCT01103154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93099179|NCT01103154|Antioxidants|antioxidants|mesh-ancestor
93099180|NCT01103154|Protective Agents|protective agents|mesh-ancestor
93099181|NCT01103154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93099182|NCT01103154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099183|NCT01103154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93099184|NCT01103154|Vasodilator Agents|vasodilator agents|mesh-ancestor
93099185|NCT01103154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93099186|NCT01103154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93099187|NCT01103154|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93099188|NCT01103154|Sympatholytics|sympatholytics|mesh-ancestor
93099189|NCT01103154|Autonomic Agents|autonomic agents|mesh-ancestor
93099190|NCT01103154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099191|NCT01100346|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92771463|NCT00931528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099193|NCT01100346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099194|NCT01100346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099195|NCT01103388|Rituximab|rituximab|mesh-list
93099196|NCT01103388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93099197|NCT01103388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099198|NCT01103388|Immunologic Factors|immunologic factors|mesh-ancestor
93099199|NCT01103388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099200|NCT01103388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099201|NCT01327326|Naltrexone|naltrexone|mesh-list
93099202|NCT01327326|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93099203|NCT01327326|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93099204|NCT01327326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099205|NCT01327326|Sensory System Agents|sensory system agents|mesh-ancestor
93099206|NCT01327326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099207|NCT03950544|Meropenem|meropenem|mesh-list
93099208|NCT03950544|Fosfomycin|fosfomycin|mesh-list
93099209|NCT03950544|Tigecycline|tigecycline|mesh-list
93099210|NCT03950544|Polymyxins|polymyxins|mesh-list
93099211|NCT03950544|Polymyxin B|polymyxin b|mesh-list
93099212|NCT03950544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099213|NCT03950544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099214|NCT03950544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93099215|NCT03950544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099216|NCT03950544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099217|NCT00028002|Imatinib Mesylate|imatinib mesylate|mesh-list
93099218|NCT00028002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099219|NCT00028002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93099220|NCT00028002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099221|NCT00028002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099222|NCT00256997|Risperidone|risperidone|mesh-list
93099223|NCT00256997|Antipsychotic Agents|antipsychotic agents|mesh-list
93099224|NCT00256997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93099225|NCT00256997|Serotonin Agents|serotonin agents|mesh-ancestor
93099226|NCT00256997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099227|NCT00256997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099228|NCT00256997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099229|NCT00256997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93099230|NCT00256997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099231|NCT00256997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93099232|NCT00256997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93099233|NCT00256997|Dopamine Agents|dopamine agents|mesh-ancestor
93099234|NCT00027846|Cyclophosphamide|cyclophosphamide|mesh-list
93099235|NCT00027846|Carboplatin|carboplatin|mesh-list
93099236|NCT00027846|Etoposide|etoposide|mesh-list
93099237|NCT00027846|Vincristine|vincristine|mesh-list
93099238|NCT00027846|Podophyllotoxin|podophyllotoxin|mesh-list
93099239|NCT00027846|Lenograstim|lenograstim|mesh-list
93099240|NCT00027846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099241|NCT00027846|Immunologic Factors|immunologic factors|mesh-ancestor
93099242|NCT00027846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099243|NCT00027846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099244|NCT00027846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93099245|NCT00027846|Alkylating Agents|alkylating agents|mesh-ancestor
93099246|NCT00027846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099247|NCT00027846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099248|NCT00027846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93099249|NCT00027846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93099250|NCT00027846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099251|NCT00027846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099252|NCT00027846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099253|NCT00027846|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93099254|NCT00027846|Tubulin Modulators|tubulin modulators|mesh-ancestor
93099255|NCT00027846|Antimitotic Agents|antimitotic agents|mesh-ancestor
93099256|NCT00027846|Mitosis Modulators|mitosis modulators|mesh-ancestor
93099257|NCT00027846|Keratolytic Agents|keratolytic agents|mesh-ancestor
93099258|NCT00027846|Dermatologic Agents|dermatologic agents|mesh-ancestor
93099259|NCT00027378|Fluoxetine|fluoxetine|mesh-list
93099260|NCT00027378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93099261|NCT00027378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93099262|NCT00027378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099263|NCT00027378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099264|NCT00027378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099265|NCT00027378|Serotonin Agents|serotonin agents|mesh-ancestor
93099266|NCT00027378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099267|NCT00027378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92689567|NCT01240928|Exemestane|exemestane|mesh-list
93099268|NCT00027378|Antidepressive Agents|antidepressive agents|mesh-ancestor
93099269|NCT00027378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93099270|NCT00027378|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93099271|NCT00027378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93099272|NCT00027378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099273|NCT03950154|Bevacizumab|bevacizumab|mesh-list
93099274|NCT03950154|Capecitabine|capecitabine|mesh-list
93099275|NCT03950154|Oxaliplatin|oxaliplatin|mesh-list
93099276|NCT03950154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93099277|NCT03950154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099278|NCT03950154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93099279|NCT03950154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93099280|NCT03950154|Growth Substances|growth substances|mesh-ancestor
93099281|NCT03950154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099282|NCT03950154|Growth Inhibitors|growth inhibitors|mesh-ancestor
93099283|NCT03950154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93099284|NCT03950154|Antimetabolites|antimetabolites|mesh-ancestor
93099285|NCT03950154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099286|NCT03949062|Rituximab|rituximab|mesh-list
93099287|NCT03949062|Lenalidomide|lenalidomide|mesh-list
93099288|NCT03949062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93099289|NCT03949062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099290|NCT03949062|Immunologic Factors|immunologic factors|mesh-ancestor
93099291|NCT03949062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099292|NCT03949062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099293|NCT03949062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93099294|NCT03949062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93099295|NCT03949062|Growth Substances|growth substances|mesh-ancestor
93099296|NCT03949062|Growth Inhibitors|growth inhibitors|mesh-ancestor
93099297|NCT00235391|Deferasirox|deferasirox|mesh-list
93099298|NCT00235391|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93099299|NCT00235391|Chelating Agents|chelating agents|mesh-ancestor
93099300|NCT00235391|Sequestering Agents|sequestering agents|mesh-ancestor
93099301|NCT00235391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099302|NCT01103622|Digoxin|digoxin|mesh-list
93099303|NCT01103622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93099304|NCT01103622|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93099305|NCT01103622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099306|NCT01103622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099307|NCT01103622|Protective Agents|protective agents|mesh-ancestor
93099308|NCT01103622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099309|NCT01072955|Heparin|heparin|mesh-list
93099310|NCT01072955|Calcium heparin|calcium heparin|mesh-list
93099311|NCT01072955|Anticoagulants|anticoagulants|mesh-ancestor
93099312|NCT01072955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93099313|NCT01072955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93099314|NCT01072955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099315|NCT00026208|Prednisone|prednisone|mesh-list
93099316|NCT00026208|Cyclophosphamide|cyclophosphamide|mesh-list
93099317|NCT00026208|Doxorubicin|doxorubicin|mesh-list
93099318|NCT00026208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93099319|NCT00026208|Etoposide|etoposide|mesh-list
93099320|NCT00026208|Etoposide phosphate|etoposide phosphate|mesh-list
93099321|NCT00026208|Vincristine|vincristine|mesh-list
93099322|NCT00026208|Bleomycin|bleomycin|mesh-list
93099323|NCT00026208|Vinblastine|vinblastine|mesh-list
93099324|NCT00026208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099325|NCT00026208|Immunologic Factors|immunologic factors|mesh-ancestor
93099326|NCT00026208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099327|NCT00026208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099328|NCT00026208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93099329|NCT00026208|Alkylating Agents|alkylating agents|mesh-ancestor
93099330|NCT00026208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099331|NCT00026208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099332|NCT00026208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93099333|NCT00026208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93099334|NCT00026208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099335|NCT00026208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099336|NCT00026208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099337|NCT00026208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099338|NCT00026208|Glucocorticoids|glucocorticoids|mesh-ancestor
93099339|NCT00026208|Hormones|hormones|mesh-ancestor
93099340|NCT00026208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099341|NCT00026208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93099342|NCT00026208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93099343|NCT00026208|Tubulin Modulators|tubulin modulators|mesh-ancestor
93099344|NCT00026208|Antimitotic Agents|antimitotic agents|mesh-ancestor
93099345|NCT00026208|Mitosis Modulators|mitosis modulators|mesh-ancestor
93099346|NCT00025662|Interleukin-2|interleukin-2|mesh-list
93099347|NCT00025662|Immunotoxins|immunotoxins|mesh-list
93099348|NCT00025662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099349|NCT00025662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93099350|NCT00025662|Analgesics|analgesics|mesh-ancestor
93099351|NCT00025662|Sensory System Agents|sensory system agents|mesh-ancestor
93099352|NCT00025662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099353|NCT00025662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099354|NCT00025662|Immunoconjugates|immunoconjugates|mesh-ancestor
93099355|NCT00025662|Immunologic Factors|immunologic factors|mesh-ancestor
93099356|NCT03759158|Acetylcysteine|acetylcysteine|mesh-list
93099357|NCT03759158|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93099358|NCT03759158|Antiviral Agents|antiviral agents|mesh-ancestor
93099359|NCT03759158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099360|NCT03759158|Expectorants|expectorants|mesh-ancestor
93099361|NCT03759158|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099362|NCT03759158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93099363|NCT03759158|Antioxidants|antioxidants|mesh-ancestor
93099364|NCT03759158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099365|NCT03759158|Protective Agents|protective agents|mesh-ancestor
93099366|NCT03759158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099367|NCT03759158|Antidotes|antidotes|mesh-ancestor
93099368|NCT02922764|Carboplatin|carboplatin|mesh-list
93099369|NCT02922764|Docetaxel|docetaxel|mesh-list
93099370|NCT02922764|Pembrolizumab|pembrolizumab|mesh-list
93099371|NCT02922764|Pemetrexed|pemetrexed|mesh-list
93099372|NCT02922764|Ipilimumab|ipilimumab|mesh-list
93099373|NCT02922764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099374|NCT02922764|Tubulin Modulators|tubulin modulators|mesh-ancestor
93099375|NCT02922764|Antimitotic Agents|antimitotic agents|mesh-ancestor
93099376|NCT02922764|Mitosis Modulators|mitosis modulators|mesh-ancestor
93099377|NCT02922764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099378|NCT02922764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93099379|NCT02922764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93099380|NCT02922764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099381|NCT02922764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93099382|NCT02922764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93099383|NCT00025506|Thalidomide|thalidomide|mesh-list
93099384|NCT00025506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099385|NCT00025506|Immunologic Factors|immunologic factors|mesh-ancestor
93099386|NCT00025506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099387|NCT00025506|Leprostatic Agents|leprostatic agents|mesh-ancestor
93099388|NCT00025506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099389|NCT00025506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099390|NCT00025506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93099391|NCT00025506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93099392|NCT00025506|Growth Substances|growth substances|mesh-ancestor
93099393|NCT00025506|Growth Inhibitors|growth inhibitors|mesh-ancestor
93099394|NCT00025506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099395|NCT00024258|Arsenic Trioxide|arsenic trioxide|mesh-list
93099396|NCT00024258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099397|NCT03756272|Bupivacaine|bupivacaine|mesh-list
93099398|NCT03756272|Anesthetics, Local|anesthetics, local|mesh-ancestor
93099399|NCT03756272|Anesthetics|anesthetics|mesh-ancestor
93099400|NCT03756272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099401|NCT03756272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099402|NCT03756272|Sensory System Agents|sensory system agents|mesh-ancestor
93099403|NCT03756272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099404|NCT03756194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93099405|NCT03756116|Epinephrine|epinephrine|mesh-list
93099406|NCT03756116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93099407|NCT03756116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93099408|NCT03756116|Adrenergic Agents|adrenergic agents|mesh-ancestor
93099409|NCT03756116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099410|NCT03756116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099411|NCT03756116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099412|NCT03756116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93099413|NCT03756116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93099414|NCT03756116|Autonomic Agents|autonomic agents|mesh-ancestor
93099415|NCT03756116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099416|NCT03756116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93099417|NCT03756116|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099418|NCT03756116|Mydriatics|mydriatics|mesh-ancestor
93099419|NCT03756116|Sympathomimetics|sympathomimetics|mesh-ancestor
93099420|NCT03756116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93099421|NCT00023712|Bortezomib|bortezomib|mesh-list
93099422|NCT00023712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099423|NCT00023322|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93099424|NCT00023322|Antiviral Agents|antiviral agents|mesh-ancestor
93099425|NCT00023322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099426|NCT04640168|Remdesivir|remdesivir|mesh-list
93099427|NCT04640168|Dexamethasone|dexamethasone|mesh-list
93099428|NCT04640168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099429|NCT04640168|Antiemetics|antiemetics|mesh-ancestor
93099430|NCT04640168|Autonomic Agents|autonomic agents|mesh-ancestor
93099431|NCT04640168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099432|NCT04640168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099433|NCT04640168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93099434|NCT04640168|Glucocorticoids|glucocorticoids|mesh-ancestor
93099435|NCT04640168|Hormones|hormones|mesh-ancestor
93099436|NCT04640168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099437|NCT04640168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93099438|NCT04640168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099439|NCT04640168|Antimetabolites|antimetabolites|mesh-ancestor
93099440|NCT04640168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099441|NCT04640168|Antiviral Agents|antiviral agents|mesh-ancestor
93099442|NCT04640168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099443|NCT00022698|Capecitabine|capecitabine|mesh-list
93099444|NCT00022698|Irinotecan|irinotecan|mesh-list
93099445|NCT00022698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93099446|NCT00022698|Antimetabolites|antimetabolites|mesh-ancestor
93099447|NCT00022698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099448|NCT00022698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099449|NCT00022698|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93099450|NCT00022698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099451|NCT00022698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099452|NCT03951402|Moxifloxacin|moxifloxacin|mesh-list
93099453|NCT03951402|Tapentadol|tapentadol|mesh-list
93099454|NCT03951402|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93099455|NCT03951402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099456|NCT03951402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099457|NCT03951402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099458|NCT03951402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099459|NCT03951402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099460|NCT03951402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099461|NCT03951402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099462|NCT03951402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93099463|NCT03951402|Contraceptive Agents|contraceptive agents|mesh-ancestor
93099464|NCT03951402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93099465|NCT03951402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099466|NCT03951402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93099467|NCT03951402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93099468|NCT03951402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93099469|NCT03951402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93099470|NCT03951402|Narcotics|narcotics|mesh-ancestor
93099471|NCT03951402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099472|NCT03951402|Analgesics|analgesics|mesh-ancestor
93099473|NCT03951402|Sensory System Agents|sensory system agents|mesh-ancestor
93099474|NCT03951402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099475|NCT03951402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93099476|NCT03951402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93099477|NCT03951402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099478|NCT03951402|Adrenergic Agents|adrenergic agents|mesh-ancestor
93099479|NCT03951402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099480|NCT01100736|Bosentan|bosentan|mesh-list
93099481|NCT01100736|Sitaxsentan|sitaxsentan|mesh-list
93099482|NCT01100736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93099483|NCT01100736|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93099484|NCT01100736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099485|NCT01584726|Magnesium Sulfate|magnesium sulfate|mesh-list
93099486|NCT01584726|Analgesics|analgesics|mesh-ancestor
93099487|NCT01584726|Sensory System Agents|sensory system agents|mesh-ancestor
93099488|NCT01584726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099489|NCT01584726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099490|NCT01584726|Anesthetics|anesthetics|mesh-ancestor
93099491|NCT01584726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099492|NCT01584726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93099493|NCT01584726|Anticonvulsants|anticonvulsants|mesh-ancestor
93099494|NCT01584726|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93099495|NCT01584726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099496|NCT01584726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099497|NCT01584726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93099498|NCT01584726|Tocolytic Agents|tocolytic agents|mesh-ancestor
93099499|NCT01584726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93099500|NCT01584804|Antitussive Agents|antitussive agents|mesh-list
93099501|NCT01584804|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099502|NCT01105494|Epoetin Alfa|epoetin alfa|mesh-list
93099503|NCT01105494|Hematinics|hematinics|mesh-ancestor
93099504|NCT03949686|Bupivacaine|bupivacaine|mesh-list
93099505|NCT03949686|Anesthetics, Local|anesthetics, local|mesh-ancestor
93099506|NCT03949686|Anesthetics|anesthetics|mesh-ancestor
93099507|NCT03949686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099508|NCT03949686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099509|NCT03949686|Sensory System Agents|sensory system agents|mesh-ancestor
93099510|NCT03949686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099511|NCT03949842|Fluticasone|fluticasone|mesh-list
93099512|NCT03949842|Xhance|xhance|mesh-list
93099513|NCT03949842|Adrenergic Agents|adrenergic agents|mesh-list
93099514|NCT03949842|Cholinergic Agents|cholinergic agents|mesh-list
93099515|NCT03949842|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93099516|NCT03949842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099517|NCT03949842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93099518|NCT03949842|Autonomic Agents|autonomic agents|mesh-ancestor
93099519|NCT03949842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099520|NCT03949842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099521|NCT03949842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93099522|NCT03949842|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099523|NCT03949842|Dermatologic Agents|dermatologic agents|mesh-ancestor
93099524|NCT03949842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93099525|NCT03949842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099526|NCT03949842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099527|NCT03949842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93099528|NCT01102608|Ifosfamide|ifosfamide|mesh-list
93099529|NCT01102608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93099530|NCT01102608|Alkylating Agents|alkylating agents|mesh-ancestor
93099531|NCT01102608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099532|NCT01102608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099533|NCT01102686|Leucovorin|leucovorin|mesh-list
93099534|NCT01102686|Pyrimethamine|pyrimethamine|mesh-list
93099535|NCT01102686|Antidotes|antidotes|mesh-ancestor
93099536|NCT01102686|Protective Agents|protective agents|mesh-ancestor
93099537|NCT01102686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099538|NCT01102686|Vitamin B Complex|vitamin b complex|mesh-ancestor
93099539|NCT01102686|Vitamins|vitamins|mesh-ancestor
93099540|NCT01102686|Micronutrients|micronutrients|mesh-ancestor
93099541|NCT01102686|Antimalarials|antimalarials|mesh-ancestor
93099542|NCT01102686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93099543|NCT01102686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93099544|NCT01102686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099545|NCT01102686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93099546|NCT01102686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099547|NCT01102686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099548|NCT03949374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93099549|NCT03949374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93099550|NCT03949374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93099551|NCT03949374|Antimetabolites|antimetabolites|mesh-ancestor
93099552|NCT03949374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099553|NCT03949374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93099554|NCT03949374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93099555|NCT03949374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099556|NCT04625972|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
93099557|NCT04625972|Antiviral Agents|antiviral agents|mesh-ancestor
93099558|NCT04625972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099559|NCT05626140|Diclofenac|diclofenac|mesh-list
93099560|NCT05626140|Lacosamide|lacosamide|mesh-list
93099561|NCT05626140|Codeine|codeine|mesh-list
93099562|NCT05626140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93099563|NCT05626140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93099564|NCT05626140|Analgesics|analgesics|mesh-ancestor
93099565|NCT05626140|Sensory System Agents|sensory system agents|mesh-ancestor
93099566|NCT05626140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099567|NCT05626140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099568|NCT05626140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099569|NCT05626140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099570|NCT05626140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771843|NCT05449171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93099571|NCT05626140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099572|NCT05626140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099573|NCT05626140|Anticonvulsants|anticonvulsants|mesh-ancestor
93099574|NCT05626140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93099575|NCT05626140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93099576|NCT05626140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099577|NCT05626140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93099578|NCT05626140|Narcotics|narcotics|mesh-ancestor
93099579|NCT05626140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099580|NCT05626140|Antitussive Agents|antitussive agents|mesh-ancestor
93099581|NCT05626140|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099582|NCT04878042|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93099583|NCT04878042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93099584|NCT04878042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099585|NCT04813614|Lidocaine|lidocaine|mesh-list
93099586|NCT04813614|Anesthetics, Local|anesthetics, local|mesh-ancestor
93099587|NCT04813614|Anesthetics|anesthetics|mesh-ancestor
93099588|NCT04813614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099589|NCT04813614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099590|NCT04813614|Sensory System Agents|sensory system agents|mesh-ancestor
93099591|NCT04813614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099592|NCT04813614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93099593|NCT04813614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93099594|NCT04813614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93099595|NCT04813614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099596|NCT04813614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099597|NCT01106118|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93099598|NCT01106118|Vasodilator Agents|vasodilator agents|mesh-ancestor
93099599|NCT01106118|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93099600|NCT01106118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93099601|NCT01106118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099602|NCT01106118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099603|NCT01106118|Urological Agents|urological agents|mesh-ancestor
93099604|NCT00234065|Aspirin|aspirin|mesh-list
93099605|NCT00234065|Cilostazol|cilostazol|mesh-list
93099606|NCT00234065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93099607|NCT00234065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93099608|NCT00234065|Analgesics|analgesics|mesh-ancestor
93099609|NCT00234065|Sensory System Agents|sensory system agents|mesh-ancestor
93099610|NCT00234065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099611|NCT00234065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099612|NCT00234065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099613|NCT00234065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099614|NCT00234065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93099615|NCT00234065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93099616|NCT00234065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099617|NCT00234065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93099618|NCT00234065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93099619|NCT00234065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099620|NCT00234065|Antipyretics|antipyretics|mesh-ancestor
93099621|NCT00234065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93099622|NCT00234065|Autonomic Agents|autonomic agents|mesh-ancestor
93099623|NCT00234065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93099624|NCT00234065|Respiratory System Agents|respiratory system agents|mesh-ancestor
93099625|NCT00234065|Vasodilator Agents|vasodilator agents|mesh-ancestor
93099626|NCT00234065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93099627|NCT00234065|Protective Agents|protective agents|mesh-ancestor
92689893|NCT01241097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099628|NCT00234065|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93099629|NCT00234065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93099630|NCT01108848|Complement C1s|complement c1s|mesh-list
93099631|NCT01108848|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93099632|NCT01108848|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
93099633|NCT01108848|Immunologic Factors|immunologic factors|mesh-ancestor
93099634|NCT01108848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099635|NCT01108848|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93099636|NCT01108848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099637|NCT00233987|Cyclophosphamide|cyclophosphamide|mesh-list
93099638|NCT00233987|Melphalan|melphalan|mesh-list
93099639|NCT00233987|Carmustine|carmustine|mesh-list
93099640|NCT00233987|Etoposide|etoposide|mesh-list
93099641|NCT00233987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099642|NCT00233987|Immunologic Factors|immunologic factors|mesh-ancestor
93099643|NCT00233987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099644|NCT00233987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099645|NCT00233987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93099647|NCT00233987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099648|NCT00233987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099649|NCT00233987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93099650|NCT00233987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93099651|NCT00233987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099652|NCT00233987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099653|NCT00233987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099654|NCT01108926|Tenofovir|tenofovir|mesh-list
93099655|NCT01108926|Emtricitabine|emtricitabine|mesh-list
93099656|NCT01108926|Efavirenz|efavirenz|mesh-list
93099657|NCT01108926|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93099658|NCT01108926|Antiviral Agents|antiviral agents|mesh-ancestor
93099659|NCT01108926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099660|NCT01108926|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93099661|NCT01108926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93099662|NCT01108926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099663|NCT01108926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099664|NCT01108926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93099665|NCT01108926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93099666|NCT01108926|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93099667|NCT01108926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93099668|NCT01108926|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93099669|NCT01108926|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93099670|NCT01108926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93099671|NCT01108926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93099672|NCT05321394|Ritonavir|ritonavir|mesh-list
93099673|NCT05321394|Nirmatrelvir|nirmatrelvir|mesh-list
93099674|NCT05321394|Sotrovimab|sotrovimab|mesh-list
93099675|NCT05321394|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
93099676|NCT05321394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93099677|NCT05321394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93099678|NCT05321394|Protease Inhibitors|protease inhibitors|mesh-ancestor
93099679|NCT05321394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099680|NCT05321394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099681|NCT05321394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93099682|NCT05321394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93099683|NCT05321394|Antiviral Agents|antiviral agents|mesh-ancestor
93099684|NCT05321394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099685|NCT05321394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93099686|NCT05321394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93099687|NCT04623242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93099688|NCT04623242|Immunologic Factors|immunologic factors|mesh-ancestor
93099689|NCT04623242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099690|NCT00233363|Rebamipide|rebamipide|mesh-list
93099691|NCT00233363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93099692|NCT00233363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93099693|NCT00233363|Antioxidants|antioxidants|mesh-ancestor
93099694|NCT00233363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099695|NCT00233363|Protective Agents|protective agents|mesh-ancestor
93099696|NCT00233363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099697|NCT00233363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099698|NCT01147666|Epoetin Alfa|epoetin alfa|mesh-list
93099699|NCT01147666|Hematinics|hematinics|mesh-ancestor
93099700|NCT01073111|Sirolimus|sirolimus|mesh-list
93099701|NCT01073111|Everolimus|everolimus|mesh-list
93099702|NCT01073111|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93099703|NCT01073111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93099704|NCT01073111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099705|NCT01073111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099706|NCT01073111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099707|NCT01073111|Immunologic Factors|immunologic factors|mesh-ancestor
93099708|NCT01073111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099709|NCT01073111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099710|NCT01073111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099711|NCT01073111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099712|NCT01073111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93099713|NCT01073111|Antifungal Agents|antifungal agents|mesh-ancestor
93099714|NCT01325987|Vitamin D|vitamin d|mesh-list
93099715|NCT01325987|Ergocalciferols|ergocalciferols|mesh-list
93099716|NCT01325987|Cholecalciferol|cholecalciferol|mesh-list
93099717|NCT01325987|Vitamins|vitamins|mesh-list
93099718|NCT01325987|Micronutrients|micronutrients|mesh-ancestor
93099719|NCT01325987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099720|NCT01325987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93099721|NCT01325987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93099722|NCT00256295|Gemcitabine|gemcitabine|mesh-list
93099723|NCT00256295|Oxaliplatin|oxaliplatin|mesh-list
93099724|NCT00256295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93099725|NCT00256295|Antimetabolites|antimetabolites|mesh-ancestor
93099726|NCT00256295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099727|NCT00256295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099728|NCT04410562|Hydroxychloroquine|hydroxychloroquine|mesh-list
93099729|NCT04410562|Antimalarials|antimalarials|mesh-ancestor
93099730|NCT04410562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93099731|NCT04410562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93099732|NCT04410562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099733|NCT04410562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099734|NCT04410562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099735|NCT04410562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099736|NCT01109160|Azithromycin|azithromycin|mesh-list
93099737|NCT01109160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099738|NCT01109160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099739|NCT01363336|Nifedipine|nifedipine|mesh-list
93099740|NCT01363336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93099741|NCT01363336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099742|NCT01363336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099743|NCT01363336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93099744|NCT01363336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099745|NCT01363336|Vasodilator Agents|vasodilator agents|mesh-ancestor
93099746|NCT01363336|Tocolytic Agents|tocolytic agents|mesh-ancestor
93099747|NCT01363336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93099748|NCT01363414|Hyaluronic Acid|hyaluronic acid|mesh-list
93099749|NCT01363414|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93099750|NCT01363414|Immunologic Factors|immunologic factors|mesh-ancestor
93099751|NCT01363414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099752|NCT01363414|Viscosupplements|viscosupplements|mesh-ancestor
93099753|NCT01363414|Protective Agents|protective agents|mesh-ancestor
93099754|NCT02223520|Chlorhexidine|chlorhexidine|mesh-list
93099755|NCT02223520|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93099756|NCT02223520|Mupirocin|mupirocin|mesh-list
93099757|NCT02223520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93099758|NCT02223520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099759|NCT02223520|Disinfectants|disinfectants|mesh-ancestor
93099760|NCT02223520|Dermatologic Agents|dermatologic agents|mesh-ancestor
93099761|NCT02223520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099762|NCT02223520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93099763|NCT02223520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099764|NCT02223520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099765|NCT01356472|Imipenem|imipenem|mesh-list
93099766|NCT01356472|Cilastatin|cilastatin|mesh-list
93099767|NCT01356472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099768|NCT01356472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099769|NCT01356472|Protease Inhibitors|protease inhibitors|mesh-ancestor
93099770|NCT01356472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099771|NCT01356472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099772|NCT02122198|Leuprolide|leuprolide|mesh-list
93099773|NCT02122198|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93099774|NCT02122198|Medroxyprogesterone|medroxyprogesterone|mesh-list
93099775|NCT02122198|Estradiol|estradiol|mesh-list
93099776|NCT02122198|Estrogens|estrogens|mesh-ancestor
93099777|NCT02122198|Hormones|hormones|mesh-ancestor
93099778|NCT02122198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099779|NCT02122198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099780|NCT02122198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93099781|NCT02122198|Contraceptive Agents|contraceptive agents|mesh-ancestor
93099782|NCT02122198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93099783|NCT02122198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93099784|NCT02122198|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93099785|NCT02122198|Fertility Agents|fertility agents|mesh-ancestor
93099786|NCT02122198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93099787|NCT02122198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099788|NCT02122198|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93099789|NCT02122198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93099790|NCT02122198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93099791|NCT02122198|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93099792|NCT01363570|Ranibizumab|ranibizumab|mesh-list
92772071|NCT05906498|Micronutrients|micronutrients|mesh-ancestor
93099793|NCT01363570|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93099794|NCT01363570|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93099795|NCT01363570|Growth Substances|growth substances|mesh-ancestor
93099796|NCT01363570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099797|NCT01363570|Growth Inhibitors|growth inhibitors|mesh-ancestor
93099798|NCT01363570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099799|NCT04608500|Minocycline|minocycline|mesh-list
93099800|NCT04608500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099801|NCT04608500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099802|NCT01363648|Choline|choline|mesh-list
93099803|NCT01363648|Lipotropic Agents|lipotropic agents|mesh-ancestor
93099804|NCT01363648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93099805|NCT01363648|Antimetabolites|antimetabolites|mesh-ancestor
93099806|NCT01363648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099807|NCT01363648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93099808|NCT01363648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93099809|NCT01363648|Nootropic Agents|nootropic agents|mesh-ancestor
93099810|NCT01107054|Moxifloxacin|moxifloxacin|mesh-list
93099811|NCT01107054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099812|NCT01107054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099813|NCT01107054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099814|NCT01107054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099815|NCT01107054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099816|NCT01107054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099817|NCT01107054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099818|NCT03944070|Ranibizumab|ranibizumab|mesh-list
93099819|NCT03944070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93099820|NCT03944070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93099821|NCT03944070|Growth Substances|growth substances|mesh-ancestor
93099822|NCT03944070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099823|NCT03944070|Growth Inhibitors|growth inhibitors|mesh-ancestor
93099824|NCT03944070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099825|NCT01363804|Tivozanib|tivozanib|mesh-list
93099826|NCT01363804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93099827|NCT01363804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099828|NCT01363804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099829|NCT03764462|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93099830|NCT03764462|AD 101|ad 101|mesh-list
93099831|NCT03764462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93099832|NCT03764462|Hormone Antagonists|hormone antagonists|mesh-ancestor
93099833|NCT03764462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099834|NCT03764462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099835|NCT03764462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93099836|NCT03764462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92690126|NCT00484484|Ketamine|ketamine|mesh-list
93099837|NCT03764462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93099838|NCT03764462|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93099839|NCT03764462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099840|NCT03764462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93099841|NCT03764462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93099842|NCT03764462|Antiviral Agents|antiviral agents|mesh-ancestor
93099843|NCT03764462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099844|NCT05460416|Aspirin|aspirin|mesh-list
93099845|NCT05460416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93099846|NCT05460416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93099847|NCT05460416|Analgesics|analgesics|mesh-ancestor
93099848|NCT05460416|Sensory System Agents|sensory system agents|mesh-ancestor
93099849|NCT05460416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099850|NCT05460416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099851|NCT05460416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099852|NCT05460416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099853|NCT05460416|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93099854|NCT05460416|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93099855|NCT05460416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099856|NCT05460416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93099857|NCT05460416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93099858|NCT05460416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099859|NCT05460416|Antipyretics|antipyretics|mesh-ancestor
93099860|NCT01364194|Bupivacaine|bupivacaine|mesh-list
93099861|NCT01364194|Anesthetics, Local|anesthetics, local|mesh-ancestor
93099862|NCT01364194|Anesthetics|anesthetics|mesh-ancestor
93099863|NCT01364194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099864|NCT01364194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099865|NCT01364194|Sensory System Agents|sensory system agents|mesh-ancestor
93099866|NCT01364194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099867|NCT04575038|Brequinar|brequinar|mesh-list
93099868|NCT04575038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099869|NCT04575038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099870|NCT04575038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099871|NCT04575038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099872|NCT04575038|Immunologic Factors|immunologic factors|mesh-ancestor
93099873|NCT04575038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099874|NCT03066622|Olanzapine|olanzapine|mesh-list
93099875|NCT03066622|Antiemetics|antiemetics|mesh-ancestor
93099876|NCT03066622|Autonomic Agents|autonomic agents|mesh-ancestor
93099877|NCT03066622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099878|NCT03066622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099879|NCT03066622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93099880|NCT03066622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93099881|NCT03066622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93099882|NCT03066622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099883|NCT03066622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93099884|NCT03066622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93099885|NCT03066622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93099886|NCT03066622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93099887|NCT03066622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099888|NCT03066622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099889|NCT03066622|Serotonin Agents|serotonin agents|mesh-ancestor
93099890|NCT01364974|Peficitinib|peficitinib|mesh-list
93099891|NCT01364974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099892|NCT01364974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099893|NCT01364974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099894|NCT01364974|Immunologic Factors|immunologic factors|mesh-ancestor
93099895|NCT01364974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099896|NCT05323214|Fentanyl|fentanyl|mesh-list
93099897|NCT05323214|Dexmedetomidine|dexmedetomidine|mesh-list
93099898|NCT05323214|Analgesics|analgesics|mesh-list
93099899|NCT05323214|Bupivacaine|bupivacaine|mesh-list
93099900|NCT05323214|Anesthetics, Local|anesthetics, local|mesh-ancestor
93099901|NCT05323214|Anesthetics|anesthetics|mesh-ancestor
93099902|NCT05323214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93099903|NCT05323214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099904|NCT05323214|Sensory System Agents|sensory system agents|mesh-ancestor
93099905|NCT05323214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099906|NCT05323214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93099907|NCT05323214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93099908|NCT05323214|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93099909|NCT05323214|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93099910|NCT05323214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93099911|NCT05323214|Adrenergic Agents|adrenergic agents|mesh-ancestor
93099912|NCT05323214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93099913|NCT05323214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099914|NCT05323214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93099915|NCT05323214|Narcotics|narcotics|mesh-ancestor
93099916|NCT05323214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93099917|NCT05323214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93099918|NCT05323214|Anesthetics, General|anesthetics, general|mesh-ancestor
93099919|NCT01936480|Moxifloxacin|moxifloxacin|mesh-list
93099920|NCT01936480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93099921|NCT01936480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099922|NCT01936480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93099923|NCT01936480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93099924|NCT01936480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099925|NCT01936480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099926|NCT01936480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099927|NCT02060188|Nivolumab|nivolumab|mesh-list
93099928|NCT02060188|Ipilimumab|ipilimumab|mesh-list
93099929|NCT02060188|Relatlimab|relatlimab|mesh-list
93099930|NCT02060188|Daratumumab|daratumumab|mesh-list
93099931|NCT02060188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93099932|NCT02060188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099933|NCT02060188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93099934|NCT02060188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099935|NCT01356862|Pasireotide|pasireotide|mesh-list
93099936|NCT01356862|Hormones|hormones|mesh-ancestor
93099937|NCT01356862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099938|NCT01356862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099939|NCT03763760|Dexamethasone|dexamethasone|mesh-list
93099940|NCT03763760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93099941|NCT03763760|Antiemetics|antiemetics|mesh-ancestor
93099942|NCT03763760|Autonomic Agents|autonomic agents|mesh-ancestor
93099943|NCT03763760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93099944|NCT03763760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099945|NCT03763760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93099946|NCT03763760|Glucocorticoids|glucocorticoids|mesh-ancestor
93099947|NCT03763760|Hormones|hormones|mesh-ancestor
93099948|NCT03763760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93099949|NCT03763760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93099950|NCT03763760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099951|NCT04501952|Remdesivir|remdesivir|mesh-list
93099952|NCT04501952|Antimetabolites|antimetabolites|mesh-ancestor
93099953|NCT04501952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099954|NCT04501952|Antiviral Agents|antiviral agents|mesh-ancestor
93099955|NCT04501952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099956|NCT00321100|Bevacizumab|bevacizumab|mesh-list
93099957|NCT00321100|Cetuximab|cetuximab|mesh-list
93099958|NCT00321100|Capecitabine|capecitabine|mesh-list
93099959|NCT00321100|Oxaliplatin|oxaliplatin|mesh-list
93099960|NCT00321100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93099961|NCT00321100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099962|NCT00321100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93099963|NCT00321100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93099964|NCT00321100|Growth Substances|growth substances|mesh-ancestor
93099965|NCT00321100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099966|NCT00321100|Growth Inhibitors|growth inhibitors|mesh-ancestor
93099967|NCT00321100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93099968|NCT00321100|Antimetabolites|antimetabolites|mesh-ancestor
93099969|NCT00321100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099970|NCT02930122|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93099971|NCT02930122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93099972|NCT01365598|Primaquine|primaquine|mesh-list
93099973|NCT01365598|Antimalarials|antimalarials|mesh-ancestor
93099974|NCT01365598|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93099975|NCT01365598|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93099976|NCT01365598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099977|NCT01365676|Hypericin|hypericin|mesh-list
93099978|NCT01365676|Antidepressive Agents|antidepressive agents|mesh-ancestor
93099979|NCT01365676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93099980|NCT01365676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93099981|NCT01365676|Antiviral Agents|antiviral agents|mesh-ancestor
93099982|NCT01365676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93099983|NCT01365676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93099984|NCT01365676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93099985|NCT01365676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93099986|NCT01365676|Immunologic Factors|immunologic factors|mesh-ancestor
93099987|NCT01365676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099988|NCT03754712|Vitamin D|vitamin d|mesh-list
93099989|NCT03754712|Cholecalciferol|cholecalciferol|mesh-list
93099990|NCT03754712|Vitamins|vitamins|mesh-ancestor
93099991|NCT03754712|Micronutrients|micronutrients|mesh-ancestor
93099992|NCT03754712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099993|NCT03754712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93099994|NCT03754712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93099995|NCT01318954|Immunomodulating Agents|immunomodulating agents|mesh-list
93099996|NCT01318954|Immunologic Factors|immunologic factors|mesh-ancestor
93099997|NCT01318954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93099998|NCT03754634|Diacerein|diacerein|mesh-list
93099999|NCT03754634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100000|NCT00070018|Prednisone|prednisone|mesh-list
93100001|NCT00070018|Cyclophosphamide|cyclophosphamide|mesh-list
93100002|NCT00070018|Rituximab|rituximab|mesh-list
93100003|NCT00070018|Doxorubicin|doxorubicin|mesh-list
93100004|NCT00070018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93100005|NCT00070018|Vincristine|vincristine|mesh-list
93100006|NCT00070018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93100007|NCT00070018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100008|NCT00070018|Immunologic Factors|immunologic factors|mesh-ancestor
93100009|NCT00070018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100010|NCT00070018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93100011|NCT00070018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93100012|NCT00070018|Alkylating Agents|alkylating agents|mesh-ancestor
93100013|NCT00070018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100014|NCT00070018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100015|NCT00070018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93100016|NCT00070018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93100017|NCT00070018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92772302|NCT05596786|Rituximab|rituximab|mesh-list
93100018|NCT00070018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100019|NCT00070018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100020|NCT00070018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100021|NCT00070018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100022|NCT00070018|Glucocorticoids|glucocorticoids|mesh-ancestor
93100023|NCT00070018|Hormones|hormones|mesh-ancestor
93100024|NCT00070018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100025|NCT00070018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100026|NCT00070018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93100027|NCT00070018|Tubulin Modulators|tubulin modulators|mesh-ancestor
93100028|NCT00070018|Antimitotic Agents|antimitotic agents|mesh-ancestor
93100029|NCT00070018|Mitosis Modulators|mitosis modulators|mesh-ancestor
93100030|NCT03991988|Montelukast|montelukast|mesh-list
93100031|NCT03991988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93100032|NCT03991988|Respiratory System Agents|respiratory system agents|mesh-ancestor
93100033|NCT03991988|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93100034|NCT03991988|Hormone Antagonists|hormone antagonists|mesh-ancestor
93100035|NCT03991988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100036|NCT03991988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100037|NCT03991988|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93100038|NCT03991988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93100039|NCT03991988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100040|NCT01073189|Fenoldopam|fenoldopam|mesh-list
93100041|NCT01073189|Furosemide|furosemide|mesh-list
93100042|NCT01073189|Diuretics|diuretics|mesh-ancestor
93100043|NCT01073189|Natriuretic Agents|natriuretic agents|mesh-ancestor
93100044|NCT01073189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100045|NCT01073189|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93100046|NCT01073189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100047|NCT01073189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100048|NCT01073189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93100049|NCT01073189|Vasodilator Agents|vasodilator agents|mesh-ancestor
93100050|NCT01073189|Dopamine Agonists|dopamine agonists|mesh-ancestor
93100051|NCT01073189|Dopamine Agents|dopamine agents|mesh-ancestor
93100052|NCT01073189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100053|NCT05191186|Immunomodulating Agents|immunomodulating agents|mesh-list
93100054|NCT05191186|Immunologic Factors|immunologic factors|mesh-ancestor
93100055|NCT05191186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100056|NCT03750656|Hyoscyamine|hyoscyamine|mesh-list
93100057|NCT03750656|Tamsulosin|tamsulosin|mesh-list
93100058|NCT03750656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93100059|NCT03750656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93100060|NCT03750656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93100061|NCT03750656|Adrenergic Agents|adrenergic agents|mesh-ancestor
93100062|NCT03750656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100063|NCT03750656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100064|NCT03750656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100065|NCT03750656|Urological Agents|urological agents|mesh-ancestor
93100066|NCT03750656|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93100067|NCT03750656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100068|NCT03750656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93100069|NCT03750656|Autonomic Agents|autonomic agents|mesh-ancestor
93100070|NCT03750656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100071|NCT03750656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93100072|NCT03750656|Respiratory System Agents|respiratory system agents|mesh-ancestor
93100073|NCT03750656|Mydriatics|mydriatics|mesh-ancestor
93100074|NCT03750656|Parasympatholytics|parasympatholytics|mesh-ancestor
93100075|NCT03750656|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93100076|NCT03750656|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93100077|NCT03750656|Cholinergic Agents|cholinergic agents|mesh-ancestor
93100078|NCT00229931|Triamcinolone|triamcinolone|mesh-list
93100079|NCT00229931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93100080|NCT00229931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93100081|NCT00229931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93100082|NCT00229931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100083|NCT00229931|Glucocorticoids|glucocorticoids|mesh-ancestor
93100084|NCT00229931|Hormones|hormones|mesh-ancestor
93100085|NCT00229931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100086|NCT00229931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100087|NCT00229931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100088|NCT00229931|Immunologic Factors|immunologic factors|mesh-ancestor
93100089|NCT00229931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772424|NCT05452772|Niacin|niacin|mesh-list
93100090|NCT00229931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100092|NCT03752294|Antithrombins|antithrombins|mesh-ancestor
93100093|NCT03752294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93100094|NCT03752294|Protease Inhibitors|protease inhibitors|mesh-ancestor
93100095|NCT03752294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100096|NCT03752294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100097|NCT03752294|Anticoagulants|anticoagulants|mesh-ancestor
93100098|NCT03135028|Cytarabine|cytarabine|mesh-list
93100099|NCT03135028|Daunorubicin|daunorubicin|mesh-list
93100100|NCT03135028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93100101|NCT03135028|Antimetabolites|antimetabolites|mesh-ancestor
93100102|NCT03135028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100103|NCT03135028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100104|NCT03135028|Antiviral Agents|antiviral agents|mesh-ancestor
93100105|NCT03135028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100106|NCT03135028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100107|NCT03135028|Immunologic Factors|immunologic factors|mesh-ancestor
93100108|NCT03135028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100109|NCT03135028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93100110|NCT03135028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100111|NCT03135028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100112|NCT03135028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100113|NCT03752138|Decitabine|decitabine|mesh-list
93100114|NCT03752138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93100115|NCT03752138|Antimetabolites|antimetabolites|mesh-ancestor
93100116|NCT03752138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100117|NCT03752138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100118|NCT03752138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100119|NCT01370434|Dexamethasone|dexamethasone|mesh-list
93100120|NCT01370434|Doxorubicin|doxorubicin|mesh-list
93100121|NCT01370434|Vincristine|vincristine|mesh-list
93100122|NCT01370434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100123|NCT01370434|Antiemetics|antiemetics|mesh-ancestor
93100124|NCT01370434|Autonomic Agents|autonomic agents|mesh-ancestor
93100125|NCT01370434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100126|NCT01370434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100127|NCT01370434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100128|NCT01370434|Glucocorticoids|glucocorticoids|mesh-ancestor
93100129|NCT01370434|Hormones|hormones|mesh-ancestor
93100130|NCT01370434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100131|NCT01370434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100132|NCT01370434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100133|NCT01370434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100134|NCT01370434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100135|NCT01370434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93100136|NCT01370434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100137|NCT01370434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100138|NCT01370434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93100139|NCT01370434|Tubulin Modulators|tubulin modulators|mesh-ancestor
93100140|NCT01370434|Antimitotic Agents|antimitotic agents|mesh-ancestor
93100141|NCT01370434|Mitosis Modulators|mitosis modulators|mesh-ancestor
93100142|NCT05190952|Dexamethasone|dexamethasone|mesh-list
93100143|NCT05190952|Ketamine|ketamine|mesh-list
93100144|NCT05190952|Bupivacaine|bupivacaine|mesh-list
93100145|NCT05190952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100146|NCT05190952|Antiemetics|antiemetics|mesh-ancestor
93100147|NCT05190952|Autonomic Agents|autonomic agents|mesh-ancestor
93100148|NCT05190952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100149|NCT05190952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100150|NCT05190952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100151|NCT05190952|Glucocorticoids|glucocorticoids|mesh-ancestor
93100152|NCT05190952|Hormones|hormones|mesh-ancestor
93100153|NCT05190952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100154|NCT05190952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100155|NCT05190952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100156|NCT05190952|Anesthetics, Local|anesthetics, local|mesh-ancestor
93100157|NCT05190952|Anesthetics|anesthetics|mesh-ancestor
93100158|NCT05190952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100159|NCT05190952|Sensory System Agents|sensory system agents|mesh-ancestor
93100160|NCT05190952|Analgesics|analgesics|mesh-ancestor
93100161|NCT05190952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93100162|NCT05190952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93100163|NCT05190952|Anesthetics, General|anesthetics, general|mesh-ancestor
93100164|NCT05190952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93100165|NCT05190952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93100166|NCT05190952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100167|NCT05190952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100168|NCT03972683|Atropine|atropine|mesh-list
93100169|NCT03972683|Adenosine|adenosine|mesh-list
93100170|NCT03972683|Nitroprusside|nitroprusside|mesh-list
93100171|NCT03972683|Phenylephrine|phenylephrine|mesh-list
93100172|NCT03972683|Oxymetazoline|oxymetazoline|mesh-list
93100173|NCT03972683|Acetylcholine|acetylcholine|mesh-list
93100174|NCT03972683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93100175|NCT03972683|Mydriatics|mydriatics|mesh-ancestor
93100176|NCT03972683|Autonomic Agents|autonomic agents|mesh-ancestor
93100177|NCT03972683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100178|NCT03972683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100179|NCT03972683|Sympathomimetics|sympathomimetics|mesh-ancestor
93100180|NCT03972683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93100181|NCT03972683|Nasal Decongestants|nasal decongestants|mesh-ancestor
93100182|NCT03972683|Respiratory System Agents|respiratory system agents|mesh-ancestor
93100183|NCT03972683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93100184|NCT03972683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93100185|NCT03972683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93100186|NCT03972683|Adrenergic Agents|adrenergic agents|mesh-ancestor
93100187|NCT03972683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100188|NCT03972683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100189|NCT03972683|Protective Agents|protective agents|mesh-ancestor
93100190|NCT03972683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93100191|NCT03972683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100192|NCT03972683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93100193|NCT03972683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93100194|NCT03972683|Parasympatholytics|parasympatholytics|mesh-ancestor
93100195|NCT03972683|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93100196|NCT03972683|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93100197|NCT03972683|Cholinergic Agents|cholinergic agents|mesh-ancestor
93100198|NCT03972683|Analgesics|analgesics|mesh-ancestor
93100199|NCT03972683|Sensory System Agents|sensory system agents|mesh-ancestor
93100200|NCT03972683|Vasodilator Agents|vasodilator agents|mesh-ancestor
93100201|NCT03972683|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93100202|NCT03972683|Purinergic Agonists|purinergic agonists|mesh-ancestor
93100203|NCT03972683|Purinergic Agents|purinergic agents|mesh-ancestor
93100204|NCT03972683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93100205|NCT03972683|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93100206|NCT03972683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93100207|NCT04411628|Bamlanivimab|bamlanivimab|mesh-list
93100208|NCT04411628|Antiviral Agents|antiviral agents|mesh-ancestor
93100209|NCT04411628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100210|NCT03754010|Hyaluronic Acid|hyaluronic acid|mesh-list
93100211|NCT03754010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93100212|NCT03754010|Immunologic Factors|immunologic factors|mesh-ancestor
93100213|NCT03754010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100214|NCT03754010|Viscosupplements|viscosupplements|mesh-ancestor
93100215|NCT03754010|Protective Agents|protective agents|mesh-ancestor
93100216|NCT00227591|Prednisone|prednisone|mesh-list
93100217|NCT00227591|Lenalidomide|lenalidomide|mesh-list
93100218|NCT00227591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100219|NCT00227591|Glucocorticoids|glucocorticoids|mesh-ancestor
93100220|NCT00227591|Hormones|hormones|mesh-ancestor
93100221|NCT00227591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100222|NCT00227591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100223|NCT00227591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100224|NCT00227591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100225|NCT00227591|Immunologic Factors|immunologic factors|mesh-ancestor
93100226|NCT00227591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93100227|NCT00227591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93100228|NCT00227591|Growth Substances|growth substances|mesh-ancestor
93100229|NCT00227591|Growth Inhibitors|growth inhibitors|mesh-ancestor
93100230|NCT01358344|Pantoprazole|pantoprazole|mesh-list
93100231|NCT01358344|Vorapaxar|vorapaxar|mesh-list
93100232|NCT01358344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93100233|NCT01358344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100234|NCT01358344|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93100235|NCT01358344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100236|NCT01358344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100237|NCT01358344|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93100238|NCT01366300|Lidocaine|lidocaine|mesh-list
93100239|NCT01366300|Propofol|propofol|mesh-list
93100240|NCT01366300|Anesthetics, Local|anesthetics, local|mesh-ancestor
93100241|NCT01366300|Anesthetics|anesthetics|mesh-ancestor
93100242|NCT01366300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100243|NCT01366300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100244|NCT01366300|Sensory System Agents|sensory system agents|mesh-ancestor
93100245|NCT01366300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100246|NCT01366300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100247|NCT01366300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93100248|NCT01366300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93100249|NCT01366300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100250|NCT01366300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100251|NCT01366300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93100252|NCT01366300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93100253|NCT01366300|Anesthetics, General|anesthetics, general|mesh-ancestor
93100254|NCT00226811|Sunitinib|sunitinib|mesh-list
93100255|NCT00226811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100256|NCT00226811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93100257|NCT00226811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93100258|NCT00226811|Growth Substances|growth substances|mesh-ancestor
93100259|NCT00226811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100260|NCT00226811|Growth Inhibitors|growth inhibitors|mesh-ancestor
93100261|NCT00226811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93100262|NCT00226811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100263|NCT00226811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100264|NCT02951052|Rilpivirine|rilpivirine|mesh-list
93100265|NCT02951052|Cabotegravir|cabotegravir|mesh-list
93100266|NCT02951052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93100267|NCT02951052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93100268|NCT02951052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100269|NCT02951052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100270|NCT02951052|Antiviral Agents|antiviral agents|mesh-ancestor
93100271|NCT02951052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100272|NCT02951052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93100273|NCT02951052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93100274|NCT02951052|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93100275|NCT02951052|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93100276|NCT05261516|Magnesium Sulfate|magnesium sulfate|mesh-list
93100277|NCT05261516|Analgesics|analgesics|mesh-ancestor
93100278|NCT05261516|Sensory System Agents|sensory system agents|mesh-ancestor
93100279|NCT05261516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100280|NCT05261516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100281|NCT05261516|Anesthetics|anesthetics|mesh-ancestor
93100282|NCT05261516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100283|NCT05261516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100284|NCT05261516|Anticonvulsants|anticonvulsants|mesh-ancestor
93100285|NCT05261516|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93100286|NCT05261516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100287|NCT05261516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100288|NCT05261516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93100289|NCT05261516|Tocolytic Agents|tocolytic agents|mesh-ancestor
93100290|NCT05261516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93100291|NCT00226655|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
93100292|NCT00226655|Hormones|hormones|mesh-ancestor
93100293|NCT00226655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100294|NCT00226655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100295|NCT01371058|Clopidogrel|clopidogrel|mesh-list
93100296|NCT01371058|Policosanol|policosanol|mesh-list
93100297|NCT01371058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93100298|NCT01371058|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93100299|NCT01371058|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93100300|NCT01371058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93100301|NCT01371058|Purinergic Agents|purinergic agents|mesh-ancestor
93100302|NCT01371058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100303|NCT01371058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100304|NCT01371058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100305|NCT01371058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93100306|NCT01371058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93100307|NCT01371058|Antimetabolites|antimetabolites|mesh-ancestor
93100308|NCT01371058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93100309|NCT01105338|Lycopene|lycopene|mesh-list
93100310|NCT01105338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100311|NCT01105338|Antioxidants|antioxidants|mesh-ancestor
93100312|NCT01105338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100313|NCT01105338|Protective Agents|protective agents|mesh-ancestor
93100314|NCT01105338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100315|NCT01105338|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93100316|NCT01105338|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93100317|NCT01105338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100318|NCT03747614|Fluorometholone|fluorometholone|mesh-list
93100319|NCT03747614|Tacrolimus|tacrolimus|mesh-list
93100320|NCT03747614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100321|NCT03747614|Immunologic Factors|immunologic factors|mesh-ancestor
93100322|NCT03747614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100323|NCT03747614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93100324|NCT03747614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100325|NCT03747614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100326|NCT03747614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100327|NCT03747614|Glucocorticoids|glucocorticoids|mesh-ancestor
93100328|NCT03747614|Hormones|hormones|mesh-ancestor
93100329|NCT03747614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100330|NCT03747614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93100331|NCT05347004|BI 425809|bi 425809|mesh-list
93100332|NCT05347004|Nootropic Agents|nootropic agents|mesh-ancestor
93100333|NCT04353596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93100334|NCT04353596|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93100335|NCT04353596|Protease Inhibitors|protease inhibitors|mesh-ancestor
93100336|NCT04353596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100337|NCT04353596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100338|NCT05190562|Zinc Sulfate|zinc sulfate|mesh-list
93100339|NCT05190562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100340|NCT05190562|Astringents|astringents|mesh-ancestor
93100341|NCT05190562|Dermatologic Agents|dermatologic agents|mesh-ancestor
93100342|NCT01366378|Methylnaltrexone|methylnaltrexone|mesh-list
93100343|NCT01366378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93100344|NCT01366378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100345|NCT01366378|Sensory System Agents|sensory system agents|mesh-ancestor
93100346|NCT01366378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100347|NCT03747536|Bromides|bromides|mesh-list
93100348|NCT03747536|Ipratropium|ipratropium|mesh-list
93100349|NCT03747536|Anticonvulsants|anticonvulsants|mesh-ancestor
93100350|NCT03747536|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93100351|NCT03747536|Autonomic Agents|autonomic agents|mesh-ancestor
93100352|NCT03747536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100353|NCT03747536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100354|NCT03747536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93100355|NCT03747536|Respiratory System Agents|respiratory system agents|mesh-ancestor
93100356|NCT03747536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93100357|NCT03747536|Cholinergic Agents|cholinergic agents|mesh-ancestor
93100358|NCT03747536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100359|NCT03747536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100360|NCT04734080|Dronabinol|dronabinol|mesh-list
93100361|NCT04734080|Hallucinogens|hallucinogens|mesh-ancestor
93100362|NCT04734080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100363|NCT04734080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93100364|NCT04734080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93100365|NCT04734080|Analgesics|analgesics|mesh-ancestor
93100366|NCT04734080|Sensory System Agents|sensory system agents|mesh-ancestor
93100367|NCT04734080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100368|NCT04734080|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93100369|NCT04734080|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93100370|NCT04734080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100371|NCT04734080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100372|NCT04734080|Hormones|hormones|mesh-ancestor
93100373|NCT04734080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100374|NCT01358500|Fentanyl|fentanyl|mesh-list
93100375|NCT01358500|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93100376|NCT01358500|Narcotics|narcotics|mesh-ancestor
93100377|NCT01358500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100378|NCT01358500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100379|NCT01358500|Analgesics|analgesics|mesh-ancestor
93100380|NCT01358500|Sensory System Agents|sensory system agents|mesh-ancestor
93100381|NCT01358500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100382|NCT01358500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93100383|NCT01358500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93100384|NCT01358500|Anesthetics, General|anesthetics, general|mesh-ancestor
93100385|NCT01358500|Anesthetics|anesthetics|mesh-ancestor
93100386|NCT03724942|Brexpiprazole|brexpiprazole|mesh-list
93100387|NCT03724942|Serotonin Agents|serotonin agents|mesh-ancestor
93100388|NCT03724942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100389|NCT03724942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100390|NCT03724942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100391|NCT03724942|Dopamine Agonists|dopamine agonists|mesh-ancestor
93100392|NCT03724942|Dopamine Agents|dopamine agents|mesh-ancestor
93100393|NCT01208766|Dexamethasone|dexamethasone|mesh-list
93100394|NCT01208766|Prednisone|prednisone|mesh-list
93100395|NCT01208766|Lenalidomide|lenalidomide|mesh-list
93100396|NCT01208766|Bortezomib|bortezomib|mesh-list
93100397|NCT01208766|Melphalan|melphalan|mesh-list
93100398|NCT01208766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100399|NCT01208766|Antiemetics|antiemetics|mesh-ancestor
93100400|NCT01208766|Autonomic Agents|autonomic agents|mesh-ancestor
93100401|NCT01208766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100402|NCT01208766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100403|NCT01208766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100404|NCT01208766|Glucocorticoids|glucocorticoids|mesh-ancestor
93100405|NCT01208766|Hormones|hormones|mesh-ancestor
93100406|NCT01208766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100407|NCT01208766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100408|NCT01208766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100409|NCT01208766|Immunologic Factors|immunologic factors|mesh-ancestor
93100410|NCT01208766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93100411|NCT01208766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93100412|NCT01208766|Growth Substances|growth substances|mesh-ancestor
93100413|NCT01208766|Growth Inhibitors|growth inhibitors|mesh-ancestor
93100414|NCT01208766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93100415|NCT01208766|Alkylating Agents|alkylating agents|mesh-ancestor
93100416|NCT01208766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100417|NCT01208766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93100418|NCT01208766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100419|NCT03751514|Azithromycin|azithromycin|mesh-list
93100420|NCT03751514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100421|NCT03751514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100422|NCT03615664|Dexamethasone|dexamethasone|mesh-list
93100423|NCT03615664|Gemcitabine|gemcitabine|mesh-list
93100424|NCT03615664|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93100425|NCT03615664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100426|NCT03615664|Antiemetics|antiemetics|mesh-ancestor
93100427|NCT03615664|Autonomic Agents|autonomic agents|mesh-ancestor
93100428|NCT03615664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100429|NCT03615664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100430|NCT03615664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100431|NCT03615664|Glucocorticoids|glucocorticoids|mesh-ancestor
93100432|NCT03615664|Hormones|hormones|mesh-ancestor
93100433|NCT03615664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100434|NCT03615664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100435|NCT03615664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100436|NCT03615664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93100437|NCT03615664|Antimetabolites|antimetabolites|mesh-ancestor
93100438|NCT03615664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100439|NCT03615664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93100440|NCT03615664|Alkylating Agents|alkylating agents|mesh-ancestor
93100441|NCT03513250|Scopolamine|scopolamine|mesh-list
93100442|NCT03513250|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93100443|NCT03513250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93100444|NCT03513250|Antiemetics|antiemetics|mesh-ancestor
93100445|NCT03513250|Autonomic Agents|autonomic agents|mesh-ancestor
93100446|NCT03513250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100447|NCT03513250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100448|NCT03513250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100449|NCT03513250|Mydriatics|mydriatics|mesh-ancestor
93100450|NCT03513250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93100451|NCT03513250|Cholinergic Agents|cholinergic agents|mesh-ancestor
93100452|NCT03513250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026433|NCT00493038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100453|NCT03513250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100454|NCT03513250|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93100455|NCT03513250|Parasympatholytics|parasympatholytics|mesh-ancestor
93100456|NCT01358812|Panitumumab|panitumumab|mesh-list
93100457|NCT01358812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93100458|NCT01358812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100459|NCT01107522|Temozolomide|temozolomide|mesh-list
93100460|NCT01107522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93100461|NCT01107522|Alkylating Agents|alkylating agents|mesh-ancestor
92772759|NCT04652700|Antiviral Agents|antiviral agents|mesh-ancestor
93100462|NCT01107522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100463|NCT01107522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100464|NCT01371448|Paroxetine|paroxetine|mesh-list
93100465|NCT01371448|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93100466|NCT01371448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93100467|NCT01371448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100468|NCT01371448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100469|NCT01371448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100470|NCT01371448|Serotonin Agents|serotonin agents|mesh-ancestor
93100471|NCT01371448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100472|NCT01371448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93100473|NCT01371448|Antidepressive Agents|antidepressive agents|mesh-ancestor
93100474|NCT01371448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93100475|NCT01371448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93100476|NCT01371448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93100477|NCT01371448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100478|NCT01371526|Cosyntropin|cosyntropin|mesh-list
93100479|NCT01371526|Hormones|hormones|mesh-ancestor
93100480|NCT01371526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100481|NCT01371526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100482|NCT03943992|Esomeprazole|esomeprazole|mesh-list
93100483|NCT03943992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93100484|NCT03943992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100485|NCT03943992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93100486|NCT03943992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100487|NCT03943992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100488|NCT01371604|Ribavirin|ribavirin|mesh-list
93100489|NCT01371604|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93100490|NCT01371604|Antimetabolites|antimetabolites|mesh-ancestor
93100491|NCT01371604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100492|NCT01371604|Antiviral Agents|antiviral agents|mesh-ancestor
93100493|NCT01371604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100494|NCT01371682|Ropinirole|ropinirole|mesh-list
93100495|NCT01371682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93100496|NCT01371682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93100497|NCT01371682|Dopamine Agonists|dopamine agonists|mesh-ancestor
93100498|NCT01371682|Dopamine Agents|dopamine agents|mesh-ancestor
93100499|NCT01371682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100500|NCT01371682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100501|NCT01371682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100502|NCT01107756|Lenograstim|lenograstim|mesh-list
93100503|NCT01107756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93100504|NCT01107756|Immunologic Factors|immunologic factors|mesh-ancestor
93100505|NCT01107756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100506|NCT03127384|Lidocaine|lidocaine|mesh-list
93100507|NCT03127384|Anesthetics, Local|anesthetics, local|mesh-ancestor
93100508|NCT03127384|Anesthetics|anesthetics|mesh-ancestor
93100509|NCT03127384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100510|NCT03127384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100511|NCT03127384|Sensory System Agents|sensory system agents|mesh-ancestor
93100512|NCT03127384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100513|NCT03127384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100514|NCT03127384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93100515|NCT03127384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93100516|NCT03127384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100517|NCT03127384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100518|NCT01111656|Interferons|interferons|mesh-list
93100519|NCT01111656|Interferon-beta|interferon-beta|mesh-list
93100520|NCT01111656|Atorvastatin|atorvastatin|mesh-list
93100521|NCT01111656|Interferon beta-1b|interferon beta-1b|mesh-list
93100522|NCT01111656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100523|NCT01111656|Antiviral Agents|antiviral agents|mesh-ancestor
93100524|NCT01111656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100525|NCT01111656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93100526|NCT01111656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93100527|NCT01111656|Antimetabolites|antimetabolites|mesh-ancestor
93100528|NCT01111656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100529|NCT01111656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93100530|NCT01111656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93100531|NCT01111656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100532|NCT01111656|Immunologic Factors|immunologic factors|mesh-ancestor
93100533|NCT01111656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100534|NCT01111656|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93100535|NCT02819752|Pembrolizumab|pembrolizumab|mesh-list
93100536|NCT02819752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93100537|NCT02819752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100538|NCT02819752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93100539|NCT02819752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100540|NCT02567578|YH12852|yh12852|mesh-list
93100541|NCT02567578|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93100542|NCT02567578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93100543|NCT02567578|Serotonin Agents|serotonin agents|mesh-ancestor
93100544|NCT02567578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100545|NCT02567578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100546|NCT02567578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100547|NCT02523274|Resveratrol|resveratrol|mesh-list
93100548|NCT02523274|Antioxidants|antioxidants|mesh-ancestor
93100549|NCT02523274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100550|NCT02523274|Protective Agents|protective agents|mesh-ancestor
93100551|NCT02523274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100552|NCT02523274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100553|NCT02523274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93100554|NCT02432560|Sirolimus|sirolimus|mesh-list
93100555|NCT02432560|Everolimus|everolimus|mesh-list
93100556|NCT02432560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93100557|NCT02432560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93100558|NCT02432560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100559|NCT02432560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100560|NCT02432560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100561|NCT02432560|Immunologic Factors|immunologic factors|mesh-ancestor
93100562|NCT02432560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100563|NCT02432560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100564|NCT02432560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100565|NCT02432560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100566|NCT02432560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93100567|NCT02432560|Antifungal Agents|antifungal agents|mesh-ancestor
93100568|NCT01111734|Acetylcysteine|acetylcysteine|mesh-list
93100569|NCT01111734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93100570|NCT01111734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100571|NCT01111734|Antiviral Agents|antiviral agents|mesh-ancestor
93100572|NCT01111734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100573|NCT01111734|Expectorants|expectorants|mesh-ancestor
93100574|NCT01111734|Respiratory System Agents|respiratory system agents|mesh-ancestor
93100575|NCT01111734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93100576|NCT01111734|Antioxidants|antioxidants|mesh-ancestor
93100577|NCT01111734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100578|NCT01111734|Protective Agents|protective agents|mesh-ancestor
93100579|NCT01111734|Antidotes|antidotes|mesh-ancestor
93100580|NCT01698138|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93100581|NCT01698138|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93100582|NCT01698138|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93100583|NCT01698138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100584|NCT01698138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100585|NCT01698138|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93100586|NCT01698138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100587|NCT01698138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100588|NCT01698138|Cholinergic Agents|cholinergic agents|mesh-ancestor
93100589|NCT01698138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100590|NCT01111890|Timolol|timolol|mesh-list
93100591|NCT01111890|Dorzolamide|dorzolamide|mesh-list
93100592|NCT01111890|Brinzolamide|brinzolamide|mesh-list
93100593|NCT01111890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93100594|NCT01111890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93100595|NCT01111890|Adrenergic Agents|adrenergic agents|mesh-ancestor
93100596|NCT01111890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100597|NCT01111890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100598|NCT01111890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100599|NCT01111890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100600|NCT01111890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93100601|NCT01111890|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93100602|NCT01111890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100603|NCT00745134|Curcumin|curcumin|mesh-list
93100604|NCT00745134|Capecitabine|capecitabine|mesh-list
93100605|NCT00745134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93100606|NCT00745134|Antimetabolites|antimetabolites|mesh-ancestor
93100607|NCT00745134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100608|NCT00745134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100609|NCT00745134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93100610|NCT00745134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93100611|NCT00745134|Analgesics|analgesics|mesh-ancestor
93100612|NCT00745134|Sensory System Agents|sensory system agents|mesh-ancestor
93100613|NCT00745134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100614|NCT00745134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100615|NCT00745134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100616|NCT00745134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93100617|NCT00745134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100619|NCT01111968|Immunologic Factors|immunologic factors|mesh-ancestor
93100620|NCT01111968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100621|NCT04398134|Entecavir|entecavir|mesh-list
93100622|NCT04398134|Antiviral Agents|antiviral agents|mesh-ancestor
93100623|NCT04398134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100624|NCT04281342|Moxifloxacin|moxifloxacin|mesh-list
93100625|NCT04281342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100626|NCT04281342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100627|NCT04281342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100628|NCT04281342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100629|NCT04281342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100630|NCT04281342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100631|NCT04281342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100632|NCT04253262|Rucaparib|rucaparib|mesh-list
93100633|NCT04253262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93100634|NCT04253262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100635|NCT04253262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100636|NCT04253262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100637|NCT01108146|Hydrocortisone|hydrocortisone|mesh-list
93100638|NCT01108146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93100639|NCT01108146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93100640|NCT01108146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93100641|NCT01108146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100642|NCT01108302|Oxytocin|oxytocin|mesh-list
93100643|NCT01108302|Oxytocics|oxytocics|mesh-ancestor
93100644|NCT01108302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93100645|NCT01108302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100646|NCT03122860|Lorecivivint|lorecivivint|mesh-list
93100647|NCT03122860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100648|NCT01319188|Ranibizumab|ranibizumab|mesh-list
93100649|NCT01319188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93100650|NCT01319188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93100651|NCT01319188|Growth Substances|growth substances|mesh-ancestor
93100652|NCT01319188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100653|NCT01319188|Growth Inhibitors|growth inhibitors|mesh-ancestor
93100654|NCT01319188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100655|NCT05167084|Hydrocortisone|hydrocortisone|mesh-list
93100656|NCT05167084|Metyrapone|metyrapone|mesh-list
93100657|NCT05167084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100658|NCT05167084|Antimetabolites|antimetabolites|mesh-ancestor
93100659|NCT05167084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100660|NCT05167084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100661|NCT00867178|Vitamin A|vitamin a|mesh-list
93100662|NCT00867178|Cyclophosphamide|cyclophosphamide|mesh-list
93100663|NCT00867178|Thiotepa|thiotepa|mesh-list
93100664|NCT00867178|Cisplatin|cisplatin|mesh-list
93100665|NCT00867178|Carboplatin|carboplatin|mesh-list
93100666|NCT00867178|Etoposide|etoposide|mesh-list
93100667|NCT00867178|Vincristine|vincristine|mesh-list
93100668|NCT00867178|Vorinostat|vorinostat|mesh-list
93100669|NCT00867178|Tretinoin|tretinoin|mesh-list
93100670|NCT00867178|Etoposide phosphate|etoposide phosphate|mesh-list
93100671|NCT00867178|Isotretinoin|isotretinoin|mesh-list
93100672|NCT00867178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100673|NCT00867178|Immunologic Factors|immunologic factors|mesh-ancestor
93100674|NCT00867178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100675|NCT00867178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93100676|NCT00867178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93100677|NCT00867178|Alkylating Agents|alkylating agents|mesh-ancestor
93100678|NCT00867178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100679|NCT00867178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100680|NCT00867178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93100681|NCT00867178|Vitamins|vitamins|mesh-ancestor
93100682|NCT00867178|Micronutrients|micronutrients|mesh-ancestor
93100683|NCT00867178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93100684|NCT00867178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100685|NCT00867178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100686|NCT00867178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100687|NCT00867178|Tubulin Modulators|tubulin modulators|mesh-ancestor
93100688|NCT00867178|Antimitotic Agents|antimitotic agents|mesh-ancestor
93100689|NCT00867178|Mitosis Modulators|mitosis modulators|mesh-ancestor
93100690|NCT00867178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93100691|NCT00867178|Keratolytic Agents|keratolytic agents|mesh-ancestor
93100692|NCT00867178|Dermatologic Agents|dermatologic agents|mesh-ancestor
93100693|NCT03945396|Calcium Carbonate|calcium carbonate|mesh-list
93100694|NCT03945396|Antacids|antacids|mesh-ancestor
93100695|NCT03945396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100696|NCT03945396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100697|NCT01109784|Clopidogrel|clopidogrel|mesh-list
93100698|NCT01109784|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93100699|NCT01109784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93100700|NCT01109784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93100701|NCT01109784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93100702|NCT01109784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93100703|NCT01109784|Purinergic Agents|purinergic agents|mesh-ancestor
93100704|NCT01109784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100705|NCT01109784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100706|NCT01109784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100707|NCT01328340|Methamphetamine|methamphetamine|mesh-list
93100708|NCT01328340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93100709|NCT01328340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100710|NCT01328340|Sympathomimetics|sympathomimetics|mesh-ancestor
93100711|NCT01328340|Autonomic Agents|autonomic agents|mesh-ancestor
93100712|NCT01328340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100713|NCT01328340|Dopamine Agents|dopamine agents|mesh-ancestor
93100714|NCT01328340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100715|NCT01328340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100716|NCT01328340|Adrenergic Agents|adrenergic agents|mesh-ancestor
93100717|NCT01328340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93100718|NCT01328340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93100719|NCT01328340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100720|NCT01328340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93100721|NCT03796728|Lidocaine|lidocaine|mesh-list
93100722|NCT03796728|Anesthetics, Local|anesthetics, local|mesh-ancestor
93100723|NCT03796728|Anesthetics|anesthetics|mesh-ancestor
93100724|NCT03796728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100725|NCT03796728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100726|NCT03796728|Sensory System Agents|sensory system agents|mesh-ancestor
93100727|NCT03796728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100728|NCT03796728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100729|NCT03796728|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93100730|NCT03796728|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93100731|NCT03796728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100732|NCT03796728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100733|NCT00352534|Dactinomycin|dactinomycin|mesh-list
93100734|NCT00352534|Cactinomycin|cactinomycin|mesh-list
93100735|NCT00352534|Doxorubicin|doxorubicin|mesh-list
93100736|NCT00352534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93100737|NCT00352534|Vincristine|vincristine|mesh-list
93100738|NCT00352534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93100739|NCT00352534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100740|NCT00352534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100741|NCT00352534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100742|NCT00352534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100743|NCT00352534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100744|NCT00352534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93100745|NCT00352534|Tubulin Modulators|tubulin modulators|mesh-ancestor
93100746|NCT00352534|Antimitotic Agents|antimitotic agents|mesh-ancestor
93100747|NCT00352534|Mitosis Modulators|mitosis modulators|mesh-ancestor
93100748|NCT00352534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100749|NCT00352534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100750|NCT00352534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93100751|NCT00352534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93100752|NCT01328106|Trametinib|trametinib|mesh-list
93100753|NCT01328106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100754|NCT01328106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93100755|NCT01328106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100756|NCT01328106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100757|NCT03122548|Pembrolizumab|pembrolizumab|mesh-list
93100758|NCT03122548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93100759|NCT03122548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100760|NCT03122548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92418170|NCT01495117|Iodine|iodine|mesh-list
93100761|NCT03122548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100762|NCT03749642|Gabapentin|gabapentin|mesh-list
93100763|NCT03749642|Trazodone|trazodone|mesh-list
93100764|NCT03749642|Analgesics|analgesics|mesh-ancestor
93100765|NCT03749642|Sensory System Agents|sensory system agents|mesh-ancestor
93100766|NCT03749642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100767|NCT03749642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100768|NCT03749642|Anticonvulsants|anticonvulsants|mesh-ancestor
93100769|NCT03749642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93100770|NCT03749642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93100771|NCT03749642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100772|NCT03749642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93100773|NCT03749642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93100774|NCT03749642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93100775|NCT03749642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100776|NCT03749642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100777|NCT03749642|Antimanic Agents|antimanic agents|mesh-ancestor
93100778|NCT03749642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93100779|NCT03749642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93100780|NCT03749642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100781|NCT03749642|Serotonin Agents|serotonin agents|mesh-ancestor
93100782|NCT03749642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93100783|NCT03749642|Antidepressive Agents|antidepressive agents|mesh-ancestor
93100784|NCT03751358|Anesthetics|anesthetics|mesh-list
93100785|NCT03751358|Anesthetics, Local|anesthetics, local|mesh-list
93100786|NCT03751358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100787|NCT03751358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100788|NCT03751358|Sensory System Agents|sensory system agents|mesh-ancestor
93100789|NCT03751358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100790|NCT04097028|Trifluridine|trifluridine|mesh-list
93100791|NCT04097028|Oxaliplatin|oxaliplatin|mesh-list
93100792|NCT04097028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100793|NCT04097028|Antimetabolites|antimetabolites|mesh-ancestor
93100794|NCT04097028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100795|NCT04097028|Antiviral Agents|antiviral agents|mesh-ancestor
93100796|NCT04097028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100797|NCT05193292|Trastuzumab|trastuzumab|mesh-list
93100798|NCT05193292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93100799|NCT05193292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100800|NCT05193214|Antibodies|antibodies|mesh-list
93100801|NCT05193214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93100802|NCT05193214|Immunologic Factors|immunologic factors|mesh-ancestor
93100803|NCT05193214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100804|NCT02529774|Leucovorin|leucovorin|mesh-list
93100805|NCT02529774|Dexamethasone|dexamethasone|mesh-list
93100806|NCT02529774|Capecitabine|capecitabine|mesh-list
93100807|NCT02529774|Oxaliplatin|oxaliplatin|mesh-list
93100808|NCT02529774|Fluorouracil|fluorouracil|mesh-list
93100809|NCT02529774|Floxuridine|floxuridine|mesh-list
93100810|NCT02529774|Heparin|heparin|mesh-list
93100811|NCT02529774|Levoleucovorin|levoleucovorin|mesh-list
93100812|NCT02529774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100813|NCT02529774|Antiemetics|antiemetics|mesh-ancestor
93100814|NCT02529774|Autonomic Agents|autonomic agents|mesh-ancestor
93100815|NCT02529774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100816|NCT02529774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100817|NCT02529774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100818|NCT02529774|Glucocorticoids|glucocorticoids|mesh-ancestor
93100819|NCT02529774|Hormones|hormones|mesh-ancestor
93100820|NCT02529774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100821|NCT02529774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93100822|NCT02529774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100823|NCT02529774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93100824|NCT02529774|Antimetabolites|antimetabolites|mesh-ancestor
93100825|NCT02529774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100826|NCT02529774|Antidotes|antidotes|mesh-ancestor
93100827|NCT02529774|Protective Agents|protective agents|mesh-ancestor
93100828|NCT02529774|Vitamin B Complex|vitamin b complex|mesh-ancestor
93100829|NCT02529774|Vitamins|vitamins|mesh-ancestor
93100830|NCT02529774|Micronutrients|micronutrients|mesh-ancestor
93100831|NCT02529774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93100832|NCT02529774|Immunologic Factors|immunologic factors|mesh-ancestor
93100833|NCT02529774|Anticoagulants|anticoagulants|mesh-ancestor
93100834|NCT02529774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93100835|NCT02529774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93100836|NCT04459598|Efavirenz|efavirenz|mesh-list
93100837|NCT04459598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93100838|NCT04459598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93100839|NCT04459598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100840|NCT04459598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100842|NCT04459598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100843|NCT04459598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93100844|NCT04459598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93100845|NCT04459598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93100846|NCT04459598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93100847|NCT04459598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93100848|NCT04459598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93100849|NCT03942354|Moxifloxacin|moxifloxacin|mesh-list
93100850|NCT03942354|Linezolid|linezolid|mesh-list
93100851|NCT03942354|Bedaquiline|bedaquiline|mesh-list
93100852|NCT03942354|Clofazimine|clofazimine|mesh-list
93100853|NCT03942354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100854|NCT03942354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100855|NCT03942354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93100856|NCT03942354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93100857|NCT03942354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100858|NCT03942354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100859|NCT03942354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100860|NCT03942354|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93100861|NCT03942354|Antitubercular Agents|antitubercular agents|mesh-ancestor
93100862|NCT03942354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100863|NCT03942354|Leprostatic Agents|leprostatic agents|mesh-ancestor
93100864|NCT05165992|Fentanyl|fentanyl|mesh-list
93100865|NCT05165992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93100866|NCT05165992|Narcotics|narcotics|mesh-ancestor
93100867|NCT05165992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100868|NCT05165992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100869|NCT05165992|Analgesics|analgesics|mesh-ancestor
93100870|NCT05165992|Sensory System Agents|sensory system agents|mesh-ancestor
93100871|NCT05165992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100872|NCT05165992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93100873|NCT05165992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93100874|NCT05165992|Anesthetics, General|anesthetics, general|mesh-ancestor
93100875|NCT05165992|Anesthetics|anesthetics|mesh-ancestor
93100876|NCT01359202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93100877|NCT01367548|Methylnaltrexone|methylnaltrexone|mesh-list
93100878|NCT01367548|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93100879|NCT01367548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100880|NCT01367548|Sensory System Agents|sensory system agents|mesh-ancestor
93100881|NCT01367548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100882|NCT01367626|Letrozole|letrozole|mesh-list
93100883|NCT01367626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100884|NCT01367626|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93100885|NCT01367626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93100886|NCT01367626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100887|NCT01367626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100888|NCT01367626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93100889|NCT01367626|Hormone Antagonists|hormone antagonists|mesh-ancestor
93100890|NCT01367626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93100891|NCT01367626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100892|NCT01112748|Lidocaine|lidocaine|mesh-list
93100893|NCT01112748|Anesthetics, Local|anesthetics, local|mesh-ancestor
93100894|NCT01112748|Anesthetics|anesthetics|mesh-ancestor
93100895|NCT01112748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100896|NCT01112748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100897|NCT01112748|Sensory System Agents|sensory system agents|mesh-ancestor
93100898|NCT01112748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100899|NCT01112748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93100900|NCT01112748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93100901|NCT01112748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93100902|NCT01112748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100903|NCT01112748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100904|NCT05192902|Anesthetics|anesthetics|mesh-list
93100905|NCT05192902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93100906|NCT05192902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100907|NCT01211808|Diltiazem|diltiazem|mesh-list
93100908|NCT01211808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93100909|NCT01211808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92691171|NCT01300351|Fulvestrant|fulvestrant|mesh-list
92773206|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
93100910|NCT01211808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100911|NCT01211808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100912|NCT01211808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93100913|NCT01211808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100914|NCT01211808|Vasodilator Agents|vasodilator agents|mesh-ancestor
93100915|NCT01209858|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93100916|NCT01209858|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93100917|NCT01209858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93100918|NCT01209858|Contraceptive Agents|contraceptive agents|mesh-ancestor
93100919|NCT01209858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93100920|NCT01209858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100921|NCT01209858|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93100922|NCT01209858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93100923|NCT01209858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93100924|NCT01209858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93100925|NCT01209858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93100926|NCT01209858|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93100927|NCT01209858|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93100928|NCT01209858|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93100929|NCT05191888|Amoxicillin|amoxicillin|mesh-list
93100930|NCT05191888|Metronidazole|metronidazole|mesh-list
93100931|NCT05191888|Clarithromycin|clarithromycin|mesh-list
93100932|NCT05191888|Rabeprazole|rabeprazole|mesh-list
93100933|NCT05191888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93100934|NCT05191888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93100935|NCT05191888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93100936|NCT05191888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93100937|NCT05191888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93100938|NCT05191888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93100939|NCT05191888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100940|NCT05191888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93100941|NCT05191888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93100942|NCT05191888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93100943|NCT05191888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93100944|NCT05191888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93100945|NCT01112826|Capecitabine|capecitabine|mesh-list
93100946|NCT01112826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93100947|NCT01112826|Antimetabolites|antimetabolites|mesh-ancestor
93100948|NCT01112826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100949|NCT01112826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100950|NCT01210014|Zinc Sulfate|zinc sulfate|mesh-list
93100951|NCT01210014|Astringents|astringents|mesh-ancestor
93100952|NCT01210014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100953|NCT01210014|Dermatologic Agents|dermatologic agents|mesh-ancestor
93100954|NCT05118256|Pirfenidone|pirfenidone|mesh-list
93100955|NCT05118256|Analgesics|analgesics|mesh-ancestor
93100956|NCT05118256|Sensory System Agents|sensory system agents|mesh-ancestor
93100957|NCT05118256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100958|NCT05118256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100959|NCT05118256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93100960|NCT05118256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93100961|NCT05118256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93100962|NCT05118256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93100963|NCT05118256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93100964|NCT01114542|Insulin|insulin|mesh-list
92691233|NCT04697355|Carotenoids|carotenoids|mesh-list
93100965|NCT01114542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93100966|NCT01114542|Insulin Glargine|insulin glargine|mesh-list
93100967|NCT01114542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93100968|NCT01114542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100969|NCT02529540|Methamphetamine|methamphetamine|mesh-list
93100970|NCT02529540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93100971|NCT02529540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100972|NCT02529540|Sympathomimetics|sympathomimetics|mesh-ancestor
93100973|NCT02529540|Autonomic Agents|autonomic agents|mesh-ancestor
93100974|NCT02529540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100975|NCT02529540|Dopamine Agents|dopamine agents|mesh-ancestor
93100976|NCT02529540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93100977|NCT02529540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100978|NCT02529540|Adrenergic Agents|adrenergic agents|mesh-ancestor
93100979|NCT02529540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93100980|NCT02529540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93100981|NCT02529540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100982|NCT02529540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93100983|NCT01359436|Antibodies|antibodies|mesh-list
93100984|NCT01359436|Immunologic Factors|immunologic factors|mesh-ancestor
93100985|NCT01359436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100986|NCT01359514|Pregabalin|pregabalin|mesh-list
93100987|NCT01359514|Calcium Channel Blockers|calcium channel blockers|mesh-list
93100988|NCT01359514|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93100989|NCT01359514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93100990|NCT01359514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93100991|NCT01359514|Analgesics|analgesics|mesh-ancestor
93100992|NCT01359514|Sensory System Agents|sensory system agents|mesh-ancestor
93100993|NCT01359514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93100994|NCT01359514|Anticonvulsants|anticonvulsants|mesh-ancestor
93100995|NCT01359514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93100996|NCT01359514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93100997|NCT01359514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93100998|NCT01359514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93100999|NCT01359514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101000|NCT01359514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93101001|NCT01359514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93101002|NCT01359514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93101003|NCT01359514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101004|NCT01359514|Antidepressive Agents|antidepressive agents|mesh-ancestor
93101005|NCT01359514|Dopamine Agents|dopamine agents|mesh-ancestor
93101006|NCT01368016|Nicotine|nicotine|mesh-list
93101007|NCT01368016|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93101008|NCT01368016|Autonomic Agents|autonomic agents|mesh-ancestor
93101009|NCT01368016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101010|NCT01368016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101011|NCT01368016|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93101012|NCT01368016|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93101013|NCT01368016|Cholinergic Agents|cholinergic agents|mesh-ancestor
93101014|NCT01368016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101015|NCT01368016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101016|NCT01208454|Vitamin A|vitamin a|mesh-list
93101017|NCT01208454|Vorinostat|vorinostat|mesh-list
93101018|NCT01208454|Tretinoin|tretinoin|mesh-list
93101019|NCT01208454|Isotretinoin|isotretinoin|mesh-list
93101020|NCT01208454|Vitamins|vitamins|mesh-ancestor
93101021|NCT01208454|Micronutrients|micronutrients|mesh-ancestor
93101022|NCT01208454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101023|NCT01208454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101024|NCT01208454|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93101025|NCT01208454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101026|NCT01208454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101027|NCT01208454|Keratolytic Agents|keratolytic agents|mesh-ancestor
93101028|NCT01208454|Dermatologic Agents|dermatologic agents|mesh-ancestor
93101029|NCT01110486|Carboplatin|carboplatin|mesh-list
93101030|NCT01110486|Docetaxel|docetaxel|mesh-list
93101031|NCT01110486|Ilorasertib|ilorasertib|mesh-list
93101032|NCT01110486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101033|NCT01110486|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101034|NCT01110486|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101035|NCT01110486|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101036|NCT01110486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101037|NCT01110486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101038|NCT01110486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101039|NCT01372306|Galantamine|galantamine|mesh-list
93101040|NCT01372306|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93101041|NCT01372306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101042|NCT01372306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101043|NCT01372306|Cholinergic Agents|cholinergic agents|mesh-ancestor
93101044|NCT01372306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101045|NCT01372306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101046|NCT01372306|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93101047|NCT01372306|Autonomic Agents|autonomic agents|mesh-ancestor
93101048|NCT01372306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101049|NCT01372306|Nootropic Agents|nootropic agents|mesh-ancestor
93101050|NCT01114854|Topiramate|topiramate|mesh-list
93101051|NCT01114854|Anticonvulsants|anticonvulsants|mesh-ancestor
93101052|NCT01114854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93101053|NCT01114854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101054|NCT01359670|Sildenafil Citrate|sildenafil citrate|mesh-list
93101055|NCT01359670|Tadalafil|tadalafil|mesh-list
93101056|NCT01359670|Vasodilator Agents|vasodilator agents|mesh-ancestor
92773350|NCT02530489|Paclitaxel|paclitaxel|mesh-list
93101057|NCT01359670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93101058|NCT01359670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93101059|NCT01359670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101060|NCT01359670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101061|NCT01359670|Urological Agents|urological agents|mesh-ancestor
93101062|NCT05188768|Mitogens|mitogens|mesh-list
93101063|NCT05188768|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101064|NCT05188768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101065|NCT01368328|Chromium|chromium|mesh-list
93101066|NCT01368328|Niacin|niacin|mesh-list
93101067|NCT01368328|Trace Elements|trace elements|mesh-ancestor
93101068|NCT01368328|Micronutrients|micronutrients|mesh-ancestor
93101069|NCT01368328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101070|NCT01368328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93101071|NCT01368328|Antimetabolites|antimetabolites|mesh-ancestor
93101072|NCT01368328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101073|NCT01368328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93101074|NCT01368328|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101075|NCT01368328|Vitamin B Complex|vitamin b complex|mesh-ancestor
93101076|NCT01368328|Vitamins|vitamins|mesh-ancestor
93101077|NCT01110642|Lovastatin|lovastatin|mesh-list
93101078|NCT01110642|L 647318|l 647318|mesh-list
93101079|NCT01110642|Dihydromevinolin|dihydromevinolin|mesh-list
93101080|NCT01110642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93101081|NCT01110642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93101082|NCT01110642|Antimetabolites|antimetabolites|mesh-ancestor
93101083|NCT01110642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101084|NCT01110642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93101085|NCT01110642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93101086|NCT01110642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101087|NCT02929498|Azacitidine|azacitidine|mesh-list
93101088|NCT02929498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93101089|NCT02929498|Antimetabolites|antimetabolites|mesh-ancestor
93101090|NCT02929498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101091|NCT02929498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101092|NCT02929498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101093|NCT01359826|Milnacipran|milnacipran|mesh-list
93101094|NCT01359826|Levomilnacipran|levomilnacipran|mesh-list
93101095|NCT01359826|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93101096|NCT01359826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93101097|NCT01359826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101098|NCT01359826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101099|NCT01359826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101100|NCT01359826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101101|NCT01359826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93101102|NCT01359826|Analgesics|analgesics|mesh-ancestor
93101103|NCT01359826|Sensory System Agents|sensory system agents|mesh-ancestor
93101104|NCT01359826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101105|NCT01359826|Antidepressive Agents|antidepressive agents|mesh-ancestor
93101106|NCT01359826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93101107|NCT03792672|Ketamine|ketamine|mesh-list
93101108|NCT03792672|Analgesics|analgesics|mesh-ancestor
93101109|NCT03792672|Sensory System Agents|sensory system agents|mesh-ancestor
93101110|NCT03792672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101111|NCT03792672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101112|NCT03792672|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93101113|NCT03792672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93101114|NCT03792672|Anesthetics, General|anesthetics, general|mesh-ancestor
93101115|NCT03792672|Anesthetics|anesthetics|mesh-ancestor
93101116|NCT03792672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101117|NCT03792672|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93101118|NCT03792672|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93101119|NCT03792672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101120|NCT03792672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101121|NCT01372540|Filanesib|filanesib|mesh-list
93101122|NCT01372540|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101123|NCT01372540|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101124|NCT01372540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101125|NCT01372540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101126|NCT01113138|Magnesium Sulfate|magnesium sulfate|mesh-list
93101127|NCT01113138|Analgesics|analgesics|mesh-ancestor
93101128|NCT01113138|Sensory System Agents|sensory system agents|mesh-ancestor
93101129|NCT01113138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101130|NCT01113138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101131|NCT01113138|Anesthetics|anesthetics|mesh-ancestor
93101132|NCT01113138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101133|NCT01113138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93101134|NCT01113138|Anticonvulsants|anticonvulsants|mesh-ancestor
93101135|NCT01113138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93101136|NCT01113138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101137|NCT01113138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101138|NCT01113138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101139|NCT01113138|Tocolytic Agents|tocolytic agents|mesh-ancestor
93101140|NCT01113138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93101141|NCT01115322|Nicotinic Acids|nicotinic acids|mesh-list
93101142|NCT01115322|Tazarotene|tazarotene|mesh-list
93101143|NCT01115322|Dermatologic Agents|dermatologic agents|mesh-ancestor
93101144|NCT01115322|Keratolytic Agents|keratolytic agents|mesh-ancestor
93101145|NCT01115322|Vitamin B Complex|vitamin b complex|mesh-ancestor
93101146|NCT01115322|Vitamins|vitamins|mesh-ancestor
93101147|NCT01115322|Micronutrients|micronutrients|mesh-ancestor
93101148|NCT01115322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101149|NCT01111188|Bortezomib|bortezomib|mesh-list
93101150|NCT01111188|Palbociclib|palbociclib|mesh-list
93101151|NCT01111188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101152|NCT01111188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101153|NCT01111188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101154|NCT01111188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101155|NCT01210482|Sirolimus|sirolimus|mesh-list
93101156|NCT01210482|Temsirolimus|temsirolimus|mesh-list
93101157|NCT01210482|MTOR Inhibitors|mtor inhibitors|mesh-list
93101158|NCT01210482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101159|NCT01210482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101160|NCT01210482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101161|NCT01210482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93101162|NCT01210482|Immunologic Factors|immunologic factors|mesh-ancestor
93101163|NCT01210482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101164|NCT01210482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101165|NCT01210482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93101166|NCT01210482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101167|NCT01210482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93101168|NCT01210482|Antifungal Agents|antifungal agents|mesh-ancestor
93101169|NCT01360060|Magnesium Sulfate|magnesium sulfate|mesh-list
93101170|NCT01360060|Analgesics|analgesics|mesh-ancestor
93101171|NCT01360060|Sensory System Agents|sensory system agents|mesh-ancestor
93101172|NCT01360060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101173|NCT01360060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101174|NCT01360060|Anesthetics|anesthetics|mesh-ancestor
93101175|NCT01360060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101176|NCT01360060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93101177|NCT01360060|Anticonvulsants|anticonvulsants|mesh-ancestor
93101178|NCT01360060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93101179|NCT01360060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101180|NCT01360060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101181|NCT01360060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101182|NCT01360060|Tocolytic Agents|tocolytic agents|mesh-ancestor
93101183|NCT01360060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93101184|NCT01210638|Oxymorphone|oxymorphone|mesh-list
93101185|NCT01210638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93101186|NCT01210638|Narcotics|narcotics|mesh-ancestor
93101187|NCT01210638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101188|NCT01210638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101189|NCT01210638|Analgesics|analgesics|mesh-ancestor
93101190|NCT01210638|Sensory System Agents|sensory system agents|mesh-ancestor
93101191|NCT01210638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101192|NCT01210638|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93101193|NCT03120676|Atezolizumab|atezolizumab|mesh-list
93101194|NCT03120676|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93101195|NCT03120676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101196|NCT03120676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101197|NCT03120676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101198|NCT01115478|Vitamin A|vitamin a|mesh-list
93101199|NCT01115478|Vitamins|vitamins|mesh-ancestor
93101200|NCT01115478|Micronutrients|micronutrients|mesh-ancestor
93101201|NCT01115478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101202|NCT01111422|Acetylcysteine|acetylcysteine|mesh-list
93101203|NCT01111422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93101204|NCT01111422|Antiviral Agents|antiviral agents|mesh-ancestor
93101205|NCT01111422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101206|NCT01111422|Expectorants|expectorants|mesh-ancestor
93101207|NCT01111422|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101208|NCT01111422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93101209|NCT01111422|Antioxidants|antioxidants|mesh-ancestor
93101210|NCT01111422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101211|NCT01111422|Protective Agents|protective agents|mesh-ancestor
93101212|NCT01111422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101213|NCT01111422|Antidotes|antidotes|mesh-ancestor
93101214|NCT01212432|Daptomycin|daptomycin|mesh-list
93101215|NCT01212432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93101216|NCT01212432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101217|NCT01213368|Dronedarone|dronedarone|mesh-list
93101218|NCT01213368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93101219|NCT01369186|Morphine|morphine|mesh-list
93101220|NCT01369186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93101221|NCT01369186|Narcotics|narcotics|mesh-ancestor
93101222|NCT01369186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101223|NCT01369186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101224|NCT01369186|Analgesics|analgesics|mesh-ancestor
93101225|NCT01369186|Sensory System Agents|sensory system agents|mesh-ancestor
93101226|NCT01369186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691474|NCT04512261|Tucatinib|tucatinib|mesh-list
93101227|NCT01115712|Pioglitazone|pioglitazone|mesh-list
93101228|NCT01115712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93101229|NCT01115712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101230|NCT01117662|Rituximab|rituximab|mesh-list
93101231|NCT01117662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101232|NCT01117662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101233|NCT01117662|Immunologic Factors|immunologic factors|mesh-ancestor
93101234|NCT01117662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101235|NCT01117662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93101236|NCT01319266|Hydrocodone|hydrocodone|mesh-list
93101237|NCT01319266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93101238|NCT01319266|Narcotics|narcotics|mesh-ancestor
93101239|NCT01319266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101240|NCT01319266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101241|NCT01319266|Analgesics|analgesics|mesh-ancestor
93101242|NCT01319266|Sensory System Agents|sensory system agents|mesh-ancestor
93101243|NCT01319266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101244|NCT01319266|Antitussive Agents|antitussive agents|mesh-ancestor
93101245|NCT01319266|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101246|NCT01115790|Prexasertib|prexasertib|mesh-list
93101247|NCT01115790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101248|NCT01115790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101249|NCT01115790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101250|NCT01115946|Enalapril|enalapril|mesh-list
93101251|NCT01115946|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93101252|NCT01115946|Protease Inhibitors|protease inhibitors|mesh-ancestor
93101253|NCT01115946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101254|NCT01115946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101255|NCT01115946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101256|NCT01113372|Clopidogrel|clopidogrel|mesh-list
93101257|NCT01113372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93101258|NCT01113372|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93101259|NCT01113372|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93101260|NCT01113372|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93101261|NCT01113372|Purinergic Agents|purinergic agents|mesh-ancestor
93101262|NCT01113372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101263|NCT01113372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101264|NCT01113372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101265|NCT03120520|Plecanatide|plecanatide|mesh-list
93101266|NCT03120520|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93101267|NCT03120520|Enzyme Activators|enzyme activators|mesh-ancestor
93101268|NCT03120520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101269|NCT03120520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93101270|NCT03941340|Aflutinib|aflutinib|mesh-list
93101271|NCT03941340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101272|NCT03941340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101273|NCT03941340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101274|NCT01372930|Etanercept|etanercept|mesh-list
93101275|NCT01372930|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93101276|NCT01372930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93101277|NCT01372930|Analgesics|analgesics|mesh-ancestor
93101278|NCT01372930|Sensory System Agents|sensory system agents|mesh-ancestor
93101279|NCT01372930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101280|NCT01372930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101281|NCT01372930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93101282|NCT01372930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93101283|NCT01372930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93101284|NCT01372930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93101285|NCT01372930|Immunologic Factors|immunologic factors|mesh-ancestor
93101286|NCT01328652|Dexlansoprazole|dexlansoprazole|mesh-list
93101287|NCT01328652|Lansoprazole|lansoprazole|mesh-list
93101288|NCT01328652|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93101289|NCT01328652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101290|NCT01328652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101291|NCT01328652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93101292|NCT01328652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93101293|NCT01373008|Beclomethasone|beclomethasone|mesh-list
93101294|NCT01373008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93101295|NCT01373008|Glucocorticoids|glucocorticoids|mesh-ancestor
93101296|NCT01373008|Hormones|hormones|mesh-ancestor
93101297|NCT01373008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101298|NCT01373008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101299|NCT01373008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93101300|NCT01373008|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101301|NCT01116180|Candesartan|candesartan|mesh-list
93101302|NCT01116180|Candesartan cilexetil|candesartan cilexetil|mesh-list
93101303|NCT01116180|Angiotensin II|angiotensin ii|mesh-list
93101304|NCT01116180|Giapreza|giapreza|mesh-list
93101305|NCT01116180|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93101306|NCT01116180|Angiotensinogen|angiotensinogen|mesh-list
93101307|NCT01116180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101308|NCT01116180|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93101309|NCT01116180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101310|NCT01116180|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93101311|NCT01116180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93101312|NCT01116180|Protease Inhibitors|protease inhibitors|mesh-ancestor
93101313|NCT01116180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101314|NCT05067166|Ansuvimab|ansuvimab|mesh-list
93101315|NCT05067166|Antiviral Agents|antiviral agents|mesh-ancestor
93101316|NCT05067166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101317|NCT01113528|Aspirin|aspirin|mesh-list
93101318|NCT01113528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93101319|NCT01113528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93101320|NCT01113528|Analgesics|analgesics|mesh-ancestor
93101321|NCT01113528|Sensory System Agents|sensory system agents|mesh-ancestor
93101322|NCT01113528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101323|NCT01113528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101324|NCT01113528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93101325|NCT01113528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93101326|NCT01113528|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93101327|NCT01113528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93101328|NCT01113528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101329|NCT01113528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93101330|NCT01113528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93101331|NCT01113528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101332|NCT01113528|Antipyretics|antipyretics|mesh-ancestor
93101333|NCT01369576|Zopiclone|zopiclone|mesh-list
93101334|NCT01369576|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93101335|NCT01369576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101336|NCT01369576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101337|NCT01113762|Cimetidine|cimetidine|mesh-list
93101338|NCT01113762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93101339|NCT01113762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93101340|NCT01113762|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93101341|NCT01113762|Histamine Antagonists|histamine antagonists|mesh-ancestor
93101342|NCT01113762|Histamine Agents|histamine agents|mesh-ancestor
93101343|NCT01113762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101344|NCT01113762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101345|NCT01113762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101346|NCT01113762|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93101347|NCT01113762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93101348|NCT01113762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101349|NCT01212666|Ropivacaine|ropivacaine|mesh-list
93101350|NCT01212666|Anesthetics, Local|anesthetics, local|mesh-ancestor
93101351|NCT01212666|Anesthetics|anesthetics|mesh-ancestor
93101352|NCT01212666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691612|NCT00507000|Vitamin D|vitamin d|mesh-list
93101353|NCT01212666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101354|NCT01212666|Sensory System Agents|sensory system agents|mesh-ancestor
93101355|NCT01212666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773657|NCT00002514|Antimetabolites|antimetabolites|mesh-ancestor
93101356|NCT01116336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93101357|NCT01116336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101358|NCT01116336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101359|NCT01116336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101360|NCT01116336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101361|NCT01213680|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93101362|NCT01213680|Ferric Compounds|ferric compounds|mesh-list
93101363|NCT01213680|Hematinics|hematinics|mesh-ancestor
93101364|NCT03937518|Strontium ranelate|strontium ranelate|mesh-list
93101365|NCT03937518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93101366|NCT03937518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101367|NCT01211496|Methamphetamine|methamphetamine|mesh-list
93101368|NCT01211496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93101369|NCT01211496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101370|NCT01211496|Sympathomimetics|sympathomimetics|mesh-ancestor
93101371|NCT01211496|Autonomic Agents|autonomic agents|mesh-ancestor
93101372|NCT01211496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101373|NCT01211496|Dopamine Agents|dopamine agents|mesh-ancestor
93101374|NCT01211496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101375|NCT01211496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101376|NCT01211496|Adrenergic Agents|adrenergic agents|mesh-ancestor
93101377|NCT01211496|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93101378|NCT01211496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93101379|NCT01211496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101380|NCT01211496|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93101381|NCT01118286|Nifedipine|nifedipine|mesh-list
93101382|NCT01118286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93101383|NCT01118286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101384|NCT01118286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101385|NCT01118286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101386|NCT01118286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101387|NCT01118286|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101388|NCT01118286|Tocolytic Agents|tocolytic agents|mesh-ancestor
93101389|NCT01118286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93101390|NCT01585350|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93101391|NCT01585350|Freund's Adjuvant|freund's adjuvant|mesh-list
93101392|NCT01585350|Poly ICLC|poly iclc|mesh-list
93101393|NCT01585350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93101394|NCT01585350|Immunologic Factors|immunologic factors|mesh-ancestor
93101395|NCT01585350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101396|NCT01585350|Interferon Inducers|interferon inducers|mesh-ancestor
93101397|NCT01118598|Nicotinic Acids|nicotinic acids|mesh-list
93101398|NCT01118598|Niacin|niacin|mesh-list
93101399|NCT01118598|Niacinamide|niacinamide|mesh-list
93101400|NCT01118598|Vitamin B Complex|vitamin b complex|mesh-ancestor
93101401|NCT01118598|Vitamins|vitamins|mesh-ancestor
93101402|NCT01118598|Micronutrients|micronutrients|mesh-ancestor
93101403|NCT01118598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101404|NCT01118598|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93101405|NCT01118598|Antimetabolites|antimetabolites|mesh-ancestor
93101406|NCT01118598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101407|NCT01118598|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93101408|NCT01118598|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101409|NCT01216020|Cisplatin|cisplatin|mesh-list
93101410|NCT01216020|Cetuximab|cetuximab|mesh-list
93101411|NCT01216020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101412|NCT01216020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101413|NCT01121796|Vitamin D|vitamin d|mesh-list
93101414|NCT01121796|Ergocalciferols|ergocalciferols|mesh-list
93101415|NCT01121796|Cholecalciferol|cholecalciferol|mesh-list
93101416|NCT01121796|Vitamins|vitamins|mesh-list
93101417|NCT01121796|Micronutrients|micronutrients|mesh-ancestor
93101418|NCT01121796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101419|NCT01121796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93101420|NCT01121796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101421|NCT03939624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93101422|NCT03939624|Protease Inhibitors|protease inhibitors|mesh-ancestor
93101423|NCT03939624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101424|NCT03939624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101425|NCT03939624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93101426|NCT03939624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101427|NCT01119144|Calcium, Dietary|calcium, dietary|mesh-list
93101428|NCT01119144|Calcium|calcium|mesh-list
93101429|NCT01119144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101430|NCT01119144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101431|NCT01119144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93101432|NCT01117038|Amlodipine|amlodipine|mesh-list
93101433|NCT01117038|Enalapril|enalapril|mesh-list
93101434|NCT01117038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101435|NCT01117038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93101436|NCT01117038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101437|NCT01117038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101438|NCT01117038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101439|NCT01117038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101440|NCT01117038|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101441|NCT01117038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93101442|NCT01117038|Protease Inhibitors|protease inhibitors|mesh-ancestor
93101443|NCT01117038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101444|NCT01119534|Camphor|camphor|mesh-list
93101445|NCT01119534|Eucalyptol|eucalyptol|mesh-list
93101446|NCT01119534|Phenylpropanolamine|phenylpropanolamine|mesh-list
93101447|NCT01119534|Menthol|menthol|mesh-list
93101448|NCT01119534|Guaifenesin|guaifenesin|mesh-list
93101449|NCT01119534|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93101450|NCT01119534|Antipruritics|antipruritics|mesh-ancestor
93101451|NCT01119534|Dermatologic Agents|dermatologic agents|mesh-ancestor
93101452|NCT01119534|Expectorants|expectorants|mesh-ancestor
93101453|NCT01119534|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101454|NCT01119534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93101455|NCT01119534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93101456|NCT01119534|Adrenergic Agents|adrenergic agents|mesh-ancestor
93101457|NCT01119534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101458|NCT01119534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101459|NCT01119534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101460|NCT01119534|Appetite Depressants|appetite depressants|mesh-ancestor
93101461|NCT01119534|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93101462|NCT01119534|Sympathomimetics|sympathomimetics|mesh-ancestor
93101463|NCT01119534|Autonomic Agents|autonomic agents|mesh-ancestor
93101464|NCT01119534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101465|NCT01119534|Nasal Decongestants|nasal decongestants|mesh-ancestor
93101466|NCT01119534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93101467|NCT01119534|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93101468|NCT01119534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101469|NCT01119534|Antitussive Agents|antitussive agents|mesh-ancestor
93101470|NCT01119534|Insect Repellents|insect repellents|mesh-ancestor
93101471|NCT01119534|Protective Agents|protective agents|mesh-ancestor
93101472|NCT01117116|Fluticasone|fluticasone|mesh-list
93101473|NCT01117116|Xhance|xhance|mesh-list
93101474|NCT01117116|Budesonide|budesonide|mesh-list
93101475|NCT01117116|Formoterol Fumarate|formoterol fumarate|mesh-list
93101476|NCT01117116|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93101477|NCT01117116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93101478|NCT01117116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93101479|NCT01117116|Autonomic Agents|autonomic agents|mesh-ancestor
93101480|NCT01117116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101481|NCT01117116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101482|NCT01117116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93101483|NCT01117116|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101484|NCT01117116|Dermatologic Agents|dermatologic agents|mesh-ancestor
93101485|NCT01117116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93101486|NCT01117116|Glucocorticoids|glucocorticoids|mesh-ancestor
93101487|NCT01117116|Hormones|hormones|mesh-ancestor
93101488|NCT01117116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101489|NCT01117116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93101490|NCT01117116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93101491|NCT01117116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93101492|NCT01117116|Adrenergic Agents|adrenergic agents|mesh-ancestor
93101493|NCT01117116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101494|NCT01117116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101495|NCT01216488|Lidocaine|lidocaine|mesh-list
93101496|NCT01216488|Anesthetics, Local|anesthetics, local|mesh-ancestor
93101497|NCT01216488|Anesthetics|anesthetics|mesh-ancestor
93101498|NCT01216488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101499|NCT01216488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101500|NCT01216488|Sensory System Agents|sensory system agents|mesh-ancestor
93101501|NCT01216488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101502|NCT01216488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93101503|NCT01216488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93101504|NCT01216488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93101505|NCT01216488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92773800|NCT00934648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93101506|NCT01216488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101507|NCT01122342|Methyltestosterone|methyltestosterone|mesh-list
93101509|NCT01122342|Testosterone undecanoate|testosterone undecanoate|mesh-list
93101510|NCT01122342|Testosterone enanthate|testosterone enanthate|mesh-list
93101511|NCT01122342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93101512|NCT01122342|Androgens|androgens|mesh-ancestor
93101513|NCT01122342|Hormones|hormones|mesh-ancestor
93101514|NCT01122342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101515|NCT01122342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101516|NCT01122342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93101517|NCT01122342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101518|NCT01122342|Anabolic Agents|anabolic agents|mesh-ancestor
93101519|NCT01213992|Iron|iron|mesh-list
93101520|NCT01213992|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93101521|NCT01213992|Ferric Compounds|ferric compounds|mesh-list
93101522|NCT01213992|Trace Elements|trace elements|mesh-ancestor
93101523|NCT01213992|Micronutrients|micronutrients|mesh-ancestor
93101524|NCT01213992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101525|NCT01213992|Hematinics|hematinics|mesh-ancestor
93101526|NCT03963414|Carboplatin|carboplatin|mesh-list
93101527|NCT03963414|Etoposide|etoposide|mesh-list
93101528|NCT03963414|Etoposide phosphate|etoposide phosphate|mesh-list
93101529|NCT03963414|Durvalumab|durvalumab|mesh-list
93101530|NCT03963414|Tremelimumab|tremelimumab|mesh-list
93101531|NCT03963414|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93101532|NCT03963414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101533|NCT03963414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93101534|NCT03963414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93101535|NCT03963414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93101536|NCT03963414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101537|NCT03963414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101538|NCT03963414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101539|NCT03963414|Immunologic Factors|immunologic factors|mesh-ancestor
93101540|NCT03963414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101541|NCT01216644|Leucovorin|leucovorin|mesh-list
93101542|NCT01216644|Docetaxel|docetaxel|mesh-list
93101543|NCT01216644|Fluorouracil|fluorouracil|mesh-list
93101544|NCT01216644|Oxaliplatin|oxaliplatin|mesh-list
93101545|NCT01216644|Epirubicin|epirubicin|mesh-list
93101546|NCT01216644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101547|NCT01216644|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101548|NCT01216644|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101549|NCT01216644|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101550|NCT01216644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101551|NCT01216644|Antimetabolites|antimetabolites|mesh-ancestor
93101552|NCT01216644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93101553|NCT01216644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93101554|NCT01216644|Immunologic Factors|immunologic factors|mesh-ancestor
93101555|NCT01216644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101556|NCT01216644|Antidotes|antidotes|mesh-ancestor
93101557|NCT01216644|Protective Agents|protective agents|mesh-ancestor
93101558|NCT01216644|Vitamin B Complex|vitamin b complex|mesh-ancestor
93101559|NCT01216644|Vitamins|vitamins|mesh-ancestor
93101560|NCT01216644|Micronutrients|micronutrients|mesh-ancestor
93101561|NCT01216644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93101562|NCT01216644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93101563|NCT01216644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93101564|NCT01216644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101565|NCT04816162|Dexmedetomidine|dexmedetomidine|mesh-list
93101566|NCT04816162|Ketamine|ketamine|mesh-list
93101567|NCT04816162|Propofol|propofol|mesh-list
93101568|NCT04816162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93101569|NCT04816162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101570|NCT04816162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101571|NCT04816162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93101572|NCT04816162|Analgesics|analgesics|mesh-ancestor
93101573|NCT04816162|Sensory System Agents|sensory system agents|mesh-ancestor
93101574|NCT04816162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101575|NCT04816162|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93101576|NCT04816162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93101577|NCT04816162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93101578|NCT04816162|Adrenergic Agents|adrenergic agents|mesh-ancestor
93101579|NCT04816162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101580|NCT04816162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101581|NCT04816162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93101582|NCT04816162|Anesthetics, General|anesthetics, general|mesh-ancestor
93101583|NCT04816162|Anesthetics|anesthetics|mesh-ancestor
93101584|NCT04816162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93101585|NCT04816162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93101586|NCT04816162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93101587|NCT04959760|Antibodies|antibodies|mesh-list
93101588|NCT04959760|Immunoglobulins|immunoglobulins|mesh-list
93101589|NCT04959760|Immunoglobulin G|immunoglobulin g|mesh-list
93101590|NCT04959760|Immunologic Factors|immunologic factors|mesh-ancestor
93101591|NCT04959760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101592|NCT01214226|Pentoxifylline|pentoxifylline|mesh-list
93101593|NCT01214226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93101594|NCT01214226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101595|NCT01214226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101596|NCT01214226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93101597|NCT01214226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93101598|NCT01214226|Protective Agents|protective agents|mesh-ancestor
93101599|NCT01214226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101600|NCT01214226|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101601|NCT01214226|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93101602|NCT01214226|Antioxidants|antioxidants|mesh-ancestor
93101603|NCT01360372|Methylnaltrexone|methylnaltrexone|mesh-list
93101604|NCT01360372|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93101605|NCT01360372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101606|NCT01360372|Sensory System Agents|sensory system agents|mesh-ancestor
93101607|NCT01360372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101608|NCT01219062|Morphine|morphine|mesh-list
93101609|NCT01219062|Bupivacaine|bupivacaine|mesh-list
93101610|NCT01219062|Anesthetics, Local|anesthetics, local|mesh-ancestor
93101611|NCT01219062|Anesthetics|anesthetics|mesh-ancestor
93101612|NCT01219062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101613|NCT01219062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101614|NCT01219062|Sensory System Agents|sensory system agents|mesh-ancestor
93101615|NCT01219062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101616|NCT01219062|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93101617|NCT01219062|Narcotics|narcotics|mesh-ancestor
93101618|NCT01219062|Analgesics|analgesics|mesh-ancestor
93101619|NCT01120158|Paclitaxel|paclitaxel|mesh-list
93101620|NCT01120158|Bevacizumab|bevacizumab|mesh-list
93101621|NCT01120158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93101622|NCT01120158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101623|NCT01120158|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101624|NCT01120158|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101625|NCT01120158|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101626|NCT01120158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101627|NCT01120158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101628|NCT01120158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93101629|NCT01120158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93101630|NCT01120158|Growth Substances|growth substances|mesh-ancestor
93101631|NCT01120158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101632|NCT01120158|Growth Inhibitors|growth inhibitors|mesh-ancestor
93101633|NCT01373398|Apaziquone|apaziquone|mesh-list
92691876|NCT01296412|Incretins|incretins|mesh-ancestor
93101634|NCT01373398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101635|NCT01124526|Cyclophosphamide|cyclophosphamide|mesh-list
93101636|NCT01124526|Rituximab|rituximab|mesh-list
93101637|NCT01124526|Fludarabine|fludarabine|mesh-list
93101638|NCT01124526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93101639|NCT01124526|Immunologic Factors|immunologic factors|mesh-ancestor
93101640|NCT01124526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101641|NCT01124526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93101642|NCT01124526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93101643|NCT01124526|Alkylating Agents|alkylating agents|mesh-ancestor
93101644|NCT01124526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101645|NCT01124526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101646|NCT01124526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93101647|NCT01124526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101648|NCT01120314|Otamixaban|otamixaban|mesh-list
93101649|NCT01120314|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93101650|NCT01120314|Antithrombins|antithrombins|mesh-ancestor
93101651|NCT01120314|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93101652|NCT01120314|Protease Inhibitors|protease inhibitors|mesh-ancestor
93101653|NCT01120314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101654|NCT01120314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101655|NCT01120314|Anticoagulants|anticoagulants|mesh-ancestor
93101656|NCT03633994|Heparin|heparin|mesh-list
93101657|NCT03633994|Anticoagulants|anticoagulants|mesh-ancestor
93101658|NCT03633994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93101659|NCT03633994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93101660|NCT03633994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101661|NCT01328886|Omalizumab|omalizumab|mesh-list
93101662|NCT01328886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93101663|NCT01328886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93101664|NCT01328886|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101665|NCT01216878|Losartan|losartan|mesh-list
93101666|NCT01216878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93101667|NCT01216878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101668|NCT01216878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93101669|NCT01216878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93101670|NCT01216878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101671|NCT04624984|Gemcitabine|gemcitabine|mesh-list
93101672|NCT04624984|Doxorubicin|doxorubicin|mesh-list
93101673|NCT04624984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93101674|NCT04624984|Vinorelbine|vinorelbine|mesh-list
93101675|NCT04624984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93101676|NCT04624984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93101677|NCT04624984|Antimetabolites|antimetabolites|mesh-ancestor
93101678|NCT04624984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101679|NCT04624984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101680|NCT04624984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93101681|NCT04624984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93101682|NCT04624984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93101683|NCT04624984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101684|NCT04624984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93101685|NCT04624984|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101686|NCT04624984|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101687|NCT04624984|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101688|NCT04624984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101689|NCT01214382|Sertraline|sertraline|mesh-list
93101690|NCT01214382|Antidepressive Agents|antidepressive agents|mesh-ancestor
93101691|NCT01214382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93101692|NCT01214382|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93101693|NCT01214382|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93101694|NCT01214382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101695|NCT01214382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101696|NCT01214382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101697|NCT01214382|Serotonin Agents|serotonin agents|mesh-ancestor
93101698|NCT01214382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101699|NCT01216956|Nicotinic Acids|nicotinic acids|mesh-list
93101700|NCT01216956|Niacin|niacin|mesh-list
93101701|NCT01216956|Niacinamide|niacinamide|mesh-list
93101702|NCT01216956|Vitamin B Complex|vitamin b complex|mesh-ancestor
93101703|NCT01216956|Vitamins|vitamins|mesh-ancestor
93101704|NCT01216956|Micronutrients|micronutrients|mesh-ancestor
93101705|NCT01216956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101706|NCT01216956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93101707|NCT01216956|Antimetabolites|antimetabolites|mesh-ancestor
93101708|NCT01216956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101709|NCT01216956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93101710|NCT01216956|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101711|NCT01217034|Sorafenib|sorafenib|mesh-list
93101712|NCT01217034|Chlorotrianisene|chlorotrianisene|mesh-list
93101713|NCT01217034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101714|NCT01217034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101715|NCT01217034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101716|NCT01217034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101717|NCT01217034|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93101718|NCT01217034|Estrogens|estrogens|mesh-ancestor
93101719|NCT01217034|Hormones|hormones|mesh-ancestor
93101720|NCT01217034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101721|NCT01217034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101722|NCT01217034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93101723|NCT01373554|Oltipraz|oltipraz|mesh-list
93101724|NCT01373554|Antiviral Agents|antiviral agents|mesh-ancestor
93101725|NCT01373554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101726|NCT01373554|Schistosomicides|schistosomicides|mesh-ancestor
93101727|NCT01373554|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93101728|NCT01373554|Anthelmintics|anthelmintics|mesh-ancestor
93101729|NCT01373554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93101730|NCT01373554|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93101731|NCT01373554|Protective Agents|protective agents|mesh-ancestor
93101732|NCT01373554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101733|NCT01373554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101734|NCT01373554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93101735|NCT01373554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93101737|NCT01373554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101738|NCT01319344|Eplerenone|eplerenone|mesh-list
93101739|NCT01319344|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93101740|NCT01319344|Hormone Antagonists|hormone antagonists|mesh-ancestor
93101741|NCT01319344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101742|NCT01319344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101743|NCT01319344|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93101744|NCT01319344|Diuretics|diuretics|mesh-ancestor
93101745|NCT01319344|Natriuretic Agents|natriuretic agents|mesh-ancestor
93101746|NCT01319344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101747|NCT01373632|Sirolimus|sirolimus|mesh-list
93101748|NCT01373632|Temsirolimus|temsirolimus|mesh-list
93101749|NCT01373632|MTOR Inhibitors|mtor inhibitors|mesh-list
93101750|NCT01373632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93101751|NCT01373632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101752|NCT01373632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93101753|NCT01373632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101754|NCT01373632|Antifungal Agents|antifungal agents|mesh-ancestor
93101755|NCT01373632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93101756|NCT01373632|Immunologic Factors|immunologic factors|mesh-ancestor
93101757|NCT01373632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101758|NCT01373632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93101759|NCT01373632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101760|NCT01373632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101761|NCT01124760|Ketoconazole|ketoconazole|mesh-list
93101762|NCT01124760|Diltiazem|diltiazem|mesh-list
93101763|NCT01124760|Antifungal Agents|antifungal agents|mesh-ancestor
93101764|NCT01124760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101765|NCT01124760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93101766|NCT01124760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93101767|NCT01124760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101768|NCT01124760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101769|NCT01124760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93101770|NCT01124760|Hormone Antagonists|hormone antagonists|mesh-ancestor
93101771|NCT01124760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101772|NCT01124760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101773|NCT01124760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93101774|NCT01124760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101775|NCT01124760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93101776|NCT01124760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101777|NCT01124760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101778|NCT01124760|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101779|NCT01214772|Heparin|heparin|mesh-list
93101780|NCT01214772|Anticoagulants|anticoagulants|mesh-ancestor
93101781|NCT01214772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93101782|NCT01214772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93101783|NCT01214772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101784|NCT01125150|Metformin|metformin|mesh-list
93101785|NCT01125150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93101786|NCT01125150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101787|NCT01373710|Trastuzumab|trastuzumab|mesh-list
93101788|NCT01373710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101789|NCT01373710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101790|NCT03935256|Paclitaxel|paclitaxel|mesh-list
93101791|NCT03935256|Carboplatin|carboplatin|mesh-list
93101792|NCT03935256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93101793|NCT03935256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101794|NCT03935256|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101795|NCT03935256|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101796|NCT03935256|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101797|NCT03935256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101798|NCT03869866|Vaccines|vaccines|mesh-list
93101799|NCT03869866|Immunologic Factors|immunologic factors|mesh-ancestor
93101800|NCT03869866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101801|NCT03783702|Acetaminophen|acetaminophen|mesh-list
93101802|NCT03783702|Ibuprofen|ibuprofen|mesh-list
93101803|NCT03783702|Oxycodone|oxycodone|mesh-list
93101804|NCT03783702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93101805|NCT03783702|Analgesics|analgesics|mesh-ancestor
93101806|NCT03783702|Sensory System Agents|sensory system agents|mesh-ancestor
93101807|NCT03783702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101808|NCT03783702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101809|NCT03783702|Antipyretics|antipyretics|mesh-ancestor
93101810|NCT03783702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93101811|NCT03783702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93101812|NCT03783702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93101813|NCT03783702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93101814|NCT03783702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101815|NCT03783702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101816|NCT03783702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93101817|NCT03783702|Narcotics|narcotics|mesh-ancestor
93101818|NCT03783702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93101819|NCT01319734|Glyburide|glyburide|mesh-list
93101820|NCT01319734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101821|NCT01319734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93101822|NCT01121016|Montelukast|montelukast|mesh-list
93101823|NCT01121016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93101824|NCT01121016|Respiratory System Agents|respiratory system agents|mesh-ancestor
93101825|NCT01121016|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93101826|NCT01121016|Hormone Antagonists|hormone antagonists|mesh-ancestor
93101827|NCT01121016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101828|NCT01121016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101829|NCT01121016|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93101830|NCT01121016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93101831|NCT01121016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101832|NCT03575572|Colchicine|colchicine|mesh-list
93101833|NCT03575572|Gout Suppressants|gout suppressants|mesh-ancestor
93101834|NCT03575572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93101835|NCT03575572|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101836|NCT03575572|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101837|NCT03575572|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101838|NCT03575572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101839|NCT03575572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101840|NCT01214928|Vitamin D|vitamin d|mesh-list
93101841|NCT01214928|Cholecalciferol|cholecalciferol|mesh-list
93101842|NCT01214928|Vitamins|vitamins|mesh-ancestor
93101843|NCT01214928|Micronutrients|micronutrients|mesh-ancestor
93101844|NCT01214928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101845|NCT01214928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93101846|NCT01214928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93101847|NCT01122966|Bevacizumab|bevacizumab|mesh-list
93101848|NCT01122966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101849|NCT01122966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101850|NCT01122966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93101851|NCT01122966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93101852|NCT01122966|Growth Substances|growth substances|mesh-ancestor
93101853|NCT01122966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101854|NCT01122966|Growth Inhibitors|growth inhibitors|mesh-ancestor
93101855|NCT01219686|Pindolol|pindolol|mesh-list
93101856|NCT01219686|Dexetimide|dexetimide|mesh-list
93101857|NCT01219686|Citalopram|citalopram|mesh-list
93101858|NCT01219686|Escitalopram|escitalopram|mesh-list
93101859|NCT01219686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93101860|NCT01219686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93101861|NCT01219686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93101862|NCT01219686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101863|NCT01219686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101864|NCT01219686|Serotonin Agents|serotonin agents|mesh-ancestor
93101865|NCT01219686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101866|NCT01219686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93101867|NCT01219686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93101868|NCT01219686|Parasympatholytics|parasympatholytics|mesh-ancestor
93101869|NCT01219686|Autonomic Agents|autonomic agents|mesh-ancestor
93101870|NCT01219686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93101871|NCT01219686|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93101872|NCT01219686|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93101873|NCT01219686|Cholinergic Agents|cholinergic agents|mesh-ancestor
93101874|NCT01219686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93101875|NCT01219686|Antidepressive Agents|antidepressive agents|mesh-ancestor
93101876|NCT01219686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93101877|NCT01219686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93101878|NCT01219686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93101879|NCT01219686|Adrenergic Agents|adrenergic agents|mesh-ancestor
93101880|NCT01219686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93101881|NCT01219686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93101882|NCT01219686|Vasodilator Agents|vasodilator agents|mesh-ancestor
93101883|NCT01219764|Amoxicillin|amoxicillin|mesh-list
93101884|NCT01219764|Metronidazole|metronidazole|mesh-list
93101885|NCT01219764|Clarithromycin|clarithromycin|mesh-list
93101886|NCT01219764|Rabeprazole|rabeprazole|mesh-list
93101887|NCT01219764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93101888|NCT01219764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101889|NCT01219764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93101890|NCT01219764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93101891|NCT01219764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93101892|NCT01219764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101893|NCT01219764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101894|NCT01219764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93101895|NCT01219764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93101896|NCT01219764|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93101897|NCT01219764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93101898|NCT01219764|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93101899|NCT03936426|Copper|copper|mesh-list
93101900|NCT03936426|Trace Elements|trace elements|mesh-ancestor
93101901|NCT03936426|Micronutrients|micronutrients|mesh-ancestor
93101902|NCT03936426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101903|NCT01215084|4-Aminopyridine|4-aminopyridine|mesh-list
93101904|NCT01215084|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93101905|NCT01215084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692162|NCT00507234|Adrenergic Agents|adrenergic agents|mesh-ancestor
93101906|NCT01215084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101907|NCT01125696|Ritonavir|ritonavir|mesh-list
93101908|NCT01125696|Lopinavir|lopinavir|mesh-list
93101909|NCT01125696|Tenofovir|tenofovir|mesh-list
93101910|NCT01125696|Lamivudine|lamivudine|mesh-list
93101911|NCT01125696|Zidovudine|zidovudine|mesh-list
93101912|NCT01125696|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93101913|NCT01125696|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93101914|NCT01125696|Protease Inhibitors|protease inhibitors|mesh-ancestor
93101915|NCT01125696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101916|NCT01125696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101917|NCT01125696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93101918|NCT01125696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93101919|NCT01125696|Antiviral Agents|antiviral agents|mesh-ancestor
93101920|NCT01125696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93101921|NCT01125696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93101922|NCT01125696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93101923|NCT01125696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93101924|NCT01125696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93101925|NCT01125696|Antimetabolites|antimetabolites|mesh-ancestor
93101926|NCT03932916|Donepezil|donepezil|mesh-list
93101927|NCT03932916|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93101928|NCT03932916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101929|NCT03932916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101930|NCT03932916|Cholinergic Agents|cholinergic agents|mesh-ancestor
93101931|NCT03932916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93101932|NCT03932916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101933|NCT03932916|Nootropic Agents|nootropic agents|mesh-ancestor
93101934|NCT03116152|Paclitaxel|paclitaxel|mesh-list
93101935|NCT03116152|Irinotecan|irinotecan|mesh-list
93101936|NCT03116152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93101937|NCT03116152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101938|NCT03116152|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101939|NCT03116152|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101940|NCT03116152|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101941|NCT03116152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101942|NCT03116152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93101943|NCT03116152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93101944|NCT03116152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101945|NCT01123278|Testosterone|testosterone|mesh-list
93101946|NCT01123278|Androgens|androgens|mesh-ancestor
93101947|NCT01123278|Hormones|hormones|mesh-ancestor
93101948|NCT01123278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101949|NCT01123278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101950|NCT01219920|Leucovorin|leucovorin|mesh-list
93101951|NCT01219920|Irinotecan|irinotecan|mesh-list
93101952|NCT01219920|Antidotes|antidotes|mesh-ancestor
93101953|NCT01219920|Protective Agents|protective agents|mesh-ancestor
93101954|NCT01219920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101955|NCT01219920|Vitamin B Complex|vitamin b complex|mesh-ancestor
93101956|NCT01219920|Vitamins|vitamins|mesh-ancestor
93101957|NCT01219920|Micronutrients|micronutrients|mesh-ancestor
93101958|NCT01219920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101959|NCT01219920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101960|NCT01219920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93101961|NCT01219920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93101962|NCT01219920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93101963|NCT01400776|Estradiol|estradiol|mesh-list
93101964|NCT01400776|Estrogens|estrogens|mesh-ancestor
93101965|NCT01400776|Hormones|hormones|mesh-ancestor
93101966|NCT01400776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101967|NCT01400776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101968|NCT01220076|Tamoxifen|tamoxifen|mesh-list
93101969|NCT01220076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93101970|NCT01220076|Hormone Antagonists|hormone antagonists|mesh-ancestor
93101971|NCT01220076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93101972|NCT01220076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101973|NCT01220076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93101974|NCT01220076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101975|NCT01220076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93101976|NCT01220076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93101977|NCT01220076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93101978|NCT01220154|Paclitaxel|paclitaxel|mesh-list
93101979|NCT01220154|Bevacizumab|bevacizumab|mesh-list
93101980|NCT01220154|Carboplatin|carboplatin|mesh-list
93101981|NCT01220154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93101982|NCT01220154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93101983|NCT01220154|Tubulin Modulators|tubulin modulators|mesh-ancestor
93101984|NCT01220154|Antimitotic Agents|antimitotic agents|mesh-ancestor
93101985|NCT01220154|Mitosis Modulators|mitosis modulators|mesh-ancestor
93101986|NCT01220154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93101987|NCT01220154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93101988|NCT01220154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93101989|NCT01220154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93101990|NCT01220154|Growth Substances|growth substances|mesh-ancestor
93101991|NCT01220154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101992|NCT01220154|Growth Inhibitors|growth inhibitors|mesh-ancestor
93101993|NCT01182766|Topiramate|topiramate|mesh-list
93101994|NCT01182766|Anticonvulsants|anticonvulsants|mesh-ancestor
93101995|NCT01182766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93101996|NCT01182766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93101997|NCT01220232|Lamivudine|lamivudine|mesh-list
93101998|NCT01220232|Abacavir|abacavir|mesh-list
93101999|NCT01220232|Dideoxynucleosides|dideoxynucleosides|mesh-list
93102000|NCT01220232|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93102001|NCT01220232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93102002|NCT01220232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102003|NCT01220232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102004|NCT01220232|Antiviral Agents|antiviral agents|mesh-ancestor
93102005|NCT01220232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102006|NCT01220232|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93102007|NCT01220232|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93102008|NCT01220232|Antimetabolites|antimetabolites|mesh-ancestor
93102009|NCT01126008|Docetaxel|docetaxel|mesh-list
93102010|NCT01126008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102011|NCT01126008|Tubulin Modulators|tubulin modulators|mesh-ancestor
93102012|NCT01126008|Antimitotic Agents|antimitotic agents|mesh-ancestor
93102013|NCT01126008|Mitosis Modulators|mitosis modulators|mesh-ancestor
93102014|NCT01126008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102015|NCT03934710|Serotonin|serotonin|mesh-list
93102016|NCT03934710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-list
93102017|NCT03934710|Serotonin Agents|serotonin agents|mesh-ancestor
93102018|NCT03934710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102019|NCT03934710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102020|NCT03934710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102021|NCT05169424|Fluticasone|fluticasone|mesh-list
93102022|NCT05169424|Xhance|xhance|mesh-list
93102023|NCT05169424|Tiotropium Bromide|tiotropium bromide|mesh-list
93102024|NCT05169424|Olodaterol|olodaterol|mesh-list
93102025|NCT05169424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102026|NCT05169424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93102027|NCT05169424|Autonomic Agents|autonomic agents|mesh-ancestor
93102028|NCT05169424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102029|NCT05169424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102030|NCT05169424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93102031|NCT05169424|Respiratory System Agents|respiratory system agents|mesh-ancestor
93102032|NCT05169424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774326|NCT02862483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93102033|NCT05169424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93102034|NCT05169424|Parasympatholytics|parasympatholytics|mesh-ancestor
93102035|NCT05169424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93102036|NCT05169424|Cholinergic Agents|cholinergic agents|mesh-ancestor
93102037|NCT05169424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102038|NCT05169424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102039|NCT03117010|Dexamethasone|dexamethasone|mesh-list
93102040|NCT03117010|Etoposide|etoposide|mesh-list
93102041|NCT03117010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102042|NCT03117010|Antiemetics|antiemetics|mesh-ancestor
93102043|NCT03117010|Autonomic Agents|autonomic agents|mesh-ancestor
93102044|NCT03117010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102045|NCT03117010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102046|NCT03117010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93102047|NCT03117010|Glucocorticoids|glucocorticoids|mesh-ancestor
93102048|NCT03117010|Hormones|hormones|mesh-ancestor
93102049|NCT03117010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102050|NCT03117010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93102051|NCT03117010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102052|NCT03117010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102053|NCT03117010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102054|NCT03117010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93102055|NCT03117010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93102056|NCT03117010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93102057|NCT01123824|Clopidogrel|clopidogrel|mesh-list
93102058|NCT01123824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93102059|NCT01123824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93102060|NCT01123824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93102061|NCT01123824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93102062|NCT01123824|Purinergic Agents|purinergic agents|mesh-ancestor
93102063|NCT01123824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102064|NCT01123824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102065|NCT01123824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102066|NCT01126086|Otamixaban|otamixaban|mesh-list
93102067|NCT01126086|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93102068|NCT01126086|Antithrombins|antithrombins|mesh-ancestor
93102069|NCT01126086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93102070|NCT01126086|Protease Inhibitors|protease inhibitors|mesh-ancestor
93102071|NCT01126086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102072|NCT01126086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102073|NCT01126086|Anticoagulants|anticoagulants|mesh-ancestor
93102074|NCT03009838|Letrozole|letrozole|mesh-list
93102075|NCT03009838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102076|NCT03009838|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93102077|NCT03009838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93102078|NCT03009838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102079|NCT03009838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102080|NCT03009838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93102081|NCT03009838|Hormone Antagonists|hormone antagonists|mesh-ancestor
93102082|NCT03009838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102083|NCT03009838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102084|NCT01124058|Heparin|heparin|mesh-list
93102085|NCT01124058|Calcium heparin|calcium heparin|mesh-list
93102086|NCT01124058|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93102087|NCT01124058|Tinzaparin|tinzaparin|mesh-list
93102088|NCT01124058|Dalteparin|dalteparin|mesh-list
93102089|NCT01124058|Warfarin|warfarin|mesh-list
93102090|NCT01124058|Anticoagulants|anticoagulants|mesh-ancestor
93102091|NCT01124058|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93102092|NCT01124058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93102093|NCT01124058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102094|NCT01375972|Cisplatin|cisplatin|mesh-list
93102095|NCT01375972|Gemcitabine|gemcitabine|mesh-list
93102096|NCT01375972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102097|NCT01375972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102098|NCT01375972|Antimetabolites|antimetabolites|mesh-ancestor
93102099|NCT01375972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102100|NCT05129644|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93102101|NCT05129644|Antiviral Agents|antiviral agents|mesh-ancestor
93102102|NCT05129644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102103|NCT01220622|Nimodipine|nimodipine|mesh-list
93102104|NCT01220622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93102105|NCT01220622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93102106|NCT01220622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102107|NCT01220622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102108|NCT01220622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93102109|NCT01220622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102110|NCT01220622|Vasodilator Agents|vasodilator agents|mesh-ancestor
93102111|NCT05123170|Lidocaine|lidocaine|mesh-list
93102112|NCT05123170|Dexmedetomidine|dexmedetomidine|mesh-list
93102113|NCT05123170|Anesthetics, Local|anesthetics, local|mesh-ancestor
93102114|NCT05123170|Anesthetics|anesthetics|mesh-ancestor
93102115|NCT05123170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102116|NCT05123170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102117|NCT05123170|Sensory System Agents|sensory system agents|mesh-ancestor
93102118|NCT05123170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102119|NCT05123170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93102120|NCT05123170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93102121|NCT05123170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93102122|NCT05123170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102123|NCT05123170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102124|NCT05123170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93102125|NCT05123170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93102126|NCT05123170|Analgesics|analgesics|mesh-ancestor
93102127|NCT05123170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93102128|NCT05123170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93102129|NCT05123170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93102130|NCT05123170|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102131|NCT05123170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102132|NCT01215708|Tamsulosin|tamsulosin|mesh-list
93102133|NCT01215708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93102134|NCT01215708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93102135|NCT01215708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93102136|NCT01215708|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102137|NCT01215708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102138|NCT01215708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102139|NCT01215708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102140|NCT01215708|Urological Agents|urological agents|mesh-ancestor
93102141|NCT01222026|Vitamin D|vitamin d|mesh-list
93102142|NCT01222026|Strontium ranelate|strontium ranelate|mesh-list
93102143|NCT01222026|Vitamins|vitamins|mesh-ancestor
93102144|NCT01222026|Micronutrients|micronutrients|mesh-ancestor
93102145|NCT01222026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102146|NCT01222026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93102147|NCT00225251|Bupropion|bupropion|mesh-list
93102148|NCT00225251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93102149|NCT00225251|Antidepressive Agents|antidepressive agents|mesh-ancestor
93102150|NCT00225251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93102151|NCT00225251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93102152|NCT00225251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93102153|NCT00225251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102154|NCT00225251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102155|NCT00225251|Dopamine Agents|dopamine agents|mesh-ancestor
93102156|NCT00225251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102157|NCT00225251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102158|NCT00225251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93102159|NCT00225251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93102160|NCT00225251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102161|NCT01376128|Paroxetine|paroxetine|mesh-list
93102162|NCT01376128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93102163|NCT01376128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93102164|NCT01376128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102165|NCT01376128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102166|NCT01376128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102167|NCT01376128|Serotonin Agents|serotonin agents|mesh-ancestor
93102168|NCT01376128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102169|NCT01376128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93102170|NCT01376128|Antidepressive Agents|antidepressive agents|mesh-ancestor
93102171|NCT01376128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93102172|NCT01376128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93102173|NCT01376128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93102174|NCT01376128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102175|NCT01376206|Fluticasone|fluticasone|mesh-list
93102176|NCT01376206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102177|NCT01376206|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93102178|NCT01376206|Autonomic Agents|autonomic agents|mesh-ancestor
93102179|NCT01376206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102180|NCT01376206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102181|NCT01376206|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93102182|NCT01376206|Respiratory System Agents|respiratory system agents|mesh-ancestor
93102183|NCT01376206|Dermatologic Agents|dermatologic agents|mesh-ancestor
93102184|NCT01376206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93102186|NCT01073501|Analgesics|analgesics|mesh-ancestor
93102187|NCT01073501|Sensory System Agents|sensory system agents|mesh-ancestor
93102188|NCT01073501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102189|NCT01073501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102190|NCT01073501|Anticonvulsants|anticonvulsants|mesh-ancestor
93102191|NCT01073501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93102192|NCT01073501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102193|NCT01073501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102194|NCT01073501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93102195|NCT01073501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93102196|NCT01073501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93102197|NCT01073501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102198|NCT01073501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93102199|NCT05005312|Ritonavir|ritonavir|mesh-list
93102200|NCT05005312|Nirmatrelvir|nirmatrelvir|mesh-list
93102201|NCT05005312|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93102202|NCT05005312|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93102203|NCT05005312|Protease Inhibitors|protease inhibitors|mesh-ancestor
93102204|NCT05005312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102205|NCT05005312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102206|NCT05005312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93102207|NCT05005312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93102208|NCT05005312|Antiviral Agents|antiviral agents|mesh-ancestor
93102209|NCT05005312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102210|NCT05005312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93102211|NCT05005312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93102212|NCT01222182|Atorvastatin|atorvastatin|mesh-list
93102213|NCT01222182|Simvastatin|simvastatin|mesh-list
93102214|NCT01222182|Pravastatin|pravastatin|mesh-list
93102215|NCT01222182|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93102216|NCT01222182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93102217|NCT01222182|Antimetabolites|antimetabolites|mesh-ancestor
93102218|NCT01222182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102219|NCT01222182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93102220|NCT01222182|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93102221|NCT01222182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102222|NCT01218750|Bevacizumab|bevacizumab|mesh-list
93102223|NCT01218750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102224|NCT01218750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102225|NCT01218750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93102226|NCT01218750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93102227|NCT01218750|Growth Substances|growth substances|mesh-ancestor
93102228|NCT01218750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102229|NCT01218750|Growth Inhibitors|growth inhibitors|mesh-ancestor
93102230|NCT01376284|Dutasteride|dutasteride|mesh-list
93102231|NCT01376284|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93102232|NCT01376284|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93102233|NCT01376284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102234|NCT01376284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102235|NCT01376284|Hormone Antagonists|hormone antagonists|mesh-ancestor
93102236|NCT01376284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102237|NCT01376284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102238|NCT01376440|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93102239|NCT01376440|Eusol|eusol|mesh-list
93102240|NCT01376440|Disinfectants|disinfectants|mesh-ancestor
93102241|NCT01376440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102242|NCT01329042|Citric Acid|citric acid|mesh-list
93102243|NCT01329042|Sodium Citrate|sodium citrate|mesh-list
93102244|NCT01329042|Anticoagulants|anticoagulants|mesh-ancestor
93102245|NCT01329042|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93102246|NCT01329042|Chelating Agents|chelating agents|mesh-ancestor
93102247|NCT01329042|Sequestering Agents|sequestering agents|mesh-ancestor
93102248|NCT01329042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102249|NCT00253643|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93102250|NCT00253643|Antioxidants|antioxidants|mesh-ancestor
93102251|NCT00253643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102252|NCT00253643|Protective Agents|protective agents|mesh-ancestor
93102253|NCT00253643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102254|NCT00253643|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93102255|NCT00253643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93102256|NCT00253643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102257|NCT00253643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93102258|NCT01222650|Silodosin|silodosin|mesh-list
93102259|NCT01222650|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93102260|NCT01222650|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93102261|NCT01222650|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93102262|NCT01222650|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102263|NCT01222650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102264|NCT01222650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102265|NCT01222650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102266|NCT01222650|Urological Agents|urological agents|mesh-ancestor
93102267|NCT04856488|Lugol's solution|lugol's solution|mesh-list
93102268|NCT04856488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93102269|NCT04856488|Hemostatics|hemostatics|mesh-ancestor
93102270|NCT04856488|Coagulants|coagulants|mesh-ancestor
93102271|NCT01073579|Vigabatrin|vigabatrin|mesh-list
93102272|NCT01073579|Anticonvulsants|anticonvulsants|mesh-ancestor
93102273|NCT01073579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102274|NCT01073579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102275|NCT01073579|GABA Agents|gaba agents|mesh-ancestor
93102276|NCT01073579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102277|NCT01073579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102278|NCT00221195|Thrombin|thrombin|mesh-list
93102279|NCT00221195|Hemostatics|hemostatics|mesh-ancestor
93102280|NCT00221195|Coagulants|coagulants|mesh-ancestor
93102281|NCT04646590|Vaccines|vaccines|mesh-list
93102282|NCT04646590|Immunologic Factors|immunologic factors|mesh-ancestor
93102283|NCT04646590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102284|NCT03931668|Maleic acid|maleic acid|mesh-list
93102285|NCT03931668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102286|NCT03931668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102287|NCT00220805|Immunoglobulins|immunoglobulins|mesh-list
93102288|NCT00220805|Antibodies|antibodies|mesh-list
93102289|NCT00220805|gamma-Globulins|gamma-globulins|mesh-list
93102290|NCT00220805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93102291|NCT00220805|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93102292|NCT00220805|Immunoglobulin G|immunoglobulin g|mesh-list
93102293|NCT00220805|Immunologic Factors|immunologic factors|mesh-ancestor
93102294|NCT00220805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102295|NCT00220727|Immunoglobulins|immunoglobulins|mesh-list
93102296|NCT00220727|Antibodies|antibodies|mesh-list
93102297|NCT00220727|gamma-Globulins|gamma-globulins|mesh-list
93102298|NCT00220727|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93102299|NCT00220727|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93102300|NCT00220727|Immunoglobulin G|immunoglobulin g|mesh-list
93102301|NCT00220727|Immunologic Factors|immunologic factors|mesh-ancestor
93102302|NCT00220727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102303|NCT01072097|Atorvastatin|atorvastatin|mesh-list
93102304|NCT01072097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93102305|NCT01072097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93102306|NCT01072097|Antimetabolites|antimetabolites|mesh-ancestor
93102307|NCT01072097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102308|NCT01072097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93102309|NCT01072097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93102310|NCT01072097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102311|NCT05760430|Bevacizumab|bevacizumab|mesh-list
93102312|NCT05760430|Apatinib|apatinib|mesh-list
93102313|NCT05760430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102314|NCT05760430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102315|NCT05760430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93102316|NCT05760430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93102317|NCT05760430|Growth Substances|growth substances|mesh-ancestor
93102318|NCT05760430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102319|NCT05760430|Growth Inhibitors|growth inhibitors|mesh-ancestor
93102320|NCT05760430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93102321|NCT05760430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102322|NCT05760430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102323|NCT01221402|Niacin|niacin|mesh-list
93102324|NCT01221402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93102325|NCT01221402|Antimetabolites|antimetabolites|mesh-ancestor
93102326|NCT01221402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102327|NCT01221402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93102328|NCT01221402|Vasodilator Agents|vasodilator agents|mesh-ancestor
93102329|NCT01221402|Vitamin B Complex|vitamin b complex|mesh-ancestor
93102330|NCT01221402|Vitamins|vitamins|mesh-ancestor
93102331|NCT01221402|Micronutrients|micronutrients|mesh-ancestor
93102332|NCT01221402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102333|NCT04214860|Azacitidine|azacitidine|mesh-list
93102334|NCT04214860|Venetoclax|venetoclax|mesh-list
93102335|NCT04214860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102336|NCT04214860|Antimetabolites|antimetabolites|mesh-ancestor
93102337|NCT04214860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102338|NCT04214860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102339|NCT04214860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102340|NCT01127490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93102341|NCT01127490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93102342|NCT01127490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93102343|NCT01127490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102344|NCT01127490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102345|NCT01127490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102346|NCT01127490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102347|NCT01127490|Analgesics|analgesics|mesh-ancestor
93102348|NCT01127490|Sensory System Agents|sensory system agents|mesh-ancestor
93102349|NCT01127490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102350|NCT01127490|Antidepressive Agents|antidepressive agents|mesh-ancestor
93102351|NCT01127490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93102352|NCT01127490|Dopamine Agents|dopamine agents|mesh-ancestor
93102353|NCT01223040|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93102354|NCT01223040|Lubricant Eye Drops|lubricant eye drops|mesh-list
93102355|NCT01223040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93102356|NCT01126866|Bevacizumab|bevacizumab|mesh-list
93102357|NCT01126866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102358|NCT01126866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102359|NCT01126866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93102360|NCT01126866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93102361|NCT01126866|Growth Substances|growth substances|mesh-ancestor
93102362|NCT01126866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102363|NCT01126866|Growth Inhibitors|growth inhibitors|mesh-ancestor
93102364|NCT04103554|Valsartan|valsartan|mesh-list
93102365|NCT04103554|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93102366|NCT04103554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93102367|NCT04103554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93102368|NCT04103554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93102369|NCT04103554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102370|NCT03740568|Progesterone|progesterone|mesh-list
93102371|NCT03740568|Progestins|progestins|mesh-ancestor
93102372|NCT03740568|Hormones|hormones|mesh-ancestor
93102373|NCT03740568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102374|NCT03740568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102375|NCT00252239|Plasminogen|plasminogen|mesh-list
93102376|NCT00252239|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93102377|NCT00252239|Tenecteplase|tenecteplase|mesh-list
93102378|NCT00252239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93102379|NCT00252239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93102380|NCT00252239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102381|NCT01127022|Choline|choline|mesh-list
93102382|NCT01127022|Lipotropic Agents|lipotropic agents|mesh-ancestor
93102383|NCT01127022|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93102384|NCT01127022|Antimetabolites|antimetabolites|mesh-ancestor
93102385|NCT01127022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102386|NCT01127022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93102387|NCT01127022|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93102388|NCT01127022|Nootropic Agents|nootropic agents|mesh-ancestor
93102389|NCT01221558|Lycopene|lycopene|mesh-list
93102390|NCT01221558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102391|NCT01221558|Antioxidants|antioxidants|mesh-ancestor
93102392|NCT01221558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102393|NCT01221558|Protective Agents|protective agents|mesh-ancestor
93102394|NCT01221558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102395|NCT01221558|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93102396|NCT01221558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93102397|NCT01221558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102398|NCT01221636|Abatacept|abatacept|mesh-list
93102399|NCT01221636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93102400|NCT01221636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102401|NCT01221636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102402|NCT01221636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102403|NCT01221636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93102404|NCT01221636|Immunologic Factors|immunologic factors|mesh-ancestor
93102405|NCT01221636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102406|NCT01221636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102408|NCT05731804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93102409|NCT05731804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93102410|NCT05731804|Protease Inhibitors|protease inhibitors|mesh-ancestor
93102411|NCT05731804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102412|NCT05731804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102413|NCT05731804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93102414|NCT05731804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93102415|NCT05731804|Antiviral Agents|antiviral agents|mesh-ancestor
93102416|NCT05731804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102417|NCT05731804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93102418|NCT05731804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93102419|NCT01127568|Propranolol|propranolol|mesh-list
93102420|NCT01127568|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93102421|NCT01127568|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93102422|NCT01127568|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102423|NCT01127568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102424|NCT01127568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102425|NCT01127568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102426|NCT01127568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93102427|NCT01127568|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93102428|NCT01127568|Vasodilator Agents|vasodilator agents|mesh-ancestor
93102429|NCT03932292|Calcium|calcium|mesh-list
93102430|NCT03932292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93102431|NCT03932292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102432|NCT01127100|Fentanyl|fentanyl|mesh-list
93102433|NCT01127100|Gabapentin|gabapentin|mesh-list
93102434|NCT01127100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93102435|NCT01127100|Narcotics|narcotics|mesh-ancestor
93102436|NCT01127100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102437|NCT01127100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102438|NCT01127100|Analgesics|analgesics|mesh-ancestor
93102439|NCT01127100|Sensory System Agents|sensory system agents|mesh-ancestor
93102440|NCT01127100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102441|NCT01127100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93102442|NCT01127100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93102443|NCT01127100|Anesthetics, General|anesthetics, general|mesh-ancestor
93102444|NCT01127100|Anesthetics|anesthetics|mesh-ancestor
93102445|NCT01127100|Anticonvulsants|anticonvulsants|mesh-ancestor
93102446|NCT01127100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93102447|NCT01127100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93102448|NCT01127100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93102449|NCT01127100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93102450|NCT01127100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93102451|NCT01127100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102452|NCT01127100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102453|NCT01127100|Antimanic Agents|antimanic agents|mesh-ancestor
93102454|NCT01127178|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
93102455|NCT01127178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93102456|NCT01127178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102457|NCT01127178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102458|NCT01127178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102459|NCT01221792|Carvedilol|carvedilol|mesh-list
93102460|NCT01221792|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93102461|NCT01221792|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93102462|NCT01221792|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102463|NCT01221792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102464|NCT01221792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102465|NCT01221792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102466|NCT01221792|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93102467|NCT01221792|Antioxidants|antioxidants|mesh-ancestor
93102468|NCT01221792|Protective Agents|protective agents|mesh-ancestor
93102469|NCT01221792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93102470|NCT01221792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102471|NCT01221792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93102472|NCT01221792|Vasodilator Agents|vasodilator agents|mesh-ancestor
93102473|NCT01221792|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93102474|NCT01221792|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93102475|NCT03932526|Apatinib|apatinib|mesh-list
93102476|NCT03932526|Vinorelbine|vinorelbine|mesh-list
93102477|NCT03932526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102478|NCT03932526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774779|NCT01143402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102480|NCT03932526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102481|NCT03932526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93102482|NCT03932526|Tubulin Modulators|tubulin modulators|mesh-ancestor
93102483|NCT03932526|Antimitotic Agents|antimitotic agents|mesh-ancestor
93102484|NCT03932526|Mitosis Modulators|mitosis modulators|mesh-ancestor
93102485|NCT01127724|Vitamins|vitamins|mesh-list
93102486|NCT01127724|Vitamin B 12|vitamin b 12|mesh-list
93102487|NCT01127724|Hydroxocobalamin|hydroxocobalamin|mesh-list
93102488|NCT01127724|Vitamin B Complex|vitamin b complex|mesh-list
93102489|NCT01127724|Micronutrients|micronutrients|mesh-ancestor
93102490|NCT01127724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102491|NCT01127724|Hematinics|hematinics|mesh-ancestor
93102492|NCT03103906|Sunscreening Agents|sunscreening agents|mesh-list
93102493|NCT03103906|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93102494|NCT03103906|Protective Agents|protective agents|mesh-ancestor
93102495|NCT03103906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102496|NCT03103906|Dermatologic Agents|dermatologic agents|mesh-ancestor
93102497|NCT05675098|Methylphenidate|methylphenidate|mesh-list
93102498|NCT05675098|Modafinil|modafinil|mesh-list
93102499|NCT05675098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93102500|NCT05675098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102501|NCT05675098|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93102502|NCT05675098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93102503|NCT05675098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102504|NCT05675098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102505|NCT05675098|Dopamine Agents|dopamine agents|mesh-ancestor
93102506|NCT05675098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102507|NCT05675098|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93102508|NCT05675098|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93102509|NCT05675098|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93102510|NCT01223742|Acetylcarnitine|acetylcarnitine|mesh-list
93102511|NCT01223742|Vitamin B Complex|vitamin b complex|mesh-ancestor
93102512|NCT01223742|Vitamins|vitamins|mesh-ancestor
93102513|NCT01223742|Micronutrients|micronutrients|mesh-ancestor
93102514|NCT01223742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102515|NCT01223742|Nootropic Agents|nootropic agents|mesh-ancestor
93102516|NCT01129518|Vaccines|vaccines|mesh-list
93102517|NCT01129518|Immunologic Factors|immunologic factors|mesh-ancestor
93102518|NCT01129518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102519|NCT01223820|Capsaicin|capsaicin|mesh-list
93102520|NCT01223820|Antipruritics|antipruritics|mesh-ancestor
93102521|NCT01223820|Dermatologic Agents|dermatologic agents|mesh-ancestor
93102522|NCT01223820|Sensory System Agents|sensory system agents|mesh-ancestor
93102523|NCT01223820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102524|NCT01223820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102525|NCT01131234|Cediranib|cediranib|mesh-list
93102526|NCT01131234|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93102527|NCT01131234|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93102528|NCT01131234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102529|NCT01131234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102530|NCT01131234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102531|NCT01131234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93102532|NCT01129596|Donepezil|donepezil|mesh-list
93102533|NCT01129596|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93102534|NCT01129596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102535|NCT01129596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102536|NCT01129596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92692784|NCT01247558|Vitamin B 12|vitamin b 12|mesh-list
93102537|NCT01129596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102538|NCT01129596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102539|NCT01129596|Nootropic Agents|nootropic agents|mesh-ancestor
93102540|NCT04680598|Antiviral Agents|antiviral agents|mesh-list
93102541|NCT04680598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102542|NCT01127880|Clindamycin|clindamycin|mesh-list
93102543|NCT01127880|Clindamycin palmitate|clindamycin palmitate|mesh-list
93102544|NCT01127880|Clindamycin phosphate|clindamycin phosphate|mesh-list
93102545|NCT01127880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93102546|NCT01127880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102547|NCT01127880|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93102548|NCT01127880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102549|NCT01127880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102550|NCT01228344|Lumefantrine|lumefantrine|mesh-list
93102551|NCT01228344|Artemether|artemether|mesh-list
92774859|NCT01167192|Carboplatin|carboplatin|mesh-list
93102552|NCT01228344|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93102553|NCT01228344|Antimalarials|antimalarials|mesh-ancestor
93102554|NCT01228344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93102555|NCT01228344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93102556|NCT01228344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102557|NCT03927456|Fulvestrant|fulvestrant|mesh-list
93102558|NCT03927456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93102559|NCT03927456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102560|NCT03927456|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93102561|NCT03927456|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93102562|NCT03927456|Hormone Antagonists|hormone antagonists|mesh-ancestor
93102563|NCT03927456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102564|NCT03927456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102565|NCT01129830|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93102566|NCT01129830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93102567|NCT01129830|Immunologic Factors|immunologic factors|mesh-ancestor
93102568|NCT01129830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102569|NCT01228422|Interferons|interferons|mesh-list
93102570|NCT01228422|Interferon-alpha|interferon-alpha|mesh-list
93102571|NCT01228422|Interferon alpha-2|interferon alpha-2|mesh-list
93102572|NCT01228422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102573|NCT01228422|Antiviral Agents|antiviral agents|mesh-ancestor
93102574|NCT01228422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102575|NCT01228422|Immunologic Factors|immunologic factors|mesh-ancestor
93102576|NCT01228422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102577|NCT01319422|Pomalidomide|pomalidomide|mesh-list
93102578|NCT01319422|Immunologic Factors|immunologic factors|mesh-ancestor
93102579|NCT01319422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102580|NCT01319422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93102581|NCT01319422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93102582|NCT01319422|Growth Substances|growth substances|mesh-ancestor
93102583|NCT01319422|Growth Inhibitors|growth inhibitors|mesh-ancestor
93102584|NCT01319422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102585|NCT01227174|Propofol|propofol|mesh-list
93102586|NCT01227174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93102587|NCT01227174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102588|NCT01227174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102589|NCT01227174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93102590|NCT01227174|Anesthetics, General|anesthetics, general|mesh-ancestor
93102591|NCT01227174|Anesthetics|anesthetics|mesh-ancestor
93102592|NCT05615974|Rituximab|rituximab|mesh-list
93102593|NCT05615974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102594|NCT05615974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102595|NCT05615974|Immunologic Factors|immunologic factors|mesh-ancestor
93102596|NCT05615974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102597|NCT05615974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102598|NCT03924492|Pregnanolone|pregnanolone|mesh-list
93102599|NCT03924492|Brexanolone|brexanolone|mesh-list
93102600|NCT03924492|Neurosteroids|neurosteroids|mesh-ancestor
93102601|NCT03924492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102602|NCT03924492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102603|NCT03924492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102604|NCT03924492|GABA Modulators|gaba modulators|mesh-ancestor
93102605|NCT03924492|GABA Agents|gaba agents|mesh-ancestor
93102606|NCT03924492|Anesthetics|anesthetics|mesh-ancestor
93102607|NCT03924492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102608|NCT01329276|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93102609|NCT01329276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93102610|NCT01329276|Respiratory System Agents|respiratory system agents|mesh-ancestor
93102611|NCT01224366|Vildagliptin|vildagliptin|mesh-list
93102612|NCT01224366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93102613|NCT01224366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102614|NCT01224366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93102615|NCT01224366|Protease Inhibitors|protease inhibitors|mesh-ancestor
93102616|NCT01224366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102617|NCT01224366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102618|NCT05415826|Dexamethasone|dexamethasone|mesh-list
93102619|NCT05415826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102620|NCT05415826|Antiemetics|antiemetics|mesh-ancestor
93102621|NCT05415826|Autonomic Agents|autonomic agents|mesh-ancestor
93102622|NCT05415826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102623|NCT05415826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102624|NCT05415826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774928|NCT01129284|Hormones|hormones|mesh-ancestor
93102625|NCT05415826|Glucocorticoids|glucocorticoids|mesh-ancestor
93102626|NCT05415826|Hormones|hormones|mesh-ancestor
93102627|NCT05415826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102628|NCT05415826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93102630|NCT05415748|Tamsulosin|tamsulosin|mesh-list
93102631|NCT05415748|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93102632|NCT05415748|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93102633|NCT05415748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93102634|NCT05415748|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102635|NCT05415748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102636|NCT05415748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102637|NCT05415748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102638|NCT05415748|Urological Agents|urological agents|mesh-ancestor
93102639|NCT03774576|Itraconazole|itraconazole|mesh-list
93102640|NCT03774576|Antifungal Agents|antifungal agents|mesh-ancestor
93102641|NCT03774576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102642|NCT03774576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93102643|NCT03774576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93102644|NCT03774576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102645|NCT03774576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102646|NCT03774576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93102647|NCT03774576|Hormone Antagonists|hormone antagonists|mesh-ancestor
93102648|NCT03774576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102649|NCT03774576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102650|NCT03774576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93102651|NCT05415436|Propofol|propofol|mesh-list
93102652|NCT05415436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93102653|NCT05415436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102654|NCT05415436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102655|NCT05415436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93102656|NCT05415436|Anesthetics, General|anesthetics, general|mesh-ancestor
93102657|NCT05415436|Anesthetics|anesthetics|mesh-ancestor
93102658|NCT01227408|Paclitaxel|paclitaxel|mesh-list
93102659|NCT01227408|Cyclophosphamide|cyclophosphamide|mesh-list
93102660|NCT01227408|Doxorubicin|doxorubicin|mesh-list
93102661|NCT01227408|Capecitabine|capecitabine|mesh-list
93102662|NCT01227408|Methotrexate|methotrexate|mesh-list
93102663|NCT01227408|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
93102664|NCT01227408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93102665|NCT01227408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102666|NCT01227408|Tubulin Modulators|tubulin modulators|mesh-ancestor
93102667|NCT01227408|Antimitotic Agents|antimitotic agents|mesh-ancestor
93102668|NCT01227408|Mitosis Modulators|mitosis modulators|mesh-ancestor
93102669|NCT01227408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102670|NCT01227408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93102671|NCT01227408|Immunologic Factors|immunologic factors|mesh-ancestor
93102672|NCT01227408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102673|NCT01227408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102674|NCT01227408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93102675|NCT01227408|Alkylating Agents|alkylating agents|mesh-ancestor
93102676|NCT01227408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93102677|NCT01227408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93102678|NCT01227408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93102679|NCT01227408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93102680|NCT01227408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102681|NCT01227408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102682|NCT01227408|Antimetabolites|antimetabolites|mesh-ancestor
93102683|NCT01227408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93102684|NCT01227408|Abortifacient Agents|abortifacient agents|mesh-ancestor
93102685|NCT01227408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93102686|NCT01227408|Dermatologic Agents|dermatologic agents|mesh-ancestor
93102687|NCT01227408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93102688|NCT01227408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93102689|NCT03773796|Nabilone|nabilone|mesh-list
93102690|NCT03773796|Antiemetics|antiemetics|mesh-ancestor
93102691|NCT03773796|Autonomic Agents|autonomic agents|mesh-ancestor
93102692|NCT03773796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102693|NCT03773796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102694|NCT03773796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93102695|NCT03773796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93102696|NCT03773796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93102697|NCT03773796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93102698|NCT03773796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93102699|NCT02927938|Cytarabine|cytarabine|mesh-list
93102700|NCT02927938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102701|NCT02927938|Antimetabolites|antimetabolites|mesh-ancestor
93102702|NCT02927938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102703|NCT02927938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102704|NCT02927938|Antiviral Agents|antiviral agents|mesh-ancestor
93102705|NCT02927938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102706|NCT02927938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93102707|NCT02927938|Immunologic Factors|immunologic factors|mesh-ancestor
93102708|NCT02927938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102709|NCT05370820|Tranexamic Acid|tranexamic acid|mesh-list
93102710|NCT05370820|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93102711|NCT05370820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93102712|NCT05370820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102713|NCT05370820|Hemostatics|hemostatics|mesh-ancestor
93102714|NCT05370820|Coagulants|coagulants|mesh-ancestor
93102715|NCT03863860|Fluzoparib|fluzoparib|mesh-list
93102716|NCT03863860|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93102717|NCT03863860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102718|NCT03863860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102719|NCT03863860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102720|NCT03923166|Capecitabine|capecitabine|mesh-list
93102721|NCT03923166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102722|NCT03923166|Antimetabolites|antimetabolites|mesh-ancestor
93102723|NCT03923166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102724|NCT03923166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102725|NCT01224756|Tinoridine|tinoridine|mesh-list
93102726|NCT01224756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93102727|NCT01224756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93102728|NCT01224756|Analgesics|analgesics|mesh-ancestor
93102729|NCT01224756|Sensory System Agents|sensory system agents|mesh-ancestor
93102730|NCT01224756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102731|NCT01224756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102732|NCT01224756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102733|NCT01224756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102734|NCT03392428|177Lu-PSMA-617|177lu-psma-617|mesh-list
93102735|NCT03392428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93102736|NCT03392428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102737|NCT03222856|Pembrolizumab|pembrolizumab|mesh-list
93102738|NCT03222856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102739|NCT03222856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102740|NCT03222856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93102741|NCT03222856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102742|NCT01130298|Testosterone|testosterone|mesh-list
93102743|NCT01130298|Androgens|androgens|mesh-ancestor
93102744|NCT01130298|Hormones|hormones|mesh-ancestor
93102745|NCT01130298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102746|NCT01130298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102747|NCT01227720|Nicotine|nicotine|mesh-list
93102748|NCT01227720|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93102749|NCT01227720|Autonomic Agents|autonomic agents|mesh-ancestor
93102750|NCT01227720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102751|NCT01227720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102752|NCT01227720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93102753|NCT01227720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93102754|NCT01227720|Cholinergic Agents|cholinergic agents|mesh-ancestor
93102755|NCT01227720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102756|NCT01227720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102757|NCT03175978|Methotrexate|methotrexate|mesh-list
93102758|NCT03175978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102759|NCT03175978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93102760|NCT03175978|Abortifacient Agents|abortifacient agents|mesh-ancestor
93102761|NCT03175978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93102762|NCT03175978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102763|NCT03175978|Antimetabolites|antimetabolites|mesh-ancestor
93102764|NCT03175978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102765|NCT03175978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102766|NCT03175978|Dermatologic Agents|dermatologic agents|mesh-ancestor
93102767|NCT03175978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102768|NCT03175978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93102769|NCT03175978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93102770|NCT03175978|Immunologic Factors|immunologic factors|mesh-ancestor
93102771|NCT03175978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102772|NCT03175978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93102773|NCT03923010|Itraconazole|itraconazole|mesh-list
93102774|NCT03923010|Antifungal Agents|antifungal agents|mesh-ancestor
93102775|NCT03923010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102776|NCT03923010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93102777|NCT03923010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93102778|NCT03923010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102779|NCT03923010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102780|NCT03923010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93102781|NCT03923010|Hormone Antagonists|hormone antagonists|mesh-ancestor
93102782|NCT03923010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102783|NCT03923010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102784|NCT03923010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93102785|NCT01227798|Interferons|interferons|mesh-list
93102786|NCT01227798|Interferon alfacon-1|interferon alfacon-1|mesh-list
93102787|NCT01227798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102788|NCT01227798|Antiviral Agents|antiviral agents|mesh-ancestor
93102789|NCT01227798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102790|NCT01130376|Aldesleukin|aldesleukin|mesh-list
93102791|NCT01130376|Interleukin-2|interleukin-2|mesh-list
93102792|NCT01130376|Hormones|hormones|mesh-list
93102793|NCT01130376|Sargramostim|sargramostim|mesh-list
93102794|NCT01130376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102795|NCT01130376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102796|NCT01130376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102797|NCT01130376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93102798|NCT01130376|Analgesics|analgesics|mesh-ancestor
93102799|NCT01130376|Sensory System Agents|sensory system agents|mesh-ancestor
93102800|NCT01130376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102801|NCT01130376|Immunologic Factors|immunologic factors|mesh-ancestor
93102802|NCT01130376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93102803|NCT01130376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93102804|NCT01130376|Antiviral Agents|antiviral agents|mesh-ancestor
93102805|NCT01130376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102806|NCT03740178|Donepezil|donepezil|mesh-list
93102807|NCT03740178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93102808|NCT03740178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102809|NCT03740178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102810|NCT03740178|Cholinergic Agents|cholinergic agents|mesh-ancestor
93102811|NCT03740178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102812|NCT03740178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102813|NCT03740178|Nootropic Agents|nootropic agents|mesh-ancestor
93102814|NCT01131468|Acetylcysteine|acetylcysteine|mesh-list
93102815|NCT01131468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93102816|NCT01131468|Antiviral Agents|antiviral agents|mesh-ancestor
93102817|NCT01131468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102818|NCT01131468|Expectorants|expectorants|mesh-ancestor
93102819|NCT01131468|Respiratory System Agents|respiratory system agents|mesh-ancestor
93102820|NCT01131468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93102821|NCT01131468|Antioxidants|antioxidants|mesh-ancestor
93102822|NCT01131468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102823|NCT01131468|Protective Agents|protective agents|mesh-ancestor
93102824|NCT01131468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102825|NCT01131468|Antidotes|antidotes|mesh-ancestor
93102826|NCT01225224|Peficitinib|peficitinib|mesh-list
93102827|NCT01225224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102828|NCT01225224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102829|NCT01225224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93102830|NCT01225224|Immunologic Factors|immunologic factors|mesh-ancestor
93102831|NCT01225224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102832|NCT01131546|Amlodipine|amlodipine|mesh-list
93102833|NCT01131546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93102834|NCT01131546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93102835|NCT01131546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93102836|NCT01131546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102837|NCT01131546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93102838|NCT01131546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102839|NCT01131546|Vasodilator Agents|vasodilator agents|mesh-ancestor
93102840|NCT01225302|Paclitaxel|paclitaxel|mesh-list
93102841|NCT01225302|Carboplatin|carboplatin|mesh-list
93102842|NCT01225302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93102843|NCT01225302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102844|NCT01225302|Tubulin Modulators|tubulin modulators|mesh-ancestor
93102845|NCT01225302|Antimitotic Agents|antimitotic agents|mesh-ancestor
93102846|NCT01225302|Mitosis Modulators|mitosis modulators|mesh-ancestor
93102847|NCT01225302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102849|NCT01229046|Clavulanic Acid|clavulanic acid|mesh-list
93102850|NCT01229046|Ticarcillin|ticarcillin|mesh-list
93102851|NCT01229046|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
93102852|NCT01229046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93102853|NCT01229046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102854|NCT01229046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102855|NCT01229046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102856|NCT01229046|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93102857|NCT03921684|Capecitabine|capecitabine|mesh-list
93102858|NCT03921684|Nivolumab|nivolumab|mesh-list
93102859|NCT03921684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102860|NCT03921684|Antimetabolites|antimetabolites|mesh-ancestor
93102861|NCT03921684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102862|NCT03921684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102863|NCT03921684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102864|NCT03921684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93102865|NCT03929094|Paclitaxel|paclitaxel|mesh-list
93102866|NCT03929094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93102867|NCT03929094|Gemcitabine|gemcitabine|mesh-list
93102868|NCT03929094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93102869|NCT03929094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102870|NCT03929094|Tubulin Modulators|tubulin modulators|mesh-ancestor
93102871|NCT03929094|Antimitotic Agents|antimitotic agents|mesh-ancestor
93102872|NCT03929094|Mitosis Modulators|mitosis modulators|mesh-ancestor
93102873|NCT03929094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102874|NCT03929094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93102875|NCT03929094|Antimetabolites|antimetabolites|mesh-ancestor
93102876|NCT01131702|Ranitidine|ranitidine|mesh-list
93102877|NCT01131702|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93102878|NCT01131702|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93102879|NCT01131702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93102880|NCT01131702|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93102881|NCT01131702|Histamine Antagonists|histamine antagonists|mesh-ancestor
93102882|NCT01131702|Histamine Agents|histamine agents|mesh-ancestor
93102883|NCT01131702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102884|NCT01131702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102885|NCT01131702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102886|NCT01228110|Hydrocortisone|hydrocortisone|mesh-list
93102887|NCT01228110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102888|NCT03925818|Metronidazole|metronidazole|mesh-list
93102889|NCT03925818|Tetracycline|tetracycline|mesh-list
93102890|NCT03925818|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
93102891|NCT03925818|Pantoprazole|pantoprazole|mesh-list
93102892|NCT03925818|Bismuth|bismuth|mesh-list
93102893|NCT03925818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102894|NCT03925818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93102895|NCT03925818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93102896|NCT03925818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93102897|NCT03925818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93102898|NCT03925818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93102899|NCT03925818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93102900|NCT03925818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102901|NCT03925818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102902|NCT03925818|Antacids|antacids|mesh-ancestor
93102903|NCT03925818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93102904|NCT03925740|Listerine|listerine|mesh-list
93102905|NCT03925740|Fluorides|fluorides|mesh-list
93102906|NCT03925740|Sodium Fluoride|sodium fluoride|mesh-list
93102907|NCT03925740|Cariostatic Agents|cariostatic agents|mesh-ancestor
93102908|NCT03925740|Protective Agents|protective agents|mesh-ancestor
93102909|NCT03925740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102910|NCT03925740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93102911|NCT03925740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102912|NCT01130688|Zileuton|zileuton|mesh-list
93102913|NCT01130688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93102914|NCT01130688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93102915|NCT01130688|Analgesics|analgesics|mesh-ancestor
93102916|NCT01130688|Sensory System Agents|sensory system agents|mesh-ancestor
93102917|NCT01130688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102918|NCT01130688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102919|NCT01130688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102920|NCT01130688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102921|NCT01130688|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93102922|NCT01130688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102923|NCT01130688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102924|NCT01130688|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93102925|NCT01130688|Hormone Antagonists|hormone antagonists|mesh-ancestor
93102926|NCT01130688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93102928|NCT03925662|Piperazine|piperazine|mesh-list
93102929|NCT03925662|Piperazine citrate|piperazine citrate|mesh-list
93102930|NCT03925662|Bevacizumab|bevacizumab|mesh-list
93102931|NCT03925662|DMP 777|dmp 777|mesh-list
93102932|NCT03925662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102933|NCT03925662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102934|NCT03925662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93102935|NCT03925662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93102936|NCT03925662|Growth Substances|growth substances|mesh-ancestor
93102937|NCT03925662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102938|NCT03925662|Growth Inhibitors|growth inhibitors|mesh-ancestor
93102939|NCT03925662|Antinematodal Agents|antinematodal agents|mesh-ancestor
93102940|NCT03925662|Anthelmintics|anthelmintics|mesh-ancestor
93102941|NCT03925662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93102942|NCT03925662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102943|NCT03925662|Tubulin Modulators|tubulin modulators|mesh-ancestor
93102944|NCT03925662|Antimitotic Agents|antimitotic agents|mesh-ancestor
93102945|NCT03925662|Mitosis Modulators|mitosis modulators|mesh-ancestor
93102946|NCT03925662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102947|NCT03925662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102948|NCT01229202|Bevacizumab|bevacizumab|mesh-list
93102949|NCT01229202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93102950|NCT01229202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102951|NCT01229202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93102952|NCT01229202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93102953|NCT01229202|Growth Substances|growth substances|mesh-ancestor
93102954|NCT01229202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102955|NCT01229202|Growth Inhibitors|growth inhibitors|mesh-ancestor
93102956|NCT01229280|Darifenacin|darifenacin|mesh-list
93102957|NCT01229280|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93102958|NCT01229280|Cholinergic Agents|cholinergic agents|mesh-list
93102959|NCT01229280|Cholinergic Antagonists|cholinergic antagonists|mesh-list
93102960|NCT01229280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102961|NCT01229280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102962|NCT01229280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102963|NCT01229280|Urological Agents|urological agents|mesh-ancestor
93102964|NCT01131780|Ibuprofen|ibuprofen|mesh-list
93102965|NCT01131780|Pseudoephedrine|pseudoephedrine|mesh-list
93102966|NCT01131780|Ephedrine|ephedrine|mesh-list
93102967|NCT01131780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93102968|NCT01131780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93102969|NCT01131780|Analgesics|analgesics|mesh-ancestor
93102970|NCT01131780|Sensory System Agents|sensory system agents|mesh-ancestor
93102971|NCT01131780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93102972|NCT01131780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93102973|NCT01131780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93102974|NCT01131780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93102975|NCT01131780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93102976|NCT01131780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102977|NCT01131780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102978|NCT01131780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93102979|NCT01131780|Autonomic Agents|autonomic agents|mesh-ancestor
93102980|NCT01131780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93102981|NCT01131780|Respiratory System Agents|respiratory system agents|mesh-ancestor
93102982|NCT01131780|Nasal Decongestants|nasal decongestants|mesh-ancestor
93102983|NCT01131780|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93102984|NCT01131780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93102985|NCT01131780|Sympathomimetics|sympathomimetics|mesh-ancestor
93102986|NCT01131780|Adrenergic Agents|adrenergic agents|mesh-ancestor
93102987|NCT01131780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93102988|NCT01130922|Moxifloxacin|moxifloxacin|mesh-list
93102989|NCT01130922|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93102990|NCT01130922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93102991|NCT01130922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93102992|NCT01130922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93102993|NCT01130922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93102994|NCT01130922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93102995|NCT01130922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93102996|NCT01130922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93102997|NCT01130922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93102998|NCT01130922|Contraceptive Agents|contraceptive agents|mesh-ancestor
93102999|NCT01130922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103000|NCT01130922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103001|NCT01130922|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93103002|NCT01130922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93103003|NCT01130922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93103004|NCT01131000|Ibuprofen|ibuprofen|mesh-list
93103005|NCT01131000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93103006|NCT01131000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93103007|NCT01131000|Analgesics|analgesics|mesh-ancestor
93103008|NCT01131000|Sensory System Agents|sensory system agents|mesh-ancestor
93103009|NCT01131000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103010|NCT01131000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103011|NCT01131000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103012|NCT01131000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103013|NCT01131000|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93103014|NCT01131000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103015|NCT01131000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103016|NCT01132170|Valproic Acid|valproic acid|mesh-list
93103017|NCT01132170|Anticonvulsants|anticonvulsants|mesh-ancestor
93103018|NCT01132170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103019|NCT01132170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103020|NCT01132170|GABA Agents|gaba agents|mesh-ancestor
93103021|NCT01132170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103022|NCT01132170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103023|NCT01132170|Antimanic Agents|antimanic agents|mesh-ancestor
93103024|NCT01132170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93103025|NCT01132170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103026|NCT01132170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93103027|NCT03925428|Entinostat|entinostat|mesh-list
93103028|NCT03925428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93103029|NCT03925428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103030|NCT03925428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103031|NCT03925428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103032|NCT03920514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93103033|NCT03920514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103034|NCT03920514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103035|NCT03919812|Cholecalciferol|cholecalciferol|mesh-list
93103036|NCT03919812|Vitamin D|vitamin d|mesh-list
93103037|NCT03919812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93103038|NCT03919812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103039|NCT03919812|Vitamins|vitamins|mesh-ancestor
93103040|NCT03919812|Micronutrients|micronutrients|mesh-ancestor
93103041|NCT03919812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93103042|NCT03919656|Dapagliflozin|dapagliflozin|mesh-list
93103043|NCT03919656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93103044|NCT03919656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103045|NCT03919656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103046|NCT03919656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103047|NCT01132248|Mefloquine|mefloquine|mesh-list
93103048|NCT01132248|Antimalarials|antimalarials|mesh-ancestor
93103049|NCT01132248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93103050|NCT01132248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93103051|NCT01132248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103052|NCT01229592|Ethanol|ethanol|mesh-list
93103053|NCT01229592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93103054|NCT01229592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103055|NCT01229592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103056|NCT01229592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103057|NCT01131936|Amlodipine|amlodipine|mesh-list
93103058|NCT01131936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93103059|NCT01131936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93103060|NCT01131936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93103061|NCT01131936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103062|NCT01131936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93103063|NCT01131936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103064|NCT01131936|Vasodilator Agents|vasodilator agents|mesh-ancestor
93103065|NCT01132404|Leuprolide|leuprolide|mesh-list
93103066|NCT01132404|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93103067|NCT01132404|Fertility Agents|fertility agents|mesh-ancestor
93103068|NCT01132404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103069|NCT01132404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103070|NCT01132404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103071|NCT01132404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103072|NCT01231854|Cyclosporine|cyclosporine|mesh-list
93103073|NCT01231854|Alitretinoin|alitretinoin|mesh-list
93103074|NCT01231854|Cyclosporins|cyclosporins|mesh-list
92693329|NCT00502034|Analgesics|analgesics|mesh-ancestor
93103075|NCT01231854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103076|NCT01231854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103077|NCT01231854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93103078|NCT01231854|Immunologic Factors|immunologic factors|mesh-ancestor
93103079|NCT01231854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103080|NCT01231854|Antifungal Agents|antifungal agents|mesh-ancestor
93103081|NCT01231854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103082|NCT01231854|Dermatologic Agents|dermatologic agents|mesh-ancestor
93103083|NCT01231854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103084|NCT01231854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93103085|NCT01231854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103086|NCT01132638|Esomeprazole|esomeprazole|mesh-list
93103087|NCT01132638|Pantoprazole|pantoprazole|mesh-list
93103088|NCT01132638|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93103089|NCT01132638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103090|NCT01132638|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93103091|NCT01132638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103092|NCT01132638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103093|NCT05402124|Aspirin|aspirin|mesh-list
93103094|NCT05402124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93103095|NCT05402124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93103096|NCT05402124|Analgesics|analgesics|mesh-ancestor
93103097|NCT05402124|Sensory System Agents|sensory system agents|mesh-ancestor
93103098|NCT05402124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103099|NCT05402124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103100|NCT05402124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103101|NCT05402124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103102|NCT05402124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93103103|NCT05402124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93103104|NCT05402124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103105|NCT05402124|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93103106|NCT05402124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93103107|NCT05402124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103108|NCT05402124|Antipyretics|antipyretics|mesh-ancestor
93103109|NCT01134432|Prednisolone|prednisolone|mesh-list
93103110|NCT01134432|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93103111|NCT01134432|Methylprednisolone|methylprednisolone|mesh-list
93103112|NCT01134432|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93103113|NCT01134432|Prednisolone acetate|prednisolone acetate|mesh-list
93103114|NCT01134432|Rituximab|rituximab|mesh-list
93103115|NCT01134432|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93103116|NCT01134432|Prednisolone phosphate|prednisolone phosphate|mesh-list
93103117|NCT01134432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93103118|NCT01134432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103119|NCT01134432|Immunologic Factors|immunologic factors|mesh-ancestor
93103120|NCT01134432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103121|NCT01134432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103122|NCT01134432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103123|NCT01134432|Glucocorticoids|glucocorticoids|mesh-ancestor
93103124|NCT01134432|Hormones|hormones|mesh-ancestor
93103125|NCT01134432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103126|NCT01134432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103127|NCT01134432|Antiemetics|antiemetics|mesh-ancestor
93103128|NCT01134432|Autonomic Agents|autonomic agents|mesh-ancestor
93103129|NCT01134432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103130|NCT01134432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103131|NCT01134432|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93103132|NCT01134432|Protective Agents|protective agents|mesh-ancestor
93103133|NCT01232010|Mirodenafil|mirodenafil|mesh-list
93103134|NCT01232010|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93103135|NCT01232010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93103136|NCT01232010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103137|NCT01232010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103138|NCT01132716|Valacyclovir|valacyclovir|mesh-list
93103139|NCT01132716|Antiviral Agents|antiviral agents|mesh-ancestor
93103140|NCT01132716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103141|NCT05401812|Glucocorticoids|glucocorticoids|mesh-list
93103142|NCT05401812|Hormones|hormones|mesh-ancestor
93103143|NCT05401812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103144|NCT05401812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103145|NCT01137708|Levonorgestrel|levonorgestrel|mesh-list
93103146|NCT01137708|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93103147|NCT01137708|Tofacitinib|tofacitinib|mesh-list
93103148|NCT01137708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93103149|NCT01137708|Contraceptive Agents|contraceptive agents|mesh-ancestor
93103150|NCT01137708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103151|NCT01137708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103152|NCT01137708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93103153|NCT01137708|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93103154|NCT01137708|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93103155|NCT01137708|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93103156|NCT01137708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93103157|NCT01137708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103158|NCT01137708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103159|NCT01137708|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93103160|NCT01137708|Estrogens|estrogens|mesh-ancestor
93103161|NCT01137708|Hormones|hormones|mesh-ancestor
93103162|NCT01137708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103163|NCT03765138|Pramipexole|pramipexole|mesh-list
93103164|NCT03765138|Antioxidants|antioxidants|mesh-ancestor
93103165|NCT03765138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103166|NCT03765138|Protective Agents|protective agents|mesh-ancestor
93103167|NCT03765138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103168|NCT03765138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93103169|NCT03765138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93103170|NCT03765138|Dopamine Agonists|dopamine agonists|mesh-ancestor
93103171|NCT03765138|Dopamine Agents|dopamine agents|mesh-ancestor
93103172|NCT03765138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103173|NCT01134666|Cetuximab|cetuximab|mesh-list
93103174|NCT01134666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93103175|NCT01134666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103176|NCT03739788|Deucravacitinib|deucravacitinib|mesh-list
93103177|NCT03739788|Dermatologic Agents|dermatologic agents|mesh-ancestor
93103178|NCT03739788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93103179|NCT03739788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103180|NCT03739788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103181|NCT01137942|Metronidazole|metronidazole|mesh-list
93103182|NCT01137942|Clarithromycin|clarithromycin|mesh-list
93103183|NCT01137942|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93103184|NCT01137942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103185|NCT01137942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103186|NCT01137942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93103187|NCT01137942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93103188|NCT01137942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93103189|NCT01137942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103190|NCT01137942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103191|NCT01137942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93103192|NCT01137942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93103193|NCT01233492|Mannitol|mannitol|mesh-list
93103194|NCT01233492|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93103195|NCT01233492|Diuretics|diuretics|mesh-ancestor
93103196|NCT01233492|Natriuretic Agents|natriuretic agents|mesh-ancestor
93103197|NCT01233492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103198|NCT01135056|Sorafenib|sorafenib|mesh-list
93103199|NCT01135056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103200|NCT01135056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93103201|NCT01135056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103202|NCT01135056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103203|NCT01132794|Dexmedetomidine|dexmedetomidine|mesh-list
93103204|NCT01132794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93103205|NCT01132794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103206|NCT01132794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693464|NCT02952807|Oxytocics|oxytocics|mesh-ancestor
93103207|NCT01132794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93103208|NCT01132794|Analgesics|analgesics|mesh-ancestor
93103209|NCT01132794|Sensory System Agents|sensory system agents|mesh-ancestor
93103210|NCT01132794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103211|NCT01132794|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93103212|NCT01132794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93103213|NCT01132794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93103214|NCT01132794|Adrenergic Agents|adrenergic agents|mesh-ancestor
93103215|NCT01132794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103216|NCT01132794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103217|NCT01135212|Candesartan|candesartan|mesh-list
92775522|NCT05438498|Antiviral Agents|antiviral agents|mesh-ancestor
93103218|NCT01135212|Candesartan cilexetil|candesartan cilexetil|mesh-list
93103219|NCT01135212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93103220|NCT01135212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93103221|NCT01135212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93103222|NCT01135212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103223|NCT01233570|Tacrolimus|tacrolimus|mesh-list
93103224|NCT01233570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93103225|NCT01233570|Immunologic Factors|immunologic factors|mesh-ancestor
93103226|NCT01233570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103227|NCT01233570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93103228|NCT01233570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103229|NCT01233570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103230|NCT01135290|Petrolatum|petrolatum|mesh-list
93103231|NCT01135290|Emollients|emollients|mesh-ancestor
93103232|NCT01135290|Dermatologic Agents|dermatologic agents|mesh-ancestor
93103233|NCT01135446|Dapagliflozin|dapagliflozin|mesh-list
93103234|NCT01135446|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93103235|NCT01135446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103236|NCT01135446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103237|NCT01135446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103238|NCT01135602|Topiramate|topiramate|mesh-list
93103239|NCT01135602|Anticonvulsants|anticonvulsants|mesh-ancestor
93103240|NCT01135602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103241|NCT01135602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103242|NCT05308212|Vaccines|vaccines|mesh-list
93103243|NCT05308212|Immunologic Factors|immunologic factors|mesh-ancestor
93103244|NCT05308212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103245|NCT01138488|Insulin|insulin|mesh-list
93103246|NCT01138488|Insulin Aspart|insulin aspart|mesh-list
93103247|NCT01138488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103248|NCT01138488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103249|NCT01135680|Moxifloxacin|moxifloxacin|mesh-list
93103250|NCT01135680|Glycerol|glycerol|mesh-list
93103251|NCT01135680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103252|NCT01135680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103253|NCT01135680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93103254|NCT01135680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93103255|NCT01135680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103256|NCT01135680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103257|NCT01135680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103258|NCT01135680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103259|NCT01135680|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93103260|NCT01135680|Protective Agents|protective agents|mesh-ancestor
93103261|NCT01135758|Ketamine|ketamine|mesh-list
93103262|NCT01135758|Analgesics|analgesics|mesh-ancestor
93103263|NCT01135758|Sensory System Agents|sensory system agents|mesh-ancestor
93103264|NCT01135758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103265|NCT01135758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103266|NCT01135758|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93103267|NCT01135758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93103268|NCT01135758|Anesthetics, General|anesthetics, general|mesh-ancestor
93103269|NCT01135758|Anesthetics|anesthetics|mesh-ancestor
93103270|NCT01135758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103271|NCT01135758|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93103272|NCT01135758|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93103273|NCT01135758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103274|NCT01135758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103275|NCT05401032|Tamsulosin|tamsulosin|mesh-list
93103276|NCT05401032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93103277|NCT05401032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93103278|NCT05401032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93103279|NCT05401032|Adrenergic Agents|adrenergic agents|mesh-ancestor
93103280|NCT05401032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103281|NCT05401032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103282|NCT05401032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103283|NCT05401032|Urological Agents|urological agents|mesh-ancestor
93103284|NCT03768726|Ziprasidone|ziprasidone|mesh-list
93103285|NCT03768726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93103286|NCT03768726|Serotonin Agents|serotonin agents|mesh-ancestor
93103287|NCT03768726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103288|NCT03768726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103289|NCT03768726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103290|NCT03768726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93103291|NCT03768726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93103292|NCT03768726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775596|NCT00648427|Serotonin Agents|serotonin agents|mesh-ancestor
93103293|NCT03768726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93103294|NCT03768726|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93103295|NCT03768726|Dopamine Agents|dopamine agents|mesh-ancestor
93103296|NCT01138956|Acetylcysteine|acetylcysteine|mesh-list
93103297|NCT01138956|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93103298|NCT01138956|Antiviral Agents|antiviral agents|mesh-ancestor
93103299|NCT01138956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103300|NCT01138956|Expectorants|expectorants|mesh-ancestor
93103301|NCT01138956|Respiratory System Agents|respiratory system agents|mesh-ancestor
93103302|NCT01138956|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93103303|NCT01138956|Antioxidants|antioxidants|mesh-ancestor
93103304|NCT01138956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103305|NCT01138956|Protective Agents|protective agents|mesh-ancestor
93103306|NCT01138956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103307|NCT01138956|Antidotes|antidotes|mesh-ancestor
93103308|NCT03917940|Glimepiride|glimepiride|mesh-list
93103309|NCT03917940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93103310|NCT03917940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103311|NCT03917940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103312|NCT03917940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93103313|NCT03917940|Immunologic Factors|immunologic factors|mesh-ancestor
93103314|NCT05287542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93103315|NCT05287542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103316|NCT05287542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103317|NCT01232244|Glucagon|glucagon|mesh-list
93103318|NCT01232244|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93103319|NCT01232244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103320|NCT01232244|Hormones|hormones|mesh-ancestor
93103321|NCT01232244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103322|NCT01232244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103323|NCT01232244|Incretins|incretins|mesh-ancestor
93103324|NCT03917784|Curcumin|curcumin|mesh-list
93103325|NCT03917784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93103326|NCT03917784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93103327|NCT03917784|Analgesics|analgesics|mesh-ancestor
93103328|NCT03917784|Sensory System Agents|sensory system agents|mesh-ancestor
93103329|NCT03917784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103330|NCT03917784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103331|NCT03917784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103332|NCT03917784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103333|NCT03917784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103334|NCT03917784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103335|NCT03917784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103336|NCT01133496|Alendronate|alendronate|mesh-list
93103337|NCT01133496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93103338|NCT01133496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103339|NCT01232400|Esmolol|esmolol|mesh-list
93103340|NCT01232400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93103341|NCT01232400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93103342|NCT01232400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93103343|NCT01232400|Adrenergic Agents|adrenergic agents|mesh-ancestor
93103344|NCT01232400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103345|NCT01232400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103346|NCT01232400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103347|NCT02528760|Erythromycin|erythromycin|mesh-list
92693604|NCT01249547|Axitinib|axitinib|mesh-list
93103348|NCT02528760|Erythromycin Estolate|erythromycin estolate|mesh-list
93103349|NCT02528760|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93103350|NCT02528760|Erythromycin stearate|erythromycin stearate|mesh-list
93103351|NCT02528760|Metoclopramide|metoclopramide|mesh-list
93103352|NCT02528760|Antiemetics|antiemetics|mesh-ancestor
93103353|NCT02528760|Autonomic Agents|autonomic agents|mesh-ancestor
93103354|NCT02528760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103355|NCT02528760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103356|NCT02528760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103357|NCT02528760|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93103358|NCT02528760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93103359|NCT02528760|Dopamine Agents|dopamine agents|mesh-ancestor
93103360|NCT02528760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103361|NCT02528760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103362|NCT02528760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103363|NCT02528760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103364|NCT02528760|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93103365|NCT02528760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103366|NCT05594472|Gentamicins|gentamicins|mesh-list
92775672|NCT04032691|Sympatholytics|sympatholytics|mesh-ancestor
93103367|NCT05594472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103368|NCT05594472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103369|NCT05594472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93103370|NCT05594472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103371|NCT05594472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103372|NCT01136538|Valacyclovir|valacyclovir|mesh-list
93103373|NCT01136538|Antiviral Agents|antiviral agents|mesh-ancestor
93103374|NCT01136538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103375|NCT03917628|Adalimumab|adalimumab|mesh-list
93103376|NCT03917628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93103377|NCT03917628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103378|NCT03917628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103379|NCT01329588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93103380|NCT01329588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103381|NCT01136850|Azithromycin|azithromycin|mesh-list
93103382|NCT01136850|Chloroquine|chloroquine|mesh-list
93103383|NCT01136850|Pyrimethamine|pyrimethamine|mesh-list
93103384|NCT01136850|Sulfadoxine|sulfadoxine|mesh-list
93103385|NCT01136850|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93103386|NCT01136850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103387|NCT01136850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103388|NCT01136850|Amebicides|amebicides|mesh-ancestor
93103389|NCT01136850|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93103390|NCT01136850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93103391|NCT01136850|Antimalarials|antimalarials|mesh-ancestor
93103392|NCT01136850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103393|NCT01136850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93103394|NCT01136850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103395|NCT01136850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103396|NCT01136850|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93103397|NCT01234116|Tenofovir|tenofovir|mesh-list
93103398|NCT01234116|Emtricitabine|emtricitabine|mesh-list
93103399|NCT01234116|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93103400|NCT01234116|Antiviral Agents|antiviral agents|mesh-ancestor
93103401|NCT01234116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103402|NCT01234116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93103403|NCT01234116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93103404|NCT01234116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103405|NCT01234116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103406|NCT01234116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93103407|NCT01234116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93103408|NCT03917004|Nitroglycerin|nitroglycerin|mesh-list
93103409|NCT03917004|Vasodilator Agents|vasodilator agents|mesh-ancestor
93103410|NCT01230996|Cisplatin|cisplatin|mesh-list
93103411|NCT01230996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103412|NCT01137084|Methylprednisolone|methylprednisolone|mesh-list
93103413|NCT01137084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93103414|NCT01137084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93103415|NCT01137084|Prednisolone|prednisolone|mesh-list
93103416|NCT01137084|Prednisolone acetate|prednisolone acetate|mesh-list
93103417|NCT01137084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93103418|NCT01137084|Prednisolone phosphate|prednisolone phosphate|mesh-list
93103419|NCT01137084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103420|NCT01137084|Antiemetics|antiemetics|mesh-ancestor
93103421|NCT01137084|Autonomic Agents|autonomic agents|mesh-ancestor
93103422|NCT01137084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103423|NCT01137084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103424|NCT01137084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103425|NCT01137084|Glucocorticoids|glucocorticoids|mesh-ancestor
93103426|NCT01137084|Hormones|hormones|mesh-ancestor
93103427|NCT01137084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103428|NCT01137084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93103429|NCT01137084|Protective Agents|protective agents|mesh-ancestor
93103430|NCT01137084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103431|NCT01137084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103432|NCT01133886|Decitabine|decitabine|mesh-list
93103433|NCT01133886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93103434|NCT01133886|Antimetabolites|antimetabolites|mesh-ancestor
93103435|NCT01133886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103436|NCT01133886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103437|NCT01133886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103438|NCT01140126|UB-421|ub-421|mesh-list
93103439|NCT01140126|Antibodies|antibodies|mesh-list
93103440|NCT01140126|Immunologic Factors|immunologic factors|mesh-ancestor
93103441|NCT01140126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103442|NCT01140126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93103443|NCT01140126|Antiviral Agents|antiviral agents|mesh-ancestor
93103444|NCT01140126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103445|NCT01231074|Metformin|metformin|mesh-list
93103446|NCT01231074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103447|NCT01231074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103448|NCT03917394|Iron|iron|mesh-list
93103449|NCT03917394|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93103450|NCT03917394|Trace Elements|trace elements|mesh-ancestor
93103451|NCT03917394|Micronutrients|micronutrients|mesh-ancestor
93103452|NCT03917394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103453|NCT03917394|Hematinics|hematinics|mesh-ancestor
93103454|NCT03769896|Nabilone|nabilone|mesh-list
93103455|NCT03769896|Antiemetics|antiemetics|mesh-ancestor
93103456|NCT03769896|Autonomic Agents|autonomic agents|mesh-ancestor
93103457|NCT03769896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103458|NCT03769896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103459|NCT03769896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103460|NCT03769896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93103461|NCT03769896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93103462|NCT03769896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103463|NCT03769896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93103464|NCT01234194|Remifentanil|remifentanil|mesh-list
93103465|NCT01234194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93103466|NCT01234194|Narcotics|narcotics|mesh-ancestor
93103467|NCT01234194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103468|NCT01234194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103469|NCT01234194|Analgesics|analgesics|mesh-ancestor
93103470|NCT01234194|Sensory System Agents|sensory system agents|mesh-ancestor
93103471|NCT01234194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103472|NCT04913922|Nivolumab|nivolumab|mesh-list
93103473|NCT04913922|Relatlimab|relatlimab|mesh-list
93103474|NCT04913922|Azacitidine|azacitidine|mesh-list
93103475|NCT04913922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93103476|NCT04913922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103477|NCT04913922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93103478|NCT04913922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103479|NCT04913922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93103480|NCT04913922|Antimetabolites|antimetabolites|mesh-ancestor
93103481|NCT04913922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103482|NCT04910022|Lomustine|lomustine|mesh-list
93103483|NCT04910022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93103484|NCT04910022|Alkylating Agents|alkylating agents|mesh-ancestor
93103485|NCT04910022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103486|NCT04910022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103487|NCT05485662|Listerine|listerine|mesh-list
93103488|NCT05485662|Fluorides|fluorides|mesh-list
93103489|NCT05485662|Sodium Fluoride|sodium fluoride|mesh-list
93103490|NCT05485662|Cariostatic Agents|cariostatic agents|mesh-ancestor
93103491|NCT05485662|Protective Agents|protective agents|mesh-ancestor
93103492|NCT05485662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103493|NCT05485662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93103494|NCT05485662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103495|NCT01234272|Morphine|morphine|mesh-list
93103496|NCT01234272|Ropivacaine|ropivacaine|mesh-list
93103497|NCT01234272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93103498|NCT01234272|Narcotics|narcotics|mesh-ancestor
93103499|NCT01234272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103500|NCT01234272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103501|NCT01234272|Analgesics|analgesics|mesh-ancestor
93103502|NCT01234272|Sensory System Agents|sensory system agents|mesh-ancestor
93103503|NCT01234272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103504|NCT01234272|Anesthetics, Local|anesthetics, local|mesh-ancestor
93103505|NCT01234272|Anesthetics|anesthetics|mesh-ancestor
93103506|NCT01140438|Metformin|metformin|mesh-list
93103507|NCT01140438|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93103508|NCT01140438|Repaglinide|repaglinide|mesh-list
93103509|NCT01140438|Insulin, Isophane|insulin, isophane|mesh-list
93103510|NCT01140438|Isophane Insulin, Human|isophane insulin, human|mesh-list
93103511|NCT01140438|Isophane insulin, beef|isophane insulin, beef|mesh-list
93103512|NCT01140438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103513|NCT01140438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103514|NCT01140438|Incretins|incretins|mesh-ancestor
93103515|NCT01140438|Hormones|hormones|mesh-ancestor
93103516|NCT01140438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103517|NCT01140438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93103518|NCT01140438|Protease Inhibitors|protease inhibitors|mesh-ancestor
93103519|NCT01140438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103520|NCT01140438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103521|NCT01234506|Vitamin D|vitamin d|mesh-list
93103522|NCT01234506|Secoisolariciresinol|secoisolariciresinol|mesh-list
93103523|NCT01234506|Vitamins|vitamins|mesh-ancestor
93103524|NCT01234506|Micronutrients|micronutrients|mesh-ancestor
93103525|NCT01234506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103526|NCT01234506|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93103527|NCT01234506|Phytoestrogens|phytoestrogens|mesh-ancestor
93103528|NCT01234506|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93103529|NCT01234506|Estrogens|estrogens|mesh-ancestor
93103530|NCT01234506|Hormones|hormones|mesh-ancestor
93103531|NCT01234506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103532|NCT04751604|Niacinamide|niacinamide|mesh-list
93103533|NCT04751604|Niacin|niacin|mesh-list
93103534|NCT04751604|Nicotinic Acids|nicotinic acids|mesh-list
93103535|NCT04751604|Vitamin B Complex|vitamin b complex|mesh-ancestor
93103536|NCT04751604|Vitamins|vitamins|mesh-ancestor
93103537|NCT04751604|Micronutrients|micronutrients|mesh-ancestor
93103538|NCT04751604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103539|NCT04751604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93103540|NCT04751604|Antimetabolites|antimetabolites|mesh-ancestor
93103541|NCT04751604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103542|NCT04751604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93103543|NCT04751604|Vasodilator Agents|vasodilator agents|mesh-ancestor
93103544|NCT01231542|Rifampin|rifampin|mesh-list
93103545|NCT01231542|Rifabutin|rifabutin|mesh-list
93103546|NCT01231542|Dolutegravir|dolutegravir|mesh-list
93103547|NCT01231542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93103548|NCT01231542|Antitubercular Agents|antitubercular agents|mesh-ancestor
93103549|NCT01231542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103550|NCT01231542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103551|NCT01231542|Leprostatic Agents|leprostatic agents|mesh-ancestor
93103552|NCT01231542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93103553|NCT01231542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103554|NCT01231542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103555|NCT01231542|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93103556|NCT01231542|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93103557|NCT01231542|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93103558|NCT01231542|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93103559|NCT01231542|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93103560|NCT01231542|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93103561|NCT01231542|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93103562|NCT01231542|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93103563|NCT01231542|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93103564|NCT01231542|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93103565|NCT01231542|Antiviral Agents|antiviral agents|mesh-ancestor
93103566|NCT01231698|Esmolol|esmolol|mesh-list
93103567|NCT01231698|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93103568|NCT01231698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93103569|NCT01231698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93103570|NCT01231698|Adrenergic Agents|adrenergic agents|mesh-ancestor
93103571|NCT01231698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103572|NCT01231698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103573|NCT01231698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103574|NCT01142778|Bevacizumab|bevacizumab|mesh-list
93103575|NCT01142778|Trastuzumab|trastuzumab|mesh-list
93103576|NCT01142778|Docetaxel|docetaxel|mesh-list
93103577|NCT01142778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93103578|NCT01142778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103579|NCT01142778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93103580|NCT01142778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93103581|NCT01142778|Growth Substances|growth substances|mesh-ancestor
93103582|NCT01142778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103583|NCT01142778|Growth Inhibitors|growth inhibitors|mesh-ancestor
93103584|NCT01142778|Tubulin Modulators|tubulin modulators|mesh-ancestor
93103585|NCT01142778|Antimitotic Agents|antimitotic agents|mesh-ancestor
93103586|NCT01142778|Mitosis Modulators|mitosis modulators|mesh-ancestor
93103587|NCT01142778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103588|NCT01142934|Chlorhexidine|chlorhexidine|mesh-list
93103589|NCT01142934|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93103590|NCT01142934|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93103591|NCT01142934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103592|NCT01142934|Disinfectants|disinfectants|mesh-ancestor
93103593|NCT01142934|Dermatologic Agents|dermatologic agents|mesh-ancestor
93103594|NCT04722978|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93103595|NCT04722978|Moxifloxacin|moxifloxacin|mesh-list
93103596|NCT04722978|Carboplatin|carboplatin|mesh-list
93103597|NCT04722978|Gemcitabine|gemcitabine|mesh-list
92775894|NCT00649441|Quinapril|quinapril|mesh-list
93103598|NCT04722978|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93103599|NCT04722978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103600|NCT04722978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93103601|NCT04722978|Antimetabolites|antimetabolites|mesh-ancestor
93103602|NCT04722978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103603|NCT04722978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103604|NCT04722978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93103605|NCT04722978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93103606|NCT04722978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103607|NCT04722978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93103608|NCT04722978|Contraceptive Agents|contraceptive agents|mesh-ancestor
93103609|NCT04722978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103610|NCT04722978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103611|NCT04722978|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93103612|NCT04722978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93103613|NCT04722978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93103614|NCT01140828|Rabeprazole|rabeprazole|mesh-list
93103615|NCT01140828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93103616|NCT01140828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103617|NCT01140828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93103618|NCT01140828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103619|NCT01140828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103620|NCT01234740|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93103621|NCT01234740|Bafetinib|bafetinib|mesh-list
93103622|NCT01234740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93103623|NCT01234740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103624|NCT01234740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103625|NCT01234818|Levonorgestrel|levonorgestrel|mesh-list
93103626|NCT01234818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93103627|NCT01234818|Contraceptive Agents|contraceptive agents|mesh-ancestor
93103628|NCT01234818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103629|NCT01234818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103630|NCT01234818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93103631|NCT01234818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93103632|NCT01234818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93103633|NCT03714594|Dapagliflozin|dapagliflozin|mesh-list
93103634|NCT03714594|Saxagliptin|saxagliptin|mesh-list
93103635|NCT03714594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93103636|NCT03714594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103637|NCT03714594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103638|NCT03714594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103639|NCT03714594|Incretins|incretins|mesh-ancestor
93103640|NCT03714594|Hormones|hormones|mesh-ancestor
93103641|NCT03714594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103642|NCT03714594|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93103643|NCT03714594|Protease Inhibitors|protease inhibitors|mesh-ancestor
93103644|NCT03714594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103645|NCT04624776|Methylprednisolone|methylprednisolone|mesh-list
93103646|NCT04624776|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93103647|NCT04624776|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93103648|NCT04624776|Prednisolone|prednisolone|mesh-list
93103649|NCT04624776|Prednisolone acetate|prednisolone acetate|mesh-list
93103650|NCT04624776|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93103651|NCT04624776|Prednisolone phosphate|prednisolone phosphate|mesh-list
93103652|NCT04624776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103653|NCT04624776|Antiemetics|antiemetics|mesh-ancestor
93103654|NCT04624776|Autonomic Agents|autonomic agents|mesh-ancestor
93103655|NCT04624776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103656|NCT04624776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103657|NCT04624776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103658|NCT04624776|Glucocorticoids|glucocorticoids|mesh-ancestor
93103659|NCT04624776|Hormones|hormones|mesh-ancestor
93103660|NCT04624776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103661|NCT04624776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93103662|NCT04624776|Protective Agents|protective agents|mesh-ancestor
93103663|NCT04624776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103664|NCT04624776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103665|NCT01234896|Nicotine|nicotine|mesh-list
93103666|NCT01234896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93103667|NCT01234896|Autonomic Agents|autonomic agents|mesh-ancestor
93103668|NCT01234896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103669|NCT01234896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103670|NCT01234896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93103671|NCT01234896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93103672|NCT01234896|Cholinergic Agents|cholinergic agents|mesh-ancestor
93103673|NCT01234896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103674|NCT01234896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103675|NCT01238094|Simvastatin|simvastatin|mesh-list
93103676|NCT01238094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93103677|NCT01238094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93103678|NCT01238094|Antimetabolites|antimetabolites|mesh-ancestor
93103679|NCT01238094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103680|NCT01238094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93103681|NCT01238094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93103682|NCT01238094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103683|NCT01236612|Chloroquine|chloroquine|mesh-list
93103684|NCT01236612|Proguanil|proguanil|mesh-list
93103685|NCT01236612|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93103686|NCT01236612|Amebicides|amebicides|mesh-ancestor
93103687|NCT01236612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93103688|NCT01236612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93103689|NCT01236612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103690|NCT01236612|Antimalarials|antimalarials|mesh-ancestor
93103691|NCT01236612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103692|NCT01236612|Antimetabolites|antimetabolites|mesh-ancestor
93103693|NCT01236612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103694|NCT03633630|Magnesium Oxide|magnesium oxide|mesh-list
93103695|NCT03633630|Antacids|antacids|mesh-ancestor
93103696|NCT03633630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103697|NCT03633630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103698|NCT01234974|Everolimus|everolimus|mesh-list
93103699|NCT01234974|Pasireotide|pasireotide|mesh-list
93103700|NCT01234974|Somatostatin|somatostatin|mesh-list
93103701|NCT01234974|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93103702|NCT01234974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93103703|NCT01234974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103704|NCT01234974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103705|NCT01234974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93103706|NCT01234974|Immunologic Factors|immunologic factors|mesh-ancestor
93103707|NCT01234974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103708|NCT01234974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103709|NCT01234974|Hormones|hormones|mesh-ancestor
93103710|NCT01234974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103711|NCT01140984|Methylprednisolone|methylprednisolone|mesh-list
93103712|NCT01140984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93103713|NCT01140984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93103714|NCT01140984|Prednisolone|prednisolone|mesh-list
93103715|NCT01140984|Prednisolone acetate|prednisolone acetate|mesh-list
93103716|NCT01140984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93103717|NCT01140984|Prednisolone phosphate|prednisolone phosphate|mesh-list
93103718|NCT01140984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103719|NCT01140984|Antiemetics|antiemetics|mesh-ancestor
93103720|NCT01140984|Autonomic Agents|autonomic agents|mesh-ancestor
93103721|NCT01140984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103722|NCT01140984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103723|NCT01140984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103724|NCT01140984|Glucocorticoids|glucocorticoids|mesh-ancestor
93103725|NCT01140984|Hormones|hormones|mesh-ancestor
93103726|NCT01140984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103727|NCT01140984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93103728|NCT01140984|Protective Agents|protective agents|mesh-ancestor
93103729|NCT01140984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103730|NCT01140984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103731|NCT01145430|Doxorubicin|doxorubicin|mesh-list
93103732|NCT01145430|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93103733|NCT01145430|Veliparib|veliparib|mesh-list
93103734|NCT01145430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93103735|NCT01145430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103736|NCT01145430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93103737|NCT01145430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93103738|NCT01145430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103739|NCT01145430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103740|NCT01145430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93103741|NCT03389724|Captopril|captopril|mesh-list
93103742|NCT03389724|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93103743|NCT03389724|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776045|NCT00650455|Naproxen|naproxen|mesh-list
93103744|NCT03389724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103745|NCT03389724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103746|NCT03389724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93103748|NCT01586052|Hematinics|hematinics|mesh-ancestor
93103749|NCT03684564|Warfarin|warfarin|mesh-list
93103750|NCT03684564|Rivaroxaban|rivaroxaban|mesh-list
93103751|NCT03684564|Anticoagulants|anticoagulants|mesh-ancestor
93103752|NCT03684564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93103753|NCT03684564|Antithrombins|antithrombins|mesh-ancestor
93103754|NCT03684564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92693997|NCT01244984|Xhance|xhance|mesh-list
93103755|NCT03684564|Protease Inhibitors|protease inhibitors|mesh-ancestor
93103756|NCT03684564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103757|NCT03684564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103758|NCT05796635|Allantoin|allantoin|mesh-list
93103759|NCT05796635|Dermatologic Agents|dermatologic agents|mesh-ancestor
93103760|NCT05796362|Azithromycin|azithromycin|mesh-list
93103761|NCT05796362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103762|NCT05796362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103763|NCT05796115|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93103764|NCT05796115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93103765|NCT05796115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103766|NCT05796115|Antitubercular Agents|antitubercular agents|mesh-ancestor
93103767|NCT05795946|Vitamin D|vitamin d|mesh-list
93103768|NCT05795946|Vitamins|vitamins|mesh-ancestor
93103769|NCT05795946|Micronutrients|micronutrients|mesh-ancestor
93103770|NCT05795946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103771|NCT05795946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93103772|NCT05795920|Gemcitabine|gemcitabine|mesh-list
93103773|NCT05795920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93103774|NCT05795920|Antimetabolites|antimetabolites|mesh-ancestor
93103775|NCT05795920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103776|NCT05795920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103777|NCT05849246|Cisplatin|cisplatin|mesh-list
93103778|NCT05849246|Carboplatin|carboplatin|mesh-list
93103779|NCT05849246|Pemetrexed|pemetrexed|mesh-list
93103780|NCT05849246|Maytansine|maytansine|mesh-list
93103781|NCT05849246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103782|NCT05849246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103783|NCT05849246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103784|NCT05849246|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93103785|NCT05849246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93103786|NCT05849246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93103787|NCT05849246|Tubulin Modulators|tubulin modulators|mesh-ancestor
93103788|NCT05849246|Antimitotic Agents|antimitotic agents|mesh-ancestor
93103789|NCT05849246|Mitosis Modulators|mitosis modulators|mesh-ancestor
93103790|NCT05849220|Dapagliflozin|dapagliflozin|mesh-list
93103791|NCT05849220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93103792|NCT05849220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103793|NCT05849220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103794|NCT05849220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103795|NCT05849090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93103796|NCT05849090|Vancomycin|vancomycin|mesh-list
93103797|NCT05849090|Clindamycin|clindamycin|mesh-list
93103798|NCT05849090|Clindamycin palmitate|clindamycin palmitate|mesh-list
93103799|NCT05849090|Clindamycin phosphate|clindamycin phosphate|mesh-list
93103800|NCT05849090|Cefazolin|cefazolin|mesh-list
93103801|NCT05849090|Ceftriaxone|ceftriaxone|mesh-list
93103802|NCT05849090|Tobramycin|tobramycin|mesh-list
93103803|NCT05849090|Cephalosporins|cephalosporins|mesh-list
93103804|NCT05849090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93103805|NCT05849090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103806|NCT05849090|Antitubercular Agents|antitubercular agents|mesh-ancestor
93103807|NCT05849090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93103808|NCT05849090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103809|NCT05849090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103810|NCT05848869|Misoprostol|misoprostol|mesh-list
93103811|NCT05848869|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93103812|NCT05848869|Abortifacient Agents|abortifacient agents|mesh-ancestor
93103813|NCT05848869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103814|NCT05848869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103815|NCT05848869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93103816|NCT05848869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103817|NCT05848869|Oxytocics|oxytocics|mesh-ancestor
92776116|NCT00650221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93103818|NCT05848713|Heparin|heparin|mesh-list
93103819|NCT05848713|Anticoagulants|anticoagulants|mesh-ancestor
93103820|NCT05848713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93103821|NCT05848713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93103822|NCT05848713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103823|NCT05848687|Dexamethasone|dexamethasone|mesh-list
93103824|NCT05848687|Methotrexate|methotrexate|mesh-list
93103825|NCT05848687|Bortezomib|bortezomib|mesh-list
93103826|NCT05848687|Asparaginase|asparaginase|mesh-list
93103827|NCT05848687|Mitoxantrone|mitoxantrone|mesh-list
93103828|NCT05848687|Mercaptopurine|mercaptopurine|mesh-list
93103829|NCT05848687|Vorinostat|vorinostat|mesh-list
93103830|NCT05848687|Blinatumomab|blinatumomab|mesh-list
93103831|NCT05848687|Pegaspargase|pegaspargase|mesh-list
93103832|NCT05848687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103833|NCT05848687|Antiemetics|antiemetics|mesh-ancestor
93103834|NCT05848687|Autonomic Agents|autonomic agents|mesh-ancestor
93103835|NCT05848687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103836|NCT05848687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103837|NCT05848687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93103838|NCT05848687|Glucocorticoids|glucocorticoids|mesh-ancestor
93103839|NCT05848687|Hormones|hormones|mesh-ancestor
93103840|NCT05848687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103841|NCT05848687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103842|NCT05848687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103843|NCT05848687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93103844|NCT05848687|Abortifacient Agents|abortifacient agents|mesh-ancestor
93103845|NCT05848687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93103846|NCT05848687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93103847|NCT05848687|Antimetabolites|antimetabolites|mesh-ancestor
93103848|NCT05848687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103849|NCT05848687|Dermatologic Agents|dermatologic agents|mesh-ancestor
93103850|NCT05848687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103851|NCT05848687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93103852|NCT05848687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93103853|NCT05848687|Immunologic Factors|immunologic factors|mesh-ancestor
93103854|NCT05848687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93103855|NCT05848687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93103856|NCT05848687|Analgesics|analgesics|mesh-ancestor
93103857|NCT05848687|Sensory System Agents|sensory system agents|mesh-ancestor
93103858|NCT05848687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93103859|NCT05848687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93103860|NCT05848687|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93103861|NCT05848635|Morphine|morphine|mesh-list
93103862|NCT05848635|Hydromorphone|hydromorphone|mesh-list
93103863|NCT05848635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93103864|NCT05848635|Narcotics|narcotics|mesh-ancestor
93103865|NCT05848635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103866|NCT05848635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103867|NCT05848635|Analgesics|analgesics|mesh-ancestor
93103868|NCT05848635|Sensory System Agents|sensory system agents|mesh-ancestor
93103869|NCT05848635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103870|NCT05848531|Clonidine|clonidine|mesh-list
93103871|NCT05848531|Analgesics|analgesics|mesh-ancestor
93103872|NCT05848531|Sensory System Agents|sensory system agents|mesh-ancestor
93103873|NCT05848531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103874|NCT05848531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103875|NCT05848531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93103876|NCT05848531|Sympatholytics|sympatholytics|mesh-ancestor
93103877|NCT05848531|Autonomic Agents|autonomic agents|mesh-ancestor
93103878|NCT05848531|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93103879|NCT05848531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93103880|NCT05848531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93103881|NCT05848531|Adrenergic Agents|adrenergic agents|mesh-ancestor
93103882|NCT05848531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103883|NCT05848531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103884|NCT05848505|Dexmedetomidine|dexmedetomidine|mesh-list
93103885|NCT05848505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93103886|NCT05848505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103887|NCT05848505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103888|NCT05848505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93103889|NCT05848505|Analgesics|analgesics|mesh-ancestor
93103890|NCT05848505|Sensory System Agents|sensory system agents|mesh-ancestor
93103891|NCT05848505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103892|NCT05848505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93103893|NCT05848505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93103894|NCT05848505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93103895|NCT05848505|Adrenergic Agents|adrenergic agents|mesh-ancestor
93103896|NCT05848505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93103897|NCT05848505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103898|NCT05848492|Fluconazole|fluconazole|mesh-list
93103899|NCT05848492|Antifungal Agents|antifungal agents|mesh-ancestor
93103900|NCT05848492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103901|NCT05848492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93103902|NCT05848492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93103903|NCT05848492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103904|NCT05848492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103905|NCT05848492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93103906|NCT05848492|Hormone Antagonists|hormone antagonists|mesh-ancestor
93103907|NCT05848492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103908|NCT05848492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103909|NCT05848492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93103910|NCT05848492|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93103911|NCT05848336|Caseins|caseins|mesh-list
93103912|NCT05848336|Chelating Agents|chelating agents|mesh-ancestor
93103913|NCT05848336|Sequestering Agents|sequestering agents|mesh-ancestor
93103914|NCT05848336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103915|NCT05848128|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93103916|NCT05848128|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93103917|NCT05848102|Dapagliflozin|dapagliflozin|mesh-list
93103918|NCT05848102|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93103919|NCT05848102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103920|NCT05848102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93103921|NCT05848102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103922|NCT05848011|Prednisone|prednisone|mesh-list
93103923|NCT05848011|Docetaxel|docetaxel|mesh-list
93103924|NCT05848011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103925|NCT05848011|Tubulin Modulators|tubulin modulators|mesh-ancestor
93103926|NCT05848011|Antimitotic Agents|antimitotic agents|mesh-ancestor
93103927|NCT05848011|Mitosis Modulators|mitosis modulators|mesh-ancestor
93103928|NCT05848011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103929|NCT05848011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93103930|NCT05848011|Glucocorticoids|glucocorticoids|mesh-ancestor
93103931|NCT05848011|Hormones|hormones|mesh-ancestor
93103932|NCT05848011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103933|NCT05848011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103934|NCT05848011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103935|NCT05847764|Carboplatin|carboplatin|mesh-list
93103936|NCT05847764|Tislelizumab|tislelizumab|mesh-list
93103937|NCT05847764|Aflutinib|aflutinib|mesh-list
93103938|NCT05847764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103939|NCT05847764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93103940|NCT05847764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93103941|NCT05847764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103942|NCT05847764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103943|NCT05846698|Tibolone|tibolone|mesh-list
93103944|NCT05846698|Androgen Antagonists|androgen antagonists|mesh-ancestor
93103945|NCT05846698|Hormone Antagonists|hormone antagonists|mesh-ancestor
93103946|NCT05846698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93103947|NCT05846698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103948|NCT05846698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93103949|NCT05846698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93103950|NCT05846698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103951|NCT05846698|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93103952|NCT05846698|Anabolic Agents|anabolic agents|mesh-ancestor
93103953|NCT05846698|Hormones|hormones|mesh-ancestor
93103954|NCT05846568|Immunoglobulins|immunoglobulins|mesh-list
93103955|NCT05846568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93103956|NCT05846568|Antibodies|antibodies|mesh-list
93103957|NCT05846568|Immunologic Factors|immunologic factors|mesh-ancestor
93103958|NCT05846568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103959|NCT05846451|Oxycodone|oxycodone|mesh-list
93103960|NCT05846451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93103961|NCT05846451|Narcotics|narcotics|mesh-ancestor
93103962|NCT05846451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93103963|NCT05846451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103964|NCT05846451|Analgesics|analgesics|mesh-ancestor
93103965|NCT05846451|Sensory System Agents|sensory system agents|mesh-ancestor
93103966|NCT05846451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93103967|NCT05846399|Amoxicillin|amoxicillin|mesh-list
93103968|NCT05846399|Ciprofloxacin|ciprofloxacin|mesh-list
93103969|NCT05846399|Clindamycin|clindamycin|mesh-list
93103970|NCT05846399|Clindamycin palmitate|clindamycin palmitate|mesh-list
93103971|NCT05846399|Clindamycin phosphate|clindamycin phosphate|mesh-list
92776265|NCT02650609|Antiemetics|antiemetics|mesh-ancestor
93103972|NCT05846399|Clavulanic Acid|clavulanic acid|mesh-list
93103973|NCT05846399|Clavulanic Acids|clavulanic acids|mesh-list
93103974|NCT05846399|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93103975|NCT05846399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93103976|NCT05846399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93103977|NCT05846399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93103978|NCT05846399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93103979|NCT05846399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93103980|NCT05846399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103981|NCT05846399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93103982|NCT05846399|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93103983|NCT05846399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93103984|NCT05846399|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93103985|NCT05846399|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93103986|NCT05846373|Niacin|niacin|mesh-list
93103987|NCT05846373|Niacinamide|niacinamide|mesh-list
93103988|NCT05846373|Nicotinic Acids|nicotinic acids|mesh-list
93103989|NCT05846373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93103990|NCT05846373|Antimetabolites|antimetabolites|mesh-ancestor
93103991|NCT05846373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93103992|NCT05846373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93103993|NCT05846373|Vasodilator Agents|vasodilator agents|mesh-ancestor
93103994|NCT05846373|Vitamin B Complex|vitamin b complex|mesh-ancestor
93103995|NCT05846373|Vitamins|vitamins|mesh-ancestor
93103996|NCT05846373|Micronutrients|micronutrients|mesh-ancestor
93103997|NCT05846373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93103998|NCT05846243|Vaccines|vaccines|mesh-list
93103999|NCT05846243|Immunologic Factors|immunologic factors|mesh-ancestor
93104000|NCT05846243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104001|NCT05846139|Chlorhexidine|chlorhexidine|mesh-list
93104002|NCT05846139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93104003|NCT05846139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104004|NCT05846139|Disinfectants|disinfectants|mesh-ancestor
93104005|NCT05845996|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93104006|NCT05845996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93104007|NCT05845996|Immunologic Factors|immunologic factors|mesh-ancestor
93104008|NCT05845996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104009|NCT05845723|Cyclophosphamide|cyclophosphamide|mesh-list
93104010|NCT05845723|Tofacitinib|tofacitinib|mesh-list
93104011|NCT05845723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104012|NCT05845723|Immunologic Factors|immunologic factors|mesh-ancestor
93104013|NCT05845723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104014|NCT05845723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104015|NCT05845723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93104016|NCT05845723|Alkylating Agents|alkylating agents|mesh-ancestor
93104017|NCT05845723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104018|NCT05845723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104019|NCT05845723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93104020|NCT05845723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93104021|NCT05845723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104022|NCT05845723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104023|NCT05845671|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
93104024|NCT05845671|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93104025|NCT05845671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104026|NCT05845671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104027|NCT05845671|Immunologic Factors|immunologic factors|mesh-ancestor
93104028|NCT05845671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104029|NCT05845567|Clarithromycin|clarithromycin|mesh-list
93104030|NCT05845567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93104031|NCT05845567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104032|NCT05845567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93104033|NCT05845567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104034|NCT05845567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104035|NCT05845567|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93104036|NCT05845567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93104037|NCT05845424|Ezetimibe|ezetimibe|mesh-list
93104038|NCT05845424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93104039|NCT05845424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93104040|NCT05845424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93104041|NCT05845424|Antimetabolites|antimetabolites|mesh-ancestor
93104042|NCT05845424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104043|NCT05845424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93104044|NCT05845424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104045|NCT05845385|Analgesics|analgesics|mesh-list
92776345|NCT00649675|Meloxicam|meloxicam|mesh-list
93104046|NCT05845385|Sensory System Agents|sensory system agents|mesh-ancestor
93104047|NCT05845385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104048|NCT05845385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104050|NCT05845359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93104051|NCT05845359|Narcotics|narcotics|mesh-ancestor
93104052|NCT05845359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104053|NCT05845359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104054|NCT05845359|Analgesics|analgesics|mesh-ancestor
93104055|NCT05845359|Sensory System Agents|sensory system agents|mesh-ancestor
93104056|NCT05845359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104057|NCT05845359|Antitussive Agents|antitussive agents|mesh-ancestor
93104058|NCT05845359|Respiratory System Agents|respiratory system agents|mesh-ancestor
93104059|NCT05845268|Tislelizumab|tislelizumab|mesh-list
93104060|NCT05845268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93104061|NCT05845268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104062|NCT05845268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104063|NCT05845268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104064|NCT05845125|Triamcinolone|triamcinolone|mesh-list
93104065|NCT05845125|Bupivacaine|bupivacaine|mesh-list
93104066|NCT05845125|Anesthetics, Local|anesthetics, local|mesh-ancestor
93104067|NCT05845125|Anesthetics|anesthetics|mesh-ancestor
93104068|NCT05845125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104069|NCT05845125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104070|NCT05845125|Sensory System Agents|sensory system agents|mesh-ancestor
93104071|NCT05845125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104072|NCT05845125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104073|NCT05845125|Glucocorticoids|glucocorticoids|mesh-ancestor
93104074|NCT05845125|Hormones|hormones|mesh-ancestor
93104075|NCT05845125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104076|NCT05844982|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93104077|NCT05844982|Faricimab|faricimab|mesh-list
93104078|NCT05844982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104079|NCT05844982|Glucocorticoids|glucocorticoids|mesh-ancestor
93104080|NCT05844982|Hormones|hormones|mesh-ancestor
93104081|NCT05844982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104082|NCT05844982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104083|NCT05844982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93104084|NCT05844982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93104085|NCT05844982|Growth Substances|growth substances|mesh-ancestor
93104086|NCT05844982|Growth Inhibitors|growth inhibitors|mesh-ancestor
93104087|NCT05844982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104088|NCT05844930|Triamcinolone|triamcinolone|mesh-list
93104089|NCT05844930|Lidocaine|lidocaine|mesh-list
93104090|NCT05844930|Anesthetics, Local|anesthetics, local|mesh-ancestor
93104091|NCT05844930|Anesthetics|anesthetics|mesh-ancestor
93104092|NCT05844930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104093|NCT05844930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104094|NCT05844930|Sensory System Agents|sensory system agents|mesh-ancestor
93104095|NCT05844930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104096|NCT05844930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93104097|NCT05844930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93104098|NCT05844930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93104099|NCT05844930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104100|NCT05844930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104101|NCT05844930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104102|NCT05844930|Glucocorticoids|glucocorticoids|mesh-ancestor
93104103|NCT05844930|Hormones|hormones|mesh-ancestor
93104104|NCT05844930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104105|NCT05844800|Bupivacaine|bupivacaine|mesh-list
93104106|NCT05844800|Anesthetics, Local|anesthetics, local|mesh-ancestor
93104107|NCT05844800|Anesthetics|anesthetics|mesh-ancestor
93104108|NCT05844800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104109|NCT05844800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104110|NCT05844800|Sensory System Agents|sensory system agents|mesh-ancestor
93104111|NCT05844800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104112|NCT05844683|Chlorhexidine|chlorhexidine|mesh-list
93104113|NCT05844683|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93104114|NCT05844683|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93104115|NCT05844683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104116|NCT05844683|Disinfectants|disinfectants|mesh-ancestor
93104117|NCT05844683|Dermatologic Agents|dermatologic agents|mesh-ancestor
93104118|NCT05844670|Vincristine|vincristine|mesh-list
93104119|NCT05844670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93104120|NCT05844670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104121|NCT05844670|Tubulin Modulators|tubulin modulators|mesh-ancestor
93104122|NCT05844670|Antimitotic Agents|antimitotic agents|mesh-ancestor
93104123|NCT05844670|Mitosis Modulators|mitosis modulators|mesh-ancestor
93104124|NCT05844670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104125|NCT05844657|Ferrous fumarate|ferrous fumarate|mesh-list
93104126|NCT05844657|Trace Elements|trace elements|mesh-ancestor
93104127|NCT05844657|Micronutrients|micronutrients|mesh-ancestor
93104128|NCT05844657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104129|NCT05844553|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93104130|NCT05844553|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93104131|NCT05844553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104132|NCT05844501|Ondansetron|ondansetron|mesh-list
93104133|NCT05844501|Antiemetics|antiemetics|mesh-ancestor
93104134|NCT05844501|Autonomic Agents|autonomic agents|mesh-ancestor
93104135|NCT05844501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104136|NCT05844501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104137|NCT05844501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104138|NCT05844501|Antipruritics|antipruritics|mesh-ancestor
93104139|NCT05844501|Dermatologic Agents|dermatologic agents|mesh-ancestor
93104140|NCT05844501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93104141|NCT05844501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93104142|NCT05844501|Serotonin Agents|serotonin agents|mesh-ancestor
93104143|NCT05844501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104144|NCT05844501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104145|NCT05844436|Pritelivir|pritelivir|mesh-list
93104146|NCT05844436|Antiviral Agents|antiviral agents|mesh-ancestor
93104147|NCT05844436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104148|NCT05844436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104149|NCT05844436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104150|NCT05844371|Oxaliplatin|oxaliplatin|mesh-list
93104151|NCT05844371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104152|NCT05844306|Deoxyglucose|deoxyglucose|mesh-list
93104153|NCT05844306|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93104154|NCT05844306|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93104155|NCT05844306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104156|NCT05844306|Antimetabolites|antimetabolites|mesh-ancestor
93104157|NCT05844306|Antiviral Agents|antiviral agents|mesh-ancestor
93104158|NCT05844306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104159|NCT05844150|Etoposide|etoposide|mesh-list
93104160|NCT05844150|Atezolizumab|atezolizumab|mesh-list
93104161|NCT05844150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93104162|NCT05844150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104163|NCT05844150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93104164|NCT05844150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93104165|NCT05844150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104166|NCT05844150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104167|NCT05844150|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104168|NCT05844150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104169|NCT05844046|Bevacizumab|bevacizumab|mesh-list
93104170|NCT05844046|Durvalumab|durvalumab|mesh-list
93104171|NCT05844046|Tremelimumab|tremelimumab|mesh-list
93104172|NCT05844046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104173|NCT05844046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104174|NCT05844046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93104175|NCT05844046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93104176|NCT05844046|Growth Substances|growth substances|mesh-ancestor
93104177|NCT05844046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104178|NCT05844046|Growth Inhibitors|growth inhibitors|mesh-ancestor
93104179|NCT05843838|Anesthetics|anesthetics|mesh-list
93104180|NCT05843838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104181|NCT05843838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104182|NCT05843812|Magnesium Sulfate|magnesium sulfate|mesh-list
93104183|NCT05843812|Analgesics|analgesics|mesh-ancestor
93104184|NCT05843812|Sensory System Agents|sensory system agents|mesh-ancestor
93104185|NCT05843812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104186|NCT05843812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104187|NCT05843812|Anesthetics|anesthetics|mesh-ancestor
93104188|NCT05843812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104189|NCT05843812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93104190|NCT05843812|Anticonvulsants|anticonvulsants|mesh-ancestor
93104191|NCT05843812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93104192|NCT05843812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104193|NCT05843812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104194|NCT05843812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93104195|NCT05843812|Tocolytic Agents|tocolytic agents|mesh-ancestor
93104196|NCT05843812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93104197|NCT05843786|Interferons|interferons|mesh-list
93104198|NCT05843786|Interferon-gamma|interferon-gamma|mesh-list
93104199|NCT05843786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104200|NCT05843786|Antiviral Agents|antiviral agents|mesh-ancestor
93104201|NCT05843786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104202|NCT05843617|Vitamins|vitamins|mesh-list
93104203|NCT05843617|Ascorbic Acid|ascorbic acid|mesh-list
93104204|NCT05843617|Micronutrients|micronutrients|mesh-ancestor
93104205|NCT05843617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104206|NCT05843617|Antioxidants|antioxidants|mesh-ancestor
93104207|NCT05843617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104208|NCT05843617|Protective Agents|protective agents|mesh-ancestor
93104209|NCT05843344|Dexmedetomidine|dexmedetomidine|mesh-list
93104210|NCT05843344|Morphine|morphine|mesh-list
93104211|NCT05843344|Ropivacaine|ropivacaine|mesh-list
93104212|NCT05843344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93104213|NCT05843344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104214|NCT05843344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104215|NCT05843344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93104216|NCT05843344|Analgesics|analgesics|mesh-ancestor
92694461|NCT02275299|Leflunomide|leflunomide|mesh-list
93104217|NCT05843344|Sensory System Agents|sensory system agents|mesh-ancestor
93104218|NCT05843344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104219|NCT05843344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93104220|NCT05843344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93104221|NCT05843344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93104222|NCT05843344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93104223|NCT05843344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104224|NCT05843344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104225|NCT05843344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93104226|NCT05843344|Narcotics|narcotics|mesh-ancestor
93104227|NCT05843344|Anesthetics, Local|anesthetics, local|mesh-ancestor
93104228|NCT05843344|Anesthetics|anesthetics|mesh-ancestor
93104229|NCT05843292|Carboplatin|carboplatin|mesh-list
93104231|NCT05843292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104232|NCT05843253|Everolimus|everolimus|mesh-list
93104233|NCT05843253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93104234|NCT05843253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104235|NCT05843253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104236|NCT05843253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104237|NCT05843253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104238|NCT05843253|Immunologic Factors|immunologic factors|mesh-ancestor
93104239|NCT05843253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104240|NCT05843253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104241|NCT05843188|Leucovorin|leucovorin|mesh-list
93104242|NCT05843188|Hydroxychloroquine|hydroxychloroquine|mesh-list
93104243|NCT05843188|Bevacizumab|bevacizumab|mesh-list
93104244|NCT05843188|Fluorouracil|fluorouracil|mesh-list
93104245|NCT05843188|Irinotecan|irinotecan|mesh-list
93104246|NCT05843188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104247|NCT05843188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104248|NCT05843188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93104249|NCT05843188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93104250|NCT05843188|Growth Substances|growth substances|mesh-ancestor
93104251|NCT05843188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104252|NCT05843188|Growth Inhibitors|growth inhibitors|mesh-ancestor
93104253|NCT05843188|Antimetabolites|antimetabolites|mesh-ancestor
93104254|NCT05843188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104255|NCT05843188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93104256|NCT05843188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104257|NCT05843188|Immunologic Factors|immunologic factors|mesh-ancestor
93104258|NCT05843188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93104259|NCT05843188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93104260|NCT05843188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104261|NCT05843188|Antidotes|antidotes|mesh-ancestor
93104262|NCT05843188|Protective Agents|protective agents|mesh-ancestor
93104263|NCT05843188|Vitamin B Complex|vitamin b complex|mesh-ancestor
93104264|NCT05843188|Vitamins|vitamins|mesh-ancestor
93104265|NCT05843188|Micronutrients|micronutrients|mesh-ancestor
93104266|NCT05843188|Antimalarials|antimalarials|mesh-ancestor
93104267|NCT05843188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93104268|NCT05843188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93104269|NCT05843188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104270|NCT05843188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104271|NCT05843162|Losartan|losartan|mesh-list
93104272|NCT05843162|Telmisartan|telmisartan|mesh-list
93104273|NCT05843162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93104274|NCT05843162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93104275|NCT05843162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93104276|NCT05843162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93104277|NCT05843162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104278|NCT05842954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93104279|NCT05842954|Antimalarials|antimalarials|mesh-ancestor
93104280|NCT05842954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93104281|NCT05842954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93104282|NCT05842954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104283|NCT05842759|Norepinephrine|norepinephrine|mesh-list
93104284|NCT05842759|Propofol|propofol|mesh-list
93104285|NCT05842759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93104286|NCT05842759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104287|NCT05842759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104288|NCT05842759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93104289|NCT05842759|Anesthetics, General|anesthetics, general|mesh-ancestor
93104290|NCT05842759|Anesthetics|anesthetics|mesh-ancestor
93104291|NCT05842759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93104292|NCT05842759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93104293|NCT05842759|Adrenergic Agents|adrenergic agents|mesh-ancestor
93104294|NCT05842759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104295|NCT05842759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104296|NCT05842759|Sympathomimetics|sympathomimetics|mesh-ancestor
93104297|NCT05842759|Autonomic Agents|autonomic agents|mesh-ancestor
93104298|NCT05842759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104299|NCT05842759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93104300|NCT05842681|Azithromycin|azithromycin|mesh-list
93104301|NCT05842681|Methylprednisolone|methylprednisolone|mesh-list
93104302|NCT05842681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93104303|NCT05842681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93104304|NCT05842681|Prednisolone|prednisolone|mesh-list
93104305|NCT05842681|Prednisolone acetate|prednisolone acetate|mesh-list
93104306|NCT05842681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93104307|NCT05842681|Prednisolone phosphate|prednisolone phosphate|mesh-list
93104308|NCT05842681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104309|NCT05842681|Antiemetics|antiemetics|mesh-ancestor
93104310|NCT05842681|Autonomic Agents|autonomic agents|mesh-ancestor
93104311|NCT05842681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104312|NCT05842681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104313|NCT05842681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104314|NCT05842681|Glucocorticoids|glucocorticoids|mesh-ancestor
93104315|NCT05842681|Hormones|hormones|mesh-ancestor
93104316|NCT05842681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104317|NCT05842681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93104318|NCT05842681|Protective Agents|protective agents|mesh-ancestor
93104319|NCT05842681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93104320|NCT05842681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104321|NCT05842681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93104322|NCT05842681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104323|NCT05842486|Antibodies|antibodies|mesh-list
93104324|NCT05842486|Immunologic Factors|immunologic factors|mesh-ancestor
93104325|NCT05842486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104326|NCT05842330|Methylphenidate|methylphenidate|mesh-list
93104327|NCT05842330|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93104328|NCT05842330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104329|NCT05842330|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93104330|NCT05842330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93104331|NCT05842330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104332|NCT05842330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104333|NCT05842330|Dopamine Agents|dopamine agents|mesh-ancestor
93104334|NCT05842330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104335|NCT05842317|Lenvatinib|lenvatinib|mesh-list
93104336|NCT05842317|Tislelizumab|tislelizumab|mesh-list
93104337|NCT05842317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104338|NCT05842317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104339|NCT05842317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104340|NCT05842317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104341|NCT05842317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104342|NCT05840848|Beta Carotene|beta carotene|mesh-list
93104343|NCT05840848|Carotenoids|carotenoids|mesh-list
93104344|NCT05840848|Antioxidants|antioxidants|mesh-ancestor
93104345|NCT05840848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104346|NCT05840848|Protective Agents|protective agents|mesh-ancestor
93104347|NCT05840848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104348|NCT05840848|Provitamins|provitamins|mesh-ancestor
93104349|NCT05840848|Vitamins|vitamins|mesh-ancestor
93104350|NCT05840848|Micronutrients|micronutrients|mesh-ancestor
93104351|NCT05840835|Tislelizumab|tislelizumab|mesh-list
93104352|NCT05840835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104353|NCT05840835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104354|NCT05840718|Thiamine|thiamine|mesh-list
93104355|NCT05840718|Vitamin B Complex|vitamin b complex|mesh-ancestor
93104356|NCT05840718|Vitamins|vitamins|mesh-ancestor
93104357|NCT05840718|Micronutrients|micronutrients|mesh-ancestor
93104358|NCT05840718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104359|NCT05840562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93104360|NCT05840562|Capsaicin|capsaicin|mesh-list
93104361|NCT05840562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93104362|NCT05840562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93104363|NCT05840562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104364|NCT05840562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104365|NCT05840562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104366|NCT05840562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104367|NCT05840562|Analgesics|analgesics|mesh-ancestor
93104368|NCT05840562|Sensory System Agents|sensory system agents|mesh-ancestor
93104369|NCT05840562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104370|NCT05840562|Antidepressive Agents|antidepressive agents|mesh-ancestor
93104371|NCT05840562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93104372|NCT05840562|Dopamine Agents|dopamine agents|mesh-ancestor
93104373|NCT05840562|Antipruritics|antipruritics|mesh-ancestor
93104374|NCT05840562|Dermatologic Agents|dermatologic agents|mesh-ancestor
93104375|NCT05840471|Tranexamic Acid|tranexamic acid|mesh-list
93104376|NCT05840471|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93104377|NCT05840471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93104378|NCT05840471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104379|NCT05840471|Hemostatics|hemostatics|mesh-ancestor
93104380|NCT05840471|Coagulants|coagulants|mesh-ancestor
93104381|NCT05840289|Rituximab|rituximab|mesh-list
93104382|NCT05840289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104383|NCT05840289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104384|NCT05840289|Immunologic Factors|immunologic factors|mesh-ancestor
93104385|NCT05840289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104386|NCT05840289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104387|NCT05839938|Vitamin D|vitamin d|mesh-list
93104388|NCT05839938|Vitamins|vitamins|mesh-ancestor
93104389|NCT05839938|Micronutrients|micronutrients|mesh-ancestor
93104390|NCT05839938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104391|NCT05839938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93104392|NCT05839756|Budesonide|budesonide|mesh-list
93104393|NCT05839756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104394|NCT05839756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93104395|NCT05839756|Autonomic Agents|autonomic agents|mesh-ancestor
93104396|NCT05839756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104397|NCT05839756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104398|NCT05839756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93104399|NCT05839756|Respiratory System Agents|respiratory system agents|mesh-ancestor
93104400|NCT05839756|Glucocorticoids|glucocorticoids|mesh-ancestor
93104401|NCT05839756|Hormones|hormones|mesh-ancestor
93104402|NCT05839756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104403|NCT05839314|Cyclosporine|cyclosporine|mesh-list
93104404|NCT05839314|Cyclosporins|cyclosporins|mesh-list
93104405|NCT05839314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104406|NCT05839314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104407|NCT05839314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104408|NCT05839314|Immunologic Factors|immunologic factors|mesh-ancestor
93104409|NCT05839314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104410|NCT05839314|Antifungal Agents|antifungal agents|mesh-ancestor
93104411|NCT05839314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104412|NCT05839314|Dermatologic Agents|dermatologic agents|mesh-ancestor
93104413|NCT05839314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104414|NCT05839314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93104415|NCT05837897|Vedolizumab|vedolizumab|mesh-list
93104416|NCT05837897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104417|NCT05836740|Minocycline|minocycline|mesh-list
93104418|NCT05836740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93104419|NCT05836740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104420|NCT05836571|Nivolumab|nivolumab|mesh-list
93104421|NCT05836571|Ipilimumab|ipilimumab|mesh-list
93104422|NCT05836571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104423|NCT05836571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104424|NCT05836571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104425|NCT05836571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104426|NCT05836272|Norepinephrine|norepinephrine|mesh-list
93104427|NCT05836272|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93104428|NCT05836272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93104429|NCT05836272|Adrenergic Agents|adrenergic agents|mesh-ancestor
93104430|NCT05836272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104431|NCT05836272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104432|NCT05836272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104433|NCT05836272|Sympathomimetics|sympathomimetics|mesh-ancestor
93104434|NCT05836272|Autonomic Agents|autonomic agents|mesh-ancestor
93104435|NCT05836272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104436|NCT05836272|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93104437|NCT05829499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93104438|NCT05829499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93104439|NCT05828095|MEDI9197|medi9197|mesh-list
93104440|NCT05828095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93104441|NCT05828095|Immunologic Factors|immunologic factors|mesh-ancestor
93104442|NCT05828095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104443|NCT05825573|Vitamin K|vitamin k|mesh-list
93104444|NCT05825573|Anticoagulants|anticoagulants|mesh-list
93104445|NCT05825573|Vitamins|vitamins|mesh-ancestor
93104446|NCT05825573|Micronutrients|micronutrients|mesh-ancestor
93104447|NCT05825573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104448|NCT05825573|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93104449|NCT05825573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93104450|NCT05825573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104451|NCT05825573|Hemostatics|hemostatics|mesh-ancestor
93104452|NCT05825573|Coagulants|coagulants|mesh-ancestor
93104453|NCT05825352|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93104454|NCT05825352|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93104455|NCT05824494|Paclitaxel|paclitaxel|mesh-list
93104456|NCT05824494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93104457|NCT05824494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104458|NCT05824494|Tubulin Modulators|tubulin modulators|mesh-ancestor
93104459|NCT05824494|Antimitotic Agents|antimitotic agents|mesh-ancestor
93104460|NCT05824494|Mitosis Modulators|mitosis modulators|mesh-ancestor
93104461|NCT05824494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104462|NCT05824000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93104463|NCT05824000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93104464|NCT05823961|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93104465|NCT05823961|Hyaluronic Acid|hyaluronic acid|mesh-list
93104466|NCT05823961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93104467|NCT05823961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93104468|NCT05823961|Immunologic Factors|immunologic factors|mesh-ancestor
93104469|NCT05823961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104470|NCT05823961|Viscosupplements|viscosupplements|mesh-ancestor
93104471|NCT05823961|Protective Agents|protective agents|mesh-ancestor
93104472|NCT05823506|Tadalafil|tadalafil|mesh-list
93104473|NCT05823506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
93104474|NCT05823506|Vasodilator Agents|vasodilator agents|mesh-ancestor
93104475|NCT05823506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93104476|NCT05823506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104477|NCT05823506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104478|NCT05823506|Urological Agents|urological agents|mesh-ancestor
93104479|NCT05822817|Propofol|propofol|mesh-list
93104480|NCT05822817|Sevoflurane|sevoflurane|mesh-list
93104481|NCT05822817|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93104482|NCT05822817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104483|NCT05822817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104484|NCT05822817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93104485|NCT05822817|Anesthetics, General|anesthetics, general|mesh-ancestor
93104486|NCT05822817|Anesthetics|anesthetics|mesh-ancestor
93104487|NCT05822817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93104488|NCT05822817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93104489|NCT05821075|Prednisolone|prednisolone|mesh-list
93104490|NCT05821075|Cerebrolysin|cerebrolysin|mesh-list
93104491|NCT05821075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104492|NCT05821075|Glucocorticoids|glucocorticoids|mesh-ancestor
93104493|NCT05821075|Hormones|hormones|mesh-ancestor
93104494|NCT05821075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104495|NCT05821075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104496|NCT05821075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93104497|NCT05821075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104498|NCT05821075|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92776789|NCT00632086|Analgesics|analgesics|mesh-ancestor
93104499|NCT05821075|Protective Agents|protective agents|mesh-ancestor
93104500|NCT05821075|Nootropic Agents|nootropic agents|mesh-ancestor
93104501|NCT05817903|Nivolumab|nivolumab|mesh-list
93104502|NCT05817903|Axitinib|axitinib|mesh-list
93104503|NCT05817903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104504|NCT05817903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104505|NCT05817903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104506|NCT05817903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104507|NCT05817903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104508|NCT05817903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104509|NCT05806931|Bevacizumab|bevacizumab|mesh-list
93104510|NCT05806931|Oxaliplatin|oxaliplatin|mesh-list
93104511|NCT05806931|Irinotecan|irinotecan|mesh-list
93104512|NCT05806931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104513|NCT05806931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104514|NCT05806931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93104515|NCT05806931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93104516|NCT05806931|Growth Substances|growth substances|mesh-ancestor
93104517|NCT05806931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104518|NCT05806931|Growth Inhibitors|growth inhibitors|mesh-ancestor
93104519|NCT05806931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93104520|NCT05806931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93104521|NCT05806931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104522|NCT05806931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104523|NCT05806021|Triamcinolone|triamcinolone|mesh-list
93104524|NCT05806021|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93104525|NCT05806021|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93104526|NCT05806021|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93104527|NCT05806021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104528|NCT05806021|Glucocorticoids|glucocorticoids|mesh-ancestor
93104529|NCT05806021|Hormones|hormones|mesh-ancestor
93104530|NCT05806021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104531|NCT05806021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104532|NCT05806021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104533|NCT05806021|Immunologic Factors|immunologic factors|mesh-ancestor
93104534|NCT05806021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104535|NCT05806021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104536|NCT05805605|Mycophenolic Acid|mycophenolic acid|mesh-list
93104537|NCT05805605|Sirolimus|sirolimus|mesh-list
93104538|NCT05805605|Cyclophosphamide|cyclophosphamide|mesh-list
93104539|NCT05805605|Fludarabine|fludarabine|mesh-list
93104540|NCT05805605|Allopurinol|allopurinol|mesh-list
93104541|NCT05805605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104542|NCT05805605|Immunologic Factors|immunologic factors|mesh-ancestor
93104543|NCT05805605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104544|NCT05805605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104545|NCT05805605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93104546|NCT05805605|Alkylating Agents|alkylating agents|mesh-ancestor
93104547|NCT05805605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104548|NCT05805605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104549|NCT05805605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93104550|NCT05805605|Antimetabolites|antimetabolites|mesh-ancestor
93104551|NCT05805605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93104552|NCT05805605|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93104553|NCT05805605|Antitubercular Agents|antitubercular agents|mesh-ancestor
93104554|NCT05805605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93104555|NCT05805605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104556|NCT05805605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104557|NCT05805605|Antifungal Agents|antifungal agents|mesh-ancestor
93104558|NCT05805605|Gout Suppressants|gout suppressants|mesh-ancestor
93104559|NCT05805605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93104560|NCT05805605|Antioxidants|antioxidants|mesh-ancestor
93104561|NCT05805605|Protective Agents|protective agents|mesh-ancestor
93104562|NCT05805436|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93104563|NCT05805436|Laxatives|laxatives|mesh-ancestor
93104564|NCT05805436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104565|NCT05805072|Cytarabine|cytarabine|mesh-list
93104566|NCT05805072|Azacitidine|azacitidine|mesh-list
93104567|NCT05805072|Decitabine|decitabine|mesh-list
93104568|NCT05805072|Homoharringtonine|homoharringtonine|mesh-list
93104569|NCT05805072|Aclacinomycins|aclacinomycins|mesh-list
93104570|NCT05805072|Lenograstim|lenograstim|mesh-list
93104571|NCT05805072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93104572|NCT05805072|Antimetabolites|antimetabolites|mesh-ancestor
93104573|NCT05805072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104574|NCT05805072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104575|NCT05805072|Antiviral Agents|antiviral agents|mesh-ancestor
93104576|NCT05805072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104577|NCT05805072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104578|NCT05805072|Immunologic Factors|immunologic factors|mesh-ancestor
93104579|NCT05805072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104580|NCT05805072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104581|NCT05805072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93104582|NCT05805072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93104583|NCT05805072|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93104584|NCT05805072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93104585|NCT05804032|Dexamethasone|dexamethasone|mesh-list
93104586|NCT05804032|Lenalidomide|lenalidomide|mesh-list
93104587|NCT05804032|Bortezomib|bortezomib|mesh-list
93104588|NCT05804032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93104589|NCT05804032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104590|NCT05804032|Antiemetics|antiemetics|mesh-ancestor
93104591|NCT05804032|Autonomic Agents|autonomic agents|mesh-ancestor
93104592|NCT05804032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104593|NCT05804032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104594|NCT05804032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104595|NCT05804032|Glucocorticoids|glucocorticoids|mesh-ancestor
93104596|NCT05804032|Hormones|hormones|mesh-ancestor
93104597|NCT05804032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104598|NCT05804032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93104599|NCT05804032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104600|NCT05804032|Immunologic Factors|immunologic factors|mesh-ancestor
93104601|NCT05804032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93104602|NCT05804032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93104603|NCT05804032|Growth Substances|growth substances|mesh-ancestor
93104604|NCT05804032|Growth Inhibitors|growth inhibitors|mesh-ancestor
93104605|NCT05803941|177Lu-PSMA-617|177lu-psma-617|mesh-list
93104606|NCT05803941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93104607|NCT05803941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104608|NCT05801913|Vaccines|vaccines|mesh-list
93104609|NCT05801913|Immunologic Factors|immunologic factors|mesh-ancestor
93104610|NCT05801913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104611|NCT05797090|Cardioplegic Solutions|cardioplegic solutions|mesh-list
93104612|NCT05797090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93104613|NCT05795504|Vitamin D|vitamin d|mesh-list
93104614|NCT05795504|Calcium|calcium|mesh-list
93104615|NCT05795504|Vitamins|vitamins|mesh-ancestor
93104616|NCT05795504|Micronutrients|micronutrients|mesh-ancestor
93104617|NCT05795504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104618|NCT05795504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93104619|NCT05795504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93104620|NCT05795101|Trastuzumab|trastuzumab|mesh-list
93104621|NCT05795101|Durvalumab|durvalumab|mesh-list
93104622|NCT05795101|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93104623|NCT05795101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104624|NCT05795101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104625|NCT05795101|Immunoconjugates|immunoconjugates|mesh-ancestor
93104626|NCT05795101|Immunologic Factors|immunologic factors|mesh-ancestor
93104627|NCT05795101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104628|NCT05782907|Upadacitinib|upadacitinib|mesh-list
93104629|NCT05782907|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93104630|NCT05782907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104631|NCT05782907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104632|NCT05782907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104633|NCT05782907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104634|NCT05772364|Calcium|calcium|mesh-list
93104635|NCT05772364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93104636|NCT05772364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104637|NCT05770180|Vaccines|vaccines|mesh-list
93104638|NCT05770180|Immunologic Factors|immunologic factors|mesh-ancestor
93104639|NCT05770180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104640|NCT05767749|Lidocaine|lidocaine|mesh-list
93104641|NCT05767749|Epinephrine|epinephrine|mesh-list
93104642|NCT05767749|Racepinephrine|racepinephrine|mesh-list
93104643|NCT05767749|Bupivacaine|bupivacaine|mesh-list
93104644|NCT05767749|Ropivacaine|ropivacaine|mesh-list
93104645|NCT05767749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93104646|NCT05767749|Epinephryl borate|epinephryl borate|mesh-list
93104647|NCT05767749|Anesthetics, Local|anesthetics, local|mesh-ancestor
93104648|NCT05767749|Anesthetics|anesthetics|mesh-ancestor
93104649|NCT05767749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104650|NCT05767749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104651|NCT05767749|Sensory System Agents|sensory system agents|mesh-ancestor
93104652|NCT05767749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776941|NCT02644915|Edaravone|edaravone|mesh-list
93104653|NCT05767749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93104654|NCT05767749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93104655|NCT05767749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93104656|NCT05767749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104657|NCT05767749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104658|NCT05767749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93104659|NCT05767749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93104660|NCT05767749|Adrenergic Agents|adrenergic agents|mesh-ancestor
93104661|NCT05767749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104662|NCT05767749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93104663|NCT05767749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93104664|NCT05767749|Autonomic Agents|autonomic agents|mesh-ancestor
93104665|NCT05767749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93104666|NCT05767749|Respiratory System Agents|respiratory system agents|mesh-ancestor
93104667|NCT05767749|Mydriatics|mydriatics|mesh-ancestor
93104668|NCT05767749|Sympathomimetics|sympathomimetics|mesh-ancestor
93104669|NCT05767749|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93104670|NCT05765682|Bupivacaine|bupivacaine|mesh-list
93104671|NCT05765682|Mepivacaine|mepivacaine|mesh-list
93104672|NCT05765682|Anesthetics, Local|anesthetics, local|mesh-ancestor
93104673|NCT05765682|Anesthetics|anesthetics|mesh-ancestor
93104674|NCT05765682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104675|NCT05765682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104676|NCT05765682|Sensory System Agents|sensory system agents|mesh-ancestor
93104677|NCT05765682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104678|NCT05765604|Vaccines|vaccines|mesh-list
93104679|NCT05765604|Immunologic Factors|immunologic factors|mesh-ancestor
93104680|NCT05765604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104681|NCT05753592|Remibrutinib|remibrutinib|mesh-list
93104682|NCT05753592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104683|NCT05753592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104684|NCT05753592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104685|NCT05736224|Sunscreening Agents|sunscreening agents|mesh-list
93104686|NCT05736224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93104687|NCT05736224|Protective Agents|protective agents|mesh-ancestor
93104688|NCT05736224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104689|NCT05736224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93104690|NCT05735431|Fluticasone|fluticasone|mesh-list
93104691|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
93104692|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104693|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93104694|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
93104695|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104696|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104697|NCT05735431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93104698|NCT05735431|Respiratory System Agents|respiratory system agents|mesh-ancestor
93104699|NCT05735431|Dermatologic Agents|dermatologic agents|mesh-ancestor
93104700|NCT05735431|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93104701|NCT05735431|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93104702|NCT05735431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93104703|NCT05735431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93104704|NCT05735431|Adrenergic Agents|adrenergic agents|mesh-ancestor
93104705|NCT05735431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104706|NCT05735431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104707|NCT05704673|Morphine|morphine|mesh-list
93104708|NCT05704673|Nalbuphine|nalbuphine|mesh-list
93104709|NCT05704673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93104710|NCT05704673|Narcotics|narcotics|mesh-ancestor
93104711|NCT05704673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104712|NCT05704673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104713|NCT05704673|Analgesics|analgesics|mesh-ancestor
93104714|NCT05704673|Sensory System Agents|sensory system agents|mesh-ancestor
93104715|NCT05704673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104716|NCT05702671|Immunoglobulins|immunoglobulins|mesh-list
93104717|NCT05702671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93104718|NCT05702671|Antibodies|antibodies|mesh-list
93104719|NCT05702671|Immunologic Factors|immunologic factors|mesh-ancestor
93104720|NCT05702671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104721|NCT05693545|Penicillins|penicillins|mesh-list
93104722|NCT05693545|Penicillin G|penicillin g|mesh-list
93104723|NCT05693545|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93104724|NCT05693545|Penicillin G Procaine|penicillin g procaine|mesh-list
93104725|NCT05693545|Penicillin V|penicillin v|mesh-list
93104726|NCT05693545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93104727|NCT05693545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104728|NCT05683574|Etoricoxib|etoricoxib|mesh-list
93104729|NCT05683574|Amitriptyline|amitriptyline|mesh-list
93104730|NCT05683574|Cyclobenzaprine|cyclobenzaprine|mesh-list
93104731|NCT05683574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93104732|NCT05683574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93104733|NCT05683574|Analgesics|analgesics|mesh-ancestor
93104734|NCT05683574|Sensory System Agents|sensory system agents|mesh-ancestor
93104735|NCT05683574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104736|NCT05683574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104737|NCT05683574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104738|NCT05683574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104739|NCT05683574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93104740|NCT05683574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93104741|NCT05683574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104742|NCT05683574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104743|NCT05683574|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93104744|NCT05683574|Antidepressive Agents|antidepressive agents|mesh-ancestor
93104745|NCT05683574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93104746|NCT05683574|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93104747|NCT05683574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93104748|NCT05683574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93104749|NCT05683574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104750|NCT05683574|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93104751|NCT05683574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93104752|NCT05683574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104753|NCT05683574|Adrenergic Agents|adrenergic agents|mesh-ancestor
93104754|NCT05683574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104755|NCT05681780|Cyclophosphamide|cyclophosphamide|mesh-list
93104757|NCT05681780|Fludarabine|fludarabine|mesh-list
93104758|NCT05681780|Interleukin-2|interleukin-2|mesh-list
93104759|NCT05681780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104760|NCT05681780|Immunologic Factors|immunologic factors|mesh-ancestor
93104761|NCT05681780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104762|NCT05681780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104763|NCT05681780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93104764|NCT05681780|Alkylating Agents|alkylating agents|mesh-ancestor
93104765|NCT05681780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104766|NCT05681780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104767|NCT05681780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93104768|NCT05681780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104769|NCT05681780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104770|NCT05681780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93104771|NCT05681780|Analgesics|analgesics|mesh-ancestor
93104772|NCT05681780|Sensory System Agents|sensory system agents|mesh-ancestor
93104773|NCT05681780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104774|NCT05678205|Cyclophosphamide|cyclophosphamide|mesh-list
93104775|NCT05678205|Fludarabine|fludarabine|mesh-list
93104776|NCT05678205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93104777|NCT05678205|Immunologic Factors|immunologic factors|mesh-ancestor
93104778|NCT05678205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104779|NCT05678205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93104780|NCT05678205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93104781|NCT05678205|Alkylating Agents|alkylating agents|mesh-ancestor
93104782|NCT05678205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104783|NCT05678205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104784|NCT05678205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93104785|NCT05673811|Paclitaxel|paclitaxel|mesh-list
93104786|NCT05673811|Gemcitabine|gemcitabine|mesh-list
93104787|NCT05673811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93104788|NCT05673811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104789|NCT05673811|Tubulin Modulators|tubulin modulators|mesh-ancestor
93104790|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
93104791|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
93104792|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104793|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93104794|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
93104795|NCT05671562|Lycopene|lycopene|mesh-list
93104796|NCT05671562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104797|NCT05671562|Antioxidants|antioxidants|mesh-ancestor
93104798|NCT05671562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104799|NCT05671562|Protective Agents|protective agents|mesh-ancestor
93104800|NCT05671562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104801|NCT05671562|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93104802|NCT05671562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93104803|NCT05671562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104804|NCT05669846|Pembrolizumab|pembrolizumab|mesh-list
92777091|NCT01167881|Glimepiride|glimepiride|mesh-list
93104805|NCT05669846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104806|NCT05669846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104807|NCT05669846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104808|NCT05669846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104809|NCT05665699|Allopurinol|allopurinol|mesh-list
93104810|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
93104811|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104812|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104813|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
93104814|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695042|NCT00520260|Ketorolac|ketorolac|mesh-list
93104815|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93104816|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
93104817|NCT05665699|Protective Agents|protective agents|mesh-ancestor
93104818|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104819|NCT05654818|Vitamin D|vitamin d|mesh-list
93104820|NCT05654818|Vitamins|vitamins|mesh-ancestor
93104821|NCT05654818|Micronutrients|micronutrients|mesh-ancestor
93104822|NCT05654818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104823|NCT05654818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93104824|NCT05634525|Adagrasib|adagrasib|mesh-list
93104825|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104826|NCT05634369|Dexamethasone|dexamethasone|mesh-list
93104827|NCT05634369|Gemcitabine|gemcitabine|mesh-list
93104828|NCT05634369|Docetaxel|docetaxel|mesh-list
93104829|NCT05634369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93104830|NCT05634369|Antiemetics|antiemetics|mesh-ancestor
93104831|NCT05634369|Autonomic Agents|autonomic agents|mesh-ancestor
93104832|NCT05634369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104833|NCT05634369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104834|NCT05634369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104835|NCT05634369|Glucocorticoids|glucocorticoids|mesh-ancestor
93104836|NCT05634369|Hormones|hormones|mesh-ancestor
93104837|NCT05634369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93104838|NCT05634369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93104839|NCT05634369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104840|NCT05634369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104841|NCT05634369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93104842|NCT05634369|Antimetabolites|antimetabolites|mesh-ancestor
93104843|NCT05634369|Tubulin Modulators|tubulin modulators|mesh-ancestor
93104844|NCT05634369|Antimitotic Agents|antimitotic agents|mesh-ancestor
93104845|NCT05634369|Mitosis Modulators|mitosis modulators|mesh-ancestor
93104846|NCT05633667|Paclitaxel|paclitaxel|mesh-list
93104847|NCT05633667|Docetaxel|docetaxel|mesh-list
93104848|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93104849|NCT05633667|Carboplatin|carboplatin|mesh-list
93104850|NCT05633667|Pemetrexed|pemetrexed|mesh-list
93104851|NCT05633667|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93104852|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93104853|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104854|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
93104855|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
93104856|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
93104857|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104858|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104859|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93104860|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93104861|NCT05633667|Immunoconjugates|immunoconjugates|mesh-ancestor
93104862|NCT05633667|Immunologic Factors|immunologic factors|mesh-ancestor
93104863|NCT05633667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104864|NCT05630859|Vaccines|vaccines|mesh-list
93104865|NCT05630859|Immunologic Factors|immunologic factors|mesh-ancestor
93104866|NCT05630859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104867|NCT05613205|Vaccines|vaccines|mesh-list
93104868|NCT05613205|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
93104869|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
93104870|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104871|NCT05613205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93104872|NCT05589181|Buprenorphine|buprenorphine|mesh-list
93104873|NCT05589181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93104874|NCT05589181|Narcotics|narcotics|mesh-ancestor
93104875|NCT05589181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104876|NCT05589181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104877|NCT05589181|Analgesics|analgesics|mesh-ancestor
93104878|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
93104879|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104880|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93104881|NCT05584137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93104882|NCT05584137|Antibodies|antibodies|mesh-list
93104883|NCT05584137|Immunoglobulins|immunoglobulins|mesh-list
93104884|NCT05584137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93104885|NCT05584137|Immunologic Factors|immunologic factors|mesh-ancestor
93104886|NCT05584137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104887|NCT05584137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104888|NCT05562349|Clavulanic Acids|clavulanic acids|mesh-list
93104889|NCT05562349|Clavulanic Acid|clavulanic acid|mesh-list
93104890|NCT05562349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93104891|NCT05562349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104892|NCT05562349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104893|NCT05562349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104894|NCT05562349|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93104895|NCT05561673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93104896|NCT05561673|Vaccines|vaccines|mesh-list
93104897|NCT05561673|Immunologic Factors|immunologic factors|mesh-ancestor
93104898|NCT05561673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104899|NCT05561673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93104900|NCT05561673|Antacids|antacids|mesh-ancestor
93104901|NCT05561673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104902|NCT05561673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104903|NCT05550714|Anesthetics|anesthetics|mesh-list
93104904|NCT05550714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104905|NCT05550714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104906|NCT05542264|Olanzapine|olanzapine|mesh-list
93104907|NCT05542264|Risperidone|risperidone|mesh-list
93104908|NCT05542264|Aripiprazole|aripiprazole|mesh-list
93104909|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93104910|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
93104911|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93104912|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
93104913|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104914|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104915|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104916|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93104917|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93104918|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93104919|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93104920|NCT05542264|Dopamine Agents|dopamine agents|mesh-ancestor
93104921|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
93104922|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
93104923|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104924|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93104925|NCT05542264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93104926|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93104927|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93104928|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
93104929|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
93104930|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93104931|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93104932|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93104933|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93104934|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
93104935|NCT05523323|Lenvatinib|lenvatinib|mesh-list
93104936|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104937|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104938|NCT05523323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104939|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104940|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93104941|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104942|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
93104943|NCT05505617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93104944|NCT05505617|Autonomic Agents|autonomic agents|mesh-ancestor
93104945|NCT05505617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93104946|NCT05505617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104947|NCT05505617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93104948|NCT05505617|Respiratory System Agents|respiratory system agents|mesh-ancestor
93104949|NCT05505617|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93104950|NCT05505617|Antioxidants|antioxidants|mesh-ancestor
93104951|NCT05505617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104952|NCT05505617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93104953|NCT05505617|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93104954|NCT05505617|Vasodilator Agents|vasodilator agents|mesh-ancestor
93104955|NCT05505617|Gasotransmitters|gasotransmitters|mesh-ancestor
93104956|NCT05505617|Protective Agents|protective agents|mesh-ancestor
93104958|NCT05487040|Nirmatrelvir|nirmatrelvir|mesh-list
93104959|NCT05487040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93104960|NCT05487040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93104961|NCT05487040|Protease Inhibitors|protease inhibitors|mesh-ancestor
93104962|NCT05487040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104963|NCT05487040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104964|NCT05487040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93104965|NCT05487040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93104966|NCT05487040|Antiviral Agents|antiviral agents|mesh-ancestor
93104967|NCT05487040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104968|NCT05487040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93104969|NCT05487040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93104970|NCT05484466|Entecavir|entecavir|mesh-list
93104971|NCT05484466|Antiviral Agents|antiviral agents|mesh-ancestor
93104972|NCT05484466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93104973|NCT05479045|Nivolumab|nivolumab|mesh-list
93104974|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93104975|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93104976|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93104977|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104978|NCT05476094|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
93104979|NCT05476094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93104980|NCT05476094|Antimetabolites|antimetabolites|mesh-ancestor
93104981|NCT05476094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104982|NCT05476094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93104983|NCT05466747|Protease Inhibitors|protease inhibitors|mesh-list
93104984|NCT05466747|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93104985|NCT05466747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93104986|NCT05466747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93104987|NCT05466747|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93104988|NCT05466747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93104989|NCT05408988|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93104990|NCT05408988|Natriuretic Agents|natriuretic agents|mesh-ancestor
93104991|NCT05408988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93104992|NCT05402111|Olanzapine|olanzapine|mesh-list
93104993|NCT05402111|Risperidone|risperidone|mesh-list
93104994|NCT05402111|Aripiprazole|aripiprazole|mesh-list
93104995|NCT05402111|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93104996|NCT05402111|Antipsychotic Agents|antipsychotic agents|mesh-list
93104997|NCT05402111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93104998|NCT05402111|Serotonin Agents|serotonin agents|mesh-ancestor
93104999|NCT05402111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105000|NCT05402111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105001|NCT05402111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105002|NCT05402111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93105003|NCT05402111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105004|NCT05402111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93105005|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93105006|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
93105007|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
93105008|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
93105009|NCT05402111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105010|NCT05402111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105011|NCT05402111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93105012|NCT05402111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93105013|NCT05402111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93105014|NCT05402111|Antidepressive Agents|antidepressive agents|mesh-ancestor
93105015|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
93105016|NCT05402111|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93105017|NCT05402111|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93105018|NCT05402111|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93105019|NCT05402111|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93105020|NCT05399173|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93105021|NCT05399173|Hemostatics|hemostatics|mesh-ancestor
93105022|NCT05399173|Coagulants|coagulants|mesh-ancestor
93105023|NCT05399173|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93105024|NCT05399173|Natriuretic Agents|natriuretic agents|mesh-ancestor
93105025|NCT05399173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105026|NCT05393791|Abiraterone Acetate|abiraterone acetate|mesh-list
93105027|NCT05393791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777314|NCT00652873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93105028|NCT05393791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93105029|NCT05393791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105030|NCT05393791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105031|NCT05393791|Hormone Antagonists|hormone antagonists|mesh-ancestor
93105032|NCT05393791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105033|NCT05393791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105034|NCT05393791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93105035|NCT05388773|Carboplatin|carboplatin|mesh-list
93105036|NCT05388773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105037|NCT05383521|Tinidazole|tinidazole|mesh-list
93105038|NCT05383521|Alkylating Agents|alkylating agents|mesh-ancestor
93105039|NCT05383521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105040|NCT05383521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93105041|NCT05383521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105042|NCT05383521|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93105043|NCT05383521|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93105044|NCT05383521|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93105045|NCT05369052|Linezolid|linezolid|mesh-list
93105046|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93105047|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105048|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93105049|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105050|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105051|NCT05361382|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93105052|NCT05361382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105053|NCT05359211|Cyclophosphamide|cyclophosphamide|mesh-list
93105054|NCT05359211|Fludarabine|fludarabine|mesh-list
93105055|NCT05359211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93105056|NCT05359211|Immunologic Factors|immunologic factors|mesh-ancestor
93105057|NCT05359211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105058|NCT05359211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105059|NCT05359211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93105060|NCT05359211|Alkylating Agents|alkylating agents|mesh-ancestor
93105061|NCT05359211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105062|NCT05359211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105063|NCT05359211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93105064|NCT05358938|Pembrolizumab|pembrolizumab|mesh-list
93105065|NCT05358938|Nivolumab|nivolumab|mesh-list
93105066|NCT05358938|Ipilimumab|ipilimumab|mesh-list
93105067|NCT05358938|Avelumab|avelumab|mesh-list
93105068|NCT05358938|Cemiplimab|cemiplimab|mesh-list
93105069|NCT05358938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93105070|NCT05358938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105071|NCT05358938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105072|NCT05358938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105073|NCT05356741|Pembrolizumab|pembrolizumab|mesh-list
93105074|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105075|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105076|NCT05356741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105077|NCT05356741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105078|NCT05349474|Metformin|metformin|mesh-list
93105079|NCT05349474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93105080|NCT05349474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105081|NCT05343481|Nivolumab|nivolumab|mesh-list
93105082|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105083|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105084|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105085|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105086|NCT05340764|Infliximab|infliximab|mesh-list
93105087|NCT05340764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93105088|NCT05340764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105089|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105090|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105091|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105092|NCT05327361|Sunscreening Agents|sunscreening agents|mesh-list
93105093|NCT05327361|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93105094|NCT05327361|Protective Agents|protective agents|mesh-ancestor
93105095|NCT05327361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105096|NCT05327361|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105097|NCT05305989|Belumosudil|belumosudil|mesh-list
93105098|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105099|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105100|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105101|NCT05305014|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93105102|NCT05305014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105103|NCT05302986|Tranexamic Acid|tranexamic acid|mesh-list
93105104|NCT05302986|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93105105|NCT05302986|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93105106|NCT05302986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105107|NCT05302986|Hemostatics|hemostatics|mesh-ancestor
93105108|NCT05302986|Coagulants|coagulants|mesh-ancestor
93105109|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93105110|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93105111|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
93105112|NCT05300451|Daratumumab|daratumumab|mesh-list
93105113|NCT05300451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105114|NCT05287321|Hydroxychloroquine|hydroxychloroquine|mesh-list
93105115|NCT05287321|Antimalarials|antimalarials|mesh-ancestor
93105116|NCT05287321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93105117|NCT05287321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93105118|NCT05287321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105119|NCT05287321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105120|NCT05287321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105121|NCT05287321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105122|NCT05285904|Ofatumumab|ofatumumab|mesh-list
93105123|NCT05285904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105124|NCT05283083|Dexmedetomidine|dexmedetomidine|mesh-list
93105125|NCT05283083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93105126|NCT05283083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105127|NCT05283083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105128|NCT05283083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93105129|NCT05283083|Analgesics|analgesics|mesh-ancestor
93105130|NCT05283083|Sensory System Agents|sensory system agents|mesh-ancestor
93105131|NCT05283083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105132|NCT05283083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93105133|NCT05283083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93105134|NCT05283083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93105135|NCT05283083|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105136|NCT05283083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105137|NCT05283083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105138|NCT05263206|Loratadine|loratadine|mesh-list
93105139|NCT05263206|Fexofenadine|fexofenadine|mesh-list
93105140|NCT05263206|Antipruritics|antipruritics|mesh-ancestor
93105141|NCT05263206|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105142|NCT05263206|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93105143|NCT05263206|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93105144|NCT05263206|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93105145|NCT05263206|Histamine Antagonists|histamine antagonists|mesh-ancestor
93105146|NCT05263206|Histamine Agents|histamine agents|mesh-ancestor
93105147|NCT05263206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105148|NCT05263206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105149|NCT05263206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105150|NCT05262855|FAPI-46|fapi-46|mesh-list
93105151|NCT05262855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93105152|NCT05262855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105153|NCT05262777|Lidocaine|lidocaine|mesh-list
93105154|NCT05262777|Anesthetics, Local|anesthetics, local|mesh-ancestor
93105155|NCT05262777|Anesthetics|anesthetics|mesh-ancestor
93105156|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105157|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105158|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
93105159|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105160|NCT05262777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93105161|NCT05262777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93105162|NCT05262777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93105163|NCT05262777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93105164|NCT05262777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105165|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
93105166|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93105167|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93105168|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105169|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
93105170|NCT05248321|Coagulants|coagulants|mesh-ancestor
93105171|NCT05241093|Cytarabine|cytarabine|mesh-list
93105172|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93105173|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
93105174|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105175|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105176|NCT05241093|Antiviral Agents|antiviral agents|mesh-ancestor
93105177|NCT05241093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105178|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93105179|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
93105180|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105182|NCT05239624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105183|NCT05239624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105184|NCT05239624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105185|NCT05239624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105186|NCT05233163|Empagliflozin|empagliflozin|mesh-list
93105187|NCT05233163|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93105188|NCT05233163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105189|NCT05233163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93105190|NCT05233163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105191|NCT05229991|Ritonavir|ritonavir|mesh-list
93105192|NCT05229991|Lonafarnib|lonafarnib|mesh-list
93105193|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93105194|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93105195|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
93105196|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105197|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105198|NCT05229991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93105199|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93105200|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
93105201|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105202|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93105203|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93105204|NCT05214911|Loratadine|loratadine|mesh-list
93105205|NCT05214911|Prednisolone|prednisolone|mesh-list
93105206|NCT05214911|Desloratadine|desloratadine|mesh-list
93105207|NCT05214911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105208|NCT05214911|Glucocorticoids|glucocorticoids|mesh-ancestor
93105209|NCT05214911|Hormones|hormones|mesh-ancestor
93105210|NCT05214911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105211|NCT05214911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105212|NCT05214911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105213|NCT05214911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105214|NCT05214911|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93105215|NCT05214911|Cholinergic Agents|cholinergic agents|mesh-ancestor
93105216|NCT05214911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105217|NCT05214911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105218|NCT05214911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93105219|NCT05214911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93105220|NCT05214911|Histamine Antagonists|histamine antagonists|mesh-ancestor
93105221|NCT05214911|Histamine Agents|histamine agents|mesh-ancestor
93105222|NCT05214911|Antipruritics|antipruritics|mesh-ancestor
93105223|NCT05214911|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105224|NCT05214911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93105225|NCT05213884|Cisplatin|cisplatin|mesh-list
93105226|NCT05213884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105227|NCT05211336|Prednisone|prednisone|mesh-list
93105228|NCT05211336|Lenalidomide|lenalidomide|mesh-list
93105229|NCT05211336|Venetoclax|venetoclax|mesh-list
93105230|NCT05211336|Obinutuzumab|obinutuzumab|mesh-list
93105231|NCT05211336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105232|NCT05211336|Glucocorticoids|glucocorticoids|mesh-ancestor
93105233|NCT05211336|Hormones|hormones|mesh-ancestor
93105234|NCT05211336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105235|NCT05211336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105236|NCT05211336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105237|NCT05211336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105238|NCT05211336|Immunologic Factors|immunologic factors|mesh-ancestor
93105239|NCT05211336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93105240|NCT05211336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93105241|NCT05211336|Growth Substances|growth substances|mesh-ancestor
93105242|NCT05211336|Growth Inhibitors|growth inhibitors|mesh-ancestor
93105243|NCT05211336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105244|NCT05211024|Penicillins|penicillins|mesh-list
93105245|NCT05211024|Penicillin G|penicillin g|mesh-list
93105246|NCT05211024|Penicillin G Benzathine|penicillin g benzathine|mesh-list
93105247|NCT05211024|Penicillin G Procaine|penicillin g procaine|mesh-list
93105248|NCT05211024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93105249|NCT05211024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105250|NCT05210439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93105251|NCT05210439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93105252|NCT05210439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105253|NCT05210439|Antitubercular Agents|antitubercular agents|mesh-ancestor
93105254|NCT05209984|Topiramate|topiramate|mesh-list
93105255|NCT05209984|Sibutramine|sibutramine|mesh-list
93105256|NCT05209984|Anticonvulsants|anticonvulsants|mesh-ancestor
93105257|NCT05209984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93105258|NCT05209984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105259|NCT05209984|Antidepressive Agents|antidepressive agents|mesh-ancestor
93105260|NCT05209984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93105261|NCT05209984|Appetite Depressants|appetite depressants|mesh-ancestor
93105262|NCT05209984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93105263|NCT05204290|Pembrolizumab|pembrolizumab|mesh-list
93105264|NCT05204290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105265|NCT05204290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105266|NCT05204290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105267|NCT05204290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105268|NCT05199311|Dexamethasone|dexamethasone|mesh-list
93105269|NCT05199311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105270|NCT05199311|Antiemetics|antiemetics|mesh-ancestor
93105271|NCT05199311|Autonomic Agents|autonomic agents|mesh-ancestor
93105272|NCT05199311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105273|NCT05199311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105274|NCT05199311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105275|NCT05199311|Glucocorticoids|glucocorticoids|mesh-ancestor
93105276|NCT05199311|Hormones|hormones|mesh-ancestor
93105277|NCT05199311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105278|NCT05199311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105279|NCT05199311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105280|NCT05179005|Imidacloprid|imidacloprid|mesh-list
93105281|NCT05179005|Cholinergic Agents|cholinergic agents|mesh-ancestor
93105282|NCT05179005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105283|NCT05179005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105284|NCT05179005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105285|NCT05176080|Fulvestrant|fulvestrant|mesh-list
93105286|NCT05176080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105287|NCT05176080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105288|NCT05176080|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93105289|NCT05176080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93105290|NCT05176080|Hormone Antagonists|hormone antagonists|mesh-ancestor
93105291|NCT05176080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105292|NCT05176080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105293|NCT05165082|Timolol|timolol|mesh-list
93105294|NCT05165082|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93105295|NCT05165082|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93105296|NCT05165082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105297|NCT05165082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92695512|NCT00523458|Efavirenz|efavirenz|mesh-list
93105298|NCT05165082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93105299|NCT05165082|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105300|NCT05165082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105301|NCT05165082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105302|NCT05165082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93105303|NCT05165082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93105304|NCT05159531|Tenofovir|tenofovir|mesh-list
93105305|NCT05159531|Emtricitabine|emtricitabine|mesh-list
93105306|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
93105307|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105308|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93105309|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93105310|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105311|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105312|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93105313|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93105314|NCT05141149|Gemcitabine|gemcitabine|mesh-list
93105315|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93105316|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
93105317|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105318|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105319|NCT05139316|Prednisolone|prednisolone|mesh-list
93105320|NCT05139316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105321|NCT05139316|Glucocorticoids|glucocorticoids|mesh-ancestor
93105322|NCT05139316|Hormones|hormones|mesh-ancestor
93105323|NCT05139316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105324|NCT05139316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105325|NCT05139316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105326|NCT05139316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105328|NCT05132504|Folfirinox|folfirinox|mesh-list
93105329|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105330|NCT05132504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105331|NCT05132504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105332|NCT05132504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105333|NCT05128071|Progesterone|progesterone|mesh-list
93105334|NCT05128071|Progestins|progestins|mesh-ancestor
93105335|NCT05128071|Hormones|hormones|mesh-ancestor
93105336|NCT05128071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105337|NCT05128071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105338|NCT05121324|Midazolam|midazolam|mesh-list
93105339|NCT05121324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93105340|NCT05121324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93105341|NCT05121324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105342|NCT05121324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105343|NCT05121324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93105344|NCT05121324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93105345|NCT05121324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93105346|NCT05121324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93105347|NCT05121324|Anesthetics, General|anesthetics, general|mesh-ancestor
93105348|NCT05121324|Anesthetics|anesthetics|mesh-ancestor
93105349|NCT05121324|GABA Modulators|gaba modulators|mesh-ancestor
93105350|NCT05121324|GABA Agents|gaba agents|mesh-ancestor
93105351|NCT05121324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105352|NCT05121324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105353|NCT05118672|Acetaminophen|acetaminophen|mesh-list
93105354|NCT05118672|Fexofenadine|fexofenadine|mesh-list
93105355|NCT05118672|Phenylephrine|phenylephrine|mesh-list
93105356|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
93105357|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93105358|NCT05118672|Analgesics|analgesics|mesh-ancestor
93105359|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
93105360|NCT05118672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105361|NCT05118672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105362|NCT05118672|Antipyretics|antipyretics|mesh-ancestor
93105363|NCT05118672|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93105364|NCT05118672|Mydriatics|mydriatics|mesh-ancestor
93105365|NCT05118672|Autonomic Agents|autonomic agents|mesh-ancestor
93105366|NCT05118672|Sympathomimetics|sympathomimetics|mesh-ancestor
93105367|NCT05118672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93105368|NCT05118672|Nasal Decongestants|nasal decongestants|mesh-ancestor
93105369|NCT05118672|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105370|NCT05118672|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93105371|NCT05118672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93105372|NCT05118672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93105373|NCT05118672|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105374|NCT05118672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105375|NCT05118672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105376|NCT05118672|Protective Agents|protective agents|mesh-ancestor
93105377|NCT05118672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93105378|NCT05118672|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93105379|NCT05118672|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93105380|NCT05118672|Histamine Antagonists|histamine antagonists|mesh-ancestor
93105381|NCT05118672|Histamine Agents|histamine agents|mesh-ancestor
93105382|NCT05114096|Betamethasone|betamethasone|mesh-list
93105383|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
93105384|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93105385|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
93105386|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93105387|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105388|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
93105389|NCT05114096|Hormones|hormones|mesh-ancestor
93105390|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105391|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105392|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93105393|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105394|NCT05109611|Nitric Oxide|nitric oxide|mesh-list
93105395|NCT05109611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93105396|NCT05109611|Autonomic Agents|autonomic agents|mesh-ancestor
93105397|NCT05109611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105398|NCT05109611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105399|NCT05109611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93105400|NCT05109611|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105401|NCT05109611|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93105402|NCT05109611|Antioxidants|antioxidants|mesh-ancestor
93105403|NCT05109611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105404|NCT05109611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105405|NCT05109611|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93105406|NCT05109611|Vasodilator Agents|vasodilator agents|mesh-ancestor
93105407|NCT05109611|Gasotransmitters|gasotransmitters|mesh-ancestor
93105408|NCT05109611|Protective Agents|protective agents|mesh-ancestor
93105409|NCT05106153|Zolpidem|zolpidem|mesh-list
93105410|NCT05106153|Suvorexant|suvorexant|mesh-list
93105411|NCT05106153|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93105412|NCT05106153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93105413|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105414|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105415|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93105416|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
93105417|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
93105418|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105419|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105420|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93105421|NCT05102591|Ketorolac|ketorolac|mesh-list
93105422|NCT05102591|Metoclopramide|metoclopramide|mesh-list
93105423|NCT05102591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93105424|NCT05102591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93105425|NCT05102591|Analgesics|analgesics|mesh-ancestor
93105426|NCT05102591|Sensory System Agents|sensory system agents|mesh-ancestor
93105427|NCT05102591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105428|NCT05102591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105429|NCT05102591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105430|NCT05102591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105431|NCT05102591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93105432|NCT05102591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105433|NCT05102591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105434|NCT05102591|Antiemetics|antiemetics|mesh-ancestor
93105435|NCT05102591|Autonomic Agents|autonomic agents|mesh-ancestor
93105436|NCT05102591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105437|NCT05102591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93105438|NCT05102591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93105439|NCT05102591|Dopamine Agents|dopamine agents|mesh-ancestor
93105440|NCT05102591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105441|NCT05097326|Misoprostol|misoprostol|mesh-list
93105442|NCT05097326|Mifepristone|mifepristone|mesh-list
93105443|NCT05097326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93105444|NCT05097326|Abortifacient Agents|abortifacient agents|mesh-ancestor
93105445|NCT05097326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93105446|NCT05097326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105447|NCT05097326|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93105448|NCT05097326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105449|NCT05097326|Oxytocics|oxytocics|mesh-ancestor
93105450|NCT05097326|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93105451|NCT05097326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93105452|NCT05097326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93105453|NCT05097326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93105454|NCT05097326|Contraceptive Agents|contraceptive agents|mesh-ancestor
93105455|NCT05097326|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93105456|NCT05097326|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93105457|NCT05097326|Hormone Antagonists|hormone antagonists|mesh-ancestor
93105458|NCT05097326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105459|NCT05097326|Luteolytic Agents|luteolytic agents|mesh-ancestor
93105460|NCT05097326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93105461|NCT05097326|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93105462|NCT05081492|Antibodies|antibodies|mesh-list
93105463|NCT05081492|Immunoglobulins|immunoglobulins|mesh-list
93105464|NCT05081492|Immunologic Factors|immunologic factors|mesh-ancestor
93105465|NCT05081492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105466|NCT05081102|Ibuprofen|ibuprofen|mesh-list
93105467|NCT05081102|Oxycodone|oxycodone|mesh-list
93105468|NCT05081102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93105469|NCT05081102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93105470|NCT05081102|Analgesics|analgesics|mesh-ancestor
93105471|NCT05081102|Sensory System Agents|sensory system agents|mesh-ancestor
93105472|NCT05081102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105473|NCT05081102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105474|NCT05081102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105475|NCT05081102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105476|NCT05081102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92777758|NCT03734770|Progesterone|progesterone|mesh-list
93105477|NCT05081102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105478|NCT05081102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105479|NCT05081102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93105480|NCT05081102|Narcotics|narcotics|mesh-ancestor
93105481|NCT05081102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105482|NCT05074992|Ipilimumab|ipilimumab|mesh-list
93105483|NCT05074992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105484|NCT05074992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105485|NCT05074992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105486|NCT05074992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105487|NCT05070403|Afatinib|afatinib|mesh-list
93105488|NCT05070403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105489|NCT05070403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105490|NCT05070403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105491|NCT05070403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105492|NCT05064085|Capecitabine|capecitabine|mesh-list
93105493|NCT05064085|Cemiplimab|cemiplimab|mesh-list
93105494|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93105495|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
93105496|NCT05064085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105497|NCT05064085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105498|NCT05064085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105499|NCT05063656|Gabapentin|gabapentin|mesh-list
93105500|NCT05063656|Analgesics|analgesics|mesh-ancestor
93105501|NCT05063656|Sensory System Agents|sensory system agents|mesh-ancestor
93105502|NCT05063656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105503|NCT05063656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105504|NCT05063656|Anticonvulsants|anticonvulsants|mesh-ancestor
93105505|NCT05063656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93105506|NCT05063656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93105507|NCT05063656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105508|NCT05063656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93105509|NCT05063656|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93105510|NCT05063656|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93105511|NCT05063656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105512|NCT05063656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105513|NCT05063656|Antimanic Agents|antimanic agents|mesh-ancestor
93105514|NCT05060237|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93105515|NCT05060237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93105516|NCT05060237|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105517|NCT05047601|Ritonavir|ritonavir|mesh-list
93105518|NCT05047601|Nirmatrelvir|nirmatrelvir|mesh-list
93105519|NCT05047601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93105520|NCT05047601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93105521|NCT05047601|Protease Inhibitors|protease inhibitors|mesh-ancestor
93105522|NCT05047601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105523|NCT05047601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105524|NCT05047601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93105525|NCT05047601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93105526|NCT05047601|Antiviral Agents|antiviral agents|mesh-ancestor
93105527|NCT05047601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105528|NCT05047601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93105529|NCT05047601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93105530|NCT05043506|Palbociclib|palbociclib|mesh-list
93105531|NCT05043506|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93105532|NCT05043506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105533|NCT05043506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105534|NCT05043506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105535|NCT05043506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105536|NCT05043506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93105537|NCT05043506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93105538|NCT05043506|Hormone Antagonists|hormone antagonists|mesh-ancestor
93105539|NCT05043506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105540|NCT05043506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105541|NCT05022329|Vaccines|vaccines|mesh-list
93105542|NCT05022329|Immunologic Factors|immunologic factors|mesh-ancestor
93105543|NCT05022329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105544|NCT05012371|Everolimus|everolimus|mesh-list
93105545|NCT05012371|Lenvatinib|lenvatinib|mesh-list
93105546|NCT05012371|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93105547|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105548|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105549|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105550|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93105551|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
93105552|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105553|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105554|NCT05011760|Amphetamine|amphetamine|mesh-list
93105555|NCT05011760|Dextroamphetamine|dextroamphetamine|mesh-list
93105556|NCT05011760|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93105557|NCT05011760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105558|NCT05011760|Sympathomimetics|sympathomimetics|mesh-ancestor
93105559|NCT05011760|Autonomic Agents|autonomic agents|mesh-ancestor
93105560|NCT05011760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105561|NCT05011760|Dopamine Agents|dopamine agents|mesh-ancestor
93105562|NCT05011760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026434|NCT00493038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105563|NCT05011760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105564|NCT05011760|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105565|NCT05011760|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93105566|NCT05011760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93105567|NCT05011760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93105568|NCT05011760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93105569|NCT05008146|Hydrocortisone|hydrocortisone|mesh-list
93105570|NCT05008146|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93105571|NCT05008146|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93105572|NCT05008146|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93105573|NCT05008146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105575|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93105576|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93105577|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105578|NCT04998669|Rituximab|rituximab|mesh-list
93105579|NCT04998669|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93105580|NCT04998669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105581|NCT04998669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105582|NCT04998669|Immunologic Factors|immunologic factors|mesh-ancestor
93105583|NCT04998669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105584|NCT04998669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105585|NCT04998604|Omalizumab|omalizumab|mesh-list
93105586|NCT04998604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93105587|NCT04998604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93105588|NCT04998604|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105589|NCT04996030|Arsenic Trioxide|arsenic trioxide|mesh-list
93105590|NCT04996030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105591|NCT04978545|Chlorhexidine|chlorhexidine|mesh-list
93105592|NCT04978545|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93105593|NCT04978545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105594|NCT04978545|Disinfectants|disinfectants|mesh-ancestor
93105595|NCT04975919|Decitabine|decitabine|mesh-list
93105596|NCT04975919|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93105597|NCT04975919|Venetoclax|venetoclax|mesh-list
93105598|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93105599|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
93105600|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105601|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105602|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105603|NCT04972292|Dipyrone|dipyrone|mesh-list
93105604|NCT04972292|Codeine|codeine|mesh-list
93105605|NCT04972292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93105606|NCT04972292|Narcotics|narcotics|mesh-ancestor
93105607|NCT04972292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105608|NCT04972292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105609|NCT04972292|Analgesics|analgesics|mesh-ancestor
93105610|NCT04972292|Sensory System Agents|sensory system agents|mesh-ancestor
93105611|NCT04972292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105612|NCT04972292|Antitussive Agents|antitussive agents|mesh-ancestor
93105613|NCT04972292|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105614|NCT04972292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93105615|NCT04972292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93105616|NCT04972292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105617|NCT04972292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105618|NCT04972292|Antipyretics|antipyretics|mesh-ancestor
93105619|NCT04958811|Bevacizumab|bevacizumab|mesh-list
93105620|NCT04958811|Atezolizumab|atezolizumab|mesh-list
93105621|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105622|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105623|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93105624|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777910|NCT01518556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105625|NCT04958811|Growth Substances|growth substances|mesh-ancestor
93105626|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105627|NCT04958811|Growth Inhibitors|growth inhibitors|mesh-ancestor
93105628|NCT04958811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105629|NCT04958811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105630|NCT04950530|Emtricitabine|emtricitabine|mesh-list
93105631|NCT04950530|Antiviral Agents|antiviral agents|mesh-ancestor
93105632|NCT04950530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105633|NCT04950530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93105634|NCT04950530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93105635|NCT04950530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105636|NCT04950530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105637|NCT04950530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93105638|NCT04950530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93105639|NCT04937699|Aspirin|aspirin|mesh-list
93105640|NCT04937699|Clopidogrel|clopidogrel|mesh-list
93105641|NCT04937699|Ticagrelor|ticagrelor|mesh-list
93105642|NCT04937699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93105643|NCT04937699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93105644|NCT04937699|Analgesics|analgesics|mesh-ancestor
93105645|NCT04937699|Sensory System Agents|sensory system agents|mesh-ancestor
93105646|NCT04937699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105647|NCT04937699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105648|NCT04937699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105649|NCT04937699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105650|NCT04937699|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93105651|NCT04937699|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93105652|NCT04937699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105653|NCT04937699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93105654|NCT04937699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93105655|NCT04937699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105656|NCT04937699|Antipyretics|antipyretics|mesh-ancestor
93105657|NCT04937699|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93105658|NCT04937699|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93105659|NCT04937699|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93105660|NCT04937699|Purinergic Agents|purinergic agents|mesh-ancestor
93105661|NCT04937699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105662|NCT04925375|Abatacept|abatacept|mesh-list
93105663|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105664|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105665|NCT04925375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105666|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105667|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93105668|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
93105669|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105670|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105671|NCT04920708|Fulvestrant|fulvestrant|mesh-list
93105672|NCT04920708|Palbociclib|palbociclib|mesh-list
93105673|NCT04920708|Ipatasertib|ipatasertib|mesh-list
93105674|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105675|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105676|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93105677|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93105678|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
93105679|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105680|NCT04920708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105681|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105682|NCT04920708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105683|NCT04920708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105684|NCT04908956|Osimertinib|osimertinib|mesh-list
93105685|NCT04908956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105686|NCT04908956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105687|NCT04908956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105688|NCT04908956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105689|NCT04891068|Azacitidine|azacitidine|mesh-list
93105690|NCT04891068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93105691|NCT04891068|Antimetabolites|antimetabolites|mesh-ancestor
93105692|NCT04891068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105693|NCT04891068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105694|NCT04891068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105695|NCT04889716|Obinutuzumab|obinutuzumab|mesh-list
93105696|NCT04889716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105697|NCT04889716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105698|NCT04885530|Fluticasone|fluticasone|mesh-list
93105699|NCT04885530|Xhance|xhance|mesh-list
93105700|NCT04885530|Ivermectin|ivermectin|mesh-list
93105701|NCT04885530|Fluvoxamine|fluvoxamine|mesh-list
93105702|NCT04885530|Montelukast|montelukast|mesh-list
93105703|NCT04885530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105704|NCT04885530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93105705|NCT04885530|Autonomic Agents|autonomic agents|mesh-ancestor
93105706|NCT04885530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105707|NCT04885530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105708|NCT04885530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93105709|NCT04885530|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105710|NCT04885530|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105711|NCT04885530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93105712|NCT04885530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93105713|NCT04885530|Hormone Antagonists|hormone antagonists|mesh-ancestor
93105714|NCT04885530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105715|NCT04885530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93105716|NCT04885530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93105717|NCT04885530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105718|NCT04885530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105719|NCT04885530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93105720|NCT04885530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105721|NCT04885530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93105722|NCT04885530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93105723|NCT04885530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105724|NCT04885530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93105725|NCT04885530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93105726|NCT04885530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93105727|NCT04885530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93105728|NCT04885530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105729|NCT04885530|Serotonin Agents|serotonin agents|mesh-ancestor
93105730|NCT04885530|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93105731|NCT04885530|Antidepressive Agents|antidepressive agents|mesh-ancestor
93105732|NCT04885530|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93105733|NCT04885530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93105734|NCT04885530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93105735|NCT04883645|Imiquimod|imiquimod|mesh-list
93105736|NCT04883645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93105737|NCT04883645|Immunologic Factors|immunologic factors|mesh-ancestor
93105738|NCT04883645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105739|NCT04883645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105740|NCT04883645|Interferon Inducers|interferon inducers|mesh-ancestor
93105741|NCT04880499|Folic Acid|folic acid|mesh-list
93105742|NCT04880499|Riboflavin|riboflavin|mesh-list
93105743|NCT04880499|Vitamins|vitamins|mesh-ancestor
93105744|NCT04880499|Micronutrients|micronutrients|mesh-ancestor
93105745|NCT04880499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105746|NCT04880499|Hematinics|hematinics|mesh-ancestor
93105747|NCT04880499|Vitamin B Complex|vitamin b complex|mesh-ancestor
93105748|NCT04880499|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93105749|NCT04880499|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105750|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
93105751|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105752|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105753|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93105754|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
93105755|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93105756|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
93105757|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
93105758|NCT04852484|Ketamine|ketamine|mesh-list
93105759|NCT04852484|Morphine|morphine|mesh-list
93105760|NCT04852484|Anesthetics|anesthetics|mesh-list
93105761|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
93105762|NCT04852484|Analgesics|analgesics|mesh-ancestor
93105763|NCT04852484|Sensory System Agents|sensory system agents|mesh-ancestor
93105764|NCT04852484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105765|NCT04852484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105766|NCT04852484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93105767|NCT04852484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93105768|NCT04852484|Anesthetics, General|anesthetics, general|mesh-ancestor
93105769|NCT04852484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105770|NCT04852484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92695983|NCT02276859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93105771|NCT04852484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92778065|NCT05287360|Apatinib|apatinib|mesh-list
93105772|NCT04852484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105773|NCT04852484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105774|NCT04852484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93105775|NCT04852484|Narcotics|narcotics|mesh-ancestor
93105776|NCT04848480|Insulin|insulin|mesh-list
93105777|NCT04848480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93105778|NCT04848480|Insulin Aspart|insulin aspart|mesh-list
93105779|NCT04848480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93105780|NCT04848480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105781|NCT04838223|Proxymetacaine|proxymetacaine|mesh-list
93105782|NCT04838223|Anesthetics, Local|anesthetics, local|mesh-ancestor
93105783|NCT04838223|Anesthetics|anesthetics|mesh-ancestor
93105784|NCT04838223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93105785|NCT04838223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105786|NCT04838223|Sensory System Agents|sensory system agents|mesh-ancestor
93105787|NCT04838223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105788|NCT04829604|Immunoconjugates|immunoconjugates|mesh-list
93105789|NCT04829604|Immunologic Factors|immunologic factors|mesh-ancestor
93105790|NCT04829604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105791|NCT04827147|Methamphetamine|methamphetamine|mesh-list
93105792|NCT04827147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93105793|NCT04827147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105794|NCT04827147|Sympathomimetics|sympathomimetics|mesh-ancestor
93105795|NCT04827147|Autonomic Agents|autonomic agents|mesh-ancestor
93105796|NCT04827147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105797|NCT04827147|Dopamine Agents|dopamine agents|mesh-ancestor
93105798|NCT04827147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105799|NCT04827147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105800|NCT04827147|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105801|NCT04827147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93105802|NCT04827147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93105803|NCT04827147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93105804|NCT04827147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93105805|NCT04808505|Miglustat|miglustat|mesh-list
93105806|NCT04808505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105807|NCT04808505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105808|NCT04808505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93105809|NCT04808505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93105810|NCT04808505|Antiviral Agents|antiviral agents|mesh-ancestor
93105811|NCT04808505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105812|NCT04808505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93105813|NCT04808505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93105814|NCT04808505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105815|NCT04786873|Clonidine|clonidine|mesh-list
93105816|NCT04786873|Analgesics|analgesics|mesh-ancestor
93105817|NCT04786873|Sensory System Agents|sensory system agents|mesh-ancestor
93105818|NCT04786873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105819|NCT04786873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105820|NCT04786873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93105821|NCT04786873|Sympatholytics|sympatholytics|mesh-ancestor
93105822|NCT04786873|Autonomic Agents|autonomic agents|mesh-ancestor
93105823|NCT04786873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93105824|NCT04786873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93105825|NCT04786873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93105826|NCT04786873|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105827|NCT04786873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105828|NCT04786873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105829|NCT04781881|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93105830|NCT04781881|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93105831|NCT04781881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105832|NCT04771728|Metronidazole|metronidazole|mesh-list
93105833|NCT04771728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105834|NCT04771728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93105835|NCT04771728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93105836|NCT04771728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93105837|NCT04767074|Phenylpropanolamine|phenylpropanolamine|mesh-list
93105838|NCT04767074|Guaifenesin|guaifenesin|mesh-list
93105839|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93105840|NCT04767074|Expectorants|expectorants|mesh-ancestor
93105841|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
93105842|NCT04767074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93105843|NCT04767074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93105844|NCT04767074|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105845|NCT04767074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105846|NCT04767074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105847|NCT04767074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105848|NCT04767074|Appetite Depressants|appetite depressants|mesh-ancestor
93105849|NCT04767074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93105850|NCT04767074|Sympathomimetics|sympathomimetics|mesh-ancestor
93105851|NCT04767074|Autonomic Agents|autonomic agents|mesh-ancestor
93105852|NCT04767074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105853|NCT04767074|Nasal Decongestants|nasal decongestants|mesh-ancestor
93105854|NCT04767074|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93105855|NCT04764942|Dexamethasone|dexamethasone|mesh-list
93105856|NCT04764942|Dexamethasone acetate|dexamethasone acetate|mesh-list
93105857|NCT04764942|Pomalidomide|pomalidomide|mesh-list
93105858|NCT04764942|Ichthammol|ichthammol|mesh-list
93105859|NCT04764942|BB 1101|bb 1101|mesh-list
93105860|NCT04764942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105861|NCT04764942|Antiemetics|antiemetics|mesh-ancestor
93105862|NCT04764942|Autonomic Agents|autonomic agents|mesh-ancestor
93105863|NCT04764942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105864|NCT04764942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105865|NCT04764942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105866|NCT04764942|Glucocorticoids|glucocorticoids|mesh-ancestor
93105867|NCT04764942|Hormones|hormones|mesh-ancestor
93105868|NCT04764942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105869|NCT04764942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105870|NCT04764942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105871|NCT04764942|Protease Inhibitors|protease inhibitors|mesh-ancestor
93105872|NCT04764942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105873|NCT04764942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105874|NCT04764942|Immunologic Factors|immunologic factors|mesh-ancestor
93105875|NCT04764942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93105876|NCT04764942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93105877|NCT04764942|Growth Substances|growth substances|mesh-ancestor
93105878|NCT04764942|Growth Inhibitors|growth inhibitors|mesh-ancestor
93105879|NCT04764942|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105880|NCT04761614|Calcium, Dietary|calcium, dietary|mesh-list
93105881|NCT04761614|Leucovorin|leucovorin|mesh-list
93105882|NCT04761614|Folic Acid|folic acid|mesh-list
93105883|NCT04761614|Bevacizumab|bevacizumab|mesh-list
93105884|NCT04761614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93105885|NCT04761614|Fluorouracil|fluorouracil|mesh-list
93105886|NCT04761614|Oxaliplatin|oxaliplatin|mesh-list
93105887|NCT04761614|Riluzole|riluzole|mesh-list
93105888|NCT04761614|Endothelial Growth Factors|endothelial growth factors|mesh-list
93105889|NCT04761614|Antibodies|antibodies|mesh-list
93105890|NCT04761614|Immunoglobulins|immunoglobulins|mesh-list
93105891|NCT04761614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93105892|NCT04761614|Immunoglobulin G|immunoglobulin g|mesh-list
93105893|NCT04761614|Calcium|calcium|mesh-list
93105894|NCT04761614|Levoleucovorin|levoleucovorin|mesh-list
93105895|NCT04761614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105896|NCT04761614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93105897|NCT04761614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93105898|NCT04761614|Growth Substances|growth substances|mesh-ancestor
93105899|NCT04761614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105900|NCT04761614|Growth Inhibitors|growth inhibitors|mesh-ancestor
93105901|NCT04761614|Immunologic Factors|immunologic factors|mesh-ancestor
93105902|NCT04761614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93105903|NCT04761614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93105904|NCT04761614|Antimetabolites|antimetabolites|mesh-ancestor
93105905|NCT04761614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105906|NCT04761614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93105907|NCT04761614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93105908|NCT04761614|Antidotes|antidotes|mesh-ancestor
93105909|NCT04761614|Protective Agents|protective agents|mesh-ancestor
93105910|NCT04761614|Vitamin B Complex|vitamin b complex|mesh-ancestor
93105911|NCT04761614|Vitamins|vitamins|mesh-ancestor
93105912|NCT04761614|Micronutrients|micronutrients|mesh-ancestor
93105913|NCT04761614|Hematinics|hematinics|mesh-ancestor
93105914|NCT04761614|Anticonvulsants|anticonvulsants|mesh-ancestor
93105915|NCT04761614|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93105916|NCT04761614|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93105917|NCT04761614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105918|NCT04761614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93105919|NCT04760860|Prazosin|prazosin|mesh-list
93105920|NCT04760860|Terazosin|terazosin|mesh-list
93105921|NCT04760860|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93105922|NCT04760860|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93105923|NCT04760860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93105924|NCT04760860|Adrenergic Agents|adrenergic agents|mesh-ancestor
93105925|NCT04760860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93105926|NCT04760860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105927|NCT04760860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105928|NCT04760860|Urological Agents|urological agents|mesh-ancestor
93105929|NCT04760860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93105930|NCT04749108|Folfirinox|folfirinox|mesh-list
93105931|NCT04749108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105932|NCT04710199|Maraviroc|maraviroc|mesh-list
93105933|NCT04710199|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93105934|NCT04710199|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93105935|NCT04710199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105936|NCT04710199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93105937|NCT04710199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93105938|NCT04710199|Antiviral Agents|antiviral agents|mesh-ancestor
93105939|NCT04710199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105940|NCT04710199|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93105941|NCT04700176|Dexamethasone|dexamethasone|mesh-list
93105942|NCT04700176|Daratumumab|daratumumab|mesh-list
93105943|NCT04700176|Pomalidomide|pomalidomide|mesh-list
93105944|NCT04700176|Tretinoin|tretinoin|mesh-list
93105945|NCT04700176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93105946|NCT04700176|Antiemetics|antiemetics|mesh-ancestor
93105947|NCT04700176|Autonomic Agents|autonomic agents|mesh-ancestor
93105948|NCT04700176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93105949|NCT04700176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105950|NCT04700176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93105951|NCT04700176|Glucocorticoids|glucocorticoids|mesh-ancestor
93105952|NCT04700176|Hormones|hormones|mesh-ancestor
93105953|NCT04700176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105954|NCT04700176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93105955|NCT04700176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105956|NCT04700176|Immunologic Factors|immunologic factors|mesh-ancestor
93105957|NCT04700176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93105958|NCT04700176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93105959|NCT04700176|Growth Substances|growth substances|mesh-ancestor
93105960|NCT04700176|Growth Inhibitors|growth inhibitors|mesh-ancestor
93105961|NCT04700176|Keratolytic Agents|keratolytic agents|mesh-ancestor
93105962|NCT04700176|Dermatologic Agents|dermatologic agents|mesh-ancestor
93105963|NCT04699240|Clotrimazole|clotrimazole|mesh-list
93105964|NCT04699240|Miconazole|miconazole|mesh-list
93105965|NCT04699240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93105966|NCT04699240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93105967|NCT04699240|Antifungal Agents|antifungal agents|mesh-ancestor
93105968|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93105969|NCT04699240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93105970|NCT04699240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105971|NCT04699240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105972|NCT04699240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93105973|NCT04699240|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026435|NCT00493038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93105974|NCT04699240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93105975|NCT04699240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105976|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93105977|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93105978|NCT04688658|Nivolumab|nivolumab|mesh-list
93105979|NCT04688658|Axitinib|axitinib|mesh-list
93105980|NCT04688658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93105981|NCT04688658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105982|NCT04688658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93105983|NCT04688658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105984|NCT04688658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93105985|NCT04688658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93105986|NCT04673617|Cyclophosphamide|cyclophosphamide|mesh-list
93105987|NCT04673617|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93105988|NCT04673617|Rituximab|rituximab|mesh-list
93105989|NCT04673617|Fludarabine|fludarabine|mesh-list
93105990|NCT04673617|Interleukin-2|interleukin-2|mesh-list
93105991|NCT04673617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93105992|NCT04673617|Immunologic Factors|immunologic factors|mesh-ancestor
93105993|NCT04673617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93105994|NCT04673617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93105995|NCT04673617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93105996|NCT04673617|Alkylating Agents|alkylating agents|mesh-ancestor
93105997|NCT04673617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93105998|NCT04673617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93105999|NCT04673617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92778292|NCT01117350|Hormones|hormones|mesh-ancestor
93106000|NCT04673617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106001|NCT04673617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93106002|NCT04673617|Analgesics|analgesics|mesh-ancestor
93106003|NCT04673617|Sensory System Agents|sensory system agents|mesh-ancestor
93106004|NCT04673617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106005|NCT04666454|Adenosine|adenosine|mesh-list
93106006|NCT04666454|Dipyridamole|dipyridamole|mesh-list
93106007|NCT04666454|Apixaban|apixaban|mesh-list
93106008|NCT04666454|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93106009|NCT04666454|Antithrombins|antithrombins|mesh-ancestor
93106010|NCT04666454|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93106011|NCT04666454|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106012|NCT04666454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106013|NCT04666454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106014|NCT04666454|Anticoagulants|anticoagulants|mesh-ancestor
93106015|NCT04666454|Analgesics|analgesics|mesh-ancestor
93106016|NCT04666454|Sensory System Agents|sensory system agents|mesh-ancestor
93106017|NCT04666454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106018|NCT04666454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106019|NCT04666454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93106020|NCT04666454|Vasodilator Agents|vasodilator agents|mesh-ancestor
93106021|NCT04666454|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93106022|NCT04666454|Purinergic Agonists|purinergic agonists|mesh-ancestor
93106023|NCT04666454|Purinergic Agents|purinergic agents|mesh-ancestor
93106024|NCT04666454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106025|NCT04666454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93106026|NCT04666454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93106027|NCT04665856|Carboplatin|carboplatin|mesh-list
93106028|NCT04665856|Etoposide|etoposide|mesh-list
93106029|NCT04665856|Atezolizumab|atezolizumab|mesh-list
93106030|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106031|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93106032|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93106033|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93106034|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106035|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696258|NCT00507962|Doxorubicin|doxorubicin|mesh-list
93106036|NCT04665856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106037|NCT04665856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106038|NCT04658784|Cyclopropane|cyclopropane|mesh-list
93106039|NCT04658784|Anesthetics|anesthetics|mesh-ancestor
93106040|NCT04658784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106041|NCT04658784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106042|NCT04657640|Iron|iron|mesh-list
93106043|NCT04657640|Trace Elements|trace elements|mesh-list
93106044|NCT04657640|Folic Acid|folic acid|mesh-list
93106045|NCT04657640|Micronutrients|micronutrients|mesh-list
93106046|NCT04657640|Vitamin B Complex|vitamin b complex|mesh-list
93106047|NCT04657640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106048|NCT04657640|Hematinics|hematinics|mesh-ancestor
93106049|NCT04657640|Vitamins|vitamins|mesh-ancestor
93106050|NCT04622813|Acetaminophen|acetaminophen|mesh-list
93106051|NCT04622813|Ketoprofen|ketoprofen|mesh-list
93106052|NCT04622813|Nefopam|nefopam|mesh-list
93106053|NCT04622813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93106054|NCT04622813|Analgesics|analgesics|mesh-ancestor
93106055|NCT04622813|Sensory System Agents|sensory system agents|mesh-ancestor
93106056|NCT04622813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106057|NCT04622813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106058|NCT04622813|Antipyretics|antipyretics|mesh-ancestor
93106059|NCT04622813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93106060|NCT04622813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106061|NCT04622813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106062|NCT04622813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93106063|NCT04622813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106064|NCT04622813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106065|NCT04616963|Tenofovir|tenofovir|mesh-list
93106066|NCT04616963|Emtricitabine|emtricitabine|mesh-list
93106067|NCT04616963|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
93106068|NCT04616963|Antiviral Agents|antiviral agents|mesh-ancestor
93106069|NCT04616963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106070|NCT04616963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93106071|NCT04616963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93106072|NCT04616963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106073|NCT04616963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106074|NCT04616963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93106075|NCT04616963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93106076|NCT04606394|Albuterol|albuterol|mesh-list
93106077|NCT04606394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93106078|NCT04606394|Autonomic Agents|autonomic agents|mesh-ancestor
93106079|NCT04606394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106080|NCT04606394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106081|NCT04606394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93106082|NCT04606394|Respiratory System Agents|respiratory system agents|mesh-ancestor
93106083|NCT04606394|Tocolytic Agents|tocolytic agents|mesh-ancestor
93106084|NCT04606394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93106085|NCT04606394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93106086|NCT04606394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93106087|NCT04606394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93106088|NCT04606394|Adrenergic Agents|adrenergic agents|mesh-ancestor
93106089|NCT04606394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106090|NCT04606394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106091|NCT04588545|Trastuzumab|trastuzumab|mesh-list
93106092|NCT04588545|Pertuzumab|pertuzumab|mesh-list
93106093|NCT04588545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106094|NCT04588545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106095|NCT04586088|Apatinib|apatinib|mesh-list
93106096|NCT04586088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106097|NCT04586088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93106098|NCT04586088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106099|NCT04586088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106100|NCT04579523|Cyclophosphamide|cyclophosphamide|mesh-list
93106101|NCT04579523|Fludarabine|fludarabine|mesh-list
93106102|NCT04579523|Fludarabine phosphate|fludarabine phosphate|mesh-list
93106103|NCT04579523|Daratumumab|daratumumab|mesh-list
93106104|NCT04579523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93106105|NCT04579523|Antibodies|antibodies|mesh-list
93106106|NCT04579523|Immunoglobulins|immunoglobulins|mesh-list
93106107|NCT04579523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93106108|NCT04579523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106109|NCT04579523|Immunologic Factors|immunologic factors|mesh-ancestor
93106110|NCT04579523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106111|NCT04579523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106112|NCT04579523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93106113|NCT04579523|Alkylating Agents|alkylating agents|mesh-ancestor
93106114|NCT04579523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106115|NCT04579523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106116|NCT04579523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93106117|NCT04579523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106118|NCT04579523|Antimetabolites|antimetabolites|mesh-ancestor
93106119|NCT04579510|Vaccines|vaccines|mesh-list
93106120|NCT04579510|Immunologic Factors|immunologic factors|mesh-ancestor
93106121|NCT04579510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106122|NCT04579120|Corticosterone|corticosterone|mesh-list
93106123|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106124|NCT04564547|Islatravir|islatravir|mesh-list
93106125|NCT04564547|Antiviral Agents|antiviral agents|mesh-ancestor
93106126|NCT04564547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106127|NCT04564547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106128|NCT04564547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106129|NCT04564547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93106130|NCT04564547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93106131|NCT04564547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93106132|NCT04557735|Ravulizumab|ravulizumab|mesh-list
93106133|NCT04557735|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93106134|NCT04557735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106135|NCT04557735|Immunologic Factors|immunologic factors|mesh-ancestor
93106136|NCT04557735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106137|NCT04552223|Nivolumab|nivolumab|mesh-list
93106138|NCT04552223|Relatlimab|relatlimab|mesh-list
93106139|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106140|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106141|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106142|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106143|NCT04550442|Azacitidine|azacitidine|mesh-list
93106144|NCT04550442|Venetoclax|venetoclax|mesh-list
93106145|NCT04550442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106146|NCT04550442|Antimetabolites|antimetabolites|mesh-ancestor
93106147|NCT04550442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106148|NCT04550442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106149|NCT04550442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106150|NCT04527900|Paclitaxel|paclitaxel|mesh-list
93106151|NCT04527900|Carboplatin|carboplatin|mesh-list
93106152|NCT04527900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92778434|NCT00902668|L 647318|l 647318|mesh-list
93106153|NCT04527900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106154|NCT04527900|Tubulin Modulators|tubulin modulators|mesh-ancestor
93106155|NCT04527900|Antimitotic Agents|antimitotic agents|mesh-ancestor
93106156|NCT04527900|Mitosis Modulators|mitosis modulators|mesh-ancestor
93106157|NCT04527900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106158|NCT04549168|Lemborexant|lemborexant|mesh-list
93106159|NCT04549168|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93106160|NCT04549168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106161|NCT04549168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106162|NCT04549168|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93106163|NCT04549168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93106164|NCT04549168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106165|NCT04549168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106166|NCT04509050|Ivacaftor|ivacaftor|mesh-list
93106167|NCT04509050|Elexacaftor|elexacaftor|mesh-list
93106168|NCT04509050|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93106169|NCT04509050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93106170|NCT04509050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106171|NCT04499248|Bimatoprost|bimatoprost|mesh-list
93106172|NCT04499248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93106173|NCT04478734|Thiamine|thiamine|mesh-list
93106174|NCT04478734|Biotin|biotin|mesh-list
93106175|NCT04478734|Vitamin B Complex|vitamin b complex|mesh-ancestor
93106176|NCT04478734|Vitamins|vitamins|mesh-ancestor
93106177|NCT04478734|Micronutrients|micronutrients|mesh-ancestor
93106178|NCT04478734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106179|NCT04459117|Acetaminophen|acetaminophen|mesh-list
93106180|NCT04459117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93106181|NCT04459117|Analgesics|analgesics|mesh-ancestor
93106182|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
93106183|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106184|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106185|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
93106186|NCT04456439|Diphenhydramine|diphenhydramine|mesh-list
93106187|NCT04456439|Promethazine|promethazine|mesh-list
93106188|NCT04456439|Remestemcel-l|remestemcel-l|mesh-list
93106189|NCT04456439|Hydrocortisone|hydrocortisone|mesh-list
93106190|NCT04456439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106191|NCT04456439|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93106192|NCT04456439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93106193|NCT04456439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106194|NCT04456439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106195|NCT04456439|Anesthetics, Local|anesthetics, local|mesh-ancestor
93106196|NCT04456439|Anesthetics|anesthetics|mesh-ancestor
93106197|NCT04456439|Sensory System Agents|sensory system agents|mesh-ancestor
93106198|NCT04456439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106199|NCT04456439|Antiemetics|antiemetics|mesh-ancestor
93106200|NCT04456439|Autonomic Agents|autonomic agents|mesh-ancestor
93106201|NCT04456439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106202|NCT04456439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93106203|NCT04456439|Histamine Antagonists|histamine antagonists|mesh-ancestor
93106204|NCT04456439|Histamine Agents|histamine agents|mesh-ancestor
93106205|NCT04456439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106206|NCT04456439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106207|NCT04456439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93106208|NCT04456439|Antipruritics|antipruritics|mesh-ancestor
93106209|NCT04456439|Dermatologic Agents|dermatologic agents|mesh-ancestor
93106210|NCT04456439|Antiviral Agents|antiviral agents|mesh-ancestor
93106211|NCT04456439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106212|NCT04445714|Dapagliflozin|dapagliflozin|mesh-list
93106213|NCT04445714|Saxagliptin|saxagliptin|mesh-list
93106214|NCT04445714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93106215|NCT04445714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106216|NCT04445714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93106217|NCT04445714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106218|NCT04445714|Incretins|incretins|mesh-ancestor
93106219|NCT04445714|Hormones|hormones|mesh-ancestor
93106220|NCT04445714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106221|NCT04445714|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93106222|NCT04445714|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106223|NCT04445714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106224|NCT04435704|Oxytocin|oxytocin|mesh-list
93106225|NCT04435704|Oxytocics|oxytocics|mesh-ancestor
93106226|NCT04435704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93106227|NCT04435704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106228|NCT04433741|Oxytocin|oxytocin|mesh-list
93106229|NCT04433741|Oxytocics|oxytocics|mesh-ancestor
93106230|NCT04433741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93106231|NCT04433741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106232|NCT04431700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93106233|NCT04431206|Oxytocin|oxytocin|mesh-list
93106234|NCT04431206|Oxytocics|oxytocics|mesh-ancestor
93106235|NCT04431206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93106236|NCT04431206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106237|NCT04427709|Oxytocin|oxytocin|mesh-list
93106238|NCT04427709|Oxytocics|oxytocics|mesh-ancestor
93106239|NCT04427709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93106240|NCT04427709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106241|NCT04415476|Mycophenolic Acid|mycophenolic acid|mesh-list
93106242|NCT04415476|Sirolimus|sirolimus|mesh-list
93106243|NCT04415476|Prednisone|prednisone|mesh-list
93106244|NCT04415476|Tacrolimus|tacrolimus|mesh-list
93106245|NCT04415476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106246|NCT04415476|Glucocorticoids|glucocorticoids|mesh-ancestor
93106247|NCT04415476|Hormones|hormones|mesh-ancestor
93106248|NCT04415476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106249|NCT04415476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106250|NCT04415476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106251|NCT04415476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106252|NCT04415476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106253|NCT04415476|Immunologic Factors|immunologic factors|mesh-ancestor
93106254|NCT04415476|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93106255|NCT04415476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106256|NCT04415476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106257|NCT04415476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93106258|NCT04415476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93106259|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
93106260|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93106261|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106262|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
93106263|NCT04389567|Famotidine|famotidine|mesh-list
93106264|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93106265|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106266|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93106267|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
93106268|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
93106269|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106270|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106271|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106272|NCT04386967|Pembrolizumab|pembrolizumab|mesh-list
93106273|NCT04386967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106274|NCT04386967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106275|NCT04386967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106276|NCT04386967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106277|NCT04384367|Naproxen|naproxen|mesh-list
93106278|NCT04384367|Rizatriptan|rizatriptan|mesh-list
93106279|NCT04384367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93106280|NCT04384367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93106281|NCT04384367|Analgesics|analgesics|mesh-ancestor
93106282|NCT04384367|Sensory System Agents|sensory system agents|mesh-ancestor
93106283|NCT04384367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106284|NCT04384367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106285|NCT04384367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106286|NCT04384367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106287|NCT04384367|Gout Suppressants|gout suppressants|mesh-ancestor
93106288|NCT04384367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93106289|NCT04384367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696506|NCT00509639|Metronidazole|metronidazole|mesh-list
93106290|NCT04384367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106291|NCT04384367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93106292|NCT04384367|Serotonin Agents|serotonin agents|mesh-ancestor
93106293|NCT04384367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106294|NCT04378933|Methamphetamine|methamphetamine|mesh-list
93106295|NCT04378933|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93106296|NCT04378933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106297|NCT04378933|Sympathomimetics|sympathomimetics|mesh-ancestor
93106298|NCT04378933|Autonomic Agents|autonomic agents|mesh-ancestor
93106299|NCT04378933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106300|NCT04378933|Dopamine Agents|dopamine agents|mesh-ancestor
93106301|NCT04378933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106302|NCT04378933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106303|NCT04378933|Adrenergic Agents|adrenergic agents|mesh-ancestor
93106304|NCT04378933|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93106305|NCT04378933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93106306|NCT04378933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93106307|NCT04378933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93106308|NCT04341259|Ipatasertib|ipatasertib|mesh-list
93106309|NCT04341259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106310|NCT04341259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93106311|NCT04341259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106312|NCT04341259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106313|NCT04341116|Plonmarlimab|plonmarlimab|mesh-list
93106314|NCT04341116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106315|NCT04341116|Antiviral Agents|antiviral agents|mesh-ancestor
93106316|NCT04341116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106317|NCT04335006|Paclitaxel|paclitaxel|mesh-list
93106318|NCT04335006|Apatinib|apatinib|mesh-list
93106319|NCT04335006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93106320|NCT04335006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106321|NCT04335006|Tubulin Modulators|tubulin modulators|mesh-ancestor
93106322|NCT04335006|Antimitotic Agents|antimitotic agents|mesh-ancestor
93106323|NCT04335006|Mitosis Modulators|mitosis modulators|mesh-ancestor
93106324|NCT04335006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106325|NCT04335006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93106326|NCT04335006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106327|NCT04323956|Prednisone|prednisone|mesh-list
93106328|NCT04323956|Cortisone|cortisone|mesh-list
93106329|NCT04323956|Cyclophosphamide|cyclophosphamide|mesh-list
93106330|NCT04323956|Rituximab|rituximab|mesh-list
93106331|NCT04323956|Doxorubicin|doxorubicin|mesh-list
93106332|NCT04323956|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93106333|NCT04323956|Vincristine|vincristine|mesh-list
93106334|NCT04323956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93106335|NCT04323956|Antibodies|antibodies|mesh-list
93106336|NCT04323956|Immunoglobulins|immunoglobulins|mesh-list
93106337|NCT04323956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93106338|NCT04323956|Lenograstim|lenograstim|mesh-list
93106339|NCT04323956|Immunoconjugates|immunoconjugates|mesh-list
93106340|NCT04323956|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93106341|NCT04323956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106342|NCT04323956|Immunologic Factors|immunologic factors|mesh-ancestor
93106343|NCT04323956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106344|NCT04323956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106345|NCT04323956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93106346|NCT04323956|Alkylating Agents|alkylating agents|mesh-ancestor
93106347|NCT04323956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106348|NCT04323956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106349|NCT04323956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93106350|NCT04323956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93106351|NCT04323956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93106352|NCT04323956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93106353|NCT04323956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106354|NCT04323956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106355|NCT04323956|Glucocorticoids|glucocorticoids|mesh-ancestor
93106356|NCT04323956|Hormones|hormones|mesh-ancestor
93106357|NCT04323956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106358|NCT04323956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106359|NCT04323956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93106360|NCT04323956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93106361|NCT04323956|Tubulin Modulators|tubulin modulators|mesh-ancestor
93106362|NCT04323956|Antimitotic Agents|antimitotic agents|mesh-ancestor
93106363|NCT04323956|Mitosis Modulators|mitosis modulators|mesh-ancestor
93106364|NCT04321330|Atezolizumab|atezolizumab|mesh-list
93106365|NCT04321330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106366|NCT04321330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106367|NCT04321330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106368|NCT04321330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106369|NCT04318548|Vaccines|vaccines|mesh-list
93106370|NCT04318548|Immunologic Factors|immunologic factors|mesh-ancestor
93106371|NCT04318548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106372|NCT04315233|Belinostat|belinostat|mesh-list
93106373|NCT04315233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106374|NCT04315233|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93106375|NCT04315233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106376|NCT04315233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106377|NCT04313088|Eluxadoline|eluxadoline|mesh-list
93106378|NCT04313088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106379|NCT04301843|Eflornithine|eflornithine|mesh-list
93106380|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106381|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93106382|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93106383|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93106384|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106385|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93106386|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106387|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106388|NCT04299373|Ethanol|ethanol|mesh-list
93106389|NCT04299373|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93106390|NCT04299373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106391|NCT04299373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106392|NCT04299373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106393|NCT04294264|Trifluridine|trifluridine|mesh-list
93106394|NCT04294264|Oxaliplatin|oxaliplatin|mesh-list
93106395|NCT04294264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106396|NCT04294264|Antimetabolites|antimetabolites|mesh-ancestor
93106397|NCT04294264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106398|NCT04294264|Antiviral Agents|antiviral agents|mesh-ancestor
93106399|NCT04294264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106400|NCT04292808|Methoxyflurane|methoxyflurane|mesh-list
93106401|NCT04292808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93106402|NCT04292808|Anesthetics, General|anesthetics, general|mesh-ancestor
93106403|NCT04292808|Anesthetics|anesthetics|mesh-ancestor
93106404|NCT04292808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106405|NCT04292808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106406|NCT04250805|Lidocaine|lidocaine|mesh-list
93106407|NCT04250805|Ropivacaine|ropivacaine|mesh-list
93106408|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
93106409|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
93106410|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106411|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106412|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
93106413|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106414|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93106415|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93106416|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93106417|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93106418|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106419|NCT04233190|Budesonide|budesonide|mesh-list
93106420|NCT04233190|Formoterol Fumarate|formoterol fumarate|mesh-list
93106421|NCT04233190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93106422|NCT04233190|Autonomic Agents|autonomic agents|mesh-ancestor
93106423|NCT04233190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106424|NCT04233190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106425|NCT04233190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93106426|NCT04233190|Respiratory System Agents|respiratory system agents|mesh-ancestor
93106427|NCT04233190|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93106428|NCT04233190|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93106429|NCT04233190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93106430|NCT04233190|Adrenergic Agents|adrenergic agents|mesh-ancestor
93106431|NCT04233190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106432|NCT04233190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106433|NCT04233190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106434|NCT04233190|Glucocorticoids|glucocorticoids|mesh-ancestor
93106435|NCT04233190|Hormones|hormones|mesh-ancestor
93106436|NCT04233190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106437|NCT04230304|Daratumumab|daratumumab|mesh-list
93106438|NCT04230304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106439|NCT04214834|Morphine|morphine|mesh-list
93106440|NCT04214834|Methadone|methadone|mesh-list
93106441|NCT04214834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93106442|NCT04214834|Narcotics|narcotics|mesh-ancestor
93106443|NCT04214834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106444|NCT04214834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106445|NCT04214834|Analgesics|analgesics|mesh-ancestor
93106446|NCT04214834|Sensory System Agents|sensory system agents|mesh-ancestor
93106447|NCT04214834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106448|NCT04214834|Antitussive Agents|antitussive agents|mesh-ancestor
93106449|NCT04214834|Respiratory System Agents|respiratory system agents|mesh-ancestor
93106450|NCT04161118|Tisagenlecleucel|tisagenlecleucel|mesh-list
93106451|NCT04161118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106452|NCT04161118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106453|NCT04134884|Talazoparib|talazoparib|mesh-list
93106454|NCT04134884|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93106455|NCT04134884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93106456|NCT04134884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106457|NCT04134884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106458|NCT04134884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106459|NCT04134884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106460|NCT04134884|Antimetabolites|antimetabolites|mesh-ancestor
93106461|NCT04119037|Morphine|morphine|mesh-list
93106462|NCT04119037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93106463|NCT04119037|Narcotics|narcotics|mesh-ancestor
93106464|NCT04119037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106465|NCT04119037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106466|NCT04119037|Analgesics|analgesics|mesh-ancestor
93106467|NCT04119037|Sensory System Agents|sensory system agents|mesh-ancestor
93106468|NCT04119037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106469|NCT04117087|Nivolumab|nivolumab|mesh-list
93106470|NCT04117087|Ipilimumab|ipilimumab|mesh-list
93106471|NCT04117087|Poly ICLC|poly iclc|mesh-list
93106472|NCT04117087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106473|NCT04117087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106474|NCT04117087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106475|NCT04117087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106476|NCT04117087|Interferon Inducers|interferon inducers|mesh-ancestor
93106477|NCT04117087|Immunologic Factors|immunologic factors|mesh-ancestor
93106478|NCT04117087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106479|NCT04071769|Xenon|xenon|mesh-list
93106480|NCT04071769|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93106481|NCT04071769|Anesthetics, General|anesthetics, general|mesh-ancestor
93106482|NCT04071769|Anesthetics|anesthetics|mesh-ancestor
93106483|NCT04071769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106484|NCT04071769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106485|NCT04052568|Psilocybin|psilocybin|mesh-list
93106486|NCT04052568|Hallucinogens|hallucinogens|mesh-ancestor
93106487|NCT04052568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106488|NCT04052568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93106489|NCT04050670|Tirzepatide|tirzepatide|mesh-list
93106490|NCT04050670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93106491|NCT04050670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106492|NCT04050670|Incretins|incretins|mesh-ancestor
93106493|NCT04050670|Hormones|hormones|mesh-ancestor
93106494|NCT04050670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106495|NCT04049084|Adenosine|adenosine|mesh-list
93106496|NCT04049084|Analgesics|analgesics|mesh-ancestor
93106497|NCT04049084|Sensory System Agents|sensory system agents|mesh-ancestor
93106498|NCT04049084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106499|NCT04049084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106500|NCT04049084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93106501|NCT04049084|Vasodilator Agents|vasodilator agents|mesh-ancestor
93106502|NCT04049084|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93106503|NCT04049084|Purinergic Agonists|purinergic agonists|mesh-ancestor
93106504|NCT04049084|Purinergic Agents|purinergic agents|mesh-ancestor
93106505|NCT04049084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106506|NCT04049084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106507|NCT04035486|Carboplatin|carboplatin|mesh-list
93106508|NCT04035486|Pemetrexed|pemetrexed|mesh-list
93106509|NCT04035486|Osimertinib|osimertinib|mesh-list
93106510|NCT04035486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106511|NCT04035486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106512|NCT04035486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106513|NCT04035486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93106514|NCT04035486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93106515|NCT04035486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93106516|NCT04022967|Ritonavir|ritonavir|mesh-list
93106517|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93106518|NCT04022967|Tenofovir|tenofovir|mesh-list
93106519|NCT04022967|Lamivudine|lamivudine|mesh-list
93106520|NCT04022967|Dolutegravir|dolutegravir|mesh-list
93106521|NCT04022967|Efavirenz|efavirenz|mesh-list
93106522|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93106523|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93106524|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106525|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106526|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106527|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93106528|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92778813|NCT02642419|Clopidogrel|clopidogrel|mesh-list
93106529|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
93106530|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106531|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93106532|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93106533|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93106534|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93106535|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93106536|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93106537|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93106538|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93106539|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93106540|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93106541|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93106542|NCT04016714|Vaccines|vaccines|mesh-list
93106543|NCT04016714|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93106544|NCT04016714|Immunologic Factors|immunologic factors|mesh-ancestor
93106545|NCT04016714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106546|NCT03988530|Scopolamine|scopolamine|mesh-list
93106547|NCT03988530|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93106548|NCT03988530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93106549|NCT03988530|Antiemetics|antiemetics|mesh-ancestor
93106550|NCT03988530|Autonomic Agents|autonomic agents|mesh-ancestor
93106551|NCT03988530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106552|NCT03988530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106553|NCT03988530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106554|NCT03988530|Mydriatics|mydriatics|mesh-ancestor
93106555|NCT03988530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93106556|NCT03988530|Cholinergic Agents|cholinergic agents|mesh-ancestor
93106557|NCT03988530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026436|NCT00493038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93106558|NCT03988530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106559|NCT03988530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93106560|NCT03988530|Parasympatholytics|parasympatholytics|mesh-ancestor
93106561|NCT03984188|Theophylline|theophylline|mesh-list
93106562|NCT03984188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93106563|NCT03984188|Autonomic Agents|autonomic agents|mesh-ancestor
93106564|NCT03984188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106565|NCT03984188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106566|NCT03984188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93106567|NCT03984188|Respiratory System Agents|respiratory system agents|mesh-ancestor
93106568|NCT03984188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93106569|NCT03984188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106570|NCT03984188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106571|NCT03984188|Vasodilator Agents|vasodilator agents|mesh-ancestor
93106572|NCT03984188|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93106573|NCT03984188|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93106574|NCT03984188|Purinergic Agents|purinergic agents|mesh-ancestor
93106575|NCT03984188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106576|NCT03983824|Cytarabine|cytarabine|mesh-list
93106577|NCT03983824|Etoposide|etoposide|mesh-list
93106578|NCT03983824|Mitoxantrone|mitoxantrone|mesh-list
93106579|NCT03983824|Etoposide phosphate|etoposide phosphate|mesh-list
93106580|NCT03983824|Peposertib|peposertib|mesh-list
93106581|NCT03983824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93106582|NCT03983824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106583|NCT03983824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93106584|NCT03983824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93106585|NCT03983824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106586|NCT03983824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106587|NCT03983824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106588|NCT03983824|Antimetabolites|antimetabolites|mesh-ancestor
93106589|NCT03983824|Antiviral Agents|antiviral agents|mesh-ancestor
93106590|NCT03983824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106591|NCT03983824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106592|NCT03983824|Immunologic Factors|immunologic factors|mesh-ancestor
93106593|NCT03983824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106594|NCT03983824|Analgesics|analgesics|mesh-ancestor
93106595|NCT03983824|Sensory System Agents|sensory system agents|mesh-ancestor
93106596|NCT03983824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106597|NCT03983824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93106598|NCT03980769|Fludarabine|fludarabine|mesh-list
93106599|NCT03980769|Fludarabine phosphate|fludarabine phosphate|mesh-list
93106600|NCT03980769|Thiotepa|thiotepa|mesh-list
93106601|NCT03980769|Treosulfan|treosulfan|mesh-list
93106602|NCT03980769|Busulfan|busulfan|mesh-list
93106603|NCT03980769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93106604|NCT03980769|Thymoglobulin|thymoglobulin|mesh-list
93106605|NCT03980769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106606|NCT03980769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106607|NCT03980769|Antimetabolites|antimetabolites|mesh-ancestor
92778885|NCT02637193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106608|NCT03980769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106609|NCT03980769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106610|NCT03980769|Immunologic Factors|immunologic factors|mesh-ancestor
93106611|NCT03980769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106612|NCT03980769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93106613|NCT03980769|Alkylating Agents|alkylating agents|mesh-ancestor
93106614|NCT03980769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93106615|NCT03972657|Cemiplimab|cemiplimab|mesh-list
93106616|NCT03972657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106617|NCT03972657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106618|NCT03971422|Rozanolixizumab|rozanolixizumab|mesh-list
93106619|NCT03971422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106620|NCT03971422|Immunologic Factors|immunologic factors|mesh-ancestor
93106621|NCT03971422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106622|NCT03948243|Tolbutamide|tolbutamide|mesh-list
93106623|NCT03948243|Dextromethorphan|dextromethorphan|mesh-list
93106624|NCT03948243|Alprazolam|alprazolam|mesh-list
93106625|NCT03948243|Caffeine|caffeine|mesh-list
93106626|NCT03948243|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93106627|NCT03948243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106628|NCT03948243|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93106629|NCT03948243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106630|NCT03948243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106631|NCT03948243|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93106632|NCT03948243|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93106633|NCT03948243|Purinergic Agents|purinergic agents|mesh-ancestor
93106634|NCT03948243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106635|NCT03948243|Antitussive Agents|antitussive agents|mesh-ancestor
93106636|NCT03948243|Respiratory System Agents|respiratory system agents|mesh-ancestor
93106637|NCT03948243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93106638|NCT03948243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93106639|NCT03948243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93106640|NCT03948243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106641|NCT03948243|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93106642|NCT03948243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93106643|NCT03948243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93106644|NCT03948243|GABA Modulators|gaba modulators|mesh-ancestor
93106645|NCT03948243|GABA Agents|gaba agents|mesh-ancestor
93106646|NCT03948243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93106647|NCT03948035|Dexamethasone|dexamethasone|mesh-list
93106648|NCT03948035|Dexamethasone acetate|dexamethasone acetate|mesh-list
93106649|NCT03948035|Lenalidomide|lenalidomide|mesh-list
93106650|NCT03948035|Elotuzumab|elotuzumab|mesh-list
93106651|NCT03948035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106652|NCT03948035|Antiemetics|antiemetics|mesh-ancestor
93106653|NCT03948035|Autonomic Agents|autonomic agents|mesh-ancestor
93106654|NCT03948035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106655|NCT03948035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106656|NCT03948035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106657|NCT03948035|Glucocorticoids|glucocorticoids|mesh-ancestor
93106658|NCT03948035|Hormones|hormones|mesh-ancestor
93106659|NCT03948035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106660|NCT03948035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106661|NCT03948035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106662|NCT03948035|Immunologic Factors|immunologic factors|mesh-ancestor
93106663|NCT03948035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93106664|NCT03948035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93106665|NCT03948035|Growth Substances|growth substances|mesh-ancestor
93106666|NCT03948035|Growth Inhibitors|growth inhibitors|mesh-ancestor
93106667|NCT03946124|Fesoterodine|fesoterodine|mesh-list
93106668|NCT03946124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93106669|NCT03946124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93106670|NCT03946124|Cholinergic Agents|cholinergic agents|mesh-ancestor
93106671|NCT03946124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106672|NCT03946124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106673|NCT03946124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106674|NCT03946124|Urological Agents|urological agents|mesh-ancestor
93106675|NCT03942224|Dexamethasone|dexamethasone|mesh-list
93106676|NCT03942224|Bortezomib|bortezomib|mesh-list
93106677|NCT03942224|Daratumumab|daratumumab|mesh-list
93106678|NCT03942224|Ixazomib|ixazomib|mesh-list
93106679|NCT03942224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106680|NCT03942224|Antiemetics|antiemetics|mesh-ancestor
93106681|NCT03942224|Autonomic Agents|autonomic agents|mesh-ancestor
93106682|NCT03942224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106683|NCT03942224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778963|NCT00653341|Insulin|insulin|mesh-list
93106684|NCT03942224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106685|NCT03942224|Glucocorticoids|glucocorticoids|mesh-ancestor
93106686|NCT03942224|Hormones|hormones|mesh-ancestor
93106687|NCT03942224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106688|NCT03942224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106689|NCT03942224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106690|NCT03942224|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106691|NCT03942224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106692|NCT03942224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106693|NCT03938701|Adalimumab|adalimumab|mesh-list
93106694|NCT03938701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93106695|NCT03938701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106696|NCT03938701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106697|NCT03936933|Goserelin|goserelin|mesh-list
93106698|NCT03936933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106699|NCT03936933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106700|NCT03936218|Goserelin|goserelin|mesh-list
93106701|NCT03936218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106702|NCT03936218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106703|NCT03895099|Desogestrel|desogestrel|mesh-list
93106704|NCT03895099|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93106705|NCT03895099|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93106706|NCT03895099|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93106707|NCT03895099|Contraceptive Agents|contraceptive agents|mesh-ancestor
93106708|NCT03895099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93106709|NCT03895099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106710|NCT03895099|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93106711|NCT03895099|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93106712|NCT03895099|Progestins|progestins|mesh-ancestor
93106713|NCT03895099|Hormones|hormones|mesh-ancestor
93106714|NCT03895099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106715|NCT03879798|Irinotecan|irinotecan|mesh-list
93106716|NCT03879798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93106717|NCT03879798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93106718|NCT03879798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106719|NCT03879798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106720|NCT03879798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106721|NCT03861390|Prednisone|prednisone|mesh-list
93106722|NCT03861390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106723|NCT03861390|Glucocorticoids|glucocorticoids|mesh-ancestor
93106724|NCT03861390|Hormones|hormones|mesh-ancestor
93106725|NCT03861390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106726|NCT03861390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106727|NCT03861390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106728|NCT03861390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106729|NCT03818685|Capecitabine|capecitabine|mesh-list
93106730|NCT03818685|Nivolumab|nivolumab|mesh-list
93106731|NCT03818685|Ipilimumab|ipilimumab|mesh-list
93106732|NCT03818685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106733|NCT03818685|Antimetabolites|antimetabolites|mesh-ancestor
93106734|NCT03818685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106735|NCT03818685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106736|NCT03818685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106737|NCT03818685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106738|NCT03815643|Avelumab|avelumab|mesh-list
93106739|NCT03815643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106740|NCT03815643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106741|NCT03815058|Pembrolizumab|pembrolizumab|mesh-list
93106742|NCT03815058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106743|NCT03815058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106744|NCT03815058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106745|NCT03815058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106746|NCT03801122|Tranexamic Acid|tranexamic acid|mesh-list
93106747|NCT03801122|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93106748|NCT03801122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93106749|NCT03801122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106750|NCT03801122|Hemostatics|hemostatics|mesh-ancestor
93106751|NCT03801122|Coagulants|coagulants|mesh-ancestor
93106752|NCT03797066|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
93106753|NCT03797066|Antiviral Agents|antiviral agents|mesh-ancestor
93106754|NCT03797066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106755|NCT03771677|Interferons|interferons|mesh-list
93106756|NCT03771677|Interferon-alpha|interferon-alpha|mesh-list
93106757|NCT03771677|Interferon alpha-2|interferon alpha-2|mesh-list
93106758|NCT03771677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106759|NCT03771677|Antiviral Agents|antiviral agents|mesh-ancestor
93106760|NCT03771677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106761|NCT03771677|Immunologic Factors|immunologic factors|mesh-ancestor
93106762|NCT03771677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106764|NCT03771651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93106765|NCT03771651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93106766|NCT03771651|Analgesics|analgesics|mesh-ancestor
93106767|NCT03771651|Sensory System Agents|sensory system agents|mesh-ancestor
93106768|NCT03771651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106769|NCT03771651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106770|NCT03771651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106771|NCT03771651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106772|NCT03771651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93106773|NCT03771651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93106774|NCT03771651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106775|NCT03771651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93106776|NCT03771651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93106777|NCT03771651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106778|NCT03771651|Antipyretics|antipyretics|mesh-ancestor
93106779|NCT03770767|Insulin|insulin|mesh-list
93106780|NCT03770767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93106781|NCT03770767|Insulin Aspart|insulin aspart|mesh-list
93106782|NCT03770767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93106783|NCT03770767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106784|NCT03769155|Nivolumab|nivolumab|mesh-list
93106785|NCT03769155|Ipilimumab|ipilimumab|mesh-list
93106786|NCT03769155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106787|NCT03769155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106788|NCT03769155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106789|NCT03769155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106790|NCT03756896|Dexamethasone|dexamethasone|mesh-list
93106791|NCT03756896|Pomalidomide|pomalidomide|mesh-list
93106792|NCT03756896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106793|NCT03756896|Antiemetics|antiemetics|mesh-ancestor
93106794|NCT03756896|Autonomic Agents|autonomic agents|mesh-ancestor
93106795|NCT03756896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106796|NCT03756896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106797|NCT03756896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106798|NCT03756896|Glucocorticoids|glucocorticoids|mesh-ancestor
93106799|NCT03756896|Hormones|hormones|mesh-ancestor
93106800|NCT03756896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106801|NCT03756896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106802|NCT03756896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106803|NCT03756896|Immunologic Factors|immunologic factors|mesh-ancestor
93106804|NCT03756896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93106805|NCT03756896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93106806|NCT03756896|Growth Substances|growth substances|mesh-ancestor
93106807|NCT03756896|Growth Inhibitors|growth inhibitors|mesh-ancestor
93106808|NCT03747575|Astegolimab|astegolimab|mesh-list
93106809|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93106810|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106811|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
93106812|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106813|NCT03747419|Avelumab|avelumab|mesh-list
93106814|NCT03747419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106815|NCT03747419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106816|NCT03733145|Angiotensin II|angiotensin ii|mesh-list
93106817|NCT03733145|Giapreza|giapreza|mesh-list
93106818|NCT03733145|Angiotensinogen|angiotensinogen|mesh-list
92697036|NCT00512057|Antimetabolites|antimetabolites|mesh-ancestor
93106819|NCT03733145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93106820|NCT03733145|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93106821|NCT03733145|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106822|NCT03733145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106823|NCT03733145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106824|NCT03715972|Hydroxyurea|hydroxyurea|mesh-list
93106825|NCT03715972|Acetazolamide|acetazolamide|mesh-list
93106826|NCT03715972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106827|NCT03715972|Antisickling Agents|antisickling agents|mesh-ancestor
93106828|NCT03715972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106829|NCT03715972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106830|NCT03715972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92779113|NCT00212836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106831|NCT03715972|Anticonvulsants|anticonvulsants|mesh-ancestor
93106832|NCT03715972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93106833|NCT03715972|Diuretics|diuretics|mesh-ancestor
93106834|NCT03715972|Natriuretic Agents|natriuretic agents|mesh-ancestor
93106835|NCT03715972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106836|NCT03702218|Antiviral Agents|antiviral agents|mesh-list
93106837|NCT03702218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93106838|NCT03691714|Cetuximab|cetuximab|mesh-list
93106839|NCT03691714|Durvalumab|durvalumab|mesh-list
93106840|NCT03691714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106841|NCT03691714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106842|NCT03691493|Tamoxifen|tamoxifen|mesh-list
93106843|NCT03691493|Letrozole|letrozole|mesh-list
93106844|NCT03691493|Fulvestrant|fulvestrant|mesh-list
93106845|NCT03691493|Palbociclib|palbociclib|mesh-list
93106846|NCT03691493|Anastrozole|anastrozole|mesh-list
93106847|NCT03691493|Exemestane|exemestane|mesh-list
93106848|NCT03691493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106849|NCT03691493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93106850|NCT03691493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93106851|NCT03691493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106852|NCT03691493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106853|NCT03691493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93106854|NCT03691493|Hormone Antagonists|hormone antagonists|mesh-ancestor
93106855|NCT03691493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106856|NCT03691493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106857|NCT03691493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106858|NCT03691493|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93106859|NCT03691493|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93106860|NCT03691493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93106861|NCT03691493|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93106862|NCT03691493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93106863|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
93106864|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106865|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106866|NCT03634540|Belzutifan|belzutifan|mesh-list
93106867|NCT03634540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106868|NCT03631706|Pembrolizumab|pembrolizumab|mesh-list
93106869|NCT03631706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106870|NCT03631706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106871|NCT03631706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106872|NCT03631706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106873|NCT03619876|Adalimumab|adalimumab|mesh-list
93106874|NCT03619876|Abatacept|abatacept|mesh-list
93106875|NCT03619876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93106876|NCT03619876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106877|NCT03619876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93106878|NCT03619876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106879|NCT03619876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106880|NCT03619876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106881|NCT03619876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106882|NCT03619876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93106883|NCT03619876|Immunologic Factors|immunologic factors|mesh-ancestor
93106884|NCT03619876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106885|NCT03605901|Methadone|methadone|mesh-list
93106886|NCT03605901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93106887|NCT03605901|Narcotics|narcotics|mesh-ancestor
93106888|NCT03605901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106889|NCT03605901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106890|NCT03605901|Analgesics|analgesics|mesh-ancestor
93106891|NCT03605901|Sensory System Agents|sensory system agents|mesh-ancestor
93106892|NCT03605901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106893|NCT03605901|Antitussive Agents|antitussive agents|mesh-ancestor
93106894|NCT03605901|Respiratory System Agents|respiratory system agents|mesh-ancestor
93106895|NCT03583255|Dexamethasone|dexamethasone|mesh-list
93106896|NCT03583255|Dexamethasone acetate|dexamethasone acetate|mesh-list
93106897|NCT03583255|Ichthammol|ichthammol|mesh-list
93106898|NCT03583255|BB 1101|bb 1101|mesh-list
93106899|NCT03583255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106900|NCT03583255|Antiemetics|antiemetics|mesh-ancestor
93106901|NCT03583255|Autonomic Agents|autonomic agents|mesh-ancestor
93106902|NCT03583255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106903|NCT03583255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106904|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106905|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
93106906|NCT03583255|Hormones|hormones|mesh-ancestor
93106907|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106908|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106909|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106910|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106911|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106912|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106913|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
93106915|NCT03579771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93106916|NCT03579771|Gemcitabine|gemcitabine|mesh-list
93106917|NCT03579771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93106918|NCT03579771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106919|NCT03579771|Tubulin Modulators|tubulin modulators|mesh-ancestor
93106920|NCT03579771|Antimitotic Agents|antimitotic agents|mesh-ancestor
93106921|NCT03579771|Mitosis Modulators|mitosis modulators|mesh-ancestor
93106922|NCT03579771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106923|NCT03579771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93106924|NCT03579771|Antimetabolites|antimetabolites|mesh-ancestor
93106925|NCT03578081|Dexamethasone|dexamethasone|mesh-list
93106926|NCT03578081|Ondansetron|ondansetron|mesh-list
93106927|NCT03578081|Olanzapine|olanzapine|mesh-list
93106928|NCT03578081|Palonosetron|palonosetron|mesh-list
93106929|NCT03578081|Fosaprepitant|fosaprepitant|mesh-list
93106930|NCT03578081|Aprepitant|aprepitant|mesh-list
93106931|NCT03578081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106932|NCT03578081|Antiemetics|antiemetics|mesh-ancestor
93106933|NCT03578081|Autonomic Agents|autonomic agents|mesh-ancestor
93106934|NCT03578081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93106935|NCT03578081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106936|NCT03578081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93106937|NCT03578081|Glucocorticoids|glucocorticoids|mesh-ancestor
93106938|NCT03578081|Hormones|hormones|mesh-ancestor
93106939|NCT03578081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93106940|NCT03578081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93106941|NCT03578081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106942|NCT03578081|Antipruritics|antipruritics|mesh-ancestor
93106943|NCT03578081|Dermatologic Agents|dermatologic agents|mesh-ancestor
93106944|NCT03578081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93106945|NCT03578081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93106946|NCT03578081|Serotonin Agents|serotonin agents|mesh-ancestor
93106947|NCT03578081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93106948|NCT03578081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106949|NCT03578081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93106950|NCT03578081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93106951|NCT03578081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93106952|NCT03578081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93106953|NCT03578081|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93106954|NCT03578081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93106955|NCT03578081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93106956|NCT03578081|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93106957|NCT03540420|Atezolizumab|atezolizumab|mesh-list
93106958|NCT03540420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93106959|NCT03540420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106960|NCT03540420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93106961|NCT03540420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93106962|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
93106963|NCT03510884|Niacin|niacin|mesh-list
93106964|NCT03510884|Niacinamide|niacinamide|mesh-list
93106965|NCT03510884|Atorvastatin|atorvastatin|mesh-list
93106966|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93106967|NCT03510884|Simvastatin|simvastatin|mesh-list
93106968|NCT03510884|Ezetimibe|ezetimibe|mesh-list
93106969|NCT03510884|Pravastatin|pravastatin|mesh-list
93106970|NCT03510884|Alirocumab|alirocumab|mesh-list
93106971|NCT03510884|Lovastatin|lovastatin|mesh-list
93106972|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
93106973|NCT03510884|Fenofibrate|fenofibrate|mesh-list
93106974|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93106975|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93106976|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
93106977|NCT03510884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93106978|NCT03510884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93106979|NCT03510884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93106980|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93106981|NCT03510884|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93106982|NCT03510884|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93106983|NCT03510884|Protease Inhibitors|protease inhibitors|mesh-ancestor
93106984|NCT03510884|Vitamin B Complex|vitamin b complex|mesh-ancestor
93106985|NCT03510884|Vitamins|vitamins|mesh-ancestor
93106986|NCT03510884|Micronutrients|micronutrients|mesh-ancestor
93106987|NCT03510884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93106988|NCT03510884|Vasodilator Agents|vasodilator agents|mesh-ancestor
93106989|NCT03506360|Dexamethasone|dexamethasone|mesh-list
93106990|NCT03506360|Dexamethasone acetate|dexamethasone acetate|mesh-list
93106991|NCT03506360|Pembrolizumab|pembrolizumab|mesh-list
93106992|NCT03506360|Ixazomib|ixazomib|mesh-list
93106993|NCT03506360|Ichthammol|ichthammol|mesh-list
93106994|NCT03506360|BB 1101|bb 1101|mesh-list
93106995|NCT03506360|Glycine|glycine|mesh-list
93106996|NCT03506360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93106997|NCT03506360|Antiemetics|antiemetics|mesh-ancestor
93106998|NCT03506360|Autonomic Agents|autonomic agents|mesh-ancestor
93106999|NCT03506360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107000|NCT03506360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107001|NCT03506360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93107002|NCT03506360|Glucocorticoids|glucocorticoids|mesh-ancestor
93107003|NCT03506360|Hormones|hormones|mesh-ancestor
93107004|NCT03506360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107005|NCT03506360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107006|NCT03506360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107007|NCT03506360|Protease Inhibitors|protease inhibitors|mesh-ancestor
93107008|NCT03506360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107009|NCT03506360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107010|NCT03506360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107011|NCT03506360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107012|NCT03506360|Dermatologic Agents|dermatologic agents|mesh-ancestor
93107013|NCT03506360|Glycine Agents|glycine agents|mesh-ancestor
93107014|NCT03506360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107015|NCT03497975|Nalbuphine|nalbuphine|mesh-list
93107016|NCT03497975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93107017|NCT03497975|Narcotics|narcotics|mesh-ancestor
93107018|NCT03497975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93107019|NCT03497975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107020|NCT03497975|Analgesics|analgesics|mesh-ancestor
93107021|NCT03497975|Sensory System Agents|sensory system agents|mesh-ancestor
93107022|NCT03497975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107023|NCT03497169|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93107024|NCT03497169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93107025|NCT03497169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107026|NCT03497169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93107027|NCT03497169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93107028|NCT03497169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93107029|NCT03497169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107030|NCT03497169|Dopamine Agents|dopamine agents|mesh-ancestor
93107031|NCT03497169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107032|NCT03497143|Lamotrigine|lamotrigine|mesh-list
93107033|NCT03497143|Anticonvulsants|anticonvulsants|mesh-ancestor
93107034|NCT03497143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93107035|NCT03497143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93107036|NCT03497143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107037|NCT03497143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93107038|NCT03497143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107039|NCT03497143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93107040|NCT03497143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93107041|NCT03497143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93107042|NCT03497143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93107043|NCT03497143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93107044|NCT03478514|Palbociclib|palbociclib|mesh-list
93107045|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107046|NCT03478514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107047|NCT03478514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107048|NCT03478514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107049|NCT03456843|Ascorbic Acid|ascorbic acid|mesh-list
93107050|NCT03456843|Docetaxel|docetaxel|mesh-list
93107051|NCT03456843|Methyltestosterone|methyltestosterone|mesh-list
93107052|NCT03456843|Hormones|hormones|mesh-list
93107053|NCT03456843|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93107054|NCT03456843|Androgens|androgens|mesh-list
93107055|NCT03456843|Androgen Antagonists|androgen antagonists|mesh-list
93107056|NCT03456843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107057|NCT03456843|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107058|NCT03456843|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107059|NCT03456843|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107060|NCT03456843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107061|NCT03456843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107062|NCT03456843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107063|NCT03456843|Antioxidants|antioxidants|mesh-ancestor
93107064|NCT03456843|Protective Agents|protective agents|mesh-ancestor
93107066|NCT03456843|Micronutrients|micronutrients|mesh-ancestor
93107067|NCT03456843|Estrogens|estrogens|mesh-ancestor
93107068|NCT03456843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107069|NCT03456843|Anabolic Agents|anabolic agents|mesh-ancestor
93107070|NCT03456843|Hormone Antagonists|hormone antagonists|mesh-ancestor
93107071|NCT03455829|Osimertinib|osimertinib|mesh-list
93107072|NCT03455829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107073|NCT03455829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107074|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107075|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107076|NCT03453489|Tryptophan|tryptophan|mesh-list
93107077|NCT03453489|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93107078|NCT03453489|Antidepressive Agents|antidepressive agents|mesh-ancestor
93107079|NCT03453489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93107080|NCT03451851|Etanercept|etanercept|mesh-list
93107081|NCT03451851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93107082|NCT03451851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93107083|NCT03451851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93107084|NCT03451851|Analgesics|analgesics|mesh-ancestor
93107085|NCT03451851|Sensory System Agents|sensory system agents|mesh-ancestor
93107086|NCT03451851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107087|NCT03451851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107088|NCT03451851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107089|NCT03451851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107090|NCT03451851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93107091|NCT03451851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107092|NCT03451851|Immunologic Factors|immunologic factors|mesh-ancestor
93107093|NCT03440190|Methylphenidate|methylphenidate|mesh-list
93107094|NCT03440190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93107095|NCT03440190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107096|NCT03440190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93107097|NCT03440190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93107098|NCT03440190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93107099|NCT03440190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107100|NCT03440190|Dopamine Agents|dopamine agents|mesh-ancestor
93107101|NCT03440190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107102|NCT03434262|Gemcitabine|gemcitabine|mesh-list
93107103|NCT03434262|Trametinib|trametinib|mesh-list
93107104|NCT03434262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107105|NCT03434262|Antimetabolites|antimetabolites|mesh-ancestor
93107106|NCT03434262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107107|NCT03434262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107108|NCT03434262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107109|NCT03434262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107110|NCT03429244|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93107111|NCT03429244|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93107112|NCT03429244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107113|NCT03422328|Macitentan|macitentan|mesh-list
93107114|NCT03422328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93107115|NCT03422328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93107116|NCT03422328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107117|NCT03422328|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93107118|NCT03408587|Ipilimumab|ipilimumab|mesh-list
93107119|NCT03408587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107120|NCT03408587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107121|NCT03408587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107122|NCT03408587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107123|NCT03387553|Immunomodulating Agents|immunomodulating agents|mesh-list
93107124|NCT03387553|Immunologic Factors|immunologic factors|mesh-ancestor
93107125|NCT03387553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107126|NCT03370276|Nivolumab|nivolumab|mesh-list
93107127|NCT03370276|Cetuximab|cetuximab|mesh-list
93107128|NCT03370276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107129|NCT03370276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107130|NCT03370276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107131|NCT03370276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107132|NCT03331341|Doxorubicin|doxorubicin|mesh-list
93107133|NCT03331341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93107134|NCT03331341|Pembrolizumab|pembrolizumab|mesh-list
93107135|NCT03331341|Dacarbazine|dacarbazine|mesh-list
93107136|NCT03331341|Vinblastine|vinblastine|mesh-list
93107137|NCT03331341|Imidazole|imidazole|mesh-list
93107138|NCT03331341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93107139|NCT03331341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107140|NCT03331341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107141|NCT03331341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107142|NCT03331341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107143|NCT03331341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107144|NCT03331341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107145|NCT03331341|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107146|NCT03331341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93107147|NCT03331341|Alkylating Agents|alkylating agents|mesh-ancestor
93107148|NCT03331341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107149|NCT03331341|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107150|NCT03331341|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107151|NCT03331341|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107152|NCT03319745|Pembrolizumab|pembrolizumab|mesh-list
93107153|NCT03319745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107154|NCT03319745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107155|NCT03319745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107156|NCT03319745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107157|NCT03314636|Dexamethasone|dexamethasone|mesh-list
93107158|NCT03314636|Lenalidomide|lenalidomide|mesh-list
93107159|NCT03314636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107160|NCT03314636|Antiemetics|antiemetics|mesh-ancestor
93107161|NCT03314636|Autonomic Agents|autonomic agents|mesh-ancestor
93107162|NCT03314636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107163|NCT03314636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107164|NCT03314636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93107165|NCT03314636|Glucocorticoids|glucocorticoids|mesh-ancestor
93107166|NCT03314636|Hormones|hormones|mesh-ancestor
93107167|NCT03314636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107168|NCT03314636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107169|NCT03314636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107170|NCT03314636|Immunologic Factors|immunologic factors|mesh-ancestor
93107171|NCT03314636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93107172|NCT03314636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93107173|NCT03314636|Growth Substances|growth substances|mesh-ancestor
93107174|NCT03314636|Growth Inhibitors|growth inhibitors|mesh-ancestor
93107175|NCT03310541|Fulvestrant|fulvestrant|mesh-list
93107176|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107177|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107178|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93107179|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93107180|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
93107181|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107182|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107183|NCT03279861|Valsartan|valsartan|mesh-list
93107184|NCT03279861|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93107185|NCT03279861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93107186|NCT03279861|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93107187|NCT03279861|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93107188|NCT03279861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107189|NCT03277729|Cyclophosphamide|cyclophosphamide|mesh-list
93107190|NCT03277729|Fludarabine|fludarabine|mesh-list
93107191|NCT03277729|Fludarabine phosphate|fludarabine phosphate|mesh-list
93107192|NCT03277729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107193|NCT03277729|Immunologic Factors|immunologic factors|mesh-ancestor
93107194|NCT03277729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107195|NCT03277729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107196|NCT03277729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93107197|NCT03277729|Alkylating Agents|alkylating agents|mesh-ancestor
93107198|NCT03277729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107199|NCT03277729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107200|NCT03277729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93107201|NCT03277729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107202|NCT03277729|Antimetabolites|antimetabolites|mesh-ancestor
93107203|NCT03250832|Bevacizumab|bevacizumab|mesh-list
93107204|NCT03250832|Dostarlimab|dostarlimab|mesh-list
93107205|NCT03250832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107206|NCT03250832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107207|NCT03250832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93107208|NCT03250832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93107209|NCT03250832|Growth Substances|growth substances|mesh-ancestor
93107210|NCT03250832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107211|NCT03250832|Growth Inhibitors|growth inhibitors|mesh-ancestor
93107212|NCT03250117|Ropinirole|ropinirole|mesh-list
93107213|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93107214|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93107215|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
93107216|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
93107217|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107218|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107219|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107220|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
93107221|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
93107222|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107223|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107224|NCT03236935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107225|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107226|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107227|NCT03230838|Meropenem|meropenem|mesh-list
93107228|NCT03230838|Tazobactam|tazobactam|mesh-list
93107229|NCT03230838|Ceftolozane|ceftolozane|mesh-list
93107230|NCT03230838|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
93107231|NCT03230838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93107232|NCT03230838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107233|NCT03230838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93107234|NCT03230838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107235|NCT03230838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107236|NCT03230838|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93107237|NCT03217136|Metronidazole|metronidazole|mesh-list
93107238|NCT03217136|Meropenem|meropenem|mesh-list
93107239|NCT03217136|Tazobactam|tazobactam|mesh-list
93107240|NCT03217136|Ceftolozane|ceftolozane|mesh-list
93107241|NCT03217136|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
93107242|NCT03217136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107243|NCT03217136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93107244|NCT03217136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93107245|NCT03217136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93107246|NCT03217136|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93107247|NCT03217136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107248|NCT03217136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107249|NCT03217136|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93107250|NCT03201939|Lisinopril|lisinopril|mesh-list
93107251|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93107252|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
93107253|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107254|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107255|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93107256|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93107257|NCT03201939|Protective Agents|protective agents|mesh-ancestor
93107258|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107259|NCT03179761|Vaccines|vaccines|mesh-list
93107260|NCT03179761|Immunologic Factors|immunologic factors|mesh-ancestor
93107261|NCT03179761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107262|NCT03173248|Azacitidine|azacitidine|mesh-list
93107263|NCT03173248|Ivosidenib|ivosidenib|mesh-list
93107264|NCT03173248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107265|NCT03173248|Antimetabolites|antimetabolites|mesh-ancestor
93107266|NCT03173248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107267|NCT03173248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107268|NCT03173248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107269|NCT03158064|Durvalumab|durvalumab|mesh-list
93107270|NCT03158064|Tremelimumab|tremelimumab|mesh-list
93107271|NCT03158064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107272|NCT03158064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107273|NCT03122886|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93107274|NCT03122886|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
93107275|NCT03122886|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93107276|NCT03122886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93107277|NCT03090165|Bicalutamide|bicalutamide|mesh-list
93107278|NCT03090165|Androgen Antagonists|androgen antagonists|mesh-ancestor
93107279|NCT03090165|Hormone Antagonists|hormone antagonists|mesh-ancestor
93107280|NCT03090165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107281|NCT03090165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107282|NCT03090165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107283|NCT03087708|Naloxegol|naloxegol|mesh-list
93107284|NCT03087708|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93107285|NCT03087708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107286|NCT03087708|Sensory System Agents|sensory system agents|mesh-ancestor
93107287|NCT03087708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107289|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93107290|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93107291|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
93107292|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107293|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107294|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107295|NCT03057847|Sofosbuvir|sofosbuvir|mesh-list
93107296|NCT03057847|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93107297|NCT03057847|Velpatasvir|velpatasvir|mesh-list
93107298|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
93107299|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107300|NCT03043599|Nivolumab|nivolumab|mesh-list
93107301|NCT03043599|Ipilimumab|ipilimumab|mesh-list
93107302|NCT03043599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107303|NCT03043599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107304|NCT03043599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107305|NCT03043599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107306|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
93107307|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93107308|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93107309|NCT03040973|Gefitinib|gefitinib|mesh-list
93107310|NCT03040973|Osimertinib|osimertinib|mesh-list
93107311|NCT03040973|Nazartinib|nazartinib|mesh-list
93107312|NCT03040973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107313|NCT03040973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107314|NCT03040973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107315|NCT03040973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107316|NCT03022773|Carotenoids|carotenoids|mesh-list
93107317|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
93107318|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107319|NCT03022773|Protective Agents|protective agents|mesh-ancestor
93107320|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107321|NCT03017820|Iodine|iodine|mesh-list
93107322|NCT03017820|Interferons|interferons|mesh-list
93107323|NCT03017820|Interferon-beta|interferon-beta|mesh-list
93107324|NCT03017820|Cyclophosphamide|cyclophosphamide|mesh-list
93107325|NCT03017820|Nivolumab|nivolumab|mesh-list
93107326|NCT03017820|Ipilimumab|ipilimumab|mesh-list
93107327|NCT03017820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107328|NCT03017820|Immunologic Factors|immunologic factors|mesh-ancestor
93107329|NCT03017820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107330|NCT03017820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107331|NCT03017820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93107332|NCT03017820|Alkylating Agents|alkylating agents|mesh-ancestor
93107333|NCT03017820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107334|NCT03017820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107335|NCT03017820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93107336|NCT03017820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107337|NCT03017820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107338|NCT03017820|Antiviral Agents|antiviral agents|mesh-ancestor
93107339|NCT03017820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107340|NCT03017820|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93107341|NCT03017820|Trace Elements|trace elements|mesh-ancestor
93107342|NCT03017820|Micronutrients|micronutrients|mesh-ancestor
93107343|NCT02946463|Eculizumab|eculizumab|mesh-list
93107344|NCT02946463|Ravulizumab|ravulizumab|mesh-list
93107345|NCT02946463|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93107346|NCT02946463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107347|NCT02946463|Immunologic Factors|immunologic factors|mesh-ancestor
93107348|NCT02946463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107349|NCT02928224|Leucovorin|leucovorin|mesh-list
93107350|NCT02928224|Folic Acid|folic acid|mesh-list
93107351|NCT02928224|Fluorouracil|fluorouracil|mesh-list
93107352|NCT02928224|Irinotecan|irinotecan|mesh-list
93107353|NCT02928224|Cetuximab|cetuximab|mesh-list
93107354|NCT02928224|Levoleucovorin|levoleucovorin|mesh-list
93107355|NCT02928224|Antimetabolites|antimetabolites|mesh-ancestor
93107356|NCT02928224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107357|NCT02928224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107358|NCT02928224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107359|NCT02928224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107360|NCT02928224|Immunologic Factors|immunologic factors|mesh-ancestor
92779633|NCT00661375|Sorafenib|sorafenib|mesh-list
93107361|NCT02928224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107362|NCT02928224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93107363|NCT02928224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107364|NCT02928224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107365|NCT02928224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107366|NCT02928224|Antidotes|antidotes|mesh-ancestor
93107367|NCT02928224|Protective Agents|protective agents|mesh-ancestor
93107368|NCT02928224|Vitamin B Complex|vitamin b complex|mesh-ancestor
93107369|NCT02928224|Vitamins|vitamins|mesh-ancestor
93107370|NCT02928224|Micronutrients|micronutrients|mesh-ancestor
93107371|NCT02928224|Hematinics|hematinics|mesh-ancestor
93107372|NCT02897375|Carboplatin|carboplatin|mesh-list
93107373|NCT02897375|Palbociclib|palbociclib|mesh-list
93107374|NCT02897375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107375|NCT02897375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107376|NCT02897375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107377|NCT02897375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107378|NCT02891603|Sirolimus|sirolimus|mesh-list
93107379|NCT02891603|Tacrolimus|tacrolimus|mesh-list
93107380|NCT02891603|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93107381|NCT02891603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107382|NCT02891603|Immunologic Factors|immunologic factors|mesh-ancestor
93107383|NCT02891603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107384|NCT02891603|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93107385|NCT02891603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107386|NCT02891603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107387|NCT02891603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93107388|NCT02891603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107389|NCT02891603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93107390|NCT02891603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107391|NCT02891603|Antifungal Agents|antifungal agents|mesh-ancestor
93107392|NCT02891603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107393|NCT02875314|Cyclophosphamide|cyclophosphamide|mesh-list
93107394|NCT02875314|Thiotepa|thiotepa|mesh-list
93107395|NCT02875314|Cisplatin|cisplatin|mesh-list
93107396|NCT02875314|Carboplatin|carboplatin|mesh-list
93107397|NCT02875314|Methotrexate|methotrexate|mesh-list
93107398|NCT02875314|Etoposide|etoposide|mesh-list
93107399|NCT02875314|Etoposide phosphate|etoposide phosphate|mesh-list
93107400|NCT02875314|Vincristine|vincristine|mesh-list
93107401|NCT02875314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107402|NCT02875314|Immunologic Factors|immunologic factors|mesh-ancestor
93107403|NCT02875314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107404|NCT02875314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107405|NCT02875314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93107406|NCT02875314|Alkylating Agents|alkylating agents|mesh-ancestor
93107407|NCT02875314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107408|NCT02875314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107409|NCT02875314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93107410|NCT02875314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93107411|NCT02875314|Abortifacient Agents|abortifacient agents|mesh-ancestor
93107412|NCT02875314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93107413|NCT02875314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107414|NCT02875314|Antimetabolites|antimetabolites|mesh-ancestor
93107415|NCT02875314|Dermatologic Agents|dermatologic agents|mesh-ancestor
93107416|NCT02875314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107417|NCT02875314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93107418|NCT02875314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93107419|NCT02875314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107420|NCT02875314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107421|NCT02875314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107422|NCT02875314|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107423|NCT02875314|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107424|NCT02875314|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107425|NCT02872116|Leucovorin|leucovorin|mesh-list
93107426|NCT02872116|Fluorouracil|fluorouracil|mesh-list
93107427|NCT02872116|Capecitabine|capecitabine|mesh-list
93107428|NCT02872116|Oxaliplatin|oxaliplatin|mesh-list
93107429|NCT02872116|Nivolumab|nivolumab|mesh-list
93107430|NCT02872116|Ipilimumab|ipilimumab|mesh-list
93107431|NCT02872116|Antimetabolites|antimetabolites|mesh-ancestor
93107432|NCT02872116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107433|NCT02872116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92779715|NCT00878995|Testosterone|testosterone|mesh-list
93107434|NCT02872116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107435|NCT02872116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107436|NCT02872116|Immunologic Factors|immunologic factors|mesh-ancestor
93107437|NCT02872116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107438|NCT02872116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107439|NCT02872116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107440|NCT02872116|Antidotes|antidotes|mesh-ancestor
93107441|NCT02872116|Protective Agents|protective agents|mesh-ancestor
93107442|NCT02872116|Vitamin B Complex|vitamin b complex|mesh-ancestor
93107443|NCT02872116|Vitamins|vitamins|mesh-ancestor
93107444|NCT02872116|Micronutrients|micronutrients|mesh-ancestor
93107445|NCT02860039|Vaccines|vaccines|mesh-list
93107446|NCT02860039|Immunologic Factors|immunologic factors|mesh-ancestor
93107447|NCT02860039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107448|NCT02819024|Alovudine|alovudine|mesh-list
93107449|NCT02819024|Dideoxynucleosides|dideoxynucleosides|mesh-list
93107450|NCT02819024|Dexamethasone|dexamethasone|mesh-list
93107451|NCT02819024|Dexamethasone acetate|dexamethasone acetate|mesh-list
93107452|NCT02819024|Ichthammol|ichthammol|mesh-list
93107453|NCT02819024|BB 1101|bb 1101|mesh-list
93107454|NCT02819024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107455|NCT02819024|Antiemetics|antiemetics|mesh-ancestor
93107456|NCT02819024|Autonomic Agents|autonomic agents|mesh-ancestor
93107457|NCT02819024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107458|NCT02819024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107459|NCT02819024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93107460|NCT02819024|Glucocorticoids|glucocorticoids|mesh-ancestor
93107461|NCT02819024|Hormones|hormones|mesh-ancestor
93107462|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107463|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107464|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107465|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
93107466|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107467|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107468|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
93107469|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
93107470|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107471|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
93107472|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93107473|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93107474|NCT02800785|Moxifloxacin|moxifloxacin|mesh-list
93107475|NCT02800785|Metronidazole|metronidazole|mesh-list
93107476|NCT02800785|Ciprofloxacin|ciprofloxacin|mesh-list
93107477|NCT02800785|Levofloxacin|levofloxacin|mesh-list
93107478|NCT02800785|Cefazolin|cefazolin|mesh-list
93107479|NCT02800785|Ceftriaxone|ceftriaxone|mesh-list
93107480|NCT02800785|Clavulanic Acids|clavulanic acids|mesh-list
93107481|NCT02800785|Clavulanic Acid|clavulanic acid|mesh-list
93107482|NCT02800785|Ertapenem|ertapenem|mesh-list
93107483|NCT02800785|Cefuroxime|cefuroxime|mesh-list
93107484|NCT02800785|Tigecycline|tigecycline|mesh-list
93107485|NCT02800785|Cefotaxime|cefotaxime|mesh-list
93107486|NCT02800785|Cefoxitin|cefoxitin|mesh-list
93107487|NCT02800785|Ticarcillin|ticarcillin|mesh-list
93107488|NCT02800785|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
93107489|NCT02800785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93107490|NCT02800785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107491|NCT02800785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107492|NCT02800785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107493|NCT02800785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107494|NCT02800785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107495|NCT02800785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107496|NCT02800785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93107497|NCT02800785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93107498|NCT02800785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93107499|NCT02800785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93107500|NCT02800785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93107501|NCT02800785|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93107502|NCT02800785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92697743|NCT00518297|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93107503|NCT02796937|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93107504|NCT02796937|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93107505|NCT02796937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93107506|NCT02796937|Protease Inhibitors|protease inhibitors|mesh-ancestor
93107507|NCT02796937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107508|NCT02796937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107509|NCT02792257|Dronabinol|dronabinol|mesh-list
93107510|NCT02792257|Hallucinogens|hallucinogens|mesh-ancestor
93107511|NCT02792257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107512|NCT02792257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93107513|NCT02792257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93107514|NCT02792257|Analgesics|analgesics|mesh-ancestor
93107515|NCT02792257|Sensory System Agents|sensory system agents|mesh-ancestor
93107516|NCT02792257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107517|NCT02792257|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93107518|NCT02792257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93107519|NCT02792257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107520|NCT02792257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107521|NCT02792257|Hormones|hormones|mesh-ancestor
93107522|NCT02792257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107523|NCT02782663|Upadacitinib|upadacitinib|mesh-list
93107524|NCT02782663|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93107525|NCT02782663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107526|NCT02782663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107527|NCT02782663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107528|NCT02782663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107529|NCT02765854|Dexamethasone|dexamethasone|mesh-list
93107530|NCT02765854|Lenalidomide|lenalidomide|mesh-list
93107531|NCT02765854|Ixazomib|ixazomib|mesh-list
93107532|NCT02765854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107533|NCT02765854|Antiemetics|antiemetics|mesh-ancestor
93107534|NCT02765854|Autonomic Agents|autonomic agents|mesh-ancestor
93107535|NCT02765854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107536|NCT02765854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107537|NCT02765854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93107538|NCT02765854|Glucocorticoids|glucocorticoids|mesh-ancestor
93107539|NCT02765854|Hormones|hormones|mesh-ancestor
93107540|NCT02765854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107541|NCT02765854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107542|NCT02765854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107543|NCT02765854|Immunologic Factors|immunologic factors|mesh-ancestor
93107544|NCT02765854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93107545|NCT02765854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93107546|NCT02765854|Growth Substances|growth substances|mesh-ancestor
93107547|NCT02765854|Growth Inhibitors|growth inhibitors|mesh-ancestor
93107548|NCT02765854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107549|NCT02765854|Protease Inhibitors|protease inhibitors|mesh-ancestor
93107550|NCT02765854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107551|NCT02761694|Paclitaxel|paclitaxel|mesh-list
93107552|NCT02761694|Fulvestrant|fulvestrant|mesh-list
93107553|NCT02761694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107554|NCT02761694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107555|NCT02761694|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107556|NCT02761694|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107557|NCT02761694|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107558|NCT02761694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107559|NCT02761694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107560|NCT02761694|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93107561|NCT02761694|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93107562|NCT02761694|Hormone Antagonists|hormone antagonists|mesh-ancestor
93107563|NCT02761694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107564|NCT02761694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107565|NCT02760030|Fulvestrant|fulvestrant|mesh-list
93107566|NCT02760030|Palbociclib|palbociclib|mesh-list
93107567|NCT02760030|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93107568|NCT02760030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107569|NCT02760030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107570|NCT02760030|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93107571|NCT02760030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93107572|NCT02760030|Hormone Antagonists|hormone antagonists|mesh-ancestor
93107573|NCT02760030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107574|NCT02760030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107575|NCT02760030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107576|NCT02760030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107577|NCT02760030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107578|NCT02760030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93107579|NCT02641093|Pembrolizumab|pembrolizumab|mesh-list
93107580|NCT02641093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107581|NCT02641093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107582|NCT02641093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107583|NCT02641093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107584|NCT02584309|Doxorubicin|doxorubicin|mesh-list
93107585|NCT02584309|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93107586|NCT02584309|Dexrazoxane|dexrazoxane|mesh-list
93107587|NCT02584309|Razoxane|razoxane|mesh-list
93107588|NCT02584309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92779863|NCT00658255|Budesonide|budesonide|mesh-list
93107589|NCT02584309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107590|NCT02584309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107591|NCT02584309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107592|NCT02584309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107593|NCT02584309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107594|NCT02584309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93107595|NCT02584309|Protective Agents|protective agents|mesh-ancestor
93107596|NCT02584309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107597|NCT02584309|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107598|NCT02584309|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107599|NCT02578732|Leucovorin|leucovorin|mesh-list
93107600|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
93107601|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107602|NCT02578732|Antidotes|antidotes|mesh-ancestor
93107603|NCT02578732|Protective Agents|protective agents|mesh-ancestor
93107604|NCT02578732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107605|NCT02578732|Vitamin B Complex|vitamin b complex|mesh-ancestor
93107606|NCT02578732|Vitamins|vitamins|mesh-ancestor
93107607|NCT02578732|Micronutrients|micronutrients|mesh-ancestor
93107608|NCT02525757|Paclitaxel|paclitaxel|mesh-list
93107609|NCT02525757|Carboplatin|carboplatin|mesh-list
93107610|NCT02525757|Atezolizumab|atezolizumab|mesh-list
93107611|NCT02525757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107612|NCT02525757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107613|NCT02525757|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107614|NCT02525757|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107615|NCT02525757|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107616|NCT02525757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107617|NCT02525757|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107618|NCT02525757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107619|NCT02519452|Daratumumab|daratumumab|mesh-list
93107620|NCT02519452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107621|NCT02505984|Oxytocin|oxytocin|mesh-list
93107622|NCT02505984|Oxytocics|oxytocics|mesh-ancestor
93107623|NCT02505984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93107624|NCT02505984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107625|NCT02486718|Gemcitabine|gemcitabine|mesh-list
93107626|NCT02486718|Docetaxel|docetaxel|mesh-list
93107627|NCT02486718|Pemetrexed|pemetrexed|mesh-list
93107628|NCT02486718|Atezolizumab|atezolizumab|mesh-list
93107629|NCT02486718|Vinorelbine|vinorelbine|mesh-list
93107630|NCT02486718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107631|NCT02486718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107632|NCT02486718|Antimetabolites|antimetabolites|mesh-ancestor
93107633|NCT02486718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107634|NCT02486718|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107635|NCT02486718|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107636|NCT02486718|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107637|NCT02486718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107638|NCT02486718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93107639|NCT02486718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93107640|NCT02486718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107641|NCT02486718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107642|NCT02486718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107643|NCT02477280|Methylphenidate|methylphenidate|mesh-list
93107644|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93107645|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107646|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93107647|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93107648|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93107649|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107650|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
93107651|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107652|NCT02438722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93107653|NCT02438722|Cetuximab|cetuximab|mesh-list
93107654|NCT02438722|Afatinib|afatinib|mesh-list
93107655|NCT02438722|Antibodies|antibodies|mesh-list
93107656|NCT02438722|Immunoglobulins|immunoglobulins|mesh-list
93107657|NCT02438722|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93107658|NCT02438722|Immunologic Factors|immunologic factors|mesh-ancestor
93107659|NCT02438722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107660|NCT02438722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107661|NCT02438722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107662|NCT02438722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107663|NCT02438722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107664|NCT02435212|Deferasirox|deferasirox|mesh-list
93107665|NCT02435212|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93107666|NCT02435212|Chelating Agents|chelating agents|mesh-ancestor
93107667|NCT02435212|Sequestering Agents|sequestering agents|mesh-ancestor
93107668|NCT02435212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107669|NCT02426658|Pemetrexed|pemetrexed|mesh-list
93107670|NCT02426658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107671|NCT02426658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107672|NCT02426658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107673|NCT02426658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93107674|NCT02426658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93107675|NCT02408770|Ulipristal acetate|ulipristal acetate|mesh-list
93107676|NCT02408770|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93107677|NCT02408770|Contraceptive Agents|contraceptive agents|mesh-ancestor
93107678|NCT02408770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93107679|NCT02408770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107680|NCT02408770|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93107681|NCT02403323|Etrolizumab|etrolizumab|mesh-list
93107682|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93107683|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
93107684|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107685|NCT02368665|Amlodipine|amlodipine|mesh-list
93107686|NCT02368665|Candesartan|candesartan|mesh-list
93107687|NCT02368665|Candesartan cilexetil|candesartan cilexetil|mesh-list
93107688|NCT02368665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93107689|NCT02368665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93107690|NCT02368665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93107691|NCT02368665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107692|NCT02368665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93107693|NCT02368665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107694|NCT02368665|Vasodilator Agents|vasodilator agents|mesh-ancestor
93107695|NCT02368665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93107696|NCT02368665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93107697|NCT02368652|Amlodipine|amlodipine|mesh-list
93107698|NCT02368652|Candesartan|candesartan|mesh-list
93107699|NCT02368652|Candesartan cilexetil|candesartan cilexetil|mesh-list
93107700|NCT02368652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93107701|NCT02368652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93107702|NCT02368652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93107703|NCT02368652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107704|NCT02368652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93107705|NCT02368652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107706|NCT02368652|Vasodilator Agents|vasodilator agents|mesh-ancestor
93107707|NCT02368652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93107708|NCT02368652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93107709|NCT02339922|Rituximab|rituximab|mesh-list
93107710|NCT02339922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93107711|NCT02339922|Ixazomib|ixazomib|mesh-list
93107712|NCT02339922|Antibodies|antibodies|mesh-list
93107713|NCT02339922|Immunoglobulins|immunoglobulins|mesh-list
93107714|NCT02339922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93107715|NCT02339922|Glycine|glycine|mesh-list
93107716|NCT02339922|Immunologic Factors|immunologic factors|mesh-ancestor
93107717|NCT02339922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107718|NCT02339922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107719|NCT02339922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107720|NCT02339922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107721|NCT02339922|Protease Inhibitors|protease inhibitors|mesh-ancestor
93107722|NCT02339922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107723|NCT02339922|Glycine Agents|glycine agents|mesh-ancestor
93107724|NCT02339922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107725|NCT02332577|Amoxicillin|amoxicillin|mesh-list
93107726|NCT02332577|Pristinamycin|pristinamycin|mesh-list
93107727|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93107728|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107729|NCT02330926|Ibuprofen|ibuprofen|mesh-list
93107730|NCT02330926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93107731|NCT02330926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93107732|NCT02330926|Analgesics|analgesics|mesh-ancestor
93107733|NCT02330926|Sensory System Agents|sensory system agents|mesh-ancestor
93107734|NCT02330926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107735|NCT02330926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107736|NCT02330926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107737|NCT02330926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107738|NCT02330926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93107739|NCT02330926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780019|NCT00668239|Triamcinolone|triamcinolone|mesh-list
93107740|NCT02330926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107741|NCT02312245|Paclitaxel|paclitaxel|mesh-list
93107742|NCT02312245|Bevacizumab|bevacizumab|mesh-list
93107743|NCT02312245|Gemcitabine|gemcitabine|mesh-list
93107744|NCT02312245|Doxorubicin|doxorubicin|mesh-list
93107745|NCT02312245|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93107746|NCT02312245|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93107747|NCT02312245|Topotecan|topotecan|mesh-list
93107748|NCT02312245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93107749|NCT02312245|Endothelial Growth Factors|endothelial growth factors|mesh-list
93107750|NCT02312245|Antibodies|antibodies|mesh-list
93107751|NCT02312245|Immunoglobulins|immunoglobulins|mesh-list
93107752|NCT02312245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93107753|NCT02312245|Immunoglobulin G|immunoglobulin g|mesh-list
93107754|NCT02312245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107755|NCT02312245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107756|NCT02312245|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107757|NCT02312245|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107758|NCT02312245|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107759|NCT02312245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107760|NCT02312245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93107761|NCT02312245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93107762|NCT02312245|Growth Substances|growth substances|mesh-ancestor
93107763|NCT02312245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107764|NCT02312245|Growth Inhibitors|growth inhibitors|mesh-ancestor
93107765|NCT02312245|Immunologic Factors|immunologic factors|mesh-ancestor
93107766|NCT02312245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107767|NCT02312245|Antimetabolites|antimetabolites|mesh-ancestor
93107768|NCT02312245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93107769|NCT02312245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107770|NCT02312245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107771|NCT02312245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107772|NCT02312245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93107773|NCT02297438|Letrozole|letrozole|mesh-list
93107774|NCT02297438|Palbociclib|palbociclib|mesh-list
93107775|NCT02297438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107776|NCT02297438|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93107777|NCT02297438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93107778|NCT02297438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107779|NCT02297438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107780|NCT02297438|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93107781|NCT02297438|Hormone Antagonists|hormone antagonists|mesh-ancestor
93107782|NCT02297438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107783|NCT02297438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107784|NCT02297438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107785|NCT02297139|Dasatinib|dasatinib|mesh-list
93107786|NCT02297139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107787|NCT02297139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107788|NCT02297139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107789|NCT02297139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107790|NCT02137759|Temozolomide|temozolomide|mesh-list
93107791|NCT02137759|Belinostat|belinostat|mesh-list
93107792|NCT02137759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93107793|NCT02137759|Alkylating Agents|alkylating agents|mesh-ancestor
93107794|NCT02137759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107795|NCT02137759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107796|NCT02137759|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93107797|NCT02137759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107798|NCT02115295|Cytarabine|cytarabine|mesh-list
93107799|NCT02115295|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93107800|NCT02115295|Venetoclax|venetoclax|mesh-list
93107801|NCT02115295|Idarubicin|idarubicin|mesh-list
93107802|NCT02115295|Cladribine|cladribine|mesh-list
93107803|NCT02115295|Midostaurin|midostaurin|mesh-list
93107804|NCT02115295|Staurosporine|staurosporine|mesh-list
93107805|NCT02115295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107806|NCT02115295|Antimetabolites|antimetabolites|mesh-ancestor
93107807|NCT02115295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107808|NCT02115295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107809|NCT02115295|Antiviral Agents|antiviral agents|mesh-ancestor
93107810|NCT02115295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107811|NCT02115295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107812|NCT02115295|Immunologic Factors|immunologic factors|mesh-ancestor
93107813|NCT02115295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107814|NCT02115295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92780082|NCT00662467|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93107815|NCT02115295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107816|NCT02115295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107817|NCT02115295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107818|NCT02115295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107819|NCT02090998|Lidocaine|lidocaine|mesh-list
93107820|NCT02090998|Amitriptyline|amitriptyline|mesh-list
93107821|NCT02090998|Anesthetics, Local|anesthetics, local|mesh-ancestor
93107822|NCT02090998|Anesthetics|anesthetics|mesh-ancestor
93107823|NCT02090998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93107824|NCT02090998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107825|NCT02090998|Sensory System Agents|sensory system agents|mesh-ancestor
93107826|NCT02090998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107827|NCT02090998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93107828|NCT02090998|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93107829|NCT02090998|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93107830|NCT02090998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026437|NCT00493038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107831|NCT02090998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107832|NCT02090998|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93107833|NCT02090998|Antidepressive Agents|antidepressive agents|mesh-ancestor
93107834|NCT02090998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93107835|NCT02090998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93107836|NCT02090998|Analgesics|analgesics|mesh-ancestor
93107837|NCT02090998|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93107838|NCT02090998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93107839|NCT02090998|Adrenergic Agents|adrenergic agents|mesh-ancestor
93107840|NCT02090998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93107841|NCT02043665|Pembrolizumab|pembrolizumab|mesh-list
93107842|NCT02043665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107843|NCT02043665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107844|NCT02043665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93107845|NCT02043665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107846|NCT01989585|Trametinib|trametinib|mesh-list
93107847|NCT01989585|Dabrafenib|dabrafenib|mesh-list
93107848|NCT01989585|Navitoclax|navitoclax|mesh-list
93107849|NCT01989585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107850|NCT01989585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107851|NCT01989585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107852|NCT01989585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107853|NCT01974440|Prednisone|prednisone|mesh-list
93107854|NCT01974440|Cyclophosphamide|cyclophosphamide|mesh-list
93107855|NCT01974440|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93107856|NCT01974440|Rituximab|rituximab|mesh-list
93107857|NCT01974440|Doxorubicin|doxorubicin|mesh-list
93107858|NCT01974440|Vincristine|vincristine|mesh-list
93107859|NCT01974440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107860|NCT01974440|Immunologic Factors|immunologic factors|mesh-ancestor
93107861|NCT01974440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107862|NCT01974440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107863|NCT01974440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93107864|NCT01974440|Alkylating Agents|alkylating agents|mesh-ancestor
93107865|NCT01974440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107866|NCT01974440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107867|NCT01974440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93107868|NCT01974440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107869|NCT01974440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93107870|NCT01974440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107871|NCT01974440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107872|NCT01974440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107873|NCT01974440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107874|NCT01974440|Glucocorticoids|glucocorticoids|mesh-ancestor
93107875|NCT01974440|Hormones|hormones|mesh-ancestor
93107876|NCT01974440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107877|NCT01974440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93107878|NCT01974440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107879|NCT01974440|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107880|NCT01974440|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107881|NCT01974440|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107882|NCT01959139|Leucovorin|leucovorin|mesh-list
93107883|NCT01959139|Fluorouracil|fluorouracil|mesh-list
93107884|NCT01959139|Oxaliplatin|oxaliplatin|mesh-list
93107885|NCT01959139|Irinotecan|irinotecan|mesh-list
93107886|NCT01959139|Levoleucovorin|levoleucovorin|mesh-list
93107887|NCT01959139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107888|NCT01959139|Antimetabolites|antimetabolites|mesh-ancestor
92698113|NCT04690647|Analgesics|analgesics|mesh-ancestor
93107889|NCT01959139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107890|NCT01959139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107891|NCT01959139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107892|NCT01959139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107893|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
93107894|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93107895|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107896|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107897|NCT01959139|Antidotes|antidotes|mesh-ancestor
93107898|NCT01959139|Protective Agents|protective agents|mesh-ancestor
93107899|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
93107900|NCT01959139|Vitamins|vitamins|mesh-ancestor
93107901|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
93107902|NCT01912651|Cephalexin|cephalexin|mesh-list
93107903|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93107904|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93107905|NCT01912625|Paclitaxel|paclitaxel|mesh-list
93107906|NCT01912625|Carboplatin|carboplatin|mesh-list
93107907|NCT01912625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93107908|NCT01912625|Trametinib|trametinib|mesh-list
93107909|NCT01912625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107910|NCT01912625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107911|NCT01912625|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107912|NCT01912625|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107913|NCT01912625|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107914|NCT01912625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107915|NCT01912625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107916|NCT01912625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107917|NCT01817166|Vitamin D|vitamin d|mesh-list
93107918|NCT01817166|Cholecalciferol|cholecalciferol|mesh-list
93107919|NCT01817166|Vitamins|vitamins|mesh-ancestor
93107920|NCT01817166|Micronutrients|micronutrients|mesh-ancestor
93107921|NCT01817166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107922|NCT01817166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93107923|NCT01817166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93107924|NCT01814813|Bevacizumab|bevacizumab|mesh-list
93107925|NCT01814813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93107926|NCT01814813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107927|NCT01814813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93107928|NCT01814813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93107929|NCT01814813|Growth Substances|growth substances|mesh-ancestor
93107930|NCT01814813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107931|NCT01814813|Growth Inhibitors|growth inhibitors|mesh-ancestor
93107932|NCT01720836|Poly ICLC|poly iclc|mesh-list
93107933|NCT01720836|Interferon Inducers|interferon inducers|mesh-ancestor
93107934|NCT01720836|Immunologic Factors|immunologic factors|mesh-ancestor
93107935|NCT01720836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107936|NCT01667120|Ketorolac|ketorolac|mesh-list
93107937|NCT01667120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93107938|NCT01667120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93107939|NCT01667120|Analgesics|analgesics|mesh-ancestor
93107940|NCT01667120|Sensory System Agents|sensory system agents|mesh-ancestor
93107941|NCT01667120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107942|NCT01667120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107943|NCT01667120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93107944|NCT01667120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93107945|NCT01667120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93107946|NCT01667120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107947|NCT01667120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107948|NCT01642251|Cisplatin|cisplatin|mesh-list
93107949|NCT01642251|Etoposide|etoposide|mesh-list
93107950|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
93107951|NCT01642251|Veliparib|veliparib|mesh-list
93107952|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
93107953|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107954|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93107955|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93107956|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93107957|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107958|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107959|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93107960|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
92698171|NCT00520169|Anesthetics|anesthetics|mesh-ancestor
93107961|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
93107962|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
93107963|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
93107964|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
93107965|NCT01606137|Nabiximols|nabiximols|mesh-list
93107966|NCT01606137|Analgesics|analgesics|mesh-ancestor
93107967|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
93107968|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107969|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107970|NCT01532518|MEN 11420|men 11420|mesh-list
93107971|NCT01532518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93107972|NCT01532518|Autonomic Agents|autonomic agents|mesh-ancestor
93107973|NCT01532518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93107974|NCT01532518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107975|NCT01532518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93107976|NCT01532518|Respiratory System Agents|respiratory system agents|mesh-ancestor
93107977|NCT01489813|Genistein|genistein|mesh-list
93107978|NCT01489813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93107979|NCT01489813|Protective Agents|protective agents|mesh-ancestor
93107980|NCT01489813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93107981|NCT01489813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107982|NCT01489813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93107983|NCT01489813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93107984|NCT01489813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107985|NCT01489813|Phytoestrogens|phytoestrogens|mesh-ancestor
93107986|NCT01489813|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93107987|NCT01489813|Estrogens|estrogens|mesh-ancestor
93107988|NCT01489813|Hormones|hormones|mesh-ancestor
93107989|NCT01489813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93107990|NCT01420874|Leucovorin|leucovorin|mesh-list
93107991|NCT01420874|Fluorouracil|fluorouracil|mesh-list
93107992|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
93107993|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
93107994|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93107995|NCT01420874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93107996|NCT01420874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93107997|NCT01420874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93107998|NCT01420874|Immunologic Factors|immunologic factors|mesh-ancestor
93107999|NCT01420874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108000|NCT01420874|Antidotes|antidotes|mesh-ancestor
93108001|NCT01420874|Protective Agents|protective agents|mesh-ancestor
93108002|NCT01420874|Vitamin B Complex|vitamin b complex|mesh-ancestor
93108003|NCT01420874|Vitamins|vitamins|mesh-ancestor
93108004|NCT01420874|Micronutrients|micronutrients|mesh-ancestor
93108005|NCT01405521|Vaccines|vaccines|mesh-list
93108006|NCT01405521|Immunologic Factors|immunologic factors|mesh-ancestor
93108007|NCT01405521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108008|NCT01027000|Sirolimus|sirolimus|mesh-list
93108009|NCT01027000|Cyclophosphamide|cyclophosphamide|mesh-list
93108010|NCT01027000|Busulfan|busulfan|mesh-list
93108011|NCT01027000|Rituximab|rituximab|mesh-list
93108012|NCT01027000|Methotrexate|methotrexate|mesh-list
93108013|NCT01027000|Fludarabine|fludarabine|mesh-list
93108014|NCT01027000|Fludarabine phosphate|fludarabine phosphate|mesh-list
93108015|NCT01027000|Tacrolimus|tacrolimus|mesh-list
93108016|NCT01027000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108017|NCT01027000|Immunologic Factors|immunologic factors|mesh-ancestor
93108018|NCT01027000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108019|NCT01027000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108020|NCT01027000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93108021|NCT01027000|Alkylating Agents|alkylating agents|mesh-ancestor
93108022|NCT01027000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108023|NCT01027000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108024|NCT01027000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93108025|NCT01027000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108026|NCT01027000|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93108027|NCT01027000|Abortifacient Agents|abortifacient agents|mesh-ancestor
93108028|NCT01027000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93108029|NCT01027000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93108030|NCT01027000|Antimetabolites|antimetabolites|mesh-ancestor
93108031|NCT01027000|Dermatologic Agents|dermatologic agents|mesh-ancestor
93108032|NCT01027000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108033|NCT01027000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93108034|NCT01027000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108035|NCT01027000|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93108036|NCT01027000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108037|NCT01027000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108038|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93108039|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
93108040|NCT00861068|Lacosamide|lacosamide|mesh-list
93108041|NCT00861068|Anticonvulsants|anticonvulsants|mesh-ancestor
93108042|NCT00861068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93108043|NCT00861068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93108044|NCT00861068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93108045|NCT00861068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108046|NCT00844285|Certolizumab Pegol|certolizumab pegol|mesh-list
93108047|NCT00844285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93108048|NCT00844285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108049|NCT00844285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108050|NCT00844285|Immunologic Factors|immunologic factors|mesh-ancestor
93108051|NCT00844285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108052|NCT00844285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108053|NCT00841789|Etanercept|etanercept|mesh-list
93108054|NCT00841789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93108055|NCT00841789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108056|NCT00841789|Analgesics|analgesics|mesh-ancestor
93108057|NCT00841789|Sensory System Agents|sensory system agents|mesh-ancestor
93108058|NCT00841789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108059|NCT00841789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108060|NCT00841789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108061|NCT00841789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108062|NCT00841789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108063|NCT00841789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108064|NCT00841789|Immunologic Factors|immunologic factors|mesh-ancestor
93108065|NCT00711646|Nabiximols|nabiximols|mesh-list
93108066|NCT00711646|Analgesics|analgesics|mesh-ancestor
93108067|NCT00711646|Sensory System Agents|sensory system agents|mesh-ancestor
93108068|NCT00711646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108069|NCT00711646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108070|NCT00702468|Nabiximols|nabiximols|mesh-list
93108071|NCT00702468|Analgesics|analgesics|mesh-ancestor
93108072|NCT00702468|Sensory System Agents|sensory system agents|mesh-ancestor
93108073|NCT00702468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108074|NCT00702468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108075|NCT00681538|Nabiximols|nabiximols|mesh-list
93108076|NCT00681538|Analgesics|analgesics|mesh-ancestor
93108077|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
93108078|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108079|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108080|NCT00634634|Sorafenib|sorafenib|mesh-list
93108081|NCT00634634|Letrozole|letrozole|mesh-list
93108082|NCT00634634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108083|NCT00634634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93108084|NCT00634634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108085|NCT00634634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108086|NCT00634634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93108087|NCT00634634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93108088|NCT00634634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93108089|NCT00634634|Hormone Antagonists|hormone antagonists|mesh-ancestor
93108090|NCT00634634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108091|NCT00634634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108092|NCT00497029|Fluorides|fluorides|mesh-list
93108093|NCT00497029|Fluorides, Topical|fluorides, topical|mesh-list
93108094|NCT00497029|Cariostatic Agents|cariostatic agents|mesh-ancestor
93108095|NCT00497029|Protective Agents|protective agents|mesh-ancestor
93108096|NCT00497029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108097|NCT00455351|Vorinostat|vorinostat|mesh-list
93108098|NCT00455351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108099|NCT00455351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93108100|NCT00455351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108101|NCT00455351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108102|NCT00379340|Dactinomycin|dactinomycin|mesh-list
93108103|NCT00379340|Cactinomycin|cactinomycin|mesh-list
93108104|NCT00379340|Cyclophosphamide|cyclophosphamide|mesh-list
93108105|NCT00379340|Doxorubicin|doxorubicin|mesh-list
93108106|NCT00379340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93108107|NCT00379340|Etoposide|etoposide|mesh-list
93108108|NCT00379340|Vincristine|vincristine|mesh-list
93108109|NCT00379340|Etoposide phosphate|etoposide phosphate|mesh-list
93108110|NCT00379340|Podophyllotoxin|podophyllotoxin|mesh-list
93108111|NCT00379340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108112|NCT00379340|Immunologic Factors|immunologic factors|mesh-ancestor
93108113|NCT00379340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108114|NCT00379340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108115|NCT00379340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93108116|NCT00379340|Alkylating Agents|alkylating agents|mesh-ancestor
93108117|NCT00379340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108118|NCT00379340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108119|NCT00379340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93108120|NCT00379340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93108121|NCT00379340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93108122|NCT00379340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93108123|NCT00379340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108124|NCT00379340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93108125|NCT00379340|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108126|NCT00379340|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108127|NCT00379340|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108128|NCT00379340|Keratolytic Agents|keratolytic agents|mesh-ancestor
93108129|NCT00379340|Dermatologic Agents|dermatologic agents|mesh-ancestor
93108130|NCT00379340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108131|NCT00379340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108132|NCT00379340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93108133|NCT00379340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108135|NCT00301808|Pemetrexed|pemetrexed|mesh-list
93108136|NCT00301808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108137|NCT00301808|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108138|NCT00301808|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108139|NCT00301808|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108140|NCT00301808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108141|NCT00301808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108142|NCT00301808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93108143|NCT00301808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108144|NCT00254670|Naltrexone|naltrexone|mesh-list
93108145|NCT00254670|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93108146|NCT00254670|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93108147|NCT00254670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108148|NCT00254670|Sensory System Agents|sensory system agents|mesh-ancestor
93108149|NCT00254670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108150|NCT00138801|Doxycycline|doxycycline|mesh-list
93108151|NCT00138801|Ceftriaxone|ceftriaxone|mesh-list
93108152|NCT00138801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108153|NCT00138801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108154|NCT00138801|Antimalarials|antimalarials|mesh-ancestor
93108155|NCT00138801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93108156|NCT00138801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93108157|NCT05795478|Pregabalin|pregabalin|mesh-list
93108158|NCT05795478|Oxycodone|oxycodone|mesh-list
93108159|NCT05795478|Analgesics|analgesics|mesh-ancestor
93108160|NCT05795478|Sensory System Agents|sensory system agents|mesh-ancestor
93108161|NCT05795478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108162|NCT05795478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108163|NCT05795478|Anticonvulsants|anticonvulsants|mesh-ancestor
93108164|NCT05795478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93108165|NCT05795478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93108166|NCT05795478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108167|NCT05795478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93108168|NCT05795478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93108169|NCT05795478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93108170|NCT05795478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108171|NCT05795478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108172|NCT05795478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93108173|NCT05795478|Narcotics|narcotics|mesh-ancestor
93108174|NCT05795413|Bupivacaine|bupivacaine|mesh-list
93108175|NCT05795413|Anesthetics, Local|anesthetics, local|mesh-ancestor
93108176|NCT05795413|Anesthetics|anesthetics|mesh-ancestor
93108177|NCT05795413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108178|NCT05795413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108179|NCT05795413|Sensory System Agents|sensory system agents|mesh-ancestor
93108180|NCT05795413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108181|NCT05795400|Dapagliflozin|dapagliflozin|mesh-list
93108182|NCT05795400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93108183|NCT05795400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108184|NCT05795400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93108185|NCT05795400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108186|NCT05795283|Dexetimide|dexetimide|mesh-list
93108187|NCT05795283|Citalopram|citalopram|mesh-list
93108188|NCT05795283|Escitalopram|escitalopram|mesh-list
93108189|NCT05795283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93108190|NCT05795283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93108191|NCT05795283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93108192|NCT05795283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108193|NCT05795283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108194|NCT05795283|Serotonin Agents|serotonin agents|mesh-ancestor
93108195|NCT05795283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108196|NCT05795283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93108197|NCT05795283|Antidepressive Agents|antidepressive agents|mesh-ancestor
93108198|NCT05795283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108199|NCT05795283|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93108200|NCT05795283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93108201|NCT05795283|Parasympatholytics|parasympatholytics|mesh-ancestor
93108202|NCT05795283|Autonomic Agents|autonomic agents|mesh-ancestor
93108203|NCT05795283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108204|NCT05795283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93108205|NCT05795283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93108206|NCT05795283|Cholinergic Agents|cholinergic agents|mesh-ancestor
93108207|NCT05795244|Nivolumab|nivolumab|mesh-list
93108208|NCT05795244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108209|NCT05795244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108210|NCT05795244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108211|NCT05795244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108212|NCT05794919|Calcium, Dietary|calcium, dietary|mesh-list
93108213|NCT05794919|Phenol|phenol|mesh-list
93108214|NCT05794919|Calcium|calcium|mesh-list
93108215|NCT05794919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93108216|NCT05794919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108217|NCT05794919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93108218|NCT05794919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93108219|NCT05794919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108220|NCT05794919|Disinfectants|disinfectants|mesh-ancestor
93108221|NCT05794919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93108222|NCT05794919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93108223|NCT05794425|Cyclosporine|cyclosporine|mesh-list
93108224|NCT05794425|Cyclosporins|cyclosporins|mesh-list
93108225|NCT05794425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108226|NCT05794425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108227|NCT05794425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108228|NCT05794425|Immunologic Factors|immunologic factors|mesh-ancestor
93108229|NCT05794425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108230|NCT05794425|Antifungal Agents|antifungal agents|mesh-ancestor
93108231|NCT05794425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108232|NCT05794425|Dermatologic Agents|dermatologic agents|mesh-ancestor
93108233|NCT05794425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108234|NCT05794425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93108235|NCT05726097|Ascorbic Acid|ascorbic acid|mesh-list
93108236|NCT05726097|Prucalopride|prucalopride|mesh-list
93108237|NCT05726097|Picosulfate sodium|picosulfate sodium|mesh-list
93108238|NCT05726097|Antioxidants|antioxidants|mesh-ancestor
93108239|NCT05726097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108240|NCT05726097|Protective Agents|protective agents|mesh-ancestor
93108241|NCT05726097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108242|NCT05726097|Vitamins|vitamins|mesh-ancestor
93108243|NCT05726097|Micronutrients|micronutrients|mesh-ancestor
93108244|NCT05726097|Laxatives|laxatives|mesh-ancestor
93108245|NCT05726097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108246|NCT05726097|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93108247|NCT05726097|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93108248|NCT05726097|Serotonin Agents|serotonin agents|mesh-ancestor
93108249|NCT05726097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108250|NCT05726097|Cathartics|cathartics|mesh-ancestor
93108251|NCT05712343|Valacyclovir|valacyclovir|mesh-list
93108252|NCT05712343|Antiviral Agents|antiviral agents|mesh-ancestor
93108253|NCT05712343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108254|NCT05703425|Sulfasalazine|sulfasalazine|mesh-list
93108255|NCT05703425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108256|NCT05703425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93108257|NCT05703425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108258|NCT05703425|Analgesics|analgesics|mesh-ancestor
93108259|NCT05703425|Sensory System Agents|sensory system agents|mesh-ancestor
93108260|NCT05703425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108261|NCT05703425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108262|NCT05703425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108263|NCT05703425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108264|NCT05703425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108265|NCT05700630|Vorinostat|vorinostat|mesh-list
93108266|NCT05700630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108267|NCT05700630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93108268|NCT05700630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108269|NCT05700630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108270|NCT05690503|Ketamine|ketamine|mesh-list
93108271|NCT05690503|Analgesics|analgesics|mesh-ancestor
93108272|NCT05690503|Sensory System Agents|sensory system agents|mesh-ancestor
93108273|NCT05690503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108274|NCT05690503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108275|NCT05690503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93108276|NCT05690503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93108277|NCT05690503|Anesthetics, General|anesthetics, general|mesh-ancestor
93108278|NCT05690503|Anesthetics|anesthetics|mesh-ancestor
93108279|NCT05690503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108280|NCT05690503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93108281|NCT05690503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93108282|NCT05690503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108283|NCT05690503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108284|NCT05667662|Itraconazole|itraconazole|mesh-list
93108285|NCT05667662|Antifungal Agents|antifungal agents|mesh-ancestor
93108286|NCT05667662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108287|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93108288|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93108289|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108290|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108291|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93108292|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
93108293|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108294|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108295|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93108296|NCT05667285|Sirolimus|sirolimus|mesh-list
93108297|NCT05667285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108298|NCT05667285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108299|NCT05667285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93108300|NCT05667285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108301|NCT05667285|Antifungal Agents|antifungal agents|mesh-ancestor
93108302|NCT05667285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108303|NCT05667285|Immunologic Factors|immunologic factors|mesh-ancestor
93108304|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108305|NCT05663515|Insulin|insulin|mesh-list
93108306|NCT05663515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93108307|NCT05663515|Exenatide|exenatide|mesh-list
93108308|NCT05663515|Biguanides|biguanides|mesh-list
93108309|NCT05663515|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93108310|NCT05663515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93108311|NCT05663515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108312|NCT05663515|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93108313|NCT05663515|Incretins|incretins|mesh-ancestor
93108314|NCT05663515|Hormones|hormones|mesh-ancestor
93108315|NCT05663515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108316|NCT05624606|Vaccines|vaccines|mesh-list
93108317|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
93108318|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108319|NCT05608070|Oxytocin|oxytocin|mesh-list
93108320|NCT05608070|Oxytocics|oxytocics|mesh-ancestor
93108321|NCT05608070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93108322|NCT05608070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108323|NCT05600062|Racecadotril|racecadotril|mesh-list
93108324|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
93108325|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108326|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
93108327|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108328|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108329|NCT05588648|Vactosertib|vactosertib|mesh-list
93108330|NCT05588648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93108331|NCT05588648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108332|NCT05588648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108333|NCT05571267|Bevacizumab|bevacizumab|mesh-list
93108334|NCT05571267|Ranibizumab|ranibizumab|mesh-list
93108335|NCT05571267|Aflibercept|aflibercept|mesh-list
93108336|NCT05571267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108337|NCT05571267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108338|NCT05571267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93108339|NCT05571267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93108340|NCT05571267|Growth Substances|growth substances|mesh-ancestor
93108341|NCT05571267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108342|NCT05571267|Growth Inhibitors|growth inhibitors|mesh-ancestor
93108343|NCT05550194|Valacyclovir|valacyclovir|mesh-list
93108344|NCT05550194|Antiviral Agents|antiviral agents|mesh-ancestor
93108345|NCT05550194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108346|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93108347|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
93108348|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108349|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108350|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93108351|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
93108352|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108353|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108354|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93108355|NCT05426486|Carboplatin|carboplatin|mesh-list
93108357|NCT05426486|Trastuzumab|trastuzumab|mesh-list
93108358|NCT05426486|Pertuzumab|pertuzumab|mesh-list
93108359|NCT05426486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108360|NCT05426486|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108361|NCT05426486|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108362|NCT05426486|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108363|NCT05426486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108364|NCT05426486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108365|NCT05399290|Doxycycline|doxycycline|mesh-list
93108366|NCT05399290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108367|NCT05399290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108368|NCT05399290|Antimalarials|antimalarials|mesh-ancestor
93108369|NCT05399290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93108370|NCT05399290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93108371|NCT05389852|Dexmedetomidine|dexmedetomidine|mesh-list
93108372|NCT05389852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93108373|NCT05389852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108374|NCT05389852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108375|NCT05389852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108376|NCT05389852|Analgesics|analgesics|mesh-ancestor
93108377|NCT05389852|Sensory System Agents|sensory system agents|mesh-ancestor
93108378|NCT05389852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108379|NCT05389852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93108380|NCT05389852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93108381|NCT05389852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93108382|NCT05389852|Adrenergic Agents|adrenergic agents|mesh-ancestor
93108383|NCT05389852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108384|NCT05389852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108385|NCT05386914|Sirolimus|sirolimus|mesh-list
93108386|NCT05386914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108387|NCT05386914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108388|NCT05386914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93108389|NCT05386914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108390|NCT05386914|Antifungal Agents|antifungal agents|mesh-ancestor
93108391|NCT05386914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108392|NCT05386914|Immunologic Factors|immunologic factors|mesh-ancestor
93108393|NCT05386914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108394|NCT05383495|Midazolam|midazolam|mesh-list
93108395|NCT05383495|Dexmedetomidine|dexmedetomidine|mesh-list
93108396|NCT05383495|Nitrous Oxide|nitrous oxide|mesh-list
93108397|NCT05383495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93108398|NCT05383495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108399|NCT05383495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108400|NCT05383495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108401|NCT05383495|Analgesics|analgesics|mesh-ancestor
93108402|NCT05383495|Sensory System Agents|sensory system agents|mesh-ancestor
93108403|NCT05383495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108404|NCT05383495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93108405|NCT05383495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93108406|NCT05383495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93108407|NCT05383495|Adrenergic Agents|adrenergic agents|mesh-ancestor
93108408|NCT05383495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108409|NCT05383495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108410|NCT05383495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93108411|NCT05383495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93108412|NCT05383495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93108413|NCT05383495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108414|NCT05383495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93108415|NCT05383495|Anesthetics, General|anesthetics, general|mesh-ancestor
93108416|NCT05383495|Anesthetics|anesthetics|mesh-ancestor
93108417|NCT05383495|GABA Modulators|gaba modulators|mesh-ancestor
93108418|NCT05383495|GABA Agents|gaba agents|mesh-ancestor
93108419|NCT05383495|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93108420|NCT05352828|Nivolumab|nivolumab|mesh-list
93108421|NCT05352828|Fludarabine|fludarabine|mesh-list
93108422|NCT05352828|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93108423|NCT05352828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108424|NCT05352828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108425|NCT05352828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108426|NCT05352828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108427|NCT05352828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93108428|NCT05352828|Alkylating Agents|alkylating agents|mesh-ancestor
93108429|NCT05318469|Ivermectin|ivermectin|mesh-list
93108430|NCT05318469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93108431|NCT05318469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108432|NCT05318248|Clonidine|clonidine|mesh-list
93108433|NCT05318248|Analgesics|analgesics|mesh-ancestor
93108434|NCT05318248|Sensory System Agents|sensory system agents|mesh-ancestor
93108435|NCT05318248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108436|NCT05318248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108437|NCT05318248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93108438|NCT05318248|Sympatholytics|sympatholytics|mesh-ancestor
93108439|NCT05318248|Autonomic Agents|autonomic agents|mesh-ancestor
93108440|NCT05318248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93108441|NCT05318248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93108442|NCT05318248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93108443|NCT05318248|Adrenergic Agents|adrenergic agents|mesh-ancestor
93108444|NCT05318248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108445|NCT05318248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108446|NCT05290493|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
93108447|NCT05290493|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
93108448|NCT05290493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108449|NCT05290493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108450|NCT05287256|Dronabinol|dronabinol|mesh-list
93108451|NCT05287256|Hallucinogens|hallucinogens|mesh-ancestor
93108452|NCT05287256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108453|NCT05287256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108454|NCT05287256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108455|NCT05287256|Analgesics|analgesics|mesh-ancestor
93108456|NCT05287256|Sensory System Agents|sensory system agents|mesh-ancestor
93108457|NCT05287256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108458|NCT05287256|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93108459|NCT05287256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93108460|NCT05287256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108461|NCT05287256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108462|NCT05287256|Hormones|hormones|mesh-ancestor
93108463|NCT05287256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108464|NCT05219266|Midostaurin|midostaurin|mesh-list
93108465|NCT05219266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108466|NCT05219266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93108467|NCT05219266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108468|NCT05219266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108469|NCT05204862|Antibodies|antibodies|mesh-list
93108470|NCT05204862|Immunologic Factors|immunologic factors|mesh-ancestor
93108471|NCT05204862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108472|NCT05193851|Ricolinostat|ricolinostat|mesh-list
93108473|NCT05193851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108474|NCT05193851|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93108475|NCT05193851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108476|NCT05193851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108477|NCT05193318|Ketamine|ketamine|mesh-list
93108478|NCT05193318|Analgesics|analgesics|mesh-ancestor
93108479|NCT05193318|Sensory System Agents|sensory system agents|mesh-ancestor
93108480|NCT05193318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108481|NCT05193318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108482|NCT05193318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93108483|NCT05193318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93108484|NCT05193318|Anesthetics, General|anesthetics, general|mesh-ancestor
93108485|NCT05193318|Anesthetics|anesthetics|mesh-ancestor
93108486|NCT05193318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108487|NCT05193318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93108488|NCT05193318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93108489|NCT05193318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108490|NCT05193318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108491|NCT05163041|Nivolumab|nivolumab|mesh-list
93108492|NCT05163041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108493|NCT05163041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108494|NCT05163041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108495|NCT05163041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108497|NCT05138575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93108498|NCT05138575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108499|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93108500|NCT05138575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108501|NCT05122559|Acetylcysteine|acetylcysteine|mesh-list
93108502|NCT05122559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93108503|NCT05122559|Antiviral Agents|antiviral agents|mesh-ancestor
93108504|NCT05122559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108505|NCT05122559|Expectorants|expectorants|mesh-ancestor
93108506|NCT05122559|Respiratory System Agents|respiratory system agents|mesh-ancestor
93108507|NCT05122559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93108508|NCT05122559|Antioxidants|antioxidants|mesh-ancestor
93108509|NCT05122559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108510|NCT05122559|Protective Agents|protective agents|mesh-ancestor
93108511|NCT05122559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108512|NCT05122559|Antidotes|antidotes|mesh-ancestor
93108513|NCT05112666|Rivaroxaban|rivaroxaban|mesh-list
93108514|NCT05112666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93108515|NCT05112666|Antithrombins|antithrombins|mesh-ancestor
93108516|NCT05112666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93108517|NCT05112666|Protease Inhibitors|protease inhibitors|mesh-ancestor
93108518|NCT05112666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108519|NCT05112666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108520|NCT05112666|Anticoagulants|anticoagulants|mesh-ancestor
93108521|NCT05080764|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93108522|NCT05080764|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93108523|NCT05080764|Dermatologic Agents|dermatologic agents|mesh-ancestor
93108524|NCT05054725|Sotorasib|sotorasib|mesh-list
93108525|NCT05054725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108526|NCT05054725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108527|NCT05054725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108528|NCT05054725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108529|NCT05047211|Dextrans|dextrans|mesh-list
93108530|NCT05047211|Iron-Dextran Complex|iron-dextran complex|mesh-list
93108531|NCT05047211|Anticoagulants|anticoagulants|mesh-ancestor
93108532|NCT05047211|Plasma Substitutes|plasma substitutes|mesh-ancestor
93108533|NCT05047211|Blood Substitutes|blood substitutes|mesh-ancestor
93108534|NCT05047211|Hematinics|hematinics|mesh-ancestor
93108535|NCT05046522|Palmidrol|palmidrol|mesh-list
93108536|NCT05046522|Analgesics|analgesics|mesh-ancestor
93108537|NCT05046522|Sensory System Agents|sensory system agents|mesh-ancestor
93108538|NCT05046522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108539|NCT05046522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108540|NCT05046522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93108541|NCT05046522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108542|NCT05046522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108543|NCT05046522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108544|NCT05046522|Antiviral Agents|antiviral agents|mesh-ancestor
93108545|NCT05046522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108546|NCT05046522|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93108547|NCT05046522|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93108548|NCT05046522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108549|NCT05046522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108550|NCT05046522|Hormones|hormones|mesh-ancestor
93108551|NCT05046522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108552|NCT05046132|Moxifloxacin|moxifloxacin|mesh-list
93108553|NCT05046132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108554|NCT05046132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108555|NCT05046132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93108556|NCT05046132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93108557|NCT05046132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108558|NCT05046132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108559|NCT05046132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108560|NCT04915482|Antibodies|antibodies|mesh-list
93108561|NCT04915482|Immunologic Factors|immunologic factors|mesh-ancestor
93108562|NCT04915482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108563|NCT04897971|Antibodies|antibodies|mesh-list
93108564|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
93108565|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108566|NCT04857827|Timolol|timolol|mesh-list
93108567|NCT04857827|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93108568|NCT04857827|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93108569|NCT04857827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780827|NCT00596947|Prednisone|prednisone|mesh-list
93108570|NCT04857827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93108571|NCT04857827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93108572|NCT04857827|Adrenergic Agents|adrenergic agents|mesh-ancestor
93108573|NCT04857827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108574|NCT04857827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108575|NCT04857827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93108576|NCT04857827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93108578|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
93108579|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108580|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93108581|NCT04716075|Acalabrutinib|acalabrutinib|mesh-list
93108582|NCT04716075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108583|NCT04712539|Oseltamivir|oseltamivir|mesh-list
93108584|NCT04712539|Baloxavir|baloxavir|mesh-list
93108585|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
93108586|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108587|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108588|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108589|NCT04688931|Mitomycins|mitomycins|mesh-list
93108590|NCT04688931|Mitomycin|mitomycin|mesh-list
93108591|NCT04688931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93108592|NCT04688931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108593|NCT04688931|Alkylating Agents|alkylating agents|mesh-ancestor
93108594|NCT04688931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108595|NCT04688931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108596|NCT04688931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108597|NCT04630769|Interleukin-2|interleukin-2|mesh-list
93108598|NCT04630769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108599|NCT04630769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108600|NCT04630769|Analgesics|analgesics|mesh-ancestor
93108601|NCT04630769|Sensory System Agents|sensory system agents|mesh-ancestor
93108602|NCT04630769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108603|NCT04630769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108604|NCT04622007|Pembrolizumab|pembrolizumab|mesh-list
93108605|NCT04622007|Pemetrexed|pemetrexed|mesh-list
93108606|NCT04622007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108607|NCT04622007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108608|NCT04622007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108609|NCT04622007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108610|NCT04622007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108611|NCT04622007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93108612|NCT04622007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108613|NCT04543188|Midazolam|midazolam|mesh-list
93108614|NCT04543188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93108615|NCT04543188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93108616|NCT04543188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108617|NCT04543188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108618|NCT04543188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93108619|NCT04543188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93108620|NCT04543188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108621|NCT04543188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93108622|NCT04543188|Anesthetics, General|anesthetics, general|mesh-ancestor
93108623|NCT04543188|Anesthetics|anesthetics|mesh-ancestor
93108624|NCT04543188|GABA Modulators|gaba modulators|mesh-ancestor
93108625|NCT04543188|GABA Agents|gaba agents|mesh-ancestor
93108626|NCT04543188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108627|NCT04543188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108628|NCT04477512|Prednisone|prednisone|mesh-list
93108629|NCT04477512|Nivolumab|nivolumab|mesh-list
93108630|NCT04477512|Abiraterone Acetate|abiraterone acetate|mesh-list
93108631|NCT04477512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108632|NCT04477512|Glucocorticoids|glucocorticoids|mesh-ancestor
93108633|NCT04477512|Hormones|hormones|mesh-ancestor
93108634|NCT04477512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108635|NCT04477512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108636|NCT04477512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93108637|NCT04477512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108638|NCT04477512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108639|NCT04477512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108640|NCT04477512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108641|NCT04477512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93108642|NCT04477512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108643|NCT04477512|Hormone Antagonists|hormone antagonists|mesh-ancestor
93108644|NCT04477512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93108645|NCT04459273|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93108646|NCT04459273|FAPI-46|fapi-46|mesh-list
93108647|NCT04459273|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93108648|NCT04459273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108649|NCT04457232|FAPI-46|fapi-46|mesh-list
93108650|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93108651|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108652|NCT04407247|Infliximab|infliximab|mesh-list
93108653|NCT04407247|Vedolizumab|vedolizumab|mesh-list
93108654|NCT04407247|Immunoglobulins|immunoglobulins|mesh-list
93108655|NCT04407247|Immunoglobulin G|immunoglobulin g|mesh-list
93108656|NCT04407247|Immunologic Factors|immunologic factors|mesh-ancestor
93108657|NCT04407247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108658|NCT04407247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93108659|NCT04407247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108660|NCT04407247|Dermatologic Agents|dermatologic agents|mesh-ancestor
93108661|NCT04407247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108662|NCT04407247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108663|NCT04349124|Nifedipine|nifedipine|mesh-list
93108664|NCT04349124|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93108665|NCT04349124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93108666|NCT04349124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108667|NCT04349124|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93108668|NCT04349124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108669|NCT04349124|Vasodilator Agents|vasodilator agents|mesh-ancestor
93108670|NCT04349124|Tocolytic Agents|tocolytic agents|mesh-ancestor
93108671|NCT04349124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93108672|NCT04348292|Sirolimus|sirolimus|mesh-list
93108673|NCT04348292|Durvalumab|durvalumab|mesh-list
93108674|NCT04348292|Immunoglobulins|immunoglobulins|mesh-list
93108675|NCT04348292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93108676|NCT04348292|Immunoglobulin G|immunoglobulin g|mesh-list
93108677|NCT04348292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108678|NCT04348292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108679|NCT04348292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93108680|NCT04348292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108681|NCT04348292|Antifungal Agents|antifungal agents|mesh-ancestor
93108682|NCT04348292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108683|NCT04348292|Immunologic Factors|immunologic factors|mesh-ancestor
93108684|NCT04348292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108685|NCT04348292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108686|NCT04316676|Regadenoson|regadenoson|mesh-list
93108687|NCT04316676|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93108688|NCT04316676|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93108689|NCT04316676|Purinergic Agonists|purinergic agonists|mesh-ancestor
93108690|NCT04316676|Purinergic Agents|purinergic agents|mesh-ancestor
93108691|NCT04316676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108692|NCT04316676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108693|NCT04316676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108694|NCT04291703|Thymoglobulin|thymoglobulin|mesh-list
93108695|NCT04291703|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93108696|NCT04291703|Immunologic Factors|immunologic factors|mesh-ancestor
93108697|NCT04291703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108698|NCT04291703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108699|NCT04147494|Edetic Acid|edetic acid|mesh-list
93108700|NCT04147494|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93108701|NCT04147494|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93108702|NCT04147494|FAPI-46|fapi-46|mesh-list
93108703|NCT04147494|Chelating Agents|chelating agents|mesh-ancestor
93108704|NCT04147494|Sequestering Agents|sequestering agents|mesh-ancestor
93108705|NCT04147494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108706|NCT04147494|Anticoagulants|anticoagulants|mesh-ancestor
93108707|NCT04147494|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93108708|NCT04147494|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93108709|NCT04138706|Vancomycin|vancomycin|mesh-list
93108710|NCT04138706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108711|NCT04138706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108712|NCT03991403|Paclitaxel|paclitaxel|mesh-list
93108713|NCT03991403|Bevacizumab|bevacizumab|mesh-list
93108714|NCT03991403|Carboplatin|carboplatin|mesh-list
93108715|NCT03991403|Pemetrexed|pemetrexed|mesh-list
93108716|NCT03991403|Atezolizumab|atezolizumab|mesh-list
93108717|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93108718|NCT03991403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108719|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108720|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108721|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108722|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108723|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108724|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93108725|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93108726|NCT03991403|Growth Substances|growth substances|mesh-ancestor
93108727|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108728|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
93108729|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108730|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93108731|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108732|NCT03991403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108733|NCT03930680|Dexrazoxane|dexrazoxane|mesh-list
93108734|NCT03930680|Razoxane|razoxane|mesh-list
93108735|NCT03930680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108736|NCT03930680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93108737|NCT03930680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93108738|NCT03930680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93108739|NCT03930680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108740|NCT03930680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108741|NCT03930680|Protective Agents|protective agents|mesh-ancestor
93108742|NCT03930680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108743|NCT03930680|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108744|NCT03930680|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108745|NCT03897439|Bupropion|bupropion|mesh-list
93108746|NCT03897439|Nicotine|nicotine|mesh-list
93108747|NCT03897439|Varenicline|varenicline|mesh-list
93108748|NCT03897439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93108749|NCT03897439|Autonomic Agents|autonomic agents|mesh-ancestor
93108750|NCT03897439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108751|NCT03897439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108752|NCT03897439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93108753|NCT03897439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93108754|NCT03897439|Cholinergic Agents|cholinergic agents|mesh-ancestor
93108755|NCT03897439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93108756|NCT03897439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108757|NCT03897439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93108758|NCT03897439|Antidepressive Agents|antidepressive agents|mesh-ancestor
93108759|NCT03897439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93108760|NCT03897439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93108761|NCT03897439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93108762|NCT03897439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93108763|NCT03897439|Dopamine Agents|dopamine agents|mesh-ancestor
93108764|NCT03897439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93108765|NCT03897439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93108766|NCT03897439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108767|NCT03830164|Vitamins|vitamins|mesh-list
93108768|NCT03830164|Vitamin E|vitamin e|mesh-list
93108769|NCT03830164|Tocopherols|tocopherols|mesh-list
93108770|NCT03830164|Tocotrienols|tocotrienols|mesh-list
93108771|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
93108772|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
93108773|NCT03830164|Atorvastatin|atorvastatin|mesh-list
93108774|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
93108775|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108776|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93108777|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93108778|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
93108779|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108780|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93108781|NCT03830164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93108782|NCT03830164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108783|NCT03830164|Antioxidants|antioxidants|mesh-ancestor
92698998|NCT02946359|Bevacizumab|bevacizumab|mesh-list
93108784|NCT03830164|Protective Agents|protective agents|mesh-ancestor
93108785|NCT03830164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93108786|NCT03830164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93108787|NCT03830164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93108788|NCT03830164|Vasodilator Agents|vasodilator agents|mesh-ancestor
93108789|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93108790|NCT03784326|Fluorouracil|fluorouracil|mesh-list
93108791|NCT03784326|Oxaliplatin|oxaliplatin|mesh-list
93108792|NCT03784326|Atezolizumab|atezolizumab|mesh-list
93108793|NCT03784326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93108794|NCT03784326|Antimetabolites|antimetabolites|mesh-ancestor
93108795|NCT03784326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781062|NCT02629627|Metformin|metformin|mesh-list
93108796|NCT03784326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93108797|NCT03784326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108798|NCT03784326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108799|NCT03784326|Immunologic Factors|immunologic factors|mesh-ancestor
93108800|NCT03784326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108801|NCT03784326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108802|NCT03784326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108803|NCT03777436|Apremilast|apremilast|mesh-list
93108804|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93108805|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108806|NCT03777436|Analgesics|analgesics|mesh-ancestor
93108807|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
93108808|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108809|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108810|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108811|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108812|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93108813|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93108814|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108815|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108816|NCT03773302|Gemcitabine|gemcitabine|mesh-list
93108817|NCT03773302|Infigratinib|infigratinib|mesh-list
93108818|NCT03773302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108819|NCT03773302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93108820|NCT03773302|Antimetabolites|antimetabolites|mesh-ancestor
93108821|NCT03773302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108822|NCT03701763|Apremilast|apremilast|mesh-list
93108823|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93108824|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93108825|NCT03701763|Analgesics|analgesics|mesh-ancestor
93108826|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
93108827|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108828|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108829|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108830|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93108831|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93108832|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93108833|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108834|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108835|NCT03673462|Vaccines|vaccines|mesh-list
93108836|NCT03673462|Immunologic Factors|immunologic factors|mesh-ancestor
93108837|NCT03673462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108838|NCT03649880|Misonidazole|misonidazole|mesh-list
93108839|NCT03649880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108840|NCT03649880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93108841|NCT03649880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93108842|NCT03649880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108843|NCT03592992|Morphine|morphine|mesh-list
93108844|NCT03592992|Hydromorphone|hydromorphone|mesh-list
93108845|NCT03592992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93108846|NCT03592992|Narcotics|narcotics|mesh-ancestor
93108847|NCT03592992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93108848|NCT03592992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108849|NCT03592992|Analgesics|analgesics|mesh-ancestor
93108850|NCT03592992|Sensory System Agents|sensory system agents|mesh-ancestor
93108851|NCT03592992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93108852|NCT03447808|Daratumumab|daratumumab|mesh-list
93108853|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108854|NCT03386240|Triclosan|triclosan|mesh-list
93108855|NCT03386240|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93108856|NCT03386240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108857|NCT03386240|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93108858|NCT03386240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93108859|NCT03386240|Antimetabolites|antimetabolites|mesh-ancestor
93108860|NCT03386240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108861|NCT03386240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93108862|NCT03366766|Cisplatin|cisplatin|mesh-list
93108863|NCT03366766|Gemcitabine|gemcitabine|mesh-list
93108864|NCT03366766|Nivolumab|nivolumab|mesh-list
93108865|NCT03366766|Pemetrexed|pemetrexed|mesh-list
93108866|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108867|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93108868|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
93108869|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108870|NCT03366766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108871|NCT03366766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108872|NCT03366766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108873|NCT03366766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93108874|NCT03366766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93108875|NCT03308448|Epoetin Alfa|epoetin alfa|mesh-list
93108876|NCT03308448|Hematinics|hematinics|mesh-ancestor
93108877|NCT03299309|Vaccines|vaccines|mesh-list
93108878|NCT03299309|Immunologic Factors|immunologic factors|mesh-ancestor
93108879|NCT03299309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108880|NCT03254927|Cetuximab|cetuximab|mesh-list
93108881|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108882|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108883|NCT03039036|Misoprostol|misoprostol|mesh-list
93108884|NCT03039036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93108885|NCT03039036|Abortifacient Agents|abortifacient agents|mesh-ancestor
93108886|NCT03039036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93108887|NCT03039036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108888|NCT03039036|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93108889|NCT03039036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108890|NCT03039036|Oxytocics|oxytocics|mesh-ancestor
93108891|NCT03025880|Gemcitabine|gemcitabine|mesh-list
93108892|NCT03025880|Pembrolizumab|pembrolizumab|mesh-list
93108893|NCT03025880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93108894|NCT03025880|Antimetabolites|antimetabolites|mesh-ancestor
93108895|NCT03025880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108896|NCT03025880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108897|NCT03025880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93108898|NCT03025880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93108899|NCT02962297|Vitamin E|vitamin e|mesh-list
93108900|NCT02962297|Vitamins|vitamins|mesh-ancestor
93108901|NCT02962297|Micronutrients|micronutrients|mesh-ancestor
93108902|NCT02962297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108903|NCT02962297|Antioxidants|antioxidants|mesh-ancestor
93108904|NCT02962297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108905|NCT02962297|Protective Agents|protective agents|mesh-ancestor
93108906|NCT02939742|Betamethasone|betamethasone|mesh-list
93108907|NCT02939742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93108908|NCT02939742|Glucocorticoids|glucocorticoids|mesh-ancestor
93108909|NCT02939742|Hormones|hormones|mesh-ancestor
93108910|NCT02939742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93108911|NCT02939742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108912|NCT02939742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93108913|NCT02939742|Respiratory System Agents|respiratory system agents|mesh-ancestor
93108914|NCT02678572|Melphalan|melphalan|mesh-list
93108915|NCT02678572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93108916|NCT02678572|Alkylating Agents|alkylating agents|mesh-ancestor
93108917|NCT02678572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108918|NCT02678572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108919|NCT02678572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93108920|NCT02678572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108921|NCT02678572|Immunologic Factors|immunologic factors|mesh-ancestor
93108922|NCT02678572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108923|NCT02581787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93108924|NCT02581787|Antibodies|antibodies|mesh-list
93108925|NCT02581787|Immunoglobulins|immunoglobulins|mesh-list
93108926|NCT02581787|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93108927|NCT02581787|Immunoglobulin G|immunoglobulin g|mesh-list
93108928|NCT02581787|Immunologic Factors|immunologic factors|mesh-ancestor
93108929|NCT02581787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108930|NCT02581787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108931|NCT02518555|Vaccines|vaccines|mesh-list
93108932|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
93108933|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108934|NCT02027376|Docetaxel|docetaxel|mesh-list
93108935|NCT02027376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108936|NCT02027376|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108937|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108938|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108939|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108940|NCT02005289|Lenalidomide|lenalidomide|mesh-list
93108941|NCT02005289|Immunologic Factors|immunologic factors|mesh-ancestor
93108942|NCT02005289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108943|NCT02005289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93108944|NCT02005289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93108945|NCT02005289|Growth Substances|growth substances|mesh-ancestor
93108946|NCT02005289|Growth Inhibitors|growth inhibitors|mesh-ancestor
93108947|NCT02005289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108948|NCT01924533|Paclitaxel|paclitaxel|mesh-list
93108949|NCT01924533|Olaparib|olaparib|mesh-list
93108950|NCT01924533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93108951|NCT01924533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108952|NCT01924533|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108953|NCT01924533|Antimitotic Agents|antimitotic agents|mesh-ancestor
93108954|NCT01924533|Mitosis Modulators|mitosis modulators|mesh-ancestor
93108955|NCT01924533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108956|NCT01924533|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93108957|NCT01924533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108958|NCT01683955|Tranexamic Acid|tranexamic acid|mesh-list
93108959|NCT01683955|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93108960|NCT01683955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93108961|NCT01683955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108962|NCT01683955|Hemostatics|hemostatics|mesh-ancestor
93108963|NCT01683955|Coagulants|coagulants|mesh-ancestor
93108964|NCT01606436|Moxifloxacin|moxifloxacin|mesh-list
93108965|NCT01606436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93108966|NCT01606436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108967|NCT01606436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93108968|NCT01606436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93108969|NCT01606436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108970|NCT01606436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108971|NCT01606436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108972|NCT01453088|Bortezomib|bortezomib|mesh-list
93108973|NCT01453088|Melphalan|melphalan|mesh-list
93108974|NCT01453088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108975|NCT01453088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93108976|NCT01453088|Alkylating Agents|alkylating agents|mesh-ancestor
93108977|NCT01453088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108978|NCT01453088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93108979|NCT01453088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93108980|NCT01453088|Immunologic Factors|immunologic factors|mesh-ancestor
93108981|NCT01453088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93108982|NCT01345175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93108983|NCT01345175|Metronidazole|metronidazole|mesh-list
93108984|NCT01345175|Rifaximin|rifaximin|mesh-list
93108985|NCT01345175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93108986|NCT01345175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108987|NCT01345175|Antitubercular Agents|antitubercular agents|mesh-ancestor
93108988|NCT01345175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93108989|NCT01345175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93108990|NCT01345175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93108991|NCT01295645|Cidofovir|cidofovir|mesh-list
93108992|NCT01295645|Antiviral Agents|antiviral agents|mesh-ancestor
93108993|NCT01295645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93108994|NCT01295645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93108995|NCT01295645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93108996|NCT01257139|Docetaxel|docetaxel|mesh-list
93108997|NCT01257139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93108998|NCT01257139|Tubulin Modulators|tubulin modulators|mesh-ancestor
93108999|NCT01257139|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109000|NCT01257139|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109001|NCT01257139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109002|NCT01243190|Ofatumumab|ofatumumab|mesh-list
93109003|NCT01243190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109004|NCT01046825|Leucovorin|leucovorin|mesh-list
93109005|NCT01046825|Folic Acid|folic acid|mesh-list
93109006|NCT01046825|Cytarabine|cytarabine|mesh-list
93109007|NCT01046825|Prednisone|prednisone|mesh-list
93109008|NCT01046825|Cyclophosphamide|cyclophosphamide|mesh-list
93109009|NCT01046825|Doxorubicin|doxorubicin|mesh-list
93109010|NCT01046825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93109011|NCT01046825|Rituximab|rituximab|mesh-list
93109012|NCT01046825|Rasburicase|rasburicase|mesh-list
93109013|NCT01046825|Lenograstim|lenograstim|mesh-list
93109014|NCT01046825|Levoleucovorin|levoleucovorin|mesh-list
93109015|NCT01046825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109016|NCT01046825|Glucocorticoids|glucocorticoids|mesh-ancestor
93109017|NCT01046825|Hormones|hormones|mesh-ancestor
93109018|NCT01046825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109019|NCT01046825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109020|NCT01046825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109021|NCT01046825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109022|NCT01046825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93109023|NCT01046825|Immunologic Factors|immunologic factors|mesh-ancestor
93109024|NCT01046825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109025|NCT01046825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109026|NCT01046825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93109027|NCT01046825|Alkylating Agents|alkylating agents|mesh-ancestor
93109028|NCT01046825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109029|NCT01046825|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93109030|NCT01046825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93109031|NCT01046825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93109032|NCT01046825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93109033|NCT01046825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109034|NCT01046825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109035|NCT01046825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109036|NCT01046825|Antimetabolites|antimetabolites|mesh-ancestor
93109037|NCT01046825|Antiviral Agents|antiviral agents|mesh-ancestor
93109038|NCT01046825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109039|NCT01046825|Antidotes|antidotes|mesh-ancestor
93109040|NCT01046825|Protective Agents|protective agents|mesh-ancestor
93109041|NCT01046825|Vitamin B Complex|vitamin b complex|mesh-ancestor
93109042|NCT01046825|Vitamins|vitamins|mesh-ancestor
93109043|NCT01046825|Micronutrients|micronutrients|mesh-ancestor
93109044|NCT01046825|Hematinics|hematinics|mesh-ancestor
93109045|NCT01046825|Gout Suppressants|gout suppressants|mesh-ancestor
93109046|NCT00936936|Carboplatin|carboplatin|mesh-list
93109047|NCT00936936|Gemcitabine|gemcitabine|mesh-list
93109048|NCT00936936|Docetaxel|docetaxel|mesh-list
93109049|NCT00936936|Etoposide|etoposide|mesh-list
93109050|NCT00936936|Melphalan|melphalan|mesh-list
93109051|NCT00936936|Ifosfamide|ifosfamide|mesh-list
92699248|NCT02945163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93109052|NCT00936936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109053|NCT00936936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109054|NCT00936936|Antimetabolites|antimetabolites|mesh-ancestor
93109055|NCT00936936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109056|NCT00936936|Tubulin Modulators|tubulin modulators|mesh-ancestor
93109057|NCT00936936|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109058|NCT00936936|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109059|NCT00936936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93109060|NCT00936936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93109061|NCT00936936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93109062|NCT00936936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109063|NCT00936936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93109064|NCT00936936|Alkylating Agents|alkylating agents|mesh-ancestor
93109065|NCT00936936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93109066|NCT00936936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109067|NCT00936936|Immunologic Factors|immunologic factors|mesh-ancestor
93109068|NCT00936936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109069|NCT04478292|Sodium thiosulfate|sodium thiosulfate|mesh-list
93109070|NCT04478292|Cisplatin|cisplatin|mesh-list
93109071|NCT04478292|Carboplatin|carboplatin|mesh-list
93109072|NCT04478292|Doxorubicin|doxorubicin|mesh-list
93109073|NCT04478292|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93109074|NCT04478292|Fluorouracil|fluorouracil|mesh-list
93109075|NCT04478292|Irinotecan|irinotecan|mesh-list
93109076|NCT04478292|Vincristine|vincristine|mesh-list
93109077|NCT04478292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109078|NCT04478292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93109079|NCT04478292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93109080|NCT04478292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93109081|NCT04478292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109082|NCT04478292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109083|NCT04478292|Antimetabolites|antimetabolites|mesh-ancestor
93109084|NCT04478292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109085|NCT04478292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109086|NCT04478292|Immunologic Factors|immunologic factors|mesh-ancestor
93109087|NCT04478292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109088|NCT04478292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93109089|NCT04478292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93109090|NCT04478292|Tubulin Modulators|tubulin modulators|mesh-ancestor
93109091|NCT04478292|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109092|NCT04478292|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109093|NCT04478292|Antidotes|antidotes|mesh-ancestor
93109094|NCT04478292|Protective Agents|protective agents|mesh-ancestor
93109095|NCT04478292|Antioxidants|antioxidants|mesh-ancestor
93109096|NCT04478292|Antitubercular Agents|antitubercular agents|mesh-ancestor
93109097|NCT04478292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109098|NCT04478292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109099|NCT04478292|Chelating Agents|chelating agents|mesh-ancestor
93109100|NCT04478292|Sequestering Agents|sequestering agents|mesh-ancestor
93109101|NCT01141296|Fenofibrate|fenofibrate|mesh-list
93109102|NCT01141296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93109103|NCT01141296|Antimetabolites|antimetabolites|mesh-ancestor
93109104|NCT01141296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109105|NCT01141296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93109106|NCT01238328|Thymoglobulin|thymoglobulin|mesh-list
93109107|NCT01238328|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93109108|NCT01238328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109109|NCT01238328|Immunologic Factors|immunologic factors|mesh-ancestor
93109110|NCT01238328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109111|NCT01238406|Pancrelipase|pancrelipase|mesh-list
93109112|NCT01238406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109114|NCT03724890|Peposertib|peposertib|mesh-list
93109115|NCT03724890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92699329|NCT02924922|Mannitol|mannitol|mesh-list
93109116|NCT03724890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109117|NCT03724890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109118|NCT03724890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109119|NCT03724890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109120|NCT01141452|Fluticasone|fluticasone|mesh-list
93109121|NCT01141452|Xhance|xhance|mesh-list
93109122|NCT01141452|Beclomethasone|beclomethasone|mesh-list
93109123|NCT01141452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109124|NCT01141452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93109125|NCT01141452|Autonomic Agents|autonomic agents|mesh-ancestor
93109126|NCT01141452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109127|NCT01141452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109128|NCT01141452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93109129|NCT01141452|Respiratory System Agents|respiratory system agents|mesh-ancestor
93109130|NCT01141452|Dermatologic Agents|dermatologic agents|mesh-ancestor
93109131|NCT01141452|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93109132|NCT01141452|Glucocorticoids|glucocorticoids|mesh-ancestor
93109133|NCT01141452|Hormones|hormones|mesh-ancestor
93109134|NCT01141452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109135|NCT00219557|Gemcitabine|gemcitabine|mesh-list
93109136|NCT00219557|Axitinib|axitinib|mesh-list
93109137|NCT00219557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109138|NCT00219557|Antimetabolites|antimetabolites|mesh-ancestor
93109139|NCT00219557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109140|NCT00219557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109141|NCT00219557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109142|NCT00219557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109143|NCT05282940|Levonorgestrel|levonorgestrel|mesh-list
93109144|NCT05282940|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93109145|NCT05282940|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93109146|NCT05282940|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93109147|NCT05282940|Estradiol|estradiol|mesh-list
93109148|NCT05282940|Estrogens|estrogens|mesh-ancestor
93109149|NCT05282940|Hormones|hormones|mesh-ancestor
93109150|NCT05282940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109151|NCT05282940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109152|NCT05282940|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93109153|NCT05282940|Contraceptive Agents|contraceptive agents|mesh-ancestor
93109154|NCT05282940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93109155|NCT05282940|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93109156|NCT05282940|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93109157|NCT05282940|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93109158|NCT05282940|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93109159|NCT05282940|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93109160|NCT05282940|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93109161|NCT05282940|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93109162|NCT05282940|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93109163|NCT01238562|Lenograstim|lenograstim|mesh-list
93109164|NCT01238562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93109165|NCT01238562|Immunologic Factors|immunologic factors|mesh-ancestor
93109166|NCT01238562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109167|NCT01329666|Vitamin D|vitamin d|mesh-list
93109168|NCT01329666|Cholecalciferol|cholecalciferol|mesh-list
93109169|NCT01329666|Vitamins|vitamins|mesh-ancestor
93109170|NCT01329666|Micronutrients|micronutrients|mesh-ancestor
93109171|NCT01329666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109172|NCT01329666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93109173|NCT01329666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93109174|NCT05255484|Antibodies|antibodies|mesh-list
93109175|NCT05255484|Immunologic Factors|immunologic factors|mesh-ancestor
93109176|NCT05255484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109177|NCT01141998|Cholecalciferol|cholecalciferol|mesh-list
93109178|NCT01141998|Vitamin D|vitamin d|mesh-list
93109179|NCT01141998|Calcium, Dietary|calcium, dietary|mesh-list
93109180|NCT01141998|Calcium|calcium|mesh-list
93109181|NCT01141998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93109182|NCT01141998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109184|NCT01141998|Micronutrients|micronutrients|mesh-ancestor
93109185|NCT01141998|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93109186|NCT01238718|Lidocaine|lidocaine|mesh-list
93109187|NCT01238718|Anesthetics, Local|anesthetics, local|mesh-ancestor
93109188|NCT01238718|Anesthetics|anesthetics|mesh-ancestor
93109189|NCT01238718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109190|NCT01238718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109191|NCT01238718|Sensory System Agents|sensory system agents|mesh-ancestor
93109192|NCT01238718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109193|NCT01238718|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93109194|NCT01238718|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93109195|NCT01238718|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93109196|NCT01238718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93109197|NCT01238718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109198|NCT01238796|Telavancin|telavancin|mesh-list
93109199|NCT01238796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109200|NCT01238796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109201|NCT01143948|Insulin|insulin|mesh-list
93109202|NCT01143948|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93109203|NCT01143948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93109204|NCT01143948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109205|NCT01145976|Cyclophosphamide|cyclophosphamide|mesh-list
93109206|NCT01145976|Fludarabine|fludarabine|mesh-list
93109207|NCT01145976|Thymoglobulin|thymoglobulin|mesh-list
93109208|NCT01145976|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93109209|NCT01145976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109210|NCT01145976|Immunologic Factors|immunologic factors|mesh-ancestor
93109211|NCT01145976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109212|NCT01145976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109213|NCT01145976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93109214|NCT01145976|Alkylating Agents|alkylating agents|mesh-ancestor
93109215|NCT01145976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109216|NCT01145976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109217|NCT01145976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93109218|NCT01238952|Carboplatin|carboplatin|mesh-list
93109219|NCT01238952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109220|NCT05158998|Propofol|propofol|mesh-list
93109221|NCT05158998|Sevoflurane|sevoflurane|mesh-list
93109222|NCT05158998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93109223|NCT05158998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109224|NCT05158998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109225|NCT05158998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93109226|NCT05158998|Anesthetics, General|anesthetics, general|mesh-ancestor
93109227|NCT05158998|Anesthetics|anesthetics|mesh-ancestor
93109228|NCT05158998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93109229|NCT05158998|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93109230|NCT01144260|Bafetinib|bafetinib|mesh-list
93109231|NCT01144260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109232|NCT01144260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109233|NCT01144260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109234|NCT01239498|Lidocaine|lidocaine|mesh-list
93109235|NCT01239498|Epinephrine|epinephrine|mesh-list
93109236|NCT01239498|Racepinephrine|racepinephrine|mesh-list
93109237|NCT01239498|Anesthetics|anesthetics|mesh-list
93109238|NCT01239498|Epinephryl borate|epinephryl borate|mesh-list
93109239|NCT01239498|Anesthetics, Local|anesthetics, local|mesh-ancestor
93109240|NCT01239498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109241|NCT01239498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109242|NCT01239498|Sensory System Agents|sensory system agents|mesh-ancestor
93109243|NCT01239498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109244|NCT01239498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93109245|NCT01239498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93109246|NCT01239498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93109247|NCT01239498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93109248|NCT01239498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109249|NCT01239498|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93109250|NCT01239498|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93109251|NCT01239498|Adrenergic Agents|adrenergic agents|mesh-ancestor
93109252|NCT01239498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109253|NCT01239498|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93109254|NCT01239498|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93109255|NCT01239498|Autonomic Agents|autonomic agents|mesh-ancestor
93109256|NCT01239498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93109257|NCT01239498|Respiratory System Agents|respiratory system agents|mesh-ancestor
93109258|NCT01239498|Mydriatics|mydriatics|mesh-ancestor
93109259|NCT01239498|Sympathomimetics|sympathomimetics|mesh-ancestor
93109260|NCT01239498|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93109261|NCT00251927|Esomeprazole|esomeprazole|mesh-list
93109262|NCT00251927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93109263|NCT00251927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109264|NCT00251927|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93109265|NCT00251927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109266|NCT00251927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109267|NCT03790800|Urapidil|urapidil|mesh-list
93109268|NCT03790800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93109269|NCT03790800|Vasodilator Agents|vasodilator agents|mesh-ancestor
93109270|NCT03790800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93109271|NCT03790800|Serotonin Agents|serotonin agents|mesh-ancestor
93109272|NCT03790800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109273|NCT03790800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109274|NCT03790800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109275|NCT03790800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93109276|NCT03790800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93109277|NCT03790800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93109278|NCT03790800|Adrenergic Agents|adrenergic agents|mesh-ancestor
93109279|NCT03971201|Sorafenib|sorafenib|mesh-list
93109280|NCT03971201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109281|NCT03971201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109282|NCT03971201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109283|NCT03971201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109284|NCT01236144|Plerixafor|plerixafor|mesh-list
93109285|NCT01236144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93109286|NCT01236144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93109287|NCT01236144|Antiviral Agents|antiviral agents|mesh-ancestor
93109288|NCT01236144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109289|NCT02528526|Inositol|inositol|mesh-list
93109290|NCT02528526|Vitamin B Complex|vitamin b complex|mesh-ancestor
93109291|NCT02528526|Vitamins|vitamins|mesh-ancestor
93109292|NCT02528526|Micronutrients|micronutrients|mesh-ancestor
93109293|NCT02528526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109294|NCT03971279|Dexamethasone|dexamethasone|mesh-list
93109295|NCT03971279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109296|NCT03971279|Antiemetics|antiemetics|mesh-ancestor
93109297|NCT03971279|Autonomic Agents|autonomic agents|mesh-ancestor
93109298|NCT03971279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109299|NCT03971279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109300|NCT03971279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109301|NCT03971279|Glucocorticoids|glucocorticoids|mesh-ancestor
93109302|NCT03971279|Hormones|hormones|mesh-ancestor
93109303|NCT03971279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109304|NCT03971279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109305|NCT03971279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109306|NCT01329744|Mecasermin|mecasermin|mesh-list
93109307|NCT01329744|Growth Substances|growth substances|mesh-ancestor
93109308|NCT01329744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109309|NCT00165503|Sodium thiosulfate|sodium thiosulfate|mesh-list
93109310|NCT00165503|Pemetrexed|pemetrexed|mesh-list
93109311|NCT00165503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109312|NCT00165503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699517|NCT00528671|Phenprocoumon|phenprocoumon|mesh-list
93109313|NCT00165503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109314|NCT00165503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93109315|NCT00165503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93109316|NCT00165503|Antidotes|antidotes|mesh-ancestor
93109317|NCT00165503|Protective Agents|protective agents|mesh-ancestor
93109318|NCT00165503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109319|NCT00165503|Antioxidants|antioxidants|mesh-ancestor
93109320|NCT00165503|Antitubercular Agents|antitubercular agents|mesh-ancestor
93109321|NCT00165503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109322|NCT00165503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109323|NCT00165503|Chelating Agents|chelating agents|mesh-ancestor
93109324|NCT00165503|Sequestering Agents|sequestering agents|mesh-ancestor
93109325|NCT01144650|Dapsone|dapsone|mesh-list
93109326|NCT01144650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109327|NCT01144650|Antimalarials|antimalarials|mesh-ancestor
93109328|NCT01144650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93109329|NCT01144650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93109330|NCT01144650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92781585|NCT00912145|Alprazolam|alprazolam|mesh-list
93109331|NCT01144650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109332|NCT01144650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109333|NCT01144650|Leprostatic Agents|leprostatic agents|mesh-ancestor
93109334|NCT01144650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109335|NCT00162773|Omalizumab|omalizumab|mesh-list
93109336|NCT00162773|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93109337|NCT00162773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93109338|NCT00162773|Respiratory System Agents|respiratory system agents|mesh-ancestor
93109339|NCT03970577|Prednisone|prednisone|mesh-list
93109340|NCT03970577|Rituximab|rituximab|mesh-list
93109341|NCT03970577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109342|NCT03970577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109343|NCT03970577|Immunologic Factors|immunologic factors|mesh-ancestor
93109344|NCT03970577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109345|NCT03970577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109346|NCT03970577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109347|NCT03970577|Glucocorticoids|glucocorticoids|mesh-ancestor
93109348|NCT03970577|Hormones|hormones|mesh-ancestor
93109349|NCT03970577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109350|NCT03970577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109351|NCT01073813|Minocycline|minocycline|mesh-list
93109352|NCT01073813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109353|NCT01073813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109354|NCT03823391|Adalimumab|adalimumab|mesh-list
93109355|NCT03823391|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93109356|NCT03823391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109357|NCT03823391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109358|NCT00161213|Gemcitabine|gemcitabine|mesh-list
93109359|NCT00161213|Imatinib Mesylate|imatinib mesylate|mesh-list
93109360|NCT00161213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109361|NCT00161213|Antimetabolites|antimetabolites|mesh-ancestor
93109362|NCT00161213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109363|NCT00161213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109364|NCT00161213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109365|NCT00161213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109366|NCT01075529|Fluoxetine|fluoxetine|mesh-list
93109367|NCT01075529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93109368|NCT01075529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93109369|NCT01075529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93109370|NCT01075529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109371|NCT01075529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109372|NCT01075529|Serotonin Agents|serotonin agents|mesh-ancestor
93109373|NCT01075529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109374|NCT01075529|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93109375|NCT01075529|Antidepressive Agents|antidepressive agents|mesh-ancestor
93109376|NCT01075529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93109377|NCT01075529|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93109378|NCT01075529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93109379|NCT01075529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109380|NCT01073891|Moxifloxacin|moxifloxacin|mesh-list
93109381|NCT01073891|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93109382|NCT01073891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109383|NCT01073891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109384|NCT01073891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93109385|NCT01073891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93109386|NCT01073891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109387|NCT01073891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109388|NCT01073891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109389|NCT01073891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93109390|NCT01073891|Contraceptive Agents|contraceptive agents|mesh-ancestor
93109391|NCT01073891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93109392|NCT01073891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109393|NCT01073891|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93109394|NCT01073891|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93109395|NCT01073891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93109396|NCT00209027|Aripiprazole|aripiprazole|mesh-list
93109397|NCT00209027|Antidepressive Agents|antidepressive agents|mesh-ancestor
93109398|NCT00209027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93109399|NCT00209027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93109400|NCT00209027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93109401|NCT00209027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109402|NCT00209027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109403|NCT00209027|Dopamine Agonists|dopamine agonists|mesh-ancestor
93109404|NCT00209027|Dopamine Agents|dopamine agents|mesh-ancestor
92781659|NCT04241380|Heparin|heparin|mesh-list
93109405|NCT00209027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109406|NCT00209027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109407|NCT00209027|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93109408|NCT00209027|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93109409|NCT00209027|Serotonin Agents|serotonin agents|mesh-ancestor
93109410|NCT00209027|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93109411|NCT00209027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93109412|NCT00209027|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93109413|NCT00209027|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93109414|NCT00160667|Brivaracetam|brivaracetam|mesh-list
93109415|NCT00160667|Anticonvulsants|anticonvulsants|mesh-ancestor
93109416|NCT00206375|Hormones|hormones|mesh-list
93109417|NCT00206375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109418|NCT00206375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109419|NCT00160199|Progesterone|progesterone|mesh-list
93109420|NCT00160199|Progestins|progestins|mesh-ancestor
93109421|NCT00160199|Hormones|hormones|mesh-ancestor
93109422|NCT00160199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109423|NCT00160199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109424|NCT00157157|Factor VIII|factor viii|mesh-list
93109425|NCT00157157|Coagulants|coagulants|mesh-ancestor
93109426|NCT00203411|Bevacizumab|bevacizumab|mesh-list
93109427|NCT00203411|Capecitabine|capecitabine|mesh-list
93109428|NCT00203411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109429|NCT00203411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109430|NCT00203411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93109431|NCT00203411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93109432|NCT00203411|Growth Substances|growth substances|mesh-ancestor
93109433|NCT00203411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109434|NCT00203411|Growth Inhibitors|growth inhibitors|mesh-ancestor
93109435|NCT00203411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109436|NCT00203411|Antimetabolites|antimetabolites|mesh-ancestor
93109437|NCT00203411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109438|NCT00203021|Glatiramer Acetate|glatiramer acetate|mesh-list
93109439|NCT00203021|(T,G)-A-L|(t,g)-a-l|mesh-list
93109440|NCT00203021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93109441|NCT00203021|Immunologic Factors|immunologic factors|mesh-ancestor
93109442|NCT00203021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109443|NCT00203021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109444|NCT00203021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109445|NCT00201851|Tamoxifen|tamoxifen|mesh-list
93109446|NCT00201851|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93109447|NCT00201851|Hormone Antagonists|hormone antagonists|mesh-ancestor
93109448|NCT00201851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109449|NCT00201851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109450|NCT00201851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109451|NCT00201851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109452|NCT00201851|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93109453|NCT00201851|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93109454|NCT00201851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93109455|NCT01074203|Nitazoxanide|nitazoxanide|mesh-list
93109456|NCT01074203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93109457|NCT01074203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109458|NCT01074281|Enalapril|enalapril|mesh-list
93109459|NCT01074281|Enalaprilat|enalaprilat|mesh-list
93109460|NCT01074281|Nitrendipine|nitrendipine|mesh-list
93109461|NCT01074281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109462|NCT01074281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109463|NCT01074281|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93109464|NCT01074281|Protease Inhibitors|protease inhibitors|mesh-ancestor
93109465|NCT01074281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93109466|NCT01074281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93109467|NCT01074281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93109468|NCT01074281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93109469|NCT01074281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109470|NCT01074281|Vasodilator Agents|vasodilator agents|mesh-ancestor
93109471|NCT03129100|Ixekizumab|ixekizumab|mesh-list
93109472|NCT03129100|Dermatologic Agents|dermatologic agents|mesh-ancestor
93109473|NCT03100006|Nivolumab|nivolumab|mesh-list
93109474|NCT03100006|Oregovomab|oregovomab|mesh-list
93109475|NCT03100006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109476|NCT03100006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109477|NCT03100006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92781730|NCT04241458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109478|NCT03100006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109479|NCT03099538|Ixekizumab|ixekizumab|mesh-list
93109480|NCT03099538|Dermatologic Agents|dermatologic agents|mesh-ancestor
93109481|NCT05149768|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93109482|NCT05149768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109483|NCT05149768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109484|NCT05149768|Immunotoxins|immunotoxins|mesh-ancestor
93109485|NCT05149768|Immunoconjugates|immunoconjugates|mesh-ancestor
93109486|NCT05149768|Immunologic Factors|immunologic factors|mesh-ancestor
93109487|NCT05149768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109488|NCT00883480|Gemcitabine|gemcitabine|mesh-list
93109489|NCT00883480|Docetaxel|docetaxel|mesh-list
93109490|NCT00883480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93109491|NCT00883480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109492|NCT00883480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109493|NCT00883480|Antimetabolites|antimetabolites|mesh-ancestor
93109494|NCT00883480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109495|NCT00883480|Tubulin Modulators|tubulin modulators|mesh-ancestor
93109496|NCT00883480|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109497|NCT00883480|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109498|NCT00883480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109499|NCT00883480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109500|NCT05418946|Dapagliflozin|dapagliflozin|mesh-list
93109501|NCT05418946|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93109502|NCT05418946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109503|NCT05418946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93109504|NCT05418946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109505|NCT03097588|Palonosetron|palonosetron|mesh-list
93109506|NCT03097588|Antiemetics|antiemetics|mesh-ancestor
93109507|NCT03097588|Autonomic Agents|autonomic agents|mesh-ancestor
93109508|NCT03097588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109509|NCT03097588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109510|NCT03097588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109511|NCT03097588|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93109512|NCT03097588|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93109513|NCT03097588|Serotonin Agents|serotonin agents|mesh-ancestor
93109514|NCT03097588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109515|NCT03097588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109516|NCT05418244|Ondansetron|ondansetron|mesh-list
93109517|NCT05418244|Antiemetics|antiemetics|mesh-ancestor
93109518|NCT05418244|Autonomic Agents|autonomic agents|mesh-ancestor
93109519|NCT05418244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109520|NCT05418244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109521|NCT05418244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109522|NCT05418244|Antipruritics|antipruritics|mesh-ancestor
93109523|NCT05418244|Dermatologic Agents|dermatologic agents|mesh-ancestor
93109524|NCT05418244|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93109525|NCT05418244|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93109526|NCT05418244|Serotonin Agents|serotonin agents|mesh-ancestor
93109527|NCT05418244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109528|NCT05418244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109529|NCT05418166|Evolocumab|evolocumab|mesh-list
93109530|NCT05418166|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93109531|NCT05418166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93109532|NCT05418166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93109533|NCT05418166|Antimetabolites|antimetabolites|mesh-ancestor
93109534|NCT05418166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109535|NCT05418166|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93109536|NCT05418166|Protease Inhibitors|protease inhibitors|mesh-ancestor
93109537|NCT05418166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109538|NCT05418166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93109539|NCT01631214|Alendronate|alendronate|mesh-list
93109540|NCT01631214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93109541|NCT01631214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93109542|NCT01631214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109543|NCT01631214|Immunologic Factors|immunologic factors|mesh-ancestor
93109544|NCT01567774|Atorvastatin|atorvastatin|mesh-list
93109545|NCT01567774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93109546|NCT01567774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93109547|NCT01567774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93109548|NCT01567774|Antimetabolites|antimetabolites|mesh-ancestor
93109549|NCT01567774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109550|NCT01567774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93109551|NCT01567774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93109552|NCT01567774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109553|NCT01567930|Sirolimus|sirolimus|mesh-list
93109554|NCT01567930|Temsirolimus|temsirolimus|mesh-list
93109555|NCT01567930|MTOR Inhibitors|mtor inhibitors|mesh-list
93109556|NCT01567930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109557|NCT01567930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109558|NCT01567930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109559|NCT01567930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109560|NCT01567930|Immunologic Factors|immunologic factors|mesh-ancestor
93109561|NCT01567930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109562|NCT01567930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109563|NCT01567930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109564|NCT01567930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109565|NCT01567930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93109566|NCT01567930|Antifungal Agents|antifungal agents|mesh-ancestor
93109567|NCT04604548|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
93109568|NCT04604548|Antioxidants|antioxidants|mesh-ancestor
93109569|NCT04604548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109570|NCT04604548|Protective Agents|protective agents|mesh-ancestor
93109571|NCT04604548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109572|NCT01142622|Ropivacaine|ropivacaine|mesh-list
93109573|NCT01142622|Anesthetics, Local|anesthetics, local|mesh-ancestor
93109574|NCT01142622|Anesthetics|anesthetics|mesh-ancestor
93109575|NCT01142622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109576|NCT01142622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109577|NCT01142622|Sensory System Agents|sensory system agents|mesh-ancestor
93109578|NCT01142622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109579|NCT01142700|Ribavirin|ribavirin|mesh-list
93109580|NCT01142700|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93109581|NCT01142700|Antimetabolites|antimetabolites|mesh-ancestor
93109582|NCT01142700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109583|NCT01142700|Antiviral Agents|antiviral agents|mesh-ancestor
93109584|NCT01142700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109585|NCT01144728|Metformin|metformin|mesh-list
93109586|NCT01144728|Glimepiride|glimepiride|mesh-list
93109587|NCT01144728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92699792|NCT02925351|Clofarabine|clofarabine|mesh-list
93109588|NCT01144728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109589|NCT01144728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93109590|NCT01144728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109591|NCT01144728|Immunologic Factors|immunologic factors|mesh-ancestor
93109592|NCT01239810|Hyaluronic Acid|hyaluronic acid|mesh-list
93109593|NCT01239810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93109594|NCT01239810|Immunologic Factors|immunologic factors|mesh-ancestor
93109595|NCT01239810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109596|NCT01239810|Viscosupplements|viscosupplements|mesh-ancestor
93109597|NCT01239810|Protective Agents|protective agents|mesh-ancestor
93109598|NCT01239888|Tibolone|tibolone|mesh-list
93109599|NCT01239888|Oxytocin|oxytocin|mesh-list
93109600|NCT01239888|Oxytocics|oxytocics|mesh-ancestor
93109601|NCT01239888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93109602|NCT01239888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109603|NCT01239888|Androgen Antagonists|androgen antagonists|mesh-ancestor
93109604|NCT01239888|Hormone Antagonists|hormone antagonists|mesh-ancestor
93109605|NCT01239888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109606|NCT01239888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93109607|NCT01239888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109608|NCT01239888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109609|NCT01239888|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93109610|NCT01239888|Anabolic Agents|anabolic agents|mesh-ancestor
93109611|NCT01239888|Hormones|hormones|mesh-ancestor
93109612|NCT01318486|Heparin|heparin|mesh-list
93109613|NCT01318486|Anticoagulants|anticoagulants|mesh-ancestor
93109614|NCT01318486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93109615|NCT01318486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93109616|NCT01318486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109617|NCT03436108|Bisphenol A|bisphenol a|mesh-list
93109618|NCT03436108|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93109619|NCT03436108|Estrogens|estrogens|mesh-ancestor
93109620|NCT03436108|Hormones|hormones|mesh-ancestor
93109621|NCT03436108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109622|NCT03436108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109623|NCT03436108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93109624|NCT03436108|Antioxidants|antioxidants|mesh-ancestor
93109625|NCT03436108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109626|NCT03436108|Protective Agents|protective agents|mesh-ancestor
93109627|NCT02870218|Nicotine|nicotine|mesh-list
93109628|NCT02870218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93109629|NCT02870218|Autonomic Agents|autonomic agents|mesh-ancestor
93109630|NCT02870218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109631|NCT02870218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109632|NCT02870218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93109633|NCT02870218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93109634|NCT02870218|Cholinergic Agents|cholinergic agents|mesh-ancestor
93109635|NCT02870218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109636|NCT02870218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109637|NCT02614690|Calpastatin|calpastatin|mesh-list
93109638|NCT02614690|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93109639|NCT02614690|Protease Inhibitors|protease inhibitors|mesh-ancestor
93109640|NCT02614690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109641|NCT02614690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109642|NCT01442194|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93109643|NCT01442194|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93109644|NCT01442194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109645|NCT01442194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109646|NCT01442194|Immunologic Factors|immunologic factors|mesh-ancestor
93109647|NCT01442194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109648|NCT00468130|Aripiprazole|aripiprazole|mesh-list
93109649|NCT00468130|Antidepressive Agents|antidepressive agents|mesh-ancestor
93109650|NCT00468130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93109651|NCT00468130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93109652|NCT00468130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93109653|NCT00468130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109654|NCT00468130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109655|NCT00468130|Dopamine Agonists|dopamine agonists|mesh-ancestor
93109656|NCT00468130|Dopamine Agents|dopamine agents|mesh-ancestor
93109657|NCT00468130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109658|NCT00468130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109659|NCT00468130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93109660|NCT00468130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93109661|NCT00468130|Serotonin Agents|serotonin agents|mesh-ancestor
93109662|NCT00468130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93109663|NCT00468130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93109664|NCT00468130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93109665|NCT00468130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93109666|NCT05196256|Sufentanil|sufentanil|mesh-list
93109667|NCT05196256|Levobupivacaine|levobupivacaine|mesh-list
93109668|NCT05196256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93109669|NCT05196256|Narcotics|narcotics|mesh-ancestor
93109670|NCT05196256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109671|NCT05196256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109672|NCT05196256|Analgesics|analgesics|mesh-ancestor
93109673|NCT05196256|Sensory System Agents|sensory system agents|mesh-ancestor
93109674|NCT05196256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109675|NCT05196256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93109676|NCT05196256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93109677|NCT05196256|Anesthetics, General|anesthetics, general|mesh-ancestor
93109678|NCT05196256|Anesthetics|anesthetics|mesh-ancestor
93109679|NCT05196256|Anesthetics, Local|anesthetics, local|mesh-ancestor
93109680|NCT01375348|Remifentanil|remifentanil|mesh-list
93109681|NCT01375348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93109682|NCT01375348|Narcotics|narcotics|mesh-ancestor
93109683|NCT01375348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109684|NCT01375348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109685|NCT01375348|Analgesics|analgesics|mesh-ancestor
93109686|NCT01375348|Sensory System Agents|sensory system agents|mesh-ancestor
93109687|NCT01375348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109688|NCT05195086|Mycophenolic Acid|mycophenolic acid|mesh-list
93109689|NCT05195086|Cyclophosphamide|cyclophosphamide|mesh-list
93109690|NCT05195086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109691|NCT05195086|Immunologic Factors|immunologic factors|mesh-ancestor
93109692|NCT05195086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109693|NCT05195086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109694|NCT05195086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93109695|NCT05195086|Alkylating Agents|alkylating agents|mesh-ancestor
93109696|NCT05195086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109697|NCT05195086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109698|NCT05195086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93109699|NCT05195086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93109700|NCT05195086|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93109701|NCT05195086|Antitubercular Agents|antitubercular agents|mesh-ancestor
93109702|NCT05195086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109703|NCT05195086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109704|NCT05195086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109705|NCT05194852|Anesthetics|anesthetics|mesh-list
93109706|NCT05194852|Anesthetics, Local|anesthetics, local|mesh-list
93109707|NCT05194852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109708|NCT05194852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109709|NCT05194852|Sensory System Agents|sensory system agents|mesh-ancestor
93109710|NCT05194852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109711|NCT01375426|Amoxicillin|amoxicillin|mesh-list
93109712|NCT01375426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109713|NCT01375426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109714|NCT05193838|Allopurinol|allopurinol|mesh-list
93109715|NCT05193838|Antimetabolites|antimetabolites|mesh-ancestor
93109716|NCT05193838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109717|NCT05193838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109718|NCT05193838|Gout Suppressants|gout suppressants|mesh-ancestor
93109719|NCT05193838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109720|NCT05193838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93109721|NCT05193838|Antioxidants|antioxidants|mesh-ancestor
93109722|NCT05193838|Protective Agents|protective agents|mesh-ancestor
93109723|NCT05193838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109724|NCT05193604|Paclitaxel|paclitaxel|mesh-list
93109725|NCT05193604|Gemcitabine|gemcitabine|mesh-list
93109726|NCT05193604|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93109727|NCT05193604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109728|NCT05193604|Tubulin Modulators|tubulin modulators|mesh-ancestor
93109729|NCT05193604|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109730|NCT05193604|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109731|NCT05193604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109732|NCT05193604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109733|NCT05193604|Antimetabolites|antimetabolites|mesh-ancestor
93109734|NCT01375816|Leucovorin|leucovorin|mesh-list
93109735|NCT01375816|Bevacizumab|bevacizumab|mesh-list
93109736|NCT01375816|Fluorouracil|fluorouracil|mesh-list
93109737|NCT01375816|Irinotecan|irinotecan|mesh-list
93109738|NCT01375816|Calcium|calcium|mesh-list
93109739|NCT01375816|Levoleucovorin|levoleucovorin|mesh-list
93109740|NCT01375816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109741|NCT01375816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109742|NCT01375816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93109743|NCT01375816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93109744|NCT01375816|Growth Substances|growth substances|mesh-ancestor
93109745|NCT01375816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109746|NCT01375816|Growth Inhibitors|growth inhibitors|mesh-ancestor
93109747|NCT01375816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93109748|NCT01375816|Antimetabolites|antimetabolites|mesh-ancestor
93109749|NCT01375816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109750|NCT01375816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93109751|NCT01375816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109752|NCT01375816|Immunologic Factors|immunologic factors|mesh-ancestor
93109753|NCT01375816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93109754|NCT01375816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93109755|NCT01375816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109756|NCT01375816|Antidotes|antidotes|mesh-ancestor
93109757|NCT01375816|Protective Agents|protective agents|mesh-ancestor
93109758|NCT01375816|Vitamin B Complex|vitamin b complex|mesh-ancestor
93109759|NCT01375816|Vitamins|vitamins|mesh-ancestor
93109760|NCT01375816|Micronutrients|micronutrients|mesh-ancestor
93109761|NCT03632824|Tranexamic Acid|tranexamic acid|mesh-list
93109762|NCT03632824|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93109763|NCT03632824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93109764|NCT03632824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109765|NCT03632824|Hemostatics|hemostatics|mesh-ancestor
93109766|NCT03632824|Coagulants|coagulants|mesh-ancestor
93109767|NCT00911820|Bevacizumab|bevacizumab|mesh-list
93109768|NCT00911820|Cisplatin|cisplatin|mesh-list
93109769|NCT00911820|Docetaxel|docetaxel|mesh-list
93109770|NCT00911820|Irinotecan|irinotecan|mesh-list
93109771|NCT00911820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109772|NCT00911820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109773|NCT00911820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93109774|NCT00911820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93109775|NCT00911820|Growth Substances|growth substances|mesh-ancestor
93109776|NCT00911820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109777|NCT00911820|Growth Inhibitors|growth inhibitors|mesh-ancestor
93109778|NCT00911820|Tubulin Modulators|tubulin modulators|mesh-ancestor
93109779|NCT00911820|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109780|NCT00911820|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109781|NCT00911820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109782|NCT00911820|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93109783|NCT00911820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93109784|NCT00911820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109785|NCT05348122|Dulaglutide|dulaglutide|mesh-list
93109786|NCT05348122|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93109787|NCT05348122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93109788|NCT05348122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109789|NCT05348122|Immunologic Factors|immunologic factors|mesh-ancestor
93109790|NCT05038618|Somatomedin B|somatomedin b|mesh-list
93109791|NCT05038618|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93109792|NCT05038618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93109793|NCT05038618|Protease Inhibitors|protease inhibitors|mesh-ancestor
93109794|NCT05038618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109795|NCT05038618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109796|NCT01244880|Ketamine|ketamine|mesh-list
93109797|NCT01244880|Analgesics|analgesics|mesh-ancestor
93109798|NCT01244880|Sensory System Agents|sensory system agents|mesh-ancestor
93109799|NCT01244880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109800|NCT01244880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109801|NCT01244880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93109802|NCT01244880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93109803|NCT01244880|Anesthetics, General|anesthetics, general|mesh-ancestor
93109804|NCT01244880|Anesthetics|anesthetics|mesh-ancestor
93109805|NCT01244880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109806|NCT01244880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93109807|NCT01244880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93109808|NCT01244880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93109809|NCT01244880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109810|NCT01244958|Rituximab|rituximab|mesh-list
93109811|NCT01244958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109812|NCT01244958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109813|NCT01244958|Immunologic Factors|immunologic factors|mesh-ancestor
93109814|NCT01244958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109815|NCT01244958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109816|NCT00246324|Interferons|interferons|mesh-list
93109817|NCT00246324|Interferon-beta|interferon-beta|mesh-list
93109818|NCT00246324|Interferon beta-1a|interferon beta-1a|mesh-list
93109819|NCT00246324|Doxycycline|doxycycline|mesh-list
93109820|NCT00246324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109821|NCT00246324|Antiviral Agents|antiviral agents|mesh-ancestor
93109822|NCT00246324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109823|NCT00246324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109824|NCT00246324|Antimalarials|antimalarials|mesh-ancestor
93109825|NCT00246324|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93109826|NCT00246324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93109827|NCT00246324|Immunologic Factors|immunologic factors|mesh-ancestor
93109828|NCT00246324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109829|NCT00246324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93109830|NCT01237782|Propolis|propolis|mesh-list
93109831|NCT01237782|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93109832|NCT01237782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109833|NCT01245660|Lapatinib|lapatinib|mesh-list
93109834|NCT01245660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109835|NCT01245660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109836|NCT01245660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109837|NCT01245660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109838|NCT03686904|Benzalkonium Compounds|benzalkonium compounds|mesh-list
93109839|NCT03686904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109840|NCT03686904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93109841|NCT03913806|Bevacizumab|bevacizumab|mesh-list
93109842|NCT03913806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109843|NCT03913806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109844|NCT03913806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93109845|NCT03913806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93109846|NCT03913806|Growth Substances|growth substances|mesh-ancestor
93109847|NCT03913806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109848|NCT03913806|Growth Inhibitors|growth inhibitors|mesh-ancestor
93109849|NCT01250808|Dexamethasone|dexamethasone|mesh-list
93109850|NCT01250808|Bortezomib|bortezomib|mesh-list
93109851|NCT01250808|Melphalan|melphalan|mesh-list
93109852|NCT01250808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109853|NCT01250808|Antiemetics|antiemetics|mesh-ancestor
92782103|NCT04745728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109854|NCT01250808|Autonomic Agents|autonomic agents|mesh-ancestor
93109855|NCT01250808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109856|NCT01250808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109857|NCT01250808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109858|NCT01250808|Glucocorticoids|glucocorticoids|mesh-ancestor
93109859|NCT01250808|Hormones|hormones|mesh-ancestor
93109860|NCT01250808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109861|NCT01250808|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109862|NCT01250808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109863|NCT01250808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93109864|NCT01250808|Alkylating Agents|alkylating agents|mesh-ancestor
93109865|NCT01250808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109866|NCT01250808|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93109867|NCT01250808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93109868|NCT01250808|Immunologic Factors|immunologic factors|mesh-ancestor
93109869|NCT01146678|Insulin Glargine|insulin glargine|mesh-list
93109870|NCT01146678|Lixisenatide|lixisenatide|mesh-list
93109871|NCT01146678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93109872|NCT01146678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109873|NCT05429866|Nivolumab|nivolumab|mesh-list
93109874|NCT05429866|Atezolizumab|atezolizumab|mesh-list
93109875|NCT05429866|Durvalumab|durvalumab|mesh-list
93109876|NCT05429866|Avelumab|avelumab|mesh-list
93109877|NCT05429866|Cemiplimab|cemiplimab|mesh-list
93109878|NCT05429866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93109879|NCT05429866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93109880|NCT05429866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109881|NCT05429866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109882|NCT01250886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93109883|NCT03632590|Magnesium Sulfate|magnesium sulfate|mesh-list
93109884|NCT03632590|Magnesium citrate|magnesium citrate|mesh-list
93109885|NCT03632590|Magnesium Oxide|magnesium oxide|mesh-list
93109886|NCT03632590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109887|NCT03632590|Analgesics|analgesics|mesh-ancestor
93109888|NCT03632590|Sensory System Agents|sensory system agents|mesh-ancestor
93109889|NCT03632590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109890|NCT03632590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109891|NCT03632590|Anesthetics|anesthetics|mesh-ancestor
93109892|NCT03632590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93109893|NCT03632590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93109894|NCT03632590|Anticonvulsants|anticonvulsants|mesh-ancestor
93109895|NCT03632590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93109896|NCT03632590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93109897|NCT03632590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93109898|NCT03632590|Tocolytic Agents|tocolytic agents|mesh-ancestor
93109899|NCT03632590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93109900|NCT03632590|Cathartics|cathartics|mesh-ancestor
93109901|NCT03632590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109902|NCT03632590|Antacids|antacids|mesh-ancestor
93109903|NCT05376670|Gentamicins|gentamicins|mesh-list
93109904|NCT05376670|Tobramycin|tobramycin|mesh-list
93109905|NCT05376670|Amikacin|amikacin|mesh-list
93109906|NCT05376670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93109907|NCT05376670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109908|NCT05376670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93109909|NCT05376670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109910|NCT05376670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109911|NCT01242774|Panobinostat|panobinostat|mesh-list
93109912|NCT01242774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109913|NCT01242774|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93109914|NCT01242774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109915|NCT01242774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109916|NCT01243086|Dexamethasone|dexamethasone|mesh-list
93109917|NCT01243086|Ranibizumab|ranibizumab|mesh-list
93109918|NCT01243086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109919|NCT01243086|Antiemetics|antiemetics|mesh-ancestor
93109920|NCT01243086|Autonomic Agents|autonomic agents|mesh-ancestor
93109921|NCT01243086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109922|NCT01243086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109923|NCT01243086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93109924|NCT01243086|Glucocorticoids|glucocorticoids|mesh-ancestor
93109925|NCT01243086|Hormones|hormones|mesh-ancestor
93109926|NCT01243086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109927|NCT01243086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93109928|NCT01243086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109929|NCT01243086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93109930|NCT01243086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93109931|NCT01243086|Growth Substances|growth substances|mesh-ancestor
93109932|NCT01243086|Growth Inhibitors|growth inhibitors|mesh-ancestor
93109933|NCT03908814|Antibodies|antibodies|mesh-list
93109934|NCT03908814|Immunologic Factors|immunologic factors|mesh-ancestor
93109935|NCT03908814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109936|NCT01253382|Ecallantide|ecallantide|mesh-list
93109937|NCT01253382|Analgesics|analgesics|mesh-ancestor
93109938|NCT01253382|Sensory System Agents|sensory system agents|mesh-ancestor
93109939|NCT01253382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93109940|NCT01253382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109941|NCT01253382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93109942|NCT01253382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93109943|NCT01253382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93109944|NCT01253382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93109945|NCT01148160|Voriconazole|voriconazole|mesh-list
93109946|NCT01148160|Antifungal Agents|antifungal agents|mesh-ancestor
93109947|NCT01148160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93109948|NCT01148160|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93109949|NCT01148160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93109950|NCT01148160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109951|NCT01148160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109952|NCT01148160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93109953|NCT01148160|Hormone Antagonists|hormone antagonists|mesh-ancestor
93109954|NCT01148160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109955|NCT01148160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109956|NCT01148160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93109957|NCT01147692|Simvastatin|simvastatin|mesh-list
93109958|NCT01147692|rGLP-1 protein|rglp-1 protein|mesh-list
93109959|NCT01147692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93109960|NCT01147692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93109961|NCT01147692|Antimetabolites|antimetabolites|mesh-ancestor
93109962|NCT01147692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109963|NCT01147692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93109964|NCT01147692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93109965|NCT01147692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109966|NCT01147692|Incretins|incretins|mesh-ancestor
93109967|NCT01147692|Hormones|hormones|mesh-ancestor
93109968|NCT01147692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93109969|NCT01147692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109970|NCT03913182|Apatinib|apatinib|mesh-list
93109971|NCT03913182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109972|NCT03913182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93109973|NCT03913182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93109974|NCT03913182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109975|NCT02713386|Paclitaxel|paclitaxel|mesh-list
93109976|NCT02713386|Carboplatin|carboplatin|mesh-list
93109977|NCT02713386|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93109978|NCT02713386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93109979|NCT02713386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93109980|NCT02713386|Tubulin Modulators|tubulin modulators|mesh-ancestor
93109981|NCT02713386|Antimitotic Agents|antimitotic agents|mesh-ancestor
93109982|NCT02713386|Mitosis Modulators|mitosis modulators|mesh-ancestor
93109983|NCT02713386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93109984|NCT01967238|Vaccines|vaccines|mesh-list
93109985|NCT01967238|Immunologic Factors|immunologic factors|mesh-ancestor
93109986|NCT01967238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109987|NCT05616000|Folic Acid|folic acid|mesh-list
93109988|NCT05616000|Acetylcarnitine|acetylcarnitine|mesh-list
93109989|NCT05616000|Hematinics|hematinics|mesh-ancestor
93109990|NCT05616000|Vitamin B Complex|vitamin b complex|mesh-ancestor
93109991|NCT05616000|Vitamins|vitamins|mesh-ancestor
93109992|NCT05616000|Micronutrients|micronutrients|mesh-ancestor
93109993|NCT05616000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93109994|NCT05616000|Nootropic Agents|nootropic agents|mesh-ancestor
93109995|NCT03912402|Paclitaxel|paclitaxel|mesh-list
93109996|NCT03912402|Bevacizumab|bevacizumab|mesh-list
93109997|NCT03912402|Carboplatin|carboplatin|mesh-list
93109998|NCT03912402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93109999|NCT03912402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110000|NCT03912402|Tubulin Modulators|tubulin modulators|mesh-ancestor
93110001|NCT03912402|Antimitotic Agents|antimitotic agents|mesh-ancestor
93110002|NCT03912402|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110003|NCT03912402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110004|NCT03912402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110005|NCT03912402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110006|NCT03912402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110007|NCT03912402|Growth Substances|growth substances|mesh-ancestor
93110008|NCT03912402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110009|NCT03912402|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110011|NCT01147770|Progestins|progestins|mesh-ancestor
93110012|NCT01147770|Hormones|hormones|mesh-ancestor
93110013|NCT01147770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110014|NCT01147770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110015|NCT01148316|Fluoxetine|fluoxetine|mesh-list
93110016|NCT01148316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93110017|NCT01148316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93110018|NCT01148316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110019|NCT01148316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110020|NCT01148316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110021|NCT01148316|Serotonin Agents|serotonin agents|mesh-ancestor
93110022|NCT01148316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700223|NCT02942888|Niacinamide|niacinamide|mesh-list
93110023|NCT01148316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93110024|NCT01148316|Antidepressive Agents|antidepressive agents|mesh-ancestor
93110025|NCT01148316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110026|NCT01148316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93110027|NCT01148316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93110028|NCT01148316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110029|NCT01249638|Bevacizumab|bevacizumab|mesh-list
93110030|NCT01249638|Capecitabine|capecitabine|mesh-list
93110031|NCT01249638|Irinotecan|irinotecan|mesh-list
93110032|NCT01249638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110033|NCT01249638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110034|NCT01249638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110035|NCT01249638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110036|NCT01249638|Growth Substances|growth substances|mesh-ancestor
93110037|NCT01249638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110038|NCT01249638|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110039|NCT01249638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93110040|NCT01249638|Antimetabolites|antimetabolites|mesh-ancestor
93110041|NCT01249638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110042|NCT01249638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93110043|NCT01249638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93110044|NCT01249638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110045|NCT03907098|Endostar protein|endostar protein|mesh-list
93110046|NCT03907098|Endostatins|endostatins|mesh-list
93110047|NCT03907098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110048|NCT03907098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110049|NCT03907098|Growth Substances|growth substances|mesh-ancestor
93110050|NCT03907098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110051|NCT03907098|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110052|NCT03907098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110053|NCT01251822|Prucalopride|prucalopride|mesh-list
93110054|NCT01251822|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93110055|NCT01251822|Laxatives|laxatives|mesh-ancestor
93110056|NCT01251822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93110057|NCT01251822|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93110058|NCT01251822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93110059|NCT01251822|Serotonin Agents|serotonin agents|mesh-ancestor
93110060|NCT01251822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110061|NCT01251822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110062|NCT01251822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110063|NCT01253694|Ranibizumab|ranibizumab|mesh-list
93110064|NCT01253694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110065|NCT01253694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110066|NCT01253694|Growth Substances|growth substances|mesh-ancestor
93110067|NCT01253694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110068|NCT01253694|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110069|NCT01253694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110070|NCT01148004|Ritonavir|ritonavir|mesh-list
93110071|NCT01148004|Lopinavir|lopinavir|mesh-list
93110072|NCT01148004|Fenofibrate|fenofibrate|mesh-list
93110073|NCT01148004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93110074|NCT01148004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93110075|NCT01148004|Protease Inhibitors|protease inhibitors|mesh-ancestor
93110076|NCT01148004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110077|NCT01148004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110078|NCT01148004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93110079|NCT01148004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93110080|NCT01148004|Antiviral Agents|antiviral agents|mesh-ancestor
93110081|NCT01148004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110082|NCT01148004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93110083|NCT01148004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93110084|NCT01148004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93110085|NCT01148004|Antimetabolites|antimetabolites|mesh-ancestor
93110086|NCT01148004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93110087|NCT01252056|Cilostazol|cilostazol|mesh-list
93110088|NCT01252056|Probucol|probucol|mesh-list
93110089|NCT01252056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93110090|NCT01252056|Autonomic Agents|autonomic agents|mesh-ancestor
93110091|NCT01252056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110092|NCT01252056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110093|NCT01252056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93110094|NCT01252056|Respiratory System Agents|respiratory system agents|mesh-ancestor
93110095|NCT01252056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93110096|NCT01252056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93110097|NCT01252056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110098|NCT01252056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93110099|NCT01252056|Vasodilator Agents|vasodilator agents|mesh-ancestor
93110100|NCT01252056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93110101|NCT01252056|Protective Agents|protective agents|mesh-ancestor
93110102|NCT01252056|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93110103|NCT01252056|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93110104|NCT01252056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110105|NCT01252056|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93110106|NCT01252056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93110107|NCT01252056|Antimetabolites|antimetabolites|mesh-ancestor
93110108|NCT01252056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93110109|NCT01252056|Antioxidants|antioxidants|mesh-ancestor
93110110|NCT02528448|Plasma-lyte 148|plasma-lyte 148|mesh-list
93110111|NCT02528448|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93110112|NCT02528448|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93110113|NCT01148472|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93110114|NCT01148472|Escitalopram|escitalopram|mesh-list
93110115|NCT01148472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93110116|NCT01148472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93110117|NCT01148472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110118|NCT01148472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110119|NCT01148472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110120|NCT01148472|Serotonin Agents|serotonin agents|mesh-ancestor
93110121|NCT01148472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110122|NCT01148472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110123|NCT01148472|Antidepressive Agents|antidepressive agents|mesh-ancestor
93110124|NCT01148472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110125|NCT01148472|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93110126|NCT01148472|Analgesics|analgesics|mesh-ancestor
93110127|NCT01148472|Sensory System Agents|sensory system agents|mesh-ancestor
93110128|NCT01148472|Dopamine Agents|dopamine agents|mesh-ancestor
93110129|NCT01147146|Fentanyl|fentanyl|mesh-list
93110130|NCT01147146|Midazolam|midazolam|mesh-list
93110131|NCT01147146|Bupivacaine|bupivacaine|mesh-list
93110132|NCT01147146|Propofol|propofol|mesh-list
93110133|NCT01147146|Atracurium|atracurium|mesh-list
93110134|NCT01147146|Anesthetics, Local|anesthetics, local|mesh-ancestor
93110135|NCT01147146|Anesthetics|anesthetics|mesh-ancestor
93110136|NCT01147146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110137|NCT01147146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110138|NCT01147146|Sensory System Agents|sensory system agents|mesh-ancestor
93110139|NCT01147146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110140|NCT01147146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93110141|NCT01147146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93110142|NCT01147146|Anesthetics, General|anesthetics, general|mesh-ancestor
93110143|NCT01147146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93110144|NCT01147146|Narcotics|narcotics|mesh-ancestor
93110145|NCT01147146|Analgesics|analgesics|mesh-ancestor
93110146|NCT01147146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93110147|NCT01147146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93110148|NCT01147146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93110149|NCT01147146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110150|NCT01147146|GABA Modulators|gaba modulators|mesh-ancestor
93110151|NCT01147146|GABA Agents|gaba agents|mesh-ancestor
93110152|NCT01147146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110153|NCT01147146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110154|NCT01147146|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93110155|NCT01147146|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93110156|NCT01147146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93110157|NCT01147146|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93110158|NCT01147146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93110159|NCT01147146|Cholinergic Agents|cholinergic agents|mesh-ancestor
93110160|NCT01250340|Aspirin|aspirin|mesh-list
93110161|NCT01250340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93110162|NCT01250340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110163|NCT01250340|Analgesics|analgesics|mesh-ancestor
93110164|NCT01250340|Sensory System Agents|sensory system agents|mesh-ancestor
93110165|NCT01250340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110166|NCT01250340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110167|NCT01250340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110168|NCT01250340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110169|NCT01250340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93110170|NCT01250340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93110171|NCT01250340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110172|NCT01250340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93110173|NCT01250340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93110174|NCT01250340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110175|NCT01250340|Antipyretics|antipyretics|mesh-ancestor
93110176|NCT03915132|Nimotuzumab|nimotuzumab|mesh-list
93110177|NCT03915132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110178|NCT03915132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110179|NCT01250652|Cetirizine|cetirizine|mesh-list
93110180|NCT01250652|Hydroxyzine|hydroxyzine|mesh-list
93110181|NCT01250652|Levocetirizine|levocetirizine|mesh-list
93110182|NCT01250652|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93110183|NCT01250652|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93110184|NCT01250652|Histamine Antagonists|histamine antagonists|mesh-ancestor
93110185|NCT01250652|Histamine Agents|histamine agents|mesh-ancestor
93110186|NCT01250652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110187|NCT01250652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110188|NCT01250652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110189|NCT01250652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93110190|NCT01250652|Antipruritics|antipruritics|mesh-ancestor
93110191|NCT01250652|Dermatologic Agents|dermatologic agents|mesh-ancestor
93110192|NCT01253928|Pioglitazone|pioglitazone|mesh-list
93110193|NCT01253928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93110194|NCT01253928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110195|NCT01252524|Calcium polycarbophil|calcium polycarbophil|mesh-list
93110196|NCT01252524|Psyllium|psyllium|mesh-list
93110197|NCT01252524|Calcium|calcium|mesh-list
93110198|NCT01252524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93110199|NCT01252524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110200|NCT01252524|Antidiarrheals|antidiarrheals|mesh-ancestor
93110201|NCT01252524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93110202|NCT01252524|Cathartics|cathartics|mesh-ancestor
93110203|NCT03914352|Antibodies|antibodies|mesh-list
93110204|NCT03914352|Immunologic Factors|immunologic factors|mesh-ancestor
93110205|NCT03914352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110206|NCT01254006|Thiamine|thiamine|mesh-list
93110207|NCT01254006|Vitamins|vitamins|mesh-ancestor
93110208|NCT01254006|Micronutrients|micronutrients|mesh-ancestor
93110209|NCT01254006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110210|NCT01254006|Vitamin B Complex|vitamin b complex|mesh-ancestor
93110211|NCT03914118|Modafinil|modafinil|mesh-list
93110212|NCT03914118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93110213|NCT03914118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110214|NCT03914118|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93110215|NCT03914118|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93110216|NCT03914118|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93110217|NCT03914118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110218|NCT02528136|Oxytocin|oxytocin|mesh-list
93110219|NCT02528136|Carbetocin|carbetocin|mesh-list
93110220|NCT02528136|Oxytocics|oxytocics|mesh-ancestor
93110221|NCT02528136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110222|NCT02528136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110223|NCT01252680|Vaccines|vaccines|mesh-list
93110224|NCT01252680|Immunologic Factors|immunologic factors|mesh-ancestor
93110225|NCT01252680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110226|NCT01252758|Albuterol|albuterol|mesh-list
93110227|NCT01252758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93110228|NCT01252758|Autonomic Agents|autonomic agents|mesh-ancestor
93110229|NCT01252758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110230|NCT01252758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110231|NCT01252758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93110232|NCT01252758|Respiratory System Agents|respiratory system agents|mesh-ancestor
93110233|NCT01252758|Tocolytic Agents|tocolytic agents|mesh-ancestor
93110234|NCT01252758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110235|NCT01252758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93110236|NCT01252758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93110237|NCT01252758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110238|NCT01252758|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110239|NCT01252758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110240|NCT01252758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110242|NCT03913884|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110243|NCT03913884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110244|NCT01147224|Ciclesonide|ciclesonide|mesh-list
93110245|NCT01147224|Glucocorticoids|glucocorticoids|mesh-ancestor
93110246|NCT01147224|Hormones|hormones|mesh-ancestor
93110247|NCT01147224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110248|NCT01147224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110249|NCT01147224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93110250|NCT03913650|Bupivacaine|bupivacaine|mesh-list
93110251|NCT03913650|Anesthetics, Local|anesthetics, local|mesh-ancestor
93110252|NCT03913650|Anesthetics|anesthetics|mesh-ancestor
93110253|NCT03913650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110254|NCT03913650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110255|NCT03913650|Sensory System Agents|sensory system agents|mesh-ancestor
93110256|NCT03913650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110257|NCT01149174|Mitomycins|mitomycins|mesh-list
93110258|NCT01149174|Mitomycin|mitomycin|mesh-list
93110259|NCT01149174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93110260|NCT01149174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110261|NCT01149174|Alkylating Agents|alkylating agents|mesh-ancestor
93110262|NCT01149174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110263|NCT01149174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93110264|NCT01149174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110265|NCT04353778|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93110266|NCT04353778|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93110267|NCT04353778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110268|NCT04353778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110269|NCT04353778|Cholinergic Agents|cholinergic agents|mesh-ancestor
93110270|NCT04353778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110271|NCT04353778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110272|NCT01148628|Everolimus|everolimus|mesh-list
93110273|NCT01148628|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93110274|NCT01148628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93110275|NCT01148628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110276|NCT01148628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110277|NCT01148628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93110278|NCT01148628|Immunologic Factors|immunologic factors|mesh-ancestor
93110279|NCT01148628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110280|NCT01148628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110281|NCT01254708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93110282|NCT01254708|Antifungal Agents|antifungal agents|mesh-ancestor
93110283|NCT01254708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110284|NCT01254708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93110285|NCT01254708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93110286|NCT03909594|Ketamine|ketamine|mesh-list
93110287|NCT03909594|Bupivacaine|bupivacaine|mesh-list
93110288|NCT03909594|Anesthetics, Local|anesthetics, local|mesh-ancestor
93110289|NCT03909594|Anesthetics|anesthetics|mesh-ancestor
93110290|NCT03909594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110291|NCT03909594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110292|NCT03909594|Sensory System Agents|sensory system agents|mesh-ancestor
93110293|NCT03909594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110294|NCT03909594|Analgesics|analgesics|mesh-ancestor
93110295|NCT03909594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93110296|NCT03909594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93110297|NCT03909594|Anesthetics, General|anesthetics, general|mesh-ancestor
93110298|NCT03909594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93110299|NCT03909594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93110300|NCT03909594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110301|NCT03909594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110302|NCT04492072|Misoprostol|misoprostol|mesh-list
93110303|NCT04492072|Oxytocin|oxytocin|mesh-list
93110304|NCT04492072|Oxytocics|oxytocics|mesh-ancestor
93110305|NCT04492072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110306|NCT04492072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110307|NCT04492072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93110308|NCT04492072|Abortifacient Agents|abortifacient agents|mesh-ancestor
93110309|NCT04492072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93110310|NCT04492072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93110311|NCT04181008|Amiloride|amiloride|mesh-list
93110312|NCT04181008|Diuretics|diuretics|mesh-ancestor
93110313|NCT04181008|Natriuretic Agents|natriuretic agents|mesh-ancestor
93110314|NCT04181008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110315|NCT04181008|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93110316|NCT04181008|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93110317|NCT04181008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110318|NCT04181008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110319|NCT04181008|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93110320|NCT04181008|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93110321|NCT03629340|Metformin|metformin|mesh-list
93110322|NCT03629340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93110323|NCT03629340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110324|NCT03904836|Tobramycin|tobramycin|mesh-list
93110325|NCT03904836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93110326|NCT03904836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110327|NCT03908580|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93110328|NCT03908580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93110329|NCT03908580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110330|NCT03908580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110331|NCT03908580|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93110332|NCT03908580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110333|NCT03908580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110334|NCT03908580|Cholinergic Agents|cholinergic agents|mesh-ancestor
93110335|NCT03908580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110336|NCT03904680|Vitamin D|vitamin d|mesh-list
93110337|NCT03904680|Methotrexate|methotrexate|mesh-list
93110338|NCT03904680|Vitamins|vitamins|mesh-ancestor
93110339|NCT03904680|Micronutrients|micronutrients|mesh-ancestor
93110340|NCT03904680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110341|NCT03904680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93110342|NCT03904680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93110343|NCT03904680|Abortifacient Agents|abortifacient agents|mesh-ancestor
93110344|NCT03904680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110345|NCT03904680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93110346|NCT03904680|Antimetabolites|antimetabolites|mesh-ancestor
93110347|NCT03904680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110348|NCT03904680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110349|NCT03904680|Dermatologic Agents|dermatologic agents|mesh-ancestor
93110350|NCT03904680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110351|NCT03904680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93110352|NCT03904680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93110353|NCT03904680|Immunologic Factors|immunologic factors|mesh-ancestor
93110354|NCT03904680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110355|NCT03904680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93110356|NCT01150266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93110357|NCT01150266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93110358|NCT01150266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93110359|NCT01150266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110360|NCT01256268|Paclitaxel|paclitaxel|mesh-list
93110361|NCT01256268|Carboplatin|carboplatin|mesh-list
93110362|NCT01256268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93110363|NCT01256268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110364|NCT01256268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93110365|NCT01256268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93110366|NCT01256268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110367|NCT01256268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110368|NCT03902106|Albuterol|albuterol|mesh-list
93110369|NCT03902106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93110370|NCT03902106|Autonomic Agents|autonomic agents|mesh-ancestor
93110371|NCT03902106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110372|NCT03902106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110373|NCT03902106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93110374|NCT03902106|Respiratory System Agents|respiratory system agents|mesh-ancestor
93110375|NCT03902106|Tocolytic Agents|tocolytic agents|mesh-ancestor
93110376|NCT03902106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110377|NCT03902106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93110378|NCT03902106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93110379|NCT03902106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110380|NCT03902106|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110381|NCT03902106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110382|NCT03902106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110383|NCT03902340|Analgesics|analgesics|mesh-list
93110384|NCT03902340|Sensory System Agents|sensory system agents|mesh-ancestor
93110385|NCT03902340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110386|NCT03902340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110387|NCT01149330|Adapalene|adapalene|mesh-list
93110388|NCT01149330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93110389|NCT01149330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110390|NCT01149330|Analgesics|analgesics|mesh-ancestor
93110391|NCT01149330|Sensory System Agents|sensory system agents|mesh-ancestor
93110392|NCT01149330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110393|NCT01149330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110394|NCT01149330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110395|NCT01149330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110396|NCT01149330|Dermatologic Agents|dermatologic agents|mesh-ancestor
93110397|NCT03984214|Dronabinol|dronabinol|mesh-list
93110398|NCT03984214|Hallucinogens|hallucinogens|mesh-ancestor
93110399|NCT03984214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110400|NCT03984214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110401|NCT03984214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110402|NCT03984214|Analgesics|analgesics|mesh-ancestor
93110403|NCT03984214|Sensory System Agents|sensory system agents|mesh-ancestor
93110404|NCT03984214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110405|NCT03984214|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93110406|NCT03984214|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93110407|NCT03984214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110408|NCT03984214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110409|NCT03984214|Hormones|hormones|mesh-ancestor
93110410|NCT03984214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110411|NCT01150344|Artemether|artemether|mesh-list
93110412|NCT01150344|Atovaquone|atovaquone|mesh-list
93110413|NCT01150344|Proguanil|proguanil|mesh-list
93110414|NCT01150344|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93110415|NCT01150344|Antimalarials|antimalarials|mesh-ancestor
93110416|NCT01150344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93110417|NCT01150344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93110418|NCT01150344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110419|NCT01150344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110420|NCT01150344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110421|NCT01150344|Antimetabolites|antimetabolites|mesh-ancestor
93110422|NCT01256580|Dexamethasone|dexamethasone|mesh-list
93110423|NCT01256580|Bevacizumab|bevacizumab|mesh-list
93110424|NCT01256580|Verteporfin|verteporfin|mesh-list
93110425|NCT01256580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110426|NCT01256580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110427|NCT01256580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110428|NCT01256580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110429|NCT01256580|Growth Substances|growth substances|mesh-ancestor
93110430|NCT01256580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110431|NCT01256580|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110432|NCT01256580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110433|NCT01256580|Antiemetics|antiemetics|mesh-ancestor
93110434|NCT01256580|Autonomic Agents|autonomic agents|mesh-ancestor
93110435|NCT01256580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110436|NCT01256580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93110437|NCT01256580|Glucocorticoids|glucocorticoids|mesh-ancestor
93110438|NCT01256580|Hormones|hormones|mesh-ancestor
93110439|NCT01256580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110440|NCT01256580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93110441|NCT01256580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93110442|NCT01256580|Dermatologic Agents|dermatologic agents|mesh-ancestor
93110443|NCT03901716|Fentanyl|fentanyl|mesh-list
93110444|NCT03901716|Midazolam|midazolam|mesh-list
93110445|NCT03901716|Sufentanil|sufentanil|mesh-list
93110446|NCT03901716|Remifentanil|remifentanil|mesh-list
93110447|NCT03901716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93110448|NCT03901716|Narcotics|narcotics|mesh-ancestor
93110449|NCT03901716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110450|NCT03901716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110451|NCT03901716|Analgesics|analgesics|mesh-ancestor
93110452|NCT03901716|Sensory System Agents|sensory system agents|mesh-ancestor
93110453|NCT03901716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110454|NCT03901716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92782701|NCT02810548|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110455|NCT03901716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93110456|NCT03901716|Anesthetics, General|anesthetics, general|mesh-ancestor
93110457|NCT03901716|Anesthetics|anesthetics|mesh-ancestor
93110458|NCT03901716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93110459|NCT03901716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93110460|NCT03901716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93110461|NCT03901716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110462|NCT03901716|GABA Modulators|gaba modulators|mesh-ancestor
93110463|NCT03901716|GABA Agents|gaba agents|mesh-ancestor
93110464|NCT03901716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110465|NCT03901716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110466|NCT04113538|Aflibercept|aflibercept|mesh-list
93110467|NCT04113538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110468|NCT04113538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110469|NCT04113538|Growth Substances|growth substances|mesh-ancestor
93110470|NCT04113538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110471|NCT04113538|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110472|NCT04113538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110473|NCT03904368|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93110474|NCT03904368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110475|NCT03904368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110476|NCT03922750|Insulin|insulin|mesh-list
93110477|NCT03922750|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93110478|NCT03922750|Insulin Glargine|insulin glargine|mesh-list
93110479|NCT03922750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93110480|NCT03922750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110481|NCT03898128|Immunotoxins|immunotoxins|mesh-list
93110482|NCT03898128|Immunoconjugates|immunoconjugates|mesh-ancestor
93110483|NCT03898128|Immunologic Factors|immunologic factors|mesh-ancestor
93110484|NCT03898128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110485|NCT01149408|Decitabine|decitabine|mesh-list
93110486|NCT01149408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93110487|NCT01149408|Antimetabolites|antimetabolites|mesh-ancestor
93110488|NCT01149408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110489|NCT01149408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110490|NCT01149408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110491|NCT03631966|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93110492|NCT03631966|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93110493|NCT03631966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110494|NCT03631966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110495|NCT03631966|Cholinergic Agents|cholinergic agents|mesh-ancestor
93110496|NCT03631966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110497|NCT03631966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110498|NCT01149018|Dronabinol|dronabinol|mesh-list
93110499|NCT01149018|Hallucinogens|hallucinogens|mesh-ancestor
93110500|NCT01149018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110501|NCT01149018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110502|NCT01149018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110503|NCT01149018|Analgesics|analgesics|mesh-ancestor
93110504|NCT01149018|Sensory System Agents|sensory system agents|mesh-ancestor
93110505|NCT01149018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110506|NCT01149018|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93110507|NCT01149018|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93110508|NCT01149018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110509|NCT01149018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110510|NCT01149018|Hormones|hormones|mesh-ancestor
93110511|NCT01149018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110512|NCT03904056|Ranibizumab|ranibizumab|mesh-list
93110513|NCT03904056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93110514|NCT03904056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93110515|NCT03904056|Growth Substances|growth substances|mesh-ancestor
93110516|NCT03904056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110517|NCT03904056|Growth Inhibitors|growth inhibitors|mesh-ancestor
93110518|NCT03904056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110519|NCT03897660|Vitamins|vitamins|mesh-list
93110520|NCT03897660|Vitamin K|vitamin k|mesh-list
93110521|NCT03897660|Vitamin K 2|vitamin k 2|mesh-list
93110522|NCT03897660|Micronutrients|micronutrients|mesh-ancestor
93110523|NCT03897660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110524|NCT03897660|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93110525|NCT03897660|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93110526|NCT03897660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110527|NCT03897660|Hemostatics|hemostatics|mesh-ancestor
93110528|NCT03897660|Coagulants|coagulants|mesh-ancestor
93110529|NCT03901170|Letrozole|letrozole|mesh-list
93110530|NCT03901170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110531|NCT03901170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93110532|NCT03901170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93110533|NCT03901170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110534|NCT03901170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110535|NCT03901170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93110536|NCT03901170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93110537|NCT03901170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110538|NCT03901170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110539|NCT03900858|Isoniazid|isoniazid|mesh-list
93110540|NCT03900858|Rifapentine|rifapentine|mesh-list
93110541|NCT03900858|Rifampin|rifampin|mesh-list
93110542|NCT03900858|Antitubercular Agents|antitubercular agents|mesh-ancestor
93110543|NCT03900858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93110544|NCT03900858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110545|NCT03900858|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93110546|NCT03900858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93110547|NCT03900858|Antimetabolites|antimetabolites|mesh-ancestor
93110548|NCT03900858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110549|NCT03900858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93110550|NCT03900858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93110551|NCT03900858|Leprostatic Agents|leprostatic agents|mesh-ancestor
93110552|NCT03900858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93110553|NCT03900858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110554|NCT03900858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93110555|NCT03900858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93110556|NCT03900858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93110557|NCT03900858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93110558|NCT03900858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93110559|NCT03900858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93110560|NCT01149564|Ibuprofen|ibuprofen|mesh-list
93110561|NCT01149564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93110562|NCT01149564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110563|NCT01149564|Analgesics|analgesics|mesh-ancestor
93110564|NCT01149564|Sensory System Agents|sensory system agents|mesh-ancestor
93110565|NCT01149564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110566|NCT01149564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110567|NCT01149564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110568|NCT01149564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110569|NCT01149564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93110570|NCT01149564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110571|NCT01149564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110572|NCT02527746|Cyclophosphamide|cyclophosphamide|mesh-list
93110573|NCT02527746|Epirubicin|epirubicin|mesh-list
93110574|NCT02527746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93110575|NCT02527746|Immunologic Factors|immunologic factors|mesh-ancestor
93110576|NCT02527746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110577|NCT02527746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110578|NCT02527746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93110579|NCT02527746|Alkylating Agents|alkylating agents|mesh-ancestor
93110580|NCT02527746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110581|NCT02527746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110582|NCT02527746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93110583|NCT02527746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93110584|NCT02527746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93110585|NCT02527746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93110586|NCT02527746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110587|NCT01586286|Nifedipine|nifedipine|mesh-list
93110588|NCT01586286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93110589|NCT01586286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110590|NCT01586286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110591|NCT01586286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93110592|NCT01586286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110593|NCT01586286|Vasodilator Agents|vasodilator agents|mesh-ancestor
93110594|NCT01586286|Tocolytic Agents|tocolytic agents|mesh-ancestor
93110595|NCT01586286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110596|NCT01257048|Budesonide|budesonide|mesh-list
93110597|NCT01257048|Formoterol Fumarate|formoterol fumarate|mesh-list
93110598|NCT01257048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110599|NCT01257048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93110600|NCT01257048|Autonomic Agents|autonomic agents|mesh-ancestor
93110601|NCT01257048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110602|NCT01257048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110603|NCT01257048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93110604|NCT01257048|Respiratory System Agents|respiratory system agents|mesh-ancestor
93110605|NCT01257048|Glucocorticoids|glucocorticoids|mesh-ancestor
93110606|NCT01257048|Hormones|hormones|mesh-ancestor
93110607|NCT01257048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110608|NCT01257048|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93110609|NCT01257048|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93110610|NCT01257048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110611|NCT01257048|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110612|NCT01257048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110613|NCT01257048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110615|NCT01258296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93110616|NCT01258296|Narcotics|narcotics|mesh-ancestor
93110617|NCT01258296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110618|NCT01258296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110619|NCT01258296|Analgesics|analgesics|mesh-ancestor
93110620|NCT01258296|Sensory System Agents|sensory system agents|mesh-ancestor
93110621|NCT01258296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110622|NCT01258296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93110623|NCT01258296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93110624|NCT01258296|Anesthetics, General|anesthetics, general|mesh-ancestor
93110625|NCT01258296|Anesthetics|anesthetics|mesh-ancestor
93110626|NCT01257126|Diclofenac|diclofenac|mesh-list
93110627|NCT01257126|Nimesulide|nimesulide|mesh-list
93110628|NCT01257126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93110629|NCT01257126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110630|NCT01257126|Analgesics|analgesics|mesh-ancestor
92700835|NCT02909751|Tocotrienols|tocotrienols|mesh-list
93110631|NCT01257126|Sensory System Agents|sensory system agents|mesh-ancestor
93110632|NCT01257126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110633|NCT01257126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110634|NCT01257126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110635|NCT01257126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110636|NCT01257126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93110637|NCT01257126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110638|NCT01257126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110639|NCT02527824|Oxaliplatin|oxaliplatin|mesh-list
93110640|NCT02527824|Irinotecan|irinotecan|mesh-list
93110641|NCT02527824|Tegafur|tegafur|mesh-list
93110642|NCT02527824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110643|NCT02527824|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93110644|NCT02527824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93110645|NCT02527824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110646|NCT02527824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110647|NCT02527824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93110648|NCT02527824|Antimetabolites|antimetabolites|mesh-ancestor
93110649|NCT01586208|Phenytoin|phenytoin|mesh-list
93110650|NCT01586208|Valproic Acid|valproic acid|mesh-list
93110651|NCT01586208|Anticonvulsants|anticonvulsants|mesh-ancestor
93110652|NCT01586208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110653|NCT01586208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110654|NCT01586208|GABA Agents|gaba agents|mesh-ancestor
93110655|NCT01586208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110656|NCT01586208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110657|NCT01586208|Antimanic Agents|antimanic agents|mesh-ancestor
93110658|NCT01586208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93110659|NCT01586208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110660|NCT01586208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110661|NCT01586208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93110662|NCT01586208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93110663|NCT01586208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110664|NCT01586208|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93110665|NCT01586208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93110666|NCT03893526|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93110667|NCT03893526|Valsartan|valsartan|mesh-list
93110668|NCT03893526|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
93110669|NCT03893526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93110670|NCT03893526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110671|NCT03893526|Incretins|incretins|mesh-ancestor
93110672|NCT03893526|Hormones|hormones|mesh-ancestor
93110673|NCT03893526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110674|NCT03893526|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93110675|NCT03893526|Protease Inhibitors|protease inhibitors|mesh-ancestor
93110676|NCT03893526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110677|NCT03893526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110678|NCT03893526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93110679|NCT03893526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93110680|NCT03893526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93110682|NCT01149798|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93110683|NCT01149798|Paclitaxel|paclitaxel|mesh-list
93110684|NCT01149798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110685|NCT01149798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93110686|NCT01149798|Tubulin Modulators|tubulin modulators|mesh-ancestor
93110687|NCT01149798|Antimitotic Agents|antimitotic agents|mesh-ancestor
93110688|NCT01149798|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110689|NCT01149798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110690|NCT01257360|Panitumumab|panitumumab|mesh-list
93110691|NCT01257360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110692|NCT01257360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110693|NCT01258452|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
93110694|NCT01258452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93110695|NCT01258452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110696|NCT01258452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110697|NCT05943028|Esketamine|esketamine|mesh-list
93110698|NCT05943028|Antidepressive Agents|antidepressive agents|mesh-ancestor
93110699|NCT05943028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110700|NCT05942963|Metformin|metformin|mesh-list
93110701|NCT05942963|Pioglitazone|pioglitazone|mesh-list
93110702|NCT05942963|Empagliflozin|empagliflozin|mesh-list
93110703|NCT05942963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93110704|NCT05942963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110705|NCT05942963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93110706|NCT05942963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110707|NCT05942911|Hydroxychloroquine|hydroxychloroquine|mesh-list
93110708|NCT05942911|Cannabidiol|cannabidiol|mesh-list
93110709|NCT05942911|Antimalarials|antimalarials|mesh-ancestor
93110710|NCT05942911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93110711|NCT05942911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93110712|NCT05942911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110713|NCT05942911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110714|NCT05942911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110715|NCT05942911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110716|NCT05942911|Anticonvulsants|anticonvulsants|mesh-ancestor
93110717|NCT05942768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93110718|NCT05942768|Antibodies|antibodies|mesh-list
93110719|NCT05942768|Immunologic Factors|immunologic factors|mesh-ancestor
93110720|NCT05942768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110721|NCT05942768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110722|NCT05942768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110723|NCT05942768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110724|NCT05942573|Paclitaxel|paclitaxel|mesh-list
93110725|NCT05942573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93110726|NCT05942573|Apatinib|apatinib|mesh-list
93110727|NCT05942573|Ramucirumab|ramucirumab|mesh-list
93110728|NCT05942573|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93110729|NCT05942573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93110730|NCT05942573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110731|NCT05942573|Tubulin Modulators|tubulin modulators|mesh-ancestor
93110732|NCT05942573|Antimitotic Agents|antimitotic agents|mesh-ancestor
93110733|NCT05942573|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110734|NCT05942573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110735|NCT05942573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93110736|NCT05942573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110737|NCT05942573|Immunologic Factors|immunologic factors|mesh-ancestor
93110738|NCT05942573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110739|NCT05942378|Vaccines|vaccines|mesh-list
93110740|NCT05942378|Immunologic Factors|immunologic factors|mesh-ancestor
93110741|NCT05942378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110742|NCT05942352|Tetramethylpyrazine|tetramethylpyrazine|mesh-list
93110743|NCT05942352|Vasodilator Agents|vasodilator agents|mesh-ancestor
93110744|NCT05942313|Buprenorphine|buprenorphine|mesh-list
93110745|NCT05942313|Methadone|methadone|mesh-list
93110746|NCT05942313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93110747|NCT05942313|Narcotics|narcotics|mesh-ancestor
93110748|NCT05942313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110749|NCT05942313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110750|NCT05942313|Analgesics|analgesics|mesh-ancestor
92782999|NCT02625103|GABA Agents|gaba agents|mesh-ancestor
93110751|NCT05942313|Sensory System Agents|sensory system agents|mesh-ancestor
93110752|NCT05942313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110753|NCT05942313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93110754|NCT05942313|Antitussive Agents|antitussive agents|mesh-ancestor
93110755|NCT05942313|Respiratory System Agents|respiratory system agents|mesh-ancestor
93110756|NCT05942300|Carboplatin|carboplatin|mesh-list
93110757|NCT05942300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110758|NCT05942053|Vitamin K|vitamin k|mesh-list
93110759|NCT05942053|Vitamin K 2|vitamin k 2|mesh-list
93110760|NCT05942053|Menaquinone 7|menaquinone 7|mesh-list
93110761|NCT05942053|Vitamins|vitamins|mesh-ancestor
92120811|NCT02447796|Propofol|propofol|mesh-list
93110762|NCT05942053|Micronutrients|micronutrients|mesh-ancestor
93110763|NCT05942053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110764|NCT05942053|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93110765|NCT05942053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93110766|NCT05942053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110767|NCT05942053|Hemostatics|hemostatics|mesh-ancestor
93110768|NCT05942053|Coagulants|coagulants|mesh-ancestor
93110769|NCT05942027|Coenzyme Q10|coenzyme q10|mesh-list
93110770|NCT05942027|Ubiquinone|ubiquinone|mesh-list
93110771|NCT05942027|Vitamins|vitamins|mesh-ancestor
93110772|NCT05942027|Micronutrients|micronutrients|mesh-ancestor
93110773|NCT05942027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110774|NCT05941897|Durvalumab|durvalumab|mesh-list
93110775|NCT05941897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110776|NCT05941897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110777|NCT05941845|Interferons|interferons|mesh-list
93110778|NCT05941845|Interferon-alpha|interferon-alpha|mesh-list
93110779|NCT05941845|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93110780|NCT05941845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110781|NCT05941845|Antiviral Agents|antiviral agents|mesh-ancestor
93110782|NCT05941845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110783|NCT05941845|Immunologic Factors|immunologic factors|mesh-ancestor
93110784|NCT05941845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110785|NCT05941806|Tamsulosin|tamsulosin|mesh-list
93110786|NCT05941806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93110787|NCT05941806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93110788|NCT05941806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93110789|NCT05941806|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110790|NCT05941806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110791|NCT05941806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110792|NCT05941806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110793|NCT05941806|Urological Agents|urological agents|mesh-ancestor
93110794|NCT05941767|Lidocaine|lidocaine|mesh-list
93110795|NCT05941767|Dexmedetomidine|dexmedetomidine|mesh-list
93110796|NCT05941767|Anesthetics, Local|anesthetics, local|mesh-ancestor
93110797|NCT05941767|Anesthetics|anesthetics|mesh-ancestor
93110798|NCT05941767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110799|NCT05941767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110800|NCT05941767|Sensory System Agents|sensory system agents|mesh-ancestor
93110801|NCT05941767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110802|NCT05941767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93110803|NCT05941767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93110804|NCT05941767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93110805|NCT05941767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93110806|NCT05941767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110807|NCT05941767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93110808|NCT05941767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110809|NCT05941767|Analgesics|analgesics|mesh-ancestor
93110810|NCT05941767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93110811|NCT05941767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93110812|NCT05941767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110813|NCT05941767|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110814|NCT05941767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110815|NCT05941741|Cisplatin|cisplatin|mesh-list
93110816|NCT05941741|Gemcitabine|gemcitabine|mesh-list
93110817|NCT05941741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93110818|NCT05941741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110819|NCT05941741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93110820|NCT05941741|Antimetabolites|antimetabolites|mesh-ancestor
93110821|NCT05941741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110822|NCT05941741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110823|NCT05941637|Axitinib|axitinib|mesh-list
93110824|NCT05941637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110825|NCT05941637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93110826|NCT05941637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701050|NCT02912793|Betadex|betadex|mesh-list
93110827|NCT05941637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110828|NCT05941585|Cytarabine|cytarabine|mesh-list
93110829|NCT05941585|Venetoclax|venetoclax|mesh-list
93110830|NCT05941585|Mitoxantrone|mitoxantrone|mesh-list
93110831|NCT05941585|Homoharringtonine|homoharringtonine|mesh-list
93110832|NCT05941585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93110833|NCT05941585|Antimetabolites|antimetabolites|mesh-ancestor
93110834|NCT05941585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110835|NCT05941585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110836|NCT05941585|Antiviral Agents|antiviral agents|mesh-ancestor
93110837|NCT05941585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93110838|NCT05941585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93110839|NCT05941585|Immunologic Factors|immunologic factors|mesh-ancestor
93110840|NCT05941585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110841|NCT05941585|Analgesics|analgesics|mesh-ancestor
93110842|NCT05941585|Sensory System Agents|sensory system agents|mesh-ancestor
93110843|NCT05941585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110844|NCT05941585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93110845|NCT05941585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93110846|NCT05941585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110847|NCT05941585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93110848|NCT05941585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93110849|NCT05941520|Tamoxifen|tamoxifen|mesh-list
93110850|NCT05941520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93110851|NCT05941520|Hormone Antagonists|hormone antagonists|mesh-ancestor
93110852|NCT05941520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110853|NCT05941520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110854|NCT05941520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93110855|NCT05941520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110856|NCT05941520|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93110857|NCT05941520|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93110858|NCT05941520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93110859|NCT05941507|Antibodies|antibodies|mesh-list
93110860|NCT05941507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93110861|NCT05941507|Immunologic Factors|immunologic factors|mesh-ancestor
93110862|NCT05941507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110863|NCT05941494|Phenylephrine|phenylephrine|mesh-list
93110864|NCT05941494|Oxymetazoline|oxymetazoline|mesh-list
93110865|NCT05941494|Ephedrine|ephedrine|mesh-list
93110866|NCT05941494|Pseudoephedrine|pseudoephedrine|mesh-list
93110867|NCT05941494|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93110868|NCT05941494|Anesthetics|anesthetics|mesh-list
93110869|NCT05941494|Propofol|propofol|mesh-list
93110870|NCT05941494|Sevoflurane|sevoflurane|mesh-list
93110871|NCT05941494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110872|NCT05941494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110873|NCT05941494|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93110874|NCT05941494|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93110875|NCT05941494|Anesthetics, General|anesthetics, general|mesh-ancestor
93110876|NCT05941494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93110877|NCT05941494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93110878|NCT05941494|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93110879|NCT05941494|Mydriatics|mydriatics|mesh-ancestor
93110880|NCT05941494|Autonomic Agents|autonomic agents|mesh-ancestor
93110881|NCT05941494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110882|NCT05941494|Sympathomimetics|sympathomimetics|mesh-ancestor
93110883|NCT05941494|Nasal Decongestants|nasal decongestants|mesh-ancestor
93110884|NCT05941494|Respiratory System Agents|respiratory system agents|mesh-ancestor
93110885|NCT05941494|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93110886|NCT05941494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93110887|NCT05941494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110888|NCT05941494|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110889|NCT05941494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110890|NCT05941494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110891|NCT05941494|Protective Agents|protective agents|mesh-ancestor
93110892|NCT05941494|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93110893|NCT05941494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93110894|NCT05941494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93110895|NCT05941481|Tislelizumab|tislelizumab|mesh-list
93110896|NCT05941481|Antibodies|antibodies|mesh-list
93110897|NCT05941481|Immunologic Factors|immunologic factors|mesh-ancestor
93110898|NCT05941481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110899|NCT05941481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93110900|NCT05941481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110901|NCT05941429|Fluorides|fluorides|mesh-list
93110902|NCT05941429|Cariostatic Agents|cariostatic agents|mesh-ancestor
93110903|NCT05941429|Protective Agents|protective agents|mesh-ancestor
93110904|NCT05941429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110905|NCT05941338|Paclitaxel|paclitaxel|mesh-list
93110906|NCT05941338|Carboplatin|carboplatin|mesh-list
93110907|NCT05941338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93110908|NCT05941338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93110909|NCT05941338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93110910|NCT05941338|Tubulin Modulators|tubulin modulators|mesh-ancestor
93110911|NCT05941338|Antimitotic Agents|antimitotic agents|mesh-ancestor
93110912|NCT05941338|Mitosis Modulators|mitosis modulators|mesh-ancestor
93110913|NCT05941338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110914|NCT05941247|Hemay005|hemay005|mesh-list
93110915|NCT05941247|Dermatologic Agents|dermatologic agents|mesh-ancestor
93110916|NCT05941247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93110917|NCT05941247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93110918|NCT05941247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110919|NCT05941247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110920|NCT05941130|Ibuprofen|ibuprofen|mesh-list
93110921|NCT05941130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93110922|NCT05941130|Methylprednisolone|methylprednisolone|mesh-list
93110923|NCT05941130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93110924|NCT05941130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110925|NCT05941130|Analgesics|analgesics|mesh-ancestor
93110926|NCT05941130|Sensory System Agents|sensory system agents|mesh-ancestor
93110927|NCT05941130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110928|NCT05941130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110929|NCT05941130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93110930|NCT05941130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93110931|NCT05941130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110932|NCT05941130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110933|NCT05941130|Antiemetics|antiemetics|mesh-ancestor
93110934|NCT05941130|Autonomic Agents|autonomic agents|mesh-ancestor
93110935|NCT05941130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93110936|NCT05941130|Glucocorticoids|glucocorticoids|mesh-ancestor
93110937|NCT05941130|Hormones|hormones|mesh-ancestor
93110938|NCT05941130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93110939|NCT05941130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93110940|NCT05941130|Protective Agents|protective agents|mesh-ancestor
93110941|NCT05939921|Metformin|metformin|mesh-list
93110942|NCT05939921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93110943|NCT05939921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110944|NCT05939518|Anesthetics|anesthetics|mesh-list
93110945|NCT05939518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110946|NCT05939518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110947|NCT05939219|Vaccines|vaccines|mesh-list
93110948|NCT05939219|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93110949|NCT05939219|Immunologic Factors|immunologic factors|mesh-ancestor
93110950|NCT05939219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110951|NCT05938517|Betahistine|betahistine|mesh-list
93110952|NCT05938517|Selegiline|selegiline|mesh-list
93110953|NCT05938517|Antidepressive Agents|antidepressive agents|mesh-ancestor
93110954|NCT05938517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93110955|NCT05938517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93110956|NCT05938517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93110957|NCT05938517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93110958|NCT05938517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93110959|NCT05938517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110960|NCT05938517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93110961|NCT05938517|Protective Agents|protective agents|mesh-ancestor
93110962|NCT05938517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110963|NCT05938517|Vasodilator Agents|vasodilator agents|mesh-ancestor
93110964|NCT05938517|Histamine Agonists|histamine agonists|mesh-ancestor
93110965|NCT05938517|Histamine Agents|histamine agents|mesh-ancestor
93110966|NCT05938517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110967|NCT05935657|Dexmedetomidine|dexmedetomidine|mesh-list
93110968|NCT05935657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93110969|NCT05935657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93110970|NCT05935657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110971|NCT05935657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93110972|NCT05935657|Analgesics|analgesics|mesh-ancestor
93110973|NCT05935657|Sensory System Agents|sensory system agents|mesh-ancestor
93110974|NCT05935657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110975|NCT05935657|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93110976|NCT05935657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93110977|NCT05935657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110978|NCT05935657|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110979|NCT05935657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783224|NCT00684229|Anesthetics|anesthetics|mesh-list
93110980|NCT05935657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110981|NCT05934942|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93110982|NCT05934942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93110983|NCT05934942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110985|NCT05922982|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93110986|NCT05922982|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93110987|NCT05922982|Adrenergic Agents|adrenergic agents|mesh-ancestor
93110988|NCT05922982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93110989|NCT05922982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93110990|NCT05922982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93110991|NCT05922982|Sympathomimetics|sympathomimetics|mesh-ancestor
93110992|NCT05922982|Autonomic Agents|autonomic agents|mesh-ancestor
93110993|NCT05922982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93110994|NCT05922982|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93110995|NCT05911321|Dexamethasone|dexamethasone|mesh-list
93110996|NCT05911321|Pomalidomide|pomalidomide|mesh-list
93110997|NCT05911321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93110998|NCT05911321|Antiemetics|antiemetics|mesh-ancestor
93110999|NCT05911321|Autonomic Agents|autonomic agents|mesh-ancestor
93111000|NCT05911321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111001|NCT05911321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111002|NCT05911321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111003|NCT05911321|Glucocorticoids|glucocorticoids|mesh-ancestor
93111004|NCT05911321|Hormones|hormones|mesh-ancestor
93111005|NCT05911321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111006|NCT05911321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111007|NCT05911321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111008|NCT05911321|Immunologic Factors|immunologic factors|mesh-ancestor
93111009|NCT05911321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93111010|NCT05911321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93111011|NCT05911321|Growth Substances|growth substances|mesh-ancestor
93111012|NCT05911321|Growth Inhibitors|growth inhibitors|mesh-ancestor
93111013|NCT05907850|Riboflavin|riboflavin|mesh-list
93111014|NCT05907850|Vitamin B Complex|vitamin b complex|mesh-ancestor
93111015|NCT05907850|Vitamins|vitamins|mesh-ancestor
93111016|NCT05907850|Micronutrients|micronutrients|mesh-ancestor
93111017|NCT05907850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111018|NCT05907850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93111019|NCT05907850|Dermatologic Agents|dermatologic agents|mesh-ancestor
93111020|NCT05906836|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93111021|NCT05906836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93111022|NCT05906836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93111023|NCT05906836|Antimetabolites|antimetabolites|mesh-ancestor
93111024|NCT05906836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111025|NCT05906836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93111026|NCT05906836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93111027|NCT05906836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111028|NCT05904730|Axitinib|axitinib|mesh-list
93111029|NCT05904730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111030|NCT05904730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111031|NCT05904730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111032|NCT05904730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111033|NCT05903859|Probenecid|probenecid|mesh-list
93111034|NCT05903859|Uricosuric Agents|uricosuric agents|mesh-ancestor
93111035|NCT05903859|Gout Suppressants|gout suppressants|mesh-ancestor
93111036|NCT05903859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111037|NCT05896384|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93111038|NCT05896384|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93111039|NCT05896384|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93111040|NCT05896384|Contraceptive Agents|contraceptive agents|mesh-ancestor
93111041|NCT05896384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93111042|NCT05896384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111043|NCT05896384|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93111044|NCT05896384|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93111045|NCT05896384|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93111046|NCT05896384|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93111047|NCT05896384|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93111048|NCT05896384|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93111049|NCT05896384|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93111050|NCT05896384|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93111051|NCT05893797|Insulin Lispro|insulin lispro|mesh-list
93111052|NCT05893797|TEMPO|tempo|mesh-list
93111053|NCT05893797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111054|NCT05893797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111055|NCT05893797|Antioxidants|antioxidants|mesh-ancestor
93111056|NCT05893797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111057|NCT05893797|Protective Agents|protective agents|mesh-ancestor
93111058|NCT05891171|Leucovorin|leucovorin|mesh-list
93111059|NCT05891171|Carboplatin|carboplatin|mesh-list
93111060|NCT05891171|Fluorouracil|fluorouracil|mesh-list
93111061|NCT05891171|Oxaliplatin|oxaliplatin|mesh-list
93111062|NCT05891171|Pemetrexed|pemetrexed|mesh-list
93111063|NCT05891171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111064|NCT05891171|Antimetabolites|antimetabolites|mesh-ancestor
93111065|NCT05891171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111066|NCT05891171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111067|NCT05891171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111068|NCT05891171|Immunologic Factors|immunologic factors|mesh-ancestor
93111069|NCT05891171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111070|NCT05891171|Antidotes|antidotes|mesh-ancestor
93111071|NCT05891171|Protective Agents|protective agents|mesh-ancestor
93111072|NCT05891171|Vitamin B Complex|vitamin b complex|mesh-ancestor
93111073|NCT05891171|Vitamins|vitamins|mesh-ancestor
93111074|NCT05891171|Micronutrients|micronutrients|mesh-ancestor
93111075|NCT05891171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111076|NCT05891171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93111077|NCT05891171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93111078|NCT05889793|Emetine|emetine|mesh-list
93111079|NCT05889793|Amebicides|amebicides|mesh-ancestor
93111080|NCT05889793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93111081|NCT05889793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93111082|NCT05889793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111083|NCT05889793|Antinematodal Agents|antinematodal agents|mesh-ancestor
93111084|NCT05889793|Anthelmintics|anthelmintics|mesh-ancestor
93111085|NCT05889793|Cathartics|cathartics|mesh-ancestor
93111086|NCT05889793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111087|NCT05889793|Emetics|emetics|mesh-ancestor
93111088|NCT05889793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111089|NCT05889793|Autonomic Agents|autonomic agents|mesh-ancestor
93111090|NCT05889793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111091|NCT05889793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93111092|NCT05889793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111093|NCT05889793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111094|NCT05860296|Pembrolizumab|pembrolizumab|mesh-list
93111095|NCT05860296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111096|NCT05860296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111097|NCT05860296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111098|NCT05860296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111099|NCT05860270|Vitamin D|vitamin d|mesh-list
93111100|NCT05860270|Cholecalciferol|cholecalciferol|mesh-list
93111101|NCT05860270|Vitamins|vitamins|mesh-ancestor
93111102|NCT05860270|Micronutrients|micronutrients|mesh-ancestor
93111103|NCT05860270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111104|NCT05860270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93111105|NCT05860270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93111106|NCT05856526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93111107|NCT05855967|Ixekizumab|ixekizumab|mesh-list
93111108|NCT05855967|Dermatologic Agents|dermatologic agents|mesh-ancestor
93111109|NCT05855395|Dexamethasone|dexamethasone|mesh-list
93111110|NCT05855395|Prednisone|prednisone|mesh-list
93111111|NCT05855395|Methylprednisolone|methylprednisolone|mesh-list
93111112|NCT05855395|Glucocorticoids|glucocorticoids|mesh-list
93111113|NCT05855395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111114|NCT05855395|Antiemetics|antiemetics|mesh-ancestor
93111115|NCT05855395|Autonomic Agents|autonomic agents|mesh-ancestor
93111116|NCT05855395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111117|NCT05855395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111118|NCT05855395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111119|NCT05855395|Hormones|hormones|mesh-ancestor
93111120|NCT05855395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111121|NCT05855395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111122|NCT05855395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111123|NCT05855395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93111124|NCT05855395|Protective Agents|protective agents|mesh-ancestor
93111125|NCT05854498|Bevacizumab|bevacizumab|mesh-list
93111126|NCT05854498|Irinotecan|irinotecan|mesh-list
93111127|NCT05854498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111128|NCT05854498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111129|NCT05854498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93111130|NCT05854498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93111131|NCT05854498|Growth Substances|growth substances|mesh-ancestor
93111132|NCT05854498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111133|NCT05854498|Growth Inhibitors|growth inhibitors|mesh-ancestor
93111134|NCT05854498|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93111135|NCT05854498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93111136|NCT05854498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111137|NCT05854498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111138|NCT05853354|Denosumab|denosumab|mesh-list
93111139|NCT05853354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93111140|NCT05853354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111141|NCT05838573|Metformin|metformin|mesh-list
93111142|NCT05838573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111143|NCT05838573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111144|NCT05833867|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93111145|NCT05833867|Immunoconjugates|immunoconjugates|mesh-ancestor
93111146|NCT05833867|Immunologic Factors|immunologic factors|mesh-ancestor
93111147|NCT05833867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111148|NCT05822830|Tirzepatide|tirzepatide|mesh-list
93111149|NCT05822830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111150|NCT05822830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111151|NCT05822830|Incretins|incretins|mesh-ancestor
93111152|NCT05822830|Hormones|hormones|mesh-ancestor
93111153|NCT05822830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111154|NCT05818826|Hydrocortisone|hydrocortisone|mesh-list
93111155|NCT05818826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93111156|NCT05818826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111157|NCT05818124|Oseltamivir|oseltamivir|mesh-list
93111158|NCT05818124|Molnupiravir|molnupiravir|mesh-list
93111159|NCT05818124|Antiviral Agents|antiviral agents|mesh-ancestor
93111160|NCT05818124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111161|NCT05818124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111162|NCT05818124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111163|NCT05808881|Naloxone|naloxone|mesh-list
93111164|NCT05808881|Nalmefene|nalmefene|mesh-list
93111165|NCT05808881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93111166|NCT05808881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111167|NCT05808881|Sensory System Agents|sensory system agents|mesh-ancestor
93111168|NCT05808881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111169|NCT05807139|Spironolactone|spironolactone|mesh-list
93111170|NCT05807139|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93111171|NCT05807139|Hormone Antagonists|hormone antagonists|mesh-ancestor
93111172|NCT05807139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111173|NCT05807139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111174|NCT05807139|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93111175|NCT05807139|Diuretics|diuretics|mesh-ancestor
93111176|NCT05807139|Natriuretic Agents|natriuretic agents|mesh-ancestor
93111177|NCT05802628|Cetylpyridinium|cetylpyridinium|mesh-list
93111178|NCT05802628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93111179|NCT05802628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111180|NCT05789082|Pembrolizumab|pembrolizumab|mesh-list
93111181|NCT05789082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111182|NCT05789082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111183|NCT05789082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111184|NCT05789082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111185|NCT05776888|Ofatumumab|ofatumumab|mesh-list
93111186|NCT05776888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111187|NCT05767021|Mirikizumab|mirikizumab|mesh-list
93111188|NCT05767021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93111189|NCT05767021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93111190|NCT05767021|Analgesics|analgesics|mesh-ancestor
93111191|NCT05767021|Sensory System Agents|sensory system agents|mesh-ancestor
93111192|NCT05767021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111193|NCT05767021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111194|NCT05767021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111195|NCT05767021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111196|NCT05767021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93111197|NCT05767021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111198|NCT05751187|Folic Acid|folic acid|mesh-list
93111199|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
93111200|NCT05751187|Dexamethasone|dexamethasone|mesh-list
93111201|NCT05751187|Bevacizumab|bevacizumab|mesh-list
93111202|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
93111203|NCT05751187|Carboplatin|carboplatin|mesh-list
93111204|NCT05751187|Pemetrexed|pemetrexed|mesh-list
93111205|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111206|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111207|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93111208|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93111209|NCT05751187|Growth Substances|growth substances|mesh-ancestor
93111210|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111211|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
93111212|NCT05751187|Vitamins|vitamins|mesh-ancestor
93111213|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
93111214|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111215|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
93111216|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
93111217|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111218|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111219|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
93111220|NCT05751187|Hormones|hormones|mesh-ancestor
93111221|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111222|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111223|NCT05751187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111224|NCT05751187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111225|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111226|NCT05751187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93111227|NCT05751187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93111228|NCT05751187|Hematinics|hematinics|mesh-ancestor
93111229|NCT05751187|Vitamin B Complex|vitamin b complex|mesh-ancestor
93111230|NCT05728645|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93111231|NCT05728645|Plasma Substitutes|plasma substitutes|mesh-ancestor
93111232|NCT05728645|Blood Substitutes|blood substitutes|mesh-ancestor
93111233|NCT05718843|BI 425809|bi 425809|mesh-list
93111234|NCT05718843|Nootropic Agents|nootropic agents|mesh-ancestor
93111235|NCT05714059|Insulin|insulin|mesh-list
93111236|NCT05714059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111237|NCT05714059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111238|NCT05712941|Letrozole|letrozole|mesh-list
93111239|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111240|NCT05712941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93111241|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93111242|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111243|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111244|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93111245|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
93111246|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111247|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111248|NCT05706506|Tirzepatide|tirzepatide|mesh-list
93111249|NCT05706506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111250|NCT05706506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111251|NCT05706506|Incretins|incretins|mesh-ancestor
93111252|NCT05706506|Hormones|hormones|mesh-ancestor
93111253|NCT05706506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111254|NCT05701241|Octreotide|octreotide|mesh-list
93111255|NCT05701241|Lanreotide|lanreotide|mesh-list
93111256|NCT05701241|Somatostatin|somatostatin|mesh-list
93111257|NCT05701241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111258|NCT05701241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111259|NCT05701241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111260|NCT05701241|Hormones|hormones|mesh-ancestor
93111261|NCT05701241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111262|NCT05701241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111263|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
93111264|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93111265|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701490|NCT02924285|Amiodarone|amiodarone|mesh-list
93111266|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111267|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
93111268|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111269|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111270|NCT05698524|Temozolomide|temozolomide|mesh-list
93111271|NCT05698524|Abexinostat|abexinostat|mesh-list
93111272|NCT05698524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93111273|NCT05698524|Alkylating Agents|alkylating agents|mesh-ancestor
93111274|NCT05698524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111275|NCT05698524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111276|NCT05698524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93111277|NCT05698524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111278|NCT05696847|Tirzepatide|tirzepatide|mesh-list
93111279|NCT05696847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111280|NCT05696847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111281|NCT05696847|Incretins|incretins|mesh-ancestor
93111282|NCT05696847|Hormones|hormones|mesh-ancestor
93111283|NCT05696847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111284|NCT05691712|Tirzepatide|tirzepatide|mesh-list
93111285|NCT05691712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111286|NCT05691712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111287|NCT05691712|Incretins|incretins|mesh-ancestor
93111288|NCT05691712|Hormones|hormones|mesh-ancestor
93111289|NCT05691712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111290|NCT05689047|Artesunate|artesunate|mesh-list
93111291|NCT05689047|Pyronaridine|pyronaridine|mesh-list
93111292|NCT05689047|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93111293|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
93111294|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93111295|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93111296|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111297|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111298|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
93111299|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
93111300|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93111301|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
93111302|NCT05677490|Calcium, Dietary|calcium, dietary|mesh-list
93111303|NCT05677490|Leucovorin|leucovorin|mesh-list
93111304|NCT05677490|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
93111305|NCT05677490|Tetrahydrofolates|tetrahydrofolates|mesh-list
93111306|NCT05677490|Fluorouracil|fluorouracil|mesh-list
93111307|NCT05677490|Oxaliplatin|oxaliplatin|mesh-list
93111308|NCT05677490|Nivolumab|nivolumab|mesh-list
93111309|NCT05677490|Irinotecan|irinotecan|mesh-list
93111310|NCT05677490|Calcium|calcium|mesh-list
93111311|NCT05677490|Levoleucovorin|levoleucovorin|mesh-list
93111312|NCT05677490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93111313|NCT05677490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111314|NCT05677490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93111315|NCT05677490|Antimetabolites|antimetabolites|mesh-ancestor
93111316|NCT05677490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111317|NCT05677490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111318|NCT05677490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111319|NCT05677490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111320|NCT05677490|Immunologic Factors|immunologic factors|mesh-ancestor
93111321|NCT05677490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111322|NCT05677490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111323|NCT05677490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93111324|NCT05677490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93111325|NCT05677490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111326|NCT05677490|Antidotes|antidotes|mesh-ancestor
93111327|NCT05677490|Protective Agents|protective agents|mesh-ancestor
93111328|NCT05677490|Vitamin B Complex|vitamin b complex|mesh-ancestor
93111329|NCT05677490|Vitamins|vitamins|mesh-ancestor
93111330|NCT05677490|Micronutrients|micronutrients|mesh-ancestor
93111331|NCT05676216|Diphenhydramine|diphenhydramine|mesh-list
93111332|NCT05676216|Promethazine|promethazine|mesh-list
93111333|NCT05676216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93111334|NCT05676216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93111335|NCT05676216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111336|NCT05676216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111337|NCT05676216|Anesthetics, Local|anesthetics, local|mesh-ancestor
93111338|NCT05676216|Anesthetics|anesthetics|mesh-ancestor
93111339|NCT05676216|Sensory System Agents|sensory system agents|mesh-ancestor
93111340|NCT05676216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111341|NCT05676216|Antiemetics|antiemetics|mesh-ancestor
93111342|NCT05676216|Autonomic Agents|autonomic agents|mesh-ancestor
93111343|NCT05676216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111344|NCT05676216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93111345|NCT05676216|Histamine Antagonists|histamine antagonists|mesh-ancestor
93111346|NCT05676216|Histamine Agents|histamine agents|mesh-ancestor
93111347|NCT05676216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111348|NCT05676216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111349|NCT05676216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93111350|NCT05676216|Antipruritics|antipruritics|mesh-ancestor
93111351|NCT05676216|Dermatologic Agents|dermatologic agents|mesh-ancestor
93111352|NCT05676112|Pirfenidone|pirfenidone|mesh-list
93111353|NCT05676112|Nintedanib|nintedanib|mesh-list
93111354|NCT05676112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111355|NCT05676112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111356|NCT05676112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111357|NCT05676112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111358|NCT05676112|Analgesics|analgesics|mesh-ancestor
93111359|NCT05676112|Sensory System Agents|sensory system agents|mesh-ancestor
93111360|NCT05676112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111361|NCT05676112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111362|NCT05676112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93111363|NCT05676112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93111364|NCT05676112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111365|NCT05676112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111366|NCT05662332|Insulin|insulin|mesh-list
93111367|NCT05662332|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93111368|NCT05662332|Insulin Glargine|insulin glargine|mesh-list
93111369|NCT05662332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111370|NCT05662332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111371|NCT05660850|Mannitol|mannitol|mesh-list
93111372|NCT05660850|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93111373|NCT05660850|Diuretics|diuretics|mesh-ancestor
93111374|NCT05660850|Natriuretic Agents|natriuretic agents|mesh-ancestor
93111375|NCT05660850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111376|NCT05647889|Lidocaine|lidocaine|mesh-list
93111377|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
93111378|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
93111379|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111380|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111381|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
93111382|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111383|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93111384|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93111385|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93111386|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93111387|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111388|NCT05646303|Psilocybin|psilocybin|mesh-list
93111389|NCT05646303|Hallucinogens|hallucinogens|mesh-ancestor
93111390|NCT05646303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111391|NCT05646303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93111392|NCT05639647|Aztreonam|aztreonam|mesh-list
93111393|NCT05639647|Avibactam|avibactam|mesh-list
93111394|NCT05639647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93111395|NCT05639647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111396|NCT05639647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93111397|NCT05639647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111398|NCT05639647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111399|NCT05613777|BI 425809|bi 425809|mesh-list
93111400|NCT05613777|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93111401|NCT05613777|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93111402|NCT05613777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93111403|NCT05613777|Contraceptive Agents|contraceptive agents|mesh-ancestor
93111404|NCT05613777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93111405|NCT05613777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111406|NCT05613777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93111407|NCT05613777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93111408|NCT05613777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93111409|NCT05613777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93111410|NCT05613777|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93111411|NCT05613777|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93111412|NCT05613777|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93111413|NCT05613777|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93111414|NCT05613777|Nootropic Agents|nootropic agents|mesh-ancestor
93111415|NCT05601440|Gemcitabine|gemcitabine|mesh-list
93111416|NCT05601440|Fulvestrant|fulvestrant|mesh-list
93111417|NCT05601440|Niraparib|niraparib|mesh-list
93111418|NCT05601440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111419|NCT05601440|Antimetabolites|antimetabolites|mesh-ancestor
93111420|NCT05601440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111421|NCT05601440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111422|NCT05601440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111423|NCT05601440|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93111424|NCT05601440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93111425|NCT05601440|Hormone Antagonists|hormone antagonists|mesh-ancestor
93111426|NCT05601440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111427|NCT05601440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111428|NCT05601440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93111429|NCT05601440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111430|NCT05583552|Imetelstat|imetelstat|mesh-list
93111431|NCT05583552|Motesanib diphosphate|motesanib diphosphate|mesh-list
93111432|NCT05583552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111433|NCT05583552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111434|NCT05583552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111435|NCT05571592|Cannabidiol|cannabidiol|mesh-list
93111436|NCT05571592|Anticonvulsants|anticonvulsants|mesh-ancestor
93111437|NCT05564039|Dulaglutide|dulaglutide|mesh-list
93111438|NCT05564039|Tirzepatide|tirzepatide|mesh-list
93111439|NCT05564039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111440|NCT05564039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111441|NCT05564039|Incretins|incretins|mesh-ancestor
93111442|NCT05564039|Hormones|hormones|mesh-ancestor
93111443|NCT05564039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111444|NCT05562947|Ranibizumab|ranibizumab|mesh-list
93111445|NCT05562947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93111446|NCT05562947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93111447|NCT05562947|Growth Substances|growth substances|mesh-ancestor
93111448|NCT05562947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111449|NCT05562947|Growth Inhibitors|growth inhibitors|mesh-ancestor
93111450|NCT05562947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111451|NCT05559905|Molnupiravir|molnupiravir|mesh-list
93111452|NCT05559905|Antiviral Agents|antiviral agents|mesh-ancestor
93111453|NCT05559905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111454|NCT05557591|Cemiplimab|cemiplimab|mesh-list
93111455|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111456|NCT05557591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111457|NCT05538663|Gemcitabine|gemcitabine|mesh-list
93111458|NCT05538663|Docetaxel|docetaxel|mesh-list
93111459|NCT05538663|BCG Vaccine|bcg vaccine|mesh-list
93111460|NCT05538663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111461|NCT05538663|Antimetabolites|antimetabolites|mesh-ancestor
93111462|NCT05538663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111463|NCT05538663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111464|NCT05538663|Tubulin Modulators|tubulin modulators|mesh-ancestor
93111465|NCT05538663|Antimitotic Agents|antimitotic agents|mesh-ancestor
93111466|NCT05538663|Mitosis Modulators|mitosis modulators|mesh-ancestor
93111467|NCT05538663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93111468|NCT05538663|Immunologic Factors|immunologic factors|mesh-ancestor
93111469|NCT05538663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111470|NCT05536791|Dabigatran|dabigatran|mesh-list
93111471|NCT05536791|Antithrombins|antithrombins|mesh-ancestor
93111472|NCT05536791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93111473|NCT05536791|Protease Inhibitors|protease inhibitors|mesh-ancestor
93111474|NCT05536791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111475|NCT05536791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111476|NCT05536791|Anticoagulants|anticoagulants|mesh-ancestor
93111477|NCT05526989|Niraparib|niraparib|mesh-list
93111478|NCT05526989|Dostarlimab|dostarlimab|mesh-list
93111479|NCT05526989|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93111480|NCT05526989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111481|NCT05526989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111482|NCT05526989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111483|NCT05522231|Everolimus|everolimus|mesh-list
93111484|NCT05522231|Axitinib|axitinib|mesh-list
93111485|NCT05522231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93111486|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111487|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111488|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111489|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111490|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
93111491|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111492|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111493|NCT05509777|Mirikizumab|mirikizumab|mesh-list
93111494|NCT05509777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93111495|NCT05509777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93111496|NCT05509777|Analgesics|analgesics|mesh-ancestor
93111497|NCT05509777|Sensory System Agents|sensory system agents|mesh-ancestor
93111498|NCT05509777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111499|NCT05509777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111500|NCT05509777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111501|NCT05509777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111502|NCT05509777|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93111503|NCT05509777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111504|NCT05484154|Protein C|protein c|mesh-list
93111505|NCT05484154|Anticoagulants|anticoagulants|mesh-ancestor
93111506|NCT05484154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93111507|NCT05484154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93111508|NCT05484154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111509|NCT05481736|Psilocybin|psilocybin|mesh-list
93111510|NCT05481736|Hallucinogens|hallucinogens|mesh-ancestor
93111511|NCT05481736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111512|NCT05481736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93111513|NCT05462756|Insulin|insulin|mesh-list
93111514|NCT05462756|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93111515|NCT05462756|Insulin Glargine|insulin glargine|mesh-list
93111516|NCT05462756|Insulin Lispro|insulin lispro|mesh-list
93111517|NCT05462756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111518|NCT05462756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111519|NCT05446298|Pembrolizumab|pembrolizumab|mesh-list
93111520|NCT05446298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111521|NCT05446298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111522|NCT05446298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111523|NCT05446298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111524|NCT05440786|Irinotecan|irinotecan|mesh-list
93111525|NCT05440786|Temozolomide|temozolomide|mesh-list
93111526|NCT05440786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93111527|NCT05440786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93111528|NCT05440786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111529|NCT05440786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111530|NCT05440786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111531|NCT05440786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93111532|NCT05440786|Alkylating Agents|alkylating agents|mesh-ancestor
93111533|NCT05433584|Tirzepatide|tirzepatide|mesh-list
93111534|NCT05433584|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93111535|NCT05433584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111536|NCT05433584|Incretins|incretins|mesh-ancestor
93111537|NCT05433584|Hormones|hormones|mesh-ancestor
93111538|NCT05433584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111539|NCT05425940|Atezolizumab|atezolizumab|mesh-list
93111540|NCT05425940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111541|NCT05425940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111542|NCT05425940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111543|NCT05425940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111544|NCT05377424|Istradefylline|istradefylline|mesh-list
93111545|NCT05377424|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93111546|NCT05377424|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93111547|NCT05377424|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93111548|NCT05377424|Purinergic Agents|purinergic agents|mesh-ancestor
93111549|NCT05377424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111550|NCT05377424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111551|NCT05377424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111552|NCT05377333|Dulaglutide|dulaglutide|mesh-list
93111553|NCT05377333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111554|NCT05377333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111555|NCT05371964|Imetelstat|imetelstat|mesh-list
93111556|NCT05371964|Motesanib diphosphate|motesanib diphosphate|mesh-list
93111557|NCT05371964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111558|NCT05371964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111559|NCT05371964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111560|NCT05355701|Cetuximab|cetuximab|mesh-list
93111561|NCT05355701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111562|NCT05355701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111563|NCT05353257|Carboplatin|carboplatin|mesh-list
93111564|NCT05353257|Etoposide|etoposide|mesh-list
93111565|NCT05353257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111566|NCT05353257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93111567|NCT05353257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93111568|NCT05353257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93111569|NCT05353257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111570|NCT05353257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111571|NCT05321043|Riboflavin|riboflavin|mesh-list
93111572|NCT05321043|Vitamins|vitamins|mesh-ancestor
93111573|NCT05321043|Micronutrients|micronutrients|mesh-ancestor
93111574|NCT05321043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111575|NCT05321043|Vitamin B Complex|vitamin b complex|mesh-ancestor
93111576|NCT05321043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93111577|NCT05321043|Dermatologic Agents|dermatologic agents|mesh-ancestor
93111578|NCT05318105|Diuretics|diuretics|mesh-list
93111579|NCT05318105|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
93111580|NCT05318105|Natriuretic Agents|natriuretic agents|mesh-ancestor
93111581|NCT05318105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111582|NCT05318105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93111583|NCT05318105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783824|NCT02801188|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93111584|NCT05303311|Dexamethasone|dexamethasone|mesh-list
93111585|NCT05303311|Meperidine|meperidine|mesh-list
93111586|NCT05303311|Bupivacaine|bupivacaine|mesh-list
93111587|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111588|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
93111589|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
93111590|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111591|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111592|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111593|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
93111594|NCT05303311|Hormones|hormones|mesh-ancestor
93111595|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111596|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111597|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111598|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
93111599|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
93111600|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111601|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
93111602|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93111603|NCT05303311|Narcotics|narcotics|mesh-ancestor
93111604|NCT05303311|Analgesics|analgesics|mesh-ancestor
93111605|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93111606|NCT05301062|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
93111607|NCT05301062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111608|NCT05285982|Nintedanib|nintedanib|mesh-list
93111609|NCT05285982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111610|NCT05285982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111611|NCT05285982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111612|NCT05285982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111613|NCT05275374|Trametinib|trametinib|mesh-list
93111614|NCT05275374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111615|NCT05275374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111616|NCT05275374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111617|NCT05275374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111618|NCT05262764|Empagliflozin|empagliflozin|mesh-list
93111619|NCT05262764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93111620|NCT05262764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111621|NCT05262764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111622|NCT05262764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111623|NCT05233579|Sulforaphane|sulforaphane|mesh-list
93111624|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93111625|NCT05233579|Protective Agents|protective agents|mesh-ancestor
93111626|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111627|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111628|NCT05227612|Psilocybin|psilocybin|mesh-list
93111629|NCT05227612|Hallucinogens|hallucinogens|mesh-ancestor
93111630|NCT05227612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111631|NCT05227612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93111632|NCT05209295|Azacitidine|azacitidine|mesh-list
93111633|NCT05209295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111634|NCT05209295|Antimetabolites|antimetabolites|mesh-ancestor
93111635|NCT05209295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111636|NCT05209295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111637|NCT05209295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111638|NCT05208892|Dexmedetomidine|dexmedetomidine|mesh-list
93111639|NCT05208892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93111640|NCT05208892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111641|NCT05208892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111642|NCT05208892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93111643|NCT05208892|Analgesics|analgesics|mesh-ancestor
93111644|NCT05208892|Sensory System Agents|sensory system agents|mesh-ancestor
93111645|NCT05208892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111646|NCT05208892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93111647|NCT05208892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93111648|NCT05208892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93111649|NCT05208892|Adrenergic Agents|adrenergic agents|mesh-ancestor
93111650|NCT05208892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111651|NCT05208892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111652|NCT05203172|Cetuximab|cetuximab|mesh-list
93111653|NCT05203172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111654|NCT05203172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111655|NCT05180097|Dexamethasone|dexamethasone|mesh-list
93111656|NCT05180097|Gemcitabine|gemcitabine|mesh-list
93111657|NCT05180097|Pembrolizumab|pembrolizumab|mesh-list
93111658|NCT05180097|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93111659|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111660|NCT05180097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111661|NCT05180097|Antiemetics|antiemetics|mesh-ancestor
93111662|NCT05180097|Autonomic Agents|autonomic agents|mesh-ancestor
93111663|NCT05180097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111664|NCT05180097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111665|NCT05180097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111666|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
93111667|NCT05180097|Hormones|hormones|mesh-ancestor
93111668|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111669|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93111670|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111671|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
93111672|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111673|NCT05180097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111674|NCT05180097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111675|NCT05180097|Immunotoxins|immunotoxins|mesh-ancestor
93111676|NCT05180097|Immunoconjugates|immunoconjugates|mesh-ancestor
93111677|NCT05180097|Immunologic Factors|immunologic factors|mesh-ancestor
93111678|NCT05173831|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93111679|NCT05173831|Hallucinogens|hallucinogens|mesh-ancestor
93111680|NCT05173831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111681|NCT05173831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93111682|NCT05173831|Serotonin Agents|serotonin agents|mesh-ancestor
93111683|NCT05173831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111684|NCT05173831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111685|NCT05173831|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93111686|NCT05173831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93111687|NCT05173831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93111688|NCT05173831|Adrenergic Agents|adrenergic agents|mesh-ancestor
93111689|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93111690|NCT05147402|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93111691|NCT05147402|Hallucinogens|hallucinogens|mesh-ancestor
93111692|NCT05147402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111693|NCT05147402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93111694|NCT05147402|Serotonin Agents|serotonin agents|mesh-ancestor
93111695|NCT05147402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111696|NCT05147402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111697|NCT05147402|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93111698|NCT05147402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93111699|NCT05147402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93111700|NCT05147402|Adrenergic Agents|adrenergic agents|mesh-ancestor
93111701|NCT05147376|Curcumin|curcumin|mesh-list
93111702|NCT05147376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93111703|NCT05147376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93111704|NCT05147376|Analgesics|analgesics|mesh-ancestor
93111705|NCT05147376|Sensory System Agents|sensory system agents|mesh-ancestor
93111706|NCT05147376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111707|NCT05147376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111708|NCT05147376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111709|NCT05147376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111710|NCT05147376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111711|NCT05147376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111712|NCT05147376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111713|NCT05146739|Leucovorin|leucovorin|mesh-list
93111714|NCT05146739|Cytarabine|cytarabine|mesh-list
93111715|NCT05146739|Fludarabine|fludarabine|mesh-list
93111716|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111717|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111718|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
93111719|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111720|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111721|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
93111722|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111723|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
93111724|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111725|NCT05146739|Antidotes|antidotes|mesh-ancestor
93111726|NCT05146739|Protective Agents|protective agents|mesh-ancestor
93111727|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
93111728|NCT05146739|Vitamins|vitamins|mesh-ancestor
93111729|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
93111730|NCT05130463|Empagliflozin|empagliflozin|mesh-list
93111731|NCT05130463|Linagliptin|linagliptin|mesh-list
93111732|NCT05130463|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92783972|NCT00693589|Vitamin B 12|vitamin b 12|mesh-list
93111733|NCT05130463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111734|NCT05130463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93111735|NCT05130463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111736|NCT05130463|Incretins|incretins|mesh-ancestor
93111737|NCT05130463|Hormones|hormones|mesh-ancestor
93111738|NCT05130463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111739|NCT05130463|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93111740|NCT05130463|Protease Inhibitors|protease inhibitors|mesh-ancestor
93111741|NCT05130463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111742|NCT05123703|Ocrelizumab|ocrelizumab|mesh-list
93111743|NCT05123703|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93111744|NCT05123703|Immunologic Factors|immunologic factors|mesh-ancestor
93111745|NCT05123703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111746|NCT05123703|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93111747|NCT05123703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111748|NCT05123703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111749|NCT05119920|Pilocarpine|pilocarpine|mesh-list
93111750|NCT05119920|Miotics|miotics|mesh-ancestor
93111751|NCT05119920|Autonomic Agents|autonomic agents|mesh-ancestor
93111752|NCT05119920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111753|NCT05119920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111754|NCT05119920|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93111755|NCT05119920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93111756|NCT05119920|Cholinergic Agents|cholinergic agents|mesh-ancestor
93111757|NCT05119920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111758|NCT05119920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111759|NCT05090371|Ofatumumab|ofatumumab|mesh-list
93111760|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111761|NCT05084638|Ofatumumab|ofatumumab|mesh-list
93111762|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111763|NCT05065736|Clofarabine|clofarabine|mesh-list
93111764|NCT05065736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111765|NCT05065736|Antimetabolites|antimetabolites|mesh-ancestor
93111766|NCT05065736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111767|NCT05065736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111768|NCT05065190|Nintedanib|nintedanib|mesh-list
93111769|NCT05065190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111770|NCT05065190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111771|NCT05065190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111772|NCT05065190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111773|NCT05054868|Ketorolac|ketorolac|mesh-list
93111774|NCT05054868|Oxycodone|oxycodone|mesh-list
93111775|NCT05054868|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93111776|NCT05054868|Narcotics|narcotics|mesh-ancestor
93111777|NCT05054868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93111778|NCT05054868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111779|NCT05054868|Analgesics|analgesics|mesh-ancestor
93111780|NCT05054868|Sensory System Agents|sensory system agents|mesh-ancestor
93111781|NCT05054868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111782|NCT05054868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93111783|NCT05054868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93111784|NCT05054868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111785|NCT05054868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111786|NCT05054868|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93111787|NCT05054868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111788|NCT05054868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111789|NCT05048342|Remibrutinib|remibrutinib|mesh-list
93111790|NCT05048342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93111791|NCT05048342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111792|NCT05048342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111793|NCT05046535|Nicotine|nicotine|mesh-list
93111794|NCT05046535|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93111795|NCT05046535|Autonomic Agents|autonomic agents|mesh-ancestor
93111796|NCT05046535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93111797|NCT05046535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111798|NCT05046535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93111799|NCT05046535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93111800|NCT05046535|Cholinergic Agents|cholinergic agents|mesh-ancestor
93111801|NCT05046535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93111802|NCT05046535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111803|NCT05009342|Calpastatin|calpastatin|mesh-list
93111804|NCT05009342|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93111805|NCT05009342|Protease Inhibitors|protease inhibitors|mesh-ancestor
93111806|NCT05009342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111807|NCT05009342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111808|NCT04998851|Ocrelizumab|ocrelizumab|mesh-list
93111809|NCT04998851|Immunologic Factors|immunologic factors|mesh-ancestor
93111810|NCT04998851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111811|NCT04987775|Acetylcysteine|acetylcysteine|mesh-list
93111812|NCT04987775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93111813|NCT04987775|Antiviral Agents|antiviral agents|mesh-ancestor
93111814|NCT04987775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111815|NCT04987775|Expectorants|expectorants|mesh-ancestor
93111816|NCT04987775|Respiratory System Agents|respiratory system agents|mesh-ancestor
93111817|NCT04987775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93111818|NCT04987775|Antioxidants|antioxidants|mesh-ancestor
93111819|NCT04987775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111820|NCT04987775|Protective Agents|protective agents|mesh-ancestor
93111821|NCT04987775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111822|NCT04987775|Antidotes|antidotes|mesh-ancestor
93111823|NCT04965597|Methotrexate|methotrexate|mesh-list
93111824|NCT04965597|Fludarabine phosphate|fludarabine phosphate|mesh-list
93111825|NCT04965597|Fludarabine|fludarabine|mesh-list
93111826|NCT04965597|Treosulfan|treosulfan|mesh-list
93111827|NCT04965597|Busulfan|busulfan|mesh-list
93111828|NCT04965597|Tacrolimus|tacrolimus|mesh-list
93111829|NCT04965597|Thymoglobulin|thymoglobulin|mesh-list
93111830|NCT04965597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93111831|NCT04965597|Immunoglobulins|immunoglobulins|mesh-list
93111832|NCT04965597|Antibodies|antibodies|mesh-list
93111833|NCT04965597|gamma-Globulins|gamma-globulins|mesh-list
93111834|NCT04965597|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93111835|NCT04965597|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93111836|NCT04965597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93111837|NCT04965597|Abortifacient Agents|abortifacient agents|mesh-ancestor
93111838|NCT04965597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93111839|NCT04965597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111840|NCT04965597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111841|NCT04965597|Antimetabolites|antimetabolites|mesh-ancestor
93111842|NCT04965597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111843|NCT04965597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111844|NCT04965597|Dermatologic Agents|dermatologic agents|mesh-ancestor
93111845|NCT04965597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111846|NCT04965597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93111847|NCT04965597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111848|NCT04965597|Immunologic Factors|immunologic factors|mesh-ancestor
93111849|NCT04965597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111850|NCT04965597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93111851|NCT04965597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93111852|NCT04965597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93111853|NCT04965597|Alkylating Agents|alkylating agents|mesh-ancestor
93111854|NCT04965597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93111855|NCT04922827|Infliximab|infliximab|mesh-list
93111856|NCT04922827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93111857|NCT04922827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93111858|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
93111859|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93111860|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93111861|NCT04921930|Artesunate|artesunate|mesh-list
93111862|NCT04921930|Antimalarials|antimalarials|mesh-ancestor
93111863|NCT04921930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93111864|NCT04921930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93111865|NCT04921930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111866|NCT04921930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111867|NCT04921930|Antiviral Agents|antiviral agents|mesh-ancestor
93111868|NCT04921930|Schistosomicides|schistosomicides|mesh-ancestor
93111869|NCT04921930|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93111870|NCT04921930|Anthelmintics|anthelmintics|mesh-ancestor
93111871|NCT04909684|Pembrolizumab|pembrolizumab|mesh-list
93111872|NCT04909684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111873|NCT04909684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111874|NCT04909684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92702092|NCT02932020|Antiemetics|antiemetics|mesh-ancestor
93111875|NCT04909684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111876|NCT04877457|Ocrelizumab|ocrelizumab|mesh-list
93111877|NCT04877457|Immunologic Factors|immunologic factors|mesh-ancestor
93111878|NCT04877457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111879|NCT04869358|Ofatumumab|ofatumumab|mesh-list
93111880|NCT04869358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111881|NCT04853251|Ranibizumab|ranibizumab|mesh-list
93111882|NCT04853251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93111883|NCT04853251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93111884|NCT04853251|Growth Substances|growth substances|mesh-ancestor
93111885|NCT04853251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111886|NCT04853251|Growth Inhibitors|growth inhibitors|mesh-ancestor
93111887|NCT04853251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111888|NCT04847063|Sodium thiosulfate|sodium thiosulfate|mesh-list
93111889|NCT04847063|Doxorubicin|doxorubicin|mesh-list
93111890|NCT04847063|Fluorouracil|fluorouracil|mesh-list
93111891|NCT04847063|Oxaliplatin|oxaliplatin|mesh-list
93111892|NCT04847063|Mitomycins|mitomycins|mesh-list
93111893|NCT04847063|Mitomycin|mitomycin|mesh-list
93111894|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111895|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93111896|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93111897|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93111898|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111899|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111900|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
93111901|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93111902|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93111903|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
93111904|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111905|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
93111906|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93111907|NCT04847063|Antidotes|antidotes|mesh-ancestor
93111908|NCT04847063|Protective Agents|protective agents|mesh-ancestor
93111909|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
93111910|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
93111911|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93111912|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93111913|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
93111914|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
93111915|NCT04821622|Talazoparib|talazoparib|mesh-list
93111916|NCT04821622|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93111917|NCT04821622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111918|NCT04821622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111919|NCT04821622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111920|NCT04768881|Pembrolizumab|pembrolizumab|mesh-list
93111921|NCT04768881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111922|NCT04768881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111923|NCT04768881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111924|NCT04768881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111925|NCT04751383|Dinutuximab|dinutuximab|mesh-list
93111926|NCT04751383|Magrolimab|magrolimab|mesh-list
93111927|NCT04751383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93111928|NCT04751383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111929|NCT04751383|Immunologic Factors|immunologic factors|mesh-ancestor
93111930|NCT04751383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111931|NCT04751383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111932|NCT04748419|Durvalumab|durvalumab|mesh-list
93111933|NCT04748419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111934|NCT04748419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111935|NCT04719273|Anastrozole|anastrozole|mesh-list
93111936|NCT04719273|Onapristone|onapristone|mesh-list
93111937|NCT04719273|Progesterone|progesterone|mesh-list
93111938|NCT04719273|Estrogens|estrogens|mesh-list
93111939|NCT04719273|Progestins|progestins|mesh-ancestor
93111940|NCT04719273|Hormones|hormones|mesh-ancestor
93111941|NCT04719273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93111942|NCT04719273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93111943|NCT04719273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92702160|NCT02920190|Liraglutide|liraglutide|mesh-list
93111944|NCT04719273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111945|NCT04719273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93111946|NCT04719273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93111947|NCT04719273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93111948|NCT04719273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111949|NCT04719273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93111950|NCT04719273|Hormone Antagonists|hormone antagonists|mesh-ancestor
93111951|NCT04719273|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93111952|NCT04719273|Fertility Agents|fertility agents|mesh-ancestor
93111953|NCT04719273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93111954|NCT04670679|Pembrolizumab|pembrolizumab|mesh-list
93111955|NCT04670679|Cetuximab|cetuximab|mesh-list
93111956|NCT04670679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93111957|NCT04670679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93111958|NCT04670679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93111959|NCT04670679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93111960|NCT04657289|Ranibizumab|ranibizumab|mesh-list
92784203|NCT02623465|Insulin Lispro|insulin lispro|mesh-list
93060746|NCT03871114|Triamcinolone|triamcinolone|mesh-list
93060984|NCT00163020|Hormones|hormones|mesh-ancestor
93061255|NCT01173640|Anesthetics|anesthetics|mesh-ancestor
93061411|NCT01284166|Timolol|timolol|mesh-list
93061552|NCT03864016|Sufentanil|sufentanil|mesh-list
93061635|NCT03863626|Furosemide|furosemide|mesh-list
93061707|NCT01175746|Nicardipine|nicardipine|mesh-list
93062533|NCT03854812|Tocolytic Agents|tocolytic agents|mesh-ancestor
92977126|NCT00873834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063507|NCT03842488|Darunavir|darunavir|mesh-list
93063583|NCT02966314|Omalizumab|omalizumab|mesh-list
93063955|NCT03818932|Narcotics|narcotics|mesh-ancestor
93064327|NCT00126672|Sirolimus|sirolimus|mesh-list
93064419|NCT01582412|Digoxin|digoxin|mesh-list
92977127|NCT00873834|Serotonin Agents|serotonin agents|mesh-ancestor
93065304|NCT01304836|Antiemetics|antiemetics|mesh-ancestor
93065678|NCT03777124|Carboplatin|carboplatin|mesh-list
93065761|NCT02043587|Hormones|hormones|mesh-ancestor
93065834|NCT01317784|Antibodies|antibodies|mesh-list
93066069|NCT01309984|Propofol|propofol|mesh-list
93066224|NCT00411671|Sorafenib|sorafenib|mesh-list
93066433|NCT03762928|Anesthetics|anesthetics|mesh-ancestor
93066576|NCT03767296|Respiratory System Agents|respiratory system agents|mesh-ancestor
93067026|NCT01081704|Dermatologic Agents|dermatologic agents|mesh-ancestor
93067706|NCT00096486|Everolimus|everolimus|mesh-list
93067856|NCT03757390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93068007|NCT01082744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93068084|NCT00096278|Growth Inhibitors|growth inhibitors|mesh-ancestor
93068245|NCT04142242|Vaccines|vaccines|mesh-list
93068317|NCT04132336|Analgesics|analgesics|mesh-ancestor
93068535|NCT00112736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069139|NCT00407537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93069284|NCT00394433|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069362|NCT03993431|Sympathomimetics|sympathomimetics|mesh-ancestor
93069597|NCT01085552|Epoetin Alfa|epoetin alfa|mesh-list
92977128|NCT00873834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069978|NCT00384293|Niacin|niacin|mesh-list
93070038|NCT00067002|Melphalan|melphalan|mesh-list
93070335|NCT01087580|Antimitotic Agents|antimitotic agents|mesh-ancestor
93070487|NCT01079481|Everolimus|everolimus|mesh-list
93071310|NCT00079040|Antibodies|antibodies|mesh-list
93071635|NCT01084473|Morphine|morphine|mesh-list
93071835|NCT01082510|Tegafur|tegafur|mesh-list
93072287|NCT05266469|Ofatumumab|ofatumumab|mesh-list
93072505|NCT04493320|Dopamine Agonists|dopamine agonists|mesh-ancestor
93072739|NCT03663205|Tislelizumab|tislelizumab|mesh-list
93072814|NCT03483012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073270|NCT05394740|Antidotes|antidotes|mesh-ancestor
93073401|NCT05001776|PENTA|penta|mesh-list
93073493|NCT04848974|Cytarabine|cytarabine|mesh-list
93073596|NCT04447183|Iodine|iodine|mesh-list
93073638|NCT04396457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92977129|NCT00873834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92977130|NCT00873834|Antidepressive Agents|antidepressive agents|mesh-ancestor
92977131|NCT00873834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702228|NCT02919332|Antimetabolites|antimetabolites|mesh-ancestor
92977132|NCT00873834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92977133|NCT00873834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92977134|NCT00873834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977135|NCT00655850|Paclitaxel|paclitaxel|mesh-list
92977136|NCT00655850|Gemcitabine|gemcitabine|mesh-list
92977137|NCT00655850|Bevacizumab|bevacizumab|mesh-list
92977138|NCT00655850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92977139|NCT00655850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977140|NCT00655850|Tubulin Modulators|tubulin modulators|mesh-ancestor
92977141|NCT00655850|Antimitotic Agents|antimitotic agents|mesh-ancestor
92977142|NCT00655850|Mitosis Modulators|mitosis modulators|mesh-ancestor
92977143|NCT00655850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977144|NCT00655850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92977145|NCT00655850|Antimetabolites|antimetabolites|mesh-ancestor
92977146|NCT00655850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977147|NCT00655850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92977148|NCT00655850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92977149|NCT00655850|Growth Substances|growth substances|mesh-ancestor
92977150|NCT00655850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977151|NCT00655850|Growth Inhibitors|growth inhibitors|mesh-ancestor
92977152|NCT00874068|Palmitic Acid|palmitic acid|mesh-list
92977153|NCT00874068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977154|NCT00874068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977155|NCT00805298|Methylprednisolone|methylprednisolone|mesh-list
92977156|NCT00805298|Epinephrine|epinephrine|mesh-list
92977157|NCT00805298|Racepinephrine|racepinephrine|mesh-list
92977158|NCT00805298|Epinephryl borate|epinephryl borate|mesh-list
92977159|NCT00805298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977160|NCT00805298|Antiemetics|antiemetics|mesh-ancestor
92977161|NCT00805298|Autonomic Agents|autonomic agents|mesh-ancestor
92977162|NCT00805298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977163|NCT00805298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977164|NCT00805298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977165|NCT00805298|Glucocorticoids|glucocorticoids|mesh-ancestor
92977166|NCT00805298|Hormones|hormones|mesh-ancestor
92977167|NCT00805298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977168|NCT00805298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92977169|NCT00805298|Protective Agents|protective agents|mesh-ancestor
92977170|NCT00805298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92977171|NCT00805298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92977172|NCT00805298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92977173|NCT00805298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977174|NCT00805298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977175|NCT00805298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92977176|NCT00805298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92977177|NCT00805298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92977178|NCT00805298|Respiratory System Agents|respiratory system agents|mesh-ancestor
92977179|NCT00805298|Mydriatics|mydriatics|mesh-ancestor
92977180|NCT00805298|Sympathomimetics|sympathomimetics|mesh-ancestor
92977181|NCT00805298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92977182|NCT00881400|Cefprozil|cefprozil|mesh-list
92977183|NCT00881400|Cephalosporins|cephalosporins|mesh-list
92977184|NCT00881400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977185|NCT00881400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977186|NCT00246571|Sunitinib|sunitinib|mesh-list
92977187|NCT00246571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977188|NCT00246571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92977189|NCT00246571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92977190|NCT00246571|Growth Substances|growth substances|mesh-ancestor
92977191|NCT00246571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977192|NCT00246571|Growth Inhibitors|growth inhibitors|mesh-ancestor
92977193|NCT00246571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92977194|NCT00246571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977195|NCT00246571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977196|NCT02553044|Vitamin D|vitamin d|mesh-list
92977197|NCT02553044|Cholecalciferol|cholecalciferol|mesh-list
92977198|NCT02553044|Vitamins|vitamins|mesh-ancestor
92977199|NCT02553044|Micronutrients|micronutrients|mesh-ancestor
92730732|NCT04547855|Temozolomide|temozolomide|mesh-list
92784276|NCT00870727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92784277|NCT00870727|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92784278|NCT00870727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92784279|NCT02787928|Hydromorphone|hydromorphone|mesh-list
92784280|NCT02787928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92784281|NCT02787928|Narcotics|narcotics|mesh-ancestor
92784282|NCT02787928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784283|NCT02787928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784284|NCT02787928|Analgesics|analgesics|mesh-ancestor
92784285|NCT02787928|Sensory System Agents|sensory system agents|mesh-ancestor
92784286|NCT02787928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784287|NCT02617069|Botulinum Toxins|botulinum toxins|mesh-list
92784288|NCT02617069|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92784289|NCT02617069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784290|NCT02617069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784291|NCT02617069|Cholinergic Agents|cholinergic agents|mesh-ancestor
92784292|NCT02617069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784293|NCT02617069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784294|NCT02788552|Vitamins|vitamins|mesh-list
92784295|NCT02788552|Thiamine|thiamine|mesh-list
92784296|NCT02788552|Micronutrients|micronutrients|mesh-ancestor
92784297|NCT02788552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784298|NCT02788552|Vitamin B Complex|vitamin b complex|mesh-ancestor
92784299|NCT01147055|Rifampin|rifampin|mesh-list
92784300|NCT01147055|Crizotinib|crizotinib|mesh-list
92784301|NCT01147055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92784302|NCT01147055|Antitubercular Agents|antitubercular agents|mesh-ancestor
92784303|NCT01147055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784304|NCT01147055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784305|NCT01147055|Leprostatic Agents|leprostatic agents|mesh-ancestor
92784306|NCT01147055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92784307|NCT01147055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784308|NCT01147055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784309|NCT01147055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92784310|NCT01147055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92784311|NCT01147055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92784312|NCT01147055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92784313|NCT01147055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92784314|NCT01147055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92784315|NCT01147055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784316|NCT01147055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784317|NCT02623231|Escitalopram|escitalopram|mesh-list
92784318|NCT02623231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92784319|NCT02623231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92784320|NCT02623231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784321|NCT02623231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784322|NCT02623231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784323|NCT02623231|Serotonin Agents|serotonin agents|mesh-ancestor
92784324|NCT02623231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784325|NCT02623153|Docetaxel|docetaxel|mesh-list
92784326|NCT02623153|Capecitabine|capecitabine|mesh-list
92784327|NCT02623153|Oxaliplatin|oxaliplatin|mesh-list
92784328|NCT02623153|Tegafur|tegafur|mesh-list
92784329|NCT02623153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784330|NCT02623153|Tubulin Modulators|tubulin modulators|mesh-ancestor
92784331|NCT02623153|Antimitotic Agents|antimitotic agents|mesh-ancestor
92784332|NCT02623153|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784333|NCT02623153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784334|NCT02623153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92784335|NCT02623153|Antimetabolites|antimetabolites|mesh-ancestor
92784336|NCT02616913|Moxifloxacin|moxifloxacin|mesh-list
92784337|NCT02616913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784338|NCT02616913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784339|NCT02616913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784340|NCT02616913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784341|NCT02616913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784342|NCT02616913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784343|NCT02616913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784344|NCT02884037|Rifaximin|rifaximin|mesh-list
92784345|NCT02884037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784346|NCT02884037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784347|NCT02884037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784348|NCT04233502|Melatonin|melatonin|mesh-list
92784349|NCT04233502|Antioxidants|antioxidants|mesh-ancestor
93046884|NCT00350792|Carboplatin|carboplatin|mesh-list
92784350|NCT04233502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784351|NCT04233502|Protective Agents|protective agents|mesh-ancestor
92784352|NCT04233502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784353|NCT04233502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784354|NCT00696475|Diazoxide|diazoxide|mesh-list
92784355|NCT00696475|Choline|choline|mesh-list
92784356|NCT00696475|Lipotropic Agents|lipotropic agents|mesh-ancestor
92784357|NCT00696475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92784358|NCT00696475|Antimetabolites|antimetabolites|mesh-ancestor
92784359|NCT00696475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784360|NCT00696475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784361|NCT00696475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92784362|NCT00696475|Nootropic Agents|nootropic agents|mesh-ancestor
92784363|NCT00696475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92784364|NCT00696475|Vasodilator Agents|vasodilator agents|mesh-ancestor
92784365|NCT03628066|Letrozole|letrozole|mesh-list
92784366|NCT03628066|Palbociclib|palbociclib|mesh-list
92784367|NCT03628066|Goserelin|goserelin|mesh-list
92784368|NCT03628066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784369|NCT03628066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92784370|NCT03628066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92784371|NCT03628066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784372|NCT03628066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784373|NCT03628066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92784374|NCT03628066|Hormone Antagonists|hormone antagonists|mesh-ancestor
92784375|NCT03628066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784376|NCT03628066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784377|NCT03628066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784378|NCT03628066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92784379|NCT00625079|Sildenafil Citrate|sildenafil citrate|mesh-list
92784380|NCT00625079|Vasodilator Agents|vasodilator agents|mesh-ancestor
92784381|NCT00625079|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92784382|NCT00625079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92784383|NCT00625079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784384|NCT00625079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784385|NCT00625079|Urological Agents|urological agents|mesh-ancestor
92784386|NCT02786992|Misoprostol|misoprostol|mesh-list
92784387|NCT02786992|Oxytocin|oxytocin|mesh-list
92784388|NCT02786992|Carbetocin|carbetocin|mesh-list
92784389|NCT02786992|Oxytocics|oxytocics|mesh-ancestor
92784390|NCT02786992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92784391|NCT02786992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784392|NCT02786992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92784393|NCT02786992|Abortifacient Agents|abortifacient agents|mesh-ancestor
92784394|NCT02786992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92784395|NCT02786992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784396|NCT04232644|Amphetamine|amphetamine|mesh-list
92784397|NCT04232644|Dextroamphetamine|dextroamphetamine|mesh-list
92784398|NCT04232644|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92784399|NCT04232644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784400|NCT04232644|Sympathomimetics|sympathomimetics|mesh-ancestor
92784401|NCT04232644|Autonomic Agents|autonomic agents|mesh-ancestor
92784402|NCT04232644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784403|NCT04232644|Dopamine Agents|dopamine agents|mesh-ancestor
92784404|NCT04232644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784405|NCT04232644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784406|NCT04232644|Adrenergic Agents|adrenergic agents|mesh-ancestor
92784407|NCT04232644|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92784408|NCT04232644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92784409|NCT04232644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784410|NCT04232644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92784411|NCT03557788|Rifaximin|rifaximin|mesh-list
92784412|NCT03557788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784413|NCT03557788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784414|NCT03557788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784415|NCT04133155|Paclitaxel|paclitaxel|mesh-list
92784416|NCT04133155|Gemcitabine|gemcitabine|mesh-list
92784417|NCT04133155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92784418|NCT04133155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784419|NCT04133155|Tubulin Modulators|tubulin modulators|mesh-ancestor
92784420|NCT04133155|Antimitotic Agents|antimitotic agents|mesh-ancestor
92784421|NCT04133155|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784422|NCT04133155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784423|NCT04133155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92784424|NCT04133155|Antimetabolites|antimetabolites|mesh-ancestor
92784425|NCT01190267|Asenapine|asenapine|mesh-list
92784426|NCT01190267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92784427|NCT01190267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92784428|NCT01190267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784429|NCT01190267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784430|NCT01190267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92784431|NCT00869089|Apremilast|apremilast|mesh-list
92784432|NCT00869089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92784433|NCT00869089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92784434|NCT00869089|Analgesics|analgesics|mesh-ancestor
92784435|NCT00869089|Sensory System Agents|sensory system agents|mesh-ancestor
92784436|NCT00869089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784437|NCT00869089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702464|NCT05467436|Analgesics|analgesics|mesh-list
92784438|NCT00869089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784439|NCT00869089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784440|NCT00869089|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92784441|NCT00869089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92784442|NCT00869089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784443|NCT00869089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784444|NCT02616367|Bupivacaine|bupivacaine|mesh-list
92784445|NCT02616367|Ropivacaine|ropivacaine|mesh-list
92784446|NCT02616367|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784447|NCT02616367|Anesthetics|anesthetics|mesh-ancestor
92784448|NCT02616367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784449|NCT02616367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784450|NCT02616367|Sensory System Agents|sensory system agents|mesh-ancestor
92784451|NCT02616367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784452|NCT04200040|Dacarbazine|dacarbazine|mesh-list
92784453|NCT04200040|Molgramostim|molgramostim|mesh-list
92784454|NCT04200040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784455|NCT04200040|Alkylating Agents|alkylating agents|mesh-ancestor
92784456|NCT04200040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784457|NCT04200040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784458|NCT04232722|Sorafenib|sorafenib|mesh-list
92784459|NCT04232722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784460|NCT04232722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784461|NCT04232722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784462|NCT04232722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784463|NCT02622685|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92784464|NCT02622685|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92784465|NCT02622685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784466|NCT02622607|Zoledronic Acid|zoledronic acid|mesh-list
92784467|NCT02622607|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92784468|NCT02622607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784469|NCT02787226|Bupivacaine|bupivacaine|mesh-list
92784470|NCT02787226|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784471|NCT02787226|Anesthetics|anesthetics|mesh-ancestor
92784472|NCT02787226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784473|NCT02787226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784474|NCT02787226|Sensory System Agents|sensory system agents|mesh-ancestor
92784475|NCT02787226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784476|NCT00697567|Vaccines|vaccines|mesh-list
92784477|NCT00697567|Immunologic Factors|immunologic factors|mesh-ancestor
92784478|NCT00697567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784479|NCT02616289|Emollients|emollients|mesh-list
92784480|NCT02616289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92784481|NCT03421756|Sirolimus|sirolimus|mesh-list
92784482|NCT03421756|Alemtuzumab|alemtuzumab|mesh-list
92784483|NCT03421756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784484|NCT03421756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784485|NCT03421756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92784486|NCT03421756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784487|NCT03421756|Antifungal Agents|antifungal agents|mesh-ancestor
92784488|NCT03421756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784489|NCT03421756|Immunologic Factors|immunologic factors|mesh-ancestor
92702521|NCT00532701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784490|NCT03421756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784491|NCT03421756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784492|NCT00870103|Moxifloxacin|moxifloxacin|mesh-list
92784493|NCT00870103|Dexamethasone|dexamethasone|mesh-list
92784494|NCT00870103|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92784495|NCT00870103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784496|NCT00870103|Antiemetics|antiemetics|mesh-ancestor
92784497|NCT00870103|Autonomic Agents|autonomic agents|mesh-ancestor
92784498|NCT00870103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784499|NCT00870103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784500|NCT00870103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784501|NCT00870103|Glucocorticoids|glucocorticoids|mesh-ancestor
92784502|NCT00870103|Hormones|hormones|mesh-ancestor
92784503|NCT00870103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784504|NCT00870103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92784505|NCT00870103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784506|NCT00870103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784507|NCT00870103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784508|NCT00870103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784509|NCT00870103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784510|NCT00870103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784511|NCT00870103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784512|NCT00870103|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92784513|NCT03365752|Anesthetics|anesthetics|mesh-list
92784514|NCT03365752|Mepivacaine|mepivacaine|mesh-list
92784515|NCT03365752|Chloroprocaine|chloroprocaine|mesh-list
92784516|NCT03365752|Anesthetics, General|anesthetics, general|mesh-list
92784517|NCT03365752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784518|NCT03365752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784519|NCT03365752|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784520|NCT03365752|Sensory System Agents|sensory system agents|mesh-ancestor
92784521|NCT03365752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784522|NCT02785666|Ribavirin|ribavirin|mesh-list
92784523|NCT02785666|Grazoprevir|grazoprevir|mesh-list
92784524|NCT02785666|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92784525|NCT02785666|Antimetabolites|antimetabolites|mesh-ancestor
92784526|NCT02785666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784527|NCT02785666|Antiviral Agents|antiviral agents|mesh-ancestor
92784528|NCT02785666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784529|NCT01145417|Pregabalin|pregabalin|mesh-list
92784530|NCT01145417|Analgesics|analgesics|mesh-ancestor
92784531|NCT01145417|Sensory System Agents|sensory system agents|mesh-ancestor
92784532|NCT01145417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784533|NCT01145417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784534|NCT01145417|Anticonvulsants|anticonvulsants|mesh-ancestor
92784535|NCT01145417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92784536|NCT01145417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784537|NCT01145417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784538|NCT01145417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92784539|NCT01145417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92784540|NCT01145417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92784541|NCT01145417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784542|NCT01145417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92784543|NCT04232332|Mitogens|mitogens|mesh-list
92784544|NCT04232332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784545|NCT04232332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784546|NCT02785276|Ropivacaine|ropivacaine|mesh-list
92784547|NCT02785276|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784548|NCT02785276|Anesthetics|anesthetics|mesh-ancestor
92784549|NCT02785276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784550|NCT02785276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784551|NCT02785276|Sensory System Agents|sensory system agents|mesh-ancestor
92784552|NCT02785276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784553|NCT04316039|Temozolomide|temozolomide|mesh-list
92784554|NCT04316039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784555|NCT04316039|Alkylating Agents|alkylating agents|mesh-ancestor
92784556|NCT04316039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784557|NCT04316039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784558|NCT00696631|Dronedarone|dronedarone|mesh-list
92784559|NCT00696631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92784560|NCT02615977|Ethanol|ethanol|mesh-list
92784561|NCT02615977|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92784562|NCT02615977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784563|NCT02615977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784564|NCT02615977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784565|NCT01189487|Ampicillin|ampicillin|mesh-list
92784566|NCT01189487|Sulbactam|sulbactam|mesh-list
92784567|NCT01189487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784568|NCT01189487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784569|NCT01189487|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92784570|NCT01189487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784571|NCT01189487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784572|NCT02621905|Itraconazole|itraconazole|mesh-list
92784573|NCT02621905|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92784574|NCT02621905|Antifungal Agents|antifungal agents|mesh-ancestor
93046885|NCT00350792|Pemetrexed|pemetrexed|mesh-list
92784575|NCT02621905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784576|NCT02621905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92784577|NCT02621905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92784578|NCT02621905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784579|NCT02621905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784580|NCT02621905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92784581|NCT02621905|Hormone Antagonists|hormone antagonists|mesh-ancestor
92784582|NCT02621905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784583|NCT02621905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784584|NCT02621905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92784585|NCT01106352|Docetaxel|docetaxel|mesh-list
92784586|NCT01106352|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92784587|NCT01106352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784588|NCT01106352|Tubulin Modulators|tubulin modulators|mesh-ancestor
92784589|NCT01106352|Antimitotic Agents|antimitotic agents|mesh-ancestor
92784590|NCT01106352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784591|NCT01106352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784592|NCT01144403|Cyclophosphamide|cyclophosphamide|mesh-list
92784593|NCT01144403|Rituximab|rituximab|mesh-list
92784594|NCT01144403|Fludarabine|fludarabine|mesh-list
92784595|NCT01144403|Mitoxantrone|mitoxantrone|mesh-list
92784596|NCT01144403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784597|NCT01144403|Immunologic Factors|immunologic factors|mesh-ancestor
92784598|NCT01144403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784599|NCT01144403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122475|NCT02428764|Gemcitabine|gemcitabine|mesh-list
92784600|NCT01144403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784601|NCT01144403|Alkylating Agents|alkylating agents|mesh-ancestor
92784602|NCT01144403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784603|NCT01144403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784604|NCT01144403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92784605|NCT01144403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784606|NCT01144403|Analgesics|analgesics|mesh-ancestor
92784607|NCT01144403|Sensory System Agents|sensory system agents|mesh-ancestor
92784608|NCT01144403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784609|NCT01144403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784610|NCT01144403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784611|NCT01144403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784612|NCT03071926|Doxorubicin|doxorubicin|mesh-list
92784613|NCT03071926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92784614|NCT03071926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92784615|NCT03071926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784616|NCT03071926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784617|NCT03071926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784618|NCT03071926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784619|NCT03071926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784620|NCT02883647|Tenofovir|tenofovir|mesh-list
92784621|NCT02883647|Entecavir|entecavir|mesh-list
92784622|NCT02883647|Antiviral Agents|antiviral agents|mesh-ancestor
92784623|NCT02883647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784624|NCT02883647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92784625|NCT02883647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92784626|NCT02883647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784627|NCT02883647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784628|NCT02883647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92784629|NCT02883647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92784630|NCT02621827|Calcifediol|calcifediol|mesh-list
92784631|NCT02621827|Vitamins|vitamins|mesh-ancestor
92784632|NCT02621827|Micronutrients|micronutrients|mesh-ancestor
92784633|NCT02621827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784634|NCT02621827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92784635|NCT01143389|Riboflavin|riboflavin|mesh-list
92784636|NCT01143389|Vitamin B Complex|vitamin b complex|mesh-ancestor
92784637|NCT01143389|Vitamins|vitamins|mesh-ancestor
92784638|NCT01143389|Micronutrients|micronutrients|mesh-ancestor
92784639|NCT01143389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784640|NCT01143389|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92784641|NCT01143389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92784642|NCT00868231|Bromides|bromides|mesh-list
92784643|NCT00868231|Tiotropium Bromide|tiotropium bromide|mesh-list
92784644|NCT00868231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92784645|NCT00868231|Autonomic Agents|autonomic agents|mesh-ancestor
92784646|NCT00868231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784647|NCT00868231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784648|NCT00868231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92784649|NCT00868231|Respiratory System Agents|respiratory system agents|mesh-ancestor
92784650|NCT00868231|Parasympatholytics|parasympatholytics|mesh-ancestor
92784651|NCT00868231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92784652|NCT00868231|Cholinergic Agents|cholinergic agents|mesh-ancestor
92784653|NCT00868231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784654|NCT00868231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784655|NCT00868231|Anticonvulsants|anticonvulsants|mesh-ancestor
92784656|NCT04231864|Durvalumab|durvalumab|mesh-list
92784657|NCT04231864|Immunoglobulins|immunoglobulins|mesh-list
92784658|NCT04231864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92784659|NCT04231864|Immunoglobulin G|immunoglobulin g|mesh-list
92702683|NCT00532818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784660|NCT04231864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784661|NCT04231864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784662|NCT04231864|Immunologic Factors|immunologic factors|mesh-ancestor
92784663|NCT04231864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784664|NCT01143077|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92784665|NCT01143077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92784666|NCT01143077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92784667|NCT01143077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784668|NCT01143077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784669|NCT01143077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92784670|NCT01143077|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92784671|NCT01143077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92784672|NCT01143077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92784673|NCT01143077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92784674|NCT01143077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784675|NCT01143077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784676|NCT01143077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92784677|NCT01143077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92784678|NCT01143077|Serotonin Agents|serotonin agents|mesh-ancestor
92784679|NCT01143077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92784680|NCT01143077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92784681|NCT01143077|Dopamine Agents|dopamine agents|mesh-ancestor
92784682|NCT02786446|Naproxen|naproxen|mesh-list
92784683|NCT02786446|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92784684|NCT02786446|Lidocaine|lidocaine|mesh-list
92784685|NCT02786446|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784686|NCT02786446|Anesthetics|anesthetics|mesh-ancestor
92784687|NCT02786446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784688|NCT02786446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784689|NCT02786446|Sensory System Agents|sensory system agents|mesh-ancestor
92784690|NCT02786446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784691|NCT02786446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92784692|NCT02786446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92784693|NCT02786446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92784694|NCT02786446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784695|NCT02786446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784696|NCT02786446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92784697|NCT02786446|Analgesics|analgesics|mesh-ancestor
92784698|NCT02786446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784699|NCT02786446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784700|NCT02786446|Gout Suppressants|gout suppressants|mesh-ancestor
92784701|NCT02786446|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92784702|NCT02786446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784703|NCT02619019|Dexamethasone|dexamethasone|mesh-list
92784704|NCT02619019|Meperidine|meperidine|mesh-list
92784705|NCT02619019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784706|NCT02619019|Antiemetics|antiemetics|mesh-ancestor
92784707|NCT02619019|Autonomic Agents|autonomic agents|mesh-ancestor
92784708|NCT02619019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784709|NCT02619019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784710|NCT02619019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784711|NCT02619019|Glucocorticoids|glucocorticoids|mesh-ancestor
92784712|NCT02619019|Hormones|hormones|mesh-ancestor
92784713|NCT02619019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784714|NCT02619019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92784715|NCT02619019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784716|NCT02619019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92784717|NCT02619019|Narcotics|narcotics|mesh-ancestor
92784718|NCT02619019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784719|NCT02619019|Analgesics|analgesics|mesh-ancestor
92784720|NCT02619019|Sensory System Agents|sensory system agents|mesh-ancestor
92784721|NCT02619019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92784722|NCT02957032|Cytarabine|cytarabine|mesh-list
92784723|NCT02957032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429790|NCT05439356|Colchicine|colchicine|mesh-list
92784724|NCT02957032|Antimetabolites|antimetabolites|mesh-ancestor
92784725|NCT02957032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784726|NCT02957032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784727|NCT02957032|Antiviral Agents|antiviral agents|mesh-ancestor
92784728|NCT02957032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784729|NCT02957032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784730|NCT02957032|Immunologic Factors|immunologic factors|mesh-ancestor
92784731|NCT02957032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784732|NCT02947516|Liver Extracts|liver extracts|mesh-list
92784733|NCT02947516|Hematinics|hematinics|mesh-ancestor
92784734|NCT01096446|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92784735|NCT01096446|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92784736|NCT01096446|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92784737|NCT01096446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92784738|NCT00864721|Sunitinib|sunitinib|mesh-list
92784739|NCT00864721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784740|NCT00864721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92784741|NCT00864721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92784742|NCT00864721|Growth Substances|growth substances|mesh-ancestor
92784743|NCT00864721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784744|NCT00864721|Growth Inhibitors|growth inhibitors|mesh-ancestor
92784745|NCT00864721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784746|NCT00864721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784747|NCT00864721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784748|NCT05308420|Morphine|morphine|mesh-list
92784749|NCT05308420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784750|NCT05308420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784751|NCT05308420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92784752|NCT05308420|Narcotics|narcotics|mesh-ancestor
92784753|NCT05308420|Analgesics|analgesics|mesh-ancestor
92784754|NCT05308420|Sensory System Agents|sensory system agents|mesh-ancestor
92784755|NCT05308420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784756|NCT02897050|Cyclophosphamide|cyclophosphamide|mesh-list
92784757|NCT02897050|Docetaxel|docetaxel|mesh-list
92784758|NCT02897050|Fluorouracil|fluorouracil|mesh-list
92784759|NCT02897050|Capecitabine|capecitabine|mesh-list
92784760|NCT02897050|Epirubicin|epirubicin|mesh-list
92784761|NCT02897050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784762|NCT02897050|Immunologic Factors|immunologic factors|mesh-ancestor
92784763|NCT02897050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784764|NCT02897050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784765|NCT02897050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784766|NCT02897050|Alkylating Agents|alkylating agents|mesh-ancestor
92784767|NCT02897050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784768|NCT02897050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784769|NCT02897050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92784770|NCT02897050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92784771|NCT02897050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92784772|NCT02897050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784773|NCT02897050|Antimetabolites|antimetabolites|mesh-ancestor
92784774|NCT02897050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92784775|NCT02897050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92784776|NCT02897050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784777|NCT02897050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784778|NCT02897050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784779|NCT01095666|Metformin|metformin|mesh-list
92784780|NCT01095666|Pioglitazone|pioglitazone|mesh-list
92784781|NCT01095666|Dapagliflozin|dapagliflozin|mesh-list
92784782|NCT01095666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92784783|NCT01095666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784784|NCT01095666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92784785|NCT01095666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784786|NCT01100658|Methylphenidate|methylphenidate|mesh-list
92784787|NCT01100658|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92784788|NCT01100658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784789|NCT01100658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92784790|NCT01100658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92784791|NCT01100658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784792|NCT01100658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784793|NCT01100658|Dopamine Agents|dopamine agents|mesh-ancestor
92784794|NCT01100658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784795|NCT05276908|Bupivacaine|bupivacaine|mesh-list
92784796|NCT05276908|Anesthetics|anesthetics|mesh-list
92784797|NCT05276908|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784798|NCT05276908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784799|NCT05276908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784800|NCT05276908|Sensory System Agents|sensory system agents|mesh-ancestor
92784801|NCT05276908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784802|NCT02785978|Levodopa|levodopa|mesh-list
92784803|NCT02785978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92784804|NCT02785978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92784805|NCT02785978|Dopamine Agents|dopamine agents|mesh-ancestor
92784806|NCT02785978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784807|NCT02785978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784808|NCT02785978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784809|NCT02786212|Dexmedetomidine|dexmedetomidine|mesh-list
92784810|NCT02786212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92784811|NCT02786212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784812|NCT02786212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784813|NCT02786212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92784814|NCT02786212|Analgesics|analgesics|mesh-ancestor
92784815|NCT02786212|Sensory System Agents|sensory system agents|mesh-ancestor
92784816|NCT02786212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784817|NCT02786212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92784818|NCT02786212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92784819|NCT02786212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92784820|NCT02786212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92784821|NCT02786212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784822|NCT02786212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784823|NCT05273710|Folic Acid|folic acid|mesh-list
92784824|NCT05273710|Hematinics|hematinics|mesh-ancestor
92784825|NCT05273710|Vitamin B Complex|vitamin b complex|mesh-ancestor
92784826|NCT05273710|Vitamins|vitamins|mesh-ancestor
92784827|NCT05273710|Micronutrients|micronutrients|mesh-ancestor
92784828|NCT05273710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784829|NCT02784808|Antirheumatic Agents|antirheumatic agents|mesh-list
92784830|NCT02784652|Zoledronic Acid|zoledronic acid|mesh-list
92784831|NCT02784652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92784832|NCT02784652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784833|NCT01100502|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92784834|NCT01100502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784835|NCT01100502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784836|NCT01100502|Immunotoxins|immunotoxins|mesh-ancestor
92784837|NCT01100502|Immunoconjugates|immunoconjugates|mesh-ancestor
92784838|NCT01100502|Immunologic Factors|immunologic factors|mesh-ancestor
92784839|NCT01100502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784840|NCT02784340|Dexamethasone|dexamethasone|mesh-list
92784841|NCT02784340|Dexamethasone acetate|dexamethasone acetate|mesh-list
92784842|NCT02784340|Bupivacaine|bupivacaine|mesh-list
92784843|NCT02784340|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92784844|NCT02784340|BB 1101|bb 1101|mesh-list
92784845|NCT02784340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784846|NCT02784340|Antiemetics|antiemetics|mesh-ancestor
92784847|NCT02784340|Autonomic Agents|autonomic agents|mesh-ancestor
92784848|NCT02784340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784849|NCT02784340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784850|NCT02784340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784851|NCT02784340|Glucocorticoids|glucocorticoids|mesh-ancestor
92784852|NCT02784340|Hormones|hormones|mesh-ancestor
92784853|NCT02784340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784854|NCT02784340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92784855|NCT02784340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784856|NCT02784340|Protease Inhibitors|protease inhibitors|mesh-ancestor
92784857|NCT02784340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702886|NCT01272193|Insulin|insulin|mesh-list
92784858|NCT02784340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784859|NCT02784340|Anesthetics, Local|anesthetics, local|mesh-ancestor
92784860|NCT02784340|Anesthetics|anesthetics|mesh-ancestor
92784861|NCT02784340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784862|NCT02784340|Sensory System Agents|sensory system agents|mesh-ancestor
92784863|NCT02389036|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92784864|NCT02389036|Ciprofloxacin|ciprofloxacin|mesh-list
92784865|NCT02389036|Ceftriaxone|ceftriaxone|mesh-list
92784866|NCT02389036|Tobramycin|tobramycin|mesh-list
92784867|NCT02389036|Colistin|colistin|mesh-list
92784868|NCT02389036|Nystatin|nystatin|mesh-list
92784869|NCT02389036|Cefotaxime|cefotaxime|mesh-list
92784870|NCT02389036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784871|NCT02389036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784872|NCT02389036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784873|NCT02389036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977200|NCT02553044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784874|NCT02389036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784875|NCT02389036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784876|NCT02389036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92784877|NCT02389036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92784878|NCT02389036|Antifungal Agents|antifungal agents|mesh-ancestor
92784879|NCT02389036|Ionophores|ionophores|mesh-ancestor
92784880|NCT02389036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784881|NCT02878512|Anesthetics|anesthetics|mesh-list
92784882|NCT02878512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784883|NCT02878512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784884|NCT01094886|Rivaroxaban|rivaroxaban|mesh-list
92784885|NCT01094886|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92784886|NCT01094886|Antithrombins|antithrombins|mesh-ancestor
92784887|NCT01094886|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92784888|NCT01094886|Protease Inhibitors|protease inhibitors|mesh-ancestor
92784889|NCT01094886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784890|NCT01094886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784891|NCT01094886|Anticoagulants|anticoagulants|mesh-ancestor
92784892|NCT01094808|Pregabalin|pregabalin|mesh-list
92784893|NCT01094808|Analgesics|analgesics|mesh-ancestor
92784894|NCT01094808|Sensory System Agents|sensory system agents|mesh-ancestor
92784895|NCT01094808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784896|NCT01094808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784897|NCT01094808|Anticonvulsants|anticonvulsants|mesh-ancestor
92784898|NCT01094808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92784899|NCT01094808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784900|NCT01094808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784901|NCT01094808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92784902|NCT01094808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92784903|NCT01094808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92784904|NCT01094808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784905|NCT01094808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92784906|NCT00864253|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92784907|NCT00864253|Dacarbazine|dacarbazine|mesh-list
92784908|NCT00864253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784909|NCT00864253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784910|NCT00864253|Alkylating Agents|alkylating agents|mesh-ancestor
92784911|NCT00864253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702946|NCT02071862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784912|NCT02782312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92784913|NCT02782312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92784914|NCT02782312|Autonomic Agents|autonomic agents|mesh-ancestor
92784915|NCT02782312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784916|NCT02782312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784917|NCT02782312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92784918|NCT02782312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92784919|NCT02782312|Glucocorticoids|glucocorticoids|mesh-ancestor
92784920|NCT02782312|Hormones|hormones|mesh-ancestor
92784921|NCT02782312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784922|NCT02782312|Sympathomimetics|sympathomimetics|mesh-ancestor
92784923|NCT04229758|Anticoagulants|anticoagulants|mesh-list
92784924|NCT00698425|Citric Acid|citric acid|mesh-list
92784925|NCT00698425|Sodium Citrate|sodium citrate|mesh-list
92784926|NCT00698425|Anticoagulants|anticoagulants|mesh-ancestor
92784927|NCT00698425|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92784928|NCT00698425|Chelating Agents|chelating agents|mesh-ancestor
92784929|NCT00698425|Sequestering Agents|sequestering agents|mesh-ancestor
92784930|NCT00698425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784931|NCT05342272|Lactoferrin|lactoferrin|mesh-list
92784932|NCT05342272|Muramidase|muramidase|mesh-list
92784933|NCT05342272|Betaine|betaine|mesh-list
92784934|NCT05342272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784935|NCT05342272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784936|NCT05342272|Lipotropic Agents|lipotropic agents|mesh-ancestor
92784937|NCT05342272|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92784938|NCT05342272|Antimetabolites|antimetabolites|mesh-ancestor
92784939|NCT05342272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784940|NCT05342272|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92784941|NCT04230460|Ethanol|ethanol|mesh-list
92784942|NCT04230460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92784943|NCT04230460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784944|NCT04230460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784945|NCT04230460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784946|NCT02783638|Pregabalin|pregabalin|mesh-list
92784947|NCT02783638|Analgesics|analgesics|mesh-ancestor
92784948|NCT02783638|Sensory System Agents|sensory system agents|mesh-ancestor
92784949|NCT02783638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784950|NCT02783638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784951|NCT02783638|Anticonvulsants|anticonvulsants|mesh-ancestor
92784952|NCT02783638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92784953|NCT02783638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92784954|NCT02783638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784955|NCT02783638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92784956|NCT02783638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92784957|NCT02783638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92784958|NCT02783638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784959|NCT02783638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92784960|NCT04230070|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92784961|NCT04230070|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92784962|NCT04230070|Levonorgestrel|levonorgestrel|mesh-list
92784963|NCT04230070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92784964|NCT04230070|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92784965|NCT04230070|Estradiol|estradiol|mesh-list
92784966|NCT04230070|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92784967|NCT04230070|Estrogens|estrogens|mesh-ancestor
92784968|NCT04230070|Hormones|hormones|mesh-ancestor
92784969|NCT04230070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784970|NCT04230070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784971|NCT04230070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92784972|NCT04230070|Contraceptive Agents|contraceptive agents|mesh-ancestor
92784973|NCT04230070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92784974|NCT04230070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92784975|NCT04230070|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92784976|NCT04230070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92784977|NCT04230070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92784978|NCT04230070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92784979|NCT02782078|Clindamycin|clindamycin|mesh-list
92784980|NCT02782078|Clindamycin palmitate|clindamycin palmitate|mesh-list
92784981|NCT02782078|Clindamycin phosphate|clindamycin phosphate|mesh-list
92784982|NCT02782078|Rifampin|rifampin|mesh-list
92784983|NCT02782078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784984|NCT02782078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784985|NCT02782078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92784986|NCT02782078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784987|NCT02782078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784988|NCT02782078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92784989|NCT02782078|Antitubercular Agents|antitubercular agents|mesh-ancestor
92784990|NCT02782078|Leprostatic Agents|leprostatic agents|mesh-ancestor
92784991|NCT02782078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92784992|NCT02782078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92784993|NCT02782078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92784994|NCT02782078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92784995|NCT02782078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92784996|NCT02782078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92784997|NCT02782078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92784998|NCT01293682|Calcitriol|calcitriol|mesh-list
92784999|NCT01293682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92785000|NCT01293682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785001|NCT01293682|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92785002|NCT01293682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92785003|NCT01293682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785004|NCT01293682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92785005|NCT01293682|Vitamins|vitamins|mesh-ancestor
92785006|NCT01293682|Micronutrients|micronutrients|mesh-ancestor
92785007|NCT01293682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92785008|NCT00864097|Diclofenac|diclofenac|mesh-list
92785009|NCT00864097|Tanezumab|tanezumab|mesh-list
92785010|NCT00864097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785011|NCT00864097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785012|NCT00864097|Analgesics|analgesics|mesh-ancestor
92785013|NCT00864097|Sensory System Agents|sensory system agents|mesh-ancestor
92785014|NCT00864097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785015|NCT00864097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703052|NCT01268059|Paclitaxel|paclitaxel|mesh-list
92785016|NCT00864097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785017|NCT00864097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785018|NCT00864097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785019|NCT00864097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785020|NCT00864097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785021|NCT02782624|Empagliflozin|empagliflozin|mesh-list
92785022|NCT02782624|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92785023|NCT02782624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785024|NCT02782624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785025|NCT02782624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785026|NCT02781766|Thrombin|thrombin|mesh-list
92785027|NCT02781766|Hemostatics|hemostatics|mesh-ancestor
92785028|NCT02781766|Coagulants|coagulants|mesh-ancestor
92785029|NCT00887536|Cyclophosphamide|cyclophosphamide|mesh-list
92785030|NCT00887536|Bevacizumab|bevacizumab|mesh-list
92785031|NCT00887536|Docetaxel|docetaxel|mesh-list
92785032|NCT00887536|Doxorubicin|doxorubicin|mesh-list
92785033|NCT00887536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92785034|NCT00887536|Immunologic Factors|immunologic factors|mesh-ancestor
92785035|NCT00887536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785036|NCT00887536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785037|NCT00887536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92785038|NCT00887536|Alkylating Agents|alkylating agents|mesh-ancestor
92785039|NCT00887536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785040|NCT00887536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785041|NCT00887536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92785042|NCT00887536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785043|NCT00887536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92785044|NCT00887536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92785045|NCT00887536|Growth Substances|growth substances|mesh-ancestor
92785046|NCT00887536|Growth Inhibitors|growth inhibitors|mesh-ancestor
92785047|NCT00887536|Tubulin Modulators|tubulin modulators|mesh-ancestor
92785048|NCT00887536|Antimitotic Agents|antimitotic agents|mesh-ancestor
92785049|NCT00887536|Mitosis Modulators|mitosis modulators|mesh-ancestor
92785050|NCT00887536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92785051|NCT00887536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92785052|NCT00887536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92785053|NCT00887536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785054|NCT02614339|Metformin|metformin|mesh-list
92785055|NCT02614339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785056|NCT02614339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785057|NCT02618395|Hydrocodone|hydrocodone|mesh-list
92785058|NCT02618395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92785059|NCT02618395|Narcotics|narcotics|mesh-ancestor
92785060|NCT02618395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785061|NCT02618395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785062|NCT02618395|Analgesics|analgesics|mesh-ancestor
92785063|NCT02618395|Sensory System Agents|sensory system agents|mesh-ancestor
92785064|NCT02618395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785065|NCT02618395|Antitussive Agents|antitussive agents|mesh-ancestor
92785066|NCT02618395|Respiratory System Agents|respiratory system agents|mesh-ancestor
92785067|NCT01183013|Pioglitazone|pioglitazone|mesh-list
92785068|NCT01183013|Linagliptin|linagliptin|mesh-list
92785069|NCT01183013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785070|NCT01183013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785071|NCT01183013|Incretins|incretins|mesh-ancestor
92785072|NCT01183013|Hormones|hormones|mesh-ancestor
92785073|NCT01183013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785074|NCT01183013|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92785075|NCT01183013|Protease Inhibitors|protease inhibitors|mesh-ancestor
92785076|NCT01183013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785077|NCT01183013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785078|NCT04229212|Cimetidine|cimetidine|mesh-list
92785079|NCT04229212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92785080|NCT04229212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785081|NCT04229212|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92785082|NCT04229212|Histamine Antagonists|histamine antagonists|mesh-ancestor
92785083|NCT04229212|Histamine Agents|histamine agents|mesh-ancestor
92785084|NCT04229212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785085|NCT04229212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785086|NCT04229212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785087|NCT04229212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92785088|NCT04229212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92785089|NCT04229212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785090|NCT02615041|Meropenem|meropenem|mesh-list
92785091|NCT02615041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92785092|NCT02615041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785093|NCT04229602|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92785094|NCT04229602|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92785095|NCT04229602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92785096|NCT04229602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046886|NCT00350792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785097|NCT04229602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785098|NCT04229602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785099|NCT04229602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785100|NCT04229602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92785101|NCT04229602|Antidepressive Agents|antidepressive agents|mesh-ancestor
92785102|NCT04229602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92785104|NCT05298163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92785105|NCT05298163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785106|NCT05298163|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92785107|NCT05298163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92785108|NCT05298163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785109|NCT05298163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92785110|NCT05298163|Vitamins|vitamins|mesh-ancestor
92785111|NCT05298163|Micronutrients|micronutrients|mesh-ancestor
92785112|NCT05298163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92785113|NCT01141283|Buprenorphine|buprenorphine|mesh-list
92785114|NCT01141283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92785115|NCT01141283|Narcotics|narcotics|mesh-ancestor
92785116|NCT01141283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785117|NCT01141283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785118|NCT01141283|Analgesics|analgesics|mesh-ancestor
92785119|NCT01141283|Sensory System Agents|sensory system agents|mesh-ancestor
92785120|NCT01141283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785121|NCT01141283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92785122|NCT05340946|Anesthetics|anesthetics|mesh-list
92785123|NCT05340946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785124|NCT05340946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785125|NCT00863707|Regadenoson|regadenoson|mesh-list
92785126|NCT00863707|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92785127|NCT00863707|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92785128|NCT00863707|Purinergic Agonists|purinergic agonists|mesh-ancestor
92785129|NCT00863707|Purinergic Agents|purinergic agents|mesh-ancestor
92785130|NCT00863707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785131|NCT00863707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785132|NCT00863707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785133|NCT05340634|Contraceptive Agents|contraceptive agents|mesh-list
92785134|NCT05340634|Contraceptives, Oral|contraceptives, oral|mesh-list
92785135|NCT05340634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92785136|NCT05340634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785137|NCT05340634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92785138|NCT05367479|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92785139|NCT05367479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785140|NCT04187807|Melatonin|melatonin|mesh-list
92785141|NCT04187807|Antioxidants|antioxidants|mesh-ancestor
92785142|NCT04187807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785143|NCT04187807|Protective Agents|protective agents|mesh-ancestor
92785144|NCT04187807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785145|NCT04187807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785146|NCT01094184|Paclitaxel|paclitaxel|mesh-list
92785147|NCT01094184|Docetaxel|docetaxel|mesh-list
92785148|NCT01094184|Bevacizumab|bevacizumab|mesh-list
92785149|NCT01094184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92785150|NCT01094184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785151|NCT01094184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92785152|NCT01094184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92785153|NCT01094184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92785154|NCT01094184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785155|NCT01094184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785156|NCT01094184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92785157|NCT01094184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92785158|NCT01094184|Growth Substances|growth substances|mesh-ancestor
92785159|NCT01094184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785160|NCT01094184|Growth Inhibitors|growth inhibitors|mesh-ancestor
92785161|NCT00697879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92785162|NCT00697879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785163|NCT00697879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785164|NCT01134731|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92785165|NCT01134731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92785166|NCT01134731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785167|NCT01134731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93046887|NCT00350792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430235|NCT04305444|Everolimus|everolimus|mesh-list
92785168|NCT01134731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785169|NCT01134731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785170|NCT01134731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92785171|NCT01134731|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92785172|NCT01134731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92785173|NCT01134731|Serotonin Agents|serotonin agents|mesh-ancestor
92785174|NCT01134731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785175|NCT01134731|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92785176|NCT01134731|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92785177|NCT01134731|Dopamine Agents|dopamine agents|mesh-ancestor
92785178|NCT04132063|Levetiracetam|levetiracetam|mesh-list
92785179|NCT04132063|Anticonvulsants|anticonvulsants|mesh-ancestor
92785180|NCT04132063|Nootropic Agents|nootropic agents|mesh-ancestor
92785181|NCT02618317|Minocycline|minocycline|mesh-list
92785182|NCT02618317|Heparin|heparin|mesh-list
92785183|NCT02618317|Anticoagulants|anticoagulants|mesh-ancestor
92785184|NCT02618317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785185|NCT02618317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92785186|NCT02618317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92785187|NCT02618317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92785188|NCT02618317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785189|NCT01140503|Apremilast|apremilast|mesh-list
92785190|NCT01140503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785191|NCT01140503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785192|NCT01140503|Analgesics|analgesics|mesh-ancestor
92785193|NCT01140503|Sensory System Agents|sensory system agents|mesh-ancestor
92785194|NCT01140503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785195|NCT01140503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785196|NCT01140503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785197|NCT01140503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785198|NCT01140503|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92785199|NCT01140503|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92785200|NCT01140503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785201|NCT01140503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785202|NCT02689726|Imiquimod|imiquimod|mesh-list
92785203|NCT02689726|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92785204|NCT02689726|Immunologic Factors|immunologic factors|mesh-ancestor
92785205|NCT02689726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785206|NCT02689726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785207|NCT02689726|Interferon Inducers|interferon inducers|mesh-ancestor
92785208|NCT00863317|Montelukast|montelukast|mesh-list
92785209|NCT00863317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92785210|NCT00863317|Respiratory System Agents|respiratory system agents|mesh-ancestor
92785211|NCT00863317|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92785212|NCT00863317|Hormone Antagonists|hormone antagonists|mesh-ancestor
92785213|NCT00863317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785214|NCT00863317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785215|NCT00863317|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92785216|NCT00863317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92785217|NCT00863317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785218|NCT02744092|Enoxaparin|enoxaparin|mesh-list
92785219|NCT02744092|Dalteparin|dalteparin|mesh-list
92785220|NCT02744092|PENTA|penta|mesh-list
92785221|NCT02744092|Warfarin|warfarin|mesh-list
92785222|NCT02744092|Rivaroxaban|rivaroxaban|mesh-list
92785223|NCT02744092|Dabigatran|dabigatran|mesh-list
92785224|NCT02744092|Apixaban|apixaban|mesh-list
92785225|NCT02744092|Edoxaban|edoxaban|mesh-list
92785226|NCT02744092|Fondaparinux|fondaparinux|mesh-list
92785227|NCT02744092|Anticoagulants|anticoagulants|mesh-ancestor
92785228|NCT02744092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92785229|NCT02744092|Antithrombins|antithrombins|mesh-ancestor
92785230|NCT02744092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92785231|NCT02744092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92785232|NCT02744092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785233|NCT02744092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785234|NCT02744092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92785235|NCT02744092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92785236|NCT01200368|Vaccines|vaccines|mesh-list
92785237|NCT01200368|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92785238|NCT01200368|Immunologic Factors|immunologic factors|mesh-ancestor
92785239|NCT01200368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785240|NCT04125121|Propofol|propofol|mesh-list
92785241|NCT04125121|Sevoflurane|sevoflurane|mesh-list
92785242|NCT04125121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92785243|NCT04125121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785244|NCT04125121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785245|NCT04125121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92785246|NCT04125121|Anesthetics, General|anesthetics, general|mesh-ancestor
92785248|NCT04125121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92785249|NCT04125121|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92785250|NCT01079130|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92785251|NCT01079130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92785252|NCT01079130|Autonomic Agents|autonomic agents|mesh-ancestor
92785253|NCT01079130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785254|NCT01079130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785255|NCT01079130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92785256|NCT01079130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92785257|NCT01079130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92785258|NCT01079130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92785259|NCT01079130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92785260|NCT01079130|Adrenergic Agents|adrenergic agents|mesh-ancestor
92785261|NCT01079130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785262|NCT01079130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785263|NCT01078974|Dexamethasone|dexamethasone|mesh-list
92785264|NCT01078974|Rituximab|rituximab|mesh-list
92785265|NCT01078974|Pomalidomide|pomalidomide|mesh-list
92785266|NCT01078974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785267|NCT01078974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785268|NCT01078974|Immunologic Factors|immunologic factors|mesh-ancestor
92785269|NCT01078974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785270|NCT01078974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785271|NCT01078974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785272|NCT01078974|Antiemetics|antiemetics|mesh-ancestor
92785273|NCT01078974|Autonomic Agents|autonomic agents|mesh-ancestor
92785274|NCT01078974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785275|NCT01078974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785276|NCT01078974|Glucocorticoids|glucocorticoids|mesh-ancestor
92785277|NCT01078974|Hormones|hormones|mesh-ancestor
92785278|NCT01078974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785279|NCT01078974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92785280|NCT01078974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92785281|NCT01078974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92785282|NCT01078974|Growth Substances|growth substances|mesh-ancestor
92785283|NCT01078974|Growth Inhibitors|growth inhibitors|mesh-ancestor
92785284|NCT04307082|Ibrexafungerp|ibrexafungerp|mesh-list
92785285|NCT04307082|Antifungal Agents|antifungal agents|mesh-ancestor
92785286|NCT04307082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785287|NCT02878200|Piperaquine|piperaquine|mesh-list
92785288|NCT02878200|Artenimol|artenimol|mesh-list
92785289|NCT02878200|Antimalarials|antimalarials|mesh-ancestor
92785290|NCT02878200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92785291|NCT02878200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92785292|NCT02878200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785293|NCT04302012|Mydriatics|mydriatics|mesh-list
92785294|NCT04302012|Autonomic Agents|autonomic agents|mesh-ancestor
92785295|NCT04302012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785296|NCT04302012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785297|NCT00869557|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92785298|NCT00869557|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92785299|NCT00869557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92785300|NCT00869557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785301|NCT00869557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785302|NCT00869557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785303|NCT00869557|Antiviral Agents|antiviral agents|mesh-ancestor
92785304|NCT00869557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785305|NCT00869557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92785306|NCT00869557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92785307|NCT02781064|Atorvastatin|atorvastatin|mesh-list
92785308|NCT02781064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92785309|NCT02781064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92785310|NCT02781064|Antimetabolites|antimetabolites|mesh-ancestor
92785311|NCT02781064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785312|NCT02781064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92785313|NCT02781064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92785314|NCT02781064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785315|NCT04205682|Cannabidiol|cannabidiol|mesh-list
92785316|NCT04205682|Anticonvulsants|anticonvulsants|mesh-ancestor
92785317|NCT01134263|Vaccines|vaccines|mesh-list
92785318|NCT01134263|Immunologic Factors|immunologic factors|mesh-ancestor
92785319|NCT01134263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785320|NCT01199822|Olaratumab|olaratumab|mesh-list
92785321|NCT01199822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785322|NCT01096056|Vaccines|vaccines|mesh-list
92785323|NCT01096056|Immunologic Factors|immunologic factors|mesh-ancestor
92785324|NCT01096056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785325|NCT00866359|Apremilast|apremilast|mesh-list
92785326|NCT00866359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785327|NCT00866359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785328|NCT00866359|Analgesics|analgesics|mesh-ancestor
92785329|NCT00866359|Sensory System Agents|sensory system agents|mesh-ancestor
92785330|NCT00866359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785331|NCT00866359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785332|NCT00866359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785333|NCT00866359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785334|NCT00866359|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92785335|NCT00866359|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92785336|NCT00866359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785337|NCT00866359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785338|NCT01199198|Tolvaptan|tolvaptan|mesh-list
92785339|NCT01199198|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92785340|NCT01199198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785341|NCT01199198|Natriuretic Agents|natriuretic agents|mesh-ancestor
92785342|NCT01199198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785343|NCT05089708|Trifarotene|trifarotene|mesh-list
92785344|NCT05089708|Dermatologic Agents|dermatologic agents|mesh-ancestor
92785345|NCT01095978|Clarithromycin|clarithromycin|mesh-list
92785346|NCT01095978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92785347|NCT01095978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785348|NCT01095978|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92785349|NCT01095978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785350|NCT01095978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785351|NCT01095978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92785352|NCT01095978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92785353|NCT01134107|Insulin|insulin|mesh-list
92785354|NCT01134107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92785355|NCT01134107|Insulin Aspart|insulin aspart|mesh-list
92785356|NCT01134107|Insulin Lispro|insulin lispro|mesh-list
92785357|NCT01134107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785358|NCT01134107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785359|NCT01198574|Vitamins|vitamins|mesh-list
92785360|NCT01198574|Folic Acid|folic acid|mesh-list
92785361|NCT01198574|Vitamin A|vitamin a|mesh-list
92785362|NCT01198574|Iron|iron|mesh-list
92785363|NCT01198574|Retinol palmitate|retinol palmitate|mesh-list
92785364|NCT01198574|Micronutrients|micronutrients|mesh-ancestor
92703423|NCT00596050|Narcotics|narcotics|mesh-ancestor
92785365|NCT01198574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785366|NCT01198574|Trace Elements|trace elements|mesh-ancestor
92785367|NCT01198574|Hematinics|hematinics|mesh-ancestor
92785368|NCT01198574|Vitamin B Complex|vitamin b complex|mesh-ancestor
92785369|NCT01198574|Antioxidants|antioxidants|mesh-ancestor
92785370|NCT01198574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785371|NCT01198574|Protective Agents|protective agents|mesh-ancestor
92785372|NCT01198574|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92785373|NCT01198574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785374|NCT02580994|Carboplatin|carboplatin|mesh-list
92785375|NCT02580994|Pembrolizumab|pembrolizumab|mesh-list
92785376|NCT02580994|Etoposide|etoposide|mesh-list
92785377|NCT02580994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785378|NCT02580994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785379|NCT02580994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92785380|NCT02580994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785381|NCT02580994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92785382|NCT02580994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92785383|NCT02580994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92785384|NCT02580994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785385|NCT01198028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92785386|NCT01198028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785387|NCT01198028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785388|NCT01198028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785389|NCT01198028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785390|NCT01092780|Modafinil|modafinil|mesh-list
92430454|NCT03964090|Methotrexate|methotrexate|mesh-list
92785391|NCT01092780|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92785392|NCT01092780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785393|NCT01092780|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92785394|NCT01092780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92785395|NCT01092780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92785396|NCT01092780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785397|NCT05338606|Bimatoprost|bimatoprost|mesh-list
92785398|NCT05338606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92785399|NCT01092702|Varenicline|varenicline|mesh-list
92785400|NCT01092702|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92785401|NCT01092702|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92785402|NCT01092702|Cholinergic Agents|cholinergic agents|mesh-ancestor
92785403|NCT01092702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785404|NCT01092702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785405|NCT01092702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785406|NCT01092546|Flutemetamol|flutemetamol|mesh-list
92785407|NCT01092546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92785408|NCT01092546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785409|NCT02779348|Warfarin|warfarin|mesh-list
92785410|NCT02779348|Anticoagulants|anticoagulants|mesh-ancestor
92785411|NCT02779582|Progesterone|progesterone|mesh-list
92785412|NCT02779582|Progestins|progestins|mesh-ancestor
92785413|NCT02779582|Hormones|hormones|mesh-ancestor
92785414|NCT02779582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785415|NCT02779582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785416|NCT00634894|Letrozole|letrozole|mesh-list
92785417|NCT00634894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785418|NCT00634894|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92785419|NCT00634894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92785420|NCT00634894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785421|NCT00634894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785422|NCT00634894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92785423|NCT00634894|Hormone Antagonists|hormone antagonists|mesh-ancestor
92785424|NCT00634894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785425|NCT00634894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785426|NCT02779270|Sunscreening Agents|sunscreening agents|mesh-list
92785427|NCT02779270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92785428|NCT02779270|Protective Agents|protective agents|mesh-ancestor
92785429|NCT02779270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785430|NCT02779270|Dermatologic Agents|dermatologic agents|mesh-ancestor
92785431|NCT01078662|Olaparib|olaparib|mesh-list
92785432|NCT01078662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92785433|NCT01078662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785434|NCT01078662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785435|NCT01078662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785436|NCT04227886|Capecitabine|capecitabine|mesh-list
92785437|NCT04227886|Irinotecan|irinotecan|mesh-list
92785438|NCT04227886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92785439|NCT04227886|Antimetabolites|antimetabolites|mesh-ancestor
92785440|NCT04227886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785441|NCT04227886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785442|NCT04227886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92785443|NCT04227886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92785444|NCT04227886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785445|NCT02200978|Cytarabine|cytarabine|mesh-list
92785446|NCT02200978|Methotrexate|methotrexate|mesh-list
92785447|NCT02200978|Mercaptopurine|mercaptopurine|mesh-list
92785448|NCT02200978|Mitoxantrone|mitoxantrone|mesh-list
92785449|NCT02200978|Tretinoin|tretinoin|mesh-list
92785450|NCT02200978|Arsenic Trioxide|arsenic trioxide|mesh-list
92785451|NCT02200978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92785452|NCT02200978|Abortifacient Agents|abortifacient agents|mesh-ancestor
92785453|NCT02200978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92785454|NCT02200978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785455|NCT02200978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92785456|NCT02200978|Antimetabolites|antimetabolites|mesh-ancestor
92785457|NCT02200978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785458|NCT02200978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785459|NCT02200978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92785460|NCT02200978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785461|NCT02200978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92785462|NCT02200978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92785463|NCT02200978|Immunologic Factors|immunologic factors|mesh-ancestor
92785464|NCT02200978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785465|NCT02200978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785466|NCT02200978|Antiviral Agents|antiviral agents|mesh-ancestor
92785467|NCT02200978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785468|NCT02200978|Analgesics|analgesics|mesh-ancestor
92785469|NCT02200978|Sensory System Agents|sensory system agents|mesh-ancestor
92785470|NCT02200978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785471|NCT02200978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92785472|NCT02200978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92785473|NCT02200978|Keratolytic Agents|keratolytic agents|mesh-ancestor
92785474|NCT02779192|Ebselen|ebselen|mesh-list
92785475|NCT02779192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785476|NCT02779192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785477|NCT02779192|Analgesics|analgesics|mesh-ancestor
92785478|NCT02779192|Sensory System Agents|sensory system agents|mesh-ancestor
92785479|NCT02779192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785480|NCT02779192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785481|NCT02779192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785482|NCT02779192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785483|NCT02779192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92785484|NCT02779192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785485|NCT02779192|Antioxidants|antioxidants|mesh-ancestor
92785486|NCT02779192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785487|NCT02779192|Protective Agents|protective agents|mesh-ancestor
92785488|NCT02779192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785489|NCT02779192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785490|NCT02779192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92785491|NCT05020210|Sivelestat|sivelestat|mesh-list
92785492|NCT05020210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92785493|NCT05020210|Protease Inhibitors|protease inhibitors|mesh-ancestor
92785494|NCT05020210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785495|NCT05020210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785496|NCT04227808|Lenvatinib|lenvatinib|mesh-list
92785497|NCT04227808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785498|NCT04227808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785499|NCT04227808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785500|NCT04227808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785501|NCT01091454|Cisplatin|cisplatin|mesh-list
92785502|NCT01091454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785503|NCT01140347|Ramucirumab|ramucirumab|mesh-list
92785504|NCT01140347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785505|NCT04227652|Ibuprofen|ibuprofen|mesh-list
92785506|NCT04227652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785507|NCT04227652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785508|NCT04227652|Analgesics|analgesics|mesh-ancestor
92785509|NCT04227652|Sensory System Agents|sensory system agents|mesh-ancestor
92785510|NCT04227652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785511|NCT04227652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785512|NCT04227652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785513|NCT04227652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785514|NCT04227652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785515|NCT04227652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785516|NCT04227652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785517|NCT02883569|Ibuprofen|ibuprofen|mesh-list
92785518|NCT02883569|Aceclofenac|aceclofenac|mesh-list
92785519|NCT02883569|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92785520|NCT02883569|Tramadol|tramadol|mesh-list
92785521|NCT02883569|Codeine|codeine|mesh-list
92785522|NCT02883569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785523|NCT02883569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785524|NCT02883569|Analgesics|analgesics|mesh-ancestor
92785525|NCT02883569|Sensory System Agents|sensory system agents|mesh-ancestor
92785526|NCT02883569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785527|NCT02883569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785528|NCT02883569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785529|NCT02883569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785530|NCT02883569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785531|NCT02883569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785532|NCT02883569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785533|NCT02883569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92785534|NCT02883569|Narcotics|narcotics|mesh-ancestor
92785535|NCT02883569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785536|NCT02883569|Antitussive Agents|antitussive agents|mesh-ancestor
92785537|NCT02883569|Respiratory System Agents|respiratory system agents|mesh-ancestor
92785538|NCT02883023|Bleomycin|bleomycin|mesh-list
92785539|NCT02883023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92785540|NCT02883023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785541|NCT02778958|Acetaminophen|acetaminophen|mesh-list
92430603|NCT03634852|Glucocorticoids|glucocorticoids|mesh-ancestor
92785542|NCT02778958|Ibuprofen|ibuprofen|mesh-list
92785543|NCT02778958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785544|NCT02778958|Analgesics|analgesics|mesh-ancestor
92785545|NCT02778958|Sensory System Agents|sensory system agents|mesh-ancestor
92785546|NCT02778958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785547|NCT02778958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785548|NCT02778958|Antipyretics|antipyretics|mesh-ancestor
92785549|NCT02778958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785550|NCT02778958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785551|NCT02778958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785552|NCT02778958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785553|NCT02778958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785554|NCT02778958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785555|NCT01197560|Rituximab|rituximab|mesh-list
92785556|NCT01197560|Gemcitabine|gemcitabine|mesh-list
92785557|NCT01197560|Oxaliplatin|oxaliplatin|mesh-list
92785558|NCT01197560|Etoposide|etoposide|mesh-list
92785559|NCT01197560|Lenalidomide|lenalidomide|mesh-list
92785560|NCT01197560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785561|NCT01197560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785562|NCT01197560|Immunologic Factors|immunologic factors|mesh-ancestor
92785563|NCT01197560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785564|NCT01197560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785565|NCT01197560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92785566|NCT01197560|Antimetabolites|antimetabolites|mesh-ancestor
92785567|NCT01197560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785568|NCT01197560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92785569|NCT01197560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92785570|NCT01197560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92785571|NCT01197560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785572|NCT01197560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92785573|NCT01197560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92785574|NCT01197560|Growth Substances|growth substances|mesh-ancestor
92785575|NCT01197560|Growth Inhibitors|growth inhibitors|mesh-ancestor
92785576|NCT04940572|Valproic Acid|valproic acid|mesh-list
92785577|NCT04940572|Anticonvulsants|anticonvulsants|mesh-ancestor
92785578|NCT04940572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785579|NCT04940572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785580|NCT04940572|GABA Agents|gaba agents|mesh-ancestor
92785581|NCT04940572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785582|NCT04940572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785583|NCT04940572|Antimanic Agents|antimanic agents|mesh-ancestor
92785584|NCT04940572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92785585|NCT04940572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785586|NCT04940572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92785587|NCT01196078|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92785588|NCT01196078|Vinorelbine|vinorelbine|mesh-list
92785589|NCT01196078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785590|NCT01196078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785591|NCT01196078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785592|NCT01196078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785593|NCT01196078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92785594|NCT01196078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92785595|NCT01196078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92785596|NCT01196078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92785597|NCT05314660|Fluorides|fluorides|mesh-list
92785598|NCT05314660|Cariostatic Agents|cariostatic agents|mesh-ancestor
92785599|NCT05314660|Protective Agents|protective agents|mesh-ancestor
92785600|NCT05314660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785601|NCT04920292|Oxfendazole|oxfendazole|mesh-list
92785602|NCT04920292|Anthelmintics|anthelmintics|mesh-ancestor
92785603|NCT04920292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92785604|NCT04920292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785605|NCT04920292|Antinematodal Agents|antinematodal agents|mesh-ancestor
92785606|NCT04317872|Dexamethasone|dexamethasone|mesh-list
92785607|NCT04317872|Dexamethasone acetate|dexamethasone acetate|mesh-list
92785608|NCT04317872|BB 1101|bb 1101|mesh-list
92785609|NCT04317872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785610|NCT04317872|Antiemetics|antiemetics|mesh-ancestor
92785611|NCT04317872|Autonomic Agents|autonomic agents|mesh-ancestor
92785612|NCT04317872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785613|NCT04317872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785614|NCT04317872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785615|NCT04317872|Glucocorticoids|glucocorticoids|mesh-ancestor
92785616|NCT04317872|Hormones|hormones|mesh-ancestor
92785617|NCT04317872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785618|NCT04317872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92785619|NCT04317872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785620|NCT04317872|Protease Inhibitors|protease inhibitors|mesh-ancestor
92785621|NCT04317872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785622|NCT04317872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785623|NCT01132547|Cyproheptadine|cyproheptadine|mesh-list
92785624|NCT01132547|Antipruritics|antipruritics|mesh-ancestor
92785625|NCT01132547|Dermatologic Agents|dermatologic agents|mesh-ancestor
92785626|NCT01132547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785627|NCT01132547|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92785628|NCT01132547|Histamine Antagonists|histamine antagonists|mesh-ancestor
92785629|NCT01132547|Histamine Agents|histamine agents|mesh-ancestor
92785630|NCT01132547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785631|NCT01132547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785632|NCT01132547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785633|NCT01132547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92785634|NCT01132547|Serotonin Agents|serotonin agents|mesh-ancestor
92785635|NCT01132547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92785636|NCT01194830|Linagliptin|linagliptin|mesh-list
92785637|NCT01194830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785638|NCT01194830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785639|NCT01194830|Incretins|incretins|mesh-ancestor
92785640|NCT01194830|Hormones|hormones|mesh-ancestor
92785641|NCT01194830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785642|NCT01194830|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92785643|NCT01194830|Protease Inhibitors|protease inhibitors|mesh-ancestor
92785644|NCT01194830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785645|NCT01194830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785646|NCT02778178|Clonidine|clonidine|mesh-list
92785647|NCT02778178|Ropivacaine|ropivacaine|mesh-list
92785648|NCT02778178|Anesthetics, Local|anesthetics, local|mesh-ancestor
92785649|NCT02778178|Anesthetics|anesthetics|mesh-ancestor
92785650|NCT02778178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785651|NCT02778178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785652|NCT02778178|Sensory System Agents|sensory system agents|mesh-ancestor
92785653|NCT02778178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785654|NCT02778178|Analgesics|analgesics|mesh-ancestor
92785655|NCT02778178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92785656|NCT02778178|Sympatholytics|sympatholytics|mesh-ancestor
92785657|NCT02778178|Autonomic Agents|autonomic agents|mesh-ancestor
92785658|NCT02778178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92785659|NCT02778178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92785660|NCT02778178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92785661|NCT02778178|Adrenergic Agents|adrenergic agents|mesh-ancestor
92785662|NCT02778178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785663|NCT02778178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785664|NCT01194440|Zoledronic Acid|zoledronic acid|mesh-list
92785665|NCT01194440|Letrozole|letrozole|mesh-list
92785666|NCT01194440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785667|NCT01194440|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92785668|NCT01194440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92785669|NCT01194440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785670|NCT01194440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785671|NCT01194440|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92785672|NCT01194440|Hormone Antagonists|hormone antagonists|mesh-ancestor
92785673|NCT01194440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785674|NCT01194440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785675|NCT01194440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92785676|NCT04823052|Sulindac|sulindac|mesh-list
92785677|NCT04823052|Gaboxadol|gaboxadol|mesh-list
92785678|NCT04823052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785679|NCT04823052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785680|NCT04823052|Analgesics|analgesics|mesh-ancestor
92785681|NCT04823052|Sensory System Agents|sensory system agents|mesh-ancestor
92785682|NCT04823052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785683|NCT04823052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785684|NCT04823052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785685|NCT04823052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785686|NCT04823052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785687|NCT04823052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785688|NCT04823052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785689|NCT04823052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785690|NCT04823052|Anticonvulsants|anticonvulsants|mesh-ancestor
92785691|NCT04823052|GABA Agonists|gaba agonists|mesh-ancestor
92785693|NCT04823052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785694|NCT00951015|Efavirenz|efavirenz|mesh-list
92785695|NCT00951015|Dolutegravir|dolutegravir|mesh-list
92785696|NCT00951015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92785697|NCT00951015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785698|NCT00951015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785699|NCT00951015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785700|NCT00951015|Antiviral Agents|antiviral agents|mesh-ancestor
92785701|NCT00951015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785702|NCT00951015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92785703|NCT00951015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92785704|NCT00951015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92785705|NCT00951015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92785706|NCT00951015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92785707|NCT00951015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92785708|NCT00951015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92785709|NCT00951015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92785710|NCT00951015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92785711|NCT00951015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92785712|NCT02777866|Bupivacaine|bupivacaine|mesh-list
92785713|NCT02777866|Anesthetics, Local|anesthetics, local|mesh-ancestor
92785714|NCT02777866|Anesthetics|anesthetics|mesh-ancestor
92785715|NCT02777866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785716|NCT02777866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785717|NCT02777866|Sensory System Agents|sensory system agents|mesh-ancestor
92785718|NCT02777866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785719|NCT00626262|Esomeprazole|esomeprazole|mesh-list
92785720|NCT00626262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92785721|NCT00626262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785722|NCT00626262|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92785723|NCT00626262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785724|NCT00626262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785725|NCT02876796|Firsocostat|firsocostat|mesh-list
92785726|NCT02876796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785727|NCT02876796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785728|NCT01193660|Epoetin Alfa|epoetin alfa|mesh-list
92785729|NCT01193660|Hematinics|hematinics|mesh-ancestor
92785730|NCT02777788|Paclitaxel|paclitaxel|mesh-list
92785731|NCT02777788|Vinorelbine|vinorelbine|mesh-list
92785732|NCT02777788|Docetaxel|docetaxel|mesh-list
92785733|NCT02777788|Carboplatin|carboplatin|mesh-list
92785734|NCT02777788|Gemcitabine|gemcitabine|mesh-list
92785735|NCT02777788|Pemetrexed|pemetrexed|mesh-list
92785736|NCT02777788|Cisplatin|cisplatin|mesh-list
92785737|NCT02777788|Nedaplatin|nedaplatin|mesh-list
92785738|NCT02777788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92785739|NCT02777788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785740|NCT02777788|Tubulin Modulators|tubulin modulators|mesh-ancestor
92785741|NCT02777788|Antimitotic Agents|antimitotic agents|mesh-ancestor
92785742|NCT02777788|Mitosis Modulators|mitosis modulators|mesh-ancestor
92785743|NCT02777788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785744|NCT02777788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92785745|NCT02777788|Antimetabolites|antimetabolites|mesh-ancestor
92785746|NCT02777788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785747|NCT02777788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92785748|NCT02777788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785749|NCT01076166|Clarithromycin|clarithromycin|mesh-list
92785750|NCT01076166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92785751|NCT01076166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785752|NCT01076166|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92785753|NCT01076166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785754|NCT01076166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785755|NCT01076166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92785756|NCT01076166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92785757|NCT02777710|Durvalumab|durvalumab|mesh-list
92785758|NCT02777710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785759|NCT02777710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785760|NCT01193582|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92785761|NCT01193582|Immunologic Factors|immunologic factors|mesh-ancestor
92785762|NCT01193582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785763|NCT00602901|Naproxen|naproxen|mesh-list
92785764|NCT00602901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785765|NCT00602901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785766|NCT00602901|Analgesics|analgesics|mesh-ancestor
92785767|NCT00602901|Sensory System Agents|sensory system agents|mesh-ancestor
92430833|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785768|NCT00602901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785769|NCT00602901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785770|NCT00602901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785771|NCT00602901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785772|NCT00602901|Gout Suppressants|gout suppressants|mesh-ancestor
92785773|NCT00602901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785774|NCT00602901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785775|NCT00602901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785776|NCT01076088|Metformin|metformin|mesh-list
92785777|NCT01076088|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92785778|NCT01076088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785779|NCT01076088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785780|NCT01076088|Incretins|incretins|mesh-ancestor
92785781|NCT01076088|Hormones|hormones|mesh-ancestor
92785782|NCT01076088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785783|NCT01076088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92785784|NCT01076088|Protease Inhibitors|protease inhibitors|mesh-ancestor
92785785|NCT01076088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785786|NCT01076088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785787|NCT02777320|Acetaminophen|acetaminophen|mesh-list
92785788|NCT02777320|Ibuprofen|ibuprofen|mesh-list
92785789|NCT02777320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785790|NCT02777320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785791|NCT02777320|Analgesics|analgesics|mesh-ancestor
92785792|NCT02777320|Sensory System Agents|sensory system agents|mesh-ancestor
92785793|NCT02777320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785794|NCT02777320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785795|NCT02777320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785796|NCT02777320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785797|NCT02777320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92785798|NCT02777320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785799|NCT02777320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785800|NCT02777320|Antipyretics|antipyretics|mesh-ancestor
92785801|NCT01193348|Eculizumab|eculizumab|mesh-list
92785802|NCT01193348|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92785803|NCT01193348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92785804|NCT01193348|Immunologic Factors|immunologic factors|mesh-ancestor
92785805|NCT01193348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785806|NCT00945321|Aprepitant|aprepitant|mesh-list
92785807|NCT00945321|Fosaprepitant|fosaprepitant|mesh-list
92785808|NCT00945321|Antiemetics|antiemetics|mesh-ancestor
92785809|NCT00945321|Autonomic Agents|autonomic agents|mesh-ancestor
92785810|NCT00945321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785811|NCT00945321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785812|NCT00945321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92785813|NCT00945321|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92785814|NCT00945321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785815|NCT00945321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785816|NCT02776228|Brotizolam|brotizolam|mesh-list
92785817|NCT02776228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92785818|NCT02776228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785819|NCT02776228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785820|NCT04872790|Prednisone|prednisone|mesh-list
92785821|NCT04872790|Cortisone|cortisone|mesh-list
92785822|NCT04872790|Rituximab|rituximab|mesh-list
92785823|NCT04872790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92785824|NCT04872790|Methotrexate|methotrexate|mesh-list
92785825|NCT04872790|Venetoclax|venetoclax|mesh-list
92785826|NCT04872790|Dasatinib|dasatinib|mesh-list
92785827|NCT04872790|Antibodies|antibodies|mesh-list
92785828|NCT04872790|Immunoglobulins|immunoglobulins|mesh-list
92785829|NCT04872790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92785830|NCT04872790|Immunologic Factors|immunologic factors|mesh-ancestor
92785831|NCT04872790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785832|NCT04872790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785833|NCT04872790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785834|NCT04872790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785835|NCT04872790|Glucocorticoids|glucocorticoids|mesh-ancestor
92785836|NCT04872790|Hormones|hormones|mesh-ancestor
92785837|NCT04872790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785838|NCT04872790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92785839|NCT04872790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92785840|NCT04872790|Abortifacient Agents|abortifacient agents|mesh-ancestor
92785841|NCT04872790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92785842|NCT04872790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430904|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92785843|NCT04872790|Antimetabolites|antimetabolites|mesh-ancestor
92785844|NCT04872790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785845|NCT04872790|Dermatologic Agents|dermatologic agents|mesh-ancestor
92785846|NCT04872790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785847|NCT04872790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92785848|NCT04872790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92785849|NCT04872790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785850|NCT04872790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785851|NCT05382728|Osimertinib|osimertinib|mesh-list
92785852|NCT05382728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785853|NCT05382728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785854|NCT05382728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785855|NCT05382728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785856|NCT01192178|Fluticasone|fluticasone|mesh-list
92785858|NCT01192178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92785859|NCT01192178|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92785860|NCT01192178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92785861|NCT01192178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92785862|NCT01192178|Autonomic Agents|autonomic agents|mesh-ancestor
92785863|NCT01192178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785864|NCT01192178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785865|NCT01192178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92785866|NCT01192178|Respiratory System Agents|respiratory system agents|mesh-ancestor
92785867|NCT01192178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92785868|NCT01192178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92785869|NCT01192178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92785870|NCT01192178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92785871|NCT01192178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92785872|NCT01192178|Adrenergic Agents|adrenergic agents|mesh-ancestor
92785873|NCT01192178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92785874|NCT01192178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785875|NCT01192178|Glucocorticoids|glucocorticoids|mesh-ancestor
92785876|NCT01192178|Hormones|hormones|mesh-ancestor
92785877|NCT01192178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92785878|NCT01192178|Sympathomimetics|sympathomimetics|mesh-ancestor
92785879|NCT04193566|Dapagliflozin|dapagliflozin|mesh-list
92785880|NCT04193566|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92785881|NCT04193566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785882|NCT04193566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785883|NCT04193566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785884|NCT00869401|Temozolomide|temozolomide|mesh-list
92785885|NCT00869401|Dasatinib|dasatinib|mesh-list
92785886|NCT00869401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92785887|NCT00869401|Alkylating Agents|alkylating agents|mesh-ancestor
92785888|NCT00869401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785889|NCT00869401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785890|NCT00869401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785891|NCT00869401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785892|NCT01076010|Sorafenib|sorafenib|mesh-list
92785893|NCT01076010|Tivozanib|tivozanib|mesh-list
92785894|NCT01076010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785895|NCT01076010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92785896|NCT01076010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785897|NCT01076010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785898|NCT04225780|Ganciclovir|ganciclovir|mesh-list
92785899|NCT04225780|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92785900|NCT04225780|Antiviral Agents|antiviral agents|mesh-ancestor
92785901|NCT04225780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785902|NCT04225780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785903|NCT04225780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785904|NCT04225780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785905|NCT04045171|Tacrolimus|tacrolimus|mesh-list
92785906|NCT04045171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92785907|NCT04045171|Immunologic Factors|immunologic factors|mesh-ancestor
92785908|NCT04045171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785909|NCT04045171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92785910|NCT04045171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785911|NCT04045171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785912|NCT01075152|Lamivudine|lamivudine|mesh-list
92785913|NCT01075152|Zidovudine|zidovudine|mesh-list
92785914|NCT01075152|Efavirenz|efavirenz|mesh-list
92785915|NCT01075152|Stavudine|stavudine|mesh-list
92785916|NCT01075152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92430978|NCT03047005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785917|NCT01075152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92785918|NCT01075152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785919|NCT01075152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785920|NCT01075152|Antiviral Agents|antiviral agents|mesh-ancestor
92785921|NCT01075152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785922|NCT01075152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92785923|NCT01075152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92785924|NCT01075152|Antimetabolites|antimetabolites|mesh-ancestor
92785925|NCT01075152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92785926|NCT01075152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92785927|NCT01075152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92785928|NCT01075152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92785929|NCT01075152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92785930|NCT01075152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92785931|NCT04134637|Bupivacaine|bupivacaine|mesh-list
92785932|NCT04134637|Anesthetics, Local|anesthetics, local|mesh-ancestor
92785933|NCT04134637|Anesthetics|anesthetics|mesh-ancestor
92785934|NCT04134637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92785935|NCT04134637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785936|NCT04134637|Sensory System Agents|sensory system agents|mesh-ancestor
92785937|NCT04134637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785938|NCT02617849|Paclitaxel|paclitaxel|mesh-list
92785939|NCT02617849|Carboplatin|carboplatin|mesh-list
92785940|NCT02617849|Pembrolizumab|pembrolizumab|mesh-list
92785941|NCT02617849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92785942|NCT02617849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785943|NCT02617849|Tubulin Modulators|tubulin modulators|mesh-ancestor
92785944|NCT02617849|Antimitotic Agents|antimitotic agents|mesh-ancestor
92785945|NCT02617849|Mitosis Modulators|mitosis modulators|mesh-ancestor
92785946|NCT02617849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785947|NCT02617849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785948|NCT02617849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92785949|NCT00950859|Dolutegravir|dolutegravir|mesh-list
92785950|NCT00950859|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92785951|NCT00950859|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92785952|NCT00950859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92785953|NCT00950859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785954|NCT00950859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92785955|NCT00950859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92785956|NCT00950859|Antiviral Agents|antiviral agents|mesh-ancestor
92785957|NCT00950859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785958|NCT02775292|Aldesleukin|aldesleukin|mesh-list
92785959|NCT02775292|Cyclophosphamide|cyclophosphamide|mesh-list
92785960|NCT02775292|Nivolumab|nivolumab|mesh-list
92785961|NCT02775292|Fludarabine|fludarabine|mesh-list
92785962|NCT02775292|Fludarabine phosphate|fludarabine phosphate|mesh-list
92785963|NCT02775292|Interleukin-2|interleukin-2|mesh-list
92785964|NCT02775292|Vaccines|vaccines|mesh-list
92785965|NCT02775292|Immunologic Factors|immunologic factors|mesh-ancestor
92785966|NCT02775292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785967|NCT02775292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92785968|NCT02775292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92785969|NCT02775292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92785970|NCT02775292|Alkylating Agents|alkylating agents|mesh-ancestor
92785971|NCT02775292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92785972|NCT02775292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92785973|NCT02775292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92785974|NCT02775292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92785975|NCT02775292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92785976|NCT02775292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92785977|NCT02775292|Antimetabolites|antimetabolites|mesh-ancestor
92785978|NCT02775292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785979|NCT02775292|Analgesics|analgesics|mesh-ancestor
92785980|NCT02775292|Sensory System Agents|sensory system agents|mesh-ancestor
92785981|NCT02775292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785982|NCT02775292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92785983|NCT02775292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92785984|NCT02775292|Antiviral Agents|antiviral agents|mesh-ancestor
92785985|NCT02775292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92785986|NCT00862849|Insulin|insulin|mesh-list
92785987|NCT00862849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92785988|NCT00862849|Insulin Lispro|insulin lispro|mesh-list
92785989|NCT00862849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92785990|NCT00862849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785991|NCT01090050|Naproxen|naproxen|mesh-list
92785992|NCT01090050|Sumatriptan|sumatriptan|mesh-list
92785993|NCT01090050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92785994|NCT01090050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92785995|NCT01090050|Analgesics|analgesics|mesh-ancestor
92785996|NCT01090050|Sensory System Agents|sensory system agents|mesh-ancestor
92785997|NCT01090050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92785998|NCT01090050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92785999|NCT01090050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786000|NCT01090050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786001|NCT01090050|Gout Suppressants|gout suppressants|mesh-ancestor
92786002|NCT01090050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786003|NCT01090050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786004|NCT01090050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786005|NCT01090050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92786006|NCT01090050|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92786007|NCT01090050|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92786008|NCT01090050|Serotonin Agents|serotonin agents|mesh-ancestor
92786009|NCT01090050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786010|NCT02775370|Apatinib|apatinib|mesh-list
92786011|NCT02775370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786012|NCT02775370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786013|NCT02775370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786014|NCT02775370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786015|NCT04225468|Analgesics, Opioid|analgesics, opioid|mesh-list
92786016|NCT04225468|Narcotics|narcotics|mesh-ancestor
92786017|NCT04225468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786018|NCT04225468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786019|NCT04225468|Analgesics|analgesics|mesh-ancestor
92786020|NCT04225468|Sensory System Agents|sensory system agents|mesh-ancestor
92786021|NCT04225468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786022|NCT02855307|Insulin|insulin|mesh-list
92786023|NCT02855307|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92786024|NCT02855307|Hormones|hormones|mesh-list
92786025|NCT02855307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786026|NCT02855307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786027|NCT02855307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786028|NCT01077960|Hormones|hormones|mesh-list
92786029|NCT01077960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786030|NCT01077960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786031|NCT04269369|Fluorouracil|fluorouracil|mesh-list
92786032|NCT04269369|Antimetabolites|antimetabolites|mesh-ancestor
92786033|NCT04269369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786034|NCT04269369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92786035|NCT04269369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786036|NCT04269369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786037|NCT04269369|Immunologic Factors|immunologic factors|mesh-ancestor
92786038|NCT04269369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786039|NCT02776540|Aspirin|aspirin|mesh-list
92786040|NCT02776540|Clopidogrel|clopidogrel|mesh-list
92786041|NCT02776540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786042|NCT02776540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786043|NCT02776540|Analgesics|analgesics|mesh-ancestor
92786044|NCT02776540|Sensory System Agents|sensory system agents|mesh-ancestor
92786045|NCT02776540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786046|NCT02776540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786047|NCT02776540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786048|NCT02776540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786049|NCT02776540|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92786050|NCT02776540|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92786051|NCT02776540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786052|NCT02776540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92786053|NCT02776540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786054|NCT02776540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786055|NCT02776540|Antipyretics|antipyretics|mesh-ancestor
92786056|NCT02776540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92786057|NCT02776540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92786058|NCT02776540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92786059|NCT02776540|Purinergic Agents|purinergic agents|mesh-ancestor
92786060|NCT02776540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786061|NCT00944697|Oxycodone|oxycodone|mesh-list
92786062|NCT00944697|Naloxone|naloxone|mesh-list
92786063|NCT00944697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92786064|NCT00944697|Narcotics|narcotics|mesh-ancestor
92786065|NCT00944697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786066|NCT00944697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786067|NCT00944697|Analgesics|analgesics|mesh-ancestor
92786068|NCT00944697|Sensory System Agents|sensory system agents|mesh-ancestor
92786069|NCT00944697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786070|NCT00944697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92786071|NCT02878122|Carboplatin|carboplatin|mesh-list
92786072|NCT02878122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786073|NCT04807348|Metformin|metformin|mesh-list
92786074|NCT04807348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786075|NCT04807348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786076|NCT04224922|Paclitaxel|paclitaxel|mesh-list
92786077|NCT04224922|Cyclophosphamide|cyclophosphamide|mesh-list
92786078|NCT04224922|Epirubicin|epirubicin|mesh-list
92786079|NCT04224922|Carboplatin|carboplatin|mesh-list
92786080|NCT04224922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92786081|NCT04224922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786082|NCT04224922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92786083|NCT04224922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92786084|NCT04224922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92786085|NCT04224922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786086|NCT04224922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786087|NCT04224922|Immunologic Factors|immunologic factors|mesh-ancestor
92786088|NCT04224922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786089|NCT04224922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786090|NCT04224922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92786091|NCT04224922|Alkylating Agents|alkylating agents|mesh-ancestor
92786092|NCT04224922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92786093|NCT04224922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92786094|NCT04224922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92786095|NCT04224922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92786096|NCT04224922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786097|NCT02877888|Fluorides|fluorides|mesh-list
92786098|NCT02877888|Fluorides, Topical|fluorides, topical|mesh-list
92704148|NCT00552656|Sirolimus|sirolimus|mesh-list
92786099|NCT02877888|Cariostatic Agents|cariostatic agents|mesh-ancestor
92786100|NCT02877888|Protective Agents|protective agents|mesh-ancestor
92786101|NCT02877888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786102|NCT02772640|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92786103|NCT02772640|Ezetimibe|ezetimibe|mesh-list
92786104|NCT02772640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92786105|NCT02772640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92786106|NCT02772640|Antimetabolites|antimetabolites|mesh-ancestor
92786107|NCT02772640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786108|NCT02772640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92786109|NCT02772640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92786110|NCT02772640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786111|NCT02772718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92786112|NCT02772718|Immunologic Factors|immunologic factors|mesh-ancestor
92786113|NCT02772718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786114|NCT00866281|Midostaurin|midostaurin|mesh-list
92786115|NCT00866281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786116|NCT00866281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786117|NCT00866281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786118|NCT00866281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786119|NCT04121611|Aspirin|aspirin|mesh-list
92786120|NCT04121611|Heparin|heparin|mesh-list
92786121|NCT04121611|Calcium heparin|calcium heparin|mesh-list
92786122|NCT04121611|Anticoagulants|anticoagulants|mesh-ancestor
92786123|NCT04121611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92786124|NCT04121611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92786125|NCT04121611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786126|NCT04121611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786127|NCT04121611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786128|NCT04121611|Analgesics|analgesics|mesh-ancestor
92786129|NCT04121611|Sensory System Agents|sensory system agents|mesh-ancestor
92786130|NCT04121611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786131|NCT04121611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786132|NCT04121611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786133|NCT04121611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786134|NCT04121611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92786135|NCT04121611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786136|NCT04121611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786137|NCT04121611|Antipyretics|antipyretics|mesh-ancestor
92786138|NCT02771860|Denosumab|denosumab|mesh-list
92786140|NCT02771860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92786141|NCT02771860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786142|NCT02771860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92431206|NCT01703949|Immunotoxins|immunotoxins|mesh-ancestor
92786143|NCT02771782|Vaccines|vaccines|mesh-list
92786144|NCT02771782|BCG Vaccine|bcg vaccine|mesh-list
92786145|NCT02771782|Immunologic Factors|immunologic factors|mesh-ancestor
92786146|NCT02771782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786147|NCT02771782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92786148|NCT02771392|Tetracaine|tetracaine|mesh-list
92786149|NCT02771392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92786150|NCT02771392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92786151|NCT02771392|Anesthetics|anesthetics|mesh-ancestor
92786152|NCT02771392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786153|NCT02771392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786154|NCT02771392|Sensory System Agents|sensory system agents|mesh-ancestor
92704206|NCT04362527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786155|NCT02771392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786156|NCT02771704|Iodine|iodine|mesh-list
92786157|NCT02771704|Chlorhexidine|chlorhexidine|mesh-list
92786158|NCT02771704|Fluorides|fluorides|mesh-list
92786159|NCT02771704|Cariostatic Agents|cariostatic agents|mesh-ancestor
92786160|NCT02771704|Protective Agents|protective agents|mesh-ancestor
92786161|NCT02771704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786162|NCT02771704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92786163|NCT02771704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786164|NCT02771704|Disinfectants|disinfectants|mesh-ancestor
92786165|NCT02771704|Trace Elements|trace elements|mesh-ancestor
92786166|NCT02771704|Micronutrients|micronutrients|mesh-ancestor
92786167|NCT02771314|Osimertinib|osimertinib|mesh-list
92786168|NCT02771314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786169|NCT02771314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786170|NCT02771314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786171|NCT02771314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786172|NCT02771158|Midodrine|midodrine|mesh-list
92786173|NCT02771158|Sympathomimetics|sympathomimetics|mesh-ancestor
92786174|NCT02771158|Autonomic Agents|autonomic agents|mesh-ancestor
92786175|NCT02771158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786176|NCT02771158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786177|NCT02771158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92786178|NCT02771158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92786179|NCT02771158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92786180|NCT02771158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92786181|NCT02771158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786182|NCT02771158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786183|NCT02771158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786184|NCT02770690|Lidocaine|lidocaine|mesh-list
92786185|NCT02770690|Ethyl Chloride|ethyl chloride|mesh-list
92786186|NCT02770690|Anesthetics, Local|anesthetics, local|mesh-ancestor
92786187|NCT02770690|Anesthetics|anesthetics|mesh-ancestor
92786188|NCT02770690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786189|NCT02770690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786190|NCT02770690|Sensory System Agents|sensory system agents|mesh-ancestor
92786191|NCT02770690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786192|NCT02770690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92786193|NCT02770690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92786194|NCT02770690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92786195|NCT02770690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786196|NCT02770690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786197|NCT02770378|Ritonavir|ritonavir|mesh-list
92786198|NCT02770378|Itraconazole|itraconazole|mesh-list
92786199|NCT02770378|Minocycline|minocycline|mesh-list
92786200|NCT02770378|Celecoxib|celecoxib|mesh-list
92786201|NCT02770378|Temozolomide|temozolomide|mesh-list
92786202|NCT02770378|Auranofin|auranofin|mesh-list
92786203|NCT02770378|Captopril|captopril|mesh-list
92786204|NCT02770378|Disulfiram|disulfiram|mesh-list
92786205|NCT02770378|Aprepitant|aprepitant|mesh-list
92786206|NCT02770378|Sertraline|sertraline|mesh-list
92786207|NCT02770378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92786208|NCT02770378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92786209|NCT02770378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92786210|NCT02770378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786211|NCT02770378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786212|NCT02770378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92786213|NCT02770378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92786214|NCT02770378|Antiviral Agents|antiviral agents|mesh-ancestor
92786215|NCT02770378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786216|NCT02770378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92786217|NCT02770378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92786218|NCT02770378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92786219|NCT02770378|Alkylating Agents|alkylating agents|mesh-ancestor
92786220|NCT02770378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704259|NCT04687878|Insulin|insulin|mesh-list
92786221|NCT02770378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786222|NCT02770378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786223|NCT02770378|Analgesics|analgesics|mesh-ancestor
92786224|NCT02770378|Sensory System Agents|sensory system agents|mesh-ancestor
92786225|NCT02770378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786226|NCT02770378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786227|NCT02770378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786228|NCT02770378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786229|NCT02770378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92786230|NCT02770378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786231|NCT02770378|Antifungal Agents|antifungal agents|mesh-ancestor
92786232|NCT02770378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92786233|NCT02770378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92786234|NCT02770378|Hormone Antagonists|hormone antagonists|mesh-ancestor
92786235|NCT02770378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786236|NCT02770378|Antidepressive Agents|antidepressive agents|mesh-ancestor
92786237|NCT02770378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92786238|NCT02770378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92786239|NCT02770378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92786240|NCT02770378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786241|NCT02770378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786242|NCT02770378|Serotonin Agents|serotonin agents|mesh-ancestor
92786243|NCT02770378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786244|NCT02770378|Antiemetics|antiemetics|mesh-ancestor
92786245|NCT02770378|Autonomic Agents|autonomic agents|mesh-ancestor
92786246|NCT02770378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92786247|NCT02770378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92786248|NCT02770378|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92786249|NCT02770378|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92786250|NCT02770378|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92786251|NCT02770378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92786252|NCT02770222|Rifampin|rifampin|mesh-list
92786253|NCT02770222|Selexipag|selexipag|mesh-list
92786254|NCT02770222|Gemfibrozil|gemfibrozil|mesh-list
92786255|NCT02770222|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92786256|NCT02770222|Antitubercular Agents|antitubercular agents|mesh-ancestor
92786257|NCT02770222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786258|NCT02770222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786259|NCT02770222|Leprostatic Agents|leprostatic agents|mesh-ancestor
92786260|NCT02770222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92786261|NCT02770222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786262|NCT02770222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786263|NCT02770222|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92786264|NCT02770222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92786265|NCT02770222|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92786266|NCT02770222|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92786267|NCT02770222|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92786268|NCT02770222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92786269|NCT02770222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92786270|NCT02770222|Antimetabolites|antimetabolites|mesh-ancestor
92786271|NCT02770222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92786272|NCT02770222|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92786273|NCT02770222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92786274|NCT02770222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92786275|NCT00943917|Exenatide|exenatide|mesh-list
92786276|NCT00943917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786277|NCT00943917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786278|NCT00943917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92786279|NCT00943917|Incretins|incretins|mesh-ancestor
92786280|NCT00943917|Hormones|hormones|mesh-ancestor
92786281|NCT00943917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786282|NCT02876250|Cyclosporine|cyclosporine|mesh-list
92786283|NCT02876250|Cyclosporins|cyclosporins|mesh-list
92786284|NCT02876250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786285|NCT02876250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786286|NCT02876250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786287|NCT02876250|Immunologic Factors|immunologic factors|mesh-ancestor
92786288|NCT02876250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786289|NCT02876250|Antifungal Agents|antifungal agents|mesh-ancestor
92786290|NCT02876250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786291|NCT02876250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92786292|NCT02876250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431364|NCT01556698|Gasotransmitters|gasotransmitters|mesh-ancestor
92786293|NCT02876250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92786294|NCT02769910|Capsaicin|capsaicin|mesh-list
92786295|NCT02769910|Antipruritics|antipruritics|mesh-ancestor
92786296|NCT02769910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92786297|NCT02769910|Sensory System Agents|sensory system agents|mesh-ancestor
92786298|NCT02769910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786299|NCT02769910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786300|NCT02876484|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92786301|NCT02876484|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92786302|NCT02876484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92786303|NCT02876484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92786304|NCT02876484|Antimetabolites|antimetabolites|mesh-ancestor
92786305|NCT02876484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786306|NCT02876484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92786307|NCT02876484|Cathartics|cathartics|mesh-ancestor
92786308|NCT02876484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92786309|NCT02876094|Celecoxib|celecoxib|mesh-list
92786310|NCT02876094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786311|NCT02876094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786312|NCT02876094|Analgesics|analgesics|mesh-ancestor
92786313|NCT02876094|Sensory System Agents|sensory system agents|mesh-ancestor
92786314|NCT02876094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786315|NCT02876094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786316|NCT02876094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786317|NCT02876094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786318|NCT02876094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92786319|NCT02876094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786320|NCT02876094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786321|NCT02876094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786322|NCT00603135|Levetiracetam|levetiracetam|mesh-list
92786323|NCT00603135|Anticonvulsants|anticonvulsants|mesh-ancestor
92786324|NCT00603135|Nootropic Agents|nootropic agents|mesh-ancestor
92786325|NCT02769286|Osimertinib|osimertinib|mesh-list
92786326|NCT02769286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786327|NCT02769286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786328|NCT02769286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786329|NCT02769286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786330|NCT02855073|Hyaluronic Acid|hyaluronic acid|mesh-list
92786331|NCT02855073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92786332|NCT02855073|Immunologic Factors|immunologic factors|mesh-ancestor
92786333|NCT02855073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786334|NCT02855073|Viscosupplements|viscosupplements|mesh-ancestor
92786335|NCT02855073|Protective Agents|protective agents|mesh-ancestor
92786336|NCT02769130|Losartan|losartan|mesh-list
92786337|NCT02769130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92786338|NCT02769130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92786339|NCT02769130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92786340|NCT02769130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92786341|NCT02769130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786342|NCT02768740|Hydrocortisone|hydrocortisone|mesh-list
92786343|NCT02768740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92786344|NCT02768740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92786345|NCT02768740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92786346|NCT02768740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786347|NCT02851095|Metformin|metformin|mesh-list
92786348|NCT02851095|Canagliflozin|canagliflozin|mesh-list
92786349|NCT02851095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786350|NCT02851095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786351|NCT02851095|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92786352|NCT02851095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786353|NCT00580047|Calcium, Dietary|calcium, dietary|mesh-list
92786354|NCT00580047|Vitamin D|vitamin d|mesh-list
92786355|NCT00580047|Zoledronic Acid|zoledronic acid|mesh-list
92786356|NCT00580047|Alendronate|alendronate|mesh-list
92786357|NCT00580047|Calcium Carbonate|calcium carbonate|mesh-list
92786358|NCT00580047|Calcium|calcium|mesh-list
92786359|NCT00580047|Vitamins|vitamins|mesh-ancestor
92786360|NCT00580047|Micronutrients|micronutrients|mesh-ancestor
92786361|NCT00580047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786362|NCT00580047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92786363|NCT00580047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92786364|NCT00580047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431437|NCT01557257|Naltrexone|naltrexone|mesh-list
92786365|NCT00580047|Antacids|antacids|mesh-ancestor
92786366|NCT00580047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92786367|NCT01074450|Pramipexole|pramipexole|mesh-list
92786369|NCT01074450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786370|NCT01074450|Protective Agents|protective agents|mesh-ancestor
92786371|NCT01074450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786372|NCT01074450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92786373|NCT01074450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92786374|NCT01074450|Dopamine Agonists|dopamine agonists|mesh-ancestor
92786375|NCT01074450|Dopamine Agents|dopamine agents|mesh-ancestor
92786376|NCT01074450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786377|NCT02768116|Sirolimus|sirolimus|mesh-list
92786378|NCT02768116|Temsirolimus|temsirolimus|mesh-list
92786379|NCT02768116|MTOR Inhibitors|mtor inhibitors|mesh-list
92786380|NCT02768116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786381|NCT02768116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786382|NCT02768116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92786383|NCT02768116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786384|NCT02768116|Antifungal Agents|antifungal agents|mesh-ancestor
92786385|NCT02768116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786386|NCT02768116|Immunologic Factors|immunologic factors|mesh-ancestor
92786387|NCT02768116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786388|NCT02768116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786389|NCT02768116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786390|NCT02768116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786391|NCT00635284|Sirolimus|sirolimus|mesh-list
92786392|NCT00635284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786393|NCT00635284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786394|NCT00635284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92786395|NCT00635284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786396|NCT00635284|Antifungal Agents|antifungal agents|mesh-ancestor
92786397|NCT00635284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786398|NCT00635284|Immunologic Factors|immunologic factors|mesh-ancestor
92786399|NCT00635284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786400|NCT04131595|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92786401|NCT04131595|Antiviral Agents|antiviral agents|mesh-ancestor
92786402|NCT04131595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786403|NCT00699049|Solifenacin Succinate|solifenacin succinate|mesh-list
92786404|NCT00699049|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92786405|NCT00699049|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92786406|NCT00699049|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92786407|NCT00699049|Cholinergic Agents|cholinergic agents|mesh-ancestor
92786408|NCT00699049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786409|NCT00699049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786410|NCT00699049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786411|NCT00699049|Urological Agents|urological agents|mesh-ancestor
92786412|NCT00699049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92786413|NCT00699049|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786414|NCT04131283|Epinephrine|epinephrine|mesh-list
92786415|NCT04131283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92786416|NCT04131283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92786417|NCT04131283|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786418|NCT04131283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786419|NCT04131283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786420|NCT04131283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786421|NCT04131283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92786422|NCT04131283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92786423|NCT04131283|Autonomic Agents|autonomic agents|mesh-ancestor
92786424|NCT04131283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786425|NCT04131283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92786426|NCT04131283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92786427|NCT04131283|Mydriatics|mydriatics|mesh-ancestor
92786428|NCT04131283|Sympathomimetics|sympathomimetics|mesh-ancestor
92786429|NCT04131283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92786430|NCT00943761|Interferons|interferons|mesh-list
92786431|NCT00943761|Ribavirin|ribavirin|mesh-list
92786432|NCT00943761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786433|NCT00943761|Antiviral Agents|antiviral agents|mesh-ancestor
92786434|NCT00943761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786435|NCT00943761|Antimetabolites|antimetabolites|mesh-ancestor
92786436|NCT00943761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786437|NCT02617771|Vitamin D|vitamin d|mesh-list
92786438|NCT02617771|Cholecalciferol|cholecalciferol|mesh-list
92786440|NCT02617771|Micronutrients|micronutrients|mesh-ancestor
92786441|NCT02617771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786442|NCT02617771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92786443|NCT02617771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92786444|NCT02696590|Vitamin D|vitamin d|mesh-list
92786445|NCT02696590|Cholecalciferol|cholecalciferol|mesh-list
92786446|NCT02696590|Vitamins|vitamins|mesh-ancestor
92786447|NCT02696590|Micronutrients|micronutrients|mesh-ancestor
92786448|NCT02696590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786449|NCT02696590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92786450|NCT02696590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92786451|NCT02617459|Betaxolol|betaxolol|mesh-list
92786452|NCT02617459|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92786453|NCT02617459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92786454|NCT02617459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92786455|NCT02617459|Sympatholytics|sympatholytics|mesh-ancestor
92786456|NCT02617459|Autonomic Agents|autonomic agents|mesh-ancestor
92786457|NCT02617459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786458|NCT02617459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786459|NCT02617459|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92786460|NCT02617459|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92786461|NCT02617459|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92786462|NCT02617459|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786463|NCT02617459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786464|NCT02617459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786465|NCT02854995|Triamcinolone|triamcinolone|mesh-list
92786466|NCT02854995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786467|NCT02854995|Glucocorticoids|glucocorticoids|mesh-ancestor
92786468|NCT02854995|Hormones|hormones|mesh-ancestor
92704474|NCT00537420|Antidepressive Agents|antidepressive agents|mesh-ancestor
92786469|NCT02854995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786470|NCT02854995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786471|NCT02696512|Thioctic Acid|thioctic acid|mesh-list
92786472|NCT02696512|Minocycline|minocycline|mesh-list
92786473|NCT02696512|Lamotrigine|lamotrigine|mesh-list
92786474|NCT02696512|Flumazenil|flumazenil|mesh-list
92786475|NCT02696512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786476|NCT02696512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786477|NCT02696512|Anticonvulsants|anticonvulsants|mesh-ancestor
92786478|NCT02696512|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92786479|NCT02696512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786480|NCT02696512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786481|NCT02696512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92786482|NCT02696512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786483|NCT02696512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92786484|NCT02696512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92786485|NCT02696512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786486|NCT02696512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92786487|NCT02696512|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92786488|NCT02696512|Antioxidants|antioxidants|mesh-ancestor
92786489|NCT02696512|Protective Agents|protective agents|mesh-ancestor
92786490|NCT02696512|Vitamin B Complex|vitamin b complex|mesh-ancestor
92786491|NCT02696512|Vitamins|vitamins|mesh-ancestor
92786492|NCT02696512|Micronutrients|micronutrients|mesh-ancestor
92786493|NCT02696512|Antidotes|antidotes|mesh-ancestor
92786494|NCT02696512|GABA Modulators|gaba modulators|mesh-ancestor
92786495|NCT02696512|GABA Agents|gaba agents|mesh-ancestor
92786496|NCT02696512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786497|NCT00949533|Oseltamivir|oseltamivir|mesh-list
92786498|NCT00949533|Antiviral Agents|antiviral agents|mesh-ancestor
92786499|NCT00949533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786500|NCT00949533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786501|NCT00949533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786502|NCT02767258|Lubricant Eye Drops|lubricant eye drops|mesh-list
92786503|NCT02767258|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92786504|NCT02767258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92786505|NCT02854761|Vitamin D|vitamin d|mesh-list
92786506|NCT02854761|Vitamins|vitamins|mesh-ancestor
92786507|NCT02854761|Micronutrients|micronutrients|mesh-ancestor
92786508|NCT02854761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786509|NCT02854761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92786510|NCT00866047|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92786511|NCT00866047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92786512|NCT00866047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786513|NCT00866047|Immunotoxins|immunotoxins|mesh-ancestor
92786514|NCT00866047|Immunoconjugates|immunoconjugates|mesh-ancestor
92786515|NCT00866047|Immunologic Factors|immunologic factors|mesh-ancestor
92786516|NCT00866047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786518|NCT01706692|Adalimumab|adalimumab|mesh-list
92786519|NCT01706692|Infliximab|infliximab|mesh-list
92786520|NCT01706692|Etanercept|etanercept|mesh-list
92786521|NCT01706692|Methotrexate|methotrexate|mesh-list
92786522|NCT01706692|Ustekinumab|ustekinumab|mesh-list
92786523|NCT01706692|Cyclosporins|cyclosporins|mesh-list
92786524|NCT01706692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92786525|NCT01706692|Abortifacient Agents|abortifacient agents|mesh-ancestor
92786526|NCT01706692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92786527|NCT01706692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786528|NCT01706692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92786529|NCT01706692|Antimetabolites|antimetabolites|mesh-ancestor
92704534|NCT04515901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786530|NCT01706692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786531|NCT01706692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786532|NCT01706692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92786533|NCT01706692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786534|NCT01706692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92786535|NCT01706692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786536|NCT01706692|Immunologic Factors|immunologic factors|mesh-ancestor
92786537|NCT01706692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786538|NCT01706692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92786539|NCT01706692|Antifungal Agents|antifungal agents|mesh-ancestor
92786540|NCT01706692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786541|NCT01706692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92786542|NCT01706692|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92786543|NCT01706692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786544|NCT01706692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92786545|NCT01706692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786546|NCT01706692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786547|NCT01706692|Analgesics|analgesics|mesh-ancestor
92786548|NCT01706692|Sensory System Agents|sensory system agents|mesh-ancestor
92786549|NCT01706692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786550|NCT00869323|Rituximab|rituximab|mesh-list
92786551|NCT00869323|Bortezomib|bortezomib|mesh-list
92786552|NCT00869323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92786553|NCT00869323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786554|NCT00869323|Immunologic Factors|immunologic factors|mesh-ancestor
92786555|NCT00869323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786556|NCT00869323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786557|NCT02767102|Melatonin|melatonin|mesh-list
92786558|NCT02767102|Antioxidants|antioxidants|mesh-ancestor
92786559|NCT02767102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786560|NCT02767102|Protective Agents|protective agents|mesh-ancestor
92786561|NCT02767102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786562|NCT02767102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786563|NCT02774902|Clarithromycin|clarithromycin|mesh-list
92786564|NCT02774902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786565|NCT02774902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786566|NCT02774902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92786567|NCT02774902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786568|NCT02774902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786569|NCT02774902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92786570|NCT02774902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92786571|NCT02767024|Nitroprusside|nitroprusside|mesh-list
92786572|NCT02767024|Dobutamine|dobutamine|mesh-list
92786573|NCT02767024|Furosemide|furosemide|mesh-list
92786574|NCT02767024|Diuretics|diuretics|mesh-ancestor
92786575|NCT02767024|Natriuretic Agents|natriuretic agents|mesh-ancestor
92786576|NCT02767024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786577|NCT02767024|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92786578|NCT02767024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786579|NCT02767024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786580|NCT02767024|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92786581|NCT02767024|Sympathomimetics|sympathomimetics|mesh-ancestor
92786582|NCT02767024|Autonomic Agents|autonomic agents|mesh-ancestor
92786583|NCT02767024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786584|NCT02767024|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92786585|NCT02767024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92786586|NCT02767024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92786587|NCT02767024|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786588|NCT02767024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786589|NCT02767024|Protective Agents|protective agents|mesh-ancestor
92786590|NCT02767024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92786591|NCT02767024|Vasodilator Agents|vasodilator agents|mesh-ancestor
92786592|NCT02767024|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92786593|NCT02774200|Apatinib|apatinib|mesh-list
92786594|NCT02774200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431661|NCT01558648|Analgesics|analgesics|mesh-list
92786595|NCT02774200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786596|NCT02774200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786597|NCT02774200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786598|NCT02766634|Lenograstim|lenograstim|mesh-list
92786599|NCT02766634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92786600|NCT02766634|Immunologic Factors|immunologic factors|mesh-ancestor
92786601|NCT02766634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786602|NCT02774044|Beractant|beractant|mesh-list
92786603|NCT02774044|Goat lung surfactant extract|goat lung surfactant extract|mesh-list
92786604|NCT02774044|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92786605|NCT02774044|Respiratory System Agents|respiratory system agents|mesh-ancestor
92786606|NCT02766556|Dexmedetomidine|dexmedetomidine|mesh-list
92786607|NCT02766556|Ropivacaine|ropivacaine|mesh-list
92786608|NCT02766556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92786609|NCT02766556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786610|NCT02766556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786611|NCT02766556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786612|NCT02766556|Analgesics|analgesics|mesh-ancestor
92786613|NCT02766556|Sensory System Agents|sensory system agents|mesh-ancestor
92786614|NCT02766556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786615|NCT02766556|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92786616|NCT02766556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92786617|NCT02766556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92786618|NCT02766556|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786619|NCT02766556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786620|NCT02766556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786621|NCT02766556|Anesthetics, Local|anesthetics, local|mesh-ancestor
92786622|NCT02766556|Anesthetics|anesthetics|mesh-ancestor
92786623|NCT01191944|Pramipexole|pramipexole|mesh-list
92786624|NCT01191944|Antioxidants|antioxidants|mesh-ancestor
92786625|NCT01191944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786626|NCT01191944|Protective Agents|protective agents|mesh-ancestor
92786627|NCT01191944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786628|NCT01191944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92786629|NCT01191944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92786630|NCT01191944|Dopamine Agonists|dopamine agonists|mesh-ancestor
92786631|NCT01191944|Dopamine Agents|dopamine agents|mesh-ancestor
92786632|NCT01191944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786633|NCT00940875|Gemcitabine|gemcitabine|mesh-list
92786634|NCT00940875|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92786635|NCT00940875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92786636|NCT00940875|Antimetabolites|antimetabolites|mesh-ancestor
92786637|NCT00940875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786638|NCT00940875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786639|NCT00940875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786640|NCT00940875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786641|NCT02766322|Ethanol|ethanol|mesh-list
92786642|NCT02766322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92786643|NCT02766322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786644|NCT02766322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786645|NCT02766322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786646|NCT05655728|Metformin|metformin|mesh-list
92786647|NCT05655728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786648|NCT05655728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786649|NCT00940485|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92786650|NCT00940485|Entecavir|entecavir|mesh-list
92786651|NCT00940485|Antiviral Agents|antiviral agents|mesh-ancestor
92786652|NCT00940485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786653|NCT04317248|Cyclophosphamide|cyclophosphamide|mesh-list
92786654|NCT04317248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786655|NCT04317248|Immunologic Factors|immunologic factors|mesh-ancestor
92786656|NCT04317248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786657|NCT04317248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786658|NCT04317248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92786659|NCT04317248|Alkylating Agents|alkylating agents|mesh-ancestor
92786660|NCT04317248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786661|NCT04317248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786662|NCT04317248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92786663|NCT05655338|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92786664|NCT05655338|Amoxicillin|amoxicillin|mesh-list
92786665|NCT05655338|Metronidazole|metronidazole|mesh-list
92786666|NCT05655338|Anti-Infective Agents|anti-infective agents|mesh-list
92431721|NCT01559025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786667|NCT05655338|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92786668|NCT05655338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92786669|NCT01132313|Ribavirin|ribavirin|mesh-list
92786670|NCT01132313|Antimetabolites|antimetabolites|mesh-ancestor
92786671|NCT01132313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786672|NCT01132313|Antiviral Agents|antiviral agents|mesh-ancestor
92786673|NCT01132313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786674|NCT00422565|Sirolimus|sirolimus|mesh-list
92786675|NCT00422565|Paclitaxel|paclitaxel|mesh-list
92786676|NCT00422565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92786677|NCT00422565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786678|NCT00422565|Tubulin Modulators|tubulin modulators|mesh-ancestor
92786679|NCT00422565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92786680|NCT00422565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92786681|NCT00422565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786682|NCT00422565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786683|NCT00422565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786684|NCT00422565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92786685|NCT00422565|Antifungal Agents|antifungal agents|mesh-ancestor
92786686|NCT00422565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786687|NCT00422565|Immunologic Factors|immunologic factors|mesh-ancestor
92786688|NCT00422565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786689|NCT04316936|Dexamethasone|dexamethasone|mesh-list
92786690|NCT04316936|Prednisolone|prednisolone|mesh-list
92786691|NCT04316936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92786692|NCT04316936|Methylprednisolone|methylprednisolone|mesh-list
92786693|NCT04316936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92786694|NCT04316936|Prednisolone acetate|prednisolone acetate|mesh-list
92786695|NCT04316936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92786696|NCT04316936|Prednisolone phosphate|prednisolone phosphate|mesh-list
92786697|NCT04316936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786698|NCT04316936|Antiemetics|antiemetics|mesh-ancestor
92786699|NCT04316936|Autonomic Agents|autonomic agents|mesh-ancestor
92786700|NCT04316936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786701|NCT04316936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786702|NCT04316936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92786703|NCT04316936|Glucocorticoids|glucocorticoids|mesh-ancestor
92786704|NCT04316936|Hormones|hormones|mesh-ancestor
92786705|NCT04316936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786706|NCT04316936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92786707|NCT04316936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704865|NCT05264142|Serotonin Agents|serotonin agents|mesh-ancestor
92786708|NCT04316936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92786709|NCT04316936|Protective Agents|protective agents|mesh-ancestor
92786710|NCT00861757|Tadalafil|tadalafil|mesh-list
92786711|NCT00861757|Tamsulosin|tamsulosin|mesh-list
92786712|NCT00861757|Vasodilator Agents|vasodilator agents|mesh-ancestor
92786713|NCT00861757|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92786714|NCT00861757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92786715|NCT00861757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786716|NCT00861757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786717|NCT00861757|Urological Agents|urological agents|mesh-ancestor
92786718|NCT00861757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92786719|NCT00861757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92786720|NCT00861757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92786721|NCT00861757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786722|NCT00861757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786723|NCT00861757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786724|NCT02762812|Infliximab|infliximab|mesh-list
92786725|NCT02762812|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92786726|NCT02762812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786727|NCT02762812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92786728|NCT02762812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92786729|NCT02762812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786730|NCT02762890|Iodine|iodine|mesh-list
92786731|NCT02762890|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92786732|NCT02762890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786733|NCT02762890|Trace Elements|trace elements|mesh-ancestor
92786734|NCT02762890|Micronutrients|micronutrients|mesh-ancestor
92786735|NCT02762890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786736|NCT02613715|Ethanol|ethanol|mesh-list
92786737|NCT02613715|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92786738|NCT02613715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786739|NCT02613715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786740|NCT02613715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786742|NCT02762656|Anesthetics, Local|anesthetics, local|mesh-ancestor
92786743|NCT02762656|Anesthetics|anesthetics|mesh-ancestor
92786744|NCT02762656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786745|NCT02762656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786746|NCT02762656|Sensory System Agents|sensory system agents|mesh-ancestor
92786747|NCT02762656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786748|NCT02762656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92786749|NCT02762656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92786750|NCT02762656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92786751|NCT02762656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786752|NCT02762656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786754|NCT00637325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92786755|NCT00637325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786756|NCT02762344|Heparin|heparin|mesh-list
92786757|NCT02762344|Anticoagulants|anticoagulants|mesh-ancestor
92786758|NCT02762344|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92786759|NCT02762344|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92786760|NCT02762344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786761|NCT04663282|Insulin|insulin|mesh-list
92786762|NCT04663282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786763|NCT04663282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786764|NCT01130597|Spironolactone|spironolactone|mesh-list
92786765|NCT01130597|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92786766|NCT01130597|Hormone Antagonists|hormone antagonists|mesh-ancestor
92786767|NCT01130597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786768|NCT01130597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786769|NCT01130597|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92786770|NCT01130597|Diuretics|diuretics|mesh-ancestor
92786771|NCT01130597|Natriuretic Agents|natriuretic agents|mesh-ancestor
92786772|NCT00939003|Adalimumab|adalimumab|mesh-list
92704899|NCT03851588|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92786773|NCT00939003|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92786774|NCT00939003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786775|NCT00939003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786776|NCT01188668|Aripiprazole|aripiprazole|mesh-list
92786777|NCT01188668|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92786778|NCT01188668|Antidepressive Agents|antidepressive agents|mesh-ancestor
92786779|NCT01188668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92786780|NCT01188668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92786781|NCT01188668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92786782|NCT01188668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786783|NCT01188668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786784|NCT01188668|Dopamine Agonists|dopamine agonists|mesh-ancestor
92786785|NCT01188668|Dopamine Agents|dopamine agents|mesh-ancestor
92786786|NCT01188668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786787|NCT01188668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786788|NCT01188668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92786789|NCT01188668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92786790|NCT01188668|Serotonin Agents|serotonin agents|mesh-ancestor
92786791|NCT01188668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92786792|NCT01188668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92786793|NCT01188668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92786794|NCT01188668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92786795|NCT01188668|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92786796|NCT01188668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92786797|NCT01188668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786798|NCT01130051|Colchicine|colchicine|mesh-list
92786799|NCT01130051|Gout Suppressants|gout suppressants|mesh-ancestor
92786800|NCT01130051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786801|NCT01130051|Tubulin Modulators|tubulin modulators|mesh-ancestor
92786802|NCT01130051|Antimitotic Agents|antimitotic agents|mesh-ancestor
92786803|NCT01130051|Mitosis Modulators|mitosis modulators|mesh-ancestor
92786804|NCT01130051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786805|NCT01130051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786806|NCT00865189|Leucovorin|leucovorin|mesh-list
92786807|NCT00865189|Folic Acid|folic acid|mesh-list
92786808|NCT00865189|Bevacizumab|bevacizumab|mesh-list
92786809|NCT00865189|Fluorouracil|fluorouracil|mesh-list
92786810|NCT00865189|Oxaliplatin|oxaliplatin|mesh-list
92786811|NCT00865189|Levoleucovorin|levoleucovorin|mesh-list
92786812|NCT00865189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92786813|NCT00865189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786814|NCT00865189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92733265|NCT01604187|Narcotics|narcotics|mesh-ancestor
92786815|NCT00865189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92786817|NCT00865189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786818|NCT00865189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92431872|NCT05570084|Tamsulosin|tamsulosin|mesh-list
92786819|NCT00865189|Antimetabolites|antimetabolites|mesh-ancestor
92786820|NCT00865189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786821|NCT00865189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92786822|NCT00865189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92786823|NCT00865189|Immunologic Factors|immunologic factors|mesh-ancestor
92786824|NCT00865189|Antidotes|antidotes|mesh-ancestor
92786825|NCT00865189|Protective Agents|protective agents|mesh-ancestor
92786826|NCT00865189|Vitamin B Complex|vitamin b complex|mesh-ancestor
92786827|NCT00865189|Vitamins|vitamins|mesh-ancestor
92786828|NCT00865189|Micronutrients|micronutrients|mesh-ancestor
92786829|NCT00865189|Hematinics|hematinics|mesh-ancestor
92786830|NCT05362292|Mirabegron|mirabegron|mesh-list
92786831|NCT05362292|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92786832|NCT05362292|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92786833|NCT05362292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92786834|NCT05362292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92786835|NCT05362292|Adrenergic Agents|adrenergic agents|mesh-ancestor
92786836|NCT05362292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786837|NCT05362292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786838|NCT05362292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786839|NCT05362292|Urological Agents|urological agents|mesh-ancestor
92786840|NCT05362292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92786841|NCT05362292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92786842|NCT05362292|Cholinergic Agents|cholinergic agents|mesh-ancestor
92786843|NCT00698269|Insulin|insulin|mesh-list
92786844|NCT00698269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92786845|NCT00698269|Insulin Aspart|insulin aspart|mesh-list
92786846|NCT00698269|Insulin, Long-Acting|insulin, long-acting|mesh-list
92786847|NCT00698269|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92786848|NCT00698269|Insulin Detemir|insulin detemir|mesh-list
92786849|NCT00698269|Biphasic Insulins|biphasic insulins|mesh-list
92786850|NCT00698269|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92786851|NCT00698269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92786852|NCT00698269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786853|NCT01182194|Drospirenone|drospirenone|mesh-list
92786854|NCT01182194|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92786855|NCT01182194|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92786856|NCT01182194|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92786857|NCT01182194|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92786858|NCT01182194|Estradiol|estradiol|mesh-list
92786859|NCT01182194|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92786860|NCT01182194|Estrogens|estrogens|mesh-ancestor
92786861|NCT01182194|Hormones|hormones|mesh-ancestor
92786862|NCT01182194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786863|NCT01182194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786864|NCT01182194|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92786865|NCT01182194|Contraceptive Agents|contraceptive agents|mesh-ancestor
92786866|NCT01182194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92786867|NCT01182194|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92786868|NCT01182194|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92786869|NCT01182194|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92786870|NCT01182194|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92786871|NCT01182194|Hormone Antagonists|hormone antagonists|mesh-ancestor
92786872|NCT01182194|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92786873|NCT01182194|Diuretics|diuretics|mesh-ancestor
92786874|NCT01182194|Natriuretic Agents|natriuretic agents|mesh-ancestor
92786875|NCT01181726|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92786876|NCT01181726|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92786877|NCT01181726|Norethindrone|norethindrone|mesh-list
92786878|NCT01181726|Norethindrone Acetate|norethindrone acetate|mesh-list
92786879|NCT01181726|Estradiol|estradiol|mesh-list
92786880|NCT01181726|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92786881|NCT01181726|Estrogens|estrogens|mesh-ancestor
92786882|NCT01181726|Hormones|hormones|mesh-ancestor
92786883|NCT01181726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786884|NCT01181726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786885|NCT01181726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92786886|NCT01181726|Contraceptive Agents|contraceptive agents|mesh-ancestor
92786887|NCT01181726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92786888|NCT01181726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92786889|NCT01181726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92786891|NCT01181726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92786892|NCT01137071|Antibodies|antibodies|mesh-list
92786893|NCT01137071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431946|NCT05522582|Methotrexate|methotrexate|mesh-list
92786894|NCT01137071|Immunologic Factors|immunologic factors|mesh-ancestor
92786895|NCT01137071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786896|NCT00603759|Celecoxib|celecoxib|mesh-list
92786897|NCT00603759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786898|NCT00603759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786899|NCT00603759|Analgesics|analgesics|mesh-ancestor
92786900|NCT00603759|Sensory System Agents|sensory system agents|mesh-ancestor
92786901|NCT00603759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786902|NCT00603759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786903|NCT00603759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786904|NCT00603759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786905|NCT00603759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92786906|NCT00603759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786907|NCT00603759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786908|NCT00603759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786909|NCT04130815|Furosemide|furosemide|mesh-list
92786910|NCT04130815|Diuretics|diuretics|mesh-ancestor
92786911|NCT04130815|Natriuretic Agents|natriuretic agents|mesh-ancestor
92786912|NCT04130815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786913|NCT04130815|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92786914|NCT04130815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786915|NCT04130815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786916|NCT04256265|Risdiplam|risdiplam|mesh-list
92786917|NCT04256265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92786918|NCT04256265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786919|NCT04256265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786920|NCT04312061|Tramadol|tramadol|mesh-list
92786921|NCT04312061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92786922|NCT04312061|Narcotics|narcotics|mesh-ancestor
92786923|NCT04312061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92786924|NCT04312061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786925|NCT04312061|Analgesics|analgesics|mesh-ancestor
92786926|NCT04312061|Sensory System Agents|sensory system agents|mesh-ancestor
92786927|NCT04312061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786928|NCT00860743|Antioxidants|antioxidants|mesh-list
92786929|NCT00860743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786930|NCT00860743|Protective Agents|protective agents|mesh-ancestor
92786931|NCT00860743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786932|NCT01186796|Fulvestrant|fulvestrant|mesh-list
92786933|NCT01186796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92786934|NCT01186796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786935|NCT01186796|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92786936|NCT01186796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92786937|NCT01186796|Hormone Antagonists|hormone antagonists|mesh-ancestor
92786938|NCT01186796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786939|NCT01186796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786940|NCT05383131|Pirfenidone|pirfenidone|mesh-list
92786941|NCT05383131|Nintedanib|nintedanib|mesh-list
92786942|NCT05383131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92786943|NCT05383131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92786944|NCT05383131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786945|NCT05383131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786946|NCT05383131|Analgesics|analgesics|mesh-ancestor
92786947|NCT05383131|Sensory System Agents|sensory system agents|mesh-ancestor
92786948|NCT05383131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786949|NCT05383131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786950|NCT05383131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786951|NCT05383131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786952|NCT05383131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786953|NCT05383131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786954|NCT02761486|Aspirin|aspirin|mesh-list
92786955|NCT02761486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92786956|NCT02761486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92786957|NCT02761486|Analgesics|analgesics|mesh-ancestor
92786958|NCT02761486|Sensory System Agents|sensory system agents|mesh-ancestor
92786959|NCT02761486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92786960|NCT02761486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786961|NCT02761486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92786962|NCT02761486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92786963|NCT02761486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92786964|NCT02761486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92786965|NCT02761486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786966|NCT02761486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92786967|NCT02761486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92786968|NCT02761486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786969|NCT02761486|Antipyretics|antipyretics|mesh-ancestor
92786970|NCT02882789|Delpazolid|delpazolid|mesh-list
92786971|NCT02882789|Oxazolidinones|oxazolidinones|mesh-list
92786972|NCT02882789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92786973|NCT02882789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786974|NCT02882789|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92786975|NCT02882789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786976|NCT02882789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786977|NCT00940017|Voriconazole|voriconazole|mesh-list
92786978|NCT00940017|Anidulafungin|anidulafungin|mesh-list
92786979|NCT00940017|Antifungal Agents|antifungal agents|mesh-ancestor
92786980|NCT00940017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92786981|NCT00940017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92786982|NCT00940017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92786983|NCT00940017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92786984|NCT00940017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786985|NCT00940017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92786986|NCT00940017|Hormone Antagonists|hormone antagonists|mesh-ancestor
92786987|NCT00940017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92786988|NCT00940017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786989|NCT00940017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92786990|NCT01129583|Botulinum Toxins|botulinum toxins|mesh-list
92786991|NCT01129583|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92786992|NCT01129583|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92786993|NCT01129583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92786994|NCT01129583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92786995|NCT01129583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92786996|NCT01129583|Cholinergic Agents|cholinergic agents|mesh-ancestor
92786997|NCT01129583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92786998|NCT01129583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92786999|NCT01129583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92787000|NCT01129583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787001|NCT01186328|Cytarabine|cytarabine|mesh-list
92787002|NCT01186328|Prednisone|prednisone|mesh-list
92787003|NCT01186328|Hydrocortisone|hydrocortisone|mesh-list
92787004|NCT01186328|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92787005|NCT01186328|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92787006|NCT01186328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92787007|NCT01186328|Cortisone|cortisone|mesh-list
92787008|NCT01186328|Doxorubicin|doxorubicin|mesh-list
92787009|NCT01186328|Methotrexate|methotrexate|mesh-list
92787010|NCT01186328|Vincristine|vincristine|mesh-list
92787011|NCT01186328|Asparaginase|asparaginase|mesh-list
92787012|NCT01186328|Pegaspargase|pegaspargase|mesh-list
92787013|NCT01186328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92787014|NCT01186328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787015|NCT01186328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92787016|NCT01186328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92787017|NCT01186328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787018|NCT01186328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787019|NCT01186328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787020|NCT01186328|Glucocorticoids|glucocorticoids|mesh-ancestor
92787021|NCT01186328|Hormones|hormones|mesh-ancestor
92787022|NCT01186328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787023|NCT01186328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787024|NCT01186328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787025|NCT01186328|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92787026|NCT01186328|Abortifacient Agents|abortifacient agents|mesh-ancestor
92787027|NCT01186328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787028|NCT01186328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92787029|NCT01186328|Antimetabolites|antimetabolites|mesh-ancestor
92787030|NCT01186328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92787031|NCT01186328|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92787032|NCT01186328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787033|NCT01186328|Immunologic Factors|immunologic factors|mesh-ancestor
92787034|NCT01186328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787035|NCT01186328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92787036|NCT01186328|Antiviral Agents|antiviral agents|mesh-ancestor
92787037|NCT01186328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787038|NCT01186328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92787039|NCT01186328|Tubulin Modulators|tubulin modulators|mesh-ancestor
92787040|NCT01186328|Antimitotic Agents|antimitotic agents|mesh-ancestor
92432095|NCT04464265|Propofol|propofol|mesh-list
92787041|NCT01186328|Mitosis Modulators|mitosis modulators|mesh-ancestor
92787042|NCT00848497|Methyltestosterone|methyltestosterone|mesh-list
92787043|NCT00848497|Sildenafil Citrate|sildenafil citrate|mesh-list
92787044|NCT00848497|Testosterone|testosterone|mesh-list
92787045|NCT00848497|Testosterone undecanoate|testosterone undecanoate|mesh-list
92787046|NCT00848497|Testosterone enanthate|testosterone enanthate|mesh-list
92787047|NCT00848497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92787048|NCT00848497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787049|NCT00848497|Androgens|androgens|mesh-ancestor
92787050|NCT00848497|Hormones|hormones|mesh-ancestor
92787051|NCT00848497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787052|NCT00848497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787053|NCT00848497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787054|NCT00848497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787055|NCT00848497|Anabolic Agents|anabolic agents|mesh-ancestor
92787056|NCT00848497|Vasodilator Agents|vasodilator agents|mesh-ancestor
92787057|NCT00848497|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92787058|NCT00848497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92787059|NCT00848497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787060|NCT00848497|Urological Agents|urological agents|mesh-ancestor
92787061|NCT02763592|Lidocaine|lidocaine|mesh-list
92787062|NCT02763592|Anesthetics, Local|anesthetics, local|mesh-ancestor
92787063|NCT02763592|Anesthetics|anesthetics|mesh-ancestor
92787064|NCT02763592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787065|NCT02763592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787066|NCT02763592|Sensory System Agents|sensory system agents|mesh-ancestor
92787067|NCT02763592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787068|NCT02763592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92787069|NCT02763592|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92787070|NCT02763592|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92787071|NCT02763592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787072|NCT02763592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787073|NCT01185782|Gonadotropins, Pituitary|gonadotropins, pituitary|mesh-list
92787074|NCT01185782|Hormones|hormones|mesh-list
92787075|NCT01185782|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92787076|NCT01185782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787077|NCT01185782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787078|NCT01185782|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92787079|NCT01185782|Fertility Agents|fertility agents|mesh-ancestor
92787080|NCT01185782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787081|NCT01185782|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92787082|NCT02761174|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92787083|NCT02761174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92787084|NCT02761174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92787085|NCT02761174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92787086|NCT02761174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92787087|NCT02761174|Adrenergic Agents|adrenergic agents|mesh-ancestor
92787088|NCT02761174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787089|NCT02761174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787090|NCT02761174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787091|NCT02882555|Capsaicin|capsaicin|mesh-list
92787092|NCT02882555|Antipruritics|antipruritics|mesh-ancestor
92787093|NCT02882555|Dermatologic Agents|dermatologic agents|mesh-ancestor
92787094|NCT02882555|Sensory System Agents|sensory system agents|mesh-ancestor
92787095|NCT02882555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787096|NCT02882555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787097|NCT00699361|Pantoprazole|pantoprazole|mesh-list
92787098|NCT00699361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92787099|NCT00699361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787100|NCT00699361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92787101|NCT00699361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787102|NCT00699361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787103|NCT01185704|Cetrorelix|cetrorelix|mesh-list
92787104|NCT01185704|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92787105|NCT01185704|Hormones|hormones|mesh-list
92787106|NCT01185704|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92977201|NCT02553044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92787107|NCT01185704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787108|NCT01185704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787109|NCT01185704|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92787110|NCT01185704|Fertility Agents|fertility agents|mesh-ancestor
92787111|NCT01185704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787112|NCT01185704|Hormone Antagonists|hormone antagonists|mesh-ancestor
92787113|NCT01128959|Carbamazepine|carbamazepine|mesh-list
92432170|NCT04182672|Triamcinolone|triamcinolone|mesh-list
92787114|NCT01128959|Anticonvulsants|anticonvulsants|mesh-ancestor
92787115|NCT01128959|Antimanic Agents|antimanic agents|mesh-ancestor
92787116|NCT01128959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92787117|NCT01128959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787118|NCT01128959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787119|NCT01128959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92787120|NCT01128959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92787121|NCT01128959|Analgesics|analgesics|mesh-ancestor
92787122|NCT01128959|Sensory System Agents|sensory system agents|mesh-ancestor
92787123|NCT01128959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787124|NCT01128959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92787125|NCT01128959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787126|NCT01128959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787127|NCT01128959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92787128|NCT01128959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92787129|NCT04119739|Ibuprofen|ibuprofen|mesh-list
92787130|NCT04119739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92787131|NCT04119739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92787132|NCT04119739|Analgesics|analgesics|mesh-ancestor
92787133|NCT04119739|Sensory System Agents|sensory system agents|mesh-ancestor
92787134|NCT04119739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787135|NCT04119739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787136|NCT04119739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787137|NCT04119739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787138|NCT04119739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92787139|NCT04119739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787140|NCT04119739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787141|NCT00859573|Modafinil|modafinil|mesh-list
92787142|NCT00859573|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92787143|NCT00859573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787144|NCT00859573|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92787145|NCT00859573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92787146|NCT00859573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92787147|NCT00859573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787148|NCT02758444|Micronutrients|micronutrients|mesh-list
92787149|NCT02758444|Trace Elements|trace elements|mesh-list
92787150|NCT02758444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787151|NCT01185548|Tolbutamide|tolbutamide|mesh-list
92787152|NCT01185548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92787153|NCT01185548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787154|NCT01128569|Fluticasone|fluticasone|mesh-list
92787155|NCT01128569|Xhance|xhance|mesh-list
92787156|NCT01128569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787157|NCT01128569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92787158|NCT01128569|Autonomic Agents|autonomic agents|mesh-ancestor
92787159|NCT01128569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787160|NCT01128569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787161|NCT01128569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92787162|NCT01128569|Respiratory System Agents|respiratory system agents|mesh-ancestor
92787163|NCT01128569|Dermatologic Agents|dermatologic agents|mesh-ancestor
92787164|NCT01128569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92787165|NCT04582942|Lactulose|lactulose|mesh-list
92787166|NCT04582942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787167|NCT02883179|Lidocaine|lidocaine|mesh-list
92787168|NCT02883179|Prilocaine|prilocaine|mesh-list
92787169|NCT02883179|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92787170|NCT02883179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92787171|NCT02883179|Anesthetics|anesthetics|mesh-ancestor
92787172|NCT02883179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787173|NCT02883179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787174|NCT02883179|Sensory System Agents|sensory system agents|mesh-ancestor
92787175|NCT02883179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787176|NCT02883179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92787177|NCT02883179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92787178|NCT02883179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92787179|NCT02883179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787180|NCT02883179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787181|NCT02883179|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92787183|NCT02758366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92787184|NCT02758366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787185|NCT02758366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92432240|NCT03710590|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92787186|NCT02758366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92787187|NCT02758366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787188|NCT02758366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787189|NCT04577326|Cyclophosphamide|cyclophosphamide|mesh-list
92787190|NCT04577326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787191|NCT04577326|Immunologic Factors|immunologic factors|mesh-ancestor
92787192|NCT04577326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787193|NCT04577326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787194|NCT04577326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92787195|NCT04577326|Alkylating Agents|alkylating agents|mesh-ancestor
92787196|NCT04577326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787197|NCT04577326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787198|NCT04577326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92787199|NCT00637403|Megestrol|megestrol|mesh-list
92787200|NCT00637403|Megestrol Acetate|megestrol acetate|mesh-list
92787201|NCT00637403|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92787202|NCT00637403|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92787203|NCT00637403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92787204|NCT00637403|Contraceptive Agents|contraceptive agents|mesh-ancestor
92787205|NCT00637403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787206|NCT00637403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787207|NCT00637403|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92787208|NCT00637403|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92787209|NCT00637403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787210|NCT00637403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787211|NCT00637403|Appetite Stimulants|appetite stimulants|mesh-ancestor
92787212|NCT00637403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92787213|NCT01185080|Adenosine|adenosine|mesh-list
92787214|NCT01185080|Analgesics|analgesics|mesh-ancestor
92787215|NCT01185080|Sensory System Agents|sensory system agents|mesh-ancestor
92787216|NCT01185080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787217|NCT01185080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787218|NCT01185080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92787219|NCT01185080|Vasodilator Agents|vasodilator agents|mesh-ancestor
92787220|NCT01185080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92787221|NCT01185080|Purinergic Agonists|purinergic agonists|mesh-ancestor
92787222|NCT01185080|Purinergic Agents|purinergic agents|mesh-ancestor
92787223|NCT01185080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787224|NCT01185080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787225|NCT01181102|Enoxaparin|enoxaparin|mesh-list
92787226|NCT01181102|Enoxaparin sodium|enoxaparin sodium|mesh-list
92787227|NCT01181102|Edoxaban|edoxaban|mesh-list
92787228|NCT01181102|Anticoagulants|anticoagulants|mesh-ancestor
92787229|NCT01181102|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92787230|NCT01181102|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92787231|NCT01181102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787232|NCT01181102|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92787233|NCT01181102|Antithrombins|antithrombins|mesh-ancestor
92787234|NCT01181102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92787235|NCT01181102|Protease Inhibitors|protease inhibitors|mesh-ancestor
92787236|NCT01181102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787237|NCT00858637|Bile Acids and Salts|bile acids and salts|mesh-list
92787238|NCT00858637|Simvastatin|simvastatin|mesh-list
92787239|NCT00858637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92787240|NCT00858637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92787241|NCT00858637|Antimetabolites|antimetabolites|mesh-ancestor
92787242|NCT00858637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787243|NCT00858637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92787244|NCT00858637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92787245|NCT00858637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787246|NCT00858637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787247|NCT02760316|Prednisolone|prednisolone|mesh-list
92787248|NCT02760316|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92787249|NCT02760316|Methylprednisolone|methylprednisolone|mesh-list
92787250|NCT02760316|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92787251|NCT02760316|Prednisolone acetate|prednisolone acetate|mesh-list
92733725|NCT01684787|Ribavirin|ribavirin|mesh-list
92787252|NCT02760316|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92787253|NCT02760316|Prednisolone phosphate|prednisolone phosphate|mesh-list
92787254|NCT02760316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787255|NCT02760316|Glucocorticoids|glucocorticoids|mesh-ancestor
92787256|NCT02760316|Hormones|hormones|mesh-ancestor
92787257|NCT02760316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787258|NCT02760316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787259|NCT02760316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787260|NCT02760316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787261|NCT02760316|Antiemetics|antiemetics|mesh-ancestor
92787262|NCT02760316|Autonomic Agents|autonomic agents|mesh-ancestor
92787263|NCT02760316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787264|NCT02760316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787265|NCT02760316|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92787266|NCT02760316|Protective Agents|protective agents|mesh-ancestor
92787267|NCT00858403|Dasatinib|dasatinib|mesh-list
92787268|NCT00858403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787269|NCT00858403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787270|NCT00858403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787271|NCT00858403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787272|NCT02760472|SMOFlipid|smoflipid|mesh-list
92787273|NCT02760472|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92787274|NCT02760472|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92787275|NCT02760472|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92787276|NCT00858247|Vitamin D|vitamin d|mesh-list
92787277|NCT00858247|Cholecalciferol|cholecalciferol|mesh-list
92787278|NCT00858247|Vitamins|vitamins|mesh-ancestor
92787279|NCT00858247|Micronutrients|micronutrients|mesh-ancestor
92787280|NCT00858247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787281|NCT00858247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92787282|NCT00858247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92787283|NCT04222348|Metformin|metformin|mesh-list
92787284|NCT04222348|Insulin Detemir|insulin detemir|mesh-list
92787285|NCT04222348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92787286|NCT04222348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787287|NCT04222114|Catumaxomab|catumaxomab|mesh-list
92787288|NCT04222114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787289|NCT00838435|Verapamil|verapamil|mesh-list
92787290|NCT00838435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92787291|NCT00838435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92787292|NCT00838435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787293|NCT00838435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787294|NCT00838435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92787295|NCT00838435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787296|NCT00838435|Vasodilator Agents|vasodilator agents|mesh-ancestor
92787297|NCT02757508|Vitamins|vitamins|mesh-list
92787298|NCT02757508|Micronutrients|micronutrients|mesh-ancestor
92787299|NCT02757508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787300|NCT04568902|Histamine Antagonists|histamine antagonists|mesh-list
92787301|NCT04568902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92787302|NCT04568902|Histamine Agents|histamine agents|mesh-ancestor
92787303|NCT04568902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787304|NCT04568902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787305|NCT04568902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787306|NCT02757196|Methylprednisolone|methylprednisolone|mesh-list
92787307|NCT02757196|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92787308|NCT02757196|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92787309|NCT02757196|Prednisolone|prednisolone|mesh-list
92787310|NCT02757196|Prednisolone acetate|prednisolone acetate|mesh-list
92787311|NCT02757196|Rituximab|rituximab|mesh-list
92787312|NCT02757196|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92787313|NCT02757196|Prednisolone phosphate|prednisolone phosphate|mesh-list
92787314|NCT02757196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92787315|NCT02757196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787316|NCT02757196|Immunologic Factors|immunologic factors|mesh-ancestor
92787317|NCT02757196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787318|NCT02757196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787319|NCT02757196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787320|NCT02757196|Antiemetics|antiemetics|mesh-ancestor
92787321|NCT02757196|Autonomic Agents|autonomic agents|mesh-ancestor
92787322|NCT02757196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787323|NCT02757196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787324|NCT02757196|Glucocorticoids|glucocorticoids|mesh-ancestor
92787325|NCT02757196|Hormones|hormones|mesh-ancestor
92787326|NCT02757196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787327|NCT02757196|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92787328|NCT02757196|Protective Agents|protective agents|mesh-ancestor
92787329|NCT02757196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787330|NCT04403698|Alendronate|alendronate|mesh-list
92787331|NCT04403698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92787332|NCT04403698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787333|NCT02759926|Quinine|quinine|mesh-list
92787334|NCT02759926|Denatonium|denatonium|mesh-list
92787335|NCT02759926|Antimalarials|antimalarials|mesh-ancestor
92787336|NCT02759926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92787337|NCT02759926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92787338|NCT02759926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787339|NCT02759926|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92787340|NCT02759926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787342|NCT02759926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787343|NCT02759926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92787344|NCT02759926|Analgesics|analgesics|mesh-ancestor
92787345|NCT02759926|Sensory System Agents|sensory system agents|mesh-ancestor
92787346|NCT02759926|Aversive Agents|aversive agents|mesh-ancestor
92787347|NCT02759926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787348|NCT02759926|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
92787349|NCT04221256|Escitalopram|escitalopram|mesh-list
92787350|NCT04221256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92787351|NCT04221256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92787352|NCT04221256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787353|NCT04221256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787354|NCT04221256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787355|NCT04221256|Serotonin Agents|serotonin agents|mesh-ancestor
92787356|NCT04221256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787357|NCT00838201|Denosumab|denosumab|mesh-list
92787358|NCT00838201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92787359|NCT00838201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787360|NCT00837967|Terbutaline|terbutaline|mesh-list
92787361|NCT00837967|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92787362|NCT00837967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92787363|NCT00837967|Respiratory System Agents|respiratory system agents|mesh-ancestor
92787364|NCT00837967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92787365|NCT00837967|Autonomic Agents|autonomic agents|mesh-ancestor
92787366|NCT00837967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787367|NCT00837967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787368|NCT00837967|Sympathomimetics|sympathomimetics|mesh-ancestor
92787369|NCT00837967|Tocolytic Agents|tocolytic agents|mesh-ancestor
92787370|NCT00837967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787371|NCT00837967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92787372|NCT00837967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92787373|NCT00837967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92787374|NCT00837967|Adrenergic Agents|adrenergic agents|mesh-ancestor
92787375|NCT00837967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787376|NCT00837967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787377|NCT02759614|Bevacizumab|bevacizumab|mesh-list
92787378|NCT02759614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92787379|NCT02759614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92787380|NCT02759614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787381|NCT02759614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92787382|NCT02759614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92787383|NCT02759614|Growth Substances|growth substances|mesh-ancestor
92787384|NCT02759614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787385|NCT02759614|Growth Inhibitors|growth inhibitors|mesh-ancestor
92787386|NCT02759614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787387|NCT02759614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787388|NCT02759614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787389|NCT02757040|Arsenic Trioxide|arsenic trioxide|mesh-list
92787390|NCT02757040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787391|NCT02759224|Irsogladine|irsogladine|mesh-list
92787392|NCT02759224|Lafutidine|lafutidine|mesh-list
92787393|NCT02759224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787394|NCT02759224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92787395|NCT02759224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787396|NCT02759224|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92787397|NCT02759224|Histamine Antagonists|histamine antagonists|mesh-ancestor
92787398|NCT02759224|Histamine Agents|histamine agents|mesh-ancestor
92787399|NCT02759224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787400|NCT02759224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787401|NCT02759224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787402|NCT02759224|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92787403|NCT02759224|Protective Agents|protective agents|mesh-ancestor
92787404|NCT02759224|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92787405|NCT02756728|Melphalan|melphalan|mesh-list
92787406|NCT02756728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92787407|NCT02756728|Alkylating Agents|alkylating agents|mesh-ancestor
92787408|NCT02756728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787409|NCT02756728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787410|NCT02756728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92787411|NCT02756728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787412|NCT02756728|Immunologic Factors|immunologic factors|mesh-ancestor
92787413|NCT02756728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787414|NCT04586920|Itraconazole|itraconazole|mesh-list
92787415|NCT04586920|Midazolam|midazolam|mesh-list
92787416|NCT04586920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92787417|NCT04586920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92787418|NCT04586920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787419|NCT04586920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787420|NCT04586920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92787421|NCT04586920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92787422|NCT04586920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92787423|NCT04586920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92787424|NCT04586920|Anesthetics, General|anesthetics, general|mesh-ancestor
92787425|NCT04586920|Anesthetics|anesthetics|mesh-ancestor
92787426|NCT04586920|GABA Modulators|gaba modulators|mesh-ancestor
92787427|NCT04586920|GABA Agents|gaba agents|mesh-ancestor
92787428|NCT04586920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787429|NCT04586920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787430|NCT04586920|Antifungal Agents|antifungal agents|mesh-ancestor
92787431|NCT04586920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787432|NCT04586920|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92787433|NCT04586920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92787434|NCT04586920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787435|NCT04586920|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92787436|NCT04586920|Hormone Antagonists|hormone antagonists|mesh-ancestor
92787437|NCT04586920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787438|NCT04586920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92787439|NCT02758990|Vitamin D|vitamin d|mesh-list
92787440|NCT02758990|Cholecalciferol|cholecalciferol|mesh-list
92787441|NCT02758990|Vitamins|vitamins|mesh-list
92787442|NCT02758990|Ascorbic Acid|ascorbic acid|mesh-list
92787443|NCT02758990|Vitamin E|vitamin e|mesh-list
92787444|NCT02758990|Tocopherols|tocopherols|mesh-list
92787445|NCT02758990|Vitamin A|vitamin a|mesh-list
92787446|NCT02758990|Niacinamide|niacinamide|mesh-list
92787447|NCT02758990|Niacin|niacin|mesh-list
92787448|NCT02758990|Nicotinic Acids|nicotinic acids|mesh-list
92787449|NCT02758990|Pyridoxine|pyridoxine|mesh-list
92787450|NCT02758990|Pyridoxal|pyridoxal|mesh-list
92787451|NCT02758990|Vitamin B 6|vitamin b 6|mesh-list
92787452|NCT02758990|Caffeine|caffeine|mesh-list
92787453|NCT02758990|Micronutrients|micronutrients|mesh-ancestor
92787454|NCT02758990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787455|NCT02758990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92787456|NCT02758990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92787457|NCT02758990|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92787458|NCT02758990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92787459|NCT02758990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787460|NCT02758990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787461|NCT02758990|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92787462|NCT02758990|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92787463|NCT02758990|Purinergic Agents|purinergic agents|mesh-ancestor
92787464|NCT02758990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787465|NCT02758990|Antioxidants|antioxidants|mesh-ancestor
92787466|NCT02758990|Protective Agents|protective agents|mesh-ancestor
92787467|NCT02758990|Vitamin B Complex|vitamin b complex|mesh-ancestor
92787468|NCT02758990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92787469|NCT02758990|Antimetabolites|antimetabolites|mesh-ancestor
92787470|NCT02758990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92787471|NCT02758990|Vasodilator Agents|vasodilator agents|mesh-ancestor
92787472|NCT02756104|Vitamin D|vitamin d|mesh-list
92787473|NCT02756104|Vitamins|vitamins|mesh-ancestor
92787474|NCT02756104|Micronutrients|micronutrients|mesh-ancestor
92787475|NCT02756104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787476|NCT02756104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92787477|NCT02756026|Micronutrients|micronutrients|mesh-list
92787478|NCT02756026|Trace Elements|trace elements|mesh-list
92787479|NCT02756026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787480|NCT02755714|Bromides|bromides|mesh-list
92432538|NCT01566760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787481|NCT02755714|Ipratropium|ipratropium|mesh-list
92787482|NCT02755714|Anticonvulsants|anticonvulsants|mesh-ancestor
92787483|NCT02755714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92787484|NCT02755714|Autonomic Agents|autonomic agents|mesh-ancestor
92705628|NCT00547170|Antimalarials|antimalarials|mesh-ancestor
92787485|NCT02755714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787486|NCT02755714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787487|NCT02755714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92787488|NCT02755714|Respiratory System Agents|respiratory system agents|mesh-ancestor
92787489|NCT02755714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92787491|NCT02755714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787492|NCT02755714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787493|NCT02758522|Insulin|insulin|mesh-list
92787494|NCT02758522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92787495|NCT02758522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92787496|NCT02758522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787497|NCT00942357|Paclitaxel|paclitaxel|mesh-list
92787498|NCT00942357|Cisplatin|cisplatin|mesh-list
92787499|NCT00942357|Carboplatin|carboplatin|mesh-list
92787500|NCT00942357|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92787501|NCT00942357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92787502|NCT00942357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787503|NCT00942357|Tubulin Modulators|tubulin modulators|mesh-ancestor
92787504|NCT00942357|Antimitotic Agents|antimitotic agents|mesh-ancestor
92787505|NCT00942357|Mitosis Modulators|mitosis modulators|mesh-ancestor
92787506|NCT00942357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787507|NCT02752828|Insulin|insulin|mesh-list
92787508|NCT02752828|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92787509|NCT02752828|Insulin Glargine|insulin glargine|mesh-list
92787510|NCT02752828|Lixisenatide|lixisenatide|mesh-list
92787511|NCT02752828|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92787512|NCT02752828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787513|NCT02753062|Rituximab|rituximab|mesh-list
92787514|NCT02753062|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92787515|NCT02753062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92787516|NCT02753062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787517|NCT02753062|Immunologic Factors|immunologic factors|mesh-ancestor
92787518|NCT02753062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787519|NCT02753062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787520|NCT02753062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92787521|NCT02753062|Alkylating Agents|alkylating agents|mesh-ancestor
92787522|NCT02753062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787523|NCT02752204|Rituximab|rituximab|mesh-list
92787524|NCT02752204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92787525|NCT02752204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787526|NCT02752204|Immunologic Factors|immunologic factors|mesh-ancestor
92787527|NCT02752204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787528|NCT02752204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787529|NCT04220398|Hormones|hormones|mesh-list
92787530|NCT04220398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787531|NCT04220398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787532|NCT04220632|Prednisone|prednisone|mesh-list
92787533|NCT04220632|Methylprednisolone|methylprednisolone|mesh-list
92787534|NCT04220632|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92787535|NCT04220632|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92787536|NCT04220632|Prednisolone|prednisolone|mesh-list
92787537|NCT04220632|Prednisolone acetate|prednisolone acetate|mesh-list
92787538|NCT04220632|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92787539|NCT04220632|Prednisolone phosphate|prednisolone phosphate|mesh-list
92787540|NCT04220632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787541|NCT04220632|Glucocorticoids|glucocorticoids|mesh-ancestor
92787542|NCT04220632|Hormones|hormones|mesh-ancestor
92787543|NCT04220632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787544|NCT04220632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787545|NCT04220632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787546|NCT04220632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787547|NCT04220632|Antiemetics|antiemetics|mesh-ancestor
92787548|NCT04220632|Autonomic Agents|autonomic agents|mesh-ancestor
92787549|NCT04220632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787550|NCT04220632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787551|NCT04220632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92787552|NCT04220632|Protective Agents|protective agents|mesh-ancestor
92787553|NCT00939627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92787555|NCT00939627|Sorafenib|sorafenib|mesh-list
92787556|NCT00939627|Antibodies|antibodies|mesh-list
92787557|NCT00939627|Immunoglobulins|immunoglobulins|mesh-list
92787558|NCT00939627|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92787559|NCT00939627|Immunologic Factors|immunologic factors|mesh-ancestor
92787560|NCT00939627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787561|NCT00939627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787562|NCT00939627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787563|NCT00939627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787564|NCT00939627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787565|NCT05382741|Durvalumab|durvalumab|mesh-list
92787566|NCT05382741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92787567|NCT05382741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787568|NCT04220476|Letrozole|letrozole|mesh-list
92787569|NCT04220476|Palbociclib|palbociclib|mesh-list
92787570|NCT04220476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787571|NCT04220476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92787572|NCT04220476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92787573|NCT04220476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787574|NCT04220476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787575|NCT04220476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92787576|NCT04220476|Hormone Antagonists|hormone antagonists|mesh-ancestor
92787577|NCT04220476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787578|NCT04220476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787579|NCT04220476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787580|NCT02695810|Metformin|metformin|mesh-list
92787581|NCT02695810|Dapagliflozin|dapagliflozin|mesh-list
92787582|NCT02695810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92787583|NCT02695810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787584|NCT02695810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92787585|NCT02695810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787586|NCT02753764|Prednisone|prednisone|mesh-list
92787587|NCT02753764|AZD7624|azd7624|mesh-list
92787588|NCT02753764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787589|NCT02753764|Glucocorticoids|glucocorticoids|mesh-ancestor
92787590|NCT02753764|Hormones|hormones|mesh-ancestor
92787591|NCT02753764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787592|NCT02753764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787593|NCT02753764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92787594|NCT02753764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787595|NCT02753764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787596|NCT02753764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787597|NCT02753764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787598|NCT02695654|Clonidine|clonidine|mesh-list
92787599|NCT02695654|Levobupivacaine|levobupivacaine|mesh-list
92787600|NCT02695654|Analgesics|analgesics|mesh-ancestor
92787601|NCT02695654|Sensory System Agents|sensory system agents|mesh-ancestor
92787602|NCT02695654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787603|NCT02695654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787604|NCT02695654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92787605|NCT02695654|Sympatholytics|sympatholytics|mesh-ancestor
92787606|NCT02695654|Autonomic Agents|autonomic agents|mesh-ancestor
92787607|NCT02695654|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92787608|NCT02695654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92787609|NCT02695654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92787610|NCT02695654|Adrenergic Agents|adrenergic agents|mesh-ancestor
92787611|NCT02695654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787612|NCT02695654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787613|NCT02695654|Anesthetics, Local|anesthetics, local|mesh-ancestor
92787614|NCT02695654|Anesthetics|anesthetics|mesh-ancestor
92787615|NCT02695654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787616|NCT02696122|Anesthetics|anesthetics|mesh-list
92787617|NCT02696122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787618|NCT02696122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787619|NCT01135511|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92787620|NCT01135511|Tofacitinib|tofacitinib|mesh-list
92787621|NCT01135511|Hyaluronic Acid|hyaluronic acid|mesh-list
92787622|NCT01135511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92787623|NCT01135511|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92787624|NCT01135511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787625|NCT01135511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787626|NCT01135511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787627|NCT01135511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92787629|NCT01135511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787630|NCT01135511|Viscosupplements|viscosupplements|mesh-ancestor
92787631|NCT01135511|Protective Agents|protective agents|mesh-ancestor
92787632|NCT02753140|Docetaxel|docetaxel|mesh-list
92787633|NCT02753140|Cetuximab|cetuximab|mesh-list
92787634|NCT02753140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787635|NCT02753140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92787636|NCT02753140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92787637|NCT02753140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92432689|NCT01570608|Ranibizumab|ranibizumab|mesh-list
92787638|NCT02753140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787639|NCT02753140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92787640|NCT02753218|Midazolam|midazolam|mesh-list
92787641|NCT02753218|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92787642|NCT02753218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92787643|NCT02753218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787644|NCT02753218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787645|NCT02753218|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92787646|NCT02753218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92787647|NCT02753218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92787648|NCT02753218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92787649|NCT02753218|Anesthetics, General|anesthetics, general|mesh-ancestor
92787650|NCT02753218|Anesthetics|anesthetics|mesh-ancestor
92787651|NCT02753218|GABA Modulators|gaba modulators|mesh-ancestor
92787652|NCT02753218|GABA Agents|gaba agents|mesh-ancestor
92787653|NCT02753218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787654|NCT02753218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787655|NCT05429554|Vildagliptin|vildagliptin|mesh-list
92787656|NCT05429554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92787657|NCT05429554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787658|NCT05429554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92787659|NCT05429554|Protease Inhibitors|protease inhibitors|mesh-ancestor
92787660|NCT05429554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705801|NCT00548067|Diuretics|diuretics|mesh-ancestor
92787661|NCT05429554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787662|NCT05429086|Propofol|propofol|mesh-list
92787663|NCT05429086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92787664|NCT05429086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787665|NCT05429086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787666|NCT05429086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92787667|NCT05429086|Anesthetics, General|anesthetics, general|mesh-ancestor
92787668|NCT05429086|Anesthetics|anesthetics|mesh-ancestor
92787669|NCT00638248|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
92787670|NCT00638248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92787671|NCT00638248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92787672|NCT00638248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787673|NCT05422144|Anti-Infective Agents|anti-infective agents|mesh-list
92787674|NCT05422144|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92787675|NCT01180790|Interferons|interferons|mesh-list
92787676|NCT01180790|Ribavirin|ribavirin|mesh-list
92787677|NCT01180790|Interferon-alpha|interferon-alpha|mesh-list
92787678|NCT01180790|Interferon alpha-2|interferon alpha-2|mesh-list
92787679|NCT01180790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92787680|NCT01180790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787681|NCT01180790|Antiviral Agents|antiviral agents|mesh-ancestor
92787682|NCT01180790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787683|NCT01180790|Antimetabolites|antimetabolites|mesh-ancestor
92787684|NCT01180790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787685|NCT01180790|Immunologic Factors|immunologic factors|mesh-ancestor
92787686|NCT01180790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787687|NCT01184846|Immunoglobulins|immunoglobulins|mesh-list
92787688|NCT01184846|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92787689|NCT01184846|Antibodies|antibodies|mesh-list
92787690|NCT01184846|Immunologic Factors|immunologic factors|mesh-ancestor
92787691|NCT01184846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787692|NCT01191086|Topiramate|topiramate|mesh-list
92787693|NCT01191086|Anticonvulsants|anticonvulsants|mesh-ancestor
92787694|NCT01191086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92787695|NCT01191086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787696|NCT01076400|Topotecan|topotecan|mesh-list
92787697|NCT01076400|Adavosertib|adavosertib|mesh-list
92787698|NCT01076400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787699|NCT01076400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92787700|NCT01076400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92787701|NCT01076400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787702|NCT01076400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787703|NCT05318560|Lidocaine|lidocaine|mesh-list
92787704|NCT05318560|Anesthetics, Local|anesthetics, local|mesh-ancestor
92787705|NCT05318560|Anesthetics|anesthetics|mesh-ancestor
92787706|NCT05318560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787707|NCT05318560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787708|NCT05318560|Sensory System Agents|sensory system agents|mesh-ancestor
92787709|NCT05318560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787710|NCT05318560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92787711|NCT05318560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92432760|NCT01571024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787712|NCT05318560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92787713|NCT05318560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787714|NCT05318560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787715|NCT04171258|Botulinum Toxins|botulinum toxins|mesh-list
92787716|NCT04171258|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92787717|NCT04171258|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92787718|NCT04171258|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92787719|NCT04171258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787720|NCT04171258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787721|NCT04171258|Cholinergic Agents|cholinergic agents|mesh-ancestor
92787722|NCT04171258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787723|NCT04171258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787724|NCT04171258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92787725|NCT04171258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787727|NCT01086384|Xhance|xhance|mesh-list
92787728|NCT01086384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787729|NCT01086384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92787730|NCT01086384|Autonomic Agents|autonomic agents|mesh-ancestor
92787731|NCT01086384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787732|NCT01086384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787733|NCT01086384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92787734|NCT01086384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92787735|NCT01086384|Dermatologic Agents|dermatologic agents|mesh-ancestor
92787736|NCT01086384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92787737|NCT04115644|Triamcinolone|triamcinolone|mesh-list
92787738|NCT04115644|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92787739|NCT04115644|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92787740|NCT04115644|Ketorolac|ketorolac|mesh-list
92787741|NCT04115644|Bupivacaine|bupivacaine|mesh-list
92787742|NCT04115644|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92787743|NCT04115644|Anesthetics, Local|anesthetics, local|mesh-ancestor
92787744|NCT04115644|Anesthetics|anesthetics|mesh-ancestor
92787745|NCT04115644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787746|NCT04115644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787747|NCT04115644|Sensory System Agents|sensory system agents|mesh-ancestor
92787748|NCT04115644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787749|NCT04115644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787750|NCT04115644|Glucocorticoids|glucocorticoids|mesh-ancestor
92787751|NCT04115644|Hormones|hormones|mesh-ancestor
92787752|NCT04115644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787753|NCT04115644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787754|NCT04115644|Immunologic Factors|immunologic factors|mesh-ancestor
92787755|NCT04115644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787756|NCT04115644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787757|NCT04115644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92787758|NCT04115644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92787759|NCT04115644|Analgesics|analgesics|mesh-ancestor
92787760|NCT04115644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787761|NCT04115644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92787762|NCT00635986|Fentanyl|fentanyl|mesh-list
92787763|NCT00635986|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92787764|NCT00635986|Narcotics|narcotics|mesh-ancestor
92787765|NCT00635986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787766|NCT00635986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787767|NCT00635986|Analgesics|analgesics|mesh-ancestor
92787768|NCT00635986|Sensory System Agents|sensory system agents|mesh-ancestor
92787769|NCT00635986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787770|NCT00635986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92787771|NCT00635986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92787772|NCT00635986|Anesthetics, General|anesthetics, general|mesh-ancestor
92787773|NCT00635986|Anesthetics|anesthetics|mesh-ancestor
92787774|NCT04799626|Levofloxacin|levofloxacin|mesh-list
92787775|NCT04799626|Meropenem|meropenem|mesh-list
92787776|NCT04799626|Tazobactam|tazobactam|mesh-list
92787777|NCT04799626|Piperacillin|piperacillin|mesh-list
92787778|NCT04799626|Tigecycline|tigecycline|mesh-list
92787779|NCT04799626|Biapenem|biapenem|mesh-list
92787780|NCT04799626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92787781|NCT04799626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787782|NCT04799626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92787783|NCT04799626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92787784|NCT04799626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92432847|NCT01571570|Simeprevir|simeprevir|mesh-list
92787785|NCT04799626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705923|NCT00548574|Mesalamine|mesalamine|mesh-list
92787786|NCT04799626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787787|NCT04799626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787788|NCT04799626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92787789|NCT04799626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92787790|NCT04799626|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92787791|NCT04799626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92787792|NCT00636064|Parecoxib|parecoxib|mesh-list
92787793|NCT00636064|Valdecoxib|valdecoxib|mesh-list
92787794|NCT00636064|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92787795|NCT00636064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92787796|NCT00636064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787797|NCT00636064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787798|NCT00636064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92787799|NCT00636064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92787800|NCT00636064|Analgesics|analgesics|mesh-ancestor
92787801|NCT00636064|Sensory System Agents|sensory system agents|mesh-ancestor
92787802|NCT00636064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787803|NCT00636064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787804|NCT00636064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92787805|NCT00636064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787806|NCT02751034|Lidocaine|lidocaine|mesh-list
92787807|NCT02751034|Anesthetics, Local|anesthetics, local|mesh-ancestor
92787808|NCT02751034|Anesthetics|anesthetics|mesh-ancestor
92787809|NCT02751034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92787810|NCT02751034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787811|NCT02751034|Sensory System Agents|sensory system agents|mesh-ancestor
92787812|NCT02751034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787813|NCT02751034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92787814|NCT02751034|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92787815|NCT02751034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92787816|NCT02751034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787817|NCT02751034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787818|NCT04217668|Isosorbide|isosorbide|mesh-list
92787819|NCT04217668|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92787820|NCT04217668|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92787821|NCT04217668|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92787822|NCT04217668|Diuretics|diuretics|mesh-ancestor
92787823|NCT04217668|Natriuretic Agents|natriuretic agents|mesh-ancestor
92787824|NCT04217668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787825|NCT04217668|Vasodilator Agents|vasodilator agents|mesh-ancestor
92787826|NCT04217668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92787827|NCT04217668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787828|NCT01127165|Zonisamide|zonisamide|mesh-list
92787829|NCT01127165|Anticonvulsants|anticonvulsants|mesh-ancestor
92787830|NCT01127165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92787831|NCT01127165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92787832|NCT01127165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787833|NCT01127165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92787834|NCT01127165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787835|NCT04335292|Pemetrexed|pemetrexed|mesh-list
92787836|NCT04335292|Osimertinib|osimertinib|mesh-list
92787837|NCT04335292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787838|NCT04335292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787839|NCT04335292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787840|NCT04335292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92787841|NCT04335292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92787842|NCT04335292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92787843|NCT04278508|Progesterone|progesterone|mesh-list
92787844|NCT04278508|Progestins|progestins|mesh-ancestor
92787845|NCT04278508|Hormones|hormones|mesh-ancestor
92787846|NCT04278508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787847|NCT04278508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787848|NCT05382351|Tenofovir|tenofovir|mesh-list
92787849|NCT05382351|Entecavir|entecavir|mesh-list
92787850|NCT05382351|Antiviral Agents|antiviral agents|mesh-ancestor
92787851|NCT05382351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787852|NCT05382351|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92787853|NCT05382351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92787854|NCT05382351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787855|NCT05382351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787856|NCT05382351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92787857|NCT05382351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92787858|NCT04218760|Isosorbide|isosorbide|mesh-list
92787859|NCT04218760|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92787860|NCT04218760|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92787861|NCT04218760|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92787863|NCT04218760|Natriuretic Agents|natriuretic agents|mesh-ancestor
92787864|NCT04218760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787865|NCT04218760|Vasodilator Agents|vasodilator agents|mesh-ancestor
92787866|NCT04218760|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92787867|NCT04218760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787868|NCT02750254|Plerixafor|plerixafor|mesh-list
92787869|NCT02750254|Cyclophosphamide|cyclophosphamide|mesh-list
92787870|NCT02750254|Melphalan|melphalan|mesh-list
92787871|NCT02750254|Busulfan|busulfan|mesh-list
92787872|NCT02750254|Fludarabine|fludarabine|mesh-list
92787873|NCT02750254|Fludarabine phosphate|fludarabine phosphate|mesh-list
92787874|NCT02750254|Azacitidine|azacitidine|mesh-list
92787875|NCT02750254|Lenograstim|lenograstim|mesh-list
92787876|NCT02750254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787877|NCT02750254|Immunologic Factors|immunologic factors|mesh-ancestor
92787878|NCT02750254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787879|NCT02750254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787880|NCT02750254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92787881|NCT02750254|Alkylating Agents|alkylating agents|mesh-ancestor
92787882|NCT02750254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787883|NCT02750254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787884|NCT02750254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92787885|NCT02750254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92787886|NCT02750254|Antimetabolites|antimetabolites|mesh-ancestor
92787887|NCT02750254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787888|NCT02750254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92787889|NCT02750254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92787890|NCT02750254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92787891|NCT02750254|Antiviral Agents|antiviral agents|mesh-ancestor
92787892|NCT02750254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787893|NCT00941655|Leucovorin|leucovorin|mesh-list
92787894|NCT00941655|Fluorouracil|fluorouracil|mesh-list
92787895|NCT00941655|Oxaliplatin|oxaliplatin|mesh-list
92787896|NCT00941655|Irinotecan|irinotecan|mesh-list
92787897|NCT00941655|Antimetabolites|antimetabolites|mesh-ancestor
92787898|NCT00941655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787899|NCT00941655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92787900|NCT00941655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787901|NCT00941655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787902|NCT00941655|Immunologic Factors|immunologic factors|mesh-ancestor
92787903|NCT00941655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787904|NCT00941655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92787905|NCT00941655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92787906|NCT00941655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787907|NCT00941655|Antidotes|antidotes|mesh-ancestor
92787908|NCT00941655|Protective Agents|protective agents|mesh-ancestor
92787909|NCT00941655|Vitamin B Complex|vitamin b complex|mesh-ancestor
92787910|NCT00941655|Vitamins|vitamins|mesh-ancestor
92787911|NCT00941655|Micronutrients|micronutrients|mesh-ancestor
92787912|NCT00605787|1-(carboxymethylthio)tetradecane|1-(carboxymethylthio)tetradecane|mesh-list
92787913|NCT00605787|Antioxidants|antioxidants|mesh-ancestor
92787914|NCT00605787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787915|NCT00605787|Protective Agents|protective agents|mesh-ancestor
92787916|NCT00605787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787917|NCT00605787|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92787918|NCT00936117|Posaconazole|posaconazole|mesh-list
92787919|NCT00936117|Antifungal Agents|antifungal agents|mesh-ancestor
92787920|NCT00936117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787921|NCT00936117|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92787922|NCT00936117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92787923|NCT00936117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92787924|NCT00936117|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92787925|NCT00936117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92787926|NCT00936117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787927|NCT00936117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787928|NCT00936117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92787929|NCT00936117|Hormone Antagonists|hormone antagonists|mesh-ancestor
92787930|NCT00936117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92787931|NCT00936117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787932|NCT04267653|Lactoferrin|lactoferrin|mesh-list
92787933|NCT04267653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787934|NCT04088500|Nivolumab|nivolumab|mesh-list
92787935|NCT04088500|Ipilimumab|ipilimumab|mesh-list
92787936|NCT04088500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92432984|NCT01572116|Autonomic Agents|autonomic agents|mesh-ancestor
92787937|NCT04088500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787938|NCT04088500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92787939|NCT04088500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787940|NCT01082874|Clonidine|clonidine|mesh-list
92787941|NCT01082874|Analgesics|analgesics|mesh-ancestor
92787942|NCT01082874|Sensory System Agents|sensory system agents|mesh-ancestor
92787943|NCT01082874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787944|NCT01082874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787945|NCT01082874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787946|NCT01082874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92787947|NCT01082874|Sympatholytics|sympatholytics|mesh-ancestor
92787948|NCT01082874|Autonomic Agents|autonomic agents|mesh-ancestor
92787949|NCT01082874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92787950|NCT01082874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92787951|NCT01082874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92787952|NCT01082874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92787953|NCT01082874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787954|NCT00607503|Terbutaline|terbutaline|mesh-list
92787955|NCT00607503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92787956|NCT00607503|Autonomic Agents|autonomic agents|mesh-ancestor
92787957|NCT00607503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92787958|NCT00607503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706101|NCT00548964|Anesthetics|anesthetics|mesh-ancestor
92787959|NCT00607503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92787960|NCT00607503|Respiratory System Agents|respiratory system agents|mesh-ancestor
92787961|NCT00607503|Sympathomimetics|sympathomimetics|mesh-ancestor
92787962|NCT00607503|Tocolytic Agents|tocolytic agents|mesh-ancestor
92787963|NCT00607503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787964|NCT00607503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92787965|NCT00607503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92787966|NCT00607503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92787967|NCT00607503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92787968|NCT00607503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92787969|NCT00607503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787970|NCT04217512|Pantoprazole|pantoprazole|mesh-list
92787971|NCT04217512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92787972|NCT04217512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92787973|NCT04217512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92787974|NCT04217512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787975|NCT04217512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787976|NCT01079988|Cyclosporine|cyclosporine|mesh-list
92787977|NCT01079988|Methotrexate|methotrexate|mesh-list
92787978|NCT01079988|Cyclosporins|cyclosporins|mesh-list
92787979|NCT01079988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92787980|NCT01079988|Abortifacient Agents|abortifacient agents|mesh-ancestor
92787981|NCT01079988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92787982|NCT01079988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92787983|NCT01079988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92787984|NCT01079988|Antimetabolites|antimetabolites|mesh-ancestor
92787985|NCT01079988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92787986|NCT01079988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92787987|NCT01079988|Dermatologic Agents|dermatologic agents|mesh-ancestor
92787988|NCT01079988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92787989|NCT01079988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92787990|NCT01079988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92787991|NCT01079988|Immunologic Factors|immunologic factors|mesh-ancestor
92787992|NCT01079988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92787993|NCT01079988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92787994|NCT01079988|Antifungal Agents|antifungal agents|mesh-ancestor
92787995|NCT01079988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92787996|NCT01079988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92787997|NCT03974152|Nicotine|nicotine|mesh-list
92787998|NCT03974152|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92787999|NCT03974152|Autonomic Agents|autonomic agents|mesh-ancestor
92788000|NCT03974152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788001|NCT03974152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788002|NCT03974152|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92788003|NCT03974152|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92788004|NCT03974152|Cholinergic Agents|cholinergic agents|mesh-ancestor
92788005|NCT03974152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788006|NCT03974152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788007|NCT02876718|Rivaroxaban|rivaroxaban|mesh-list
92788008|NCT02876718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92788009|NCT02876718|Antithrombins|antithrombins|mesh-ancestor
92788010|NCT02876718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92788011|NCT02876718|Protease Inhibitors|protease inhibitors|mesh-ancestor
92788012|NCT02876718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788013|NCT02876718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788014|NCT02876718|Anticoagulants|anticoagulants|mesh-ancestor
92788015|NCT03508570|Nivolumab|nivolumab|mesh-list
92788016|NCT03508570|Ipilimumab|ipilimumab|mesh-list
92788017|NCT03508570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788018|NCT03508570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788019|NCT03508570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92788020|NCT03508570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788021|NCT01074216|Vitamin D|vitamin d|mesh-list
92788022|NCT01074216|Ergocalciferols|ergocalciferols|mesh-list
92788023|NCT01074216|Cholecalciferol|cholecalciferol|mesh-list
92788024|NCT01074216|Vitamins|vitamins|mesh-list
92788025|NCT01074216|Micronutrients|micronutrients|mesh-ancestor
92788026|NCT01074216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788027|NCT01074216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92788028|NCT01074216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92788029|NCT00636142|Infliximab|infliximab|mesh-list
92788030|NCT00636142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92788031|NCT00636142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788032|NCT00636142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788033|NCT00636142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788034|NCT00636142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788035|NCT02499562|Entecavir|entecavir|mesh-list
92788036|NCT02499562|Antiviral Agents|antiviral agents|mesh-ancestor
92788037|NCT02499562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788038|NCT04304430|Dapagliflozin|dapagliflozin|mesh-list
92788039|NCT04304430|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92788040|NCT04304430|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92788041|NCT04304430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788042|NCT04304430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788043|NCT04304430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788044|NCT04304430|Protease Inhibitors|protease inhibitors|mesh-ancestor
92788045|NCT04304430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788046|NCT02875002|Belinostat|belinostat|mesh-list
92788047|NCT02875002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788048|NCT02875002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92788049|NCT02875002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788050|NCT02875002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788051|NCT02749396|Interferons|interferons|mesh-list
92788052|NCT02749396|Interferon-beta|interferon-beta|mesh-list
92788053|NCT02749396|Interferon beta-1a|interferon beta-1a|mesh-list
92788054|NCT02749396|Interferon beta-1b|interferon beta-1b|mesh-list
92788055|NCT02749396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788056|NCT02749396|Antiviral Agents|antiviral agents|mesh-ancestor
92788057|NCT02749396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788058|NCT02749396|Immunologic Factors|immunologic factors|mesh-ancestor
92788059|NCT02749396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788060|NCT02749396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92788061|NCT04745910|Rasburicase|rasburicase|mesh-list
92788062|NCT04745910|Uric Acid|uric acid|mesh-list
92788063|NCT04745910|Gout Suppressants|gout suppressants|mesh-ancestor
92788064|NCT04745910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788065|NCT04745910|Antioxidants|antioxidants|mesh-ancestor
92788066|NCT04745910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788067|NCT04745910|Protective Agents|protective agents|mesh-ancestor
92788068|NCT04745910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788069|NCT02749162|Acetaminophen|acetaminophen|mesh-list
92788070|NCT02749162|Dexamethasone|dexamethasone|mesh-list
92788071|NCT02749162|Lidocaine|lidocaine|mesh-list
92788072|NCT02749162|Morphine|morphine|mesh-list
92788073|NCT02749162|Ropivacaine|ropivacaine|mesh-list
92788074|NCT02749162|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92788075|NCT02749162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788076|NCT02749162|Antiemetics|antiemetics|mesh-ancestor
92788077|NCT02749162|Autonomic Agents|autonomic agents|mesh-ancestor
92788078|NCT02749162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788079|NCT02749162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788080|NCT02749162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788081|NCT02749162|Glucocorticoids|glucocorticoids|mesh-ancestor
92788082|NCT02749162|Hormones|hormones|mesh-ancestor
92788083|NCT02749162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788084|NCT02749162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92788085|NCT02749162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433153|NCT01572688|Melphalan|melphalan|mesh-list
92788086|NCT02749162|Anesthetics, Local|anesthetics, local|mesh-ancestor
92788087|NCT02749162|Anesthetics|anesthetics|mesh-ancestor
92788088|NCT02749162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788089|NCT02749162|Sensory System Agents|sensory system agents|mesh-ancestor
92788090|NCT02749162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92788091|NCT02749162|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92788092|NCT02749162|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92788093|NCT02749162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788094|NCT02749162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788095|NCT02749162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92788096|NCT02749162|Narcotics|narcotics|mesh-ancestor
92788097|NCT02749162|Analgesics|analgesics|mesh-ancestor
92788098|NCT02749162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92788099|NCT02749162|Antipyretics|antipyretics|mesh-ancestor
92788100|NCT02041234|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92788101|NCT02041234|Liraglutide|liraglutide|mesh-list
92788102|NCT02041234|Empagliflozin|empagliflozin|mesh-list
92788103|NCT02041234|Linagliptin|linagliptin|mesh-list
92788104|NCT02041234|Canagliflozin|canagliflozin|mesh-list
92788105|NCT02041234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92788106|NCT02041234|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92788107|NCT02041234|Orlistat|orlistat|mesh-list
92788108|NCT02041234|Incretins|incretins|mesh-list
92788109|NCT02041234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788110|NCT02041234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788111|NCT02041234|Hormones|hormones|mesh-ancestor
92788112|NCT02041234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788113|NCT02041234|Protease Inhibitors|protease inhibitors|mesh-ancestor
92788114|NCT02041234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788115|NCT02041234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788116|NCT02041234|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92788117|NCT02041234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92788118|NCT02695732|Carvedilol|carvedilol|mesh-list
92788119|NCT02695732|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92788120|NCT02695732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92788121|NCT02695732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92788122|NCT02695732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788123|NCT02695732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788124|NCT02695732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788125|NCT02695732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92788126|NCT02695732|Antioxidants|antioxidants|mesh-ancestor
92788127|NCT02695732|Protective Agents|protective agents|mesh-ancestor
92788128|NCT02695732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92788129|NCT02695732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788130|NCT02695732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92788131|NCT02695732|Vasodilator Agents|vasodilator agents|mesh-ancestor
92788132|NCT02695732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92788133|NCT02695732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92788134|NCT02751268|Ropivacaine|ropivacaine|mesh-list
92788135|NCT02751268|Anesthetics, Local|anesthetics, local|mesh-ancestor
92788136|NCT02751268|Anesthetics|anesthetics|mesh-ancestor
92788137|NCT02751268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788138|NCT02751268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788139|NCT02751268|Sensory System Agents|sensory system agents|mesh-ancestor
92788140|NCT02751268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788141|NCT02748772|Thalidomide|thalidomide|mesh-list
92788142|NCT02748772|Endostar protein|endostar protein|mesh-list
92788143|NCT02748772|Endostatins|endostatins|mesh-list
92788144|NCT02748772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788145|NCT02748772|Immunologic Factors|immunologic factors|mesh-ancestor
92788146|NCT02748772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788147|NCT02748772|Leprostatic Agents|leprostatic agents|mesh-ancestor
92788148|NCT02748772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788149|NCT02748772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788150|NCT02748772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92788151|NCT02748772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92788152|NCT02748772|Growth Substances|growth substances|mesh-ancestor
92788153|NCT02748772|Growth Inhibitors|growth inhibitors|mesh-ancestor
92788154|NCT02748772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788155|NCT04216888|Ketamine|ketamine|mesh-list
92788156|NCT04216888|Analgesics|analgesics|mesh-ancestor
92788157|NCT04216888|Sensory System Agents|sensory system agents|mesh-ancestor
92788158|NCT04216888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788159|NCT04216888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788160|NCT04216888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92788161|NCT04216888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92433208|NCT01573286|Hormones|hormones|mesh-ancestor
92788162|NCT04216888|Anesthetics, General|anesthetics, general|mesh-ancestor
92788163|NCT04216888|Anesthetics|anesthetics|mesh-ancestor
92788164|NCT04216888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788165|NCT04216888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92788166|NCT04216888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92788167|NCT04216888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788168|NCT04216888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788169|NCT02746744|Rituximab|rituximab|mesh-list
92788170|NCT02746744|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92788171|NCT02746744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788172|NCT02746744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788173|NCT02746744|Immunologic Factors|immunologic factors|mesh-ancestor
92788174|NCT02746744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788175|NCT02746744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788176|NCT02746744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788177|NCT02746744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788178|NCT02748304|Aspirin|aspirin|mesh-list
92788179|NCT02748304|Sorafenib|sorafenib|mesh-list
92788180|NCT02748304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92788181|NCT02748304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92788182|NCT02748304|Analgesics|analgesics|mesh-ancestor
92788183|NCT02748304|Sensory System Agents|sensory system agents|mesh-ancestor
92788184|NCT02748304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788185|NCT02748304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788186|NCT02748304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788187|NCT02748304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788188|NCT02748304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92788189|NCT02748304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92788190|NCT02748304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788191|NCT02748304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92788192|NCT02748304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92788193|NCT02748304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788194|NCT02748304|Antipyretics|antipyretics|mesh-ancestor
92788195|NCT02748304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788196|NCT02748304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788197|NCT02746276|Metronidazole|metronidazole|mesh-list
92788198|NCT02746276|Ceftriaxone|ceftriaxone|mesh-list
92788199|NCT02746276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788200|NCT02746276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788201|NCT02746276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92788202|NCT02746276|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788203|NCT02745886|Metformin|metformin|mesh-list
92788204|NCT02745886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788205|NCT02745886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788206|NCT02742142|Fluorides|fluorides|mesh-list
92788207|NCT02742142|Cariostatic Agents|cariostatic agents|mesh-ancestor
92788208|NCT02742142|Protective Agents|protective agents|mesh-ancestor
92788209|NCT02742142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788210|NCT00636298|Bevacizumab|bevacizumab|mesh-list
92788211|NCT00636298|Cetuximab|cetuximab|mesh-list
92788212|NCT00636298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788213|NCT00636298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788214|NCT00636298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92788215|NCT00636298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92788216|NCT00636298|Growth Substances|growth substances|mesh-ancestor
92788217|NCT00636298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788218|NCT00636298|Growth Inhibitors|growth inhibitors|mesh-ancestor
92788219|NCT02744716|Aspirin|aspirin|mesh-list
92788220|NCT02744716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92788221|NCT02744716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92788222|NCT02744716|Analgesics|analgesics|mesh-ancestor
92788223|NCT02744716|Sensory System Agents|sensory system agents|mesh-ancestor
92788224|NCT02744716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788225|NCT02744716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788226|NCT02744716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788227|NCT02744716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788228|NCT02744716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92788229|NCT02744716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92788230|NCT02744716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788231|NCT02744716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92788232|NCT02744716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92788233|NCT02744716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788234|NCT02744716|Antipyretics|antipyretics|mesh-ancestor
92788235|NCT02744872|Felodipine|felodipine|mesh-list
92788236|NCT02744872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92788237|NCT02744872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92788238|NCT02744872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92788239|NCT02744872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788240|NCT02744872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788241|NCT02744872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92788242|NCT02744872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788243|NCT02744872|Vasodilator Agents|vasodilator agents|mesh-ancestor
92788244|NCT02744638|Metronidazole|metronidazole|mesh-list
92788245|NCT02744638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788246|NCT02744638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788247|NCT02744638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92788248|NCT02744638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788249|NCT02740894|Gefitinib|gefitinib|mesh-list
92788250|NCT02740894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788251|NCT02740894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788252|NCT02740894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788253|NCT02740894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788254|NCT00857389|Cyclophosphamide|cyclophosphamide|mesh-list
92788255|NCT00857389|Busulfan|busulfan|mesh-list
92788256|NCT00857389|Thiotepa|thiotepa|mesh-list
92788257|NCT00857389|Methotrexate|methotrexate|mesh-list
92788258|NCT00857389|Clofarabine|clofarabine|mesh-list
92788259|NCT00857389|Tacrolimus|tacrolimus|mesh-list
92788260|NCT00857389|Thymoglobulin|thymoglobulin|mesh-list
92788261|NCT00857389|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92788262|NCT00857389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788263|NCT00857389|Immunologic Factors|immunologic factors|mesh-ancestor
92788264|NCT00857389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788265|NCT00857389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788266|NCT00857389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92788267|NCT00857389|Alkylating Agents|alkylating agents|mesh-ancestor
92788268|NCT00857389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788269|NCT00857389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788270|NCT00857389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92788271|NCT00857389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92788272|NCT00857389|Abortifacient Agents|abortifacient agents|mesh-ancestor
92788273|NCT00857389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92788274|NCT00857389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788275|NCT00857389|Antimetabolites|antimetabolites|mesh-ancestor
92788276|NCT00857389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788277|NCT00857389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788278|NCT00857389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92788279|NCT00857389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92788280|NCT00857389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92788281|NCT02744482|Risedronic Acid|risedronic acid|mesh-list
92788282|NCT02744482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92788283|NCT02744482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788284|NCT02744482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788285|NCT02744482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92788286|NCT02744482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788287|NCT02744482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92788288|NCT01071798|Rituximab|rituximab|mesh-list
92788289|NCT01071798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788290|NCT01071798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788291|NCT01071798|Immunologic Factors|immunologic factors|mesh-ancestor
92788292|NCT01071798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788293|NCT01071798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788294|NCT00857311|Vaccines|vaccines|mesh-list
92788295|NCT00857311|Immunologic Factors|immunologic factors|mesh-ancestor
92788296|NCT00857311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788297|NCT02874768|Dexmedetomidine|dexmedetomidine|mesh-list
92788298|NCT02874768|Propofol|propofol|mesh-list
92788299|NCT02874768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92788300|NCT02874768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788301|NCT02874768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788302|NCT02874768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92788304|NCT02874768|Sensory System Agents|sensory system agents|mesh-ancestor
92788305|NCT02874768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788306|NCT02874768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92788307|NCT02874768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92788308|NCT02874768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92788309|NCT02874768|Adrenergic Agents|adrenergic agents|mesh-ancestor
92788310|NCT02874768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788311|NCT02874768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788312|NCT02874768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92788313|NCT02874768|Anesthetics, General|anesthetics, general|mesh-ancestor
92433360|NCT01574508|Insulin|insulin|mesh-list
92788315|NCT00857233|Memantine|memantine|mesh-list
92788316|NCT00857233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92788317|NCT00857233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92788318|NCT00857233|Dopamine Agents|dopamine agents|mesh-ancestor
92788319|NCT00857233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788320|NCT00857233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788321|NCT00857233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706456|NCT00551889|Celecoxib|celecoxib|mesh-list
92788322|NCT00857233|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92788323|NCT00857233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92788324|NCT02740426|Pirarubicin|pirarubicin|mesh-list
92788325|NCT02740426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788326|NCT02743234|Vancomycin|vancomycin|mesh-list
92788327|NCT02743234|Fidaxomicin|fidaxomicin|mesh-list
92788328|NCT02743234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788329|NCT02743234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788330|NCT02740270|Spartalizumab|spartalizumab|mesh-list
92788331|NCT02740270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92788332|NCT02740270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788333|NCT02740270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788334|NCT02740270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788335|NCT00856843|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92788336|NCT00856843|Laxatives|laxatives|mesh-ancestor
92788337|NCT00856843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788338|NCT02740192|Bupivacaine|bupivacaine|mesh-list
92788339|NCT02740192|Ropivacaine|ropivacaine|mesh-list
92788340|NCT02740192|Anesthetics, Local|anesthetics, local|mesh-ancestor
92788341|NCT02740192|Anesthetics|anesthetics|mesh-ancestor
92788342|NCT02740192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788343|NCT02740192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788344|NCT02740192|Sensory System Agents|sensory system agents|mesh-ancestor
92788345|NCT02740192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788346|NCT02743390|Infliximab|infliximab|mesh-list
92788347|NCT02743390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92788348|NCT02743390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788349|NCT02743390|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788350|NCT02743390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788351|NCT02743390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788352|NCT00856609|Exenatide|exenatide|mesh-list
92788353|NCT00856609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788354|NCT00856609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788355|NCT00856609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92788356|NCT00856609|Incretins|incretins|mesh-ancestor
92788357|NCT00856609|Hormones|hormones|mesh-ancestor
92788358|NCT00856609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788359|NCT02739958|Propofol|propofol|mesh-list
92788360|NCT02739958|Isoflurane|isoflurane|mesh-list
92788361|NCT02739958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92788362|NCT02739958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788363|NCT02739958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788364|NCT02739958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92788365|NCT02739958|Anesthetics, General|anesthetics, general|mesh-ancestor
92788366|NCT02739958|Anesthetics|anesthetics|mesh-ancestor
92788367|NCT02739958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92788368|NCT02739880|Hyaluronic Acid|hyaluronic acid|mesh-list
92788369|NCT02739880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92788370|NCT02739880|Immunologic Factors|immunologic factors|mesh-ancestor
92788371|NCT02739880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788372|NCT02739880|Viscosupplements|viscosupplements|mesh-ancestor
92788373|NCT02739880|Protective Agents|protective agents|mesh-ancestor
92788374|NCT01071096|Botulinum Toxins|botulinum toxins|mesh-list
92788375|NCT01071096|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92788376|NCT01071096|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92788377|NCT01071096|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92788378|NCT01071096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788379|NCT01071096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788381|NCT01071096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788382|NCT01071096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788383|NCT01071096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92788384|NCT01071096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788385|NCT00856375|Irinotecan|irinotecan|mesh-list
92788386|NCT00856375|Etirinotecan pegol|etirinotecan pegol|mesh-list
92788387|NCT00856375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92788388|NCT00856375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92788389|NCT00856375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788390|NCT00856375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788391|NCT00856375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788392|NCT00856375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92788394|NCT01070784|Formoterol Fumarate|formoterol fumarate|mesh-list
92788395|NCT01070784|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92788396|NCT01070784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788397|NCT01070784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92788398|NCT01070784|Autonomic Agents|autonomic agents|mesh-ancestor
92788399|NCT01070784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788400|NCT01070784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788401|NCT01070784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92788402|NCT01070784|Respiratory System Agents|respiratory system agents|mesh-ancestor
92788403|NCT01070784|Glucocorticoids|glucocorticoids|mesh-ancestor
92788404|NCT01070784|Hormones|hormones|mesh-ancestor
92788405|NCT01070784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788406|NCT01070784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92788407|NCT01070784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92788408|NCT01070784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92788409|NCT01070784|Adrenergic Agents|adrenergic agents|mesh-ancestor
92788410|NCT01070784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788411|NCT01070784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788412|NCT02694874|Rosiglitazone|rosiglitazone|mesh-list
92788413|NCT02694874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788414|NCT02694874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788415|NCT00837577|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92788416|NCT00837577|Voglibose|voglibose|mesh-list
92788417|NCT00837577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788418|NCT00837577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788419|NCT00837577|Incretins|incretins|mesh-ancestor
92788420|NCT00837577|Hormones|hormones|mesh-ancestor
92788421|NCT00837577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788422|NCT00837577|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92788423|NCT00837577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92788424|NCT00837577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788425|NCT00837577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788426|NCT00837577|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92788427|NCT01070550|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92788428|NCT01070550|Antiviral Agents|antiviral agents|mesh-ancestor
92788429|NCT01070550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788430|NCT04189900|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92788431|NCT04189900|Luteolytic Agents|luteolytic agents|mesh-ancestor
92788432|NCT04189900|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92788433|NCT04189900|Contraceptive Agents|contraceptive agents|mesh-ancestor
92788434|NCT04189900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92788435|NCT04189900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788436|NCT04189900|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92788437|NCT04189900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92788438|NCT04189900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788439|NCT00848107|Treprostinil|treprostinil|mesh-list
92788440|NCT00848107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92788441|NCT04030741|Metronidazole|metronidazole|mesh-list
92788442|NCT04030741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788443|NCT04030741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788444|NCT04030741|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92788445|NCT04030741|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788446|NCT02736760|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92788447|NCT02736760|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92788448|NCT02736760|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788449|NCT05620108|Rocuronium|rocuronium|mesh-list
92788450|NCT05620108|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92788451|NCT05620108|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92788452|NCT05620108|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92788453|NCT05620108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788454|NCT05620108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788455|NCT00856297|Vaccines|vaccines|mesh-list
92788456|NCT00856297|Immunologic Factors|immunologic factors|mesh-ancestor
92788457|NCT00856297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788458|NCT02736604|Nitrous Oxide|nitrous oxide|mesh-list
92788459|NCT02736604|Anesthetics|anesthetics|mesh-list
92788460|NCT02736604|Sevoflurane|sevoflurane|mesh-list
92788461|NCT02736604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788462|NCT02736604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433517|NCT01576185|Sorafenib|sorafenib|mesh-list
92788463|NCT02736604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92788464|NCT02736604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92788465|NCT02736604|Anesthetics, General|anesthetics, general|mesh-ancestor
92788466|NCT02736604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92788467|NCT02736604|Analgesics|analgesics|mesh-ancestor
92788468|NCT02736604|Sensory System Agents|sensory system agents|mesh-ancestor
92788469|NCT02736604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788470|NCT02613013|Proxymetacaine|proxymetacaine|mesh-list
92788471|NCT02613013|Pilocarpine|pilocarpine|mesh-list
92788472|NCT02613013|Miotics|miotics|mesh-ancestor
92788473|NCT02613013|Autonomic Agents|autonomic agents|mesh-ancestor
92788474|NCT02613013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788475|NCT02613013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788476|NCT02613013|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92788477|NCT02613013|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92788478|NCT02613013|Cholinergic Agents|cholinergic agents|mesh-ancestor
92788479|NCT02613013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788480|NCT02613013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788481|NCT02613013|Anesthetics, Local|anesthetics, local|mesh-ancestor
92788482|NCT02613013|Anesthetics|anesthetics|mesh-ancestor
92788483|NCT02613013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788484|NCT02613013|Sensory System Agents|sensory system agents|mesh-ancestor
92788485|NCT04306510|Antibodies|antibodies|mesh-list
92788486|NCT04306510|Immunoglobulins|immunoglobulins|mesh-list
92788487|NCT04306510|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92788488|NCT04306510|Immunologic Factors|immunologic factors|mesh-ancestor
92788489|NCT04306510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788490|NCT02611921|Ketamine|ketamine|mesh-list
92788491|NCT02611921|Analgesics|analgesics|mesh-ancestor
92788492|NCT02611921|Sensory System Agents|sensory system agents|mesh-ancestor
92788493|NCT02611921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788494|NCT02611921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788495|NCT02611921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92788496|NCT02611921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92788497|NCT02611921|Anesthetics, General|anesthetics, general|mesh-ancestor
92788498|NCT02611921|Anesthetics|anesthetics|mesh-ancestor
92788499|NCT02611921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788500|NCT02611921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92788501|NCT02611921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92788502|NCT02611921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788503|NCT02611921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788504|NCT02736448|Capecitabine|capecitabine|mesh-list
92788505|NCT02736448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788506|NCT02736448|Antimetabolites|antimetabolites|mesh-ancestor
92788507|NCT02736448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788508|NCT02736448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788509|NCT00703651|Vaccines|vaccines|mesh-list
92788510|NCT00703651|Immunologic Factors|immunologic factors|mesh-ancestor
92788511|NCT00703651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788512|NCT01046136|Phenylpropanolamine|phenylpropanolamine|mesh-list
92788513|NCT01046136|Guaifenesin|guaifenesin|mesh-list
92788514|NCT01046136|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92788515|NCT01046136|Expectorants|expectorants|mesh-ancestor
92788516|NCT01046136|Respiratory System Agents|respiratory system agents|mesh-ancestor
92788517|NCT01046136|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92788518|NCT01046136|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92788519|NCT01046136|Adrenergic Agents|adrenergic agents|mesh-ancestor
92788520|NCT01046136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788521|NCT01046136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788522|NCT01046136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788523|NCT01046136|Appetite Depressants|appetite depressants|mesh-ancestor
92788524|NCT01046136|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92788525|NCT01046136|Sympathomimetics|sympathomimetics|mesh-ancestor
92788526|NCT01046136|Autonomic Agents|autonomic agents|mesh-ancestor
92788527|NCT01046136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788528|NCT01046136|Nasal Decongestants|nasal decongestants|mesh-ancestor
92788529|NCT01046136|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92788530|NCT02736682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92788531|NCT02736682|Metronidazole|metronidazole|mesh-list
92788532|NCT02736682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92788533|NCT02736682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788534|NCT02736682|Antitubercular Agents|antitubercular agents|mesh-ancestor
92788535|NCT02736682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92433581|NCT01576692|Immunologic Factors|immunologic factors|mesh-ancestor
92788536|NCT02736682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788537|NCT00701155|Insulin Detemir|insulin detemir|mesh-list
92788538|NCT00701155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788539|NCT00701155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788540|NCT02874690|Methylphenidate|methylphenidate|mesh-list
92788541|NCT02874690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92788542|NCT02874690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788543|NCT02874690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92788544|NCT02874690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92788545|NCT02874690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788546|NCT02874690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788547|NCT02874690|Dopamine Agents|dopamine agents|mesh-ancestor
92788548|NCT02874690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788550|NCT02738632|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92788551|NCT02738632|Telmisartan|telmisartan|mesh-list
92788552|NCT02738632|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92788553|NCT02738632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92788554|NCT02738632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92788555|NCT02738632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788556|NCT02738632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788557|NCT02738632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92788558|NCT02738632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788559|NCT02738632|Vasodilator Agents|vasodilator agents|mesh-ancestor
92788560|NCT02738632|Diuretics|diuretics|mesh-ancestor
92788561|NCT02738632|Natriuretic Agents|natriuretic agents|mesh-ancestor
92788562|NCT02738632|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92788563|NCT02738632|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92788564|NCT02738632|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92788565|NCT01070394|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92788566|NCT01070394|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92788567|NCT01070394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788568|NCT01070394|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92788569|NCT01070394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92788570|NCT01070394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788571|NCT01070394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788572|NCT01070394|Dopamine Agents|dopamine agents|mesh-ancestor
92788573|NCT01070394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788574|NCT00703807|Everolimus|everolimus|mesh-list
92788575|NCT00703807|Topotecan|topotecan|mesh-list
92788576|NCT00703807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92788577|NCT00703807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788578|NCT00703807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788579|NCT00703807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788580|NCT00703807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788581|NCT00703807|Immunologic Factors|immunologic factors|mesh-ancestor
92788582|NCT00703807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788583|NCT00703807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788584|NCT00703807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92788585|NCT00703807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92788586|NCT03649438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92788587|NCT03649438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788588|NCT03649438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788589|NCT03649438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788590|NCT03649438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92788591|NCT00701233|Botulinum Toxins|botulinum toxins|mesh-list
92788592|NCT00701233|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92788593|NCT00701233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92788594|NCT00701233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788595|NCT00701233|Cholinergic Agents|cholinergic agents|mesh-ancestor
92788596|NCT00701233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788597|NCT00701233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788598|NCT03633058|Ketamine|ketamine|mesh-list
92788599|NCT03633058|Analgesics|analgesics|mesh-ancestor
92788600|NCT03633058|Sensory System Agents|sensory system agents|mesh-ancestor
92788601|NCT03633058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788602|NCT03633058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788603|NCT03633058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92788604|NCT03633058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92788605|NCT03633058|Anesthetics, General|anesthetics, general|mesh-ancestor
92788606|NCT03633058|Anesthetics|anesthetics|mesh-ancestor
92788607|NCT03633058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788608|NCT03633058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92788609|NCT03633058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92788610|NCT03633058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788611|NCT03633058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788612|NCT01070316|Everolimus|everolimus|mesh-list
92788613|NCT01070316|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92788614|NCT01070316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788615|NCT01070316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788616|NCT01070316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788617|NCT01070316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788618|NCT01070316|Immunologic Factors|immunologic factors|mesh-ancestor
92788619|NCT01070316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788620|NCT01070316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788621|NCT02737774|Carboplatin|carboplatin|mesh-list
92788622|NCT02737774|Pemetrexed|pemetrexed|mesh-list
92788623|NCT02737774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788624|NCT02737774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788625|NCT02737774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788626|NCT02737774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92788627|NCT02737774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92788628|NCT02735590|Isoniazid|isoniazid|mesh-list
92788629|NCT02735590|Rifapentine|rifapentine|mesh-list
92788630|NCT02735590|Antitubercular Agents|antitubercular agents|mesh-ancestor
92706766|NCT02894645|Antiviral Agents|antiviral agents|mesh-ancestor
92788631|NCT02735590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788632|NCT02735590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788633|NCT02735590|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92788634|NCT02735590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92788635|NCT02735590|Antimetabolites|antimetabolites|mesh-ancestor
92788636|NCT02735590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788637|NCT02735590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92788638|NCT02735590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92788639|NCT02735590|Leprostatic Agents|leprostatic agents|mesh-ancestor
92788640|NCT05626348|Hydroxychloroquine|hydroxychloroquine|mesh-list
92788641|NCT05626348|Adalimumab|adalimumab|mesh-list
92788642|NCT05626348|Methotrexate|methotrexate|mesh-list
92788643|NCT05626348|Leflunomide|leflunomide|mesh-list
92788644|NCT05626348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92788645|NCT05626348|Abortifacient Agents|abortifacient agents|mesh-ancestor
92788646|NCT05626348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92788647|NCT05626348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788648|NCT05626348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788649|NCT05626348|Antimetabolites|antimetabolites|mesh-ancestor
92788650|NCT05626348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788651|NCT05626348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788652|NCT05626348|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788653|NCT05626348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788654|NCT05626348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92788655|NCT05626348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788656|NCT05626348|Immunologic Factors|immunologic factors|mesh-ancestor
92788657|NCT05626348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788658|NCT05626348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92788659|NCT05626348|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92788660|NCT05626348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788661|NCT05626348|Antimalarials|antimalarials|mesh-ancestor
92788662|NCT05626348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92788663|NCT05626348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788664|NCT05626348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788665|NCT02737696|Analgesics, Opioid|analgesics, opioid|mesh-list
92788666|NCT02737696|Narcotics|narcotics|mesh-ancestor
92788667|NCT02737696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788668|NCT02737696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788669|NCT02737696|Analgesics|analgesics|mesh-ancestor
92788670|NCT02737696|Sensory System Agents|sensory system agents|mesh-ancestor
92788671|NCT02737696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788672|NCT02737228|Gemcitabine|gemcitabine|mesh-list
92788673|NCT02737228|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92788674|NCT02737228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788675|NCT02737228|Antimetabolites|antimetabolites|mesh-ancestor
92788676|NCT02737228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788677|NCT02737228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788678|NCT02737228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788679|NCT02737228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788681|NCT01126541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788682|NCT01126541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788683|NCT01126541|Immunologic Factors|immunologic factors|mesh-ancestor
92788684|NCT01126541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788685|NCT01126541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788687|NCT02737150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788688|NCT02737150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788689|NCT02735356|Itraconazole|itraconazole|mesh-list
92788690|NCT02735356|Antifungal Agents|antifungal agents|mesh-ancestor
92788691|NCT02735356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788692|NCT02735356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92788693|NCT02735356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92788694|NCT02735356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788695|NCT02735356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788696|NCT02735356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92788697|NCT02735356|Hormone Antagonists|hormone antagonists|mesh-ancestor
92788698|NCT02735356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788699|NCT02735356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788700|NCT02735356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92788701|NCT00625469|Bosentan|bosentan|mesh-list
92788702|NCT00625469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92788703|NCT00625469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92788704|NCT00625469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788705|NCT05577910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92788706|NCT05577910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92788707|NCT00637481|Atorvastatin|atorvastatin|mesh-list
92788708|NCT00637481|Calcium|calcium|mesh-list
92788709|NCT00637481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92788710|NCT00637481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788711|NCT00637481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92788712|NCT00637481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92788713|NCT00637481|Antimetabolites|antimetabolites|mesh-ancestor
92788714|NCT00637481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788715|NCT00637481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92788716|NCT00637481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92788717|NCT00637481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788718|NCT00637559|Esomeprazole|esomeprazole|mesh-list
92788719|NCT00637559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92788720|NCT00637559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788721|NCT00637559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92788722|NCT00637559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788723|NCT00637559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788724|NCT00836875|Voriconazole|voriconazole|mesh-list
92788725|NCT00836875|Antifungal Agents|antifungal agents|mesh-ancestor
92788726|NCT00836875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788727|NCT00836875|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92788728|NCT00836875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92788729|NCT00836875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788730|NCT00836875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788731|NCT00836875|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92788732|NCT00836875|Hormone Antagonists|hormone antagonists|mesh-ancestor
92788733|NCT00836875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788734|NCT00836875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788735|NCT00836875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92788736|NCT02732314|Desonide|desonide|mesh-list
92788737|NCT02732314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788738|NCT01125917|Buprenorphine|buprenorphine|mesh-list
92788739|NCT01125917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92788740|NCT01125917|Narcotics|narcotics|mesh-ancestor
92788741|NCT01125917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788742|NCT01125917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788743|NCT01125917|Analgesics|analgesics|mesh-ancestor
92788744|NCT01125917|Sensory System Agents|sensory system agents|mesh-ancestor
92788745|NCT01125917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788746|NCT01125917|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92788747|NCT02732236|Rituximab|rituximab|mesh-list
92706890|NCT01211665|Glucocorticoids|glucocorticoids|mesh-ancestor
92788748|NCT02732236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92788749|NCT02732236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788750|NCT02732236|Immunologic Factors|immunologic factors|mesh-ancestor
92788751|NCT02732236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788752|NCT02732236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788753|NCT01121549|Exemestane|exemestane|mesh-list
92788754|NCT01121549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788755|NCT01121549|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92788756|NCT01121549|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92788757|NCT01121549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788758|NCT01121549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788759|NCT01121549|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92788760|NCT01121549|Hormone Antagonists|hormone antagonists|mesh-ancestor
92788761|NCT01121549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788762|NCT01121549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788763|NCT00847405|Sumatriptan|sumatriptan|mesh-list
92788764|NCT00847405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92788765|NCT00847405|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92788766|NCT00847405|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92788767|NCT00847405|Serotonin Agents|serotonin agents|mesh-ancestor
92788768|NCT00847405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788769|NCT00847405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788770|NCT00847405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788771|NCT02731846|Fluticasone|fluticasone|mesh-list
92788773|NCT02731846|Albuterol|albuterol|mesh-list
92788774|NCT02731846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788775|NCT02731846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92788776|NCT02731846|Autonomic Agents|autonomic agents|mesh-ancestor
92788777|NCT02731846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788778|NCT02731846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788779|NCT02731846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92788780|NCT02731846|Respiratory System Agents|respiratory system agents|mesh-ancestor
92788781|NCT02731846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788782|NCT02731846|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92788783|NCT02731846|Tocolytic Agents|tocolytic agents|mesh-ancestor
92788784|NCT02731846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92788785|NCT02731846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92788786|NCT02731846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92788787|NCT02731846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92788788|NCT02731846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92788789|NCT02731846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788790|NCT02731846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788791|NCT04248712|Loratadine|loratadine|mesh-list
92788792|NCT04248712|Famotidine|famotidine|mesh-list
92788793|NCT04248712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92788794|NCT04248712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788795|NCT04248712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92788796|NCT04248712|Histamine Antagonists|histamine antagonists|mesh-ancestor
92788797|NCT04248712|Histamine Agents|histamine agents|mesh-ancestor
92788798|NCT04248712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788799|NCT04248712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788800|NCT04248712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788801|NCT04248712|Antipruritics|antipruritics|mesh-ancestor
92788802|NCT04248712|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788803|NCT04248712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92788804|NCT04248712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92788805|NCT04248712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92788806|NCT02734732|Ciprofloxacin|ciprofloxacin|mesh-list
92788807|NCT02734732|Trimethoprim|trimethoprim|mesh-list
92788808|NCT02734732|Sulfamethoxazole|sulfamethoxazole|mesh-list
92788809|NCT02734732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788810|NCT02734732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788811|NCT02734732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92788812|NCT02734732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92788813|NCT02734732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788814|NCT02734732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788815|NCT02734732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788816|NCT02734732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92788817|NCT02734732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92788818|NCT02734732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92788819|NCT02734732|Antimalarials|antimalarials|mesh-ancestor
92788820|NCT02734732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92788821|NCT02734732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788822|NCT02734732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92788823|NCT02734732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92788824|NCT02734732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92788825|NCT02731378|Iron|iron|mesh-list
92788826|NCT02731378|Dextrans|dextrans|mesh-list
92788827|NCT02731378|Epoetin Alfa|epoetin alfa|mesh-list
92788828|NCT02731378|Iron-Dextran Complex|iron-dextran complex|mesh-list
92788829|NCT02731378|Trace Elements|trace elements|mesh-ancestor
92433877|NCT01578343|Hormones|hormones|mesh-ancestor
92788830|NCT02731378|Micronutrients|micronutrients|mesh-ancestor
92788831|NCT02731378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788832|NCT02731378|Hematinics|hematinics|mesh-ancestor
92788833|NCT02731378|Anticoagulants|anticoagulants|mesh-ancestor
92788834|NCT02731378|Plasma Substitutes|plasma substitutes|mesh-ancestor
92788835|NCT02731378|Blood Substitutes|blood substitutes|mesh-ancestor
92788836|NCT02731534|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92788837|NCT02731534|Hematinics|hematinics|mesh-ancestor
92788838|NCT02734420|Tolonium Chloride|tolonium chloride|mesh-list
92788839|NCT02734420|Hemostatics|hemostatics|mesh-ancestor
92788840|NCT02734420|Coagulants|coagulants|mesh-ancestor
92788841|NCT02734420|Heparin Antagonists|heparin antagonists|mesh-ancestor
92788842|NCT02734420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788843|NCT00704275|Cyclosporine|cyclosporine|mesh-list
92788844|NCT00704275|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92788845|NCT00704275|Cyclosporins|cyclosporins|mesh-list
92788846|NCT00704275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788847|NCT00704275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788848|NCT00704275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92788849|NCT00704275|Immunologic Factors|immunologic factors|mesh-ancestor
92788850|NCT00704275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788851|NCT00704275|Antifungal Agents|antifungal agents|mesh-ancestor
92788852|NCT00704275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788853|NCT00704275|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788854|NCT00704275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788855|NCT00704275|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92788856|NCT00704275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92788857|NCT00847015|Gemcitabine|gemcitabine|mesh-list
92788858|NCT00847015|Sunitinib|sunitinib|mesh-list
92788859|NCT00847015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788860|NCT00847015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788861|NCT00847015|Antimetabolites|antimetabolites|mesh-ancestor
92788862|NCT00847015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788863|NCT00847015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92788864|NCT00847015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92788865|NCT00847015|Growth Substances|growth substances|mesh-ancestor
92788866|NCT00847015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788867|NCT00847015|Growth Inhibitors|growth inhibitors|mesh-ancestor
92788868|NCT00847015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788869|NCT00847015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788870|NCT00627354|Prednisone|prednisone|mesh-list
92788871|NCT00627354|Etoposide|etoposide|mesh-list
92788872|NCT00627354|Vinorelbine|vinorelbine|mesh-list
92788873|NCT00627354|Mitoxantrone|mitoxantrone|mesh-list
92788874|NCT00627354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788875|NCT00627354|Glucocorticoids|glucocorticoids|mesh-ancestor
92788876|NCT00627354|Hormones|hormones|mesh-ancestor
92788877|NCT00627354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788878|NCT00627354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788879|NCT00627354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92788880|NCT00627354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788881|NCT00627354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92788882|NCT00627354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92788883|NCT00627354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92788884|NCT00627354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788885|NCT00627354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788886|NCT00627354|Tubulin Modulators|tubulin modulators|mesh-ancestor
92788887|NCT00627354|Antimitotic Agents|antimitotic agents|mesh-ancestor
92788888|NCT00627354|Mitosis Modulators|mitosis modulators|mesh-ancestor
92788889|NCT00627354|Analgesics|analgesics|mesh-ancestor
92788890|NCT00627354|Sensory System Agents|sensory system agents|mesh-ancestor
92788891|NCT00627354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788892|NCT00704431|Darapladib|darapladib|mesh-list
92788893|NCT00704431|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92788894|NCT00704431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788895|NCT00704431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788896|NCT02734186|Praziquantel|praziquantel|mesh-list
92788897|NCT02734186|Anthelmintics|anthelmintics|mesh-ancestor
92788898|NCT02734186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788899|NCT02734186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788900|NCT00704509|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92788901|NCT00704509|Antidepressive Agents|antidepressive agents|mesh-ancestor
92788902|NCT00704509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92788903|NCT00704509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92788904|NCT00704509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92788905|NCT00704509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92788906|NCT00704509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788908|NCT02733952|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92788909|NCT02733952|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92788910|NCT02733952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788911|NCT02733952|Hemostatics|hemostatics|mesh-ancestor
92788912|NCT02733952|Coagulants|coagulants|mesh-ancestor
92788913|NCT02733640|Pantoprazole|pantoprazole|mesh-list
92788914|NCT02733640|Ranitidine|ranitidine|mesh-list
92788915|NCT02733640|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92788916|NCT02733640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92788917|NCT02733640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92788918|NCT02733640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92788919|NCT02733640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707056|NCT05288907|Sensory System Agents|sensory system agents|mesh-ancestor
92788920|NCT02733640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788921|NCT02733640|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92788922|NCT02733640|Histamine Antagonists|histamine antagonists|mesh-ancestor
92788923|NCT02733640|Histamine Agents|histamine agents|mesh-ancestor
92788924|NCT02733640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92788925|NCT02733640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788926|NCT02730676|Menthol|menthol|mesh-list
92788927|NCT02730676|Antipruritics|antipruritics|mesh-ancestor
92788928|NCT02730676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788929|NCT00855595|Metronidazole|metronidazole|mesh-list
92788930|NCT00855595|Doxycycline|doxycycline|mesh-list
92788931|NCT00855595|Azelaic acid|azelaic acid|mesh-list
92788932|NCT00855595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788933|NCT00855595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92788934|NCT00855595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92788935|NCT00855595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92788936|NCT00855595|Antimalarials|antimalarials|mesh-ancestor
92788937|NCT00855595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788938|NCT00855595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788939|NCT05433532|Azacitidine|azacitidine|mesh-list
92788940|NCT05433532|Venetoclax|venetoclax|mesh-list
92788941|NCT05433532|Flumatinib|flumatinib|mesh-list
92788942|NCT05433532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92788943|NCT05433532|Antimetabolites|antimetabolites|mesh-ancestor
92788944|NCT05433532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788945|NCT05433532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92788946|NCT05433532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788947|NCT05433532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92788948|NCT00855439|Exenatide|exenatide|mesh-list
92788949|NCT00855439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92788950|NCT00855439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788951|NCT00855439|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92788952|NCT00855439|Incretins|incretins|mesh-ancestor
92788953|NCT00855439|Hormones|hormones|mesh-ancestor
92788954|NCT00855439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788955|NCT01064856|Adalimumab|adalimumab|mesh-list
92788956|NCT01064856|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92788957|NCT01064856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788958|NCT01064856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92788959|NCT02730442|Fluconazole|fluconazole|mesh-list
92788960|NCT02730442|Antifungal Agents|antifungal agents|mesh-list
92788961|NCT02730442|Clotrimazole|clotrimazole|mesh-list
92788962|NCT02730442|Miconazole|miconazole|mesh-list
92788963|NCT02730442|Olorofim|olorofim|mesh-list
92788964|NCT02730442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92788965|NCT02730442|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92788966|NCT02730442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92788967|NCT02730442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92788968|NCT02730442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788969|NCT02730442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92788970|NCT02730442|Hormone Antagonists|hormone antagonists|mesh-ancestor
92788971|NCT02730442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788972|NCT02730442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788973|NCT02730442|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92788974|NCT02730442|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92788975|NCT02730442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92788976|NCT02730442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92788977|NCT02733874|Betamethasone|betamethasone|mesh-list
92788978|NCT02733874|Clobetasol|clobetasol|mesh-list
92788979|NCT02733874|Calcipotriene|calcipotriene|mesh-list
92788980|NCT02733874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92788981|NCT02733874|Glucocorticoids|glucocorticoids|mesh-ancestor
92788982|NCT02733874|Hormones|hormones|mesh-ancestor
92788983|NCT02733874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92788984|NCT02733874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788985|NCT02733874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92788986|NCT02733874|Respiratory System Agents|respiratory system agents|mesh-ancestor
92788987|NCT02733874|Dermatologic Agents|dermatologic agents|mesh-ancestor
92788989|NCT02730364|Pheniramine|pheniramine|mesh-list
92788990|NCT02730364|Phenylephrine|phenylephrine|mesh-list
92788991|NCT02730364|Oxymetazoline|oxymetazoline|mesh-list
92788992|NCT02730364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92788993|NCT02730364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92788994|NCT02730364|Analgesics|analgesics|mesh-ancestor
92788995|NCT02730364|Sensory System Agents|sensory system agents|mesh-ancestor
92788996|NCT02730364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92788997|NCT02730364|Antipyretics|antipyretics|mesh-ancestor
92788998|NCT02730364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92788999|NCT02730364|Protective Agents|protective agents|mesh-ancestor
92789000|NCT02730364|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92789001|NCT02730364|Mydriatics|mydriatics|mesh-ancestor
92789002|NCT02730364|Autonomic Agents|autonomic agents|mesh-ancestor
92789003|NCT02730364|Sympathomimetics|sympathomimetics|mesh-ancestor
92789004|NCT02730364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92789005|NCT02730364|Nasal Decongestants|nasal decongestants|mesh-ancestor
92789006|NCT02730364|Respiratory System Agents|respiratory system agents|mesh-ancestor
92789007|NCT02730364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92789008|NCT02730364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92789009|NCT02730364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92789010|NCT02730364|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789011|NCT02730364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789012|NCT02730364|Antipruritics|antipruritics|mesh-ancestor
92789013|NCT02730364|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789014|NCT02730364|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92789015|NCT02730364|Histamine Antagonists|histamine antagonists|mesh-ancestor
92789016|NCT02730364|Histamine Agents|histamine agents|mesh-ancestor
92789017|NCT02730364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92789018|NCT01042392|Ramipril|ramipril|mesh-list
92789019|NCT01042392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92789020|NCT01042392|Protease Inhibitors|protease inhibitors|mesh-ancestor
92789021|NCT01042392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789022|NCT01042392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789023|NCT01042392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92789024|NCT00704665|Methocarbamol|methocarbamol|mesh-list
92789025|NCT00704665|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92789026|NCT00704665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789027|NCT00704665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92789028|NCT00704665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789029|NCT00913315|Tamsulosin|tamsulosin|mesh-list
92789030|NCT00913315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92789031|NCT00913315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92789032|NCT00913315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92789033|NCT00913315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92789034|NCT00913315|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789035|NCT00913315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789036|NCT00913315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789037|NCT00913315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789038|NCT00913315|Urological Agents|urological agents|mesh-ancestor
92789039|NCT00913315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92789040|NCT00913315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92789041|NCT00913315|Cholinergic Agents|cholinergic agents|mesh-ancestor
92789042|NCT00701857|Pemetrexed|pemetrexed|mesh-list
92789043|NCT00701857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789044|NCT00701857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789045|NCT00701857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789046|NCT00701857|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92789047|NCT00701857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789048|NCT02729662|Tolvaptan|tolvaptan|mesh-list
92789049|NCT02729662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92789050|NCT02729662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789051|NCT02729662|Natriuretic Agents|natriuretic agents|mesh-ancestor
92789052|NCT02729662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789053|NCT02733250|Paclitaxel|paclitaxel|mesh-list
92789054|NCT02733250|Pembrolizumab|pembrolizumab|mesh-list
92789055|NCT02733250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789056|NCT02733250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434094|NCT01579279|Antidepressive Agents|antidepressive agents|mesh-ancestor
92789057|NCT02733250|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789059|NCT02733250|Mitosis Modulators|mitosis modulators|mesh-ancestor
92789060|NCT02733250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789061|NCT02733250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92789062|NCT02733250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92789063|NCT03188068|Sirolimus|sirolimus|mesh-list
92789064|NCT03188068|Prednisolone|prednisolone|mesh-list
92789065|NCT03188068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789066|NCT03188068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789067|NCT03188068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92789068|NCT03188068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789069|NCT03188068|Antifungal Agents|antifungal agents|mesh-ancestor
92789070|NCT03188068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789071|NCT03188068|Immunologic Factors|immunologic factors|mesh-ancestor
92789072|NCT03188068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789073|NCT03188068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92789074|NCT03188068|Glucocorticoids|glucocorticoids|mesh-ancestor
92789075|NCT03188068|Hormones|hormones|mesh-ancestor
92789076|NCT03188068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789077|NCT03188068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92789078|NCT01064310|Sunitinib|sunitinib|mesh-list
92789079|NCT01064310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789080|NCT01064310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92789081|NCT01064310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92789082|NCT01064310|Growth Substances|growth substances|mesh-ancestor
92789083|NCT01064310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789084|NCT01064310|Growth Inhibitors|growth inhibitors|mesh-ancestor
92789085|NCT01064310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92789086|NCT01064310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789087|NCT01064310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789088|NCT02726854|Apatinib|apatinib|mesh-list
92789089|NCT02726854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789090|NCT02726854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92789091|NCT02726854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789092|NCT02726854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789093|NCT04724928|Immunomodulating Agents|immunomodulating agents|mesh-list
92789094|NCT04724928|Immunologic Factors|immunologic factors|mesh-ancestor
92789095|NCT04724928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789096|NCT02728492|Paclitaxel|paclitaxel|mesh-list
92789097|NCT02728492|Carboplatin|carboplatin|mesh-list
92789098|NCT02728492|Gemcitabine|gemcitabine|mesh-list
92789099|NCT02728492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789100|NCT02728492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789101|NCT02728492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789102|NCT02728492|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789103|NCT02728492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707235|NCT05093205|Estrogens|estrogens|mesh-ancestor
92789104|NCT02728492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789105|NCT02728492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789106|NCT02728492|Antimetabolites|antimetabolites|mesh-ancestor
92789107|NCT02726308|Dexamethasone|dexamethasone|mesh-list
92789108|NCT02726308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92789109|NCT02726308|Antiemetics|antiemetics|mesh-ancestor
92789110|NCT02726308|Autonomic Agents|autonomic agents|mesh-ancestor
92789111|NCT02726308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789112|NCT02726308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789113|NCT02726308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92789114|NCT02726308|Glucocorticoids|glucocorticoids|mesh-ancestor
92789115|NCT02726308|Hormones|hormones|mesh-ancestor
92789116|NCT02726308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789117|NCT02726308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92789118|NCT02726308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789119|NCT01037244|Udenafil|udenafil|mesh-list
92789120|NCT01037244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92789121|NCT01037244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92789122|NCT01037244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789123|NCT01037244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789124|NCT00627432|Gemcitabine|gemcitabine|mesh-list
92789125|NCT00627432|Oxaliplatin|oxaliplatin|mesh-list
92789126|NCT00627432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789127|NCT00627432|Antimetabolites|antimetabolites|mesh-ancestor
92789128|NCT00627432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789129|NCT00627432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789130|NCT02727712|Anesthetics|anesthetics|mesh-list
92434171|NCT01579786|Acetaminophen|acetaminophen|mesh-list
92789131|NCT02727712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789132|NCT02727712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789134|NCT01042236|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92789135|NCT01042236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92789136|NCT01042236|Cholinergic Agents|cholinergic agents|mesh-ancestor
92789137|NCT01042236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789138|NCT01042236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789139|NCT01042236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789140|NCT01042236|Urological Agents|urological agents|mesh-ancestor
92789141|NCT02725918|Pemetrexed|pemetrexed|mesh-list
92789142|NCT02725918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789143|NCT02725918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789144|NCT02725918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789145|NCT02725918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92789146|NCT02725918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789147|NCT00592501|Fluorouracil|fluorouracil|mesh-list
92789148|NCT00592501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789149|NCT00592501|Antimetabolites|antimetabolites|mesh-ancestor
92789150|NCT00592501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789151|NCT00592501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789152|NCT00592501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789153|NCT00592501|Immunologic Factors|immunologic factors|mesh-ancestor
92789154|NCT00592501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789155|NCT01040832|Cetuximab|cetuximab|mesh-list
92789156|NCT01040832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92789157|NCT01040832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789158|NCT02721238|Plasma-lyte 148|plasma-lyte 148|mesh-list
92707312|NCT05073627|Dabigatran|dabigatran|mesh-list
92789159|NCT02721238|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92789160|NCT02721238|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92789161|NCT04304196|TEMPO|tempo|mesh-list
92789162|NCT04304196|Antioxidants|antioxidants|mesh-ancestor
92789163|NCT04304196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789164|NCT04304196|Protective Agents|protective agents|mesh-ancestor
92789165|NCT04304196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789166|NCT02720770|Hormones|hormones|mesh-list
92789167|NCT02720770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789168|NCT02720770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789169|NCT02720926|Capecitabine|capecitabine|mesh-list
92789170|NCT02720926|Oxaliplatin|oxaliplatin|mesh-list
92789171|NCT02720926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789172|NCT02720926|Antimetabolites|antimetabolites|mesh-ancestor
92789173|NCT02720926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789174|NCT02720926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789175|NCT00854581|Interferons|interferons|mesh-list
92789176|NCT00854581|Interferon-alpha|interferon-alpha|mesh-list
92789177|NCT00854581|Interferon alpha-2|interferon alpha-2|mesh-list
92789178|NCT00854581|Zidovudine|zidovudine|mesh-list
92789179|NCT00854581|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92789180|NCT00854581|Valproic Acid|valproic acid|mesh-list
92789181|NCT00854581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789182|NCT00854581|Antiviral Agents|antiviral agents|mesh-ancestor
92789183|NCT00854581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789184|NCT00854581|Immunologic Factors|immunologic factors|mesh-ancestor
92789185|NCT00854581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789186|NCT00854581|Antimetabolites|antimetabolites|mesh-ancestor
92789187|NCT00854581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789188|NCT00854581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92789189|NCT00854581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789190|NCT00854581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789191|NCT00854581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92789192|NCT00854581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92789193|NCT00854581|Anticonvulsants|anticonvulsants|mesh-ancestor
92789194|NCT00854581|GABA Agents|gaba agents|mesh-ancestor
92789195|NCT00854581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789196|NCT00854581|Antimanic Agents|antimanic agents|mesh-ancestor
92789197|NCT00854581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92789198|NCT00854581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789199|NCT00854581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92789200|NCT02720458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92789201|NCT02720458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789202|NCT02720458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789203|NCT00833911|Tramadol|tramadol|mesh-list
92789204|NCT00833911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92789205|NCT00833911|Narcotics|narcotics|mesh-ancestor
92789206|NCT00833911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789207|NCT00833911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789208|NCT00833911|Analgesics|analgesics|mesh-ancestor
92789209|NCT00833911|Sensory System Agents|sensory system agents|mesh-ancestor
92789210|NCT00833911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789212|NCT02719756|Dapagliflozin|dapagliflozin|mesh-list
92789213|NCT02719756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92789214|NCT02719756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789215|NCT02719756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92789216|NCT02719756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789217|NCT01125293|Rituximab|rituximab|mesh-list
92789218|NCT01125293|Everolimus|everolimus|mesh-list
92789219|NCT01125293|Bortezomib|bortezomib|mesh-list
92789220|NCT01125293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92789221|NCT01125293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789222|NCT01125293|Immunologic Factors|immunologic factors|mesh-ancestor
92789223|NCT01125293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789224|NCT01125293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789225|NCT01125293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92789226|NCT01125293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92789227|NCT01125293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789228|NCT01125293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789229|NCT01125293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789230|NCT02719834|Acetaminophen|acetaminophen|mesh-list
92789231|NCT02719834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92789232|NCT02719834|Analgesics|analgesics|mesh-ancestor
92789233|NCT02719834|Sensory System Agents|sensory system agents|mesh-ancestor
92789234|NCT02719834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789235|NCT02719834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789236|NCT02719834|Antipyretics|antipyretics|mesh-ancestor
92789237|NCT02719210|Mannitol|mannitol|mesh-list
92789238|NCT02719210|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92789239|NCT02719210|Diuretics|diuretics|mesh-ancestor
92789240|NCT02719210|Natriuretic Agents|natriuretic agents|mesh-ancestor
92789241|NCT02719210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789242|NCT02719132|Metformin|metformin|mesh-list
92789243|NCT02719132|Dapagliflozin|dapagliflozin|mesh-list
92789244|NCT02719132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92789245|NCT02719132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789246|NCT02719132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92789247|NCT02719132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789248|NCT02718820|Docetaxel|docetaxel|mesh-list
92789249|NCT02718820|Pembrolizumab|pembrolizumab|mesh-list
92789250|NCT02718820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789251|NCT02718820|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789252|NCT02718820|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789253|NCT02718820|Mitosis Modulators|mitosis modulators|mesh-ancestor
92789254|NCT02718820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789255|NCT02718820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92789256|NCT02718820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92789257|NCT02718976|Lidocaine|lidocaine|mesh-list
92789258|NCT02718976|Epinephrine|epinephrine|mesh-list
92789259|NCT02718976|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92789260|NCT02718976|Anesthetics, Local|anesthetics, local|mesh-ancestor
92789261|NCT02718976|Anesthetics|anesthetics|mesh-ancestor
92789262|NCT02718976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789263|NCT02718976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789264|NCT02718976|Sensory System Agents|sensory system agents|mesh-ancestor
92789265|NCT02718976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789266|NCT02718976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92789267|NCT02718976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92789268|NCT02718976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92789269|NCT02718976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92789270|NCT02718976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789271|NCT02718976|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92789272|NCT02718976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92789273|NCT02718976|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789274|NCT02718976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789275|NCT02718976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92789276|NCT02718976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92789277|NCT02718976|Autonomic Agents|autonomic agents|mesh-ancestor
92789278|NCT02718976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92789279|NCT02718976|Respiratory System Agents|respiratory system agents|mesh-ancestor
92789281|NCT02718976|Sympathomimetics|sympathomimetics|mesh-ancestor
92789282|NCT02718976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92789283|NCT02718976|Chelating Agents|chelating agents|mesh-ancestor
92789284|NCT02718976|Sequestering Agents|sequestering agents|mesh-ancestor
92789285|NCT02718742|Paclitaxel|paclitaxel|mesh-list
92789286|NCT02718742|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92789287|NCT02718742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789288|NCT02718742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789289|NCT02718742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789290|NCT02718742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789291|NCT02718742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92789292|NCT02718742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789293|NCT02717884|Cytarabine|cytarabine|mesh-list
92789294|NCT02717884|Tretinoin|tretinoin|mesh-list
92789295|NCT02717884|Tranylcypromine|tranylcypromine|mesh-list
92789296|NCT02717884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789297|NCT02717884|Antimetabolites|antimetabolites|mesh-ancestor
92789298|NCT02717884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789299|NCT02717884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789300|NCT02717884|Antiviral Agents|antiviral agents|mesh-ancestor
92789301|NCT02717884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789302|NCT02717884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789303|NCT02717884|Immunologic Factors|immunologic factors|mesh-ancestor
92789304|NCT02717884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789305|NCT02717884|Keratolytic Agents|keratolytic agents|mesh-ancestor
92789306|NCT02717884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789307|NCT02717884|Antidepressive Agents|antidepressive agents|mesh-ancestor
92789308|NCT02717884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92789309|NCT02717884|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92789310|NCT02717884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789311|NCT02717884|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92789312|NCT02717884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92789313|NCT02717884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789314|NCT02717572|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92789315|NCT02717572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92789316|NCT02717572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789317|NCT01121393|Gemcitabine|gemcitabine|mesh-list
92789318|NCT01121393|Afatinib|afatinib|mesh-list
92789319|NCT01121393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789320|NCT01121393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789321|NCT01121393|Antimetabolites|antimetabolites|mesh-ancestor
92789322|NCT01121393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789323|NCT01121393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92789324|NCT01121393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789325|NCT02882477|Metformin|metformin|mesh-list
92789326|NCT02882477|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92789327|NCT02882477|Acetylcysteine|acetylcysteine|mesh-list
92789328|NCT02882477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92789329|NCT02882477|Deferiprone|deferiprone|mesh-list
92789330|NCT02882477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92789331|NCT02882477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789332|NCT02882477|Incretins|incretins|mesh-ancestor
92789333|NCT02882477|Hormones|hormones|mesh-ancestor
92789334|NCT02882477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789335|NCT02882477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92789336|NCT02882477|Protease Inhibitors|protease inhibitors|mesh-ancestor
92789337|NCT02882477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789338|NCT02882477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789339|NCT02882477|Antiviral Agents|antiviral agents|mesh-ancestor
92789340|NCT02882477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789341|NCT02882477|Expectorants|expectorants|mesh-ancestor
92789342|NCT02882477|Respiratory System Agents|respiratory system agents|mesh-ancestor
92789343|NCT02882477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92789344|NCT02882477|Antioxidants|antioxidants|mesh-ancestor
92789345|NCT02882477|Protective Agents|protective agents|mesh-ancestor
92789346|NCT02882477|Antidotes|antidotes|mesh-ancestor
92789347|NCT02882477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92789348|NCT02882477|Chelating Agents|chelating agents|mesh-ancestor
92789349|NCT02882477|Sequestering Agents|sequestering agents|mesh-ancestor
92789350|NCT04163224|Imidacloprid|imidacloprid|mesh-list
92789351|NCT04163224|Cholinergic Agents|cholinergic agents|mesh-ancestor
92789352|NCT04163224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789353|NCT04163224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789354|NCT04163224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789355|NCT02716792|Ibandronic Acid|ibandronic acid|mesh-list
92789356|NCT02716792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92789357|NCT02716792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789359|NCT04964284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789360|NCT04964284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789361|NCT02716090|Adapalene|adapalene|mesh-list
92789362|NCT02716090|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92789363|NCT02716090|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789364|NCT02716090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92789365|NCT02716090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92789366|NCT02716090|Analgesics|analgesics|mesh-ancestor
92789367|NCT02716090|Sensory System Agents|sensory system agents|mesh-ancestor
92789368|NCT02716090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789369|NCT02716090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789370|NCT02716090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92789371|NCT02716090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789372|NCT01227616|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92789373|NCT01227616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92789374|NCT01227616|Hematinics|hematinics|mesh-ancestor
92789375|NCT01227616|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92789376|NCT01227616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92789377|NCT04189276|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92789378|NCT04189276|Antiviral Agents|antiviral agents|mesh-ancestor
92789379|NCT04189276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789380|NCT02714998|Methotrexate|methotrexate|mesh-list
92789381|NCT02714998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92789382|NCT02714998|Abortifacient Agents|abortifacient agents|mesh-ancestor
92789383|NCT02714998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789384|NCT02714998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789385|NCT02714998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789386|NCT02714998|Antimetabolites|antimetabolites|mesh-ancestor
92789387|NCT02714998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789388|NCT02714998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789389|NCT02714998|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789390|NCT02714998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789391|NCT02714998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92789392|NCT02714998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789393|NCT02714998|Immunologic Factors|immunologic factors|mesh-ancestor
92789394|NCT02714998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789395|NCT02714998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789396|NCT00765310|Thioctic Acid|thioctic acid|mesh-list
92789397|NCT00765310|Antioxidants|antioxidants|mesh-ancestor
92789398|NCT00765310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789399|NCT00765310|Protective Agents|protective agents|mesh-ancestor
92789400|NCT00765310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789401|NCT00765310|Vitamin B Complex|vitamin b complex|mesh-ancestor
92789402|NCT00765310|Vitamins|vitamins|mesh-ancestor
92789403|NCT00765310|Micronutrients|micronutrients|mesh-ancestor
92789404|NCT02715154|Dexmedetomidine|dexmedetomidine|mesh-list
92789405|NCT02715154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92789406|NCT02715154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789407|NCT02715154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789408|NCT02715154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92789409|NCT02715154|Analgesics|analgesics|mesh-ancestor
92789410|NCT02715154|Sensory System Agents|sensory system agents|mesh-ancestor
92789411|NCT02715154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789412|NCT02715154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92789413|NCT02715154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92789414|NCT02715154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92789415|NCT02715154|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789416|NCT02715154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789417|NCT02715154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789418|NCT02715232|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92789419|NCT02715232|Cyproterone Acetate|cyproterone acetate|mesh-list
92789420|NCT02715232|Lynestrenol|lynestrenol|mesh-list
92789421|NCT02715232|Estradiol|estradiol|mesh-list
92789422|NCT02715232|Testosterone|testosterone|mesh-list
92789423|NCT02715232|Cyproterone|cyproterone|mesh-list
92789424|NCT02715232|Estrogens|estrogens|mesh-ancestor
92789425|NCT02715232|Hormones|hormones|mesh-ancestor
92789426|NCT02715232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789427|NCT02715232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789428|NCT02715232|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92789429|NCT02715232|Contraceptive Agents|contraceptive agents|mesh-ancestor
92789430|NCT02715232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789431|NCT02715232|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92789432|NCT02715232|Androgens|androgens|mesh-ancestor
92789433|NCT02715232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92789434|NCT02715232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789435|NCT02715232|Luteolytic Agents|luteolytic agents|mesh-ancestor
92789436|NCT02715232|Androgen Antagonists|androgen antagonists|mesh-ancestor
92789437|NCT02715232|Hormone Antagonists|hormone antagonists|mesh-ancestor
92789438|NCT02715232|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92789439|NCT02715232|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92789440|NCT02715232|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92789441|NCT02715232|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92789442|NCT02693860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92789443|NCT02693860|Immunologic Factors|immunologic factors|mesh-ancestor
92789444|NCT02693860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789445|NCT02714842|Diclofenac|diclofenac|mesh-list
92789446|NCT02714842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92789447|NCT02714842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92789448|NCT02714842|Analgesics|analgesics|mesh-ancestor
92789449|NCT02714842|Sensory System Agents|sensory system agents|mesh-ancestor
92789450|NCT02714842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789451|NCT02714842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789452|NCT02714842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92789453|NCT02714842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789454|NCT02714842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92789455|NCT02714842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789456|NCT02714842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789457|NCT02714530|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92789458|NCT02714530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789459|NCT02714530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92789460|NCT02714530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789461|NCT02714530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789462|NCT02713750|Contraceptive Agents|contraceptive agents|mesh-list
92789463|NCT02713750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789464|NCT02713750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789465|NCT04738162|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92789466|NCT04738162|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92789467|NCT04738162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789468|NCT04000906|Paclitaxel|paclitaxel|mesh-list
92789469|NCT04000906|Cisplatin|cisplatin|mesh-list
92789470|NCT04000906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789471|NCT04000906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789472|NCT04000906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789473|NCT04000906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789474|NCT04000906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92789475|NCT04000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789476|NCT00636766|Metformin|metformin|mesh-list
92789477|NCT00636766|Rosiglitazone|rosiglitazone|mesh-list
92789478|NCT00636766|Rimonabant|rimonabant|mesh-list
92789479|NCT00636766|Atorvastatin|atorvastatin|mesh-list
92789480|NCT00636766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92789481|NCT00636766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789482|NCT00636766|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92789483|NCT00636766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92789484|NCT00636766|Antimetabolites|antimetabolites|mesh-ancestor
92789485|NCT00636766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789486|NCT00636766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92789487|NCT00636766|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92789488|NCT00636766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789489|NCT00636766|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92789490|NCT00636766|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92789491|NCT00636766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92789492|NCT00636766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789493|NCT00636766|Hormones|hormones|mesh-ancestor
92789494|NCT00636766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789495|NCT03998176|Tenofovir|tenofovir|mesh-list
92789496|NCT03998176|Emtricitabine|emtricitabine|mesh-list
92789497|NCT03998176|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92789498|NCT03998176|Antiviral Agents|antiviral agents|mesh-ancestor
92789499|NCT03998176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789500|NCT03998176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92789501|NCT03998176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789502|NCT03998176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789503|NCT03998176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789504|NCT03998176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92789505|NCT03998176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92789506|NCT02713282|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92789507|NCT02713282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92789508|NCT02713282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92789509|NCT02713282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789510|NCT02713282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789511|NCT02713282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92789512|NCT02713282|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92789513|NCT02713282|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92789514|NCT02713282|Serotonin Agents|serotonin agents|mesh-ancestor
92789515|NCT02713282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789516|NCT02713282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789517|NCT02713282|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92789518|NCT02713282|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92789519|NCT02713282|Dopamine Agents|dopamine agents|mesh-ancestor
92789520|NCT00611416|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92789522|NCT00611416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92789523|NCT00611416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789524|NCT00611416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92789525|NCT00611416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789526|NCT00611416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789527|NCT00611416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92789528|NCT00611416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92789529|NCT00611416|Purinergic Agents|purinergic agents|mesh-ancestor
92789530|NCT00611416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789531|NCT00611416|Antioxidants|antioxidants|mesh-ancestor
92789532|NCT00611416|Protective Agents|protective agents|mesh-ancestor
92789533|NCT00611416|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92789534|NCT00611416|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92789535|NCT00611416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789536|NCT00611416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92789537|NCT02712658|Terbutaline|terbutaline|mesh-list
92789538|NCT02712658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92789539|NCT02712658|Autonomic Agents|autonomic agents|mesh-ancestor
92789540|NCT02712658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789541|NCT02712658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789542|NCT02712658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92789543|NCT02712658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92789544|NCT02712658|Sympathomimetics|sympathomimetics|mesh-ancestor
92789545|NCT02712658|Tocolytic Agents|tocolytic agents|mesh-ancestor
92789546|NCT02712658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789547|NCT02712658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92789548|NCT02712658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92789549|NCT02712658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92789550|NCT02712658|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789551|NCT02712658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789552|NCT02712658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789553|NCT00611494|Mycophenolic Acid|mycophenolic acid|mesh-list
92789554|NCT00611494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92789555|NCT00611494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789556|NCT00611494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92789557|NCT00611494|Antitubercular Agents|antitubercular agents|mesh-ancestor
92789558|NCT00611494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789559|NCT00611494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789560|NCT00611494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789561|NCT00611494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789562|NCT02712502|Amoxicillin|amoxicillin|mesh-list
92789563|NCT02712502|Levofloxacin|levofloxacin|mesh-list
92789564|NCT02712502|Clavulanic Acid|clavulanic acid|mesh-list
92789565|NCT02712502|Clavulanic Acids|clavulanic acids|mesh-list
92789566|NCT02712502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92789567|NCT02712502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789568|NCT02712502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789569|NCT02712502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92789570|NCT02712502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92789571|NCT02712502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92789572|NCT02712502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789573|NCT02712502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789574|NCT02712502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789575|NCT02712502|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92789576|NCT02712502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92789577|NCT02712502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92789578|NCT02712346|Ambrisentan|ambrisentan|mesh-list
92789579|NCT02712346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92789580|NCT04617028|Hydroxyurea|hydroxyurea|mesh-list
92789581|NCT04617028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789582|NCT04617028|Antisickling Agents|antisickling agents|mesh-ancestor
92789583|NCT04617028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789584|NCT04617028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789585|NCT04617028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789586|NCT02711410|Clopidogrel|clopidogrel|mesh-list
92789587|NCT02711410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92789588|NCT02711410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92789589|NCT02711410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92789590|NCT02711410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92789591|NCT02711410|Purinergic Agents|purinergic agents|mesh-ancestor
92789592|NCT02711410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789593|NCT02711410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789594|NCT02711410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789595|NCT02711176|Amoxicillin|amoxicillin|mesh-list
92789596|NCT02711176|Clarithromycin|clarithromycin|mesh-list
92789598|NCT02711176|Esomeprazole|esomeprazole|mesh-list
92789599|NCT02711176|Lansoprazole|lansoprazole|mesh-list
92789600|NCT02711176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789601|NCT02711176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789602|NCT02711176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92789603|NCT02711176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92789604|NCT02711176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92789605|NCT02711176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789606|NCT02711176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789607|NCT02711176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92789608|NCT02711176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92789609|NCT02711176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92789610|NCT02711176|Alkylating Agents|alkylating agents|mesh-ancestor
92789611|NCT02711176|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92789612|NCT02711176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92789613|NCT02711176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92789614|NCT00611650|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92789615|NCT00611650|Antioxidants|antioxidants|mesh-ancestor
92789616|NCT00611650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789617|NCT00611650|Protective Agents|protective agents|mesh-ancestor
92789618|NCT00611650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789619|NCT00611650|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92789620|NCT00611650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92789621|NCT00611650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789622|NCT00611650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92789623|NCT02710552|Amlodipine|amlodipine|mesh-list
92789624|NCT02710552|Antihypertensive Agents|antihypertensive agents|mesh-list
92789625|NCT02710552|Perindopril|perindopril|mesh-list
92789626|NCT02710552|Indapamide|indapamide|mesh-list
92789627|NCT02710552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92789628|NCT02710552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92789629|NCT02710552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707766|NCT01230814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92789630|NCT02710552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92789631|NCT02710552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789632|NCT02710552|Vasodilator Agents|vasodilator agents|mesh-ancestor
92789633|NCT02710552|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92789634|NCT02710552|Protease Inhibitors|protease inhibitors|mesh-ancestor
92789635|NCT02710552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789636|NCT02710552|Diuretics|diuretics|mesh-ancestor
92789637|NCT02710552|Natriuretic Agents|natriuretic agents|mesh-ancestor
92789638|NCT02710552|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92789639|NCT02710396|Paclitaxel|paclitaxel|mesh-list
92789640|NCT02710396|Carboplatin|carboplatin|mesh-list
92789641|NCT02710396|Pembrolizumab|pembrolizumab|mesh-list
92789642|NCT02710396|Pemetrexed|pemetrexed|mesh-list
92789643|NCT02710396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789644|NCT02710396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789645|NCT02710396|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789646|NCT02710396|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789647|NCT02710396|Mitosis Modulators|mitosis modulators|mesh-ancestor
92789648|NCT02710396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789649|NCT02710396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92789650|NCT02710396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92789651|NCT02710396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789652|NCT02710396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92434694|NCT01591980|Anticonvulsants|anticonvulsants|mesh-ancestor
92789654|NCT02710162|Capsaicin|capsaicin|mesh-list
92789655|NCT02710162|Antipruritics|antipruritics|mesh-ancestor
92789656|NCT02710162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789657|NCT02710162|Sensory System Agents|sensory system agents|mesh-ancestor
92789658|NCT02710162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789659|NCT02710162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789660|NCT00611728|Irinotecan|irinotecan|mesh-list
92789661|NCT00611728|Sunitinib|sunitinib|mesh-list
92789662|NCT00611728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92789663|NCT00611728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92789664|NCT00611728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789665|NCT00611728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789666|NCT00611728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789667|NCT00611728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92789668|NCT00611728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92789669|NCT00611728|Growth Substances|growth substances|mesh-ancestor
92789670|NCT00611728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789671|NCT00611728|Growth Inhibitors|growth inhibitors|mesh-ancestor
92789672|NCT00611728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92789673|NCT02709304|Lidocaine|lidocaine|mesh-list
92789674|NCT02709304|Anesthetics, Local|anesthetics, local|mesh-ancestor
92789675|NCT02709304|Anesthetics|anesthetics|mesh-ancestor
92789676|NCT02709304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789677|NCT02709304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789678|NCT02709304|Sensory System Agents|sensory system agents|mesh-ancestor
92789679|NCT02709304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789680|NCT02709304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92789681|NCT02709304|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92789682|NCT02709304|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92789683|NCT02709304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92789684|NCT02709304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789685|NCT04189666|Melatonin|melatonin|mesh-list
92789686|NCT04189666|Rivastigmine|rivastigmine|mesh-list
92789687|NCT04189666|Antioxidants|antioxidants|mesh-ancestor
92789688|NCT04189666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789689|NCT04189666|Protective Agents|protective agents|mesh-ancestor
92789690|NCT04189666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789691|NCT04189666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789692|NCT04189666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92789693|NCT04189666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789694|NCT04189666|Cholinergic Agents|cholinergic agents|mesh-ancestor
92789695|NCT04189666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789696|NCT04189666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92789697|NCT03944512|Pravastatin|pravastatin|mesh-list
92789698|NCT03944512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92789699|NCT03944512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92789700|NCT03944512|Antimetabolites|antimetabolites|mesh-ancestor
92789701|NCT03944512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789702|NCT03944512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92789703|NCT03944512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92789704|NCT03944512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789705|NCT00937521|Antipyretics|antipyretics|mesh-list
92789706|NCT00937521|Vaccines|vaccines|mesh-list
92789707|NCT00937521|Immunologic Factors|immunologic factors|mesh-ancestor
92789708|NCT00937521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789709|NCT02709382|Tazobactam|tazobactam|mesh-list
92789710|NCT02709382|Cefepime|cefepime|mesh-list
92789711|NCT02709382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789712|NCT02709382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789713|NCT02709382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92789714|NCT02709382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789715|NCT02709382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789716|NCT02708992|Azithromycin|azithromycin|mesh-list
92789717|NCT02708992|Cefixime|cefixime|mesh-list
92789718|NCT02708992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789719|NCT02708992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789720|NCT00611962|Paclitaxel|paclitaxel|mesh-list
92789721|NCT00611962|Oxaliplatin|oxaliplatin|mesh-list
92789722|NCT00611962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789723|NCT00611962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789724|NCT00611962|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789725|NCT00611962|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789726|NCT00611962|Mitosis Modulators|mitosis modulators|mesh-ancestor
92434777|NCT01592214|Benzocaine|benzocaine|mesh-list
92789727|NCT00611962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789728|NCT05380713|Cyclophosphamide|cyclophosphamide|mesh-list
92789729|NCT05380713|Durvalumab|durvalumab|mesh-list
92789730|NCT05380713|Tremelimumab|tremelimumab|mesh-list
92789731|NCT05380713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789732|NCT05380713|Immunologic Factors|immunologic factors|mesh-ancestor
92789733|NCT05380713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789734|NCT05380713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789735|NCT05380713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92789736|NCT05380713|Alkylating Agents|alkylating agents|mesh-ancestor
92789737|NCT05380713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789738|NCT05380713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789739|NCT05380713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92789740|NCT05380713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92789741|NCT00606099|Adefovir|adefovir|mesh-list
92789742|NCT00606099|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92789743|NCT00606099|Telbivudine|telbivudine|mesh-list
92789744|NCT00606099|Antiviral Agents|antiviral agents|mesh-ancestor
92789745|NCT00606099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789746|NCT00606099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92789747|NCT00606099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789748|NCT00606099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789749|NCT00606099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789750|NCT00935883|Eculizumab|eculizumab|mesh-list
92789751|NCT00935883|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92789752|NCT00935883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789753|NCT00935883|Immunologic Factors|immunologic factors|mesh-ancestor
92789754|NCT00935883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789755|NCT02708446|Misoprostol|misoprostol|mesh-list
92789756|NCT02708446|Mifepristone|mifepristone|mesh-list
92789757|NCT02708446|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92789758|NCT02708446|Abortifacient Agents|abortifacient agents|mesh-ancestor
92789759|NCT02708446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789760|NCT02708446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789761|NCT02708446|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92789762|NCT02708446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92789763|NCT02708446|Oxytocics|oxytocics|mesh-ancestor
92789764|NCT02708446|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92789765|NCT02708446|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92789766|NCT02708446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92789767|NCT02708446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92789768|NCT02708446|Contraceptive Agents|contraceptive agents|mesh-ancestor
92789769|NCT02708446|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92789770|NCT02708446|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92789771|NCT02708446|Hormone Antagonists|hormone antagonists|mesh-ancestor
92789772|NCT02708446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789773|NCT02708446|Luteolytic Agents|luteolytic agents|mesh-ancestor
92789774|NCT02708446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92789775|NCT02708446|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92789776|NCT05378919|Folic Acid|folic acid|mesh-list
92789777|NCT05378919|Leucovorin|leucovorin|mesh-list
92789778|NCT05378919|Fluorouracil|fluorouracil|mesh-list
92789779|NCT05378919|Oxaliplatin|oxaliplatin|mesh-list
92789780|NCT05378919|Levoleucovorin|levoleucovorin|mesh-list
92789781|NCT05378919|Antimetabolites|antimetabolites|mesh-ancestor
92789782|NCT05378919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789783|NCT05378919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789784|NCT05378919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789785|NCT05378919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789786|NCT05378919|Immunologic Factors|immunologic factors|mesh-ancestor
92789787|NCT05378919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789788|NCT05378919|Hematinics|hematinics|mesh-ancestor
92789789|NCT05378919|Vitamin B Complex|vitamin b complex|mesh-ancestor
92789790|NCT05378919|Vitamins|vitamins|mesh-ancestor
92789791|NCT05378919|Micronutrients|micronutrients|mesh-ancestor
92789792|NCT05378919|Antidotes|antidotes|mesh-ancestor
92789793|NCT05378919|Protective Agents|protective agents|mesh-ancestor
92789794|NCT00607581|Dexamethasone|dexamethasone|mesh-list
92789795|NCT00607581|Cyclophosphamide|cyclophosphamide|mesh-list
92789796|NCT00607581|Lenalidomide|lenalidomide|mesh-list
92789797|NCT00607581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789798|NCT00607581|Immunologic Factors|immunologic factors|mesh-ancestor
92789799|NCT00607581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789800|NCT00607581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789801|NCT00607581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92789802|NCT00607581|Alkylating Agents|alkylating agents|mesh-ancestor
92789803|NCT00607581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789804|NCT00607581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789805|NCT00607581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92789806|NCT00607581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92789807|NCT00607581|Antiemetics|antiemetics|mesh-ancestor
92789808|NCT00607581|Autonomic Agents|autonomic agents|mesh-ancestor
92789809|NCT00607581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789810|NCT00607581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92789811|NCT00607581|Glucocorticoids|glucocorticoids|mesh-ancestor
92789813|NCT00607581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789814|NCT00607581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92789815|NCT00607581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92789816|NCT00607581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92789817|NCT00607581|Growth Substances|growth substances|mesh-ancestor
92789818|NCT00607581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92789819|NCT02707900|Vorinostat|vorinostat|mesh-list
92789820|NCT02707900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789821|NCT02707900|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92789822|NCT02707900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789823|NCT02707900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789824|NCT05380479|Megestrol|megestrol|mesh-list
92789825|NCT05380479|Megestrol Acetate|megestrol acetate|mesh-list
92789826|NCT05380479|Mirtazapine|mirtazapine|mesh-list
92789827|NCT05380479|Antidepressive Agents|antidepressive agents|mesh-ancestor
92789828|NCT05380479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92789829|NCT05380479|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92789830|NCT05380479|Histamine Antagonists|histamine antagonists|mesh-ancestor
92789831|NCT05380479|Histamine Agents|histamine agents|mesh-ancestor
92789832|NCT05380479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789833|NCT05380479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789834|NCT05380479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789835|NCT05380479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92789836|NCT05380479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92789837|NCT05380479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789838|NCT05380479|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92789839|NCT05380479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92789840|NCT05380479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92789841|NCT05380479|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789842|NCT05380479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92789843|NCT05380479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92789844|NCT05380479|Serotonin Agents|serotonin agents|mesh-ancestor
92789845|NCT05380479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92789846|NCT05380479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92789847|NCT05380479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92789848|NCT05380479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92789849|NCT05380479|Contraceptive Agents|contraceptive agents|mesh-ancestor
92789850|NCT05380479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789851|NCT05380479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92789852|NCT05380479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92789853|NCT05380479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92789854|NCT05380479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789855|NCT05380479|Appetite Stimulants|appetite stimulants|mesh-ancestor
92789856|NCT05380479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92789857|NCT00936975|Listerine|listerine|mesh-list
92789858|NCT00936975|Fluorides|fluorides|mesh-list
92789859|NCT00936975|Sodium Fluoride|sodium fluoride|mesh-list
92789860|NCT00936975|Cariostatic Agents|cariostatic agents|mesh-ancestor
92789861|NCT00936975|Protective Agents|protective agents|mesh-ancestor
92789862|NCT00936975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789863|NCT00936975|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92789864|NCT00936975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789865|NCT02707120|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92789866|NCT02707120|Lubricant Eye Drops|lubricant eye drops|mesh-list
92789867|NCT02707120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92789868|NCT02693470|Ustekinumab|ustekinumab|mesh-list
92789869|NCT02693470|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789870|NCT00936897|Denosumab|denosumab|mesh-list
92789871|NCT00936897|Ibandronic Acid|ibandronic acid|mesh-list
92789872|NCT00936897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92789873|NCT00936897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789874|NCT05265676|Enoxaparin|enoxaparin|mesh-list
92789875|NCT05265676|Enoxaparin sodium|enoxaparin sodium|mesh-list
92789876|NCT05265676|Anticoagulants|anticoagulants|mesh-ancestor
92789877|NCT05265676|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92789878|NCT05265676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92789879|NCT05265676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789880|NCT00606333|Sirolimus|sirolimus|mesh-list
92789881|NCT00606333|Paclitaxel|paclitaxel|mesh-list
92789882|NCT00606333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92789883|NCT00606333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92789884|NCT00606333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789885|NCT00606333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92789886|NCT00606333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92789887|NCT00606333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92789888|NCT00606333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789889|NCT00606333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789890|NCT00606333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789891|NCT00606333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92789892|NCT00606333|Antifungal Agents|antifungal agents|mesh-ancestor
92789893|NCT00606333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789894|NCT00606333|Immunologic Factors|immunologic factors|mesh-ancestor
92789895|NCT00606333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789896|NCT05265442|Methadone|methadone|mesh-list
92789897|NCT05265442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92789898|NCT05265442|Narcotics|narcotics|mesh-ancestor
92789899|NCT05265442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92789900|NCT05265442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789901|NCT05265442|Analgesics|analgesics|mesh-ancestor
92789902|NCT05265442|Sensory System Agents|sensory system agents|mesh-ancestor
92789903|NCT05265442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789904|NCT05265442|Antitussive Agents|antitussive agents|mesh-ancestor
92789905|NCT05265442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92789906|NCT00606411|Topiramate|topiramate|mesh-list
92789907|NCT00606411|Anticonvulsants|anticonvulsants|mesh-ancestor
92789908|NCT00606411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92789909|NCT00606411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789910|NCT00607737|Insulin Detemir|insulin detemir|mesh-list
92789911|NCT00607737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92789912|NCT00607737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789913|NCT01120691|Glycopyrrolate|glycopyrrolate|mesh-list
92789914|NCT01120691|Albuterol|albuterol|mesh-list
92789915|NCT01120691|Tiotropium Bromide|tiotropium bromide|mesh-list
92789916|NCT01120691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92789917|NCT01120691|Autonomic Agents|autonomic agents|mesh-ancestor
92789918|NCT01120691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92789919|NCT01120691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789920|NCT01120691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92789921|NCT01120691|Respiratory System Agents|respiratory system agents|mesh-ancestor
92789922|NCT01120691|Parasympatholytics|parasympatholytics|mesh-ancestor
92789923|NCT01120691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92789924|NCT01120691|Cholinergic Agents|cholinergic agents|mesh-ancestor
92789925|NCT01120691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92789926|NCT01120691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789927|NCT01120691|Tocolytic Agents|tocolytic agents|mesh-ancestor
92789928|NCT01120691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789929|NCT01120691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92789930|NCT01120691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92789931|NCT01120691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92789932|NCT01120691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92789933|NCT01120691|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92789934|NCT01120691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92789935|NCT04231318|Triamcinolone|triamcinolone|mesh-list
92789936|NCT04231318|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92789937|NCT04231318|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92789938|NCT04231318|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92789939|NCT04231318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92789940|NCT04231318|Glucocorticoids|glucocorticoids|mesh-ancestor
92789941|NCT04231318|Hormones|hormones|mesh-ancestor
92789942|NCT04231318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92789943|NCT04231318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789944|NCT04231318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789945|NCT04231318|Immunologic Factors|immunologic factors|mesh-ancestor
92789946|NCT04231318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789947|NCT04231318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789948|NCT00612274|Sirolimus|sirolimus|mesh-list
92789949|NCT00612274|Methotrexate|methotrexate|mesh-list
92789950|NCT00612274|Tacrolimus|tacrolimus|mesh-list
92789951|NCT00612274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92789952|NCT00612274|Abortifacient Agents|abortifacient agents|mesh-ancestor
92789953|NCT00612274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789954|NCT00612274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789955|NCT00612274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789956|NCT00612274|Antimetabolites|antimetabolites|mesh-ancestor
92789957|NCT00612274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789958|NCT00612274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789959|NCT00612274|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789960|NCT00612274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789961|NCT00612274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92789962|NCT00612274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789963|NCT00612274|Immunologic Factors|immunologic factors|mesh-ancestor
92789964|NCT00612274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789965|NCT00612274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789966|NCT00612274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92789967|NCT00612274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92789968|NCT00612274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92789969|NCT00612274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92789970|NCT00612274|Antifungal Agents|antifungal agents|mesh-ancestor
92789971|NCT05263882|Gemcitabine|gemcitabine|mesh-list
92789972|NCT05263882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789973|NCT05263882|Antimetabolites|antimetabolites|mesh-ancestor
92789974|NCT05263882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789975|NCT05263882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789976|NCT02724904|Methotrexate|methotrexate|mesh-list
92789977|NCT02724904|Fludarabine|fludarabine|mesh-list
92789978|NCT02724904|Thiotepa|thiotepa|mesh-list
92789979|NCT02724904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92789980|NCT02724904|Abortifacient Agents|abortifacient agents|mesh-ancestor
92789981|NCT02724904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92789982|NCT02724904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92789983|NCT02724904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92789984|NCT02724904|Antimetabolites|antimetabolites|mesh-ancestor
92789985|NCT02724904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92789986|NCT02724904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92789987|NCT02724904|Dermatologic Agents|dermatologic agents|mesh-ancestor
92789988|NCT02724904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92789989|NCT02724904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92789990|NCT02724904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92789991|NCT02724904|Immunologic Factors|immunologic factors|mesh-ancestor
92789992|NCT02724904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92789993|NCT02724904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92789994|NCT02724904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92789995|NCT02724904|Alkylating Agents|alkylating agents|mesh-ancestor
92789996|NCT02724904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92789997|NCT00935493|Guanfacine|guanfacine|mesh-list
92789998|NCT00935493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92789999|NCT00935493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92790000|NCT00935493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92790001|NCT00935493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92790002|NCT00935493|Adrenergic Agents|adrenergic agents|mesh-ancestor
92790003|NCT00935493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790004|NCT00935493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790005|NCT00935493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790006|NCT05380245|Clarithromycin|clarithromycin|mesh-list
92790007|NCT05380245|Voriconazole|voriconazole|mesh-list
92790008|NCT05380245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790009|NCT05380245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790010|NCT05380245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92790011|NCT05380245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790012|NCT05380245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790013|NCT05380245|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92790014|NCT05380245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92790015|NCT05380245|Antifungal Agents|antifungal agents|mesh-ancestor
92790016|NCT05380245|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92790017|NCT05380245|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92790018|NCT05380245|Hormone Antagonists|hormone antagonists|mesh-ancestor
92790019|NCT05380245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790020|NCT05380245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790021|NCT00935259|Simvastatin|simvastatin|mesh-list
92790022|NCT00935259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92790023|NCT00935259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92790024|NCT00935259|Antimetabolites|antimetabolites|mesh-ancestor
92790025|NCT00935259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435080|NCT01593995|Mitogens|mitogens|mesh-list
92790026|NCT00935259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92790027|NCT00935259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92790028|NCT00935259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790029|NCT02937766|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92790030|NCT02937766|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92790031|NCT02937766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92790032|NCT02937766|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026438|NCT00493038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790033|NCT02937766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790034|NCT02937766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790035|NCT02937766|Progestins|progestins|mesh-ancestor
92790036|NCT02937766|Hormones|hormones|mesh-ancestor
92790037|NCT00607971|Renzapride|renzapride|mesh-list
92790038|NCT00607971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92790039|NCT00607971|Serotonin Agents|serotonin agents|mesh-ancestor
92790040|NCT00607971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790041|NCT00607971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790042|NCT00607971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790043|NCT02724358|Chlorotrianisene|chlorotrianisene|mesh-list
92790044|NCT02724358|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92790045|NCT02724358|Estrogens|estrogens|mesh-ancestor
92790046|NCT02724358|Hormones|hormones|mesh-ancestor
92790047|NCT02724358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790048|NCT02724358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790049|NCT02724358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790050|NCT02724358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790051|NCT02724202|Curcumin|curcumin|mesh-list
92790052|NCT02724202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92790053|NCT02724202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92790054|NCT02724202|Analgesics|analgesics|mesh-ancestor
92790055|NCT02724202|Sensory System Agents|sensory system agents|mesh-ancestor
92790056|NCT02724202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790057|NCT02724202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790058|NCT02724202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790059|NCT02724202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790060|NCT02724202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790061|NCT02724202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790062|NCT02724202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790063|NCT00605397|Trastuzumab|trastuzumab|mesh-list
92790064|NCT00605397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790065|NCT00605397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790066|NCT00625547|Levodopa|levodopa|mesh-list
92790067|NCT00625547|Cabergoline|cabergoline|mesh-list
92790068|NCT00625547|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92790069|NCT00625547|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92790070|NCT00625547|Dopamine Agents|dopamine agents|mesh-ancestor
92790071|NCT00625547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790072|NCT00625547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790073|NCT00625547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790074|NCT00625547|Dopamine Agonists|dopamine agonists|mesh-ancestor
92790075|NCT05241340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92790076|NCT05241340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790077|NCT05241340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790078|NCT05241340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790079|NCT02724046|Ciprofloxacin|ciprofloxacin|mesh-list
92790080|NCT02724046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790081|NCT02724046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790082|NCT02724046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92790083|NCT02724046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92790084|NCT02724046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790085|NCT02724046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790086|NCT02724046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790087|NCT02724046|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92790088|NCT02724046|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92790089|NCT01124045|Prednisolone|prednisolone|mesh-list
92790090|NCT01124045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92790091|NCT01124045|Methylprednisolone|methylprednisolone|mesh-list
92790092|NCT01124045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92790093|NCT01124045|Prednisolone acetate|prednisolone acetate|mesh-list
92790094|NCT01124045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92790095|NCT01124045|Prednisolone phosphate|prednisolone phosphate|mesh-list
92790096|NCT01124045|Difluprednate|difluprednate|mesh-list
92790097|NCT01124045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790098|NCT01124045|Glucocorticoids|glucocorticoids|mesh-ancestor
92790099|NCT01124045|Hormones|hormones|mesh-ancestor
92790100|NCT01124045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790101|NCT01124045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790102|NCT01124045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790103|NCT01124045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790105|NCT01124045|Autonomic Agents|autonomic agents|mesh-ancestor
92790106|NCT01124045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790107|NCT01124045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790108|NCT01124045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92790109|NCT01124045|Protective Agents|protective agents|mesh-ancestor
92790110|NCT01123889|Lidocaine|lidocaine|mesh-list
92790111|NCT01123889|Ropivacaine|ropivacaine|mesh-list
92790112|NCT01123889|Anesthetics, Local|anesthetics, local|mesh-ancestor
92790113|NCT01123889|Anesthetics|anesthetics|mesh-ancestor
92790114|NCT01123889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790115|NCT01123889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790116|NCT01123889|Sensory System Agents|sensory system agents|mesh-ancestor
92790117|NCT01123889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790118|NCT01123889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92790119|NCT01123889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92790120|NCT01123889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92790121|NCT01123889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790122|NCT01123889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790123|NCT02723968|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92790124|NCT00606957|Vitamin D|vitamin d|mesh-list
92790125|NCT00606957|Cholecalciferol|cholecalciferol|mesh-list
92790126|NCT00606957|Vitamins|vitamins|mesh-ancestor
92790127|NCT00606957|Micronutrients|micronutrients|mesh-ancestor
92790128|NCT00606957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790129|NCT00606957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92790130|NCT00606957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92790131|NCT00934947|Propranolol|propranolol|mesh-list
92790132|NCT00934947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92790133|NCT00934947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92790134|NCT00934947|Adrenergic Agents|adrenergic agents|mesh-ancestor
92790135|NCT00934947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790136|NCT00934947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790137|NCT00934947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790138|NCT00934947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92790139|NCT00934947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92790140|NCT00934947|Vasodilator Agents|vasodilator agents|mesh-ancestor
92790141|NCT02723578|Pemetrexed|pemetrexed|mesh-list
92790142|NCT02723578|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92790143|NCT02723578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790144|NCT02723578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790145|NCT02723578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790146|NCT02723578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92790147|NCT02723578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790148|NCT02723578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790149|NCT04189198|Bupivacaine|bupivacaine|mesh-list
92790150|NCT04189198|Carticaine|carticaine|mesh-list
92790151|NCT04189198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92790152|NCT04189198|Anesthetics|anesthetics|mesh-ancestor
92790153|NCT04189198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790154|NCT04189198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790155|NCT04189198|Sensory System Agents|sensory system agents|mesh-ancestor
92790156|NCT04189198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790157|NCT00608361|Dasatinib|dasatinib|mesh-list
92790158|NCT00608361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790159|NCT00608361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790160|NCT00608361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790161|NCT00608361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790162|NCT00934791|Mycophenolic Acid|mycophenolic acid|mesh-list
92790163|NCT00934791|Sirolimus|sirolimus|mesh-list
92790164|NCT00934791|Prednisone|prednisone|mesh-list
92790165|NCT00934791|Tacrolimus|tacrolimus|mesh-list
92790166|NCT00934791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790167|NCT00934791|Glucocorticoids|glucocorticoids|mesh-ancestor
92790168|NCT00934791|Hormones|hormones|mesh-ancestor
92790169|NCT00934791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790170|NCT00934791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790171|NCT00934791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790172|NCT00934791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790173|NCT00934791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790174|NCT00934791|Immunologic Factors|immunologic factors|mesh-ancestor
92790175|NCT00934791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92790176|NCT00934791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790177|NCT00934791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790178|NCT00934791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92790179|NCT00934791|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92790180|NCT00934791|Antitubercular Agents|antitubercular agents|mesh-ancestor
92790181|NCT00934791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790182|NCT00934791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790183|NCT00934791|Antifungal Agents|antifungal agents|mesh-ancestor
92790184|NCT00607035|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92790186|NCT00607035|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92790187|NCT00607035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92790189|NCT00607035|Natriuretic Agents|natriuretic agents|mesh-ancestor
92790190|NCT00607035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790191|NCT00607035|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92790192|NCT00607035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790193|NCT00607035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790194|NCT00607035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92790195|NCT00607035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92790196|NCT02723266|Tin Fluorides|tin fluorides|mesh-list
92790197|NCT02723266|Cariostatic Agents|cariostatic agents|mesh-ancestor
92790198|NCT02723266|Protective Agents|protective agents|mesh-ancestor
92790199|NCT02723266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790200|NCT02722954|Pembrolizumab|pembrolizumab|mesh-list
92790201|NCT02722954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790202|NCT02722954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790203|NCT02722954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92790204|NCT02722954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790205|NCT00625859|Bupropion|bupropion|mesh-list
92790206|NCT00625859|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92790207|NCT00625859|Antidepressive Agents|antidepressive agents|mesh-ancestor
92790208|NCT00625859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92790209|NCT00625859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92790210|NCT00625859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92790211|NCT00625859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790212|NCT00625859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790213|NCT00625859|Dopamine Agents|dopamine agents|mesh-ancestor
92790214|NCT00625859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790215|NCT00625859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790216|NCT00625859|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92790217|NCT00625859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92790218|NCT00625859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790219|NCT02691195|Ropivacaine|ropivacaine|mesh-list
92790220|NCT02691195|Anesthetics, Local|anesthetics, local|mesh-list
92790221|NCT02691195|Anesthetics|anesthetics|mesh-list
92790222|NCT02691195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790223|NCT02691195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790224|NCT02691195|Sensory System Agents|sensory system agents|mesh-ancestor
92790225|NCT02691195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790226|NCT03808090|Calcium|calcium|mesh-list
92790227|NCT03808090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92790228|NCT03808090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790229|NCT01111019|Hormones|hormones|mesh-list
92790230|NCT01111019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790231|NCT01111019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790232|NCT02883400|Spironolactone|spironolactone|mesh-list
92790233|NCT02883400|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92790234|NCT02883400|Hormone Antagonists|hormone antagonists|mesh-ancestor
92790235|NCT02883400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790236|NCT02883400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790237|NCT02883400|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92790238|NCT02883400|Diuretics|diuretics|mesh-ancestor
92736652|NCT00599274|Interferons|interferons|mesh-list
92790239|NCT02883400|Natriuretic Agents|natriuretic agents|mesh-ancestor
92790240|NCT01119287|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92790241|NCT01119287|Dexamethasone|dexamethasone|mesh-list
92790242|NCT01119287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92790243|NCT01119287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790244|NCT01119287|Antiemetics|antiemetics|mesh-ancestor
92790245|NCT01119287|Autonomic Agents|autonomic agents|mesh-ancestor
92790246|NCT01119287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790247|NCT01119287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790248|NCT01119287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790249|NCT01119287|Glucocorticoids|glucocorticoids|mesh-ancestor
92790250|NCT01119287|Hormones|hormones|mesh-ancestor
92790251|NCT01119287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790252|NCT01119287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790253|NCT01119287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790254|NCT01119287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92790255|NCT01119287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92790256|NCT01119287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92790257|NCT01119287|Analgesics|analgesics|mesh-ancestor
92790258|NCT01119287|Sensory System Agents|sensory system agents|mesh-ancestor
92790259|NCT01119287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790260|NCT01119287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92790261|NCT01119287|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92790262|NCT01119287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92790263|NCT01119287|Histamine Antagonists|histamine antagonists|mesh-ancestor
92790264|NCT01119287|Histamine Agents|histamine agents|mesh-ancestor
92790265|NCT01119287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790266|NCT01119287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790267|NCT01110707|Hormones|hormones|mesh-list
92790268|NCT01110707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92790269|NCT01110707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790270|NCT01110707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790271|NCT04931368|Rituximab|rituximab|mesh-list
92790272|NCT04931368|Methotrexate|methotrexate|mesh-list
92790273|NCT04931368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708422|NCT00541008|Sunitinib|sunitinib|mesh-list
92790274|NCT04931368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790275|NCT04931368|Immunologic Factors|immunologic factors|mesh-ancestor
92790276|NCT04931368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790277|NCT04931368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790278|NCT04931368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92790279|NCT04931368|Abortifacient Agents|abortifacient agents|mesh-ancestor
92790280|NCT04931368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92790281|NCT04931368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790282|NCT04931368|Antimetabolites|antimetabolites|mesh-ancestor
92790283|NCT04931368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790284|NCT04931368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92790285|NCT04931368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790286|NCT04931368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92790287|NCT04931368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790288|NCT04931368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790289|NCT01119131|Vitamin D|vitamin d|mesh-list
92790290|NCT01119131|Cholecalciferol|cholecalciferol|mesh-list
92790291|NCT01119131|Calcium|calcium|mesh-list
92790292|NCT01119131|Vitamins|vitamins|mesh-ancestor
92790293|NCT01119131|Micronutrients|micronutrients|mesh-ancestor
92790294|NCT01119131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790295|NCT01119131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92790296|NCT01119131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92790297|NCT00636922|Everolimus|everolimus|mesh-list
92790298|NCT00636922|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92790299|NCT00636922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790300|NCT00636922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790301|NCT00636922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790302|NCT00636922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790303|NCT00636922|Immunologic Factors|immunologic factors|mesh-ancestor
92790304|NCT00636922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790305|NCT00636922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790306|NCT02722096|Lidocaine|lidocaine|mesh-list
92790307|NCT02722096|Ropivacaine|ropivacaine|mesh-list
92790308|NCT02722096|Anesthetics|anesthetics|mesh-list
92790309|NCT02722096|Anesthetics, Local|anesthetics, local|mesh-ancestor
92790310|NCT02722096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790311|NCT02722096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790312|NCT02722096|Sensory System Agents|sensory system agents|mesh-ancestor
92790313|NCT02722096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790314|NCT02722096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92790315|NCT02722096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92790316|NCT02722096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92790317|NCT02722096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790318|NCT02722096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790319|NCT04862962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92790320|NCT04862962|Ezetimibe|ezetimibe|mesh-list
92790321|NCT04862962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92790322|NCT04862962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92790323|NCT04862962|Antimetabolites|antimetabolites|mesh-ancestor
92790324|NCT04862962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790325|NCT04862962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92790326|NCT04862962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92790327|NCT04862962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790328|NCT01118975|Lapatinib|lapatinib|mesh-list
92790329|NCT01118975|Vorinostat|vorinostat|mesh-list
92790330|NCT01118975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790331|NCT01118975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790332|NCT01118975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790333|NCT01118975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790334|NCT01118975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92790335|NCT02721940|Zoledronic Acid|zoledronic acid|mesh-list
92790336|NCT02721940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92790337|NCT02721940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790338|NCT04829422|Lazertinib|lazertinib|mesh-list
92790339|NCT04829422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790340|NCT04829422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790341|NCT04829422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790342|NCT02721862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92790343|NCT02721862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92790344|NCT02721862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790345|NCT00612898|Lamivudine|lamivudine|mesh-list
92790346|NCT00612898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92790347|NCT00612898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790348|NCT00612898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790349|NCT00612898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790350|NCT00612898|Antiviral Agents|antiviral agents|mesh-ancestor
92790351|NCT00612898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790352|NCT00612898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92790353|NCT00612898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92790354|NCT01118663|Acetylcysteine|acetylcysteine|mesh-list
92790355|NCT01118663|Edetic Acid|edetic acid|mesh-list
92790356|NCT01118663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92790357|NCT01118663|Pentetic Acid|pentetic acid|mesh-list
92790358|NCT01118663|Antiviral Agents|antiviral agents|mesh-ancestor
92790359|NCT01118663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790360|NCT01118663|Expectorants|expectorants|mesh-ancestor
92790361|NCT01118663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92790362|NCT01118663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92790363|NCT01118663|Antioxidants|antioxidants|mesh-ancestor
92790364|NCT01118663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790365|NCT01118663|Protective Agents|protective agents|mesh-ancestor
92790366|NCT01118663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790367|NCT01118663|Antidotes|antidotes|mesh-ancestor
92790368|NCT01118663|Anticoagulants|anticoagulants|mesh-ancestor
92790369|NCT01118663|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92790370|NCT01118663|Chelating Agents|chelating agents|mesh-ancestor
92790371|NCT01118663|Sequestering Agents|sequestering agents|mesh-ancestor
92790372|NCT01118663|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92790373|NCT01118351|Sunitinib|sunitinib|mesh-list
92790374|NCT01118351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790375|NCT01118351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92790376|NCT01118351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92790377|NCT01118351|Growth Substances|growth substances|mesh-ancestor
92790378|NCT01118351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790379|NCT01118351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92790380|NCT01118351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790381|NCT01118351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790382|NCT01118351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790383|NCT01110005|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92790384|NCT02693392|Metformin|metformin|mesh-list
92790385|NCT02693392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92790386|NCT02693392|Fenugreek seed meal|fenugreek seed meal|mesh-list
92790387|NCT02693392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790388|NCT04175626|Sirolimus|sirolimus|mesh-list
92790390|NCT04175626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790391|NCT04175626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92790392|NCT04175626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790393|NCT04175626|Antifungal Agents|antifungal agents|mesh-ancestor
92790394|NCT04175626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790395|NCT04175626|Immunologic Factors|immunologic factors|mesh-ancestor
92790396|NCT04175626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790397|NCT00613054|Imatinib Mesylate|imatinib mesylate|mesh-list
92790398|NCT00613054|Hydroxyurea|hydroxyurea|mesh-list
92790399|NCT00613054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790400|NCT00613054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790401|NCT00613054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790402|NCT00613054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790403|NCT00613054|Antisickling Agents|antisickling agents|mesh-ancestor
92790404|NCT00613054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790405|NCT00613132|Everolimus|everolimus|mesh-list
92790406|NCT00613132|Imatinib Mesylate|imatinib mesylate|mesh-list
92790407|NCT00613132|Hydroxyurea|hydroxyurea|mesh-list
92790408|NCT00613132|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92790409|NCT00613132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790410|NCT00613132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790411|NCT00613132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790412|NCT00613132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790413|NCT00613132|Immunologic Factors|immunologic factors|mesh-ancestor
92790414|NCT00613132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790415|NCT00613132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790416|NCT00613132|Antisickling Agents|antisickling agents|mesh-ancestor
92790417|NCT00613132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790418|NCT04558216|Rifampin|rifampin|mesh-list
92790419|NCT04558216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92790420|NCT04558216|Antitubercular Agents|antitubercular agents|mesh-ancestor
92790421|NCT04558216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790422|NCT04558216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790423|NCT04558216|Leprostatic Agents|leprostatic agents|mesh-ancestor
92790424|NCT04558216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790425|NCT04558216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790426|NCT04558216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790427|NCT04558216|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92790428|NCT04558216|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92790429|NCT04558216|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92790430|NCT04558216|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92790431|NCT04558216|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92790432|NCT04558216|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92790433|NCT04120870|Ketamine|ketamine|mesh-list
92790434|NCT04120870|Etomidate|etomidate|mesh-list
92790435|NCT04120870|Analgesics|analgesics|mesh-ancestor
92790436|NCT04120870|Sensory System Agents|sensory system agents|mesh-ancestor
92790437|NCT04120870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790438|NCT04120870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790439|NCT04120870|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92790440|NCT04120870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92790441|NCT04120870|Anesthetics, General|anesthetics, general|mesh-ancestor
92790442|NCT04120870|Anesthetics|anesthetics|mesh-ancestor
92790443|NCT04120870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790444|NCT04120870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92790445|NCT04120870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92790446|NCT04120870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790447|NCT04120870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790448|NCT04120870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92790449|NCT03747562|Gabapentin|gabapentin|mesh-list
92790450|NCT03747562|Analgesics|analgesics|mesh-ancestor
92790451|NCT03747562|Sensory System Agents|sensory system agents|mesh-ancestor
92790452|NCT03747562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790453|NCT03747562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790454|NCT03747562|Anticonvulsants|anticonvulsants|mesh-ancestor
92790455|NCT03747562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92790456|NCT03747562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92790457|NCT03747562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790458|NCT03747562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92790459|NCT03747562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92790460|NCT03747562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92790461|NCT03747562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790462|NCT03747562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790463|NCT03747562|Antimanic Agents|antimanic agents|mesh-ancestor
92790464|NCT01109849|Methylphenidate|methylphenidate|mesh-list
92790465|NCT01109849|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92790466|NCT01109849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790467|NCT01109849|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92790468|NCT01109849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92790469|NCT01109849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790470|NCT01109849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790471|NCT01109849|Dopamine Agents|dopamine agents|mesh-ancestor
92790472|NCT01109849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790474|NCT01061736|Methotrexate|methotrexate|mesh-list
92790475|NCT01061736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92790476|NCT01061736|Abortifacient Agents|abortifacient agents|mesh-ancestor
92790477|NCT01061736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92790478|NCT01061736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790479|NCT01061736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790480|NCT01061736|Antimetabolites|antimetabolites|mesh-ancestor
92790481|NCT01061736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790482|NCT01061736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790483|NCT01061736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92790484|NCT01061736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790485|NCT01061736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92790486|NCT01061736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790487|NCT01061736|Immunologic Factors|immunologic factors|mesh-ancestor
92790488|NCT01061736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790489|NCT01061736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790490|NCT01061736|Hematinics|hematinics|mesh-ancestor
92790491|NCT01061736|Vitamin B Complex|vitamin b complex|mesh-ancestor
92790492|NCT01061736|Vitamins|vitamins|mesh-ancestor
92790493|NCT01061736|Micronutrients|micronutrients|mesh-ancestor
92790494|NCT02874378|Dexmedetomidine|dexmedetomidine|mesh-list
92790495|NCT02874378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92790496|NCT02874378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790497|NCT02874378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790498|NCT02874378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92790499|NCT02874378|Analgesics|analgesics|mesh-ancestor
92790500|NCT02874378|Sensory System Agents|sensory system agents|mesh-ancestor
92790501|NCT02874378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790502|NCT02874378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92790503|NCT02874378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92790504|NCT02874378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92790505|NCT02874378|Adrenergic Agents|adrenergic agents|mesh-ancestor
92790506|NCT02874378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790507|NCT02874378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790508|NCT01117181|Methylphenidate|methylphenidate|mesh-list
92790509|NCT01117181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92790510|NCT01117181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790511|NCT01117181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92790512|NCT01117181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92790513|NCT01117181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790514|NCT01117181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790515|NCT01117181|Dopamine Agents|dopamine agents|mesh-ancestor
92790516|NCT01117181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790517|NCT02881619|Etodolac|etodolac|mesh-list
92790518|NCT02881619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92790519|NCT02881619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92790520|NCT02881619|Analgesics|analgesics|mesh-ancestor
92790521|NCT02881619|Sensory System Agents|sensory system agents|mesh-ancestor
92790522|NCT02881619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790523|NCT02881619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790524|NCT02881619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790525|NCT02881619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790526|NCT02881619|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92790527|NCT02881619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92790528|NCT02881619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790529|NCT02881619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790530|NCT04303806|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92790531|NCT04303806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92790532|NCT04303806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92790533|NCT04303806|Antimetabolites|antimetabolites|mesh-ancestor
92790534|NCT04303806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790536|NCT04303806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92790537|NCT04303806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790538|NCT02882087|Methotrexate|methotrexate|mesh-list
92790539|NCT02882087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92790540|NCT02882087|Abortifacient Agents|abortifacient agents|mesh-ancestor
92790541|NCT02882087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92790542|NCT02882087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790543|NCT02882087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790544|NCT02882087|Antimetabolites|antimetabolites|mesh-ancestor
92790545|NCT02882087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790546|NCT02882087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790547|NCT02882087|Dermatologic Agents|dermatologic agents|mesh-ancestor
92790548|NCT02882087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790549|NCT02882087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92790550|NCT02882087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790551|NCT02882087|Immunologic Factors|immunologic factors|mesh-ancestor
92790552|NCT02882087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790553|NCT02882087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790554|NCT04303884|Pembrolizumab|pembrolizumab|mesh-list
92790555|NCT04303884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790556|NCT04303884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790557|NCT04303884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92790558|NCT04303884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790559|NCT01040130|Olodaterol|olodaterol|mesh-list
92790560|NCT01040130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92790561|NCT01040130|Autonomic Agents|autonomic agents|mesh-ancestor
92790562|NCT01040130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790563|NCT01040130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790564|NCT01040130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92790565|NCT01040130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92790566|NCT00932451|Crizotinib|crizotinib|mesh-list
92790567|NCT00932451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790568|NCT00932451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790569|NCT00932451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790570|NCT00932451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790571|NCT05297682|Propofol|propofol|mesh-list
92790572|NCT05297682|Anesthetics|anesthetics|mesh-ancestor
92790573|NCT05297682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790574|NCT05297682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790575|NCT05297682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92790576|NCT05297682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92790577|NCT05297682|Anesthetics, General|anesthetics, general|mesh-ancestor
92790578|NCT01108055|Paclitaxel|paclitaxel|mesh-list
92790579|NCT01108055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92790580|NCT01108055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790581|NCT01108055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92790582|NCT01108055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92790583|NCT01108055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92790584|NCT01108055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790585|NCT00609375|Cefepime|cefepime|mesh-list
92790586|NCT00609375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790587|NCT00609375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790588|NCT01107899|Clopidogrel|clopidogrel|mesh-list
92790589|NCT01107899|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92790590|NCT01107899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92790591|NCT01107899|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92790592|NCT01107899|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92790593|NCT01107899|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92790594|NCT01107899|Purinergic Agents|purinergic agents|mesh-ancestor
92790595|NCT01107899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790596|NCT01107899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790597|NCT01107899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790598|NCT01107743|Amlodipine|amlodipine|mesh-list
92790599|NCT01107743|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92790600|NCT01107743|Atorvastatin|atorvastatin|mesh-list
92790601|NCT01107743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92790602|NCT01107743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92790603|NCT01107743|Antimetabolites|antimetabolites|mesh-ancestor
92790604|NCT01107743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790605|NCT01107743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92790606|NCT01107743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92790607|NCT01107743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790608|NCT01107743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92790609|NCT01107743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92790610|NCT01107743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790611|NCT01107743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92790612|NCT01107743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790613|NCT01107743|Vasodilator Agents|vasodilator agents|mesh-ancestor
92790614|NCT01059864|Atorvastatin|atorvastatin|mesh-list
92790615|NCT01059864|Tofacitinib|tofacitinib|mesh-list
92790616|NCT01059864|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92790617|NCT01059864|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92790618|NCT01059864|Antimetabolites|antimetabolites|mesh-ancestor
92790619|NCT01059864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790620|NCT01059864|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92708756|NCT00542607|Levocetirizine|levocetirizine|mesh-list
92790621|NCT01059864|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92790622|NCT01059864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790623|NCT01059864|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92790624|NCT01059864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790625|NCT01035138|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
92790626|NCT01035138|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92790627|NCT01035138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790628|NCT01035138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790630|NCT03739840|Anticonvulsants|anticonvulsants|mesh-ancestor
92790631|NCT00613600|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92790632|NCT00613600|Cathartics|cathartics|mesh-ancestor
92790633|NCT00613600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790634|NCT04302402|Rifaximin|rifaximin|mesh-list
92790635|NCT04302402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790636|NCT04302402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790637|NCT04302402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790638|NCT03931408|Gentamicins|gentamicins|mesh-list
92790639|NCT03931408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92790640|NCT03931408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790641|NCT03931408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92790642|NCT03931408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790643|NCT03931408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790644|NCT03398824|Metformin|metformin|mesh-list
92790645|NCT03398824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92790646|NCT03398824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790647|NCT01033734|Oseltamivir|oseltamivir|mesh-list
92790648|NCT01033734|Antiviral Agents|antiviral agents|mesh-ancestor
92790649|NCT01033734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790650|NCT01033734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790651|NCT01033734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790652|NCT03792256|Cytarabine|cytarabine|mesh-list
92790653|NCT03792256|Prednisone|prednisone|mesh-list
92790654|NCT03792256|Prednisolone|prednisolone|mesh-list
92790655|NCT03792256|Hydrocortisone|hydrocortisone|mesh-list
92790656|NCT03792256|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92790657|NCT03792256|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92790658|NCT03792256|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92790659|NCT03792256|Doxorubicin|doxorubicin|mesh-list
92790660|NCT03792256|Methotrexate|methotrexate|mesh-list
92790661|NCT03792256|Vincristine|vincristine|mesh-list
92790662|NCT03792256|Palbociclib|palbociclib|mesh-list
92790663|NCT03792256|Pegaspargase|pegaspargase|mesh-list
92790664|NCT03792256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92790665|NCT03792256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790666|NCT03792256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92790667|NCT03792256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92790668|NCT03792256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790669|NCT03792256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790670|NCT03792256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790671|NCT03792256|Glucocorticoids|glucocorticoids|mesh-ancestor
92790672|NCT03792256|Hormones|hormones|mesh-ancestor
92790673|NCT03792256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790674|NCT03792256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790675|NCT03792256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790676|NCT03792256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92790677|NCT03792256|Abortifacient Agents|abortifacient agents|mesh-ancestor
92737084|NCT00601692|Irinotecan|irinotecan|mesh-list
92790678|NCT03792256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92708820|NCT04652765|Protease Inhibitors|protease inhibitors|mesh-ancestor
92790679|NCT03792256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790680|NCT03792256|Antimetabolites|antimetabolites|mesh-ancestor
92790681|NCT03792256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92790682|NCT03792256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92790683|NCT03792256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790684|NCT03792256|Immunologic Factors|immunologic factors|mesh-ancestor
92790685|NCT03792256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790686|NCT03792256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790687|NCT03792256|Antiviral Agents|antiviral agents|mesh-ancestor
92790688|NCT03792256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790689|NCT03792256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92790690|NCT03792256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92790691|NCT03792256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92790692|NCT03792256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92790693|NCT03792256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790694|NCT00613288|Testosterone|testosterone|mesh-list
92790695|NCT00613288|Androgens|androgens|mesh-ancestor
92790696|NCT00613288|Hormones|hormones|mesh-ancestor
92790697|NCT00613288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790698|NCT00613288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790699|NCT03711838|Acetylcysteine|acetylcysteine|mesh-list
92790700|NCT03711838|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92790701|NCT03711838|Antiviral Agents|antiviral agents|mesh-ancestor
92790702|NCT03711838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790703|NCT03711838|Expectorants|expectorants|mesh-ancestor
92790704|NCT03711838|Respiratory System Agents|respiratory system agents|mesh-ancestor
92790705|NCT03711838|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92790706|NCT03711838|Antioxidants|antioxidants|mesh-ancestor
92790707|NCT03711838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790708|NCT03711838|Protective Agents|protective agents|mesh-ancestor
92790709|NCT03711838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790710|NCT03711838|Antidotes|antidotes|mesh-ancestor
92790711|NCT04275778|Hydroxychloroquine|hydroxychloroquine|mesh-list
92790712|NCT04275778|Antimalarials|antimalarials|mesh-ancestor
92790713|NCT04275778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92790714|NCT04275778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92790715|NCT04275778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790716|NCT04275778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790717|NCT04275778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790718|NCT04275778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790719|NCT01115855|Eplerenone|eplerenone|mesh-list
92790720|NCT01115855|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92790721|NCT01115855|Hormone Antagonists|hormone antagonists|mesh-ancestor
92790722|NCT01115855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790723|NCT01115855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790724|NCT01115855|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92790725|NCT01115855|Diuretics|diuretics|mesh-ancestor
92790726|NCT01115855|Natriuretic Agents|natriuretic agents|mesh-ancestor
92790727|NCT01115855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92790728|NCT03615508|Phenylephrine|phenylephrine|mesh-list
92790729|NCT03615508|Oxymetazoline|oxymetazoline|mesh-list
92790730|NCT03615508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92790731|NCT03615508|Mydriatics|mydriatics|mesh-ancestor
92790732|NCT03615508|Autonomic Agents|autonomic agents|mesh-ancestor
92790733|NCT03615508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790734|NCT03615508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790735|NCT03615508|Sympathomimetics|sympathomimetics|mesh-ancestor
92790736|NCT03615508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92790737|NCT03615508|Nasal Decongestants|nasal decongestants|mesh-ancestor
92790738|NCT03615508|Respiratory System Agents|respiratory system agents|mesh-ancestor
92790739|NCT03615508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92790740|NCT03615508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92790741|NCT03615508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92790742|NCT03615508|Adrenergic Agents|adrenergic agents|mesh-ancestor
92790743|NCT03615508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790744|NCT03615508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790745|NCT03615508|Protective Agents|protective agents|mesh-ancestor
92790746|NCT02880995|Amisulpride|amisulpride|mesh-list
92790747|NCT02880995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92790748|NCT02880995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92790749|NCT02880995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790750|NCT02880995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790751|NCT02880995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92790752|NCT02880995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92790753|NCT02880995|Dopamine Agents|dopamine agents|mesh-ancestor
92790754|NCT02880995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790755|NCT02880995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790756|NCT02880995|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92790757|NCT02880995|Antidepressive Agents|antidepressive agents|mesh-ancestor
92790758|NCT03522064|Carboplatin|carboplatin|mesh-list
92790759|NCT03522064|Methyltestosterone|methyltestosterone|mesh-list
92790760|NCT03522064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92790761|NCT03522064|Testosterone|testosterone|mesh-list
92790762|NCT03522064|Testosterone undecanoate|testosterone undecanoate|mesh-list
92790764|NCT03522064|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92790765|NCT03522064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790766|NCT03522064|Androgens|androgens|mesh-ancestor
92790767|NCT03522064|Hormones|hormones|mesh-ancestor
92790768|NCT03522064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790769|NCT03522064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790770|NCT03522064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790771|NCT03522064|Anabolic Agents|anabolic agents|mesh-ancestor
92790772|NCT04310579|Midazolam|midazolam|mesh-list
92790773|NCT04310579|Oxycodone|oxycodone|mesh-list
92790774|NCT04310579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92790775|NCT04310579|Paroxetine|paroxetine|mesh-list
92790776|NCT04310579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92790777|NCT04310579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92790778|NCT04310579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790779|NCT04310579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790780|NCT04310579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92790781|NCT04310579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92790782|NCT04310579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92790783|NCT04310579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92790784|NCT04310579|Anesthetics, General|anesthetics, general|mesh-ancestor
92790785|NCT04310579|Anesthetics|anesthetics|mesh-ancestor
92790786|NCT04310579|GABA Modulators|gaba modulators|mesh-ancestor
92790787|NCT04310579|GABA Agents|gaba agents|mesh-ancestor
92790788|NCT04310579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790789|NCT04310579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790790|NCT04310579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92790791|NCT04310579|Narcotics|narcotics|mesh-ancestor
92790792|NCT04310579|Analgesics|analgesics|mesh-ancestor
92790793|NCT04310579|Sensory System Agents|sensory system agents|mesh-ancestor
92790794|NCT04310579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790795|NCT04310579|Antidepressive Agents|antidepressive agents|mesh-ancestor
92790796|NCT04310579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92790797|NCT04310579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92790798|NCT04310579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92790799|NCT04310579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790800|NCT04310579|Serotonin Agents|serotonin agents|mesh-ancestor
92708944|NCT00557921|Purinergic Agents|purinergic agents|mesh-ancestor
92790801|NCT04310579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92790802|NCT04310579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92790803|NCT04310579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92790804|NCT04310579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790805|NCT05244538|Remifentanil|remifentanil|mesh-list
92790806|NCT05244538|Propofol|propofol|mesh-list
92790807|NCT05244538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92790808|NCT05244538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790809|NCT05244538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790810|NCT05244538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92790811|NCT05244538|Anesthetics, General|anesthetics, general|mesh-ancestor
92790812|NCT05244538|Anesthetics|anesthetics|mesh-ancestor
92790813|NCT05244538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92790814|NCT05244538|Narcotics|narcotics|mesh-ancestor
92790815|NCT05244538|Analgesics|analgesics|mesh-ancestor
92790816|NCT05244538|Sensory System Agents|sensory system agents|mesh-ancestor
92790817|NCT05244538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790818|NCT03638128|Denosumab|denosumab|mesh-list
92790819|NCT03638128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92790820|NCT03638128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790821|NCT03481660|Aflibercept|aflibercept|mesh-list
92790822|NCT03481660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92790823|NCT03481660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92790824|NCT03481660|Growth Substances|growth substances|mesh-ancestor
92790825|NCT03481660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790826|NCT03481660|Growth Inhibitors|growth inhibitors|mesh-ancestor
92790827|NCT03481660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790828|NCT05345236|Aflibercept|aflibercept|mesh-list
92790829|NCT05345236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92790830|NCT05345236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92790831|NCT05345236|Growth Substances|growth substances|mesh-ancestor
92790832|NCT05345236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790833|NCT05345236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92790834|NCT05345236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790835|NCT02692534|Cocaine|cocaine|mesh-list
92790836|NCT02692534|Anesthetics, Local|anesthetics, local|mesh-ancestor
92790837|NCT02692534|Anesthetics|anesthetics|mesh-ancestor
92790838|NCT02692534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790839|NCT02692534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790840|NCT02692534|Sensory System Agents|sensory system agents|mesh-ancestor
92790841|NCT02692534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790842|NCT02692534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92790843|NCT02692534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92790844|NCT02692534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92790845|NCT02692534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92790846|NCT02692534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790847|NCT02692534|Dopamine Agents|dopamine agents|mesh-ancestor
92790848|NCT02692534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790849|NCT00614536|Rabeprazole|rabeprazole|mesh-list
92790850|NCT00614536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92790851|NCT00614536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790852|NCT00614536|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92790853|NCT00614536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790854|NCT00614536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790855|NCT04333654|Hydroxychloroquine|hydroxychloroquine|mesh-list
92790856|NCT04333654|Antimalarials|antimalarials|mesh-ancestor
92790857|NCT04333654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92790858|NCT04333654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92790859|NCT04333654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92790860|NCT04333654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790861|NCT04333654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790862|NCT04333654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790863|NCT01059630|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92790864|NCT01059630|Obinutuzumab|obinutuzumab|mesh-list
92790865|NCT01059630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92790866|NCT01059630|Alkylating Agents|alkylating agents|mesh-ancestor
92790867|NCT01059630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790868|NCT01059630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790869|NCT01059630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790870|NCT04142086|Vaccines|vaccines|mesh-list
92790871|NCT04142086|Immunologic Factors|immunologic factors|mesh-ancestor
92790872|NCT04142086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790873|NCT03664882|Fexofenadine|fexofenadine|mesh-list
92790874|NCT03664882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92790875|NCT03664882|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92790876|NCT03664882|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92790877|NCT03664882|Histamine Antagonists|histamine antagonists|mesh-ancestor
92790878|NCT03664882|Histamine Agents|histamine agents|mesh-ancestor
92790879|NCT03664882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92790880|NCT03664882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790881|NCT03664882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790882|NCT03951142|Losartan|losartan|mesh-list
92790883|NCT03951142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92790884|NCT03951142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92790885|NCT03951142|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92790886|NCT03951142|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92790887|NCT03951142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790888|NCT03903016|Insulin|insulin|mesh-list
92790889|NCT03903016|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92790890|NCT03903016|Insulin Lispro|insulin lispro|mesh-list
92790891|NCT03903016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92790892|NCT03903016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790893|NCT03514732|Melatonin|melatonin|mesh-list
92790894|NCT03514732|Antioxidants|antioxidants|mesh-ancestor
92790895|NCT03514732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790896|NCT03514732|Protective Agents|protective agents|mesh-ancestor
92790897|NCT03514732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790898|NCT03514732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92790899|NCT03800836|Paclitaxel|paclitaxel|mesh-list
92790900|NCT03800836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92790901|NCT03800836|Atezolizumab|atezolizumab|mesh-list
92790902|NCT03800836|Ipatasertib|ipatasertib|mesh-list
92790903|NCT03800836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92790904|NCT03800836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790905|NCT03800836|Tubulin Modulators|tubulin modulators|mesh-ancestor
92790906|NCT03800836|Antimitotic Agents|antimitotic agents|mesh-ancestor
92790907|NCT03800836|Mitosis Modulators|mitosis modulators|mesh-ancestor
92790908|NCT03800836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790909|NCT03800836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92790910|NCT03800836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790911|NCT03800836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92790912|NCT03800836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790913|NCT01976182|Cyclophosphamide|cyclophosphamide|mesh-list
92790914|NCT01976182|Methotrexate|methotrexate|mesh-list
92790915|NCT01976182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790916|NCT01976182|Immunologic Factors|immunologic factors|mesh-ancestor
92790917|NCT01976182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790918|NCT01976182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790919|NCT01976182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92790920|NCT01976182|Alkylating Agents|alkylating agents|mesh-ancestor
93026439|NCT00493038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790921|NCT01976182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790922|NCT01976182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790923|NCT01976182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92790924|NCT01976182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92790925|NCT01976182|Abortifacient Agents|abortifacient agents|mesh-ancestor
92790926|NCT01976182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92790927|NCT01976182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790928|NCT01976182|Antimetabolites|antimetabolites|mesh-ancestor
92790929|NCT01976182|Dermatologic Agents|dermatologic agents|mesh-ancestor
92790930|NCT01976182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790931|NCT01976182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92790932|NCT01976182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92790933|NCT00932373|Trastuzumab|trastuzumab|mesh-list
92790934|NCT00932373|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92790935|NCT00932373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790936|NCT00932373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790937|NCT00932373|Immunotoxins|immunotoxins|mesh-ancestor
92790938|NCT00932373|Immunoconjugates|immunoconjugates|mesh-ancestor
92790939|NCT00932373|Immunologic Factors|immunologic factors|mesh-ancestor
92790940|NCT00932373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790941|NCT00932373|Tubulin Modulators|tubulin modulators|mesh-ancestor
92790942|NCT00932373|Antimitotic Agents|antimitotic agents|mesh-ancestor
92790943|NCT00932373|Mitosis Modulators|mitosis modulators|mesh-ancestor
92790944|NCT00932373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790945|NCT04265001|Hyaluronic Acid|hyaluronic acid|mesh-list
92790946|NCT04265001|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92790947|NCT04265001|Immunologic Factors|immunologic factors|mesh-ancestor
92790948|NCT04265001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790949|NCT04265001|Viscosupplements|viscosupplements|mesh-ancestor
92790950|NCT04265001|Protective Agents|protective agents|mesh-ancestor
92790951|NCT00608595|Celecoxib|celecoxib|mesh-list
92790952|NCT00608595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92790953|NCT00608595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92790954|NCT00608595|Analgesics|analgesics|mesh-ancestor
92790955|NCT00608595|Sensory System Agents|sensory system agents|mesh-ancestor
92790956|NCT00608595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790957|NCT00608595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790958|NCT00608595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790959|NCT00608595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790960|NCT00608595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92790961|NCT00608595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92790962|NCT00608595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92790963|NCT00608595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790964|NCT03761134|Metformin|metformin|mesh-list
92790965|NCT03761134|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92790966|NCT03761134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92790967|NCT03761134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790968|NCT03761134|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92709128|NCT05476432|Leucovorin|leucovorin|mesh-list
92790969|NCT03761134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790970|NCT01055496|Dexamethasone|dexamethasone|mesh-list
92790971|NCT01055496|Prednisone|prednisone|mesh-list
92790972|NCT01055496|Cyclophosphamide|cyclophosphamide|mesh-list
92790973|NCT01055496|Rituximab|rituximab|mesh-list
92790974|NCT01055496|Gemcitabine|gemcitabine|mesh-list
92790975|NCT01055496|Vincristine|vincristine|mesh-list
92790976|NCT01055496|Cisplatin|cisplatin|mesh-list
92790977|NCT01055496|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92790978|NCT01055496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92790979|NCT01055496|Immunologic Factors|immunologic factors|mesh-ancestor
92790980|NCT01055496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92790981|NCT01055496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92790982|NCT01055496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92790983|NCT01055496|Alkylating Agents|alkylating agents|mesh-ancestor
92790984|NCT01055496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92790985|NCT01055496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92790986|NCT01055496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92790987|NCT01055496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92790988|NCT01055496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92790989|NCT01055496|Antiemetics|antiemetics|mesh-ancestor
92790990|NCT01055496|Autonomic Agents|autonomic agents|mesh-ancestor
92790991|NCT01055496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92790992|NCT01055496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92790993|NCT01055496|Glucocorticoids|glucocorticoids|mesh-ancestor
92790994|NCT01055496|Hormones|hormones|mesh-ancestor
92790995|NCT01055496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92790996|NCT01055496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92790997|NCT01055496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92790998|NCT01055496|Antimetabolites|antimetabolites|mesh-ancestor
92790999|NCT01055496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92791000|NCT01055496|Tubulin Modulators|tubulin modulators|mesh-ancestor
92791001|NCT01055496|Antimitotic Agents|antimitotic agents|mesh-ancestor
92791002|NCT01055496|Mitosis Modulators|mitosis modulators|mesh-ancestor
92791003|NCT01055496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92791004|NCT01055496|Immunotoxins|immunotoxins|mesh-ancestor
92791005|NCT01055496|Immunoconjugates|immunoconjugates|mesh-ancestor
92791006|NCT03436498|Insulin|insulin|mesh-list
92791007|NCT03436498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92791008|NCT03436498|Insulin Aspart|insulin aspart|mesh-list
92791009|NCT03436498|Insulin, Long-Acting|insulin, long-acting|mesh-list
92791010|NCT03436498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92791011|NCT03436498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791012|NCT03436498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791013|NCT03435952|Doxycycline|doxycycline|mesh-list
92791014|NCT03435952|Pembrolizumab|pembrolizumab|mesh-list
92791015|NCT03435952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92791016|NCT03435952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791017|NCT03435952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92791018|NCT03435952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791019|NCT03435952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92791020|NCT03435952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791021|NCT03435952|Antimalarials|antimalarials|mesh-ancestor
92791022|NCT03435952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92791023|NCT03435952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92791024|NCT00609531|Citalopram|citalopram|mesh-list
92791025|NCT00609531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92791026|NCT00609531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92791027|NCT00609531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791028|NCT00609531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791029|NCT00609531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791030|NCT00609531|Serotonin Agents|serotonin agents|mesh-ancestor
92791031|NCT00609531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791032|NCT00609531|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92791033|NCT00609531|Antidepressive Agents|antidepressive agents|mesh-ancestor
92791034|NCT00609531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791035|NCT03406000|Insulin Glargine|insulin glargine|mesh-list
92791036|NCT03406000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791037|NCT03406000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791038|NCT01052844|Gabapentin|gabapentin|mesh-list
92791039|NCT01052844|Analgesics|analgesics|mesh-ancestor
92791040|NCT01052844|Sensory System Agents|sensory system agents|mesh-ancestor
92791041|NCT01052844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791042|NCT01052844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791043|NCT01052844|Anticonvulsants|anticonvulsants|mesh-ancestor
92791044|NCT01052844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92791045|NCT01052844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92791046|NCT01052844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791047|NCT01052844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791048|NCT01052844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92791049|NCT01052844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92791050|NCT01052844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791051|NCT01052844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791052|NCT01052844|Antimanic Agents|antimanic agents|mesh-ancestor
92791053|NCT01049412|Insulin Glargine|insulin glargine|mesh-list
92791054|NCT01049412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791055|NCT01049412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791056|NCT02584426|Cefazolin|cefazolin|mesh-list
92791057|NCT02584426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92791058|NCT02584426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791059|NCT00934089|Latanoprost|latanoprost|mesh-list
92791060|NCT00934089|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92791061|NCT00934089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92791062|NCT01032174|Azithromycin|azithromycin|mesh-list
92791063|NCT01032174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92791064|NCT01032174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791065|NCT02704780|Misoprostol|misoprostol|mesh-list
92791066|NCT02704780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92791067|NCT02704780|Abortifacient Agents|abortifacient agents|mesh-ancestor
92791068|NCT02704780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791069|NCT02704780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791070|NCT02704780|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92791071|NCT02704780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791072|NCT02704780|Oxytocics|oxytocics|mesh-ancestor
92791073|NCT02704546|Methylphenidate|methylphenidate|mesh-list
92791074|NCT02704546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92791075|NCT02704546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791076|NCT02704546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92791077|NCT02704546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92791078|NCT02704546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791079|NCT02704546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791080|NCT02704546|Dopamine Agents|dopamine agents|mesh-ancestor
92791081|NCT02704546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791082|NCT01032018|Bupropion|bupropion|mesh-list
92791083|NCT01032018|Citalopram|citalopram|mesh-list
92791084|NCT01032018|Sertraline|sertraline|mesh-list
92791085|NCT01032018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92791086|NCT01032018|Antidepressive Agents|antidepressive agents|mesh-ancestor
92791087|NCT01032018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791088|NCT01032018|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92791089|NCT01032018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92791090|NCT01032018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791091|NCT01032018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791092|NCT01032018|Dopamine Agents|dopamine agents|mesh-ancestor
92791093|NCT01032018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791094|NCT01032018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791095|NCT01032018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92791096|NCT01032018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92791097|NCT01032018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791098|NCT01032018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92791099|NCT01032018|Serotonin Agents|serotonin agents|mesh-ancestor
92791100|NCT00927069|Adalimumab|adalimumab|mesh-list
92791101|NCT00927069|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92791102|NCT00927069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791103|NCT00927069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791104|NCT01031628|Imatinib Mesylate|imatinib mesylate|mesh-list
92791105|NCT01031628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791106|NCT01031628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791107|NCT01031628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791108|NCT01031628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791109|NCT00609843|Ethiodized Oil|ethiodized oil|mesh-list
92791110|NCT00609843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791111|NCT00608673|Betamethasone|betamethasone|mesh-list
92791112|NCT00608673|Betamethasone Valerate|betamethasone valerate|mesh-list
92791113|NCT00608673|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92791114|NCT00608673|Betamethasone benzoate|betamethasone benzoate|mesh-list
92791115|NCT00608673|Pimecrolimus|pimecrolimus|mesh-list
92791116|NCT00608673|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92791117|NCT00608673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791118|NCT00608673|Glucocorticoids|glucocorticoids|mesh-ancestor
92791119|NCT00608673|Hormones|hormones|mesh-ancestor
92791120|NCT00608673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791121|NCT00608673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791122|NCT00608673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92791123|NCT00608673|Respiratory System Agents|respiratory system agents|mesh-ancestor
92791124|NCT00608673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92791125|NCT00608673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791126|NCT00608673|Analgesics|analgesics|mesh-ancestor
92791127|NCT00608673|Sensory System Agents|sensory system agents|mesh-ancestor
92791128|NCT00608673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791129|NCT00608673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791130|NCT00608673|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791131|NCT00608673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791132|NCT00608673|Immunologic Factors|immunologic factors|mesh-ancestor
92791133|NCT00608673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92791134|NCT00608673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791135|NCT00608673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791137|NCT04263519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791138|NCT04263519|Immunologic Factors|immunologic factors|mesh-ancestor
92791139|NCT04263519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791140|NCT04263519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92791141|NCT04263519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791142|NCT04263519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791143|NCT00637767|Melphalan|melphalan|mesh-list
92791144|NCT00637767|Antibodies|antibodies|mesh-list
92791145|NCT00637767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92791146|NCT00637767|Immunologic Factors|immunologic factors|mesh-ancestor
92791147|NCT00637767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791148|NCT00637767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92791149|NCT00637767|Alkylating Agents|alkylating agents|mesh-ancestor
92791150|NCT00637767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791151|NCT00637767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791152|NCT00637767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92791153|NCT00637767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791154|NCT05101629|Pembrolizumab|pembrolizumab|mesh-list
92791155|NCT05101629|Lenvatinib|lenvatinib|mesh-list
92791156|NCT05101629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92791157|NCT05101629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791158|NCT05101629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92791159|NCT05101629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791160|NCT05101629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791161|NCT05101629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791162|NCT00609999|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92791163|NCT00609999|Dasatinib|dasatinib|mesh-list
92791164|NCT00609999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791165|NCT00609999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791166|NCT00609999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791167|NCT00609999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791168|NCT00627250|Amantadine|amantadine|mesh-list
92791169|NCT00627250|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92791170|NCT00627250|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92791171|NCT00627250|Antiviral Agents|antiviral agents|mesh-ancestor
92791172|NCT00627250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791173|NCT00627250|Dopamine Agents|dopamine agents|mesh-ancestor
92791174|NCT00627250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791175|NCT00627250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791176|NCT00627250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791177|NCT00627250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791178|NCT00627250|Analgesics|analgesics|mesh-ancestor
92791179|NCT00627250|Sensory System Agents|sensory system agents|mesh-ancestor
92791180|NCT00627250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791181|NCT04300374|Anesthetics|anesthetics|mesh-list
92791182|NCT04300374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791183|NCT04300374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791184|NCT02703376|Prednisone|prednisone|mesh-list
92791185|NCT02703376|Prednisolone|prednisolone|mesh-list
92791186|NCT02703376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791187|NCT02703376|Glucocorticoids|glucocorticoids|mesh-ancestor
92791188|NCT02703376|Hormones|hormones|mesh-ancestor
92791189|NCT02703376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791190|NCT02703376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791191|NCT02703376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791192|NCT02703376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791193|NCT00610077|Letrozole|letrozole|mesh-list
92791194|NCT00610077|Clomiphene|clomiphene|mesh-list
92791195|NCT00610077|Enclomiphene|enclomiphene|mesh-list
92791196|NCT00610077|Zuclomiphene|zuclomiphene|mesh-list
92791197|NCT00610077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791198|NCT00610077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791199|NCT00610077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92791200|NCT00610077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92791201|NCT00610077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791202|NCT00610077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92791203|NCT00610077|Hormone Antagonists|hormone antagonists|mesh-ancestor
92791204|NCT00610077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791205|NCT00610077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791206|NCT00610077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92791207|NCT00610077|Fertility Agents|fertility agents|mesh-ancestor
92791208|NCT00610077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791209|NCT00610077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92791211|NCT00823576|Ropivacaine|ropivacaine|mesh-list
92791212|NCT00823576|Anesthetics, Local|anesthetics, local|mesh-ancestor
92791213|NCT00823576|Anesthetics|anesthetics|mesh-ancestor
92791214|NCT00823576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791215|NCT00823576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791216|NCT00823576|Sensory System Agents|sensory system agents|mesh-ancestor
92791217|NCT00823576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791218|NCT01028352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92791219|NCT01028352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92791220|NCT01028352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92791221|NCT01028352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791222|NCT01028352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791223|NCT01028352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791224|NCT01028352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791225|NCT01028352|Analgesics|analgesics|mesh-ancestor
92791226|NCT01028352|Sensory System Agents|sensory system agents|mesh-ancestor
92791227|NCT01028352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791228|NCT01028352|Antidepressive Agents|antidepressive agents|mesh-ancestor
92791229|NCT01028352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791230|NCT01028352|Dopamine Agents|dopamine agents|mesh-ancestor
92791231|NCT03172780|Diclofenac|diclofenac|mesh-list
92791232|NCT03172780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92791233|NCT03172780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791234|NCT03172780|Analgesics|analgesics|mesh-ancestor
92791235|NCT03172780|Sensory System Agents|sensory system agents|mesh-ancestor
92791236|NCT03172780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791237|NCT03172780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791238|NCT03172780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791239|NCT03172780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791240|NCT03172780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92791241|NCT03172780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791242|NCT03172780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791243|NCT05011617|Anesthetics|anesthetics|mesh-list
92791244|NCT05011617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791245|NCT05011617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791246|NCT03169972|Factor VIII|factor viii|mesh-list
92791247|NCT03169972|BAX 855|bax 855|mesh-list
92791248|NCT03169972|Coagulants|coagulants|mesh-ancestor
92791249|NCT00926367|Clindamycin|clindamycin|mesh-list
92791250|NCT00926367|Clindamycin palmitate|clindamycin palmitate|mesh-list
92791251|NCT00926367|Clindamycin phosphate|clindamycin phosphate|mesh-list
92791252|NCT00926367|Adapalene|adapalene|mesh-list
92791253|NCT00926367|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92791254|NCT00926367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92791255|NCT00926367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791256|NCT00926367|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92791257|NCT00926367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791258|NCT00926367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791259|NCT00926367|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791260|NCT00926367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92791261|NCT00926367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791262|NCT00926367|Analgesics|analgesics|mesh-ancestor
92791263|NCT00926367|Sensory System Agents|sensory system agents|mesh-ancestor
92791264|NCT00926367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791265|NCT00926367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791266|NCT00926367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791267|NCT00926367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791268|NCT04261023|Abatacept|abatacept|mesh-list
92791269|NCT04261023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92791270|NCT04261023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791271|NCT04261023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92791272|NCT04261023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791273|NCT04261023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791274|NCT04261023|Immunologic Factors|immunologic factors|mesh-ancestor
92791275|NCT04261023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791276|NCT04261023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791278|NCT01114529|Everolimus|everolimus|mesh-list
92791279|NCT01114529|Tacrolimus|tacrolimus|mesh-list
92791280|NCT01114529|Cyclosporins|cyclosporins|mesh-list
92791281|NCT01114529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791282|NCT01114529|Immunologic Factors|immunologic factors|mesh-ancestor
92791283|NCT01114529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791284|NCT01114529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92791286|NCT01114529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791287|NCT01114529|Antifungal Agents|antifungal agents|mesh-ancestor
92791288|NCT01114529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791289|NCT01114529|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791290|NCT01114529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791291|NCT01114529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92791292|NCT01114529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791293|NCT01114529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791294|NCT00926289|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92791295|NCT00926289|Telmisartan|telmisartan|mesh-list
92791296|NCT00926289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92791297|NCT00926289|Diuretics|diuretics|mesh-ancestor
92791298|NCT00926289|Natriuretic Agents|natriuretic agents|mesh-ancestor
92791299|NCT00926289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791300|NCT00926289|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92791301|NCT00926289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791302|NCT00926289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791303|NCT00926289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92791304|NCT00926289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92791305|NCT04309643|Levonorgestrel|levonorgestrel|mesh-list
92791306|NCT04309643|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92791307|NCT04309643|Contraceptive Agents|contraceptive agents|mesh-list
92791308|NCT04309643|Contraceptives, Oral|contraceptives, oral|mesh-list
92791309|NCT04309643|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92791310|NCT04309643|Estradiol|estradiol|mesh-list
92791311|NCT04309643|Estrogens|estrogens|mesh-ancestor
92791312|NCT04309643|Hormones|hormones|mesh-ancestor
92791313|NCT04309643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791314|NCT04309643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791315|NCT04309643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92791316|NCT04309643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791317|NCT04309643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92791318|NCT04309643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92791319|NCT04309643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92791320|NCT03188146|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92791321|NCT03188146|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92791322|NCT03188146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791323|NCT04259073|Pregabalin|pregabalin|mesh-list
92791324|NCT04259073|Analgesics|analgesics|mesh-ancestor
92791325|NCT04259073|Sensory System Agents|sensory system agents|mesh-ancestor
92791326|NCT04259073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791327|NCT04259073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791328|NCT04259073|Anticonvulsants|anticonvulsants|mesh-ancestor
92791329|NCT04259073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92791330|NCT04259073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791331|NCT04259073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791332|NCT04259073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92791333|NCT04259073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92791334|NCT04259073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92791335|NCT04259073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791336|NCT04259073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791337|NCT00609063|Atorvastatin|atorvastatin|mesh-list
92791338|NCT00609063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92791339|NCT00609063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92791340|NCT00609063|Antimetabolites|antimetabolites|mesh-ancestor
92791341|NCT00609063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791342|NCT00609063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92791343|NCT00609063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92791344|NCT00609063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791345|NCT02703064|Fenugreek seed meal|fenugreek seed meal|mesh-list
92791346|NCT02703064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791347|NCT02703064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791348|NCT01114373|Melatonin|melatonin|mesh-list
92791349|NCT01114373|Antioxidants|antioxidants|mesh-ancestor
92791350|NCT01114373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791351|NCT01114373|Protective Agents|protective agents|mesh-ancestor
92791352|NCT01114373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791353|NCT01114373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791354|NCT00925899|Melatonin|melatonin|mesh-list
92791355|NCT00925899|Antioxidants|antioxidants|mesh-ancestor
92791356|NCT00925899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791357|NCT00925899|Protective Agents|protective agents|mesh-ancestor
92791358|NCT00925899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791359|NCT00925899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791361|NCT02601586|Levodopa|levodopa|mesh-list
92791362|NCT02601586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92791363|NCT02601586|Narcotics|narcotics|mesh-ancestor
92791364|NCT02601586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791365|NCT02601586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791366|NCT02601586|Analgesics|analgesics|mesh-ancestor
92791367|NCT02601586|Sensory System Agents|sensory system agents|mesh-ancestor
92791368|NCT02601586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791369|NCT02601586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92791370|NCT02601586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92791371|NCT02601586|Dopamine Agents|dopamine agents|mesh-ancestor
92791372|NCT02601586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791373|NCT02601586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791374|NCT00609141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92791375|NCT00609141|Immunologic Factors|immunologic factors|mesh-ancestor
92791376|NCT00609141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791377|NCT00610389|Immunomodulating Agents|immunomodulating agents|mesh-list
92791378|NCT00610389|Immunologic Factors|immunologic factors|mesh-ancestor
92791379|NCT00610389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791380|NCT01114217|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92791381|NCT01114217|Hematinics|hematinics|mesh-ancestor
92791382|NCT01114217|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92791383|NCT01114217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92791384|NCT01030536|Immunotoxin HA22|immunotoxin ha22|mesh-list
92791385|NCT01030536|Immunotoxins|immunotoxins|mesh-ancestor
92791386|NCT01030536|Immunoconjugates|immunoconjugates|mesh-ancestor
92791387|NCT01030536|Immunologic Factors|immunologic factors|mesh-ancestor
92791388|NCT01030536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791389|NCT01030536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791390|NCT01030458|Amlodipine|amlodipine|mesh-list
92791391|NCT01030458|Valsartan|valsartan|mesh-list
92791392|NCT01030458|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92791393|NCT01030458|Bisoprolol|bisoprolol|mesh-list
92791394|NCT01030458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92791395|NCT01030458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92791396|NCT01030458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791397|NCT01030458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791398|NCT01030458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92791399|NCT01030458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791400|NCT01030458|Vasodilator Agents|vasodilator agents|mesh-ancestor
92791401|NCT01030458|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92791402|NCT01030458|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92791403|NCT01030458|Diuretics|diuretics|mesh-ancestor
92791404|NCT01030458|Natriuretic Agents|natriuretic agents|mesh-ancestor
92791405|NCT01030458|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92791406|NCT01030458|Sympatholytics|sympatholytics|mesh-ancestor
92791407|NCT01030458|Autonomic Agents|autonomic agents|mesh-ancestor
92791408|NCT01030458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791409|NCT01030458|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92791410|NCT01030458|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92709572|NCT04645940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92791411|NCT01030458|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92791412|NCT01030458|Adrenergic Agents|adrenergic agents|mesh-ancestor
92791413|NCT01030458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791414|NCT02702674|Propranolol|propranolol|mesh-list
92791415|NCT02702674|Oxytocin|oxytocin|mesh-list
92791416|NCT02702674|Oxytocics|oxytocics|mesh-ancestor
92791417|NCT02702674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791418|NCT02702674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791419|NCT02702674|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92791420|NCT02702674|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92791421|NCT02702674|Adrenergic Agents|adrenergic agents|mesh-ancestor
92791422|NCT02702674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791423|NCT02702674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791424|NCT02702674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92791425|NCT02702674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92791426|NCT02702674|Vasodilator Agents|vasodilator agents|mesh-ancestor
92791427|NCT01114139|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92791428|NCT01114139|Hematinics|hematinics|mesh-ancestor
92791429|NCT01114139|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92436499|NCT04969250|Vaccines|vaccines|mesh-list
92791430|NCT01114139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92791431|NCT01027884|Idebenone|idebenone|mesh-list
92791432|NCT01027884|Antioxidants|antioxidants|mesh-ancestor
92791433|NCT01027884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791434|NCT01027884|Protective Agents|protective agents|mesh-ancestor
92791435|NCT01027884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791436|NCT02699008|Clopidogrel|clopidogrel|mesh-list
92791437|NCT02699008|Ticagrelor|ticagrelor|mesh-list
92791438|NCT02699008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92791439|NCT02699008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92791440|NCT02699008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92791441|NCT02699008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92791442|NCT02699008|Purinergic Agents|purinergic agents|mesh-ancestor
92791443|NCT02699008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791444|NCT02699008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791445|NCT02699008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791446|NCT00627666|Leucovorin|leucovorin|mesh-list
92791447|NCT00627666|Methotrexate|methotrexate|mesh-list
92791448|NCT00627666|Fludarabine phosphate|fludarabine phosphate|mesh-list
92791449|NCT00627666|Fludarabine|fludarabine|mesh-list
92791450|NCT00627666|Busulfan|busulfan|mesh-list
92791451|NCT00627666|Calcium|calcium|mesh-list
92791452|NCT00627666|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92791453|NCT00627666|Levoleucovorin|levoleucovorin|mesh-list
92791454|NCT00627666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92791455|NCT00627666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791456|NCT00627666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92791457|NCT00627666|Abortifacient Agents|abortifacient agents|mesh-ancestor
92791458|NCT00627666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791459|NCT00627666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92791460|NCT00627666|Antimetabolites|antimetabolites|mesh-ancestor
92791461|NCT00627666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791462|NCT00627666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791463|NCT00627666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791464|NCT00627666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791465|NCT00627666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92791466|NCT00627666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791467|NCT00627666|Immunologic Factors|immunologic factors|mesh-ancestor
92791468|NCT00627666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791469|NCT00627666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92791470|NCT00627666|Antidotes|antidotes|mesh-ancestor
92791471|NCT00627666|Protective Agents|protective agents|mesh-ancestor
92791472|NCT00627666|Vitamin B Complex|vitamin b complex|mesh-ancestor
92791473|NCT00627666|Vitamins|vitamins|mesh-ancestor
92791474|NCT00627666|Micronutrients|micronutrients|mesh-ancestor
92791475|NCT00627666|Alkylating Agents|alkylating agents|mesh-ancestor
92791476|NCT00627666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92791477|NCT00627666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92791478|NCT01022580|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92791479|NCT01022580|Calfactant|calfactant|mesh-list
92791480|NCT01022580|Respiratory System Agents|respiratory system agents|mesh-ancestor
92791481|NCT02698930|Dexmedetomidine|dexmedetomidine|mesh-list
92791482|NCT02698930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92791483|NCT02698930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791484|NCT02698930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791485|NCT02698930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791486|NCT02698930|Analgesics|analgesics|mesh-ancestor
92791487|NCT02698930|Sensory System Agents|sensory system agents|mesh-ancestor
92791488|NCT02698930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791489|NCT02698930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92791490|NCT02698930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92791491|NCT02698930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92791492|NCT02698930|Adrenergic Agents|adrenergic agents|mesh-ancestor
92791493|NCT02698930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791494|NCT02698930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791495|NCT01107353|Imipramine|imipramine|mesh-list
92791496|NCT01107353|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92791497|NCT01107353|Antidepressive Agents|antidepressive agents|mesh-ancestor
92791498|NCT01107353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791499|NCT01107353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92791500|NCT01107353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92791501|NCT01107353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791502|NCT01107353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791503|NCT01107353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436565|NCT04742634|Decitabine|decitabine|mesh-list
92791504|NCT01107353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791505|NCT01107353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791506|NCT02702206|Triamcinolone|triamcinolone|mesh-list
92791507|NCT02702206|Hyaluronic Acid|hyaluronic acid|mesh-list
92791508|NCT02702206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791509|NCT02702206|Glucocorticoids|glucocorticoids|mesh-ancestor
92791510|NCT02702206|Hormones|hormones|mesh-ancestor
92791511|NCT02702206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791512|NCT02702206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791513|NCT02702206|Immunologic Factors|immunologic factors|mesh-ancestor
92791514|NCT02702206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92791515|NCT02702206|Viscosupplements|viscosupplements|mesh-ancestor
92791516|NCT02702206|Protective Agents|protective agents|mesh-ancestor
92791517|NCT04216186|Ubiquinone|ubiquinone|mesh-list
92791518|NCT04216186|Coenzyme Q10|coenzyme q10|mesh-list
92791519|NCT04216186|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92791520|NCT04216186|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92791521|NCT04216186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92791522|NCT04216186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791523|NCT04216186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791524|NCT04216186|Adrenergic Agents|adrenergic agents|mesh-ancestor
92791525|NCT04216186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791526|NCT04216186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791527|NCT04216186|Micronutrients|micronutrients|mesh-ancestor
92791528|NCT04216186|Vitamins|vitamins|mesh-ancestor
92791529|NCT01989598|Trametinib|trametinib|mesh-list
92791530|NCT01989598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791531|NCT01989598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791532|NCT01989598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791533|NCT01989598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791534|NCT04214938|Lidocaine|lidocaine|mesh-list
92791535|NCT04214938|Xylometazoline|xylometazoline|mesh-list
92791536|NCT04214938|Anesthetics, Local|anesthetics, local|mesh-ancestor
92791537|NCT04214938|Anesthetics|anesthetics|mesh-ancestor
92791538|NCT04214938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791539|NCT04214938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791540|NCT04214938|Sensory System Agents|sensory system agents|mesh-ancestor
92791541|NCT04214938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791542|NCT04214938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92791543|NCT04214938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92791544|NCT04214938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92791545|NCT04214938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791546|NCT04214938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791547|NCT04214938|Nasal Decongestants|nasal decongestants|mesh-ancestor
92791548|NCT04214938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92791549|NCT04214938|Respiratory System Agents|respiratory system agents|mesh-ancestor
92791550|NCT00615160|Dacarbazine|dacarbazine|mesh-list
92791551|NCT00615160|Vatalanib|vatalanib|mesh-list
92791552|NCT00615160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92791553|NCT00615160|Alkylating Agents|alkylating agents|mesh-ancestor
92791554|NCT00615160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791555|NCT00615160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791556|NCT00615160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791557|NCT00615160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791558|NCT01112267|Acetaminophen|acetaminophen|mesh-list
92791559|NCT01112267|Tramadol|tramadol|mesh-list
92791560|NCT01112267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791561|NCT01112267|Analgesics|analgesics|mesh-ancestor
92791562|NCT01112267|Sensory System Agents|sensory system agents|mesh-ancestor
92791563|NCT01112267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791564|NCT01112267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791565|NCT01112267|Antipyretics|antipyretics|mesh-ancestor
92791566|NCT01112267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92791567|NCT01112267|Narcotics|narcotics|mesh-ancestor
92791568|NCT01112267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791569|NCT00925587|Darbepoetin alfa|darbepoetin alfa|mesh-list
92791570|NCT00925587|Hematinics|hematinics|mesh-ancestor
92791571|NCT02698306|Dexamethasone|dexamethasone|mesh-list
92791572|NCT02698306|Diclofenac|diclofenac|mesh-list
92791573|NCT02698306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791574|NCT02698306|Antiemetics|antiemetics|mesh-ancestor
92791575|NCT02698306|Autonomic Agents|autonomic agents|mesh-ancestor
92791576|NCT02698306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791577|NCT02698306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791578|NCT02698306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791579|NCT02698306|Glucocorticoids|glucocorticoids|mesh-ancestor
92791580|NCT02698306|Hormones|hormones|mesh-ancestor
92791581|NCT02698306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791582|NCT02698306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791583|NCT02698306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791584|NCT02698306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92791585|NCT02698306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791586|NCT02698306|Analgesics|analgesics|mesh-ancestor
92791587|NCT02698306|Sensory System Agents|sensory system agents|mesh-ancestor
92791588|NCT02698306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791589|NCT02698306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92791590|NCT02698306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791591|NCT02698306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791592|NCT02698228|Morphine|morphine|mesh-list
92791593|NCT02698228|Bupivacaine|bupivacaine|mesh-list
92791594|NCT02698228|Anesthetics, Local|anesthetics, local|mesh-ancestor
92791595|NCT02698228|Anesthetics|anesthetics|mesh-ancestor
92791596|NCT02698228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791597|NCT02698228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791598|NCT02698228|Sensory System Agents|sensory system agents|mesh-ancestor
92791599|NCT02698228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791600|NCT02698228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92791601|NCT02698228|Narcotics|narcotics|mesh-ancestor
92791602|NCT02698228|Analgesics|analgesics|mesh-ancestor
92791603|NCT02702128|Tranexamic Acid|tranexamic acid|mesh-list
92791604|NCT02702128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92791605|NCT02702128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92791606|NCT02702128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791607|NCT02702128|Hemostatics|hemostatics|mesh-ancestor
92791608|NCT02702128|Coagulants|coagulants|mesh-ancestor
92791609|NCT00610545|Atorvastatin|atorvastatin|mesh-list
92791610|NCT00610545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92791611|NCT00610545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92791612|NCT00610545|Antimetabolites|antimetabolites|mesh-ancestor
92791613|NCT00610545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791614|NCT00610545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92791615|NCT00610545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92791616|NCT00610545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791617|NCT00193414|Gemcitabine|gemcitabine|mesh-list
92791618|NCT00193414|Pemetrexed|pemetrexed|mesh-list
92791619|NCT00193414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92791620|NCT00193414|Antimetabolites|antimetabolites|mesh-ancestor
92791621|NCT00193414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791622|NCT00193414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791623|NCT00193414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791624|NCT00193414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92791625|NCT00193414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92791626|NCT04260711|Interferons|interferons|mesh-list
92791627|NCT04260711|Teriflunomide|teriflunomide|mesh-list
92791628|NCT04260711|Glatiramer Acetate|glatiramer acetate|mesh-list
92791629|NCT04260711|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92791630|NCT04260711|(T,G)-A-L|(t,g)-a-l|mesh-list
92791631|NCT04260711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791632|NCT04260711|Antiviral Agents|antiviral agents|mesh-ancestor
92791633|NCT04260711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791634|NCT04260711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92791635|NCT04260711|Immunologic Factors|immunologic factors|mesh-ancestor
92791636|NCT04260711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791637|NCT04260711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791638|NCT04260711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791639|NCT04260711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92791640|NCT04260711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791641|NCT04260711|Analgesics|analgesics|mesh-ancestor
92791642|NCT04260711|Sensory System Agents|sensory system agents|mesh-ancestor
92791643|NCT04260711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791644|NCT04260711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791645|NCT04260711|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791646|NCT00610623|Azithromycin|azithromycin|mesh-list
92791647|NCT00610623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92791648|NCT00610623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791649|NCT02697838|Paclitaxel|paclitaxel|mesh-list
92791650|NCT02697838|Apatinib|apatinib|mesh-list
92791651|NCT02697838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92791652|NCT02697838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791653|NCT02697838|Tubulin Modulators|tubulin modulators|mesh-ancestor
92791654|NCT02697838|Antimitotic Agents|antimitotic agents|mesh-ancestor
92791655|NCT02697838|Mitosis Modulators|mitosis modulators|mesh-ancestor
92791656|NCT02697838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791657|NCT02697838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791658|NCT02697838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791660|NCT00928707|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92791661|NCT00928707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791662|NCT00928707|Antisickling Agents|antisickling agents|mesh-ancestor
92791663|NCT00928707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791664|NCT00928707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791665|NCT00928707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92791666|NCT00928707|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92791667|NCT04956705|Vitamin D|vitamin d|mesh-list
92791668|NCT04956705|Calcium|calcium|mesh-list
92791669|NCT04956705|Vitamins|vitamins|mesh-ancestor
92791670|NCT04956705|Micronutrients|micronutrients|mesh-ancestor
92791671|NCT04956705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791672|NCT04956705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92791673|NCT04956705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92791674|NCT02705950|Baclofen|baclofen|mesh-list
92791675|NCT02705950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92791676|NCT02705950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791677|NCT02705950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92791678|NCT02705950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791679|NCT02705950|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92791680|NCT02705950|GABA Agonists|gaba agonists|mesh-ancestor
92791681|NCT02705950|GABA Agents|gaba agents|mesh-ancestor
92791682|NCT02705950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791683|NCT02705950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791684|NCT04951323|Vaccines|vaccines|mesh-list
92791685|NCT04951323|Immunologic Factors|immunologic factors|mesh-ancestor
92791686|NCT04951323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791687|NCT02705872|Sufentanil|sufentanil|mesh-list
92791688|NCT02705872|Dsuvia|dsuvia|mesh-list
92791689|NCT02705872|Levobupivacaine|levobupivacaine|mesh-list
92791690|NCT02705872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92791691|NCT02705872|Narcotics|narcotics|mesh-ancestor
92791692|NCT02705872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791693|NCT02705872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791694|NCT02705872|Analgesics|analgesics|mesh-ancestor
92791695|NCT02705872|Sensory System Agents|sensory system agents|mesh-ancestor
92791696|NCT02705872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791697|NCT02705872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92791698|NCT02705872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92791699|NCT02705872|Anesthetics, General|anesthetics, general|mesh-ancestor
92791700|NCT02705872|Anesthetics|anesthetics|mesh-ancestor
92791701|NCT02705872|Anesthetics, Local|anesthetics, local|mesh-ancestor
92791702|NCT02701348|Letrozole|letrozole|mesh-list
92791703|NCT02701348|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92791704|NCT02701348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791705|NCT02701348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92791706|NCT02701348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791707|NCT02701348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791708|NCT02701348|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92791709|NCT02701348|Hormone Antagonists|hormone antagonists|mesh-ancestor
92791710|NCT02701348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791711|NCT02701348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791712|NCT05324800|Turmeric extract|turmeric extract|mesh-list
92791713|NCT05324800|Antioxidants|antioxidants|mesh-ancestor
92791714|NCT05324800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791715|NCT05324800|Protective Agents|protective agents|mesh-ancestor
92791716|NCT05324800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791717|NCT04258371|Dapagliflozin|dapagliflozin|mesh-list
92791718|NCT04258371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92791719|NCT04258371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791720|NCT04258371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791721|NCT04258371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791722|NCT00930579|Metformin|metformin|mesh-list
92791723|NCT00930579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791724|NCT00930579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791726|NCT03367156|Dexamethasone acetate|dexamethasone acetate|mesh-list
92791727|NCT03367156|Ichthammol|ichthammol|mesh-list
92791728|NCT03367156|BB 1101|bb 1101|mesh-list
92791729|NCT03367156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791730|NCT03367156|Antiemetics|antiemetics|mesh-ancestor
92791731|NCT03367156|Autonomic Agents|autonomic agents|mesh-ancestor
92791732|NCT03367156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791733|NCT03367156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791734|NCT03367156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791735|NCT03367156|Glucocorticoids|glucocorticoids|mesh-ancestor
92791736|NCT03367156|Hormones|hormones|mesh-ancestor
92791737|NCT03367156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791738|NCT03367156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791739|NCT03367156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791740|NCT03367156|Protease Inhibitors|protease inhibitors|mesh-ancestor
92791741|NCT03367156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791742|NCT03367156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791743|NCT03367156|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791744|NCT02700568|Axitinib|axitinib|mesh-list
92791745|NCT02700568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791746|NCT02700568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92791747|NCT02700568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791748|NCT02700568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791749|NCT00925353|Lidocaine|lidocaine|mesh-list
92791750|NCT00925353|Anesthetics, Local|anesthetics, local|mesh-ancestor
92791751|NCT00925353|Anesthetics|anesthetics|mesh-ancestor
92791752|NCT00925353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791753|NCT00925353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791754|NCT00925353|Sensory System Agents|sensory system agents|mesh-ancestor
92791755|NCT00925353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791756|NCT00925353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92791757|NCT00925353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92791758|NCT00925353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92791759|NCT00925353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791760|NCT00925353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791761|NCT02705482|Durvalumab|durvalumab|mesh-list
92791762|NCT02705482|Tremelimumab|tremelimumab|mesh-list
92791763|NCT02705482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92791764|NCT02705482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791765|NCT02705638|Rituximab|rituximab|mesh-list
92791766|NCT02705638|Lenalidomide|lenalidomide|mesh-list
92791767|NCT02705638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92791768|NCT02705638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791769|NCT02705638|Immunologic Factors|immunologic factors|mesh-ancestor
92791770|NCT02705638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791771|NCT02705638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791772|NCT02705638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92791773|NCT02705638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92791774|NCT02705638|Growth Substances|growth substances|mesh-ancestor
92791775|NCT02705638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92791776|NCT02691910|Chloroquine|chloroquine|mesh-list
92791777|NCT02691910|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92791778|NCT02691910|Primaquine|primaquine|mesh-list
92791779|NCT02691910|Amebicides|amebicides|mesh-ancestor
92791780|NCT02691910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92791781|NCT02691910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92791782|NCT02691910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791783|NCT02691910|Antimalarials|antimalarials|mesh-ancestor
92791784|NCT02691910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791785|NCT02691910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92791786|NCT02691910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791787|NCT02691910|Analgesics|analgesics|mesh-ancestor
92791788|NCT02691910|Sensory System Agents|sensory system agents|mesh-ancestor
92791789|NCT02691910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791790|NCT02691910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791791|NCT02691910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791792|NCT02691910|Filaricides|filaricides|mesh-ancestor
92791793|NCT02691910|Antinematodal Agents|antinematodal agents|mesh-ancestor
92791794|NCT02691910|Anthelmintics|anthelmintics|mesh-ancestor
92791795|NCT02705014|Hormones|hormones|mesh-list
92791796|NCT02705014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791797|NCT02705014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791798|NCT02704624|Vitamin D|vitamin d|mesh-list
92791799|NCT02704624|Vitamins|vitamins|mesh-ancestor
92791800|NCT02704624|Micronutrients|micronutrients|mesh-ancestor
92791801|NCT02704624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791802|NCT02704624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92791803|NCT02700022|Prednisone|prednisone|mesh-list
92791804|NCT02700022|Cyclophosphamide|cyclophosphamide|mesh-list
92791805|NCT02700022|Doxorubicin|doxorubicin|mesh-list
92436849|NCT03272685|Nicotine|nicotine|mesh-list
92791806|NCT02700022|Etoposide|etoposide|mesh-list
92791807|NCT02700022|Vincristine|vincristine|mesh-list
92791808|NCT02700022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791810|NCT02700022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791811|NCT02700022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791812|NCT02700022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92791813|NCT02700022|Alkylating Agents|alkylating agents|mesh-ancestor
92791814|NCT02700022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791815|NCT02700022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791816|NCT02700022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92791817|NCT02700022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92791818|NCT02700022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92791819|NCT02700022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92791820|NCT02700022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791821|NCT02700022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791822|NCT02700022|Glucocorticoids|glucocorticoids|mesh-ancestor
92791823|NCT02700022|Hormones|hormones|mesh-ancestor
92791824|NCT02700022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791825|NCT02700022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791826|NCT02700022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92791827|NCT02700022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92791828|NCT02700022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92791829|NCT02700022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92791830|NCT02699710|Folic Acid|folic acid|mesh-list
92791831|NCT02699710|Methotrexate|methotrexate|mesh-list
92791832|NCT02699710|Rabeprazole|rabeprazole|mesh-list
92791833|NCT02699710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92791834|NCT02699710|Abortifacient Agents|abortifacient agents|mesh-ancestor
92791835|NCT02699710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791836|NCT02699710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791837|NCT02699710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92791838|NCT02699710|Antimetabolites|antimetabolites|mesh-ancestor
92791839|NCT02699710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791840|NCT02699710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791841|NCT02699710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791842|NCT02699710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791843|NCT02699710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92791844|NCT02699710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791845|NCT02699710|Immunologic Factors|immunologic factors|mesh-ancestor
92791846|NCT02699710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92791847|NCT02699710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92791848|NCT02699710|Hematinics|hematinics|mesh-ancestor
92791849|NCT02699710|Vitamin B Complex|vitamin b complex|mesh-ancestor
92791850|NCT02699710|Vitamins|vitamins|mesh-ancestor
92791851|NCT02699710|Micronutrients|micronutrients|mesh-ancestor
92791852|NCT02699710|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92791853|NCT02699710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791854|NCT02699710|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92791855|NCT03140488|Oxytocin|oxytocin|mesh-list
92791856|NCT03140488|Oxytocics|oxytocics|mesh-ancestor
92791857|NCT03140488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92791858|NCT03140488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791859|NCT00616408|Octreotide|octreotide|mesh-list
92791860|NCT00616408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791861|NCT00616408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791862|NCT00616408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791863|NCT02691754|Acetaminophen|acetaminophen|mesh-list
92791864|NCT02691754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92791865|NCT02691754|Analgesics|analgesics|mesh-ancestor
92791866|NCT02691754|Sensory System Agents|sensory system agents|mesh-ancestor
92791867|NCT02691754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791868|NCT02691754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791869|NCT02691754|Antipyretics|antipyretics|mesh-ancestor
92791870|NCT02691676|Plasma-lyte 148|plasma-lyte 148|mesh-list
92791871|NCT02691676|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92791872|NCT02691676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92791873|NCT05321602|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92791874|NCT05321602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92791875|NCT05321602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92791876|NCT05321602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791877|NCT05321602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791879|NCT05321602|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92791880|NCT05321602|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92791881|NCT05321602|Serotonin Agents|serotonin agents|mesh-ancestor
92791882|NCT05321602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436917|NCT05704959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92791883|NCT05321602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791884|NCT05321602|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92791885|NCT05321602|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92791886|NCT05321602|Dopamine Agents|dopamine agents|mesh-ancestor
92791888|NCT01106651|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92791889|NCT01106651|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92791890|NCT01106651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791891|NCT01106651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791892|NCT00637078|Amlodipine|amlodipine|mesh-list
92791893|NCT00637078|Spironolactone|spironolactone|mesh-list
92791894|NCT00637078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92791895|NCT00637078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92791896|NCT00637078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791897|NCT00637078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791898|NCT00637078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92791899|NCT00637078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791900|NCT00637078|Vasodilator Agents|vasodilator agents|mesh-ancestor
92791901|NCT00637078|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92791902|NCT00637078|Hormone Antagonists|hormone antagonists|mesh-ancestor
92791903|NCT00637078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791904|NCT00637078|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92791905|NCT00637078|Diuretics|diuretics|mesh-ancestor
92791906|NCT00637078|Natriuretic Agents|natriuretic agents|mesh-ancestor
92791907|NCT00625781|Insulin|insulin|mesh-list
92791908|NCT00625781|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92791909|NCT00625781|Insulin Aspart|insulin aspart|mesh-list
92791910|NCT00625781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791911|NCT00625781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791912|NCT01027650|Dexamethasone|dexamethasone|mesh-list
92791913|NCT01027650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92791914|NCT01027650|Antiemetics|antiemetics|mesh-ancestor
92791915|NCT01027650|Autonomic Agents|autonomic agents|mesh-ancestor
92791916|NCT01027650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791917|NCT01027650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791918|NCT01027650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791919|NCT01027650|Glucocorticoids|glucocorticoids|mesh-ancestor
92791920|NCT01027650|Hormones|hormones|mesh-ancestor
92791921|NCT01027650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791922|NCT01027650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791923|NCT01027650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791924|NCT00616876|Lactulose|lactulose|mesh-list
92791925|NCT00616876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92791926|NCT01106027|Eculizumab|eculizumab|mesh-list
92791927|NCT01106027|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92791928|NCT01106027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92791929|NCT01106027|Immunologic Factors|immunologic factors|mesh-ancestor
92791930|NCT01106027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791931|NCT01027416|Tamoxifen|tamoxifen|mesh-list
92791932|NCT01027416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92791933|NCT01027416|Hormone Antagonists|hormone antagonists|mesh-ancestor
92791934|NCT01027416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791935|NCT01027416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791936|NCT01027416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92791937|NCT01027416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92791938|NCT01027416|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92791939|NCT01027416|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92791940|NCT01027416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92791941|NCT02873520|Immunomodulating Agents|immunomodulating agents|mesh-list
92791942|NCT02873520|Immunologic Factors|immunologic factors|mesh-ancestor
92791943|NCT02873520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791944|NCT05026203|Midazolam|midazolam|mesh-list
92791945|NCT05026203|Ketamine|ketamine|mesh-list
92791946|NCT05026203|Analgesics|analgesics|mesh-ancestor
92791947|NCT05026203|Sensory System Agents|sensory system agents|mesh-ancestor
92791948|NCT05026203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92791949|NCT05026203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738346|NCT00624754|Hormones|hormones|mesh-ancestor
92791950|NCT05026203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92791951|NCT05026203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92791952|NCT05026203|Anesthetics, General|anesthetics, general|mesh-ancestor
92791953|NCT05026203|Anesthetics|anesthetics|mesh-ancestor
92791954|NCT05026203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92791955|NCT05026203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92791956|NCT05026203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92791957|NCT05026203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92791958|NCT05026203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791959|NCT05026203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92791960|NCT05026203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92791961|NCT05026203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92791962|NCT05026203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92791963|NCT05026203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92791964|NCT05026203|GABA Modulators|gaba modulators|mesh-ancestor
92791965|NCT05026203|GABA Agents|gaba agents|mesh-ancestor
92791966|NCT01015638|Clindamycin|clindamycin|mesh-list
92791967|NCT01015638|Clindamycin palmitate|clindamycin palmitate|mesh-list
92791968|NCT01015638|Clindamycin phosphate|clindamycin phosphate|mesh-list
92791969|NCT01015638|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92791970|NCT01015638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92791971|NCT01015638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92791972|NCT01015638|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92791973|NCT01015638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791974|NCT01015638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791975|NCT01015638|Dermatologic Agents|dermatologic agents|mesh-ancestor
92791976|NCT00627744|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92791977|NCT00627744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92791978|NCT00627744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791979|NCT00627744|Incretins|incretins|mesh-ancestor
92791981|NCT00627744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92791982|NCT00627744|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92791983|NCT00627744|Protease Inhibitors|protease inhibitors|mesh-ancestor
92791984|NCT00627744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92791985|NCT00627744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791986|NCT01105091|Epoprostenol|epoprostenol|mesh-list
92791987|NCT01105091|Tezosentan|tezosentan|mesh-list
92791988|NCT01105091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92791989|NCT01105091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92791990|NCT01105091|Vasodilator Agents|vasodilator agents|mesh-ancestor
92791991|NCT00628056|Perhexiline|perhexiline|mesh-list
92791992|NCT00628056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92791993|NCT00628056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92791994|NCT00628056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92791995|NCT00628056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92791996|NCT00628056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92791997|NCT00628056|Vasodilator Agents|vasodilator agents|mesh-ancestor
92791998|NCT00924729|Moxifloxacin|moxifloxacin|mesh-list
92791999|NCT00924729|Besifloxacin|besifloxacin|mesh-list
92792000|NCT00924729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92792001|NCT00924729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92792002|NCT00924729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792003|NCT00924729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792004|NCT00924729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92792005|NCT00924729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92792006|NCT00924729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792007|NCT00924729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792008|NCT00924729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792009|NCT01099709|Oxycodone|oxycodone|mesh-list
92792010|NCT01099709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92792011|NCT01099709|Narcotics|narcotics|mesh-ancestor
92792012|NCT01099709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792013|NCT01099709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792014|NCT01099709|Analgesics|analgesics|mesh-ancestor
92792015|NCT01099709|Sensory System Agents|sensory system agents|mesh-ancestor
92792016|NCT01099709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792017|NCT04907019|Rifampin|rifampin|mesh-list
92792018|NCT04907019|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92792019|NCT04907019|Antitubercular Agents|antitubercular agents|mesh-ancestor
92792020|NCT04907019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792021|NCT04907019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792022|NCT04907019|Leprostatic Agents|leprostatic agents|mesh-ancestor
92792023|NCT04907019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92792025|NCT04907019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792026|NCT04907019|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92792027|NCT04907019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92792028|NCT04907019|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92437074|NCT04911621|Temozolomide|temozolomide|mesh-list
92792029|NCT04907019|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92792030|NCT04907019|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92792031|NCT04907019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92792032|NCT01022424|Tolvaptan|tolvaptan|mesh-list
92792033|NCT01022424|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92792034|NCT01022424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792035|NCT01022424|Natriuretic Agents|natriuretic agents|mesh-ancestor
92792036|NCT01022424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792037|NCT05329857|Metformin|metformin|mesh-list
92792038|NCT05329857|Vildagliptin|vildagliptin|mesh-list
92792039|NCT05329857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792040|NCT05329857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792041|NCT05329857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92792042|NCT05329857|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792043|NCT05329857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792044|NCT05329857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792045|NCT01026948|Dinoprostone|dinoprostone|mesh-list
92792046|NCT01026948|Oxytocics|oxytocics|mesh-ancestor
92792047|NCT01026948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92792048|NCT01026948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792049|NCT01104779|Cariprazine|cariprazine|mesh-list
92792050|NCT01104779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92792051|NCT01104779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92792052|NCT01104779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792053|NCT01104779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792054|NCT01104779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792055|NCT00918957|Tobramycin|tobramycin|mesh-list
92792056|NCT00918957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792057|NCT00918957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792058|NCT04308161|Vitamin D|vitamin d|mesh-list
92792059|NCT04308161|Miconazole|miconazole|mesh-list
92792060|NCT04308161|Vitamins|vitamins|mesh-ancestor
92792061|NCT04308161|Micronutrients|micronutrients|mesh-ancestor
92792062|NCT04308161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792063|NCT04308161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92792064|NCT04308161|Antifungal Agents|antifungal agents|mesh-ancestor
92792065|NCT04308161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792066|NCT04308161|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92792067|NCT04308161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92792068|NCT04308161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792069|NCT04308161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792070|NCT04308161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92792071|NCT04308161|Hormone Antagonists|hormone antagonists|mesh-ancestor
92792072|NCT04308161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792073|NCT04308161|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92792074|NCT04308161|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92792075|NCT04939467|Pirfenidone|pirfenidone|mesh-list
92792076|NCT04939467|Nintedanib|nintedanib|mesh-list
92792077|NCT04939467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792078|NCT04939467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92792079|NCT04939467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792080|NCT04939467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792081|NCT04939467|Analgesics|analgesics|mesh-ancestor
92792082|NCT04939467|Sensory System Agents|sensory system agents|mesh-ancestor
92792083|NCT04939467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792084|NCT04939467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792085|NCT04939467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92792086|NCT04939467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792087|NCT04939467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792088|NCT04939467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792089|NCT01015560|Antibodies|antibodies|mesh-list
92792090|NCT01015560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92792091|NCT01015560|Immunologic Factors|immunologic factors|mesh-ancestor
92792092|NCT01015560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792093|NCT04253223|Volagidemab|volagidemab|mesh-list
92792094|NCT04253223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738500|NCT01077739|Antimetabolites|antimetabolites|mesh-ancestor
92792095|NCT04253223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792096|NCT00918879|Saxagliptin|saxagliptin|mesh-list
92792097|NCT00918879|Incretins|incretins|mesh-ancestor
92792098|NCT00918879|Hormones|hormones|mesh-ancestor
92792099|NCT00918879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792100|NCT00918879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792101|NCT00918879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92792102|NCT00918879|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792104|NCT00918879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792105|NCT00918879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792106|NCT01026792|Sirolimus|sirolimus|mesh-list
92792107|NCT01026792|Temsirolimus|temsirolimus|mesh-list
92792108|NCT01026792|MTOR Inhibitors|mtor inhibitors|mesh-list
92792109|NCT01026792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92792110|NCT01026792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792111|NCT01026792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792112|NCT01026792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792113|NCT01026792|Immunologic Factors|immunologic factors|mesh-ancestor
92792114|NCT01026792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792115|NCT01026792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792116|NCT01026792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792117|NCT01026792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792118|NCT01026792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92792119|NCT01026792|Antifungal Agents|antifungal agents|mesh-ancestor
92792120|NCT01026324|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
92792121|NCT01026324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92792122|NCT01026324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792123|NCT01026324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792124|NCT04300686|Adalimumab|adalimumab|mesh-list
92792125|NCT04300686|Antibodies|antibodies|mesh-list
92792126|NCT04300686|Immunoglobulins|immunoglobulins|mesh-list
92792127|NCT04300686|Immunologic Factors|immunologic factors|mesh-ancestor
92792128|NCT04300686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792129|NCT04300686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92792130|NCT04300686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792131|NCT04300686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792132|NCT01098539|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92792133|NCT01098539|rGLP-1 protein|rglp-1 protein|mesh-list
92792134|NCT01098539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792135|NCT01098539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792136|NCT01098539|Incretins|incretins|mesh-ancestor
92792137|NCT01098539|Hormones|hormones|mesh-ancestor
92792138|NCT01098539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792139|NCT01098539|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92792140|NCT01098539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792141|NCT01098539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792142|NCT01098539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792143|NCT04922723|Daratumumab|daratumumab|mesh-list
92792144|NCT04922723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792145|NCT01098461|rGLP-1 protein|rglp-1 protein|mesh-list
92792146|NCT01098461|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92792147|NCT01098461|Incretins|incretins|mesh-ancestor
92792148|NCT01098461|Hormones|hormones|mesh-ancestor
92792149|NCT01098461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792150|NCT01098461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792151|NCT01098305|Varenicline|varenicline|mesh-list
92792152|NCT01098305|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92792153|NCT01098305|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92792154|NCT01098305|Cholinergic Agents|cholinergic agents|mesh-ancestor
92792155|NCT01098305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792156|NCT01098305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792157|NCT01098305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792158|NCT00833833|Aspirin|aspirin|mesh-list
92792159|NCT00833833|Dexamethasone|dexamethasone|mesh-list
92792160|NCT00833833|Dexamethasone acetate|dexamethasone acetate|mesh-list
92792161|NCT00833833|Pomalidomide|pomalidomide|mesh-list
92792162|NCT00833833|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92792163|NCT00833833|BB 1101|bb 1101|mesh-list
92792164|NCT00833833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792165|NCT00833833|Antiemetics|antiemetics|mesh-ancestor
92792166|NCT00833833|Autonomic Agents|autonomic agents|mesh-ancestor
92792167|NCT00833833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792168|NCT00833833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792169|NCT00833833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92792170|NCT00833833|Glucocorticoids|glucocorticoids|mesh-ancestor
92792171|NCT00833833|Hormones|hormones|mesh-ancestor
92792172|NCT00833833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792173|NCT00833833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92792174|NCT00833833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792175|NCT00833833|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792176|NCT00833833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437221|NCT03841110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92792177|NCT00833833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792178|NCT00833833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92792179|NCT00833833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792181|NCT00833833|Sensory System Agents|sensory system agents|mesh-ancestor
92792182|NCT00833833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792183|NCT00833833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92792184|NCT00833833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92792185|NCT00833833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92792186|NCT00833833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92792187|NCT00833833|Antipyretics|antipyretics|mesh-ancestor
92792188|NCT00833833|Immunologic Factors|immunologic factors|mesh-ancestor
92792189|NCT00833833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92792190|NCT00833833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92792191|NCT00833833|Growth Substances|growth substances|mesh-ancestor
92792192|NCT00833833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92792193|NCT01098071|Mometasone Furoate|mometasone furoate|mesh-list
92792194|NCT01098071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792195|NCT01098071|Dermatologic Agents|dermatologic agents|mesh-ancestor
92792196|NCT01098071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92792197|NCT02612545|Piperaquine|piperaquine|mesh-list
92792198|NCT02612545|Artenimol|artenimol|mesh-list
92792199|NCT02612545|Mefloquine|mefloquine|mesh-list
92792200|NCT02612545|Antimalarials|antimalarials|mesh-ancestor
92792201|NCT02612545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92792202|NCT02612545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92792203|NCT02612545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792204|NCT00704743|Calpastatin|calpastatin|mesh-list
92792205|NCT00704743|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92792206|NCT00704743|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792207|NCT00704743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792208|NCT00704743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792209|NCT01097057|Plerixafor|plerixafor|mesh-list
92792210|NCT01097057|Rituximab|rituximab|mesh-list
92792211|NCT01097057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92792212|NCT01097057|Carboplatin|carboplatin|mesh-list
92792213|NCT01097057|Etoposide|etoposide|mesh-list
92792214|NCT01097057|Etoposide phosphate|etoposide phosphate|mesh-list
92792215|NCT01097057|Ifosfamide|ifosfamide|mesh-list
92792216|NCT01097057|Isophosphamide mustard|isophosphamide mustard|mesh-list
92792217|NCT01097057|Podophyllotoxin|podophyllotoxin|mesh-list
92792218|NCT01097057|Antibodies|antibodies|mesh-list
92792219|NCT01097057|Immunoglobulins|immunoglobulins|mesh-list
92792220|NCT01097057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92792221|NCT01097057|Lenograstim|lenograstim|mesh-list
92792222|NCT01097057|Immunologic Factors|immunologic factors|mesh-ancestor
92792223|NCT01097057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792224|NCT01097057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792225|NCT01097057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792226|NCT01097057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92792227|NCT01097057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92792228|NCT01097057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92792229|NCT01097057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792230|NCT01097057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792231|NCT01097057|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92792232|NCT01097057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92792233|NCT01097057|Alkylating Agents|alkylating agents|mesh-ancestor
92792234|NCT01097057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92792235|NCT01097057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92792236|NCT01097057|Antiviral Agents|antiviral agents|mesh-ancestor
92792237|NCT01097057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792238|NCT01097057|Keratolytic Agents|keratolytic agents|mesh-ancestor
92792239|NCT01097057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92792240|NCT01097057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792241|NCT01097057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792242|NCT01097057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792243|NCT02612701|Nicotine|nicotine|mesh-list
92792244|NCT02612701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92792245|NCT02612701|Autonomic Agents|autonomic agents|mesh-ancestor
92792246|NCT02612701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792247|NCT02612701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792248|NCT02612701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92792249|NCT02612701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92792250|NCT02612701|Cholinergic Agents|cholinergic agents|mesh-ancestor
92792251|NCT02612701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792252|NCT02612701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792253|NCT01096667|Ertugliflozin|ertugliflozin|mesh-list
92792254|NCT01096667|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92792255|NCT01096667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92792256|NCT01096667|Diuretics|diuretics|mesh-ancestor
92792257|NCT01096667|Natriuretic Agents|natriuretic agents|mesh-ancestor
92792258|NCT01096667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792259|NCT01096667|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92792260|NCT01096667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792261|NCT01096667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792262|NCT01096667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92792263|NCT01096667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792264|NCT01014624|Clopidogrel|clopidogrel|mesh-list
92792265|NCT01014624|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92792266|NCT01014624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92792267|NCT01014624|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92792268|NCT01014624|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92792269|NCT01014624|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92792270|NCT01014624|Purinergic Agents|purinergic agents|mesh-ancestor
92792271|NCT01014624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792272|NCT01014624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792273|NCT01014624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792274|NCT01021878|Icodextrin|icodextrin|mesh-list
92792275|NCT01021878|Dialysis Solutions|dialysis solutions|mesh-ancestor
92792276|NCT01021878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92792277|NCT02872428|Valproic Acid|valproic acid|mesh-list
92792278|NCT02872428|Anticonvulsants|anticonvulsants|mesh-ancestor
92792279|NCT02872428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792280|NCT02872428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792281|NCT02872428|GABA Agents|gaba agents|mesh-ancestor
92792282|NCT02872428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792283|NCT02872428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792284|NCT02872428|Antimanic Agents|antimanic agents|mesh-ancestor
92792285|NCT02872428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92792286|NCT02872428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792287|NCT02872428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792288|NCT02873364|Vitamin D|vitamin d|mesh-list
92792289|NCT02873364|Ergocalciferols|ergocalciferols|mesh-list
92792290|NCT02873364|Cholecalciferol|cholecalciferol|mesh-list
92792291|NCT02873364|Vitamins|vitamins|mesh-list
92792292|NCT02873364|Micronutrients|micronutrients|mesh-ancestor
92792293|NCT02873364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792294|NCT02873364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92792295|NCT02873364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92792296|NCT00628290|Cannabidiol|cannabidiol|mesh-list
92792297|NCT00628290|Amisulpride|amisulpride|mesh-list
92792298|NCT00628290|Anticonvulsants|anticonvulsants|mesh-ancestor
92792299|NCT00628290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92792300|NCT00628290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92792301|NCT00628290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792302|NCT00628290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792303|NCT00628290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792304|NCT00628290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92792305|NCT00628290|Dopamine Agents|dopamine agents|mesh-ancestor
92792306|NCT00628290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792307|NCT00628290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792308|NCT00628290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92792309|NCT00628290|Antidepressive Agents|antidepressive agents|mesh-ancestor
92792310|NCT04559412|Etanercept|etanercept|mesh-list
92792311|NCT04559412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92792312|NCT04559412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792313|NCT04559412|Analgesics|analgesics|mesh-ancestor
92792314|NCT04559412|Sensory System Agents|sensory system agents|mesh-ancestor
92792315|NCT04559412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792316|NCT04559412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792317|NCT04559412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792318|NCT04559412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792319|NCT04559412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92792320|NCT04559412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792321|NCT04559412|Immunologic Factors|immunologic factors|mesh-ancestor
92792322|NCT00854113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92792323|NCT00854113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792325|NCT00854113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792326|NCT02872584|Prednisone|prednisone|mesh-list
92792327|NCT02872584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792328|NCT02872584|Glucocorticoids|glucocorticoids|mesh-ancestor
92792329|NCT02872584|Hormones|hormones|mesh-ancestor
92792330|NCT02872584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792331|NCT02872584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792332|NCT02872584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92792333|NCT02872584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792334|NCT00704821|Docetaxel|docetaxel|mesh-list
92792335|NCT00704821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792336|NCT00704821|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792337|NCT00704821|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792338|NCT00704821|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792339|NCT00704821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792340|NCT00704899|Amitriptyline|amitriptyline|mesh-list
92792341|NCT00704899|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92792342|NCT00704899|Antidepressive Agents|antidepressive agents|mesh-ancestor
92792343|NCT00704899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792344|NCT00704899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792345|NCT00704899|Analgesics|analgesics|mesh-ancestor
92792346|NCT00704899|Sensory System Agents|sensory system agents|mesh-ancestor
92710489|NCT00445406|Growth Substances|growth substances|mesh-ancestor
92792347|NCT00704899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792348|NCT00704899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792349|NCT00704899|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92792350|NCT00704899|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92792351|NCT00704899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792352|NCT00704899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792353|NCT00704899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92792354|NCT00704899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792355|NCT01104701|Exenatide|exenatide|mesh-list
92792356|NCT01104701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792357|NCT01104701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792358|NCT01104701|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92792359|NCT01104701|Incretins|incretins|mesh-ancestor
92792360|NCT01104701|Hormones|hormones|mesh-ancestor
92792361|NCT01104701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792362|NCT00833755|Ketamine|ketamine|mesh-list
92792363|NCT00833755|Analgesics|analgesics|mesh-ancestor
92792364|NCT00833755|Sensory System Agents|sensory system agents|mesh-ancestor
92792365|NCT00833755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792366|NCT00833755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792367|NCT00833755|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92792368|NCT00833755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92792369|NCT00833755|Anesthetics, General|anesthetics, general|mesh-ancestor
92792370|NCT00833755|Anesthetics|anesthetics|mesh-ancestor
92792371|NCT00833755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792372|NCT00833755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92792373|NCT00833755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92792374|NCT00833755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792375|NCT00833755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792376|NCT01021332|Tamsulosin|tamsulosin|mesh-list
92792377|NCT01021332|Solifenacin Succinate|solifenacin succinate|mesh-list
92792378|NCT01021332|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92792379|NCT01021332|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92792380|NCT01021332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92792381|NCT01021332|Adrenergic Agents|adrenergic agents|mesh-ancestor
92792382|NCT01021332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792383|NCT01021332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792384|NCT01021332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792385|NCT01021332|Urological Agents|urological agents|mesh-ancestor
92792386|NCT01021332|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92792387|NCT01021332|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92792388|NCT01021332|Cholinergic Agents|cholinergic agents|mesh-ancestor
92792389|NCT00923091|Amlodipine|amlodipine|mesh-list
92792390|NCT00923091|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92792391|NCT00923091|Olmesartan|olmesartan|mesh-list
92792392|NCT00923091|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92792393|NCT00923091|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
92792394|NCT00923091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92792395|NCT00923091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92792396|NCT00923091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792397|NCT00923091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792398|NCT00923091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92792399|NCT00923091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792400|NCT00923091|Vasodilator Agents|vasodilator agents|mesh-ancestor
92792401|NCT00923091|Diuretics|diuretics|mesh-ancestor
92792402|NCT00923091|Natriuretic Agents|natriuretic agents|mesh-ancestor
92792403|NCT00923091|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92792404|NCT00923091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92792405|NCT00923091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92792406|NCT00853957|Amlodipine|amlodipine|mesh-list
92792407|NCT00853957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92792408|NCT00853957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92792409|NCT00853957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792410|NCT00853957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792411|NCT00853957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92792412|NCT00853957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792413|NCT00853957|Vasodilator Agents|vasodilator agents|mesh-ancestor
92792414|NCT01021020|Colchicine|colchicine|mesh-list
92792415|NCT01021020|Probenecid|probenecid|mesh-list
92792416|NCT01021020|Gout Suppressants|gout suppressants|mesh-ancestor
92792417|NCT01021020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792418|NCT01021020|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792419|NCT01021020|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792420|NCT01021020|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792421|NCT01021020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792422|NCT01021020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792423|NCT01021020|Uricosuric Agents|uricosuric agents|mesh-ancestor
92792424|NCT00833053|Infliximab|infliximab|mesh-list
92792425|NCT00833053|Methotrexate|methotrexate|mesh-list
92792426|NCT00833053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92792427|NCT00833053|Abortifacient Agents|abortifacient agents|mesh-ancestor
92792428|NCT00833053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92792429|NCT00833053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792430|NCT00833053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92792431|NCT00833053|Antimetabolites|antimetabolites|mesh-ancestor
92792432|NCT00833053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792433|NCT00833053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792434|NCT00833053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92792435|NCT00833053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792436|NCT00833053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92792437|NCT00833053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792438|NCT00833053|Immunologic Factors|immunologic factors|mesh-ancestor
92792439|NCT00833053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792440|NCT00833053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92792441|NCT00833053|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92792442|NCT00833053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792443|NCT00833053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92792444|NCT01020786|Carboplatin|carboplatin|mesh-list
92792445|NCT01020786|Pemetrexed|pemetrexed|mesh-list
92792446|NCT01020786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792447|NCT01020786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792448|NCT01020786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792449|NCT01020786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92792450|NCT01020786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92792451|NCT00918645|Calcium|calcium|mesh-list
92792452|NCT00918645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92792453|NCT00918645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792454|NCT01020474|Pregabalin|pregabalin|mesh-list
92792455|NCT01020474|Analgesics|analgesics|mesh-ancestor
92792456|NCT01020474|Sensory System Agents|sensory system agents|mesh-ancestor
92792457|NCT01020474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792458|NCT01020474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792459|NCT01020474|Anticonvulsants|anticonvulsants|mesh-ancestor
92792460|NCT01020474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92792461|NCT01020474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792462|NCT01020474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792463|NCT01020474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92792464|NCT01020474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92792465|NCT01020474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92792466|NCT01020474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792467|NCT01020474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792468|NCT02872818|Metformin|metformin|mesh-list
92792469|NCT02872818|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92792470|NCT02872818|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92792471|NCT02872818|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92792472|NCT02872818|Medroxyprogesterone|medroxyprogesterone|mesh-list
92792473|NCT02872818|Estradiol|estradiol|mesh-list
92792474|NCT02872818|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92437520|NCT02039063|Immunologic Factors|immunologic factors|mesh-ancestor
92792475|NCT02872818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792476|NCT02872818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792477|NCT02872818|Estrogens|estrogens|mesh-ancestor
92792478|NCT02872818|Hormones|hormones|mesh-ancestor
92792479|NCT02872818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792480|NCT02872818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92792481|NCT02872818|Contraceptive Agents|contraceptive agents|mesh-ancestor
92792482|NCT02872818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92792483|NCT02872818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92792484|NCT02872818|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92792485|NCT02872818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92792486|NCT02872818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92792487|NCT02872818|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92792488|NCT02872818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92792489|NCT02872818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792490|NCT00922779|Ribavirin|ribavirin|mesh-list
92792491|NCT00922779|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92792492|NCT00922779|Antimetabolites|antimetabolites|mesh-ancestor
92792493|NCT00922779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792494|NCT00922779|Antiviral Agents|antiviral agents|mesh-ancestor
92792495|NCT00922779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792496|NCT04528680|Paclitaxel|paclitaxel|mesh-list
92792497|NCT04528680|Carboplatin|carboplatin|mesh-list
92792498|NCT04528680|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92792499|NCT04528680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92792500|NCT04528680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792501|NCT04528680|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792502|NCT04528680|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792503|NCT04528680|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792504|NCT04528680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792505|NCT04570410|Gemcitabine|gemcitabine|mesh-list
92792506|NCT04570410|Tislelizumab|tislelizumab|mesh-list
92792507|NCT04570410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792508|NCT04570410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92792509|NCT04570410|Antimetabolites|antimetabolites|mesh-ancestor
92792510|NCT04570410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792511|NCT04570410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92792512|NCT04203771|Ibuprofen|ibuprofen|mesh-list
92792513|NCT04203771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92792514|NCT04203771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792515|NCT04203771|Analgesics|analgesics|mesh-ancestor
92792516|NCT04203771|Sensory System Agents|sensory system agents|mesh-ancestor
92792517|NCT04203771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792518|NCT04203771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792519|NCT04203771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792520|NCT04203771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792521|NCT04203771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92792522|NCT04203771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792523|NCT04203771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792524|NCT04256733|Capsaicin|capsaicin|mesh-list
92792525|NCT04256733|Antipruritics|antipruritics|mesh-ancestor
92792526|NCT04256733|Dermatologic Agents|dermatologic agents|mesh-ancestor
92792527|NCT04256733|Sensory System Agents|sensory system agents|mesh-ancestor
92792528|NCT04256733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792529|NCT04256733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792530|NCT01025232|Ranibizumab|ranibizumab|mesh-list
92792531|NCT01025232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92792532|NCT01025232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92792533|NCT01025232|Growth Substances|growth substances|mesh-ancestor
92792534|NCT01025232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792535|NCT01025232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92792536|NCT01025232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792537|NCT05321199|Tranexamic Acid|tranexamic acid|mesh-list
92792538|NCT05321199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92792539|NCT05321199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92792540|NCT05321199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792541|NCT05321199|Hemostatics|hemostatics|mesh-ancestor
92792542|NCT05321199|Coagulants|coagulants|mesh-ancestor
92792543|NCT04300452|Carbetocin|carbetocin|mesh-list
92792545|NCT04300452|Oxytocics|oxytocics|mesh-ancestor
92792546|NCT04300452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92792547|NCT04300452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792548|NCT01025154|Cytarabine|cytarabine|mesh-list
92792549|NCT01025154|Clofarabine|clofarabine|mesh-list
92792550|NCT01025154|Idarubicin|idarubicin|mesh-list
92792551|NCT01025154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92792552|NCT01025154|Antimetabolites|antimetabolites|mesh-ancestor
92792553|NCT01025154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792554|NCT01025154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792555|NCT01025154|Antiviral Agents|antiviral agents|mesh-ancestor
92792556|NCT01025154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792557|NCT01025154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792558|NCT01025154|Immunologic Factors|immunologic factors|mesh-ancestor
92792559|NCT01025154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792560|NCT01025154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92792561|NCT01025154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92792562|NCT01025154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92792563|NCT01025154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792564|NCT04252365|Pembrolizumab|pembrolizumab|mesh-list
92792565|NCT04252365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92792566|NCT04252365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792567|NCT04252365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92792568|NCT04252365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792569|NCT04252443|Analgesics, Opioid|analgesics, opioid|mesh-list
92792571|NCT04252443|Narcotics|narcotics|mesh-ancestor
92792572|NCT04252443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792573|NCT04252443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792574|NCT04252443|Sensory System Agents|sensory system agents|mesh-ancestor
92792575|NCT04252443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792576|NCT00832819|Paclitaxel|paclitaxel|mesh-list
92792577|NCT00832819|Carboplatin|carboplatin|mesh-list
92792578|NCT00832819|Lenvatinib|lenvatinib|mesh-list
92792579|NCT00832819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92792580|NCT00832819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792581|NCT00832819|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792582|NCT00832819|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792583|NCT00832819|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792584|NCT00832819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792585|NCT00832819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92792586|NCT00832819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792587|NCT04820361|Parasympatholytics|parasympatholytics|mesh-list
92792588|NCT04820361|Autonomic Agents|autonomic agents|mesh-ancestor
92792589|NCT04820361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792590|NCT04820361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792591|NCT00853723|Teriparatide|teriparatide|mesh-list
92792592|NCT00853723|Hormones|hormones|mesh-list
92792593|NCT00853723|Parathyroid Hormone|parathyroid hormone|mesh-list
92792594|NCT00853723|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92792595|NCT00853723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92792596|NCT00853723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792597|NCT00853723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92792598|NCT00853723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92792599|NCT00918255|Adalimumab|adalimumab|mesh-list
92792600|NCT00918255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92792601|NCT00918255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792602|NCT00918255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792603|NCT01096589|Monensin|monensin|mesh-list
92792604|NCT01096589|Antifungal Agents|antifungal agents|mesh-ancestor
92792605|NCT01096589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792606|NCT01096589|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92792607|NCT01096589|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92792608|NCT01096589|Coccidiostats|coccidiostats|mesh-ancestor
92792609|NCT01096589|Proton Ionophores|proton ionophores|mesh-ancestor
92792610|NCT01096589|Uncoupling Agents|uncoupling agents|mesh-ancestor
92792611|NCT01096589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792612|NCT01096589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792613|NCT01096589|Ionophores|ionophores|mesh-ancestor
92792614|NCT01096589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792615|NCT01096589|Sodium Ionophores|sodium ionophores|mesh-ancestor
92792616|NCT04252521|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92792617|NCT04252521|Ketoprofen|ketoprofen|mesh-list
92792618|NCT04252521|Metoclopramide|metoclopramide|mesh-list
92792619|NCT04252521|Antiemetics|antiemetics|mesh-ancestor
92792620|NCT04252521|Autonomic Agents|autonomic agents|mesh-ancestor
92792621|NCT04252521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792622|NCT04252521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792623|NCT04252521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92792624|NCT04252521|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92792625|NCT04252521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92792627|NCT04252521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792628|NCT04252521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792629|NCT04252521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92792630|NCT04252521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792631|NCT04252521|Analgesics|analgesics|mesh-ancestor
92792632|NCT04252521|Sensory System Agents|sensory system agents|mesh-ancestor
92792633|NCT04252521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792634|NCT04252521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792635|NCT04252521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92792636|NCT04252521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792637|NCT00845065|Ribavirin|ribavirin|mesh-list
92792638|NCT00845065|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92792639|NCT00845065|Antimetabolites|antimetabolites|mesh-ancestor
92792640|NCT00845065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792641|NCT00845065|Antiviral Agents|antiviral agents|mesh-ancestor
92792642|NCT00845065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792643|NCT04772001|Carboplatin|carboplatin|mesh-list
92792644|NCT04772001|Cisplatin|cisplatin|mesh-list
92792645|NCT04772001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792646|NCT00702091|Ramipril|ramipril|mesh-list
92792647|NCT00702091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92792648|NCT00702091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792649|NCT00702091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792650|NCT00702091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792651|NCT00702091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92792652|NCT00832585|Alefacept|alefacept|mesh-list
92792653|NCT00832585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92792654|NCT00832585|Immunologic Factors|immunologic factors|mesh-ancestor
92792655|NCT00832585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792656|NCT00918567|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92792657|NCT00918567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92792658|NCT00918567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92792659|NCT00918567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792660|NCT00918567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792661|NCT00918567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92792662|NCT00918567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792663|NCT00918567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792664|NCT05252325|Lidocaine|lidocaine|mesh-list
92792665|NCT05252325|Hyaluronic Acid|hyaluronic acid|mesh-list
92792666|NCT05252325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92792667|NCT05252325|Anesthetics|anesthetics|mesh-ancestor
92792668|NCT05252325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792669|NCT05252325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792670|NCT05252325|Sensory System Agents|sensory system agents|mesh-ancestor
92792671|NCT05252325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792672|NCT05252325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92792673|NCT05252325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92792674|NCT05252325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92792675|NCT05252325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792676|NCT05252325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792677|NCT05252325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92792678|NCT05252325|Immunologic Factors|immunologic factors|mesh-ancestor
92792679|NCT05252325|Viscosupplements|viscosupplements|mesh-ancestor
92792680|NCT05252325|Protective Agents|protective agents|mesh-ancestor
92792681|NCT01024920|Sunitinib|sunitinib|mesh-list
92792682|NCT01024920|Nintedanib|nintedanib|mesh-list
92792683|NCT01024920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792684|NCT01024920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92792685|NCT01024920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92792686|NCT01024920|Growth Substances|growth substances|mesh-ancestor
92792687|NCT01024920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792688|NCT01024920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92792689|NCT01024920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92792690|NCT01024920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792691|NCT01024920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792692|NCT00832117|Cisplatin|cisplatin|mesh-list
92792693|NCT00832117|Epothilones|epothilones|mesh-list
92792694|NCT00832117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792695|NCT00832117|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792696|NCT00832117|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792697|NCT00832117|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792698|NCT00832117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792699|NCT02872272|Amikacin|amikacin|mesh-list
92437756|NCT02727803|Antimetabolites|antimetabolites|mesh-ancestor
92792700|NCT02872272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792701|NCT02872272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792702|NCT00831493|Vorinostat|vorinostat|mesh-list
92792703|NCT00831493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792704|NCT00831493|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92792705|NCT00831493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792706|NCT00831493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792707|NCT00705445|Zinc|zinc|mesh-list
92792708|NCT00705445|Trace Elements|trace elements|mesh-list
92792709|NCT00705445|Micronutrients|micronutrients|mesh-list
92792710|NCT00705445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792711|NCT02879981|Trimethoprim|trimethoprim|mesh-list
92792712|NCT02879981|Sulfamethoxazole|sulfamethoxazole|mesh-list
92792713|NCT02879981|Phenylpropanolamine|phenylpropanolamine|mesh-list
92792714|NCT02879981|Guaifenesin|guaifenesin|mesh-list
92792715|NCT02879981|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92792716|NCT02879981|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92792717|NCT02879981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792718|NCT02879981|Antimalarials|antimalarials|mesh-ancestor
92792719|NCT02879981|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92792720|NCT02879981|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92792721|NCT02879981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92792722|NCT02879981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792723|NCT02879981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792724|NCT02879981|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92792725|NCT02879981|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92792726|NCT02879981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92792727|NCT02879981|Expectorants|expectorants|mesh-ancestor
92792728|NCT02879981|Respiratory System Agents|respiratory system agents|mesh-ancestor
92710867|NCT03455322|Norepinephrine|norepinephrine|mesh-list
92792729|NCT02879981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92792730|NCT02879981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92792731|NCT02879981|Adrenergic Agents|adrenergic agents|mesh-ancestor
92792732|NCT02879981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792733|NCT02879981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792734|NCT02879981|Appetite Depressants|appetite depressants|mesh-ancestor
92792735|NCT02879981|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92792736|NCT02879981|Sympathomimetics|sympathomimetics|mesh-ancestor
92792737|NCT02879981|Autonomic Agents|autonomic agents|mesh-ancestor
92792738|NCT02879981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792739|NCT02879981|Nasal Decongestants|nasal decongestants|mesh-ancestor
92792740|NCT02879981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92792741|NCT04307693|Ritonavir|ritonavir|mesh-list
92792742|NCT04307693|Lopinavir|lopinavir|mesh-list
92792743|NCT04307693|Hydroxychloroquine|hydroxychloroquine|mesh-list
92792744|NCT04307693|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92792745|NCT04307693|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92792746|NCT04307693|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792747|NCT04307693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792748|NCT04307693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792749|NCT04307693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92792750|NCT04307693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92792751|NCT04307693|Antiviral Agents|antiviral agents|mesh-ancestor
92792752|NCT04307693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792753|NCT04307693|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92792754|NCT04307693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92792755|NCT04307693|Antimalarials|antimalarials|mesh-ancestor
92792756|NCT04307693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92792757|NCT04307693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92792758|NCT04307693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792759|NCT02878421|Nicotine|nicotine|mesh-list
92792760|NCT02878421|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92792761|NCT02878421|Autonomic Agents|autonomic agents|mesh-ancestor
92792762|NCT02878421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792763|NCT02878421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792764|NCT02878421|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92792765|NCT02878421|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92792766|NCT02878421|Cholinergic Agents|cholinergic agents|mesh-ancestor
92792767|NCT02878421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792768|NCT02878421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792769|NCT01019694|Albuterol|albuterol|mesh-list
92792770|NCT01019694|Ipratropium|ipratropium|mesh-list
92792772|NCT01019694|Autonomic Agents|autonomic agents|mesh-ancestor
92437884|NCT01599572|Zinc|zinc|mesh-list
92792773|NCT01019694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792774|NCT01019694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792775|NCT01019694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92792776|NCT01019694|Respiratory System Agents|respiratory system agents|mesh-ancestor
92792777|NCT01019694|Tocolytic Agents|tocolytic agents|mesh-ancestor
92792778|NCT01019694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92792779|NCT01019694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92792780|NCT01019694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92792781|NCT01019694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92792782|NCT01019694|Adrenergic Agents|adrenergic agents|mesh-ancestor
92792783|NCT01019694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792784|NCT01019694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792785|NCT01019694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92792786|NCT01019694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92792787|NCT00831415|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92792788|NCT00831415|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92792789|NCT00831415|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92792790|NCT00831415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792791|NCT00831415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792792|NCT00831415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792793|NCT00831415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792794|NCT00831415|Antidepressive Agents|antidepressive agents|mesh-ancestor
92792795|NCT00831415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792796|NCT01095653|Metformin|metformin|mesh-list
92792797|NCT01095653|Dapagliflozin|dapagliflozin|mesh-list
92792798|NCT01095653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92792799|NCT01095653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792800|NCT01095653|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92792801|NCT01095653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792802|NCT00920907|Ipilimumab|ipilimumab|mesh-list
92792803|NCT00920907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92792804|NCT00920907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792805|NCT00920907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92792806|NCT00920907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792807|NCT00700297|Colchicine|colchicine|mesh-list
92792808|NCT00700297|Gout Suppressants|gout suppressants|mesh-ancestor
92792809|NCT00700297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792810|NCT00700297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792811|NCT00700297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792812|NCT00700297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792813|NCT00700297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792814|NCT00700297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792815|NCT04307147|Capecitabine|capecitabine|mesh-list
92792816|NCT04307147|Vinorelbine|vinorelbine|mesh-list
92792817|NCT04307147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92792818|NCT04307147|Antimetabolites|antimetabolites|mesh-ancestor
92792819|NCT04307147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792820|NCT04307147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792821|NCT04307147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92792822|NCT04307147|Tubulin Modulators|tubulin modulators|mesh-ancestor
92792823|NCT04307147|Antimitotic Agents|antimitotic agents|mesh-ancestor
92792824|NCT04307147|Mitosis Modulators|mitosis modulators|mesh-ancestor
92792825|NCT00844831|Lubiprostone|lubiprostone|mesh-list
92792826|NCT00844831|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92792827|NCT00844831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792828|NCT00844831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792829|NCT00920829|Naltrexone|naltrexone|mesh-list
92792830|NCT00920829|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92792831|NCT00920829|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92792832|NCT00920829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792833|NCT00920829|Sensory System Agents|sensory system agents|mesh-ancestor
92792834|NCT00920829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792835|NCT05010876|Icatibant|icatibant|mesh-list
92792836|NCT05010876|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92792837|NCT05010876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92792838|NCT05010876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92792839|NCT05010876|Analgesics|analgesics|mesh-ancestor
92792840|NCT05010876|Sensory System Agents|sensory system agents|mesh-ancestor
92792841|NCT05010876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792842|NCT05010876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792843|NCT05010876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792844|NCT05010876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792845|NCT05010876|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92792846|NCT05010876|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92792847|NCT05010876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792848|NCT05010876|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92792849|NCT05010876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792850|NCT05010876|Immunologic Factors|immunologic factors|mesh-ancestor
92792852|NCT04307069|Oxytocics|oxytocics|mesh-ancestor
92792853|NCT04307069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92792854|NCT04307069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792855|NCT04251741|Adalimumab|adalimumab|mesh-list
92792856|NCT04251741|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92792857|NCT04251741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92792858|NCT04251741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92792859|NCT02878265|Vitamins|vitamins|mesh-list
92792860|NCT02878265|Vitamin A|vitamin a|mesh-list
92792861|NCT02878265|Zinc|zinc|mesh-list
92792862|NCT02878265|Retinol palmitate|retinol palmitate|mesh-list
92792863|NCT02878265|Micronutrients|micronutrients|mesh-ancestor
92792864|NCT02878265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792865|NCT02878265|Trace Elements|trace elements|mesh-ancestor
92792866|NCT02878265|Antioxidants|antioxidants|mesh-ancestor
92792867|NCT02878265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792868|NCT02878265|Protective Agents|protective agents|mesh-ancestor
92792869|NCT02878265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92792870|NCT02878265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792871|NCT00831181|Leucovorin|leucovorin|mesh-list
92792872|NCT00831181|Fluorouracil|fluorouracil|mesh-list
92792873|NCT00831181|Oxaliplatin|oxaliplatin|mesh-list
92792874|NCT00831181|Antimetabolites|antimetabolites|mesh-ancestor
92792875|NCT00831181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792876|NCT00831181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92792877|NCT00831181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792878|NCT00831181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792879|NCT00831181|Immunologic Factors|immunologic factors|mesh-ancestor
92792880|NCT00831181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792881|NCT00831181|Antidotes|antidotes|mesh-ancestor
92792882|NCT00831181|Protective Agents|protective agents|mesh-ancestor
92792883|NCT00831181|Vitamin B Complex|vitamin b complex|mesh-ancestor
92792884|NCT00831181|Vitamins|vitamins|mesh-ancestor
92792885|NCT00831181|Micronutrients|micronutrients|mesh-ancestor
92792886|NCT01023672|Modafinil|modafinil|mesh-list
92792887|NCT01023672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92792888|NCT01023672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792889|NCT01023672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92792890|NCT01023672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92792891|NCT01023672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92792892|NCT01023672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792893|NCT00705835|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92792894|NCT00705835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92792895|NCT00705835|Immunologic Factors|immunologic factors|mesh-ancestor
92792896|NCT00705835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792897|NCT00705835|Antacids|antacids|mesh-ancestor
92792898|NCT00705835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792899|NCT00705835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92792900|NCT00702637|Modafinil|modafinil|mesh-list
92792901|NCT00702637|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92792902|NCT00702637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792903|NCT00702637|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92792904|NCT00702637|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92792905|NCT00702637|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92792906|NCT00702637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792907|NCT04786275|Fentanyl|fentanyl|mesh-list
92792908|NCT04786275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92792909|NCT04786275|Narcotics|narcotics|mesh-ancestor
92792910|NCT04786275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92792911|NCT04786275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792912|NCT04786275|Analgesics|analgesics|mesh-ancestor
92792913|NCT04786275|Sensory System Agents|sensory system agents|mesh-ancestor
92792914|NCT04786275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792915|NCT04786275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92792916|NCT04786275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92792917|NCT04786275|Anesthetics, General|anesthetics, general|mesh-ancestor
92792919|NCT00844753|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92792920|NCT00844753|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92792921|NCT00844753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92792922|NCT00844753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792923|NCT00844753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792924|NCT00844753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92792925|NCT00844753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792926|NCT00844753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792927|NCT05525611|Cabergoline|cabergoline|mesh-list
92792928|NCT05525611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92792929|NCT05525611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92792930|NCT05525611|Dopamine Agonists|dopamine agonists|mesh-ancestor
92792931|NCT05525611|Dopamine Agents|dopamine agents|mesh-ancestor
92792932|NCT05525611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026440|NCT00493038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92792933|NCT05525611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792934|NCT05525611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792935|NCT00917553|Doxycycline|doxycycline|mesh-list
92792936|NCT00917553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792937|NCT00917553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792938|NCT00917553|Antimalarials|antimalarials|mesh-ancestor
92792939|NCT00917553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92792940|NCT00917553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92792941|NCT04255251|Fluorides|fluorides|mesh-list
92792942|NCT04255251|Fluorides, Topical|fluorides, topical|mesh-list
92792943|NCT04255251|Cariostatic Agents|cariostatic agents|mesh-ancestor
92792944|NCT04255251|Protective Agents|protective agents|mesh-ancestor
92792945|NCT04255251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792946|NCT01018680|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92792947|NCT01018680|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92792948|NCT01018680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92792949|NCT01018680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92792950|NCT01018680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792951|NCT01018680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92792952|NCT01018680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792953|NCT01018680|Analgesics|analgesics|mesh-ancestor
92792954|NCT01018680|Sensory System Agents|sensory system agents|mesh-ancestor
92792955|NCT01018680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92792956|NCT01018680|Antidepressive Agents|antidepressive agents|mesh-ancestor
92792957|NCT01018680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92792958|NCT01018680|Dopamine Agents|dopamine agents|mesh-ancestor
92792959|NCT04255017|Ritonavir|ritonavir|mesh-list
92792960|NCT04255017|Lopinavir|lopinavir|mesh-list
92792961|NCT04255017|Oseltamivir|oseltamivir|mesh-list
92792962|NCT04255017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92792963|NCT04255017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92792964|NCT04255017|Protease Inhibitors|protease inhibitors|mesh-ancestor
92792965|NCT04255017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92792966|NCT04255017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792967|NCT04255017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92792968|NCT04255017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92792969|NCT04255017|Antiviral Agents|antiviral agents|mesh-ancestor
92792970|NCT04255017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792971|NCT04255017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92792972|NCT04255017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92792973|NCT04592991|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92792974|NCT04592991|Chelating Agents|chelating agents|mesh-ancestor
92792975|NCT04592991|Sequestering Agents|sequestering agents|mesh-ancestor
92792976|NCT04592991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92792977|NCT01017120|Tazarotene|tazarotene|mesh-list
92792978|NCT01017120|Dermatologic Agents|dermatologic agents|mesh-ancestor
92792979|NCT01017120|Keratolytic Agents|keratolytic agents|mesh-ancestor
92792980|NCT02872038|Cefazolin|cefazolin|mesh-list
92792981|NCT02872038|Ceftazidime|ceftazidime|mesh-list
92792982|NCT02872038|Cefepime|cefepime|mesh-list
92792983|NCT02872038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792984|NCT02872038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792985|NCT00627900|Sirolimus|sirolimus|mesh-list
92792986|NCT00627900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92792987|NCT00627900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92792988|NCT00627900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92792989|NCT00627900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92792990|NCT00627900|Antifungal Agents|antifungal agents|mesh-ancestor
92792991|NCT00627900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92792992|NCT00627900|Immunologic Factors|immunologic factors|mesh-ancestor
92792993|NCT00627900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92792994|NCT02996110|Nivolumab|nivolumab|mesh-list
92792995|NCT02996110|Ipilimumab|ipilimumab|mesh-list
92792996|NCT02996110|Relatlimab|relatlimab|mesh-list
92792997|NCT02996110|Linrodostat|linrodostat|mesh-list
92792998|NCT02996110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92792999|NCT02996110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793000|NCT02996110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92793001|NCT02996110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793002|NCT02996110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793003|NCT01103063|Azithromycin|azithromycin|mesh-list
92793004|NCT01103063|Chloroquine|chloroquine|mesh-list
92793005|NCT01103063|Pyrimethamine|pyrimethamine|mesh-list
92793006|NCT01103063|Sulfadoxine|sulfadoxine|mesh-list
92793007|NCT01103063|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92793008|NCT01103063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92793009|NCT01103063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793010|NCT01103063|Amebicides|amebicides|mesh-ancestor
92793011|NCT01103063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92793012|NCT01103063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92793013|NCT01103063|Antimalarials|antimalarials|mesh-ancestor
92793014|NCT01103063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793015|NCT01103063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92793016|NCT01103063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793017|NCT01103063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793018|NCT01103063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92793019|NCT02987998|Pembrolizumab|pembrolizumab|mesh-list
92793020|NCT02987998|Etoposide|etoposide|mesh-list
92793021|NCT02987998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793022|NCT02987998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92793023|NCT02987998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92793024|NCT02987998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793025|NCT02987998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793026|NCT02987998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92793027|NCT02987998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92793028|NCT02987998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793029|NCT04213378|Paclitaxel|paclitaxel|mesh-list
92793030|NCT04213378|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92793031|NCT04213378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793032|NCT04213378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793033|NCT04213378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793034|NCT04213378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793035|NCT04213378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793036|NCT04213378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793037|NCT04213924|Ibuprofen|ibuprofen|mesh-list
92793038|NCT04213924|Lidocaine|lidocaine|mesh-list
92793039|NCT04213924|Bupivacaine|bupivacaine|mesh-list
92793040|NCT04213924|Anesthetics, Local|anesthetics, local|mesh-ancestor
92793041|NCT04213924|Anesthetics|anesthetics|mesh-ancestor
92793042|NCT04213924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793043|NCT04213924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793044|NCT04213924|Sensory System Agents|sensory system agents|mesh-ancestor
92793045|NCT04213924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793046|NCT04213924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92793047|NCT04213924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92793048|NCT04213924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92793049|NCT04213924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793050|NCT04213924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793051|NCT04213924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92793052|NCT04213924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793053|NCT04213924|Analgesics|analgesics|mesh-ancestor
92793054|NCT04213924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793055|NCT04213924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793056|NCT04213924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92793057|NCT04213924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793058|NCT00616720|Interferons|interferons|mesh-list
92793059|NCT00616720|Aldesleukin|aldesleukin|mesh-list
92793060|NCT00616720|Interferon-gamma|interferon-gamma|mesh-list
92793061|NCT00616720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793062|NCT00616720|Antiviral Agents|antiviral agents|mesh-ancestor
92793063|NCT00616720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793064|NCT00616720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92793065|NCT00616720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92793066|NCT01091675|Etoricoxib|etoricoxib|mesh-list
92793067|NCT01091675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92793068|NCT01091675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793069|NCT01091675|Analgesics|analgesics|mesh-ancestor
92793070|NCT01091675|Sensory System Agents|sensory system agents|mesh-ancestor
92793071|NCT01091675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793072|NCT01091675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793073|NCT01091675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793074|NCT01091675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793075|NCT01091675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92438120|NCT01608217|Hormones|hormones|mesh-ancestor
92793076|NCT01091675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92793077|NCT01091675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793078|NCT01091675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793079|NCT02739412|Aldesleukin|aldesleukin|mesh-list
92793080|NCT02739412|Interleukin-2|interleukin-2|mesh-list
92793081|NCT02739412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793082|NCT02739412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793083|NCT02739412|Analgesics|analgesics|mesh-ancestor
92793084|NCT02739412|Sensory System Agents|sensory system agents|mesh-ancestor
92793085|NCT02739412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793086|NCT02739412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793087|NCT02739412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92793088|NCT02739412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92793089|NCT02739412|Antiviral Agents|antiviral agents|mesh-ancestor
92793090|NCT02739412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793091|NCT04213612|Cyclophosphamide|cyclophosphamide|mesh-list
92793092|NCT04213612|Doxorubicin|doxorubicin|mesh-list
92793093|NCT04213612|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92793094|NCT04213612|Vincristine|vincristine|mesh-list
92793095|NCT04213612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793096|NCT04213612|Immunologic Factors|immunologic factors|mesh-ancestor
92793097|NCT04213612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793098|NCT04213612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793099|NCT04213612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92793100|NCT04213612|Alkylating Agents|alkylating agents|mesh-ancestor
92793101|NCT04213612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793102|NCT04213612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793103|NCT04213612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92793104|NCT04213612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92793105|NCT04213612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92793106|NCT04213612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92793107|NCT04213612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793108|NCT04213612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793109|NCT04213612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793110|NCT04213612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793111|NCT04213612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793112|NCT01091519|Fesoterodine|fesoterodine|mesh-list
92793113|NCT01091519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92793114|NCT01091519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92793115|NCT01091519|Cholinergic Agents|cholinergic agents|mesh-ancestor
92793116|NCT01091519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793117|NCT01091519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793118|NCT01091519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793119|NCT01091519|Urological Agents|urological agents|mesh-ancestor
92793120|NCT02703220|Acetazolamide|acetazolamide|mesh-list
92793121|NCT02703220|Finasteride|finasteride|mesh-list
92793122|NCT02703220|Anticonvulsants|anticonvulsants|mesh-ancestor
92793123|NCT02703220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92793124|NCT02703220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793125|NCT02703220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793126|NCT02703220|Diuretics|diuretics|mesh-ancestor
92793127|NCT02703220|Natriuretic Agents|natriuretic agents|mesh-ancestor
92793128|NCT02703220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793129|NCT02703220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92793130|NCT02703220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92793131|NCT02703220|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026441|NCT00493038|Contraceptive Agents|contraceptive agents|mesh-ancestor
92793132|NCT02703220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793133|NCT02703220|Urological Agents|urological agents|mesh-ancestor
92793134|NCT02878031|Amoxicillin|amoxicillin|mesh-list
92793135|NCT02878031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92793136|NCT02878031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793137|NCT02879669|Cyclophosphamide|cyclophosphamide|mesh-list
92793138|NCT02879669|Carboplatin|carboplatin|mesh-list
92793139|NCT02879669|Pemetrexed|pemetrexed|mesh-list
92793140|NCT02879669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793141|NCT02879669|Immunologic Factors|immunologic factors|mesh-ancestor
92793142|NCT02879669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793143|NCT02879669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793144|NCT02879669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92793145|NCT02879669|Alkylating Agents|alkylating agents|mesh-ancestor
92793146|NCT02879669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793147|NCT02879669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793148|NCT02879669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92793149|NCT02879669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793150|NCT02879669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92793151|NCT02879669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92793152|NCT04875533|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92793153|NCT04875533|Immunologic Factors|immunologic factors|mesh-ancestor
92793154|NCT04875533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793156|NCT00918333|Panobinostat|panobinostat|mesh-list
92793157|NCT00918333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92793158|NCT00918333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92793159|NCT00918333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92793160|NCT00918333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793161|NCT00918333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793162|NCT00918333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793163|NCT00918333|Immunologic Factors|immunologic factors|mesh-ancestor
92793164|NCT00918333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793165|NCT00918333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793166|NCT01090973|Panobinostat|panobinostat|mesh-list
92793167|NCT01090973|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92793168|NCT01090973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793169|NCT01090973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793170|NCT01090973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793171|NCT02607904|Cannabidiol|cannabidiol|mesh-list
92793172|NCT02607904|Anticonvulsants|anticonvulsants|mesh-ancestor
92793173|NCT05295394|Lamivudine|lamivudine|mesh-list
92793174|NCT05295394|Dolutegravir|dolutegravir|mesh-list
92793175|NCT05295394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92793176|NCT05295394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92793177|NCT05295394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793178|NCT05295394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793179|NCT05295394|Antiviral Agents|antiviral agents|mesh-ancestor
92793180|NCT05295394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793181|NCT05295394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92793182|NCT05295394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92793183|NCT05295394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92793184|NCT05295394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92793185|NCT02871648|Fludrocortisone|fludrocortisone|mesh-list
92793186|NCT02871648|Eplerenone|eplerenone|mesh-list
92793187|NCT02871648|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92793188|NCT02871648|Hormone Antagonists|hormone antagonists|mesh-ancestor
92793189|NCT02871648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793190|NCT02871648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793191|NCT02871648|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92793192|NCT02871648|Diuretics|diuretics|mesh-ancestor
92793193|NCT02871648|Natriuretic Agents|natriuretic agents|mesh-ancestor
92793194|NCT02871648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92793195|NCT02871648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793196|NCT00637845|Esomeprazole|esomeprazole|mesh-list
92793197|NCT00637845|Lansoprazole|lansoprazole|mesh-list
92793198|NCT00637845|Dexlansoprazole|dexlansoprazole|mesh-list
92793199|NCT00637845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92793200|NCT00637845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793201|NCT00637845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92793202|NCT00637845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793203|NCT00637845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793204|NCT04738695|Antibodies|antibodies|mesh-list
92793205|NCT04738695|Immunologic Factors|immunologic factors|mesh-ancestor
92793206|NCT04738695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793207|NCT02497300|Amiloride|amiloride|mesh-list
92793208|NCT02497300|Spironolactone|spironolactone|mesh-list
92793209|NCT02497300|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92793210|NCT02497300|Hormone Antagonists|hormone antagonists|mesh-ancestor
92793211|NCT02497300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793212|NCT02497300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793213|NCT02497300|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92793214|NCT02497300|Diuretics|diuretics|mesh-ancestor
92793215|NCT02497300|Natriuretic Agents|natriuretic agents|mesh-ancestor
92793216|NCT02497300|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92793217|NCT02497300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92793218|NCT02497300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793219|NCT02497300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793220|NCT02497300|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92793221|NCT04254471|Carboplatin|carboplatin|mesh-list
92793222|NCT04254471|Etoposide|etoposide|mesh-list
92793223|NCT04254471|Rabeprazole|rabeprazole|mesh-list
92793224|NCT04254471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438274|NCT01611324|Autonomic Agents|autonomic agents|mesh-ancestor
92793225|NCT04254471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793226|NCT04254471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92793227|NCT04254471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92793228|NCT04254471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793229|NCT04254471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793230|NCT04254471|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92793231|NCT04254471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793232|NCT04254471|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92793233|NCT00631527|Sunitinib|sunitinib|mesh-list
92793234|NCT00631527|Leuprolide|leuprolide|mesh-list
92793235|NCT00631527|Goserelin|goserelin|mesh-list
92793236|NCT00631527|Bicalutamide|bicalutamide|mesh-list
92793237|NCT00631527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793238|NCT00631527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92793239|NCT00631527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92793240|NCT00631527|Growth Substances|growth substances|mesh-ancestor
92793241|NCT00631527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793242|NCT00631527|Growth Inhibitors|growth inhibitors|mesh-ancestor
92793243|NCT00631527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92793244|NCT00631527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793245|NCT00631527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793246|NCT00631527|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92793247|NCT00631527|Fertility Agents|fertility agents|mesh-ancestor
92793248|NCT00631527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92793249|NCT00631527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92793250|NCT00631527|Androgen Antagonists|androgen antagonists|mesh-ancestor
92793251|NCT00631527|Hormone Antagonists|hormone antagonists|mesh-ancestor
92793252|NCT00631527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793253|NCT00620620|Zaleplon|zaleplon|mesh-list
92793254|NCT00620620|Anticonvulsants|anticonvulsants|mesh-ancestor
92793255|NCT00620620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92793256|NCT00620620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793257|NCT00620620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793258|NCT00620620|GABA Modulators|gaba modulators|mesh-ancestor
92793259|NCT00620620|GABA Agents|gaba agents|mesh-ancestor
92793260|NCT00620620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793261|NCT00620620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793262|NCT00916383|Donepezil|donepezil|mesh-list
92793263|NCT00916383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92793264|NCT00916383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793265|NCT00916383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793266|NCT00916383|Cholinergic Agents|cholinergic agents|mesh-ancestor
92793267|NCT00916383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793268|NCT00916383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793269|NCT00916383|Nootropic Agents|nootropic agents|mesh-ancestor
92793270|NCT00617500|Hormones|hormones|mesh-list
92793271|NCT00617500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793272|NCT00617500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793273|NCT04254081|Lidocaine|lidocaine|mesh-list
92793274|NCT04254081|Buprenorphine|buprenorphine|mesh-list
92793275|NCT04254081|Anesthetics, Local|anesthetics, local|mesh-ancestor
92793276|NCT04254081|Anesthetics|anesthetics|mesh-ancestor
92793277|NCT04254081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793278|NCT04254081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793279|NCT04254081|Sensory System Agents|sensory system agents|mesh-ancestor
92793280|NCT04254081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793281|NCT04254081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92793282|NCT04254081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92793283|NCT04254081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92793284|NCT04254081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793285|NCT04254081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793286|NCT04254081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92793287|NCT04254081|Narcotics|narcotics|mesh-ancestor
92793288|NCT04254081|Analgesics|analgesics|mesh-ancestor
92793289|NCT04254081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92793291|NCT04209478|Tramadol|tramadol|mesh-list
92793292|NCT04209478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92793293|NCT04209478|Narcotics|narcotics|mesh-ancestor
92793294|NCT04209478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793295|NCT04209478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793296|NCT04209478|Analgesics|analgesics|mesh-ancestor
92793297|NCT04209478|Sensory System Agents|sensory system agents|mesh-ancestor
92793298|NCT04209478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793299|NCT05252715|Vaccines|vaccines|mesh-list
92793300|NCT05252715|Immunologic Factors|immunologic factors|mesh-ancestor
92793301|NCT05252715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793302|NCT04209166|Norepinephrine|norepinephrine|mesh-list
92793303|NCT04209166|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92793304|NCT04209166|Serotonin|serotonin|mesh-list
92793305|NCT04209166|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92793306|NCT04209166|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
92793307|NCT04209166|Antidepressive Agents|antidepressive agents|mesh-ancestor
92793308|NCT04209166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92793309|NCT04209166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92793310|NCT04209166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92793311|NCT04209166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793312|NCT04209166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793313|NCT04209166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92793314|NCT04209166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92793315|NCT04209166|Adrenergic Agents|adrenergic agents|mesh-ancestor
92793316|NCT04209166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793317|NCT04209166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793318|NCT04209166|Sympathomimetics|sympathomimetics|mesh-ancestor
92793319|NCT04209166|Autonomic Agents|autonomic agents|mesh-ancestor
92793320|NCT04209166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793321|NCT04209166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92793322|NCT04209166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92793323|NCT04209166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793324|NCT04209166|Serotonin Agents|serotonin agents|mesh-ancestor
92793325|NCT04209166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92793326|NCT04766008|Metformin|metformin|mesh-list
92793327|NCT04766008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92793328|NCT04766008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793329|NCT00916149|Lamotrigine|lamotrigine|mesh-list
92793330|NCT00916149|Levetiracetam|levetiracetam|mesh-list
92793331|NCT00916149|Anticonvulsants|anticonvulsants|mesh-ancestor
92793332|NCT00916149|Nootropic Agents|nootropic agents|mesh-ancestor
92793333|NCT00916149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92793334|NCT00916149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793335|NCT00916149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793336|NCT00916149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92793337|NCT00916149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793338|NCT00916149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92793339|NCT00916149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92793340|NCT00916149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793341|NCT00916149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92793342|NCT00916149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92793343|NCT00617656|Cisplatin|cisplatin|mesh-list
92793344|NCT00617656|Gemcitabine|gemcitabine|mesh-list
92793345|NCT00617656|Docetaxel|docetaxel|mesh-list
92793346|NCT00617656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793347|NCT00617656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793348|NCT00617656|Antimetabolites|antimetabolites|mesh-ancestor
92793349|NCT00617656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793350|NCT00617656|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793351|NCT00617656|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793352|NCT00617656|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793353|NCT00175162|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92793354|NCT00175162|Vasodilator Agents|vasodilator agents|mesh-ancestor
92793355|NCT00175162|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92793356|NCT00175162|Protective Agents|protective agents|mesh-ancestor
92793357|NCT00175162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793358|NCT04648540|Acetaminophen|acetaminophen|mesh-list
92793359|NCT04648540|Celecoxib|celecoxib|mesh-list
92793360|NCT04648540|Ketorolac|ketorolac|mesh-list
92793361|NCT04648540|Lidocaine|lidocaine|mesh-list
92793362|NCT04648540|Pregabalin|pregabalin|mesh-list
92793363|NCT04648540|Fentanyl|fentanyl|mesh-list
92793364|NCT04648540|Dexmedetomidine|dexmedetomidine|mesh-list
92793365|NCT04648540|Morphine|morphine|mesh-list
92739762|NCT01100320|Oxycodone|oxycodone|mesh-list
92793366|NCT04648540|Anesthetics, Local|anesthetics, local|mesh-ancestor
92793368|NCT04648540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793369|NCT04648540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793370|NCT04648540|Sensory System Agents|sensory system agents|mesh-ancestor
92793371|NCT04648540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793372|NCT04648540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92793373|NCT04648540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92793374|NCT04648540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92438426|NCT01612377|Prednisone|prednisone|mesh-list
92793375|NCT04648540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793376|NCT04648540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793377|NCT04648540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92793378|NCT04648540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793379|NCT04648540|Analgesics|analgesics|mesh-ancestor
92793380|NCT04648540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92793381|NCT04648540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92793382|NCT04648540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92793383|NCT04648540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92793384|NCT04648540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793385|NCT04648540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92793386|NCT04648540|Narcotics|narcotics|mesh-ancestor
92793387|NCT04648540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92793388|NCT04648540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92793389|NCT04648540|Anesthetics, General|anesthetics, general|mesh-ancestor
92793390|NCT04648540|Antipyretics|antipyretics|mesh-ancestor
92793391|NCT04648540|Anticonvulsants|anticonvulsants|mesh-ancestor
92793392|NCT04648540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92793393|NCT04648540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92793394|NCT04648540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92793395|NCT04648540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92793396|NCT04648540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92793397|NCT04648540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92793398|NCT04648540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793399|NCT04648540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793400|NCT04648540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92793401|NCT04648540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92793402|NCT04648540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793403|NCT04213222|Bevacizumab|bevacizumab|mesh-list
92793404|NCT04213222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92793405|NCT04213222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793406|NCT04213222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92793407|NCT04213222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92793408|NCT04213222|Growth Substances|growth substances|mesh-ancestor
92793409|NCT04213222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793410|NCT04213222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92793411|NCT00621166|Ritonavir|ritonavir|mesh-list
92793412|NCT00621166|Lopinavir|lopinavir|mesh-list
92793413|NCT00621166|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92793414|NCT00621166|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92793415|NCT00621166|Protease Inhibitors|protease inhibitors|mesh-ancestor
92793416|NCT00621166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793417|NCT00621166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793418|NCT00621166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92793419|NCT00621166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92793420|NCT00621166|Antiviral Agents|antiviral agents|mesh-ancestor
92793421|NCT00621166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793422|NCT00621166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92793423|NCT00621166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92793424|NCT04555798|Meropenem|meropenem|mesh-list
92793425|NCT04555798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92793426|NCT04555798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793427|NCT00617968|Docetaxel|docetaxel|mesh-list
92793428|NCT00617968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793429|NCT00617968|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793430|NCT00617968|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793431|NCT00617968|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793432|NCT00617968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793433|NCT00621400|Dexamethasone|dexamethasone|mesh-list
92793434|NCT00621400|Lenalidomide|lenalidomide|mesh-list
92793435|NCT00621400|Melphalan|melphalan|mesh-list
92793436|NCT00621400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793437|NCT00621400|Antiemetics|antiemetics|mesh-ancestor
92793438|NCT00621400|Autonomic Agents|autonomic agents|mesh-ancestor
92793439|NCT00621400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739824|NCT01106092|Vaccines|vaccines|mesh-list
92793440|NCT00621400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793441|NCT00621400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793442|NCT00621400|Glucocorticoids|glucocorticoids|mesh-ancestor
92793443|NCT00621400|Hormones|hormones|mesh-ancestor
92793444|NCT00621400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793445|NCT00621400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92793446|NCT00621400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793447|NCT00621400|Immunologic Factors|immunologic factors|mesh-ancestor
92793448|NCT00621400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92793449|NCT00621400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92793450|NCT00621400|Growth Substances|growth substances|mesh-ancestor
92793451|NCT00621400|Growth Inhibitors|growth inhibitors|mesh-ancestor
92793452|NCT00621400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92793453|NCT00621400|Alkylating Agents|alkylating agents|mesh-ancestor
92793454|NCT00621400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793455|NCT00621400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92793456|NCT00621400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793457|NCT04208854|Vinorelbine|vinorelbine|mesh-list
92793458|NCT04208854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793459|NCT04208854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793460|NCT04208854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793461|NCT04208854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793462|NCT04208854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793463|NCT04208854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793464|NCT01090427|Ustekinumab|ustekinumab|mesh-list
92793465|NCT01090427|Dermatologic Agents|dermatologic agents|mesh-ancestor
92793466|NCT04208776|Propranolol|propranolol|mesh-list
92793467|NCT04208776|Midodrine|midodrine|mesh-list
92793468|NCT04208776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92793469|NCT04208776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92793470|NCT04208776|Adrenergic Agents|adrenergic agents|mesh-ancestor
92793471|NCT04208776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793472|NCT04208776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793473|NCT04208776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793474|NCT04208776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92793475|NCT04208776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92793476|NCT04208776|Vasodilator Agents|vasodilator agents|mesh-ancestor
92793477|NCT04208776|Sympathomimetics|sympathomimetics|mesh-ancestor
92793478|NCT04208776|Autonomic Agents|autonomic agents|mesh-ancestor
92793479|NCT04208776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793480|NCT04208776|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92793481|NCT04208776|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92793482|NCT04208776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92793483|NCT04208776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92793484|NCT02879435|Bupivacaine|bupivacaine|mesh-list
92793485|NCT02879435|Anesthetics, Local|anesthetics, local|mesh-ancestor
92793486|NCT02879435|Anesthetics|anesthetics|mesh-ancestor
92793487|NCT02879435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793488|NCT02879435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793489|NCT02879435|Sensory System Agents|sensory system agents|mesh-ancestor
92793490|NCT02879435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793491|NCT02879513|Paclitaxel|paclitaxel|mesh-list
92793492|NCT02879513|Cyclophosphamide|cyclophosphamide|mesh-list
92793493|NCT02879513|Epirubicin|epirubicin|mesh-list
92793494|NCT02879513|Fluorouracil|fluorouracil|mesh-list
92793495|NCT02879513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793496|NCT02879513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793497|NCT02879513|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793498|NCT02879513|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793499|NCT02879513|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793500|NCT02879513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793501|NCT02879513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793502|NCT02879513|Immunologic Factors|immunologic factors|mesh-ancestor
92793503|NCT02879513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793504|NCT02879513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793505|NCT02879513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92793506|NCT02879513|Alkylating Agents|alkylating agents|mesh-ancestor
92793507|NCT02879513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92793508|NCT02879513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92793509|NCT02879513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92793510|NCT02879513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92793511|NCT02879513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793512|NCT02879513|Antimetabolites|antimetabolites|mesh-ancestor
92793513|NCT02879513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793515|NCT00621478|Lorazepam|lorazepam|mesh-list
92793516|NCT00621478|Anticonvulsants|anticonvulsants|mesh-ancestor
92793517|NCT00621478|Antiemetics|antiemetics|mesh-ancestor
92793518|NCT00621478|Autonomic Agents|autonomic agents|mesh-ancestor
92793519|NCT00621478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793520|NCT00621478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793521|NCT00621478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793522|NCT00621478|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92793523|NCT00621478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793524|NCT00621478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92793525|NCT00621478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92793526|NCT00621478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92793527|NCT00621478|GABA Modulators|gaba modulators|mesh-ancestor
92793528|NCT00621478|GABA Agents|gaba agents|mesh-ancestor
92793529|NCT00621478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793530|NCT00621478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793531|NCT00621478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92793532|NCT00621478|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92793533|NCT00621478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92793534|NCT00621478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92793535|NCT00621478|Anesthetics, General|anesthetics, general|mesh-ancestor
92793536|NCT00621478|Anesthetics|anesthetics|mesh-ancestor
92793537|NCT00621556|Secretin|secretin|mesh-list
92793538|NCT00621556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793539|NCT00621556|Hormones|hormones|mesh-ancestor
92793540|NCT00621556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793541|NCT00621556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793542|NCT00618046|Oxcarbazepine|oxcarbazepine|mesh-list
92793543|NCT00618046|Anticonvulsants|anticonvulsants|mesh-ancestor
92793544|NCT00618046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92793545|NCT00618046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92793546|NCT00618046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793547|NCT00618046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793548|NCT00618046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92793549|NCT00618046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92793550|NCT04308551|Aspirin|aspirin|mesh-list
92793551|NCT04308551|Indobufen|indobufen|mesh-list
92793552|NCT04308551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92793553|NCT04308551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793554|NCT04308551|Analgesics|analgesics|mesh-ancestor
92793555|NCT04308551|Sensory System Agents|sensory system agents|mesh-ancestor
92793556|NCT04308551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793557|NCT04308551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793558|NCT04308551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793559|NCT04308551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793560|NCT04308551|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92793561|NCT04308551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92793562|NCT04308551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793563|NCT04308551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92793564|NCT04308551|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92793565|NCT04308551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793566|NCT04308551|Antipyretics|antipyretics|mesh-ancestor
92793567|NCT04306913|Cardioplegic Solutions|cardioplegic solutions|mesh-list
92793568|NCT04306913|Esmolol|esmolol|mesh-list
92793569|NCT04306913|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92793570|NCT04306913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92793571|NCT04306913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92793572|NCT04306913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92793573|NCT04306913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793574|NCT04306913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793575|NCT04306913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793576|NCT04306913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92793577|NCT02299414|Antihypertensive Agents|antihypertensive agents|mesh-list
92793578|NCT02299414|Nifedipine|nifedipine|mesh-list
92793579|NCT02299414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92793580|NCT02299414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793581|NCT02299414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793582|NCT02299414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92793583|NCT02299414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793584|NCT02299414|Vasodilator Agents|vasodilator agents|mesh-ancestor
92793585|NCT02299414|Tocolytic Agents|tocolytic agents|mesh-ancestor
92793586|NCT02299414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92793587|NCT01016262|Mesalamine|mesalamine|mesh-list
92711736|NCT02927405|Anticonvulsants|anticonvulsants|mesh-ancestor
92793588|NCT01016262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92793589|NCT01016262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793590|NCT01016262|Analgesics|analgesics|mesh-ancestor
92793591|NCT01016262|Sensory System Agents|sensory system agents|mesh-ancestor
92793592|NCT01016262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793593|NCT01016262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793594|NCT01016262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793595|NCT01016262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793596|NCT00625937|Docetaxel|docetaxel|mesh-list
92793597|NCT00625937|Tegafur|tegafur|mesh-list
92793598|NCT00625937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793599|NCT00625937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793600|NCT00625937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793601|NCT00625937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793602|NCT00625937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793603|NCT00625937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793604|NCT00625937|Antimetabolites|antimetabolites|mesh-ancestor
92793605|NCT01001910|Carboplatin|carboplatin|mesh-list
92793606|NCT01001910|Pemetrexed|pemetrexed|mesh-list
92793607|NCT01001910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793608|NCT01001910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793609|NCT01001910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793610|NCT01001910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92793611|NCT01001910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92793612|NCT04308317|Tetrandrine|tetrandrine|mesh-list
92793613|NCT04308317|Antimalarials|antimalarials|mesh-ancestor
92793614|NCT04308317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92793615|NCT04308317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92793616|NCT04308317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793617|NCT04308317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793618|NCT04308317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793619|NCT04308317|Antiviral Agents|antiviral agents|mesh-ancestor
92793620|NCT04308317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92793621|NCT04308317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793622|NCT04308317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793623|NCT04308317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92793624|NCT04308317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793625|NCT04308317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793626|NCT04308317|Immunologic Factors|immunologic factors|mesh-ancestor
92793627|NCT01009554|Listerine|listerine|mesh-list
92793628|NCT01009554|Fluorides|fluorides|mesh-list
92793629|NCT01009554|Sodium Fluoride|sodium fluoride|mesh-list
92793630|NCT01009554|Cariostatic Agents|cariostatic agents|mesh-ancestor
92793631|NCT01009554|Protective Agents|protective agents|mesh-ancestor
92793632|NCT01009554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793633|NCT01009554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92793634|NCT01009554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793635|NCT04211896|Nivolumab|nivolumab|mesh-list
92793636|NCT04211896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92793637|NCT04211896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793638|NCT04211896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92793639|NCT04211896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793640|NCT04188184|Epinephrine|epinephrine|mesh-list
92793641|NCT04188184|Tranexamic Acid|tranexamic acid|mesh-list
92793642|NCT04188184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92793643|NCT04188184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92793644|NCT04188184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793645|NCT04188184|Hemostatics|hemostatics|mesh-ancestor
92793646|NCT04188184|Coagulants|coagulants|mesh-ancestor
92793647|NCT04188184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92711793|NCT02926976|Antimanic Agents|antimanic agents|mesh-ancestor
92793648|NCT04188184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92793649|NCT04188184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92793650|NCT04188184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793651|NCT04188184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793652|NCT04188184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92793653|NCT04188184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92793654|NCT04188184|Autonomic Agents|autonomic agents|mesh-ancestor
92793655|NCT04188184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793656|NCT04188184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92793657|NCT04188184|Respiratory System Agents|respiratory system agents|mesh-ancestor
92793658|NCT04188184|Mydriatics|mydriatics|mesh-ancestor
92793659|NCT04188184|Sympathomimetics|sympathomimetics|mesh-ancestor
92793660|NCT04188184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92793661|NCT01006590|Metformin|metformin|mesh-list
92793662|NCT01006590|Saxagliptin|saxagliptin|mesh-list
92793664|NCT01006590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793665|NCT01006590|Incretins|incretins|mesh-ancestor
92793666|NCT01006590|Hormones|hormones|mesh-ancestor
92793667|NCT01006590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793668|NCT01006590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92793669|NCT01006590|Protease Inhibitors|protease inhibitors|mesh-ancestor
92793670|NCT01006590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793671|NCT01006590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793672|NCT04212832|Bupivacaine|bupivacaine|mesh-list
92793673|NCT04212832|Anesthetics, Local|anesthetics, local|mesh-ancestor
92793674|NCT04212832|Anesthetics|anesthetics|mesh-ancestor
92793675|NCT04212832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793676|NCT04212832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793677|NCT04212832|Sensory System Agents|sensory system agents|mesh-ancestor
92793678|NCT04212832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793679|NCT00621790|Fenoldopam|fenoldopam|mesh-list
92793680|NCT00621790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92793681|NCT00621790|Vasodilator Agents|vasodilator agents|mesh-ancestor
92793682|NCT00621790|Dopamine Agonists|dopamine agonists|mesh-ancestor
92793683|NCT00621790|Dopamine Agents|dopamine agents|mesh-ancestor
92793684|NCT00621790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793685|NCT00621790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793686|NCT00621790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793687|NCT00618124|Capecitabine|capecitabine|mesh-list
92793688|NCT00618124|Sunitinib|sunitinib|mesh-list
92793689|NCT00618124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793690|NCT00618124|Antimetabolites|antimetabolites|mesh-ancestor
92793691|NCT00618124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793692|NCT00618124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793693|NCT00618124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92793694|NCT00618124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92793695|NCT00618124|Growth Substances|growth substances|mesh-ancestor
92793696|NCT00618124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793697|NCT00618124|Growth Inhibitors|growth inhibitors|mesh-ancestor
92793698|NCT00618124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92793699|NCT00618124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793700|NCT00621868|Ipragliflozin|ipragliflozin|mesh-list
92793701|NCT00621868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92793702|NCT00621868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793703|NCT00621868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92793704|NCT00621868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793705|NCT01882660|Decitabine|decitabine|mesh-list
92793706|NCT01882660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793707|NCT01882660|Antimetabolites|antimetabolites|mesh-ancestor
92793708|NCT01882660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793709|NCT01882660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793710|NCT01882660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793711|NCT01001832|Abatacept|abatacept|mesh-list
92793712|NCT01001832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92793713|NCT01001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793714|NCT01001832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92793715|NCT01001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793716|NCT01001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793717|NCT01001832|Immunologic Factors|immunologic factors|mesh-ancestor
92793718|NCT01001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793719|NCT01001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793720|NCT01001598|Danazol|danazol|mesh-list
92793721|NCT01001598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92793722|NCT01001598|Hormone Antagonists|hormone antagonists|mesh-ancestor
92793723|NCT01001598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793724|NCT01001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793725|NCT01006356|Hydromorphone|hydromorphone|mesh-list
92793726|NCT01006356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92793727|NCT01006356|Narcotics|narcotics|mesh-ancestor
92793728|NCT01006356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793729|NCT01006356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793730|NCT01006356|Analgesics|analgesics|mesh-ancestor
92793731|NCT01006356|Sensory System Agents|sensory system agents|mesh-ancestor
92793732|NCT01006356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793733|NCT01089725|Tanezumab|tanezumab|mesh-list
92793734|NCT01089725|Analgesics|analgesics|mesh-ancestor
92793735|NCT01089725|Sensory System Agents|sensory system agents|mesh-ancestor
92793736|NCT01089725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793737|NCT01089725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793738|NCT01190930|Calcium, Dietary|calcium, dietary|mesh-list
92793739|NCT01190930|Leucovorin|leucovorin|mesh-list
92793740|NCT01190930|Folic Acid|folic acid|mesh-list
92793741|NCT01190930|Cytarabine|cytarabine|mesh-list
92793742|NCT01190930|Dexamethasone|dexamethasone|mesh-list
92793743|NCT01190930|Dexamethasone acetate|dexamethasone acetate|mesh-list
92793744|NCT01190930|Cyclophosphamide|cyclophosphamide|mesh-list
92793745|NCT01190930|Doxorubicin|doxorubicin|mesh-list
92793746|NCT01190930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92793747|NCT01190930|Methotrexate|methotrexate|mesh-list
92793748|NCT01190930|Vincristine|vincristine|mesh-list
92793749|NCT01190930|Asparaginase|asparaginase|mesh-list
92793750|NCT01190930|Mercaptopurine|mercaptopurine|mesh-list
92793751|NCT01190930|Pegaspargase|pegaspargase|mesh-list
92793752|NCT01190930|Thioguanine|thioguanine|mesh-list
92793753|NCT01190930|BB 1101|bb 1101|mesh-list
92793754|NCT01190930|Calcium|calcium|mesh-list
92793755|NCT01190930|2-Aminopurine|2-aminopurine|mesh-list
92793756|NCT01190930|Levoleucovorin|levoleucovorin|mesh-list
92793757|NCT01190930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793758|NCT01190930|Immunologic Factors|immunologic factors|mesh-ancestor
92793759|NCT01190930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793760|NCT01190930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793761|NCT01190930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92793762|NCT01190930|Alkylating Agents|alkylating agents|mesh-ancestor
92793763|NCT01190930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793764|NCT01190930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793765|NCT01190930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92793766|NCT01190930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793767|NCT01190930|Antiemetics|antiemetics|mesh-ancestor
92793768|NCT01190930|Autonomic Agents|autonomic agents|mesh-ancestor
92793769|NCT01190930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793770|NCT01190930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793771|NCT01190930|Glucocorticoids|glucocorticoids|mesh-ancestor
92793772|NCT01190930|Hormones|hormones|mesh-ancestor
92793773|NCT01190930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793774|NCT01190930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92793775|NCT01190930|Protease Inhibitors|protease inhibitors|mesh-ancestor
92793776|NCT01190930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793777|NCT01190930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92793778|NCT01190930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92793779|NCT01190930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92793780|NCT01190930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92793781|NCT01190930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92793782|NCT01190930|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92793783|NCT01190930|Abortifacient Agents|abortifacient agents|mesh-ancestor
92793784|NCT01190930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92793785|NCT01190930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793786|NCT01190930|Antimetabolites|antimetabolites|mesh-ancestor
92793787|NCT01190930|Dermatologic Agents|dermatologic agents|mesh-ancestor
92793788|NCT01190930|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92793789|NCT01190930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92793790|NCT01190930|Antiviral Agents|antiviral agents|mesh-ancestor
92793791|NCT01190930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793792|NCT01190930|Antidotes|antidotes|mesh-ancestor
92793793|NCT01190930|Protective Agents|protective agents|mesh-ancestor
92793794|NCT01190930|Vitamin B Complex|vitamin b complex|mesh-ancestor
92793795|NCT01190930|Vitamins|vitamins|mesh-ancestor
92793796|NCT01190930|Micronutrients|micronutrients|mesh-ancestor
92793797|NCT01190930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92793798|NCT01190930|Tubulin Modulators|tubulin modulators|mesh-ancestor
92793799|NCT01190930|Antimitotic Agents|antimitotic agents|mesh-ancestor
92793800|NCT01190930|Mitosis Modulators|mitosis modulators|mesh-ancestor
92793801|NCT01190930|Hematinics|hematinics|mesh-ancestor
92793802|NCT00619216|Mycophenolic Acid|mycophenolic acid|mesh-list
92793803|NCT00619216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92793804|NCT00619216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793805|NCT00619216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92793806|NCT00619216|Antitubercular Agents|antitubercular agents|mesh-ancestor
92793807|NCT00619216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92793808|NCT00619216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793809|NCT00619216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793810|NCT00619216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793811|NCT00619372|Muromonab-CD3|muromonab-cd3|mesh-list
92793812|NCT00619372|Immunologic Factors|immunologic factors|mesh-ancestor
92793813|NCT00619372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793814|NCT00619372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793815|NCT00618202|Balsalazide|balsalazide|mesh-list
92793816|NCT00618202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92793817|NCT00618202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92793818|NCT00618202|Analgesics|analgesics|mesh-ancestor
92793819|NCT00618202|Sensory System Agents|sensory system agents|mesh-ancestor
92793820|NCT00618202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793821|NCT00618202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793822|NCT00618202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793823|NCT00618202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92793824|NCT00618202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793825|NCT00626015|Temozolomide|temozolomide|mesh-list
92793826|NCT00626015|Daclizumab|daclizumab|mesh-list
92793827|NCT00626015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92793828|NCT00626015|Alkylating Agents|alkylating agents|mesh-ancestor
92793829|NCT00626015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793830|NCT00626015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793831|NCT00626015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793832|NCT00626015|Immunologic Factors|immunologic factors|mesh-ancestor
92793833|NCT00626015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793834|NCT00618280|Nicotine|nicotine|mesh-list
92793835|NCT00618280|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92793836|NCT00618280|Autonomic Agents|autonomic agents|mesh-ancestor
92793837|NCT00618280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793838|NCT00618280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793839|NCT00618280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92793840|NCT00618280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92793841|NCT00618280|Cholinergic Agents|cholinergic agents|mesh-ancestor
92793842|NCT00618280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793843|NCT00618280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793844|NCT01101191|Oxycodone|oxycodone|mesh-list
92793845|NCT01101191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92793846|NCT01101191|Narcotics|narcotics|mesh-ancestor
92793847|NCT01101191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793848|NCT01101191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793849|NCT01101191|Analgesics|analgesics|mesh-ancestor
92793850|NCT01101191|Sensory System Agents|sensory system agents|mesh-ancestor
92711983|NCT01228656|Analgesics|analgesics|mesh-ancestor
92793851|NCT01101191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793852|NCT00622258|Everolimus|everolimus|mesh-list
92793853|NCT00622258|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92793854|NCT00622258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92793855|NCT00622258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793856|NCT00622258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793857|NCT00622258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793858|NCT00622258|Immunologic Factors|immunologic factors|mesh-ancestor
92793859|NCT00622258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793860|NCT00622258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793861|NCT01812616|Nabiximols|nabiximols|mesh-list
92793862|NCT01812616|Analgesics|analgesics|mesh-ancestor
92793863|NCT01812616|Sensory System Agents|sensory system agents|mesh-ancestor
92793864|NCT01812616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793865|NCT01812616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793866|NCT00618358|Thrombin|thrombin|mesh-list
92793867|NCT00618358|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92793868|NCT00618358|Hemostatics|hemostatics|mesh-ancestor
92793869|NCT00618358|Coagulants|coagulants|mesh-ancestor
92793870|NCT01178762|Azithromycin|azithromycin|mesh-list
92793871|NCT01178762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92793872|NCT01178762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793873|NCT03563560|Cytarabine|cytarabine|mesh-list
92793874|NCT03563560|Mitoxantrone|mitoxantrone|mesh-list
92793875|NCT03563560|Alvocidib|alvocidib|mesh-list
92793876|NCT03563560|Daunorubicin|daunorubicin|mesh-list
92793877|NCT03563560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793878|NCT03563560|Antimetabolites|antimetabolites|mesh-ancestor
92793879|NCT03563560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793880|NCT03563560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793881|NCT03563560|Antiviral Agents|antiviral agents|mesh-ancestor
92793882|NCT03563560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92793883|NCT03563560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793884|NCT03563560|Immunologic Factors|immunologic factors|mesh-ancestor
92793885|NCT03563560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793886|NCT03563560|Analgesics|analgesics|mesh-ancestor
92793887|NCT03563560|Sensory System Agents|sensory system agents|mesh-ancestor
92793888|NCT03563560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793889|NCT03563560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92793890|NCT03563560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92793891|NCT03563560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793892|NCT03563560|Growth Inhibitors|growth inhibitors|mesh-ancestor
92793893|NCT03563560|Growth Substances|growth substances|mesh-ancestor
92793894|NCT03563560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92793895|NCT03563560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92793896|NCT01178138|Prazosin|prazosin|mesh-list
92793897|NCT01178138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92793898|NCT01178138|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92793899|NCT01178138|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92793900|NCT01178138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92793901|NCT01178138|Adrenergic Agents|adrenergic agents|mesh-ancestor
92793902|NCT01178138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793903|NCT01178138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793904|NCT01178138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793905|NCT01190228|Vaccines|vaccines|mesh-list
92793906|NCT01190228|Immunologic Factors|immunologic factors|mesh-ancestor
92793907|NCT01190228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793908|NCT01009086|Ustekinumab|ustekinumab|mesh-list
92793909|NCT01009086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92793910|NCT01190150|Tranexamic Acid|tranexamic acid|mesh-list
92793911|NCT01190150|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92793912|NCT01190150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92793913|NCT01190150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793914|NCT01190150|Hemostatics|hemostatics|mesh-ancestor
92793915|NCT01190150|Coagulants|coagulants|mesh-ancestor
92793916|NCT04315688|Insulin|insulin|mesh-list
92793917|NCT04315688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92793918|NCT04315688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793919|NCT05210062|Succinylcholine|succinylcholine|mesh-list
92793920|NCT05210062|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92793921|NCT05210062|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92793922|NCT05210062|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92793923|NCT05210062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793924|NCT05210062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793925|NCT01001520|Tolcapone|tolcapone|mesh-list
92793926|NCT01001520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92793927|NCT01001520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92793928|NCT01001520|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92793929|NCT01001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793930|NCT01001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793931|NCT00619840|Methylphenidate|methylphenidate|mesh-list
92793932|NCT00619840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92793933|NCT00619840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793934|NCT00619840|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92793935|NCT00619840|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92793936|NCT00619840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92793937|NCT00619840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793938|NCT00619840|Dopamine Agents|dopamine agents|mesh-ancestor
92793939|NCT00619840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92793940|NCT01189604|Propofol|propofol|mesh-list
92793941|NCT01189604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92793942|NCT01189604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92793943|NCT01189604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793944|NCT01189604|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92793945|NCT01189604|Anesthetics, General|anesthetics, general|mesh-ancestor
92793946|NCT01189604|Anesthetics|anesthetics|mesh-ancestor
92793947|NCT02697058|Calcium, Dietary|calcium, dietary|mesh-list
92793948|NCT02697058|Leucovorin|leucovorin|mesh-list
92793949|NCT02697058|Fluorouracil|fluorouracil|mesh-list
92793950|NCT02697058|Calcium|calcium|mesh-list
92793951|NCT02697058|Levoleucovorin|levoleucovorin|mesh-list
92793952|NCT02697058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92793953|NCT02697058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793954|NCT02697058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92793955|NCT02697058|Antimetabolites|antimetabolites|mesh-ancestor
92793956|NCT02697058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793957|NCT02697058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92793958|NCT02697058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793959|NCT02697058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92793960|NCT02697058|Immunologic Factors|immunologic factors|mesh-ancestor
92793961|NCT02697058|Antidotes|antidotes|mesh-ancestor
92793962|NCT02697058|Protective Agents|protective agents|mesh-ancestor
92793963|NCT02697058|Vitamin B Complex|vitamin b complex|mesh-ancestor
92793964|NCT02697058|Vitamins|vitamins|mesh-ancestor
92793965|NCT02697058|Micronutrients|micronutrients|mesh-ancestor
92793966|NCT00622414|Aflibercept|aflibercept|mesh-list
92793967|NCT00622414|Endothelial Growth Factors|endothelial growth factors|mesh-list
92793968|NCT00622414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92793969|NCT00622414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92793970|NCT00622414|Growth Substances|growth substances|mesh-ancestor
92793971|NCT00622414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793972|NCT00622414|Growth Inhibitors|growth inhibitors|mesh-ancestor
92793973|NCT00622414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92793974|NCT01008696|Rabeprazole|rabeprazole|mesh-list
92793975|NCT01008696|Lansoprazole|lansoprazole|mesh-list
92793976|NCT01008696|Dexlansoprazole|dexlansoprazole|mesh-list
92793977|NCT01008696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92793978|NCT01008696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92793979|NCT01008696|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92793980|NCT01008696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92793981|NCT01008696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92793982|NCT01955980|Budesonide|budesonide|mesh-list
92793983|NCT01955980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92793984|NCT01955980|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92793985|NCT01955980|Autonomic Agents|autonomic agents|mesh-ancestor
92793986|NCT01955980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92793987|NCT01955980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92793988|NCT01955980|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92793989|NCT01955980|Respiratory System Agents|respiratory system agents|mesh-ancestor
92793990|NCT01955980|Glucocorticoids|glucocorticoids|mesh-ancestor
92793992|NCT01955980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92793993|NCT02870478|Atropine|atropine|mesh-list
92793994|NCT02870478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92793995|NCT02870478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92793996|NCT02870478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92793997|NCT02870478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92793998|NCT02870478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92793999|NCT02870478|Autonomic Agents|autonomic agents|mesh-ancestor
92794000|NCT02870478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794001|NCT02870478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794002|NCT02870478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794003|NCT02870478|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794004|NCT02870478|Mydriatics|mydriatics|mesh-ancestor
92794005|NCT02870478|Parasympatholytics|parasympatholytics|mesh-ancestor
92794006|NCT02870478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92794007|NCT02870478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92794008|NCT02870478|Cholinergic Agents|cholinergic agents|mesh-ancestor
92794009|NCT02870478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794010|NCT02870478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794011|NCT04296162|Capecitabine|capecitabine|mesh-list
92794012|NCT04296162|Trastuzumab|trastuzumab|mesh-list
92794013|NCT04296162|Vinorelbine|vinorelbine|mesh-list
92794014|NCT04296162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92794015|NCT04296162|Antimetabolites|antimetabolites|mesh-ancestor
92794016|NCT04296162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794017|NCT04296162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794018|NCT04296162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794019|NCT04296162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794020|NCT04296162|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794021|NCT04296162|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794022|NCT04296162|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794023|NCT00619996|Docetaxel|docetaxel|mesh-list
92794024|NCT00619996|Sorafenib|sorafenib|mesh-list
92794025|NCT00619996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794026|NCT00619996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794027|NCT00619996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794028|NCT00619996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794029|NCT00619996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794030|NCT00619996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794031|NCT00619996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794032|NCT02870790|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92794033|NCT02870790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92794034|NCT02870790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92794035|NCT02870790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794036|NCT02870790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794037|NCT02870790|Antiviral Agents|antiviral agents|mesh-ancestor
92794038|NCT02870790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794039|NCT02870790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92794040|NCT02870790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92794041|NCT00622570|Pentobarbital|pentobarbital|mesh-list
92794042|NCT00622570|Thiopental|thiopental|mesh-list
92794043|NCT00622570|Anticonvulsants|anticonvulsants|mesh-ancestor
92794044|NCT00622570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92794045|NCT00622570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794046|NCT00622570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794047|NCT00622570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92794048|NCT00622570|Anesthetics, General|anesthetics, general|mesh-ancestor
92794049|NCT00622570|Anesthetics|anesthetics|mesh-ancestor
92794050|NCT00622570|GABA Modulators|gaba modulators|mesh-ancestor
92794051|NCT00622570|GABA Agents|gaba agents|mesh-ancestor
92794052|NCT00622570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794053|NCT00622570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794054|NCT00622570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92794055|NCT00890266|Riboflavin|riboflavin|mesh-list
92794056|NCT00890266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92794057|NCT00890266|Vitamins|vitamins|mesh-ancestor
92794058|NCT00890266|Micronutrients|micronutrients|mesh-ancestor
92794059|NCT00890266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794060|NCT00890266|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92794061|NCT00890266|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794062|NCT01176968|Eplerenone|eplerenone|mesh-list
92794063|NCT01176968|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92794064|NCT01176968|Hormone Antagonists|hormone antagonists|mesh-ancestor
92794065|NCT01176968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92794066|NCT01176968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794067|NCT01176968|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92794068|NCT01176968|Diuretics|diuretics|mesh-ancestor
92794069|NCT01176968|Natriuretic Agents|natriuretic agents|mesh-ancestor
92794070|NCT01176968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92794071|NCT02697370|Factor VIII|factor viii|mesh-list
92794072|NCT02697370|Coagulants|coagulants|mesh-ancestor
92794073|NCT02691442|Epinephrine|epinephrine|mesh-list
92794074|NCT02691442|Ropivacaine|ropivacaine|mesh-list
92794075|NCT02691442|Levobupivacaine|levobupivacaine|mesh-list
92794076|NCT02691442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92794077|NCT02691442|Anesthetics|anesthetics|mesh-ancestor
92794078|NCT02691442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794079|NCT02691442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794080|NCT02691442|Sensory System Agents|sensory system agents|mesh-ancestor
92794081|NCT02691442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794082|NCT02691442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92794083|NCT02691442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92794084|NCT02691442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92794085|NCT02691442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794086|NCT02691442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794087|NCT02691442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92794088|NCT02691442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92794089|NCT02691442|Autonomic Agents|autonomic agents|mesh-ancestor
92794090|NCT02691442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794091|NCT02691442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794092|NCT02691442|Mydriatics|mydriatics|mesh-ancestor
92794093|NCT02691442|Sympathomimetics|sympathomimetics|mesh-ancestor
92794094|NCT02691442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92794095|NCT00622648|Enoxaparin|enoxaparin|mesh-list
92794096|NCT00622648|Anticoagulants|anticoagulants|mesh-ancestor
92794097|NCT00622648|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92794098|NCT00622648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92794099|NCT00622648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794100|NCT02687854|Vitamin K|vitamin k|mesh-list
92794101|NCT02687854|Apixaban|apixaban|mesh-list
92794102|NCT02687854|Vitamins|vitamins|mesh-ancestor
92794103|NCT02687854|Micronutrients|micronutrients|mesh-ancestor
92794104|NCT02687854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794105|NCT02687854|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92794106|NCT02687854|Antithrombins|antithrombins|mesh-ancestor
92794107|NCT02687854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92794108|NCT02687854|Protease Inhibitors|protease inhibitors|mesh-ancestor
92794109|NCT02687854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794110|NCT02687854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794111|NCT02687854|Anticoagulants|anticoagulants|mesh-ancestor
92794112|NCT02687854|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92794113|NCT02687854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92794114|NCT02687854|Hemostatics|hemostatics|mesh-ancestor
92794115|NCT02687854|Coagulants|coagulants|mesh-ancestor
92794116|NCT01005966|Listerine|listerine|mesh-list
92794117|NCT01005966|Fluorides|fluorides|mesh-list
92794118|NCT01005966|Sodium Fluoride|sodium fluoride|mesh-list
92794119|NCT01005966|Fluorophosphate|fluorophosphate|mesh-list
92794120|NCT01005966|Cariostatic Agents|cariostatic agents|mesh-ancestor
92794121|NCT01005966|Protective Agents|protective agents|mesh-ancestor
92794122|NCT01005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794123|NCT01005966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92794124|NCT01005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794125|NCT00628680|Heparin|heparin|mesh-list
92794126|NCT00628680|Anticoagulants|anticoagulants|mesh-ancestor
92794127|NCT00628680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92794128|NCT00628680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92794129|NCT00628680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794130|NCT00603304|Saw palmetto extract|saw palmetto extract|mesh-list
92794131|NCT00603304|Urological Agents|urological agents|mesh-ancestor
92794132|NCT01176032|Losartan|losartan|mesh-list
92794133|NCT01176032|Amlodipine|amlodipine|mesh-list
92794134|NCT01176032|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92794135|NCT01176032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92794136|NCT01176032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92794137|NCT01176032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92794138|NCT01176032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794139|NCT01176032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92794140|NCT01176032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794141|NCT01176032|Vasodilator Agents|vasodilator agents|mesh-ancestor
92794142|NCT01176032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92794143|NCT01176032|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92794144|NCT01176032|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92794145|NCT01176032|Diuretics|diuretics|mesh-ancestor
92794146|NCT01176032|Natriuretic Agents|natriuretic agents|mesh-ancestor
92794147|NCT01176032|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92794148|NCT01008618|Fentanyl|fentanyl|mesh-list
92794149|NCT01008618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92794150|NCT01008618|Narcotics|narcotics|mesh-ancestor
92794151|NCT01008618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794152|NCT01008618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794153|NCT01008618|Analgesics|analgesics|mesh-ancestor
92794154|NCT01008618|Sensory System Agents|sensory system agents|mesh-ancestor
92794155|NCT01008618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794156|NCT01008618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92794157|NCT01008618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92794158|NCT01008618|Anesthetics, General|anesthetics, general|mesh-ancestor
92794159|NCT01008618|Anesthetics|anesthetics|mesh-ancestor
92794160|NCT01001208|Etanercept|etanercept|mesh-list
92794161|NCT01001208|Methotrexate|methotrexate|mesh-list
92794162|NCT01001208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92794163|NCT01001208|Abortifacient Agents|abortifacient agents|mesh-ancestor
92794164|NCT01001208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92794165|NCT01001208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794166|NCT01001208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92794167|NCT01001208|Antimetabolites|antimetabolites|mesh-ancestor
92794168|NCT01001208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794169|NCT01001208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794170|NCT01001208|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794171|NCT01001208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794172|NCT01001208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92794173|NCT01001208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794174|NCT01001208|Immunologic Factors|immunologic factors|mesh-ancestor
92794175|NCT01001208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794176|NCT01001208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92794177|NCT01001208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794178|NCT01001208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794179|NCT01001208|Analgesics|analgesics|mesh-ancestor
92794180|NCT01001208|Sensory System Agents|sensory system agents|mesh-ancestor
92794181|NCT01001208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794182|NCT01001208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794183|NCT01001208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794184|NCT01000974|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92794185|NCT01000974|Immunologic Factors|immunologic factors|mesh-ancestor
92794186|NCT01000974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794187|NCT01193842|Prednisone|prednisone|mesh-list
92794188|NCT01193842|Cortisone|cortisone|mesh-list
92794189|NCT01193842|Cyclophosphamide|cyclophosphamide|mesh-list
92794190|NCT01193842|Rituximab|rituximab|mesh-list
92794191|NCT01193842|Doxorubicin|doxorubicin|mesh-list
92794192|NCT01193842|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92794193|NCT01193842|Etoposide|etoposide|mesh-list
92794194|NCT01193842|Vincristine|vincristine|mesh-list
92794195|NCT01193842|Etoposide phosphate|etoposide phosphate|mesh-list
92794196|NCT01193842|Vorinostat|vorinostat|mesh-list
92794197|NCT01193842|Podophyllotoxin|podophyllotoxin|mesh-list
92794198|NCT01193842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92794199|NCT01193842|Antibodies|antibodies|mesh-list
92794200|NCT01193842|Immunoglobulins|immunoglobulins|mesh-list
92794201|NCT01193842|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92794202|NCT01193842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794203|NCT01193842|Immunologic Factors|immunologic factors|mesh-ancestor
92794204|NCT01193842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794205|NCT01193842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794206|NCT01193842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794207|NCT01193842|Alkylating Agents|alkylating agents|mesh-ancestor
92794208|NCT01193842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794209|NCT01193842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794210|NCT01193842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92794211|NCT01193842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92794212|NCT01193842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92794213|NCT01193842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92794214|NCT01193842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794215|NCT01193842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794217|NCT01193842|Hormones|hormones|mesh-ancestor
92794218|NCT01193842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92794219|NCT01193842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92794220|NCT01193842|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794221|NCT01193842|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794222|NCT01193842|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794223|NCT01193842|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794224|NCT01193842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92794225|NCT01193842|Keratolytic Agents|keratolytic agents|mesh-ancestor
92794226|NCT01193842|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794227|NCT04401774|Nivolumab|nivolumab|mesh-list
92794228|NCT04401774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794229|NCT04401774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794230|NCT04401774|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92794231|NCT04401774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794232|NCT01004406|Atorvastatin|atorvastatin|mesh-list
92794233|NCT01004406|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92794234|NCT01004406|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92794235|NCT01004406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92794236|NCT01004406|Antimetabolites|antimetabolites|mesh-ancestor
92794237|NCT01004406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794238|NCT01004406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92794239|NCT01004406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794240|NCT01093612|Copper|copper|mesh-list
92794241|NCT01093612|Trastuzumab|trastuzumab|mesh-list
92794242|NCT01093612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794243|NCT01093612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794244|NCT01093612|Trace Elements|trace elements|mesh-ancestor
92794245|NCT01093612|Micronutrients|micronutrients|mesh-ancestor
92794246|NCT01093612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794247|NCT01182350|Bevacizumab|bevacizumab|mesh-list
92794248|NCT01182350|Temozolomide|temozolomide|mesh-list
92794249|NCT01182350|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92794250|NCT01182350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794251|NCT01182350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794252|NCT01182350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92794253|NCT01182350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92794254|NCT01182350|Growth Substances|growth substances|mesh-ancestor
92712389|NCT02894307|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92794255|NCT01182350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794256|NCT01182350|Growth Inhibitors|growth inhibitors|mesh-ancestor
92794257|NCT01182350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794258|NCT01182350|Alkylating Agents|alkylating agents|mesh-ancestor
92794259|NCT01182350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794260|NCT01182350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794261|NCT01182350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794262|NCT00603538|Paclitaxel|paclitaxel|mesh-list
92794263|NCT00603538|Carboplatin|carboplatin|mesh-list
92794264|NCT00603538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794265|NCT00603538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794266|NCT00603538|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794267|NCT00603538|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794268|NCT00603538|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794269|NCT00603538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794270|NCT04185766|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92794271|NCT02537860|Fentanyl|fentanyl|mesh-list
92794272|NCT02537860|Bupivacaine|bupivacaine|mesh-list
92794273|NCT02537860|Anesthetics, Local|anesthetics, local|mesh-ancestor
92794274|NCT02537860|Anesthetics|anesthetics|mesh-ancestor
92794275|NCT02537860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794276|NCT02537860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794277|NCT02537860|Sensory System Agents|sensory system agents|mesh-ancestor
92794278|NCT02537860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794279|NCT02537860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92794280|NCT02537860|Narcotics|narcotics|mesh-ancestor
92794281|NCT02537860|Analgesics|analgesics|mesh-ancestor
92794282|NCT02537860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92794283|NCT02537860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92794284|NCT02537860|Anesthetics, General|anesthetics, general|mesh-ancestor
92794285|NCT03844750|Pembrolizumab|pembrolizumab|mesh-list
92794286|NCT03844750|Vactosertib|vactosertib|mesh-list
92794287|NCT03844750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794288|NCT03844750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794289|NCT03844750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92794290|NCT03844750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794291|NCT03844750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794292|NCT03844750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794293|NCT04521946|Mycophenolic Acid|mycophenolic acid|mesh-list
92794294|NCT04521946|Fludarabine|fludarabine|mesh-list
92794295|NCT04521946|Fludarabine phosphate|fludarabine phosphate|mesh-list
92794296|NCT04521946|Etoposide|etoposide|mesh-list
92794297|NCT04521946|Etoposide phosphate|etoposide phosphate|mesh-list
92794298|NCT04521946|Melphalan|melphalan|mesh-list
92794299|NCT04521946|Mechlorethamine|mechlorethamine|mesh-list
92794300|NCT04521946|Thiotepa|thiotepa|mesh-list
92794301|NCT04521946|Podophyllotoxin|podophyllotoxin|mesh-list
92794302|NCT04521946|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92794303|NCT04521946|Tacrolimus|tacrolimus|mesh-list
92794304|NCT04521946|Thymoglobulin|thymoglobulin|mesh-list
92794305|NCT04521946|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92794306|NCT04521946|Immunoglobulins|immunoglobulins|mesh-list
92794307|NCT04521946|Antibodies|antibodies|mesh-list
92794308|NCT04521946|gamma-Globulins|gamma-globulins|mesh-list
92794309|NCT04521946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92794310|NCT04521946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92794311|NCT04521946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794312|NCT04521946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92794313|NCT04521946|Antimetabolites|antimetabolites|mesh-ancestor
92794314|NCT04521946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794315|NCT04521946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794316|NCT04521946|Immunologic Factors|immunologic factors|mesh-ancestor
92794317|NCT04521946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794318|NCT04521946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794319|NCT04521946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92794320|NCT04521946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92794321|NCT04521946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794322|NCT04521946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92794323|NCT04521946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92794324|NCT04521946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92794325|NCT04521946|Antitubercular Agents|antitubercular agents|mesh-ancestor
92794326|NCT04521946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92794327|NCT04521946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794328|NCT04521946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794329|NCT04521946|Alkylating Agents|alkylating agents|mesh-ancestor
92794330|NCT04521946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92794331|NCT04521946|Keratolytic Agents|keratolytic agents|mesh-ancestor
92794332|NCT04521946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794333|NCT04521946|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794334|NCT04521946|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794335|NCT04521946|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794336|NCT01162304|Oxycodone|oxycodone|mesh-list
92794337|NCT01162304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92794338|NCT01162304|Narcotics|narcotics|mesh-ancestor
92794339|NCT01162304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794340|NCT01162304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794341|NCT01162304|Analgesics|analgesics|mesh-ancestor
92794342|NCT01162304|Sensory System Agents|sensory system agents|mesh-ancestor
92794343|NCT01162304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794344|NCT04515394|Cetuximab|cetuximab|mesh-list
92794345|NCT04515394|Tepotinib|tepotinib|mesh-list
92794346|NCT04515394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794347|NCT04515394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794348|NCT04206176|Ticagrelor|ticagrelor|mesh-list
92794349|NCT04206176|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92794350|NCT04206176|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92794351|NCT04206176|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92794352|NCT04206176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92794353|NCT04206176|Purinergic Agents|purinergic agents|mesh-ancestor
92794354|NCT04206176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794355|NCT04206176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794356|NCT04206176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794357|NCT01175018|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92794358|NCT01175018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794359|NCT00638326|Clopidogrel|clopidogrel|mesh-list
92794360|NCT00638326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92794361|NCT00638326|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92794362|NCT00638326|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92794363|NCT00638326|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92794364|NCT00638326|Purinergic Agents|purinergic agents|mesh-ancestor
92794365|NCT00638326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794366|NCT00638326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794367|NCT00638326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794368|NCT04314674|Mannitol|mannitol|mesh-list
92794369|NCT04314674|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92794370|NCT04314674|Diuretics|diuretics|mesh-ancestor
92794371|NCT04314674|Natriuretic Agents|natriuretic agents|mesh-ancestor
92794372|NCT04314674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794373|NCT00639262|Temozolomide|temozolomide|mesh-list
92794374|NCT00639262|Sorafenib|sorafenib|mesh-list
92794375|NCT00639262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794376|NCT00639262|Alkylating Agents|alkylating agents|mesh-ancestor
92794377|NCT00639262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794378|NCT00639262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794379|NCT00639262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794380|NCT00639262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794381|NCT02885558|Efonidipine|efonidipine|mesh-list
92794382|NCT02885558|Nifedipine|nifedipine|mesh-list
92794383|NCT02885558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92794384|NCT02885558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92794385|NCT02885558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794386|NCT02885558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92794387|NCT02885558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794388|NCT02885558|Vasodilator Agents|vasodilator agents|mesh-ancestor
92794389|NCT02885558|Tocolytic Agents|tocolytic agents|mesh-ancestor
92794390|NCT02885558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92794391|NCT02885558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92794392|NCT02885558|Diuretics|diuretics|mesh-ancestor
92794393|NCT02885558|Natriuretic Agents|natriuretic agents|mesh-ancestor
92794394|NCT01008150|Paclitaxel|paclitaxel|mesh-list
92794395|NCT01008150|Cyclophosphamide|cyclophosphamide|mesh-list
92794396|NCT01008150|Doxorubicin|doxorubicin|mesh-list
92794397|NCT01008150|Trastuzumab|trastuzumab|mesh-list
92794398|NCT01008150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794399|NCT01008150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794400|NCT01008150|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794401|NCT01008150|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794402|NCT01008150|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794403|NCT01008150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794404|NCT01008150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794405|NCT01008150|Immunologic Factors|immunologic factors|mesh-ancestor
92794406|NCT01008150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794407|NCT01008150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794408|NCT01008150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794409|NCT01008150|Alkylating Agents|alkylating agents|mesh-ancestor
92794410|NCT01008150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92794411|NCT01008150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92794412|NCT01008150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92794413|NCT01008150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92794414|NCT01008150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794415|NCT01008150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794416|NCT04186936|Simethicone|simethicone|mesh-list
92794417|NCT04186936|Loperamide|loperamide|mesh-list
92794418|NCT04186936|Antidiarrheals|antidiarrheals|mesh-list
92794419|NCT04186936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794420|NCT04186936|Antifoaming Agents|antifoaming agents|mesh-ancestor
92794421|NCT04186936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794422|NCT04186936|Emollients|emollients|mesh-ancestor
92794423|NCT04186936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794424|NCT02689180|Furosemide|furosemide|mesh-list
92794425|NCT02689180|Diuretics|diuretics|mesh-ancestor
92794426|NCT02689180|Natriuretic Agents|natriuretic agents|mesh-ancestor
92794427|NCT02689180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794428|NCT02689180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92794429|NCT02689180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92794430|NCT02689180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794431|NCT02689336|Temozolomide|temozolomide|mesh-list
92794432|NCT02689336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92794433|NCT02689336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794434|NCT02689336|Alkylating Agents|alkylating agents|mesh-ancestor
92794435|NCT02689336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794436|NCT02689336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794437|NCT02689336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794438|NCT02689336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794439|NCT03650764|Pembrolizumab|pembrolizumab|mesh-list
92794440|NCT03650764|Ramucirumab|ramucirumab|mesh-list
92794441|NCT03650764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794442|NCT03650764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794443|NCT03650764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92794444|NCT03650764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794445|NCT02685592|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92794446|NCT02685592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92794447|NCT02685592|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794448|NCT01007448|Bexarotene|bexarotene|mesh-list
92794449|NCT01007448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794450|NCT02686684|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92794451|NCT02686684|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794452|NCT02686684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794453|NCT02686684|Immunologic Factors|immunologic factors|mesh-ancestor
92794454|NCT02686684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794455|NCT04294056|Propofol|propofol|mesh-list
92794456|NCT04294056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92794457|NCT04294056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794458|NCT04294056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794459|NCT04294056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92794460|NCT04294056|Anesthetics, General|anesthetics, general|mesh-ancestor
92794461|NCT04294056|Anesthetics|anesthetics|mesh-ancestor
92794462|NCT04186702|Ranibizumab|ranibizumab|mesh-list
92794463|NCT04186702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92794464|NCT04186702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92794465|NCT04186702|Growth Substances|growth substances|mesh-ancestor
92794466|NCT04186702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794467|NCT04186702|Growth Inhibitors|growth inhibitors|mesh-ancestor
92794468|NCT04186702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794469|NCT04187014|Tranexamic Acid|tranexamic acid|mesh-list
92794470|NCT04187014|Aminocaproic Acid|aminocaproic acid|mesh-list
92794471|NCT04187014|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92794472|NCT04187014|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92794473|NCT04187014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794474|NCT04187014|Hemostatics|hemostatics|mesh-ancestor
92794475|NCT04187014|Coagulants|coagulants|mesh-ancestor
92794476|NCT02686840|Misoprostol|misoprostol|mesh-list
92794477|NCT02686840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92794478|NCT02686840|Abortifacient Agents|abortifacient agents|mesh-ancestor
92794479|NCT02686840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92794480|NCT02686840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794481|NCT02686840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92794482|NCT02686840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794483|NCT02686840|Oxytocics|oxytocics|mesh-ancestor
92794484|NCT02689024|Acetaminophen|acetaminophen|mesh-list
92794485|NCT02689024|Dipyrone|dipyrone|mesh-list
92794486|NCT02689024|Ibuprofen|ibuprofen|mesh-list
92794487|NCT02689024|Diclofenac|diclofenac|mesh-list
92794488|NCT02689024|Naproxen|naproxen|mesh-list
92794489|NCT02689024|Fentanyl|fentanyl|mesh-list
92794490|NCT02689024|Morphine|morphine|mesh-list
92794491|NCT02689024|Bupivacaine|bupivacaine|mesh-list
92794492|NCT02689024|Ropivacaine|ropivacaine|mesh-list
92794493|NCT02689024|Levobupivacaine|levobupivacaine|mesh-list
92794494|NCT02689024|Anesthetics, Local|anesthetics, local|mesh-ancestor
92794495|NCT02689024|Anesthetics|anesthetics|mesh-ancestor
92794496|NCT02689024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794497|NCT02689024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794498|NCT02689024|Sensory System Agents|sensory system agents|mesh-ancestor
92794499|NCT02689024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794500|NCT02689024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92794502|NCT02689024|Analgesics|analgesics|mesh-ancestor
92794503|NCT02689024|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92794504|NCT02689024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92794505|NCT02689024|Anesthetics, General|anesthetics, general|mesh-ancestor
92794506|NCT02689024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794507|NCT02689024|Antipyretics|antipyretics|mesh-ancestor
92794508|NCT02689024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794509|NCT02689024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794510|NCT02689024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794511|NCT02689024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92794512|NCT02689024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794513|NCT02689024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794514|NCT02689024|Gout Suppressants|gout suppressants|mesh-ancestor
92794515|NCT00638482|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92794516|NCT00638482|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92794517|NCT00638482|Diuretics|diuretics|mesh-ancestor
92794518|NCT00638482|Natriuretic Agents|natriuretic agents|mesh-ancestor
92794519|NCT00638482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794520|NCT00638482|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92794521|NCT00638482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92794522|NCT00638482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794523|NCT00638560|Vitamins|vitamins|mesh-list
92794524|NCT00638560|Vitamin E|vitamin e|mesh-list
92794525|NCT00638560|Antioxidants|antioxidants|mesh-list
92794526|NCT00638560|Micronutrients|micronutrients|mesh-ancestor
92794527|NCT00638560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794528|NCT00638560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794529|NCT00638560|Protective Agents|protective agents|mesh-ancestor
92794530|NCT00638638|Abciximab|abciximab|mesh-list
92794531|NCT00638638|Anticoagulants|anticoagulants|mesh-ancestor
92794532|NCT00638638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92794533|NCT02684812|Tranexamic Acid|tranexamic acid|mesh-list
92794534|NCT02684812|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92794535|NCT02684812|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92794536|NCT02684812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794537|NCT02684812|Hemostatics|hemostatics|mesh-ancestor
92794538|NCT02684812|Coagulants|coagulants|mesh-ancestor
92794539|NCT04203160|Cisplatin|cisplatin|mesh-list
92794540|NCT04203160|Gemcitabine|gemcitabine|mesh-list
92794541|NCT04203160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794542|NCT04203160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92794543|NCT04203160|Antimetabolites|antimetabolites|mesh-ancestor
92712669|NCT02910518|Hormones|hormones|mesh-ancestor
92794544|NCT04203160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794545|NCT01004250|Bevacizumab|bevacizumab|mesh-list
92794546|NCT01004250|Pemetrexed|pemetrexed|mesh-list
92794547|NCT01004250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794548|NCT01004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794549|NCT01004250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92794550|NCT01004250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92794551|NCT01004250|Growth Substances|growth substances|mesh-ancestor
92794552|NCT01004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794553|NCT01004250|Growth Inhibitors|growth inhibitors|mesh-ancestor
92794554|NCT01004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794555|NCT01004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794556|NCT01004250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92794557|NCT01004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92794558|NCT02688634|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92794559|NCT02688634|Amoxicillin|amoxicillin|mesh-list
92794560|NCT02688634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794561|NCT00639496|Acetylcysteine|acetylcysteine|mesh-list
92794562|NCT00639496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92794563|NCT00639496|Antiviral Agents|antiviral agents|mesh-ancestor
92794564|NCT00639496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794565|NCT00639496|Expectorants|expectorants|mesh-ancestor
92794566|NCT00639496|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794567|NCT00639496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92794568|NCT00639496|Antioxidants|antioxidants|mesh-ancestor
92794569|NCT00639496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794570|NCT00639496|Protective Agents|protective agents|mesh-ancestor
92794571|NCT00639496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794572|NCT00639496|Antidotes|antidotes|mesh-ancestor
92794573|NCT02688400|Celecoxib|celecoxib|mesh-list
92794574|NCT02688400|Diacerein|diacerein|mesh-list
92794575|NCT02688400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794576|NCT02688400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794577|NCT02688400|Analgesics|analgesics|mesh-ancestor
92794578|NCT02688400|Sensory System Agents|sensory system agents|mesh-ancestor
92794579|NCT02688400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794580|NCT02688400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794581|NCT02688400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794582|NCT02688400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794583|NCT02688400|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92794584|NCT02688400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92794585|NCT02688400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794586|NCT02688400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794587|NCT00639574|Nefopam|nefopam|mesh-list
92794588|NCT00639574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794589|NCT00639574|Analgesics|analgesics|mesh-ancestor
92794590|NCT00639574|Sensory System Agents|sensory system agents|mesh-ancestor
92794591|NCT00639574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794592|NCT00639574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794593|NCT02685046|Imatinib Mesylate|imatinib mesylate|mesh-list
92794594|NCT02685046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794595|NCT02685046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794596|NCT02685046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794597|NCT02685046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794599|NCT01004172|Trastuzumab|trastuzumab|mesh-list
92794600|NCT01004172|Carboplatin|carboplatin|mesh-list
92794601|NCT01004172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794602|NCT01004172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794603|NCT01004172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92794604|NCT01004172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92794605|NCT01004172|Growth Substances|growth substances|mesh-ancestor
92794606|NCT01004172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794607|NCT01004172|Growth Inhibitors|growth inhibitors|mesh-ancestor
92794608|NCT02688322|Sulbactam|sulbactam|mesh-list
92794609|NCT02688322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92794610|NCT02688322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794611|NCT02688322|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92794612|NCT02688322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794613|NCT02688322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794614|NCT02685748|Aspirin|aspirin|mesh-list
92794615|NCT02685748|Pantoprazole|pantoprazole|mesh-list
92794616|NCT02685748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794617|NCT02685748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794618|NCT02685748|Analgesics|analgesics|mesh-ancestor
92794619|NCT02685748|Sensory System Agents|sensory system agents|mesh-ancestor
92794620|NCT02685748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794621|NCT02685748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794622|NCT02685748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794623|NCT02685748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794624|NCT02685748|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92794625|NCT02685748|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92794626|NCT02685748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794627|NCT02685748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92794628|NCT02685748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92794629|NCT02685748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794630|NCT02685748|Antipyretics|antipyretics|mesh-ancestor
92794631|NCT02685748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92794632|NCT02685748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794633|NCT02685748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92794634|NCT02685670|Cyclophosphamide|cyclophosphamide|mesh-list
92794635|NCT02685670|Fludarabine|fludarabine|mesh-list
92794636|NCT02685670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794637|NCT02685670|Immunologic Factors|immunologic factors|mesh-ancestor
92794638|NCT02685670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794639|NCT02685670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794640|NCT02685670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794641|NCT02685670|Alkylating Agents|alkylating agents|mesh-ancestor
92794642|NCT02685670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794643|NCT02685670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794644|NCT02685670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92794645|NCT02687932|Valsartan|valsartan|mesh-list
92794646|NCT02687932|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92794647|NCT02687932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92794648|NCT02687932|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92794649|NCT02687932|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92794650|NCT02687932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794651|NCT00641602|Esomeprazole|esomeprazole|mesh-list
92794652|NCT00641602|Lansoprazole|lansoprazole|mesh-list
92794653|NCT00641602|Dexlansoprazole|dexlansoprazole|mesh-list
92794654|NCT00641602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92794655|NCT00641602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794656|NCT00641602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92794657|NCT00641602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794658|NCT00641602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794659|NCT05663944|Sirolimus|sirolimus|mesh-list
92794660|NCT05663944|Liver Extracts|liver extracts|mesh-list
92794661|NCT05663944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92794662|NCT05663944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794663|NCT05663944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92794664|NCT05663944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794665|NCT05663944|Antifungal Agents|antifungal agents|mesh-ancestor
92794666|NCT05663944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439693|NCT01619683|Clomiphene|clomiphene|mesh-list
92794667|NCT05663944|Immunologic Factors|immunologic factors|mesh-ancestor
92794668|NCT05663944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794669|NCT05663944|Hematinics|hematinics|mesh-ancestor
92794670|NCT02682862|Bromides|bromides|mesh-list
92794671|NCT02682862|Tiotropium Bromide|tiotropium bromide|mesh-list
92794672|NCT02682862|Olodaterol|olodaterol|mesh-list
92794673|NCT02682862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92794674|NCT02682862|Autonomic Agents|autonomic agents|mesh-ancestor
92794675|NCT02682862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794676|NCT02682862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794677|NCT02682862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794678|NCT02682862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794679|NCT02682862|Parasympatholytics|parasympatholytics|mesh-ancestor
92794680|NCT02682862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92794681|NCT02682862|Cholinergic Agents|cholinergic agents|mesh-ancestor
92794682|NCT02682862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794683|NCT02682862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794684|NCT02682862|Anticonvulsants|anticonvulsants|mesh-ancestor
92794685|NCT02073838|Ribavirin|ribavirin|mesh-list
92794686|NCT02073838|Decitabine|decitabine|mesh-list
92794687|NCT02073838|Antimetabolites|antimetabolites|mesh-ancestor
93026442|NCT00493038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92794688|NCT02073838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794689|NCT02073838|Antiviral Agents|antiviral agents|mesh-ancestor
92794690|NCT02073838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794691|NCT02073838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92794692|NCT02073838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794693|NCT02073838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794694|NCT00640198|Memantine|memantine|mesh-list
92794695|NCT00640198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92794696|NCT00640198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92794697|NCT00640198|Dopamine Agents|dopamine agents|mesh-ancestor
92794698|NCT00640198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794699|NCT00640198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794700|NCT00640198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794701|NCT00640198|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92794702|NCT00640198|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92794703|NCT02031250|Carboplatin|carboplatin|mesh-list
92794704|NCT02031250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794705|NCT04293822|Cetirizine|cetirizine|mesh-list
92794706|NCT04293822|Minoxidil|minoxidil|mesh-list
92794707|NCT04293822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92794708|NCT04293822|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92794709|NCT04293822|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92794710|NCT04293822|Histamine Antagonists|histamine antagonists|mesh-ancestor
92794711|NCT04293822|Histamine Agents|histamine agents|mesh-ancestor
92794712|NCT04293822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794713|NCT04293822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794714|NCT04293822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794715|NCT04293822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92794716|NCT04293822|Vasodilator Agents|vasodilator agents|mesh-ancestor
92794717|NCT02680600|Cefepime|cefepime|mesh-list
92794718|NCT02680600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92794719|NCT02680600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794720|NCT02680678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92794721|NCT04182724|Paclitaxel|paclitaxel|mesh-list
92794722|NCT04182724|Apatinib|apatinib|mesh-list
92794723|NCT04182724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794724|NCT04182724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794725|NCT04182724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794726|NCT04182724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794728|NCT04182724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794729|NCT04182724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794730|NCT04182724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794731|NCT04184518|Durvalumab|durvalumab|mesh-list
92794732|NCT04184518|Cediranib|cediranib|mesh-list
92794733|NCT04184518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794734|NCT04184518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794735|NCT04184518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794736|NCT04184518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794737|NCT04184518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794738|NCT01174238|Paclitaxel|paclitaxel|mesh-list
92794739|NCT01174238|Carboplatin|carboplatin|mesh-list
92794740|NCT01174238|Axitinib|axitinib|mesh-list
92794741|NCT01174238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92794742|NCT01174238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794743|NCT01174238|Tubulin Modulators|tubulin modulators|mesh-ancestor
92794744|NCT01174238|Antimitotic Agents|antimitotic agents|mesh-ancestor
92794745|NCT01174238|Mitosis Modulators|mitosis modulators|mesh-ancestor
92794746|NCT01174238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794747|NCT01174238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794748|NCT01174238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794749|NCT02928406|Atezolizumab|atezolizumab|mesh-list
92794750|NCT02928406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92794751|NCT02928406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794752|NCT02928406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794753|NCT02928406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794754|NCT04315454|Levobupivacaine|levobupivacaine|mesh-list
92794755|NCT04315454|Anesthetics, Local|anesthetics, local|mesh-ancestor
92794756|NCT04315454|Anesthetics|anesthetics|mesh-ancestor
92794757|NCT04315454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794758|NCT04315454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794759|NCT04315454|Sensory System Agents|sensory system agents|mesh-ancestor
92794760|NCT04315454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794761|NCT01161446|Antibodies|antibodies|mesh-list
92794762|NCT01161446|Immunoglobulins|immunoglobulins|mesh-list
92794763|NCT01161446|Immunologic Factors|immunologic factors|mesh-ancestor
92794764|NCT01161446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794765|NCT00641680|Fluticasone|fluticasone|mesh-list
92794766|NCT00641680|Xhance|xhance|mesh-list
92794767|NCT00641680|Budesonide|budesonide|mesh-list
92794768|NCT00641680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794769|NCT00641680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92794770|NCT00641680|Autonomic Agents|autonomic agents|mesh-ancestor
92794771|NCT00641680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794772|NCT00641680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794773|NCT00641680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794774|NCT00641680|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794775|NCT00641680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794776|NCT00641680|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92794777|NCT00641680|Glucocorticoids|glucocorticoids|mesh-ancestor
92794778|NCT00641680|Hormones|hormones|mesh-ancestor
92794779|NCT00641680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92794780|NCT01174004|Pimavanserin|pimavanserin|mesh-list
92794781|NCT01174004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92794782|NCT01174004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92794783|NCT01174004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92794784|NCT01174004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92794785|NCT01174004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794786|NCT01174004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794787|NCT01174004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92794788|NCT01174004|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92794789|NCT01174004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92794790|NCT01174004|Serotonin Agents|serotonin agents|mesh-ancestor
92794791|NCT01174004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794792|NCT01174004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794793|NCT01173692|Minocycline|minocycline|mesh-list
92794794|NCT01173692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92794795|NCT01173692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794796|NCT00641758|Pycnogenols|pycnogenols|mesh-list
92794797|NCT00641758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92794798|NCT00641758|Immunologic Factors|immunologic factors|mesh-ancestor
92794799|NCT00641758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794800|NCT00641758|Antioxidants|antioxidants|mesh-ancestor
92741140|NCT02871193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794801|NCT00641758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794802|NCT00641758|Protective Agents|protective agents|mesh-ancestor
92794803|NCT00641758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92794804|NCT00640276|Pitavastatin|pitavastatin|mesh-list
92794805|NCT00640276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92794806|NCT00640276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92794807|NCT00640276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92794808|NCT00640276|Antimetabolites|antimetabolites|mesh-ancestor
92794809|NCT00640276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794810|NCT00640276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794811|NCT00640276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92794812|NCT02680132|Esomeprazole|esomeprazole|mesh-list
92794813|NCT02680132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92794814|NCT02680132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794815|NCT02680132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92794816|NCT02680132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794817|NCT02680132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439835|NCT01620437|Insulin Aspart|insulin aspart|mesh-list
92794819|NCT02683564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92794820|NCT02683564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794821|NCT02683564|Dermatologic Agents|dermatologic agents|mesh-ancestor
92794822|NCT02683564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794823|NCT02683564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794824|NCT01101035|Allopurinol|allopurinol|mesh-list
92794825|NCT01101035|Febuxostat|febuxostat|mesh-list
92794826|NCT01101035|Antimetabolites|antimetabolites|mesh-ancestor
92794827|NCT01101035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794828|NCT01101035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794829|NCT01101035|Gout Suppressants|gout suppressants|mesh-ancestor
92794830|NCT01101035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794831|NCT01101035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92794832|NCT01101035|Antioxidants|antioxidants|mesh-ancestor
92794833|NCT01101035|Protective Agents|protective agents|mesh-ancestor
92794834|NCT01101035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794835|NCT01160822|Naproxen|naproxen|mesh-list
92794836|NCT01160822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92794837|NCT01160822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794838|NCT01160822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794839|NCT01160822|Analgesics|analgesics|mesh-ancestor
92794840|NCT01160822|Sensory System Agents|sensory system agents|mesh-ancestor
92794841|NCT01160822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794842|NCT01160822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794843|NCT01160822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794844|NCT01160822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794845|NCT01160822|Gout Suppressants|gout suppressants|mesh-ancestor
92794846|NCT01160822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92794847|NCT01160822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794848|NCT01160822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794849|NCT01160822|Immunologic Factors|immunologic factors|mesh-ancestor
92794850|NCT01006980|Dacarbazine|dacarbazine|mesh-list
92794851|NCT01006980|Vemurafenib|vemurafenib|mesh-list
92794852|NCT01006980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794853|NCT01006980|Alkylating Agents|alkylating agents|mesh-ancestor
92794854|NCT01006980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794855|NCT01006980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794856|NCT01006980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92794857|NCT01006980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794858|NCT04296240|Capecitabine|capecitabine|mesh-list
92794859|NCT04296240|Oxaliplatin|oxaliplatin|mesh-list
92794860|NCT04296240|Antiemetics|antiemetics|mesh-list
92794861|NCT04296240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92794862|NCT04296240|Antimetabolites|antimetabolites|mesh-ancestor
92794863|NCT04296240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794864|NCT04296240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794865|NCT04296240|Autonomic Agents|autonomic agents|mesh-ancestor
92794866|NCT04296240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794867|NCT04296240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794868|NCT04296240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92794869|NCT04205058|Caffeine|caffeine|mesh-list
92794870|NCT04205058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92794871|NCT04205058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794872|NCT04205058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92794873|NCT04205058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794874|NCT04205058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794875|NCT04205058|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92794876|NCT04205058|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92794877|NCT04205058|Purinergic Agents|purinergic agents|mesh-ancestor
92794878|NCT04205058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794879|NCT04183738|Ritonavir|ritonavir|mesh-list
92794880|NCT04183738|Darunavir|darunavir|mesh-list
92794881|NCT04183738|Dolutegravir|dolutegravir|mesh-list
92794882|NCT04183738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92794883|NCT04183738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92794884|NCT04183738|Protease Inhibitors|protease inhibitors|mesh-ancestor
92794885|NCT04183738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794886|NCT04183738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794887|NCT04183738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92794888|NCT04183738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92794889|NCT04183738|Antiviral Agents|antiviral agents|mesh-ancestor
92794890|NCT04183738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794891|NCT04183738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92794892|NCT04183738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92794893|NCT04183738|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92794894|NCT04183738|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92794895|NCT02682082|Bupivacaine|bupivacaine|mesh-list
92794896|NCT02682082|Anesthetics, Local|anesthetics, local|mesh-ancestor
92794897|NCT02682082|Anesthetics|anesthetics|mesh-ancestor
92794898|NCT02682082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92794899|NCT02682082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794900|NCT02682082|Sensory System Agents|sensory system agents|mesh-ancestor
92794901|NCT02682082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794902|NCT00640432|Celecoxib|celecoxib|mesh-list
92794903|NCT00640432|Diclofenac|diclofenac|mesh-list
92794904|NCT00640432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794905|NCT00640432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794906|NCT00640432|Analgesics|analgesics|mesh-ancestor
92794907|NCT00640432|Sensory System Agents|sensory system agents|mesh-ancestor
92794908|NCT00640432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794909|NCT00640432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794910|NCT00640432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794911|NCT00640432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794912|NCT00640432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92794913|NCT00640432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92794914|NCT00640432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794915|NCT00640432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794916|NCT02679664|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92794917|NCT02679664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92794918|NCT02679664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92794919|NCT02679664|Antimetabolites|antimetabolites|mesh-ancestor
92794920|NCT02679664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794921|NCT02679664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92794922|NCT02679664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92794923|NCT02679664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794924|NCT00641212|Budesonide|budesonide|mesh-list
92794925|NCT00641212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794926|NCT00641212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92794927|NCT00641212|Autonomic Agents|autonomic agents|mesh-ancestor
92794928|NCT00641212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794929|NCT00641212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794930|NCT00641212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794931|NCT00641212|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794932|NCT00641212|Glucocorticoids|glucocorticoids|mesh-ancestor
92794933|NCT00641212|Hormones|hormones|mesh-ancestor
92794934|NCT00641212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92794935|NCT04183192|Reslizumab|reslizumab|mesh-list
92794936|NCT04183192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794937|NCT04183192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794938|NCT02681848|Nicotine|nicotine|mesh-list
92794939|NCT02681848|Varenicline|varenicline|mesh-list
92794940|NCT02681848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92794941|NCT02681848|Autonomic Agents|autonomic agents|mesh-ancestor
92794942|NCT02681848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794943|NCT02681848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794944|NCT02681848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92794945|NCT02681848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92794946|NCT02681848|Cholinergic Agents|cholinergic agents|mesh-ancestor
92794947|NCT02681848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92794948|NCT02681848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794949|NCT00997386|Melphalan|melphalan|mesh-list
92794950|NCT00997386|Busulfan|busulfan|mesh-list
92794951|NCT00997386|Alemtuzumab|alemtuzumab|mesh-list
92713097|NCT00556062|Vaccines|vaccines|mesh-list
92794952|NCT00997386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92794953|NCT00997386|Alkylating Agents|alkylating agents|mesh-ancestor
92794954|NCT00997386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794955|NCT00997386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92794956|NCT00997386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92794957|NCT00997386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92794958|NCT00997386|Immunologic Factors|immunologic factors|mesh-ancestor
92794959|NCT00997386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794960|NCT00997386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92794961|NCT02679820|Copper|copper|mesh-list
92794962|NCT02679820|Trace Elements|trace elements|mesh-ancestor
92794963|NCT02679820|Micronutrients|micronutrients|mesh-ancestor
92794964|NCT02679820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794965|NCT00641914|Budesonide|budesonide|mesh-list
92794966|NCT00641914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794967|NCT00641914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92794968|NCT00641914|Autonomic Agents|autonomic agents|mesh-ancestor
92794969|NCT00641914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794970|NCT00641914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794971|NCT00641914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92794972|NCT00641914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92794973|NCT00641914|Glucocorticoids|glucocorticoids|mesh-ancestor
92794975|NCT00641914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92794976|NCT00640588|Adefovir|adefovir|mesh-list
92794977|NCT00640588|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92794978|NCT00640588|Telbivudine|telbivudine|mesh-list
92794979|NCT00640588|Antiviral Agents|antiviral agents|mesh-ancestor
92794980|NCT00640588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92794981|NCT00640588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92794982|NCT00640588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92794983|NCT00640588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794984|NCT00640588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794985|NCT05663398|Ibuprofen|ibuprofen|mesh-list
92794986|NCT05663398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92794987|NCT05663398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92794988|NCT05663398|Analgesics|analgesics|mesh-ancestor
92794989|NCT05663398|Sensory System Agents|sensory system agents|mesh-ancestor
92794990|NCT05663398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92794991|NCT05663398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92794992|NCT05663398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92794993|NCT05663398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92794994|NCT05663398|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92794995|NCT05663398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92794996|NCT05663398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92794997|NCT00640744|Atorvastatin|atorvastatin|mesh-list
92794998|NCT00640744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92794999|NCT00640744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92795000|NCT00640744|Antimetabolites|antimetabolites|mesh-ancestor
92795001|NCT00640744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795002|NCT00640744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92795003|NCT00640744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92795004|NCT00640744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795005|NCT02678104|Chlorhexidine|chlorhexidine|mesh-list
92795006|NCT02678104|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92795007|NCT02678104|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92795008|NCT02678104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795009|NCT02678104|Disinfectants|disinfectants|mesh-ancestor
92795010|NCT02678104|Dermatologic Agents|dermatologic agents|mesh-ancestor
92795011|NCT02681536|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92795012|NCT02681536|Contraceptive Agents|contraceptive agents|mesh-list
92795013|NCT02681536|Contraceptives, Oral|contraceptives, oral|mesh-list
92795014|NCT02681536|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92795015|NCT02681536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92795016|NCT02681536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795017|NCT02681536|Luteolytic Agents|luteolytic agents|mesh-ancestor
92795018|NCT02681536|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92795019|NCT02681536|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92795020|NCT02681536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795021|NCT02681536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795022|NCT04183114|Vaccines|vaccines|mesh-list
92795023|NCT04183114|Immunologic Factors|immunologic factors|mesh-ancestor
92795024|NCT04183114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795026|NCT00996996|Tositumomab I-131|tositumomab i-131|mesh-list
92795027|NCT00996996|Antibodies|antibodies|mesh-list
92795028|NCT00996996|Immunoglobulins|immunoglobulins|mesh-list
92795029|NCT00996996|Immunologic Factors|immunologic factors|mesh-ancestor
92795030|NCT00996996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795031|NCT00996996|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92795032|NCT00996996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795033|NCT00996996|Trace Elements|trace elements|mesh-ancestor
92795034|NCT00996996|Micronutrients|micronutrients|mesh-ancestor
92795035|NCT00996996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795036|NCT04182568|Paclitaxel|paclitaxel|mesh-list
92795037|NCT04182568|Docetaxel|docetaxel|mesh-list
92795038|NCT04182568|Cyclophosphamide|cyclophosphamide|mesh-list
92795039|NCT04182568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92795040|NCT04182568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440057|NCT01621698|Atracurium|atracurium|mesh-list
92795041|NCT04182568|Tubulin Modulators|tubulin modulators|mesh-ancestor
92795042|NCT04182568|Antimitotic Agents|antimitotic agents|mesh-ancestor
92795043|NCT04182568|Mitosis Modulators|mitosis modulators|mesh-ancestor
92795044|NCT04182568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795045|NCT04182568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795046|NCT04182568|Immunologic Factors|immunologic factors|mesh-ancestor
92795047|NCT04182568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795048|NCT04182568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795049|NCT04182568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92795050|NCT04182568|Alkylating Agents|alkylating agents|mesh-ancestor
92795051|NCT04182568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92795053|NCT00641446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795054|NCT00641446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92795055|NCT00641446|Autonomic Agents|autonomic agents|mesh-ancestor
92795056|NCT00641446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795057|NCT00641446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795058|NCT00641446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92795059|NCT00641446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92795060|NCT00641446|Glucocorticoids|glucocorticoids|mesh-ancestor
92795061|NCT00641446|Hormones|hormones|mesh-ancestor
92795062|NCT00641446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795063|NCT05663164|Thiamine|thiamine|mesh-list
92795064|NCT05663164|Vitamins|vitamins|mesh-ancestor
92795065|NCT05663164|Micronutrients|micronutrients|mesh-ancestor
92795066|NCT05663164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795067|NCT05663164|Vitamin B Complex|vitamin b complex|mesh-ancestor
92795068|NCT02537470|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
92795069|NCT02537470|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92795070|NCT02537470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795071|NCT02537470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92795072|NCT02537470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795073|NCT02678728|Dexmedetomidine|dexmedetomidine|mesh-list
92795074|NCT02678728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92795075|NCT02678728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795076|NCT02678728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795077|NCT02678728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92795078|NCT02678728|Analgesics|analgesics|mesh-ancestor
92795079|NCT02678728|Sensory System Agents|sensory system agents|mesh-ancestor
92795080|NCT02678728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795081|NCT02678728|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92795082|NCT02678728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92795083|NCT02678728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92795084|NCT02678728|Adrenergic Agents|adrenergic agents|mesh-ancestor
92795085|NCT02678728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795086|NCT02678728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795087|NCT04180072|Bevacizumab|bevacizumab|mesh-list
92795088|NCT04180072|Atezolizumab|atezolizumab|mesh-list
92795089|NCT04180072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795090|NCT04180072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795091|NCT04180072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92795092|NCT04180072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92795093|NCT04180072|Growth Substances|growth substances|mesh-ancestor
92795094|NCT04180072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795095|NCT04180072|Growth Inhibitors|growth inhibitors|mesh-ancestor
92795096|NCT04180072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92795097|NCT04180072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795098|NCT02678650|Anesthetics|anesthetics|mesh-list
92795099|NCT02678650|Propofol|propofol|mesh-list
92795100|NCT02678650|Isoflurane|isoflurane|mesh-list
92795101|NCT02678650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795102|NCT02678650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795103|NCT02678650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92795104|NCT02678650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92795105|NCT02678650|Anesthetics, General|anesthetics, general|mesh-ancestor
92795106|NCT02678650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92795107|NCT04180150|Entecavir|entecavir|mesh-list
92795108|NCT04180150|Antiviral Agents|antiviral agents|mesh-ancestor
92795109|NCT04180150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795110|NCT02678338|Magrolimab|magrolimab|mesh-list
92795111|NCT02678338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795112|NCT02678338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795113|NCT00642226|Triamcinolone|triamcinolone|mesh-list
92795114|NCT00642226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795115|NCT00642226|Glucocorticoids|glucocorticoids|mesh-ancestor
92795116|NCT00642226|Hormones|hormones|mesh-ancestor
92795117|NCT00642226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795118|NCT00642226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795120|NCT05511610|Desflurane|desflurane|mesh-list
92795121|NCT05511610|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92795122|NCT05511610|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92795123|NCT05511610|Anesthetics, General|anesthetics, general|mesh-ancestor
92795124|NCT05511610|Anesthetics|anesthetics|mesh-ancestor
92795125|NCT05511610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795126|NCT05511610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795127|NCT02675530|Ketamine|ketamine|mesh-list
92795128|NCT02675530|Analgesics|analgesics|mesh-ancestor
92795129|NCT02675530|Sensory System Agents|sensory system agents|mesh-ancestor
92795130|NCT02675530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795131|NCT02675530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795132|NCT02675530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92795133|NCT02675530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92795134|NCT02675530|Anesthetics, General|anesthetics, general|mesh-ancestor
92795135|NCT02675530|Anesthetics|anesthetics|mesh-ancestor
92795136|NCT02675530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795137|NCT02675530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92795138|NCT02675530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92713276|NCT01779453|Atorvastatin|atorvastatin|mesh-list
92795139|NCT02675530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795140|NCT02675530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795141|NCT02675374|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92795142|NCT02675374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92795143|NCT02675374|Histamine Antagonists|histamine antagonists|mesh-ancestor
92795144|NCT02675374|Histamine Agents|histamine agents|mesh-ancestor
92795145|NCT02675374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795146|NCT02675374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795147|NCT02675374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795148|NCT02678260|Spartalizumab|spartalizumab|mesh-list
92795149|NCT02678260|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92795150|NCT02678260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795151|NCT02678260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795152|NCT02678260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795153|NCT04179604|Simendan|simendan|mesh-list
92795154|NCT04179604|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92795155|NCT04179604|Vasodilator Agents|vasodilator agents|mesh-ancestor
92795156|NCT04179604|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92795157|NCT04179604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92795158|NCT04179604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795159|NCT04179604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795160|NCT04179604|Protective Agents|protective agents|mesh-ancestor
92795161|NCT04179604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795162|NCT02675140|Vitamins|vitamins|mesh-list
92795163|NCT02675140|Vitamin A|vitamin a|mesh-list
92795164|NCT02675140|Albendazole|albendazole|mesh-list
92795165|NCT02675140|Retinol palmitate|retinol palmitate|mesh-list
92795166|NCT02675140|Micronutrients|micronutrients|mesh-ancestor
92795167|NCT02675140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795168|NCT02675140|Antioxidants|antioxidants|mesh-ancestor
92795169|NCT02675140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795170|NCT02675140|Protective Agents|protective agents|mesh-ancestor
92795171|NCT02675140|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92795172|NCT02675140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795173|NCT02675140|Anthelmintics|anthelmintics|mesh-ancestor
92795174|NCT02675140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92795175|NCT02675140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795177|NCT02675140|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92795178|NCT02675140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92795179|NCT02675140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92795180|NCT02675140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92795181|NCT02675140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92795182|NCT02674906|Heparin|heparin|mesh-list
92795183|NCT02674906|Calcium heparin|calcium heparin|mesh-list
92795184|NCT02674906|Anticoagulants|anticoagulants|mesh-list
92795185|NCT02674906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795186|NCT02674906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92795187|NCT02674906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92795188|NCT01160744|Carboplatin|carboplatin|mesh-list
92795189|NCT01160744|Gemcitabine|gemcitabine|mesh-list
92795190|NCT01160744|Pemetrexed|pemetrexed|mesh-list
92795191|NCT01160744|Ramucirumab|ramucirumab|mesh-list
92795192|NCT01160744|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92795193|NCT01160744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795194|NCT01160744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92795195|NCT01160744|Antimetabolites|antimetabolites|mesh-ancestor
92795196|NCT01160744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795197|NCT01160744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795198|NCT01160744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92795199|NCT01160744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92795200|NCT01160744|Immunologic Factors|immunologic factors|mesh-ancestor
92795201|NCT01160744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795202|NCT02677246|Denosumab|denosumab|mesh-list
92795203|NCT02677246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92795204|NCT02677246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795205|NCT01160354|Plerixafor|plerixafor|mesh-list
92795206|NCT01160354|Clofarabine|clofarabine|mesh-list
92713350|NCT04322123|Azithromycin|azithromycin|mesh-list
92795207|NCT01160354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92795208|NCT01160354|Antimetabolites|antimetabolites|mesh-ancestor
92795209|NCT01160354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795210|NCT01160354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795211|NCT01160354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92795212|NCT01160354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92795213|NCT01160354|Antiviral Agents|antiviral agents|mesh-ancestor
92795214|NCT01160354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795215|NCT04178512|Dexamethasone|dexamethasone|mesh-list
92795216|NCT04178512|Dexamethasone acetate|dexamethasone acetate|mesh-list
92795217|NCT04178512|Fentanyl|fentanyl|mesh-list
92795218|NCT04178512|BB 1101|bb 1101|mesh-list
92795219|NCT04178512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795220|NCT04178512|Antiemetics|antiemetics|mesh-ancestor
92795221|NCT04178512|Autonomic Agents|autonomic agents|mesh-ancestor
92795222|NCT04178512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795223|NCT04178512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795224|NCT04178512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92795225|NCT04178512|Glucocorticoids|glucocorticoids|mesh-ancestor
92795226|NCT04178512|Hormones|hormones|mesh-ancestor
92795227|NCT04178512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795228|NCT04178512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795229|NCT04178512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795230|NCT04178512|Protease Inhibitors|protease inhibitors|mesh-ancestor
92795231|NCT04178512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795232|NCT04178512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795233|NCT04178512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92795234|NCT04178512|Narcotics|narcotics|mesh-ancestor
92795235|NCT04178512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795236|NCT04178512|Analgesics|analgesics|mesh-ancestor
92795237|NCT04178512|Sensory System Agents|sensory system agents|mesh-ancestor
92795238|NCT04178512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92795239|NCT04178512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92795240|NCT04178512|Anesthetics, General|anesthetics, general|mesh-ancestor
92795241|NCT04178512|Anesthetics|anesthetics|mesh-ancestor
92795242|NCT01160198|Ascorbic Acid|ascorbic acid|mesh-list
92795243|NCT01160198|Chelating Agents|chelating agents|mesh-list
92795244|NCT01160198|Glycine|glycine|mesh-list
92795245|NCT01160198|Sequestering Agents|sequestering agents|mesh-ancestor
92795246|NCT01160198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795247|NCT01160198|Glycine Agents|glycine agents|mesh-ancestor
92795248|NCT01160198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795249|NCT01160198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795250|NCT01160198|Antioxidants|antioxidants|mesh-ancestor
92795251|NCT01160198|Protective Agents|protective agents|mesh-ancestor
92795252|NCT01160198|Vitamins|vitamins|mesh-ancestor
92795253|NCT01160198|Micronutrients|micronutrients|mesh-ancestor
92795255|NCT02676934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795256|NCT02676934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795257|NCT05351086|Dihydroergotamine|dihydroergotamine|mesh-list
92795258|NCT05351086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92795259|NCT05351086|Dopamine Agonists|dopamine agonists|mesh-ancestor
92795260|NCT05351086|Dopamine Agents|dopamine agents|mesh-ancestor
92795261|NCT05351086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795262|NCT05351086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795263|NCT05351086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795264|NCT05351086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92795265|NCT05351086|Analgesics|analgesics|mesh-ancestor
92795266|NCT05351086|Sensory System Agents|sensory system agents|mesh-ancestor
92795267|NCT05351086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795268|NCT02885168|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92795269|NCT02885168|Phenylephrine|phenylephrine|mesh-list
92795270|NCT02885168|Protein C|protein c|mesh-list
92795272|NCT02885168|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92795273|NCT02885168|Mydriatics|mydriatics|mesh-ancestor
92795274|NCT02885168|Autonomic Agents|autonomic agents|mesh-ancestor
92795275|NCT02885168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795276|NCT02885168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795277|NCT02885168|Sympathomimetics|sympathomimetics|mesh-ancestor
92795278|NCT02885168|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92795279|NCT02885168|Nasal Decongestants|nasal decongestants|mesh-ancestor
92795280|NCT02885168|Respiratory System Agents|respiratory system agents|mesh-ancestor
92795281|NCT02885168|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92795282|NCT02885168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92795283|NCT02885168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92795284|NCT02885168|Adrenergic Agents|adrenergic agents|mesh-ancestor
92795285|NCT02885168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795286|NCT02885168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795287|NCT02885168|Protective Agents|protective agents|mesh-ancestor
92795288|NCT02885168|Anticoagulants|anticoagulants|mesh-ancestor
92795289|NCT02885168|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92795290|NCT02885168|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92795291|NCT02885168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795292|NCT01159574|Clarithromycin|clarithromycin|mesh-list
92795293|NCT01159574|Dexamethasone|dexamethasone|mesh-list
92795294|NCT01159574|Pomalidomide|pomalidomide|mesh-list
92795295|NCT01159574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795296|NCT01159574|Antiemetics|antiemetics|mesh-ancestor
92795297|NCT01159574|Autonomic Agents|autonomic agents|mesh-ancestor
92795298|NCT01159574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795299|NCT01159574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795300|NCT01159574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92795301|NCT01159574|Glucocorticoids|glucocorticoids|mesh-ancestor
92795302|NCT01159574|Hormones|hormones|mesh-ancestor
92795303|NCT01159574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795304|NCT01159574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795305|NCT01159574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795306|NCT01159574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92795307|NCT01159574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795308|NCT01159574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92795309|NCT01159574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795310|NCT01159574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795311|NCT01159574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92795312|NCT01159574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92795313|NCT01159574|Immunologic Factors|immunologic factors|mesh-ancestor
92795314|NCT01159574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92795315|NCT01159574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92795316|NCT01159574|Growth Substances|growth substances|mesh-ancestor
92795317|NCT01159574|Growth Inhibitors|growth inhibitors|mesh-ancestor
92795318|NCT01158950|Tolcapone|tolcapone|mesh-list
92795319|NCT01158950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92795320|NCT01158950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92795321|NCT01158950|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92795322|NCT01158950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795323|NCT01158950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795324|NCT00910234|Epoetin Alfa|epoetin alfa|mesh-list
92795325|NCT00910234|Hematinics|hematinics|mesh-ancestor
92795326|NCT05652322|Furosemide|furosemide|mesh-list
92795327|NCT05652322|Diuretics|diuretics|mesh-ancestor
92795328|NCT05652322|Natriuretic Agents|natriuretic agents|mesh-ancestor
92795329|NCT05652322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795330|NCT05652322|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92795331|NCT05652322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92795332|NCT05652322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795333|NCT01172288|Acetylcysteine|acetylcysteine|mesh-list
92795334|NCT01172288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92795335|NCT01172288|Antiviral Agents|antiviral agents|mesh-ancestor
92795336|NCT01172288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795337|NCT01172288|Expectorants|expectorants|mesh-ancestor
92795338|NCT01172288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92795339|NCT01172288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92795340|NCT01172288|Antioxidants|antioxidants|mesh-ancestor
92795341|NCT01172288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795342|NCT01172288|Protective Agents|protective agents|mesh-ancestor
92795343|NCT01172288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795344|NCT01172288|Antidotes|antidotes|mesh-ancestor
92795345|NCT02676622|Aldesleukin|aldesleukin|mesh-list
92795346|NCT02676622|Cyclophosphamide|cyclophosphamide|mesh-list
92795347|NCT02676622|Thymoglobulin|thymoglobulin|mesh-list
92795348|NCT02676622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795349|NCT02676622|Immunologic Factors|immunologic factors|mesh-ancestor
92795350|NCT02676622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795351|NCT02676622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795352|NCT02676622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92795353|NCT02676622|Alkylating Agents|alkylating agents|mesh-ancestor
92795354|NCT02676622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795355|NCT02676622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795356|NCT02676622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92795357|NCT02676622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92795358|NCT02676622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92795359|NCT02676622|Antiviral Agents|antiviral agents|mesh-ancestor
92795360|NCT02676622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795361|NCT00644020|Fluorouracil|fluorouracil|mesh-list
92795362|NCT00644020|Mitomycins|mitomycins|mesh-list
92795363|NCT00644020|Mitomycin|mitomycin|mesh-list
92795364|NCT00644020|Antimetabolites|antimetabolites|mesh-ancestor
92795365|NCT00644020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795366|NCT00644020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92795367|NCT00644020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795368|NCT00644020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795369|NCT00644020|Immunologic Factors|immunologic factors|mesh-ancestor
92795370|NCT00644020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795371|NCT00644020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92795372|NCT00644020|Alkylating Agents|alkylating agents|mesh-ancestor
92795373|NCT00644020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92795374|NCT00644020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795375|NCT04178980|Simvastatin|simvastatin|mesh-list
92795376|NCT04178980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92795377|NCT04178980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92795378|NCT04178980|Antimetabolites|antimetabolites|mesh-ancestor
92795379|NCT04178980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795380|NCT04178980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92795381|NCT04178980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92795382|NCT04178980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795383|NCT02674048|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92795384|NCT02674048|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92795385|NCT02674048|Dermatologic Agents|dermatologic agents|mesh-ancestor
92795386|NCT02672566|Enoxaparin|enoxaparin|mesh-list
92795387|NCT02672566|Anticoagulants|anticoagulants|mesh-ancestor
92795388|NCT02672566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92795389|NCT02672566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92795390|NCT02672566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795391|NCT02672488|Metformin|metformin|mesh-list
92795392|NCT02672488|Sorafenib|sorafenib|mesh-list
92795393|NCT02672488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92795394|NCT02672488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795395|NCT02672488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795396|NCT02672488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92795397|NCT02672488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795398|NCT02672488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795399|NCT02537392|Folic Acid|folic acid|mesh-list
92795400|NCT02537392|Vitamin B Complex|vitamin b complex|mesh-list
92795401|NCT02537392|Vitamins|vitamins|mesh-ancestor
92795402|NCT02537392|Micronutrients|micronutrients|mesh-ancestor
92795403|NCT02537392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795404|NCT02537392|Hematinics|hematinics|mesh-ancestor
92795405|NCT02673814|Durvalumab|durvalumab|mesh-list
92795406|NCT02673814|Bavituximab|bavituximab|mesh-list
92795407|NCT02673814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795408|NCT02673814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795409|NCT00644176|Azithromycin|azithromycin|mesh-list
92795410|NCT00644176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92795411|NCT00644176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795412|NCT04178200|Lidocaine|lidocaine|mesh-list
92795413|NCT04178200|Bupivacaine|bupivacaine|mesh-list
92795414|NCT04178200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92795415|NCT04178200|Anesthetics, Local|anesthetics, local|mesh-ancestor
92795416|NCT04178200|Anesthetics|anesthetics|mesh-ancestor
92795417|NCT04178200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795418|NCT04178200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795419|NCT04178200|Sensory System Agents|sensory system agents|mesh-ancestor
92795420|NCT04178200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795421|NCT04178200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92795422|NCT04178200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92795423|NCT04178200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92795424|NCT04178200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92795425|NCT04178200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795426|NCT02537158|Sorafenib|sorafenib|mesh-list
92795427|NCT02537158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795428|NCT02537158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92795429|NCT02537158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795430|NCT02537158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795431|NCT02676154|Fesoterodine|fesoterodine|mesh-list
92795432|NCT02676154|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92795433|NCT02676154|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92795434|NCT02676154|Cholinergic Agents|cholinergic agents|mesh-ancestor
92795435|NCT02676154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795436|NCT02676154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795437|NCT02676154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795438|NCT02676154|Urological Agents|urological agents|mesh-ancestor
92795439|NCT02676310|Bimatoprost|bimatoprost|mesh-list
92795440|NCT02676310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92795441|NCT04177186|Botulinum Toxins|botulinum toxins|mesh-list
92795442|NCT04177186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92795443|NCT04177186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92795444|NCT04177186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795445|NCT04177186|Cholinergic Agents|cholinergic agents|mesh-ancestor
92795446|NCT04177186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795447|NCT04177186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795448|NCT04180384|Paclitaxel|paclitaxel|mesh-list
92795449|NCT04180384|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92795450|NCT04180384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92795451|NCT04180384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795452|NCT04180384|Tubulin Modulators|tubulin modulators|mesh-ancestor
92795453|NCT04180384|Antimitotic Agents|antimitotic agents|mesh-ancestor
92795454|NCT04180384|Mitosis Modulators|mitosis modulators|mesh-ancestor
92795455|NCT04180384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795456|NCT00643240|Antibodies|antibodies|mesh-list
92795457|NCT00643240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92795458|NCT00643240|Immunologic Factors|immunologic factors|mesh-ancestor
92795459|NCT00643240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795460|NCT02671708|Cyclophosphamide|cyclophosphamide|mesh-list
92795461|NCT02671708|Busulfan|busulfan|mesh-list
92795462|NCT02671708|Idarubicin|idarubicin|mesh-list
92795463|NCT02671708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795464|NCT02671708|Immunologic Factors|immunologic factors|mesh-ancestor
92795465|NCT02671708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795466|NCT02671708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795467|NCT02671708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92795468|NCT02671708|Alkylating Agents|alkylating agents|mesh-ancestor
92795469|NCT02671708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795470|NCT02671708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795471|NCT02671708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92795472|NCT02671708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92795473|NCT02671708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92795474|NCT02671708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92795475|NCT02671708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795476|NCT05280340|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92795477|NCT05280340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795478|NCT04176328|Teicoplanin|teicoplanin|mesh-list
92795479|NCT04176328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92795480|NCT04176328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795481|NCT04177342|Fentanyl|fentanyl|mesh-list
92795482|NCT04177342|Oxycodone|oxycodone|mesh-list
92795483|NCT04177342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92795484|NCT04177342|Narcotics|narcotics|mesh-ancestor
92795485|NCT04177342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795486|NCT04177342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795487|NCT04177342|Analgesics|analgesics|mesh-ancestor
92795488|NCT04177342|Sensory System Agents|sensory system agents|mesh-ancestor
92795489|NCT04177342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795490|NCT04177342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92795491|NCT04177342|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92795492|NCT04177342|Anesthetics, General|anesthetics, general|mesh-ancestor
92795493|NCT04177342|Anesthetics|anesthetics|mesh-ancestor
92795494|NCT05243524|Cyclophosphamide|cyclophosphamide|mesh-list
92795495|NCT05243524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795496|NCT05243524|Immunologic Factors|immunologic factors|mesh-ancestor
92795497|NCT05243524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795498|NCT05243524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795499|NCT05243524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92795500|NCT05243524|Alkylating Agents|alkylating agents|mesh-ancestor
92795501|NCT05243524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795502|NCT05243524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795503|NCT05243524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92795504|NCT04175158|Bevacizumab|bevacizumab|mesh-list
92795505|NCT04175158|Endothelial Growth Factors|endothelial growth factors|mesh-list
92795506|NCT04175158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795507|NCT04175158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795508|NCT04175158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92795509|NCT04175158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92795510|NCT04175158|Growth Substances|growth substances|mesh-ancestor
92795511|NCT04175158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795512|NCT04175158|Growth Inhibitors|growth inhibitors|mesh-ancestor
92795513|NCT02671318|Sirolimus|sirolimus|mesh-list
92795514|NCT02671318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92795515|NCT02671318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795516|NCT02671318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92795517|NCT02671318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795518|NCT02671318|Antifungal Agents|antifungal agents|mesh-ancestor
92795519|NCT02671318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795520|NCT02671318|Immunologic Factors|immunologic factors|mesh-ancestor
92795521|NCT02671318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795522|NCT00644722|Pyrithione zinc|pyrithione zinc|mesh-list
92795523|NCT00644722|Keratolytic Agents|keratolytic agents|mesh-ancestor
92795524|NCT00644722|Dermatologic Agents|dermatologic agents|mesh-ancestor
92795525|NCT02668588|Octreotide|octreotide|mesh-list
92795526|NCT02668588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92795527|NCT02668588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795528|NCT02668588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795529|NCT02671084|Sevoflurane|sevoflurane|mesh-list
92133453|NCT01484951|Timolol|timolol|mesh-list
92795530|NCT02671084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92795531|NCT02671084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92795532|NCT02671084|Anesthetics, General|anesthetics, general|mesh-ancestor
92795533|NCT02671084|Anesthetics|anesthetics|mesh-ancestor
92795534|NCT02671084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795535|NCT02671084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795536|NCT00644800|Ziprasidone|ziprasidone|mesh-list
92795537|NCT00644800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92795538|NCT00644800|Serotonin Agents|serotonin agents|mesh-ancestor
92795539|NCT00644800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795540|NCT00644800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795541|NCT00644800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795542|NCT00644800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92795543|NCT00644800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92795544|NCT00644800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795545|NCT00644800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92795546|NCT00644800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92795547|NCT00644800|Dopamine Agents|dopamine agents|mesh-ancestor
92795548|NCT02670616|Prednisolone|prednisolone|mesh-list
92795549|NCT02670616|Cyclophosphamide|cyclophosphamide|mesh-list
92795550|NCT02670616|Rituximab|rituximab|mesh-list
92795551|NCT02670616|Doxorubicin|doxorubicin|mesh-list
92795552|NCT02670616|Vincristine|vincristine|mesh-list
92795553|NCT02670616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795554|NCT02670616|Immunologic Factors|immunologic factors|mesh-ancestor
92795555|NCT02670616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795556|NCT02670616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795557|NCT02670616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92795558|NCT02670616|Alkylating Agents|alkylating agents|mesh-ancestor
92795559|NCT02670616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795560|NCT02670616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795561|NCT02670616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92795562|NCT02670616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795563|NCT02670616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92795564|NCT02670616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92795565|NCT02670616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92795566|NCT02670616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795567|NCT02670616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92795568|NCT02670616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92795569|NCT02670616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92795570|NCT02670616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92795571|NCT02670616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795572|NCT02670616|Glucocorticoids|glucocorticoids|mesh-ancestor
92795573|NCT02670616|Hormones|hormones|mesh-ancestor
92795574|NCT02670616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795575|NCT02670616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795577|NCT00645502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92795578|NCT00645502|Serotonin Agents|serotonin agents|mesh-ancestor
92795579|NCT00645502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795580|NCT00645502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795581|NCT00645502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795582|NCT00645502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92795583|NCT00645502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92795584|NCT00645502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795585|NCT00645502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92795586|NCT00645502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92795587|NCT00645502|Dopamine Agents|dopamine agents|mesh-ancestor
92795588|NCT00644956|Sildenafil Citrate|sildenafil citrate|mesh-list
92795589|NCT00644956|Tadalafil|tadalafil|mesh-list
92795590|NCT00644956|Vasodilator Agents|vasodilator agents|mesh-ancestor
92795591|NCT00644956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92795592|NCT00644956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92795593|NCT00644956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795594|NCT00644956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795595|NCT00644956|Urological Agents|urological agents|mesh-ancestor
92795596|NCT04175002|Progesterone|progesterone|mesh-list
92795597|NCT04175002|Progestins|progestins|mesh-ancestor
92795598|NCT04175002|Hormones|hormones|mesh-ancestor
92795599|NCT04175002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795600|NCT04175002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795601|NCT02670772|Tenofovir|tenofovir|mesh-list
92795602|NCT02670772|Stavudine|stavudine|mesh-list
92713730|NCT01215916|Pemetrexed|pemetrexed|mesh-list
92795603|NCT02670772|Antiviral Agents|antiviral agents|mesh-ancestor
92795604|NCT02670772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795605|NCT02670772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92795606|NCT02670772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92795607|NCT02670772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795608|NCT02670772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795609|NCT02670772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92795610|NCT02670772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92795611|NCT02670772|Antimetabolites|antimetabolites|mesh-ancestor
92795612|NCT02667730|Acetaminophen|acetaminophen|mesh-list
92795613|NCT02667730|Celecoxib|celecoxib|mesh-list
92795614|NCT02667730|Naproxen|naproxen|mesh-list
92795615|NCT02667730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92795616|NCT02667730|Analgesics|analgesics|mesh-ancestor
92795617|NCT02667730|Sensory System Agents|sensory system agents|mesh-ancestor
92795618|NCT02667730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795619|NCT02667730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795620|NCT02667730|Antipyretics|antipyretics|mesh-ancestor
92795621|NCT02667730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92795622|NCT02667730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795623|NCT02667730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795624|NCT02667730|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92795625|NCT02667730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92795626|NCT02667730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795627|NCT02667730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795628|NCT02667730|Gout Suppressants|gout suppressants|mesh-ancestor
92795629|NCT04294992|Ondansetron|ondansetron|mesh-list
92795630|NCT04294992|Antiemetics|antiemetics|mesh-ancestor
92795631|NCT04294992|Autonomic Agents|autonomic agents|mesh-ancestor
92795632|NCT04294992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795633|NCT04294992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795634|NCT04294992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92795635|NCT04294992|Antipruritics|antipruritics|mesh-ancestor
92795636|NCT04294992|Dermatologic Agents|dermatologic agents|mesh-ancestor
92795637|NCT04294992|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92795638|NCT04294992|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92795639|NCT04294992|Serotonin Agents|serotonin agents|mesh-ancestor
92795640|NCT04294992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795641|NCT04294992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795642|NCT00628914|Dexetimide|dexetimide|mesh-list
92795643|NCT00628914|Eszopiclone|eszopiclone|mesh-list
92795644|NCT00628914|Citalopram|citalopram|mesh-list
92795645|NCT00628914|Escitalopram|escitalopram|mesh-list
92795646|NCT00628914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92795647|NCT00628914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92795648|NCT00628914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92795649|NCT00628914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795650|NCT00628914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795651|NCT00628914|Serotonin Agents|serotonin agents|mesh-ancestor
92795652|NCT00628914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795653|NCT00628914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92795654|NCT00628914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92795655|NCT00628914|Parasympatholytics|parasympatholytics|mesh-ancestor
92795656|NCT00628914|Autonomic Agents|autonomic agents|mesh-ancestor
92795657|NCT00628914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795658|NCT00628914|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92795659|NCT00628914|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92795660|NCT00628914|Cholinergic Agents|cholinergic agents|mesh-ancestor
92795661|NCT00628914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92795662|NCT00628914|Antidepressive Agents|antidepressive agents|mesh-ancestor
92795663|NCT00628914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92795664|NCT00628914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92795665|NCT00628914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795666|NCT02870634|Copper|copper|mesh-list
92795667|NCT02870634|Trace Elements|trace elements|mesh-ancestor
92795668|NCT02870634|Micronutrients|micronutrients|mesh-ancestor
92795669|NCT02870634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795670|NCT00645580|Fluvoxamine|fluvoxamine|mesh-list
92795671|NCT00645580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92795672|NCT00645580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92795673|NCT00645580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795674|NCT00645580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795675|NCT00645580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92795676|NCT00645580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92713803|NCT03813875|Narcotics|narcotics|mesh-ancestor
92795677|NCT00645580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92795678|NCT00645580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92795679|NCT00645580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795680|NCT00645580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795681|NCT00645580|Serotonin Agents|serotonin agents|mesh-ancestor
92795682|NCT00645580|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92795683|NCT00645580|Antidepressive Agents|antidepressive agents|mesh-ancestor
92795684|NCT00645580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92795685|NCT00645580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92795686|NCT00645580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795687|NCT00645580|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92795688|NCT02670304|Aspirin|aspirin|mesh-list
92795689|NCT02670304|Letrozole|letrozole|mesh-list
92795690|NCT02670304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92795691|NCT02670304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92795692|NCT02670304|Analgesics|analgesics|mesh-ancestor
92795693|NCT02670304|Sensory System Agents|sensory system agents|mesh-ancestor
92795694|NCT02670304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795695|NCT02670304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795696|NCT02670304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795697|NCT02670304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795698|NCT02670304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92795699|NCT02670304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92795700|NCT02670304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795701|NCT02670304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92795702|NCT02670304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92795703|NCT02670304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795704|NCT02670304|Antipyretics|antipyretics|mesh-ancestor
92795705|NCT02670304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795706|NCT02670304|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92795707|NCT02670304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92795708|NCT02670304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92795709|NCT02670304|Hormone Antagonists|hormone antagonists|mesh-ancestor
92795710|NCT02670304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795712|NCT00998946|Folic Acid|folic acid|mesh-list
92795713|NCT00998946|Vitamin B 12|vitamin b 12|mesh-list
92795714|NCT00998946|Vitamin B Complex|vitamin b complex|mesh-list
92795715|NCT00998946|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92795716|NCT00998946|Micronutrients|micronutrients|mesh-ancestor
92795717|NCT00998946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795718|NCT00998946|Hematinics|hematinics|mesh-ancestor
92795719|NCT00998946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795720|NCT00998946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92795721|NCT00998946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795722|NCT00998946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795723|NCT01158404|LY900009|ly900009|mesh-list
92795724|NCT01158404|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92795725|NCT01158404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795726|NCT01158404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795727|NCT02670070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92795728|NCT02670070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92795729|NCT02670070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92795730|NCT02670070|Antimetabolites|antimetabolites|mesh-ancestor
92795731|NCT02670070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795732|NCT02670070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92795733|NCT02670070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92795734|NCT02670070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795735|NCT00645034|Sildenafil Citrate|sildenafil citrate|mesh-list
92795736|NCT00645034|Vasodilator Agents|vasodilator agents|mesh-ancestor
92795737|NCT00645034|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92795738|NCT00645034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92795739|NCT00645034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795740|NCT00645034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795741|NCT00645034|Urological Agents|urological agents|mesh-ancestor
92795742|NCT04173832|Amantadine|amantadine|mesh-list
92795743|NCT04173832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92795744|NCT04173832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92795745|NCT04173832|Antiviral Agents|antiviral agents|mesh-ancestor
92795746|NCT04173832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795747|NCT04173832|Dopamine Agents|dopamine agents|mesh-ancestor
92795748|NCT04173832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795749|NCT04173832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795750|NCT04173832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795751|NCT04173832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92795752|NCT04173832|Analgesics|analgesics|mesh-ancestor
92795753|NCT04173832|Sensory System Agents|sensory system agents|mesh-ancestor
92795754|NCT04173832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795755|NCT00645658|Testosterone|testosterone|mesh-list
92795756|NCT00645658|Androgens|androgens|mesh-ancestor
92795757|NCT00645658|Hormones|hormones|mesh-ancestor
92795758|NCT00645658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795759|NCT00645658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795760|NCT02666170|Thioctic Acid|thioctic acid|mesh-list
92795761|NCT02666170|Antioxidants|antioxidants|mesh-ancestor
92795762|NCT02666170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795763|NCT02666170|Protective Agents|protective agents|mesh-ancestor
92795764|NCT02666170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795765|NCT02666170|Vitamin B Complex|vitamin b complex|mesh-ancestor
92795766|NCT02666170|Vitamins|vitamins|mesh-ancestor
92795767|NCT02666170|Micronutrients|micronutrients|mesh-ancestor
92795768|NCT02667262|Analgesics, Opioid|analgesics, opioid|mesh-list
92795769|NCT02667262|Narcotics|narcotics|mesh-ancestor
92795770|NCT02667262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795771|NCT02667262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795772|NCT02667262|Analgesics|analgesics|mesh-ancestor
92795773|NCT02667262|Sensory System Agents|sensory system agents|mesh-ancestor
92795774|NCT02667262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795775|NCT00646126|Artesunate|artesunate|mesh-list
92795776|NCT00646126|Pyrimethamine|pyrimethamine|mesh-list
92795777|NCT00646126|Sulfadoxine|sulfadoxine|mesh-list
92795778|NCT00646126|Antimalarials|antimalarials|mesh-ancestor
92795779|NCT00646126|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92742115|NCT01073566|Insulin|insulin|mesh-list
92795780|NCT00646126|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92795781|NCT00646126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795782|NCT00646126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795783|NCT00646126|Antiviral Agents|antiviral agents|mesh-ancestor
92795784|NCT00646126|Schistosomicides|schistosomicides|mesh-ancestor
92795785|NCT00646126|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92795786|NCT00646126|Anthelmintics|anthelmintics|mesh-ancestor
92795787|NCT00646126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92795788|NCT00646126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795789|NCT00646126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795790|NCT00646126|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92795791|NCT02537080|Nimodipine|nimodipine|mesh-list
92795792|NCT02537080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92795793|NCT02537080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92795794|NCT02537080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92795795|NCT02537080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795796|NCT02537080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92795797|NCT02537080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795798|NCT02537080|Vasodilator Agents|vasodilator agents|mesh-ancestor
92795799|NCT02667496|Sargramostim|sargramostim|mesh-list
92795800|NCT02667496|Immunologic Factors|immunologic factors|mesh-ancestor
92795801|NCT02667496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795802|NCT00645112|Azithromycin|azithromycin|mesh-list
92795803|NCT00645112|Cefdinir|cefdinir|mesh-list
92795804|NCT00645112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92795805|NCT00645112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795806|NCT02666092|Antibodies|antibodies|mesh-list
92795807|NCT02666092|Immunologic Factors|immunologic factors|mesh-ancestor
92795808|NCT02666092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795809|NCT00645814|Adalimumab|adalimumab|mesh-list
92795810|NCT00645814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92795811|NCT00645814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795812|NCT00645814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795813|NCT04174378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92795814|NCT04174378|Luteolytic Agents|luteolytic agents|mesh-ancestor
92795815|NCT04174378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92795816|NCT04174378|Contraceptive Agents|contraceptive agents|mesh-ancestor
92795817|NCT04174378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92795818|NCT04174378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795819|NCT04174378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92795820|NCT04174378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795821|NCT04174378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795822|NCT00645892|Adalimumab|adalimumab|mesh-list
92795823|NCT00645892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92795824|NCT00645892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795825|NCT00645892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795826|NCT00645190|Galantamine|galantamine|mesh-list
92795827|NCT00645190|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92795828|NCT00645190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795829|NCT00645190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795830|NCT00645190|Cholinergic Agents|cholinergic agents|mesh-ancestor
92795831|NCT00645190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795832|NCT00645190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795833|NCT00645190|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92795834|NCT00645190|Autonomic Agents|autonomic agents|mesh-ancestor
92795835|NCT00645190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795836|NCT00645190|Nootropic Agents|nootropic agents|mesh-ancestor
92795837|NCT00910390|Ethylene|ethylene|mesh-list
92795838|NCT00910390|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92795839|NCT00910390|Growth Substances|growth substances|mesh-ancestor
92795840|NCT00910390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795841|NCT02665936|Dexamethasone|dexamethasone|mesh-list
92795842|NCT02665936|Dexamethasone acetate|dexamethasone acetate|mesh-list
92795843|NCT02665936|Levobupivacaine|levobupivacaine|mesh-list
92795844|NCT02665936|BB 1101|bb 1101|mesh-list
92795845|NCT02665936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795846|NCT02665936|Antiemetics|antiemetics|mesh-ancestor
92795847|NCT02665936|Autonomic Agents|autonomic agents|mesh-ancestor
92795848|NCT02665936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795849|NCT02665936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795850|NCT02665936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92795851|NCT02665936|Glucocorticoids|glucocorticoids|mesh-ancestor
92795852|NCT02665936|Hormones|hormones|mesh-ancestor
92795853|NCT02665936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795854|NCT02665936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795855|NCT02665936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795856|NCT02665936|Protease Inhibitors|protease inhibitors|mesh-ancestor
92795857|NCT02665936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795858|NCT02665936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795859|NCT02665936|Anesthetics, Local|anesthetics, local|mesh-ancestor
92795860|NCT02665936|Anesthetics|anesthetics|mesh-ancestor
92795861|NCT02665936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795862|NCT02665936|Sensory System Agents|sensory system agents|mesh-ancestor
92795863|NCT02665780|Cetylpyridinium|cetylpyridinium|mesh-list
92795864|NCT02665780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92795865|NCT02665780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795867|NCT04292886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795868|NCT04292886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92795869|NCT04292886|Hormone Antagonists|hormone antagonists|mesh-ancestor
92795870|NCT04292886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795871|NCT04292886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92795872|NCT04292886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795873|NCT04292886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92795874|NCT04292886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92795875|NCT04292886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92795876|NCT04292418|Mycophenolic Acid|mycophenolic acid|mesh-list
92795877|NCT04292418|Tacrolimus|tacrolimus|mesh-list
92795878|NCT04292418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795879|NCT04292418|Immunologic Factors|immunologic factors|mesh-ancestor
92795880|NCT04292418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795881|NCT04292418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92795882|NCT04292418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795883|NCT04292418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795884|NCT04292418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92795885|NCT04292418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795886|NCT04292418|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92795887|NCT04292418|Antitubercular Agents|antitubercular agents|mesh-ancestor
92795888|NCT04292418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92714028|NCT04679064|Paclitaxel|paclitaxel|mesh-list
92795889|NCT04292418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795890|NCT02666716|Fluconazole|fluconazole|mesh-list
92795891|NCT02666716|Antifungal Agents|antifungal agents|mesh-ancestor
92795892|NCT02666716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92795893|NCT02666716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92795894|NCT02666716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92795895|NCT02666716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795896|NCT02666716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795897|NCT02666716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92795898|NCT02666716|Hormone Antagonists|hormone antagonists|mesh-ancestor
92795899|NCT02666716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795900|NCT02666716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795901|NCT02666716|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92795902|NCT02666716|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92795903|NCT04064476|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92795904|NCT04064476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92795905|NCT04064476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92795906|NCT04064476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795907|NCT04064476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795908|NCT04064476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92795909|NCT04064476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92795910|NCT04064476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92795911|NCT04064476|Serotonin Agents|serotonin agents|mesh-ancestor
92795912|NCT04064476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795913|NCT04064476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795914|NCT04064476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92795915|NCT04064476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92795916|NCT04064476|Dopamine Agents|dopamine agents|mesh-ancestor
92795917|NCT02669368|Magnesium Sulfate|magnesium sulfate|mesh-list
92795918|NCT02669368|Rocuronium|rocuronium|mesh-list
92795919|NCT02669368|Analgesics|analgesics|mesh-ancestor
92795920|NCT02669368|Sensory System Agents|sensory system agents|mesh-ancestor
92795921|NCT02669368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795922|NCT02669368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795923|NCT02669368|Anesthetics|anesthetics|mesh-ancestor
92795924|NCT02669368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92795925|NCT02669368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92795926|NCT02669368|Anticonvulsants|anticonvulsants|mesh-ancestor
92795927|NCT02669368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92795928|NCT02669368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026443|NCT00493038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795929|NCT02669368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795930|NCT02669368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92795931|NCT02669368|Tocolytic Agents|tocolytic agents|mesh-ancestor
92795932|NCT02669368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92795933|NCT02669368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92795934|NCT02669368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92795935|NCT02669368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92795936|NCT00645268|Sildenafil Citrate|sildenafil citrate|mesh-list
92795937|NCT00645268|Vasodilator Agents|vasodilator agents|mesh-ancestor
92795938|NCT00645268|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92795939|NCT00645268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92795940|NCT00645268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795941|NCT00645268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795942|NCT00645268|Urological Agents|urological agents|mesh-ancestor
92795943|NCT02666014|Neostigmine|neostigmine|mesh-list
92795944|NCT02666014|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92795945|NCT02666014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92795946|NCT02666014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795948|NCT02666014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795949|NCT02666014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795950|NCT02666014|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92795951|NCT02666014|Autonomic Agents|autonomic agents|mesh-ancestor
92795952|NCT02666014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795953|NCT02665702|Cisplatin|cisplatin|mesh-list
92795954|NCT02665702|Vinorelbine|vinorelbine|mesh-list
92795955|NCT02665702|Endostar protein|endostar protein|mesh-list
92795956|NCT02665702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795957|NCT02665702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92795958|NCT02665702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92795959|NCT02665702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92795960|NCT02665702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92795961|NCT02665702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795962|NCT02665702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92795963|NCT02665702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92795964|NCT02665702|Growth Substances|growth substances|mesh-ancestor
92795965|NCT02665702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795966|NCT02665702|Growth Inhibitors|growth inhibitors|mesh-ancestor
92795967|NCT00646750|Rituximab|rituximab|mesh-list
92795968|NCT00646750|Melphalan|melphalan|mesh-list
92795969|NCT00646750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92795970|NCT00646750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92795971|NCT00646750|Immunologic Factors|immunologic factors|mesh-ancestor
92795972|NCT00646750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795973|NCT00646750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92795974|NCT00646750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92795975|NCT00646750|Alkylating Agents|alkylating agents|mesh-ancestor
92795976|NCT00646750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795977|NCT00646750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92795978|NCT00646750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92795979|NCT00646516|Budesonide|budesonide|mesh-list
92795980|NCT00646516|Formoterol Fumarate|formoterol fumarate|mesh-list
92795981|NCT00646516|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92795982|NCT00646516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92795983|NCT00646516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92795984|NCT00646516|Autonomic Agents|autonomic agents|mesh-ancestor
92795985|NCT00646516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92795986|NCT00646516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92795987|NCT00646516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92795988|NCT00646516|Respiratory System Agents|respiratory system agents|mesh-ancestor
92795989|NCT00646516|Glucocorticoids|glucocorticoids|mesh-ancestor
92795990|NCT00646516|Hormones|hormones|mesh-ancestor
92795991|NCT00646516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92795992|NCT00646516|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92795993|NCT00646516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92795994|NCT00646516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92795995|NCT00646516|Adrenergic Agents|adrenergic agents|mesh-ancestor
92795996|NCT00646516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92795997|NCT00646516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92795998|NCT02665624|Calcium, Dietary|calcium, dietary|mesh-list
92795999|NCT02665624|Sennosides|sennosides|mesh-list
92796000|NCT02665624|Senna Extract|senna extract|mesh-list
92796001|NCT02665624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92796002|NCT02665624|Calcium|calcium|mesh-list
92796003|NCT02665624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92796004|NCT02665624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796005|NCT02665624|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92796006|NCT02665624|Laxatives|laxatives|mesh-ancestor
92796007|NCT02665624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796008|NCT02665624|Cathartics|cathartics|mesh-ancestor
92796009|NCT00646594|Fluticasone|fluticasone|mesh-list
92796010|NCT00646594|Budesonide|budesonide|mesh-list
92796011|NCT00646594|Formoterol Fumarate|formoterol fumarate|mesh-list
92796012|NCT00646594|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92796013|NCT00646594|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92796014|NCT00646594|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92796015|NCT00646594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796016|NCT00646594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92796017|NCT00646594|Autonomic Agents|autonomic agents|mesh-ancestor
92796018|NCT00646594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441042|NCT01628471|Hormones|hormones|mesh-ancestor
92796019|NCT00646594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796020|NCT00646594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92796021|NCT00646594|Respiratory System Agents|respiratory system agents|mesh-ancestor
92796023|NCT00646594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92796024|NCT00646594|Glucocorticoids|glucocorticoids|mesh-ancestor
92796025|NCT00646594|Hormones|hormones|mesh-ancestor
92796026|NCT00646594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796027|NCT00646594|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92796028|NCT00646594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92796029|NCT00646594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92796030|NCT00646594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796031|NCT00646594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796032|NCT00646594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796033|NCT00646594|Sympathomimetics|sympathomimetics|mesh-ancestor
92796034|NCT00646984|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92796035|NCT00646984|Antiviral Agents|antiviral agents|mesh-ancestor
92796036|NCT00646984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796037|NCT04773184|Capsaicin|capsaicin|mesh-list
92796038|NCT04773184|Antipruritics|antipruritics|mesh-ancestor
92796039|NCT04773184|Dermatologic Agents|dermatologic agents|mesh-ancestor
92796040|NCT04773184|Sensory System Agents|sensory system agents|mesh-ancestor
92796041|NCT04773184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796042|NCT04773184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796043|NCT00647140|Levodopa|levodopa|mesh-list
92796044|NCT00647140|Dopamine Agents|dopamine agents|mesh-ancestor
92796045|NCT00647140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796046|NCT00647140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796047|NCT00647140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796048|NCT00647140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92796049|NCT00647140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92796050|NCT00647218|Paclitaxel|paclitaxel|mesh-list
92796051|NCT00647218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92796052|NCT00647218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796053|NCT00647218|Tubulin Modulators|tubulin modulators|mesh-ancestor
92796054|NCT00647218|Antimitotic Agents|antimitotic agents|mesh-ancestor
92796055|NCT00647218|Mitosis Modulators|mitosis modulators|mesh-ancestor
92796056|NCT00647218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796057|NCT00994890|Tanezumab|tanezumab|mesh-list
92796058|NCT00994890|Analgesics|analgesics|mesh-ancestor
92796059|NCT00994890|Sensory System Agents|sensory system agents|mesh-ancestor
92796060|NCT00994890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796061|NCT00994890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796062|NCT02663830|Sildenafil Citrate|sildenafil citrate|mesh-list
92796063|NCT02663830|Clomiphene|clomiphene|mesh-list
92796064|NCT02663830|Enclomiphene|enclomiphene|mesh-list
92796065|NCT02663830|Zuclomiphene|zuclomiphene|mesh-list
92796066|NCT02663830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796067|NCT02663830|Vasodilator Agents|vasodilator agents|mesh-ancestor
92796068|NCT02663830|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92796069|NCT02663830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92796070|NCT02663830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796071|NCT02663830|Urological Agents|urological agents|mesh-ancestor
92796072|NCT02663830|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92796073|NCT02663830|Hormone Antagonists|hormone antagonists|mesh-ancestor
92796074|NCT02663830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796075|NCT02663830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796076|NCT02663830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92796077|NCT02663830|Fertility Agents|fertility agents|mesh-ancestor
92796078|NCT02663830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92796079|NCT02663830|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92796080|NCT02663830|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92796081|NCT00648544|Pravastatin|pravastatin|mesh-list
92796082|NCT00648544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92796083|NCT00648544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92796084|NCT00648544|Antimetabolites|antimetabolites|mesh-ancestor
92796085|NCT00648544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796086|NCT00648544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92796087|NCT00648544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92796088|NCT00648544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796089|NCT00648622|Carvedilol|carvedilol|mesh-list
92796090|NCT00648622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92796091|NCT00648622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92796092|NCT00648622|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796093|NCT00648622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796094|NCT00648622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796095|NCT00648622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796096|NCT00648622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796097|NCT00648622|Antioxidants|antioxidants|mesh-ancestor
92796098|NCT00648622|Protective Agents|protective agents|mesh-ancestor
92796099|NCT00648622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92796100|NCT00648622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796101|NCT00648622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92796102|NCT00648622|Vasodilator Agents|vasodilator agents|mesh-ancestor
92796103|NCT00648622|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92796104|NCT00648622|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92796105|NCT00994422|Ivermectin|ivermectin|mesh-list
92796106|NCT00994422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92796107|NCT00994422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796108|NCT00648778|Loxapine|loxapine|mesh-list
92796109|NCT00648778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92796110|NCT00648778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92796111|NCT00648778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796112|NCT00648778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796113|NCT00648778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796114|NCT00648778|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92796115|NCT00648778|Dopamine Agents|dopamine agents|mesh-ancestor
92796116|NCT00648778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796117|NCT00648778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796118|NCT00645424|Atorvastatin|atorvastatin|mesh-list
92796119|NCT00645424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92796120|NCT00645424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92796121|NCT00645424|Antimetabolites|antimetabolites|mesh-ancestor
92796122|NCT00645424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796123|NCT00645424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92714268|NCT04661709|Sympatholytics|sympatholytics|mesh-ancestor
92796124|NCT00645424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92796125|NCT00645424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796126|NCT04172740|Calcium|calcium|mesh-list
92796127|NCT04172740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92796128|NCT04172740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796129|NCT02663596|Vancomycin|vancomycin|mesh-list
92796130|NCT02663596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92796131|NCT02663596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796132|NCT00647530|Fluorouracil|fluorouracil|mesh-list
92796133|NCT00647530|Capecitabine|capecitabine|mesh-list
92796134|NCT00647530|Oxaliplatin|oxaliplatin|mesh-list
92796135|NCT00647530|Panitumumab|panitumumab|mesh-list
92796136|NCT00647530|Antimetabolites|antimetabolites|mesh-ancestor
92796137|NCT00647530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796138|NCT00647530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92796139|NCT00647530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796140|NCT00647530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92796141|NCT00647530|Immunologic Factors|immunologic factors|mesh-ancestor
92796142|NCT00647530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796143|NCT00647530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92796144|NCT00647608|Propranolol|propranolol|mesh-list
92796145|NCT00647608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92796146|NCT00647608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92796147|NCT00647608|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796148|NCT00647608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796149|NCT00647608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796150|NCT00647608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796151|NCT00647608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92796152|NCT00647608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796153|NCT00647608|Vasodilator Agents|vasodilator agents|mesh-ancestor
92796154|NCT02663440|Temozolomide|temozolomide|mesh-list
92796155|NCT02663440|Molgramostim|molgramostim|mesh-list
92796156|NCT02663440|Sargramostim|sargramostim|mesh-list
92796157|NCT02663440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92796158|NCT02663440|Alkylating Agents|alkylating agents|mesh-ancestor
92796159|NCT02663440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796160|NCT02663440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796161|NCT02663440|Immunologic Factors|immunologic factors|mesh-ancestor
92796162|NCT02663440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796163|NCT04171180|Budesonide|budesonide|mesh-list
92796164|NCT04171180|Formoterol Fumarate|formoterol fumarate|mesh-list
92796165|NCT04171180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796166|NCT04171180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92796167|NCT04171180|Autonomic Agents|autonomic agents|mesh-ancestor
92796168|NCT04171180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796169|NCT04171180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796170|NCT04171180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92796171|NCT04171180|Respiratory System Agents|respiratory system agents|mesh-ancestor
92796172|NCT04171180|Glucocorticoids|glucocorticoids|mesh-ancestor
92796173|NCT04171180|Hormones|hormones|mesh-ancestor
92796174|NCT04171180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796175|NCT04171180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92796176|NCT04171180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92796177|NCT04171180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92796178|NCT04171180|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796179|NCT04171180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796180|NCT04171180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796181|NCT02660008|Glucagon|glucagon|mesh-list
92796182|NCT02660008|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92796183|NCT02660008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796184|NCT02660008|Hormones|hormones|mesh-ancestor
92796185|NCT02660008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796186|NCT02660008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796187|NCT02660008|Incretins|incretins|mesh-ancestor
92796188|NCT00649168|Bromocriptine|bromocriptine|mesh-list
92796189|NCT00649168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92796190|NCT00649168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92796191|NCT00649168|Hormone Antagonists|hormone antagonists|mesh-ancestor
92796192|NCT00649168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796193|NCT00649168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796194|NCT00649168|Dopamine Agonists|dopamine agonists|mesh-ancestor
92796195|NCT00649168|Dopamine Agents|dopamine agents|mesh-ancestor
92796196|NCT00649168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796197|NCT00649168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796198|NCT02663206|Botulinum Toxins|botulinum toxins|mesh-list
92796199|NCT02663206|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92796200|NCT02663206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796201|NCT02663206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796202|NCT02663206|Cholinergic Agents|cholinergic agents|mesh-ancestor
92796203|NCT02663206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796204|NCT02663206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796205|NCT02663284|Ropivacaine|ropivacaine|mesh-list
92796206|NCT02663284|Anesthetics, Local|anesthetics, local|mesh-ancestor
92796207|NCT02663284|Anesthetics|anesthetics|mesh-ancestor
92796208|NCT02663284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796209|NCT02663284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796210|NCT02663284|Sensory System Agents|sensory system agents|mesh-ancestor
92796211|NCT02663284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796212|NCT00647686|Fentanyl|fentanyl|mesh-list
92796213|NCT00647686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92796214|NCT00647686|Narcotics|narcotics|mesh-ancestor
92796215|NCT00647686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796216|NCT00647686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796217|NCT00647686|Analgesics|analgesics|mesh-ancestor
92796218|NCT00647686|Sensory System Agents|sensory system agents|mesh-ancestor
92796219|NCT00647686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796220|NCT00647686|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92796221|NCT00647686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92796222|NCT00647686|Anesthetics, General|anesthetics, general|mesh-ancestor
92796223|NCT00647686|Anesthetics|anesthetics|mesh-ancestor
92796224|NCT02663050|Diclofenac|diclofenac|mesh-list
92796225|NCT02663050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92796226|NCT02663050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796227|NCT02663050|Analgesics|analgesics|mesh-ancestor
92796228|NCT02663050|Sensory System Agents|sensory system agents|mesh-ancestor
92796229|NCT02663050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796230|NCT02663050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796231|NCT02663050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796232|NCT02663050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796233|NCT02663050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92796234|NCT02663050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796235|NCT02663050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796236|NCT00648856|Sertraline|sertraline|mesh-list
92796237|NCT00648856|Antidepressive Agents|antidepressive agents|mesh-ancestor
92796238|NCT00648856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796239|NCT00648856|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92796240|NCT00648856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92796241|NCT00648856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796242|NCT00648856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796243|NCT00648856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796244|NCT00648856|Serotonin Agents|serotonin agents|mesh-ancestor
92796245|NCT00648856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796246|NCT01171976|Ranibizumab|ranibizumab|mesh-list
92796247|NCT01171976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92796248|NCT01171976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92796249|NCT01171976|Growth Substances|growth substances|mesh-ancestor
92796250|NCT01171976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796251|NCT01171976|Growth Inhibitors|growth inhibitors|mesh-ancestor
92796252|NCT01171976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796253|NCT00996216|Antiviral Agents|antiviral agents|mesh-list
92796254|NCT00996216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796255|NCT00647842|Fentanyl|fentanyl|mesh-list
92796256|NCT00647842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92796257|NCT00647842|Narcotics|narcotics|mesh-ancestor
92796258|NCT00647842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796259|NCT00647842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796260|NCT00647842|Analgesics|analgesics|mesh-ancestor
92796261|NCT00647842|Sensory System Agents|sensory system agents|mesh-ancestor
92796262|NCT00647842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796263|NCT00647842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92796264|NCT00647842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92796265|NCT00647842|Anesthetics, General|anesthetics, general|mesh-ancestor
92796266|NCT00647842|Anesthetics|anesthetics|mesh-ancestor
92796267|NCT02662972|Botulinum Toxins|botulinum toxins|mesh-list
92796268|NCT02662972|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92796269|NCT02662972|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92796270|NCT02662972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92796271|NCT02662972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796272|NCT02662972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796273|NCT02662972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92796274|NCT02662972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796275|NCT02662972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796276|NCT02662972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92796277|NCT02662972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796278|NCT02662894|Valsartan|valsartan|mesh-list
92796279|NCT02662894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92796280|NCT02662894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92796281|NCT02662894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92796282|NCT02662894|Antimetabolites|antimetabolites|mesh-ancestor
92796283|NCT02662894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796284|NCT02662894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92796285|NCT02662894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92796286|NCT02662894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796287|NCT02662894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796288|NCT02662894|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92796289|NCT02662894|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92796290|NCT04291794|Propofol|propofol|mesh-list
92796291|NCT04291794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92796292|NCT04291794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796293|NCT04291794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796294|NCT04291794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92796295|NCT04291794|Anesthetics, General|anesthetics, general|mesh-ancestor
92796296|NCT04291794|Anesthetics|anesthetics|mesh-ancestor
92796297|NCT02662660|Acetaminophen|acetaminophen|mesh-list
92796298|NCT02662660|Dipyrone|dipyrone|mesh-list
92796299|NCT02662660|Bupivacaine|bupivacaine|mesh-list
92796300|NCT02662660|Levobupivacaine|levobupivacaine|mesh-list
92796301|NCT02662660|Anesthetics, Local|anesthetics, local|mesh-ancestor
92796302|NCT02662660|Anesthetics|anesthetics|mesh-ancestor
92796303|NCT02662660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796304|NCT02662660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796305|NCT02662660|Sensory System Agents|sensory system agents|mesh-ancestor
92796306|NCT02662660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796307|NCT02662660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796308|NCT02662660|Analgesics|analgesics|mesh-ancestor
92796309|NCT02662660|Antipyretics|antipyretics|mesh-ancestor
92796310|NCT02662660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92796311|NCT02662660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796312|NCT02662660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796313|NCT02868606|Insulin|insulin|mesh-list
92441334|NCT01630564|Analgesics|analgesics|mesh-ancestor
92796314|NCT02868606|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92796315|NCT02868606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796316|NCT02868606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796317|NCT00647920|Adalimumab|adalimumab|mesh-list
92796318|NCT00647920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92796319|NCT00647920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796320|NCT00647920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796321|NCT00830869|Ixazomib|ixazomib|mesh-list
92796322|NCT00830869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796323|NCT00830869|Protease Inhibitors|protease inhibitors|mesh-ancestor
92796324|NCT00830869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796325|NCT00830869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796326|NCT02662504|Cisplatin|cisplatin|mesh-list
92796327|NCT02662504|Pemetrexed|pemetrexed|mesh-list
92796328|NCT02662504|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92796329|NCT02662504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796330|NCT02662504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796331|NCT02662504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796332|NCT02662504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92796333|NCT02662504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92796334|NCT02662504|Dermatologic Agents|dermatologic agents|mesh-ancestor
92796335|NCT02662504|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92796336|NCT00648934|Topiramate|topiramate|mesh-list
92796337|NCT00648934|Anticonvulsants|anticonvulsants|mesh-ancestor
92796338|NCT00648934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796339|NCT00648934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796340|NCT02659228|Anesthetics|anesthetics|mesh-list
92796341|NCT02659228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92796342|NCT02659228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796343|NCT02659228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796344|NCT02659228|Anesthetics, General|anesthetics, general|mesh-ancestor
92796345|NCT00844519|Maraviroc|maraviroc|mesh-list
92796346|NCT00844519|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92796347|NCT00844519|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92796348|NCT00844519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796349|NCT00844519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92796350|NCT00844519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92796351|NCT00844519|Antiviral Agents|antiviral agents|mesh-ancestor
92796352|NCT00844519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796353|NCT00844519|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92796354|NCT00702793|Varenicline|varenicline|mesh-list
92796355|NCT00702793|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92796356|NCT00702793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92796357|NCT00702793|Cholinergic Agents|cholinergic agents|mesh-ancestor
92796358|NCT00702793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796359|NCT00702793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796360|NCT00702793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796361|NCT02662426|Oseltamivir|oseltamivir|mesh-list
92796362|NCT02662426|Antiviral Agents|antiviral agents|mesh-ancestor
92796363|NCT02662426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796364|NCT02662426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796365|NCT02662426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796366|NCT00994110|Pasireotide|pasireotide|mesh-list
92796367|NCT00994110|Hormones|hormones|mesh-ancestor
92796368|NCT00994110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796369|NCT00994110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796370|NCT02662348|Aldesleukin|aldesleukin|mesh-list
92796371|NCT02662348|Interleukin-2|interleukin-2|mesh-list
92796372|NCT02662348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796373|NCT02662348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796374|NCT02662348|Analgesics|analgesics|mesh-ancestor
92796375|NCT02662348|Sensory System Agents|sensory system agents|mesh-ancestor
92796376|NCT02662348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796377|NCT02662348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796378|NCT02662348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92796379|NCT02662348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92796380|NCT02662348|Antiviral Agents|antiviral agents|mesh-ancestor
92796381|NCT02662348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796382|NCT02868372|Povidone-Iodine|povidone-iodine|mesh-list
92796383|NCT02868372|Povidone|povidone|mesh-list
92796384|NCT02868372|Plasma Substitutes|plasma substitutes|mesh-ancestor
92796385|NCT02868372|Blood Substitutes|blood substitutes|mesh-ancestor
92796386|NCT02868372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92796387|NCT02868372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796388|NCT00629148|Capecitabine|capecitabine|mesh-list
92796389|NCT00629148|Vinorelbine|vinorelbine|mesh-list
92796390|NCT00629148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92796391|NCT00629148|Antimetabolites|antimetabolites|mesh-ancestor
92441407|NCT01631058|Immunologic Factors|immunologic factors|mesh-ancestor
92796392|NCT00629148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796393|NCT00629148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796394|NCT00629148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92796395|NCT00629148|Tubulin Modulators|tubulin modulators|mesh-ancestor
92796396|NCT00629148|Antimitotic Agents|antimitotic agents|mesh-ancestor
92796397|NCT00629148|Mitosis Modulators|mitosis modulators|mesh-ancestor
92796398|NCT01157234|Metoprolol|metoprolol|mesh-list
92796399|NCT01157234|Nebivolol|nebivolol|mesh-list
92796400|NCT01157234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92796401|NCT01157234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796402|NCT01157234|Sympatholytics|sympatholytics|mesh-ancestor
92796403|NCT01157234|Autonomic Agents|autonomic agents|mesh-ancestor
92796404|NCT01157234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796405|NCT01157234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796406|NCT01157234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92796407|NCT01157234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92796408|NCT01157234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92796409|NCT01157234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796410|NCT01157234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796411|NCT01157234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796412|NCT01157234|Vasodilator Agents|vasodilator agents|mesh-ancestor
92796413|NCT01157234|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92796414|NCT01157234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92796415|NCT01157234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92796416|NCT04170790|Saxagliptin|saxagliptin|mesh-list
92796417|NCT04170790|Sildenafil Citrate|sildenafil citrate|mesh-list
92796418|NCT04170790|Vasodilator Agents|vasodilator agents|mesh-ancestor
92796419|NCT04170790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92796420|NCT04170790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92796421|NCT04170790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796422|NCT04170790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796423|NCT04170790|Urological Agents|urological agents|mesh-ancestor
92796424|NCT04170790|Incretins|incretins|mesh-ancestor
92796425|NCT04170790|Hormones|hormones|mesh-ancestor
92796426|NCT04170790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796427|NCT04170790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796428|NCT04170790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92796429|NCT04170790|Protease Inhibitors|protease inhibitors|mesh-ancestor
92796430|NCT04170790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796431|NCT00995670|Sevoflurane|sevoflurane|mesh-list
92796432|NCT00995670|Simvastatin|simvastatin|mesh-list
92796433|NCT00995670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796434|NCT00995670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92796435|NCT00995670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92796436|NCT00995670|Antimetabolites|antimetabolites|mesh-ancestor
92796437|NCT00995670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796438|NCT00995670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92796439|NCT00995670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92796440|NCT00995670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796441|NCT00995670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92796442|NCT00995670|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92796443|NCT00995670|Anesthetics, General|anesthetics, general|mesh-ancestor
92796444|NCT00995670|Anesthetics|anesthetics|mesh-ancestor
92796445|NCT00995670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796446|NCT02658838|Heparin|heparin|mesh-list
92796447|NCT02658838|Calcium heparin|calcium heparin|mesh-list
92796448|NCT02658838|Enoxaparin|enoxaparin|mesh-list
92796449|NCT02658838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92796450|NCT02658838|Tinzaparin|tinzaparin|mesh-list
92796451|NCT02658838|Dalteparin|dalteparin|mesh-list
92796452|NCT02658838|Enoxaparin sodium|enoxaparin sodium|mesh-list
92796453|NCT02658838|Ticagrelor|ticagrelor|mesh-list
92796454|NCT02658838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92796455|NCT02658838|Anticoagulants|anticoagulants|mesh-ancestor
92796456|NCT02658838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92796457|NCT02658838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92796458|NCT02658838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796459|NCT02658838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92796460|NCT02658838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92796461|NCT02658838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92796462|NCT02658838|Purinergic Agents|purinergic agents|mesh-ancestor
92796463|NCT02658838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796464|NCT02658838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796465|NCT00648076|Valproic Acid|valproic acid|mesh-list
92796466|NCT00648076|Anticonvulsants|anticonvulsants|mesh-ancestor
92796467|NCT00648076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796468|NCT00648076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796469|NCT00648076|GABA Agents|gaba agents|mesh-ancestor
92796470|NCT00648076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796471|NCT00648076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796472|NCT00648076|Antimanic Agents|antimanic agents|mesh-ancestor
92796473|NCT00648076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92796474|NCT00648076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796475|NCT00648076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796476|NCT00649012|Pioglitazone|pioglitazone|mesh-list
92796477|NCT00649012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796478|NCT00649012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796479|NCT04685590|Dasatinib|dasatinib|mesh-list
92796480|NCT04685590|Quercetin|quercetin|mesh-list
92796481|NCT04685590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796482|NCT04685590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92796483|NCT04685590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796484|NCT04685590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796485|NCT04685590|Antioxidants|antioxidants|mesh-ancestor
92796486|NCT04685590|Protective Agents|protective agents|mesh-ancestor
92796487|NCT04685590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714636|NCT04659915|Hormones|hormones|mesh-ancestor
92796488|NCT04170088|Tranexamic Acid|tranexamic acid|mesh-list
92796489|NCT04170088|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92796490|NCT04170088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92796491|NCT04170088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796492|NCT04170088|Hemostatics|hemostatics|mesh-ancestor
92796493|NCT04170088|Coagulants|coagulants|mesh-ancestor
92796494|NCT00648154|Letrozole|letrozole|mesh-list
92796495|NCT00648154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796496|NCT00648154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92796497|NCT00648154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92796498|NCT00648154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796499|NCT00648154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796500|NCT00648154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92796501|NCT00648154|Hormone Antagonists|hormone antagonists|mesh-ancestor
92796502|NCT00648154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796503|NCT00648154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796504|NCT02664142|Anesthetics|anesthetics|mesh-list
92796505|NCT02664142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796506|NCT02664142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796507|NCT04169854|Lidocaine|lidocaine|mesh-list
92796508|NCT04169854|Anesthetics, Local|anesthetics, local|mesh-ancestor
92796509|NCT04169854|Anesthetics|anesthetics|mesh-ancestor
92796510|NCT04169854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796511|NCT04169854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796512|NCT04169854|Sensory System Agents|sensory system agents|mesh-ancestor
92796513|NCT04169854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796514|NCT04169854|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92796515|NCT04169854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92796516|NCT04169854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92796517|NCT04169854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796518|NCT04169854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796519|NCT02661100|Pembrolizumab|pembrolizumab|mesh-list
92796520|NCT02661100|Poly ICLC|poly iclc|mesh-list
92796521|NCT02661100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92796522|NCT02661100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796523|NCT02661100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92796524|NCT02661100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796525|NCT02661100|Interferon Inducers|interferon inducers|mesh-ancestor
92796526|NCT02661100|Immunologic Factors|immunologic factors|mesh-ancestor
92796527|NCT02661100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796528|NCT00601354|Orlistat|orlistat|mesh-list
92796529|NCT00601354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796530|NCT00601354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796531|NCT00601354|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92796532|NCT00601354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92796533|NCT02660866|Vorapaxar|vorapaxar|mesh-list
92796534|NCT02660866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92796535|NCT00853099|Adalimumab|adalimumab|mesh-list
92796536|NCT00853099|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92796537|NCT00853099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796538|NCT00853099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796539|NCT00648310|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92796540|NCT00648310|Estrogens|estrogens|mesh-list
92796541|NCT00648310|Hormones|hormones|mesh-ancestor
92796542|NCT00648310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796543|NCT00648310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796544|NCT00648310|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92796545|NCT00648310|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92796547|NCT00648310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796548|NCT00648310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796549|NCT00648310|Urological Agents|urological agents|mesh-ancestor
92796550|NCT00702871|Ranitidine|ranitidine|mesh-list
92796551|NCT00702871|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92796552|NCT00702871|Sucralfate|sucralfate|mesh-list
92796553|NCT00702871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92796554|NCT00702871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796555|NCT00702871|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92796556|NCT00702871|Histamine Antagonists|histamine antagonists|mesh-ancestor
92796557|NCT00702871|Histamine Agents|histamine agents|mesh-ancestor
92796558|NCT00702871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714709|NCT00541112|Vitamins|vitamins|mesh-ancestor
92796559|NCT00702871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796560|NCT00702871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796561|NCT00830167|Pregabalin|pregabalin|mesh-list
92796562|NCT00830167|Analgesics|analgesics|mesh-ancestor
92796563|NCT00830167|Sensory System Agents|sensory system agents|mesh-ancestor
92796564|NCT00830167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796565|NCT00830167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796566|NCT00830167|Anticonvulsants|anticonvulsants|mesh-ancestor
92796567|NCT00830167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92796568|NCT00830167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796569|NCT00830167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796570|NCT00830167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92796571|NCT00830167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92796572|NCT00830167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92796573|NCT00830167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796574|NCT00830167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796575|NCT00992394|Etanercept|etanercept|mesh-list
92796576|NCT00992394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92796577|NCT00992394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796578|NCT00992394|Analgesics|analgesics|mesh-ancestor
92796579|NCT00992394|Sensory System Agents|sensory system agents|mesh-ancestor
92796580|NCT00992394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796581|NCT00992394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796582|NCT00992394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796583|NCT00992394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796584|NCT00992394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796585|NCT00992394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92796586|NCT00992394|Immunologic Factors|immunologic factors|mesh-ancestor
92796587|NCT00829933|Warfarin|warfarin|mesh-list
92796588|NCT00829933|Edoxaban|edoxaban|mesh-list
92796589|NCT00829933|Anticoagulants|anticoagulants|mesh-ancestor
92796590|NCT00829933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92796591|NCT00829933|Antithrombins|antithrombins|mesh-ancestor
92796592|NCT00829933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92796593|NCT00829933|Protease Inhibitors|protease inhibitors|mesh-ancestor
92796594|NCT00829933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796595|NCT00829933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796596|NCT01170962|Ribavirin|ribavirin|mesh-list
92796597|NCT01170962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92796598|NCT01170962|Antimetabolites|antimetabolites|mesh-ancestor
92742934|NCT04322214|Cobicistat|cobicistat|mesh-list
92796599|NCT01170962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796600|NCT01170962|Antiviral Agents|antiviral agents|mesh-ancestor
92796601|NCT01170962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796602|NCT00843193|Fluticasone|fluticasone|mesh-list
92796604|NCT00843193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796605|NCT00843193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92796606|NCT00843193|Autonomic Agents|autonomic agents|mesh-ancestor
92796607|NCT00843193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796608|NCT00843193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796609|NCT00843193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92796610|NCT00843193|Respiratory System Agents|respiratory system agents|mesh-ancestor
92796611|NCT00843193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92796612|NCT00843193|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92796613|NCT00853021|Aldesleukin|aldesleukin|mesh-list
92796614|NCT00853021|Bevacizumab|bevacizumab|mesh-list
92796615|NCT00853021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92796616|NCT00853021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796617|NCT00853021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92796618|NCT00853021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92796619|NCT00853021|Growth Substances|growth substances|mesh-ancestor
92796620|NCT00853021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796621|NCT00853021|Growth Inhibitors|growth inhibitors|mesh-ancestor
92796622|NCT00853021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92796623|NCT00853021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92796624|NCT00853021|Antiviral Agents|antiviral agents|mesh-ancestor
92796625|NCT00853021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796626|NCT00913237|Desipramine|desipramine|mesh-list
92796627|NCT00913237|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92796628|NCT00913237|Antidepressive Agents|antidepressive agents|mesh-ancestor
92796629|NCT00913237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796630|NCT00913237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796631|NCT00913237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796632|NCT00913237|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92796633|NCT00913237|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92796634|NCT00913237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796635|NCT00913237|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796636|NCT00913237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796637|NCT00913237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796638|NCT05367284|Testosterone|testosterone|mesh-list
92796639|NCT05367284|Androgens|androgens|mesh-ancestor
92796640|NCT05367284|Hormones|hormones|mesh-ancestor
92796641|NCT05367284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796642|NCT05367284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796643|NCT00843115|Donepezil|donepezil|mesh-list
92796644|NCT00843115|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92796645|NCT00843115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796646|NCT00843115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796647|NCT00843115|Cholinergic Agents|cholinergic agents|mesh-ancestor
92796648|NCT00843115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796649|NCT00843115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796650|NCT00843115|Nootropic Agents|nootropic agents|mesh-ancestor
92796651|NCT01156376|Listerine|listerine|mesh-list
92796652|NCT01156376|Fluorides|fluorides|mesh-list
92796653|NCT01156376|Cariostatic Agents|cariostatic agents|mesh-ancestor
92796654|NCT01156376|Protective Agents|protective agents|mesh-ancestor
92796655|NCT01156376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796656|NCT01156376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92796657|NCT01156376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92796658|NCT01156142|Doxepin|doxepin|mesh-list
92796659|NCT01156142|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92796660|NCT01156142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92796661|NCT01156142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796662|NCT01156142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796663|NCT01156142|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92796664|NCT01156142|Antidepressive Agents|antidepressive agents|mesh-ancestor
92796665|NCT01156142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796666|NCT01156142|Histamine Antagonists|histamine antagonists|mesh-ancestor
92796667|NCT01156142|Histamine Agents|histamine agents|mesh-ancestor
92796668|NCT01156142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796669|NCT01156142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796670|NCT00842257|Panitumumab|panitumumab|mesh-list
92796671|NCT00842257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92796672|NCT00842257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796673|NCT00706069|Capecitabine|capecitabine|mesh-list
92796674|NCT00706069|Vinorelbine|vinorelbine|mesh-list
92796675|NCT00706069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92796676|NCT00706069|Antimetabolites|antimetabolites|mesh-ancestor
92796677|NCT00706069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796678|NCT00706069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796679|NCT00706069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92796680|NCT00706069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92796681|NCT00706069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92796682|NCT00706069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92796683|NCT01155284|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92796684|NCT01155284|Lansoprazole|lansoprazole|mesh-list
92796685|NCT01155284|Dexlansoprazole|dexlansoprazole|mesh-list
92796686|NCT01155284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796687|NCT01155284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796688|NCT01155284|Incretins|incretins|mesh-ancestor
92796689|NCT01155284|Hormones|hormones|mesh-ancestor
92796690|NCT01155284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796691|NCT01155284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92796692|NCT01155284|Protease Inhibitors|protease inhibitors|mesh-ancestor
92796693|NCT01155284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796694|NCT01155284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796695|NCT01155284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92714848|NCT00542243|Finasteride|finasteride|mesh-list
92796696|NCT01155284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796697|NCT01155284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92796699|NCT00852397|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92796700|NCT00852397|Antithrombins|antithrombins|mesh-ancestor
92796701|NCT00852397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92796702|NCT00852397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92796703|NCT00852397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796704|NCT00852397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796705|NCT00852397|Anticoagulants|anticoagulants|mesh-ancestor
92796706|NCT00852241|Hyaluronic Acid|hyaluronic acid|mesh-list
92796707|NCT00852241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92796708|NCT00852241|Immunologic Factors|immunologic factors|mesh-ancestor
92796709|NCT00852241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796710|NCT00852241|Viscosupplements|viscosupplements|mesh-ancestor
92796711|NCT00852241|Protective Agents|protective agents|mesh-ancestor
92796712|NCT02612233|Pregabalin|pregabalin|mesh-list
92796713|NCT02612233|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92796714|NCT02612233|Analgesics|analgesics|mesh-ancestor
92796715|NCT02612233|Sensory System Agents|sensory system agents|mesh-ancestor
92796716|NCT02612233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796717|NCT02612233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796718|NCT02612233|Anticonvulsants|anticonvulsants|mesh-ancestor
92796719|NCT02612233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92796720|NCT02612233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796721|NCT02612233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796722|NCT02612233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92796723|NCT02612233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92796724|NCT02612233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92796725|NCT02612233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796726|NCT02612233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796727|NCT02612233|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92796728|NCT02612233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92796729|NCT02612233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796730|NCT02612233|Antidepressive Agents|antidepressive agents|mesh-ancestor
92796731|NCT02612233|Dopamine Agents|dopamine agents|mesh-ancestor
92796732|NCT01169636|Carboplatin|carboplatin|mesh-list
92796733|NCT01169636|Etoposide|etoposide|mesh-list
92796734|NCT01169636|Ifosfamide|ifosfamide|mesh-list
92796735|NCT01169636|Panobinostat|panobinostat|mesh-list
92796736|NCT01169636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796737|NCT01169636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92796738|NCT01169636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92796739|NCT01169636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92796740|NCT01169636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796741|NCT01169636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796742|NCT01169636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92796743|NCT01169636|Alkylating Agents|alkylating agents|mesh-ancestor
92796744|NCT01169636|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92796745|NCT00706225|Bazedoxifene|bazedoxifene|mesh-list
92796746|NCT00706225|Estrogens|estrogens|mesh-list
92796747|NCT00706225|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92796748|NCT00706225|Hormones|hormones|mesh-ancestor
92796749|NCT00706225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796750|NCT00706225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796751|NCT00706225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92796752|NCT00706225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92796753|NCT00706225|Hormone Antagonists|hormone antagonists|mesh-ancestor
92796754|NCT00706225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92796756|NCT04117009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92796757|NCT04117009|Narcotics|narcotics|mesh-ancestor
92796758|NCT04117009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796759|NCT04117009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796760|NCT04117009|Analgesics|analgesics|mesh-ancestor
92796761|NCT04117009|Sensory System Agents|sensory system agents|mesh-ancestor
92796762|NCT04117009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796763|NCT04117243|Misoprostol|misoprostol|mesh-list
92796764|NCT04117243|Tranexamic Acid|tranexamic acid|mesh-list
92796765|NCT04117243|Oxytocin|oxytocin|mesh-list
92796766|NCT04117243|Oxytocics|oxytocics|mesh-ancestor
92796767|NCT04117243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92796768|NCT04117243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796769|NCT04117243|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92796770|NCT04117243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92796771|NCT04117243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796772|NCT04117243|Hemostatics|hemostatics|mesh-ancestor
92796773|NCT04117243|Coagulants|coagulants|mesh-ancestor
92796774|NCT04117243|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92796775|NCT04117243|Abortifacient Agents|abortifacient agents|mesh-ancestor
92796776|NCT04117243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92796777|NCT04117243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796778|NCT01169558|Bevacizumab|bevacizumab|mesh-list
92796779|NCT01169558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92796780|NCT01169558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796781|NCT01169558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92796782|NCT01169558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92796783|NCT01169558|Growth Substances|growth substances|mesh-ancestor
92796784|NCT01169558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796785|NCT01169558|Growth Inhibitors|growth inhibitors|mesh-ancestor
92796786|NCT00700687|Aspirin|aspirin|mesh-list
92796787|NCT00700687|Celecoxib|celecoxib|mesh-list
92796788|NCT00700687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92796789|NCT00700687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796790|NCT00700687|Analgesics|analgesics|mesh-ancestor
92796791|NCT00700687|Sensory System Agents|sensory system agents|mesh-ancestor
92796792|NCT00700687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796793|NCT00700687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796794|NCT00700687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796795|NCT00700687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796796|NCT00700687|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92796797|NCT00700687|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92796798|NCT00700687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796799|NCT00700687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92796800|NCT00700687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92796801|NCT00700687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796802|NCT00700687|Antipyretics|antipyretics|mesh-ancestor
92796803|NCT00700687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92796804|NCT00840463|Ambrisentan|ambrisentan|mesh-list
92796805|NCT00840463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796806|NCT00700765|Insulin Detemir|insulin detemir|mesh-list
92796807|NCT00700765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796808|NCT00700765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796809|NCT00839527|Metformin|metformin|mesh-list
92796810|NCT00839527|Pioglitazone|pioglitazone|mesh-list
92796811|NCT00839527|Glimepiride|glimepiride|mesh-list
92796812|NCT00839527|rGLP-1 protein|rglp-1 protein|mesh-list
92796813|NCT00839527|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92796814|NCT00839527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796815|NCT00839527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796816|NCT00839527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92796817|NCT00839527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92796818|NCT00839527|Immunologic Factors|immunologic factors|mesh-ancestor
92796819|NCT00839527|Incretins|incretins|mesh-ancestor
92796820|NCT00839527|Hormones|hormones|mesh-ancestor
92796821|NCT00839527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796822|NCT00706927|Timolol|timolol|mesh-list
92796823|NCT00706927|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92796824|NCT00706927|Latanoprost|latanoprost|mesh-list
92796825|NCT00706927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92796826|NCT00706927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92796827|NCT00706927|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796828|NCT00706927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796829|NCT00706927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796830|NCT00706927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796831|NCT00706927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92796832|NCT00706927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796833|NCT00706927|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92796834|NCT00706927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92796835|NCT00706927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92796836|NCT00706927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92796837|NCT00706927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92796838|NCT00707083|Dexamethasone|dexamethasone|mesh-list
92796839|NCT00707083|Methotrexate|methotrexate|mesh-list
92796840|NCT00707083|Vincristine|vincristine|mesh-list
92796841|NCT00707083|Mercaptopurine|mercaptopurine|mesh-list
92796842|NCT00707083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92796843|NCT00707083|Antiemetics|antiemetics|mesh-ancestor
92796844|NCT00707083|Autonomic Agents|autonomic agents|mesh-ancestor
92796845|NCT00707083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796846|NCT00707083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796847|NCT00707083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796848|NCT00707083|Glucocorticoids|glucocorticoids|mesh-ancestor
92796850|NCT00707083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796851|NCT00707083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92796852|NCT00707083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796853|NCT00707083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92796854|NCT00707083|Abortifacient Agents|abortifacient agents|mesh-ancestor
92796855|NCT00707083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92796856|NCT00707083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92796857|NCT00707083|Antimetabolites|antimetabolites|mesh-ancestor
92796858|NCT00707083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796859|NCT00707083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92796860|NCT00707083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796861|NCT00707083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92796862|NCT00707083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92796863|NCT00707083|Immunologic Factors|immunologic factors|mesh-ancestor
92796864|NCT00707083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92796865|NCT00707083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92796866|NCT00707083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92796867|NCT00707083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92796868|NCT00707083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92796869|NCT00707083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92796870|NCT05500261|Dexmedetomidine|dexmedetomidine|mesh-list
92796871|NCT05500261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92796872|NCT05500261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796873|NCT05500261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796874|NCT05500261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796875|NCT05500261|Analgesics|analgesics|mesh-ancestor
92796876|NCT05500261|Sensory System Agents|sensory system agents|mesh-ancestor
92796877|NCT05500261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796878|NCT05500261|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92796879|NCT05500261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92796880|NCT05500261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92796881|NCT05500261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796882|NCT05500261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796883|NCT05500261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796884|NCT04116931|Clopidogrel|clopidogrel|mesh-list
92796885|NCT04116931|Ticagrelor|ticagrelor|mesh-list
92796886|NCT04116931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92796887|NCT04116931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92796888|NCT04116931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92796889|NCT04116931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92796890|NCT04116931|Purinergic Agents|purinergic agents|mesh-ancestor
92796891|NCT04116931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796892|NCT04116931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796893|NCT04116931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796894|NCT00600886|Octreotide|octreotide|mesh-list
92796895|NCT00600886|Pasireotide|pasireotide|mesh-list
92796896|NCT00600886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92796897|NCT00600886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92796898|NCT00600886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796899|NCT00600886|Hormones|hormones|mesh-ancestor
92796900|NCT00600886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796901|NCT00600886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796902|NCT00649324|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92796903|NCT00649324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92796904|NCT00649324|Diuretics|diuretics|mesh-ancestor
92796905|NCT00649324|Natriuretic Agents|natriuretic agents|mesh-ancestor
92796906|NCT00649324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715048|NCT00543842|Growth Inhibitors|growth inhibitors|mesh-ancestor
92796907|NCT00649324|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92796908|NCT00649324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92796909|NCT00649324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796910|NCT00648388|Cilostazol|cilostazol|mesh-list
92796911|NCT00648388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92796912|NCT00648388|Autonomic Agents|autonomic agents|mesh-ancestor
92796913|NCT00648388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796914|NCT00648388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796915|NCT00648388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92796916|NCT00648388|Respiratory System Agents|respiratory system agents|mesh-ancestor
92796917|NCT00648388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92796918|NCT00648388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92796919|NCT00648388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796920|NCT00648388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92796921|NCT00648388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92796922|NCT00648388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92796923|NCT00648388|Protective Agents|protective agents|mesh-ancestor
92796924|NCT00648388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92796925|NCT00648388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92796926|NCT00648388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796927|NCT02658760|Dexmedetomidine|dexmedetomidine|mesh-list
92796928|NCT02658760|Bupivacaine|bupivacaine|mesh-list
92796929|NCT02658760|Anesthetics, Local|anesthetics, local|mesh-ancestor
92796930|NCT02658760|Anesthetics|anesthetics|mesh-ancestor
92796931|NCT02658760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796932|NCT02658760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796933|NCT02658760|Sensory System Agents|sensory system agents|mesh-ancestor
92796934|NCT02658760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796935|NCT02658760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92796936|NCT02658760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92796937|NCT02658760|Analgesics|analgesics|mesh-ancestor
92796938|NCT02658760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92796939|NCT02658760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92796940|NCT02658760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92796941|NCT02658760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92796942|NCT02658760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796943|NCT02658760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796944|NCT02536690|Midazolam|midazolam|mesh-list
92796945|NCT02536690|Remifentanil|remifentanil|mesh-list
92796946|NCT02536690|Propofol|propofol|mesh-list
92796947|NCT02536690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92796948|NCT02536690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92796949|NCT02536690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796950|NCT02536690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92796951|NCT02536690|Anesthetics, General|anesthetics, general|mesh-ancestor
92796952|NCT02536690|Anesthetics|anesthetics|mesh-ancestor
92796953|NCT02536690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92796954|NCT02536690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92796955|NCT02536690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92796956|NCT02536690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92796957|NCT02536690|GABA Modulators|gaba modulators|mesh-ancestor
92796958|NCT02536690|GABA Agents|gaba agents|mesh-ancestor
92796959|NCT02536690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796960|NCT02536690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796961|NCT02536690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92796962|NCT02536690|Narcotics|narcotics|mesh-ancestor
92796963|NCT02536690|Analgesics|analgesics|mesh-ancestor
92796964|NCT02536690|Sensory System Agents|sensory system agents|mesh-ancestor
92796965|NCT02536690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92796966|NCT00649090|Exemestane|exemestane|mesh-list
92796967|NCT00649090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92796968|NCT00649090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92796969|NCT00649090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92796970|NCT00649090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796971|NCT00649090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796972|NCT00649090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92796973|NCT00649090|Hormone Antagonists|hormone antagonists|mesh-ancestor
92796974|NCT00649090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796975|NCT00649090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796976|NCT00838903|Metformin|metformin|mesh-list
92796977|NCT00838903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92796978|NCT00838903|Glimepiride|glimepiride|mesh-list
92796979|NCT00838903|rGLP-1 protein|rglp-1 protein|mesh-list
92796980|NCT00838903|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92796981|NCT00838903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92796982|NCT00838903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92796983|NCT00838903|Incretins|incretins|mesh-ancestor
92796984|NCT00838903|Hormones|hormones|mesh-ancestor
92796985|NCT00838903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92796986|NCT00838903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92796987|NCT00838903|Protease Inhibitors|protease inhibitors|mesh-ancestor
92796988|NCT00838903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92796989|NCT00838903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92796990|NCT00838903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92796991|NCT00838903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92796992|NCT00838903|Immunologic Factors|immunologic factors|mesh-ancestor
92796993|NCT00648466|Sumatriptan|sumatriptan|mesh-list
92796994|NCT00648466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92796995|NCT00648466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92796996|NCT00648466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92796997|NCT00648466|Serotonin Agents|serotonin agents|mesh-ancestor
92796998|NCT00648466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92796999|NCT00648466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797000|NCT00648466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797001|NCT00649402|Amlodipine|amlodipine|mesh-list
92797002|NCT00649402|Benazepril|benazepril|mesh-list
92797003|NCT00649402|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92797004|NCT00649402|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92797005|NCT00649402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797006|NCT00649402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797007|NCT00649402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797008|NCT00649402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797009|NCT00649402|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797010|NCT00649402|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92797011|NCT00649402|Protease Inhibitors|protease inhibitors|mesh-ancestor
92797012|NCT00649402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797013|NCT04477486|Venetoclax|venetoclax|mesh-list
92797014|NCT04477486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797015|NCT00649480|Balsalazide|balsalazide|mesh-list
92797016|NCT00649480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92797017|NCT00649480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92797018|NCT00649480|Analgesics|analgesics|mesh-ancestor
92797019|NCT00649480|Sensory System Agents|sensory system agents|mesh-ancestor
92797020|NCT00649480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797021|NCT00649480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797022|NCT00649480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797023|NCT00649480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92797024|NCT00649480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797025|NCT02656342|Cycloserine|cycloserine|mesh-list
92797026|NCT02656342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92797027|NCT02656342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797028|NCT02656342|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92797029|NCT02656342|Antitubercular Agents|antitubercular agents|mesh-ancestor
92797030|NCT02656342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92797031|NCT02656342|Antimetabolites|antimetabolites|mesh-ancestor
92797032|NCT02656342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797033|NCT04169464|Sofosbuvir|sofosbuvir|mesh-list
92797034|NCT04169464|Antiviral Agents|antiviral agents|mesh-ancestor
92797035|NCT04169464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797036|NCT00650416|Carvedilol|carvedilol|mesh-list
92797037|NCT00650416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92797038|NCT00650416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92797039|NCT00650416|Adrenergic Agents|adrenergic agents|mesh-ancestor
92797040|NCT00650416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797041|NCT00650416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715195|NCT00544505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92797042|NCT00650416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797043|NCT00650416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92797044|NCT00650416|Antioxidants|antioxidants|mesh-ancestor
92797045|NCT00650416|Protective Agents|protective agents|mesh-ancestor
92797046|NCT00650416|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92797047|NCT00650416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797048|NCT00650416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797049|NCT00650416|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797050|NCT00650416|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92797051|NCT00650416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92797053|NCT00649948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92797054|NCT00649948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797055|NCT04167982|Isotretinoin|isotretinoin|mesh-list
92797056|NCT04167982|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92797057|NCT04167982|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797058|NCT04167982|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92797059|NCT00649558|Pioglitazone|pioglitazone|mesh-list
92797060|NCT00649558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92797061|NCT00649558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797062|NCT02658526|Anesthetics|anesthetics|mesh-list
92797063|NCT02658526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797064|NCT02658526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797065|NCT00650494|Valacyclovir|valacyclovir|mesh-list
92797066|NCT00650494|Antiviral Agents|antiviral agents|mesh-ancestor
92797067|NCT00650494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797068|NCT02655874|Vaccines|vaccines|mesh-list
92797069|NCT02655874|Immunologic Factors|immunologic factors|mesh-ancestor
92797070|NCT02655874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797071|NCT00828139|Aflibercept|aflibercept|mesh-list
92797072|NCT00828139|Topotecan|topotecan|mesh-list
92797073|NCT00828139|Endothelial Growth Factors|endothelial growth factors|mesh-list
92797074|NCT00828139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92797075|NCT00828139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92797076|NCT00828139|Growth Substances|growth substances|mesh-ancestor
92797077|NCT00828139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797078|NCT00828139|Growth Inhibitors|growth inhibitors|mesh-ancestor
92797079|NCT00828139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797080|NCT00828139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92797081|NCT00828139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92797082|NCT00828139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797083|NCT00828139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797084|NCT04224688|Rozanolixizumab|rozanolixizumab|mesh-list
92797085|NCT04224688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797086|NCT04224688|Immunologic Factors|immunologic factors|mesh-ancestor
92797087|NCT04224688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797088|NCT02658214|Leucovorin|leucovorin|mesh-list
92797089|NCT02658214|Folic Acid|folic acid|mesh-list
92797090|NCT02658214|Paclitaxel|paclitaxel|mesh-list
92797091|NCT02658214|Etoposide|etoposide|mesh-list
92797092|NCT02658214|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92797093|NCT02658214|Carboplatin|carboplatin|mesh-list
92797094|NCT02658214|Gemcitabine|gemcitabine|mesh-list
92797095|NCT02658214|Fluorouracil|fluorouracil|mesh-list
92797096|NCT02658214|Oxaliplatin|oxaliplatin|mesh-list
92797097|NCT02658214|Durvalumab|durvalumab|mesh-list
92797098|NCT02658214|Tremelimumab|tremelimumab|mesh-list
92797099|NCT02658214|Levoleucovorin|levoleucovorin|mesh-list
92797100|NCT02658214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92797101|NCT02658214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797102|NCT02658214|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797103|NCT02658214|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797104|NCT02658214|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797105|NCT02658214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797106|NCT02658214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92797107|NCT02658214|Antimetabolites|antimetabolites|mesh-ancestor
92797108|NCT02658214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797109|NCT02658214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797110|NCT02658214|Immunologic Factors|immunologic factors|mesh-ancestor
92797111|NCT02658214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92797112|NCT02658214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92797113|NCT02658214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797114|NCT02658214|Antidotes|antidotes|mesh-ancestor
92797115|NCT02658214|Protective Agents|protective agents|mesh-ancestor
92797116|NCT02658214|Vitamin B Complex|vitamin b complex|mesh-ancestor
92797117|NCT02658214|Vitamins|vitamins|mesh-ancestor
92797118|NCT02658214|Micronutrients|micronutrients|mesh-ancestor
92797119|NCT02658214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92797120|NCT02658214|Hematinics|hematinics|mesh-ancestor
92797121|NCT04169230|Citalopram|citalopram|mesh-list
92797122|NCT04169230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92797123|NCT04169230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92797124|NCT04169230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797125|NCT04169230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797126|NCT04169230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797127|NCT04169230|Serotonin Agents|serotonin agents|mesh-ancestor
92797128|NCT04169230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797129|NCT04169230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92797130|NCT04169230|Antidepressive Agents|antidepressive agents|mesh-ancestor
92797131|NCT04169230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797132|NCT04201756|Afatinib|afatinib|mesh-list
92797133|NCT04201756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797134|NCT04201756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92797135|NCT04201756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797136|NCT04201756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797137|NCT02651350|Methylprednisolone|methylprednisolone|mesh-list
92797138|NCT02651350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92797139|NCT02651350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92797140|NCT02651350|Prednisolone|prednisolone|mesh-list
92797141|NCT02651350|Prednisolone acetate|prednisolone acetate|mesh-list
92797142|NCT02651350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92797143|NCT02651350|Prednisolone phosphate|prednisolone phosphate|mesh-list
92797144|NCT02651350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797145|NCT02651350|Antiemetics|antiemetics|mesh-ancestor
92797146|NCT02651350|Autonomic Agents|autonomic agents|mesh-ancestor
92797147|NCT02651350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797148|NCT02651350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797149|NCT02651350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797150|NCT02651350|Glucocorticoids|glucocorticoids|mesh-ancestor
92797151|NCT02651350|Hormones|hormones|mesh-ancestor
92797152|NCT02651350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797153|NCT02651350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92797154|NCT02651350|Protective Agents|protective agents|mesh-ancestor
92797155|NCT02651350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92797156|NCT02651350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797157|NCT02658292|Naftifine|naftifine|mesh-list
92797158|NCT02658292|Antifungal Agents|antifungal agents|mesh-ancestor
92797159|NCT02658292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797160|NCT02651038|Micafungin|micafungin|mesh-list
92797161|NCT02651038|Antifungal Agents|antifungal agents|mesh-ancestor
92797162|NCT02651038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797163|NCT00650026|Adalimumab|adalimumab|mesh-list
92797164|NCT00650026|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92797165|NCT00650026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797166|NCT00650026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92797167|NCT00838513|Eculizumab|eculizumab|mesh-list
92797168|NCT00838513|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92797169|NCT00838513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797170|NCT00838513|Immunologic Factors|immunologic factors|mesh-ancestor
92797171|NCT00838513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797172|NCT00649636|Fluoxetine|fluoxetine|mesh-list
92797173|NCT00649636|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92797174|NCT00649636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92797175|NCT00649636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797176|NCT00649636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797177|NCT00649636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797178|NCT00649636|Serotonin Agents|serotonin agents|mesh-ancestor
92797179|NCT00649636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797180|NCT00649636|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92797181|NCT00649636|Antidepressive Agents|antidepressive agents|mesh-ancestor
92797182|NCT00649636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797183|NCT00649636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92797184|NCT00649636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92797185|NCT00649636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797186|NCT04030663|Nitroglycerin|nitroglycerin|mesh-list
92797187|NCT04030663|Papaverine|papaverine|mesh-list
92797188|NCT04030663|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797189|NCT04030663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92797190|NCT04030663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797191|NCT04030663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797192|NCT04030663|Urological Agents|urological agents|mesh-ancestor
92797193|NCT00700921|Lovastatin|lovastatin|mesh-list
92797194|NCT00700921|L 647318|l 647318|mesh-list
92797195|NCT00700921|Dihydromevinolin|dihydromevinolin|mesh-list
92797196|NCT00700921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92797197|NCT00700921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92797198|NCT00700921|Antimetabolites|antimetabolites|mesh-ancestor
92797199|NCT00700921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797201|NCT00700921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92797202|NCT00700921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797203|NCT00850993|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92797204|NCT00850993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797205|NCT00850993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797206|NCT02657512|Rivaroxaban|rivaroxaban|mesh-list
92797207|NCT02657512|Charcoal|charcoal|mesh-list
92797208|NCT02657512|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92797209|NCT02657512|Antithrombins|antithrombins|mesh-ancestor
92797210|NCT02657512|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92797211|NCT02657512|Protease Inhibitors|protease inhibitors|mesh-ancestor
92797212|NCT02657512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797213|NCT02657512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797214|NCT02657512|Anticoagulants|anticoagulants|mesh-ancestor
92797215|NCT02657512|Antidotes|antidotes|mesh-ancestor
92797216|NCT02657512|Protective Agents|protective agents|mesh-ancestor
92797217|NCT02657512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797218|NCT00818779|Amlodipine|amlodipine|mesh-list
92797219|NCT00818779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92797220|NCT00818779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92797221|NCT00818779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797222|NCT00818779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797223|NCT00818779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797224|NCT00818779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797225|NCT00818779|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797227|NCT00649714|Anticonvulsants|anticonvulsants|mesh-ancestor
92797228|NCT00649714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92797229|NCT00649714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797230|NCT00649714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797231|NCT00649714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797232|NCT00649714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797233|NCT00600028|Thalidomide|thalidomide|mesh-list
92797234|NCT00600028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797235|NCT00600028|Immunologic Factors|immunologic factors|mesh-ancestor
92797236|NCT00600028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797237|NCT00600028|Leprostatic Agents|leprostatic agents|mesh-ancestor
92797238|NCT00600028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92797239|NCT00600028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797240|NCT00600028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92797241|NCT00600028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92797242|NCT00600028|Growth Substances|growth substances|mesh-ancestor
92797243|NCT00600028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92797244|NCT00600028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797245|NCT02650102|Olanzapine|olanzapine|mesh-list
92797246|NCT02650102|Risperidone|risperidone|mesh-list
92797247|NCT02650102|Aripiprazole|aripiprazole|mesh-list
92797248|NCT02650102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92797249|NCT02650102|Ziprasidone|ziprasidone|mesh-list
92797250|NCT02650102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92797251|NCT02650102|Serotonin Agents|serotonin agents|mesh-ancestor
92797252|NCT02650102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797253|NCT02650102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797254|NCT02650102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797255|NCT02650102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92797256|NCT02650102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92797257|NCT02650102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797258|NCT02650102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797259|NCT02650102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92797260|NCT02650102|Dopamine Agents|dopamine agents|mesh-ancestor
92797261|NCT02650102|Antiemetics|antiemetics|mesh-ancestor
92797262|NCT02650102|Autonomic Agents|autonomic agents|mesh-ancestor
92797263|NCT02650102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797264|NCT02650102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797265|NCT02650102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92797266|NCT02650102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92797267|NCT02650102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797268|NCT02650102|Antidepressive Agents|antidepressive agents|mesh-ancestor
92797269|NCT02650102|Dopamine Agonists|dopamine agonists|mesh-ancestor
92797270|NCT02650102|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92797271|NCT02650102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92797272|NCT02650102|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92797273|NCT02650102|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92797274|NCT00650182|Fentanyl|fentanyl|mesh-list
92797275|NCT00650182|Naltrexone|naltrexone|mesh-list
92797276|NCT00650182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92797277|NCT00650182|Narcotics|narcotics|mesh-ancestor
92797278|NCT00650182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797279|NCT00650182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797280|NCT00650182|Analgesics|analgesics|mesh-ancestor
92797281|NCT00650182|Sensory System Agents|sensory system agents|mesh-ancestor
92797282|NCT00650182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797283|NCT00650182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92797284|NCT00650182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92797285|NCT00650182|Anesthetics, General|anesthetics, general|mesh-ancestor
92797286|NCT00650182|Anesthetics|anesthetics|mesh-ancestor
92797287|NCT00650182|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92797288|NCT00650182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92797289|NCT00910780|Olanzapine|olanzapine|mesh-list
92797290|NCT00910780|Aripiprazole|aripiprazole|mesh-list
92797291|NCT00910780|Antidepressive Agents|antidepressive agents|mesh-ancestor
92797292|NCT00910780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797293|NCT00910780|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92797294|NCT00910780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92797295|NCT00910780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797296|NCT00910780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797297|NCT00910780|Dopamine Agonists|dopamine agonists|mesh-ancestor
92797298|NCT00910780|Dopamine Agents|dopamine agents|mesh-ancestor
92797299|NCT00910780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797300|NCT00910780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797301|NCT00910780|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92797302|NCT00910780|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92797303|NCT00910780|Serotonin Agents|serotonin agents|mesh-ancestor
92797304|NCT00910780|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92797305|NCT00910780|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92797306|NCT00910780|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92797307|NCT00910780|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92797308|NCT00910780|Antiemetics|antiemetics|mesh-ancestor
92797309|NCT00910780|Autonomic Agents|autonomic agents|mesh-ancestor
92797310|NCT00910780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797311|NCT00910780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797312|NCT00910780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92797313|NCT00910780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92797314|NCT00910780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797315|NCT02656810|Teriparatide|teriparatide|mesh-list
92797316|NCT02656810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797317|NCT02656810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797318|NCT02656810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92797319|NCT02649478|Fluticasone|fluticasone|mesh-list
92797320|NCT02649478|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92797321|NCT02649478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92797322|NCT02649478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797323|NCT02649478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92797324|NCT02649478|Autonomic Agents|autonomic agents|mesh-ancestor
92797325|NCT02649478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797326|NCT02649478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797327|NCT02649478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92797328|NCT02649478|Respiratory System Agents|respiratory system agents|mesh-ancestor
92797329|NCT02649478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797330|NCT02649478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92797331|NCT02649478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92797332|NCT02649478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92797333|NCT02649478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92797334|NCT02649478|Adrenergic Agents|adrenergic agents|mesh-ancestor
92797335|NCT02649478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797336|NCT02649478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797337|NCT02649478|Glucocorticoids|glucocorticoids|mesh-ancestor
92797338|NCT02649478|Hormones|hormones|mesh-ancestor
92797339|NCT02649478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797340|NCT02649478|Sympathomimetics|sympathomimetics|mesh-ancestor
92797341|NCT04167592|Benzydamine|benzydamine|mesh-list
92797342|NCT04167592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797343|NCT04168294|Propofol|propofol|mesh-list
92797344|NCT04168294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92797345|NCT04168294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797346|NCT04168294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797347|NCT04168294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92797348|NCT04168294|Anesthetics, General|anesthetics, general|mesh-ancestor
92797349|NCT04168294|Anesthetics|anesthetics|mesh-ancestor
92797350|NCT04168138|Cytarabine|cytarabine|mesh-list
92797351|NCT04168138|Decitabine|decitabine|mesh-list
92797352|NCT04168138|Aclarubicin|aclarubicin|mesh-list
92797353|NCT04168138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92797354|NCT04168138|Antimetabolites|antimetabolites|mesh-ancestor
92797355|NCT04168138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797356|NCT04168138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797357|NCT04168138|Antiviral Agents|antiviral agents|mesh-ancestor
92797358|NCT04168138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797359|NCT04168138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797360|NCT04168138|Immunologic Factors|immunologic factors|mesh-ancestor
92797361|NCT04168138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797362|NCT04168138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797363|NCT04168138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92797364|NCT04168138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92797365|NCT04168138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92797366|NCT00649870|Valacyclovir|valacyclovir|mesh-list
92797367|NCT00649870|Antiviral Agents|antiviral agents|mesh-ancestor
92797368|NCT00649870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797369|NCT04167280|Ipratropium|ipratropium|mesh-list
92797370|NCT04167280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92797371|NCT04167280|Autonomic Agents|autonomic agents|mesh-ancestor
92797372|NCT04167280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797373|NCT04167280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797374|NCT04167280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92797375|NCT04167280|Respiratory System Agents|respiratory system agents|mesh-ancestor
92797376|NCT04167280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92797377|NCT04167280|Cholinergic Agents|cholinergic agents|mesh-ancestor
92797378|NCT04167280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797379|NCT04167280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797381|NCT02648854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92797382|NCT02648854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797383|NCT02652598|Tolcapone|tolcapone|mesh-list
92797384|NCT02652598|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92797385|NCT02652598|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92797386|NCT02652598|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92797387|NCT02652598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797388|NCT02652598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797389|NCT02648776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92797390|NCT02648776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797391|NCT02648776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797392|NCT02648464|Hydroxychloroquine|hydroxychloroquine|mesh-list
92797393|NCT02648464|Antimalarials|antimalarials|mesh-ancestor
92797394|NCT02648464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92797395|NCT02648464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92797396|NCT02648464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797397|NCT02648464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797398|NCT02648464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797399|NCT02648464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92797400|NCT02645032|Vaccines|vaccines|mesh-list
92797401|NCT02645032|Immunologic Factors|immunologic factors|mesh-ancestor
92797402|NCT02645032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797403|NCT02644954|Metformin|metformin|mesh-list
92797404|NCT02644954|Calcipotriene|calcipotriene|mesh-list
92797405|NCT02644954|Coal Tar|coal tar|mesh-list
92797406|NCT02644954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92797407|NCT02644954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797408|NCT02644954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797409|NCT02644954|Keratolytic Agents|keratolytic agents|mesh-ancestor
92797410|NCT00650338|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92797411|NCT00650338|Latanoprost|latanoprost|mesh-list
92797412|NCT00650338|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92797413|NCT02644720|Dexamethasone|dexamethasone|mesh-list
92797414|NCT02644720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797415|NCT02644720|Antiemetics|antiemetics|mesh-ancestor
92797416|NCT02644720|Autonomic Agents|autonomic agents|mesh-ancestor
92797417|NCT02644720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797418|NCT02644720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797419|NCT02644720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797420|NCT02644720|Glucocorticoids|glucocorticoids|mesh-ancestor
92797421|NCT02644720|Hormones|hormones|mesh-ancestor
92797422|NCT02644720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797423|NCT02644720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92797424|NCT02644720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797425|NCT03542266|Azacitidine|azacitidine|mesh-list
92797426|NCT03542266|Cc-486|cc-486|mesh-list
92797427|NCT03542266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92797428|NCT03542266|Antimetabolites|antimetabolites|mesh-ancestor
92797429|NCT03542266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797430|NCT03542266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797431|NCT03542266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797432|NCT00652600|Propranolol|propranolol|mesh-list
92797433|NCT00652600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92797434|NCT00652600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92797435|NCT00652600|Adrenergic Agents|adrenergic agents|mesh-ancestor
92797436|NCT00652600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797437|NCT00652600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797438|NCT00652600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797439|NCT00652600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92797440|NCT00652600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92797441|NCT00652600|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797442|NCT03201250|Dexamethasone|dexamethasone|mesh-list
92797443|NCT03201250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797444|NCT03201250|Antiemetics|antiemetics|mesh-ancestor
92797445|NCT03201250|Autonomic Agents|autonomic agents|mesh-ancestor
92797446|NCT03201250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797447|NCT03201250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797448|NCT03201250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797449|NCT03201250|Glucocorticoids|glucocorticoids|mesh-ancestor
92797450|NCT03201250|Hormones|hormones|mesh-ancestor
92797451|NCT03201250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797452|NCT03201250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92797453|NCT03201250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797454|NCT04166578|Lidocaine|lidocaine|mesh-list
92797455|NCT04166578|Anesthetics, Local|anesthetics, local|mesh-ancestor
92797456|NCT04166578|Anesthetics|anesthetics|mesh-ancestor
92797457|NCT04166578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797458|NCT04166578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797459|NCT04166578|Sensory System Agents|sensory system agents|mesh-ancestor
92797460|NCT04166578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797461|NCT04166578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92797462|NCT04166578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92797463|NCT04166578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92797464|NCT04166578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797465|NCT04166578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797466|NCT04166734|Pembrolizumab|pembrolizumab|mesh-list
92797467|NCT04166734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92797468|NCT04166734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797469|NCT04166734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715611|NCT04860141|Gabapentin|gabapentin|mesh-list
92797470|NCT04166734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797471|NCT00651352|Nicotine|nicotine|mesh-list
92797472|NCT00651352|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92797473|NCT00651352|Autonomic Agents|autonomic agents|mesh-ancestor
92797474|NCT00651352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797475|NCT00651352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797476|NCT00651352|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92797477|NCT00651352|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92797478|NCT00651352|Cholinergic Agents|cholinergic agents|mesh-ancestor
92797479|NCT00651352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797480|NCT00651352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797481|NCT02641210|Albendazole|albendazole|mesh-list
92797482|NCT02641210|Anthelmintics|anthelmintics|mesh-ancestor
92797483|NCT02641210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92797484|NCT02641210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797485|NCT02641210|Anticestodal Agents|anticestodal agents|mesh-ancestor
92797486|NCT02641210|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92797487|NCT02641210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92797488|NCT02641210|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797489|NCT02641210|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797490|NCT02641210|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797491|NCT02641210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797492|NCT02641210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797493|NCT02644408|Megestrol|megestrol|mesh-list
92797494|NCT02644408|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92797495|NCT02644408|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92797496|NCT02644408|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92797497|NCT02644408|Contraceptive Agents|contraceptive agents|mesh-ancestor
92797498|NCT02644408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92797499|NCT02644408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797500|NCT02644408|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92797501|NCT02644408|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92797502|NCT02644408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92797503|NCT02644408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797504|NCT05758597|Midazolam|midazolam|mesh-list
92797505|NCT05758597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92797506|NCT05758597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92797507|NCT05758597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797508|NCT05758597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797509|NCT05758597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92797510|NCT05758597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92797511|NCT05758597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797512|NCT05758597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92797513|NCT05758597|Anesthetics, General|anesthetics, general|mesh-ancestor
92797514|NCT05758597|Anesthetics|anesthetics|mesh-ancestor
92797515|NCT05758597|GABA Modulators|gaba modulators|mesh-ancestor
92797516|NCT05758597|GABA Agents|gaba agents|mesh-ancestor
92797517|NCT05758597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797518|NCT05758597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797519|NCT02644486|Irbesartan|irbesartan|mesh-list
92797520|NCT02644486|Sevelamer|sevelamer|mesh-list
92797521|NCT02644486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92797522|NCT02644486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92797523|NCT02644486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92797524|NCT02644486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797525|NCT02644486|Chelating Agents|chelating agents|mesh-ancestor
92797526|NCT02644486|Sequestering Agents|sequestering agents|mesh-ancestor
92797527|NCT00827359|Everolimus|everolimus|mesh-list
92797528|NCT00827359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92797529|NCT00827359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92797530|NCT00827359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797531|NCT00827359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797532|NCT00827359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797533|NCT00827359|Immunologic Factors|immunologic factors|mesh-ancestor
92797534|NCT00827359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797535|NCT00827359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797536|NCT02641288|Ropivacaine|ropivacaine|mesh-list
92797537|NCT02641288|Anesthetics, Local|anesthetics, local|mesh-ancestor
92797538|NCT02641288|Anesthetics|anesthetics|mesh-ancestor
92797539|NCT02641288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797540|NCT02641288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797541|NCT02641288|Sensory System Agents|sensory system agents|mesh-ancestor
92797542|NCT02641288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797543|NCT04165174|Apatinib|apatinib|mesh-list
92797544|NCT04165174|Antibodies|antibodies|mesh-list
92797545|NCT04165174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92797546|NCT04165174|Immunologic Factors|immunologic factors|mesh-ancestor
92797547|NCT04165174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797548|NCT04165174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797549|NCT04165174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92797550|NCT04165174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797551|NCT04165174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797552|NCT02613247|Hylan|hylan|mesh-list
92797553|NCT02613247|Viscosupplements|viscosupplements|mesh-ancestor
92797554|NCT02613247|Protective Agents|protective agents|mesh-ancestor
92797555|NCT02613247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797556|NCT02641132|Mitomycins|mitomycins|mesh-list
92797557|NCT02641132|Mitomycin|mitomycin|mesh-list
92797558|NCT02641132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92797559|NCT02641132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797560|NCT02641132|Alkylating Agents|alkylating agents|mesh-ancestor
92797561|NCT02641132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797562|NCT02641132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92797563|NCT02641132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797564|NCT00653614|Drospirenone|drospirenone|mesh-list
92797565|NCT00653614|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92797566|NCT00653614|Hormone Antagonists|hormone antagonists|mesh-ancestor
92797567|NCT00653614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797568|NCT00653614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797569|NCT00653614|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92797570|NCT00653614|Diuretics|diuretics|mesh-ancestor
92797571|NCT00653614|Natriuretic Agents|natriuretic agents|mesh-ancestor
92797572|NCT02644252|Tocotrienols|tocotrienols|mesh-list
92797573|NCT02644252|Vitamin E|vitamin e|mesh-list
92797574|NCT02644252|Tocopherols|tocopherols|mesh-list
92797575|NCT02644252|Carboplatin|carboplatin|mesh-list
92797576|NCT02644252|Vinorelbine|vinorelbine|mesh-list
92797577|NCT02644252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797578|NCT02644252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92797579|NCT02644252|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797580|NCT02644252|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797581|NCT02644252|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797582|NCT02644252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797583|NCT02644252|Antioxidants|antioxidants|mesh-ancestor
92797584|NCT02644252|Protective Agents|protective agents|mesh-ancestor
92797585|NCT02644252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797586|NCT02644252|Vitamins|vitamins|mesh-ancestor
92797587|NCT02644252|Micronutrients|micronutrients|mesh-ancestor
92797588|NCT00818389|Riluzole|riluzole|mesh-list
92797589|NCT00818389|Lithium Carbonate|lithium carbonate|mesh-list
92797590|NCT00818389|Antidepressive Agents|antidepressive agents|mesh-ancestor
92797591|NCT00818389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797592|NCT00818389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797593|NCT00818389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797594|NCT00818389|Antimanic Agents|antimanic agents|mesh-ancestor
92797595|NCT00818389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92797596|NCT00818389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797598|NCT00818389|Anticonvulsants|anticonvulsants|mesh-ancestor
92797599|NCT00818389|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92797600|NCT00818389|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92797601|NCT00818389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797602|NCT00818389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92797603|NCT00818389|Protective Agents|protective agents|mesh-ancestor
92797604|NCT02640976|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92797605|NCT02640976|Cetrorelix|cetrorelix|mesh-list
92797606|NCT02640976|Menotropins|menotropins|mesh-list
92797607|NCT02640976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92797608|NCT02640976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797609|NCT02640976|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92797610|NCT02640976|Fertility Agents|fertility agents|mesh-ancestor
92797611|NCT02640976|Hormone Antagonists|hormone antagonists|mesh-ancestor
92797612|NCT02640976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797613|NCT02644018|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
92797614|NCT02644018|Antiviral Agents|antiviral agents|mesh-ancestor
92797615|NCT02644018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797616|NCT02647918|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92797617|NCT02647918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92797618|NCT02647918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797619|NCT02647918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92797620|NCT02647918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797621|NCT03130036|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92797622|NCT03130036|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92797623|NCT03130036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797624|NCT02535988|Thymalfasin|thymalfasin|mesh-list
92797625|NCT02535988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92797626|NCT02535988|Immunologic Factors|immunologic factors|mesh-ancestor
92797627|NCT02535988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797628|NCT02640898|Docetaxel|docetaxel|mesh-list
92797629|NCT02640898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797630|NCT02640898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797631|NCT02640898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797632|NCT02640898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797633|NCT02640898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797634|NCT02535910|Vitamin D|vitamin d|mesh-list
92797635|NCT02535910|Cholecalciferol|cholecalciferol|mesh-list
92797636|NCT02535910|Calcifediol|calcifediol|mesh-list
92797637|NCT02535910|Vitamins|vitamins|mesh-ancestor
92797638|NCT02535910|Micronutrients|micronutrients|mesh-ancestor
92797639|NCT02535910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797640|NCT02535910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92797641|NCT02535910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797642|NCT00849901|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92797643|NCT00849901|Fluoxetine|fluoxetine|mesh-list
92797644|NCT00849901|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92797645|NCT00849901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92797646|NCT00849901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797647|NCT00849901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797648|NCT00849901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797649|NCT00849901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797650|NCT00849901|Analgesics|analgesics|mesh-ancestor
92797651|NCT00849901|Sensory System Agents|sensory system agents|mesh-ancestor
92797652|NCT00849901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797653|NCT00849901|Antidepressive Agents|antidepressive agents|mesh-ancestor
92797654|NCT00849901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92797655|NCT00849901|Dopamine Agents|dopamine agents|mesh-ancestor
92797656|NCT00849901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92797657|NCT00849901|Serotonin Agents|serotonin agents|mesh-ancestor
92797658|NCT00849901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92797659|NCT00849901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92797660|NCT00849901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92797661|NCT00849901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797662|NCT02641054|Levodopa|levodopa|mesh-list
92797663|NCT02641054|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92797664|NCT02641054|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92797665|NCT02641054|Dopamine Agents|dopamine agents|mesh-ancestor
92797666|NCT02641054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797667|NCT02641054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797668|NCT02641054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797669|NCT02643784|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92797670|NCT02643784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92797671|NCT02643784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92797672|NCT02643784|Antimetabolites|antimetabolites|mesh-ancestor
92797673|NCT02643784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797674|NCT02643784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92797675|NCT02643784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92797676|NCT02643784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797677|NCT04166890|Epinephrine|epinephrine|mesh-list
92797678|NCT04166890|Carticaine|carticaine|mesh-list
92797679|NCT04166890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92797680|NCT04166890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92797681|NCT04166890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92797682|NCT04166890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797683|NCT04166890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797684|NCT04166890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797685|NCT04166890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92797686|NCT04166890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92797687|NCT04166890|Autonomic Agents|autonomic agents|mesh-ancestor
92797688|NCT04166890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797689|NCT04166890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92797690|NCT04166890|Respiratory System Agents|respiratory system agents|mesh-ancestor
92797691|NCT04166890|Mydriatics|mydriatics|mesh-ancestor
92797692|NCT04166890|Sympathomimetics|sympathomimetics|mesh-ancestor
92797693|NCT04166890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92797694|NCT04166890|Anesthetics, Local|anesthetics, local|mesh-ancestor
92797695|NCT04166890|Anesthetics|anesthetics|mesh-ancestor
92797696|NCT04166890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797697|NCT04166890|Sensory System Agents|sensory system agents|mesh-ancestor
92797698|NCT00652912|Clonazepam|clonazepam|mesh-list
92797699|NCT00652912|Anticonvulsants|anticonvulsants|mesh-ancestor
92797700|NCT00652912|GABA Modulators|gaba modulators|mesh-ancestor
92797701|NCT00652912|GABA Agents|gaba agents|mesh-ancestor
92797702|NCT00652912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797703|NCT00652912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797704|NCT00652912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797705|NCT01168232|Epothilones|epothilones|mesh-list
92797706|NCT01168232|Epothilone B|epothilone b|mesh-list
92797707|NCT01168232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797708|NCT01168232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797709|NCT01168232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797710|NCT01168232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797711|NCT01168232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797712|NCT00817531|Dasatinib|dasatinib|mesh-list
92797713|NCT00817531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797714|NCT00817531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92797715|NCT00817531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797716|NCT00817531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797717|NCT00651586|Ciprofloxacin|ciprofloxacin|mesh-list
92797718|NCT00651586|Gatifloxacin|gatifloxacin|mesh-list
92797719|NCT00651586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92797720|NCT00651586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92797721|NCT00651586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92797722|NCT00651586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797723|NCT00651586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92797724|NCT00651586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92797726|NCT00651586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797727|NCT00651586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797728|NCT00651586|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92797729|NCT00651586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92797730|NCT02640508|Lenvatinib|lenvatinib|mesh-list
92797731|NCT02640508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797732|NCT02640508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92797733|NCT02640508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797734|NCT02640508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797735|NCT05312606|Chlorhexidine|chlorhexidine|mesh-list
92797736|NCT05312606|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92797737|NCT05312606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92797738|NCT05312606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797739|NCT05312606|Disinfectants|disinfectants|mesh-ancestor
92797740|NCT05312606|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797741|NCT05259566|Menthol|menthol|mesh-list
92797742|NCT05259566|Antipruritics|antipruritics|mesh-ancestor
92797743|NCT05259566|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797744|NCT02643550|Cetuximab|cetuximab|mesh-list
92797745|NCT02643550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92797746|NCT02643550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797747|NCT00817063|Alitretinoin|alitretinoin|mesh-list
92797748|NCT00817063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797749|NCT00817063|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797750|NCT04313270|Evolocumab|evolocumab|mesh-list
92797751|NCT04313270|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92797752|NCT04313270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92797753|NCT04313270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92797754|NCT04313270|Antimetabolites|antimetabolites|mesh-ancestor
92797755|NCT04313270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797756|NCT04313270|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92797757|NCT04313270|Protease Inhibitors|protease inhibitors|mesh-ancestor
92797758|NCT04313270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797759|NCT04313270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92797760|NCT02640118|Lixisenatide|lixisenatide|mesh-list
92797761|NCT02640118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92797762|NCT02640118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797763|NCT00826267|Trastuzumab|trastuzumab|mesh-list
92797764|NCT00826267|Lapatinib|lapatinib|mesh-list
92797765|NCT00826267|Afatinib|afatinib|mesh-list
92797766|NCT00826267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92797767|NCT00826267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797768|NCT00826267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92797769|NCT00826267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797770|NCT00826267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797771|NCT00653848|Docetaxel|docetaxel|mesh-list
92797772|NCT00653848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797773|NCT00653848|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797774|NCT00653848|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797775|NCT00653848|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797776|NCT00653848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797777|NCT00707551|Ketoconazole|ketoconazole|mesh-list
92797778|NCT00707551|Verapamil|verapamil|mesh-list
92797779|NCT00707551|Antifungal Agents|antifungal agents|mesh-ancestor
92797780|NCT00707551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797781|NCT00707551|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92797782|NCT00707551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92797783|NCT00707551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797784|NCT00707551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797785|NCT00707551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92797786|NCT00707551|Hormone Antagonists|hormone antagonists|mesh-ancestor
92797787|NCT00707551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797788|NCT00707551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797789|NCT00707551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92797790|NCT00707551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92797791|NCT00707551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92797792|NCT00707551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797793|NCT00707551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797794|NCT00707551|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797795|NCT00986154|Heparin|heparin|mesh-list
92797796|NCT00986154|Calcium heparin|calcium heparin|mesh-list
92797797|NCT00986154|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92797798|NCT00986154|Tinzaparin|tinzaparin|mesh-list
92797799|NCT00986154|Dalteparin|dalteparin|mesh-list
92797800|NCT00986154|Warfarin|warfarin|mesh-list
92797801|NCT00986154|Edoxaban|edoxaban|mesh-list
92797802|NCT00986154|Anticoagulants|anticoagulants|mesh-ancestor
92797803|NCT00986154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92797804|NCT00986154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92797805|NCT00986154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797806|NCT00986154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92797807|NCT00986154|Antithrombins|antithrombins|mesh-ancestor
92797808|NCT00986154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92797809|NCT00986154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92797810|NCT00986154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797811|NCT00653926|Epinephrine|epinephrine|mesh-list
92797812|NCT00653926|Ropivacaine|ropivacaine|mesh-list
92797813|NCT00653926|Anesthetics, Local|anesthetics, local|mesh-ancestor
92797814|NCT00653926|Anesthetics|anesthetics|mesh-ancestor
92797815|NCT00653926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797816|NCT00653926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797817|NCT00653926|Sensory System Agents|sensory system agents|mesh-ancestor
92442835|NCT01638962|Diclofenac|diclofenac|mesh-list
92797818|NCT00653926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797819|NCT00653926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92797820|NCT00653926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92797821|NCT00653926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92797822|NCT00653926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797823|NCT00653926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797824|NCT00653926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92797825|NCT00653926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92797826|NCT00653926|Autonomic Agents|autonomic agents|mesh-ancestor
92797827|NCT00653926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92797828|NCT00653926|Respiratory System Agents|respiratory system agents|mesh-ancestor
92797829|NCT00653926|Mydriatics|mydriatics|mesh-ancestor
92797830|NCT00653926|Sympathomimetics|sympathomimetics|mesh-ancestor
92797831|NCT00653926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92797833|NCT02613091|Antipruritics|antipruritics|mesh-ancestor
92797834|NCT02613091|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797835|NCT02613091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92797836|NCT02613091|Histamine Antagonists|histamine antagonists|mesh-ancestor
92797837|NCT02613091|Histamine Agents|histamine agents|mesh-ancestor
92797838|NCT02613091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797839|NCT02613091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797840|NCT02613091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797841|NCT02613091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92797842|NCT02639806|Lidocaine|lidocaine|mesh-list
92797843|NCT02639806|Sevoflurane|sevoflurane|mesh-list
92797844|NCT02639806|Anesthetics, Local|anesthetics, local|mesh-ancestor
92797845|NCT02639806|Anesthetics|anesthetics|mesh-ancestor
92797846|NCT02639806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92797847|NCT02639806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797848|NCT02639806|Sensory System Agents|sensory system agents|mesh-ancestor
92797849|NCT02639806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797850|NCT02639806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92797851|NCT02639806|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92797852|NCT02639806|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92797853|NCT02639806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797854|NCT02639806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797855|NCT02639806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92797856|NCT02639806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92797857|NCT02639806|Anesthetics, General|anesthetics, general|mesh-ancestor
92797858|NCT02646904|Beclomethasone|beclomethasone|mesh-list
92797859|NCT02646904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797860|NCT02646904|Glucocorticoids|glucocorticoids|mesh-ancestor
92797861|NCT02646904|Hormones|hormones|mesh-ancestor
92797862|NCT02646904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797863|NCT02646904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797864|NCT02646904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92797865|NCT02646904|Respiratory System Agents|respiratory system agents|mesh-ancestor
92797866|NCT00848965|Fluticasone|fluticasone|mesh-list
92797867|NCT00848965|Xhance|xhance|mesh-list
92797868|NCT00848965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797869|NCT00848965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92797870|NCT00848965|Autonomic Agents|autonomic agents|mesh-ancestor
92797871|NCT00848965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797872|NCT00848965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797873|NCT00848965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92797874|NCT00848965|Respiratory System Agents|respiratory system agents|mesh-ancestor
92797875|NCT00848965|Dermatologic Agents|dermatologic agents|mesh-ancestor
92797876|NCT00848965|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92797877|NCT00654082|Sildenafil Citrate|sildenafil citrate|mesh-list
92797878|NCT00654082|Vasodilator Agents|vasodilator agents|mesh-ancestor
92797879|NCT00654082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92797880|NCT00654082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92797881|NCT00654082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797882|NCT00654082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797883|NCT00654082|Urological Agents|urological agents|mesh-ancestor
92797885|NCT00654160|Fluorouracil|fluorouracil|mesh-list
92797886|NCT00654160|Irinotecan|irinotecan|mesh-list
92797887|NCT00654160|Calcium|calcium|mesh-list
92797888|NCT00654160|Levoleucovorin|levoleucovorin|mesh-list
92797889|NCT00654160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92797890|NCT00654160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797891|NCT00654160|Antimetabolites|antimetabolites|mesh-ancestor
92797892|NCT00654160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797893|NCT00654160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92797894|NCT00654160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797895|NCT00654160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797896|NCT00654160|Immunologic Factors|immunologic factors|mesh-ancestor
92797897|NCT00654160|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92797898|NCT00654160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92797899|NCT00654160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797900|NCT00654160|Antidotes|antidotes|mesh-ancestor
92797901|NCT00654160|Protective Agents|protective agents|mesh-ancestor
92797902|NCT00654160|Vitamin B Complex|vitamin b complex|mesh-ancestor
92797903|NCT00654160|Vitamins|vitamins|mesh-ancestor
92797904|NCT00654160|Micronutrients|micronutrients|mesh-ancestor
92797905|NCT02642380|Dexamethasone|dexamethasone|mesh-list
92797906|NCT02642380|Dexamethasone acetate|dexamethasone acetate|mesh-list
92797907|NCT02642380|BB 1101|bb 1101|mesh-list
92797908|NCT02642380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92797909|NCT02642380|Antiemetics|antiemetics|mesh-ancestor
92797910|NCT02642380|Autonomic Agents|autonomic agents|mesh-ancestor
92797911|NCT02642380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797912|NCT02642380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797913|NCT02642380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92797914|NCT02642380|Glucocorticoids|glucocorticoids|mesh-ancestor
92797915|NCT02642380|Hormones|hormones|mesh-ancestor
92797916|NCT02642380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92797917|NCT02642380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92797918|NCT02642380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797919|NCT02642380|Protease Inhibitors|protease inhibitors|mesh-ancestor
92797920|NCT02642380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797921|NCT02642380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797922|NCT01154036|Atorvastatin|atorvastatin|mesh-list
92797923|NCT01154036|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92797924|NCT01154036|Ezetimibe|ezetimibe|mesh-list
92797925|NCT01154036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92797926|NCT01154036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92797927|NCT01154036|Antimetabolites|antimetabolites|mesh-ancestor
92797928|NCT01154036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797929|NCT01154036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92797930|NCT01154036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92797931|NCT01154036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797932|NCT00816595|Cyclophosphamide|cyclophosphamide|mesh-list
92797933|NCT00816595|Bevacizumab|bevacizumab|mesh-list
92797934|NCT00816595|Rituximab|rituximab|mesh-list
92797935|NCT00816595|Pentostatin|pentostatin|mesh-list
92797936|NCT00816595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92797937|NCT00816595|Immunologic Factors|immunologic factors|mesh-ancestor
92797938|NCT00816595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797939|NCT00816595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92797940|NCT00816595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92797941|NCT00816595|Alkylating Agents|alkylating agents|mesh-ancestor
92797942|NCT00816595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797943|NCT00816595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797944|NCT00816595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92797945|NCT00816595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92797946|NCT00816595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92797947|NCT00816595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92797948|NCT00816595|Growth Substances|growth substances|mesh-ancestor
92797949|NCT00816595|Growth Inhibitors|growth inhibitors|mesh-ancestor
92797950|NCT00816595|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92797951|NCT00816595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797952|NCT01166438|Solifenacin Succinate|solifenacin succinate|mesh-list
92797953|NCT01166438|Trospium chloride|trospium chloride|mesh-list
92797954|NCT01166438|Botulinum Toxins|botulinum toxins|mesh-list
92797955|NCT01166438|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92797956|NCT01166438|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92797957|NCT01166438|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92797958|NCT01166438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797959|NCT01166438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797960|NCT01166438|Cholinergic Agents|cholinergic agents|mesh-ancestor
92797961|NCT01166438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92797962|NCT01166438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797963|NCT01166438|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92797964|NCT01166438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797965|NCT01166438|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92797966|NCT01166438|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92797967|NCT01166438|Urological Agents|urological agents|mesh-ancestor
92797968|NCT01166438|Parasympatholytics|parasympatholytics|mesh-ancestor
92797969|NCT01166438|Autonomic Agents|autonomic agents|mesh-ancestor
92797970|NCT00707707|Paclitaxel|paclitaxel|mesh-list
92797971|NCT00707707|Olaparib|olaparib|mesh-list
92797972|NCT00707707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92797973|NCT00707707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92797974|NCT00707707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92797975|NCT00707707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92797976|NCT00707707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92797977|NCT00707707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797978|NCT00707707|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92797979|NCT00707707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92797980|NCT01153958|Metronidazole|metronidazole|mesh-list
92797981|NCT01153958|Chlorquinaldol|chlorquinaldol|mesh-list
92797982|NCT01153958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92797983|NCT01153958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92797984|NCT01153958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92797985|NCT01153958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92797986|NCT00707785|Vitamin A|vitamin a|mesh-list
92797987|NCT00707785|Vitamins|vitamins|mesh-ancestor
92797988|NCT00707785|Micronutrients|micronutrients|mesh-ancestor
92797989|NCT00707785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797990|NCT00599638|Pregabalin|pregabalin|mesh-list
92797991|NCT00599638|Analgesics|analgesics|mesh-ancestor
92797992|NCT00599638|Sensory System Agents|sensory system agents|mesh-ancestor
92797993|NCT00599638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92797994|NCT00599638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92797995|NCT00599638|Anticonvulsants|anticonvulsants|mesh-ancestor
92797996|NCT00599638|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92797997|NCT00599638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92797998|NCT00599638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92797999|NCT00599638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92798000|NCT00599638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92798001|NCT00599638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798002|NCT00599638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798003|NCT00599638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798004|NCT02642146|Calcium Channel Blockers|calcium channel blockers|mesh-list
92798005|NCT02642146|Vasodilator Agents|vasodilator agents|mesh-list
92798006|NCT02642146|Calcium|calcium|mesh-list
92798007|NCT02642146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
92798008|NCT02642146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92798009|NCT02642146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798010|NCT02642146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798011|NCT02642146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798012|NCT02642146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798013|NCT00654394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92798014|NCT00654394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92798015|NCT00654394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92798016|NCT00654394|Antimetabolites|antimetabolites|mesh-ancestor
92798017|NCT00654394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798018|NCT00654394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92798019|NCT00654394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92798020|NCT00654394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798021|NCT00653302|Metformin|metformin|mesh-list
92798022|NCT00653302|Insulin Glargine|insulin glargine|mesh-list
92798023|NCT00653302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798024|NCT00653302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798025|NCT02638870|Amitriptyline|amitriptyline|mesh-list
92798026|NCT02638870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92798027|NCT02638870|Antidepressive Agents|antidepressive agents|mesh-ancestor
92798029|NCT02638870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92798030|NCT02638870|Analgesics|analgesics|mesh-ancestor
92798031|NCT02638870|Sensory System Agents|sensory system agents|mesh-ancestor
92716180|NCT01792934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798032|NCT02638870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798033|NCT02638870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798034|NCT02638870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92798035|NCT02638870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92798036|NCT02638870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798037|NCT02638870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798038|NCT02638870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92798039|NCT02638870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798040|NCT02641990|Exenatide|exenatide|mesh-list
92798041|NCT02641990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798042|NCT02641990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798043|NCT02641990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92798045|NCT02641990|Hormones|hormones|mesh-ancestor
92798046|NCT02641990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798047|NCT00653380|Doxycycline|doxycycline|mesh-list
92798048|NCT00653380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798049|NCT00653380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798050|NCT00653380|Antimalarials|antimalarials|mesh-ancestor
92798051|NCT00653380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92798052|NCT00653380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92798053|NCT02646592|Alfentanil|alfentanil|mesh-list
92798054|NCT02646592|Propofol|propofol|mesh-list
92798055|NCT02646592|Sevoflurane|sevoflurane|mesh-list
92798056|NCT02646592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92798057|NCT02646592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798058|NCT02646592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798059|NCT02646592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92798060|NCT02646592|Anesthetics, General|anesthetics, general|mesh-ancestor
92798061|NCT02646592|Anesthetics|anesthetics|mesh-ancestor
92798062|NCT02646592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92798063|NCT02646592|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92798064|NCT02646592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92798065|NCT02646592|Narcotics|narcotics|mesh-ancestor
92798066|NCT02646592|Analgesics|analgesics|mesh-ancestor
92798067|NCT02646592|Sensory System Agents|sensory system agents|mesh-ancestor
92798068|NCT02646592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798069|NCT02646670|Ranibizumab|ranibizumab|mesh-list
92798070|NCT02646670|Aflibercept|aflibercept|mesh-list
92798071|NCT02646670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92798072|NCT02646670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92798073|NCT02646670|Growth Substances|growth substances|mesh-ancestor
92798074|NCT02646670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798075|NCT02646670|Growth Inhibitors|growth inhibitors|mesh-ancestor
92798076|NCT02646670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798077|NCT00651976|Letrozole|letrozole|mesh-list
92798078|NCT00651976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798079|NCT00651976|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92798080|NCT00651976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92798081|NCT00651976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798082|NCT00651976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798083|NCT00651976|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92798084|NCT00651976|Hormone Antagonists|hormone antagonists|mesh-ancestor
92798085|NCT00651976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798086|NCT00651976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798087|NCT01166282|Adalimumab|adalimumab|mesh-list
92798088|NCT01166282|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92798089|NCT01166282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798090|NCT01166282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92798091|NCT01153724|Fluconazole|fluconazole|mesh-list
92798092|NCT01153724|Antifungal Agents|antifungal agents|mesh-ancestor
92798093|NCT01153724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798094|NCT01153724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92798095|NCT01153724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92798096|NCT01153724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798097|NCT01153724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798098|NCT01153724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92798099|NCT01153724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92798100|NCT01153724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798101|NCT01153724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798102|NCT01153724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92798103|NCT01153724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92798104|NCT02884388|Anesthetics|anesthetics|mesh-list
92798105|NCT02884388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798106|NCT02884388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798107|NCT02885948|Naloxone|naloxone|mesh-list
92798108|NCT02885948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92798109|NCT02885948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798110|NCT02885948|Sensory System Agents|sensory system agents|mesh-ancestor
92798111|NCT02885948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798112|NCT01152788|Dacarbazine|dacarbazine|mesh-list
92798113|NCT01152788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92798114|NCT01152788|Alkylating Agents|alkylating agents|mesh-ancestor
92798115|NCT01152788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798116|NCT01152788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798117|NCT01165424|Mometasone Furoate|mometasone furoate|mesh-list
92798118|NCT01165424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798119|NCT01165424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92798120|NCT01165424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92798121|NCT00598702|Acetaminophen|acetaminophen|mesh-list
92798122|NCT00598702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92798123|NCT00598702|Analgesics|analgesics|mesh-ancestor
92798124|NCT00598702|Sensory System Agents|sensory system agents|mesh-ancestor
92798125|NCT00598702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798126|NCT00598702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798127|NCT00598702|Antipyretics|antipyretics|mesh-ancestor
92798128|NCT01148810|Siponimod|siponimod|mesh-list
92798129|NCT01148810|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92798130|NCT01148810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798131|NCT01148810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92798132|NCT01148810|Immunologic Factors|immunologic factors|mesh-ancestor
92798133|NCT01148810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798134|NCT02884310|Remifentanil|remifentanil|mesh-list
92798135|NCT02884310|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92798136|NCT02884310|Narcotics|narcotics|mesh-ancestor
92798137|NCT02884310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798138|NCT02884310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798139|NCT02884310|Analgesics|analgesics|mesh-ancestor
92798140|NCT02884310|Sensory System Agents|sensory system agents|mesh-ancestor
92798141|NCT02884310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798142|NCT01164956|Methylphenidate|methylphenidate|mesh-list
92798143|NCT01164956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92798144|NCT01164956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798145|NCT01164956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92798146|NCT01164956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92798147|NCT01164956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798148|NCT01164956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798149|NCT01164956|Dopamine Agents|dopamine agents|mesh-ancestor
92798150|NCT01164956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798151|NCT01151540|Rufinamide|rufinamide|mesh-list
92798152|NCT01151540|Anticonvulsants|anticonvulsants|mesh-ancestor
92798153|NCT01151540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92798154|NCT01151540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92798155|NCT01151540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798156|NCT01151540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798157|NCT01163786|Bortezomib|bortezomib|mesh-list
92798158|NCT01163786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798159|NCT05367362|Minocycline|minocycline|mesh-list
92798160|NCT05367362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798161|NCT05367362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798162|NCT00984282|Sorafenib|sorafenib|mesh-list
92798163|NCT00984282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798164|NCT00984282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92798165|NCT00984282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798166|NCT00984282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798167|NCT04187196|Propofol|propofol|mesh-list
92798168|NCT04187196|Methohexital|methohexital|mesh-list
92798169|NCT04187196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92798170|NCT04187196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798171|NCT04187196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798172|NCT04187196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92798173|NCT04187196|Anesthetics, General|anesthetics, general|mesh-ancestor
92798174|NCT04187196|Anesthetics|anesthetics|mesh-ancestor
92798175|NCT04292184|Sodium thiosulfate|sodium thiosulfate|mesh-list
92798176|NCT04292184|Antidotes|antidotes|mesh-ancestor
92798177|NCT04292184|Protective Agents|protective agents|mesh-ancestor
92798178|NCT04292184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798179|NCT04292184|Antioxidants|antioxidants|mesh-ancestor
92798180|NCT04292184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798181|NCT04292184|Antitubercular Agents|antitubercular agents|mesh-ancestor
92798182|NCT04292184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798183|NCT04292184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798184|NCT04292184|Chelating Agents|chelating agents|mesh-ancestor
92798185|NCT04292184|Sequestering Agents|sequestering agents|mesh-ancestor
92798186|NCT01147640|Metronidazole|metronidazole|mesh-list
92798187|NCT01147640|Meropenem|meropenem|mesh-list
92798188|NCT01147640|Tazobactam|tazobactam|mesh-list
92798189|NCT01147640|Ceftolozane|ceftolozane|mesh-list
92798190|NCT01147640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798191|NCT01147640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798192|NCT01147640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92798193|NCT01147640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92798194|NCT01147640|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92798195|NCT01147640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798196|NCT01147640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798197|NCT02867982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92798198|NCT02867982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798199|NCT01121900|Trazodone|trazodone|mesh-list
92798200|NCT01121900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92798201|NCT01121900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798202|NCT01121900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798203|NCT01121900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798204|NCT01121900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798205|NCT01121900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92798206|NCT01121900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92798207|NCT01121900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798208|NCT01121900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798209|NCT01121900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798210|NCT01121900|Serotonin Agents|serotonin agents|mesh-ancestor
92798211|NCT01121900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92798212|NCT01121900|Antidepressive Agents|antidepressive agents|mesh-ancestor
92798213|NCT01121666|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92798214|NCT01121666|Hormones|hormones|mesh-ancestor
92798215|NCT01121666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798216|NCT01121666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798217|NCT00984126|Factor VIII|factor viii|mesh-list
92798218|NCT00984126|Coagulants|coagulants|mesh-ancestor
92798219|NCT02868996|Kallikreins|kallikreins|mesh-list
92798220|NCT02868996|Coagulants|coagulants|mesh-ancestor
92798221|NCT02868996|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92798222|NCT02868996|Fertility Agents|fertility agents|mesh-ancestor
92798223|NCT02868996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92798224|NCT02868996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798225|NCT00629226|Cetuximab|cetuximab|mesh-list
92798226|NCT00629226|Bortezomib|bortezomib|mesh-list
92798227|NCT00629226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798228|NCT00629226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92798229|NCT00629304|Antithrombin III|antithrombin iii|mesh-list
92798230|NCT00629304|Antithrombins|antithrombins|mesh-list
92798231|NCT00629304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92798232|NCT00629304|Protease Inhibitors|protease inhibitors|mesh-ancestor
92798233|NCT00629304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798234|NCT00629304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798235|NCT00629304|Anticoagulants|anticoagulants|mesh-ancestor
92798236|NCT05297929|Irbesartan|irbesartan|mesh-list
92798237|NCT05297929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92798238|NCT05297929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92798239|NCT05297929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92798240|NCT05297929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798241|NCT00826111|Eszopiclone|eszopiclone|mesh-list
92798242|NCT00826111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92798243|NCT00826111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798244|NCT00826111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798245|NCT00982644|Insulin|insulin|mesh-list
92798246|NCT00982644|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92798247|NCT00982644|Insulin Glargine|insulin glargine|mesh-list
92798248|NCT00982644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798249|NCT00982644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798250|NCT00815659|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92798251|NCT00815659|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92798252|NCT00815659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92798253|NCT00815659|Antimetabolites|antimetabolites|mesh-ancestor
92798254|NCT00815659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798255|NCT00815659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92798256|NCT00815659|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92798257|NCT00815659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798258|NCT02867904|Methylprednisolone|methylprednisolone|mesh-list
92798259|NCT02867904|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92798260|NCT02867904|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92798261|NCT02867904|Prednisolone|prednisolone|mesh-list
92798262|NCT02867904|Prednisolone acetate|prednisolone acetate|mesh-list
92798263|NCT02867904|Bupivacaine|bupivacaine|mesh-list
92798264|NCT02867904|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92798265|NCT02867904|Prednisolone phosphate|prednisolone phosphate|mesh-list
92798266|NCT02867904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798267|NCT02867904|Antiemetics|antiemetics|mesh-ancestor
92798268|NCT02867904|Autonomic Agents|autonomic agents|mesh-ancestor
92798269|NCT02867904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798270|NCT02867904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798271|NCT02867904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92798272|NCT02867904|Glucocorticoids|glucocorticoids|mesh-ancestor
92798273|NCT02867904|Hormones|hormones|mesh-ancestor
92798274|NCT02867904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798275|NCT02867904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92798276|NCT02867904|Protective Agents|protective agents|mesh-ancestor
92798277|NCT02867904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92798278|NCT02867904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798279|NCT02867904|Anesthetics, Local|anesthetics, local|mesh-ancestor
92798280|NCT02867904|Anesthetics|anesthetics|mesh-ancestor
92798281|NCT02867904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798282|NCT02867904|Sensory System Agents|sensory system agents|mesh-ancestor
92798283|NCT04290936|Tenofovir|tenofovir|mesh-list
92798284|NCT04290936|Antiviral Agents|antiviral agents|mesh-ancestor
92798285|NCT04290936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798286|NCT04290936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92798287|NCT04290936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92798288|NCT04290936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798289|NCT04290936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798290|NCT04290936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92798291|NCT04290936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92798292|NCT00707941|Oseltamivir|oseltamivir|mesh-list
92798293|NCT00707941|Antiviral Agents|antiviral agents|mesh-ancestor
92798294|NCT00707941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798295|NCT00707941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798296|NCT00707941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798297|NCT00824473|Azelastine|azelastine|mesh-list
92798298|NCT00824473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92798299|NCT00824473|Autonomic Agents|autonomic agents|mesh-ancestor
92798300|NCT00824473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798301|NCT00824473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798302|NCT00824473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92798303|NCT00824473|Respiratory System Agents|respiratory system agents|mesh-ancestor
92798304|NCT00824473|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92798305|NCT00824473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798306|NCT00824473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798307|NCT00824473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92798308|NCT00824473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92798309|NCT00824473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92798310|NCT00824473|Histamine Antagonists|histamine antagonists|mesh-ancestor
92798311|NCT00824473|Histamine Agents|histamine agents|mesh-ancestor
92798312|NCT00824473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798313|NCT04291092|Immunomodulating Agents|immunomodulating agents|mesh-list
92798314|NCT04291092|Immunologic Factors|immunologic factors|mesh-ancestor
92798315|NCT04291092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798316|NCT02867280|Sorafenib|sorafenib|mesh-list
92798317|NCT02867280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798318|NCT02867280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92798319|NCT02867280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798320|NCT02867280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798321|NCT04290390|Itraconazole|itraconazole|mesh-list
92798322|NCT04290390|Rifampin|rifampin|mesh-list
92798323|NCT04290390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92798324|NCT04290390|Estradiol|estradiol|mesh-list
92798325|NCT04290390|Estrogens|estrogens|mesh-ancestor
92798326|NCT04290390|Hormones|hormones|mesh-ancestor
92798327|NCT04290390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798328|NCT04290390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798329|NCT04290390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92798330|NCT04290390|Contraceptive Agents|contraceptive agents|mesh-ancestor
92798331|NCT04290390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92798332|NCT04290390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92798333|NCT04290390|Antifungal Agents|antifungal agents|mesh-ancestor
92798334|NCT04290390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798335|NCT04290390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92798336|NCT04290390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92798337|NCT04290390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798338|NCT04290390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798339|NCT04290390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92798340|NCT04290390|Hormone Antagonists|hormone antagonists|mesh-ancestor
92443365|NCT01650727|Rituximab|rituximab|mesh-list
92798341|NCT04290390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92798342|NCT04290390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92798343|NCT04290390|Antitubercular Agents|antitubercular agents|mesh-ancestor
92798344|NCT04290390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798345|NCT04290390|Leprostatic Agents|leprostatic agents|mesh-ancestor
92798346|NCT04290390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92798347|NCT04290390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92798348|NCT04290390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92798349|NCT04290390|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92798350|NCT04290390|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92798351|NCT04290390|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92798352|NCT04290390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92798353|NCT04290390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92798354|NCT04290390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92798355|NCT04290858|Nitric Oxide|nitric oxide|mesh-list
92798356|NCT04290858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92798357|NCT04290858|Autonomic Agents|autonomic agents|mesh-ancestor
92798358|NCT04290858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716515|NCT00560274|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92798359|NCT04290858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798360|NCT04290858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92798361|NCT04290858|Respiratory System Agents|respiratory system agents|mesh-ancestor
92798362|NCT04290858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92798363|NCT04290858|Antioxidants|antioxidants|mesh-ancestor
92798364|NCT04290858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798365|NCT04290858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798366|NCT04290858|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92798367|NCT04290858|Vasodilator Agents|vasodilator agents|mesh-ancestor
92798368|NCT04290858|Gasotransmitters|gasotransmitters|mesh-ancestor
92798369|NCT04290858|Protective Agents|protective agents|mesh-ancestor
92798370|NCT05326555|Imidacloprid|imidacloprid|mesh-list
92798371|NCT05326555|Cholinergic Agents|cholinergic agents|mesh-ancestor
92798372|NCT05326555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798373|NCT05326555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798374|NCT05326555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798375|NCT02610829|Vitamin E|vitamin e|mesh-list
92798376|NCT02610829|Tocopherols|tocopherols|mesh-list
92798377|NCT02610829|Tocotrienols|tocotrienols|mesh-list
92798378|NCT02610829|alpha-Tocopherol|alpha-tocopherol|mesh-list
92798379|NCT02610829|gamma-Tocopherol|gamma-tocopherol|mesh-list
92798380|NCT02610829|Vitamins|vitamins|mesh-ancestor
92798381|NCT02610829|Micronutrients|micronutrients|mesh-ancestor
92798382|NCT02610829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798383|NCT02610829|Antioxidants|antioxidants|mesh-ancestor
92798384|NCT02610829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798385|NCT02610829|Protective Agents|protective agents|mesh-ancestor
92798386|NCT04104672|Paclitaxel|paclitaxel|mesh-list
92798387|NCT04104672|Gemcitabine|gemcitabine|mesh-list
92798388|NCT04104672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92798389|NCT04104672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798390|NCT04104672|Tubulin Modulators|tubulin modulators|mesh-ancestor
92798391|NCT04104672|Antimitotic Agents|antimitotic agents|mesh-ancestor
92798392|NCT04104672|Mitosis Modulators|mitosis modulators|mesh-ancestor
92798393|NCT04104672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798394|NCT04104672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92798395|NCT04104672|Antimetabolites|antimetabolites|mesh-ancestor
92798396|NCT02865564|Gentamicins|gentamicins|mesh-list
92798397|NCT02865564|Ampicillin|ampicillin|mesh-list
92798398|NCT02865564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798399|NCT02865564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798401|NCT02865564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798402|NCT02865564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798403|NCT00814879|Raltegravir Potassium|raltegravir potassium|mesh-list
92798404|NCT00814879|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92798405|NCT00814879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92798406|NCT00814879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92798407|NCT00814879|Antiviral Agents|antiviral agents|mesh-ancestor
92798408|NCT00814879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798409|NCT00814879|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92798410|NCT00814879|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92798411|NCT00814879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798412|NCT00814879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798413|NCT00814879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92798414|NCT00814879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92443436|NCT01651312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798415|NCT00814879|Protease Inhibitors|protease inhibitors|mesh-ancestor
92798417|NCT00814801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92798418|NCT00814801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798419|NCT00814801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798420|NCT00814801|Cholinergic Agents|cholinergic agents|mesh-ancestor
92798421|NCT00814801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798422|NCT00814801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798423|NCT00814801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92798424|NCT00814801|Autonomic Agents|autonomic agents|mesh-ancestor
92798425|NCT00814801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798426|NCT00814801|Nootropic Agents|nootropic agents|mesh-ancestor
92798427|NCT00653458|Ondansetron|ondansetron|mesh-list
92798428|NCT00653458|Antiemetics|antiemetics|mesh-ancestor
92798429|NCT00653458|Autonomic Agents|autonomic agents|mesh-ancestor
92798430|NCT00653458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798431|NCT00653458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798432|NCT00653458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92798433|NCT00653458|Antipruritics|antipruritics|mesh-ancestor
92798434|NCT00653458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92798435|NCT00653458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92798436|NCT00653458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92798437|NCT00653458|Serotonin Agents|serotonin agents|mesh-ancestor
92798438|NCT00653458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798439|NCT00653458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798440|NCT02708836|Anesthetics|anesthetics|mesh-list
92798441|NCT02708836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798442|NCT02708836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798443|NCT00708565|Iloprost|iloprost|mesh-list
92798444|NCT00708565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92798445|NCT00708565|Vasodilator Agents|vasodilator agents|mesh-ancestor
92798446|NCT00812461|Nalmefene|nalmefene|mesh-list
92798447|NCT00812461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92798448|NCT00812461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798449|NCT00812461|Sensory System Agents|sensory system agents|mesh-ancestor
92798450|NCT00812461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798451|NCT00599326|Deferasirox|deferasirox|mesh-list
92798452|NCT00599326|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92798453|NCT00599326|Chelating Agents|chelating agents|mesh-ancestor
92798454|NCT00599326|Sequestering Agents|sequestering agents|mesh-ancestor
92798455|NCT00599326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798456|NCT00978432|Everolimus|everolimus|mesh-list
92798457|NCT00978432|Panobinostat|panobinostat|mesh-list
92798458|NCT00978432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92798459|NCT00978432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92798460|NCT00978432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798461|NCT00978432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798462|NCT00978432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92798463|NCT00978432|Immunologic Factors|immunologic factors|mesh-ancestor
92798464|NCT00978432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798465|NCT00978432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798466|NCT00978432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92798467|NCT04166812|Nitric Oxide|nitric oxide|mesh-list
92798468|NCT04166812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92798469|NCT04166812|Autonomic Agents|autonomic agents|mesh-ancestor
92798470|NCT04166812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798471|NCT04166812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798472|NCT04166812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92798473|NCT04166812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92798474|NCT04166812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92798475|NCT04166812|Antioxidants|antioxidants|mesh-ancestor
92798476|NCT04166812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798477|NCT04166812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798478|NCT04166812|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92798479|NCT04166812|Vasodilator Agents|vasodilator agents|mesh-ancestor
92798480|NCT04166812|Gasotransmitters|gasotransmitters|mesh-ancestor
92798481|NCT04166812|Protective Agents|protective agents|mesh-ancestor
92798482|NCT00708799|Azithromycin|azithromycin|mesh-list
92798483|NCT00708799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798484|NCT00708799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798485|NCT02610127|Factor VIII|factor viii|mesh-list
92798486|NCT02610127|Coagulants|coagulants|mesh-ancestor
92798487|NCT00814333|Thrombin|thrombin|mesh-list
92798488|NCT00814333|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
92798489|NCT00814333|Hemostatics|hemostatics|mesh-ancestor
92798490|NCT00814333|Coagulants|coagulants|mesh-ancestor
92798491|NCT01147250|Lixisenatide|lixisenatide|mesh-list
92798492|NCT01147250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798493|NCT01147250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798494|NCT00813943|Temozolomide|temozolomide|mesh-list
92798495|NCT00813943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92798496|NCT00813943|Alkylating Agents|alkylating agents|mesh-ancestor
92798497|NCT00813943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798498|NCT00813943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798499|NCT00821509|Disinfectants|disinfectants|mesh-list
92798500|NCT00821509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798501|NCT01134614|Ipilimumab|ipilimumab|mesh-list
92798502|NCT01134614|Sargramostim|sargramostim|mesh-list
92798503|NCT01134614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92798504|NCT01134614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798505|NCT01134614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92798506|NCT01134614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798507|NCT01134614|Immunologic Factors|immunologic factors|mesh-ancestor
92798508|NCT01134614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798509|NCT00913861|Fentanyl|fentanyl|mesh-list
92798510|NCT00913861|Propofol|propofol|mesh-list
92798511|NCT00913861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92798512|NCT00913861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798513|NCT00913861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798514|NCT00913861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92798515|NCT00913861|Anesthetics, General|anesthetics, general|mesh-ancestor
92798516|NCT00913861|Anesthetics|anesthetics|mesh-ancestor
92798517|NCT00913861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92798518|NCT00913861|Narcotics|narcotics|mesh-ancestor
92798519|NCT00913861|Analgesics|analgesics|mesh-ancestor
92798520|NCT00913861|Sensory System Agents|sensory system agents|mesh-ancestor
92798521|NCT00913861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798522|NCT00913861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92798523|NCT00709189|Folic Acid|folic acid|mesh-list
92798524|NCT00709189|Norgestimate|norgestimate|mesh-list
92798525|NCT00709189|Estradiol|estradiol|mesh-list
92798526|NCT00709189|Estrogens|estrogens|mesh-ancestor
92798527|NCT00709189|Hormones|hormones|mesh-ancestor
92798528|NCT00709189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798529|NCT00709189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798530|NCT00709189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92798531|NCT00709189|Contraceptive Agents|contraceptive agents|mesh-ancestor
92798532|NCT00709189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92798533|NCT00709189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92798534|NCT00709189|Hematinics|hematinics|mesh-ancestor
92798535|NCT00709189|Vitamin B Complex|vitamin b complex|mesh-ancestor
92798536|NCT00709189|Vitamins|vitamins|mesh-ancestor
92798537|NCT00709189|Micronutrients|micronutrients|mesh-ancestor
92798538|NCT00709189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92798539|NCT00709189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92798540|NCT00709267|Folic Acid|folic acid|mesh-list
92798541|NCT00709267|Hematinics|hematinics|mesh-ancestor
92798542|NCT00709267|Vitamin B Complex|vitamin b complex|mesh-ancestor
92798543|NCT00709267|Vitamins|vitamins|mesh-ancestor
92798544|NCT00709267|Micronutrients|micronutrients|mesh-ancestor
92798545|NCT00709267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798546|NCT00591565|Acamprosate|acamprosate|mesh-list
92798547|NCT00591565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92798548|NCT00978120|Vaccines|vaccines|mesh-list
92798549|NCT00978120|Immunologic Factors|immunologic factors|mesh-ancestor
92798550|NCT00978120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798551|NCT01133678|Paclitaxel|paclitaxel|mesh-list
92798552|NCT01133678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92798553|NCT01133678|Cisplatin|cisplatin|mesh-list
92798555|NCT01133678|Everolimus|everolimus|mesh-list
92798556|NCT01133678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92798557|NCT01133678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798558|NCT01133678|Tubulin Modulators|tubulin modulators|mesh-ancestor
92798559|NCT01133678|Antimitotic Agents|antimitotic agents|mesh-ancestor
92798560|NCT01133678|Mitosis Modulators|mitosis modulators|mesh-ancestor
92798561|NCT01133678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798562|NCT01133678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92798563|NCT01133678|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92798564|NCT01133678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92798565|NCT01133678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798566|NCT01133678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92798567|NCT01133678|Immunologic Factors|immunologic factors|mesh-ancestor
92798568|NCT01133678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798569|NCT00652132|Sodium thiosulfate|sodium thiosulfate|mesh-list
92443587|NCT01652014|Fludarabine|fludarabine|mesh-list
92798571|NCT00652132|Protective Agents|protective agents|mesh-ancestor
92798572|NCT00652132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798573|NCT00652132|Antioxidants|antioxidants|mesh-ancestor
92798574|NCT00652132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798575|NCT00652132|Antitubercular Agents|antitubercular agents|mesh-ancestor
92798576|NCT00652132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798577|NCT00652132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798578|NCT00652132|Chelating Agents|chelating agents|mesh-ancestor
92798579|NCT00652132|Sequestering Agents|sequestering agents|mesh-ancestor
92798580|NCT00655174|Fluvoxamine|fluvoxamine|mesh-list
92798581|NCT00655174|Sertraline|sertraline|mesh-list
92798582|NCT00655174|Antidepressive Agents|antidepressive agents|mesh-ancestor
92798583|NCT00655174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798584|NCT00655174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92798585|NCT00655174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92798586|NCT00655174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798587|NCT00655174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798588|NCT00655174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798589|NCT00655174|Serotonin Agents|serotonin agents|mesh-ancestor
92798590|NCT00655174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798591|NCT00655174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92798592|NCT00655174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798593|NCT00655174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798594|NCT00655174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92798595|NCT00655174|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92798596|NCT00655174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92798597|NCT00655174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798598|NCT00655174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92798599|NCT00655018|Ascorbic Acid|ascorbic acid|mesh-list
92798600|NCT00655018|Tocopherols|tocopherols|mesh-list
92798601|NCT00655018|Vitamin E|vitamin e|mesh-list
92798602|NCT00655018|alpha-Tocopherol|alpha-tocopherol|mesh-list
92798603|NCT00655018|Vitamins|vitamins|mesh-ancestor
92798604|NCT00655018|Micronutrients|micronutrients|mesh-ancestor
92798605|NCT00655018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798606|NCT00655018|Antioxidants|antioxidants|mesh-ancestor
92798607|NCT00655018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798608|NCT00655018|Protective Agents|protective agents|mesh-ancestor
92798609|NCT02635750|Donepezil|donepezil|mesh-list
92798610|NCT02635750|BI 409306|bi 409306|mesh-list
92798611|NCT02635750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92798612|NCT02635750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798613|NCT02635750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798614|NCT02635750|Cholinergic Agents|cholinergic agents|mesh-ancestor
92798615|NCT02635750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798616|NCT02635750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798617|NCT02635750|Nootropic Agents|nootropic agents|mesh-ancestor
92798618|NCT02635750|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92798619|NCT04164238|Paclitaxel|paclitaxel|mesh-list
92798620|NCT04164238|Carboplatin|carboplatin|mesh-list
92798621|NCT04164238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92798622|NCT04164238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798623|NCT04164238|Tubulin Modulators|tubulin modulators|mesh-ancestor
92798624|NCT04164238|Antimitotic Agents|antimitotic agents|mesh-ancestor
92798625|NCT04164238|Mitosis Modulators|mitosis modulators|mesh-ancestor
92798626|NCT04164238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798627|NCT02645734|Bevacizumab|bevacizumab|mesh-list
92798628|NCT02645734|Aflibercept|aflibercept|mesh-list
92798629|NCT02645734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92798630|NCT02645734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798631|NCT02645734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92798632|NCT02645734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92798633|NCT02645734|Growth Substances|growth substances|mesh-ancestor
92798634|NCT02645734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798635|NCT02645734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92798636|NCT01133522|Evolocumab|evolocumab|mesh-list
92798637|NCT01133522|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92798638|NCT01133522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92798639|NCT01133522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92798640|NCT01133522|Antimetabolites|antimetabolites|mesh-ancestor
92798641|NCT01133522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798642|NCT01133522|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92798643|NCT01133522|Protease Inhibitors|protease inhibitors|mesh-ancestor
92798644|NCT01133522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798645|NCT01133522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92798647|NCT00682318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92798648|NCT00682318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798649|NCT00682318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798650|NCT00682318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798651|NCT02881892|Dialysis Solutions|dialysis solutions|mesh-list
92798652|NCT02881892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92798653|NCT00655252|Everolimus|everolimus|mesh-list
92798654|NCT00655252|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92798655|NCT00655252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92798656|NCT00655252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798657|NCT00655252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798658|NCT00655252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92798659|NCT00655252|Immunologic Factors|immunologic factors|mesh-ancestor
92798660|NCT00655252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798661|NCT00655252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798662|NCT00883090|Fibrinolysin|fibrinolysin|mesh-list
92798663|NCT00883090|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92798664|NCT00883090|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92798665|NCT00883090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798666|NCT02645656|Curcumin|curcumin|mesh-list
92798667|NCT02645656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92798668|NCT02645656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92798669|NCT02645656|Analgesics|analgesics|mesh-ancestor
92798670|NCT02645656|Sensory System Agents|sensory system agents|mesh-ancestor
92798671|NCT02645656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798672|NCT02645656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798673|NCT02645656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798674|NCT02645656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92798675|NCT02645656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798676|NCT02645656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798677|NCT02645656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798678|NCT01132820|Cediranib|cediranib|mesh-list
92798679|NCT01132820|Maleic acid|maleic acid|mesh-list
92798680|NCT01132820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798681|NCT01132820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798682|NCT01132820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798683|NCT01132820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92798684|NCT00655330|Valsartan|valsartan|mesh-list
92798685|NCT00655330|Probucol|probucol|mesh-list
92798686|NCT00655330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92798687|NCT00655330|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92798688|NCT00655330|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92798689|NCT00655330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798690|NCT00655330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92798691|NCT00655330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92798692|NCT00655330|Antimetabolites|antimetabolites|mesh-ancestor
92798693|NCT00655330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92798694|NCT00655330|Antioxidants|antioxidants|mesh-ancestor
92798695|NCT00655330|Protective Agents|protective agents|mesh-ancestor
92798696|NCT00655330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798698|NCT00655408|Trace Elements|trace elements|mesh-ancestor
92798699|NCT00655408|Micronutrients|micronutrients|mesh-ancestor
92798700|NCT00655408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798701|NCT04163536|Methylprednisolone|methylprednisolone|mesh-list
92798702|NCT04163536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92798703|NCT04163536|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92745085|NCT01192191|Xhance|xhance|mesh-list
92798704|NCT04163536|Prednisolone|prednisolone|mesh-list
92798705|NCT04163536|Prednisolone acetate|prednisolone acetate|mesh-list
92798706|NCT04163536|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92798707|NCT04163536|Prednisolone phosphate|prednisolone phosphate|mesh-list
92798708|NCT04163536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798709|NCT04163536|Antiemetics|antiemetics|mesh-ancestor
92798710|NCT04163536|Autonomic Agents|autonomic agents|mesh-ancestor
92798711|NCT04163536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798712|NCT04163536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798713|NCT04163536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92798714|NCT04163536|Glucocorticoids|glucocorticoids|mesh-ancestor
92798715|NCT04163536|Hormones|hormones|mesh-ancestor
92798716|NCT04163536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798717|NCT04163536|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92798718|NCT04163536|Protective Agents|protective agents|mesh-ancestor
92798719|NCT04163536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92798720|NCT04163536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798721|NCT00652288|Insulin|insulin|mesh-list
92798722|NCT00652288|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92798723|NCT00652288|Insulin Glargine|insulin glargine|mesh-list
92798724|NCT00652288|Insulin Aspart|insulin aspart|mesh-list
92798725|NCT00652288|Insulin, Long-Acting|insulin, long-acting|mesh-list
92798726|NCT00652288|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92798727|NCT00652288|Insulin Lispro|insulin lispro|mesh-list
92798728|NCT00652288|Insulin Detemir|insulin detemir|mesh-list
92798729|NCT00652288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798730|NCT00652288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798731|NCT00911092|Fluorouracil|fluorouracil|mesh-list
92798732|NCT00911092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798733|NCT00911092|Antimetabolites|antimetabolites|mesh-ancestor
92798734|NCT00911092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798735|NCT00911092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92798736|NCT00911092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92798737|NCT00911092|Immunologic Factors|immunologic factors|mesh-ancestor
92798738|NCT00911092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798739|NCT02635360|Pembrolizumab|pembrolizumab|mesh-list
92798740|NCT02635360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798741|NCT02635360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92798742|NCT02635360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92798743|NCT02635360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798744|NCT02635282|Fentanyl|fentanyl|mesh-list
92798745|NCT02635282|Midazolam|midazolam|mesh-list
92798746|NCT02635282|Ketamine|ketamine|mesh-list
92798747|NCT02635282|Analgesics|analgesics|mesh-ancestor
92798748|NCT02635282|Sensory System Agents|sensory system agents|mesh-ancestor
92798749|NCT02635282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798750|NCT02635282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798751|NCT02635282|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92798752|NCT02635282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92798753|NCT02635282|Anesthetics, General|anesthetics, general|mesh-ancestor
92798754|NCT02635282|Anesthetics|anesthetics|mesh-ancestor
92798755|NCT02635282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798756|NCT02635282|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92798757|NCT02635282|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92798758|NCT02635282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798759|NCT02635282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798760|NCT02635282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92798761|NCT02635282|Narcotics|narcotics|mesh-ancestor
92798762|NCT02635282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92798763|NCT02635282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92798764|NCT02635282|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92798765|NCT02635282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798766|NCT02635282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798767|NCT02635282|GABA Modulators|gaba modulators|mesh-ancestor
92798768|NCT02635282|GABA Agents|gaba agents|mesh-ancestor
92798769|NCT00655798|Antioxidants|antioxidants|mesh-list
92798770|NCT00655798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798771|NCT00655798|Protective Agents|protective agents|mesh-ancestor
92798772|NCT00655798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798773|NCT02637700|Immunoglobulins|immunoglobulins|mesh-list
92798774|NCT02637700|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92798775|NCT02637700|Antibodies|antibodies|mesh-list
92798776|NCT02637700|gamma-Globulins|gamma-globulins|mesh-list
92798777|NCT02637700|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92798778|NCT02637700|Immunologic Factors|immunologic factors|mesh-ancestor
92798779|NCT02637700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798780|NCT02637466|Vortioxetine|vortioxetine|mesh-list
92798782|NCT02637466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798783|NCT02637466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92798784|NCT02637466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798785|NCT02637466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798786|NCT02637466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798787|NCT02637466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92798788|NCT02637466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92798789|NCT02637466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798790|NCT02637466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798791|NCT02637466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798792|NCT02637466|Serotonin Agents|serotonin agents|mesh-ancestor
92798793|NCT02637466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92798794|NCT02637466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92798795|NCT02637466|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92798796|NCT02637466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92798797|NCT02634970|Ranibizumab|ranibizumab|mesh-list
92798798|NCT02634970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92798799|NCT02634970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92798800|NCT02634970|Growth Substances|growth substances|mesh-ancestor
92798801|NCT02634970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798802|NCT02634970|Growth Inhibitors|growth inhibitors|mesh-ancestor
92798803|NCT02634970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798805|NCT00885352|Pioglitazone|pioglitazone|mesh-list
92798806|NCT00885352|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92798807|NCT00885352|Glipizide|glipizide|mesh-list
92798808|NCT00885352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798809|NCT00885352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798810|NCT00885352|Incretins|incretins|mesh-ancestor
92798811|NCT00885352|Hormones|hormones|mesh-ancestor
92798812|NCT00885352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798813|NCT00885352|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92798814|NCT00885352|Protease Inhibitors|protease inhibitors|mesh-ancestor
92798815|NCT00885352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798816|NCT00885352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798817|NCT00656032|Cinacalcet|cinacalcet|mesh-list
92798818|NCT00656032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92798819|NCT00656032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798820|NCT00656032|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92798821|NCT00656032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92798822|NCT00656032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798823|NCT00885118|Empagliflozin|empagliflozin|mesh-list
92798824|NCT00885118|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92798825|NCT00885118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798826|NCT00885118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798827|NCT00885118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798828|NCT00656812|Rituximab|rituximab|mesh-list
92798829|NCT00656812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92798830|NCT00656812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798831|NCT00656812|Immunologic Factors|immunologic factors|mesh-ancestor
92798832|NCT00656812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798833|NCT00656812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92798834|NCT00656110|Ethanol|ethanol|mesh-list
92798835|NCT00656110|Methylprednisolone|methylprednisolone|mesh-list
92798836|NCT00656110|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92798837|NCT00656110|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92798838|NCT00656110|Prednisolone|prednisolone|mesh-list
92798839|NCT00656110|Prednisolone acetate|prednisolone acetate|mesh-list
92798840|NCT00656110|Lidocaine|lidocaine|mesh-list
92798841|NCT00656110|Bupivacaine|bupivacaine|mesh-list
92798842|NCT00656110|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92798843|NCT00656110|Prednisolone phosphate|prednisolone phosphate|mesh-list
92798844|NCT00656110|Anesthetics, Local|anesthetics, local|mesh-ancestor
92798845|NCT00656110|Anesthetics|anesthetics|mesh-ancestor
92798846|NCT00656110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798847|NCT00656110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798848|NCT00656110|Sensory System Agents|sensory system agents|mesh-ancestor
92798849|NCT00656110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798850|NCT00656110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92798851|NCT00656110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92798852|NCT00656110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92798853|NCT00656110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798854|NCT00656110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798855|NCT00656110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798856|NCT00656110|Antiemetics|antiemetics|mesh-ancestor
92798857|NCT00656110|Autonomic Agents|autonomic agents|mesh-ancestor
92798858|NCT00656110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92798859|NCT00656110|Glucocorticoids|glucocorticoids|mesh-ancestor
92798860|NCT00656110|Hormones|hormones|mesh-ancestor
92798861|NCT00656110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92798862|NCT00656110|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92798863|NCT00656110|Protective Agents|protective agents|mesh-ancestor
92798864|NCT00656110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92798865|NCT00656110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798866|NCT00656110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92798867|NCT00656110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798868|NCT00656188|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92798869|NCT00656188|Vasodilator Agents|vasodilator agents|mesh-ancestor
92798870|NCT00656188|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92798871|NCT00656188|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92798872|NCT00656188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798873|NCT00656188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798874|NCT00656188|Urological Agents|urological agents|mesh-ancestor
92798875|NCT00880906|Fluticasone|fluticasone|mesh-list
92798876|NCT00880906|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92798877|NCT00880906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92798878|NCT00880906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92798879|NCT00880906|Autonomic Agents|autonomic agents|mesh-ancestor
92798880|NCT00880906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798881|NCT00880906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798882|NCT00880906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92798883|NCT00880906|Respiratory System Agents|respiratory system agents|mesh-ancestor
92798884|NCT00880906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92798885|NCT00880906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92798886|NCT00880906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798887|NCT00880906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798888|NCT04160026|Pyrimethamine|pyrimethamine|mesh-list
92798889|NCT04160026|Piperaquine|piperaquine|mesh-list
92798890|NCT04160026|Sulfadoxine|sulfadoxine|mesh-list
92798891|NCT04160026|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92798892|NCT04160026|Antimalarials|antimalarials|mesh-ancestor
92798893|NCT04160026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92798894|NCT04160026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92798895|NCT04160026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798896|NCT04160026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92798897|NCT04160026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798898|NCT04160026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798899|NCT04160026|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92798900|NCT04159870|Rifaximin|rifaximin|mesh-list
92798901|NCT04159870|Norfloxacin|norfloxacin|mesh-list
92798902|NCT04159870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798903|NCT04159870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798904|NCT04159870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92798905|NCT04159870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92798906|NCT04159870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92798907|NCT04159870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798908|NCT04159870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798909|NCT04159870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798910|NCT04159870|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92798911|NCT04159870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92798912|NCT00657514|Ranolazine|ranolazine|mesh-list
92798913|NCT00657514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92798914|NCT00657514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92798915|NCT00657514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798916|NCT00656266|Mycophenolic Acid|mycophenolic acid|mesh-list
92798917|NCT00656266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92798918|NCT00656266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798919|NCT00656266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92798920|NCT00656266|Antitubercular Agents|antitubercular agents|mesh-ancestor
92798921|NCT00656266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92798922|NCT00656266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798923|NCT00656266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717063|NCT05186675|Epinephryl borate|epinephryl borate|mesh-list
92798924|NCT00656266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798925|NCT00882310|Gemcitabine|gemcitabine|mesh-list
92798926|NCT00882310|Capecitabine|capecitabine|mesh-list
92798927|NCT00882310|Docetaxel|docetaxel|mesh-list
92798928|NCT00882310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92798929|NCT00882310|Antimetabolites|antimetabolites|mesh-ancestor
92798930|NCT00882310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798931|NCT00882310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92798932|NCT00882310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92798933|NCT00882310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92798934|NCT00882310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92798935|NCT00884650|Analgesics|analgesics|mesh-list
92798936|NCT00884650|Sensory System Agents|sensory system agents|mesh-ancestor
92798937|NCT00884650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798938|NCT00884650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798939|NCT02636842|Aripiprazole|aripiprazole|mesh-list
92798940|NCT02636842|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
92798941|NCT02636842|Antidepressive Agents|antidepressive agents|mesh-ancestor
92798942|NCT02636842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798943|NCT02636842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92798944|NCT02636842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798945|NCT02636842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798946|NCT02636842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798947|NCT02636842|Dopamine Agonists|dopamine agonists|mesh-ancestor
92798948|NCT02636842|Dopamine Agents|dopamine agents|mesh-ancestor
92798949|NCT02636842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92798950|NCT02636842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798951|NCT02636842|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92798952|NCT02636842|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92798953|NCT02636842|Serotonin Agents|serotonin agents|mesh-ancestor
92798954|NCT02636842|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92798955|NCT02636842|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92798956|NCT02636842|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92798957|NCT02636842|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92798958|NCT04161976|Insulin Lispro|insulin lispro|mesh-list
92798959|NCT04161976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798960|NCT04161976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798961|NCT00656422|Insulin|insulin|mesh-list
92798962|NCT00656422|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92798963|NCT00656422|Insulin Detemir|insulin detemir|mesh-list
92798964|NCT00656422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92798965|NCT00656422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798966|NCT02634034|Pitavastatin|pitavastatin|mesh-list
92798967|NCT02634034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92798968|NCT02634034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92798969|NCT02634034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92798970|NCT02634034|Antimetabolites|antimetabolites|mesh-ancestor
92798971|NCT02634034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798972|NCT02634034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798973|NCT02634034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92798974|NCT00657748|Triacetin|triacetin|mesh-list
92798975|NCT00657748|Lithium Carbonate|lithium carbonate|mesh-list
92798976|NCT00657748|Antidepressive Agents|antidepressive agents|mesh-ancestor
92798977|NCT00657748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92798978|NCT00657748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92798979|NCT00657748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92798980|NCT00657748|Antimanic Agents|antimanic agents|mesh-ancestor
92798981|NCT00657748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92798982|NCT00657748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798983|NCT00657748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798984|NCT00657748|Antifungal Agents|antifungal agents|mesh-ancestor
92798985|NCT00657748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92798986|NCT04161586|Prilocaine|prilocaine|mesh-list
92798987|NCT04161586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92798988|NCT04161586|Anesthetics|anesthetics|mesh-ancestor
92798989|NCT04161586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92798990|NCT04161586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798991|NCT04161586|Sensory System Agents|sensory system agents|mesh-ancestor
92798992|NCT04161586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798993|NCT02636218|Ketamine|ketamine|mesh-list
92798994|NCT02636218|Analgesics|analgesics|mesh-ancestor
92798995|NCT02636218|Sensory System Agents|sensory system agents|mesh-ancestor
92798996|NCT02636218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92798997|NCT02636218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92798998|NCT02636218|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92798999|NCT02636218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92799000|NCT02636218|Anesthetics, General|anesthetics, general|mesh-ancestor
92799001|NCT02636218|Anesthetics|anesthetics|mesh-ancestor
92799002|NCT02636218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799003|NCT02636218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92799004|NCT02636218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92799005|NCT02636218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799006|NCT02636218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799007|NCT04161508|Glycopyrrolate|glycopyrrolate|mesh-list
92799008|NCT04161508|Neostigmine|neostigmine|mesh-list
92799009|NCT04161508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92799010|NCT04161508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799011|NCT04161508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799012|NCT04161508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92799013|NCT04161508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799014|NCT04161508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799015|NCT04161508|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92799016|NCT04161508|Autonomic Agents|autonomic agents|mesh-ancestor
92799017|NCT04161508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799018|NCT04161508|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92799019|NCT04161508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92799020|NCT04161508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92799021|NCT00598078|Sodium Oxybate|sodium oxybate|mesh-list
92799022|NCT00598078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92799023|NCT00598078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92799024|NCT00598078|Anesthetics, General|anesthetics, general|mesh-ancestor
92799025|NCT00598078|Anesthetics|anesthetics|mesh-ancestor
92799026|NCT00598078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799027|NCT00598078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799028|NCT00883558|Insulin|insulin|mesh-list
92799029|NCT00883558|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92799030|NCT00883558|Insulin Glargine|insulin glargine|mesh-list
92799031|NCT00883558|Insulin Lispro|insulin lispro|mesh-list
92799032|NCT00883558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92799033|NCT00883558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799034|NCT04162834|Papaverine|papaverine|mesh-list
92799035|NCT04162834|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92799036|NCT04162834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799037|NCT04162834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799038|NCT04162834|Vasodilator Agents|vasodilator agents|mesh-ancestor
92799039|NCT04162834|Urological Agents|urological agents|mesh-ancestor
92799040|NCT00657904|Bicalutamide|bicalutamide|mesh-list
92799041|NCT00657904|Androgen Antagonists|androgen antagonists|mesh-ancestor
92799042|NCT00657904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92799043|NCT00657904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799044|NCT00657904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799045|NCT00657904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799046|NCT02633878|Progesterone|progesterone|mesh-list
92799047|NCT02633878|Progestins|progestins|mesh-ancestor
92799048|NCT02633878|Hormones|hormones|mesh-ancestor
92799049|NCT02633878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799050|NCT02633878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799051|NCT00597766|Triamcinolone|triamcinolone|mesh-list
92799052|NCT00597766|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92799053|NCT00597766|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92799054|NCT00597766|Lidocaine|lidocaine|mesh-list
92799055|NCT00597766|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92799056|NCT00597766|Anesthetics, Local|anesthetics, local|mesh-ancestor
92799057|NCT00597766|Anesthetics|anesthetics|mesh-ancestor
92799058|NCT00597766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799059|NCT00597766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799060|NCT00597766|Sensory System Agents|sensory system agents|mesh-ancestor
92799061|NCT00597766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799062|NCT00597766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92799063|NCT00597766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92799064|NCT00597766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92799065|NCT00597766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799066|NCT00597766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799067|NCT00597766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799068|NCT00597766|Glucocorticoids|glucocorticoids|mesh-ancestor
92799069|NCT00597766|Hormones|hormones|mesh-ancestor
92799070|NCT00597766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799071|NCT00597766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799072|NCT00597766|Immunologic Factors|immunologic factors|mesh-ancestor
92799073|NCT00597766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799074|NCT04161274|Silver Nitrate|silver nitrate|mesh-list
92799075|NCT04161274|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92799076|NCT04161274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799077|NCT00657982|Everolimus|everolimus|mesh-list
92799079|NCT00657982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92799080|NCT00657982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799081|NCT00657982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799082|NCT00657982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799083|NCT00657982|Immunologic Factors|immunologic factors|mesh-ancestor
92799084|NCT00657982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799085|NCT00657982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799086|NCT04159246|Sofosbuvir|sofosbuvir|mesh-list
92799087|NCT04159246|Antiviral Agents|antiviral agents|mesh-ancestor
92799088|NCT04159246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799089|NCT00979992|Sunitinib|sunitinib|mesh-list
92799090|NCT00979992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799091|NCT00979992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92799092|NCT00979992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92799093|NCT00979992|Growth Substances|growth substances|mesh-ancestor
92799094|NCT00979992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799095|NCT00979992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92799096|NCT00979992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92799097|NCT00979992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799098|NCT00979992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799100|NCT01079741|Mineral Oil|mineral oil|mesh-list
92799101|NCT01079741|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92799102|NCT01079741|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92799103|NCT01079741|Freund's Adjuvant|freund's adjuvant|mesh-list
92799104|NCT01079741|Poly ICLC|poly iclc|mesh-list
92799105|NCT01079741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92799106|NCT01079741|Immunologic Factors|immunologic factors|mesh-ancestor
92799107|NCT01079741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799108|NCT01079741|Interferon Inducers|interferon inducers|mesh-ancestor
92799109|NCT01079741|Laxatives|laxatives|mesh-ancestor
92799110|NCT01079741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799111|NCT01079741|Antiviral Agents|antiviral agents|mesh-ancestor
92799112|NCT01079741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799113|NCT01079741|Emollients|emollients|mesh-ancestor
92799114|NCT01079741|Dermatologic Agents|dermatologic agents|mesh-ancestor
92799115|NCT02877641|Vitamin D|vitamin d|mesh-list
92799116|NCT02877641|Cholecalciferol|cholecalciferol|mesh-list
92799117|NCT02877641|Vitamins|vitamins|mesh-list
92799118|NCT02877641|Micronutrients|micronutrients|mesh-ancestor
92799119|NCT02877641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799120|NCT02877641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92799121|NCT02877641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92799122|NCT01079663|Chlorhexidine|chlorhexidine|mesh-list
92799123|NCT01079663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92799124|NCT01079663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799125|NCT01079663|Disinfectants|disinfectants|mesh-ancestor
92799126|NCT02867046|Dexamethasone|dexamethasone|mesh-list
92799127|NCT02867046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799128|NCT02867046|Antiemetics|antiemetics|mesh-ancestor
92799129|NCT02867046|Autonomic Agents|autonomic agents|mesh-ancestor
92799130|NCT02867046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799131|NCT02867046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799132|NCT02867046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799133|NCT02867046|Glucocorticoids|glucocorticoids|mesh-ancestor
92799134|NCT02867046|Hormones|hormones|mesh-ancestor
92799135|NCT02867046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799136|NCT02867046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92799137|NCT02867046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799138|NCT02865174|Heparin|heparin|mesh-list
92799139|NCT02865174|Enoxaparin|enoxaparin|mesh-list
92799140|NCT02865174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92799141|NCT02865174|Tinzaparin|tinzaparin|mesh-list
92799142|NCT02865174|Dalteparin|dalteparin|mesh-list
92799143|NCT02865174|Tranylcypromine|tranylcypromine|mesh-list
92799144|NCT02865174|Tranexamic Acid|tranexamic acid|mesh-list
92799145|NCT02865174|Thrombin|thrombin|mesh-list
92799146|NCT02865174|Anticoagulants|anticoagulants|mesh-ancestor
92799147|NCT02865174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92799148|NCT02865174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92799149|NCT02865174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799150|NCT02865174|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92799151|NCT02865174|Hemostatics|hemostatics|mesh-ancestor
92799152|NCT02865174|Coagulants|coagulants|mesh-ancestor
92799153|NCT02865174|Antidepressive Agents|antidepressive agents|mesh-ancestor
92799154|NCT02865174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92799155|NCT02865174|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92799156|NCT02865174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799157|NCT02865174|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92799158|NCT02865174|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92799159|NCT02865174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799160|NCT02865174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799162|NCT00879814|Immunologic Factors|immunologic factors|mesh-ancestor
92799163|NCT00879814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799164|NCT02633176|Docetaxel|docetaxel|mesh-list
92799165|NCT02633176|Capecitabine|capecitabine|mesh-list
92799166|NCT02633176|Cetuximab|cetuximab|mesh-list
92799167|NCT02633176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799168|NCT02633176|Tubulin Modulators|tubulin modulators|mesh-ancestor
92799169|NCT02633176|Antimitotic Agents|antimitotic agents|mesh-ancestor
92799170|NCT02633176|Mitosis Modulators|mitosis modulators|mesh-ancestor
92799171|NCT02633176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799172|NCT02633176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92799173|NCT02633176|Antimetabolites|antimetabolites|mesh-ancestor
92799174|NCT02633176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799175|NCT04156984|Golimumab|golimumab|mesh-list
92799176|NCT04156984|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92799177|NCT04156984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799178|NCT04156984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799179|NCT04156984|Immunologic Factors|immunologic factors|mesh-ancestor
92799180|NCT04156984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799181|NCT04158778|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92799182|NCT04158778|Hallucinogens|hallucinogens|mesh-ancestor
92799183|NCT04158778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799184|NCT04158778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92799185|NCT04158778|Serotonin Agents|serotonin agents|mesh-ancestor
92799186|NCT04158778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799187|NCT04158778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799188|NCT04158778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92799189|NCT04158778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92799190|NCT04158778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799191|NCT04158778|Adrenergic Agents|adrenergic agents|mesh-ancestor
92799192|NCT01132664|Capecitabine|capecitabine|mesh-list
92799193|NCT01132664|Trastuzumab|trastuzumab|mesh-list
92799194|NCT01132664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92799195|NCT01132664|Antimetabolites|antimetabolites|mesh-ancestor
92799196|NCT01132664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799197|NCT01132664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799198|NCT01132664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799199|NCT01078805|Teriparatide|teriparatide|mesh-list
92799200|NCT01078805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92799201|NCT01078805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799202|NCT01078805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92799203|NCT00820027|Ibuprofen|ibuprofen|mesh-list
92799204|NCT00820027|Etoricoxib|etoricoxib|mesh-list
92799205|NCT00820027|Morphine|morphine|mesh-list
92799206|NCT00820027|Oxycodone|oxycodone|mesh-list
92799207|NCT00820027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92799208|NCT00820027|Narcotics|narcotics|mesh-ancestor
92799209|NCT00820027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799210|NCT00820027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799211|NCT00820027|Analgesics|analgesics|mesh-ancestor
92799212|NCT00820027|Sensory System Agents|sensory system agents|mesh-ancestor
92799213|NCT00820027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799214|NCT00820027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92799215|NCT00820027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799216|NCT00820027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799217|NCT00820027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799218|NCT00820027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92799219|NCT00820027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799220|NCT00820027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799221|NCT00820027|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92799222|NCT02876549|Chloroquine|chloroquine|mesh-list
92799223|NCT02876549|Primaquine|primaquine|mesh-list
92799224|NCT02876549|Amebicides|amebicides|mesh-ancestor
92799225|NCT02876549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92799226|NCT02876549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92799227|NCT02876549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799228|NCT02876549|Antimalarials|antimalarials|mesh-ancestor
92799229|NCT02876549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799230|NCT00913549|Clemastine|clemastine|mesh-list
92799231|NCT00913549|Antipruritics|antipruritics|mesh-ancestor
92745548|NCT05926180|Anesthetics|anesthetics|mesh-ancestor
92799232|NCT00913549|Dermatologic Agents|dermatologic agents|mesh-ancestor
92799233|NCT00913549|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92799234|NCT00913549|Histamine Antagonists|histamine antagonists|mesh-ancestor
92799235|NCT00913549|Histamine Agents|histamine agents|mesh-ancestor
92799236|NCT00913549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799237|NCT00913549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799238|NCT00913549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799239|NCT00913549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92799240|NCT01076153|Clarithromycin|clarithromycin|mesh-list
92799241|NCT01076153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92799242|NCT01076153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799243|NCT01076153|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92799244|NCT01076153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799245|NCT01076153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799246|NCT01076153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92799247|NCT01076153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92799249|NCT01076075|Pioglitazone|pioglitazone|mesh-list
92799250|NCT01076075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92799251|NCT01076075|Glimepiride|glimepiride|mesh-list
92799252|NCT01076075|Gliclazide|gliclazide|mesh-list
92799253|NCT01076075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92799254|NCT01076075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799255|NCT01076075|Incretins|incretins|mesh-ancestor
92799256|NCT01076075|Hormones|hormones|mesh-ancestor
92799257|NCT01076075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799258|NCT01076075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92799259|NCT01076075|Protease Inhibitors|protease inhibitors|mesh-ancestor
92799260|NCT01076075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799261|NCT01076075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799262|NCT01076075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92799263|NCT01076075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799264|NCT01076075|Immunologic Factors|immunologic factors|mesh-ancestor
92799265|NCT01075763|Interferons|interferons|mesh-list
92799266|NCT01075763|Interferon-beta|interferon-beta|mesh-list
92799267|NCT01075763|Interferon beta-1a|interferon beta-1a|mesh-list
92799268|NCT01075763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799269|NCT01075763|Antiviral Agents|antiviral agents|mesh-ancestor
92799270|NCT01075763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799271|NCT01075763|Immunologic Factors|immunologic factors|mesh-ancestor
92799272|NCT01075763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799273|NCT01075763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92799274|NCT00881530|Metformin|metformin|mesh-list
92799275|NCT00881530|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92799276|NCT00881530|Empagliflozin|empagliflozin|mesh-list
92799277|NCT00881530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92799278|NCT00881530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799279|NCT00881530|Incretins|incretins|mesh-ancestor
92799280|NCT00881530|Hormones|hormones|mesh-ancestor
92799281|NCT00881530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799282|NCT00881530|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92799283|NCT00881530|Protease Inhibitors|protease inhibitors|mesh-ancestor
92799284|NCT00881530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799285|NCT00881530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799286|NCT00881530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92799287|NCT02632474|Tenofovir|tenofovir|mesh-list
92799288|NCT02632474|Lamivudine|lamivudine|mesh-list
92799289|NCT02632474|Efavirenz|efavirenz|mesh-list
92799290|NCT02632474|Antiviral Agents|antiviral agents|mesh-ancestor
92799291|NCT02632474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799292|NCT02632474|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92799293|NCT02632474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92799294|NCT02632474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799295|NCT02632474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799296|NCT02632474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92799297|NCT02632474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92799298|NCT02632474|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92799299|NCT02632474|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92799300|NCT02632474|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92799301|NCT02632474|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92799302|NCT02632474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92799303|NCT02632474|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92799304|NCT04156750|Metformin|metformin|mesh-list
92799305|NCT04156750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92799306|NCT04156750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799308|NCT02877173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92799309|NCT02877173|Vasodilator Agents|vasodilator agents|mesh-ancestor
92799310|NCT02877173|Urological Agents|urological agents|mesh-ancestor
92799311|NCT04305743|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92799312|NCT04305743|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92799313|NCT04305743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92717478|NCT04655040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92799314|NCT04305743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799315|NCT04305743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799316|NCT04305743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92799317|NCT04305743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799318|NCT04305743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799319|NCT04305743|Cholinergic Agents|cholinergic agents|mesh-ancestor
92799320|NCT04305743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799321|NCT00661180|Sorafenib|sorafenib|mesh-list
92799322|NCT00661180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799323|NCT00661180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92799324|NCT00661180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799325|NCT00661180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799326|NCT01078571|Adalimumab|adalimumab|mesh-list
92799327|NCT01078571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92799328|NCT01078571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799329|NCT01078571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799330|NCT04160416|Capecitabine|capecitabine|mesh-list
92799331|NCT04160416|Oxaliplatin|oxaliplatin|mesh-list
92799332|NCT04160416|Irinotecan|irinotecan|mesh-list
92799333|NCT04160416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92799334|NCT04160416|Antimetabolites|antimetabolites|mesh-ancestor
92799335|NCT04160416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799336|NCT04160416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799337|NCT04160416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92799338|NCT04160416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92799339|NCT04160416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799340|NCT00661336|Melphalan|melphalan|mesh-list
92799341|NCT00661336|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
92799342|NCT00661336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92799343|NCT00661336|Alkylating Agents|alkylating agents|mesh-ancestor
92799344|NCT00661336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799345|NCT00661336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799346|NCT00661336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92799347|NCT00661336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799348|NCT00661336|Immunologic Factors|immunologic factors|mesh-ancestor
92799349|NCT00661336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799350|NCT00661336|Antimetabolites|antimetabolites|mesh-ancestor
92799351|NCT00661336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92799352|NCT00661336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799353|NCT00661336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92799354|NCT00661336|Protective Agents|protective agents|mesh-ancestor
92799355|NCT04158700|Pembrolizumab|pembrolizumab|mesh-list
92799356|NCT04158700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799357|NCT04158700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799358|NCT04158700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92799359|NCT04158700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799360|NCT00657202|Ranibizumab|ranibizumab|mesh-list
92799361|NCT00657202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92799362|NCT00657202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92799363|NCT00657202|Growth Substances|growth substances|mesh-ancestor
92799364|NCT00657202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799365|NCT00657202|Growth Inhibitors|growth inhibitors|mesh-ancestor
92799366|NCT00657202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799367|NCT00626483|Basiliximab|basiliximab|mesh-list
92799368|NCT00626483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799369|NCT00626483|Immunologic Factors|immunologic factors|mesh-ancestor
92799370|NCT00626483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799371|NCT00626717|Riboflavin|riboflavin|mesh-list
92799372|NCT00626717|Vitamin B Complex|vitamin b complex|mesh-ancestor
92799373|NCT00626717|Vitamins|vitamins|mesh-ancestor
92799374|NCT00626717|Micronutrients|micronutrients|mesh-ancestor
92799375|NCT00626717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799376|NCT00626717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92799377|NCT00626717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92799378|NCT04156204|Tacrolimus|tacrolimus|mesh-list
92799379|NCT04156204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799380|NCT04156204|Immunologic Factors|immunologic factors|mesh-ancestor
92799381|NCT04156204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799382|NCT04156204|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92799383|NCT04156204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026444|NCT00493038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92799384|NCT04156204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799385|NCT02631694|Propranolol|propranolol|mesh-list
92799386|NCT02631694|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92799387|NCT02631694|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92799388|NCT02631694|Adrenergic Agents|adrenergic agents|mesh-ancestor
92799389|NCT02631694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799390|NCT02631694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799391|NCT02631694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799392|NCT02631694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92799393|NCT02631694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92799394|NCT02631694|Vasodilator Agents|vasodilator agents|mesh-ancestor
92799395|NCT04305587|Clopidogrel|clopidogrel|mesh-list
92799396|NCT04305587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92799397|NCT04305587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92799398|NCT04305587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92799399|NCT04305587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92799400|NCT04305587|Purinergic Agents|purinergic agents|mesh-ancestor
92799401|NCT04305587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799402|NCT04305587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799403|NCT04305587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799404|NCT00658840|Capecitabine|capecitabine|mesh-list
92799405|NCT00658840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92799406|NCT00658840|Antimetabolites|antimetabolites|mesh-ancestor
92799407|NCT00658840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799408|NCT00658840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799409|NCT00658918|Ciclesonide|ciclesonide|mesh-list
92799410|NCT00658918|Glucocorticoids|glucocorticoids|mesh-ancestor
92799411|NCT00658918|Hormones|hormones|mesh-ancestor
92799412|NCT00658918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799413|NCT00658918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799414|NCT00658918|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92799415|NCT02876081|Afatinib|afatinib|mesh-list
92799416|NCT02876081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799417|NCT02876081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92799418|NCT02876081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799419|NCT02876081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799420|NCT02631616|Somatostatin|somatostatin|mesh-list
92799421|NCT02631616|Hormones|hormones|mesh-ancestor
92799422|NCT02631616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799423|NCT02631616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799424|NCT00661648|Pancrelipase|pancrelipase|mesh-list
92799425|NCT00661648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799426|NCT00659074|Ondansetron|ondansetron|mesh-list
92799427|NCT00659074|Antiemetics|antiemetics|mesh-ancestor
92799428|NCT00659074|Autonomic Agents|autonomic agents|mesh-ancestor
92799429|NCT00659074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799430|NCT00659074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799431|NCT00659074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799432|NCT00659074|Antipruritics|antipruritics|mesh-ancestor
92799433|NCT00659074|Dermatologic Agents|dermatologic agents|mesh-ancestor
92799434|NCT00659074|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92799435|NCT00659074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92799436|NCT00659074|Serotonin Agents|serotonin agents|mesh-ancestor
92799437|NCT00659074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799438|NCT00659074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799439|NCT01077713|Bevacizumab|bevacizumab|mesh-list
92799440|NCT01077713|Gemcitabine|gemcitabine|mesh-list
92799441|NCT01077713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799442|NCT01077713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799443|NCT01077713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92799444|NCT01077713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92799445|NCT01077713|Growth Substances|growth substances|mesh-ancestor
92799446|NCT01077713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799447|NCT01077713|Growth Inhibitors|growth inhibitors|mesh-ancestor
92799448|NCT01077713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92799449|NCT01077713|Antimetabolites|antimetabolites|mesh-ancestor
92799450|NCT01077713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799451|NCT00813709|Interferon beta-1a|interferon beta-1a|mesh-list
92799452|NCT00813709|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92799453|NCT00813709|Immunologic Factors|immunologic factors|mesh-ancestor
92799454|NCT00813709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799455|NCT00813709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799456|NCT00813709|Antiviral Agents|antiviral agents|mesh-ancestor
92799457|NCT00813709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799458|NCT01077323|Exenatide|exenatide|mesh-list
92799459|NCT01077323|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92799460|NCT01077323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799461|NCT01077323|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92799462|NCT01077323|Incretins|incretins|mesh-ancestor
92799463|NCT01077323|Hormones|hormones|mesh-ancestor
92799464|NCT01077323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799465|NCT03870438|Lamivudine|lamivudine|mesh-list
92799466|NCT03870438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92799467|NCT03870438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92799468|NCT03870438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799469|NCT03870438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799470|NCT03870438|Antiviral Agents|antiviral agents|mesh-ancestor
92799471|NCT03870438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799472|NCT03870438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92799473|NCT03870438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92799474|NCT05758831|Rituximab|rituximab|mesh-list
92799475|NCT05758831|Ocrelizumab|ocrelizumab|mesh-list
92799476|NCT05758831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799477|NCT05758831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799478|NCT05758831|Immunologic Factors|immunologic factors|mesh-ancestor
92799479|NCT05758831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799480|NCT05758831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799481|NCT04287894|Pemetrexed|pemetrexed|mesh-list
92799482|NCT04287894|Durvalumab|durvalumab|mesh-list
92799483|NCT04287894|Tremelimumab|tremelimumab|mesh-list
92799484|NCT04287894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799485|NCT04287894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799486|NCT04287894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799487|NCT04287894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92799488|NCT04287894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92799489|NCT04287894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799490|NCT04287426|Remifentanil|remifentanil|mesh-list
92799491|NCT04287426|Rocuronium|rocuronium|mesh-list
92799492|NCT04287426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92799493|NCT04287426|Narcotics|narcotics|mesh-ancestor
92799494|NCT04287426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799495|NCT04287426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799496|NCT04287426|Analgesics|analgesics|mesh-ancestor
92799497|NCT04287426|Sensory System Agents|sensory system agents|mesh-ancestor
92799498|NCT04287426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799499|NCT04287426|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92799500|NCT04287426|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92799501|NCT04287426|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92799502|NCT04047576|Sirolimus|sirolimus|mesh-list
92799503|NCT04047576|Prednisone|prednisone|mesh-list
92799504|NCT04047576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799505|NCT04047576|Glucocorticoids|glucocorticoids|mesh-ancestor
92799506|NCT04047576|Hormones|hormones|mesh-ancestor
92799507|NCT04047576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799508|NCT04047576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799509|NCT04047576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92799510|NCT04047576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799511|NCT04047576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92799512|NCT04047576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799513|NCT04047576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92799514|NCT04047576|Antifungal Agents|antifungal agents|mesh-ancestor
92799515|NCT04047576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799516|NCT04047576|Immunologic Factors|immunologic factors|mesh-ancestor
92799517|NCT00976950|Ritonavir|ritonavir|mesh-list
92799518|NCT00976950|Tipranavir|tipranavir|mesh-list
92799519|NCT00976950|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92799520|NCT00976950|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92799521|NCT00976950|Protease Inhibitors|protease inhibitors|mesh-ancestor
92799522|NCT00976950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799523|NCT00976950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799524|NCT00976950|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92799525|NCT00976950|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92799526|NCT00976950|Antiviral Agents|antiviral agents|mesh-ancestor
92799527|NCT00976950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799528|NCT00976950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92799529|NCT00976950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92799530|NCT00629382|Polymyxins|polymyxins|mesh-list
92799531|NCT00629382|Polymyxin B|polymyxin b|mesh-list
92799532|NCT00629382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92799533|NCT00629382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799534|NCT02866032|Ciclopirox|ciclopirox|mesh-list
92799535|NCT02866032|Antifungal Agents|antifungal agents|mesh-ancestor
92799536|NCT02866032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799537|NCT00976716|Celecoxib|celecoxib|mesh-list
92799538|NCT00976716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92799539|NCT00976716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799540|NCT00976716|Analgesics|analgesics|mesh-ancestor
92799541|NCT00976716|Sensory System Agents|sensory system agents|mesh-ancestor
92799542|NCT00976716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799543|NCT00976716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799544|NCT00976716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799545|NCT00976716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799546|NCT00976716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92799547|NCT00976716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92799548|NCT00976716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799549|NCT00976716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799551|NCT00973674|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92799552|NCT00973674|Hormones|hormones|mesh-ancestor
92799553|NCT00973674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799554|NCT00973674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799555|NCT00819091|Linagliptin|linagliptin|mesh-list
92799556|NCT00819091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92799557|NCT00819091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799558|NCT00819091|Incretins|incretins|mesh-ancestor
92799559|NCT00819091|Hormones|hormones|mesh-ancestor
92799560|NCT00819091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799561|NCT00819091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92799562|NCT00819091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92799563|NCT00819091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799564|NCT00819091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799565|NCT02864784|Calcium Carbonate|calcium carbonate|mesh-list
92799566|NCT02864784|Calcium|calcium|mesh-list
92799567|NCT02864784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92799568|NCT02864784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799569|NCT02864784|Antacids|antacids|mesh-ancestor
92799570|NCT02864784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799571|NCT02864784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799572|NCT00819013|Vaccines|vaccines|mesh-list
92799573|NCT00819013|Immunologic Factors|immunologic factors|mesh-ancestor
92799574|NCT00819013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799575|NCT04868461|Caseins|caseins|mesh-list
92799576|NCT04868461|Chelating Agents|chelating agents|mesh-ancestor
92799577|NCT04868461|Sequestering Agents|sequestering agents|mesh-ancestor
92799578|NCT04868461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799579|NCT02865642|Escitalopram|escitalopram|mesh-list
92799580|NCT02865642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92799581|NCT02865642|Serotonin|serotonin|mesh-list
92799582|NCT02865642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92799583|NCT02865642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799584|NCT02865642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799585|NCT02865642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799586|NCT02865642|Serotonin Agents|serotonin agents|mesh-ancestor
92799587|NCT02865642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799588|NCT02865642|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92799589|NCT03762564|Paclitaxel|paclitaxel|mesh-list
92799590|NCT03762564|Ramucirumab|ramucirumab|mesh-list
92799591|NCT03762564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92799592|NCT03762564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799593|NCT03762564|Tubulin Modulators|tubulin modulators|mesh-ancestor
92799594|NCT03762564|Antimitotic Agents|antimitotic agents|mesh-ancestor
92799595|NCT03762564|Mitosis Modulators|mitosis modulators|mesh-ancestor
92799596|NCT03762564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799597|NCT00629616|Fulvestrant|fulvestrant|mesh-list
92799598|NCT00629616|Anastrozole|anastrozole|mesh-list
92799599|NCT00629616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92799600|NCT00629616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799601|NCT00629616|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92799602|NCT00629616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92799603|NCT00629616|Hormone Antagonists|hormone antagonists|mesh-ancestor
92799604|NCT00629616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799605|NCT00629616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799606|NCT00629616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92799607|NCT00629616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92799608|NCT00629616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799609|NCT00629616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799610|NCT02864628|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92799611|NCT02864628|Antiviral Agents|antiviral agents|mesh-ancestor
92799612|NCT02864628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799613|NCT01120184|Paclitaxel|paclitaxel|mesh-list
92799614|NCT01120184|Maytansine|maytansine|mesh-list
92799615|NCT01120184|Docetaxel|docetaxel|mesh-list
92799616|NCT01120184|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92799617|NCT01120184|Trastuzumab|trastuzumab|mesh-list
92799618|NCT01120184|Pertuzumab|pertuzumab|mesh-list
92799619|NCT01120184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92444622|NCT01657201|Voriconazole|voriconazole|mesh-list
92799620|NCT01120184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799621|NCT01120184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92799622|NCT01120184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92799623|NCT01120184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92799624|NCT01120184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799625|NCT01120184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799626|NCT01120184|Immunotoxins|immunotoxins|mesh-ancestor
92799627|NCT01120184|Immunoconjugates|immunoconjugates|mesh-ancestor
92799628|NCT01120184|Immunologic Factors|immunologic factors|mesh-ancestor
92799629|NCT01120184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799630|NCT01120028|Sirolimus|sirolimus|mesh-list
92799631|NCT01120028|Alemtuzumab|alemtuzumab|mesh-list
92799632|NCT01120028|Tacrolimus|tacrolimus|mesh-list
92799633|NCT01120028|Basiliximab|basiliximab|mesh-list
92799634|NCT01120028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799635|NCT01120028|Immunologic Factors|immunologic factors|mesh-ancestor
92799636|NCT01120028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799637|NCT01120028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92799638|NCT01120028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799639|NCT01120028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799640|NCT01120028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92799641|NCT01120028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799642|NCT01120028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92799643|NCT01120028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799644|NCT01120028|Antifungal Agents|antifungal agents|mesh-ancestor
92799645|NCT01120028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799646|NCT00878800|Doxorubicin|doxorubicin|mesh-list
92799647|NCT00878800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92799648|NCT00878800|Belinostat|belinostat|mesh-list
92799649|NCT00878800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92799650|NCT00878800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799651|NCT00878800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92799652|NCT00878800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92799653|NCT00878800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799654|NCT00878800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799655|NCT00878800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92799656|NCT00662272|Vaccines|vaccines|mesh-list
92799657|NCT00662272|Immunologic Factors|immunologic factors|mesh-ancestor
92799658|NCT00662272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799659|NCT04158856|Trastuzumab|trastuzumab|mesh-list
92799660|NCT04158856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799661|NCT04158856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799662|NCT01119950|Glycopyrrolate|glycopyrrolate|mesh-list
92799663|NCT01119950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92799664|NCT01119950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92799665|NCT01119950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92799666|NCT01119950|Cholinergic Agents|cholinergic agents|mesh-ancestor
92799667|NCT01119950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799668|NCT01119950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799669|NCT01119950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799670|NCT02882828|Tacrolimus|tacrolimus|mesh-list
92799671|NCT02882828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92799672|NCT02882828|Immunologic Factors|immunologic factors|mesh-ancestor
92799673|NCT02882828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799674|NCT02882828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92799675|NCT02882828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799676|NCT02882828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799677|NCT02882126|Treprostinil|treprostinil|mesh-list
92799678|NCT02882126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92799679|NCT01145222|Midazolam|midazolam|mesh-list
92799680|NCT01145222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92799681|NCT01145222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92799682|NCT01145222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799683|NCT01145222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799684|NCT01145222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92799685|NCT01145222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92799686|NCT01145222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92799687|NCT01145222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92799688|NCT01145222|Anesthetics, General|anesthetics, general|mesh-ancestor
92799689|NCT01145222|Anesthetics|anesthetics|mesh-ancestor
92799690|NCT01145222|GABA Modulators|gaba modulators|mesh-ancestor
92799691|NCT01145222|GABA Agents|gaba agents|mesh-ancestor
92799692|NCT01145222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799693|NCT01145222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799694|NCT01145066|Borage oil|borage oil|mesh-list
92799695|NCT01145066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799696|NCT01132118|Hydroxychloroquine|hydroxychloroquine|mesh-list
92799697|NCT01132118|Antimalarials|antimalarials|mesh-ancestor
92799698|NCT01132118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92799699|NCT01132118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92799700|NCT01132118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799701|NCT01132118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799702|NCT01132118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799703|NCT01132118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799704|NCT00637442|Galantamine|galantamine|mesh-list
92799705|NCT00637442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92799706|NCT00637442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799707|NCT00637442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799708|NCT00637442|Cholinergic Agents|cholinergic agents|mesh-ancestor
92799709|NCT00637442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799710|NCT00637442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799711|NCT00637442|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92799712|NCT00637442|Autonomic Agents|autonomic agents|mesh-ancestor
92799713|NCT00637442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799714|NCT00637442|Nootropic Agents|nootropic agents|mesh-ancestor
92799715|NCT00969618|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92799716|NCT00969618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92799717|NCT00969618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92799718|NCT00969618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799719|NCT00969618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799720|NCT00969618|Adrenergic Agents|adrenergic agents|mesh-ancestor
92799721|NCT00969618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799722|NCT00969618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799723|NCT02864472|Ranibizumab|ranibizumab|mesh-list
92799724|NCT02864472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92799725|NCT02864472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92799726|NCT02864472|Growth Substances|growth substances|mesh-ancestor
92799727|NCT02864472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799728|NCT02864472|Growth Inhibitors|growth inhibitors|mesh-ancestor
92799729|NCT02864472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799730|NCT00975000|Cinacalcet|cinacalcet|mesh-list
92799731|NCT00975000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92799732|NCT00975000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799733|NCT00975000|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92799734|NCT00975000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92799735|NCT00975000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799736|NCT02863614|Ibuprofen|ibuprofen|mesh-list
92799737|NCT02863614|Lorazepam|lorazepam|mesh-list
92799738|NCT02863614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92799739|NCT02863614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799740|NCT02863614|Analgesics|analgesics|mesh-ancestor
92799741|NCT02863614|Sensory System Agents|sensory system agents|mesh-ancestor
93026445|NCT00493038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92799742|NCT02863614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799743|NCT02863614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799744|NCT02863614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799745|NCT02863614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799746|NCT02863614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92799747|NCT02863614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799748|NCT02863614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799749|NCT02863614|Anticonvulsants|anticonvulsants|mesh-ancestor
92799750|NCT02863614|Antiemetics|antiemetics|mesh-ancestor
92799751|NCT02863614|Autonomic Agents|autonomic agents|mesh-ancestor
92799752|NCT02863614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799753|NCT02863614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92799754|NCT02863614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799755|NCT02863614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92799756|NCT02863614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92799757|NCT02863614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92799758|NCT02863614|GABA Modulators|gaba modulators|mesh-ancestor
92799759|NCT02863614|GABA Agents|gaba agents|mesh-ancestor
92799760|NCT02863614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799762|NCT00974922|Cholecalciferol|cholecalciferol|mesh-list
92799763|NCT00974922|Vitamins|vitamins|mesh-ancestor
92799764|NCT00974922|Micronutrients|micronutrients|mesh-ancestor
92799765|NCT00974922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799766|NCT00974922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92799767|NCT00974922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92799768|NCT00972504|Cetirizine|cetirizine|mesh-list
92799769|NCT00972504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92799770|NCT00972504|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92799771|NCT00972504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92799772|NCT00972504|Histamine Antagonists|histamine antagonists|mesh-ancestor
92799773|NCT00972504|Histamine Agents|histamine agents|mesh-ancestor
92799774|NCT00972504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799775|NCT00972504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799776|NCT00972504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799777|NCT00969150|Milnacipran|milnacipran|mesh-list
92799778|NCT00969150|Levomilnacipran|levomilnacipran|mesh-list
92799779|NCT00969150|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92799780|NCT00969150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92799781|NCT00969150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799782|NCT00969150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799783|NCT00969150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799784|NCT00969150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799785|NCT00969150|Antidepressive Agents|antidepressive agents|mesh-ancestor
92799786|NCT00969150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92799787|NCT00969150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799788|NCT00969150|Analgesics|analgesics|mesh-ancestor
92799789|NCT00969150|Sensory System Agents|sensory system agents|mesh-ancestor
92799790|NCT00969150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799791|NCT03925194|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92799792|NCT03925194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799793|NCT00974220|Fentanyl|fentanyl|mesh-list
92799794|NCT00974220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92799795|NCT00974220|Narcotics|narcotics|mesh-ancestor
92799796|NCT00974220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799797|NCT00974220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799798|NCT00974220|Analgesics|analgesics|mesh-ancestor
92799799|NCT00974220|Sensory System Agents|sensory system agents|mesh-ancestor
92799800|NCT00974220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799801|NCT00974220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92799802|NCT00974220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92799803|NCT00974220|Anesthetics, General|anesthetics, general|mesh-ancestor
92799804|NCT00974220|Anesthetics|anesthetics|mesh-ancestor
92799805|NCT00971178|Dexmedetomidine|dexmedetomidine|mesh-list
92799806|NCT00971178|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92799807|NCT00971178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799808|NCT00971178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799809|NCT00971178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799810|NCT00971178|Analgesics|analgesics|mesh-ancestor
92799811|NCT00971178|Sensory System Agents|sensory system agents|mesh-ancestor
92799812|NCT00971178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413071|NCT01459445|Contraceptive Agents|contraceptive agents|mesh-ancestor
92799813|NCT00971178|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92799814|NCT00971178|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92799815|NCT00971178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92799816|NCT00971178|Adrenergic Agents|adrenergic agents|mesh-ancestor
92799817|NCT00971178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799818|NCT00971178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799819|NCT00970944|Amantadine|amantadine|mesh-list
92799820|NCT00970944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92799821|NCT00970944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92799822|NCT00970944|Antiviral Agents|antiviral agents|mesh-ancestor
92799823|NCT00970944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799824|NCT00970944|Dopamine Agents|dopamine agents|mesh-ancestor
92799825|NCT00970944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799826|NCT00970944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799827|NCT00970944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799828|NCT00970944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799830|NCT00970944|Sensory System Agents|sensory system agents|mesh-ancestor
92799831|NCT00970944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799832|NCT05780723|Mesalamine|mesalamine|mesh-list
92799833|NCT05780723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92799834|NCT05780723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92799835|NCT05780723|Analgesics|analgesics|mesh-ancestor
92799836|NCT05780723|Sensory System Agents|sensory system agents|mesh-ancestor
92799837|NCT05780723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799838|NCT05780723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799839|NCT05780723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92799840|NCT05780723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799841|NCT05780515|Immunoglobulins|immunoglobulins|mesh-list
92799842|NCT05780515|Immunoglobulin G|immunoglobulin g|mesh-list
92799843|NCT05780515|Immunologic Factors|immunologic factors|mesh-ancestor
92799844|NCT05780515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444830|NCT01657981|Darexaban|darexaban|mesh-list
92799845|NCT05780489|Estradiol|estradiol|mesh-list
92799846|NCT05780489|Progesterone|progesterone|mesh-list
92799847|NCT05780489|Estrogens|estrogens|mesh-ancestor
92799848|NCT05780489|Hormones|hormones|mesh-ancestor
92799849|NCT05780489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92799850|NCT05780489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799851|NCT05780489|Progestins|progestins|mesh-ancestor
92799852|NCT05780320|Amiodarone|amiodarone|mesh-list
92799853|NCT05780320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92799854|NCT05780320|Vasodilator Agents|vasodilator agents|mesh-ancestor
92799855|NCT05780320|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92799856|NCT05780320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799857|NCT05780320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799858|NCT05780320|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92799859|NCT05780320|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92799860|NCT05780320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92799861|NCT05780320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799862|NCT05780320|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92799863|NCT05780320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92799864|NCT05780320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92799865|NCT05780294|Asparaginase|asparaginase|mesh-list
92799866|NCT05780294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799867|NCT05780229|Analgesics|analgesics|mesh-list
92799868|NCT05780229|Sensory System Agents|sensory system agents|mesh-ancestor
92799869|NCT05780229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799870|NCT05780229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799871|NCT05780151|Insulin Glargine|insulin glargine|mesh-list
92799872|NCT05780151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92799873|NCT05780151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799874|NCT05780086|Icodextrin|icodextrin|mesh-list
92799875|NCT05780086|Dialysis Solutions|dialysis solutions|mesh-ancestor
92799876|NCT05780086|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92799877|NCT05779514|Mirabegron|mirabegron|mesh-list
92799878|NCT05779514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92799879|NCT05779514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92799880|NCT05779514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92799881|NCT05779514|Adrenergic Agents|adrenergic agents|mesh-ancestor
92799882|NCT05779514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799883|NCT05779514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799884|NCT05779514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799885|NCT05779514|Urological Agents|urological agents|mesh-ancestor
92799886|NCT05779423|Nivolumab|nivolumab|mesh-list
92799887|NCT05779423|Ipilimumab|ipilimumab|mesh-list
92799888|NCT05779423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92799889|NCT05779423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799890|NCT05779423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92799891|NCT05779423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799892|NCT05779410|Vitamin D|vitamin d|mesh-list
92799893|NCT05779410|Ergocalciferols|ergocalciferols|mesh-list
92799894|NCT05779410|Cholecalciferol|cholecalciferol|mesh-list
92799895|NCT05779410|Vitamins|vitamins|mesh-list
92799896|NCT05779410|Micronutrients|micronutrients|mesh-ancestor
92799897|NCT05779410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799898|NCT05779410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92799899|NCT05779410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92799900|NCT05779254|Metronidazole|metronidazole|mesh-list
92799901|NCT05779254|Neomycin|neomycin|mesh-list
92746227|NCT04867785|Dulaglutide|dulaglutide|mesh-list
92799902|NCT05779254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799903|NCT05779254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92799904|NCT05779254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92799905|NCT05779254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92799906|NCT05779254|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92799907|NCT05779254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799908|NCT05779254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799909|NCT05779059|Ticagrelor|ticagrelor|mesh-list
92799910|NCT05779059|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92799911|NCT05779059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92799912|NCT05779059|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92799913|NCT05779059|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92799914|NCT05779059|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92799915|NCT05779059|Purinergic Agents|purinergic agents|mesh-ancestor
92799916|NCT05779059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799917|NCT05779059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799918|NCT05779059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799919|NCT05778422|Anesthetics|anesthetics|mesh-list
92799920|NCT05778422|Anesthetics, Local|anesthetics, local|mesh-list
92799921|NCT05778422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799922|NCT05778422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799923|NCT05778422|Sensory System Agents|sensory system agents|mesh-ancestor
92799924|NCT05778422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799925|NCT05774366|Desflurane|desflurane|mesh-list
92799926|NCT05774366|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92799927|NCT05774366|Anesthetics, General|anesthetics, general|mesh-ancestor
92799928|NCT05774366|Anesthetics|anesthetics|mesh-ancestor
92799929|NCT05774366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799930|NCT05774366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799931|NCT05774067|Terlipressin|terlipressin|mesh-list
92799932|NCT05774067|Vasopressins|vasopressins|mesh-list
92799933|NCT05774067|Norepinephrine|norepinephrine|mesh-list
92799934|NCT05774067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92799935|NCT05774067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92799936|NCT05774067|Adrenergic Agents|adrenergic agents|mesh-ancestor
92799937|NCT05774067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799938|NCT05774067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799939|NCT05774067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799940|NCT05774067|Sympathomimetics|sympathomimetics|mesh-ancestor
92799941|NCT05774067|Autonomic Agents|autonomic agents|mesh-ancestor
92799942|NCT05774067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92799943|NCT05774067|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92799944|NCT05774067|Hemostatics|hemostatics|mesh-ancestor
92799945|NCT05774067|Coagulants|coagulants|mesh-ancestor
92799946|NCT05774067|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92799947|NCT05774067|Natriuretic Agents|natriuretic agents|mesh-ancestor
92799948|NCT05774067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92799949|NCT05769842|Propofol|propofol|mesh-list
92799950|NCT05769842|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92799951|NCT05769842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799952|NCT05769842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799953|NCT05769842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92799954|NCT05769842|Anesthetics, General|anesthetics, general|mesh-ancestor
92799955|NCT05769842|Anesthetics|anesthetics|mesh-ancestor
92799956|NCT05755997|Cerebrolysin|cerebrolysin|mesh-list
92799957|NCT05755997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92799958|NCT05755997|Protective Agents|protective agents|mesh-ancestor
92799959|NCT05755997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799960|NCT05755997|Nootropic Agents|nootropic agents|mesh-ancestor
92799961|NCT05739929|Colchicine|colchicine|mesh-list
92799962|NCT05739929|Gout Suppressants|gout suppressants|mesh-ancestor
92799963|NCT05739929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92799964|NCT05739929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92799965|NCT05739929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92799966|NCT05739929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92799967|NCT05739929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799968|NCT05739929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92799969|NCT05734508|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92799970|NCT05734508|Antiviral Agents|antiviral agents|mesh-ancestor
92799971|NCT05734508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92799972|NCT05712265|Fluvoxamine|fluvoxamine|mesh-list
92799973|NCT05712265|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92799974|NCT05712265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92799975|NCT05712265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92799976|NCT05712265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92799977|NCT05712265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92799978|NCT05712265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92799979|NCT05712265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92799980|NCT05712265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92799981|NCT05712265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799982|NCT05712265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92799984|NCT05712265|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92799985|NCT05712265|Antidepressive Agents|antidepressive agents|mesh-ancestor
92799986|NCT05712265|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92799987|NCT05712265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92799988|NCT05712265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92799989|NCT05712265|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92799990|NCT05659654|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92799991|NCT05659654|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92799992|NCT05659654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92799993|NCT05637060|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92799994|NCT05637060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92799995|NCT05637060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92799996|NCT05637060|Antimetabolites|antimetabolites|mesh-ancestor
92799997|NCT05637060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92799998|NCT05637060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92799999|NCT05637060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92800000|NCT05637060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800001|NCT05635604|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
92800002|NCT05635604|Growth Substances|growth substances|mesh-ancestor
92800003|NCT05635604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800004|NCT05635604|Vasodilator Agents|vasodilator agents|mesh-ancestor
92800005|NCT05635604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800006|NCT05635604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800007|NCT05620784|Furosemide|furosemide|mesh-list
92800008|NCT05620784|Diuretics|diuretics|mesh-list
92800009|NCT05620784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92800010|NCT05620784|Natriuretic Agents|natriuretic agents|mesh-ancestor
92800011|NCT05620784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800012|NCT05620784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800013|NCT05620784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800014|NCT05617859|Lenvatinib|lenvatinib|mesh-list
92800015|NCT05617859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413278|NCT01461746|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800016|NCT05617859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92800017|NCT05617859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800018|NCT05617859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800019|NCT05616494|Docetaxel|docetaxel|mesh-list
92800020|NCT05616494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800021|NCT05616494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800022|NCT05616494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800023|NCT05616494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800024|NCT05616494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800025|NCT05614609|Lidocaine|lidocaine|mesh-list
92800026|NCT05614609|Anesthetics, Local|anesthetics, local|mesh-ancestor
92800027|NCT05614609|Anesthetics|anesthetics|mesh-ancestor
92800028|NCT05614609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800029|NCT05614609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800030|NCT05614609|Sensory System Agents|sensory system agents|mesh-ancestor
92800031|NCT05614609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800032|NCT05614609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92800033|NCT05614609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92800034|NCT05614609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92800035|NCT05614609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800036|NCT05614609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800037|NCT05598957|Vitamin D|vitamin d|mesh-list
92800038|NCT05598957|Vitamins|vitamins|mesh-ancestor
92800039|NCT05598957|Micronutrients|micronutrients|mesh-ancestor
92800040|NCT05598957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800041|NCT05598957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92800042|NCT05567068|Mesalamine|mesalamine|mesh-list
92800043|NCT05567068|Atorvastatin|atorvastatin|mesh-list
92800044|NCT05567068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92800045|NCT05567068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92800046|NCT05567068|Antimetabolites|antimetabolites|mesh-ancestor
92800047|NCT05567068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800048|NCT05567068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92800049|NCT05567068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92800050|NCT05567068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800051|NCT05567068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92800052|NCT05567068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92800054|NCT05567068|Sensory System Agents|sensory system agents|mesh-ancestor
92800055|NCT05567068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800056|NCT05567068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800057|NCT05567068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800058|NCT05567068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800059|NCT05565001|Cromakalim|cromakalim|mesh-list
92800060|NCT05565001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92800061|NCT05565001|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92800062|NCT05565001|Autonomic Agents|autonomic agents|mesh-ancestor
92800063|NCT05565001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800064|NCT05565001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800065|NCT05565001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92445062|NCT01659242|Analgesics|analgesics|mesh-ancestor
92800066|NCT05565001|Respiratory System Agents|respiratory system agents|mesh-ancestor
92800067|NCT05565001|Parasympatholytics|parasympatholytics|mesh-ancestor
92800068|NCT05565001|Vasodilator Agents|vasodilator agents|mesh-ancestor
92800069|NCT05561062|Atorvastatin|atorvastatin|mesh-list
92800070|NCT05561062|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92800071|NCT05561062|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92800072|NCT05561062|Antimetabolites|antimetabolites|mesh-ancestor
92800073|NCT05561062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800074|NCT05561062|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92800075|NCT05561062|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92800076|NCT05561062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800077|NCT05550402|Bromides|bromides|mesh-list
92800078|NCT05550402|Albuterol|albuterol|mesh-list
92800079|NCT05550402|Ipratropium|ipratropium|mesh-list
92800080|NCT05550402|Anticonvulsants|anticonvulsants|mesh-ancestor
92800081|NCT05550402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92800082|NCT05550402|Autonomic Agents|autonomic agents|mesh-ancestor
92800083|NCT05550402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800084|NCT05550402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800085|NCT05550402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92800086|NCT05550402|Respiratory System Agents|respiratory system agents|mesh-ancestor
92800087|NCT05550402|Tocolytic Agents|tocolytic agents|mesh-ancestor
92800088|NCT05550402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92800089|NCT05550402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92800090|NCT05550402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92800091|NCT05550402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92800092|NCT05550402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92800093|NCT05550402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800094|NCT05550402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800095|NCT05550402|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92800096|NCT05550402|Cholinergic Agents|cholinergic agents|mesh-ancestor
92800097|NCT05444946|Itraconazole|itraconazole|mesh-list
92800098|NCT05444946|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92800099|NCT05444946|Prednisone|prednisone|mesh-list
92800100|NCT05444946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800101|NCT05444946|Glucocorticoids|glucocorticoids|mesh-ancestor
92800102|NCT05444946|Hormones|hormones|mesh-ancestor
92800103|NCT05444946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800104|NCT05444946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800105|NCT05444946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800106|NCT05444946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800107|NCT05444946|Antifungal Agents|antifungal agents|mesh-ancestor
92800108|NCT05444946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800109|NCT05444946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92800110|NCT05444946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92800111|NCT05444946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800112|NCT05444946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800113|NCT05444946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92800114|NCT05444946|Hormone Antagonists|hormone antagonists|mesh-ancestor
92800115|NCT05444946|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92800116|NCT05409157|Bisacodyl|bisacodyl|mesh-list
92800117|NCT05409157|Cathartics|cathartics|mesh-ancestor
92800118|NCT05409157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800119|NCT05409157|Laxatives|laxatives|mesh-ancestor
92800120|NCT05407519|Tislelizumab|tislelizumab|mesh-list
92746446|NCT04268277|Rituximab|rituximab|mesh-list
92800121|NCT05407519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800122|NCT05407519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800123|NCT05380856|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92800124|NCT05380856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800125|NCT05380856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800127|NCT05355311|Vitamin B Complex|vitamin b complex|mesh-ancestor
92800128|NCT05355311|Vitamins|vitamins|mesh-ancestor
92800129|NCT05355311|Micronutrients|micronutrients|mesh-ancestor
92800130|NCT05355311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800131|NCT05355311|Nootropic Agents|nootropic agents|mesh-ancestor
92800132|NCT05311033|Tranexamic Acid|tranexamic acid|mesh-list
92800133|NCT05311033|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92800134|NCT05311033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92800135|NCT05311033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800136|NCT05311033|Hemostatics|hemostatics|mesh-ancestor
92800137|NCT05311033|Coagulants|coagulants|mesh-ancestor
92800138|NCT05281562|Ascorbic Acid|ascorbic acid|mesh-list
92800139|NCT05281562|Vitamins|vitamins|mesh-ancestor
92800140|NCT05281562|Micronutrients|micronutrients|mesh-ancestor
92445128|NCT01659476|Methacholine Chloride|methacholine chloride|mesh-list
92800141|NCT05281562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800142|NCT05281562|Antioxidants|antioxidants|mesh-ancestor
92800143|NCT05281562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800144|NCT05281562|Protective Agents|protective agents|mesh-ancestor
92800145|NCT05276596|Norepinephrine|norepinephrine|mesh-list
92800146|NCT05276596|Ephedrine|ephedrine|mesh-list
92800147|NCT05276596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92800148|NCT05276596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92800149|NCT05276596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92800150|NCT05276596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800151|NCT05276596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800152|NCT05276596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800153|NCT05276596|Sympathomimetics|sympathomimetics|mesh-ancestor
92800154|NCT05276596|Autonomic Agents|autonomic agents|mesh-ancestor
92800155|NCT05276596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800156|NCT05276596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92800157|NCT05276596|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92800158|NCT05241262|Acetylcysteine|acetylcysteine|mesh-list
92800159|NCT05241262|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92800160|NCT05241262|Antiviral Agents|antiviral agents|mesh-ancestor
92800161|NCT05241262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800162|NCT05241262|Expectorants|expectorants|mesh-ancestor
92800163|NCT05241262|Respiratory System Agents|respiratory system agents|mesh-ancestor
92800164|NCT05241262|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92800165|NCT05241262|Antioxidants|antioxidants|mesh-ancestor
92800166|NCT05241262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800167|NCT05241262|Protective Agents|protective agents|mesh-ancestor
92800168|NCT05241262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800169|NCT05241262|Antidotes|antidotes|mesh-ancestor
92800170|NCT05178849|Anesthetics|anesthetics|mesh-list
92800171|NCT05178849|Anesthetics, Local|anesthetics, local|mesh-list
92800172|NCT05178849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800173|NCT05178849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800174|NCT05178849|Sensory System Agents|sensory system agents|mesh-ancestor
92800175|NCT05178849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800176|NCT05161936|Lumasiran|lumasiran|mesh-list
92800177|NCT05161936|Renal Agents|renal agents|mesh-ancestor
92800178|NCT05143424|Morphine|morphine|mesh-list
92800179|NCT05143424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92800180|NCT05143424|Narcotics|narcotics|mesh-ancestor
92800181|NCT05143424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800182|NCT05143424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800183|NCT05143424|Analgesics|analgesics|mesh-ancestor
92800184|NCT05143424|Sensory System Agents|sensory system agents|mesh-ancestor
92800185|NCT05143424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800186|NCT05137067|Cisplatin|cisplatin|mesh-list
92800187|NCT05137067|Docetaxel|docetaxel|mesh-list
92800188|NCT05137067|Antineoplastic Agents|antineoplastic agents|mesh-list
92800189|NCT05137067|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800190|NCT05137067|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800191|NCT05137067|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800192|NCT05137067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800193|NCT05126238|Lithium Carbonate|lithium carbonate|mesh-list
92800194|NCT05126238|Antidepressive Agents|antidepressive agents|mesh-ancestor
92800195|NCT05126238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92800196|NCT05126238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800197|NCT05126238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800198|NCT05126238|Antimanic Agents|antimanic agents|mesh-ancestor
92800199|NCT05126238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92800200|NCT05126238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800201|NCT05126238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800202|NCT05108649|Nicotine|nicotine|mesh-list
92800203|NCT05108649|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92800204|NCT05108649|Autonomic Agents|autonomic agents|mesh-ancestor
92800205|NCT05108649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800206|NCT05108649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800207|NCT05108649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92800208|NCT05108649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92800209|NCT05108649|Cholinergic Agents|cholinergic agents|mesh-ancestor
92800210|NCT05108649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445186|NCT01659905|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92800211|NCT05108649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800212|NCT05023070|Cannabidiol|cannabidiol|mesh-list
92800213|NCT05023070|Anticonvulsants|anticonvulsants|mesh-ancestor
92800214|NCT05003713|Prednisone|prednisone|mesh-list
92800215|NCT05003713|Cortisone|cortisone|mesh-list
92800216|NCT05003713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800217|NCT05003713|Glucocorticoids|glucocorticoids|mesh-ancestor
92800218|NCT05003713|Hormones|hormones|mesh-ancestor
92800219|NCT05003713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800220|NCT05003713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800221|NCT05003713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800222|NCT05003713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800223|NCT04990128|Triamcinolone|triamcinolone|mesh-list
92800224|NCT04990128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800225|NCT04990128|Glucocorticoids|glucocorticoids|mesh-ancestor
92800226|NCT04990128|Hormones|hormones|mesh-ancestor
92800227|NCT04990128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800228|NCT04990128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800229|NCT04907370|Cisplatin|cisplatin|mesh-list
92800230|NCT04907370|Gemcitabine|gemcitabine|mesh-list
92800231|NCT04907370|Antibodies|antibodies|mesh-list
92800232|NCT04907370|Antibodies, Blocking|antibodies, blocking|mesh-list
92800233|NCT04907370|Immunologic Factors|immunologic factors|mesh-ancestor
92800234|NCT04907370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800235|NCT04907370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800236|NCT04907370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92800237|NCT04907370|Antimetabolites|antimetabolites|mesh-ancestor
92800238|NCT04907370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800239|NCT04903054|Mycophenolic Acid|mycophenolic acid|mesh-list
92800240|NCT04903054|Prednisone|prednisone|mesh-list
92800241|NCT04903054|Methylprednisolone|methylprednisolone|mesh-list
92800242|NCT04903054|Tacrolimus|tacrolimus|mesh-list
92800243|NCT04903054|Thymoglobulin|thymoglobulin|mesh-list
92800244|NCT04903054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92800245|NCT04903054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800246|NCT04903054|Glucocorticoids|glucocorticoids|mesh-ancestor
92800247|NCT04903054|Hormones|hormones|mesh-ancestor
92800248|NCT04903054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800249|NCT04903054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800250|NCT04903054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800251|NCT04903054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800252|NCT04903054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800253|NCT04903054|Immunologic Factors|immunologic factors|mesh-ancestor
92800254|NCT04903054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92800255|NCT04903054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800256|NCT04903054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800257|NCT04903054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92800258|NCT04903054|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92800259|NCT04903054|Antitubercular Agents|antitubercular agents|mesh-ancestor
92800260|NCT04903054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92800261|NCT04903054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800262|NCT04903054|Antiemetics|antiemetics|mesh-ancestor
92800263|NCT04903054|Autonomic Agents|autonomic agents|mesh-ancestor
92800264|NCT04903054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800265|NCT04903054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800266|NCT04903054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92800267|NCT04903054|Protective Agents|protective agents|mesh-ancestor
92800268|NCT04901702|Irinotecan|irinotecan|mesh-list
92800269|NCT04901702|Temozolomide|temozolomide|mesh-list
92800270|NCT04901702|Talazoparib|talazoparib|mesh-list
92800271|NCT04901702|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92800272|NCT04901702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92800273|NCT04901702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800274|NCT04901702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800275|NCT04901702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800276|NCT04901702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800277|NCT04901702|Alkylating Agents|alkylating agents|mesh-ancestor
92800278|NCT04901702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92800279|NCT04897321|Cyclophosphamide|cyclophosphamide|mesh-list
92800281|NCT04897321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800282|NCT04897321|Immunologic Factors|immunologic factors|mesh-ancestor
92800283|NCT04897321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800284|NCT04897321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800285|NCT04897321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800286|NCT04897321|Alkylating Agents|alkylating agents|mesh-ancestor
92800287|NCT04897321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800288|NCT04897321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800289|NCT04897321|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92800290|NCT04879225|Menthol|menthol|mesh-list
92800291|NCT04879225|Antipruritics|antipruritics|mesh-ancestor
92800292|NCT04879225|Dermatologic Agents|dermatologic agents|mesh-ancestor
92800293|NCT04834557|Digoxin|digoxin|mesh-list
92800294|NCT04834557|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92800295|NCT04834557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92800296|NCT04834557|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92800297|NCT04834557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800298|NCT04834557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800299|NCT04834557|Protective Agents|protective agents|mesh-ancestor
92800300|NCT04834557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800301|NCT04834557|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92800302|NCT04834557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800303|NCT04825093|Vitamin D|vitamin d|mesh-list
92800304|NCT04825093|Vitamins|vitamins|mesh-ancestor
92800305|NCT04825093|Micronutrients|micronutrients|mesh-ancestor
92800306|NCT04825093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800307|NCT04825093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92800308|NCT04793152|Vancomycin|vancomycin|mesh-list
92800309|NCT04793152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92800310|NCT04793152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800311|NCT04770493|Lamotrigine|lamotrigine|mesh-list
92800312|NCT04770493|Anticonvulsants|anticonvulsants|mesh-ancestor
92800313|NCT04770493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92800314|NCT04770493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800315|NCT04770493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800316|NCT04770493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92800317|NCT04770493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800318|NCT04770493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92800319|NCT04770493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92800320|NCT04770493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800321|NCT04770493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92800322|NCT04770493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92800323|NCT04741464|Tinzaparin|tinzaparin|mesh-list
92800324|NCT04741464|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92800325|NCT04741464|Dalteparin|dalteparin|mesh-list
92800326|NCT04741464|Anticoagulants|anticoagulants|mesh-ancestor
92800327|NCT04741464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92800328|NCT04741464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92800329|NCT04741464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800330|NCT04663555|Dexamethasone|dexamethasone|mesh-list
92800331|NCT04663555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800332|NCT04663555|Antiemetics|antiemetics|mesh-ancestor
92800333|NCT04663555|Autonomic Agents|autonomic agents|mesh-ancestor
92800334|NCT04663555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800335|NCT04663555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800336|NCT04663555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800337|NCT04663555|Glucocorticoids|glucocorticoids|mesh-ancestor
92800338|NCT04663555|Hormones|hormones|mesh-ancestor
92800339|NCT04663555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800340|NCT04663555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800341|NCT04663555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800342|NCT04637763|Cyclophosphamide|cyclophosphamide|mesh-list
92800343|NCT04637763|Fludarabine|fludarabine|mesh-list
92800344|NCT04637763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800345|NCT04637763|Immunologic Factors|immunologic factors|mesh-ancestor
92800346|NCT04637763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800347|NCT04637763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800348|NCT04637763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800349|NCT04637763|Alkylating Agents|alkylating agents|mesh-ancestor
92800350|NCT04637763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800351|NCT04637763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800352|NCT04637763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92800353|NCT04565288|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92800354|NCT04565288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92800355|NCT04565288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92800356|NCT04565288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800357|NCT04565288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800358|NCT04565288|Adrenergic Agents|adrenergic agents|mesh-ancestor
92800359|NCT04565288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800360|NCT04565288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800361|NCT04501861|Vasopressins|vasopressins|mesh-list
92800362|NCT04501861|Arginine Vasopressin|arginine vasopressin|mesh-list
92800363|NCT04501861|Norepinephrine|norepinephrine|mesh-list
92800364|NCT04501861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92800365|NCT04501861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92800366|NCT04501861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92800367|NCT04501861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800368|NCT04501861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800369|NCT04501861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800370|NCT04501861|Sympathomimetics|sympathomimetics|mesh-ancestor
92800371|NCT04501861|Autonomic Agents|autonomic agents|mesh-ancestor
92800372|NCT04501861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800373|NCT04501861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92800374|NCT04501861|Hemostatics|hemostatics|mesh-ancestor
92800375|NCT04501861|Coagulants|coagulants|mesh-ancestor
92800376|NCT04501861|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92800377|NCT04501861|Natriuretic Agents|natriuretic agents|mesh-ancestor
92800378|NCT04496024|Ofloxacin|ofloxacin|mesh-list
92800379|NCT04496024|Levofloxacin|levofloxacin|mesh-list
92800380|NCT04496024|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92800381|NCT04496024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800382|NCT04496024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92800383|NCT04496024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92800384|NCT04496024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92800385|NCT04496024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800386|NCT04496024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800387|NCT04496024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800388|NCT04496024|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92800389|NCT04496024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92800390|NCT04425473|Esketamine|esketamine|mesh-list
92800391|NCT04425473|Antidepressive Agents|antidepressive agents|mesh-ancestor
92800392|NCT04425473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92800393|NCT04387071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92800394|NCT04387071|Antibodies|antibodies|mesh-list
92800395|NCT04387071|Immunoglobulins|immunoglobulins|mesh-list
92800396|NCT04387071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92800397|NCT04387071|Immunologic Factors|immunologic factors|mesh-ancestor
92800398|NCT04387071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800399|NCT04387071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800400|NCT04350502|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92800401|NCT04350502|Amoxicillin|amoxicillin|mesh-list
92800402|NCT04350502|Clavulanic Acids|clavulanic acids|mesh-list
92800403|NCT04350502|Clavulanic Acid|clavulanic acid|mesh-list
92800404|NCT04350502|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92800405|NCT04350502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800406|NCT04350502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800407|NCT04350502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800408|NCT04350502|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92800409|NCT04300920|Acetylcysteine|acetylcysteine|mesh-list
92800410|NCT04300920|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92800411|NCT04300920|Antiviral Agents|antiviral agents|mesh-ancestor
92800412|NCT04300920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800413|NCT04300920|Expectorants|expectorants|mesh-ancestor
92800414|NCT04300920|Respiratory System Agents|respiratory system agents|mesh-ancestor
92800415|NCT04300920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92800416|NCT04300920|Antioxidants|antioxidants|mesh-ancestor
92800417|NCT04300920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800418|NCT04300920|Protective Agents|protective agents|mesh-ancestor
92800419|NCT04300920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800420|NCT04300920|Antidotes|antidotes|mesh-ancestor
92800421|NCT04252768|Paclitaxel|paclitaxel|mesh-list
92800422|NCT04252768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92800423|NCT04252768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800424|NCT04252768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800425|NCT04252768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800426|NCT04252768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800427|NCT04252768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800428|NCT04222010|Anesthetics|anesthetics|mesh-list
92800429|NCT04222010|Ropivacaine|ropivacaine|mesh-list
92800430|NCT04222010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800431|NCT04222010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800432|NCT04222010|Anesthetics, Local|anesthetics, local|mesh-ancestor
92800433|NCT04222010|Sensory System Agents|sensory system agents|mesh-ancestor
92800434|NCT04222010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800435|NCT04200651|Dexamethasone|dexamethasone|mesh-list
92800436|NCT04200651|Prednisolone|prednisolone|mesh-list
92800437|NCT04200651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92800438|NCT04200651|Methylprednisolone|methylprednisolone|mesh-list
92800439|NCT04200651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92800440|NCT04200651|Prednisolone acetate|prednisolone acetate|mesh-list
92800441|NCT04200651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92800442|NCT04200651|Prednisolone phosphate|prednisolone phosphate|mesh-list
92800443|NCT04200651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800445|NCT04200651|Autonomic Agents|autonomic agents|mesh-ancestor
92800446|NCT04200651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800447|NCT04200651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800448|NCT04200651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800449|NCT04200651|Glucocorticoids|glucocorticoids|mesh-ancestor
92800450|NCT04200651|Hormones|hormones|mesh-ancestor
92800451|NCT04200651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800452|NCT04200651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800453|NCT04200651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800454|NCT04200651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92800455|NCT04200651|Protective Agents|protective agents|mesh-ancestor
92800456|NCT04150900|Pembrolizumab|pembrolizumab|mesh-list
92800457|NCT04150900|Bavituximab|bavituximab|mesh-list
92800458|NCT04150900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800459|NCT04150900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800460|NCT04150900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92800461|NCT04150900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800462|NCT04084171|Insulin|insulin|mesh-list
92800463|NCT04084171|Pancrelipase|pancrelipase|mesh-list
92800464|NCT04084171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92800465|NCT04084171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800466|NCT04084171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800467|NCT04047706|Nivolumab|nivolumab|mesh-list
92800468|NCT04047706|Temozolomide|temozolomide|mesh-list
92800469|NCT04047706|Linrodostat|linrodostat|mesh-list
92800470|NCT04047706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800471|NCT04047706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800472|NCT04047706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92800473|NCT04047706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800474|NCT04047706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800475|NCT04047706|Alkylating Agents|alkylating agents|mesh-ancestor
92800476|NCT04047706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800477|NCT04034251|Paclitaxel|paclitaxel|mesh-list
92800478|NCT04034251|Capecitabine|capecitabine|mesh-list
92800479|NCT04034251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92800480|NCT04034251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800481|NCT04034251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800482|NCT04034251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800483|NCT04034251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800484|NCT04034251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800485|NCT04034251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92800486|NCT04034251|Antimetabolites|antimetabolites|mesh-ancestor
92800487|NCT03967249|Octreotide|octreotide|mesh-list
92800488|NCT03967249|Lanreotide|lanreotide|mesh-list
92800489|NCT03967249|Somatostatin|somatostatin|mesh-list
92800490|NCT03967249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800491|NCT03967249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800492|NCT03967249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800493|NCT03967249|Hormones|hormones|mesh-ancestor
92800494|NCT03967249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800495|NCT03967249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800496|NCT03935139|Glycerol|glycerol|mesh-list
92800497|NCT03935139|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92800498|NCT03935139|Protective Agents|protective agents|mesh-ancestor
92800499|NCT03935139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800500|NCT03927079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92413771|NCT01467531|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92800501|NCT03927079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92800502|NCT03927079|Dimercaprol|dimercaprol|mesh-list
92800503|NCT03927079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800504|NCT03927079|Antitubercular Agents|antitubercular agents|mesh-ancestor
92800505|NCT03927079|Chelating Agents|chelating agents|mesh-ancestor
92800506|NCT03927079|Sequestering Agents|sequestering agents|mesh-ancestor
92800507|NCT03927079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800508|NCT03926403|Anesthetics|anesthetics|mesh-list
92800509|NCT03926403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800510|NCT03926403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800511|NCT03884101|Paclitaxel|paclitaxel|mesh-list
92800512|NCT03884101|Carboplatin|carboplatin|mesh-list
92800513|NCT03884101|Pembrolizumab|pembrolizumab|mesh-list
92800514|NCT03884101|Lenvatinib|lenvatinib|mesh-list
92800515|NCT03884101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92800516|NCT03884101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800517|NCT03884101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800518|NCT03884101|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800519|NCT03884101|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800520|NCT03884101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800521|NCT03884101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800522|NCT03884101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92800523|NCT03884101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92800524|NCT03884101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800526|NCT03871621|Dapagliflozin|dapagliflozin|mesh-list
92800527|NCT03871621|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92800528|NCT03871621|Meglitinide|meglitinide|mesh-list
92800529|NCT03871621|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92800530|NCT03871621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800531|NCT03871621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92800532|NCT03871621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800533|NCT03867188|Bupivacaine|bupivacaine|mesh-list
92800534|NCT03867188|Anesthetics, Local|anesthetics, local|mesh-ancestor
92800535|NCT03867188|Anesthetics|anesthetics|mesh-ancestor
92800536|NCT03867188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800537|NCT03867188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800538|NCT03867188|Sensory System Agents|sensory system agents|mesh-ancestor
92800539|NCT03867188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800540|NCT03796884|Linaclotide|linaclotide|mesh-list
92800541|NCT03796884|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92800542|NCT03796884|Enzyme Activators|enzyme activators|mesh-ancestor
92800543|NCT03796884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800544|NCT03796884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800545|NCT03745040|Bupivacaine|bupivacaine|mesh-list
92800546|NCT03745040|Anesthetics, Local|anesthetics, local|mesh-ancestor
92800547|NCT03745040|Anesthetics|anesthetics|mesh-ancestor
92800548|NCT03745040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800549|NCT03745040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800550|NCT03745040|Sensory System Agents|sensory system agents|mesh-ancestor
92800551|NCT03745040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800552|NCT03740737|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92800553|NCT03740737|Hormones|hormones|mesh-ancestor
92800554|NCT03740737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800555|NCT03740737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800556|NCT03686345|Midostaurin|midostaurin|mesh-list
92800557|NCT03686345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800558|NCT03686345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92800559|NCT03686345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800560|NCT03686345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800561|NCT03671967|Meropenem|meropenem|mesh-list
92800562|NCT03671967|Tazobactam|tazobactam|mesh-list
92800563|NCT03671967|Piperacillin|piperacillin|mesh-list
92800564|NCT03671967|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92800565|NCT03671967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92800566|NCT03671967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800567|NCT03671967|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92800568|NCT03671967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413846|NCT01468038|Trazodone|trazodone|mesh-list
92800569|NCT03671967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800570|NCT03657810|Acetaminophen|acetaminophen|mesh-list
92800571|NCT03657810|Promethazine|promethazine|mesh-list
92800572|NCT03657810|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92800573|NCT03657810|Hydrocodone|hydrocodone|mesh-list
92800574|NCT03657810|Oxycodone|oxycodone|mesh-list
92800575|NCT03657810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92800577|NCT03657810|Sensory System Agents|sensory system agents|mesh-ancestor
92800578|NCT03657810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800579|NCT03657810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800580|NCT03657810|Antipyretics|antipyretics|mesh-ancestor
92800581|NCT03657810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92800582|NCT03657810|Narcotics|narcotics|mesh-ancestor
92800583|NCT03657810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800584|NCT03657810|Antitussive Agents|antitussive agents|mesh-ancestor
92800585|NCT03657810|Respiratory System Agents|respiratory system agents|mesh-ancestor
92800586|NCT03657810|Antipruritics|antipruritics|mesh-ancestor
92800587|NCT03657810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92800588|NCT03657810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92800589|NCT03657810|Histamine Antagonists|histamine antagonists|mesh-ancestor
92800590|NCT03657810|Histamine Agents|histamine agents|mesh-ancestor
92800591|NCT03657810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800592|NCT03657810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800593|NCT03657810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92800594|NCT03657810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92800595|NCT03657810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800596|NCT03657810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800598|NCT03640026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800599|NCT03640026|Immunologic Factors|immunologic factors|mesh-ancestor
92800600|NCT03640026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800601|NCT03640026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92800602|NCT03640026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800603|NCT03640026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800604|NCT03638297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
92800605|NCT03638297|Antibodies|antibodies|mesh-list
92800606|NCT03638297|Immunologic Factors|immunologic factors|mesh-ancestor
92800607|NCT03638297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800608|NCT03638297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800609|NCT03638297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800610|NCT03638297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92800611|NCT03638297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92800612|NCT03638297|Analgesics|analgesics|mesh-ancestor
92800613|NCT03638297|Sensory System Agents|sensory system agents|mesh-ancestor
92800614|NCT03638297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800615|NCT03638297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800616|NCT03638297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800617|NCT03544736|Paclitaxel|paclitaxel|mesh-list
92800618|NCT03544736|Carboplatin|carboplatin|mesh-list
92800619|NCT03544736|Nivolumab|nivolumab|mesh-list
92800620|NCT03544736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92800621|NCT03544736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800622|NCT03544736|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800623|NCT03544736|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800624|NCT03544736|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800625|NCT03544736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800626|NCT03544736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800627|NCT03544736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92800628|NCT03533010|Vitamin D|vitamin d|mesh-list
92800629|NCT03533010|Vitamins|vitamins|mesh-ancestor
92800630|NCT03533010|Micronutrients|micronutrients|mesh-ancestor
92800631|NCT03533010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800632|NCT03533010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92800633|NCT03409198|Cyclophosphamide|cyclophosphamide|mesh-list
92800634|NCT03409198|Doxorubicin|doxorubicin|mesh-list
92800635|NCT03409198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92800636|NCT03409198|Nivolumab|nivolumab|mesh-list
92800637|NCT03409198|Ipilimumab|ipilimumab|mesh-list
92800638|NCT03409198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800639|NCT03409198|Immunologic Factors|immunologic factors|mesh-ancestor
92800640|NCT03409198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800641|NCT03409198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800642|NCT03409198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800643|NCT03409198|Alkylating Agents|alkylating agents|mesh-ancestor
92800644|NCT03409198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800645|NCT03409198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800646|NCT03409198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92800647|NCT03409198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92800648|NCT03409198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92800649|NCT03409198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92800650|NCT03409198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800651|NCT03409198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800652|NCT03409198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92800653|NCT03382548|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92800654|NCT03382548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92800655|NCT03382548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800656|NCT03382548|Antitubercular Agents|antitubercular agents|mesh-ancestor
92800657|NCT03326245|Methylphenidate|methylphenidate|mesh-list
92800658|NCT03326245|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92800659|NCT03326245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800660|NCT03326245|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92800661|NCT03326245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92800662|NCT03326245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800663|NCT03326245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800664|NCT03326245|Dopamine Agents|dopamine agents|mesh-ancestor
92800665|NCT03326245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800666|NCT03321656|Tacrolimus|tacrolimus|mesh-list
92800667|NCT03321656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800668|NCT03321656|Immunologic Factors|immunologic factors|mesh-ancestor
92800669|NCT03321656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800670|NCT03321656|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92800671|NCT03321656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800672|NCT03321656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800674|NCT03236987|Clarithromycin|clarithromycin|mesh-list
92800675|NCT03236987|Rifampin|rifampin|mesh-list
92800676|NCT03236987|Ethambutol|ethambutol|mesh-list
92800677|NCT03236987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92800678|NCT03236987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800679|NCT03236987|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92800680|NCT03236987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800681|NCT03236987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800682|NCT03236987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92800683|NCT03236987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92800684|NCT03236987|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92800685|NCT03236987|Antitubercular Agents|antitubercular agents|mesh-ancestor
92800686|NCT03236987|Leprostatic Agents|leprostatic agents|mesh-ancestor
92800687|NCT03236987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92800688|NCT03236987|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92800689|NCT03236987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92800690|NCT03236987|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92800691|NCT03236987|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92800692|NCT03236987|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92800693|NCT03236987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92800694|NCT03094637|Pembrolizumab|pembrolizumab|mesh-list
92800695|NCT03094637|Azacitidine|azacitidine|mesh-list
92800696|NCT03094637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800697|NCT03094637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800698|NCT03094637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92800699|NCT03094637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800700|NCT03094637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92800701|NCT03094637|Antimetabolites|antimetabolites|mesh-ancestor
92800702|NCT03094637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800703|NCT03055507|Acetaminophen|acetaminophen|mesh-list
92800704|NCT03055507|Ibuprofen|ibuprofen|mesh-list
92800705|NCT03055507|Oxycodone|oxycodone|mesh-list
92800706|NCT03055507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92800707|NCT03055507|Analgesics|analgesics|mesh-ancestor
92800708|NCT03055507|Sensory System Agents|sensory system agents|mesh-ancestor
92800709|NCT03055507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800710|NCT03055507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800711|NCT03055507|Antipyretics|antipyretics|mesh-ancestor
92800712|NCT03055507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92800713|NCT03055507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800714|NCT03055507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800715|NCT03055507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92800716|NCT03055507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800717|NCT03055507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800718|NCT03055507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92800719|NCT03055507|Narcotics|narcotics|mesh-ancestor
92800720|NCT03055507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800721|NCT03038256|Capecitabine|capecitabine|mesh-list
92800722|NCT03038256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92800723|NCT03038256|Antimetabolites|antimetabolites|mesh-ancestor
92800724|NCT03038256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800725|NCT03038256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800726|NCT02870738|Triamcinolone|triamcinolone|mesh-list
92800727|NCT02870738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800728|NCT02870738|Glucocorticoids|glucocorticoids|mesh-ancestor
92800729|NCT02870738|Hormones|hormones|mesh-ancestor
92800730|NCT02870738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800731|NCT02870738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800732|NCT02789982|Propranolol|propranolol|mesh-list
92800733|NCT02789982|Adrenergic Agents|adrenergic agents|mesh-list
92800734|NCT02789982|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92800735|NCT02789982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92800736|NCT02789982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800737|NCT02789982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800738|NCT02789982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800739|NCT02789982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92445706|NCT01663077|GABA Antagonists|gaba antagonists|mesh-ancestor
92800741|NCT02789982|Vasodilator Agents|vasodilator agents|mesh-ancestor
92800742|NCT02667886|Axitinib|axitinib|mesh-list
92800743|NCT02667886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800744|NCT02667886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92800745|NCT02667886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800746|NCT02667886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800747|NCT02623972|Cyclophosphamide|cyclophosphamide|mesh-list
92800748|NCT02623972|Doxorubicin|doxorubicin|mesh-list
92800749|NCT02623972|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92800750|NCT02623972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800751|NCT02623972|Immunologic Factors|immunologic factors|mesh-ancestor
92800752|NCT02623972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800753|NCT02623972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800754|NCT02623972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800755|NCT02623972|Alkylating Agents|alkylating agents|mesh-ancestor
92800756|NCT02623972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800757|NCT02623972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800758|NCT02623972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92800759|NCT02623972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92800760|NCT02623972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92800761|NCT02623972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92800762|NCT02623972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800763|NCT02614066|Cyclophosphamide|cyclophosphamide|mesh-list
92800764|NCT02614066|Fludarabine|fludarabine|mesh-list
92800765|NCT02614066|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92800766|NCT02614066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800767|NCT02614066|Immunologic Factors|immunologic factors|mesh-ancestor
92800768|NCT02614066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800769|NCT02614066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800770|NCT02614066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800771|NCT02614066|Alkylating Agents|alkylating agents|mesh-ancestor
92800772|NCT02614066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800773|NCT02614066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800774|NCT02614066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92800775|NCT02614066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800776|NCT02587195|Teriflunomide|teriflunomide|mesh-list
92800777|NCT02587195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92800778|NCT02587195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92800779|NCT02587195|Analgesics|analgesics|mesh-ancestor
92800780|NCT02587195|Sensory System Agents|sensory system agents|mesh-ancestor
92800781|NCT02587195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800782|NCT02587195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800783|NCT02587195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800784|NCT02587195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800785|NCT02587195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800786|NCT02587195|Immunologic Factors|immunologic factors|mesh-ancestor
92800787|NCT02582008|Bupropion|bupropion|mesh-list
92800788|NCT02582008|Nicotine|nicotine|mesh-list
92800789|NCT02582008|Varenicline|varenicline|mesh-list
92800790|NCT02582008|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92800791|NCT02582008|Autonomic Agents|autonomic agents|mesh-ancestor
92800792|NCT02582008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800793|NCT02582008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800794|NCT02582008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92800795|NCT02582008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92800796|NCT02582008|Cholinergic Agents|cholinergic agents|mesh-ancestor
92800797|NCT02582008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800798|NCT02582008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800799|NCT02582008|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92800800|NCT02582008|Antidepressive Agents|antidepressive agents|mesh-ancestor
92800801|NCT02582008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92800802|NCT02582008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92800803|NCT02582008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92800804|NCT02582008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800805|NCT02582008|Dopamine Agents|dopamine agents|mesh-ancestor
92800806|NCT02582008|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92800807|NCT02582008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92800808|NCT02582008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800809|NCT02502799|Methylphenidate|methylphenidate|mesh-list
92800810|NCT02502799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92800811|NCT02502799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800812|NCT02502799|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92800813|NCT02502799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92800814|NCT02502799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800815|NCT02502799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800816|NCT02502799|Dopamine Agents|dopamine agents|mesh-ancestor
92800817|NCT02502799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800819|NCT02135133|Idelalisib|idelalisib|mesh-list
92800820|NCT02135133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800821|NCT02135133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800822|NCT02135133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800823|NCT01993836|Anesthetics|anesthetics|mesh-list
92800824|NCT01993836|Propofol|propofol|mesh-list
92800825|NCT01993836|Isoflurane|isoflurane|mesh-list
92800826|NCT01993836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92800827|NCT01993836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800828|NCT01993836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92800829|NCT01993836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92800830|NCT01993836|Anesthetics, General|anesthetics, general|mesh-ancestor
92800831|NCT01993836|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92800832|NCT01818739|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92800833|NCT01717586|Pravastatin|pravastatin|mesh-list
92800834|NCT01717586|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92800835|NCT01717586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92800836|NCT01717586|Antimetabolites|antimetabolites|mesh-ancestor
92800837|NCT01717586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800838|NCT01717586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92800839|NCT01717586|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92800840|NCT01717586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800841|NCT01523977|Prednisone|prednisone|mesh-list
92800842|NCT01523977|Doxorubicin|doxorubicin|mesh-list
92800843|NCT01523977|Dexrazoxane|dexrazoxane|mesh-list
92800844|NCT01523977|Vincristine|vincristine|mesh-list
92800845|NCT01523977|Everolimus|everolimus|mesh-list
92800846|NCT01523977|Asparaginase|asparaginase|mesh-list
92800847|NCT01523977|Pegaspargase|pegaspargase|mesh-list
92800848|NCT01523977|Razoxane|razoxane|mesh-list
92800849|NCT01523977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92800850|NCT01523977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800851|NCT01523977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92800852|NCT01523977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92800853|NCT01523977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800854|NCT01523977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800855|NCT01523977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92800856|NCT01523977|Glucocorticoids|glucocorticoids|mesh-ancestor
92800857|NCT01523977|Hormones|hormones|mesh-ancestor
92800858|NCT01523977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800859|NCT01523977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800860|NCT01523977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800861|NCT01523977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92800862|NCT01523977|Tubulin Modulators|tubulin modulators|mesh-ancestor
92800863|NCT01523977|Antimitotic Agents|antimitotic agents|mesh-ancestor
92800864|NCT01523977|Mitosis Modulators|mitosis modulators|mesh-ancestor
92800865|NCT01523977|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92800866|NCT01523977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92800867|NCT01523977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800868|NCT01523977|Immunologic Factors|immunologic factors|mesh-ancestor
92800869|NCT01523977|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92800870|NCT01523977|Protective Agents|protective agents|mesh-ancestor
92800871|NCT01107717|Metformin|metformin|mesh-list
92800872|NCT01107717|Pioglitazone|pioglitazone|mesh-list
92800873|NCT01107717|Exenatide|exenatide|mesh-list
92800875|NCT01107717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92800876|NCT01107717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800877|NCT01107717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92800878|NCT01107717|Incretins|incretins|mesh-ancestor
92800879|NCT01107717|Hormones|hormones|mesh-ancestor
92800880|NCT01107717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800881|NCT00782574|Olaparib|olaparib|mesh-list
92800882|NCT00782574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800883|NCT00782574|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92800884|NCT00782574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800885|NCT00782574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800886|NCT00753545|Olaparib|olaparib|mesh-list
92800887|NCT00753545|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92800888|NCT00753545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445857|NCT01664845|Metformin|metformin|mesh-list
92800889|NCT00753545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800890|NCT00753545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800891|NCT00635362|Levonorgestrel|levonorgestrel|mesh-list
92800892|NCT00635362|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92800893|NCT00635362|Contraceptive Agents|contraceptive agents|mesh-ancestor
92800894|NCT00635362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92800895|NCT00635362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800896|NCT00635362|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92800897|NCT00635362|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92800898|NCT00635362|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92800899|NCT00408447|Fludarabine|fludarabine|mesh-list
92800901|NCT00408447|Alemtuzumab|alemtuzumab|mesh-list
92800902|NCT00408447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800903|NCT00408447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800904|NCT00408447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800905|NCT00408447|Immunologic Factors|immunologic factors|mesh-ancestor
92800906|NCT00408447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800907|NCT00408447|Alkylating Agents|alkylating agents|mesh-ancestor
92800908|NCT00408447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92800909|NCT00408447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92800910|NCT00408447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800911|NCT00278915|Fulvestrant|fulvestrant|mesh-list
92800912|NCT00278915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92800913|NCT00278915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800914|NCT00278915|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92800915|NCT00278915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92800916|NCT00278915|Hormone Antagonists|hormone antagonists|mesh-ancestor
92800917|NCT00278915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800918|NCT00278915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800919|NCT04285320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92800920|NCT04285320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92800921|NCT04285320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800922|NCT04285320|Antitubercular Agents|antitubercular agents|mesh-ancestor
92800923|NCT00970632|Tadalafil|tadalafil|mesh-list
92800924|NCT00970632|Tamsulosin|tamsulosin|mesh-list
92800925|NCT00970632|Vasodilator Agents|vasodilator agents|mesh-ancestor
92800926|NCT00970632|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92800927|NCT00970632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92800928|NCT00970632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800929|NCT00970632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800930|NCT00970632|Urological Agents|urological agents|mesh-ancestor
92800931|NCT00970632|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92800932|NCT00970632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92800933|NCT00970632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92800934|NCT00970632|Adrenergic Agents|adrenergic agents|mesh-ancestor
92800935|NCT00970632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800936|NCT00970632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800937|NCT01144364|Rituximab|rituximab|mesh-list
92800938|NCT01144364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92800939|NCT01144364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800940|NCT01144364|Immunologic Factors|immunologic factors|mesh-ancestor
92800941|NCT01144364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800942|NCT01144364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92800943|NCT00965094|Mycophenolic Acid|mycophenolic acid|mesh-list
92800944|NCT00965094|Everolimus|everolimus|mesh-list
92800945|NCT00965094|Tacrolimus|tacrolimus|mesh-list
92800946|NCT00965094|Basiliximab|basiliximab|mesh-list
92800947|NCT00965094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92800948|NCT00965094|Immunologic Factors|immunologic factors|mesh-ancestor
92800949|NCT00965094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800950|NCT00965094|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92800951|NCT00965094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800952|NCT00965094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800953|NCT00965094|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92800954|NCT00965094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92800955|NCT00965094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800956|NCT00965094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92800957|NCT00965094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92800958|NCT00965094|Antitubercular Agents|antitubercular agents|mesh-ancestor
92800959|NCT00965094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92800960|NCT00965094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92800962|NCT01131182|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92800964|NCT01131182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800965|NCT01131182|Incretins|incretins|mesh-ancestor
92800966|NCT01131182|Hormones|hormones|mesh-ancestor
92800967|NCT01131182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92800968|NCT01131182|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92800969|NCT01131182|Protease Inhibitors|protease inhibitors|mesh-ancestor
92800970|NCT01131182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800971|NCT01131182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800972|NCT01131104|Sildenafil Citrate|sildenafil citrate|mesh-list
92800973|NCT01131104|Tadalafil|tadalafil|mesh-list
92800974|NCT01131104|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92800975|NCT01131104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92800976|NCT01131104|Vasodilator Agents|vasodilator agents|mesh-ancestor
92800977|NCT01131104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92800978|NCT01131104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92800979|NCT01131104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800980|NCT01131104|Urological Agents|urological agents|mesh-ancestor
92800981|NCT04264884|Daratumumab|daratumumab|mesh-list
92800982|NCT04264884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92800983|NCT01118780|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92800984|NCT01118780|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92800985|NCT01118780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92800986|NCT01118780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92800987|NCT01118780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92800988|NCT01118780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92800989|NCT01118780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92800990|NCT01118780|Analgesics|analgesics|mesh-ancestor
92800991|NCT01118780|Sensory System Agents|sensory system agents|mesh-ancestor
92800992|NCT01118780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92800993|NCT01118780|Antidepressive Agents|antidepressive agents|mesh-ancestor
92800994|NCT01118780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92800995|NCT01118780|Dopamine Agents|dopamine agents|mesh-ancestor
92800996|NCT00629928|Esomeprazole|esomeprazole|mesh-list
92800997|NCT00629928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92800998|NCT00629928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92800999|NCT00629928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92801000|NCT00629928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801001|NCT00629928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801002|NCT00964782|Sildenafil Citrate|sildenafil citrate|mesh-list
92801003|NCT00964782|Vasodilator Agents|vasodilator agents|mesh-ancestor
92801004|NCT00964782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92801005|NCT00964782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92801006|NCT00964782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801007|NCT00964782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801008|NCT00964782|Urological Agents|urological agents|mesh-ancestor
92801009|NCT02882984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92801010|NCT02882984|Gefitinib|gefitinib|mesh-list
92801011|NCT02882984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801012|NCT02882984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92801013|NCT02882984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801014|NCT02882984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801015|NCT00966654|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92801016|NCT00966654|Incretins|incretins|mesh-ancestor
92801017|NCT00966654|Hormones|hormones|mesh-ancestor
92801018|NCT00966654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92801019|NCT00966654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801020|NCT00625196|Fluticasone|fluticasone|mesh-list
92801021|NCT00625196|Xhance|xhance|mesh-list
92801022|NCT00625196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801023|NCT00625196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92801024|NCT00625196|Autonomic Agents|autonomic agents|mesh-ancestor
92801025|NCT00625196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801026|NCT00625196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801027|NCT00625196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92801028|NCT00625196|Respiratory System Agents|respiratory system agents|mesh-ancestor
92801029|NCT00625196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801030|NCT00625196|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92801031|NCT03262116|Insulin|insulin|mesh-list
92801032|NCT03262116|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92801033|NCT03262116|Insulin Lispro|insulin lispro|mesh-list
92801034|NCT03262116|Insulin Aspart|insulin aspart|mesh-list
92801035|NCT03262116|Pancrelipase|pancrelipase|mesh-list
92801036|NCT03262116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92801037|NCT03262116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801038|NCT03262116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92801039|NCT01130168|Amlodipine|amlodipine|mesh-list
92801040|NCT01130168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92801041|NCT01130168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92801042|NCT01130168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801043|NCT01130168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801044|NCT01130168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92801045|NCT01130168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801046|NCT01130168|Vasodilator Agents|vasodilator agents|mesh-ancestor
92801047|NCT04284852|Niraparib|niraparib|mesh-list
92801048|NCT04284852|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92801049|NCT04284852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801050|NCT04284852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801051|NCT04284852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801052|NCT04283292|Capsaicin|capsaicin|mesh-list
92801053|NCT04283292|Antipruritics|antipruritics|mesh-ancestor
92801054|NCT04283292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801055|NCT04283292|Sensory System Agents|sensory system agents|mesh-ancestor
92801056|NCT04283292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801057|NCT04283292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801058|NCT01144052|Interferons|interferons|mesh-list
92801059|NCT01144052|Interferon-beta|interferon-beta|mesh-list
92801060|NCT01144052|Natalizumab|natalizumab|mesh-list
92801061|NCT01144052|Interferon beta-1b|interferon beta-1b|mesh-list
92801062|NCT01144052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801063|NCT01144052|Antiviral Agents|antiviral agents|mesh-ancestor
92801064|NCT01144052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801065|NCT01144052|Immunologic Factors|immunologic factors|mesh-ancestor
92801066|NCT01144052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801067|NCT01144052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92801068|NCT04283526|Decitabine|decitabine|mesh-list
92801069|NCT04283526|Spartalizumab|spartalizumab|mesh-list
92801070|NCT04283526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801071|NCT04283526|Antimetabolites|antimetabolites|mesh-ancestor
92801072|NCT04283526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801073|NCT04283526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801074|NCT04283526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801075|NCT04283526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92801076|NCT04283526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801077|NCT01118312|Mometasone Furoate|mometasone furoate|mesh-list
92801078|NCT01118312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801079|NCT01118312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801080|NCT01118312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92801081|NCT01117766|Pregabalin|pregabalin|mesh-list
92801082|NCT01117766|Analgesics|analgesics|mesh-ancestor
92801083|NCT01117766|Sensory System Agents|sensory system agents|mesh-ancestor
92801084|NCT01117766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801085|NCT01117766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801086|NCT01117766|Anticonvulsants|anticonvulsants|mesh-ancestor
92801087|NCT01117766|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92801088|NCT01117766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801089|NCT01117766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801090|NCT01117766|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92801091|NCT01117766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92801092|NCT01117766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92801093|NCT01117766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801094|NCT01117766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92414397|NCT01471678|Tamsulosin|tamsulosin|mesh-list
92801095|NCT04312880|Tranexamic Acid|tranexamic acid|mesh-list
92801096|NCT04312880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92801097|NCT04312880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92801098|NCT04312880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801099|NCT04312880|Hemostatics|hemostatics|mesh-ancestor
92801100|NCT04312880|Coagulants|coagulants|mesh-ancestor
92801101|NCT01117454|Flecainide|flecainide|mesh-list
92801102|NCT01117454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92801103|NCT01117454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92801104|NCT01117454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92801105|NCT01117454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801106|NCT01117454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801107|NCT01117454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801108|NCT01117454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92801109|NCT01117454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92801110|NCT01117454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92801111|NCT01117454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801113|NCT01129622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801114|NCT01129622|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92801115|NCT01129622|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92801116|NCT01129622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801117|NCT01129622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801118|NCT01129622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92801119|NCT01129622|Hormone Antagonists|hormone antagonists|mesh-ancestor
92801120|NCT01129622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92801121|NCT01129622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801122|NCT01128842|Capecitabine|capecitabine|mesh-list
92801123|NCT01128842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801124|NCT01128842|Antimetabolites|antimetabolites|mesh-ancestor
92801125|NCT01128842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801126|NCT01128842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801127|NCT00625274|Esomeprazole|esomeprazole|mesh-list
92801128|NCT00625274|Pantoprazole|pantoprazole|mesh-list
92801129|NCT00625274|Lansoprazole|lansoprazole|mesh-list
92801130|NCT00625274|Dexlansoprazole|dexlansoprazole|mesh-list
92801131|NCT00625274|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92801132|NCT00625274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92801133|NCT00625274|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92801134|NCT00625274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801135|NCT00625274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801136|NCT03624036|Cyclophosphamide|cyclophosphamide|mesh-list
92801137|NCT03624036|Fludarabine|fludarabine|mesh-list
92801138|NCT03624036|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92801139|NCT03624036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801140|NCT03624036|Immunologic Factors|immunologic factors|mesh-ancestor
92801141|NCT03624036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801142|NCT03624036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801143|NCT03624036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92801144|NCT03624036|Alkylating Agents|alkylating agents|mesh-ancestor
92801145|NCT03624036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801146|NCT03624036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801147|NCT03624036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92801148|NCT03624036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801149|NCT00915525|Botulinum Toxins|botulinum toxins|mesh-list
92801150|NCT00915525|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92801151|NCT00915525|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92801152|NCT00915525|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92801153|NCT00915525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801154|NCT00915525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801155|NCT00915525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92801156|NCT00915525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801157|NCT00915525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801158|NCT00915525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92801159|NCT00915525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801160|NCT04669041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92801161|NCT04669041|Ezetimibe|ezetimibe|mesh-list
92801162|NCT04669041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801163|NCT04669041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801164|NCT04669041|Antimetabolites|antimetabolites|mesh-ancestor
92801165|NCT04669041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801166|NCT04669041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801167|NCT04669041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92801168|NCT04669041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801169|NCT05132595|Ketorolac|ketorolac|mesh-list
92801170|NCT05132595|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92801171|NCT05132595|Esketamine|esketamine|mesh-list
92801172|NCT05132595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92801173|NCT05132595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801174|NCT05132595|Analgesics|analgesics|mesh-ancestor
92801175|NCT05132595|Sensory System Agents|sensory system agents|mesh-ancestor
92801176|NCT05132595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801177|NCT05132595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801178|NCT05132595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801179|NCT05132595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801180|NCT05132595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92801181|NCT05132595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801182|NCT05132595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446159|NCT01666600|Nintedanib|nintedanib|mesh-list
92801183|NCT05132595|Antidepressive Agents|antidepressive agents|mesh-ancestor
92801184|NCT05132595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92801185|NCT01074047|Azacitidine|azacitidine|mesh-list
92801186|NCT01074047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801187|NCT01074047|Antimetabolites|antimetabolites|mesh-ancestor
92801188|NCT01074047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801189|NCT01074047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801190|NCT01074047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801191|NCT05226117|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92801192|NCT05226117|Immunoconjugates|immunoconjugates|mesh-ancestor
92801193|NCT05226117|Immunologic Factors|immunologic factors|mesh-ancestor
92801194|NCT05226117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801195|NCT01142726|Methotrexate|methotrexate|mesh-list
92801196|NCT01142726|Abatacept|abatacept|mesh-list
92801197|NCT01142726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92801198|NCT01142726|Abortifacient Agents|abortifacient agents|mesh-ancestor
92801199|NCT01142726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92801200|NCT01142726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801201|NCT01142726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801202|NCT01142726|Antimetabolites|antimetabolites|mesh-ancestor
93026446|NCT00493038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92801203|NCT01142726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801204|NCT01142726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801205|NCT01142726|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801206|NCT01142726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801207|NCT01142726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92801208|NCT01142726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801209|NCT01142726|Immunologic Factors|immunologic factors|mesh-ancestor
92801210|NCT01142726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801211|NCT01142726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92801212|NCT01142726|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92801213|NCT01142726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801214|NCT04472637|Atorvastatin|atorvastatin|mesh-list
92801215|NCT04472637|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801216|NCT04472637|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801217|NCT04472637|Antimetabolites|antimetabolites|mesh-ancestor
92801218|NCT04472637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801219|NCT04472637|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801220|NCT04472637|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92801221|NCT04472637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801222|NCT01142336|Simvastatin|simvastatin|mesh-list
92801223|NCT01142336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801224|NCT01142336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801225|NCT01142336|Antimetabolites|antimetabolites|mesh-ancestor
92801226|NCT01142336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801227|NCT01142336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801228|NCT01142336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92801229|NCT01142336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801230|NCT00915681|Silybin|silybin|mesh-list
92801231|NCT00915681|Protective Agents|protective agents|mesh-ancestor
92801232|NCT00915681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801233|NCT00915681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92801234|NCT00915681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801235|NCT01128296|Hydroxychloroquine|hydroxychloroquine|mesh-list
92801236|NCT01128296|Gemcitabine|gemcitabine|mesh-list
92801237|NCT01128296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801238|NCT01128296|Antimetabolites|antimetabolites|mesh-ancestor
92801239|NCT01128296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801240|NCT01128296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801241|NCT01128296|Antimalarials|antimalarials|mesh-ancestor
92801242|NCT01128296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92801243|NCT01128296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92801244|NCT01128296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801245|NCT01128296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801246|NCT01128296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801247|NCT05082909|Probenecid|probenecid|mesh-list
92801248|NCT05082909|Uricosuric Agents|uricosuric agents|mesh-ancestor
92801249|NCT05082909|Gout Suppressants|gout suppressants|mesh-ancestor
92801250|NCT05082909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801251|NCT04253145|Atezolizumab|atezolizumab|mesh-list
92801252|NCT04253145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92801253|NCT04253145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801254|NCT04253145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801255|NCT04253145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801256|NCT04240509|Tenofovir|tenofovir|mesh-list
92801257|NCT04240509|Emtricitabine|emtricitabine|mesh-list
92801258|NCT04240509|Antiviral Agents|antiviral agents|mesh-ancestor
92801259|NCT04240509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801260|NCT04240509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92801261|NCT04240509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92801262|NCT04240509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801263|NCT04240509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801264|NCT04240509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92801265|NCT04240509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92801266|NCT04450329|Aflibercept|aflibercept|mesh-list
92801267|NCT04450329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92801268|NCT04450329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92801269|NCT04450329|Growth Substances|growth substances|mesh-ancestor
92801270|NCT04450329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801271|NCT04450329|Growth Inhibitors|growth inhibitors|mesh-ancestor
92801272|NCT04450329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801273|NCT01115738|Clopidogrel|clopidogrel|mesh-list
92801274|NCT01115738|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92801275|NCT01115738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92801276|NCT01115738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92801277|NCT01115738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92801278|NCT01115738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92801279|NCT01115738|Purinergic Agents|purinergic agents|mesh-ancestor
92801280|NCT01115738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801281|NCT01115738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801282|NCT01115738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801283|NCT00632073|Maleic acid|maleic acid|mesh-list
92801284|NCT00632073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801285|NCT00632073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801286|NCT01141478|Sorafenib|sorafenib|mesh-list
92801287|NCT01141478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801288|NCT01141478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92801289|NCT01141478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801290|NCT01141478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801291|NCT01114880|Adalimumab|adalimumab|mesh-list
92801292|NCT01114880|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92801293|NCT01114880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801294|NCT01114880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801295|NCT00625352|Gemcitabine|gemcitabine|mesh-list
92801296|NCT00625352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801297|NCT00625352|Antimetabolites|antimetabolites|mesh-ancestor
92801298|NCT00625352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801299|NCT00625352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801300|NCT04539873|Colchicine|colchicine|mesh-list
92801301|NCT04539873|Gout Suppressants|gout suppressants|mesh-ancestor
92801302|NCT04539873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801303|NCT04539873|Tubulin Modulators|tubulin modulators|mesh-ancestor
92801304|NCT04539873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92801305|NCT04539873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92801306|NCT04539873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801307|NCT04539873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801308|NCT02861040|Vincristine|vincristine|mesh-list
92801309|NCT02861040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92801310|NCT02861040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801311|NCT02861040|Tubulin Modulators|tubulin modulators|mesh-ancestor
92801312|NCT02861040|Antimitotic Agents|antimitotic agents|mesh-ancestor
92801313|NCT02861040|Mitosis Modulators|mitosis modulators|mesh-ancestor
92801314|NCT02861040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801315|NCT04646187|Adalimumab|adalimumab|mesh-list
92801316|NCT04646187|Infliximab|infliximab|mesh-list
92801317|NCT04646187|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92801318|NCT04646187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801320|NCT04646187|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801321|NCT04646187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92801322|NCT04282902|Pirfenidone|pirfenidone|mesh-list
92801323|NCT04282902|Analgesics|analgesics|mesh-ancestor
92801324|NCT04282902|Sensory System Agents|sensory system agents|mesh-ancestor
92801325|NCT04282902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801326|NCT04282902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801327|NCT04282902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92801328|NCT04282902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801329|NCT04282902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801330|NCT04282902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801331|NCT04282902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801333|NCT02860962|Antitussive Agents|antitussive agents|mesh-ancestor
92801334|NCT02860962|Respiratory System Agents|respiratory system agents|mesh-ancestor
92801335|NCT02860962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92801336|NCT02860962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92801337|NCT02860962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801338|NCT02860962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801339|NCT02860962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801340|NCT04432623|Benserazide|benserazide|mesh-list
92801341|NCT04432623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92801342|NCT04432623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92801343|NCT04432623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801344|NCT04432623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801345|NCT04432623|Dopamine Agents|dopamine agents|mesh-ancestor
92801346|NCT04432623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801347|NCT04432623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801348|NCT00878722|Idarubicin|idarubicin|mesh-list
92801349|NCT00878722|Belinostat|belinostat|mesh-list
92801350|NCT00878722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92801351|NCT00878722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801352|NCT00878722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92801353|NCT00878722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92801354|NCT00878722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801355|NCT00878722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801356|NCT00878722|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92801357|NCT03432897|Olaparib|olaparib|mesh-list
92801358|NCT03432897|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92801359|NCT03432897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801360|NCT03432897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801361|NCT03432897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801362|NCT00659386|Immunoglobulins|immunoglobulins|mesh-list
92801363|NCT00659386|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92801364|NCT00659386|Antibodies|antibodies|mesh-list
92801365|NCT00659386|gamma-Globulins|gamma-globulins|mesh-list
92801366|NCT00659386|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92801367|NCT00659386|Immunologic Factors|immunologic factors|mesh-ancestor
92801368|NCT00659386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801369|NCT04160325|Azathioprine|azathioprine|mesh-list
92801370|NCT04160325|Antimetabolites|antimetabolites|mesh-ancestor
92801371|NCT04160325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801372|NCT04160325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801373|NCT04160325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801374|NCT04160325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801375|NCT04160325|Immunologic Factors|immunologic factors|mesh-ancestor
92801376|NCT04160325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801377|NCT04160325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801378|NCT04155814|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92801379|NCT04155814|Hematinics|hematinics|mesh-ancestor
92801380|NCT04547439|Melatonin|melatonin|mesh-list
92801381|NCT04547439|Antioxidants|antioxidants|mesh-ancestor
92801382|NCT04547439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801383|NCT04547439|Protective Agents|protective agents|mesh-ancestor
92801384|NCT04547439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801385|NCT04547439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801386|NCT04158076|Amlodipine|amlodipine|mesh-list
92801387|NCT04158076|Telmisartan|telmisartan|mesh-list
92801388|NCT04158076|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92801389|NCT04158076|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92801390|NCT04158076|Ezetimibe|ezetimibe|mesh-list
92801391|NCT04158076|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92801392|NCT04158076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92801393|NCT04158076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801394|NCT04158076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801395|NCT04158076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92801396|NCT04158076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801397|NCT04158076|Vasodilator Agents|vasodilator agents|mesh-ancestor
92801398|NCT04158076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801399|NCT04158076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801400|NCT04158076|Antimetabolites|antimetabolites|mesh-ancestor
92801401|NCT04158076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801402|NCT04158076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92801403|NCT04158076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801404|NCT04158076|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92801405|NCT04158076|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92801406|NCT00961350|Aspirin|aspirin|mesh-list
92801407|NCT00961350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92801408|NCT00961350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801409|NCT00961350|Analgesics|analgesics|mesh-ancestor
92801410|NCT00961350|Sensory System Agents|sensory system agents|mesh-ancestor
92801411|NCT00961350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801412|NCT00961350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801413|NCT00961350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801414|NCT00961350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801415|NCT00961350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92801416|NCT00961350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92801417|NCT00961350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801418|NCT00961350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92801419|NCT00961350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92801420|NCT00961350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801421|NCT00961350|Antipyretics|antipyretics|mesh-ancestor
92801422|NCT03537690|Paclitaxel|paclitaxel|mesh-list
92801423|NCT03537690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92801424|NCT03537690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92801425|NCT03537690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801426|NCT03537690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92801427|NCT03537690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92801428|NCT03537690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92801429|NCT03537690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801430|NCT04032184|Chlorhexidine|chlorhexidine|mesh-list
92801431|NCT04032184|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92801432|NCT04032184|Fluorides|fluorides|mesh-list
92801433|NCT04032184|Cariostatic Agents|cariostatic agents|mesh-ancestor
92801434|NCT04032184|Protective Agents|protective agents|mesh-ancestor
92801435|NCT04032184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801436|NCT04032184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92801437|NCT04032184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801438|NCT04032184|Disinfectants|disinfectants|mesh-ancestor
92801439|NCT04032184|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801440|NCT04246437|Carbidopa|carbidopa|mesh-list
92801441|NCT04246437|Entacapone|entacapone|mesh-list
92801442|NCT04246437|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92801443|NCT04246437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92801444|NCT04246437|Dopamine Agents|dopamine agents|mesh-ancestor
92801445|NCT04246437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801446|NCT04246437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801447|NCT04246437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801448|NCT04246437|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92801449|NCT04246437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801450|NCT04246437|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92801451|NCT00662896|Ibuprofen|ibuprofen|mesh-list
92801452|NCT00662896|Naproxen|naproxen|mesh-list
92801453|NCT00662896|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92801454|NCT00662896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92801455|NCT00662896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801456|NCT00662896|Analgesics|analgesics|mesh-ancestor
92801457|NCT00662896|Sensory System Agents|sensory system agents|mesh-ancestor
92801458|NCT00662896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801459|NCT00662896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801460|NCT00662896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801461|NCT00662896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801462|NCT00662896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92801463|NCT00662896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801464|NCT00662896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801465|NCT00662896|Gout Suppressants|gout suppressants|mesh-ancestor
92801466|NCT00662896|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92801467|NCT00963924|Cycloserine|cycloserine|mesh-list
92801468|NCT00963924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92801469|NCT00963924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801470|NCT00963924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92801471|NCT00963924|Antitubercular Agents|antitubercular agents|mesh-ancestor
92801472|NCT00963924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92801473|NCT00963924|Antimetabolites|antimetabolites|mesh-ancestor
92801474|NCT00963924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801476|NCT04155658|Cariostatic Agents|cariostatic agents|mesh-ancestor
92801477|NCT04155658|Protective Agents|protective agents|mesh-ancestor
92801478|NCT04155658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446449|NCT01668680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801479|NCT02861976|Analgesics, Opioid|analgesics, opioid|mesh-list
92801480|NCT02861976|Narcotics|narcotics|mesh-ancestor
92801481|NCT02861976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801482|NCT02861976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801483|NCT02861976|Analgesics|analgesics|mesh-ancestor
92801484|NCT02861976|Sensory System Agents|sensory system agents|mesh-ancestor
92801485|NCT02861976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801486|NCT00666484|Prednisolone|prednisolone|mesh-list
92801487|NCT00666484|Cyclophosphamide|cyclophosphamide|mesh-list
92801488|NCT00666484|Doxorubicin|doxorubicin|mesh-list
92801489|NCT00666484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92801490|NCT00666484|Etoposide|etoposide|mesh-list
92801491|NCT00666484|Vincristine|vincristine|mesh-list
92801492|NCT00666484|Procarbazine|procarbazine|mesh-list
92801493|NCT00666484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801494|NCT00666484|Immunologic Factors|immunologic factors|mesh-ancestor
92801495|NCT00666484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801496|NCT00666484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801497|NCT00666484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92801498|NCT00666484|Alkylating Agents|alkylating agents|mesh-ancestor
92801499|NCT00666484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801500|NCT00666484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801501|NCT00666484|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92801502|NCT00666484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92801503|NCT00666484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92801504|NCT00666484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92801505|NCT00666484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801506|NCT00666484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92801507|NCT00666484|Tubulin Modulators|tubulin modulators|mesh-ancestor
92801508|NCT00666484|Antimitotic Agents|antimitotic agents|mesh-ancestor
92801509|NCT00666484|Mitosis Modulators|mitosis modulators|mesh-ancestor
92801510|NCT00666484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801511|NCT00666484|Glucocorticoids|glucocorticoids|mesh-ancestor
92801512|NCT00666484|Hormones|hormones|mesh-ancestor
92801513|NCT00666484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92801514|NCT00666484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92801515|NCT00663130|Tadalafil|tadalafil|mesh-list
92801516|NCT00663130|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92801517|NCT00663130|Vasodilator Agents|vasodilator agents|mesh-ancestor
92801518|NCT00663130|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92801519|NCT00663130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92801520|NCT00663130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801521|NCT00663130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801522|NCT00663130|Urological Agents|urological agents|mesh-ancestor
92801523|NCT00965562|Fluoxetine|fluoxetine|mesh-list
92801524|NCT00965562|Calcium|calcium|mesh-list
92801525|NCT00965562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92801526|NCT00965562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801527|NCT00965562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92801528|NCT00965562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92801529|NCT00965562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801530|NCT00965562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801531|NCT00965562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801532|NCT00965562|Serotonin Agents|serotonin agents|mesh-ancestor
92801533|NCT00965562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92801534|NCT00965562|Antidepressive Agents|antidepressive agents|mesh-ancestor
92801535|NCT00965562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92801536|NCT00965562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92801537|NCT00965562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92801538|NCT00965562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801539|NCT00659698|Pancrelipase|pancrelipase|mesh-list
92747885|NCT03661723|Bevacizumab|bevacizumab|mesh-list
92801540|NCT00659698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92801542|NCT00666796|Gabapentin|gabapentin|mesh-list
92801543|NCT00666796|Analgesics|analgesics|mesh-ancestor
92801544|NCT00666796|Sensory System Agents|sensory system agents|mesh-ancestor
92801545|NCT00666796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801546|NCT00666796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801547|NCT00666796|Anticonvulsants|anticonvulsants|mesh-ancestor
92801548|NCT00666796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92801549|NCT00666796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92801550|NCT00666796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801551|NCT00666796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92801552|NCT00666796|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92801553|NCT00666796|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92801554|NCT00666796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801555|NCT00666796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801556|NCT00666796|Antimanic Agents|antimanic agents|mesh-ancestor
92801557|NCT00666796|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92801558|NCT00666796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801559|NCT00912093|Icatibant|icatibant|mesh-list
92801560|NCT00912093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92801561|NCT00912093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801562|NCT00912093|Analgesics|analgesics|mesh-ancestor
92801563|NCT00912093|Sensory System Agents|sensory system agents|mesh-ancestor
92801564|NCT00912093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801565|NCT00912093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801566|NCT00912093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801567|NCT00912093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801568|NCT00912093|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92801569|NCT00912093|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92801570|NCT00912093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801571|NCT00912093|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92801572|NCT00912093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801573|NCT00912093|Immunologic Factors|immunologic factors|mesh-ancestor
92801574|NCT00659776|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92801575|NCT00659776|Hematinics|hematinics|mesh-ancestor
92801576|NCT00659776|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92801577|NCT00659776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92801578|NCT03500484|Liraglutide|liraglutide|mesh-list
92801579|NCT03500484|Glucagon|glucagon|mesh-list
92801580|NCT03500484|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92801581|NCT03500484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92801582|NCT03500484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801583|NCT03500484|Incretins|incretins|mesh-ancestor
92801584|NCT03500484|Hormones|hormones|mesh-ancestor
92801585|NCT03500484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92801586|NCT03500484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92801587|NCT03929601|Rituximab|rituximab|mesh-list
92801588|NCT03929601|Abatacept|abatacept|mesh-list
92801589|NCT03929601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801590|NCT03929601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801591|NCT03929601|Immunologic Factors|immunologic factors|mesh-ancestor
92801592|NCT03929601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801593|NCT03929601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801594|NCT03929601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92801595|NCT03929601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801596|NCT03929601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801597|NCT02631460|Carboplatin|carboplatin|mesh-list
92801598|NCT02631460|Pemetrexed|pemetrexed|mesh-list
92801599|NCT02631460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801600|NCT02631460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801601|NCT02631460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801602|NCT02631460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92801603|NCT02631460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92801604|NCT04282824|Edetic Acid|edetic acid|mesh-list
92801605|NCT04282824|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92801606|NCT04282824|Chelating Agents|chelating agents|mesh-ancestor
92801607|NCT04282824|Sequestering Agents|sequestering agents|mesh-ancestor
92801608|NCT04282824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801609|NCT04282824|Anticoagulants|anticoagulants|mesh-ancestor
92801610|NCT04282824|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92801611|NCT04282824|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92801612|NCT00663286|Clindamycin|clindamycin|mesh-list
92801613|NCT00663286|Clindamycin palmitate|clindamycin palmitate|mesh-list
92801614|NCT00663286|Clindamycin phosphate|clindamycin phosphate|mesh-list
92801616|NCT00663286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92801617|NCT00663286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801618|NCT00663286|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92801619|NCT00663286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801620|NCT00663286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801621|NCT00663286|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801622|NCT03237702|Carotenoids|carotenoids|mesh-list
92801623|NCT03237702|Antioxidants|antioxidants|mesh-ancestor
92801624|NCT03237702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801625|NCT03237702|Protective Agents|protective agents|mesh-ancestor
92801626|NCT03237702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801627|NCT00667108|Gabapentin|gabapentin|mesh-list
92801628|NCT00667108|Analgesics|analgesics|mesh-ancestor
92801629|NCT00667108|Sensory System Agents|sensory system agents|mesh-ancestor
92801630|NCT00667108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801631|NCT00667108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801632|NCT00667108|Anticonvulsants|anticonvulsants|mesh-ancestor
92801633|NCT00667108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92801634|NCT00667108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92801635|NCT00667108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801636|NCT00667108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92801637|NCT00667108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92801638|NCT00667108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92801639|NCT00667108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801640|NCT00667108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801641|NCT00667108|Antimanic Agents|antimanic agents|mesh-ancestor
92801642|NCT00961116|Fenofibrate|fenofibrate|mesh-list
92801643|NCT00961116|Fenofibric acid|fenofibric acid|mesh-list
92801644|NCT00961116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801645|NCT00961116|Antimetabolites|antimetabolites|mesh-ancestor
92801646|NCT00961116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801647|NCT00961116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801648|NCT00961116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801649|NCT04158388|Tryptophan|tryptophan|mesh-list
92801650|NCT04158388|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92801651|NCT04158388|Antidepressive Agents|antidepressive agents|mesh-ancestor
92801652|NCT04158388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92801653|NCT04283136|Padsevonil|padsevonil|mesh-list
92801654|NCT04283136|Anticonvulsants|anticonvulsants|mesh-ancestor
92801655|NCT04283058|Ketamine|ketamine|mesh-list
92801656|NCT04283058|Anesthetics|anesthetics|mesh-list
92801657|NCT04283058|Analgesics|analgesics|mesh-ancestor
92801658|NCT04283058|Sensory System Agents|sensory system agents|mesh-ancestor
92801659|NCT04283058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801660|NCT04283058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801661|NCT04283058|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92801662|NCT04283058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92801663|NCT04283058|Anesthetics, General|anesthetics, general|mesh-ancestor
92801664|NCT04283058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801665|NCT04283058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92801666|NCT04283058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92801667|NCT04283058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801668|NCT04283058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801669|NCT00631995|Vaccines|vaccines|mesh-list
92414955|NCT01475760|Coagulants|coagulants|mesh-ancestor
92801670|NCT00631995|Immunologic Factors|immunologic factors|mesh-ancestor
92801671|NCT00631995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801672|NCT00663442|Methylphenidate|methylphenidate|mesh-list
92801673|NCT00663442|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92801674|NCT00663442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801675|NCT00663442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92801676|NCT00663442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92801677|NCT00663442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801678|NCT00663442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801679|NCT00663442|Dopamine Agents|dopamine agents|mesh-ancestor
92801680|NCT00663442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801681|NCT00912015|Tramadol|tramadol|mesh-list
92801682|NCT00912015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92801683|NCT00912015|Narcotics|narcotics|mesh-ancestor
92801684|NCT00912015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801685|NCT00912015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801686|NCT00912015|Analgesics|analgesics|mesh-ancestor
92801687|NCT00912015|Sensory System Agents|sensory system agents|mesh-ancestor
92748024|NCT04296214|Azacitidine|azacitidine|mesh-list
92801688|NCT00912015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801689|NCT00960804|Tanezumab|tanezumab|mesh-list
92801690|NCT00960804|Analgesics|analgesics|mesh-ancestor
92801691|NCT00960804|Sensory System Agents|sensory system agents|mesh-ancestor
92801692|NCT00960804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801693|NCT00960804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801694|NCT01126580|Metformin|metformin|mesh-list
92801695|NCT01126580|Dulaglutide|dulaglutide|mesh-list
92801696|NCT01126580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92801697|NCT01126580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801698|NCT00911157|Heparin|heparin|mesh-list
92801699|NCT00911157|Calcium heparin|calcium heparin|mesh-list
92801700|NCT00911157|PENTA|penta|mesh-list
92801701|NCT00911157|Fondaparinux|fondaparinux|mesh-list
92801702|NCT00911157|Anticoagulants|anticoagulants|mesh-ancestor
92446646|NCT01669967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92801703|NCT00911157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92801704|NCT00911157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92801705|NCT00911157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801706|NCT00911157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92801707|NCT00911157|Antithrombins|antithrombins|mesh-ancestor
92801708|NCT00911157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92801709|NCT00911157|Protease Inhibitors|protease inhibitors|mesh-ancestor
92801710|NCT00911157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801711|NCT00960570|Efavirenz|efavirenz|mesh-list
92801712|NCT00960570|Fenofibric acid|fenofibric acid|mesh-list
92801713|NCT00960570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92801714|NCT00960570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92801715|NCT00960570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801716|NCT00960570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801717|NCT00960570|Antiviral Agents|antiviral agents|mesh-ancestor
92801718|NCT00960570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801719|NCT00960570|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92801720|NCT00960570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92801721|NCT00960570|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92801722|NCT00960570|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92801723|NCT00960570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92801724|NCT00960570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92801725|NCT00960570|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801726|NCT00960570|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801727|NCT00960570|Antimetabolites|antimetabolites|mesh-ancestor
92801728|NCT00960570|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801729|NCT04204278|Hyaluronic Acid|hyaluronic acid|mesh-list
92801730|NCT04204278|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92801731|NCT04204278|Immunologic Factors|immunologic factors|mesh-ancestor
92801732|NCT04204278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801733|NCT04204278|Viscosupplements|viscosupplements|mesh-ancestor
92801734|NCT04204278|Protective Agents|protective agents|mesh-ancestor
92801735|NCT00625430|Fludarabine|fludarabine|mesh-list
92801736|NCT00625430|Fludarabine phosphate|fludarabine phosphate|mesh-list
92801737|NCT00625430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801738|NCT00625430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801739|NCT00625430|Antimetabolites|antimetabolites|mesh-ancestor
92801740|NCT00625430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801741|NCT00625430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801742|NCT00625430|Immunologic Factors|immunologic factors|mesh-ancestor
92801743|NCT00625430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801744|NCT04282746|Ketamine|ketamine|mesh-list
92801745|NCT04282746|Analgesics|analgesics|mesh-ancestor
92801746|NCT04282746|Sensory System Agents|sensory system agents|mesh-ancestor
92801747|NCT04282746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801748|NCT04282746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801749|NCT04282746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92801750|NCT04282746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92801751|NCT04282746|Anesthetics, General|anesthetics, general|mesh-ancestor
92801752|NCT04282746|Anesthetics|anesthetics|mesh-ancestor
92801753|NCT04282746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801754|NCT04282746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92801755|NCT04282746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92801756|NCT04282746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801757|NCT04282746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801758|NCT03773445|Golimumab|golimumab|mesh-list
92801759|NCT03773445|Antibodies|antibodies|mesh-list
92801760|NCT03773445|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92801761|NCT03773445|Immunologic Factors|immunologic factors|mesh-ancestor
92801762|NCT03773445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801763|NCT03773445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92801764|NCT03773445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801765|NCT03773445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801766|NCT00630084|Interferons|interferons|mesh-list
92801767|NCT00630084|Ribavirin|ribavirin|mesh-list
92801768|NCT00630084|Interferon-alpha|interferon-alpha|mesh-list
92801769|NCT00630084|Interferon alpha-2|interferon alpha-2|mesh-list
92801770|NCT00630084|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92801771|NCT00630084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801772|NCT00630084|Antiviral Agents|antiviral agents|mesh-ancestor
92801773|NCT00630084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801774|NCT00630084|Antimetabolites|antimetabolites|mesh-ancestor
92801775|NCT00630084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446725|NCT01672359|Choline|choline|mesh-list
92801776|NCT00630084|Immunologic Factors|immunologic factors|mesh-ancestor
92801777|NCT00630084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801778|NCT01126424|Solifenacin Succinate|solifenacin succinate|mesh-list
92801779|NCT01126424|Oxybutynin|oxybutynin|mesh-list
92801780|NCT01126424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92801781|NCT01126424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92801782|NCT01126424|Cholinergic Agents|cholinergic agents|mesh-ancestor
92801783|NCT01126424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801784|NCT01126424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801785|NCT01126424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801786|NCT01126424|Urological Agents|urological agents|mesh-ancestor
92801787|NCT01126424|Parasympatholytics|parasympatholytics|mesh-ancestor
92801788|NCT01126424|Autonomic Agents|autonomic agents|mesh-ancestor
92801789|NCT01126424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801790|NCT04204902|Tepotinib|tepotinib|mesh-list
92801791|NCT04204902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801792|NCT01126268|Retapamulin|retapamulin|mesh-list
92801793|NCT01126268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92801794|NCT01126268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801795|NCT04284150|Midazolam|midazolam|mesh-list
92801796|NCT04284150|Dexmedetomidine|dexmedetomidine|mesh-list
92801797|NCT04284150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92801798|NCT04284150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801799|NCT04284150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801800|NCT04284150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801801|NCT04284150|Analgesics|analgesics|mesh-ancestor
92801802|NCT04284150|Sensory System Agents|sensory system agents|mesh-ancestor
92801803|NCT04284150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801804|NCT04284150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92801805|NCT04284150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92801806|NCT04284150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92801807|NCT04284150|Adrenergic Agents|adrenergic agents|mesh-ancestor
92801808|NCT04284150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801809|NCT04284150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801810|NCT04284150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92801811|NCT04284150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92801812|NCT04284150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92801813|NCT04284150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92801814|NCT04284150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92801815|NCT04284150|Anesthetics, General|anesthetics, general|mesh-ancestor
92801816|NCT04284150|Anesthetics|anesthetics|mesh-ancestor
92801817|NCT04284150|GABA Modulators|gaba modulators|mesh-ancestor
92801818|NCT04284150|GABA Agents|gaba agents|mesh-ancestor
92801819|NCT03311334|Pembrolizumab|pembrolizumab|mesh-list
92801820|NCT03311334|Nivolumab|nivolumab|mesh-list
92801821|NCT03311334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801822|NCT03311334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801823|NCT03311334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92801824|NCT03311334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801825|NCT04313036|Defibrotide|defibrotide|mesh-list
92801826|NCT04313036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92801827|NCT04313036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92801828|NCT04313036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801829|NCT04313036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92801830|NCT00879658|Siponimod|siponimod|mesh-list
92801831|NCT00879658|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92801832|NCT00879658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801833|NCT00879658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801834|NCT00879658|Immunologic Factors|immunologic factors|mesh-ancestor
92801835|NCT00879658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801836|NCT00959946|Capecitabine|capecitabine|mesh-list
92801837|NCT00959946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801838|NCT00959946|Antimetabolites|antimetabolites|mesh-ancestor
92801839|NCT00959946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801840|NCT00959946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801841|NCT00667264|Ropivacaine|ropivacaine|mesh-list
92801842|NCT00667264|Anesthetics, Local|anesthetics, local|mesh-ancestor
92801843|NCT00667264|Anesthetics|anesthetics|mesh-ancestor
92801844|NCT00667264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801845|NCT00667264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801846|NCT00667264|Sensory System Agents|sensory system agents|mesh-ancestor
92801847|NCT00667264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801848|NCT00660244|Anastrozole|anastrozole|mesh-list
92801849|NCT00660244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92801850|NCT00660244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801851|NCT00660244|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92801852|NCT00660244|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92801853|NCT00660244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801854|NCT00660244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801855|NCT00660244|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92801856|NCT00660244|Hormone Antagonists|hormone antagonists|mesh-ancestor
92801857|NCT00660244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92801858|NCT00660244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801859|NCT04282200|Ketorolac|ketorolac|mesh-list
92801860|NCT04282200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92801861|NCT04282200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92801862|NCT04282200|Analgesics|analgesics|mesh-ancestor
92801863|NCT04282200|Sensory System Agents|sensory system agents|mesh-ancestor
92801864|NCT04282200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801865|NCT04282200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801866|NCT04282200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92801867|NCT04282200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92801868|NCT04282200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92801869|NCT04282200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801870|NCT04282200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801871|NCT00667498|Metformin|metformin|mesh-list
92801872|NCT00667498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92801873|NCT00667498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801874|NCT02860650|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92801875|NCT02860650|Antiviral Agents|antiviral agents|mesh-ancestor
92801876|NCT02860650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801877|NCT00667966|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92801878|NCT00667966|Vasodilator Agents|vasodilator agents|mesh-ancestor
92801879|NCT00667966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92801880|NCT00667966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92801881|NCT00667966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801882|NCT00667966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801883|NCT00667966|Urological Agents|urological agents|mesh-ancestor
92801884|NCT04283916|Botulinum Toxins|botulinum toxins|mesh-list
92801885|NCT04283916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92801886|NCT04283916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92801887|NCT04283916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801888|NCT04283916|Cholinergic Agents|cholinergic agents|mesh-ancestor
92801889|NCT04283916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801890|NCT04283916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801891|NCT00911937|Fesoterodine|fesoterodine|mesh-list
92801892|NCT00911937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92801893|NCT00911937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92801894|NCT00911937|Cholinergic Agents|cholinergic agents|mesh-ancestor
92801895|NCT00911937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92801896|NCT00911937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801897|NCT00911937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801898|NCT00911937|Urological Agents|urological agents|mesh-ancestor
92801899|NCT00663598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92801900|NCT00663598|Vasodilator Agents|vasodilator agents|mesh-ancestor
92801901|NCT00663598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92801902|NCT00663598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92801903|NCT00663598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801904|NCT00663598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801905|NCT00663598|Urological Agents|urological agents|mesh-ancestor
92801906|NCT02859480|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92801907|NCT02859480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92801908|NCT02859480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92801909|NCT02859480|Antimetabolites|antimetabolites|mesh-ancestor
92801910|NCT02859480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801911|NCT02859480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92801912|NCT02859480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92801913|NCT02859480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801914|NCT01076543|Sirolimus|sirolimus|mesh-list
92801915|NCT01076543|Lenalidomide|lenalidomide|mesh-list
92801916|NCT01076543|Temsirolimus|temsirolimus|mesh-list
92801917|NCT01076543|MTOR Inhibitors|mtor inhibitors|mesh-list
92801918|NCT01076543|Immunologic Factors|immunologic factors|mesh-ancestor
92801919|NCT01076543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801920|NCT01076543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92801921|NCT01076543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92801922|NCT01076543|Growth Substances|growth substances|mesh-ancestor
92801923|NCT01076543|Growth Inhibitors|growth inhibitors|mesh-ancestor
92801925|NCT01076543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92801926|NCT01076543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801927|NCT01076543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92801928|NCT01076543|Antifungal Agents|antifungal agents|mesh-ancestor
92801929|NCT01076543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801930|NCT01076543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92801931|NCT01076543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801932|NCT01076543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801933|NCT00668044|Ciprofloxacin|ciprofloxacin|mesh-list
92801934|NCT00668044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92801935|NCT00668044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801936|NCT00668044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92801937|NCT00668044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92801938|NCT00668044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801939|NCT00668044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801940|NCT00668044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801941|NCT00668044|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92801942|NCT00668044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92801943|NCT02860494|Everolimus|everolimus|mesh-list
92801944|NCT02860494|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92801945|NCT02860494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92801946|NCT02860494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801947|NCT02860494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801948|NCT02860494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92801949|NCT02860494|Immunologic Factors|immunologic factors|mesh-ancestor
92801950|NCT02860494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801951|NCT02860494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801952|NCT00663832|Panobinostat|panobinostat|mesh-list
92801953|NCT00663832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801954|NCT00663832|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92801955|NCT00663832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801956|NCT00663832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801957|NCT04281576|Capecitabine|capecitabine|mesh-list
92801958|NCT04281576|Oxaliplatin|oxaliplatin|mesh-list
92801959|NCT04281576|Trastuzumab|trastuzumab|mesh-list
92801960|NCT04281576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92801961|NCT04281576|Antimetabolites|antimetabolites|mesh-ancestor
92801962|NCT04281576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801963|NCT04281576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801964|NCT04281576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92801965|NCT00668122|Ciprofloxacin|ciprofloxacin|mesh-list
92801966|NCT00668122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92801967|NCT00668122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801968|NCT00668122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92801969|NCT00668122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92801970|NCT00668122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92801971|NCT00668122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801972|NCT00668122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92801973|NCT00668122|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92801974|NCT00668122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92801975|NCT04304807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92801976|NCT04304807|Melatonin|melatonin|mesh-list
92801977|NCT04304807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92801978|NCT04304807|Antioxidants|antioxidants|mesh-ancestor
92801979|NCT04304807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92801980|NCT04304807|Protective Agents|protective agents|mesh-ancestor
92801981|NCT04304807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801982|NCT04304807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92801983|NCT04280874|Dinoprostone|dinoprostone|mesh-list
92801984|NCT04280874|Oxytocics|oxytocics|mesh-ancestor
92801985|NCT04280874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92801986|NCT04280874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801987|NCT00663910|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92801988|NCT00663910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92801989|NCT00663910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92801990|NCT04157998|Metoclopramide|metoclopramide|mesh-list
92801991|NCT04157998|Antiemetics|antiemetics|mesh-ancestor
92801992|NCT04157998|Autonomic Agents|autonomic agents|mesh-ancestor
92801993|NCT04157998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92801994|NCT04157998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92801995|NCT04157998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446946|NCT05596890|Tislelizumab|tislelizumab|mesh-list
92801996|NCT04157998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92801997|NCT04157998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92801998|NCT04157998|Dopamine Agents|dopamine agents|mesh-ancestor
92801999|NCT04157998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802000|NCT04157998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802001|NCT01072877|Polidocanol|polidocanol|mesh-list
92802002|NCT01072877|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92802003|NCT01072877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92802004|NCT00630474|Xylometazoline|xylometazoline|mesh-list
92802005|NCT00630474|Nasal Decongestants|nasal decongestants|mesh-ancestor
92802006|NCT00630474|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92802007|NCT00630474|Respiratory System Agents|respiratory system agents|mesh-ancestor
92802008|NCT00957528|Methyltestosterone|methyltestosterone|mesh-list
92802009|NCT00957528|Testosterone|testosterone|mesh-list
92802010|NCT00957528|Testosterone undecanoate|testosterone undecanoate|mesh-list
92802011|NCT00957528|Testosterone enanthate|testosterone enanthate|mesh-list
92802012|NCT00957528|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92802013|NCT00957528|Androgens|androgens|mesh-ancestor
92802014|NCT00957528|Hormones|hormones|mesh-ancestor
92802015|NCT00957528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802016|NCT00957528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802017|NCT00957528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92802018|NCT00957528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802019|NCT00957528|Anabolic Agents|anabolic agents|mesh-ancestor
92802020|NCT02857062|Emollients|emollients|mesh-list
92802021|NCT02857062|Dermatologic Agents|dermatologic agents|mesh-ancestor
92802022|NCT00958776|Peramivir|peramivir|mesh-list
92802023|NCT00958776|Antiviral Agents|antiviral agents|mesh-ancestor
92802024|NCT00958776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802025|NCT00958776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802026|NCT00958776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802027|NCT02858856|Juzentaihoto|juzentaihoto|mesh-list
92802028|NCT02858856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802029|NCT02858856|Mitogens|mitogens|mesh-ancestor
92802030|NCT02858856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802031|NCT02858856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802032|NCT02858622|Fentanyl|fentanyl|mesh-list
92802033|NCT02858622|Meperidine|meperidine|mesh-list
92802034|NCT02858622|Bupivacaine|bupivacaine|mesh-list
92802035|NCT02858622|Anesthetics, Local|anesthetics, local|mesh-ancestor
92802036|NCT02858622|Anesthetics|anesthetics|mesh-ancestor
92802037|NCT02858622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802038|NCT02858622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802039|NCT02858622|Sensory System Agents|sensory system agents|mesh-ancestor
92802040|NCT02858622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802041|NCT02858622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92802042|NCT02858622|Narcotics|narcotics|mesh-ancestor
92802043|NCT02858622|Analgesics|analgesics|mesh-ancestor
92802044|NCT02858622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92802045|NCT02858622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92802046|NCT02858622|Anesthetics, General|anesthetics, general|mesh-ancestor
92802047|NCT02191566|Oxaliplatin|oxaliplatin|mesh-list
92802048|NCT02191566|Tegafur|tegafur|mesh-list
92802049|NCT02191566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802050|NCT02191566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802051|NCT02191566|Antimetabolites|antimetabolites|mesh-ancestor
92802052|NCT02191566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802053|NCT00596830|Paclitaxel|paclitaxel|mesh-list
92802054|NCT00596830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92802055|NCT00596830|Carboplatin|carboplatin|mesh-list
92802056|NCT00596830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802057|NCT00596830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802058|NCT00596830|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802059|NCT00596830|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802060|NCT00596830|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802061|NCT00596830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802062|NCT00957372|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92802063|NCT00957372|Anticonvulsants|anticonvulsants|mesh-ancestor
92802064|NCT00957372|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92802065|NCT00957372|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92802066|NCT00957372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802067|NCT00957372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802068|NCT04270968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92802069|NCT05143164|Gentamicins|gentamicins|mesh-list
92802070|NCT05143164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92802071|NCT05143164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802072|NCT05143164|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92802073|NCT05143164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802074|NCT05143164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802075|NCT00664144|Rasburicase|rasburicase|mesh-list
92802076|NCT00664144|Gout Suppressants|gout suppressants|mesh-ancestor
92802077|NCT00664144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802078|NCT02819856|Ebselen|ebselen|mesh-list
92802079|NCT02819856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92802080|NCT02819856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802081|NCT02819856|Analgesics|analgesics|mesh-ancestor
92802082|NCT02819856|Sensory System Agents|sensory system agents|mesh-ancestor
92802083|NCT02819856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802084|NCT02819856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802085|NCT02819856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802086|NCT02819856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802087|NCT02819856|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92802088|NCT02819856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802089|NCT02819856|Antioxidants|antioxidants|mesh-ancestor
92802090|NCT02819856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802091|NCT02819856|Protective Agents|protective agents|mesh-ancestor
92802092|NCT02819856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92802093|NCT02819856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802094|NCT02819856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92802095|NCT02630290|Dexmedetomidine|dexmedetomidine|mesh-list
92802096|NCT02630290|Ropivacaine|ropivacaine|mesh-list
92802097|NCT02630290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92802098|NCT02630290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802099|NCT02630290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802100|NCT02630290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802101|NCT02630290|Analgesics|analgesics|mesh-ancestor
92802102|NCT02630290|Sensory System Agents|sensory system agents|mesh-ancestor
92802103|NCT02630290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802104|NCT02630290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92802105|NCT02630290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92802106|NCT02630290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92802107|NCT02630290|Adrenergic Agents|adrenergic agents|mesh-ancestor
92802108|NCT02630290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802109|NCT02630290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802110|NCT02630290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92802111|NCT02630290|Anesthetics|anesthetics|mesh-ancestor
92802112|NCT02856906|Salicylic Acid|salicylic acid|mesh-list
92802113|NCT02856906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802114|NCT02856906|Antifungal Agents|antifungal agents|mesh-ancestor
92802115|NCT02856906|Keratolytic Agents|keratolytic agents|mesh-ancestor
92802116|NCT02856906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92802117|NCT00668356|Didanosine|didanosine|mesh-list
92802118|NCT00668356|Antimetabolites|antimetabolites|mesh-ancestor
92802119|NCT00668356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802120|NCT00668356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92802121|NCT00668356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92802122|NCT00668356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802123|NCT00668356|Antiviral Agents|antiviral agents|mesh-ancestor
92802124|NCT00668356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802125|NCT00668356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92802126|NCT00668356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92802127|NCT00664222|Furosemide|furosemide|mesh-list
92802128|NCT00664222|Spironolactone|spironolactone|mesh-list
92802129|NCT00664222|Diuretics|diuretics|mesh-ancestor
92802130|NCT00664222|Natriuretic Agents|natriuretic agents|mesh-ancestor
92802131|NCT00664222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802132|NCT00664222|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92802133|NCT00664222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802134|NCT00664222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802135|NCT00664222|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92802136|NCT00664222|Hormone Antagonists|hormone antagonists|mesh-ancestor
92802137|NCT00664222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802138|NCT00664222|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92802139|NCT00952614|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92802140|NCT00952614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802141|NCT00952614|Glucocorticoids|glucocorticoids|mesh-ancestor
92802142|NCT00952614|Hormones|hormones|mesh-ancestor
92802143|NCT00952614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802144|NCT00952614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802145|NCT00911859|Prednisone|prednisone|mesh-list
92802146|NCT00911859|Bortezomib|bortezomib|mesh-list
92802147|NCT00911859|Melphalan|melphalan|mesh-list
92802148|NCT00911859|Siltuximab|siltuximab|mesh-list
92802149|NCT00911859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92802150|NCT00911859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802151|NCT00911859|Glucocorticoids|glucocorticoids|mesh-ancestor
92802152|NCT00911859|Hormones|hormones|mesh-ancestor
92802153|NCT00911859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802154|NCT00911859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802155|NCT00911859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92802156|NCT00911859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802157|NCT00911859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92802158|NCT00911859|Alkylating Agents|alkylating agents|mesh-ancestor
92802159|NCT00911859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802160|NCT00911859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92802161|NCT00911859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802162|NCT00911859|Immunologic Factors|immunologic factors|mesh-ancestor
92802163|NCT00955968|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92802164|NCT00955968|Antiviral Agents|antiviral agents|mesh-ancestor
92802165|NCT00955968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802166|NCT02725593|Dapagliflozin|dapagliflozin|mesh-list
92802167|NCT02725593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92802168|NCT02725593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802169|NCT02725593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802170|NCT02725593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802171|NCT00911625|Insulin|insulin|mesh-list
92802172|NCT00911625|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92802173|NCT00911625|Insulin Glargine|insulin glargine|mesh-list
92802174|NCT00911625|Insulin glulisine|insulin glulisine|mesh-list
92802175|NCT00911625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802176|NCT00911625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802177|NCT00596752|Alprostadil|alprostadil|mesh-list
92802178|NCT00596752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92802179|NCT00596752|Vasodilator Agents|vasodilator agents|mesh-ancestor
92802180|NCT00596752|Urological Agents|urological agents|mesh-ancestor
92802181|NCT04151277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92802182|NCT04151277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802183|NCT00958074|Vorinostat|vorinostat|mesh-list
92802184|NCT00958074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802185|NCT00958074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92802186|NCT00958074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802187|NCT00958074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415482|NCT01478685|Cc-486|cc-486|mesh-list
92802188|NCT00660868|Pentoxifylline|pentoxifylline|mesh-list
92802189|NCT00660868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92802190|NCT00660868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802191|NCT00660868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802192|NCT00660868|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92802193|NCT00660868|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92802194|NCT00660868|Protective Agents|protective agents|mesh-ancestor
92802195|NCT00660868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802196|NCT00660868|Vasodilator Agents|vasodilator agents|mesh-ancestor
92802197|NCT00660868|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92802198|NCT00660868|Antioxidants|antioxidants|mesh-ancestor
92802199|NCT00664690|Celecoxib|celecoxib|mesh-list
92802200|NCT00664690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92802201|NCT00664690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802202|NCT00664690|Analgesics|analgesics|mesh-ancestor
92802203|NCT00664690|Sensory System Agents|sensory system agents|mesh-ancestor
92802204|NCT00664690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802205|NCT00664690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802206|NCT00664690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802207|NCT00664690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802208|NCT00664690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92802209|NCT00664690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92802210|NCT00664690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802211|NCT00664690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802212|NCT00809965|Rivaroxaban|rivaroxaban|mesh-list
92802213|NCT00809965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92802214|NCT00809965|Antithrombins|antithrombins|mesh-ancestor
92802215|NCT00809965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92802216|NCT00809965|Protease Inhibitors|protease inhibitors|mesh-ancestor
92802217|NCT00809965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802218|NCT00809965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802219|NCT00809965|Anticoagulants|anticoagulants|mesh-ancestor
92802220|NCT04338165|Evolocumab|evolocumab|mesh-list
92802221|NCT04338165|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92802222|NCT04338165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92802224|NCT04338165|Antimetabolites|antimetabolites|mesh-ancestor
92802225|NCT04338165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802226|NCT04338165|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92802227|NCT04338165|Protease Inhibitors|protease inhibitors|mesh-ancestor
92802228|NCT04338165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802229|NCT04338165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92802230|NCT00664846|Aspirin|aspirin|mesh-list
92802231|NCT00664846|Clopidogrel|clopidogrel|mesh-list
92802232|NCT00664846|Atorvastatin|atorvastatin|mesh-list
92802233|NCT00664846|Simvastatin|simvastatin|mesh-list
92802234|NCT00664846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92802235|NCT00664846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802236|NCT00664846|Analgesics|analgesics|mesh-ancestor
92802237|NCT00664846|Sensory System Agents|sensory system agents|mesh-ancestor
92802238|NCT00664846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802239|NCT00664846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802240|NCT00664846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802241|NCT00664846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802242|NCT00664846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92802243|NCT00664846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92802244|NCT00664846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802245|NCT00664846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92802246|NCT00664846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92802247|NCT00664846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802248|NCT00664846|Antipyretics|antipyretics|mesh-ancestor
92802249|NCT00664846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92802250|NCT00664846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92802251|NCT00664846|Antimetabolites|antimetabolites|mesh-ancestor
92802252|NCT00664846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92802253|NCT00664846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92802254|NCT00664846|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92802255|NCT00664846|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92802256|NCT00664846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92802257|NCT00664846|Purinergic Agents|purinergic agents|mesh-ancestor
92802258|NCT00664846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802259|NCT00913783|Clomipramine|clomipramine|mesh-list
92802260|NCT00913783|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92802261|NCT00913783|Antidepressive Agents|antidepressive agents|mesh-ancestor
92802262|NCT00913783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92802263|NCT00913783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92802264|NCT00913783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92802265|NCT00913783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802266|NCT00913783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802267|NCT00913783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802268|NCT00913783|Serotonin Agents|serotonin agents|mesh-ancestor
92802269|NCT00913783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802270|NCT00661102|Capecitabine|capecitabine|mesh-list
92802271|NCT00661102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802272|NCT00661102|Antimetabolites|antimetabolites|mesh-ancestor
92802273|NCT00661102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802274|NCT00661102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802275|NCT00669370|Docetaxel|docetaxel|mesh-list
92802276|NCT00669370|Capecitabine|capecitabine|mesh-list
92802277|NCT00669370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802278|NCT00669370|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802279|NCT00669370|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802280|NCT00669370|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802281|NCT00669370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802282|NCT00669370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802283|NCT00669370|Antimetabolites|antimetabolites|mesh-ancestor
92802284|NCT00665314|Plerixafor|plerixafor|mesh-list
92802285|NCT00665314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92802286|NCT00665314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92802287|NCT00665314|Antiviral Agents|antiviral agents|mesh-ancestor
92802288|NCT00665314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802289|NCT04154722|Azithromycin|azithromycin|mesh-list
92802290|NCT04154722|Meropenem|meropenem|mesh-list
92802291|NCT04154722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92802292|NCT04154722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802293|NCT02631928|Insulin|insulin|mesh-list
92802294|NCT02631928|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92802295|NCT02631928|Biphasic Insulins|biphasic insulins|mesh-list
92802296|NCT02631928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447248|NCT04925960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802297|NCT02631928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802298|NCT00632385|Eletriptan|eletriptan|mesh-list
92802299|NCT00632385|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92802300|NCT00632385|Serotonin Agents|serotonin agents|mesh-ancestor
92802301|NCT00632385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802302|NCT00632385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802303|NCT00632385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802304|NCT00910689|Propranolol|propranolol|mesh-list
92802305|NCT00910689|Nadolol|nadolol|mesh-list
92802306|NCT00910689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92802307|NCT00910689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92802308|NCT00910689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92802309|NCT00910689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802310|NCT00910689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802311|NCT00910689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802312|NCT00910689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92802313|NCT00910689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92802314|NCT00910689|Vasodilator Agents|vasodilator agents|mesh-ancestor
92802315|NCT00910689|Sympatholytics|sympatholytics|mesh-ancestor
92802316|NCT00910689|Autonomic Agents|autonomic agents|mesh-ancestor
92802317|NCT00910689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802318|NCT04669717|Amoxicillin|amoxicillin|mesh-list
92802319|NCT04669717|Azithromycin|azithromycin|mesh-list
92802320|NCT04669717|Metronidazole|metronidazole|mesh-list
92802321|NCT04669717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92802322|NCT04669717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802323|NCT04669717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92802324|NCT04669717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92802325|NCT00809341|Prednisone|prednisone|mesh-list
92802326|NCT00809341|Cyclophosphamide|cyclophosphamide|mesh-list
92802327|NCT00809341|Ifosfamide|ifosfamide|mesh-list
92802328|NCT00809341|Rituximab|rituximab|mesh-list
92802329|NCT00809341|Carboplatin|carboplatin|mesh-list
92802330|NCT00809341|Doxorubicin|doxorubicin|mesh-list
92802331|NCT00809341|Etoposide|etoposide|mesh-list
92802332|NCT00809341|Vincristine|vincristine|mesh-list
92802333|NCT00809341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802334|NCT00809341|Immunologic Factors|immunologic factors|mesh-ancestor
92802335|NCT00809341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802336|NCT00809341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802337|NCT00809341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92802338|NCT00809341|Alkylating Agents|alkylating agents|mesh-ancestor
92802339|NCT00809341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802340|NCT00809341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802341|NCT00809341|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92802342|NCT00809341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802343|NCT00809341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92802344|NCT00809341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802345|NCT00809341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802346|NCT00809341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802347|NCT00809341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802348|NCT00809341|Glucocorticoids|glucocorticoids|mesh-ancestor
92802349|NCT00809341|Hormones|hormones|mesh-ancestor
92802350|NCT00809341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802351|NCT00809341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92802352|NCT00809341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802353|NCT00809341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802354|NCT00809341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802355|NCT00809341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802356|NCT02609581|Immunomodulating Agents|immunomodulating agents|mesh-list
92802357|NCT02609581|Immunologic Factors|immunologic factors|mesh-list
92802358|NCT02609581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802360|NCT00811135|Trastuzumab|trastuzumab|mesh-list
92802361|NCT00811135|Capecitabine|capecitabine|mesh-list
92802362|NCT00811135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802363|NCT00811135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802364|NCT00811135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92802365|NCT00811135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92802366|NCT00811135|Growth Substances|growth substances|mesh-ancestor
92802367|NCT00811135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802368|NCT00811135|Growth Inhibitors|growth inhibitors|mesh-ancestor
92802369|NCT00811135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802370|NCT00811135|Antimetabolites|antimetabolites|mesh-ancestor
92802371|NCT00811135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802372|NCT00811057|Indomethacin|indomethacin|mesh-list
92802373|NCT00811057|Magnesium Sulfate|magnesium sulfate|mesh-list
92802374|NCT00811057|Nifedipine|nifedipine|mesh-list
92802375|NCT00811057|Analgesics|analgesics|mesh-ancestor
92802376|NCT00811057|Sensory System Agents|sensory system agents|mesh-ancestor
92802377|NCT00811057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802378|NCT00811057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802379|NCT00811057|Anesthetics|anesthetics|mesh-ancestor
92802380|NCT00811057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802381|NCT00811057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92802382|NCT00811057|Anticonvulsants|anticonvulsants|mesh-ancestor
92802383|NCT00811057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92802384|NCT00811057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802385|NCT00811057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802386|NCT00811057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92802387|NCT00811057|Tocolytic Agents|tocolytic agents|mesh-ancestor
92802388|NCT00811057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92802389|NCT00811057|Vasodilator Agents|vasodilator agents|mesh-ancestor
92802390|NCT00811057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92802391|NCT00811057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802392|NCT00811057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802393|NCT00811057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802394|NCT00811057|Gout Suppressants|gout suppressants|mesh-ancestor
92802395|NCT00811057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92802396|NCT00811057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802397|NCT00879970|Vitamin D|vitamin d|mesh-list
92802398|NCT00879970|Pioglitazone|pioglitazone|mesh-list
92802399|NCT00879970|Rosiglitazone|rosiglitazone|mesh-list
92802400|NCT00879970|Vitamins|vitamins|mesh-ancestor
92802401|NCT00879970|Micronutrients|micronutrients|mesh-ancestor
92802402|NCT00879970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802403|NCT00879970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92802404|NCT00879970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802405|NCT00808639|Doxorubicin|doxorubicin|mesh-list
92802406|NCT00808639|Methotrexate|methotrexate|mesh-list
92802407|NCT00808639|Vinblastine|vinblastine|mesh-list
92802408|NCT00808639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802409|NCT00808639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92802410|NCT00808639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802411|NCT00808639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802412|NCT00808639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802413|NCT00808639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802414|NCT00808639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92802415|NCT00808639|Abortifacient Agents|abortifacient agents|mesh-ancestor
92802416|NCT00808639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92802417|NCT00808639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802418|NCT00808639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802419|NCT00808639|Antimetabolites|antimetabolites|mesh-ancestor
92802420|NCT00808639|Dermatologic Agents|dermatologic agents|mesh-ancestor
92802421|NCT00808639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92802422|NCT00808639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802423|NCT00808639|Immunologic Factors|immunologic factors|mesh-ancestor
92802424|NCT00808639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802425|NCT00808639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92802426|NCT00808639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802427|NCT00808639|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802428|NCT00808639|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802429|NCT00808639|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802430|NCT00910299|Clopidogrel|clopidogrel|mesh-list
92802431|NCT00910299|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92802432|NCT00910299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92802433|NCT00910299|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92802434|NCT00910299|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92802435|NCT00910299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92802436|NCT00910299|Purinergic Agents|purinergic agents|mesh-ancestor
92802437|NCT00910299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802438|NCT00910299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802439|NCT00910299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802440|NCT03007329|Dapagliflozin|dapagliflozin|mesh-list
92802441|NCT03007329|Exenatide|exenatide|mesh-list
92802442|NCT03007329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92802443|NCT03007329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802444|NCT03007329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802445|NCT03007329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802446|NCT03007329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92802447|NCT03007329|Incretins|incretins|mesh-ancestor
92802448|NCT03007329|Hormones|hormones|mesh-ancestor
92802449|NCT03007329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802450|NCT04072341|Propolis|propolis|mesh-list
92802451|NCT04072341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802452|NCT04030039|Interferons|interferons|mesh-list
92802453|NCT04030039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802454|NCT04030039|Antiviral Agents|antiviral agents|mesh-ancestor
92802455|NCT04030039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802456|NCT02628574|Gemcitabine|gemcitabine|mesh-list
92802457|NCT02628574|Pembrolizumab|pembrolizumab|mesh-list
92802458|NCT02628574|Nivolumab|nivolumab|mesh-list
92802459|NCT02628574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802460|NCT02628574|Antimetabolites|antimetabolites|mesh-ancestor
92802461|NCT02628574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802462|NCT02628574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802463|NCT02628574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802464|NCT02628574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92802465|NCT00596362|Bevacizumab|bevacizumab|mesh-list
92802466|NCT00596362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802467|NCT00596362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802468|NCT00596362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92802469|NCT00596362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92802470|NCT00596362|Growth Substances|growth substances|mesh-ancestor
92802471|NCT00596362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802472|NCT00596362|Growth Inhibitors|growth inhibitors|mesh-ancestor
92802473|NCT00907803|Tecovirimat|tecovirimat|mesh-list
92802474|NCT00907803|Antiviral Agents|antiviral agents|mesh-ancestor
92802475|NCT00907803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802476|NCT00669994|Ciprofloxacin|ciprofloxacin|mesh-list
92802477|NCT00669994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92802478|NCT00669994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802479|NCT00669994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802480|NCT00669994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802481|NCT00669994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802482|NCT00669994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802483|NCT00669994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802484|NCT00669994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92802485|NCT00669994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92802486|NCT02790723|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92802487|NCT02790723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802488|NCT00676156|Thioctic Acid|thioctic acid|mesh-list
92802489|NCT00676156|Antioxidants|antioxidants|mesh-ancestor
92802490|NCT00676156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802491|NCT00676156|Protective Agents|protective agents|mesh-ancestor
92802492|NCT00676156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802493|NCT00676156|Vitamin B Complex|vitamin b complex|mesh-ancestor
92802494|NCT00676156|Vitamins|vitamins|mesh-ancestor
92802495|NCT00676156|Micronutrients|micronutrients|mesh-ancestor
92802496|NCT00670150|Arsenic Trioxide|arsenic trioxide|mesh-list
92802497|NCT00670150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802498|NCT00914017|Atorvastatin|atorvastatin|mesh-list
92802499|NCT00914017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92802500|NCT00914017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92802501|NCT00914017|Antimetabolites|antimetabolites|mesh-ancestor
92802502|NCT00914017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802503|NCT00914017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92802504|NCT00914017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92802505|NCT00914017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802506|NCT00671320|Diclofenac|diclofenac|mesh-list
92802507|NCT00671320|Valdecoxib|valdecoxib|mesh-list
92802508|NCT00671320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92802509|NCT00671320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802510|NCT00671320|Analgesics|analgesics|mesh-ancestor
92802511|NCT00671320|Sensory System Agents|sensory system agents|mesh-ancestor
92802512|NCT00671320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802513|NCT00671320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802514|NCT00671320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802515|NCT00671320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802516|NCT00671320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92802517|NCT00671320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802518|NCT00671320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802519|NCT00671320|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92802520|NCT00676468|Montelukast|montelukast|mesh-list
92802521|NCT00676468|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92802522|NCT00676468|Respiratory System Agents|respiratory system agents|mesh-ancestor
92802523|NCT00676468|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92802524|NCT00676468|Hormone Antagonists|hormone antagonists|mesh-ancestor
92802525|NCT00676468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802526|NCT00676468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802527|NCT00676468|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92802528|NCT00676468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92802529|NCT00676468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802530|NCT00591253|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92802531|NCT00591253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92802532|NCT00591253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92802533|NCT00591253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802534|NCT00676702|Vitamin K|vitamin k|mesh-list
92802535|NCT00676702|Pancrelipase|pancrelipase|mesh-list
92802536|NCT00676702|Pancreatin|pancreatin|mesh-list
92802537|NCT00676702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802538|NCT00676702|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92802539|NCT00676702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92802540|NCT00676702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802541|NCT00676702|Hemostatics|hemostatics|mesh-ancestor
92802542|NCT00676702|Coagulants|coagulants|mesh-ancestor
92802543|NCT00676702|Vitamins|vitamins|mesh-ancestor
92802544|NCT00676702|Micronutrients|micronutrients|mesh-ancestor
92802545|NCT00676702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802546|NCT05753371|Metformin|metformin|mesh-list
92802547|NCT05753371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802548|NCT05753371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802549|NCT00671476|Doxorubicin|doxorubicin|mesh-list
92802550|NCT00671476|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92802551|NCT00671476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92802552|NCT00671476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802553|NCT00671476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802554|NCT00671476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802555|NCT00671476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802556|NCT00671476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802557|NCT00908583|Methylprednisolone|methylprednisolone|mesh-list
92802558|NCT00908583|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92802559|NCT00908583|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92802560|NCT00908583|Prednisolone|prednisolone|mesh-list
92802561|NCT00908583|Prednisolone acetate|prednisolone acetate|mesh-list
92802562|NCT00908583|Rituximab|rituximab|mesh-list
92802563|NCT00908583|Bortezomib|bortezomib|mesh-list
92802564|NCT00908583|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92802565|NCT00908583|Prednisolone phosphate|prednisolone phosphate|mesh-list
92802566|NCT00908583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802567|NCT00908583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802568|NCT00908583|Immunologic Factors|immunologic factors|mesh-ancestor
92802569|NCT00908583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802570|NCT00908583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802571|NCT00908583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802572|NCT00908583|Antiemetics|antiemetics|mesh-ancestor
92802573|NCT00908583|Autonomic Agents|autonomic agents|mesh-ancestor
92802574|NCT00908583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802575|NCT00908583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802576|NCT00908583|Glucocorticoids|glucocorticoids|mesh-ancestor
92802577|NCT00908583|Hormones|hormones|mesh-ancestor
92802578|NCT00908583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802579|NCT00908583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92802580|NCT00908583|Protective Agents|protective agents|mesh-ancestor
92802581|NCT00908583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92802582|NCT05519241|Paclitaxel|paclitaxel|mesh-list
92802583|NCT05519241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802584|NCT05519241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802585|NCT05519241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802586|NCT05519241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802587|NCT05519241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802588|NCT05519241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802589|NCT00671632|Triazolam|triazolam|mesh-list
92802590|NCT00671632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92802591|NCT00671632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92802592|NCT00671632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92802593|NCT00671632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802594|NCT00671632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802595|NCT00671632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92802596|NCT00671632|GABA Modulators|gaba modulators|mesh-ancestor
92802597|NCT00671632|GABA Agents|gaba agents|mesh-ancestor
92802598|NCT00671632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802599|NCT00671632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802600|NCT04153708|Antibodies|antibodies|mesh-list
92802601|NCT04153708|Immunoglobulins|immunoglobulins|mesh-list
92802602|NCT04153708|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92802603|NCT04153708|Immunologic Factors|immunologic factors|mesh-ancestor
92802604|NCT04153708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802605|NCT00676936|Methylprednisolone|methylprednisolone|mesh-list
92802606|NCT00676936|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92802607|NCT00676936|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92802608|NCT00676936|Prednisolone|prednisolone|mesh-list
92802609|NCT00676936|Prednisolone acetate|prednisolone acetate|mesh-list
92802610|NCT00676936|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92802611|NCT00676936|Prednisolone phosphate|prednisolone phosphate|mesh-list
92802612|NCT00676936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802613|NCT00676936|Antiemetics|antiemetics|mesh-ancestor
92802614|NCT00676936|Autonomic Agents|autonomic agents|mesh-ancestor
92802615|NCT00676936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802616|NCT00676936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802617|NCT00676936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802618|NCT00676936|Glucocorticoids|glucocorticoids|mesh-ancestor
92802619|NCT00676936|Hormones|hormones|mesh-ancestor
92802620|NCT00676936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802621|NCT00676936|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92802622|NCT00676936|Protective Agents|protective agents|mesh-ancestor
92802623|NCT00676936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92802624|NCT00676936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802625|NCT02629744|Etrolizumab|etrolizumab|mesh-list
92802626|NCT02629744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802627|NCT02629744|Immunologic Factors|immunologic factors|mesh-ancestor
92802628|NCT02629744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802629|NCT00677170|Pevonedistat|pevonedistat|mesh-list
92802630|NCT00677170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802631|NCT00677170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802632|NCT00908349|Oxcarbazepine|oxcarbazepine|mesh-list
92802633|NCT00908349|Anticonvulsants|anticonvulsants|mesh-ancestor
92802634|NCT00908349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92802635|NCT00908349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92802636|NCT00908349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802637|NCT00908349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802638|NCT00908349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92802639|NCT00908349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92802640|NCT01125566|Trastuzumab|trastuzumab|mesh-list
92802641|NCT01125566|Vinorelbine|vinorelbine|mesh-list
92802642|NCT01125566|Afatinib|afatinib|mesh-list
92802643|NCT01125566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802644|NCT01125566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802645|NCT01125566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802646|NCT01125566|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802647|NCT01125566|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802648|NCT01125566|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802649|NCT01125566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802650|NCT01125566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92802651|NCT01125566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802652|NCT04031872|Capecitabine|capecitabine|mesh-list
92802653|NCT04031872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802654|NCT04031872|Antimetabolites|antimetabolites|mesh-ancestor
92802655|NCT04031872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802656|NCT04031872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802657|NCT00670696|Tetracaine|tetracaine|mesh-list
92802658|NCT00670696|Anesthetics, Local|anesthetics, local|mesh-ancestor
92802659|NCT00670696|Anesthetics|anesthetics|mesh-ancestor
92802660|NCT00670696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802661|NCT00670696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802662|NCT00670696|Sensory System Agents|sensory system agents|mesh-ancestor
92802663|NCT00670696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802664|NCT00677248|Ezetimibe|ezetimibe|mesh-list
92802665|NCT00677248|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92802666|NCT00677248|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92802667|NCT00677248|Antimetabolites|antimetabolites|mesh-ancestor
92802668|NCT00677248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802669|NCT00677248|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92802670|NCT00671710|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92802671|NCT00671710|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92802672|NCT00671710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92447626|NCT03119038|Ketorolac|ketorolac|mesh-list
92802673|NCT00671008|Insulin|insulin|mesh-list
92802674|NCT00671008|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92802675|NCT00671008|Insulin Aspart|insulin aspart|mesh-list
92802676|NCT00671008|Insulin Detemir|insulin detemir|mesh-list
92802677|NCT00671008|Biphasic Insulins|biphasic insulins|mesh-list
92802678|NCT00671008|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92802679|NCT00671008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802680|NCT00671008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802681|NCT00911716|Cyclophosphamide|cyclophosphamide|mesh-list
92802682|NCT00911716|Bevacizumab|bevacizumab|mesh-list
92802683|NCT00911716|Docetaxel|docetaxel|mesh-list
92802684|NCT00911716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802685|NCT00911716|Immunologic Factors|immunologic factors|mesh-ancestor
92802686|NCT00911716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802687|NCT00911716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802688|NCT00911716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92802689|NCT00911716|Alkylating Agents|alkylating agents|mesh-ancestor
92802690|NCT00911716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802691|NCT00911716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802692|NCT00911716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92802693|NCT00911716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802694|NCT00911716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92802695|NCT00911716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92802696|NCT00911716|Growth Substances|growth substances|mesh-ancestor
92802697|NCT00911716|Growth Inhibitors|growth inhibitors|mesh-ancestor
92802698|NCT00911716|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802699|NCT00911716|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802700|NCT00911716|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802701|NCT00595582|Curcumin|curcumin|mesh-list
92802702|NCT00595582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92802703|NCT00595582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802704|NCT00595582|Analgesics|analgesics|mesh-ancestor
92802705|NCT00595582|Sensory System Agents|sensory system agents|mesh-ancestor
92802706|NCT00595582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802707|NCT00595582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802708|NCT00595582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802709|NCT00595582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802710|NCT00595582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802711|NCT00595582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802712|NCT00595582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802713|NCT00680446|Immunoglobulins|immunoglobulins|mesh-list
92802714|NCT00680446|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92802715|NCT00680446|Antibodies|antibodies|mesh-list
92802716|NCT00680446|Immunoglobulin G|immunoglobulin g|mesh-list
92802717|NCT00680446|Immunologic Factors|immunologic factors|mesh-ancestor
92802718|NCT00680446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802719|NCT00672022|Miglustat|miglustat|mesh-list
92802720|NCT00672022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802721|NCT00672022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802722|NCT00672022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92802723|NCT00672022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92802724|NCT00672022|Antiviral Agents|antiviral agents|mesh-ancestor
92802725|NCT00672022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802726|NCT00672022|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92802727|NCT00672022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802728|NCT00672022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802729|NCT00680602|Sertraline|sertraline|mesh-list
92802730|NCT00680602|Fluoxetine|fluoxetine|mesh-list
92802731|NCT00680602|Paroxetine|paroxetine|mesh-list
92802732|NCT00680602|Citalopram|citalopram|mesh-list
92802733|NCT00680602|Antidepressive Agents|antidepressive agents|mesh-ancestor
92802734|NCT00680602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92802735|NCT00680602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92802736|NCT00680602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92802737|NCT00680602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802738|NCT00680602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802739|NCT00680602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802740|NCT00680602|Serotonin Agents|serotonin agents|mesh-ancestor
92802741|NCT00680602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802742|NCT00680602|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92802743|NCT00680602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92802744|NCT00680602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92802745|NCT00680602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416040|NCT01482117|Autonomic Agents|autonomic agents|mesh-ancestor
92802747|NCT00680680|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92802748|NCT00680680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92802749|NCT00680680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802750|NCT00680680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802751|NCT00680680|Hormone Antagonists|hormone antagonists|mesh-ancestor
92802752|NCT00680680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802753|NCT00680680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802754|NCT00808015|Varenicline|varenicline|mesh-list
92802755|NCT00808015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92802756|NCT00808015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92802757|NCT00808015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92802758|NCT00808015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802759|NCT00808015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802760|NCT00808015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802761|NCT00680758|Paclitaxel|paclitaxel|mesh-list
92802762|NCT00680758|Everolimus|everolimus|mesh-list
92802763|NCT00680758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802764|NCT00680758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802765|NCT00680758|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802766|NCT00680758|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802767|NCT00680758|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802768|NCT00680758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802769|NCT00680758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92802770|NCT00680758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92802771|NCT00680758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802772|NCT00680758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802773|NCT00680758|Immunologic Factors|immunologic factors|mesh-ancestor
92802774|NCT00680758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802775|NCT00678106|Dalbavancin|dalbavancin|mesh-list
92802776|NCT00678106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92802777|NCT00678106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802778|NCT00810199|Methotrexate|methotrexate|mesh-list
92802779|NCT00810199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92802780|NCT00810199|Abortifacient Agents|abortifacient agents|mesh-ancestor
92802781|NCT00810199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92802782|NCT00810199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802783|NCT00810199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802784|NCT00810199|Antimetabolites|antimetabolites|mesh-ancestor
92802785|NCT00810199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802786|NCT00810199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802787|NCT00810199|Dermatologic Agents|dermatologic agents|mesh-ancestor
92802788|NCT00810199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802789|NCT00810199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92802790|NCT00810199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802791|NCT00810199|Immunologic Factors|immunologic factors|mesh-ancestor
92802792|NCT00810199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802793|NCT00810199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92802794|NCT00877006|Prednisone|prednisone|mesh-list
92802795|NCT00877006|Cyclophosphamide|cyclophosphamide|mesh-list
92802796|NCT00877006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92802797|NCT00877006|Rituximab|rituximab|mesh-list
92802798|NCT00877006|Doxorubicin|doxorubicin|mesh-list
92802799|NCT00877006|Vincristine|vincristine|mesh-list
92802800|NCT00877006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802801|NCT00877006|Immunologic Factors|immunologic factors|mesh-ancestor
92802802|NCT00877006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802803|NCT00877006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802804|NCT00877006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92802805|NCT00877006|Alkylating Agents|alkylating agents|mesh-ancestor
92802806|NCT00877006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802807|NCT00877006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802808|NCT00877006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92802809|NCT00877006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802810|NCT00877006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92802811|NCT00877006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802812|NCT00877006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802813|NCT00877006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802814|NCT00877006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92802815|NCT00877006|Glucocorticoids|glucocorticoids|mesh-ancestor
92802816|NCT00877006|Hormones|hormones|mesh-ancestor
92802817|NCT00877006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802818|NCT00877006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92802819|NCT00877006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802820|NCT00877006|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802821|NCT00877006|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802822|NCT00877006|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802823|NCT00678184|Atorvastatin|atorvastatin|mesh-list
92802824|NCT00678184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92802825|NCT00678184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92802826|NCT00678184|Antimetabolites|antimetabolites|mesh-ancestor
92802827|NCT00678184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802828|NCT00678184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92802829|NCT00678184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92802830|NCT00678184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802831|NCT00876928|Vitamin D|vitamin d|mesh-list
92802832|NCT00876928|Vitamins|vitamins|mesh-ancestor
92802833|NCT00876928|Micronutrients|micronutrients|mesh-ancestor
92802834|NCT00876928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802835|NCT00876928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92802836|NCT02627950|Metoclopramide|metoclopramide|mesh-list
92802837|NCT02627950|Ticagrelor|ticagrelor|mesh-list
92802838|NCT02627950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92802839|NCT02627950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92802840|NCT02627950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92802841|NCT02627950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92802842|NCT02627950|Purinergic Agents|purinergic agents|mesh-ancestor
92802843|NCT02627950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802844|NCT02627950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802845|NCT02627950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802846|NCT02627950|Antiemetics|antiemetics|mesh-ancestor
92802847|NCT02627950|Autonomic Agents|autonomic agents|mesh-ancestor
92802848|NCT02627950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802849|NCT02627950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802850|NCT02627950|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92802851|NCT02627950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92802852|NCT02627950|Dopamine Agents|dopamine agents|mesh-ancestor
92802853|NCT00807937|Lorazepam|lorazepam|mesh-list
92802854|NCT00807937|Anticonvulsants|anticonvulsants|mesh-ancestor
92802855|NCT00807937|Antiemetics|antiemetics|mesh-ancestor
92802856|NCT00807937|Autonomic Agents|autonomic agents|mesh-ancestor
92802857|NCT00807937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802858|NCT00807937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802859|NCT00807937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802860|NCT00807937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92802861|NCT00807937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802862|NCT00807937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92802863|NCT00807937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92802864|NCT00807937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92802865|NCT00807937|GABA Modulators|gaba modulators|mesh-ancestor
92802866|NCT00807937|GABA Agents|gaba agents|mesh-ancestor
92802867|NCT00807937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802868|NCT00807937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802869|NCT00681148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92802870|NCT00681148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92802871|NCT00681148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802872|NCT00681148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802873|NCT00681148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92802874|NCT00681148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802875|NCT00681148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802876|NCT00681148|Cholinergic Agents|cholinergic agents|mesh-ancestor
92802877|NCT00681148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802878|NCT04935229|Nivolumab|nivolumab|mesh-list
92802879|NCT04935229|Ipilimumab|ipilimumab|mesh-list
92802880|NCT04935229|Relatlimab|relatlimab|mesh-list
92802881|NCT04935229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92802882|NCT04935229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802883|NCT04935229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92802884|NCT04935229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802885|NCT00681226|Ramipril|ramipril|mesh-list
92802886|NCT00681226|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92802887|NCT00681226|Protease Inhibitors|protease inhibitors|mesh-ancestor
92802888|NCT00681226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802889|NCT00681226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802890|NCT00681226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92802891|NCT00678964|Carboplatin|carboplatin|mesh-list
92802892|NCT00678964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92802893|NCT00678964|Vinorelbine|vinorelbine|mesh-list
92802894|NCT00678964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802895|NCT00678964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92447853|NCT05837845|Hallucinogens|hallucinogens|mesh-ancestor
92802897|NCT00678964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802898|NCT00678964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802899|NCT00678964|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802900|NCT00678964|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802901|NCT00678964|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802902|NCT02627248|Cyclophosphamide|cyclophosphamide|mesh-list
92802903|NCT02627248|Docetaxel|docetaxel|mesh-list
92802904|NCT02627248|Epirubicin|epirubicin|mesh-list
92802905|NCT02627248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802906|NCT02627248|Immunologic Factors|immunologic factors|mesh-ancestor
92802907|NCT02627248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802908|NCT02627248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92802909|NCT02627248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92802910|NCT02627248|Alkylating Agents|alkylating agents|mesh-ancestor
92802911|NCT02627248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802912|NCT02627248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802913|NCT02627248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92802914|NCT02627248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92802915|NCT02627248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92802916|NCT02627248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92802917|NCT02627248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92802918|NCT02627248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802919|NCT02627248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802920|NCT02627248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802921|NCT03993535|Serotonin|serotonin|mesh-list
92802922|NCT03993535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92802923|NCT03993535|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92802924|NCT03993535|Serotonin Agents|serotonin agents|mesh-ancestor
92802925|NCT03993535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802926|NCT03993535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802927|NCT03993535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802928|NCT03993535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92802929|NCT03993535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92802930|NCT02626936|Insulin|insulin|mesh-list
92802931|NCT02626936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92802932|NCT02626936|Glucagon|glucagon|mesh-list
92802933|NCT02626936|Hormones|hormones|mesh-list
92802934|NCT02626936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802935|NCT02626936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802936|NCT02626936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92802937|NCT02626936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92802938|NCT00912262|Capsaicin|capsaicin|mesh-list
92802939|NCT00912262|Antipruritics|antipruritics|mesh-ancestor
92802940|NCT00912262|Dermatologic Agents|dermatologic agents|mesh-ancestor
92802941|NCT00912262|Sensory System Agents|sensory system agents|mesh-ancestor
92802942|NCT00912262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802943|NCT00912262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802944|NCT00906945|Cytarabine|cytarabine|mesh-list
92802945|NCT00906945|Plerixafor|plerixafor|mesh-list
92802946|NCT00906945|Etoposide|etoposide|mesh-list
92802947|NCT00906945|Mitoxantrone|mitoxantrone|mesh-list
92802948|NCT00906945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92802949|NCT00906945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92802950|NCT00906945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92802951|NCT00906945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92802952|NCT00906945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92802953|NCT00906945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802954|NCT00906945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92802955|NCT00906945|Antimetabolites|antimetabolites|mesh-ancestor
92802956|NCT00906945|Antiviral Agents|antiviral agents|mesh-ancestor
92802957|NCT00906945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92802958|NCT00906945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92802959|NCT00906945|Immunologic Factors|immunologic factors|mesh-ancestor
92802960|NCT00906945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802961|NCT00906945|Analgesics|analgesics|mesh-ancestor
92802962|NCT00906945|Sensory System Agents|sensory system agents|mesh-ancestor
92802963|NCT00906945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802964|NCT00906945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92802965|NCT00906945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92802966|NCT00807235|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92802967|NCT00807235|Respiratory System Agents|respiratory system agents|mesh-ancestor
92802968|NCT02627560|Tranexamic Acid|tranexamic acid|mesh-list
92802969|NCT02627560|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92802970|NCT02627560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92802971|NCT02627560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802973|NCT02627560|Coagulants|coagulants|mesh-ancestor
92802974|NCT00681460|Metformin|metformin|mesh-list
92802975|NCT00681460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92802976|NCT00681460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802977|NCT00876694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92802978|NCT00876694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92802979|NCT00876694|Autonomic Agents|autonomic agents|mesh-ancestor
92802980|NCT00876694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92802981|NCT00876694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802982|NCT00876694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92802983|NCT00876694|Respiratory System Agents|respiratory system agents|mesh-ancestor
92802984|NCT00876694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92802985|NCT00876694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92802986|NCT00876694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92802987|NCT00876694|Adrenergic Agents|adrenergic agents|mesh-ancestor
92802988|NCT00876694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92802989|NCT00876694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92802990|NCT05752903|Dexmedetomidine|dexmedetomidine|mesh-list
92802991|NCT05752903|Ketamine|ketamine|mesh-list
92802992|NCT05752903|Propofol|propofol|mesh-list
92802993|NCT05752903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92802994|NCT05752903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92802995|NCT05752903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92802996|NCT05752903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92802997|NCT05752903|Analgesics|analgesics|mesh-ancestor
92802998|NCT05752903|Sensory System Agents|sensory system agents|mesh-ancestor
92802999|NCT05752903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803000|NCT05752903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92803001|NCT05752903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92803002|NCT05752903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92803003|NCT05752903|Adrenergic Agents|adrenergic agents|mesh-ancestor
92803004|NCT05752903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803005|NCT05752903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803006|NCT05752903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92803007|NCT05752903|Anesthetics, General|anesthetics, general|mesh-ancestor
92803008|NCT05752903|Anesthetics|anesthetics|mesh-ancestor
92803009|NCT05752903|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92803010|NCT05752903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92803011|NCT05752903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92803012|NCT00590317|Ondansetron|ondansetron|mesh-list
92803013|NCT00590317|Prochlorperazine|prochlorperazine|mesh-list
92803014|NCT00590317|Antiemetics|antiemetics|mesh-ancestor
92803015|NCT00590317|Autonomic Agents|autonomic agents|mesh-ancestor
92803016|NCT00590317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803017|NCT00590317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803018|NCT00590317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92803019|NCT00590317|Antipruritics|antipruritics|mesh-ancestor
92803020|NCT00590317|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803021|NCT00590317|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92803022|NCT00590317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92803023|NCT00590317|Serotonin Agents|serotonin agents|mesh-ancestor
92803024|NCT00590317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803025|NCT00590317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803026|NCT00590317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92803027|NCT00590317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92803028|NCT00590317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803029|NCT00590317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92803030|NCT00590317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92803031|NCT00590317|Dopamine Agents|dopamine agents|mesh-ancestor
92803032|NCT01139762|Tadalafil|tadalafil|mesh-list
92803033|NCT01139762|Finasteride|finasteride|mesh-list
92803034|NCT01139762|Vasodilator Agents|vasodilator agents|mesh-ancestor
92803035|NCT01139762|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92803036|NCT01139762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92803037|NCT01139762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803038|NCT01139762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803039|NCT01139762|Urological Agents|urological agents|mesh-ancestor
92803040|NCT01139762|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92803041|NCT01139762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92803042|NCT01139762|Hormone Antagonists|hormone antagonists|mesh-ancestor
92803043|NCT01139762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448005|NCT05727579|Ertugliflozin|ertugliflozin|mesh-list
92803044|NCT01139762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803045|NCT00805285|Budesonide|budesonide|mesh-list
92803046|NCT00805285|Hydrocortisone|hydrocortisone|mesh-list
92803047|NCT00805285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803048|NCT00805285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92803049|NCT00805285|Autonomic Agents|autonomic agents|mesh-ancestor
92803050|NCT00805285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803051|NCT00805285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803052|NCT00805285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92803053|NCT00805285|Respiratory System Agents|respiratory system agents|mesh-ancestor
92803054|NCT00805285|Glucocorticoids|glucocorticoids|mesh-ancestor
92803055|NCT00805285|Hormones|hormones|mesh-ancestor
92803056|NCT00805285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803057|NCT02606773|Ascorbic Acid|ascorbic acid|mesh-list
92803058|NCT02606773|Antioxidants|antioxidants|mesh-ancestor
92803059|NCT02606773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803060|NCT02606773|Protective Agents|protective agents|mesh-ancestor
92803061|NCT02606773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803062|NCT02606773|Vitamins|vitamins|mesh-ancestor
92803063|NCT02606773|Micronutrients|micronutrients|mesh-ancestor
92803064|NCT04310774|Tegafur|tegafur|mesh-list
92803065|NCT04310774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92803066|NCT04310774|Antimetabolites|antimetabolites|mesh-ancestor
92803067|NCT04310774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803068|NCT04310774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803069|NCT01139450|Tacrolimus|tacrolimus|mesh-list
92803070|NCT01139450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92803071|NCT01139450|Immunologic Factors|immunologic factors|mesh-ancestor
92803072|NCT01139450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803073|NCT01139450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92803074|NCT01139450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803075|NCT01139450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803076|NCT05110742|Cyclophosphamide|cyclophosphamide|mesh-list
92803077|NCT05110742|Fludarabine|fludarabine|mesh-list
92803078|NCT05110742|Fludarabine phosphate|fludarabine phosphate|mesh-list
92803079|NCT05110742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92803080|NCT05110742|Immunologic Factors|immunologic factors|mesh-ancestor
92803081|NCT05110742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803082|NCT05110742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92803083|NCT05110742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92803084|NCT05110742|Alkylating Agents|alkylating agents|mesh-ancestor
92803085|NCT05110742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803086|NCT05110742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803087|NCT05110742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92803088|NCT05110742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92803089|NCT05110742|Antimetabolites|antimetabolites|mesh-ancestor
92803090|NCT00805207|Estradiol|estradiol|mesh-list
92803091|NCT00805207|Estrogens|estrogens|mesh-list
92803092|NCT00805207|Testosterone|testosterone|mesh-list
92803093|NCT00805207|Progesterone|progesterone|mesh-list
92803094|NCT00805207|Glucocorticoids|glucocorticoids|mesh-list
92803095|NCT00805207|Hormones|hormones|mesh-ancestor
92803096|NCT00805207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803097|NCT00805207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803098|NCT00805207|Androgens|androgens|mesh-ancestor
92803099|NCT00805207|Progestins|progestins|mesh-ancestor
92803100|NCT00805675|Tenofovir|tenofovir|mesh-list
92803101|NCT00805675|Telbivudine|telbivudine|mesh-list
92803102|NCT00805675|Antiviral Agents|antiviral agents|mesh-ancestor
92803103|NCT00805675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803104|NCT00805675|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92803105|NCT00805675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92803107|NCT00805675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803108|NCT00805675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92803109|NCT00805675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92803110|NCT03958201|Rocuronium|rocuronium|mesh-list
92803111|NCT03958201|Neostigmine|neostigmine|mesh-list
92803112|NCT03958201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92803113|NCT03958201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92803114|NCT03958201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92803115|NCT03958201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803116|NCT03958201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803117|NCT03958201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92803118|NCT03958201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803119|NCT03958201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803120|NCT03958201|Cholinergic Agents|cholinergic agents|mesh-ancestor
92803121|NCT03958201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803122|NCT03958201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92803123|NCT03958201|Autonomic Agents|autonomic agents|mesh-ancestor
92803124|NCT00589303|Metoprolol|metoprolol|mesh-list
92803125|NCT00589303|Amiodarone|amiodarone|mesh-list
92803126|NCT00589303|Verapamil|verapamil|mesh-list
92803127|NCT00589303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92803128|NCT00589303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803129|NCT00589303|Sympatholytics|sympatholytics|mesh-ancestor
92803130|NCT00589303|Autonomic Agents|autonomic agents|mesh-ancestor
92803131|NCT00589303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803132|NCT00589303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803133|NCT00589303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92803134|NCT00589303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92803135|NCT00589303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92803136|NCT00589303|Adrenergic Agents|adrenergic agents|mesh-ancestor
92803137|NCT00589303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803138|NCT00589303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803139|NCT00589303|Vasodilator Agents|vasodilator agents|mesh-ancestor
92803140|NCT00589303|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92803141|NCT00589303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803142|NCT00589303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92803143|NCT00589303|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92803144|NCT00589303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92803145|NCT00589303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803146|NCT00589303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92803147|NCT00589303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92803148|NCT00589303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92803149|NCT00589303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92803150|NCT00589303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92803151|NCT02607943|Insulin|insulin|mesh-list
92803152|NCT02607943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92803153|NCT02607943|Insulin Glargine|insulin glargine|mesh-list
92803154|NCT02607943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92803155|NCT02607943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803156|NCT02606617|Mosapride|mosapride|mesh-list
92803157|NCT02606617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92803158|NCT02606617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92803159|NCT02606617|Serotonin Agents|serotonin agents|mesh-ancestor
92803160|NCT02606617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803161|NCT02606617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803162|NCT02606617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803163|NCT00914095|Methylphenidate|methylphenidate|mesh-list
92803164|NCT00914095|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92803165|NCT00914095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803166|NCT00914095|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92803167|NCT00914095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92803168|NCT00914095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803169|NCT00914095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803170|NCT00914095|Dopamine Agents|dopamine agents|mesh-ancestor
92803171|NCT00914095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803172|NCT03903835|Prednisone|prednisone|mesh-list
92803173|NCT03903835|Carboplatin|carboplatin|mesh-list
92803174|NCT03903835|Docetaxel|docetaxel|mesh-list
92803175|NCT03903835|Abiraterone Acetate|abiraterone acetate|mesh-list
92803176|NCT03903835|Niraparib|niraparib|mesh-list
92803177|NCT03903835|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92803178|NCT03903835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92803179|NCT03903835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803180|NCT03903835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92803181|NCT03903835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92803182|NCT03903835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92803183|NCT03903835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803184|NCT03903835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803185|NCT03903835|Glucocorticoids|glucocorticoids|mesh-ancestor
92803186|NCT03903835|Hormones|hormones|mesh-ancestor
92803187|NCT03903835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803188|NCT03903835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803189|NCT03903835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803190|NCT03903835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92803191|NCT03903835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803192|NCT03903835|Hormone Antagonists|hormone antagonists|mesh-ancestor
92803193|NCT03903835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92803194|NCT03903835|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92803196|NCT05745337|Verapamil|verapamil|mesh-list
92803197|NCT05745337|Diltiazem|diltiazem|mesh-list
92803198|NCT05745337|Calcium Channel Blockers|calcium channel blockers|mesh-list
92803199|NCT05745337|Calcium|calcium|mesh-list
92803200|NCT05745337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92803201|NCT05745337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92803202|NCT05745337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803203|NCT05745337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92803204|NCT05745337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803205|NCT05745337|Sympatholytics|sympatholytics|mesh-ancestor
92803206|NCT05745337|Autonomic Agents|autonomic agents|mesh-ancestor
92803207|NCT05745337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803208|NCT05745337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92803209|NCT05745337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92803210|NCT05745337|Adrenergic Agents|adrenergic agents|mesh-ancestor
92803211|NCT05745337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803212|NCT05745337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803213|NCT05745337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803214|NCT05745337|Vasodilator Agents|vasodilator agents|mesh-ancestor
92803215|NCT00952380|Dalteparin|dalteparin|mesh-list
92803216|NCT00952380|Tinzaparin|tinzaparin|mesh-list
92803217|NCT00952380|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92803218|NCT00952380|Anticoagulants|anticoagulants|mesh-ancestor
92803219|NCT00952380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92803220|NCT00952380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92803221|NCT00952380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803222|NCT03859921|Dydrogesterone|dydrogesterone|mesh-list
92803223|NCT03859921|Progestins|progestins|mesh-ancestor
92803224|NCT03859921|Hormones|hormones|mesh-ancestor
92803225|NCT03859921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803226|NCT03859921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803227|NCT02856750|Gabapentin|gabapentin|mesh-list
92803228|NCT02856750|Analgesics|analgesics|mesh-ancestor
92803229|NCT02856750|Sensory System Agents|sensory system agents|mesh-ancestor
92803230|NCT02856750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803231|NCT02856750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803232|NCT02856750|Anticonvulsants|anticonvulsants|mesh-ancestor
92803233|NCT02856750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92803234|NCT02856750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92803235|NCT02856750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803236|NCT02856750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92803237|NCT02856750|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92803238|NCT02856750|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92803239|NCT02856750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803240|NCT02856750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803241|NCT02856750|Antimanic Agents|antimanic agents|mesh-ancestor
92803242|NCT05751967|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92803243|NCT05751967|Fenofibrate|fenofibrate|mesh-list
92803244|NCT05751967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92803245|NCT05751967|Antimetabolites|antimetabolites|mesh-ancestor
92803246|NCT05751967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803247|NCT05751967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92803248|NCT05751967|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92803249|NCT05751967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92803250|NCT02857920|Bevacizumab|bevacizumab|mesh-list
92803251|NCT02857920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92803252|NCT02857920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803253|NCT02857920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92803254|NCT02857920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92803255|NCT02857920|Growth Substances|growth substances|mesh-ancestor
92803256|NCT02857920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803257|NCT02857920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92803258|NCT02607631|Pembrolizumab|pembrolizumab|mesh-list
92803259|NCT02607631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92803260|NCT02607631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803261|NCT02607631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92803262|NCT02607631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803263|NCT02857842|Prednisolone|prednisolone|mesh-list
92803264|NCT02857842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803265|NCT02857842|Glucocorticoids|glucocorticoids|mesh-ancestor
92803266|NCT02857842|Hormones|hormones|mesh-ancestor
92803267|NCT02857842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803268|NCT02857842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803269|NCT02857842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803270|NCT02857842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803271|NCT03635437|Alprazolam|alprazolam|mesh-list
92803272|NCT03635437|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92803273|NCT03635437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92803274|NCT03635437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803275|NCT03635437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803276|NCT03635437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92803277|NCT03635437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92803278|NCT03635437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92803279|NCT03635437|GABA Modulators|gaba modulators|mesh-ancestor
92803280|NCT03635437|GABA Agents|gaba agents|mesh-ancestor
92803281|NCT03635437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416581|NCT01485939|Anesthetics, Local|anesthetics, local|mesh-ancestor
92803282|NCT03635437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803283|NCT00803179|Hormones|hormones|mesh-list
92803284|NCT00803179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803285|NCT00803179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803286|NCT00804193|Ciclopirox|ciclopirox|mesh-list
92803287|NCT00804193|Antifungal Agents|antifungal agents|mesh-ancestor
92803288|NCT00804193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803289|NCT05697211|Ferric maltol|ferric maltol|mesh-list
92803290|NCT05697211|Hematinics|hematinics|mesh-ancestor
92803291|NCT00957996|Peramivir|peramivir|mesh-list
92803292|NCT00957996|Antiviral Agents|antiviral agents|mesh-ancestor
92803293|NCT00957996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803294|NCT00957996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803295|NCT00957996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803296|NCT02606539|Leucovorin|leucovorin|mesh-list
92803297|NCT02606539|Folic Acid|folic acid|mesh-list
92803298|NCT02606539|Methotrexate|methotrexate|mesh-list
92803299|NCT02606539|Levoleucovorin|levoleucovorin|mesh-list
92803300|NCT02606539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92803301|NCT02606539|Abortifacient Agents|abortifacient agents|mesh-ancestor
92803302|NCT02606539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92803303|NCT02606539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803304|NCT02606539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92803305|NCT02606539|Antimetabolites|antimetabolites|mesh-ancestor
92803306|NCT02606539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803307|NCT02606539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803308|NCT02606539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803309|NCT02606539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803310|NCT02606539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92803311|NCT02606539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92803312|NCT02606539|Immunologic Factors|immunologic factors|mesh-ancestor
92803313|NCT02606539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92803314|NCT02606539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92803315|NCT02606539|Antidotes|antidotes|mesh-ancestor
92803316|NCT02606539|Protective Agents|protective agents|mesh-ancestor
92803317|NCT02606539|Vitamin B Complex|vitamin b complex|mesh-ancestor
92803318|NCT02606539|Vitamins|vitamins|mesh-ancestor
92803319|NCT02606539|Micronutrients|micronutrients|mesh-ancestor
92803320|NCT02606539|Hematinics|hematinics|mesh-ancestor
92803321|NCT00589693|Imipenem|imipenem|mesh-list
92803322|NCT00589693|Doripenem|doripenem|mesh-list
92803323|NCT00589693|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92803324|NCT00589693|Cilastatin|cilastatin|mesh-list
92803325|NCT00589693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92803326|NCT00589693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803327|NCT00589693|Protease Inhibitors|protease inhibitors|mesh-ancestor
92803328|NCT00589693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803329|NCT00589693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803330|NCT02606383|Ketoconazole|ketoconazole|mesh-list
92803331|NCT02606383|Antifungal Agents|antifungal agents|mesh-ancestor
92803332|NCT02606383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803333|NCT02606383|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92803334|NCT02606383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92803335|NCT02606383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803336|NCT02606383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803337|NCT02606383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92803338|NCT02606383|Hormone Antagonists|hormone antagonists|mesh-ancestor
92803339|NCT02606383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803340|NCT02606383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803341|NCT02606383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92803342|NCT05660473|Cytarabine|cytarabine|mesh-list
92448312|NCT04319224|Nivolumab|nivolumab|mesh-list
92803343|NCT05660473|Dexamethasone|dexamethasone|mesh-list
92803345|NCT05660473|Cyclophosphamide|cyclophosphamide|mesh-list
92803346|NCT05660473|Methotrexate|methotrexate|mesh-list
92803347|NCT05660473|Vincristine|vincristine|mesh-list
92803348|NCT05660473|Daunorubicin|daunorubicin|mesh-list
92803349|NCT05660473|Venetoclax|venetoclax|mesh-list
92803350|NCT05660473|Mercaptopurine|mercaptopurine|mesh-list
92803351|NCT05660473|Pegaspargase|pegaspargase|mesh-list
92803352|NCT05660473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92803353|NCT05660473|Immunologic Factors|immunologic factors|mesh-ancestor
92803354|NCT05660473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803355|NCT05660473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92803356|NCT05660473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92803357|NCT05660473|Alkylating Agents|alkylating agents|mesh-ancestor
92148700|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92803358|NCT05660473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803359|NCT05660473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803360|NCT05660473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92803361|NCT05660473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803362|NCT05660473|Antiemetics|antiemetics|mesh-ancestor
92803363|NCT05660473|Autonomic Agents|autonomic agents|mesh-ancestor
92803364|NCT05660473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803365|NCT05660473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92803366|NCT05660473|Glucocorticoids|glucocorticoids|mesh-ancestor
92803367|NCT05660473|Hormones|hormones|mesh-ancestor
92803368|NCT05660473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803369|NCT05660473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803370|NCT05660473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92803371|NCT05660473|Abortifacient Agents|abortifacient agents|mesh-ancestor
92803372|NCT05660473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92803373|NCT05660473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92803374|NCT05660473|Antimetabolites|antimetabolites|mesh-ancestor
92803375|NCT05660473|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803376|NCT05660473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803377|NCT05660473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92803378|NCT05660473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92803379|NCT05660473|Antiviral Agents|antiviral agents|mesh-ancestor
92803380|NCT05660473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803381|NCT05660473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92803382|NCT05660473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92803383|NCT05660473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92803384|NCT05660473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92803385|NCT05660473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92803386|NCT05660473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92803387|NCT05660473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92803388|NCT00803101|Protein C|protein c|mesh-list
92803389|NCT00803101|Protein S|protein s|mesh-list
92803390|NCT00803101|Anticoagulants|anticoagulants|mesh-ancestor
92803391|NCT00803101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92803392|NCT00803101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92803393|NCT00803101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803394|NCT00801229|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92803395|NCT00801229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92803396|NCT00801229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803397|NCT00801229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92803398|NCT00801229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92803399|NCT00801229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803400|NCT00801229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803401|NCT00801229|Dopamine Agents|dopamine agents|mesh-ancestor
92803402|NCT00801229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803403|NCT04269954|Heparin|heparin|mesh-list
92803404|NCT04269954|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92803405|NCT04269954|Tinzaparin|tinzaparin|mesh-list
92803406|NCT04269954|Dalteparin|dalteparin|mesh-list
92803407|NCT04269954|Batroxobin|batroxobin|mesh-list
92803408|NCT04269954|Anticoagulants|anticoagulants|mesh-ancestor
92803409|NCT04269954|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92803410|NCT04269954|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92803411|NCT04269954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803412|NCT04269954|Hemostatics|hemostatics|mesh-ancestor
92803413|NCT04269954|Coagulants|coagulants|mesh-ancestor
92803414|NCT00630630|Levetiracetam|levetiracetam|mesh-list
92803415|NCT00630630|Anticonvulsants|anticonvulsants|mesh-ancestor
92803416|NCT00630630|Nootropic Agents|nootropic agents|mesh-ancestor
92803417|NCT01254864|Prednisone|prednisone|mesh-list
92803418|NCT01254864|Sunitinib|sunitinib|mesh-list
92803419|NCT01254864|Dasatinib|dasatinib|mesh-list
92803420|NCT01254864|Abiraterone Acetate|abiraterone acetate|mesh-list
92803421|NCT01254864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803422|NCT01254864|Glucocorticoids|glucocorticoids|mesh-ancestor
92803423|NCT01254864|Hormones|hormones|mesh-ancestor
92803424|NCT01254864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803425|NCT01254864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803426|NCT01254864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803427|NCT01254864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803428|NCT01254864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92803429|NCT01254864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92803430|NCT01254864|Growth Substances|growth substances|mesh-ancestor
92803431|NCT01254864|Growth Inhibitors|growth inhibitors|mesh-ancestor
92803432|NCT01254864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92803433|NCT01254864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803434|NCT01254864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803435|NCT01254864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92803436|NCT01254864|Hormone Antagonists|hormone antagonists|mesh-ancestor
92803437|NCT01254864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92803438|NCT02854722|Calcium, Dietary|calcium, dietary|mesh-list
92803439|NCT02854722|Vitamin D|vitamin d|mesh-list
92803440|NCT02854722|Ergocalciferols|ergocalciferols|mesh-list
92803441|NCT02854722|Cholecalciferol|cholecalciferol|mesh-list
92803442|NCT02854722|Vitamins|vitamins|mesh-list
92803443|NCT02854722|Calcium|calcium|mesh-list
92803444|NCT02854722|Deferasirox|deferasirox|mesh-list
92803445|NCT02854722|Micronutrients|micronutrients|mesh-ancestor
92803446|NCT02854722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803447|NCT02854722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92803448|NCT02854722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92803449|NCT02854722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92803450|NCT02854722|Chelating Agents|chelating agents|mesh-ancestor
92803451|NCT02854722|Sequestering Agents|sequestering agents|mesh-ancestor
92803452|NCT02854722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803453|NCT00800683|Linagliptin|linagliptin|mesh-list
92803454|NCT00800683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92803455|NCT00800683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803456|NCT00800683|Incretins|incretins|mesh-ancestor
92803457|NCT00800683|Hormones|hormones|mesh-ancestor
92803458|NCT00800683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803459|NCT00800683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92803460|NCT00800683|Protease Inhibitors|protease inhibitors|mesh-ancestor
92803461|NCT00800683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803462|NCT00800683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803463|NCT01113710|Rotigotine|rotigotine|mesh-list
92803464|NCT01113710|Dopamine Agonists|dopamine agonists|mesh-ancestor
92803465|NCT01113710|Dopamine Agents|dopamine agents|mesh-ancestor
92803466|NCT01113710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803467|NCT01113710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803468|NCT01113710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803469|NCT01124162|Losartan|losartan|mesh-list
92803470|NCT01124162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92803471|NCT01124162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803472|NCT01124162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92803473|NCT01124162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92803474|NCT01124162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803475|NCT00923533|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92803476|NCT00923533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803477|NCT00923533|Diuretics|diuretics|mesh-ancestor
92803478|NCT00923533|Natriuretic Agents|natriuretic agents|mesh-ancestor
92803479|NCT00923533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803480|NCT00923533|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92803481|NCT00923533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803482|NCT00923533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803484|NCT00906399|Interferon-beta|interferon-beta|mesh-list
92803485|NCT00906399|Interferon beta-1a|interferon beta-1a|mesh-list
92803486|NCT00906399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803487|NCT00906399|Antiviral Agents|antiviral agents|mesh-ancestor
92803488|NCT00906399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803489|NCT00906399|Immunologic Factors|immunologic factors|mesh-ancestor
92803490|NCT00906399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803491|NCT00906399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92803492|NCT00947856|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92803493|NCT00947856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92803494|NCT00947856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803495|NCT00947856|Immunotoxins|immunotoxins|mesh-ancestor
92803496|NCT00947856|Immunoconjugates|immunoconjugates|mesh-ancestor
92803497|NCT00947856|Immunologic Factors|immunologic factors|mesh-ancestor
92803498|NCT00947856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803499|NCT00947544|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92803500|NCT00947544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803501|NCT00907335|Tretinoin|tretinoin|mesh-list
92803502|NCT00907335|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92803503|NCT00907335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803504|NCT00907335|Keratolytic Agents|keratolytic agents|mesh-ancestor
92803505|NCT00907335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803506|NCT00947154|Aripiprazole|aripiprazole|mesh-list
92803507|NCT00947154|Antidepressive Agents|antidepressive agents|mesh-ancestor
92803508|NCT00947154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92803509|NCT00947154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92803510|NCT00947154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92803511|NCT00947154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803512|NCT00947154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803513|NCT00947154|Dopamine Agonists|dopamine agonists|mesh-ancestor
92803514|NCT00947154|Dopamine Agents|dopamine agents|mesh-ancestor
92803515|NCT00947154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803516|NCT00947154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803517|NCT00947154|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92803518|NCT00947154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92803519|NCT00947154|Serotonin Agents|serotonin agents|mesh-ancestor
92803520|NCT00947154|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92803521|NCT00947154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92803522|NCT00947154|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92803523|NCT00947154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92803524|NCT01862952|Anticonvulsants|anticonvulsants|mesh-list
92803525|NCT00952068|Tramadol|tramadol|mesh-list
92803526|NCT00952068|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92803527|NCT00952068|Narcotics|narcotics|mesh-ancestor
92803528|NCT00952068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803529|NCT00952068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803530|NCT00952068|Analgesics|analgesics|mesh-ancestor
92803531|NCT00952068|Sensory System Agents|sensory system agents|mesh-ancestor
92803532|NCT00952068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803533|NCT00951912|Genistein|genistein|mesh-list
92803534|NCT00951912|Daidzein|daidzein|mesh-list
92803535|NCT00951912|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92803536|NCT00951912|Protective Agents|protective agents|mesh-ancestor
92803537|NCT00951912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803538|NCT00951912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803539|NCT00951912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92803540|NCT00951912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803541|NCT00951912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803542|NCT00951912|Phytoestrogens|phytoestrogens|mesh-ancestor
92803543|NCT00951912|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92803544|NCT00951912|Estrogens|estrogens|mesh-ancestor
92803545|NCT00951912|Hormones|hormones|mesh-ancestor
92803546|NCT00951912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803547|NCT02882594|Anesthetics|anesthetics|mesh-list
92803548|NCT02882594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803549|NCT02882594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803550|NCT02856048|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92803551|NCT02856048|Luteolytic Agents|luteolytic agents|mesh-ancestor
92803552|NCT02856048|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92803553|NCT02856048|Contraceptive Agents|contraceptive agents|mesh-ancestor
92803554|NCT02856048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92803555|NCT02856048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803556|NCT02856048|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92803557|NCT02856048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803558|NCT02856048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803559|NCT03844815|Decitabine|decitabine|mesh-list
92803560|NCT03844815|Venetoclax|venetoclax|mesh-list
92803561|NCT03844815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92803562|NCT03844815|Antimetabolites|antimetabolites|mesh-ancestor
92803563|NCT03844815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803564|NCT03844815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803565|NCT03844815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803566|NCT01123070|Rituximab|rituximab|mesh-list
92803567|NCT01123070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92803568|NCT01123070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803569|NCT01123070|Immunologic Factors|immunologic factors|mesh-ancestor
92803570|NCT01123070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803572|NCT02857686|Anesthetics|anesthetics|mesh-list
92803573|NCT02857686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803574|NCT02857686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803575|NCT03198741|Aspirin|aspirin|mesh-list
92803576|NCT03198741|Clopidogrel|clopidogrel|mesh-list
92416871|NCT01487629|Bevacizumab|bevacizumab|mesh-list
92803577|NCT03198741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92803578|NCT03198741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92803579|NCT03198741|Analgesics|analgesics|mesh-ancestor
92803580|NCT03198741|Sensory System Agents|sensory system agents|mesh-ancestor
92803581|NCT03198741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803582|NCT03198741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803583|NCT03198741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803584|NCT03198741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92803585|NCT03198741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92803586|NCT03198741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92803587|NCT03198741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803588|NCT03198741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92803589|NCT03198741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92803590|NCT03198741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803591|NCT03198741|Antipyretics|antipyretics|mesh-ancestor
92803592|NCT03198741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92803593|NCT03198741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92803594|NCT03198741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92803595|NCT03198741|Purinergic Agents|purinergic agents|mesh-ancestor
92803596|NCT03198741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803597|NCT01122680|Bromides|bromides|mesh-list
92803598|NCT01122680|Tiotropium Bromide|tiotropium bromide|mesh-list
92803599|NCT01122680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92803600|NCT01122680|Autonomic Agents|autonomic agents|mesh-ancestor
92803601|NCT01122680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803602|NCT01122680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803603|NCT01122680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92803604|NCT01122680|Respiratory System Agents|respiratory system agents|mesh-ancestor
92803605|NCT01122680|Parasympatholytics|parasympatholytics|mesh-ancestor
92803606|NCT01122680|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92803607|NCT01122680|Cholinergic Agents|cholinergic agents|mesh-ancestor
92803608|NCT01122680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803609|NCT01122680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803610|NCT01122680|Anticonvulsants|anticonvulsants|mesh-ancestor
92803611|NCT00946998|Sertraline|sertraline|mesh-list
92803612|NCT00946998|Antidepressive Agents|antidepressive agents|mesh-ancestor
92803613|NCT00946998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92803614|NCT00946998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92803615|NCT00946998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92803616|NCT00946998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803617|NCT00946998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803618|NCT00946998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803619|NCT00946998|Serotonin Agents|serotonin agents|mesh-ancestor
92803620|NCT00946998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803621|NCT01138826|Amlodipine|amlodipine|mesh-list
92803622|NCT01138826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803623|NCT01138826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92803624|NCT01138826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803625|NCT01138826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803626|NCT01138826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92803627|NCT01138826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803628|NCT01138826|Vasodilator Agents|vasodilator agents|mesh-ancestor
92803629|NCT00906087|Timolol|timolol|mesh-list
92803630|NCT00906087|Dorzolamide|dorzolamide|mesh-list
92803631|NCT00906087|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92803632|NCT00906087|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92803633|NCT00906087|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92803634|NCT00906087|Adrenergic Agents|adrenergic agents|mesh-ancestor
92803635|NCT00906087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803636|NCT00906087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803637|NCT00906087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803638|NCT00906087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92803639|NCT00906087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803640|NCT00906087|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92803641|NCT00906087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803642|NCT00906087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92803643|NCT03525795|Ipilimumab|ipilimumab|mesh-list
92803644|NCT03525795|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
92803645|NCT03525795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148701|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92803646|NCT03525795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803647|NCT03525795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92803648|NCT03525795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803649|NCT03525795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803650|NCT03522831|Albuterol|albuterol|mesh-list
92803651|NCT03522831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92803652|NCT03522831|Autonomic Agents|autonomic agents|mesh-ancestor
92803653|NCT03522831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803654|NCT03522831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803655|NCT03522831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92803656|NCT03522831|Respiratory System Agents|respiratory system agents|mesh-ancestor
92803657|NCT03522831|Tocolytic Agents|tocolytic agents|mesh-ancestor
92803658|NCT03522831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92803659|NCT03522831|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92803660|NCT03522831|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92803661|NCT03522831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92803662|NCT03522831|Adrenergic Agents|adrenergic agents|mesh-ancestor
92803663|NCT03522831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803664|NCT03522831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803665|NCT03504501|Lamotrigine|lamotrigine|mesh-list
92803666|NCT03504501|Lovastatin|lovastatin|mesh-list
92803667|NCT03504501|L 647318|l 647318|mesh-list
92803668|NCT03504501|Dihydromevinolin|dihydromevinolin|mesh-list
92803669|NCT03504501|Anticonvulsants|anticonvulsants|mesh-ancestor
92803670|NCT03504501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92803671|NCT03504501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803672|NCT03504501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803673|NCT03504501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92803674|NCT03504501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803675|NCT03504501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92803676|NCT03504501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92803677|NCT03504501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803678|NCT03504501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92803679|NCT03504501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92803680|NCT03504501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92803681|NCT03504501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92803682|NCT03504501|Antimetabolites|antimetabolites|mesh-ancestor
92803683|NCT03504501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92803684|NCT03504501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92803685|NCT03504501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803686|NCT02420574|Albendazole|albendazole|mesh-list
92803687|NCT02420574|Anthelmintics|anthelmintics|mesh-ancestor
92803688|NCT02420574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92803689|NCT02420574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803690|NCT02420574|Anticestodal Agents|anticestodal agents|mesh-ancestor
92803691|NCT02420574|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92803692|NCT02420574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92803693|NCT02420574|Tubulin Modulators|tubulin modulators|mesh-ancestor
92803694|NCT02420574|Antimitotic Agents|antimitotic agents|mesh-ancestor
92803695|NCT02420574|Mitosis Modulators|mitosis modulators|mesh-ancestor
92803696|NCT02420574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803697|NCT02420574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803698|NCT02855502|Prednisolone|prednisolone|mesh-list
92803699|NCT02855502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803700|NCT02855502|Glucocorticoids|glucocorticoids|mesh-ancestor
92803702|NCT02855502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803703|NCT02855502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803704|NCT02855502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803705|NCT02855502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803706|NCT02853864|Dexmedetomidine|dexmedetomidine|mesh-list
92803707|NCT02853864|Propofol|propofol|mesh-list
92803708|NCT02853864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92803709|NCT02853864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803710|NCT02853864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803711|NCT02853864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92803712|NCT02853864|Analgesics|analgesics|mesh-ancestor
92803713|NCT02853864|Sensory System Agents|sensory system agents|mesh-ancestor
92803714|NCT02853864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803715|NCT02853864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92803716|NCT02853864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92803717|NCT02853864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92803718|NCT02853864|Adrenergic Agents|adrenergic agents|mesh-ancestor
92803719|NCT02853864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803720|NCT02853864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803721|NCT02853864|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92803722|NCT02853864|Anesthetics, General|anesthetics, general|mesh-ancestor
92803723|NCT02853864|Anesthetics|anesthetics|mesh-ancestor
92803724|NCT00907257|Tretinoin|tretinoin|mesh-list
92803725|NCT00907257|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92803726|NCT00907257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803727|NCT00907257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803728|NCT00907257|Keratolytic Agents|keratolytic agents|mesh-ancestor
92803729|NCT01138046|Paclitaxel|paclitaxel|mesh-list
92803730|NCT01138046|Lapatinib|lapatinib|mesh-list
92803731|NCT01138046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92803732|NCT01138046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803733|NCT01138046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92803734|NCT01138046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92803735|NCT01138046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92803736|NCT01138046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803737|NCT01138046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92803738|NCT01138046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803739|NCT02350764|Nivolumab|nivolumab|mesh-list
92803740|NCT02350764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92803741|NCT02350764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803742|NCT02350764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92803743|NCT02350764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803744|NCT00876460|Docetaxel|docetaxel|mesh-list
92803745|NCT00876460|Nintedanib|nintedanib|mesh-list
92803746|NCT00876460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803747|NCT00876460|Tubulin Modulators|tubulin modulators|mesh-ancestor
92803748|NCT00876460|Antimitotic Agents|antimitotic agents|mesh-ancestor
92803749|NCT00876460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92803750|NCT00876460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803751|NCT00876460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92803752|NCT00876460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803753|NCT01137812|Metformin|metformin|mesh-list
92803754|NCT01137812|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92803755|NCT01137812|Canagliflozin|canagliflozin|mesh-list
92803756|NCT01137812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92803757|NCT01137812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803758|NCT01137812|Incretins|incretins|mesh-ancestor
92803759|NCT01137812|Hormones|hormones|mesh-ancestor
92803760|NCT01137812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803761|NCT01137812|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92803762|NCT01137812|Protease Inhibitors|protease inhibitors|mesh-ancestor
92803763|NCT01137812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803764|NCT01137812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803765|NCT01137812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92803766|NCT00679510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92803767|NCT00679510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92803768|NCT00679510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92803769|NCT00679510|Antimetabolites|antimetabolites|mesh-ancestor
92803770|NCT00679510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803771|NCT00679510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92803772|NCT00679510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92417085|NCT01489059|Ipilimumab|ipilimumab|mesh-list
92803773|NCT00679510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803774|NCT04146220|Prednisolone|prednisolone|mesh-list
92803775|NCT04146220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803776|NCT04146220|Glucocorticoids|glucocorticoids|mesh-ancestor
92803777|NCT04146220|Hormones|hormones|mesh-ancestor
92803778|NCT04146220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803779|NCT04146220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803780|NCT04146220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803781|NCT04146220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803782|NCT00679666|Riboflavin|riboflavin|mesh-list
92803783|NCT00679666|Vitamins|vitamins|mesh-ancestor
92803784|NCT00679666|Micronutrients|micronutrients|mesh-ancestor
92803785|NCT00679666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803786|NCT00679666|Vitamin B Complex|vitamin b complex|mesh-ancestor
92803787|NCT00679666|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92803788|NCT00679666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803789|NCT00679744|Pyrimethamine|pyrimethamine|mesh-list
92803790|NCT00679744|Antimalarials|antimalarials|mesh-ancestor
92803791|NCT00679744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92803792|NCT00679744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92803793|NCT00679744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803794|NCT00679744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92803795|NCT00679744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803796|NCT00679744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803797|NCT00681772|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92803798|NCT00681772|Vasodilator Agents|vasodilator agents|mesh-ancestor
92803799|NCT00681772|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92803800|NCT00681772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92803801|NCT00681772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803802|NCT00681772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803803|NCT00681772|Urological Agents|urological agents|mesh-ancestor
92803804|NCT00946920|Goserelin|goserelin|mesh-list
92803805|NCT00946920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803806|NCT00946920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803807|NCT00679900|SR 46349B|sr 46349b|mesh-list
92803808|NCT00679900|Lormetazepam|lormetazepam|mesh-list
92803809|NCT00679900|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92803810|NCT00679900|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92803811|NCT00679900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803812|NCT00679900|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92803813|NCT00679900|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92803814|NCT00679900|Serotonin Agents|serotonin agents|mesh-ancestor
92803815|NCT00679900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803816|NCT00679900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803817|NCT00679900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92803818|NCT00679900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803819|NCT00945906|Fibrinolysin|fibrinolysin|mesh-list
92803820|NCT00945906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92803821|NCT00945906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92803822|NCT00945906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803823|NCT00681928|Letrozole|letrozole|mesh-list
92803824|NCT00681928|Anastrozole|anastrozole|mesh-list
92803825|NCT00681928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803826|NCT00681928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92803827|NCT00681928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92803828|NCT00681928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803829|NCT00681928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803830|NCT00681928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92803831|NCT00681928|Hormone Antagonists|hormone antagonists|mesh-ancestor
92803832|NCT00681928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803833|NCT00681928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803834|NCT00681928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92803835|NCT00594646|Tenofovir|tenofovir|mesh-list
92803836|NCT00594646|Emtricitabine|emtricitabine|mesh-list
92803837|NCT00594646|Raltegravir Potassium|raltegravir potassium|mesh-list
92803838|NCT00594646|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92803839|NCT00594646|Antiviral Agents|antiviral agents|mesh-ancestor
92803840|NCT00594646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803841|NCT00594646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92803842|NCT00594646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92803843|NCT00594646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803844|NCT00594646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803845|NCT00594646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92803846|NCT00594646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92803847|NCT00594646|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92803848|NCT00594646|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92803850|NCT00680134|Antifungal Agents|antifungal agents|mesh-ancestor
92803851|NCT00680134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803852|NCT00680212|Beta Carotene|beta carotene|mesh-list
92803853|NCT00680212|Carotenoids|carotenoids|mesh-list
92803854|NCT00680212|Antioxidants|antioxidants|mesh-ancestor
92803855|NCT00680212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803856|NCT00680212|Protective Agents|protective agents|mesh-ancestor
92803857|NCT00680212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803858|NCT00680212|Provitamins|provitamins|mesh-ancestor
92803859|NCT00680212|Vitamins|vitamins|mesh-ancestor
92803860|NCT00680212|Micronutrients|micronutrients|mesh-ancestor
92803861|NCT00682006|Chlorhexidine|chlorhexidine|mesh-list
92803862|NCT00682006|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92803863|NCT00682006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92803864|NCT00682006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803865|NCT00682006|Disinfectants|disinfectants|mesh-ancestor
92803866|NCT00682006|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803867|NCT02855346|Dapivirine|dapivirine|mesh-list
92803868|NCT02855346|Levonorgestrel|levonorgestrel|mesh-list
92803869|NCT02855346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92803870|NCT02855346|Contraceptive Agents|contraceptive agents|mesh-ancestor
92803871|NCT02855346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92803872|NCT02855346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803873|NCT02855346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92803874|NCT02855346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92803875|NCT02855346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92803876|NCT02855346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92803877|NCT02855346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92803878|NCT02855346|Antiviral Agents|antiviral agents|mesh-ancestor
92803879|NCT02855346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803880|NCT01111604|Ramucirumab|ramucirumab|mesh-list
92803881|NCT01111604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803882|NCT00950742|Trastuzumab|trastuzumab|mesh-list
92803883|NCT00950742|Afatinib|afatinib|mesh-list
92803884|NCT00950742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92803885|NCT00950742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803886|NCT00950742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92803887|NCT00950742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803888|NCT00950742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803889|NCT05061368|Sildenafil Citrate|sildenafil citrate|mesh-list
92803890|NCT05061368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803891|NCT05061368|Vasodilator Agents|vasodilator agents|mesh-ancestor
92803892|NCT05061368|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92803893|NCT05061368|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92803894|NCT05061368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803895|NCT05061368|Urological Agents|urological agents|mesh-ancestor
92803896|NCT04310228|Favipiravir|favipiravir|mesh-list
92803897|NCT04310228|Antiviral Agents|antiviral agents|mesh-ancestor
92803898|NCT04310228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92803899|NCT00955110|Oxymorphone|oxymorphone|mesh-list
92803900|NCT00955110|Oxycodone|oxycodone|mesh-list
92803901|NCT00955110|Hydromorphone|hydromorphone|mesh-list
92803902|NCT00955110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92803903|NCT00955110|Narcotics|narcotics|mesh-ancestor
92803904|NCT00955110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803905|NCT00955110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803906|NCT00955110|Analgesics|analgesics|mesh-ancestor
92803907|NCT00955110|Sensory System Agents|sensory system agents|mesh-ancestor
92803908|NCT00955110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803909|NCT00955110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92803910|NCT05056142|Anesthetics|anesthetics|mesh-list
92803911|NCT05056142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92803912|NCT05056142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803913|NCT00950664|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92803914|NCT00950664|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92803915|NCT00950664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92803916|NCT00950664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803917|NCT00950664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803918|NCT00950664|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92803919|NCT00950664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92803920|NCT00950664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803921|NCT00950664|Cholinergic Agents|cholinergic agents|mesh-ancestor
92803922|NCT00950664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803923|NCT01111526|Panobinostat|panobinostat|mesh-list
92803924|NCT01111526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803925|NCT01111526|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92803926|NCT01111526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803927|NCT01111526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803928|NCT02881346|Betamethasone|betamethasone|mesh-list
92803929|NCT02881346|Betamethasone Valerate|betamethasone valerate|mesh-list
92803930|NCT02881346|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92803931|NCT02881346|Betamethasone benzoate|betamethasone benzoate|mesh-list
92803932|NCT02881346|Calcipotriene|calcipotriene|mesh-list
92803933|NCT02881346|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92803934|NCT02881346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803935|NCT02881346|Glucocorticoids|glucocorticoids|mesh-ancestor
92803936|NCT02881346|Hormones|hormones|mesh-ancestor
92803937|NCT02881346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92803938|NCT02881346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803939|NCT02881346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92803940|NCT02881346|Respiratory System Agents|respiratory system agents|mesh-ancestor
92803941|NCT02881346|Dermatologic Agents|dermatologic agents|mesh-ancestor
92803942|NCT00630708|Losartan|losartan|mesh-list
92803944|NCT00630708|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92803945|NCT00630708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803946|NCT00630708|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92803947|NCT00630708|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92803948|NCT00630708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803949|NCT00630708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92803950|NCT00630708|Protease Inhibitors|protease inhibitors|mesh-ancestor
92803951|NCT00630708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803952|NCT01111292|Inositol|inositol|mesh-list
92803953|NCT01111292|Vitamin B Complex|vitamin b complex|mesh-ancestor
92803954|NCT01111292|Vitamins|vitamins|mesh-ancestor
92803955|NCT01111292|Micronutrients|micronutrients|mesh-ancestor
92803956|NCT01111292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803957|NCT02853630|Metformin|metformin|mesh-list
92803958|NCT02853630|Vildagliptin|vildagliptin|mesh-list
92803959|NCT02853630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92803960|NCT02853630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803961|NCT02853630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92803962|NCT02853630|Protease Inhibitors|protease inhibitors|mesh-ancestor
92803963|NCT02853630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803964|NCT02853630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803965|NCT04309838|Treprostinil|treprostinil|mesh-list
92803966|NCT04309838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92803967|NCT05367206|Paclitaxel|paclitaxel|mesh-list
92803968|NCT05367206|Carboplatin|carboplatin|mesh-list
92803969|NCT05367206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92803970|NCT05367206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92803971|NCT05367206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92803972|NCT05367206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92803973|NCT05367206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92803974|NCT05367206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92803975|NCT05367206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803976|NCT00637286|Zolmitriptan|zolmitriptan|mesh-list
92803977|NCT00637286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92803978|NCT00637286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92803979|NCT00637286|Serotonin Agents|serotonin agents|mesh-ancestor
92803980|NCT00637286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92803981|NCT00637286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803982|NCT00637286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803983|NCT00944658|Apremilast|apremilast|mesh-list
92803984|NCT00944658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92803985|NCT00944658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92803986|NCT00944658|Analgesics|analgesics|mesh-ancestor
92803987|NCT00944658|Sensory System Agents|sensory system agents|mesh-ancestor
92803988|NCT00944658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92803989|NCT00944658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92803990|NCT00944658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92803991|NCT00944658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92803992|NCT00944658|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92803993|NCT00944658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92803994|NCT00944658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92803995|NCT00944658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92803996|NCT01110200|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92803997|NCT01110200|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92803998|NCT01110200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92803999|NCT01110200|Autonomic Agents|autonomic agents|mesh-ancestor
92804000|NCT01110200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804001|NCT01110200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804002|NCT01110200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92804003|NCT01110200|Respiratory System Agents|respiratory system agents|mesh-ancestor
92804004|NCT01110200|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92804005|NCT01110200|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92804006|NCT01110200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92804007|NCT01110200|Adrenergic Agents|adrenergic agents|mesh-ancestor
92804008|NCT01110200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804009|NCT01110200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804010|NCT01110200|Glucocorticoids|glucocorticoids|mesh-ancestor
92804011|NCT01110200|Hormones|hormones|mesh-ancestor
92804012|NCT01110200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804013|NCT01110200|Sympathomimetics|sympathomimetics|mesh-ancestor
92804014|NCT05182112|Gemcitabine|gemcitabine|mesh-list
92804015|NCT05182112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804016|NCT05182112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92804017|NCT05182112|Antimetabolites|antimetabolites|mesh-ancestor
92804018|NCT05182112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804019|NCT01136954|Zonisamide|zonisamide|mesh-list
92804020|NCT01136954|Anticonvulsants|anticonvulsants|mesh-ancestor
92804021|NCT01136954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92804022|NCT01136954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804023|NCT01136954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804024|NCT01136954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92804025|NCT01136954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804026|NCT01108094|Itraconazole|itraconazole|mesh-list
92804027|NCT01108094|Antifungal Agents|antifungal agents|mesh-ancestor
92804028|NCT01108094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804029|NCT01108094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92804030|NCT01108094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92804031|NCT01108094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804032|NCT01108094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804033|NCT01108094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92804034|NCT01108094|Hormone Antagonists|hormone antagonists|mesh-ancestor
92804035|NCT01108094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804036|NCT01108094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804037|NCT01108094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92804038|NCT00954174|Paclitaxel|paclitaxel|mesh-list
92804039|NCT00954174|Carboplatin|carboplatin|mesh-list
92804040|NCT00954174|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92804041|NCT00954174|Ifosfamide|ifosfamide|mesh-list
92804042|NCT00954174|Isophosphamide mustard|isophosphamide mustard|mesh-list
92804043|NCT00954174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92804044|NCT00954174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804045|NCT00954174|Tubulin Modulators|tubulin modulators|mesh-ancestor
92804046|NCT00954174|Antimitotic Agents|antimitotic agents|mesh-ancestor
92804047|NCT00954174|Mitosis Modulators|mitosis modulators|mesh-ancestor
92804048|NCT00954174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804049|NCT00954174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92804050|NCT00954174|Alkylating Agents|alkylating agents|mesh-ancestor
92804051|NCT04309058|Vitamin D|vitamin d|mesh-list
92804052|NCT04309058|Vitamins|vitamins|mesh-ancestor
92804053|NCT04309058|Micronutrients|micronutrients|mesh-ancestor
92804054|NCT04309058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804055|NCT04309058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92804056|NCT01136408|Warfarin|warfarin|mesh-list
92804057|NCT01136408|Dabigatran|dabigatran|mesh-list
92804058|NCT01136408|Anticoagulants|anticoagulants|mesh-ancestor
92804059|NCT01136408|Antithrombins|antithrombins|mesh-ancestor
92804060|NCT01136408|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92804061|NCT01136408|Protease Inhibitors|protease inhibitors|mesh-ancestor
92804062|NCT01136408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804063|NCT01136408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804064|NCT01136174|Nintedanib|nintedanib|mesh-list
92804065|NCT01136174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804066|NCT01136174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804067|NCT01136174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804068|NCT01136174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804069|NCT01135394|Pioglitazone|pioglitazone|mesh-list
92804070|NCT01135394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804071|NCT01135394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804072|NCT00949884|Losartan|losartan|mesh-list
92804073|NCT00949884|Olmesartan|olmesartan|mesh-list
92804074|NCT00949884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92804075|NCT00949884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92804076|NCT00949884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92804077|NCT00949884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92804078|NCT00949884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92804079|NCT00949884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804080|NCT00949650|Pemetrexed|pemetrexed|mesh-list
92804081|NCT00949650|Afatinib|afatinib|mesh-list
92804082|NCT00949650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804083|NCT00949650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804084|NCT00949650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804085|NCT00949650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92804086|NCT00949650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92804087|NCT00949650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804088|NCT03082755|Gabapentin|gabapentin|mesh-list
92804089|NCT03082755|Analgesics|analgesics|mesh-ancestor
92804090|NCT03082755|Sensory System Agents|sensory system agents|mesh-ancestor
92804091|NCT03082755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804092|NCT03082755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804093|NCT03082755|Anticonvulsants|anticonvulsants|mesh-ancestor
92804094|NCT03082755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92804095|NCT03082755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92804096|NCT03082755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804097|NCT03082755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804098|NCT03082755|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92804099|NCT03082755|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92804100|NCT03082755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804101|NCT03082755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804102|NCT03082755|Antimanic Agents|antimanic agents|mesh-ancestor
92804103|NCT05332353|BCG Vaccine|bcg vaccine|mesh-list
92804104|NCT05332353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92804105|NCT05332353|Immunologic Factors|immunologic factors|mesh-ancestor
92804106|NCT05332353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804107|NCT00904215|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92804108|NCT00904215|Telmisartan|telmisartan|mesh-list
92804109|NCT00904215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92804110|NCT00904215|Diuretics|diuretics|mesh-ancestor
92804111|NCT00904215|Natriuretic Agents|natriuretic agents|mesh-ancestor
92804112|NCT00904215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804113|NCT00904215|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92804114|NCT00904215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804115|NCT00904215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804116|NCT00904215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92804117|NCT00904215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92804118|NCT05317689|Psilocybin|psilocybin|mesh-list
92804119|NCT05317689|Psilocin|psilocin|mesh-list
92804120|NCT05317689|Hallucinogens|hallucinogens|mesh-ancestor
92804121|NCT05317689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804122|NCT05317689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804123|NCT05293665|Vaccines|vaccines|mesh-list
92804124|NCT05293665|Immunologic Factors|immunologic factors|mesh-ancestor
92804125|NCT05293665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804126|NCT00905307|Aripiprazole|aripiprazole|mesh-list
92804127|NCT00905307|Antidepressive Agents|antidepressive agents|mesh-ancestor
92804128|NCT00905307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804129|NCT00905307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92804130|NCT00905307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92804131|NCT00905307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804132|NCT00905307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804133|NCT00905307|Dopamine Agonists|dopamine agonists|mesh-ancestor
92804134|NCT00905307|Dopamine Agents|dopamine agents|mesh-ancestor
92804135|NCT00905307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804136|NCT00905307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804137|NCT00905307|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92804138|NCT00905307|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92804139|NCT00905307|Serotonin Agents|serotonin agents|mesh-ancestor
92804140|NCT00905307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92804141|NCT00905307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92804142|NCT00905307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92804143|NCT00905307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92804144|NCT00904839|Bevacizumab|bevacizumab|mesh-list
92804145|NCT00904839|Nintedanib|nintedanib|mesh-list
92804146|NCT00904839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804147|NCT00904839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804148|NCT00904839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92804149|NCT00904839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92804150|NCT00904839|Growth Substances|growth substances|mesh-ancestor
92804151|NCT00904839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804152|NCT00904839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92804153|NCT00904839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804154|NCT00904839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804155|NCT00904839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804156|NCT04985955|Tofacitinib|tofacitinib|mesh-list
92804157|NCT04985955|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92804158|NCT04985955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804159|NCT04985955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804160|NCT04985955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804162|NCT02821923|Vasodilator Agents|vasodilator agents|mesh-ancestor
92804163|NCT00903357|Ascorbic Acid|ascorbic acid|mesh-list
92804164|NCT00903357|Montelukast|montelukast|mesh-list
92804165|NCT00903357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92804166|NCT00903357|Respiratory System Agents|respiratory system agents|mesh-ancestor
92804167|NCT00903357|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92804168|NCT00903357|Hormone Antagonists|hormone antagonists|mesh-ancestor
92804169|NCT00903357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804170|NCT00903357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804171|NCT00903357|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92804172|NCT00903357|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92804173|NCT00903357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804174|NCT00903357|Antioxidants|antioxidants|mesh-ancestor
92804175|NCT00903357|Protective Agents|protective agents|mesh-ancestor
92804176|NCT00903357|Vitamins|vitamins|mesh-ancestor
92804177|NCT00903357|Micronutrients|micronutrients|mesh-ancestor
92804178|NCT02754063|3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol|mesh-list
92804179|NCT02754063|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92804180|NCT02754063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92804181|NCT02754063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804182|NCT02754063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804183|NCT02754063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804184|NCT02754063|Dopamine Agonists|dopamine agonists|mesh-ancestor
92804185|NCT02754063|Dopamine Agents|dopamine agents|mesh-ancestor
92804186|NCT02754063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804187|NCT02754063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804188|NCT04202289|Sulfadiazine|sulfadiazine|mesh-list
92804189|NCT04202289|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92804190|NCT04202289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92804191|NCT04202289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804192|NCT04202289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92804193|NCT04202289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92804194|NCT04202289|Coccidiostats|coccidiostats|mesh-ancestor
92804195|NCT04202289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92804196|NCT02122185|Metformin|metformin|mesh-list
92417496|NCT01490749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92804197|NCT02122185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804198|NCT02122185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804199|NCT02087865|Donepezil|donepezil|mesh-list
92804200|NCT02087865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92804201|NCT02087865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804202|NCT02087865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804203|NCT02087865|Cholinergic Agents|cholinergic agents|mesh-ancestor
92804204|NCT02087865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804205|NCT02087865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804206|NCT02087865|Nootropic Agents|nootropic agents|mesh-ancestor
92804207|NCT01730313|Pyridoxine|pyridoxine|mesh-list
92804208|NCT01730313|Vitamin B 6|vitamin b 6|mesh-list
92804209|NCT01730313|Phenytoin|phenytoin|mesh-list
92804210|NCT01730313|Valproic Acid|valproic acid|mesh-list
92804211|NCT01730313|Vitamins|vitamins|mesh-ancestor
92804212|NCT01730313|Micronutrients|micronutrients|mesh-ancestor
92804213|NCT01730313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804214|NCT01730313|Vitamin B Complex|vitamin b complex|mesh-ancestor
92804215|NCT01730313|Anticonvulsants|anticonvulsants|mesh-ancestor
92804216|NCT01730313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804217|NCT01730313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804218|NCT01730313|GABA Agents|gaba agents|mesh-ancestor
92804219|NCT01730313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804220|NCT01730313|Antimanic Agents|antimanic agents|mesh-ancestor
92804221|NCT01730313|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92804222|NCT01730313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804223|NCT01730313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804224|NCT01730313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92804225|NCT01730313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92804226|NCT01730313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804227|NCT01730313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92804228|NCT01730313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92804229|NCT02849379|Immunomodulating Agents|immunomodulating agents|mesh-list
92804230|NCT02849379|Immunologic Factors|immunologic factors|mesh-ancestor
92804231|NCT02849379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804232|NCT01104662|Vancomycin|vancomycin|mesh-list
92804233|NCT01104662|Daptomycin|daptomycin|mesh-list
92804234|NCT01104662|Penicillins|penicillins|mesh-list
92804235|NCT01104662|Cloxacillin|cloxacillin|mesh-list
92804236|NCT01104662|Oxacillin|oxacillin|mesh-list
92804237|NCT01104662|Nafcillin|nafcillin|mesh-list
92804238|NCT01104662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92449203|NCT01692808|Vitamins|vitamins|mesh-list
92804239|NCT01104662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804240|NCT05062785|Insulin|insulin|mesh-list
92804241|NCT05062785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804242|NCT05062785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804243|NCT01103960|Amlodipine|amlodipine|mesh-list
92804244|NCT01103960|Telmisartan|telmisartan|mesh-list
92804245|NCT01103960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92804246|NCT01103960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92804247|NCT01103960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804248|NCT01103960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804249|NCT01103960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92804250|NCT01103960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804251|NCT01103960|Vasodilator Agents|vasodilator agents|mesh-ancestor
92804252|NCT01103960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92804253|NCT01103960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92804254|NCT04413279|Dexamethasone|dexamethasone|mesh-list
92804255|NCT04413279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92804256|NCT04413279|Antiemetics|antiemetics|mesh-ancestor
92804257|NCT04413279|Autonomic Agents|autonomic agents|mesh-ancestor
92804258|NCT04413279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804259|NCT04413279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804260|NCT04413279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92804261|NCT04413279|Glucocorticoids|glucocorticoids|mesh-ancestor
92804262|NCT04413279|Hormones|hormones|mesh-ancestor
92417574|NCT01491048|Nootropic Agents|nootropic agents|mesh-ancestor
92804263|NCT04413279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804264|NCT04413279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92804265|NCT04413279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804266|NCT04975256|Adagrasib|adagrasib|mesh-list
92804267|NCT04975256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804268|NCT02880800|Morphine|morphine|mesh-list
92804269|NCT02880800|Hydromorphone|hydromorphone|mesh-list
92804270|NCT02880800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92804271|NCT02880800|Narcotics|narcotics|mesh-ancestor
92804272|NCT02880800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804273|NCT02880800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804274|NCT02880800|Analgesics|analgesics|mesh-ancestor
92804275|NCT02880800|Sensory System Agents|sensory system agents|mesh-ancestor
92804276|NCT02880800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804277|NCT01107392|Botulinum Toxins|botulinum toxins|mesh-list
92804278|NCT01107392|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92804279|NCT01107392|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92804280|NCT01107392|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92804281|NCT01107392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804282|NCT01107392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804283|NCT01107392|Cholinergic Agents|cholinergic agents|mesh-ancestor
92804284|NCT01107392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804285|NCT01107392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804286|NCT01107392|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92804287|NCT01107392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804288|NCT05037279|BCG Vaccine|bcg vaccine|mesh-list
92804289|NCT05037279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92804290|NCT05037279|Immunologic Factors|immunologic factors|mesh-ancestor
92804291|NCT05037279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804292|NCT01106846|Ketamine|ketamine|mesh-list
92804293|NCT01106846|Analgesics|analgesics|mesh-ancestor
92804294|NCT01106846|Sensory System Agents|sensory system agents|mesh-ancestor
92804295|NCT01106846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804296|NCT01106846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750624|NCT00927589|Docetaxel|docetaxel|mesh-list
92804297|NCT01106846|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92804298|NCT01106846|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92804299|NCT01106846|Anesthetics, General|anesthetics, general|mesh-ancestor
92804300|NCT01106846|Anesthetics|anesthetics|mesh-ancestor
92804301|NCT01106846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804302|NCT01106846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92804303|NCT01106846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92804304|NCT01106846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804305|NCT01106846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804306|NCT05034783|Exenatide|exenatide|mesh-list
92804307|NCT05034783|Edetic Acid|edetic acid|mesh-list
92804308|NCT05034783|Chelating Agents|chelating agents|mesh-ancestor
92804309|NCT05034783|Sequestering Agents|sequestering agents|mesh-ancestor
92804310|NCT05034783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804311|NCT05034783|Anticoagulants|anticoagulants|mesh-ancestor
92804312|NCT05034783|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92449279|NCT01693328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92804313|NCT05034783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804314|NCT05034783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804315|NCT05034783|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92804316|NCT05034783|Incretins|incretins|mesh-ancestor
92804317|NCT05034783|Hormones|hormones|mesh-ancestor
92804318|NCT05034783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804319|NCT00902577|Misonidazole|misonidazole|mesh-list
92804320|NCT00902577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804321|NCT00902577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92804322|NCT00902577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92804323|NCT00902577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804324|NCT04202367|Bupivacaine|bupivacaine|mesh-list
92804325|NCT04202367|Anesthetics, Local|anesthetics, local|mesh-ancestor
92804326|NCT04202367|Anesthetics|anesthetics|mesh-ancestor
92804327|NCT04202367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804328|NCT04202367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804329|NCT04202367|Sensory System Agents|sensory system agents|mesh-ancestor
92804330|NCT04202367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804331|NCT02846493|Dexamethasone|dexamethasone|mesh-list
92804332|NCT02846493|Bromocriptine|bromocriptine|mesh-list
92804333|NCT02846493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92804334|NCT02846493|Antiemetics|antiemetics|mesh-ancestor
92804335|NCT02846493|Autonomic Agents|autonomic agents|mesh-ancestor
92804336|NCT02846493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804337|NCT02846493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804338|NCT02846493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92804339|NCT02846493|Glucocorticoids|glucocorticoids|mesh-ancestor
92804340|NCT02846493|Hormones|hormones|mesh-ancestor
92804341|NCT02846493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804342|NCT02846493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92804343|NCT02846493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804344|NCT02846493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92804345|NCT02846493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92804346|NCT02846493|Hormone Antagonists|hormone antagonists|mesh-ancestor
92804347|NCT02846493|Dopamine Agonists|dopamine agonists|mesh-ancestor
92804348|NCT02846493|Dopamine Agents|dopamine agents|mesh-ancestor
92804349|NCT02846493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804350|NCT02846493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804351|NCT01106690|Metformin|metformin|mesh-list
92804352|NCT01106690|Pioglitazone|pioglitazone|mesh-list
92804353|NCT01106690|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92804354|NCT01106690|Canagliflozin|canagliflozin|mesh-list
92804355|NCT01106690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804356|NCT01106690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804357|NCT01106690|Incretins|incretins|mesh-ancestor
92804358|NCT01106690|Hormones|hormones|mesh-ancestor
92804359|NCT01106690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804360|NCT01106690|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92804361|NCT01106690|Protease Inhibitors|protease inhibitors|mesh-ancestor
92804362|NCT01106690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804363|NCT01106690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804364|NCT01106690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92804365|NCT04286529|Calcitriol|calcitriol|mesh-list
92804366|NCT04286529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92804367|NCT04286529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804368|NCT04286529|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92804369|NCT04286529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804370|NCT04286529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804371|NCT04286529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92804372|NCT04286529|Vitamins|vitamins|mesh-ancestor
92804373|NCT04286529|Micronutrients|micronutrients|mesh-ancestor
92804374|NCT04286529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92804375|NCT01103180|Escitalopram|escitalopram|mesh-list
92804376|NCT01103180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92804377|NCT01103180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92804378|NCT01103180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804379|NCT01103180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804380|NCT01103180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804381|NCT01103180|Serotonin Agents|serotonin agents|mesh-ancestor
92804382|NCT01103180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804383|NCT00625898|Cyclophosphamide|cyclophosphamide|mesh-list
92804384|NCT00625898|Bevacizumab|bevacizumab|mesh-list
92804385|NCT00625898|Carboplatin|carboplatin|mesh-list
92804386|NCT00625898|Docetaxel|docetaxel|mesh-list
92804387|NCT00625898|Fluorouracil|fluorouracil|mesh-list
92804388|NCT00625898|Trastuzumab|trastuzumab|mesh-list
92804389|NCT00625898|Epirubicin|epirubicin|mesh-list
92804390|NCT00625898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92804391|NCT00625898|Immunologic Factors|immunologic factors|mesh-ancestor
92804392|NCT00625898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804393|NCT00625898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92804394|NCT00625898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92804395|NCT00625898|Alkylating Agents|alkylating agents|mesh-ancestor
92804396|NCT00625898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804397|NCT00625898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804398|NCT00625898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92804399|NCT00625898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804400|NCT00625898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92804401|NCT00625898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92804402|NCT00625898|Growth Substances|growth substances|mesh-ancestor
92804403|NCT00625898|Growth Inhibitors|growth inhibitors|mesh-ancestor
92804404|NCT00625898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92804405|NCT00625898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92804406|NCT00625898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92804407|NCT00625898|Antimetabolites|antimetabolites|mesh-ancestor
92804408|NCT00625898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92804409|NCT00625898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92804410|NCT00625898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92804411|NCT00625898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92804412|NCT00625898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804413|NCT02853552|Misoprostol|misoprostol|mesh-list
92804414|NCT02853552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92804415|NCT02853552|Abortifacient Agents|abortifacient agents|mesh-ancestor
92804416|NCT02853552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92804417|NCT02853552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804418|NCT02853552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92804419|NCT02853552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92804420|NCT02853552|Oxytocics|oxytocics|mesh-ancestor
92804421|NCT04268472|Darunavir|darunavir|mesh-list
92804422|NCT04268472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92804423|NCT04268472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92804424|NCT04268472|Protease Inhibitors|protease inhibitors|mesh-ancestor
92804425|NCT04268472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804426|NCT04268472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804427|NCT04268472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92804428|NCT04268472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92804429|NCT04268472|Antiviral Agents|antiviral agents|mesh-ancestor
92804430|NCT04268472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804431|NCT02844621|Omeprazole|omeprazole|mesh-list
92804432|NCT02844621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92804433|NCT02844621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92804434|NCT02844621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92804435|NCT02844621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804436|NCT02844621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804437|NCT01106534|Aspirin|aspirin|mesh-list
92804438|NCT01106534|Everolimus|everolimus|mesh-list
92804439|NCT01106534|Clopidogrel|clopidogrel|mesh-list
92804440|NCT01106534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92804441|NCT01106534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92804442|NCT01106534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92804443|NCT01106534|Analgesics|analgesics|mesh-ancestor
92804444|NCT01106534|Sensory System Agents|sensory system agents|mesh-ancestor
92804445|NCT01106534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804446|NCT01106534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804447|NCT01106534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92804448|NCT01106534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92804449|NCT01106534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92804450|NCT01106534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92804451|NCT01106534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804452|NCT01106534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92804453|NCT01106534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92804454|NCT01106534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804455|NCT01106534|Antipyretics|antipyretics|mesh-ancestor
92804456|NCT01106534|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92804457|NCT01106534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804458|NCT01106534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92804459|NCT01106534|Immunologic Factors|immunologic factors|mesh-ancestor
92804460|NCT01106534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804461|NCT01106534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92804462|NCT01106534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92449427|NCT05288374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92804463|NCT01106534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92804464|NCT01106534|Purinergic Agents|purinergic agents|mesh-ancestor
92804465|NCT01106534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804466|NCT00941304|Oxycodone|oxycodone|mesh-list
92804467|NCT00941304|Buprenorphine|buprenorphine|mesh-list
92804468|NCT00941304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92804469|NCT00941304|Narcotics|narcotics|mesh-ancestor
92804470|NCT00941304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804471|NCT00941304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804472|NCT00941304|Analgesics|analgesics|mesh-ancestor
92804473|NCT00941304|Sensory System Agents|sensory system agents|mesh-ancestor
92804474|NCT00941304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804475|NCT00941304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92804476|NCT02846025|Folic Acid|folic acid|mesh-list
92804477|NCT02846025|Vitamin B Complex|vitamin b complex|mesh-list
92804478|NCT02846025|Antioxidants|antioxidants|mesh-list
92804479|NCT02846025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804480|NCT02846025|Protective Agents|protective agents|mesh-ancestor
92804481|NCT02846025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804482|NCT02846025|Hematinics|hematinics|mesh-ancestor
92804483|NCT02846025|Vitamins|vitamins|mesh-ancestor
92804484|NCT02846025|Micronutrients|micronutrients|mesh-ancestor
92804485|NCT02880410|Temozolomide|temozolomide|mesh-list
92804486|NCT02880410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92804487|NCT02880410|Alkylating Agents|alkylating agents|mesh-ancestor
92804488|NCT02880410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804489|NCT02880410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804490|NCT02879006|Omalizumab|omalizumab|mesh-list
92804491|NCT02879006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92804492|NCT02879006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92804493|NCT02879006|Respiratory System Agents|respiratory system agents|mesh-ancestor
92804494|NCT00941070|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92804495|NCT00941070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92804496|NCT00941070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804497|NCT02857218|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92804498|NCT02857218|Hematinics|hematinics|mesh-ancestor
92804499|NCT02857218|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92804500|NCT02857218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92804501|NCT00602316|Chelating Agents|chelating agents|mesh-list
92804502|NCT00602316|Sequestering Agents|sequestering agents|mesh-ancestor
92804503|NCT00602316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804504|NCT00602394|Lithium Carbonate|lithium carbonate|mesh-list
92804505|NCT00602394|Antidepressive Agents|antidepressive agents|mesh-ancestor
92804506|NCT00602394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804507|NCT00602394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804508|NCT00602394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804509|NCT00602394|Antimanic Agents|antimanic agents|mesh-ancestor
92804510|NCT00602394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92804511|NCT00602394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804512|NCT00602394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804513|NCT04956302|Dexamethasone|dexamethasone|mesh-list
92804514|NCT04956302|Dexamethasone acetate|dexamethasone acetate|mesh-list
92804515|NCT04956302|Bortezomib|bortezomib|mesh-list
92804516|NCT04956302|Daratumumab|daratumumab|mesh-list
92804517|NCT04956302|Panobinostat|panobinostat|mesh-list
92804518|NCT04956302|Ichthammol|ichthammol|mesh-list
92804519|NCT04956302|BB 1101|bb 1101|mesh-list
92804520|NCT04956302|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92804521|NCT04956302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92804523|NCT04956302|Autonomic Agents|autonomic agents|mesh-ancestor
92804524|NCT04956302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804525|NCT04956302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804526|NCT04956302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92804527|NCT04956302|Glucocorticoids|glucocorticoids|mesh-ancestor
92804528|NCT04956302|Hormones|hormones|mesh-ancestor
92804529|NCT04956302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804530|NCT04956302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92804531|NCT04956302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804532|NCT04956302|Protease Inhibitors|protease inhibitors|mesh-ancestor
92804533|NCT04956302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804534|NCT04956302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804535|NCT04956302|Immunologic Factors|immunologic factors|mesh-ancestor
92804536|NCT04956302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92804537|NCT04956302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92804538|NCT02848443|Trifluridine|trifluridine|mesh-list
92449506|NCT05290948|Bevacizumab|bevacizumab|mesh-list
92804539|NCT02848443|Bevacizumab|bevacizumab|mesh-list
92804540|NCT02848443|Nivolumab|nivolumab|mesh-list
92804541|NCT02848443|Oxaliplatin|oxaliplatin|mesh-list
92804542|NCT02848443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804543|NCT02848443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804544|NCT02848443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92804545|NCT02848443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92804546|NCT02848443|Growth Substances|growth substances|mesh-ancestor
92804547|NCT02848443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804548|NCT02848443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92804549|NCT02848443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92804550|NCT02848443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804551|NCT02848443|Antimetabolites|antimetabolites|mesh-ancestor
92804552|NCT02848443|Antiviral Agents|antiviral agents|mesh-ancestor
92804553|NCT02848443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804554|NCT00632697|Pentoxifylline|pentoxifylline|mesh-list
92804555|NCT00632697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92804556|NCT00632697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804557|NCT00632697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804558|NCT00632697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92804559|NCT00632697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92804560|NCT00632697|Protective Agents|protective agents|mesh-ancestor
92804561|NCT00632697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804562|NCT00632697|Vasodilator Agents|vasodilator agents|mesh-ancestor
92804563|NCT00632697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92804564|NCT00632697|Antioxidants|antioxidants|mesh-ancestor
92804566|NCT02848209|Croton Oil|croton oil|mesh-list
92804567|NCT02848209|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92804568|NCT02848209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804569|NCT02848209|Disinfectants|disinfectants|mesh-ancestor
92804570|NCT02848209|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92804571|NCT02848209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92804572|NCT02848209|Dermatologic Agents|dermatologic agents|mesh-ancestor
92804573|NCT05337969|Metformin|metformin|mesh-list
92804574|NCT05337969|Vildagliptin|vildagliptin|mesh-list
92804575|NCT05337969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804576|NCT05337969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804577|NCT05337969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92804578|NCT05337969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92804579|NCT05337969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804580|NCT05337969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804581|NCT02844153|Metformin|metformin|mesh-list
92804582|NCT02844153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804583|NCT02844153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804584|NCT02844387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92804585|NCT02844075|Pembrolizumab|pembrolizumab|mesh-list
92804586|NCT02844075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804587|NCT02844075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804588|NCT02844075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92804589|NCT02844075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804590|NCT02844309|Thalidomide|thalidomide|mesh-list
92804591|NCT02844309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92804592|NCT02844309|Immunologic Factors|immunologic factors|mesh-ancestor
92804593|NCT02844309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804594|NCT02844309|Leprostatic Agents|leprostatic agents|mesh-ancestor
92804595|NCT02844309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92804596|NCT02844309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804597|NCT02844309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92804598|NCT02844309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92804599|NCT02844309|Growth Substances|growth substances|mesh-ancestor
92804600|NCT02844309|Growth Inhibitors|growth inhibitors|mesh-ancestor
92804601|NCT02844309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804603|NCT02845713|Albendazole|albendazole|mesh-list
92804604|NCT02845713|Diethylcarbamazine|diethylcarbamazine|mesh-list
92804605|NCT02845713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92804606|NCT02845713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804607|NCT02845713|Anthelmintics|anthelmintics|mesh-ancestor
92804608|NCT02845713|Anticestodal Agents|anticestodal agents|mesh-ancestor
92804609|NCT02845713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92804610|NCT02845713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92804611|NCT02845713|Tubulin Modulators|tubulin modulators|mesh-ancestor
92804612|NCT02845713|Antimitotic Agents|antimitotic agents|mesh-ancestor
92804613|NCT02845713|Mitosis Modulators|mitosis modulators|mesh-ancestor
92804614|NCT02845713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449579|NCT05292742|Capecitabine|capecitabine|mesh-list
92804615|NCT02845713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804616|NCT02845713|Filaricides|filaricides|mesh-ancestor
92804617|NCT02845713|Antinematodal Agents|antinematodal agents|mesh-ancestor
92804618|NCT02845713|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92804619|NCT02845713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804620|NCT00902265|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92804621|NCT00902265|Hemostatics|hemostatics|mesh-ancestor
92804622|NCT00902265|Coagulants|coagulants|mesh-ancestor
92804623|NCT00902265|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92804624|NCT00902265|Natriuretic Agents|natriuretic agents|mesh-ancestor
92804625|NCT00902265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804626|NCT02848287|Ropivacaine|ropivacaine|mesh-list
92804627|NCT02848287|Anesthetics, Local|anesthetics, local|mesh-ancestor
92804628|NCT02848287|Anesthetics|anesthetics|mesh-ancestor
92804629|NCT02848287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804630|NCT02848287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804631|NCT02848287|Sensory System Agents|sensory system agents|mesh-ancestor
92804632|NCT02848287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804634|NCT05337657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804635|NCT05337657|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92804636|NCT05337657|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92804637|NCT05337657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804638|NCT05337657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804639|NCT05337657|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92804640|NCT05337657|Hormone Antagonists|hormone antagonists|mesh-ancestor
92804641|NCT05337657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804642|NCT05337657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804643|NCT02690883|Exenatide|exenatide|mesh-list
92804644|NCT02690883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804645|NCT02690883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804646|NCT02690883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92804647|NCT02690883|Incretins|incretins|mesh-ancestor
92804648|NCT02690883|Hormones|hormones|mesh-ancestor
92804649|NCT02690883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804650|NCT02844933|Cannabidiol|cannabidiol|mesh-list
92804651|NCT02844933|Anticonvulsants|anticonvulsants|mesh-ancestor
92804652|NCT05104047|Lobeline|lobeline|mesh-list
92804653|NCT05104047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92804654|NCT05104047|Autonomic Agents|autonomic agents|mesh-ancestor
92804655|NCT05104047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804656|NCT05104047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804657|NCT05104047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92804658|NCT05104047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92804659|NCT05104047|Cholinergic Agents|cholinergic agents|mesh-ancestor
92804660|NCT05104047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804661|NCT05104047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804662|NCT05104047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92804663|NCT04385589|Dapagliflozin|dapagliflozin|mesh-list
92804664|NCT04385589|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92804665|NCT04385589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804666|NCT04385589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804667|NCT04385589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804668|NCT02847429|Crenolanib|crenolanib|mesh-list
92804669|NCT02847429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804670|NCT04750005|Listerine|listerine|mesh-list
92804671|NCT04750005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92804672|NCT04750005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804673|NCT05336721|Capecitabine|capecitabine|mesh-list
92804674|NCT05336721|Chiauranib|chiauranib|mesh-list
92804675|NCT05336721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92804676|NCT05336721|Antimetabolites|antimetabolites|mesh-ancestor
92804677|NCT05336721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804678|NCT05336721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804679|NCT05336721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804680|NCT05336721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804681|NCT00653913|Ezetimibe|ezetimibe|mesh-list
92804682|NCT00653913|Pitavastatin|pitavastatin|mesh-list
92804683|NCT00653913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92804684|NCT00653913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92804685|NCT00653913|Antimetabolites|antimetabolites|mesh-ancestor
92804686|NCT00653913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804687|NCT00653913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92804688|NCT00653913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92804689|NCT00653913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804690|NCT00652431|Niacin|niacin|mesh-list
92449653|NCT05294822|Insulin|insulin|mesh-list
92804691|NCT00652431|Niacinamide|niacinamide|mesh-list
92804692|NCT00652431|Nicotinic Acids|nicotinic acids|mesh-list
92804693|NCT00652431|Simvastatin|simvastatin|mesh-list
92804694|NCT00652431|Ezetimibe|ezetimibe|mesh-list
92804695|NCT00652431|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92804696|NCT00652431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92804697|NCT00652431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92804698|NCT00652431|Antimetabolites|antimetabolites|mesh-ancestor
92804699|NCT00652431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804700|NCT00652431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92804701|NCT00652431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92804702|NCT00652431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804703|NCT00652431|Vasodilator Agents|vasodilator agents|mesh-ancestor
92418018|NCT01494311|Anesthetics|anesthetics|mesh-ancestor
92804704|NCT00652431|Vitamin B Complex|vitamin b complex|mesh-ancestor
92804705|NCT00652431|Vitamins|vitamins|mesh-ancestor
92804706|NCT00652431|Micronutrients|micronutrients|mesh-ancestor
92804707|NCT00652431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804708|NCT00380523|Etoricoxib|etoricoxib|mesh-list
92804709|NCT00380523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92804710|NCT00380523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92804711|NCT00380523|Analgesics|analgesics|mesh-ancestor
92804712|NCT00380523|Sensory System Agents|sensory system agents|mesh-ancestor
92804713|NCT00380523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804714|NCT00380523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804715|NCT00380523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92804716|NCT00380523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92804717|NCT00380523|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92804718|NCT00380523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92804719|NCT00380523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804720|NCT00380523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804721|NCT00319995|Loratadine|loratadine|mesh-list
92804722|NCT00319995|Montelukast|montelukast|mesh-list
92804723|NCT00319995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92804724|NCT00319995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92804725|NCT00319995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92804726|NCT00319995|Hormone Antagonists|hormone antagonists|mesh-ancestor
92804727|NCT00319995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804728|NCT00319995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804729|NCT00319995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92804730|NCT00319995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92804731|NCT00319995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804732|NCT00319995|Antipruritics|antipruritics|mesh-ancestor
92804733|NCT00319995|Dermatologic Agents|dermatologic agents|mesh-ancestor
92804734|NCT00319995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92804735|NCT00319995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92804736|NCT00319995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92804737|NCT00319995|Histamine Antagonists|histamine antagonists|mesh-ancestor
92804738|NCT00319995|Histamine Agents|histamine agents|mesh-ancestor
92804739|NCT00319995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804740|NCT03304821|Sargramostim|sargramostim|mesh-list
92804741|NCT03304821|Immunologic Factors|immunologic factors|mesh-ancestor
92804742|NCT03304821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804743|NCT02842281|Levan|levan|mesh-list
92804744|NCT02842281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804745|NCT03721341|Hormones|hormones|mesh-list
92804746|NCT03721341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804747|NCT03721341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804748|NCT02842437|Dexmedetomidine|dexmedetomidine|mesh-list
92804749|NCT02842437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92804750|NCT02842437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804751|NCT02842437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804752|NCT02842437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92804753|NCT02842437|Analgesics|analgesics|mesh-ancestor
92804754|NCT02842437|Sensory System Agents|sensory system agents|mesh-ancestor
92804755|NCT02842437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804756|NCT02842437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92804757|NCT02842437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92804758|NCT02842437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92804759|NCT02842437|Adrenergic Agents|adrenergic agents|mesh-ancestor
92804760|NCT02842437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804761|NCT02842437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804762|NCT00157911|Simvastatin|simvastatin|mesh-list
92804763|NCT00157911|Ezetimibe|ezetimibe|mesh-list
92804764|NCT00157911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92804765|NCT00157911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92804766|NCT00157911|Antimetabolites|antimetabolites|mesh-ancestor
92804767|NCT00157911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804768|NCT00157911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92804769|NCT00157911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92804770|NCT00157911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804771|NCT05336175|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92804772|NCT05336175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92804773|NCT05336175|Vasodilator Agents|vasodilator agents|mesh-ancestor
92804774|NCT02842125|Pembrolizumab|pembrolizumab|mesh-list
92804775|NCT02842125|Nivolumab|nivolumab|mesh-list
92804776|NCT02842125|Capecitabine|capecitabine|mesh-list
92804777|NCT02842125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804778|NCT02842125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804779|NCT02842125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92804780|NCT02842125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804781|NCT02842125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92804782|NCT02842125|Antimetabolites|antimetabolites|mesh-ancestor
92804783|NCT03708549|Metformin|metformin|mesh-list
92804784|NCT03708549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804785|NCT03708549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804786|NCT00156117|Olanzapine|olanzapine|mesh-list
92804787|NCT00156117|Asenapine|asenapine|mesh-list
92804788|NCT00156117|Antiemetics|antiemetics|mesh-ancestor
92804789|NCT00156117|Autonomic Agents|autonomic agents|mesh-ancestor
92804790|NCT00156117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804791|NCT00156117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804792|NCT00156117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92804793|NCT00156117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92804794|NCT00156117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92804795|NCT00156117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804796|NCT00156117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804797|NCT00156117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92804798|NCT00156117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92804799|NCT00156117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804800|NCT00156117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804801|NCT00156117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804802|NCT00156117|Serotonin Agents|serotonin agents|mesh-ancestor
92804803|NCT00140985|Losartan|losartan|mesh-list
92804804|NCT00140985|Amlodipine|amlodipine|mesh-list
92804805|NCT00140985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92804806|NCT00140985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92804807|NCT00140985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804808|NCT00140985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804809|NCT00140985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92804810|NCT00140985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804811|NCT00140985|Vasodilator Agents|vasodilator agents|mesh-ancestor
92804812|NCT00140985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92804813|NCT00140985|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92804814|NCT00140985|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92804815|NCT00140907|Losartan|losartan|mesh-list
92804816|NCT00140907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92804817|NCT00140907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92804818|NCT00140907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92804820|NCT00140907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804821|NCT00132717|Atorvastatin|atorvastatin|mesh-list
92804822|NCT00132717|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92804823|NCT00132717|Simvastatin|simvastatin|mesh-list
92804824|NCT00132717|Ezetimibe|ezetimibe|mesh-list
92804825|NCT00132717|Pravastatin|pravastatin|mesh-list
92804826|NCT00132717|Lovastatin|lovastatin|mesh-list
92804827|NCT00132717|L 647318|l 647318|mesh-list
92804828|NCT00132717|Dihydromevinolin|dihydromevinolin|mesh-list
92804829|NCT00132717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92804830|NCT00132717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92804831|NCT00132717|Antimetabolites|antimetabolites|mesh-ancestor
92804832|NCT00132717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804833|NCT00132717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92804834|NCT00132717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92804835|NCT00132717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804836|NCT00127179|Finasteride|finasteride|mesh-list
92804837|NCT00127179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804838|NCT00127179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804839|NCT00127179|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92804840|NCT00127179|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92804841|NCT00127179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804842|NCT00127179|Hormone Antagonists|hormone antagonists|mesh-ancestor
92804843|NCT00127179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92804844|NCT00127179|Urological Agents|urological agents|mesh-ancestor
92804846|NCT00953706|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92804847|NCT00953706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804848|NCT00953706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804849|NCT02852382|Morphine|morphine|mesh-list
92804850|NCT02852382|Bupivacaine|bupivacaine|mesh-list
92804851|NCT02852382|Anesthetics, Local|anesthetics, local|mesh-ancestor
92804852|NCT02852382|Anesthetics|anesthetics|mesh-ancestor
92804853|NCT02852382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804854|NCT02852382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804855|NCT02852382|Sensory System Agents|sensory system agents|mesh-ancestor
92804856|NCT02852382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804857|NCT02852382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92804858|NCT02852382|Narcotics|narcotics|mesh-ancestor
92804859|NCT02852382|Analgesics|analgesics|mesh-ancestor
92804860|NCT00630942|Minocycline|minocycline|mesh-list
92804861|NCT00630942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92804862|NCT00630942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804863|NCT00602550|Zidovudine|zidovudine|mesh-list
92804864|NCT00602550|Antimetabolites|antimetabolites|mesh-ancestor
92804865|NCT00602550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804866|NCT00602550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92804867|NCT00602550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92804868|NCT00602550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804869|NCT00602550|Antiviral Agents|antiviral agents|mesh-ancestor
92804870|NCT00602550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804871|NCT00602550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92804872|NCT00602550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92804873|NCT00602706|Melphalan|melphalan|mesh-list
92804874|NCT00602706|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92804875|NCT00602706|Sargramostim|sargramostim|mesh-list
92804876|NCT00602706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92804877|NCT00602706|Alkylating Agents|alkylating agents|mesh-ancestor
92804878|NCT00602706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804879|NCT00602706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804880|NCT00602706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92804881|NCT00602706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92804882|NCT00602706|Immunologic Factors|immunologic factors|mesh-ancestor
92804883|NCT00602706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804884|NCT00602706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92804885|NCT00602706|Analgesics|analgesics|mesh-ancestor
92804886|NCT00602706|Sensory System Agents|sensory system agents|mesh-ancestor
92804887|NCT00602706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804888|NCT00604344|Insulin|insulin|mesh-list
92804889|NCT00604344|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92804890|NCT00604344|Insulin Detemir|insulin detemir|mesh-list
92804891|NCT00604344|Isophane Insulin, Human|isophane insulin, human|mesh-list
92804892|NCT00604344|Insulin, Isophane|insulin, isophane|mesh-list
92804893|NCT00604344|Isophane insulin, beef|isophane insulin, beef|mesh-list
92804894|NCT00604344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92804895|NCT00604344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804896|NCT02851914|Antidepressive Agents|antidepressive agents|mesh-list
92804897|NCT02851914|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
92804898|NCT02851914|Serotonin|serotonin|mesh-list
92804899|NCT02851914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92804900|NCT02851914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804901|NCT02851914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92804902|NCT02851914|Serotonin Agents|serotonin agents|mesh-ancestor
92804903|NCT02851914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804904|NCT02851914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804905|NCT02851914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804906|NCT02851914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92804907|NCT02851914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804908|NCT00938964|Lidocaine|lidocaine|mesh-list
92804909|NCT00938964|Anesthetics, Local|anesthetics, local|mesh-ancestor
92804910|NCT00938964|Anesthetics|anesthetics|mesh-ancestor
92804911|NCT00938964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92804912|NCT00938964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804913|NCT00938964|Sensory System Agents|sensory system agents|mesh-ancestor
92804914|NCT00938964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804915|NCT00938964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92804916|NCT00938964|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92804917|NCT00938964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92804918|NCT00938964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804919|NCT00938964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804920|NCT00938886|Naltrexone|naltrexone|mesh-list
92804921|NCT00938886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92804922|NCT00938886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92804923|NCT00938886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804924|NCT00938886|Sensory System Agents|sensory system agents|mesh-ancestor
92804925|NCT00938886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804926|NCT02852070|Dimercaprol|dimercaprol|mesh-list
92804927|NCT02852070|Chelating Agents|chelating agents|mesh-ancestor
92804928|NCT02852070|Sequestering Agents|sequestering agents|mesh-ancestor
92804929|NCT02852070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804930|NCT00602862|Bevacizumab|bevacizumab|mesh-list
92804931|NCT00602862|Sorafenib|sorafenib|mesh-list
92804932|NCT00602862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804933|NCT00602862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804934|NCT00602862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92804935|NCT00602862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92804936|NCT00602862|Growth Substances|growth substances|mesh-ancestor
92804937|NCT00602862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804938|NCT00602862|Growth Inhibitors|growth inhibitors|mesh-ancestor
92804939|NCT00602862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92804940|NCT00602862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804941|NCT00602862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804942|NCT00942708|Fluoxetine|fluoxetine|mesh-list
92804943|NCT00942708|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92804944|NCT00942708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92804945|NCT00942708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92804946|NCT00942708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804947|NCT00942708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92804948|NCT00942708|Serotonin Agents|serotonin agents|mesh-ancestor
92804949|NCT00942708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804950|NCT00942708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92804951|NCT00942708|Antidepressive Agents|antidepressive agents|mesh-ancestor
92804952|NCT00942708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92804953|NCT00942708|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92804954|NCT00942708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92804955|NCT00942708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804956|NCT00942084|Acyclovir|acyclovir|mesh-list
92804957|NCT00942084|Antiviral Agents|antiviral agents|mesh-ancestor
92804958|NCT00942084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92804959|NCT00941928|Cyclophosphamide|cyclophosphamide|mesh-list
92804960|NCT00941928|Fludarabine|fludarabine|mesh-list
92804961|NCT00941928|Fludarabine phosphate|fludarabine phosphate|mesh-list
92804962|NCT00941928|Interleukin-2|interleukin-2|mesh-list
92804963|NCT00941928|Epratuzumab|epratuzumab|mesh-list
92804964|NCT00941928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92804965|NCT00941928|Immunologic Factors|immunologic factors|mesh-ancestor
92804966|NCT00941928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804967|NCT00941928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92804968|NCT00941928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92804969|NCT00941928|Alkylating Agents|alkylating agents|mesh-ancestor
92804970|NCT00941928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804971|NCT00941928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804972|NCT00941928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92804973|NCT00941928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92804974|NCT00941928|Antimetabolites|antimetabolites|mesh-ancestor
92804975|NCT00941928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92804976|NCT00941928|Analgesics|analgesics|mesh-ancestor
92418290|NCT01495624|Protease Inhibitors|protease inhibitors|mesh-ancestor
92804977|NCT00941928|Sensory System Agents|sensory system agents|mesh-ancestor
92804978|NCT00941928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92804979|NCT00941928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92804980|NCT02852694|Adalimumab|adalimumab|mesh-list
92804981|NCT02852694|Methotrexate|methotrexate|mesh-list
92804982|NCT02852694|Mercaptopurine|mercaptopurine|mesh-list
92804983|NCT02852694|Azathioprine|azathioprine|mesh-list
92804984|NCT02852694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92804985|NCT02852694|Abortifacient Agents|abortifacient agents|mesh-ancestor
92804986|NCT02852694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92804987|NCT02852694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92804988|NCT02852694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92804989|NCT02852694|Antimetabolites|antimetabolites|mesh-ancestor
92804990|NCT02852694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92804991|NCT02852694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92804992|NCT02852694|Dermatologic Agents|dermatologic agents|mesh-ancestor
92804993|NCT02852694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92804994|NCT02852694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92804995|NCT02852694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92804996|NCT02852694|Immunologic Factors|immunologic factors|mesh-ancestor
92804997|NCT02852694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92804998|NCT02852694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92804999|NCT02852694|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92805000|NCT02852694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805001|NCT00604578|Pioglitazone|pioglitazone|mesh-list
92805002|NCT00604578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805003|NCT00604578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805005|NCT00937560|Bevacizumab|bevacizumab|mesh-list
92805006|NCT00937560|Carboplatin|carboplatin|mesh-list
92805007|NCT00937560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92805008|NCT00937560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805009|NCT00937560|Tubulin Modulators|tubulin modulators|mesh-ancestor
92805010|NCT00937560|Antimitotic Agents|antimitotic agents|mesh-ancestor
92805011|NCT00937560|Mitosis Modulators|mitosis modulators|mesh-ancestor
92805012|NCT00937560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805013|NCT00937560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92805014|NCT00937560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92805015|NCT00937560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92805016|NCT00937560|Growth Substances|growth substances|mesh-ancestor
92805017|NCT00937560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805018|NCT00937560|Growth Inhibitors|growth inhibitors|mesh-ancestor
92805019|NCT04268394|Metformin|metformin|mesh-list
92805020|NCT04268394|Itraconazole|itraconazole|mesh-list
92805021|NCT04268394|Rifampin|rifampin|mesh-list
92805022|NCT04268394|Sulfasalazine|sulfasalazine|mesh-list
92805023|NCT04268394|Methotrexate|methotrexate|mesh-list
92805024|NCT04268394|Digoxin|digoxin|mesh-list
92805025|NCT04268394|Midazolam|midazolam|mesh-list
92805026|NCT04268394|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92805027|NCT04268394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805028|NCT04268394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805029|NCT04268394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92805030|NCT04268394|Abortifacient Agents|abortifacient agents|mesh-ancestor
92805031|NCT04268394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92805032|NCT04268394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92805033|NCT04268394|Antimetabolites|antimetabolites|mesh-ancestor
92805034|NCT04268394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805035|NCT04268394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805036|NCT04268394|Dermatologic Agents|dermatologic agents|mesh-ancestor
92805037|NCT04268394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805038|NCT04268394|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92805039|NCT04268394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805040|NCT04268394|Immunologic Factors|immunologic factors|mesh-ancestor
92805041|NCT04268394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805042|NCT04268394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92805043|NCT04268394|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92805044|NCT04268394|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92805045|NCT04268394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805046|NCT04268394|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92805047|NCT04268394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92805048|NCT04268394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92805049|NCT04268394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92805050|NCT04268394|Anesthetics, General|anesthetics, general|mesh-ancestor
92805051|NCT04268394|Anesthetics|anesthetics|mesh-ancestor
92805052|NCT04268394|GABA Modulators|gaba modulators|mesh-ancestor
92805053|NCT04268394|GABA Agents|gaba agents|mesh-ancestor
92805054|NCT04268394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805055|NCT04268394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805056|NCT04268394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805057|NCT04268394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805058|NCT04268394|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805059|NCT04268394|Antifungal Agents|antifungal agents|mesh-ancestor
92805060|NCT04268394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805061|NCT04268394|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92805062|NCT04268394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92805063|NCT04268394|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92805064|NCT04268394|Hormone Antagonists|hormone antagonists|mesh-ancestor
92805065|NCT04268394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805066|NCT04268394|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92805067|NCT04268394|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92805068|NCT04268394|Antitubercular Agents|antitubercular agents|mesh-ancestor
92805069|NCT04268394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92805070|NCT04268394|Leprostatic Agents|leprostatic agents|mesh-ancestor
92805071|NCT04268394|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92805072|NCT04268394|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92805073|NCT04268394|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92805074|NCT04268394|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92805075|NCT04268394|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92805076|NCT04268394|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92805077|NCT04268394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92805078|NCT04268394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92805079|NCT04268394|Protective Agents|protective agents|mesh-ancestor
92805080|NCT04268394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92805081|NCT04268394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92805082|NCT04268394|Analgesics|analgesics|mesh-ancestor
92805083|NCT04268394|Sensory System Agents|sensory system agents|mesh-ancestor
92805084|NCT04268394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805085|NCT04268394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805086|NCT04268394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805088|NCT02851212|Canagliflozin|canagliflozin|mesh-list
92805089|NCT02851212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805090|NCT02851212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805091|NCT02851212|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92805092|NCT02851212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805093|NCT00594568|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
92805094|NCT00594568|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92805095|NCT00594568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805096|NCT00594568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805097|NCT04143802|Dulaglutide|dulaglutide|mesh-list
92805098|NCT04143802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805099|NCT04143802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805100|NCT00682630|Artesunate|artesunate|mesh-list
92805101|NCT00682630|Pyronaridine|pyronaridine|mesh-list
92805102|NCT00682630|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92805103|NCT00682630|Antimalarials|antimalarials|mesh-ancestor
92805104|NCT00682630|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92805105|NCT00682630|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92805106|NCT00682630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805107|NCT00682630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805108|NCT00682630|Antiviral Agents|antiviral agents|mesh-ancestor
92805109|NCT00682630|Schistosomicides|schistosomicides|mesh-ancestor
92805110|NCT00682630|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92805111|NCT00682630|Anthelmintics|anthelmintics|mesh-ancestor
92805112|NCT00875056|Vorinostat|vorinostat|mesh-list
92805113|NCT00875056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805114|NCT00875056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92805115|NCT00875056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805116|NCT00875056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805118|NCT00685594|Cholecalciferol|cholecalciferol|mesh-list
92805119|NCT00685594|Vitamins|vitamins|mesh-ancestor
92805120|NCT00685594|Micronutrients|micronutrients|mesh-ancestor
92805121|NCT00685594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805122|NCT00685594|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92805123|NCT00685594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92805124|NCT00685672|Epinephrine|epinephrine|mesh-list
92805125|NCT00685672|Racepinephrine|racepinephrine|mesh-list
92805126|NCT00685672|Epinephryl borate|epinephryl borate|mesh-list
92805127|NCT00685672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92805128|NCT00685672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92805129|NCT00685672|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805130|NCT00685672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805131|NCT00685672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805132|NCT00685672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450110|NCT05189444|Antacids|antacids|mesh-ancestor
92805133|NCT00685672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92805134|NCT00685672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92805135|NCT00685672|Autonomic Agents|autonomic agents|mesh-ancestor
92805136|NCT00685672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805137|NCT00685672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92805138|NCT00685672|Respiratory System Agents|respiratory system agents|mesh-ancestor
92805140|NCT00685672|Sympathomimetics|sympathomimetics|mesh-ancestor
92805141|NCT00685672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92805142|NCT00683176|Choline|choline|mesh-list
92805143|NCT00683176|Fenofibrate|fenofibrate|mesh-list
92805144|NCT00683176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805145|NCT00683176|Antimetabolites|antimetabolites|mesh-ancestor
92805146|NCT00683176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805147|NCT00683176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805148|NCT00683176|Lipotropic Agents|lipotropic agents|mesh-ancestor
92805149|NCT00683176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805150|NCT00683176|Nootropic Agents|nootropic agents|mesh-ancestor
92805151|NCT02626234|Digoxin|digoxin|mesh-list
92805152|NCT02626234|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92805153|NCT02626234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805154|NCT02626234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805155|NCT02626234|Antimetabolites|antimetabolites|mesh-ancestor
92805156|NCT02626234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805157|NCT02626234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805158|NCT02626234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805159|NCT02626234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805160|NCT02626234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92805161|NCT02626234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92805162|NCT02626234|Protective Agents|protective agents|mesh-ancestor
92805163|NCT02626234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805164|NCT00685828|Imatinib Mesylate|imatinib mesylate|mesh-list
92805165|NCT00685828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805166|NCT00685828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805167|NCT00685828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805168|NCT00685828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805169|NCT00685906|Ticagrelor|ticagrelor|mesh-list
92805170|NCT00685906|Levonorgestrel|levonorgestrel|mesh-list
92805171|NCT00685906|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92805172|NCT00685906|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92805173|NCT00685906|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92805174|NCT00685906|Estradiol|estradiol|mesh-list
92805175|NCT00685906|Estrogens|estrogens|mesh-ancestor
92805176|NCT00685906|Hormones|hormones|mesh-ancestor
92805177|NCT00685906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805178|NCT00685906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418484|NCT01496989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92805179|NCT00685906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92805180|NCT00685906|Contraceptive Agents|contraceptive agents|mesh-ancestor
92805181|NCT00685906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92805182|NCT00685906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92805183|NCT00685906|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92805184|NCT00685906|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92805185|NCT00685906|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92805186|NCT00685906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92805187|NCT00685906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92805188|NCT00685906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92805189|NCT00685906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92805190|NCT00685906|Purinergic Agents|purinergic agents|mesh-ancestor
92805191|NCT00685906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805192|NCT00685906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805193|NCT00685906|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92805194|NCT00685906|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92805195|NCT00685906|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92805196|NCT00685906|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92805198|NCT04139824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92805199|NCT04139824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92805200|NCT04139824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92805201|NCT04139824|Analgesics|analgesics|mesh-ancestor
92805202|NCT04139824|Sensory System Agents|sensory system agents|mesh-ancestor
92805203|NCT04139824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805204|NCT04139824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805205|NCT04139824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805206|NCT04139824|Gout Suppressants|gout suppressants|mesh-ancestor
92805207|NCT04139824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92805208|NCT04139824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805209|NCT04139824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805211|NCT00940602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92805212|NCT00940602|Chelating Agents|chelating agents|mesh-ancestor
92805213|NCT00940602|Sequestering Agents|sequestering agents|mesh-ancestor
92805214|NCT00940602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805215|NCT00686140|Celecoxib|celecoxib|mesh-list
92805216|NCT00686140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92805217|NCT00686140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92805218|NCT00686140|Analgesics|analgesics|mesh-ancestor
92805219|NCT00686140|Sensory System Agents|sensory system agents|mesh-ancestor
92805220|NCT00686140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805221|NCT00686140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805222|NCT00686140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805223|NCT00686140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805224|NCT00686140|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92805225|NCT00686140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92805226|NCT00686140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805227|NCT00686140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805228|NCT00686218|Imatinib Mesylate|imatinib mesylate|mesh-list
92805229|NCT00686218|Panobinostat|panobinostat|mesh-list
92805230|NCT00686218|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92805231|NCT00686218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805232|NCT00686218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805233|NCT00686218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805234|NCT00686218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805235|NCT00683956|Propofol|propofol|mesh-list
92805236|NCT00683956|Anesthetics|anesthetics|mesh-ancestor
92805237|NCT00683956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805238|NCT00683956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805239|NCT00683956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92805240|NCT00683956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92805241|NCT00683956|Anesthetics, General|anesthetics, general|mesh-ancestor
92805242|NCT02850744|Temozolomide|temozolomide|mesh-list
92805243|NCT02850744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92805244|NCT02850744|Alkylating Agents|alkylating agents|mesh-ancestor
92805245|NCT02850744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805246|NCT02850744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805247|NCT04139668|Naltrexone|naltrexone|mesh-list
92805248|NCT04139668|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92805249|NCT04139668|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92805250|NCT04139668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805251|NCT04139668|Sensory System Agents|sensory system agents|mesh-ancestor
92805252|NCT04139668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805253|NCT04266756|Selexipag|selexipag|mesh-list
92805254|NCT04266756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92805255|NCT00606060|Factor VIII|factor viii|mesh-list
92805256|NCT00606060|Coagulants|coagulants|mesh-ancestor
92805257|NCT00875524|Vaccines|vaccines|mesh-list
92805258|NCT00875524|Immunologic Factors|immunologic factors|mesh-ancestor
92805259|NCT00875524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805260|NCT01094288|Docetaxel|docetaxel|mesh-list
92805261|NCT01094288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805262|NCT01094288|Tubulin Modulators|tubulin modulators|mesh-ancestor
92805263|NCT01094288|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751596|NCT04268498|Lenalidomide|lenalidomide|mesh-list
92805264|NCT01094288|Mitosis Modulators|mitosis modulators|mesh-ancestor
92805265|NCT01094288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805266|NCT05380986|Apatinib|apatinib|mesh-list
92805267|NCT05380986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805268|NCT05380986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805269|NCT05380986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805270|NCT05380986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805271|NCT00684112|Gabapentin|gabapentin|mesh-list
92805272|NCT00684112|Analgesics|analgesics|mesh-ancestor
92805273|NCT00684112|Sensory System Agents|sensory system agents|mesh-ancestor
92805274|NCT00684112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805275|NCT00684112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805276|NCT00684112|Anticonvulsants|anticonvulsants|mesh-ancestor
92805277|NCT00684112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92805278|NCT00684112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92805279|NCT00684112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805280|NCT00684112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92805281|NCT00684112|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92805282|NCT00684112|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92805283|NCT00684112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805284|NCT00684112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805285|NCT00684112|Antimanic Agents|antimanic agents|mesh-ancestor
92805286|NCT00684190|Esomeprazole|esomeprazole|mesh-list
92805287|NCT00684190|Lesogaberan|lesogaberan|mesh-list
92805288|NCT00684190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92805289|NCT00684190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805290|NCT00684190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92805291|NCT00684190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805292|NCT00684190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805293|NCT00684190|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92805294|NCT00684190|GABA Agonists|gaba agonists|mesh-ancestor
92805295|NCT00684190|GABA Agents|gaba agents|mesh-ancestor
92805296|NCT00684190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805297|NCT00684190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805298|NCT00684268|Silybin|silybin|mesh-list
92805299|NCT00684268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92805300|NCT00684268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805301|NCT00684268|Protective Agents|protective agents|mesh-ancestor
92805302|NCT00684268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805303|NCT00604656|Insulin Aspart|insulin aspart|mesh-list
92805304|NCT00604656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805305|NCT00604656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805306|NCT00684346|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92805307|NCT00684346|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92805308|NCT00684346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805309|NCT00874120|Phenylephrine|phenylephrine|mesh-list
92805310|NCT00874120|Oxymetazoline|oxymetazoline|mesh-list
92805311|NCT00874120|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92805312|NCT00874120|Mydriatics|mydriatics|mesh-ancestor
92805313|NCT00874120|Autonomic Agents|autonomic agents|mesh-ancestor
92805314|NCT00874120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805315|NCT00874120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805316|NCT00874120|Sympathomimetics|sympathomimetics|mesh-ancestor
92805317|NCT00874120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92805318|NCT00874120|Nasal Decongestants|nasal decongestants|mesh-ancestor
92805319|NCT00874120|Respiratory System Agents|respiratory system agents|mesh-ancestor
92805320|NCT00874120|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92805321|NCT00874120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92805322|NCT00874120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92805323|NCT00874120|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805324|NCT00874120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805325|NCT00874120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805326|NCT00874120|Protective Agents|protective agents|mesh-ancestor
92805327|NCT00939822|Simvastatin|simvastatin|mesh-list
92805328|NCT00939822|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805329|NCT00939822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805330|NCT00939822|Antimetabolites|antimetabolites|mesh-ancestor
92805331|NCT00939822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805332|NCT00939822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805333|NCT00939822|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805334|NCT00939822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805335|NCT00685126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92805336|NCT00685126|Albuterol|albuterol|mesh-list
92805337|NCT00685126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92805338|NCT00685126|Autonomic Agents|autonomic agents|mesh-ancestor
92805339|NCT00685126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805340|NCT00685126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805341|NCT00685126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92805342|NCT00685126|Respiratory System Agents|respiratory system agents|mesh-ancestor
92805343|NCT00685126|Tocolytic Agents|tocolytic agents|mesh-ancestor
92805344|NCT00685126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92805345|NCT00685126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92805346|NCT00685126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92805347|NCT00685126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92805348|NCT00685126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805349|NCT00685126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805350|NCT00685126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805351|NCT00687388|Celecoxib|celecoxib|mesh-list
92805352|NCT00687388|Doxazosin|doxazosin|mesh-list
92805353|NCT00687388|Prazosin|prazosin|mesh-list
92805354|NCT00687388|Tamsulosin|tamsulosin|mesh-list
92805355|NCT00687388|Alfuzosin|alfuzosin|mesh-list
92805356|NCT00687388|Terazosin|terazosin|mesh-list
92805357|NCT00687388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92805358|NCT00687388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92805359|NCT00687388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92805360|NCT00687388|Analgesics|analgesics|mesh-ancestor
92805361|NCT00687388|Sensory System Agents|sensory system agents|mesh-ancestor
92805362|NCT00687388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805363|NCT00687388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805364|NCT00687388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805365|NCT00687388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805366|NCT00687388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92805367|NCT00687388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92805368|NCT00687388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805369|NCT00687388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805370|NCT00687388|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92805371|NCT00687388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92805372|NCT00687388|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805373|NCT00687388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805374|NCT00687388|Urological Agents|urological agents|mesh-ancestor
92805375|NCT00687388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92805376|NCT00939510|Lenalidomide|lenalidomide|mesh-list
92805377|NCT00939510|Sargramostim|sargramostim|mesh-list
92805378|NCT00939510|Immunologic Factors|immunologic factors|mesh-ancestor
92805379|NCT00939510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805380|NCT00939510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92805381|NCT00939510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92805382|NCT00939510|Growth Substances|growth substances|mesh-ancestor
92805383|NCT00939510|Growth Inhibitors|growth inhibitors|mesh-ancestor
92805384|NCT00939510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805385|NCT00687466|Insulin|insulin|mesh-list
92805386|NCT00687466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805387|NCT00687466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805388|NCT04266288|Ketamine|ketamine|mesh-list
92805389|NCT04266288|Analgesics|analgesics|mesh-ancestor
92805390|NCT04266288|Sensory System Agents|sensory system agents|mesh-ancestor
92805391|NCT04266288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805392|NCT04266288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805393|NCT04266288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92805394|NCT04266288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92805395|NCT04266288|Anesthetics, General|anesthetics, general|mesh-ancestor
92805396|NCT04266288|Anesthetics|anesthetics|mesh-ancestor
92805397|NCT04266288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805398|NCT04266288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92805399|NCT04266288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92805400|NCT04266288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805401|NCT04266288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805402|NCT00687622|Trametinib|trametinib|mesh-list
92805403|NCT00687622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805404|NCT00687622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805405|NCT00687622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805406|NCT00687622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805407|NCT00687700|Propranolol|propranolol|mesh-list
92805408|NCT00687700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92805409|NCT00687700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92805410|NCT00687700|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805411|NCT00687700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805412|NCT00687700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805413|NCT00687700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805414|NCT00687700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92805415|NCT00687700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92805416|NCT00687700|Vasodilator Agents|vasodilator agents|mesh-ancestor
92805417|NCT00935532|Insulin|insulin|mesh-list
92805418|NCT00935532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92805419|NCT00935532|Insulin Glargine|insulin glargine|mesh-list
92805420|NCT00935532|Exenatide|exenatide|mesh-list
92805421|NCT00935532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805422|NCT00935532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805423|NCT00935532|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92805424|NCT00935532|Incretins|incretins|mesh-ancestor
92805425|NCT00935532|Hormones|hormones|mesh-ancestor
92805426|NCT00935532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805427|NCT04138420|Bevacizumab|bevacizumab|mesh-list
92805428|NCT04138420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92805429|NCT04138420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805430|NCT04138420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92450449|NCT04562831|Niacin|niacin|mesh-list
92805431|NCT04138420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92805432|NCT04138420|Growth Substances|growth substances|mesh-ancestor
92805433|NCT04138420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805434|NCT04138420|Growth Inhibitors|growth inhibitors|mesh-ancestor
92805435|NCT05378646|Interferons|interferons|mesh-list
92805436|NCT05378646|Interferon-gamma|interferon-gamma|mesh-list
92805437|NCT05378646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805438|NCT05378646|Antiviral Agents|antiviral agents|mesh-ancestor
92805439|NCT05378646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805440|NCT01093586|Cyclosporine|cyclosporine|mesh-list
92805441|NCT01093586|Mycophenolic Acid|mycophenolic acid|mesh-list
92805442|NCT01093586|Methylprednisolone|methylprednisolone|mesh-list
92805443|NCT01093586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92805444|NCT01093586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92805445|NCT01093586|Prednisolone|prednisolone|mesh-list
92805446|NCT01093586|Prednisolone acetate|prednisolone acetate|mesh-list
92805447|NCT01093586|Cyclophosphamide|cyclophosphamide|mesh-list
92805449|NCT01093586|Cyclosporins|cyclosporins|mesh-list
92805450|NCT01093586|Thymoglobulin|thymoglobulin|mesh-list
92805451|NCT01093586|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92805452|NCT01093586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92805453|NCT01093586|Prednisolone phosphate|prednisolone phosphate|mesh-list
92805454|NCT01093586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805455|NCT01093586|Immunologic Factors|immunologic factors|mesh-ancestor
92805456|NCT01093586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805457|NCT01093586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805458|NCT01093586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92805459|NCT01093586|Alkylating Agents|alkylating agents|mesh-ancestor
92805460|NCT01093586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805461|NCT01093586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805462|NCT01093586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92805463|NCT01093586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805464|NCT01093586|Antifungal Agents|antifungal agents|mesh-ancestor
92805465|NCT01093586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805466|NCT01093586|Dermatologic Agents|dermatologic agents|mesh-ancestor
92805467|NCT01093586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92805468|NCT01093586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92805469|NCT01093586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92805470|NCT01093586|Antitubercular Agents|antitubercular agents|mesh-ancestor
92805471|NCT01093586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92805472|NCT01093586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805473|NCT01093586|Antiemetics|antiemetics|mesh-ancestor
92805474|NCT01093586|Autonomic Agents|autonomic agents|mesh-ancestor
92805475|NCT01093586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805476|NCT01093586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805477|NCT01093586|Glucocorticoids|glucocorticoids|mesh-ancestor
92805478|NCT01093586|Hormones|hormones|mesh-ancestor
92805479|NCT01093586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805480|NCT01093586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92805481|NCT01093586|Protective Agents|protective agents|mesh-ancestor
92805482|NCT01093586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92805483|NCT04266132|Bupivacaine|bupivacaine|mesh-list
92805484|NCT04266132|Anesthetics, Local|anesthetics, local|mesh-ancestor
92805485|NCT04266132|Anesthetics|anesthetics|mesh-ancestor
92805486|NCT04266132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805487|NCT04266132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805488|NCT04266132|Sensory System Agents|sensory system agents|mesh-ancestor
92805489|NCT04266132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805490|NCT02625454|Acetaminophen|acetaminophen|mesh-list
92805491|NCT02625454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92805492|NCT02625454|Analgesics|analgesics|mesh-ancestor
92805493|NCT02625454|Sensory System Agents|sensory system agents|mesh-ancestor
92805494|NCT02625454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805495|NCT02625454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805496|NCT02625454|Antipyretics|antipyretics|mesh-ancestor
92805497|NCT00606450|Thalidomide|thalidomide|mesh-list
92805499|NCT00606450|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92805500|NCT00606450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450486|NCT04508504|Sensory System Agents|sensory system agents|mesh-ancestor
92805501|NCT00606450|Analgesics|analgesics|mesh-ancestor
92805502|NCT00606450|Sensory System Agents|sensory system agents|mesh-ancestor
92805503|NCT00606450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805504|NCT00606450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805505|NCT00606450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805506|NCT00606450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805507|NCT00606450|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92805508|NCT00606450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92805509|NCT00606450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805510|NCT00606450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805511|NCT00606450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805512|NCT00606450|Immunologic Factors|immunologic factors|mesh-ancestor
92805513|NCT00606450|Leprostatic Agents|leprostatic agents|mesh-ancestor
92805514|NCT00606450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92805515|NCT00606450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805516|NCT00606450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92805517|NCT00606450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92805518|NCT00606450|Growth Substances|growth substances|mesh-ancestor
92805519|NCT00606450|Growth Inhibitors|growth inhibitors|mesh-ancestor
92805520|NCT00606450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805521|NCT04138888|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92805522|NCT04138888|Olmesartan|olmesartan|mesh-list
92805523|NCT04138888|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92805524|NCT04138888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92805525|NCT04138888|Diuretics|diuretics|mesh-ancestor
92805526|NCT04138888|Natriuretic Agents|natriuretic agents|mesh-ancestor
92805527|NCT04138888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805528|NCT04138888|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92805529|NCT04138888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92805530|NCT04138888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805531|NCT04138888|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92805532|NCT04138888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92805533|NCT01098110|Asenapine|asenapine|mesh-list
92805534|NCT01098110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92805535|NCT01098110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92418854|NCT01499121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805536|NCT01098110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805537|NCT01098110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805538|NCT01098110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92805539|NCT00688402|Lesogaberan|lesogaberan|mesh-list
92805540|NCT00688402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805541|NCT00688402|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92805542|NCT00688402|GABA Agonists|gaba agonists|mesh-ancestor
92805543|NCT00688402|GABA Agents|gaba agents|mesh-ancestor
92805544|NCT00688402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805545|NCT00688402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805546|NCT00688402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805547|NCT04138264|Analgesics, Opioid|analgesics, opioid|mesh-list
92805548|NCT04138264|Narcotics|narcotics|mesh-ancestor
92805549|NCT04138264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92805550|NCT04138264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805551|NCT04138264|Analgesics|analgesics|mesh-ancestor
92805552|NCT04138264|Sensory System Agents|sensory system agents|mesh-ancestor
92805553|NCT04138264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805554|NCT00688480|Allopurinol|allopurinol|mesh-list
92805555|NCT00688480|Antimetabolites|antimetabolites|mesh-ancestor
92805556|NCT00688480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805557|NCT00688480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805558|NCT00688480|Gout Suppressants|gout suppressants|mesh-ancestor
92805559|NCT00688480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805560|NCT00688480|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92805561|NCT00688480|Antioxidants|antioxidants|mesh-ancestor
92805562|NCT00688480|Protective Agents|protective agents|mesh-ancestor
92805563|NCT00688480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805564|NCT01092728|Dasatinib|dasatinib|mesh-list
92805565|NCT01092728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805566|NCT01092728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805567|NCT01092728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805568|NCT01092728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805569|NCT00688558|Simvastatin|simvastatin|mesh-list
92805570|NCT00688558|Dalcetrapib|dalcetrapib|mesh-list
92805571|NCT00688558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805572|NCT00688558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805573|NCT00688558|Antimetabolites|antimetabolites|mesh-ancestor
92805574|NCT00688558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805575|NCT00688558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805576|NCT00688558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805577|NCT00688558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805578|NCT02625376|Resveratrol|resveratrol|mesh-list
92805579|NCT02625376|Antioxidants|antioxidants|mesh-ancestor
92805580|NCT02625376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450560|NCT04353284|Gabexate|gabexate|mesh-list
92805581|NCT02625376|Protective Agents|protective agents|mesh-ancestor
92805582|NCT02625376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805583|NCT02625376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805584|NCT02625376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92805585|NCT04153084|Picosulfate sodium|picosulfate sodium|mesh-list
92805586|NCT04153084|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92805587|NCT04153084|Cathartics|cathartics|mesh-ancestor
92805588|NCT04153084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805589|NCT04153084|Laxatives|laxatives|mesh-ancestor
92805590|NCT00688948|Alfuzosin|alfuzosin|mesh-list
92805591|NCT00688948|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92805592|NCT00688948|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92805593|NCT00688948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92805594|NCT00688948|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805595|NCT00688948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805596|NCT00688948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805597|NCT00688948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805598|NCT00688948|Urological Agents|urological agents|mesh-ancestor
92805599|NCT04152694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92805600|NCT04152694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92805601|NCT04152694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805602|NCT00873730|Etanercept|etanercept|mesh-list
92805603|NCT00873730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92805604|NCT00873730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92805605|NCT00873730|Analgesics|analgesics|mesh-ancestor
92805606|NCT00873730|Sensory System Agents|sensory system agents|mesh-ancestor
92805607|NCT00873730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805608|NCT00873730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805609|NCT00873730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805610|NCT00873730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805611|NCT00873730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805612|NCT00873730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805613|NCT00873730|Immunologic Factors|immunologic factors|mesh-ancestor
92805614|NCT00689416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92805615|NCT00689416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805616|NCT00689416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805617|NCT00689416|Antimetabolites|antimetabolites|mesh-ancestor
92805618|NCT00689416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805619|NCT00689416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805620|NCT00689416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805621|NCT00689416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805622|NCT00689494|Levonorgestrel|levonorgestrel|mesh-list
92805623|NCT00689494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92805624|NCT00689494|Contraceptive Agents|contraceptive agents|mesh-ancestor
92805625|NCT00689494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92805626|NCT00689494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805627|NCT00689494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92805628|NCT00689494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92805629|NCT00689494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92805630|NCT00672568|Capsaicin|capsaicin|mesh-list
92805631|NCT00672568|Antipruritics|antipruritics|mesh-ancestor
92805632|NCT00672568|Dermatologic Agents|dermatologic agents|mesh-ancestor
92805633|NCT00672568|Sensory System Agents|sensory system agents|mesh-ancestor
92805634|NCT00672568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805635|NCT00672568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805636|NCT00604032|Tretinoin|tretinoin|mesh-list
92805637|NCT00604032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805638|NCT00604032|Keratolytic Agents|keratolytic agents|mesh-ancestor
92805639|NCT00604032|Dermatologic Agents|dermatologic agents|mesh-ancestor
92805640|NCT00874432|Lisinopril|lisinopril|mesh-list
92805641|NCT00874432|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92805642|NCT00874432|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92805643|NCT00874432|Protease Inhibitors|protease inhibitors|mesh-ancestor
92805644|NCT00874432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805645|NCT00874432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92805646|NCT00874432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92805647|NCT00874432|Protective Agents|protective agents|mesh-ancestor
92805648|NCT00874432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805649|NCT00935220|Linagliptin|linagliptin|mesh-list
92805650|NCT00935220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805651|NCT00935220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805652|NCT00935220|Incretins|incretins|mesh-ancestor
92805653|NCT00935220|Hormones|hormones|mesh-ancestor
92805654|NCT00935220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805655|NCT00935220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92805656|NCT00935220|Protease Inhibitors|protease inhibitors|mesh-ancestor
92805657|NCT00935220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805658|NCT00935220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805660|NCT00691912|Doxorubicin|doxorubicin|mesh-list
92805661|NCT00691912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92805662|NCT00691912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92805663|NCT00691912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805664|NCT00691912|Tubulin Modulators|tubulin modulators|mesh-ancestor
92805665|NCT00691912|Antimitotic Agents|antimitotic agents|mesh-ancestor
92805666|NCT00691912|Mitosis Modulators|mitosis modulators|mesh-ancestor
92805667|NCT00691912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805668|NCT00691912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92805669|NCT00691912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92805670|NCT00691912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92805671|NCT00691912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805672|NCT05382390|Cytarabine|cytarabine|mesh-list
92805673|NCT05382390|Decitabine|decitabine|mesh-list
92805674|NCT05382390|Aclarubicin|aclarubicin|mesh-list
92805675|NCT05382390|Lenograstim|lenograstim|mesh-list
92805676|NCT05382390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92805677|NCT05382390|Antimetabolites|antimetabolites|mesh-ancestor
92805678|NCT05382390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805679|NCT05382390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805680|NCT05382390|Antiviral Agents|antiviral agents|mesh-ancestor
92805681|NCT05382390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805682|NCT05382390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805683|NCT05382390|Immunologic Factors|immunologic factors|mesh-ancestor
92805684|NCT05382390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805685|NCT05382390|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92805686|NCT05382390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805687|NCT05382390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92805688|NCT05382390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92805689|NCT05382390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92805690|NCT00689806|Lovastatin|lovastatin|mesh-list
92805691|NCT00689806|L 647318|l 647318|mesh-list
92805692|NCT00689806|Dihydromevinolin|dihydromevinolin|mesh-list
92805693|NCT00689806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805694|NCT00689806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805695|NCT00689806|Antimetabolites|antimetabolites|mesh-ancestor
92805696|NCT00689806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805697|NCT00689806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805698|NCT00689806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805699|NCT00689806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805700|NCT00594958|Vaccines|vaccines|mesh-list
92805701|NCT00594958|Immunologic Factors|immunologic factors|mesh-ancestor
92805702|NCT00594958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805703|NCT04204044|Folic Acid|folic acid|mesh-list
92805704|NCT04204044|Vitamin B Complex|vitamin b complex|mesh-list
92805705|NCT04204044|Inositol|inositol|mesh-list
92805706|NCT04204044|Metformin|metformin|mesh-list
92805707|NCT04204044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805708|NCT04204044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805709|NCT04204044|Hematinics|hematinics|mesh-ancestor
92805710|NCT04204044|Vitamins|vitamins|mesh-ancestor
92805711|NCT04204044|Micronutrients|micronutrients|mesh-ancestor
92805712|NCT00594880|Interferons|interferons|mesh-list
92805713|NCT00594880|Interferon-alpha|interferon-alpha|mesh-list
92805714|NCT00594880|Interferon alpha-2|interferon alpha-2|mesh-list
92805715|NCT00594880|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92805716|NCT00594880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805717|NCT00594880|Antiviral Agents|antiviral agents|mesh-ancestor
92805718|NCT00594880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805719|NCT00594880|Immunologic Factors|immunologic factors|mesh-ancestor
92805720|NCT00594880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805721|NCT00690118|Pioglitazone|pioglitazone|mesh-list
92805722|NCT00690118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805723|NCT00690118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805725|NCT00694252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805726|NCT00694252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805727|NCT00694252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805728|NCT00694252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805729|NCT00871858|Fulvestrant|fulvestrant|mesh-list
92805730|NCT00871858|Anastrozole|anastrozole|mesh-list
92805731|NCT00871858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92805732|NCT00871858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805733|NCT00871858|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92805734|NCT00871858|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92805735|NCT00871858|Hormone Antagonists|hormone antagonists|mesh-ancestor
92805736|NCT00871858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805737|NCT00871858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805738|NCT00871858|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92805739|NCT00871858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92805740|NCT00871858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805741|NCT00871858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805743|NCT00673270|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92805744|NCT00673270|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92805745|NCT00673270|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92805746|NCT00673270|Fludrocortisone|fludrocortisone|mesh-list
92805747|NCT00673270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805748|NCT00871780|Natalizumab|natalizumab|mesh-list
92805749|NCT00871780|Immunologic Factors|immunologic factors|mesh-ancestor
92805750|NCT00871780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805751|NCT00694408|Methylprednisolone|methylprednisolone|mesh-list
92805752|NCT00694408|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92805753|NCT00694408|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92805754|NCT00694408|Prednisolone|prednisolone|mesh-list
92805755|NCT00694408|Prednisolone acetate|prednisolone acetate|mesh-list
92805756|NCT00694408|Hydrocortisone|hydrocortisone|mesh-list
92805757|NCT00694408|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92805758|NCT00694408|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92805759|NCT00694408|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92805760|NCT00694408|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92805761|NCT00694408|Prednisolone phosphate|prednisolone phosphate|mesh-list
92805762|NCT00694408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805763|NCT00694408|Antiemetics|antiemetics|mesh-ancestor
92805764|NCT00694408|Autonomic Agents|autonomic agents|mesh-ancestor
92805765|NCT00694408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805766|NCT00694408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805767|NCT00694408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92805768|NCT00694408|Glucocorticoids|glucocorticoids|mesh-ancestor
92805769|NCT00694408|Hormones|hormones|mesh-ancestor
92805770|NCT00694408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805771|NCT00694408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92805772|NCT00694408|Protective Agents|protective agents|mesh-ancestor
92805773|NCT00694408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92805774|NCT00694408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805775|NCT04136782|Paclitaxel|paclitaxel|mesh-list
92805776|NCT04136782|Docetaxel|docetaxel|mesh-list
92805777|NCT04136782|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92805778|NCT04136782|Carboplatin|carboplatin|mesh-list
92805779|NCT04136782|Epirubicin|epirubicin|mesh-list
92805780|NCT04136782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92805781|NCT04136782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805782|NCT04136782|Tubulin Modulators|tubulin modulators|mesh-ancestor
92805783|NCT04136782|Antimitotic Agents|antimitotic agents|mesh-ancestor
92805784|NCT04136782|Mitosis Modulators|mitosis modulators|mesh-ancestor
92805785|NCT04136782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805786|NCT04136782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92805787|NCT04136782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92805788|NCT04136782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92805789|NCT04136782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805790|NCT04137640|Cyclophosphamide|cyclophosphamide|mesh-list
92805791|NCT04137640|Docetaxel|docetaxel|mesh-list
92805792|NCT04137640|Letrozole|letrozole|mesh-list
92805793|NCT04137640|Epirubicin|epirubicin|mesh-list
92805794|NCT04137640|Palbociclib|palbociclib|mesh-list
92805795|NCT04137640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805796|NCT04137640|Immunologic Factors|immunologic factors|mesh-ancestor
92805797|NCT04137640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805798|NCT04137640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805799|NCT04137640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92805800|NCT04137640|Alkylating Agents|alkylating agents|mesh-ancestor
92805801|NCT04137640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805802|NCT04137640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805803|NCT04137640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92805804|NCT04137640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92805805|NCT04137640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92805806|NCT04137640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92805807|NCT04137640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92805808|NCT04137640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92805809|NCT04137640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805810|NCT04137640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92805811|NCT04137640|Hormone Antagonists|hormone antagonists|mesh-ancestor
92805812|NCT04137640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805813|NCT04137640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92805814|NCT04137640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92805815|NCT04137640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92805816|NCT04137640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805817|NCT02624830|Glyburide|glyburide|mesh-list
92805818|NCT02624830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805819|NCT02624830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805820|NCT02629042|Prednisolone|prednisolone|mesh-list
92805821|NCT02629042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805822|NCT02629042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805823|NCT02629042|Glucocorticoids|glucocorticoids|mesh-ancestor
92805824|NCT02629042|Hormones|hormones|mesh-ancestor
92805825|NCT02629042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805826|NCT02629042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92805827|NCT02629042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805828|NCT00692614|Triamcinolone|triamcinolone|mesh-list
92805829|NCT00692614|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92805830|NCT00692614|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92805831|NCT00692614|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92805832|NCT00692614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805833|NCT00692614|Glucocorticoids|glucocorticoids|mesh-ancestor
92805834|NCT00692614|Hormones|hormones|mesh-ancestor
92805835|NCT00692614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805836|NCT00692614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805837|NCT00692614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805838|NCT00692614|Immunologic Factors|immunologic factors|mesh-ancestor
92805839|NCT00692614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805840|NCT00692614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805841|NCT04136470|Nivolumab|nivolumab|mesh-list
92805842|NCT04136470|Ipilimumab|ipilimumab|mesh-list
92805843|NCT04136470|Atezolizumab|atezolizumab|mesh-list
92805844|NCT04136470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92805845|NCT04136470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805846|NCT04136470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92805847|NCT04136470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805848|NCT00673426|Enoxaparin|enoxaparin|mesh-list
92805849|NCT00673426|Anticoagulants|anticoagulants|mesh-ancestor
92805850|NCT00673426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92805851|NCT00673426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92805852|NCT00673426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805853|NCT00673504|Gemcitabine|gemcitabine|mesh-list
92805854|NCT00673504|Sunitinib|sunitinib|mesh-list
92805855|NCT00673504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92805856|NCT00673504|Antimetabolites|antimetabolites|mesh-ancestor
92805857|NCT00673504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805858|NCT00673504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805859|NCT00673504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92805860|NCT00673504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92805861|NCT00673504|Growth Substances|growth substances|mesh-ancestor
92805862|NCT00673504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805863|NCT00673504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92805864|NCT00673504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805865|NCT00673504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805866|NCT00673582|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92805867|NCT00673582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92805868|NCT00673582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92805869|NCT00673582|Antimetabolites|antimetabolites|mesh-ancestor
92805870|NCT00673582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805871|NCT00673582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92805872|NCT00673582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92805873|NCT00673582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805874|NCT00912574|Molgramostim|molgramostim|mesh-list
92805875|NCT00912574|Sargramostim|sargramostim|mesh-list
92805876|NCT00912574|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92805877|NCT00912574|Freund's Adjuvant|freund's adjuvant|mesh-list
92805878|NCT00912574|Immunologic Factors|immunologic factors|mesh-ancestor
92805879|NCT00912574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805880|NCT00912574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805881|NCT00912574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92805883|NCT00695032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805884|NCT00695032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92805885|NCT00695032|Alkylating Agents|alkylating agents|mesh-ancestor
92805886|NCT00695032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805887|NCT04137328|Liraglutide|liraglutide|mesh-list
92805888|NCT04137328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92805889|NCT04137328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805890|NCT04137328|Incretins|incretins|mesh-ancestor
92805891|NCT04137328|Hormones|hormones|mesh-ancestor
92805892|NCT04137328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92805893|NCT00693004|Donepezil|donepezil|mesh-list
92805894|NCT00693004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92805895|NCT00693004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805896|NCT00693004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805897|NCT00693004|Cholinergic Agents|cholinergic agents|mesh-ancestor
92805898|NCT00693004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805899|NCT00693004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805900|NCT00693004|Nootropic Agents|nootropic agents|mesh-ancestor
92805901|NCT00695344|Mycophenolic Acid|mycophenolic acid|mesh-list
92805902|NCT00695344|Everolimus|everolimus|mesh-list
92805903|NCT00695344|Azathioprine|azathioprine|mesh-list
92805904|NCT00695344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92805905|NCT00695344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805906|NCT00695344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805907|NCT00695344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805908|NCT00695344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805909|NCT00695344|Immunologic Factors|immunologic factors|mesh-ancestor
92805910|NCT00695344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805911|NCT00695344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805912|NCT00695344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92805913|NCT00695344|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92805914|NCT00695344|Antitubercular Agents|antitubercular agents|mesh-ancestor
92805915|NCT00695344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92805916|NCT00695344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805917|NCT00695344|Antimetabolites|antimetabolites|mesh-ancestor
92805918|NCT00695344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92805919|NCT00695344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92805920|NCT02624362|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
92805921|NCT02624362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92805922|NCT02624362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805923|NCT02624362|Disinfectants|disinfectants|mesh-ancestor
92805924|NCT00607542|Baclofen|baclofen|mesh-list
92805925|NCT00607542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92805926|NCT00607542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805927|NCT00607542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92805928|NCT00607542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805929|NCT00607542|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92805930|NCT00607542|GABA Agonists|gaba agonists|mesh-ancestor
92805931|NCT00607542|GABA Agents|gaba agents|mesh-ancestor
92805932|NCT00607542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805933|NCT00607542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805934|NCT00936858|Everolimus|everolimus|mesh-list
92805935|NCT00936858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92805936|NCT00936858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805937|NCT00936858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805938|NCT00936858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805939|NCT00936858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92805940|NCT00936858|Immunologic Factors|immunologic factors|mesh-ancestor
92805941|NCT00936858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805942|NCT00936858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92805943|NCT02624440|Clarithromycin|clarithromycin|mesh-list
92805944|NCT02624440|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92805946|NCT02624440|Sulfamethoxazole|sulfamethoxazole|mesh-list
92805947|NCT02624440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92805948|NCT02624440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92805949|NCT02624440|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92805950|NCT02624440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805951|NCT02624440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805952|NCT02624440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92805953|NCT02624440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92805954|NCT02624440|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92805955|NCT02624440|Antimalarials|antimalarials|mesh-ancestor
92805956|NCT02624440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92805957|NCT02624440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92805958|NCT02624440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92805959|NCT02624440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92805960|NCT02624440|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92805961|NCT04136080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92805962|NCT00693862|Levodopa|levodopa|mesh-list
92805963|NCT00693862|Carbidopa|carbidopa|mesh-list
92805964|NCT00693862|Entacapone|entacapone|mesh-list
92805965|NCT00693862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92805966|NCT00693862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92805967|NCT00693862|Dopamine Agents|dopamine agents|mesh-ancestor
92805968|NCT00693862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805969|NCT00693862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805970|NCT00693862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805971|NCT00693862|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92805972|NCT00693862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805973|NCT00693862|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92805974|NCT05377788|Lazertinib|lazertinib|mesh-list
92805975|NCT05377788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92805976|NCT05377788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92805977|NCT05377788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805978|NCT00674050|Fluticasone|fluticasone|mesh-list
92805979|NCT00674050|Albuterol|albuterol|mesh-list
92805980|NCT00674050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92805981|NCT00674050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92805982|NCT00674050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92805983|NCT00674050|Autonomic Agents|autonomic agents|mesh-ancestor
92805984|NCT00674050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92805985|NCT00674050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92805986|NCT00674050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92805987|NCT00674050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92805988|NCT00674050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92805989|NCT00674050|Tocolytic Agents|tocolytic agents|mesh-ancestor
92805990|NCT00674050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92805991|NCT00674050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92805992|NCT00674050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92805993|NCT00674050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92805994|NCT00674050|Adrenergic Agents|adrenergic agents|mesh-ancestor
92805995|NCT00674050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92805996|NCT00674050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92805997|NCT00872170|Sildenafil Citrate|sildenafil citrate|mesh-list
92805998|NCT00872170|Vasodilator Agents|vasodilator agents|mesh-ancestor
92805999|NCT00872170|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92806000|NCT00872170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92806001|NCT00872170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806002|NCT00872170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806003|NCT00872170|Urological Agents|urological agents|mesh-ancestor
92806004|NCT00936702|Paclitaxel|paclitaxel|mesh-list
92806005|NCT00936702|Carboplatin|carboplatin|mesh-list
92806006|NCT00936702|Everolimus|everolimus|mesh-list
92806007|NCT00936702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92806008|NCT00936702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806009|NCT00936702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92806010|NCT00936702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806011|NCT00936702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92806012|NCT00936702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806013|NCT00936702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92806014|NCT00936702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806015|NCT00936702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806016|NCT00936702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752342|NCT05940545|Ribavirin|ribavirin|mesh-list
92806017|NCT00936702|Immunologic Factors|immunologic factors|mesh-ancestor
92806018|NCT00936702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806019|NCT00694174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92806020|NCT00607932|Indole-3-carbinol|indole-3-carbinol|mesh-list
92806021|NCT00607932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92806022|NCT00607932|Protective Agents|protective agents|mesh-ancestor
92806023|NCT00607932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806024|NCT00607932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806025|NCT00674596|Ramipril|ramipril|mesh-list
92806026|NCT00674596|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92806027|NCT00674596|Protease Inhibitors|protease inhibitors|mesh-ancestor
92806028|NCT00674596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806029|NCT00674596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806030|NCT00674596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92806031|NCT00674674|Topotecan|topotecan|mesh-list
92806032|NCT00674674|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92806033|NCT00674674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92806034|NCT00674674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806035|NCT00674674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806036|NCT00674674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806037|NCT02628886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92806038|NCT02628886|Immunologic Factors|immunologic factors|mesh-ancestor
92806039|NCT02628886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806040|NCT04265508|Hemostatics|hemostatics|mesh-list
92806041|NCT04265508|Coagulants|coagulants|mesh-ancestor
92806042|NCT02623738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92806043|NCT02623738|Latanoprost|latanoprost|mesh-list
92806044|NCT02623738|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92806045|NCT00607074|Albendazole|albendazole|mesh-list
92806046|NCT00607074|Anthelmintics|anthelmintics|mesh-list
92806047|NCT00607074|Secnidazole|secnidazole|mesh-list
92806048|NCT00607074|Metronidazole|metronidazole|mesh-list
92806049|NCT00607074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92806050|NCT00607074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806051|NCT00607074|Anticestodal Agents|anticestodal agents|mesh-ancestor
92806052|NCT00607074|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92806053|NCT00607074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92806054|NCT00607074|Tubulin Modulators|tubulin modulators|mesh-ancestor
92806055|NCT00607074|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806056|NCT00607074|Mitosis Modulators|mitosis modulators|mesh-ancestor
92806057|NCT00607074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806058|NCT00607074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806059|NCT00607074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806060|NCT02623582|Cyclophosphamide|cyclophosphamide|mesh-list
92806061|NCT02623582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92806062|NCT02623582|Immunologic Factors|immunologic factors|mesh-ancestor
92806063|NCT02623582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806064|NCT02623582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806065|NCT02623582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806066|NCT02623582|Alkylating Agents|alkylating agents|mesh-ancestor
92806067|NCT02623582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806068|NCT02623582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806069|NCT02623582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92806070|NCT00696202|Levonorgestrel|levonorgestrel|mesh-list
92806071|NCT00696202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92806072|NCT00696202|Contraceptive Agents|contraceptive agents|mesh-ancestor
92806073|NCT00696202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92806074|NCT00696202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806075|NCT00696202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92806076|NCT00696202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92806077|NCT00696202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92806078|NCT00674752|Gabapentin|gabapentin|mesh-list
92806079|NCT00674752|Analgesics|analgesics|mesh-ancestor
92806080|NCT00674752|Sensory System Agents|sensory system agents|mesh-ancestor
92806081|NCT00674752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806082|NCT00674752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806083|NCT00674752|Anticonvulsants|anticonvulsants|mesh-ancestor
92806084|NCT00674752|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92806085|NCT00674752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92806086|NCT00674752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806087|NCT00674752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92806088|NCT00674752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92806089|NCT00674752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92806090|NCT00674752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806091|NCT00674752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806092|NCT00674752|Antimanic Agents|antimanic agents|mesh-ancestor
92806093|NCT04265274|Copper|copper|mesh-list
92806094|NCT04265274|Disulfiram|disulfiram|mesh-list
92806095|NCT04265274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806096|NCT04265274|Trace Elements|trace elements|mesh-ancestor
92806097|NCT04265274|Micronutrients|micronutrients|mesh-ancestor
92806098|NCT04265274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806099|NCT04265274|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92806100|NCT04265274|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92806101|NCT04265274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806102|NCT00607152|Allopurinol|allopurinol|mesh-list
92806103|NCT00607152|Rasburicase|rasburicase|mesh-list
92806104|NCT00607152|Antimetabolites|antimetabolites|mesh-ancestor
92806105|NCT00607152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806106|NCT00607152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806107|NCT00607152|Gout Suppressants|gout suppressants|mesh-ancestor
92806108|NCT00607152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806109|NCT00607152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92806110|NCT00607152|Antioxidants|antioxidants|mesh-ancestor
92806111|NCT00607152|Protective Agents|protective agents|mesh-ancestor
92806112|NCT00607152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806113|NCT00696748|Methyltestosterone|methyltestosterone|mesh-list
92806114|NCT00696748|Testosterone|testosterone|mesh-list
92806115|NCT00696748|Testosterone undecanoate|testosterone undecanoate|mesh-list
92806116|NCT00696748|Testosterone enanthate|testosterone enanthate|mesh-list
92806117|NCT00696748|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92806118|NCT00696748|Androgens|androgens|mesh-ancestor
92806120|NCT00696748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806121|NCT00696748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806122|NCT00696748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92806123|NCT00696748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806124|NCT00696748|Anabolic Agents|anabolic agents|mesh-ancestor
92806125|NCT02621554|Resveratrol|resveratrol|mesh-list
92806126|NCT02621554|Antioxidants|antioxidants|mesh-ancestor
92806127|NCT02621554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806128|NCT02621554|Protective Agents|protective agents|mesh-ancestor
92806129|NCT02621554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806130|NCT02621554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806131|NCT02621554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92806132|NCT02623036|Enalapril|enalapril|mesh-list
92806133|NCT02623036|Lisinopril|lisinopril|mesh-list
92806134|NCT02623036|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92806135|NCT02623036|Protease Inhibitors|protease inhibitors|mesh-ancestor
92806136|NCT02623036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806137|NCT02623036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806138|NCT02623036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92806139|NCT02623036|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92806140|NCT02623036|Protective Agents|protective agents|mesh-ancestor
92806141|NCT02623036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806142|NCT00696826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92806143|NCT00696826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92806144|NCT00696826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806145|NCT00696826|Incretins|incretins|mesh-ancestor
92806146|NCT00696826|Hormones|hormones|mesh-ancestor
92806147|NCT00696826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806148|NCT00696826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92806149|NCT00696826|Protease Inhibitors|protease inhibitors|mesh-ancestor
92806150|NCT00696826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806151|NCT00696826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806152|NCT01092182|Prednisone|prednisone|mesh-list
92806153|NCT01092182|Cyclophosphamide|cyclophosphamide|mesh-list
92806154|NCT01092182|Rituximab|rituximab|mesh-list
92806155|NCT01092182|Doxorubicin|doxorubicin|mesh-list
92806156|NCT01092182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92806157|NCT01092182|Etoposide|etoposide|mesh-list
92806158|NCT01092182|Etoposide phosphate|etoposide phosphate|mesh-list
92806159|NCT01092182|Vincristine|vincristine|mesh-list
92806160|NCT01092182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92806161|NCT01092182|Immunologic Factors|immunologic factors|mesh-ancestor
92806162|NCT01092182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806163|NCT01092182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806164|NCT01092182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806165|NCT01092182|Alkylating Agents|alkylating agents|mesh-ancestor
92806166|NCT01092182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806167|NCT01092182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806168|NCT01092182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92806169|NCT01092182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806170|NCT01092182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92806171|NCT01092182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92806172|NCT01092182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92806173|NCT01092182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806174|NCT01092182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806175|NCT01092182|Glucocorticoids|glucocorticoids|mesh-ancestor
92806177|NCT01092182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806178|NCT01092182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92806179|NCT01092182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92806180|NCT01092182|Tubulin Modulators|tubulin modulators|mesh-ancestor
92806181|NCT01092182|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806182|NCT01092182|Mitosis Modulators|mitosis modulators|mesh-ancestor
92451151|NCT05759156|Tranexamic Acid|tranexamic acid|mesh-list
92806183|NCT04135378|Ascorbic Acid|ascorbic acid|mesh-list
92806184|NCT04135378|Vitamins|vitamins|mesh-ancestor
92806185|NCT04135378|Micronutrients|micronutrients|mesh-ancestor
92806186|NCT04135378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806187|NCT04135378|Antioxidants|antioxidants|mesh-ancestor
92806188|NCT04135378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806189|NCT04135378|Protective Agents|protective agents|mesh-ancestor
92806190|NCT04135690|Sorafenib|sorafenib|mesh-list
92806191|NCT04135690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806192|NCT04135690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806193|NCT04135690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806194|NCT04135690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806195|NCT02878772|Aspirin|aspirin|mesh-list
92806196|NCT02878772|Vinpocetine|vinpocetine|mesh-list
92806197|NCT02878772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92806198|NCT02878772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92806199|NCT02878772|Analgesics|analgesics|mesh-ancestor
92806200|NCT02878772|Sensory System Agents|sensory system agents|mesh-ancestor
92806201|NCT02878772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806202|NCT02878772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806203|NCT02878772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806204|NCT02878772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806205|NCT02878772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92806206|NCT02878772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92806207|NCT02878772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806208|NCT02878772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92806209|NCT02878772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92806210|NCT02878772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806211|NCT02878772|Antipyretics|antipyretics|mesh-ancestor
92806212|NCT02878772|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92806213|NCT02878772|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806214|NCT02878772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92806215|NCT02878772|Protective Agents|protective agents|mesh-ancestor
92806216|NCT02878772|Nootropic Agents|nootropic agents|mesh-ancestor
92806217|NCT02623114|Methylphenidate|methylphenidate|mesh-list
92806218|NCT02623114|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92806219|NCT02623114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92806220|NCT02623114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806221|NCT02623114|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92806222|NCT02623114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92806223|NCT02623114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806224|NCT02623114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806225|NCT02623114|Dopamine Agents|dopamine agents|mesh-ancestor
92806226|NCT02623114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806227|NCT02623114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92806228|NCT02623114|Adrenergic Agents|adrenergic agents|mesh-ancestor
92806229|NCT00932646|Olodaterol|olodaterol|mesh-list
92806230|NCT00932646|Formoterol Fumarate|formoterol fumarate|mesh-list
92806231|NCT00932646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92806232|NCT00932646|Autonomic Agents|autonomic agents|mesh-ancestor
92806233|NCT00932646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806234|NCT00932646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806235|NCT00932646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92806236|NCT00932646|Respiratory System Agents|respiratory system agents|mesh-ancestor
92806237|NCT00932646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92806238|NCT00932646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92806239|NCT00932646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92806240|NCT00932646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92806241|NCT00932646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806242|NCT00932646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806243|NCT00871234|Etravirine|etravirine|mesh-list
92806244|NCT00871234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92806245|NCT00871234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92806246|NCT00871234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806247|NCT00871234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806248|NCT00871234|Antiviral Agents|antiviral agents|mesh-ancestor
92806249|NCT00871234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806250|NCT04267224|Ticagrelor|ticagrelor|mesh-list
92806251|NCT04267224|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92806252|NCT04267224|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92419567|NCT01502267|Immunologic Factors|immunologic factors|mesh-ancestor
92806253|NCT04267224|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92806254|NCT04267224|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92806255|NCT04267224|Purinergic Agents|purinergic agents|mesh-ancestor
92451228|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
92806256|NCT04267224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806257|NCT04267224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806258|NCT04267224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806259|NCT00675220|Insulin Aspart|insulin aspart|mesh-list
92806260|NCT00675220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92806261|NCT00675220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806262|NCT04264260|Colchicine|colchicine|mesh-list
92806263|NCT04264260|Gout Suppressants|gout suppressants|mesh-ancestor
92806264|NCT04264260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806265|NCT04264260|Tubulin Modulators|tubulin modulators|mesh-ancestor
92806266|NCT04264260|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806267|NCT04264260|Mitosis Modulators|mitosis modulators|mesh-ancestor
92806268|NCT04264260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806269|NCT04264260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806270|NCT04267146|Nivolumab|nivolumab|mesh-list
92806271|NCT04267146|Temozolomide|temozolomide|mesh-list
92806272|NCT04267146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806273|NCT04267146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806274|NCT04267146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92806275|NCT04267146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806276|NCT04267146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806277|NCT04267146|Alkylating Agents|alkylating agents|mesh-ancestor
92806278|NCT02691078|Octreotide|octreotide|mesh-list
92806279|NCT02691078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806280|NCT02691078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92806281|NCT02691078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806282|NCT02621320|Vitamin D|vitamin d|mesh-list
92806283|NCT02621320|Vitamins|vitamins|mesh-ancestor
92806284|NCT02621320|Micronutrients|micronutrients|mesh-ancestor
92806285|NCT02621320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806286|NCT02621320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92806287|NCT01097330|Amiodarone|amiodarone|mesh-list
92806288|NCT01097330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92806289|NCT01097330|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806290|NCT01097330|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92806291|NCT01097330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806292|NCT01097330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806293|NCT01097330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92806294|NCT01097330|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92806295|NCT01097330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92806296|NCT01097330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806297|NCT01097330|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92806298|NCT01097330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92806299|NCT01097330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92806300|NCT00934440|Bevacizumab|bevacizumab|mesh-list
92806301|NCT00934440|Azacitidine|azacitidine|mesh-list
92806302|NCT00934440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806303|NCT00934440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806304|NCT00934440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92806305|NCT00934440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92806306|NCT00934440|Growth Substances|growth substances|mesh-ancestor
92806307|NCT00934440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806308|NCT00934440|Growth Inhibitors|growth inhibitors|mesh-ancestor
92806309|NCT00934440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92806310|NCT00934440|Antimetabolites|antimetabolites|mesh-ancestor
92806311|NCT00934440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806312|NCT00934440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806313|NCT02622802|Acetaminophen|acetaminophen|mesh-list
92806314|NCT02622802|Azithromycin|azithromycin|mesh-list
92806315|NCT02622802|Erythromycin|erythromycin|mesh-list
92806316|NCT02622802|Erythromycin Estolate|erythromycin estolate|mesh-list
92806317|NCT02622802|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92806318|NCT02622802|Erythromycin stearate|erythromycin stearate|mesh-list
92806319|NCT02622802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92806320|NCT02622802|Analgesics|analgesics|mesh-ancestor
92806321|NCT02622802|Sensory System Agents|sensory system agents|mesh-ancestor
92806322|NCT02622802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806323|NCT02622802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806324|NCT02622802|Antipyretics|antipyretics|mesh-ancestor
92806325|NCT02622802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806326|NCT02622802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806327|NCT02622802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806328|NCT02622802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92806329|NCT02622802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451307|NCT05371886|Midazolam|midazolam|mesh-list
92806330|NCT02622802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806331|NCT05158374|Aspirin|aspirin|mesh-list
92806332|NCT05158374|Metformin|metformin|mesh-list
92806333|NCT05158374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92806334|NCT05158374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806335|NCT05158374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92806336|NCT05158374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92806337|NCT05158374|Analgesics|analgesics|mesh-ancestor
92806338|NCT05158374|Sensory System Agents|sensory system agents|mesh-ancestor
92806339|NCT05158374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806340|NCT05158374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806341|NCT05158374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806342|NCT05158374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92806343|NCT05158374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92806344|NCT05158374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806345|NCT05158374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92806346|NCT05158374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92806347|NCT05158374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806348|NCT05158374|Antipyretics|antipyretics|mesh-ancestor
92806349|NCT00934362|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92806350|NCT00934362|Respiratory System Agents|respiratory system agents|mesh-ancestor
92806351|NCT00675688|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92806352|NCT00675688|Bazedoxifene|bazedoxifene|mesh-list
92806353|NCT00675688|Estrogens|estrogens|mesh-list
92806354|NCT00675688|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92806355|NCT00675688|Hormones|hormones|mesh-ancestor
92806356|NCT00675688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806357|NCT00675688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806358|NCT00675688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92806359|NCT00675688|Hormone Antagonists|hormone antagonists|mesh-ancestor
92806360|NCT00675688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92806361|NCT00675688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92806362|NCT00675688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92806363|NCT02622334|Latanoprost|latanoprost|mesh-list
92806364|NCT02622334|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92806365|NCT02622334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92806366|NCT00696514|Vitamin D|vitamin d|mesh-list
92806367|NCT00696514|Ergocalciferols|ergocalciferols|mesh-list
92806368|NCT00696514|Cholecalciferol|cholecalciferol|mesh-list
92806369|NCT00696514|Vitamins|vitamins|mesh-list
92806370|NCT00696514|Folic Acid|folic acid|mesh-list
92806371|NCT00696514|Vitamin B 12|vitamin b 12|mesh-list
92806372|NCT00696514|Micronutrients|micronutrients|mesh-ancestor
92806373|NCT00696514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806374|NCT00696514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92806375|NCT00696514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92806376|NCT00696514|Hematinics|hematinics|mesh-ancestor
92806377|NCT00696514|Vitamin B Complex|vitamin b complex|mesh-ancestor
92806378|NCT04263870|Capecitabine|capecitabine|mesh-list
92806379|NCT04263870|Oxaliplatin|oxaliplatin|mesh-list
92806380|NCT04263870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92806381|NCT04263870|Antimetabolites|antimetabolites|mesh-ancestor
92806382|NCT04263870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806383|NCT04263870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806384|NCT05317182|Salicylic Acid|salicylic acid|mesh-list
92806385|NCT05317182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806386|NCT05317182|Antifungal Agents|antifungal agents|mesh-ancestor
92806387|NCT05317182|Keratolytic Agents|keratolytic agents|mesh-ancestor
92806388|NCT05317182|Dermatologic Agents|dermatologic agents|mesh-ancestor
92806389|NCT00871000|Pentetic Acid|pentetic acid|mesh-list
92806390|NCT00871000|Antidotes|antidotes|mesh-ancestor
92806391|NCT00871000|Protective Agents|protective agents|mesh-ancestor
92806392|NCT00871000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806393|NCT00871000|Chelating Agents|chelating agents|mesh-ancestor
92806394|NCT00871000|Sequestering Agents|sequestering agents|mesh-ancestor
92806395|NCT00871000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806396|NCT00871000|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92806397|NCT01096784|Mecasermin|mecasermin|mesh-list
92806398|NCT01096784|Growth Substances|growth substances|mesh-ancestor
92806399|NCT01096784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806400|NCT00696592|Bevacizumab|bevacizumab|mesh-list
92806401|NCT00696592|Verteporfin|verteporfin|mesh-list
92806402|NCT00696592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806403|NCT00696592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806404|NCT00696592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92806405|NCT00696592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92806406|NCT00696592|Growth Substances|growth substances|mesh-ancestor
92806407|NCT00696592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806408|NCT00696592|Growth Inhibitors|growth inhibitors|mesh-ancestor
92806409|NCT00696592|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92806410|NCT00696592|Dermatologic Agents|dermatologic agents|mesh-ancestor
92806411|NCT02622022|Morphine|morphine|mesh-list
92806412|NCT02622022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92806413|NCT02622022|Narcotics|narcotics|mesh-ancestor
92806414|NCT02622022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806415|NCT02622022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806416|NCT02622022|Analgesics|analgesics|mesh-ancestor
92806417|NCT02622022|Sensory System Agents|sensory system agents|mesh-ancestor
92806418|NCT02622022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806419|NCT00934050|Inositol|inositol|mesh-list
92806420|NCT00934050|Vitamin B Complex|vitamin b complex|mesh-ancestor
92806421|NCT00934050|Vitamins|vitamins|mesh-ancestor
92806422|NCT00934050|Micronutrients|micronutrients|mesh-ancestor
92806423|NCT00934050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806424|NCT02620618|Infliximab|infliximab|mesh-list
92806425|NCT02620618|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92806426|NCT02620618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806427|NCT02620618|Dermatologic Agents|dermatologic agents|mesh-ancestor
92806428|NCT02620618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806429|NCT02620618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806430|NCT04135456|Mannitol|mannitol|mesh-list
92806431|NCT04135456|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92806432|NCT04135456|Diuretics|diuretics|mesh-ancestor
92806433|NCT04135456|Natriuretic Agents|natriuretic agents|mesh-ancestor
92806434|NCT04135456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806435|NCT01091168|Alkylating Agents|alkylating agents|mesh-list
92806436|NCT01091168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419773|NCT01503450|Olanzapine|olanzapine|mesh-list
92806437|NCT05321576|Analgesics, Opioid|analgesics, opioid|mesh-list
92806438|NCT05321576|Narcotics|narcotics|mesh-ancestor
92806439|NCT05321576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806440|NCT05321576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806441|NCT05321576|Analgesics|analgesics|mesh-ancestor
92806442|NCT05321576|Sensory System Agents|sensory system agents|mesh-ancestor
92806443|NCT05321576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806444|NCT00864916|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92806445|NCT00864916|Pentoxifylline|pentoxifylline|mesh-list
92806446|NCT00864916|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92806447|NCT00864916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806448|NCT00864916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806449|NCT00864916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92806450|NCT00864916|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92806451|NCT00864916|Protective Agents|protective agents|mesh-ancestor
92806452|NCT00864916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806453|NCT00864916|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806454|NCT00864916|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92806455|NCT00864916|Antioxidants|antioxidants|mesh-ancestor
92806456|NCT00864916|Antiviral Agents|antiviral agents|mesh-ancestor
92806457|NCT00864916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806458|NCT00864682|Lidocaine|lidocaine|mesh-list
92806459|NCT00864682|Propofol|propofol|mesh-list
92806460|NCT00864682|Anesthetics, Local|anesthetics, local|mesh-ancestor
92806461|NCT00864682|Anesthetics|anesthetics|mesh-ancestor
92806462|NCT00864682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806463|NCT00864682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806464|NCT00864682|Sensory System Agents|sensory system agents|mesh-ancestor
92806465|NCT00864682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806466|NCT00864682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92806467|NCT00864682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92806469|NCT00864682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806470|NCT00864682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806471|NCT00864682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92806472|NCT00864682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92806473|NCT00864682|Anesthetics, General|anesthetics, general|mesh-ancestor
92806474|NCT00931944|Pramipexole|pramipexole|mesh-list
92806475|NCT00931944|Antioxidants|antioxidants|mesh-ancestor
92806476|NCT00931944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806477|NCT00931944|Protective Agents|protective agents|mesh-ancestor
92806478|NCT00931944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806479|NCT00931944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92806480|NCT00931944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92806481|NCT00931944|Dopamine Agonists|dopamine agonists|mesh-ancestor
92806482|NCT00931944|Dopamine Agents|dopamine agents|mesh-ancestor
92451454|NCT04880278|Nabilone|nabilone|mesh-list
92806483|NCT00931944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806485|NCT02614456|Interferon-gamma|interferon-gamma|mesh-list
92806486|NCT02614456|Nivolumab|nivolumab|mesh-list
92806487|NCT02614456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806488|NCT02614456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806489|NCT02614456|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92806490|NCT02614456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806491|NCT02614456|Antiviral Agents|antiviral agents|mesh-ancestor
92806492|NCT02614456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806493|NCT04130230|Choline|choline|mesh-list
92806494|NCT04130230|Neostigmine|neostigmine|mesh-list
92806495|NCT04130230|Lipotropic Agents|lipotropic agents|mesh-ancestor
92806496|NCT04130230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92806497|NCT04130230|Antimetabolites|antimetabolites|mesh-ancestor
92806498|NCT04130230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806499|NCT04130230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806500|NCT04130230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92806501|NCT04130230|Nootropic Agents|nootropic agents|mesh-ancestor
92419823|NCT01503658|Antipyretics|antipyretics|mesh-ancestor
92806502|NCT04130230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92806503|NCT04130230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806504|NCT04130230|Cholinergic Agents|cholinergic agents|mesh-ancestor
92806505|NCT04130230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806506|NCT04130230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806507|NCT04130230|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92806508|NCT04130230|Autonomic Agents|autonomic agents|mesh-ancestor
92806509|NCT04130230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806510|NCT05148702|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92806511|NCT05148702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92806512|NCT05148702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806513|NCT05148702|Antitubercular Agents|antitubercular agents|mesh-ancestor
92806514|NCT02616874|Romidepsin|romidepsin|mesh-list
92806515|NCT02616874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92806516|NCT02616874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806517|NCT02616874|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92806518|NCT02616874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806519|NCT02616874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806520|NCT04133428|Valsartan|valsartan|mesh-list
92806521|NCT04133428|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92806522|NCT04133428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92806523|NCT04133428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92806524|NCT04133428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92806525|NCT04133428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806526|NCT00869050|Capecitabine|capecitabine|mesh-list
92806527|NCT00869050|Temozolomide|temozolomide|mesh-list
92806528|NCT00869050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92806529|NCT00869050|Antimetabolites|antimetabolites|mesh-ancestor
92806530|NCT00869050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806531|NCT00869050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806532|NCT00869050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806533|NCT00869050|Alkylating Agents|alkylating agents|mesh-ancestor
92806534|NCT04133506|Aspirin|aspirin|mesh-list
92806535|NCT04133506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92806536|NCT04133506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92806537|NCT04133506|Analgesics|analgesics|mesh-ancestor
92806538|NCT04133506|Sensory System Agents|sensory system agents|mesh-ancestor
92806539|NCT04133506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806540|NCT04133506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806541|NCT04133506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806542|NCT04133506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806543|NCT04133506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92806544|NCT04133506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92806545|NCT04133506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806546|NCT04133506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92806547|NCT04133506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92806548|NCT04133506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806549|NCT04133506|Antipyretics|antipyretics|mesh-ancestor
92806550|NCT04872218|Abatacept|abatacept|mesh-list
92806551|NCT04872218|Immunologic Factors|immunologic factors|mesh-ancestor
92806552|NCT04872218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806553|NCT04872218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92806554|NCT04872218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806555|NCT04872218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806556|NCT04872218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806557|NCT04872218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92806559|NCT04133194|Mesalamine|mesalamine|mesh-list
92806560|NCT04133194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92806561|NCT04133194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92806562|NCT04133194|Analgesics|analgesics|mesh-ancestor
92806563|NCT04133194|Sensory System Agents|sensory system agents|mesh-ancestor
92806564|NCT04133194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806565|NCT04133194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806566|NCT04133194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806567|NCT04133194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806568|NCT00698464|Pasireotide|pasireotide|mesh-list
92806569|NCT00698464|Hormones|hormones|mesh-ancestor
92806570|NCT00698464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806571|NCT00698464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806572|NCT04933682|Rifampin|rifampin|mesh-list
92806573|NCT04933682|Fluconazole|fluconazole|mesh-list
92806574|NCT04933682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92806575|NCT04933682|Antitubercular Agents|antitubercular agents|mesh-ancestor
92806576|NCT04933682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806577|NCT04933682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806578|NCT04933682|Leprostatic Agents|leprostatic agents|mesh-ancestor
92806579|NCT04933682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92806580|NCT04933682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806581|NCT04933682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806582|NCT04933682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92806583|NCT04933682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92806584|NCT04933682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92806585|NCT04933682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92806586|NCT04933682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92806587|NCT04933682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92806588|NCT04933682|Antifungal Agents|antifungal agents|mesh-ancestor
92806589|NCT04933682|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92806590|NCT04933682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92806591|NCT04933682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92806592|NCT04933682|Hormone Antagonists|hormone antagonists|mesh-ancestor
92806593|NCT04933682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806594|NCT04933682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806595|NCT04933682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92806596|NCT04933682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92806597|NCT00927186|Zoledronic Acid|zoledronic acid|mesh-list
92806598|NCT00927186|Teriparatide|teriparatide|mesh-list
92806599|NCT00927186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92806600|NCT00927186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806601|NCT00927186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92806602|NCT00593554|Fludarabine|fludarabine|mesh-list
92806603|NCT00593554|Thiotepa|thiotepa|mesh-list
92806604|NCT00593554|Thymoglobulin|thymoglobulin|mesh-list
92806605|NCT00593554|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92806606|NCT00593554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806607|NCT00593554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806608|NCT00593554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92806609|NCT00593554|Immunologic Factors|immunologic factors|mesh-ancestor
92806610|NCT00593554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806611|NCT00593554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806612|NCT00593554|Alkylating Agents|alkylating agents|mesh-ancestor
92806613|NCT00593554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92806615|NCT01101308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92806616|NCT01101308|Narcotics|narcotics|mesh-ancestor
92806617|NCT01101308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806618|NCT01101308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806619|NCT01101308|Analgesics|analgesics|mesh-ancestor
92806620|NCT01101308|Sensory System Agents|sensory system agents|mesh-ancestor
92806621|NCT01101308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806622|NCT00626054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92806623|NCT00926796|Azithromycin|azithromycin|mesh-list
92806624|NCT00926796|Gentamicins|gentamicins|mesh-list
92451609|NCT04510311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92806625|NCT00926796|Gemifloxacin|gemifloxacin|mesh-list
92806626|NCT00926796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806627|NCT00926796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806628|NCT00926796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92806629|NCT00926796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806630|NCT00926796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806631|NCT00926796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92806632|NCT00926796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92806633|NCT00926796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806634|NCT00696982|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92806635|NCT00696982|Glyburide|glyburide|mesh-list
92806636|NCT00696982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92806637|NCT00696982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806638|NCT00696982|Incretins|incretins|mesh-ancestor
92806639|NCT00696982|Hormones|hormones|mesh-ancestor
92806640|NCT00696982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806641|NCT00696982|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92806642|NCT00696982|Protease Inhibitors|protease inhibitors|mesh-ancestor
92806643|NCT00696982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806644|NCT00696982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806645|NCT01087736|Topiramate|topiramate|mesh-list
92806646|NCT01087736|Anticonvulsants|anticonvulsants|mesh-ancestor
92806647|NCT01087736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92806648|NCT01087736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806649|NCT04262388|Durvalumab|durvalumab|mesh-list
92806650|NCT04262388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806651|NCT04262388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806652|NCT00608712|Esomeprazole|esomeprazole|mesh-list
92806653|NCT00608712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92806654|NCT00608712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806655|NCT00608712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92806656|NCT00608712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806657|NCT00608712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806658|NCT01079936|Lenalidomide|lenalidomide|mesh-list
92806659|NCT01079936|Melphalan|melphalan|mesh-list
92806660|NCT01079936|Immunologic Factors|immunologic factors|mesh-ancestor
92806661|NCT01079936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806662|NCT01079936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92806663|NCT01079936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92806664|NCT01079936|Growth Substances|growth substances|mesh-ancestor
92806665|NCT01079936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92806666|NCT01079936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806667|NCT01079936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806668|NCT01079936|Alkylating Agents|alkylating agents|mesh-ancestor
92806669|NCT01079936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806670|NCT01079936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92806671|NCT01079936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92806672|NCT00931710|Losartan|losartan|mesh-list
92806673|NCT00931710|Amlodipine|amlodipine|mesh-list
92806674|NCT00931710|Valsartan|valsartan|mesh-list
92806675|NCT00931710|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92806676|NCT00931710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92806677|NCT00931710|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92806678|NCT00931710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806679|NCT00931710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806680|NCT00931710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92806681|NCT00931710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806682|NCT00931710|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806683|NCT00931710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92806684|NCT00931710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92806685|NCT00931710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92806686|NCT00931710|Diuretics|diuretics|mesh-ancestor
92806687|NCT00931710|Natriuretic Agents|natriuretic agents|mesh-ancestor
92806688|NCT00931710|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92806689|NCT01100528|Interferons|interferons|mesh-list
92806690|NCT01100528|Interferon-alpha|interferon-alpha|mesh-list
92806691|NCT01100528|Interferon alpha-2|interferon alpha-2|mesh-list
92806692|NCT01100528|Dacarbazine|dacarbazine|mesh-list
92806693|NCT01100528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806694|NCT01100528|Antiviral Agents|antiviral agents|mesh-ancestor
92806695|NCT01100528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806696|NCT01100528|Immunologic Factors|immunologic factors|mesh-ancestor
92806697|NCT01100528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806698|NCT01100528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92806699|NCT01100528|Alkylating Agents|alkylating agents|mesh-ancestor
92806700|NCT01100528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806701|NCT01079234|Insulin|insulin|mesh-list
92806702|NCT01079234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92806704|NCT01079234|Insulin Aspart|insulin aspart|mesh-list
92806705|NCT01079234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92806706|NCT01079234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806707|NCT00931632|Nitric Oxide|nitric oxide|mesh-list
92806708|NCT00931632|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92806709|NCT00931632|Autonomic Agents|autonomic agents|mesh-ancestor
92806710|NCT00931632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806711|NCT00931632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806712|NCT00931632|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92806713|NCT00931632|Respiratory System Agents|respiratory system agents|mesh-ancestor
92806714|NCT00931632|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92806715|NCT00931632|Antioxidants|antioxidants|mesh-ancestor
92806716|NCT00931632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806717|NCT00931632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806718|NCT00931632|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92806719|NCT00931632|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806720|NCT00931632|Gasotransmitters|gasotransmitters|mesh-ancestor
92806721|NCT00931632|Protective Agents|protective agents|mesh-ancestor
92806722|NCT00608790|Albuterol|albuterol|mesh-list
92806723|NCT00608790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92806724|NCT00608790|Autonomic Agents|autonomic agents|mesh-ancestor
92806725|NCT00608790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806726|NCT00608790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806727|NCT00608790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92806728|NCT00608790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92806729|NCT00608790|Tocolytic Agents|tocolytic agents|mesh-ancestor
92806730|NCT00608790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92806731|NCT00608790|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92806732|NCT00608790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92806733|NCT00608790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92806734|NCT00608790|Adrenergic Agents|adrenergic agents|mesh-ancestor
92806735|NCT00608790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806736|NCT00608790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806737|NCT01078922|Ofatumumab|ofatumumab|mesh-list
92806738|NCT01078922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806739|NCT00609570|Calcium|calcium|mesh-list
92806740|NCT00609570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92806741|NCT00609570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806742|NCT00863746|Sorafenib|sorafenib|mesh-list
92806743|NCT00863746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806744|NCT00863746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806745|NCT00863746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806746|NCT00863746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806747|NCT04992156|Palbociclib|palbociclib|mesh-list
92806748|NCT04992156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806749|NCT04992156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806750|NCT04992156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806751|NCT04992156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806752|NCT00608946|Copper|copper|mesh-list
92806753|NCT00608946|Trace Elements|trace elements|mesh-ancestor
92806754|NCT00608946|Micronutrients|micronutrients|mesh-ancestor
92806755|NCT00608946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806756|NCT02615938|Hydroxychloroquine|hydroxychloroquine|mesh-list
92806757|NCT02615938|Antimalarials|antimalarials|mesh-ancestor
92806758|NCT02615938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92806759|NCT02615938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92806760|NCT02615938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806761|NCT02615938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806762|NCT02615938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806763|NCT02615938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92806765|NCT00926328|Fluorides|fluorides|mesh-list
92806766|NCT00926328|Cariostatic Agents|cariostatic agents|mesh-ancestor
92806767|NCT00926328|Protective Agents|protective agents|mesh-ancestor
92806768|NCT00926328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806769|NCT00926328|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92806770|NCT00926328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806771|NCT00926328|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92806772|NCT00926328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92806773|NCT00926328|Antimetabolites|antimetabolites|mesh-ancestor
92806774|NCT00926328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806775|NCT00926328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92806776|NCT04203732|Anesthetics|anesthetics|mesh-list
92806777|NCT04203732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806778|NCT04203732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806779|NCT00863512|Gemcitabine|gemcitabine|mesh-list
92806780|NCT00863512|Docetaxel|docetaxel|mesh-list
92806781|NCT00863512|Pemetrexed|pemetrexed|mesh-list
92806782|NCT00863512|Vinorelbine|vinorelbine|mesh-list
92806783|NCT00863512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806784|NCT00863512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92806785|NCT00863512|Antimetabolites|antimetabolites|mesh-ancestor
92806786|NCT00863512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806787|NCT00863512|Tubulin Modulators|tubulin modulators|mesh-ancestor
92806788|NCT00863512|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806789|NCT00863512|Mitosis Modulators|mitosis modulators|mesh-ancestor
92806790|NCT00863512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806791|NCT00863512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92806792|NCT00863512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92806793|NCT00863512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92806794|NCT02619994|Levofloxacin|levofloxacin|mesh-list
92806795|NCT02619994|Linezolid|linezolid|mesh-list
92806796|NCT02619994|Pyrazinamide|pyrazinamide|mesh-list
92806797|NCT02619994|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92806798|NCT02619994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806799|NCT02619994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806800|NCT02619994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92806801|NCT02619994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92806802|NCT02619994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806803|NCT02619994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806804|NCT02619994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806805|NCT02619994|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92806806|NCT02619994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92806807|NCT02619994|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92806808|NCT02619994|Antitubercular Agents|antitubercular agents|mesh-ancestor
92806809|NCT04263402|Methylprednisolone|methylprednisolone|mesh-list
92806810|NCT04263402|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92806811|NCT04263402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92806812|NCT04263402|Prednisolone|prednisolone|mesh-list
92806813|NCT04263402|Prednisolone acetate|prednisolone acetate|mesh-list
92806814|NCT04263402|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92806815|NCT04263402|Prednisolone phosphate|prednisolone phosphate|mesh-list
92806816|NCT04263402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806817|NCT04263402|Antiemetics|antiemetics|mesh-ancestor
92806818|NCT04263402|Autonomic Agents|autonomic agents|mesh-ancestor
92806819|NCT04263402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806820|NCT04263402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806821|NCT04263402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806822|NCT04263402|Glucocorticoids|glucocorticoids|mesh-ancestor
92806823|NCT04263402|Hormones|hormones|mesh-ancestor
92806824|NCT04263402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806825|NCT04263402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92806826|NCT04263402|Protective Agents|protective agents|mesh-ancestor
92806827|NCT04263402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92806828|NCT04263402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806829|NCT00868192|Bevacizumab|bevacizumab|mesh-list
92806830|NCT00868192|Pemetrexed|pemetrexed|mesh-list
92806831|NCT00868192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806832|NCT00868192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806833|NCT00868192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92806834|NCT00868192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92806835|NCT00868192|Growth Substances|growth substances|mesh-ancestor
92806836|NCT00868192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806837|NCT00868192|Growth Inhibitors|growth inhibitors|mesh-ancestor
92806838|NCT00868192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806839|NCT00868192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806840|NCT00868192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92806841|NCT00868192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92806843|NCT02615782|Tamsulosin|tamsulosin|mesh-list
92806844|NCT02615782|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806845|NCT02615782|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92806846|NCT02615782|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92806847|NCT02615782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806848|NCT02615782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806849|NCT02615782|Urological Agents|urological agents|mesh-ancestor
92806850|NCT02615782|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92806851|NCT02615782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92451830|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
92806852|NCT02615782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92806853|NCT02615782|Adrenergic Agents|adrenergic agents|mesh-ancestor
92806854|NCT02615782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806855|NCT02615782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806856|NCT00930930|Paclitaxel|paclitaxel|mesh-list
92806857|NCT00930930|Everolimus|everolimus|mesh-list
92806858|NCT00930930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92806859|NCT00930930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806860|NCT00930930|Tubulin Modulators|tubulin modulators|mesh-ancestor
92806861|NCT00930930|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806862|NCT00930930|Mitosis Modulators|mitosis modulators|mesh-ancestor
92806863|NCT00930930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806864|NCT00930930|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92806865|NCT00930930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806866|NCT00930930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806867|NCT00930930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92806868|NCT00930930|Immunologic Factors|immunologic factors|mesh-ancestor
92806869|NCT00930930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806870|NCT00698776|Lenalidomide|lenalidomide|mesh-list
92806871|NCT00698776|KRN 7000|krn 7000|mesh-list
92806872|NCT00698776|Immunologic Factors|immunologic factors|mesh-ancestor
92806873|NCT00698776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806874|NCT00698776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92806875|NCT00698776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92806876|NCT00698776|Growth Substances|growth substances|mesh-ancestor
92806877|NCT00698776|Growth Inhibitors|growth inhibitors|mesh-ancestor
92806878|NCT00698776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806879|NCT00698776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92806880|NCT04122040|Roxithromycin|roxithromycin|mesh-list
92806881|NCT04122040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92806882|NCT04122040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806883|NCT04258956|Avelumab|avelumab|mesh-list
92806884|NCT04258956|Axitinib|axitinib|mesh-list
92806885|NCT04258956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806886|NCT04258956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806887|NCT04258956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806888|NCT04258956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026447|NCT00493038|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92806889|NCT04258956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806890|NCT00862654|Ketoconazole|ketoconazole|mesh-list
92806891|NCT00862654|Clobetasol|clobetasol|mesh-list
92806892|NCT00862654|Antifungal Agents|antifungal agents|mesh-ancestor
92806893|NCT00862654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92806894|NCT00862654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92806895|NCT00862654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92806896|NCT00862654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806897|NCT00862654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806898|NCT00862654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92806899|NCT00862654|Hormone Antagonists|hormone antagonists|mesh-ancestor
92806900|NCT00862654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92806901|NCT00862654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806902|NCT00862654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92806903|NCT00862654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92806904|NCT00862654|Glucocorticoids|glucocorticoids|mesh-ancestor
92806905|NCT00862654|Hormones|hormones|mesh-ancestor
92806906|NCT00609180|Antioxidants|antioxidants|mesh-list
92806907|NCT00609180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806908|NCT00609180|Protective Agents|protective agents|mesh-ancestor
92806909|NCT00609180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806910|NCT00867490|Amlodipine|amlodipine|mesh-list
92806911|NCT00867490|Candesartan|candesartan|mesh-list
92806912|NCT00867490|Candesartan cilexetil|candesartan cilexetil|mesh-list
92806913|NCT00867490|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92806914|NCT00867490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92806915|NCT00867490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92806916|NCT00867490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806917|NCT00867490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806918|NCT00867490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92806919|NCT00867490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806920|NCT00867490|Vasodilator Agents|vasodilator agents|mesh-ancestor
92806921|NCT00867490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92806922|NCT00867490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92806923|NCT00867490|Diuretics|diuretics|mesh-ancestor
92806924|NCT00867490|Natriuretic Agents|natriuretic agents|mesh-ancestor
92806925|NCT00867490|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92806926|NCT00697060|Docetaxel|docetaxel|mesh-list
92806927|NCT00697060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806928|NCT00697060|Tubulin Modulators|tubulin modulators|mesh-ancestor
92420285|NCT01505894|BI 409306|bi 409306|mesh-list
92806929|NCT00697060|Antimitotic Agents|antimitotic agents|mesh-ancestor
92806930|NCT00697060|Mitosis Modulators|mitosis modulators|mesh-ancestor
92806931|NCT00697060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806932|NCT00867334|Imatinib Mesylate|imatinib mesylate|mesh-list
92806933|NCT00867334|Panitumumab|panitumumab|mesh-list
92806934|NCT00867334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92806935|NCT00867334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92806936|NCT00867334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92806937|NCT00867334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806938|NCT00867334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92806939|NCT00925704|Calcitriol|calcitriol|mesh-list
92806940|NCT00925704|Sevelamer|sevelamer|mesh-list
92806941|NCT00925704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92806942|NCT00925704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806943|NCT00925704|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92806944|NCT00925704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806945|NCT00925704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806946|NCT00925704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92806947|NCT00925704|Vitamins|vitamins|mesh-ancestor
92806948|NCT00925704|Micronutrients|micronutrients|mesh-ancestor
92806949|NCT00925704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92806950|NCT00925704|Chelating Agents|chelating agents|mesh-ancestor
92806951|NCT00925704|Sequestering Agents|sequestering agents|mesh-ancestor
92806952|NCT00697138|Amphetamine|amphetamine|mesh-list
92806953|NCT00697138|Dextroamphetamine|dextroamphetamine|mesh-list
92806954|NCT00697138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92806955|NCT00697138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92806956|NCT00697138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92806957|NCT00697138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92806958|NCT00697138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806959|NCT00697138|Adrenergic Agents|adrenergic agents|mesh-ancestor
92806960|NCT00697138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806961|NCT00697138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806962|NCT00697138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92806963|NCT00697138|Sympathomimetics|sympathomimetics|mesh-ancestor
92806964|NCT00697138|Autonomic Agents|autonomic agents|mesh-ancestor
92806965|NCT00697138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806966|NCT00697138|Dopamine Agents|dopamine agents|mesh-ancestor
92806967|NCT00697138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92806968|NCT00609960|Midazolam|midazolam|mesh-list
92806969|NCT00609960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92806970|NCT00609960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92806971|NCT00609960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92806972|NCT00609960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806973|NCT00609960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92806974|NCT00609960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92806975|NCT00609960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92806976|NCT00609960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92806977|NCT00609960|Anesthetics, General|anesthetics, general|mesh-ancestor
92806978|NCT00609960|Anesthetics|anesthetics|mesh-ancestor
92806979|NCT00609960|GABA Modulators|gaba modulators|mesh-ancestor
92806980|NCT00609960|GABA Agents|gaba agents|mesh-ancestor
92806981|NCT00609960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806982|NCT00609960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806984|NCT04879134|Emetics|emetics|mesh-ancestor
92806985|NCT04879134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92806986|NCT04879134|Autonomic Agents|autonomic agents|mesh-ancestor
92806987|NCT04879134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92806988|NCT04879134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92806989|NCT04879134|Dopamine Agonists|dopamine agonists|mesh-ancestor
92806990|NCT04879134|Dopamine Agents|dopamine agents|mesh-ancestor
92806991|NCT04879134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92806992|NCT04879134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92806993|NCT04134130|Methyltestosterone|methyltestosterone|mesh-list
92806994|NCT04134130|Testosterone|testosterone|mesh-list
92806995|NCT04134130|Testosterone undecanoate|testosterone undecanoate|mesh-list
92806996|NCT04134130|Testosterone enanthate|testosterone enanthate|mesh-list
92806997|NCT04134130|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92806998|NCT04134130|Androgens|androgens|mesh-ancestor
92806999|NCT04134130|Hormones|hormones|mesh-ancestor
92807000|NCT04134130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807001|NCT04134130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807002|NCT04134130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92807003|NCT04134130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807004|NCT04134130|Anabolic Agents|anabolic agents|mesh-ancestor
92807005|NCT04258644|Paclitaxel|paclitaxel|mesh-list
92807006|NCT04258644|Apatinib|apatinib|mesh-list
92807007|NCT04258644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92807008|NCT04258644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807009|NCT04258644|Tubulin Modulators|tubulin modulators|mesh-ancestor
92807010|NCT04258644|Antimitotic Agents|antimitotic agents|mesh-ancestor
92807011|NCT04258644|Mitosis Modulators|mitosis modulators|mesh-ancestor
92807012|NCT04258644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807013|NCT04258644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807014|NCT04258644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807015|NCT02619448|Paclitaxel|paclitaxel|mesh-list
92807016|NCT02619448|Carboplatin|carboplatin|mesh-list
92807017|NCT02619448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92807018|NCT02619448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807019|NCT02619448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92807020|NCT02619448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92807021|NCT02619448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92807022|NCT02619448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807023|NCT00610038|Glyburide|glyburide|mesh-list
92807024|NCT00610038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92807025|NCT00610038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807026|NCT02619526|Carvedilol|carvedilol|mesh-list
92807027|NCT02619526|Nebivolol|nebivolol|mesh-list
92807028|NCT02619526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92807029|NCT02619526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92807030|NCT02619526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92807031|NCT02619526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807032|NCT02619526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807033|NCT02619526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807034|NCT02619526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92807035|NCT02619526|Antioxidants|antioxidants|mesh-ancestor
92807036|NCT02619526|Protective Agents|protective agents|mesh-ancestor
92807037|NCT02619526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92807038|NCT02619526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92807039|NCT02619526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92807040|NCT02619526|Vasodilator Agents|vasodilator agents|mesh-ancestor
92807041|NCT02619526|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92807042|NCT02619526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92807043|NCT02619526|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92807044|NCT02619526|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92807045|NCT02619526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92807046|NCT04119622|Capecitabine|capecitabine|mesh-list
92807047|NCT04119622|Oxaliplatin|oxaliplatin|mesh-list
92807048|NCT04119622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92807049|NCT04119622|Antimetabolites|antimetabolites|mesh-ancestor
92807050|NCT04119622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807051|NCT04119622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807052|NCT00925548|Cyclophosphamide|cyclophosphamide|mesh-list
92807053|NCT00925548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807054|NCT00925548|Immunologic Factors|immunologic factors|mesh-ancestor
92807055|NCT00925548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807056|NCT00925548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753368|NCT05261399|Carboplatin|carboplatin|mesh-list
92807057|NCT00925548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92807058|NCT00925548|Alkylating Agents|alkylating agents|mesh-ancestor
92807059|NCT00925548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807060|NCT00925548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807061|NCT00925548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92807062|NCT00866788|Omalizumab|omalizumab|mesh-list
92807063|NCT00866788|Diphenhydramine|diphenhydramine|mesh-list
92807064|NCT00866788|Promethazine|promethazine|mesh-list
92807065|NCT00866788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92807066|NCT00866788|Histamine Antagonists|histamine antagonists|mesh-list
92807067|NCT00866788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92807068|NCT00866788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92807069|NCT00866788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92807070|NCT00866788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92807071|NCT00866788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807072|NCT00866788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807073|NCT00866788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807074|NCT00866788|Anesthetics, Local|anesthetics, local|mesh-ancestor
92807075|NCT00866788|Anesthetics|anesthetics|mesh-ancestor
92807076|NCT00866788|Sensory System Agents|sensory system agents|mesh-ancestor
92807077|NCT00866788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807079|NCT00866788|Autonomic Agents|autonomic agents|mesh-ancestor
92807080|NCT00866788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807081|NCT00866788|Histamine Agents|histamine agents|mesh-ancestor
92807082|NCT00866788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807083|NCT00866788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807084|NCT00866788|Antipruritics|antipruritics|mesh-ancestor
92807085|NCT00866788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92807086|NCT04132570|Budesonide|budesonide|mesh-list
92807087|NCT04132570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807088|NCT04132570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92807089|NCT04132570|Autonomic Agents|autonomic agents|mesh-ancestor
92807090|NCT04132570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807091|NCT04132570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807092|NCT04132570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92807093|NCT04132570|Respiratory System Agents|respiratory system agents|mesh-ancestor
92807094|NCT04132570|Glucocorticoids|glucocorticoids|mesh-ancestor
92807095|NCT04132570|Hormones|hormones|mesh-ancestor
92807096|NCT04132570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807097|NCT00699244|Anesthetics|anesthetics|mesh-list
92807098|NCT00699244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807099|NCT00699244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807100|NCT00699322|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92807101|NCT00699322|Glimepiride|glimepiride|mesh-list
92807102|NCT00699322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92807103|NCT00699322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807104|NCT00699322|Incretins|incretins|mesh-ancestor
92807105|NCT00699322|Hormones|hormones|mesh-ancestor
92807106|NCT00699322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807107|NCT00699322|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92807108|NCT00699322|Protease Inhibitors|protease inhibitors|mesh-ancestor
92807109|NCT00699322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807110|NCT00699322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807111|NCT00699322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92807112|NCT00699322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807113|NCT00699322|Immunologic Factors|immunologic factors|mesh-ancestor
92807114|NCT00860470|Iron|iron|mesh-list
92807115|NCT00860470|Trace Elements|trace elements|mesh-list
92807116|NCT00860470|Folic Acid|folic acid|mesh-list
92807117|NCT00860470|Micronutrients|micronutrients|mesh-list
92807118|NCT00860470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807119|NCT00860470|Hematinics|hematinics|mesh-ancestor
92807120|NCT00860470|Vitamin B Complex|vitamin b complex|mesh-ancestor
92807121|NCT00860470|Vitamins|vitamins|mesh-ancestor
92807122|NCT00923364|Cyclophosphamide|cyclophosphamide|mesh-list
92807123|NCT00923364|Fludarabine|fludarabine|mesh-list
92807124|NCT00923364|Fludarabine phosphate|fludarabine phosphate|mesh-list
92807125|NCT00923364|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92807126|NCT00923364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807127|NCT00923364|Immunologic Factors|immunologic factors|mesh-ancestor
92807128|NCT00923364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807129|NCT00923364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807130|NCT00923364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92807131|NCT00923364|Alkylating Agents|alkylating agents|mesh-ancestor
92807132|NCT00923364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807133|NCT00923364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807134|NCT00923364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92807135|NCT00923364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92807136|NCT00923364|Antimetabolites|antimetabolites|mesh-ancestor
92807138|NCT02613676|Antioxidants|antioxidants|mesh-ancestor
92807139|NCT02613676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807140|NCT02613676|Protective Agents|protective agents|mesh-ancestor
92807141|NCT02613676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807142|NCT00860158|Dasatinib|dasatinib|mesh-list
92807143|NCT00860158|Leuprolide|leuprolide|mesh-list
92807144|NCT00860158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807145|NCT00860158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807146|NCT00860158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420467|NCT01506544|Hydroxyurea|hydroxyurea|mesh-list
92807147|NCT00860158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807148|NCT00860158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92807149|NCT00860158|Fertility Agents|fertility agents|mesh-ancestor
92807150|NCT00860158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92807151|NCT00860158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452126|NCT03785106|Vitamins|vitamins|mesh-list
92807152|NCT00860158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92807153|NCT02878538|Deferiprone|deferiprone|mesh-list
92807154|NCT02878538|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92807155|NCT02878538|Chelating Agents|chelating agents|mesh-ancestor
92807156|NCT02878538|Sequestering Agents|sequestering agents|mesh-ancestor
92807157|NCT02878538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807158|NCT04134598|Tamoxifen|tamoxifen|mesh-list
92807159|NCT04134598|Letrozole|letrozole|mesh-list
92807160|NCT04134598|Anastrozole|anastrozole|mesh-list
92807161|NCT04134598|Exemestane|exemestane|mesh-list
92807162|NCT04134598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807163|NCT04134598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92807164|NCT04134598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92807165|NCT04134598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807166|NCT04134598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807167|NCT04134598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92807168|NCT04134598|Hormone Antagonists|hormone antagonists|mesh-ancestor
92807169|NCT04134598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807170|NCT04134598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807171|NCT04134598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92807172|NCT04134598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92807173|NCT04134598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92807174|NCT04134598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92807175|NCT04134052|Midazolam|midazolam|mesh-list
92807176|NCT04134052|Ketamine|ketamine|mesh-list
92807177|NCT04134052|Analgesics|analgesics|mesh-ancestor
92807178|NCT04134052|Sensory System Agents|sensory system agents|mesh-ancestor
92807179|NCT04134052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807180|NCT04134052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807181|NCT04134052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92807182|NCT04134052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92807183|NCT04134052|Anesthetics, General|anesthetics, general|mesh-ancestor
92807184|NCT04134052|Anesthetics|anesthetics|mesh-ancestor
92807185|NCT04134052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807186|NCT04134052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92807187|NCT04134052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92807188|NCT04134052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807189|NCT04134052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807190|NCT04134052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92807191|NCT04134052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807192|NCT04134052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92807193|NCT04134052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807194|NCT04134052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807195|NCT04134052|GABA Modulators|gaba modulators|mesh-ancestor
92807196|NCT04134052|GABA Agents|gaba agents|mesh-ancestor
92807197|NCT02615080|Pemirolast|pemirolast|mesh-list
92807198|NCT02615080|Histamine Antagonists|histamine antagonists|mesh-ancestor
92807199|NCT02615080|Histamine Agents|histamine agents|mesh-ancestor
92420542|NCT01506765|Antidotes|antidotes|mesh-ancestor
92807200|NCT02615080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807201|NCT02615080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807202|NCT02615080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807203|NCT00859456|Sunitinib|sunitinib|mesh-list
92807204|NCT00859456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807205|NCT00859456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807206|NCT00859456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807207|NCT00859456|Growth Substances|growth substances|mesh-ancestor
92807208|NCT00859456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807209|NCT00859456|Growth Inhibitors|growth inhibitors|mesh-ancestor
92807210|NCT00859456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807211|NCT00859456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807212|NCT00859456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807213|NCT01075646|Ropivacaine|ropivacaine|mesh-list
92807214|NCT01075646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92807215|NCT01075646|Anesthetics, Local|anesthetics, local|mesh-ancestor
92807216|NCT01075646|Anesthetics|anesthetics|mesh-ancestor
92807217|NCT01075646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807218|NCT01075646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807219|NCT01075646|Sensory System Agents|sensory system agents|mesh-ancestor
92807220|NCT01075646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807221|NCT00799903|Darapladib|darapladib|mesh-list
92807222|NCT00799903|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92807223|NCT00799903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807224|NCT00799903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807225|NCT01075256|Calcium, Dietary|calcium, dietary|mesh-list
92452206|NCT03760835|Hormones|hormones|mesh-ancestor
92807226|NCT01075256|Calcium|calcium|mesh-list
92807227|NCT01075256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92807228|NCT01075256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807229|NCT01075256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92807230|NCT02876432|Diclofenac|diclofenac|mesh-list
92807231|NCT02876432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92807232|NCT02876432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92807233|NCT02876432|Analgesics|analgesics|mesh-ancestor
92807234|NCT02876432|Sensory System Agents|sensory system agents|mesh-ancestor
92807235|NCT02876432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807236|NCT02876432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807237|NCT02876432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807238|NCT02876432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807239|NCT02876432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92807240|NCT02876432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807241|NCT02876432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807242|NCT02876276|Hyaluronic Acid|hyaluronic acid|mesh-list
92807243|NCT02876276|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92807244|NCT02876276|Immunologic Factors|immunologic factors|mesh-ancestor
92807245|NCT02876276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807246|NCT02876276|Viscosupplements|viscosupplements|mesh-ancestor
92807247|NCT02876276|Protective Agents|protective agents|mesh-ancestor
92807248|NCT00923130|Bevacizumab|bevacizumab|mesh-list
92807249|NCT00923130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807250|NCT00923130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807251|NCT00923130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807252|NCT00923130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807253|NCT00923130|Growth Substances|growth substances|mesh-ancestor
92807254|NCT00923130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807255|NCT00923130|Growth Inhibitors|growth inhibitors|mesh-ancestor
92807256|NCT04258098|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92807257|NCT04258098|Metronidazole|metronidazole|mesh-list
92807258|NCT04258098|Streptomycin|streptomycin|mesh-list
92807259|NCT04258098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807260|NCT04258098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92807261|NCT04258098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92807262|NCT04258098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92807263|NCT04258098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807264|NCT04258098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807265|NCT02605915|Cyclophosphamide|cyclophosphamide|mesh-list
92807266|NCT02605915|Carboplatin|carboplatin|mesh-list
92807267|NCT02605915|Docetaxel|docetaxel|mesh-list
92807268|NCT02605915|Doxorubicin|doxorubicin|mesh-list
92807269|NCT02605915|Trastuzumab|trastuzumab|mesh-list
92807270|NCT02605915|Atezolizumab|atezolizumab|mesh-list
92807271|NCT02605915|Pertuzumab|pertuzumab|mesh-list
92807272|NCT02605915|Maytansine|maytansine|mesh-list
92807273|NCT02605915|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92807274|NCT02605915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807275|NCT02605915|Immunologic Factors|immunologic factors|mesh-ancestor
92807276|NCT02605915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807277|NCT02605915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807278|NCT02605915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92807279|NCT02605915|Alkylating Agents|alkylating agents|mesh-ancestor
92807280|NCT02605915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807281|NCT02605915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807282|NCT02605915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92807283|NCT02605915|Tubulin Modulators|tubulin modulators|mesh-ancestor
92807284|NCT02605915|Antimitotic Agents|antimitotic agents|mesh-ancestor
92807285|NCT02605915|Mitosis Modulators|mitosis modulators|mesh-ancestor
92807286|NCT02605915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92807287|NCT02605915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92807288|NCT02605915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92807289|NCT02605915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807290|NCT02605915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807291|NCT02605915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92807292|NCT02605915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92807293|NCT02605915|Immunotoxins|immunotoxins|mesh-ancestor
92807294|NCT02605915|Immunoconjugates|immunoconjugates|mesh-ancestor
92807295|NCT04028323|Octreotide|octreotide|mesh-list
92807296|NCT04028323|Terlipressin|terlipressin|mesh-list
92807297|NCT04028323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807298|NCT04028323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92807299|NCT04028323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807300|NCT04028323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92807301|NCT04028323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92807302|NCT02607163|Dexmedetomidine|dexmedetomidine|mesh-list
92807303|NCT02607163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807304|NCT02607163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807305|NCT02607163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807306|NCT02607163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92807307|NCT02607163|Analgesics|analgesics|mesh-ancestor
92807308|NCT02607163|Sensory System Agents|sensory system agents|mesh-ancestor
92807309|NCT02607163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807310|NCT02607163|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92807311|NCT02607163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92807312|NCT02607163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92807313|NCT02607163|Adrenergic Agents|adrenergic agents|mesh-ancestor
92807314|NCT02607163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807315|NCT02607163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807316|NCT01075100|Carboplatin|carboplatin|mesh-list
92807317|NCT01075100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807318|NCT02876354|Vitamin K|vitamin k|mesh-list
92807319|NCT02876354|Vitamin K 2|vitamin k 2|mesh-list
92807320|NCT02876354|Vitamins|vitamins|mesh-ancestor
92807321|NCT02876354|Micronutrients|micronutrients|mesh-ancestor
92807322|NCT02876354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807323|NCT02876354|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92807324|NCT02876354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92807325|NCT02876354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807326|NCT02876354|Hemostatics|hemostatics|mesh-ancestor
92807327|NCT02876354|Coagulants|coagulants|mesh-ancestor
92807328|NCT00626678|Prednisone|prednisone|mesh-list
92807329|NCT00626678|Azathioprine|azathioprine|mesh-list
92807330|NCT00626678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807331|NCT00626678|Glucocorticoids|glucocorticoids|mesh-ancestor
92807332|NCT00626678|Hormones|hormones|mesh-ancestor
92807333|NCT00626678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807334|NCT00626678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807335|NCT00626678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92807336|NCT00626678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807337|NCT00626678|Antimetabolites|antimetabolites|mesh-ancestor
92807338|NCT00626678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807339|NCT00626678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92807340|NCT00626678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807341|NCT00626678|Immunologic Factors|immunologic factors|mesh-ancestor
92807342|NCT00626678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807343|NCT00803023|Sodium Oxybate|sodium oxybate|mesh-list
92807344|NCT00803023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92807345|NCT00803023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92807346|NCT00803023|Anesthetics, General|anesthetics, general|mesh-ancestor
92807347|NCT00803023|Anesthetics|anesthetics|mesh-ancestor
92807348|NCT00803023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807349|NCT00803023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807350|NCT03076021|Dextromethorphan|dextromethorphan|mesh-list
92807351|NCT03076021|Isotretinoin|isotretinoin|mesh-list
92807352|NCT03076021|Antitussive Agents|antitussive agents|mesh-ancestor
92807353|NCT03076021|Respiratory System Agents|respiratory system agents|mesh-ancestor
92807354|NCT03076021|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92807355|NCT03076021|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92807356|NCT03076021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807357|NCT03076021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807358|NCT03076021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807359|NCT03076021|Dermatologic Agents|dermatologic agents|mesh-ancestor
92807360|NCT00859222|Bevacizumab|bevacizumab|mesh-list
92807361|NCT00859222|Panobinostat|panobinostat|mesh-list
92807362|NCT00859222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807363|NCT00859222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807364|NCT00859222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807365|NCT00859222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807366|NCT00859222|Growth Substances|growth substances|mesh-ancestor
92807367|NCT00859222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807368|NCT00859222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92807369|NCT00859222|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92807370|NCT00859222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807371|NCT00859222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807372|NCT00858988|Rifaximin|rifaximin|mesh-list
92807373|NCT00858988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807374|NCT00858988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807375|NCT00858988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807376|NCT00858832|Methylergonovine|methylergonovine|mesh-list
92452356|NCT03573115|Adapalene|adapalene|mesh-list
92807377|NCT00858832|Oxytocics|oxytocics|mesh-ancestor
92807378|NCT00858832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92807379|NCT00858832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807380|NCT01071512|Natalizumab|natalizumab|mesh-list
92807381|NCT01071512|Immunologic Factors|immunologic factors|mesh-ancestor
92807382|NCT01071512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807383|NCT00626834|Vigabatrin|vigabatrin|mesh-list
92807384|NCT00626834|Anticonvulsants|anticonvulsants|mesh-ancestor
92807385|NCT00626834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807386|NCT00626834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807387|NCT00626834|GABA Agents|gaba agents|mesh-ancestor
92807388|NCT00626834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807389|NCT00626834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807390|NCT04255992|Calcium, Dietary|calcium, dietary|mesh-list
92807391|NCT04255992|Vitamin D|vitamin d|mesh-list
92807392|NCT04255992|Calcium|calcium|mesh-list
92807393|NCT04255992|Vitamins|vitamins|mesh-ancestor
92807394|NCT04255992|Micronutrients|micronutrients|mesh-ancestor
92807395|NCT04255992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807396|NCT04255992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92807397|NCT04255992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92807398|NCT02618824|Tryptophan|tryptophan|mesh-list
92807399|NCT02618824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92807400|NCT02618824|Antidepressive Agents|antidepressive agents|mesh-ancestor
92807401|NCT02618824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807402|NCT00610350|Simendan|simendan|mesh-list
92807403|NCT00610350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92807404|NCT00610350|Vasodilator Agents|vasodilator agents|mesh-ancestor
92807405|NCT00610350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92807406|NCT00610350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92807407|NCT00610350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807408|NCT00610350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807409|NCT00610350|Protective Agents|protective agents|mesh-ancestor
92807410|NCT00610350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807411|NCT01071200|Hormones|hormones|mesh-list
92807412|NCT01071200|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92807413|NCT01071200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807414|NCT01071200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807415|NCT04255836|Durvalumab|durvalumab|mesh-list
92807416|NCT04255836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807417|NCT04255836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807418|NCT00699478|Vitamin B 12|vitamin b 12|mesh-list
92807419|NCT00699478|Vitamin B Complex|vitamin b complex|mesh-ancestor
92807420|NCT00699478|Vitamins|vitamins|mesh-ancestor
92807421|NCT00699478|Micronutrients|micronutrients|mesh-ancestor
92807422|NCT00699478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807423|NCT01070888|Budesonide|budesonide|mesh-list
92807424|NCT01070888|Formoterol Fumarate|formoterol fumarate|mesh-list
92807425|NCT01070888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807426|NCT01070888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92807427|NCT01070888|Autonomic Agents|autonomic agents|mesh-ancestor
92807428|NCT01070888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807429|NCT01070888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807430|NCT01070888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92807431|NCT01070888|Respiratory System Agents|respiratory system agents|mesh-ancestor
92807433|NCT01070888|Hormones|hormones|mesh-ancestor
92807434|NCT01070888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807435|NCT01070888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92807436|NCT01070888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92807437|NCT01070888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92807438|NCT01070888|Adrenergic Agents|adrenergic agents|mesh-ancestor
92807439|NCT01070888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807440|NCT01070888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807441|NCT00857896|Fesoterodine|fesoterodine|mesh-list
92807442|NCT00857896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92807443|NCT00857896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92807444|NCT00857896|Cholinergic Agents|cholinergic agents|mesh-ancestor
92807445|NCT00857896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807446|NCT00857896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807447|NCT00857896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807448|NCT00857896|Urological Agents|urological agents|mesh-ancestor
92807449|NCT05652673|Nivolumab|nivolumab|mesh-list
92452434|NCT03500549|Eculizumab|eculizumab|mesh-list
92807450|NCT05652673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807451|NCT05652673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807452|NCT05652673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92807453|NCT05652673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807454|NCT00857818|Risperidone|risperidone|mesh-list
92807455|NCT00857818|Aripiprazole|aripiprazole|mesh-list
92807456|NCT00857818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92807457|NCT00857818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92807458|NCT00857818|Serotonin Agents|serotonin agents|mesh-ancestor
92807459|NCT00857818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807460|NCT00857818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807461|NCT00857818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807462|NCT00857818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92807463|NCT00857818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807464|NCT00857818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807465|NCT00857818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807466|NCT00857818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92807467|NCT00857818|Dopamine Agents|dopamine agents|mesh-ancestor
92807468|NCT00857818|Antidepressive Agents|antidepressive agents|mesh-ancestor
92420805|NCT01507857|Vaccines|vaccines|mesh-list
92807469|NCT00857818|Dopamine Agonists|dopamine agonists|mesh-ancestor
92807470|NCT00857818|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92807471|NCT00857818|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92807472|NCT00857818|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92807473|NCT00857818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92807474|NCT02618668|Ketamine|ketamine|mesh-list
92807475|NCT02618668|Propofol|propofol|mesh-list
92807476|NCT02618668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807477|NCT02618668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807478|NCT02618668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807479|NCT02618668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92807480|NCT02618668|Anesthetics, General|anesthetics, general|mesh-ancestor
92807481|NCT02618668|Anesthetics|anesthetics|mesh-ancestor
92807482|NCT02618668|Analgesics|analgesics|mesh-ancestor
92807483|NCT02618668|Sensory System Agents|sensory system agents|mesh-ancestor
92807484|NCT02618668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807485|NCT02618668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92807486|NCT02618668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92807487|NCT02618668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92807488|NCT02618668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807489|NCT02618668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807490|NCT01074944|Eliglustat|eliglustat|mesh-list
92807491|NCT01074944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807492|NCT01074944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807493|NCT00802945|Etirinotecan pegol|etirinotecan pegol|mesh-list
92807494|NCT00802945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807495|NCT00802945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92807496|NCT00802945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92807497|NCT00802945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807498|NCT00802945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807499|NCT01074554|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92807500|NCT01074554|Azithromycin|azithromycin|mesh-list
92807501|NCT01074554|Levofloxacin|levofloxacin|mesh-list
92807502|NCT01074554|Rifampin|rifampin|mesh-list
92807503|NCT01074554|Ethambutol|ethambutol|mesh-list
92753824|NCT04166877|Tocolytic Agents|tocolytic agents|mesh-ancestor
92807504|NCT01074554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807505|NCT01074554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92807506|NCT01074554|Antitubercular Agents|antitubercular agents|mesh-ancestor
92807507|NCT01074554|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92807508|NCT01074554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92807509|NCT01074554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92807510|NCT01074554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807511|NCT01074554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807512|NCT01074554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807513|NCT01074554|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92807514|NCT01074554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92807515|NCT01074554|Leprostatic Agents|leprostatic agents|mesh-ancestor
92807516|NCT01074554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92807517|NCT01074554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92807518|NCT01074554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92807519|NCT01074554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92807520|NCT01074554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92807521|NCT01074554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92807522|NCT01074554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92807523|NCT00857584|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92807524|NCT00857584|Sertraline|sertraline|mesh-list
92807525|NCT00857584|Antidepressive Agents|antidepressive agents|mesh-ancestor
92807526|NCT00857584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807527|NCT00857584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92807528|NCT00857584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807529|NCT00857584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807530|NCT00857584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807531|NCT00857584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92807532|NCT00857584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92807533|NCT00857584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92807534|NCT00857584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807535|NCT00857584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807537|NCT00798967|Teduglutide|teduglutide|mesh-list
92807538|NCT00798967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807539|NCT00798967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92807540|NCT00798967|Protective Agents|protective agents|mesh-ancestor
92807541|NCT00798967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807542|NCT04132102|Afatinib|afatinib|mesh-list
92807543|NCT04132102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807544|NCT04132102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807545|NCT04132102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807546|NCT04132102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807547|NCT02618356|Raltitrexed|raltitrexed|mesh-list
92807548|NCT02618356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92807549|NCT02618356|Antimetabolites|antimetabolites|mesh-ancestor
92807550|NCT02618356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807551|NCT02618356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807552|NCT02618356|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92807553|NCT02618356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807554|NCT00697996|Rituximab|rituximab|mesh-list
92807555|NCT00697996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807556|NCT00697996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807557|NCT00697996|Immunologic Factors|immunologic factors|mesh-ancestor
92807558|NCT00697996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807559|NCT00697996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807560|NCT04118842|Rifampin|rifampin|mesh-list
92807561|NCT04118842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92807562|NCT04118842|Antitubercular Agents|antitubercular agents|mesh-ancestor
92807563|NCT04118842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807564|NCT04118842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807565|NCT04118842|Leprostatic Agents|leprostatic agents|mesh-ancestor
92807566|NCT04118842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92807567|NCT04118842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807568|NCT04118842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807569|NCT04118842|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92807570|NCT04118842|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92807571|NCT04118842|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92807572|NCT04118842|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92807573|NCT04118842|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92807574|NCT04118842|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92807575|NCT00699634|Nabilone|nabilone|mesh-list
92807576|NCT00699634|Antiemetics|antiemetics|mesh-ancestor
92807577|NCT00699634|Autonomic Agents|autonomic agents|mesh-ancestor
92807578|NCT00699634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807579|NCT00699634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807580|NCT00699634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807581|NCT00699634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92807582|NCT00699634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807583|NCT00699634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807584|NCT00699634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807585|NCT00798889|Sunitinib|sunitinib|mesh-list
92807586|NCT00798889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807587|NCT00798889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807588|NCT00798889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807589|NCT00798889|Growth Substances|growth substances|mesh-ancestor
92807590|NCT00798889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807591|NCT00798889|Growth Inhibitors|growth inhibitors|mesh-ancestor
92807592|NCT00798889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807593|NCT00798889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807594|NCT00798889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807595|NCT04113889|Acetylcarnitine|acetylcarnitine|mesh-list
92807596|NCT04113889|Metformin|metformin|mesh-list
92807597|NCT04113889|Pioglitazone|pioglitazone|mesh-list
92807598|NCT04113889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92807599|NCT04113889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807600|NCT04113889|Vitamin B Complex|vitamin b complex|mesh-ancestor
92807601|NCT04113889|Vitamins|vitamins|mesh-ancestor
92807602|NCT04113889|Micronutrients|micronutrients|mesh-ancestor
92807603|NCT04113889|Nootropic Agents|nootropic agents|mesh-ancestor
92807604|NCT00796861|Sunitinib|sunitinib|mesh-list
92807605|NCT00796861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807606|NCT00796861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807607|NCT00796861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807608|NCT00796861|Growth Substances|growth substances|mesh-ancestor
92807609|NCT00796861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807610|NCT00796861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92807611|NCT00796861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807612|NCT00796861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807613|NCT00796861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807614|NCT00914563|Lithium Carbonate|lithium carbonate|mesh-list
92807615|NCT00914563|Antidepressive Agents|antidepressive agents|mesh-ancestor
92807616|NCT00914563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807617|NCT00914563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807618|NCT00914563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807619|NCT00914563|Antimanic Agents|antimanic agents|mesh-ancestor
92807620|NCT00914563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807621|NCT00914563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807622|NCT00914563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807623|NCT00914797|Terbutaline|terbutaline|mesh-list
92807624|NCT00914797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92807625|NCT00914797|Autonomic Agents|autonomic agents|mesh-ancestor
92807626|NCT00914797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807627|NCT00914797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807628|NCT00914797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92807629|NCT00914797|Respiratory System Agents|respiratory system agents|mesh-ancestor
92807630|NCT00914797|Sympathomimetics|sympathomimetics|mesh-ancestor
92807631|NCT00914797|Tocolytic Agents|tocolytic agents|mesh-ancestor
92807632|NCT00914797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92807633|NCT00914797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92807634|NCT00914797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92807635|NCT00914797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92807636|NCT00914797|Adrenergic Agents|adrenergic agents|mesh-ancestor
92807637|NCT00914797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807638|NCT00914797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807639|NCT00798655|Cisplatin|cisplatin|mesh-list
92807640|NCT00798655|Panitumumab|panitumumab|mesh-list
92807641|NCT00798655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807642|NCT00798655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807643|NCT00914641|Apixaban|apixaban|mesh-list
92807644|NCT00914641|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92807645|NCT00914641|Antithrombins|antithrombins|mesh-ancestor
92807646|NCT00914641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92807647|NCT00914641|Protease Inhibitors|protease inhibitors|mesh-ancestor
92807648|NCT00914641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807649|NCT00914641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807650|NCT00914641|Anticoagulants|anticoagulants|mesh-ancestor
92807651|NCT00796549|Afatinib|afatinib|mesh-list
92807652|NCT00796549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807653|NCT00796549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807654|NCT00796549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807655|NCT00796549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807656|NCT00856492|Paclitaxel|paclitaxel|mesh-list
92807657|NCT00856492|Cyclophosphamide|cyclophosphamide|mesh-list
92807658|NCT00856492|Bevacizumab|bevacizumab|mesh-list
92807659|NCT00856492|Doxorubicin|doxorubicin|mesh-list
92807660|NCT00856492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92807661|NCT00856492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92807662|NCT00856492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92807663|NCT00856492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807664|NCT00856492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92807665|NCT00856492|Antimitotic Agents|antimitotic agents|mesh-ancestor
92807666|NCT00856492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92807667|NCT00856492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807668|NCT00856492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807669|NCT00856492|Immunologic Factors|immunologic factors|mesh-ancestor
92807670|NCT00856492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807671|NCT00856492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807672|NCT00856492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92807673|NCT00856492|Alkylating Agents|alkylating agents|mesh-ancestor
92807674|NCT00856492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92807675|NCT00856492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807676|NCT00856492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807677|NCT00856492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807678|NCT00856492|Growth Substances|growth substances|mesh-ancestor
92807679|NCT00856492|Growth Inhibitors|growth inhibitors|mesh-ancestor
92145703|NCT03510390|Metformin|metformin|mesh-list
92807680|NCT00856492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92807681|NCT00856492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92807682|NCT00856492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92807683|NCT00856492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807685|NCT04111159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807686|NCT04111159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807687|NCT04111159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807688|NCT04111159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92807689|NCT04111159|Anesthetics, General|anesthetics, general|mesh-ancestor
92807690|NCT04111159|Anesthetics|anesthetics|mesh-ancestor
92807691|NCT00697372|Sirolimus|sirolimus|mesh-list
92807692|NCT00697372|Everolimus|everolimus|mesh-list
92807693|NCT00697372|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92807694|NCT00697372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807695|NCT00697372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807696|NCT00697372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807697|NCT00697372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807698|NCT00697372|Immunologic Factors|immunologic factors|mesh-ancestor
92807699|NCT00697372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807700|NCT00697372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807701|NCT00697372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807702|NCT00697372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807703|NCT00697372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92807704|NCT00697372|Antifungal Agents|antifungal agents|mesh-ancestor
92807705|NCT04111003|Anesthetics|anesthetics|mesh-list
92807706|NCT04111003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807707|NCT04111003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807708|NCT00856180|Cyclophosphamide|cyclophosphamide|mesh-list
92807709|NCT00856180|Bevacizumab|bevacizumab|mesh-list
92807710|NCT00856180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92807711|NCT00856180|Immunologic Factors|immunologic factors|mesh-ancestor
92807712|NCT00856180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807713|NCT00856180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807714|NCT00856180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92807715|NCT00856180|Alkylating Agents|alkylating agents|mesh-ancestor
92807716|NCT00856180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807717|NCT00856180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807718|NCT00856180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92807719|NCT00856180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807720|NCT00856180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92807721|NCT00856180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92807722|NCT00856180|Growth Substances|growth substances|mesh-ancestor
92807723|NCT00856180|Growth Inhibitors|growth inhibitors|mesh-ancestor
92807724|NCT02605213|Vancomycin|vancomycin|mesh-list
92807725|NCT02605213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807726|NCT02605213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807727|NCT00900627|Paclitaxel|paclitaxel|mesh-list
92807728|NCT00900627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92807729|NCT00900627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807730|NCT00900627|Tubulin Modulators|tubulin modulators|mesh-ancestor
92807731|NCT00900627|Antimitotic Agents|antimitotic agents|mesh-ancestor
92807732|NCT00900627|Mitosis Modulators|mitosis modulators|mesh-ancestor
92807733|NCT00900627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807734|NCT00866320|Sorafenib|sorafenib|mesh-list
92807735|NCT00866320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807736|NCT00866320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807737|NCT00866320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807738|NCT00866320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807739|NCT04115449|Dexmedetomidine|dexmedetomidine|mesh-list
92807740|NCT04115449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807741|NCT04115449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807742|NCT04115449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807743|NCT04115449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92807744|NCT04115449|Analgesics|analgesics|mesh-ancestor
92807745|NCT04115449|Sensory System Agents|sensory system agents|mesh-ancestor
92807746|NCT04115449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807747|NCT04115449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92807748|NCT04115449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92807749|NCT04115449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92807750|NCT04115449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92807751|NCT04115449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807752|NCT04115449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807753|NCT04133974|Methadone|methadone|mesh-list
92807754|NCT04133974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92807755|NCT04133974|Narcotics|narcotics|mesh-ancestor
92807756|NCT04133974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807757|NCT04133974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807758|NCT04133974|Analgesics|analgesics|mesh-ancestor
92807759|NCT04133974|Sensory System Agents|sensory system agents|mesh-ancestor
92807760|NCT04133974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807761|NCT04133974|Antitussive Agents|antitussive agents|mesh-ancestor
92807762|NCT04133974|Respiratory System Agents|respiratory system agents|mesh-ancestor
92807763|NCT03679611|Neostigmine|neostigmine|mesh-list
92807764|NCT03679611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92807765|NCT03679611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807766|NCT03679611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807767|NCT03679611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92807768|NCT03679611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807769|NCT03679611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807770|NCT03679611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92807771|NCT03679611|Autonomic Agents|autonomic agents|mesh-ancestor
92807772|NCT03679611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807773|NCT00914953|Oxytocin|oxytocin|mesh-list
92807774|NCT00914953|Oxytocics|oxytocics|mesh-ancestor
92807775|NCT00914953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92807776|NCT00914953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807777|NCT00869518|Trimethoprim|trimethoprim|mesh-list
92807778|NCT00869518|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92807779|NCT00869518|Sulfamethoxazole|sulfamethoxazole|mesh-list
92807780|NCT00869518|Rifabutin|rifabutin|mesh-list
92807781|NCT00869518|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92807782|NCT00869518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807783|NCT00869518|Antimalarials|antimalarials|mesh-ancestor
92807784|NCT00869518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92807785|NCT00869518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92807786|NCT00869518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92807787|NCT00869518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807788|NCT00869518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807789|NCT00869518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92807790|NCT00869518|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92807791|NCT00869518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92807792|NCT00869518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807793|NCT00869518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92807794|NCT00869518|Antitubercular Agents|antitubercular agents|mesh-ancestor
92807795|NCT00869440|Midazolam|midazolam|mesh-list
92807796|NCT00869440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92807797|NCT00869440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807798|NCT00869440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807799|NCT00869440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807800|NCT00869440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92807801|NCT00869440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807802|NCT00869440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807803|NCT00869440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92807804|NCT00869440|Anesthetics, General|anesthetics, general|mesh-ancestor
92807805|NCT00869440|Anesthetics|anesthetics|mesh-ancestor
92807806|NCT00869440|GABA Modulators|gaba modulators|mesh-ancestor
92807807|NCT00869440|GABA Agents|gaba agents|mesh-ancestor
92807808|NCT00869440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807809|NCT00869440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807810|NCT00895947|Interferons|interferons|mesh-list
92807811|NCT00895947|Interferon-alpha|interferon-alpha|mesh-list
92807812|NCT00895947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807813|NCT00895947|Antiviral Agents|antiviral agents|mesh-ancestor
92807814|NCT00895947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807815|NCT00895947|Immunologic Factors|immunologic factors|mesh-ancestor
92807816|NCT00895947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807817|NCT02604823|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92807818|NCT02604823|Antiviral Agents|antiviral agents|mesh-ancestor
92807819|NCT02604823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807820|NCT02841579|Osimertinib|osimertinib|mesh-list
92807821|NCT02841579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807822|NCT02841579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452805|NCT03164889|Molgramostim|molgramostim|mesh-list
92807823|NCT02841579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807824|NCT02841579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807825|NCT00588445|Gefitinib|gefitinib|mesh-list
92807826|NCT00588445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807827|NCT00588445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807828|NCT00588445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807829|NCT00588445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807830|NCT00092781|Celecoxib|celecoxib|mesh-list
92807831|NCT00092781|Etoricoxib|etoricoxib|mesh-list
92807832|NCT00092781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92807833|NCT00092781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92807834|NCT00092781|Analgesics|analgesics|mesh-ancestor
92807835|NCT00092781|Sensory System Agents|sensory system agents|mesh-ancestor
92807836|NCT00092781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807837|NCT00092781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807838|NCT00092781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807839|NCT00092781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807840|NCT00092781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92807841|NCT00092781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92807842|NCT00092781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807843|NCT00092781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807844|NCT00092703|Diclofenac|diclofenac|mesh-list
92807845|NCT00092703|Etoricoxib|etoricoxib|mesh-list
92807846|NCT00092703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92807847|NCT00092703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92807848|NCT00092703|Analgesics|analgesics|mesh-ancestor
92807849|NCT00092703|Sensory System Agents|sensory system agents|mesh-ancestor
92807850|NCT00092703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807851|NCT00092703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807852|NCT00092703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807853|NCT00092703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807854|NCT00092703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92807855|NCT00092703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807856|NCT00092703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807857|NCT00092703|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92807858|NCT00699946|Olanzapine|olanzapine|mesh-list
92807859|NCT00699946|Antiemetics|antiemetics|mesh-ancestor
92807860|NCT00699946|Autonomic Agents|autonomic agents|mesh-ancestor
92807861|NCT00699946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807862|NCT00699946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807863|NCT00699946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807864|NCT00699946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92807865|NCT00699946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807866|NCT00699946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807867|NCT00699946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807868|NCT00699946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92807869|NCT00699946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92807870|NCT00699946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92807871|NCT00699946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807872|NCT00699946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807873|NCT00699946|Serotonin Agents|serotonin agents|mesh-ancestor
92807875|NCT00796315|Doxylamine succinate|doxylamine succinate|mesh-list
92807876|NCT00796315|Antiemetics|antiemetics|mesh-ancestor
92807877|NCT00796315|Autonomic Agents|autonomic agents|mesh-ancestor
92807878|NCT00796315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807879|NCT00796315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807880|NCT00796315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807881|NCT00796315|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92807882|NCT00796315|Histamine Antagonists|histamine antagonists|mesh-ancestor
92807883|NCT00796315|Histamine Agents|histamine agents|mesh-ancestor
92807884|NCT00796315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807885|NCT00796315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807886|NCT00855166|Metformin|metformin|mesh-list
92807887|NCT00855166|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92807888|NCT00855166|Dapagliflozin|dapagliflozin|mesh-list
92807889|NCT00855166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92807890|NCT00855166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807891|NCT00855166|Incretins|incretins|mesh-ancestor
92807892|NCT00855166|Hormones|hormones|mesh-ancestor
92807893|NCT00855166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807894|NCT00855166|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92807895|NCT00855166|Protease Inhibitors|protease inhibitors|mesh-ancestor
92452881|NCT03012815|Antimanic Agents|antimanic agents|mesh-ancestor
92807896|NCT00855166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807897|NCT00855166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807898|NCT00855166|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92807899|NCT00854620|Sorafenib|sorafenib|mesh-list
92807900|NCT00854620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807901|NCT00854620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807902|NCT00854620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807903|NCT00854620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807904|NCT00793585|Allopurinol|allopurinol|mesh-list
92807905|NCT00793585|Antimetabolites|antimetabolites|mesh-ancestor
92807906|NCT00793585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807907|NCT00793585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807908|NCT00793585|Gout Suppressants|gout suppressants|mesh-ancestor
92807909|NCT00793585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92807910|NCT00793585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92807911|NCT00793585|Antioxidants|antioxidants|mesh-ancestor
92807912|NCT00793585|Protective Agents|protective agents|mesh-ancestor
92807913|NCT00793585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807914|NCT02013141|Telavancin|telavancin|mesh-list
92807915|NCT02013141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92807916|NCT02013141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92807917|NCT04107103|Nivolumab|nivolumab|mesh-list
92807918|NCT04107103|Pemetrexed|pemetrexed|mesh-list
92807919|NCT04107103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92807920|NCT04107103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807921|NCT04107103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92807922|NCT04107103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807923|NCT04107103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807924|NCT04107103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92807925|NCT04107103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92807926|NCT02617810|Midazolam|midazolam|mesh-list
92807927|NCT02617810|Warfarin|warfarin|mesh-list
92807928|NCT02617810|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92807929|NCT02617810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807930|NCT02617810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807931|NCT02617810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807932|NCT02617810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92807933|NCT02617810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92807934|NCT02617810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807935|NCT02617810|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92807936|NCT02617810|Anesthetics, General|anesthetics, general|mesh-ancestor
92807937|NCT02617810|Anesthetics|anesthetics|mesh-ancestor
92807938|NCT02617810|GABA Modulators|gaba modulators|mesh-ancestor
92807939|NCT02617810|GABA Agents|gaba agents|mesh-ancestor
92807940|NCT02617810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807941|NCT02617810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807942|NCT02617810|Anticoagulants|anticoagulants|mesh-ancestor
92807943|NCT00898443|Anesthetics|anesthetics|mesh-list
92807944|NCT00898443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807945|NCT00898443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807946|NCT02614612|Prednisone|prednisone|mesh-list
92807947|NCT02614612|Methylprednisolone|methylprednisolone|mesh-list
92807948|NCT02614612|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92807949|NCT02614612|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92807950|NCT02614612|Prednisolone|prednisolone|mesh-list
92807951|NCT02614612|Prednisolone acetate|prednisolone acetate|mesh-list
92807952|NCT02614612|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92807953|NCT02614612|Prednisolone phosphate|prednisolone phosphate|mesh-list
92807954|NCT02614612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92807955|NCT02614612|Glucocorticoids|glucocorticoids|mesh-ancestor
92807956|NCT02614612|Hormones|hormones|mesh-ancestor
92807957|NCT02614612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92807958|NCT02614612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807959|NCT02614612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92807960|NCT02614612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807961|NCT02614612|Antiemetics|antiemetics|mesh-ancestor
92807962|NCT02614612|Autonomic Agents|autonomic agents|mesh-ancestor
92807963|NCT02614612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92807964|NCT02614612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92807965|NCT02614612|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92807966|NCT02614612|Protective Agents|protective agents|mesh-ancestor
92807967|NCT00900159|Eszopiclone|eszopiclone|mesh-list
92807968|NCT00900159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807969|NCT00900159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807970|NCT00900159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807971|NCT01689909|Zolpidem|zolpidem|mesh-list
92807972|NCT01689909|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92807973|NCT01689909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92807974|NCT01689909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92807975|NCT01689909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807976|NCT01689909|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92807978|NCT01689909|GABA Agents|gaba agents|mesh-ancestor
92807979|NCT01689909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807980|NCT01689909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807981|NCT00854308|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92807982|NCT00854308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92807983|NCT00854308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92807984|NCT00854308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92807985|NCT00854308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807986|NCT00592852|Fluoxetine|fluoxetine|mesh-list
92807987|NCT00592852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92807988|NCT00592852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92807989|NCT00592852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92807990|NCT00592852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92807991|NCT00592852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92807992|NCT00592852|Serotonin Agents|serotonin agents|mesh-ancestor
92807993|NCT00592852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92807994|NCT00592852|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92807995|NCT00592852|Antidepressive Agents|antidepressive agents|mesh-ancestor
92807996|NCT00592852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92807997|NCT00592852|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92807998|NCT00592852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92807999|NCT00592852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808000|NCT00895245|Dexamethasone|dexamethasone|mesh-list
92808001|NCT00895245|Palonosetron|palonosetron|mesh-list
92808002|NCT00895245|Fosaprepitant|fosaprepitant|mesh-list
92808003|NCT00895245|Aprepitant|aprepitant|mesh-list
92808004|NCT00895245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808005|NCT00895245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808006|NCT00895245|Antiemetics|antiemetics|mesh-ancestor
92808007|NCT00895245|Autonomic Agents|autonomic agents|mesh-ancestor
92808008|NCT00895245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808009|NCT00895245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808010|NCT00895245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808011|NCT00895245|Glucocorticoids|glucocorticoids|mesh-ancestor
92808012|NCT00895245|Hormones|hormones|mesh-ancestor
92808013|NCT00895245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808014|NCT00895245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808015|NCT00895245|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92808016|NCT00895245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92808017|NCT00895245|Serotonin Agents|serotonin agents|mesh-ancestor
92808018|NCT00895245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808019|NCT00895245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808020|NCT00895245|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92808021|NCT03172377|Adalimumab|adalimumab|mesh-list
92808022|NCT03172377|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92808023|NCT03172377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808024|NCT03172377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808025|NCT02617654|Liraglutide|liraglutide|mesh-list
92808026|NCT02617654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92808027|NCT02617654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808028|NCT02617654|Incretins|incretins|mesh-ancestor
92808030|NCT02617654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808031|NCT00700024|Methyltestosterone|methyltestosterone|mesh-list
92808032|NCT00700024|Testosterone|testosterone|mesh-list
92808033|NCT00700024|Testosterone undecanoate|testosterone undecanoate|mesh-list
92808034|NCT00700024|Testosterone enanthate|testosterone enanthate|mesh-list
92808035|NCT00700024|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92808036|NCT00700024|Androgens|androgens|mesh-ancestor
92808037|NCT00700024|Hormones|hormones|mesh-ancestor
92808038|NCT00700024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808039|NCT00700024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808040|NCT00700024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808041|NCT00700024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808042|NCT00700024|Anabolic Agents|anabolic agents|mesh-ancestor
92808043|NCT00697450|Insulin Detemir|insulin detemir|mesh-list
92808044|NCT00697450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92808045|NCT00697450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808046|NCT00796003|Decitabine|decitabine|mesh-list
92808047|NCT00796003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92808048|NCT00796003|Antimetabolites|antimetabolites|mesh-ancestor
92808049|NCT00796003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808050|NCT00796003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808051|NCT00796003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808052|NCT04110535|Midazolam|midazolam|mesh-list
92808053|NCT04110535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92808054|NCT04110535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92808055|NCT04110535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808056|NCT04110535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808057|NCT04110535|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92808058|NCT04110535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808059|NCT04110535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808060|NCT04110535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92808061|NCT04110535|Anesthetics, General|anesthetics, general|mesh-ancestor
92808062|NCT04110535|Anesthetics|anesthetics|mesh-ancestor
92808063|NCT04110535|GABA Modulators|gaba modulators|mesh-ancestor
92808064|NCT04110535|GABA Agents|gaba agents|mesh-ancestor
92808065|NCT04110535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808066|NCT04110535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808067|NCT04025203|Ibuprofen|ibuprofen|mesh-list
92808068|NCT04025203|Ibuprofen arginine|ibuprofen arginine|mesh-list
92808069|NCT04025203|Gabapentin|gabapentin|mesh-list
92808070|NCT04025203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808071|NCT04025203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808072|NCT04025203|Analgesics|analgesics|mesh-ancestor
92808073|NCT04025203|Sensory System Agents|sensory system agents|mesh-ancestor
92808074|NCT04025203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808075|NCT04025203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808076|NCT04025203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808077|NCT04025203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808078|NCT04025203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92808079|NCT04025203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808080|NCT04025203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808081|NCT04025203|Anticonvulsants|anticonvulsants|mesh-ancestor
92808082|NCT04025203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92808083|NCT04025203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808084|NCT04025203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808085|NCT04025203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808086|NCT04025203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92808087|NCT04025203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92808088|NCT04025203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808089|NCT04025203|Antimanic Agents|antimanic agents|mesh-ancestor
92808090|NCT02843607|Immunomodulating Agents|immunomodulating agents|mesh-list
92808091|NCT02843607|Immunologic Factors|immunologic factors|mesh-ancestor
92808092|NCT02843607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808093|NCT02843685|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92808094|NCT02843685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808095|NCT00915577|Interferons|interferons|mesh-list
92808096|NCT00915577|Interferon-beta|interferon-beta|mesh-list
92808097|NCT00915577|Interferon beta-1a|interferon beta-1a|mesh-list
92808098|NCT00915577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808099|NCT00915577|Antiviral Agents|antiviral agents|mesh-ancestor
92808100|NCT00915577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808101|NCT00915577|Immunologic Factors|immunologic factors|mesh-ancestor
92808102|NCT00915577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808103|NCT00915577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92808104|NCT00899847|Acetaminophen|acetaminophen|mesh-list
92808105|NCT00899847|Diphenhydramine|diphenhydramine|mesh-list
92808106|NCT00899847|Promethazine|promethazine|mesh-list
92808107|NCT00899847|Cyclosporine|cyclosporine|mesh-list
92808108|NCT00899847|Mycophenolic Acid|mycophenolic acid|mesh-list
92808109|NCT00899847|Hydrocortisone|hydrocortisone|mesh-list
92808110|NCT00899847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92808111|NCT00899847|Cyclophosphamide|cyclophosphamide|mesh-list
92808112|NCT00899847|Melphalan|melphalan|mesh-list
92808113|NCT00899847|Mechlorethamine|mechlorethamine|mesh-list
92808114|NCT00899847|Cyclosporins|cyclosporins|mesh-list
92808115|NCT00899847|Thymoglobulin|thymoglobulin|mesh-list
92808116|NCT00899847|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92808117|NCT00899847|Lenograstim|lenograstim|mesh-list
92808118|NCT00899847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808119|NCT00899847|Immunologic Factors|immunologic factors|mesh-ancestor
92808120|NCT00899847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808121|NCT00899847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808122|NCT00899847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92808123|NCT00899847|Alkylating Agents|alkylating agents|mesh-ancestor
92808124|NCT00899847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808125|NCT00899847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808126|NCT00899847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92808127|NCT00899847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92808128|NCT00899847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808129|NCT00899847|Antifungal Agents|antifungal agents|mesh-ancestor
92808130|NCT00899847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808131|NCT00899847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92808132|NCT00899847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92808133|NCT00899847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808134|NCT00899847|Analgesics|analgesics|mesh-ancestor
92808135|NCT00899847|Sensory System Agents|sensory system agents|mesh-ancestor
93026448|NCT00392223|Azithromycin|azithromycin|mesh-list
92808136|NCT00899847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808137|NCT00899847|Antipyretics|antipyretics|mesh-ancestor
92808138|NCT00899847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92808139|NCT00899847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92808140|NCT00899847|Antitubercular Agents|antitubercular agents|mesh-ancestor
92808141|NCT00899847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808142|NCT00899847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808143|NCT00899847|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92808144|NCT00899847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92808145|NCT00899847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808146|NCT00899847|Anesthetics, Local|anesthetics, local|mesh-ancestor
92808147|NCT00899847|Anesthetics|anesthetics|mesh-ancestor
92808148|NCT00899847|Antiemetics|antiemetics|mesh-ancestor
92808149|NCT00899847|Autonomic Agents|autonomic agents|mesh-ancestor
92808150|NCT00899847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808151|NCT00899847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92808152|NCT00899847|Histamine Antagonists|histamine antagonists|mesh-ancestor
92808153|NCT00899847|Histamine Agents|histamine agents|mesh-ancestor
92808154|NCT00899847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808155|NCT00899847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92808156|NCT00899847|Antipruritics|antipruritics|mesh-ancestor
92808157|NCT00899847|Glucocorticoids|glucocorticoids|mesh-ancestor
92808158|NCT00899847|Hormones|hormones|mesh-ancestor
92808159|NCT00899847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808160|NCT00899847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92808161|NCT00899847|Protective Agents|protective agents|mesh-ancestor
92808162|NCT00899847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808163|NCT04106791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92808164|NCT00529113|Gemcitabine|gemcitabine|mesh-list
92808165|NCT00529113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92808166|NCT00529113|Antimetabolites|antimetabolites|mesh-ancestor
92808167|NCT00529113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808168|NCT00529113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808169|NCT04106557|Gaboxadol|gaboxadol|mesh-list
92808170|NCT04106557|Analgesics|analgesics|mesh-ancestor
92808171|NCT04106557|Sensory System Agents|sensory system agents|mesh-ancestor
92808172|NCT04106557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808173|NCT04106557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808174|NCT04106557|Anticonvulsants|anticonvulsants|mesh-ancestor
92808175|NCT04106557|GABA Agonists|gaba agonists|mesh-ancestor
92808176|NCT04106557|GABA Agents|gaba agents|mesh-ancestor
92808177|NCT04106557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808178|NCT04106557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808179|NCT04117750|Cholecalciferol|cholecalciferol|mesh-list
92808181|NCT04117750|Calcium Carbonate|calcium carbonate|mesh-list
92808182|NCT04117750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92808183|NCT04117750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808184|NCT04117750|Vitamins|vitamins|mesh-ancestor
92808185|NCT04117750|Micronutrients|micronutrients|mesh-ancestor
92808186|NCT04117750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92808187|NCT04117750|Antacids|antacids|mesh-ancestor
92808188|NCT04117750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808189|NCT04117750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808190|NCT04131322|Adalimumab|adalimumab|mesh-list
92808191|NCT04131322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92808192|NCT04131322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92808193|NCT04131322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808194|NCT04131322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808195|NCT02840175|Adalimumab|adalimumab|mesh-list
92808196|NCT02840175|Etanercept|etanercept|mesh-list
92808197|NCT02840175|Abatacept|abatacept|mesh-list
92808198|NCT02840175|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92808199|NCT02840175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808201|NCT02840175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808202|NCT02840175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808203|NCT02840175|Analgesics|analgesics|mesh-ancestor
92808204|NCT02840175|Sensory System Agents|sensory system agents|mesh-ancestor
92808205|NCT02840175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808206|NCT02840175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808207|NCT02840175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808208|NCT02840175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808209|NCT02840175|Immunologic Factors|immunologic factors|mesh-ancestor
92808210|NCT02840175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92808211|NCT02840175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808212|NCT02840175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92808213|NCT02840175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808214|NCT02603497|Peficitinib|peficitinib|mesh-list
92808215|NCT02603497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808216|NCT02603497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808217|NCT02603497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808218|NCT02603497|Immunologic Factors|immunologic factors|mesh-ancestor
92808219|NCT02603497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808220|NCT02840409|Bevacizumab|bevacizumab|mesh-list
92808221|NCT02840409|Vinblastine|vinblastine|mesh-list
92808222|NCT02840409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92808223|NCT02840409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808224|NCT02840409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92808225|NCT02840409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92808226|NCT02840409|Growth Substances|growth substances|mesh-ancestor
92808227|NCT02840409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808228|NCT02840409|Growth Inhibitors|growth inhibitors|mesh-ancestor
92808229|NCT02840409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92808230|NCT02840409|Tubulin Modulators|tubulin modulators|mesh-ancestor
92808231|NCT02840409|Antimitotic Agents|antimitotic agents|mesh-ancestor
92808232|NCT02840409|Mitosis Modulators|mitosis modulators|mesh-ancestor
92808233|NCT02840409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808234|NCT02839941|Mycophenolic Acid|mycophenolic acid|mesh-list
92808235|NCT02839941|Tacrolimus|tacrolimus|mesh-list
92808236|NCT02839941|Glucocorticoids|glucocorticoids|mesh-list
92808237|NCT02839941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808238|NCT02839941|Immunologic Factors|immunologic factors|mesh-ancestor
92808239|NCT02839941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808240|NCT02839941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92808241|NCT02839941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808242|NCT02839941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808243|NCT02839941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92808244|NCT02839941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808245|NCT02839941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92808246|NCT02839941|Antitubercular Agents|antitubercular agents|mesh-ancestor
92808247|NCT02839941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808248|NCT02839941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808249|NCT02839941|Hormones|hormones|mesh-ancestor
92808250|NCT02839941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808251|NCT02842983|Esmolol|esmolol|mesh-list
92808252|NCT02842983|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92808253|NCT02842983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92808254|NCT02842983|Adrenergic Agents|adrenergic agents|mesh-ancestor
92808255|NCT02842983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808256|NCT02842983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808257|NCT02842983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808258|NCT02842983|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92808259|NCT02839785|Ibuprofen|ibuprofen|mesh-list
92808260|NCT02839785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808261|NCT02839785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808262|NCT02839785|Analgesics|analgesics|mesh-ancestor
92808263|NCT02839785|Sensory System Agents|sensory system agents|mesh-ancestor
92808264|NCT02839785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808265|NCT02839785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808266|NCT02839785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808267|NCT02839785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808268|NCT02839785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92808269|NCT02839785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808270|NCT02839785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808271|NCT02843061|Rituximab|rituximab|mesh-list
92808272|NCT02843061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92808273|NCT02843061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808274|NCT02843061|Immunologic Factors|immunologic factors|mesh-ancestor
92808275|NCT02843061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808276|NCT02843061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808277|NCT02839239|Vitamin D|vitamin d|mesh-list
92808278|NCT02839239|Ergocalciferols|ergocalciferols|mesh-list
92808279|NCT02839239|Cholecalciferol|cholecalciferol|mesh-list
92808280|NCT02839239|Vitamins|vitamins|mesh-list
92808281|NCT02839239|Micronutrients|micronutrients|mesh-ancestor
92808282|NCT02839239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808283|NCT02839239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92808284|NCT02839239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92808285|NCT02837835|Ceftazidime|ceftazidime|mesh-list
92808286|NCT02837835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808287|NCT02837835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808288|NCT02839161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92808289|NCT02839161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92808290|NCT02839161|Immunologic Factors|immunologic factors|mesh-ancestor
92808291|NCT02839161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808292|NCT02839161|Antacids|antacids|mesh-ancestor
92808293|NCT02839161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808294|NCT02839161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808295|NCT04249713|Brodalumab|brodalumab|mesh-list
92808296|NCT04249713|Dermatologic Agents|dermatologic agents|mesh-ancestor
92808297|NCT00610506|Dexetimide|dexetimide|mesh-list
92808298|NCT00610506|Citalopram|citalopram|mesh-list
92808299|NCT00610506|Escitalopram|escitalopram|mesh-list
92808300|NCT00610506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92808301|NCT00610506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92808302|NCT00610506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808303|NCT00610506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808304|NCT00610506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808305|NCT00610506|Serotonin Agents|serotonin agents|mesh-ancestor
92808306|NCT00610506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808307|NCT00610506|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92808308|NCT00610506|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92808309|NCT00610506|Parasympatholytics|parasympatholytics|mesh-ancestor
92808310|NCT00610506|Autonomic Agents|autonomic agents|mesh-ancestor
92808311|NCT00610506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808312|NCT00610506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92808313|NCT00610506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92808314|NCT00610506|Cholinergic Agents|cholinergic agents|mesh-ancestor
92808315|NCT00610506|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92808316|NCT00610506|Antidepressive Agents|antidepressive agents|mesh-ancestor
92808317|NCT00610506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808318|NCT04260828|Aspirin|aspirin|mesh-list
92808319|NCT04260828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808320|NCT04260828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808321|NCT04260828|Analgesics|analgesics|mesh-ancestor
92808322|NCT04260828|Sensory System Agents|sensory system agents|mesh-ancestor
92808323|NCT04260828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808324|NCT04260828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808325|NCT04260828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808326|NCT04260828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808327|NCT04260828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92808328|NCT04260828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92808329|NCT04260828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808330|NCT04260828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92808331|NCT04260828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92808332|NCT04260828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808333|NCT04260828|Antipyretics|antipyretics|mesh-ancestor
92808334|NCT00928746|Bromides|bromides|mesh-list
92808335|NCT00928746|Ipratropium|ipratropium|mesh-list
92808336|NCT00928746|Anticonvulsants|anticonvulsants|mesh-ancestor
92808337|NCT00928746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92808338|NCT00928746|Autonomic Agents|autonomic agents|mesh-ancestor
92808339|NCT00928746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808340|NCT00928746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808341|NCT00928746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92808342|NCT00928746|Respiratory System Agents|respiratory system agents|mesh-ancestor
92808343|NCT00928746|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92808344|NCT00928746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92808345|NCT00928746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421692|NCT01512199|Paclitaxel|paclitaxel|mesh-list
92808346|NCT00928746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808347|NCT04468815|Esomeprazole|esomeprazole|mesh-list
92808348|NCT04468815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92808349|NCT04468815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808350|NCT04468815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92808351|NCT04468815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808352|NCT04468815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808353|NCT00610584|Cetirizine|cetirizine|mesh-list
92808354|NCT00610584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92808355|NCT00610584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92808356|NCT00610584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92808357|NCT00610584|Histamine Antagonists|histamine antagonists|mesh-ancestor
92808358|NCT00610584|Histamine Agents|histamine agents|mesh-ancestor
92808359|NCT00610584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808360|NCT00610584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808361|NCT00610584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808362|NCT00894543|Escitalopram|escitalopram|mesh-list
92808363|NCT00894543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92808364|NCT00894543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92808365|NCT00894543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808366|NCT00894543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808367|NCT00894543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808368|NCT00894543|Serotonin Agents|serotonin agents|mesh-ancestor
92808369|NCT00894543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808370|NCT00922272|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92808371|NCT00922272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92808372|NCT00922272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808373|NCT00922272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92808374|NCT00922272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92808375|NCT00922272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808376|NCT00922272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808377|NCT00922272|Dopamine Agents|dopamine agents|mesh-ancestor
92808378|NCT00922272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808379|NCT00853372|Sunitinib|sunitinib|mesh-list
92808380|NCT00853372|Trebananib|trebananib|mesh-list
92808381|NCT00853372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92808382|NCT00853372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808383|NCT00853372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92808384|NCT00853372|Growth Substances|growth substances|mesh-ancestor
92808385|NCT00853372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808386|NCT00853372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92808387|NCT00853372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92808388|NCT00853372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808389|NCT00853372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808390|NCT02836977|Tegafur|tegafur|mesh-list
92808391|NCT02836977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92808392|NCT02836977|Antimetabolites|antimetabolites|mesh-ancestor
92808393|NCT02836977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808394|NCT02836977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808395|NCT04988256|Cyclosporine|cyclosporine|mesh-list
92808396|NCT04988256|Prednisone|prednisone|mesh-list
92808397|NCT04988256|Methylprednisolone|methylprednisolone|mesh-list
92808398|NCT04988256|Cyclosporins|cyclosporins|mesh-list
92808399|NCT04988256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808400|NCT04988256|Glucocorticoids|glucocorticoids|mesh-ancestor
92808401|NCT04988256|Hormones|hormones|mesh-ancestor
92808402|NCT04988256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808403|NCT04988256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808404|NCT04988256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808405|NCT04988256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808406|NCT04988256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808407|NCT04988256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808408|NCT04988256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808409|NCT04988256|Immunologic Factors|immunologic factors|mesh-ancestor
92808410|NCT04988256|Antifungal Agents|antifungal agents|mesh-ancestor
92808411|NCT04988256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808412|NCT04988256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92808413|NCT04988256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808414|NCT04988256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92808415|NCT04988256|Antiemetics|antiemetics|mesh-ancestor
92808416|NCT04988256|Autonomic Agents|autonomic agents|mesh-ancestor
92808417|NCT04988256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808418|NCT04988256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808419|NCT04988256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92808420|NCT04988256|Protective Agents|protective agents|mesh-ancestor
92808421|NCT00848536|Travoprost|travoprost|mesh-list
92808422|NCT00848536|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92808423|NCT00848536|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92808424|NCT00848536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92808425|NCT00922116|Epoetin Alfa|epoetin alfa|mesh-list
92808426|NCT00922116|Hematinics|hematinics|mesh-ancestor
92808427|NCT04260516|Acetylcysteine|acetylcysteine|mesh-list
92808428|NCT04260516|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92808429|NCT04260516|Antiviral Agents|antiviral agents|mesh-ancestor
92808430|NCT04260516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808431|NCT04260516|Expectorants|expectorants|mesh-ancestor
92808432|NCT04260516|Respiratory System Agents|respiratory system agents|mesh-ancestor
92808433|NCT04260516|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92808434|NCT04260516|Antioxidants|antioxidants|mesh-ancestor
92808435|NCT04260516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808436|NCT04260516|Protective Agents|protective agents|mesh-ancestor
92808437|NCT04260516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808438|NCT04260516|Antidotes|antidotes|mesh-ancestor
92808439|NCT00921024|Ceftazidime|ceftazidime|mesh-list
92808440|NCT00921024|Ceftolozane|ceftolozane|mesh-list
92808441|NCT00921024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808442|NCT00921024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808443|NCT00928668|Olodaterol|olodaterol|mesh-list
92808444|NCT00928668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92808445|NCT00928668|Autonomic Agents|autonomic agents|mesh-ancestor
92808446|NCT00928668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808447|NCT00928668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808448|NCT00928668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92808449|NCT00928668|Respiratory System Agents|respiratory system agents|mesh-ancestor
92808450|NCT00700960|Insulin Detemir|insulin detemir|mesh-list
92808451|NCT00700960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92808452|NCT00700960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808453|NCT00700492|Progesterone|progesterone|mesh-list
92808454|NCT00700492|Progestins|progestins|mesh-ancestor
92808455|NCT00700492|Hormones|hormones|mesh-ancestor
92808456|NCT00700492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808457|NCT00700492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808458|NCT00700648|Insulin Aspart|insulin aspart|mesh-list
92808459|NCT00700648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92808460|NCT00700648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808461|NCT00703300|Bortezomib|bortezomib|mesh-list
92808462|NCT00703300|Decitabine|decitabine|mesh-list
92808463|NCT00703300|Azacitidine|azacitidine|mesh-list
92808464|NCT00703300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808465|NCT00703300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92808466|NCT00703300|Antimetabolites|antimetabolites|mesh-ancestor
92808467|NCT00703300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808468|NCT00703300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808469|NCT00703378|Docetaxel|docetaxel|mesh-list
92808470|NCT00703378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808471|NCT00703378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92808472|NCT00703378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92808473|NCT00703378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92808474|NCT00703378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808475|NCT00852202|Cariprazine|cariprazine|mesh-list
92808476|NCT00852202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92808477|NCT00852202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808478|NCT00852202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808479|NCT00852202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808480|NCT00852202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808481|NCT01074008|Ritonavir|ritonavir|mesh-list
92808482|NCT01074008|Ribavirin|ribavirin|mesh-list
92808483|NCT01074008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92808484|NCT01074008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92808485|NCT01074008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92808486|NCT01074008|Protease Inhibitors|protease inhibitors|mesh-ancestor
92808487|NCT01074008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808488|NCT01074008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808489|NCT01074008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92808490|NCT01074008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92808491|NCT01074008|Antiviral Agents|antiviral agents|mesh-ancestor
92808492|NCT01074008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808493|NCT01074008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92808494|NCT01074008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92808495|NCT01074008|Antimetabolites|antimetabolites|mesh-ancestor
92808496|NCT02613052|Propofol|propofol|mesh-list
92808497|NCT02613052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92808498|NCT02613052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808499|NCT02613052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808500|NCT02613052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92808501|NCT02613052|Anesthetics, General|anesthetics, general|mesh-ancestor
92808502|NCT02613052|Anesthetics|anesthetics|mesh-ancestor
92808503|NCT01073930|Bisacodyl|bisacodyl|mesh-list
92808504|NCT01073930|Picosulfate sodium|picosulfate sodium|mesh-list
92808505|NCT01073930|Cathartics|cathartics|mesh-ancestor
92808506|NCT01073930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808507|NCT01073930|Laxatives|laxatives|mesh-ancestor
92808508|NCT01073618|Voriconazole|voriconazole|mesh-list
92808509|NCT01073618|Antifungal Agents|antifungal agents|mesh-ancestor
92808510|NCT01073618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808511|NCT01073618|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92808512|NCT01073618|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92808513|NCT01073618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808514|NCT01073618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808515|NCT01073618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92808516|NCT01073618|Hormone Antagonists|hormone antagonists|mesh-ancestor
92808517|NCT01073618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808518|NCT01073618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808519|NCT01073618|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92808520|NCT00789373|Pemetrexed|pemetrexed|mesh-list
92808521|NCT00789373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808522|NCT00789373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808523|NCT00789373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808524|NCT00789373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92421877|NCT01513499|Oxytocin|oxytocin|mesh-list
92808525|NCT00789373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92808526|NCT00851890|Interferons|interferons|mesh-list
92808527|NCT00851890|Ribavirin|ribavirin|mesh-list
92808528|NCT00851890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808529|NCT00851890|Antiviral Agents|antiviral agents|mesh-ancestor
92808530|NCT00851890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808531|NCT00851890|Antimetabolites|antimetabolites|mesh-ancestor
92808532|NCT00851890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808533|NCT00592072|Decanoic acid|decanoic acid|mesh-list
92808534|NCT00592072|Antifungal Agents|antifungal agents|mesh-ancestor
92808535|NCT00592072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808536|NCT00626288|Mesalamine|mesalamine|mesh-list
92808537|NCT00626288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808538|NCT00626288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808539|NCT00626288|Analgesics|analgesics|mesh-ancestor
92808540|NCT00626288|Sensory System Agents|sensory system agents|mesh-ancestor
92808541|NCT00626288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808542|NCT00626288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808543|NCT00626288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808544|NCT00626288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808545|NCT00792571|Epoprostenol|epoprostenol|mesh-list
92808546|NCT00792571|Beraprost|beraprost|mesh-list
92808547|NCT00792571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92808548|NCT00792571|Vasodilator Agents|vasodilator agents|mesh-ancestor
92808549|NCT00792571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92808550|NCT00794365|Varenicline|varenicline|mesh-list
92808551|NCT00794365|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92808552|NCT00794365|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92808553|NCT00794365|Cholinergic Agents|cholinergic agents|mesh-ancestor
92808554|NCT00794365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808555|NCT00794365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808556|NCT00794365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808558|NCT01067144|Lorazepam|lorazepam|mesh-list
92808559|NCT01067144|Analgesics|analgesics|mesh-ancestor
92808560|NCT01067144|Sensory System Agents|sensory system agents|mesh-ancestor
92808561|NCT01067144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808562|NCT01067144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808563|NCT01067144|Anticonvulsants|anticonvulsants|mesh-ancestor
92808564|NCT01067144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92808565|NCT01067144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808566|NCT01067144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808567|NCT01067144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808568|NCT01067144|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92808569|NCT01067144|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92808570|NCT01067144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808571|NCT01067144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808572|NCT01067144|Antimanic Agents|antimanic agents|mesh-ancestor
92808573|NCT01067144|Antiemetics|antiemetics|mesh-ancestor
92808574|NCT01067144|Autonomic Agents|autonomic agents|mesh-ancestor
92808575|NCT01067144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808576|NCT01067144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92808577|NCT01067144|GABA Modulators|gaba modulators|mesh-ancestor
92808578|NCT01067144|GABA Agents|gaba agents|mesh-ancestor
92808579|NCT01078298|Varenicline|varenicline|mesh-list
92808580|NCT01078298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92808581|NCT01078298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92808582|NCT01078298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92808583|NCT01078298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808584|NCT01078298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808585|NCT01078298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808586|NCT00788593|Pancreatin|pancreatin|mesh-list
92808587|NCT00788593|Pancrelipase|pancrelipase|mesh-list
92808588|NCT00788593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808589|NCT04106011|Gabapentin|gabapentin|mesh-list
92808590|NCT04106011|Analgesics|analgesics|mesh-ancestor
92808591|NCT04106011|Sensory System Agents|sensory system agents|mesh-ancestor
92808592|NCT04106011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808593|NCT04106011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808594|NCT04106011|Anticonvulsants|anticonvulsants|mesh-ancestor
92808595|NCT04106011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92808596|NCT04106011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808597|NCT04106011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808598|NCT04106011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808599|NCT04106011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92808600|NCT04106011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92808601|NCT04106011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808602|NCT04106011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808603|NCT04106011|Antimanic Agents|antimanic agents|mesh-ancestor
92808604|NCT02875886|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92808605|NCT02875886|Amiloride|amiloride|mesh-list
92808606|NCT02875886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92808607|NCT02875886|Diuretics|diuretics|mesh-ancestor
92808608|NCT02875886|Natriuretic Agents|natriuretic agents|mesh-ancestor
92808609|NCT02875886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808610|NCT02875886|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92808611|NCT02875886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808612|NCT02875886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808613|NCT02875886|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92808614|NCT02875886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92808615|NCT02875886|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92808616|NCT02875886|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92808617|NCT00793819|Silodosin|silodosin|mesh-list
92808618|NCT00793819|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92808619|NCT00793819|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92808620|NCT00793819|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92808621|NCT00793819|Adrenergic Agents|adrenergic agents|mesh-ancestor
92808622|NCT00793819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808623|NCT00793819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808624|NCT00793819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808625|NCT00793819|Urological Agents|urological agents|mesh-ancestor
92808626|NCT04109833|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92808628|NCT02836665|Dermatologic Agents|dermatologic agents|mesh-list
92808629|NCT02836821|Rifampin|rifampin|mesh-list
92808630|NCT02836821|Apatinib|apatinib|mesh-list
92808631|NCT02836821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808632|NCT02836821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92808633|NCT02836821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808634|NCT02836821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808635|NCT02836821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92808636|NCT02836821|Antitubercular Agents|antitubercular agents|mesh-ancestor
92808637|NCT02836821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808638|NCT02836821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808639|NCT02836821|Leprostatic Agents|leprostatic agents|mesh-ancestor
92808640|NCT02836821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92808641|NCT02836821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92808642|NCT02836821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92808643|NCT02836821|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92808644|NCT02836821|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92808645|NCT02836821|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92808646|NCT02836821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92808647|NCT02836743|Melatonin|melatonin|mesh-list
92808648|NCT02836743|Antioxidants|antioxidants|mesh-ancestor
92808649|NCT02836743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808650|NCT02836743|Protective Agents|protective agents|mesh-ancestor
92808651|NCT02836743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808652|NCT02836743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808653|NCT04255368|Choline|choline|mesh-list
92808654|NCT04255368|Lipotropic Agents|lipotropic agents|mesh-ancestor
92808655|NCT04255368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92808656|NCT04255368|Antimetabolites|antimetabolites|mesh-ancestor
92808657|NCT04255368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808658|NCT04255368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808659|NCT04255368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92808660|NCT04255368|Nootropic Agents|nootropic agents|mesh-ancestor
92808661|NCT00610818|Mitogens|mitogens|mesh-list
92808662|NCT00610818|Mitosis Modulators|mitosis modulators|mesh-ancestor
92808663|NCT00610818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808664|NCT00787891|Rabeprazole|rabeprazole|mesh-list
92808665|NCT00787891|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92808666|NCT00787891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808667|NCT00787891|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92808668|NCT00787891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808669|NCT00787891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808670|NCT00892437|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92808671|NCT00892437|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92808672|NCT00892437|Cobicistat|cobicistat|mesh-list
92808673|NCT00892437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92808674|NCT00892437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92808675|NCT00892437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808676|NCT00892437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808677|NCT00892437|Antiviral Agents|antiviral agents|mesh-ancestor
92808678|NCT00892437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808679|NCT00892437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92808680|NCT00892437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92808681|NCT00892437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92808682|NCT00892437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92808683|NCT00892437|Protease Inhibitors|protease inhibitors|mesh-ancestor
92808684|NCT00892437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92808685|NCT00892437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92808686|NCT02838537|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
92808687|NCT02838537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92808688|NCT02838537|Serotonin Agents|serotonin agents|mesh-ancestor
92808689|NCT02838537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808690|NCT02838537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808691|NCT02838537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808692|NCT02836509|Acetaminophen|acetaminophen|mesh-list
92808693|NCT02836509|Ibuprofen|ibuprofen|mesh-list
92808694|NCT02836509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808695|NCT02836509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808696|NCT02836509|Analgesics|analgesics|mesh-ancestor
92808697|NCT02836509|Sensory System Agents|sensory system agents|mesh-ancestor
92808698|NCT02836509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808699|NCT02836509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808700|NCT02836509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808701|NCT02836509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808702|NCT02836509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92808703|NCT02836509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808704|NCT02836509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808705|NCT02836509|Antipyretics|antipyretics|mesh-ancestor
92808706|NCT05306379|Simvastatin|simvastatin|mesh-list
92808707|NCT05306379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92808708|NCT05306379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92808709|NCT05306379|Antimetabolites|antimetabolites|mesh-ancestor
92808710|NCT05306379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808711|NCT05306379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92808712|NCT05306379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92808713|NCT05306379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808714|NCT05304663|Lomustine|lomustine|mesh-list
92808715|NCT05304663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92808716|NCT05304663|Alkylating Agents|alkylating agents|mesh-ancestor
92808717|NCT05304663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808718|NCT05304663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808719|NCT04109755|Pembrolizumab|pembrolizumab|mesh-list
92808720|NCT04109755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92808721|NCT04109755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808722|NCT04109755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92808723|NCT04109755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808724|NCT04248309|Progesterone|progesterone|mesh-list
92808725|NCT04248309|Progestins|progestins|mesh-ancestor
92808726|NCT04248309|Hormones|hormones|mesh-ancestor
92808727|NCT04248309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808728|NCT04248309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808729|NCT00892281|Doxycycline|doxycycline|mesh-list
92808730|NCT00892281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808731|NCT00892281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808732|NCT00892281|Antimalarials|antimalarials|mesh-ancestor
92808733|NCT00892281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92808734|NCT00892281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92808735|NCT02836353|Rifaximin|rifaximin|mesh-list
92808736|NCT02836353|Somatostatin|somatostatin|mesh-list
92808737|NCT02836353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92808738|NCT02836353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808739|NCT02836353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808740|NCT02836353|Hormones|hormones|mesh-ancestor
92808741|NCT02836353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808742|NCT02836353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808743|NCT02836431|Dexmedetomidine|dexmedetomidine|mesh-list
92808744|NCT02836431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92808745|NCT02836431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808746|NCT02836431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808747|NCT02836431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808748|NCT02836431|Analgesics|analgesics|mesh-ancestor
92808749|NCT02836431|Sensory System Agents|sensory system agents|mesh-ancestor
92808750|NCT02836431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808751|NCT02836431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92808752|NCT02836431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92808753|NCT02836431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92808754|NCT02836431|Adrenergic Agents|adrenergic agents|mesh-ancestor
92808755|NCT02836431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808756|NCT02836431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808757|NCT05326425|Lazertinib|lazertinib|mesh-list
92808758|NCT05326425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92808759|NCT05326425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808760|NCT05326425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808761|NCT00784693|Tanezumab|tanezumab|mesh-list
92808762|NCT00784693|Analgesics|analgesics|mesh-ancestor
92808763|NCT00784693|Sensory System Agents|sensory system agents|mesh-ancestor
92808764|NCT00784693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808765|NCT00784693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808766|NCT00915811|Fludarabine|fludarabine|mesh-list
92808767|NCT00915811|Busulfan|busulfan|mesh-list
92808768|NCT00915811|Thymoglobulin|thymoglobulin|mesh-list
92808769|NCT00915811|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92808770|NCT00915811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808771|NCT00915811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808772|NCT00915811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808773|NCT00915811|Immunologic Factors|immunologic factors|mesh-ancestor
92808774|NCT00915811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808775|NCT00915811|Alkylating Agents|alkylating agents|mesh-ancestor
92422123|NCT01514825|Darexaban|darexaban|mesh-list
92808776|NCT00915811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92808777|NCT00915811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92808778|NCT00892047|Aripiprazole|aripiprazole|mesh-list
92808779|NCT00892047|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92808780|NCT00892047|Antidepressive Agents|antidepressive agents|mesh-ancestor
92808781|NCT00892047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808782|NCT00892047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92808783|NCT00892047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808784|NCT00892047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92808785|NCT00892047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808786|NCT00892047|Dopamine Agonists|dopamine agonists|mesh-ancestor
92808787|NCT00892047|Dopamine Agents|dopamine agents|mesh-ancestor
92808788|NCT00892047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808789|NCT00892047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808790|NCT00892047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92808791|NCT00892047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92808792|NCT00892047|Serotonin Agents|serotonin agents|mesh-ancestor
92808793|NCT00892047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92453790|NCT01695122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92808794|NCT00892047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92808795|NCT00892047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92808796|NCT00892047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92808797|NCT00892047|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92808798|NCT00892047|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92808799|NCT00892047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808800|NCT00892047|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92808801|NCT02835729|Cytarabine|cytarabine|mesh-list
92808802|NCT02835729|Idarubicin|idarubicin|mesh-list
92808803|NCT02835729|Tryptophan|tryptophan|mesh-list
92808804|NCT02835729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92808805|NCT02835729|Antimetabolites|antimetabolites|mesh-ancestor
92808806|NCT02835729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808807|NCT02835729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808808|NCT02835729|Antiviral Agents|antiviral agents|mesh-ancestor
92808809|NCT02835729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92808810|NCT02835729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808811|NCT02835729|Immunologic Factors|immunologic factors|mesh-ancestor
92808812|NCT02835729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808813|NCT02835729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92808814|NCT02835729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92808815|NCT02835729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92808816|NCT02835729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808817|NCT02835729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92808818|NCT02835729|Antidepressive Agents|antidepressive agents|mesh-ancestor
92808819|NCT02835729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92808820|NCT02835651|Palmitic Acid|palmitic acid|mesh-list
92808821|NCT02835651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808822|NCT02835651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808823|NCT00787267|Dasatinib|dasatinib|mesh-list
92808824|NCT00787267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808825|NCT00787267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92808826|NCT00787267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808827|NCT00787267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808828|NCT02838615|Dexamethasone|dexamethasone|mesh-list
92808829|NCT02838615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808830|NCT02838615|Antiemetics|antiemetics|mesh-ancestor
92808831|NCT02838615|Autonomic Agents|autonomic agents|mesh-ancestor
92808832|NCT02838615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808833|NCT02838615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808834|NCT02838615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92808835|NCT02838615|Glucocorticoids|glucocorticoids|mesh-ancestor
92808836|NCT02838615|Hormones|hormones|mesh-ancestor
92808837|NCT02838615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808838|NCT02838615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808839|NCT02838615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808840|NCT02833701|Vitamins|vitamins|mesh-list
92808841|NCT02833701|Ascorbic Acid|ascorbic acid|mesh-list
92808842|NCT02833701|Bevacizumab|bevacizumab|mesh-list
92808843|NCT02833701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92808844|NCT02833701|Endothelial Growth Factors|endothelial growth factors|mesh-list
92808845|NCT02833701|Antibodies|antibodies|mesh-list
92808846|NCT02833701|Immunoglobulins|immunoglobulins|mesh-list
92808847|NCT02833701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92808848|NCT02833701|Immunoglobulin G|immunoglobulin g|mesh-list
92808849|NCT02833701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808850|NCT02833701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92808851|NCT02833701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92808852|NCT02833701|Growth Substances|growth substances|mesh-ancestor
92808853|NCT02833701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808854|NCT02833701|Growth Inhibitors|growth inhibitors|mesh-ancestor
92808855|NCT02833701|Micronutrients|micronutrients|mesh-ancestor
92808856|NCT02833701|Immunologic Factors|immunologic factors|mesh-ancestor
92808857|NCT02833701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808858|NCT02833701|Antioxidants|antioxidants|mesh-ancestor
92808859|NCT02833701|Protective Agents|protective agents|mesh-ancestor
92808860|NCT02838225|Cyclophosphamide|cyclophosphamide|mesh-list
92808861|NCT02838225|Docetaxel|docetaxel|mesh-list
92808862|NCT02838225|Doxorubicin|doxorubicin|mesh-list
92808863|NCT02838225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92808864|NCT02838225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808865|NCT02838225|Immunologic Factors|immunologic factors|mesh-ancestor
92808866|NCT02838225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808867|NCT02838225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808868|NCT02838225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92808869|NCT02838225|Alkylating Agents|alkylating agents|mesh-ancestor
92808870|NCT02838225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808871|NCT02838225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808872|NCT02838225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92808873|NCT02838225|Tubulin Modulators|tubulin modulators|mesh-ancestor
92808874|NCT02838225|Antimitotic Agents|antimitotic agents|mesh-ancestor
92808875|NCT02838225|Mitosis Modulators|mitosis modulators|mesh-ancestor
92808876|NCT02838225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92808877|NCT02838225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92808878|NCT02838225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92808879|NCT02838225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808881|NCT00928434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92808882|NCT00928434|Fertility Agents|fertility agents|mesh-ancestor
92808883|NCT00928434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92808884|NCT00928434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808885|NCT00928434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808886|NCT00928434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808887|NCT04248621|Goserelin|goserelin|mesh-list
92808888|NCT04248621|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92808889|NCT04248621|Leuprolide|leuprolide|mesh-list
92808890|NCT04248621|Flutamide|flutamide|mesh-list
92808891|NCT04248621|Bicalutamide|bicalutamide|mesh-list
92808892|NCT04248621|Androgens|androgens|mesh-list
92808893|NCT04248621|Androgen Antagonists|androgen antagonists|mesh-list
92808894|NCT04248621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92808895|NCT04248621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808896|NCT04248621|Hormones|hormones|mesh-ancestor
92808897|NCT04248621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92808898|NCT04248621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808899|NCT04248621|Hormone Antagonists|hormone antagonists|mesh-ancestor
92808900|NCT04248621|Luteolytic Agents|luteolytic agents|mesh-ancestor
92808901|NCT04248621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92808902|NCT04248621|Contraceptive Agents|contraceptive agents|mesh-ancestor
92808903|NCT04248621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92808904|NCT04248621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92808905|NCT04248621|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92808906|NCT04248621|Fertility Agents|fertility agents|mesh-ancestor
92808907|NCT00784459|Abatacept|abatacept|mesh-list
92808908|NCT00784459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92808909|NCT00784459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808910|NCT00784459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92808911|NCT00784459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808912|NCT00784459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808913|NCT00784459|Immunologic Factors|immunologic factors|mesh-ancestor
92808914|NCT00784459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808915|NCT00784459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808916|NCT02835183|Insulin|insulin|mesh-list
92808917|NCT02835183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92808918|NCT02835183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808919|NCT02602483|Ascorbic Acid|ascorbic acid|mesh-list
92808920|NCT02602483|Ibuprofen|ibuprofen|mesh-list
92808921|NCT02602483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92808922|NCT02602483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92808923|NCT02602483|Analgesics|analgesics|mesh-ancestor
92808924|NCT02602483|Sensory System Agents|sensory system agents|mesh-ancestor
92808925|NCT02602483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92808926|NCT02602483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808927|NCT02602483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92808928|NCT02602483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808929|NCT02602483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92808930|NCT02602483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808931|NCT02602483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808932|NCT02602483|Antioxidants|antioxidants|mesh-ancestor
92808933|NCT02602483|Protective Agents|protective agents|mesh-ancestor
92808935|NCT02602483|Micronutrients|micronutrients|mesh-ancestor
92808936|NCT00784147|Ibalizumab|ibalizumab|mesh-list
92808937|NCT00784147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92808938|NCT00784147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92808939|NCT00784147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92808940|NCT00784147|Antiviral Agents|antiviral agents|mesh-ancestor
92808941|NCT00784147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453948|NCT01696617|Dopamine Agents|dopamine agents|mesh-ancestor
92808942|NCT00784147|Immunologic Factors|immunologic factors|mesh-ancestor
92808943|NCT00784147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808944|NCT04260360|Docetaxel|docetaxel|mesh-list
92808945|NCT04260360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808947|NCT04260360|Antimitotic Agents|antimitotic agents|mesh-ancestor
92808948|NCT04260360|Mitosis Modulators|mitosis modulators|mesh-ancestor
92808949|NCT04260360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808950|NCT04254822|Carvedilol|carvedilol|mesh-list
92808951|NCT04254822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92808952|NCT04254822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92808953|NCT04254822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92808954|NCT04254822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808955|NCT04254822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808956|NCT04254822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808957|NCT04254822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92808958|NCT04254822|Antioxidants|antioxidants|mesh-ancestor
92808959|NCT04254822|Protective Agents|protective agents|mesh-ancestor
92808960|NCT04254822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92808961|NCT04254822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808962|NCT04254822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92808963|NCT04254822|Vasodilator Agents|vasodilator agents|mesh-ancestor
92808964|NCT04254822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92808965|NCT04254822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92808966|NCT00891813|Ergocalciferols|ergocalciferols|mesh-list
92808967|NCT00891813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92808968|NCT00891813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808969|NCT00891813|Vitamins|vitamins|mesh-ancestor
92808970|NCT00891813|Micronutrients|micronutrients|mesh-ancestor
92808971|NCT00891813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92808972|NCT04255056|Cyclophosphamide|cyclophosphamide|mesh-list
92808973|NCT04255056|Epirubicin|epirubicin|mesh-list
92808974|NCT04255056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92808975|NCT04255056|Immunologic Factors|immunologic factors|mesh-ancestor
92808976|NCT04255056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808977|NCT04255056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92808978|NCT04255056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92808979|NCT04255056|Alkylating Agents|alkylating agents|mesh-ancestor
93026449|NCT00392223|Minocycline|minocycline|mesh-list
92808980|NCT04255056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808981|NCT04255056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92808982|NCT04255056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92808983|NCT04255056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92808984|NCT04255056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92808985|NCT04255056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92808986|NCT04255056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92808987|NCT00783835|Methylphenidate|methylphenidate|mesh-list
92808988|NCT00783835|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92808989|NCT00783835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92808990|NCT00783835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92808991|NCT00783835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92808992|NCT00783835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92808993|NCT00783835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92808994|NCT00783835|Dopamine Agents|dopamine agents|mesh-ancestor
92808995|NCT00783835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92808996|NCT04254744|Sevoflurane|sevoflurane|mesh-list
92808997|NCT04254744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92808998|NCT04254744|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92808999|NCT04254744|Anesthetics, General|anesthetics, general|mesh-ancestor
92809000|NCT04254744|Anesthetics|anesthetics|mesh-ancestor
92809001|NCT04254744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809002|NCT04254744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809003|NCT02831361|Metformin|metformin|mesh-list
92809004|NCT02831361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92809005|NCT02831361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809006|NCT04103905|Antibodies|antibodies|mesh-list
92809007|NCT04103905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92809008|NCT04103905|Immunologic Factors|immunologic factors|mesh-ancestor
92809009|NCT04103905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809010|NCT02831205|Cobalt|cobalt|mesh-list
92809011|NCT02831205|Chromium|chromium|mesh-list
92809012|NCT02831205|Everolimus|everolimus|mesh-list
92809013|NCT02831205|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92809014|NCT02831205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809015|NCT02831205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809016|NCT02831205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809017|NCT02831205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809018|NCT02831205|Immunologic Factors|immunologic factors|mesh-ancestor
92454033|NCT01697098|BB 1101|bb 1101|mesh-list
92809019|NCT02831205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809020|NCT02831205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809021|NCT02831205|Trace Elements|trace elements|mesh-ancestor
92809022|NCT02831205|Micronutrients|micronutrients|mesh-ancestor
92809023|NCT00783289|Benralizumab|benralizumab|mesh-list
92809024|NCT00783289|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92809025|NCT00783289|Respiratory System Agents|respiratory system agents|mesh-ancestor
92809026|NCT02828163|Triamcinolone|triamcinolone|mesh-list
92809027|NCT02828163|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92809028|NCT02828163|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92809029|NCT02828163|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92809030|NCT02828163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92809031|NCT02828163|Glucocorticoids|glucocorticoids|mesh-ancestor
92809032|NCT02828163|Hormones|hormones|mesh-ancestor
92809033|NCT02828163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809034|NCT02828163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809035|NCT02828163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809036|NCT02828163|Immunologic Factors|immunologic factors|mesh-ancestor
92809037|NCT02828163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809038|NCT02828163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809039|NCT04107805|Midazolam|midazolam|mesh-list
92809040|NCT04107805|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92809041|NCT04107805|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92809042|NCT04107805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809043|NCT04107805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809044|NCT04107805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92809045|NCT04107805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92809046|NCT04107805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92809047|NCT04107805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92809048|NCT04107805|Anesthetics, General|anesthetics, general|mesh-ancestor
92809049|NCT04107805|Anesthetics|anesthetics|mesh-ancestor
92809050|NCT04107805|GABA Modulators|gaba modulators|mesh-ancestor
92809051|NCT04107805|GABA Agents|gaba agents|mesh-ancestor
92809052|NCT04107805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809053|NCT04107805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809054|NCT02833155|Exemestane|exemestane|mesh-list
92809055|NCT02833155|Entinostat|entinostat|mesh-list
92809056|NCT02833155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809057|NCT02833155|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92809058|NCT02833155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92809059|NCT02833155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809060|NCT02833155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809061|NCT02833155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92809062|NCT02833155|Hormone Antagonists|hormone antagonists|mesh-ancestor
92809063|NCT02833155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809064|NCT02833155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809065|NCT02833155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92809066|NCT04672460|Talazoparib|talazoparib|mesh-list
92809067|NCT04672460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92809068|NCT04672460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809069|NCT04672460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809070|NCT04672460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809071|NCT00847912|Fluorouracil|fluorouracil|mesh-list
92809072|NCT00847912|Antimetabolites|antimetabolites|mesh-ancestor
92809073|NCT00847912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809074|NCT00847912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92809075|NCT00847912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809076|NCT00847912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809077|NCT00847912|Immunologic Factors|immunologic factors|mesh-ancestor
92809078|NCT00847912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809079|NCT00850564|Hormones|hormones|mesh-list
92809080|NCT00850564|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92809081|NCT00850564|Tesamorelin|tesamorelin|mesh-list
92809082|NCT00850564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809083|NCT00850564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809084|NCT00850564|Growth Substances|growth substances|mesh-ancestor
92809085|NCT00837148|Sorafenib|sorafenib|mesh-list
92809086|NCT00837148|Dacarbazine|dacarbazine|mesh-list
92809087|NCT00837148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809088|NCT00837148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809089|NCT00837148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809090|NCT00837148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422453|NCT01516580|Rituximab|rituximab|mesh-list
92809091|NCT00837148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92809092|NCT00837148|Alkylating Agents|alkylating agents|mesh-ancestor
92809093|NCT00703690|Fenofibrate|fenofibrate|mesh-list
92809094|NCT00703690|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92809095|NCT00703690|Antimetabolites|antimetabolites|mesh-ancestor
92809096|NCT00703690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809097|NCT00703690|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92809098|NCT05297968|Oseltamivir|oseltamivir|mesh-list
92809099|NCT05297968|Antiviral Agents|antiviral agents|mesh-ancestor
92809100|NCT05297968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809101|NCT05297968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809102|NCT05297968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809103|NCT02613130|Fluorides|fluorides|mesh-list
92809104|NCT02613130|Tin Fluorides|tin fluorides|mesh-list
92809105|NCT02613130|Cariostatic Agents|cariostatic agents|mesh-ancestor
92809106|NCT02613130|Protective Agents|protective agents|mesh-ancestor
92809107|NCT02613130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809108|NCT00849472|Paclitaxel|paclitaxel|mesh-list
92809109|NCT00849472|Cyclophosphamide|cyclophosphamide|mesh-list
92809110|NCT00849472|Doxorubicin|doxorubicin|mesh-list
92809111|NCT00849472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92809112|NCT00849472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809113|NCT00849472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809114|NCT00849472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809115|NCT00849472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809116|NCT00849472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809117|NCT00849472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809118|NCT00849472|Immunologic Factors|immunologic factors|mesh-ancestor
92809119|NCT00849472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809120|NCT00849472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809121|NCT00849472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92809122|NCT00849472|Alkylating Agents|alkylating agents|mesh-ancestor
92809123|NCT00849472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92809124|NCT00849472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92809125|NCT00849472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92809126|NCT00849472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92809127|NCT00849472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809128|NCT00782509|Olodaterol|olodaterol|mesh-list
92809129|NCT00782509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92809130|NCT00782509|Autonomic Agents|autonomic agents|mesh-ancestor
92809131|NCT00782509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809132|NCT00782509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809133|NCT00782509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92809134|NCT00782509|Respiratory System Agents|respiratory system agents|mesh-ancestor
92809135|NCT00701428|Losartan|losartan|mesh-list
92809136|NCT00701428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92809137|NCT00701428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92809138|NCT00701428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92809139|NCT00701428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92809140|NCT00701428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809141|NCT00848926|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92809142|NCT00848926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92809143|NCT00848926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809144|NCT00848926|Immunotoxins|immunotoxins|mesh-ancestor
92809145|NCT00848926|Immunoconjugates|immunoconjugates|mesh-ancestor
92809147|NCT00848926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809148|NCT00706888|Vitamin B 6|vitamin b 6|mesh-list
92809149|NCT00706888|Pyridoxal|pyridoxal|mesh-list
92809150|NCT00706888|Pyridoxine|pyridoxine|mesh-list
92809151|NCT00706888|Vitamins|vitamins|mesh-ancestor
92809152|NCT00706888|Micronutrients|micronutrients|mesh-ancestor
92809153|NCT00706888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809154|NCT00706888|Vitamin B Complex|vitamin b complex|mesh-ancestor
92809155|NCT05019534|Cetuximab|cetuximab|mesh-list
92809156|NCT05019534|Vemurafenib|vemurafenib|mesh-list
92809157|NCT05019534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92809158|NCT05019534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809159|NCT05019534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809160|NCT05019534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809161|NCT05019534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809162|NCT04254042|Perindopril|perindopril|mesh-list
92809163|NCT04254042|Zofenopril|zofenopril|mesh-list
92809164|NCT04254042|Captopril|captopril|mesh-list
92809165|NCT04254042|Calcium|calcium|mesh-list
92809166|NCT04254042|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809167|NCT04254042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809168|NCT04254042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92809169|NCT04254042|Protease Inhibitors|protease inhibitors|mesh-ancestor
92809170|NCT04254042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809171|NCT04254042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809172|NCT04254042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92809173|NCT00918138|Metformin|metformin|mesh-list
92809174|NCT00918138|Saxagliptin|saxagliptin|mesh-list
92809175|NCT00918138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92809176|NCT00918138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809177|NCT00918138|Incretins|incretins|mesh-ancestor
92809178|NCT00918138|Hormones|hormones|mesh-ancestor
92809179|NCT00918138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809180|NCT00918138|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92809181|NCT00918138|Protease Inhibitors|protease inhibitors|mesh-ancestor
92809182|NCT00918138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809183|NCT00918138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809184|NCT04253574|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92809185|NCT04253574|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92809186|NCT04253574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809187|NCT00782275|Sirolimus|sirolimus|mesh-list
92809188|NCT00782275|Bevacizumab|bevacizumab|mesh-list
92809189|NCT00782275|Temsirolimus|temsirolimus|mesh-list
92809190|NCT00782275|MTOR Inhibitors|mtor inhibitors|mesh-list
92809191|NCT00782275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92809192|NCT00782275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809193|NCT00782275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809194|NCT00782275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809195|NCT00782275|Growth Substances|growth substances|mesh-ancestor
92809196|NCT00782275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809197|NCT00782275|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809198|NCT00782275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809199|NCT00782275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809200|NCT00782275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809201|NCT00782275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809202|NCT00782275|Immunologic Factors|immunologic factors|mesh-ancestor
92809203|NCT00782275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92809204|NCT00782275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422566|NCT01517165|Pioglitazone|pioglitazone|mesh-list
92809205|NCT00782275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92809206|NCT00782275|Antifungal Agents|antifungal agents|mesh-ancestor
92809207|NCT00791557|Infliximab|infliximab|mesh-list
92809208|NCT00791557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92809209|NCT00791557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92809210|NCT00791557|Dermatologic Agents|dermatologic agents|mesh-ancestor
92809211|NCT00791557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92809212|NCT00791557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809213|NCT00920790|Mogamulizumab|mogamulizumab|mesh-list
92809214|NCT00920790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809215|NCT05176314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92809216|NCT05176314|Pirtobrutinib|pirtobrutinib|mesh-list
92809217|NCT05176314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92809218|NCT05176314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92809219|NCT05176314|Antimetabolites|antimetabolites|mesh-ancestor
92809220|NCT05176314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809221|NCT05176314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92809222|NCT05176314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92809223|NCT05176314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809224|NCT05176314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809225|NCT00920556|Bortezomib|bortezomib|mesh-list
92809226|NCT00920556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809227|NCT00781885|Beraprost|beraprost|mesh-list
92809228|NCT00781885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92809229|NCT00781885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92809230|NCT04901676|Leronlimab|leronlimab|mesh-list
92809231|NCT04901676|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92809232|NCT04901676|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92809233|NCT04901676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809234|NCT04901676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92809235|NCT04901676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92809236|NCT04901676|Antiviral Agents|antiviral agents|mesh-ancestor
92809237|NCT04901676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809238|NCT04831086|Tocolytic Agents|tocolytic agents|mesh-list
92809239|NCT04831086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92809240|NCT04831086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809241|NCT02603965|Copper|copper|mesh-list
92809242|NCT02603965|Trace Elements|trace elements|mesh-ancestor
92809243|NCT02603965|Micronutrients|micronutrients|mesh-ancestor
92809244|NCT02603965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454244|NCT01698593|Epinephrine|epinephrine|mesh-list
92809245|NCT00918684|Escitalopram|escitalopram|mesh-list
92809246|NCT00918684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92809247|NCT00918684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92809248|NCT00918684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809249|NCT00918684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809250|NCT00918684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809251|NCT00918684|Serotonin Agents|serotonin agents|mesh-ancestor
92809252|NCT00918684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809253|NCT00919854|Ritonavir|ritonavir|mesh-list
92809254|NCT00919854|Darunavir|darunavir|mesh-list
92809255|NCT00919854|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92809256|NCT00919854|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92809257|NCT00919854|Protease Inhibitors|protease inhibitors|mesh-ancestor
92809258|NCT00919854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809259|NCT00919854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809260|NCT00919854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92809261|NCT00919854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92809262|NCT00919854|Antiviral Agents|antiviral agents|mesh-ancestor
92809263|NCT00919854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809264|NCT00919854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92809265|NCT00919854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92809266|NCT04669782|Teriparatide|teriparatide|mesh-list
92809267|NCT04669782|Vitamin K|vitamin k|mesh-list
92809268|NCT04669782|Vitamins|vitamins|mesh-ancestor
92809269|NCT04669782|Micronutrients|micronutrients|mesh-ancestor
92809270|NCT04669782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809271|NCT04669782|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92809272|NCT04669782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92809273|NCT04669782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809274|NCT04669782|Hemostatics|hemostatics|mesh-ancestor
92809275|NCT04669782|Coagulants|coagulants|mesh-ancestor
92809276|NCT04669782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809277|NCT04669782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92809278|NCT00891735|Ranibizumab|ranibizumab|mesh-list
92809279|NCT00891735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809280|NCT00891735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809281|NCT00891735|Growth Substances|growth substances|mesh-ancestor
92809282|NCT00891735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809283|NCT00891735|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809284|NCT00891735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809285|NCT04252248|Decitabine|decitabine|mesh-list
92809286|NCT04252248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92809287|NCT04252248|Antimetabolites|antimetabolites|mesh-ancestor
92809288|NCT04252248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809289|NCT04252248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809290|NCT04252248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809291|NCT04247373|Ropivacaine|ropivacaine|mesh-list
92809292|NCT04247373|Anesthetics, Local|anesthetics, local|mesh-ancestor
92809293|NCT04247373|Anesthetics|anesthetics|mesh-ancestor
92809294|NCT04247373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809295|NCT04247373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809296|NCT04247373|Sensory System Agents|sensory system agents|mesh-ancestor
92809297|NCT04247373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809298|NCT02832999|Liraglutide|liraglutide|mesh-list
92809299|NCT02832999|Vildagliptin|vildagliptin|mesh-list
92809300|NCT02832999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92809301|NCT02832999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809302|NCT02832999|Incretins|incretins|mesh-ancestor
92809303|NCT02832999|Hormones|hormones|mesh-ancestor
92809304|NCT02832999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809305|NCT02832999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92809306|NCT02832999|Protease Inhibitors|protease inhibitors|mesh-ancestor
92809307|NCT02832999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809308|NCT02832999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809309|NCT04245033|Piperaquine|piperaquine|mesh-list
92809310|NCT04245033|Artenimol|artenimol|mesh-list
92809311|NCT04245033|Antimalarials|antimalarials|mesh-ancestor
92809312|NCT04245033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92809313|NCT04245033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92809314|NCT04245033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809315|NCT00915018|Paclitaxel|paclitaxel|mesh-list
92809316|NCT00915018|Trastuzumab|trastuzumab|mesh-list
92809317|NCT00915018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92809318|NCT00915018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92809319|NCT00915018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809320|NCT00915018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809321|NCT00915018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809322|NCT00915018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809323|NCT00915018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809324|NCT00915018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92809325|NCT04246905|Sulforaphane|sulforaphane|mesh-list
92809326|NCT04246905|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92809327|NCT04246905|Protective Agents|protective agents|mesh-ancestor
92809328|NCT04246905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809329|NCT04246905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809330|NCT02830347|Amoxicillin|amoxicillin|mesh-list
92809331|NCT02830347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92809332|NCT02830347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809333|NCT00916578|Capecitabine|capecitabine|mesh-list
92809334|NCT00916578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92809335|NCT00916578|Antimetabolites|antimetabolites|mesh-ancestor
92809336|NCT00916578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809337|NCT00916578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809338|NCT04675866|Paclitaxel|paclitaxel|mesh-list
92809339|NCT04675866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92809340|NCT04675866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92809341|NCT04675866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809342|NCT04675866|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809343|NCT04675866|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809344|NCT04675866|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809345|NCT04675866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809346|NCT02829879|Listerine|listerine|mesh-list
92809347|NCT02829879|Fluorides|fluorides|mesh-list
92809348|NCT02829879|Sodium Fluoride|sodium fluoride|mesh-list
92809349|NCT02829879|Fluorophosphate|fluorophosphate|mesh-list
92809350|NCT02829879|Cariostatic Agents|cariostatic agents|mesh-ancestor
92809351|NCT02829879|Protective Agents|protective agents|mesh-ancestor
92809352|NCT02829879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809353|NCT02829879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92809354|NCT02829879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809355|NCT05246007|Dexmedetomidine|dexmedetomidine|mesh-list
92809356|NCT05246007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92809357|NCT05246007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809358|NCT05246007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809359|NCT05246007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92809360|NCT05246007|Analgesics|analgesics|mesh-ancestor
92809361|NCT05246007|Sensory System Agents|sensory system agents|mesh-ancestor
92809362|NCT05246007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809363|NCT05246007|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92809364|NCT05246007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92809365|NCT05246007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92809366|NCT05246007|Adrenergic Agents|adrenergic agents|mesh-ancestor
92809367|NCT05246007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809368|NCT05246007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809369|NCT00914940|Fludarabine|fludarabine|mesh-list
92809370|NCT00914940|Fludarabine phosphate|fludarabine phosphate|mesh-list
92809371|NCT00914940|Thiotepa|thiotepa|mesh-list
92809372|NCT00914940|Tacrolimus|tacrolimus|mesh-list
92809373|NCT00914940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809374|NCT00914940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92809375|NCT00914940|Antimetabolites|antimetabolites|mesh-ancestor
92809376|NCT00914940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809377|NCT00914940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809378|NCT00914940|Immunologic Factors|immunologic factors|mesh-ancestor
92809379|NCT00914940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809380|NCT00914940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92809381|NCT00914940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809382|NCT00914940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92809383|NCT00914940|Alkylating Agents|alkylating agents|mesh-ancestor
92809384|NCT00914940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92809385|NCT00835978|Axitinib|axitinib|mesh-list
92809386|NCT00835978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809387|NCT00835978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809388|NCT00835978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809389|NCT00835978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809390|NCT01077518|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92809391|NCT01077518|Ofatumumab|ofatumumab|mesh-list
92809392|NCT01077518|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92809393|NCT01077518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92809394|NCT01077518|Alkylating Agents|alkylating agents|mesh-ancestor
92809395|NCT01077518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809396|NCT01077518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809397|NCT01077518|Immunologic Factors|immunologic factors|mesh-ancestor
92809398|NCT01077518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809400|NCT04203186|Artemether|artemether|mesh-list
92809401|NCT04203186|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92809402|NCT04203186|Atovaquone|atovaquone|mesh-list
92809403|NCT04203186|Proguanil|proguanil|mesh-list
92809404|NCT04203186|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92809405|NCT04203186|Antimalarials|antimalarials|mesh-ancestor
92809406|NCT04203186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92809407|NCT04203186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92809408|NCT04203186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809409|NCT04203186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809410|NCT04203186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809411|NCT04203186|Antimetabolites|antimetabolites|mesh-ancestor
92809412|NCT00835120|Pioglitazone|pioglitazone|mesh-list
92809413|NCT00835120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92809414|NCT00835120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809415|NCT00914316|Ranolazine|ranolazine|mesh-list
92809416|NCT00914316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92809417|NCT00914316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809418|NCT00914316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809419|NCT00701740|Isotretinoin|isotretinoin|mesh-list
92809420|NCT00701740|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
92809421|NCT00701740|Dermatologic Agents|dermatologic agents|mesh-ancestor
92809422|NCT00701740|Sunscreening Agents|sunscreening agents|mesh-ancestor
92809423|NCT00701740|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92809424|NCT00701740|Protective Agents|protective agents|mesh-ancestor
92809425|NCT00701740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809426|NCT04938882|Lidocaine|lidocaine|mesh-list
92809427|NCT04938882|Ropivacaine|ropivacaine|mesh-list
92809428|NCT04938882|Anesthetics, Local|anesthetics, local|mesh-ancestor
92809429|NCT04938882|Anesthetics|anesthetics|mesh-ancestor
92809430|NCT04938882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809431|NCT04938882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809432|NCT04938882|Sensory System Agents|sensory system agents|mesh-ancestor
92809433|NCT04938882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809434|NCT04938882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92809435|NCT04938882|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92809436|NCT04938882|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92809437|NCT04938882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809438|NCT04938882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809439|NCT00704080|Temozolomide|temozolomide|mesh-list
92809440|NCT00704080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92809441|NCT00704080|Alkylating Agents|alkylating agents|mesh-ancestor
92809442|NCT00704080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809443|NCT00704080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809444|NCT05253066|Docetaxel|docetaxel|mesh-list
92809445|NCT05253066|Epirubicin|epirubicin|mesh-list
92809446|NCT05253066|Exemestane|exemestane|mesh-list
92809447|NCT05253066|Goserelin|goserelin|mesh-list
92809448|NCT05253066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809449|NCT05253066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809450|NCT05253066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809451|NCT05253066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809452|NCT05253066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809453|NCT05253066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92809454|NCT05253066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92809455|NCT05253066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92809456|NCT05253066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809457|NCT05253066|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92809458|NCT05253066|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92809459|NCT05253066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92809460|NCT05253066|Hormone Antagonists|hormone antagonists|mesh-ancestor
92809461|NCT05253066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809462|NCT05253066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809463|NCT05253066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92809464|NCT04303598|Tenofovir|tenofovir|mesh-list
92809465|NCT04303598|Lamivudine|lamivudine|mesh-list
92809466|NCT04303598|Efavirenz|efavirenz|mesh-list
92809467|NCT04303598|Antiviral Agents|antiviral agents|mesh-ancestor
92809468|NCT04303598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809469|NCT04303598|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92809470|NCT04303598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92809472|NCT04303598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809473|NCT04303598|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92809474|NCT04303598|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92809475|NCT04303598|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92809476|NCT04303598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92809477|NCT04303598|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92809478|NCT04303598|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92148780|NCT01397825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809479|NCT04303598|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92809480|NCT04303598|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92809481|NCT04607460|Coal Tar|coal tar|mesh-list
92809482|NCT04607460|Keratolytic Agents|keratolytic agents|mesh-ancestor
92809483|NCT04607460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92809484|NCT04636086|Cholecalciferol|cholecalciferol|mesh-list
92809485|NCT04636086|Vitamin D|vitamin d|mesh-list
92809486|NCT04636086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809487|NCT04636086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809488|NCT04636086|Vitamins|vitamins|mesh-ancestor
92809489|NCT04636086|Micronutrients|micronutrients|mesh-ancestor
92809490|NCT04636086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92809491|NCT00827242|Tadalafil|tadalafil|mesh-list
92809492|NCT00827242|Vasodilator Agents|vasodilator agents|mesh-ancestor
92809493|NCT00827242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92527986|NCT00034840|Valsartan|valsartan|mesh-list
92429477|NCT05839652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92809494|NCT00827242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92429556|NCT05839470|Vitamins|vitamins|mesh-ancestor
92809495|NCT00827242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430075|NCT04710368|Antimetabolites|antimetabolites|mesh-ancestor
92809496|NCT00827242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809497|NCT00827242|Urological Agents|urological agents|mesh-ancestor
92155005|NCT03587129|Apatinib|apatinib|mesh-list
92809498|NCT01077362|Ustekinumab|ustekinumab|mesh-list
92809501|NCT00846586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92809502|NCT00846586|Autonomic Agents|autonomic agents|mesh-ancestor
92431948|NCT05522582|Antibodies|antibodies|mesh-list
92432396|NCT02553941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432468|NCT01564095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432691|NCT01570608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92432853|NCT01571583|Interferons|interferons|mesh-list
92809504|NCT00846586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809506|NCT00846586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92809507|NCT00846586|Parasympatholytics|parasympatholytics|mesh-ancestor
92809508|NCT00846586|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92809509|NCT00846586|Cholinergic Agents|cholinergic agents|mesh-ancestor
92809510|NCT00846586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809511|NCT00846586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809512|NCT00785785|Imatinib Mesylate|imatinib mesylate|mesh-list
92809513|NCT00785785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809514|NCT00785785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809515|NCT00785785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809516|NCT00785785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809517|NCT00707278|Capecitabine|capecitabine|mesh-list
92809518|NCT00707278|Oxaliplatin|oxaliplatin|mesh-list
92809519|NCT00707278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92809520|NCT00707278|Antimetabolites|antimetabolites|mesh-ancestor
92809521|NCT00707278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809522|NCT00707278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809523|NCT01077284|Allopurinol|allopurinol|mesh-list
92809524|NCT01077284|Febuxostat|febuxostat|mesh-list
92809525|NCT01077284|Antimetabolites|antimetabolites|mesh-ancestor
92809526|NCT01077284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809527|NCT01077284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809528|NCT01077284|Gout Suppressants|gout suppressants|mesh-ancestor
92809529|NCT01077284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809530|NCT01077284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92809531|NCT01077284|Antioxidants|antioxidants|mesh-ancestor
92809532|NCT01077284|Protective Agents|protective agents|mesh-ancestor
92809533|NCT01077284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809534|NCT00704314|Simvastatin|simvastatin|mesh-list
92809535|NCT00704314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92809536|NCT00704314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92809537|NCT00704314|Antimetabolites|antimetabolites|mesh-ancestor
92809538|NCT00704314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809539|NCT00704314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92809540|NCT00704314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92809541|NCT00704314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809542|NCT00704392|XL647|xl647|mesh-list
92809543|NCT00704392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454545|NCT01700400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92809544|NCT00704392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809545|NCT00704392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422907|NCT01518855|Vasodilator Agents|vasodilator agents|mesh-ancestor
92809546|NCT00704392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809547|NCT04103125|Hyaluronic Acid|hyaluronic acid|mesh-list
92809548|NCT04103125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92809549|NCT04103125|Immunologic Factors|immunologic factors|mesh-ancestor
92809550|NCT04103125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809551|NCT04103125|Viscosupplements|viscosupplements|mesh-ancestor
92809552|NCT04103125|Protective Agents|protective agents|mesh-ancestor
92809553|NCT00826618|Ranibizumab|ranibizumab|mesh-list
92809554|NCT00826618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809555|NCT00826618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809556|NCT00826618|Growth Substances|growth substances|mesh-ancestor
92809557|NCT00826618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809558|NCT00826618|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809559|NCT00826618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809560|NCT02876822|Vitamin D|vitamin d|mesh-list
92809561|NCT02876822|Cholecalciferol|cholecalciferol|mesh-list
92809562|NCT02876822|Vitamins|vitamins|mesh-ancestor
92809563|NCT02876822|Micronutrients|micronutrients|mesh-ancestor
92809564|NCT02876822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809565|NCT02876822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92809566|NCT02876822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809567|NCT00826540|Bevacizumab|bevacizumab|mesh-list
92809568|NCT00826540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92809569|NCT00826540|Sorafenib|sorafenib|mesh-list
92809570|NCT00826540|Antibodies|antibodies|mesh-list
92809571|NCT00826540|Immunoglobulins|immunoglobulins|mesh-list
92809572|NCT00826540|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92809573|NCT00826540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809574|NCT00826540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809575|NCT00826540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809576|NCT00826540|Growth Substances|growth substances|mesh-ancestor
92809577|NCT00826540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809578|NCT00826540|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809579|NCT00826540|Immunologic Factors|immunologic factors|mesh-ancestor
92809580|NCT00826540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809581|NCT00826540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809582|NCT00826540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809583|NCT04303130|Endostar protein|endostar protein|mesh-list
92809584|NCT04303130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809585|NCT04303130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809586|NCT04303130|Growth Substances|growth substances|mesh-ancestor
92809587|NCT04303130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809588|NCT04303130|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809589|NCT04303130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809590|NCT00626600|Oxycodone|oxycodone|mesh-list
92809591|NCT00626600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92809592|NCT00626600|Narcotics|narcotics|mesh-ancestor
92809593|NCT00626600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809594|NCT00626600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809595|NCT00626600|Analgesics|analgesics|mesh-ancestor
92809596|NCT00626600|Sensory System Agents|sensory system agents|mesh-ancestor
92809597|NCT00626600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809598|NCT00707512|Natalizumab|natalizumab|mesh-list
92809599|NCT00707512|Immunologic Factors|immunologic factors|mesh-ancestor
92809600|NCT00707512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809601|NCT00704548|Simvastatin|simvastatin|mesh-list
92809602|NCT00704548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92809603|NCT00704548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92809604|NCT00704548|Antimetabolites|antimetabolites|mesh-ancestor
92809605|NCT00704548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809606|NCT00704548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92809607|NCT00704548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92809608|NCT00704548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809609|NCT00592384|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92809610|NCT00592384|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92809611|NCT00592384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92809612|NCT00592384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809613|NCT00592384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809614|NCT00592384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809615|NCT00592384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809616|NCT00592384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92809617|NCT00592384|Antidepressive Agents|antidepressive agents|mesh-ancestor
92809618|NCT00592384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92809619|NCT00846040|Fallypride|fallypride|mesh-list
92809620|NCT00846040|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92809621|NCT00846040|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92809622|NCT00846040|Dopamine Agents|dopamine agents|mesh-ancestor
92809623|NCT00846040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809624|NCT00846040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809625|NCT00846040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809626|NCT02611336|Tadalafil|tadalafil|mesh-list
92809627|NCT02611336|Vasodilator Agents|vasodilator agents|mesh-ancestor
92809628|NCT02611336|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92809629|NCT02611336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92809630|NCT02611336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809631|NCT02611336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809632|NCT02611336|Urological Agents|urological agents|mesh-ancestor
92809633|NCT00704704|Thalidomide|thalidomide|mesh-list
92809634|NCT00704704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809635|NCT00704704|Immunologic Factors|immunologic factors|mesh-ancestor
92809636|NCT00704704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809637|NCT00704704|Leprostatic Agents|leprostatic agents|mesh-ancestor
92809638|NCT00704704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92809639|NCT00704704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809640|NCT00704704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809641|NCT00704704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809642|NCT00704704|Growth Substances|growth substances|mesh-ancestor
92809643|NCT00704704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809644|NCT00704704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809645|NCT00707824|Nalbuphine|nalbuphine|mesh-list
92809646|NCT00707824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92809647|NCT00707824|Narcotics|narcotics|mesh-ancestor
92809648|NCT00707824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809649|NCT00707824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809650|NCT00707824|Analgesics|analgesics|mesh-ancestor
92809651|NCT00707824|Sensory System Agents|sensory system agents|mesh-ancestor
92809652|NCT00707824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809653|NCT00826228|Teriparatide|teriparatide|mesh-list
92809654|NCT00826228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809655|NCT00826228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809656|NCT00826228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92809657|NCT00791479|Dulaglutide|dulaglutide|mesh-list
92809658|NCT00791479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92809659|NCT00791479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809660|NCT00890097|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92809661|NCT00890097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92809662|NCT02831751|Vaccines|vaccines|mesh-list
92809663|NCT02831751|Immunologic Factors|immunologic factors|mesh-ancestor
92423051|NCT01519687|Antidepressive Agents|antidepressive agents|mesh-ancestor
92809664|NCT02831751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809665|NCT00913458|Etanercept|etanercept|mesh-list
92809666|NCT00913458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92809667|NCT00913458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92809668|NCT00913458|Analgesics|analgesics|mesh-ancestor
92809669|NCT00913458|Sensory System Agents|sensory system agents|mesh-ancestor
92809670|NCT00913458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809671|NCT00913458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809672|NCT00913458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92809673|NCT00913458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809674|NCT00913458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92809675|NCT00913458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809676|NCT00913458|Immunologic Factors|immunologic factors|mesh-ancestor
92809677|NCT05208333|Albendazole|albendazole|mesh-list
92809678|NCT05208333|Anthelmintics|anthelmintics|mesh-ancestor
92809679|NCT05208333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92809680|NCT05208333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809681|NCT05208333|Anticestodal Agents|anticestodal agents|mesh-ancestor
92809682|NCT05208333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92809683|NCT05208333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92809684|NCT05208333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809685|NCT05208333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809686|NCT05208333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809687|NCT05208333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809688|NCT05208333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809689|NCT04309773|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92809690|NCT04309773|Bezafibrate|bezafibrate|mesh-list
92809691|NCT04309773|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92809692|NCT04309773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92809693|NCT04309773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92809694|NCT04309773|Antimetabolites|antimetabolites|mesh-ancestor
92809695|NCT04309773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809696|NCT04309773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92809698|NCT02829333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809699|NCT02829333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809700|NCT05251662|Bevacizumab|bevacizumab|mesh-list
92809701|NCT05251662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92809702|NCT05251662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809703|NCT05251662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809704|NCT05251662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809705|NCT05251662|Growth Substances|growth substances|mesh-ancestor
92809706|NCT05251662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809707|NCT05251662|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809708|NCT02829177|Allopurinol|allopurinol|mesh-list
92809709|NCT02829177|Antimetabolites|antimetabolites|mesh-ancestor
92809710|NCT02829177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809711|NCT02829177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809712|NCT02829177|Gout Suppressants|gout suppressants|mesh-ancestor
92809713|NCT02829177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809714|NCT02829177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92809715|NCT02829177|Antioxidants|antioxidants|mesh-ancestor
92809716|NCT02829177|Protective Agents|protective agents|mesh-ancestor
92809717|NCT02829177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809718|NCT05112081|Botulinum Toxins|botulinum toxins|mesh-list
92809719|NCT05112081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92809720|NCT05112081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92809721|NCT05112081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92809722|NCT05112081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809723|NCT05112081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809724|NCT05112081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92809725|NCT05112081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809726|NCT05112081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809727|NCT05112081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92809728|NCT05112081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809729|NCT04244097|Bupivacaine|bupivacaine|mesh-list
92809730|NCT04244097|Neostigmine|neostigmine|mesh-list
92809731|NCT04244097|Anesthetics, Local|anesthetics, local|mesh-ancestor
92809732|NCT04244097|Anesthetics|anesthetics|mesh-ancestor
92809733|NCT04244097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809734|NCT04244097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809735|NCT04244097|Sensory System Agents|sensory system agents|mesh-ancestor
92809736|NCT04244097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809737|NCT04244097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92809738|NCT04244097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809739|NCT04244097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809740|NCT04244097|Cholinergic Agents|cholinergic agents|mesh-ancestor
92809741|NCT04244097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809742|NCT04244097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92809744|NCT00785629|Calcium|calcium|mesh-list
92809745|NCT00785629|Sevelamer|sevelamer|mesh-list
92809746|NCT00785629|Calcium acetate|calcium acetate|mesh-list
92809747|NCT00785629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809748|NCT00785629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809749|NCT00785629|Chelating Agents|chelating agents|mesh-ancestor
92809750|NCT00785629|Sequestering Agents|sequestering agents|mesh-ancestor
92809751|NCT00785629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809752|NCT00915733|Aspirin|aspirin|mesh-list
92809753|NCT00915733|Cilostazol|cilostazol|mesh-list
92809754|NCT00915733|Clopidogrel|clopidogrel|mesh-list
92809755|NCT00915733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92809756|NCT00915733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92809757|NCT00915733|Analgesics|analgesics|mesh-ancestor
92809758|NCT00915733|Sensory System Agents|sensory system agents|mesh-ancestor
92809759|NCT00915733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809760|NCT00915733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809761|NCT00915733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92809762|NCT00915733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92809763|NCT00915733|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92809764|NCT00915733|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92809765|NCT00915733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809766|NCT00915733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92809767|NCT00915733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92809768|NCT00915733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809770|NCT00915733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92809771|NCT00915733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92809772|NCT00915733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92809773|NCT00915733|Purinergic Agents|purinergic agents|mesh-ancestor
92809774|NCT00915733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809775|NCT00915733|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92809776|NCT00915733|Autonomic Agents|autonomic agents|mesh-ancestor
92809777|NCT00915733|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92809778|NCT00915733|Respiratory System Agents|respiratory system agents|mesh-ancestor
92809779|NCT00915733|Vasodilator Agents|vasodilator agents|mesh-ancestor
92809780|NCT00915733|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92809781|NCT00915733|Protective Agents|protective agents|mesh-ancestor
92809782|NCT00915733|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92809783|NCT00915733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92809784|NCT00913770|Buprenorphine|buprenorphine|mesh-list
92809785|NCT00913770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92809786|NCT00913770|Narcotics|narcotics|mesh-ancestor
92809787|NCT00913770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809788|NCT00913770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809789|NCT00913770|Analgesics|analgesics|mesh-ancestor
92809790|NCT00913770|Sensory System Agents|sensory system agents|mesh-ancestor
92809791|NCT00913770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809792|NCT00913770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92809793|NCT00912912|Sunitinib|sunitinib|mesh-list
92809794|NCT00912912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809795|NCT00912912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809796|NCT00912912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809797|NCT00912912|Growth Substances|growth substances|mesh-ancestor
92809798|NCT00912912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809799|NCT00912912|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809800|NCT00912912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809801|NCT00912912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809802|NCT00912912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809803|NCT00913692|Glycine|glycine|mesh-list
92809804|NCT00913692|Glycine Agents|glycine agents|mesh-ancestor
92809805|NCT00913692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809806|NCT00913692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809807|NCT00913692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809808|NCT00784927|Dexamethasone|dexamethasone|mesh-list
92809809|NCT00784927|Cyclophosphamide|cyclophosphamide|mesh-list
92809810|NCT00784927|Rituximab|rituximab|mesh-list
92809811|NCT00784927|Lenalidomide|lenalidomide|mesh-list
92809812|NCT00784927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809813|NCT00784927|Immunologic Factors|immunologic factors|mesh-ancestor
92809814|NCT00784927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809816|NCT00784927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92809817|NCT00784927|Alkylating Agents|alkylating agents|mesh-ancestor
92809818|NCT00784927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809819|NCT00784927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809820|NCT00784927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92809821|NCT00784927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92809822|NCT00784927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92809823|NCT00784927|Antiemetics|antiemetics|mesh-ancestor
92809824|NCT00784927|Autonomic Agents|autonomic agents|mesh-ancestor
92809825|NCT00784927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809826|NCT00784927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92809827|NCT00784927|Glucocorticoids|glucocorticoids|mesh-ancestor
92809828|NCT00784927|Hormones|hormones|mesh-ancestor
92809829|NCT00784927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809830|NCT00784927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92809831|NCT00784927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92809832|NCT00784927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92809833|NCT00784927|Growth Substances|growth substances|mesh-ancestor
92809834|NCT00784927|Growth Inhibitors|growth inhibitors|mesh-ancestor
92809835|NCT00637884|Fexofenadine|fexofenadine|mesh-list
92809836|NCT00637884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92809837|NCT00637884|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92809838|NCT00637884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92809839|NCT00637884|Histamine Antagonists|histamine antagonists|mesh-ancestor
92809840|NCT00637884|Histamine Agents|histamine agents|mesh-ancestor
92454856|NCT01702129|Doxorubicin|doxorubicin|mesh-list
92809841|NCT00637884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809842|NCT00637884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809843|NCT00637884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809844|NCT04203342|Ketoconazole|ketoconazole|mesh-list
92809845|NCT04203342|Antifungal Agents|antifungal agents|mesh-ancestor
92809846|NCT04203342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809847|NCT04203342|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92809848|NCT04203342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92809849|NCT04203342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809850|NCT04203342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809851|NCT04203342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92809852|NCT04203342|Hormone Antagonists|hormone antagonists|mesh-ancestor
92809853|NCT04203342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809854|NCT04203342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809855|NCT04203342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92809856|NCT05539729|Vancomycin|vancomycin|mesh-list
92809857|NCT05539729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92809858|NCT05539729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92809859|NCT04834206|Docetaxel|docetaxel|mesh-list
92809860|NCT04834206|Fluorouracil|fluorouracil|mesh-list
92809861|NCT04834206|Nedaplatin|nedaplatin|mesh-list
92809862|NCT04834206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809863|NCT04834206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809864|NCT04834206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809865|NCT04834206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809866|NCT04834206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809867|NCT04834206|Antimetabolites|antimetabolites|mesh-ancestor
92809868|NCT04834206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92809869|NCT04834206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809870|NCT04834206|Immunologic Factors|immunologic factors|mesh-ancestor
92809871|NCT04834206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809872|NCT00631722|Haloperidol|haloperidol|mesh-list
92809873|NCT00631722|Haloperidol decanoate|haloperidol decanoate|mesh-list
92809874|NCT00631722|Antiemetics|antiemetics|mesh-ancestor
92809875|NCT00631722|Autonomic Agents|autonomic agents|mesh-ancestor
92809876|NCT00631722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809877|NCT00631722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809878|NCT00631722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92809879|NCT00631722|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92809880|NCT00631722|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92809881|NCT00631722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809882|NCT00631722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92809883|NCT00631722|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92809884|NCT00631722|Dopamine Agents|dopamine agents|mesh-ancestor
92809885|NCT00631722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809886|NCT00631722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809888|NCT00845728|Tiotropium Bromide|tiotropium bromide|mesh-list
92809889|NCT00845728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92809890|NCT00845728|Autonomic Agents|autonomic agents|mesh-ancestor
92809891|NCT00845728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809892|NCT00845728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809893|NCT00845728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92809894|NCT00845728|Respiratory System Agents|respiratory system agents|mesh-ancestor
92809895|NCT00845728|Parasympatholytics|parasympatholytics|mesh-ancestor
92809896|NCT00845728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92809897|NCT00845728|Cholinergic Agents|cholinergic agents|mesh-ancestor
92809898|NCT00845728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809899|NCT00845728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809900|NCT00779467|Fentanyl|fentanyl|mesh-list
92809901|NCT00779467|Bupivacaine|bupivacaine|mesh-list
92809902|NCT00779467|Neostigmine|neostigmine|mesh-list
92809903|NCT00779467|Anesthetics, Local|anesthetics, local|mesh-ancestor
92809904|NCT00779467|Anesthetics|anesthetics|mesh-ancestor
92809905|NCT00779467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809906|NCT00779467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809907|NCT00779467|Sensory System Agents|sensory system agents|mesh-ancestor
92809908|NCT00779467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809909|NCT00779467|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92809910|NCT00779467|Narcotics|narcotics|mesh-ancestor
92809911|NCT00779467|Analgesics|analgesics|mesh-ancestor
92809912|NCT00779467|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92809913|NCT00779467|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92809914|NCT00779467|Anesthetics, General|anesthetics, general|mesh-ancestor
92809915|NCT00779467|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92454924|NCT01702688|Angiotensinogen|angiotensinogen|mesh-list
92809916|NCT00779467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809917|NCT00779467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809918|NCT00779467|Cholinergic Agents|cholinergic agents|mesh-ancestor
92809919|NCT00779467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809920|NCT00779467|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92809921|NCT00779467|Autonomic Agents|autonomic agents|mesh-ancestor
92809922|NCT04559100|Carbon Monoxide|carbon monoxide|mesh-list
92809923|NCT04559100|Antimetabolites|antimetabolites|mesh-ancestor
92809924|NCT04559100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809925|NCT04559100|Gasotransmitters|gasotransmitters|mesh-ancestor
92809926|NCT04559100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809927|NCT04559100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809928|NCT00778921|Amlodipine|amlodipine|mesh-list
92809929|NCT00778921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92809930|NCT00778921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92809931|NCT00778921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809932|NCT00778921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809933|NCT00778921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92809934|NCT00778921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809935|NCT00778921|Vasodilator Agents|vasodilator agents|mesh-ancestor
92809936|NCT04173312|Bupivacaine|bupivacaine|mesh-list
92809937|NCT04173312|Anesthetics, Local|anesthetics, local|mesh-ancestor
92809938|NCT04173312|Anesthetics|anesthetics|mesh-ancestor
92809939|NCT04173312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92809940|NCT04173312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809941|NCT04173312|Sensory System Agents|sensory system agents|mesh-ancestor
92809942|NCT04173312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92809943|NCT00587431|Docetaxel|docetaxel|mesh-list
92809944|NCT00587431|Leuprolide|leuprolide|mesh-list
92809945|NCT00587431|Testosterone|testosterone|mesh-list
92809946|NCT00587431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809947|NCT00587431|Tubulin Modulators|tubulin modulators|mesh-ancestor
92809948|NCT00587431|Antimitotic Agents|antimitotic agents|mesh-ancestor
92809949|NCT00587431|Mitosis Modulators|mitosis modulators|mesh-ancestor
92809950|NCT00587431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809951|NCT00587431|Androgens|androgens|mesh-ancestor
92809952|NCT00587431|Hormones|hormones|mesh-ancestor
92809953|NCT00587431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809954|NCT00587431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809955|NCT00587431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92809956|NCT00587431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92809957|NCT00587431|Fertility Agents|fertility agents|mesh-ancestor
92809958|NCT00587431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92809959|NCT00776659|Exemestane|exemestane|mesh-list
92809960|NCT00776659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809962|NCT00776659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92809963|NCT00776659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809964|NCT00776659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809965|NCT00776659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92809966|NCT00776659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92809967|NCT00776659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92809968|NCT00776659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809969|NCT00632268|Leucovorin|leucovorin|mesh-list
92809970|NCT00632268|Everolimus|everolimus|mesh-list
92809971|NCT00632268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92809972|NCT00632268|Antidotes|antidotes|mesh-ancestor
92809973|NCT00632268|Protective Agents|protective agents|mesh-ancestor
92809974|NCT00632268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809975|NCT00632268|Vitamin B Complex|vitamin b complex|mesh-ancestor
92809976|NCT00632268|Vitamins|vitamins|mesh-ancestor
92809977|NCT00632268|Micronutrients|micronutrients|mesh-ancestor
92809978|NCT00632268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92809979|NCT00632268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92809980|NCT00632268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92809981|NCT00632268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92809982|NCT00632268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92809983|NCT00632268|Immunologic Factors|immunologic factors|mesh-ancestor
92809984|NCT04145076|Citalopram|citalopram|mesh-list
92809985|NCT04145076|Tianeptine|tianeptine|mesh-list
92809986|NCT04145076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92809987|NCT04145076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92809988|NCT04145076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92809989|NCT04145076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455000|NCT01703234|Ramipril|ramipril|mesh-list
92809990|NCT04145076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92809991|NCT04145076|Serotonin Agents|serotonin agents|mesh-ancestor
92809992|NCT04145076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92809993|NCT04145076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92809994|NCT04145076|Antidepressive Agents|antidepressive agents|mesh-ancestor
92809995|NCT04145076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92809996|NCT04145076|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92809997|NCT00707902|Chlorhexidine|chlorhexidine|mesh-list
92809998|NCT00707902|Lidocaine|lidocaine|mesh-list
92809999|NCT00707902|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810000|NCT00707902|Anesthetics|anesthetics|mesh-ancestor
92810001|NCT00707902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810002|NCT00707902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810003|NCT00707902|Sensory System Agents|sensory system agents|mesh-ancestor
92810004|NCT00707902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810005|NCT00707902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92810006|NCT00707902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92810007|NCT00707902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92810008|NCT00707902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810009|NCT00707902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810010|NCT00707902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92810011|NCT00707902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810012|NCT00707902|Disinfectants|disinfectants|mesh-ancestor
92810013|NCT00704860|Antidepressive Agents|antidepressive agents|mesh-list
92810014|NCT00704860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810015|NCT05511337|Citric Acid|citric acid|mesh-list
92810016|NCT05511337|Sodium Citrate|sodium citrate|mesh-list
92810017|NCT05511337|Anticoagulants|anticoagulants|mesh-ancestor
92810018|NCT05511337|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92810019|NCT05511337|Chelating Agents|chelating agents|mesh-ancestor
92810020|NCT05511337|Sequestering Agents|sequestering agents|mesh-ancestor
92810021|NCT05511337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810022|NCT00833794|Tramadol|tramadol|mesh-list
92810023|NCT00833794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810024|NCT00833794|Narcotics|narcotics|mesh-ancestor
92810025|NCT00833794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810026|NCT00833794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810027|NCT00833794|Analgesics|analgesics|mesh-ancestor
92810028|NCT00833794|Sensory System Agents|sensory system agents|mesh-ancestor
92810029|NCT00833794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810030|NCT00778375|Cytarabine|cytarabine|mesh-list
92810031|NCT00778375|Decitabine|decitabine|mesh-list
92810032|NCT00778375|Clofarabine|clofarabine|mesh-list
92810033|NCT00778375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92810034|NCT00778375|Antimetabolites|antimetabolites|mesh-ancestor
92810035|NCT00778375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810036|NCT00778375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810037|NCT00778375|Antiviral Agents|antiviral agents|mesh-ancestor
92810038|NCT00778375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810039|NCT00778375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810040|NCT00778375|Immunologic Factors|immunologic factors|mesh-ancestor
92810041|NCT00778375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810042|NCT00778375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810043|NCT04102267|Epinephrine|epinephrine|mesh-list
92810044|NCT04102267|Bupivacaine|bupivacaine|mesh-list
92810045|NCT04102267|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810046|NCT04102267|Anesthetics|anesthetics|mesh-ancestor
92810047|NCT04102267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810048|NCT04102267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810049|NCT04102267|Sensory System Agents|sensory system agents|mesh-ancestor
92810050|NCT04102267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810051|NCT04102267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92810052|NCT04102267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92810053|NCT04102267|Adrenergic Agents|adrenergic agents|mesh-ancestor
92810054|NCT04102267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810055|NCT04102267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810056|NCT04102267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92810057|NCT04102267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92810058|NCT04102267|Autonomic Agents|autonomic agents|mesh-ancestor
92810059|NCT04102267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92810060|NCT04102267|Respiratory System Agents|respiratory system agents|mesh-ancestor
92810061|NCT04102267|Mydriatics|mydriatics|mesh-ancestor
92810062|NCT04102267|Sympathomimetics|sympathomimetics|mesh-ancestor
92810063|NCT04102267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92810064|NCT00777829|Zolpidem|zolpidem|mesh-list
92810065|NCT00777829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92810066|NCT00777829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92810067|NCT00777829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810068|NCT00777829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810069|NCT00777829|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92810070|NCT00777829|GABA Agonists|gaba agonists|mesh-ancestor
92810071|NCT00777829|GABA Agents|gaba agents|mesh-ancestor
92810072|NCT00777829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810073|NCT00777829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810074|NCT00916045|Vidarabine|vidarabine|mesh-list
92810075|NCT00916045|Cyclosporine|cyclosporine|mesh-list
92810076|NCT00916045|Mycophenolic Acid|mycophenolic acid|mesh-list
92810077|NCT00916045|Cyclophosphamide|cyclophosphamide|mesh-list
92810078|NCT00916045|Melphalan|melphalan|mesh-list
92810079|NCT00916045|Busulfan|busulfan|mesh-list
92810080|NCT00916045|Thiotepa|thiotepa|mesh-list
92810081|NCT00916045|Fludarabine|fludarabine|mesh-list
92810082|NCT00916045|Fludarabine phosphate|fludarabine phosphate|mesh-list
92810083|NCT00916045|Cyclosporins|cyclosporins|mesh-list
92810084|NCT00916045|Thymoglobulin|thymoglobulin|mesh-list
92810085|NCT00916045|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92810086|NCT00916045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810087|NCT00916045|Immunologic Factors|immunologic factors|mesh-ancestor
92810088|NCT00916045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810089|NCT00916045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810090|NCT00916045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92810091|NCT00916045|Alkylating Agents|alkylating agents|mesh-ancestor
92810092|NCT00916045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810093|NCT00916045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810094|NCT00916045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92810095|NCT00916045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92810096|NCT00916045|Antimetabolites|antimetabolites|mesh-ancestor
92810097|NCT00916045|Antiviral Agents|antiviral agents|mesh-ancestor
92810098|NCT00916045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810099|NCT00916045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810100|NCT00916045|Antifungal Agents|antifungal agents|mesh-ancestor
92810101|NCT00916045|Dermatologic Agents|dermatologic agents|mesh-ancestor
92810102|NCT00916045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92810103|NCT00916045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92810104|NCT00916045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92810105|NCT00916045|Antitubercular Agents|antitubercular agents|mesh-ancestor
92810106|NCT00916045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92810107|NCT00916123|Prednisone|prednisone|mesh-list
92810108|NCT00916123|Docetaxel|docetaxel|mesh-list
92810109|NCT00916123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810110|NCT00916123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810111|NCT00916123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810112|NCT00916123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810113|NCT00916123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810114|NCT00916123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810115|NCT00916123|Glucocorticoids|glucocorticoids|mesh-ancestor
92810116|NCT00916123|Hormones|hormones|mesh-ancestor
92810117|NCT00916123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810118|NCT00916123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810119|NCT00916123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92810120|NCT00916201|Cannabidiol|cannabidiol|mesh-list
92810121|NCT00916201|Anticonvulsants|anticonvulsants|mesh-ancestor
92810122|NCT00833638|Tadalafil|tadalafil|mesh-list
92810123|NCT00833638|Vasodilator Agents|vasodilator agents|mesh-ancestor
92810124|NCT00833638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92810125|NCT00833638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92810126|NCT00833638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810127|NCT00833638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810128|NCT00833638|Urological Agents|urological agents|mesh-ancestor
92810129|NCT01041404|Fluorouracil|fluorouracil|mesh-list
92810130|NCT01041404|Capecitabine|capecitabine|mesh-list
92810131|NCT01041404|Trastuzumab|trastuzumab|mesh-list
92810132|NCT01041404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810133|NCT01041404|Antimetabolites|antimetabolites|mesh-ancestor
92810134|NCT01041404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810135|NCT01041404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92810136|NCT01041404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810137|NCT01041404|Immunologic Factors|immunologic factors|mesh-ancestor
92810138|NCT01041404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810139|NCT01041404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810140|NCT00777049|Panobinostat|panobinostat|mesh-list
92810141|NCT00777049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810142|NCT00777049|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92810143|NCT00777049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810144|NCT00777049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810145|NCT00774787|Imiquimod|imiquimod|mesh-list
92810146|NCT00774787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92810147|NCT00774787|Immunologic Factors|immunologic factors|mesh-ancestor
92810148|NCT00774787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810149|NCT00774787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810150|NCT00774787|Interferon Inducers|interferon inducers|mesh-ancestor
92810151|NCT00888927|Mogamulizumab|mogamulizumab|mesh-list
92810152|NCT00888927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810153|NCT01040780|Gefitinib|gefitinib|mesh-list
92810154|NCT01040780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810155|NCT01040780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92810156|NCT01040780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810157|NCT01040780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810158|NCT04303988|Bevacizumab|bevacizumab|mesh-list
92810159|NCT04303988|Carboplatin|carboplatin|mesh-list
92810160|NCT04303988|Temozolomide|temozolomide|mesh-list
92810161|NCT04303988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810162|NCT04303988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810163|NCT04303988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92810164|NCT04303988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92810165|NCT04303988|Growth Substances|growth substances|mesh-ancestor
92810166|NCT04303988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810167|NCT04303988|Growth Inhibitors|growth inhibitors|mesh-ancestor
92810168|NCT04303988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92810169|NCT04303988|Alkylating Agents|alkylating agents|mesh-ancestor
92810170|NCT04303988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810171|NCT04991493|Tramadol|tramadol|mesh-list
92810172|NCT04991493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810173|NCT04991493|Narcotics|narcotics|mesh-ancestor
92810174|NCT04991493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810175|NCT04991493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810176|NCT04991493|Analgesics|analgesics|mesh-ancestor
92810177|NCT04991493|Sensory System Agents|sensory system agents|mesh-ancestor
92810178|NCT04991493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810179|NCT01059812|Insulin|insulin|mesh-list
92810180|NCT01059812|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92810181|NCT01059812|Insulin Aspart|insulin aspart|mesh-list
92810182|NCT01059812|Insulin, Long-Acting|insulin, long-acting|mesh-list
92810183|NCT01059812|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92810184|NCT01059812|Biphasic Insulins|biphasic insulins|mesh-list
92977202|NCT02553044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92810185|NCT01059812|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92810187|NCT01059812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810188|NCT00888615|Paclitaxel|paclitaxel|mesh-list
92810189|NCT00888615|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92810190|NCT00888615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92810191|NCT00888615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810192|NCT00888615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810193|NCT00888615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810194|NCT00888615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810195|NCT00888615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810196|NCT04241601|Aldesleukin|aldesleukin|mesh-list
92810197|NCT04241601|Interleukin-2|interleukin-2|mesh-list
92810198|NCT04241601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810199|NCT04241601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92810200|NCT04241601|Analgesics|analgesics|mesh-ancestor
92810201|NCT04241601|Sensory System Agents|sensory system agents|mesh-ancestor
92810202|NCT04241601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810203|NCT04241601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810204|NCT04241601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92810205|NCT04241601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92810206|NCT04241601|Antiviral Agents|antiviral agents|mesh-ancestor
92810207|NCT04241601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810208|NCT00845650|Immunoglobulins|immunoglobulins|mesh-list
92810209|NCT00845650|gamma-Globulins|gamma-globulins|mesh-list
92810210|NCT00845650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92810211|NCT00845650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92810212|NCT00845650|Immunologic Factors|immunologic factors|mesh-ancestor
92810213|NCT00845650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810214|NCT00888381|Vaccines|vaccines|mesh-list
92810215|NCT00888381|Immunologic Factors|immunologic factors|mesh-ancestor
92810216|NCT00888381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810217|NCT00833560|Dexamethasone|dexamethasone|mesh-list
92810218|NCT00833560|Cyclophosphamide|cyclophosphamide|mesh-list
92810219|NCT00833560|Bortezomib|bortezomib|mesh-list
92810220|NCT00833560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810221|NCT00833560|Immunologic Factors|immunologic factors|mesh-ancestor
92810222|NCT00833560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810223|NCT00833560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810224|NCT00833560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92810225|NCT00833560|Alkylating Agents|alkylating agents|mesh-ancestor
92810226|NCT00833560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810227|NCT00833560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810228|NCT00833560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92810229|NCT00833560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810230|NCT00833560|Antiemetics|antiemetics|mesh-ancestor
92810231|NCT00833560|Autonomic Agents|autonomic agents|mesh-ancestor
92810232|NCT00833560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810233|NCT00833560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810234|NCT00833560|Glucocorticoids|glucocorticoids|mesh-ancestor
92810235|NCT00833560|Hormones|hormones|mesh-ancestor
92810236|NCT00833560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810237|NCT00833560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92810238|NCT04242927|Nicotinic Acids|nicotinic acids|mesh-list
92810239|NCT04242927|Niacin|niacin|mesh-list
92810240|NCT04242927|Niacinamide|niacinamide|mesh-list
92810241|NCT04242927|Vitamin B Complex|vitamin b complex|mesh-ancestor
92810242|NCT04242927|Vitamins|vitamins|mesh-ancestor
92810243|NCT04242927|Micronutrients|micronutrients|mesh-ancestor
92810244|NCT04242927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810245|NCT04242927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92810246|NCT04242927|Antimetabolites|antimetabolites|mesh-ancestor
92810247|NCT04242927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810248|NCT04242927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92810249|NCT04242927|Vasodilator Agents|vasodilator agents|mesh-ancestor
92810250|NCT00887679|Escitalopram|escitalopram|mesh-list
92810251|NCT00887679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92810252|NCT00887679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92810253|NCT00887679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810254|NCT00887679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810255|NCT00887679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810256|NCT00887679|Serotonin Agents|serotonin agents|mesh-ancestor
92810257|NCT00887679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810258|NCT04241523|Lenvatinib|lenvatinib|mesh-list
92810259|NCT04241523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810260|NCT04241523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92810262|NCT04241523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810263|NCT00833482|Ritonavir|ritonavir|mesh-list
92810264|NCT00833482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92810265|NCT00833482|Voriconazole|voriconazole|mesh-list
92810266|NCT00833482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92810267|NCT00833482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92810268|NCT00833482|Protease Inhibitors|protease inhibitors|mesh-ancestor
92810269|NCT00833482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810270|NCT00833482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810271|NCT00833482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92810272|NCT00833482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92810273|NCT00833482|Antiviral Agents|antiviral agents|mesh-ancestor
92810274|NCT00833482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810275|NCT00833482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92810276|NCT00833482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92810277|NCT00833482|Antifungal Agents|antifungal agents|mesh-ancestor
92810278|NCT00833482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92810279|NCT00833482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92810280|NCT00833482|Hormone Antagonists|hormone antagonists|mesh-ancestor
92810281|NCT00833482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810282|NCT00833482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810283|NCT00845182|Pioglitazone|pioglitazone|mesh-list
92810284|NCT00845182|Exenatide|exenatide|mesh-list
92810285|NCT00845182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92810286|NCT00845182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810287|NCT00845182|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92810288|NCT00845182|Incretins|incretins|mesh-ancestor
92810289|NCT00845182|Hormones|hormones|mesh-ancestor
92810290|NCT00845182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810291|NCT00833248|Goserelin|goserelin|mesh-list
92810292|NCT00833248|Bicalutamide|bicalutamide|mesh-list
92810293|NCT00833248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92810294|NCT00833248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810295|NCT00833248|Androgen Antagonists|androgen antagonists|mesh-ancestor
92810296|NCT00833248|Hormone Antagonists|hormone antagonists|mesh-ancestor
92810297|NCT00833248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810298|NCT00833248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810299|NCT00702130|Pravastatin|pravastatin|mesh-list
92810300|NCT00702130|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92810301|NCT00702130|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92810302|NCT00702130|Antimetabolites|antimetabolites|mesh-ancestor
92810303|NCT00702130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810304|NCT00702130|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92810305|NCT00702130|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92810306|NCT00702130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810307|NCT00823264|Charcoal|charcoal|mesh-list
92810308|NCT00823264|Antidotes|antidotes|mesh-ancestor
92810309|NCT00823264|Protective Agents|protective agents|mesh-ancestor
92810310|NCT00823264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810311|NCT04241211|Denosumab|denosumab|mesh-list
92810312|NCT04241211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92810313|NCT04241211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810314|NCT00702442|Droperidol|droperidol|mesh-list
92810315|NCT00702442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92810316|NCT00702442|Antiemetics|antiemetics|mesh-ancestor
92810317|NCT00702442|Autonomic Agents|autonomic agents|mesh-ancestor
92810318|NCT00702442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810319|NCT00702442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810320|NCT00702442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810321|NCT00702442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92810322|NCT00702442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92810323|NCT00702442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810324|NCT00702442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810325|NCT00702442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92810326|NCT00702442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92810327|NCT00702442|Dopamine Agents|dopamine agents|mesh-ancestor
92810328|NCT00702442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810329|NCT00702442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810330|NCT02612272|Ketorolac|ketorolac|mesh-list
92810331|NCT02612272|Betamethasone|betamethasone|mesh-list
92810332|NCT02612272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92810333|NCT02612272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92810334|NCT02612272|Analgesics|analgesics|mesh-ancestor
92810335|NCT02612272|Sensory System Agents|sensory system agents|mesh-ancestor
92810336|NCT02612272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810337|NCT02612272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810338|NCT02612272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810339|NCT02612272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810340|NCT02612272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92810341|NCT02612272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810342|NCT02612272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810343|NCT02612272|Glucocorticoids|glucocorticoids|mesh-ancestor
92810344|NCT02612272|Hormones|hormones|mesh-ancestor
92810345|NCT02612272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810346|NCT02612272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92810347|NCT02612272|Respiratory System Agents|respiratory system agents|mesh-ancestor
92810348|NCT00832624|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92810349|NCT00832624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92810350|NCT00832624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810351|NCT00832624|Incretins|incretins|mesh-ancestor
92810352|NCT00832624|Hormones|hormones|mesh-ancestor
92810353|NCT00832624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810354|NCT00832624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92810355|NCT00832624|Protease Inhibitors|protease inhibitors|mesh-ancestor
92810356|NCT00832624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810357|NCT00832624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810358|NCT00913120|Enoxaparin|enoxaparin|mesh-list
92810359|NCT00913120|Anticoagulants|anticoagulants|mesh-ancestor
92810360|NCT00913120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92810361|NCT00913120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92810362|NCT00913120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810363|NCT00822172|Cilostazol|cilostazol|mesh-list
92810364|NCT00822172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92810365|NCT00822172|Autonomic Agents|autonomic agents|mesh-ancestor
92810366|NCT00822172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455395|NCT01705457|Vitamin A|vitamin a|mesh-list
92810367|NCT00822172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810368|NCT00822172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92810369|NCT00822172|Respiratory System Agents|respiratory system agents|mesh-ancestor
92810370|NCT00822172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92810371|NCT00822172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92810372|NCT00822172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810373|NCT00822172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92810374|NCT00822172|Vasodilator Agents|vasodilator agents|mesh-ancestor
92810375|NCT00822172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92810376|NCT00822172|Protective Agents|protective agents|mesh-ancestor
92810377|NCT00822172|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92810378|NCT00822172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92810379|NCT00822172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810381|NCT00832000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92810382|NCT00832000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92810383|NCT00832000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92810384|NCT00832000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810385|NCT00832000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810386|NCT04202952|Sofosbuvir|sofosbuvir|mesh-list
92810387|NCT04202952|Antiviral Agents|antiviral agents|mesh-ancestor
92810388|NCT04202952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810389|NCT04054674|Salicylic Acid|salicylic acid|mesh-list
92810390|NCT04054674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810391|NCT04054674|Antifungal Agents|antifungal agents|mesh-ancestor
92810392|NCT04054674|Keratolytic Agents|keratolytic agents|mesh-ancestor
92810393|NCT04054674|Dermatologic Agents|dermatologic agents|mesh-ancestor
92810394|NCT04166292|Lidocaine|lidocaine|mesh-list
92810395|NCT04166292|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810396|NCT04166292|Anesthetics|anesthetics|mesh-ancestor
92810397|NCT04166292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810398|NCT04166292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810399|NCT04166292|Sensory System Agents|sensory system agents|mesh-ancestor
92810400|NCT04166292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810401|NCT04166292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92810402|NCT04166292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92810403|NCT04166292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92810404|NCT04166292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810405|NCT04166292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810407|NCT04099771|Analgesics|analgesics|mesh-ancestor
92810408|NCT04099771|Sensory System Agents|sensory system agents|mesh-ancestor
92810409|NCT04099771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810410|NCT04099771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810411|NCT04099771|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92810412|NCT04099771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92810413|NCT04099771|Anesthetics, General|anesthetics, general|mesh-ancestor
92810414|NCT04099771|Anesthetics|anesthetics|mesh-ancestor
92810415|NCT04099771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810416|NCT04099771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92810417|NCT04099771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92810418|NCT04099771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810419|NCT04099771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810420|NCT00768469|Paclitaxel|paclitaxel|mesh-list
92423787|NCT01523860|Analgesics|analgesics|mesh-ancestor
92810421|NCT00768469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92810422|NCT00768469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810423|NCT00768469|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810424|NCT00768469|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810425|NCT00768469|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810426|NCT00768469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810427|NCT02825121|Iodine|iodine|mesh-list
92810428|NCT02825121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92810429|NCT02825121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810430|NCT02825121|Trace Elements|trace elements|mesh-ancestor
92810431|NCT02825121|Micronutrients|micronutrients|mesh-ancestor
92810432|NCT02825121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810433|NCT02825199|Caffeine|caffeine|mesh-list
92810434|NCT02825199|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92810435|NCT02825199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810436|NCT02825199|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92810437|NCT02825199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810438|NCT02825199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455475|NCT01706172|Lidocaine|lidocaine|mesh-list
92810439|NCT02825199|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92810440|NCT02825199|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92810441|NCT02825199|Purinergic Agents|purinergic agents|mesh-ancestor
92810442|NCT02825199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810443|NCT02824965|Pembrolizumab|pembrolizumab|mesh-list
92810444|NCT02824965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810445|NCT02824965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810446|NCT02824965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92810447|NCT02824965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810448|NCT00886743|Oprelvekin|oprelvekin|mesh-list
92810449|NCT00886743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810450|NCT02826759|Insulin|insulin|mesh-list
92810451|NCT02826759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92810452|NCT02826759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810453|NCT02823951|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92810454|NCT02823951|Dermatologic Agents|dermatologic agents|mesh-ancestor
92810455|NCT02823951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810456|NCT02823951|Immunologic Factors|immunologic factors|mesh-ancestor
92810457|NCT02823951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810458|NCT02826837|Bevacizumab|bevacizumab|mesh-list
92810459|NCT02826837|Cetuximab|cetuximab|mesh-list
92810460|NCT02826837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810461|NCT02826837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810462|NCT02826837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92810463|NCT02826837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92810464|NCT02826837|Growth Substances|growth substances|mesh-ancestor
92810465|NCT02826837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810466|NCT02826837|Growth Inhibitors|growth inhibitors|mesh-ancestor
92810467|NCT02822547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92810468|NCT02822547|Antiviral Agents|antiviral agents|mesh-ancestor
92810469|NCT02822547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810470|NCT02823483|Sunscreening Agents|sunscreening agents|mesh-list
92810471|NCT02823483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92810472|NCT02823483|Protective Agents|protective agents|mesh-ancestor
92810473|NCT02823483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810474|NCT02823483|Dermatologic Agents|dermatologic agents|mesh-ancestor
92810475|NCT04848597|Paclitaxel|paclitaxel|mesh-list
92810476|NCT04848597|Antibodies|antibodies|mesh-list
92810477|NCT04848597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92810478|NCT04848597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92810479|NCT04848597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810480|NCT04848597|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810481|NCT04848597|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810482|NCT04848597|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810483|NCT04848597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810484|NCT04848597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810485|NCT04848597|Immunologic Factors|immunologic factors|mesh-ancestor
92810486|NCT05037045|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92810487|NCT05037045|Incretins|incretins|mesh-ancestor
92810488|NCT05037045|Hormones|hormones|mesh-ancestor
92810489|NCT05037045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810490|NCT05037045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810491|NCT05660811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92810492|NCT02823405|Pembrolizumab|pembrolizumab|mesh-list
92810493|NCT02823405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810494|NCT02823405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810495|NCT02823405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92810496|NCT02823405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810497|NCT02823249|Erythritol|erythritol|mesh-list
92810498|NCT02823249|Tryptophan|tryptophan|mesh-list
92810499|NCT02823249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92810500|NCT02823249|Antidepressive Agents|antidepressive agents|mesh-ancestor
92810501|NCT02823249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810502|NCT02823249|Vasodilator Agents|vasodilator agents|mesh-ancestor
92810503|NCT00768079|Benralizumab|benralizumab|mesh-list
92810504|NCT00768079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92810505|NCT00768079|Respiratory System Agents|respiratory system agents|mesh-ancestor
92810506|NCT02603575|Caspofungin|caspofungin|mesh-list
92810507|NCT02603575|Sulfanilamide|sulfanilamide|mesh-list
92810508|NCT02603575|Sulfanilamides|sulfanilamides|mesh-list
92810509|NCT02603575|Methylprednisolone|methylprednisolone|mesh-list
92810510|NCT02603575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810511|NCT02603575|Antiemetics|antiemetics|mesh-ancestor
92810512|NCT02603575|Autonomic Agents|autonomic agents|mesh-ancestor
92455542|NCT01706627|Melatonin|melatonin|mesh-list
92810513|NCT02603575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810514|NCT02603575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810515|NCT02603575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810516|NCT02603575|Glucocorticoids|glucocorticoids|mesh-ancestor
92810517|NCT02603575|Hormones|hormones|mesh-ancestor
92810518|NCT02603575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810519|NCT02603575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92810520|NCT02603575|Protective Agents|protective agents|mesh-ancestor
92810521|NCT02603575|Antifungal Agents|antifungal agents|mesh-ancestor
92810522|NCT02603575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810523|NCT02603575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810524|NCT02603575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810525|NCT02603575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92810526|NCT02601859|Lithium Carbonate|lithium carbonate|mesh-list
92810527|NCT02601859|Antidepressive Agents|antidepressive agents|mesh-ancestor
92810528|NCT02601859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810529|NCT02601859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810530|NCT02601859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810531|NCT02601859|Antimanic Agents|antimanic agents|mesh-ancestor
92810532|NCT02601859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92810533|NCT02601859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810534|NCT02601859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810535|NCT02822157|Paclitaxel|paclitaxel|mesh-list
92810536|NCT02822157|Carboplatin|carboplatin|mesh-list
92810537|NCT02822157|Gemcitabine|gemcitabine|mesh-list
92810538|NCT02822157|Doxorubicin|doxorubicin|mesh-list
92810539|NCT02822157|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92810540|NCT02822157|Topotecan|topotecan|mesh-list
92810541|NCT02822157|Olaparib|olaparib|mesh-list
92810542|NCT02822157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92810543|NCT02822157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810544|NCT02822157|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810545|NCT02822157|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810546|NCT02822157|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810547|NCT02822157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810548|NCT02822157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92810549|NCT02822157|Antimetabolites|antimetabolites|mesh-ancestor
92810550|NCT02822157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92810551|NCT02822157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92810552|NCT02822157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92810553|NCT02822157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810554|NCT02822157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92810555|NCT02822157|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92810557|NCT02822937|Methylphenidate|methylphenidate|mesh-list
92810558|NCT02822937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92810559|NCT02822937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810560|NCT02822937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92810561|NCT02822937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92810562|NCT02822937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810563|NCT02822937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810564|NCT02822937|Dopamine Agents|dopamine agents|mesh-ancestor
92810565|NCT02822937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810566|NCT02822937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92810567|NCT02822937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92810568|NCT02822937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92810569|NCT02822937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810570|NCT02822937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810571|NCT02822937|GABA Modulators|gaba modulators|mesh-ancestor
92810572|NCT02822937|GABA Agents|gaba agents|mesh-ancestor
92810573|NCT04200885|Dexamethasone|dexamethasone|mesh-list
92810574|NCT04200885|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92810575|NCT04200885|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92810576|NCT04200885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810577|NCT04200885|Antiemetics|antiemetics|mesh-ancestor
92810578|NCT04200885|Autonomic Agents|autonomic agents|mesh-ancestor
92810579|NCT04200885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810580|NCT04200885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810581|NCT04200885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810582|NCT04200885|Glucocorticoids|glucocorticoids|mesh-ancestor
92810583|NCT04200885|Hormones|hormones|mesh-ancestor
92810584|NCT04200885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810585|NCT04200885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92810586|NCT04200885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810587|NCT04200885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92810588|NCT04200885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92810589|NCT04200885|Analgesics|analgesics|mesh-ancestor
92810590|NCT04200885|Sensory System Agents|sensory system agents|mesh-ancestor
92810591|NCT04200885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810592|NCT05659251|Paclitaxel|paclitaxel|mesh-list
92810593|NCT05659251|Carboplatin|carboplatin|mesh-list
92810594|NCT05659251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92810595|NCT05659251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810596|NCT05659251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810597|NCT05659251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810598|NCT05659251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810599|NCT05659251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810600|NCT00766831|Hydromorphone|hydromorphone|mesh-list
92810601|NCT00766831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810602|NCT00766831|Narcotics|narcotics|mesh-ancestor
92810603|NCT00766831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810604|NCT00766831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810605|NCT00766831|Analgesics|analgesics|mesh-ancestor
92810606|NCT00766831|Sensory System Agents|sensory system agents|mesh-ancestor
92810607|NCT00766831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810608|NCT02821689|Pirfenidone|pirfenidone|mesh-list
92810609|NCT02821689|Analgesics|analgesics|mesh-ancestor
92810610|NCT02821689|Sensory System Agents|sensory system agents|mesh-ancestor
92810611|NCT02821689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810612|NCT02821689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810613|NCT02821689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92810614|NCT02821689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92810615|NCT02821689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810616|NCT02821689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810617|NCT02821689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424037|NCT01525537|Dsuvia|dsuvia|mesh-list
92810618|NCT02821533|Cisplatin|cisplatin|mesh-list
92810619|NCT02821533|Antineoplastic Agents|antineoplastic agents|mesh-list
92810620|NCT05659407|Rituximab|rituximab|mesh-list
92810621|NCT05659407|Belimumab|belimumab|mesh-list
92810622|NCT05659407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810623|NCT05659407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810624|NCT05659407|Immunologic Factors|immunologic factors|mesh-ancestor
92810625|NCT05659407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810626|NCT05659407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810627|NCT05659407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810628|NCT00766675|Acetaminophen|acetaminophen|mesh-list
92810629|NCT00766675|Tramadol|tramadol|mesh-list
92810630|NCT00766675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92810631|NCT00766675|Analgesics|analgesics|mesh-ancestor
92810632|NCT00766675|Sensory System Agents|sensory system agents|mesh-ancestor
92810633|NCT00766675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810634|NCT00766675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810635|NCT00766675|Antipyretics|antipyretics|mesh-ancestor
92810636|NCT00766675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810637|NCT00766675|Narcotics|narcotics|mesh-ancestor
92810638|NCT00766675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810639|NCT02820441|Zopiclone|zopiclone|mesh-list
92810640|NCT02820441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92810641|NCT02820441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810642|NCT02820441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810643|NCT02821377|Furosemide|furosemide|mesh-list
92810644|NCT02821377|Diuretics|diuretics|mesh-ancestor
92810645|NCT02821377|Natriuretic Agents|natriuretic agents|mesh-ancestor
92810646|NCT02821377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810647|NCT02821377|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92810648|NCT02821377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810649|NCT02821377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810650|NCT02820987|Meropenem|meropenem|mesh-list
92810651|NCT02820987|Tazobactam|tazobactam|mesh-list
92810652|NCT02820987|Piperacillin|piperacillin|mesh-list
92810653|NCT02820987|Cefepime|cefepime|mesh-list
92810654|NCT02820987|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92810655|NCT02820987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92810656|NCT02820987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810657|NCT02820987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92810658|NCT02820987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810659|NCT02820987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810660|NCT04052490|Salicylic Acid|salicylic acid|mesh-list
92810661|NCT04052490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810662|NCT04052490|Antifungal Agents|antifungal agents|mesh-ancestor
92810663|NCT04052490|Keratolytic Agents|keratolytic agents|mesh-ancestor
92810664|NCT04052490|Dermatologic Agents|dermatologic agents|mesh-ancestor
92810665|NCT00773383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92810666|NCT00773383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810667|NCT00773383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92810668|NCT00773383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810669|NCT00773383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810670|NCT02818881|Methamphetamine|methamphetamine|mesh-list
92810671|NCT02818881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92810672|NCT02818881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810673|NCT02818881|Sympathomimetics|sympathomimetics|mesh-ancestor
92810674|NCT02818881|Autonomic Agents|autonomic agents|mesh-ancestor
92810675|NCT02818881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810676|NCT02818881|Dopamine Agents|dopamine agents|mesh-ancestor
92810677|NCT02818881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810678|NCT02818881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810679|NCT02818881|Adrenergic Agents|adrenergic agents|mesh-ancestor
92810680|NCT02818881|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92810681|NCT02818881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92810682|NCT02818881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810683|NCT02818881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92810685|NCT02818803|Miconazole|miconazole|mesh-list
92810686|NCT02818803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810687|NCT02818803|Antifungal Agents|antifungal agents|mesh-ancestor
92810688|NCT02818803|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92810689|NCT02818803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92810690|NCT02818803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810691|NCT02818803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424042|NCT01525537|Analgesics|analgesics|mesh-ancestor
92810692|NCT02818803|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92810693|NCT02818803|Hormone Antagonists|hormone antagonists|mesh-ancestor
92810694|NCT02818803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810695|NCT02818803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810696|NCT02818803|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92810697|NCT02818803|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92810698|NCT02818725|Cisplatin|cisplatin|mesh-list
92810699|NCT02818725|Doxorubicin|doxorubicin|mesh-list
92810700|NCT02818725|Methotrexate|methotrexate|mesh-list
92810701|NCT02818725|Panitumumab|panitumumab|mesh-list
92810702|NCT02818725|Vinblastine|vinblastine|mesh-list
92810703|NCT02818725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810704|NCT02818725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92810705|NCT02818725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92810706|NCT02818725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92810707|NCT02818725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810708|NCT02818725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810709|NCT02818725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92810710|NCT02818725|Abortifacient Agents|abortifacient agents|mesh-ancestor
92810711|NCT02818725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92810712|NCT02818725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810713|NCT02818725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92810714|NCT02818725|Antimetabolites|antimetabolites|mesh-ancestor
92810715|NCT02818725|Dermatologic Agents|dermatologic agents|mesh-ancestor
92810716|NCT02818725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92810717|NCT02818725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810718|NCT02818725|Immunologic Factors|immunologic factors|mesh-ancestor
92810719|NCT02818725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810720|NCT02818725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92810721|NCT02818725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810722|NCT02818725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92810723|NCT02818725|Tubulin Modulators|tubulin modulators|mesh-ancestor
92810724|NCT02818725|Antimitotic Agents|antimitotic agents|mesh-ancestor
92810725|NCT02818725|Mitosis Modulators|mitosis modulators|mesh-ancestor
92810726|NCT02820051|Lidocaine|lidocaine|mesh-list
92810727|NCT02820051|Midazolam|midazolam|mesh-list
92810728|NCT02820051|Nalbuphine|nalbuphine|mesh-list
92810729|NCT02820051|Propofol|propofol|mesh-list
92810730|NCT02820051|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810731|NCT02820051|Anesthetics|anesthetics|mesh-ancestor
92810732|NCT02820051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810733|NCT02820051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810734|NCT02820051|Sensory System Agents|sensory system agents|mesh-ancestor
92810735|NCT02820051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810736|NCT02820051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92810737|NCT02820051|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92810738|NCT02820051|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92810739|NCT02820051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810740|NCT02820051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810741|NCT02820051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92810742|NCT02820051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92810743|NCT02820051|Anesthetics, General|anesthetics, general|mesh-ancestor
92810744|NCT02820051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92810745|NCT02820051|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92810746|NCT02820051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92810747|NCT02820051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810748|NCT02820051|GABA Modulators|gaba modulators|mesh-ancestor
92810749|NCT02820051|GABA Agents|gaba agents|mesh-ancestor
92810750|NCT02820051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810751|NCT02820051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810752|NCT02820051|Narcotics|narcotics|mesh-ancestor
92810753|NCT02820051|Analgesics|analgesics|mesh-ancestor
92810754|NCT02817243|Simvastatin|simvastatin|mesh-list
92810755|NCT02817243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92810756|NCT02817243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92810757|NCT02817243|Antimetabolites|antimetabolites|mesh-ancestor
92810758|NCT02817243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810759|NCT02817243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92810760|NCT02817243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92810761|NCT02817243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810762|NCT00766363|Rivastigmine|rivastigmine|mesh-list
92810764|NCT00766363|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92810765|NCT00766363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810766|NCT00766363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810767|NCT00766363|Cholinergic Agents|cholinergic agents|mesh-ancestor
92810768|NCT00766363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810769|NCT00766363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810770|NCT00766363|Nootropic Agents|nootropic agents|mesh-ancestor
92810771|NCT00766363|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92810772|NCT00766363|Protective Agents|protective agents|mesh-ancestor
92810773|NCT02636946|Bimatoprost|bimatoprost|mesh-list
92810774|NCT02636946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92810775|NCT02819661|Morphine|morphine|mesh-list
92810776|NCT02819661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977203|NCT00545103|Mesalamine|mesalamine|mesh-list
92810777|NCT02819661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810778|NCT02819661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810779|NCT02819661|Narcotics|narcotics|mesh-ancestor
92810780|NCT02819661|Analgesics|analgesics|mesh-ancestor
92810781|NCT02819661|Sensory System Agents|sensory system agents|mesh-ancestor
92810782|NCT02819661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810783|NCT00765817|Exenatide|exenatide|mesh-list
92810784|NCT00765817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92810785|NCT00765817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810786|NCT00765817|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92810787|NCT00765817|Incretins|incretins|mesh-ancestor
92810788|NCT00765817|Hormones|hormones|mesh-ancestor
92810789|NCT00765817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810790|NCT02818491|Dexamethasone|dexamethasone|mesh-list
92810791|NCT02818491|Dexamethasone acetate|dexamethasone acetate|mesh-list
92810792|NCT02818491|Ropivacaine|ropivacaine|mesh-list
92810793|NCT02818491|BB 1101|bb 1101|mesh-list
92810794|NCT02818491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810795|NCT02818491|Antiemetics|antiemetics|mesh-ancestor
92810796|NCT02818491|Autonomic Agents|autonomic agents|mesh-ancestor
92810797|NCT02818491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810798|NCT02818491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810799|NCT02818491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810800|NCT02818491|Glucocorticoids|glucocorticoids|mesh-ancestor
92810801|NCT02818491|Hormones|hormones|mesh-ancestor
92810802|NCT02818491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810803|NCT02818491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92810804|NCT02818491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810805|NCT02818491|Protease Inhibitors|protease inhibitors|mesh-ancestor
92810806|NCT02818491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810807|NCT02818491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810808|NCT02818491|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810809|NCT02818491|Anesthetics|anesthetics|mesh-ancestor
92810810|NCT02818491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810811|NCT02818491|Sensory System Agents|sensory system agents|mesh-ancestor
92810812|NCT02816853|Moxifloxacin|moxifloxacin|mesh-list
92810813|NCT02816853|Domperidone|domperidone|mesh-list
92810814|NCT02816853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92810815|NCT02816853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810816|NCT02816853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92810817|NCT02816853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92810818|NCT02816853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810819|NCT02816853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810820|NCT02816853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810821|NCT02816853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810822|NCT02816853|Antiemetics|antiemetics|mesh-ancestor
92810823|NCT02816853|Autonomic Agents|autonomic agents|mesh-ancestor
92810824|NCT02816853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810825|NCT02816853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810826|NCT02816853|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92810827|NCT02816853|Dopamine Agents|dopamine agents|mesh-ancestor
92810828|NCT02816853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810829|NCT00772603|Oxcarbazepine|oxcarbazepine|mesh-list
92810830|NCT00772603|Anticonvulsants|anticonvulsants|mesh-ancestor
92810831|NCT00772603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92810832|NCT00772603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92424192|NCT01526278|Vitamins|vitamins|mesh-ancestor
92810833|NCT00772603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810834|NCT00772603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810835|NCT00772603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92810836|NCT00772603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92810837|NCT05658861|Caseins|caseins|mesh-list
92810838|NCT05658861|Chelating Agents|chelating agents|mesh-ancestor
92810839|NCT05658861|Sequestering Agents|sequestering agents|mesh-ancestor
92810840|NCT05658861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810841|NCT00772447|Vancomycin|vancomycin|mesh-list
92810842|NCT00772447|Daptomycin|daptomycin|mesh-list
92810843|NCT00772447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92810844|NCT00772447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810845|NCT04238169|Bevacizumab|bevacizumab|mesh-list
92810846|NCT04238169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810847|NCT04238169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810848|NCT04238169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92810849|NCT04238169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92810850|NCT04238169|Growth Substances|growth substances|mesh-ancestor
92810851|NCT04238169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810852|NCT04238169|Growth Inhibitors|growth inhibitors|mesh-ancestor
92810853|NCT00831844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92810854|NCT00831844|Immunologic Factors|immunologic factors|mesh-ancestor
92810855|NCT00831844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810856|NCT00764881|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92810857|NCT00764881|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92810858|NCT00764881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92810859|NCT00764881|Contraceptive Agents|contraceptive agents|mesh-ancestor
92810860|NCT00764881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92810861|NCT00764881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810862|NCT00764881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92810863|NCT00764881|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92810864|NCT00764881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92810865|NCT00764881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92810866|NCT00764881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92810867|NCT00764881|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92810868|NCT00764881|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92810869|NCT00764881|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92810870|NCT00702676|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92810871|NCT00702676|Antidepressive Agents|antidepressive agents|mesh-ancestor
92810872|NCT00702676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92810873|NCT00702676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92810874|NCT00702676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92810875|NCT00702676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810876|NCT00702676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810878|NCT02817477|Morphine|morphine|mesh-list
92810879|NCT02817477|Analgesics|analgesics|mesh-ancestor
92810880|NCT02817477|Sensory System Agents|sensory system agents|mesh-ancestor
92810881|NCT02817477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810882|NCT02817477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810883|NCT02817477|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92810884|NCT02817477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92810885|NCT02817477|Anesthetics, General|anesthetics, general|mesh-ancestor
92810886|NCT02817477|Anesthetics|anesthetics|mesh-ancestor
92810887|NCT02817477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810888|NCT02817477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92810889|NCT02817477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92810891|NCT02817477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810892|NCT02817477|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810893|NCT02817477|Narcotics|narcotics|mesh-ancestor
92810894|NCT02819115|Vaccines|vaccines|mesh-list
92810895|NCT02819115|Immunologic Factors|immunologic factors|mesh-ancestor
92810896|NCT02819115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810897|NCT04099069|Anesthetics|anesthetics|mesh-list
92810898|NCT04099069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810899|NCT04099069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810900|NCT02816151|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92810901|NCT02816151|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92810902|NCT02816151|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92810903|NCT02816151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810904|NCT02816151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810905|NCT02816151|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92810906|NCT02816151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810907|NCT02816151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810908|NCT02816151|Cholinergic Agents|cholinergic agents|mesh-ancestor
92810909|NCT02816151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92810910|NCT04101019|Lidocaine|lidocaine|mesh-list
92810911|NCT04101019|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810912|NCT04101019|Anesthetics|anesthetics|mesh-ancestor
92810913|NCT04101019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810914|NCT04101019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810915|NCT04101019|Sensory System Agents|sensory system agents|mesh-ancestor
92810916|NCT04101019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810917|NCT04101019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92810918|NCT04101019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92810919|NCT04101019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92810920|NCT04101019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92810921|NCT04101019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810922|NCT02817321|Morphine|morphine|mesh-list
92810923|NCT02817321|Ropivacaine|ropivacaine|mesh-list
92810924|NCT02817321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92810925|NCT02817321|Narcotics|narcotics|mesh-ancestor
92810926|NCT02817321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92810927|NCT02817321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810928|NCT02817321|Analgesics|analgesics|mesh-ancestor
92810929|NCT02817321|Sensory System Agents|sensory system agents|mesh-ancestor
92810930|NCT02817321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92810931|NCT02817321|Anesthetics, Local|anesthetics, local|mesh-ancestor
92810932|NCT02817321|Anesthetics|anesthetics|mesh-ancestor
92810933|NCT00844480|Zoledronic Acid|zoledronic acid|mesh-list
92810934|NCT00844480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92810935|NCT00844480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810936|NCT00771901|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92810937|NCT00771901|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92810938|NCT00771901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810939|NCT00771901|Antiviral Agents|antiviral agents|mesh-ancestor
92810940|NCT00771901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810941|NCT00771901|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92810942|NCT00771901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92810943|NCT00705562|Caseins|caseins|mesh-list
92810944|NCT00705562|Chelating Agents|chelating agents|mesh-ancestor
92810945|NCT00705562|Sequestering Agents|sequestering agents|mesh-ancestor
92810946|NCT00705562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810947|NCT00843856|Mycophenolic Acid|mycophenolic acid|mesh-list
92810948|NCT00843856|Tacrolimus|tacrolimus|mesh-list
92810949|NCT00843856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810950|NCT00843856|Immunologic Factors|immunologic factors|mesh-ancestor
92810951|NCT00843856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810952|NCT00843856|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92810953|NCT00843856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810954|NCT00843856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810955|NCT00843856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92810956|NCT00843856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810957|NCT00843856|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92810958|NCT00843856|Antitubercular Agents|antitubercular agents|mesh-ancestor
92810959|NCT00843856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92810960|NCT00843856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810961|NCT04480125|Azacitidine|azacitidine|mesh-list
92810962|NCT04480125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92810963|NCT04480125|Antimetabolites|antimetabolites|mesh-ancestor
92810964|NCT04480125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810965|NCT04480125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810966|NCT04480125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92810967|NCT00705640|Freund's Adjuvant|freund's adjuvant|mesh-list
92810968|NCT00705640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92810969|NCT00705640|Immunologic Factors|immunologic factors|mesh-ancestor
92810970|NCT00705640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810971|NCT00705796|Methyltestosterone|methyltestosterone|mesh-list
92810972|NCT00705796|Testosterone|testosterone|mesh-list
92810973|NCT00705796|Testosterone undecanoate|testosterone undecanoate|mesh-list
92810974|NCT00705796|Testosterone enanthate|testosterone enanthate|mesh-list
92810975|NCT00705796|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92810976|NCT00705796|Androgens|androgens|mesh-ancestor
92810977|NCT00705796|Hormones|hormones|mesh-ancestor
92810978|NCT00705796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92810979|NCT00705796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810980|NCT00705796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92810981|NCT00705796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810982|NCT00705796|Anabolic Agents|anabolic agents|mesh-ancestor
92810983|NCT00843778|Certolizumab Pegol|certolizumab pegol|mesh-list
92810984|NCT00843778|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92810985|NCT00843778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92810986|NCT00843778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92810987|NCT00843778|Immunologic Factors|immunologic factors|mesh-ancestor
92810988|NCT00843778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92810989|NCT00843778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92810990|NCT04432935|Lactoferrin|lactoferrin|mesh-list
92810991|NCT04432935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92810992|NCT05631249|Sotorasib|sotorasib|mesh-list
92810993|NCT05631249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92810994|NCT05631249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92810995|NCT05631249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92810996|NCT05631249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92810997|NCT05629923|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92810998|NCT05629923|Antiviral Agents|antiviral agents|mesh-ancestor
92810999|NCT05629923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811000|NCT00820222|Capecitabine|capecitabine|mesh-list
92811001|NCT00820222|Trastuzumab|trastuzumab|mesh-list
92811002|NCT00820222|Lapatinib|lapatinib|mesh-list
92811003|NCT00820222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92811004|NCT00820222|Antimetabolites|antimetabolites|mesh-ancestor
92811005|NCT00820222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811006|NCT00820222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811007|NCT00820222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92811008|NCT00820222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92811009|NCT00820222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811011|NCT02815449|Trace Elements|trace elements|mesh-ancestor
92811012|NCT02815449|Micronutrients|micronutrients|mesh-ancestor
92811013|NCT02815449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811014|NCT01039688|Antirheumatic Agents|antirheumatic agents|mesh-list
92811015|NCT01039688|Tofacitinib|tofacitinib|mesh-list
92811016|NCT01039688|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92811017|NCT01039688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92811018|NCT01039688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811019|NCT01039688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811020|NCT02237508|Budesonide|budesonide|mesh-list
92811021|NCT02237508|Formoterol Fumarate|formoterol fumarate|mesh-list
92811022|NCT02237508|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92811023|NCT02237508|Charcoal|charcoal|mesh-list
92811024|NCT02237508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811025|NCT02237508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92811026|NCT02237508|Autonomic Agents|autonomic agents|mesh-ancestor
92811027|NCT02237508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811028|NCT02237508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811029|NCT02237508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92811030|NCT02237508|Respiratory System Agents|respiratory system agents|mesh-ancestor
92811031|NCT02237508|Glucocorticoids|glucocorticoids|mesh-ancestor
92811032|NCT02237508|Hormones|hormones|mesh-ancestor
92811033|NCT02237508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811034|NCT02237508|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92811035|NCT02237508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92811036|NCT02237508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92811037|NCT02237508|Adrenergic Agents|adrenergic agents|mesh-ancestor
92811038|NCT02237508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811039|NCT02237508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811040|NCT02237508|Antidotes|antidotes|mesh-ancestor
92811041|NCT02237508|Protective Agents|protective agents|mesh-ancestor
92811042|NCT05579574|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92811043|NCT05579574|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92811044|NCT05579574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92811045|NCT05579574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92811046|NCT05579574|Contraceptive Agents|contraceptive agents|mesh-ancestor
92811047|NCT05579574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92811048|NCT05579574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811049|NCT05579574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92811050|NCT05579574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92811051|NCT05579574|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92811052|NCT05579574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92811053|NCT02809755|Lidocaine|lidocaine|mesh-list
92811054|NCT02809755|Anesthetics, Local|anesthetics, local|mesh-ancestor
92811055|NCT02809755|Anesthetics|anesthetics|mesh-ancestor
92811056|NCT02809755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811057|NCT02809755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811058|NCT02809755|Sensory System Agents|sensory system agents|mesh-ancestor
92811059|NCT02809755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811060|NCT02809755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92811061|NCT02809755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92811062|NCT02809755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92811063|NCT02809755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811064|NCT02809755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811065|NCT02812719|Salicylic Acid|salicylic acid|mesh-list
92811066|NCT02812719|Salicylates|salicylates|mesh-list
92811067|NCT02812719|Glycolic acid|glycolic acid|mesh-list
92811068|NCT02812719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811069|NCT02812719|Antifungal Agents|antifungal agents|mesh-ancestor
92811070|NCT02812719|Keratolytic Agents|keratolytic agents|mesh-ancestor
92811071|NCT02812719|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811072|NCT02812719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92811073|NCT02812719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811074|NCT02812719|Analgesics|analgesics|mesh-ancestor
92811075|NCT02812719|Sensory System Agents|sensory system agents|mesh-ancestor
92811076|NCT02812719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811077|NCT02812719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811078|NCT02812719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811079|NCT02812719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811080|NCT02812719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92811081|NCT02812719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811082|NCT02812719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811083|NCT02876978|Cyclophosphamide|cyclophosphamide|mesh-list
92811084|NCT02876978|Fludarabine|fludarabine|mesh-list
92811085|NCT02876978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811086|NCT02876978|Immunologic Factors|immunologic factors|mesh-ancestor
92811087|NCT02876978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811088|NCT02876978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811089|NCT02876978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811090|NCT02876978|Alkylating Agents|alkylating agents|mesh-ancestor
92811091|NCT02876978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811092|NCT02876978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811093|NCT02876978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92811094|NCT00909480|Insulin|insulin|mesh-list
92811095|NCT00909480|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92811096|NCT00909480|Insulin Glargine|insulin glargine|mesh-list
92811097|NCT00909480|Insulin Detemir|insulin detemir|mesh-list
92811098|NCT00909480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811099|NCT00909480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811100|NCT05642715|Varenicline|varenicline|mesh-list
92811101|NCT05642715|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92811102|NCT05642715|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92811103|NCT05642715|Cholinergic Agents|cholinergic agents|mesh-ancestor
92811104|NCT05642715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811105|NCT05642715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811106|NCT05642715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811107|NCT02874326|Octreotide|octreotide|mesh-list
92811108|NCT02874326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92811109|NCT02874326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92811110|NCT02874326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456125|NCT01710462|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92811112|NCT02812641|Cisplatin|cisplatin|mesh-list
92811113|NCT02812641|Fluorouracil|fluorouracil|mesh-list
92811114|NCT02812641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92424479|NCT01527474|Serotonin Agents|serotonin agents|mesh-ancestor
92811115|NCT02812641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811116|NCT02812641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92811117|NCT02812641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92811118|NCT02812641|Growth Substances|growth substances|mesh-ancestor
92811119|NCT02812641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811120|NCT02812641|Growth Inhibitors|growth inhibitors|mesh-ancestor
92811121|NCT02812641|Antimetabolites|antimetabolites|mesh-ancestor
92811122|NCT02812641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811123|NCT02812641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92811124|NCT02812641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811125|NCT02812641|Immunologic Factors|immunologic factors|mesh-ancestor
92811126|NCT01058096|Cariprazine|cariprazine|mesh-list
92811127|NCT01058096|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92811128|NCT01058096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811129|NCT01058096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811130|NCT01058096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811131|NCT01058096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811132|NCT00626990|Temozolomide|temozolomide|mesh-list
92811133|NCT00626990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811134|NCT00626990|Alkylating Agents|alkylating agents|mesh-ancestor
92811135|NCT00626990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811136|NCT00626990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811137|NCT01057862|Naltrexone|naltrexone|mesh-list
92811138|NCT01057862|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92811139|NCT01057862|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92811140|NCT01057862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811141|NCT01057862|Sensory System Agents|sensory system agents|mesh-ancestor
92811142|NCT01057862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811143|NCT01038128|Memantine|memantine|mesh-list
92811144|NCT01038128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92811145|NCT01038128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92811146|NCT01038128|Dopamine Agents|dopamine agents|mesh-ancestor
92155737|NCT00957333|Analgesics|analgesics|mesh-ancestor
92811147|NCT01038128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811148|NCT01038128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811149|NCT01038128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811150|NCT01038128|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92811151|NCT01038128|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92811152|NCT04303520|Cyclophosphamide|cyclophosphamide|mesh-list
92811153|NCT04303520|Fludarabine|fludarabine|mesh-list
92811154|NCT04303520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811155|NCT04303520|Immunologic Factors|immunologic factors|mesh-ancestor
92811156|NCT04303520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811157|NCT04303520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811158|NCT04303520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811159|NCT04303520|Alkylating Agents|alkylating agents|mesh-ancestor
92811160|NCT04303520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811161|NCT04303520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811162|NCT04303520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92811163|NCT02562378|Doxorubicin|doxorubicin|mesh-list
92811164|NCT02562378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92811165|NCT02562378|Trastuzumab|trastuzumab|mesh-list
92811166|NCT02562378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92811167|NCT02562378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811168|NCT02562378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92811169|NCT02562378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92811170|NCT02562378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811171|NCT02562378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811172|NCT02562378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92811173|NCT00842530|Vaccines|vaccines|mesh-list
92811174|NCT00842530|Immunologic Factors|immunologic factors|mesh-ancestor
92811175|NCT00842530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811176|NCT05580510|Empagliflozin|empagliflozin|mesh-list
92811177|NCT05580510|Valsartan|valsartan|mesh-list
92811178|NCT05580510|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92811179|NCT05580510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92811180|NCT05580510|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92811181|NCT05580510|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92811182|NCT05580510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456202|NCT01710722|Ephedrine|ephedrine|mesh-list
92811183|NCT05580510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92811184|NCT05580510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811185|NCT05580510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811186|NCT02811627|Memantine|memantine|mesh-list
92811187|NCT02811627|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92811188|NCT02811627|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92811189|NCT02811627|Dopamine Agents|dopamine agents|mesh-ancestor
92811190|NCT02811627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811191|NCT02811627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811192|NCT02811627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811193|NCT02811627|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92811194|NCT02811627|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92811195|NCT00634413|Budesonide|budesonide|mesh-list
92811196|NCT00634413|Theophylline|theophylline|mesh-list
92811197|NCT00634413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811198|NCT00634413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92811199|NCT00634413|Autonomic Agents|autonomic agents|mesh-ancestor
92811200|NCT00634413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811201|NCT00634413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811202|NCT00634413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92811203|NCT00634413|Respiratory System Agents|respiratory system agents|mesh-ancestor
92811204|NCT00634413|Glucocorticoids|glucocorticoids|mesh-ancestor
92811205|NCT00634413|Hormones|hormones|mesh-ancestor
92811206|NCT00634413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811207|NCT00634413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92811208|NCT00634413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811209|NCT00634413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811210|NCT00634413|Vasodilator Agents|vasodilator agents|mesh-ancestor
92811211|NCT00634413|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92811212|NCT00634413|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92811213|NCT00634413|Purinergic Agents|purinergic agents|mesh-ancestor
92811214|NCT00634413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811215|NCT02815059|Prednisone|prednisone|mesh-list
92811216|NCT02815059|Dasatinib|dasatinib|mesh-list
92811217|NCT02815059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811218|NCT02815059|Glucocorticoids|glucocorticoids|mesh-ancestor
92811219|NCT02815059|Hormones|hormones|mesh-ancestor
92811220|NCT02815059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811221|NCT02815059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811222|NCT02815059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92811223|NCT02815059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811224|NCT02815059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92811225|NCT02815059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811226|NCT02815059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811227|NCT00819910|Rosiglitazone|rosiglitazone|mesh-list
92811228|NCT00819910|Fenofibrate|fenofibrate|mesh-list
92811229|NCT00819910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811230|NCT00819910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811231|NCT00819910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92811232|NCT00819910|Antimetabolites|antimetabolites|mesh-ancestor
92811233|NCT00819910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811234|NCT00819910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92811235|NCT02808117|Micronutrients|micronutrients|mesh-list
92811236|NCT02808117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811237|NCT04321395|Vigabatrin|vigabatrin|mesh-list
92811238|NCT04321395|Anticonvulsants|anticonvulsants|mesh-ancestor
92811239|NCT04321395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811240|NCT04321395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811241|NCT04321395|GABA Agents|gaba agents|mesh-ancestor
92811242|NCT04321395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811243|NCT04321395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811244|NCT02814669|Atezolizumab|atezolizumab|mesh-list
92811245|NCT02814669|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92811246|NCT02814669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92811247|NCT02814669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811248|NCT02814669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92811249|NCT02814669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811250|NCT02808741|Olorofim|olorofim|mesh-list
92811251|NCT02808741|Antifungal Agents|antifungal agents|mesh-ancestor
92811252|NCT02808741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811253|NCT02807727|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92811254|NCT02807727|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92811255|NCT02807727|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92811256|NCT02807727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92811257|NCT02807415|Ivacaftor|ivacaftor|mesh-list
92811258|NCT02807415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92811259|NCT02807415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811260|NCT02807415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811261|NCT02804841|Vitamin D|vitamin d|mesh-list
92811262|NCT02804841|Ergocalciferols|ergocalciferols|mesh-list
92811263|NCT02804841|Cholecalciferol|cholecalciferol|mesh-list
92811264|NCT02804841|Vitamins|vitamins|mesh-list
92811265|NCT02804841|Micronutrients|micronutrients|mesh-ancestor
92811266|NCT02804841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811267|NCT02804841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92811268|NCT02804841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92811269|NCT00634491|Acetazolamide|acetazolamide|mesh-list
92811270|NCT00634491|Anticonvulsants|anticonvulsants|mesh-ancestor
92811271|NCT00634491|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92811272|NCT00634491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811273|NCT00634491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811274|NCT00634491|Diuretics|diuretics|mesh-ancestor
92811275|NCT00634491|Natriuretic Agents|natriuretic agents|mesh-ancestor
92811276|NCT00634491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811277|NCT02807103|Cyclophosphamide|cyclophosphamide|mesh-list
92811278|NCT02807103|Rituximab|rituximab|mesh-list
92811279|NCT02807103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811280|NCT02807103|Immunologic Factors|immunologic factors|mesh-ancestor
92811281|NCT02807103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811282|NCT02807103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811283|NCT02807103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811284|NCT02807103|Alkylating Agents|alkylating agents|mesh-ancestor
92811285|NCT02807103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811286|NCT02807103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811287|NCT02807103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92811288|NCT02807103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92811289|NCT02806791|Lenograstim|lenograstim|mesh-list
92811290|NCT02806791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92811291|NCT02806791|Immunologic Factors|immunologic factors|mesh-ancestor
92811292|NCT02806791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811293|NCT00830128|Pregabalin|pregabalin|mesh-list
92811294|NCT00830128|Analgesics|analgesics|mesh-ancestor
92811295|NCT00830128|Sensory System Agents|sensory system agents|mesh-ancestor
92811296|NCT00830128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811297|NCT00830128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811298|NCT00830128|Anticonvulsants|anticonvulsants|mesh-ancestor
92811299|NCT00830128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92811300|NCT00830128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811301|NCT00830128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811302|NCT00830128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92811303|NCT00830128|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92811304|NCT00830128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811305|NCT00830128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811306|NCT00830128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811307|NCT05498103|Methazolamide|methazolamide|mesh-list
92811308|NCT05498103|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92811309|NCT05498103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811310|NCT05498103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811311|NCT05498103|Diuretics|diuretics|mesh-ancestor
92811312|NCT05498103|Natriuretic Agents|natriuretic agents|mesh-ancestor
92811313|NCT05498103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811314|NCT00771667|Ustekinumab|ustekinumab|mesh-list
92811315|NCT00771667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811316|NCT05579964|Dexmedetomidine|dexmedetomidine|mesh-list
92811317|NCT05579964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92811318|NCT05579964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811319|NCT05579964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811320|NCT05579964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811321|NCT05579964|Analgesics|analgesics|mesh-ancestor
92811322|NCT05579964|Sensory System Agents|sensory system agents|mesh-ancestor
92811323|NCT05579964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811324|NCT05579964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92811325|NCT05579964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92811326|NCT05579964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92811327|NCT05579964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92811328|NCT05579964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811329|NCT05579964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811330|NCT03893175|Acetaminophen|acetaminophen|mesh-list
92811331|NCT03893175|Ibuprofen|ibuprofen|mesh-list
92811332|NCT03893175|Oxycodone|oxycodone|mesh-list
92811333|NCT03893175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811334|NCT03893175|Analgesics|analgesics|mesh-ancestor
92811335|NCT03893175|Sensory System Agents|sensory system agents|mesh-ancestor
92811336|NCT03893175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811337|NCT03893175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811338|NCT03893175|Antipyretics|antipyretics|mesh-ancestor
92811339|NCT03893175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92811340|NCT03893175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811341|NCT03893175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811342|NCT03893175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92811343|NCT03893175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811344|NCT03893175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811345|NCT03893175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92811346|NCT03893175|Narcotics|narcotics|mesh-ancestor
92811347|NCT03893175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811348|NCT04236453|Tenofovir|tenofovir|mesh-list
92811349|NCT04236453|Emtricitabine|emtricitabine|mesh-list
92811350|NCT04236453|Darunavir|darunavir|mesh-list
92811351|NCT04236453|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92811352|NCT04236453|Cobicistat|cobicistat|mesh-list
92811353|NCT04236453|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92811354|NCT04236453|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92811355|NCT04236453|Antiviral Agents|antiviral agents|mesh-ancestor
92811356|NCT04236453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811357|NCT04236453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92811358|NCT04236453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92811359|NCT04236453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811360|NCT04236453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811361|NCT04236453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92811362|NCT04236453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92811363|NCT04236453|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92811364|NCT04236453|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92811365|NCT04236453|Protease Inhibitors|protease inhibitors|mesh-ancestor
92811366|NCT04236453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92811367|NCT04236453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92811368|NCT02807571|Anesthetics|anesthetics|mesh-list
92811369|NCT02807571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811370|NCT02807571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811371|NCT05333250|Modafinil|modafinil|mesh-list
92811372|NCT05333250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92811373|NCT05333250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811374|NCT05333250|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92811375|NCT05333250|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92811376|NCT05333250|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92811377|NCT05333250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811378|NCT05461339|Ranibizumab|ranibizumab|mesh-list
92811379|NCT05461339|Antibodies|antibodies|mesh-list
92811380|NCT05461339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92811381|NCT05461339|Immunologic Factors|immunologic factors|mesh-ancestor
92811382|NCT05461339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811383|NCT05461339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92811384|NCT05461339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92811385|NCT05461339|Growth Substances|growth substances|mesh-ancestor
92811386|NCT05461339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92811387|NCT05461339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811388|NCT03409848|Nivolumab|nivolumab|mesh-list
92811389|NCT03409848|Ipilimumab|ipilimumab|mesh-list
92811390|NCT03409848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92811391|NCT03409848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811392|NCT03409848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92811393|NCT03409848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811394|NCT00763555|Calcitriol|calcitriol|mesh-list
92811395|NCT00763555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92811396|NCT00763555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811397|NCT00763555|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92811398|NCT00763555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811399|NCT00763555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811400|NCT00763555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92811401|NCT00763555|Vitamins|vitamins|mesh-ancestor
92811402|NCT00763555|Micronutrients|micronutrients|mesh-ancestor
92811403|NCT00763555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92811404|NCT02804373|Oxytocin|oxytocin|mesh-list
92811405|NCT02804373|Oxytocics|oxytocics|mesh-ancestor
92811406|NCT02804373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92811407|NCT02804373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811408|NCT00763321|Acetaminophen|acetaminophen|mesh-list
92811409|NCT00763321|Hydrocodone|hydrocodone|mesh-list
92811410|NCT00763321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811411|NCT00763321|Analgesics|analgesics|mesh-ancestor
92811412|NCT00763321|Sensory System Agents|sensory system agents|mesh-ancestor
92811413|NCT00763321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811414|NCT00763321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811415|NCT00763321|Antipyretics|antipyretics|mesh-ancestor
92811416|NCT00763321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92811417|NCT00763321|Narcotics|narcotics|mesh-ancestor
92811418|NCT00763321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811419|NCT00763321|Antitussive Agents|antitussive agents|mesh-ancestor
92811420|NCT00763321|Respiratory System Agents|respiratory system agents|mesh-ancestor
92811421|NCT02799927|Calcium|calcium|mesh-list
92811422|NCT02799927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92811423|NCT02799927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811424|NCT00770653|Metformin|metformin|mesh-list
92811425|NCT00770653|Pioglitazone|pioglitazone|mesh-list
92811426|NCT00770653|Glimepiride|glimepiride|mesh-list
92811427|NCT00770653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811428|NCT00770653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811429|NCT00770653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92811430|NCT00770653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811431|NCT00770653|Immunologic Factors|immunologic factors|mesh-ancestor
92811432|NCT02799615|Infliximab|infliximab|mesh-list
92811433|NCT02799615|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92811434|NCT02799615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811435|NCT02799615|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811436|NCT02799615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92811437|NCT02799615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811438|NCT00819052|Nevirapine|nevirapine|mesh-list
92811439|NCT00819052|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92811440|NCT00819052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92811442|NCT00819052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811443|NCT00819052|Antiviral Agents|antiviral agents|mesh-ancestor
92811444|NCT00819052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811445|NCT00819052|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92811446|NCT00819052|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92811447|NCT00819052|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92811448|NCT00819052|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92811449|NCT00763009|Dipyridamole|dipyridamole|mesh-list
92811450|NCT00763009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92811451|NCT00763009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811452|NCT00763009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811453|NCT00763009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92811454|NCT00763009|Vasodilator Agents|vasodilator agents|mesh-ancestor
92811455|NCT02799459|Anesthetics|anesthetics|mesh-list
92811456|NCT02799459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811457|NCT02799459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811458|NCT05477589|Cyclophosphamide|cyclophosphamide|mesh-list
92811459|NCT05477589|Melphalan|melphalan|mesh-list
92811460|NCT05477589|Busulfan|busulfan|mesh-list
92811461|NCT05477589|Fludarabine|fludarabine|mesh-list
92811462|NCT05477589|Clofarabine|clofarabine|mesh-list
92811463|NCT05477589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811464|NCT05477589|Immunologic Factors|immunologic factors|mesh-ancestor
92811465|NCT05477589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811466|NCT05477589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811467|NCT05477589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811468|NCT05477589|Alkylating Agents|alkylating agents|mesh-ancestor
92811469|NCT05477589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811470|NCT05477589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811471|NCT05477589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92811472|NCT05477589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92811473|NCT05477589|Antimetabolites|antimetabolites|mesh-ancestor
92811474|NCT00841672|Amlodipine|amlodipine|mesh-list
92811475|NCT00841672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92811476|NCT00841672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92811477|NCT00841672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811478|NCT00841672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811479|NCT00841672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92811480|NCT00841672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811481|NCT00841672|Vasodilator Agents|vasodilator agents|mesh-ancestor
92811482|NCT05549115|Amoxicillin|amoxicillin|mesh-list
92811483|NCT05549115|Clarithromycin|clarithromycin|mesh-list
92811484|NCT05549115|Levofloxacin|levofloxacin|mesh-list
92811486|NCT05549115|Furazolidone|furazolidone|mesh-list
92811487|NCT05549115|Bismuth|bismuth|mesh-list
92811488|NCT05549115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92811489|NCT05549115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811490|NCT05549115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92811491|NCT05549115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811492|NCT05549115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811493|NCT05549115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92811494|NCT05549115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92811495|NCT05549115|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92811496|NCT05549115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92811497|NCT05549115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92811498|NCT05549115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811499|NCT05549115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92811500|NCT05549115|Antacids|antacids|mesh-ancestor
92811501|NCT05549115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92811502|NCT05549115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92811503|NCT05549115|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92811504|NCT05549115|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92811505|NCT05549115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92811506|NCT05549115|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92811507|NCT04236219|Rasburicase|rasburicase|mesh-list
92811508|NCT04236219|Gout Suppressants|gout suppressants|mesh-ancestor
92811509|NCT04236219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811510|NCT00908232|Dexamethasone|dexamethasone|mesh-list
92811511|NCT00908232|Cyclophosphamide|cyclophosphamide|mesh-list
92811512|NCT00908232|Lenalidomide|lenalidomide|mesh-list
92811513|NCT00908232|Bortezomib|bortezomib|mesh-list
92156129|NCT03829319|Pemetrexed|pemetrexed|mesh-list
92811514|NCT00908232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811515|NCT00908232|Immunologic Factors|immunologic factors|mesh-ancestor
92811516|NCT00908232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811517|NCT00908232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811518|NCT00908232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811519|NCT00908232|Alkylating Agents|alkylating agents|mesh-ancestor
92811520|NCT00908232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811521|NCT00908232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811522|NCT00908232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92811523|NCT00908232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811524|NCT00908232|Antiemetics|antiemetics|mesh-ancestor
92811525|NCT00908232|Autonomic Agents|autonomic agents|mesh-ancestor
92811526|NCT00908232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811527|NCT00908232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92811528|NCT00908232|Glucocorticoids|glucocorticoids|mesh-ancestor
92811529|NCT00908232|Hormones|hormones|mesh-ancestor
92811530|NCT00908232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811531|NCT00908232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92811532|NCT00908232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92811533|NCT00908232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92811534|NCT00908232|Growth Substances|growth substances|mesh-ancestor
92811535|NCT00908232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92811536|NCT00770341|Vancomycin|vancomycin|mesh-list
92811537|NCT00770341|Daptomycin|daptomycin|mesh-list
92811538|NCT00770341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92811539|NCT00770341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811540|NCT05472753|Selenium|selenium|mesh-list
92811541|NCT05472753|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92811542|NCT05472753|Curcumin|curcumin|mesh-list
92811543|NCT05472753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92811544|NCT05472753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811545|NCT05472753|Analgesics|analgesics|mesh-ancestor
92811546|NCT05472753|Sensory System Agents|sensory system agents|mesh-ancestor
92811547|NCT05472753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811548|NCT05472753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811549|NCT05472753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811550|NCT05472753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811551|NCT05472753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811552|NCT05472753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811553|NCT05472753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811554|NCT05472753|Antioxidants|antioxidants|mesh-ancestor
92811555|NCT05472753|Protective Agents|protective agents|mesh-ancestor
92811556|NCT05472753|Trace Elements|trace elements|mesh-ancestor
92456575|NCT01712568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92811558|NCT05472753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811559|NCT05472753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92811560|NCT03396276|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92811561|NCT03396276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92811562|NCT03396276|Narcotics|narcotics|mesh-ancestor
92811563|NCT03396276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811564|NCT03396276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811565|NCT03396276|Analgesics|analgesics|mesh-ancestor
92811566|NCT03396276|Sensory System Agents|sensory system agents|mesh-ancestor
92811567|NCT03396276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811568|NCT03396276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92811569|NCT02799147|Fludarabine|fludarabine|mesh-list
92811570|NCT02799147|Fludarabine phosphate|fludarabine phosphate|mesh-list
92811571|NCT02799147|Busulfan|busulfan|mesh-list
92811572|NCT02799147|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92811573|NCT02799147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811574|NCT02799147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92811575|NCT02799147|Antimetabolites|antimetabolites|mesh-ancestor
92811576|NCT02799147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811577|NCT02799147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811578|NCT02799147|Immunologic Factors|immunologic factors|mesh-ancestor
92811579|NCT02799147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811580|NCT02799147|Alkylating Agents|alkylating agents|mesh-ancestor
92811581|NCT02799147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92811582|NCT02799147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92811583|NCT02798913|Clopidogrel|clopidogrel|mesh-list
92811584|NCT02798913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92811585|NCT02798913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92811586|NCT02798913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92811587|NCT02798913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92811588|NCT02798913|Purinergic Agents|purinergic agents|mesh-ancestor
92811589|NCT02798913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811590|NCT02798913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811591|NCT02798913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811592|NCT00762463|Celecoxib|celecoxib|mesh-list
92811593|NCT00762463|Diclofenac|diclofenac|mesh-list
92811594|NCT00762463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92811595|NCT00762463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811596|NCT00762463|Analgesics|analgesics|mesh-ancestor
92811597|NCT00762463|Sensory System Agents|sensory system agents|mesh-ancestor
92811598|NCT00762463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811599|NCT00762463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811600|NCT00762463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811601|NCT00762463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811602|NCT00762463|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92811603|NCT00762463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92811604|NCT00762463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811605|NCT00762463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811606|NCT03326310|Azacitidine|azacitidine|mesh-list
92811607|NCT03326310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92811608|NCT03326310|Antimetabolites|antimetabolites|mesh-ancestor
92811609|NCT03326310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811610|NCT03326310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811611|NCT03326310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811612|NCT05511909|Lofexidine|lofexidine|mesh-list
92811613|NCT05511909|Buspirone|buspirone|mesh-list
92811614|NCT05511909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92811615|NCT05511909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811616|NCT05511909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811617|NCT05511909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811618|NCT05511909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811619|NCT05511909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92811620|NCT05511909|Serotonin Agents|serotonin agents|mesh-ancestor
92811621|NCT05511909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811622|NCT05511909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811623|NCT05511909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92811624|NCT05511909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92811625|NCT05511909|Sensory System Agents|sensory system agents|mesh-ancestor
92811626|NCT05511909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811627|NCT05511909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92811628|NCT05511909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92811629|NCT05511909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92811630|NCT05511909|Adrenergic Agents|adrenergic agents|mesh-ancestor
92811631|NCT00906282|Carboplatin|carboplatin|mesh-list
92811632|NCT00906282|Pemetrexed|pemetrexed|mesh-list
92811633|NCT00906282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811634|NCT00906282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811635|NCT00906282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811636|NCT00906282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92811637|NCT00906282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92811638|NCT02798757|Dapagliflozin|dapagliflozin|mesh-list
92811639|NCT02798757|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92811640|NCT02798757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811641|NCT02798757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811642|NCT02798757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811643|NCT02798367|Melatonin|melatonin|mesh-list
92811644|NCT02798367|Antioxidants|antioxidants|mesh-ancestor
92811645|NCT02798367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811646|NCT02798367|Protective Agents|protective agents|mesh-ancestor
92811647|NCT02798367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811648|NCT02798367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811649|NCT00762229|Ezetimibe|ezetimibe|mesh-list
92811650|NCT00762229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92811651|NCT00762229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92811652|NCT00762229|Antimetabolites|antimetabolites|mesh-ancestor
92811653|NCT00762229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811654|NCT00762229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92811655|NCT00907374|Benazepril|benazepril|mesh-list
92811656|NCT00907374|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92811657|NCT00907374|Protease Inhibitors|protease inhibitors|mesh-ancestor
92811658|NCT00907374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811659|NCT00907374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811660|NCT00907374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92811661|NCT02805231|Vitamin D|vitamin d|mesh-list
92811662|NCT02805231|Vitamins|vitamins|mesh-ancestor
92811663|NCT02805231|Micronutrients|micronutrients|mesh-ancestor
92811664|NCT02805231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811665|NCT02805231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92811666|NCT03230604|Z 350|z 350|mesh-list
92811667|NCT03230604|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92811668|NCT03230604|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92811669|NCT03230604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811670|NCT03230604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811671|NCT03230604|Hormone Antagonists|hormone antagonists|mesh-ancestor
92811672|NCT03230604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811673|NCT03230604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811674|NCT02798055|Bosentan|bosentan|mesh-list
92811675|NCT02798055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92811676|NCT02798055|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92811677|NCT02798055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811678|NCT05331768|Terlipressin|terlipressin|mesh-list
92811679|NCT05331768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92811680|NCT05331768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92811681|NCT04235439|Insulin Lispro|insulin lispro|mesh-list
92811682|NCT04235439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92811683|NCT04235439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811684|NCT02640222|Vitamin K|vitamin k|mesh-list
92811685|NCT02640222|Rivaroxaban|rivaroxaban|mesh-list
92811686|NCT02640222|Apixaban|apixaban|mesh-list
92811687|NCT02640222|Dabigatran|dabigatran|mesh-list
92811688|NCT02640222|Vitamins|vitamins|mesh-ancestor
92811689|NCT02640222|Micronutrients|micronutrients|mesh-ancestor
92811690|NCT02640222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811691|NCT02640222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92811692|NCT02640222|Antithrombins|antithrombins|mesh-ancestor
92811693|NCT02640222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92811694|NCT02640222|Protease Inhibitors|protease inhibitors|mesh-ancestor
92811695|NCT02640222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811696|NCT02640222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811697|NCT02640222|Anticoagulants|anticoagulants|mesh-ancestor
92811698|NCT02640222|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92811699|NCT02640222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92811700|NCT02640222|Hemostatics|hemostatics|mesh-ancestor
92811701|NCT02640222|Coagulants|coagulants|mesh-ancestor
92811702|NCT00818662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92456729|NCT01713387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811703|NCT00818662|Immunoglobulins|immunoglobulins|mesh-list
92811704|NCT00818662|Antibodies|antibodies|mesh-list
92811706|NCT00818662|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92811707|NCT00818662|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92811708|NCT00818662|Immunoglobulin G|immunoglobulin g|mesh-list
92811709|NCT00818662|Immunologic Factors|immunologic factors|mesh-ancestor
92811710|NCT00818662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811711|NCT03983031|Rituximab|rituximab|mesh-list
92811712|NCT03983031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92811713|NCT03983031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811714|NCT03983031|Immunologic Factors|immunologic factors|mesh-ancestor
92811715|NCT03983031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811716|NCT03983031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92811717|NCT00703066|Vaccines|vaccines|mesh-list
92811718|NCT00703066|Immunologic Factors|immunologic factors|mesh-ancestor
92811719|NCT00703066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811720|NCT00762073|Budesonide|budesonide|mesh-list
92811721|NCT00762073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811722|NCT00762073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92811723|NCT00762073|Autonomic Agents|autonomic agents|mesh-ancestor
92811724|NCT00762073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811725|NCT00762073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811726|NCT00762073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92811727|NCT00762073|Respiratory System Agents|respiratory system agents|mesh-ancestor
92811728|NCT00762073|Glucocorticoids|glucocorticoids|mesh-ancestor
92811729|NCT00762073|Hormones|hormones|mesh-ancestor
92811730|NCT00762073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92811731|NCT03847857|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92811732|NCT03847857|Hemostatics|hemostatics|mesh-ancestor
92811733|NCT03847857|Coagulants|coagulants|mesh-ancestor
92811734|NCT02630628|Mycophenolic Acid|mycophenolic acid|mesh-list
92811735|NCT02630628|Tacrolimus|tacrolimus|mesh-list
92811736|NCT02630628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811737|NCT02630628|Immunologic Factors|immunologic factors|mesh-ancestor
92811738|NCT02630628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811739|NCT02630628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92811740|NCT02630628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811741|NCT02630628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811742|NCT02630628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92811743|NCT02630628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811744|NCT02630628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92811745|NCT02630628|Antitubercular Agents|antitubercular agents|mesh-ancestor
92811746|NCT02630628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92811747|NCT02630628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811748|NCT00913588|Fluoxetine|fluoxetine|mesh-list
92811749|NCT00913588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92811750|NCT00913588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92811751|NCT00913588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811752|NCT00913588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811753|NCT00913588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811754|NCT00913588|Serotonin Agents|serotonin agents|mesh-ancestor
92811755|NCT00913588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811756|NCT00913588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92811757|NCT00913588|Antidepressive Agents|antidepressive agents|mesh-ancestor
92811758|NCT00913588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811759|NCT00913588|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92811760|NCT00913588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92811761|NCT00913588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811762|NCT02797587|Nicotine|nicotine|mesh-list
92811763|NCT02797587|Varenicline|varenicline|mesh-list
92811764|NCT02797587|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92811765|NCT02797587|Autonomic Agents|autonomic agents|mesh-ancestor
92811766|NCT02797587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811767|NCT02797587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811768|NCT02797587|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92811769|NCT02797587|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92811770|NCT02797587|Cholinergic Agents|cholinergic agents|mesh-ancestor
92811771|NCT02797587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811772|NCT02797587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811773|NCT00761605|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92811774|NCT00761605|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92811775|NCT00761605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811776|NCT00761605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811777|NCT00761605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811778|NCT00761605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811779|NCT00761605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92811780|NCT00761605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92811781|NCT00761605|Serotonin Agents|serotonin agents|mesh-ancestor
92811782|NCT00761605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811783|NCT00761605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811784|NCT00761605|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92811785|NCT00761605|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92811786|NCT00761605|Dopamine Agents|dopamine agents|mesh-ancestor
92811787|NCT00761527|Desloratadine|desloratadine|mesh-list
92811788|NCT00761527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92811789|NCT00761527|Cholinergic Agents|cholinergic agents|mesh-ancestor
92811790|NCT00761527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811791|NCT00761527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811792|NCT00761527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811793|NCT00761527|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92811794|NCT00761527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92811795|NCT00761527|Histamine Antagonists|histamine antagonists|mesh-ancestor
92811796|NCT00761527|Histamine Agents|histamine agents|mesh-ancestor
92811797|NCT00770029|Botulinum Toxins|botulinum toxins|mesh-list
92811798|NCT00770029|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92811799|NCT00770029|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92811800|NCT00770029|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92811801|NCT00770029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92811802|NCT00770029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811803|NCT00770029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811804|NCT00770029|Cholinergic Agents|cholinergic agents|mesh-ancestor
92811805|NCT00770029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811806|NCT00770029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811807|NCT00770029|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92811808|NCT00770029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811810|NCT04235985|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92811811|NCT04235985|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92811812|NCT04235985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811813|NCT04235985|Disinfectants|disinfectants|mesh-ancestor
92811814|NCT04235985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811815|NCT00769561|Salicylic Acid|salicylic acid|mesh-list
92811816|NCT00769561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811817|NCT00769561|Antifungal Agents|antifungal agents|mesh-ancestor
92811818|NCT00769561|Keratolytic Agents|keratolytic agents|mesh-ancestor
92811819|NCT00769561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811820|NCT02797041|Bortezomib|bortezomib|mesh-list
92811821|NCT02797041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811822|NCT02794779|Oxytocin|oxytocin|mesh-list
92811823|NCT02794779|Oxytocics|oxytocics|mesh-ancestor
92811824|NCT02794779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92811825|NCT02794779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811826|NCT00761215|Tedizolid phosphate|tedizolid phosphate|mesh-list
92811827|NCT00761215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92811828|NCT00761215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811829|NCT05805098|Cytarabine|cytarabine|mesh-list
92811830|NCT05805098|Venetoclax|venetoclax|mesh-list
92811831|NCT05805098|Homoharringtonine|homoharringtonine|mesh-list
92811832|NCT05805098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92811833|NCT05805098|Antimetabolites|antimetabolites|mesh-ancestor
92811834|NCT05805098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811835|NCT05805098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92811836|NCT05805098|Antiviral Agents|antiviral agents|mesh-ancestor
92811837|NCT05805098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811838|NCT05805098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92811839|NCT05805098|Immunologic Factors|immunologic factors|mesh-ancestor
92811840|NCT05805098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811841|NCT05805098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92811842|NCT05805098|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92811843|NCT05805098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811844|NCT05804903|Fexofenadine|fexofenadine|mesh-list
92811845|NCT05804903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92811846|NCT05804903|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92811847|NCT05804903|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92811848|NCT05804903|Histamine Antagonists|histamine antagonists|mesh-ancestor
92811849|NCT05804903|Histamine Agents|histamine agents|mesh-ancestor
92811850|NCT05804903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811851|NCT05804903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456884|NCT01714154|Ritonavir|ritonavir|mesh-list
92811852|NCT05804903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811853|NCT05804734|Vitamin K|vitamin k|mesh-list
92811855|NCT05804734|Vitamins|vitamins|mesh-ancestor
92811856|NCT05804734|Micronutrients|micronutrients|mesh-ancestor
92811857|NCT05804734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811858|NCT05804734|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92811859|NCT05804734|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92811860|NCT05804734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811861|NCT05804734|Hemostatics|hemostatics|mesh-ancestor
92811862|NCT05804734|Coagulants|coagulants|mesh-ancestor
92811863|NCT05804721|Aripiprazole|aripiprazole|mesh-list
92811864|NCT05804721|Antidepressive Agents|antidepressive agents|mesh-ancestor
92811865|NCT05804721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811866|NCT05804721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92811867|NCT05804721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811868|NCT05804721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811869|NCT05804721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811870|NCT05804721|Dopamine Agonists|dopamine agonists|mesh-ancestor
92811871|NCT05804721|Dopamine Agents|dopamine agents|mesh-ancestor
92811872|NCT05804721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811873|NCT05804721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811874|NCT05804721|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92811875|NCT05804721|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92811876|NCT05804721|Serotonin Agents|serotonin agents|mesh-ancestor
92811877|NCT05804721|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92811878|NCT05804721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92811879|NCT05804721|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92811880|NCT05804721|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92811881|NCT05804630|Lidocaine|lidocaine|mesh-list
92811882|NCT05804630|Anesthetics|anesthetics|mesh-list
92811883|NCT05804630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811884|NCT05804630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811885|NCT05804630|Anesthetics, Local|anesthetics, local|mesh-ancestor
92811886|NCT05804630|Sensory System Agents|sensory system agents|mesh-ancestor
92811887|NCT05804630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811888|NCT05804630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92811889|NCT05804630|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92811890|NCT05804630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92811891|NCT05804630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811892|NCT05804630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811894|NCT05804591|Analgesics|analgesics|mesh-ancestor
92811895|NCT05804591|Sensory System Agents|sensory system agents|mesh-ancestor
92811896|NCT05804591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811897|NCT05804591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811898|NCT05804591|Anticonvulsants|anticonvulsants|mesh-ancestor
92811899|NCT05804591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92811900|NCT05804591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811901|NCT05804591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811902|NCT05804591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92811903|NCT05804591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92811904|NCT05804591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811905|NCT05804591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811906|NCT05804591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811907|NCT05804370|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92811908|NCT05804370|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92811909|NCT05804370|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811910|NCT05804305|Misoprostol|misoprostol|mesh-list
92811911|NCT05804305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92811912|NCT05804305|Abortifacient Agents|abortifacient agents|mesh-ancestor
92811913|NCT05804305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92811914|NCT05804305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811915|NCT05804305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92811916|NCT05804305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92811917|NCT05804305|Oxytocics|oxytocics|mesh-ancestor
92811918|NCT05803863|Atropine|atropine|mesh-list
92811919|NCT05803863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92811920|NCT05803863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92811921|NCT05803863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92811922|NCT05803863|Autonomic Agents|autonomic agents|mesh-ancestor
92811923|NCT05803863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811924|NCT05803863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811925|NCT05803863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92811926|NCT05803863|Respiratory System Agents|respiratory system agents|mesh-ancestor
92811927|NCT05803863|Mydriatics|mydriatics|mesh-ancestor
92811928|NCT05803863|Parasympatholytics|parasympatholytics|mesh-ancestor
92811929|NCT05803863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92811930|NCT05803863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92811931|NCT05803863|Cholinergic Agents|cholinergic agents|mesh-ancestor
92811932|NCT05803863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811933|NCT05803863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811934|NCT05803811|Riboflavin|riboflavin|mesh-list
92811935|NCT05803811|Vitamin B Complex|vitamin b complex|mesh-ancestor
92811936|NCT05803811|Vitamins|vitamins|mesh-ancestor
92811937|NCT05803811|Micronutrients|micronutrients|mesh-ancestor
92811938|NCT05803811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811939|NCT05803811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92811940|NCT05803811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92811941|NCT05803746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92811942|NCT05803746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92811943|NCT05803746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811944|NCT05803642|Haloperidol|haloperidol|mesh-list
92811945|NCT05803642|Olanzapine|olanzapine|mesh-list
92811946|NCT05803642|Haloperidol decanoate|haloperidol decanoate|mesh-list
92811947|NCT05803642|Antiemetics|antiemetics|mesh-ancestor
92811948|NCT05803642|Autonomic Agents|autonomic agents|mesh-ancestor
92811949|NCT05803642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811950|NCT05803642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811951|NCT05803642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92811952|NCT05803642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92811953|NCT05803642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92811954|NCT05803642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811955|NCT05803642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92811956|NCT05803642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92811957|NCT05803642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92811958|NCT05803642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92811959|NCT05803642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811960|NCT05803642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92811961|NCT05803642|Serotonin Agents|serotonin agents|mesh-ancestor
92811962|NCT05803642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92811963|NCT05803642|Dopamine Agents|dopamine agents|mesh-ancestor
92811964|NCT05803642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92811965|NCT05803590|Chlorhexidine|chlorhexidine|mesh-list
92811966|NCT05803590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92811967|NCT05803590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92811968|NCT05803590|Disinfectants|disinfectants|mesh-ancestor
92811969|NCT05803135|Tofacitinib|tofacitinib|mesh-list
92811970|NCT05803135|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92811971|NCT05803135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92811972|NCT05803135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92811973|NCT05803135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92811974|NCT05803096|Nitrous Oxide|nitrous oxide|mesh-list
92811975|NCT05803096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92811976|NCT05803096|Anesthetics, General|anesthetics, general|mesh-ancestor
92811977|NCT05803096|Anesthetics|anesthetics|mesh-ancestor
92811978|NCT05803096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92811979|NCT05803096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811980|NCT05803096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92811981|NCT05803096|Analgesics|analgesics|mesh-ancestor
92811982|NCT05803096|Sensory System Agents|sensory system agents|mesh-ancestor
92811983|NCT05803096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92811984|NCT05803083|Hyaluronic Acid|hyaluronic acid|mesh-list
92811985|NCT05803083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92811986|NCT05803083|Immunologic Factors|immunologic factors|mesh-ancestor
92811987|NCT05803083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92811988|NCT05803083|Viscosupplements|viscosupplements|mesh-ancestor
92811989|NCT05803083|Protective Agents|protective agents|mesh-ancestor
92811990|NCT05803070|Cetirizine|cetirizine|mesh-list
92811991|NCT05803070|Betamethasone|betamethasone|mesh-list
92811992|NCT05803070|Betamethasone Valerate|betamethasone valerate|mesh-list
92811993|NCT05803070|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92811994|NCT05803070|Betamethasone benzoate|betamethasone benzoate|mesh-list
92811995|NCT05803070|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92811996|NCT05803070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92811997|NCT05803070|Glucocorticoids|glucocorticoids|mesh-ancestor
92811998|NCT05803070|Hormones|hormones|mesh-ancestor
92811999|NCT05803070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812000|NCT05803070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812001|NCT05803070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92812002|NCT05803070|Respiratory System Agents|respiratory system agents|mesh-ancestor
92812003|NCT05803070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92812004|NCT05803070|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92812005|NCT05803070|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92812006|NCT05803070|Histamine Antagonists|histamine antagonists|mesh-ancestor
92812007|NCT05803070|Histamine Agents|histamine agents|mesh-ancestor
92812008|NCT05803070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812009|NCT05803070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812010|NCT05803031|Tea Tree Oil|tea tree oil|mesh-list
92812011|NCT05803031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92812012|NCT05803031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812013|NCT05802992|Dexamethasone|dexamethasone|mesh-list
92812014|NCT05802992|Dexamethasone acetate|dexamethasone acetate|mesh-list
92812015|NCT05802992|Lenalidomide|lenalidomide|mesh-list
92812016|NCT05802992|Colchicine|colchicine|mesh-list
92812017|NCT05802992|BB 1101|bb 1101|mesh-list
92812018|NCT05802992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812019|NCT05802992|Antiemetics|antiemetics|mesh-ancestor
92812020|NCT05802992|Autonomic Agents|autonomic agents|mesh-ancestor
92812021|NCT05802992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812022|NCT05802992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812023|NCT05802992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92812024|NCT05802992|Glucocorticoids|glucocorticoids|mesh-ancestor
92812025|NCT05802992|Hormones|hormones|mesh-ancestor
92812026|NCT05802992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812027|NCT05802992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812028|NCT05802992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812029|NCT05802992|Protease Inhibitors|protease inhibitors|mesh-ancestor
92812030|NCT05802992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812031|NCT05802992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812032|NCT05802992|Immunologic Factors|immunologic factors|mesh-ancestor
92812033|NCT05802992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92812034|NCT05802992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92812035|NCT05802992|Growth Substances|growth substances|mesh-ancestor
92812036|NCT05802992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92812037|NCT05802992|Gout Suppressants|gout suppressants|mesh-ancestor
92812038|NCT05802992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812039|NCT05802992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92812040|NCT05802992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92812041|NCT05802992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92812042|NCT05802979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-list
92812044|NCT05802888|Tetracycline|tetracycline|mesh-list
92812045|NCT05802888|Esomeprazole|esomeprazole|mesh-list
92812046|NCT05802888|Bismuth|bismuth|mesh-list
92812047|NCT05802888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92812048|NCT05802888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812049|NCT05802888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92812050|NCT05802888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92812051|NCT05802888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92812052|NCT05802888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812053|NCT05802888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812054|NCT05802888|Antacids|antacids|mesh-ancestor
92812055|NCT05802888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92812056|NCT05802862|Insulin|insulin|mesh-list
92812057|NCT05802862|Insulin Aspart|insulin aspart|mesh-list
92812058|NCT05802862|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92812059|NCT05802862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92812060|NCT05802862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812061|NCT05800574|Cisplatin|cisplatin|mesh-list
92812062|NCT05800574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812063|NCT05776875|Bevacizumab|bevacizumab|mesh-list
92812064|NCT05776875|Atezolizumab|atezolizumab|mesh-list
92812065|NCT05776875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812066|NCT05776875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812067|NCT05776875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92812068|NCT05776875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92812069|NCT05776875|Growth Substances|growth substances|mesh-ancestor
92812070|NCT05776875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812071|NCT05776875|Growth Inhibitors|growth inhibitors|mesh-ancestor
92812072|NCT05776875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812073|NCT05776875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812074|NCT05776290|Hyaluronic Acid|hyaluronic acid|mesh-list
92812075|NCT05776290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92812076|NCT05776290|Immunologic Factors|immunologic factors|mesh-ancestor
92812077|NCT05776290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812078|NCT05776290|Viscosupplements|viscosupplements|mesh-ancestor
92812079|NCT05776290|Protective Agents|protective agents|mesh-ancestor
92812080|NCT05768711|Venetoclax|venetoclax|mesh-list
92812081|NCT05768711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812083|NCT05766670|Gentamicins|gentamicins|mesh-list
92812084|NCT05766670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92812085|NCT05766670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812086|NCT05766670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92812087|NCT05766670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812088|NCT05766670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812089|NCT05765227|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92812090|NCT05765227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92812091|NCT05765227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812092|NCT05761444|Atorvastatin|atorvastatin|mesh-list
92812093|NCT05761444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92812094|NCT05761444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92812095|NCT05761444|Antimetabolites|antimetabolites|mesh-ancestor
92812096|NCT05761444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812097|NCT05761444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92812098|NCT05761444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92812099|NCT05761444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812100|NCT05758948|Formaldehyde|formaldehyde|mesh-list
92812101|NCT05758948|Disinfectants|disinfectants|mesh-ancestor
92812102|NCT05758948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812103|NCT05757791|Empagliflozin|empagliflozin|mesh-list
92812104|NCT05757791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92812105|NCT05757791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812106|NCT05757791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92812107|NCT05757791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812108|NCT05752734|Dexamethasone|dexamethasone|mesh-list
92812109|NCT05752734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812111|NCT05752734|Autonomic Agents|autonomic agents|mesh-ancestor
92812112|NCT05752734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812113|NCT05752734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812114|NCT05752734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92812115|NCT05752734|Glucocorticoids|glucocorticoids|mesh-ancestor
92812116|NCT05752734|Hormones|hormones|mesh-ancestor
92812117|NCT05752734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812118|NCT05752734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812119|NCT05752734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812120|NCT05728775|Propofol|propofol|mesh-list
92812121|NCT05728775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92812122|NCT05728775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812123|NCT05728775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812124|NCT05728775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92812125|NCT05728775|Anesthetics, General|anesthetics, general|mesh-ancestor
92812126|NCT05728775|Anesthetics|anesthetics|mesh-ancestor
92812127|NCT05715671|Esketamine|esketamine|mesh-list
92812128|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
92812129|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92812130|NCT05705089|Warfarin|warfarin|mesh-list
92812131|NCT05705089|Rivaroxaban|rivaroxaban|mesh-list
92812132|NCT05705089|Anticoagulants|anticoagulants|mesh-ancestor
92812133|NCT05705089|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92812134|NCT05705089|Antithrombins|antithrombins|mesh-ancestor
92812135|NCT05705089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92812136|NCT05705089|Protease Inhibitors|protease inhibitors|mesh-ancestor
92812137|NCT05705089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812138|NCT05705089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812139|NCT05701917|Heparin|heparin|mesh-list
92812140|NCT05701917|Calcium heparin|calcium heparin|mesh-list
92812141|NCT05701917|Rivaroxaban|rivaroxaban|mesh-list
92812142|NCT05701917|Apixaban|apixaban|mesh-list
92812143|NCT05701917|Warfarin|warfarin|mesh-list
92812144|NCT05701917|Anticoagulants|anticoagulants|mesh-ancestor
92812145|NCT05701917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92812146|NCT05701917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92812147|NCT05701917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812148|NCT05701917|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92812149|NCT05701917|Antithrombins|antithrombins|mesh-ancestor
92812150|NCT05701917|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92812151|NCT05701917|Protease Inhibitors|protease inhibitors|mesh-ancestor
92812152|NCT05701917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812153|NCT05693766|Capecitabine|capecitabine|mesh-list
92812154|NCT05693766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457176|NCT01715636|Tenofovir|tenofovir|mesh-list
92812155|NCT05693766|Antimetabolites|antimetabolites|mesh-ancestor
92812156|NCT05693766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812157|NCT05693766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812158|NCT05687721|Avelumab|avelumab|mesh-list
92812159|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812160|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812161|NCT05672901|Estradiol|estradiol|mesh-list
92812162|NCT05672901|Estrogens|estrogens|mesh-ancestor
92812163|NCT05672901|Hormones|hormones|mesh-ancestor
92812164|NCT05672901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812165|NCT05672901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812166|NCT05671822|Capecitabine|capecitabine|mesh-list
92812167|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
92812168|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812169|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
92812170|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812171|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812172|NCT05649540|Amoxicillin|amoxicillin|mesh-list
92812173|NCT05649540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92812174|NCT05649540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812175|NCT05646693|Sertraline|sertraline|mesh-list
92812176|NCT05646693|Magnesium Oxide|magnesium oxide|mesh-list
92812177|NCT05646693|Antidepressive Agents|antidepressive agents|mesh-ancestor
92812178|NCT05646693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92812179|NCT05646693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92812180|NCT05646693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92812181|NCT05646693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92812182|NCT05646693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812183|NCT05646693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812184|NCT05646693|Serotonin Agents|serotonin agents|mesh-ancestor
92812185|NCT05646693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812187|NCT05646693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92812188|NCT05624359|Ropivacaine|ropivacaine|mesh-list
92812189|NCT05624359|Anesthetics, Local|anesthetics, local|mesh-ancestor
92812190|NCT05624359|Anesthetics|anesthetics|mesh-ancestor
92812191|NCT05624359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812192|NCT05624359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812193|NCT05624359|Sensory System Agents|sensory system agents|mesh-ancestor
92812194|NCT05624359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812195|NCT05616624|Gemcitabine|gemcitabine|mesh-list
92812196|NCT05616624|Docetaxel|docetaxel|mesh-list
92425572|NCT01533376|Timolol|timolol|mesh-list
92812197|NCT05616624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812198|NCT05616624|Antimetabolites|antimetabolites|mesh-ancestor
92812199|NCT05616624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812200|NCT05616624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812201|NCT05616624|Tubulin Modulators|tubulin modulators|mesh-ancestor
92812202|NCT05616624|Antimitotic Agents|antimitotic agents|mesh-ancestor
92812203|NCT05616624|Mitosis Modulators|mitosis modulators|mesh-ancestor
92812204|NCT05601817|Tocopherols|tocopherols|mesh-list
92812205|NCT05601817|Vitamin E|vitamin e|mesh-list
92812206|NCT05601817|alpha-Tocopherol|alpha-tocopherol|mesh-list
92812207|NCT05601817|Antioxidants|antioxidants|mesh-ancestor
92812208|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812209|NCT05601817|Protective Agents|protective agents|mesh-ancestor
92812210|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812211|NCT05601817|Vitamins|vitamins|mesh-ancestor
92812212|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
92812213|NCT05558124|Cytarabine|cytarabine|mesh-list
92812214|NCT05558124|Daunorubicin|daunorubicin|mesh-list
92812215|NCT05558124|Gemtuzumab|gemtuzumab|mesh-list
92812216|NCT05558124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812217|NCT05558124|Antimetabolites|antimetabolites|mesh-ancestor
92812218|NCT05558124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812219|NCT05558124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812220|NCT05558124|Antiviral Agents|antiviral agents|mesh-ancestor
92812221|NCT05558124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812222|NCT05558124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812223|NCT05558124|Immunologic Factors|immunologic factors|mesh-ancestor
92812224|NCT05558124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812225|NCT05558124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92812226|NCT05558124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92812227|NCT05558124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92812228|NCT05558124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812229|NCT05558124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812230|NCT05558124|Immunotoxins|immunotoxins|mesh-ancestor
92812231|NCT05558124|Immunoconjugates|immunoconjugates|mesh-ancestor
92812232|NCT05535023|Cemiplimab|cemiplimab|mesh-list
92812233|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812234|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812236|NCT05519579|Blinatumomab|blinatumomab|mesh-list
92812237|NCT05519579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92812238|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
92812239|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92812240|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812241|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812242|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
92812243|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812244|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812245|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
92812246|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812247|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92812248|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812249|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
92812250|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812251|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92812252|NCT05515978|Metformin|metformin|mesh-list
92812253|NCT05515978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92812254|NCT05515978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812255|NCT05513469|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92812256|NCT05513469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92812257|NCT05513469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812258|NCT05494593|Rituximab|rituximab|mesh-list
92812259|NCT05494593|Methotrexate|methotrexate|mesh-list
92812260|NCT05494593|Immunoglobulins|immunoglobulins|mesh-list
92812261|NCT05494593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92812262|NCT05494593|Antibodies|antibodies|mesh-list
92812264|NCT05494593|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92812265|NCT05494593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812266|NCT05494593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812267|NCT05494593|Immunologic Factors|immunologic factors|mesh-ancestor
92812268|NCT05494593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812269|NCT05494593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812270|NCT05494593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92812271|NCT05494593|Abortifacient Agents|abortifacient agents|mesh-ancestor
92812272|NCT05494593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92812273|NCT05494593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812274|NCT05494593|Antimetabolites|antimetabolites|mesh-ancestor
92812275|NCT05494593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812276|NCT05494593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92812277|NCT05494593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812278|NCT05494593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92812279|NCT05494593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812280|NCT05494593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92812281|NCT05484349|Clonidine|clonidine|mesh-list
92812282|NCT05484349|Tizanidine|tizanidine|mesh-list
92812283|NCT05484349|Analgesics|analgesics|mesh-ancestor
92812284|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
92812285|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812286|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812287|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
92812288|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92812289|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92812290|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
92812291|NCT05484349|Autonomic Agents|autonomic agents|mesh-ancestor
92812292|NCT05484349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92812293|NCT05484349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92812294|NCT05484349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92812295|NCT05484349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92812296|NCT05484349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812297|NCT05484349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812298|NCT05484349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92812299|NCT05484349|Sympatholytics|sympatholytics|mesh-ancestor
92812300|NCT05470244|Analgesics|analgesics|mesh-list
92812301|NCT05470244|Sensory System Agents|sensory system agents|mesh-ancestor
92812302|NCT05470244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812303|NCT05470244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812304|NCT05449548|Lenalidomide|lenalidomide|mesh-list
92812305|NCT05449548|Immunologic Factors|immunologic factors|mesh-ancestor
92812306|NCT05449548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812307|NCT05449548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92812308|NCT05449548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92812309|NCT05449548|Growth Substances|growth substances|mesh-ancestor
92812310|NCT05449548|Growth Inhibitors|growth inhibitors|mesh-ancestor
92812311|NCT05449548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812313|NCT05438264|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92812314|NCT05438264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812315|NCT05438264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812316|NCT05438264|Cholinergic Agents|cholinergic agents|mesh-ancestor
92812317|NCT05438264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812318|NCT05438264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812319|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
92812320|NCT05365035|Cytarabine|cytarabine|mesh-list
92812321|NCT05365035|Azacitidine|azacitidine|mesh-list
92812322|NCT05365035|Venetoclax|venetoclax|mesh-list
92812323|NCT05365035|Cladribine|cladribine|mesh-list
92812324|NCT05365035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812325|NCT05365035|Antimetabolites|antimetabolites|mesh-ancestor
92812326|NCT05365035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812327|NCT05365035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812328|NCT05365035|Antiviral Agents|antiviral agents|mesh-ancestor
92812329|NCT05365035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812330|NCT05365035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812331|NCT05365035|Immunologic Factors|immunologic factors|mesh-ancestor
92812332|NCT05365035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812333|NCT05365035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812334|NCT05359861|Bevacizumab|bevacizumab|mesh-list
92812335|NCT05359861|Atezolizumab|atezolizumab|mesh-list
92812336|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812337|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812338|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92812339|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92812340|NCT05359861|Growth Substances|growth substances|mesh-ancestor
92812341|NCT05359861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812342|NCT05359861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92812343|NCT05359861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812344|NCT05359861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812345|NCT05355857|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92812346|NCT05355857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92812347|NCT05355857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812348|NCT05350085|Midazolam|midazolam|mesh-list
92812349|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92812350|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92812351|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812352|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812353|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92812354|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92812355|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92812356|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92812357|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
92812358|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
92812359|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
92812360|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
92812361|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812362|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812363|NCT05313308|Midazolam|midazolam|mesh-list
92812364|NCT05313308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92812365|NCT05313308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92812366|NCT05313308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812367|NCT05313308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812368|NCT05313308|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92812369|NCT05313308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92812370|NCT05313308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92812371|NCT05313308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92812372|NCT05313308|Anesthetics, General|anesthetics, general|mesh-ancestor
92812373|NCT05313308|Anesthetics|anesthetics|mesh-ancestor
92812374|NCT05313308|GABA Modulators|gaba modulators|mesh-ancestor
92812375|NCT05313308|GABA Agents|gaba agents|mesh-ancestor
92812376|NCT05313308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812377|NCT05313308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812378|NCT05289349|Propofol|propofol|mesh-list
92812379|NCT05289349|Sevoflurane|sevoflurane|mesh-list
92812380|NCT05289349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92812381|NCT05289349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812382|NCT05289349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812383|NCT05289349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92812384|NCT05289349|Anesthetics, General|anesthetics, general|mesh-ancestor
92812385|NCT05289349|Anesthetics|anesthetics|mesh-ancestor
92812386|NCT05289349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92812387|NCT05289349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92812388|NCT05273359|Benralizumab|benralizumab|mesh-list
92812389|NCT05273359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92812390|NCT05273359|Respiratory System Agents|respiratory system agents|mesh-ancestor
92812391|NCT05226455|Azacitidine|azacitidine|mesh-list
92812392|NCT05226455|Venetoclax|venetoclax|mesh-list
92812393|NCT05226455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812394|NCT05226455|Antimetabolites|antimetabolites|mesh-ancestor
92812395|NCT05226455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812396|NCT05226455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812397|NCT05226455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812398|NCT05169905|Vaccines|vaccines|mesh-list
92812399|NCT05169905|Immunologic Factors|immunologic factors|mesh-ancestor
92812400|NCT05169905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812401|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
92812402|NCT05163223|Capecitabine|capecitabine|mesh-list
92812403|NCT05163223|Sargramostim|sargramostim|mesh-list
92812404|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812405|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812406|NCT05163223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812407|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812408|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812409|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
92812410|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
92812411|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812412|NCT05101122|Dronabinol|dronabinol|mesh-list
92812413|NCT05101122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92812414|NCT05101122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92812415|NCT05101122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92812416|NCT05101122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92812417|NCT05101122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812418|NCT05101122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92812419|NCT05101122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812420|NCT05101122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812421|NCT05101122|Hallucinogens|hallucinogens|mesh-ancestor
92812422|NCT05101122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92812423|NCT05101122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92812425|NCT05101122|Sensory System Agents|sensory system agents|mesh-ancestor
92812426|NCT05101122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812427|NCT05101122|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92812428|NCT05101122|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92812429|NCT05101122|Hormones|hormones|mesh-ancestor
92812430|NCT05101122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812431|NCT05092945|Niacin|niacin|mesh-list
92812432|NCT05092945|Nicotinic Acids|nicotinic acids|mesh-list
92812433|NCT05092945|Niacinamide|niacinamide|mesh-list
92812434|NCT05092945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92812435|NCT05092945|Antimetabolites|antimetabolites|mesh-ancestor
92812436|NCT05092945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812437|NCT05092945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92812438|NCT05092945|Vasodilator Agents|vasodilator agents|mesh-ancestor
92812439|NCT05092945|Vitamin B Complex|vitamin b complex|mesh-ancestor
92812440|NCT05092945|Vitamins|vitamins|mesh-ancestor
92812441|NCT05092945|Micronutrients|micronutrients|mesh-ancestor
92812442|NCT05092945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812443|NCT05087771|Naltrexone|naltrexone|mesh-list
92812444|NCT05087771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92812445|NCT05087771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92812446|NCT05087771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812447|NCT05087771|Sensory System Agents|sensory system agents|mesh-ancestor
92812448|NCT05087771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812449|NCT05084235|Empagliflozin|empagliflozin|mesh-list
92812450|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92812451|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812452|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92812453|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812454|NCT05082142|Tranexamic Acid|tranexamic acid|mesh-list
92812455|NCT05082142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92812456|NCT05082142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92812457|NCT05082142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812458|NCT05082142|Hemostatics|hemostatics|mesh-ancestor
92812459|NCT05082142|Coagulants|coagulants|mesh-ancestor
92457475|NCT01717911|Metformin|metformin|mesh-list
92812460|NCT05061017|Cyclophosphamide|cyclophosphamide|mesh-list
92812461|NCT05061017|Nivolumab|nivolumab|mesh-list
92812462|NCT05061017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812463|NCT05061017|Immunologic Factors|immunologic factors|mesh-ancestor
92812464|NCT05061017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812465|NCT05061017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812466|NCT05061017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92812467|NCT05061017|Alkylating Agents|alkylating agents|mesh-ancestor
92812468|NCT05061017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812469|NCT05061017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812470|NCT05061017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92812471|NCT05061017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812472|NCT05061017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812473|NCT05048901|Lanreotide|lanreotide|mesh-list
92812474|NCT05048901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812475|NCT05042973|Empagliflozin|empagliflozin|mesh-list
92812476|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92812477|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812478|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92812479|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812480|NCT05030272|Nicotine|nicotine|mesh-list
92812481|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92812482|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
92812483|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812484|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812485|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92812486|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92812487|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
92812488|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812489|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812490|NCT04976257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92812491|NCT04976257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92812492|NCT04976257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812493|NCT04954365|Amisulpride|amisulpride|mesh-list
92812494|NCT04954365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92812495|NCT04954365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92812496|NCT04954365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812497|NCT04954365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812498|NCT04954365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92812499|NCT04954365|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92812500|NCT04954365|Dopamine Agents|dopamine agents|mesh-ancestor
92812501|NCT04954365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812502|NCT04954365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812503|NCT04954365|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92812504|NCT04954365|Antidepressive Agents|antidepressive agents|mesh-ancestor
92812506|NCT04952389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812507|NCT04952389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92812508|NCT04952389|Autonomic Agents|autonomic agents|mesh-ancestor
92812509|NCT04952389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812510|NCT04952389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812511|NCT04952389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92812512|NCT04952389|Respiratory System Agents|respiratory system agents|mesh-ancestor
92812513|NCT04952389|Glucocorticoids|glucocorticoids|mesh-ancestor
92812514|NCT04952389|Hormones|hormones|mesh-ancestor
92812515|NCT04952389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812516|NCT04920617|Cyclophosphamide|cyclophosphamide|mesh-list
92812517|NCT04920617|Pembrolizumab|pembrolizumab|mesh-list
92812518|NCT04920617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812519|NCT04920617|Immunologic Factors|immunologic factors|mesh-ancestor
92812520|NCT04920617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812521|NCT04920617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812522|NCT04920617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92812523|NCT04920617|Alkylating Agents|alkylating agents|mesh-ancestor
92812524|NCT04920617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812525|NCT04920617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812526|NCT04920617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92812527|NCT04920617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812528|NCT04920617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812529|NCT04860804|Aspirin|aspirin|mesh-list
92812530|NCT04860804|Ketamine|ketamine|mesh-list
92812531|NCT04860804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92812532|NCT04860804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92812533|NCT04860804|Analgesics|analgesics|mesh-ancestor
92812534|NCT04860804|Sensory System Agents|sensory system agents|mesh-ancestor
92812535|NCT04860804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812536|NCT04860804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812537|NCT04860804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812538|NCT04860804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812539|NCT04860804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92812540|NCT04860804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92812541|NCT04860804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812542|NCT04860804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92812543|NCT04860804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92812544|NCT04860804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812545|NCT04860804|Antipyretics|antipyretics|mesh-ancestor
92812546|NCT04860804|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92812547|NCT04860804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92812548|NCT04860804|Anesthetics, General|anesthetics, general|mesh-ancestor
92812549|NCT04860804|Anesthetics|anesthetics|mesh-ancestor
92812550|NCT04860804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812551|NCT04860804|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92812552|NCT04860804|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92812553|NCT04860804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812554|NCT04817345|Plerixafor|plerixafor|mesh-list
92812555|NCT04817345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92812556|NCT04817345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92812557|NCT04817345|Antiviral Agents|antiviral agents|mesh-ancestor
92812558|NCT04817345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812559|NCT04764396|Heparin|heparin|mesh-list
92812560|NCT04764396|Calcium heparin|calcium heparin|mesh-list
92812561|NCT04764396|Anticoagulants|anticoagulants|mesh-ancestor
92812562|NCT04764396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92812563|NCT04764396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92812564|NCT04764396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812565|NCT04684589|Tadalafil|tadalafil|mesh-list
92812566|NCT04684589|Vasodilator Agents|vasodilator agents|mesh-ancestor
92812567|NCT04684589|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92812568|NCT04684589|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92812569|NCT04684589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812570|NCT04684589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812571|NCT04684589|Urological Agents|urological agents|mesh-ancestor
92812572|NCT04609514|Nicotine|nicotine|mesh-list
92812573|NCT04609514|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92812574|NCT04609514|Autonomic Agents|autonomic agents|mesh-ancestor
92812575|NCT04609514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812576|NCT04609514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812577|NCT04609514|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92812578|NCT04609514|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92812579|NCT04609514|Cholinergic Agents|cholinergic agents|mesh-ancestor
92812580|NCT04609514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812581|NCT04609514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812582|NCT04569461|Pembrolizumab|pembrolizumab|mesh-list
92812583|NCT04569461|Androgens|androgens|mesh-list
92812584|NCT04569461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812585|NCT04569461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812586|NCT04569461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812587|NCT04569461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812588|NCT04569461|Hormones|hormones|mesh-ancestor
92812589|NCT04569461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812590|NCT04569461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812591|NCT04527289|Amantadine|amantadine|mesh-list
92812592|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92812593|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92812594|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
92812595|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812596|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
92812597|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812598|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812599|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812600|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92812601|NCT04527289|Analgesics|analgesics|mesh-ancestor
92812602|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
92812603|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812604|NCT04505735|Corticosterone|corticosterone|mesh-list
92812605|NCT04505735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812606|NCT04460872|Methyltestosterone|methyltestosterone|mesh-list
92812607|NCT04460872|Testosterone|testosterone|mesh-list
92812608|NCT04460872|Testosterone undecanoate|testosterone undecanoate|mesh-list
92812610|NCT04460872|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92812611|NCT04460872|Androgens|androgens|mesh-ancestor
92812612|NCT04460872|Hormones|hormones|mesh-ancestor
92812613|NCT04460872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812614|NCT04460872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812615|NCT04460872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812616|NCT04460872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812617|NCT04460872|Anabolic Agents|anabolic agents|mesh-ancestor
92812618|NCT04446351|Dostarlimab|dostarlimab|mesh-list
92812619|NCT04446351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812620|NCT04703920|Talazoparib|talazoparib|mesh-list
92812621|NCT04703920|Belinostat|belinostat|mesh-list
92812622|NCT04703920|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92812623|NCT04703920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812624|NCT04703920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812625|NCT04703920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812626|NCT04703920|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92812627|NCT04422795|Ethyl Chloride|ethyl chloride|mesh-list
92812628|NCT04422795|Anesthetics, Local|anesthetics, local|mesh-ancestor
92812629|NCT04422795|Anesthetics|anesthetics|mesh-ancestor
92812630|NCT04422795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812631|NCT04422795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812632|NCT04422795|Sensory System Agents|sensory system agents|mesh-ancestor
92812633|NCT04422795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812634|NCT04413617|Tofacitinib|tofacitinib|mesh-list
92812635|NCT04413617|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92812636|NCT04413617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92812637|NCT04413617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812638|NCT04413617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812639|NCT04408625|Sirolimus|sirolimus|mesh-list
92812640|NCT04408625|Prednisone|prednisone|mesh-list
92812641|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
92812642|NCT04408625|Rituximab|rituximab|mesh-list
92812643|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812644|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812645|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
92812646|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812647|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812648|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812649|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
92812650|NCT04408625|Hormones|hormones|mesh-ancestor
92812651|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812652|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812653|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92812654|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812655|NCT04408625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92812656|NCT04408625|Antifungal Agents|antifungal agents|mesh-ancestor
92812657|NCT04408625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812658|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
92812659|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
92812660|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812661|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92812662|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92812663|NCT04408625|Protective Agents|protective agents|mesh-ancestor
92812664|NCT04231760|Nitric Oxide|nitric oxide|mesh-list
92812665|NCT04231760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92812666|NCT04231760|Autonomic Agents|autonomic agents|mesh-ancestor
92812667|NCT04231760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812668|NCT04231760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812669|NCT04231760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92812670|NCT04231760|Respiratory System Agents|respiratory system agents|mesh-ancestor
92812671|NCT04231760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92812672|NCT04231760|Antioxidants|antioxidants|mesh-ancestor
92812673|NCT04231760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812674|NCT04231760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812675|NCT04231760|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92812676|NCT04231760|Vasodilator Agents|vasodilator agents|mesh-ancestor
92812677|NCT04231760|Gasotransmitters|gasotransmitters|mesh-ancestor
92812678|NCT04231760|Protective Agents|protective agents|mesh-ancestor
92812679|NCT04218565|Golimumab|golimumab|mesh-list
92812680|NCT04218565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92812681|NCT04218565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426061|NCT01536223|Cisplatin|cisplatin|mesh-list
92812682|NCT04218565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92812683|NCT04218565|Immunologic Factors|immunologic factors|mesh-ancestor
92812684|NCT04218565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812685|NCT04193293|Pembrolizumab|pembrolizumab|mesh-list
92812686|NCT04193293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92812687|NCT04193293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812688|NCT04193293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812689|NCT04193293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812690|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
92812691|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92812692|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
92812693|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812694|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812695|NCT04181359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92812696|NCT04181359|Respiratory System Agents|respiratory system agents|mesh-ancestor
92812697|NCT04181359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92812698|NCT04181359|Antioxidants|antioxidants|mesh-ancestor
92812699|NCT04181359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812700|NCT04181359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812701|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92812702|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
92812703|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
92812704|NCT04181359|Protective Agents|protective agents|mesh-ancestor
92812705|NCT04129502|Carboplatin|carboplatin|mesh-list
92812706|NCT04129502|Pemetrexed|pemetrexed|mesh-list
92812707|NCT04129502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812708|NCT04129502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812709|NCT04129502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812710|NCT04129502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92812711|NCT04129502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92812712|NCT04093362|Gemcitabine|gemcitabine|mesh-list
92812713|NCT04093362|Futibatinib|futibatinib|mesh-list
92812714|NCT04093362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812715|NCT04093362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812716|NCT04093362|Antimetabolites|antimetabolites|mesh-ancestor
92812717|NCT04093362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812718|NCT04060849|Ethanol|ethanol|mesh-list
92812719|NCT04060849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92812720|NCT04060849|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92812721|NCT04060849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812722|NCT04060849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812723|NCT04060849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812724|NCT04055116|Lidocaine|lidocaine|mesh-list
92812725|NCT04055116|Anesthetics, Local|anesthetics, local|mesh-ancestor
92812726|NCT04055116|Anesthetics|anesthetics|mesh-ancestor
92812727|NCT04055116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812728|NCT04055116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812729|NCT04055116|Sensory System Agents|sensory system agents|mesh-ancestor
92812730|NCT04055116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812731|NCT04055116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92812732|NCT04055116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92812733|NCT04055116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92812734|NCT04055116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92812735|NCT04055116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812736|NCT04045028|Rituximab|rituximab|mesh-list
92812737|NCT04045028|Atezolizumab|atezolizumab|mesh-list
92812738|NCT04045028|Daratumumab|daratumumab|mesh-list
92812739|NCT04045028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812740|NCT04045028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812741|NCT04045028|Immunologic Factors|immunologic factors|mesh-ancestor
92812742|NCT04045028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812743|NCT04045028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812744|NCT04045028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812745|NCT04045028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812746|NCT04039867|Gemcitabine|gemcitabine|mesh-list
92812747|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
92812748|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812749|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
92812750|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812751|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812752|NCT03990623|Liver Extracts|liver extracts|mesh-list
92812753|NCT03990623|Hematinics|hematinics|mesh-ancestor
92812754|NCT03916328|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92812755|NCT03916328|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92812756|NCT03916328|Contraceptive Agents|contraceptive agents|mesh-ancestor
92457787|NCT01719419|Orlistat|orlistat|mesh-list
92812757|NCT03916328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92812758|NCT03916328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812759|NCT03916328|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92812760|NCT03916328|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92812761|NCT03916328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812762|NCT03916328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812763|NCT03867500|Niacin|niacin|mesh-list
92812764|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92812765|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
92812766|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812767|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92812768|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
92812769|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
92812770|NCT03867500|Vitamins|vitamins|mesh-ancestor
92812771|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
92812772|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812773|NCT03839446|Etoposide|etoposide|mesh-list
92812774|NCT03839446|Mitoxantrone|mitoxantrone|mesh-list
92812775|NCT03839446|Gemtuzumab|gemtuzumab|mesh-list
92812776|NCT03839446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92812777|NCT03839446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812778|NCT03839446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92812779|NCT03839446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92812780|NCT03839446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812781|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812782|NCT03839446|Analgesics|analgesics|mesh-ancestor
92812784|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812785|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812786|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812787|NCT03839446|Immunotoxins|immunotoxins|mesh-ancestor
92812788|NCT03839446|Immunoconjugates|immunoconjugates|mesh-ancestor
92812789|NCT03839446|Immunologic Factors|immunologic factors|mesh-ancestor
92812790|NCT03781986|Carboplatin|carboplatin|mesh-list
92812791|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812792|NCT03743402|Analgesics, Opioid|analgesics, opioid|mesh-list
92812793|NCT03743402|Narcotics|narcotics|mesh-ancestor
92812794|NCT03743402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812795|NCT03743402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812796|NCT03743402|Analgesics|analgesics|mesh-ancestor
92812797|NCT03743402|Sensory System Agents|sensory system agents|mesh-ancestor
92812798|NCT03743402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812799|NCT03735433|Aspirin|aspirin|mesh-list
92812800|NCT03735433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92812801|NCT03735433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92812802|NCT03735433|Analgesics|analgesics|mesh-ancestor
92812803|NCT03735433|Sensory System Agents|sensory system agents|mesh-ancestor
92812804|NCT03735433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812805|NCT03735433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812806|NCT03735433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812807|NCT03735433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812808|NCT03735433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92812809|NCT03735433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92812810|NCT03735433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812811|NCT03735433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92426184|NCT01536743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812812|NCT03735433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92812813|NCT03735433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812814|NCT03735433|Antipyretics|antipyretics|mesh-ancestor
92812815|NCT03729401|Aspirin|aspirin|mesh-list
92812816|NCT03729401|Clopidogrel|clopidogrel|mesh-list
92812817|NCT03729401|Ticagrelor|ticagrelor|mesh-list
92812818|NCT03729401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92812819|NCT03729401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92812820|NCT03729401|Analgesics|analgesics|mesh-ancestor
92812821|NCT03729401|Sensory System Agents|sensory system agents|mesh-ancestor
92812822|NCT03729401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812823|NCT03729401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812824|NCT03729401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812825|NCT03729401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812826|NCT03729401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92812827|NCT03729401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92812828|NCT03729401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812829|NCT03729401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92812830|NCT03729401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92812831|NCT03729401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812832|NCT03729401|Antipyretics|antipyretics|mesh-ancestor
92812833|NCT03729401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92812834|NCT03729401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92812835|NCT03729401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92812836|NCT03729401|Purinergic Agents|purinergic agents|mesh-ancestor
92812837|NCT03729401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92812838|NCT03562416|Nintedanib|nintedanib|mesh-list
92812839|NCT03562416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812840|NCT03562416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92812841|NCT03562416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812842|NCT03562416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812843|NCT03512262|Abaloparatide|abaloparatide|mesh-list
92812844|NCT03512262|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92812845|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92812846|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812847|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92812848|NCT03503058|Chloroquine|chloroquine|mesh-list
92812849|NCT03503058|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92812850|NCT03503058|Amebicides|amebicides|mesh-ancestor
92812851|NCT03503058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92812852|NCT03503058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92812853|NCT03503058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812854|NCT03503058|Antimalarials|antimalarials|mesh-ancestor
92812855|NCT03503058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812856|NCT03503058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92812857|NCT03503058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92812859|NCT03503058|Sensory System Agents|sensory system agents|mesh-ancestor
92812860|NCT03503058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92812861|NCT03503058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812862|NCT03503058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812863|NCT03503058|Filaricides|filaricides|mesh-ancestor
92812864|NCT03503058|Antinematodal Agents|antinematodal agents|mesh-ancestor
92812865|NCT03503058|Anthelmintics|anthelmintics|mesh-ancestor
92812866|NCT03396211|Nivolumab|nivolumab|mesh-list
92812867|NCT03396211|Apatinib|apatinib|mesh-list
92812868|NCT03396211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812869|NCT03396211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812870|NCT03396211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812871|NCT03396211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812872|NCT03396211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92812873|NCT03396211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812874|NCT03301896|Spartalizumab|spartalizumab|mesh-list
92812875|NCT03301896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812876|NCT03301896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812877|NCT03301896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812878|NCT03301896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812879|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
92812880|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812881|NCT03260322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812882|NCT03260322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92812883|NCT03260322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812884|NCT03257761|Durvalumab|durvalumab|mesh-list
92812885|NCT03257761|Guadecitabine|guadecitabine|mesh-list
92812886|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812887|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812888|NCT03218085|Tenofovir|tenofovir|mesh-list
92812889|NCT03218085|Emtricitabine|emtricitabine|mesh-list
92812890|NCT03218085|Antiviral Agents|antiviral agents|mesh-ancestor
92812891|NCT03218085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812892|NCT03218085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92812893|NCT03218085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92812894|NCT03218085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812895|NCT03218085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812896|NCT03218085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92812897|NCT03218085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92812898|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
92812899|NCT03197077|Desogestrel|desogestrel|mesh-list
92812900|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
92812901|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92812902|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92812903|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92812904|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812905|NCT03197077|Hormones|hormones|mesh-ancestor
92812906|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812907|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92812908|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92812909|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92812910|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92812911|NCT03197077|Progestins|progestins|mesh-ancestor
92812912|NCT03153280|Capecitabine|capecitabine|mesh-list
92812913|NCT03153280|Oxaliplatin|oxaliplatin|mesh-list
92812914|NCT03153280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92812915|NCT03153280|Antimetabolites|antimetabolites|mesh-ancestor
92812916|NCT03153280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812917|NCT03153280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812919|NCT03098836|Abiraterone Acetate|abiraterone acetate|mesh-list
92812920|NCT03098836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92812921|NCT03098836|Glucocorticoids|glucocorticoids|mesh-ancestor
92812922|NCT03098836|Hormones|hormones|mesh-ancestor
92812923|NCT03098836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812924|NCT03098836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812925|NCT03098836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812926|NCT03098836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812927|NCT03098836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92812928|NCT03098836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812929|NCT03098836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157561|NCT04291209|Expectorants|expectorants|mesh-ancestor
92812930|NCT03098836|Hormone Antagonists|hormone antagonists|mesh-ancestor
92812931|NCT03098836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92812932|NCT03078855|Vitamin D|vitamin d|mesh-list
92812933|NCT03078855|Cholecalciferol|cholecalciferol|mesh-list
92812934|NCT03078855|Rituximab|rituximab|mesh-list
92812935|NCT03078855|Vitamins|vitamins|mesh-ancestor
92812936|NCT03078855|Micronutrients|micronutrients|mesh-ancestor
92812937|NCT03078855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812938|NCT03078855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812939|NCT03078855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812940|NCT03078855|Immunologic Factors|immunologic factors|mesh-ancestor
92812941|NCT03078855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812942|NCT03078855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92812943|NCT03078855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92812944|NCT03007979|Letrozole|letrozole|mesh-list
92812945|NCT03007979|Fulvestrant|fulvestrant|mesh-list
92812946|NCT03007979|Palbociclib|palbociclib|mesh-list
92812947|NCT03007979|Goserelin|goserelin|mesh-list
92812948|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812949|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92812950|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92812951|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812952|NCT03007979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812953|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92812954|NCT03007979|Hormone Antagonists|hormone antagonists|mesh-ancestor
92812955|NCT03007979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92812956|NCT03007979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812957|NCT03007979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92812958|NCT03007979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92812959|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92812960|NCT02912572|Avelumab|avelumab|mesh-list
92812961|NCT02912572|Axitinib|axitinib|mesh-list
92812962|NCT02912572|Talazoparib|talazoparib|mesh-list
92812963|NCT02912572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92812964|NCT02912572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812965|NCT02912572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92812966|NCT02912572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812967|NCT02912572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812968|NCT02912572|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92812969|NCT02910414|Ethanol|ethanol|mesh-list
92812970|NCT02910414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92812971|NCT02910414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92812972|NCT02910414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92812973|NCT02910414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812974|NCT02867813|Evolocumab|evolocumab|mesh-list
92812975|NCT02867813|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92812976|NCT02867813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92812977|NCT02867813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92812978|NCT02867813|Antimetabolites|antimetabolites|mesh-ancestor
92812979|NCT02867813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812980|NCT02867813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92812981|NCT02867813|Protease Inhibitors|protease inhibitors|mesh-ancestor
92812982|NCT02867813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92812983|NCT02867813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92812984|NCT02845596|Cyclosporine|cyclosporine|mesh-list
92812985|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
92812986|NCT02845596|Methotrexate|methotrexate|mesh-list
92812987|NCT02845596|Fludarabine|fludarabine|mesh-list
92812988|NCT02845596|Cyclosporins|cyclosporins|mesh-list
92812989|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
92812990|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92812991|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92812992|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
92812993|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92812994|NCT02845596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92812995|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92812996|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
92812997|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92812998|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92812999|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92813000|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92813001|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
92813002|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813003|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813004|NCT02845596|Antimetabolites|antimetabolites|mesh-ancestor
92813005|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
92813007|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92813008|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92813009|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
92813010|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813011|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92813012|NCT02737787|Nivolumab|nivolumab|mesh-list
92813013|NCT02737787|Vaccines|vaccines|mesh-list
92813014|NCT02737787|Immunologic Factors|immunologic factors|mesh-ancestor
92813015|NCT02737787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813016|NCT02737787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813017|NCT02737787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813018|NCT02737787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92813019|NCT02737787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813020|NCT02646839|Biotin|biotin|mesh-list
92813021|NCT02646839|Vitamin B Complex|vitamin b complex|mesh-ancestor
92813022|NCT02646839|Vitamins|vitamins|mesh-ancestor
92813023|NCT02646839|Micronutrients|micronutrients|mesh-ancestor
92813024|NCT02646839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813025|NCT02494570|Sirolimus|sirolimus|mesh-list
92813026|NCT02494570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92813027|NCT02494570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813028|NCT02494570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92813029|NCT02494570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813030|NCT02494570|Antifungal Agents|antifungal agents|mesh-ancestor
92813031|NCT02494570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813032|NCT02494570|Immunologic Factors|immunologic factors|mesh-ancestor
92813033|NCT02494570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813034|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
92813035|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813036|NCT02437071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813037|NCT02437071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92813038|NCT02437071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813039|NCT02341274|Tacrolimus|tacrolimus|mesh-list
92813040|NCT02341274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813041|NCT02341274|Immunologic Factors|immunologic factors|mesh-ancestor
92813042|NCT02341274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813043|NCT02341274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92813044|NCT02341274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813045|NCT02341274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813046|NCT02289209|Pembrolizumab|pembrolizumab|mesh-list
92813047|NCT02289209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813048|NCT02289209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813049|NCT02289209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92813050|NCT02289209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813051|NCT02256865|Ketoconazole|ketoconazole|mesh-list
92813052|NCT02256865|Hydrocortisone|hydrocortisone|mesh-list
92813053|NCT02256865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92813054|NCT02256865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92813055|NCT02256865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92813056|NCT02256865|Methyltestosterone|methyltestosterone|mesh-list
92813057|NCT02256865|Testosterone|testosterone|mesh-list
92813058|NCT02256865|Testosterone undecanoate|testosterone undecanoate|mesh-list
92813059|NCT02256865|Testosterone enanthate|testosterone enanthate|mesh-list
92813060|NCT02256865|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92813061|NCT02256865|Androgens|androgens|mesh-ancestor
92813062|NCT02256865|Hormones|hormones|mesh-ancestor
92813063|NCT02256865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813064|NCT02256865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813065|NCT02256865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92813066|NCT02256865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813067|NCT02256865|Anabolic Agents|anabolic agents|mesh-ancestor
92813068|NCT02256865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813069|NCT02256865|Antifungal Agents|antifungal agents|mesh-ancestor
92813070|NCT02256865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813071|NCT02256865|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92813072|NCT02256865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92813073|NCT02256865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813074|NCT02256865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813075|NCT02256865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92813076|NCT02256865|Hormone Antagonists|hormone antagonists|mesh-ancestor
92813077|NCT02256865|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92813078|NCT02231879|Plerixafor|plerixafor|mesh-list
92813079|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92813080|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92813081|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
92813082|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813083|NCT01968460|Pramipexole|pramipexole|mesh-list
92813085|NCT01968460|Antioxidants|antioxidants|mesh-ancestor
92813086|NCT01968460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813087|NCT01968460|Protective Agents|protective agents|mesh-ancestor
92426454|NCT01538537|ON 01910|on 01910|mesh-list
92813088|NCT01968460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813089|NCT01968460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92813090|NCT01968460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92813091|NCT01968460|Dopamine Agonists|dopamine agonists|mesh-ancestor
92813092|NCT01968460|Dopamine Agents|dopamine agents|mesh-ancestor
92813093|NCT01968460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813094|NCT01968460|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92813095|NCT01968460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813096|NCT01968460|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92813097|NCT01906853|Vaccines|vaccines|mesh-list
92813098|NCT01906853|BCG Vaccine|bcg vaccine|mesh-list
92813099|NCT01906853|Immunologic Factors|immunologic factors|mesh-ancestor
92813100|NCT01906853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813101|NCT01906853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92813102|NCT01712490|Doxorubicin|doxorubicin|mesh-list
92813103|NCT01712490|Bleomycin|bleomycin|mesh-list
92813104|NCT01712490|Dacarbazine|dacarbazine|mesh-list
92813105|NCT01712490|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92813106|NCT01712490|Vinblastine|vinblastine|mesh-list
92813107|NCT01712490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92813108|NCT01712490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813109|NCT01712490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92813110|NCT01712490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92813111|NCT01712490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813112|NCT01712490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813113|NCT01712490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92813114|NCT01712490|Alkylating Agents|alkylating agents|mesh-ancestor
92813115|NCT01712490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813116|NCT01712490|Immunotoxins|immunotoxins|mesh-ancestor
92813117|NCT01712490|Immunoconjugates|immunoconjugates|mesh-ancestor
92813118|NCT01712490|Immunologic Factors|immunologic factors|mesh-ancestor
92813119|NCT01712490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813120|NCT01712490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92813121|NCT01712490|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813122|NCT01712490|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813123|NCT01712490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813124|NCT01527747|Saxagliptin|saxagliptin|mesh-list
92813125|NCT01527747|Incretins|incretins|mesh-ancestor
92813126|NCT01527747|Hormones|hormones|mesh-ancestor
92813127|NCT01527747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813128|NCT01527747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813129|NCT01527747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92813130|NCT01527747|Protease Inhibitors|protease inhibitors|mesh-ancestor
92813131|NCT01527747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458158|NCT01730495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92813132|NCT01527747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813133|NCT01527747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92813134|NCT01439802|Copper|copper|mesh-list
92813135|NCT01439802|Trace Elements|trace elements|mesh-ancestor
92813136|NCT01439802|Micronutrients|micronutrients|mesh-ancestor
92813137|NCT01439802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813138|NCT01434316|Veliparib|veliparib|mesh-list
92813139|NCT01434316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92813140|NCT01434316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813141|NCT01434316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813142|NCT01434316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813143|NCT00646230|Fenretinide|fenretinide|mesh-list
92813144|NCT00646230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813145|NCT00646230|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92813146|NCT00646230|Protective Agents|protective agents|mesh-ancestor
92813147|NCT00646230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813148|NCT00544414|Leucovorin|leucovorin|mesh-list
92813149|NCT00544414|Gemcitabine|gemcitabine|mesh-list
92813150|NCT00544414|Docetaxel|docetaxel|mesh-list
92813151|NCT00544414|Fluorouracil|fluorouracil|mesh-list
92813152|NCT00544414|Calcium|calcium|mesh-list
92813153|NCT00544414|Levoleucovorin|levoleucovorin|mesh-list
92813154|NCT00544414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813155|NCT00544414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92157794|NCT01072773|Hormones|hormones|mesh-ancestor
92813156|NCT00544414|Antimetabolites|antimetabolites|mesh-ancestor
92813157|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813158|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813159|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813160|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813161|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92813162|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813163|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813164|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
92813165|NCT00544414|Antidotes|antidotes|mesh-ancestor
92813166|NCT00544414|Protective Agents|protective agents|mesh-ancestor
92813167|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
92813168|NCT00544414|Vitamins|vitamins|mesh-ancestor
92813169|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
92813170|NCT00816556|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92813171|NCT00816556|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92813172|NCT00816556|Estradiol|estradiol|mesh-list
92813173|NCT00816556|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92813174|NCT00816556|Estrogens|estrogens|mesh-ancestor
92813175|NCT00816556|Hormones|hormones|mesh-ancestor
92813176|NCT00816556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813177|NCT00816556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813178|NCT00816556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92813179|NCT00816556|Contraceptive Agents|contraceptive agents|mesh-ancestor
92813180|NCT00816556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813181|NCT00816556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92813182|NCT04100473|Insulin|insulin|mesh-list
92813183|NCT04100473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92813184|NCT04100473|Insulin Lispro|insulin lispro|mesh-list
92813185|NCT04100473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92813186|NCT04100473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813187|NCT02796807|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92813188|NCT02796807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92813189|NCT02796807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813190|NCT00760747|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92813191|NCT00760747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92813192|NCT00760747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92813193|NCT00760747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92813194|NCT00760747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813195|NCT00760747|Adrenergic Agents|adrenergic agents|mesh-ancestor
92813196|NCT00760747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813197|NCT00760747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813198|NCT00760669|Infliximab|infliximab|mesh-list
92813199|NCT00760669|Methotrexate|methotrexate|mesh-list
92813200|NCT00760669|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92813201|NCT00760669|Abortifacient Agents|abortifacient agents|mesh-ancestor
92813202|NCT00760669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813203|NCT00760669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813204|NCT00760669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813205|NCT00760669|Antimetabolites|antimetabolites|mesh-ancestor
92813206|NCT00760669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813207|NCT00760669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813208|NCT00760669|Dermatologic Agents|dermatologic agents|mesh-ancestor
92813209|NCT00760669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813210|NCT00760669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92813211|NCT00760669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813212|NCT00760669|Immunologic Factors|immunologic factors|mesh-ancestor
92813213|NCT00760669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813214|NCT00760669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92813215|NCT00760669|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92813216|NCT00760669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813217|NCT00760669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813219|NCT02796183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813220|NCT02796183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813221|NCT02796183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92813222|NCT02796183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92813223|NCT02796183|Growth Substances|growth substances|mesh-ancestor
92813224|NCT02796183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813225|NCT02796183|Growth Inhibitors|growth inhibitors|mesh-ancestor
92813226|NCT02796105|Ganirelix|ganirelix|mesh-list
92813227|NCT02796105|Hormone Antagonists|hormone antagonists|mesh-ancestor
92813228|NCT02796105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813229|NCT02796105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813230|NCT02795949|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92813231|NCT02795949|Amoxicillin|amoxicillin|mesh-list
92813232|NCT02795949|Ciprofloxacin|ciprofloxacin|mesh-list
92813233|NCT02795949|Meropenem|meropenem|mesh-list
92813234|NCT02795949|Tazobactam|tazobactam|mesh-list
92813235|NCT02795949|Piperacillin|piperacillin|mesh-list
92813236|NCT02795949|Clavulanic Acid|clavulanic acid|mesh-list
92813237|NCT02795949|Imipenem|imipenem|mesh-list
92813238|NCT02795949|Ceftazidime|ceftazidime|mesh-list
92813239|NCT02795949|Ampicillin|ampicillin|mesh-list
92813240|NCT02795949|Ertapenem|ertapenem|mesh-list
92813241|NCT02795949|Cefuroxime|cefuroxime|mesh-list
92813242|NCT02795949|Cefepime|cefepime|mesh-list
92813243|NCT02795949|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92813244|NCT02795949|Lactams|lactams|mesh-list
92813245|NCT02795949|Aztreonam|aztreonam|mesh-list
92813246|NCT02795949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92813247|NCT02795949|beta-Lactams|beta-lactams|mesh-list
92813248|NCT02795949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92813249|NCT02795949|Trimethoprim|trimethoprim|mesh-list
92813250|NCT02795949|Sulfamethoxazole|sulfamethoxazole|mesh-list
92813251|NCT02795949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813252|NCT02795949|Antitubercular Agents|antitubercular agents|mesh-ancestor
92813253|NCT02795949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92813254|NCT02795949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92813255|NCT02795949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813256|NCT02795949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813257|NCT02795949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813258|NCT02795949|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92813259|NCT02795949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92813260|NCT02795949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92813261|NCT02795949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92813262|NCT02795949|Antimalarials|antimalarials|mesh-ancestor
92813263|NCT02795949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92813264|NCT02795949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92813265|NCT02795949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92813266|NCT02795949|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92813267|NCT02795949|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92813268|NCT00769483|Gemcitabine|gemcitabine|mesh-list
92813269|NCT00769483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92813270|NCT00769483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813271|NCT00769483|Antimetabolites|antimetabolites|mesh-ancestor
92813272|NCT00769483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813273|NCT00769483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813274|NCT00769483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92813275|NCT00769483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813276|NCT02794389|Acetylcysteine|acetylcysteine|mesh-list
92813277|NCT02794389|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92813278|NCT02794389|Antiviral Agents|antiviral agents|mesh-ancestor
92813279|NCT02794389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813280|NCT02794389|Expectorants|expectorants|mesh-ancestor
92813281|NCT02794389|Respiratory System Agents|respiratory system agents|mesh-ancestor
92813282|NCT02794389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92813283|NCT02794389|Antioxidants|antioxidants|mesh-ancestor
92813284|NCT02794389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813285|NCT02794389|Protective Agents|protective agents|mesh-ancestor
92813286|NCT02794389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813287|NCT02794389|Antidotes|antidotes|mesh-ancestor
92813288|NCT02601703|Tacrolimus|tacrolimus|mesh-list
92813289|NCT02601703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813290|NCT02601703|Immunologic Factors|immunologic factors|mesh-ancestor
92813291|NCT02601703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813292|NCT02601703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92813293|NCT02601703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813294|NCT02601703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813295|NCT04234191|Buprenorphine|buprenorphine|mesh-list
92813296|NCT04234191|Hydromorphone|hydromorphone|mesh-list
92813297|NCT04234191|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92813298|NCT04234191|Naloxone|naloxone|mesh-list
92813299|NCT04234191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92813300|NCT04234191|Narcotics|narcotics|mesh-ancestor
92813301|NCT04234191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813302|NCT04234191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813303|NCT04234191|Analgesics|analgesics|mesh-ancestor
92813304|NCT04234191|Sensory System Agents|sensory system agents|mesh-ancestor
92813305|NCT04234191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813306|NCT04234191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92813307|NCT02801799|Ropivacaine|ropivacaine|mesh-list
92813308|NCT02801799|Anesthetics, Local|anesthetics, local|mesh-ancestor
92813309|NCT02801799|Anesthetics|anesthetics|mesh-ancestor
92813310|NCT02801799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813311|NCT02801799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813312|NCT02801799|Sensory System Agents|sensory system agents|mesh-ancestor
92813313|NCT02801799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813314|NCT02690103|Ribavirin|ribavirin|mesh-list
92813315|NCT02690103|Antimetabolites|antimetabolites|mesh-ancestor
92813316|NCT02690103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813317|NCT02690103|Antiviral Agents|antiviral agents|mesh-ancestor
92813318|NCT02690103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813319|NCT02790099|Morphine|morphine|mesh-list
92813320|NCT02790099|Bupivacaine|bupivacaine|mesh-list
92813321|NCT02790099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92813322|NCT02790099|Anesthetics|anesthetics|mesh-ancestor
92813323|NCT02790099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813324|NCT02790099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813325|NCT02790099|Sensory System Agents|sensory system agents|mesh-ancestor
92813326|NCT02790099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813327|NCT02790099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92813328|NCT02790099|Narcotics|narcotics|mesh-ancestor
92813329|NCT02790099|Analgesics|analgesics|mesh-ancestor
92813330|NCT02790177|Hyaluronic Acid|hyaluronic acid|mesh-list
92813331|NCT02790177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92813332|NCT02790177|Immunologic Factors|immunologic factors|mesh-ancestor
92813333|NCT02790177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813334|NCT02790177|Viscosupplements|viscosupplements|mesh-ancestor
92813335|NCT02790177|Protective Agents|protective agents|mesh-ancestor
92813336|NCT04100083|Spironolactone|spironolactone|mesh-list
92813337|NCT04100083|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92813338|NCT04100083|Hormone Antagonists|hormone antagonists|mesh-ancestor
92813339|NCT04100083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813340|NCT04100083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813341|NCT04100083|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92813342|NCT04100083|Diuretics|diuretics|mesh-ancestor
92813343|NCT04100083|Natriuretic Agents|natriuretic agents|mesh-ancestor
92813344|NCT02794155|Insulin|insulin|mesh-list
92813345|NCT02794155|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92813346|NCT02794155|Insulin Lispro|insulin lispro|mesh-list
92813347|NCT02794155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92813348|NCT02794155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813349|NCT02793843|Dexamethasone|dexamethasone|mesh-list
92813350|NCT02793843|Ondansetron|ondansetron|mesh-list
92813351|NCT02793843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813352|NCT02793843|Antiemetics|antiemetics|mesh-ancestor
92813353|NCT02793843|Autonomic Agents|autonomic agents|mesh-ancestor
92813354|NCT02793843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813355|NCT02793843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813356|NCT02793843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813357|NCT02793843|Glucocorticoids|glucocorticoids|mesh-ancestor
92813358|NCT02793843|Hormones|hormones|mesh-ancestor
92813359|NCT02793843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813360|NCT02793843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92813361|NCT02793843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813362|NCT02793843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813363|NCT02793843|Antipruritics|antipruritics|mesh-ancestor
92813364|NCT02793843|Dermatologic Agents|dermatologic agents|mesh-ancestor
92813365|NCT02793843|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92813366|NCT02793843|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92813367|NCT02793843|Serotonin Agents|serotonin agents|mesh-ancestor
92813368|NCT02793843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813369|NCT02793687|Emoxypine succinate|emoxypine succinate|mesh-list
92813370|NCT02793687|Antioxidants|antioxidants|mesh-ancestor
92813371|NCT02793687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813372|NCT02793687|Protective Agents|protective agents|mesh-ancestor
92813373|NCT02793687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813374|NCT02793687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92813375|NCT02793687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92813376|NCT02801487|Cisplatin|cisplatin|mesh-list
92813377|NCT02801487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813378|NCT02793765|Docetaxel|docetaxel|mesh-list
92813379|NCT02793765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813380|NCT02793765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813381|NCT02793765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813382|NCT02793765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813383|NCT02793765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813384|NCT02793219|Docetaxel|docetaxel|mesh-list
92813385|NCT02793219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813386|NCT02793219|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813387|NCT02793219|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813388|NCT02793219|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813389|NCT02793219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813390|NCT02801409|Anesthetics|anesthetics|mesh-list
92813391|NCT02801409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813392|NCT02801409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813393|NCT03787251|Apatinib|apatinib|mesh-list
92813394|NCT03787251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813395|NCT03787251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92813396|NCT03787251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813397|NCT03787251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813398|NCT02789865|Metronidazole|metronidazole|mesh-list
92813399|NCT02789865|Levofloxacin|levofloxacin|mesh-list
92813400|NCT02789865|Ertapenem|ertapenem|mesh-list
92813401|NCT02789865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813402|NCT02789865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92813403|NCT02789865|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92813404|NCT02789865|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92813405|NCT02789865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92813406|NCT02789865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92813407|NCT02789865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92813408|NCT02789865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813409|NCT02789865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813410|NCT02789865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813411|NCT02789865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92813412|NCT02789865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92813413|NCT02792673|Hyaluronic Acid|hyaluronic acid|mesh-list
92813414|NCT02792673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92813415|NCT02792673|Immunologic Factors|immunologic factors|mesh-ancestor
92813416|NCT02792673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813417|NCT02792673|Viscosupplements|viscosupplements|mesh-ancestor
92813418|NCT02792673|Protective Agents|protective agents|mesh-ancestor
92813419|NCT00906204|Thymoglobulin|thymoglobulin|mesh-list
92813420|NCT00906204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92813421|NCT00906204|Immunologic Factors|immunologic factors|mesh-ancestor
92813422|NCT00906204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813423|NCT00906204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813424|NCT02794077|Cyclophosphamide|cyclophosphamide|mesh-list
92813425|NCT02794077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813426|NCT02794077|Immunologic Factors|immunologic factors|mesh-ancestor
92813427|NCT02794077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813428|NCT02794077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813429|NCT02794077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92813430|NCT02794077|Alkylating Agents|alkylating agents|mesh-ancestor
92813431|NCT02794077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813432|NCT02794077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813433|NCT02794077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92813434|NCT02791737|Coal Tar|coal tar|mesh-list
92813435|NCT02791737|Keratolytic Agents|keratolytic agents|mesh-ancestor
92813436|NCT02791737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92813437|NCT02535936|Anesthetics|anesthetics|mesh-list
92813438|NCT02535936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813439|NCT02535936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813440|NCT05332470|Lamivudine|lamivudine|mesh-list
92813441|NCT05332470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92813442|NCT05332470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92813443|NCT05332470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813444|NCT05332470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813445|NCT05332470|Antiviral Agents|antiviral agents|mesh-ancestor
92813446|NCT05332470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813447|NCT05332470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92813448|NCT05332470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92813449|NCT02791815|Selexipag|selexipag|mesh-list
92813450|NCT02791815|Midazolam|midazolam|mesh-list
92813451|NCT02791815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92813452|NCT02791815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92813453|NCT02791815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813454|NCT02791815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813455|NCT02791815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92813456|NCT02791815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92813457|NCT02791815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92813458|NCT02791815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92813459|NCT02791815|Anesthetics, General|anesthetics, general|mesh-ancestor
92813460|NCT02791815|Anesthetics|anesthetics|mesh-ancestor
92813461|NCT02791815|GABA Modulators|gaba modulators|mesh-ancestor
92813462|NCT02791815|GABA Agents|gaba agents|mesh-ancestor
92813463|NCT02791815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813464|NCT02791815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813465|NCT02791815|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92813466|NCT02389374|Lumefantrine|lumefantrine|mesh-list
92813467|NCT02389374|Chloroquine|chloroquine|mesh-list
92813468|NCT02389374|Artemether|artemether|mesh-list
92813469|NCT02389374|Primaquine|primaquine|mesh-list
92813470|NCT02389374|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92813471|NCT02389374|Antimalarials|antimalarials|mesh-ancestor
92813472|NCT02389374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92813473|NCT02389374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92813474|NCT02389374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813475|NCT02389374|Amebicides|amebicides|mesh-ancestor
92813476|NCT02389374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813477|NCT02789475|Amlodipine|amlodipine|mesh-list
92813478|NCT02789475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92813479|NCT02789475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92813480|NCT02789475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92813481|NCT02789475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92813482|NCT02789475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813483|NCT02789475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92813484|NCT02789475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813485|NCT02789475|Vasodilator Agents|vasodilator agents|mesh-ancestor
92813486|NCT02789475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92813487|NCT02789475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92813488|NCT02789475|Antimetabolites|antimetabolites|mesh-ancestor
92813489|NCT02789475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92813490|NCT02789475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92813491|NCT02789475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813492|NCT04202484|Oxaliplatin|oxaliplatin|mesh-list
92813493|NCT04202484|Tegafur|tegafur|mesh-list
92813494|NCT04202484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813495|NCT04202484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813496|NCT04202484|Antimetabolites|antimetabolites|mesh-ancestor
92813497|NCT04202484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813498|NCT03068910|Spironolactone|spironolactone|mesh-list
92813499|NCT03068910|Progesterone|progesterone|mesh-list
92813500|NCT03068910|Progestins|progestins|mesh-ancestor
92813501|NCT03068910|Hormones|hormones|mesh-ancestor
92813502|NCT03068910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813503|NCT03068910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813504|NCT03068910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92813505|NCT03068910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92813506|NCT03068910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92813507|NCT03068910|Diuretics|diuretics|mesh-ancestor
92813508|NCT03068910|Natriuretic Agents|natriuretic agents|mesh-ancestor
92813509|NCT02790957|Plerixafor|plerixafor|mesh-list
92813510|NCT02790957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92813511|NCT02790957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92813512|NCT02790957|Antiviral Agents|antiviral agents|mesh-ancestor
92813513|NCT02790957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813514|NCT00905424|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92813515|NCT00905424|Antidepressive Agents|antidepressive agents|mesh-list
92813516|NCT00905424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92813517|NCT00905424|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92813518|NCT00905424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813519|NCT00905424|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92813520|NCT00905424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92813521|NCT00905424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92813522|NCT00905424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813523|NCT00905424|Dopamine Agents|dopamine agents|mesh-ancestor
92813524|NCT00905424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813525|NCT02791035|Ipragliflozin|ipragliflozin|mesh-list
92813526|NCT02791035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92813527|NCT02791035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813528|NCT02791035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92813529|NCT02791035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813530|NCT03753243|Pembrolizumab|pembrolizumab|mesh-list
92813531|NCT03753243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813532|NCT03753243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813533|NCT03753243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92813534|NCT03753243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813535|NCT02339532|Carboplatin|carboplatin|mesh-list
92813536|NCT02339532|Docetaxel|docetaxel|mesh-list
92813537|NCT02339532|Trastuzumab|trastuzumab|mesh-list
92813538|NCT02339532|Pertuzumab|pertuzumab|mesh-list
92813539|NCT02339532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813540|NCT02339532|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813541|NCT02339532|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813542|NCT02339532|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813543|NCT02339532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813544|NCT02339532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813545|NCT00632580|Ropivacaine|ropivacaine|mesh-list
92813546|NCT00632580|Anesthetics, Local|anesthetics, local|mesh-ancestor
92813547|NCT00632580|Anesthetics|anesthetics|mesh-ancestor
92813548|NCT00632580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813549|NCT00632580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813550|NCT00632580|Sensory System Agents|sensory system agents|mesh-ancestor
92813551|NCT00632580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813552|NCT02789397|Rituximab|rituximab|mesh-list
92813553|NCT02789397|Azathioprine|azathioprine|mesh-list
92813554|NCT02789397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813555|NCT02789397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813556|NCT02789397|Immunologic Factors|immunologic factors|mesh-ancestor
92813557|NCT02789397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813558|NCT02789397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813559|NCT02789397|Antimetabolites|antimetabolites|mesh-ancestor
92813560|NCT02789397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813561|NCT02789397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813562|NCT02789397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813563|NCT00816166|Aspirin|aspirin|mesh-list
92813564|NCT00816166|Clopidogrel|clopidogrel|mesh-list
92813565|NCT00816166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92813566|NCT00816166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92813567|NCT00816166|Analgesics|analgesics|mesh-ancestor
92813568|NCT00816166|Sensory System Agents|sensory system agents|mesh-ancestor
92813569|NCT00816166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813570|NCT00816166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813571|NCT00816166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813572|NCT00816166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813573|NCT00816166|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92813574|NCT00816166|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92813575|NCT00816166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813576|NCT00816166|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92813577|NCT00816166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92813578|NCT00816166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813579|NCT00816166|Antipyretics|antipyretics|mesh-ancestor
92813580|NCT00816166|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92813581|NCT00816166|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92813582|NCT00816166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92426969|NCT01541137|Diclofenac|diclofenac|mesh-list
92813583|NCT00816166|Purinergic Agents|purinergic agents|mesh-ancestor
92813584|NCT00816166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813585|NCT02788851|Guanfacine|guanfacine|mesh-list
92813586|NCT02788851|Methylphenidate|methylphenidate|mesh-list
92813587|NCT02788851|Amphetamine|amphetamine|mesh-list
92813589|NCT02788851|Dextroamphetamine|dextroamphetamine|mesh-list
92813590|NCT02788851|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92813591|NCT02788851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92813592|NCT02788851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813593|NCT02788851|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92813594|NCT02788851|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92813595|NCT02788851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92813596|NCT02788851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813597|NCT02788851|Dopamine Agents|dopamine agents|mesh-ancestor
92813598|NCT02788851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813599|NCT02788851|Sympathomimetics|sympathomimetics|mesh-ancestor
92813600|NCT02788851|Autonomic Agents|autonomic agents|mesh-ancestor
92813601|NCT02788851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813602|NCT02788851|Adrenergic Agents|adrenergic agents|mesh-ancestor
92813603|NCT02788851|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92813604|NCT02788851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92813605|NCT02788851|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92813606|NCT02788851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92813607|NCT02788851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92813608|NCT02786823|Folic Acid|folic acid|mesh-list
92813609|NCT02786823|Vitamin B 12|vitamin b 12|mesh-list
92813610|NCT02786823|Metformin|metformin|mesh-list
92813611|NCT02786823|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92813612|NCT02786823|Vitamins|vitamins|mesh-ancestor
92813613|NCT02786823|Micronutrients|micronutrients|mesh-ancestor
92813614|NCT02786823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813615|NCT02786823|Hematinics|hematinics|mesh-ancestor
92813616|NCT02786823|Vitamin B Complex|vitamin b complex|mesh-ancestor
92813617|NCT05332314|Ibuprofen|ibuprofen|mesh-list
92813618|NCT05332314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92813619|NCT05332314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92813620|NCT05332314|Analgesics|analgesics|mesh-ancestor
92813621|NCT05332314|Sensory System Agents|sensory system agents|mesh-ancestor
92813622|NCT05332314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813623|NCT05332314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813624|NCT05332314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813625|NCT05332314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813626|NCT05332314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92813627|NCT05332314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813628|NCT05332314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813629|NCT00815308|Paclitaxel|paclitaxel|mesh-list
92813630|NCT00815308|Cetuximab|cetuximab|mesh-list
92813631|NCT00815308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92813632|NCT00815308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813633|NCT00815308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813634|NCT00815308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813635|NCT00815308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813636|NCT00815308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813637|NCT00815308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813638|NCT01039376|Ofatumumab|ofatumumab|mesh-list
92813639|NCT01039376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813640|NCT02610712|Ketamine|ketamine|mesh-list
92813641|NCT02610712|Analgesics|analgesics|mesh-ancestor
92813642|NCT02610712|Sensory System Agents|sensory system agents|mesh-ancestor
92813643|NCT02610712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813644|NCT02610712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813645|NCT02610712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92813646|NCT02610712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92813647|NCT02610712|Anesthetics, General|anesthetics, general|mesh-ancestor
92813648|NCT02610712|Anesthetics|anesthetics|mesh-ancestor
92813649|NCT02610712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813650|NCT02610712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92813651|NCT02610712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92813652|NCT02610712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813653|NCT02610712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813654|NCT00905034|Dexamethasone|dexamethasone|mesh-list
92813655|NCT00905034|Rituximab|rituximab|mesh-list
92813656|NCT00905034|Methotrexate|methotrexate|mesh-list
92813657|NCT00905034|Vincristine|vincristine|mesh-list
92813658|NCT00905034|Asparaginase|asparaginase|mesh-list
92813659|NCT00905034|Pegaspargase|pegaspargase|mesh-list
92813660|NCT00905034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813661|NCT00905034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813662|NCT00905034|Immunologic Factors|immunologic factors|mesh-ancestor
92813663|NCT00905034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813664|NCT00905034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813665|NCT00905034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813666|NCT00905034|Antiemetics|antiemetics|mesh-ancestor
92813667|NCT00905034|Autonomic Agents|autonomic agents|mesh-ancestor
92813668|NCT00905034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813669|NCT00905034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813670|NCT00905034|Glucocorticoids|glucocorticoids|mesh-ancestor
92813671|NCT00905034|Hormones|hormones|mesh-ancestor
92813672|NCT00905034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813673|NCT00905034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92813674|NCT00905034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92813675|NCT00905034|Abortifacient Agents|abortifacient agents|mesh-ancestor
92813676|NCT00905034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813677|NCT00905034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813678|NCT00905034|Antimetabolites|antimetabolites|mesh-ancestor
92813679|NCT00905034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813680|NCT00905034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92813682|NCT00905034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92813683|NCT00905034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813684|NCT00905034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92813685|NCT00905034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92813686|NCT00905034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813687|NCT00905034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813688|NCT00905034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813689|NCT02611804|Diclofenac|diclofenac|mesh-list
92813690|NCT02611804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92813691|NCT02611804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92813692|NCT02611804|Analgesics|analgesics|mesh-ancestor
92813693|NCT02611804|Sensory System Agents|sensory system agents|mesh-ancestor
92813694|NCT02611804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813695|NCT02611804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813696|NCT02611804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813697|NCT02611804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813698|NCT02611804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92813699|NCT02611804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813700|NCT02611804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813701|NCT00706186|Sodium Oxybate|sodium oxybate|mesh-list
92813702|NCT00706186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92813703|NCT00706186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92813704|NCT00706186|Anesthetics, General|anesthetics, general|mesh-ancestor
92813705|NCT00706186|Anesthetics|anesthetics|mesh-ancestor
92813706|NCT00706186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813707|NCT00706186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813708|NCT02611492|Cytarabine|cytarabine|mesh-list
92813709|NCT02611492|Dexamethasone|dexamethasone|mesh-list
92813710|NCT02611492|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92813711|NCT02611492|Methotrexate|methotrexate|mesh-list
92813712|NCT02611492|Vincristine|vincristine|mesh-list
92813713|NCT02611492|Mercaptopurine|mercaptopurine|mesh-list
92813714|NCT02611492|Lenograstim|lenograstim|mesh-list
92813715|NCT02611492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813716|NCT02611492|Antiemetics|antiemetics|mesh-ancestor
92813717|NCT02611492|Autonomic Agents|autonomic agents|mesh-ancestor
92813718|NCT02611492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813719|NCT02611492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813720|NCT02611492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813721|NCT02611492|Glucocorticoids|glucocorticoids|mesh-ancestor
92813722|NCT02611492|Hormones|hormones|mesh-ancestor
92813723|NCT02611492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813724|NCT02611492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92813725|NCT02611492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813726|NCT02611492|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92813727|NCT02611492|Abortifacient Agents|abortifacient agents|mesh-ancestor
92813728|NCT02611492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813729|NCT02611492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92813730|NCT02611492|Antimetabolites|antimetabolites|mesh-ancestor
92813731|NCT02611492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813732|NCT02611492|Dermatologic Agents|dermatologic agents|mesh-ancestor
92813733|NCT02611492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813734|NCT02611492|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92813735|NCT02611492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92813736|NCT02611492|Immunologic Factors|immunologic factors|mesh-ancestor
92813737|NCT02611492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813738|NCT02611492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92813739|NCT02611492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92813740|NCT02611492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813741|NCT02611492|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813742|NCT02611492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813743|NCT02611492|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92813744|NCT02611492|Antiviral Agents|antiviral agents|mesh-ancestor
92813745|NCT02611492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813746|NCT00706576|Mitogens|mitogens|mesh-list
92813747|NCT00706576|Enkephalins|enkephalins|mesh-list
92813748|NCT00706576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813749|NCT00706576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813750|NCT00706576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813751|NCT00706576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813752|NCT00828568|Imiquimod|imiquimod|mesh-list
92813753|NCT00828568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92813754|NCT00828568|Immunologic Factors|immunologic factors|mesh-ancestor
92813755|NCT00828568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813756|NCT00828568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813757|NCT00828568|Interferon Inducers|interferon inducers|mesh-ancestor
92813759|NCT01038752|Carboplatin|carboplatin|mesh-list
92813760|NCT01038752|Docetaxel|docetaxel|mesh-list
92813761|NCT01038752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813762|NCT01038752|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813763|NCT01038752|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813764|NCT01038752|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813765|NCT01038752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813766|NCT01038752|Antinematodal Agents|antinematodal agents|mesh-ancestor
92813767|NCT01038752|Anthelmintics|anthelmintics|mesh-ancestor
92813768|NCT01038752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92813769|NCT01038752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813770|NCT01038752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92813771|NCT01038752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92813772|NCT00903630|Doxorubicin|doxorubicin|mesh-list
92813773|NCT00903630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92813774|NCT00903630|Lenalidomide|lenalidomide|mesh-list
92813775|NCT00903630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92813776|NCT00903630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813777|NCT00903630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92813778|NCT00903630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92813779|NCT00903630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813780|NCT00903630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813781|NCT00903630|Immunologic Factors|immunologic factors|mesh-ancestor
92813782|NCT00903630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813783|NCT00903630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92427141|NCT01542047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813784|NCT00903630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92813785|NCT00903630|Growth Substances|growth substances|mesh-ancestor
92813786|NCT00903630|Growth Inhibitors|growth inhibitors|mesh-ancestor
92813787|NCT04302584|Vasopressins|vasopressins|mesh-list
92813788|NCT04302584|Arginine Vasopressin|arginine vasopressin|mesh-list
92813789|NCT04302584|Norepinephrine|norepinephrine|mesh-list
92813790|NCT04302584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92813791|NCT04302584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92813792|NCT04302584|Adrenergic Agents|adrenergic agents|mesh-ancestor
92813793|NCT04302584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813794|NCT04302584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813795|NCT04302584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813796|NCT04302584|Sympathomimetics|sympathomimetics|mesh-ancestor
92813797|NCT04302584|Autonomic Agents|autonomic agents|mesh-ancestor
92813798|NCT04302584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813799|NCT04302584|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92813800|NCT04302584|Hemostatics|hemostatics|mesh-ancestor
92813801|NCT04302584|Coagulants|coagulants|mesh-ancestor
92813802|NCT04302584|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92813803|NCT04302584|Natriuretic Agents|natriuretic agents|mesh-ancestor
92813804|NCT00703144|Tazobactam|tazobactam|mesh-list
92813805|NCT00703144|Piperacillin|piperacillin|mesh-list
92813806|NCT00703144|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92813807|NCT00703144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92813808|NCT00703144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813809|NCT00703144|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92813810|NCT00703144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813811|NCT00703144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813812|NCT01054820|Diclofenac|diclofenac|mesh-list
92813813|NCT01054820|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92813814|NCT01054820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92813815|NCT01054820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92813816|NCT01054820|Analgesics|analgesics|mesh-ancestor
92813817|NCT01054820|Sensory System Agents|sensory system agents|mesh-ancestor
92813818|NCT01054820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813819|NCT01054820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813820|NCT01054820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813821|NCT01054820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813822|NCT01054820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92813823|NCT01054820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813824|NCT01054820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813825|NCT03105843|Methacholine Chloride|methacholine chloride|mesh-list
92813826|NCT03105843|Miotics|miotics|mesh-ancestor
92813827|NCT03105843|Autonomic Agents|autonomic agents|mesh-ancestor
92813828|NCT03105843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813829|NCT03105843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813830|NCT03105843|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92813831|NCT03105843|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92813832|NCT03105843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92813833|NCT03105843|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92813834|NCT03105843|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92813835|NCT03105843|Cholinergic Agents|cholinergic agents|mesh-ancestor
92813836|NCT03105843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813837|NCT03105843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813838|NCT02874248|Drospirenone|drospirenone|mesh-list
92813839|NCT02874248|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92813840|NCT02874248|Hormone Antagonists|hormone antagonists|mesh-ancestor
92813841|NCT02874248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813842|NCT02874248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813843|NCT02874248|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92813844|NCT02874248|Diuretics|diuretics|mesh-ancestor
92813845|NCT02874248|Natriuretic Agents|natriuretic agents|mesh-ancestor
92813846|NCT02787603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92813847|NCT02787603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92813848|NCT02004834|Levobupivacaine|levobupivacaine|mesh-list
92813849|NCT02004834|Anesthetics, Local|anesthetics, local|mesh-ancestor
92813850|NCT02004834|Anesthetics|anesthetics|mesh-ancestor
92813851|NCT02004834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813852|NCT02004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813853|NCT02004834|Sensory System Agents|sensory system agents|mesh-ancestor
92813854|NCT02004834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813855|NCT02788305|Misoprostol|misoprostol|mesh-list
92813856|NCT02788305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92813857|NCT02788305|Abortifacient Agents|abortifacient agents|mesh-ancestor
92813858|NCT02788305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813859|NCT02788305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813860|NCT02788305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92813861|NCT02788305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813862|NCT02788305|Oxytocics|oxytocics|mesh-ancestor
92813863|NCT05758012|Oxytocin|oxytocin|mesh-list
92813864|NCT05758012|Carbetocin|carbetocin|mesh-list
92813865|NCT05758012|Oxytocics|oxytocics|mesh-ancestor
92813866|NCT05758012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813867|NCT05758012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813868|NCT02786667|Rotigotine|rotigotine|mesh-list
92813869|NCT02786667|Dopamine Agonists|dopamine agonists|mesh-ancestor
92813870|NCT02786667|Dopamine Agents|dopamine agents|mesh-ancestor
92813871|NCT02786667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813872|NCT02786667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813873|NCT02786667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813874|NCT00913276|Propofol|propofol|mesh-list
92813875|NCT00913276|Sevoflurane|sevoflurane|mesh-list
92813876|NCT00913276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92813877|NCT00913276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813878|NCT00913276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813879|NCT00913276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92813880|NCT00913276|Anesthetics, General|anesthetics, general|mesh-ancestor
92813881|NCT00913276|Anesthetics|anesthetics|mesh-ancestor
92813882|NCT00913276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92813883|NCT00913276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92813884|NCT04302116|Prednisolone|prednisolone|mesh-list
92813885|NCT04302116|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92813886|NCT04302116|Methylprednisolone|methylprednisolone|mesh-list
92813887|NCT04302116|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92813888|NCT04302116|Prednisolone acetate|prednisolone acetate|mesh-list
92813889|NCT04302116|Vigabatrin|vigabatrin|mesh-list
92813890|NCT04302116|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92813891|NCT04302116|Prednisolone phosphate|prednisolone phosphate|mesh-list
92813892|NCT04302116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92813893|NCT04302116|Glucocorticoids|glucocorticoids|mesh-ancestor
92813894|NCT04302116|Hormones|hormones|mesh-ancestor
92813895|NCT04302116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813896|NCT04302116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813897|NCT04302116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92813898|NCT04302116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813899|NCT04302116|Antiemetics|antiemetics|mesh-ancestor
92813900|NCT04302116|Autonomic Agents|autonomic agents|mesh-ancestor
92813901|NCT04302116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813902|NCT04302116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92813903|NCT04302116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92813904|NCT04302116|Protective Agents|protective agents|mesh-ancestor
92813905|NCT04302116|Anticonvulsants|anticonvulsants|mesh-ancestor
92813906|NCT04302116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813907|NCT04302116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813908|NCT04302116|GABA Agents|gaba agents|mesh-ancestor
92813909|NCT04302116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813910|NCT05756998|Copper|copper|mesh-list
92813911|NCT05756998|Trace Elements|trace elements|mesh-ancestor
92813912|NCT05756998|Micronutrients|micronutrients|mesh-ancestor
92813913|NCT05756998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813914|NCT02890212|Selenium|selenium|mesh-list
92813915|NCT02890212|Antioxidants|antioxidants|mesh-ancestor
92813916|NCT02890212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813917|NCT02890212|Protective Agents|protective agents|mesh-ancestor
92813918|NCT02890212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813919|NCT02890212|Trace Elements|trace elements|mesh-ancestor
92813920|NCT02890212|Micronutrients|micronutrients|mesh-ancestor
92813921|NCT05387577|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92813922|NCT05387577|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92813923|NCT05387577|Estradiol|estradiol|mesh-list
92813924|NCT05387577|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92813925|NCT05387577|Estrogens|estrogens|mesh-ancestor
92813926|NCT05387577|Hormones|hormones|mesh-ancestor
92813927|NCT05387577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813928|NCT05387577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813929|NCT05387577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92813930|NCT05387577|Contraceptive Agents|contraceptive agents|mesh-ancestor
92813931|NCT05387577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92813932|NCT05387577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92813933|NCT03044613|Paclitaxel|paclitaxel|mesh-list
92813934|NCT03044613|Carboplatin|carboplatin|mesh-list
92813935|NCT03044613|Nivolumab|nivolumab|mesh-list
92813936|NCT03044613|Relatlimab|relatlimab|mesh-list
92813937|NCT03044613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92813938|NCT03044613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813939|NCT03044613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92813940|NCT03044613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92813941|NCT03044613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92813942|NCT03044613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813943|NCT03044613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813944|NCT03044613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92813945|NCT01372254|Nicotine|nicotine|mesh-list
92813946|NCT01372254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92813947|NCT01372254|Autonomic Agents|autonomic agents|mesh-ancestor
92813948|NCT01372254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813949|NCT01372254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813950|NCT01372254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92813951|NCT01372254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92813952|NCT01372254|Cholinergic Agents|cholinergic agents|mesh-ancestor
92813953|NCT01372254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92813954|NCT01372254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813955|NCT02785653|Sevoflurane|sevoflurane|mesh-list
92813956|NCT02785653|Rocuronium|rocuronium|mesh-list
92813957|NCT02785653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92813958|NCT02785653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92813959|NCT02785653|Anesthetics, General|anesthetics, general|mesh-ancestor
92813960|NCT02785653|Anesthetics|anesthetics|mesh-ancestor
92813961|NCT02785653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813962|NCT02785653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813963|NCT02785653|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92813964|NCT02785653|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92813965|NCT02785653|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92813966|NCT02785653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92813967|NCT02787447|Gefitinib|gefitinib|mesh-list
92813968|NCT02787447|Thymalfasin|thymalfasin|mesh-list
92813969|NCT02787447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813970|NCT02787447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92813971|NCT02787447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92813972|NCT02787447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92813973|NCT02787447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92813974|NCT02787447|Immunologic Factors|immunologic factors|mesh-ancestor
92813975|NCT02787447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813976|NCT00904722|Rituximab|rituximab|mesh-list
92813977|NCT00904722|Pidilizumab|pidilizumab|mesh-list
92813978|NCT00904722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92813979|NCT00904722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813980|NCT00904722|Immunologic Factors|immunologic factors|mesh-ancestor
92813981|NCT00904722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813982|NCT00904722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92813983|NCT02909361|Fulvestrant|fulvestrant|mesh-list
92813984|NCT02909361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92813985|NCT02909361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92813986|NCT02909361|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92813987|NCT02909361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92813988|NCT02909361|Hormone Antagonists|hormone antagonists|mesh-ancestor
92813989|NCT02909361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92813990|NCT02909361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813991|NCT04301024|Nitrous Oxide|nitrous oxide|mesh-list
92813992|NCT04301024|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92813993|NCT04301024|Anesthetics, General|anesthetics, general|mesh-ancestor
92813994|NCT04301024|Anesthetics|anesthetics|mesh-ancestor
92813995|NCT04301024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92813996|NCT04301024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92813997|NCT04301024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92813998|NCT04301024|Analgesics|analgesics|mesh-ancestor
92813999|NCT04301024|Sensory System Agents|sensory system agents|mesh-ancestor
92814000|NCT04301024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814001|NCT01340430|Trastuzumab|trastuzumab|mesh-list
92814002|NCT01340430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814003|NCT01340430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814004|NCT01029782|Cefazolin|cefazolin|mesh-list
92814005|NCT01029782|Cephalexin|cephalexin|mesh-list
92814006|NCT01029782|Probenecid|probenecid|mesh-list
92814007|NCT01029782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92814008|NCT01029782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814009|NCT01029782|Uricosuric Agents|uricosuric agents|mesh-ancestor
92814010|NCT01029782|Gout Suppressants|gout suppressants|mesh-ancestor
92814011|NCT01029782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814012|NCT04232007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92814013|NCT02901717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92814014|NCT02901717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92814015|NCT02901717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814016|NCT02901717|Antitubercular Agents|antitubercular agents|mesh-ancestor
92814017|NCT02849730|Fentanyl|fentanyl|mesh-list
92814018|NCT02849730|Analgesics|analgesics|mesh-list
92814019|NCT02849730|Ropivacaine|ropivacaine|mesh-list
92814020|NCT02849730|Anesthetics, Local|anesthetics, local|mesh-ancestor
92814021|NCT02849730|Anesthetics|anesthetics|mesh-ancestor
92814022|NCT02849730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814023|NCT02849730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814024|NCT02849730|Sensory System Agents|sensory system agents|mesh-ancestor
92814025|NCT02849730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814026|NCT02849730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92814027|NCT02849730|Narcotics|narcotics|mesh-ancestor
92814028|NCT02849730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92814029|NCT02849730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92814030|NCT02849730|Anesthetics, General|anesthetics, general|mesh-ancestor
92814031|NCT02849340|Immunomodulating Agents|immunomodulating agents|mesh-list
92814032|NCT02849340|Immunologic Factors|immunologic factors|mesh-ancestor
92814033|NCT02849340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814034|NCT03936192|Meloxicam|meloxicam|mesh-list
92814035|NCT03936192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92814036|NCT03936192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814037|NCT03936192|Analgesics|analgesics|mesh-ancestor
92814038|NCT03936192|Sensory System Agents|sensory system agents|mesh-ancestor
92814039|NCT03936192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814040|NCT03936192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814041|NCT03936192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814042|NCT03936192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814043|NCT03936192|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92814044|NCT03936192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92814045|NCT03936192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814046|NCT03936192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814047|NCT00930228|Flutamide|flutamide|mesh-list
92814048|NCT00930228|Androgen Antagonists|androgen antagonists|mesh-ancestor
92814049|NCT00930228|Hormone Antagonists|hormone antagonists|mesh-ancestor
92814050|NCT00930228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814051|NCT00930228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814052|NCT00930228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814053|NCT00930228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814054|NCT05043870|Infliximab|infliximab|mesh-list
92814055|NCT05043870|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92814056|NCT05043870|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92814057|NCT05043870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814058|NCT05043870|Dermatologic Agents|dermatologic agents|mesh-ancestor
92814059|NCT05043870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92814060|NCT05043870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814061|NCT05043870|Immunologic Factors|immunologic factors|mesh-ancestor
92814062|NCT05043870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814063|NCT01029704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92814064|NCT01029704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814065|NCT01029704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92814066|NCT01029704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814067|NCT02786979|Aspirin|aspirin|mesh-list
92814068|NCT02786979|Beraprost|beraprost|mesh-list
92814069|NCT02786979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92814070|NCT02786979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814071|NCT02786979|Analgesics|analgesics|mesh-ancestor
92814072|NCT02786979|Sensory System Agents|sensory system agents|mesh-ancestor
92814073|NCT02786979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814074|NCT02786979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814075|NCT02786979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814076|NCT02786979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814077|NCT02786979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92814078|NCT02786979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92814079|NCT02786979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814080|NCT02786979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92814081|NCT02786979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92814082|NCT02786979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814083|NCT02786979|Antipyretics|antipyretics|mesh-ancestor
92814084|NCT02786979|Vasodilator Agents|vasodilator agents|mesh-ancestor
92814085|NCT02689869|Obinutuzumab|obinutuzumab|mesh-list
92814086|NCT02689869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814087|NCT02689869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814088|NCT02785809|Contraceptive Agents|contraceptive agents|mesh-list
92814089|NCT02785809|Contraceptives, Oral|contraceptives, oral|mesh-list
92814090|NCT02785809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814091|NCT02785809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814092|NCT02785809|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92814093|NCT00221988|Levetiracetam|levetiracetam|mesh-list
92814094|NCT00221988|Anticonvulsants|anticonvulsants|mesh-ancestor
92814095|NCT00221988|Nootropic Agents|nootropic agents|mesh-ancestor
92814096|NCT02341911|Carboplatin|carboplatin|mesh-list
92814097|NCT02341911|Gemcitabine|gemcitabine|mesh-list
92814098|NCT02341911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814099|NCT02341911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814100|NCT02341911|Antimetabolites|antimetabolites|mesh-ancestor
92814101|NCT02341911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814102|NCT02847000|Decitabine|decitabine|mesh-list
92814103|NCT02847000|Tetrahydrouridine|tetrahydrouridine|mesh-list
92814104|NCT02847000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814105|NCT02847000|Antimetabolites|antimetabolites|mesh-ancestor
92814106|NCT02847000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814107|NCT02847000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814108|NCT02847000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814109|NCT02784327|Ropivacaine|ropivacaine|mesh-list
92814110|NCT02784327|Anesthetics, Local|anesthetics, local|mesh-ancestor
92814111|NCT02784327|Anesthetics|anesthetics|mesh-ancestor
92814112|NCT02784327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814113|NCT02784327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814114|NCT02784327|Sensory System Agents|sensory system agents|mesh-ancestor
92814115|NCT02784327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814116|NCT02845050|Cisplatin|cisplatin|mesh-list
92814117|NCT02845050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814118|NCT02690922|Dexamethasone|dexamethasone|mesh-list
92814119|NCT02690922|Prednisone|prednisone|mesh-list
92814120|NCT02690922|Methotrexate|methotrexate|mesh-list
92814121|NCT02690922|Dasatinib|dasatinib|mesh-list
92814122|NCT02690922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814123|NCT02690922|Antiemetics|antiemetics|mesh-ancestor
92814124|NCT02690922|Autonomic Agents|autonomic agents|mesh-ancestor
92814125|NCT02690922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814126|NCT02690922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814127|NCT02690922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92814128|NCT02690922|Glucocorticoids|glucocorticoids|mesh-ancestor
92814129|NCT02690922|Hormones|hormones|mesh-ancestor
92814130|NCT02690922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814131|NCT02690922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814133|NCT02690922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92814134|NCT02690922|Abortifacient Agents|abortifacient agents|mesh-ancestor
92814135|NCT02690922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814136|NCT02690922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814137|NCT02690922|Antimetabolites|antimetabolites|mesh-ancestor
92814138|NCT02690922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814139|NCT02690922|Dermatologic Agents|dermatologic agents|mesh-ancestor
92814140|NCT02690922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814141|NCT02690922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92814142|NCT02690922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814143|NCT02690922|Immunologic Factors|immunologic factors|mesh-ancestor
92814144|NCT02690922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814145|NCT02690922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92814146|NCT02690922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814147|NCT02848950|Metformin|metformin|mesh-list
92814148|NCT02848950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92814149|NCT02848950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814150|NCT04202406|Acetaminophen|acetaminophen|mesh-list
92814151|NCT04202406|Codeine|codeine|mesh-list
92814152|NCT04202406|Caffeine|caffeine|mesh-list
92814153|NCT04202406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814154|NCT04202406|Analgesics|analgesics|mesh-ancestor
92814155|NCT04202406|Sensory System Agents|sensory system agents|mesh-ancestor
92814156|NCT04202406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814157|NCT04202406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814158|NCT04202406|Antipyretics|antipyretics|mesh-ancestor
92814159|NCT04202406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92814160|NCT04202406|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92814161|NCT04202406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814162|NCT04202406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814163|NCT04202406|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92814164|NCT04202406|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92814165|NCT04202406|Purinergic Agents|purinergic agents|mesh-ancestor
92814166|NCT04202406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814167|NCT04202406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92814168|NCT04202406|Narcotics|narcotics|mesh-ancestor
92814169|NCT04202406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814170|NCT04202406|Antitussive Agents|antitussive agents|mesh-ancestor
92814171|NCT04202406|Respiratory System Agents|respiratory system agents|mesh-ancestor
92814172|NCT02846766|Lenvatinib|lenvatinib|mesh-list
92814173|NCT02846766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814174|NCT02846766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814175|NCT02846766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814176|NCT02846766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814177|NCT00839956|Bortezomib|bortezomib|mesh-list
92814178|NCT00839956|Vorinostat|vorinostat|mesh-list
92814179|NCT00839956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814180|NCT00839956|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92814181|NCT00839956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814182|NCT00839956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814183|NCT00839800|Terbutaline|terbutaline|mesh-list
92814184|NCT00839800|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92814185|NCT00839800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92814186|NCT00839800|Respiratory System Agents|respiratory system agents|mesh-ancestor
92814187|NCT00839800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92814188|NCT00839800|Autonomic Agents|autonomic agents|mesh-ancestor
92814189|NCT00839800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814190|NCT00839800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814191|NCT00839800|Sympathomimetics|sympathomimetics|mesh-ancestor
92814192|NCT00839800|Tocolytic Agents|tocolytic agents|mesh-ancestor
92814193|NCT00839800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814194|NCT00839800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92814195|NCT00839800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92814196|NCT00839800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92814197|NCT00839800|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814198|NCT00839800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814199|NCT00839800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814200|NCT00867321|Bevacizumab|bevacizumab|mesh-list
92814201|NCT00867321|Sorafenib|sorafenib|mesh-list
92814202|NCT00867321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814203|NCT00867321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814204|NCT00867321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92158857|NCT04903119|Trametinib|trametinib|mesh-list
92814205|NCT00867321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92814206|NCT00867321|Growth Substances|growth substances|mesh-ancestor
92814207|NCT00867321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814208|NCT00867321|Growth Inhibitors|growth inhibitors|mesh-ancestor
92814209|NCT00867321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814210|NCT00867321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814211|NCT00867321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814213|NCT00913666|Interferon-beta|interferon-beta|mesh-list
92814214|NCT00913666|Interferon beta-1a|interferon beta-1a|mesh-list
92814215|NCT00913666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814216|NCT00913666|Antiviral Agents|antiviral agents|mesh-ancestor
92814217|NCT00913666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814218|NCT00913666|Immunologic Factors|immunologic factors|mesh-ancestor
92814219|NCT00913666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814220|NCT00913666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92814221|NCT05756764|Liraglutide|liraglutide|mesh-list
92814222|NCT05756764|Topiramate|topiramate|mesh-list
92814223|NCT05756764|Phentermine|phentermine|mesh-list
92814224|NCT05756764|Glucagon|glucagon|mesh-list
92814225|NCT05756764|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92814226|NCT05756764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92814227|NCT05756764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814228|NCT05756764|Incretins|incretins|mesh-ancestor
92814229|NCT05756764|Hormones|hormones|mesh-ancestor
92814230|NCT05756764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814231|NCT05756764|Anticonvulsants|anticonvulsants|mesh-ancestor
92814232|NCT05756764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92814233|NCT05756764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92814234|NCT05756764|Appetite Depressants|appetite depressants|mesh-ancestor
92814235|NCT05756764|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92814236|NCT05756764|Sympathomimetics|sympathomimetics|mesh-ancestor
92814237|NCT05756764|Autonomic Agents|autonomic agents|mesh-ancestor
92814238|NCT05756764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814239|NCT05756764|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814240|NCT05756764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814241|NCT05756764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814242|NCT05190471|Decitabine|decitabine|mesh-list
92814243|NCT05190471|Oblimersen|oblimersen|mesh-list
92814244|NCT05190471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814245|NCT05190471|Antimetabolites|antimetabolites|mesh-ancestor
92814246|NCT05190471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814247|NCT05190471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814248|NCT05190471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814249|NCT05308095|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92814250|NCT05308095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814251|NCT02601157|Aspirin|aspirin|mesh-list
92814252|NCT02601157|Clopidogrel|clopidogrel|mesh-list
92814253|NCT02601157|Ticagrelor|ticagrelor|mesh-list
92814254|NCT02601157|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92814255|NCT02601157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92814256|NCT02601157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814257|NCT02601157|Analgesics|analgesics|mesh-ancestor
92814258|NCT02601157|Sensory System Agents|sensory system agents|mesh-ancestor
92814259|NCT02601157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814260|NCT02601157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814261|NCT02601157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814262|NCT02601157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814263|NCT02601157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92814264|NCT02601157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92814265|NCT02601157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814266|NCT02601157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92814267|NCT02601157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92814268|NCT02601157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814269|NCT02601157|Antipyretics|antipyretics|mesh-ancestor
92814270|NCT02601157|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92814271|NCT02601157|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92427627|NCT01544959|Fentanyl|fentanyl|mesh-list
92814272|NCT02601157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92814274|NCT02601157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814275|NCT02784717|Rivaroxaban|rivaroxaban|mesh-list
92814276|NCT02784717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92814277|NCT02784717|Antithrombins|antithrombins|mesh-ancestor
92814278|NCT02784717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92814279|NCT02784717|Protease Inhibitors|protease inhibitors|mesh-ancestor
92814280|NCT02784717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158915|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
92814281|NCT02784717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814282|NCT02784717|Anticoagulants|anticoagulants|mesh-ancestor
92814284|NCT00902304|Valsartan|valsartan|mesh-list
92814285|NCT00902304|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92814286|NCT00902304|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92814287|NCT00902304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92814288|NCT00902304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92814289|NCT00902304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92814290|NCT00902304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814291|NCT00902304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92814292|NCT00902304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814293|NCT00902304|Vasodilator Agents|vasodilator agents|mesh-ancestor
92814294|NCT00902304|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92814295|NCT00902304|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92814296|NCT00902304|Diuretics|diuretics|mesh-ancestor
92814297|NCT00902304|Natriuretic Agents|natriuretic agents|mesh-ancestor
92814298|NCT00902304|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92814299|NCT02784795|Carboplatin|carboplatin|mesh-list
92814300|NCT02784795|Gemcitabine|gemcitabine|mesh-list
92814301|NCT02784795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814302|NCT02784795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814303|NCT02784795|Antimetabolites|antimetabolites|mesh-ancestor
92814304|NCT02784795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814305|NCT05282277|Raclopride|raclopride|mesh-list
92814306|NCT05282277|Estradiol|estradiol|mesh-list
92814307|NCT05282277|Progesterone|progesterone|mesh-list
92814308|NCT05282277|Estrogens|estrogens|mesh-ancestor
92814309|NCT05282277|Hormones|hormones|mesh-ancestor
92814310|NCT05282277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814311|NCT05282277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814312|NCT05282277|Progestins|progestins|mesh-ancestor
92814313|NCT05282277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92814314|NCT05282277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92814315|NCT05282277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814316|NCT05282277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92814317|NCT05282277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92814318|NCT05282277|Dopamine Agents|dopamine agents|mesh-ancestor
92814319|NCT05282277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814320|NCT05282277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814321|NCT00759109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92814322|NCT00759109|Antiviral Agents|antiviral agents|mesh-ancestor
92814323|NCT00759109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814324|NCT02848794|Irinotecan|irinotecan|mesh-list
92814325|NCT02848794|Apatinib|apatinib|mesh-list
92814326|NCT02848794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92814327|NCT02848794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92814328|NCT02848794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814329|NCT02848794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814330|NCT02848794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814331|NCT02848794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814332|NCT04096027|Cabergoline|cabergoline|mesh-list
92814333|NCT04096027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92814334|NCT04096027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92814335|NCT04096027|Dopamine Agonists|dopamine agonists|mesh-ancestor
92814336|NCT04096027|Dopamine Agents|dopamine agents|mesh-ancestor
92814337|NCT04096027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814338|NCT04096027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814339|NCT04096027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814340|NCT04216134|Edetic Acid|edetic acid|mesh-list
92814341|NCT04216134|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92814342|NCT04216134|Chelating Agents|chelating agents|mesh-ancestor
92814343|NCT04216134|Sequestering Agents|sequestering agents|mesh-ancestor
92814344|NCT04216134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814345|NCT04216134|Anticoagulants|anticoagulants|mesh-ancestor
92814346|NCT04216134|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92814347|NCT04216134|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92814348|NCT00638079|Megestrol|megestrol|mesh-list
92814349|NCT00638079|Megestrol Acetate|megestrol acetate|mesh-list
92814350|NCT00638079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92814351|NCT00638079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92814352|NCT00638079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92814353|NCT00638079|Contraceptive Agents|contraceptive agents|mesh-ancestor
92814354|NCT00638079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814355|NCT00638079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814356|NCT00638079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92814357|NCT00638079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92814358|NCT00638079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814359|NCT00638079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814360|NCT00638079|Appetite Stimulants|appetite stimulants|mesh-ancestor
92814361|NCT00638079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92814362|NCT00759031|Listerine|listerine|mesh-list
92814363|NCT00759031|Triclosan|triclosan|mesh-list
92814364|NCT00759031|Fluorides|fluorides|mesh-list
92814365|NCT00759031|Sodium Fluoride|sodium fluoride|mesh-list
92814366|NCT00759031|Fluorophosphate|fluorophosphate|mesh-list
92814367|NCT00759031|Cariostatic Agents|cariostatic agents|mesh-ancestor
92814368|NCT00759031|Protective Agents|protective agents|mesh-ancestor
92814369|NCT00759031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814370|NCT00759031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92814371|NCT00759031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814372|NCT00759031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92814373|NCT00759031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92814374|NCT00759031|Antimetabolites|antimetabolites|mesh-ancestor
92814375|NCT00759031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814376|NCT00759031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92814377|NCT04197219|Pembrolizumab|pembrolizumab|mesh-list
92814378|NCT04197219|Axitinib|axitinib|mesh-list
92814379|NCT04197219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814380|NCT04197219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814381|NCT04197219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92814382|NCT04197219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814383|NCT04197219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814384|NCT04197219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814385|NCT04834908|Immune Sera|immune sera|mesh-list
92814386|NCT04834908|Immunologic Factors|immunologic factors|mesh-ancestor
92814387|NCT04834908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814388|NCT02512497|Fludarabine|fludarabine|mesh-list
92814389|NCT02512497|Fludarabine phosphate|fludarabine phosphate|mesh-list
92814390|NCT02512497|Busulfan|busulfan|mesh-list
92814391|NCT02512497|Romidepsin|romidepsin|mesh-list
92814392|NCT02512497|Thymoglobulin|thymoglobulin|mesh-list
92814393|NCT02512497|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92814394|NCT02512497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814395|NCT02512497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814396|NCT02512497|Antimetabolites|antimetabolites|mesh-ancestor
92814397|NCT02512497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814398|NCT02512497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814399|NCT02512497|Immunologic Factors|immunologic factors|mesh-ancestor
92814400|NCT02512497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814401|NCT02512497|Alkylating Agents|alkylating agents|mesh-ancestor
92814402|NCT02512497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92814403|NCT02512497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92814404|NCT02512497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92814405|NCT02512497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92814406|NCT02512497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814407|NCT00916669|Etoposide|etoposide|mesh-list
92814408|NCT00916669|Enoxaparin|enoxaparin|mesh-list
92814409|NCT00916669|Enoxaparin sodium|enoxaparin sodium|mesh-list
92814410|NCT00916669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814411|NCT00916669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92814412|NCT00916669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92814413|NCT00916669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92814414|NCT00916669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814415|NCT00916669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814416|NCT00916669|Anticoagulants|anticoagulants|mesh-ancestor
92814417|NCT00916669|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92814418|NCT00916669|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92814419|NCT02784015|Cyclophosphamide|cyclophosphamide|mesh-list
92814420|NCT02784015|Melphalan|melphalan|mesh-list
92814421|NCT02784015|Ifosfamide|ifosfamide|mesh-list
92814422|NCT02784015|Thiotepa|thiotepa|mesh-list
92814423|NCT02784015|Carboplatin|carboplatin|mesh-list
92814424|NCT02784015|Doxorubicin|doxorubicin|mesh-list
92814425|NCT02784015|Etoposide|etoposide|mesh-list
92814426|NCT02784015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814427|NCT02784015|Immunologic Factors|immunologic factors|mesh-ancestor
92814428|NCT02784015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814429|NCT02784015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814430|NCT02784015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92814431|NCT02784015|Alkylating Agents|alkylating agents|mesh-ancestor
92814432|NCT02784015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814433|NCT02784015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814434|NCT02784015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92814435|NCT02784015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92814436|NCT02784015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92814437|NCT02784015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92814438|NCT02784015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814439|NCT02784015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92814440|NCT02601235|Pyrilamine|pyrilamine|mesh-list
92814441|NCT02601235|Phenylephrine|phenylephrine|mesh-list
92814442|NCT02601235|Oxymetazoline|oxymetazoline|mesh-list
92814443|NCT02601235|Naphazoline|naphazoline|mesh-list
92814444|NCT02601235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814445|NCT02601235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92814446|NCT02601235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92814447|NCT02601235|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814448|NCT02601235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814449|NCT02601235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814450|NCT02601235|Sympathomimetics|sympathomimetics|mesh-ancestor
92814451|NCT02601235|Autonomic Agents|autonomic agents|mesh-ancestor
92814452|NCT02601235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814453|NCT02601235|Nasal Decongestants|nasal decongestants|mesh-ancestor
92814454|NCT02601235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92814455|NCT02601235|Respiratory System Agents|respiratory system agents|mesh-ancestor
92814456|NCT02601235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92814457|NCT02601235|Mydriatics|mydriatics|mesh-ancestor
92814458|NCT02601235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92814459|NCT02601235|Protective Agents|protective agents|mesh-ancestor
92814460|NCT02601235|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92814461|NCT02601235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92814462|NCT02601235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814463|NCT02601235|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92814464|NCT02601235|Histamine Antagonists|histamine antagonists|mesh-ancestor
92814465|NCT02601235|Histamine Agents|histamine agents|mesh-ancestor
92814466|NCT02601235|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92814467|NCT02783937|Lenograstim|lenograstim|mesh-list
92814468|NCT02783937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92814469|NCT02783937|Immunologic Factors|immunologic factors|mesh-ancestor
92814470|NCT02783937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814471|NCT02846142|Levonorgestrel|levonorgestrel|mesh-list
92814472|NCT02846142|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92814473|NCT02846142|Estradiol|estradiol|mesh-list
92814474|NCT02846142|Estrogens|estrogens|mesh-ancestor
92814475|NCT02846142|Hormones|hormones|mesh-ancestor
92427839|NCT01546896|Serotonin Agents|serotonin agents|mesh-ancestor
92814476|NCT02846142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814477|NCT02846142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814478|NCT02846142|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92814479|NCT02846142|Contraceptive Agents|contraceptive agents|mesh-ancestor
92814480|NCT02846142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814481|NCT02846142|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92814482|NCT02846142|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92814483|NCT02846142|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92814484|NCT02846142|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92814485|NCT00757783|Ritonavir|ritonavir|mesh-list
92814486|NCT00757783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92814487|NCT00757783|Darunavir|darunavir|mesh-list
92814488|NCT00757783|Tenofovir|tenofovir|mesh-list
92814489|NCT00757783|Emtricitabine|emtricitabine|mesh-list
92814490|NCT00757783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92814491|NCT00757783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92814492|NCT00757783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92814493|NCT00757783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814494|NCT00757783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814495|NCT00757783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92814496|NCT00757783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92814497|NCT00757783|Antiviral Agents|antiviral agents|mesh-ancestor
92814498|NCT00757783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459508|NCT01739634|Antidiarrheals|antidiarrheals|mesh-list
92814499|NCT00757783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92814500|NCT00757783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92814501|NCT00757783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92814502|NCT00757783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92814504|NCT05242926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814505|NCT05242926|Tubulin Modulators|tubulin modulators|mesh-ancestor
92814506|NCT05242926|Antimitotic Agents|antimitotic agents|mesh-ancestor
92814507|NCT05242926|Mitosis Modulators|mitosis modulators|mesh-ancestor
92814508|NCT05242926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814509|NCT02782221|Hormones|hormones|mesh-list
92814510|NCT02782221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814511|NCT02782221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814512|NCT04231617|Glyburide|glyburide|mesh-list
92814513|NCT04231617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92814514|NCT04231617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814515|NCT00757705|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92814516|NCT00757705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92814517|NCT00757705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92814518|NCT00757705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814519|NCT00757705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814520|NCT00757705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92814521|NCT00757705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92814522|NCT00757705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92814523|NCT00757705|Serotonin Agents|serotonin agents|mesh-ancestor
92814524|NCT00757705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814525|NCT00757705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814526|NCT00757705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92814527|NCT00757705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92814528|NCT00757705|Dopamine Agents|dopamine agents|mesh-ancestor
92814529|NCT02845908|Leucovorin|leucovorin|mesh-list
92814530|NCT02845908|Fluorouracil|fluorouracil|mesh-list
92814531|NCT02845908|Oxaliplatin|oxaliplatin|mesh-list
92814532|NCT02845908|Antimetabolites|antimetabolites|mesh-ancestor
92814533|NCT02845908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814534|NCT02845908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814535|NCT02845908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814536|NCT02845908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814537|NCT02845908|Immunologic Factors|immunologic factors|mesh-ancestor
92814538|NCT02845908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814539|NCT02845908|Antidotes|antidotes|mesh-ancestor
92814540|NCT02845908|Protective Agents|protective agents|mesh-ancestor
92814541|NCT02845908|Vitamin B Complex|vitamin b complex|mesh-ancestor
92814542|NCT02845908|Vitamins|vitamins|mesh-ancestor
92814543|NCT02845908|Micronutrients|micronutrients|mesh-ancestor
92814544|NCT02784483|Atezolizumab|atezolizumab|mesh-list
92814545|NCT02784483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92814546|NCT02784483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814547|NCT02784483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814548|NCT02784483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814549|NCT02784561|Cytarabine|cytarabine|mesh-list
92814550|NCT02784561|Fludarabine|fludarabine|mesh-list
92814551|NCT02784561|Fludarabine phosphate|fludarabine phosphate|mesh-list
92814552|NCT02784561|Busulfan|busulfan|mesh-list
92814553|NCT02784561|Thymoglobulin|thymoglobulin|mesh-list
92814554|NCT02784561|Lenograstim|lenograstim|mesh-list
92814555|NCT02784561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814556|NCT02784561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814557|NCT02784561|Antimetabolites|antimetabolites|mesh-ancestor
92814558|NCT02784561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814559|NCT02784561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814560|NCT02784561|Immunologic Factors|immunologic factors|mesh-ancestor
92814561|NCT02784561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814562|NCT02784561|Antiviral Agents|antiviral agents|mesh-ancestor
92814563|NCT02784561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814564|NCT02784561|Alkylating Agents|alkylating agents|mesh-ancestor
92814565|NCT02784561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92814566|NCT02784561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92814567|NCT02784561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92814568|NCT00757627|Etoricoxib|etoricoxib|mesh-list
92814569|NCT00757627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92814570|NCT00757627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814571|NCT00757627|Analgesics|analgesics|mesh-ancestor
92814572|NCT00757627|Sensory System Agents|sensory system agents|mesh-ancestor
92459585|NCT01740245|Disinfectants|disinfectants|mesh-ancestor
92814573|NCT00757627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814574|NCT00757627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814575|NCT00757627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814576|NCT00757627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814577|NCT00757627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92814578|NCT00757627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92814579|NCT00757627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814580|NCT00757627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814581|NCT02600455|Abatacept|abatacept|mesh-list
92814582|NCT02600455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92814583|NCT02600455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814584|NCT02600455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814585|NCT02600455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814586|NCT02600455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814587|NCT02600455|Immunologic Factors|immunologic factors|mesh-ancestor
92814588|NCT02600455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814589|NCT02600455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814590|NCT01023308|Dexamethasone|dexamethasone|mesh-list
92814591|NCT01023308|Bortezomib|bortezomib|mesh-list
92814592|NCT01023308|Panobinostat|panobinostat|mesh-list
92814593|NCT01023308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814594|NCT01023308|Antiemetics|antiemetics|mesh-ancestor
92814595|NCT01023308|Autonomic Agents|autonomic agents|mesh-ancestor
92814596|NCT01023308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814597|NCT01023308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814598|NCT01023308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92814599|NCT01023308|Glucocorticoids|glucocorticoids|mesh-ancestor
92814600|NCT01023308|Hormones|hormones|mesh-ancestor
92814601|NCT01023308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814602|NCT01023308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814603|NCT01023308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814604|NCT01023308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92814605|NCT01023308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814606|NCT01023308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814607|NCT02781909|Ibuprofen|ibuprofen|mesh-list
92814608|NCT02781909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92814609|NCT02781909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814610|NCT02781909|Analgesics|analgesics|mesh-ancestor
92814611|NCT02781909|Sensory System Agents|sensory system agents|mesh-ancestor
92814612|NCT02781909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814613|NCT02781909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814614|NCT02781909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814615|NCT02781909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814616|NCT02781909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92814617|NCT02781909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814618|NCT02781909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814619|NCT01022996|Everolimus|everolimus|mesh-list
92814620|NCT01022996|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92814621|NCT01022996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814622|NCT01022996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814623|NCT01022996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814624|NCT01022996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814625|NCT01022996|Immunologic Factors|immunologic factors|mesh-ancestor
92814626|NCT01022996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814627|NCT01022996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814628|NCT02781597|Tranexamic Acid|tranexamic acid|mesh-list
92814629|NCT02781597|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92814630|NCT02781597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92814631|NCT02781597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814632|NCT02781597|Hemostatics|hemostatics|mesh-ancestor
92814633|NCT02781597|Coagulants|coagulants|mesh-ancestor
92814634|NCT00757237|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92814635|NCT00757237|Tobramycin|tobramycin|mesh-list
92814636|NCT00757237|Aztreonam|aztreonam|mesh-list
92814637|NCT00757237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92814638|NCT00757237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92814639|NCT00757237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814640|NCT00757237|Antitubercular Agents|antitubercular agents|mesh-ancestor
92814641|NCT01029392|Vitamin D|vitamin d|mesh-list
92814642|NCT01029392|Cholecalciferol|cholecalciferol|mesh-list
92814643|NCT01029392|Vitamins|vitamins|mesh-ancestor
92814644|NCT01029392|Micronutrients|micronutrients|mesh-ancestor
92814645|NCT01029392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814646|NCT01029392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92459661|NCT01741038|Cetuximab|cetuximab|mesh-list
92814647|NCT01029392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92814648|NCT02781753|Interferons|interferons|mesh-list
92814649|NCT02781753|Interferon-alpha|interferon-alpha|mesh-list
92814650|NCT02781753|Interferon alpha-2|interferon alpha-2|mesh-list
92814651|NCT02781753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814652|NCT02781753|Antiviral Agents|antiviral agents|mesh-ancestor
92814653|NCT02781753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814654|NCT02781753|Immunologic Factors|immunologic factors|mesh-ancestor
92814655|NCT02781753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814657|NCT00903006|Fulvestrant|fulvestrant|mesh-list
92814658|NCT00903006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814659|NCT00903006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814660|NCT00903006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814661|NCT00903006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814662|NCT00903006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814663|NCT00903006|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92814664|NCT00903006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92814665|NCT00903006|Hormone Antagonists|hormone antagonists|mesh-ancestor
92814666|NCT00903006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814667|NCT00903006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814668|NCT04097899|Anti-Infective Agents|anti-infective agents|mesh-list
92814669|NCT04097899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92814670|NCT02845986|Oxaliplatin|oxaliplatin|mesh-list
92814671|NCT02845986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814672|NCT00839332|Gemcitabine|gemcitabine|mesh-list
92814673|NCT00839332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814674|NCT00839332|Antimetabolites|antimetabolites|mesh-ancestor
92814675|NCT00839332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814676|NCT00839332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814677|NCT04095169|Complement System Proteins|complement system proteins|mesh-list
92814678|NCT04095169|Complement C3|complement c3|mesh-list
92814679|NCT04095169|Complement C3d|complement c3d|mesh-list
92814680|NCT04095169|Immunologic Factors|immunologic factors|mesh-ancestor
92814681|NCT04095169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814682|NCT05241912|Dobutamine|dobutamine|mesh-list
92814683|NCT05241912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92814684|NCT05241912|Sympathomimetics|sympathomimetics|mesh-ancestor
92814685|NCT05241912|Autonomic Agents|autonomic agents|mesh-ancestor
92814686|NCT05241912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814687|NCT05241912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814688|NCT05241912|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92814689|NCT05241912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92814690|NCT05241912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92814691|NCT05241912|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814692|NCT05241912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814693|NCT05241912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814694|NCT05241912|Protective Agents|protective agents|mesh-ancestor
92814695|NCT05217654|Dapagliflozin|dapagliflozin|mesh-list
92814696|NCT05217654|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92814697|NCT05217654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814698|NCT05217654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92814699|NCT05217654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814700|NCT04229355|Sorafenib|sorafenib|mesh-list
92814701|NCT04229355|Lenvatinib|lenvatinib|mesh-list
92814702|NCT04229355|Chlorotrianisene|chlorotrianisene|mesh-list
92814703|NCT04229355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92814704|NCT04229355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814705|NCT04229355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814706|NCT04229355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814707|NCT04229355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814708|NCT04229355|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92814709|NCT04229355|Estrogens|estrogens|mesh-ancestor
92814710|NCT04229355|Hormones|hormones|mesh-ancestor
92814711|NCT04229355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814712|NCT04229355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814713|NCT04229355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814714|NCT04229355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814715|NCT02848170|Olmesartan|olmesartan|mesh-list
92814716|NCT02848170|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92814717|NCT02848170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92814718|NCT02848170|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92814719|NCT02848170|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92814720|NCT02848170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814721|NCT04420884|Pembrolizumab|pembrolizumab|mesh-list
92814722|NCT04420884|Fluorouracil|fluorouracil|mesh-list
92814723|NCT04420884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814724|NCT04420884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814725|NCT04420884|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92814726|NCT04420884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814727|NCT04420884|Antimetabolites|antimetabolites|mesh-ancestor
92814728|NCT04420884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814729|NCT04420884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814730|NCT04420884|Immunologic Factors|immunologic factors|mesh-ancestor
92814731|NCT04420884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814732|NCT05341401|Prednisolone|prednisolone|mesh-list
92814733|NCT05341401|Budesonide|budesonide|mesh-list
92814734|NCT05341401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814735|NCT05341401|Glucocorticoids|glucocorticoids|mesh-ancestor
92814736|NCT05341401|Hormones|hormones|mesh-ancestor
92814737|NCT05341401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814738|NCT05341401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814739|NCT05341401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92814740|NCT05341401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814741|NCT05341401|Autonomic Agents|autonomic agents|mesh-ancestor
92814742|NCT05341401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814743|NCT05341401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92814744|NCT05341401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92814745|NCT05341401|Respiratory System Agents|respiratory system agents|mesh-ancestor
92814746|NCT05340153|Lumefantrine|lumefantrine|mesh-list
92814747|NCT05340153|Artemether|artemether|mesh-list
92814748|NCT05340153|Piperaquine|piperaquine|mesh-list
92814749|NCT05340153|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92814750|NCT05340153|Artenimol|artenimol|mesh-list
92814751|NCT05340153|Antimalarials|antimalarials|mesh-ancestor
92814752|NCT05340153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92814753|NCT05340153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92814754|NCT05340153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814755|NCT05078502|Vitamin D|vitamin d|mesh-list
92814756|NCT05078502|Cholecalciferol|cholecalciferol|mesh-list
92814757|NCT05078502|Vitamins|vitamins|mesh-ancestor
92814758|NCT05078502|Micronutrients|micronutrients|mesh-ancestor
92814759|NCT05078502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814760|NCT05078502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92814761|NCT05078502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92814762|NCT02844894|Dexmedetomidine|dexmedetomidine|mesh-list
92814763|NCT02844894|Esmolol|esmolol|mesh-list
92814764|NCT02844894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92814765|NCT02844894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814766|NCT02844894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814767|NCT02844894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814768|NCT02844894|Analgesics|analgesics|mesh-ancestor
92814769|NCT02844894|Sensory System Agents|sensory system agents|mesh-ancestor
92814770|NCT02844894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814771|NCT02844894|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92814772|NCT02844894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92814773|NCT02844894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92814774|NCT02844894|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814775|NCT02844894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814776|NCT02844894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814777|NCT02844894|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92814778|NCT02844894|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92814779|NCT02844894|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92814780|NCT04778904|Nivolumab|nivolumab|mesh-list
92814781|NCT04778904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814782|NCT04778904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814783|NCT04778904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92814784|NCT04778904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814785|NCT00634725|Gemcitabine|gemcitabine|mesh-list
92814786|NCT00634725|Capecitabine|capecitabine|mesh-list
92814787|NCT00634725|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92814788|NCT00634725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814789|NCT00634725|Antimetabolites|antimetabolites|mesh-ancestor
92814790|NCT00634725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814791|NCT00634725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814792|NCT00634725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92814793|NCT00634725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814794|NCT05325489|Budesonide|budesonide|mesh-list
92814795|NCT05325489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814796|NCT05325489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92814797|NCT05325489|Autonomic Agents|autonomic agents|mesh-ancestor
92814798|NCT05325489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814799|NCT05325489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814800|NCT05325489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92159445|NCT03362047|Macitentan|macitentan|mesh-list
92814801|NCT05325489|Respiratory System Agents|respiratory system agents|mesh-ancestor
92814802|NCT05325489|Glucocorticoids|glucocorticoids|mesh-ancestor
92814804|NCT05325489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814805|NCT00902538|Amlodipine|amlodipine|mesh-list
92814806|NCT00902538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92814807|NCT00902538|Olmesartan|olmesartan|mesh-list
92814808|NCT00902538|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92814809|NCT00902538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92814810|NCT00902538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92814811|NCT00902538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92814812|NCT00902538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814813|NCT00902538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92814814|NCT00902538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814815|NCT00902538|Vasodilator Agents|vasodilator agents|mesh-ancestor
92814816|NCT00902538|Diuretics|diuretics|mesh-ancestor
92814817|NCT00902538|Natriuretic Agents|natriuretic agents|mesh-ancestor
92814818|NCT00902538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92814819|NCT00902538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92814820|NCT00902538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92814821|NCT02780505|Ascorbic Acid|ascorbic acid|mesh-list
92814822|NCT02780505|Vitamins|vitamins|mesh-ancestor
92814823|NCT02780505|Micronutrients|micronutrients|mesh-ancestor
92814824|NCT02780505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814825|NCT02780505|Antioxidants|antioxidants|mesh-ancestor
92814826|NCT02780505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814827|NCT02780505|Protective Agents|protective agents|mesh-ancestor
92814828|NCT02690844|Clonazepam|clonazepam|mesh-list
92814829|NCT02690844|Anticonvulsants|anticonvulsants|mesh-ancestor
92814830|NCT02690844|GABA Modulators|gaba modulators|mesh-ancestor
92814831|NCT02690844|GABA Agents|gaba agents|mesh-ancestor
92814832|NCT02690844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814833|NCT02690844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814834|NCT02690844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814835|NCT04201860|Hemostatics|hemostatics|mesh-list
92814836|NCT04201860|Coagulants|coagulants|mesh-ancestor
92814837|NCT02847702|Naproxen|naproxen|mesh-list
92814838|NCT02847702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92814839|NCT02847702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814840|NCT02847702|Analgesics|analgesics|mesh-ancestor
92814841|NCT02847702|Sensory System Agents|sensory system agents|mesh-ancestor
92814842|NCT02847702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814843|NCT02847702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814844|NCT02847702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92814845|NCT02847702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92814846|NCT02847702|Gout Suppressants|gout suppressants|mesh-ancestor
92814847|NCT02847702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92814848|NCT02847702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814849|NCT02847702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814850|NCT02779413|Insulin|insulin|mesh-list
92814851|NCT02779413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92814852|NCT02779413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814853|NCT04887402|Clomiphene|clomiphene|mesh-list
92814854|NCT04887402|Enclomiphene|enclomiphene|mesh-list
92814855|NCT04887402|Zuclomiphene|zuclomiphene|mesh-list
92814856|NCT04887402|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92814857|NCT04887402|Hormone Antagonists|hormone antagonists|mesh-ancestor
92814858|NCT04887402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92814859|NCT04887402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814860|NCT04887402|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92814861|NCT04887402|Fertility Agents|fertility agents|mesh-ancestor
92814862|NCT04887402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814863|NCT04887402|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92814864|NCT04887402|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92814865|NCT04793568|Interferons|interferons|mesh-list
92814866|NCT04793568|Interferon-gamma|interferon-gamma|mesh-list
92814867|NCT04793568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814868|NCT04793568|Antiviral Agents|antiviral agents|mesh-ancestor
92814869|NCT04793568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814870|NCT01979211|Cetuximab|cetuximab|mesh-list
92814871|NCT01979211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92814872|NCT01979211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814873|NCT05339217|Aldesleukin|aldesleukin|mesh-list
92814874|NCT05339217|Interleukin-2|interleukin-2|mesh-list
92814875|NCT05339217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159515|NCT03070054|Epinephrine|epinephrine|mesh-list
92814876|NCT05339217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814877|NCT05339217|Analgesics|analgesics|mesh-ancestor
92814878|NCT05339217|Sensory System Agents|sensory system agents|mesh-ancestor
92814879|NCT05339217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814880|NCT05339217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814881|NCT05339217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92814882|NCT05339217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92814883|NCT05339217|Antiviral Agents|antiviral agents|mesh-ancestor
92814884|NCT05339217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814885|NCT04793490|Acetaminophen|acetaminophen|mesh-list
92814886|NCT04793490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814887|NCT04793490|Analgesics|analgesics|mesh-ancestor
92814888|NCT04793490|Sensory System Agents|sensory system agents|mesh-ancestor
92814889|NCT04793490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814890|NCT04793490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814891|NCT04793490|Antipyretics|antipyretics|mesh-ancestor
92814892|NCT00779532|Moxifloxacin|moxifloxacin|mesh-list
92814893|NCT00779532|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92814894|NCT00779532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92814895|NCT00779532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92814896|NCT00779532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92814897|NCT00779532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92814898|NCT00779532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814899|NCT00779532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814900|NCT00779532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814901|NCT00779532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92814902|NCT00779532|Contraceptive Agents|contraceptive agents|mesh-ancestor
92814903|NCT00779532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92814904|NCT00779532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814905|NCT00779532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92814906|NCT00779532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92814907|NCT00779532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92814908|NCT05319093|Ozanimod|ozanimod|mesh-list
92814909|NCT05319093|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92814910|NCT05319093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814911|NCT05319093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92814912|NCT05319093|Immunologic Factors|immunologic factors|mesh-ancestor
92814913|NCT05319093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814914|NCT00752557|Calcium, Dietary|calcium, dietary|mesh-list
92814915|NCT00752557|Vitamin D|vitamin d|mesh-list
92814916|NCT00752557|Ergocalciferols|ergocalciferols|mesh-list
92814917|NCT00752557|Cholecalciferol|cholecalciferol|mesh-list
92814918|NCT00752557|Diphosphonates|diphosphonates|mesh-list
92814919|NCT00752557|Vitamins|vitamins|mesh-list
92814920|NCT00752557|Calcium|calcium|mesh-list
92814921|NCT00752557|Micronutrients|micronutrients|mesh-ancestor
92814922|NCT00752557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814923|NCT00752557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92814924|NCT00752557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92814925|NCT04570176|Epinephrine|epinephrine|mesh-list
92814926|NCT04570176|Racepinephrine|racepinephrine|mesh-list
92814927|NCT04570176|Epinephryl borate|epinephryl borate|mesh-list
92814928|NCT04570176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92814929|NCT04570176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92814930|NCT04570176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814931|NCT04570176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814932|NCT04570176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814933|NCT04570176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814934|NCT04570176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92814935|NCT04570176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92814936|NCT04570176|Autonomic Agents|autonomic agents|mesh-ancestor
92814937|NCT04570176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814938|NCT04570176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92814939|NCT04570176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92814940|NCT04570176|Mydriatics|mydriatics|mesh-ancestor
92814941|NCT04570176|Sympathomimetics|sympathomimetics|mesh-ancestor
92814942|NCT04570176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92814943|NCT00751218|Cetirizine|cetirizine|mesh-list
92814944|NCT00751218|Desloratadine|desloratadine|mesh-list
92814945|NCT00751218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92814946|NCT00751218|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92459963|NCT01742702|Bisoprolol|bisoprolol|mesh-list
92814947|NCT00751218|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92814949|NCT00751218|Histamine Agents|histamine agents|mesh-ancestor
92814950|NCT00751218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814951|NCT00751218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814952|NCT00751218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814953|NCT00751218|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92814954|NCT00751218|Cholinergic Agents|cholinergic agents|mesh-ancestor
92814955|NCT02779569|Decitabine|decitabine|mesh-list
92814956|NCT02779569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92814957|NCT02779569|Antimetabolites|antimetabolites|mesh-ancestor
92814958|NCT02779569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814959|NCT02779569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92814960|NCT02779569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814961|NCT04095013|Fentanyl|fentanyl|mesh-list
92814962|NCT04095013|Dexmedetomidine|dexmedetomidine|mesh-list
92814963|NCT04095013|Bupivacaine|bupivacaine|mesh-list
92814964|NCT04095013|Anesthetics, Local|anesthetics, local|mesh-ancestor
92814965|NCT04095013|Anesthetics|anesthetics|mesh-ancestor
92814966|NCT04095013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92814967|NCT04095013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92814968|NCT04095013|Sensory System Agents|sensory system agents|mesh-ancestor
92814969|NCT04095013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92814970|NCT04095013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92814971|NCT04095013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92814972|NCT04095013|Analgesics|analgesics|mesh-ancestor
92814973|NCT04095013|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92814974|NCT04095013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92814975|NCT04095013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92814976|NCT04095013|Adrenergic Agents|adrenergic agents|mesh-ancestor
92814977|NCT04095013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92814978|NCT04095013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814979|NCT04095013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92814980|NCT04095013|Narcotics|narcotics|mesh-ancestor
92814981|NCT04095013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92814982|NCT04095013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92814983|NCT04095013|Anesthetics, General|anesthetics, general|mesh-ancestor
92814984|NCT02779881|Caseins|caseins|mesh-list
92814985|NCT02779881|Chelating Agents|chelating agents|mesh-ancestor
92814986|NCT02779881|Sequestering Agents|sequestering agents|mesh-ancestor
92814987|NCT02779881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814988|NCT00651378|Atorvastatin|atorvastatin|mesh-list
92814989|NCT00651378|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92814990|NCT00651378|Ezetimibe|ezetimibe|mesh-list
92814991|NCT00651378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92814992|NCT00651378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92814993|NCT00651378|Antimetabolites|antimetabolites|mesh-ancestor
92814994|NCT00651378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92814995|NCT00651378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92814996|NCT00651378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92814997|NCT00651378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92814998|NCT00747643|Varenicline|varenicline|mesh-list
92814999|NCT00747643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92815000|NCT00747643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92815001|NCT00747643|Cholinergic Agents|cholinergic agents|mesh-ancestor
92815002|NCT00747643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815003|NCT00747643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815004|NCT00747643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815005|NCT00627692|Prucalopride|prucalopride|mesh-list
92815006|NCT00627692|Laxatives|laxatives|mesh-ancestor
92815007|NCT00627692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815008|NCT00627692|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92815009|NCT00627692|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92815010|NCT00627692|Serotonin Agents|serotonin agents|mesh-ancestor
92815011|NCT00627692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815012|NCT00627692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815013|NCT00627692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815014|NCT00634881|Alemtuzumab|alemtuzumab|mesh-list
92815015|NCT00634881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92815016|NCT00634881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815017|NCT04301882|Interferons|interferons|mesh-list
92815018|NCT04301882|Ribavirin|ribavirin|mesh-list
92815019|NCT04301882|Antiviral Agents|antiviral agents|mesh-list
92815020|NCT04301882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815021|NCT04301882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815022|NCT04301882|Antimetabolites|antimetabolites|mesh-ancestor
92815023|NCT04301882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815024|NCT04300322|Progesterone|progesterone|mesh-list
92815025|NCT04300322|Progestins|progestins|mesh-ancestor
92815026|NCT04300322|Hormones|hormones|mesh-ancestor
92815027|NCT04300322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428411|NCT01550354|Alfentanil|alfentanil|mesh-list
92815028|NCT04300322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815030|NCT01022762|Gliclazide|gliclazide|mesh-list
92815031|NCT01022762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92815032|NCT01022762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815033|NCT05338671|Anesthetics|anesthetics|mesh-list
92815034|NCT05338671|Anesthetics, Local|anesthetics, local|mesh-list
92815035|NCT05338671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815036|NCT05338671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815037|NCT05338671|Sensory System Agents|sensory system agents|mesh-ancestor
92815038|NCT05338671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815039|NCT00311844|Desloratadine|desloratadine|mesh-list
92815040|NCT00311844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92815041|NCT00311844|Cholinergic Agents|cholinergic agents|mesh-ancestor
92815042|NCT00311844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815043|NCT00311844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815044|NCT00311844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815045|NCT00311844|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92815046|NCT00311844|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92815047|NCT00311844|Histamine Antagonists|histamine antagonists|mesh-ancestor
92815048|NCT00311844|Histamine Agents|histamine agents|mesh-ancestor
92815049|NCT02599675|Vitamin D|vitamin d|mesh-list
92815050|NCT02599675|Cholecalciferol|cholecalciferol|mesh-list
92815051|NCT02599675|Vitamins|vitamins|mesh-ancestor
92815052|NCT02599675|Micronutrients|micronutrients|mesh-ancestor
92815053|NCT02599675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815054|NCT02599675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92815055|NCT02599675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92815056|NCT02778789|Adalimumab|adalimumab|mesh-list
92815057|NCT02778789|Infliximab|infliximab|mesh-list
92815058|NCT02778789|Golimumab|golimumab|mesh-list
92815059|NCT02778789|Certolizumab Pegol|certolizumab pegol|mesh-list
92815060|NCT02778789|Etanercept|etanercept|mesh-list
92815061|NCT02778789|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92815062|NCT02778789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815063|NCT02778789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92815064|NCT02778789|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815065|NCT02778789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815066|NCT02778789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92815067|NCT02778789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815068|NCT02778789|Analgesics|analgesics|mesh-ancestor
92815069|NCT02778789|Sensory System Agents|sensory system agents|mesh-ancestor
92815070|NCT02778789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815071|NCT02778789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815072|NCT02778789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92815073|NCT02778789|Immunologic Factors|immunologic factors|mesh-ancestor
92815074|NCT00212784|Olanzapine|olanzapine|mesh-list
92815075|NCT00212784|Asenapine|asenapine|mesh-list
92815076|NCT00212784|Antiemetics|antiemetics|mesh-ancestor
92815077|NCT00212784|Autonomic Agents|autonomic agents|mesh-ancestor
92815078|NCT00212784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815079|NCT00212784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815080|NCT00212784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815081|NCT00212784|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92815082|NCT00212784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815083|NCT00212784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815084|NCT00212784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815085|NCT00212784|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92815086|NCT00212784|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92815087|NCT00212784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815088|NCT00212784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815089|NCT00212784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815090|NCT00212784|Serotonin Agents|serotonin agents|mesh-ancestor
92815091|NCT00751933|Vaccines|vaccines|mesh-list
92815092|NCT00751933|Immunologic Factors|immunologic factors|mesh-ancestor
92815093|NCT00751933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815094|NCT04092751|Ibrexafungerp|ibrexafungerp|mesh-list
92815095|NCT04092751|Antifungal Agents|antifungal agents|mesh-ancestor
92815096|NCT04092751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815097|NCT02778945|Rocuronium|rocuronium|mesh-list
92815098|NCT02778945|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92815099|NCT02778945|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92815100|NCT02778945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92815101|NCT02778945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815102|NCT02778945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815103|NCT02721342|Ramipril|ramipril|mesh-list
92815104|NCT02721342|Irbesartan|irbesartan|mesh-list
92815105|NCT02721342|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92815106|NCT02721342|Protease Inhibitors|protease inhibitors|mesh-ancestor
92815107|NCT02721342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815108|NCT02721342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815109|NCT02721342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92815110|NCT02721342|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92815111|NCT02721342|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92815112|NCT02779101|Pembrolizumab|pembrolizumab|mesh-list
92815113|NCT02779101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92815114|NCT02779101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815115|NCT02779101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92815116|NCT02779101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815117|NCT02779959|Prochlorperazine|prochlorperazine|mesh-list
92815118|NCT02779959|Antiemetics|antiemetics|mesh-ancestor
92815119|NCT02779959|Autonomic Agents|autonomic agents|mesh-ancestor
92815120|NCT02779959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815121|NCT02779959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815122|NCT02779959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815123|NCT02779959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92815124|NCT02779959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815125|NCT02779959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815126|NCT02779959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815127|NCT02779959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92815128|NCT02779959|Dopamine Agents|dopamine agents|mesh-ancestor
92815129|NCT02779959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815130|NCT02779959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815131|NCT05335278|Nintedanib|nintedanib|mesh-list
92815132|NCT05335278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815133|NCT05335278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92815134|NCT05335278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815135|NCT05335278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815136|NCT00092898|Ezetimibe|ezetimibe|mesh-list
92815137|NCT00092898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92815138|NCT00092898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92815139|NCT00092898|Antimetabolites|antimetabolites|mesh-ancestor
92815140|NCT00092898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815141|NCT00092898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92815142|NCT04094467|Leuprolide|leuprolide|mesh-list
92815143|NCT04094467|Cetrorelix|cetrorelix|mesh-list
92815144|NCT04094467|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92815145|NCT04094467|Fertility Agents|fertility agents|mesh-ancestor
92815146|NCT04094467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92815147|NCT04094467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815148|NCT04094467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92815149|NCT04094467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815150|NCT04094467|Hormone Antagonists|hormone antagonists|mesh-ancestor
92815151|NCT04094467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815152|NCT04987281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92815153|NCT00092820|Ezetimibe|ezetimibe|mesh-list
92815154|NCT00092820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92815155|NCT00092820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92815156|NCT00092820|Antimetabolites|antimetabolites|mesh-ancestor
92815157|NCT00092820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815158|NCT00092820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92815159|NCT04228263|Aspirin|aspirin|mesh-list
92815160|NCT04228263|Folic Acid|folic acid|mesh-list
92815161|NCT04228263|Hydroxychloroquine|hydroxychloroquine|mesh-list
92815162|NCT04228263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92815163|NCT04228263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815164|NCT04228263|Analgesics|analgesics|mesh-ancestor
92815165|NCT04228263|Sensory System Agents|sensory system agents|mesh-ancestor
92815166|NCT04228263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815167|NCT04228263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815168|NCT04228263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815169|NCT04228263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92815170|NCT04228263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92815171|NCT04228263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92815172|NCT04228263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815173|NCT04228263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92815174|NCT04228263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92815175|NCT04228263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815176|NCT04228263|Antipyretics|antipyretics|mesh-ancestor
92815177|NCT04228263|Antimalarials|antimalarials|mesh-ancestor
92815178|NCT04228263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92815179|NCT04228263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92815180|NCT04228263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815181|NCT04228263|Hematinics|hematinics|mesh-ancestor
92815182|NCT04228263|Vitamin B Complex|vitamin b complex|mesh-ancestor
92815183|NCT04228263|Vitamins|vitamins|mesh-ancestor
92815184|NCT04228263|Micronutrients|micronutrients|mesh-ancestor
92815185|NCT00092742|Diclofenac|diclofenac|mesh-list
92815186|NCT00092742|Etoricoxib|etoricoxib|mesh-list
92815187|NCT00092742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92815188|NCT00092742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815189|NCT00092742|Analgesics|analgesics|mesh-ancestor
92815190|NCT00092742|Sensory System Agents|sensory system agents|mesh-ancestor
92815191|NCT00092742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815192|NCT00092742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815193|NCT00092742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815194|NCT00092742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92815195|NCT00092742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92815196|NCT00092742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815197|NCT00092742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815198|NCT00092742|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92815199|NCT02844270|Sirolimus|sirolimus|mesh-list
92815200|NCT02844270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815201|NCT02844270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815202|NCT02844270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92815203|NCT02844270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815204|NCT02844270|Antifungal Agents|antifungal agents|mesh-ancestor
92815205|NCT02844270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92815206|NCT02844270|Immunologic Factors|immunologic factors|mesh-ancestor
92815207|NCT02844270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815208|NCT00634959|Maraviroc|maraviroc|mesh-list
92815209|NCT00634959|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92815210|NCT00634959|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92815211|NCT00634959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815212|NCT00634959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92815213|NCT00634959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92815214|NCT00634959|Antiviral Agents|antiviral agents|mesh-ancestor
92815215|NCT00634959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815216|NCT00634959|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92815217|NCT02598427|Trastuzumab|trastuzumab|mesh-list
92815218|NCT02598427|Pertuzumab|pertuzumab|mesh-list
92815219|NCT02598427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92815220|NCT02598427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815221|NCT04092595|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92815222|NCT04092595|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92815223|NCT04092595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92815224|NCT04092595|Antimetabolites|antimetabolites|mesh-ancestor
92815225|NCT04092595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815226|NCT04092595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92815227|NCT04092595|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92815228|NCT04092595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815229|NCT04092205|N,N'-Bis(2-mercaptoethyl)isophthalamide|n,n'-bis(2-mercaptoethyl)isophthalamide|mesh-list
92815230|NCT04092205|Chelating Agents|chelating agents|mesh-ancestor
92815231|NCT04092205|Sequestering Agents|sequestering agents|mesh-ancestor
92815232|NCT04092205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815233|NCT05117853|Parathyroid Hormone|parathyroid hormone|mesh-list
92815234|NCT05117853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92815235|NCT05117853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815236|NCT01028222|Dacarbazine|dacarbazine|mesh-list
92815237|NCT01028222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92815238|NCT01028222|Alkylating Agents|alkylating agents|mesh-ancestor
92815239|NCT01028222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815240|NCT01028222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815241|NCT00586495|Sorafenib|sorafenib|mesh-list
92815242|NCT00586495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815243|NCT00586495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92815244|NCT00586495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815245|NCT00586495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815246|NCT02776137|Docetaxel|docetaxel|mesh-list
92815247|NCT02776137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815248|NCT02776137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92815249|NCT02776137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92815250|NCT02776137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92815251|NCT02776137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815253|NCT01027754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92815254|NCT01027754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92815255|NCT01027754|Cholinergic Agents|cholinergic agents|mesh-ancestor
92815256|NCT01027754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815257|NCT01027754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815258|NCT01027754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815259|NCT02773017|Dexmedetomidine|dexmedetomidine|mesh-list
92815260|NCT02773017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92815261|NCT02773017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815262|NCT02773017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815263|NCT02773017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815264|NCT02773017|Analgesics|analgesics|mesh-ancestor
92815265|NCT02773017|Sensory System Agents|sensory system agents|mesh-ancestor
92815266|NCT02773017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815267|NCT02773017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92815268|NCT02773017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92815269|NCT02773017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92815270|NCT02773017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815271|NCT02773017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815272|NCT02773017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815273|NCT02776059|Prednisolone|prednisolone|mesh-list
92815274|NCT02776059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815275|NCT02776059|Glucocorticoids|glucocorticoids|mesh-ancestor
92815276|NCT02776059|Hormones|hormones|mesh-ancestor
92815277|NCT02776059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815278|NCT02776059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815279|NCT02776059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92815280|NCT02776059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815281|NCT00774930|Lanreotide|lanreotide|mesh-list
92815282|NCT00774930|Somatostatin|somatostatin|mesh-list
92815283|NCT00774930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815284|NCT00774930|Hormones|hormones|mesh-ancestor
92815285|NCT00774930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815286|NCT00774930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815287|NCT02841774|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92815288|NCT02841774|Pravastatin|pravastatin|mesh-list
92815289|NCT02841774|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92815290|NCT02841774|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92815291|NCT02841774|Antimetabolites|antimetabolites|mesh-ancestor
92815292|NCT02841774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815293|NCT02841774|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92815294|NCT02841774|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92815295|NCT02841774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815296|NCT02772237|Riboflavin|riboflavin|mesh-list
92815297|NCT02772237|Vitamins|vitamins|mesh-ancestor
92815298|NCT02772237|Micronutrients|micronutrients|mesh-ancestor
92815299|NCT02772237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815300|NCT02772237|Vitamin B Complex|vitamin b complex|mesh-ancestor
92815301|NCT02772237|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92815302|NCT02772237|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815303|NCT02841306|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92815304|NCT02841306|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92815305|NCT02841306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815306|NCT01316250|Imatinib Mesylate|imatinib mesylate|mesh-list
92815307|NCT01316250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815308|NCT01316250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92815309|NCT01316250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815310|NCT01316250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815311|NCT02771925|Gabapentin|gabapentin|mesh-list
92815312|NCT02771925|Analgesics|analgesics|mesh-ancestor
92815313|NCT02771925|Sensory System Agents|sensory system agents|mesh-ancestor
92815314|NCT02771925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815315|NCT02771925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815316|NCT02771925|Anticonvulsants|anticonvulsants|mesh-ancestor
92815317|NCT02771925|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92815318|NCT02771925|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815319|NCT02771925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815320|NCT02771925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460339|NCT01744470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815321|NCT02771925|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92815322|NCT02771925|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92815323|NCT02771925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815324|NCT02771925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815325|NCT02771925|Antimanic Agents|antimanic agents|mesh-ancestor
92815326|NCT03205956|Levodopa|levodopa|mesh-list
92815327|NCT03205956|Carbidopa|carbidopa|mesh-list
92815328|NCT03205956|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92815329|NCT03205956|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92815330|NCT03205956|Dopamine Agents|dopamine agents|mesh-ancestor
92815331|NCT03205956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815332|NCT03205956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815333|NCT03205956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815334|NCT03205956|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92815335|NCT03205956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815336|NCT02840994|Pembrolizumab|pembrolizumab|mesh-list
92815337|NCT02840994|Nivolumab|nivolumab|mesh-list
92815338|NCT02840994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92815339|NCT02840994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815340|NCT02840994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92815341|NCT02840994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815342|NCT02771457|Infliximab|infliximab|mesh-list
92815343|NCT02771457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92815344|NCT02771457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815345|NCT02771457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815346|NCT02771457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815347|NCT02771457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92815348|NCT02843802|Immunomodulating Agents|immunomodulating agents|mesh-list
92815349|NCT02843802|Immunologic Factors|immunologic factors|mesh-ancestor
92815350|NCT02843802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815351|NCT02771379|Idebenone|idebenone|mesh-list
92815352|NCT02771379|Antioxidants|antioxidants|mesh-ancestor
92815353|NCT02771379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815354|NCT02771379|Protective Agents|protective agents|mesh-ancestor
92815355|NCT02771379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815356|NCT01026870|Mometasone Furoate|mometasone furoate|mesh-list
92815357|NCT01026870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815358|NCT01026870|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815359|NCT01026870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92815360|NCT02844114|Cisplatin|cisplatin|mesh-list
92815361|NCT02844114|Gemcitabine|gemcitabine|mesh-list
92815362|NCT02844114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815363|NCT02844114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92815364|NCT02844114|Antimetabolites|antimetabolites|mesh-ancestor
92815365|NCT02844114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815366|NCT02696733|Cephalosporins|cephalosporins|mesh-list
92815367|NCT02696733|Lidocaine|lidocaine|mesh-list
92815368|NCT02696733|Anesthetics, Local|anesthetics, local|mesh-ancestor
92815369|NCT02696733|Anesthetics|anesthetics|mesh-ancestor
92815370|NCT02696733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815371|NCT02696733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815372|NCT02696733|Sensory System Agents|sensory system agents|mesh-ancestor
92815373|NCT02696733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815374|NCT02696733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92815375|NCT02696733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92815376|NCT02696733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92815377|NCT02696733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815378|NCT02696733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815379|NCT02696733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815380|NCT02696733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815381|NCT00897390|Metformin|metformin|mesh-list
92815382|NCT00897390|Saxagliptin|saxagliptin|mesh-list
92815383|NCT00897390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92815384|NCT00897390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815385|NCT00897390|Incretins|incretins|mesh-ancestor
92815386|NCT00897390|Hormones|hormones|mesh-ancestor
92815387|NCT00897390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815388|NCT00897390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92815389|NCT00897390|Protease Inhibitors|protease inhibitors|mesh-ancestor
92815390|NCT00897390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815391|NCT00897390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815392|NCT01034462|Milnacipran|milnacipran|mesh-list
92815393|NCT01034462|Levomilnacipran|levomilnacipran|mesh-list
92815394|NCT01034462|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92815395|NCT01034462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92815396|NCT01034462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815397|NCT01034462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815398|NCT01034462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815399|NCT01034462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815400|NCT01034462|Antidepressive Agents|antidepressive agents|mesh-ancestor
92815401|NCT01034462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815402|NCT01034462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815404|NCT01034462|Sensory System Agents|sensory system agents|mesh-ancestor
92815405|NCT01034462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815406|NCT01033448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92815407|NCT01033448|Antiviral Agents|antiviral agents|mesh-ancestor
92815408|NCT01033448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815409|NCT02873234|Antidepressive Agents|antidepressive agents|mesh-list
92815410|NCT02873234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815411|NCT02774811|Bimatoprost|bimatoprost|mesh-list
92815412|NCT02774811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92815413|NCT00817050|Fluticasone|fluticasone|mesh-list
92815414|NCT00817050|Mometasone Furoate|mometasone furoate|mesh-list
92815415|NCT00817050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815416|NCT00817050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92815417|NCT00817050|Autonomic Agents|autonomic agents|mesh-ancestor
92815418|NCT00817050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815419|NCT00817050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815420|NCT00817050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92815421|NCT00817050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92815422|NCT00817050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815423|NCT00817050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92815424|NCT04224831|Mitogens|mitogens|mesh-list
92815425|NCT04224831|Mitosis Modulators|mitosis modulators|mesh-ancestor
92815426|NCT04224831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815427|NCT00816972|Loratadine|loratadine|mesh-list
92815428|NCT00816972|Mandelic Acids|mandelic acids|mesh-list
92815429|NCT00816972|Oxybutynin|oxybutynin|mesh-list
92815430|NCT00816972|Desloratadine|desloratadine|mesh-list
92815431|NCT00816972|Parasympatholytics|parasympatholytics|mesh-ancestor
92815432|NCT00816972|Autonomic Agents|autonomic agents|mesh-ancestor
92815433|NCT00816972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815434|NCT00816972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428811|NCT01553357|Dexamethasone|dexamethasone|mesh-list
92815435|NCT00816972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92815436|NCT00816972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92815437|NCT00816972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92815438|NCT00816972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815439|NCT00816972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815440|NCT00816972|Urological Agents|urological agents|mesh-ancestor
92815441|NCT00816972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92815442|NCT00816972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815443|NCT00816972|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92815444|NCT00816972|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92815445|NCT00816972|Histamine Antagonists|histamine antagonists|mesh-ancestor
92815446|NCT00816972|Histamine Agents|histamine agents|mesh-ancestor
92815447|NCT00816972|Antipruritics|antipruritics|mesh-ancestor
92815448|NCT00816972|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815449|NCT00816972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92815450|NCT02774499|Methadone|methadone|mesh-list
92815451|NCT02774499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92815452|NCT02774499|Narcotics|narcotics|mesh-ancestor
92815453|NCT02774499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815454|NCT02774499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815455|NCT02774499|Analgesics|analgesics|mesh-ancestor
92815456|NCT02774499|Sensory System Agents|sensory system agents|mesh-ancestor
92815457|NCT02774499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815458|NCT02774499|Antitussive Agents|antitussive agents|mesh-ancestor
92815459|NCT02774499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92815460|NCT02770443|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92815461|NCT02770443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92815462|NCT02770443|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815463|NCT02770443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815464|NCT02770443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815465|NCT02770443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815466|NCT02774187|Leucovorin|leucovorin|mesh-list
92815467|NCT02774187|Fluorouracil|fluorouracil|mesh-list
92815468|NCT02774187|Oxaliplatin|oxaliplatin|mesh-list
92815469|NCT02774187|Sorafenib|sorafenib|mesh-list
92460491|NCT01745640|Dexamethasone|dexamethasone|mesh-list
92815470|NCT02774187|Antimetabolites|antimetabolites|mesh-ancestor
92815471|NCT02774187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815472|NCT02774187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92815473|NCT02774187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815474|NCT02774187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92815475|NCT02774187|Immunologic Factors|immunologic factors|mesh-ancestor
92815476|NCT02774187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815478|NCT02774187|Protective Agents|protective agents|mesh-ancestor
92815479|NCT02774187|Vitamin B Complex|vitamin b complex|mesh-ancestor
92815480|NCT02774187|Vitamins|vitamins|mesh-ancestor
92815481|NCT02774187|Micronutrients|micronutrients|mesh-ancestor
92815482|NCT02774187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92815483|NCT02774187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815484|NCT02773797|Dexmedetomidine|dexmedetomidine|mesh-list
92815485|NCT02773797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92815486|NCT02773797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815487|NCT02773797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815488|NCT02773797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815489|NCT02773797|Analgesics|analgesics|mesh-ancestor
92815490|NCT02773797|Sensory System Agents|sensory system agents|mesh-ancestor
92815491|NCT02773797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815492|NCT02773797|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92815493|NCT02773797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92815494|NCT02773797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92815495|NCT02773797|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815496|NCT02773797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815497|NCT02773797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815498|NCT02773875|Pancrelipase|pancrelipase|mesh-list
92815499|NCT02773875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815500|NCT02768961|Sofosbuvir|sofosbuvir|mesh-list
92815501|NCT02768961|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92815502|NCT02768961|Ledipasvir|ledipasvir|mesh-list
92815503|NCT02768961|Antiviral Agents|antiviral agents|mesh-ancestor
92815504|NCT02768961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815505|NCT02773641|Botulinum Toxins|botulinum toxins|mesh-list
92815506|NCT02773641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92815507|NCT02773641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92815508|NCT02773641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92815509|NCT02773641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815510|NCT02773641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815511|NCT02773641|Cholinergic Agents|cholinergic agents|mesh-ancestor
92815512|NCT02773641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815513|NCT02773641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815514|NCT02773641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92815515|NCT02773641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815516|NCT02768805|Vaccines|vaccines|mesh-list
92815517|NCT02768805|Immunologic Factors|immunologic factors|mesh-ancestor
92815518|NCT02768805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815519|NCT02773251|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92815520|NCT02773251|Hyaluronic Acid|hyaluronic acid|mesh-list
92815521|NCT02773251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92815522|NCT02773251|Immunologic Factors|immunologic factors|mesh-ancestor
92815523|NCT02773251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815524|NCT02773251|Viscosupplements|viscosupplements|mesh-ancestor
92815525|NCT02773251|Protective Agents|protective agents|mesh-ancestor
92815526|NCT02773251|Laxatives|laxatives|mesh-ancestor
92815527|NCT02773251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815528|NCT02768649|Risperidone|risperidone|mesh-list
92815529|NCT02768649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92815530|NCT02768649|Serotonin Agents|serotonin agents|mesh-ancestor
92815531|NCT02768649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815532|NCT02768649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815533|NCT02768649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815534|NCT02768649|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92815535|NCT02768649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815536|NCT02768649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815537|NCT02768649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815538|NCT02768649|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92815539|NCT02768649|Dopamine Agents|dopamine agents|mesh-ancestor
92815540|NCT02773407|Azithromycin|azithromycin|mesh-list
92815541|NCT02773407|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92815542|NCT02773407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815543|NCT02773407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815544|NCT02773407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92815545|NCT02773407|Antimalarials|antimalarials|mesh-ancestor
92815547|NCT02773407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92815548|NCT04224675|Atenolol|atenolol|mesh-list
92815549|NCT04224675|Captopril|captopril|mesh-list
92815550|NCT04224675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92815551|NCT04224675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92815552|NCT04224675|Sympatholytics|sympatholytics|mesh-ancestor
92815553|NCT04224675|Autonomic Agents|autonomic agents|mesh-ancestor
92815554|NCT04224675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815555|NCT04224675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815556|NCT04224675|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92815557|NCT04224675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92815558|NCT04224675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92815559|NCT04224675|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815560|NCT04224675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815561|NCT04224675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815562|NCT04224675|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92815563|NCT04224675|Protease Inhibitors|protease inhibitors|mesh-ancestor
92815564|NCT04224675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815565|NCT02768493|Ropivacaine|ropivacaine|mesh-list
92815566|NCT02768493|Anesthetics, Local|anesthetics, local|mesh-ancestor
92815567|NCT02768493|Anesthetics|anesthetics|mesh-ancestor
92815568|NCT02768493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815569|NCT02768493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815570|NCT02768493|Sensory System Agents|sensory system agents|mesh-ancestor
92815571|NCT02768493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815572|NCT02768415|Apatinib|apatinib|mesh-list
92815573|NCT02768415|Vinorelbine|vinorelbine|mesh-list
92815574|NCT02768415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815575|NCT02768415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92815576|NCT02768415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815577|NCT02768415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815578|NCT02768415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92815579|NCT02768415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92815580|NCT02768415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92815581|NCT02768415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92815582|NCT02773095|Lactitol|lactitol|mesh-list
92815583|NCT02773095|Cathartics|cathartics|mesh-ancestor
92815584|NCT02773095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815585|NCT02768337|Afatinib|afatinib|mesh-list
92815586|NCT02768337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815587|NCT02768337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92815588|NCT02768337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815589|NCT02768337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815590|NCT02768571|Cerebrolysin|cerebrolysin|mesh-list
92815591|NCT02768571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92815592|NCT02768571|Protective Agents|protective agents|mesh-ancestor
92815593|NCT02768571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815594|NCT02768571|Nootropic Agents|nootropic agents|mesh-ancestor
92815595|NCT02767713|Dexamethasone|dexamethasone|mesh-list
92815596|NCT02767713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815597|NCT02767713|Antiemetics|antiemetics|mesh-ancestor
92815598|NCT02767713|Autonomic Agents|autonomic agents|mesh-ancestor
92815599|NCT02767713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815600|NCT02767713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815601|NCT02767713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815602|NCT02767713|Glucocorticoids|glucocorticoids|mesh-ancestor
92815603|NCT02767713|Hormones|hormones|mesh-ancestor
92815604|NCT02767713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815605|NCT02767713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92815606|NCT02767713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815607|NCT02767245|Thiamine|thiamine|mesh-list
92815608|NCT02767245|Vitamins|vitamins|mesh-ancestor
92815609|NCT02767245|Micronutrients|micronutrients|mesh-ancestor
92815610|NCT02767245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815611|NCT02767245|Vitamin B Complex|vitamin b complex|mesh-ancestor
92815612|NCT02767401|Aspirin|aspirin|mesh-list
92815613|NCT02767401|Metoprolol|metoprolol|mesh-list
92815614|NCT02767401|Clopidogrel|clopidogrel|mesh-list
92815615|NCT02767401|Ticagrelor|ticagrelor|mesh-list
92815616|NCT02767401|Atorvastatin|atorvastatin|mesh-list
92815617|NCT02767401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92815618|NCT02767401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92815619|NCT02767401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815620|NCT02767401|Analgesics|analgesics|mesh-ancestor
92815621|NCT02767401|Sensory System Agents|sensory system agents|mesh-ancestor
92815622|NCT02767401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815623|NCT02767401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815624|NCT02767401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815625|NCT02767401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92815626|NCT02767401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92815627|NCT02767401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92160357|NCT01110135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815628|NCT02767401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815630|NCT02767401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92815631|NCT02767401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815632|NCT02767401|Antipyretics|antipyretics|mesh-ancestor
92815633|NCT02767401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92815634|NCT02767401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92815635|NCT02767401|Antimetabolites|antimetabolites|mesh-ancestor
92815636|NCT02767401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92815637|NCT02767401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92815638|NCT02767401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92815639|NCT02767401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92815640|NCT02767401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92815641|NCT02767401|Purinergic Agents|purinergic agents|mesh-ancestor
92815642|NCT02767401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815643|NCT02767401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92815644|NCT02767401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92815645|NCT02767401|Sympatholytics|sympatholytics|mesh-ancestor
92815646|NCT02767401|Autonomic Agents|autonomic agents|mesh-ancestor
92815647|NCT02767401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92815648|NCT02767401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92815649|NCT02767401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92815650|NCT02767401|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815651|NCT02767479|Esomeprazole|esomeprazole|mesh-list
92815652|NCT02767479|Rabeprazole|rabeprazole|mesh-list
92815653|NCT02767479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92815654|NCT02767479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815655|NCT02767479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92815656|NCT02767479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815657|NCT02767479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815658|NCT02767635|Triamcinolone|triamcinolone|mesh-list
92815659|NCT02767635|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92815660|NCT02767635|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92815661|NCT02767635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92815662|NCT02767635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92815663|NCT02767635|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92815664|NCT02767635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92815665|NCT02767635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815666|NCT02767635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815667|NCT02767635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92815668|NCT02767635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815669|NCT02767635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815670|NCT02767635|Cholinergic Agents|cholinergic agents|mesh-ancestor
92815671|NCT02767635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815672|NCT02767635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815673|NCT02767635|Glucocorticoids|glucocorticoids|mesh-ancestor
92815674|NCT02767635|Hormones|hormones|mesh-ancestor
92815675|NCT02767635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815676|NCT02767635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92815677|NCT02767635|Immunologic Factors|immunologic factors|mesh-ancestor
92815678|NCT02767635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815679|NCT04224441|Temozolomide|temozolomide|mesh-list
92815680|NCT04224441|Chlorpromazine|chlorpromazine|mesh-list
92815681|NCT04224441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92815682|NCT04224441|Alkylating Agents|alkylating agents|mesh-ancestor
92815683|NCT04224441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815684|NCT04224441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815685|NCT04224441|Antiemetics|antiemetics|mesh-ancestor
92815686|NCT04224441|Autonomic Agents|autonomic agents|mesh-ancestor
92815687|NCT04224441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815688|NCT04224441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815689|NCT04224441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815690|NCT04224441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92815691|NCT04224441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815692|NCT04224441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815693|NCT04224441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815694|NCT04224441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92815695|NCT04224441|Dopamine Agents|dopamine agents|mesh-ancestor
92815696|NCT04224441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815697|NCT02767089|Prednisone|prednisone|mesh-list
92815698|NCT02767089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815699|NCT02767089|Glucocorticoids|glucocorticoids|mesh-ancestor
92815700|NCT02767089|Hormones|hormones|mesh-ancestor
92160429|NCT01114503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815701|NCT02767089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815702|NCT02767089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815703|NCT02767089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92815704|NCT02767089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815706|NCT02766855|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92815707|NCT02766855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815708|NCT02762643|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92815709|NCT02762643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92815710|NCT02762643|Hormone Antagonists|hormone antagonists|mesh-ancestor
92815711|NCT02762643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815712|NCT02762643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815713|NCT02762643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92815714|NCT02762643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92815715|NCT02762643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92815716|NCT04224051|Metformin|metformin|mesh-list
92815717|NCT04224051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92815718|NCT04224051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815719|NCT02762253|Riboflavin|riboflavin|mesh-list
92815720|NCT02762253|Vitamin B Complex|vitamin b complex|mesh-ancestor
92815721|NCT02762253|Vitamins|vitamins|mesh-ancestor
92815722|NCT02762253|Micronutrients|micronutrients|mesh-ancestor
92815723|NCT02762253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815724|NCT02762253|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92815725|NCT02762253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92815726|NCT00746941|Mefloquine|mefloquine|mesh-list
92815727|NCT00746941|Antimalarials|antimalarials|mesh-ancestor
92815728|NCT00746941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92815729|NCT00746941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92815730|NCT00746941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815731|NCT04532463|Fluconazole|fluconazole|mesh-list
92815732|NCT04532463|Amphotericin B|amphotericin b|mesh-list
92815733|NCT04532463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92815734|NCT04532463|Flucytosine|flucytosine|mesh-list
92815735|NCT04532463|Antifungal Agents|antifungal agents|mesh-ancestor
92815736|NCT04532463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815737|NCT04532463|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92815738|NCT04532463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92815739|NCT04532463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815740|NCT04532463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815741|NCT04532463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92815742|NCT04532463|Hormone Antagonists|hormone antagonists|mesh-ancestor
92815743|NCT04532463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815744|NCT04532463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815745|NCT04532463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92815746|NCT04532463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92815747|NCT04532463|Amebicides|amebicides|mesh-ancestor
92815748|NCT04532463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92815749|NCT04532463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92815750|NCT04532463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815751|NCT04532463|Antimetabolites|antimetabolites|mesh-ancestor
92815752|NCT04091971|Ketamine|ketamine|mesh-list
92815753|NCT04091971|Analgesics|analgesics|mesh-ancestor
92815754|NCT04091971|Sensory System Agents|sensory system agents|mesh-ancestor
92815755|NCT04091971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815756|NCT04091971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815757|NCT04091971|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92815758|NCT04091971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92815759|NCT04091971|Anesthetics, General|anesthetics, general|mesh-ancestor
92815760|NCT04091971|Anesthetics|anesthetics|mesh-ancestor
92815761|NCT04091971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815762|NCT04091971|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92815763|NCT04091971|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92815764|NCT04091971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815765|NCT04091971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815766|NCT04091815|Anesthetics|anesthetics|mesh-list
92815767|NCT04091815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815768|NCT04091815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815769|NCT00746785|Olanzapine|olanzapine|mesh-list
92815770|NCT00746785|Antiemetics|antiemetics|mesh-ancestor
92815771|NCT00746785|Autonomic Agents|autonomic agents|mesh-ancestor
92815772|NCT00746785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815774|NCT00746785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815775|NCT00746785|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92815776|NCT00746785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815777|NCT00746785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815778|NCT00746785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815779|NCT00746785|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92815780|NCT00746785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92815781|NCT00746785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815782|NCT00746785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815783|NCT00746785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815784|NCT00746785|Serotonin Agents|serotonin agents|mesh-ancestor
92815785|NCT04090021|Amoxicillin|amoxicillin|mesh-list
92815786|NCT04090021|Metronidazole|metronidazole|mesh-list
92815787|NCT04090021|Clarithromycin|clarithromycin|mesh-list
92815788|NCT04090021|Levofloxacin|levofloxacin|mesh-list
92815789|NCT04090021|Rifabutin|rifabutin|mesh-list
92815790|NCT04090021|Esomeprazole|esomeprazole|mesh-list
92815791|NCT04090021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815792|NCT04090021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815793|NCT04090021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92815794|NCT04090021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92815795|NCT04090021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92815796|NCT04090021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815797|NCT04090021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92815798|NCT04090021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815799|NCT04090021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815800|NCT04090021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92815801|NCT04090021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92815802|NCT04090021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92815803|NCT04090021|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92815804|NCT04090021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92815805|NCT04090021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92815806|NCT04090021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815807|NCT04090021|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92815808|NCT04090021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92815809|NCT04090021|Antitubercular Agents|antitubercular agents|mesh-ancestor
92815810|NCT04223973|Insulin|insulin|mesh-list
92815811|NCT04223973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92815812|NCT04223973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815813|NCT00750919|Mirtazapine|mirtazapine|mesh-list
92815814|NCT00750919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92815815|NCT00750919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815816|NCT00750919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92815817|NCT00750919|Histamine Antagonists|histamine antagonists|mesh-ancestor
92815818|NCT00750919|Histamine Agents|histamine agents|mesh-ancestor
92815819|NCT00750919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815820|NCT00750919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815821|NCT00750919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815822|NCT00750919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92815823|NCT00750919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815824|NCT00750919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815825|NCT00750919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92815826|NCT00750919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92815827|NCT00750919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92815828|NCT00750919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815829|NCT00750919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92815830|NCT00750919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92815831|NCT00750919|Serotonin Agents|serotonin agents|mesh-ancestor
92815832|NCT00750919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92815833|NCT02761161|Mianserin|mianserin|mesh-list
92815834|NCT02761161|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92815835|NCT02761161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92815836|NCT02761161|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815837|NCT02761161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815838|NCT02761161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815839|NCT02761161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815840|NCT02761161|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92815841|NCT02761161|Histamine Antagonists|histamine antagonists|mesh-ancestor
92815842|NCT02761161|Histamine Agents|histamine agents|mesh-ancestor
92460866|NCT01747746|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92815843|NCT02761161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92815844|NCT02761161|Serotonin Agents|serotonin agents|mesh-ancestor
92815845|NCT02761161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92815846|NCT02761161|Antidepressive Agents|antidepressive agents|mesh-ancestor
92815847|NCT02761161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815848|NCT02761395|Deferasirox|deferasirox|mesh-list
92815849|NCT02761395|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92815850|NCT02761395|Chelating Agents|chelating agents|mesh-ancestor
92815851|NCT02761395|Sequestering Agents|sequestering agents|mesh-ancestor
92815852|NCT02761395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815853|NCT02761317|Bisacodyl|bisacodyl|mesh-list
92815854|NCT02761317|Cathartics|cathartics|mesh-ancestor
92815855|NCT02761317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815856|NCT02761317|Laxatives|laxatives|mesh-ancestor
92815857|NCT00746551|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92815858|NCT00746551|Hematinics|hematinics|mesh-ancestor
92815859|NCT02696577|Aspirin|aspirin|mesh-list
92815860|NCT02696577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92815861|NCT02696577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92815862|NCT02696577|Analgesics|analgesics|mesh-ancestor
92815863|NCT02696577|Sensory System Agents|sensory system agents|mesh-ancestor
92815864|NCT02696577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815865|NCT02696577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815866|NCT02696577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815867|NCT02696577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92815868|NCT02696577|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92815869|NCT02696577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92815870|NCT02696577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815871|NCT02696577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92815872|NCT02696577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92815873|NCT02696577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815874|NCT02696577|Antipyretics|antipyretics|mesh-ancestor
92815875|NCT04222491|Immunomodulating Agents|immunomodulating agents|mesh-list
92815876|NCT04222491|Immunologic Factors|immunologic factors|mesh-ancestor
92815877|NCT04222491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815878|NCT00750061|Lithium Carbonate|lithium carbonate|mesh-list
92815879|NCT00750061|Antidepressive Agents|antidepressive agents|mesh-ancestor
92815880|NCT00750061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815881|NCT00750061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815882|NCT00750061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815883|NCT00750061|Antimanic Agents|antimanic agents|mesh-ancestor
92815884|NCT00750061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815885|NCT00750061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815886|NCT00750061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815887|NCT04223739|Amiodarone|amiodarone|mesh-list
92815888|NCT04223739|Landiolol|landiolol|mesh-list
92815889|NCT04223739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92815890|NCT04223739|Vasodilator Agents|vasodilator agents|mesh-ancestor
92815891|NCT04223739|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92815892|NCT04223739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92815893|NCT04223739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815894|NCT04223739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92815895|NCT04223739|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92815896|NCT04223739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92815897|NCT04223739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815898|NCT04223739|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92815899|NCT04223739|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92815900|NCT04223739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92815901|NCT04223739|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92815902|NCT04223739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92815903|NCT04223739|Adrenergic Agents|adrenergic agents|mesh-ancestor
92815904|NCT04223739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815905|NCT04223739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815906|NCT02765373|Letrozole|letrozole|mesh-list
92815907|NCT02765373|Anastrozole|anastrozole|mesh-list
92815908|NCT02765373|Exemestane|exemestane|mesh-list
92815909|NCT02765373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815910|NCT02765373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92815911|NCT02765373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92815912|NCT02765373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815913|NCT02765373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815914|NCT02765373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92815915|NCT02765373|Hormone Antagonists|hormone antagonists|mesh-ancestor
92815916|NCT02765373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815917|NCT02765373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815918|NCT02765373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92815920|NCT02760615|Midazolam|midazolam|mesh-list
92815921|NCT02760615|Dextromethorphan|dextromethorphan|mesh-list
92815922|NCT02760615|Caffeine|caffeine|mesh-list
92815923|NCT02760615|Omeprazole|omeprazole|mesh-list
92815924|NCT02760615|Vedolizumab|vedolizumab|mesh-list
92815925|NCT02760615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92815926|NCT02760615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92815927|NCT02760615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92815928|NCT02760615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815929|NCT02760615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92815930|NCT02760615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92815931|NCT02760615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92815932|NCT02760615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92815933|NCT02760615|Anesthetics, General|anesthetics, general|mesh-ancestor
92815934|NCT02760615|Anesthetics|anesthetics|mesh-ancestor
92815935|NCT02760615|GABA Modulators|gaba modulators|mesh-ancestor
92815936|NCT02760615|GABA Agents|gaba agents|mesh-ancestor
92815937|NCT02760615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92815938|NCT02760615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815939|NCT02760615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92815940|NCT02760615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92815941|NCT02760615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92815942|NCT02760615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92815943|NCT02760615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92815944|NCT02760615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92815945|NCT02760615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815946|NCT02760615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92815947|NCT02760615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92815948|NCT02760615|Purinergic Agents|purinergic agents|mesh-ancestor
92815949|NCT02760615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92815950|NCT02760615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815951|NCT02760615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92815952|NCT02760615|Antitussive Agents|antitussive agents|mesh-ancestor
92815953|NCT02760615|Respiratory System Agents|respiratory system agents|mesh-ancestor
92815954|NCT02760615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92815955|NCT02760615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92815956|NCT02760459|Dexamethasone|dexamethasone|mesh-list
92815957|NCT02760459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92815958|NCT02760459|Antiemetics|antiemetics|mesh-ancestor
92815959|NCT02760459|Autonomic Agents|autonomic agents|mesh-ancestor
92815960|NCT02760459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92815961|NCT02760459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815962|NCT02760459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92815963|NCT02760459|Glucocorticoids|glucocorticoids|mesh-ancestor
92815964|NCT02760459|Hormones|hormones|mesh-ancestor
92815965|NCT02760459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92815966|NCT02760459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92815967|NCT02760459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815968|NCT02765217|Amoxicillin|amoxicillin|mesh-list
92815969|NCT02765217|Clavulanic Acids|clavulanic acids|mesh-list
92815970|NCT02765217|Clavulanic Acid|clavulanic acid|mesh-list
92815971|NCT02765217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92815972|NCT02765217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815973|NCT02765217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815974|NCT02765217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815975|NCT02765217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815976|NCT02765217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92815977|NCT02760381|Acetic Acid|acetic acid|mesh-list
92815978|NCT02760381|Retinol acetate|retinol acetate|mesh-list
92815979|NCT02760381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92815980|NCT02760381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92815981|NCT02760381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92815982|NCT02760381|Immunologic Factors|immunologic factors|mesh-ancestor
92815983|NCT02760381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92815984|NCT02760381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92815985|NCT02760381|Protective Agents|protective agents|mesh-ancestor
92815986|NCT02760381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815987|NCT02760225|Pembrolizumab|pembrolizumab|mesh-list
92815988|NCT02760225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92815989|NCT02760225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815990|NCT02760225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92433078|NCT01572363|Urological Agents|urological agents|mesh-ancestor
92815991|NCT02760225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815992|NCT00744757|Decitabine|decitabine|mesh-list
92815993|NCT00744757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92815994|NCT00744757|Antimetabolites|antimetabolites|mesh-ancestor
92815995|NCT00744757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92815996|NCT00744757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92815997|NCT00744757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92815998|NCT00917527|Atorvastatin|atorvastatin|mesh-list
92815999|NCT00917527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92816000|NCT00917527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92816001|NCT00917527|Antimetabolites|antimetabolites|mesh-ancestor
92816002|NCT00917527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816003|NCT00917527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92816004|NCT00917527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92816005|NCT00917527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816006|NCT00745849|Esomeprazole|esomeprazole|mesh-list
92816007|NCT00745849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92816008|NCT00745849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816009|NCT00745849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92816010|NCT00745849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816011|NCT00745849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816012|NCT02759991|Vaccines|vaccines|mesh-list
92816013|NCT02759991|Immunologic Factors|immunologic factors|mesh-ancestor
92816014|NCT02759991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816015|NCT04112277|Morphine|morphine|mesh-list
92816016|NCT04112277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92816017|NCT04112277|Narcotics|narcotics|mesh-ancestor
92816018|NCT04112277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816019|NCT04112277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816020|NCT04112277|Analgesics|analgesics|mesh-ancestor
92816021|NCT04112277|Sensory System Agents|sensory system agents|mesh-ancestor
92816022|NCT04112277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816023|NCT00749203|Midazolam|midazolam|mesh-list
92816024|NCT00749203|Ketamine|ketamine|mesh-list
92816025|NCT00749203|Analgesics|analgesics|mesh-ancestor
92816026|NCT00749203|Sensory System Agents|sensory system agents|mesh-ancestor
92816027|NCT00749203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816028|NCT00749203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816029|NCT00749203|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92816030|NCT00749203|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92816031|NCT00749203|Anesthetics, General|anesthetics, general|mesh-ancestor
92816032|NCT00749203|Anesthetics|anesthetics|mesh-ancestor
92816033|NCT00749203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816034|NCT00749203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92816035|NCT00749203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92816036|NCT00749203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816037|NCT00749203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816038|NCT00749203|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92816039|NCT00749203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92816040|NCT00749203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92816041|NCT00749203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92816042|NCT00749203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816043|NCT00749203|GABA Modulators|gaba modulators|mesh-ancestor
92816044|NCT00749203|GABA Agents|gaba agents|mesh-ancestor
92816045|NCT02764515|Methotrexate|methotrexate|mesh-list
92816046|NCT02764515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92816047|NCT02764515|Abortifacient Agents|abortifacient agents|mesh-ancestor
92816048|NCT02764515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816049|NCT02764515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816050|NCT02764515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816051|NCT02764515|Antimetabolites|antimetabolites|mesh-ancestor
92816052|NCT02764515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816053|NCT02764515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816054|NCT02764515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816055|NCT02764515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816056|NCT02764515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92816057|NCT02764515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816058|NCT02764515|Immunologic Factors|immunologic factors|mesh-ancestor
92816059|NCT02764515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816060|NCT02764515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92816061|NCT02764749|Phenol|phenol|mesh-list
92816062|NCT02764749|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92816063|NCT02764749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816064|NCT02764749|Disinfectants|disinfectants|mesh-ancestor
92816065|NCT02764749|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92816066|NCT02764749|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92816067|NCT02764359|Vancomycin|vancomycin|mesh-list
92816068|NCT02764359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92816069|NCT02764359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816070|NCT02764125|Levodopa|levodopa|mesh-list
92816071|NCT02764125|Carbidopa|carbidopa|mesh-list
92816072|NCT02764125|Entacapone|entacapone|mesh-list
92816073|NCT02764125|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92816074|NCT02764125|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92816075|NCT02764125|Dopamine Agents|dopamine agents|mesh-ancestor
92816076|NCT02764125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816077|NCT02764125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816078|NCT02764125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816079|NCT02764125|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92816080|NCT02764125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816081|NCT02764125|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92816082|NCT02764281|Dexamethasone|dexamethasone|mesh-list
92816083|NCT02764281|Methotrexate|methotrexate|mesh-list
92816084|NCT02764281|Etoposide|etoposide|mesh-list
92816085|NCT02764281|Pegaspargase|pegaspargase|mesh-list
92816086|NCT02764281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816087|NCT02764281|Antiemetics|antiemetics|mesh-ancestor
92816088|NCT02764281|Autonomic Agents|autonomic agents|mesh-ancestor
92816089|NCT02764281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816090|NCT02764281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816091|NCT02764281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816092|NCT02764281|Glucocorticoids|glucocorticoids|mesh-ancestor
92816093|NCT02764281|Hormones|hormones|mesh-ancestor
92816094|NCT02764281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816095|NCT02764281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92816096|NCT02764281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816097|NCT02764281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816098|NCT02764281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816099|NCT02764281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92816100|NCT02764281|Abortifacient Agents|abortifacient agents|mesh-ancestor
92816101|NCT02764281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816102|NCT02764281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816103|NCT02764281|Antimetabolites|antimetabolites|mesh-ancestor
92816104|NCT02764281|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816105|NCT02764281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92816106|NCT02764281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816107|NCT02764281|Immunologic Factors|immunologic factors|mesh-ancestor
92816108|NCT02764281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816109|NCT02764281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92816110|NCT02764281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92816111|NCT02764281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92816112|NCT02764281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92816113|NCT02763969|Interferons|interferons|mesh-list
92816114|NCT02763969|Interferon-alpha|interferon-alpha|mesh-list
92816115|NCT02763969|Interferon alpha-2|interferon alpha-2|mesh-list
92816116|NCT02763969|Ustekinumab|ustekinumab|mesh-list
92816117|NCT02763969|Famotidine|famotidine|mesh-list
92816118|NCT02763969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816119|NCT02763969|Antiviral Agents|antiviral agents|mesh-ancestor
92816120|NCT02763969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816121|NCT02763969|Immunologic Factors|immunologic factors|mesh-ancestor
92816122|NCT02763969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816123|NCT02763969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816124|NCT02763969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92816125|NCT02763969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816126|NCT02763969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92816127|NCT02763969|Histamine Antagonists|histamine antagonists|mesh-ancestor
92816128|NCT02763969|Histamine Agents|histamine agents|mesh-ancestor
92816129|NCT02763969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816130|NCT02763969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816131|NCT04660929|Pembrolizumab|pembrolizumab|mesh-list
92816132|NCT04660929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816133|NCT04660929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816134|NCT04660929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92816135|NCT04660929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816136|NCT02758587|Pembrolizumab|pembrolizumab|mesh-list
92816137|NCT02758587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816138|NCT02758587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816139|NCT02758587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92816140|NCT02758587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816141|NCT02758509|Interferons|interferons|mesh-list
92816142|NCT02758509|Ritonavir|ritonavir|mesh-list
92816143|NCT02758509|Ribavirin|ribavirin|mesh-list
92816144|NCT02758509|Interferon-alpha|interferon-alpha|mesh-list
92816145|NCT02758509|Interferon alpha-2|interferon alpha-2|mesh-list
92461164|NCT01749228|Etodolac|etodolac|mesh-list
92816146|NCT02758509|Sofosbuvir|sofosbuvir|mesh-list
92816147|NCT02758509|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92816148|NCT02758509|Ledipasvir|ledipasvir|mesh-list
92816149|NCT02758509|Simeprevir|simeprevir|mesh-list
92816150|NCT02758509|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92816151|NCT02758509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816152|NCT02758509|Antiviral Agents|antiviral agents|mesh-ancestor
92816153|NCT02758509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816154|NCT02758509|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92816155|NCT02758509|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92816156|NCT02758509|Protease Inhibitors|protease inhibitors|mesh-ancestor
92816157|NCT02758509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816158|NCT02758509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816159|NCT02758509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92816160|NCT02758509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92816161|NCT02758509|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92816162|NCT02758509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92816163|NCT02758509|Antimetabolites|antimetabolites|mesh-ancestor
92816164|NCT02758509|Immunologic Factors|immunologic factors|mesh-ancestor
92816165|NCT02758509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816166|NCT02762955|Adalimumab|adalimumab|mesh-list
92816167|NCT02762955|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92816168|NCT02762955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816169|NCT02762955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816170|NCT04191681|Valsartan|valsartan|mesh-list
92816171|NCT04191681|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92816172|NCT04191681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92816173|NCT04191681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92816174|NCT04191681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92816175|NCT04191681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816176|NCT02757651|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92816177|NCT02757651|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92816178|NCT02757651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816179|NCT02752503|Nalmefene|nalmefene|mesh-list
92816180|NCT02752503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92816181|NCT02752503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816182|NCT02752503|Sensory System Agents|sensory system agents|mesh-ancestor
92816183|NCT02752503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816184|NCT04479579|Apixaban|apixaban|mesh-list
92816185|NCT04479579|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92816186|NCT04479579|Antithrombins|antithrombins|mesh-ancestor
92816187|NCT04479579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92816188|NCT04479579|Protease Inhibitors|protease inhibitors|mesh-ancestor
92816189|NCT04479579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816190|NCT04479579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816191|NCT04479579|Anticoagulants|anticoagulants|mesh-ancestor
92816192|NCT02757495|Dexmedetomidine|dexmedetomidine|mesh-list
92816193|NCT02757495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92816194|NCT02757495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816195|NCT02757495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816196|NCT02757495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816197|NCT02757495|Analgesics|analgesics|mesh-ancestor
92816198|NCT02757495|Sensory System Agents|sensory system agents|mesh-ancestor
92816199|NCT02757495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816200|NCT02757495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92816201|NCT02757495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92816202|NCT02757495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92816203|NCT02757495|Adrenergic Agents|adrenergic agents|mesh-ancestor
92816204|NCT02757495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816205|NCT02757495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816206|NCT02757261|Salicylic Acid|salicylic acid|mesh-list
92816207|NCT02757261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816208|NCT02757261|Antifungal Agents|antifungal agents|mesh-ancestor
92816209|NCT02757261|Keratolytic Agents|keratolytic agents|mesh-ancestor
92816210|NCT02757261|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816211|NCT02752113|Metformin|metformin|mesh-list
92816212|NCT02752113|Empagliflozin|empagliflozin|mesh-list
92816213|NCT02752113|Linagliptin|linagliptin|mesh-list
92816215|NCT02752113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816216|NCT02752113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92816217|NCT02752113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816218|NCT02752113|Incretins|incretins|mesh-ancestor
92816219|NCT02752113|Hormones|hormones|mesh-ancestor
92461247|NCT01749475|Anesthetics|anesthetics|mesh-ancestor
92816220|NCT02752113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816221|NCT02752113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92816222|NCT02752113|Protease Inhibitors|protease inhibitors|mesh-ancestor
92816223|NCT02752113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816225|NCT02756715|Desflurane|desflurane|mesh-list
92816226|NCT02756715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92816227|NCT02756715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816228|NCT02756715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816229|NCT02756715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92816230|NCT02756715|Anesthetics, General|anesthetics, general|mesh-ancestor
92816231|NCT02756715|Anesthetics|anesthetics|mesh-ancestor
92816232|NCT02756715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92816233|NCT04221321|Atorvastatin|atorvastatin|mesh-list
92816234|NCT04221321|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92816235|NCT04221321|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92816236|NCT04221321|Antimetabolites|antimetabolites|mesh-ancestor
92816237|NCT04221321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816238|NCT04221321|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92816239|NCT04221321|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92816240|NCT04221321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816241|NCT02755857|Itraconazole|itraconazole|mesh-list
92816242|NCT02755857|Antifungal Agents|antifungal agents|mesh-ancestor
92816243|NCT02755857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816244|NCT02755857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92816245|NCT02755857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92816246|NCT02755857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816247|NCT02755857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816248|NCT02755857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92816249|NCT02755857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92816250|NCT02755857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816251|NCT02755857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816252|NCT02755857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92816253|NCT02755545|Salicylic Acid|salicylic acid|mesh-list
92816254|NCT02755545|Adapalene|adapalene|mesh-list
92816255|NCT02755545|Salicylates|salicylates|mesh-list
92816256|NCT02755545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92816257|NCT02755545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816258|NCT02755545|Analgesics|analgesics|mesh-ancestor
92816259|NCT02755545|Sensory System Agents|sensory system agents|mesh-ancestor
92816260|NCT02755545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816261|NCT02755545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816262|NCT02755545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816263|NCT02755545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816264|NCT02755545|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816265|NCT02755545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816266|NCT02755545|Antifungal Agents|antifungal agents|mesh-ancestor
92816267|NCT02755545|Keratolytic Agents|keratolytic agents|mesh-ancestor
92816268|NCT02755545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92816269|NCT02755545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816270|NCT02755545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816271|NCT02695797|Prednisolone|prednisolone|mesh-list
92816272|NCT02695797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816273|NCT02695797|Glucocorticoids|glucocorticoids|mesh-ancestor
92816274|NCT02695797|Hormones|hormones|mesh-ancestor
92816275|NCT02695797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816276|NCT02695797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816277|NCT02695797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92816278|NCT02695797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816279|NCT02755311|Cisplatin|cisplatin|mesh-list
92816280|NCT02755311|Carboplatin|carboplatin|mesh-list
92816281|NCT02755311|Fluorouracil|fluorouracil|mesh-list
92816282|NCT02755311|Epirubicin|epirubicin|mesh-list
92816283|NCT02755311|Ethiodized Oil|ethiodized oil|mesh-list
92816284|NCT02755311|Pirarubicin|pirarubicin|mesh-list
92816285|NCT02755311|Doxorubicin|doxorubicin|mesh-list
92816286|NCT02755311|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92816287|NCT02755311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816288|NCT02755311|Antimetabolites|antimetabolites|mesh-ancestor
92816289|NCT02755311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816290|NCT02755311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816291|NCT02755311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816292|NCT02755311|Immunologic Factors|immunologic factors|mesh-ancestor
92816293|NCT02755311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816294|NCT02755311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92816295|NCT02755311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92816296|NCT02755311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92816297|NCT02755311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816298|NCT02755311|Hemostatics|hemostatics|mesh-ancestor
92816299|NCT02755311|Coagulants|coagulants|mesh-ancestor
92816300|NCT04554771|Paclitaxel|paclitaxel|mesh-list
92816301|NCT04554771|Carboplatin|carboplatin|mesh-list
92816302|NCT04554771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92816303|NCT04554771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816304|NCT04554771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92816305|NCT04554771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92816306|NCT04554771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92816307|NCT04554771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816308|NCT02754765|Moxifloxacin|moxifloxacin|mesh-list
92816309|NCT02754765|Levofloxacin|levofloxacin|mesh-list
92816310|NCT02754765|Linezolid|linezolid|mesh-list
92816311|NCT02754765|Pyrazinamide|pyrazinamide|mesh-list
92816312|NCT02754765|Bedaquiline|bedaquiline|mesh-list
92816313|NCT02754765|Clofazimine|clofazimine|mesh-list
92816314|NCT02754765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92816315|NCT02754765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816316|NCT02754765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92816317|NCT02754765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92816318|NCT02754765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816319|NCT02754765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816320|NCT02754765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816321|NCT02754765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92816322|NCT02754765|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92816323|NCT02754765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92816324|NCT02754765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92816325|NCT02754765|Antitubercular Agents|antitubercular agents|mesh-ancestor
92816326|NCT02754765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816327|NCT02754765|Leprostatic Agents|leprostatic agents|mesh-ancestor
92816328|NCT04358289|Anti-Infective Agents|anti-infective agents|mesh-list
92816329|NCT04358289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92816330|NCT04090801|Ethanol|ethanol|mesh-list
92816331|NCT04090801|Minoxidil|minoxidil|mesh-list
92816332|NCT04090801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92816333|NCT04090801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816334|NCT04090801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816335|NCT04090801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816336|NCT04090801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92816337|NCT04090801|Vasodilator Agents|vasodilator agents|mesh-ancestor
92816338|NCT04089631|Capecitabine|capecitabine|mesh-list
92816339|NCT04089631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816340|NCT04089631|Antimetabolites|antimetabolites|mesh-ancestor
92816341|NCT04089631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816342|NCT04089631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816343|NCT00917059|Bupropion|bupropion|mesh-list
92816344|NCT00917059|Escitalopram|escitalopram|mesh-list
92816345|NCT00917059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92816346|NCT00917059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92816347|NCT00917059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92816348|NCT00917059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816349|NCT00917059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816350|NCT00917059|Serotonin Agents|serotonin agents|mesh-ancestor
92816351|NCT00917059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816352|NCT00917059|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92816353|NCT00917059|Antidepressive Agents|antidepressive agents|mesh-ancestor
92816354|NCT00917059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816355|NCT00917059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92816356|NCT00917059|Dopamine Agents|dopamine agents|mesh-ancestor
92816357|NCT00917059|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92816358|NCT00917059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92816359|NCT00917059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816360|NCT02754687|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92816361|NCT02754687|Nandrolone|nandrolone|mesh-list
92816362|NCT02754687|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92816364|NCT02754687|Hormones|hormones|mesh-ancestor
92816365|NCT02754687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816366|NCT02754687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816367|NCT02754687|Anabolic Agents|anabolic agents|mesh-ancestor
92816368|NCT02754687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92816369|NCT05429775|Budesonide|budesonide|mesh-list
92816370|NCT05429775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816371|NCT05429775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92816372|NCT05429775|Autonomic Agents|autonomic agents|mesh-ancestor
92816373|NCT05429775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816374|NCT05429775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816375|NCT05429775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92816376|NCT05429775|Respiratory System Agents|respiratory system agents|mesh-ancestor
92816377|NCT05429775|Glucocorticoids|glucocorticoids|mesh-ancestor
92816378|NCT05429775|Hormones|hormones|mesh-ancestor
92816379|NCT05429775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816380|NCT04220073|Antibodies|antibodies|mesh-list
92816381|NCT04220073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92816382|NCT04220073|Immunologic Factors|immunologic factors|mesh-ancestor
92816383|NCT04220073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816384|NCT05429151|Acyclovir|acyclovir|mesh-list
92816385|NCT05429151|Antiviral Agents|antiviral agents|mesh-ancestor
92816386|NCT05429151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816387|NCT04219995|Methylprednisolone|methylprednisolone|mesh-list
92816388|NCT04219995|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92816389|NCT04219995|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92816390|NCT04219995|Prednisolone|prednisolone|mesh-list
92816391|NCT04219995|Prednisolone acetate|prednisolone acetate|mesh-list
92816392|NCT04219995|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92816393|NCT04219995|Prednisolone phosphate|prednisolone phosphate|mesh-list
92816394|NCT04219995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816395|NCT04219995|Antiemetics|antiemetics|mesh-ancestor
92816396|NCT04219995|Autonomic Agents|autonomic agents|mesh-ancestor
92816397|NCT04219995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816398|NCT04219995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816399|NCT04219995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816400|NCT04219995|Glucocorticoids|glucocorticoids|mesh-ancestor
92816401|NCT04219995|Hormones|hormones|mesh-ancestor
92816402|NCT04219995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816403|NCT04219995|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92816404|NCT04219995|Protective Agents|protective agents|mesh-ancestor
92816405|NCT04219995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92816406|NCT04219995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816407|NCT04544475|Estrogens|estrogens|mesh-list
92816408|NCT04544475|Estradiol|estradiol|mesh-list
92816409|NCT04544475|Hormones|hormones|mesh-ancestor
92816410|NCT04544475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816411|NCT04544475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816412|NCT04200417|Mitomycins|mitomycins|mesh-list
92816413|NCT04200417|Mitomycin|mitomycin|mesh-list
92816414|NCT04200417|Ethiodized Oil|ethiodized oil|mesh-list
92816415|NCT04200417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92816416|NCT04200417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816417|NCT04200417|Alkylating Agents|alkylating agents|mesh-ancestor
92816418|NCT04200417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816419|NCT04200417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92816420|NCT04200417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816421|NCT02753205|Dexmedetomidine|dexmedetomidine|mesh-list
92816422|NCT02753205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92816423|NCT02753205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816424|NCT02753205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816425|NCT02753205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816426|NCT02753205|Analgesics|analgesics|mesh-ancestor
92816427|NCT02753205|Sensory System Agents|sensory system agents|mesh-ancestor
92816428|NCT02753205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816429|NCT02753205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92816430|NCT02753205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92816431|NCT02753205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92816432|NCT02753205|Adrenergic Agents|adrenergic agents|mesh-ancestor
92816433|NCT02753205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816434|NCT02753205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816435|NCT04188873|Varenicline|varenicline|mesh-list
92816436|NCT04188873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816437|NCT04188873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816438|NCT04188873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816439|NCT04188873|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92816440|NCT04188873|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92816441|NCT04188873|Cholinergic Agents|cholinergic agents|mesh-ancestor
92816442|NCT02695641|Bevacizumab|bevacizumab|mesh-list
92816443|NCT02695641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816444|NCT02695641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816446|NCT02695641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92816447|NCT02695641|Growth Substances|growth substances|mesh-ancestor
92816448|NCT02695641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816449|NCT02695641|Growth Inhibitors|growth inhibitors|mesh-ancestor
92816450|NCT02750475|Sunscreening Agents|sunscreening agents|mesh-list
92816451|NCT02750475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92816452|NCT02750475|Protective Agents|protective agents|mesh-ancestor
92816453|NCT02750475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816454|NCT02750475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816455|NCT04217265|Letrozole|letrozole|mesh-list
92816456|NCT04217265|Misoprostol|misoprostol|mesh-list
92816457|NCT04217265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816458|NCT04217265|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92816459|NCT04217265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92816460|NCT04217265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816461|NCT04217265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816462|NCT04217265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92816463|NCT04217265|Hormone Antagonists|hormone antagonists|mesh-ancestor
92816464|NCT04217265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816465|NCT04217265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816466|NCT04217265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92816467|NCT04217265|Abortifacient Agents|abortifacient agents|mesh-ancestor
92816468|NCT04217265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816469|NCT04217265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92816470|NCT04217265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816471|NCT04217265|Oxytocics|oxytocics|mesh-ancestor
92816472|NCT00635973|Gefitinib|gefitinib|mesh-list
92816473|NCT00635973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816474|NCT00635973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92816475|NCT00635973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816476|NCT00635973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816477|NCT02752971|Diclofenac|diclofenac|mesh-list
92816478|NCT02752971|Bupivacaine|bupivacaine|mesh-list
92816479|NCT02752971|Anesthetics, Local|anesthetics, local|mesh-ancestor
92816480|NCT02752971|Anesthetics|anesthetics|mesh-ancestor
92816481|NCT02752971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816482|NCT02752971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816483|NCT02752971|Sensory System Agents|sensory system agents|mesh-ancestor
92816484|NCT02752971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816485|NCT02752971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92816486|NCT02752971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816487|NCT02752971|Analgesics|analgesics|mesh-ancestor
92816488|NCT02752971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816489|NCT02752971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816490|NCT02752971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92816491|NCT02752971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816492|NCT02752971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816493|NCT02750163|Acetaminophen|acetaminophen|mesh-list
92816494|NCT02750163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816495|NCT02750163|Analgesics|analgesics|mesh-ancestor
92816496|NCT02750163|Sensory System Agents|sensory system agents|mesh-ancestor
92816497|NCT02750163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816498|NCT02750163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816499|NCT02750163|Antipyretics|antipyretics|mesh-ancestor
92816500|NCT04217421|Allopurinol|allopurinol|mesh-list
92816501|NCT04217421|Mannitol|mannitol|mesh-list
92816502|NCT04217421|Antimetabolites|antimetabolites|mesh-ancestor
92816503|NCT04217421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816504|NCT04217421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816505|NCT04217421|Gout Suppressants|gout suppressants|mesh-ancestor
92816506|NCT04217421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816507|NCT04217421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92816508|NCT04217421|Antioxidants|antioxidants|mesh-ancestor
92816509|NCT04217421|Protective Agents|protective agents|mesh-ancestor
92816510|NCT04217421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816511|NCT04217421|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92816512|NCT04217421|Diuretics|diuretics|mesh-ancestor
92816513|NCT04217421|Natriuretic Agents|natriuretic agents|mesh-ancestor
92816514|NCT04036929|Bazedoxifene|bazedoxifene|mesh-list
92816515|NCT04036929|Estrogens|estrogens|mesh-list
92461541|NCT01751828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816516|NCT04036929|Hormones|hormones|mesh-ancestor
92816517|NCT04036929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816518|NCT04036929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816519|NCT04036929|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92816520|NCT04036929|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92816522|NCT04036929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92816523|NCT04281147|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92816524|NCT04281147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816525|NCT04218981|Antipsychotic Agents|antipsychotic agents|mesh-list
92816526|NCT04218981|Paroxetine|paroxetine|mesh-list
92816527|NCT04218981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92816528|NCT04218981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92816529|NCT04218981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92816530|NCT04218981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816531|NCT04218981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816532|NCT04218981|Serotonin Agents|serotonin agents|mesh-ancestor
92816533|NCT04218981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816534|NCT04218981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92816535|NCT04218981|Antidepressive Agents|antidepressive agents|mesh-ancestor
92816536|NCT04218981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816537|NCT04218981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92816538|NCT04218981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92816539|NCT04218981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816540|NCT04218981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92816541|NCT04218981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816542|NCT04218513|Edaravone|edaravone|mesh-list
92816543|NCT04218513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92816544|NCT04218513|Antioxidants|antioxidants|mesh-ancestor
92816545|NCT04218513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816546|NCT04218513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92816547|NCT04218513|Protective Agents|protective agents|mesh-ancestor
92816548|NCT04218513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816549|NCT04218435|Valsartan|valsartan|mesh-list
92816550|NCT04218435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92816551|NCT04218435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92816552|NCT04218435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92816553|NCT04218435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92816554|NCT04218435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816555|NCT04138875|Rituximab|rituximab|mesh-list
92816556|NCT04138875|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92816557|NCT04138875|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92816558|NCT04138875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816559|NCT04138875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816560|NCT04138875|Immunologic Factors|immunologic factors|mesh-ancestor
92816561|NCT04138875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816562|NCT04138875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816563|NCT04138875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92816564|NCT04138875|Alkylating Agents|alkylating agents|mesh-ancestor
92816565|NCT04138875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816566|NCT04138875|Immunotoxins|immunotoxins|mesh-ancestor
92816567|NCT04138875|Immunoconjugates|immunoconjugates|mesh-ancestor
92816568|NCT02748135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92816569|NCT02748135|Immunologic Factors|immunologic factors|mesh-ancestor
92816570|NCT02748135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816571|NCT02695563|Lactoferrin|lactoferrin|mesh-list
92816572|NCT02695563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816573|NCT02747823|Bevacizumab|bevacizumab|mesh-list
92816574|NCT02747823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816575|NCT02747823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816576|NCT02747823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92816577|NCT02747823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92816578|NCT02747823|Growth Substances|growth substances|mesh-ancestor
92816579|NCT02747823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816580|NCT02747823|Growth Inhibitors|growth inhibitors|mesh-ancestor
92816581|NCT02747511|Haloperidol|haloperidol|mesh-list
92816582|NCT02747511|Haloperidol decanoate|haloperidol decanoate|mesh-list
92816583|NCT02747511|Antiemetics|antiemetics|mesh-ancestor
92816584|NCT02747511|Autonomic Agents|autonomic agents|mesh-ancestor
92816585|NCT02747511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816586|NCT02747511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816587|NCT02747511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816588|NCT02747511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92816589|NCT02747511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461615|NCT01752322|Sensory System Agents|sensory system agents|mesh-ancestor
92816590|NCT02747511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816591|NCT02747511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816592|NCT02747511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92816593|NCT02747511|Dopamine Agents|dopamine agents|mesh-ancestor
92816594|NCT02747511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816595|NCT02747511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816596|NCT02747511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92816597|NCT04217733|Ethosuximide|ethosuximide|mesh-list
92816599|NCT04217733|Alverine|alverine|mesh-list
92816600|NCT04217733|Anticonvulsants|anticonvulsants|mesh-ancestor
92816601|NCT04217733|Parasympatholytics|parasympatholytics|mesh-ancestor
92816602|NCT04217733|Autonomic Agents|autonomic agents|mesh-ancestor
92816603|NCT04217733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816604|NCT04217733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816605|NCT00636285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92816606|NCT00636285|Immunologic Factors|immunologic factors|mesh-ancestor
92816607|NCT00636285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816608|NCT02746185|Heparin|heparin|mesh-list
92816609|NCT02746185|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92816610|NCT02746185|Tinzaparin|tinzaparin|mesh-list
92816611|NCT02746185|Dalteparin|dalteparin|mesh-list
92816612|NCT02746185|Rivaroxaban|rivaroxaban|mesh-list
92816613|NCT02746185|Anticoagulants|anticoagulants|mesh-ancestor
92816614|NCT02746185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92816615|NCT02746185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92816616|NCT02746185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816617|NCT02746185|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92816618|NCT02746185|Antithrombins|antithrombins|mesh-ancestor
92816619|NCT02746185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92816620|NCT02746185|Protease Inhibitors|protease inhibitors|mesh-ancestor
92816621|NCT02746185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816622|NCT02742051|Cyclophosphamide|cyclophosphamide|mesh-list
92816623|NCT02742051|Fluorouracil|fluorouracil|mesh-list
92816624|NCT02742051|Everolimus|everolimus|mesh-list
92816625|NCT02742051|Letrozole|letrozole|mesh-list
92816626|NCT02742051|Epirubicin|epirubicin|mesh-list
92816627|NCT02742051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816628|NCT02742051|Immunologic Factors|immunologic factors|mesh-ancestor
92816629|NCT02742051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816630|NCT02742051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816631|NCT02742051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92816632|NCT02742051|Alkylating Agents|alkylating agents|mesh-ancestor
92816633|NCT02742051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816634|NCT02742051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816635|NCT02742051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92816636|NCT02742051|Antimetabolites|antimetabolites|mesh-ancestor
92816637|NCT02742051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816638|NCT02742051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92816639|NCT02742051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92816640|NCT02742051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816641|NCT02742051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92816642|NCT02742051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92816643|NCT02742051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92816644|NCT02742051|Hormone Antagonists|hormone antagonists|mesh-ancestor
92816645|NCT02742051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816646|NCT02742051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92816647|NCT02742051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92816648|NCT02742051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92816649|NCT02741817|Aspirin|aspirin|mesh-list
92816650|NCT02741817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92816651|NCT02741817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816652|NCT02741817|Analgesics|analgesics|mesh-ancestor
92816653|NCT02741817|Sensory System Agents|sensory system agents|mesh-ancestor
92816654|NCT02741817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816655|NCT02741817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816656|NCT02741817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816657|NCT02741817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816658|NCT02741817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92816659|NCT02741817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92816660|NCT02741817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816661|NCT02741817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92816662|NCT02741817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92816663|NCT02741817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816664|NCT02741817|Antipyretics|antipyretics|mesh-ancestor
92816665|NCT02745873|Ascorbic Acid|ascorbic acid|mesh-list
92816666|NCT02745873|Vitamins|vitamins|mesh-ancestor
92816667|NCT02745873|Micronutrients|micronutrients|mesh-ancestor
92816668|NCT02745873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816669|NCT02745873|Antioxidants|antioxidants|mesh-ancestor
92816670|NCT02745873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816671|NCT02745873|Protective Agents|protective agents|mesh-ancestor
92816672|NCT02745639|Capecitabine|capecitabine|mesh-list
92816673|NCT02745639|Oxaliplatin|oxaliplatin|mesh-list
92816674|NCT02745639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816675|NCT02745639|Antimetabolites|antimetabolites|mesh-ancestor
92816676|NCT02745639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816677|NCT02745639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816678|NCT02745717|Cyclosporine|cyclosporine|mesh-list
92816679|NCT02745717|Cyclosporins|cyclosporins|mesh-list
92816680|NCT02745717|Thymoglobulin|thymoglobulin|mesh-list
92816681|NCT02745717|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92816682|NCT02745717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816683|NCT02745717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816684|NCT02745717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816685|NCT02745717|Immunologic Factors|immunologic factors|mesh-ancestor
92816686|NCT02745717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816687|NCT02745717|Antifungal Agents|antifungal agents|mesh-ancestor
92816688|NCT02745717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816689|NCT02745717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816690|NCT02745717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816691|NCT02745717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92816692|NCT02745561|Oxaliplatin|oxaliplatin|mesh-list
92816693|NCT02745561|Endostatins|endostatins|mesh-list
92816694|NCT02745561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816695|NCT02745561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92816696|NCT02745561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92816697|NCT02745561|Growth Substances|growth substances|mesh-ancestor
92816698|NCT02745561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816699|NCT02745561|Growth Inhibitors|growth inhibitors|mesh-ancestor
92816700|NCT02741427|Carbamide Peroxide|carbamide peroxide|mesh-list
92816701|NCT02741427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92816702|NCT02741427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816703|NCT02745093|Misoprostol|misoprostol|mesh-list
92816704|NCT02745093|Mifepristone|mifepristone|mesh-list
92816705|NCT02745093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92816706|NCT02745093|Abortifacient Agents|abortifacient agents|mesh-ancestor
92816707|NCT02745093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816708|NCT02745093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816709|NCT02745093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92816710|NCT02745093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92816711|NCT02745093|Oxytocics|oxytocics|mesh-ancestor
92816712|NCT02745093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92816713|NCT02745093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92816714|NCT02745093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92816715|NCT02745093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92816716|NCT02745093|Contraceptive Agents|contraceptive agents|mesh-ancestor
92816717|NCT02745093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92816718|NCT02745093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92816719|NCT02745093|Hormone Antagonists|hormone antagonists|mesh-ancestor
92816720|NCT02745093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816721|NCT02745093|Luteolytic Agents|luteolytic agents|mesh-ancestor
92816722|NCT02745093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92816723|NCT02745093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92816724|NCT00839254|Vaccines|vaccines|mesh-list
92816725|NCT00839254|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92816726|NCT00839254|Immunologic Factors|immunologic factors|mesh-ancestor
92816727|NCT00839254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816728|NCT02741115|Udenafil|udenafil|mesh-list
92816729|NCT02741115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92816730|NCT02741115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92816731|NCT02741115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816732|NCT02741115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816735|NCT02740803|Sodium Fluoride|sodium fluoride|mesh-list
92816736|NCT02740803|Tin Fluorides|tin fluorides|mesh-list
92816737|NCT02740803|Fluorophosphate|fluorophosphate|mesh-list
92816738|NCT02740803|Cariostatic Agents|cariostatic agents|mesh-ancestor
92816739|NCT02740803|Protective Agents|protective agents|mesh-ancestor
92816740|NCT02740803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816741|NCT02740803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92816742|NCT02740803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816744|NCT02740647|Clavulanic Acid|clavulanic acid|mesh-list
92816745|NCT02740647|Clavulanic Acids|clavulanic acids|mesh-list
92816746|NCT02740647|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92816747|NCT02740647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92816748|NCT02740647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816749|NCT02740647|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92816750|NCT02740647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816751|NCT02740647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816752|NCT03737253|Menotropins|menotropins|mesh-list
92816753|NCT03737253|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92816754|NCT03737253|Hormones|hormones|mesh-ancestor
92816755|NCT03737253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816756|NCT03737253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816757|NCT03737253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92816758|NCT03737253|Fertility Agents|fertility agents|mesh-ancestor
92816759|NCT03737253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816760|NCT00812968|Lenalidomide|lenalidomide|mesh-list
92816761|NCT00812968|Immunologic Factors|immunologic factors|mesh-ancestor
92816762|NCT00812968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816763|NCT00812968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92816764|NCT00812968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92816765|NCT00812968|Growth Substances|growth substances|mesh-ancestor
92816766|NCT00812968|Growth Inhibitors|growth inhibitors|mesh-ancestor
92816767|NCT00812968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816768|NCT02744703|Capecitabine|capecitabine|mesh-list
92816769|NCT02744703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92816770|NCT02744703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816771|NCT02744703|Antimetabolites|antimetabolites|mesh-ancestor
92816772|NCT02744703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816773|NCT02744703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816774|NCT02744937|Aspirin|aspirin|mesh-list
92816775|NCT02744937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92816776|NCT02744937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92816777|NCT02744937|Analgesics|analgesics|mesh-ancestor
92816778|NCT02744937|Sensory System Agents|sensory system agents|mesh-ancestor
92816779|NCT02744937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816780|NCT02744937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816781|NCT02744937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92816782|NCT02744937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92816783|NCT02744937|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92816784|NCT02744937|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92816785|NCT02744937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816786|NCT02744937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92816787|NCT02744937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92816788|NCT02744937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816789|NCT02744937|Antipyretics|antipyretics|mesh-ancestor
92816790|NCT02744625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92816791|NCT02744625|Propofol|propofol|mesh-list
92816792|NCT02744625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92816793|NCT02744625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92816794|NCT02744625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816795|NCT02744625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92816796|NCT02744625|Anesthetics, General|anesthetics, general|mesh-ancestor
92816797|NCT02744625|Anesthetics|anesthetics|mesh-ancestor
92816798|NCT02610556|Cisplatin|cisplatin|mesh-list
92816799|NCT02610556|Docetaxel|docetaxel|mesh-list
92816800|NCT02610556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816801|NCT02610556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92816802|NCT02610556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92816803|NCT02610556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92816804|NCT02610556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816805|NCT02740101|Oxytocin|oxytocin|mesh-list
92816806|NCT02740101|Oxytocics|oxytocics|mesh-ancestor
92816807|NCT02740101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816808|NCT02740101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816810|NCT02612116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92816811|NCT02612116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92816812|NCT02612116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92816813|NCT02612116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92816814|NCT02612116|Purinergic Agents|purinergic agents|mesh-ancestor
92816815|NCT02612116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816816|NCT02612116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816817|NCT02612116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816819|NCT00813748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92816820|NCT00813748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92816821|NCT00813748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92816822|NCT00813592|Pasireotide|pasireotide|mesh-list
92816823|NCT00813592|Hormones|hormones|mesh-ancestor
92816824|NCT00813592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816825|NCT00813592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816826|NCT02739633|Paclitaxel|paclitaxel|mesh-list
92816827|NCT02739633|genexol-PM|genexol-pm|mesh-list
92816828|NCT02739633|Gemcitabine|gemcitabine|mesh-list
92816829|NCT02739633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92816830|NCT02739633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816831|NCT02739633|Tubulin Modulators|tubulin modulators|mesh-ancestor
92816832|NCT02739633|Antimitotic Agents|antimitotic agents|mesh-ancestor
92816833|NCT02739633|Mitosis Modulators|mitosis modulators|mesh-ancestor
92816834|NCT02739633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816835|NCT02739633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92816836|NCT02739633|Antimetabolites|antimetabolites|mesh-ancestor
92816837|NCT02739477|Favipiravir|favipiravir|mesh-list
92816838|NCT02739477|Antiviral Agents|antiviral agents|mesh-ancestor
92816839|NCT02739477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816840|NCT02739399|Phenylephrine|phenylephrine|mesh-list
92816841|NCT02739399|Oxymetazoline|oxymetazoline|mesh-list
92816842|NCT02739399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92816843|NCT02739399|Mydriatics|mydriatics|mesh-ancestor
92816844|NCT02739399|Autonomic Agents|autonomic agents|mesh-ancestor
92816845|NCT02739399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92816846|NCT02739399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816847|NCT02739399|Sympathomimetics|sympathomimetics|mesh-ancestor
92816848|NCT02739399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92816849|NCT02739399|Nasal Decongestants|nasal decongestants|mesh-ancestor
92816850|NCT02739399|Respiratory System Agents|respiratory system agents|mesh-ancestor
92816851|NCT02739399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92816852|NCT02739399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92816853|NCT02739399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92816854|NCT02739399|Adrenergic Agents|adrenergic agents|mesh-ancestor
92816855|NCT02739399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816856|NCT02739399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816857|NCT02739399|Protective Agents|protective agents|mesh-ancestor
92816858|NCT02743065|Doxorubicin|doxorubicin|mesh-list
92816859|NCT02743065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92816860|NCT02743065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816861|NCT02743065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92816862|NCT02743065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92816863|NCT02743065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816864|NCT02743065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816865|NCT02742909|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92816866|NCT02742909|Natriuretic Agents|natriuretic agents|mesh-ancestor
92816867|NCT02742909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816868|NCT02742675|Leuprolide|leuprolide|mesh-list
92816869|NCT02742675|Goserelin|goserelin|mesh-list
92816870|NCT02742675|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92816871|NCT02742675|Flutamide|flutamide|mesh-list
92816872|NCT02742675|Bicalutamide|bicalutamide|mesh-list
92816873|NCT02742675|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92816874|NCT02742675|Fertility Agents|fertility agents|mesh-ancestor
92816875|NCT02742675|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816876|NCT02742675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816877|NCT02742675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92816878|NCT02742675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816879|NCT02742675|Androgen Antagonists|androgen antagonists|mesh-ancestor
92816880|NCT02742675|Hormone Antagonists|hormone antagonists|mesh-ancestor
92816881|NCT02742675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816882|NCT02742675|Luteolytic Agents|luteolytic agents|mesh-ancestor
92816883|NCT02742675|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92816884|NCT02742675|Contraceptive Agents|contraceptive agents|mesh-ancestor
92816885|NCT02742675|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92816887|NCT00812812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92816888|NCT00812812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92816889|NCT00812812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92816890|NCT00812812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461914|NCT01755286|Ciprofloxacin|ciprofloxacin|mesh-list
92816891|NCT00812812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816892|NCT00812812|Serotonin Agents|serotonin agents|mesh-ancestor
92816893|NCT00812812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816894|NCT00812812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92816895|NCT00812812|Antidepressive Agents|antidepressive agents|mesh-ancestor
92816896|NCT00812812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816897|NCT00812812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92816898|NCT00812812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92816899|NCT00812812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816900|NCT02742285|Lumefantrine|lumefantrine|mesh-list
92816901|NCT02742285|Artemether|artemether|mesh-list
92816902|NCT02742285|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92816903|NCT02742285|Antimalarials|antimalarials|mesh-ancestor
92816904|NCT02742285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92816905|NCT02742285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92816906|NCT02742285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816907|NCT03673527|Tacrolimus|tacrolimus|mesh-list
92816908|NCT03673527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816909|NCT03673527|Immunologic Factors|immunologic factors|mesh-ancestor
92816910|NCT03673527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816911|NCT03673527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92816912|NCT03673527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816913|NCT03673527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816914|NCT02738931|Lamivudine|lamivudine|mesh-list
92816915|NCT02738931|Dolutegravir|dolutegravir|mesh-list
92816916|NCT02738931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92816917|NCT02738931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92816918|NCT02738931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816919|NCT02738931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816920|NCT02738931|Antiviral Agents|antiviral agents|mesh-ancestor
92816921|NCT02738931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92816922|NCT02738931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92816923|NCT02738931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92816924|NCT02738931|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92816925|NCT02738931|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92816926|NCT02738619|Vitamin D|vitamin d|mesh-list
92816927|NCT02738619|Ergocalciferols|ergocalciferols|mesh-list
92816928|NCT02738619|Cholecalciferol|cholecalciferol|mesh-list
92816929|NCT02738619|Vitamins|vitamins|mesh-list
92816930|NCT02738619|Micronutrients|micronutrients|mesh-ancestor
92816931|NCT02738619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816932|NCT02738619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92816933|NCT02738619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92816934|NCT04016116|Pembrolizumab|pembrolizumab|mesh-list
92816935|NCT04016116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816936|NCT04016116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816937|NCT04016116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92816938|NCT04016116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816939|NCT02736591|Hormones|hormones|mesh-list
92816940|NCT02736591|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92816941|NCT02736591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92816942|NCT02736591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816943|NCT05757466|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92816944|NCT05757466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92816945|NCT05757466|Alkylating Agents|alkylating agents|mesh-ancestor
92816946|NCT05757466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816947|NCT05757466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816948|NCT02736513|Osimertinib|osimertinib|mesh-list
92816949|NCT02736513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816950|NCT02736513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92816951|NCT02736513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816952|NCT02736513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816953|NCT02736435|Leuprolide|leuprolide|mesh-list
92816954|NCT02736435|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92816955|NCT02736435|Fertility Agents|fertility agents|mesh-ancestor
92816956|NCT02736435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92816957|NCT02736435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816958|NCT02736435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92816959|NCT02736435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816960|NCT02736279|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92816961|NCT02736279|Dermatologic Agents|dermatologic agents|mesh-ancestor
92816962|NCT02736279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92816963|NCT02736279|Immunologic Factors|immunologic factors|mesh-ancestor
92461988|NCT01755520|Aspirin|aspirin|mesh-list
92816964|NCT02736279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816966|NCT00748189|Chlorambucil|chlorambucil|mesh-list
92816967|NCT00748189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816968|NCT00748189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92816969|NCT00748189|Alkylating Agents|alkylating agents|mesh-ancestor
92816970|NCT00748189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816971|NCT02609230|TIC10 compound|tic10 compound|mesh-list
92816972|NCT02609230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816973|NCT00913822|Desipramine|desipramine|mesh-list
92816974|NCT00913822|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92816975|NCT00913822|Antidepressive Agents|antidepressive agents|mesh-ancestor
92816976|NCT00913822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92816977|NCT00913822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92816978|NCT00913822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816979|NCT00913822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92816980|NCT00913822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92816981|NCT00913822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92816982|NCT00913822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92816983|NCT00913822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816984|NCT00913822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92816985|NCT02736123|Nivolumab|nivolumab|mesh-list
92816986|NCT02736123|Ipilimumab|ipilimumab|mesh-list
92816987|NCT02736123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92816988|NCT02736123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92816989|NCT02736123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92816990|NCT02736123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816991|NCT00744055|Prazosin|prazosin|mesh-list
92816992|NCT00744055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92816993|NCT00744055|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92816994|NCT00744055|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92816995|NCT00744055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92816996|NCT00744055|Adrenergic Agents|adrenergic agents|mesh-ancestor
92816997|NCT00744055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92816998|NCT00744055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92816999|NCT00744055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817000|NCT02738073|Tranexamic Acid|tranexamic acid|mesh-list
92817001|NCT02738073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92817002|NCT02738073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92817003|NCT02738073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817004|NCT02738073|Hemostatics|hemostatics|mesh-ancestor
92817005|NCT02738073|Coagulants|coagulants|mesh-ancestor
92817006|NCT03967483|Indomethacin|indomethacin|mesh-list
92817007|NCT03967483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92817008|NCT03967483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92817009|NCT03967483|Analgesics|analgesics|mesh-ancestor
92817010|NCT03967483|Sensory System Agents|sensory system agents|mesh-ancestor
92817011|NCT03967483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817012|NCT03967483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817013|NCT03967483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817014|NCT03967483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92817015|NCT03967483|Gout Suppressants|gout suppressants|mesh-ancestor
92817016|NCT03967483|Tocolytic Agents|tocolytic agents|mesh-ancestor
92817017|NCT03967483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92817018|NCT03967483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92817019|NCT03967483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817020|NCT03967483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817021|NCT00740779|Silodosin|silodosin|mesh-list
92817022|NCT00740779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92817023|NCT00740779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92817024|NCT00740779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92817025|NCT00740779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92817026|NCT00740779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817027|NCT00740779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817028|NCT00740779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817029|NCT00740779|Urological Agents|urological agents|mesh-ancestor
92817030|NCT00735475|Vaccines|vaccines|mesh-list
92817031|NCT00735475|Immunologic Factors|immunologic factors|mesh-ancestor
92817032|NCT00735475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817033|NCT01026818|Tadalafil|tadalafil|mesh-list
92817034|NCT01026818|Vasodilator Agents|vasodilator agents|mesh-ancestor
92817035|NCT01026818|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92817036|NCT01026818|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92817037|NCT01026818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817038|NCT01026818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817039|NCT01026818|Urological Agents|urological agents|mesh-ancestor
92817040|NCT02593747|Loratadine|loratadine|mesh-list
92817041|NCT02593747|Antipruritics|antipruritics|mesh-ancestor
92817042|NCT02593747|Dermatologic Agents|dermatologic agents|mesh-ancestor
92817043|NCT02593747|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92817044|NCT02593747|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92817045|NCT02593747|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92817046|NCT02593747|Histamine Antagonists|histamine antagonists|mesh-ancestor
92817047|NCT02593747|Histamine Agents|histamine agents|mesh-ancestor
92817048|NCT02593747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817049|NCT02593747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817050|NCT02593747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817051|NCT00743509|Sirolimus|sirolimus|mesh-list
92817052|NCT00743509|Cyclophosphamide|cyclophosphamide|mesh-list
92817053|NCT00743509|Temsirolimus|temsirolimus|mesh-list
92817054|NCT00743509|MTOR Inhibitors|mtor inhibitors|mesh-list
92817055|NCT00743509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92817056|NCT00743509|Immunologic Factors|immunologic factors|mesh-ancestor
92817057|NCT00743509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817058|NCT00743509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92817059|NCT00743509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92817060|NCT00743509|Alkylating Agents|alkylating agents|mesh-ancestor
92817061|NCT00743509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817062|NCT00743509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817063|NCT00743509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92817064|NCT00743509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92817065|NCT00743509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817066|NCT00743509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92817067|NCT00743509|Antifungal Agents|antifungal agents|mesh-ancestor
92817068|NCT00743509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817069|NCT00743509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817070|NCT00734929|Dexamethasone|dexamethasone|mesh-list
92817071|NCT00734929|Dexamethasone acetate|dexamethasone acetate|mesh-list
92817072|NCT00734929|Ondansetron|ondansetron|mesh-list
92817073|NCT00734929|Aprepitant|aprepitant|mesh-list
92817074|NCT00734929|BB 1101|bb 1101|mesh-list
92817075|NCT00734929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817076|NCT00734929|Antiemetics|antiemetics|mesh-ancestor
92817077|NCT00734929|Autonomic Agents|autonomic agents|mesh-ancestor
92817078|NCT00734929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817079|NCT00734929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817080|NCT00734929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718930|NCT02179151|CKD732|ckd732|mesh-list
92817081|NCT00734929|Glucocorticoids|glucocorticoids|mesh-ancestor
92817082|NCT00734929|Hormones|hormones|mesh-ancestor
92817083|NCT00734929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817084|NCT00734929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92817085|NCT00734929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817086|NCT00734929|Protease Inhibitors|protease inhibitors|mesh-ancestor
92817087|NCT00734929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817088|NCT00734929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817089|NCT00734929|Antipruritics|antipruritics|mesh-ancestor
92817090|NCT00734929|Dermatologic Agents|dermatologic agents|mesh-ancestor
92817091|NCT00734929|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92817092|NCT00734929|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92817093|NCT00734929|Serotonin Agents|serotonin agents|mesh-ancestor
92817094|NCT00734929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817095|NCT00734929|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92817096|NCT00734851|Docetaxel|docetaxel|mesh-list
92817097|NCT00734851|Sunitinib|sunitinib|mesh-list
92817098|NCT00734851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817099|NCT00734851|Tubulin Modulators|tubulin modulators|mesh-ancestor
92817100|NCT00734851|Antimitotic Agents|antimitotic agents|mesh-ancestor
92817101|NCT00734851|Mitosis Modulators|mitosis modulators|mesh-ancestor
92817102|NCT00734851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817103|NCT00734851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92433085|NCT01572454|Analgesics|analgesics|mesh-ancestor
92817104|NCT00734851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92817105|NCT00734851|Growth Substances|growth substances|mesh-ancestor
92817106|NCT00734851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817107|NCT00734851|Growth Inhibitors|growth inhibitors|mesh-ancestor
92817108|NCT00734851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817109|NCT00734851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817110|NCT00734617|Nicotine|nicotine|mesh-list
92817111|NCT00734617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92817112|NCT00734617|Autonomic Agents|autonomic agents|mesh-ancestor
92817113|NCT00734617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817114|NCT00734617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817115|NCT00734617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92817116|NCT00734617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92817117|NCT00734617|Cholinergic Agents|cholinergic agents|mesh-ancestor
92817118|NCT00734617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817119|NCT00734617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817120|NCT00743431|Doxorubicin|doxorubicin|mesh-list
92817121|NCT00743431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92817122|NCT00743431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817123|NCT00743431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92817124|NCT00743431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92817125|NCT00743431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817126|NCT00743431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817127|NCT02737605|Moxifloxacin|moxifloxacin|mesh-list
92817128|NCT02737605|Esketamine|esketamine|mesh-list
92817129|NCT02737605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92817130|NCT02737605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817131|NCT02737605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92817132|NCT02737605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92817133|NCT02737605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817134|NCT02737605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817135|NCT02737605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817136|NCT02737605|Antidepressive Agents|antidepressive agents|mesh-ancestor
92817137|NCT02737605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817138|NCT02737371|Antifungal Agents|antifungal agents|mesh-list
92817139|NCT02737371|Clotrimazole|clotrimazole|mesh-list
92817140|NCT02737371|Miconazole|miconazole|mesh-list
92817141|NCT02737371|Olorofim|olorofim|mesh-list
92817142|NCT02737371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817143|NCT02737371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92817144|NCT02737371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92817145|NCT02737371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92817146|NCT02737371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817147|NCT02737371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817148|NCT02737371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92817149|NCT02737371|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817150|NCT02737371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817151|NCT02737371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817152|NCT02737371|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92817153|NCT02737371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92817154|NCT02737527|Levobupivacaine|levobupivacaine|mesh-list
92817155|NCT02737527|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817156|NCT02737527|Anesthetics|anesthetics|mesh-ancestor
92817157|NCT02737527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817158|NCT02737527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817159|NCT02737527|Sensory System Agents|sensory system agents|mesh-ancestor
92817160|NCT02737527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817161|NCT00734539|Fluconazole|fluconazole|mesh-list
92817162|NCT00734539|Antifungal Agents|antifungal agents|mesh-ancestor
92817163|NCT00734539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817164|NCT00734539|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92817165|NCT00734539|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92817166|NCT00734539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817167|NCT00734539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817168|NCT00734539|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92817169|NCT00734539|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817170|NCT00734539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817171|NCT00734539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817172|NCT00734539|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92817173|NCT00734539|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92817174|NCT02737059|Codeine|codeine|mesh-list
92817175|NCT02737059|Naloxegol|naloxegol|mesh-list
92817176|NCT02737059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92817178|NCT02737059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817179|NCT02737059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817180|NCT02737059|Analgesics|analgesics|mesh-ancestor
92817181|NCT02737059|Sensory System Agents|sensory system agents|mesh-ancestor
92817182|NCT02737059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817183|NCT02737059|Antitussive Agents|antitussive agents|mesh-ancestor
92462215|NCT01756521|Moxifloxacin|moxifloxacin|mesh-list
92817184|NCT02737059|Respiratory System Agents|respiratory system agents|mesh-ancestor
92817185|NCT02737059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92817187|NCT02731911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817188|NCT02731911|Antiemetics|antiemetics|mesh-ancestor
92817189|NCT02731911|Autonomic Agents|autonomic agents|mesh-ancestor
92817190|NCT02731911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817191|NCT02731911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817192|NCT02731911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92817193|NCT02731911|Glucocorticoids|glucocorticoids|mesh-ancestor
92817194|NCT02731911|Hormones|hormones|mesh-ancestor
92817195|NCT02731911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817196|NCT02731911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92817197|NCT02731911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817198|NCT00734149|Prednisone|prednisone|mesh-list
92817199|NCT00734149|Bortezomib|bortezomib|mesh-list
92817200|NCT00734149|Melphalan|melphalan|mesh-list
92817201|NCT00734149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817202|NCT00734149|Glucocorticoids|glucocorticoids|mesh-ancestor
92817203|NCT00734149|Hormones|hormones|mesh-ancestor
92817204|NCT00734149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817205|NCT00734149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817206|NCT00734149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92817207|NCT00734149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817208|NCT00734149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92817209|NCT00734149|Alkylating Agents|alkylating agents|mesh-ancestor
92817210|NCT00734149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817211|NCT00734149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92817212|NCT00734149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92817213|NCT00734149|Immunologic Factors|immunologic factors|mesh-ancestor
92817214|NCT04089163|Flucytosine|flucytosine|mesh-list
92817215|NCT04089163|Antifungal Agents|antifungal agents|mesh-ancestor
92817216|NCT04089163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817217|NCT04089163|Antimetabolites|antimetabolites|mesh-ancestor
92817218|NCT04089163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817219|NCT00743197|Aspirin|aspirin|mesh-list
92817220|NCT00743197|Lisinopril|lisinopril|mesh-list
92817221|NCT00743197|Simvastatin|simvastatin|mesh-list
92817222|NCT00743197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92817223|NCT00743197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92817224|NCT00743197|Analgesics|analgesics|mesh-ancestor
92817225|NCT00743197|Sensory System Agents|sensory system agents|mesh-ancestor
92817226|NCT00743197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817227|NCT00743197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817228|NCT00743197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817229|NCT00743197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92817230|NCT00743197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92817231|NCT00743197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92817232|NCT00743197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817233|NCT00743197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92817234|NCT00743197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92817235|NCT00743197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817236|NCT00743197|Antipyretics|antipyretics|mesh-ancestor
92817237|NCT00743197|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92817238|NCT00743197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92817239|NCT00743197|Antimetabolites|antimetabolites|mesh-ancestor
92817240|NCT00743197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92817241|NCT00743197|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92817242|NCT00743197|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92817243|NCT00743197|Protease Inhibitors|protease inhibitors|mesh-ancestor
92817244|NCT00743197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92817245|NCT00743197|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92817246|NCT00743197|Protective Agents|protective agents|mesh-ancestor
92817247|NCT02731287|Timolol|timolol|mesh-list
92817248|NCT02731287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817249|NCT02731287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92817250|NCT02731287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92817252|NCT02731287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817253|NCT02731287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817254|NCT02731287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92817255|NCT02731287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92817256|NCT02735343|Ketamine|ketamine|mesh-list
92817257|NCT02735343|Prochlorperazine|prochlorperazine|mesh-list
92817258|NCT02735343|Analgesics|analgesics|mesh-ancestor
92817259|NCT02735343|Sensory System Agents|sensory system agents|mesh-ancestor
92817260|NCT02735343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817261|NCT02735343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817262|NCT02735343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92817263|NCT02735343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92817264|NCT02735343|Anesthetics, General|anesthetics, general|mesh-ancestor
92817265|NCT02735343|Anesthetics|anesthetics|mesh-ancestor
92817266|NCT02735343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817267|NCT02735343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92817268|NCT02735343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92817269|NCT02735343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817270|NCT02735343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817271|NCT02735343|Antiemetics|antiemetics|mesh-ancestor
92817272|NCT02735343|Autonomic Agents|autonomic agents|mesh-ancestor
92817273|NCT02735343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92817274|NCT02735343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92817275|NCT02735343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92817276|NCT02735343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817277|NCT02735343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92817278|NCT02735343|Dopamine Agents|dopamine agents|mesh-ancestor
92817279|NCT02730975|Abiraterone Acetate|abiraterone acetate|mesh-list
92817280|NCT02730975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817281|NCT02730975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92817282|NCT02730975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817283|NCT02730975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817284|NCT02730975|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817285|NCT02730975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817286|NCT02730975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817287|NCT02730975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92817288|NCT00734071|Vortioxetine|vortioxetine|mesh-list
92817289|NCT00734071|Antidepressive Agents|antidepressive agents|mesh-ancestor
92817290|NCT00734071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817291|NCT00734071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92817292|NCT00734071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92817293|NCT00734071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817294|NCT00734071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817295|NCT00734071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92817296|NCT00734071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92817297|NCT00734071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817298|NCT00734071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817299|NCT00734071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817300|NCT00734071|Serotonin Agents|serotonin agents|mesh-ancestor
92817301|NCT00734071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92817302|NCT00734071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92817303|NCT00734071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92817304|NCT00734071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92817305|NCT03255915|Tenofovir|tenofovir|mesh-list
92817306|NCT03255915|Emtricitabine|emtricitabine|mesh-list
92817307|NCT03255915|Antiviral Agents|antiviral agents|mesh-ancestor
92817308|NCT03255915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817309|NCT03255915|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92817310|NCT03255915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92817311|NCT03255915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817312|NCT03255915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817313|NCT03255915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92817314|NCT03255915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92817315|NCT04188951|Pembrolizumab|pembrolizumab|mesh-list
92817316|NCT04188951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92817317|NCT04188951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817318|NCT04188951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92817319|NCT04188951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817320|NCT00739297|Montelukast|montelukast|mesh-list
92817321|NCT00739297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92433086|NCT01572454|Sensory System Agents|sensory system agents|mesh-ancestor
92817322|NCT00739297|Respiratory System Agents|respiratory system agents|mesh-ancestor
92817323|NCT00739297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92817324|NCT00739297|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817325|NCT00739297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817326|NCT00739297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817327|NCT00739297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92817328|NCT00739297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92817329|NCT00739297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817330|NCT05430243|Empagliflozin|empagliflozin|mesh-list
92817331|NCT05430243|Diuretics|diuretics|mesh-list
92817332|NCT05430243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92817333|NCT05430243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817334|NCT05430243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92817335|NCT05430243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817336|NCT05430243|Natriuretic Agents|natriuretic agents|mesh-ancestor
92817337|NCT02730117|Cephalosporins|cephalosporins|mesh-list
92817338|NCT02730117|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92817339|NCT02730117|Dobutamine|dobutamine|mesh-list
92817340|NCT02730117|Dopamine|dopamine|mesh-list
92817341|NCT02730117|Milrinone|milrinone|mesh-list
92817342|NCT02730117|Norepinephrine|norepinephrine|mesh-list
92817343|NCT02730117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92817344|NCT02730117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92817345|NCT02730117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92817346|NCT02730117|Adrenergic Agents|adrenergic agents|mesh-ancestor
92817347|NCT02730117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817348|NCT02730117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817349|NCT02730117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817350|NCT02730117|Sympathomimetics|sympathomimetics|mesh-ancestor
92817351|NCT02730117|Autonomic Agents|autonomic agents|mesh-ancestor
92817352|NCT02730117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817353|NCT02730117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92817354|NCT02730117|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92817355|NCT02730117|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92817356|NCT02730117|Protective Agents|protective agents|mesh-ancestor
92817357|NCT02730117|Dopamine Agents|dopamine agents|mesh-ancestor
92817358|NCT02730117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92817359|NCT02730117|Vasodilator Agents|vasodilator agents|mesh-ancestor
92817360|NCT02730117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92817361|NCT02730117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92817362|NCT02730117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817363|NCT02730117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817364|NCT02595463|Lidocaine|lidocaine|mesh-list
92817365|NCT02595463|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817366|NCT02595463|Anesthetics|anesthetics|mesh-ancestor
92817367|NCT02595463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817368|NCT02595463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817369|NCT02595463|Sensory System Agents|sensory system agents|mesh-ancestor
92817370|NCT02595463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817371|NCT02595463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92817372|NCT02595463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92817373|NCT02595463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817374|NCT02595463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817375|NCT02595463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817376|NCT02593669|Dexamethasone|dexamethasone|mesh-list
92817377|NCT02593669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817378|NCT02593669|Antiemetics|antiemetics|mesh-ancestor
92817379|NCT02593669|Autonomic Agents|autonomic agents|mesh-ancestor
92817380|NCT02593669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817381|NCT02593669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817382|NCT02593669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92817383|NCT02593669|Glucocorticoids|glucocorticoids|mesh-ancestor
92817384|NCT02593669|Hormones|hormones|mesh-ancestor
92817385|NCT02593669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817386|NCT02593669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92817387|NCT02593669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817388|NCT02729961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92817389|NCT02729961|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92817390|NCT02729961|Ceritinib|ceritinib|mesh-list
92817391|NCT02729961|Antibodies|antibodies|mesh-list
92817392|NCT02729961|Immunoglobulins|immunoglobulins|mesh-list
92817393|NCT02729961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92817394|NCT02729961|Immunoconjugates|immunoconjugates|mesh-list
92817395|NCT02729961|Immunologic Factors|immunologic factors|mesh-ancestor
92817396|NCT02729961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817397|NCT02729961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817398|NCT02729961|Immunotoxins|immunotoxins|mesh-ancestor
92817399|NCT02729961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817400|NCT02729961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817401|NCT02729961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817402|NCT02735031|Exenatide|exenatide|mesh-list
92817403|NCT02735031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92817404|NCT02735031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462435|NCT01757795|Otaplimastat|otaplimastat|mesh-list
92817405|NCT02735031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92817406|NCT02735031|Incretins|incretins|mesh-ancestor
92817407|NCT02735031|Hormones|hormones|mesh-ancestor
92817408|NCT02735031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817409|NCT02595541|Milrinone|milrinone|mesh-list
92817410|NCT02595541|Sildenafil Citrate|sildenafil citrate|mesh-list
92817411|NCT02595541|Vasodilator Agents|vasodilator agents|mesh-ancestor
92817412|NCT02595541|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92817413|NCT02595541|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92817414|NCT02595541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817415|NCT02595541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817416|NCT02595541|Urological Agents|urological agents|mesh-ancestor
92817417|NCT02595541|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92817418|NCT02595541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92817419|NCT02595541|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92817420|NCT02595541|Protective Agents|protective agents|mesh-ancestor
92817421|NCT02595541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817422|NCT00739063|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92817423|NCT00739063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817424|NCT00739063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817425|NCT00739063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817426|NCT00739063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817427|NCT01026194|Pioglitazone|pioglitazone|mesh-list
92817428|NCT01026194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92817429|NCT01026194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817430|NCT02734875|Anticoagulants|anticoagulants|mesh-list
92817431|NCT04088461|Metformin|metformin|mesh-list
92817432|NCT04088461|Linagliptin|linagliptin|mesh-list
92817433|NCT04088461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92817434|NCT04088461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817435|NCT04088461|Incretins|incretins|mesh-ancestor
92817436|NCT04088461|Hormones|hormones|mesh-ancestor
92817437|NCT04088461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817438|NCT04088461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92817439|NCT04088461|Protease Inhibitors|protease inhibitors|mesh-ancestor
92817440|NCT04088461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817441|NCT04088461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817442|NCT00636519|Antitoxins|antitoxins|mesh-list
92817443|NCT00636519|Botulinum Antitoxin|botulinum antitoxin|mesh-list
92817444|NCT00636519|Immunologic Factors|immunologic factors|mesh-ancestor
92817445|NCT00636519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817446|NCT00811954|Ritonavir|ritonavir|mesh-list
92817447|NCT00811954|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92817448|NCT00811954|Darunavir|darunavir|mesh-list
92817449|NCT00811954|Tenofovir|tenofovir|mesh-list
92817450|NCT00811954|Emtricitabine|emtricitabine|mesh-list
92817451|NCT00811954|Raltegravir Potassium|raltegravir potassium|mesh-list
92817452|NCT00811954|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92817453|NCT00811954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92817454|NCT00811954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92817455|NCT00811954|Protease Inhibitors|protease inhibitors|mesh-ancestor
92817456|NCT00811954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817457|NCT00811954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817458|NCT00811954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92817459|NCT00811954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92817460|NCT00811954|Antiviral Agents|antiviral agents|mesh-ancestor
92817461|NCT00811954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817462|NCT00811954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92817463|NCT00811954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92817464|NCT00811954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92817465|NCT00811954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92817466|NCT00811954|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92817467|NCT00811954|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92817468|NCT00917839|Lamotrigine|lamotrigine|mesh-list
92817469|NCT00917839|Anticonvulsants|anticonvulsants|mesh-ancestor
92817470|NCT00917839|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92817471|NCT00917839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817472|NCT00917839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817473|NCT00917839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92817474|NCT00917839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817475|NCT00917839|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92817476|NCT00917839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92817477|NCT00917839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817478|NCT00917839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817479|NCT00917839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817480|NCT01032200|Modafinil|modafinil|mesh-list
92817481|NCT01032200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92817482|NCT01032200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817483|NCT01032200|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92817484|NCT01032200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92817485|NCT01032200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92817486|NCT01032200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817487|NCT03345771|Anti-Infective Agents|anti-infective agents|mesh-list
92817488|NCT03345771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92817489|NCT00586105|Sorafenib|sorafenib|mesh-list
92817490|NCT00586105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817491|NCT00586105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817492|NCT00586105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817493|NCT00586105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817494|NCT05510427|Bevacizumab|bevacizumab|mesh-list
92817495|NCT05510427|Atezolizumab|atezolizumab|mesh-list
92817496|NCT05510427|Infigratinib|infigratinib|mesh-list
92817497|NCT05510427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92817498|NCT05510427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817499|NCT05510427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92817500|NCT05510427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92817501|NCT05510427|Growth Substances|growth substances|mesh-ancestor
92817502|NCT05510427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817503|NCT05510427|Growth Inhibitors|growth inhibitors|mesh-ancestor
92817504|NCT05510427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92817505|NCT05510427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817506|NCT05757310|Vidarabine|vidarabine|mesh-list
92817507|NCT05757310|Cyclophosphamide|cyclophosphamide|mesh-list
92817508|NCT05757310|Pentostatin|pentostatin|mesh-list
92817509|NCT05757310|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92817510|NCT05757310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92817511|NCT05757310|Immunologic Factors|immunologic factors|mesh-ancestor
92817512|NCT05757310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817513|NCT05757310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92817514|NCT05757310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92817515|NCT05757310|Alkylating Agents|alkylating agents|mesh-ancestor
92817516|NCT05757310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817517|NCT05757310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817518|NCT05757310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92817519|NCT05757310|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92817520|NCT05757310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817521|NCT05757310|Antimetabolites|antimetabolites|mesh-ancestor
92817522|NCT05757310|Antiviral Agents|antiviral agents|mesh-ancestor
92817523|NCT05757310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817524|NCT00743119|Dronabinol|dronabinol|mesh-list
92817525|NCT00743119|Hallucinogens|hallucinogens|mesh-ancestor
92817526|NCT00743119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817527|NCT00743119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817528|NCT00743119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92817529|NCT00743119|Analgesics|analgesics|mesh-ancestor
92817530|NCT00743119|Sensory System Agents|sensory system agents|mesh-ancestor
92817531|NCT00743119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817532|NCT00743119|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92817533|NCT00743119|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92817534|NCT00743119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817535|NCT00743119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817536|NCT00743119|Hormones|hormones|mesh-ancestor
92817537|NCT00743119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817538|NCT02610010|Cisplatin|cisplatin|mesh-list
92817539|NCT02610010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817540|NCT02610088|Dapagliflozin|dapagliflozin|mesh-list
92817542|NCT02610088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92817543|NCT02610088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817544|NCT02610088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92817545|NCT02610088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817546|NCT02734407|Aflibercept|aflibercept|mesh-list
92817547|NCT02734407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92817548|NCT02734407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92817549|NCT02734407|Growth Substances|growth substances|mesh-ancestor
92817550|NCT02734407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817551|NCT02734407|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719416|NCT01909427|Methotrexate|methotrexate|mesh-list
92817552|NCT02734407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817553|NCT02734173|Ritonavir|ritonavir|mesh-list
92817554|NCT02734173|Ribavirin|ribavirin|mesh-list
92817555|NCT02734173|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92817556|NCT02734173|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92817557|NCT02734173|Protease Inhibitors|protease inhibitors|mesh-ancestor
92817558|NCT02734173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817559|NCT02734173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817560|NCT02734173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92817561|NCT02734173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92817562|NCT02734173|Antiviral Agents|antiviral agents|mesh-ancestor
92817563|NCT02734173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817564|NCT02734173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92817565|NCT02734173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92817566|NCT02734173|Antimetabolites|antimetabolites|mesh-ancestor
92817567|NCT05297422|Ketamine|ketamine|mesh-list
92817568|NCT05297422|Ropivacaine|ropivacaine|mesh-list
92817569|NCT05297422|Analgesics|analgesics|mesh-ancestor
92817570|NCT05297422|Sensory System Agents|sensory system agents|mesh-ancestor
92817571|NCT05297422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817572|NCT05297422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817573|NCT05297422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92817574|NCT05297422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92817575|NCT05297422|Anesthetics, General|anesthetics, general|mesh-ancestor
92817576|NCT05297422|Anesthetics|anesthetics|mesh-ancestor
92817577|NCT05297422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817578|NCT05297422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92817579|NCT05297422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92817580|NCT05297422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817581|NCT05297422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817582|NCT05297422|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817583|NCT00813124|Fludarabine|fludarabine|mesh-list
92817584|NCT00813124|Fludarabine phosphate|fludarabine phosphate|mesh-list
92817585|NCT00813124|Azacitidine|azacitidine|mesh-list
92817586|NCT00813124|Busulfan|busulfan|mesh-list
92817587|NCT00813124|Thymoglobulin|thymoglobulin|mesh-list
92817588|NCT00813124|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92817589|NCT00813124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817590|NCT00813124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92817591|NCT00813124|Antimetabolites|antimetabolites|mesh-ancestor
92817592|NCT00813124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817593|NCT00813124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92817594|NCT00813124|Immunologic Factors|immunologic factors|mesh-ancestor
92817595|NCT00813124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817596|NCT00813124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817597|NCT00813124|Alkylating Agents|alkylating agents|mesh-ancestor
92817598|NCT00813124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92817599|NCT00813124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92817600|NCT00733291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92817601|NCT02728869|Vaccines|vaccines|mesh-list
92817602|NCT02728869|Immunologic Factors|immunologic factors|mesh-ancestor
92817603|NCT02728869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817604|NCT02594761|Trastuzumab|trastuzumab|mesh-list
92817605|NCT02594761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92817606|NCT02594761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817607|NCT02728947|Rotigotine|rotigotine|mesh-list
92817608|NCT02728947|Dopamine Agonists|dopamine agonists|mesh-ancestor
92817609|NCT02728947|Dopamine Agents|dopamine agents|mesh-ancestor
92817610|NCT02728947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817611|NCT02728947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817612|NCT02728947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817613|NCT02729103|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92817614|NCT02729103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817615|NCT02733705|Fentanyl|fentanyl|mesh-list
92817616|NCT02733705|Propofol|propofol|mesh-list
92817617|NCT02733705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92817618|NCT02733705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817619|NCT02733705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817620|NCT02733705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92817621|NCT02733705|Anesthetics, General|anesthetics, general|mesh-ancestor
92817622|NCT02733705|Anesthetics|anesthetics|mesh-ancestor
92817623|NCT02733705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92817624|NCT02733705|Narcotics|narcotics|mesh-ancestor
92817625|NCT02733705|Analgesics|analgesics|mesh-ancestor
92817626|NCT02733705|Sensory System Agents|sensory system agents|mesh-ancestor
92817627|NCT02733705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817628|NCT02733705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92817629|NCT02597257|Lidocaine|lidocaine|mesh-list
92817631|NCT02597257|Anesthetics|anesthetics|mesh-ancestor
92817632|NCT02597257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817633|NCT02597257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817634|NCT02597257|Sensory System Agents|sensory system agents|mesh-ancestor
92817635|NCT02597257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817636|NCT02597257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92817637|NCT02597257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92817638|NCT02597257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817639|NCT02597257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817640|NCT02597257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817641|NCT02596555|Dabigatran|dabigatran|mesh-list
92817642|NCT02596555|Antithrombins|antithrombins|mesh-ancestor
92817643|NCT02596555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92817644|NCT02596555|Protease Inhibitors|protease inhibitors|mesh-ancestor
92817645|NCT02596555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817646|NCT02596555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817647|NCT02596555|Anticoagulants|anticoagulants|mesh-ancestor
92817648|NCT02733471|Lidocaine|lidocaine|mesh-list
92817649|NCT02733471|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817650|NCT02733471|Anesthetics|anesthetics|mesh-ancestor
92817651|NCT02733471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817652|NCT02733471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817653|NCT02733471|Sensory System Agents|sensory system agents|mesh-ancestor
92817654|NCT02733471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817655|NCT02733471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92817656|NCT02733471|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92817657|NCT02733471|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817658|NCT02733471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817659|NCT02733471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817660|NCT02733237|Oxytocin|oxytocin|mesh-list
92817661|NCT02733237|Oxytocics|oxytocics|mesh-ancestor
92817662|NCT02733237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92817663|NCT02733237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817664|NCT04206813|Vaccines|vaccines|mesh-list
92817665|NCT04206813|Immunologic Factors|immunologic factors|mesh-ancestor
92817666|NCT04206813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817667|NCT02728323|Levobupivacaine|levobupivacaine|mesh-list
92817668|NCT02728323|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817669|NCT02728323|Anesthetics|anesthetics|mesh-ancestor
92817670|NCT02728323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817671|NCT02728323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817672|NCT02728323|Sensory System Agents|sensory system agents|mesh-ancestor
92817673|NCT02728323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817674|NCT00811720|Nalmefene|nalmefene|mesh-list
92817675|NCT00811720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92817676|NCT00811720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817677|NCT00811720|Sensory System Agents|sensory system agents|mesh-ancestor
92817678|NCT00811720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817679|NCT04202679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92817680|NCT04202679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817681|NCT04202679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817682|NCT00811642|Posaconazole|posaconazole|mesh-list
92817683|NCT00811642|Antifungal Agents|antifungal agents|mesh-ancestor
92817684|NCT00811642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817685|NCT00811642|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92817686|NCT00811642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92817687|NCT00811642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92817688|NCT00811642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92817689|NCT00811642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92817690|NCT00811642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817691|NCT00811642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817692|NCT00811642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92817693|NCT00811642|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817694|NCT00811642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817695|NCT00811642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817697|NCT02609152|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92817698|NCT02609152|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92817699|NCT02609152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92817700|NCT02609152|Adrenergic Agents|adrenergic agents|mesh-ancestor
92817701|NCT02609152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817702|NCT02609152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817703|NCT02609152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817704|NCT02733393|Lidocaine|lidocaine|mesh-list
92817705|NCT02733393|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817706|NCT02733393|Anesthetics|anesthetics|mesh-ancestor
92817707|NCT02733393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817708|NCT02733393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817709|NCT02733393|Sensory System Agents|sensory system agents|mesh-ancestor
92817710|NCT02733393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817711|NCT02733393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92817712|NCT02733393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92817713|NCT02733393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817714|NCT02733393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817715|NCT02733393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817716|NCT00809926|Valsartan|valsartan|mesh-list
92817717|NCT00809926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92817718|NCT00809926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92817719|NCT00809926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92817720|NCT00809926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817721|NCT02728245|Dienogest|dienogest|mesh-list
92817722|NCT02728245|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92817723|NCT02728245|Contraceptive Agents|contraceptive agents|mesh-ancestor
92817724|NCT02728245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92817725|NCT02728245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817726|NCT02728245|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92817727|NCT02728245|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92817728|NCT02728245|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92817729|NCT02728245|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92817730|NCT02728245|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817731|NCT02728245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817732|NCT02728245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92817733|NCT02728245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817734|NCT04770610|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92817735|NCT04770610|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92817736|NCT02690415|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92817737|NCT02690415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92817738|NCT02690415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817739|NCT02690415|Antitubercular Agents|antitubercular agents|mesh-ancestor
92817740|NCT05753722|Pembrolizumab|pembrolizumab|mesh-list
92817741|NCT05753722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92817742|NCT05753722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817743|NCT05753722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92817744|NCT05753722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817745|NCT02727621|Dexmedetomidine|dexmedetomidine|mesh-list
92817746|NCT02727621|Propofol|propofol|mesh-list
92817747|NCT02727621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92817748|NCT02727621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817749|NCT02727621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817750|NCT02727621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92817751|NCT02727621|Analgesics|analgesics|mesh-ancestor
92817752|NCT02727621|Sensory System Agents|sensory system agents|mesh-ancestor
92817753|NCT02727621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817754|NCT02727621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92817755|NCT02727621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92817756|NCT02727621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92817757|NCT02727621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92817758|NCT02727621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817759|NCT02727621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817760|NCT02727621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92817761|NCT02727621|Anesthetics, General|anesthetics, general|mesh-ancestor
92817762|NCT02727621|Anesthetics|anesthetics|mesh-ancestor
92817763|NCT02608606|Tacrolimus|tacrolimus|mesh-list
92817764|NCT02608606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92817765|NCT02608606|Immunologic Factors|immunologic factors|mesh-ancestor
92817766|NCT02608606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817767|NCT02608606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92817768|NCT02608606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817769|NCT02608606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817770|NCT02608918|BMS-955176|bms-955176|mesh-list
92817771|NCT02608918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92817772|NCT02608918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92817773|NCT02608918|Antiviral Agents|antiviral agents|mesh-ancestor
92817774|NCT02608918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817775|NCT05755204|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92817777|NCT05755204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92817778|NCT05755204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92817779|NCT05755204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817780|NCT05755204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817781|NCT05755204|Antiviral Agents|antiviral agents|mesh-ancestor
92817782|NCT05755204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817783|NCT05755204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92817784|NCT05755204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92817785|NCT05755204|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92817786|NCT05755204|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92817787|NCT02727309|Apatinib|apatinib|mesh-list
92817788|NCT02727309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817789|NCT02727309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817790|NCT02727309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817791|NCT02727309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817792|NCT05755750|Genipin|genipin|mesh-list
92817793|NCT05755750|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92817794|NCT05755750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92817795|NCT02732067|Anesthetics|anesthetics|mesh-list
92817796|NCT02732067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817797|NCT02732067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817798|NCT02609932|Interferons|interferons|mesh-list
92817799|NCT02609932|Interferon-gamma|interferon-gamma|mesh-list
92817800|NCT02609932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817801|NCT02609932|Antiviral Agents|antiviral agents|mesh-ancestor
92817802|NCT02609932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92817803|NCT02726919|Clobazam|clobazam|mesh-list
92817804|NCT02726919|Anticonvulsants|anticonvulsants|mesh-ancestor
92817805|NCT02726919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92817806|NCT02726919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92817807|NCT02726919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817808|NCT02726919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817809|NCT02726919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817810|NCT02726919|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92817811|NCT02726919|GABA Agonists|gaba agonists|mesh-ancestor
92817812|NCT02726919|GABA Agents|gaba agents|mesh-ancestor
92817813|NCT02726919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817814|NCT02726919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817815|NCT00590902|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92817816|NCT00590902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817817|NCT00590902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92817818|NCT00590902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817819|NCT00590902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817820|NCT05753566|Androgens|androgens|mesh-list
92817821|NCT05753566|Hormones|hormones|mesh-ancestor
92817822|NCT05753566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817823|NCT05753566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817824|NCT00590824|Interleukin-2|interleukin-2|mesh-list
92817825|NCT00590824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817826|NCT00590824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92817827|NCT00590824|Analgesics|analgesics|mesh-ancestor
92817828|NCT00590824|Sensory System Agents|sensory system agents|mesh-ancestor
92817829|NCT00590824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817830|NCT00590824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817831|NCT02720991|Misoprostol|misoprostol|mesh-list
92817832|NCT02720991|Mifepristone|mifepristone|mesh-list
92817833|NCT02720991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92817834|NCT02720991|Abortifacient Agents|abortifacient agents|mesh-ancestor
92817835|NCT02720991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92817836|NCT02720991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817837|NCT02720991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92817838|NCT02720991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92817839|NCT02720991|Oxytocics|oxytocics|mesh-ancestor
92817840|NCT02720991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92817841|NCT02720991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92817842|NCT02720991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92817843|NCT02720991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92817844|NCT02720991|Contraceptive Agents|contraceptive agents|mesh-ancestor
92817845|NCT02720991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92817846|NCT02720991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92817847|NCT02720991|Hormone Antagonists|hormone antagonists|mesh-ancestor
92817848|NCT02720991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92817849|NCT02720991|Luteolytic Agents|luteolytic agents|mesh-ancestor
92817850|NCT02720991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92817851|NCT02720991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92817853|NCT02720601|Irinotecan|irinotecan|mesh-list
92817854|NCT02720601|Camptothecin|camptothecin|mesh-list
92817855|NCT02720601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92817856|NCT02720601|Antimetabolites|antimetabolites|mesh-ancestor
92817857|NCT02720601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817858|NCT02720601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817859|NCT02720601|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92817860|NCT02720601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92817861|NCT02720601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817862|NCT02720601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92817863|NCT00590590|Diphenhydramine|diphenhydramine|mesh-list
92817864|NCT00590590|Promethazine|promethazine|mesh-list
92817865|NCT00590590|Lidocaine|lidocaine|mesh-list
92817866|NCT00590590|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817867|NCT00590590|Anesthetics|anesthetics|mesh-ancestor
92817868|NCT00590590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817869|NCT00590590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817870|NCT00590590|Sensory System Agents|sensory system agents|mesh-ancestor
92719731|NCT04608669|Analgesics|analgesics|mesh-ancestor
92817871|NCT00590590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817872|NCT00590590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92817873|NCT00590590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92817874|NCT00590590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92817875|NCT00590590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817876|NCT00590590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817877|NCT00590590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92817878|NCT00590590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92817879|NCT00590590|Antiemetics|antiemetics|mesh-ancestor
92817880|NCT00590590|Autonomic Agents|autonomic agents|mesh-ancestor
92817881|NCT00590590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92817882|NCT00590590|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92817883|NCT00590590|Histamine Antagonists|histamine antagonists|mesh-ancestor
92817884|NCT00590590|Histamine Agents|histamine agents|mesh-ancestor
92817885|NCT00590590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817886|NCT00590590|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92817887|NCT00590590|Antipruritics|antipruritics|mesh-ancestor
92817888|NCT00590590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92817889|NCT02720367|Gemcitabine|gemcitabine|mesh-list
92817890|NCT02720367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92817891|NCT02720367|Antimetabolites|antimetabolites|mesh-ancestor
92817892|NCT02720367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817893|NCT02720367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817894|NCT02693769|Fluticasone|fluticasone|mesh-list
92817895|NCT02693769|Xhance|xhance|mesh-list
92817896|NCT02693769|Glycopyrrolate|glycopyrrolate|mesh-list
92817897|NCT02693769|Bromides|bromides|mesh-list
92817898|NCT02693769|Formoterol Fumarate|formoterol fumarate|mesh-list
92817899|NCT02693769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92817900|NCT02693769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92817901|NCT02693769|Autonomic Agents|autonomic agents|mesh-ancestor
92817902|NCT02693769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817903|NCT02693769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817904|NCT02693769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92817905|NCT02693769|Respiratory System Agents|respiratory system agents|mesh-ancestor
92817906|NCT02693769|Dermatologic Agents|dermatologic agents|mesh-ancestor
92817907|NCT02693769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92817908|NCT02693769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92817909|NCT02693769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92817910|NCT02693769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92817911|NCT02693769|Adrenergic Agents|adrenergic agents|mesh-ancestor
92817912|NCT02693769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817913|NCT02693769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817914|NCT02693769|Anticonvulsants|anticonvulsants|mesh-ancestor
92817915|NCT02693769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92817916|NCT02693769|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92817917|NCT02693769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92817918|NCT02693769|Cholinergic Agents|cholinergic agents|mesh-ancestor
92817920|NCT02725359|Bupivacaine|bupivacaine|mesh-list
92817921|NCT02725359|Anesthetics, Local|anesthetics, local|mesh-ancestor
92817922|NCT02725359|Anesthetics|anesthetics|mesh-ancestor
92462943|NCT01760278|Cetrorelix|cetrorelix|mesh-list
92817923|NCT02725359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817924|NCT02725359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817925|NCT02725359|Sensory System Agents|sensory system agents|mesh-ancestor
92817926|NCT02725359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817927|NCT02725359|Analgesics|analgesics|mesh-ancestor
92817928|NCT02725359|Anticonvulsants|anticonvulsants|mesh-ancestor
92817929|NCT02725359|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92817930|NCT02725359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92817931|NCT02725359|Parasympatholytics|parasympatholytics|mesh-ancestor
92817932|NCT02725359|Autonomic Agents|autonomic agents|mesh-ancestor
92817933|NCT02725359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92817934|NCT02725359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92817935|NCT02725359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92817936|NCT02725359|Adrenergic Agents|adrenergic agents|mesh-ancestor
92817937|NCT02725359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817938|NCT02725359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817939|NCT00731731|Temozolomide|temozolomide|mesh-list
92817940|NCT00731731|Vorinostat|vorinostat|mesh-list
92817941|NCT00731731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92817942|NCT00731731|Alkylating Agents|alkylating agents|mesh-ancestor
92817943|NCT00731731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817944|NCT00731731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817945|NCT00731731|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92817946|NCT00731731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92817947|NCT05755048|Trastuzumab|trastuzumab|mesh-list
92817948|NCT05755048|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92817949|NCT05755048|Maytansine|maytansine|mesh-list
92817950|NCT05755048|Antibodies|antibodies|mesh-list
92817951|NCT05755048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92817952|NCT05755048|Immunologic Factors|immunologic factors|mesh-ancestor
92817953|NCT05755048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817954|NCT05755048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92817955|NCT05755048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92817956|NCT05755048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92817957|NCT05755048|Tubulin Modulators|tubulin modulators|mesh-ancestor
92817958|NCT05755048|Antimitotic Agents|antimitotic agents|mesh-ancestor
92817959|NCT05755048|Mitosis Modulators|mitosis modulators|mesh-ancestor
92817960|NCT05755048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817961|NCT05755048|Immunotoxins|immunotoxins|mesh-ancestor
92817962|NCT05755048|Immunoconjugates|immunoconjugates|mesh-ancestor
92817963|NCT02719431|Warfarin|warfarin|mesh-list
92817964|NCT02719431|Anticoagulants|anticoagulants|mesh-ancestor
92817965|NCT00806494|Fesoterodine|fesoterodine|mesh-list
92817966|NCT00806494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92817967|NCT00806494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92817968|NCT00806494|Cholinergic Agents|cholinergic agents|mesh-ancestor
92817969|NCT00806494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817970|NCT00806494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817971|NCT00806494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817972|NCT00806494|Urological Agents|urological agents|mesh-ancestor
92817973|NCT00806416|Vitamin D|vitamin d|mesh-list
92817974|NCT00806416|Cholecalciferol|cholecalciferol|mesh-list
92817975|NCT00806416|Alendronate|alendronate|mesh-list
92817976|NCT00806416|Vitamins|vitamins|mesh-ancestor
92817977|NCT00806416|Micronutrients|micronutrients|mesh-ancestor
92817978|NCT00806416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817979|NCT00806416|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92817980|NCT00806416|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92817981|NCT00811252|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92817982|NCT00811252|Vortioxetine|vortioxetine|mesh-list
92817983|NCT00811252|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92817984|NCT00811252|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92817985|NCT00811252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92817986|NCT00811252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92817987|NCT00811252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92817988|NCT00811252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92817989|NCT00811252|Analgesics|analgesics|mesh-ancestor
92817990|NCT00811252|Sensory System Agents|sensory system agents|mesh-ancestor
92817991|NCT00811252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92817992|NCT00811252|Antidepressive Agents|antidepressive agents|mesh-ancestor
92817993|NCT00811252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92817994|NCT00811252|Dopamine Agents|dopamine agents|mesh-ancestor
92817995|NCT00811252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92817996|NCT00811252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92817997|NCT00811252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92817998|NCT00811252|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92817999|NCT00811252|Serotonin Agents|serotonin agents|mesh-ancestor
92818000|NCT00811252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92818001|NCT00811252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92818002|NCT00811252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92818003|NCT00811252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92818004|NCT02608996|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92818005|NCT02608996|Natriuretic Agents|natriuretic agents|mesh-ancestor
92818006|NCT02608996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818007|NCT00736957|Acetaminophen|acetaminophen|mesh-list
92818008|NCT00736957|Tramadol|tramadol|mesh-list
92818009|NCT00736957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818010|NCT00736957|Analgesics|analgesics|mesh-ancestor
92818011|NCT00736957|Sensory System Agents|sensory system agents|mesh-ancestor
92818012|NCT00736957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818013|NCT00736957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818014|NCT00736957|Antipyretics|antipyretics|mesh-ancestor
92818015|NCT00736957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92818016|NCT00736957|Narcotics|narcotics|mesh-ancestor
92818017|NCT00736957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818018|NCT05294523|Rocuronium|rocuronium|mesh-list
92818019|NCT05294523|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92818020|NCT05294523|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92818021|NCT05294523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92818022|NCT05294523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818023|NCT05294523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818024|NCT00736879|Dapagliflozin|dapagliflozin|mesh-list
92818025|NCT00736879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92818026|NCT00736879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818027|NCT00736879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92818028|NCT00736879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818029|NCT02718261|Pantoprazole|pantoprazole|mesh-list
92818030|NCT02718261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92818031|NCT02718261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818032|NCT02718261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92818033|NCT02718261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818034|NCT02718261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818035|NCT00806260|Ethanol|ethanol|mesh-list
92818036|NCT00806260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92818037|NCT00806260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818038|NCT00806260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818039|NCT00806260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818040|NCT02718183|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92818041|NCT02718183|Carbamide Peroxide|carbamide peroxide|mesh-list
92818042|NCT02718183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92818043|NCT02718183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818044|NCT00811174|gamma-Globulins|gamma-globulins|mesh-list
92818045|NCT00811174|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92818046|NCT00811174|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92818047|NCT00811174|Immunologic Factors|immunologic factors|mesh-ancestor
92818048|NCT00811174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818049|NCT02723487|Bupivacaine|bupivacaine|mesh-list
92818050|NCT02723487|Anesthetics, Local|anesthetics, local|mesh-ancestor
92818051|NCT02723487|Anesthetics|anesthetics|mesh-ancestor
92818052|NCT02723487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818053|NCT02723487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818054|NCT02723487|Sensory System Agents|sensory system agents|mesh-ancestor
92818055|NCT02723487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818056|NCT02717871|Moxifloxacin|moxifloxacin|mesh-list
92818057|NCT02717871|Ciprofloxacin|ciprofloxacin|mesh-list
92818058|NCT02717871|Levofloxacin|levofloxacin|mesh-list
92818060|NCT02717871|Gentamicins|gentamicins|mesh-list
92818061|NCT02717871|Cefazolin|cefazolin|mesh-list
92818062|NCT02717871|Tobramycin|tobramycin|mesh-list
92818063|NCT02717871|Gatifloxacin|gatifloxacin|mesh-list
92818064|NCT02717871|Fluoroquinolones|fluoroquinolones|mesh-list
92818065|NCT02717871|Besifloxacin|besifloxacin|mesh-list
92818066|NCT02717871|Prednisolone|prednisolone|mesh-list
92818067|NCT02717871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92818068|NCT02717871|Methylprednisolone|methylprednisolone|mesh-list
92818069|NCT02717871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92818070|NCT02717871|Prednisolone acetate|prednisolone acetate|mesh-list
92818071|NCT02717871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92818072|NCT02717871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92818073|NCT02717871|Prednisolone phosphate|prednisolone phosphate|mesh-list
92818074|NCT02717871|Cyclopentolate|cyclopentolate|mesh-list
92818075|NCT02717871|Mydriatics|mydriatics|mesh-list
92818076|NCT02717871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818077|NCT02717871|Glucocorticoids|glucocorticoids|mesh-ancestor
92818078|NCT02717871|Hormones|hormones|mesh-ancestor
92818079|NCT02717871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818080|NCT02717871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818081|NCT02717871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92818082|NCT02717871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818083|NCT02717871|Antiemetics|antiemetics|mesh-ancestor
92818084|NCT02717871|Autonomic Agents|autonomic agents|mesh-ancestor
92818085|NCT02717871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818086|NCT02717871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818087|NCT02717871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92818088|NCT02717871|Protective Agents|protective agents|mesh-ancestor
92818089|NCT02717871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92818090|NCT02717871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818091|NCT02717871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92818092|NCT02717871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92818093|NCT02717871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818094|NCT02717871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818095|NCT02717871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92818096|NCT02717871|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92818097|NCT02717871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92818098|NCT02717871|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92818099|NCT02717871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92818100|NCT02717871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92818101|NCT02717871|Parasympatholytics|parasympatholytics|mesh-ancestor
92818102|NCT02717871|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92818103|NCT02717871|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92818104|NCT02717871|Cholinergic Agents|cholinergic agents|mesh-ancestor
92818105|NCT02717871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818106|NCT02723253|Raltitrexed|raltitrexed|mesh-list
92818107|NCT02723253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818108|NCT02723253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92818109|NCT02723253|Antimetabolites|antimetabolites|mesh-ancestor
92818110|NCT02723253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818111|NCT02723253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92818112|NCT02723253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818113|NCT00730405|Albaconazole|albaconazole|mesh-list
92818114|NCT00730405|Antifungal Agents|antifungal agents|mesh-ancestor
92818115|NCT00730405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818116|NCT02594449|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92818117|NCT02594449|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92818118|NCT02594449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818119|NCT02722083|Chlorpheniramine|chlorpheniramine|mesh-list
92818120|NCT02722083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818121|NCT02722083|Antipruritics|antipruritics|mesh-ancestor
92818122|NCT02722083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92818123|NCT02722083|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92818124|NCT02722083|Histamine Antagonists|histamine antagonists|mesh-ancestor
92818125|NCT02722083|Histamine Agents|histamine agents|mesh-ancestor
92818126|NCT02722083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818127|NCT02722083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818128|NCT02722083|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92818129|NCT05201079|Fidaxomicin|fidaxomicin|mesh-list
92818130|NCT05201079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92818131|NCT05201079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818132|NCT00736645|Selenium|selenium|mesh-list
92818133|NCT00736645|Finasteride|finasteride|mesh-list
92818134|NCT00736645|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92818135|NCT00736645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92818137|NCT00736645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818138|NCT00736645|Hormone Antagonists|hormone antagonists|mesh-ancestor
92818139|NCT00736645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818140|NCT00736645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818141|NCT00736645|Urological Agents|urological agents|mesh-ancestor
92818142|NCT00736645|Antioxidants|antioxidants|mesh-ancestor
92818143|NCT00736645|Protective Agents|protective agents|mesh-ancestor
92720014|NCT00555386|Selenium|selenium|mesh-list
92818144|NCT00736645|Trace Elements|trace elements|mesh-ancestor
92818145|NCT00736645|Micronutrients|micronutrients|mesh-ancestor
92818146|NCT00736489|Formoterol Fumarate|formoterol fumarate|mesh-list
92818147|NCT00736489|AZD-3199|azd-3199|mesh-list
92818148|NCT00736489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92818149|NCT00736489|Autonomic Agents|autonomic agents|mesh-ancestor
92818150|NCT00736489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818152|NCT00736489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92818153|NCT00736489|Respiratory System Agents|respiratory system agents|mesh-ancestor
92818154|NCT00736489|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92818155|NCT00736489|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92818156|NCT00736489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92818157|NCT00736489|Adrenergic Agents|adrenergic agents|mesh-ancestor
92818158|NCT00736489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818159|NCT00736489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818160|NCT02716233|Pegaspargase|pegaspargase|mesh-list
92818161|NCT02716233|Asparaginase|asparaginase|mesh-list
92818162|NCT02716233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818163|NCT01999569|Letrozole|letrozole|mesh-list
92818164|NCT01999569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818165|NCT01999569|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92818166|NCT01999569|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92818167|NCT01999569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818168|NCT01999569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818169|NCT01999569|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92818170|NCT01999569|Hormone Antagonists|hormone antagonists|mesh-ancestor
92818171|NCT01999569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818172|NCT01999569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818173|NCT04087915|Evolocumab|evolocumab|mesh-list
92818174|NCT04087915|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92818175|NCT04087915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92818176|NCT04087915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92818177|NCT04087915|Antimetabolites|antimetabolites|mesh-ancestor
92818178|NCT04087915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818179|NCT04087915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92818180|NCT04087915|Protease Inhibitors|protease inhibitors|mesh-ancestor
92818181|NCT04087915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818182|NCT04087915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92818183|NCT02715687|Amiodarone|amiodarone|mesh-list
92818184|NCT02715687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92818185|NCT02715687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92818186|NCT02715687|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92818187|NCT02715687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818188|NCT02715687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818189|NCT02715687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92818190|NCT02715687|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92818191|NCT02715687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92818192|NCT02715687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818193|NCT02715687|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92818194|NCT02715687|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92818195|NCT02715687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92818196|NCT02715531|Leucovorin|leucovorin|mesh-list
92818197|NCT02715531|Paclitaxel|paclitaxel|mesh-list
92818198|NCT02715531|Bevacizumab|bevacizumab|mesh-list
92818199|NCT02715531|Gemcitabine|gemcitabine|mesh-list
92818200|NCT02715531|Capecitabine|capecitabine|mesh-list
92818201|NCT02715531|Oxaliplatin|oxaliplatin|mesh-list
92818202|NCT02715531|Atezolizumab|atezolizumab|mesh-list
92818203|NCT02715531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92818204|NCT02715531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818205|NCT02715531|Tubulin Modulators|tubulin modulators|mesh-ancestor
92818206|NCT02715531|Antimitotic Agents|antimitotic agents|mesh-ancestor
92818207|NCT02715531|Mitosis Modulators|mitosis modulators|mesh-ancestor
92818208|NCT02715531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818209|NCT02715531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162970|NCT00631111|Analgesics|analgesics|mesh-ancestor
92818210|NCT02715531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92818211|NCT02715531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92818212|NCT02715531|Growth Substances|growth substances|mesh-ancestor
92818213|NCT02715531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818214|NCT02715531|Growth Inhibitors|growth inhibitors|mesh-ancestor
92818215|NCT02715531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92818216|NCT02715531|Antimetabolites|antimetabolites|mesh-ancestor
92818217|NCT02715531|Antidotes|antidotes|mesh-ancestor
92818218|NCT02715531|Protective Agents|protective agents|mesh-ancestor
92818219|NCT02715531|Vitamin B Complex|vitamin b complex|mesh-ancestor
92818220|NCT02715531|Vitamins|vitamins|mesh-ancestor
92818221|NCT02715531|Micronutrients|micronutrients|mesh-ancestor
92818222|NCT02715531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92818223|NCT00811018|Sitaxsentan|sitaxsentan|mesh-list
92818224|NCT00811018|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92818225|NCT00811018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818226|NCT04037085|Ketamine|ketamine|mesh-list
92818227|NCT04037085|Analgesics|analgesics|mesh-ancestor
92818228|NCT04037085|Sensory System Agents|sensory system agents|mesh-ancestor
92818229|NCT04037085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818230|NCT04037085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818231|NCT04037085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92818232|NCT04037085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92818233|NCT04037085|Anesthetics, General|anesthetics, general|mesh-ancestor
92818234|NCT04037085|Anesthetics|anesthetics|mesh-ancestor
92818235|NCT04037085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818236|NCT04037085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92818237|NCT04037085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92818238|NCT04037085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818239|NCT04037085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818240|NCT00914056|Lactulose|lactulose|mesh-list
92818241|NCT00914056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818242|NCT00730171|Linaclotide|linaclotide|mesh-list
92818243|NCT00730171|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92818244|NCT00730171|Enzyme Activators|enzyme activators|mesh-ancestor
92818245|NCT00730171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818246|NCT00730171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818247|NCT04787835|Anesthetics|anesthetics|mesh-list
92818248|NCT04787835|Anesthetics, Local|anesthetics, local|mesh-list
92818249|NCT04787835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818250|NCT04787835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818251|NCT04787835|Sensory System Agents|sensory system agents|mesh-ancestor
92818252|NCT04787835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818253|NCT00730015|Linaclotide|linaclotide|mesh-list
92818254|NCT00730015|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92818255|NCT00730015|Enzyme Activators|enzyme activators|mesh-ancestor
92818256|NCT00730015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818257|NCT00730015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818258|NCT00806026|Pregabalin|pregabalin|mesh-list
92818259|NCT00806026|Pramipexole|pramipexole|mesh-list
92818260|NCT00806026|Analgesics|analgesics|mesh-ancestor
92818261|NCT00806026|Sensory System Agents|sensory system agents|mesh-ancestor
92818262|NCT00806026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818263|NCT00806026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818264|NCT00806026|Anticonvulsants|anticonvulsants|mesh-ancestor
92818265|NCT00806026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92818266|NCT00806026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818267|NCT00806026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818268|NCT00806026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92818269|NCT00806026|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92818270|NCT00806026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92818271|NCT00806026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818272|NCT00806026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92818273|NCT00806026|Antioxidants|antioxidants|mesh-ancestor
92818274|NCT00806026|Protective Agents|protective agents|mesh-ancestor
92818275|NCT00806026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92818276|NCT00806026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92818277|NCT00806026|Dopamine Agonists|dopamine agonists|mesh-ancestor
92818278|NCT00806026|Dopamine Agents|dopamine agents|mesh-ancestor
92818279|NCT00806026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818280|NCT04227093|Acetazolamide|acetazolamide|mesh-list
92818281|NCT04227093|Anticonvulsants|anticonvulsants|mesh-ancestor
92818282|NCT04227093|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92818283|NCT04227093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818284|NCT04227093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818286|NCT04227093|Natriuretic Agents|natriuretic agents|mesh-ancestor
92818287|NCT04227093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818288|NCT00805792|Donepezil|donepezil|mesh-list
92818289|NCT00805792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92818290|NCT00805792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818291|NCT00805792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818292|NCT00805792|Cholinergic Agents|cholinergic agents|mesh-ancestor
92818293|NCT00805792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818294|NCT00805792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818295|NCT00805792|Nootropic Agents|nootropic agents|mesh-ancestor
92818296|NCT04777929|Progesterone|progesterone|mesh-list
92818297|NCT04777929|Estrogens|estrogens|mesh-list
92818298|NCT04777929|Progestins|progestins|mesh-ancestor
92818299|NCT04777929|Hormones|hormones|mesh-ancestor
92818300|NCT04777929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818301|NCT04777929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818302|NCT00590044|Insulin|insulin|mesh-list
92818303|NCT00590044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92818304|NCT00590044|Insulin Glargine|insulin glargine|mesh-list
92818305|NCT00590044|Insulin, Isophane|insulin, isophane|mesh-list
92818306|NCT00590044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92818307|NCT00590044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818308|NCT02714361|Vitamin D|vitamin d|mesh-list
92818309|NCT02714361|Cholecalciferol|cholecalciferol|mesh-list
92818310|NCT02714361|Vitamins|vitamins|mesh-ancestor
92818311|NCT02714361|Micronutrients|micronutrients|mesh-ancestor
92818312|NCT02714361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818313|NCT02714361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92818314|NCT02714361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92818315|NCT00248703|Docetaxel|docetaxel|mesh-list
92818316|NCT00248703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818317|NCT00248703|Tubulin Modulators|tubulin modulators|mesh-ancestor
92818318|NCT00248703|Antimitotic Agents|antimitotic agents|mesh-ancestor
92818319|NCT00248703|Mitosis Modulators|mitosis modulators|mesh-ancestor
92818320|NCT00248703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818321|NCT02713893|Econazole|econazole|mesh-list
92818322|NCT02713893|Benzydamine|benzydamine|mesh-list
92818323|NCT02713893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818324|NCT02713893|Antifungal Agents|antifungal agents|mesh-ancestor
92818325|NCT02713893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818326|NCT02713893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92818327|NCT02713893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92818328|NCT02713893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818329|NCT02713893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818330|NCT02713893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92818331|NCT02713893|Hormone Antagonists|hormone antagonists|mesh-ancestor
92818332|NCT02713893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818333|NCT02713893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818334|NCT00729937|Clindamycin|clindamycin|mesh-list
92818335|NCT00729937|Clindamycin palmitate|clindamycin palmitate|mesh-list
92818336|NCT00729937|Clindamycin phosphate|clindamycin phosphate|mesh-list
92818337|NCT00729937|Cephalexin|cephalexin|mesh-list
92818338|NCT00729937|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92818339|NCT00729937|Trimethoprim|trimethoprim|mesh-list
92818340|NCT00729937|Sulfamethoxazole|sulfamethoxazole|mesh-list
92818341|NCT00729937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92818342|NCT00729937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818343|NCT00729937|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92818344|NCT00729937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818345|NCT00729937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818346|NCT00729937|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92818347|NCT00729937|Antimalarials|antimalarials|mesh-ancestor
92818348|NCT00729937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92818349|NCT00729937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92818350|NCT00729937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92818351|NCT00729937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92818352|NCT00729937|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92818353|NCT00729937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92818354|NCT00729859|Methyltestosterone|methyltestosterone|mesh-list
92818355|NCT00729859|Anastrozole|anastrozole|mesh-list
92818356|NCT00729859|Testosterone|testosterone|mesh-list
92818357|NCT00729859|Testosterone undecanoate|testosterone undecanoate|mesh-list
92818359|NCT00729859|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92818360|NCT00729859|Acyline|acyline|mesh-list
92818361|NCT00729859|Androgens|androgens|mesh-ancestor
92818362|NCT00729859|Hormones|hormones|mesh-ancestor
92818363|NCT00729859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818364|NCT00729859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818365|NCT00729859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92818366|NCT00729859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818367|NCT00729859|Anabolic Agents|anabolic agents|mesh-ancestor
92818368|NCT00729859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92818369|NCT00729859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92818370|NCT00729859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818371|NCT00729859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818372|NCT00729859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92818373|NCT00729859|Hormone Antagonists|hormone antagonists|mesh-ancestor
92818374|NCT00810394|Sorafenib|sorafenib|mesh-list
92818375|NCT00810394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818376|NCT00810394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92818377|NCT00810394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818378|NCT00810394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818379|NCT00736333|Doxorubicin|doxorubicin|mesh-list
92818380|NCT00736333|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92818381|NCT00736333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92818382|NCT00736333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818383|NCT00736333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92818384|NCT00736333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92818385|NCT00736333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818386|NCT00736333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818387|NCT00736255|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92818388|NCT00736255|Dextroamphetamine|dextroamphetamine|mesh-list
92818390|NCT00736255|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92818391|NCT00736255|Autonomic Agents|autonomic agents|mesh-ancestor
92818392|NCT00736255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818393|NCT00736255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818394|NCT00736255|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92818395|NCT00736255|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92818396|NCT00736255|Cholinergic Agents|cholinergic agents|mesh-ancestor
92818397|NCT00736255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818398|NCT00736255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818399|NCT00736255|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92818400|NCT00736255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92818401|NCT00736255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92818402|NCT00736255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818403|NCT00736255|Dopamine Agents|dopamine agents|mesh-ancestor
92818404|NCT00742183|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92818405|NCT00742183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92818406|NCT00742183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818407|NCT00808444|Vaccines|vaccines|mesh-list
92818408|NCT00808444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92818409|NCT00808444|Immunologic Factors|immunologic factors|mesh-ancestor
92818410|NCT00808444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818411|NCT00914134|Levodopa|levodopa|mesh-list
92818412|NCT00914134|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92818413|NCT00914134|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92818414|NCT00914134|Dopamine Agents|dopamine agents|mesh-ancestor
92818415|NCT00914134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818416|NCT00914134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818417|NCT00914134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818418|NCT05754736|Bevacizumab|bevacizumab|mesh-list
92818419|NCT05754736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92818420|NCT05754736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818421|NCT05754736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92818422|NCT05754736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92818423|NCT05754736|Growth Substances|growth substances|mesh-ancestor
92818424|NCT05754736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818425|NCT05754736|Growth Inhibitors|growth inhibitors|mesh-ancestor
92818426|NCT00742027|Panobinostat|panobinostat|mesh-list
92818427|NCT00742027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818428|NCT00742027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92818429|NCT00742027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818430|NCT00742027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818431|NCT02609698|Aspirin|aspirin|mesh-list
92818432|NCT02609698|Clopidogrel|clopidogrel|mesh-list
92818433|NCT02609698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92818434|NCT02609698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818435|NCT02609698|Analgesics|analgesics|mesh-ancestor
92818436|NCT02609698|Sensory System Agents|sensory system agents|mesh-ancestor
92818437|NCT02609698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818438|NCT02609698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818439|NCT02609698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818440|NCT02609698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92818441|NCT02609698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92818442|NCT02609698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92818443|NCT02609698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818444|NCT02609698|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92818445|NCT02609698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92818446|NCT02609698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463467|NCT01762787|Hormones|hormones|mesh-ancestor
92818448|NCT02609698|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92818449|NCT02609698|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92818450|NCT02609698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92818451|NCT02609698|Purinergic Agents|purinergic agents|mesh-ancestor
92818452|NCT02609698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818453|NCT05750134|Pancrelipase|pancrelipase|mesh-list
92818454|NCT05750134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818455|NCT05749822|Fenofibrate|fenofibrate|mesh-list
92818456|NCT05749822|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92818457|NCT05749822|Antimetabolites|antimetabolites|mesh-ancestor
92818458|NCT05749822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818459|NCT05749822|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92818460|NCT02713191|Fentanyl|fentanyl|mesh-list
92818461|NCT02713191|Midazolam|midazolam|mesh-list
92818462|NCT02713191|Dexmedetomidine|dexmedetomidine|mesh-list
92818463|NCT02713191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92818464|NCT02713191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818465|NCT02713191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818466|NCT02713191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818467|NCT02713191|Analgesics|analgesics|mesh-ancestor
92818468|NCT02713191|Sensory System Agents|sensory system agents|mesh-ancestor
92818469|NCT02713191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818470|NCT02713191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92818471|NCT02713191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92818472|NCT02713191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92818473|NCT02713191|Adrenergic Agents|adrenergic agents|mesh-ancestor
92818474|NCT02713191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818475|NCT02713191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818476|NCT02713191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92818477|NCT02713191|Narcotics|narcotics|mesh-ancestor
92818478|NCT02713191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92818479|NCT02713191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92818480|NCT02713191|Anesthetics, General|anesthetics, general|mesh-ancestor
92818481|NCT02713191|Anesthetics|anesthetics|mesh-ancestor
92818482|NCT02713191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92818483|NCT02713191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92818484|NCT02713191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92818485|NCT02713191|GABA Modulators|gaba modulators|mesh-ancestor
92818486|NCT02713191|GABA Agents|gaba agents|mesh-ancestor
92818487|NCT00611169|Tirofiban|tirofiban|mesh-list
92818488|NCT00611169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92818489|NCT00611169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92818490|NCT00611169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818491|NCT00611169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92818492|NCT05754502|Trastuzumab|trastuzumab|mesh-list
92818493|NCT05754502|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92818494|NCT05754502|Maytansine|maytansine|mesh-list
92818495|NCT05754502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92818496|NCT05754502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818497|NCT05754502|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92818498|NCT05754502|Tubulin Modulators|tubulin modulators|mesh-ancestor
92818499|NCT05754502|Antimitotic Agents|antimitotic agents|mesh-ancestor
92818500|NCT05754502|Mitosis Modulators|mitosis modulators|mesh-ancestor
92818501|NCT05754502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818502|NCT05754502|Immunotoxins|immunotoxins|mesh-ancestor
92818503|NCT05754502|Immunoconjugates|immunoconjugates|mesh-ancestor
92818504|NCT05754502|Immunologic Factors|immunologic factors|mesh-ancestor
92818505|NCT05754502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818506|NCT02712957|Naproxen|naproxen|mesh-list
92818507|NCT02712957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92818508|NCT02712957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818509|NCT02712957|Analgesics|analgesics|mesh-ancestor
92818510|NCT02712957|Sensory System Agents|sensory system agents|mesh-ancestor
92818511|NCT02712957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818512|NCT02712957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818513|NCT02712957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818514|NCT02712957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92818515|NCT02712957|Gout Suppressants|gout suppressants|mesh-ancestor
92818516|NCT02712957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92818517|NCT02712957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818518|NCT02712957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463548|NCT01763281|Hormones|hormones|mesh-ancestor
92818519|NCT04226625|Propofol|propofol|mesh-list
92818520|NCT04226625|Desflurane|desflurane|mesh-list
92818521|NCT04226625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92818522|NCT04226625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818523|NCT04226625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818524|NCT04226625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92818525|NCT04226625|Anesthetics, General|anesthetics, general|mesh-ancestor
92818526|NCT04226625|Anesthetics|anesthetics|mesh-ancestor
92818527|NCT04226625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92818528|NCT02777619|Dexmedetomidine|dexmedetomidine|mesh-list
92818529|NCT02777619|Propofol|propofol|mesh-list
92818530|NCT02777619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92818531|NCT02777619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818532|NCT02777619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818533|NCT02777619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818534|NCT02777619|Analgesics|analgesics|mesh-ancestor
92818535|NCT02777619|Sensory System Agents|sensory system agents|mesh-ancestor
92818536|NCT02777619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818537|NCT02777619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92818538|NCT02777619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92818539|NCT02777619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92818540|NCT02777619|Adrenergic Agents|adrenergic agents|mesh-ancestor
92818541|NCT02777619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818542|NCT02777619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818543|NCT02777619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92818544|NCT02777619|Anesthetics, General|anesthetics, general|mesh-ancestor
92818545|NCT02777619|Anesthetics|anesthetics|mesh-ancestor
92818546|NCT05754424|Insulin Aspart|insulin aspart|mesh-list
92818547|NCT05754424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92818548|NCT05754424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818549|NCT00636831|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92818550|NCT00636831|Cefazolin|cefazolin|mesh-list
92818551|NCT00636831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818552|NCT04193631|Cannabidiol|cannabidiol|mesh-list
92818553|NCT04193631|Anticonvulsants|anticonvulsants|mesh-ancestor
92818554|NCT04856631|Cetuximab|cetuximab|mesh-list
92818555|NCT04856631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92818556|NCT04856631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818557|NCT00808210|Methylprednisolone|methylprednisolone|mesh-list
92818558|NCT00808210|Infliximab|infliximab|mesh-list
92818559|NCT00808210|Methotrexate|methotrexate|mesh-list
92818560|NCT00808210|Ocrelizumab|ocrelizumab|mesh-list
92818561|NCT00808210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92818562|NCT00808210|Abortifacient Agents|abortifacient agents|mesh-ancestor
92818563|NCT00808210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92818564|NCT00808210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818565|NCT00808210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92818566|NCT00808210|Antimetabolites|antimetabolites|mesh-ancestor
92818567|NCT00808210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818568|NCT00808210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818569|NCT00808210|Dermatologic Agents|dermatologic agents|mesh-ancestor
92818570|NCT00808210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818571|NCT00808210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92818572|NCT00808210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92818573|NCT00808210|Immunologic Factors|immunologic factors|mesh-ancestor
92818574|NCT00808210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92818575|NCT00808210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92818576|NCT00808210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818577|NCT00808210|Antiemetics|antiemetics|mesh-ancestor
92818578|NCT00808210|Autonomic Agents|autonomic agents|mesh-ancestor
92818579|NCT00808210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818580|NCT00808210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818581|NCT00808210|Glucocorticoids|glucocorticoids|mesh-ancestor
92818582|NCT00808210|Hormones|hormones|mesh-ancestor
92818583|NCT00808210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818584|NCT00808210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92818585|NCT00808210|Protective Agents|protective agents|mesh-ancestor
92818586|NCT00808210|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92818588|NCT02777229|Lamivudine|lamivudine|mesh-list
92818589|NCT02777229|Efavirenz|efavirenz|mesh-list
92818590|NCT02777229|Dolutegravir|dolutegravir|mesh-list
92818591|NCT02777229|Antiviral Agents|antiviral agents|mesh-ancestor
92818592|NCT02777229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818593|NCT02777229|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92818594|NCT02777229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92463615|NCT01763658|Dexamethasone|dexamethasone|mesh-list
92818595|NCT02777229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818596|NCT02777229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818597|NCT02777229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92818598|NCT02777229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92818599|NCT02777229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92818600|NCT02777229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92818601|NCT02777229|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92818602|NCT02777229|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92818603|NCT02777229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92818604|NCT02777229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92818605|NCT02777229|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92818606|NCT02777229|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92818607|NCT02712177|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92818608|NCT02712177|Immunologic Factors|immunologic factors|mesh-ancestor
92818609|NCT02712177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818610|NCT00635037|Bupivacaine|bupivacaine|mesh-list
92818611|NCT00635037|Anesthetics, Local|anesthetics, local|mesh-ancestor
92818612|NCT00635037|Anesthetics|anesthetics|mesh-ancestor
92818613|NCT00635037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818614|NCT00635037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818615|NCT00635037|Sensory System Agents|sensory system agents|mesh-ancestor
92818616|NCT00635037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818617|NCT02777151|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
92818618|NCT02777151|Atoltivimab|atoltivimab|mesh-list
92818619|NCT02777151|Antiviral Agents|antiviral agents|mesh-ancestor
92818620|NCT02777151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818621|NCT02777073|Dapagliflozin|dapagliflozin|mesh-list
92818622|NCT02777073|Liraglutide|liraglutide|mesh-list
92818623|NCT02777073|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93026450|NCT00392223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92818624|NCT02777073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818625|NCT02777073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92818626|NCT02777073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818627|NCT02777073|Incretins|incretins|mesh-ancestor
92818628|NCT02777073|Hormones|hormones|mesh-ancestor
92818629|NCT02777073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818630|NCT02711865|Antibodies|antibodies|mesh-list
92818631|NCT02711865|Immunologic Factors|immunologic factors|mesh-ancestor
92818632|NCT02711865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818633|NCT02711943|Levofloxacin|levofloxacin|mesh-list
92818634|NCT02711943|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92818635|NCT02711943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818636|NCT02711943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92818637|NCT02711943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92818638|NCT02711943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92818639|NCT02711943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818640|NCT02711943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818641|NCT02711943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818642|NCT02711943|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92818643|NCT02711943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92818644|NCT02776761|Vaccines|vaccines|mesh-list
92818645|NCT02776761|Immunologic Factors|immunologic factors|mesh-ancestor
92818646|NCT02776761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818647|NCT00736099|Pioglitazone|pioglitazone|mesh-list
92818648|NCT00736099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92818649|NCT00736099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818650|NCT04616547|Edetic Acid|edetic acid|mesh-list
92818651|NCT04616547|Pentetic Acid|pentetic acid|mesh-list
92818652|NCT04616547|Antidotes|antidotes|mesh-ancestor
92818653|NCT04616547|Protective Agents|protective agents|mesh-ancestor
92818654|NCT04616547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818655|NCT04616547|Chelating Agents|chelating agents|mesh-ancestor
92818656|NCT04616547|Sequestering Agents|sequestering agents|mesh-ancestor
92818657|NCT04616547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818658|NCT04616547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92818659|NCT04616547|Anticoagulants|anticoagulants|mesh-ancestor
92818660|NCT04616547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92818661|NCT02711241|Dipyrone|dipyrone|mesh-list
92818662|NCT02711241|Papaverine|papaverine|mesh-list
92818663|NCT02711241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92818664|NCT02711241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818665|NCT02711241|Analgesics|analgesics|mesh-ancestor
92818666|NCT02711241|Sensory System Agents|sensory system agents|mesh-ancestor
92818667|NCT02711241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818668|NCT02711241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818669|NCT02711241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818670|NCT02711241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92818671|NCT02711241|Antipyretics|antipyretics|mesh-ancestor
92818672|NCT02711241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92818673|NCT02711241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818674|NCT02711241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818675|NCT02711241|Vasodilator Agents|vasodilator agents|mesh-ancestor
92818676|NCT02711241|Urological Agents|urological agents|mesh-ancestor
92818677|NCT02711007|Apatinib|apatinib|mesh-list
92818678|NCT02711007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818679|NCT02711007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92818680|NCT02711007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818681|NCT02711007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818682|NCT02710539|Amlodipine|amlodipine|mesh-list
92818683|NCT02710539|Perindopril|perindopril|mesh-list
92818684|NCT02710539|Indapamide|indapamide|mesh-list
92818685|NCT02710539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92818686|NCT02710539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92818687|NCT02710539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818688|NCT02710539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818689|NCT02710539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92818690|NCT02710539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818691|NCT02710539|Vasodilator Agents|vasodilator agents|mesh-ancestor
92818692|NCT02710539|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92818693|NCT02710539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92818694|NCT02710539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818695|NCT02710539|Diuretics|diuretics|mesh-ancestor
92818696|NCT02710539|Natriuretic Agents|natriuretic agents|mesh-ancestor
92818697|NCT02710539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92818698|NCT00735709|Vortioxetine|vortioxetine|mesh-list
92818699|NCT00735709|Antidepressive Agents|antidepressive agents|mesh-ancestor
92818700|NCT00735709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92818701|NCT00735709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92818702|NCT00735709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92818703|NCT00735709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818704|NCT00735709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818705|NCT00735709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92818706|NCT00735709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92818707|NCT00735709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818708|NCT00735709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818709|NCT00735709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818710|NCT00735709|Serotonin Agents|serotonin agents|mesh-ancestor
92818711|NCT00735709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92818712|NCT00735709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92818713|NCT00735709|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92818714|NCT00735709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92818715|NCT02776527|Apatinib|apatinib|mesh-list
92818716|NCT02776527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818717|NCT02776527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92818718|NCT02776527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818719|NCT02776527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818720|NCT00729157|Deoxyglucose|deoxyglucose|mesh-list
92818721|NCT00729157|Aflibercept|aflibercept|mesh-list
92818722|NCT00729157|Endothelial Growth Factors|endothelial growth factors|mesh-list
92818723|NCT00729157|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92818724|NCT00729157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92818725|NCT00729157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92818726|NCT00729157|Growth Substances|growth substances|mesh-ancestor
92818727|NCT00729157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818728|NCT00729157|Growth Inhibitors|growth inhibitors|mesh-ancestor
92818729|NCT00729157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818730|NCT00729157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818731|NCT00729157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92818732|NCT00729157|Antimetabolites|antimetabolites|mesh-ancestor
92818733|NCT00729157|Antiviral Agents|antiviral agents|mesh-ancestor
92818734|NCT00729157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818735|NCT02710305|Lidocaine|lidocaine|mesh-list
92818736|NCT02710305|Scopolamine|scopolamine|mesh-list
92818737|NCT02710305|Bromides|bromides|mesh-list
92818738|NCT02710305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92818739|NCT02710305|Anesthetics, Local|anesthetics, local|mesh-ancestor
92818740|NCT02710305|Anesthetics|anesthetics|mesh-ancestor
92818741|NCT02710305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818742|NCT02710305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818743|NCT02710305|Sensory System Agents|sensory system agents|mesh-ancestor
92818744|NCT02710305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818745|NCT02710305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92818746|NCT02710305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92818747|NCT02710305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92818748|NCT02710305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818749|NCT02710305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818750|NCT02710305|Anticonvulsants|anticonvulsants|mesh-ancestor
92818751|NCT02710305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92818752|NCT02710305|Antiemetics|antiemetics|mesh-ancestor
92818753|NCT02710305|Autonomic Agents|autonomic agents|mesh-ancestor
92818754|NCT02710305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818755|NCT02710305|Mydriatics|mydriatics|mesh-ancestor
92818756|NCT02710305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92818757|NCT02710305|Cholinergic Agents|cholinergic agents|mesh-ancestor
92818758|NCT02710305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818759|NCT02710305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92818760|NCT02710305|Parasympatholytics|parasympatholytics|mesh-ancestor
92818761|NCT02708511|Copper|copper|mesh-list
92818762|NCT02708511|Trace Elements|trace elements|mesh-ancestor
92818763|NCT02708511|Micronutrients|micronutrients|mesh-ancestor
92818764|NCT02708511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818765|NCT00728689|Tecovirimat|tecovirimat|mesh-list
92818766|NCT00728689|Antiviral Agents|antiviral agents|mesh-ancestor
92818767|NCT00728689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818768|NCT02596243|Vaccines|vaccines|mesh-list
92818769|NCT02596243|Immunologic Factors|immunologic factors|mesh-ancestor
92818770|NCT02596243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818771|NCT02717091|Paclitaxel|paclitaxel|mesh-list
92818772|NCT02717091|Gemcitabine|gemcitabine|mesh-list
92818773|NCT02717091|Folfirinox|folfirinox|mesh-list
92818774|NCT02717091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92818775|NCT02717091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818776|NCT02717091|Tubulin Modulators|tubulin modulators|mesh-ancestor
92818777|NCT02717091|Antimitotic Agents|antimitotic agents|mesh-ancestor
92818778|NCT02717091|Mitosis Modulators|mitosis modulators|mesh-ancestor
92818779|NCT02717091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818780|NCT02717091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92818781|NCT02717091|Antimetabolites|antimetabolites|mesh-ancestor
92818782|NCT00726895|Quinine|quinine|mesh-list
92818783|NCT00726895|Antimalarials|antimalarials|mesh-ancestor
92818784|NCT00726895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92818785|NCT00726895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92818786|NCT00726895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818787|NCT00726895|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92818788|NCT00726895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818789|NCT00726895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92818790|NCT00726895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818791|NCT00726895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818792|NCT00726895|Analgesics|analgesics|mesh-ancestor
92818793|NCT00726895|Sensory System Agents|sensory system agents|mesh-ancestor
92818794|NCT02593201|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92818795|NCT02593201|Cefazolin|cefazolin|mesh-list
92818796|NCT02593201|Ceftazidime|ceftazidime|mesh-list
92818797|NCT02593201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92818798|NCT02593201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818799|NCT02593201|Antitubercular Agents|antitubercular agents|mesh-ancestor
92818800|NCT02707809|Dexmedetomidine|dexmedetomidine|mesh-list
92818801|NCT02707809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92818802|NCT02707809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818803|NCT02707809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818804|NCT02707809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818805|NCT02707809|Analgesics|analgesics|mesh-ancestor
92818806|NCT02707809|Sensory System Agents|sensory system agents|mesh-ancestor
92818807|NCT02707809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818808|NCT02707809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92818809|NCT02707809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92818810|NCT02707809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92818811|NCT02707809|Adrenergic Agents|adrenergic agents|mesh-ancestor
92818812|NCT02707809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818813|NCT02707809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818814|NCT00585325|Lidocaine|lidocaine|mesh-list
92818815|NCT00585325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92818816|NCT00585325|Anesthetics|anesthetics|mesh-ancestor
92818817|NCT00585325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818818|NCT00585325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818819|NCT00585325|Sensory System Agents|sensory system agents|mesh-ancestor
92818820|NCT00585325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818821|NCT00585325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92818822|NCT00585325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92818823|NCT00585325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92818824|NCT00585325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818825|NCT00585325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818826|NCT02716857|Oxycodone|oxycodone|mesh-list
92818827|NCT02716857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92818828|NCT02716857|Narcotics|narcotics|mesh-ancestor
92818829|NCT02716857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818830|NCT02716857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818831|NCT02716857|Analgesics|analgesics|mesh-ancestor
92818832|NCT02716857|Sensory System Agents|sensory system agents|mesh-ancestor
92818833|NCT02716857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818834|NCT00917761|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92818835|NCT00917761|Interferon-alpha|interferon-alpha|mesh-list
92818836|NCT00917761|Entecavir|entecavir|mesh-list
92818837|NCT00917761|Antiviral Agents|antiviral agents|mesh-ancestor
92818838|NCT00917761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818839|NCT00917761|Immunologic Factors|immunologic factors|mesh-ancestor
92818840|NCT00917761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818841|NCT02709603|Scopolamine|scopolamine|mesh-list
92818842|NCT02709603|Bromides|bromides|mesh-list
92818843|NCT02709603|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92818844|NCT02709603|Anticonvulsants|anticonvulsants|mesh-ancestor
92818845|NCT02709603|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92818846|NCT02709603|Antiemetics|antiemetics|mesh-ancestor
92818847|NCT02709603|Autonomic Agents|autonomic agents|mesh-ancestor
92818848|NCT02709603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818849|NCT02709603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818850|NCT02709603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92818851|NCT02709603|Mydriatics|mydriatics|mesh-ancestor
92818852|NCT02709603|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92818853|NCT02709603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92818854|NCT02709603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818855|NCT02709603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818856|NCT02709603|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92818857|NCT02709603|Parasympatholytics|parasympatholytics|mesh-ancestor
92818858|NCT00611793|Bevacizumab|bevacizumab|mesh-list
92818859|NCT00611793|Vatalanib|vatalanib|mesh-list
92818860|NCT00611793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92818861|NCT00611793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818862|NCT00611793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92818863|NCT00611793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92818864|NCT00611793|Growth Substances|growth substances|mesh-ancestor
92818865|NCT00611793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818866|NCT00611793|Growth Inhibitors|growth inhibitors|mesh-ancestor
92818867|NCT00611793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92818868|NCT00611793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818869|NCT00611793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818870|NCT00611871|Propranolol|propranolol|mesh-list
92818871|NCT00611871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92818872|NCT00611871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92818873|NCT00611871|Adrenergic Agents|adrenergic agents|mesh-ancestor
92818874|NCT00611871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818875|NCT00611871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818876|NCT00611871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818877|NCT00611871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92818878|NCT00611871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92818879|NCT00611871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92818880|NCT02709525|Hyaluronic Acid|hyaluronic acid|mesh-list
92818881|NCT02709525|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92818882|NCT02709525|Immunologic Factors|immunologic factors|mesh-ancestor
92818883|NCT02709525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818884|NCT02709525|Viscosupplements|viscosupplements|mesh-ancestor
92818885|NCT02709525|Protective Agents|protective agents|mesh-ancestor
92818886|NCT05087589|Tofacitinib|tofacitinib|mesh-list
92818887|NCT05087589|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92818888|NCT05087589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92818889|NCT05087589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818890|NCT05087589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818891|NCT00612651|Temozolomide|temozolomide|mesh-list
92818892|NCT00612651|Lonafarnib|lonafarnib|mesh-list
92818893|NCT00612651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92818894|NCT00612651|Alkylating Agents|alkylating agents|mesh-ancestor
92818895|NCT00612651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818896|NCT00612651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818897|NCT00612651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818898|NCT00918307|Varenicline|varenicline|mesh-list
92818899|NCT00918307|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92818900|NCT00918307|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92818901|NCT00918307|Cholinergic Agents|cholinergic agents|mesh-ancestor
92818902|NCT00918307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818903|NCT00918307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818904|NCT00918307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818905|NCT00741013|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92818906|NCT00741013|Protein C|protein c|mesh-list
92818907|NCT00741013|Lovastatin|lovastatin|mesh-list
92818908|NCT00741013|L 647318|l 647318|mesh-list
92818909|NCT00741013|Dihydromevinolin|dihydromevinolin|mesh-list
92818910|NCT00741013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92818911|NCT00741013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92818912|NCT00741013|Antimetabolites|antimetabolites|mesh-ancestor
92818913|NCT00741013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818914|NCT00741013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92818915|NCT00741013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92818916|NCT00741013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818917|NCT00741013|Anticoagulants|anticoagulants|mesh-ancestor
92818918|NCT00741013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92818919|NCT00741013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92818920|NCT00741013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818921|NCT04087759|Bedaquiline|bedaquiline|mesh-list
92818922|NCT04087759|Diarylquinolines|diarylquinolines|mesh-list
92818923|NCT04087759|Antitubercular Agents|antitubercular agents|mesh-ancestor
92818924|NCT04087759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92818925|NCT04087759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92818926|NCT00740857|Ibuprofen|ibuprofen|mesh-list
92818927|NCT00740857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92818928|NCT00740857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92818929|NCT00740857|Analgesics|analgesics|mesh-ancestor
92818930|NCT00740857|Sensory System Agents|sensory system agents|mesh-ancestor
92818931|NCT00740857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92818932|NCT00740857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818933|NCT00740857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92818934|NCT00740857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92818935|NCT00740857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92818936|NCT00740857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92818937|NCT00740857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818938|NCT00808132|Bazedoxifene|bazedoxifene|mesh-list
92818939|NCT00808132|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92818940|NCT00808132|Medroxyprogesterone|medroxyprogesterone|mesh-list
92818941|NCT00808132|Estrogens|estrogens|mesh-list
92818942|NCT00808132|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92818943|NCT00808132|Hormones|hormones|mesh-ancestor
92818944|NCT00808132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92818945|NCT00808132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818946|NCT00808132|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92818947|NCT00808132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92818948|NCT00808132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92818949|NCT00808132|Contraceptive Agents|contraceptive agents|mesh-ancestor
92818950|NCT00808132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92818951|NCT00808132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92818952|NCT00808132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92818953|NCT00808132|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92818954|NCT00808132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92818955|NCT00808132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818956|NCT00808132|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92818957|NCT00808132|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92818958|NCT00808132|Hormone Antagonists|hormone antagonists|mesh-ancestor
92818959|NCT00808132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92818960|NCT00727441|Cyclophosphamide|cyclophosphamide|mesh-list
92818961|NCT00727441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92818962|NCT00727441|Immunologic Factors|immunologic factors|mesh-ancestor
92818963|NCT00727441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818964|NCT00727441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92818965|NCT00727441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92818966|NCT00727441|Alkylating Agents|alkylating agents|mesh-ancestor
92818967|NCT00727441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818968|NCT00727441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818969|NCT00727441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92818970|NCT00914368|Clopidogrel|clopidogrel|mesh-list
92818971|NCT00914368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92463990|NCT01765855|Betrixaban|betrixaban|mesh-list
92818972|NCT00914368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92818973|NCT00914368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92818974|NCT00914368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92818975|NCT00914368|Purinergic Agents|purinergic agents|mesh-ancestor
92818976|NCT00914368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92818977|NCT00914368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818978|NCT00914368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818979|NCT02607982|Paclitaxel|paclitaxel|mesh-list
92818980|NCT02607982|Oxaliplatin|oxaliplatin|mesh-list
92818981|NCT02607982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92818982|NCT02607982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92818983|NCT02607982|Tubulin Modulators|tubulin modulators|mesh-ancestor
92818984|NCT02607982|Antimitotic Agents|antimitotic agents|mesh-ancestor
92818985|NCT02607982|Mitosis Modulators|mitosis modulators|mesh-ancestor
92818986|NCT02607982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818987|NCT02692989|Anesthetics|anesthetics|mesh-list
92818988|NCT02692989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92818989|NCT02692989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92818990|NCT04126473|Ivacaftor|ivacaftor|mesh-list
92818991|NCT04126473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92818992|NCT04126473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92818993|NCT04126473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92818994|NCT03643276|Cytarabine|cytarabine|mesh-list
92818995|NCT03643276|Dexamethasone|dexamethasone|mesh-list
92818996|NCT03643276|Prednisone|prednisone|mesh-list
92818997|NCT03643276|Prednisolone|prednisolone|mesh-list
92818998|NCT03643276|Cyclophosphamide|cyclophosphamide|mesh-list
92818999|NCT03643276|Ifosfamide|ifosfamide|mesh-list
92819000|NCT03643276|Doxorubicin|doxorubicin|mesh-list
92819001|NCT03643276|Methotrexate|methotrexate|mesh-list
92819002|NCT03643276|Fludarabine|fludarabine|mesh-list
92819003|NCT03643276|Fludarabine phosphate|fludarabine phosphate|mesh-list
92819004|NCT03643276|Etoposide|etoposide|mesh-list
92819005|NCT03643276|Vincristine|vincristine|mesh-list
92819006|NCT03643276|Bortezomib|bortezomib|mesh-list
92819007|NCT03643276|Daunorubicin|daunorubicin|mesh-list
92819008|NCT03643276|Mercaptopurine|mercaptopurine|mesh-list
92819009|NCT03643276|Pegaspargase|pegaspargase|mesh-list
92819010|NCT03643276|Blinatumomab|blinatumomab|mesh-list
92819011|NCT03643276|Vindesine|vindesine|mesh-list
92819012|NCT03643276|Asparaginase|asparaginase|mesh-list
92819013|NCT03643276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92819014|NCT03643276|Immunologic Factors|immunologic factors|mesh-ancestor
92819015|NCT03643276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819016|NCT03643276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819017|NCT03643276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92819018|NCT03643276|Alkylating Agents|alkylating agents|mesh-ancestor
92819019|NCT03643276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819020|NCT03643276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819021|NCT03643276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92819022|NCT03643276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819023|NCT03643276|Antiemetics|antiemetics|mesh-ancestor
92819024|NCT03643276|Autonomic Agents|autonomic agents|mesh-ancestor
92819025|NCT03643276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819026|NCT03643276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819027|NCT03643276|Glucocorticoids|glucocorticoids|mesh-ancestor
92819028|NCT03643276|Hormones|hormones|mesh-ancestor
92819029|NCT03643276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819030|NCT03643276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92819031|NCT03643276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92819032|NCT03643276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92819033|NCT03643276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92819034|NCT03643276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819035|NCT03643276|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92819036|NCT03643276|Abortifacient Agents|abortifacient agents|mesh-ancestor
92819037|NCT03643276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819038|NCT03643276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92819039|NCT03643276|Antimetabolites|antimetabolites|mesh-ancestor
92819040|NCT03643276|Dermatologic Agents|dermatologic agents|mesh-ancestor
92819041|NCT03643276|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92819042|NCT03643276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92819043|NCT03643276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92819044|NCT03643276|Antiviral Agents|antiviral agents|mesh-ancestor
92464065|NCT01766323|Modafinil|modafinil|mesh-list
92819045|NCT03643276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819046|NCT03643276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819047|NCT03643276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92819048|NCT03643276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819049|NCT04882293|Atorvastatin|atorvastatin|mesh-list
92819050|NCT04882293|Fenofibrate|fenofibrate|mesh-list
92819051|NCT04882293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92819052|NCT04882293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92819053|NCT04882293|Antimetabolites|antimetabolites|mesh-ancestor
92819054|NCT04882293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819055|NCT04882293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92819056|NCT04882293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92819057|NCT04882293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819058|NCT02608060|Epoetin Alfa|epoetin alfa|mesh-list
92819059|NCT02608060|Hematinics|hematinics|mesh-ancestor
92819060|NCT04085575|Tranexamic Acid|tranexamic acid|mesh-list
92819061|NCT04085575|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92819062|NCT04085575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92819063|NCT04085575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819064|NCT04085575|Hemostatics|hemostatics|mesh-ancestor
92819065|NCT04085575|Coagulants|coagulants|mesh-ancestor
92819066|NCT00585169|Memantine|memantine|mesh-list
92819067|NCT00585169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92819068|NCT00585169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92819069|NCT00585169|Dopamine Agents|dopamine agents|mesh-ancestor
92819070|NCT00585169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819071|NCT00585169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819072|NCT00585169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819073|NCT00585169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92819074|NCT00585169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92819075|NCT00807742|Nicotine|nicotine|mesh-list
92819076|NCT00807742|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92819077|NCT00807742|Autonomic Agents|autonomic agents|mesh-ancestor
92819078|NCT00807742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819079|NCT00807742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819080|NCT00807742|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92819081|NCT00807742|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92819082|NCT00807742|Cholinergic Agents|cholinergic agents|mesh-ancestor
92819083|NCT00807742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819084|NCT00807742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819085|NCT04741815|Carbon Fiber|carbon fiber|mesh-list
92819086|NCT04741815|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92819087|NCT04741815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819088|NCT05738434|Apatinib|apatinib|mesh-list
92819089|NCT05738434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819090|NCT05738434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819091|NCT05738434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819092|NCT05738434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819093|NCT00803452|Azithromycin|azithromycin|mesh-list
92819094|NCT00803452|Doxycycline|doxycycline|mesh-list
92819095|NCT00803452|Minocycline|minocycline|mesh-list
92819096|NCT00803452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92819097|NCT00803452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819098|NCT00803452|Antimalarials|antimalarials|mesh-ancestor
92819099|NCT00803452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92819100|NCT00803452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92819101|NCT04546113|Ropivacaine|ropivacaine|mesh-list
92819102|NCT04546113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92819103|NCT04546113|Anesthetics|anesthetics|mesh-ancestor
92819104|NCT04546113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819105|NCT04546113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819106|NCT04546113|Sensory System Agents|sensory system agents|mesh-ancestor
92819107|NCT04546113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819109|NCT05737342|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92819110|NCT05737342|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92819111|NCT05737342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92819112|NCT05737342|Antimetabolites|antimetabolites|mesh-ancestor
92819113|NCT05737342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819114|NCT05737342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819115|NCT05737342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92819116|NCT00914212|Sibutramine|sibutramine|mesh-list
92819117|NCT00914212|Antidepressive Agents|antidepressive agents|mesh-ancestor
92819118|NCT00914212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92819119|NCT00914212|Appetite Depressants|appetite depressants|mesh-ancestor
92819120|NCT00914212|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92819121|NCT04456023|Tisagenlecleucel|tisagenlecleucel|mesh-list
92819122|NCT04456023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819123|NCT04456023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819124|NCT04188483|Selenium|selenium|mesh-list
92819125|NCT04188483|Antioxidants|antioxidants|mesh-ancestor
92819126|NCT04188483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819127|NCT04188483|Protective Agents|protective agents|mesh-ancestor
92819128|NCT04188483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819130|NCT04188483|Micronutrients|micronutrients|mesh-ancestor
92819131|NCT02693145|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92819132|NCT02693145|Antiviral Agents|antiviral agents|mesh-ancestor
92819133|NCT02693145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819134|NCT00717067|Ritonavir|ritonavir|mesh-list
92819135|NCT00717067|Saquinavir|saquinavir|mesh-list
92819136|NCT00717067|Maraviroc|maraviroc|mesh-list
92819137|NCT00717067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92819138|NCT00717067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92819139|NCT00717067|Protease Inhibitors|protease inhibitors|mesh-ancestor
92819140|NCT00717067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819141|NCT00717067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819142|NCT00717067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92819143|NCT00717067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92819144|NCT00717067|Antiviral Agents|antiviral agents|mesh-ancestor
92819145|NCT00717067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819146|NCT00717067|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92819147|NCT00717067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92819148|NCT00717067|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92819149|NCT00717067|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92819150|NCT00717067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92819151|NCT05731960|Dexamethasone|dexamethasone|mesh-list
92819152|NCT05731960|Metoclopramide|metoclopramide|mesh-list
92819153|NCT05731960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819154|NCT05731960|Antiemetics|antiemetics|mesh-ancestor
92819155|NCT05731960|Autonomic Agents|autonomic agents|mesh-ancestor
92819156|NCT05731960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819157|NCT05731960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819158|NCT05731960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819159|NCT05731960|Glucocorticoids|glucocorticoids|mesh-ancestor
92819160|NCT05731960|Hormones|hormones|mesh-ancestor
92819161|NCT05731960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819162|NCT05731960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92819163|NCT05731960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819164|NCT05731960|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92819165|NCT05731960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92819166|NCT05731960|Dopamine Agents|dopamine agents|mesh-ancestor
92819167|NCT05731960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819168|NCT05731960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819169|NCT04393311|Urinastatin|urinastatin|mesh-list
92819170|NCT04393311|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92819171|NCT04393311|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92819172|NCT04393311|Protease Inhibitors|protease inhibitors|mesh-ancestor
92819173|NCT04393311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819174|NCT04393311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819175|NCT02607436|Aspirin|aspirin|mesh-list
92819176|NCT02607436|Sarpogrelate|sarpogrelate|mesh-list
92819177|NCT02607436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92819178|NCT02607436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92819179|NCT02607436|Analgesics|analgesics|mesh-ancestor
92819180|NCT02607436|Sensory System Agents|sensory system agents|mesh-ancestor
92819181|NCT02607436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819182|NCT02607436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819183|NCT02607436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819184|NCT02607436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819185|NCT02607436|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92819186|NCT02607436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92819187|NCT02607436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819188|NCT02607436|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92819189|NCT02607436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92819190|NCT02607436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819191|NCT02607436|Antipyretics|antipyretics|mesh-ancestor
92819192|NCT02607436|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92819193|NCT02607436|Serotonin Agents|serotonin agents|mesh-ancestor
92819194|NCT02607436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819195|NCT02607592|Pemetrexed|pemetrexed|mesh-list
92819196|NCT02607592|Nedaplatin|nedaplatin|mesh-list
92819197|NCT02607592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819198|NCT02607592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819199|NCT02607592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819200|NCT02607592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92819201|NCT02607592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92819202|NCT04356339|Interferons|interferons|mesh-list
92819203|NCT04356339|Interferon-beta|interferon-beta|mesh-list
92819204|NCT04356339|Interferon beta-1b|interferon beta-1b|mesh-list
92819205|NCT04356339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819206|NCT04356339|Antiviral Agents|antiviral agents|mesh-ancestor
92819207|NCT04356339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819208|NCT04356339|Immunologic Factors|immunologic factors|mesh-ancestor
92819209|NCT04356339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819210|NCT04356339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92819211|NCT03511846|Capsaicin|capsaicin|mesh-list
92819212|NCT03511846|Antipruritics|antipruritics|mesh-ancestor
92819213|NCT03511846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92819214|NCT03511846|Sensory System Agents|sensory system agents|mesh-ancestor
92819215|NCT03511846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819216|NCT03511846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819217|NCT04331145|Ticagrelor|ticagrelor|mesh-list
92819218|NCT04331145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92819219|NCT04331145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92819220|NCT04331145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92819221|NCT04331145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92819222|NCT04331145|Purinergic Agents|purinergic agents|mesh-ancestor
92819223|NCT04331145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819224|NCT04331145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819225|NCT04331145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819226|NCT03460522|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92819227|NCT03460522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819228|NCT03460522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819229|NCT03460522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92819230|NCT03460522|Immunotoxins|immunotoxins|mesh-ancestor
92819231|NCT03460522|Immunoconjugates|immunoconjugates|mesh-ancestor
92819232|NCT03460522|Immunologic Factors|immunologic factors|mesh-ancestor
92819233|NCT03460522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819234|NCT02605720|Piperaquine|piperaquine|mesh-list
92819235|NCT02605720|Artenimol|artenimol|mesh-list
92819236|NCT02605720|Antimalarials|antimalarials|mesh-ancestor
92819237|NCT02605720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92819238|NCT02605720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92819239|NCT02605720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819240|NCT04188561|Hyaluronic Acid|hyaluronic acid|mesh-list
92819241|NCT04188561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92819242|NCT04188561|Immunologic Factors|immunologic factors|mesh-ancestor
92819243|NCT04188561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819244|NCT04188561|Viscosupplements|viscosupplements|mesh-ancestor
92819245|NCT04188561|Protective Agents|protective agents|mesh-ancestor
92819246|NCT00588952|Ketamine|ketamine|mesh-list
92819247|NCT00588952|Analgesics|analgesics|mesh-ancestor
92819248|NCT00588952|Sensory System Agents|sensory system agents|mesh-ancestor
92819249|NCT00588952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819250|NCT00588952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819251|NCT00588952|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92819252|NCT00588952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92819253|NCT00588952|Anesthetics, General|anesthetics, general|mesh-ancestor
92819254|NCT00588952|Anesthetics|anesthetics|mesh-ancestor
92819255|NCT00588952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819256|NCT00588952|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92819257|NCT00588952|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92819258|NCT00588952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819259|NCT00588952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819260|NCT04885257|Methylphenidate|methylphenidate|mesh-list
92819261|NCT04885257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92819262|NCT04885257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819263|NCT04885257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92819264|NCT04885257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92819265|NCT04885257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819266|NCT04885257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819267|NCT04885257|Dopamine Agents|dopamine agents|mesh-ancestor
92819268|NCT04885257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819269|NCT03484923|Spartalizumab|spartalizumab|mesh-list
92819270|NCT03484923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92819271|NCT03484923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819272|NCT03484923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819273|NCT03484923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819274|NCT00802360|Menotropins|menotropins|mesh-list
92819275|NCT00802360|Progesterone|progesterone|mesh-list
92819276|NCT00802360|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92819277|NCT00802360|Ganirelix|ganirelix|mesh-list
92819278|NCT00802360|Progestins|progestins|mesh-ancestor
92819279|NCT00802360|Hormones|hormones|mesh-ancestor
92819280|NCT00802360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819281|NCT00802360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819282|NCT00802360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92819283|NCT00802360|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92819284|NCT00802360|Fertility Agents|fertility agents|mesh-ancestor
92819285|NCT00802360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819286|NCT04908423|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92819287|NCT04908423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92819288|NCT04908423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819289|NCT04908423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819290|NCT04908423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92721157|NCT01153009|Analgesics|analgesics|mesh-ancestor
92819291|NCT04908423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819292|NCT04908423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819293|NCT04908423|Cholinergic Agents|cholinergic agents|mesh-ancestor
92819294|NCT04908423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819295|NCT04811625|Aspirin|aspirin|mesh-list
92819296|NCT04811625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92819297|NCT04811625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92819298|NCT04811625|Analgesics|analgesics|mesh-ancestor
92819299|NCT04811625|Sensory System Agents|sensory system agents|mesh-ancestor
92819300|NCT04811625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819301|NCT04811625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819302|NCT04811625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819303|NCT04811625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819304|NCT04811625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92819305|NCT04811625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92819306|NCT04811625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819307|NCT04811625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92819308|NCT04811625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92819309|NCT04811625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819310|NCT04811625|Antipyretics|antipyretics|mesh-ancestor
92819311|NCT02764593|Nivolumab|nivolumab|mesh-list
92819312|NCT02764593|Cetuximab|cetuximab|mesh-list
92819313|NCT02764593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819314|NCT02764593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819315|NCT02764593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92819316|NCT02764593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819317|NCT04028596|Acetaminophen|acetaminophen|mesh-list
92819318|NCT04028596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92819319|NCT04028596|Analgesics|analgesics|mesh-ancestor
92819320|NCT04028596|Sensory System Agents|sensory system agents|mesh-ancestor
92819321|NCT04028596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819322|NCT04028596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819323|NCT04028596|Antipyretics|antipyretics|mesh-ancestor
92819324|NCT02692599|Vaccines|vaccines|mesh-list
92819325|NCT02692599|Immunologic Factors|immunologic factors|mesh-ancestor
92819326|NCT02692599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819327|NCT01026038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92819328|NCT01026038|Immunologic Factors|immunologic factors|mesh-ancestor
92819329|NCT01026038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819330|NCT02606266|Valganciclovir|valganciclovir|mesh-list
92819331|NCT02606266|Antiviral Agents|antiviral agents|mesh-ancestor
92819332|NCT02606266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819333|NCT04115020|Naltrexone|naltrexone|mesh-list
92819334|NCT04115020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92819335|NCT04115020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92819336|NCT04115020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819337|NCT04115020|Sensory System Agents|sensory system agents|mesh-ancestor
92819338|NCT04115020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819339|NCT02801266|Contraceptive Agents|contraceptive agents|mesh-list
92819340|NCT02801266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819341|NCT02801266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819342|NCT03292666|Warfarin|warfarin|mesh-list
92819343|NCT03292666|Rivaroxaban|rivaroxaban|mesh-list
92819344|NCT03292666|Dabigatran|dabigatran|mesh-list
92819345|NCT03292666|Apixaban|apixaban|mesh-list
92819346|NCT03292666|Anticoagulants|anticoagulants|mesh-list
92819347|NCT03292666|Edoxaban|edoxaban|mesh-list
92819348|NCT03292666|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92819349|NCT03292666|Antithrombins|antithrombins|mesh-ancestor
92464362|NCT01768273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92819350|NCT03292666|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92819351|NCT03292666|Protease Inhibitors|protease inhibitors|mesh-ancestor
92819352|NCT03292666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819353|NCT03292666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819354|NCT02707653|Misoprostol|misoprostol|mesh-list
92819355|NCT02707653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92819356|NCT02707653|Abortifacient Agents|abortifacient agents|mesh-ancestor
92819357|NCT02707653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819358|NCT02707653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819359|NCT02707653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92819360|NCT02707653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819361|NCT02707653|Oxytocics|oxytocics|mesh-ancestor
92819362|NCT03901131|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92819363|NCT03901131|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92819364|NCT03901131|Norethindrone|norethindrone|mesh-list
92819365|NCT03901131|Norethindrone Acetate|norethindrone acetate|mesh-list
92819366|NCT03901131|Norethindrone enanthate|norethindrone enanthate|mesh-list
92819367|NCT03901131|Estradiol|estradiol|mesh-list
92819368|NCT03901131|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92819369|NCT03901131|Estrogens|estrogens|mesh-ancestor
92819370|NCT03901131|Hormones|hormones|mesh-ancestor
92819371|NCT03901131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819372|NCT03901131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819373|NCT03901131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92819374|NCT03901131|Contraceptive Agents|contraceptive agents|mesh-ancestor
92819375|NCT03901131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819376|NCT03901131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92819377|NCT03901131|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92819378|NCT03901131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92819379|NCT03901131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92819380|NCT02607202|Paclitaxel|paclitaxel|mesh-list
92819381|NCT02607202|Carboplatin|carboplatin|mesh-list
92819382|NCT02607202|Gemcitabine|gemcitabine|mesh-list
92819383|NCT02607202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92819384|NCT02607202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819385|NCT02607202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819386|NCT02607202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92819387|NCT02607202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819388|NCT02607202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819389|NCT02607202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92819390|NCT02607202|Antimetabolites|antimetabolites|mesh-ancestor
92819391|NCT02731612|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92819392|NCT02731612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92819393|NCT02731612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92819394|NCT02731612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819395|NCT02731612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819396|NCT02731612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92819397|NCT02731612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92819398|NCT02731612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92819399|NCT02731612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92819400|NCT02731612|Adrenergic Agents|adrenergic agents|mesh-ancestor
92819401|NCT02731612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819402|NCT02731612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819403|NCT02731612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92819404|NCT02731612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92819405|NCT02731612|Serotonin Agents|serotonin agents|mesh-ancestor
92819406|NCT02731612|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92819407|NCT02731612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92819408|NCT02731612|Dopamine Agents|dopamine agents|mesh-ancestor
92819409|NCT04371393|Remestemcel-l|remestemcel-l|mesh-list
92819410|NCT04371393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819411|NCT04371393|Antiviral Agents|antiviral agents|mesh-ancestor
92819412|NCT04371393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819413|NCT00923182|Alemtuzumab|alemtuzumab|mesh-list
92819414|NCT00923182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819415|NCT00923182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819416|NCT03868839|Telmisartan|telmisartan|mesh-list
92819417|NCT03868839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92819418|NCT03868839|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92819419|NCT03868839|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92819420|NCT03868839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819421|NCT00589420|Docetaxel|docetaxel|mesh-list
92819422|NCT00589420|Sorafenib|sorafenib|mesh-list
92819423|NCT00589420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464435|NCT01768377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92819424|NCT00589420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819425|NCT00589420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92819426|NCT00589420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819427|NCT00589420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819428|NCT00589420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819429|NCT00589420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819430|NCT04114630|Erenumab|erenumab|mesh-list
92819431|NCT04114630|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92819432|NCT04114630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819433|NCT04114630|Analgesics|analgesics|mesh-ancestor
92819434|NCT04114630|Sensory System Agents|sensory system agents|mesh-ancestor
92819435|NCT04114630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819436|NCT04114630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819437|NCT04112212|Vedolizumab|vedolizumab|mesh-list
92819438|NCT04112212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819439|NCT00914524|Olmesartan|olmesartan|mesh-list
92819440|NCT00914524|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92819441|NCT00914524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92819442|NCT00914524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92819443|NCT00914524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92819444|NCT00914524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819445|NCT03787095|Cemiplimab|cemiplimab|mesh-list
92819446|NCT03787095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819447|NCT03787095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819448|NCT04103385|Risedronic Acid|risedronic acid|mesh-list
92819449|NCT04103385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92819450|NCT04103385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819451|NCT04103385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819452|NCT04103385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92819453|NCT04103385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819454|NCT04103385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92819455|NCT00796978|Trastuzumab|trastuzumab|mesh-list
92819456|NCT00796978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819457|NCT00796978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819458|NCT03779295|Clindamycin|clindamycin|mesh-list
92819459|NCT03779295|Clindamycin palmitate|clindamycin palmitate|mesh-list
92819460|NCT03779295|Clindamycin phosphate|clindamycin phosphate|mesh-list
92819461|NCT03779295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92819462|NCT03779295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819463|NCT03779295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92819464|NCT03779295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819465|NCT03779295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819466|NCT00613665|Vaccines|vaccines|mesh-list
92819467|NCT00613665|Immunologic Factors|immunologic factors|mesh-ancestor
92819468|NCT00613665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819469|NCT00923572|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92819470|NCT00923572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819471|NCT00923572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819472|NCT03746769|Gastrins|gastrins|mesh-list
92819473|NCT03746769|Hormones|hormones|mesh-ancestor
92819474|NCT03746769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819475|NCT03746769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819477|NCT00796822|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92819478|NCT00796822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819479|NCT00796822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819480|NCT00796822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92819481|NCT00796822|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92819482|NCT00796822|Protective Agents|protective agents|mesh-ancestor
92819483|NCT00796822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819484|NCT00796822|Vasodilator Agents|vasodilator agents|mesh-ancestor
92819485|NCT00796822|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92819486|NCT00796822|Antioxidants|antioxidants|mesh-ancestor
92819487|NCT04007991|Ecopipam|ecopipam|mesh-list
92819488|NCT04007991|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92819489|NCT04007991|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92819490|NCT04007991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819491|NCT04007991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819492|NCT04007991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92819493|NCT04007991|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92819494|NCT04007991|Dopamine Agents|dopamine agents|mesh-ancestor
92819495|NCT04007991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819496|NCT04007991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819497|NCT03822507|Cinacalcet|cinacalcet|mesh-list
92819498|NCT03822507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92819499|NCT03822507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819500|NCT03822507|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92819501|NCT03822507|Hormone Antagonists|hormone antagonists|mesh-ancestor
92819502|NCT03822507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819503|NCT04301726|Tetrabenazine|tetrabenazine|mesh-list
92819504|NCT04301726|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92819505|NCT04301726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92819506|NCT04301726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819507|NCT04301726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819508|NCT04301726|Adrenergic Agents|adrenergic agents|mesh-ancestor
92819509|NCT04301726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819510|NCT04301726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819511|NCT00614679|Tigecycline|tigecycline|mesh-list
92819512|NCT00614679|Heparin|heparin|mesh-list
92819513|NCT00614679|Anticoagulants|anticoagulants|mesh-ancestor
92819514|NCT00614679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92819515|NCT00614679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92819516|NCT00614679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819517|NCT00614679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92819518|NCT00614679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819519|NCT00614679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92819520|NCT00614679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819521|NCT03760965|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92819522|NCT03760965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92819523|NCT03760965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819524|NCT03760965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92819525|NCT03760965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819526|NCT03703869|Insulin Glargine|insulin glargine|mesh-list
92819527|NCT03703869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92819528|NCT03703869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819529|NCT01024946|Everolimus|everolimus|mesh-list
92819530|NCT01024946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92819531|NCT01024946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819532|NCT01024946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819533|NCT01024946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819534|NCT01024946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92819535|NCT01024946|Immunologic Factors|immunologic factors|mesh-ancestor
92819536|NCT01024946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819537|NCT01024946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819538|NCT00724867|Belimumab|belimumab|mesh-list
92819539|NCT00724867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92819540|NCT00724867|Immunologic Factors|immunologic factors|mesh-ancestor
92819541|NCT00724867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819542|NCT00627536|Mitogens|mitogens|mesh-list
92819543|NCT00627536|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819544|NCT00627536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819545|NCT00724711|Tenofovir|tenofovir|mesh-list
92819546|NCT00724711|Lamivudine|lamivudine|mesh-list
92819547|NCT00724711|Emtricitabine|emtricitabine|mesh-list
92819549|NCT00724711|Antiviral Agents|antiviral agents|mesh-ancestor
92819550|NCT00724711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819551|NCT00724711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92819552|NCT00724711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92819553|NCT00724711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819554|NCT00724711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819555|NCT00724711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92819556|NCT00724711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92819557|NCT00721279|Pramipexole|pramipexole|mesh-list
92819558|NCT00721279|Antioxidants|antioxidants|mesh-ancestor
92819559|NCT00721279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819560|NCT00721279|Protective Agents|protective agents|mesh-ancestor
92819561|NCT00721279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819562|NCT00721279|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92819563|NCT00721279|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92819564|NCT00721279|Dopamine Agonists|dopamine agonists|mesh-ancestor
92819565|NCT00721279|Dopamine Agents|dopamine agents|mesh-ancestor
92819566|NCT00721279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819567|NCT01030952|Acarbose|acarbose|mesh-list
92819568|NCT01030952|Nateglinide|nateglinide|mesh-list
92819569|NCT01030952|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92721439|NCT04619303|Antiemetics|antiemetics|mesh-ancestor
92819570|NCT01030952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819571|NCT01030952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819572|NCT01030952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92819573|NCT01030952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819574|NCT03611751|Apremilast|apremilast|mesh-list
92819575|NCT03611751|Deucravacitinib|deucravacitinib|mesh-list
92819576|NCT03611751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92819577|NCT03611751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92819578|NCT03611751|Analgesics|analgesics|mesh-ancestor
92819579|NCT03611751|Sensory System Agents|sensory system agents|mesh-ancestor
92819580|NCT03611751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819581|NCT03611751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819582|NCT03611751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819583|NCT03611751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819584|NCT03611751|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92819585|NCT03611751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92819586|NCT03611751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819587|NCT03611751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819588|NCT03611751|Dermatologic Agents|dermatologic agents|mesh-ancestor
92819589|NCT03611751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819590|NCT00613743|Morphine|morphine|mesh-list
92819591|NCT00613743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92819592|NCT00613743|Narcotics|narcotics|mesh-ancestor
92819593|NCT00613743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819594|NCT00613743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819595|NCT00613743|Analgesics|analgesics|mesh-ancestor
92819596|NCT00613743|Sensory System Agents|sensory system agents|mesh-ancestor
92819597|NCT00613743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819598|NCT00614757|Acetylcysteine|acetylcysteine|mesh-list
92819599|NCT00614757|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92819600|NCT00614757|Antiviral Agents|antiviral agents|mesh-ancestor
92819601|NCT00614757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819602|NCT00614757|Expectorants|expectorants|mesh-ancestor
92819603|NCT00614757|Respiratory System Agents|respiratory system agents|mesh-ancestor
92819604|NCT00614757|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92819605|NCT00614757|Antioxidants|antioxidants|mesh-ancestor
92819606|NCT00614757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819607|NCT00614757|Protective Agents|protective agents|mesh-ancestor
92819608|NCT00614757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819609|NCT00614757|Antidotes|antidotes|mesh-ancestor
92819610|NCT02692365|Manganese|manganese|mesh-list
92819611|NCT02692365|Trace Elements|trace elements|mesh-ancestor
92819612|NCT02692365|Micronutrients|micronutrients|mesh-ancestor
92819613|NCT02692365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819614|NCT03492099|Buprenorphine|buprenorphine|mesh-list
92819615|NCT03492099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92819616|NCT03492099|Narcotics|narcotics|mesh-ancestor
92819617|NCT03492099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819618|NCT03492099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819619|NCT03492099|Analgesics|analgesics|mesh-ancestor
92819620|NCT03492099|Sensory System Agents|sensory system agents|mesh-ancestor
92819621|NCT03492099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819622|NCT03492099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92819623|NCT03481959|Methylphenidate|methylphenidate|mesh-list
92819624|NCT03481959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92819625|NCT03481959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819626|NCT03481959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92819627|NCT03481959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92819628|NCT03481959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819629|NCT03481959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819631|NCT03481959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819632|NCT03245229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92819633|NCT03245229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92819634|NCT03245229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92819635|NCT03245229|Antimetabolites|antimetabolites|mesh-ancestor
92819636|NCT03245229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819637|NCT03245229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92819638|NCT03245229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92819639|NCT03245229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819640|NCT03462069|Empagliflozin|empagliflozin|mesh-list
93026451|NCT00392223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026452|NCT00402285|Lycopene|lycopene|mesh-list
92819641|NCT03462069|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92819642|NCT03462069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92464658|NCT01769651|Antitussive Agents|antitussive agents|mesh-ancestor
92819643|NCT03462069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819644|NCT03462069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92819645|NCT03462069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819646|NCT03414723|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92819647|NCT03414723|Ramipril|ramipril|mesh-list
92819648|NCT03414723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92819649|NCT03414723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92819650|NCT03414723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819651|NCT03414723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819652|NCT03414723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92819653|NCT03414723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92819654|NCT03414723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92819655|NCT03414723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819656|NCT03387657|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92819657|NCT03387657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92819658|NCT03387657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92819659|NCT03387657|Diuretics|diuretics|mesh-ancestor
92819660|NCT03387657|Natriuretic Agents|natriuretic agents|mesh-ancestor
92819661|NCT03387657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819662|NCT03387657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92819663|NCT03387657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819664|NCT03387657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819665|NCT03387657|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92819666|NCT03387657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92819667|NCT00720499|Bromides|bromides|mesh-list
92819668|NCT00720499|Tiotropium Bromide|tiotropium bromide|mesh-list
92819669|NCT00720499|Olodaterol|olodaterol|mesh-list
92819670|NCT00720499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92819671|NCT00720499|Autonomic Agents|autonomic agents|mesh-ancestor
92819672|NCT00720499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819673|NCT00720499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819674|NCT00720499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92819675|NCT00720499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92819676|NCT00720499|Parasympatholytics|parasympatholytics|mesh-ancestor
92819677|NCT00720499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92819678|NCT00720499|Cholinergic Agents|cholinergic agents|mesh-ancestor
92819679|NCT00720499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819680|NCT00720499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819681|NCT00720499|Anticonvulsants|anticonvulsants|mesh-ancestor
92819682|NCT00724243|Infliximab|infliximab|mesh-list
92819683|NCT00724243|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92819684|NCT00724243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819685|NCT00724243|Dermatologic Agents|dermatologic agents|mesh-ancestor
92819686|NCT00724243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819687|NCT00724243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819688|NCT02590705|Lidocaine|lidocaine|mesh-list
92819689|NCT02590705|Anesthetics, Local|anesthetics, local|mesh-ancestor
92819690|NCT02590705|Anesthetics|anesthetics|mesh-ancestor
92819691|NCT02590705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92819692|NCT02590705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819693|NCT02590705|Sensory System Agents|sensory system agents|mesh-ancestor
92819694|NCT02590705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819695|NCT02590705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92819696|NCT02590705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92819697|NCT02590705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92819698|NCT02590705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92819699|NCT02590705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819700|NCT00720343|Choline|choline|mesh-list
92819701|NCT00720343|Lipotropic Agents|lipotropic agents|mesh-ancestor
92819702|NCT00720343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92819703|NCT00720343|Antimetabolites|antimetabolites|mesh-ancestor
92819704|NCT00720343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819705|NCT00720343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819706|NCT00720343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92819707|NCT00720343|Nootropic Agents|nootropic agents|mesh-ancestor
92819708|NCT00720109|Calcium, Dietary|calcium, dietary|mesh-list
92819709|NCT00720109|Leucovorin|leucovorin|mesh-list
92819710|NCT00720109|Folic Acid|folic acid|mesh-list
92819711|NCT00720109|Cytarabine|cytarabine|mesh-list
92819712|NCT00720109|Dexamethasone|dexamethasone|mesh-list
92819713|NCT00720109|Dexamethasone acetate|dexamethasone acetate|mesh-list
92819714|NCT00720109|Prednisone|prednisone|mesh-list
92819716|NCT00720109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92819717|NCT00720109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92819718|NCT00720109|Prednisolone|prednisolone|mesh-list
92819719|NCT00720109|Prednisolone acetate|prednisolone acetate|mesh-list
92819720|NCT00720109|Hydrocortisone|hydrocortisone|mesh-list
92819721|NCT00720109|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92819722|NCT00720109|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92819723|NCT00720109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92819724|NCT00720109|Cortisone|cortisone|mesh-list
92819725|NCT00720109|Cyclophosphamide|cyclophosphamide|mesh-list
92819726|NCT00720109|Ifosfamide|ifosfamide|mesh-list
92819727|NCT00720109|Isophosphamide mustard|isophosphamide mustard|mesh-list
92819728|NCT00720109|Methotrexate|methotrexate|mesh-list
92819729|NCT00720109|Etoposide|etoposide|mesh-list
92819730|NCT00720109|Vincristine|vincristine|mesh-list
92819731|NCT00720109|Etoposide phosphate|etoposide phosphate|mesh-list
92819732|NCT00720109|Daunorubicin|daunorubicin|mesh-list
92819733|NCT00720109|Asparaginase|asparaginase|mesh-list
92819734|NCT00720109|Dasatinib|dasatinib|mesh-list
92819735|NCT00720109|Mercaptopurine|mercaptopurine|mesh-list
92819736|NCT00720109|Podophyllotoxin|podophyllotoxin|mesh-list
92819737|NCT00720109|Pegaspargase|pegaspargase|mesh-list
92819738|NCT00720109|Lenograstim|lenograstim|mesh-list
92819739|NCT00720109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92819740|NCT00720109|Prednisolone phosphate|prednisolone phosphate|mesh-list
92819741|NCT00720109|BB 1101|bb 1101|mesh-list
92819742|NCT00720109|Calcium|calcium|mesh-list
92819743|NCT00720109|Levoleucovorin|levoleucovorin|mesh-list
92819744|NCT00720109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92819745|NCT00720109|Immunologic Factors|immunologic factors|mesh-ancestor
92819746|NCT00720109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819747|NCT00720109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819748|NCT00720109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92819749|NCT00720109|Alkylating Agents|alkylating agents|mesh-ancestor
92819750|NCT00720109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819751|NCT00720109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819752|NCT00720109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92819753|NCT00720109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819754|NCT00720109|Antiemetics|antiemetics|mesh-ancestor
92819755|NCT00720109|Autonomic Agents|autonomic agents|mesh-ancestor
92819756|NCT00720109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819757|NCT00720109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819758|NCT00720109|Glucocorticoids|glucocorticoids|mesh-ancestor
92819759|NCT00720109|Hormones|hormones|mesh-ancestor
92819760|NCT00720109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819761|NCT00720109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92819762|NCT00720109|Protease Inhibitors|protease inhibitors|mesh-ancestor
92819763|NCT00720109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819764|NCT00720109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92819765|NCT00720109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92819766|NCT00720109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92819767|NCT00720109|Abortifacient Agents|abortifacient agents|mesh-ancestor
92819768|NCT00720109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819769|NCT00720109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92819771|NCT00720109|Dermatologic Agents|dermatologic agents|mesh-ancestor
92819772|NCT00720109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92819773|NCT00720109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92819774|NCT00720109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92819775|NCT00720109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92819776|NCT00720109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92819777|NCT00720109|Antiviral Agents|antiviral agents|mesh-ancestor
92819778|NCT00720109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819779|NCT00720109|Antidotes|antidotes|mesh-ancestor
92819780|NCT00720109|Protective Agents|protective agents|mesh-ancestor
92819781|NCT00720109|Vitamin B Complex|vitamin b complex|mesh-ancestor
92819782|NCT00720109|Vitamins|vitamins|mesh-ancestor
92819783|NCT00720109|Micronutrients|micronutrients|mesh-ancestor
92819784|NCT00720109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92819785|NCT00720109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819786|NCT00720109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92819787|NCT00720109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819788|NCT00720109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92819789|NCT00720109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92819790|NCT00720109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819791|NCT00720109|Hematinics|hematinics|mesh-ancestor
92819792|NCT00720109|Keratolytic Agents|keratolytic agents|mesh-ancestor
92819793|NCT01705977|Belimumab|belimumab|mesh-list
92819794|NCT01705977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92819795|NCT01705977|Immunologic Factors|immunologic factors|mesh-ancestor
92819796|NCT01705977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819797|NCT02590627|Lumefantrine|lumefantrine|mesh-list
92819798|NCT02590627|Artemether|artemether|mesh-list
92819799|NCT02590627|Piperaquine|piperaquine|mesh-list
92819800|NCT02590627|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92819801|NCT02590627|Artenimol|artenimol|mesh-list
92819802|NCT02590627|Antimalarials|antimalarials|mesh-ancestor
92819803|NCT02590627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92819804|NCT02590627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92819805|NCT02590627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819806|NCT01015118|Paclitaxel|paclitaxel|mesh-list
92819807|NCT01015118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92819808|NCT01015118|Carboplatin|carboplatin|mesh-list
92819809|NCT01015118|Nintedanib|nintedanib|mesh-list
92819810|NCT01015118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92819811|NCT01015118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819812|NCT01015118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819813|NCT01015118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92819814|NCT01015118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819815|NCT01015118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819816|NCT01015118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819817|NCT01015118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819818|NCT02415153|Pomalidomide|pomalidomide|mesh-list
92819819|NCT02415153|Immunologic Factors|immunologic factors|mesh-ancestor
92819820|NCT02415153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819821|NCT02415153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92819822|NCT02415153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92819823|NCT02415153|Growth Substances|growth substances|mesh-ancestor
92819824|NCT02415153|Growth Inhibitors|growth inhibitors|mesh-ancestor
92819825|NCT02415153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819826|NCT04111822|Tranexamic Acid|tranexamic acid|mesh-list
92819827|NCT04111822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92819828|NCT04111822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92819829|NCT04111822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819830|NCT04111822|Hemostatics|hemostatics|mesh-ancestor
92819831|NCT04111822|Coagulants|coagulants|mesh-ancestor
92819832|NCT00628160|Terlipressin|terlipressin|mesh-list
92819833|NCT00628160|Dopamine|dopamine|mesh-list
92819834|NCT00628160|Norepinephrine|norepinephrine|mesh-list
92819835|NCT00628160|Adrenergic Agents|adrenergic agents|mesh-list
92819836|NCT00628160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92819837|NCT00628160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92819838|NCT00628160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819839|NCT00628160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819840|NCT00628160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819841|NCT00628160|Sympathomimetics|sympathomimetics|mesh-ancestor
92819842|NCT00628160|Autonomic Agents|autonomic agents|mesh-ancestor
92819843|NCT00628160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819844|NCT00628160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92819845|NCT00628160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92819846|NCT00628160|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92819847|NCT00628160|Dopamine Agents|dopamine agents|mesh-ancestor
92819848|NCT00628160|Protective Agents|protective agents|mesh-ancestor
92819849|NCT02274285|Vaccines|vaccines|mesh-list
92819850|NCT02274285|Immunologic Factors|immunologic factors|mesh-ancestor
92819851|NCT02274285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819852|NCT02283112|Anti-Infective Agents|anti-infective agents|mesh-list
92819853|NCT02283112|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92819854|NCT02283112|Antiviral Agents|antiviral agents|mesh-list
92819855|NCT02283112|Contraceptive Agents|contraceptive agents|mesh-list
92819856|NCT02283112|Contraceptives, Oral|contraceptives, oral|mesh-list
92819857|NCT02283112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819858|NCT02283112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819859|NCT02283112|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92819860|NCT00614835|Gemcitabine|gemcitabine|mesh-list
92819861|NCT00614835|Docetaxel|docetaxel|mesh-list
92819862|NCT00614835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92819863|NCT00614835|Antimetabolites|antimetabolites|mesh-ancestor
92819864|NCT00614835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819865|NCT00614835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819866|NCT00614835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92819867|NCT00614835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92819868|NCT00614835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92819869|NCT00715429|Vitamin D|vitamin d|mesh-list
92819870|NCT00715429|Ergocalciferols|ergocalciferols|mesh-list
92819871|NCT00715429|Vitamins|vitamins|mesh-ancestor
92819872|NCT00715429|Micronutrients|micronutrients|mesh-ancestor
92819873|NCT00715429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819874|NCT00715429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92819875|NCT00715429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92819876|NCT02606032|Metronidazole|metronidazole|mesh-list
92819877|NCT02606032|Doxycycline|doxycycline|mesh-list
92819878|NCT02606032|Terbinafine|terbinafine|mesh-list
92819879|NCT02606032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819880|NCT02606032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92819881|NCT02606032|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92819882|NCT02606032|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92819883|NCT02606032|Antimalarials|antimalarials|mesh-ancestor
92819884|NCT02606032|Antifungal Agents|antifungal agents|mesh-ancestor
92819885|NCT02606032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819886|NCT02606032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819887|NCT02145507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92819888|NCT01743651|Baclofen|baclofen|mesh-list
92819889|NCT01743651|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92819890|NCT01743651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819891|NCT01743651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92819892|NCT01743651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819893|NCT01743651|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92819894|NCT01743651|GABA Agonists|gaba agonists|mesh-ancestor
92819895|NCT01743651|GABA Agents|gaba agents|mesh-ancestor
92819896|NCT01743651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819897|NCT01743651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819898|NCT00715117|Naltrexone|naltrexone|mesh-list
92819899|NCT00715117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92819900|NCT00715117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92819901|NCT00715117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819902|NCT00715117|Sensory System Agents|sensory system agents|mesh-ancestor
92819903|NCT00715117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92819904|NCT00723229|Acyclovir|acyclovir|mesh-list
92819905|NCT00723229|Antiviral Agents|antiviral agents|mesh-ancestor
92819906|NCT00723229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819907|NCT01093521|Gallium nitrate|gallium nitrate|mesh-list
92819908|NCT01093521|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92819909|NCT01093521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819910|NCT01093521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819911|NCT01030718|Dasatinib|dasatinib|mesh-list
92819912|NCT01030718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819913|NCT01030718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819914|NCT01030718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819915|NCT01030718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819916|NCT00722761|Drospirenone|drospirenone|mesh-list
92819917|NCT00722761|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92819918|NCT00722761|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92819919|NCT00722761|Estradiol|estradiol|mesh-list
92819920|NCT00722761|Estrogens|estrogens|mesh-ancestor
92819921|NCT00722761|Hormones|hormones|mesh-ancestor
92819922|NCT00722761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92819923|NCT00722761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819924|NCT00722761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92819925|NCT00722761|Contraceptive Agents|contraceptive agents|mesh-ancestor
92819926|NCT00722761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92819927|NCT00722761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92819928|NCT00722761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92819929|NCT00722761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92819930|NCT00722761|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92819931|NCT00722761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92819932|NCT00722761|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92819933|NCT00722761|Diuretics|diuretics|mesh-ancestor
92819934|NCT00722761|Natriuretic Agents|natriuretic agents|mesh-ancestor
92819935|NCT00628238|Rituximab|rituximab|mesh-list
92819936|NCT00628238|Lenalidomide|lenalidomide|mesh-list
92819937|NCT00628238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819938|NCT00628238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819939|NCT00628238|Immunologic Factors|immunologic factors|mesh-ancestor
92819940|NCT00628238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819941|NCT00628238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819942|NCT00628238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92819943|NCT00628238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92819944|NCT00628238|Growth Substances|growth substances|mesh-ancestor
92819945|NCT00628238|Growth Inhibitors|growth inhibitors|mesh-ancestor
92819946|NCT05132179|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92819947|NCT05132179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92819948|NCT05132179|Disinfectants|disinfectants|mesh-ancestor
92819949|NCT05132179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92819950|NCT01019486|Regadenoson|regadenoson|mesh-list
92819951|NCT01019486|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92819952|NCT01019486|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92819953|NCT01019486|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92819954|NCT01019486|Purinergic Agonists|purinergic agonists|mesh-ancestor
92819955|NCT01019486|Purinergic Agents|purinergic agents|mesh-ancestor
92819956|NCT01019486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819957|NCT01019486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819958|NCT01019486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819959|NCT01019486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92819960|NCT02803203|Bevacizumab|bevacizumab|mesh-list
92819961|NCT02803203|Osimertinib|osimertinib|mesh-list
92819962|NCT02803203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92819963|NCT02803203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92819964|NCT02803203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92819965|NCT02803203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92819966|NCT02803203|Growth Substances|growth substances|mesh-ancestor
92819967|NCT02803203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819968|NCT02803203|Growth Inhibitors|growth inhibitors|mesh-ancestor
92819969|NCT02803203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92819970|NCT02803203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819971|NCT02803203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819972|NCT00714493|Infliximab|infliximab|mesh-list
92819973|NCT00714493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92819974|NCT00714493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92819975|NCT00714493|Dermatologic Agents|dermatologic agents|mesh-ancestor
92819976|NCT00714493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819977|NCT00714493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92819978|NCT01013870|Atorvastatin|atorvastatin|mesh-list
92819979|NCT01013870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92819980|NCT01013870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92819981|NCT01013870|Antimetabolites|antimetabolites|mesh-ancestor
92819982|NCT01013870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819983|NCT01013870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92819984|NCT01013870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92819985|NCT01013870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819986|NCT05020184|Cimetidine|cimetidine|mesh-list
92819987|NCT05020184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92819988|NCT05020184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92819989|NCT05020184|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92819990|NCT05020184|Histamine Antagonists|histamine antagonists|mesh-ancestor
92819991|NCT05020184|Histamine Agents|histamine agents|mesh-ancestor
92819992|NCT05020184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92819993|NCT05020184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92819994|NCT05020184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92819995|NCT05020184|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92819996|NCT05020184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92819997|NCT05020184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92819998|NCT00628316|Caffeine|caffeine|mesh-list
92819999|NCT00628316|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92820000|NCT00628316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820001|NCT00628316|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92820002|NCT00628316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820003|NCT00628316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820004|NCT00628316|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92820005|NCT00628316|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92820006|NCT00628316|Purinergic Agents|purinergic agents|mesh-ancestor
92820007|NCT00628316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820008|NCT01018862|Azelastine|azelastine|mesh-list
92820009|NCT01018862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92820010|NCT01018862|Autonomic Agents|autonomic agents|mesh-ancestor
92820011|NCT01018862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820012|NCT01018862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820013|NCT01018862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92820014|NCT01018862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92820015|NCT01018862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92820016|NCT01018862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820017|NCT01018862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820018|NCT01018862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92820019|NCT01018862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92820020|NCT01018862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92820021|NCT01018862|Histamine Antagonists|histamine antagonists|mesh-ancestor
92820022|NCT01018862|Histamine Agents|histamine agents|mesh-ancestor
92820023|NCT01018862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820024|NCT01018394|Nicotine|nicotine|mesh-list
92820025|NCT01018394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92820026|NCT01018394|Autonomic Agents|autonomic agents|mesh-ancestor
92820027|NCT01018394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820028|NCT01018394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820029|NCT01018394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92820030|NCT01018394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92820031|NCT01018394|Cholinergic Agents|cholinergic agents|mesh-ancestor
92820032|NCT01018394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820033|NCT01018394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820034|NCT04301336|Zinc|zinc|mesh-list
92820035|NCT04301336|Folic Acid|folic acid|mesh-list
92820036|NCT04301336|Vitamin B Complex|vitamin b complex|mesh-list
92820037|NCT04301336|Hydroxyurea|hydroxyurea|mesh-list
92820038|NCT04301336|Morphine|morphine|mesh-list
92820039|NCT04301336|Zinc Sulfate|zinc sulfate|mesh-list
92820040|NCT04301336|Simvastatin|simvastatin|mesh-list
92820041|NCT04301336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92820042|NCT04301336|Narcotics|narcotics|mesh-ancestor
92820043|NCT04301336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820044|NCT04301336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820045|NCT04301336|Analgesics|analgesics|mesh-ancestor
92820046|NCT04301336|Sensory System Agents|sensory system agents|mesh-ancestor
92820047|NCT04301336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820048|NCT04301336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92820049|NCT04301336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92820050|NCT04301336|Antimetabolites|antimetabolites|mesh-ancestor
92820051|NCT04301336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820052|NCT04301336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92820053|NCT04301336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92820054|NCT04301336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820055|NCT04301336|Trace Elements|trace elements|mesh-ancestor
92820056|NCT04301336|Micronutrients|micronutrients|mesh-ancestor
92820057|NCT04301336|Hematinics|hematinics|mesh-ancestor
92820058|NCT04301336|Vitamins|vitamins|mesh-ancestor
92820059|NCT04301336|Astringents|astringents|mesh-ancestor
92820060|NCT04301336|Dermatologic Agents|dermatologic agents|mesh-ancestor
92820061|NCT04301336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820062|NCT04301336|Antisickling Agents|antisickling agents|mesh-ancestor
92820063|NCT04301336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820064|NCT00627848|Rivastigmine|rivastigmine|mesh-list
92820065|NCT00627848|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92820066|NCT00627848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820067|NCT00627848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820068|NCT00627848|Cholinergic Agents|cholinergic agents|mesh-ancestor
92820069|NCT00627848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820070|NCT00627848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820071|NCT00627848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92820072|NCT00627848|Protective Agents|protective agents|mesh-ancestor
92820073|NCT04299854|Dinoprostone|dinoprostone|mesh-list
92820074|NCT04299854|Oxytocics|oxytocics|mesh-ancestor
92820075|NCT04299854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92820076|NCT04299854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820077|NCT01017146|Tazarotene|tazarotene|mesh-list
92820078|NCT01017146|Dermatologic Agents|dermatologic agents|mesh-ancestor
92820079|NCT01017146|Keratolytic Agents|keratolytic agents|mesh-ancestor
92820080|NCT02872064|Verteporfin|verteporfin|mesh-list
92820081|NCT02872064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92820082|NCT02872064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92820083|NCT04205240|Mycophenolic Acid|mycophenolic acid|mesh-list
92820084|NCT04205240|Cyclophosphamide|cyclophosphamide|mesh-list
92820085|NCT04205240|Melphalan|melphalan|mesh-list
92820086|NCT04205240|Mechlorethamine|mechlorethamine|mesh-list
92820087|NCT04205240|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92820088|NCT04205240|Fludarabine|fludarabine|mesh-list
92820089|NCT04205240|Daratumumab|daratumumab|mesh-list
92820090|NCT04205240|Tacrolimus|tacrolimus|mesh-list
92820091|NCT04205240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820092|NCT04205240|Immunologic Factors|immunologic factors|mesh-ancestor
92820093|NCT04205240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820094|NCT04205240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820095|NCT04205240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820096|NCT04205240|Alkylating Agents|alkylating agents|mesh-ancestor
92820097|NCT04205240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820098|NCT04205240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820099|NCT04205240|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92820100|NCT04205240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92820101|NCT04205240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820102|NCT04205240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820103|NCT04205240|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92820104|NCT04205240|Antitubercular Agents|antitubercular agents|mesh-ancestor
92820105|NCT04205240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92820106|NCT04205240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820108|NCT01010750|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92820109|NCT01010750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92820110|NCT01010750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820111|NCT01010750|Sympathomimetics|sympathomimetics|mesh-ancestor
92820112|NCT01010750|Autonomic Agents|autonomic agents|mesh-ancestor
92820113|NCT01010750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820114|NCT01010750|Dopamine Agents|dopamine agents|mesh-ancestor
92820115|NCT01010750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820116|NCT01010750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820117|NCT01010750|Adrenergic Agents|adrenergic agents|mesh-ancestor
92820118|NCT01010750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92820119|NCT01010750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92820120|NCT01010750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820121|NCT01010750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92820122|NCT01012622|Methylphenidate|methylphenidate|mesh-list
92820123|NCT01012622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92820124|NCT01012622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820125|NCT01012622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92820126|NCT01012622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92820127|NCT01012622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820128|NCT01012622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820129|NCT01012622|Dopamine Agents|dopamine agents|mesh-ancestor
92820130|NCT01012622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820131|NCT00722371|Metformin|metformin|mesh-list
92820132|NCT00722371|Pioglitazone|pioglitazone|mesh-list
92820133|NCT00722371|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92820134|NCT00722371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92820135|NCT00722371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820136|NCT00722371|Incretins|incretins|mesh-ancestor
92820137|NCT00722371|Hormones|hormones|mesh-ancestor
92820138|NCT00722371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820139|NCT00722371|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92820140|NCT00722371|Protease Inhibitors|protease inhibitors|mesh-ancestor
92820141|NCT00722371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820142|NCT00722371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820143|NCT02871986|Estrogens|estrogens|mesh-list
92820144|NCT02871986|Hormones|hormones|mesh-ancestor
92820145|NCT02871986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433100|NCT01572558|Ciprofloxacin|ciprofloxacin|mesh-list
92820146|NCT02871986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820148|NCT00722137|Cyclophosphamide|cyclophosphamide|mesh-list
92820149|NCT00722137|Rituximab|rituximab|mesh-list
92820150|NCT00722137|Doxorubicin|doxorubicin|mesh-list
92820151|NCT00722137|Vincristine|vincristine|mesh-list
92820152|NCT00722137|Bortezomib|bortezomib|mesh-list
92820153|NCT00722137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820154|NCT00722137|Immunologic Factors|immunologic factors|mesh-ancestor
92820155|NCT00722137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820156|NCT00722137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820157|NCT00722137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820158|NCT00722137|Alkylating Agents|alkylating agents|mesh-ancestor
92820159|NCT00722137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820160|NCT00722137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820161|NCT00722137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92820162|NCT00722137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820163|NCT00722137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820164|NCT00722137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92820165|NCT00722137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92820166|NCT00722137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820167|NCT00722137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92820168|NCT00722137|Glucocorticoids|glucocorticoids|mesh-ancestor
92820169|NCT00722137|Hormones|hormones|mesh-ancestor
92820170|NCT00722137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820171|NCT00722137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92820172|NCT00722137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92465179|NCT01772940|Tenofovir|tenofovir|mesh-list
92820173|NCT00722137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92820174|NCT00722137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92820175|NCT00722137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92820176|NCT04114396|Antibodies|antibodies|mesh-list
92820177|NCT04114396|Immunologic Factors|immunologic factors|mesh-ancestor
92820178|NCT04114396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820179|NCT00796666|Sildenafil Citrate|sildenafil citrate|mesh-list
92820180|NCT00796666|Sitaxsentan|sitaxsentan|mesh-list
92820181|NCT00796666|Vasodilator Agents|vasodilator agents|mesh-ancestor
92820182|NCT00796666|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92820183|NCT00796666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92820184|NCT00796666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820185|NCT00796666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820186|NCT00796666|Urological Agents|urological agents|mesh-ancestor
92820187|NCT00796666|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92820188|NCT00799708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92820189|NCT00799708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92820190|NCT00799708|Estradiol|estradiol|mesh-list
92820191|NCT00799708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92820192|NCT00799708|Estrogens|estrogens|mesh-ancestor
92820193|NCT00799708|Hormones|hormones|mesh-ancestor
92820194|NCT00799708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820195|NCT00799708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820196|NCT00799708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92820197|NCT00799708|Contraceptive Agents|contraceptive agents|mesh-ancestor
92820198|NCT00799708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92820199|NCT00799708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92820200|NCT00796510|Sildenafil Citrate|sildenafil citrate|mesh-list
92820201|NCT00796510|Sitaxsentan|sitaxsentan|mesh-list
92820202|NCT00796510|Vasodilator Agents|vasodilator agents|mesh-ancestor
92820203|NCT00796510|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92820204|NCT00796510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92820205|NCT00796510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820206|NCT00796510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820207|NCT00796510|Urological Agents|urological agents|mesh-ancestor
92820208|NCT00796510|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92820209|NCT04111432|Vaccines|vaccines|mesh-list
92820210|NCT04111432|Immunologic Factors|immunologic factors|mesh-ancestor
92820211|NCT04111432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820212|NCT00915070|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92820213|NCT00915070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820214|NCT00915070|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92820215|NCT00915070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820216|NCT00588640|Methadone|methadone|mesh-list
92820217|NCT00588640|D-methadone|d-methadone|mesh-list
92820218|NCT00588640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92820219|NCT00588640|Narcotics|narcotics|mesh-ancestor
92820221|NCT00588640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820222|NCT00588640|Analgesics|analgesics|mesh-ancestor
92820223|NCT00588640|Sensory System Agents|sensory system agents|mesh-ancestor
92820224|NCT00588640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820225|NCT00588640|Antitussive Agents|antitussive agents|mesh-ancestor
92820226|NCT00588640|Respiratory System Agents|respiratory system agents|mesh-ancestor
92820227|NCT00588640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92820228|NCT01016912|Ribavirin|ribavirin|mesh-list
92820229|NCT01016912|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92820230|NCT01016912|Antimetabolites|antimetabolites|mesh-ancestor
92820231|NCT01016912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820232|NCT01016912|Antiviral Agents|antiviral agents|mesh-ancestor
92820233|NCT01016912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820234|NCT02604940|Dexmedetomidine|dexmedetomidine|mesh-list
92820235|NCT02604940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92820236|NCT02604940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820237|NCT02604940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820238|NCT02604940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92820239|NCT02604940|Analgesics|analgesics|mesh-ancestor
92820240|NCT02604940|Sensory System Agents|sensory system agents|mesh-ancestor
92820241|NCT02604940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820242|NCT02604940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92820243|NCT02604940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92820244|NCT02604940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92820245|NCT02604940|Adrenergic Agents|adrenergic agents|mesh-ancestor
92820246|NCT02604940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465254|NCT01773174|Protease Inhibitors|protease inhibitors|mesh-ancestor
92820247|NCT02604940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820249|NCT02605798|Antiviral Agents|antiviral agents|mesh-ancestor
92820250|NCT02605798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820251|NCT00802672|Ciclopirox|ciclopirox|mesh-list
92820252|NCT00802672|Antifungal Agents|antifungal agents|mesh-ancestor
92820253|NCT00802672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820254|NCT04113772|Nitisinone|nitisinone|mesh-list
92820255|NCT04113772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820256|NCT04113772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820257|NCT04113928|Mechlorethamine|mechlorethamine|mesh-list
92820258|NCT04113928|Alkylating Agents|alkylating agents|mesh-ancestor
92820259|NCT04113928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820260|NCT04113928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820261|NCT04113928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820262|NCT04115800|Sirolimus|sirolimus|mesh-list
92820263|NCT04115800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92820264|NCT04115800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820265|NCT04115800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820266|NCT04115800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820267|NCT04115800|Antifungal Agents|antifungal agents|mesh-ancestor
92820268|NCT04115800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820269|NCT04115800|Immunologic Factors|immunologic factors|mesh-ancestor
92820270|NCT04115800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820271|NCT04115410|Cisplatin|cisplatin|mesh-list
92820272|NCT04115410|Carboplatin|carboplatin|mesh-list
92820273|NCT04115410|Gemcitabine|gemcitabine|mesh-list
92820274|NCT04115410|Docetaxel|docetaxel|mesh-list
92820275|NCT04115410|Pemetrexed|pemetrexed|mesh-list
92820276|NCT04115410|Vinorelbine|vinorelbine|mesh-list
92820277|NCT04115410|Gefitinib|gefitinib|mesh-list
92820278|NCT04115410|Mitomycins|mitomycins|mesh-list
92820279|NCT04115410|Mitomycin|mitomycin|mesh-list
92820280|NCT04115410|Osimertinib|osimertinib|mesh-list
92820281|NCT04115410|Afatinib|afatinib|mesh-list
92820282|NCT04115410|Vinblastine|vinblastine|mesh-list
92820283|NCT04115410|Crizotinib|crizotinib|mesh-list
92820284|NCT04115410|Ceritinib|ceritinib|mesh-list
92820285|NCT04115410|Antineoplastic Agents|antineoplastic agents|mesh-list
92820286|NCT04115410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92820287|NCT04115410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92820288|NCT04115410|Antimetabolites|antimetabolites|mesh-ancestor
92820289|NCT04115410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820290|NCT04115410|Tubulin Modulators|tubulin modulators|mesh-ancestor
92820291|NCT04115410|Antimitotic Agents|antimitotic agents|mesh-ancestor
92820292|NCT04115410|Mitosis Modulators|mitosis modulators|mesh-ancestor
92820293|NCT04115410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820294|NCT04115410|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92820295|NCT04115410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820296|NCT04115410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92820297|NCT04115410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92820298|NCT04115410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820299|NCT04115410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820301|NCT02604628|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92820302|NCT02604628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820303|NCT02604784|Cisplatin|cisplatin|mesh-list
92820304|NCT02604784|Doxorubicin|doxorubicin|mesh-list
92820305|NCT02604784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92820306|NCT02604784|Oxaliplatin|oxaliplatin|mesh-list
92820307|NCT02604784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820308|NCT02604784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820309|NCT02604784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92820310|NCT02604784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92820311|NCT02604784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820312|NCT02604784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820313|NCT04110808|Phentolamine|phentolamine|mesh-list
92820314|NCT04110808|Antihypertensive Agents|antihypertensive agents|mesh-list
92820315|NCT04110808|Nitroglycerin|nitroglycerin|mesh-list
92820316|NCT04110808|Anesthetics|anesthetics|mesh-list
92820317|NCT04110808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820318|NCT04110808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820319|NCT04110808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92820320|NCT04110808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92465329|NCT01773681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92820321|NCT04110808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92820322|NCT04110808|Adrenergic Agents|adrenergic agents|mesh-ancestor
92820323|NCT04110808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820324|NCT04110808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820325|NCT00714259|Fludarabine|fludarabine|mesh-list
92820326|NCT00714259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820327|NCT00796120|Doxorubicin|doxorubicin|mesh-list
92820328|NCT00796120|Ifosfamide|ifosfamide|mesh-list
92820329|NCT00796120|Trabectedin|trabectedin|mesh-list
92820330|NCT00796120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820331|NCT00796120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820332|NCT00796120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92820333|NCT00796120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92820334|NCT00796120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820335|NCT00796120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820336|NCT00796120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820337|NCT00796120|Alkylating Agents|alkylating agents|mesh-ancestor
92820338|NCT00795886|Sirolimus|sirolimus|mesh-list
92820339|NCT00795886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92820340|NCT00795886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820341|NCT00795886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92820342|NCT00795886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820343|NCT00795886|Antifungal Agents|antifungal agents|mesh-ancestor
92820344|NCT00795886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820345|NCT00795886|Immunologic Factors|immunologic factors|mesh-ancestor
92820346|NCT00795886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820347|NCT04110418|Terlipressin|terlipressin|mesh-list
92820348|NCT04110418|Methylene Blue|methylene blue|mesh-list
92820349|NCT04110418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820350|NCT04110418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820351|NCT04110418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820352|NCT04110418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92820353|NCT04110028|Niacinamide|niacinamide|mesh-list
92820354|NCT04110028|Niacin|niacin|mesh-list
92820355|NCT04110028|Nicotinic Acids|nicotinic acids|mesh-list
92820356|NCT04110028|Vitamin B Complex|vitamin b complex|mesh-ancestor
92820357|NCT04110028|Vitamins|vitamins|mesh-ancestor
92820358|NCT04110028|Micronutrients|micronutrients|mesh-ancestor
92820359|NCT04110028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820360|NCT04110028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92820361|NCT04110028|Antimetabolites|antimetabolites|mesh-ancestor
92820362|NCT04110028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820363|NCT04110028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92820364|NCT04110028|Vasodilator Agents|vasodilator agents|mesh-ancestor
92820365|NCT02589457|Tenofovir|tenofovir|mesh-list
92820366|NCT02589457|Antiviral Agents|antiviral agents|mesh-ancestor
92820367|NCT02589457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820368|NCT02589457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92820369|NCT02589457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820370|NCT02589457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433103|NCT01572558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820371|NCT02589457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820372|NCT02589457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92820373|NCT02589457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92820374|NCT00718861|Zoledronic Acid|zoledronic acid|mesh-list
92820375|NCT00718861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92820376|NCT00718861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820377|NCT05310643|Nivolumab|nivolumab|mesh-list
92820378|NCT05310643|Ipilimumab|ipilimumab|mesh-list
92820379|NCT05310643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820380|NCT05310643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820381|NCT05310643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92820382|NCT05310643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820383|NCT05257213|Heparin|heparin|mesh-list
92820384|NCT05257213|Anticoagulants|anticoagulants|mesh-ancestor
92820385|NCT05257213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92820386|NCT05257213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92820387|NCT05257213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820388|NCT00918853|Pancrelipase|pancrelipase|mesh-list
92820389|NCT00918853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92820390|NCT01016600|Lenalidomide|lenalidomide|mesh-list
92820391|NCT01016600|Azacitidine|azacitidine|mesh-list
92820392|NCT01016600|Immunologic Factors|immunologic factors|mesh-ancestor
92820393|NCT01016600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820394|NCT01016600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92820395|NCT01016600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92820396|NCT01016600|Growth Substances|growth substances|mesh-ancestor
92820397|NCT01016600|Growth Inhibitors|growth inhibitors|mesh-ancestor
92465414|NCT01774474|Analgesics|analgesics|mesh-ancestor
92820398|NCT01016600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820399|NCT01016600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92820400|NCT01016600|Antimetabolites|antimetabolites|mesh-ancestor
92820401|NCT01016600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820402|NCT01016600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820403|NCT05175235|Pembrolizumab|pembrolizumab|mesh-list
92820404|NCT05175235|Nivolumab|nivolumab|mesh-list
92820405|NCT05175235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820406|NCT05175235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820407|NCT05175235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92820408|NCT05175235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820409|NCT04298684|Metformin|metformin|mesh-list
92820410|NCT04298684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92820411|NCT04298684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92820412|NCT04298684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820413|NCT04298684|Incretins|incretins|mesh-ancestor
92820414|NCT04298684|Hormones|hormones|mesh-ancestor
92820415|NCT04298684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820416|NCT04298684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92820417|NCT04298684|Protease Inhibitors|protease inhibitors|mesh-ancestor
92820418|NCT04298684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820419|NCT04298684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820420|NCT04298372|Lenalidomide|lenalidomide|mesh-list
92820421|NCT04298372|Immunologic Factors|immunologic factors|mesh-ancestor
92820422|NCT04298372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820423|NCT04298372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92820424|NCT04298372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92820425|NCT04298372|Growth Substances|growth substances|mesh-ancestor
92820426|NCT04298372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92820427|NCT04298372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820428|NCT01010204|Varenicline|varenicline|mesh-list
92820429|NCT01010204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92820430|NCT01010204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92820431|NCT01010204|Cholinergic Agents|cholinergic agents|mesh-ancestor
92820432|NCT01010204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820433|NCT01010204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820434|NCT01010204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820435|NCT00718549|Cyclophosphamide|cyclophosphamide|mesh-list
92820436|NCT00718549|Rituximab|rituximab|mesh-list
92820437|NCT00718549|Cladribine|cladribine|mesh-list
92820438|NCT00718549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820439|NCT00718549|Immunologic Factors|immunologic factors|mesh-ancestor
92820440|NCT00718549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820441|NCT00718549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820442|NCT00718549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820443|NCT00718549|Alkylating Agents|alkylating agents|mesh-ancestor
92820444|NCT00718549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820445|NCT00718549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820446|NCT00718549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92820447|NCT00718549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820448|NCT00793624|Formoterol Fumarate|formoterol fumarate|mesh-list
92820449|NCT00793624|Olodaterol|olodaterol|mesh-list
92820450|NCT00793624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92820451|NCT00793624|Autonomic Agents|autonomic agents|mesh-ancestor
92820452|NCT00793624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820453|NCT00793624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820454|NCT00793624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92820455|NCT00793624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92820456|NCT00793624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92820457|NCT00793624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92820458|NCT00793624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92820459|NCT00793624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92820460|NCT00793624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820461|NCT00793624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820462|NCT00919243|Prednisone|prednisone|mesh-list
92820463|NCT00919243|Allopurinol|allopurinol|mesh-list
92820464|NCT00919243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92820465|NCT00919243|Glucocorticoids|glucocorticoids|mesh-ancestor
92820466|NCT00919243|Hormones|hormones|mesh-ancestor
92820467|NCT00919243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820468|NCT00919243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820469|NCT00919243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92820470|NCT00919243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820471|NCT00919243|Antimetabolites|antimetabolites|mesh-ancestor
92820472|NCT00919243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465483|NCT01775579|Metformin|metformin|mesh-list
92820473|NCT00919243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820474|NCT00919243|Gout Suppressants|gout suppressants|mesh-ancestor
92820475|NCT00919243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820476|NCT00919243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92820477|NCT00919243|Antioxidants|antioxidants|mesh-ancestor
92820478|NCT00919243|Protective Agents|protective agents|mesh-ancestor
92820479|NCT00794950|Sunitinib|sunitinib|mesh-list
92820480|NCT00794950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820481|NCT00794950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92820482|NCT00794950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92820483|NCT00794950|Growth Substances|growth substances|mesh-ancestor
92820484|NCT00794950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820485|NCT00794950|Growth Inhibitors|growth inhibitors|mesh-ancestor
92820486|NCT00794950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92820487|NCT00794950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820488|NCT00794950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820489|NCT02591173|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92820490|NCT02591173|Angiotensin II|angiotensin ii|mesh-list
92820491|NCT02591173|Angiotensinogen|angiotensinogen|mesh-list
92820492|NCT02591173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820493|NCT02591173|Vasodilator Agents|vasodilator agents|mesh-ancestor
92820494|NCT02591173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92820495|NCT02591173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92820496|NCT02591173|Protease Inhibitors|protease inhibitors|mesh-ancestor
92820497|NCT02591173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820498|NCT02591173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820499|NCT00793546|Exemestane|exemestane|mesh-list
92820500|NCT00793546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820501|NCT00793546|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92820502|NCT00793546|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92820503|NCT00793546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820504|NCT00793546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820505|NCT00793546|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92820506|NCT00793546|Hormone Antagonists|hormone antagonists|mesh-ancestor
92820507|NCT00793546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820508|NCT00793546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820509|NCT02604238|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92820510|NCT02604238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92820511|NCT02604238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92820512|NCT02604238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820513|NCT00798694|Travoprost|travoprost|mesh-list
92820514|NCT00798694|Latanoprost|latanoprost|mesh-list
92820515|NCT00798694|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92820516|NCT00798694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92820517|NCT00798694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820518|NCT00718315|Erythromycin|erythromycin|mesh-list
92820520|NCT00718315|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92820521|NCT00718315|Erythromycin stearate|erythromycin stearate|mesh-list
92820522|NCT00718315|Fusidic Acid|fusidic acid|mesh-list
92820523|NCT00718315|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92820524|NCT00718315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820525|NCT00718315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92820526|NCT00718315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820527|NCT00718315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820528|NCT00718315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92820529|NCT00718315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820530|NCT00718315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92820531|NCT00718315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92820532|NCT00798304|Vaccines|vaccines|mesh-list
92820533|NCT00798304|Immunologic Factors|immunologic factors|mesh-ancestor
92820534|NCT00798304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820535|NCT04109872|Lenalidomide|lenalidomide|mesh-list
92820536|NCT04109872|Immunologic Factors|immunologic factors|mesh-ancestor
92820537|NCT04109872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820538|NCT04109872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92820539|NCT04109872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92820540|NCT04109872|Growth Substances|growth substances|mesh-ancestor
92820541|NCT04109872|Growth Inhibitors|growth inhibitors|mesh-ancestor
92820542|NCT04109872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820543|NCT00793780|Naltrexone|naltrexone|mesh-list
92820544|NCT00793780|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92820545|NCT00793780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92820546|NCT00793780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820547|NCT00793780|Sensory System Agents|sensory system agents|mesh-ancestor
92820548|NCT00793780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820549|NCT04107220|Valsartan|valsartan|mesh-list
92820550|NCT04107220|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92820551|NCT04107220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820552|NCT04107220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92820553|NCT04107220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92820554|NCT04107220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820555|NCT02591017|Ketamine|ketamine|mesh-list
92820556|NCT02591017|Morphine|morphine|mesh-list
92820557|NCT02591017|Chitosan|chitosan|mesh-list
92820558|NCT02591017|Analgesics|analgesics|mesh-ancestor
92820559|NCT02591017|Sensory System Agents|sensory system agents|mesh-ancestor
92820560|NCT02591017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820561|NCT02591017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820562|NCT02591017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92820563|NCT02591017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92820564|NCT02591017|Anesthetics, General|anesthetics, general|mesh-ancestor
92820565|NCT02591017|Anesthetics|anesthetics|mesh-ancestor
92820566|NCT02591017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820567|NCT02591017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92820568|NCT02591017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92820569|NCT02591017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820570|NCT02591017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820571|NCT02591017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92820572|NCT02591017|Narcotics|narcotics|mesh-ancestor
92820573|NCT02591017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92820574|NCT02591017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92820575|NCT02591017|Antimetabolites|antimetabolites|mesh-ancestor
92820576|NCT02591017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92820577|NCT02591017|Chelating Agents|chelating agents|mesh-ancestor
92820578|NCT02591017|Sequestering Agents|sequestering agents|mesh-ancestor
92820579|NCT02591017|Hemostatics|hemostatics|mesh-ancestor
92820580|NCT02591017|Coagulants|coagulants|mesh-ancestor
92820581|NCT02591095|Navitoclax|navitoclax|mesh-list
92820582|NCT02591095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820583|NCT02588755|Chlorotrianisene|chlorotrianisene|mesh-list
92820584|NCT02588755|Tegafur|tegafur|mesh-list
92820585|NCT02588755|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92820586|NCT02588755|Estrogens|estrogens|mesh-ancestor
92820587|NCT02588755|Hormones|hormones|mesh-ancestor
92820588|NCT02588755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820589|NCT02588755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820590|NCT02588755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92820591|NCT02588755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820592|NCT02588755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92820593|NCT02588755|Antimetabolites|antimetabolites|mesh-ancestor
92820594|NCT02588755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820595|NCT00919321|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92820596|NCT00919321|Immunologic Factors|immunologic factors|mesh-ancestor
92820597|NCT00919321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820598|NCT02643303|Durvalumab|durvalumab|mesh-list
92820599|NCT02643303|Tremelimumab|tremelimumab|mesh-list
92820600|NCT02643303|Poly ICLC|poly iclc|mesh-list
92820601|NCT02643303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820602|NCT02643303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820603|NCT02643303|Interferon Inducers|interferon inducers|mesh-ancestor
92820604|NCT02643303|Immunologic Factors|immunologic factors|mesh-ancestor
92820605|NCT02643303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820606|NCT00615147|Fibrin fragment D|fibrin fragment d|mesh-list
92820607|NCT00615147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92820608|NCT00615147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92820609|NCT00615147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820610|NCT00615147|Hemostatics|hemostatics|mesh-ancestor
92820611|NCT00615147|Coagulants|coagulants|mesh-ancestor
92820612|NCT01029717|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92820613|NCT01029717|Minocycline|minocycline|mesh-list
92820614|NCT01029717|Rifampin|rifampin|mesh-list
92820615|NCT01029717|Heparin|heparin|mesh-list
92820616|NCT01029717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820617|NCT01029717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92820618|NCT01029717|Antitubercular Agents|antitubercular agents|mesh-ancestor
92820619|NCT01029717|Anticoagulants|anticoagulants|mesh-ancestor
92820620|NCT01029717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92820621|NCT01029717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92820622|NCT01029717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820623|NCT01029717|Leprostatic Agents|leprostatic agents|mesh-ancestor
92820624|NCT01029717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820625|NCT01029717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820626|NCT01029717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92820627|NCT01029717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92820628|NCT01029717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92820629|NCT01029717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92820630|NCT01029717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92820631|NCT01029717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92820632|NCT00790036|Everolimus|everolimus|mesh-list
92820633|NCT00790036|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92820634|NCT00790036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92820635|NCT00790036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820636|NCT00790036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820637|NCT00790036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820638|NCT00790036|Immunologic Factors|immunologic factors|mesh-ancestor
92820639|NCT00790036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820640|NCT00790036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820641|NCT05563168|Diltiazem|diltiazem|mesh-list
92820642|NCT05563168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820643|NCT05563168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92820644|NCT05563168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820645|NCT05563168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820646|NCT05563168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92820647|NCT05563168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820648|NCT05563168|Vasodilator Agents|vasodilator agents|mesh-ancestor
92820649|NCT00789958|Gemcitabine|gemcitabine|mesh-list
92820650|NCT00789958|Capecitabine|capecitabine|mesh-list
92820651|NCT00789958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92820652|NCT00789958|Antimetabolites|antimetabolites|mesh-ancestor
92722507|NCT04597775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92820653|NCT00789958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820654|NCT00789958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820655|NCT00789880|Vitamin D|vitamin d|mesh-list
92820656|NCT00789880|Ergocalciferols|ergocalciferols|mesh-list
92820657|NCT00789880|Cholecalciferol|cholecalciferol|mesh-list
92820658|NCT00789880|Vitamins|vitamins|mesh-list
92820659|NCT00789880|Micronutrients|micronutrients|mesh-ancestor
92820660|NCT00789880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820661|NCT00789880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92820662|NCT00789880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92820663|NCT00915616|Melatonin|melatonin|mesh-list
92820664|NCT00915616|Antioxidants|antioxidants|mesh-ancestor
92820665|NCT00915616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820666|NCT00915616|Protective Agents|protective agents|mesh-ancestor
92820667|NCT00915616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820668|NCT00915616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820669|NCT00914836|Betamethasone|betamethasone|mesh-list
92820670|NCT00914836|Betamethasone Valerate|betamethasone valerate|mesh-list
92820671|NCT00914836|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92820672|NCT00914836|Betamethasone benzoate|betamethasone benzoate|mesh-list
92820673|NCT00914836|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
92820674|NCT00914836|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92820675|NCT00914836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92820676|NCT00914836|Glucocorticoids|glucocorticoids|mesh-ancestor
92820677|NCT00914836|Hormones|hormones|mesh-ancestor
92820678|NCT00914836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820679|NCT00914836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820680|NCT00914836|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92820681|NCT00914836|Respiratory System Agents|respiratory system agents|mesh-ancestor
92820682|NCT04106752|Caffeine|caffeine|mesh-list
92820683|NCT04106752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92820684|NCT04106752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820685|NCT04106752|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92820686|NCT04106752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820687|NCT04106752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820688|NCT04106752|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92820689|NCT04106752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92820690|NCT04106752|Purinergic Agents|purinergic agents|mesh-ancestor
92820691|NCT04106752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820692|NCT00792298|Suvorexant|suvorexant|mesh-list
92820693|NCT00792298|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92820694|NCT00792298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92820695|NCT00792298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820696|NCT00792298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820697|NCT00792298|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92820698|NCT00792298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820699|NCT00792298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820700|NCT04108468|Golimumab|golimumab|mesh-list
92820701|NCT04108468|Methotrexate|methotrexate|mesh-list
92820702|NCT04108468|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92820703|NCT04108468|Abortifacient Agents|abortifacient agents|mesh-ancestor
92820704|NCT04108468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92820705|NCT04108468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820706|NCT04108468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92820707|NCT04108468|Antimetabolites|antimetabolites|mesh-ancestor
92820708|NCT04108468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820709|NCT04108468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820710|NCT04108468|Dermatologic Agents|dermatologic agents|mesh-ancestor
92820711|NCT04108468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820712|NCT04108468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92820713|NCT04108468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92820714|NCT04108468|Immunologic Factors|immunologic factors|mesh-ancestor
92820715|NCT04108468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820716|NCT04108468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820717|NCT04108468|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92820718|NCT04108468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92820719|NCT02603068|Treprostinil|treprostinil|mesh-list
92820720|NCT02603068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92820721|NCT00718081|Sufentanil|sufentanil|mesh-list
92820722|NCT00718081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92820723|NCT00718081|Narcotics|narcotics|mesh-ancestor
92820724|NCT00718081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820725|NCT00718081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820726|NCT00718081|Analgesics|analgesics|mesh-ancestor
92820727|NCT00718081|Sensory System Agents|sensory system agents|mesh-ancestor
92820728|NCT00718081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820729|NCT00718081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92820730|NCT00718081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92820731|NCT00718081|Anesthetics, General|anesthetics, general|mesh-ancestor
92820732|NCT00718081|Anesthetics|anesthetics|mesh-ancestor
92820733|NCT00788710|Etoricoxib|etoricoxib|mesh-list
92820734|NCT00788710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92820735|NCT00788710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92820736|NCT00788710|Analgesics|analgesics|mesh-ancestor
92820737|NCT00788710|Sensory System Agents|sensory system agents|mesh-ancestor
92820738|NCT00788710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820739|NCT00788710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820740|NCT00788710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92820741|NCT00788710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820742|NCT00788710|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92820743|NCT00788710|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92820744|NCT00788710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820745|NCT00788710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820746|NCT04084093|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92820747|NCT04084093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92820748|NCT04083625|Carbetocin|carbetocin|mesh-list
92820749|NCT04083625|Oxytocics|oxytocics|mesh-ancestor
92820750|NCT04083625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92820751|NCT04083625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820752|NCT00787930|Valproic Acid|valproic acid|mesh-list
92820753|NCT00787930|Anticonvulsants|anticonvulsants|mesh-ancestor
92820754|NCT00787930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820755|NCT00787930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820756|NCT00787930|GABA Agents|gaba agents|mesh-ancestor
92820757|NCT00787930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820758|NCT00787930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820759|NCT00787930|Antimanic Agents|antimanic agents|mesh-ancestor
92820760|NCT00787930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92820761|NCT00787930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820762|NCT00787930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92820763|NCT04106050|Lidocaine|lidocaine|mesh-list
92820764|NCT04106050|Anesthetics, Local|anesthetics, local|mesh-ancestor
92820765|NCT04106050|Anesthetics|anesthetics|mesh-ancestor
92820766|NCT04106050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820767|NCT04106050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820768|NCT04106050|Sensory System Agents|sensory system agents|mesh-ancestor
92820769|NCT04106050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820770|NCT04106050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92820771|NCT04106050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92820772|NCT04106050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92820773|NCT04106050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820774|NCT04106050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820775|NCT00588094|Rituximab|rituximab|mesh-list
92820776|NCT00588094|Carboplatin|carboplatin|mesh-list
92820777|NCT00588094|Etoposide|etoposide|mesh-list
92820778|NCT00588094|Ifosfamide|ifosfamide|mesh-list
92820779|NCT00588094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92820780|NCT00588094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820781|NCT00588094|Immunologic Factors|immunologic factors|mesh-ancestor
92820782|NCT00588094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820783|NCT00588094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820784|NCT00588094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92820785|NCT00588094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92820786|NCT00588094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92820787|NCT00588094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820788|NCT00588094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820789|NCT00588094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820790|NCT00588094|Alkylating Agents|alkylating agents|mesh-ancestor
92820791|NCT05194735|Aldesleukin|aldesleukin|mesh-list
92820792|NCT05194735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820793|NCT05194735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92820794|NCT05194735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92820795|NCT05194735|Antiviral Agents|antiviral agents|mesh-ancestor
92820796|NCT05194735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820797|NCT03373383|Padsevonil|padsevonil|mesh-list
92820798|NCT03373383|Anticonvulsants|anticonvulsants|mesh-ancestor
92820799|NCT02605252|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92820800|NCT02605252|Antiviral Agents|antiviral agents|mesh-ancestor
92820801|NCT02605252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820802|NCT00482157|Vitamin D|vitamin d|mesh-list
92820803|NCT00482157|Calcitriol|calcitriol|mesh-list
92820804|NCT00482157|Vitamins|vitamins|mesh-ancestor
92820805|NCT00482157|Micronutrients|micronutrients|mesh-ancestor
92820806|NCT00482157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820807|NCT00482157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92820808|NCT00482157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92820809|NCT00482157|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92820810|NCT00482157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820811|NCT00482157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820812|NCT00482157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92820813|NCT02706015|Dipyrone|dipyrone|mesh-list
92820814|NCT02706015|Dihydroergotamine|dihydroergotamine|mesh-list
92820815|NCT02706015|Caffeine|caffeine|mesh-list
92820816|NCT02706015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92820817|NCT02706015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820818|NCT02706015|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92820819|NCT02706015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820820|NCT02706015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820821|NCT02706015|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92820822|NCT02706015|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92820823|NCT02706015|Purinergic Agents|purinergic agents|mesh-ancestor
92820824|NCT02706015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820825|NCT02706015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92820826|NCT02706015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92820827|NCT02706015|Analgesics|analgesics|mesh-ancestor
92820828|NCT02706015|Sensory System Agents|sensory system agents|mesh-ancestor
92820829|NCT02706015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820830|NCT02706015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92820831|NCT02706015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820832|NCT02706015|Antipyretics|antipyretics|mesh-ancestor
92820833|NCT02706015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92820834|NCT02706015|Dopamine Agonists|dopamine agonists|mesh-ancestor
92820835|NCT02706015|Dopamine Agents|dopamine agents|mesh-ancestor
92820836|NCT02707575|Ranibizumab|ranibizumab|mesh-list
92820837|NCT02707575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92820838|NCT02707575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92820839|NCT02707575|Growth Substances|growth substances|mesh-ancestor
92820840|NCT02707575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820841|NCT02707575|Growth Inhibitors|growth inhibitors|mesh-ancestor
92820842|NCT02707575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820843|NCT00919399|Tamoxifen|tamoxifen|mesh-list
92820844|NCT00919399|Exemestane|exemestane|mesh-list
92820845|NCT00919399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92820846|NCT00919399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92820847|NCT00919399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820848|NCT00919399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820849|NCT00919399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92820850|NCT00919399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820851|NCT00919399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92820852|NCT00919399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92820853|NCT00919399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92820854|NCT00919399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92820855|NCT00919399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92820856|NCT00919399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820857|NCT00919399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820858|NCT00784654|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92820859|NCT00784654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92820860|NCT00784654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820861|NCT00784654|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92820862|NCT00784654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92820863|NCT00784654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820864|NCT00784654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820865|NCT00784654|Dopamine Agents|dopamine agents|mesh-ancestor
92820866|NCT00784654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820868|NCT02588287|Antiviral Agents|antiviral agents|mesh-ancestor
92820869|NCT02588287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820870|NCT02588287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92820871|NCT02588287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820872|NCT02588287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820873|NCT02588287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820874|NCT02588287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92820875|NCT02588287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92820876|NCT02707107|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
92820877|NCT02707107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92820878|NCT02707107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820879|NCT02707263|Heparin|heparin|mesh-list
92820880|NCT02707263|Calcium heparin|calcium heparin|mesh-list
92820881|NCT02707263|Anticoagulants|anticoagulants|mesh-ancestor
92820882|NCT02707263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92820883|NCT02707263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92820884|NCT02707263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820885|NCT02705547|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92820886|NCT02705547|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92820887|NCT02705547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92820888|NCT02705547|Antimetabolites|antimetabolites|mesh-ancestor
92820889|NCT02705547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820890|NCT02705547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92820891|NCT02705547|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92820892|NCT02705547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820893|NCT00615303|Simethicone|simethicone|mesh-list
92820894|NCT00615303|Antifoaming Agents|antifoaming agents|mesh-ancestor
92820895|NCT00615303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820896|NCT00615303|Emollients|emollients|mesh-ancestor
92820897|NCT00615303|Dermatologic Agents|dermatologic agents|mesh-ancestor
92820898|NCT00787150|Warfarin|warfarin|mesh-list
92820899|NCT00787150|Apixaban|apixaban|mesh-list
92820900|NCT00787150|Anticoagulants|anticoagulants|mesh-ancestor
92820901|NCT00787150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92820902|NCT00787150|Antithrombins|antithrombins|mesh-ancestor
92820903|NCT00787150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92820904|NCT00787150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92820905|NCT00787150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820906|NCT00787150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820907|NCT03606837|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92820908|NCT03606837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92820909|NCT03606837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820910|NCT02705313|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92820911|NCT02705313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92820912|NCT02705313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820913|NCT00786838|Trabectedin|trabectedin|mesh-list
92820914|NCT00786838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92820915|NCT00786838|Alkylating Agents|alkylating agents|mesh-ancestor
92820916|NCT00786838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820917|NCT00786838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820918|NCT02604004|Lamivudine|lamivudine|mesh-list
92820919|NCT02604004|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92820920|NCT02604004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92820921|NCT02604004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820922|NCT02604004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820923|NCT02604004|Antiviral Agents|antiviral agents|mesh-ancestor
92820924|NCT02604004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92820925|NCT02604004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92820926|NCT02604004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92820927|NCT05095207|Bicalutamide|bicalutamide|mesh-list
92820928|NCT05095207|Androgen Antagonists|androgen antagonists|mesh-ancestor
92820929|NCT05095207|Hormone Antagonists|hormone antagonists|mesh-ancestor
92820930|NCT05095207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820931|NCT05095207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820932|NCT05095207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820933|NCT03354039|Tamoxifen|tamoxifen|mesh-list
92820934|NCT03354039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92820935|NCT03354039|Hormone Antagonists|hormone antagonists|mesh-ancestor
92820936|NCT03354039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92820937|NCT03354039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820938|NCT03354039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92820939|NCT03354039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820940|NCT03354039|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92820941|NCT03354039|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92820942|NCT03354039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92820943|NCT04105426|Antioxidants|antioxidants|mesh-list
92820944|NCT04105426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820945|NCT04105426|Protective Agents|protective agents|mesh-ancestor
92820946|NCT04105426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820947|NCT02704923|Atropine|atropine|mesh-list
92820948|NCT02704923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92820949|NCT02704923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92820950|NCT02704923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92820951|NCT02704923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92820952|NCT02704923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92820953|NCT02704923|Autonomic Agents|autonomic agents|mesh-ancestor
92820954|NCT02704923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820955|NCT02704923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820956|NCT02704923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92820957|NCT02704923|Respiratory System Agents|respiratory system agents|mesh-ancestor
92820958|NCT02704923|Mydriatics|mydriatics|mesh-ancestor
92820959|NCT02704923|Parasympatholytics|parasympatholytics|mesh-ancestor
92820960|NCT02704923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92820962|NCT02704923|Cholinergic Agents|cholinergic agents|mesh-ancestor
92820963|NCT02704923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820964|NCT02704923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820965|NCT04815967|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92820966|NCT04815967|Botulinum Toxins|botulinum toxins|mesh-list
92820967|NCT04815967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92820968|NCT04815967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92820969|NCT04815967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92820970|NCT04815967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92820971|NCT04815967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820972|NCT04815967|Cholinergic Agents|cholinergic agents|mesh-ancestor
92820973|NCT04815967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92820974|NCT04815967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820975|NCT04815967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92820976|NCT04815967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92820977|NCT04815967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92820978|NCT02704767|Apatinib|apatinib|mesh-list
92820979|NCT02704767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92820980|NCT02704767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92820981|NCT02704767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92820982|NCT02704767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92820983|NCT02704767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92820984|NCT02587273|Fentanyl|fentanyl|mesh-list
92820985|NCT02587273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92820986|NCT02587273|Narcotics|narcotics|mesh-ancestor
92820987|NCT02587273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92820988|NCT02587273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820989|NCT02587273|Analgesics|analgesics|mesh-ancestor
92820990|NCT02587273|Sensory System Agents|sensory system agents|mesh-ancestor
92820991|NCT02587273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466007|NCT01779882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92820992|NCT02587273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92820993|NCT02587273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92820994|NCT02587273|Anesthetics, General|anesthetics, general|mesh-ancestor
92820995|NCT02587273|Anesthetics|anesthetics|mesh-ancestor
92820996|NCT02704299|Immunomodulating Agents|immunomodulating agents|mesh-list
92820997|NCT02704299|Immunologic Factors|immunologic factors|mesh-ancestor
92820998|NCT02704299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92820999|NCT02587741|Metformin|metformin|mesh-list
92821000|NCT02587741|Acarbose|acarbose|mesh-list
92821001|NCT02587741|Gliclazide|gliclazide|mesh-list
92821002|NCT02587741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92821003|NCT02587741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821004|NCT02587741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821005|NCT02587741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92821006|NCT02587741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026453|NCT00402285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821007|NCT02587741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821008|NCT02703363|Minocycline|minocycline|mesh-list
92821009|NCT02703363|Celecoxib|celecoxib|mesh-list
92821010|NCT02703363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92821011|NCT02703363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821012|NCT02703363|Analgesics|analgesics|mesh-ancestor
92821013|NCT02703363|Sensory System Agents|sensory system agents|mesh-ancestor
92821014|NCT02703363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821015|NCT02703363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821016|NCT02703363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821017|NCT02703363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92821018|NCT02703363|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92821019|NCT02703363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92821020|NCT02703363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821021|NCT02703363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821022|NCT02703363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92821023|NCT02703363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821024|NCT05018221|Vitamins|vitamins|mesh-list
92821025|NCT05018221|Vitamin K|vitamin k|mesh-list
92821026|NCT05018221|Vitamin K 1|vitamin k 1|mesh-list
92821027|NCT05018221|Sodium thiosulfate|sodium thiosulfate|mesh-list
92821028|NCT05018221|Magnesium citrate|magnesium citrate|mesh-list
92821029|NCT05018221|Citric Acid|citric acid|mesh-list
92821030|NCT05018221|Sodium Citrate|sodium citrate|mesh-list
92821031|NCT05018221|Micronutrients|micronutrients|mesh-ancestor
92821032|NCT05018221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821033|NCT05018221|Anticoagulants|anticoagulants|mesh-ancestor
92821034|NCT05018221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92821035|NCT05018221|Chelating Agents|chelating agents|mesh-ancestor
92821036|NCT05018221|Sequestering Agents|sequestering agents|mesh-ancestor
92821037|NCT05018221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821038|NCT05018221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92821039|NCT05018221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92821040|NCT05018221|Hemostatics|hemostatics|mesh-ancestor
92821041|NCT05018221|Coagulants|coagulants|mesh-ancestor
92821042|NCT05018221|Antidotes|antidotes|mesh-ancestor
92821043|NCT05018221|Protective Agents|protective agents|mesh-ancestor
92821044|NCT05018221|Antioxidants|antioxidants|mesh-ancestor
92821045|NCT05018221|Antitubercular Agents|antitubercular agents|mesh-ancestor
92821046|NCT05018221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92821047|NCT05018221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821048|NCT05018221|Cathartics|cathartics|mesh-ancestor
92821049|NCT05018221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821050|NCT00615381|Insulin|insulin|mesh-list
92821051|NCT00615381|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92821052|NCT00615381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821053|NCT00615381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821054|NCT00785980|Ciprofloxacin|ciprofloxacin|mesh-list
92821055|NCT00785980|Quinine|quinine|mesh-list
92821056|NCT00785980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92821057|NCT00785980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821058|NCT00785980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92821059|NCT00785980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92821060|NCT00785980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821061|NCT00785980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821062|NCT00785980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821063|NCT00785980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92821064|NCT00785980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92821065|NCT00785980|Antimalarials|antimalarials|mesh-ancestor
92821066|NCT00785980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92821067|NCT00785980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92821068|NCT00785980|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92466087|NCT01780467|Dopamine|dopamine|mesh-list
92821069|NCT00785980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821070|NCT00785980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92821071|NCT00785980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821072|NCT00785980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821073|NCT00785980|Analgesics|analgesics|mesh-ancestor
92821074|NCT00785980|Sensory System Agents|sensory system agents|mesh-ancestor
92821075|NCT04805073|Promethazine|promethazine|mesh-list
92821076|NCT04805073|Diphenhydramine|diphenhydramine|mesh-list
92821077|NCT04805073|Antipruritics|antipruritics|mesh-ancestor
92821078|NCT04805073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92821079|NCT04805073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92821080|NCT04805073|Histamine Antagonists|histamine antagonists|mesh-ancestor
92821081|NCT04805073|Histamine Agents|histamine agents|mesh-ancestor
92821082|NCT04805073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821083|NCT04805073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821084|NCT04805073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821085|NCT04805073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92821086|NCT04805073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92821087|NCT04805073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821088|NCT04805073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821089|NCT04805073|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821090|NCT04805073|Anesthetics|anesthetics|mesh-ancestor
92821091|NCT04805073|Sensory System Agents|sensory system agents|mesh-ancestor
92821092|NCT04805073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821093|NCT04805073|Antiemetics|antiemetics|mesh-ancestor
92821094|NCT04805073|Autonomic Agents|autonomic agents|mesh-ancestor
92821095|NCT04805073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821096|NCT00915694|Nelfinavir|nelfinavir|mesh-list
92821097|NCT00915694|Temozolomide|temozolomide|mesh-list
92821098|NCT00915694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92821099|NCT00915694|Alkylating Agents|alkylating agents|mesh-ancestor
92821100|NCT00915694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821101|NCT00915694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821102|NCT00915694|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92821103|NCT00915694|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92821104|NCT00915694|Protease Inhibitors|protease inhibitors|mesh-ancestor
92821105|NCT00915694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821106|NCT00915694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92821107|NCT00915694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92821108|NCT00915694|Antiviral Agents|antiviral agents|mesh-ancestor
92821109|NCT00915694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821110|NCT02703051|Lenograstim|lenograstim|mesh-list
92821111|NCT02703051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92821112|NCT02703051|Immunologic Factors|immunologic factors|mesh-ancestor
92821113|NCT02703051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821114|NCT00785512|Nebivolol|nebivolol|mesh-list
92821115|NCT00785512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92821116|NCT00785512|Vasodilator Agents|vasodilator agents|mesh-ancestor
92821117|NCT00785512|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92821118|NCT00785512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92821119|NCT00785512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92821120|NCT00785512|Adrenergic Agents|adrenergic agents|mesh-ancestor
92821121|NCT00785512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821122|NCT00785512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821123|NCT00785512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821124|NCT02702817|Naproxen|naproxen|mesh-list
92821125|NCT02702817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92821126|NCT02702817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821127|NCT02702817|Analgesics|analgesics|mesh-ancestor
92821128|NCT02702817|Sensory System Agents|sensory system agents|mesh-ancestor
92821129|NCT02702817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821130|NCT02702817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821131|NCT02702817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821132|NCT02702817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92821133|NCT02702817|Gout Suppressants|gout suppressants|mesh-ancestor
92821134|NCT02702817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92821135|NCT02702817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821136|NCT02702817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821137|NCT02702739|Ribavirin|ribavirin|mesh-list
92821138|NCT02702739|Sofosbuvir|sofosbuvir|mesh-list
92821139|NCT02702739|Simeprevir|simeprevir|mesh-list
92821140|NCT02702739|Antimetabolites|antimetabolites|mesh-ancestor
92821141|NCT02702739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821142|NCT02702739|Antiviral Agents|antiviral agents|mesh-ancestor
92821143|NCT02702739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821144|NCT02702739|Protease Inhibitors|protease inhibitors|mesh-ancestor
92821146|NCT02602444|Ticagrelor|ticagrelor|mesh-list
92821147|NCT02602444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92821148|NCT02602444|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92821149|NCT02602444|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92821150|NCT02602444|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92821151|NCT02602444|Purinergic Agents|purinergic agents|mesh-ancestor
92821152|NCT02602444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821153|NCT02602444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821154|NCT02602444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821155|NCT02702661|Anesthetics|anesthetics|mesh-list
92821156|NCT02702661|Levobupivacaine|levobupivacaine|mesh-list
92821157|NCT02702661|Anesthetics, Local|anesthetics, local|mesh-list
92821158|NCT02702661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821159|NCT02702661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821160|NCT02702661|Sensory System Agents|sensory system agents|mesh-ancestor
92821161|NCT02702661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821162|NCT02702349|Penicillins|penicillins|mesh-list
92821163|NCT02702349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92821164|NCT02702349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821165|NCT04104334|Remifentanil|remifentanil|mesh-list
92821166|NCT04104334|Desflurane|desflurane|mesh-list
92821167|NCT04104334|Anesthetics|anesthetics|mesh-ancestor
92821168|NCT04104334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821169|NCT04104334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821170|NCT04104334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92821171|NCT04104334|Narcotics|narcotics|mesh-ancestor
92821172|NCT04104334|Analgesics|analgesics|mesh-ancestor
92821173|NCT04104334|Sensory System Agents|sensory system agents|mesh-ancestor
92821174|NCT04104334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821175|NCT04104334|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92821176|NCT04104334|Anesthetics, General|anesthetics, general|mesh-ancestor
92821177|NCT04215393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92821178|NCT04215393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92821179|NCT02602600|Liraglutide|liraglutide|mesh-list
92821180|NCT02602600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821181|NCT02602600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821182|NCT02602600|Incretins|incretins|mesh-ancestor
92821183|NCT02602600|Hormones|hormones|mesh-ancestor
92821184|NCT02602600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92821185|NCT00615615|Levetiracetam|levetiracetam|mesh-list
92821186|NCT00615615|Anticonvulsants|anticonvulsants|mesh-ancestor
92821187|NCT00615615|Nootropic Agents|nootropic agents|mesh-ancestor
92821188|NCT00784810|Acetaminophen|acetaminophen|mesh-list
92821189|NCT00784810|Oxycodone|oxycodone|mesh-list
92821190|NCT00784810|Codeine|codeine|mesh-list
92821191|NCT00784810|Naloxone|naloxone|mesh-list
92821192|NCT00784810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821193|NCT00784810|Analgesics|analgesics|mesh-ancestor
92821194|NCT00784810|Sensory System Agents|sensory system agents|mesh-ancestor
92821195|NCT00784810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821196|NCT00784810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821197|NCT00784810|Antipyretics|antipyretics|mesh-ancestor
92821198|NCT00784810|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92821199|NCT00784810|Narcotics|narcotics|mesh-ancestor
92821200|NCT00784810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821201|NCT00784810|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92821202|NCT00784810|Antitussive Agents|antitussive agents|mesh-ancestor
92821203|NCT00784810|Respiratory System Agents|respiratory system agents|mesh-ancestor
92821204|NCT02603770|Lovastatin|lovastatin|mesh-list
92821205|NCT02603770|L 647318|l 647318|mesh-list
92821206|NCT02603770|Dihydromevinolin|dihydromevinolin|mesh-list
92821207|NCT02603770|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92821208|NCT02603770|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92821209|NCT02603770|Antimetabolites|antimetabolites|mesh-ancestor
92821210|NCT02603770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821211|NCT02603770|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92821212|NCT02603770|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92821213|NCT02603770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821214|NCT04081909|Fentanyl|fentanyl|mesh-list
92821215|NCT04081909|Dexmedetomidine|dexmedetomidine|mesh-list
92821216|NCT04081909|Ketamine|ketamine|mesh-list
92821217|NCT04081909|Remifentanil|remifentanil|mesh-list
92821218|NCT04081909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821219|NCT04081909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821220|NCT04081909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821221|NCT04081909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821222|NCT04081909|Analgesics|analgesics|mesh-ancestor
92821223|NCT04081909|Sensory System Agents|sensory system agents|mesh-ancestor
92821224|NCT04081909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821225|NCT04081909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92821226|NCT04081909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92821227|NCT04081909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92821228|NCT04081909|Adrenergic Agents|adrenergic agents|mesh-ancestor
92821229|NCT04081909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821230|NCT04081909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821231|NCT04081909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92821232|NCT04081909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92821233|NCT04081909|Anesthetics, General|anesthetics, general|mesh-ancestor
92821234|NCT04081909|Anesthetics|anesthetics|mesh-ancestor
92821235|NCT04081909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92821236|NCT04081909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92821237|NCT04081909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92821238|NCT04081909|Narcotics|narcotics|mesh-ancestor
92821239|NCT04081909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92821240|NCT03272217|Bevacizumab|bevacizumab|mesh-list
92821241|NCT03272217|Atezolizumab|atezolizumab|mesh-list
92821242|NCT03272217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92821243|NCT03272217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821244|NCT03272217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92821245|NCT03272217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92821246|NCT03272217|Growth Substances|growth substances|mesh-ancestor
92821247|NCT03272217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821248|NCT03272217|Growth Inhibitors|growth inhibitors|mesh-ancestor
92821249|NCT03272217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92821250|NCT03272217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821251|NCT03262701|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92821252|NCT03262701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92821253|NCT03262701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821254|NCT00915382|Cisplatin|cisplatin|mesh-list
92821255|NCT00915382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821256|NCT05344443|Lemborexant|lemborexant|mesh-list
92821257|NCT05344443|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92821258|NCT05344443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821259|NCT05344443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821260|NCT05344443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92821261|NCT05344443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821262|NCT05344443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821263|NCT05344443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821264|NCT00919555|Pioglitazone|pioglitazone|mesh-list
92821265|NCT00919555|Tretinoin|tretinoin|mesh-list
92821266|NCT00919555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821267|NCT00919555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821268|NCT00919555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821269|NCT00919555|Keratolytic Agents|keratolytic agents|mesh-ancestor
92821270|NCT00919555|Dermatologic Agents|dermatologic agents|mesh-ancestor
92821271|NCT02979093|Oxytocin|oxytocin|mesh-list
92821272|NCT02979093|Oxytocics|oxytocics|mesh-ancestor
92821273|NCT02979093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92821274|NCT02979093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821275|NCT02588131|Durvalumab|durvalumab|mesh-list
92821276|NCT02588131|Tremelimumab|tremelimumab|mesh-list
92821277|NCT02588131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92821278|NCT02588131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821279|NCT04766983|Dimercaprol|dimercaprol|mesh-list
92821280|NCT04766983|Chelating Agents|chelating agents|mesh-ancestor
92821281|NCT04766983|Sequestering Agents|sequestering agents|mesh-ancestor
92821282|NCT04766983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821283|NCT04766437|Ticagrelor|ticagrelor|mesh-list
92821284|NCT04766437|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92821285|NCT04766437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92821286|NCT04766437|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92821287|NCT04766437|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92821288|NCT04766437|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92821289|NCT04766437|Purinergic Agents|purinergic agents|mesh-ancestor
92821290|NCT04766437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821291|NCT04766437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821292|NCT04766437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821293|NCT00776230|Vaccines|vaccines|mesh-list
92821294|NCT00776230|Immunologic Factors|immunologic factors|mesh-ancestor
92821295|NCT00776230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821296|NCT05561959|Nitroglycerin|nitroglycerin|mesh-list
92821297|NCT05561959|Vasodilator Agents|vasodilator agents|mesh-ancestor
92821299|NCT02586259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821300|NCT02586259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92821301|NCT02586259|Autonomic Agents|autonomic agents|mesh-ancestor
92821302|NCT02586259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821303|NCT02586259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821304|NCT02586259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92821305|NCT02586259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92821306|NCT02586259|Glucocorticoids|glucocorticoids|mesh-ancestor
92821307|NCT02586259|Hormones|hormones|mesh-ancestor
92821308|NCT02586259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92821309|NCT00775606|Ritonavir|ritonavir|mesh-list
92821310|NCT00775606|Lopinavir|lopinavir|mesh-list
92821311|NCT00775606|Efavirenz|efavirenz|mesh-list
92821312|NCT00775606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92821313|NCT00775606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92821314|NCT00775606|Protease Inhibitors|protease inhibitors|mesh-ancestor
92821315|NCT00775606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821316|NCT00775606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821317|NCT00775606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92821318|NCT00775606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92821319|NCT00775606|Antiviral Agents|antiviral agents|mesh-ancestor
92821320|NCT00775606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821321|NCT00775606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92821322|NCT00775606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92821323|NCT00775606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92821324|NCT00775606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92821325|NCT00775606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92821326|NCT00775606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92821327|NCT00775606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92821328|NCT00775606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92821329|NCT00775606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92821330|NCT04761601|Paclitaxel|paclitaxel|mesh-list
92821331|NCT04761601|Gemcitabine|gemcitabine|mesh-list
92821332|NCT04761601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92821333|NCT04761601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821334|NCT04761601|Tubulin Modulators|tubulin modulators|mesh-ancestor
92821335|NCT04761601|Antimitotic Agents|antimitotic agents|mesh-ancestor
92821336|NCT04761601|Mitosis Modulators|mitosis modulators|mesh-ancestor
92821337|NCT04761601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821338|NCT04761601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92821339|NCT04761601|Antimetabolites|antimetabolites|mesh-ancestor
92821340|NCT02960763|Aripiprazole|aripiprazole|mesh-list
92821341|NCT02960763|Lithium Carbonate|lithium carbonate|mesh-list
92821343|NCT02960763|Nortriptyline|nortriptyline|mesh-list
92821344|NCT02960763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92821345|NCT02960763|Antidepressive Agents|antidepressive agents|mesh-ancestor
92821346|NCT02960763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92821347|NCT02960763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92821348|NCT02960763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92821349|NCT02960763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821350|NCT02960763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821351|NCT02960763|Dopamine Agents|dopamine agents|mesh-ancestor
92821352|NCT02960763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821353|NCT02960763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821354|NCT02960763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92821355|NCT02960763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92821356|NCT02960763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821357|NCT02960763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92821358|NCT02960763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92821359|NCT02960763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821360|NCT02960763|Dopamine Agonists|dopamine agonists|mesh-ancestor
92821361|NCT02960763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92821362|NCT02960763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92821363|NCT02960763|Serotonin Agents|serotonin agents|mesh-ancestor
92821364|NCT02960763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92821365|NCT02960763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92821366|NCT02960763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92821367|NCT02960763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92821368|NCT02960763|Antimanic Agents|antimanic agents|mesh-ancestor
92821369|NCT02960763|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92466400|NCT01782924|Brodalumab|brodalumab|mesh-list
92821370|NCT02960763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92821371|NCT02960763|Adrenergic Agents|adrenergic agents|mesh-ancestor
92821372|NCT00775528|Pancrelipase|pancrelipase|mesh-list
92821373|NCT00775528|Pancreatin|pancreatin|mesh-list
92821374|NCT00775528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821375|NCT04977271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92821376|NCT04977271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92821377|NCT04977271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92821378|NCT04977271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821379|NCT04977271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821380|NCT04977271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821381|NCT04977271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821382|NCT04977271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92821383|NCT04977271|Antidepressive Agents|antidepressive agents|mesh-ancestor
92821384|NCT04977271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92821385|NCT02701179|Lidocaine|lidocaine|mesh-list
92821386|NCT02701179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92821387|NCT02701179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821388|NCT02701179|Anesthetics|anesthetics|mesh-ancestor
92821389|NCT02701179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821390|NCT02701179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821391|NCT02701179|Sensory System Agents|sensory system agents|mesh-ancestor
92821392|NCT02701179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821393|NCT02701179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92821394|NCT02701179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92821395|NCT02701179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92821396|NCT02701179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821397|NCT02701179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821398|NCT02586961|Betamethasone|betamethasone|mesh-list
92821399|NCT02586961|Betamethasone Valerate|betamethasone valerate|mesh-list
92821400|NCT02586961|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92821401|NCT02586961|Betamethasone benzoate|betamethasone benzoate|mesh-list
92821402|NCT02586961|Epinephrine|epinephrine|mesh-list
92821403|NCT02586961|Racepinephrine|racepinephrine|mesh-list
92821404|NCT02586961|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92821405|NCT02586961|Epinephryl borate|epinephryl borate|mesh-list
92821406|NCT02586961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821407|NCT02586961|Glucocorticoids|glucocorticoids|mesh-ancestor
92821408|NCT02586961|Hormones|hormones|mesh-ancestor
92821409|NCT02586961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92821410|NCT02586961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821411|NCT02586961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92821412|NCT02586961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92821413|NCT02586961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92821414|NCT02586961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92821415|NCT02586961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92821416|NCT02586961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821417|NCT02586961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821418|NCT02586961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92821419|NCT02586961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92821420|NCT02586961|Autonomic Agents|autonomic agents|mesh-ancestor
92821421|NCT02586961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821422|NCT02586961|Mydriatics|mydriatics|mesh-ancestor
92821423|NCT02586961|Sympathomimetics|sympathomimetics|mesh-ancestor
92821424|NCT02586961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92821425|NCT02700711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92821426|NCT02700711|Methylphenidate|methylphenidate|mesh-list
92821427|NCT02700711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92821428|NCT02700711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821429|NCT02700711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92821430|NCT02700711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92821431|NCT02700711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821432|NCT02700711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821433|NCT02700711|Dopamine Agents|dopamine agents|mesh-ancestor
92821434|NCT02700711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821435|NCT02700711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92821436|NCT02700711|Analgesics|analgesics|mesh-ancestor
92821437|NCT02700711|Sensory System Agents|sensory system agents|mesh-ancestor
92821438|NCT02700711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821439|NCT02700711|Antidepressive Agents|antidepressive agents|mesh-ancestor
92821440|NCT02700711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92821441|NCT04215159|Gemcitabine|gemcitabine|mesh-list
92466464|NCT01783197|Paclitaxel|paclitaxel|mesh-list
92821442|NCT04215159|Trastuzumab|trastuzumab|mesh-list
92821444|NCT04215159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92821445|NCT04215159|Antimetabolites|antimetabolites|mesh-ancestor
92821446|NCT04215159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821447|NCT04215159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821448|NCT04215159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92821449|NCT04215159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92821450|NCT04215159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92821451|NCT04215159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821452|NCT00775450|Vaccines|vaccines|mesh-list
92821453|NCT00775450|Immunologic Factors|immunologic factors|mesh-ancestor
92821454|NCT00775450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821455|NCT02700477|Fenugreek seed meal|fenugreek seed meal|mesh-list
92821456|NCT02700477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821457|NCT02700477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821458|NCT02699385|Domperidone|domperidone|mesh-list
92821459|NCT02699385|Antiemetics|antiemetics|mesh-ancestor
92821460|NCT02699385|Autonomic Agents|autonomic agents|mesh-ancestor
92821461|NCT02699385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821462|NCT02699385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821463|NCT02699385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821464|NCT02699385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92821465|NCT02699385|Dopamine Agents|dopamine agents|mesh-ancestor
92821466|NCT02699385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821467|NCT02699385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821468|NCT02700087|Famotidine|famotidine|mesh-list
92821469|NCT02700087|Ranitidine|ranitidine|mesh-list
92821470|NCT02700087|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92821471|NCT02700087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92821472|NCT02700087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821473|NCT02700087|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92821474|NCT02700087|Histamine Antagonists|histamine antagonists|mesh-ancestor
92821475|NCT02700087|Histamine Agents|histamine agents|mesh-ancestor
92821476|NCT02700087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821477|NCT02700087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821478|NCT02700087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821479|NCT02586181|Calcium, Dietary|calcium, dietary|mesh-list
92821480|NCT02586181|Vitamin D|vitamin d|mesh-list
92821481|NCT02586181|Ergocalciferols|ergocalciferols|mesh-list
92821482|NCT02586181|Cholecalciferol|cholecalciferol|mesh-list
92821483|NCT02586181|Vitamins|vitamins|mesh-list
92821484|NCT02586181|Folic Acid|folic acid|mesh-list
92821485|NCT02586181|Calcium|calcium|mesh-list
92821486|NCT02586181|Micronutrients|micronutrients|mesh-ancestor
92821487|NCT02586181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821488|NCT02586181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92821489|NCT02586181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92821490|NCT02586181|Vitamin B Complex|vitamin b complex|mesh-ancestor
92821491|NCT02586181|Hematinics|hematinics|mesh-ancestor
92821492|NCT03181035|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92821493|NCT03181035|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92821494|NCT03181035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821495|NCT00775138|Amikacin|amikacin|mesh-list
92821496|NCT00775138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92821497|NCT00775138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821498|NCT03236805|Ketamine|ketamine|mesh-list
92821499|NCT03236805|Morphine|morphine|mesh-list
92821500|NCT03236805|Analgesics|analgesics|mesh-ancestor
92821501|NCT03236805|Sensory System Agents|sensory system agents|mesh-ancestor
92821502|NCT03236805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821503|NCT03236805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821504|NCT03236805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92821505|NCT03236805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92821506|NCT03236805|Anesthetics, General|anesthetics, general|mesh-ancestor
92821507|NCT03236805|Anesthetics|anesthetics|mesh-ancestor
92821508|NCT03236805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93026454|NCT00402285|Antioxidants|antioxidants|mesh-ancestor
92821509|NCT03236805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92821510|NCT03236805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92821511|NCT03236805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821512|NCT03236805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821513|NCT03236805|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92821514|NCT03236805|Narcotics|narcotics|mesh-ancestor
92821515|NCT02698995|Acetaminophen|acetaminophen|mesh-list
92821516|NCT02698995|Dexamethasone|dexamethasone|mesh-list
92821517|NCT02698995|Lidocaine|lidocaine|mesh-list
92821518|NCT02698995|Morphine|morphine|mesh-list
92821519|NCT02698995|Ropivacaine|ropivacaine|mesh-list
92821520|NCT02698995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821521|NCT02698995|Antiemetics|antiemetics|mesh-ancestor
92821522|NCT02698995|Autonomic Agents|autonomic agents|mesh-ancestor
92821523|NCT02698995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821524|NCT02698995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821525|NCT02698995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821526|NCT02698995|Glucocorticoids|glucocorticoids|mesh-ancestor
92821527|NCT02698995|Hormones|hormones|mesh-ancestor
92821528|NCT02698995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92821529|NCT02698995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92821530|NCT02698995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821531|NCT02698995|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821532|NCT02698995|Anesthetics|anesthetics|mesh-ancestor
92821533|NCT02698995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821534|NCT02698995|Sensory System Agents|sensory system agents|mesh-ancestor
92821535|NCT02698995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92821536|NCT02698995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92821537|NCT02698995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92821538|NCT02698995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821539|NCT02698995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821540|NCT02698995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92821541|NCT02698995|Narcotics|narcotics|mesh-ancestor
92821542|NCT02698995|Analgesics|analgesics|mesh-ancestor
92821543|NCT02698995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821544|NCT02698995|Antipyretics|antipyretics|mesh-ancestor
92821545|NCT00920101|Atorvastatin|atorvastatin|mesh-list
92821546|NCT00920101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92821547|NCT00920101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92821548|NCT00920101|Antimetabolites|antimetabolites|mesh-ancestor
92821549|NCT00920101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821550|NCT00920101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92821551|NCT00920101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92821552|NCT00920101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821553|NCT00616785|Irinotecan|irinotecan|mesh-list
92821554|NCT00616785|Etoposide|etoposide|mesh-list
92821555|NCT00616785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821556|NCT00616785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92821557|NCT00616785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92821558|NCT00616785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166360|NCT01314417|Antimetabolites|antimetabolites|mesh-ancestor
92821559|NCT00616785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821560|NCT00616785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92821561|NCT00616785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92821562|NCT00616005|Irinotecan|irinotecan|mesh-list
92821563|NCT00616005|Temozolomide|temozolomide|mesh-list
92821564|NCT00616005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92821565|NCT00616005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92821566|NCT00616005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821567|NCT00616005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821568|NCT00616005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821569|NCT00616005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92821570|NCT00616005|Alkylating Agents|alkylating agents|mesh-ancestor
92821571|NCT02698527|Lidocaine|lidocaine|mesh-list
92821572|NCT02698527|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821573|NCT02698527|Anesthetics|anesthetics|mesh-ancestor
92821574|NCT02698527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821575|NCT02698527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821576|NCT02698527|Sensory System Agents|sensory system agents|mesh-ancestor
92821577|NCT02698527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821578|NCT02698527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92821579|NCT02698527|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92821580|NCT02698527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92821581|NCT02698527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821582|NCT02698527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821583|NCT04215237|Atorvastatin|atorvastatin|mesh-list
92821584|NCT04215237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92821585|NCT04215237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92821586|NCT04215237|Antimetabolites|antimetabolites|mesh-ancestor
92821587|NCT04215237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821588|NCT04215237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92821589|NCT04215237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92821590|NCT04215237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821591|NCT02586649|Bromides|bromides|mesh-list
92821592|NCT02586649|Tiotropium Bromide|tiotropium bromide|mesh-list
92821593|NCT02586649|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92821595|NCT02586649|Autonomic Agents|autonomic agents|mesh-ancestor
92821596|NCT02586649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821597|NCT02586649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821598|NCT02586649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92821599|NCT02586649|Respiratory System Agents|respiratory system agents|mesh-ancestor
92821600|NCT02586649|Parasympatholytics|parasympatholytics|mesh-ancestor
92821601|NCT02586649|Cholinergic Agents|cholinergic agents|mesh-ancestor
92821602|NCT02586649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821603|NCT02586649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821604|NCT02586649|Anticonvulsants|anticonvulsants|mesh-ancestor
92821605|NCT04213833|Lidocaine|lidocaine|mesh-list
92821606|NCT04213833|Dexmedetomidine|dexmedetomidine|mesh-list
92821607|NCT04213833|Propofol|propofol|mesh-list
92821608|NCT04213833|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821609|NCT04213833|Anesthetics|anesthetics|mesh-ancestor
92821610|NCT04213833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821611|NCT04213833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821612|NCT04213833|Sensory System Agents|sensory system agents|mesh-ancestor
92821613|NCT04213833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821614|NCT04213833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92821615|NCT04213833|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92821616|NCT04213833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92821617|NCT04213833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821618|NCT04213833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821619|NCT04213833|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821620|NCT04213833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821621|NCT04213833|Analgesics|analgesics|mesh-ancestor
92821622|NCT04213833|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92821623|NCT04213833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92821624|NCT04213833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92821625|NCT04213833|Adrenergic Agents|adrenergic agents|mesh-ancestor
92821626|NCT04213833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821627|NCT04213833|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92821628|NCT04213833|Anesthetics, General|anesthetics, general|mesh-ancestor
92821629|NCT04605991|Insulin Glargine|insulin glargine|mesh-list
92821630|NCT04605991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821631|NCT04605991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821632|NCT00783796|Everolimus|everolimus|mesh-list
92821633|NCT00783796|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92821634|NCT00783796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92821635|NCT00783796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821636|NCT00783796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821637|NCT00783796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92821638|NCT00783796|Immunologic Factors|immunologic factors|mesh-ancestor
92821639|NCT00783796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821640|NCT00783796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821641|NCT00637065|Bosentan|bosentan|mesh-list
92821642|NCT00637065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92821643|NCT00637065|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92821644|NCT00637065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821645|NCT00616863|Oxcarbazepine|oxcarbazepine|mesh-list
92821646|NCT00616863|Anticonvulsants|anticonvulsants|mesh-ancestor
92821647|NCT00616863|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92821648|NCT00616863|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92723488|NCT00568295|Antipyretics|antipyretics|mesh-ancestor
92821649|NCT00616863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821650|NCT00616863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821651|NCT00616863|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92821652|NCT00616863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92821653|NCT04947553|Dextromethorphan|dextromethorphan|mesh-list
92821654|NCT04947553|Bupropion|bupropion|mesh-list
92821655|NCT04947553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92821656|NCT04947553|Antidepressive Agents|antidepressive agents|mesh-ancestor
92821657|NCT04947553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92821658|NCT04947553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92821659|NCT04947553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92821660|NCT04947553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821661|NCT04947553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821662|NCT04947553|Dopamine Agents|dopamine agents|mesh-ancestor
92821663|NCT04947553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821664|NCT04947553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821665|NCT04947553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92821666|NCT04947553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92821667|NCT04947553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821668|NCT04947553|Antitussive Agents|antitussive agents|mesh-ancestor
92821669|NCT04947553|Respiratory System Agents|respiratory system agents|mesh-ancestor
92821670|NCT04947553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92821671|NCT04947553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92821672|NCT04079647|Immunomodulating Agents|immunomodulating agents|mesh-list
92821673|NCT04079647|Immunologic Factors|immunologic factors|mesh-ancestor
92821674|NCT04079647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821676|NCT00617253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821677|NCT00617253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92821678|NCT00617253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92821679|NCT00617253|Growth Substances|growth substances|mesh-ancestor
92821680|NCT00617253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821681|NCT00617253|Growth Inhibitors|growth inhibitors|mesh-ancestor
92821682|NCT00617253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92821683|NCT00617253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821684|NCT00617253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821685|NCT02585947|Tenofovir|tenofovir|mesh-list
92821686|NCT02585947|Antiviral Agents|antiviral agents|mesh-ancestor
92821687|NCT02585947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821688|NCT02585947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92821689|NCT02585947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92821690|NCT02585947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821691|NCT02585947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821692|NCT02585947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92821693|NCT02585947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92821694|NCT02607891|Cannabidiol|cannabidiol|mesh-list
92821695|NCT02607891|Anticonvulsants|anticonvulsants|mesh-ancestor
92821696|NCT02607813|Spartalizumab|spartalizumab|mesh-list
92821697|NCT02607813|Naporafenib|naporafenib|mesh-list
92821698|NCT02607813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92821699|NCT02607813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821700|NCT02607813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92821701|NCT02607813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821702|NCT02607813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92821703|NCT02607813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821704|NCT04079725|Mitomycins|mitomycins|mesh-list
92821705|NCT04079725|Mitomycin|mitomycin|mesh-list
92821706|NCT04079725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92821707|NCT04079725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821708|NCT04079725|Alkylating Agents|alkylating agents|mesh-ancestor
92821709|NCT04079725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821710|NCT04079725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92821711|NCT04079725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821712|NCT00783718|Vedolizumab|vedolizumab|mesh-list
92821713|NCT00783718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821714|NCT04213287|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92821715|NCT04213287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821716|NCT04213287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92821717|NCT04213287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821718|NCT04213287|Analgesics|analgesics|mesh-ancestor
92723548|NCT04575675|Antioxidants|antioxidants|mesh-ancestor
92821719|NCT04213287|Sensory System Agents|sensory system agents|mesh-ancestor
92821720|NCT04213287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821721|NCT04213287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821722|NCT04213287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92821723|NCT02585791|Glycerol|glycerol|mesh-list
92821724|NCT02585791|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92821725|NCT02585791|Protective Agents|protective agents|mesh-ancestor
92821726|NCT02585791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821727|NCT04913389|Acetazolamide|acetazolamide|mesh-list
92821728|NCT04913389|Anticonvulsants|anticonvulsants|mesh-ancestor
92821729|NCT04913389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92821730|NCT04913389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821731|NCT04913389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821732|NCT04913389|Diuretics|diuretics|mesh-ancestor
92821733|NCT04913389|Natriuretic Agents|natriuretic agents|mesh-ancestor
92821734|NCT04913389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821735|NCT04904965|Propofol|propofol|mesh-list
92821736|NCT04904965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821737|NCT04904965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821738|NCT04904965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821739|NCT04904965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92821740|NCT04904965|Anesthetics, General|anesthetics, general|mesh-ancestor
92821742|NCT00617565|Insulin|insulin|mesh-list
92821743|NCT00617565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92821744|NCT00617565|Insulin Aspart|insulin aspart|mesh-list
92821745|NCT00617565|Biphasic Insulins|biphasic insulins|mesh-list
92821746|NCT00617565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821747|NCT00617565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821748|NCT04079413|Insulin|insulin|mesh-list
92821749|NCT04079413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92821750|NCT04079413|Insulin Aspart|insulin aspart|mesh-list
92821751|NCT04079413|Insulin, Long-Acting|insulin, long-acting|mesh-list
92821752|NCT04079413|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92821753|NCT04079413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821754|NCT04079413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821755|NCT00915460|Interferons|interferons|mesh-list
92821756|NCT00915460|Interferon-beta|interferon-beta|mesh-list
92821757|NCT00915460|Interferon beta-1a|interferon beta-1a|mesh-list
92821758|NCT00915460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821759|NCT00915460|Antiviral Agents|antiviral agents|mesh-ancestor
92821760|NCT00915460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821761|NCT00915460|Immunologic Factors|immunologic factors|mesh-ancestor
92821762|NCT00915460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821763|NCT00915460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92821764|NCT00617643|Nevirapine|nevirapine|mesh-list
92821765|NCT00617643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92821766|NCT00617643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92821767|NCT00617643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821768|NCT00617643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821769|NCT00617643|Antiviral Agents|antiviral agents|mesh-ancestor
92821770|NCT00617643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821771|NCT00617643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92821772|NCT00617643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92821773|NCT00617643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92821774|NCT00617643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92821775|NCT04566133|Hydroxychloroquine|hydroxychloroquine|mesh-list
92821776|NCT04566133|Trametinib|trametinib|mesh-list
92821777|NCT04566133|Antimalarials|antimalarials|mesh-ancestor
92821778|NCT04566133|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92821779|NCT04566133|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92821780|NCT04566133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821781|NCT04566133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821782|NCT04566133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821783|NCT04566133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92821784|NCT04566133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821785|NCT04566133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92821786|NCT02584075|Metformin|metformin|mesh-list
92821787|NCT02584075|Exenatide|exenatide|mesh-list
92821788|NCT02584075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821789|NCT02584075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821790|NCT02584075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92821791|NCT02584075|Incretins|incretins|mesh-ancestor
92821792|NCT02584075|Hormones|hormones|mesh-ancestor
92821793|NCT02584075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92821794|NCT02585479|Oxaliplatin|oxaliplatin|mesh-list
92821795|NCT02585479|Ethiodized Oil|ethiodized oil|mesh-list
92821796|NCT02585479|Pirarubicin|pirarubicin|mesh-list
92821797|NCT02585479|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92821798|NCT02585479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821799|NCT02585479|Hemostatics|hemostatics|mesh-ancestor
92821800|NCT02585479|Coagulants|coagulants|mesh-ancestor
92821801|NCT00583453|Celecoxib|celecoxib|mesh-list
92821802|NCT00583453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92821803|NCT00583453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92821804|NCT00583453|Analgesics|analgesics|mesh-ancestor
92821805|NCT00583453|Sensory System Agents|sensory system agents|mesh-ancestor
92821806|NCT00583453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821807|NCT00583453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821808|NCT00583453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92821809|NCT00583453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92821810|NCT00583453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92821811|NCT00583453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92821812|NCT00583453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821813|NCT00583453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821814|NCT02584231|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92821815|NCT02584231|Hemostatics|hemostatics|mesh-ancestor
92821816|NCT02584231|Coagulants|coagulants|mesh-ancestor
92821817|NCT02584231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92821818|NCT02584231|Natriuretic Agents|natriuretic agents|mesh-ancestor
92821819|NCT02584231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821820|NCT04630873|Botulinum Toxins|botulinum toxins|mesh-list
92821821|NCT04630873|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92821822|NCT04630873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821823|NCT04630873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821824|NCT04630873|Cholinergic Agents|cholinergic agents|mesh-ancestor
92821825|NCT04630873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821826|NCT04630873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821827|NCT02584153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92821828|NCT02584153|Hemostatics|hemostatics|mesh-ancestor
92821829|NCT02584153|Coagulants|coagulants|mesh-ancestor
92821830|NCT02585401|Aflibercept|aflibercept|mesh-list
92821831|NCT02585401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92821832|NCT02585401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92821833|NCT02585401|Growth Substances|growth substances|mesh-ancestor
92821834|NCT02585401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821835|NCT02585401|Growth Inhibitors|growth inhibitors|mesh-ancestor
92821836|NCT02585401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821837|NCT04874311|Doxorubicin|doxorubicin|mesh-list
92821838|NCT04874311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92821839|NCT04874311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821840|NCT04874311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92821841|NCT04874311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92821842|NCT04874311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821843|NCT04874311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821844|NCT04873453|Cannabidiol|cannabidiol|mesh-list
92821845|NCT04873453|Anticonvulsants|anticonvulsants|mesh-ancestor
92821846|NCT04080349|Misoprostol|misoprostol|mesh-list
92821847|NCT04080349|Dinoprostone|dinoprostone|mesh-list
92821848|NCT04080349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92821849|NCT04080349|Abortifacient Agents|abortifacient agents|mesh-ancestor
92821850|NCT04080349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92821851|NCT04080349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821852|NCT04080349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92821853|NCT04080349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92821854|NCT04080349|Oxytocics|oxytocics|mesh-ancestor
92821855|NCT02585011|Epinephrine|epinephrine|mesh-list
92821856|NCT02585011|Ropivacaine|ropivacaine|mesh-list
92821857|NCT02585011|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821858|NCT02585011|Anesthetics|anesthetics|mesh-ancestor
92821859|NCT02585011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821860|NCT02585011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821861|NCT02585011|Sensory System Agents|sensory system agents|mesh-ancestor
92821862|NCT02585011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821863|NCT02585011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92821864|NCT02585011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92821865|NCT02585011|Adrenergic Agents|adrenergic agents|mesh-ancestor
92821866|NCT02585011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148781|NCT01397825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92821867|NCT02585011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821868|NCT02585011|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92821869|NCT02585011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92821870|NCT02585011|Autonomic Agents|autonomic agents|mesh-ancestor
92821871|NCT02585011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92821872|NCT02585011|Respiratory System Agents|respiratory system agents|mesh-ancestor
92821873|NCT02585011|Mydriatics|mydriatics|mesh-ancestor
92821874|NCT02585011|Sympathomimetics|sympathomimetics|mesh-ancestor
92821875|NCT02585011|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92821876|NCT00920725|Insulin|insulin|mesh-list
92821877|NCT00920725|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92821878|NCT00920725|Insulin Aspart|insulin aspart|mesh-list
92821879|NCT00920725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92821880|NCT00920725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821881|NCT02583451|Lemborexant|lemborexant|mesh-list
92821882|NCT02583451|Zopiclone|zopiclone|mesh-list
92821883|NCT02583451|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92821884|NCT02583451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821885|NCT02583451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821886|NCT02583451|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92821887|NCT02583451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821888|NCT02583451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821889|NCT02583451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821890|NCT05435911|Propofol|propofol|mesh-list
92821891|NCT05435911|Flumazenil|flumazenil|mesh-list
92821892|NCT05435911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92821893|NCT05435911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821894|NCT05435911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821895|NCT05435911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92821896|NCT05435911|Anesthetics, General|anesthetics, general|mesh-ancestor
92821897|NCT05435911|Anesthetics|anesthetics|mesh-ancestor
92821898|NCT05435911|Antidotes|antidotes|mesh-ancestor
92821899|NCT05435911|Protective Agents|protective agents|mesh-ancestor
92821900|NCT05435911|GABA Modulators|gaba modulators|mesh-ancestor
92821901|NCT05435911|GABA Agents|gaba agents|mesh-ancestor
92821902|NCT05435911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821903|NCT05435911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821904|NCT04472299|Ropivacaine|ropivacaine|mesh-list
92821905|NCT04472299|Anesthetics, Local|anesthetics, local|mesh-ancestor
92821906|NCT04472299|Anesthetics|anesthetics|mesh-ancestor
92821907|NCT04472299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92821908|NCT04472299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821909|NCT04472299|Sensory System Agents|sensory system agents|mesh-ancestor
92821910|NCT04472299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821911|NCT02583685|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92821912|NCT02583685|Interferon-alpha|interferon-alpha|mesh-list
92821913|NCT02583685|Ribavirin|ribavirin|mesh-list
92821914|NCT02583685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92821915|NCT02583685|Simeprevir|simeprevir|mesh-list
92821916|NCT02583685|Antiviral Agents|antiviral agents|mesh-ancestor
92821917|NCT02583685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821918|NCT02583685|Immunologic Factors|immunologic factors|mesh-ancestor
92821919|NCT02583685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821920|NCT02583685|Antimetabolites|antimetabolites|mesh-ancestor
92821921|NCT02583685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821922|NCT02583685|Protease Inhibitors|protease inhibitors|mesh-ancestor
92821923|NCT02583685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821924|NCT04606771|Osimertinib|osimertinib|mesh-list
92821925|NCT04606771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821926|NCT04606771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92821927|NCT04606771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821928|NCT04606771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821929|NCT04504123|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92821930|NCT04504123|Doxycycline|doxycycline|mesh-list
92821931|NCT04504123|Tetracycline|tetracycline|mesh-list
92821932|NCT04504123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92821933|NCT04504123|Antimalarials|antimalarials|mesh-ancestor
92821934|NCT04504123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92821935|NCT04504123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92821936|NCT04504123|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92723765|NCT00571142|Temazepam|temazepam|mesh-list
92821937|NCT04504123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821938|NCT04504123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821940|NCT02584543|Immunologic Factors|immunologic factors|mesh-ancestor
92821941|NCT02584543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821942|NCT04077853|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92821943|NCT04077853|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92821944|NCT04077853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92821945|NCT04077853|Hormone Antagonists|hormone antagonists|mesh-ancestor
92821946|NCT04077853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92821947|NCT04077853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821948|NCT04077853|Progestins|progestins|mesh-ancestor
92821949|NCT04077853|Hormones|hormones|mesh-ancestor
92821950|NCT04502407|Cisplatin|cisplatin|mesh-list
92821951|NCT04502407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821952|NCT00583219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92821953|NCT00583219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92821954|NCT00583219|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92821955|NCT00583219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92821956|NCT00583219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92821957|NCT00583219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821958|NCT00583219|Cholinergic Agents|cholinergic agents|mesh-ancestor
92821959|NCT00583219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821960|NCT00583219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821961|NCT00583219|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92821962|NCT00583219|Protective Agents|protective agents|mesh-ancestor
92821963|NCT00583219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92821964|NCT00583219|Antioxidants|antioxidants|mesh-ancestor
92821965|NCT00583219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92821966|NCT00583219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92821967|NCT04501939|Venetoclax|venetoclax|mesh-list
92821968|NCT04501939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821969|NCT05674669|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92821970|NCT05674669|Hallucinogens|hallucinogens|mesh-ancestor
92821971|NCT05674669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821972|NCT05674669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92821973|NCT05674669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92821974|NCT05674669|Serotonin Agents|serotonin agents|mesh-ancestor
92821975|NCT05674669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92821976|NCT05674669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821977|NCT05674669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92821978|NCT04116073|Antibodies|antibodies|mesh-list
92821979|NCT04116073|Immunologic Factors|immunologic factors|mesh-ancestor
92821980|NCT04116073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92821981|NCT02581501|Gemcitabine|gemcitabine|mesh-list
92821982|NCT02581501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92821983|NCT02581501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92821984|NCT02581501|Antimetabolites|antimetabolites|mesh-ancestor
92821985|NCT02581501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821986|NCT02581501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821987|NCT01072175|Trametinib|trametinib|mesh-list
92821988|NCT01072175|Dabrafenib|dabrafenib|mesh-list
92821989|NCT01072175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92821990|NCT01072175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92821991|NCT01072175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92821992|NCT01072175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821993|NCT04078711|Losartan|losartan|mesh-list
92821994|NCT04078711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92821995|NCT04078711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92821996|NCT04078711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92821997|NCT04078711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92821998|NCT04078711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92821999|NCT05290129|Oxytocin|oxytocin|mesh-list
92822000|NCT05290129|Oxytocics|oxytocics|mesh-ancestor
92822001|NCT05290129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92822002|NCT05290129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822003|NCT04304573|Calcium|calcium|mesh-list
92822004|NCT04304573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92822005|NCT04304573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822006|NCT04426669|Aldesleukin|aldesleukin|mesh-list
92822007|NCT04426669|Cyclophosphamide|cyclophosphamide|mesh-list
92822008|NCT04426669|Fludarabine|fludarabine|mesh-list
92822009|NCT04426669|Interleukin-2|interleukin-2|mesh-list
92822010|NCT04426669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822011|NCT04426669|Immunologic Factors|immunologic factors|mesh-ancestor
92822012|NCT04426669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822013|NCT04426669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822014|NCT04426669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92822015|NCT04426669|Alkylating Agents|alkylating agents|mesh-ancestor
92822016|NCT04426669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822017|NCT04426669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822018|NCT04426669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92822019|NCT04426669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92822021|NCT04426669|Sensory System Agents|sensory system agents|mesh-ancestor
92822022|NCT04426669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822023|NCT04426669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92822024|NCT04426669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92822025|NCT04426669|Antiviral Agents|antiviral agents|mesh-ancestor
92822026|NCT04426669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822027|NCT02874989|Dasatinib|dasatinib|mesh-list
92822028|NCT02874989|Quercetin|quercetin|mesh-list
92822029|NCT02874989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822030|NCT02874989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822031|NCT02874989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822032|NCT02874989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822033|NCT02874989|Antioxidants|antioxidants|mesh-ancestor
92822034|NCT02874989|Protective Agents|protective agents|mesh-ancestor
92822035|NCT02874989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822036|NCT01071317|Naproxen|naproxen|mesh-list
92822037|NCT01071317|Sumatriptan|sumatriptan|mesh-list
92822038|NCT01071317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92822039|NCT01071317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92822040|NCT01071317|Analgesics|analgesics|mesh-ancestor
92822041|NCT01071317|Sensory System Agents|sensory system agents|mesh-ancestor
92822042|NCT01071317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822043|NCT01071317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822044|NCT01071317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822045|NCT01071317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822046|NCT01071317|Gout Suppressants|gout suppressants|mesh-ancestor
92822047|NCT01071317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92822048|NCT01071317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822049|NCT01071317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822050|NCT01071317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92822051|NCT01071317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92822052|NCT01071317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92822053|NCT01071317|Serotonin Agents|serotonin agents|mesh-ancestor
92822054|NCT01071317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822055|NCT00783094|Tadalafil|tadalafil|mesh-list
92822056|NCT00783094|Vasodilator Agents|vasodilator agents|mesh-ancestor
92822057|NCT00783094|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92822058|NCT00783094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92822059|NCT00783094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822060|NCT00783094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822061|NCT00783094|Urological Agents|urological agents|mesh-ancestor
92822062|NCT00790582|Lithium Carbonate|lithium carbonate|mesh-list
92822063|NCT00790582|Antidepressive Agents|antidepressive agents|mesh-ancestor
92822064|NCT00790582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822065|NCT00790582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822066|NCT00790582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822067|NCT00790582|Antimanic Agents|antimanic agents|mesh-ancestor
92822068|NCT00790582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92822069|NCT00790582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822070|NCT00790582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822071|NCT02583217|Ketamine|ketamine|mesh-list
92822072|NCT02583217|Remifentanil|remifentanil|mesh-list
92822073|NCT02583217|Propofol|propofol|mesh-list
92822074|NCT02583217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92822075|NCT02583217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822076|NCT02583217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822077|NCT02583217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92822078|NCT02583217|Anesthetics, General|anesthetics, general|mesh-ancestor
92822079|NCT02583217|Anesthetics|anesthetics|mesh-ancestor
92822080|NCT02583217|Analgesics|analgesics|mesh-ancestor
92822081|NCT02583217|Sensory System Agents|sensory system agents|mesh-ancestor
92822082|NCT02583217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822083|NCT02583217|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92166881|NCT02196831|Tesamorelin|tesamorelin|mesh-list
92822084|NCT02583217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92822085|NCT02583217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92822086|NCT02583217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822087|NCT02583217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822088|NCT02583217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92822090|NCT00774046|Cytarabine|cytarabine|mesh-list
92822091|NCT00774046|Etoposide|etoposide|mesh-list
92822092|NCT00774046|Mitoxantrone|mitoxantrone|mesh-list
92822093|NCT00774046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92822094|NCT00774046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822095|NCT00774046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92822096|NCT00774046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92822097|NCT00774046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822098|NCT00774046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822099|NCT00774046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822100|NCT00774046|Antimetabolites|antimetabolites|mesh-ancestor
92822101|NCT00774046|Antiviral Agents|antiviral agents|mesh-ancestor
92822102|NCT00774046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822103|NCT00774046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822104|NCT00774046|Immunologic Factors|immunologic factors|mesh-ancestor
92822105|NCT00774046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822106|NCT00774046|Analgesics|analgesics|mesh-ancestor
92822107|NCT00774046|Sensory System Agents|sensory system agents|mesh-ancestor
92822108|NCT00774046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822109|NCT01046903|Dalteparin|dalteparin|mesh-list
92822110|NCT01046903|Tinzaparin|tinzaparin|mesh-list
92822111|NCT01046903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92822112|NCT01046903|Anticoagulants|anticoagulants|mesh-ancestor
92822113|NCT01046903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92822114|NCT01046903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92822115|NCT01046903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822116|NCT02581423|Capecitabine|capecitabine|mesh-list
92822117|NCT02581423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822118|NCT02581423|Antimetabolites|antimetabolites|mesh-ancestor
92822119|NCT02581423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822120|NCT02581423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822121|NCT04102072|Dobutamine|dobutamine|mesh-list
92822122|NCT04102072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92822123|NCT04102072|Sympathomimetics|sympathomimetics|mesh-ancestor
92822124|NCT04102072|Autonomic Agents|autonomic agents|mesh-ancestor
92822125|NCT04102072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822126|NCT04102072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822127|NCT04102072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92822128|NCT04102072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92822129|NCT04102072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92822130|NCT04102072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92822131|NCT04102072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822132|NCT04102072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822133|NCT04102072|Protective Agents|protective agents|mesh-ancestor
92822134|NCT02875457|Cisplatin|cisplatin|mesh-list
92822135|NCT02875457|Etoposide|etoposide|mesh-list
92822136|NCT02875457|Etoposide phosphate|etoposide phosphate|mesh-list
92822137|NCT02875457|Apatinib|apatinib|mesh-list
92822138|NCT02875457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822139|NCT02875457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92822140|NCT02875457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92822141|NCT02875457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92822142|NCT02875457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822143|NCT02875457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822144|NCT02875457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822145|NCT00773968|Epoetin Alfa|epoetin alfa|mesh-list
92822146|NCT00773968|Hematinics|hematinics|mesh-ancestor
92822147|NCT04060381|Ibuprofen|ibuprofen|mesh-list
92822148|NCT04060381|Dopamine|dopamine|mesh-list
92822149|NCT04060381|Epinephrine|epinephrine|mesh-list
92822150|NCT04060381|Norepinephrine|norepinephrine|mesh-list
92822151|NCT04060381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92822152|NCT04060381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92822153|NCT04060381|Analgesics|analgesics|mesh-ancestor
92822154|NCT04060381|Sensory System Agents|sensory system agents|mesh-ancestor
92822155|NCT04060381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822156|NCT04060381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822157|NCT04060381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822158|NCT04060381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822159|NCT04060381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92822160|NCT04060381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822161|NCT04060381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822162|NCT04060381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92822163|NCT04060381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92822164|NCT04060381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92822165|NCT04060381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822166|NCT04060381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92822167|NCT04060381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92822168|NCT04060381|Autonomic Agents|autonomic agents|mesh-ancestor
92822169|NCT04060381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92822170|NCT04060381|Respiratory System Agents|respiratory system agents|mesh-ancestor
92822171|NCT04060381|Mydriatics|mydriatics|mesh-ancestor
92822172|NCT04060381|Sympathomimetics|sympathomimetics|mesh-ancestor
92822173|NCT04060381|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92822174|NCT04060381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92822175|NCT04060381|Dopamine Agents|dopamine agents|mesh-ancestor
92822176|NCT04060381|Protective Agents|protective agents|mesh-ancestor
92822178|NCT00782626|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92822179|NCT00782626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822180|NCT00782626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822181|NCT00782626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822182|NCT00782626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822183|NCT00782626|Immunologic Factors|immunologic factors|mesh-ancestor
92822184|NCT00782626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822185|NCT00782626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822186|NCT04076371|Olanzapine|olanzapine|mesh-list
92822187|NCT04076371|Risperidone|risperidone|mesh-list
92822188|NCT04076371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92822189|NCT04076371|Ziprasidone|ziprasidone|mesh-list
92822190|NCT04076371|Sertraline|sertraline|mesh-list
92822191|NCT04076371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92822192|NCT04076371|Serotonin Agents|serotonin agents|mesh-ancestor
92822193|NCT04076371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822194|NCT04076371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822195|NCT04076371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822196|NCT04076371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92822197|NCT04076371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92822198|NCT04076371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822199|NCT04076371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822200|NCT04076371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92822201|NCT04076371|Dopamine Agents|dopamine agents|mesh-ancestor
92822202|NCT04076371|Antiemetics|antiemetics|mesh-ancestor
92822203|NCT04076371|Autonomic Agents|autonomic agents|mesh-ancestor
92822204|NCT04076371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822205|NCT04076371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822206|NCT04076371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92822207|NCT04076371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92822208|NCT04076371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92822209|NCT04076371|Antidepressive Agents|antidepressive agents|mesh-ancestor
92822210|NCT04076371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92822211|NCT04076371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92822212|NCT03977467|Atezolizumab|atezolizumab|mesh-list
92822213|NCT03977467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92822214|NCT03977467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822215|NCT03977467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822216|NCT03977467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822217|NCT01071083|Interferons|interferons|mesh-list
92822218|NCT01071083|Interferon-beta|interferon-beta|mesh-list
92822219|NCT01071083|Interferon beta-1a|interferon beta-1a|mesh-list
92822220|NCT01071083|Methylprednisolone|methylprednisolone|mesh-list
92822221|NCT01071083|Glatiramer Acetate|glatiramer acetate|mesh-list
92822222|NCT01071083|Natalizumab|natalizumab|mesh-list
92822223|NCT01071083|(T,G)-A-L|(t,g)-a-l|mesh-list
92822224|NCT01071083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822225|NCT01071083|Antiviral Agents|antiviral agents|mesh-ancestor
92822226|NCT01071083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822227|NCT01071083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822228|NCT01071083|Antiemetics|antiemetics|mesh-ancestor
92822229|NCT01071083|Autonomic Agents|autonomic agents|mesh-ancestor
92822230|NCT01071083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822231|NCT01071083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822232|NCT01071083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822233|NCT01071083|Glucocorticoids|glucocorticoids|mesh-ancestor
92822235|NCT01071083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92822236|NCT01071083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92822237|NCT01071083|Protective Agents|protective agents|mesh-ancestor
92822238|NCT01071083|Immunologic Factors|immunologic factors|mesh-ancestor
92822239|NCT01071083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92822240|NCT01071083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822241|NCT01071083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822242|NCT03973333|Atezolizumab|atezolizumab|mesh-list
92822243|NCT03973333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92822244|NCT03973333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822245|NCT03973333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822246|NCT03973333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822247|NCT03968341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92822248|NCT03968341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822249|NCT04078399|Interferons|interferons|mesh-list
92822250|NCT04078399|Azacitidine|azacitidine|mesh-list
92822251|NCT04078399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822252|NCT04078399|Antiviral Agents|antiviral agents|mesh-ancestor
92822253|NCT04078399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822254|NCT04078399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822255|NCT04078399|Antimetabolites|antimetabolites|mesh-ancestor
92822256|NCT04078399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822257|NCT04078399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822258|NCT05189509|Plasminogen|plasminogen|mesh-list
92822259|NCT05189509|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92822260|NCT05189509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92822261|NCT05189509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92822262|NCT05189509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822263|NCT03897751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92822264|NCT01010126|Sirolimus|sirolimus|mesh-list
92822265|NCT01010126|Bevacizumab|bevacizumab|mesh-list
92822266|NCT01010126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92822267|NCT01010126|Temsirolimus|temsirolimus|mesh-list
92822268|NCT01010126|MTOR Inhibitors|mtor inhibitors|mesh-list
92822269|NCT01010126|Endothelial Growth Factors|endothelial growth factors|mesh-list
92822270|NCT01010126|Antibodies|antibodies|mesh-list
92822271|NCT01010126|Immunoglobulins|immunoglobulins|mesh-list
92822272|NCT01010126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92822273|NCT01010126|Immunoglobulin G|immunoglobulin g|mesh-list
92822274|NCT01010126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822275|NCT01010126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92822276|NCT01010126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92822277|NCT01010126|Growth Substances|growth substances|mesh-ancestor
92822278|NCT01010126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822279|NCT01010126|Growth Inhibitors|growth inhibitors|mesh-ancestor
92822280|NCT01010126|Immunologic Factors|immunologic factors|mesh-ancestor
92822281|NCT01010126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822282|NCT01010126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822283|NCT01010126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92822284|NCT01010126|Antifungal Agents|antifungal agents|mesh-ancestor
92822285|NCT01010126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822286|NCT01010126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822287|NCT01010126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822288|NCT01010126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822289|NCT04076137|Decitabine|decitabine|mesh-list
92822290|NCT04076137|Antibodies|antibodies|mesh-list
92822291|NCT04076137|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92822292|NCT04076137|Immunologic Factors|immunologic factors|mesh-ancestor
92822293|NCT04076137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822294|NCT04076137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822295|NCT04076137|Antimetabolites|antimetabolites|mesh-ancestor
92822296|NCT04076137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822297|NCT04076137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822298|NCT04076137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822299|NCT03879577|Tamoxifen|tamoxifen|mesh-list
92822300|NCT03879577|Docetaxel|docetaxel|mesh-list
92822301|NCT03879577|Trastuzumab|trastuzumab|mesh-list
92822302|NCT03879577|Letrozole|letrozole|mesh-list
92822303|NCT03879577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822304|NCT03879577|Tubulin Modulators|tubulin modulators|mesh-ancestor
92822305|NCT03879577|Antimitotic Agents|antimitotic agents|mesh-ancestor
92822306|NCT03879577|Mitosis Modulators|mitosis modulators|mesh-ancestor
92822307|NCT03879577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822308|NCT03879577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822309|NCT03879577|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92822310|NCT03879577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92822311|NCT03879577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822312|NCT03879577|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92822313|NCT03879577|Hormone Antagonists|hormone antagonists|mesh-ancestor
92822314|NCT03879577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92822315|NCT03879577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822316|NCT03879577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92822317|NCT03879577|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92822318|NCT03879577|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92822319|NCT03879577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92822321|NCT03862495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822322|NCT03862495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822323|NCT00617799|Aldesleukin|aldesleukin|mesh-list
92822324|NCT00617799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822325|NCT00617799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92822326|NCT00617799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92822327|NCT00617799|Antiviral Agents|antiviral agents|mesh-ancestor
92822328|NCT00617799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822329|NCT00617877|Losartan|losartan|mesh-list
92822330|NCT00617877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92822331|NCT00617877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92822332|NCT00617877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92822333|NCT00617877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92822334|NCT00617877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92822335|NCT00617877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822336|NCT00617877|Diuretics|diuretics|mesh-ancestor
92822337|NCT00617877|Natriuretic Agents|natriuretic agents|mesh-ancestor
92822338|NCT00617877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822339|NCT00617877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92822340|NCT00617877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92822341|NCT00617955|Aprotinin|aprotinin|mesh-list
92822342|NCT00617955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822343|NCT00617955|Hemostatics|hemostatics|mesh-ancestor
92822344|NCT00617955|Coagulants|coagulants|mesh-ancestor
92822345|NCT00617955|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92822346|NCT00617955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92822347|NCT00617955|Protease Inhibitors|protease inhibitors|mesh-ancestor
92822348|NCT00617955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467370|NCT01789437|Antiemetics|antiemetics|mesh-ancestor
92822349|NCT02582437|Analgesics, Opioid|analgesics, opioid|mesh-list
92822350|NCT02582437|Narcotics|narcotics|mesh-ancestor
92822351|NCT02582437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822352|NCT02582437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822353|NCT02582437|Analgesics|analgesics|mesh-ancestor
92822354|NCT02582437|Sensory System Agents|sensory system agents|mesh-ancestor
92822355|NCT02582437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822356|NCT05674201|Dexmedetomidine|dexmedetomidine|mesh-list
92822357|NCT05674201|Remifentanil|remifentanil|mesh-list
92822359|NCT05674201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92822360|NCT05674201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822361|NCT05674201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822362|NCT05674201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92822363|NCT05674201|Analgesics|analgesics|mesh-ancestor
92822364|NCT05674201|Sensory System Agents|sensory system agents|mesh-ancestor
92822365|NCT05674201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822366|NCT05674201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92822367|NCT05674201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92822368|NCT05674201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92822369|NCT05674201|Adrenergic Agents|adrenergic agents|mesh-ancestor
92822370|NCT05674201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822371|NCT05674201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822372|NCT05674201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92822373|NCT05674201|Anesthetics, General|anesthetics, general|mesh-ancestor
92822374|NCT05674201|Anesthetics|anesthetics|mesh-ancestor
92822375|NCT05674201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92822376|NCT05674201|Narcotics|narcotics|mesh-ancestor
92822377|NCT01070303|Adalimumab|adalimumab|mesh-list
92822378|NCT01070303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92822379|NCT01070303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822380|NCT01070303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822381|NCT00618111|Granisetron|granisetron|mesh-list
92822382|NCT00618111|Antiemetics|antiemetics|mesh-ancestor
92822383|NCT00618111|Autonomic Agents|autonomic agents|mesh-ancestor
92822384|NCT00618111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822386|NCT00618111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822387|NCT00618111|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92822388|NCT00618111|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92822389|NCT00618111|Serotonin Agents|serotonin agents|mesh-ancestor
92822390|NCT00618111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822391|NCT00618111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822392|NCT01009814|Ritonavir|ritonavir|mesh-list
92822393|NCT01009814|Fostemsavir|fostemsavir|mesh-list
92822394|NCT01009814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92822395|NCT01009814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92822396|NCT01009814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92822397|NCT01009814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822398|NCT01009814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822399|NCT01009814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92822400|NCT01009814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92822401|NCT01009814|Antiviral Agents|antiviral agents|mesh-ancestor
92822402|NCT01009814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822403|NCT01009814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92822404|NCT01009814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92822405|NCT01009814|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92822406|NCT01009814|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92822407|NCT03824587|Calcium, Dietary|calcium, dietary|mesh-list
92822408|NCT03824587|Calcium Carbonate|calcium carbonate|mesh-list
92822409|NCT03824587|Calcium|calcium|mesh-list
92822410|NCT03824587|Sevelamer|sevelamer|mesh-list
92822411|NCT03824587|Calcium acetate|calcium acetate|mesh-list
92822412|NCT03824587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92822413|NCT03824587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822414|NCT03824587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92822415|NCT03824587|Chelating Agents|chelating agents|mesh-ancestor
92822416|NCT03824587|Sequestering Agents|sequestering agents|mesh-ancestor
92822417|NCT03824587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822418|NCT03824587|Antacids|antacids|mesh-ancestor
92822419|NCT03824587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822420|NCT00773734|Thalidomide|thalidomide|mesh-list
92822421|NCT00773734|Apremilast|apremilast|mesh-list
92822422|NCT00773734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92822423|NCT00773734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92822424|NCT00773734|Analgesics|analgesics|mesh-ancestor
92822425|NCT00773734|Sensory System Agents|sensory system agents|mesh-ancestor
92822426|NCT00773734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822427|NCT00773734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822428|NCT00773734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822429|NCT00773734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822430|NCT00773734|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92822431|NCT00773734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92822432|NCT00773734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822433|NCT00773734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822434|NCT00773734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822435|NCT00773734|Immunologic Factors|immunologic factors|mesh-ancestor
92822436|NCT00773734|Leprostatic Agents|leprostatic agents|mesh-ancestor
92822437|NCT00773734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822438|NCT00773734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822439|NCT00773734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92822440|NCT00773734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92822441|NCT00773734|Growth Substances|growth substances|mesh-ancestor
92822442|NCT00773734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92822443|NCT00773734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822444|NCT04297202|Apatinib|apatinib|mesh-list
92822445|NCT04297202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822446|NCT04297202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822447|NCT04297202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822448|NCT04297202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822449|NCT02691897|Melatonin|melatonin|mesh-list
92822450|NCT02691897|Antioxidants|antioxidants|mesh-ancestor
92822451|NCT02691897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822452|NCT02691897|Protective Agents|protective agents|mesh-ancestor
92822453|NCT02691897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822454|NCT02691897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822455|NCT03067155|Antiviral Agents|antiviral agents|mesh-list
92822456|NCT03067155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822457|NCT01009580|Insulin|insulin|mesh-list
92822458|NCT01009580|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92822460|NCT01009580|Insulin, Long-Acting|insulin, long-acting|mesh-list
92822461|NCT01009580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92822462|NCT01009580|Biphasic Insulins|biphasic insulins|mesh-list
92822463|NCT01009580|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92822464|NCT01009580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92822465|NCT01009580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822466|NCT01009346|Cisplatin|cisplatin|mesh-list
92822467|NCT01009346|Carboplatin|carboplatin|mesh-list
92822468|NCT01009346|Cetuximab|cetuximab|mesh-list
92822469|NCT01009346|Everolimus|everolimus|mesh-list
92822470|NCT01009346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822471|NCT01009346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822472|NCT01009346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92822473|NCT01009346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822474|NCT01009346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822475|NCT01009346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822476|NCT01009346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822477|NCT01009346|Immunologic Factors|immunologic factors|mesh-ancestor
92822478|NCT01009346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822479|NCT04101682|Bupivacaine|bupivacaine|mesh-list
92822480|NCT04101682|Anesthetics, Local|anesthetics, local|mesh-ancestor
92822481|NCT04101682|Anesthetics|anesthetics|mesh-ancestor
92822482|NCT04101682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822483|NCT04101682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822484|NCT04101682|Sensory System Agents|sensory system agents|mesh-ancestor
92822485|NCT04101682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822486|NCT01001702|Aripiprazole|aripiprazole|mesh-list
92822487|NCT01001702|Antidepressive Agents|antidepressive agents|mesh-ancestor
92822488|NCT01001702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822489|NCT01001702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92822490|NCT01001702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92822491|NCT01001702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822492|NCT01001702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822493|NCT01001702|Dopamine Agonists|dopamine agonists|mesh-ancestor
92822494|NCT01001702|Dopamine Agents|dopamine agents|mesh-ancestor
92822495|NCT01001702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822496|NCT01001702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822497|NCT01001702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92822498|NCT01001702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92467519|NCT01792804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92822499|NCT01001702|Serotonin Agents|serotonin agents|mesh-ancestor
92822500|NCT01001702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92822501|NCT01001702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92822502|NCT01001702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92822503|NCT01001702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92822504|NCT02602210|Hydrocortisone|hydrocortisone|mesh-list
92822505|NCT02602210|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92822506|NCT02602210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822507|NCT00618345|Everolimus|everolimus|mesh-list
92822508|NCT00618345|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92822509|NCT00618345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822510|NCT00618345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822511|NCT00618345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822512|NCT00618345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822513|NCT00618345|Immunologic Factors|immunologic factors|mesh-ancestor
92822514|NCT00618345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822515|NCT00618345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822516|NCT02601898|Thioctic Acid|thioctic acid|mesh-list
92822517|NCT02601898|Progesterone|progesterone|mesh-list
92822518|NCT02601898|Progestins|progestins|mesh-ancestor
92822519|NCT02601898|Hormones|hormones|mesh-ancestor
92822520|NCT02601898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92822521|NCT02601898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822522|NCT02601898|Antioxidants|antioxidants|mesh-ancestor
92822523|NCT02601898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822524|NCT02601898|Protective Agents|protective agents|mesh-ancestor
92822525|NCT02601898|Vitamin B Complex|vitamin b complex|mesh-ancestor
92822526|NCT02601898|Vitamins|vitamins|mesh-ancestor
92822527|NCT02601898|Micronutrients|micronutrients|mesh-ancestor
92822528|NCT00618423|Ketamine|ketamine|mesh-list
92822529|NCT00618423|Analgesics|analgesics|mesh-ancestor
92822530|NCT00618423|Sensory System Agents|sensory system agents|mesh-ancestor
92822531|NCT00618423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167348|NCT05586763|Promethazine|promethazine|mesh-list
92822532|NCT00618423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822533|NCT00618423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92822534|NCT00618423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92822535|NCT00618423|Anesthetics, General|anesthetics, general|mesh-ancestor
92822536|NCT00618423|Anesthetics|anesthetics|mesh-ancestor
92822537|NCT00618423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822538|NCT00618423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92822539|NCT00618423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92822540|NCT00618423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822541|NCT00618423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822542|NCT04101760|Lenograstim|lenograstim|mesh-list
92822543|NCT04101760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92822544|NCT04101760|Immunologic Factors|immunologic factors|mesh-ancestor
92822545|NCT04101760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822546|NCT00616551|Octreotide|octreotide|mesh-list
92822547|NCT00616551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822548|NCT00616551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92822549|NCT00616551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822550|NCT04478942|Misoprostol|misoprostol|mesh-list
92822551|NCT04478942|Oxytocin|oxytocin|mesh-list
92822552|NCT04478942|Oxytocics|oxytocics|mesh-ancestor
92822553|NCT04478942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92822554|NCT04478942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822555|NCT04478942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92822556|NCT04478942|Abortifacient Agents|abortifacient agents|mesh-ancestor
92822557|NCT04478942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92822558|NCT04478942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822559|NCT04214145|Phenylephrine|phenylephrine|mesh-list
92822560|NCT04214145|Vasopressins|vasopressins|mesh-list
92822561|NCT04214145|Arginine Vasopressin|arginine vasopressin|mesh-list
92822562|NCT04214145|Oxymetazoline|oxymetazoline|mesh-list
92822563|NCT04214145|Norepinephrine|norepinephrine|mesh-list
92822564|NCT04214145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92822565|NCT04214145|Mydriatics|mydriatics|mesh-ancestor
92822566|NCT04214145|Autonomic Agents|autonomic agents|mesh-ancestor
92822567|NCT04214145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822568|NCT04214145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822569|NCT04214145|Sympathomimetics|sympathomimetics|mesh-ancestor
92822570|NCT04214145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92822571|NCT04214145|Nasal Decongestants|nasal decongestants|mesh-ancestor
92822572|NCT04214145|Respiratory System Agents|respiratory system agents|mesh-ancestor
92822573|NCT04214145|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92822574|NCT04214145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92822575|NCT04214145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92822576|NCT04214145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92822577|NCT04214145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822578|NCT04214145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822579|NCT04214145|Protective Agents|protective agents|mesh-ancestor
92822580|NCT04214145|Hemostatics|hemostatics|mesh-ancestor
92822581|NCT04214145|Coagulants|coagulants|mesh-ancestor
92822582|NCT04214145|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92822583|NCT04214145|Natriuretic Agents|natriuretic agents|mesh-ancestor
92822584|NCT04212429|Moxifloxacin|moxifloxacin|mesh-list
92822585|NCT04212429|Levofloxacin|levofloxacin|mesh-list
92822586|NCT04212429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92822587|NCT04212429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92724405|NCT00199797|Leucovorin|leucovorin|mesh-list
92822588|NCT04212429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822589|NCT04212429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822590|NCT04212429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92822591|NCT04212429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92822592|NCT04212429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822593|NCT04212429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822594|NCT04212429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822595|NCT04212429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92822596|NCT04212429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92822597|NCT04212429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92822598|NCT01068665|Insulin|insulin|mesh-list
92822599|NCT01068665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92822600|NCT01068665|Insulin Glargine|insulin glargine|mesh-list
92822601|NCT01068665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92822602|NCT01068665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822603|NCT00618501|Leucovorin|leucovorin|mesh-list
92822604|NCT00618501|Cytarabine|cytarabine|mesh-list
92822605|NCT00618501|Prednisolone|prednisolone|mesh-list
92822606|NCT00618501|Hydrocortisone|hydrocortisone|mesh-list
92822607|NCT00618501|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92822608|NCT00618501|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92822609|NCT00618501|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92822611|NCT00618501|Etoposide|etoposide|mesh-list
92822612|NCT00618501|Vincristine|vincristine|mesh-list
92822613|NCT00618501|Imatinib Mesylate|imatinib mesylate|mesh-list
92822614|NCT00618501|Daunorubicin|daunorubicin|mesh-list
92822615|NCT00618501|Levoleucovorin|levoleucovorin|mesh-list
92822616|NCT00618501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822617|NCT00618501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92822618|NCT00618501|Abortifacient Agents|abortifacient agents|mesh-ancestor
92822619|NCT00618501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92822620|NCT00618501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822621|NCT00618501|Antimetabolites|antimetabolites|mesh-ancestor
92822622|NCT00618501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822623|NCT00618501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822624|NCT00618501|Dermatologic Agents|dermatologic agents|mesh-ancestor
92822625|NCT00618501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822626|NCT00618501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92822627|NCT00618501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822628|NCT00618501|Immunologic Factors|immunologic factors|mesh-ancestor
92822629|NCT00618501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822630|NCT00618501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92822631|NCT00618501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92822632|NCT00618501|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92822633|NCT00618501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92822634|NCT00618501|Antiviral Agents|antiviral agents|mesh-ancestor
92822635|NCT00618501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822636|NCT00618501|Antidotes|antidotes|mesh-ancestor
92822637|NCT00618501|Protective Agents|protective agents|mesh-ancestor
92822638|NCT00618501|Vitamin B Complex|vitamin b complex|mesh-ancestor
92822639|NCT00618501|Vitamins|vitamins|mesh-ancestor
92822640|NCT00618501|Micronutrients|micronutrients|mesh-ancestor
92822641|NCT00618501|Tubulin Modulators|tubulin modulators|mesh-ancestor
92822642|NCT00618501|Antimitotic Agents|antimitotic agents|mesh-ancestor
92822643|NCT00618501|Mitosis Modulators|mitosis modulators|mesh-ancestor
92822644|NCT00618501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822645|NCT00618501|Glucocorticoids|glucocorticoids|mesh-ancestor
92822646|NCT00618501|Hormones|hormones|mesh-ancestor
92822647|NCT00618501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92822648|NCT00618501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92822649|NCT00618501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92467668|NCT01797718|Letrozole|letrozole|mesh-list
92822650|NCT00618501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92822651|NCT00772954|Vaccines|vaccines|mesh-list
92822652|NCT00772954|Immunologic Factors|immunologic factors|mesh-ancestor
92822654|NCT05322681|Pregabalin|pregabalin|mesh-list
92822655|NCT05322681|Analgesics|analgesics|mesh-ancestor
92822656|NCT05322681|Sensory System Agents|sensory system agents|mesh-ancestor
92822657|NCT05322681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822658|NCT05322681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822659|NCT05322681|Anticonvulsants|anticonvulsants|mesh-ancestor
92822660|NCT05322681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92822661|NCT05322681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92822662|NCT05322681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822663|NCT05322681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92822664|NCT05322681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92822665|NCT05322681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92822666|NCT05322681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822667|NCT05322681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822668|NCT05322603|Diclofenac|diclofenac|mesh-list
92822669|NCT05322603|Morphine|morphine|mesh-list
92822670|NCT05322603|Analgesics|analgesics|mesh-list
92822671|NCT05322603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92822672|NCT05322603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92822673|NCT05322603|Narcotics|narcotics|mesh-ancestor
92822674|NCT05322603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822675|NCT05322603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822676|NCT05322603|Sensory System Agents|sensory system agents|mesh-ancestor
92822677|NCT05322603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822678|NCT05322603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92822679|NCT05322603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822680|NCT05322603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822681|NCT05322603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92822682|NCT05322603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822683|NCT05322603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822685|NCT00618579|Anticoagulants|anticoagulants|mesh-ancestor
92822686|NCT00781768|Ondansetron|ondansetron|mesh-list
92822687|NCT00781768|Aprepitant|aprepitant|mesh-list
92822688|NCT00781768|Antiemetics|antiemetics|mesh-ancestor
92822689|NCT00781768|Autonomic Agents|autonomic agents|mesh-ancestor
92822690|NCT00781768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822691|NCT00781768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822692|NCT00781768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822693|NCT00781768|Antipruritics|antipruritics|mesh-ancestor
92822694|NCT00781768|Dermatologic Agents|dermatologic agents|mesh-ancestor
92822695|NCT00781768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92822696|NCT00781768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92822697|NCT00781768|Serotonin Agents|serotonin agents|mesh-ancestor
92822698|NCT00781768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822699|NCT00781768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822700|NCT00781768|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92822701|NCT01005680|Gemcitabine|gemcitabine|mesh-list
92822702|NCT01005680|Pemetrexed|pemetrexed|mesh-list
92822703|NCT01005680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822704|NCT01005680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822705|NCT01005680|Antimetabolites|antimetabolites|mesh-ancestor
92822706|NCT01005680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822707|NCT01005680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822708|NCT01005680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92822709|NCT01005680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92822710|NCT04101370|Bosentan|bosentan|mesh-list
92822711|NCT04101370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92822712|NCT04101370|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92822713|NCT04101370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822714|NCT00618657|Paclitaxel|paclitaxel|mesh-list
92822715|NCT00618657|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92822716|NCT00618657|Bevacizumab|bevacizumab|mesh-list
92822717|NCT00618657|Carboplatin|carboplatin|mesh-list
92822718|NCT00618657|Trastuzumab|trastuzumab|mesh-list
92822719|NCT00618657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92822720|NCT00618657|Antibodies|antibodies|mesh-list
92822721|NCT00618657|Immunoglobulins|immunoglobulins|mesh-list
92822722|NCT00618657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92822723|NCT00618657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92822724|NCT00618657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822725|NCT00618657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92822726|NCT00618657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92822727|NCT00618657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92822728|NCT00618657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822729|NCT00618657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92822730|NCT00618657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92822731|NCT00618657|Growth Substances|growth substances|mesh-ancestor
92822732|NCT00618657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822733|NCT00618657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92822734|NCT00618657|Immunologic Factors|immunologic factors|mesh-ancestor
92822735|NCT04188249|Golimumab|golimumab|mesh-list
92822736|NCT04188249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92822737|NCT04188249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822738|NCT04188249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822739|NCT04188249|Immunologic Factors|immunologic factors|mesh-ancestor
92822740|NCT04188249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822741|NCT01005602|Digoxin|digoxin|mesh-list
92822742|NCT01005602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92822743|NCT01005602|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92822744|NCT01005602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822745|NCT01005602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822746|NCT01005602|Protective Agents|protective agents|mesh-ancestor
92822747|NCT01005602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822748|NCT05490940|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92822749|NCT05490940|Hemostatics|hemostatics|mesh-ancestor
92822750|NCT05490940|Coagulants|coagulants|mesh-ancestor
92822751|NCT04304261|Metformin|metformin|mesh-list
92822752|NCT04304261|Dapagliflozin|dapagliflozin|mesh-list
92822753|NCT04304261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92822754|NCT04304261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822755|NCT04304261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92822756|NCT04304261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822757|NCT04103398|Sorafenib|sorafenib|mesh-list
92822758|NCT04103398|Chlorotrianisene|chlorotrianisene|mesh-list
92822759|NCT04103398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822760|NCT04103398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822761|NCT04103398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822762|NCT04103398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822763|NCT04103398|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92822764|NCT04103398|Estrogens|estrogens|mesh-ancestor
92822765|NCT04103398|Hormones|hormones|mesh-ancestor
92822766|NCT04103398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92822767|NCT04103398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822768|NCT04103398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92822769|NCT00768430|Midazolam|midazolam|mesh-list
92822770|NCT00768430|Ketamine|ketamine|mesh-list
92822771|NCT00768430|Analgesics|analgesics|mesh-ancestor
92822772|NCT00768430|Sensory System Agents|sensory system agents|mesh-ancestor
92822773|NCT00768430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822774|NCT00768430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822775|NCT00768430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92822776|NCT00768430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92822777|NCT00768430|Anesthetics, General|anesthetics, general|mesh-ancestor
92822778|NCT00768430|Anesthetics|anesthetics|mesh-ancestor
92822779|NCT00768430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822780|NCT00768430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92822781|NCT00768430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92822782|NCT00768430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822783|NCT00768430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822784|NCT00768430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92822785|NCT00768430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92822786|NCT00768430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92822787|NCT00768430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92822788|NCT00768430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822789|NCT00768430|GABA Modulators|gaba modulators|mesh-ancestor
92822790|NCT00768430|GABA Agents|gaba agents|mesh-ancestor
92822791|NCT04101136|Atorvastatin|atorvastatin|mesh-list
92822792|NCT04101136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92822793|NCT04101136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92822794|NCT04101136|Antimetabolites|antimetabolites|mesh-ancestor
92822795|NCT04101136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822796|NCT04101136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92822797|NCT04101136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92822798|NCT04101136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822799|NCT00618969|Busulfan|busulfan|mesh-list
92822800|NCT00618969|Melphalan|melphalan|mesh-list
92822801|NCT00618969|Alkylating Agents|alkylating agents|mesh-ancestor
92822802|NCT00618969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822803|NCT00618969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92822804|NCT00618969|Immunologic Factors|immunologic factors|mesh-ancestor
92822805|NCT00618969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822806|NCT00618969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92822807|NCT00618969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822808|NCT00618969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92822809|NCT01064297|Lamotrigine|lamotrigine|mesh-list
92822810|NCT01064297|Anticonvulsants|anticonvulsants|mesh-list
92822811|NCT01064297|Valproic Acid|valproic acid|mesh-list
92822812|NCT01064297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92822813|NCT01064297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92822814|NCT01064297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822815|NCT01064297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92822816|NCT01064297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822817|NCT01064297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92822818|NCT01064297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92822819|NCT01064297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822820|NCT01064297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822821|NCT01064297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92822822|NCT01064297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822823|NCT01064297|GABA Agents|gaba agents|mesh-ancestor
92822824|NCT01064297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822825|NCT01064297|Antimanic Agents|antimanic agents|mesh-ancestor
92822826|NCT00781456|Levonorgestrel|levonorgestrel|mesh-list
92822827|NCT00781456|Contraceptive Agents|contraceptive agents|mesh-list
92822828|NCT00781456|Contraceptives, Oral|contraceptives, oral|mesh-list
92822829|NCT00781456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92822830|NCT00781456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92822831|NCT00781456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822832|NCT00781456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92822833|NCT00781456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92822834|NCT00582907|Rilonacept|rilonacept|mesh-list
92822835|NCT00582907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822836|NCT01062113|Celecoxib|celecoxib|mesh-list
92822837|NCT01062113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92822838|NCT01062113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92822839|NCT01062113|Analgesics|analgesics|mesh-ancestor
92822840|NCT01062113|Sensory System Agents|sensory system agents|mesh-ancestor
92822841|NCT01062113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822842|NCT01062113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822843|NCT01062113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822844|NCT01062113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92822845|NCT01062113|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92822846|NCT01062113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92822847|NCT01062113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822848|NCT01062113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822849|NCT00916396|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92822850|NCT00916396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92822851|NCT00916396|Immunologic Factors|immunologic factors|mesh-ancestor
92822852|NCT00916396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822853|NCT04075201|Vaccines|vaccines|mesh-list
92822854|NCT04075201|Immunologic Factors|immunologic factors|mesh-ancestor
92822855|NCT04075201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822856|NCT01038869|Azelaic acid|azelaic acid|mesh-list
92822857|NCT01038869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822858|NCT01038869|Dermatologic Agents|dermatologic agents|mesh-ancestor
92822859|NCT02580331|Metformin|metformin|mesh-list
92822860|NCT02580331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92822861|NCT02580331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822862|NCT00767806|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92822863|NCT00767806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92822864|NCT00767806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92822865|NCT00767806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92822866|NCT00767806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822867|NCT00767806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92822868|NCT00767806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822869|NCT00767806|Analgesics|analgesics|mesh-ancestor
92822870|NCT00767806|Sensory System Agents|sensory system agents|mesh-ancestor
92822871|NCT00767806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822872|NCT00767806|Antidepressive Agents|antidepressive agents|mesh-ancestor
92822873|NCT00767806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822874|NCT00767806|Dopamine Agents|dopamine agents|mesh-ancestor
92822875|NCT00780910|Ribavirin|ribavirin|mesh-list
92822876|NCT00780910|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92822877|NCT00780910|Antimetabolites|antimetabolites|mesh-ancestor
92822878|NCT00780910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822879|NCT00780910|Antiviral Agents|antiviral agents|mesh-ancestor
92822880|NCT00780910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822881|NCT02582203|Vancomycin|vancomycin|mesh-list
92822882|NCT02582203|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92822883|NCT02582203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822884|NCT02582203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822885|NCT05035927|Psilocybin|psilocybin|mesh-list
92822886|NCT05035927|Hallucinogens|hallucinogens|mesh-ancestor
92822887|NCT05035927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822888|NCT05035927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92822889|NCT00771472|Vorinostat|vorinostat|mesh-list
92822890|NCT00771472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822891|NCT00771472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92822892|NCT00771472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822893|NCT00771472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822894|NCT00771316|Meropenem|meropenem|mesh-list
92822895|NCT00771316|Ertapenem|ertapenem|mesh-list
92822896|NCT00771316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822897|NCT00771316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822898|NCT00770770|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92822899|NCT00770770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92822900|NCT00770770|Glucocorticoids|glucocorticoids|mesh-ancestor
92822901|NCT00770770|Hormones|hormones|mesh-ancestor
92822902|NCT00770770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92822903|NCT00770770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822904|NCT00766636|Gemcitabine|gemcitabine|mesh-list
92822905|NCT00766636|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92822906|NCT00766636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92822907|NCT00766636|Antimetabolites|antimetabolites|mesh-ancestor
92822908|NCT00766636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822909|NCT00766636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822910|NCT00766636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92822911|NCT00766636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822912|NCT04348045|Durvalumab|durvalumab|mesh-list
92822913|NCT04348045|Olaparib|olaparib|mesh-list
92822914|NCT04348045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822915|NCT04348045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822916|NCT04348045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92822917|NCT04348045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822918|NCT04348045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822919|NCT03337009|Naloxone|naloxone|mesh-list
92822920|NCT03337009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92822921|NCT03337009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822922|NCT03337009|Sensory System Agents|sensory system agents|mesh-ancestor
92822923|NCT03337009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822924|NCT02581969|Factor VIII|factor viii|mesh-list
92822925|NCT02581969|Coagulants|coagulants|mesh-ancestor
92822926|NCT00770692|Eszopiclone|eszopiclone|mesh-list
92822927|NCT00770692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92822928|NCT00770692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822929|NCT00770692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822930|NCT02816203|Hemostatics|hemostatics|mesh-list
92822931|NCT02816203|Coagulants|coagulants|mesh-ancestor
92822932|NCT04099732|Dabigatran|dabigatran|mesh-list
92822933|NCT04099732|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92822934|NCT04099732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92822935|NCT04099732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92822936|NCT04099732|Antimetabolites|antimetabolites|mesh-ancestor
92822937|NCT04099732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822938|NCT04099732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92822939|NCT04099732|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92822940|NCT04099732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822941|NCT04099732|Antithrombins|antithrombins|mesh-ancestor
92822942|NCT04099732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92822943|NCT04099732|Protease Inhibitors|protease inhibitors|mesh-ancestor
92822944|NCT04099732|Anticoagulants|anticoagulants|mesh-ancestor
92822945|NCT03183115|Lugol's solution|lugol's solution|mesh-list
92822946|NCT03183115|Hemostatics|hemostatics|mesh-ancestor
92822947|NCT03183115|Coagulants|coagulants|mesh-ancestor
92822948|NCT02743897|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92822949|NCT02743897|Antiviral Agents|antiviral agents|mesh-ancestor
92822950|NCT02743897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822951|NCT02743819|Pembrolizumab|pembrolizumab|mesh-list
92822952|NCT02743819|Ipilimumab|ipilimumab|mesh-list
92822953|NCT02743819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822954|NCT02743819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822955|NCT02743819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92822956|NCT02743819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822957|NCT04074421|Rifaximin|rifaximin|mesh-list
92822958|NCT04074421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92822959|NCT04074421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92822960|NCT04074421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92822961|NCT02579707|Ivosidenib|ivosidenib|mesh-list
92822962|NCT02579707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822963|NCT02579707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92822964|NCT02579707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822965|NCT02713009|Vitamin D|vitamin d|mesh-list
92822966|NCT02713009|Ergocalciferols|ergocalciferols|mesh-list
92822967|NCT02713009|Cholecalciferol|cholecalciferol|mesh-list
92822968|NCT02713009|Vitamins|vitamins|mesh-list
92822969|NCT02713009|Micronutrients|micronutrients|mesh-ancestor
92822970|NCT02713009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822971|NCT02713009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92822972|NCT02713009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92822973|NCT03085225|Durvalumab|durvalumab|mesh-list
92822974|NCT03085225|Trabectedin|trabectedin|mesh-list
92822975|NCT03085225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92822976|NCT03085225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92822977|NCT03085225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92822978|NCT03085225|Alkylating Agents|alkylating agents|mesh-ancestor
92822979|NCT03085225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92822980|NCT02705287|Vitamin D|vitamin d|mesh-list
92822981|NCT02705287|Ergocalciferols|ergocalciferols|mesh-list
92822982|NCT02705287|Cholecalciferol|cholecalciferol|mesh-list
92822983|NCT02705287|Vitamins|vitamins|mesh-list
92822984|NCT02705287|Micronutrients|micronutrients|mesh-ancestor
92822985|NCT02705287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822986|NCT02705287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92822987|NCT02705287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92822988|NCT04295408|Ropivacaine|ropivacaine|mesh-list
92822989|NCT04295408|Anesthetics, Local|anesthetics, local|mesh-ancestor
92822990|NCT04295408|Anesthetics|anesthetics|mesh-ancestor
92822991|NCT04295408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92822992|NCT04295408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92822993|NCT04295408|Sensory System Agents|sensory system agents|mesh-ancestor
92822994|NCT04295408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92822995|NCT02578537|Clopidogrel|clopidogrel|mesh-list
92822996|NCT02578537|Ticagrelor|ticagrelor|mesh-list
92822997|NCT02578537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92822998|NCT02578537|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92822999|NCT02578537|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92823000|NCT02578537|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92823001|NCT02578537|Purinergic Agents|purinergic agents|mesh-ancestor
92823002|NCT02578537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823003|NCT02578537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823004|NCT02578537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823005|NCT03011671|Temozolomide|temozolomide|mesh-list
92823006|NCT03011671|Acetazolamide|acetazolamide|mesh-list
92823007|NCT03011671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823008|NCT03011671|Alkylating Agents|alkylating agents|mesh-ancestor
92823009|NCT03011671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823010|NCT03011671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823011|NCT03011671|Anticonvulsants|anticonvulsants|mesh-ancestor
92823012|NCT03011671|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92823013|NCT03011671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823014|NCT03011671|Diuretics|diuretics|mesh-ancestor
92823015|NCT03011671|Natriuretic Agents|natriuretic agents|mesh-ancestor
92823016|NCT03011671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823017|NCT00628706|Dronabinol|dronabinol|mesh-list
92823018|NCT00628706|Hallucinogens|hallucinogens|mesh-ancestor
92823019|NCT00628706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823020|NCT00628706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92823021|NCT00628706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92823022|NCT00628706|Analgesics|analgesics|mesh-ancestor
92823023|NCT00628706|Sensory System Agents|sensory system agents|mesh-ancestor
92823024|NCT00628706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823025|NCT00628706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92823026|NCT00628706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92823027|NCT00628706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823028|NCT00628706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823029|NCT00628706|Hormones|hormones|mesh-ancestor
92823030|NCT00628706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823031|NCT01001234|Rizatriptan|rizatriptan|mesh-list
92823032|NCT01001234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92823033|NCT01001234|Serotonin Agents|serotonin agents|mesh-ancestor
92823034|NCT01001234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823035|NCT01001234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823036|NCT01001234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823037|NCT01004510|Zoledronic Acid|zoledronic acid|mesh-list
92823038|NCT01004510|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92823039|NCT01004510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823040|NCT02609503|Pembrolizumab|pembrolizumab|mesh-list
92823041|NCT02609503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823042|NCT02609503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823043|NCT02609503|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92823044|NCT02609503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823045|NCT04073953|Primaquine|primaquine|mesh-list
92823046|NCT04073953|Antimalarials|antimalarials|mesh-ancestor
92823047|NCT04073953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92823048|NCT04073953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92823049|NCT04073953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823050|NCT01004432|Golimumab|golimumab|mesh-list
92823051|NCT01004432|Methotrexate|methotrexate|mesh-list
92823052|NCT01004432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92823053|NCT01004432|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92823054|NCT01004432|Abortifacient Agents|abortifacient agents|mesh-ancestor
92823055|NCT01004432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92823056|NCT01004432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823057|NCT01004432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823058|NCT01004432|Antimetabolites|antimetabolites|mesh-ancestor
92823059|NCT01004432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823060|NCT01004432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823061|NCT01004432|Dermatologic Agents|dermatologic agents|mesh-ancestor
92823062|NCT01004432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823063|NCT01004432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92823064|NCT01004432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823065|NCT01004432|Immunologic Factors|immunologic factors|mesh-ancestor
92823066|NCT01004432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823067|NCT01004432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823068|NCT01004432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92823069|NCT01004432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823070|NCT02539537|Leucovorin|leucovorin|mesh-list
92823071|NCT02539537|Folic Acid|folic acid|mesh-list
92823072|NCT02539537|Gemcitabine|gemcitabine|mesh-list
92823073|NCT02539537|Fluorouracil|fluorouracil|mesh-list
92823074|NCT02539537|Oxaliplatin|oxaliplatin|mesh-list
92823075|NCT02539537|Irinotecan|irinotecan|mesh-list
92823076|NCT02539537|Levoleucovorin|levoleucovorin|mesh-list
92823077|NCT02539537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823078|NCT02539537|Antimetabolites|antimetabolites|mesh-ancestor
92823079|NCT02539537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823080|NCT02539537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823081|NCT02539537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92823082|NCT02539537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92823083|NCT02539537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823084|NCT02539537|Antidotes|antidotes|mesh-ancestor
92823085|NCT02539537|Protective Agents|protective agents|mesh-ancestor
92823086|NCT02539537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823087|NCT02539537|Vitamin B Complex|vitamin b complex|mesh-ancestor
92823088|NCT02539537|Vitamins|vitamins|mesh-ancestor
92823089|NCT02539537|Micronutrients|micronutrients|mesh-ancestor
92823090|NCT02539537|Hematinics|hematinics|mesh-ancestor
92823091|NCT02539537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823092|NCT02539537|Immunologic Factors|immunologic factors|mesh-ancestor
92823093|NCT02576275|Rituximab|rituximab|mesh-list
92823094|NCT02576275|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92823095|NCT02576275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823096|NCT02576275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823097|NCT02576275|Immunologic Factors|immunologic factors|mesh-ancestor
92823098|NCT02576275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823099|NCT02576275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823100|NCT02576275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823101|NCT02576275|Alkylating Agents|alkylating agents|mesh-ancestor
92823102|NCT02576275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823103|NCT01000610|Methylprednisolone|methylprednisolone|mesh-list
92823104|NCT01000610|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92823105|NCT01000610|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92823107|NCT01000610|Prednisolone acetate|prednisolone acetate|mesh-list
92823108|NCT01000610|Rituximab|rituximab|mesh-list
92823109|NCT01000610|Methotrexate|methotrexate|mesh-list
92823110|NCT01000610|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92823111|NCT01000610|Prednisolone phosphate|prednisolone phosphate|mesh-list
92823112|NCT01000610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823113|NCT01000610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823114|NCT01000610|Immunologic Factors|immunologic factors|mesh-ancestor
92823115|NCT01000610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823116|NCT01000610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823117|NCT01000610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92823118|NCT01000610|Abortifacient Agents|abortifacient agents|mesh-ancestor
92823119|NCT01000610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92823120|NCT01000610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823121|NCT01000610|Antimetabolites|antimetabolites|mesh-ancestor
92823122|NCT01000610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823123|NCT01000610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92823124|NCT01000610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823125|NCT01000610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92823126|NCT01000610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823127|NCT01000610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823128|NCT01000610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823129|NCT01000610|Antiemetics|antiemetics|mesh-ancestor
92823130|NCT01000610|Autonomic Agents|autonomic agents|mesh-ancestor
92823131|NCT01000610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823132|NCT01000610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823133|NCT01000610|Glucocorticoids|glucocorticoids|mesh-ancestor
92823134|NCT01000610|Hormones|hormones|mesh-ancestor
92823135|NCT01000610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823136|NCT01000610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92823137|NCT01000610|Protective Agents|protective agents|mesh-ancestor
92823138|NCT01000610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823139|NCT02523469|Nivolumab|nivolumab|mesh-list
92823140|NCT02523469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823141|NCT02523469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823142|NCT02523469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92823143|NCT02523469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823144|NCT00586924|Immunotoxin HA22|immunotoxin ha22|mesh-list
92823145|NCT00586924|Immunotoxins|immunotoxins|mesh-ancestor
92823146|NCT00586924|Immunoconjugates|immunoconjugates|mesh-ancestor
92823147|NCT00586924|Immunologic Factors|immunologic factors|mesh-ancestor
92823148|NCT00586924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823149|NCT00586924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823150|NCT04211961|Scopolamine|scopolamine|mesh-list
92823151|NCT04211961|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92823152|NCT04211961|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92823153|NCT04211961|Antiemetics|antiemetics|mesh-ancestor
92823154|NCT04211961|Autonomic Agents|autonomic agents|mesh-ancestor
92823155|NCT04211961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823156|NCT04211961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823157|NCT04211961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823158|NCT04211961|Mydriatics|mydriatics|mesh-ancestor
92823159|NCT04211961|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92823160|NCT04211961|Cholinergic Agents|cholinergic agents|mesh-ancestor
92823161|NCT04211961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823162|NCT04211961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823163|NCT04211961|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92823164|NCT04211961|Parasympatholytics|parasympatholytics|mesh-ancestor
92823165|NCT01000376|Ketoconazole|ketoconazole|mesh-list
92823166|NCT01000376|Antifungal Agents|antifungal agents|mesh-ancestor
92823167|NCT01000376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823168|NCT01000376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92823169|NCT01000376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92823170|NCT01000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823171|NCT01000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823172|NCT01000376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92823173|NCT01000376|Hormone Antagonists|hormone antagonists|mesh-ancestor
92823174|NCT01000376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823175|NCT01000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823176|NCT01000376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92823177|NCT01038635|Lenalidomide|lenalidomide|mesh-list
92823178|NCT01038635|Azacitidine|azacitidine|mesh-list
92823179|NCT01038635|Immunologic Factors|immunologic factors|mesh-ancestor
92823180|NCT01038635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823181|NCT01038635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92823182|NCT01038635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92823183|NCT01038635|Growth Substances|growth substances|mesh-ancestor
92823184|NCT01038635|Growth Inhibitors|growth inhibitors|mesh-ancestor
92823185|NCT01038635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823186|NCT01038635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823187|NCT01038635|Antimetabolites|antimetabolites|mesh-ancestor
92823188|NCT01038635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823189|NCT01038635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823190|NCT00619203|Acetaminophen|acetaminophen|mesh-list
92823191|NCT00619203|Glycerol|glycerol|mesh-list
92823192|NCT00619203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92823193|NCT00619203|Analgesics|analgesics|mesh-ancestor
92823194|NCT00619203|Sensory System Agents|sensory system agents|mesh-ancestor
92823195|NCT00619203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823196|NCT00619203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823197|NCT00619203|Antipyretics|antipyretics|mesh-ancestor
92823198|NCT00619203|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92823199|NCT00619203|Protective Agents|protective agents|mesh-ancestor
92823200|NCT04072471|Lesinurad|lesinurad|mesh-list
92823201|NCT04072471|Gout Suppressants|gout suppressants|mesh-ancestor
92823202|NCT04072471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823203|NCT04072471|Uricosuric Agents|uricosuric agents|mesh-ancestor
92823204|NCT01000064|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92823205|NCT01000064|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92823206|NCT01000064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823207|NCT01000064|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92823208|NCT01000064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92823209|NCT01000064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92823210|NCT01000064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823211|NCT01000064|Dopamine Agents|dopamine agents|mesh-ancestor
92823212|NCT01000064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823213|NCT01812603|Nabiximols|nabiximols|mesh-list
92823214|NCT01812603|Analgesics|analgesics|mesh-ancestor
92823215|NCT01812603|Sensory System Agents|sensory system agents|mesh-ancestor
92823216|NCT01812603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823217|NCT01812603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823218|NCT04211805|Tenofovir|tenofovir|mesh-list
92823219|NCT04211805|Vaccines|vaccines|mesh-list
92823220|NCT04211805|Immunologic Factors|immunologic factors|mesh-ancestor
92823221|NCT04211805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823222|NCT04211805|Antiviral Agents|antiviral agents|mesh-ancestor
92823223|NCT04211805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823224|NCT04211805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92823225|NCT04211805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823226|NCT04211805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823227|NCT04211805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823228|NCT04211805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92823229|NCT04211805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92823230|NCT02874287|Hydroxychloroquine|hydroxychloroquine|mesh-list
92823231|NCT02874287|Antimalarials|antimalarials|mesh-ancestor
92823232|NCT02874287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92823233|NCT02874287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92823234|NCT02874287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823235|NCT02874287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823236|NCT02874287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725054|NCT04605419|Calcium|calcium|mesh-list
92823237|NCT02874287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823238|NCT00580801|Interferons|interferons|mesh-list
92823239|NCT00580801|Ribavirin|ribavirin|mesh-list
92823240|NCT00580801|Interferon-alpha|interferon-alpha|mesh-list
92823241|NCT00580801|Interferon alpha-2|interferon alpha-2|mesh-list
92823242|NCT00580801|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92823243|NCT00580801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823244|NCT00580801|Antiviral Agents|antiviral agents|mesh-ancestor
92823245|NCT00580801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823246|NCT00580801|Antimetabolites|antimetabolites|mesh-ancestor
92823247|NCT00580801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823248|NCT00580801|Immunologic Factors|immunologic factors|mesh-ancestor
92823249|NCT00580801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823250|NCT00619671|Rituximab|rituximab|mesh-list
92823251|NCT00619671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823252|NCT00619671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823253|NCT00619671|Immunologic Factors|immunologic factors|mesh-ancestor
92823254|NCT00619671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468290|NCT01804374|Everolimus|everolimus|mesh-list
92823255|NCT00619671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823256|NCT00628550|Vasopressins|vasopressins|mesh-list
92823257|NCT00628550|Arginine Vasopressin|arginine vasopressin|mesh-list
92823258|NCT00628550|Epinephrine|epinephrine|mesh-list
92823259|NCT00628550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92823260|NCT00628550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92823261|NCT00628550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92823262|NCT00628550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823263|NCT00628550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823264|NCT00628550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823265|NCT00628550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92823266|NCT00628550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92823267|NCT00628550|Autonomic Agents|autonomic agents|mesh-ancestor
92823268|NCT00628550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823269|NCT00628550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92823270|NCT00628550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92823271|NCT00628550|Mydriatics|mydriatics|mesh-ancestor
92823272|NCT00628550|Sympathomimetics|sympathomimetics|mesh-ancestor
92823273|NCT00628550|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92823274|NCT00628550|Hemostatics|hemostatics|mesh-ancestor
92823275|NCT00628550|Coagulants|coagulants|mesh-ancestor
92823276|NCT00628550|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92823277|NCT00628550|Natriuretic Agents|natriuretic agents|mesh-ancestor
92823278|NCT01059539|Cariprazine|cariprazine|mesh-list
92823279|NCT01059539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92823280|NCT01059539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92823281|NCT01059539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823282|NCT01059539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823283|NCT01059539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92823284|NCT00999908|Tiotropium Bromide|tiotropium bromide|mesh-list
92823285|NCT00999908|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92823286|NCT00999908|Autonomic Agents|autonomic agents|mesh-ancestor
92823287|NCT00999908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823288|NCT00999908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823289|NCT00999908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92823290|NCT00999908|Respiratory System Agents|respiratory system agents|mesh-ancestor
92823291|NCT00999908|Parasympatholytics|parasympatholytics|mesh-ancestor
92823292|NCT00999908|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92823293|NCT00999908|Cholinergic Agents|cholinergic agents|mesh-ancestor
92823294|NCT00999908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823295|NCT00999908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823296|NCT02576119|Moxifloxacin|moxifloxacin|mesh-list
92823297|NCT02576119|BMS-955176|bms-955176|mesh-list
92823298|NCT02576119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92823299|NCT02576119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823300|NCT02576119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92823301|NCT02576119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92823302|NCT02576119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823303|NCT02576119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823304|NCT02576119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823305|NCT02576119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92823306|NCT02576119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92823307|NCT02576119|Antiviral Agents|antiviral agents|mesh-ancestor
92823308|NCT02871518|Cisplatin|cisplatin|mesh-list
92823309|NCT02871518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823310|NCT04304144|Dexamethasone|dexamethasone|mesh-list
92823311|NCT04304144|Cyclophosphamide|cyclophosphamide|mesh-list
92823312|NCT04304144|Bortezomib|bortezomib|mesh-list
92823313|NCT04304144|Daratumumab|daratumumab|mesh-list
92823314|NCT04304144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823315|NCT04304144|Immunologic Factors|immunologic factors|mesh-ancestor
92823316|NCT04304144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823317|NCT04304144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823318|NCT04304144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823319|NCT04304144|Alkylating Agents|alkylating agents|mesh-ancestor
92823320|NCT04304144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823321|NCT04304144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823322|NCT04304144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92823323|NCT04304144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823324|NCT04304144|Antiemetics|antiemetics|mesh-ancestor
92823325|NCT04304144|Autonomic Agents|autonomic agents|mesh-ancestor
92823326|NCT04304144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823327|NCT04304144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823328|NCT04304144|Glucocorticoids|glucocorticoids|mesh-ancestor
92823329|NCT04304144|Hormones|hormones|mesh-ancestor
92823330|NCT04304144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823331|NCT04304144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823333|NCT04676867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92823334|NCT04676867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92823335|NCT04676867|Antimetabolites|antimetabolites|mesh-ancestor
92823336|NCT04676867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823337|NCT04676867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92823338|NCT00770224|Prednisone|prednisone|mesh-list
92823339|NCT00770224|Cyclophosphamide|cyclophosphamide|mesh-list
92823340|NCT00770224|Rituximab|rituximab|mesh-list
92823341|NCT00770224|Doxorubicin|doxorubicin|mesh-list
92823342|NCT00770224|Vincristine|vincristine|mesh-list
92823343|NCT00770224|Tositumomab I-131|tositumomab i-131|mesh-list
92823344|NCT00770224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823345|NCT00770224|Immunologic Factors|immunologic factors|mesh-ancestor
92823346|NCT00770224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823347|NCT00770224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823348|NCT00770224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823349|NCT00770224|Alkylating Agents|alkylating agents|mesh-ancestor
92823350|NCT00770224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823351|NCT00770224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823352|NCT00770224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92823353|NCT00770224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823354|NCT00770224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92823355|NCT00770224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92823356|NCT00770224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92823357|NCT00770224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823358|NCT00770224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823359|NCT00770224|Glucocorticoids|glucocorticoids|mesh-ancestor
92823360|NCT00770224|Hormones|hormones|mesh-ancestor
92823361|NCT00770224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823362|NCT00770224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823363|NCT00770224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92823364|NCT00770224|Tubulin Modulators|tubulin modulators|mesh-ancestor
92823365|NCT00770224|Antimitotic Agents|antimitotic agents|mesh-ancestor
92823366|NCT00770224|Mitosis Modulators|mitosis modulators|mesh-ancestor
92823367|NCT04594811|Nivolumab|nivolumab|mesh-list
92823368|NCT04594811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823369|NCT04594811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823370|NCT04594811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92823371|NCT04594811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823372|NCT02399215|Nintedanib|nintedanib|mesh-list
92823373|NCT02399215|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92823374|NCT02399215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823375|NCT02399215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92823376|NCT02399215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823377|NCT02399215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823378|NCT02389465|Celecoxib|celecoxib|mesh-list
92823379|NCT02389465|Dexetimide|dexetimide|mesh-list
92823380|NCT02389465|Citalopram|citalopram|mesh-list
92823381|NCT02389465|Escitalopram|escitalopram|mesh-list
92823382|NCT02389465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92823383|NCT02389465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92823384|NCT02389465|Analgesics|analgesics|mesh-ancestor
92823385|NCT02389465|Sensory System Agents|sensory system agents|mesh-ancestor
92823386|NCT02389465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823387|NCT02389465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823388|NCT02389465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823389|NCT02389465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823390|NCT02389465|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92823391|NCT02389465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92823392|NCT02389465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823393|NCT02389465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823394|NCT02389465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92823395|NCT02389465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92823396|NCT02389465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92823397|NCT02389465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823398|NCT02389465|Serotonin Agents|serotonin agents|mesh-ancestor
92823399|NCT02389465|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92823400|NCT02389465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92823401|NCT02389465|Parasympatholytics|parasympatholytics|mesh-ancestor
92823402|NCT02389465|Autonomic Agents|autonomic agents|mesh-ancestor
92823403|NCT02389465|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92823404|NCT02389465|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92823405|NCT02389465|Cholinergic Agents|cholinergic agents|mesh-ancestor
92823406|NCT02389465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92823408|NCT02389465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92823409|NCT01057589|Folic Acid|folic acid|mesh-list
92823410|NCT01057589|Vitamin B 12|vitamin b 12|mesh-list
92823411|NCT01057589|Pemetrexed|pemetrexed|mesh-list
92823412|NCT01057589|Cetuximab|cetuximab|mesh-list
92823413|NCT01057589|Vitamins|vitamins|mesh-ancestor
92823414|NCT01057589|Micronutrients|micronutrients|mesh-ancestor
92823415|NCT01057589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823416|NCT01057589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823417|NCT01057589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823418|NCT01057589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823419|NCT01057589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92823420|NCT01057589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823421|NCT01057589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823422|NCT01057589|Hematinics|hematinics|mesh-ancestor
92823423|NCT01057589|Vitamin B Complex|vitamin b complex|mesh-ancestor
92823424|NCT02575885|Nicotine|nicotine|mesh-list
92823425|NCT02575885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92823426|NCT02575885|Autonomic Agents|autonomic agents|mesh-ancestor
92823427|NCT02575885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823428|NCT02575885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823429|NCT02575885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92823430|NCT02575885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92823431|NCT02575885|Cholinergic Agents|cholinergic agents|mesh-ancestor
92823432|NCT02575885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823433|NCT02575885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823434|NCT02575729|Betamethasone|betamethasone|mesh-list
92823436|NCT02575729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823437|NCT02575729|Hormones|hormones|mesh-ancestor
92823438|NCT02575729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823439|NCT02575729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823440|NCT02575729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92823441|NCT02575729|Respiratory System Agents|respiratory system agents|mesh-ancestor
92823442|NCT02575651|Fluzoparib|fluzoparib|mesh-list
92823443|NCT02575651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92823444|NCT02575651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823445|NCT02575651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823446|NCT02575651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823447|NCT01716117|Calcium Carbonate|calcium carbonate|mesh-list
92823448|NCT01716117|Antacids|antacids|mesh-ancestor
92823449|NCT01716117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823450|NCT01716117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823451|NCT00579553|Progesterone|progesterone|mesh-list
92823452|NCT00579553|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92823453|NCT00579553|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92823454|NCT00579553|Progestins|progestins|mesh-ancestor
92823455|NCT00579553|Hormones|hormones|mesh-ancestor
92823456|NCT00579553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823457|NCT00579553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823458|NCT00579553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92823459|NCT00579553|Hormone Antagonists|hormone antagonists|mesh-ancestor
92823460|NCT04209933|Potassium Citrate|potassium citrate|mesh-list
92823461|NCT04209933|Bismuth|bismuth|mesh-list
92823462|NCT04209933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823463|NCT04209933|Antacids|antacids|mesh-ancestor
92823464|NCT04209933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823465|NCT04209933|Diuretics|diuretics|mesh-ancestor
92823466|NCT04209933|Natriuretic Agents|natriuretic agents|mesh-ancestor
92823467|NCT04209933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823468|NCT04209933|Expectorants|expectorants|mesh-ancestor
92823469|NCT04209933|Respiratory System Agents|respiratory system agents|mesh-ancestor
92823470|NCT00619905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92823471|NCT00619905|Immunologic Factors|immunologic factors|mesh-ancestor
92823472|NCT00619905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823473|NCT04209699|Deucravacitinib|deucravacitinib|mesh-list
92823474|NCT04209699|Famotidine|famotidine|mesh-list
92823475|NCT04209699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92823476|NCT04209699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823477|NCT04209699|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92823478|NCT04209699|Histamine Antagonists|histamine antagonists|mesh-ancestor
92823479|NCT04209699|Histamine Agents|histamine agents|mesh-ancestor
92823480|NCT04209699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468490|NCT01808495|Mitomycins|mitomycins|mesh-list
92823481|NCT04209699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823482|NCT04209699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823483|NCT04209699|Dermatologic Agents|dermatologic agents|mesh-ancestor
92823484|NCT04209699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92823485|NCT04209699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823486|NCT00620295|Gemcitabine|gemcitabine|mesh-list
92823487|NCT00620295|Bortezomib|bortezomib|mesh-list
92823488|NCT00620295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823489|NCT00620295|Antimetabolites|antimetabolites|mesh-ancestor
92823490|NCT00620295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823491|NCT00620295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823492|NCT00581893|Phenytoin|phenytoin|mesh-list
92823493|NCT00581893|Anticonvulsants|anticonvulsants|mesh-ancestor
92823494|NCT00581893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92823495|NCT00581893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92823496|NCT00581893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92823497|NCT00581893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823498|NCT00581893|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92823499|NCT00581893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92823500|NCT04211103|Pembrolizumab|pembrolizumab|mesh-list
92823501|NCT04211103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823502|NCT04211103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823503|NCT04211103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92823504|NCT04211103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823505|NCT04209777|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92823506|NCT04209777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823507|NCT02334865|Lenalidomide|lenalidomide|mesh-list
92823508|NCT02334865|Sargramostim|sargramostim|mesh-list
92823509|NCT02334865|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92823510|NCT02334865|Freund's Adjuvant|freund's adjuvant|mesh-list
92823511|NCT02334865|Immunologic Factors|immunologic factors|mesh-ancestor
92823512|NCT02334865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823513|NCT02334865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92823514|NCT02334865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92823515|NCT02334865|Growth Substances|growth substances|mesh-ancestor
92823516|NCT02334865|Growth Inhibitors|growth inhibitors|mesh-ancestor
92823517|NCT02334865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823518|NCT02334865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92823519|NCT04073719|Acetic Acid|acetic acid|mesh-list
92823520|NCT04073719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92823521|NCT04073719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823522|NCT00379431|Methylprednisolone|methylprednisolone|mesh-list
92823523|NCT00379431|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92823524|NCT00379431|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92823525|NCT00379431|Prednisolone|prednisolone|mesh-list
92823526|NCT00379431|Prednisolone acetate|prednisolone acetate|mesh-list
92823527|NCT00379431|Rituximab|rituximab|mesh-list
92823528|NCT00379431|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92823529|NCT00379431|Prednisolone phosphate|prednisolone phosphate|mesh-list
92823530|NCT00379431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823531|NCT00379431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823532|NCT00379431|Immunologic Factors|immunologic factors|mesh-ancestor
92823533|NCT00379431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823534|NCT00379431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823535|NCT00379431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823536|NCT00379431|Antiemetics|antiemetics|mesh-ancestor
92823537|NCT00379431|Autonomic Agents|autonomic agents|mesh-ancestor
92823538|NCT00379431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823539|NCT00379431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823540|NCT00379431|Glucocorticoids|glucocorticoids|mesh-ancestor
92823541|NCT00379431|Hormones|hormones|mesh-ancestor
92823542|NCT00379431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823543|NCT00379431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92823544|NCT00379431|Protective Agents|protective agents|mesh-ancestor
92823545|NCT00379431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823546|NCT04954989|Epoetin Alfa|epoetin alfa|mesh-list
92823547|NCT04954989|Hematinics|hematinics|mesh-ancestor
92823548|NCT00621699|Ezetimibe|ezetimibe|mesh-list
92823549|NCT00621699|Tacrolimus|tacrolimus|mesh-list
92823550|NCT00621699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823551|NCT00621699|Immunologic Factors|immunologic factors|mesh-ancestor
92823552|NCT00621699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823553|NCT00621699|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92823554|NCT00621699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823555|NCT00621699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468567|NCT01809158|Minocycline|minocycline|mesh-list
92823556|NCT00621699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92823557|NCT00621699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92823558|NCT00621699|Antimetabolites|antimetabolites|mesh-ancestor
92823559|NCT00621699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92823560|NCT00612183|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92823561|NCT00612183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823562|NCT00612183|Alkylating Agents|alkylating agents|mesh-ancestor
92823563|NCT00612183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823564|NCT00612183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823565|NCT00770146|Mipomersen|mipomersen|mesh-list
92823566|NCT00770146|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92823567|NCT00770146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92823568|NCT00770146|Antimetabolites|antimetabolites|mesh-ancestor
92823569|NCT00770146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823570|NCT00770146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92823571|NCT00915850|Cisplatin|cisplatin|mesh-list
92823572|NCT00915850|Docetaxel|docetaxel|mesh-list
92823573|NCT00915850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823574|NCT00915850|Tubulin Modulators|tubulin modulators|mesh-ancestor
92823575|NCT00915850|Antimitotic Agents|antimitotic agents|mesh-ancestor
92823576|NCT00915850|Mitosis Modulators|mitosis modulators|mesh-ancestor
92823577|NCT00915850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823578|NCT04208763|Imipenem|imipenem|mesh-list
92823579|NCT04208763|Colistin|colistin|mesh-list
92823580|NCT04208763|Tigecycline|tigecycline|mesh-list
92823581|NCT04208763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92823582|NCT04208763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823583|NCT04208763|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92823584|NCT04208763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823585|NCT04208763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823586|NCT00620919|Secretin|secretin|mesh-list
92823587|NCT00620919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823588|NCT00620919|Hormones|hormones|mesh-ancestor
92823589|NCT00620919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823590|NCT00620919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823591|NCT00916552|Epoetin Alfa|epoetin alfa|mesh-list
92823592|NCT00916552|Hematinics|hematinics|mesh-ancestor
92823593|NCT03950037|Albendazole|albendazole|mesh-list
92823594|NCT03950037|Anthelmintics|anthelmintics|mesh-ancestor
92823595|NCT03950037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92823596|NCT03950037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823597|NCT03950037|Anticestodal Agents|anticestodal agents|mesh-ancestor
92823598|NCT03950037|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92823599|NCT03950037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92823600|NCT03950037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92823601|NCT03950037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92823602|NCT03950037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92823603|NCT03950037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823604|NCT03950037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823605|NCT04188171|Polidocanol|polidocanol|mesh-list
92823606|NCT04188171|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92823607|NCT04188171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92823608|NCT00620997|Proxymetacaine|proxymetacaine|mesh-list
92823609|NCT00620997|Anesthetics, Local|anesthetics, local|mesh-ancestor
92823610|NCT00620997|Anesthetics|anesthetics|mesh-ancestor
92823611|NCT00620997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823612|NCT00620997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823613|NCT00620997|Sensory System Agents|sensory system agents|mesh-ancestor
92823614|NCT00620997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823615|NCT00622011|Risperidone|risperidone|mesh-list
92823616|NCT00622011|Zotepine|zotepine|mesh-list
92823617|NCT00622011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92823618|NCT00622011|Serotonin Agents|serotonin agents|mesh-ancestor
92823619|NCT00622011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823620|NCT00622011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823621|NCT00622011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823622|NCT00622011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92823623|NCT00622011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92823624|NCT00622011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823625|NCT00622011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92823626|NCT00622011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92823627|NCT00622011|Dopamine Agents|dopamine agents|mesh-ancestor
92823628|NCT03936309|Lidocaine|lidocaine|mesh-list
92823629|NCT03936309|Anesthetics, Local|anesthetics, local|mesh-ancestor
92823630|NCT03936309|Anesthetics|anesthetics|mesh-ancestor
92823631|NCT03936309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823632|NCT03936309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823633|NCT03936309|Sensory System Agents|sensory system agents|mesh-ancestor
92823634|NCT03936309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823635|NCT03936309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92823636|NCT03936309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92823637|NCT03936309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92823638|NCT03936309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92823639|NCT03936309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823640|NCT04208373|Itraconazole|itraconazole|mesh-list
92823641|NCT04208373|Etravirine|etravirine|mesh-list
92823642|NCT04208373|Antifungal Agents|antifungal agents|mesh-ancestor
92823643|NCT04208373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823644|NCT04208373|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92823645|NCT04208373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92823646|NCT04208373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823647|NCT04208373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823648|NCT04208373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92823649|NCT04208373|Hormone Antagonists|hormone antagonists|mesh-ancestor
92823650|NCT04208373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823651|NCT04208373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823652|NCT04208373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92823653|NCT04208373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92823654|NCT04208373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823655|NCT04208373|Antiviral Agents|antiviral agents|mesh-ancestor
92823656|NCT00622245|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92823657|NCT00622245|Antidepressive Agents|antidepressive agents|mesh-ancestor
92823658|NCT00622245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92823659|NCT00622245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92823660|NCT00622245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92823661|NCT00622245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823662|NCT00622245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823663|NCT01056341|Propranolol|propranolol|mesh-list
92823664|NCT01056341|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92823665|NCT01056341|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92823666|NCT01056341|Adrenergic Agents|adrenergic agents|mesh-ancestor
92823667|NCT01056341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823668|NCT01056341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823669|NCT01056341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823670|NCT01056341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92823671|NCT01056341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92823672|NCT01056341|Vasodilator Agents|vasodilator agents|mesh-ancestor
92823673|NCT00999518|Tanezumab|tanezumab|mesh-list
92823674|NCT00999518|Analgesics|analgesics|mesh-ancestor
92823675|NCT00999518|Sensory System Agents|sensory system agents|mesh-ancestor
92823676|NCT00999518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823677|NCT00999518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823678|NCT00621387|Ofloxacin|ofloxacin|mesh-list
92823679|NCT00621387|Roxithromycin|roxithromycin|mesh-list
92823680|NCT00621387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92823681|NCT00621387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823682|NCT00621387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92823683|NCT00621387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92823684|NCT00621387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92823685|NCT00621387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823686|NCT00621387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823687|NCT00621387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823688|NCT00621387|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92823689|NCT00621387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92823690|NCT02873273|Dexamethasone|dexamethasone|mesh-list
92823691|NCT02873273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823692|NCT02873273|Antiemetics|antiemetics|mesh-ancestor
92823693|NCT02873273|Autonomic Agents|autonomic agents|mesh-ancestor
92823694|NCT02873273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823695|NCT02873273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823696|NCT02873273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823697|NCT02873273|Glucocorticoids|glucocorticoids|mesh-ancestor
92823698|NCT02873273|Hormones|hormones|mesh-ancestor
92823699|NCT02873273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823700|NCT02873273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823701|NCT02873273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823702|NCT04208841|Sulfamethazine|sulfamethazine|mesh-list
92823703|NCT04208841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823704|NCT01056263|Axitinib|axitinib|mesh-list
92468777|NCT01810809|Hylan|hylan|mesh-list
92823705|NCT01056263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823706|NCT01056263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92823707|NCT01056263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823708|NCT01056263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823709|NCT00637143|Cyclosporine|cyclosporine|mesh-list
92823710|NCT00637143|Tacrolimus|tacrolimus|mesh-list
92823711|NCT00637143|Cyclosporins|cyclosporins|mesh-list
92823712|NCT00637143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823713|NCT00637143|Immunologic Factors|immunologic factors|mesh-ancestor
92823714|NCT00637143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823715|NCT00637143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92823716|NCT00637143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823717|NCT00637143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823718|NCT00637143|Antifungal Agents|antifungal agents|mesh-ancestor
92823719|NCT00637143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823720|NCT00637143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92823721|NCT00637143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823722|NCT01056107|Glucagon|glucagon|mesh-list
92823723|NCT01056107|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92823724|NCT01056107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823725|NCT01056107|Hormones|hormones|mesh-ancestor
92823726|NCT01056107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823727|NCT01056107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823728|NCT01056107|Incretins|incretins|mesh-ancestor
92823729|NCT03548805|Mitomycins|mitomycins|mesh-list
92823730|NCT03548805|Mitomycin|mitomycin|mesh-list
92823731|NCT03548805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92823732|NCT03548805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823734|NCT03548805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823735|NCT03548805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823736|NCT03548805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823737|NCT01003886|Doxazosin|doxazosin|mesh-list
92823738|NCT01003886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92823739|NCT01003886|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92823740|NCT01003886|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92823741|NCT01003886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92823742|NCT01003886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92823743|NCT01003886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823744|NCT01003886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823745|NCT01003886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823746|NCT04138641|Cangrelor|cangrelor|mesh-list
92823747|NCT04138641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92823748|NCT04138641|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92823749|NCT04138641|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92823750|NCT04138641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92823751|NCT04138641|Purinergic Agents|purinergic agents|mesh-ancestor
92823752|NCT04138641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823753|NCT04138641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823754|NCT04138641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823755|NCT01003184|Exenatide|exenatide|mesh-list
92823756|NCT01003184|Insulin Detemir|insulin detemir|mesh-list
92823757|NCT01003184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92823758|NCT01003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823759|NCT01003184|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92823760|NCT01003184|Incretins|incretins|mesh-ancestor
92823761|NCT01003184|Hormones|hormones|mesh-ancestor
92823762|NCT01003184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823763|NCT04314219|Cyclophosphamide|cyclophosphamide|mesh-list
92823764|NCT04314219|Methotrexate|methotrexate|mesh-list
92823765|NCT04314219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823766|NCT04314219|Immunologic Factors|immunologic factors|mesh-ancestor
92823767|NCT04314219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823768|NCT04314219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823769|NCT04314219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823770|NCT04314219|Alkylating Agents|alkylating agents|mesh-ancestor
92823771|NCT04314219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823772|NCT04314219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823773|NCT04314219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92823774|NCT04314219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92823775|NCT04314219|Abortifacient Agents|abortifacient agents|mesh-ancestor
92823776|NCT04314219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92823777|NCT04314219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823778|NCT04314219|Antimetabolites|antimetabolites|mesh-ancestor
92823780|NCT04314219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823781|NCT04314219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92823782|NCT04314219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823783|NCT02407119|Amoxicillin|amoxicillin|mesh-list
92823784|NCT02407119|Clarithromycin|clarithromycin|mesh-list
92823785|NCT02407119|Omeprazole|omeprazole|mesh-list
92823786|NCT02407119|Rabeprazole|rabeprazole|mesh-list
92823787|NCT02407119|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92823788|NCT02407119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92823789|NCT02407119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823790|NCT02407119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92823791|NCT02407119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823792|NCT02407119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823793|NCT02407119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823794|NCT02407119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92823795|NCT02407119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92823796|NCT02407119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92823797|NCT01008410|Budesonide|budesonide|mesh-list
92823798|NCT01008410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823799|NCT01008410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92823800|NCT01008410|Autonomic Agents|autonomic agents|mesh-ancestor
92823801|NCT01008410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823802|NCT01008410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823803|NCT01008410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92168654|NCT04190433|Carvedilol|carvedilol|mesh-list
92823804|NCT01008410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92823805|NCT01008410|Glucocorticoids|glucocorticoids|mesh-ancestor
92823806|NCT01008410|Hormones|hormones|mesh-ancestor
92823807|NCT01008410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823808|NCT00627653|Fenofibrate|fenofibrate|mesh-list
92823809|NCT00627653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92823810|NCT00627653|Antimetabolites|antimetabolites|mesh-ancestor
92823811|NCT00627653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823812|NCT00627653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92823813|NCT02347917|Pemetrexed|pemetrexed|mesh-list
92823814|NCT02347917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823815|NCT02347917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823816|NCT02347917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823817|NCT02347917|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92823818|NCT02347917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823819|NCT01972035|Valacyclovir|valacyclovir|mesh-list
92823820|NCT01972035|Valganciclovir|valganciclovir|mesh-list
92823821|NCT01972035|Antiviral Agents|antiviral agents|mesh-ancestor
92823822|NCT01972035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823823|NCT00622479|Sorafenib|sorafenib|mesh-list
92823824|NCT00622479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823825|NCT00622479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92823826|NCT00622479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823827|NCT00622479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823828|NCT01207011|Docetaxel|docetaxel|mesh-list
92823829|NCT01207011|Amrubicin|amrubicin|mesh-list
92823830|NCT01207011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823831|NCT01207011|Tubulin Modulators|tubulin modulators|mesh-ancestor
92823832|NCT01207011|Antimitotic Agents|antimitotic agents|mesh-ancestor
92823833|NCT01207011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92823834|NCT01207011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823835|NCT05264805|Bupivacaine|bupivacaine|mesh-list
92823836|NCT05264805|Anesthetics, Local|anesthetics, local|mesh-ancestor
92823837|NCT05264805|Anesthetics|anesthetics|mesh-ancestor
92823838|NCT05264805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823839|NCT05264805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823840|NCT05264805|Sensory System Agents|sensory system agents|mesh-ancestor
92823841|NCT05264805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823842|NCT05264493|Naloxone|naloxone|mesh-list
92823843|NCT05264493|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92823844|NCT05264493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823845|NCT05264493|Sensory System Agents|sensory system agents|mesh-ancestor
92823846|NCT05264493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823847|NCT00612261|Triamcinolone|triamcinolone|mesh-list
92823848|NCT00612261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92823849|NCT00612261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92823850|NCT00612261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92823851|NCT00612261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823852|NCT00612261|Glucocorticoids|glucocorticoids|mesh-ancestor
92823853|NCT00612261|Hormones|hormones|mesh-ancestor
92468869|NCT01811251|Analgesics|analgesics|mesh-ancestor
92823854|NCT00612261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823855|NCT00612261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823856|NCT00612261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823857|NCT00612261|Immunologic Factors|immunologic factors|mesh-ancestor
92823858|NCT00612261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823859|NCT00612261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823860|NCT00636909|Cyclosporine|cyclosporine|mesh-list
92823861|NCT00636909|Cyclophosphamide|cyclophosphamide|mesh-list
92823862|NCT00636909|Methotrexate|methotrexate|mesh-list
92823863|NCT00636909|Fludarabine|fludarabine|mesh-list
92823864|NCT00636909|Cyclosporins|cyclosporins|mesh-list
92823865|NCT00636909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823866|NCT00636909|Immunologic Factors|immunologic factors|mesh-ancestor
92823867|NCT00636909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823868|NCT00636909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92823869|NCT00636909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92823870|NCT00636909|Alkylating Agents|alkylating agents|mesh-ancestor
92823871|NCT00636909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823872|NCT00636909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823873|NCT00636909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92823874|NCT00636909|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92823875|NCT00636909|Abortifacient Agents|abortifacient agents|mesh-ancestor
92823876|NCT00636909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92823877|NCT00636909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823878|NCT00636909|Antimetabolites|antimetabolites|mesh-ancestor
92823879|NCT00636909|Dermatologic Agents|dermatologic agents|mesh-ancestor
92823880|NCT00636909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823881|NCT00636909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92823882|NCT00636909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92823883|NCT00636909|Antifungal Agents|antifungal agents|mesh-ancestor
92823884|NCT00636909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823885|NCT00636909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92823886|NCT02697669|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92823887|NCT02697669|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92823888|NCT02697669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823889|NCT02697201|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92823890|NCT02697201|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92823891|NCT02697201|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92823892|NCT02697201|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92823893|NCT02697045|Aripiprazole|aripiprazole|mesh-list
92823894|NCT02697045|Antidepressive Agents|antidepressive agents|mesh-ancestor
92823895|NCT02697045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92823896|NCT02697045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92823897|NCT02697045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92823898|NCT02697045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92823899|NCT02697045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823900|NCT02697045|Dopamine Agonists|dopamine agonists|mesh-ancestor
92823901|NCT02697045|Dopamine Agents|dopamine agents|mesh-ancestor
92823902|NCT02697045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92823903|NCT02697045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823904|NCT02697045|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92823905|NCT02697045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92823906|NCT02697045|Serotonin Agents|serotonin agents|mesh-ancestor
92823907|NCT02697045|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92823908|NCT02697045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92823909|NCT02697045|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92823910|NCT02697045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92823911|NCT01007942|Trastuzumab|trastuzumab|mesh-list
92823912|NCT01007942|Everolimus|everolimus|mesh-list
92823913|NCT01007942|Vinorelbine|vinorelbine|mesh-list
92823914|NCT01007942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823915|NCT01007942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823916|NCT01007942|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92823917|NCT01007942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92823918|NCT01007942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92823919|NCT01007942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823920|NCT01007942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823921|NCT01007942|Immunologic Factors|immunologic factors|mesh-ancestor
92823922|NCT01007942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823923|NCT01007942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92823924|NCT01007942|Tubulin Modulators|tubulin modulators|mesh-ancestor
92823925|NCT01007942|Antimitotic Agents|antimitotic agents|mesh-ancestor
92823926|NCT01007942|Mitosis Modulators|mitosis modulators|mesh-ancestor
92823927|NCT01023035|Ribavirin|ribavirin|mesh-list
92823928|NCT01023035|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92823929|NCT01023035|Epoetin Alfa|epoetin alfa|mesh-list
92823930|NCT01023035|Antimetabolites|antimetabolites|mesh-ancestor
92823931|NCT01023035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823932|NCT01023035|Antiviral Agents|antiviral agents|mesh-ancestor
92823933|NCT01023035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823934|NCT01023035|Hematinics|hematinics|mesh-ancestor
92823935|NCT01028651|Treprostinil|treprostinil|mesh-list
92823936|NCT01028651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92823937|NCT00627731|Methylprednisolone|methylprednisolone|mesh-list
92823938|NCT00627731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92823939|NCT00627731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92823940|NCT00627731|Prednisolone|prednisolone|mesh-list
92823941|NCT00627731|Prednisolone acetate|prednisolone acetate|mesh-list
92823942|NCT00627731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92823943|NCT00627731|Prednisolone phosphate|prednisolone phosphate|mesh-list
92823944|NCT00627731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823945|NCT00627731|Antiemetics|antiemetics|mesh-ancestor
92823946|NCT00627731|Autonomic Agents|autonomic agents|mesh-ancestor
92823947|NCT00627731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823948|NCT00627731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823949|NCT00627731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823950|NCT00627731|Glucocorticoids|glucocorticoids|mesh-ancestor
92823951|NCT00627731|Hormones|hormones|mesh-ancestor
92823952|NCT00627731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823953|NCT00627731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92823954|NCT00627731|Protective Agents|protective agents|mesh-ancestor
92823955|NCT00627731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823956|NCT00627731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823957|NCT01028027|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92823958|NCT01028027|Tobramycin|tobramycin|mesh-list
92823959|NCT01028027|Dexamethasone|dexamethasone|mesh-list
92823960|NCT01028027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92823961|NCT01028027|Antiemetics|antiemetics|mesh-ancestor
92823962|NCT01028027|Autonomic Agents|autonomic agents|mesh-ancestor
92823963|NCT01028027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92823964|NCT01028027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823965|NCT01028027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92823966|NCT01028027|Glucocorticoids|glucocorticoids|mesh-ancestor
92823967|NCT01028027|Hormones|hormones|mesh-ancestor
92823968|NCT01028027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92823969|NCT01028027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92823970|NCT01028027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823971|NCT01028027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92823972|NCT01028027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92823973|NCT01028027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92823974|NCT01007552|Bevacizumab|bevacizumab|mesh-list
92823975|NCT01007552|Gemcitabine|gemcitabine|mesh-list
92823976|NCT01007552|Capecitabine|capecitabine|mesh-list
92823977|NCT01007552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92823978|NCT01007552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823979|NCT01007552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92823980|NCT01007552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92823981|NCT01007552|Growth Substances|growth substances|mesh-ancestor
92823982|NCT01007552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823983|NCT01007552|Growth Inhibitors|growth inhibitors|mesh-ancestor
92823984|NCT01007552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823985|NCT01007552|Antimetabolites|antimetabolites|mesh-ancestor
92823986|NCT01007552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823987|NCT02870036|Leucovorin|leucovorin|mesh-list
92823988|NCT02870036|Thalidomide|thalidomide|mesh-list
92823989|NCT02870036|Fluorouracil|fluorouracil|mesh-list
92823990|NCT02870036|Calcium|calcium|mesh-list
92823991|NCT02870036|Levoleucovorin|levoleucovorin|mesh-list
92823992|NCT02870036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92823993|NCT02870036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92823994|NCT02870036|Antimetabolites|antimetabolites|mesh-ancestor
92823995|NCT02870036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92823996|NCT02870036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92823997|NCT02870036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92823998|NCT02870036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92823999|NCT02870036|Immunologic Factors|immunologic factors|mesh-ancestor
92824000|NCT02870036|Antidotes|antidotes|mesh-ancestor
92824001|NCT02870036|Protective Agents|protective agents|mesh-ancestor
92824002|NCT02870036|Vitamin B Complex|vitamin b complex|mesh-ancestor
92824003|NCT02870036|Vitamins|vitamins|mesh-ancestor
92824004|NCT02870036|Micronutrients|micronutrients|mesh-ancestor
92824005|NCT02870036|Leprostatic Agents|leprostatic agents|mesh-ancestor
92824006|NCT02870036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824007|NCT02870036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824008|NCT02870036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92824009|NCT02870036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92824010|NCT02870036|Growth Substances|growth substances|mesh-ancestor
92824011|NCT02870036|Growth Inhibitors|growth inhibitors|mesh-ancestor
92824012|NCT04296422|Ibuprofen|ibuprofen|mesh-list
92824013|NCT04296422|Diclofenac|diclofenac|mesh-list
92824014|NCT04296422|Naproxen|naproxen|mesh-list
92148782|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92824015|NCT04296422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92824016|NCT04296422|Piroxicam|piroxicam|mesh-list
92824017|NCT04296422|Contraceptive Agents|contraceptive agents|mesh-list
92824018|NCT04296422|Contraceptives, Oral|contraceptives, oral|mesh-list
92824019|NCT04296422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92824020|NCT04296422|Analgesics|analgesics|mesh-ancestor
92824021|NCT04296422|Sensory System Agents|sensory system agents|mesh-ancestor
92824022|NCT04296422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824023|NCT04296422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824024|NCT04296422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824025|NCT04296422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92824026|NCT04296422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92824027|NCT04296422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824028|NCT04296422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824029|NCT04296422|Gout Suppressants|gout suppressants|mesh-ancestor
92824030|NCT04296422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824031|NCT04296422|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92824033|NCT00998738|Magnesium Sulfate|magnesium sulfate|mesh-list
92824034|NCT00998738|Calcium|calcium|mesh-list
92824035|NCT00998738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92824036|NCT00998738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824037|NCT00998738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92824038|NCT00998738|Analgesics|analgesics|mesh-ancestor
92824039|NCT00998738|Sensory System Agents|sensory system agents|mesh-ancestor
92824040|NCT00998738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824041|NCT00998738|Anesthetics|anesthetics|mesh-ancestor
92824042|NCT00998738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824043|NCT00998738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92824044|NCT00998738|Anticonvulsants|anticonvulsants|mesh-ancestor
92824045|NCT00998738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92824046|NCT00998738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824047|NCT00998738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824048|NCT00998738|Tocolytic Agents|tocolytic agents|mesh-ancestor
92824049|NCT00998738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824050|NCT00997334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92824051|NCT00997334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824052|NCT00997334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824053|NCT00997334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824054|NCT00997334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824055|NCT04369664|Atorvastatin|atorvastatin|mesh-list
92824056|NCT04369664|Ezetimibe|ezetimibe|mesh-list
92824057|NCT04369664|Evolocumab|evolocumab|mesh-list
92824058|NCT04369664|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92824059|NCT04369664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92824060|NCT04369664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824061|NCT04369664|Antimetabolites|antimetabolites|mesh-ancestor
92824062|NCT04369664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824063|NCT04369664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824064|NCT04369664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92824065|NCT04369664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824066|NCT04369664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92824067|NCT04369664|Protease Inhibitors|protease inhibitors|mesh-ancestor
92824068|NCT04296578|Selenious Acid|selenious acid|mesh-list
92824069|NCT04296578|Sodium Selenite|sodium selenite|mesh-list
92824070|NCT04296578|Prednisone|prednisone|mesh-list
92824071|NCT04296578|Abiraterone Acetate|abiraterone acetate|mesh-list
92824072|NCT04296578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824073|NCT04296578|Glucocorticoids|glucocorticoids|mesh-ancestor
92824074|NCT04296578|Hormones|hormones|mesh-ancestor
92824075|NCT04296578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824076|NCT04296578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824077|NCT04296578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92824078|NCT04296578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824079|NCT04296578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92824080|NCT04296578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469100|NCT01812954|Antimetabolites|antimetabolites|mesh-ancestor
92824081|NCT04296578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824082|NCT04296578|Hormone Antagonists|hormone antagonists|mesh-ancestor
92824083|NCT04296578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92824084|NCT04296578|Trace Elements|trace elements|mesh-ancestor
92824085|NCT04296578|Micronutrients|micronutrients|mesh-ancestor
92824086|NCT00996944|Ropinirole|ropinirole|mesh-list
92824087|NCT00996944|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92824088|NCT00996944|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92824089|NCT00996944|Dopamine Agonists|dopamine agonists|mesh-ancestor
92824090|NCT00996944|Dopamine Agents|dopamine agents|mesh-ancestor
92824091|NCT00996944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824092|NCT00996944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824093|NCT00996944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824094|NCT01027949|Treprostinil|treprostinil|mesh-list
92824095|NCT01027949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92824096|NCT01038323|Milnacipran|milnacipran|mesh-list
92824097|NCT01038323|Levomilnacipran|levomilnacipran|mesh-list
92824098|NCT01038323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92824099|NCT01038323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92824100|NCT01038323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824101|NCT01038323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824102|NCT01038323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824103|NCT01038323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824104|NCT01038323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92824105|NCT01038323|Analgesics|analgesics|mesh-ancestor
92824106|NCT01038323|Sensory System Agents|sensory system agents|mesh-ancestor
92824107|NCT01038323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824108|NCT01038323|Antidepressive Agents|antidepressive agents|mesh-ancestor
92824109|NCT01038323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824110|NCT01027871|Insulin Glargine|insulin glargine|mesh-list
92824111|NCT01027871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92824112|NCT01027871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824113|NCT04301375|Paclitaxel|paclitaxel|mesh-list
92824114|NCT04301375|Trastuzumab|trastuzumab|mesh-list
92824115|NCT04301375|Pertuzumab|pertuzumab|mesh-list
92824116|NCT04301375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92824117|NCT04301375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824118|NCT04301375|Tubulin Modulators|tubulin modulators|mesh-ancestor
92824119|NCT04301375|Antimitotic Agents|antimitotic agents|mesh-ancestor
92824120|NCT04301375|Mitosis Modulators|mitosis modulators|mesh-ancestor
92824121|NCT04301375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824122|NCT04301375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824123|NCT01021553|Diketopiperazines|diketopiperazines|mesh-list
92824124|NCT01021553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824125|NCT01021553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824126|NCT01026389|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92824127|NCT01026389|Chelating Agents|chelating agents|mesh-ancestor
92824128|NCT01026389|Sequestering Agents|sequestering agents|mesh-ancestor
92824129|NCT01026389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824130|NCT01025843|Candesartan|candesartan|mesh-list
92824131|NCT01025843|Candesartan cilexetil|candesartan cilexetil|mesh-list
92824132|NCT01025843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92824133|NCT01025843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92824134|NCT01025843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92824135|NCT01025843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824136|NCT02873351|Levodopa|levodopa|mesh-list
92824137|NCT02873351|Carbidopa|carbidopa|mesh-list
92824138|NCT02873351|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92824139|NCT02873351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92824140|NCT02873351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92824141|NCT02873351|Dopamine Agents|dopamine agents|mesh-ancestor
92824142|NCT02873351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824143|NCT02873351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824144|NCT02873351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824145|NCT02873351|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92824146|NCT02873351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824147|NCT02873351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92824148|NCT02873351|Immunologic Factors|immunologic factors|mesh-ancestor
92824149|NCT02873351|Dopamine Agonists|dopamine agonists|mesh-ancestor
92824150|NCT04299971|Methotrexate|methotrexate|mesh-list
92824151|NCT04299971|Tofacitinib|tofacitinib|mesh-list
92824152|NCT04299971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92824153|NCT04299971|Abortifacient Agents|abortifacient agents|mesh-ancestor
92824154|NCT04299971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824155|NCT04299971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824156|NCT04299971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92824157|NCT04299971|Antimetabolites|antimetabolites|mesh-ancestor
92824158|NCT04299971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824159|NCT04299971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824160|NCT04299971|Dermatologic Agents|dermatologic agents|mesh-ancestor
92824161|NCT04299971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824162|NCT04299971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92824163|NCT04299971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824164|NCT04299971|Immunologic Factors|immunologic factors|mesh-ancestor
92824165|NCT04299971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92824166|NCT04299971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92824167|NCT04299971|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92824168|NCT04299971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824169|NCT01020305|Sirolimus|sirolimus|mesh-list
92824170|NCT01020305|Temsirolimus|temsirolimus|mesh-list
92824171|NCT01020305|MTOR Inhibitors|mtor inhibitors|mesh-list
92824172|NCT01020305|Bicalutamide|bicalutamide|mesh-list
92824173|NCT01020305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824174|NCT01020305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824175|NCT01020305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824176|NCT01020305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824178|NCT01020305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824179|NCT01020305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824180|NCT01020305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824181|NCT01020305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824182|NCT01020305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824183|NCT01020305|Antifungal Agents|antifungal agents|mesh-ancestor
92824184|NCT01020305|Androgen Antagonists|androgen antagonists|mesh-ancestor
92824185|NCT01020305|Hormone Antagonists|hormone antagonists|mesh-ancestor
92824186|NCT01020305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824187|NCT00627575|Lamotrigine|lamotrigine|mesh-list
92824188|NCT00627575|Phenytoin|phenytoin|mesh-list
92824189|NCT00627575|Atorvastatin|atorvastatin|mesh-list
92824190|NCT00627575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92824191|NCT00627575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824192|NCT00627575|Antimetabolites|antimetabolites|mesh-ancestor
92824193|NCT00627575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824194|NCT00627575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824195|NCT00627575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92824196|NCT00627575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824197|NCT00627575|Anticonvulsants|anticonvulsants|mesh-ancestor
92824198|NCT00627575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92824199|NCT00627575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824200|NCT00627575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92824201|NCT00627575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824202|NCT00627575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92824203|NCT00627575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92824204|NCT00627575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824205|NCT00627575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824206|NCT00627575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92824207|NCT00627575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92824208|NCT00627575|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92824209|NCT00627575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92824210|NCT00627809|Streptokinase|streptokinase|mesh-list
92824211|NCT00627809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92824212|NCT00627809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92824213|NCT00627809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824214|NCT01024751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92824215|NCT02872649|Warfarin|warfarin|mesh-list
92824216|NCT02872649|Dabigatran|dabigatran|mesh-list
92824217|NCT02872649|Phenprocoumon|phenprocoumon|mesh-list
92824218|NCT02872649|Anticoagulants|anticoagulants|mesh-ancestor
92824219|NCT02872649|Antithrombins|antithrombins|mesh-ancestor
92824220|NCT02872649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92824221|NCT02872649|Protease Inhibitors|protease inhibitors|mesh-ancestor
92824222|NCT02872649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824223|NCT02872649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824224|NCT01019369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92824225|NCT01019369|Medroxyprogesterone|medroxyprogesterone|mesh-list
92824226|NCT01019369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92469248|NCT01813643|Dopamine Agents|dopamine agents|mesh-ancestor
92824227|NCT01019369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92824228|NCT01019369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92824229|NCT01019369|Contraceptive Agents|contraceptive agents|mesh-ancestor
92824230|NCT01019369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726009|NCT04575389|Uric Acid|uric acid|mesh-list
92824231|NCT01019369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824232|NCT01019369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92824233|NCT01019369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92824234|NCT01019369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92824235|NCT01019369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92824236|NCT01019369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824238|NCT01018511|Solifenacin Succinate|solifenacin succinate|mesh-list
92824239|NCT01018511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92824240|NCT01018511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92824241|NCT01018511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92824242|NCT01018511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92824243|NCT01018511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824244|NCT01018511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824245|NCT01018511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824246|NCT01018511|Urological Agents|urological agents|mesh-ancestor
92824248|NCT01018511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92824249|NCT01018511|Cholinergic Agents|cholinergic agents|mesh-ancestor
92824250|NCT00996476|Simeprevir|simeprevir|mesh-list
92824251|NCT00996476|Antiviral Agents|antiviral agents|mesh-ancestor
92824252|NCT00996476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824253|NCT00996476|Protease Inhibitors|protease inhibitors|mesh-ancestor
92824254|NCT00996476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824255|NCT00996476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824256|NCT02269267|Imatinib Mesylate|imatinib mesylate|mesh-list
92824257|NCT02269267|Dasatinib|dasatinib|mesh-list
92824258|NCT02269267|Tin Fluorides|tin fluorides|mesh-list
92824259|NCT02269267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824260|NCT02269267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824261|NCT02269267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824262|NCT02269267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824263|NCT02269267|Cariostatic Agents|cariostatic agents|mesh-ancestor
92824264|NCT02269267|Protective Agents|protective agents|mesh-ancestor
92824265|NCT02269267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824266|NCT02575495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92824267|NCT02575495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92824268|NCT02575495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824269|NCT02575495|Antitubercular Agents|antitubercular agents|mesh-ancestor
92824270|NCT02575261|Immunomodulating Agents|immunomodulating agents|mesh-list
92824271|NCT02575261|Immunologic Factors|immunologic factors|mesh-ancestor
92824272|NCT02575261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824273|NCT01017731|Diphenhydramine|diphenhydramine|mesh-list
92824274|NCT01017731|Promethazine|promethazine|mesh-list
92824275|NCT01017731|Moxifloxacin|moxifloxacin|mesh-list
92824276|NCT01017731|Ramucirumab|ramucirumab|mesh-list
92824277|NCT01017731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824278|NCT01017731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824279|NCT01017731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92824280|NCT01017731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92824281|NCT01017731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824282|NCT01017731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824283|NCT01017731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824284|NCT01017731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824285|NCT01017731|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92824286|NCT01017731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92824287|NCT01017731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824288|NCT01017731|Anesthetics, Local|anesthetics, local|mesh-ancestor
92824289|NCT01017731|Anesthetics|anesthetics|mesh-ancestor
92824290|NCT01017731|Sensory System Agents|sensory system agents|mesh-ancestor
92824291|NCT01017731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824292|NCT01017731|Antiemetics|antiemetics|mesh-ancestor
92824293|NCT01017731|Autonomic Agents|autonomic agents|mesh-ancestor
92824294|NCT01017731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92824295|NCT01017731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92824296|NCT01017731|Histamine Antagonists|histamine antagonists|mesh-ancestor
92824297|NCT01017731|Histamine Agents|histamine agents|mesh-ancestor
92824298|NCT01017731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824299|NCT01017731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92469318|NCT01814059|Immunologic Factors|immunologic factors|mesh-ancestor
92824300|NCT01017731|Antipruritics|antipruritics|mesh-ancestor
92824301|NCT01017731|Dermatologic Agents|dermatologic agents|mesh-ancestor
92824302|NCT02575183|Varenicline|varenicline|mesh-list
92824303|NCT02575183|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92824304|NCT02575183|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92824305|NCT02575183|Cholinergic Agents|cholinergic agents|mesh-ancestor
92824306|NCT02575183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824307|NCT02575183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824308|NCT02575183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824309|NCT02255305|Anti-Infective Agents|anti-infective agents|mesh-list
92824310|NCT02255305|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92824311|NCT00779584|Gemcitabine|gemcitabine|mesh-list
92824312|NCT00779584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92824313|NCT00779584|Antimetabolites|antimetabolites|mesh-ancestor
92824314|NCT00779584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824315|NCT00779584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824316|NCT00779506|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92824317|NCT00779506|Antidepressive Agents|antidepressive agents|mesh-ancestor
92824318|NCT00779506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824319|NCT00779506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92824320|NCT00779506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92169180|NCT05904106|Immunologic Factors|immunologic factors|mesh-ancestor
92824321|NCT00779506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824322|NCT00779506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824324|NCT01385059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824325|NCT01385059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824326|NCT01385059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824327|NCT01385059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824328|NCT00769132|Niacin|niacin|mesh-list
92824329|NCT00769132|Niacinamide|niacinamide|mesh-list
92824330|NCT00769132|Nicotinic Acids|nicotinic acids|mesh-list
92824331|NCT00769132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824332|NCT00769132|Antimetabolites|antimetabolites|mesh-ancestor
92824333|NCT00769132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824334|NCT00769132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824335|NCT00769132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92824336|NCT00769132|Vitamin B Complex|vitamin b complex|mesh-ancestor
92824337|NCT00769132|Vitamins|vitamins|mesh-ancestor
92824338|NCT00769132|Micronutrients|micronutrients|mesh-ancestor
92824339|NCT00769132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824340|NCT04070755|Minocycline|minocycline|mesh-list
92824341|NCT04070755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824342|NCT04070755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824343|NCT04100434|Evolocumab|evolocumab|mesh-list
92824344|NCT04100434|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92824345|NCT04100434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92824346|NCT04100434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824347|NCT04100434|Antimetabolites|antimetabolites|mesh-ancestor
92824348|NCT04100434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824349|NCT04100434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92824350|NCT04100434|Protease Inhibitors|protease inhibitors|mesh-ancestor
92824351|NCT04100434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824352|NCT04100434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824353|NCT00991952|Irinotecan|irinotecan|mesh-list
92824354|NCT00991952|Alvocidib|alvocidib|mesh-list
92824355|NCT00991952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92824356|NCT00991952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92824357|NCT00991952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824358|NCT00991952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824359|NCT00991952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824360|NCT00991952|Growth Inhibitors|growth inhibitors|mesh-ancestor
92824361|NCT00991952|Growth Substances|growth substances|mesh-ancestor
92824362|NCT00991952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824363|NCT00991952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824364|NCT00779038|Fentanyl|fentanyl|mesh-list
92824365|NCT00779038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92824366|NCT00779038|Narcotics|narcotics|mesh-ancestor
92824367|NCT00779038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824368|NCT00779038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824369|NCT00779038|Analgesics|analgesics|mesh-ancestor
92824370|NCT00779038|Sensory System Agents|sensory system agents|mesh-ancestor
92824371|NCT00779038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824372|NCT00779038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92824373|NCT00779038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92824374|NCT00779038|Anesthetics, General|anesthetics, general|mesh-ancestor
92824375|NCT00779038|Anesthetics|anesthetics|mesh-ancestor
92824376|NCT04292990|Fentanyl|fentanyl|mesh-list
92469392|NCT01814410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92824378|NCT04292990|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92824379|NCT04292990|Narcotics|narcotics|mesh-ancestor
92824380|NCT04292990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824381|NCT04292990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824382|NCT04292990|Analgesics|analgesics|mesh-ancestor
92824383|NCT04292990|Sensory System Agents|sensory system agents|mesh-ancestor
92824384|NCT04292990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824385|NCT04292990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92824386|NCT04292990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92824387|NCT04292990|Anesthetics, General|anesthetics, general|mesh-ancestor
92824388|NCT04292990|Anesthetics|anesthetics|mesh-ancestor
92824389|NCT02868632|Durvalumab|durvalumab|mesh-list
92824390|NCT02868632|Tremelimumab|tremelimumab|mesh-list
92824391|NCT02868632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824392|NCT02868632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824393|NCT04021498|Simvastatin|simvastatin|mesh-list
92824394|NCT04021498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92824395|NCT04021498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824396|NCT04021498|Antimetabolites|antimetabolites|mesh-ancestor
92824397|NCT04021498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824398|NCT04021498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824399|NCT04021498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92824400|NCT04021498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824401|NCT00994682|Pioglitazone|pioglitazone|mesh-list
92824402|NCT00994682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92824403|NCT00994682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824404|NCT00994448|Bupropion|bupropion|mesh-list
92824405|NCT00994448|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92824406|NCT00994448|Antidepressive Agents|antidepressive agents|mesh-ancestor
92824407|NCT00994448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824408|NCT00994448|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92824409|NCT00994448|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92824410|NCT00994448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824411|NCT00994448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824412|NCT00994448|Dopamine Agents|dopamine agents|mesh-ancestor
92824413|NCT00994448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824414|NCT00994448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824415|NCT00994448|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92824416|NCT00994448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92824417|NCT00994448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824418|NCT04292444|Oxytocin|oxytocin|mesh-list
92824419|NCT04292444|Oxytocics|oxytocics|mesh-ancestor
92824420|NCT04292444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824421|NCT04292444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824422|NCT01017575|Ribavirin|ribavirin|mesh-list
92824423|NCT01017575|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92824424|NCT01017575|Antimetabolites|antimetabolites|mesh-ancestor
92824425|NCT01017575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824426|NCT01017575|Antiviral Agents|antiviral agents|mesh-ancestor
92824427|NCT01017575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824428|NCT01017263|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92824429|NCT01017263|Dextroamphetamine|dextroamphetamine|mesh-list
92824430|NCT01017263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92824431|NCT01017263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824432|NCT01017263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92824433|NCT01017263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92824434|NCT01017263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824435|NCT01017263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824436|NCT01017263|Dopamine Agents|dopamine agents|mesh-ancestor
92824437|NCT01017263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824438|NCT01253161|Pasireotide|pasireotide|mesh-list
92824439|NCT01253161|Hormones|hormones|mesh-ancestor
92824440|NCT01253161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824441|NCT01253161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824442|NCT00709423|Moxaverine|moxaverine|mesh-list
92824443|NCT00709423|Parasympatholytics|parasympatholytics|mesh-ancestor
92824444|NCT00709423|Autonomic Agents|autonomic agents|mesh-ancestor
92824445|NCT00709423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824446|NCT00709423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824447|NCT00627887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92824448|NCT00627887|Antidepressive Agents|antidepressive agents|mesh-ancestor
92824449|NCT00627887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92469472|NCT01814618|Budesonide|budesonide|mesh-list
92824450|NCT00627887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824451|NCT00627887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824452|NCT00627887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92824453|NCT00627887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92824454|NCT00627887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824455|NCT00627887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824456|NCT00627887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92824457|NCT02576665|Flucytosine|flucytosine|mesh-list
92824458|NCT02576665|Antifungal Agents|antifungal agents|mesh-ancestor
92824459|NCT02576665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824460|NCT02576665|Antimetabolites|antimetabolites|mesh-ancestor
92824461|NCT02576665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824462|NCT00627965|Sildenafil Citrate|sildenafil citrate|mesh-list
92824463|NCT00627965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824464|NCT00627965|Vasodilator Agents|vasodilator agents|mesh-ancestor
92824465|NCT00627965|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92824466|NCT00627965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92824467|NCT00627965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824468|NCT00627965|Urological Agents|urological agents|mesh-ancestor
92824470|NCT02576353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92824471|NCT02576353|Narcotics|narcotics|mesh-ancestor
92824472|NCT02576353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824473|NCT02576353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824474|NCT02576353|Analgesics|analgesics|mesh-ancestor
92824475|NCT02576353|Sensory System Agents|sensory system agents|mesh-ancestor
92824476|NCT02576353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824477|NCT02576353|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92824478|NCT02576353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92824479|NCT02576353|Anesthetics, General|anesthetics, general|mesh-ancestor
92824480|NCT02576353|Anesthetics|anesthetics|mesh-ancestor
92824481|NCT01016015|Sirolimus|sirolimus|mesh-list
92824482|NCT01016015|Temsirolimus|temsirolimus|mesh-list
92824483|NCT01016015|MTOR Inhibitors|mtor inhibitors|mesh-list
92824484|NCT01016015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92824485|NCT01016015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824486|NCT01016015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824487|NCT01016015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824488|NCT01016015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824489|NCT01016015|Antifungal Agents|antifungal agents|mesh-ancestor
92824490|NCT01016015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824491|NCT01016015|Immunologic Factors|immunologic factors|mesh-ancestor
92824492|NCT01016015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824493|NCT01016015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824494|NCT01016015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824495|NCT01016015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824496|NCT00628043|Epoetin Alfa|epoetin alfa|mesh-list
92824497|NCT00628043|Hematinics|hematinics|mesh-ancestor
92824498|NCT00709657|Bevacizumab|bevacizumab|mesh-list
92824499|NCT00709657|Ranibizumab|ranibizumab|mesh-list
92824500|NCT00709657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824501|NCT00709657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824502|NCT00709657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92824503|NCT00709657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92824504|NCT00709657|Growth Substances|growth substances|mesh-ancestor
92824505|NCT00709657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824506|NCT00709657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92824507|NCT04073173|Analgesics, Opioid|analgesics, opioid|mesh-list
92824508|NCT04073173|Analgesics|analgesics|mesh-list
92824509|NCT04073173|Narcotics|narcotics|mesh-ancestor
92824510|NCT04073173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824511|NCT04073173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824512|NCT04073173|Sensory System Agents|sensory system agents|mesh-ancestor
92824513|NCT04073173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824514|NCT00628121|Cetrorelix|cetrorelix|mesh-list
92824515|NCT00628121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92824516|NCT00628121|Fertility Agents|fertility agents|mesh-ancestor
92824517|NCT00628121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824518|NCT00628121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824519|NCT00628121|Hormone Antagonists|hormone antagonists|mesh-ancestor
92824520|NCT00628121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824521|NCT00709969|Lumefantrine|lumefantrine|mesh-list
92824522|NCT00709969|Artemether|artemether|mesh-list
92824523|NCT00709969|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92824524|NCT00709969|Antimalarials|antimalarials|mesh-ancestor
92824525|NCT00709969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92824526|NCT00709969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92824527|NCT00709969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824528|NCT00710125|Doxorubicin|doxorubicin|mesh-list
92824529|NCT00710125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824530|NCT00710125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824531|NCT00710125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92824532|NCT00710125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92824533|NCT00710125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824534|NCT00710125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824535|NCT02573701|Risperidone|risperidone|mesh-list
92824536|NCT02573701|Antipsychotic Agents|antipsychotic agents|mesh-list
92824537|NCT02573701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92824538|NCT02573701|Serotonin Agents|serotonin agents|mesh-ancestor
92824539|NCT02573701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824540|NCT02573701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824541|NCT02573701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824542|NCT02573701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92824543|NCT02573701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824544|NCT02573701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824545|NCT02573701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92824546|NCT02573701|Dopamine Agents|dopamine agents|mesh-ancestor
92824547|NCT01017029|Mycophenolic Acid|mycophenolic acid|mesh-list
92824549|NCT01017029|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92824550|NCT01017029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824551|NCT01017029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824552|NCT01017029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824553|NCT01017029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824554|NCT01017029|Immunologic Factors|immunologic factors|mesh-ancestor
92824555|NCT01017029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824556|NCT01017029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824557|NCT01017029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824558|NCT01017029|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92824559|NCT01017029|Antitubercular Agents|antitubercular agents|mesh-ancestor
92824560|NCT01017029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824561|NCT01017029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824563|NCT00714649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824564|NCT00714649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824565|NCT00710359|Vitamins|vitamins|mesh-list
92824566|NCT00710359|Vitamin B 12|vitamin b 12|mesh-list
92824567|NCT00710359|Hydroxocobalamin|hydroxocobalamin|mesh-list
92824568|NCT00710359|Vitamin B Complex|vitamin b complex|mesh-list
92824569|NCT00710359|Micronutrients|micronutrients|mesh-ancestor
92726331|NCT00590603|Vitamins|vitamins|mesh-ancestor
92824570|NCT00710359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824571|NCT00710359|Hematinics|hematinics|mesh-ancestor
92824572|NCT02578849|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92824573|NCT02578849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92824574|NCT02578849|Immunologic Factors|immunologic factors|mesh-ancestor
92824575|NCT02578849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824576|NCT02578849|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92824577|NCT02578849|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92824578|NCT02578849|Dopamine Agonists|dopamine agonists|mesh-ancestor
92824579|NCT02578849|Dopamine Agents|dopamine agents|mesh-ancestor
92824580|NCT02578849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824581|NCT02578849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824582|NCT00710437|Dexmedetomidine|dexmedetomidine|mesh-list
92824583|NCT00710437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92824584|NCT00710437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824585|NCT00710437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824586|NCT00710437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92824587|NCT00710437|Analgesics|analgesics|mesh-ancestor
92824588|NCT00710437|Sensory System Agents|sensory system agents|mesh-ancestor
92824589|NCT00710437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824590|NCT00710437|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92824591|NCT00710437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92824592|NCT00710437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92824593|NCT00710437|Adrenergic Agents|adrenergic agents|mesh-ancestor
92824594|NCT00710437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824595|NCT00710437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824596|NCT02574715|Levonorgestrel|levonorgestrel|mesh-list
92824597|NCT02574715|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92469615|NCT01815437|Vitamins|vitamins|mesh-list
92824598|NCT02574715|Contraceptive Agents|contraceptive agents|mesh-ancestor
92824599|NCT02574715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824600|NCT02574715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824601|NCT02574715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92824602|NCT02574715|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92824603|NCT02574715|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92824604|NCT00714883|Sirolimus|sirolimus|mesh-list
92824605|NCT00714883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824606|NCT00714883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824607|NCT00714883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824608|NCT00714883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824609|NCT00714883|Antifungal Agents|antifungal agents|mesh-ancestor
92824610|NCT00714883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824611|NCT00714883|Immunologic Factors|immunologic factors|mesh-ancestor
92824612|NCT00714883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824613|NCT00710827|Testosterone undecanoate|testosterone undecanoate|mesh-list
92824614|NCT00710827|Androgens|androgens|mesh-ancestor
92824615|NCT00710827|Hormones|hormones|mesh-ancestor
92824616|NCT00710827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824617|NCT00710827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169477|NCT05878093|Hormones|hormones|mesh-ancestor
92824618|NCT01034657|Panobinostat|panobinostat|mesh-list
92824619|NCT01034657|Epoetin Alfa|epoetin alfa|mesh-list
92824620|NCT01034657|Hematinics|hematinics|mesh-ancestor
92824621|NCT01034657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824622|NCT01034657|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92824623|NCT01034657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824624|NCT01034657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824626|NCT01014767|Dactinomycin|dactinomycin|mesh-list
92824627|NCT01014767|Cyclophosphamide|cyclophosphamide|mesh-list
92824628|NCT01014767|Temozolomide|temozolomide|mesh-list
92824629|NCT01014767|Cisplatin|cisplatin|mesh-list
92824630|NCT01014767|Carboplatin|carboplatin|mesh-list
92824631|NCT01014767|Doxorubicin|doxorubicin|mesh-list
92824632|NCT01014767|Methotrexate|methotrexate|mesh-list
92824633|NCT01014767|Irinotecan|irinotecan|mesh-list
92824634|NCT01014767|Etoposide|etoposide|mesh-list
92824635|NCT01014767|Vincristine|vincristine|mesh-list
92824636|NCT01014767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824637|NCT01014767|Immunologic Factors|immunologic factors|mesh-ancestor
92824638|NCT01014767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824639|NCT01014767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726402|NCT00591188|Interferons|interferons|mesh-list
92824640|NCT01014767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92824641|NCT01014767|Alkylating Agents|alkylating agents|mesh-ancestor
92824642|NCT01014767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824643|NCT01014767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824644|NCT01014767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92824645|NCT01014767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824646|NCT01014767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92824647|NCT01014767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92824648|NCT01014767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824649|NCT01014767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92824650|NCT01014767|Abortifacient Agents|abortifacient agents|mesh-ancestor
92824651|NCT01014767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92824652|NCT01014767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92824653|NCT01014767|Antimetabolites|antimetabolites|mesh-ancestor
92824654|NCT01014767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92824655|NCT01014767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92824656|NCT01014767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92824657|NCT01014767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92824658|NCT01014767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92824659|NCT01014767|Antidotes|antidotes|mesh-ancestor
92824660|NCT01014767|Protective Agents|protective agents|mesh-ancestor
92824661|NCT01014767|Vitamin B Complex|vitamin b complex|mesh-ancestor
92824662|NCT01014767|Vitamins|vitamins|mesh-ancestor
92824663|NCT01014767|Micronutrients|micronutrients|mesh-ancestor
92824664|NCT01014767|Tubulin Modulators|tubulin modulators|mesh-ancestor
92824665|NCT01014767|Antimitotic Agents|antimitotic agents|mesh-ancestor
92824666|NCT01014767|Mitosis Modulators|mitosis modulators|mesh-ancestor
92824667|NCT01014767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824668|NCT01014767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824669|NCT01014767|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92824670|NCT01014689|Lymecycline|lymecycline|mesh-list
92824671|NCT01014689|Adapalene|adapalene|mesh-list
92824672|NCT01014689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92824673|NCT01014689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92824674|NCT01014689|Analgesics|analgesics|mesh-ancestor
92824675|NCT01014689|Sensory System Agents|sensory system agents|mesh-ancestor
92824676|NCT01014689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824677|NCT01014689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824678|NCT01014689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824679|NCT01014689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92824680|NCT01014689|Dermatologic Agents|dermatologic agents|mesh-ancestor
92824681|NCT01014689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824682|NCT01014689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824683|NCT01014533|Gabapentin|gabapentin|mesh-list
92824684|NCT01014533|Analgesics|analgesics|mesh-ancestor
92824685|NCT01014533|Sensory System Agents|sensory system agents|mesh-ancestor
92824686|NCT01014533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824687|NCT01014533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824688|NCT01014533|Anticonvulsants|anticonvulsants|mesh-ancestor
92824689|NCT01014533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92824690|NCT01014533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92824691|NCT01014533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824692|NCT01014533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824693|NCT01014533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92824694|NCT01014533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92169554|NCT05826574|Rifampin|rifampin|mesh-list
92824696|NCT01014533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824697|NCT01014533|Antimanic Agents|antimanic agents|mesh-ancestor
92824698|NCT02013427|Naproxen|naproxen|mesh-list
92824699|NCT02013427|Omeprazole|omeprazole|mesh-list
92824700|NCT02013427|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92824701|NCT02013427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92824702|NCT02013427|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92824703|NCT02013427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824704|NCT02013427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824705|NCT02013427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92824706|NCT02013427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92824707|NCT02013427|Analgesics|analgesics|mesh-ancestor
92824708|NCT02013427|Sensory System Agents|sensory system agents|mesh-ancestor
92824709|NCT02013427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824710|NCT02013427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824711|NCT02013427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824712|NCT02013427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92824713|NCT02013427|Gout Suppressants|gout suppressants|mesh-ancestor
92824714|NCT02013427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92824715|NCT01014143|Chlorhexidine|chlorhexidine|mesh-list
92824716|NCT01014143|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92824717|NCT01014143|Triclosan|triclosan|mesh-list
92824718|NCT01014143|Fluorides|fluorides|mesh-list
92824719|NCT01014143|Cariostatic Agents|cariostatic agents|mesh-ancestor
92824720|NCT01014143|Protective Agents|protective agents|mesh-ancestor
92824721|NCT01014143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824722|NCT01014143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92824723|NCT01014143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824724|NCT01014143|Disinfectants|disinfectants|mesh-ancestor
92824725|NCT01014143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92824726|NCT01014143|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92824727|NCT01014143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824728|NCT01014143|Antimetabolites|antimetabolites|mesh-ancestor
92824729|NCT01014143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824730|NCT01014143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824731|NCT00714961|Clopidogrel|clopidogrel|mesh-list
92824732|NCT00714961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92824733|NCT00714961|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92824734|NCT00714961|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92824735|NCT00714961|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92824736|NCT00714961|Purinergic Agents|purinergic agents|mesh-ancestor
92824737|NCT00714961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824738|NCT00714961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824739|NCT00714961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824740|NCT02574403|Eculizumab|eculizumab|mesh-list
92824741|NCT02574403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92824742|NCT02574403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824743|NCT02574403|Immunologic Factors|immunologic factors|mesh-ancestor
92824744|NCT02574403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824745|NCT01013753|Formoterol Fumarate|formoterol fumarate|mesh-list
92824746|NCT01013753|Olodaterol|olodaterol|mesh-list
92824747|NCT01013753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92824748|NCT01013753|Autonomic Agents|autonomic agents|mesh-ancestor
92824749|NCT01013753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824750|NCT01013753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824751|NCT01013753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92824752|NCT01013753|Respiratory System Agents|respiratory system agents|mesh-ancestor
92824753|NCT01013753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92824754|NCT01013753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92824755|NCT01013753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92824756|NCT01013753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92824757|NCT01013753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824758|NCT01013753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824759|NCT00715039|Lorazepam|lorazepam|mesh-list
92824760|NCT00715039|Paroxetine|paroxetine|mesh-list
92824761|NCT00715039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92824762|NCT00715039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92824763|NCT00715039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92824764|NCT00715039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824765|NCT00715039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824766|NCT00715039|Serotonin Agents|serotonin agents|mesh-ancestor
92824767|NCT00715039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824768|NCT00715039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92824770|NCT00715039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92824771|NCT00715039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92824772|NCT00715039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92824773|NCT00715039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824774|NCT00715039|Anticonvulsants|anticonvulsants|mesh-ancestor
92824775|NCT00715039|Antiemetics|antiemetics|mesh-ancestor
92824776|NCT00715039|Autonomic Agents|autonomic agents|mesh-ancestor
92824777|NCT00715039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824778|NCT00715039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92824779|NCT00715039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92824780|NCT00715039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92824781|NCT00715039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92824782|NCT00715039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92824783|NCT00715039|GABA Modulators|gaba modulators|mesh-ancestor
92824784|NCT00715039|GABA Agents|gaba agents|mesh-ancestor
92824785|NCT00711295|Vaccines|vaccines|mesh-list
92824786|NCT00711295|Immunologic Factors|immunologic factors|mesh-ancestor
92726552|NCT03450317|Antipyretics|antipyretics|mesh-ancestor
92824787|NCT00711295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824788|NCT02871869|Buformin|buformin|mesh-list
92824789|NCT02871869|Prednisone|prednisone|mesh-list
92824790|NCT02871869|Cyclophosphamide|cyclophosphamide|mesh-list
92824791|NCT02871869|Rituximab|rituximab|mesh-list
92824792|NCT02871869|Epirubicin|epirubicin|mesh-list
92824793|NCT02871869|Vindesine|vindesine|mesh-list
92824794|NCT02871869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92824795|NCT02871869|Immunologic Factors|immunologic factors|mesh-ancestor
92824796|NCT02871869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824797|NCT02871869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92824798|NCT02871869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92824799|NCT02871869|Alkylating Agents|alkylating agents|mesh-ancestor
92824800|NCT02871869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824801|NCT02871869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824802|NCT02871869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92824803|NCT02871869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824804|NCT02871869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824805|NCT02871869|Glucocorticoids|glucocorticoids|mesh-ancestor
92824806|NCT02871869|Hormones|hormones|mesh-ancestor
92824807|NCT02871869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824808|NCT02871869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92824809|NCT02871869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92824810|NCT02871869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92824811|NCT02871869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92824812|NCT02871869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824813|NCT02871869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92824814|NCT02871869|Tubulin Modulators|tubulin modulators|mesh-ancestor
92824815|NCT02871869|Antimitotic Agents|antimitotic agents|mesh-ancestor
92824816|NCT02871869|Mitosis Modulators|mitosis modulators|mesh-ancestor
92824817|NCT02871869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92824818|NCT01013597|Panobinostat|panobinostat|mesh-list
92824819|NCT01013597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824820|NCT01013597|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92824821|NCT01013597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824822|NCT01013597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824823|NCT00715273|Niacin|niacin|mesh-list
92824824|NCT00715273|Niacinamide|niacinamide|mesh-list
92824825|NCT00715273|Nicotinic Acids|nicotinic acids|mesh-list
92824826|NCT00715273|Atorvastatin|atorvastatin|mesh-list
92824827|NCT00715273|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92824828|NCT00715273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92824830|NCT00715273|Antimetabolites|antimetabolites|mesh-ancestor
92824831|NCT00715273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824832|NCT00715273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824833|NCT00715273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92824834|NCT00715273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824835|NCT00715273|Vasodilator Agents|vasodilator agents|mesh-ancestor
92824836|NCT00715273|Vitamin B Complex|vitamin b complex|mesh-ancestor
92824837|NCT00715273|Vitamins|vitamins|mesh-ancestor
92824838|NCT00715273|Micronutrients|micronutrients|mesh-ancestor
92824839|NCT00715273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824840|NCT01013285|Bevacizumab|bevacizumab|mesh-list
92824841|NCT01013285|Temozolomide|temozolomide|mesh-list
92824842|NCT01013285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824843|NCT01013285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824844|NCT01013285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92824845|NCT01013285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92824846|NCT01013285|Growth Substances|growth substances|mesh-ancestor
92824847|NCT01013285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824848|NCT01013285|Growth Inhibitors|growth inhibitors|mesh-ancestor
92824849|NCT01013285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92824850|NCT01013285|Alkylating Agents|alkylating agents|mesh-ancestor
92824851|NCT01013285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824852|NCT00715351|Insulin|insulin|mesh-list
92824853|NCT00715351|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92824854|NCT00715351|Insulin Detemir|insulin detemir|mesh-list
92824855|NCT00715351|Isophane Insulin, Human|isophane insulin, human|mesh-list
92824856|NCT00715351|Insulin, Isophane|insulin, isophane|mesh-list
92824857|NCT00715351|Isophane insulin, beef|isophane insulin, beef|mesh-list
92824858|NCT00715351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92824859|NCT00715351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824860|NCT04245085|Paclitaxel|paclitaxel|mesh-list
92824861|NCT04245085|Bevacizumab|bevacizumab|mesh-list
92824862|NCT04245085|Carboplatin|carboplatin|mesh-list
92824863|NCT04245085|Pemetrexed|pemetrexed|mesh-list
92824864|NCT04245085|Atezolizumab|atezolizumab|mesh-list
92824865|NCT04245085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92824866|NCT04245085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824867|NCT04245085|Tubulin Modulators|tubulin modulators|mesh-ancestor
92824868|NCT04245085|Antimitotic Agents|antimitotic agents|mesh-ancestor
92824869|NCT04245085|Mitosis Modulators|mitosis modulators|mesh-ancestor
92824870|NCT04245085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824871|NCT04245085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824872|NCT04245085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92824873|NCT04245085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92824874|NCT04245085|Growth Substances|growth substances|mesh-ancestor
92824875|NCT04245085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824876|NCT04245085|Growth Inhibitors|growth inhibitors|mesh-ancestor
92824877|NCT04245085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824878|NCT04245085|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92824879|NCT04245085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92824880|NCT04245085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92824881|NCT00711841|Dexamethasone|dexamethasone|mesh-list
92824882|NCT00711841|Dexamethasone acetate|dexamethasone acetate|mesh-list
92824883|NCT00711841|BB 1101|bb 1101|mesh-list
92824884|NCT00711841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824885|NCT00711841|Antiemetics|antiemetics|mesh-ancestor
92824886|NCT00711841|Autonomic Agents|autonomic agents|mesh-ancestor
92824887|NCT00711841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824888|NCT00711841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824889|NCT00711841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92824890|NCT00711841|Glucocorticoids|glucocorticoids|mesh-ancestor
92824891|NCT00711841|Hormones|hormones|mesh-ancestor
92824892|NCT00711841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824893|NCT00711841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92824894|NCT00711841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824895|NCT00711841|Protease Inhibitors|protease inhibitors|mesh-ancestor
92824896|NCT00711841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824897|NCT00711841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824898|NCT00711919|Pitavastatin|pitavastatin|mesh-list
92824899|NCT00711919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92824900|NCT00711919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92824901|NCT00711919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92824902|NCT00711919|Antimetabolites|antimetabolites|mesh-ancestor
92824903|NCT00711919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824904|NCT00711919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824905|NCT00711919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92824906|NCT00715663|Insulin Aspart|insulin aspart|mesh-list
92824907|NCT00715663|Biphasic Insulins|biphasic insulins|mesh-list
92824908|NCT00715663|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92726693|NCT00196976|Anticoagulants|anticoagulants|mesh-ancestor
92824909|NCT00715663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92824910|NCT00715663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824911|NCT00712465|Digoxin|digoxin|mesh-list
92824912|NCT00712465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92824913|NCT00712465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92824914|NCT00712465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824915|NCT00712465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824916|NCT00712465|Protective Agents|protective agents|mesh-ancestor
92824917|NCT00712465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824918|NCT00715975|Clobetasol|clobetasol|mesh-list
92824919|NCT00715975|Halobetasol|halobetasol|mesh-list
92824920|NCT00715975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824921|NCT00715975|Glucocorticoids|glucocorticoids|mesh-ancestor
92824922|NCT00715975|Hormones|hormones|mesh-ancestor
92824923|NCT00715975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824924|NCT00715975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824925|NCT00715975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92824926|NCT02572687|Durvalumab|durvalumab|mesh-list
92824927|NCT02572687|Ramucirumab|ramucirumab|mesh-list
92824928|NCT02572687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92824929|NCT02572687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824930|NCT00712777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92824931|NCT00712777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92824932|NCT00712777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92824933|NCT00712777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92824934|NCT00712777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92824935|NCT00712777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92824936|NCT00712777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92824937|NCT00712777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726741|NCT00195494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824938|NCT00712777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824939|NCT00603447|Dexamethasone|dexamethasone|mesh-list
92824940|NCT00603447|Lenalidomide|lenalidomide|mesh-list
92824941|NCT00603447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824942|NCT00603447|Antiemetics|antiemetics|mesh-ancestor
92824943|NCT00603447|Autonomic Agents|autonomic agents|mesh-ancestor
92824944|NCT00603447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824945|NCT00603447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824946|NCT00603447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92824947|NCT00603447|Glucocorticoids|glucocorticoids|mesh-ancestor
92824948|NCT00603447|Hormones|hormones|mesh-ancestor
92824949|NCT00603447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92824950|NCT00603447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92824951|NCT00603447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824952|NCT00603447|Immunologic Factors|immunologic factors|mesh-ancestor
92824953|NCT00603447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92824954|NCT00603447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92824955|NCT00603447|Growth Substances|growth substances|mesh-ancestor
92824956|NCT00603447|Growth Inhibitors|growth inhibitors|mesh-ancestor
92824957|NCT00718705|Josamycin|josamycin|mesh-list
92824958|NCT00718705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92824959|NCT00718705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92824960|NCT00639015|Phenylephrine|phenylephrine|mesh-list
92824961|NCT00639015|Oxymetazoline|oxymetazoline|mesh-list
92824962|NCT00639015|Norepinephrine|norepinephrine|mesh-list
92824963|NCT00639015|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92824964|NCT00639015|Mydriatics|mydriatics|mesh-ancestor
92824965|NCT00639015|Autonomic Agents|autonomic agents|mesh-ancestor
92824966|NCT00639015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824967|NCT00639015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824968|NCT00639015|Sympathomimetics|sympathomimetics|mesh-ancestor
92824969|NCT00639015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92824970|NCT00639015|Nasal Decongestants|nasal decongestants|mesh-ancestor
92824971|NCT00639015|Respiratory System Agents|respiratory system agents|mesh-ancestor
92824972|NCT00639015|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92824973|NCT00639015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92824974|NCT00639015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92824975|NCT00639015|Adrenergic Agents|adrenergic agents|mesh-ancestor
92824976|NCT00639015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726805|NCT02486367|Clopidogrel|clopidogrel|mesh-list
92824977|NCT00639015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824978|NCT00639015|Protective Agents|protective agents|mesh-ancestor
92824980|NCT00712855|Mapatumumab|mapatumumab|mesh-list
92824981|NCT00712855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92824982|NCT00712855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92824983|NCT00712855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824984|NCT00712855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824985|NCT02537925|Celecoxib|celecoxib|mesh-list
92824986|NCT02537925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92824987|NCT02537925|Nedaplatin|nedaplatin|mesh-list
92824988|NCT02537925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92824989|NCT02537925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92824990|NCT02537925|Analgesics|analgesics|mesh-ancestor
92824991|NCT02537925|Sensory System Agents|sensory system agents|mesh-ancestor
92824992|NCT02537925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92824993|NCT02537925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92824994|NCT02537925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92824995|NCT02537925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92824996|NCT02537925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92824997|NCT02537925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92824998|NCT02537925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92824999|NCT02537925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825001|NCT00713011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92825002|NCT00713011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726810|NCT02486367|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92825003|NCT00713011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825004|NCT00713011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825005|NCT00713011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825006|NCT00713011|Vasodilator Agents|vasodilator agents|mesh-ancestor
92825007|NCT00713011|Tocolytic Agents|tocolytic agents|mesh-ancestor
92825008|NCT00713011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92825009|NCT04185675|Anesthetics|anesthetics|mesh-list
92825010|NCT04185675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825011|NCT04185675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825012|NCT04208061|Ritonavir|ritonavir|mesh-list
92825013|NCT04208061|Darunavir|darunavir|mesh-list
92825014|NCT04208061|Dabigatran|dabigatran|mesh-list
92825015|NCT04208061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92825016|NCT04208061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92825017|NCT04208061|Protease Inhibitors|protease inhibitors|mesh-ancestor
92825018|NCT04208061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825019|NCT04208061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825020|NCT04208061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92825021|NCT04208061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92825022|NCT04208061|Antiviral Agents|antiviral agents|mesh-ancestor
92825023|NCT04208061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825024|NCT04208061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92825025|NCT04208061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825026|NCT04208061|Antithrombins|antithrombins|mesh-ancestor
92825027|NCT04208061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92825028|NCT04208061|Anticoagulants|anticoagulants|mesh-ancestor
92825029|NCT00988208|Prednisone|prednisone|mesh-list
92825030|NCT00988208|Docetaxel|docetaxel|mesh-list
92825031|NCT00988208|Lenalidomide|lenalidomide|mesh-list
92825032|NCT00988208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825033|NCT00988208|Tubulin Modulators|tubulin modulators|mesh-ancestor
92825034|NCT00988208|Antimitotic Agents|antimitotic agents|mesh-ancestor
92825035|NCT00988208|Mitosis Modulators|mitosis modulators|mesh-ancestor
92825036|NCT00988208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825037|NCT00988208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825038|NCT00988208|Glucocorticoids|glucocorticoids|mesh-ancestor
92825039|NCT00988208|Hormones|hormones|mesh-ancestor
92825040|NCT00988208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825041|NCT00988208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825042|NCT00988208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92825043|NCT00988208|Immunologic Factors|immunologic factors|mesh-ancestor
92825044|NCT00988208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92825045|NCT00988208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92825046|NCT00988208|Growth Substances|growth substances|mesh-ancestor
92825047|NCT00988208|Growth Inhibitors|growth inhibitors|mesh-ancestor
92825048|NCT00639249|SA 4503|sa 4503|mesh-list
92470059|NCT01818973|Growth Inhibitors|growth inhibitors|mesh-ancestor
92825049|NCT00639249|Nootropic Agents|nootropic agents|mesh-ancestor
92825050|NCT04185831|Everolimus|everolimus|mesh-list
92825051|NCT04185831|Atezolizumab|atezolizumab|mesh-list
92825052|NCT04185831|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92825053|NCT04185831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92825054|NCT04185831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825055|NCT04185831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825056|NCT04185831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825057|NCT04185831|Immunologic Factors|immunologic factors|mesh-ancestor
92825058|NCT04185831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825059|NCT04185831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825060|NCT04185831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92825061|NCT04185831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825062|NCT02686983|Betamethasone|betamethasone|mesh-list
92825063|NCT02686983|Anesthetics|anesthetics|mesh-list
92825064|NCT02686983|Anesthetics, Local|anesthetics, local|mesh-list
92825065|NCT02686983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825066|NCT02686983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825067|NCT02686983|Sensory System Agents|sensory system agents|mesh-ancestor
92825068|NCT02686983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825069|NCT02686983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825070|NCT02686983|Glucocorticoids|glucocorticoids|mesh-ancestor
92825071|NCT02686983|Hormones|hormones|mesh-ancestor
92825072|NCT02686983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825073|NCT02686983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92825074|NCT02686983|Respiratory System Agents|respiratory system agents|mesh-ancestor
92825075|NCT02686905|Calcium, Dietary|calcium, dietary|mesh-list
92825076|NCT02686905|Vitamin D|vitamin d|mesh-list
92825077|NCT02686905|Vitamins|vitamins|mesh-list
92825078|NCT02686905|Hydroxocobalamin|hydroxocobalamin|mesh-list
92825079|NCT02686905|Vitamin B 12|vitamin b 12|mesh-list
92825080|NCT02686905|Calcium|calcium|mesh-list
92825081|NCT02686905|Micronutrients|micronutrients|mesh-ancestor
92825082|NCT02686905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825083|NCT02686905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825084|NCT02686905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92825085|NCT02686905|Hematinics|hematinics|mesh-ancestor
92825086|NCT02686905|Vitamin B Complex|vitamin b complex|mesh-ancestor
92825087|NCT00990704|Maxacalcitol|maxacalcitol|mesh-list
92825088|NCT00990704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825089|NCT00990704|Dermatologic Agents|dermatologic agents|mesh-ancestor
92825090|NCT00990704|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92825091|NCT00990704|Protective Agents|protective agents|mesh-ancestor
92825092|NCT00990704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825093|NCT00639327|Irinotecan|irinotecan|mesh-list
92825094|NCT00639327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92825095|NCT00639327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92825096|NCT00639327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825097|NCT00639327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825098|NCT00639327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825099|NCT02686749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92825100|NCT04089553|Durvalumab|durvalumab|mesh-list
92825101|NCT04089553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825102|NCT04089553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825103|NCT02867852|Abiraterone Acetate|abiraterone acetate|mesh-list
92825104|NCT02867852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825105|NCT02867852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92825106|NCT02867852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825107|NCT02867852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825108|NCT02867852|Hormone Antagonists|hormone antagonists|mesh-ancestor
92825109|NCT02867852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825110|NCT02867852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825111|NCT02867852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825112|NCT02686827|Vitamin D|vitamin d|mesh-list
92825113|NCT02686827|Ergocalciferols|ergocalciferols|mesh-list
92825114|NCT02686827|Vitamins|vitamins|mesh-ancestor
92825115|NCT02686827|Micronutrients|micronutrients|mesh-ancestor
92825116|NCT02686827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825117|NCT02686827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92825118|NCT02686827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825119|NCT00713167|Grape Seed Extract|grape seed extract|mesh-list
92825120|NCT00713167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92825121|NCT00713167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825122|NCT00713167|Antioxidants|antioxidants|mesh-ancestor
92825123|NCT00713167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825124|NCT00713167|Protective Agents|protective agents|mesh-ancestor
92825125|NCT00713167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825126|NCT00716521|Zolpidem|zolpidem|mesh-list
92825127|NCT00716521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92825128|NCT00716521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825129|NCT00716521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825130|NCT00716521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825131|NCT00716521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92825132|NCT00716521|GABA Agonists|gaba agonists|mesh-ancestor
92825133|NCT00716521|GABA Agents|gaba agents|mesh-ancestor
92825134|NCT00716521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825135|NCT00716521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825136|NCT00993668|Certolizumab Pegol|certolizumab pegol|mesh-list
92825137|NCT00993668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92825138|NCT00993668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825139|NCT00993668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825140|NCT00993668|Immunologic Factors|immunologic factors|mesh-ancestor
92825141|NCT00993668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825142|NCT00993668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825144|NCT00778102|Bevacizumab|bevacizumab|mesh-list
92825145|NCT00778102|Oxaliplatin|oxaliplatin|mesh-list
92825146|NCT00778102|Irinotecan|irinotecan|mesh-list
92825147|NCT00778102|Fluorouracil|fluorouracil|mesh-list
92825148|NCT00778102|Levoleucovorin|levoleucovorin|mesh-list
92825149|NCT00778102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825150|NCT00778102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825151|NCT00778102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92825152|NCT00778102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92825153|NCT00778102|Growth Substances|growth substances|mesh-ancestor
92825154|NCT00778102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825155|NCT00778102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92825156|NCT00778102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92825157|NCT00778102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92825158|NCT00778102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825159|NCT00778102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825160|NCT00778102|Antidotes|antidotes|mesh-ancestor
92825161|NCT00778102|Protective Agents|protective agents|mesh-ancestor
92825162|NCT00778102|Vitamin B Complex|vitamin b complex|mesh-ancestor
92825163|NCT00778102|Vitamins|vitamins|mesh-ancestor
92825164|NCT00778102|Micronutrients|micronutrients|mesh-ancestor
92825165|NCT00778102|Antimetabolites|antimetabolites|mesh-ancestor
92825166|NCT00778102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92825167|NCT00778102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825168|NCT00778102|Immunologic Factors|immunologic factors|mesh-ancestor
92825169|NCT00713557|Tirofiban|tirofiban|mesh-list
92825170|NCT00713557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92825171|NCT00713557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92825172|NCT00713557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825173|NCT00713557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92825174|NCT00719095|Naltrexone|naltrexone|mesh-list
92825175|NCT00719095|Buprenorphine|buprenorphine|mesh-list
92825176|NCT00719095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92825177|NCT00719095|Narcotics|narcotics|mesh-ancestor
92825178|NCT00719095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825179|NCT00719095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825180|NCT00719095|Analgesics|analgesics|mesh-ancestor
92825181|NCT00719095|Sensory System Agents|sensory system agents|mesh-ancestor
92825182|NCT00719095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825183|NCT00719095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92825184|NCT00719095|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92825185|NCT00916630|Pemetrexed|pemetrexed|mesh-list
92825186|NCT00916630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825187|NCT00916630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825188|NCT00916630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825189|NCT00916630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92825190|NCT00916630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92825191|NCT02572375|Phenylpropanolamine|phenylpropanolamine|mesh-list
92825192|NCT02572375|Codeine|codeine|mesh-list
92825193|NCT02572375|Guaifenesin|guaifenesin|mesh-list
92825194|NCT02572375|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92825195|NCT02572375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92825196|NCT02572375|Narcotics|narcotics|mesh-ancestor
92825197|NCT02572375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825198|NCT02572375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825199|NCT02572375|Analgesics|analgesics|mesh-ancestor
92825200|NCT02572375|Sensory System Agents|sensory system agents|mesh-ancestor
92825201|NCT02572375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825202|NCT02572375|Antitussive Agents|antitussive agents|mesh-ancestor
92470204|NCT01820026|Cefotaxime|cefotaxime|mesh-list
92825203|NCT02572375|Respiratory System Agents|respiratory system agents|mesh-ancestor
92825204|NCT02572375|Expectorants|expectorants|mesh-ancestor
92825205|NCT02572375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92825206|NCT02572375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92825207|NCT02572375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92825208|NCT02572375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825209|NCT02572375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825210|NCT02572375|Appetite Depressants|appetite depressants|mesh-ancestor
92825211|NCT02572375|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92825212|NCT02572375|Sympathomimetics|sympathomimetics|mesh-ancestor
92825213|NCT02572375|Autonomic Agents|autonomic agents|mesh-ancestor
92825214|NCT02572375|Nasal Decongestants|nasal decongestants|mesh-ancestor
92825215|NCT02572375|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92825216|NCT00716911|Ganciclovir|ganciclovir|mesh-list
92825218|NCT00716911|Antiviral Agents|antiviral agents|mesh-ancestor
92825219|NCT00716911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825220|NCT00716911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92825221|NCT00716911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825222|NCT00716911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825223|NCT00612495|Fluorouracil|fluorouracil|mesh-list
92825224|NCT00612495|Oxaliplatin|oxaliplatin|mesh-list
92825225|NCT00612495|Antimetabolites|antimetabolites|mesh-ancestor
92825226|NCT00612495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825227|NCT00612495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92825228|NCT00612495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825229|NCT00612495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825230|NCT00612495|Immunologic Factors|immunologic factors|mesh-ancestor
92825231|NCT00612495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825232|NCT00719173|Cyclophosphamide|cyclophosphamide|mesh-list
92825233|NCT00719173|Aprepitant|aprepitant|mesh-list
92825234|NCT00719173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825235|NCT00719173|Immunologic Factors|immunologic factors|mesh-ancestor
92825236|NCT00719173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825237|NCT00719173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825238|NCT00719173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92825239|NCT00719173|Alkylating Agents|alkylating agents|mesh-ancestor
92825240|NCT00719173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825241|NCT00719173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825242|NCT00719173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92825243|NCT00719173|Antiemetics|antiemetics|mesh-ancestor
92825244|NCT00719173|Autonomic Agents|autonomic agents|mesh-ancestor
92825245|NCT00719173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825246|NCT00719173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92825247|NCT00719173|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92825248|NCT00719173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825249|NCT00756886|Atorvastatin|atorvastatin|mesh-list
92825250|NCT00756886|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92825251|NCT00756886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92825252|NCT00756886|Antimetabolites|antimetabolites|mesh-ancestor
92825253|NCT00756886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825254|NCT00756886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92825255|NCT00756886|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92825256|NCT00756886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825257|NCT00756730|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92825258|NCT00756730|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92825259|NCT00756730|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92825260|NCT00756730|Protease Inhibitors|protease inhibitors|mesh-ancestor
92825261|NCT00756730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825262|NCT00756730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825263|NCT00756730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92825264|NCT00756730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92825265|NCT00756730|Antiviral Agents|antiviral agents|mesh-ancestor
92825266|NCT00756730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825267|NCT02573935|Clarithromycin|clarithromycin|mesh-list
92825268|NCT02573935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92825269|NCT02573935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825270|NCT02573935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92825271|NCT02573935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825272|NCT02573935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825273|NCT02573935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92825274|NCT02573935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825275|NCT00984620|Interferons|interferons|mesh-list
92825276|NCT00984620|Ribavirin|ribavirin|mesh-list
92825277|NCT00984620|Interferon-alpha|interferon-alpha|mesh-list
92825278|NCT00984620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825279|NCT00984620|Antiviral Agents|antiviral agents|mesh-ancestor
92825280|NCT00984620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825281|NCT00984620|Antimetabolites|antimetabolites|mesh-ancestor
92825282|NCT00984620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825283|NCT00984620|Immunologic Factors|immunologic factors|mesh-ancestor
92825284|NCT00984620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825285|NCT00717145|Risedronic Acid|risedronic acid|mesh-list
92825286|NCT00717145|Etidronic Acid|etidronic acid|mesh-list
92825287|NCT00717145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92825288|NCT00717145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92825289|NCT00717145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825290|NCT00717145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825291|NCT00717145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825292|NCT00717145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92825294|NCT00639483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92825295|NCT00639483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825296|NCT00639483|Analgesics|analgesics|mesh-ancestor
92825297|NCT00639483|Sensory System Agents|sensory system agents|mesh-ancestor
92825298|NCT00639483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825299|NCT00639483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825300|NCT00639483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825301|NCT00639483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825302|NCT00639483|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92825303|NCT00639483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92825304|NCT00639483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825305|NCT00639483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825306|NCT00777946|Amlodipine|amlodipine|mesh-list
92825307|NCT00777946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92825308|NCT00777946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92825309|NCT00777946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92825310|NCT00777946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825311|NCT00777946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825312|NCT00777946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825313|NCT00777946|Vasodilator Agents|vasodilator agents|mesh-ancestor
92825314|NCT02686047|Hyaluronic Acid|hyaluronic acid|mesh-list
92825315|NCT02686047|Hylan|hylan|mesh-list
92825316|NCT02686047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92825317|NCT02686047|Immunologic Factors|immunologic factors|mesh-ancestor
92825318|NCT02686047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825319|NCT02686047|Viscosupplements|viscosupplements|mesh-ancestor
92825320|NCT02686047|Protective Agents|protective agents|mesh-ancestor
92825321|NCT00713947|Amoxicillin|amoxicillin|mesh-list
92825322|NCT00713947|Metronidazole|metronidazole|mesh-list
92825323|NCT00713947|Clarithromycin|clarithromycin|mesh-list
92825324|NCT00713947|Pantoprazole|pantoprazole|mesh-list
92825325|NCT00713947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92825326|NCT00713947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825327|NCT00713947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92825328|NCT00713947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92825329|NCT00713947|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92825330|NCT00713947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825331|NCT00713947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825332|NCT00713947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92825333|NCT00713947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825334|NCT00713947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92825335|NCT00713947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92825336|NCT00713947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92825337|NCT00990314|Epoprostenol|epoprostenol|mesh-list
92825338|NCT00990314|Beraprost|beraprost|mesh-list
92825339|NCT00990314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92825340|NCT00990314|Vasodilator Agents|vasodilator agents|mesh-ancestor
92825341|NCT00990314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92825342|NCT00909831|Hydroxychloroquine|hydroxychloroquine|mesh-list
92825343|NCT00909831|Sirolimus|sirolimus|mesh-list
92825344|NCT00909831|Temsirolimus|temsirolimus|mesh-list
92825345|NCT00909831|MTOR Inhibitors|mtor inhibitors|mesh-list
92825346|NCT00909831|Antimalarials|antimalarials|mesh-ancestor
92825347|NCT00909831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92825348|NCT00909831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92825349|NCT00909831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825350|NCT00909831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825351|NCT00909831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825352|NCT00909831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825353|NCT00909831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92825354|NCT00909831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825355|NCT00909831|Immunologic Factors|immunologic factors|mesh-ancestor
92825356|NCT00909831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825357|NCT00909831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825358|NCT00909831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92825359|NCT00909831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92825360|NCT00909831|Antifungal Agents|antifungal agents|mesh-ancestor
92825361|NCT00717379|Mycophenolic Acid|mycophenolic acid|mesh-list
92825362|NCT00717379|Prednisone|prednisone|mesh-list
92825363|NCT00717379|Methylprednisolone|methylprednisolone|mesh-list
92825364|NCT00717379|Tacrolimus|tacrolimus|mesh-list
92825365|NCT00717379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825366|NCT00717379|Glucocorticoids|glucocorticoids|mesh-ancestor
92825367|NCT00717379|Hormones|hormones|mesh-ancestor
92825368|NCT00717379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825369|NCT00717379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825370|NCT00717379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92825371|NCT00717379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825372|NCT00717379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825373|NCT00717379|Immunologic Factors|immunologic factors|mesh-ancestor
92825374|NCT00717379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92825375|NCT00717379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825376|NCT00717379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825377|NCT00717379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92825378|NCT00717379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92825379|NCT00717379|Antitubercular Agents|antitubercular agents|mesh-ancestor
92825380|NCT00717379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92825381|NCT00717379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825382|NCT00717379|Antiemetics|antiemetics|mesh-ancestor
92825383|NCT00717379|Autonomic Agents|autonomic agents|mesh-ancestor
92825384|NCT00717379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825385|NCT00717379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92825386|NCT00717379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92825387|NCT00717379|Protective Agents|protective agents|mesh-ancestor
92825388|NCT02867306|Methotrexate|methotrexate|mesh-list
92825389|NCT02867306|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92825390|NCT02867306|Abortifacient Agents|abortifacient agents|mesh-ancestor
92825391|NCT02867306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92825392|NCT02867306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825393|NCT02867306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92825394|NCT02867306|Antimetabolites|antimetabolites|mesh-ancestor
92825395|NCT02867306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825396|NCT02867306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825397|NCT02867306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92825398|NCT02867306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727218|NCT00479882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92825399|NCT02867306|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92825400|NCT02867306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825401|NCT02867306|Immunologic Factors|immunologic factors|mesh-ancestor
92825402|NCT02867306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825403|NCT02867306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92825404|NCT00777556|Levonorgestrel|levonorgestrel|mesh-list
92825405|NCT00777556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92825406|NCT00777556|Contraceptive Agents|contraceptive agents|mesh-ancestor
92825407|NCT00777556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92825408|NCT00777556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825409|NCT00777556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92825410|NCT00777556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92825411|NCT00777556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92825412|NCT02685657|Cyclophosphamide|cyclophosphamide|mesh-list
92825413|NCT02685657|Docetaxel|docetaxel|mesh-list
92825414|NCT02685657|Doxorubicin|doxorubicin|mesh-list
92825415|NCT02685657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825416|NCT02685657|Immunologic Factors|immunologic factors|mesh-ancestor
92825417|NCT02685657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825418|NCT02685657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825419|NCT02685657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92825420|NCT02685657|Alkylating Agents|alkylating agents|mesh-ancestor
92825421|NCT02685657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825422|NCT02685657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825423|NCT02685657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92825424|NCT02685657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92825425|NCT02685657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92825426|NCT02685657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92825427|NCT02685657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92825428|NCT02685657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92825429|NCT02685657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92825430|NCT02685657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825431|NCT04290884|Tranexamic Acid|tranexamic acid|mesh-list
92825432|NCT04290884|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92825433|NCT04290884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92825434|NCT04290884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825435|NCT04290884|Hemostatics|hemostatics|mesh-ancestor
92825436|NCT04290884|Coagulants|coagulants|mesh-ancestor
92825437|NCT00719407|Epoetin Alfa|epoetin alfa|mesh-list
92825438|NCT00719407|Hematinics|hematinics|mesh-ancestor
92825439|NCT00714025|Everolimus|everolimus|mesh-list
92825440|NCT00714025|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92825441|NCT00714025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92825442|NCT00714025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825443|NCT00714025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825444|NCT00714025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825445|NCT00714025|Immunologic Factors|immunologic factors|mesh-ancestor
92825446|NCT00714025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825447|NCT00714025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825448|NCT02685345|Firuglipel|firuglipel|mesh-list
92825449|NCT02685345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92825450|NCT02685345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825451|NCT02869100|Listerine|listerine|mesh-list
92825452|NCT02869100|Fluorides|fluorides|mesh-list
92825453|NCT02869100|Sodium Fluoride|sodium fluoride|mesh-list
92825454|NCT02869100|Cariostatic Agents|cariostatic agents|mesh-ancestor
92825455|NCT02869100|Protective Agents|protective agents|mesh-ancestor
92825456|NCT02869100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825457|NCT02869100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92825458|NCT02869100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825459|NCT04096768|Dexmedetomidine|dexmedetomidine|mesh-list
92825460|NCT04096768|Ketamine|ketamine|mesh-list
92825461|NCT04096768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825462|NCT04096768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825463|NCT04096768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825464|NCT04096768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825465|NCT04096768|Analgesics|analgesics|mesh-ancestor
92825466|NCT04096768|Sensory System Agents|sensory system agents|mesh-ancestor
92825467|NCT04096768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825468|NCT04096768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92825469|NCT04096768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92825470|NCT04096768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92825471|NCT04096768|Adrenergic Agents|adrenergic agents|mesh-ancestor
92825472|NCT04096768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825473|NCT04096768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825474|NCT04096768|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92825475|NCT04096768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92825476|NCT04096768|Anesthetics, General|anesthetics, general|mesh-ancestor
92825477|NCT04096768|Anesthetics|anesthetics|mesh-ancestor
92825478|NCT04096768|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92825479|NCT04096768|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92825480|NCT00714103|Adenosine|adenosine|mesh-list
92825481|NCT00714103|Analgesics|analgesics|mesh-ancestor
92825482|NCT00714103|Sensory System Agents|sensory system agents|mesh-ancestor
92825483|NCT00714103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825484|NCT00714103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825485|NCT00714103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92825486|NCT00714103|Vasodilator Agents|vasodilator agents|mesh-ancestor
92825487|NCT00714103|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92825488|NCT00714103|Purinergic Agonists|purinergic agonists|mesh-ancestor
92825489|NCT00714103|Purinergic Agents|purinergic agents|mesh-ancestor
92825490|NCT00714103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825491|NCT00714103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825492|NCT00993044|Bevacizumab|bevacizumab|mesh-list
92825493|NCT00993044|Irinotecan|irinotecan|mesh-list
92825494|NCT00993044|Vincristine|vincristine|mesh-list
92825495|NCT00993044|Temozolomide|temozolomide|mesh-list
92825496|NCT00993044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825497|NCT00993044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825498|NCT00993044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92825499|NCT00993044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92825500|NCT00993044|Growth Substances|growth substances|mesh-ancestor
92825501|NCT00993044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825502|NCT00993044|Growth Inhibitors|growth inhibitors|mesh-ancestor
92825503|NCT00993044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92825504|NCT00993044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92825505|NCT00993044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825506|NCT00993044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825507|NCT00993044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92825508|NCT00993044|Tubulin Modulators|tubulin modulators|mesh-ancestor
92825509|NCT00993044|Antimitotic Agents|antimitotic agents|mesh-ancestor
92825510|NCT00993044|Mitosis Modulators|mitosis modulators|mesh-ancestor
92825511|NCT00993044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92825512|NCT00993044|Alkylating Agents|alkylating agents|mesh-ancestor
92825513|NCT00714181|Hydroxychloroquine|hydroxychloroquine|mesh-list
92825514|NCT00714181|Temozolomide|temozolomide|mesh-list
92727330|NCT00475865|Teriflunomide|teriflunomide|mesh-list
92825515|NCT00714181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92825516|NCT00714181|Alkylating Agents|alkylating agents|mesh-ancestor
92825517|NCT00714181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825518|NCT00714181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825519|NCT00714181|Antimalarials|antimalarials|mesh-ancestor
92825520|NCT00714181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92825521|NCT00714181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92825522|NCT00714181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825523|NCT00714181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825524|NCT00714181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825525|NCT02600806|Azithromycin|azithromycin|mesh-list
92825526|NCT02600806|Levofloxacin|levofloxacin|mesh-list
92825527|NCT02600806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92825528|NCT02600806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825529|NCT02600806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92825530|NCT02600806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92825531|NCT02600806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92825532|NCT02600806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825533|NCT02600806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825534|NCT02600806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825535|NCT02600806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92825536|NCT02600806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825537|NCT00639873|Doxycycline|doxycycline|mesh-list
92825538|NCT00639873|Artesunate|artesunate|mesh-list
92825539|NCT00639873|Quinine|quinine|mesh-list
92825540|NCT00639873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92825541|NCT00639873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825542|NCT00639873|Antimalarials|antimalarials|mesh-ancestor
92825543|NCT00639873|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92825544|NCT00639873|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92825545|NCT00639873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825546|NCT00639873|Antiviral Agents|antiviral agents|mesh-ancestor
92825547|NCT00639873|Schistosomicides|schistosomicides|mesh-ancestor
92825548|NCT00639873|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92825549|NCT00639873|Anthelmintics|anthelmintics|mesh-ancestor
92825550|NCT00639873|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92825551|NCT00639873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825552|NCT00639873|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92825553|NCT00639873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825554|NCT00639873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825555|NCT00639873|Analgesics|analgesics|mesh-ancestor
92825556|NCT00639873|Sensory System Agents|sensory system agents|mesh-ancestor
92825557|NCT04291118|Budesonide|budesonide|mesh-list
92825558|NCT04291118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825559|NCT04291118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92825560|NCT04291118|Autonomic Agents|autonomic agents|mesh-ancestor
92825561|NCT04291118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825562|NCT04291118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825563|NCT04291118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92825564|NCT04291118|Respiratory System Agents|respiratory system agents|mesh-ancestor
92825565|NCT04291118|Glucocorticoids|glucocorticoids|mesh-ancestor
92825566|NCT04291118|Hormones|hormones|mesh-ancestor
92825567|NCT04291118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825568|NCT02868944|Sufentanil|sufentanil|mesh-list
92825569|NCT02868944|Morphine|morphine|mesh-list
92825570|NCT02868944|Levobupivacaine|levobupivacaine|mesh-list
92825571|NCT02868944|Anesthetics|anesthetics|mesh-list
92825572|NCT02868944|Anesthetics, Local|anesthetics, local|mesh-list
92825573|NCT02868944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92825574|NCT02868944|Narcotics|narcotics|mesh-ancestor
92825575|NCT02868944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825576|NCT02868944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825577|NCT02868944|Analgesics|analgesics|mesh-ancestor
92825578|NCT02868944|Sensory System Agents|sensory system agents|mesh-ancestor
92825579|NCT02868944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825580|NCT02868944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92825581|NCT02868944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92825582|NCT02868944|Anesthetics, General|anesthetics, general|mesh-ancestor
92825583|NCT03292809|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92825584|NCT03292809|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92825585|NCT00722839|Vaccines|vaccines|mesh-list
92825586|NCT00722839|Immunologic Factors|immunologic factors|mesh-ancestor
92825587|NCT00722839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825588|NCT04096690|Pegaspargase|pegaspargase|mesh-list
92825589|NCT04096690|Antibodies|antibodies|mesh-list
92825590|NCT04096690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92825591|NCT04096690|Immunologic Factors|immunologic factors|mesh-ancestor
92825592|NCT04096690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825593|NCT04096690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825595|NCT03565783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825596|NCT03565783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825597|NCT00719797|Leucovorin|leucovorin|mesh-list
92825598|NCT00719797|Bevacizumab|bevacizumab|mesh-list
92825599|NCT00719797|Fluorouracil|fluorouracil|mesh-list
92825600|NCT00719797|Oxaliplatin|oxaliplatin|mesh-list
92825601|NCT00719797|Irinotecan|irinotecan|mesh-list
92825602|NCT00719797|Calcium|calcium|mesh-list
92825603|NCT00719797|Levoleucovorin|levoleucovorin|mesh-list
92825604|NCT00719797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825605|NCT00719797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825606|NCT00719797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92825607|NCT00719797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92825608|NCT00719797|Growth Substances|growth substances|mesh-ancestor
92825609|NCT00719797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825610|NCT00719797|Growth Inhibitors|growth inhibitors|mesh-ancestor
92825611|NCT00719797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825612|NCT00719797|Antimetabolites|antimetabolites|mesh-ancestor
92825613|NCT00719797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825614|NCT00719797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92825615|NCT00719797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825616|NCT00719797|Immunologic Factors|immunologic factors|mesh-ancestor
92825617|NCT00719797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92825618|NCT00719797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92825619|NCT00719797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825620|NCT00719797|Antidotes|antidotes|mesh-ancestor
92825621|NCT00719797|Protective Agents|protective agents|mesh-ancestor
92825622|NCT00719797|Vitamin B Complex|vitamin b complex|mesh-ancestor
92825623|NCT00719797|Vitamins|vitamins|mesh-ancestor
92825624|NCT00719797|Micronutrients|micronutrients|mesh-ancestor
92825625|NCT00979628|Insulin|insulin|mesh-list
92825626|NCT00979628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92825627|NCT00979628|Insulin Glargine|insulin glargine|mesh-list
92825628|NCT00979628|Insulin glulisine|insulin glulisine|mesh-list
92825629|NCT00979628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92825630|NCT00979628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825631|NCT00719875|Vorinostat|vorinostat|mesh-list
92825632|NCT00719875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92825633|NCT00719875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825634|NCT00719875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825635|NCT00719875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825636|NCT02685111|Lenograstim|lenograstim|mesh-list
92825637|NCT02685111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92825638|NCT02685111|Immunologic Factors|immunologic factors|mesh-ancestor
92825639|NCT02685111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825640|NCT00717925|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92727456|NCT04555707|Betamethasone|betamethasone|mesh-list
92825641|NCT00717925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825642|NCT00717925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825643|NCT00717925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92825644|NCT00717925|Immunotoxins|immunotoxins|mesh-ancestor
92825645|NCT00717925|Immunoconjugates|immunoconjugates|mesh-ancestor
92825646|NCT00717925|Immunologic Factors|immunologic factors|mesh-ancestor
92825647|NCT00717925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825648|NCT03258723|Metformin|metformin|mesh-list
92825649|NCT03258723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92825650|NCT03258723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825651|NCT00640029|Meloxicam|meloxicam|mesh-list
92825652|NCT00640029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92825653|NCT00640029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825654|NCT00640029|Analgesics|analgesics|mesh-ancestor
92470651|NCT01822951|Donepezil|donepezil|mesh-list
92825655|NCT00640029|Sensory System Agents|sensory system agents|mesh-ancestor
92825656|NCT00640029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825657|NCT00640029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825658|NCT00640029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92825659|NCT00640029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825660|NCT00640029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92825661|NCT00640029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92825662|NCT00640029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727475|NCT04555707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92825663|NCT00640029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825664|NCT02684799|Cenicriviroc|cenicriviroc|mesh-list
92825665|NCT02684799|Omeprazole|omeprazole|mesh-list
92825666|NCT02684799|Famotidine|famotidine|mesh-list
92825667|NCT02684799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92825668|NCT02684799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92825669|NCT02684799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92825670|NCT02684799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825671|NCT02684799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825672|NCT02684799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92825673|NCT02684799|Histamine Antagonists|histamine antagonists|mesh-ancestor
92825674|NCT02684799|Histamine Agents|histamine agents|mesh-ancestor
92825675|NCT02684799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825676|NCT02684799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825677|NCT02684799|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92825678|NCT02684799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92825679|NCT02684799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92825680|NCT02684799|Antiviral Agents|antiviral agents|mesh-ancestor
92825681|NCT02684799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825682|NCT02685189|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92825683|NCT02685189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825684|NCT02685189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825685|NCT00992108|Lidocaine|lidocaine|mesh-list
92825686|NCT00992108|Anesthetics, Local|anesthetics, local|mesh-ancestor
92825687|NCT00992108|Anesthetics|anesthetics|mesh-ancestor
92825688|NCT00992108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825689|NCT00992108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825690|NCT00992108|Sensory System Agents|sensory system agents|mesh-ancestor
92825691|NCT00992108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825692|NCT00992108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92825693|NCT00992108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92825694|NCT00992108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92825695|NCT00992108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92825696|NCT00992108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825697|NCT00752986|Fulvestrant|fulvestrant|mesh-list
92825698|NCT00752986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92825699|NCT00752986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825700|NCT00752986|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92825701|NCT00752986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92825702|NCT00752986|Hormone Antagonists|hormone antagonists|mesh-ancestor
92825703|NCT00752986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825704|NCT00752986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825705|NCT02684487|Vitamin D|vitamin d|mesh-list
92825706|NCT02684487|Cholecalciferol|cholecalciferol|mesh-list
92825707|NCT02684487|Vitamins|vitamins|mesh-ancestor
92825708|NCT02684487|Micronutrients|micronutrients|mesh-ancestor
92825709|NCT02684487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825710|NCT02684487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92825711|NCT02684487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825712|NCT02684409|Sumatriptan|sumatriptan|mesh-list
92825713|NCT02684409|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92825714|NCT02684409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92825715|NCT02684409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92825716|NCT02684409|Serotonin Agents|serotonin agents|mesh-ancestor
92825717|NCT02684409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825718|NCT02684409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825719|NCT02684409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825720|NCT00762892|Tenofovir|tenofovir|mesh-list
92825721|NCT00762892|Emtricitabine|emtricitabine|mesh-list
92825722|NCT00762892|Raltegravir Potassium|raltegravir potassium|mesh-list
92825723|NCT00762892|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92825724|NCT00762892|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92825725|NCT00762892|Antiviral Agents|antiviral agents|mesh-ancestor
92825726|NCT00762892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825727|NCT00762892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92825728|NCT00762892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92825729|NCT00762892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825730|NCT00762892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825731|NCT00762892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92825732|NCT00762892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92825733|NCT00762892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92825734|NCT00762892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92825735|NCT00762892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92825736|NCT00762892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92825737|NCT00762892|Protease Inhibitors|protease inhibitors|mesh-ancestor
92825738|NCT04290572|Isotretinoin|isotretinoin|mesh-list
92825739|NCT04290572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92825740|NCT04069429|Heparin|heparin|mesh-list
92825741|NCT04069429|Anticoagulants|anticoagulants|mesh-ancestor
92825742|NCT04069429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92825743|NCT04069429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92825744|NCT04069429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825745|NCT00755716|Topiramate|topiramate|mesh-list
92825746|NCT00755716|Nicotine|nicotine|mesh-list
92825747|NCT00755716|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92825748|NCT00755716|Autonomic Agents|autonomic agents|mesh-ancestor
92825749|NCT00755716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825750|NCT00755716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825751|NCT00755716|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92825752|NCT00755716|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92825753|NCT00755716|Cholinergic Agents|cholinergic agents|mesh-ancestor
92825754|NCT00755716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825755|NCT00755716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825756|NCT00755716|Anticonvulsants|anticonvulsants|mesh-ancestor
92825757|NCT00755716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92825758|NCT00629252|Risperidone|risperidone|mesh-list
92825759|NCT00629252|Sertindole|sertindole|mesh-list
92825760|NCT00629252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92825761|NCT00629252|Serotonin Agents|serotonin agents|mesh-ancestor
92825762|NCT00629252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825763|NCT00629252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727572|NCT02212821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825764|NCT00629252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825765|NCT00629252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92825766|NCT00629252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92825767|NCT00629252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825768|NCT00629252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92825769|NCT00629252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92825770|NCT00629252|Dopamine Agents|dopamine agents|mesh-ancestor
92825771|NCT04096144|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92825772|NCT04096144|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92825773|NCT04096144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825774|NCT04096144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825775|NCT04095754|Dexmedetomidine|dexmedetomidine|mesh-list
92825776|NCT04095754|Anesthetics|anesthetics|mesh-list
92825777|NCT04095754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825778|NCT04095754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825779|NCT04095754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825780|NCT04095754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825781|NCT04095754|Analgesics|analgesics|mesh-ancestor
92825782|NCT04095754|Sensory System Agents|sensory system agents|mesh-ancestor
92825783|NCT04095754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825784|NCT04095754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92825785|NCT04095754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92825786|NCT04095754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92825787|NCT04095754|Adrenergic Agents|adrenergic agents|mesh-ancestor
92825788|NCT04095754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825789|NCT04095754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825790|NCT00720265|Tacrolimus|tacrolimus|mesh-list
92825791|NCT00720265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825792|NCT00720265|Immunologic Factors|immunologic factors|mesh-ancestor
92825793|NCT00720265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825794|NCT00720265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92825795|NCT00720265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825796|NCT00720265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825797|NCT02600650|Testosterone|testosterone|mesh-list
92825798|NCT02600650|Androgens|androgens|mesh-ancestor
92825799|NCT02600650|Hormones|hormones|mesh-ancestor
92825800|NCT02600650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825801|NCT02600650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825802|NCT03084471|Durvalumab|durvalumab|mesh-list
92825803|NCT03084471|Tremelimumab|tremelimumab|mesh-list
92825804|NCT03084471|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92825805|NCT03084471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825806|NCT03084471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825807|NCT03084471|Immunologic Factors|immunologic factors|mesh-ancestor
92825808|NCT03084471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825809|NCT00718471|Heparin|heparin|mesh-list
92825810|NCT00718471|Enoxaparin|enoxaparin|mesh-list
92825811|NCT00718471|Calcium heparin|calcium heparin|mesh-list
92825812|NCT00718471|Anticoagulants|anticoagulants|mesh-ancestor
92825813|NCT00718471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92825814|NCT00718471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92825815|NCT00718471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825816|NCT00723307|Metformin|metformin|mesh-list
92825817|NCT00723307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92825818|NCT00723307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825820|NCT00723385|Cholecalciferol|cholecalciferol|mesh-list
92825821|NCT00723385|Vitamins|vitamins|mesh-ancestor
92825822|NCT00723385|Micronutrients|micronutrients|mesh-ancestor
92825823|NCT00723385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727650|NCT01087502|Incretins|incretins|mesh-ancestor
92825824|NCT00723385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92825825|NCT00723385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825826|NCT00754936|Escitalopram|escitalopram|mesh-list
92825827|NCT00754936|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92825828|NCT00754936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92825829|NCT00754936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92825830|NCT00754936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825831|NCT00754936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825832|NCT00754936|Serotonin Agents|serotonin agents|mesh-ancestor
92825833|NCT00754936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825834|NCT02684019|Magnesium Sulfate|magnesium sulfate|mesh-list
92825835|NCT02684019|Dexmedetomidine|dexmedetomidine|mesh-list
92825836|NCT02684019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825837|NCT02684019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825838|NCT02684019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825839|NCT02684019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825840|NCT02684019|Analgesics|analgesics|mesh-ancestor
92825841|NCT02684019|Sensory System Agents|sensory system agents|mesh-ancestor
92825842|NCT02684019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825843|NCT02684019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92825844|NCT02684019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92825845|NCT02684019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92825846|NCT02684019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92825847|NCT02684019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825848|NCT02684019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825849|NCT02684019|Anesthetics|anesthetics|mesh-ancestor
92825850|NCT02684019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92825851|NCT02684019|Anticonvulsants|anticonvulsants|mesh-ancestor
92825852|NCT02684019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92825853|NCT02684019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92825854|NCT02684019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92825855|NCT02684019|Tocolytic Agents|tocolytic agents|mesh-ancestor
92825856|NCT02684019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92825857|NCT00720421|Lorazepam|lorazepam|mesh-list
92825858|NCT00720421|Anticonvulsants|anticonvulsants|mesh-ancestor
92825859|NCT00720421|Antiemetics|antiemetics|mesh-ancestor
92825860|NCT00720421|Autonomic Agents|autonomic agents|mesh-ancestor
92825861|NCT00720421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825862|NCT00720421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825863|NCT00720421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92825864|NCT00720421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825865|NCT00720421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825866|NCT00720421|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92825867|NCT00720421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92825868|NCT00720421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92825869|NCT00720421|GABA Modulators|gaba modulators|mesh-ancestor
92825870|NCT00720421|GABA Agents|gaba agents|mesh-ancestor
92825871|NCT00720421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825872|NCT00720421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825873|NCT02689713|Voriconazole|voriconazole|mesh-list
92825874|NCT02689713|Antifungal Agents|antifungal agents|mesh-ancestor
92825875|NCT02689713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825876|NCT02689713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92825877|NCT02689713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825878|NCT02689713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825879|NCT02689713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825880|NCT02689713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92825881|NCT02689713|Hormone Antagonists|hormone antagonists|mesh-ancestor
92825882|NCT02689713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92825883|NCT02689713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825884|NCT02689713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92825885|NCT02601508|Rocuronium|rocuronium|mesh-list
92825886|NCT02601508|Atracurium|atracurium|mesh-list
92825887|NCT02601508|Cisatracurium|cisatracurium|mesh-list
92825888|NCT02601508|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92825889|NCT02601508|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92825890|NCT02601508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92825891|NCT02601508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825892|NCT02601508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825893|NCT02601508|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92825894|NCT02601508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92825895|NCT02601508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92825896|NCT02601508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727701|NCT01085201|Regadenoson|regadenoson|mesh-list
92825897|NCT02601508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825898|NCT02570581|Acetaminophen|acetaminophen|mesh-list
92825899|NCT02570581|Ramipril|ramipril|mesh-list
92825900|NCT02570581|Furosemide|furosemide|mesh-list
92825901|NCT02570581|Memantine|memantine|mesh-list
92825902|NCT02570581|Alprazolam|alprazolam|mesh-list
92825903|NCT02570581|Zopiclone|zopiclone|mesh-list
92825904|NCT02570581|Oxazepam|oxazepam|mesh-list
92825905|NCT02570581|Donepezil|donepezil|mesh-list
92825906|NCT02570581|Clopidogrel|clopidogrel|mesh-list
92825907|NCT02570581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92825908|NCT02570581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92825909|NCT02570581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92825910|NCT02570581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92825911|NCT02570581|Purinergic Agents|purinergic agents|mesh-ancestor
92825912|NCT02570581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825913|NCT02570581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825914|NCT02570581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825915|NCT02570581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825916|NCT02570581|Analgesics|analgesics|mesh-ancestor
92825917|NCT02570581|Sensory System Agents|sensory system agents|mesh-ancestor
92825918|NCT02570581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825919|NCT02570581|Antipyretics|antipyretics|mesh-ancestor
92825920|NCT02570581|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92825921|NCT02570581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825922|NCT02570581|Cholinergic Agents|cholinergic agents|mesh-ancestor
92825923|NCT02570581|Nootropic Agents|nootropic agents|mesh-ancestor
92825924|NCT02570581|Diuretics|diuretics|mesh-ancestor
92825925|NCT02570581|Natriuretic Agents|natriuretic agents|mesh-ancestor
92825926|NCT02570581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92825927|NCT02570581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92825928|NCT02570581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92825929|NCT02570581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92825930|NCT02570581|Dopamine Agents|dopamine agents|mesh-ancestor
92825931|NCT02570581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92825932|NCT02570581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92825933|NCT02570581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92825934|NCT02570581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92825935|NCT02570581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92825936|NCT02570581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825937|NCT02570581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825938|NCT02570581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92825939|NCT02570581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92825940|NCT02570581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92825941|NCT02570581|GABA Modulators|gaba modulators|mesh-ancestor
92825942|NCT02570581|GABA Agents|gaba agents|mesh-ancestor
92825943|NCT00640263|Ritonavir|ritonavir|mesh-list
92825944|NCT00640263|Lopinavir|lopinavir|mesh-list
92825945|NCT00640263|Lamivudine|lamivudine|mesh-list
92825946|NCT00640263|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92825947|NCT00640263|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92825948|NCT00640263|Protease Inhibitors|protease inhibitors|mesh-ancestor
92825949|NCT00640263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92825950|NCT00640263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825951|NCT00640263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92825952|NCT00640263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92825953|NCT00640263|Antiviral Agents|antiviral agents|mesh-ancestor
92825954|NCT00640263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92825955|NCT00640263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92825956|NCT00640263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92825957|NCT00640263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92825958|NCT00640263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727789|NCT01084538|Vitamins|vitamins|mesh-ancestor
92825959|NCT02683863|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92825960|NCT02683863|Dermatologic Agents|dermatologic agents|mesh-ancestor
92825961|NCT02683863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92825962|NCT02683863|Immunologic Factors|immunologic factors|mesh-ancestor
92825963|NCT02683863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825964|NCT04019288|Durvalumab|durvalumab|mesh-list
92825965|NCT04019288|Immunoglobulins|immunoglobulins|mesh-list
92825966|NCT04019288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92825968|NCT04019288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92825969|NCT04019288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92825970|NCT04019288|Immunologic Factors|immunologic factors|mesh-ancestor
92825971|NCT04019288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825972|NCT02865668|Metformin|metformin|mesh-list
92825973|NCT02865668|Canagliflozin|canagliflozin|mesh-list
92825974|NCT02865668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92825975|NCT02865668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825976|NCT02865668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92825977|NCT02865668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825978|NCT02867930|Dexmedetomidine|dexmedetomidine|mesh-list
92825979|NCT02867930|Ketamine|ketamine|mesh-list
92825980|NCT02867930|Propofol|propofol|mesh-list
92825981|NCT02867930|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92825982|NCT02867930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92825983|NCT02867930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92825984|NCT02867930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92825985|NCT02867930|Analgesics|analgesics|mesh-ancestor
92825986|NCT02867930|Sensory System Agents|sensory system agents|mesh-ancestor
92825987|NCT02867930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92825988|NCT02867930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92825989|NCT02867930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92825990|NCT02867930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92825991|NCT02867930|Adrenergic Agents|adrenergic agents|mesh-ancestor
92825992|NCT02867930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92825993|NCT02867930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92825994|NCT02867930|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92825995|NCT02867930|Anesthetics, General|anesthetics, general|mesh-ancestor
92825996|NCT02867930|Anesthetics|anesthetics|mesh-ancestor
92825997|NCT02867930|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92825998|NCT02867930|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92825999|NCT02867930|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92826000|NCT02570893|Paclitaxel|paclitaxel|mesh-list
92826001|NCT02570893|Carboplatin|carboplatin|mesh-list
92826002|NCT02570893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92826003|NCT02570893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826004|NCT02570893|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826005|NCT02570893|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826006|NCT02570893|Mitosis Modulators|mitosis modulators|mesh-ancestor
92826007|NCT02570893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826008|NCT02538081|Risperidone|risperidone|mesh-list
92826009|NCT02538081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92826010|NCT02538081|Serotonin Agents|serotonin agents|mesh-ancestor
92826011|NCT02538081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826012|NCT02538081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826013|NCT02538081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826014|NCT02538081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92826015|NCT02538081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92826016|NCT02538081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826017|NCT02538081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92826018|NCT02538081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92826019|NCT02538081|Dopamine Agents|dopamine agents|mesh-ancestor
92826020|NCT02570971|Mannitol|mannitol|mesh-list
92826021|NCT02570971|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92826022|NCT02570971|Diuretics|diuretics|mesh-ancestor
92826023|NCT02570971|Natriuretic Agents|natriuretic agents|mesh-ancestor
92826024|NCT02570971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826025|NCT02866214|Febuxostat|febuxostat|mesh-list
92826026|NCT02866214|Gout Suppressants|gout suppressants|mesh-ancestor
92826027|NCT02866214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826028|NCT02866448|Aspirin|aspirin|mesh-list
92826029|NCT02866448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92826030|NCT02866448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826031|NCT02866448|Analgesics|analgesics|mesh-ancestor
92826032|NCT02866448|Sensory System Agents|sensory system agents|mesh-ancestor
92826033|NCT02866448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826034|NCT02866448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471024|NCT01825603|Antimetabolites|antimetabolites|mesh-ancestor
92826035|NCT02866448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826036|NCT02866448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826037|NCT02866448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92826038|NCT02866448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92826039|NCT02866448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826040|NCT02866448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92826041|NCT02866448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92826042|NCT02866448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826043|NCT02866448|Antipyretics|antipyretics|mesh-ancestor
92826044|NCT00578227|Vaccines|vaccines|mesh-list
92826045|NCT00578227|Immunologic Factors|immunologic factors|mesh-ancestor
92826046|NCT00578227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826047|NCT00720577|Pioglitazone|pioglitazone|mesh-list
92826048|NCT00720577|Losartan|losartan|mesh-list
92826049|NCT00720577|Simvastatin|simvastatin|mesh-list
92826050|NCT00720577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92826051|NCT00720577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92826052|NCT00720577|Antimetabolites|antimetabolites|mesh-ancestor
92826053|NCT00720577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826054|NCT00720577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92826055|NCT00720577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92826056|NCT00720577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826057|NCT00720577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92826058|NCT00720577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826059|NCT00720577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92826060|NCT00720577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92826061|NCT00720577|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92826062|NCT00720577|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92826063|NCT05373277|Ticagrelor|ticagrelor|mesh-list
92826064|NCT05373277|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92826065|NCT05373277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92826066|NCT05373277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92826067|NCT05373277|Antimetabolites|antimetabolites|mesh-ancestor
92826068|NCT05373277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826069|NCT05373277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92826070|NCT05373277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92826071|NCT05373277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826072|NCT05373277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92826073|NCT05373277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92826074|NCT05373277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92826075|NCT05373277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92826076|NCT05373277|Purinergic Agents|purinergic agents|mesh-ancestor
92826077|NCT05373277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826078|NCT05373277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826079|NCT00724321|Iloprost|iloprost|mesh-list
92826080|NCT00724321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92826081|NCT00724321|Vasodilator Agents|vasodilator agents|mesh-ancestor
92826082|NCT00720811|Acetaminophen|acetaminophen|mesh-list
92826083|NCT00720811|Amoxicillin|amoxicillin|mesh-list
92826084|NCT00720811|Lumefantrine|lumefantrine|mesh-list
92826085|NCT00720811|Artemether|artemether|mesh-list
92826086|NCT00720811|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92826087|NCT00720811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826088|NCT00720811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826089|NCT00720811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826090|NCT00720811|Analgesics|analgesics|mesh-ancestor
92826091|NCT00720811|Sensory System Agents|sensory system agents|mesh-ancestor
92826092|NCT00720811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826093|NCT00720811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826094|NCT00720811|Antipyretics|antipyretics|mesh-ancestor
92826095|NCT00720811|Antimalarials|antimalarials|mesh-ancestor
92826096|NCT00720811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92826097|NCT00720811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92826098|NCT00724633|Dialysis Solutions|dialysis solutions|mesh-list
92826099|NCT00724633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92826100|NCT00577993|Interferons|interferons|mesh-list
92826101|NCT00577993|Interferon-alpha|interferon-alpha|mesh-list
92826102|NCT00577993|Interferon alpha-2|interferon alpha-2|mesh-list
92826103|NCT00577993|Dexamethasone|dexamethasone|mesh-list
92826104|NCT00577993|Prednisone|prednisone|mesh-list
92826105|NCT00577993|Prednisolone|prednisolone|mesh-list
92826106|NCT00577993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92826107|NCT00577993|Methylprednisolone|methylprednisolone|mesh-list
92826108|NCT00577993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92826109|NCT00577993|Prednisolone acetate|prednisolone acetate|mesh-list
92826110|NCT00577993|Cyclophosphamide|cyclophosphamide|mesh-list
92826111|NCT00577993|Rituximab|rituximab|mesh-list
92826112|NCT00577993|Doxorubicin|doxorubicin|mesh-list
92826113|NCT00577993|Fludarabine|fludarabine|mesh-list
92826114|NCT00577993|Etoposide|etoposide|mesh-list
92826115|NCT00577993|Vincristine|vincristine|mesh-list
92826116|NCT00577993|Mitoxantrone|mitoxantrone|mesh-list
92826117|NCT00577993|Bleomycin|bleomycin|mesh-list
92826118|NCT00577993|Procarbazine|procarbazine|mesh-list
92826120|NCT00577993|Prednisolone phosphate|prednisolone phosphate|mesh-list
92826121|NCT00577993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826122|NCT00577993|Immunologic Factors|immunologic factors|mesh-ancestor
92826123|NCT00577993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826124|NCT00577993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826125|NCT00577993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92826126|NCT00577993|Alkylating Agents|alkylating agents|mesh-ancestor
92826127|NCT00577993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826128|NCT00577993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826129|NCT00577993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92826130|NCT00577993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92826131|NCT00577993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826132|NCT00577993|Antiemetics|antiemetics|mesh-ancestor
92826133|NCT00577993|Autonomic Agents|autonomic agents|mesh-ancestor
92826134|NCT00577993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826135|NCT00577993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826136|NCT00577993|Glucocorticoids|glucocorticoids|mesh-ancestor
92826137|NCT00577993|Hormones|hormones|mesh-ancestor
92826138|NCT00577993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826139|NCT00577993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92826140|NCT00577993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826141|NCT00577993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826142|NCT00577993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826143|NCT00577993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826144|NCT00577993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92826145|NCT00577993|Antiviral Agents|antiviral agents|mesh-ancestor
92826146|NCT00577993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826147|NCT00577993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826148|NCT00577993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826149|NCT00577993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92826150|NCT00577993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92826151|NCT00577993|Protective Agents|protective agents|mesh-ancestor
92826152|NCT00577993|Analgesics|analgesics|mesh-ancestor
92826153|NCT00577993|Sensory System Agents|sensory system agents|mesh-ancestor
92826154|NCT00975806|Lenalidomide|lenalidomide|mesh-list
92826155|NCT00975806|Sunitinib|sunitinib|mesh-list
92826156|NCT00975806|Immunologic Factors|immunologic factors|mesh-ancestor
92826157|NCT00975806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826158|NCT00975806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92826159|NCT00975806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92826160|NCT00975806|Growth Substances|growth substances|mesh-ancestor
92826161|NCT00975806|Growth Inhibitors|growth inhibitors|mesh-ancestor
92826162|NCT00975806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826163|NCT00975806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92826164|NCT00975806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826165|NCT00975806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826166|NCT00721201|Mifepristone|mifepristone|mesh-list
92826167|NCT00721201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92826168|NCT00721201|Abortifacient Agents|abortifacient agents|mesh-ancestor
92826169|NCT00721201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826170|NCT00721201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826171|NCT00721201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92826172|NCT00721201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92826173|NCT00721201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92826174|NCT00721201|Contraceptive Agents|contraceptive agents|mesh-ancestor
92826175|NCT00721201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92826176|NCT00721201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92826177|NCT00721201|Hormone Antagonists|hormone antagonists|mesh-ancestor
92826178|NCT00721201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826179|NCT00721201|Luteolytic Agents|luteolytic agents|mesh-ancestor
92826180|NCT00721201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92826181|NCT00721201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92826182|NCT02866370|Paclitaxel|paclitaxel|mesh-list
92826183|NCT02866370|Carboplatin|carboplatin|mesh-list
92826184|NCT02866370|Doxorubicin|doxorubicin|mesh-list
92826185|NCT02866370|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92826186|NCT02866370|Topotecan|topotecan|mesh-list
92826187|NCT02866370|Nintedanib|nintedanib|mesh-list
92826188|NCT02866370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92826189|NCT02866370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826190|NCT02866370|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826191|NCT02866370|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826192|NCT02866370|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727992|NCT01081145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826193|NCT02866370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826194|NCT02866370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826195|NCT02866370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826196|NCT02866370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826198|NCT02866370|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92826199|NCT02866370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92826201|NCT00978068|Lopinavir|lopinavir|mesh-list
92826202|NCT00978068|Nevirapine|nevirapine|mesh-list
92826203|NCT00978068|Efavirenz|efavirenz|mesh-list
92826204|NCT00978068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92826205|NCT00978068|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92826206|NCT00978068|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92826207|NCT00978068|Protease Inhibitors|protease inhibitors|mesh-ancestor
92826208|NCT00978068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826209|NCT00978068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826210|NCT00978068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92826211|NCT00978068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92826212|NCT00978068|Antiviral Agents|antiviral agents|mesh-ancestor
92826213|NCT00978068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826214|NCT00978068|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92826215|NCT00978068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92826216|NCT00978068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92826217|NCT00978068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92826218|NCT00978068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92826219|NCT00978068|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92826220|NCT00978068|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92826221|NCT00978068|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92826222|NCT00629642|Solifenacin Succinate|solifenacin succinate|mesh-list
92826223|NCT00629642|Oxybutynin|oxybutynin|mesh-list
92826224|NCT00629642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92826225|NCT00629642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92826226|NCT00629642|Cholinergic Agents|cholinergic agents|mesh-ancestor
92826227|NCT00629642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826228|NCT00629642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826229|NCT00629642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826230|NCT00629642|Urological Agents|urological agents|mesh-ancestor
92826231|NCT00629642|Parasympatholytics|parasympatholytics|mesh-ancestor
92826232|NCT00629642|Autonomic Agents|autonomic agents|mesh-ancestor
92826233|NCT00629642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826234|NCT02865356|Cyclosporine|cyclosporine|mesh-list
92826235|NCT02865356|Cyclosporins|cyclosporins|mesh-list
92826236|NCT02865356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826237|NCT02865356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826238|NCT02865356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826239|NCT02865356|Immunologic Factors|immunologic factors|mesh-ancestor
92826240|NCT02865356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826241|NCT02865356|Antifungal Agents|antifungal agents|mesh-ancestor
92826242|NCT02865356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826243|NCT02865356|Dermatologic Agents|dermatologic agents|mesh-ancestor
92826244|NCT02865356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826245|NCT02865356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92826246|NCT04287842|Sevoflurane|sevoflurane|mesh-list
92826247|NCT04287842|Desflurane|desflurane|mesh-list
92826248|NCT04287842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92826249|NCT04287842|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92826250|NCT04287842|Anesthetics, General|anesthetics, general|mesh-ancestor
92826251|NCT04287842|Anesthetics|anesthetics|mesh-ancestor
92826252|NCT04287842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826253|NCT04287842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826254|NCT00721747|Cyclophosphamide|cyclophosphamide|mesh-list
92826255|NCT00721747|Docetaxel|docetaxel|mesh-list
92826256|NCT00721747|Doxorubicin|doxorubicin|mesh-list
92826257|NCT00721747|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92826258|NCT00721747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826259|NCT00721747|Immunologic Factors|immunologic factors|mesh-ancestor
92826260|NCT00721747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826261|NCT00721747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826262|NCT00721747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92826263|NCT00721747|Alkylating Agents|alkylating agents|mesh-ancestor
92471257|NCT01827540|Anesthetics|anesthetics|mesh-ancestor
92826264|NCT00721747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826265|NCT00721747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826266|NCT00721747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92826267|NCT00721747|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826268|NCT00721747|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826269|NCT00721747|Mitosis Modulators|mitosis modulators|mesh-ancestor
92826270|NCT00721747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826271|NCT00721747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826272|NCT00721747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826273|NCT00721747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826275|NCT00603525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826276|NCT02570191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92826277|NCT02570191|Antiviral Agents|antiviral agents|mesh-ancestor
92826278|NCT02570191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826279|NCT02689401|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92826280|NCT02689401|Hematinics|hematinics|mesh-ancestor
92826281|NCT02689401|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92826282|NCT02689401|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92826283|NCT00640575|Triamcinolone|triamcinolone|mesh-list
92826284|NCT00640575|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92826285|NCT00640575|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92826286|NCT00640575|Lidocaine|lidocaine|mesh-list
92826287|NCT00640575|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92826288|NCT00640575|Anesthetics, Local|anesthetics, local|mesh-ancestor
92826289|NCT00640575|Anesthetics|anesthetics|mesh-ancestor
92826290|NCT00640575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826291|NCT00640575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826292|NCT00640575|Sensory System Agents|sensory system agents|mesh-ancestor
92826293|NCT00640575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826294|NCT00640575|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92826295|NCT00640575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92826296|NCT00640575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92826297|NCT00640575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92826298|NCT00640575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826299|NCT00640575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826300|NCT00640575|Glucocorticoids|glucocorticoids|mesh-ancestor
92826301|NCT00640575|Hormones|hormones|mesh-ancestor
92826302|NCT00640575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826303|NCT00640575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826304|NCT00640575|Immunologic Factors|immunologic factors|mesh-ancestor
92826305|NCT00640575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826306|NCT04067791|Melatonin|melatonin|mesh-list
92826307|NCT04067791|Antioxidants|antioxidants|mesh-ancestor
92728125|NCT00479856|Paclitaxel|paclitaxel|mesh-list
92826308|NCT04067791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826309|NCT04067791|Protective Agents|protective agents|mesh-ancestor
92826310|NCT04067791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826311|NCT04067791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826312|NCT00762034|Paclitaxel|paclitaxel|mesh-list
92826313|NCT00762034|Bevacizumab|bevacizumab|mesh-list
92826314|NCT00762034|Carboplatin|carboplatin|mesh-list
92826315|NCT00762034|Pemetrexed|pemetrexed|mesh-list
92826316|NCT00762034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92826317|NCT00762034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826318|NCT00762034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826319|NCT00762034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826320|NCT00762034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92826321|NCT00762034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826322|NCT00762034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92826323|NCT00762034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92826324|NCT00762034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92826325|NCT00762034|Growth Substances|growth substances|mesh-ancestor
92826326|NCT00762034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826327|NCT00762034|Growth Inhibitors|growth inhibitors|mesh-ancestor
92826328|NCT00762034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826329|NCT00762034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92728159|NCT00479388|Niacin|niacin|mesh-list
92826330|NCT00762034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92826331|NCT02387229|Rivaroxaban|rivaroxaban|mesh-list
92826332|NCT02387229|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92826333|NCT02387229|Antithrombins|antithrombins|mesh-ancestor
92826334|NCT02387229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92826335|NCT02387229|Protease Inhibitors|protease inhibitors|mesh-ancestor
92826336|NCT02387229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826337|NCT02387229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826338|NCT02387229|Anticoagulants|anticoagulants|mesh-ancestor
92826339|NCT04183881|Brodalumab|brodalumab|mesh-list
92826340|NCT04183881|Dermatologic Agents|dermatologic agents|mesh-ancestor
92826341|NCT04093648|Cyclophosphamide|cyclophosphamide|mesh-list
92171282|NCT03672539|Cytarabine|cytarabine|mesh-list
92826342|NCT04093648|Fludarabine|fludarabine|mesh-list
92826343|NCT04093648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826344|NCT04093648|Immunologic Factors|immunologic factors|mesh-ancestor
92826345|NCT04093648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826346|NCT04093648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826347|NCT04093648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92826348|NCT04093648|Alkylating Agents|alkylating agents|mesh-ancestor
92826349|NCT04093648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826350|NCT04093648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826351|NCT04093648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92826352|NCT04184115|Scopolamine|scopolamine|mesh-list
92826353|NCT04184115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92826354|NCT04184115|Antiemetics|antiemetics|mesh-ancestor
92826355|NCT04184115|Autonomic Agents|autonomic agents|mesh-ancestor
92826356|NCT04184115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826357|NCT04184115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826358|NCT04184115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826359|NCT04184115|Mydriatics|mydriatics|mesh-ancestor
92826360|NCT04184115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92826361|NCT04184115|Cholinergic Agents|cholinergic agents|mesh-ancestor
92826362|NCT04184115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826363|NCT04184115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826364|NCT04184115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92826365|NCT00722215|Nifedipine|nifedipine|mesh-list
92826366|NCT00722215|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-list
92826367|NCT00722215|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92826368|NCT00722215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92826369|NCT00722215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826370|NCT00722215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92826371|NCT00722215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728198|NCT00556127|Etoposide|etoposide|mesh-list
92826372|NCT00722215|Vasodilator Agents|vasodilator agents|mesh-ancestor
92826373|NCT00722215|Tocolytic Agents|tocolytic agents|mesh-ancestor
92826374|NCT00722215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826375|NCT00722215|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92826376|NCT00640809|Ibuprofen|ibuprofen|mesh-list
92826377|NCT00640809|Celecoxib|celecoxib|mesh-list
92826378|NCT00640809|Omeprazole|omeprazole|mesh-list
92826379|NCT00640809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92826380|NCT00640809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826381|NCT00640809|Analgesics|analgesics|mesh-ancestor
92826382|NCT00640809|Sensory System Agents|sensory system agents|mesh-ancestor
92826383|NCT00640809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826384|NCT00640809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826385|NCT00640809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826386|NCT00640809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826387|NCT00640809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92826388|NCT00640809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826389|NCT00640809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826390|NCT00640809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92826391|NCT00640809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92826392|NCT00640809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826393|NCT00640809|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92826394|NCT00754624|Insulin|insulin|mesh-list
92826395|NCT00754624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92826396|NCT00754624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826397|NCT05630209|Doxorubicin|doxorubicin|mesh-list
92826398|NCT05630209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826399|NCT05630209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826400|NCT05630209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826401|NCT05630209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826402|NCT05630209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826403|NCT05630209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826404|NCT00722293|Doxorubicin|doxorubicin|mesh-list
92826405|NCT00722293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92826406|NCT00722293|Epirubicin|epirubicin|mesh-list
92826407|NCT00722293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826408|NCT00722293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826409|NCT00722293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826410|NCT00722293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826411|NCT00722293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826412|NCT00722293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826413|NCT00726505|Dapagliflozin|dapagliflozin|mesh-list
92433127|NCT01572597|Antiviral Agents|antiviral agents|mesh-ancestor
92826414|NCT00726505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92826415|NCT00726505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826416|NCT00726505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92826417|NCT00726505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826419|NCT02683005|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92826420|NCT02683005|Ledipasvir|ledipasvir|mesh-list
92826421|NCT02683005|Antiviral Agents|antiviral agents|mesh-ancestor
92826422|NCT02683005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826423|NCT03583957|Caffeine|caffeine|mesh-list
92826424|NCT03583957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92826425|NCT03583957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826426|NCT03583957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92826427|NCT03583957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826428|NCT03583957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826429|NCT03583957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92826430|NCT03583957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92826431|NCT03583957|Purinergic Agents|purinergic agents|mesh-ancestor
92826432|NCT03583957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826433|NCT02176863|Immunoglobulins|immunoglobulins|mesh-list
92826434|NCT02176863|gamma-Globulins|gamma-globulins|mesh-list
92826435|NCT02176863|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92826436|NCT02176863|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92826437|NCT02176863|Immunologic Factors|immunologic factors|mesh-ancestor
92826438|NCT02176863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826439|NCT02571283|Epinephrine|epinephrine|mesh-list
92826440|NCT02571283|Bupivacaine|bupivacaine|mesh-list
92826441|NCT02571283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92826442|NCT02571283|Anesthetics|anesthetics|mesh-ancestor
92826443|NCT02571283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826444|NCT02571283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826445|NCT02571283|Sensory System Agents|sensory system agents|mesh-ancestor
92826446|NCT02571283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826447|NCT02571283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826448|NCT02571283|Autonomic Agents|autonomic agents|mesh-ancestor
92826449|NCT02571283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92826450|NCT02571283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92826451|NCT02571283|Adrenergic Agents|adrenergic agents|mesh-ancestor
92826452|NCT02571283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826453|NCT02571283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92826454|NCT02571283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92826455|NCT02571283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92826456|NCT02571283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92826457|NCT02571283|Mydriatics|mydriatics|mesh-ancestor
92826458|NCT02571283|Sympathomimetics|sympathomimetics|mesh-ancestor
92826459|NCT02571283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92826460|NCT02682693|Denosumab|denosumab|mesh-list
92826461|NCT02682693|Paclitaxel|paclitaxel|mesh-list
92826462|NCT02682693|Cyclophosphamide|cyclophosphamide|mesh-list
92826463|NCT02682693|Carboplatin|carboplatin|mesh-list
92826464|NCT02682693|Trastuzumab|trastuzumab|mesh-list
92826465|NCT02682693|Epirubicin|epirubicin|mesh-list
92826466|NCT02682693|Pertuzumab|pertuzumab|mesh-list
92826467|NCT02682693|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92826468|NCT02682693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826469|NCT02682693|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826470|NCT02682693|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826471|NCT02682693|Mitosis Modulators|mitosis modulators|mesh-ancestor
92826472|NCT02682693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826473|NCT02682693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826474|NCT02682693|Immunologic Factors|immunologic factors|mesh-ancestor
92826475|NCT02682693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826476|NCT02682693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826477|NCT02682693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92826478|NCT02682693|Alkylating Agents|alkylating agents|mesh-ancestor
92826479|NCT02682693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92826480|NCT02682693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92826481|NCT02682693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826482|NCT02682693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826483|NCT02682693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826484|NCT02682693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826485|NCT02682693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92826486|NCT02571517|Methylprednisolone|methylprednisolone|mesh-list
92826487|NCT02571517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92826488|NCT02571517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92471479|NCT01829178|Antioxidants|antioxidants|mesh-ancestor
92826489|NCT02571517|Prednisolone|prednisolone|mesh-list
92826490|NCT02571517|Prednisolone acetate|prednisolone acetate|mesh-list
92826491|NCT02571517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92826492|NCT02571517|Prednisolone phosphate|prednisolone phosphate|mesh-list
92826493|NCT02571517|Glucocorticoids|glucocorticoids|mesh-list
92826494|NCT02571517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826495|NCT02571517|Antiemetics|antiemetics|mesh-ancestor
92826496|NCT02571517|Autonomic Agents|autonomic agents|mesh-ancestor
92826497|NCT02571517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826498|NCT02571517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826499|NCT02571517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826500|NCT02571517|Hormones|hormones|mesh-ancestor
92826501|NCT02571517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826502|NCT02571517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92826503|NCT02571517|Protective Agents|protective agents|mesh-ancestor
92826504|NCT02571517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92826505|NCT02571517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826506|NCT00586846|Doxorubicin|doxorubicin|mesh-list
92826507|NCT00586846|Methotrexate|methotrexate|mesh-list
92826508|NCT00586846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826509|NCT00586846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826510|NCT00586846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826511|NCT00586846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826512|NCT00586846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826513|NCT00586846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826514|NCT00586846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92826515|NCT00586846|Abortifacient Agents|abortifacient agents|mesh-ancestor
92826516|NCT00586846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826517|NCT00586846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826518|NCT00586846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92826519|NCT00586846|Antimetabolites|antimetabolites|mesh-ancestor
92826520|NCT00586846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92826521|NCT00586846|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92826522|NCT00586846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826523|NCT00586846|Immunologic Factors|immunologic factors|mesh-ancestor
92826524|NCT00586846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826525|NCT00586846|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92826526|NCT04144465|Phenylephrine|phenylephrine|mesh-list
92826527|NCT04144465|Oxymetazoline|oxymetazoline|mesh-list
92826528|NCT04144465|Norepinephrine|norepinephrine|mesh-list
92826529|NCT04144465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92826530|NCT04144465|Mydriatics|mydriatics|mesh-ancestor
92826531|NCT04144465|Autonomic Agents|autonomic agents|mesh-ancestor
92826532|NCT04144465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826533|NCT04144465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826534|NCT04144465|Sympathomimetics|sympathomimetics|mesh-ancestor
92826535|NCT04144465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92826536|NCT04144465|Nasal Decongestants|nasal decongestants|mesh-ancestor
92826537|NCT04144465|Respiratory System Agents|respiratory system agents|mesh-ancestor
92826538|NCT04144465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92826539|NCT04144465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92826540|NCT04144465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92826541|NCT04144465|Adrenergic Agents|adrenergic agents|mesh-ancestor
92826542|NCT04144465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826543|NCT04144465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826544|NCT04144465|Protective Agents|protective agents|mesh-ancestor
92826545|NCT00754390|Calcium, Dietary|calcium, dietary|mesh-list
92826546|NCT00754390|Calcium|calcium|mesh-list
92826547|NCT00754390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92826548|NCT00754390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826549|NCT00754390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92826550|NCT04066621|Ceftriaxone|ceftriaxone|mesh-list
92826551|NCT04066621|Sulbactam|sulbactam|mesh-list
92826552|NCT04066621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826553|NCT04066621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826554|NCT04066621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92826555|NCT04066621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826556|NCT04066621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826557|NCT00629564|Esomeprazole|esomeprazole|mesh-list
92826558|NCT00629564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92826559|NCT00629564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471555|NCT01829893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92826560|NCT00629564|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92826561|NCT00629564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826562|NCT00629564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826563|NCT02865824|Aspirin|aspirin|mesh-list
92826564|NCT02865824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92826565|NCT02865824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826566|NCT02865824|Analgesics|analgesics|mesh-ancestor
92826567|NCT02865824|Sensory System Agents|sensory system agents|mesh-ancestor
92826568|NCT02865824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826569|NCT02865824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826570|NCT02865824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826571|NCT02865824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826572|NCT02865824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92826573|NCT02865824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92826574|NCT02865824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826575|NCT02865824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92826576|NCT02865824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92826577|NCT02865824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826578|NCT02865824|Antipyretics|antipyretics|mesh-ancestor
92826579|NCT02570035|Mirabegron|mirabegron|mesh-list
92826580|NCT02570035|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92826581|NCT02570035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92826582|NCT02570035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92826583|NCT02570035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92826584|NCT02570035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826585|NCT02570035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826586|NCT02570035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826587|NCT02570035|Urological Agents|urological agents|mesh-ancestor
92826588|NCT02865980|Povidone-Iodine|povidone-iodine|mesh-list
92826589|NCT02865980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92826590|NCT02865980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826591|NCT04098796|Antibodies|antibodies|mesh-list
92826592|NCT04098796|Immunologic Factors|immunologic factors|mesh-ancestor
92826593|NCT04098796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826594|NCT00522145|XL647|xl647|mesh-list
92826595|NCT00522145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826596|NCT00522145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92826597|NCT00522145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826598|NCT00522145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826599|NCT00726973|Ranibizumab|ranibizumab|mesh-list
92826600|NCT00726973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92826601|NCT00726973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92826602|NCT00726973|Growth Substances|growth substances|mesh-ancestor
92826603|NCT00726973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826604|NCT00726973|Growth Inhibitors|growth inhibitors|mesh-ancestor
92826605|NCT00726973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826606|NCT02571361|Acetaminophen|acetaminophen|mesh-list
92826607|NCT02571361|Ibuprofen|ibuprofen|mesh-list
92826608|NCT02571361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826609|NCT02571361|Analgesics|analgesics|mesh-ancestor
92826610|NCT02571361|Sensory System Agents|sensory system agents|mesh-ancestor
92826611|NCT02571361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826612|NCT02571361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826613|NCT02571361|Antipyretics|antipyretics|mesh-ancestor
92826614|NCT02571361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92826615|NCT02571361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826616|NCT02571361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826617|NCT02571361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92826618|NCT02571361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826619|NCT02571361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826620|NCT04290104|Ampicillin|ampicillin|mesh-list
92826621|NCT04290104|Sulbactam|sulbactam|mesh-list
92826622|NCT04290104|Sultamicillin|sultamicillin|mesh-list
92826623|NCT04290104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826624|NCT04290104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826625|NCT04290104|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92826626|NCT04290104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826627|NCT04290104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826628|NCT02571205|Testosterone|testosterone|mesh-list
92826629|NCT02571205|Androgens|androgens|mesh-ancestor
92826630|NCT02571205|Hormones|hormones|mesh-ancestor
92826631|NCT02571205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826632|NCT02571205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826633|NCT04290026|Metoclopramide|metoclopramide|mesh-list
92826634|NCT04290026|Granisetron|granisetron|mesh-list
92826635|NCT04290026|Antiemetics|antiemetics|mesh-ancestor
92826636|NCT04290026|Autonomic Agents|autonomic agents|mesh-ancestor
92826637|NCT04290026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826638|NCT04290026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826639|NCT04290026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826640|NCT04290026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92826641|NCT04290026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92826642|NCT04290026|Dopamine Agents|dopamine agents|mesh-ancestor
92826643|NCT04290026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728477|NCT02215473|Chlorhexidine|chlorhexidine|mesh-list
92826644|NCT04290026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826645|NCT04290026|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92826646|NCT04290026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92826647|NCT04290026|Serotonin Agents|serotonin agents|mesh-ancestor
92826648|NCT00640887|Ritonavir|ritonavir|mesh-list
92826649|NCT00640887|Lopinavir|lopinavir|mesh-list
92826650|NCT00640887|Nevirapine|nevirapine|mesh-list
92826651|NCT00640887|Efavirenz|efavirenz|mesh-list
92826652|NCT00640887|Rifabutin|rifabutin|mesh-list
92826653|NCT00640887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92826654|NCT00640887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92826655|NCT00640887|Protease Inhibitors|protease inhibitors|mesh-ancestor
92826656|NCT00640887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826657|NCT00640887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826658|NCT00640887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92826659|NCT00640887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92826660|NCT00640887|Antiviral Agents|antiviral agents|mesh-ancestor
92826661|NCT00640887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826662|NCT00640887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92826663|NCT00640887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92826664|NCT00640887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92826665|NCT00640887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92826666|NCT00640887|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92826667|NCT00640887|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92826668|NCT00640887|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92826669|NCT00640887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92826670|NCT00640887|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92826671|NCT00640887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826672|NCT00640887|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92826673|NCT00640887|Antitubercular Agents|antitubercular agents|mesh-ancestor
92826674|NCT05615623|Doxorubicin|doxorubicin|mesh-list
92826675|NCT05615623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92826676|NCT05615623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826677|NCT05615623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92826678|NCT05615623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92826679|NCT05615623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826680|NCT05615623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826681|NCT00730093|Vitamin B 12|vitamin b 12|mesh-list
92826682|NCT00730093|Hydroxocobalamin|hydroxocobalamin|mesh-list
92826683|NCT00730093|Vitamins|vitamins|mesh-ancestor
92826684|NCT00730093|Micronutrients|micronutrients|mesh-ancestor
92826685|NCT00730093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826686|NCT00730093|Vitamin B Complex|vitamin b complex|mesh-ancestor
92826687|NCT00730093|Hematinics|hematinics|mesh-ancestor
92826688|NCT00727129|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92826689|NCT00727129|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92826690|NCT00727129|Estradiol|estradiol|mesh-list
92826691|NCT00727129|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92826692|NCT00727129|Estrogens|estrogens|mesh-ancestor
92826693|NCT00727129|Hormones|hormones|mesh-ancestor
92826694|NCT00727129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92826695|NCT00727129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826696|NCT00727129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92826697|NCT00727129|Contraceptive Agents|contraceptive agents|mesh-ancestor
92826698|NCT00727129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826699|NCT00727129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92826700|NCT04183725|Oseltamivir|oseltamivir|mesh-list
92826701|NCT04183725|Antiviral Agents|antiviral agents|mesh-ancestor
92826702|NCT04183725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826703|NCT04183725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826704|NCT04183725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826705|NCT00730249|Methylphenidate|methylphenidate|mesh-list
92826706|NCT00730249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92826707|NCT00730249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826708|NCT00730249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92826709|NCT00730249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92826710|NCT00730249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92826711|NCT00730249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826712|NCT00730249|Dopamine Agents|dopamine agents|mesh-ancestor
92826713|NCT00730249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826714|NCT02570347|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92826715|NCT02570347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826716|NCT02570347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826717|NCT02570347|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92826718|NCT02570347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826719|NCT02570347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826721|NCT01632657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92826722|NCT01632657|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92826723|NCT01632657|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92826724|NCT01632657|Serotonin Agents|serotonin agents|mesh-ancestor
92826725|NCT01632657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826726|NCT01632657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753739|NCT04499950|Dopamine Agents|dopamine agents|mesh-ancestor
92826727|NCT01632657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826728|NCT00727207|Everolimus|everolimus|mesh-list
92826729|NCT00727207|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92826730|NCT00727207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92826731|NCT00727207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826732|NCT00727207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826733|NCT00727207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826734|NCT00727207|Immunologic Factors|immunologic factors|mesh-ancestor
92826735|NCT00727207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826736|NCT00727207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826737|NCT02682459|Lisinopril|lisinopril|mesh-list
92826738|NCT02682459|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92826739|NCT02682459|Protease Inhibitors|protease inhibitors|mesh-ancestor
92826740|NCT02682459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826741|NCT02682459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826742|NCT02682459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92826743|NCT02682459|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92826744|NCT02682459|Protective Agents|protective agents|mesh-ancestor
92826745|NCT02682459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826746|NCT02620579|Propranolol|propranolol|mesh-list
92826747|NCT02620579|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92826748|NCT02620579|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92826749|NCT02620579|Adrenergic Agents|adrenergic agents|mesh-ancestor
92728596|NCT00575861|Zileuton|zileuton|mesh-list
92826750|NCT02620579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826751|NCT02620579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826752|NCT02620579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826753|NCT02620579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92826754|NCT02620579|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92826755|NCT02620579|Vasodilator Agents|vasodilator agents|mesh-ancestor
92826756|NCT02682225|Ketamine|ketamine|mesh-list
92826757|NCT02682225|Esketamine|esketamine|mesh-list
92826758|NCT02682225|Analgesics|analgesics|mesh-ancestor
92826759|NCT02682225|Sensory System Agents|sensory system agents|mesh-ancestor
92826760|NCT02682225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826761|NCT02682225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826762|NCT02682225|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92826763|NCT02682225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92826764|NCT02682225|Anesthetics, General|anesthetics, general|mesh-ancestor
92753999|NCT03637543|Nivolumab|nivolumab|mesh-list
92826765|NCT02682225|Anesthetics|anesthetics|mesh-ancestor
92826766|NCT02682225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826767|NCT02682225|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92826768|NCT02682225|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92826769|NCT02682225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826770|NCT02682225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826771|NCT02682225|Antidepressive Agents|antidepressive agents|mesh-ancestor
92826772|NCT02682225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92826773|NCT00365157|Halichondrin B|halichondrin b|mesh-list
92826774|NCT00365157|Tubulin Modulators|tubulin modulators|mesh-ancestor
92826775|NCT00365157|Antimitotic Agents|antimitotic agents|mesh-ancestor
92826776|NCT00365157|Mitosis Modulators|mitosis modulators|mesh-ancestor
92826777|NCT00365157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826778|NCT00365157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826779|NCT04066231|Erythromycin|erythromycin|mesh-list
92826780|NCT04066231|Erythromycin Estolate|erythromycin estolate|mesh-list
92826781|NCT04066231|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92826782|NCT04066231|Erythromycin stearate|erythromycin stearate|mesh-list
92826783|NCT04066231|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
92826784|NCT04066231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826785|NCT04066231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826786|NCT04066231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826787|NCT04066231|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92826788|NCT04066231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826789|NCT04066231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826791|NCT04183491|Interferon-beta|interferon-beta|mesh-list
92826792|NCT04183491|Interferon beta-1a|interferon beta-1a|mesh-list
92826793|NCT04183491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826794|NCT04183491|Antiviral Agents|antiviral agents|mesh-ancestor
92826795|NCT04183491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826796|NCT04183491|Immunologic Factors|immunologic factors|mesh-ancestor
92826797|NCT04183491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826798|NCT04183491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92826799|NCT03702283|Penicillins|penicillins|mesh-list
92826800|NCT03702283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826801|NCT03702283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826802|NCT00727753|Bevacizumab|bevacizumab|mesh-list
92826803|NCT00727753|Ranibizumab|ranibizumab|mesh-list
92826804|NCT00727753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92826805|NCT00727753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826806|NCT00727753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92826807|NCT00727753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92826808|NCT00727753|Growth Substances|growth substances|mesh-ancestor
92826809|NCT00727753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826810|NCT00727753|Growth Inhibitors|growth inhibitors|mesh-ancestor
92826811|NCT00727831|Leucovorin|leucovorin|mesh-list
92826812|NCT00727831|Methotrexate|methotrexate|mesh-list
92826813|NCT00727831|Calcium|calcium|mesh-list
92826814|NCT00727831|Levoleucovorin|levoleucovorin|mesh-list
92826815|NCT00727831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92826816|NCT00727831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826817|NCT00727831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92826818|NCT00727831|Abortifacient Agents|abortifacient agents|mesh-ancestor
92826819|NCT00727831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826820|NCT00727831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92826821|NCT00727831|Antimetabolites|antimetabolites|mesh-ancestor
92826822|NCT00727831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826823|NCT00727831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826824|NCT00727831|Dermatologic Agents|dermatologic agents|mesh-ancestor
92826825|NCT00727831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826826|NCT00727831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92826827|NCT00727831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826828|NCT00727831|Immunologic Factors|immunologic factors|mesh-ancestor
92826829|NCT00727831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826830|NCT00727831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92826831|NCT00727831|Antidotes|antidotes|mesh-ancestor
92826832|NCT00727831|Protective Agents|protective agents|mesh-ancestor
92826833|NCT00727831|Vitamin B Complex|vitamin b complex|mesh-ancestor
92826834|NCT00727831|Vitamins|vitamins|mesh-ancestor
92826835|NCT00727831|Micronutrients|micronutrients|mesh-ancestor
92826836|NCT00727987|Golimumab|golimumab|mesh-list
92826837|NCT00727987|Methotrexate|methotrexate|mesh-list
92826838|NCT00727987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92826839|NCT00727987|Abortifacient Agents|abortifacient agents|mesh-ancestor
92826840|NCT00727987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826841|NCT00727987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826842|NCT00727987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92826843|NCT00727987|Antimetabolites|antimetabolites|mesh-ancestor
92826844|NCT00727987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826845|NCT00727987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826846|NCT00727987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92826847|NCT00727987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826848|NCT00727987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92826849|NCT00727987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92826850|NCT00727987|Immunologic Factors|immunologic factors|mesh-ancestor
92826851|NCT00727987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826852|NCT00727987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92826853|NCT00727987|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92826854|NCT00727987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826855|NCT02681913|Adenosine|adenosine|mesh-list
92826856|NCT02681913|Analgesics|analgesics|mesh-ancestor
92826857|NCT02681913|Sensory System Agents|sensory system agents|mesh-ancestor
92826858|NCT02681913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826859|NCT02681913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826861|NCT02681913|Vasodilator Agents|vasodilator agents|mesh-ancestor
92826862|NCT02681913|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92826863|NCT02681913|Purinergic Agonists|purinergic agonists|mesh-ancestor
92826864|NCT02681913|Purinergic Agents|purinergic agents|mesh-ancestor
92826865|NCT02681913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92826866|NCT02681913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826868|NCT02681679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92826869|NCT02681679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92728714|NCT02278458|Gemcitabine|gemcitabine|mesh-list
92826870|NCT02681679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92826871|NCT02681679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826872|NCT02681679|Analgesics|analgesics|mesh-ancestor
92826873|NCT02681679|Sensory System Agents|sensory system agents|mesh-ancestor
92826874|NCT02681679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826875|NCT02681679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826876|NCT02681679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826877|NCT02681679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826878|NCT04183257|Vitamin D|vitamin d|mesh-list
92826879|NCT04183257|Ergocalciferols|ergocalciferols|mesh-list
92826880|NCT04183257|Cholecalciferol|cholecalciferol|mesh-list
92826881|NCT04183257|Vitamins|vitamins|mesh-list
92826882|NCT04183257|Micronutrients|micronutrients|mesh-ancestor
92826883|NCT04183257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826884|NCT04183257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92826885|NCT04183257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92826886|NCT00641433|Sulfadiazine|sulfadiazine|mesh-list
92826887|NCT00641433|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92826888|NCT00641433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92826889|NCT00641433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92826890|NCT00641433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92826891|NCT00641433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92826892|NCT00641433|Coccidiostats|coccidiostats|mesh-ancestor
92826893|NCT00641433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92826894|NCT00641589|Epoetin Alfa|epoetin alfa|mesh-list
92826895|NCT00641589|Hematinics|hematinics|mesh-ancestor
92826896|NCT00734383|Propofol|propofol|mesh-list
92826897|NCT00734383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92826898|NCT00734383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826899|NCT00734383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826900|NCT00734383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92826901|NCT00734383|Anesthetics, General|anesthetics, general|mesh-ancestor
92826902|NCT00734383|Anesthetics|anesthetics|mesh-ancestor
92826903|NCT00586612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92826904|NCT00586612|Immunologic Factors|immunologic factors|mesh-ancestor
92826905|NCT00586612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826906|NCT02680977|Levodopa|levodopa|mesh-list
92826907|NCT02680977|Benserazide|benserazide|mesh-list
92826908|NCT02680977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92826909|NCT02680977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92826910|NCT02680977|Dopamine Agents|dopamine agents|mesh-ancestor
92826911|NCT02680977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728753|NCT00576173|Antipyretics|antipyretics|mesh-ancestor
92826912|NCT02680977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826913|NCT02680977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826914|NCT02680977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826915|NCT00734695|Vitamins|vitamins|mesh-list
92826916|NCT00734695|Ascorbic Acid|ascorbic acid|mesh-list
92826917|NCT00734695|Micronutrients|micronutrients|mesh-ancestor
92826918|NCT00734695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826919|NCT00734695|Antioxidants|antioxidants|mesh-ancestor
92826920|NCT00734695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826921|NCT00734695|Protective Agents|protective agents|mesh-ancestor
92826922|NCT00586690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92826923|NCT00586690|Antibodies|antibodies|mesh-list
92826924|NCT00586690|Immunoglobulins|immunoglobulins|mesh-list
92826925|NCT00586690|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92826926|NCT00586690|Immunologic Factors|immunologic factors|mesh-ancestor
92826927|NCT00586690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826928|NCT00586690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826929|NCT00728611|Hyaluronic Acid|hyaluronic acid|mesh-list
92826930|NCT00728611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92826931|NCT00728611|Immunologic Factors|immunologic factors|mesh-ancestor
92826932|NCT00728611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826933|NCT00728611|Viscosupplements|viscosupplements|mesh-ancestor
92826934|NCT00728611|Protective Agents|protective agents|mesh-ancestor
92826935|NCT05663775|Mesalamine|mesalamine|mesh-list
92826936|NCT05663775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92826937|NCT05663775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92826939|NCT05663775|Sensory System Agents|sensory system agents|mesh-ancestor
92826940|NCT05663775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728782|NCT01126879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826941|NCT05663775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826942|NCT05663775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92826943|NCT05663775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826944|NCT00909987|Bevacizumab|bevacizumab|mesh-list
92826945|NCT00909987|Capecitabine|capecitabine|mesh-list
92826946|NCT00909987|Oxaliplatin|oxaliplatin|mesh-list
92826947|NCT00909987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92826948|NCT00909987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826949|NCT00909987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92826950|NCT00909987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92826951|NCT00909987|Growth Substances|growth substances|mesh-ancestor
92826952|NCT00909987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826953|NCT00909987|Growth Inhibitors|growth inhibitors|mesh-ancestor
92826954|NCT00909987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92826955|NCT00909987|Antimetabolites|antimetabolites|mesh-ancestor
92728807|NCT00625456|Sargramostim|sargramostim|mesh-list
92826956|NCT00909987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826957|NCT00729001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92826958|NCT00729001|Immunologic Factors|immunologic factors|mesh-ancestor
92826959|NCT00729001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826960|NCT00760474|Pregabalin|pregabalin|mesh-list
92826961|NCT00760474|Analgesics|analgesics|mesh-ancestor
92826962|NCT00760474|Sensory System Agents|sensory system agents|mesh-ancestor
92826963|NCT00760474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92826964|NCT00760474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826965|NCT00760474|Anticonvulsants|anticonvulsants|mesh-ancestor
92826966|NCT00760474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92826967|NCT00760474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92826968|NCT00760474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826969|NCT00760474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92826970|NCT00760474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92826971|NCT00760474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92826972|NCT00760474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92826973|NCT00760474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92826974|NCT02843035|Venglustat|venglustat|mesh-list
92826975|NCT02843035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92826976|NCT02843035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826977|NCT02680119|Esomeprazole|esomeprazole|mesh-list
92826978|NCT02680119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92826979|NCT02680119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92826980|NCT02680119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92826981|NCT02680119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728828|NCT02882581|Metformin|metformin|mesh-list
92826982|NCT02680119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92826983|NCT00734773|Cytarabine|cytarabine|mesh-list
92826984|NCT00734773|Rituximab|rituximab|mesh-list
92826985|NCT00734773|Methotrexate|methotrexate|mesh-list
92826986|NCT00734773|Vincristine|vincristine|mesh-list
92826987|NCT00734773|Procarbazine|procarbazine|mesh-list
92826988|NCT00734773|Motexafin gadolinium|motexafin gadolinium|mesh-list
92728836|NCT00576368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92826989|NCT00734773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92826990|NCT00734773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92826991|NCT00734773|Immunologic Factors|immunologic factors|mesh-ancestor
92826992|NCT00734773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92826993|NCT00734773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92826994|NCT00734773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92826995|NCT00734773|Abortifacient Agents|abortifacient agents|mesh-ancestor
92826996|NCT00734773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92826997|NCT00734773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92826998|NCT00734773|Antimetabolites|antimetabolites|mesh-ancestor
92826999|NCT00734773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827000|NCT00734773|Dermatologic Agents|dermatologic agents|mesh-ancestor
92827001|NCT00734773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827002|NCT00734773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92827003|NCT00734773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827004|NCT00734773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92827005|NCT00734773|Antiviral Agents|antiviral agents|mesh-ancestor
92827006|NCT00734773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827007|NCT00734773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92827008|NCT00734773|Tubulin Modulators|tubulin modulators|mesh-ancestor
92827009|NCT00734773|Antimitotic Agents|antimitotic agents|mesh-ancestor
92827010|NCT00734773|Mitosis Modulators|mitosis modulators|mesh-ancestor
92827012|NCT04289090|Propofol|propofol|mesh-list
92827013|NCT04289090|Sevoflurane|sevoflurane|mesh-list
92827014|NCT04289090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92827015|NCT04289090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827016|NCT04289090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827017|NCT04289090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92827018|NCT04289090|Anesthetics, General|anesthetics, general|mesh-ancestor
92827019|NCT04289090|Anesthetics|anesthetics|mesh-ancestor
92827020|NCT04289090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92827021|NCT04289090|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92827022|NCT00975416|Oxytocin|oxytocin|mesh-list
92827023|NCT00975416|Oxytocics|oxytocics|mesh-ancestor
92827024|NCT00975416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92827025|NCT00975416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827026|NCT02679963|Olaparib|olaparib|mesh-list
92728877|NCT01125748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92827027|NCT02679963|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92827028|NCT02679963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827029|NCT02679963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827030|NCT02679963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827031|NCT00760084|Decitabine|decitabine|mesh-list
92827032|NCT00760084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92827033|NCT00760084|Antimetabolites|antimetabolites|mesh-ancestor
92827034|NCT00760084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827035|NCT00760084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827036|NCT00760084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827037|NCT00735241|Leucovorin|leucovorin|mesh-list
92827038|NCT00735241|Folic Acid|folic acid|mesh-list
92827039|NCT00735241|Bevacizumab|bevacizumab|mesh-list
92827040|NCT00735241|Fluorouracil|fluorouracil|mesh-list
92827041|NCT00735241|Oxaliplatin|oxaliplatin|mesh-list
92827042|NCT00735241|Levoleucovorin|levoleucovorin|mesh-list
92827043|NCT00735241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92827044|NCT00735241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827045|NCT00735241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92827046|NCT00735241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92827047|NCT00735241|Growth Substances|growth substances|mesh-ancestor
92827048|NCT00735241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827049|NCT00735241|Growth Inhibitors|growth inhibitors|mesh-ancestor
92827050|NCT00735241|Antimetabolites|antimetabolites|mesh-ancestor
92827051|NCT00735241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827052|NCT00735241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92827053|NCT00735241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827054|NCT00735241|Immunologic Factors|immunologic factors|mesh-ancestor
92827055|NCT00735241|Antidotes|antidotes|mesh-ancestor
92827056|NCT00735241|Protective Agents|protective agents|mesh-ancestor
92827057|NCT00735241|Vitamin B Complex|vitamin b complex|mesh-ancestor
92827058|NCT00735241|Vitamins|vitamins|mesh-ancestor
92827059|NCT00735241|Micronutrients|micronutrients|mesh-ancestor
92827060|NCT00735241|Hematinics|hematinics|mesh-ancestor
92827061|NCT00729313|Lanreotide|lanreotide|mesh-list
92827062|NCT00729313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827063|NCT00641979|Budesonide|budesonide|mesh-list
92827064|NCT00641979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827065|NCT00641979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92827066|NCT00641979|Autonomic Agents|autonomic agents|mesh-ancestor
92827067|NCT00641979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827068|NCT00641979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827069|NCT00641979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92827070|NCT00641979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827071|NCT00641979|Glucocorticoids|glucocorticoids|mesh-ancestor
92827072|NCT00641979|Hormones|hormones|mesh-ancestor
92827073|NCT00641979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827074|NCT02679339|Lidocaine|lidocaine|mesh-list
92827075|NCT02679339|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827076|NCT02679339|Anesthetics|anesthetics|mesh-ancestor
92827077|NCT02679339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827078|NCT02679339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827079|NCT02679339|Sensory System Agents|sensory system agents|mesh-ancestor
92827080|NCT02679339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827081|NCT02679339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92827082|NCT02679339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92827083|NCT02679339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92827084|NCT02679339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827085|NCT02679339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827086|NCT02679261|Atorvastatin|atorvastatin|mesh-list
92827087|NCT02679261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92728937|NCT04545801|Anesthetics|anesthetics|mesh-ancestor
92827088|NCT02679261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92827089|NCT02679261|Antimetabolites|antimetabolites|mesh-ancestor
92827090|NCT02679261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827091|NCT02679261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92827092|NCT02679261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92827093|NCT02679261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827094|NCT00752206|Saracatinib|saracatinib|mesh-list
92827095|NCT00752206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827096|NCT00752206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827097|NCT00752206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827098|NCT02678949|Fluticasone|fluticasone|mesh-list
92827100|NCT02678949|Albuterol|albuterol|mesh-list
92728948|NCT04558424|Vitamins|vitamins|mesh-ancestor
92827101|NCT02678949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827102|NCT02678949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92827103|NCT02678949|Autonomic Agents|autonomic agents|mesh-ancestor
92827104|NCT02678949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827105|NCT02678949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728959|NCT00637585|Fexofenadine|fexofenadine|mesh-list
92827106|NCT02678949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92827107|NCT02678949|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827108|NCT02678949|Dermatologic Agents|dermatologic agents|mesh-ancestor
92827109|NCT02678949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92827110|NCT02678949|Tocolytic Agents|tocolytic agents|mesh-ancestor
92827111|NCT02678949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92827112|NCT02678949|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92827113|NCT02678949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92827114|NCT02678949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92827115|NCT02678949|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827116|NCT02678949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827117|NCT02678949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827118|NCT00642135|Phenylephrine|phenylephrine|mesh-list
92827119|NCT00642135|Oxymetazoline|oxymetazoline|mesh-list
92827120|NCT00642135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92827121|NCT00642135|Tropicamide|tropicamide|mesh-list
92827122|NCT00642135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92827123|NCT00642135|Mydriatics|mydriatics|mesh-ancestor
92827124|NCT00642135|Autonomic Agents|autonomic agents|mesh-ancestor
92827125|NCT00642135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827126|NCT00642135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827127|NCT00642135|Sympathomimetics|sympathomimetics|mesh-ancestor
92827128|NCT00642135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92827129|NCT00642135|Nasal Decongestants|nasal decongestants|mesh-ancestor
92827130|NCT00642135|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827131|NCT00642135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92827132|NCT00642135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92827133|NCT00642135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92827134|NCT00642135|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827135|NCT00642135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827136|NCT00642135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827137|NCT00642135|Protective Agents|protective agents|mesh-ancestor
92827138|NCT00642135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92827139|NCT00642135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92728983|NCT01125046|Growth Substances|growth substances|mesh-ancestor
92827140|NCT00642135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92827141|NCT00642135|Cholinergic Agents|cholinergic agents|mesh-ancestor
92827142|NCT00642291|Emtricitabine|emtricitabine|mesh-list
92827143|NCT00642291|Antiviral Agents|antiviral agents|mesh-ancestor
92827144|NCT00642291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827145|NCT00642291|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92154664|NCT04143581|Empagliflozin|empagliflozin|mesh-list
92827146|NCT00642291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92827147|NCT00642291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827148|NCT00642291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827149|NCT00642291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92827150|NCT00642291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92827151|NCT02600260|Enoxaparin|enoxaparin|mesh-list
92827152|NCT02600260|Enoxaparin sodium|enoxaparin sodium|mesh-list
92827153|NCT02600260|Anticoagulants|anticoagulants|mesh-ancestor
92827154|NCT02600260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92827155|NCT02600260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827156|NCT02600260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827157|NCT02537379|Ribavirin|ribavirin|mesh-list
92827158|NCT02537379|Antimetabolites|antimetabolites|mesh-ancestor
92827159|NCT02537379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827160|NCT02537379|Antiviral Agents|antiviral agents|mesh-ancestor
92827161|NCT02537379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827162|NCT05442034|Mitogens|mitogens|mesh-list
92154807|NCT04728633|Carmustine|carmustine|mesh-list
92827163|NCT05442034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92827164|NCT05442034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827165|NCT04179747|Sildenafil Citrate|sildenafil citrate|mesh-list
92827166|NCT04179747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827167|NCT04179747|Vasodilator Agents|vasodilator agents|mesh-ancestor
92827168|NCT04179747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92827169|NCT04179747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92827170|NCT04179747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827171|NCT04179747|Urological Agents|urological agents|mesh-ancestor
92827172|NCT04204772|Charcoal|charcoal|mesh-list
92827173|NCT04204772|Antidotes|antidotes|mesh-ancestor
92827174|NCT04204772|Protective Agents|protective agents|mesh-ancestor
92729027|NCT04579133|Olaparib|olaparib|mesh-list
92827175|NCT04204772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827176|NCT02675205|Aspirin|aspirin|mesh-list
92827177|NCT02675205|Clopidogrel|clopidogrel|mesh-list
92827178|NCT02675205|Ticagrelor|ticagrelor|mesh-list
92827179|NCT02675205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827180|NCT02675205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827181|NCT02675205|Analgesics|analgesics|mesh-ancestor
92827182|NCT02675205|Sensory System Agents|sensory system agents|mesh-ancestor
92827183|NCT02675205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729040|NCT02212340|Remifentanil|remifentanil|mesh-list
92827184|NCT02675205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827185|NCT02675205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827186|NCT02675205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827187|NCT02675205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92827188|NCT02675205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827189|NCT02675205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827190|NCT02675205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92729044|NCT02212340|Narcotics|narcotics|mesh-ancestor
92827191|NCT02675205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92827192|NCT02675205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827193|NCT02675205|Antipyretics|antipyretics|mesh-ancestor
92827194|NCT02675205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92827195|NCT02675205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92827196|NCT02675205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92827197|NCT02675205|Purinergic Agents|purinergic agents|mesh-ancestor
92827198|NCT02675205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827199|NCT00753454|Certolizumab Pegol|certolizumab pegol|mesh-list
92827200|NCT00753454|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92827201|NCT00753454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827202|NCT00753454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827203|NCT00753454|Immunologic Factors|immunologic factors|mesh-ancestor
92827204|NCT00753454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827205|NCT00753454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827206|NCT00643539|Azithromycin|azithromycin|mesh-list
92827207|NCT00643539|Amoxicillin|amoxicillin|mesh-list
92827208|NCT00643539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827209|NCT00643539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827210|NCT00759148|Moxifloxacin|moxifloxacin|mesh-list
92827211|NCT00759148|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92827212|NCT00759148|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92827213|NCT00759148|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92827214|NCT00759148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827215|NCT00759148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827216|NCT00759148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92827217|NCT00759148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92827218|NCT00759148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827219|NCT00759148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827220|NCT00759148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827221|NCT00759148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92827222|NCT00759148|Contraceptive Agents|contraceptive agents|mesh-ancestor
92827223|NCT00759148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729083|NCT00577109|Leucovorin|leucovorin|mesh-list
92827224|NCT00759148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827225|NCT00759148|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92827226|NCT00759148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92827227|NCT00759148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92827228|NCT00910065|Aspirin|aspirin|mesh-list
92827229|NCT00910065|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
92827230|NCT00910065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827231|NCT00910065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827232|NCT00910065|Analgesics|analgesics|mesh-ancestor
92729086|NCT00577109|Irinotecan|irinotecan|mesh-list
92827233|NCT00910065|Sensory System Agents|sensory system agents|mesh-ancestor
92433134|NCT01572623|Clopidogrel|clopidogrel|mesh-list
92827234|NCT00910065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827235|NCT00910065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827236|NCT00910065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827237|NCT00910065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827238|NCT00910065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92472216|NCT01843075|Liraglutide|liraglutide|mesh-list
92827239|NCT00910065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827240|NCT00910065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827241|NCT00910065|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92827242|NCT00910065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92827243|NCT00910065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827244|NCT00910065|Antipyretics|antipyretics|mesh-ancestor
92827245|NCT02601040|Vaccines|vaccines|mesh-list
92827246|NCT02601040|Immunologic Factors|immunologic factors|mesh-ancestor
92729106|NCT01124422|Tiotropium Bromide|tiotropium bromide|mesh-list
92827247|NCT02601040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827248|NCT04179513|Methotrexate|methotrexate|mesh-list
92827249|NCT04179513|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92827250|NCT04179513|Abortifacient Agents|abortifacient agents|mesh-ancestor
92827251|NCT04179513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92155554|NCT01673087|Metyrapone|metyrapone|mesh-list
92827252|NCT04179513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827253|NCT04179513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92827254|NCT04179513|Antimetabolites|antimetabolites|mesh-ancestor
92827255|NCT04179513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827256|NCT04179513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827257|NCT04179513|Dermatologic Agents|dermatologic agents|mesh-ancestor
92827258|NCT04179513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827259|NCT04179513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92827260|NCT04179513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827261|NCT04179513|Immunologic Factors|immunologic factors|mesh-ancestor
92827262|NCT04179513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827263|NCT04179513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92827264|NCT02675049|Dexmedetomidine|dexmedetomidine|mesh-list
92827265|NCT02675049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92827266|NCT02675049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729127|NCT00625495|Esomeprazole|esomeprazole|mesh-list
92827267|NCT02675049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827268|NCT02675049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827269|NCT02675049|Analgesics|analgesics|mesh-ancestor
92827270|NCT02675049|Sensory System Agents|sensory system agents|mesh-ancestor
92827271|NCT02675049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827272|NCT02675049|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92827273|NCT02675049|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92827274|NCT02675049|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92827275|NCT02675049|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827276|NCT02675049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827277|NCT02675049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827278|NCT02674737|Flurbiprofen|flurbiprofen|mesh-list
92827279|NCT02674737|Dexmedetomidine|dexmedetomidine|mesh-list
92827280|NCT02674737|Tramadol|tramadol|mesh-list
92827281|NCT02674737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92827282|NCT02674737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827283|NCT02674737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827284|NCT02674737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827285|NCT02674737|Analgesics|analgesics|mesh-ancestor
92827286|NCT02674737|Sensory System Agents|sensory system agents|mesh-ancestor
92827287|NCT02674737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729153|NCT04545099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92827288|NCT02674737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92827289|NCT02674737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92827290|NCT02674737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92827291|NCT02674737|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827292|NCT02674737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827293|NCT02674737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827294|NCT02674737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92827295|NCT02674737|Narcotics|narcotics|mesh-ancestor
92827296|NCT02674737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827297|NCT02674737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827298|NCT02674737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827299|NCT02674737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92827300|NCT02674737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827301|NCT02674893|Liraglutide|liraglutide|mesh-list
92827302|NCT02674893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92827303|NCT02674893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827304|NCT02674893|Incretins|incretins|mesh-ancestor
92827305|NCT02674893|Hormones|hormones|mesh-ancestor
92827306|NCT02674893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827308|NCT02717455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827309|NCT02717455|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92827310|NCT02717455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827311|NCT02717455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827312|NCT02674581|Fostemsavir|fostemsavir|mesh-list
92827314|NCT02674581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92827315|NCT02674581|Antiviral Agents|antiviral agents|mesh-ancestor
92827316|NCT02674581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827317|NCT02674581|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92827318|NCT02674581|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92827319|NCT02674581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827320|NCT04065919|Epinephrine|epinephrine|mesh-list
92827321|NCT04065919|Bupivacaine|bupivacaine|mesh-list
92827322|NCT04065919|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827323|NCT04065919|Anesthetics|anesthetics|mesh-ancestor
92827324|NCT04065919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827325|NCT04065919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827326|NCT04065919|Sensory System Agents|sensory system agents|mesh-ancestor
92827327|NCT04065919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827328|NCT04065919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92827329|NCT04065919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92827330|NCT04065919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827331|NCT04065919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827332|NCT04065919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827333|NCT04065919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92827334|NCT04065919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92827335|NCT04065919|Autonomic Agents|autonomic agents|mesh-ancestor
92827336|NCT04065919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92827337|NCT04065919|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827338|NCT04065919|Mydriatics|mydriatics|mesh-ancestor
92827339|NCT04065919|Sympathomimetics|sympathomimetics|mesh-ancestor
92827340|NCT04065919|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92827341|NCT04065529|Zinc|zinc|mesh-list
92827342|NCT04065529|Trace Elements|trace elements|mesh-ancestor
92827343|NCT04065529|Micronutrients|micronutrients|mesh-ancestor
92827344|NCT04065529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827345|NCT04179045|Sirolimus|sirolimus|mesh-list
92827346|NCT04179045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827347|NCT04179045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827348|NCT04179045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92827349|NCT04179045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827350|NCT04179045|Antifungal Agents|antifungal agents|mesh-ancestor
92827351|NCT04179045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827352|NCT04179045|Immunologic Factors|immunologic factors|mesh-ancestor
92827353|NCT04179045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827354|NCT00970268|Bromides|bromides|mesh-list
92827355|NCT00970268|Anticonvulsants|anticonvulsants|mesh-ancestor
92827356|NCT02674113|Bupivacaine|bupivacaine|mesh-list
92827357|NCT02674113|Anesthetics|anesthetics|mesh-list
92827358|NCT02674113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827359|NCT02674113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827360|NCT02674113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827361|NCT02674113|Sensory System Agents|sensory system agents|mesh-ancestor
92827362|NCT02674113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827363|NCT00644085|Aspirin|aspirin|mesh-list
92827364|NCT00644085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827365|NCT00644085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827366|NCT00644085|Analgesics|analgesics|mesh-ancestor
92827367|NCT00644085|Sensory System Agents|sensory system agents|mesh-ancestor
92827368|NCT00644085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827369|NCT00644085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827370|NCT00644085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827371|NCT00644085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827372|NCT00644085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92827373|NCT00644085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827374|NCT00644085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827375|NCT00644085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92827376|NCT00644085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92827377|NCT00644085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827378|NCT00644085|Antipyretics|antipyretics|mesh-ancestor
92827379|NCT00731575|Prednisolone|prednisolone|mesh-list
92827380|NCT00731575|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92827381|NCT00731575|Methylprednisolone|methylprednisolone|mesh-list
92827382|NCT00731575|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92827383|NCT00731575|Prednisolone acetate|prednisolone acetate|mesh-list
92827384|NCT00731575|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92827385|NCT00731575|Prednisolone phosphate|prednisolone phosphate|mesh-list
92827386|NCT00731575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827387|NCT00731575|Glucocorticoids|glucocorticoids|mesh-ancestor
92827389|NCT00731575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827390|NCT00731575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827391|NCT00731575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92827392|NCT00731575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827394|NCT00731575|Autonomic Agents|autonomic agents|mesh-ancestor
92827395|NCT00731575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827396|NCT00731575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92827397|NCT00731575|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92827398|NCT00731575|Protective Agents|protective agents|mesh-ancestor
92827399|NCT02674191|Clindamycin|clindamycin|mesh-list
92827400|NCT02674191|Clindamycin palmitate|clindamycin palmitate|mesh-list
92827401|NCT02674191|Clindamycin phosphate|clindamycin phosphate|mesh-list
92827402|NCT02674191|Povidone-Iodine|povidone-iodine|mesh-list
92827403|NCT02674191|Mepivacaine|mepivacaine|mesh-list
92827404|NCT02674191|Benzocaine|benzocaine|mesh-list
92827405|NCT02674191|Povidone|povidone|mesh-list
92827406|NCT02674191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827407|NCT02674191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827408|NCT02674191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92827409|NCT02674191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827410|NCT02674191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827411|NCT02674191|Plasma Substitutes|plasma substitutes|mesh-ancestor
92827412|NCT02674191|Blood Substitutes|blood substitutes|mesh-ancestor
92827413|NCT02674191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92827414|NCT02674191|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827415|NCT02674191|Anesthetics|anesthetics|mesh-ancestor
92827416|NCT02674191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827417|NCT02674191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827418|NCT02674191|Sensory System Agents|sensory system agents|mesh-ancestor
92827419|NCT02674191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827420|NCT00736021|Escitalopram|escitalopram|mesh-list
92827421|NCT00736021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92827422|NCT00736021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92827423|NCT00736021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729228|NCT00577967|Gabapentin|gabapentin|mesh-list
92827424|NCT00736021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827425|NCT00736021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827426|NCT00736021|Serotonin Agents|serotonin agents|mesh-ancestor
92827427|NCT00736021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827428|NCT04178655|Tranexamic Acid|tranexamic acid|mesh-list
92827429|NCT04178655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92827430|NCT04178655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827431|NCT04178655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827432|NCT04178655|Hemostatics|hemostatics|mesh-ancestor
92827433|NCT04178655|Coagulants|coagulants|mesh-ancestor
92827434|NCT00738517|Immunoglobulins|immunoglobulins|mesh-list
92827435|NCT00738517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92827436|NCT00738517|Antibodies|antibodies|mesh-list
92827437|NCT00738517|Immunologic Factors|immunologic factors|mesh-ancestor
92827438|NCT00738517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827439|NCT02673879|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92827440|NCT02673879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92827441|NCT02673879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827442|NCT02673879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827443|NCT00738595|Nicotine|nicotine|mesh-list
92827444|NCT00738595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92827445|NCT00738595|Autonomic Agents|autonomic agents|mesh-ancestor
92827446|NCT00738595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827447|NCT00738595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827448|NCT00738595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92827449|NCT00738595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92827450|NCT00738595|Cholinergic Agents|cholinergic agents|mesh-ancestor
92827451|NCT00738595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827452|NCT00738595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827453|NCT05273775|Vitamin K|vitamin k|mesh-list
92827454|NCT05273775|Vitamin K 1|vitamin k 1|mesh-list
92827455|NCT05273775|Digoxin|digoxin|mesh-list
92827456|NCT05273775|Midazolam|midazolam|mesh-list
92827457|NCT05273775|Omeprazole|omeprazole|mesh-list
92827458|NCT05273775|Warfarin|warfarin|mesh-list
92827460|NCT05273775|Vitamins|vitamins|mesh-ancestor
92827461|NCT05273775|Micronutrients|micronutrients|mesh-ancestor
92827462|NCT05273775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827463|NCT05273775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92827464|NCT05273775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92827465|NCT05273775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827466|NCT05273775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92827467|NCT05273775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92827468|NCT05273775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92827469|NCT05273775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92827470|NCT05273775|Anesthetics, General|anesthetics, general|mesh-ancestor
92827471|NCT05273775|Anesthetics|anesthetics|mesh-ancestor
92827472|NCT05273775|GABA Modulators|gaba modulators|mesh-ancestor
92827473|NCT05273775|GABA Agents|gaba agents|mesh-ancestor
92827474|NCT05273775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827475|NCT05273775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827476|NCT05273775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92827477|NCT05273775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92827478|NCT05273775|Antimetabolites|antimetabolites|mesh-ancestor
92827479|NCT05273775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92827480|NCT05273775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92827481|NCT05273775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827482|NCT05273775|Anticoagulants|anticoagulants|mesh-ancestor
92827483|NCT05273775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92827484|NCT05273775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92827485|NCT05273775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92827486|NCT05273775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92827487|NCT05273775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92827488|NCT05273775|Protective Agents|protective agents|mesh-ancestor
92827489|NCT05273775|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92827490|NCT05273775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92827491|NCT05273775|Hemostatics|hemostatics|mesh-ancestor
92827492|NCT05273775|Coagulants|coagulants|mesh-ancestor
92827493|NCT02671851|Acetaminophen|acetaminophen|mesh-list
92827494|NCT02671851|Dipyrone|dipyrone|mesh-list
92827495|NCT02671851|Fentanyl|fentanyl|mesh-list
92827496|NCT02671851|Tramadol|tramadol|mesh-list
92827497|NCT02671851|Bupivacaine|bupivacaine|mesh-list
92827498|NCT02671851|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827499|NCT02671851|Anesthetics|anesthetics|mesh-ancestor
92827500|NCT02671851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827501|NCT02671851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827502|NCT02671851|Sensory System Agents|sensory system agents|mesh-ancestor
92827503|NCT02671851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827504|NCT02671851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92827505|NCT02671851|Narcotics|narcotics|mesh-ancestor
92827506|NCT02671851|Analgesics|analgesics|mesh-ancestor
92827507|NCT02671851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92827508|NCT02671851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92827509|NCT02671851|Anesthetics, General|anesthetics, general|mesh-ancestor
92827510|NCT02671851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827511|NCT02671851|Antipyretics|antipyretics|mesh-ancestor
92827512|NCT02671851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827513|NCT02671851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827514|NCT02671851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827515|NCT02135419|Fluorouracil|fluorouracil|mesh-list
92827516|NCT02135419|Imiquimod|imiquimod|mesh-list
92827517|NCT02135419|Antimetabolites|antimetabolites|mesh-ancestor
92827518|NCT02135419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827519|NCT02135419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92827520|NCT02135419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827521|NCT02135419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827522|NCT02135419|Immunologic Factors|immunologic factors|mesh-ancestor
92827523|NCT02135419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827524|NCT02135419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92827525|NCT02135419|Interferon Inducers|interferon inducers|mesh-ancestor
92827526|NCT04177095|Sirolimus|sirolimus|mesh-list
92827527|NCT04177095|Prednisone|prednisone|mesh-list
92827528|NCT04177095|Everolimus|everolimus|mesh-list
92827529|NCT04177095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827530|NCT04177095|Glucocorticoids|glucocorticoids|mesh-ancestor
92827531|NCT04177095|Hormones|hormones|mesh-ancestor
92827532|NCT04177095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827533|NCT04177095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827534|NCT04177095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92827535|NCT04177095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827536|NCT04177095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92827537|NCT04177095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92827538|NCT04177095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827539|NCT04177095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827540|NCT04177095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827541|NCT04177095|Immunologic Factors|immunologic factors|mesh-ancestor
92827542|NCT04177095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92827543|NCT04177095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827544|NCT04177095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827545|NCT04177095|Antifungal Agents|antifungal agents|mesh-ancestor
92827546|NCT02671695|Amlodipine|amlodipine|mesh-list
92827547|NCT02671695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92827548|NCT02671695|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92827549|NCT02671695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827550|NCT02671695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827551|NCT02671695|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92827552|NCT02671695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827553|NCT02671695|Vasodilator Agents|vasodilator agents|mesh-ancestor
92827554|NCT00644631|Sildenafil Citrate|sildenafil citrate|mesh-list
92827555|NCT00644631|Vasodilator Agents|vasodilator agents|mesh-ancestor
92827556|NCT00644631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92827557|NCT00644631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92827558|NCT00644631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827559|NCT00644631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827560|NCT00644631|Urological Agents|urological agents|mesh-ancestor
92827561|NCT02671383|Lopinavir|lopinavir|mesh-list
92827562|NCT02671383|Darunavir|darunavir|mesh-list
92827563|NCT02671383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92827564|NCT02671383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92827565|NCT02671383|Protease Inhibitors|protease inhibitors|mesh-ancestor
92827566|NCT02671383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827567|NCT02671383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827568|NCT02671383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92827569|NCT02671383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92827570|NCT02671383|Antiviral Agents|antiviral agents|mesh-ancestor
92827571|NCT02671383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827572|NCT02671383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92827573|NCT02671383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92827574|NCT00738751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92827575|NCT00738751|Panobinostat|panobinostat|mesh-list
92729375|NCT04536129|Hydrocortisone|hydrocortisone|mesh-list
92827576|NCT00738751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92827577|NCT00738751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827578|NCT00738751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92827579|NCT00738751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827580|NCT00738751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827581|NCT05243823|Estradiol|estradiol|mesh-list
92827582|NCT05243823|Estrogens|estrogens|mesh-ancestor
92827583|NCT05243823|Hormones|hormones|mesh-ancestor
92827584|NCT05243823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827585|NCT05243823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827586|NCT00736801|Fluticasone|fluticasone|mesh-list
92827587|NCT00736801|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92827588|NCT00736801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827589|NCT00736801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92827590|NCT00736801|Autonomic Agents|autonomic agents|mesh-ancestor
92827591|NCT00736801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827592|NCT00736801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827593|NCT00736801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92827594|NCT00736801|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827595|NCT00736801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92827596|NCT00736801|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92827597|NCT00736801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92827598|NCT00736801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92827599|NCT00736801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92827600|NCT00736801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827601|NCT00736801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827602|NCT00736801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827603|NCT00738829|Rituximab|rituximab|mesh-list
92827604|NCT00738829|Fludarabine|fludarabine|mesh-list
92827605|NCT00738829|Fludarabine phosphate|fludarabine phosphate|mesh-list
92827606|NCT00738829|Lenalidomide|lenalidomide|mesh-list
92827607|NCT00738829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92827608|NCT00738829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827609|NCT00738829|Immunologic Factors|immunologic factors|mesh-ancestor
92827610|NCT00738829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827611|NCT00738829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827612|NCT00738829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92827613|NCT00738829|Antimetabolites|antimetabolites|mesh-ancestor
92827614|NCT00738829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827615|NCT00738829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827616|NCT00738829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92827617|NCT00738829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92827618|NCT00738829|Growth Substances|growth substances|mesh-ancestor
92827619|NCT00738829|Growth Inhibitors|growth inhibitors|mesh-ancestor
92827621|NCT02671227|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827622|NCT02671227|Anesthetics|anesthetics|mesh-ancestor
92827623|NCT02671227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827624|NCT02671227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827625|NCT02671227|Sensory System Agents|sensory system agents|mesh-ancestor
92827626|NCT02671227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827627|NCT00644709|Atorvastatin|atorvastatin|mesh-list
92827628|NCT00644709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92827629|NCT00644709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92827630|NCT00644709|Antimetabolites|antimetabolites|mesh-ancestor
92827631|NCT00644709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827632|NCT00644709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92827633|NCT00644709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92827634|NCT00644709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827635|NCT00738985|Simvastatin|simvastatin|mesh-list
92827636|NCT00738985|Ezetimibe|ezetimibe|mesh-list
92827637|NCT00738985|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92827638|NCT00738985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92827639|NCT00738985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92827640|NCT00738985|Antimetabolites|antimetabolites|mesh-ancestor
92827641|NCT00738985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827642|NCT00738985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92827643|NCT00738985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92827644|NCT00738985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827645|NCT05216211|Bupivacaine|bupivacaine|mesh-list
92827646|NCT05216211|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827647|NCT05216211|Anesthetics|anesthetics|mesh-ancestor
92827648|NCT05216211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827649|NCT05216211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827650|NCT05216211|Sensory System Agents|sensory system agents|mesh-ancestor
92827651|NCT05216211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827652|NCT00732121|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92827653|NCT00732121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92827654|NCT00732121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827655|NCT00732121|Incretins|incretins|mesh-ancestor
92827656|NCT00732121|Hormones|hormones|mesh-ancestor
92827657|NCT00732121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827658|NCT00732121|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92827659|NCT00732121|Protease Inhibitors|protease inhibitors|mesh-ancestor
92827660|NCT00732121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827661|NCT00732121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827662|NCT02537223|Cisplatin|cisplatin|mesh-list
92827663|NCT02537223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827664|NCT02568943|Panobinostat|panobinostat|mesh-list
92827665|NCT02568943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827666|NCT02568943|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92827667|NCT02568943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827668|NCT02568943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827669|NCT00732277|Hydrocortisone|hydrocortisone|mesh-list
92827670|NCT00732277|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92827671|NCT00732277|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92827672|NCT00732277|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92827673|NCT00732277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827674|NCT00739453|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92827675|NCT00739453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827676|NCT00739453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92827677|NCT00739453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827678|NCT00739453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827679|NCT02668497|Botulinum Toxins|botulinum toxins|mesh-list
92827680|NCT02668497|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92827681|NCT02668497|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92827682|NCT02668497|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92827683|NCT02668497|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92827684|NCT02668497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827685|NCT02668497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827686|NCT02668497|Cholinergic Agents|cholinergic agents|mesh-ancestor
92827687|NCT02668497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827688|NCT02668497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827689|NCT02668497|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92827690|NCT02668497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827692|NCT00737113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827693|NCT00737113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827694|NCT00737191|Olanzapine|olanzapine|mesh-list
92827695|NCT00737191|Antiemetics|antiemetics|mesh-ancestor
92827696|NCT00737191|Autonomic Agents|autonomic agents|mesh-ancestor
92827697|NCT00737191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827698|NCT00737191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827699|NCT00737191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92827700|NCT00737191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92827701|NCT00737191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92827702|NCT00737191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827703|NCT00737191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92827704|NCT00737191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92827705|NCT00737191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92827706|NCT00737191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827707|NCT00737191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827708|NCT00737191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827709|NCT00737191|Serotonin Agents|serotonin agents|mesh-ancestor
92827710|NCT04175067|Antioxidants|antioxidants|mesh-list
92827711|NCT04175067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827712|NCT04175067|Protective Agents|protective agents|mesh-ancestor
92827713|NCT04175067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827714|NCT00758602|Mycophenolic Acid|mycophenolic acid|mesh-list
92827715|NCT00758602|Tacrolimus|tacrolimus|mesh-list
92827716|NCT00758602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827717|NCT00758602|Immunologic Factors|immunologic factors|mesh-ancestor
92827718|NCT00758602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827719|NCT00758602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92827720|NCT00758602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827721|NCT00758602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827722|NCT00758602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92827723|NCT00758602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827724|NCT00758602|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92827725|NCT00758602|Antitubercular Agents|antitubercular agents|mesh-ancestor
92827726|NCT00758602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827727|NCT00758602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827728|NCT02667561|Methyltestosterone|methyltestosterone|mesh-list
92827729|NCT02667561|Testosterone|testosterone|mesh-list
92827730|NCT02667561|Testosterone undecanoate|testosterone undecanoate|mesh-list
92827731|NCT02667561|Testosterone enanthate|testosterone enanthate|mesh-list
92827732|NCT02667561|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92827733|NCT02667561|Androgens|androgens|mesh-ancestor
92827734|NCT02667561|Hormones|hormones|mesh-ancestor
92827735|NCT02667561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827736|NCT02667561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827737|NCT02667561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92827738|NCT02667561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827739|NCT02667561|Anabolic Agents|anabolic agents|mesh-ancestor
92827740|NCT00732511|Metoprolol|metoprolol|mesh-list
92827741|NCT00732511|Carvedilol|carvedilol|mesh-list
92827742|NCT00732511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92827743|NCT00732511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92827744|NCT00732511|Sympatholytics|sympatholytics|mesh-ancestor
92827745|NCT00732511|Autonomic Agents|autonomic agents|mesh-ancestor
92827746|NCT00732511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827747|NCT00732511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827748|NCT00732511|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92827749|NCT00732511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92827750|NCT00732511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92827751|NCT00732511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92827752|NCT00732511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827753|NCT00732511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827754|NCT00732511|Antioxidants|antioxidants|mesh-ancestor
92827755|NCT00732511|Protective Agents|protective agents|mesh-ancestor
92827756|NCT00732511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92827757|NCT00732511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827758|NCT00732511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92827759|NCT00732511|Vasodilator Agents|vasodilator agents|mesh-ancestor
92827760|NCT00732511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92827761|NCT00732511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92827762|NCT00739531|Nitric Oxide|nitric oxide|mesh-list
92827763|NCT00739531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92827764|NCT00739531|Autonomic Agents|autonomic agents|mesh-ancestor
92827765|NCT00739531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827766|NCT00739531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827767|NCT00739531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92827768|NCT00739531|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827769|NCT00739531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92827770|NCT00739531|Antioxidants|antioxidants|mesh-ancestor
92827771|NCT00739531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827772|NCT00739531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827773|NCT00739531|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92827774|NCT00739531|Vasodilator Agents|vasodilator agents|mesh-ancestor
92827775|NCT00739531|Gasotransmitters|gasotransmitters|mesh-ancestor
92827776|NCT00739531|Protective Agents|protective agents|mesh-ancestor
92827777|NCT00739609|Tryptophan|tryptophan|mesh-list
92827778|NCT00739609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92827779|NCT00739609|Antidepressive Agents|antidepressive agents|mesh-ancestor
92827780|NCT00739609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92827781|NCT00645723|Colistin|colistin|mesh-list
92827782|NCT00645723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827783|NCT00645723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827784|NCT00711529|Gabapentin|gabapentin|mesh-list
92827785|NCT00711529|Analgesics|analgesics|mesh-ancestor
92827786|NCT00711529|Sensory System Agents|sensory system agents|mesh-ancestor
92827787|NCT00711529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827788|NCT00711529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827789|NCT00711529|Anticonvulsants|anticonvulsants|mesh-ancestor
92827790|NCT00711529|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92827791|NCT00711529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92827792|NCT00711529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827793|NCT00711529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92827794|NCT00711529|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92827795|NCT00711529|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92827796|NCT00711529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827797|NCT00711529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827798|NCT00711529|Antimanic Agents|antimanic agents|mesh-ancestor
92827799|NCT00732589|Lidocaine|lidocaine|mesh-list
92827800|NCT00732589|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827801|NCT00732589|Anesthetics|anesthetics|mesh-ancestor
92827802|NCT00732589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827803|NCT00732589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827804|NCT00732589|Sensory System Agents|sensory system agents|mesh-ancestor
92827805|NCT00732589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827806|NCT00732589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92827807|NCT00732589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92827808|NCT00732589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92827809|NCT00732589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827810|NCT00732589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827811|NCT00645879|Citric Acid|citric acid|mesh-list
92827812|NCT00645879|Sodium Citrate|sodium citrate|mesh-list
92827813|NCT00645879|Anticoagulants|anticoagulants|mesh-ancestor
92827814|NCT00645879|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92827815|NCT00645879|Chelating Agents|chelating agents|mesh-ancestor
92827816|NCT00645879|Sequestering Agents|sequestering agents|mesh-ancestor
92827817|NCT00645879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827818|NCT00737659|Mycophenolic Acid|mycophenolic acid|mesh-list
92827819|NCT00737659|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92827820|NCT00737659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827821|NCT00737659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92827822|NCT00737659|Antitubercular Agents|antitubercular agents|mesh-ancestor
92827823|NCT00737659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92827824|NCT00737659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827825|NCT00737659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827826|NCT00737659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827827|NCT02666703|Methylprednisolone|methylprednisolone|mesh-list
92827828|NCT02666703|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92827829|NCT02666703|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92827830|NCT02666703|Prednisolone|prednisolone|mesh-list
92827831|NCT02666703|Prednisolone acetate|prednisolone acetate|mesh-list
92827832|NCT02666703|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92827833|NCT02666703|Prednisolone phosphate|prednisolone phosphate|mesh-list
92827834|NCT02666703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827835|NCT02666703|Antiemetics|antiemetics|mesh-ancestor
92827836|NCT02666703|Autonomic Agents|autonomic agents|mesh-ancestor
92472826|NCT01846390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827837|NCT02666703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827838|NCT02666703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827840|NCT02666703|Glucocorticoids|glucocorticoids|mesh-ancestor
92827842|NCT02666703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827843|NCT02666703|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92827844|NCT02666703|Protective Agents|protective agents|mesh-ancestor
92827845|NCT02666703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92827846|NCT02666703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827847|NCT05560009|Levodopa|levodopa|mesh-list
92827848|NCT05560009|Fluorides|fluorides|mesh-list
92827849|NCT05560009|Cariostatic Agents|cariostatic agents|mesh-ancestor
92827850|NCT05560009|Protective Agents|protective agents|mesh-ancestor
92827851|NCT05560009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827852|NCT05560009|Dopamine Agents|dopamine agents|mesh-ancestor
92827853|NCT05560009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92827854|NCT05560009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827855|NCT05560009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92827856|NCT05560009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92827857|NCT04174131|Lidocaine|lidocaine|mesh-list
92827858|NCT04174131|Hyaluronic Acid|hyaluronic acid|mesh-list
92827859|NCT04174131|Anesthetics, Local|anesthetics, local|mesh-ancestor
92827860|NCT04174131|Anesthetics|anesthetics|mesh-ancestor
92827861|NCT04174131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827862|NCT04174131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827863|NCT04174131|Sensory System Agents|sensory system agents|mesh-ancestor
92827864|NCT04174131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827865|NCT04174131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92827866|NCT04174131|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92827867|NCT04174131|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92827868|NCT04174131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92827869|NCT04174131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827870|NCT04174131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92827871|NCT04174131|Immunologic Factors|immunologic factors|mesh-ancestor
92827872|NCT04174131|Viscosupplements|viscosupplements|mesh-ancestor
92827873|NCT04174131|Protective Agents|protective agents|mesh-ancestor
92827874|NCT00646035|Ergocalciferols|ergocalciferols|mesh-list
92827875|NCT00646035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92827876|NCT00646035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827877|NCT00646035|Vitamins|vitamins|mesh-ancestor
92827878|NCT00646035|Micronutrients|micronutrients|mesh-ancestor
92827879|NCT00646035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92827880|NCT00646191|Adalimumab|adalimumab|mesh-list
92827881|NCT00646191|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92827882|NCT00646191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827883|NCT00646191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827884|NCT02666157|Rivaroxaban|rivaroxaban|mesh-list
92827885|NCT02666157|Apixaban|apixaban|mesh-list
92827886|NCT02666157|Dabigatran|dabigatran|mesh-list
92827887|NCT02666157|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92827888|NCT02666157|Antithrombins|antithrombins|mesh-ancestor
92827889|NCT02666157|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92827890|NCT02666157|Protease Inhibitors|protease inhibitors|mesh-ancestor
92827891|NCT02666157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827892|NCT02666157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827893|NCT02666157|Anticoagulants|anticoagulants|mesh-ancestor
92827894|NCT02666001|Fostemsavir|fostemsavir|mesh-list
92827895|NCT02666001|Buprenorphine|buprenorphine|mesh-list
92827896|NCT02666001|Methadone|methadone|mesh-list
92827897|NCT02666001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92827898|NCT02666001|Narcotics|narcotics|mesh-ancestor
92827899|NCT02666001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827900|NCT02666001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827901|NCT02666001|Analgesics|analgesics|mesh-ancestor
92827902|NCT02666001|Sensory System Agents|sensory system agents|mesh-ancestor
92827903|NCT02666001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827904|NCT02666001|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92827905|NCT02666001|Antitussive Agents|antitussive agents|mesh-ancestor
92827906|NCT02666001|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827907|NCT02666001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92827908|NCT02666001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92827909|NCT02666001|Antiviral Agents|antiviral agents|mesh-ancestor
92827910|NCT02666001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827911|NCT02666001|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92827912|NCT02666001|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92827913|NCT02666001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827915|NCT02665845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827916|NCT02665845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827917|NCT02665845|Analgesics|analgesics|mesh-ancestor
92827918|NCT02665845|Sensory System Agents|sensory system agents|mesh-ancestor
92827919|NCT02665845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827920|NCT02665845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827921|NCT02665845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827922|NCT02665845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827923|NCT00646425|Basiliximab|basiliximab|mesh-list
92827924|NCT00646425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827925|NCT00646425|Immunologic Factors|immunologic factors|mesh-ancestor
92827926|NCT00646425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827927|NCT04837209|Niraparib|niraparib|mesh-list
92827928|NCT04837209|Dostarlimab|dostarlimab|mesh-list
92827929|NCT04837209|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92827930|NCT04837209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827931|NCT04837209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827932|NCT04837209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827933|NCT02665533|Dexamethasone|dexamethasone|mesh-list
92827934|NCT02665533|Dexamethasone acetate|dexamethasone acetate|mesh-list
92827935|NCT02665533|Diclofenac|diclofenac|mesh-list
92827936|NCT02665533|Codeine|codeine|mesh-list
92827937|NCT02665533|BB 1101|bb 1101|mesh-list
92827938|NCT02665533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827939|NCT02665533|Antiemetics|antiemetics|mesh-ancestor
92827940|NCT02665533|Autonomic Agents|autonomic agents|mesh-ancestor
92827941|NCT02665533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827942|NCT02665533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827943|NCT02665533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92827944|NCT02665533|Glucocorticoids|glucocorticoids|mesh-ancestor
92827945|NCT02665533|Hormones|hormones|mesh-ancestor
92827946|NCT02665533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92827947|NCT02665533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92827948|NCT02665533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827949|NCT02665533|Protease Inhibitors|protease inhibitors|mesh-ancestor
92827950|NCT02665533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827951|NCT02665533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827952|NCT02665533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827953|NCT02665533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92827954|NCT02665533|Analgesics|analgesics|mesh-ancestor
92827955|NCT02665533|Sensory System Agents|sensory system agents|mesh-ancestor
92827956|NCT02665533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827957|NCT02665533|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92827958|NCT02665533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92827959|NCT02665533|Narcotics|narcotics|mesh-ancestor
92827960|NCT02665533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92827961|NCT02665533|Antitussive Agents|antitussive agents|mesh-ancestor
92827962|NCT02665533|Respiratory System Agents|respiratory system agents|mesh-ancestor
92827963|NCT00646503|Telbivudine|telbivudine|mesh-list
92827964|NCT00646503|Antiviral Agents|antiviral agents|mesh-ancestor
92827965|NCT00646503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92827966|NCT00646503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92827967|NCT00646503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92827968|NCT00646503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827969|NCT04173039|Antibodies|antibodies|mesh-list
92827970|NCT04173039|Immunologic Factors|immunologic factors|mesh-ancestor
92827971|NCT04173039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827972|NCT00646659|Carboplatin|carboplatin|mesh-list
92827973|NCT00646659|Docetaxel|docetaxel|mesh-list
92827974|NCT00646659|Fluorouracil|fluorouracil|mesh-list
92827975|NCT00646659|Cetuximab|cetuximab|mesh-list
92827976|NCT00646659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92827977|NCT00646659|Tubulin Modulators|tubulin modulators|mesh-ancestor
92827978|NCT00646659|Antimitotic Agents|antimitotic agents|mesh-ancestor
92827979|NCT00646659|Mitosis Modulators|mitosis modulators|mesh-ancestor
92827980|NCT00646659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92827981|NCT00646659|Antimetabolites|antimetabolites|mesh-ancestor
92827982|NCT00646659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92827983|NCT00646659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92827984|NCT00646659|Immunologic Factors|immunologic factors|mesh-ancestor
92827985|NCT00646659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827986|NCT00646659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92827987|NCT00648531|Balsalazide|balsalazide|mesh-list
92472972|NCT01847690|Hydrocortisone|hydrocortisone|mesh-list
92827988|NCT00648531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92827990|NCT00648531|Analgesics|analgesics|mesh-ancestor
92827991|NCT00648531|Sensory System Agents|sensory system agents|mesh-ancestor
92827992|NCT00648531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92827993|NCT00648531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92827994|NCT00648531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92827995|NCT00648531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92827996|NCT00648531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92827997|NCT00648765|Anagrelide|anagrelide|mesh-list
92827998|NCT00648765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92827999|NCT00648765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92828000|NCT00648765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828001|NCT00648765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92828002|NCT00648843|Oxybutynin|oxybutynin|mesh-list
92828003|NCT00648843|Parasympatholytics|parasympatholytics|mesh-ancestor
92828004|NCT00648843|Autonomic Agents|autonomic agents|mesh-ancestor
92828005|NCT00648843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828006|NCT00648843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828007|NCT00648843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92828008|NCT00648843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92828009|NCT00648843|Cholinergic Agents|cholinergic agents|mesh-ancestor
92828010|NCT00648843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828011|NCT00648843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828012|NCT00648843|Urological Agents|urological agents|mesh-ancestor
92828013|NCT02662959|Irinotecan|irinotecan|mesh-list
92828014|NCT02662959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92828015|NCT02662959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92828016|NCT02662959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828017|NCT02662959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828018|NCT02662959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828019|NCT02662647|Cytarabine|cytarabine|mesh-list
92828020|NCT02662647|Decitabine|decitabine|mesh-list
92828021|NCT02662647|Aclacinomycins|aclacinomycins|mesh-list
92828022|NCT02662647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92828023|NCT02662647|Antimetabolites|antimetabolites|mesh-ancestor
92828024|NCT02662647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828025|NCT02662647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828026|NCT02662647|Antiviral Agents|antiviral agents|mesh-ancestor
92828027|NCT02662647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828028|NCT02662647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828029|NCT02662647|Immunologic Factors|immunologic factors|mesh-ancestor
92828030|NCT02662647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828031|NCT02662647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828032|NCT02662647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92828033|NCT02662647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92828034|NCT02662725|Ipilimumab|ipilimumab|mesh-list
92828035|NCT02662725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92828036|NCT02662725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828037|NCT02662725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92828038|NCT02662725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828039|NCT00648921|Olanzapine|olanzapine|mesh-list
92828040|NCT00648921|Antiemetics|antiemetics|mesh-ancestor
92828041|NCT00648921|Autonomic Agents|autonomic agents|mesh-ancestor
92828042|NCT00648921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828043|NCT00648921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828044|NCT00648921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92828045|NCT00648921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92828046|NCT00648921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92828047|NCT00648921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828048|NCT00648921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92828049|NCT00648921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92828050|NCT00648921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92828051|NCT00648921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92828052|NCT00648921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828053|NCT00648921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828054|NCT00648921|Serotonin Agents|serotonin agents|mesh-ancestor
92828055|NCT02662491|Calcium, Dietary|calcium, dietary|mesh-list
92828056|NCT02662491|Vitamin D|vitamin d|mesh-list
92828057|NCT02662491|Ergocalciferols|ergocalciferols|mesh-list
92828058|NCT02662491|Cholecalciferol|cholecalciferol|mesh-list
92828059|NCT02662491|Vitamins|vitamins|mesh-list
92828060|NCT02662491|Calcium|calcium|mesh-list
92828061|NCT02662491|Micronutrients|micronutrients|mesh-ancestor
92473053|NCT01848197|Paclitaxel|paclitaxel|mesh-list
92828062|NCT02662491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828063|NCT02662491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92828064|NCT02662491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92828066|NCT00648999|Lopinavir|lopinavir|mesh-list
92828067|NCT00648999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92828068|NCT00648999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92828069|NCT00648999|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828070|NCT00648999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828071|NCT00648999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828072|NCT00648999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92828073|NCT00648999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92828074|NCT00648999|Antiviral Agents|antiviral agents|mesh-ancestor
92828075|NCT00648999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828076|NCT00648999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92828077|NCT00648999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92828078|NCT02661711|Aflibercept|aflibercept|mesh-list
92828079|NCT02661711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92828080|NCT02661711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828081|NCT02661711|Growth Substances|growth substances|mesh-ancestor
92828082|NCT02661711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828083|NCT02661711|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828084|NCT02661711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828085|NCT02661789|Goserelin|goserelin|mesh-list
92828086|NCT02661789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92828087|NCT02661789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828088|NCT02661477|Interferons|interferons|mesh-list
92828089|NCT02661477|Interferon-alpha|interferon-alpha|mesh-list
92828090|NCT02661477|Interferon alpha-2|interferon alpha-2|mesh-list
92828091|NCT02661477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828092|NCT02661477|Antiviral Agents|antiviral agents|mesh-ancestor
92828093|NCT02661477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828094|NCT02661477|Immunologic Factors|immunologic factors|mesh-ancestor
92828095|NCT02661477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828096|NCT00649077|Meloxicam|meloxicam|mesh-list
92828097|NCT00649077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92828098|NCT00649077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92828099|NCT00649077|Analgesics|analgesics|mesh-ancestor
92828100|NCT00649077|Sensory System Agents|sensory system agents|mesh-ancestor
92828101|NCT00649077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828102|NCT00649077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828103|NCT00649077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92828104|NCT00649077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828105|NCT00649077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92828106|NCT00649077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92828107|NCT00649077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828108|NCT00649077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828109|NCT02656251|Ethanol|ethanol|mesh-list
92828110|NCT02656251|Chlorhexidine|chlorhexidine|mesh-list
92828111|NCT02656251|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92828112|NCT02656251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92828113|NCT02656251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828114|NCT02656251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828115|NCT02656251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828116|NCT02656251|Disinfectants|disinfectants|mesh-ancestor
92828117|NCT02656251|Dermatologic Agents|dermatologic agents|mesh-ancestor
92828118|NCT02656095|Heparin|heparin|mesh-list
92828119|NCT02656095|Anticoagulants|anticoagulants|mesh-ancestor
92828120|NCT02656095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92828121|NCT02656095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92828122|NCT02656095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828123|NCT00649935|Azithromycin|azithromycin|mesh-list
92828124|NCT00649935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828125|NCT00649935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828126|NCT02655705|Cyclosporine|cyclosporine|mesh-list
92828127|NCT02655705|Methotrexate|methotrexate|mesh-list
92828128|NCT02655705|Cyclosporins|cyclosporins|mesh-list
92828129|NCT02655705|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92828130|NCT02655705|Abortifacient Agents|abortifacient agents|mesh-ancestor
92828131|NCT02655705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92828132|NCT02655705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828133|NCT02655705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92828134|NCT02655705|Antimetabolites|antimetabolites|mesh-ancestor
92828135|NCT02655705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828136|NCT02655705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828137|NCT02655705|Dermatologic Agents|dermatologic agents|mesh-ancestor
92828138|NCT02655705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828139|NCT02655705|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92828140|NCT02655705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828141|NCT02655705|Immunologic Factors|immunologic factors|mesh-ancestor
92828142|NCT02655705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828143|NCT02655705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92828144|NCT02655705|Antifungal Agents|antifungal agents|mesh-ancestor
92828145|NCT02655705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828146|NCT02655705|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92828147|NCT02655471|Zidovudine|zidovudine|mesh-list
92828148|NCT02655471|Raltegravir Potassium|raltegravir potassium|mesh-list
92828149|NCT02655471|Antimetabolites|antimetabolites|mesh-ancestor
92828150|NCT02655471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828151|NCT02655471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92828152|NCT02655471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92828153|NCT02655471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828154|NCT02655471|Antiviral Agents|antiviral agents|mesh-ancestor
92828155|NCT02655471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828156|NCT02655471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92828157|NCT02655471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92828158|NCT02655471|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92828159|NCT02655471|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92828160|NCT00650013|Midodrine|midodrine|mesh-list
92828161|NCT00650013|Sympathomimetics|sympathomimetics|mesh-ancestor
92828162|NCT00650013|Autonomic Agents|autonomic agents|mesh-ancestor
92828163|NCT00650013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828164|NCT00650013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828165|NCT00650013|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92828166|NCT00650013|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92828167|NCT00650013|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92828168|NCT00650013|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92828169|NCT00650013|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828170|NCT00650013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828171|NCT00650013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828172|NCT00712933|Belimumab|belimumab|mesh-list
92828173|NCT00712933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828174|NCT00712933|Immunologic Factors|immunologic factors|mesh-ancestor
92828175|NCT00712933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828176|NCT02654847|Norepinephrine|norepinephrine|mesh-list
92828177|NCT02654847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92828178|NCT02654847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92828179|NCT02654847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828180|NCT02654847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828181|NCT02654847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828182|NCT02654847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828183|NCT02654847|Sympathomimetics|sympathomimetics|mesh-ancestor
92828184|NCT02654847|Autonomic Agents|autonomic agents|mesh-ancestor
92828185|NCT02654847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828186|NCT02654847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92828187|NCT02536209|Oxycodone|oxycodone|mesh-list
92828188|NCT02536209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92828189|NCT02536209|Narcotics|narcotics|mesh-ancestor
92828190|NCT02536209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828191|NCT02536209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828192|NCT02536209|Analgesics|analgesics|mesh-ancestor
92828193|NCT02536209|Sensory System Agents|sensory system agents|mesh-ancestor
92828194|NCT02536209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828195|NCT00732745|Docetaxel|docetaxel|mesh-list
92828196|NCT00732745|Oxaliplatin|oxaliplatin|mesh-list
92828197|NCT00732745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828198|NCT00732745|Tubulin Modulators|tubulin modulators|mesh-ancestor
92828199|NCT00732745|Antimitotic Agents|antimitotic agents|mesh-ancestor
92828200|NCT00732745|Mitosis Modulators|mitosis modulators|mesh-ancestor
92828201|NCT00732745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828202|NCT00737815|Magnesium citrate|magnesium citrate|mesh-list
92828203|NCT00737815|Cathartics|cathartics|mesh-ancestor
92828204|NCT00737815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92828205|NCT02654379|Rituximab|rituximab|mesh-list
92828206|NCT02654379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92828208|NCT02654379|Immunologic Factors|immunologic factors|mesh-ancestor
92828209|NCT02654379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828210|NCT02654379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828211|NCT04341129|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92828212|NCT04341129|Chelating Agents|chelating agents|mesh-ancestor
92828214|NCT04341129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828215|NCT00712543|Lactulose|lactulose|mesh-list
92828216|NCT00712543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92828217|NCT00650169|Clopidogrel|clopidogrel|mesh-list
92828218|NCT00650169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92828219|NCT00650169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92828220|NCT00650169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92828221|NCT00650169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92828222|NCT00650169|Purinergic Agents|purinergic agents|mesh-ancestor
92828223|NCT00650169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828224|NCT00650169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828225|NCT00650169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828226|NCT04064125|Minocycline|minocycline|mesh-list
92828227|NCT04064125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828228|NCT04064125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828229|NCT00740389|Etravirine|etravirine|mesh-list
92828230|NCT00740389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92828231|NCT00740389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92828232|NCT00740389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828233|NCT00740389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828234|NCT00740389|Antiviral Agents|antiviral agents|mesh-ancestor
92828235|NCT00740389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828236|NCT00740467|Cyclosporine|cyclosporine|mesh-list
92828237|NCT00740467|Mycophenolic Acid|mycophenolic acid|mesh-list
92828238|NCT00740467|Cyclophosphamide|cyclophosphamide|mesh-list
92828239|NCT00740467|Busulfan|busulfan|mesh-list
92828240|NCT00740467|Fludarabine|fludarabine|mesh-list
92828241|NCT00740467|Fludarabine phosphate|fludarabine phosphate|mesh-list
92828242|NCT00740467|Cyclosporins|cyclosporins|mesh-list
92828243|NCT00740467|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92828244|NCT00740467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828245|NCT00740467|Immunologic Factors|immunologic factors|mesh-ancestor
92828246|NCT00740467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828247|NCT00740467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828248|NCT00740467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92828249|NCT00740467|Alkylating Agents|alkylating agents|mesh-ancestor
92828250|NCT00740467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828251|NCT00740467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828252|NCT00740467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92828253|NCT00740467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92828254|NCT00740467|Antimetabolites|antimetabolites|mesh-ancestor
92828255|NCT00740467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828256|NCT00740467|Antifungal Agents|antifungal agents|mesh-ancestor
92828257|NCT00740467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828258|NCT00740467|Dermatologic Agents|dermatologic agents|mesh-ancestor
92828259|NCT00740467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92828260|NCT00740467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92828261|NCT00740467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92828262|NCT00740467|Antitubercular Agents|antitubercular agents|mesh-ancestor
92828263|NCT00740467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828264|NCT00740545|Enoxaparin|enoxaparin|mesh-list
92828265|NCT00740545|Anticoagulants|anticoagulants|mesh-ancestor
92828266|NCT00740545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92828267|NCT00740545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92828268|NCT00740545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828269|NCT02653833|Tadalafil|tadalafil|mesh-list
92828270|NCT02653833|Vasodilator Agents|vasodilator agents|mesh-ancestor
92828271|NCT02653833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92828272|NCT02653833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92828273|NCT02653833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828274|NCT02653833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828275|NCT02653833|Urological Agents|urological agents|mesh-ancestor
92828276|NCT00733057|Minocycline|minocycline|mesh-list
92828277|NCT00733057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828278|NCT00733057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828279|NCT00737971|Triamcinolone|triamcinolone|mesh-list
92828280|NCT00737971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92828281|NCT00737971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92828283|NCT00737971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92828284|NCT00737971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92828285|NCT00737971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828286|NCT00737971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92473273|NCT01850095|Azelaic acid|azelaic acid|mesh-list
92828287|NCT00737971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828288|NCT00737971|Growth Substances|growth substances|mesh-ancestor
92828289|NCT00737971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828290|NCT00737971|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828291|NCT00737971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92828292|NCT00737971|Glucocorticoids|glucocorticoids|mesh-ancestor
92828293|NCT00737971|Hormones|hormones|mesh-ancestor
92730077|NCT02213159|Narcotics|narcotics|mesh-ancestor
92828294|NCT00737971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828295|NCT00737971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828296|NCT00737971|Immunologic Factors|immunologic factors|mesh-ancestor
92828297|NCT00737971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828298|NCT00737971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828299|NCT00650247|Sumatriptan|sumatriptan|mesh-list
92828300|NCT00650247|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92828301|NCT00650247|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92828302|NCT00650247|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92828303|NCT00650247|Serotonin Agents|serotonin agents|mesh-ancestor
92828304|NCT00650247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828305|NCT00650247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828306|NCT00650247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828307|NCT02568709|Oxytocin|oxytocin|mesh-list
92828308|NCT02568709|Oxytocics|oxytocics|mesh-ancestor
92828309|NCT02568709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92828310|NCT02568709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828311|NCT04316169|Hydroxychloroquine|hydroxychloroquine|mesh-list
92828312|NCT04316169|Letrozole|letrozole|mesh-list
92828313|NCT04316169|Fulvestrant|fulvestrant|mesh-list
92828314|NCT04316169|Anastrozole|anastrozole|mesh-list
92828315|NCT04316169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828316|NCT04316169|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92828317|NCT04316169|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92828318|NCT04316169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828319|NCT04316169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828320|NCT04316169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92828321|NCT04316169|Hormone Antagonists|hormone antagonists|mesh-ancestor
92828322|NCT04316169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828323|NCT04316169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828324|NCT04316169|Antimalarials|antimalarials|mesh-ancestor
92828325|NCT04316169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92828326|NCT04316169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92828327|NCT04316169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828328|NCT04316169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828329|NCT04316169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92828330|NCT04316169|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92828331|NCT02653209|Pioglitazone|pioglitazone|mesh-list
92828332|NCT02653209|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92828333|NCT02653209|Canagliflozin|canagliflozin|mesh-list
92828334|NCT02653209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828335|NCT02653209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828336|NCT02653209|Incretins|incretins|mesh-ancestor
92828337|NCT02653209|Hormones|hormones|mesh-ancestor
92828338|NCT02653209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828339|NCT02653209|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92828340|NCT02653209|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828341|NCT02653209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828342|NCT02653209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828343|NCT02653209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92828344|NCT02653131|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92828345|NCT02653131|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92828346|NCT02653131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828347|NCT02653131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828348|NCT02653131|Incretins|incretins|mesh-ancestor
92828349|NCT02653131|Hormones|hormones|mesh-ancestor
92828350|NCT02653131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828351|NCT02653131|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828352|NCT02653131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828353|NCT02653131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828355|NCT02652585|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92828356|NCT02652585|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92828357|NCT02652585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828358|NCT02652585|Sensory System Agents|sensory system agents|mesh-ancestor
92828359|NCT02652585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473346|NCT01850628|Paclitaxel|paclitaxel|mesh-list
92828360|NCT00741169|Rifampin|rifampin|mesh-list
92828361|NCT00741169|Simeprevir|simeprevir|mesh-list
92828362|NCT00741169|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92828363|NCT00741169|Antitubercular Agents|antitubercular agents|mesh-ancestor
92828364|NCT00741169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828365|NCT00741169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828366|NCT00741169|Leprostatic Agents|leprostatic agents|mesh-ancestor
92828367|NCT00741169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92828368|NCT00741169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828369|NCT00741169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828370|NCT00741169|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92828371|NCT00741169|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92828372|NCT00741169|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92828373|NCT00741169|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92828374|NCT00741169|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92828375|NCT00741169|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92828376|NCT00741169|Antiviral Agents|antiviral agents|mesh-ancestor
92828377|NCT00741169|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828378|NCT00741325|Plerixafor|plerixafor|mesh-list
92828379|NCT00741325|Lenograstim|lenograstim|mesh-list
92828380|NCT00741325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92828381|NCT00741325|Immunologic Factors|immunologic factors|mesh-ancestor
92828382|NCT00741325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828383|NCT00741325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92828384|NCT00741325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92828385|NCT00741325|Antiviral Agents|antiviral agents|mesh-ancestor
92828386|NCT00741325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828387|NCT02652741|Enalapril|enalapril|mesh-list
92828388|NCT02652741|Enalaprilat|enalaprilat|mesh-list
92828389|NCT02652741|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92828390|NCT02652741|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828391|NCT02652741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828392|NCT02652741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828393|NCT02652741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92828394|NCT02652507|Dexmedetomidine|dexmedetomidine|mesh-list
92828395|NCT02652507|Ketamine|ketamine|mesh-list
92828396|NCT02652507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92828397|NCT02652507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828398|NCT02652507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828399|NCT02652507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92828400|NCT02652507|Analgesics|analgesics|mesh-ancestor
92828401|NCT02652507|Sensory System Agents|sensory system agents|mesh-ancestor
92828402|NCT02652507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828403|NCT02652507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92828404|NCT02652507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92828405|NCT02652507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92828406|NCT02652507|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828407|NCT02652507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828408|NCT02652507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828409|NCT02652507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92828410|NCT02652507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92828411|NCT02652507|Anesthetics, General|anesthetics, general|mesh-ancestor
92828412|NCT02652507|Anesthetics|anesthetics|mesh-ancestor
92828413|NCT02652507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92828414|NCT02652507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92828415|NCT05742295|Vitamin K|vitamin k|mesh-list
92828416|NCT05742295|Vitamins|vitamins|mesh-ancestor
92828417|NCT05742295|Micronutrients|micronutrients|mesh-ancestor
92828418|NCT05742295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828419|NCT05742295|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92828420|NCT05742295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92828421|NCT05742295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828422|NCT05742295|Hemostatics|hemostatics|mesh-ancestor
92828423|NCT05742295|Coagulants|coagulants|mesh-ancestor
92828424|NCT02652273|Abatacept|abatacept|mesh-list
92828425|NCT02652273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92828426|NCT02652273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828427|NCT02652273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92828428|NCT02652273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828429|NCT02652273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828430|NCT02652273|Immunologic Factors|immunologic factors|mesh-ancestor
92828431|NCT02652273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828432|NCT02652273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828434|NCT00650325|Antidepressive Agents|antidepressive agents|mesh-ancestor
92828435|NCT00650325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92828436|NCT00650325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92828437|NCT00650325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92828438|NCT00650325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92828439|NCT00650325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828440|NCT00650325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828441|NCT00650325|Serotonin Agents|serotonin agents|mesh-ancestor
92828442|NCT00650325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828443|NCT00650403|Paroxetine|paroxetine|mesh-list
92828444|NCT00650403|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92828445|NCT00650403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92828446|NCT00650403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92828447|NCT00650403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828448|NCT00650403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828449|NCT00650403|Serotonin Agents|serotonin agents|mesh-ancestor
92828450|NCT00650403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828451|NCT00650403|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92828452|NCT00650403|Antidepressive Agents|antidepressive agents|mesh-ancestor
92828453|NCT00650403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92828454|NCT00650403|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92828455|NCT00650403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92828456|NCT00650403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828457|NCT02568319|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92828458|NCT02568319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92828459|NCT02568319|Autonomic Agents|autonomic agents|mesh-ancestor
92828460|NCT02568319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828461|NCT02568319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828462|NCT02568319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92828463|NCT02568319|Respiratory System Agents|respiratory system agents|mesh-ancestor
92828464|NCT02568319|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92828465|NCT02568319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92828466|NCT02568319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92828467|NCT02568319|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828468|NCT02568319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828469|NCT02568319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828470|NCT00920803|Resveratrol|resveratrol|mesh-list
92828471|NCT00920803|Antioxidants|antioxidants|mesh-ancestor
92828472|NCT00920803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828473|NCT00920803|Protective Agents|protective agents|mesh-ancestor
92828474|NCT00920803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828475|NCT00920803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828476|NCT00920803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92828477|NCT03912363|Insulin|insulin|mesh-list
92828478|NCT03912363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828479|NCT03912363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828480|NCT05740969|Fluorouracil|fluorouracil|mesh-list
92828481|NCT05740969|Imiquimod|imiquimod|mesh-list
92828482|NCT05740969|Melatonin|melatonin|mesh-list
92828483|NCT05740969|Antimetabolites|antimetabolites|mesh-ancestor
92828484|NCT05740969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828485|NCT05740969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92828486|NCT05740969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828487|NCT05740969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828488|NCT05740969|Immunologic Factors|immunologic factors|mesh-ancestor
92828489|NCT05740969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828490|NCT05740969|Antioxidants|antioxidants|mesh-ancestor
92828491|NCT05740969|Protective Agents|protective agents|mesh-ancestor
92828492|NCT05740969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828493|NCT05740969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92828494|NCT05740969|Interferon Inducers|interferon inducers|mesh-ancestor
92828495|NCT02568241|Interferons|interferons|mesh-list
92828496|NCT02568241|Interferon-alpha|interferon-alpha|mesh-list
92828497|NCT02568241|Interferon alpha-2|interferon alpha-2|mesh-list
92828498|NCT02568241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828499|NCT02568241|Antiviral Agents|antiviral agents|mesh-ancestor
92828500|NCT02568241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828501|NCT02568241|Immunologic Factors|immunologic factors|mesh-ancestor
92828502|NCT02568241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828503|NCT05551897|Itraconazole|itraconazole|mesh-list
92828504|NCT05551897|Antifungal Agents|antifungal agents|mesh-ancestor
92828505|NCT05551897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828506|NCT05551897|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92828507|NCT05551897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92828509|NCT05551897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828510|NCT05551897|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92828511|NCT05551897|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730298|NCT01117051|Prucalopride|prucalopride|mesh-list
92828512|NCT05551897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828513|NCT05551897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828514|NCT05551897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92828515|NCT02647671|Calcium Carbonate|calcium carbonate|mesh-list
92828516|NCT02647671|Calcium|calcium|mesh-list
92828517|NCT02647671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92828518|NCT02647671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828519|NCT02647671|Antacids|antacids|mesh-ancestor
92828520|NCT02647671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828521|NCT02647671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92828522|NCT04578613|Rituximab|rituximab|mesh-list
92828523|NCT04578613|Chlorambucil|chlorambucil|mesh-list
92828524|NCT04578613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92828525|NCT04578613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828526|NCT04578613|Immunologic Factors|immunologic factors|mesh-ancestor
92828527|NCT04578613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828528|NCT04578613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828529|NCT04578613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92828530|NCT04578613|Alkylating Agents|alkylating agents|mesh-ancestor
92828531|NCT04578613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828532|NCT02647515|Ranibizumab|ranibizumab|mesh-list
92828533|NCT02647515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92828534|NCT02647515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828535|NCT02647515|Growth Substances|growth substances|mesh-ancestor
92828536|NCT02647515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828537|NCT02647515|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828538|NCT02647515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828539|NCT03818763|Factor VIII|factor viii|mesh-list
92828540|NCT03818763|Coagulants|coagulants|mesh-ancestor
92828541|NCT02647047|Acetaminophen|acetaminophen|mesh-list
92828542|NCT02647047|Ketorolac|ketorolac|mesh-list
92828543|NCT02647047|Sufentanil|sufentanil|mesh-list
92828544|NCT02647047|Ropivacaine|ropivacaine|mesh-list
92828545|NCT02647047|Anesthetics, Local|anesthetics, local|mesh-ancestor
92828546|NCT02647047|Anesthetics|anesthetics|mesh-ancestor
92828547|NCT02647047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828548|NCT02647047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828549|NCT02647047|Sensory System Agents|sensory system agents|mesh-ancestor
92828550|NCT02647047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828551|NCT02647047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92828552|NCT02647047|Analgesics|analgesics|mesh-ancestor
92828553|NCT02647047|Antipyretics|antipyretics|mesh-ancestor
92828554|NCT02647047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92828555|NCT02647047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92828556|NCT02647047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828557|NCT02647047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92828558|NCT02647047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828559|NCT02647047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828560|NCT02647047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92828561|NCT02647047|Narcotics|narcotics|mesh-ancestor
92828562|NCT02647047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92828563|NCT02647047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92828564|NCT02647047|Anesthetics, General|anesthetics, general|mesh-ancestor
92828565|NCT00651651|Budesonide|budesonide|mesh-list
92828566|NCT00651651|Formoterol Fumarate|formoterol fumarate|mesh-list
92828567|NCT00651651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92828568|NCT00651651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92828569|NCT00651651|Autonomic Agents|autonomic agents|mesh-ancestor
92828570|NCT00651651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828571|NCT00651651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828572|NCT00651651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92828573|NCT00651651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92828574|NCT00651651|Glucocorticoids|glucocorticoids|mesh-ancestor
92828575|NCT00651651|Hormones|hormones|mesh-ancestor
92828576|NCT00651651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828577|NCT00651651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92828578|NCT00651651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92828579|NCT00651651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92828580|NCT00651651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828581|NCT00651651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828582|NCT00651651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828583|NCT00709111|Maraviroc|maraviroc|mesh-list
92828584|NCT00709111|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92828585|NCT00709111|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92828586|NCT00709111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828587|NCT00709111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92828588|NCT00709111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92828589|NCT00709111|Antiviral Agents|antiviral agents|mesh-ancestor
92828590|NCT00709111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828591|NCT00709111|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92828592|NCT00651729|Botulinum Toxins|botulinum toxins|mesh-list
92828593|NCT00651729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92828594|NCT00651729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92828595|NCT00651729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92828596|NCT00651729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92828597|NCT00651729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828598|NCT00651729|Cholinergic Agents|cholinergic agents|mesh-ancestor
92828599|NCT00651729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828600|NCT00651729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828601|NCT00651729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92828602|NCT00651729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828603|NCT02646735|Fulvestrant|fulvestrant|mesh-list
92828604|NCT02646735|Exemestane|exemestane|mesh-list
92828605|NCT02646735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92828606|NCT02646735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828607|NCT02646735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92828608|NCT02646735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92828609|NCT02646735|Hormone Antagonists|hormone antagonists|mesh-ancestor
92828610|NCT02646735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828611|NCT02646735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828612|NCT02646735|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92828613|NCT02646735|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92828614|NCT02646735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828615|NCT02646735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828616|NCT02646501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92828617|NCT02646657|Vedolizumab|vedolizumab|mesh-list
92828618|NCT02646657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92828619|NCT00652041|Thalidomide|thalidomide|mesh-list
92828620|NCT00652041|Bortezomib|bortezomib|mesh-list
92828621|NCT00652041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828622|NCT00652041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828623|NCT00652041|Immunologic Factors|immunologic factors|mesh-ancestor
92828624|NCT00652041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828625|NCT00652041|Leprostatic Agents|leprostatic agents|mesh-ancestor
92828626|NCT00652041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828627|NCT00652041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828628|NCT00652041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92828629|NCT00652041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828630|NCT00652041|Growth Substances|growth substances|mesh-ancestor
92828631|NCT00652041|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828632|NCT02646111|Ribavirin|ribavirin|mesh-list
92828633|NCT02646111|Antimetabolites|antimetabolites|mesh-ancestor
92828634|NCT02646111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828635|NCT02646111|Antiviral Agents|antiviral agents|mesh-ancestor
92828636|NCT02646111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828637|NCT00652119|Paclitaxel|paclitaxel|mesh-list
92828638|NCT00652119|Bevacizumab|bevacizumab|mesh-list
92828639|NCT00652119|Carboplatin|carboplatin|mesh-list
92828640|NCT00652119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92828641|NCT00652119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828642|NCT00652119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92828643|NCT00652119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92828644|NCT00652119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92828645|NCT00652119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828646|NCT00652119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92828647|NCT00652119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92828648|NCT00652119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828649|NCT00652119|Growth Substances|growth substances|mesh-ancestor
92828650|NCT00652119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828651|NCT00652119|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828653|NCT05740657|Sufentanil|sufentanil|mesh-list
92828654|NCT05740657|Morphine|morphine|mesh-list
92828655|NCT05740657|Remifentanil|remifentanil|mesh-list
92828656|NCT05740657|Oxycodone|oxycodone|mesh-list
92828657|NCT05740657|Hydromorphone|hydromorphone|mesh-list
92828659|NCT05740657|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92828660|NCT05740657|Narcotics|narcotics|mesh-ancestor
92828661|NCT05740657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828662|NCT05740657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828663|NCT05740657|Analgesics|analgesics|mesh-ancestor
92828664|NCT05740657|Sensory System Agents|sensory system agents|mesh-ancestor
92828665|NCT05740657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828666|NCT05740657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92828667|NCT05740657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92828668|NCT05740657|Anesthetics, General|anesthetics, general|mesh-ancestor
92828669|NCT05740657|Anesthetics|anesthetics|mesh-ancestor
92828670|NCT02646267|Warfarin|warfarin|mesh-list
92828671|NCT02646267|Dabigatran|dabigatran|mesh-list
92828672|NCT02646267|Anticoagulants|anticoagulants|mesh-ancestor
92828673|NCT02646267|Antithrombins|antithrombins|mesh-ancestor
92828674|NCT02646267|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92828675|NCT02646267|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828676|NCT02646267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828677|NCT02646267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828678|NCT02646189|Interferons|interferons|mesh-list
92828679|NCT02646189|Interferon-alpha|interferon-alpha|mesh-list
92828680|NCT02646189|Interferon alpha-2|interferon alpha-2|mesh-list
92828681|NCT02646189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92828682|NCT02646189|REP 2139|rep 2139|mesh-list
92828683|NCT02646189|Thymalfasin|thymalfasin|mesh-list
92828684|NCT02646189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828685|NCT02646189|Antiviral Agents|antiviral agents|mesh-ancestor
92828686|NCT02646189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828687|NCT02646189|Immunologic Factors|immunologic factors|mesh-ancestor
92828688|NCT02646189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828689|NCT02646189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92828690|NCT02645565|Methylprednisolone|methylprednisolone|mesh-list
92828691|NCT02645565|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92828692|NCT02645565|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92828693|NCT02645565|Prednisolone|prednisolone|mesh-list
92828694|NCT02645565|Prednisolone acetate|prednisolone acetate|mesh-list
92828695|NCT02645565|Cyclophosphamide|cyclophosphamide|mesh-list
92828696|NCT02645565|Azathioprine|azathioprine|mesh-list
92828697|NCT02645565|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92828698|NCT02645565|Prednisolone phosphate|prednisolone phosphate|mesh-list
92828699|NCT02645565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828700|NCT02645565|Immunologic Factors|immunologic factors|mesh-ancestor
92828701|NCT02645565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828702|NCT02645565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92828703|NCT02645565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92828704|NCT02645565|Alkylating Agents|alkylating agents|mesh-ancestor
92828705|NCT02645565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828706|NCT02645565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828707|NCT02645565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92828708|NCT02645565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92828709|NCT02645565|Antiemetics|antiemetics|mesh-ancestor
92828710|NCT02645565|Autonomic Agents|autonomic agents|mesh-ancestor
92828711|NCT02645565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828712|NCT02645565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92828713|NCT02645565|Glucocorticoids|glucocorticoids|mesh-ancestor
92828714|NCT02645565|Hormones|hormones|mesh-ancestor
92828715|NCT02645565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828716|NCT02645565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92828717|NCT02645565|Protective Agents|protective agents|mesh-ancestor
92828718|NCT02645565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92828719|NCT02645565|Antimetabolites|antimetabolites|mesh-ancestor
92828720|NCT02645565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92828721|NCT00699907|Flutamide|flutamide|mesh-list
92828722|NCT00699907|Androgen Antagonists|androgen antagonists|mesh-ancestor
92828723|NCT00699907|Hormone Antagonists|hormone antagonists|mesh-ancestor
92828724|NCT00699907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828725|NCT00699907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828726|NCT00699907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92828727|NCT00699907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828728|NCT00599313|Sunitinib|sunitinib|mesh-list
92828729|NCT00599313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828730|NCT00599313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92828731|NCT00599313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828732|NCT00599313|Growth Substances|growth substances|mesh-ancestor
92828733|NCT00599313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828734|NCT00599313|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828735|NCT00599313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92828736|NCT00599313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828737|NCT00599313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828738|NCT03159897|Doxorubicin|doxorubicin|mesh-list
92828739|NCT03159897|Bleomycin|bleomycin|mesh-list
92828740|NCT03159897|Dacarbazine|dacarbazine|mesh-list
92828741|NCT03159897|Vinblastine|vinblastine|mesh-list
92828742|NCT03159897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92828743|NCT03159897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828744|NCT03159897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92828745|NCT03159897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92828746|NCT03159897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828747|NCT03159897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828748|NCT03159897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92828749|NCT03159897|Alkylating Agents|alkylating agents|mesh-ancestor
92828750|NCT03159897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92828751|NCT03159897|Tubulin Modulators|tubulin modulators|mesh-ancestor
92828752|NCT03159897|Antimitotic Agents|antimitotic agents|mesh-ancestor
92828753|NCT03159897|Mitosis Modulators|mitosis modulators|mesh-ancestor
92828754|NCT00708175|Pioglitazone|pioglitazone|mesh-list
92828755|NCT00708175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828756|NCT00708175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828757|NCT05740345|Metformin|metformin|mesh-list
92828758|NCT05740345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828759|NCT05740345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828760|NCT02641431|Ajmaline|ajmaline|mesh-list
92828761|NCT02641431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92828762|NCT02641431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92828763|NCT02641431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92828764|NCT02641431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92828765|NCT02641431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828766|NCT00733525|Fluoxetine|fluoxetine|mesh-list
92828767|NCT00733525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92828768|NCT00733525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92828769|NCT00733525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92828770|NCT00733525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828771|NCT00733525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828772|NCT00733525|Serotonin Agents|serotonin agents|mesh-ancestor
92828773|NCT00733525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828774|NCT00733525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92828775|NCT00733525|Antidepressive Agents|antidepressive agents|mesh-ancestor
92828776|NCT00733525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92828777|NCT00733525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92828778|NCT00733525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92828779|NCT00733525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828780|NCT02567149|Cidofovir|cidofovir|mesh-list
92828781|NCT02567149|Antiviral Agents|antiviral agents|mesh-ancestor
92828782|NCT02567149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828783|NCT02567149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828784|NCT02567149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828785|NCT00707239|Imipenem|imipenem|mesh-list
92828786|NCT00707239|Tigecycline|tigecycline|mesh-list
92828787|NCT00707239|Cilastatin|cilastatin|mesh-list
92828788|NCT00707239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92828789|NCT00707239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828790|NCT00707239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92828791|NCT00707239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828792|NCT00707239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828793|NCT00707239|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828794|NCT00968708|Alogliptin|alogliptin|mesh-list
92828795|NCT00968708|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828796|NCT00968708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828797|NCT00968708|Incretins|incretins|mesh-ancestor
92828798|NCT00968708|Hormones|hormones|mesh-ancestor
92828799|NCT00968708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92828800|NCT00968708|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92828802|NCT00968708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828803|NCT00968708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828804|NCT05417269|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92828805|NCT05417269|Dermatologic Agents|dermatologic agents|mesh-ancestor
92828806|NCT05417269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828807|NCT05417269|Immunologic Factors|immunologic factors|mesh-ancestor
92473797|NCT01853813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828808|NCT05417269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828809|NCT04062565|Treprostinil|treprostinil|mesh-list
92828810|NCT04062565|Riociguat|riociguat|mesh-list
92828811|NCT04062565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92828812|NCT04062565|Enzyme Activators|enzyme activators|mesh-ancestor
92828813|NCT04062565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828814|NCT00967694|Nitrous Oxide|nitrous oxide|mesh-list
92828815|NCT00967694|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92828816|NCT00967694|Anesthetics, General|anesthetics, general|mesh-ancestor
92828817|NCT00967694|Anesthetics|anesthetics|mesh-ancestor
92828818|NCT00967694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828819|NCT00967694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828820|NCT00967694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92828821|NCT00967694|Analgesics|analgesics|mesh-ancestor
92828822|NCT00967694|Sensory System Agents|sensory system agents|mesh-ancestor
92828823|NCT00967694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828824|NCT04288700|Timolol|timolol|mesh-list
92828825|NCT04288700|Propranolol|propranolol|mesh-list
92828826|NCT04288700|Captopril|captopril|mesh-list
92828827|NCT04288700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92828828|NCT04288700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92828829|NCT04288700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828830|NCT04288700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828831|NCT04288700|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92828832|NCT04288700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92828833|NCT04288700|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828834|NCT04288700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828835|NCT04288700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828836|NCT04288700|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92828837|NCT04288700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92828838|NCT04288700|Vasodilator Agents|vasodilator agents|mesh-ancestor
92828839|NCT04288700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92828840|NCT04288700|Protease Inhibitors|protease inhibitors|mesh-ancestor
92828841|NCT02863406|Dimercaprol|dimercaprol|mesh-list
92828842|NCT02863406|Chelating Agents|chelating agents|mesh-ancestor
92828843|NCT02863406|Sequestering Agents|sequestering agents|mesh-ancestor
92828844|NCT02863406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828845|NCT03664232|JNJ-42165279|jnj-42165279|mesh-list
92828846|NCT03664232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828847|NCT03664232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828848|NCT00629720|Alfuzosin|alfuzosin|mesh-list
92828849|NCT00629720|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92828850|NCT00629720|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92828851|NCT00629720|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92828852|NCT00629720|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828853|NCT00629720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828854|NCT00629720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828855|NCT00629720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828856|NCT00629720|Urological Agents|urological agents|mesh-ancestor
92828857|NCT00967616|Leucovorin|leucovorin|mesh-list
92828858|NCT00967616|Fluorouracil|fluorouracil|mesh-list
92828859|NCT00967616|Irinotecan|irinotecan|mesh-list
92828860|NCT00967616|Efatutazone|efatutazone|mesh-list
92828861|NCT00967616|Levoleucovorin|levoleucovorin|mesh-list
92828862|NCT00967616|Antimetabolites|antimetabolites|mesh-ancestor
92828863|NCT00967616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828864|NCT00967616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92828865|NCT00967616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828866|NCT00967616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828867|NCT00967616|Immunologic Factors|immunologic factors|mesh-ancestor
92828868|NCT00967616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828869|NCT00967616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92828870|NCT00967616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92828871|NCT00967616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828872|NCT00967616|Antidotes|antidotes|mesh-ancestor
92828873|NCT00967616|Protective Agents|protective agents|mesh-ancestor
92828875|NCT00967616|Vitamins|vitamins|mesh-ancestor
92828876|NCT00967616|Micronutrients|micronutrients|mesh-ancestor
92828877|NCT04288232|Aflibercept|aflibercept|mesh-list
92828878|NCT04288232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92828879|NCT04288232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92828880|NCT04288232|Growth Substances|growth substances|mesh-ancestor
92828881|NCT04288232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828882|NCT04288232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92828883|NCT04288232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473873|NCT01854476|Hemostatics|hemostatics|mesh-ancestor
92828885|NCT02864264|Interferon-gamma|interferon-gamma|mesh-list
92828886|NCT02864264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828887|NCT02864264|Antiviral Agents|antiviral agents|mesh-ancestor
92828888|NCT02864264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828889|NCT03107793|Ustekinumab|ustekinumab|mesh-list
92828890|NCT03107793|Dermatologic Agents|dermatologic agents|mesh-ancestor
92828891|NCT02640417|Vitamin B Complex|vitamin b complex|mesh-list
92828892|NCT02640417|Vitamins|vitamins|mesh-ancestor
92828893|NCT02640417|Micronutrients|micronutrients|mesh-ancestor
92828894|NCT02640417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828895|NCT02640495|Artesunate|artesunate|mesh-list
92828896|NCT02640495|Antimalarials|antimalarials|mesh-ancestor
92828897|NCT02640495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92828898|NCT02640495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92828899|NCT02640495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828900|NCT02640495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828901|NCT02640495|Antiviral Agents|antiviral agents|mesh-ancestor
92828902|NCT02640495|Schistosomicides|schistosomicides|mesh-ancestor
92828903|NCT02640495|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92828904|NCT02640495|Anthelmintics|anthelmintics|mesh-ancestor
92828905|NCT00653757|Leuprolide|leuprolide|mesh-list
92828906|NCT00653757|Goserelin|goserelin|mesh-list
92828907|NCT00653757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92828908|NCT00653757|Fertility Agents|fertility agents|mesh-ancestor
92828909|NCT00653757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92828910|NCT00653757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828911|NCT00653757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92828912|NCT00653757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828913|NCT00654225|Atorvastatin|atorvastatin|mesh-list
92828914|NCT00654225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92828915|NCT00654225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92828916|NCT00654225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92828917|NCT00654225|Antimetabolites|antimetabolites|mesh-ancestor
92828918|NCT00654225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828919|NCT00654225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92828920|NCT00654225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92828921|NCT00654225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828922|NCT00974090|Glimepiride|glimepiride|mesh-list
92828923|NCT00974090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92828924|NCT00974090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92828925|NCT00974090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828926|NCT00974090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92828927|NCT00974090|Immunologic Factors|immunologic factors|mesh-ancestor
92828928|NCT00654303|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92828929|NCT00654303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92828930|NCT00654303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92828931|NCT00654303|Antimetabolites|antimetabolites|mesh-ancestor
92828932|NCT00654303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828933|NCT00654303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92828934|NCT00654303|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92828935|NCT00654303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828936|NCT02639091|Pemetrexed|pemetrexed|mesh-list
92828937|NCT02639091|Anetumab ravtansine|anetumab ravtansine|mesh-list
92828938|NCT02639091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828939|NCT02639091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828940|NCT02639091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828941|NCT02639091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92828942|NCT02639091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92828943|NCT02639091|Immunoconjugates|immunoconjugates|mesh-ancestor
92828944|NCT02639091|Immunologic Factors|immunologic factors|mesh-ancestor
92828945|NCT02639091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828946|NCT00654459|Policosanol|policosanol|mesh-list
92828947|NCT00654459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92828948|NCT00654459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92828949|NCT00654459|Antimetabolites|antimetabolites|mesh-ancestor
92828950|NCT00654459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828951|NCT00654459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92828952|NCT00654459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92828953|NCT00654537|Atorvastatin|atorvastatin|mesh-list
92828954|NCT00654537|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92828955|NCT00654537|Simvastatin|simvastatin|mesh-list
92828956|NCT00654537|Pravastatin|pravastatin|mesh-list
92828957|NCT00654537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92828958|NCT00654537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92828959|NCT00654537|Antimetabolites|antimetabolites|mesh-ancestor
92828960|NCT00654537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828961|NCT00654537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92828962|NCT00654537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92828963|NCT00654537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828964|NCT02638857|Epirubicin|epirubicin|mesh-list
92828965|NCT02638857|Mitomycins|mitomycins|mesh-list
92828966|NCT02638857|Mitomycin|mitomycin|mesh-list
92828967|NCT02638857|Ethiodized Oil|ethiodized oil|mesh-list
92828968|NCT02638857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92828969|NCT02638857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92828970|NCT02638857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92828971|NCT02638857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92828972|NCT02638857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92828973|NCT02638857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828974|NCT02638857|Alkylating Agents|alkylating agents|mesh-ancestor
92828975|NCT02638857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92828976|NCT02638545|Dexmedetomidine|dexmedetomidine|mesh-list
92828977|NCT02638545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92828978|NCT02638545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92828979|NCT02638545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92828980|NCT02638545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92828981|NCT02638545|Analgesics|analgesics|mesh-ancestor
92828982|NCT02638545|Sensory System Agents|sensory system agents|mesh-ancestor
92828983|NCT02638545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92828984|NCT02638545|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92828985|NCT02638545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92828986|NCT02638545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92828987|NCT02638545|Adrenergic Agents|adrenergic agents|mesh-ancestor
92828988|NCT02638545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92828989|NCT02638545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92828990|NCT02638233|Sofosbuvir|sofosbuvir|mesh-list
92828991|NCT02638233|Ledipasvir|ledipasvir|mesh-list
92828992|NCT02638233|Antiviral Agents|antiviral agents|mesh-ancestor
92828993|NCT02638233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92828994|NCT04285268|Rituximab|rituximab|mesh-list
92828995|NCT04285268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92828996|NCT04285268|Bortezomib|bortezomib|mesh-list
92828997|NCT04285268|Venetoclax|venetoclax|mesh-list
92828998|NCT04285268|Antibodies|antibodies|mesh-list
92828999|NCT04285268|Immunoglobulins|immunoglobulins|mesh-list
92829000|NCT04285268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92829001|NCT04285268|Immunologic Factors|immunologic factors|mesh-ancestor
92829002|NCT04285268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829003|NCT04285268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829004|NCT04285268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829005|NCT00699751|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92829006|NCT00699751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829007|NCT01842399|Resveratrol|resveratrol|mesh-list
92829008|NCT01842399|Antioxidants|antioxidants|mesh-ancestor
92829009|NCT01842399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829010|NCT01842399|Protective Agents|protective agents|mesh-ancestor
92829011|NCT01842399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829012|NCT01842399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829013|NCT01842399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93046888|NCT00350792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046889|NCT00350792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93046890|NCT00350792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93046891|NCT00317772|Topotecan|topotecan|mesh-list
93046892|NCT00317772|Gefitinib|gefitinib|mesh-list
93046893|NCT00317772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93046894|NCT00317772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93046895|NCT00317772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046896|NCT00317772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046897|NCT00317772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046898|NCT00317772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046899|NCT01325298|Riboflavin|riboflavin|mesh-list
93046900|NCT01325298|Vitamin B Complex|vitamin b complex|mesh-ancestor
93046901|NCT01325298|Vitamins|vitamins|mesh-ancestor
93046902|NCT01325298|Micronutrients|micronutrients|mesh-ancestor
93046903|NCT01325298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046904|NCT01325298|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93046905|NCT01325298|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046907|NCT00350636|Oxybutynin|oxybutynin|mesh-list
93046908|NCT00350636|Parasympatholytics|parasympatholytics|mesh-ancestor
93046909|NCT00350636|Autonomic Agents|autonomic agents|mesh-ancestor
93046910|NCT00350636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046911|NCT00350636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829014|NCT00970502|Celecoxib|celecoxib|mesh-list
92829015|NCT00970502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92829016|NCT00970502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829017|NCT00970502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829018|NCT00970502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829019|NCT00970502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829020|NCT00970502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92829021|NCT00970502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92829022|NCT00970502|Analgesics|analgesics|mesh-ancestor
92829023|NCT00970502|Sensory System Agents|sensory system agents|mesh-ancestor
92829024|NCT00970502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829025|NCT00970502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829026|NCT00970502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829027|NCT00970502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829028|NCT00970502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92829029|NCT00970502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92829030|NCT02635893|Cycloserine|cycloserine|mesh-list
92829031|NCT02635893|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92829032|NCT02635893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829033|NCT02635893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92829034|NCT02635893|Antitubercular Agents|antitubercular agents|mesh-ancestor
92829035|NCT02635893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92829036|NCT02635893|Antimetabolites|antimetabolites|mesh-ancestor
92829037|NCT02635893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829038|NCT02567773|Itraconazole|itraconazole|mesh-list
92829039|NCT02567773|GSK2881078|gsk2881078|mesh-list
92829040|NCT02567773|Antifungal Agents|antifungal agents|mesh-ancestor
92829041|NCT02567773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829042|NCT02567773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92829043|NCT02567773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92829044|NCT02567773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829045|NCT02567773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829046|NCT02567773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92829047|NCT02567773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92829048|NCT02567773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829049|NCT02567773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829050|NCT02567773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92829051|NCT02567773|Anabolic Agents|anabolic agents|mesh-ancestor
92829052|NCT02567773|Hormones|hormones|mesh-ancestor
92829053|NCT00967226|Prednisolone|prednisolone|mesh-list
92829054|NCT00967226|Propranolol|propranolol|mesh-list
92829055|NCT00967226|Prednisolone phosphate|prednisolone phosphate|mesh-list
92829056|NCT00967226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829057|NCT00967226|Glucocorticoids|glucocorticoids|mesh-ancestor
92829058|NCT00967226|Hormones|hormones|mesh-ancestor
92829059|NCT00967226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829060|NCT00967226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829061|NCT00967226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92829062|NCT00967226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829063|NCT00967226|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92829064|NCT00967226|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92829065|NCT00967226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829066|NCT00967226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829067|NCT00967226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829068|NCT00967226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92829069|NCT00967226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92829070|NCT00967226|Vasodilator Agents|vasodilator agents|mesh-ancestor
92829071|NCT00706381|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92829072|NCT00706381|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92829073|NCT00706381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92829074|NCT00964886|Benztropine|benztropine|mesh-list
92829075|NCT00964886|Desipramine|desipramine|mesh-list
92829076|NCT00964886|Clomipramine|clomipramine|mesh-list
92829077|NCT00964886|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92829078|NCT00964886|Antidepressive Agents|antidepressive agents|mesh-ancestor
92829079|NCT00964886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92829080|NCT00964886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829081|NCT00964886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829082|NCT00964886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92829083|NCT00964886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92829084|NCT00964886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829085|NCT00964886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829086|NCT00964886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829087|NCT00964886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829088|NCT00964886|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92829089|NCT00964886|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92829090|NCT00964886|Parasympatholytics|parasympatholytics|mesh-ancestor
92829091|NCT00964886|Autonomic Agents|autonomic agents|mesh-ancestor
92829092|NCT00964886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829093|NCT00964886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92829094|NCT00964886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92829095|NCT00964886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92829096|NCT00964886|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92829097|NCT00964886|Dopamine Agents|dopamine agents|mesh-ancestor
92829098|NCT00964886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92829099|NCT00964886|Serotonin Agents|serotonin agents|mesh-ancestor
92829100|NCT02861222|Doxorubicin|doxorubicin|mesh-list
92829101|NCT02861222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92829102|NCT02861222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829103|NCT02861222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92829104|NCT02861222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92829105|NCT02861222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829106|NCT02861222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829107|NCT04062019|Aldesleukin|aldesleukin|mesh-list
92829108|NCT04062019|Interleukin-2|interleukin-2|mesh-list
92829109|NCT04062019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829110|NCT04062019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92829111|NCT04062019|Analgesics|analgesics|mesh-ancestor
92829112|NCT04062019|Sensory System Agents|sensory system agents|mesh-ancestor
92829113|NCT04062019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829114|NCT04062019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829115|NCT04062019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92829116|NCT04062019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92829117|NCT04062019|Antiviral Agents|antiviral agents|mesh-ancestor
92829118|NCT04062019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829119|NCT04061863|Nivolumab|nivolumab|mesh-list
92829120|NCT04061863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829121|NCT04061863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829122|NCT04061863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92829123|NCT04061863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829124|NCT02861378|Phentolamine|phentolamine|mesh-list
92829125|NCT02861378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92829126|NCT02861378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92829127|NCT02861378|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829128|NCT02861378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829129|NCT02861378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829130|NCT02861378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829131|NCT02861378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92829132|NCT03630224|Plasma-lyte 148|plasma-lyte 148|mesh-list
92829133|NCT03630224|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92829134|NCT03630224|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92829135|NCT00705757|Bimatoprost|bimatoprost|mesh-list
92829136|NCT00705757|Travoprost|travoprost|mesh-list
92829137|NCT00705757|Latanoprost|latanoprost|mesh-list
92829138|NCT00705757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92829139|NCT00705757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92829140|NCT00705757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92829141|NCT04284644|Propofol|propofol|mesh-list
92829142|NCT04284644|Sevoflurane|sevoflurane|mesh-list
92829143|NCT04284644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92829144|NCT04284644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829145|NCT04284644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829146|NCT04284644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92829147|NCT04284644|Anesthetics, General|anesthetics, general|mesh-ancestor
92829148|NCT04284644|Anesthetics|anesthetics|mesh-ancestor
92829149|NCT04284644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92829150|NCT04284644|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92829151|NCT05330143|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92829152|NCT05330143|Antiviral Agents|antiviral agents|mesh-ancestor
92829153|NCT05330143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829154|NCT04284722|Metformin|metformin|mesh-list
92829155|NCT04284722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829156|NCT04284722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829157|NCT04283240|Sildenafil Citrate|sildenafil citrate|mesh-list
92829158|NCT04283240|Vasodilator Agents|vasodilator agents|mesh-ancestor
92829159|NCT04283240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92829160|NCT04283240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92829161|NCT04283240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829162|NCT04283240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829164|NCT03588884|Cholecalciferol|cholecalciferol|mesh-list
92829165|NCT03588884|Vitamin D|vitamin d|mesh-list
92829166|NCT03588884|Calcifediol|calcifediol|mesh-list
92829167|NCT03588884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92829168|NCT03588884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829169|NCT03588884|Vitamins|vitamins|mesh-ancestor
92829170|NCT03588884|Micronutrients|micronutrients|mesh-ancestor
92829171|NCT03588884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92829172|NCT02862782|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92829173|NCT02862782|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92829174|NCT02862782|Luteolytic Agents|luteolytic agents|mesh-ancestor
92829175|NCT02862782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92829176|NCT02862782|Contraceptive Agents|contraceptive agents|mesh-ancestor
92829177|NCT02862782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92829178|NCT02862782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829179|NCT02862782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92829180|NCT02862782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92829181|NCT02862782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829182|NCT04283162|Calcium, Dietary|calcium, dietary|mesh-list
92829183|NCT04283162|Calcium Dobesilate|calcium dobesilate|mesh-list
92829184|NCT04283162|Calcium|calcium|mesh-list
92829185|NCT04283162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92829186|NCT04283162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829187|NCT04283162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92829188|NCT04283162|Hemostatics|hemostatics|mesh-ancestor
92829189|NCT04283162|Coagulants|coagulants|mesh-ancestor
92829190|NCT00758524|Eplerenone|eplerenone|mesh-list
92829191|NCT00758524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92829192|NCT00758524|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730999|NCT01680471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92829193|NCT00758524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829194|NCT00758524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829195|NCT00758524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92829196|NCT00758524|Diuretics|diuretics|mesh-ancestor
92829197|NCT00758524|Natriuretic Agents|natriuretic agents|mesh-ancestor
92829198|NCT00758524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92829199|NCT02601196|Ulipristal acetate|ulipristal acetate|mesh-list
92829200|NCT02601196|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92829201|NCT02601196|Contraceptive Agents|contraceptive agents|mesh-ancestor
92829202|NCT02601196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92829203|NCT02601196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829204|NCT02601196|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92829205|NCT00757588|Insulin|insulin|mesh-list
92829206|NCT00757588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92829207|NCT00757588|Saxagliptin|saxagliptin|mesh-list
92829208|NCT00757588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829209|NCT00757588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829210|NCT00757588|Incretins|incretins|mesh-ancestor
92829211|NCT00757588|Hormones|hormones|mesh-ancestor
92829212|NCT00757588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829213|NCT00757588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92829214|NCT00757588|Protease Inhibitors|protease inhibitors|mesh-ancestor
92829215|NCT00757588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829216|NCT00757588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829217|NCT00917254|Enoxaparin|enoxaparin|mesh-list
92829218|NCT00917254|Anticoagulants|anticoagulants|mesh-ancestor
92829219|NCT00917254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92829220|NCT00917254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92829221|NCT00917254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829222|NCT02599792|Ivacaftor|ivacaftor|mesh-list
92829223|NCT02599792|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92829224|NCT02599792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829225|NCT02599792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829226|NCT00705679|Tenofovir|tenofovir|mesh-list
92829227|NCT00705679|Emtricitabine|emtricitabine|mesh-list
92977204|NCT00545103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92829228|NCT00705679|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92829230|NCT00705679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829231|NCT00705679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92829232|NCT00705679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92829233|NCT00705679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829234|NCT00705679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829235|NCT00705679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92474261|NCT01856556|Glycine|glycine|mesh-list
92829236|NCT00705679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92829237|NCT04092868|Protamines|protamines|mesh-list
92829238|NCT04092868|Heparin Antagonists|heparin antagonists|mesh-ancestor
92829239|NCT04092868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829240|NCT04092868|Coagulants|coagulants|mesh-ancestor
92829241|NCT05695573|Cystatins|cystatins|mesh-list
92829242|NCT05695573|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92829243|NCT05695573|Protease Inhibitors|protease inhibitors|mesh-ancestor
92829244|NCT05695573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829245|NCT05695573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829246|NCT00916942|Lidocaine|lidocaine|mesh-list
92829247|NCT00916942|Prilocaine|prilocaine|mesh-list
92829248|NCT00916942|Capsaicin|capsaicin|mesh-list
92829249|NCT00916942|Anesthetics, Local|anesthetics, local|mesh-ancestor
92829250|NCT00916942|Anesthetics|anesthetics|mesh-ancestor
92829251|NCT00916942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829252|NCT00916942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829253|NCT00916942|Sensory System Agents|sensory system agents|mesh-ancestor
92829254|NCT00916942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829255|NCT00916942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92829256|NCT00916942|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92829257|NCT00916942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92829258|NCT00916942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829259|NCT00916942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829260|NCT00916942|Antipruritics|antipruritics|mesh-ancestor
92829261|NCT00916942|Dermatologic Agents|dermatologic agents|mesh-ancestor
92829262|NCT00751114|Metformin|metformin|mesh-list
92829263|NCT00751114|Insulin Glargine|insulin glargine|mesh-list
92829264|NCT00751114|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92829265|NCT00751114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829266|NCT00751114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829267|NCT00751114|Incretins|incretins|mesh-ancestor
92829268|NCT00751114|Hormones|hormones|mesh-ancestor
92829269|NCT00751114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829270|NCT00751114|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92829271|NCT00751114|Protease Inhibitors|protease inhibitors|mesh-ancestor
92829272|NCT00751114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829273|NCT00751114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829274|NCT00960440|Tofacitinib|tofacitinib|mesh-list
92829275|NCT00960440|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92829276|NCT00960440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829277|NCT00960440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829278|NCT00960440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829279|NCT04092478|Anesthetics|anesthetics|mesh-list
92829280|NCT04092478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829281|NCT04092478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829282|NCT02598466|Abatacept|abatacept|mesh-list
92829283|NCT02598466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92829284|NCT02598466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829285|NCT02598466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829286|NCT02598466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829287|NCT02598466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92829288|NCT02598466|Immunologic Factors|immunologic factors|mesh-ancestor
92829289|NCT02598466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829290|NCT02598466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829291|NCT04089592|Fentanyl|fentanyl|mesh-list
92829292|NCT04089592|Dexmedetomidine|dexmedetomidine|mesh-list
92829293|NCT04089592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92829294|NCT04089592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829295|NCT04089592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829296|NCT04089592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92829297|NCT04089592|Analgesics|analgesics|mesh-ancestor
92829298|NCT04089592|Sensory System Agents|sensory system agents|mesh-ancestor
92829299|NCT04089592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829300|NCT04089592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92829301|NCT04089592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92829302|NCT04089592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92829303|NCT04089592|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829304|NCT04089592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829305|NCT04089592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829306|NCT04089592|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92829307|NCT04089592|Narcotics|narcotics|mesh-ancestor
92829308|NCT04089592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92829309|NCT04089592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92829310|NCT04089592|Anesthetics, General|anesthetics, general|mesh-ancestor
92829311|NCT04089592|Anesthetics|anesthetics|mesh-ancestor
92829312|NCT00751036|Imatinib Mesylate|imatinib mesylate|mesh-list
92829313|NCT00751036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829314|NCT00751036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829315|NCT00751036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829316|NCT00751036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829317|NCT00961298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92829318|NCT00961298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92829319|NCT00961298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92829320|NCT00961298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829321|NCT00961298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829322|NCT00961298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829323|NCT00961298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829324|NCT00961298|Analgesics|analgesics|mesh-ancestor
92829325|NCT00961298|Sensory System Agents|sensory system agents|mesh-ancestor
92829326|NCT00961298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829327|NCT00961298|Antidepressive Agents|antidepressive agents|mesh-ancestor
92829328|NCT00961298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92829329|NCT00961298|Dopamine Agents|dopamine agents|mesh-ancestor
92829330|NCT00744328|Sertraline|sertraline|mesh-list
92829331|NCT00744328|Estradiol|estradiol|mesh-list
92829332|NCT00744328|Estrogens|estrogens|mesh-ancestor
92829333|NCT00744328|Hormones|hormones|mesh-ancestor
92829334|NCT00744328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829335|NCT00744328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829336|NCT00744328|Antidepressive Agents|antidepressive agents|mesh-ancestor
92829337|NCT00744328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92829338|NCT00744328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92829339|NCT00744328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92829340|NCT00744328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829341|NCT00744328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829342|NCT00744328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829343|NCT00744328|Serotonin Agents|serotonin agents|mesh-ancestor
92829344|NCT04019782|Hylan|hylan|mesh-list
92829345|NCT04019782|Viscosupplements|viscosupplements|mesh-ancestor
92829346|NCT04019782|Protective Agents|protective agents|mesh-ancestor
92829347|NCT04019782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829348|NCT02599480|Mirabegron|mirabegron|mesh-list
92829349|NCT02599480|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92829350|NCT02599480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92829351|NCT02599480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92829352|NCT02599480|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829353|NCT02599480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829354|NCT02599480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829355|NCT02599480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829356|NCT02599480|Urological Agents|urological agents|mesh-ancestor
92829357|NCT03245840|Budesonide|budesonide|mesh-list
92829358|NCT03245840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829359|NCT03245840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92829360|NCT03245840|Autonomic Agents|autonomic agents|mesh-ancestor
92829361|NCT03245840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829362|NCT03245840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829363|NCT03245840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92829364|NCT03245840|Respiratory System Agents|respiratory system agents|mesh-ancestor
92829365|NCT03245840|Glucocorticoids|glucocorticoids|mesh-ancestor
92829366|NCT03245840|Hormones|hormones|mesh-ancestor
92829367|NCT03245840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829368|NCT04091698|Coenzyme Q10|coenzyme q10|mesh-list
92829369|NCT04091698|Ubiquinone|ubiquinone|mesh-list
92829370|NCT04091698|Vitamins|vitamins|mesh-ancestor
92829371|NCT04091698|Micronutrients|micronutrients|mesh-ancestor
92829372|NCT04091698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829373|NCT04281290|Bleomycin|bleomycin|mesh-list
92829374|NCT04281290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92829375|NCT04281290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829376|NCT04091932|Pembrolizumab|pembrolizumab|mesh-list
92829377|NCT04091932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92829378|NCT04091932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829379|NCT04091932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829380|NCT04091932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829381|NCT00959894|Tenofovir|tenofovir|mesh-list
92829382|NCT00959894|Emtricitabine|emtricitabine|mesh-list
93046912|NCT00350636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92474414|NCT01857349|Ethanol|ethanol|mesh-list
92829383|NCT00959894|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92829384|NCT00959894|Etravirine|etravirine|mesh-list
92829385|NCT00959894|Antiviral Agents|antiviral agents|mesh-ancestor
92829386|NCT00959894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829387|NCT00959894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92829388|NCT00959894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92829389|NCT00959894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829390|NCT00959894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829391|NCT00959894|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92829392|NCT00959894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92829393|NCT02599168|Dexmedetomidine|dexmedetomidine|mesh-list
92829394|NCT02599168|Propofol|propofol|mesh-list
92829395|NCT02599168|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92829396|NCT02599168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829397|NCT02599168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829398|NCT02599168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92829399|NCT02599168|Analgesics|analgesics|mesh-ancestor
92829400|NCT02599168|Sensory System Agents|sensory system agents|mesh-ancestor
92829401|NCT02599168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829402|NCT02599168|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92829403|NCT02599168|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92829404|NCT02599168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92829405|NCT02599168|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829406|NCT02599168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829407|NCT02599168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829408|NCT02599168|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92829409|NCT02599168|Anesthetics, General|anesthetics, general|mesh-ancestor
92829410|NCT02599168|Anesthetics|anesthetics|mesh-ancestor
92829411|NCT00746590|Tretazicar|tretazicar|mesh-list
92829412|NCT00746590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829413|NCT01032629|Canagliflozin|canagliflozin|mesh-list
92829414|NCT01032629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92829415|NCT01032629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829416|NCT01032629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829417|NCT01032629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829418|NCT04205201|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92829419|NCT04205201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92829420|NCT04205201|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92829421|NCT04205201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92829422|NCT04205201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92829423|NCT04205201|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829424|NCT04205201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829425|NCT04205201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829426|NCT04205201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829427|NCT00749944|Varenicline|varenicline|mesh-list
92829428|NCT00749944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92829429|NCT00749944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92829430|NCT00749944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92829431|NCT00749944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829432|NCT00749944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829433|NCT00749944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829434|NCT02597140|Lidocaine|lidocaine|mesh-list
92829435|NCT02597140|Propofol|propofol|mesh-list
92829436|NCT02597140|Anesthetics, Local|anesthetics, local|mesh-ancestor
92829437|NCT02597140|Anesthetics|anesthetics|mesh-ancestor
92829438|NCT02597140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829439|NCT02597140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829440|NCT02597140|Sensory System Agents|sensory system agents|mesh-ancestor
92829441|NCT02597140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829442|NCT02597140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92829443|NCT02597140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92829444|NCT02597140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92829445|NCT02597140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829446|NCT02597140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829447|NCT02597140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92829448|NCT02597140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92829450|NCT02598310|Paclitaxel|paclitaxel|mesh-list
92829451|NCT02598310|Trastuzumab|trastuzumab|mesh-list
92829452|NCT02598310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92829453|NCT02598310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829454|NCT02598310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92829455|NCT02598310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92829456|NCT02598310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92829457|NCT02598310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829458|NCT02598310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829459|NCT04091074|Clopidogrel|clopidogrel|mesh-list
92829460|NCT04091074|Ticagrelor|ticagrelor|mesh-list
92829461|NCT04091074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92829462|NCT04091074|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92829463|NCT04091074|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92829464|NCT04091074|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92829465|NCT04091074|Purinergic Agents|purinergic agents|mesh-ancestor
92829466|NCT04091074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829467|NCT04091074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829468|NCT04091074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829469|NCT00749398|Infliximab|infliximab|mesh-list
92829470|NCT00749398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92829471|NCT00749398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829472|NCT00749398|Dermatologic Agents|dermatologic agents|mesh-ancestor
92829473|NCT00749398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92829474|NCT00749398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829475|NCT01012973|Aflibercept|aflibercept|mesh-list
92829476|NCT01012973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92829477|NCT01012973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92829478|NCT01012973|Growth Substances|growth substances|mesh-ancestor
92829479|NCT01012973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829480|NCT01012973|Growth Inhibitors|growth inhibitors|mesh-ancestor
92829481|NCT01012973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829482|NCT03974464|Arginine Vasopressin|arginine vasopressin|mesh-list
92829483|NCT03974464|Hemostatics|hemostatics|mesh-ancestor
92829484|NCT03974464|Coagulants|coagulants|mesh-ancestor
92829485|NCT03974464|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92829486|NCT03974464|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92829487|NCT03974464|Natriuretic Agents|natriuretic agents|mesh-ancestor
92829488|NCT03974464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829489|NCT00742924|Zoledronic Acid|zoledronic acid|mesh-list
92829490|NCT00742924|Leucovorin|leucovorin|mesh-list
92829491|NCT00742924|Cisplatin|cisplatin|mesh-list
92829492|NCT00742924|Doxorubicin|doxorubicin|mesh-list
92829493|NCT00742924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92829494|NCT00742924|Methotrexate|methotrexate|mesh-list
92829495|NCT00742924|Etoposide|etoposide|mesh-list
92829496|NCT00742924|Ifosfamide|ifosfamide|mesh-list
92829497|NCT00742924|Isophosphamide mustard|isophosphamide mustard|mesh-list
92829498|NCT00742924|Dexrazoxane|dexrazoxane|mesh-list
92829499|NCT00742924|Razoxane|razoxane|mesh-list
92829500|NCT00742924|Imidazole|imidazole|mesh-list
92829501|NCT00742924|Lenograstim|lenograstim|mesh-list
92829502|NCT00742924|Levoleucovorin|levoleucovorin|mesh-list
92829503|NCT00742924|Mesna|mesna|mesh-list
92829504|NCT00742924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829505|NCT00742924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92829506|NCT00742924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92829507|NCT00742924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92829508|NCT00742924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829509|NCT00742924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829510|NCT00742924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829511|NCT00742924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92829512|NCT00742924|Abortifacient Agents|abortifacient agents|mesh-ancestor
92829513|NCT00742924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92829514|NCT00742924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92829515|NCT00742924|Antimetabolites|antimetabolites|mesh-ancestor
92829516|NCT00742924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92829517|NCT00742924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92829518|NCT00742924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92829519|NCT00742924|Immunologic Factors|immunologic factors|mesh-ancestor
92829520|NCT00742924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829521|NCT00742924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92829522|NCT00742924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92829523|NCT00742924|Antidotes|antidotes|mesh-ancestor
92829524|NCT00742924|Protective Agents|protective agents|mesh-ancestor
92829525|NCT00742924|Vitamin B Complex|vitamin b complex|mesh-ancestor
92829526|NCT00742924|Vitamins|vitamins|mesh-ancestor
92829527|NCT00742924|Micronutrients|micronutrients|mesh-ancestor
92829528|NCT00742924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92829529|NCT00742924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92829530|NCT00742924|Alkylating Agents|alkylating agents|mesh-ancestor
92829531|NCT00742924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92829532|NCT00742924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92829533|NCT00742924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92829534|NCT00742924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92829535|NCT02596984|Caspofungin|caspofungin|mesh-list
92829536|NCT02596984|Antifungal Agents|antifungal agents|mesh-ancestor
92829537|NCT02596984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829538|NCT02596984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829539|NCT02596984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829540|NCT00698815|Pemetrexed|pemetrexed|mesh-list
92829541|NCT00698815|Sunitinib|sunitinib|mesh-list
92829542|NCT00698815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829543|NCT00698815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829544|NCT00698815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829545|NCT00698815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92829546|NCT00698815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92829547|NCT00698815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92829548|NCT00698815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92829549|NCT00698815|Growth Substances|growth substances|mesh-ancestor
92829550|NCT00698815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829551|NCT00698815|Growth Inhibitors|growth inhibitors|mesh-ancestor
92829552|NCT00698815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829553|NCT02599090|Temozolomide|temozolomide|mesh-list
92829554|NCT02599090|Sorafenib|sorafenib|mesh-list
92829555|NCT02599090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92829556|NCT02599090|Alkylating Agents|alkylating agents|mesh-ancestor
92829557|NCT02599090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829558|NCT02599090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829559|NCT02599090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829560|NCT02599090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829561|NCT00745498|Bevacizumab|bevacizumab|mesh-list
92829562|NCT00745498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829563|NCT00745498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829564|NCT00745498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92829565|NCT00745498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92829566|NCT00745498|Growth Substances|growth substances|mesh-ancestor
92829567|NCT00745498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829568|NCT00745498|Growth Inhibitors|growth inhibitors|mesh-ancestor
92829569|NCT02596828|Sirolimus|sirolimus|mesh-list
92829570|NCT02596828|Irinotecan|irinotecan|mesh-list
92829571|NCT02596828|Temozolomide|temozolomide|mesh-list
92829572|NCT02596828|Dasatinib|dasatinib|mesh-list
92829573|NCT02596828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92829574|NCT02596828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92829575|NCT02596828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829576|NCT02596828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829577|NCT02596828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829578|NCT02596828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92829579|NCT02596828|Alkylating Agents|alkylating agents|mesh-ancestor
92829580|NCT02596828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92829581|NCT02596828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829582|NCT02596828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92829583|NCT02596828|Antifungal Agents|antifungal agents|mesh-ancestor
92829584|NCT02596828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92829585|NCT02596828|Immunologic Factors|immunologic factors|mesh-ancestor
92829586|NCT02596828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829587|NCT02596828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829588|NCT03896815|INCB054329|incb054329|mesh-list
92829589|NCT03896815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829590|NCT02598856|Naloxone|naloxone|mesh-list
92829591|NCT02598856|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92829592|NCT02598856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829593|NCT02598856|Sensory System Agents|sensory system agents|mesh-ancestor
92829594|NCT02598856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829595|NCT04827979|Daratumumab|daratumumab|mesh-list
92829596|NCT04827979|Abatacept|abatacept|mesh-list
92829597|NCT04827979|Immunoglobulins|immunoglobulins|mesh-list
92829598|NCT04827979|Immunoglobulin G|immunoglobulin g|mesh-list
92829600|NCT04827979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829601|NCT04827979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829602|NCT04827979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92829603|NCT04827979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829604|NCT04827979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829605|NCT04827979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92829606|NCT04827979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829607|NCT02597998|BI 409306|bi 409306|mesh-list
92829608|NCT02597998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92474643|NCT01858090|Autonomic Agents|autonomic agents|mesh-ancestor
92829609|NCT02597998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829610|NCT02597998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829611|NCT02595658|Insulin, Short-Acting|insulin, short-acting|mesh-list
92829612|NCT02595658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829613|NCT02595658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829614|NCT00576901|Bevacizumab|bevacizumab|mesh-list
92829615|NCT00576901|Docetaxel|docetaxel|mesh-list
92829616|NCT00576901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829617|NCT00576901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829618|NCT00576901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92829619|NCT00576901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92829620|NCT00576901|Growth Substances|growth substances|mesh-ancestor
92829621|NCT00576901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829622|NCT00576901|Growth Inhibitors|growth inhibitors|mesh-ancestor
92829623|NCT00576901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92829624|NCT00576901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92829625|NCT00576901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92829626|NCT00576901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829627|NCT00699283|Brivaracetam|brivaracetam|mesh-list
92829628|NCT00699283|Anticonvulsants|anticonvulsants|mesh-ancestor
92829629|NCT04062721|Immunomodulating Agents|immunomodulating agents|mesh-list
92829630|NCT04062721|Immunologic Factors|immunologic factors|mesh-ancestor
92829631|NCT04062721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829632|NCT01023815|Cyclosporine|cyclosporine|mesh-list
92829633|NCT01023815|Everolimus|everolimus|mesh-list
92829634|NCT01023815|Cyclosporins|cyclosporins|mesh-list
92829635|NCT01023815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829636|NCT01023815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829637|NCT01023815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92829638|NCT01023815|Immunologic Factors|immunologic factors|mesh-ancestor
92829639|NCT01023815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829640|NCT01023815|Antifungal Agents|antifungal agents|mesh-ancestor
92829641|NCT01023815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829642|NCT01023815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92829643|NCT01023815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829644|NCT01023815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92829645|NCT01023815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92829646|NCT01023815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92829647|NCT01023815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829648|NCT02567383|Docetaxel|docetaxel|mesh-list
92829649|NCT02567383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829650|NCT02567383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92829651|NCT02567383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92829652|NCT02567383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92829653|NCT02567383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829654|NCT01023659|Bupropion|bupropion|mesh-list
92829655|NCT01023659|Varenicline|varenicline|mesh-list
92829656|NCT01023659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92829657|NCT01023659|Antidepressive Agents|antidepressive agents|mesh-ancestor
92829658|NCT01023659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92829659|NCT01023659|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92829660|NCT01023659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92829661|NCT01023659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829662|NCT01023659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829663|NCT01023659|Dopamine Agents|dopamine agents|mesh-ancestor
92829664|NCT01023659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829665|NCT01023659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829666|NCT01023659|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92829667|NCT01023659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92829668|NCT01023659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829669|NCT01023659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92829670|NCT01023659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92829671|NCT01023659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92829672|NCT00740116|Tranexamic Acid|tranexamic acid|mesh-list
92829673|NCT00740116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92829674|NCT00740116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92829675|NCT00740116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829676|NCT00740116|Hemostatics|hemostatics|mesh-ancestor
92829677|NCT00740116|Coagulants|coagulants|mesh-ancestor
92829678|NCT02567461|Aspirin|aspirin|mesh-list
92829679|NCT02567461|Edoxaban|edoxaban|mesh-list
92829680|NCT02567461|Clopidogrel|clopidogrel|mesh-list
92829681|NCT02567461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92829682|NCT02567461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92829683|NCT02567461|Analgesics|analgesics|mesh-ancestor
92829684|NCT02567461|Sensory System Agents|sensory system agents|mesh-ancestor
92829685|NCT02567461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829686|NCT02567461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829687|NCT02567461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829688|NCT02567461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829689|NCT02567461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92829690|NCT02567461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92829691|NCT02567461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829692|NCT02567461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92829693|NCT02567461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92829694|NCT02567461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829695|NCT02567461|Antipyretics|antipyretics|mesh-ancestor
92829696|NCT02567461|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92829697|NCT02567461|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92829698|NCT02567461|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92829699|NCT02567461|Purinergic Agents|purinergic agents|mesh-ancestor
92829700|NCT02567461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829701|NCT02567461|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92829702|NCT02567461|Antithrombins|antithrombins|mesh-ancestor
92829703|NCT02567461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92829704|NCT02567461|Protease Inhibitors|protease inhibitors|mesh-ancestor
92829705|NCT02567461|Anticoagulants|anticoagulants|mesh-ancestor
92829706|NCT00698581|Brivaracetam|brivaracetam|mesh-list
92829707|NCT00698581|Anticonvulsants|anticonvulsants|mesh-ancestor
92829708|NCT02595346|Hydroxychloroquine|hydroxychloroquine|mesh-list
92829709|NCT02595346|Antimalarials|antimalarials|mesh-ancestor
92829710|NCT02595346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92829711|NCT02595346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92829712|NCT02595346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829713|NCT02595346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829714|NCT02595346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829715|NCT02595346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829716|NCT01023581|Metformin|metformin|mesh-list
92829717|NCT01023581|Alogliptin|alogliptin|mesh-list
92829718|NCT01023581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829719|NCT01023581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829720|NCT01023581|Incretins|incretins|mesh-ancestor
92829721|NCT01023581|Hormones|hormones|mesh-ancestor
92829722|NCT01023581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829723|NCT01023581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92829724|NCT01023581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92829725|NCT01023581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829726|NCT01023581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829727|NCT05571787|Rabeprazole|rabeprazole|mesh-list
92829728|NCT05571787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92829729|NCT05571787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92829730|NCT05571787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92829731|NCT05571787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829732|NCT05571787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829733|NCT04063189|Clarithromycin|clarithromycin|mesh-list
92829734|NCT04063189|Dexamethasone|dexamethasone|mesh-list
92829735|NCT04063189|Lenalidomide|lenalidomide|mesh-list
92829736|NCT04063189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829737|NCT04063189|Antiemetics|antiemetics|mesh-ancestor
92829738|NCT04063189|Autonomic Agents|autonomic agents|mesh-ancestor
92829739|NCT04063189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829740|NCT04063189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829741|NCT04063189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92829742|NCT04063189|Glucocorticoids|glucocorticoids|mesh-ancestor
92829743|NCT04063189|Hormones|hormones|mesh-ancestor
92829744|NCT04063189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829745|NCT04063189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92829746|NCT04063189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829747|NCT04063189|Immunologic Factors|immunologic factors|mesh-ancestor
92829748|NCT04063189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92829749|NCT04063189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92829750|NCT04063189|Growth Substances|growth substances|mesh-ancestor
92829751|NCT04063189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92829752|NCT04063189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92829753|NCT04063189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829754|NCT04063189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92829755|NCT04063189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829756|NCT04063189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829757|NCT04063189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92829758|NCT04063189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92829759|NCT02567929|Propofol|propofol|mesh-list
92829760|NCT02567929|Sevoflurane|sevoflurane|mesh-list
92829761|NCT02567929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92829762|NCT02567929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829763|NCT02567929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829764|NCT02567929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92829765|NCT02567929|Anesthetics, General|anesthetics, general|mesh-ancestor
92829766|NCT02567929|Anesthetics|anesthetics|mesh-ancestor
92829767|NCT02567929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92829768|NCT02567929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92829769|NCT05188417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92829770|NCT05188417|Tirofiban|tirofiban|mesh-list
92829771|NCT05188417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92829772|NCT05188417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92829773|NCT05188417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829774|NCT05188417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92829775|NCT00962780|Vaccines|vaccines|mesh-list
92829776|NCT00962780|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92829777|NCT00962780|Immunologic Factors|immunologic factors|mesh-ancestor
92829778|NCT00962780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829779|NCT02567851|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92829780|NCT02567851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829781|NCT02567851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829782|NCT02567851|Immunotoxins|immunotoxins|mesh-ancestor
92829783|NCT02567851|Immunoconjugates|immunoconjugates|mesh-ancestor
92829784|NCT02567851|Immunologic Factors|immunologic factors|mesh-ancestor
92829785|NCT02567851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829786|NCT00739882|Antibodies|antibodies|mesh-list
92829787|NCT00739882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92829788|NCT00739882|Immunologic Factors|immunologic factors|mesh-ancestor
92829789|NCT00739882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829790|NCT00961220|Carmustine|carmustine|mesh-list
92829791|NCT00961220|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92829792|NCT00961220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92829793|NCT00961220|Alkylating Agents|alkylating agents|mesh-ancestor
92829794|NCT00961220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829795|NCT00961220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829796|NCT00961220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829797|NCT00734656|Ethanol|ethanol|mesh-list
92829798|NCT00734656|Dutasteride|dutasteride|mesh-list
92829799|NCT00734656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92829800|NCT00734656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829801|NCT00734656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829802|NCT00734656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829803|NCT00734656|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92829804|NCT00734656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92829805|NCT00734656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829806|NCT00734656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829807|NCT00734656|Hormone Antagonists|hormone antagonists|mesh-ancestor
92829808|NCT00734656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829809|NCT04644289|Durvalumab|durvalumab|mesh-list
92829810|NCT04644289|Olaparib|olaparib|mesh-list
92829811|NCT04644289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829812|NCT04644289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829813|NCT04644289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92829814|NCT04644289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829815|NCT04644289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829816|NCT02565979|Resveratrol|resveratrol|mesh-list
92829817|NCT02565979|Antioxidants|antioxidants|mesh-ancestor
92829818|NCT02565979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829820|NCT02565979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829821|NCT02565979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829822|NCT02565979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92829823|NCT04062175|Azithromycin|azithromycin|mesh-list
92829824|NCT04062175|Cephalosporins|cephalosporins|mesh-list
92829825|NCT04062175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92829826|NCT04062175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829827|NCT02859584|Hydrocortisone|hydrocortisone|mesh-list
92829828|NCT02859584|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92829829|NCT02859584|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92829830|NCT02859584|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92829831|NCT02859584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829832|NCT04391569|Ganaxolone|ganaxolone|mesh-list
92829833|NCT04391569|Neurosteroids|neurosteroids|mesh-ancestor
92829834|NCT04391569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829835|NCT04391569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829836|NCT04391569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829837|NCT04391569|GABA Modulators|gaba modulators|mesh-ancestor
92829838|NCT04391569|GABA Agents|gaba agents|mesh-ancestor
92829839|NCT05324917|Rituximab|rituximab|mesh-list
92829840|NCT05324917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829841|NCT05324917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829842|NCT05324917|Immunologic Factors|immunologic factors|mesh-ancestor
92829843|NCT05324917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829844|NCT05324917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92829845|NCT00739648|Levofloxacin|levofloxacin|mesh-list
92829846|NCT00739648|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92829847|NCT00739648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92829848|NCT00739648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92829849|NCT00739648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92829850|NCT00739648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92829851|NCT00739648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829852|NCT00739648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829853|NCT00739648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829854|NCT00739648|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92829855|NCT00739648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92829856|NCT01032239|Baclofen|baclofen|mesh-list
92829857|NCT01032239|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92829858|NCT01032239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829859|NCT01032239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92829860|NCT01032239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829861|NCT01032239|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92829862|NCT01032239|GABA Agonists|gaba agonists|mesh-ancestor
92829863|NCT01032239|GABA Agents|gaba agents|mesh-ancestor
92829864|NCT01032239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829865|NCT01032239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829866|NCT02871713|Morphine|morphine|mesh-list
92829867|NCT02871713|Ropivacaine|ropivacaine|mesh-list
92829868|NCT02871713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92829869|NCT02871713|Narcotics|narcotics|mesh-ancestor
92829870|NCT02871713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829871|NCT02871713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829872|NCT02871713|Analgesics|analgesics|mesh-ancestor
92829873|NCT02871713|Sensory System Agents|sensory system agents|mesh-ancestor
92829874|NCT02871713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829875|NCT02871713|Anesthetics, Local|anesthetics, local|mesh-ancestor
92829876|NCT02871713|Anesthetics|anesthetics|mesh-ancestor
92829877|NCT04342975|Niacinamide|niacinamide|mesh-list
92829879|NCT04342975|Nicotinic Acids|nicotinic acids|mesh-list
92829880|NCT04342975|Vitamin B Complex|vitamin b complex|mesh-ancestor
92829881|NCT04342975|Vitamins|vitamins|mesh-ancestor
92829882|NCT04342975|Micronutrients|micronutrients|mesh-ancestor
92829883|NCT04342975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829884|NCT04342975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92829885|NCT04342975|Antimetabolites|antimetabolites|mesh-ancestor
92829886|NCT04342975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829887|NCT04342975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92829888|NCT04342975|Vasodilator Agents|vasodilator agents|mesh-ancestor
92829889|NCT00734578|Guanfacine|guanfacine|mesh-list
92829890|NCT00734578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92829891|NCT00734578|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92829892|NCT00734578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92829893|NCT00734578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92829894|NCT00734578|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829895|NCT00734578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829896|NCT00734578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829897|NCT00734578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829898|NCT00637715|Alfuzosin|alfuzosin|mesh-list
92829899|NCT00637715|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92829900|NCT00637715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92829901|NCT00637715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92829902|NCT00637715|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829903|NCT00637715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829904|NCT00637715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829905|NCT00637715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474930|NCT01859858|Irinotecan|irinotecan|mesh-list
92829906|NCT00637715|Urological Agents|urological agents|mesh-ancestor
92829907|NCT02596282|Anesthetics|anesthetics|mesh-list
92829908|NCT02596282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829909|NCT02596282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829910|NCT04557085|Cenobamate|cenobamate|mesh-list
92829911|NCT04557085|Anticonvulsants|anticonvulsants|mesh-ancestor
92829912|NCT02593708|Paclitaxel|paclitaxel|mesh-list
92829913|NCT02593708|Trastuzumab|trastuzumab|mesh-list
92829914|NCT02593708|Pertuzumab|pertuzumab|mesh-list
92829915|NCT02593708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92829916|NCT02593708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829917|NCT02593708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92829918|NCT02593708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92829919|NCT02593708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92829920|NCT02593708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829921|NCT02593708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92829922|NCT00959192|Saponin QA-21V1|saponin qa-21v1|mesh-list
92829923|NCT00959192|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92829924|NCT00959192|Immunologic Factors|immunologic factors|mesh-ancestor
92829925|NCT00959192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829926|NCT00696787|Pregabalin|pregabalin|mesh-list
92829927|NCT00696787|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92829928|NCT00696787|Analgesics|analgesics|mesh-ancestor
92829929|NCT00696787|Sensory System Agents|sensory system agents|mesh-ancestor
92829930|NCT00696787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829931|NCT00696787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829932|NCT00696787|Anticonvulsants|anticonvulsants|mesh-ancestor
92829933|NCT00696787|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92829934|NCT00696787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92829935|NCT00696787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829936|NCT00696787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92829937|NCT00696787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92829938|NCT00696787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92829939|NCT00696787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829940|NCT00696787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92829941|NCT00696787|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92829942|NCT00696787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92829943|NCT00696787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829944|NCT00696787|Antidepressive Agents|antidepressive agents|mesh-ancestor
92829945|NCT01012037|Linagliptin|linagliptin|mesh-list
92829946|NCT01012037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92829947|NCT01012037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829948|NCT01012037|Incretins|incretins|mesh-ancestor
92829949|NCT01012037|Hormones|hormones|mesh-ancestor
92829950|NCT01012037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829951|NCT01012037|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92829952|NCT01012037|Protease Inhibitors|protease inhibitors|mesh-ancestor
92829953|NCT01012037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829954|NCT01012037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829955|NCT00630110|Docetaxel|docetaxel|mesh-list
92829956|NCT00630110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92829957|NCT00630110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92829958|NCT00630110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92829959|NCT00630110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92829960|NCT00630110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829961|NCT00734032|Darapladib|darapladib|mesh-list
92829962|NCT00734032|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92829963|NCT00734032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829964|NCT00734032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829965|NCT04284098|Dexmedetomidine|dexmedetomidine|mesh-list
92829966|NCT04284098|Bupivacaine|bupivacaine|mesh-list
92829967|NCT04284098|Anesthetics, Local|anesthetics, local|mesh-ancestor
92829968|NCT04284098|Anesthetics|anesthetics|mesh-ancestor
92829969|NCT04284098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92829970|NCT04284098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829971|NCT04284098|Sensory System Agents|sensory system agents|mesh-ancestor
92829972|NCT04284098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92829973|NCT04284098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92829974|NCT04284098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92829975|NCT04284098|Analgesics|analgesics|mesh-ancestor
92829976|NCT04284098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92829977|NCT04284098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92829978|NCT04284098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92829979|NCT04284098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92829980|NCT04284098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92829981|NCT04284098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829982|NCT01010633|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92829983|NCT01010633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92829985|NCT00733954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92829986|NCT00733954|Glucocorticoids|glucocorticoids|mesh-ancestor
92829987|NCT00733954|Hormones|hormones|mesh-ancestor
92829988|NCT00733954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92829989|NCT00733954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92829990|NCT02595268|Pitavastatin|pitavastatin|mesh-list
92829991|NCT02595268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92829992|NCT02595268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92829993|NCT02595268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92829994|NCT02595268|Antimetabolites|antimetabolites|mesh-ancestor
92829995|NCT02595268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92829996|NCT02595268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92829997|NCT02595268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92829998|NCT00921505|Acetaminophen|acetaminophen|mesh-list
92829999|NCT00921505|Ibuprofen|ibuprofen|mesh-list
92830000|NCT00921505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92830001|NCT00921505|Analgesics|analgesics|mesh-ancestor
92830002|NCT00921505|Sensory System Agents|sensory system agents|mesh-ancestor
92830003|NCT00921505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830004|NCT00921505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830005|NCT00921505|Antipyretics|antipyretics|mesh-ancestor
92830006|NCT00921505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92830007|NCT00921505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830008|NCT00921505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830009|NCT00921505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92830010|NCT00921505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830011|NCT00921505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830012|NCT04280588|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92830013|NCT04280588|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92830014|NCT04280588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830015|NCT04280588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830016|NCT04280588|Immunologic Factors|immunologic factors|mesh-ancestor
92830017|NCT04280588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830018|NCT04298021|Durvalumab|durvalumab|mesh-list
92830019|NCT04298021|Olaparib|olaparib|mesh-list
92830020|NCT04298021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830021|NCT04298021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830022|NCT04298021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92830023|NCT04298021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830024|NCT04298021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830025|NCT02595190|Gabapentin|gabapentin|mesh-list
92830026|NCT02595190|Tramadol|tramadol|mesh-list
92830027|NCT02595190|Analgesics|analgesics|mesh-ancestor
92830028|NCT02595190|Sensory System Agents|sensory system agents|mesh-ancestor
92830029|NCT02595190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830030|NCT02595190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830031|NCT02595190|Anticonvulsants|anticonvulsants|mesh-ancestor
92830032|NCT02595190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92830033|NCT02595190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92830034|NCT02595190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830035|NCT02595190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830036|NCT02595190|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92830037|NCT02595190|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92830038|NCT02595190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830039|NCT02595190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175075|NCT01307605|Rituximab|rituximab|mesh-list
92830040|NCT02595190|Antimanic Agents|antimanic agents|mesh-ancestor
92830041|NCT02595190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92830042|NCT02595190|Narcotics|narcotics|mesh-ancestor
92830043|NCT04061473|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92830044|NCT04061473|Empagliflozin|empagliflozin|mesh-list
92830045|NCT04061473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92830046|NCT04061473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830047|NCT04061473|Incretins|incretins|mesh-ancestor
92830048|NCT04061473|Hormones|hormones|mesh-ancestor
92830049|NCT04061473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830050|NCT04061473|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92830051|NCT04061473|Protease Inhibitors|protease inhibitors|mesh-ancestor
92830052|NCT04061473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830053|NCT04061473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830054|NCT04061473|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92830055|NCT04502693|Vaccines|vaccines|mesh-list
92830056|NCT04502693|Immunologic Factors|immunologic factors|mesh-ancestor
92830057|NCT04502693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830058|NCT00733408|Paclitaxel|paclitaxel|mesh-list
92830059|NCT00733408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92830060|NCT00733408|Bevacizumab|bevacizumab|mesh-list
92830061|NCT00733408|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92830062|NCT00733408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92830063|NCT00733408|Antibodies|antibodies|mesh-list
92830064|NCT00733408|Immunoglobulins|immunoglobulins|mesh-list
92830065|NCT00733408|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92830066|NCT00733408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830067|NCT00733408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830068|NCT00733408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830069|NCT00733408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830070|NCT00733408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830071|NCT00733408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830072|NCT00733408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92830073|NCT00733408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92830074|NCT00733408|Growth Substances|growth substances|mesh-ancestor
92830075|NCT00733408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830076|NCT00733408|Growth Inhibitors|growth inhibitors|mesh-ancestor
92830077|NCT00733408|Immunologic Factors|immunologic factors|mesh-ancestor
92830078|NCT00733408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92830079|NCT00733408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830080|NCT04296383|Azithromycin|azithromycin|mesh-list
92830081|NCT04296383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92830082|NCT04296383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830083|NCT00576823|Alfuzosin|alfuzosin|mesh-list
92830084|NCT00576823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92830085|NCT00576823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92830086|NCT00576823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92830087|NCT00576823|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830088|NCT00576823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830089|NCT00576823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830090|NCT00576823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830091|NCT00576823|Urological Agents|urological agents|mesh-ancestor
92830092|NCT00732940|Belimumab|belimumab|mesh-list
92830093|NCT00732940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830094|NCT00732940|Immunologic Factors|immunologic factors|mesh-ancestor
92830095|NCT00732940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830096|NCT00962390|Equol|equol|mesh-list
92830097|NCT00962390|Phytoestrogens|phytoestrogens|mesh-ancestor
92830098|NCT00962390|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92830099|NCT00962390|Estrogens|estrogens|mesh-ancestor
92830100|NCT00962390|Hormones|hormones|mesh-ancestor
92830101|NCT00962390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830102|NCT00962390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830103|NCT00742807|Alfentanil|alfentanil|mesh-list
92830104|NCT00742807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92830105|NCT00742807|Narcotics|narcotics|mesh-ancestor
92830106|NCT00742807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830107|NCT00742807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830108|NCT00742807|Analgesics|analgesics|mesh-ancestor
92830109|NCT00742807|Sensory System Agents|sensory system agents|mesh-ancestor
92830110|NCT00742807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830111|NCT00742807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92830112|NCT00742807|Anesthetics, General|anesthetics, general|mesh-ancestor
92830113|NCT00742807|Anesthetics|anesthetics|mesh-ancestor
92830114|NCT03221257|Mycophenolic Acid|mycophenolic acid|mesh-list
92830115|NCT03221257|Pirfenidone|pirfenidone|mesh-list
92830116|NCT03221257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92830117|NCT03221257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830118|NCT03221257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92830119|NCT03221257|Antitubercular Agents|antitubercular agents|mesh-ancestor
92830120|NCT03221257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92830121|NCT03221257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830122|NCT03221257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830123|NCT03221257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830124|NCT03221257|Analgesics|analgesics|mesh-ancestor
92830125|NCT03221257|Sensory System Agents|sensory system agents|mesh-ancestor
92830126|NCT03221257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830127|NCT03221257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830128|NCT03221257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92830129|NCT03221257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92830130|NCT03221257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830131|NCT03221257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830132|NCT00960986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92830133|NCT00960986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92830134|NCT00960986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830135|NCT00960986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830136|NCT00960986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830137|NCT00960986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830138|NCT00960986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830139|NCT00960986|Analgesics|analgesics|mesh-ancestor
92830140|NCT00960986|Sensory System Agents|sensory system agents|mesh-ancestor
92830141|NCT00960986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830142|NCT00960986|Antidepressive Agents|antidepressive agents|mesh-ancestor
92830143|NCT00960986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830144|NCT00960986|Dopamine Agents|dopamine agents|mesh-ancestor
92830145|NCT00732238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92830146|NCT00732238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830147|NCT00958880|Yohimbine|yohimbine|mesh-list
92830148|NCT00958880|Mydriatics|mydriatics|mesh-ancestor
92830149|NCT00958880|Autonomic Agents|autonomic agents|mesh-ancestor
92830150|NCT00958880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830151|NCT00958880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830152|NCT00958880|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92830153|NCT00958880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92830154|NCT00958880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92830155|NCT00958880|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830156|NCT00958880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830157|NCT00958880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830158|NCT00958880|Urological Agents|urological agents|mesh-ancestor
92830159|NCT02595034|Clindamycin|clindamycin|mesh-list
92830160|NCT02595034|Clindamycin palmitate|clindamycin palmitate|mesh-list
92830161|NCT02595034|Clindamycin phosphate|clindamycin phosphate|mesh-list
92830162|NCT02595034|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92830163|NCT02595034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92830164|NCT02595034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830165|NCT02595034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92830166|NCT02595034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830167|NCT02595034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830168|NCT02595034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92830169|NCT00958724|Vinorelbine|vinorelbine|mesh-list
92830170|NCT00958724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830171|NCT00958724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830172|NCT00958724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830173|NCT00958724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830174|NCT00958724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830175|NCT00958724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830176|NCT00738400|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92830177|NCT00738400|Vasodilator Agents|vasodilator agents|mesh-ancestor
92830178|NCT00738400|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92830179|NCT00738400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92830180|NCT00738400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830181|NCT00738400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830182|NCT00738400|Urological Agents|urological agents|mesh-ancestor
92830183|NCT00958568|Olanzapine|olanzapine|mesh-list
92830184|NCT00958568|Fluoxetine|fluoxetine|mesh-list
92830185|NCT00958568|Antiemetics|antiemetics|mesh-ancestor
92830186|NCT00958568|Autonomic Agents|autonomic agents|mesh-ancestor
92830187|NCT00958568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830188|NCT00958568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830189|NCT00958568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830191|NCT00958568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92830192|NCT00958568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830193|NCT00958568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830194|NCT00958568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92830195|NCT00958568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830196|NCT00958568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830197|NCT00958568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830198|NCT00958568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830199|NCT00958568|Serotonin Agents|serotonin agents|mesh-ancestor
92732012|NCT01199731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92830200|NCT00958568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92830201|NCT00958568|Antidepressive Agents|antidepressive agents|mesh-ancestor
92830202|NCT00958568|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92830203|NCT00958568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92830204|NCT00958568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830205|NCT00630500|Memantine|memantine|mesh-list
92830206|NCT00630500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92830207|NCT00630500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92830208|NCT00630500|Dopamine Agents|dopamine agents|mesh-ancestor
92830209|NCT00630500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830210|NCT00630500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830211|NCT00630500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830212|NCT00630500|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92830213|NCT00630500|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92830214|NCT02858804|Cytarabine|cytarabine|mesh-list
92830215|NCT02858804|Thalidomide|thalidomide|mesh-list
92830216|NCT02858804|Dexamethasone|dexamethasone|mesh-list
92830217|NCT02858804|Prednisone|prednisone|mesh-list
92830218|NCT02858804|Cyclophosphamide|cyclophosphamide|mesh-list
92830219|NCT02858804|Rituximab|rituximab|mesh-list
92830220|NCT02858804|Doxorubicin|doxorubicin|mesh-list
92830221|NCT02858804|Etoposide|etoposide|mesh-list
92830222|NCT02858804|Vincristine|vincristine|mesh-list
92830223|NCT02858804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830224|NCT02858804|Immunologic Factors|immunologic factors|mesh-ancestor
92830225|NCT02858804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830226|NCT02858804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830227|NCT02858804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92830228|NCT02858804|Alkylating Agents|alkylating agents|mesh-ancestor
92830229|NCT02858804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830230|NCT02858804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830231|NCT02858804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92830232|NCT02858804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830233|NCT02858804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830234|NCT02858804|Antiemetics|antiemetics|mesh-ancestor
92830235|NCT02858804|Autonomic Agents|autonomic agents|mesh-ancestor
92830236|NCT02858804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830237|NCT02858804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830238|NCT02858804|Glucocorticoids|glucocorticoids|mesh-ancestor
92830239|NCT02858804|Hormones|hormones|mesh-ancestor
92830240|NCT02858804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830241|NCT02858804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92830242|NCT02858804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92830243|NCT02858804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92830244|NCT02858804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92830245|NCT02858804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830246|NCT02858804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830247|NCT02858804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92830248|NCT02858804|Antimetabolites|antimetabolites|mesh-ancestor
92830249|NCT02858804|Antiviral Agents|antiviral agents|mesh-ancestor
92830250|NCT02858804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830251|NCT02858804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830252|NCT02858804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830253|NCT02858804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830254|NCT02858804|Leprostatic Agents|leprostatic agents|mesh-ancestor
92830255|NCT02858804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92830256|NCT02858804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92830257|NCT02858804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92830258|NCT02858804|Growth Substances|growth substances|mesh-ancestor
92830259|NCT02858804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92830260|NCT00958256|Cyclophosphamide|cyclophosphamide|mesh-list
92830261|NCT00958256|Rituximab|rituximab|mesh-list
92830262|NCT00958256|Bortezomib|bortezomib|mesh-list
92830263|NCT00958256|Lenograstim|lenograstim|mesh-list
92830264|NCT00958256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830265|NCT00958256|Immunologic Factors|immunologic factors|mesh-ancestor
92830266|NCT00958256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830267|NCT00958256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830268|NCT00958256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92830269|NCT00958256|Alkylating Agents|alkylating agents|mesh-ancestor
92830270|NCT00958256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830271|NCT00958256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830272|NCT00958256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92830273|NCT00958256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830274|NCT00958256|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92830275|NCT01006265|Ponesimod|ponesimod|mesh-list
92830276|NCT01006265|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92830277|NCT01006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830278|NCT01006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830279|NCT01006265|Immunologic Factors|immunologic factors|mesh-ancestor
92830280|NCT01006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830281|NCT02861690|Paclitaxel|paclitaxel|mesh-list
92830282|NCT02861690|Nedaplatin|nedaplatin|mesh-list
92830283|NCT02861690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830284|NCT02861690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830285|NCT02861690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830286|NCT02861690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830287|NCT02861690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830288|NCT02861690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830289|NCT05141552|Dapagliflozin|dapagliflozin|mesh-list
92830290|NCT05141552|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92830291|NCT05141552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830292|NCT05141552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92830293|NCT05141552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830294|NCT02564107|Ibandronic Acid|ibandronic acid|mesh-list
92830295|NCT02564107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92830296|NCT02564107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830297|NCT00628667|Esomeprazole|esomeprazole|mesh-list
92830298|NCT00628667|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92830299|NCT00628667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830300|NCT00628667|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92830301|NCT00628667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830302|NCT00628667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830303|NCT02858258|Rituximab|rituximab|mesh-list
92830304|NCT02858258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830305|NCT02858258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830306|NCT02858258|Immunologic Factors|immunologic factors|mesh-ancestor
92830307|NCT02858258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830308|NCT02858258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830309|NCT01008995|Ustekinumab|ustekinumab|mesh-list
92830310|NCT01008995|Dermatologic Agents|dermatologic agents|mesh-ancestor
92830311|NCT04295993|Norepinephrine|norepinephrine|mesh-list
92830312|NCT04295993|Methylene Blue|methylene blue|mesh-list
92830313|NCT04295993|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92830314|NCT04295993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92830315|NCT04295993|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830316|NCT04295993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830317|NCT04295993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830318|NCT04295993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830319|NCT04295993|Sympathomimetics|sympathomimetics|mesh-ancestor
92830320|NCT04295993|Autonomic Agents|autonomic agents|mesh-ancestor
92830321|NCT04295993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830322|NCT04295993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92830323|NCT04295993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830324|NCT00743587|Naproxen|naproxen|mesh-list
92830325|NCT00743587|Oxycodone|oxycodone|mesh-list
92830326|NCT00743587|Tramadol|tramadol|mesh-list
92830327|NCT00743587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92830328|NCT00743587|Narcotics|narcotics|mesh-ancestor
92830329|NCT00743587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830330|NCT00743587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830331|NCT00743587|Analgesics|analgesics|mesh-ancestor
92830332|NCT00743587|Sensory System Agents|sensory system agents|mesh-ancestor
92830333|NCT00743587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830334|NCT00743587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92830335|NCT00743587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92830336|NCT00743587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830337|NCT00743587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830338|NCT00743587|Gout Suppressants|gout suppressants|mesh-ancestor
92830339|NCT00743587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92830340|NCT00743587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830341|NCT00743587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830342|NCT00957944|Rotigotine|rotigotine|mesh-list
92830343|NCT00957944|Dopamine Agonists|dopamine agonists|mesh-ancestor
92830344|NCT00957944|Dopamine Agents|dopamine agents|mesh-ancestor
92830345|NCT00957944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830346|NCT00957944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830347|NCT00957944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830348|NCT02871323|Durvalumab|durvalumab|mesh-list
92830349|NCT02871323|Immunoglobulins|immunoglobulins|mesh-list
92830350|NCT02871323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92830351|NCT02871323|Immunoglobulin G|immunoglobulin g|mesh-list
92830352|NCT02871323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830353|NCT02871323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475381|NCT01863147|Hormones|hormones|mesh-ancestor
92830354|NCT02871323|Immunologic Factors|immunologic factors|mesh-ancestor
92830355|NCT02871323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830356|NCT04296149|Octreotide|octreotide|mesh-list
92830357|NCT04296149|Edotreotide|edotreotide|mesh-list
92830358|NCT04296149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830359|NCT04296149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92830360|NCT04296149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830361|NCT04296149|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92830362|NCT04296149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830363|NCT01005875|Sorafenib|sorafenib|mesh-list
92830364|NCT01005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830365|NCT01005875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92830366|NCT01005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830367|NCT01005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830368|NCT02701088|Mitomycins|mitomycins|mesh-list
92830369|NCT02701088|Mitomycin|mitomycin|mesh-list
92830370|NCT02701088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92830371|NCT02701088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830372|NCT02701088|Alkylating Agents|alkylating agents|mesh-ancestor
92830373|NCT02701088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830374|NCT02701088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92830375|NCT02701088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830376|NCT04279106|Chlorhexidine|chlorhexidine|mesh-list
92830377|NCT04279106|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92830378|NCT04279106|Listerine|listerine|mesh-list
92830379|NCT04279106|Fluorides|fluorides|mesh-list
92830380|NCT04279106|Sodium Fluoride|sodium fluoride|mesh-list
92830381|NCT04279106|Cariostatic Agents|cariostatic agents|mesh-ancestor
92830382|NCT04279106|Protective Agents|protective agents|mesh-ancestor
92830383|NCT04279106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830384|NCT04279106|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92830385|NCT04279106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830386|NCT04279106|Disinfectants|disinfectants|mesh-ancestor
92830387|NCT04279106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92830388|NCT00743743|Resveratrol|resveratrol|mesh-list
92830389|NCT00743743|Antioxidants|antioxidants|mesh-ancestor
92830390|NCT00743743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830391|NCT00743743|Protective Agents|protective agents|mesh-ancestor
92830392|NCT00743743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830393|NCT00743743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830394|NCT00743743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92830395|NCT01005719|Omeprazole|omeprazole|mesh-list
92830396|NCT01005719|Lansoprazole|lansoprazole|mesh-list
92732212|NCT01199068|Efatutazone|efatutazone|mesh-list
92830397|NCT01005719|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92830398|NCT01005719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92830399|NCT01005719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830400|NCT01005719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92830401|NCT01005719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830402|NCT01005719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830403|NCT02856854|Cocaine|cocaine|mesh-list
92830404|NCT02856854|Oxazepam|oxazepam|mesh-list
92830405|NCT02856854|Metyrapone|metyrapone|mesh-list
92830406|NCT02856854|Anesthetics, Local|anesthetics, local|mesh-ancestor
92830407|NCT02856854|Anesthetics|anesthetics|mesh-ancestor
92830408|NCT02856854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830409|NCT02856854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830410|NCT02856854|Sensory System Agents|sensory system agents|mesh-ancestor
92830411|NCT02856854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830412|NCT02856854|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92830413|NCT02856854|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92830414|NCT02856854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830415|NCT02856854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830416|NCT02856854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830417|NCT02856854|Dopamine Agents|dopamine agents|mesh-ancestor
92830418|NCT02856854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830419|NCT02856854|Antimetabolites|antimetabolites|mesh-ancestor
92830420|NCT02856854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830421|NCT02856854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92830422|NCT02856854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92830423|NCT02856854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92830424|NCT02856854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830425|NCT02856854|GABA Modulators|gaba modulators|mesh-ancestor
92830426|NCT02856854|GABA Agents|gaba agents|mesh-ancestor
92475456|NCT01863407|Glucocorticoids|glucocorticoids|mesh-ancestor
92830427|NCT02857166|Antibodies|antibodies|mesh-list
92830428|NCT02857166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92830429|NCT02857166|Immunologic Factors|immunologic factors|mesh-ancestor
92830430|NCT02857166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830431|NCT02856932|Methamphetamine|methamphetamine|mesh-list
92830432|NCT02856932|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92830433|NCT02856932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830434|NCT02856932|Sympathomimetics|sympathomimetics|mesh-ancestor
92830435|NCT02856932|Autonomic Agents|autonomic agents|mesh-ancestor
92830436|NCT02856932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830437|NCT02856932|Dopamine Agents|dopamine agents|mesh-ancestor
92830438|NCT02856932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830439|NCT02856932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830440|NCT02856932|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830441|NCT02856932|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92830442|NCT02856932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830443|NCT02856932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830444|NCT02856932|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92830445|NCT02563951|Granisetron|granisetron|mesh-list
92830446|NCT02563951|Antiemetics|antiemetics|mesh-ancestor
92830447|NCT02563951|Autonomic Agents|autonomic agents|mesh-ancestor
92830448|NCT02563951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830449|NCT02563951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830450|NCT02563951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830451|NCT02563951|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92830452|NCT02563951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92830453|NCT02563951|Serotonin Agents|serotonin agents|mesh-ancestor
92830454|NCT02563951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830455|NCT02563951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830456|NCT00953576|Ketoconazole|ketoconazole|mesh-list
92830457|NCT00953576|Hydrocortisone|hydrocortisone|mesh-list
92830458|NCT00953576|Lapatinib|lapatinib|mesh-list
92830459|NCT00953576|Dutasteride|dutasteride|mesh-list
92830460|NCT00953576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830461|NCT00953576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830462|NCT00953576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92830463|NCT00953576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830464|NCT00953576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830465|NCT00953576|Antifungal Agents|antifungal agents|mesh-ancestor
92830466|NCT00953576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830467|NCT00953576|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92830468|NCT00953576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92148863|NCT04399525|Cetirizine|cetirizine|mesh-list
92830469|NCT00953576|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92830470|NCT00953576|Hormone Antagonists|hormone antagonists|mesh-ancestor
92830471|NCT00953576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830472|NCT00953576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830473|NCT00953576|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92830474|NCT00953576|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92830475|NCT02100956|Oxytocin|oxytocin|mesh-list
92830476|NCT02100956|Oxytocics|oxytocics|mesh-ancestor
92830477|NCT02100956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92830478|NCT02100956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830479|NCT02073968|Paclitaxel|paclitaxel|mesh-list
92830480|NCT02073968|Carboplatin|carboplatin|mesh-list
92830481|NCT02073968|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92830482|NCT02073968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830483|NCT02073968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830484|NCT02073968|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830485|NCT02073968|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830486|NCT02073968|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830487|NCT02073968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830488|NCT01005329|Paclitaxel|paclitaxel|mesh-list
92830489|NCT01005329|Bevacizumab|bevacizumab|mesh-list
92830490|NCT01005329|Cisplatin|cisplatin|mesh-list
92830491|NCT01005329|Carboplatin|carboplatin|mesh-list
92830492|NCT01005329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92830493|NCT01005329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92830494|NCT01005329|Endothelial Growth Factors|endothelial growth factors|mesh-list
92830495|NCT01005329|Antibodies|antibodies|mesh-list
92830496|NCT01005329|Immunoglobulins|immunoglobulins|mesh-list
92830497|NCT01005329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92830498|NCT01005329|Immunoglobulin G|immunoglobulin g|mesh-list
92830499|NCT01005329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830500|NCT01005329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830501|NCT01005329|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830502|NCT01005329|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830503|NCT01005329|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830504|NCT01005329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830505|NCT01005329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92830506|NCT01005329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92830507|NCT01005329|Growth Substances|growth substances|mesh-ancestor
92830508|NCT01005329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830509|NCT01005329|Growth Inhibitors|growth inhibitors|mesh-ancestor
92830510|NCT01005329|Immunologic Factors|immunologic factors|mesh-ancestor
92830511|NCT00921349|Nadolol|nadolol|mesh-list
92830512|NCT00921349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92830513|NCT00921349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92830514|NCT00921349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830515|NCT00921349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830516|NCT00921349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830517|NCT00921349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830518|NCT00921349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92830519|NCT00921349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92830520|NCT00921349|Sympatholytics|sympatholytics|mesh-ancestor
92830521|NCT00921349|Autonomic Agents|autonomic agents|mesh-ancestor
92830522|NCT00921349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830523|NCT01005251|Lesogaberan|lesogaberan|mesh-list
92830524|NCT01005251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830525|NCT01005251|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92830526|NCT01005251|GABA Agonists|gaba agonists|mesh-ancestor
92830527|NCT01005251|GABA Agents|gaba agents|mesh-ancestor
92830528|NCT01005251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830529|NCT01005251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830530|NCT01005251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830531|NCT03048578|Liraglutide|liraglutide|mesh-list
92830532|NCT03048578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92830533|NCT03048578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830534|NCT03048578|Incretins|incretins|mesh-ancestor
92830535|NCT03048578|Hormones|hormones|mesh-ancestor
92830536|NCT03048578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830537|NCT02856776|Vitamin D|vitamin d|mesh-list
92830538|NCT02856776|Cholecalciferol|cholecalciferol|mesh-list
92830539|NCT02856776|Vitamins|vitamins|mesh-ancestor
92830540|NCT02856776|Micronutrients|micronutrients|mesh-ancestor
92830541|NCT02856776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830542|NCT02856776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92830543|NCT02856776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92830544|NCT04296851|Niclosamide|niclosamide|mesh-list
92830545|NCT04296851|Anticestodal Agents|anticestodal agents|mesh-ancestor
92830546|NCT04296851|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92830547|NCT04296851|Anthelmintics|anthelmintics|mesh-ancestor
92830548|NCT04296851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92830549|NCT04296851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830550|NCT04296851|Antinematodal Agents|antinematodal agents|mesh-ancestor
92830551|NCT02858024|Dapivirine|dapivirine|mesh-list
92830552|NCT02858024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92830553|NCT02858024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92830554|NCT02858024|Antiviral Agents|antiviral agents|mesh-ancestor
92830555|NCT02858024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830556|NCT02857946|Linagliptin|linagliptin|mesh-list
92830557|NCT02857946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92830558|NCT02857946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830559|NCT02857946|Incretins|incretins|mesh-ancestor
92830560|NCT02857946|Hormones|hormones|mesh-ancestor
92830561|NCT02857946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830562|NCT02857946|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92830564|NCT02857946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830565|NCT02857946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830566|NCT02857712|Axitinib|axitinib|mesh-list
92830567|NCT02857712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830568|NCT02857712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92830569|NCT02857712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830570|NCT02857712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830571|NCT00696241|Olmesartan|olmesartan|mesh-list
92830572|NCT00696241|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92830573|NCT00696241|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92830574|NCT00696241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92830575|NCT00696241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92830576|NCT00696241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92830577|NCT00696241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830578|NCT00630968|Levetiracetam|levetiracetam|mesh-list
92830579|NCT00630968|Anticonvulsants|anticonvulsants|mesh-ancestor
92830580|NCT00630968|Nootropic Agents|nootropic agents|mesh-ancestor
92830581|NCT00952484|Immunoglobulin G|immunoglobulin g|mesh-list
92830582|NCT00952484|Immunologic Factors|immunologic factors|mesh-ancestor
92830583|NCT00952484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830584|NCT00689611|Bupropion|bupropion|mesh-list
92830585|NCT00689611|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92830586|NCT00689611|Antidepressive Agents|antidepressive agents|mesh-ancestor
92830587|NCT00689611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830588|NCT00689611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92830589|NCT00689611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830590|NCT00689611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830591|NCT00689611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830592|NCT00689611|Dopamine Agents|dopamine agents|mesh-ancestor
92830593|NCT00689611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830594|NCT00689611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830595|NCT00689611|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92830596|NCT00689611|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92830597|NCT00689611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830598|NCT02563795|Fentanyl|fentanyl|mesh-list
92830599|NCT02563795|Bupivacaine|bupivacaine|mesh-list
92830600|NCT02563795|Anesthetics, Local|anesthetics, local|mesh-ancestor
92830601|NCT02563795|Anesthetics|anesthetics|mesh-ancestor
92830602|NCT02563795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830603|NCT02563795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830604|NCT02563795|Sensory System Agents|sensory system agents|mesh-ancestor
92830605|NCT02563795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830606|NCT02563795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92830607|NCT02563795|Narcotics|narcotics|mesh-ancestor
92830608|NCT02563795|Analgesics|analgesics|mesh-ancestor
92830609|NCT02563795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92830610|NCT02563795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92830611|NCT02563795|Anesthetics, General|anesthetics, general|mesh-ancestor
92830612|NCT04281680|Octreotide|octreotide|mesh-list
92830613|NCT04281680|Pasireotide|pasireotide|mesh-list
92830614|NCT04281680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830615|NCT04281680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92830616|NCT04281680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830617|NCT04281680|Hormones|hormones|mesh-ancestor
92830618|NCT04281680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830619|NCT04281680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830620|NCT00744445|Epoetin Alfa|epoetin alfa|mesh-list
92830621|NCT00744445|Hematinics|hematinics|mesh-ancestor
92830622|NCT02854748|Empagliflozin|empagliflozin|mesh-list
92830623|NCT02854748|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92830624|NCT02854748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830625|NCT02854748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92830626|NCT02854748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830627|NCT03881917|Cystatins|cystatins|mesh-list
92830628|NCT03881917|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92830629|NCT03881917|Protease Inhibitors|protease inhibitors|mesh-ancestor
92830630|NCT03881917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830631|NCT03881917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830632|NCT00744679|Natalizumab|natalizumab|mesh-list
92830633|NCT00744679|Immunologic Factors|immunologic factors|mesh-ancestor
92830634|NCT00744679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830635|NCT04060459|Paclitaxel|paclitaxel|mesh-list
92830636|NCT04060459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830637|NCT04060459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830638|NCT04060459|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830639|NCT04060459|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830640|NCT04060459|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830641|NCT04060459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830642|NCT01007435|Methotrexate|methotrexate|mesh-list
92830643|NCT01007435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92830644|NCT01007435|Abortifacient Agents|abortifacient agents|mesh-ancestor
92830645|NCT01007435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92830646|NCT01007435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830647|NCT01007435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92830648|NCT01007435|Antimetabolites|antimetabolites|mesh-ancestor
92830649|NCT01007435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830650|NCT01007435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830651|NCT01007435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92830652|NCT01007435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830653|NCT01007435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92830654|NCT01007435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830655|NCT01007435|Immunologic Factors|immunologic factors|mesh-ancestor
92830656|NCT01007435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830657|NCT01007435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92830658|NCT00948896|Pyrimethamine|pyrimethamine|mesh-list
92830659|NCT00948896|Piperaquine|piperaquine|mesh-list
92830660|NCT00948896|Sulfadoxine|sulfadoxine|mesh-list
92830661|NCT00948896|Trimethoprim|trimethoprim|mesh-list
92830662|NCT00948896|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92830663|NCT00948896|Artenimol|artenimol|mesh-list
92830664|NCT00948896|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92830665|NCT00948896|Sulfamethoxazole|sulfamethoxazole|mesh-list
92830666|NCT00948896|Antimalarials|antimalarials|mesh-ancestor
92830667|NCT00948896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92830668|NCT00948896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92830669|NCT00948896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830670|NCT00948896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92830671|NCT00948896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830672|NCT00948896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830673|NCT00948896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92830674|NCT00948896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92830675|NCT00948896|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92830676|NCT00948896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92830677|NCT00948896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92830678|NCT01004159|Irinotecan|irinotecan|mesh-list
92830679|NCT01004159|Cetuximab|cetuximab|mesh-list
92830680|NCT01004159|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92830681|NCT01004159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92830682|NCT01004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830683|NCT01004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830684|NCT01004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830685|NCT01004159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830686|NCT00948818|Linaclotide|linaclotide|mesh-list
92830687|NCT00948818|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92830688|NCT00948818|Enzyme Activators|enzyme activators|mesh-ancestor
92830689|NCT00948818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830690|NCT00948818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830691|NCT02854592|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92830692|NCT02854592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92830693|NCT02854592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92830694|NCT02854592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830695|NCT00948506|Cidofovir|cidofovir|mesh-list
92830696|NCT00948506|Antiviral Agents|antiviral agents|mesh-ancestor
92830697|NCT00948506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830698|NCT00948506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830699|NCT00948506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830700|NCT00689221|Temozolomide|temozolomide|mesh-list
92830701|NCT00689221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92830702|NCT00689221|Alkylating Agents|alkylating agents|mesh-ancestor
92830703|NCT00689221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830704|NCT00689221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830705|NCT04060771|Dexamethasone|dexamethasone|mesh-list
92830706|NCT04060771|Palonosetron|palonosetron|mesh-list
92830707|NCT04060771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830708|NCT04060771|Antiemetics|antiemetics|mesh-ancestor
92830709|NCT04060771|Autonomic Agents|autonomic agents|mesh-ancestor
92830710|NCT04060771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830711|NCT04060771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830712|NCT04060771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830713|NCT04060771|Glucocorticoids|glucocorticoids|mesh-ancestor
92830714|NCT04060771|Hormones|hormones|mesh-ancestor
92830715|NCT04060771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830716|NCT04060771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92830717|NCT04060771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830718|NCT04060771|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92830719|NCT04060771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92830720|NCT04060771|Serotonin Agents|serotonin agents|mesh-ancestor
92830721|NCT04060771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830722|NCT04060771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830723|NCT00744913|Nicotine|nicotine|mesh-list
92830724|NCT00744913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92830725|NCT00744913|Autonomic Agents|autonomic agents|mesh-ancestor
92830726|NCT00744913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830727|NCT00744913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830728|NCT00744913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92830729|NCT00744913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92830730|NCT00744913|Cholinergic Agents|cholinergic agents|mesh-ancestor
92475751|NCT01865305|Biphasic Insulins|biphasic insulins|mesh-list
92830731|NCT00744913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830732|NCT00744913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830733|NCT01875445|Inositol|inositol|mesh-list
92830734|NCT01875445|Vitamin B Complex|vitamin b complex|mesh-ancestor
92830735|NCT01875445|Vitamins|vitamins|mesh-ancestor
92830736|NCT01875445|Micronutrients|micronutrients|mesh-ancestor
92830737|NCT01875445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830738|NCT00745069|Tapentadol|tapentadol|mesh-list
92830739|NCT00745069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92830740|NCT00745069|Narcotics|narcotics|mesh-ancestor
92830741|NCT00745069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830742|NCT00745069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830743|NCT00745069|Analgesics|analgesics|mesh-ancestor
92830744|NCT00745069|Sensory System Agents|sensory system agents|mesh-ancestor
92830745|NCT00745069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830746|NCT00745069|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92830747|NCT00745069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830748|NCT00745069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830749|NCT00745069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830750|NCT00745069|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830751|NCT00745069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830752|NCT00745147|Laxatives|laxatives|mesh-list
92830753|NCT00745147|Lactulose|lactulose|mesh-list
92732571|NCT01194973|Eculizumab|eculizumab|mesh-list
92830754|NCT00745147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92830755|NCT00688909|Letrozole|letrozole|mesh-list
92830756|NCT00688909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830757|NCT00688909|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92830758|NCT00688909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92830759|NCT00688909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830760|NCT00688909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830761|NCT00688909|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92830762|NCT00688909|Hormone Antagonists|hormone antagonists|mesh-ancestor
92830763|NCT00688909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830764|NCT00688909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830765|NCT00948428|Imiquimod|imiquimod|mesh-list
92830766|NCT00948428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92830767|NCT00948428|Immunologic Factors|immunologic factors|mesh-ancestor
92830768|NCT00948428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830769|NCT00948428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830770|NCT00948428|Interferon Inducers|interferon inducers|mesh-ancestor
92830771|NCT00948194|Nitric Oxide|nitric oxide|mesh-list
92830772|NCT00948194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92830773|NCT00948194|Autonomic Agents|autonomic agents|mesh-ancestor
92830774|NCT00948194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830775|NCT00948194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830776|NCT00948194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92830777|NCT00948194|Respiratory System Agents|respiratory system agents|mesh-ancestor
92830778|NCT00948194|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92830779|NCT00948194|Antioxidants|antioxidants|mesh-ancestor
92830780|NCT00948194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830781|NCT00948194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830782|NCT00948194|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92830784|NCT00948194|Gasotransmitters|gasotransmitters|mesh-ancestor
92830785|NCT00948194|Protective Agents|protective agents|mesh-ancestor
92830786|NCT00691483|Varenicline|varenicline|mesh-list
92830787|NCT00691483|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92830788|NCT00691483|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92830789|NCT00691483|Cholinergic Agents|cholinergic agents|mesh-ancestor
92830790|NCT00691483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830791|NCT00691483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830792|NCT00691483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830793|NCT00691093|Fesoterodine|fesoterodine|mesh-list
92830794|NCT00691093|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92830795|NCT00691093|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92830796|NCT00691093|Cholinergic Agents|cholinergic agents|mesh-ancestor
92830797|NCT00691093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830798|NCT00691093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830799|NCT00691093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830800|NCT00691093|Urological Agents|urological agents|mesh-ancestor
92830801|NCT03646825|Antioxidants|antioxidants|mesh-list
92830802|NCT03646825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830803|NCT03646825|Protective Agents|protective agents|mesh-ancestor
92830804|NCT03646825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830805|NCT00745225|Pioglitazone|pioglitazone|mesh-list
92830806|NCT00745225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92830807|NCT00745225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830808|NCT02856542|Betamethasone|betamethasone|mesh-list
92830809|NCT02856542|Betamethasone Valerate|betamethasone valerate|mesh-list
92830810|NCT02856542|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92830811|NCT02856542|Betamethasone benzoate|betamethasone benzoate|mesh-list
92830812|NCT02856542|Calcipotriene|calcipotriene|mesh-list
92830813|NCT02856542|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92830814|NCT02856542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830815|NCT02856542|Glucocorticoids|glucocorticoids|mesh-ancestor
92830816|NCT02856542|Hormones|hormones|mesh-ancestor
92830817|NCT02856542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830818|NCT02856542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830819|NCT02856542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92830820|NCT02856542|Respiratory System Agents|respiratory system agents|mesh-ancestor
92830821|NCT02856542|Dermatologic Agents|dermatologic agents|mesh-ancestor
92830822|NCT00688753|Everolimus|everolimus|mesh-list
92830823|NCT00688753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92830824|NCT00688753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92830825|NCT00688753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830826|NCT00688753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830827|NCT00688753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830828|NCT00688753|Immunologic Factors|immunologic factors|mesh-ancestor
92830829|NCT00688753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830830|NCT00688753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830831|NCT04204382|Levofloxacin|levofloxacin|mesh-list
92830832|NCT04204382|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92830833|NCT04204382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92830834|NCT04204382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92830835|NCT04204382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92830836|NCT04204382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92830837|NCT04204382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830838|NCT04204382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830839|NCT04204382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830840|NCT04204382|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92830841|NCT04204382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92830842|NCT02856230|Paclitaxel|paclitaxel|mesh-list
92830843|NCT02856230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92830844|NCT02856230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830845|NCT02856230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92830846|NCT02856230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92830847|NCT02856230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92830848|NCT02856230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830849|NCT00631124|Drospirenone|drospirenone|mesh-list
92830850|NCT00631124|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92830851|NCT00631124|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92830852|NCT00631124|Estradiol|estradiol|mesh-list
92830853|NCT00631124|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92830854|NCT00631124|Estrogens|estrogens|mesh-ancestor
92830855|NCT00631124|Hormones|hormones|mesh-ancestor
92830856|NCT00631124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830858|NCT00631124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92830859|NCT00631124|Contraceptive Agents|contraceptive agents|mesh-ancestor
92830860|NCT00631124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92830861|NCT00631124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92830862|NCT00631124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92830863|NCT00631124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92830864|NCT00631124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92830865|NCT00631124|Diuretics|diuretics|mesh-ancestor
92830866|NCT00631124|Natriuretic Agents|natriuretic agents|mesh-ancestor
92830867|NCT02855684|Insulin|insulin|mesh-list
92830868|NCT02855684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92830869|NCT02855684|Insulin Glargine|insulin glargine|mesh-list
92830870|NCT02855684|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92830871|NCT02855684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830872|NCT01667744|Citalopram|citalopram|mesh-list
92830873|NCT01667744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92830874|NCT01667744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92830875|NCT01667744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830876|NCT01667744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830877|NCT01667744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830878|NCT01667744|Serotonin Agents|serotonin agents|mesh-ancestor
92830879|NCT01667744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830880|NCT01667744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92830881|NCT01667744|Antidepressive Agents|antidepressive agents|mesh-ancestor
92830882|NCT01667744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830883|NCT04274270|Endostar protein|endostar protein|mesh-list
92830884|NCT04274270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92830885|NCT04274270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92830886|NCT04274270|Growth Substances|growth substances|mesh-ancestor
92830887|NCT04274270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830888|NCT04274270|Growth Inhibitors|growth inhibitors|mesh-ancestor
92830889|NCT04274270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830890|NCT02855294|Drospirenone|drospirenone|mesh-list
92830891|NCT02855294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92830892|NCT02855294|Hormone Antagonists|hormone antagonists|mesh-ancestor
92830893|NCT02855294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92830894|NCT02855294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830895|NCT02855294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92830896|NCT02855294|Diuretics|diuretics|mesh-ancestor
92830897|NCT02855294|Natriuretic Agents|natriuretic agents|mesh-ancestor
92830898|NCT00950690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92830899|NCT00950690|Latanoprost|latanoprost|mesh-list
92830900|NCT00950690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92830901|NCT02855138|Isotretinoin|isotretinoin|mesh-list
92830902|NCT02855138|Dermatologic Agents|dermatologic agents|mesh-ancestor
92830903|NCT00694369|Acetaminophen|acetaminophen|mesh-list
92830904|NCT00694369|Ibuprofen|ibuprofen|mesh-list
92830905|NCT00694369|Etoricoxib|etoricoxib|mesh-list
92830906|NCT00694369|Codeine|codeine|mesh-list
92830907|NCT00694369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92830908|NCT00694369|Analgesics|analgesics|mesh-ancestor
92830909|NCT00694369|Sensory System Agents|sensory system agents|mesh-ancestor
92830910|NCT00694369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830911|NCT00694369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830912|NCT00694369|Antipyretics|antipyretics|mesh-ancestor
92830913|NCT00694369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92830914|NCT00694369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830915|NCT00694369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830916|NCT00694369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92830917|NCT00694369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830918|NCT00694369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830919|NCT00694369|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92830920|NCT00694369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92830921|NCT00694369|Narcotics|narcotics|mesh-ancestor
92830922|NCT00694369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830923|NCT00694369|Antitussive Agents|antitussive agents|mesh-ancestor
92830924|NCT00694369|Respiratory System Agents|respiratory system agents|mesh-ancestor
92830925|NCT00745693|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92830926|NCT00745693|BQ 788|bq 788|mesh-list
92830927|NCT00745693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92830928|NCT00745693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92175973|NCT01420653|Acetaminophen|acetaminophen|mesh-list
92830929|NCT00745693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830930|NCT00745693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92830931|NCT02563405|Doxazosin|doxazosin|mesh-list
92830932|NCT02563405|Nifedipine|nifedipine|mesh-list
92830933|NCT02563405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92830934|NCT02563405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830935|NCT02563405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830936|NCT02563405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92830937|NCT02563405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830938|NCT02563405|Vasodilator Agents|vasodilator agents|mesh-ancestor
92830939|NCT02563405|Tocolytic Agents|tocolytic agents|mesh-ancestor
92830940|NCT02563405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92830941|NCT02563405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92830942|NCT02563405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92830943|NCT02563405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92830944|NCT02563405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92830945|NCT02563405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92830946|NCT02563405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92830947|NCT03412747|Adalimumab|adalimumab|mesh-list
92830948|NCT03412747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92830949|NCT03412747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92830950|NCT03412747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92830951|NCT00513019|Lamotrigine|lamotrigine|mesh-list
92830952|NCT00513019|Anticonvulsants|anticonvulsants|mesh-list
92830953|NCT00513019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92830954|NCT00513019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92830955|NCT00513019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830956|NCT00513019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92830957|NCT00513019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830958|NCT00513019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92830959|NCT00513019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92830960|NCT00513019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92830961|NCT00513019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92830962|NCT00513019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92830963|NCT00053677|Naltrexone|naltrexone|mesh-list
92830964|NCT00053677|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92830965|NCT00053677|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92830966|NCT00053677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830967|NCT00053677|Sensory System Agents|sensory system agents|mesh-ancestor
92830968|NCT00053677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92830969|NCT00954512|Leucovorin|leucovorin|mesh-list
92830970|NCT00954512|Folic Acid|folic acid|mesh-list
92830971|NCT00954512|Carboplatin|carboplatin|mesh-list
92830972|NCT00954512|Gemcitabine|gemcitabine|mesh-list
92830973|NCT00954512|Trastuzumab|trastuzumab|mesh-list
92830974|NCT00954512|Irinotecan|irinotecan|mesh-list
92830975|NCT00954512|Cetuximab|cetuximab|mesh-list
92830976|NCT00954512|Everolimus|everolimus|mesh-list
92830977|NCT00954512|Epirubicin|epirubicin|mesh-list
92830978|NCT00954512|Levoleucovorin|levoleucovorin|mesh-list
92830979|NCT00954512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92830980|NCT00954512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92830981|NCT00954512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92830982|NCT00954512|Antimetabolites|antimetabolites|mesh-ancestor
92830983|NCT00954512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92830984|NCT00954512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92830985|NCT00954512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92830986|NCT00954512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92830987|NCT00954512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92830988|NCT00954512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92830989|NCT00954512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92830990|NCT00954512|Immunologic Factors|immunologic factors|mesh-ancestor
92830991|NCT00954512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92830992|NCT00954512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92830993|NCT00954512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92830994|NCT00954512|Antidotes|antidotes|mesh-ancestor
92830995|NCT00954512|Protective Agents|protective agents|mesh-ancestor
92830996|NCT00954512|Vitamin B Complex|vitamin b complex|mesh-ancestor
92830997|NCT00954512|Vitamins|vitamins|mesh-ancestor
92830998|NCT00954512|Micronutrients|micronutrients|mesh-ancestor
92830999|NCT00954512|Hematinics|hematinics|mesh-ancestor
92831000|NCT00691015|Cytarabine|cytarabine|mesh-list
92831001|NCT00691015|Cyclophosphamide|cyclophosphamide|mesh-list
92831002|NCT00691015|Melphalan|melphalan|mesh-list
92831003|NCT00691015|Busulfan|busulfan|mesh-list
92831004|NCT00691015|Carmustine|carmustine|mesh-list
92831005|NCT00691015|Rituximab|rituximab|mesh-list
92831006|NCT00691015|Fludarabine|fludarabine|mesh-list
92831007|NCT00691015|Fludarabine phosphate|fludarabine phosphate|mesh-list
92831008|NCT00691015|Etoposide|etoposide|mesh-list
92831009|NCT00691015|Thymoglobulin|thymoglobulin|mesh-list
92831010|NCT00691015|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92831011|NCT00691015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831012|NCT00691015|Immunologic Factors|immunologic factors|mesh-ancestor
92831013|NCT00691015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831014|NCT00691015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831015|NCT00691015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831016|NCT00691015|Alkylating Agents|alkylating agents|mesh-ancestor
92831017|NCT00691015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831018|NCT00691015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831019|NCT00691015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92831020|NCT00691015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831021|NCT00691015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831022|NCT00691015|Antimetabolites|antimetabolites|mesh-ancestor
92831023|NCT00691015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92831024|NCT00691015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92831025|NCT00691015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92831026|NCT00691015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831027|NCT00691015|Antiviral Agents|antiviral agents|mesh-ancestor
92831028|NCT00691015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831029|NCT00950300|Cyclophosphamide|cyclophosphamide|mesh-list
92831030|NCT00950300|Docetaxel|docetaxel|mesh-list
92831031|NCT00950300|Fluorouracil|fluorouracil|mesh-list
92831032|NCT00950300|Trastuzumab|trastuzumab|mesh-list
92831033|NCT00950300|Epirubicin|epirubicin|mesh-list
92831034|NCT00950300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831035|NCT00950300|Immunologic Factors|immunologic factors|mesh-ancestor
92831036|NCT00950300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831037|NCT00950300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831038|NCT00950300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831039|NCT00950300|Alkylating Agents|alkylating agents|mesh-ancestor
92831040|NCT00950300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831041|NCT00950300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831042|NCT00950300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92831043|NCT00950300|Tubulin Modulators|tubulin modulators|mesh-ancestor
92831044|NCT00950300|Antimitotic Agents|antimitotic agents|mesh-ancestor
92831045|NCT00950300|Mitosis Modulators|mitosis modulators|mesh-ancestor
92831046|NCT00950300|Antimetabolites|antimetabolites|mesh-ancestor
92831047|NCT00950300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831048|NCT00950300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831049|NCT00950300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92831050|NCT00950300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92831051|NCT00950300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92831052|NCT00950300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831053|NCT00949988|Rituximab|rituximab|mesh-list
92831054|NCT00949988|Dasatinib|dasatinib|mesh-list
92831055|NCT00949988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831056|NCT00949988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831057|NCT00949988|Immunologic Factors|immunologic factors|mesh-ancestor
92831058|NCT00949988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831059|NCT00949988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831060|NCT00949988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831061|NCT00949988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831062|NCT00949988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831063|NCT00731692|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92831064|NCT00731692|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92831065|NCT00731692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831066|NCT00731692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831067|NCT00731692|Immunologic Factors|immunologic factors|mesh-ancestor
92831068|NCT00731692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831069|NCT02593474|Naltrexone|naltrexone|mesh-list
92831070|NCT02593474|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92831071|NCT02593474|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92831072|NCT02593474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831073|NCT02593474|Sensory System Agents|sensory system agents|mesh-ancestor
92831074|NCT02593474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831075|NCT00687193|Tofacitinib|tofacitinib|mesh-list
92831076|NCT00687193|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92831077|NCT00687193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831078|NCT00687193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831079|NCT00687193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831080|NCT00917878|Calcium|calcium|mesh-list
92831081|NCT00917878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92831082|NCT00917878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831083|NCT00730912|Loratadine|loratadine|mesh-list
92831084|NCT00730912|Antipruritics|antipruritics|mesh-ancestor
92831085|NCT00730912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831086|NCT00730912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92831087|NCT00730912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92831088|NCT00730912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92831089|NCT00730912|Histamine Antagonists|histamine antagonists|mesh-ancestor
92831090|NCT00730912|Histamine Agents|histamine agents|mesh-ancestor
92831091|NCT00730912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831092|NCT00730912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831093|NCT00730912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831094|NCT00730756|Fluticasone|fluticasone|mesh-list
92831095|NCT00730756|Xhance|xhance|mesh-list
92831096|NCT00730756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831097|NCT00730756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92831098|NCT00730756|Autonomic Agents|autonomic agents|mesh-ancestor
92831099|NCT00730756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831100|NCT00730756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831101|NCT00730756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92831102|NCT00730756|Respiratory System Agents|respiratory system agents|mesh-ancestor
92831103|NCT00730756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831104|NCT00730756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92831105|NCT00730132|Ezetimibe|ezetimibe|mesh-list
92831106|NCT00730132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92831107|NCT00730132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831108|NCT00730132|Antimetabolites|antimetabolites|mesh-ancestor
92831109|NCT00730132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831110|NCT00730132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831111|NCT00737464|Epoetin Alfa|epoetin alfa|mesh-list
92831112|NCT00737464|Hematinics|hematinics|mesh-ancestor
92831113|NCT00729586|Tamoxifen|tamoxifen|mesh-list
92831114|NCT00729586|Sirolimus|sirolimus|mesh-list
92831115|NCT00729586|Temsirolimus|temsirolimus|mesh-list
92831116|NCT00729586|Megestrol|megestrol|mesh-list
92831117|NCT00729586|Megestrol Acetate|megestrol acetate|mesh-list
92831118|NCT00729586|MTOR Inhibitors|mtor inhibitors|mesh-list
92831119|NCT00729586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831120|NCT00729586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92831121|NCT00729586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831122|NCT00729586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92831123|NCT00729586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831124|NCT00729586|Antifungal Agents|antifungal agents|mesh-ancestor
92831125|NCT00729586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831126|NCT00729586|Immunologic Factors|immunologic factors|mesh-ancestor
92831127|NCT00729586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831128|NCT00729586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831129|NCT00729586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831130|NCT00729586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92831131|NCT00729586|Hormone Antagonists|hormone antagonists|mesh-ancestor
92831132|NCT00729586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831133|NCT00729586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831134|NCT00729586|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92831135|NCT00729586|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92831136|NCT00729586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92831137|NCT00729586|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92831138|NCT00729586|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92831139|NCT00729586|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92831140|NCT00729586|Contraceptive Agents|contraceptive agents|mesh-ancestor
92831141|NCT00729586|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92831142|NCT00729586|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92831143|NCT00729586|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92831144|NCT00729586|Appetite Stimulants|appetite stimulants|mesh-ancestor
92831145|NCT00729586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92831146|NCT00949910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92831147|NCT00949910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831148|NCT00949910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831149|NCT00949910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831150|NCT00949910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831151|NCT02594800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92831152|NCT02594800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92831153|NCT02594800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831154|NCT02594800|Antimetabolites|antimetabolites|mesh-ancestor
92831155|NCT02594800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831156|NCT02594800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831157|NCT02594800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92831158|NCT02594800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831159|NCT02593162|Ribavirin|ribavirin|mesh-list
92831160|NCT02593162|Antimetabolites|antimetabolites|mesh-ancestor
92831161|NCT02593162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831162|NCT02593162|Antiviral Agents|antiviral agents|mesh-ancestor
92831163|NCT02593162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831164|NCT00686959|Paclitaxel|paclitaxel|mesh-list
92831165|NCT00686959|Etoposide|etoposide|mesh-list
92831166|NCT00686959|Vinorelbine|vinorelbine|mesh-list
92831167|NCT00686959|Carboplatin|carboplatin|mesh-list
92831168|NCT00686959|Pemetrexed|pemetrexed|mesh-list
92831169|NCT00686959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92831170|NCT00686959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831171|NCT00686959|Tubulin Modulators|tubulin modulators|mesh-ancestor
92831172|NCT00686959|Antimitotic Agents|antimitotic agents|mesh-ancestor
92831173|NCT00686959|Mitosis Modulators|mitosis modulators|mesh-ancestor
92831174|NCT00686959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831175|NCT00686959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92831176|NCT00686959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92831177|NCT00686959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831178|NCT00686959|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92831179|NCT00686959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92831180|NCT04088110|Trastuzumab|trastuzumab|mesh-list
92831181|NCT04088110|Letrozole|letrozole|mesh-list
92831182|NCT04088110|Anastrozole|anastrozole|mesh-list
92831183|NCT04088110|Exemestane|exemestane|mesh-list
92831184|NCT04088110|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92831185|NCT04088110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831186|NCT04088110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831187|NCT04088110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92831188|NCT04088110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831189|NCT04088110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831190|NCT04088110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92831191|NCT04088110|Hormone Antagonists|hormone antagonists|mesh-ancestor
92831192|NCT04088110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831193|NCT04088110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831194|NCT04088110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831195|NCT04088266|Buprenorphine|buprenorphine|mesh-list
92831196|NCT04088266|Naloxone|naloxone|mesh-list
92831197|NCT04088266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92831198|NCT04088266|Narcotics|narcotics|mesh-ancestor
92831199|NCT04088266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831200|NCT04088266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831201|NCT04088266|Analgesics|analgesics|mesh-ancestor
92831202|NCT04088266|Sensory System Agents|sensory system agents|mesh-ancestor
92831203|NCT04088266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831204|NCT04088266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92831205|NCT05311579|Niraparib|niraparib|mesh-list
92831206|NCT05311579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92831207|NCT05311579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831208|NCT05311579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831209|NCT05311579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831210|NCT00602342|Terbinafine|terbinafine|mesh-list
92831211|NCT00602342|Antifungal Agents|antifungal agents|mesh-ancestor
92831212|NCT00602342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831213|NCT00602342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831214|NCT00602342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831215|NCT00602498|Clarithromycin|clarithromycin|mesh-list
92831216|NCT00602498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92831217|NCT00602498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831218|NCT00602498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92831219|NCT00602498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831220|NCT00602498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831221|NCT00602498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92831222|NCT00602498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92831223|NCT00749359|Paroxetine|paroxetine|mesh-list
92831224|NCT00749359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92831225|NCT00749359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92831226|NCT00749359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92831227|NCT00749359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831228|NCT00749359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831230|NCT00749359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831231|NCT00749359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92831232|NCT00749359|Antidepressive Agents|antidepressive agents|mesh-ancestor
92831233|NCT00749359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92831234|NCT00749359|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92831235|NCT00749359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92831236|NCT00749359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831237|NCT00946088|Progesterone|progesterone|mesh-list
92831238|NCT00946088|Progestins|progestins|mesh-ancestor
92831239|NCT00946088|Hormones|hormones|mesh-ancestor
92831240|NCT00946088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831241|NCT00946088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831242|NCT02562313|Insulin Lispro|insulin lispro|mesh-list
92831243|NCT02562313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92831244|NCT02562313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831245|NCT00736996|Pioglitazone|pioglitazone|mesh-list
92831246|NCT00736996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92831247|NCT00736996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831248|NCT00741949|Propofol|propofol|mesh-list
92831249|NCT00741949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92831250|NCT00741949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831251|NCT00741949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831252|NCT00741949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92831253|NCT00741949|Anesthetics, General|anesthetics, general|mesh-ancestor
92831254|NCT00741949|Anesthetics|anesthetics|mesh-ancestor
92831255|NCT01410344|Vidarabine|vidarabine|mesh-list
92831256|NCT01410344|Cyclophosphamide|cyclophosphamide|mesh-list
92831257|NCT01410344|Melphalan|melphalan|mesh-list
92831258|NCT01410344|Busulfan|busulfan|mesh-list
92831259|NCT01410344|Fludarabine|fludarabine|mesh-list
92831260|NCT01410344|Fludarabine phosphate|fludarabine phosphate|mesh-list
92831261|NCT01410344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831262|NCT01410344|Immunologic Factors|immunologic factors|mesh-ancestor
92831263|NCT01410344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831264|NCT01410344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831265|NCT01410344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831266|NCT01410344|Alkylating Agents|alkylating agents|mesh-ancestor
92831267|NCT01410344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831268|NCT01410344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831269|NCT01410344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92831270|NCT01410344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831271|NCT01410344|Antimetabolites|antimetabolites|mesh-ancestor
92831272|NCT01410344|Antiviral Agents|antiviral agents|mesh-ancestor
92831273|NCT01410344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831274|NCT02594410|Lercanidipine|lercanidipine|mesh-list
92831275|NCT02594410|Clopidogrel|clopidogrel|mesh-list
92831276|NCT02594410|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92831277|NCT02594410|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92831278|NCT02594410|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92831279|NCT02594410|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92831280|NCT02594410|Purinergic Agents|purinergic agents|mesh-ancestor
92831281|NCT02594410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831282|NCT02594410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831283|NCT02594410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831284|NCT02594410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92831285|NCT02594410|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92831286|NCT02594410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92831287|NCT02594410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92831288|NCT00954122|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92831289|NCT00954122|Antidepressive Agents|antidepressive agents|mesh-ancestor
92831290|NCT00954122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92831291|NCT00954122|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92831292|NCT00954122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92831293|NCT00954122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831294|NCT00954122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831295|NCT00586066|Memantine|memantine|mesh-list
92831296|NCT00586066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92831297|NCT00586066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92831298|NCT00586066|Dopamine Agents|dopamine agents|mesh-ancestor
92831299|NCT00586066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831300|NCT00586066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831301|NCT00586066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831302|NCT00586066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92831303|NCT00586066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92831304|NCT00630890|Capecitabine|capecitabine|mesh-list
92831305|NCT00630890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831306|NCT00630890|Antimetabolites|antimetabolites|mesh-ancestor
92831307|NCT00630890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831308|NCT00630890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831309|NCT00728494|Ribavirin|ribavirin|mesh-list
92831310|NCT00728494|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92831311|NCT00728494|Interferon-alpha|interferon-alpha|mesh-list
92831312|NCT00728494|Antimetabolites|antimetabolites|mesh-ancestor
92831313|NCT00728494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831314|NCT00728494|Antiviral Agents|antiviral agents|mesh-ancestor
92831315|NCT00728494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831316|NCT00728494|Immunologic Factors|immunologic factors|mesh-ancestor
92831317|NCT00728494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831318|NCT02854904|Dexmedetomidine|dexmedetomidine|mesh-list
92831319|NCT02854904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92831320|NCT02854904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831321|NCT02854904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831322|NCT02854904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92831323|NCT02854904|Analgesics|analgesics|mesh-ancestor
92831324|NCT02854904|Sensory System Agents|sensory system agents|mesh-ancestor
92831325|NCT02854904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831326|NCT02854904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92831327|NCT02854904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92831328|NCT02854904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92831329|NCT02854904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92831330|NCT02854904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831331|NCT02854904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831332|NCT00728416|Mometasone Furoate|mometasone furoate|mesh-list
92831333|NCT00728416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831334|NCT00728416|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831335|NCT00728416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92831336|NCT00941330|Cyclophosphamide|cyclophosphamide|mesh-list
92831338|NCT00941330|Exemestane|exemestane|mesh-list
92831339|NCT00941330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831340|NCT00941330|Immunologic Factors|immunologic factors|mesh-ancestor
92831341|NCT00941330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831342|NCT00941330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831343|NCT00941330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831344|NCT00941330|Alkylating Agents|alkylating agents|mesh-ancestor
92831345|NCT00941330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831346|NCT00941330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831347|NCT00941330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92831348|NCT00941330|Tubulin Modulators|tubulin modulators|mesh-ancestor
92831349|NCT00941330|Antimitotic Agents|antimitotic agents|mesh-ancestor
92831350|NCT00941330|Mitosis Modulators|mitosis modulators|mesh-ancestor
92831351|NCT00941330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92831352|NCT00941330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92831353|NCT00941330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831354|NCT00941330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92831355|NCT00941330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92831356|NCT00941330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831357|NCT00736450|Prednisone|prednisone|mesh-list
92831358|NCT00736450|Cyclophosphamide|cyclophosphamide|mesh-list
92831359|NCT00736450|Rituximab|rituximab|mesh-list
92831360|NCT00736450|Doxorubicin|doxorubicin|mesh-list
92831361|NCT00736450|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92831362|NCT00736450|Vincristine|vincristine|mesh-list
92831363|NCT00736450|Oblimersen|oblimersen|mesh-list
92831364|NCT00736450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831365|NCT00736450|Immunologic Factors|immunologic factors|mesh-ancestor
92831366|NCT00736450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831367|NCT00736450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831368|NCT00736450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831369|NCT00736450|Alkylating Agents|alkylating agents|mesh-ancestor
92831370|NCT00736450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831371|NCT00736450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831372|NCT00736450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92831373|NCT00736450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831374|NCT00736450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92831375|NCT00736450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92831376|NCT00736450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92831377|NCT00736450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831378|NCT00736450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831379|NCT00736450|Glucocorticoids|glucocorticoids|mesh-ancestor
92831380|NCT00736450|Hormones|hormones|mesh-ancestor
92831381|NCT00736450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831382|NCT00736450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831383|NCT00736450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92831384|NCT00736450|Tubulin Modulators|tubulin modulators|mesh-ancestor
92831385|NCT00736450|Antimitotic Agents|antimitotic agents|mesh-ancestor
92831386|NCT00736450|Mitosis Modulators|mitosis modulators|mesh-ancestor
92831387|NCT00686881|Interferons|interferons|mesh-list
92831388|NCT00686881|Interferon-alpha|interferon-alpha|mesh-list
92831389|NCT00686881|Interferon alpha-2|interferon alpha-2|mesh-list
92831390|NCT00686881|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92831391|NCT00686881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831392|NCT00686881|Antiviral Agents|antiviral agents|mesh-ancestor
92831393|NCT00686881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831394|NCT00686881|Immunologic Factors|immunologic factors|mesh-ancestor
92831395|NCT00686881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831396|NCT02857244|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92831397|NCT02857244|Modafinil|modafinil|mesh-list
92831398|NCT02857244|Donepezil|donepezil|mesh-list
92831399|NCT02857244|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92831400|NCT02857244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92831401|NCT02857244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92831402|NCT02857244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831403|NCT02857244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831404|NCT02857244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831405|NCT02857244|Analgesics|analgesics|mesh-ancestor
92831406|NCT02857244|Sensory System Agents|sensory system agents|mesh-ancestor
92831407|NCT02857244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831408|NCT02857244|Antidepressive Agents|antidepressive agents|mesh-ancestor
92831409|NCT02857244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92831410|NCT02857244|Dopamine Agents|dopamine agents|mesh-ancestor
92831411|NCT02857244|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92831412|NCT02857244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831413|NCT02857244|Cholinergic Agents|cholinergic agents|mesh-ancestor
92831414|NCT02857244|Nootropic Agents|nootropic agents|mesh-ancestor
92831415|NCT02857244|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92831416|NCT02857244|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92831417|NCT02857244|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92831418|NCT02857244|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92831419|NCT04273256|Inositol|inositol|mesh-list
92831420|NCT04273256|Vitamin B Complex|vitamin b complex|mesh-ancestor
92831421|NCT04273256|Vitamins|vitamins|mesh-ancestor
92831422|NCT04273256|Micronutrients|micronutrients|mesh-ancestor
92831423|NCT04273256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831424|NCT00921661|Aflibercept|aflibercept|mesh-list
92831425|NCT00921661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92831426|NCT00921661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92831427|NCT00921661|Growth Substances|growth substances|mesh-ancestor
92831428|NCT00921661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831429|NCT00921661|Growth Inhibitors|growth inhibitors|mesh-ancestor
92831430|NCT00921661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831431|NCT04088032|Durvalumab|durvalumab|mesh-list
92831432|NCT04088032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92831433|NCT04088032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831434|NCT04088032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831435|NCT04088032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92831436|NCT04088032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831437|NCT04088032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831438|NCT04088032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92831439|NCT04088032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92831440|NCT04088032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831441|NCT04088032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831442|NCT00688597|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
92831443|NCT00688597|Antiviral Agents|antiviral agents|mesh-ancestor
92831444|NCT00688597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831445|NCT00688597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831446|NCT00688597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831447|NCT00735904|Gemcitabine|gemcitabine|mesh-list
92831448|NCT00735904|Axitinib|axitinib|mesh-list
92831449|NCT00735904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831450|NCT00735904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831451|NCT00735904|Antimetabolites|antimetabolites|mesh-ancestor
92977205|NCT00545103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92831452|NCT00735904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831453|NCT00735904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831454|NCT00735904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831455|NCT02561923|Rivaroxaban|rivaroxaban|mesh-list
92831456|NCT02561923|Tranexamic Acid|tranexamic acid|mesh-list
92831457|NCT02561923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92831458|NCT02561923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92831459|NCT02561923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831460|NCT02561923|Hemostatics|hemostatics|mesh-ancestor
92831461|NCT02561923|Coagulants|coagulants|mesh-ancestor
92831462|NCT02561923|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92831463|NCT02561923|Antithrombins|antithrombins|mesh-ancestor
92831464|NCT02561923|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92831465|NCT02561923|Protease Inhibitors|protease inhibitors|mesh-ancestor
92831466|NCT02561923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831467|NCT02561923|Anticoagulants|anticoagulants|mesh-ancestor
92831468|NCT00918190|Dexamethasone|dexamethasone|mesh-list
92831469|NCT00918190|Dexamethasone acetate|dexamethasone acetate|mesh-list
92831470|NCT00918190|Midazolam|midazolam|mesh-list
92831471|NCT00918190|Ondansetron|ondansetron|mesh-list
92831472|NCT00918190|BB 1101|bb 1101|mesh-list
92831473|NCT00918190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831474|NCT00918190|Antiemetics|antiemetics|mesh-ancestor
92831475|NCT00918190|Autonomic Agents|autonomic agents|mesh-ancestor
92831476|NCT00918190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831477|NCT00918190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831478|NCT00918190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92831479|NCT00918190|Glucocorticoids|glucocorticoids|mesh-ancestor
92831480|NCT00918190|Hormones|hormones|mesh-ancestor
92831481|NCT00918190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733297|NCT01682408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92831482|NCT00918190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831483|NCT00918190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831484|NCT00918190|Protease Inhibitors|protease inhibitors|mesh-ancestor
92831485|NCT00918190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831486|NCT00918190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831487|NCT00918190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92831488|NCT00918190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92831489|NCT00918190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831490|NCT00918190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92831491|NCT00918190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92831492|NCT00918190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92831493|NCT00918190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92831494|NCT00918190|Anesthetics, General|anesthetics, general|mesh-ancestor
92831495|NCT00918190|Anesthetics|anesthetics|mesh-ancestor
92831496|NCT00918190|GABA Modulators|gaba modulators|mesh-ancestor
92831497|NCT00918190|GABA Agents|gaba agents|mesh-ancestor
92831498|NCT00918190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831499|NCT00918190|Antipruritics|antipruritics|mesh-ancestor
92831500|NCT00918190|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831501|NCT00918190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92831502|NCT00918190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92831503|NCT00918190|Serotonin Agents|serotonin agents|mesh-ancestor
92831505|NCT02563327|Vitamin B 6|vitamin b 6|mesh-list
92831506|NCT02563327|Moxifloxacin|moxifloxacin|mesh-list
92831507|NCT02563327|Rifampin|rifampin|mesh-list
92831508|NCT02563327|Isoniazid|isoniazid|mesh-list
92831509|NCT02563327|Pyrazinamide|pyrazinamide|mesh-list
92831510|NCT02563327|Ethambutol|ethambutol|mesh-list
92831511|NCT02563327|Rifapentine|rifapentine|mesh-list
92831512|NCT02563327|Vitamins|vitamins|mesh-ancestor
92831513|NCT02563327|Micronutrients|micronutrients|mesh-ancestor
92831514|NCT02563327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831515|NCT02563327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92831516|NCT02563327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831517|NCT02563327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92831518|NCT02563327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92831519|NCT02563327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831520|NCT02563327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831521|NCT02563327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831522|NCT02563327|Vitamin B Complex|vitamin b complex|mesh-ancestor
92831523|NCT02563327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92831524|NCT02563327|Antitubercular Agents|antitubercular agents|mesh-ancestor
92831525|NCT02563327|Leprostatic Agents|leprostatic agents|mesh-ancestor
92831526|NCT02563327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92831527|NCT02563327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92831528|NCT02563327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92831529|NCT02563327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92176574|NCT04778917|Dalteparin|dalteparin|mesh-list
92831530|NCT02563327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92831531|NCT02563327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92831532|NCT02563327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92831533|NCT02563327|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92831534|NCT02563327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831535|NCT02563327|Antimetabolites|antimetabolites|mesh-ancestor
92831536|NCT02563327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831537|NCT00918034|Talaporfin|talaporfin|mesh-list
92831538|NCT00918034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831539|NCT00918034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92831540|NCT00918034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831541|NCT02593942|Remifentanil|remifentanil|mesh-list
92831542|NCT02593942|Propofol|propofol|mesh-list
92831543|NCT02593942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92831544|NCT02593942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831545|NCT02593942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831546|NCT02593942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92831547|NCT02593942|Anesthetics, General|anesthetics, general|mesh-ancestor
92831548|NCT02593942|Anesthetics|anesthetics|mesh-ancestor
92831549|NCT02593942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92831550|NCT02593942|Narcotics|narcotics|mesh-ancestor
92831551|NCT02593942|Analgesics|analgesics|mesh-ancestor
92831552|NCT02593942|Sensory System Agents|sensory system agents|mesh-ancestor
92831553|NCT02593942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831554|NCT00742339|Octreotide|octreotide|mesh-list
92831555|NCT00742339|Terlipressin|terlipressin|mesh-list
92831556|NCT00742339|Midodrine|midodrine|mesh-list
92831557|NCT00742339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92831558|NCT00742339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92733365|NCT01683032|Dopamine Agents|dopamine agents|mesh-ancestor
92831559|NCT00742339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831560|NCT00742339|Sympathomimetics|sympathomimetics|mesh-ancestor
92831561|NCT00742339|Autonomic Agents|autonomic agents|mesh-ancestor
92831562|NCT00742339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831563|NCT00742339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831564|NCT00742339|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92831565|NCT00742339|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92831566|NCT00742339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92831567|NCT00742339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92831568|NCT00742339|Adrenergic Agents|adrenergic agents|mesh-ancestor
92831569|NCT00742339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831570|NCT00742339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831571|NCT00742339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92831572|NCT02592772|Menthol|menthol|mesh-list
92831573|NCT02592772|Nicotine|nicotine|mesh-list
92831574|NCT02592772|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92831575|NCT02592772|Autonomic Agents|autonomic agents|mesh-ancestor
92831576|NCT02592772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831577|NCT02592772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831578|NCT02592772|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92831579|NCT02592772|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92831580|NCT02592772|Cholinergic Agents|cholinergic agents|mesh-ancestor
92831581|NCT02592772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831582|NCT02592772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831583|NCT02592772|Antipruritics|antipruritics|mesh-ancestor
92831584|NCT02592772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831585|NCT00631202|Epoetin Alfa|epoetin alfa|mesh-list
92831586|NCT00631202|Hematinics|hematinics|mesh-ancestor
92831587|NCT02851784|Immunomodulating Agents|immunomodulating agents|mesh-list
92831588|NCT02851784|Immunologic Factors|immunologic factors|mesh-ancestor
92831589|NCT02851784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831590|NCT00721630|Capecitabine|capecitabine|mesh-list
92831591|NCT00721630|Lapatinib|lapatinib|mesh-list
92831592|NCT00721630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831593|NCT00721630|Antimetabolites|antimetabolites|mesh-ancestor
92831594|NCT00721630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831595|NCT00721630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831596|NCT00721630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831597|NCT00721630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831598|NCT00686725|Temozolomide|temozolomide|mesh-list
92831599|NCT00686725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831600|NCT00686725|Alkylating Agents|alkylating agents|mesh-ancestor
92831601|NCT00686725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831602|NCT00686725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831603|NCT04055623|Aldesleukin|aldesleukin|mesh-list
92831604|NCT04055623|Interleukin-2|interleukin-2|mesh-list
92831605|NCT04055623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176650|NCT02740595|Nicotine|nicotine|mesh-list
92831606|NCT04055623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92831607|NCT04055623|Analgesics|analgesics|mesh-ancestor
92831608|NCT04055623|Sensory System Agents|sensory system agents|mesh-ancestor
92831609|NCT04055623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831610|NCT04055623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831611|NCT04055623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92831612|NCT04055623|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92831613|NCT04055623|Antiviral Agents|antiviral agents|mesh-ancestor
92831614|NCT04055623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831615|NCT02561845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92831616|NCT02561845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92831617|NCT02561845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831618|NCT02561845|Antimetabolites|antimetabolites|mesh-ancestor
92831619|NCT02561845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831620|NCT02561845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831621|NCT02561845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92831622|NCT02561845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831623|NCT00727246|Choline|choline|mesh-list
92831624|NCT00727246|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92831625|NCT00727246|Lipotropic Agents|lipotropic agents|mesh-ancestor
92831626|NCT00727246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831627|NCT00727246|Antimetabolites|antimetabolites|mesh-ancestor
92831628|NCT00727246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831629|NCT00727246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92831630|NCT00727246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831631|NCT00727246|Nootropic Agents|nootropic agents|mesh-ancestor
92831632|NCT05381558|Triamcinolone|triamcinolone|mesh-list
92831633|NCT05381558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831634|NCT05381558|Glucocorticoids|glucocorticoids|mesh-ancestor
92831635|NCT05381558|Hormones|hormones|mesh-ancestor
92831636|NCT05381558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831637|NCT05381558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831639|NCT04055233|Polihexanide|polihexanide|mesh-list
92831640|NCT04055233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831641|NCT04055233|Disinfectants|disinfectants|mesh-ancestor
92831642|NCT04055233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92831643|NCT04055233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831644|NCT04268966|Brincidofovir|brincidofovir|mesh-list
92831645|NCT04268966|Antiviral Agents|antiviral agents|mesh-ancestor
92831646|NCT04268966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831647|NCT04269278|Dexmedetomidine|dexmedetomidine|mesh-list
92831648|NCT04269278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92831649|NCT04269278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831650|NCT04269278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831651|NCT04269278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92831652|NCT04269278|Analgesics|analgesics|mesh-ancestor
92831653|NCT04269278|Sensory System Agents|sensory system agents|mesh-ancestor
92831654|NCT04269278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831655|NCT04269278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92831656|NCT04269278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92831657|NCT04269278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92831658|NCT04269278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92831659|NCT04269278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831660|NCT04269278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831661|NCT02853578|Budesonide|budesonide|mesh-list
92831662|NCT02853578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831663|NCT02853578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92831664|NCT02853578|Autonomic Agents|autonomic agents|mesh-ancestor
92831665|NCT02853578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831666|NCT02853578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831667|NCT02853578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92831668|NCT02853578|Respiratory System Agents|respiratory system agents|mesh-ancestor
92831669|NCT02853578|Glucocorticoids|glucocorticoids|mesh-ancestor
92831670|NCT02853578|Hormones|hormones|mesh-ancestor
92831671|NCT02853578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831672|NCT02592694|Tenecteplase|tenecteplase|mesh-list
92831673|NCT02592694|Tirofiban|tirofiban|mesh-list
92831674|NCT02592694|Bivalirudin|bivalirudin|mesh-list
92831675|NCT02592694|Antithrombins|antithrombins|mesh-ancestor
92831676|NCT02592694|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92831677|NCT02592694|Protease Inhibitors|protease inhibitors|mesh-ancestor
92831678|NCT02592694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831679|NCT02592694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831680|NCT02592694|Anticoagulants|anticoagulants|mesh-ancestor
92831681|NCT02592694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92831682|NCT02592694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92831683|NCT02592694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92831684|NCT02591836|Atorvastatin|atorvastatin|mesh-list
92831685|NCT02591836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92831686|NCT02591836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831687|NCT02591836|Antimetabolites|antimetabolites|mesh-ancestor
92831688|NCT02591836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831689|NCT02591836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831690|NCT02591836|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92831691|NCT02591836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831692|NCT02851472|Nitric Oxide|nitric oxide|mesh-list
92831693|NCT02851472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92831694|NCT02851472|Autonomic Agents|autonomic agents|mesh-ancestor
92831695|NCT02851472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831696|NCT02851472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831697|NCT02851472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92831698|NCT02851472|Respiratory System Agents|respiratory system agents|mesh-ancestor
92831699|NCT02851472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92831700|NCT02851472|Antioxidants|antioxidants|mesh-ancestor
92831701|NCT02851472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831702|NCT02851472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831703|NCT02851472|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92831704|NCT02851472|Vasodilator Agents|vasodilator agents|mesh-ancestor
92831705|NCT02851472|Gasotransmitters|gasotransmitters|mesh-ancestor
92831706|NCT02851472|Protective Agents|protective agents|mesh-ancestor
92831707|NCT00687973|Atenolol|atenolol|mesh-list
92831708|NCT00687973|Amlodipine|amlodipine|mesh-list
92831709|NCT00687973|Valsartan|valsartan|mesh-list
92831710|NCT00687973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92831711|NCT00687973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92831712|NCT00687973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92831713|NCT00687973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831714|NCT00687973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92831715|NCT00687973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831716|NCT00687973|Vasodilator Agents|vasodilator agents|mesh-ancestor
92831717|NCT00687973|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92831718|NCT00687973|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92831719|NCT00687973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92831720|NCT00687973|Sympatholytics|sympatholytics|mesh-ancestor
92831721|NCT00687973|Autonomic Agents|autonomic agents|mesh-ancestor
92831722|NCT00687973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831723|NCT00687973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92831724|NCT00687973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92831725|NCT00687973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92831726|NCT00687973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92831727|NCT00687973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831728|NCT00747097|Gemcitabine|gemcitabine|mesh-list
92831729|NCT00747097|Cetuximab|cetuximab|mesh-list
92831730|NCT00747097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831731|NCT00747097|Antimetabolites|antimetabolites|mesh-ancestor
92831732|NCT00747097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831733|NCT00747097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831734|NCT00747097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831735|NCT00747331|Fenoldopam|fenoldopam|mesh-list
92831736|NCT00747331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92831737|NCT00747331|Vasodilator Agents|vasodilator agents|mesh-ancestor
92831738|NCT00747331|Dopamine Agonists|dopamine agonists|mesh-ancestor
92831739|NCT00747331|Dopamine Agents|dopamine agents|mesh-ancestor
92831740|NCT00747331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831741|NCT00747331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831742|NCT00747331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831743|NCT00747409|Insulin|insulin|mesh-list
92831744|NCT00747409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92831745|NCT00747409|Insulin Aspart|insulin aspart|mesh-list
92831746|NCT00747409|Insulin Detemir|insulin detemir|mesh-list
92831747|NCT00747409|Insulin, Long-Acting|insulin, long-acting|mesh-list
92831748|NCT00747409|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92831749|NCT00747409|Insulin, Isophane|insulin, isophane|mesh-list
92831750|NCT00747409|Isophane Insulin, Human|isophane insulin, human|mesh-list
92831751|NCT00747409|Isophane insulin, beef|isophane insulin, beef|mesh-list
92831752|NCT00747409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92831753|NCT00747409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831754|NCT00752011|Carboplatin|carboplatin|mesh-list
92831755|NCT00752011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831756|NCT00721396|Vaccines|vaccines|mesh-list
92977206|NCT00545103|Analgesics|analgesics|mesh-ancestor
92831757|NCT00721396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92831758|NCT00721396|Immunologic Factors|immunologic factors|mesh-ancestor
92831759|NCT00721396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831760|NCT00943826|Bevacizumab|bevacizumab|mesh-list
92831761|NCT00943826|Temozolomide|temozolomide|mesh-list
92831762|NCT00943826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831763|NCT00943826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831764|NCT00943826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92831765|NCT00943826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92831766|NCT00943826|Growth Substances|growth substances|mesh-ancestor
92831767|NCT00943826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831768|NCT00943826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92831769|NCT00943826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831770|NCT00943826|Alkylating Agents|alkylating agents|mesh-ancestor
92831771|NCT00943826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831772|NCT04268888|Nivolumab|nivolumab|mesh-list
92831773|NCT04268888|Chlorotrianisene|chlorotrianisene|mesh-list
92831774|NCT04268888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831775|NCT04268888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831776|NCT04268888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92831777|NCT04268888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831778|NCT04268888|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92831779|NCT04268888|Estrogens|estrogens|mesh-ancestor
92831780|NCT04268888|Hormones|hormones|mesh-ancestor
92831781|NCT04268888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831782|NCT04268888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831783|NCT04268888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831784|NCT00603356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92831785|NCT00603356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831786|NCT00603356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831787|NCT00603356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831788|NCT00603356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831789|NCT02851394|Tramadol|tramadol|mesh-list
92831790|NCT02851394|Levobupivacaine|levobupivacaine|mesh-list
92831791|NCT02851394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92831792|NCT02851394|Narcotics|narcotics|mesh-ancestor
92831793|NCT02851394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831794|NCT02851394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831795|NCT02851394|Analgesics|analgesics|mesh-ancestor
92831796|NCT02851394|Sensory System Agents|sensory system agents|mesh-ancestor
92831797|NCT02851394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831798|NCT02851394|Anesthetics, Local|anesthetics, local|mesh-ancestor
92831799|NCT02851394|Anesthetics|anesthetics|mesh-ancestor
92831800|NCT00603434|Methylphenidate|methylphenidate|mesh-list
92831801|NCT00603434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92831802|NCT00603434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831803|NCT00603434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92831804|NCT00603434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92831805|NCT00603434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92831806|NCT00603434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831807|NCT00603434|Dopamine Agents|dopamine agents|mesh-ancestor
92831808|NCT00603434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92831809|NCT01004003|Sorafenib|sorafenib|mesh-list
92831810|NCT01004003|Nintedanib|nintedanib|mesh-list
92831811|NCT01004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831812|NCT01004003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831813|NCT01004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831814|NCT01004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831815|NCT00943670|Trastuzumab|trastuzumab|mesh-list
92831816|NCT00943670|Pertuzumab|pertuzumab|mesh-list
92831817|NCT00943670|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92831818|NCT00943670|Maytansine|maytansine|mesh-list
92831819|NCT00943670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831820|NCT00943670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831821|NCT00943670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92831822|NCT00943670|Tubulin Modulators|tubulin modulators|mesh-ancestor
92831823|NCT00943670|Antimitotic Agents|antimitotic agents|mesh-ancestor
92831824|NCT00943670|Mitosis Modulators|mitosis modulators|mesh-ancestor
92831825|NCT00943670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831826|NCT00943670|Immunotoxins|immunotoxins|mesh-ancestor
92831827|NCT00943670|Immunoconjugates|immunoconjugates|mesh-ancestor
92831828|NCT00943670|Immunologic Factors|immunologic factors|mesh-ancestor
92831829|NCT00943670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831830|NCT02851004|Pembrolizumab|pembrolizumab|mesh-list
92831831|NCT02851004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831832|NCT02851004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831833|NCT02851004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92831834|NCT02851004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831835|NCT00938366|Cladribine|cladribine|mesh-list
92831836|NCT00938366|Pantoprazole|pantoprazole|mesh-list
92831837|NCT00938366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92831838|NCT00938366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92831839|NCT00938366|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92831840|NCT00938366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831841|NCT00938366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831842|NCT00938366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831843|NCT00938366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831844|NCT00938366|Immunologic Factors|immunologic factors|mesh-ancestor
92831845|NCT00938366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831846|NCT00943592|Melphalan|melphalan|mesh-list
92831847|NCT00943592|Alemtuzumab|alemtuzumab|mesh-list
92831848|NCT00943592|Clofarabine|clofarabine|mesh-list
92831849|NCT00943592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92831850|NCT00943592|Alkylating Agents|alkylating agents|mesh-ancestor
92831851|NCT00943592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831852|NCT00943592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831853|NCT00943592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92831854|NCT00943592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92831855|NCT00943592|Immunologic Factors|immunologic factors|mesh-ancestor
92831856|NCT00943592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831857|NCT00943592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92476901|NCT01872546|Adalimumab|adalimumab|mesh-list
92831858|NCT00943592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92831859|NCT00943592|Antimetabolites|antimetabolites|mesh-ancestor
92831860|NCT00943124|Niacin|niacin|mesh-list
92831861|NCT00943124|Niacinamide|niacinamide|mesh-list
92831862|NCT00943124|Nicotinic Acids|nicotinic acids|mesh-list
92831863|NCT00943124|Simvastatin|simvastatin|mesh-list
92831864|NCT00943124|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92831865|NCT00943124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92831866|NCT00943124|Antimetabolites|antimetabolites|mesh-ancestor
92831867|NCT00943124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831868|NCT00943124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92831869|NCT00943124|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92831870|NCT00943124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831871|NCT00943124|Vasodilator Agents|vasodilator agents|mesh-ancestor
92831872|NCT00943124|Vitamin B Complex|vitamin b complex|mesh-ancestor
92831873|NCT00943124|Vitamins|vitamins|mesh-ancestor
92831874|NCT00943124|Micronutrients|micronutrients|mesh-ancestor
92831875|NCT00943124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831876|NCT00492050|Valacyclovir|valacyclovir|mesh-list
92831877|NCT00492050|Rituximab|rituximab|mesh-list
92831878|NCT00492050|Bortezomib|bortezomib|mesh-list
92831879|NCT00492050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831880|NCT00492050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831881|NCT00492050|Immunologic Factors|immunologic factors|mesh-ancestor
92831882|NCT00492050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831883|NCT00492050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831884|NCT00492050|Antiviral Agents|antiviral agents|mesh-ancestor
92831885|NCT00492050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831886|NCT00940316|Irinotecan|irinotecan|mesh-list
92831887|NCT00940316|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92831888|NCT00940316|Panitumumab|panitumumab|mesh-list
92831889|NCT00940316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92831890|NCT00940316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92831891|NCT00940316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831892|NCT00940316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831893|NCT00940316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831894|NCT00940316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92831895|NCT00940316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92831896|NCT02850848|Entecavir|entecavir|mesh-list
92831897|NCT02850848|Antiviral Agents|antiviral agents|mesh-ancestor
92831898|NCT02850848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92831899|NCT05381168|Calcium, Dietary|calcium, dietary|mesh-list
92831900|NCT05381168|Calcium Carbonate|calcium carbonate|mesh-list
92831901|NCT05381168|Calcium|calcium|mesh-list
92831902|NCT05381168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92831903|NCT05381168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831904|NCT05381168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92831906|NCT05381168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831907|NCT05381168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92831908|NCT00726388|Diclofenac|diclofenac|mesh-list
92831909|NCT00726388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92831910|NCT00726388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92831911|NCT00726388|Analgesics|analgesics|mesh-ancestor
92831912|NCT00726388|Sensory System Agents|sensory system agents|mesh-ancestor
92831913|NCT00726388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831914|NCT00726388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831915|NCT00726388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831916|NCT00726388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92831917|NCT00726388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92831918|NCT00726388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733734|NCT01649258|Granisetron|granisetron|mesh-list
92831919|NCT00726388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831920|NCT00572455|Latanoprost|latanoprost|mesh-list
92831921|NCT00572455|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92831922|NCT00572455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92831923|NCT00752323|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92831924|NCT00752323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92831925|NCT00752323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92831926|NCT00686335|Prednisone|prednisone|mesh-list
92831927|NCT00686335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92831928|NCT00686335|Glucocorticoids|glucocorticoids|mesh-ancestor
92831929|NCT00686335|Hormones|hormones|mesh-ancestor
92831930|NCT00686335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831931|NCT00686335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831932|NCT00686335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831933|NCT00686335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831934|NCT00685945|Isosorbide|isosorbide|mesh-list
92831935|NCT00685945|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92831936|NCT00685945|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92831937|NCT00685945|Sildenafil Citrate|sildenafil citrate|mesh-list
92831939|NCT00685945|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92831940|NCT00685945|Kininogens|kininogens|mesh-list
92831941|NCT00685945|Vasodilator Agents|vasodilator agents|mesh-ancestor
92831942|NCT00685945|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92831943|NCT00685945|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92831944|NCT00685945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92831945|NCT00685945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831946|NCT00685945|Urological Agents|urological agents|mesh-ancestor
92831947|NCT00685945|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92831948|NCT00685945|Diuretics|diuretics|mesh-ancestor
92831949|NCT00685945|Natriuretic Agents|natriuretic agents|mesh-ancestor
92831950|NCT00685945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831951|NCT00685945|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92831952|NCT00685945|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92831953|NCT00685945|Protease Inhibitors|protease inhibitors|mesh-ancestor
92831954|NCT00747487|Idebenone|idebenone|mesh-list
92831955|NCT00747487|Antioxidants|antioxidants|mesh-ancestor
92831956|NCT00747487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831957|NCT00747487|Protective Agents|protective agents|mesh-ancestor
92831958|NCT00747487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831959|NCT00750217|Buprenorphine|buprenorphine|mesh-list
92831960|NCT00750217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92831961|NCT00750217|Narcotics|narcotics|mesh-ancestor
92831962|NCT00750217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831963|NCT00750217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831964|NCT00750217|Analgesics|analgesics|mesh-ancestor
92831965|NCT00750217|Sensory System Agents|sensory system agents|mesh-ancestor
92831966|NCT00750217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92831967|NCT00750217|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92831968|NCT00687739|Leuprolide|leuprolide|mesh-list
92831969|NCT00687739|Estradiol|estradiol|mesh-list
92831970|NCT00687739|Estrogens|estrogens|mesh-ancestor
92831971|NCT00687739|Hormones|hormones|mesh-ancestor
92831972|NCT00687739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92831973|NCT00687739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831974|NCT00687739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92831975|NCT00687739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92831976|NCT00687739|Fertility Agents|fertility agents|mesh-ancestor
92831977|NCT00687739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92831978|NCT00687739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92831979|NCT00752401|Vitamin D|vitamin d|mesh-list
92831980|NCT00752401|Cholecalciferol|cholecalciferol|mesh-list
92831981|NCT00752401|Vitamins|vitamins|mesh-ancestor
92831982|NCT00752401|Micronutrients|micronutrients|mesh-ancestor
92831983|NCT00752401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92831984|NCT00752401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92831985|NCT00752401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92831986|NCT00750451|Heparin|heparin|mesh-list
92831987|NCT00750451|Enoxaparin|enoxaparin|mesh-list
92831988|NCT00750451|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92831989|NCT00750451|Tinzaparin|tinzaparin|mesh-list
92831990|NCT00750451|Dalteparin|dalteparin|mesh-list
92831991|NCT00750451|Enoxaparin sodium|enoxaparin sodium|mesh-list
92831992|NCT00750451|Anticoagulants|anticoagulants|mesh-ancestor
92831993|NCT00750451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92831994|NCT00750451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92831995|NCT00750451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92831996|NCT00747721|Dexmedetomidine|dexmedetomidine|mesh-list
92831997|NCT00747721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92831998|NCT00747721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92831999|NCT00747721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832000|NCT00747721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832001|NCT00747721|Analgesics|analgesics|mesh-ancestor
92832002|NCT00747721|Sensory System Agents|sensory system agents|mesh-ancestor
92832003|NCT00747721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832004|NCT00747721|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92832005|NCT00747721|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92832006|NCT00747721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92832007|NCT00747721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92832008|NCT00747721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832009|NCT00747721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832010|NCT01006889|Exenatide|exenatide|mesh-list
92477036|NCT01873027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832011|NCT01006889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832012|NCT01006889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832013|NCT01006889|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92832014|NCT01006889|Incretins|incretins|mesh-ancestor
92832015|NCT01006889|Hormones|hormones|mesh-ancestor
92832016|NCT01006889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832017|NCT02561767|Mycophenolic Acid|mycophenolic acid|mesh-list
92832018|NCT02561767|Tacrolimus|tacrolimus|mesh-list
92832019|NCT02561767|Basiliximab|basiliximab|mesh-list
92832020|NCT02561767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832021|NCT02561767|Immunologic Factors|immunologic factors|mesh-ancestor
92832022|NCT02561767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832023|NCT02561767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92832024|NCT02561767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832025|NCT02561767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832026|NCT02561767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92832027|NCT02561767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832028|NCT02561767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92832029|NCT02561767|Antitubercular Agents|antitubercular agents|mesh-ancestor
92832030|NCT02561767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832031|NCT02561767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832032|NCT00747799|Fluorouracil|fluorouracil|mesh-list
92832033|NCT00747799|Sorafenib|sorafenib|mesh-list
92832034|NCT00747799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832035|NCT00747799|Antimetabolites|antimetabolites|mesh-ancestor
92832036|NCT00747799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832037|NCT00747799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92832038|NCT00747799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832039|NCT00747799|Immunologic Factors|immunologic factors|mesh-ancestor
92832040|NCT00747799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832041|NCT00747799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92832042|NCT00747799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832043|NCT04294823|Esomeprazole|esomeprazole|mesh-list
92832044|NCT04294823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92832045|NCT04294823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832046|NCT04294823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92832047|NCT04294823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832048|NCT04294823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832049|NCT04294511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92832050|NCT04294511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832051|NCT04294511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832052|NCT04294511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832053|NCT01001429|Dexmedetomidine|dexmedetomidine|mesh-list
92832054|NCT01001429|Propofol|propofol|mesh-list
92832055|NCT01001429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92832056|NCT01001429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832057|NCT01001429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832058|NCT01001429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832059|NCT01001429|Analgesics|analgesics|mesh-ancestor
92832060|NCT01001429|Sensory System Agents|sensory system agents|mesh-ancestor
92832061|NCT01001429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832062|NCT01001429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92832063|NCT01001429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92832064|NCT01001429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92832065|NCT01001429|Adrenergic Agents|adrenergic agents|mesh-ancestor
92832066|NCT01001429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832067|NCT01001429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832068|NCT01001429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92832069|NCT01001429|Anesthetics, General|anesthetics, general|mesh-ancestor
92832070|NCT01001429|Anesthetics|anesthetics|mesh-ancestor
92832071|NCT01000961|Cysteamine|cysteamine|mesh-list
92832072|NCT01000961|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92832073|NCT01000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832074|NCT01000805|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92832075|NCT01000805|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92832076|NCT01000805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92832077|NCT01000805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92832078|NCT01000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832079|NCT01000805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832080|NCT01000805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832081|NCT01000805|Analgesics|analgesics|mesh-ancestor
92832082|NCT01000805|Sensory System Agents|sensory system agents|mesh-ancestor
92832083|NCT01000805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832084|NCT01000805|Antidepressive Agents|antidepressive agents|mesh-ancestor
92832085|NCT01000805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92832086|NCT01000805|Dopamine Agents|dopamine agents|mesh-ancestor
92832087|NCT00684307|Vitamin K|vitamin k|mesh-list
92832088|NCT00684307|Warfarin|warfarin|mesh-list
92832089|NCT00684307|Vitamins|vitamins|mesh-ancestor
92832090|NCT00684307|Micronutrients|micronutrients|mesh-ancestor
92832091|NCT00684307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832092|NCT00684307|Anticoagulants|anticoagulants|mesh-ancestor
92832093|NCT00684307|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92832094|NCT00684307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92832095|NCT00684307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832096|NCT00684307|Hemostatics|hemostatics|mesh-ancestor
92832097|NCT00684307|Coagulants|coagulants|mesh-ancestor
92832098|NCT00683917|Leuprolide|leuprolide|mesh-list
92832099|NCT00683917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92832100|NCT00683917|Fertility Agents|fertility agents|mesh-ancestor
92832101|NCT00683917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92832102|NCT00683917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832103|NCT00683917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92832104|NCT00683917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832105|NCT00750529|Donepezil|donepezil|mesh-list
92832106|NCT00750529|Galantamine|galantamine|mesh-list
92832107|NCT00750529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92832108|NCT00750529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832109|NCT00750529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832110|NCT00750529|Cholinergic Agents|cholinergic agents|mesh-ancestor
92832111|NCT00750529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832112|NCT00750529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832113|NCT00750529|Nootropic Agents|nootropic agents|mesh-ancestor
92832114|NCT00750529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92832115|NCT00750529|Autonomic Agents|autonomic agents|mesh-ancestor
92832116|NCT00750529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832117|NCT00747877|Cyclophosphamide|cyclophosphamide|mesh-list
92832118|NCT00747877|Melphalan|melphalan|mesh-list
92832119|NCT00747877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832120|NCT00747877|Immunologic Factors|immunologic factors|mesh-ancestor
92832121|NCT00747877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832122|NCT00747877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832123|NCT00747877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92832124|NCT00747877|Alkylating Agents|alkylating agents|mesh-ancestor
92832125|NCT00747877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832126|NCT00747877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832127|NCT00747877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92832128|NCT00750763|Picosulfate sodium|picosulfate sodium|mesh-list
92832129|NCT00750763|Cathartics|cathartics|mesh-ancestor
92832130|NCT00750763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832131|NCT00752479|Cyclosporine|cyclosporine|mesh-list
92832132|NCT00752479|Mycophenolic Acid|mycophenolic acid|mesh-list
92832133|NCT00752479|Methylprednisolone|methylprednisolone|mesh-list
92832134|NCT00752479|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92832135|NCT00752479|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92832136|NCT00752479|Prednisolone|prednisolone|mesh-list
92832137|NCT00752479|Prednisolone acetate|prednisolone acetate|mesh-list
92832138|NCT00752479|Cyclosporins|cyclosporins|mesh-list
92832139|NCT00752479|Basiliximab|basiliximab|mesh-list
92832140|NCT00752479|Thymoglobulin|thymoglobulin|mesh-list
92832141|NCT00752479|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92832142|NCT00752479|Prednisolone phosphate|prednisolone phosphate|mesh-list
92832143|NCT00752479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832144|NCT00752479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832145|NCT00752479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832146|NCT00752479|Immunologic Factors|immunologic factors|mesh-ancestor
92832147|NCT00752479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832148|NCT00752479|Antifungal Agents|antifungal agents|mesh-ancestor
92832149|NCT00752479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832150|NCT00752479|Dermatologic Agents|dermatologic agents|mesh-ancestor
92832151|NCT00752479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832152|NCT00752479|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92832153|NCT00752479|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92832154|NCT00752479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832155|NCT00752479|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92832156|NCT00752479|Antitubercular Agents|antitubercular agents|mesh-ancestor
92832157|NCT00752479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832158|NCT00752479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832159|NCT00752479|Antiemetics|antiemetics|mesh-ancestor
92832160|NCT00752479|Autonomic Agents|autonomic agents|mesh-ancestor
92832161|NCT00752479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832162|NCT00752479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832163|NCT00752479|Glucocorticoids|glucocorticoids|mesh-ancestor
92832165|NCT00752479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832166|NCT00752479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92832167|NCT00752479|Protective Agents|protective agents|mesh-ancestor
92832168|NCT00752479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92832169|NCT00752635|Moxifloxacin|moxifloxacin|mesh-list
92832170|NCT00752635|Cyproterone Acetate|cyproterone acetate|mesh-list
92832171|NCT00752635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92832172|NCT00752635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92832173|NCT00752635|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92832174|NCT00752635|Norgestimate|norgestimate|mesh-list
92832175|NCT00752635|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92832176|NCT00752635|Estradiol|estradiol|mesh-list
92832177|NCT00752635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92832178|NCT00752635|Cyproterone|cyproterone|mesh-list
92832179|NCT00752635|Estrogens|estrogens|mesh-ancestor
92832180|NCT00752635|Hormones|hormones|mesh-ancestor
92832181|NCT00752635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832182|NCT00752635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832183|NCT00752635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92832184|NCT00752635|Contraceptive Agents|contraceptive agents|mesh-ancestor
92832185|NCT00752635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92832186|NCT00752635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92832187|NCT00752635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92832188|NCT00752635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92832189|NCT00752635|Androgen Antagonists|androgen antagonists|mesh-ancestor
92832190|NCT00752635|Hormone Antagonists|hormone antagonists|mesh-ancestor
92832191|NCT00752635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832192|NCT00752635|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92832193|NCT00752635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92832194|NCT00752635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832195|NCT00752635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832196|NCT00752635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92832197|NCT00752635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92832198|NCT00752635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832199|NCT00752635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832200|NCT00752635|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92832201|NCT00750997|Dextrans|dextrans|mesh-list
92832202|NCT00750997|Anticoagulants|anticoagulants|mesh-ancestor
92832203|NCT00750997|Plasma Substitutes|plasma substitutes|mesh-ancestor
92832204|NCT00750997|Blood Substitutes|blood substitutes|mesh-ancestor
92832205|NCT00748345|Caspofungin|caspofungin|mesh-list
92832206|NCT00748345|Antifungal Agents|antifungal agents|mesh-ancestor
92832207|NCT00748345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832208|NCT00748345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832209|NCT00748345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832210|NCT00752869|Dutasteride|dutasteride|mesh-list
92832211|NCT00752869|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92832212|NCT00752869|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92832213|NCT00752869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832214|NCT00752869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832215|NCT00752869|Hormone Antagonists|hormone antagonists|mesh-ancestor
92832216|NCT00752869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832217|NCT00752869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832218|NCT00751153|Raltegravir Potassium|raltegravir potassium|mesh-list
92832219|NCT00751153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92832220|NCT00751153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92832221|NCT00751153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92832222|NCT00751153|Antiviral Agents|antiviral agents|mesh-ancestor
92832223|NCT00751153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832224|NCT00751153|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92832225|NCT00751153|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92832226|NCT00751153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832227|NCT00751153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832228|NCT00751153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92832229|NCT00751153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92832230|NCT00751153|Protease Inhibitors|protease inhibitors|mesh-ancestor
92832231|NCT00748423|Nitric Oxide|nitric oxide|mesh-list
92832232|NCT00748423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92832233|NCT00748423|Autonomic Agents|autonomic agents|mesh-ancestor
92832234|NCT00748423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832235|NCT00748423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832236|NCT00748423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92832237|NCT00748423|Respiratory System Agents|respiratory system agents|mesh-ancestor
92832238|NCT00748423|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92832239|NCT00748423|Antioxidants|antioxidants|mesh-ancestor
92832240|NCT00748423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832241|NCT00748423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832242|NCT00748423|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92832243|NCT00748423|Vasodilator Agents|vasodilator agents|mesh-ancestor
92832244|NCT00748423|Gasotransmitters|gasotransmitters|mesh-ancestor
92832245|NCT00748423|Protective Agents|protective agents|mesh-ancestor
92832246|NCT00687271|Atorvastatin|atorvastatin|mesh-list
92832247|NCT00687271|Calcium|calcium|mesh-list
92832248|NCT00687271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92832249|NCT00687271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832250|NCT00687271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92832251|NCT00687271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92832252|NCT00687271|Antimetabolites|antimetabolites|mesh-ancestor
92832253|NCT00687271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832254|NCT00687271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92832255|NCT00687271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92832256|NCT00687271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832257|NCT02562625|Pembrolizumab|pembrolizumab|mesh-list
92832258|NCT02562625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832259|NCT02562625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832260|NCT02562625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92832261|NCT02562625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832262|NCT00752947|Moxifloxacin|moxifloxacin|mesh-list
92832263|NCT00752947|Metronidazole|metronidazole|mesh-list
92832264|NCT00752947|Levofloxacin|levofloxacin|mesh-list
92832265|NCT00752947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832266|NCT00752947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832267|NCT00752947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92832268|NCT00752947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92832269|NCT00752947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832270|NCT00752947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832271|NCT00752947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832272|NCT00752947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92832273|NCT00752947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92832274|NCT00752947|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92832275|NCT00752947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92832276|NCT00752947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92832277|NCT04614545|Phentermine|phentermine|mesh-list
92832278|NCT04614545|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92832279|NCT04614545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832281|NCT04614545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92832282|NCT04614545|Sympathomimetics|sympathomimetics|mesh-ancestor
92832283|NCT04614545|Autonomic Agents|autonomic agents|mesh-ancestor
92734092|NCT01688960|Aflibercept|aflibercept|mesh-list
92832284|NCT04614545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832285|NCT04614545|Adrenergic Agents|adrenergic agents|mesh-ancestor
92832286|NCT04614545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832287|NCT04614545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832288|NCT01031381|Bevacizumab|bevacizumab|mesh-list
92832289|NCT01031381|Everolimus|everolimus|mesh-list
92832290|NCT01031381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832291|NCT01031381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832292|NCT01031381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92832293|NCT01031381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92832294|NCT01031381|Growth Substances|growth substances|mesh-ancestor
92832295|NCT01031381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832296|NCT01031381|Growth Inhibitors|growth inhibitors|mesh-ancestor
92832297|NCT01031381|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92832298|NCT01031381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92832299|NCT01031381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832300|NCT01031381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832301|NCT01031381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832302|NCT01031381|Immunologic Factors|immunologic factors|mesh-ancestor
92832303|NCT00685399|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92832304|NCT00685399|Immunologic Factors|immunologic factors|mesh-ancestor
92832305|NCT00685399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832306|NCT00751699|Mesalamine|mesalamine|mesh-list
92832307|NCT00751699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92477334|NCT05694260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832308|NCT00751699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832309|NCT00751699|Analgesics|analgesics|mesh-ancestor
92832310|NCT00751699|Sensory System Agents|sensory system agents|mesh-ancestor
92832311|NCT00751699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832312|NCT00751699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832313|NCT00751699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832314|NCT00751699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832315|NCT00753103|Mycophenolic Acid|mycophenolic acid|mesh-list
92832316|NCT00753103|Methylprednisolone|methylprednisolone|mesh-list
92832317|NCT00753103|Prednisolone|prednisolone|mesh-list
92832318|NCT00753103|Infliximab|infliximab|mesh-list
92832319|NCT00753103|Cyclophosphamide|cyclophosphamide|mesh-list
92832320|NCT00753103|Azathioprine|azathioprine|mesh-list
92832321|NCT00753103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832322|NCT00753103|Immunologic Factors|immunologic factors|mesh-ancestor
92832323|NCT00753103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832324|NCT00753103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832325|NCT00753103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92832326|NCT00753103|Alkylating Agents|alkylating agents|mesh-ancestor
92832327|NCT00753103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832328|NCT00753103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832329|NCT00753103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92832330|NCT00753103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92832331|NCT00753103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92832332|NCT00753103|Antitubercular Agents|antitubercular agents|mesh-ancestor
92832333|NCT00753103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832334|NCT00753103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832335|NCT00753103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832336|NCT00753103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832337|NCT00753103|Antiemetics|antiemetics|mesh-ancestor
92832338|NCT00753103|Autonomic Agents|autonomic agents|mesh-ancestor
92832339|NCT00753103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832340|NCT00753103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832341|NCT00753103|Glucocorticoids|glucocorticoids|mesh-ancestor
92832342|NCT00753103|Hormones|hormones|mesh-ancestor
92832343|NCT00753103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832344|NCT00753103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92832345|NCT00753103|Protective Agents|protective agents|mesh-ancestor
92832346|NCT00753103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92832347|NCT00753103|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92832348|NCT00753103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92832349|NCT00753103|Antimetabolites|antimetabolites|mesh-ancestor
92832350|NCT00753103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92832351|NCT00748891|Cediranib|cediranib|mesh-list
92832352|NCT00748891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832353|NCT00748891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92734160|NCT01687127|Calcium|calcium|mesh-list
92832355|NCT00748891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832356|NCT00685165|Primidone|primidone|mesh-list
92832357|NCT00685165|Anticonvulsants|anticonvulsants|mesh-ancestor
92832358|NCT00685165|GABA Modulators|gaba modulators|mesh-ancestor
92832359|NCT00685165|GABA Agents|gaba agents|mesh-ancestor
92832360|NCT00685165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832361|NCT00685165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832362|NCT00685165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832363|NCT00749047|Pioglitazone|pioglitazone|mesh-list
92832364|NCT00749047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832365|NCT00749047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832366|NCT05393713|Antibodies|antibodies|mesh-list
92832367|NCT05393713|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92832368|NCT05393713|Immunologic Factors|immunologic factors|mesh-ancestor
92832369|NCT05393713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832370|NCT00751855|Hydrocortisone|hydrocortisone|mesh-list
92832371|NCT00751855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832372|NCT00755833|Insulin Aspart|insulin aspart|mesh-list
92832373|NCT00755833|Biphasic Insulins|biphasic insulins|mesh-list
92832374|NCT00755833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832375|NCT00755833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832376|NCT00753493|Topiramate|topiramate|mesh-list
92832377|NCT00753493|Anticonvulsants|anticonvulsants|mesh-ancestor
92832378|NCT00753493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832379|NCT00753493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832380|NCT00753571|Cardiac Glycosides|cardiac glycosides|mesh-list
92832381|NCT00753571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92832382|NCT00753571|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92832383|NCT00753571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832384|NCT00753571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832385|NCT00753571|Protective Agents|protective agents|mesh-ancestor
92832386|NCT00753571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832387|NCT00753727|Sunitinib|sunitinib|mesh-list
92832388|NCT00753727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832389|NCT00753727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92832390|NCT00753727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92832391|NCT00753727|Growth Substances|growth substances|mesh-ancestor
92832392|NCT00753727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832393|NCT00753727|Growth Inhibitors|growth inhibitors|mesh-ancestor
92832394|NCT00753727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92832395|NCT00753727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832396|NCT00753727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832397|NCT00755989|Morphine|morphine|mesh-list
92832398|NCT00755989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92832399|NCT00755989|Narcotics|narcotics|mesh-ancestor
92832400|NCT00755989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832401|NCT00755989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832402|NCT00755989|Analgesics|analgesics|mesh-ancestor
92832403|NCT00755989|Sensory System Agents|sensory system agents|mesh-ancestor
92832404|NCT00755989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832405|NCT00756067|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92832406|NCT00756067|Immunologic Factors|immunologic factors|mesh-ancestor
92832407|NCT00756067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832408|NCT05388877|Dabrafenib|dabrafenib|mesh-list
92832409|NCT05388877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832410|NCT05388877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92832411|NCT05388877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832412|NCT05388877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832413|NCT04053205|Paclitaxel|paclitaxel|mesh-list
92832414|NCT04053205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92832415|NCT04053205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832416|NCT04053205|Tubulin Modulators|tubulin modulators|mesh-ancestor
92832417|NCT04053205|Antimitotic Agents|antimitotic agents|mesh-ancestor
92832418|NCT04053205|Mitosis Modulators|mitosis modulators|mesh-ancestor
92832419|NCT04053205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832420|NCT02559973|Buprenorphine|buprenorphine|mesh-list
92832421|NCT02559973|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92832422|NCT02559973|Naloxone|naloxone|mesh-list
92832423|NCT02559973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92832424|NCT02559973|Narcotics|narcotics|mesh-ancestor
92832425|NCT02559973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832426|NCT02559973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832428|NCT02559973|Sensory System Agents|sensory system agents|mesh-ancestor
92832429|NCT02559973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832430|NCT02559973|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92832431|NCT00753883|Simvastatin|simvastatin|mesh-list
92832432|NCT00753883|Ezetimibe|ezetimibe|mesh-list
92832433|NCT00753883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92832434|NCT00753883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92832435|NCT00753883|Antimetabolites|antimetabolites|mesh-ancestor
92832436|NCT00753883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832437|NCT00753883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92832438|NCT00753883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92832439|NCT00753883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832440|NCT00720382|Mometasone Furoate|mometasone furoate|mesh-list
92832441|NCT00720382|Azelastine|azelastine|mesh-list
92832442|NCT00720382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832443|NCT00720382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92832444|NCT00720382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92832445|NCT00720382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92832446|NCT00720382|Autonomic Agents|autonomic agents|mesh-ancestor
92832447|NCT00720382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832448|NCT00720382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832449|NCT00720382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92832450|NCT00720382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92832451|NCT00720382|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92832452|NCT00720382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832453|NCT00720382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832454|NCT00720382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92832455|NCT00720382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92832456|NCT00720382|Histamine Antagonists|histamine antagonists|mesh-ancestor
92832457|NCT00720382|Histamine Agents|histamine agents|mesh-ancestor
92832458|NCT00720382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832459|NCT00754039|Fenofibrate|fenofibrate|mesh-list
92832460|NCT00754039|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92832461|NCT00754039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92832462|NCT00754039|Antimetabolites|antimetabolites|mesh-ancestor
92832463|NCT00754039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832464|NCT00754039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92832465|NCT00754039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92832466|NCT02560909|Vaccines|vaccines|mesh-list
92832467|NCT02560909|Immunologic Factors|immunologic factors|mesh-ancestor
92832468|NCT02560909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832469|NCT02592226|Anesthetics|anesthetics|mesh-list
92832470|NCT02592226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832471|NCT02592226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832472|NCT00756301|Lidocaine|lidocaine|mesh-list
92832473|NCT00756301|Anesthetics, Local|anesthetics, local|mesh-ancestor
92832474|NCT00756301|Anesthetics|anesthetics|mesh-ancestor
92832475|NCT00756301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832476|NCT00756301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832477|NCT00756301|Sensory System Agents|sensory system agents|mesh-ancestor
92832478|NCT00756301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832479|NCT00756301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92832480|NCT00756301|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92832481|NCT00756301|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92832482|NCT00756301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92832483|NCT00756301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832484|NCT00756691|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92832485|NCT00756691|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92832486|NCT00756691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832487|NCT00720226|Losartan|losartan|mesh-list
92832488|NCT00720226|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92832489|NCT00720226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92832490|NCT00720226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92832491|NCT00720226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92832492|NCT00720226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832493|NCT00725920|Topiramate|topiramate|mesh-list
92832494|NCT00725920|Anticonvulsants|anticonvulsants|mesh-ancestor
92832495|NCT00725920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832496|NCT00725920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832497|NCT00725842|Ribavirin|ribavirin|mesh-list
92832498|NCT00725842|Interferon alpha-2|interferon alpha-2|mesh-list
92832499|NCT00725842|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92177547|NCT01895621|Thioctic Acid|thioctic acid|mesh-list
92832500|NCT00725842|Antimetabolites|antimetabolites|mesh-ancestor
92832501|NCT00725842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832502|NCT00725842|Antiviral Agents|antiviral agents|mesh-ancestor
92832503|NCT00725842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832504|NCT00725842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832505|NCT04051723|Dexamethasone|dexamethasone|mesh-list
92832506|NCT04051723|Ropivacaine|ropivacaine|mesh-list
92832507|NCT04051723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832508|NCT04051723|Antiemetics|antiemetics|mesh-ancestor
92832509|NCT04051723|Autonomic Agents|autonomic agents|mesh-ancestor
92832510|NCT04051723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832511|NCT04051723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832512|NCT04051723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832513|NCT04051723|Glucocorticoids|glucocorticoids|mesh-ancestor
92832514|NCT04051723|Hormones|hormones|mesh-ancestor
92832515|NCT04051723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832516|NCT04051723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92832517|NCT04051723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832518|NCT04051723|Anesthetics, Local|anesthetics, local|mesh-ancestor
92832519|NCT04051723|Anesthetics|anesthetics|mesh-ancestor
92832520|NCT04051723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832521|NCT04051723|Sensory System Agents|sensory system agents|mesh-ancestor
92832522|NCT00918424|Oxcarbazepine|oxcarbazepine|mesh-list
92832523|NCT00918424|Anticonvulsants|anticonvulsants|mesh-ancestor
92832524|NCT00918424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92832525|NCT00918424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92832526|NCT00918424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92832527|NCT00918424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832528|NCT00918424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92832529|NCT00918424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92832530|NCT00756847|Paclitaxel|paclitaxel|mesh-list
92832531|NCT00756847|Carboplatin|carboplatin|mesh-list
92832532|NCT00756847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92477568|NCT05302999|Gabapentin|gabapentin|mesh-list
92832533|NCT00756847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832534|NCT00756847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92832535|NCT00756847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92832536|NCT00756847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92832537|NCT00756847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832538|NCT04051567|Aspirin|aspirin|mesh-list
92832539|NCT04051567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92832540|NCT04051567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832541|NCT04051567|Analgesics|analgesics|mesh-ancestor
92832542|NCT04051567|Sensory System Agents|sensory system agents|mesh-ancestor
92832543|NCT04051567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832544|NCT04051567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832545|NCT04051567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832546|NCT04051567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832547|NCT04051567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92832548|NCT04051567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92832549|NCT04051567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832550|NCT04051567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92832551|NCT04051567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92832552|NCT04051567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832553|NCT04051567|Antipyretics|antipyretics|mesh-ancestor
92832554|NCT00757081|Deoxycholic Acid|deoxycholic acid|mesh-list
92832555|NCT00757081|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92832556|NCT00757081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832557|NCT00757315|Triamcinolone|triamcinolone|mesh-list
92832558|NCT00757315|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92832559|NCT00757315|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92832560|NCT00757315|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92832561|NCT00757315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832562|NCT00757315|Glucocorticoids|glucocorticoids|mesh-ancestor
92832563|NCT00757315|Hormones|hormones|mesh-ancestor
92832564|NCT00757315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832565|NCT00757315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832566|NCT00757315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832567|NCT00757315|Immunologic Factors|immunologic factors|mesh-ancestor
92832568|NCT00757315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832569|NCT00757315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832570|NCT00757393|Calcium, Dietary|calcium, dietary|mesh-list
92832571|NCT00757393|Vitamin D|vitamin d|mesh-list
92832572|NCT00757393|Ergocalciferols|ergocalciferols|mesh-list
92832573|NCT00757393|Cholecalciferol|cholecalciferol|mesh-list
92832574|NCT00757393|Vitamins|vitamins|mesh-list
92832575|NCT00757393|Calcium|calcium|mesh-list
92832576|NCT00757393|Micronutrients|micronutrients|mesh-ancestor
92832577|NCT00757393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832578|NCT00757393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92832579|NCT00757393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92832580|NCT00754351|Bevacizumab|bevacizumab|mesh-list
92832581|NCT00754351|Gemcitabine|gemcitabine|mesh-list
92832582|NCT00754351|Docetaxel|docetaxel|mesh-list
92832583|NCT00754351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832584|NCT00754351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832585|NCT00754351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92832586|NCT00754351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92832587|NCT00754351|Growth Substances|growth substances|mesh-ancestor
92832588|NCT00754351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832589|NCT00754351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92832590|NCT00754351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92832591|NCT00754351|Antimetabolites|antimetabolites|mesh-ancestor
92832592|NCT00754351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832593|NCT00754351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92832594|NCT00754351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92832595|NCT00754351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92832596|NCT00754429|Losartan|losartan|mesh-list
92832597|NCT00754429|Amlodipine|amlodipine|mesh-list
92832598|NCT00754429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92832599|NCT00754429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92832600|NCT00754429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92832601|NCT00754429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832602|NCT00754429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92832603|NCT00754429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832604|NCT00754429|Vasodilator Agents|vasodilator agents|mesh-ancestor
92832605|NCT00754429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92832606|NCT00754429|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92832607|NCT00754429|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92832608|NCT00754507|Atorvastatin|atorvastatin|mesh-list
92832609|NCT00754507|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92832610|NCT00754507|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92832611|NCT00754507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92832612|NCT00754507|Antimetabolites|antimetabolites|mesh-ancestor
92832613|NCT00754507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832614|NCT00754507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92832615|NCT00754507|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92832616|NCT00754507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832617|NCT00725608|Buprenorphine|buprenorphine|mesh-list
92832618|NCT00725608|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92832619|NCT00725608|Naloxone|naloxone|mesh-list
92832620|NCT00725608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92832621|NCT00725608|Narcotics|narcotics|mesh-ancestor
92832622|NCT00725608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832623|NCT00725608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832624|NCT00725608|Analgesics|analgesics|mesh-ancestor
92832625|NCT00725608|Sensory System Agents|sensory system agents|mesh-ancestor
92832626|NCT00725608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832627|NCT00725608|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92832628|NCT00725452|Infliximab|infliximab|mesh-list
92832629|NCT00725452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92832630|NCT00725452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832631|NCT00725452|Dermatologic Agents|dermatologic agents|mesh-ancestor
92832632|NCT00725452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832633|NCT00725452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832634|NCT00725296|Infliximab|infliximab|mesh-list
92832635|NCT00725296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92832636|NCT00725296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832637|NCT00725296|Dermatologic Agents|dermatologic agents|mesh-ancestor
92832638|NCT00725296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832639|NCT00725296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832640|NCT00585052|Paclitaxel|paclitaxel|mesh-list
92832641|NCT00585052|Lovastatin|lovastatin|mesh-list
92832642|NCT00585052|L 647318|l 647318|mesh-list
92832643|NCT00585052|Dihydromevinolin|dihydromevinolin|mesh-list
92832644|NCT00585052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92832645|NCT00585052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832646|NCT00585052|Tubulin Modulators|tubulin modulators|mesh-ancestor
92832647|NCT00585052|Antimitotic Agents|antimitotic agents|mesh-ancestor
92832648|NCT00585052|Mitosis Modulators|mitosis modulators|mesh-ancestor
92832649|NCT00585052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832650|NCT00585052|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92832651|NCT00585052|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92832653|NCT00585052|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92832654|NCT00585052|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92832655|NCT00585052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832656|NCT00724282|Eszopiclone|eszopiclone|mesh-list
92832657|NCT00724282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92832658|NCT00724282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832659|NCT00724282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832660|NCT04086238|Decitabine|decitabine|mesh-list
92832661|NCT04086238|Tetrahydrouridine|tetrahydrouridine|mesh-list
92832662|NCT04086238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92832663|NCT04086238|Antimetabolites|antimetabolites|mesh-ancestor
92832664|NCT04086238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832665|NCT04086238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832666|NCT04086238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832667|NCT00724126|Rifaximin|rifaximin|mesh-list
92832668|NCT00724126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832669|NCT00724126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832670|NCT00724126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832671|NCT00723892|Ribavirin|ribavirin|mesh-list
92832672|NCT00723892|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92832673|NCT00723892|Interferon-alpha|interferon-alpha|mesh-list
92832674|NCT00723892|Antimetabolites|antimetabolites|mesh-ancestor
92832675|NCT00723892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832676|NCT00723892|Antiviral Agents|antiviral agents|mesh-ancestor
92832677|NCT00723892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832678|NCT00723892|Immunologic Factors|immunologic factors|mesh-ancestor
92832679|NCT00723892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832680|NCT04086940|Esmolol|esmolol|mesh-list
92832681|NCT04086940|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92832682|NCT04086940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92832683|NCT04086940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92832684|NCT04086940|Adrenergic Agents|adrenergic agents|mesh-ancestor
92832685|NCT04086940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832686|NCT04086940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832687|NCT04086940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832688|NCT02590900|Acetaminophen|acetaminophen|mesh-list
92832689|NCT02590900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832690|NCT02590900|Analgesics|analgesics|mesh-ancestor
92832691|NCT02590900|Sensory System Agents|sensory system agents|mesh-ancestor
92832692|NCT02590900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832693|NCT02590900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832694|NCT02590900|Antipyretics|antipyretics|mesh-ancestor
92832695|NCT02591914|Bevacizumab|bevacizumab|mesh-list
92832696|NCT02591914|Ranibizumab|ranibizumab|mesh-list
92832697|NCT02591914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832698|NCT02591914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832699|NCT02591914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92832700|NCT02591914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92832701|NCT02591914|Growth Substances|growth substances|mesh-ancestor
92832702|NCT02591914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832703|NCT02591914|Growth Inhibitors|growth inhibitors|mesh-ancestor
92832704|NCT00723190|Clonidine|clonidine|mesh-list
92832705|NCT00723190|Analgesics|analgesics|mesh-ancestor
92832706|NCT00723190|Sensory System Agents|sensory system agents|mesh-ancestor
92832707|NCT00723190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832708|NCT00723190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832709|NCT00723190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92832710|NCT00723190|Sympatholytics|sympatholytics|mesh-ancestor
92832711|NCT00723190|Autonomic Agents|autonomic agents|mesh-ancestor
92832712|NCT00723190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92832713|NCT00723190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92832714|NCT00723190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92832715|NCT00723190|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734516|NCT01332630|Ranitidine|ranitidine|mesh-list
92832716|NCT00723190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832717|NCT00723190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832718|NCT00722800|Drospirenone|drospirenone|mesh-list
92832719|NCT00722800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92832720|NCT00722800|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92832721|NCT00722800|Estradiol|estradiol|mesh-list
92832722|NCT00722800|Estrogens|estrogens|mesh-ancestor
92832723|NCT00722800|Hormones|hormones|mesh-ancestor
92832724|NCT00722800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832725|NCT00722800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832726|NCT00722800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92832727|NCT00722800|Contraceptive Agents|contraceptive agents|mesh-ancestor
92832728|NCT00722800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92832729|NCT00722800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92832730|NCT00722800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92832731|NCT00722800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92832732|NCT00722800|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92832733|NCT00722800|Hormone Antagonists|hormone antagonists|mesh-ancestor
92832734|NCT00722800|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92832735|NCT00722800|Diuretics|diuretics|mesh-ancestor
92832736|NCT00722800|Natriuretic Agents|natriuretic agents|mesh-ancestor
92832737|NCT00741598|Galantamine|galantamine|mesh-list
92832738|NCT00741598|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92832739|NCT00741598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832740|NCT00741598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832741|NCT00741598|Cholinergic Agents|cholinergic agents|mesh-ancestor
92832742|NCT00741598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832743|NCT00741598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832744|NCT00741598|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92832745|NCT00741598|Autonomic Agents|autonomic agents|mesh-ancestor
92832746|NCT00741598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832747|NCT00741598|Nootropic Agents|nootropic agents|mesh-ancestor
92832748|NCT03947632|Chrysarobin|chrysarobin|mesh-list
92832749|NCT03947632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92832750|NCT03947632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832751|NCT03947632|Analgesics|analgesics|mesh-ancestor
92832752|NCT03947632|Sensory System Agents|sensory system agents|mesh-ancestor
92832753|NCT03947632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832754|NCT03947632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832755|NCT03947632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832756|NCT03947632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832757|NCT04085770|Alfacalcidol|alfacalcidol|mesh-list
92832758|NCT04085770|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92477782|NCT04804007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832759|NCT04085770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92832760|NCT04085770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832762|NCT04085770|Micronutrients|micronutrients|mesh-ancestor
92832763|NCT00741286|Aspirin|aspirin|mesh-list
92832764|NCT00741286|Cilostazol|cilostazol|mesh-list
92832765|NCT00741286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92832766|NCT00741286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832767|NCT00741286|Analgesics|analgesics|mesh-ancestor
92832768|NCT00741286|Sensory System Agents|sensory system agents|mesh-ancestor
92832769|NCT00741286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832770|NCT00741286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832771|NCT00741286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832772|NCT00741286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832773|NCT00741286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92832774|NCT00741286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92832775|NCT00741286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832776|NCT00741286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92832777|NCT00741286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92832778|NCT00741286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832779|NCT00741286|Antipyretics|antipyretics|mesh-ancestor
92832780|NCT00741286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92832781|NCT00741286|Autonomic Agents|autonomic agents|mesh-ancestor
92832782|NCT00741286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92832783|NCT00741286|Respiratory System Agents|respiratory system agents|mesh-ancestor
92832784|NCT00741286|Vasodilator Agents|vasodilator agents|mesh-ancestor
92832785|NCT00741286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92734591|NCT01332318|Promethazine|promethazine|mesh-list
92832786|NCT00741286|Protective Agents|protective agents|mesh-ancestor
92832787|NCT00741286|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92832788|NCT00741286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92832789|NCT05040334|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92832790|NCT05040334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832791|NCT00716092|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92832792|NCT00716092|Linagliptin|linagliptin|mesh-list
92832793|NCT00716092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832794|NCT00716092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832795|NCT00716092|Incretins|incretins|mesh-ancestor
92832796|NCT00716092|Hormones|hormones|mesh-ancestor
92832797|NCT00716092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832798|NCT00716092|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92832799|NCT00716092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92832800|NCT00716092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832801|NCT00716092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832802|NCT02590510|Methotrexate|methotrexate|mesh-list
92832803|NCT02590510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92832804|NCT02590510|Abortifacient Agents|abortifacient agents|mesh-ancestor
92832805|NCT02590510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92832806|NCT02590510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832807|NCT02590510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92832808|NCT02590510|Antimetabolites|antimetabolites|mesh-ancestor
92832809|NCT02590510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832810|NCT02590510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832811|NCT02590510|Dermatologic Agents|dermatologic agents|mesh-ancestor
92832812|NCT02590510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832813|NCT02590510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92832814|NCT02590510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92832815|NCT02590510|Immunologic Factors|immunologic factors|mesh-ancestor
92832816|NCT02590510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832817|NCT02590510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92832818|NCT00919204|Axitinib|axitinib|mesh-list
92832819|NCT00919204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832820|NCT00919204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92832821|NCT00919204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832822|NCT00919204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832823|NCT00715624|Metformin|metformin|mesh-list
92832824|NCT00715624|Lixisenatide|lixisenatide|mesh-list
92832825|NCT00715624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92832826|NCT00715624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832827|NCT00919282|Leucovorin|leucovorin|mesh-list
92832828|NCT00919282|Folic Acid|folic acid|mesh-list
92832829|NCT00919282|Gemcitabine|gemcitabine|mesh-list
92832830|NCT00919282|Levoleucovorin|levoleucovorin|mesh-list
92832831|NCT00919282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92832832|NCT00919282|Antimetabolites|antimetabolites|mesh-ancestor
92832833|NCT00919282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832834|NCT00919282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832835|NCT00919282|Antidotes|antidotes|mesh-ancestor
92832836|NCT00919282|Protective Agents|protective agents|mesh-ancestor
92832837|NCT00919282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832838|NCT00919282|Vitamin B Complex|vitamin b complex|mesh-ancestor
92832839|NCT00919282|Vitamins|vitamins|mesh-ancestor
92832840|NCT00919282|Micronutrients|micronutrients|mesh-ancestor
92832841|NCT00919282|Hematinics|hematinics|mesh-ancestor
92832842|NCT05414305|Lidocaine|lidocaine|mesh-list
92832843|NCT05414305|Heparin|heparin|mesh-list
92832844|NCT05414305|Anesthetics, Local|anesthetics, local|mesh-ancestor
92832845|NCT05414305|Anesthetics|anesthetics|mesh-ancestor
92832846|NCT05414305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832847|NCT05414305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832848|NCT05414305|Sensory System Agents|sensory system agents|mesh-ancestor
92832849|NCT05414305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832850|NCT05414305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92832851|NCT05414305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92832852|NCT05414305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92832853|NCT05414305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92832854|NCT05414305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832855|NCT05414305|Anticoagulants|anticoagulants|mesh-ancestor
92832856|NCT05414305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92832857|NCT05414305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92832858|NCT00757549|Cetuximab|cetuximab|mesh-list
92832859|NCT00757549|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92832860|NCT00757549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832861|NCT00757549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832862|NCT00757549|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92832863|NCT00757549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832864|NCT00576199|Bevacizumab|bevacizumab|mesh-list
92832865|NCT00576199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92832866|NCT00576199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832867|NCT00576199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92832868|NCT00576199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92832869|NCT00576199|Growth Substances|growth substances|mesh-ancestor
92832870|NCT00576199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832871|NCT00576199|Growth Inhibitors|growth inhibitors|mesh-ancestor
92832873|NCT00754819|Gout Suppressants|gout suppressants|mesh-ancestor
92832874|NCT00754819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92832875|NCT00754819|Tubulin Modulators|tubulin modulators|mesh-ancestor
92832876|NCT00754819|Antimitotic Agents|antimitotic agents|mesh-ancestor
92832877|NCT00754819|Mitosis Modulators|mitosis modulators|mesh-ancestor
92832878|NCT00754819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832879|NCT00754819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832880|NCT05684692|Siltuximab|siltuximab|mesh-list
92832881|NCT05684692|Erenumab|erenumab|mesh-list
92832882|NCT05684692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92832883|NCT05684692|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92832884|NCT05684692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832885|NCT05684692|Analgesics|analgesics|mesh-ancestor
92832886|NCT05684692|Sensory System Agents|sensory system agents|mesh-ancestor
92832887|NCT05684692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832888|NCT05684692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832889|NCT05684692|Immunologic Factors|immunologic factors|mesh-ancestor
92832890|NCT05684692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832891|NCT02589652|Interferons|interferons|mesh-list
92832892|NCT02589652|Interferon-alpha|interferon-alpha|mesh-list
92832893|NCT02589652|Interferon alpha-2|interferon alpha-2|mesh-list
92832894|NCT02589652|Entecavir|entecavir|mesh-list
92832895|NCT02589652|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92832896|NCT02589652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832897|NCT02589652|Antiviral Agents|antiviral agents|mesh-ancestor
92832898|NCT02589652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832899|NCT02589652|Immunologic Factors|immunologic factors|mesh-ancestor
92832900|NCT02589652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832901|NCT00679627|Galantamine|galantamine|mesh-list
92832902|NCT00679627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92832903|NCT00679627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832904|NCT00679627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832905|NCT00679627|Cholinergic Agents|cholinergic agents|mesh-ancestor
92832906|NCT00679627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832907|NCT00679627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832908|NCT00679627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92832909|NCT00679627|Autonomic Agents|autonomic agents|mesh-ancestor
92832910|NCT00679627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832912|NCT00714688|Methylphenidate|methylphenidate|mesh-list
92832913|NCT00714688|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92832914|NCT00714688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832915|NCT00714688|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92832916|NCT00714688|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92832917|NCT00714688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92832918|NCT00714688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832919|NCT00714688|Dopamine Agents|dopamine agents|mesh-ancestor
92832920|NCT00714688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832921|NCT05165212|Amoxicillin|amoxicillin|mesh-list
92832922|NCT05165212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92832923|NCT05165212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832924|NCT04051099|Dexmedetomidine|dexmedetomidine|mesh-list
92832925|NCT04051099|Bupivacaine|bupivacaine|mesh-list
92832926|NCT04051099|Propofol|propofol|mesh-list
92832927|NCT04051099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92832928|NCT04051099|Anesthetics|anesthetics|mesh-ancestor
92832929|NCT04051099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832930|NCT04051099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832931|NCT04051099|Sensory System Agents|sensory system agents|mesh-ancestor
92832932|NCT04051099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832933|NCT04051099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92832934|NCT04051099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92832935|NCT04051099|Analgesics|analgesics|mesh-ancestor
92832936|NCT04051099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92832937|NCT04051099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92832938|NCT04051099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92832939|NCT04051099|Adrenergic Agents|adrenergic agents|mesh-ancestor
92832940|NCT04051099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832941|NCT04051099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832942|NCT04051099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92832943|NCT04051099|Anesthetics, General|anesthetics, general|mesh-ancestor
92832944|NCT01031069|Vaccines|vaccines|mesh-list
92832945|NCT01031069|Immunologic Factors|immunologic factors|mesh-ancestor
92832946|NCT01031069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832947|NCT04084912|Dexamethasone|dexamethasone|mesh-list
92832948|NCT04084912|Dexamethasone acetate|dexamethasone acetate|mesh-list
92832949|NCT04084912|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92832950|NCT04084912|BB 1101|bb 1101|mesh-list
92832951|NCT04084912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92832952|NCT04084912|Antiemetics|antiemetics|mesh-ancestor
92832953|NCT04084912|Autonomic Agents|autonomic agents|mesh-ancestor
92832954|NCT04084912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92832955|NCT04084912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832956|NCT04084912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92832957|NCT04084912|Glucocorticoids|glucocorticoids|mesh-ancestor
92832958|NCT04084912|Hormones|hormones|mesh-ancestor
92832959|NCT04084912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832960|NCT04084912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92832961|NCT04084912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92832962|NCT04084912|Protease Inhibitors|protease inhibitors|mesh-ancestor
92832963|NCT04084912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832964|NCT04084912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832965|NCT00755053|Clotrimazole|clotrimazole|mesh-list
92832966|NCT00755053|Miconazole|miconazole|mesh-list
92832967|NCT00755053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92832968|NCT00755053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92832969|NCT00755053|Antifungal Agents|antifungal agents|mesh-ancestor
92832970|NCT00755053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92832971|NCT00755053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92832972|NCT00755053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92832973|NCT00755053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832974|NCT00755053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92832975|NCT00755053|Hormone Antagonists|hormone antagonists|mesh-ancestor
92832976|NCT00755053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92832977|NCT00755053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832978|NCT00755053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92832979|NCT00755053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92832980|NCT00755209|Tranexamic Acid|tranexamic acid|mesh-list
92832981|NCT00755209|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92832982|NCT00755209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92832983|NCT00755209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832985|NCT00755209|Coagulants|coagulants|mesh-ancestor
92832986|NCT02589340|Buspirone|buspirone|mesh-list
92832987|NCT02589340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92832988|NCT02589340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92832989|NCT02589340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92832990|NCT02589340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92832991|NCT02589340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92832992|NCT02589340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92832993|NCT02589340|Serotonin Agents|serotonin agents|mesh-ancestor
92832994|NCT02589340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92832995|NCT02589340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92832996|NCT00682435|Hydromorphone|hydromorphone|mesh-list
92832997|NCT00682435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92832998|NCT00682435|Narcotics|narcotics|mesh-ancestor
92832999|NCT00682435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734803|NCT04328493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92833000|NCT00682435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833001|NCT00682435|Analgesics|analgesics|mesh-ancestor
92833002|NCT00682435|Sensory System Agents|sensory system agents|mesh-ancestor
92833003|NCT00682435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833004|NCT05340205|Misoprostol|misoprostol|mesh-list
92833005|NCT05340205|Tranexamic Acid|tranexamic acid|mesh-list
92833006|NCT05340205|Oxytocin|oxytocin|mesh-list
92833007|NCT05340205|Oxytocics|oxytocics|mesh-ancestor
92833008|NCT05340205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92833009|NCT05340205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833010|NCT05340205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92833011|NCT05340205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92833012|NCT05340205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833013|NCT05340205|Hemostatics|hemostatics|mesh-ancestor
92833014|NCT05340205|Coagulants|coagulants|mesh-ancestor
92833015|NCT05340205|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92833016|NCT05340205|Abortifacient Agents|abortifacient agents|mesh-ancestor
92833017|NCT05340205|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92833018|NCT05340205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833019|NCT00713830|Metformin|metformin|mesh-list
92833020|NCT00713830|Lixisenatide|lixisenatide|mesh-list
92833021|NCT00713830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833022|NCT00713830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833024|NCT05291221|Dexmedetomidine|dexmedetomidine|mesh-list
92833025|NCT05291221|Anesthetics, Local|anesthetics, local|mesh-ancestor
92833026|NCT05291221|Anesthetics|anesthetics|mesh-ancestor
92833027|NCT05291221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833028|NCT05291221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833029|NCT05291221|Sensory System Agents|sensory system agents|mesh-ancestor
92833030|NCT05291221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833031|NCT05291221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92833032|NCT05291221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92833033|NCT05291221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92833034|NCT05291221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92833035|NCT05291221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833036|NCT05291221|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92833037|NCT05291221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92833038|NCT05291221|Analgesics|analgesics|mesh-ancestor
92833039|NCT05291221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92833040|NCT05291221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92833041|NCT05291221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92833042|NCT05291221|Adrenergic Agents|adrenergic agents|mesh-ancestor
92833043|NCT05291221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833044|NCT00755521|Etoricoxib|etoricoxib|mesh-list
92833045|NCT00755521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92833046|NCT00755521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92833047|NCT00755521|Analgesics|analgesics|mesh-ancestor
92833048|NCT00755521|Sensory System Agents|sensory system agents|mesh-ancestor
92833049|NCT00755521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833050|NCT00755521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833051|NCT00755521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833052|NCT00755521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833053|NCT00755521|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92833054|NCT00755521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92833055|NCT00755521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833056|NCT00755521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833057|NCT00681187|Lanreotide|lanreotide|mesh-list
92833058|NCT00681187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833059|NCT00681109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92833060|NCT00681109|Lubricant Eye Drops|lubricant eye drops|mesh-list
92833061|NCT00681109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833062|NCT00681109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92833063|NCT00681109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92833064|NCT00680407|Silymarin|silymarin|mesh-list
92833065|NCT00680407|Antioxidants|antioxidants|mesh-ancestor
92833066|NCT00680407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833067|NCT00680407|Protective Agents|protective agents|mesh-ancestor
92833068|NCT00680407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833069|NCT02560519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92833070|NCT04007809|Glucagon|glucagon|mesh-list
92833071|NCT04007809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833072|NCT04007809|Hormones|hormones|mesh-ancestor
92734882|NCT02893371|Escitalopram|escitalopram|mesh-list
92833073|NCT04007809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833074|NCT04007809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833075|NCT04083664|Hepcidins|hepcidins|mesh-list
92833076|NCT04083664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833077|NCT05202730|Anesthetics|anesthetics|mesh-list
92833078|NCT05202730|Anesthetics, Local|anesthetics, local|mesh-list
92833079|NCT05202730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833080|NCT05202730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833081|NCT05202730|Sensory System Agents|sensory system agents|mesh-ancestor
92833082|NCT05202730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833083|NCT00677365|Levofloxacin|levofloxacin|mesh-list
92833084|NCT00677365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92833085|NCT00677365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833086|NCT00677365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92833087|NCT00677365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92833088|NCT00677365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92833089|NCT00677365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833090|NCT00677365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833091|NCT00677365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833092|NCT00677365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92833093|NCT00677365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92833094|NCT05039944|Irinotecan|irinotecan|mesh-list
92833095|NCT05039944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92833096|NCT05039944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92833097|NCT05039944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833098|NCT05039944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833099|NCT05039944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833100|NCT05038462|Lactoferrin|lactoferrin|mesh-list
92833101|NCT05038462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833102|NCT03719131|Rituximab|rituximab|mesh-list
92833103|NCT03719131|Nivolumab|nivolumab|mesh-list
92833104|NCT03719131|Ipilimumab|ipilimumab|mesh-list
92833105|NCT03719131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92833106|NCT03719131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833107|NCT03719131|Immunologic Factors|immunologic factors|mesh-ancestor
92833108|NCT03719131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833109|NCT03719131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833110|NCT03719131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92833111|NCT03719131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833112|NCT05190094|Letrozole|letrozole|mesh-list
92833113|NCT05190094|Palbociclib|palbociclib|mesh-list
92833114|NCT05190094|Anastrozole|anastrozole|mesh-list
92833115|NCT05190094|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92833116|NCT05190094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833117|NCT05190094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92833118|NCT05190094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833119|NCT05190094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833120|NCT05190094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92833121|NCT05190094|Hormone Antagonists|hormone antagonists|mesh-ancestor
92833122|NCT05190094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833123|NCT05190094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833124|NCT05190094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92833125|NCT05190094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833126|NCT00680017|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92833127|NCT00680017|Fenofibric acid|fenofibric acid|mesh-list
92833128|NCT00680017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92833129|NCT00680017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92833130|NCT00680017|Antimetabolites|antimetabolites|mesh-ancestor
92833131|NCT00680017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833132|NCT00680017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92833133|NCT00680017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92833134|NCT00680017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833135|NCT00676663|Exemestane|exemestane|mesh-list
92833136|NCT00676663|Entinostat|entinostat|mesh-list
92833137|NCT00676663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833138|NCT00676663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92833139|NCT00676663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92833140|NCT00676663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833141|NCT00676663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833142|NCT00676663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92833143|NCT00676663|Hormone Antagonists|hormone antagonists|mesh-ancestor
92833144|NCT00676663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833145|NCT00676663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833146|NCT00676663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92833147|NCT02560207|Cefotaxime|cefotaxime|mesh-list
92833148|NCT02560207|Cefoxitin|cefoxitin|mesh-list
92833149|NCT02560207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92833150|NCT02560207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833151|NCT00678691|Modafinil|modafinil|mesh-list
92833152|NCT00678691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92833153|NCT00678691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833154|NCT00678691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92833155|NCT00678691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92833156|NCT00678691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92833157|NCT00678691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833158|NCT05003752|Goserelin|goserelin|mesh-list
92833159|NCT05003752|Androgens|androgens|mesh-list
92833160|NCT05003752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833161|NCT05003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833162|NCT05003752|Hormones|hormones|mesh-ancestor
92833163|NCT05003752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833164|NCT05003752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833165|NCT04997980|Amiodarone|amiodarone|mesh-list
92833166|NCT04997980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92833167|NCT04997980|Vasodilator Agents|vasodilator agents|mesh-ancestor
92833168|NCT04997980|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92833169|NCT04997980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92833170|NCT04997980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833171|NCT04997980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92833172|NCT04997980|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92833173|NCT04997980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92833174|NCT04997980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833175|NCT04997980|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92833176|NCT04997980|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92833177|NCT04997980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92833178|NCT05101798|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92833179|NCT05101798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92833180|NCT05101798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833181|NCT05683912|Aflibercept|aflibercept|mesh-list
92833182|NCT05683912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92833183|NCT05683912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92833184|NCT05683912|Growth Substances|growth substances|mesh-ancestor
92833185|NCT05683912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833186|NCT05683912|Growth Inhibitors|growth inhibitors|mesh-ancestor
92833187|NCT05683912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833188|NCT00679939|Metformin|metformin|mesh-list
92833189|NCT00679939|Rosiglitazone|rosiglitazone|mesh-list
92833190|NCT00679939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833191|NCT00679939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833192|NCT04082260|Alemtuzumab|alemtuzumab|mesh-list
92833193|NCT04082260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92833194|NCT04082260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833195|NCT02587390|Simvastatin|simvastatin|mesh-list
92833196|NCT02587390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92833197|NCT02587390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92833198|NCT02587390|Antimetabolites|antimetabolites|mesh-ancestor
92833199|NCT02587390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833200|NCT02587390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92833201|NCT02587390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92833202|NCT02587390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833203|NCT00760981|Imatinib Mesylate|imatinib mesylate|mesh-list
92833204|NCT00760981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833205|NCT00760981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92833206|NCT00760981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833207|NCT00760981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833208|NCT02588716|Terlipressin|terlipressin|mesh-list
92833209|NCT02588716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92833210|NCT02588716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92833211|NCT00673933|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92833212|NCT00673933|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92833213|NCT00673933|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92833214|NCT00673933|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833215|NCT00761449|Lenalidomide|lenalidomide|mesh-list
92833216|NCT00761449|Immunologic Factors|immunologic factors|mesh-ancestor
92833217|NCT00761449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833218|NCT00761449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92833219|NCT00761449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92833220|NCT00761449|Growth Substances|growth substances|mesh-ancestor
92833221|NCT00761449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92833222|NCT00761449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833223|NCT04968106|Doxorubicin|doxorubicin|mesh-list
92833224|NCT04968106|Ifosfamide|ifosfamide|mesh-list
92833225|NCT04968106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92833226|NCT04968106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833227|NCT04968106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92833228|NCT04968106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92833229|NCT04968106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833230|NCT04968106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833231|NCT04968106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92833232|NCT04968106|Alkylating Agents|alkylating agents|mesh-ancestor
92833233|NCT00919438|Diuretics|diuretics|mesh-list
92833234|NCT00919438|Natriuretic Agents|natriuretic agents|mesh-ancestor
92833235|NCT00919438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833236|NCT04082182|Immunomodulating Agents|immunomodulating agents|mesh-list
92833237|NCT04082182|Immunologic Factors|immunologic factors|mesh-ancestor
92833238|NCT04082182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833239|NCT00571519|Metformin|metformin|mesh-list
92833240|NCT00571519|Pioglitazone|pioglitazone|mesh-list
92833241|NCT00571519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833242|NCT00571519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833243|NCT02588404|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92833244|NCT02588404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833245|NCT02588404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833246|NCT02588404|Luteolytic Agents|luteolytic agents|mesh-ancestor
92833247|NCT02588404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92833248|NCT02588404|Contraceptive Agents|contraceptive agents|mesh-ancestor
92833249|NCT02588404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92833250|NCT02588404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833251|NCT02588404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92833253|NCT04935034|Vitamins|vitamins|mesh-ancestor
92833254|NCT04935034|Micronutrients|micronutrients|mesh-ancestor
92833255|NCT04935034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833256|NCT04935034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92833257|NCT04807816|Gemcitabine|gemcitabine|mesh-list
92833258|NCT04807816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833259|NCT04807816|Antimetabolites|antimetabolites|mesh-ancestor
92833260|NCT04807816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833261|NCT04807816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833262|NCT00762151|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92833263|NCT00762151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833264|NCT00921973|Vaccines|vaccines|mesh-list
92833265|NCT00921973|Immunologic Factors|immunologic factors|mesh-ancestor
92833266|NCT00921973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833267|NCT00676195|Acetylcysteine|acetylcysteine|mesh-list
92833268|NCT00676195|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92833269|NCT00676195|Antiviral Agents|antiviral agents|mesh-ancestor
92833270|NCT00676195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833271|NCT00676195|Expectorants|expectorants|mesh-ancestor
92833272|NCT00676195|Respiratory System Agents|respiratory system agents|mesh-ancestor
92833273|NCT00676195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92833274|NCT00676195|Antioxidants|antioxidants|mesh-ancestor
92833275|NCT00676195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833276|NCT00676195|Protective Agents|protective agents|mesh-ancestor
92833277|NCT00676195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833278|NCT00676195|Antidotes|antidotes|mesh-ancestor
92478311|NCT03147859|Vedolizumab|vedolizumab|mesh-list
92833279|NCT02558959|Capecitabine|capecitabine|mesh-list
92833280|NCT02558959|Irinotecan|irinotecan|mesh-list
92833281|NCT02558959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833282|NCT02558959|Antimetabolites|antimetabolites|mesh-ancestor
92833283|NCT02558959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833284|NCT02558959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833285|NCT02558959|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92833286|NCT02558959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92833287|NCT02558959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833288|NCT04049539|Cytarabine|cytarabine|mesh-list
92833289|NCT04049539|Daunorubicin|daunorubicin|mesh-list
92833290|NCT04049539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833291|NCT04049539|Antimetabolites|antimetabolites|mesh-ancestor
92833292|NCT04049539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833293|NCT04049539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833294|NCT04049539|Antiviral Agents|antiviral agents|mesh-ancestor
92833295|NCT04049539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833296|NCT04049539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833297|NCT04049539|Immunologic Factors|immunologic factors|mesh-ancestor
92833298|NCT04049539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833299|NCT04049539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92833300|NCT04049539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92833301|NCT04049539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92833302|NCT04049539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833303|NCT04082962|Dexamethasone|dexamethasone|mesh-list
92833304|NCT04082962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833305|NCT04082962|Antiemetics|antiemetics|mesh-ancestor
92833306|NCT04082962|Autonomic Agents|autonomic agents|mesh-ancestor
92833307|NCT04082962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833308|NCT04082962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833309|NCT04082962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833310|NCT04082962|Glucocorticoids|glucocorticoids|mesh-ancestor
92833311|NCT04082962|Hormones|hormones|mesh-ancestor
92833312|NCT04082962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833313|NCT04082962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833314|NCT04082962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833315|NCT02471833|Telmisartan|telmisartan|mesh-list
92833316|NCT02471833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92833317|NCT02471833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92833318|NCT02471833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92833319|NCT02471833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833320|NCT04895410|Dexamethasone|dexamethasone|mesh-list
92833321|NCT04895410|Daratumumab|daratumumab|mesh-list
92833322|NCT04895410|Pomalidomide|pomalidomide|mesh-list
92833323|NCT04895410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833324|NCT04895410|Antiemetics|antiemetics|mesh-ancestor
92833325|NCT04895410|Autonomic Agents|autonomic agents|mesh-ancestor
92833326|NCT04895410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833327|NCT04895410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833328|NCT04895410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833329|NCT04895410|Glucocorticoids|glucocorticoids|mesh-ancestor
92833330|NCT04895410|Hormones|hormones|mesh-ancestor
92833331|NCT04895410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833332|NCT04895410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833333|NCT04895410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833334|NCT04895410|Immunologic Factors|immunologic factors|mesh-ancestor
92833335|NCT04895410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92833336|NCT04895410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92833337|NCT04895410|Growth Substances|growth substances|mesh-ancestor
92833338|NCT04895410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92833339|NCT00675025|Donepezil|donepezil|mesh-list
92833340|NCT00675025|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92833341|NCT00675025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833342|NCT00675025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833343|NCT00675025|Cholinergic Agents|cholinergic agents|mesh-ancestor
92833344|NCT00675025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833345|NCT00675025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833346|NCT00675025|Nootropic Agents|nootropic agents|mesh-ancestor
92833347|NCT00758407|Methylphenidate|methylphenidate|mesh-list
92833348|NCT00758407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92833349|NCT00758407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833350|NCT00758407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92833351|NCT00758407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92833352|NCT00758407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92833353|NCT00758407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478383|NCT02412566|SMOFlipid|smoflipid|mesh-list
92833354|NCT00758407|Dopamine Agents|dopamine agents|mesh-ancestor
92833355|NCT00758407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833356|NCT00759421|Olanzapine|olanzapine|mesh-list
92833357|NCT00759421|Sertindole|sertindole|mesh-list
92833358|NCT00759421|Antiemetics|antiemetics|mesh-ancestor
92833359|NCT00759421|Autonomic Agents|autonomic agents|mesh-ancestor
92833360|NCT00759421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735171|NCT01600274|Contraceptive Agents|contraceptive agents|mesh-ancestor
92833361|NCT00759421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833362|NCT00759421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833363|NCT00759421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92833364|NCT00759421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92833365|NCT00759421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833366|NCT00759421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92833367|NCT00759421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92833368|NCT00759421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92833369|NCT00759421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92833370|NCT00759421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833371|NCT00759421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833372|NCT00759421|Serotonin Agents|serotonin agents|mesh-ancestor
92833373|NCT00762775|Vitamin D|vitamin d|mesh-list
92833374|NCT00762775|Calcium|calcium|mesh-list
92833375|NCT00762775|Vitamins|vitamins|mesh-ancestor
92833376|NCT00762775|Micronutrients|micronutrients|mesh-ancestor
92833377|NCT00762775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833378|NCT00762775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92833379|NCT00762775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92833380|NCT00763165|Triclosan|triclosan|mesh-list
92833381|NCT00763165|Fluorides|fluorides|mesh-list
92833382|NCT00763165|Cariostatic Agents|cariostatic agents|mesh-ancestor
92833383|NCT00763165|Protective Agents|protective agents|mesh-ancestor
92833384|NCT00763165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833385|NCT00763165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92833386|NCT00763165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833387|NCT00763165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92833388|NCT00763165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92833389|NCT00763165|Antimetabolites|antimetabolites|mesh-ancestor
92977207|NCT00545103|Sensory System Agents|sensory system agents|mesh-ancestor
92833390|NCT00763165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833391|NCT00763165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92833393|NCT04049227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833394|NCT04049227|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92833395|NCT04049227|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92833396|NCT04049227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833397|NCT04049227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833398|NCT04049227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92833399|NCT04049227|Hormone Antagonists|hormone antagonists|mesh-ancestor
92833400|NCT04049227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833401|NCT04049227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833402|NCT00759733|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92833403|NCT00759733|Natriuretic Agents|natriuretic agents|mesh-ancestor
92833404|NCT00759733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833405|NCT00760045|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92833406|NCT00760045|Hyaluronic Acid|hyaluronic acid|mesh-list
92833407|NCT00760045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92833408|NCT00760045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92833409|NCT00760045|Immunologic Factors|immunologic factors|mesh-ancestor
92833410|NCT00760045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833411|NCT00760045|Viscosupplements|viscosupplements|mesh-ancestor
92833412|NCT00760045|Protective Agents|protective agents|mesh-ancestor
92833413|NCT00678379|Lidocaine|lidocaine|mesh-list
92833414|NCT00678379|Clonidine|clonidine|mesh-list
92833415|NCT00678379|Bupivacaine|bupivacaine|mesh-list
92833416|NCT00678379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92833417|NCT00678379|Anesthetics|anesthetics|mesh-ancestor
92833418|NCT00678379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833419|NCT00678379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833420|NCT00678379|Sensory System Agents|sensory system agents|mesh-ancestor
92833421|NCT00678379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833422|NCT00678379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92833423|NCT00678379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92833424|NCT00678379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92833425|NCT00678379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92833426|NCT00678379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833427|NCT00678379|Analgesics|analgesics|mesh-ancestor
92833428|NCT00678379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92833429|NCT00678379|Sympatholytics|sympatholytics|mesh-ancestor
92833430|NCT00678379|Autonomic Agents|autonomic agents|mesh-ancestor
92833431|NCT00678379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92833432|NCT00678379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92833433|NCT00678379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92833434|NCT00678379|Adrenergic Agents|adrenergic agents|mesh-ancestor
92833435|NCT00678379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833436|NCT00760279|Azithromycin|azithromycin|mesh-list
92833437|NCT00760279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92833438|NCT00760279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833439|NCT00674323|Ranibizumab|ranibizumab|mesh-list
92833440|NCT00674323|Verteporfin|verteporfin|mesh-list
92833441|NCT00674323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92833442|NCT00674323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92833443|NCT00674323|Growth Substances|growth substances|mesh-ancestor
92833444|NCT00674323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833445|NCT00674323|Growth Inhibitors|growth inhibitors|mesh-ancestor
92833446|NCT00674323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833447|NCT00674323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92833448|NCT00674323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833449|NCT00763633|Vitamins|vitamins|mesh-list
92833450|NCT00763633|Vitamin B 6|vitamin b 6|mesh-list
92833451|NCT00763633|Pyridoxal|pyridoxal|mesh-list
92833452|NCT00763633|Pyridoxine|pyridoxine|mesh-list
92833453|NCT00763633|Vitamin B Complex|vitamin b complex|mesh-list
92833454|NCT00763633|Micronutrients|micronutrients|mesh-ancestor
92833455|NCT00763633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833456|NCT00763789|Remifentanil|remifentanil|mesh-list
92833457|NCT00763789|Anesthetics|anesthetics|mesh-list
92833458|NCT00763789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833459|NCT00763789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833460|NCT00763789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92833461|NCT00763789|Narcotics|narcotics|mesh-ancestor
92833462|NCT00763789|Analgesics|analgesics|mesh-ancestor
92833463|NCT00763789|Sensory System Agents|sensory system agents|mesh-ancestor
92833464|NCT00763789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833465|NCT04115956|Dexamethasone|dexamethasone|mesh-list
92833466|NCT04115956|Melphalan|melphalan|mesh-list
92833467|NCT04115956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833468|NCT04115956|Antiemetics|antiemetics|mesh-ancestor
92833469|NCT04115956|Autonomic Agents|autonomic agents|mesh-ancestor
92833470|NCT04115956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833471|NCT04115956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833472|NCT04115956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833473|NCT04115956|Glucocorticoids|glucocorticoids|mesh-ancestor
92833474|NCT04115956|Hormones|hormones|mesh-ancestor
92833475|NCT04115956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833476|NCT04115956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833477|NCT04115956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833478|NCT04115956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92833479|NCT04115956|Alkylating Agents|alkylating agents|mesh-ancestor
92833480|NCT04115956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833481|NCT04115956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92833482|NCT04115956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833483|NCT04115956|Immunologic Factors|immunologic factors|mesh-ancestor
92833484|NCT04081480|Valacyclovir|valacyclovir|mesh-list
92833485|NCT04081480|Antiviral Agents|antiviral agents|mesh-ancestor
92833486|NCT04081480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833487|NCT00678301|Vaccines|vaccines|mesh-list
92833488|NCT00678301|Immunologic Factors|immunologic factors|mesh-ancestor
92833489|NCT00678301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833490|NCT02586454|Morphine|morphine|mesh-list
92833491|NCT02586454|Ropivacaine|ropivacaine|mesh-list
92833492|NCT02586454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92833493|NCT02586454|Narcotics|narcotics|mesh-ancestor
92833494|NCT02586454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833495|NCT02586454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833496|NCT02586454|Analgesics|analgesics|mesh-ancestor
92833497|NCT02586454|Sensory System Agents|sensory system agents|mesh-ancestor
92833498|NCT02586454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833499|NCT02586454|Anesthetics, Local|anesthetics, local|mesh-ancestor
92833500|NCT02586454|Anesthetics|anesthetics|mesh-ancestor
92833501|NCT00939770|Crizotinib|crizotinib|mesh-list
92833502|NCT00939770|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92833503|NCT00939770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92833504|NCT00939770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833505|NCT00939770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833506|NCT00939770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833507|NCT02558569|Levobupivacaine|levobupivacaine|mesh-list
92833508|NCT02558569|Anesthetics, Local|anesthetics, local|mesh-ancestor
92833509|NCT02558569|Anesthetics|anesthetics|mesh-ancestor
92833510|NCT02558569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833511|NCT02558569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833512|NCT02558569|Sensory System Agents|sensory system agents|mesh-ancestor
92833513|NCT02558569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833514|NCT00939692|Topiramate|topiramate|mesh-list
92833515|NCT00939692|Anticonvulsants|anticonvulsants|mesh-ancestor
92833516|NCT00939692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833517|NCT00939692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833518|NCT00920608|Methotrexate|methotrexate|mesh-list
92833519|NCT00920608|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92833520|NCT00920608|Abortifacient Agents|abortifacient agents|mesh-ancestor
92833521|NCT00920608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92833522|NCT00920608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833523|NCT00920608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833524|NCT00920608|Antimetabolites|antimetabolites|mesh-ancestor
92833525|NCT00920608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833526|NCT00920608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833527|NCT00920608|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833528|NCT00920608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833529|NCT00920608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92833530|NCT00920608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833531|NCT00920608|Immunologic Factors|immunologic factors|mesh-ancestor
92833532|NCT00920608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833533|NCT00920608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92833534|NCT04674514|Dexamethasone|dexamethasone|mesh-list
92833535|NCT04674514|Lenalidomide|lenalidomide|mesh-list
92833536|NCT04674514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833537|NCT04674514|Antiemetics|antiemetics|mesh-ancestor
92833538|NCT04674514|Autonomic Agents|autonomic agents|mesh-ancestor
92833539|NCT04674514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833540|NCT04674514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833541|NCT04674514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833542|NCT04674514|Glucocorticoids|glucocorticoids|mesh-ancestor
92833544|NCT04674514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833545|NCT04674514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833546|NCT04674514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833547|NCT04674514|Immunologic Factors|immunologic factors|mesh-ancestor
92833548|NCT04674514|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92833549|NCT04674514|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92833550|NCT04674514|Growth Substances|growth substances|mesh-ancestor
92833551|NCT04674514|Growth Inhibitors|growth inhibitors|mesh-ancestor
92833552|NCT04081012|Acetylcysteine|acetylcysteine|mesh-list
92833553|NCT04081012|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92833554|NCT04081012|Antiviral Agents|antiviral agents|mesh-ancestor
92833555|NCT04081012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833556|NCT04081012|Expectorants|expectorants|mesh-ancestor
92833557|NCT04081012|Respiratory System Agents|respiratory system agents|mesh-ancestor
92833558|NCT04081012|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92833559|NCT04081012|Antioxidants|antioxidants|mesh-ancestor
92833560|NCT04081012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833561|NCT04081012|Protective Agents|protective agents|mesh-ancestor
92833562|NCT04081012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833563|NCT04081012|Antidotes|antidotes|mesh-ancestor
92833564|NCT04551040|Terazosin|terazosin|mesh-list
92833565|NCT04551040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92833566|NCT04551040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92833567|NCT04551040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92833568|NCT04551040|Adrenergic Agents|adrenergic agents|mesh-ancestor
92833569|NCT04551040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833570|NCT04551040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833571|NCT04551040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833572|NCT04551040|Urological Agents|urological agents|mesh-ancestor
92833573|NCT00942968|Dalteparin|dalteparin|mesh-list
92833574|NCT00942968|Tinzaparin|tinzaparin|mesh-list
92833575|NCT00942968|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92833576|NCT00942968|Anticoagulants|anticoagulants|mesh-ancestor
92833577|NCT00942968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92833578|NCT00942968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92833579|NCT00942968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833580|NCT00942734|Everolimus|everolimus|mesh-list
92833581|NCT00942734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92833582|NCT00942734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92833583|NCT00942734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92833584|NCT00942734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833585|NCT00942734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833586|NCT00942734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833587|NCT00942734|Immunologic Factors|immunologic factors|mesh-ancestor
92833588|NCT00942734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833589|NCT00942734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833590|NCT02586142|Botulinum Toxins|botulinum toxins|mesh-list
92833591|NCT02586142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92833592|NCT02586142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92833593|NCT02586142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92833594|NCT02586142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92833595|NCT02586142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833596|NCT02586142|Cholinergic Agents|cholinergic agents|mesh-ancestor
92833597|NCT02586142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833598|NCT02586142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833599|NCT02586142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92833600|NCT02586142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833601|NCT00919984|Paclitaxel|paclitaxel|mesh-list
92833602|NCT00919984|Carboplatin|carboplatin|mesh-list
92833603|NCT00919984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92833604|NCT00919984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833605|NCT00919984|Tubulin Modulators|tubulin modulators|mesh-ancestor
92833606|NCT00919984|Antimitotic Agents|antimitotic agents|mesh-ancestor
92833607|NCT00919984|Mitosis Modulators|mitosis modulators|mesh-ancestor
92833608|NCT00919984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833609|NCT00942422|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92833610|NCT00942422|Antioxidants|antioxidants|mesh-ancestor
92833611|NCT00942422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833612|NCT00942422|Protective Agents|protective agents|mesh-ancestor
92833613|NCT00942422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833614|NCT00942422|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92833615|NCT00942422|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92833616|NCT00942422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833617|NCT00942422|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92833618|NCT05380934|Methotrexate|methotrexate|mesh-list
92833619|NCT05380934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92833620|NCT05380934|Abortifacient Agents|abortifacient agents|mesh-ancestor
92833621|NCT05380934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92833622|NCT05380934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833623|NCT05380934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833624|NCT05380934|Antimetabolites|antimetabolites|mesh-ancestor
92833625|NCT05380934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833626|NCT05380934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833627|NCT05380934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833628|NCT05380934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833629|NCT05380934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92833630|NCT05380934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833631|NCT05380934|Immunologic Factors|immunologic factors|mesh-ancestor
92833632|NCT05380934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833633|NCT05380934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92833634|NCT00603824|PENTA|penta|mesh-list
92833635|NCT00603824|Lepirudin|lepirudin|mesh-list
92833636|NCT00603824|Fondaparinux|fondaparinux|mesh-list
92833637|NCT00603824|Argatroban|argatroban|mesh-list
92833638|NCT00603824|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92833639|NCT00603824|Antithrombins|antithrombins|mesh-ancestor
92833640|NCT00603824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92833641|NCT00603824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92833642|NCT00603824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833643|NCT00603824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833644|NCT00603824|Anticoagulants|anticoagulants|mesh-ancestor
92833645|NCT00603824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92833646|NCT00603824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92833647|NCT00603824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92833648|NCT00677833|Azithromycin|azithromycin|mesh-list
92833649|NCT00677833|Lumefantrine|lumefantrine|mesh-list
92833650|NCT00677833|Chloroquine|chloroquine|mesh-list
92833651|NCT00677833|Artemether|artemether|mesh-list
92833652|NCT00677833|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92833653|NCT00677833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92833654|NCT00677833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833655|NCT00677833|Antimalarials|antimalarials|mesh-ancestor
92833656|NCT00677833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92833657|NCT00677833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92833658|NCT00677833|Amebicides|amebicides|mesh-ancestor
92833659|NCT00677833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833660|NCT05086874|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92833661|NCT05086874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92833662|NCT05086874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92833663|NCT05086874|Protective Agents|protective agents|mesh-ancestor
92833664|NCT05086874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833665|NCT02585674|Insulin Glargine|insulin glargine|mesh-list
92833666|NCT02585674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833667|NCT02585674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833668|NCT00942266|Calcium, Dietary|calcium, dietary|mesh-list
92833669|NCT00942266|Leucovorin|leucovorin|mesh-list
92833670|NCT00942266|Fluorouracil|fluorouracil|mesh-list
92833671|NCT00942266|Vorinostat|vorinostat|mesh-list
92833672|NCT00942266|Calcium|calcium|mesh-list
92833673|NCT00942266|Levoleucovorin|levoleucovorin|mesh-list
92833674|NCT00942266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92833675|NCT00942266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833676|NCT00942266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92833677|NCT00942266|Antimetabolites|antimetabolites|mesh-ancestor
92833678|NCT00942266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833679|NCT00942266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833680|NCT00942266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833681|NCT00942266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833682|NCT00942266|Immunologic Factors|immunologic factors|mesh-ancestor
92833683|NCT00942266|Antidotes|antidotes|mesh-ancestor
92833684|NCT00942266|Protective Agents|protective agents|mesh-ancestor
92833685|NCT00942266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92833686|NCT00942266|Vitamins|vitamins|mesh-ancestor
92833687|NCT00942266|Micronutrients|micronutrients|mesh-ancestor
92833688|NCT00942266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92833689|NCT00942266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833690|NCT05382182|Androgens|androgens|mesh-list
92833691|NCT05382182|Hormones|hormones|mesh-ancestor
92833692|NCT05382182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833693|NCT05382182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833694|NCT04727242|Gemcitabine|gemcitabine|mesh-list
92833695|NCT04727242|Dacarbazine|dacarbazine|mesh-list
92833696|NCT04727242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833697|NCT04727242|Antimetabolites|antimetabolites|mesh-ancestor
92833698|NCT04727242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833699|NCT04727242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833700|NCT04727242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92833701|NCT04727242|Alkylating Agents|alkylating agents|mesh-ancestor
92833702|NCT04079374|Etanercept|etanercept|mesh-list
92833703|NCT04079374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92833704|NCT04079374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92833705|NCT04079374|Analgesics|analgesics|mesh-ancestor
92833706|NCT04079374|Sensory System Agents|sensory system agents|mesh-ancestor
92833707|NCT04079374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833708|NCT04079374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833709|NCT04079374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833710|NCT04079374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833711|NCT04079374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833712|NCT04079374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833713|NCT04079374|Immunologic Factors|immunologic factors|mesh-ancestor
92833714|NCT00673231|Dapagliflozin|dapagliflozin|mesh-list
92833715|NCT00673231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92833716|NCT00673231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833717|NCT00673231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833718|NCT00673231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833719|NCT02583958|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92833720|NCT02583958|Laxatives|laxatives|mesh-ancestor
92833721|NCT02583958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833722|NCT00604058|Vaccines|vaccines|mesh-list
92833723|NCT00604058|Immunologic Factors|immunologic factors|mesh-ancestor
92833724|NCT00604058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833725|NCT02852798|Docetaxel|docetaxel|mesh-list
92833726|NCT02852798|Apatinib|apatinib|mesh-list
92833727|NCT02852798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833728|NCT02852798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92833729|NCT02852798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92833730|NCT02852798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92833731|NCT02852798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833732|NCT02852798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92833733|NCT02852798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478764|NCT01874314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92833734|NCT02586610|Pembrolizumab|pembrolizumab|mesh-list
92833735|NCT02586610|Capecitabine|capecitabine|mesh-list
92833736|NCT02586610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92833737|NCT02586610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833738|NCT02586610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92833739|NCT02586610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833740|NCT02586610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833742|NCT00604682|Apremilast|apremilast|mesh-list
92833743|NCT00604682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92833744|NCT00604682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92833745|NCT00604682|Analgesics|analgesics|mesh-ancestor
92833746|NCT00604682|Sensory System Agents|sensory system agents|mesh-ancestor
92833747|NCT00604682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833748|NCT00604682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833749|NCT00604682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833750|NCT00604682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833751|NCT00604682|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92833752|NCT00604682|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92833753|NCT00604682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833754|NCT00604682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833755|NCT00672841|Antifungal Agents|antifungal agents|mesh-list
92833756|NCT00672841|Clotrimazole|clotrimazole|mesh-list
92833757|NCT00672841|Miconazole|miconazole|mesh-list
92833758|NCT00672841|Anidulafungin|anidulafungin|mesh-list
92833759|NCT00672841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833760|NCT00672841|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92833761|NCT00672841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92833762|NCT00672841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92833763|NCT00672841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833764|NCT00672841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833765|NCT00672841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92833766|NCT00672841|Hormone Antagonists|hormone antagonists|mesh-ancestor
92833767|NCT00672841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833768|NCT00672841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833769|NCT00672841|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92833770|NCT00672841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92833771|NCT00920296|Cabotegravir|cabotegravir|mesh-list
92833772|NCT00920296|Etravirine|etravirine|mesh-list
92833773|NCT00920296|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92833774|NCT00920296|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92833775|NCT00920296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833776|NCT00920296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833777|NCT00920296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92833778|NCT00920296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92833779|NCT00920296|Antiviral Agents|antiviral agents|mesh-ancestor
92833780|NCT00920296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833781|NCT00920296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92833782|NCT00920296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92833783|NCT04080388|Diuretics|diuretics|mesh-list
92833784|NCT04080388|Natriuretic Agents|natriuretic agents|mesh-ancestor
92833785|NCT04080388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833786|NCT00765115|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
92833787|NCT00765115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92833788|NCT00765115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833789|NCT00765115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833790|NCT04080622|Selenium|selenium|mesh-list
92833791|NCT04080622|Antioxidants|antioxidants|mesh-ancestor
92833792|NCT04080622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833793|NCT04080622|Protective Agents|protective agents|mesh-ancestor
92833794|NCT04080622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833795|NCT04080622|Trace Elements|trace elements|mesh-ancestor
92833796|NCT04080622|Micronutrients|micronutrients|mesh-ancestor
92833797|NCT04079140|Dinoprostone|dinoprostone|mesh-list
92833798|NCT04079140|Oxytocics|oxytocics|mesh-ancestor
92833799|NCT04079140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92833800|NCT04079140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833801|NCT00673465|Metformin|metformin|mesh-list
92833802|NCT00673465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833803|NCT00673465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833804|NCT00764413|Methylprednisolone|methylprednisolone|mesh-list
92833805|NCT00764413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92478845|NCT01875107|Insulin|insulin|mesh-list
92833806|NCT00764413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92833808|NCT00764413|Prednisolone acetate|prednisolone acetate|mesh-list
92833809|NCT00764413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92833810|NCT00764413|Prednisolone phosphate|prednisolone phosphate|mesh-list
92833811|NCT00764413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833812|NCT00764413|Antiemetics|antiemetics|mesh-ancestor
92833813|NCT00764413|Autonomic Agents|autonomic agents|mesh-ancestor
92833814|NCT00764413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833815|NCT00764413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833816|NCT00764413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833817|NCT00764413|Glucocorticoids|glucocorticoids|mesh-ancestor
92833818|NCT00764413|Hormones|hormones|mesh-ancestor
92833819|NCT00764413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92833820|NCT00764413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92833821|NCT00764413|Protective Agents|protective agents|mesh-ancestor
92833822|NCT00764413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92833823|NCT00764413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833824|NCT00941798|Mometasone Furoate|mometasone furoate|mesh-list
92833825|NCT00941798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833826|NCT00941798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833827|NCT00941798|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92833828|NCT00583102|Cytarabine|cytarabine|mesh-list
92833829|NCT00583102|Lovastatin|lovastatin|mesh-list
92833830|NCT00583102|L 647318|l 647318|mesh-list
92833831|NCT00583102|Dihydromevinolin|dihydromevinolin|mesh-list
92833832|NCT00583102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92833833|NCT00583102|Antimetabolites|antimetabolites|mesh-ancestor
92833834|NCT00583102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833835|NCT00583102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833836|NCT00583102|Antiviral Agents|antiviral agents|mesh-ancestor
92833837|NCT00583102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833838|NCT00583102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833839|NCT00583102|Immunologic Factors|immunologic factors|mesh-ancestor
92833840|NCT00583102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833841|NCT00583102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92833843|NCT00583102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92833844|NCT00583102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92833845|NCT00583102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833846|NCT02585440|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
92833847|NCT02585440|Antiviral Agents|antiviral agents|mesh-ancestor
92833848|NCT02585440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92833849|NCT02585440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92833850|NCT02585440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92833851|NCT00605930|Niacinamide|niacinamide|mesh-list
92833852|NCT00605930|Niacin|niacin|mesh-list
92833853|NCT00605930|Nicotinic Acids|nicotinic acids|mesh-list
92833854|NCT00605930|Vitamin B Complex|vitamin b complex|mesh-ancestor
92833855|NCT00605930|Vitamins|vitamins|mesh-ancestor
92833856|NCT00605930|Micronutrients|micronutrients|mesh-ancestor
92833857|NCT00605930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833858|NCT00605930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92833859|NCT00605930|Antimetabolites|antimetabolites|mesh-ancestor
92833860|NCT00605930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833861|NCT00605930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92833862|NCT00605930|Vasodilator Agents|vasodilator agents|mesh-ancestor
92833863|NCT04699630|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92833864|NCT04699630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92833865|NCT04699630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833866|NCT00602186|Prazosin|prazosin|mesh-list
92833867|NCT00602186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92833868|NCT00602186|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92833869|NCT00602186|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92833870|NCT00602186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92833871|NCT00602186|Adrenergic Agents|adrenergic agents|mesh-ancestor
92833872|NCT00602186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833873|NCT00602186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833874|NCT00602186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833875|NCT04204304|Isotretinoin|isotretinoin|mesh-list
92833876|NCT04204304|Dermatologic Agents|dermatologic agents|mesh-ancestor
92833877|NCT05380778|Anesthetics|anesthetics|mesh-list
92833878|NCT05380778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833879|NCT05380778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833880|NCT02852720|Anesthetics|anesthetics|mesh-list
92833881|NCT02852720|Levobupivacaine|levobupivacaine|mesh-list
92833882|NCT02852720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833883|NCT02852720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833884|NCT02852720|Anesthetics, Local|anesthetics, local|mesh-ancestor
92833885|NCT02852720|Sensory System Agents|sensory system agents|mesh-ancestor
92833886|NCT02852720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833887|NCT05857631|Cisplatin|cisplatin|mesh-list
92833888|NCT05857631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833889|NCT05857306|Olvanil|olvanil|mesh-list
92833890|NCT05857306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92833891|NCT05857306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92833892|NCT05857306|Analgesics|analgesics|mesh-ancestor
92833893|NCT05857306|Sensory System Agents|sensory system agents|mesh-ancestor
92833894|NCT05857306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833895|NCT05857306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833896|NCT05857306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92833897|NCT05857306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92833898|NCT05857267|Timolol|timolol|mesh-list
92833899|NCT05857267|Dorzolamide|dorzolamide|mesh-list
92833900|NCT05857267|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92833901|NCT05857267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92833902|NCT05857267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92833903|NCT05857267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92833904|NCT05857267|Adrenergic Agents|adrenergic agents|mesh-ancestor
92833905|NCT05857267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833906|NCT05857267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833907|NCT05857267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833908|NCT05857267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92833909|NCT05857267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92833910|NCT05857267|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92833911|NCT05857267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833912|NCT05857202|Analgesics, Opioid|analgesics, opioid|mesh-list
92833913|NCT05857202|Analgesics|analgesics|mesh-list
92178979|NCT00585559|Antipyretics|antipyretics|mesh-ancestor
92833914|NCT05857202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92833916|NCT05857202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833917|NCT05857202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833918|NCT05857202|Sensory System Agents|sensory system agents|mesh-ancestor
92833919|NCT05857202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92833920|NCT05857085|Empagliflozin|empagliflozin|mesh-list
92833921|NCT05857085|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92833922|NCT05857085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833923|NCT05857085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92833924|NCT05857085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833925|NCT05857059|Misoprostol|misoprostol|mesh-list
92833926|NCT05857059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92833927|NCT05857059|Abortifacient Agents|abortifacient agents|mesh-ancestor
92833928|NCT05857059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92833929|NCT05857059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833930|NCT05857059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92833931|NCT05857059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92833932|NCT05857059|Oxytocics|oxytocics|mesh-ancestor
92833933|NCT05857046|Melatonin|melatonin|mesh-list
92833934|NCT05857046|Antioxidants|antioxidants|mesh-ancestor
92833935|NCT05857046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833936|NCT05857046|Protective Agents|protective agents|mesh-ancestor
92833937|NCT05857046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833938|NCT05857046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833939|NCT05856994|Tacrolimus|tacrolimus|mesh-list
92833940|NCT05856994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92833941|NCT05856994|Immunologic Factors|immunologic factors|mesh-ancestor
92833942|NCT05856994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833943|NCT05856994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92833944|NCT05856994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833945|NCT05856994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833946|NCT05856630|Goserelin|goserelin|mesh-list
92833947|NCT05856630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92148864|NCT04399525|Loratadine|loratadine|mesh-list
92833948|NCT05856630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833949|NCT05856578|Canagliflozin|canagliflozin|mesh-list
92833950|NCT05856578|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92833951|NCT05856578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92833952|NCT05856578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833953|NCT05856578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833954|NCT05856396|Vaccines|vaccines|mesh-list
92833955|NCT05856396|Immunologic Factors|immunologic factors|mesh-ancestor
92833956|NCT05856396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833957|NCT05856383|Vinorelbine|vinorelbine|mesh-list
92833958|NCT05856383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92833959|NCT05856383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833960|NCT05856383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92833961|NCT05856383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92833962|NCT05856383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92833963|NCT05856383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833964|NCT05856084|Vaccines|vaccines|mesh-list
92833965|NCT05856084|Immunologic Factors|immunologic factors|mesh-ancestor
92833966|NCT05856084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833967|NCT05852132|Temazepam|temazepam|mesh-list
92833968|NCT05852132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92833969|NCT05852132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92833970|NCT05852132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833971|NCT05852132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92833972|NCT05852132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92833973|NCT05852132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92833974|NCT05852132|GABA Modulators|gaba modulators|mesh-ancestor
92833975|NCT05852132|GABA Agents|gaba agents|mesh-ancestor
92833976|NCT05852132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92833977|NCT05852132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833978|NCT05851313|Vitamin D|vitamin d|mesh-list
92833979|NCT05851313|Vitamins|vitamins|mesh-ancestor
92833980|NCT05851313|Micronutrients|micronutrients|mesh-ancestor
92833981|NCT05851313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92833982|NCT05851313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92833983|NCT05850611|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92833984|NCT05850611|Methylene Blue|methylene blue|mesh-list
92833985|NCT05850611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833986|NCT05850611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833987|NCT05850611|Hemostatics|hemostatics|mesh-ancestor
92833989|NCT05844813|Doxorubicin|doxorubicin|mesh-list
92833990|NCT05844813|Ifosfamide|ifosfamide|mesh-list
92833991|NCT05844813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92833992|NCT05844813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92833993|NCT05844813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92833994|NCT05844813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92833995|NCT05844813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92833996|NCT05844813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92833997|NCT05844813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92833998|NCT05844813|Alkylating Agents|alkylating agents|mesh-ancestor
92833999|NCT05812417|DA-8010|da-8010|mesh-list
92834000|NCT05812417|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92834001|NCT05812417|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92834002|NCT05812417|Cholinergic Agents|cholinergic agents|mesh-ancestor
92834003|NCT05812417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834004|NCT05812417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834005|NCT05812417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834006|NCT05790681|Insulin|insulin|mesh-list
92834007|NCT05790681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92834008|NCT05790681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834009|NCT05766540|Metformin|metformin|mesh-list
92834010|NCT05766540|Aripiprazole|aripiprazole|mesh-list
92834011|NCT05766540|Clozapine|clozapine|mesh-list
92834012|NCT05766540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92834013|NCT05766540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834014|NCT05766540|Antidepressive Agents|antidepressive agents|mesh-ancestor
92834015|NCT05766540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92834016|NCT05766540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92834017|NCT05766540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92834018|NCT05766540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834019|NCT05766540|Dopamine Agonists|dopamine agonists|mesh-ancestor
92834020|NCT05766540|Dopamine Agents|dopamine agents|mesh-ancestor
92834021|NCT05766540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148865|NCT04399525|Levocetirizine|levocetirizine|mesh-list
92834022|NCT05766540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834023|NCT05766540|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92834024|NCT05766540|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92834025|NCT05766540|Serotonin Agents|serotonin agents|mesh-ancestor
92834026|NCT05766540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92834027|NCT05766540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92834028|NCT05766540|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92834029|NCT05766540|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92834030|NCT05766540|GABA Antagonists|gaba antagonists|mesh-ancestor
92834031|NCT05766540|GABA Agents|gaba agents|mesh-ancestor
92834032|NCT05765084|Pemetrexed|pemetrexed|mesh-list
92834033|NCT05765084|Atezolizumab|atezolizumab|mesh-list
92834034|NCT05765084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834035|NCT05765084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834036|NCT05765084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834037|NCT05765084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92834038|NCT05765084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92834039|NCT05765084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834040|NCT05765084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834041|NCT05757167|Lumefantrine|lumefantrine|mesh-list
92834042|NCT05757167|Artemether|artemether|mesh-list
92834043|NCT05757167|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92834044|NCT05757167|Antimalarials|antimalarials|mesh-ancestor
92834045|NCT05757167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92834046|NCT05757167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92834047|NCT05757167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834048|NCT05751668|Paclitaxel|paclitaxel|mesh-list
92834049|NCT05751668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92834050|NCT05751668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834051|NCT05751668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92834052|NCT05751668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92834053|NCT05751668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92834054|NCT05751668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834055|NCT05746806|Androgens|androgens|mesh-list
92834056|NCT05746806|Hormones|hormones|mesh-ancestor
92834057|NCT05746806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834058|NCT05746806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834059|NCT05741229|Nitroglycerin|nitroglycerin|mesh-list
92834060|NCT05741229|Vasodilator Agents|vasodilator agents|mesh-ancestor
92834061|NCT05733715|Pembrolizumab|pembrolizumab|mesh-list
92834062|NCT05733715|Lenvatinib|lenvatinib|mesh-list
92179171|NCT03007563|Bilirubin|bilirubin|mesh-list
92834063|NCT05733715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834064|NCT05733715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834065|NCT05733715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834066|NCT05733715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834067|NCT05733715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834068|NCT05733715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834069|NCT05721755|Paclitaxel|paclitaxel|mesh-list
92834070|NCT05721755|Cisplatin|cisplatin|mesh-list
92834071|NCT05721755|Carboplatin|carboplatin|mesh-list
92834072|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
92834073|NCT05721755|Fluorouracil|fluorouracil|mesh-list
92834074|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92834075|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92834076|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834077|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
92834078|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
92834079|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
92834080|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834081|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834082|NCT05721755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834083|NCT05721755|Antimetabolites|antimetabolites|mesh-ancestor
92834084|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834085|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834086|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
92834087|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834088|NCT05700422|Varenicline|varenicline|mesh-list
92834089|NCT05700422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92834090|NCT05700422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92834091|NCT05700422|Cholinergic Agents|cholinergic agents|mesh-ancestor
92834092|NCT05700422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834093|NCT05700422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834094|NCT05700422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834095|NCT05678647|Iron|iron|mesh-list
92834096|NCT05678647|Trace Elements|trace elements|mesh-ancestor
92834097|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
92834098|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834099|NCT05641324|Dexamethasone|dexamethasone|mesh-list
92834100|NCT05641324|Lenalidomide|lenalidomide|mesh-list
92834101|NCT05641324|Daratumumab|daratumumab|mesh-list
92834102|NCT05641324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834103|NCT05641324|Antiemetics|antiemetics|mesh-ancestor
92834104|NCT05641324|Autonomic Agents|autonomic agents|mesh-ancestor
92479134|NCT01877226|Narcotics|narcotics|mesh-ancestor
92834105|NCT05641324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834106|NCT05641324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834107|NCT05641324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834108|NCT05641324|Glucocorticoids|glucocorticoids|mesh-ancestor
92834110|NCT05641324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834111|NCT05641324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834112|NCT05641324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834113|NCT05641324|Immunologic Factors|immunologic factors|mesh-ancestor
92834114|NCT05641324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92834115|NCT05641324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92834116|NCT05641324|Growth Substances|growth substances|mesh-ancestor
92834117|NCT05641324|Growth Inhibitors|growth inhibitors|mesh-ancestor
92834118|NCT05639907|Ethanol|ethanol|mesh-list
92834119|NCT05639907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92834120|NCT05639907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834121|NCT05639907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834122|NCT05639907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834123|NCT05625334|Aspirin|aspirin|mesh-list
92834124|NCT05625334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92834125|NCT05625334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92834126|NCT05625334|Analgesics|analgesics|mesh-ancestor
92834127|NCT05625334|Sensory System Agents|sensory system agents|mesh-ancestor
92834128|NCT05625334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834129|NCT05625334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834130|NCT05625334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834131|NCT05625334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834132|NCT05625334|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92834133|NCT05625334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92834134|NCT05625334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834135|NCT05625334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92834136|NCT05625334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92834137|NCT05625334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834138|NCT05625334|Antipyretics|antipyretics|mesh-ancestor
92834139|NCT05623319|Pembrolizumab|pembrolizumab|mesh-list
92834140|NCT05623319|Olaparib|olaparib|mesh-list
92834141|NCT05623319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834142|NCT05623319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834143|NCT05623319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834144|NCT05623319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834145|NCT05623319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92834146|NCT05623319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834147|NCT05615636|Lenalidomide|lenalidomide|mesh-list
92834148|NCT05615636|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92834149|NCT05615636|Immunologic Factors|immunologic factors|mesh-ancestor
92834150|NCT05615636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834151|NCT05615636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92834152|NCT05615636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92834153|NCT05615636|Growth Substances|growth substances|mesh-ancestor
92834154|NCT05615636|Growth Inhibitors|growth inhibitors|mesh-ancestor
92834155|NCT05615636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834156|NCT05615636|Immunoconjugates|immunoconjugates|mesh-ancestor
92834157|NCT05614115|Empagliflozin|empagliflozin|mesh-list
92834158|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92834159|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834160|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92834161|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834162|NCT05604794|Ketamine|ketamine|mesh-list
92834163|NCT05604794|Analgesics|analgesics|mesh-ancestor
92834164|NCT05604794|Sensory System Agents|sensory system agents|mesh-ancestor
92834165|NCT05604794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834166|NCT05604794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834167|NCT05604794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92834168|NCT05604794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92834169|NCT05604794|Anesthetics, General|anesthetics, general|mesh-ancestor
92834170|NCT05604794|Anesthetics|anesthetics|mesh-ancestor
92834171|NCT05604794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834172|NCT05604794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92834173|NCT05604794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92834174|NCT05604794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834175|NCT05604794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834176|NCT05589688|Acyclovir|acyclovir|mesh-list
92834177|NCT05589688|Antiviral Agents|antiviral agents|mesh-ancestor
92834178|NCT05589688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834179|NCT05564598|Valganciclovir|valganciclovir|mesh-list
92834180|NCT05564598|Ganciclovir|ganciclovir|mesh-list
92834181|NCT05564598|Antiviral Agents|antiviral agents|mesh-list
92834182|NCT05564598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834183|NCT05551936|Rituximab|rituximab|mesh-list
92834184|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92834185|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834186|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834187|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
92834188|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834189|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834190|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92834191|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
92834192|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834193|NCT05542134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92834194|NCT05419089|Cisplatin|cisplatin|mesh-list
92834195|NCT05419089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834196|NCT05366829|Tislelizumab|tislelizumab|mesh-list
92834197|NCT05366829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834198|NCT05366829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834199|NCT05356897|Trifluridine|trifluridine|mesh-list
92834200|NCT05356897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92834201|NCT05356897|Trastuzumab|trastuzumab|mesh-list
92834202|NCT05356897|Tucatinib|tucatinib|mesh-list
92834203|NCT05356897|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92834204|NCT05356897|Antibodies|antibodies|mesh-list
92834205|NCT05356897|Immunoglobulins|immunoglobulins|mesh-list
92834206|NCT05356897|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92834207|NCT05356897|Immunologic Factors|immunologic factors|mesh-ancestor
92834208|NCT05356897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834209|NCT05356897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834210|NCT05356897|Antimetabolites|antimetabolites|mesh-ancestor
92834211|NCT05356897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834212|NCT05356897|Antiviral Agents|antiviral agents|mesh-ancestor
92834213|NCT05356897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834214|NCT05356897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834215|NCT05356897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834216|NCT05305248|Dexmedetomidine|dexmedetomidine|mesh-list
92834217|NCT05305248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92834218|NCT05305248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834219|NCT05305248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834220|NCT05305248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92834221|NCT05305248|Analgesics|analgesics|mesh-ancestor
92834222|NCT05305248|Sensory System Agents|sensory system agents|mesh-ancestor
92834223|NCT05305248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834224|NCT05305248|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92736027|NCT00594633|Cholinergic Agents|cholinergic agents|mesh-ancestor
92834225|NCT05305248|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92834226|NCT05305248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92834227|NCT05305248|Adrenergic Agents|adrenergic agents|mesh-ancestor
92834228|NCT05305248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834229|NCT05305248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834230|NCT05286996|Anesthetics|anesthetics|mesh-list
92834231|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
92834232|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834233|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834234|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
92834235|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834236|NCT05248984|Ketorolac|ketorolac|mesh-list
92834237|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92834238|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92834239|NCT05248984|Analgesics|analgesics|mesh-ancestor
92834240|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
92834241|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834242|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834243|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834244|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834245|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92834246|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834247|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834248|NCT05210166|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92834249|NCT05210166|Antioxidants|antioxidants|mesh-ancestor
92834250|NCT05210166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834251|NCT05210166|Protective Agents|protective agents|mesh-ancestor
92834252|NCT05210166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834253|NCT05210166|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92834254|NCT05210166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479284|NCT01878539|Anticoagulants|anticoagulants|mesh-list
92834255|NCT05169593|Adalimumab|adalimumab|mesh-list
92834256|NCT05169593|Infliximab|infliximab|mesh-list
92834257|NCT05169593|Ustekinumab|ustekinumab|mesh-list
92834258|NCT05169593|Vedolizumab|vedolizumab|mesh-list
92834259|NCT05169593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92834260|NCT05169593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834261|NCT05169593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834262|NCT05169593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92834263|NCT05169593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834264|NCT05168163|Atezolizumab|atezolizumab|mesh-list
92834265|NCT05168163|Lenvatinib|lenvatinib|mesh-list
92834266|NCT05168163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92834267|NCT05168163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834268|NCT05168163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834269|NCT05168163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834270|NCT05168163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834271|NCT05168163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834272|NCT05168163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834273|NCT05168163|Immunologic Factors|immunologic factors|mesh-ancestor
92834274|NCT05168163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834275|NCT05158153|Furosemide|furosemide|mesh-list
92834276|NCT05158153|Diuretics|diuretics|mesh-ancestor
92834277|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
92834278|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834279|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92834280|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92834281|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834282|NCT05148234|Decitabine|decitabine|mesh-list
92834283|NCT05148234|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92834284|NCT05148234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834285|NCT05148234|Antimetabolites|antimetabolites|mesh-ancestor
92834286|NCT05148234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834287|NCT05148234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834288|NCT05148234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834290|NCT05147558|Lenvatinib|lenvatinib|mesh-list
92834291|NCT05147558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834292|NCT05147558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834293|NCT05147558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834294|NCT05147558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834295|NCT05147558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834296|NCT05147558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834297|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
92834298|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92834299|NCT05110001|Natamycin|natamycin|mesh-list
92834300|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
92834301|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92834302|NCT05110001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834303|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
92834304|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
92834305|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92834306|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92834307|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92834308|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834309|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834310|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834311|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
92834312|NCT05098366|Furosemide|furosemide|mesh-list
92834313|NCT05098366|Diuretics|diuretics|mesh-ancestor
92834314|NCT05098366|Natriuretic Agents|natriuretic agents|mesh-ancestor
92834315|NCT05098366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834316|NCT05098366|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92834317|NCT05098366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92834318|NCT05098366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834319|NCT05082480|Hyaluronic Acid|hyaluronic acid|mesh-list
92834320|NCT05082480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92834321|NCT05082480|Immunologic Factors|immunologic factors|mesh-ancestor
92834322|NCT05082480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834323|NCT05082480|Viscosupplements|viscosupplements|mesh-ancestor
92834324|NCT05082480|Protective Agents|protective agents|mesh-ancestor
92834325|NCT05073250|Rituximab|rituximab|mesh-list
92834326|NCT05073250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834327|NCT05073250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834328|NCT05073250|Immunologic Factors|immunologic factors|mesh-ancestor
92834329|NCT05073250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834330|NCT05073250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834331|NCT05063162|Rozanolixizumab|rozanolixizumab|mesh-list
92834332|NCT05063162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834333|NCT05063162|Immunologic Factors|immunologic factors|mesh-ancestor
92834334|NCT05063162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834335|NCT05041270|Dexmedetomidine|dexmedetomidine|mesh-list
92834336|NCT05041270|Nalbuphine|nalbuphine|mesh-list
92834337|NCT05041270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92834338|NCT05041270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834339|NCT05041270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834340|NCT05041270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92834341|NCT05041270|Analgesics|analgesics|mesh-ancestor
92834342|NCT05041270|Sensory System Agents|sensory system agents|mesh-ancestor
92834343|NCT05041270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834344|NCT05041270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92834345|NCT05041270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92834346|NCT05041270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92834347|NCT05041270|Adrenergic Agents|adrenergic agents|mesh-ancestor
92834348|NCT05041270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834349|NCT05041270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834350|NCT05041270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92834351|NCT05041270|Narcotics|narcotics|mesh-ancestor
92834352|NCT05039736|Nivolumab|nivolumab|mesh-list
92834353|NCT05039736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834354|NCT05039736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834355|NCT05039736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834356|NCT05039736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834357|NCT05010590|Denosumab|denosumab|mesh-list
92834358|NCT05010590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92834359|NCT05010590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834360|NCT04983940|Methyltestosterone|methyltestosterone|mesh-list
92834361|NCT04983940|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92834363|NCT04983940|Testosterone undecanoate|testosterone undecanoate|mesh-list
92834364|NCT04983940|Testosterone enanthate|testosterone enanthate|mesh-list
92834365|NCT04983940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834366|NCT04983940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834367|NCT04983940|Anabolic Agents|anabolic agents|mesh-ancestor
92834368|NCT04983940|Hormones|hormones|mesh-ancestor
92834369|NCT04983940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834370|NCT04983940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834371|NCT04983940|Androgens|androgens|mesh-ancestor
92834372|NCT04940637|Niraparib|niraparib|mesh-list
92834373|NCT04940637|Dostarlimab|dostarlimab|mesh-list
92834374|NCT04940637|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92834375|NCT04940637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834376|NCT04940637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834377|NCT04940637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834378|NCT04939090|Megestrol|megestrol|mesh-list
92834379|NCT04939090|Megestrol Acetate|megestrol acetate|mesh-list
92834380|NCT04939090|Olanzapine|olanzapine|mesh-list
92834381|NCT04939090|Antiemetics|antiemetics|mesh-ancestor
92834382|NCT04939090|Autonomic Agents|autonomic agents|mesh-ancestor
92834383|NCT04939090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834384|NCT04939090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834385|NCT04939090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834386|NCT04939090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92834387|NCT04939090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92834388|NCT04939090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834389|NCT04939090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92834390|NCT04939090|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92834391|NCT04939090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92834392|NCT04939090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92834393|NCT04939090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834394|NCT04939090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834395|NCT04939090|Serotonin Agents|serotonin agents|mesh-ancestor
92834396|NCT04939090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92834397|NCT04939090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92834398|NCT04939090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92834399|NCT04939090|Contraceptive Agents|contraceptive agents|mesh-ancestor
92834400|NCT04939090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92834401|NCT04939090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92834402|NCT04939090|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92834403|NCT04939090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834404|NCT04939090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834405|NCT04939090|Appetite Stimulants|appetite stimulants|mesh-ancestor
92834406|NCT04939090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92834407|NCT04911660|Empagliflozin|empagliflozin|mesh-list
92834408|NCT04911660|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92834409|NCT04911660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834410|NCT04911660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92834411|NCT04911660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834412|NCT04881682|Immunoglobulins|immunoglobulins|mesh-list
92834413|NCT04881682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92834414|NCT04881682|Antibodies|antibodies|mesh-list
92834415|NCT04881682|Immunologic Factors|immunologic factors|mesh-ancestor
92834416|NCT04881682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834417|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92834418|NCT04839185|Hematinics|hematinics|mesh-ancestor
92834419|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92834420|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92834421|NCT04809220|Dulaglutide|dulaglutide|mesh-list
92834422|NCT04809220|Biguanides|biguanides|mesh-list
92834423|NCT04809220|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92834424|NCT04809220|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92834425|NCT04809220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92834426|NCT04809220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834427|NCT04809220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834428|NCT04809220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834429|NCT04806906|Azacitidine|azacitidine|mesh-list
92834430|NCT04806906|Cc-486|cc-486|mesh-list
92834431|NCT04806906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834432|NCT04806906|Antimetabolites|antimetabolites|mesh-ancestor
92834433|NCT04806906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834434|NCT04806906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834435|NCT04806906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834436|NCT04803201|Prednisone|prednisone|mesh-list
92834437|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
92834438|NCT04803201|Doxorubicin|doxorubicin|mesh-list
92834439|NCT04803201|Etoposide|etoposide|mesh-list
92834440|NCT04803201|Vincristine|vincristine|mesh-list
92834441|NCT04803201|Azacitidine|azacitidine|mesh-list
92834442|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834443|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
92834444|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834445|NCT04803201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834446|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92834447|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
92834448|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834449|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834450|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92834451|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92834452|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92834453|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92834454|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834455|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834456|NCT04803201|Glucocorticoids|glucocorticoids|mesh-ancestor
92834457|NCT04803201|Hormones|hormones|mesh-ancestor
92834458|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834459|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834460|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92834461|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
92834462|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
92834463|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
92834464|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834465|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
92834466|NCT04752059|Trastuzumab|trastuzumab|mesh-list
92834467|NCT04752059|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92834468|NCT04752059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834469|NCT04752059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834470|NCT04752059|Immunoconjugates|immunoconjugates|mesh-ancestor
92834471|NCT04752059|Immunologic Factors|immunologic factors|mesh-ancestor
92834472|NCT04752059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834473|NCT04750473|Edetic Acid|edetic acid|mesh-list
92834474|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92834475|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
92834476|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
92834477|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834478|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
92834479|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92834480|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92834481|NCT04745351|Remdesivir|remdesivir|mesh-list
92834482|NCT04745351|Antimetabolites|antimetabolites|mesh-ancestor
92834483|NCT04745351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834484|NCT04745351|Antiviral Agents|antiviral agents|mesh-ancestor
92834485|NCT04745351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834486|NCT04735549|Hormones|hormones|mesh-list
92834487|NCT04735549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834488|NCT04735549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834489|NCT04710277|Analgesics, Opioid|analgesics, opioid|mesh-list
92834490|NCT04710277|Narcotics|narcotics|mesh-ancestor
92834491|NCT04710277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834492|NCT04710277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834493|NCT04710277|Analgesics|analgesics|mesh-ancestor
92736268|NCT01172275|Acetylcysteine|acetylcysteine|mesh-list
92834494|NCT04710277|Sensory System Agents|sensory system agents|mesh-ancestor
92834495|NCT04710277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834496|NCT04665089|Erythromycin|erythromycin|mesh-list
92834497|NCT04665089|Erythromycin Estolate|erythromycin estolate|mesh-list
92834498|NCT04665089|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92834499|NCT04665089|Erythromycin stearate|erythromycin stearate|mesh-list
92834500|NCT04665089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92834501|NCT04665089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834502|NCT04665089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834503|NCT04665089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92834504|NCT04665089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834505|NCT04665089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834506|NCT04626791|Cytarabine|cytarabine|mesh-list
92834507|NCT04626791|Prednisone|prednisone|mesh-list
92834508|NCT04626791|Cortisone|cortisone|mesh-list
92834509|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
92834510|NCT04626791|Rituximab|rituximab|mesh-list
92834512|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92834513|NCT04626791|Bortezomib|bortezomib|mesh-list
92834514|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
92834515|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92834516|NCT04626791|Antibodies|antibodies|mesh-list
92834517|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
92834518|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92834519|NCT04626791|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92834520|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834521|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
92834522|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834523|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834524|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92834525|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
92834526|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834527|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834528|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92834529|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92834530|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92834531|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92834532|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834533|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834534|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
92834535|NCT04626791|Hormones|hormones|mesh-ancestor
92834536|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834537|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834538|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834539|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
92834540|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
92834541|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834542|NCT04626791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834543|NCT04612790|Benralizumab|benralizumab|mesh-list
92834544|NCT04612790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92834545|NCT04612790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92834546|NCT04591002|Osimertinib|osimertinib|mesh-list
92834547|NCT04591002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834548|NCT04591002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834549|NCT04591002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834550|NCT04591002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834551|NCT04576455|Fulvestrant|fulvestrant|mesh-list
92834552|NCT04576455|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92834553|NCT04576455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834554|NCT04576455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834555|NCT04576455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92834556|NCT04576455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92834557|NCT04576455|Hormone Antagonists|hormone antagonists|mesh-ancestor
92834558|NCT04576455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834559|NCT04576455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834560|NCT04576455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92834561|NCT04576455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834562|NCT04576455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834564|NCT04544111|Dabrafenib|dabrafenib|mesh-list
92834565|NCT04544111|Spartalizumab|spartalizumab|mesh-list
92834566|NCT04544111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834567|NCT04544111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834568|NCT04544111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834569|NCT04544111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834570|NCT04544111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834571|NCT04544111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834572|NCT04498780|Valsartan|valsartan|mesh-list
92834573|NCT04498780|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92834574|NCT04498780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92834575|NCT04498780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92834576|NCT04498780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92834577|NCT04498780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834578|NCT04493333|Calcium polycarbophil|calcium polycarbophil|mesh-list
92834579|NCT04493333|Psyllium|psyllium|mesh-list
92834580|NCT04493333|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92834581|NCT04493333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92834582|NCT04493333|Immunologic Factors|immunologic factors|mesh-ancestor
92834583|NCT04493333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834584|NCT04493333|Antidiarrheals|antidiarrheals|mesh-ancestor
92834585|NCT04493333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834586|NCT04493333|Cathartics|cathartics|mesh-ancestor
92834587|NCT04427501|Bamlanivimab|bamlanivimab|mesh-list
92834588|NCT04427501|Antiviral Agents|antiviral agents|mesh-ancestor
92834589|NCT04427501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834590|NCT04403165|Norepinephrine|norepinephrine|mesh-list
92834591|NCT04403165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92834592|NCT04403165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92834593|NCT04403165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92834594|NCT04403165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834595|NCT04403165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834596|NCT04403165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834597|NCT04403165|Sympathomimetics|sympathomimetics|mesh-ancestor
92834598|NCT04403165|Autonomic Agents|autonomic agents|mesh-ancestor
92834599|NCT04403165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834600|NCT04403165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92834601|NCT04379596|Pembrolizumab|pembrolizumab|mesh-list
92834602|NCT04379596|Fluorouracil|fluorouracil|mesh-list
92834603|NCT04379596|Capecitabine|capecitabine|mesh-list
92834604|NCT04379596|Oxaliplatin|oxaliplatin|mesh-list
92834605|NCT04379596|Trastuzumab|trastuzumab|mesh-list
92834606|NCT04379596|Durvalumab|durvalumab|mesh-list
92834607|NCT04379596|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92834608|NCT04379596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834609|NCT04379596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834610|NCT04379596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92179690|NCT04803474|Hormones|hormones|mesh-list
92834611|NCT04379596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834613|NCT04379596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834614|NCT04379596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834615|NCT04379596|Immunologic Factors|immunologic factors|mesh-ancestor
92834616|NCT04379596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834617|NCT04379596|Immunoconjugates|immunoconjugates|mesh-ancestor
92834618|NCT04289779|Atezolizumab|atezolizumab|mesh-list
92834619|NCT04289779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834620|NCT04289779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834621|NCT04289779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834622|NCT04289779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834623|NCT04271202|Erenumab|erenumab|mesh-list
92834624|NCT04271202|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92834625|NCT04271202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834626|NCT04271202|Analgesics|analgesics|mesh-ancestor
92834627|NCT04271202|Sensory System Agents|sensory system agents|mesh-ancestor
92834628|NCT04271202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834629|NCT04271202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834630|NCT04269213|Cytarabine|cytarabine|mesh-list
92834631|NCT04269213|Daunorubicin|daunorubicin|mesh-list
92834632|NCT04269213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834633|NCT04269213|Antimetabolites|antimetabolites|mesh-ancestor
92834634|NCT04269213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834635|NCT04269213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834636|NCT04269213|Antiviral Agents|antiviral agents|mesh-ancestor
92834637|NCT04269213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834638|NCT04269213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834639|NCT04269213|Immunologic Factors|immunologic factors|mesh-ancestor
92834640|NCT04269213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834641|NCT04269213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92834642|NCT04269213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92834643|NCT04269213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92834644|NCT04269213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834645|NCT04228965|Varenicline|varenicline|mesh-list
92834646|NCT04228965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92834647|NCT04228965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92834648|NCT04228965|Cholinergic Agents|cholinergic agents|mesh-ancestor
92834649|NCT04228965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834650|NCT04228965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834651|NCT04228965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834652|NCT04197687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92834653|NCT04197687|Trastuzumab|trastuzumab|mesh-list
92834654|NCT04197687|Pertuzumab|pertuzumab|mesh-list
92834655|NCT04197687|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92834656|NCT04197687|Maytansine|maytansine|mesh-list
92834657|NCT04197687|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92834658|NCT04197687|Vaccines|vaccines|mesh-list
92834659|NCT04197687|Antibodies|antibodies|mesh-list
92834660|NCT04197687|Immunoglobulins|immunoglobulins|mesh-list
92834661|NCT04197687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92834662|NCT04197687|Sargramostim|sargramostim|mesh-list
92834663|NCT04197687|Immunoconjugates|immunoconjugates|mesh-list
92834664|NCT04197687|Immunologic Factors|immunologic factors|mesh-ancestor
92834665|NCT04197687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834666|NCT04197687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834667|NCT04197687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92834668|NCT04197687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92834669|NCT04197687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92834670|NCT04197687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92834671|NCT04197687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834672|NCT04197687|Immunotoxins|immunotoxins|mesh-ancestor
92834673|NCT04153760|Aspirin|aspirin|mesh-list
92834674|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92834675|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92834676|NCT04153760|Analgesics|analgesics|mesh-ancestor
92834677|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
92834678|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834679|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834680|NCT04153760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834681|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834682|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92834683|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92834684|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834685|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92834686|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92834687|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834688|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
92834689|NCT04130516|Pembrolizumab|pembrolizumab|mesh-list
92834690|NCT04130516|Antibodies|antibodies|mesh-list
92834691|NCT04130516|Immunologic Factors|immunologic factors|mesh-ancestor
92834692|NCT04130516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834693|NCT04130516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834694|NCT04130516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834695|NCT04130516|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834696|NCT04130516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834697|NCT03989778|Vitamin D|vitamin d|mesh-list
92834698|NCT03989778|Vitamins|vitamins|mesh-ancestor
92834699|NCT03989778|Micronutrients|micronutrients|mesh-ancestor
92834700|NCT03989778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834701|NCT03989778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92834702|NCT03976063|Nifedipine|nifedipine|mesh-list
92834703|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92834704|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92834705|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834706|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92834707|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834708|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
92834709|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
92834710|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92834711|NCT03962855|Ifetroban|ifetroban|mesh-list
92834712|NCT03962855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92834713|NCT03959527|Azithromycin|azithromycin|mesh-list
92834714|NCT03959527|Ceftriaxone|ceftriaxone|mesh-list
92834715|NCT03959527|Zoliflodacin|zoliflodacin|mesh-list
92834716|NCT03959527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92834717|NCT03959527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834718|NCT03959527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92834719|NCT03959527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92834720|NCT03959527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834721|NCT03959527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834722|NCT03959527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834723|NCT03955172|Everolimus|everolimus|mesh-list
92834724|NCT03955172|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92834725|NCT03955172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834726|NCT03955172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834727|NCT03955172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834728|NCT03955172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834729|NCT03955172|Immunologic Factors|immunologic factors|mesh-ancestor
92834730|NCT03955172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834731|NCT03955172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834732|NCT03947216|Pimavanserin|pimavanserin|mesh-list
92834733|NCT03947216|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92834734|NCT03947216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92834735|NCT03947216|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92834736|NCT03947216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92834737|NCT03947216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834738|NCT03947216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834739|NCT03947216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92834740|NCT03947216|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92834741|NCT03947216|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92834742|NCT03947216|Serotonin Agents|serotonin agents|mesh-ancestor
92834743|NCT03947216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834744|NCT03947216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834745|NCT03889249|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92834746|NCT03889249|Tenecteplase|tenecteplase|mesh-list
92834747|NCT03889249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92834748|NCT03889249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92834749|NCT03889249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834750|NCT03844620|Trifluridine|trifluridine|mesh-list
92834751|NCT03844620|Antimetabolites|antimetabolites|mesh-ancestor
92834752|NCT03844620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834753|NCT03844620|Antiviral Agents|antiviral agents|mesh-ancestor
92834754|NCT03844620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834755|NCT03841201|Nivolumab|nivolumab|mesh-list
92834756|NCT03841201|Lenvatinib|lenvatinib|mesh-list
92834757|NCT03841201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834758|NCT03841201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179835|NCT04791774|Caseins|caseins|mesh-list
92834760|NCT03841201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834761|NCT03841201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92834762|NCT03841201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834763|NCT03806166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92834764|NCT03806166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834765|NCT03733535|Benralizumab|benralizumab|mesh-list
92834766|NCT03733535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92834767|NCT03733535|Respiratory System Agents|respiratory system agents|mesh-ancestor
92834768|NCT03728972|Pembrolizumab|pembrolizumab|mesh-list
92834769|NCT03728972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834770|NCT03728972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834771|NCT03728972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834772|NCT03728972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834773|NCT03719092|Vitamins|vitamins|mesh-list
92834774|NCT03719092|Vitamin A|vitamin a|mesh-list
92834775|NCT03719092|Retinol palmitate|retinol palmitate|mesh-list
92834776|NCT03719092|Micronutrients|micronutrients|mesh-ancestor
92834777|NCT03719092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834778|NCT03719092|Antioxidants|antioxidants|mesh-ancestor
92834779|NCT03719092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479821|NCT01883323|Analgesics|analgesics|mesh-ancestor
92834780|NCT03719092|Protective Agents|protective agents|mesh-ancestor
92834781|NCT03719092|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92834782|NCT03719092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834783|NCT03661385|Nitric Oxide|nitric oxide|mesh-list
92834784|NCT03661385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92834785|NCT03661385|Autonomic Agents|autonomic agents|mesh-ancestor
92834786|NCT03661385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834787|NCT03661385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834788|NCT03661385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92834789|NCT03661385|Respiratory System Agents|respiratory system agents|mesh-ancestor
92834790|NCT03661385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92834791|NCT03661385|Antioxidants|antioxidants|mesh-ancestor
92834792|NCT03661385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834793|NCT03661385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834794|NCT03661385|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92834795|NCT03661385|Vasodilator Agents|vasodilator agents|mesh-ancestor
92834796|NCT03661385|Gasotransmitters|gasotransmitters|mesh-ancestor
92834797|NCT03661385|Protective Agents|protective agents|mesh-ancestor
92834798|NCT03630055|Rivaroxaban|rivaroxaban|mesh-list
92834799|NCT03630055|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92834800|NCT03630055|Antithrombins|antithrombins|mesh-ancestor
92834801|NCT03630055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92834802|NCT03630055|Protease Inhibitors|protease inhibitors|mesh-ancestor
92834803|NCT03630055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834804|NCT03630055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834805|NCT03630055|Anticoagulants|anticoagulants|mesh-ancestor
92834806|NCT03617731|Dexamethasone|dexamethasone|mesh-list
92834807|NCT03617731|Lenalidomide|lenalidomide|mesh-list
92834808|NCT03617731|Bortezomib|bortezomib|mesh-list
92834809|NCT03617731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834810|NCT03617731|Antiemetics|antiemetics|mesh-ancestor
92834811|NCT03617731|Autonomic Agents|autonomic agents|mesh-ancestor
92834812|NCT03617731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834813|NCT03617731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834814|NCT03617731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834815|NCT03617731|Glucocorticoids|glucocorticoids|mesh-ancestor
92834816|NCT03617731|Hormones|hormones|mesh-ancestor
92834817|NCT03617731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834818|NCT03617731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834819|NCT03617731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834820|NCT03617731|Immunologic Factors|immunologic factors|mesh-ancestor
92834821|NCT03617731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92834822|NCT03617731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92834823|NCT03617731|Growth Substances|growth substances|mesh-ancestor
92834824|NCT03617731|Growth Inhibitors|growth inhibitors|mesh-ancestor
92834825|NCT03531736|Cyclophosphamide|cyclophosphamide|mesh-list
92834826|NCT03531736|Fludarabine|fludarabine|mesh-list
92834827|NCT03531736|Rituximab|rituximab|mesh-list
92834828|NCT03531736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92834829|NCT03531736|Thymoglobulin|thymoglobulin|mesh-list
92834830|NCT03531736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834831|NCT03531736|Immunologic Factors|immunologic factors|mesh-ancestor
92834832|NCT03531736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834833|NCT03531736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834834|NCT03531736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92834835|NCT03531736|Alkylating Agents|alkylating agents|mesh-ancestor
92834836|NCT03531736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834837|NCT03531736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834838|NCT03531736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92834839|NCT03531736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834840|NCT03526874|Lidocaine|lidocaine|mesh-list
92834841|NCT03526874|Anesthetics, Local|anesthetics, local|mesh-ancestor
92834842|NCT03526874|Anesthetics|anesthetics|mesh-ancestor
92834843|NCT03526874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834844|NCT03526874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834845|NCT03526874|Sensory System Agents|sensory system agents|mesh-ancestor
92834846|NCT03526874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834847|NCT03526874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92834848|NCT03526874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92834849|NCT03526874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92834850|NCT03526874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92834851|NCT03526874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834852|NCT03520660|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92479891|NCT01884272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92834853|NCT03520660|Antiviral Agents|antiviral agents|mesh-ancestor
92834854|NCT03520660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834855|NCT03493789|Deoxyglucose|deoxyglucose|mesh-list
92834856|NCT03493789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92834857|NCT03493789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92834858|NCT03493789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834859|NCT03493789|Antimetabolites|antimetabolites|mesh-ancestor
92834860|NCT03493789|Antiviral Agents|antiviral agents|mesh-ancestor
92834861|NCT03493789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834862|NCT03451799|Temozolomide|temozolomide|mesh-list
92834863|NCT03451799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92834864|NCT03451799|Alkylating Agents|alkylating agents|mesh-ancestor
92834865|NCT03451799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834866|NCT03451799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834867|NCT03439124|Cephalosporins|cephalosporins|mesh-list
92834868|NCT03439124|Ceftobiprole|ceftobiprole|mesh-list
92834869|NCT03439124|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92834870|NCT03439124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92834871|NCT03439124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834873|NCT03393741|Vinorelbine|vinorelbine|mesh-list
92834874|NCT03393741|Docetaxel|docetaxel|mesh-list
92834875|NCT03393741|Epothilones|epothilones|mesh-list
92834876|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
92834877|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92834878|NCT03393741|Taxane|taxane|mesh-list
92834879|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92834880|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834881|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
92834882|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
92834883|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
92834884|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834885|NCT03304093|Nivolumab|nivolumab|mesh-list
92834886|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834887|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834888|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834889|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834890|NCT03279471|Sertraline|sertraline|mesh-list
92834891|NCT03279471|Antidepressive Agents|antidepressive agents|mesh-ancestor
92834892|NCT03279471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92834893|NCT03279471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92834894|NCT03279471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92834895|NCT03279471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92834896|NCT03279471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834897|NCT03279471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92834898|NCT03279471|Serotonin Agents|serotonin agents|mesh-ancestor
92834899|NCT03279471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834900|NCT03267888|Pembrolizumab|pembrolizumab|mesh-list
92834901|NCT03267888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92834902|NCT03267888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834903|NCT03267888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92834904|NCT03267888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834905|NCT03263117|Anesthetics|anesthetics|mesh-list
92834906|NCT03263117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92834907|NCT03263117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834909|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
92834910|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92834911|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834912|NCT03212989|Vorinostat|vorinostat|mesh-list
92834913|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834914|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92834915|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834916|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834917|NCT03199053|Dapagliflozin|dapagliflozin|mesh-list
92834918|NCT03199053|Saxagliptin|saxagliptin|mesh-list
92834919|NCT03199053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92834920|NCT03199053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834921|NCT03199053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92834922|NCT03199053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834923|NCT03199053|Incretins|incretins|mesh-ancestor
92834924|NCT03199053|Hormones|hormones|mesh-ancestor
92834925|NCT03199053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834926|NCT03199053|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92479966|NCT01884441|Antimetabolites|antimetabolites|mesh-ancestor
92834927|NCT03199053|Protease Inhibitors|protease inhibitors|mesh-ancestor
92834928|NCT03199053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834929|NCT03158688|Dexamethasone|dexamethasone|mesh-list
92834930|NCT03158688|Daratumumab|daratumumab|mesh-list
92834931|NCT03158688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92834932|NCT03158688|Antiemetics|antiemetics|mesh-ancestor
92834933|NCT03158688|Autonomic Agents|autonomic agents|mesh-ancestor
92834934|NCT03158688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834935|NCT03158688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834936|NCT03158688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92834937|NCT03158688|Glucocorticoids|glucocorticoids|mesh-ancestor
92834938|NCT03158688|Hormones|hormones|mesh-ancestor
92834939|NCT03158688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92834940|NCT03158688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92834941|NCT03158688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834942|NCT03138733|Daptomycin|daptomycin|mesh-list
92834943|NCT03138733|Ceftobiprole|ceftobiprole|mesh-list
92834944|NCT03138733|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92834945|NCT03138733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92834946|NCT03138733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834947|NCT03137173|Vancomycin|vancomycin|mesh-list
92834948|NCT03137173|Aztreonam|aztreonam|mesh-list
92834949|NCT03137173|Ceftobiprole|ceftobiprole|mesh-list
92834950|NCT03137173|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92834951|NCT03137173|Cephalosporins|cephalosporins|mesh-list
92834952|NCT03137173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92834953|NCT03137173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834954|NCT03107988|Cyclophosphamide|cyclophosphamide|mesh-list
92834955|NCT03107988|Topotecan|topotecan|mesh-list
92834956|NCT03107988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834957|NCT03107988|Immunologic Factors|immunologic factors|mesh-ancestor
92834958|NCT03107988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834959|NCT03107988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92834960|NCT03107988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92834961|NCT03107988|Alkylating Agents|alkylating agents|mesh-ancestor
92834962|NCT03107988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834963|NCT03107988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834964|NCT03107988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92834965|NCT03107988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92834966|NCT03107988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92834967|NCT03107988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834968|NCT03089957|Urinastatin|urinastatin|mesh-list
92834969|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92834970|NCT03089957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92834971|NCT03089957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92834972|NCT03089957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92834973|NCT03089957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834974|NCT03080883|Apixaban|apixaban|mesh-list
92834975|NCT03080883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92834976|NCT03080883|Antithrombins|antithrombins|mesh-ancestor
92834977|NCT03080883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92834978|NCT03080883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92834979|NCT03080883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977208|NCT00545103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92834980|NCT03080883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834981|NCT03080883|Anticoagulants|anticoagulants|mesh-ancestor
92834982|NCT03072147|Teriparatide|teriparatide|mesh-list
92834983|NCT03072147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92834984|NCT03072147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834985|NCT03072147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92834986|NCT02835222|Cytarabine|cytarabine|mesh-list
92834987|NCT02835222|Daunorubicin|daunorubicin|mesh-list
92834988|NCT02835222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92834989|NCT02835222|Antimetabolites|antimetabolites|mesh-ancestor
92834990|NCT02835222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92834991|NCT02835222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92834992|NCT02835222|Antiviral Agents|antiviral agents|mesh-ancestor
92834993|NCT02835222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92834994|NCT02835222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92834995|NCT02835222|Immunologic Factors|immunologic factors|mesh-ancestor
92834996|NCT02835222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92834997|NCT02835222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92834998|NCT02835222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92834999|NCT02835222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92835000|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835001|NCT02723513|Xenon|xenon|mesh-list
92835002|NCT02723513|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92835003|NCT02723513|Anesthetics, General|anesthetics, general|mesh-ancestor
92835004|NCT02723513|Anesthetics|anesthetics|mesh-ancestor
92835005|NCT02723513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835006|NCT02723513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835008|NCT02706054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92835009|NCT02706054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835010|NCT02706054|Analgesics|analgesics|mesh-ancestor
92835011|NCT02706054|Sensory System Agents|sensory system agents|mesh-ancestor
92835012|NCT02706054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835013|NCT02706054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835014|NCT02706054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835015|NCT02706054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835016|NCT02706054|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92835017|NCT02706054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92835018|NCT02706054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835019|NCT02706054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835020|NCT02630641|Hormones|hormones|mesh-list
92835021|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835022|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835023|NCT02600117|Tenofovir|tenofovir|mesh-list
92835024|NCT02600117|Antiviral Agents|antiviral agents|mesh-ancestor
92835025|NCT02600117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835026|NCT02600117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92835027|NCT02600117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92835028|NCT02600117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835029|NCT02600117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835030|NCT02600117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92835031|NCT02600117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92835032|NCT02599714|Fulvestrant|fulvestrant|mesh-list
92835033|NCT02599714|Palbociclib|palbociclib|mesh-list
92835034|NCT02599714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92835035|NCT02599714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835036|NCT02599714|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92835037|NCT02599714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92835038|NCT02599714|Hormone Antagonists|hormone antagonists|mesh-ancestor
92835039|NCT02599714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835040|NCT02599714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835041|NCT02599714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835042|NCT02599714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835043|NCT02599714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835044|NCT02337634|Silymarin|silymarin|mesh-list
92835045|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
92835046|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835047|NCT02337634|Protective Agents|protective agents|mesh-ancestor
92835048|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835049|NCT02288195|Capecitabine|capecitabine|mesh-list
92835050|NCT02288195|Oxaliplatin|oxaliplatin|mesh-list
92835051|NCT02288195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92835052|NCT02288195|Antimetabolites|antimetabolites|mesh-ancestor
92835053|NCT02288195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835054|NCT02288195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835055|NCT02265874|Nicotine|nicotine|mesh-list
92835056|NCT02265874|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92835057|NCT02265874|Autonomic Agents|autonomic agents|mesh-ancestor
92835058|NCT02265874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835059|NCT02265874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835060|NCT02265874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92835061|NCT02265874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92835062|NCT02265874|Cholinergic Agents|cholinergic agents|mesh-ancestor
92835063|NCT02265874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835064|NCT02265874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835065|NCT02168140|Thioctic Acid|thioctic acid|mesh-list
92835066|NCT02168140|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92835067|NCT02168140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92835068|NCT02168140|Alkylating Agents|alkylating agents|mesh-ancestor
92835069|NCT02168140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835070|NCT02168140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835071|NCT02168140|Antioxidants|antioxidants|mesh-ancestor
92835072|NCT02168140|Protective Agents|protective agents|mesh-ancestor
92835073|NCT02168140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835074|NCT02168140|Vitamin B Complex|vitamin b complex|mesh-ancestor
92835075|NCT02168140|Vitamins|vitamins|mesh-ancestor
92835076|NCT02168140|Micronutrients|micronutrients|mesh-ancestor
92835077|NCT02087423|Durvalumab|durvalumab|mesh-list
92835078|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92835079|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835081|NCT01996436|Nicardipine|nicardipine|mesh-list
92835082|NCT01996436|Nitroglycerin|nitroglycerin|mesh-list
92835083|NCT01996436|Vasodilator Agents|vasodilator agents|mesh-ancestor
92835084|NCT01996436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92835085|NCT01996436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92835086|NCT01996436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835087|NCT01996436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835088|NCT01996436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92835089|NCT01996436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835090|NCT01996436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835091|NCT01845337|Capecitabine|capecitabine|mesh-list
92835092|NCT01845337|Tegafur|tegafur|mesh-list
92835093|NCT01845337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92835094|NCT01845337|Antimetabolites|antimetabolites|mesh-ancestor
92835095|NCT01845337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835096|NCT01845337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835097|NCT01760005|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92835098|NCT01760005|Immunologic Factors|immunologic factors|mesh-ancestor
92835099|NCT01760005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835100|NCT01613118|Irbesartan|irbesartan|mesh-list
92835101|NCT01613118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835102|NCT01613118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92835103|NCT01613118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92835104|NCT01613118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835105|NCT00836537|Benazepril|benazepril|mesh-list
92835106|NCT00836537|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92835107|NCT00836537|Protease Inhibitors|protease inhibitors|mesh-ancestor
92835108|NCT00836537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835109|NCT00836537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835110|NCT00836537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835111|NCT00680901|Capecitabine|capecitabine|mesh-list
92835112|NCT00680901|Oxaliplatin|oxaliplatin|mesh-list
92835113|NCT00680901|Lapatinib|lapatinib|mesh-list
92835114|NCT00680901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92835115|NCT00680901|Antimetabolites|antimetabolites|mesh-ancestor
92835116|NCT00680901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835117|NCT00680901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835118|NCT00680901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835119|NCT00680901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835120|NCT00572169|Thalidomide|thalidomide|mesh-list
92835121|NCT00572169|Dexamethasone|dexamethasone|mesh-list
92835122|NCT00572169|Cyclophosphamide|cyclophosphamide|mesh-list
92835123|NCT00572169|Cisplatin|cisplatin|mesh-list
92835124|NCT00572169|Doxorubicin|doxorubicin|mesh-list
92835125|NCT00572169|Etoposide|etoposide|mesh-list
92835126|NCT00572169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92835127|NCT00572169|Bortezomib|bortezomib|mesh-list
92835128|NCT00572169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835129|NCT00572169|Immunologic Factors|immunologic factors|mesh-ancestor
92835130|NCT00572169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835131|NCT00572169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835132|NCT00572169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92835133|NCT00572169|Alkylating Agents|alkylating agents|mesh-ancestor
92835134|NCT00572169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835135|NCT00572169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835136|NCT00572169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92835137|NCT00572169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835138|NCT00572169|Antiemetics|antiemetics|mesh-ancestor
92835139|NCT00572169|Autonomic Agents|autonomic agents|mesh-ancestor
92835140|NCT00572169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835141|NCT00572169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835142|NCT00572169|Glucocorticoids|glucocorticoids|mesh-ancestor
92835143|NCT00572169|Hormones|hormones|mesh-ancestor
92835144|NCT00572169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835145|NCT00572169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92835146|NCT00572169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92835147|NCT00572169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92835148|NCT00572169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92835149|NCT00572169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835150|NCT00572169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92835151|NCT00572169|Leprostatic Agents|leprostatic agents|mesh-ancestor
92480192|NCT01886001|Povidone|povidone|mesh-list
92835152|NCT00572169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92835153|NCT00572169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835154|NCT00572169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92835155|NCT00572169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92835156|NCT00572169|Growth Substances|growth substances|mesh-ancestor
92835157|NCT00572169|Growth Inhibitors|growth inhibitors|mesh-ancestor
92835158|NCT00505063|Vaccines|vaccines|mesh-list
92835159|NCT00505063|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92835160|NCT00505063|Immunologic Factors|immunologic factors|mesh-ancestor
92835161|NCT00505063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835162|NCT00941720|Cyclophosphamide|cyclophosphamide|mesh-list
92835163|NCT00941720|Busulfan|busulfan|mesh-list
92835164|NCT00941720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835165|NCT00941720|Immunologic Factors|immunologic factors|mesh-ancestor
92835166|NCT00941720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835167|NCT00941720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835168|NCT00941720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92835169|NCT00941720|Alkylating Agents|alkylating agents|mesh-ancestor
92835170|NCT00941720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835171|NCT00941720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835172|NCT00941720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92835173|NCT02583568|Bevacizumab|bevacizumab|mesh-list
92835174|NCT02583568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92835175|NCT02583568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835176|NCT02583568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92835177|NCT02583568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92835178|NCT02583568|Growth Substances|growth substances|mesh-ancestor
92835179|NCT02583568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835180|NCT02583568|Growth Inhibitors|growth inhibitors|mesh-ancestor
92835181|NCT02852564|Ethacrynic Acid|ethacrynic acid|mesh-list
92835182|NCT02852564|Diuretics|diuretics|mesh-ancestor
92835183|NCT02852564|Natriuretic Agents|natriuretic agents|mesh-ancestor
92835184|NCT02852564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835185|NCT02852564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835186|NCT02852564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835187|NCT05593042|Vaccines|vaccines|mesh-list
92835188|NCT05593042|Immunologic Factors|immunologic factors|mesh-ancestor
92835189|NCT05593042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835190|NCT05509816|Midazolam|midazolam|mesh-list
92835191|NCT05509816|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92835192|NCT05509816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92835193|NCT05509816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835194|NCT05509816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835195|NCT05509816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92835196|NCT05509816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92835197|NCT05509816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92835198|NCT05509816|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92835199|NCT05509816|Anesthetics, General|anesthetics, general|mesh-ancestor
92835200|NCT05509816|Anesthetics|anesthetics|mesh-ancestor
92835201|NCT05509816|GABA Modulators|gaba modulators|mesh-ancestor
92835202|NCT05509816|GABA Agents|gaba agents|mesh-ancestor
92835203|NCT05509816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835204|NCT05509816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835206|NCT04080310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92835207|NCT04080310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92835208|NCT04080310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92835209|NCT04080310|Antimetabolites|antimetabolites|mesh-ancestor
92835210|NCT04080310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835211|NCT04080310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92835212|NCT04080310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835213|NCT04078048|Vitamins|vitamins|mesh-list
92835214|NCT04078048|Vitamin E|vitamin e|mesh-list
92835215|NCT04078048|Antioxidants|antioxidants|mesh-list
92835216|NCT04078048|Micronutrients|micronutrients|mesh-ancestor
92835217|NCT04078048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835218|NCT04078048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835219|NCT04078048|Protective Agents|protective agents|mesh-ancestor
92835220|NCT00673387|Pramlintide|pramlintide|mesh-list
92835221|NCT00673387|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92835222|NCT00673387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92835223|NCT00673387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835224|NCT00673387|Appetite Depressants|appetite depressants|mesh-ancestor
92835225|NCT00673387|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92835226|NCT00673387|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
93046913|NCT00350636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92835227|NCT00673387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835228|NCT00933608|Memantine|memantine|mesh-list
92835229|NCT00933608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92835230|NCT00933608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92835231|NCT00933608|Dopamine Agents|dopamine agents|mesh-ancestor
92835232|NCT00933608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835233|NCT00933608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835234|NCT00933608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835235|NCT00933608|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92835236|NCT00933608|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92835237|NCT05380310|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92835238|NCT02558023|Nicardipine|nicardipine|mesh-list
92835239|NCT02558023|Urapidil|urapidil|mesh-list
92835240|NCT02558023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835241|NCT02558023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92835242|NCT02558023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835243|NCT02558023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835244|NCT02558023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92835245|NCT02558023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835246|NCT02558023|Vasodilator Agents|vasodilator agents|mesh-ancestor
92835247|NCT02558023|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92835248|NCT02558023|Serotonin Agents|serotonin agents|mesh-ancestor
92835249|NCT02558023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835250|NCT02558023|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92835251|NCT02558023|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92835252|NCT02558023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92835253|NCT02558023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835254|NCT00607568|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92835255|NCT00607568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92835256|NCT00607568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92835257|NCT00607568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835258|NCT00607568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835259|NCT00607568|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835260|NCT00607568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835261|NCT00607568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835262|NCT00606164|Bryostatin 1|bryostatin 1|mesh-list
92835263|NCT00606164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92835264|NCT00606164|Immunologic Factors|immunologic factors|mesh-ancestor
92835265|NCT00606164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835266|NCT00606164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835267|NCT00574951|Motesanib diphosphate|motesanib diphosphate|mesh-list
92835268|NCT00574951|Imetelstat|imetelstat|mesh-list
92835269|NCT00574951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835270|NCT00574951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835271|NCT00574951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835272|NCT02584816|Vaccines|vaccines|mesh-list
92835273|NCT02584816|Immunologic Factors|immunologic factors|mesh-ancestor
92835274|NCT02584816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835275|NCT02584738|Methylprednisolone|methylprednisolone|mesh-list
92835277|NCT02584738|Magnesium Sulfate|magnesium sulfate|mesh-list
92835278|NCT02584738|Bromides|bromides|mesh-list
92835279|NCT02584738|Albuterol|albuterol|mesh-list
92835280|NCT02584738|Ipratropium|ipratropium|mesh-list
92835281|NCT02584738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835282|NCT02584738|Antiemetics|antiemetics|mesh-ancestor
92835283|NCT02584738|Autonomic Agents|autonomic agents|mesh-ancestor
92835284|NCT02584738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835285|NCT02584738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835286|NCT02584738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835287|NCT02584738|Glucocorticoids|glucocorticoids|mesh-ancestor
92835288|NCT02584738|Hormones|hormones|mesh-ancestor
92835289|NCT02584738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835290|NCT02584738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92835291|NCT02584738|Protective Agents|protective agents|mesh-ancestor
92835292|NCT02584738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92835293|NCT02584738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835294|NCT02584738|Anticonvulsants|anticonvulsants|mesh-ancestor
92835295|NCT02584738|Analgesics|analgesics|mesh-ancestor
92835296|NCT02584738|Sensory System Agents|sensory system agents|mesh-ancestor
92835297|NCT02584738|Anesthetics|anesthetics|mesh-ancestor
92835298|NCT02584738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835299|NCT02584738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92835300|NCT02584738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93046914|NCT00350636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92835301|NCT02584738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835302|NCT02584738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835303|NCT02584738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92835304|NCT02584738|Tocolytic Agents|tocolytic agents|mesh-ancestor
92835305|NCT02584738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92835306|NCT02584738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92835307|NCT02584738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92835308|NCT02584738|Respiratory System Agents|respiratory system agents|mesh-ancestor
92835309|NCT02584738|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92835310|NCT02584738|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92835311|NCT02584738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92835312|NCT02584738|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835313|NCT02584738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835314|NCT02584738|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92835315|NCT02584738|Cholinergic Agents|cholinergic agents|mesh-ancestor
92835316|NCT00765271|Ritonavir|ritonavir|mesh-list
92835317|NCT00765271|Darunavir|darunavir|mesh-list
92835318|NCT00765271|Raltegravir Potassium|raltegravir potassium|mesh-list
92835319|NCT00765271|Abacavir|abacavir|mesh-list
92835320|NCT00765271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92835321|NCT00765271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92835322|NCT00765271|Protease Inhibitors|protease inhibitors|mesh-ancestor
92835323|NCT00765271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835324|NCT00765271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835325|NCT00765271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92835326|NCT00765271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92835327|NCT00765271|Antiviral Agents|antiviral agents|mesh-ancestor
92835328|NCT00765271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835329|NCT00765271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92835330|NCT00765271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92835331|NCT00765271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92835332|NCT00765271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92835333|NCT00765271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92835334|NCT00765271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92835335|NCT04416568|Nivolumab|nivolumab|mesh-list
92835336|NCT04416568|Ipilimumab|ipilimumab|mesh-list
92835337|NCT04416568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92835338|NCT04416568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835339|NCT04416568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92835340|NCT04416568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835341|NCT02583022|Pimecrolimus|pimecrolimus|mesh-list
92835342|NCT02583022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92835343|NCT02583022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835344|NCT02583022|Analgesics|analgesics|mesh-ancestor
92835345|NCT02583022|Sensory System Agents|sensory system agents|mesh-ancestor
92835346|NCT02583022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835347|NCT02583022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835348|NCT02583022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835349|NCT02583022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835350|NCT02583022|Dermatologic Agents|dermatologic agents|mesh-ancestor
92835351|NCT02583022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835352|NCT02583022|Immunologic Factors|immunologic factors|mesh-ancestor
92835353|NCT02583022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92835354|NCT02583022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835355|NCT02583022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835356|NCT00764725|Sulfasalazine|sulfasalazine|mesh-list
92835357|NCT00764725|Infliximab|infliximab|mesh-list
92835358|NCT00764725|Methotrexate|methotrexate|mesh-list
92835359|NCT00764725|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92835360|NCT00764725|Abortifacient Agents|abortifacient agents|mesh-ancestor
92835361|NCT00764725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92835362|NCT00764725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835363|NCT00764725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92835364|NCT00764725|Antimetabolites|antimetabolites|mesh-ancestor
92835365|NCT00764725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835366|NCT00764725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835367|NCT00764725|Dermatologic Agents|dermatologic agents|mesh-ancestor
92835368|NCT00764725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835369|NCT00764725|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92835370|NCT00764725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835371|NCT00764725|Immunologic Factors|immunologic factors|mesh-ancestor
92835372|NCT00764725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835373|NCT00764725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92480419|NCT01887275|Interferons|interferons|mesh-list
92835374|NCT00764725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92835375|NCT00764725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835376|NCT00764725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835377|NCT00764725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835378|NCT00764725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92835379|NCT00764725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835380|NCT00764725|Analgesics|analgesics|mesh-ancestor
92835381|NCT00764725|Sensory System Agents|sensory system agents|mesh-ancestor
92835382|NCT00764725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835383|NCT00936884|Methylnaltrexone|methylnaltrexone|mesh-list
92835384|NCT00936884|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92835385|NCT00936884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835386|NCT00936884|Sensory System Agents|sensory system agents|mesh-ancestor
92835387|NCT00936884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835388|NCT04077892|Budesonide|budesonide|mesh-list
92835389|NCT04077892|Montelukast|montelukast|mesh-list
92835390|NCT04077892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835391|NCT04077892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92835392|NCT04077892|Autonomic Agents|autonomic agents|mesh-ancestor
92835393|NCT04077892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835394|NCT04077892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835395|NCT04077892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92835396|NCT04077892|Respiratory System Agents|respiratory system agents|mesh-ancestor
92835397|NCT04077892|Glucocorticoids|glucocorticoids|mesh-ancestor
92835398|NCT04077892|Hormones|hormones|mesh-ancestor
92835399|NCT04077892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835400|NCT04077892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92835401|NCT04077892|Hormone Antagonists|hormone antagonists|mesh-ancestor
92835402|NCT04077892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92835403|NCT04077892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92835404|NCT04077892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835405|NCT00606242|Fluticasone|fluticasone|mesh-list
92835406|NCT00606242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835407|NCT00606242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92835408|NCT00606242|Autonomic Agents|autonomic agents|mesh-ancestor
92835409|NCT00606242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835410|NCT00606242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835411|NCT00606242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92835412|NCT00606242|Respiratory System Agents|respiratory system agents|mesh-ancestor
92835413|NCT00606242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92835414|NCT00606242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92835415|NCT00607646|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92835416|NCT00607646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92835417|NCT00607646|Immunologic Factors|immunologic factors|mesh-ancestor
92835418|NCT00607646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835419|NCT00770263|Sirolimus|sirolimus|mesh-list
92835420|NCT00770263|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92835421|NCT00770263|Temsirolimus|temsirolimus|mesh-list
92835423|NCT00770263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835424|NCT00770263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835425|NCT00770263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835426|NCT00770263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835427|NCT00770263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835428|NCT00770263|Immunologic Factors|immunologic factors|mesh-ancestor
92835429|NCT00770263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835430|NCT00770263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737182|NCT01106677|Metformin|metformin|mesh-list
92835431|NCT00770263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835432|NCT00770263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92835433|NCT00770263|Antifungal Agents|antifungal agents|mesh-ancestor
92835434|NCT02691026|Pembrolizumab|pembrolizumab|mesh-list
92835435|NCT02691026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92835436|NCT02691026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835437|NCT02691026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92835438|NCT02691026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835439|NCT05400148|Bupivacaine|bupivacaine|mesh-list
92835440|NCT05400148|Anesthetics, Local|anesthetics, local|mesh-ancestor
92835441|NCT05400148|Anesthetics|anesthetics|mesh-ancestor
92835442|NCT05400148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835443|NCT05400148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835444|NCT05400148|Sensory System Agents|sensory system agents|mesh-ancestor
92835445|NCT05400148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835446|NCT00765427|Retinol acetate|retinol acetate|mesh-list
92835447|NCT00765427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92835448|NCT00765427|Immunologic Factors|immunologic factors|mesh-ancestor
92835449|NCT00765427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835450|NCT00765427|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92835451|NCT00765427|Protective Agents|protective agents|mesh-ancestor
92835452|NCT00765427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835453|NCT02584582|Liraglutide|liraglutide|mesh-list
92835454|NCT02584582|Exenatide|exenatide|mesh-list
92835455|NCT02584582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92835456|NCT02584582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835457|NCT02584582|Incretins|incretins|mesh-ancestor
92835458|NCT02584582|Hormones|hormones|mesh-ancestor
92835459|NCT02584582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835460|NCT02584582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92835461|NCT04266002|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92835462|NCT04266002|Antiviral Agents|antiviral agents|mesh-ancestor
92835463|NCT04266002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835464|NCT00765973|Topotecan|topotecan|mesh-list
92835465|NCT00765973|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92835466|NCT00765973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92835467|NCT00765973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835468|NCT00765973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835469|NCT00765973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835470|NCT00775177|Doxycycline|doxycycline|mesh-list
92835471|NCT00775177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92835472|NCT00775177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835473|NCT00775177|Antimalarials|antimalarials|mesh-ancestor
92835474|NCT00775177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92835475|NCT00775177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92835476|NCT00770497|Pioglitazone|pioglitazone|mesh-list
92835477|NCT00770497|Ramipril|ramipril|mesh-list
92835478|NCT00770497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92835479|NCT00770497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835480|NCT00770497|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92835481|NCT00770497|Protease Inhibitors|protease inhibitors|mesh-ancestor
92835482|NCT00770497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835483|NCT00770497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835484|NCT00770497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835485|NCT02581696|Irsogladine|irsogladine|mesh-list
92835486|NCT02581696|Lafutidine|lafutidine|mesh-list
92835487|NCT02581696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835488|NCT02581696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92835489|NCT02581696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835490|NCT02581696|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92835491|NCT02581696|Histamine Antagonists|histamine antagonists|mesh-ancestor
92835492|NCT02581696|Histamine Agents|histamine agents|mesh-ancestor
92835493|NCT02581696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835494|NCT02581696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835495|NCT02581696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835496|NCT02581696|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92835497|NCT02581696|Protective Agents|protective agents|mesh-ancestor
92835498|NCT02581696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92835500|NCT00607958|Tipranavir|tipranavir|mesh-list
92835501|NCT00607958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92835502|NCT00607958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92835503|NCT00607958|Protease Inhibitors|protease inhibitors|mesh-ancestor
92835504|NCT00607958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835505|NCT00607958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835506|NCT00607958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92835507|NCT00607958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92835508|NCT00607958|Antiviral Agents|antiviral agents|mesh-ancestor
92835509|NCT00607958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835510|NCT00607958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92835511|NCT00607958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92835512|NCT00770575|Pioglitazone|pioglitazone|mesh-list
92835513|NCT00770575|Atorvastatin|atorvastatin|mesh-list
92835514|NCT00770575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92835515|NCT00770575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92835516|NCT00770575|Antimetabolites|antimetabolites|mesh-ancestor
92835517|NCT00770575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835518|NCT00770575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92835519|NCT00770575|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92835520|NCT00770575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835521|NCT00770575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92835522|NCT00770575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835523|NCT00770731|Sirolimus|sirolimus|mesh-list
92835524|NCT00770731|Bortezomib|bortezomib|mesh-list
92835525|NCT00770731|Topotecan|topotecan|mesh-list
92835526|NCT00770731|Temsirolimus|temsirolimus|mesh-list
92835527|NCT00770731|MTOR Inhibitors|mtor inhibitors|mesh-list
92835528|NCT00770731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835529|NCT00770731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92835530|NCT00770731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92835531|NCT00770731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835532|NCT00770731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835533|NCT00770731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835534|NCT00770731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835535|NCT00770731|Immunologic Factors|immunologic factors|mesh-ancestor
92835536|NCT00770731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835537|NCT00770731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92835538|NCT00770731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835539|NCT00770731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92835540|NCT00770731|Antifungal Agents|antifungal agents|mesh-ancestor
92835541|NCT00775255|Clarithromycin|clarithromycin|mesh-list
92835542|NCT00775255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92835543|NCT00775255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835544|NCT00775255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92835545|NCT00775255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835546|NCT00775255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835547|NCT00775255|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92835548|NCT00775255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92835549|NCT00606866|Sorafenib|sorafenib|mesh-list
92835550|NCT00606866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835551|NCT00606866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835552|NCT00606866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835553|NCT00606866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835554|NCT00766285|Vaccines|vaccines|mesh-list
92835555|NCT00766285|Immunologic Factors|immunologic factors|mesh-ancestor
92835556|NCT00766285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835557|NCT04265456|Acetaminophen|acetaminophen|mesh-list
92835558|NCT04265456|Pregabalin|pregabalin|mesh-list
92835559|NCT04265456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835560|NCT04265456|Analgesics|analgesics|mesh-ancestor
92835561|NCT04265456|Sensory System Agents|sensory system agents|mesh-ancestor
92835562|NCT04265456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835563|NCT04265456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835564|NCT04265456|Antipyretics|antipyretics|mesh-ancestor
92835565|NCT04265456|Anticonvulsants|anticonvulsants|mesh-ancestor
92835566|NCT04265456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92835567|NCT04265456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835568|NCT04265456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835569|NCT04265456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92835570|NCT04265456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92835571|NCT04265456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92835572|NCT04265456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835573|NCT04265456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92835574|NCT04379518|Interferons|interferons|mesh-list
92835575|NCT04379518|Interferon-alpha|interferon-alpha|mesh-list
92835576|NCT04379518|Interferon alpha-2|interferon alpha-2|mesh-list
92835577|NCT04379518|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92737329|NCT04328636|Anticonvulsants|anticonvulsants|mesh-ancestor
92835578|NCT04379518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835579|NCT04379518|Antiviral Agents|antiviral agents|mesh-ancestor
92835580|NCT04379518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835581|NCT04379518|Immunologic Factors|immunologic factors|mesh-ancestor
92835582|NCT04379518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835583|NCT04378426|Midazolam|midazolam|mesh-list
92835584|NCT04378426|Nitrous Oxide|nitrous oxide|mesh-list
92835585|NCT04378426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92835586|NCT04378426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92835587|NCT04378426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835588|NCT04378426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835589|NCT04378426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92835590|NCT04378426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92835591|NCT04378426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92835592|NCT04378426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92835593|NCT04378426|Anesthetics, General|anesthetics, general|mesh-ancestor
92835594|NCT04378426|Anesthetics|anesthetics|mesh-ancestor
92835595|NCT04378426|GABA Modulators|gaba modulators|mesh-ancestor
92835596|NCT04378426|GABA Agents|gaba agents|mesh-ancestor
92835597|NCT04378426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835598|NCT04378426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835599|NCT04378426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92835600|NCT04378426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835602|NCT04378426|Sensory System Agents|sensory system agents|mesh-ancestor
92835603|NCT04378426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835604|NCT02581462|Trastuzumab|trastuzumab|mesh-list
92835605|NCT02581462|Pertuzumab|pertuzumab|mesh-list
92835606|NCT02581462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92835607|NCT02581462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835608|NCT00668863|Leucovorin|leucovorin|mesh-list
92835609|NCT00668863|Fluorouracil|fluorouracil|mesh-list
92835610|NCT00668863|Irinotecan|irinotecan|mesh-list
92835611|NCT00668863|Sunitinib|sunitinib|mesh-list
92835612|NCT00668863|Levoleucovorin|levoleucovorin|mesh-list
92835613|NCT00668863|Antimetabolites|antimetabolites|mesh-ancestor
92835614|NCT00668863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835615|NCT00668863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92835616|NCT00668863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835617|NCT00668863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835618|NCT00668863|Immunologic Factors|immunologic factors|mesh-ancestor
92835619|NCT00668863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835620|NCT00668863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92835621|NCT00668863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92835622|NCT00668863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835623|NCT00668863|Antidotes|antidotes|mesh-ancestor
92835624|NCT00668863|Protective Agents|protective agents|mesh-ancestor
92835625|NCT00668863|Vitamin B Complex|vitamin b complex|mesh-ancestor
92835626|NCT00668863|Vitamins|vitamins|mesh-ancestor
92835627|NCT00668863|Micronutrients|micronutrients|mesh-ancestor
92835628|NCT00668863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92835629|NCT00668863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92835630|NCT00668863|Growth Substances|growth substances|mesh-ancestor
92835631|NCT00668863|Growth Inhibitors|growth inhibitors|mesh-ancestor
92835632|NCT00668863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835633|NCT04077736|Aldesleukin|aldesleukin|mesh-list
92835634|NCT04077736|Interleukin-2|interleukin-2|mesh-list
92835635|NCT04077736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835636|NCT04077736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835637|NCT04077736|Analgesics|analgesics|mesh-ancestor
92835638|NCT04077736|Sensory System Agents|sensory system agents|mesh-ancestor
92835639|NCT04077736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835640|NCT04077736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835641|NCT04077736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92835642|NCT04077736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92835643|NCT04077736|Antiviral Agents|antiviral agents|mesh-ancestor
92835644|NCT04077736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835645|NCT00766441|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92835646|NCT00766441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92835647|NCT00766441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835648|NCT00766441|Incretins|incretins|mesh-ancestor
92835649|NCT00766441|Hormones|hormones|mesh-ancestor
92977209|NCT00545103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835650|NCT00766441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835651|NCT00766441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92835652|NCT00766441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92835653|NCT00766441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835654|NCT00766441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835655|NCT00771043|Natalizumab|natalizumab|mesh-list
92835656|NCT00771043|Immunologic Factors|immunologic factors|mesh-ancestor
92835657|NCT00771043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835658|NCT04267250|Levonorgestrel|levonorgestrel|mesh-list
92835659|NCT04267250|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92835660|NCT04267250|Estradiol|estradiol|mesh-list
92835661|NCT04267250|PF-06700841|pf-06700841|mesh-list
92835662|NCT04267250|Estrogens|estrogens|mesh-ancestor
92835663|NCT04267250|Hormones|hormones|mesh-ancestor
92835664|NCT04267250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835665|NCT04267250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835666|NCT04267250|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92835667|NCT04267250|Contraceptive Agents|contraceptive agents|mesh-ancestor
92835668|NCT04267250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92835669|NCT04267250|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92835670|NCT04267250|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92835671|NCT04267250|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92835672|NCT04267250|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92835673|NCT04267250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92835674|NCT04267250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835675|NCT04267250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835676|NCT00775489|Beclomethasone|beclomethasone|mesh-list
92835677|NCT00775489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835678|NCT00775489|Glucocorticoids|glucocorticoids|mesh-ancestor
92835679|NCT00775489|Hormones|hormones|mesh-ancestor
92835680|NCT00775489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835681|NCT00775489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835682|NCT00775489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92835683|NCT00775489|Respiratory System Agents|respiratory system agents|mesh-ancestor
92835684|NCT00771199|Fentanyl|fentanyl|mesh-list
92835685|NCT00771199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92835686|NCT00771199|Narcotics|narcotics|mesh-ancestor
92835687|NCT00771199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835688|NCT00771199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835689|NCT00771199|Analgesics|analgesics|mesh-ancestor
92835690|NCT00771199|Sensory System Agents|sensory system agents|mesh-ancestor
92835691|NCT00771199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835692|NCT00771199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92835693|NCT00771199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92835694|NCT00771199|Anesthetics, General|anesthetics, general|mesh-ancestor
92835695|NCT00771199|Anesthetics|anesthetics|mesh-ancestor
92835696|NCT04264130|Artesunate|artesunate|mesh-list
92835697|NCT04264130|Lumefantrine|lumefantrine|mesh-list
92835698|NCT04264130|Artemether|artemether|mesh-list
92835699|NCT04264130|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92835700|NCT04264130|Pyronaridine|pyronaridine|mesh-list
92835701|NCT04264130|Artefenomel|artefenomel|mesh-list
92835702|NCT04264130|Ferroquine|ferroquine|mesh-list
92835703|NCT04264130|Antimalarials|antimalarials|mesh-ancestor
92835704|NCT04264130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92835705|NCT04264130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92835706|NCT04264130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835707|NCT04264130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835708|NCT04264130|Antiviral Agents|antiviral agents|mesh-ancestor
92835709|NCT04264130|Schistosomicides|schistosomicides|mesh-ancestor
92835710|NCT04264130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92835711|NCT04264130|Anthelmintics|anthelmintics|mesh-ancestor
92835712|NCT02557867|Dexmedetomidine|dexmedetomidine|mesh-list
92835713|NCT02557867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92835714|NCT02557867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835715|NCT02557867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835716|NCT02557867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835717|NCT02557867|Analgesics|analgesics|mesh-ancestor
92835718|NCT02557867|Sensory System Agents|sensory system agents|mesh-ancestor
92835719|NCT02557867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835720|NCT02557867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92835721|NCT02557867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92835722|NCT02557867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92835723|NCT02557867|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835724|NCT02557867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835725|NCT02557867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835726|NCT00605774|Epinephrine|epinephrine|mesh-list
92835727|NCT00605774|Racepinephrine|racepinephrine|mesh-list
92835728|NCT00605774|Epinephryl borate|epinephryl borate|mesh-list
92835729|NCT00605774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92835730|NCT00605774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92835731|NCT00605774|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835732|NCT00605774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835733|NCT00605774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835734|NCT00605774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835735|NCT00605774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92835736|NCT00605774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92835737|NCT00605774|Autonomic Agents|autonomic agents|mesh-ancestor
92835738|NCT00605774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835739|NCT00605774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92835740|NCT00605774|Respiratory System Agents|respiratory system agents|mesh-ancestor
92835741|NCT00605774|Mydriatics|mydriatics|mesh-ancestor
92835742|NCT00605774|Sympathomimetics|sympathomimetics|mesh-ancestor
92835743|NCT00605774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92835744|NCT04264286|Esmolol|esmolol|mesh-list
92835745|NCT04264286|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92835746|NCT04264286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92835747|NCT04264286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92835748|NCT04264286|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835749|NCT04264286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835750|NCT04264286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835751|NCT04264286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835752|NCT02582476|Bumetanide|bumetanide|mesh-list
92480789|NCT01888835|Histamine Agents|histamine agents|mesh-ancestor
92835753|NCT02582476|Diuretics|diuretics|mesh-ancestor
92835755|NCT02582476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835756|NCT02582476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92835757|NCT02582476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835758|NCT02582476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835759|NCT04078204|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92835760|NCT04078204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92835761|NCT04078204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92835762|NCT04078204|Protective Agents|protective agents|mesh-ancestor
92835763|NCT04078204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835764|NCT00668707|Melatonin|melatonin|mesh-list
92835765|NCT00668707|Antioxidants|antioxidants|mesh-ancestor
92835766|NCT00668707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835767|NCT00668707|Protective Agents|protective agents|mesh-ancestor
92835768|NCT00668707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835769|NCT00668707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835770|NCT00766909|Cyclosporine|cyclosporine|mesh-list
92835771|NCT00766909|Tacrolimus|tacrolimus|mesh-list
92835772|NCT00766909|Cyclosporins|cyclosporins|mesh-list
92835773|NCT00766909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835774|NCT00766909|Immunologic Factors|immunologic factors|mesh-ancestor
92835775|NCT00766909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835776|NCT00766909|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92835777|NCT00766909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835778|NCT00766909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835779|NCT00766909|Antifungal Agents|antifungal agents|mesh-ancestor
92835780|NCT00766909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835781|NCT00766909|Dermatologic Agents|dermatologic agents|mesh-ancestor
92835782|NCT00766909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835783|NCT00771433|Lenograstim|lenograstim|mesh-list
92835784|NCT00771433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92835785|NCT00771433|Immunologic Factors|immunologic factors|mesh-ancestor
92835786|NCT00771433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835787|NCT00668395|Efavirenz|efavirenz|mesh-list
92835788|NCT00668395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92835789|NCT00668395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92835790|NCT00668395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835791|NCT00668395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835792|NCT00668395|Antiviral Agents|antiviral agents|mesh-ancestor
92835793|NCT00668395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835794|NCT00668395|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92835795|NCT00668395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92835796|NCT00668395|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92180882|NCT05614518|Listerine|listerine|mesh-list
92835797|NCT00668395|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92835798|NCT00668395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92835799|NCT00668395|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92835800|NCT00668317|Omeprazole|omeprazole|mesh-list
92835801|NCT00668317|Ranitidine|ranitidine|mesh-list
92835802|NCT00668317|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92835803|NCT00668317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92835804|NCT00668317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835805|NCT00668317|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92835806|NCT00668317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835807|NCT00668317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835808|NCT00668317|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92835809|NCT00668317|Histamine Antagonists|histamine antagonists|mesh-ancestor
92835810|NCT00668317|Histamine Agents|histamine agents|mesh-ancestor
92835811|NCT00668317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835812|NCT00668317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835813|NCT00775879|Sevoflurane|sevoflurane|mesh-list
92835814|NCT00775879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92835815|NCT00775879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92835816|NCT00775879|Anesthetics, General|anesthetics, general|mesh-ancestor
92835817|NCT00775879|Anesthetics|anesthetics|mesh-ancestor
92835818|NCT00775879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835819|NCT00775879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835820|NCT00767221|Budesonide|budesonide|mesh-list
92835821|NCT00767221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92835822|NCT00767221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92835823|NCT00767221|Autonomic Agents|autonomic agents|mesh-ancestor
92835824|NCT00767221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835825|NCT00767221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835826|NCT00767221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92835827|NCT00767221|Respiratory System Agents|respiratory system agents|mesh-ancestor
92835828|NCT00767221|Glucocorticoids|glucocorticoids|mesh-ancestor
92835829|NCT00767221|Hormones|hormones|mesh-ancestor
92835830|NCT00767221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835831|NCT04024072|Brinzolamide|brinzolamide|mesh-list
92835832|NCT04024072|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92835833|NCT04024072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835834|NCT04024072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835835|NCT00771511|Capsaicin|capsaicin|mesh-list
92835836|NCT00771511|Antipruritics|antipruritics|mesh-ancestor
92835837|NCT00771511|Dermatologic Agents|dermatologic agents|mesh-ancestor
92835838|NCT00771511|Sensory System Agents|sensory system agents|mesh-ancestor
92835839|NCT00771511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835840|NCT00771511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835841|NCT00776113|Carvedilol|carvedilol|mesh-list
92835842|NCT00776113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92835843|NCT00776113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92835844|NCT00776113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835845|NCT00776113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835846|NCT00776113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835847|NCT00776113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835848|NCT00776113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835849|NCT00776113|Antioxidants|antioxidants|mesh-ancestor
92835850|NCT00776113|Protective Agents|protective agents|mesh-ancestor
92835851|NCT00776113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92835852|NCT00776113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92835853|NCT00776113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92835854|NCT00776113|Vasodilator Agents|vasodilator agents|mesh-ancestor
92835855|NCT00776113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92835856|NCT00776113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92835857|NCT02580448|Seviteronel|seviteronel|mesh-list
92835858|NCT02580448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835859|NCT02580448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92835860|NCT02580448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835861|NCT02580448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835862|NCT04008238|Trabectedin|trabectedin|mesh-list
92835863|NCT04008238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92835864|NCT04008238|Alkylating Agents|alkylating agents|mesh-ancestor
92835865|NCT04008238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835866|NCT04008238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835867|NCT00672139|Bromides|bromides|mesh-list
92835868|NCT00672139|Methylnaltrexone|methylnaltrexone|mesh-list
92835869|NCT00672139|Anticonvulsants|anticonvulsants|mesh-ancestor
92835870|NCT00672139|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92835871|NCT00672139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835872|NCT00672139|Sensory System Agents|sensory system agents|mesh-ancestor
92835873|NCT00672139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835874|NCT02557789|Lefamulin|lefamulin|mesh-list
92835875|NCT02557789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92835876|NCT02557789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835877|NCT00771823|Maraviroc|maraviroc|mesh-list
92835878|NCT00771823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92835879|NCT00771823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92835880|NCT00771823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835881|NCT00771823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92835882|NCT00771823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92835883|NCT00771823|Antiviral Agents|antiviral agents|mesh-ancestor
92835884|NCT00771823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835885|NCT00771823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92835886|NCT04219540|Buprenorphine|buprenorphine|mesh-list
92835887|NCT04219540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92835888|NCT04219540|Narcotics|narcotics|mesh-ancestor
92835889|NCT04219540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92835890|NCT04219540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835891|NCT04219540|Analgesics|analgesics|mesh-ancestor
92835892|NCT04219540|Sensory System Agents|sensory system agents|mesh-ancestor
92835893|NCT04219540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835894|NCT04219540|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92835895|NCT03955042|Pemetrexed|pemetrexed|mesh-list
92835896|NCT03955042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835897|NCT03955042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835898|NCT03955042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835899|NCT03955042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92835900|NCT03955042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92835902|NCT00570739|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92835903|NCT00570739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92835904|NCT00570739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835905|NCT00570739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92835906|NCT00570739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92835907|NCT00570739|Antimetabolites|antimetabolites|mesh-ancestor
92835908|NCT00570739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835909|NCT00570739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92835910|NCT04076098|Minocycline|minocycline|mesh-list
92835911|NCT04076098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92835912|NCT04076098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92835913|NCT00771979|Saracatinib|saracatinib|mesh-list
92835914|NCT00771979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835915|NCT00771979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737673|NCT01324388|Dulaglutide|dulaglutide|mesh-list
92835916|NCT00771979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835917|NCT00767689|Pyridoxine|pyridoxine|mesh-list
92835918|NCT00767689|Pyridoxal|pyridoxal|mesh-list
92835919|NCT00767689|Vitamin B 6|vitamin b 6|mesh-list
92835920|NCT00767689|Vitamins|vitamins|mesh-ancestor
92835921|NCT00767689|Micronutrients|micronutrients|mesh-ancestor
92835922|NCT00767689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835923|NCT00767689|Vitamin B Complex|vitamin b complex|mesh-ancestor
92835924|NCT00772057|Propranolol|propranolol|mesh-list
92835925|NCT00772057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92835926|NCT00772057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92835927|NCT00772057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92835928|NCT00772057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835929|NCT00772057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835930|NCT00772057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835931|NCT00772057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92835932|NCT00772057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92835933|NCT00772057|Vasodilator Agents|vasodilator agents|mesh-ancestor
92835934|NCT00776347|Donepezil|donepezil|mesh-list
92835935|NCT00776347|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92835936|NCT00776347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835937|NCT00776347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835938|NCT00776347|Cholinergic Agents|cholinergic agents|mesh-ancestor
92835939|NCT00776347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92835940|NCT00776347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835941|NCT00776347|Nootropic Agents|nootropic agents|mesh-ancestor
92835942|NCT00776425|Epoetin Alfa|epoetin alfa|mesh-list
92835943|NCT00776425|Hematinics|hematinics|mesh-ancestor
92835944|NCT03913702|Methylprednisolone|methylprednisolone|mesh-list
92835945|NCT03913702|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92835946|NCT03913702|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92835948|NCT03913702|Prednisolone acetate|prednisolone acetate|mesh-list
92835949|NCT03913702|Ketorolac|ketorolac|mesh-list
92835950|NCT03913702|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92835951|NCT03913702|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92835952|NCT03913702|Prednisolone phosphate|prednisolone phosphate|mesh-list
92835953|NCT03913702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835954|NCT03913702|Antiemetics|antiemetics|mesh-ancestor
92835955|NCT03913702|Autonomic Agents|autonomic agents|mesh-ancestor
92835956|NCT03913702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835957|NCT03913702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835958|NCT03913702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835959|NCT03913702|Glucocorticoids|glucocorticoids|mesh-ancestor
92835960|NCT03913702|Hormones|hormones|mesh-ancestor
92835961|NCT03913702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835962|NCT03913702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92835963|NCT03913702|Protective Agents|protective agents|mesh-ancestor
92835964|NCT03913702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92835965|NCT03913702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835966|NCT03913702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92835967|NCT03913702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92835968|NCT03913702|Analgesics|analgesics|mesh-ancestor
92835969|NCT03913702|Sensory System Agents|sensory system agents|mesh-ancestor
92835970|NCT03913702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835971|NCT03913702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92835972|NCT03913702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92835973|NCT03913702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835974|NCT03909412|Dexamethasone|dexamethasone|mesh-list
92835975|NCT03909412|Cyclophosphamide|cyclophosphamide|mesh-list
92835976|NCT03909412|Lenograstim|lenograstim|mesh-list
92835977|NCT03909412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92835978|NCT03909412|Immunologic Factors|immunologic factors|mesh-ancestor
92835979|NCT03909412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92835980|NCT03909412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92835981|NCT03909412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92835982|NCT03909412|Alkylating Agents|alkylating agents|mesh-ancestor
92835983|NCT03909412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835984|NCT03909412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92835985|NCT03909412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92835986|NCT03909412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92835987|NCT03909412|Antiemetics|antiemetics|mesh-ancestor
92835988|NCT03909412|Autonomic Agents|autonomic agents|mesh-ancestor
92835989|NCT03909412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92835990|NCT03909412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92835991|NCT03909412|Glucocorticoids|glucocorticoids|mesh-ancestor
92835992|NCT03909412|Hormones|hormones|mesh-ancestor
92835993|NCT03909412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92835994|NCT03909412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92835995|NCT03909412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92835996|NCT00772135|Sildenafil Citrate|sildenafil citrate|mesh-list
92835997|NCT00772135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92835998|NCT00772135|Vasodilator Agents|vasodilator agents|mesh-ancestor
92835999|NCT00772135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92836000|NCT00772135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92836001|NCT00772135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836002|NCT00772135|Urological Agents|urological agents|mesh-ancestor
92836003|NCT00776503|Vorinostat|vorinostat|mesh-list
92836004|NCT00776503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836005|NCT00776503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92836006|NCT00776503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836007|NCT00776503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836008|NCT04075006|Ketamine|ketamine|mesh-list
92836009|NCT04075006|Analgesics|analgesics|mesh-ancestor
92836010|NCT04075006|Sensory System Agents|sensory system agents|mesh-ancestor
92836011|NCT04075006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836012|NCT04075006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836013|NCT04075006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92836014|NCT04075006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92836015|NCT04075006|Anesthetics, General|anesthetics, general|mesh-ancestor
92836016|NCT04075006|Anesthetics|anesthetics|mesh-ancestor
92836017|NCT04075006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836018|NCT04075006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92836019|NCT04075006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92836020|NCT04075006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836021|NCT04075006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836022|NCT04188106|Hydroxyzine|hydroxyzine|mesh-list
92836023|NCT04188106|Varenicline|varenicline|mesh-list
92836024|NCT04188106|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92836025|NCT04188106|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92836026|NCT04188106|Cholinergic Agents|cholinergic agents|mesh-ancestor
92836027|NCT04188106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836028|NCT04188106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836029|NCT04188106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836030|NCT04188106|Antipruritics|antipruritics|mesh-ancestor
92836031|NCT04188106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92836032|NCT04188106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92836033|NCT04188106|Histamine Antagonists|histamine antagonists|mesh-ancestor
92836034|NCT04188106|Histamine Agents|histamine agents|mesh-ancestor
92836035|NCT00669955|Amoxicillin|amoxicillin|mesh-list
92836036|NCT00669955|Metronidazole|metronidazole|mesh-list
92836037|NCT00669955|Clarithromycin|clarithromycin|mesh-list
92836038|NCT00669955|Tetracycline|tetracycline|mesh-list
92836039|NCT00669955|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92836040|NCT00669955|Omeprazole|omeprazole|mesh-list
92836041|NCT00669955|Bismuth|bismuth|mesh-list
92836042|NCT00669955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92836043|NCT00669955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836044|NCT00669955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92836045|NCT00669955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92836046|NCT00669955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92836047|NCT00669955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836048|NCT00669955|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92836049|NCT00669955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836050|NCT00669955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836051|NCT00669955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92836052|NCT00669955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92836053|NCT00669955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92836055|NCT00772291|Pregabalin|pregabalin|mesh-list
92836056|NCT00772291|Analgesics|analgesics|mesh-ancestor
92836057|NCT00772291|Sensory System Agents|sensory system agents|mesh-ancestor
92836058|NCT00772291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836059|NCT00772291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836060|NCT00772291|Anticonvulsants|anticonvulsants|mesh-ancestor
92836061|NCT00772291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92836062|NCT00772291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92836063|NCT00772291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836064|NCT00772291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836065|NCT00772291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92836066|NCT00772291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92836067|NCT00772291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836068|NCT00772291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836069|NCT03595150|Diclofenac|diclofenac|mesh-list
92836070|NCT03595150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836071|NCT03595150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836072|NCT03595150|Analgesics|analgesics|mesh-ancestor
92836073|NCT03595150|Sensory System Agents|sensory system agents|mesh-ancestor
92836074|NCT03595150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836075|NCT03595150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836076|NCT03595150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836077|NCT03595150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836078|NCT03595150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92836079|NCT03595150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836080|NCT03595150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836081|NCT00768157|Lamivudine|lamivudine|mesh-list
92836082|NCT00768157|Entecavir|entecavir|mesh-list
92836083|NCT00768157|Antiviral Agents|antiviral agents|mesh-list
92836084|NCT00768157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92836085|NCT00768157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92836086|NCT00768157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836087|NCT00768157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836088|NCT00768157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836089|NCT00768157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92836090|NCT00768157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92836091|NCT00671749|Clindamycin|clindamycin|mesh-list
92836092|NCT00671749|Clindamycin palmitate|clindamycin palmitate|mesh-list
92836093|NCT00671749|Clindamycin phosphate|clindamycin phosphate|mesh-list
92836094|NCT00671749|Adapalene|adapalene|mesh-list
92836095|NCT00671749|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92836096|NCT00671749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92836097|NCT00671749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836098|NCT00671749|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92836099|NCT00671749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836100|NCT00671749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836101|NCT00671749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92836102|NCT00671749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836103|NCT00671749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836104|NCT00671749|Analgesics|analgesics|mesh-ancestor
92836105|NCT00671749|Sensory System Agents|sensory system agents|mesh-ancestor
92836106|NCT00671749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836107|NCT00671749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836108|NCT00671749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836109|NCT00671749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836110|NCT04149106|Pyrimethamine|pyrimethamine|mesh-list
92836111|NCT04149106|Sulfadoxine|sulfadoxine|mesh-list
92836112|NCT04149106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92836113|NCT04149106|Amodiaquine|amodiaquine|mesh-list
92836114|NCT04149106|Artenimol|artenimol|mesh-list
92836115|NCT04149106|Antimalarials|antimalarials|mesh-ancestor
92836116|NCT04149106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92836117|NCT04149106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92836118|NCT04149106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836119|NCT04149106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92836120|NCT04149106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836121|NCT04149106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836122|NCT04149106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92836123|NCT02580604|Calcium|calcium|mesh-list
92836124|NCT02580604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836125|NCT02580604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481169|NCT01899105|Ivacaftor|ivacaftor|mesh-list
92836126|NCT00768391|Olaratumab|olaratumab|mesh-list
92836127|NCT00768391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836128|NCT00669877|Cytarabine|cytarabine|mesh-list
92836129|NCT00669877|Dexamethasone|dexamethasone|mesh-list
92836130|NCT00669877|Cyclophosphamide|cyclophosphamide|mesh-list
92836131|NCT00669877|Rituximab|rituximab|mesh-list
92836132|NCT00669877|Doxorubicin|doxorubicin|mesh-list
92836133|NCT00669877|Methotrexate|methotrexate|mesh-list
92836134|NCT00669877|Vincristine|vincristine|mesh-list
92836135|NCT00669877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92836136|NCT00669877|Immunologic Factors|immunologic factors|mesh-ancestor
92836137|NCT00669877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836138|NCT00669877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836139|NCT00669877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92836140|NCT00669877|Alkylating Agents|alkylating agents|mesh-ancestor
92836141|NCT00669877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836142|NCT00669877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836143|NCT00669877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92836144|NCT00669877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836145|NCT00669877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836146|NCT00669877|Antiemetics|antiemetics|mesh-ancestor
92836147|NCT00669877|Autonomic Agents|autonomic agents|mesh-ancestor
92836148|NCT00669877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836149|NCT00669877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836150|NCT00669877|Glucocorticoids|glucocorticoids|mesh-ancestor
92836151|NCT00669877|Hormones|hormones|mesh-ancestor
92836152|NCT00669877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92836153|NCT00669877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92836154|NCT00669877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92836155|NCT00669877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92836156|NCT00669877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92836157|NCT00669877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836158|NCT00669877|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92836159|NCT00669877|Abortifacient Agents|abortifacient agents|mesh-ancestor
92836160|NCT00669877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92836161|NCT00669877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92836162|NCT00669877|Antimetabolites|antimetabolites|mesh-ancestor
92836163|NCT00669877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92836164|NCT00669877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92836165|NCT00669877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92836166|NCT00669877|Antiviral Agents|antiviral agents|mesh-ancestor
92836167|NCT00669877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836168|NCT00669877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92836169|NCT00669877|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836170|NCT00669877|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836171|NCT00669877|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836172|NCT00772681|Docetaxel|docetaxel|mesh-list
92836174|NCT00772681|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836175|NCT00772681|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836176|NCT00772681|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836177|NCT00772681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836178|NCT00772759|AZD-3199|azd-3199|mesh-list
92836179|NCT00772759|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92836180|NCT00772759|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92836181|NCT00772759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92836182|NCT00772759|Adrenergic Agents|adrenergic agents|mesh-ancestor
92836183|NCT00772759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836184|NCT00772759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836185|NCT00772759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836186|NCT03866668|Esomeprazole|esomeprazole|mesh-list
92836187|NCT03866668|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92836188|NCT03866668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836189|NCT03866668|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92836190|NCT03866668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836191|NCT03866668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836192|NCT00772837|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92836193|NCT00772837|Amoxicillin|amoxicillin|mesh-list
92836194|NCT00772837|Clarithromycin|clarithromycin|mesh-list
92836195|NCT00772837|Omeprazole|omeprazole|mesh-list
92836196|NCT00772837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836197|NCT00772837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92836198|NCT00772837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836199|NCT00772837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92836200|NCT00772837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836201|NCT00772837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836202|NCT00772837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92836203|NCT00772837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92836204|NCT00772837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92836206|NCT00773149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836207|NCT00773149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836208|NCT00768859|Paclitaxel|paclitaxel|mesh-list
92836209|NCT00768859|Carboplatin|carboplatin|mesh-list
92836210|NCT00768859|Trastuzumab|trastuzumab|mesh-list
92836211|NCT00768859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92836212|NCT00768859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836213|NCT00768859|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836214|NCT00768859|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836215|NCT00768859|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836216|NCT00768859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836217|NCT00768859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836218|NCT00768937|Sorafenib|sorafenib|mesh-list
92836219|NCT00768937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836220|NCT00768937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92836221|NCT00768937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836222|NCT00768937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836223|NCT04047745|Bupivacaine|bupivacaine|mesh-list
92836224|NCT04047745|Ropivacaine|ropivacaine|mesh-list
92836225|NCT04047745|Anesthetics, Local|anesthetics, local|mesh-ancestor
92836226|NCT04047745|Anesthetics|anesthetics|mesh-ancestor
92836227|NCT04047745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836228|NCT04047745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836229|NCT04047745|Sensory System Agents|sensory system agents|mesh-ancestor
92836230|NCT04047745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836231|NCT00777439|Domperidone|domperidone|mesh-list
92836232|NCT00777439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836233|NCT00777439|Antiemetics|antiemetics|mesh-ancestor
92836234|NCT00777439|Autonomic Agents|autonomic agents|mesh-ancestor
92836235|NCT00777439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836236|NCT00777439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836237|NCT00777439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836238|NCT00777439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92836239|NCT00777439|Dopamine Agents|dopamine agents|mesh-ancestor
92836240|NCT00777439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836241|NCT00769093|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92836242|NCT00769093|Hematinics|hematinics|mesh-ancestor
92836243|NCT00769093|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92836244|NCT00769093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92836245|NCT00671437|Cetuximab|cetuximab|mesh-list
92836246|NCT00671437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836247|NCT00671437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836248|NCT00777517|Atorvastatin|atorvastatin|mesh-list
92836249|NCT00777517|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92836250|NCT00777517|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92836251|NCT00777517|Antimetabolites|antimetabolites|mesh-ancestor
92836252|NCT00777517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836253|NCT00777517|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92836254|NCT00777517|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92836255|NCT00777517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836256|NCT00769171|Moxifloxacin|moxifloxacin|mesh-list
92836257|NCT00769171|Metronidazole|metronidazole|mesh-list
92836258|NCT00769171|Ceftriaxone|ceftriaxone|mesh-list
92836259|NCT00769171|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92836260|NCT00769171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92836261|NCT00769171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836262|NCT00769171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92836263|NCT00769171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92836264|NCT00769171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836265|NCT00769171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836266|NCT00769171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836267|NCT00769171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92836268|NCT00769171|Contraceptive Agents|contraceptive agents|mesh-ancestor
92836269|NCT00769171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92836270|NCT00769171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836271|NCT00769171|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92836272|NCT00769171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92836273|NCT00769171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92836274|NCT00769171|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92836275|NCT00769171|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92738050|NCT01323621|Xhance|xhance|mesh-list
92836276|NCT00777595|Moxifloxacin|moxifloxacin|mesh-list
92836277|NCT00777595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92836278|NCT00777595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836279|NCT00777595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92836280|NCT00777595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92836281|NCT00777595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836282|NCT00777595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836283|NCT00777595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836284|NCT00769405|Leucovorin|leucovorin|mesh-list
92836285|NCT00769405|Fluorouracil|fluorouracil|mesh-list
92836286|NCT00769405|Oxaliplatin|oxaliplatin|mesh-list
92836287|NCT00769405|Calcium|calcium|mesh-list
92836288|NCT00769405|Levoleucovorin|levoleucovorin|mesh-list
92836289|NCT00769405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836290|NCT00769405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836291|NCT00769405|Antimetabolites|antimetabolites|mesh-ancestor
92836292|NCT00769405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836293|NCT00769405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92836294|NCT00769405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836295|NCT00769405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92836296|NCT00769405|Immunologic Factors|immunologic factors|mesh-ancestor
92836297|NCT00769405|Antidotes|antidotes|mesh-ancestor
92836298|NCT00769405|Protective Agents|protective agents|mesh-ancestor
92836299|NCT00769405|Vitamin B Complex|vitamin b complex|mesh-ancestor
92836300|NCT00769405|Vitamins|vitamins|mesh-ancestor
92836301|NCT00769405|Micronutrients|micronutrients|mesh-ancestor
92836302|NCT02829502|Exenatide|exenatide|mesh-list
92836303|NCT02829502|Glucagon|glucagon|mesh-list
92836304|NCT02829502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92836305|NCT02829502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92836306|NCT02829502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836307|NCT02829502|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92836308|NCT02829502|Incretins|incretins|mesh-ancestor
92836309|NCT02829502|Hormones|hormones|mesh-ancestor
92836310|NCT02829502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92836311|NCT02829502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836312|NCT02635191|Amoxicillin|amoxicillin|mesh-list
92836313|NCT02635191|Metronidazole|metronidazole|mesh-list
92836314|NCT02635191|Clarithromycin|clarithromycin|mesh-list
92836315|NCT02635191|Esomeprazole|esomeprazole|mesh-list
92836316|NCT02635191|Omeprazole|omeprazole|mesh-list
92836317|NCT02635191|Rabeprazole|rabeprazole|mesh-list
92836318|NCT02635191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92836319|NCT02635191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836320|NCT02635191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92836321|NCT02635191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92836322|NCT02635191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92836323|NCT02635191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836324|NCT02635191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92836325|NCT02635191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836326|NCT02635191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836328|NCT02635191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92836329|NCT02635191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92836330|NCT00777673|Paclitaxel|paclitaxel|mesh-list
92836331|NCT00777673|Cyclophosphamide|cyclophosphamide|mesh-list
92836332|NCT00777673|Bevacizumab|bevacizumab|mesh-list
92836333|NCT00777673|Carboplatin|carboplatin|mesh-list
92836334|NCT00777673|Doxorubicin|doxorubicin|mesh-list
92836335|NCT00777673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92836336|NCT00777673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92836337|NCT00777673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836338|NCT00777673|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836339|NCT00777673|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836340|NCT00777673|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836341|NCT00777673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836342|NCT00777673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92836343|NCT00777673|Immunologic Factors|immunologic factors|mesh-ancestor
92836344|NCT00777673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836345|NCT00777673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836346|NCT00777673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92836347|NCT00777673|Alkylating Agents|alkylating agents|mesh-ancestor
92836348|NCT00777673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92836349|NCT00777673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836350|NCT00777673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92836351|NCT00777673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92836352|NCT00777673|Growth Substances|growth substances|mesh-ancestor
92836353|NCT00777673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92836354|NCT00777673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92836355|NCT00777673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92836356|NCT00777673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92836357|NCT00777673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836358|NCT02579902|Vitamin D|vitamin d|mesh-list
92836359|NCT02579902|Cholecalciferol|cholecalciferol|mesh-list
92836360|NCT02579902|Vitamins|vitamins|mesh-ancestor
92836361|NCT02579902|Micronutrients|micronutrients|mesh-ancestor
92836362|NCT02579902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836363|NCT02579902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92836364|NCT02579902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836365|NCT02557087|Meperidine|meperidine|mesh-list
92836366|NCT02557087|Scopolamine|scopolamine|mesh-list
92836367|NCT02557087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92836368|NCT02557087|Narcotics|narcotics|mesh-ancestor
92836369|NCT02557087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836370|NCT02557087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836371|NCT02557087|Analgesics|analgesics|mesh-ancestor
92836372|NCT02557087|Sensory System Agents|sensory system agents|mesh-ancestor
92836373|NCT02557087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836374|NCT02557087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92836375|NCT02557087|Antiemetics|antiemetics|mesh-ancestor
92836376|NCT02557087|Autonomic Agents|autonomic agents|mesh-ancestor
92836377|NCT02557087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836378|NCT02557087|Mydriatics|mydriatics|mesh-ancestor
92836379|NCT02557087|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92836380|NCT02557087|Cholinergic Agents|cholinergic agents|mesh-ancestor
92836381|NCT02557087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836382|NCT02557087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836383|NCT02557087|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92836384|NCT02579590|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92836385|NCT02579590|Medroxyprogesterone|medroxyprogesterone|mesh-list
92836386|NCT02579590|Desogestrel|desogestrel|mesh-list
92836387|NCT02579590|Etonogestrel|etonogestrel|mesh-list
92836388|NCT02579590|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92836389|NCT02579590|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92836390|NCT02579590|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92836391|NCT02579590|Contraceptive Agents|contraceptive agents|mesh-ancestor
92836392|NCT02579590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92836393|NCT02579590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836394|NCT02579590|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92836395|NCT02579590|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92836396|NCT02579590|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92836397|NCT02579590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92836398|NCT02579590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836399|NCT02579590|Progestins|progestins|mesh-ancestor
92836400|NCT02579590|Hormones|hormones|mesh-ancestor
92836401|NCT02579590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92836402|NCT02634723|Factor VIII|factor viii|mesh-list
92836403|NCT02634723|Coagulants|coagulants|mesh-ancestor
92836404|NCT02634489|Tamsulosin|tamsulosin|mesh-list
92836405|NCT02634489|Solifenacin Succinate|solifenacin succinate|mesh-list
92836406|NCT02634489|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92836407|NCT02634489|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92836408|NCT02634489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92836409|NCT02634489|Adrenergic Agents|adrenergic agents|mesh-ancestor
92836410|NCT02634489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836411|NCT02634489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836412|NCT02634489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836413|NCT02634489|Urological Agents|urological agents|mesh-ancestor
92836414|NCT02634489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92836415|NCT02634489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92836416|NCT02634489|Cholinergic Agents|cholinergic agents|mesh-ancestor
92836417|NCT00582712|Lithium Carbonate|lithium carbonate|mesh-list
92836418|NCT00582712|Antidepressive Agents|antidepressive agents|mesh-ancestor
92836419|NCT00582712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836420|NCT00582712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836421|NCT00582712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836422|NCT00582712|Antimanic Agents|antimanic agents|mesh-ancestor
92836423|NCT00582712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92836424|NCT00582712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738161|NCT01321008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92836425|NCT00582712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836426|NCT03920566|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92836427|NCT03920566|Dalteparin|dalteparin|mesh-list
92836428|NCT03920566|Anticoagulants|anticoagulants|mesh-ancestor
92836429|NCT03920566|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92836430|NCT03920566|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92836431|NCT03920566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836433|NCT00582790|Interleukin-2|interleukin-2|mesh-list
92836434|NCT00582790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836435|NCT00582790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836436|NCT00582790|Analgesics|analgesics|mesh-ancestor
92836437|NCT00582790|Sensory System Agents|sensory system agents|mesh-ancestor
92836438|NCT00582790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836439|NCT00582790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836440|NCT00582790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92836441|NCT00774007|Mesalamine|mesalamine|mesh-list
92836442|NCT00774007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836443|NCT00774007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836444|NCT00774007|Analgesics|analgesics|mesh-ancestor
92836445|NCT00774007|Sensory System Agents|sensory system agents|mesh-ancestor
92836446|NCT00774007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836447|NCT00774007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836448|NCT00774007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836449|NCT00774007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836450|NCT00769873|Heparin|heparin|mesh-list
92836451|NCT00769873|Enoxaparin|enoxaparin|mesh-list
92836452|NCT00769873|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92836453|NCT00769873|Tinzaparin|tinzaparin|mesh-list
92836454|NCT00769873|Dalteparin|dalteparin|mesh-list
92836455|NCT00769873|Anticoagulants|anticoagulants|mesh-ancestor
92836456|NCT00769873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92836457|NCT00769873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92836458|NCT00769873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836459|NCT00777985|Bosentan|bosentan|mesh-list
92836460|NCT00777985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92836461|NCT00777985|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92836462|NCT00777985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836463|NCT00770107|Thiamine|thiamine|mesh-list
92836464|NCT00770107|Vitamin B Complex|vitamin b complex|mesh-ancestor
92836465|NCT00770107|Vitamins|vitamins|mesh-ancestor
92836466|NCT00770107|Micronutrients|micronutrients|mesh-ancestor
92836467|NCT00770107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836468|NCT00774241|Bevacizumab|bevacizumab|mesh-list
92836469|NCT00774241|Docetaxel|docetaxel|mesh-list
92836470|NCT00774241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836471|NCT00774241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836472|NCT00774241|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92836473|NCT00774241|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92836474|NCT00774241|Growth Substances|growth substances|mesh-ancestor
92836475|NCT00774241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836476|NCT00774241|Growth Inhibitors|growth inhibitors|mesh-ancestor
92836477|NCT00774241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836478|NCT00774241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836479|NCT00774241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836480|NCT00774241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836481|NCT00774319|Cisplatin|cisplatin|mesh-list
92836482|NCT00774319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836483|NCT00881751|Bevacizumab|bevacizumab|mesh-list
92836484|NCT00881751|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92836485|NCT00881751|Sorafenib|sorafenib|mesh-list
92836486|NCT00881751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836487|NCT00881751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836488|NCT00881751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92836489|NCT00881751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92836490|NCT00881751|Growth Substances|growth substances|mesh-ancestor
92836491|NCT00881751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836492|NCT00881751|Growth Inhibitors|growth inhibitors|mesh-ancestor
92836493|NCT00881751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92836494|NCT00881751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836495|NCT00881751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836496|NCT02634255|Fentanyl|fentanyl|mesh-list
92836497|NCT02634255|Propofol|propofol|mesh-list
92836498|NCT02634255|Rocuronium|rocuronium|mesh-list
92836499|NCT02634255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92836500|NCT02634255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836501|NCT02634255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836502|NCT02634255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92836503|NCT02634255|Anesthetics, General|anesthetics, general|mesh-ancestor
92836504|NCT02634255|Anesthetics|anesthetics|mesh-ancestor
92836505|NCT02634255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92836506|NCT02634255|Narcotics|narcotics|mesh-ancestor
92836507|NCT02634255|Analgesics|analgesics|mesh-ancestor
92836508|NCT02634255|Sensory System Agents|sensory system agents|mesh-ancestor
92836509|NCT02634255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836510|NCT02634255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92836511|NCT02634255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92836512|NCT02634255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92836513|NCT02634255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92836514|NCT02634021|Midazolam|midazolam|mesh-list
92836515|NCT02634021|Dexmedetomidine|dexmedetomidine|mesh-list
92836516|NCT02634021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92836517|NCT02634021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836518|NCT02634021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836519|NCT02634021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836520|NCT02634021|Analgesics|analgesics|mesh-ancestor
92836521|NCT02634021|Sensory System Agents|sensory system agents|mesh-ancestor
92836522|NCT02634021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836523|NCT02634021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92836524|NCT02634021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92836525|NCT02634021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92836526|NCT02634021|Adrenergic Agents|adrenergic agents|mesh-ancestor
92836527|NCT02634021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836528|NCT02634021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836529|NCT02634021|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92836530|NCT02634021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92836531|NCT02634021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92836532|NCT02634021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836533|NCT02634021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92836534|NCT02634021|Anesthetics, General|anesthetics, general|mesh-ancestor
92836535|NCT02634021|Anesthetics|anesthetics|mesh-ancestor
92836536|NCT02634021|GABA Modulators|gaba modulators|mesh-ancestor
92836537|NCT02634021|GABA Agents|gaba agents|mesh-ancestor
92836538|NCT04161729|Magnesium Sulfate|magnesium sulfate|mesh-list
92836539|NCT04161729|Analgesics|analgesics|mesh-ancestor
92836540|NCT04161729|Sensory System Agents|sensory system agents|mesh-ancestor
92836541|NCT04161729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836542|NCT04161729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836543|NCT04161729|Anesthetics|anesthetics|mesh-ancestor
92836544|NCT04161729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836545|NCT04161729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92836546|NCT04161729|Anticonvulsants|anticonvulsants|mesh-ancestor
92836547|NCT04161729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92836548|NCT04161729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92836549|NCT04161729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836550|NCT04161729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836551|NCT04161729|Tocolytic Agents|tocolytic agents|mesh-ancestor
92836552|NCT04161729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92836553|NCT04161339|Hydroxychloroquine|hydroxychloroquine|mesh-list
92836554|NCT04161339|Antimalarials|antimalarials|mesh-ancestor
92836555|NCT04161339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92836556|NCT04161339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92836557|NCT04161339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836558|NCT04161339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836559|NCT04161339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836560|NCT04161339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836561|NCT00934856|Docetaxel|docetaxel|mesh-list
92836562|NCT00934856|Trastuzumab|trastuzumab|mesh-list
92836563|NCT00934856|Pertuzumab|pertuzumab|mesh-list
92836564|NCT00934856|Maytansine|maytansine|mesh-list
92836565|NCT00934856|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92836566|NCT00934856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836567|NCT00934856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836568|NCT00934856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836569|NCT00934856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836570|NCT00934856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836571|NCT00934856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836572|NCT00934856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92836573|NCT00934856|Immunotoxins|immunotoxins|mesh-ancestor
92836574|NCT00934856|Immunoconjugates|immunoconjugates|mesh-ancestor
92836575|NCT00934856|Immunologic Factors|immunologic factors|mesh-ancestor
92836576|NCT00934856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836577|NCT00934700|Xenon|xenon|mesh-list
92836578|NCT00934700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92836579|NCT00934700|Anesthetics, General|anesthetics, general|mesh-ancestor
92836580|NCT00934700|Anesthetics|anesthetics|mesh-ancestor
92836581|NCT00934700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836582|NCT00934700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836583|NCT00669409|Tanezumab|tanezumab|mesh-list
92836584|NCT00669409|Analgesics|analgesics|mesh-ancestor
92836585|NCT00669409|Sensory System Agents|sensory system agents|mesh-ancestor
92836586|NCT00669409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836587|NCT00669409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836588|NCT00778141|Metformin|metformin|mesh-list
92836589|NCT00778141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92836590|NCT00778141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836591|NCT00774475|Clopidogrel|clopidogrel|mesh-list
92836592|NCT00774475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92836593|NCT00774475|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92836594|NCT00774475|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92836595|NCT00774475|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92836596|NCT00774475|Purinergic Agents|purinergic agents|mesh-ancestor
92836597|NCT00774475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836598|NCT00774475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836599|NCT00774475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836600|NCT00669331|Mannitol|mannitol|mesh-list
92836601|NCT00669331|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92836602|NCT00669331|Diuretics|diuretics|mesh-ancestor
92836603|NCT00669331|Natriuretic Agents|natriuretic agents|mesh-ancestor
92836604|NCT00669331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836605|NCT00778297|Vaccines|vaccines|mesh-list
92836606|NCT00778297|Immunologic Factors|immunologic factors|mesh-ancestor
92836607|NCT00778297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836608|NCT00779233|Zidovudine|zidovudine|mesh-list
92836609|NCT00779233|Antimetabolites|antimetabolites|mesh-ancestor
92836610|NCT00779233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836611|NCT00779233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92836612|NCT00779233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92836613|NCT00779233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836614|NCT00779233|Antiviral Agents|antiviral agents|mesh-ancestor
92836615|NCT00779233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836616|NCT00779233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92836617|NCT00779233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92836618|NCT00607178|Vaccines|vaccines|mesh-list
92836619|NCT00607178|Immunologic Factors|immunologic factors|mesh-ancestor
92836620|NCT00607178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836621|NCT02556463|Durvalumab|durvalumab|mesh-list
92836622|NCT02556463|MEDI9197|medi9197|mesh-list
92836623|NCT02556463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836624|NCT02556463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836625|NCT02556463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92836626|NCT02556463|Immunologic Factors|immunologic factors|mesh-ancestor
92836627|NCT02556463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836628|NCT00779389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92836629|NCT00779389|Dasatinib|dasatinib|mesh-list
92836630|NCT00779389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836631|NCT00779389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92836633|NCT00779389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836634|NCT00778609|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92836635|NCT00778609|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92836636|NCT00778609|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92836637|NCT00778609|Contraceptive Agents|contraceptive agents|mesh-ancestor
92836638|NCT00778609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92836639|NCT00778609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836640|NCT00778609|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92836641|NCT00778609|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92836642|NCT00778609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92836643|NCT00778609|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92836644|NCT00778609|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92836645|NCT00778609|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92836646|NCT00778609|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92836647|NCT00778609|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92836648|NCT00778765|Gabapentin|gabapentin|mesh-list
92836649|NCT00778765|Analgesics|analgesics|mesh-ancestor
92836650|NCT00778765|Sensory System Agents|sensory system agents|mesh-ancestor
92836651|NCT00778765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836652|NCT00778765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836653|NCT00778765|Anticonvulsants|anticonvulsants|mesh-ancestor
92836654|NCT00778765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92836655|NCT00778765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92836656|NCT00778765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836657|NCT00778765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836658|NCT00778765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92836659|NCT00778765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92836660|NCT00778765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836661|NCT00778765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836662|NCT00778765|Antimanic Agents|antimanic agents|mesh-ancestor
92836663|NCT00779935|Infliximab|infliximab|mesh-list
92836664|NCT00779935|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92836665|NCT00779935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836666|NCT00779935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92836667|NCT00779935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836668|NCT00779935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836669|NCT00780013|Metformin|metformin|mesh-list
92836670|NCT00780013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92836671|NCT00780013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836672|NCT00667225|Cantharidin|cantharidin|mesh-list
92836673|NCT00667225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836674|NCT00667225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836675|NCT00780169|Sorafenib|sorafenib|mesh-list
92836676|NCT00780169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836677|NCT00780169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92836678|NCT00780169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836679|NCT00780169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836680|NCT00780325|Celecoxib|celecoxib|mesh-list
92836681|NCT00780325|Naproxen|naproxen|mesh-list
92836682|NCT00780325|Acetazolamide|acetazolamide|mesh-list
92836683|NCT00780325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836684|NCT00780325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836685|NCT00780325|Analgesics|analgesics|mesh-ancestor
92836686|NCT00780325|Sensory System Agents|sensory system agents|mesh-ancestor
92836687|NCT00780325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836688|NCT00780325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836689|NCT00780325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836690|NCT00780325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836691|NCT00780325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92836692|NCT00780325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92836693|NCT00780325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836694|NCT00780325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836695|NCT00780325|Gout Suppressants|gout suppressants|mesh-ancestor
92836696|NCT00780325|Anticonvulsants|anticonvulsants|mesh-ancestor
92836697|NCT00780325|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92836698|NCT00780325|Diuretics|diuretics|mesh-ancestor
92836699|NCT00780325|Natriuretic Agents|natriuretic agents|mesh-ancestor
92836700|NCT02556229|Aflibercept|aflibercept|mesh-list
92836701|NCT02556229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92181790|NCT05327491|Sotorasib|sotorasib|mesh-list
92836702|NCT02556229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92836703|NCT02556229|Growth Substances|growth substances|mesh-ancestor
92836704|NCT02556229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836705|NCT02556229|Growth Inhibitors|growth inhibitors|mesh-ancestor
92836706|NCT02556229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836707|NCT00929864|Adalimumab|adalimumab|mesh-list
92836708|NCT00929864|Abatacept|abatacept|mesh-list
92836709|NCT00929864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92836710|NCT00929864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836711|NCT00929864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836712|NCT00929864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92836713|NCT00929864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836714|NCT00929864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836715|NCT00929864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836716|NCT00929864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92836717|NCT00929864|Immunologic Factors|immunologic factors|mesh-ancestor
92836718|NCT00929864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836719|NCT00597753|Epoetin Alfa|epoetin alfa|mesh-list
92836720|NCT00597753|Hematinics|hematinics|mesh-ancestor
92836721|NCT04262804|Gemcitabine|gemcitabine|mesh-list
92836722|NCT04262804|Capecitabine|capecitabine|mesh-list
92836723|NCT04262804|Trastuzumab|trastuzumab|mesh-list
92836724|NCT04262804|Vinorelbine|vinorelbine|mesh-list
92836725|NCT04262804|Margetuximab|margetuximab|mesh-list
92836726|NCT04262804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92836727|NCT04262804|Antimetabolites|antimetabolites|mesh-ancestor
92836728|NCT04262804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836729|NCT04262804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836730|NCT04262804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92836731|NCT04262804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92836732|NCT04262804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836733|NCT04262804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836734|NCT04262804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836735|NCT00665431|Celecoxib|celecoxib|mesh-list
92836736|NCT00665431|Antacids|antacids|mesh-list
92836737|NCT00665431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836738|NCT00665431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836739|NCT00665431|Analgesics|analgesics|mesh-ancestor
92836740|NCT00665431|Sensory System Agents|sensory system agents|mesh-ancestor
92836741|NCT00665431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836742|NCT00665431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836743|NCT00665431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836744|NCT00665431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836745|NCT00665431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92836746|NCT00665431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92836747|NCT00665431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836748|NCT00665431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836749|NCT00665431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836750|NCT02633709|Itraconazole|itraconazole|mesh-list
92836751|NCT02633709|Risdiplam|risdiplam|mesh-list
92836752|NCT02633709|Antifungal Agents|antifungal agents|mesh-ancestor
92836753|NCT02633709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836754|NCT02633709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92836755|NCT02633709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92836756|NCT02633709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836757|NCT02633709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836758|NCT02633709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92836759|NCT02633709|Hormone Antagonists|hormone antagonists|mesh-ancestor
92836760|NCT02633709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92836761|NCT02633709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836762|NCT02633709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92836763|NCT02633709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92836764|NCT02633709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836765|NCT04264988|Tin Fluorides|tin fluorides|mesh-list
92836766|NCT04264988|Cariostatic Agents|cariostatic agents|mesh-ancestor
92836767|NCT04264988|Protective Agents|protective agents|mesh-ancestor
92836768|NCT04264988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836769|NCT00657033|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92836770|NCT00657033|Vasodilator Agents|vasodilator agents|mesh-ancestor
92836771|NCT00657033|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92836772|NCT00657033|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92836773|NCT00657033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836774|NCT00657033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836775|NCT00657033|Urological Agents|urological agents|mesh-ancestor
92836777|NCT02633007|Carbidopa|carbidopa|mesh-list
92836778|NCT02633007|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92836779|NCT02633007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92836780|NCT02633007|Dopamine Agents|dopamine agents|mesh-ancestor
92836781|NCT02633007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836782|NCT02633007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836783|NCT02633007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836784|NCT02633007|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92836785|NCT02633007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836786|NCT01000727|Darapladib|darapladib|mesh-list
92836787|NCT01000727|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92836788|NCT01000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836789|NCT01000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836790|NCT00881205|Rivastigmine|rivastigmine|mesh-list
92836791|NCT00881205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92836792|NCT00881205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836793|NCT00881205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836794|NCT00881205|Cholinergic Agents|cholinergic agents|mesh-ancestor
92836795|NCT00881205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836796|NCT00881205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836797|NCT00881205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92836798|NCT00881205|Protective Agents|protective agents|mesh-ancestor
92836799|NCT00879879|Losartan|losartan|mesh-list
92836800|NCT00879879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92836801|NCT00879879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92836802|NCT00879879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92836803|NCT00879879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92836804|NCT00879879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836805|NCT00661999|Darbepoetin alfa|darbepoetin alfa|mesh-list
92481844|NCT01903824|Donepezil|donepezil|mesh-list
92836806|NCT00661999|Ferric gluconate|ferric gluconate|mesh-list
92836807|NCT00661999|Hematinics|hematinics|mesh-ancestor
92836808|NCT00661167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92836809|NCT00661167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836810|NCT04156815|Isotretinoin|isotretinoin|mesh-list
92836811|NCT04156815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92836812|NCT04156425|Golimumab|golimumab|mesh-list
92836813|NCT04156425|Dexetimide|dexetimide|mesh-list
92836814|NCT04156425|Citalopram|citalopram|mesh-list
92836815|NCT04156425|Calcium|calcium|mesh-list
92836816|NCT04156425|Escitalopram|escitalopram|mesh-list
92836817|NCT04156425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836818|NCT04156425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836819|NCT04156425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92836820|NCT04156425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92836821|NCT04156425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92836822|NCT04156425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836823|NCT04156425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836824|NCT04156425|Serotonin Agents|serotonin agents|mesh-ancestor
92836825|NCT04156425|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92836826|NCT04156425|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92836827|NCT04156425|Parasympatholytics|parasympatholytics|mesh-ancestor
92836828|NCT04156425|Autonomic Agents|autonomic agents|mesh-ancestor
92836829|NCT04156425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836830|NCT04156425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92836831|NCT04156425|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92836832|NCT04156425|Cholinergic Agents|cholinergic agents|mesh-ancestor
92836833|NCT04156425|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92836834|NCT04156425|Antidepressive Agents|antidepressive agents|mesh-ancestor
92836835|NCT04156425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836836|NCT04156425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92836837|NCT04156425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836838|NCT04156425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92836839|NCT04156425|Immunologic Factors|immunologic factors|mesh-ancestor
92836840|NCT02555059|Ciprofloxacin|ciprofloxacin|mesh-list
92836841|NCT02555059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92836842|NCT02555059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836843|NCT02555059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92836844|NCT02555059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92836845|NCT02555059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836846|NCT02555059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836847|NCT02555059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836848|NCT02555059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92836849|NCT02555059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92836851|NCT00790075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92836852|NCT00790075|Serotonin Agents|serotonin agents|mesh-ancestor
92836853|NCT00790075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836854|NCT00790075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836855|NCT00790075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836856|NCT00790075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92836857|NCT00790075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92836858|NCT00790075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836859|NCT00790075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836860|NCT00790075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92836861|NCT00790075|Dopamine Agents|dopamine agents|mesh-ancestor
92836862|NCT00785083|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92836863|NCT00785083|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92836864|NCT00785083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836865|NCT00785083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92836866|NCT00785083|Immunologic Factors|immunologic factors|mesh-ancestor
92836867|NCT00785083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836868|NCT00780637|Bradykinin|bradykinin|mesh-list
92836869|NCT00780637|Kininogens|kininogens|mesh-list
92836870|NCT00780637|Vasodilator Agents|vasodilator agents|mesh-ancestor
92836871|NCT00780637|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92836872|NCT00780637|Protease Inhibitors|protease inhibitors|mesh-ancestor
92836873|NCT00780637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836874|NCT00780637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836875|NCT00661401|gamma-Globulins|gamma-globulins|mesh-list
92836876|NCT00661401|Immunologic Factors|immunologic factors|mesh-ancestor
92836877|NCT00661401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836878|NCT00790153|Insulin|insulin|mesh-list
92836879|NCT00790153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92836880|NCT00790153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836882|NCT02631603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836883|NCT02631603|Glucocorticoids|glucocorticoids|mesh-ancestor
92836884|NCT02631603|Hormones|hormones|mesh-ancestor
92836885|NCT02631603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92836886|NCT02631603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836887|NCT02631603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92836888|NCT02631603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836889|NCT00790387|Heparin|heparin|mesh-list
92836890|NCT00790387|Enoxaparin|enoxaparin|mesh-list
92836891|NCT00790387|Calcium heparin|calcium heparin|mesh-list
92836892|NCT00790387|Tirofiban|tirofiban|mesh-list
92836893|NCT00790387|Anticoagulants|anticoagulants|mesh-ancestor
92836894|NCT00790387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92836895|NCT00790387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92836896|NCT00790387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836897|NCT00790387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92836898|NCT04156035|Lamotrigine|lamotrigine|mesh-list
92836899|NCT04156035|Ketamine|ketamine|mesh-list
92836900|NCT04156035|Analgesics|analgesics|mesh-ancestor
92836901|NCT04156035|Sensory System Agents|sensory system agents|mesh-ancestor
92836902|NCT04156035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836903|NCT04156035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836904|NCT04156035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92836905|NCT04156035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92836906|NCT04156035|Anesthetics, General|anesthetics, general|mesh-ancestor
92836907|NCT04156035|Anesthetics|anesthetics|mesh-ancestor
92836908|NCT04156035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836909|NCT04156035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92836910|NCT04156035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92836911|NCT04156035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836912|NCT04156035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836913|NCT04156035|Anticonvulsants|anticonvulsants|mesh-ancestor
92836914|NCT04156035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92836915|NCT04156035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92836916|NCT04156035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92836917|NCT04156035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92836918|NCT04156035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92836919|NCT04156035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92836920|NCT04156035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92836921|NCT00662337|Diphenhydramine|diphenhydramine|mesh-list
92836922|NCT00662337|Promethazine|promethazine|mesh-list
92836923|NCT00662337|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92836924|NCT00662337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92836925|NCT00662337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92836926|NCT00662337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836927|NCT00662337|Anesthetics, Local|anesthetics, local|mesh-ancestor
92836928|NCT00662337|Anesthetics|anesthetics|mesh-ancestor
92836929|NCT00662337|Sensory System Agents|sensory system agents|mesh-ancestor
92836930|NCT00662337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836931|NCT00662337|Antiemetics|antiemetics|mesh-ancestor
92836932|NCT00662337|Autonomic Agents|autonomic agents|mesh-ancestor
92836933|NCT00662337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92836934|NCT00662337|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92836935|NCT00662337|Histamine Antagonists|histamine antagonists|mesh-ancestor
92836936|NCT00662337|Histamine Agents|histamine agents|mesh-ancestor
92836937|NCT00662337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836938|NCT00662337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836939|NCT00662337|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92836940|NCT00662337|Antipruritics|antipruritics|mesh-ancestor
92836941|NCT00662337|Dermatologic Agents|dermatologic agents|mesh-ancestor
92836942|NCT00665353|Pioglitazone|pioglitazone|mesh-list
92836943|NCT00665353|Ribavirin|ribavirin|mesh-list
92836944|NCT00665353|Antimetabolites|antimetabolites|mesh-ancestor
92836945|NCT00665353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836946|NCT00665353|Antiviral Agents|antiviral agents|mesh-ancestor
92836947|NCT00665353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92836948|NCT00665353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92836949|NCT00665353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836950|NCT00785395|Oxytocin|oxytocin|mesh-list
92836951|NCT00785395|Oxytocics|oxytocics|mesh-ancestor
92836952|NCT00785395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92836953|NCT00785395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836954|NCT00662571|Acamprosate|acamprosate|mesh-list
92836955|NCT00662571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92836956|NCT00780793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92836957|NCT00780793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836958|NCT00661635|Valdecoxib|valdecoxib|mesh-list
92836959|NCT00661635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92836960|NCT00661635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92836961|NCT00661635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92836962|NCT00661635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836963|NCT00661635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92836964|NCT00661635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92836965|NCT00661635|Analgesics|analgesics|mesh-ancestor
92836966|NCT00661635|Sensory System Agents|sensory system agents|mesh-ancestor
92836967|NCT00661635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836968|NCT00661635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836969|NCT00661635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836970|NCT00661635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836971|NCT02555761|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92836972|NCT02555761|Alcaftadine|alcaftadine|mesh-list
92836973|NCT02555761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92836974|NCT02555761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92836975|NCT02555761|Histamine Antagonists|histamine antagonists|mesh-ancestor
92836976|NCT02555761|Histamine Agents|histamine agents|mesh-ancestor
92836977|NCT02555761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92836978|NCT02555761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836979|NCT02555761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836980|NCT04155879|Colchicine|colchicine|mesh-list
92836981|NCT04155879|Gout Suppressants|gout suppressants|mesh-ancestor
92836982|NCT04155879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92836983|NCT04155879|Tubulin Modulators|tubulin modulators|mesh-ancestor
92836984|NCT04155879|Antimitotic Agents|antimitotic agents|mesh-ancestor
92836985|NCT04155879|Mitosis Modulators|mitosis modulators|mesh-ancestor
92836986|NCT04155879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92836987|NCT04155879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92836988|NCT00662805|Fluticasone|fluticasone|mesh-list
92836989|NCT00662805|Xhance|xhance|mesh-list
92836990|NCT00662805|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92836991|NCT00662805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92836992|NCT00662805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92836993|NCT00662805|Autonomic Agents|autonomic agents|mesh-ancestor
92836994|NCT00662805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92836995|NCT00662805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92836996|NCT00662805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92836997|NCT00662805|Respiratory System Agents|respiratory system agents|mesh-ancestor
92836999|NCT00662805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92837000|NCT00662805|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92837001|NCT00662805|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92837002|NCT00662805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837003|NCT00662805|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837004|NCT00662805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837005|NCT00662805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837006|NCT00662883|Mometasone Furoate|mometasone furoate|mesh-list
92837007|NCT00662883|Ketamine|ketamine|mesh-list
92837008|NCT00662883|Analgesics|analgesics|mesh-ancestor
92837009|NCT00662883|Sensory System Agents|sensory system agents|mesh-ancestor
92837010|NCT00662883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837011|NCT00662883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837012|NCT00662883|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92837013|NCT00662883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92837014|NCT00662883|Anesthetics, General|anesthetics, general|mesh-ancestor
92837015|NCT00662883|Anesthetics|anesthetics|mesh-ancestor
92837016|NCT00662883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837017|NCT00662883|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92837018|NCT00662883|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92837019|NCT00662883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837020|NCT00662883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837021|NCT00662883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837022|NCT00662883|Dermatologic Agents|dermatologic agents|mesh-ancestor
92837023|NCT00662883|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92837024|NCT00785473|Cholecalciferol|cholecalciferol|mesh-list
92837025|NCT00785473|Vitamin D|vitamin d|mesh-list
92837026|NCT00785473|Calcium Carbonate|calcium carbonate|mesh-list
92837027|NCT00785473|Calcium|calcium|mesh-list
92837028|NCT00785473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92837029|NCT00785473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837030|NCT00785473|Vitamins|vitamins|mesh-ancestor
92837031|NCT00785473|Micronutrients|micronutrients|mesh-ancestor
92482076|NCT01905150|Antidotes|antidotes|mesh-ancestor
92837032|NCT00785473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92837033|NCT00785473|Antacids|antacids|mesh-ancestor
92837034|NCT00785473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837035|NCT00785473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92837036|NCT00785551|Quinine|quinine|mesh-list
92837037|NCT00785551|Antimalarials|antimalarials|mesh-ancestor
92837038|NCT00785551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92837039|NCT00785551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92837040|NCT00785551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837041|NCT00785551|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92837042|NCT00785551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837043|NCT00785551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92837044|NCT00785551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837045|NCT00785551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837046|NCT00785551|Analgesics|analgesics|mesh-ancestor
92837047|NCT00785551|Sensory System Agents|sensory system agents|mesh-ancestor
92837048|NCT00790777|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92837049|NCT00790777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92837050|NCT00790777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92837051|NCT00790777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837052|NCT00790777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837053|NCT00790777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837054|NCT00790777|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92837055|NCT00790777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92837056|NCT00790777|Serotonin Agents|serotonin agents|mesh-ancestor
92837057|NCT00790777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837058|NCT00790777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837059|NCT00790777|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92837060|NCT00790777|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92837061|NCT00790777|Dopamine Agents|dopamine agents|mesh-ancestor
92837062|NCT00663195|Furosemide|furosemide|mesh-list
92837063|NCT00663195|Spironolactone|spironolactone|mesh-list
92837064|NCT00663195|Diuretics|diuretics|mesh-ancestor
92837065|NCT00663195|Natriuretic Agents|natriuretic agents|mesh-ancestor
92837066|NCT00663195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837067|NCT00663195|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92837068|NCT00663195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837069|NCT00663195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837070|NCT00663195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92837072|NCT00663195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837073|NCT00663195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92837074|NCT00791011|Bortezomib|bortezomib|mesh-list
92837075|NCT00791011|Vorinostat|vorinostat|mesh-list
92837076|NCT00791011|Conatumumab|conatumumab|mesh-list
92837077|NCT00791011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837078|NCT00791011|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92837079|NCT00791011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837080|NCT00791011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738826|NCT01087489|Lidocaine|lidocaine|mesh-list
92837081|NCT00791011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92837082|NCT00781105|Telbivudine|telbivudine|mesh-list
92837083|NCT00781105|Antiviral Agents|antiviral agents|mesh-ancestor
92837084|NCT00781105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837085|NCT00781105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92837086|NCT00781105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837087|NCT00781105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837088|NCT00785863|Ketorolac|ketorolac|mesh-list
92837089|NCT00785863|Parecoxib|parecoxib|mesh-list
92837090|NCT00785863|Remifentanil|remifentanil|mesh-list
92837091|NCT00785863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92837092|NCT00785863|Narcotics|narcotics|mesh-ancestor
92837093|NCT00785863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837094|NCT00785863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837095|NCT00785863|Analgesics|analgesics|mesh-ancestor
92837096|NCT00785863|Sensory System Agents|sensory system agents|mesh-ancestor
92837097|NCT00785863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837098|NCT00785863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92837099|NCT00785863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837100|NCT00785863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837101|NCT00785863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837102|NCT00785863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92837103|NCT00785863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837104|NCT00785863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482148|NCT01906073|Fentanyl|fentanyl|mesh-list
92837105|NCT00785863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92837106|NCT00664105|Carboplatin|carboplatin|mesh-list
92837107|NCT00664105|Docetaxel|docetaxel|mesh-list
92837108|NCT00664105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837109|NCT00664105|Tubulin Modulators|tubulin modulators|mesh-ancestor
92837110|NCT00664105|Antimitotic Agents|antimitotic agents|mesh-ancestor
92837111|NCT00664105|Mitosis Modulators|mitosis modulators|mesh-ancestor
92837112|NCT00664105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837113|NCT00785941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92837114|NCT00785941|Immunologic Factors|immunologic factors|mesh-ancestor
92837115|NCT00785941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837116|NCT02555605|Dexmedetomidine|dexmedetomidine|mesh-list
92837117|NCT02555605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92837118|NCT02555605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837119|NCT02555605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837120|NCT02555605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837121|NCT02555605|Analgesics|analgesics|mesh-ancestor
92837122|NCT02555605|Sensory System Agents|sensory system agents|mesh-ancestor
92837123|NCT02555605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837124|NCT02555605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92837125|NCT02555605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92837126|NCT02555605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837127|NCT02555605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837128|NCT02555605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837129|NCT02555605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837130|NCT00791167|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92837131|NCT00791167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92837132|NCT00791167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92837133|NCT00791167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837134|NCT00791167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837135|NCT00791167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837136|NCT00791167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92837137|NCT00791167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92837138|NCT00791167|Serotonin Agents|serotonin agents|mesh-ancestor
92837139|NCT00791167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837140|NCT00791167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837141|NCT00791167|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92837142|NCT00791167|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92837143|NCT00791167|Dopamine Agents|dopamine agents|mesh-ancestor
92837145|NCT00663741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837146|NCT00663741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92837147|NCT00663741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738885|NCT01102426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92837148|NCT00663741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837149|NCT00663897|Lansoprazole|lansoprazole|mesh-list
92837150|NCT00663897|Dexlansoprazole|dexlansoprazole|mesh-list
92837151|NCT00663897|Mosapride|mosapride|mesh-list
92837152|NCT00663897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92837153|NCT00663897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92837154|NCT00663897|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92837155|NCT00663897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837156|NCT00663897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837157|NCT00663897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92837158|NCT00663897|Serotonin Agents|serotonin agents|mesh-ancestor
92837159|NCT00663897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837160|NCT00663897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837161|NCT00664053|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92837162|NCT00664053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92837163|NCT00664053|Immunologic Factors|immunologic factors|mesh-ancestor
92837164|NCT00664053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837165|NCT04031859|Aspirin|aspirin|mesh-list
92837166|NCT04031859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92837167|NCT04031859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837168|NCT04031859|Analgesics|analgesics|mesh-ancestor
92837169|NCT04031859|Sensory System Agents|sensory system agents|mesh-ancestor
92837170|NCT04031859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837171|NCT04031859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837172|NCT04031859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837173|NCT04031859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837174|NCT04031859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92837175|NCT04031859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92837176|NCT04031859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837177|NCT04031859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92837178|NCT04031859|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92837179|NCT04031859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837180|NCT04031859|Antipyretics|antipyretics|mesh-ancestor
92837181|NCT00664287|Niacin|niacin|mesh-list
92837182|NCT00664287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92837183|NCT00664287|Antimetabolites|antimetabolites|mesh-ancestor
92837184|NCT00664287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837185|NCT00664287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92837186|NCT00664287|Vasodilator Agents|vasodilator agents|mesh-ancestor
92837187|NCT00664287|Vitamin B Complex|vitamin b complex|mesh-ancestor
92837188|NCT00664287|Vitamins|vitamins|mesh-ancestor
92837189|NCT00664287|Micronutrients|micronutrients|mesh-ancestor
92837190|NCT00664287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837191|NCT00664599|Rituximab|rituximab|mesh-list
92837192|NCT00664599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92837193|NCT00664599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837194|NCT00664599|Immunologic Factors|immunologic factors|mesh-ancestor
92837195|NCT00664599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837196|NCT00664599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837197|NCT02631135|Dexmedetomidine|dexmedetomidine|mesh-list
92837198|NCT02631135|Remifentanil|remifentanil|mesh-list
92837199|NCT02631135|Propofol|propofol|mesh-list
92837200|NCT02631135|Rocuronium|rocuronium|mesh-list
92837201|NCT02631135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92837202|NCT02631135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837203|NCT02631135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837204|NCT02631135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837205|NCT02631135|Analgesics|analgesics|mesh-ancestor
92837206|NCT02631135|Sensory System Agents|sensory system agents|mesh-ancestor
92837207|NCT02631135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837208|NCT02631135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92837209|NCT02631135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92837210|NCT02631135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837211|NCT02631135|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837212|NCT02631135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837213|NCT02631135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837214|NCT02631135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92837215|NCT02631135|Anesthetics, General|anesthetics, general|mesh-ancestor
92837216|NCT02631135|Anesthetics|anesthetics|mesh-ancestor
92837217|NCT02631135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92837218|NCT02631135|Narcotics|narcotics|mesh-ancestor
92837219|NCT02631135|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92837220|NCT02631135|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92837221|NCT02631135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92837222|NCT00664677|Masoprocol|masoprocol|mesh-list
92837223|NCT00664677|Antioxidants|antioxidants|mesh-ancestor
92837224|NCT00664677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837225|NCT00664677|Protective Agents|protective agents|mesh-ancestor
92837226|NCT00664677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837227|NCT00664677|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92837228|NCT00664677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837229|NCT00664677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92837230|NCT00664677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92837231|NCT00664677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837232|NCT00664677|Analgesics|analgesics|mesh-ancestor
92837233|NCT00664677|Sensory System Agents|sensory system agents|mesh-ancestor
92837234|NCT00664677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837235|NCT00664677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837236|NCT00664677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837237|NCT00596817|Vortioxetine|vortioxetine|mesh-list
92837238|NCT00596817|Antidepressive Agents|antidepressive agents|mesh-ancestor
92837239|NCT00596817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837240|NCT00596817|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92837241|NCT00596817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92837242|NCT00596817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837243|NCT00596817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837244|NCT00596817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92837245|NCT00596817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92837246|NCT00596817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837247|NCT00596817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837248|NCT00596817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837249|NCT00596817|Serotonin Agents|serotonin agents|mesh-ancestor
92837250|NCT00596817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92837251|NCT00596817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92837252|NCT00596817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92837253|NCT00596817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92837254|NCT01000649|Vasopressins|vasopressins|mesh-list
92837255|NCT01000649|Hemostatics|hemostatics|mesh-ancestor
92837256|NCT01000649|Coagulants|coagulants|mesh-ancestor
92837257|NCT01000649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92837258|NCT01000649|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92837259|NCT01000649|Natriuretic Agents|natriuretic agents|mesh-ancestor
92837260|NCT01000649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837261|NCT00664833|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92837262|NCT00664833|Vasodilator Agents|vasodilator agents|mesh-ancestor
92837263|NCT00664833|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92837264|NCT00664833|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92837265|NCT00664833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837266|NCT00664833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837267|NCT00664833|Urological Agents|urological agents|mesh-ancestor
92837268|NCT00879411|Telmisartan|telmisartan|mesh-list
92837269|NCT00879411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92837270|NCT00879411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92837271|NCT00879411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92837272|NCT00879411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837273|NCT00671151|Theophylline|theophylline|mesh-list
92837274|NCT00671151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92837275|NCT00671151|Autonomic Agents|autonomic agents|mesh-ancestor
92837276|NCT00671151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837277|NCT00671151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837278|NCT00671151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837279|NCT00671151|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837280|NCT00671151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92837281|NCT00671151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837282|NCT00671151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837283|NCT00671151|Vasodilator Agents|vasodilator agents|mesh-ancestor
92837284|NCT00671151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92837285|NCT00671151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92837286|NCT00671151|Purinergic Agents|purinergic agents|mesh-ancestor
92837287|NCT00671151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837288|NCT00666757|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92837289|NCT00666757|Sertraline|sertraline|mesh-list
92837290|NCT00666757|Fluoxetine|fluoxetine|mesh-list
92837291|NCT00666757|Paroxetine|paroxetine|mesh-list
92837292|NCT00666757|Citalopram|citalopram|mesh-list
92837293|NCT00666757|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92837294|NCT00666757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92837295|NCT00666757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837296|NCT00666757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837297|NCT00666757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837298|NCT00666757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837299|NCT00666757|Analgesics|analgesics|mesh-ancestor
92837300|NCT00666757|Sensory System Agents|sensory system agents|mesh-ancestor
92837301|NCT00666757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837302|NCT00666757|Antidepressive Agents|antidepressive agents|mesh-ancestor
92837303|NCT00666757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837304|NCT00666757|Dopamine Agents|dopamine agents|mesh-ancestor
92837305|NCT00666757|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92837306|NCT00666757|Serotonin Agents|serotonin agents|mesh-ancestor
92837307|NCT00666757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92837308|NCT00666757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92837309|NCT00666757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92837310|NCT00666757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837311|NCT01000337|Propofol|propofol|mesh-list
92837312|NCT01000337|Sevoflurane|sevoflurane|mesh-list
92837313|NCT01000337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92837314|NCT01000337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837315|NCT01000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837316|NCT01000337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92837317|NCT01000337|Anesthetics, General|anesthetics, general|mesh-ancestor
92837318|NCT01000337|Anesthetics|anesthetics|mesh-ancestor
92837319|NCT01000337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92837320|NCT01000337|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92837321|NCT02869763|Ethanol|ethanol|mesh-list
92837322|NCT02869763|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92837323|NCT02869763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837324|NCT02869763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837325|NCT02869763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837326|NCT04153383|Milrinone|milrinone|mesh-list
92837327|NCT04153383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92837328|NCT04153383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92837329|NCT04153383|Vasodilator Agents|vasodilator agents|mesh-ancestor
92837330|NCT04153383|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92837331|NCT04153383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92837332|NCT04153383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837333|NCT04153383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837334|NCT04153383|Protective Agents|protective agents|mesh-ancestor
92837335|NCT04153383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837337|NCT00671697|Arsenic Trioxide|arsenic trioxide|mesh-list
92837338|NCT00671697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92837339|NCT00671697|Antimetabolites|antimetabolites|mesh-ancestor
92837340|NCT00671697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837341|NCT00671697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837342|NCT00671697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837343|NCT00666679|Mometasone Furoate|mometasone furoate|mesh-list
92837344|NCT00666679|Montelukast|montelukast|mesh-list
92837345|NCT00666679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837346|NCT00666679|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837347|NCT00666679|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92837348|NCT00666679|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837349|NCT00666679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837350|NCT00666679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837351|NCT00666679|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92837352|NCT00666679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92837353|NCT00666679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837354|NCT00666679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837355|NCT00666679|Dermatologic Agents|dermatologic agents|mesh-ancestor
92837356|NCT00666679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92837357|NCT00791401|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92837358|NCT00791401|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92837359|NCT00791401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92837360|NCT00791401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182462|NCT01676415|Prednisone|prednisone|mesh-list
92837361|NCT00791401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837362|NCT00791401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837363|NCT00791401|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92837364|NCT00791401|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92837365|NCT00791401|Serotonin Agents|serotonin agents|mesh-ancestor
92837366|NCT00791401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837367|NCT00791401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837368|NCT00791401|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92837369|NCT00791401|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92837370|NCT00791401|Dopamine Agents|dopamine agents|mesh-ancestor
92837371|NCT00786253|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92837372|NCT00786253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92837373|NCT00786253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92837374|NCT00786253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92837375|NCT00786253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837376|NCT00786253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837377|NCT00786253|Urological Agents|urological agents|mesh-ancestor
92837379|NCT00595413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92837380|NCT00595413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837381|NCT00595413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837382|NCT00781261|Zoledronic Acid|zoledronic acid|mesh-list
92837383|NCT00781261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92837384|NCT00781261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837385|NCT00786331|Carboplatin|carboplatin|mesh-list
92837386|NCT00786331|Pemetrexed|pemetrexed|mesh-list
92837387|NCT00786331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837388|NCT00786331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837389|NCT00786331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837390|NCT00786331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92837391|NCT00786331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92837392|NCT00791713|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92837393|NCT00791713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92837394|NCT00791713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92837395|NCT00791713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837396|NCT00791713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837397|NCT00791713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837398|NCT00791713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92837399|NCT00791713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92837400|NCT00791713|Serotonin Agents|serotonin agents|mesh-ancestor
92837401|NCT00791713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837402|NCT00791713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837403|NCT00791713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92837404|NCT00791713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92837405|NCT00791713|Dopamine Agents|dopamine agents|mesh-ancestor
92837406|NCT00595335|Methylprednisolone|methylprednisolone|mesh-list
92837407|NCT00595335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92837408|NCT00595335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92837409|NCT00595335|Prednisolone|prednisolone|mesh-list
92837410|NCT00595335|Prednisolone acetate|prednisolone acetate|mesh-list
92837411|NCT00595335|Rituximab|rituximab|mesh-list
92837412|NCT00595335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92837413|NCT00595335|Prednisolone phosphate|prednisolone phosphate|mesh-list
92837414|NCT00595335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92837415|NCT00595335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837416|NCT00595335|Immunologic Factors|immunologic factors|mesh-ancestor
92837417|NCT00595335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837418|NCT00595335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837419|NCT00595335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837420|NCT00595335|Antiemetics|antiemetics|mesh-ancestor
92837421|NCT00595335|Autonomic Agents|autonomic agents|mesh-ancestor
92837422|NCT00595335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837423|NCT00595335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92837424|NCT00595335|Glucocorticoids|glucocorticoids|mesh-ancestor
92837425|NCT00595335|Hormones|hormones|mesh-ancestor
92837426|NCT00595335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837427|NCT00595335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92837428|NCT00595335|Protective Agents|protective agents|mesh-ancestor
92837429|NCT00595335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92837430|NCT00781417|Vitamin D|vitamin d|mesh-list
92837431|NCT00781417|Ergocalciferols|ergocalciferols|mesh-list
92837432|NCT00781417|Cholecalciferol|cholecalciferol|mesh-list
92837433|NCT00781417|Vitamins|vitamins|mesh-list
92837434|NCT00781417|Micronutrients|micronutrients|mesh-ancestor
92182530|NCT01708629|Ustekinumab|ustekinumab|mesh-list
92837435|NCT00781417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837436|NCT00781417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92837437|NCT00781417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92837438|NCT00672165|Antibodies|antibodies|mesh-list
92837439|NCT00672165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92837440|NCT00672165|Immunologic Factors|immunologic factors|mesh-ancestor
92837441|NCT00672165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837442|NCT04293809|Bupivacaine|bupivacaine|mesh-list
92837443|NCT04293809|Anesthetics, Local|anesthetics, local|mesh-ancestor
92837444|NCT04293809|Anesthetics|anesthetics|mesh-ancestor
92837445|NCT04293809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837446|NCT04293809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837447|NCT04293809|Sensory System Agents|sensory system agents|mesh-ancestor
92837448|NCT04293809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837449|NCT00672399|Exenatide|exenatide|mesh-list
92837450|NCT00672399|Moxifloxacin|moxifloxacin|mesh-list
92837451|NCT00672399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837452|NCT00672399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837453|NCT00672399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92837454|NCT00672399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92837455|NCT00672399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837456|NCT00672399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837457|NCT00672399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837458|NCT00672399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837459|NCT00672399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92837460|NCT00672399|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92837461|NCT00672399|Incretins|incretins|mesh-ancestor
92837462|NCT00672399|Hormones|hormones|mesh-ancestor
92837463|NCT00672399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837464|NCT00661531|Anastrozole|anastrozole|mesh-list
92837465|NCT00661531|Estradiol|estradiol|mesh-list
92837466|NCT00661531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92837467|NCT00661531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837468|NCT00661531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92837469|NCT00661531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92837470|NCT00661531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837471|NCT00661531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837472|NCT00661531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92837473|NCT00661531|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837474|NCT00661531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837475|NCT00661531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837476|NCT00661531|Estrogens|estrogens|mesh-ancestor
92837477|NCT00661531|Hormones|hormones|mesh-ancestor
92837478|NCT00998309|Azithromycin|azithromycin|mesh-list
92837479|NCT00998309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837480|NCT00998309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837481|NCT02629575|Sirolimus|sirolimus|mesh-list
92837482|NCT02629575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837483|NCT02629575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837484|NCT02629575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92837485|NCT02629575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837486|NCT02629575|Antifungal Agents|antifungal agents|mesh-ancestor
92837487|NCT02629575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92837488|NCT02629575|Immunologic Factors|immunologic factors|mesh-ancestor
92837489|NCT02629575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837490|NCT00781573|Clopidogrel|clopidogrel|mesh-list
92837491|NCT00781573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92837492|NCT00781573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92837493|NCT00781573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92837494|NCT00781573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92837495|NCT00781573|Purinergic Agents|purinergic agents|mesh-ancestor
92837496|NCT00781573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837497|NCT00781573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837498|NCT00781573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837499|NCT00671541|Gentamicins|gentamicins|mesh-list
92837500|NCT00671541|Bacitracin|bacitracin|mesh-list
92837501|NCT00671541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837502|NCT00671541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837503|NCT00671541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92837504|NCT00671541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837505|NCT00671541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837506|NCT00671541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92837507|NCT04152681|Apatinib|apatinib|mesh-list
92837508|NCT04152681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837509|NCT04152681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92837510|NCT04152681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837511|NCT04152681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837513|NCT00999713|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92837514|NCT00999713|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837515|NCT00672867|Adefovir|adefovir|mesh-list
92837516|NCT00672867|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92837517|NCT00672867|Clevudine|clevudine|mesh-list
92837518|NCT00672867|Antiviral Agents|antiviral agents|mesh-ancestor
92837519|NCT00672867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837520|NCT00672867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92837521|NCT00672867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92837522|NCT00672867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837523|NCT00672867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837524|NCT00997373|Letrozole|letrozole|mesh-list
92837525|NCT00997373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837526|NCT00997373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92837527|NCT00997373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92837528|NCT00997373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837529|NCT00997373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837530|NCT00997373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92837531|NCT00997373|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837532|NCT00997373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837533|NCT00997373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837534|NCT04152759|Golimumab|golimumab|mesh-list
92837535|NCT04152759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92837536|NCT04152759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837537|NCT04152759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92837538|NCT04152759|Immunologic Factors|immunologic factors|mesh-ancestor
92837539|NCT04152759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837540|NCT00792025|Sunitinib|sunitinib|mesh-list
92837541|NCT00792025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837542|NCT00792025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92837543|NCT00792025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92837544|NCT00792025|Growth Substances|growth substances|mesh-ancestor
92837545|NCT00792025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837546|NCT00792025|Growth Inhibitors|growth inhibitors|mesh-ancestor
92837547|NCT00792025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92837548|NCT00792025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837549|NCT00792025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482599|NCT01909063|Vitamin E|vitamin e|mesh-list
92837550|NCT02870231|Liraglutide|liraglutide|mesh-list
92837551|NCT02870231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92837552|NCT02870231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837553|NCT02870231|Incretins|incretins|mesh-ancestor
92837554|NCT02870231|Hormones|hormones|mesh-ancestor
92837555|NCT02870231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837556|NCT00782041|Leucovorin|leucovorin|mesh-list
92837557|NCT00782041|Folic Acid|folic acid|mesh-list
92837558|NCT00782041|Fluorouracil|fluorouracil|mesh-list
92837559|NCT00782041|Oxaliplatin|oxaliplatin|mesh-list
92837560|NCT00782041|Levoleucovorin|levoleucovorin|mesh-list
92837561|NCT00782041|Antimetabolites|antimetabolites|mesh-ancestor
92837562|NCT00782041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837563|NCT00782041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92837564|NCT00782041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837565|NCT00782041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92837566|NCT00782041|Immunologic Factors|immunologic factors|mesh-ancestor
92837567|NCT00782041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837568|NCT00782041|Antidotes|antidotes|mesh-ancestor
92837569|NCT00782041|Protective Agents|protective agents|mesh-ancestor
92837570|NCT00782041|Vitamin B Complex|vitamin b complex|mesh-ancestor
92837571|NCT00782041|Vitamins|vitamins|mesh-ancestor
92837572|NCT00782041|Micronutrients|micronutrients|mesh-ancestor
92837573|NCT00782041|Hematinics|hematinics|mesh-ancestor
92837574|NCT00673569|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92837575|NCT00673569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837576|NCT00673569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92837577|NCT00673569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837578|NCT00673569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837579|NCT00792181|Midazolam|midazolam|mesh-list
92837580|NCT00792181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92837581|NCT00792181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92182674|NCT04425564|Oxaliplatin|oxaliplatin|mesh-list
92837582|NCT00792181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837583|NCT00792181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837584|NCT00792181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92837585|NCT00792181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92837586|NCT00792181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837587|NCT00792181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92837588|NCT00792181|Anesthetics, General|anesthetics, general|mesh-ancestor
92837590|NCT00792181|GABA Modulators|gaba modulators|mesh-ancestor
92837591|NCT00792181|GABA Agents|gaba agents|mesh-ancestor
92837592|NCT00792181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837593|NCT00792181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837594|NCT00792337|Simvastatin|simvastatin|mesh-list
92837595|NCT00792337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92837596|NCT00792337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92837597|NCT00792337|Antimetabolites|antimetabolites|mesh-ancestor
92837598|NCT00792337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837599|NCT00792337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92837600|NCT00792337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92837601|NCT00792337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837602|NCT00787111|Fluoxetine|fluoxetine|mesh-list
92837603|NCT00787111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92837604|NCT00787111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92837605|NCT00787111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837606|NCT00787111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837607|NCT00787111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837608|NCT00787111|Serotonin Agents|serotonin agents|mesh-ancestor
92837609|NCT00787111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837610|NCT00787111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92837611|NCT00787111|Antidepressive Agents|antidepressive agents|mesh-ancestor
92837612|NCT00787111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92837613|NCT00787111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92837614|NCT00787111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92837615|NCT00787111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837616|NCT00782197|Hyaluronic Acid|hyaluronic acid|mesh-list
92837617|NCT00782197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92837618|NCT00782197|Immunologic Factors|immunologic factors|mesh-ancestor
92837619|NCT00782197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837620|NCT00782197|Viscosupplements|viscosupplements|mesh-ancestor
92837621|NCT00782197|Protective Agents|protective agents|mesh-ancestor
92837622|NCT04152291|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92837623|NCT04152291|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92837624|NCT04152291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92837625|NCT00996593|Iodine|iodine|mesh-list
92837626|NCT00996593|Tositumomab I-131|tositumomab i-131|mesh-list
92837627|NCT00996593|Antibodies|antibodies|mesh-list
92837628|NCT00996593|Immunoglobulins|immunoglobulins|mesh-list
92837629|NCT00996593|Immunologic Factors|immunologic factors|mesh-ancestor
92837630|NCT00996593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837631|NCT00996593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92837632|NCT00996593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837633|NCT00996593|Trace Elements|trace elements|mesh-ancestor
92837634|NCT00996593|Micronutrients|micronutrients|mesh-ancestor
92837635|NCT00996593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837636|NCT00570661|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92837637|NCT00570661|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92837638|NCT00570661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837639|NCT00570661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837640|NCT02870153|Oxaliplatin|oxaliplatin|mesh-list
92837641|NCT02870153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837642|NCT00787501|Fluoxetine|fluoxetine|mesh-list
92837643|NCT00787501|Sertraline|sertraline|mesh-list
92837644|NCT00787501|Escitalopram|escitalopram|mesh-list
92837645|NCT00787501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92837646|NCT00787501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92837647|NCT00787501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837648|NCT00787501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837649|NCT00787501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837650|NCT00787501|Serotonin Agents|serotonin agents|mesh-ancestor
92837651|NCT00787501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837652|NCT00787501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92837653|NCT00787501|Antidepressive Agents|antidepressive agents|mesh-ancestor
92837655|NCT00787501|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92837656|NCT00787501|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92837657|NCT00787501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837658|NCT00787657|Interferons|interferons|mesh-list
92837659|NCT00787657|Interferon-beta|interferon-beta|mesh-list
92837660|NCT00787657|Interferon beta-1b|interferon beta-1b|mesh-list
92837661|NCT00787657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837662|NCT00787657|Antiviral Agents|antiviral agents|mesh-ancestor
92837663|NCT00787657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837664|NCT00787657|Immunologic Factors|immunologic factors|mesh-ancestor
92837665|NCT00787657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837666|NCT00787657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92837667|NCT04264676|Metronidazole|metronidazole|mesh-list
92837668|NCT04264676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837669|NCT04264676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837670|NCT04264676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92837671|NCT04264676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92837672|NCT02869841|Levobupivacaine|levobupivacaine|mesh-list
92837673|NCT02869841|Anesthetics, Local|anesthetics, local|mesh-ancestor
92837674|NCT02869841|Anesthetics|anesthetics|mesh-ancestor
92837675|NCT02869841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837676|NCT02869841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837677|NCT02869841|Sensory System Agents|sensory system agents|mesh-ancestor
92837678|NCT02869841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837679|NCT00637637|Ritonavir|ritonavir|mesh-list
92837680|NCT00637637|Indinavir|indinavir|mesh-list
92837681|NCT00637637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92837682|NCT00637637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92837683|NCT00637637|Protease Inhibitors|protease inhibitors|mesh-ancestor
92837684|NCT00637637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837685|NCT00637637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837686|NCT00637637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92837687|NCT00637637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92837688|NCT00637637|Antiviral Agents|antiviral agents|mesh-ancestor
92837689|NCT00637637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837690|NCT00637637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92837691|NCT00637637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92837692|NCT00927758|Fluticasone|fluticasone|mesh-list
92837693|NCT00927758|Xhance|xhance|mesh-list
92837694|NCT00927758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92837695|NCT00927758|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92837696|NCT00927758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837697|NCT00927758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92837698|NCT00927758|Autonomic Agents|autonomic agents|mesh-ancestor
92837699|NCT00927758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837700|NCT00927758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837701|NCT00927758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837702|NCT00927758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837703|NCT00927758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92837704|NCT00927758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92837705|NCT00927758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92837706|NCT00927758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92837707|NCT00927758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837708|NCT00927758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837709|NCT00927758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837710|NCT00927758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837711|NCT00927758|Glucocorticoids|glucocorticoids|mesh-ancestor
92837712|NCT00927758|Hormones|hormones|mesh-ancestor
92739457|NCT00623207|Atropine|atropine|mesh-list
92837713|NCT00927758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837714|NCT00927758|Sympathomimetics|sympathomimetics|mesh-ancestor
92837715|NCT00783523|Doxycycline|doxycycline|mesh-list
92837716|NCT00783523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837717|NCT00783523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837718|NCT00783523|Antimalarials|antimalarials|mesh-ancestor
92837719|NCT00783523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92837720|NCT00783523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92837721|NCT00783601|Montelukast|montelukast|mesh-list
92837722|NCT00783601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837723|NCT00783601|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837724|NCT00783601|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92837725|NCT00783601|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837726|NCT00783601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837727|NCT00783601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837728|NCT00783601|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92837729|NCT00783601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92837730|NCT00783601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837731|NCT00787813|Acetylcysteine|acetylcysteine|mesh-list
92837732|NCT00787813|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92837733|NCT00787813|Antiviral Agents|antiviral agents|mesh-ancestor
92837734|NCT00787813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837735|NCT00787813|Expectorants|expectorants|mesh-ancestor
92837736|NCT00787813|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837737|NCT00787813|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92837738|NCT00787813|Antioxidants|antioxidants|mesh-ancestor
92837739|NCT00787813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837740|NCT00787813|Protective Agents|protective agents|mesh-ancestor
92837741|NCT00787813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837742|NCT00787813|Antidotes|antidotes|mesh-ancestor
92837743|NCT04261634|Mitogens|mitogens|mesh-list
92837744|NCT04261634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92837745|NCT04261634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837746|NCT00787969|Sirolimus|sirolimus|mesh-list
92837747|NCT00787969|Rituximab|rituximab|mesh-list
92837748|NCT00787969|Temsirolimus|temsirolimus|mesh-list
92837749|NCT00787969|Cladribine|cladribine|mesh-list
92837750|NCT00787969|MTOR Inhibitors|mtor inhibitors|mesh-list
92837751|NCT00787969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92837752|NCT00787969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837753|NCT00787969|Immunologic Factors|immunologic factors|mesh-ancestor
92837754|NCT00787969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837755|NCT00787969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92837756|NCT00787969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92837757|NCT00787969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837758|NCT00787969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837759|NCT00787969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92837760|NCT00787969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92837761|NCT00787969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837762|NCT00787969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92837763|NCT00787969|Antifungal Agents|antifungal agents|mesh-ancestor
92837764|NCT00609596|Dutasteride|dutasteride|mesh-list
92837765|NCT00609596|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92837766|NCT00609596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92837767|NCT00609596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837768|NCT00609596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837769|NCT00609596|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837770|NCT00609596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837771|NCT00609596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837772|NCT00608816|Epinephrine|epinephrine|mesh-list
92837773|NCT00608816|Racepinephrine|racepinephrine|mesh-list
92837774|NCT00608816|Epinephryl borate|epinephryl borate|mesh-list
92837775|NCT00608816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92837776|NCT00608816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837777|NCT00608816|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837778|NCT00608816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837779|NCT00608816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837780|NCT00608816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837781|NCT00608816|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92837782|NCT00608816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92837783|NCT00608816|Autonomic Agents|autonomic agents|mesh-ancestor
92837784|NCT00608816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837785|NCT00608816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92739525|NCT05643651|Aspirin|aspirin|mesh-list
92837786|NCT00608816|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837787|NCT00608816|Mydriatics|mydriatics|mesh-ancestor
92837788|NCT00608816|Sympathomimetics|sympathomimetics|mesh-ancestor
92837789|NCT00608816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92837791|NCT02535273|Dexmedetomidine|dexmedetomidine|mesh-list
92837792|NCT02535273|Anesthetics, Local|anesthetics, local|mesh-ancestor
92837793|NCT02535273|Anesthetics|anesthetics|mesh-ancestor
92837794|NCT02535273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837795|NCT02535273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837796|NCT02535273|Sensory System Agents|sensory system agents|mesh-ancestor
92837797|NCT02535273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837798|NCT02535273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92837799|NCT02535273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92837800|NCT02535273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92837801|NCT02535273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837802|NCT02535273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837803|NCT02535273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92837804|NCT02535273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92837805|NCT02535273|Analgesics|analgesics|mesh-ancestor
92837806|NCT02535273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92837807|NCT02535273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92837808|NCT02535273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837809|NCT02535273|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837810|NCT02535273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837811|NCT00788047|Dextromethorphan|dextromethorphan|mesh-list
92837812|NCT00788047|Antitussive Agents|antitussive agents|mesh-ancestor
92837813|NCT00788047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837814|NCT00788047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92837815|NCT00788047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92837816|NCT00788047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837817|NCT00788047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837818|NCT00788047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837819|NCT04152369|Anti-Infective Agents|anti-infective agents|mesh-list
92837820|NCT04152369|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92837821|NCT04259684|Nitric Oxide|nitric oxide|mesh-list
92837822|NCT04259684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92837823|NCT04259684|Autonomic Agents|autonomic agents|mesh-ancestor
92837824|NCT04259684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837825|NCT04259684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837826|NCT04259684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837827|NCT04259684|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837828|NCT04259684|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92837829|NCT04259684|Antioxidants|antioxidants|mesh-ancestor
92837830|NCT04259684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837831|NCT04259684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837832|NCT04259684|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92837833|NCT04259684|Vasodilator Agents|vasodilator agents|mesh-ancestor
92837834|NCT04259684|Gasotransmitters|gasotransmitters|mesh-ancestor
92837835|NCT04259684|Protective Agents|protective agents|mesh-ancestor
92837836|NCT00788515|Lormetazepam|lormetazepam|mesh-list
92837837|NCT00788515|Volinanserin|volinanserin|mesh-list
92837838|NCT00788515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92837839|NCT00788515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837840|NCT00788515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837841|NCT00788515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92837842|NCT00788515|Serotonin Agents|serotonin agents|mesh-ancestor
92837843|NCT00788515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837844|NCT00788515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837845|NCT04259606|Magnesium Oxide|magnesium oxide|mesh-list
92837846|NCT04259606|Antacids|antacids|mesh-ancestor
92837847|NCT04259606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837848|NCT04259606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482905|NCT01910883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837849|NCT00788749|Fluticasone|fluticasone|mesh-list
92837850|NCT00788749|Xhance|xhance|mesh-list
92837851|NCT00788749|Prednisolone|prednisolone|mesh-list
92837852|NCT00788749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837853|NCT00788749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92837854|NCT00788749|Autonomic Agents|autonomic agents|mesh-ancestor
92837855|NCT00788749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837856|NCT00788749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837857|NCT00788749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837858|NCT00788749|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837859|NCT00788749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92837860|NCT00788749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92837861|NCT00788749|Glucocorticoids|glucocorticoids|mesh-ancestor
92837862|NCT00788749|Hormones|hormones|mesh-ancestor
92837863|NCT00788749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837864|NCT00788749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92837865|NCT00788749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837866|NCT00609752|Prednisolone|prednisolone|mesh-list
92837867|NCT00609752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92837868|NCT00609752|Glucocorticoids|glucocorticoids|mesh-ancestor
92837869|NCT00609752|Hormones|hormones|mesh-ancestor
92837870|NCT00609752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837871|NCT00609752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837872|NCT00609752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92837873|NCT00609752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837874|NCT00662857|Insulin|insulin|mesh-list
92837875|NCT00662857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92837876|NCT00662857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92837877|NCT00662857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837878|NCT00878553|Zaleplon|zaleplon|mesh-list
92837879|NCT00878553|Anticonvulsants|anticonvulsants|mesh-ancestor
92837880|NCT00878553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92837881|NCT00878553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837882|NCT00878553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837883|NCT00878553|GABA Modulators|gaba modulators|mesh-ancestor
92837884|NCT00878553|GABA Agents|gaba agents|mesh-ancestor
92837885|NCT00878553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837886|NCT00878553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837887|NCT05220020|Lenvatinib|lenvatinib|mesh-list
92837888|NCT05220020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837889|NCT05220020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92837890|NCT05220020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837891|NCT05220020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837892|NCT00789061|Lansoprazole|lansoprazole|mesh-list
92837893|NCT00789061|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92837894|NCT00789061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92837895|NCT00789061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92837896|NCT00789061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837897|NCT00789061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837898|NCT00996437|Ranibizumab|ranibizumab|mesh-list
92837899|NCT00996437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92837900|NCT00996437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92837901|NCT00996437|Growth Substances|growth substances|mesh-ancestor
92837902|NCT00996437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837903|NCT00996437|Growth Inhibitors|growth inhibitors|mesh-ancestor
92837904|NCT00996437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837905|NCT02628951|Paclitaxel|paclitaxel|mesh-list
92837906|NCT02628951|Ramucirumab|ramucirumab|mesh-list
92837907|NCT02628951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92837908|NCT02628951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837909|NCT02628951|Tubulin Modulators|tubulin modulators|mesh-ancestor
92837910|NCT02628951|Antimitotic Agents|antimitotic agents|mesh-ancestor
92837911|NCT02628951|Mitosis Modulators|mitosis modulators|mesh-ancestor
92837912|NCT02628951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837913|NCT00662311|Paclitaxel|paclitaxel|mesh-list
92837914|NCT00662311|Vorinostat|vorinostat|mesh-list
92837915|NCT00662311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92837916|NCT00662311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837917|NCT00662311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92837918|NCT00662311|Antimitotic Agents|antimitotic agents|mesh-ancestor
92837919|NCT00662311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92837920|NCT00662311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837921|NCT00662311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92837922|NCT00662311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837923|NCT00929708|Formoterol Fumarate|formoterol fumarate|mesh-list
92837924|NCT00929708|AZD-3199|azd-3199|mesh-list
92837926|NCT00929708|Autonomic Agents|autonomic agents|mesh-ancestor
92837927|NCT00929708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837928|NCT00929708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837929|NCT00929708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837930|NCT00929708|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837931|NCT00929708|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92837932|NCT00929708|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92837933|NCT00929708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837934|NCT00929708|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837935|NCT00929708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837936|NCT00929708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837937|NCT00996281|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92837938|NCT00996281|Olmesartan|olmesartan|mesh-list
92837939|NCT00996281|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92837940|NCT00996281|Chlorthalidone|chlorthalidone|mesh-list
92837941|NCT00996281|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92837942|NCT00996281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92837943|NCT00996281|Diuretics|diuretics|mesh-ancestor
92837944|NCT00996281|Natriuretic Agents|natriuretic agents|mesh-ancestor
92837945|NCT00996281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837946|NCT00996281|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92837947|NCT00996281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92837948|NCT00996281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837949|NCT00996281|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92837950|NCT00996281|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92837951|NCT04046653|Sulforaphane|sulforaphane|mesh-list
92837952|NCT04046653|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92837953|NCT04046653|Protective Agents|protective agents|mesh-ancestor
92837954|NCT04046653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837955|NCT04046653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837956|NCT04293887|Interferons|interferons|mesh-list
92837957|NCT04293887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837958|NCT04293887|Antiviral Agents|antiviral agents|mesh-ancestor
92837959|NCT04293887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92837960|NCT00675207|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92837961|NCT00675207|Dorzolamide|dorzolamide|mesh-list
92837962|NCT00675207|Brinzolamide|brinzolamide|mesh-list
92837963|NCT00675207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92837964|NCT00675207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92837965|NCT00675207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92837966|NCT00675207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92837967|NCT00675207|Adrenergic Agents|adrenergic agents|mesh-ancestor
92837968|NCT00675207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92837969|NCT00675207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837970|NCT00675207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837971|NCT00675207|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92837972|NCT00675207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92837973|NCT00795223|Morphine|morphine|mesh-list
92837974|NCT00795223|Bupivacaine|bupivacaine|mesh-list
92837975|NCT00795223|Anesthetics, Local|anesthetics, local|mesh-ancestor
92837976|NCT00795223|Anesthetics|anesthetics|mesh-ancestor
92837977|NCT00795223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92837978|NCT00795223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837979|NCT00795223|Sensory System Agents|sensory system agents|mesh-ancestor
92837980|NCT00795223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92837981|NCT00795223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92837982|NCT00795223|Narcotics|narcotics|mesh-ancestor
92837983|NCT00795223|Analgesics|analgesics|mesh-ancestor
92837984|NCT00795301|Capecitabine|capecitabine|mesh-list
92837985|NCT00795301|Oxaliplatin|oxaliplatin|mesh-list
92837986|NCT00795301|Cetuximab|cetuximab|mesh-list
92837987|NCT00795301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92837988|NCT00795301|Antimetabolites|antimetabolites|mesh-ancestor
92837989|NCT00795301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92837990|NCT00795301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92837991|NCT00795301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92837992|NCT00675285|Montelukast|montelukast|mesh-list
92837993|NCT00675285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92837994|NCT00675285|Respiratory System Agents|respiratory system agents|mesh-ancestor
92837995|NCT00675285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92837996|NCT00675285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92837997|NCT00675285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92837998|NCT00675285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92837999|NCT00675285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92838000|NCT00675285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92838001|NCT00675285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838002|NCT00996203|Antirheumatic Agents|antirheumatic agents|mesh-list
92838004|NCT00789763|Sorafenib|sorafenib|mesh-list
92838005|NCT00789763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92838006|NCT00789763|Antimetabolites|antimetabolites|mesh-ancestor
92838007|NCT00789763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838008|NCT00789763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838009|NCT00789763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92838010|NCT00789763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838011|NCT02554357|Bupivacaine|bupivacaine|mesh-list
92838012|NCT02554357|Anesthetics, Local|anesthetics, local|mesh-ancestor
92838013|NCT02554357|Anesthetics|anesthetics|mesh-ancestor
92838014|NCT02554357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838015|NCT02554357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838016|NCT02554357|Sensory System Agents|sensory system agents|mesh-ancestor
92838017|NCT02554357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838018|NCT00877929|Amlodipine|amlodipine|mesh-list
92838019|NCT00877929|Telmisartan|telmisartan|mesh-list
92838020|NCT00877929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838021|NCT00877929|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92838022|NCT00877929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92838023|NCT00877929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838024|NCT00877929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92838025|NCT00877929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838026|NCT00877929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92838027|NCT00877929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92838028|NCT00877929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92838029|NCT00795457|Poly I-C|poly i-c|mesh-list
92838030|NCT00795457|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92838031|NCT00795457|Vaccines|vaccines|mesh-list
92838032|NCT00795457|Poly ICLC|poly iclc|mesh-list
92838033|NCT00795457|Immunologic Factors|immunologic factors|mesh-ancestor
92838034|NCT00795457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838035|NCT00795457|Interferon Inducers|interferon inducers|mesh-ancestor
92838036|NCT00795457|Laxatives|laxatives|mesh-ancestor
92838037|NCT00795457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838038|NCT00795457|Antiviral Agents|antiviral agents|mesh-ancestor
92838039|NCT00795457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838040|NCT00793195|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92838041|NCT00793195|SMOFlipid|smoflipid|mesh-list
92838042|NCT00793195|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92838043|NCT00793195|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92838044|NCT00793195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92838045|NCT00793273|Insulin Detemir|insulin detemir|mesh-list
92838046|NCT00793273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92838047|NCT00793273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838048|NCT04979780|Heparin|heparin|mesh-list
92838049|NCT04979780|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92838050|NCT04979780|Tinzaparin|tinzaparin|mesh-list
92838051|NCT04979780|Dalteparin|dalteparin|mesh-list
92838052|NCT04979780|Rivaroxaban|rivaroxaban|mesh-list
92838053|NCT04979780|Anticoagulants|anticoagulants|mesh-list
92838054|NCT04979780|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92838055|NCT04979780|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92838056|NCT04979780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838057|NCT04979780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92838058|NCT04979780|Antithrombins|antithrombins|mesh-ancestor
92838059|NCT04979780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92838060|NCT04979780|Protease Inhibitors|protease inhibitors|mesh-ancestor
92838061|NCT04979780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838062|NCT04598009|Imatinib Mesylate|imatinib mesylate|mesh-list
92838063|NCT04598009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838064|NCT04598009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92838065|NCT04598009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838066|NCT04598009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838067|NCT00795613|Doxorubicin|doxorubicin|mesh-list
92838068|NCT00795613|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92838069|NCT00795613|Vincristine|vincristine|mesh-list
92838070|NCT00795613|Procarbazine|procarbazine|mesh-list
92838071|NCT00795613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838072|NCT00795613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838073|NCT00795613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92838074|NCT00795613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92838075|NCT00795613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838076|NCT00795613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838077|NCT00795613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92838078|NCT00795613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92838079|NCT00795613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92838080|NCT00795613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92838081|NCT00800761|Deferiprone|deferiprone|mesh-list
92838082|NCT00800761|Deferoxamine|deferoxamine|mesh-list
92838083|NCT00800761|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92838084|NCT00800761|Chelating Agents|chelating agents|mesh-ancestor
92838085|NCT00800761|Sequestering Agents|sequestering agents|mesh-ancestor
92838086|NCT00800761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838087|NCT00800761|Siderophores|siderophores|mesh-ancestor
92838088|NCT00676221|Mycophenolic Acid|mycophenolic acid|mesh-list
92838089|NCT00676221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838090|NCT00676221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838091|NCT00676221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92838092|NCT00676221|Antitubercular Agents|antitubercular agents|mesh-ancestor
92838093|NCT00676221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92838094|NCT00676221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838095|NCT00676221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838096|NCT00676221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838097|NCT00800917|Sirolimus|sirolimus|mesh-list
92838098|NCT00800917|Bevacizumab|bevacizumab|mesh-list
92838099|NCT00800917|Temsirolimus|temsirolimus|mesh-list
92838100|NCT00800917|MTOR Inhibitors|mtor inhibitors|mesh-list
92838101|NCT00800917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838102|NCT00800917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838103|NCT00800917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92838104|NCT00800917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92838105|NCT00800917|Growth Substances|growth substances|mesh-ancestor
92838106|NCT00800917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838107|NCT00800917|Growth Inhibitors|growth inhibitors|mesh-ancestor
92838108|NCT00800917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92838109|NCT00800917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838110|NCT00800917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838111|NCT00800917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92838112|NCT00800917|Immunologic Factors|immunologic factors|mesh-ancestor
92838113|NCT00800917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92838114|NCT00800917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838115|NCT00800917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838116|NCT00800917|Antifungal Agents|antifungal agents|mesh-ancestor
92838117|NCT05003102|Fentanyl|fentanyl|mesh-list
92838118|NCT05003102|Dexmedetomidine|dexmedetomidine|mesh-list
92838119|NCT05003102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92838120|NCT05003102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838121|NCT05003102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838122|NCT05003102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92838123|NCT05003102|Analgesics|analgesics|mesh-ancestor
92838124|NCT05003102|Sensory System Agents|sensory system agents|mesh-ancestor
92838125|NCT05003102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838126|NCT05003102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92838127|NCT05003102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92838128|NCT05003102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92838129|NCT05003102|Adrenergic Agents|adrenergic agents|mesh-ancestor
92838130|NCT05003102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838131|NCT05003102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838132|NCT05003102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92838133|NCT05003102|Narcotics|narcotics|mesh-ancestor
92838134|NCT05003102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92838135|NCT05003102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92838136|NCT05003102|Anesthetics, General|anesthetics, general|mesh-ancestor
92838137|NCT05003102|Anesthetics|anesthetics|mesh-ancestor
92838138|NCT00676377|Neostigmine|neostigmine|mesh-list
92838139|NCT00676377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92838140|NCT00676377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838141|NCT00676377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838142|NCT00676377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92838143|NCT00676377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838144|NCT00676377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838145|NCT00676377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92838146|NCT00676377|Autonomic Agents|autonomic agents|mesh-ancestor
92838147|NCT00676377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838148|NCT00676533|Ciprofloxacin|ciprofloxacin|mesh-list
92838149|NCT00676533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92838150|NCT00676533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838151|NCT00676533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92838152|NCT00676533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92838153|NCT00676533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838154|NCT00676533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838155|NCT00676533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838156|NCT00676533|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92838157|NCT00676533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92838158|NCT00676845|Olmesartan|olmesartan|mesh-list
92838159|NCT00676845|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92838160|NCT00676845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838161|NCT00676845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92838162|NCT00676845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92838163|NCT00676845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838164|NCT04152057|Paclitaxel|paclitaxel|mesh-list
92838165|NCT04152057|Trastuzumab|trastuzumab|mesh-list
92838166|NCT04152057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92838167|NCT04152057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838168|NCT04152057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92838169|NCT04152057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92838170|NCT04152057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92838171|NCT04152057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838172|NCT04152057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838173|NCT00610142|Hydrocortisone|hydrocortisone|mesh-list
92838174|NCT00610142|Pimecrolimus|pimecrolimus|mesh-list
92838175|NCT00610142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92838176|NCT00610142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92838177|NCT00610142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92838178|NCT00610142|Analgesics|analgesics|mesh-ancestor
92838179|NCT00610142|Sensory System Agents|sensory system agents|mesh-ancestor
92838180|NCT00610142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838181|NCT00610142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838182|NCT00610142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92838183|NCT00610142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92838184|NCT00610142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92838185|NCT00610142|Immunologic Factors|immunologic factors|mesh-ancestor
92838186|NCT00610142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92838187|NCT00610142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838188|NCT00610142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838190|NCT04151823|Cholecalciferol|cholecalciferol|mesh-list
92838191|NCT04151823|Vitamins|vitamins|mesh-ancestor
92838192|NCT04151823|Micronutrients|micronutrients|mesh-ancestor
92838193|NCT04151823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838194|NCT04151823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92838195|NCT04151823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92838196|NCT05199038|Octreotide|octreotide|mesh-list
92838197|NCT05199038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838198|NCT05199038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92838199|NCT05199038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838200|NCT00660907|Metformin|metformin|mesh-list
92838201|NCT00660907|Dapagliflozin|dapagliflozin|mesh-list
92838202|NCT00660907|Glipizide|glipizide|mesh-list
92838203|NCT00660907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92838204|NCT00660907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838205|NCT00660907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92838206|NCT00660907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838207|NCT04992572|Lidocaine|lidocaine|mesh-list
92838208|NCT04992572|Propofol|propofol|mesh-list
92838209|NCT04992572|Anesthetics, Local|anesthetics, local|mesh-ancestor
92838210|NCT04992572|Anesthetics|anesthetics|mesh-ancestor
92838211|NCT04992572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838212|NCT04992572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838213|NCT04992572|Sensory System Agents|sensory system agents|mesh-ancestor
92838214|NCT04992572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838215|NCT04992572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92838216|NCT04992572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92838217|NCT04992572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92838218|NCT04992572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92838219|NCT04992572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838220|NCT04992572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92838221|NCT04992572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92838222|NCT04992572|Anesthetics, General|anesthetics, general|mesh-ancestor
92838223|NCT05083052|Propolis|propolis|mesh-list
92838224|NCT05083052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838226|NCT04031703|Docetaxel|docetaxel|mesh-list
92838227|NCT04031703|Cyclophosphamide|cyclophosphamide|mesh-list
92838228|NCT04031703|Carboplatin|carboplatin|mesh-list
92838229|NCT04031703|Fluorouracil|fluorouracil|mesh-list
92838230|NCT04031703|Epirubicin|epirubicin|mesh-list
92838231|NCT04031703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92838232|NCT04031703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838233|NCT04031703|Tubulin Modulators|tubulin modulators|mesh-ancestor
92838234|NCT04031703|Antimitotic Agents|antimitotic agents|mesh-ancestor
92838235|NCT04031703|Mitosis Modulators|mitosis modulators|mesh-ancestor
92838236|NCT04031703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838237|NCT04031703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92838238|NCT04031703|Immunologic Factors|immunologic factors|mesh-ancestor
92838239|NCT04031703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838240|NCT04031703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92838241|NCT04031703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92838242|NCT04031703|Alkylating Agents|alkylating agents|mesh-ancestor
92838243|NCT04031703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92838244|NCT04031703|Antimetabolites|antimetabolites|mesh-ancestor
92838245|NCT04031703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92838246|NCT04031703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838247|NCT04031703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92838248|NCT04031703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92838249|NCT04031703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838250|NCT00795847|Losartan|losartan|mesh-list
92838251|NCT00795847|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92838252|NCT00795847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92838253|NCT00795847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838254|NCT00795847|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92838255|NCT00795847|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92838256|NCT00795847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838257|NCT00795847|Diuretics|diuretics|mesh-ancestor
92838258|NCT00795847|Natriuretic Agents|natriuretic agents|mesh-ancestor
92838259|NCT00795847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838260|NCT00795847|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92838261|NCT00795847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92838262|NCT00877773|Sirolimus|sirolimus|mesh-list
92838263|NCT00877773|Temsirolimus|temsirolimus|mesh-list
92838264|NCT00877773|MTOR Inhibitors|mtor inhibitors|mesh-list
92838265|NCT00877773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92838266|NCT00877773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838267|NCT00877773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838268|NCT00877773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92838269|NCT00877773|Immunologic Factors|immunologic factors|mesh-ancestor
92838270|NCT00877773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838271|NCT00877773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838272|NCT00877773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92838273|NCT00877773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838274|NCT00877773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838275|NCT00877773|Antifungal Agents|antifungal agents|mesh-ancestor
92838276|NCT00659815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92838277|NCT00994643|Aldesleukin|aldesleukin|mesh-list
92838278|NCT00994643|Rituximab|rituximab|mesh-list
92838279|NCT00994643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92838280|NCT00994643|Interleukin-2|interleukin-2|mesh-list
92838281|NCT00994643|Antibodies|antibodies|mesh-list
92838282|NCT00994643|Immunoglobulins|immunoglobulins|mesh-list
92838283|NCT00994643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92838284|NCT00994643|Immunologic Factors|immunologic factors|mesh-ancestor
92838285|NCT00994643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838286|NCT00994643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838287|NCT00994643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92838288|NCT00994643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92838289|NCT00994643|Analgesics|analgesics|mesh-ancestor
92838290|NCT00994643|Sensory System Agents|sensory system agents|mesh-ancestor
92838291|NCT00994643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838292|NCT00994643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92838293|NCT00994643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92838294|NCT00994643|Antiviral Agents|antiviral agents|mesh-ancestor
92838295|NCT00994643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838296|NCT00912171|Budesonide|budesonide|mesh-list
92838297|NCT00912171|Montelukast|montelukast|mesh-list
92838298|NCT00912171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92838299|NCT00912171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92838300|NCT00912171|Autonomic Agents|autonomic agents|mesh-ancestor
92838301|NCT00912171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838302|NCT00912171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838303|NCT00912171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838304|NCT00912171|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838305|NCT00912171|Glucocorticoids|glucocorticoids|mesh-ancestor
92838306|NCT00912171|Hormones|hormones|mesh-ancestor
92838307|NCT00912171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838308|NCT00912171|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92838309|NCT00912171|Hormone Antagonists|hormone antagonists|mesh-ancestor
92838310|NCT00912171|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92838311|NCT00912171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92838312|NCT00912171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838313|NCT00677391|Sibutramine|sibutramine|mesh-list
92838314|NCT00677391|Antidepressive Agents|antidepressive agents|mesh-ancestor
92838315|NCT00677391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838316|NCT00677391|Appetite Depressants|appetite depressants|mesh-ancestor
92838317|NCT00677391|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92838318|NCT00629057|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92838319|NCT00629057|Antiviral Agents|antiviral agents|mesh-ancestor
92838320|NCT00629057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838321|NCT00660829|Azelastine|azelastine|mesh-list
92838322|NCT00660829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92838323|NCT00660829|Autonomic Agents|autonomic agents|mesh-ancestor
92838324|NCT00660829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838325|NCT00660829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838326|NCT00660829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838327|NCT00660829|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838328|NCT00660829|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92838329|NCT00660829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838330|NCT00660829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838331|NCT00660829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92838332|NCT00660829|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92838333|NCT00660829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92838334|NCT00660829|Histamine Antagonists|histamine antagonists|mesh-ancestor
92838335|NCT00660829|Histamine Agents|histamine agents|mesh-ancestor
92838336|NCT00660829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838337|NCT00677469|Cholestyramine Resin|cholestyramine resin|mesh-list
92838338|NCT00677469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92838339|NCT00677469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92838340|NCT00677469|Antimetabolites|antimetabolites|mesh-ancestor
92838341|NCT00677469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838342|NCT00677469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92838343|NCT00629135|Moxifloxacin|moxifloxacin|mesh-list
92838344|NCT00629135|Metronidazole|metronidazole|mesh-list
92838346|NCT00629135|Piperacillin|piperacillin|mesh-list
92838347|NCT00629135|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92838348|NCT00629135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92838349|NCT00629135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838350|NCT00629135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92838351|NCT00629135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92838352|NCT00629135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838353|NCT00629135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838354|NCT00629135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838355|NCT00629135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92838356|NCT00629135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92838357|NCT00629135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92838358|NCT00795925|Propiverine|propiverine|mesh-list
92838359|NCT00795925|Parasympatholytics|parasympatholytics|mesh-ancestor
92838360|NCT00795925|Autonomic Agents|autonomic agents|mesh-ancestor
92838361|NCT00795925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838362|NCT00795925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838363|NCT00795925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92838364|NCT00795925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92838365|NCT00795925|Cholinergic Agents|cholinergic agents|mesh-ancestor
92838366|NCT00795925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838367|NCT00795925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838368|NCT00795925|Urological Agents|urological agents|mesh-ancestor
92838369|NCT04293419|Durvalumab|durvalumab|mesh-list
92838370|NCT04293419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838371|NCT04293419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838372|NCT00793429|Prucalopride|prucalopride|mesh-list
92838373|NCT00793429|Laxatives|laxatives|mesh-ancestor
92838374|NCT00793429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838375|NCT00793429|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92838376|NCT00793429|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92838377|NCT00793429|Serotonin Agents|serotonin agents|mesh-ancestor
92838378|NCT00793429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838379|NCT00793429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838380|NCT00793429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838382|NCT00801151|Vorinostat|vorinostat|mesh-list
92838383|NCT00801151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92838384|NCT00801151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838385|NCT00801151|Tubulin Modulators|tubulin modulators|mesh-ancestor
92838386|NCT00801151|Antimitotic Agents|antimitotic agents|mesh-ancestor
92838387|NCT00801151|Mitosis Modulators|mitosis modulators|mesh-ancestor
92838388|NCT00801151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838389|NCT00801151|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92838390|NCT00801151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838391|NCT00796081|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92838392|NCT00796081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92838393|NCT00796081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92838394|NCT00796081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838395|NCT00796081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838396|NCT00796081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838397|NCT00796081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92838398|NCT00796081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92838399|NCT00796081|Serotonin Agents|serotonin agents|mesh-ancestor
92838400|NCT00796081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838401|NCT00796081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838402|NCT00796081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92838403|NCT00796081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92838404|NCT00796081|Dopamine Agents|dopamine agents|mesh-ancestor
92838405|NCT00877383|Tiotropium Bromide|tiotropium bromide|mesh-list
92838406|NCT00877383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92838407|NCT00877383|Autonomic Agents|autonomic agents|mesh-ancestor
92838408|NCT00877383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838409|NCT00877383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838410|NCT00877383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838411|NCT00877383|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838412|NCT00877383|Parasympatholytics|parasympatholytics|mesh-ancestor
92838413|NCT00877383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92838414|NCT00877383|Cholinergic Agents|cholinergic agents|mesh-ancestor
92838415|NCT00877383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838416|NCT00877383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838417|NCT00796159|Olmesartan|olmesartan|mesh-list
92838418|NCT00796159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92838419|NCT00796159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838420|NCT00796159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92838421|NCT00796159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92838422|NCT00796159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838423|NCT00993473|Insulin|insulin|mesh-list
92838424|NCT00993473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92838425|NCT00993473|Insulin Glargine|insulin glargine|mesh-list
92838426|NCT00993473|Insulin Lispro|insulin lispro|mesh-list
92838427|NCT00993473|Protamines|protamines|mesh-list
92838428|NCT00993473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92838429|NCT00993473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838430|NCT00993473|Heparin Antagonists|heparin antagonists|mesh-ancestor
92838431|NCT00993473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838432|NCT00993473|Coagulants|coagulants|mesh-ancestor
92838433|NCT00660595|Risperidone|risperidone|mesh-list
92838434|NCT00660595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92838435|NCT00660595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92838436|NCT00660595|Serotonin Agents|serotonin agents|mesh-ancestor
92838437|NCT00660595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740160|NCT01057693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92838438|NCT00660595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838439|NCT00660595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838440|NCT00660595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92838441|NCT00660595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92838442|NCT00660595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838443|NCT00660595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838444|NCT00660595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92838445|NCT00660595|Dopamine Agents|dopamine agents|mesh-ancestor
92838446|NCT00660595|Antidepressive Agents|antidepressive agents|mesh-ancestor
92838447|NCT00929240|Bevacizumab|bevacizumab|mesh-list
92838448|NCT00929240|Capecitabine|capecitabine|mesh-list
92838449|NCT00929240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838450|NCT00929240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838451|NCT00929240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92838452|NCT00929240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92838453|NCT00929240|Growth Substances|growth substances|mesh-ancestor
92838454|NCT00929240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838455|NCT00929240|Growth Inhibitors|growth inhibitors|mesh-ancestor
92838456|NCT00929240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92838457|NCT00929240|Antimetabolites|antimetabolites|mesh-ancestor
92838458|NCT00929240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838460|NCT00793663|Dexamethasone acetate|dexamethasone acetate|mesh-list
92838461|NCT00793663|Ondansetron|ondansetron|mesh-list
92838462|NCT00793663|Sevoflurane|sevoflurane|mesh-list
92838463|NCT00793663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92838464|NCT00793663|Antiemetics|antiemetics|mesh-ancestor
92838465|NCT00793663|Autonomic Agents|autonomic agents|mesh-ancestor
92838466|NCT00793663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838467|NCT00793663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838468|NCT00793663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838469|NCT00793663|Glucocorticoids|glucocorticoids|mesh-ancestor
92838470|NCT00793663|Hormones|hormones|mesh-ancestor
92838471|NCT00793663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838472|NCT00793663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92838473|NCT00793663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838474|NCT00793663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92838475|NCT00793663|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92838476|NCT00793663|Anesthetics, General|anesthetics, general|mesh-ancestor
92838477|NCT00793663|Anesthetics|anesthetics|mesh-ancestor
92838478|NCT00793663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838479|NCT00793663|Antipruritics|antipruritics|mesh-ancestor
92838480|NCT00793663|Dermatologic Agents|dermatologic agents|mesh-ancestor
92838481|NCT00793663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92838482|NCT00793663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92838483|NCT00793663|Serotonin Agents|serotonin agents|mesh-ancestor
92838484|NCT00793663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838485|NCT00793663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838486|NCT02554045|Tadalafil|tadalafil|mesh-list
92838487|NCT02554045|Vasodilator Agents|vasodilator agents|mesh-ancestor
92838488|NCT02554045|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92838489|NCT02554045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92838490|NCT02554045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838491|NCT02554045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838492|NCT02554045|Urological Agents|urological agents|mesh-ancestor
92838493|NCT05330390|Levetiracetam|levetiracetam|mesh-list
92838494|NCT05330390|Anticonvulsants|anticonvulsants|mesh-ancestor
92838495|NCT05330390|Nootropic Agents|nootropic agents|mesh-ancestor
92838496|NCT00993317|Certolizumab Pegol|certolizumab pegol|mesh-list
92838497|NCT00993317|Methotrexate|methotrexate|mesh-list
92838498|NCT00993317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92838499|NCT00993317|Abortifacient Agents|abortifacient agents|mesh-ancestor
92838500|NCT00993317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92838501|NCT00993317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838502|NCT00993317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92838503|NCT00993317|Antimetabolites|antimetabolites|mesh-ancestor
92838504|NCT00993317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838505|NCT00993317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838506|NCT00993317|Dermatologic Agents|dermatologic agents|mesh-ancestor
92838507|NCT00993317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838508|NCT00993317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92838509|NCT00993317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92838510|NCT00993317|Immunologic Factors|immunologic factors|mesh-ancestor
92838511|NCT00993317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92838512|NCT00993317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92838513|NCT00993317|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92838514|NCT00993317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92838515|NCT00801385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92838516|NCT00801385|Sorafenib|sorafenib|mesh-list
92838517|NCT00801385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838518|NCT00801385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92838519|NCT00801385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838520|NCT00801385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838521|NCT00677001|R 306465|r 306465|mesh-list
92838522|NCT00677001|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92838523|NCT00677001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838524|NCT00677001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838525|NCT00877071|Doxorubicin|doxorubicin|mesh-list
92838526|NCT00877071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838527|NCT00877071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838528|NCT00877071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92838529|NCT00877071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92838530|NCT00877071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838531|NCT00877071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838532|NCT02868827|Vitamin D|vitamin d|mesh-list
92838533|NCT02868827|Cholecalciferol|cholecalciferol|mesh-list
92838534|NCT02868827|Vitamins|vitamins|mesh-ancestor
92838535|NCT02868827|Micronutrients|micronutrients|mesh-ancestor
92838536|NCT02868827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838537|NCT02868827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92838538|NCT02868827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92838539|NCT00987389|Glucocorticoids|glucocorticoids|mesh-list
92838540|NCT00987389|Hormones|hormones|mesh-ancestor
92838541|NCT00987389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838542|NCT00987389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838543|NCT00929162|Paclitaxel|paclitaxel|mesh-list
92838544|NCT00929162|Carboplatin|carboplatin|mesh-list
92838545|NCT00929162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92838546|NCT00929162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838547|NCT00929162|Tubulin Modulators|tubulin modulators|mesh-ancestor
92838548|NCT00929162|Antimitotic Agents|antimitotic agents|mesh-ancestor
92838549|NCT00929162|Mitosis Modulators|mitosis modulators|mesh-ancestor
92838550|NCT00929162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838551|NCT02627625|Tiotropium Bromide|tiotropium bromide|mesh-list
92838552|NCT02627625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92838553|NCT02627625|Autonomic Agents|autonomic agents|mesh-ancestor
92838554|NCT02627625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838555|NCT02627625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838556|NCT02627625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838557|NCT02627625|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838558|NCT02627625|Parasympatholytics|parasympatholytics|mesh-ancestor
92838559|NCT02627625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92838560|NCT02627625|Cholinergic Agents|cholinergic agents|mesh-ancestor
92838561|NCT02627625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838562|NCT02627625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838563|NCT00678483|Rimonabant|rimonabant|mesh-list
92838564|NCT00678483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92838565|NCT00678483|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92838566|NCT00678483|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92838567|NCT00678483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838568|NCT00678483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838569|NCT00678483|Hormones|hormones|mesh-ancestor
92838570|NCT00678483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838571|NCT00678483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838572|NCT00610454|Levetiracetam|levetiracetam|mesh-list
92838573|NCT00610454|Anticonvulsants|anticonvulsants|mesh-ancestor
92838574|NCT00610454|Nootropic Agents|nootropic agents|mesh-ancestor
92838575|NCT04151355|Atorvastatin|atorvastatin|mesh-list
92838576|NCT04151355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92838577|NCT04151355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92838578|NCT04151355|Antimetabolites|antimetabolites|mesh-ancestor
92838579|NCT04151355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838580|NCT04151355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92838581|NCT04151355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92838582|NCT04151355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838583|NCT00609284|Carboplatin|carboplatin|mesh-list
92838584|NCT00609284|Cetuximab|cetuximab|mesh-list
92838585|NCT00609284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838586|NCT00609284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838587|NCT00992459|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92838588|NCT00992459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838589|NCT00930722|Quinapril|quinapril|mesh-list
92838590|NCT00930722|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92838591|NCT00930722|Protease Inhibitors|protease inhibitors|mesh-ancestor
92838592|NCT00930722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838593|NCT00930722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838594|NCT00930722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838595|NCT00610610|Paroxetine|paroxetine|mesh-list
92483651|NCT01915979|Betamethasone|betamethasone|mesh-list
92838596|NCT00610610|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92838597|NCT00610610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92838598|NCT00610610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92838599|NCT00610610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838600|NCT00610610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838601|NCT00610610|Serotonin Agents|serotonin agents|mesh-ancestor
92838602|NCT00610610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838603|NCT00610610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92838604|NCT00610610|Antidepressive Agents|antidepressive agents|mesh-ancestor
92838605|NCT00610610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838606|NCT00610610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92838607|NCT00610610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92838608|NCT00610610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838609|NCT00912327|Cetuximab|cetuximab|mesh-list
92838610|NCT00912327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838611|NCT00912327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838612|NCT04257812|Tazobactam|tazobactam|mesh-list
92838613|NCT04257812|Ceftolozane|ceftolozane|mesh-list
92838614|NCT04257812|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92838615|NCT04257812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92838616|NCT04257812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838617|NCT04257812|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92838618|NCT04257812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838619|NCT04257812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838620|NCT04257812|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92838621|NCT02868749|Hyaluronic Acid|hyaluronic acid|mesh-list
92838622|NCT02868749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92838623|NCT02868749|Immunologic Factors|immunologic factors|mesh-ancestor
92838624|NCT02868749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838625|NCT02868749|Viscosupplements|viscosupplements|mesh-ancestor
92838626|NCT02868749|Protective Agents|protective agents|mesh-ancestor
92838627|NCT00659581|Telmisartan|telmisartan|mesh-list
92838628|NCT00659581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838629|NCT00659581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92838630|NCT00659581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92838631|NCT00659581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838632|NCT00793741|Somatostatin|somatostatin|mesh-list
92838633|NCT00793741|Hormones|hormones|mesh-ancestor
92838634|NCT00793741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838635|NCT00793741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838636|NCT00796471|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92838637|NCT00796471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92838638|NCT00796471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92838639|NCT00796471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838640|NCT00796471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838641|NCT00796471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838642|NCT00796471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92838643|NCT00796471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92838644|NCT00796471|Serotonin Agents|serotonin agents|mesh-ancestor
92838645|NCT00796471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838646|NCT00796471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838647|NCT00796471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92838648|NCT00796471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92838649|NCT00796471|Dopamine Agents|dopamine agents|mesh-ancestor
92838650|NCT00991289|Interferons|interferons|mesh-list
92838651|NCT00991289|Ribavirin|ribavirin|mesh-list
92838652|NCT00991289|Interferon-alpha|interferon-alpha|mesh-list
92838653|NCT00991289|Interferon alpha-2|interferon alpha-2|mesh-list
92838654|NCT00991289|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92838655|NCT00991289|Nitazoxanide|nitazoxanide|mesh-list
92838656|NCT00991289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838657|NCT00991289|Antiviral Agents|antiviral agents|mesh-ancestor
92838658|NCT00991289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838659|NCT00991289|Antimetabolites|antimetabolites|mesh-ancestor
92838660|NCT00991289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838661|NCT00991289|Immunologic Factors|immunologic factors|mesh-ancestor
92838662|NCT00991289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838663|NCT00991289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92838664|NCT04046029|Heparin|heparin|mesh-list
92838665|NCT04046029|Bivalirudin|bivalirudin|mesh-list
92838666|NCT04046029|Anticoagulants|anticoagulants|mesh-ancestor
92838667|NCT04046029|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92838668|NCT04046029|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93046915|NCT00350636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838669|NCT04046029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838670|NCT04046029|Antithrombins|antithrombins|mesh-ancestor
92838671|NCT04046029|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92838672|NCT04046029|Protease Inhibitors|protease inhibitors|mesh-ancestor
92838673|NCT04046029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838674|NCT00679653|Sibutramine|sibutramine|mesh-list
92838675|NCT00679653|Metoprolol|metoprolol|mesh-list
92838676|NCT00679653|Verapamil|verapamil|mesh-list
92838677|NCT00679653|Felodipine|felodipine|mesh-list
92838678|NCT00679653|Ramipril|ramipril|mesh-list
92838679|NCT00679653|Trandolapril|trandolapril|mesh-list
92838680|NCT00679653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92838681|NCT00679653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92838682|NCT00679653|Sympatholytics|sympatholytics|mesh-ancestor
92838683|NCT00679653|Autonomic Agents|autonomic agents|mesh-ancestor
92838684|NCT00679653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838685|NCT00679653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838686|NCT00679653|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92838687|NCT00679653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92838688|NCT00679653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92838689|NCT00679653|Adrenergic Agents|adrenergic agents|mesh-ancestor
92838690|NCT00679653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838691|NCT00679653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838692|NCT00679653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92838693|NCT00679653|Protease Inhibitors|protease inhibitors|mesh-ancestor
92838694|NCT00679653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838695|NCT00679653|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92838696|NCT00679653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92838697|NCT00679653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92838698|NCT00679653|Vasodilator Agents|vasodilator agents|mesh-ancestor
92838699|NCT00679653|Antidepressive Agents|antidepressive agents|mesh-ancestor
92838700|NCT00679653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838701|NCT00679653|Appetite Depressants|appetite depressants|mesh-ancestor
92838702|NCT00679653|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92838703|NCT00793897|Paclitaxel|paclitaxel|mesh-list
92838704|NCT00793897|Carboplatin|carboplatin|mesh-list
92838705|NCT00793897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92838706|NCT00793897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838707|NCT00793897|Tubulin Modulators|tubulin modulators|mesh-ancestor
92838708|NCT00793897|Antimitotic Agents|antimitotic agents|mesh-ancestor
92838709|NCT00793897|Mitosis Modulators|mitosis modulators|mesh-ancestor
92838710|NCT00793897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838711|NCT00793975|Ramucirumab|ramucirumab|mesh-list
92838712|NCT00793975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838713|NCT00679965|Tavaborole|tavaborole|mesh-list
92838714|NCT00679965|Antifungal Agents|antifungal agents|mesh-ancestor
92838715|NCT00679965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838716|NCT00930644|Teduglutide|teduglutide|mesh-list
92838717|NCT00930644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838718|NCT00930644|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92838719|NCT00930644|Protective Agents|protective agents|mesh-ancestor
92838720|NCT00930644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838721|NCT02627469|Listerine|listerine|mesh-list
92838722|NCT02627469|Fluorides|fluorides|mesh-list
92838723|NCT02627469|Sodium Fluoride|sodium fluoride|mesh-list
92838724|NCT02627469|Cariostatic Agents|cariostatic agents|mesh-ancestor
92838725|NCT02627469|Protective Agents|protective agents|mesh-ancestor
92838726|NCT02627469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838727|NCT02627469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92838728|NCT02627469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838729|NCT00680277|Carotenoids|carotenoids|mesh-list
92838730|NCT00680277|Antioxidants|antioxidants|mesh-ancestor
92838731|NCT00680277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838732|NCT00680277|Protective Agents|protective agents|mesh-ancestor
92838733|NCT00680277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838734|NCT00680355|Carotenoids|carotenoids|mesh-list
92838735|NCT00680355|Antioxidants|antioxidants|mesh-ancestor
92838736|NCT00680355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838737|NCT00680355|Protective Agents|protective agents|mesh-ancestor
92838738|NCT00680355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838739|NCT00801697|Vaccines|vaccines|mesh-list
92838740|NCT00801697|Immunologic Factors|immunologic factors|mesh-ancestor
92838741|NCT00801697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838742|NCT00684489|Antihypertensive Agents|antihypertensive agents|mesh-list
92838743|NCT00684489|Coal Tar|coal tar|mesh-list
92838744|NCT00684489|Keratolytic Agents|keratolytic agents|mesh-ancestor
92838745|NCT00684489|Dermatologic Agents|dermatologic agents|mesh-ancestor
92838746|NCT00990821|Midazolam|midazolam|mesh-list
92838747|NCT00990821|Aprepitant|aprepitant|mesh-list
92838748|NCT00990821|Fosaprepitant|fosaprepitant|mesh-list
92838749|NCT00990821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92838750|NCT00990821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92838751|NCT00990821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838752|NCT00990821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838753|NCT00990821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92838754|NCT00990821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92838755|NCT00990821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838756|NCT00990821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92838757|NCT00990821|Anesthetics, General|anesthetics, general|mesh-ancestor
92838758|NCT00990821|Anesthetics|anesthetics|mesh-ancestor
92838759|NCT00990821|GABA Modulators|gaba modulators|mesh-ancestor
92838760|NCT00990821|GABA Agents|gaba agents|mesh-ancestor
92838761|NCT00990821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838762|NCT00990821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838763|NCT00990821|Antiemetics|antiemetics|mesh-ancestor
92838764|NCT00990821|Autonomic Agents|autonomic agents|mesh-ancestor
92838765|NCT00990821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838766|NCT00990821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838767|NCT00990821|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92838768|NCT00801853|Interleukin-4|interleukin-4|mesh-list
92838769|NCT00801853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92838770|NCT00801853|Immunologic Factors|immunologic factors|mesh-ancestor
92838771|NCT00801853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838772|NCT00801853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838773|NCT00801853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92838774|NCT00990665|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92838775|NCT00990665|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92838776|NCT00990665|Contraceptive Agents|contraceptive agents|mesh-ancestor
92838777|NCT00990665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92838778|NCT00990665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838779|NCT00990665|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92838780|NCT00990665|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92838781|NCT00990665|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92838782|NCT00658567|Pimavanserin|pimavanserin|mesh-list
92838783|NCT00658567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92838784|NCT00658567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92838785|NCT00658567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92838786|NCT00658567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92838787|NCT00658567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838788|NCT00658567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838789|NCT00658567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92838790|NCT00658567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92838791|NCT00658567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92838792|NCT00658567|Serotonin Agents|serotonin agents|mesh-ancestor
92838793|NCT00658567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838794|NCT00658567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838795|NCT00875433|Afatinib|afatinib|mesh-list
92838796|NCT00875433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838797|NCT00875433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92838798|NCT00875433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838799|NCT00875433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838800|NCT00684957|Hormones|hormones|mesh-list
92838801|NCT00684957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838802|NCT00684957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838803|NCT00685191|Raltegravir Potassium|raltegravir potassium|mesh-list
92838804|NCT00685191|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92838805|NCT00685191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92838806|NCT00685191|Antiviral Agents|antiviral agents|mesh-ancestor
92838807|NCT00685191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838808|NCT00685191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92838809|NCT00685191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92838810|NCT00685191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838811|NCT00685191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838812|NCT00685269|Eszopiclone|eszopiclone|mesh-list
92838813|NCT00685269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92838814|NCT00685269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838815|NCT00685269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838816|NCT00794209|Fentanyl|fentanyl|mesh-list
92838817|NCT00794209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92838818|NCT00794209|Narcotics|narcotics|mesh-ancestor
92838819|NCT00794209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838820|NCT00794209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483874|NCT01917045|Anesthetics|anesthetics|mesh-ancestor
92838821|NCT00794209|Analgesics|analgesics|mesh-ancestor
92838822|NCT00794209|Sensory System Agents|sensory system agents|mesh-ancestor
92838823|NCT00794209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838824|NCT00794209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92838825|NCT00794209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92838826|NCT00794209|Anesthetics, General|anesthetics, general|mesh-ancestor
92838827|NCT00794209|Anesthetics|anesthetics|mesh-ancestor
92838828|NCT00985985|Nicotine|nicotine|mesh-list
92838829|NCT00985985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92838830|NCT00985985|Autonomic Agents|autonomic agents|mesh-ancestor
92838831|NCT00985985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838832|NCT00985985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838833|NCT00985985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92838834|NCT00985985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92838835|NCT00985985|Cholinergic Agents|cholinergic agents|mesh-ancestor
92838836|NCT00985985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838837|NCT00985985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838838|NCT00685347|Albuterol|albuterol|mesh-list
92838839|NCT00685347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92838840|NCT00685347|Autonomic Agents|autonomic agents|mesh-ancestor
92838841|NCT00685347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838842|NCT00685347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838843|NCT00685347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838844|NCT00685347|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838845|NCT00685347|Tocolytic Agents|tocolytic agents|mesh-ancestor
92838846|NCT00685347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92838847|NCT00685347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92838848|NCT00685347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92838849|NCT00685347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92838850|NCT00685347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92838851|NCT00685347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838852|NCT00685347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838854|NCT00685425|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92838855|NCT00685425|Autonomic Agents|autonomic agents|mesh-ancestor
92838856|NCT00685425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838857|NCT00685425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838858|NCT00685425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838859|NCT00685425|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838860|NCT00685425|Tocolytic Agents|tocolytic agents|mesh-ancestor
92838861|NCT00685425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92838862|NCT00685425|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92838863|NCT00685425|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92838864|NCT00685425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92838865|NCT00685425|Adrenergic Agents|adrenergic agents|mesh-ancestor
92838866|NCT00685425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92838867|NCT00685425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838868|NCT04290455|Castor Oil|castor oil|mesh-list
92838869|NCT04290455|Cathartics|cathartics|mesh-ancestor
92838870|NCT04290455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838871|NCT00685503|Ranibizumab|ranibizumab|mesh-list
92838872|NCT00685503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92838873|NCT00685503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92838874|NCT00685503|Growth Substances|growth substances|mesh-ancestor
92838875|NCT00685503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838876|NCT00685503|Growth Inhibitors|growth inhibitors|mesh-ancestor
92838877|NCT00685503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838878|NCT00802009|Dexamethasone|dexamethasone|mesh-list
92838879|NCT00802009|Mepivacaine|mepivacaine|mesh-list
92838880|NCT00802009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92838881|NCT00802009|Antiemetics|antiemetics|mesh-ancestor
92838882|NCT00802009|Autonomic Agents|autonomic agents|mesh-ancestor
92838883|NCT00802009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838884|NCT00802009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838885|NCT00802009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92838886|NCT00802009|Glucocorticoids|glucocorticoids|mesh-ancestor
92838887|NCT00802009|Hormones|hormones|mesh-ancestor
92838888|NCT00802009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838889|NCT00802009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92838890|NCT00802009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838891|NCT00802009|Anesthetics, Local|anesthetics, local|mesh-ancestor
92838892|NCT00802009|Anesthetics|anesthetics|mesh-ancestor
92838893|NCT00802009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838894|NCT00802009|Sensory System Agents|sensory system agents|mesh-ancestor
92838895|NCT02868437|Hyaluronic Acid|hyaluronic acid|mesh-list
92838896|NCT02868437|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92838897|NCT02868437|Immunologic Factors|immunologic factors|mesh-ancestor
92838898|NCT02868437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838899|NCT02868437|Viscosupplements|viscosupplements|mesh-ancestor
92838900|NCT02868437|Protective Agents|protective agents|mesh-ancestor
92838901|NCT00802087|Acetaminophen|acetaminophen|mesh-list
92838902|NCT00802087|Hydrocodone|hydrocodone|mesh-list
92838903|NCT00802087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92838904|NCT00802087|Analgesics|analgesics|mesh-ancestor
92838905|NCT00802087|Sensory System Agents|sensory system agents|mesh-ancestor
92838906|NCT00802087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838907|NCT00802087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838908|NCT00802087|Antipyretics|antipyretics|mesh-ancestor
92838909|NCT00802087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92838910|NCT00802087|Narcotics|narcotics|mesh-ancestor
92838911|NCT00802087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838912|NCT00802087|Antitussive Agents|antitussive agents|mesh-ancestor
92838913|NCT00802087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838914|NCT00923936|Bevacizumab|bevacizumab|mesh-list
92838915|NCT00923936|Doxorubicin|doxorubicin|mesh-list
92838916|NCT00923936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92838917|NCT00923936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838918|NCT00923936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838919|NCT00923936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92838920|NCT00923936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92838921|NCT00923936|Growth Substances|growth substances|mesh-ancestor
92838922|NCT00923936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838923|NCT00923936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92838924|NCT00923936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92838925|NCT00923936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92838926|NCT00923936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92838927|NCT00923936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838928|NCT00923936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838930|NCT00797017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92838931|NCT00797017|Narcotics|narcotics|mesh-ancestor
92838932|NCT00797017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92838933|NCT00797017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838934|NCT00797017|Analgesics|analgesics|mesh-ancestor
92838935|NCT00797017|Sensory System Agents|sensory system agents|mesh-ancestor
92838936|NCT00797017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92838937|NCT00797017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92838938|NCT00797017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92838939|NCT00797017|Anesthetics, General|anesthetics, general|mesh-ancestor
92838940|NCT00797017|Anesthetics|anesthetics|mesh-ancestor
92838941|NCT05330000|Voriconazole|voriconazole|mesh-list
92838942|NCT05330000|Antifungal Agents|antifungal agents|mesh-ancestor
92838943|NCT05330000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92838944|NCT05330000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92838945|NCT05330000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92838946|NCT05330000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838947|NCT05330000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838948|NCT05330000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92838949|NCT05330000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92838950|NCT05330000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838951|NCT05330000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838952|NCT05330000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92838953|NCT00794443|Diphosphonates|diphosphonates|mesh-list
92838954|NCT00794443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92838955|NCT00794443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838956|NCT00924950|Calcitriol|calcitriol|mesh-list
92838957|NCT00924950|Betamethasone|betamethasone|mesh-list
92838958|NCT00924950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92838959|NCT00924950|Glucocorticoids|glucocorticoids|mesh-ancestor
92838960|NCT00924950|Hormones|hormones|mesh-ancestor
92838961|NCT00924950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92838962|NCT00924950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838963|NCT00924950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92838964|NCT00924950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92838965|NCT00924950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92838966|NCT00924950|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92838967|NCT00924950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92838968|NCT00924950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838969|NCT00924950|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92838970|NCT00924950|Vitamins|vitamins|mesh-ancestor
92838972|NCT00924950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92838973|NCT02626065|Nivolumab|nivolumab|mesh-list
92838974|NCT02626065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92838975|NCT02626065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92838976|NCT02626065|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92838977|NCT02626065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838978|NCT00794755|Vitamin K|vitamin k|mesh-list
92838979|NCT00794755|Vitamin K 1|vitamin k 1|mesh-list
92838980|NCT00794755|Vitamins|vitamins|mesh-ancestor
92838981|NCT00794755|Micronutrients|micronutrients|mesh-ancestor
92838982|NCT00794755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838983|NCT00794755|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92838984|NCT00794755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92838985|NCT00794755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838986|NCT00794755|Hemostatics|hemostatics|mesh-ancestor
92838987|NCT00794755|Coagulants|coagulants|mesh-ancestor
92838988|NCT00685971|Cholecalciferol|cholecalciferol|mesh-list
92838989|NCT00685971|Vitamin D|vitamin d|mesh-list
92838990|NCT00685971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92838991|NCT00685971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92838992|NCT00685971|Vitamins|vitamins|mesh-ancestor
92838993|NCT00685971|Micronutrients|micronutrients|mesh-ancestor
92838994|NCT00685971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92838995|NCT00802243|Leflunomide|leflunomide|mesh-list
92838996|NCT00802243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92838997|NCT00802243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92838998|NCT00802243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92838999|NCT00802243|Immunologic Factors|immunologic factors|mesh-ancestor
92839000|NCT00802243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839001|NCT00988637|Calcitriol|calcitriol|mesh-list
92839002|NCT00988637|Clobetasol|clobetasol|mesh-list
92839003|NCT00988637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92839004|NCT00988637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839005|NCT00988637|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92839006|NCT00988637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839007|NCT00988637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839008|NCT00988637|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92839009|NCT00988637|Vitamins|vitamins|mesh-ancestor
92839010|NCT00988637|Micronutrients|micronutrients|mesh-ancestor
92839011|NCT00988637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92839012|NCT00988637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839013|NCT00988637|Glucocorticoids|glucocorticoids|mesh-ancestor
92839014|NCT00988637|Hormones|hormones|mesh-ancestor
92839015|NCT00988637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92839016|NCT00802321|Dutasteride|dutasteride|mesh-list
92839017|NCT00802321|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92839018|NCT00802321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92839019|NCT00802321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839020|NCT00802321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839021|NCT00802321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92839022|NCT00802321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92839023|NCT00802321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839024|NCT00686361|Choline|choline|mesh-list
92839025|NCT00686361|Lipotropic Agents|lipotropic agents|mesh-ancestor
92839026|NCT00686361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839027|NCT00686361|Antimetabolites|antimetabolites|mesh-ancestor
92839028|NCT00686361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839029|NCT00686361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92839030|NCT00686361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839031|NCT00686361|Nootropic Agents|nootropic agents|mesh-ancestor
92839032|NCT00686439|Adalimumab|adalimumab|mesh-list
92839033|NCT00686439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92839034|NCT00686439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839035|NCT00686439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92839036|NCT00797485|Leucovorin|leucovorin|mesh-list
92839037|NCT00797485|Bevacizumab|bevacizumab|mesh-list
92839038|NCT00797485|Fluorouracil|fluorouracil|mesh-list
92839039|NCT00797485|Capecitabine|capecitabine|mesh-list
92839040|NCT00797485|Irinotecan|irinotecan|mesh-list
92839041|NCT00797485|Calcium|calcium|mesh-list
92839042|NCT00797485|Levoleucovorin|levoleucovorin|mesh-list
92839043|NCT00797485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839044|NCT00797485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484105|NCT01918241|Lenograstim|lenograstim|mesh-list
92839045|NCT00797485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92839046|NCT00797485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92839047|NCT00797485|Growth Substances|growth substances|mesh-ancestor
92839048|NCT00797485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839049|NCT00797485|Growth Inhibitors|growth inhibitors|mesh-ancestor
92839050|NCT00797485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92839051|NCT00797485|Antimetabolites|antimetabolites|mesh-ancestor
92839052|NCT00797485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839053|NCT00797485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839054|NCT00797485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839055|NCT00797485|Immunologic Factors|immunologic factors|mesh-ancestor
92839056|NCT00797485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92839057|NCT00797485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92839058|NCT00797485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839059|NCT00797485|Antidotes|antidotes|mesh-ancestor
92839060|NCT00797485|Protective Agents|protective agents|mesh-ancestor
92839061|NCT00797485|Vitamin B Complex|vitamin b complex|mesh-ancestor
92839063|NCT00797485|Micronutrients|micronutrients|mesh-ancestor
92839064|NCT00686985|Carboplatin|carboplatin|mesh-list
92839065|NCT00686985|Docetaxel|docetaxel|mesh-list
92839066|NCT00686985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839067|NCT00686985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92839068|NCT00686985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92839069|NCT00686985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92839070|NCT00686985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839071|NCT00687063|Insulin Detemir|insulin detemir|mesh-list
92839072|NCT00687063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92839073|NCT00687063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839074|NCT02866955|Tamoxifen|tamoxifen|mesh-list
92839075|NCT02866955|Estramustine|estramustine|mesh-list
92839076|NCT02866955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92839077|NCT02866955|Hormone Antagonists|hormone antagonists|mesh-ancestor
92839078|NCT02866955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92839079|NCT02866955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839080|NCT02866955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92839081|NCT02866955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839082|NCT02866955|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92839083|NCT02866955|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92839084|NCT02866955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92839085|NCT02866955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92839086|NCT02866955|Alkylating Agents|alkylating agents|mesh-ancestor
92839087|NCT02866955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839088|NCT02625753|Acetaminophen|acetaminophen|mesh-list
92839089|NCT02625753|Codeine|codeine|mesh-list
92839090|NCT02625753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839091|NCT02625753|Analgesics|analgesics|mesh-ancestor
92839092|NCT02625753|Sensory System Agents|sensory system agents|mesh-ancestor
92839093|NCT02625753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839094|NCT02625753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839095|NCT02625753|Antipyretics|antipyretics|mesh-ancestor
92839096|NCT02625753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92839097|NCT02625753|Narcotics|narcotics|mesh-ancestor
92839098|NCT02625753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839099|NCT02625753|Antitussive Agents|antitussive agents|mesh-ancestor
92839100|NCT02625753|Respiratory System Agents|respiratory system agents|mesh-ancestor
92839101|NCT04257656|Remdesivir|remdesivir|mesh-list
92839102|NCT04257656|Antimetabolites|antimetabolites|mesh-ancestor
92839103|NCT04257656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839104|NCT04257656|Antiviral Agents|antiviral agents|mesh-ancestor
92839105|NCT04257656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839106|NCT05329844|Vildagliptin|vildagliptin|mesh-list
92839107|NCT05329844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92839108|NCT05329844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839109|NCT05329844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92839110|NCT05329844|Protease Inhibitors|protease inhibitors|mesh-ancestor
92839111|NCT05329844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839112|NCT05329844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839113|NCT00687999|Interferons|interferons|mesh-list
92839114|NCT00687999|Ribavirin|ribavirin|mesh-list
92839115|NCT00687999|Interferon-alpha|interferon-alpha|mesh-list
92839116|NCT00687999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839117|NCT00687999|Antiviral Agents|antiviral agents|mesh-ancestor
92839118|NCT00687999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839119|NCT00687999|Antimetabolites|antimetabolites|mesh-ancestor
92839120|NCT00687999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839121|NCT00687999|Immunologic Factors|immunologic factors|mesh-ancestor
92839122|NCT00687999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839123|NCT00688077|Calcitonin|calcitonin|mesh-list
92839124|NCT00688077|Salmon calcitonin|salmon calcitonin|mesh-list
92839125|NCT00688077|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92839126|NCT00688077|Katacalcin|katacalcin|mesh-list
92839127|NCT00688077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92839128|NCT00688077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839129|NCT00688077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92839130|NCT00688077|Vasodilator Agents|vasodilator agents|mesh-ancestor
92839131|NCT00923156|Ramipril|ramipril|mesh-list
92839132|NCT00923156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92839133|NCT00923156|Protease Inhibitors|protease inhibitors|mesh-ancestor
92839134|NCT00923156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839135|NCT00923156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839136|NCT00923156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92839137|NCT00688857|Diazoxide|diazoxide|mesh-list
92839138|NCT00688857|Choline|choline|mesh-list
92839139|NCT00688857|Lipotropic Agents|lipotropic agents|mesh-ancestor
92839140|NCT00688857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839141|NCT00688857|Antimetabolites|antimetabolites|mesh-ancestor
92839142|NCT00688857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839143|NCT00688857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92839144|NCT00688857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839145|NCT00688857|Nootropic Agents|nootropic agents|mesh-ancestor
92839146|NCT00688857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92839147|NCT00688857|Vasodilator Agents|vasodilator agents|mesh-ancestor
92839148|NCT04256798|Chlorhexidine|chlorhexidine|mesh-list
92839149|NCT04256798|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92839150|NCT04256798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839151|NCT04256798|Disinfectants|disinfectants|mesh-ancestor
92839152|NCT00687843|polysaccharide-K|polysaccharide-k|mesh-list
92839153|NCT00687843|Tegafur|tegafur|mesh-list
92839154|NCT00687843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839155|NCT00687843|Antimetabolites|antimetabolites|mesh-ancestor
92839156|NCT00687843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839157|NCT00687843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839158|NCT00687843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92839159|NCT00687843|Immunologic Factors|immunologic factors|mesh-ancestor
92839160|NCT00687843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839161|NCT00687843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92839162|NCT00687843|Antiviral Agents|antiviral agents|mesh-ancestor
92839163|NCT00687843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839164|NCT00687843|Interferon Inducers|interferon inducers|mesh-ancestor
92839165|NCT00687843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92839166|NCT00687843|Protective Agents|protective agents|mesh-ancestor
92839167|NCT00689169|Cytarabine|cytarabine|mesh-list
92839168|NCT00689169|Rituximab|rituximab|mesh-list
92839169|NCT00689169|Etoposide|etoposide|mesh-list
92839170|NCT00689169|Melphalan|melphalan|mesh-list
92839171|NCT00689169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839172|NCT00689169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839173|NCT00689169|Immunologic Factors|immunologic factors|mesh-ancestor
92839174|NCT00689169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839175|NCT00689169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92839176|NCT00689169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839177|NCT00689169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92839178|NCT00689169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92839179|NCT00689169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839180|NCT00689169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839181|NCT00689169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92839182|NCT00689169|Alkylating Agents|alkylating agents|mesh-ancestor
92839183|NCT00689169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92839184|NCT00689169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839185|NCT00689169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839186|NCT00689169|Antimetabolites|antimetabolites|mesh-ancestor
92839187|NCT00689169|Antiviral Agents|antiviral agents|mesh-ancestor
92839188|NCT00689169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839189|NCT04203914|Empagliflozin|empagliflozin|mesh-list
92839190|NCT04203914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92839191|NCT04203914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839192|NCT04203914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92839193|NCT04203914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839194|NCT00874731|Sirolimus|sirolimus|mesh-list
92839195|NCT00874731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92839196|NCT00874731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839197|NCT00874731|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92839198|NCT00874731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839199|NCT00874731|Antifungal Agents|antifungal agents|mesh-ancestor
92839200|NCT00874731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839201|NCT00874731|Immunologic Factors|immunologic factors|mesh-ancestor
92839202|NCT00874731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839203|NCT02625519|Hormones|hormones|mesh-list
92839204|NCT02625519|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92839205|NCT02625519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92839206|NCT02625519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839207|NCT00912483|Heparin|heparin|mesh-list
92839208|NCT00912483|Calcium heparin|calcium heparin|mesh-list
92839209|NCT00912483|Anticoagulants|anticoagulants|mesh-ancestor
92839210|NCT00912483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92839211|NCT00912483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92839212|NCT00912483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839213|NCT04257032|Dabigatran|dabigatran|mesh-list
92839214|NCT04257032|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92839215|NCT04257032|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92839216|NCT04257032|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839217|NCT04257032|Antimetabolites|antimetabolites|mesh-ancestor
92839218|NCT04257032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839219|NCT04257032|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839220|NCT04257032|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92839221|NCT04257032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839222|NCT04257032|Antithrombins|antithrombins|mesh-ancestor
92839223|NCT04257032|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92839224|NCT04257032|Protease Inhibitors|protease inhibitors|mesh-ancestor
92839225|NCT04257032|Anticoagulants|anticoagulants|mesh-ancestor
92839226|NCT00924560|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92839227|NCT00924560|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92839228|NCT00924560|Levonorgestrel|levonorgestrel|mesh-list
92839229|NCT00924560|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92839230|NCT00924560|Contraceptive Agents|contraceptive agents|mesh-list
92839231|NCT00924560|Contraceptives, Oral|contraceptives, oral|mesh-list
92839232|NCT00924560|Estradiol|estradiol|mesh-list
92839233|NCT00924560|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92839234|NCT00924560|Estrogens|estrogens|mesh-ancestor
92839235|NCT00924560|Hormones|hormones|mesh-ancestor
92839236|NCT00924560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92839237|NCT00924560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839238|NCT00924560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92839239|NCT00924560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92839240|NCT00924560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92839241|NCT00924560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92839242|NCT00924560|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92839243|NCT00689559|Aripiprazole|aripiprazole|mesh-list
92839244|NCT00689559|Antidepressive Agents|antidepressive agents|mesh-ancestor
92839245|NCT00689559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92839246|NCT00689559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92839247|NCT00689559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92839248|NCT00689559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839249|NCT00689559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839250|NCT00689559|Dopamine Agonists|dopamine agonists|mesh-ancestor
92839251|NCT00689559|Dopamine Agents|dopamine agents|mesh-ancestor
92839252|NCT00689559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839253|NCT00689559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839254|NCT00689559|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92839255|NCT00689559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92839256|NCT00689559|Serotonin Agents|serotonin agents|mesh-ancestor
92839257|NCT00689559|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92839258|NCT00689559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92839259|NCT00689559|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92839260|NCT00689559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92839261|NCT00689637|Warfarin|warfarin|mesh-list
92839262|NCT00689637|Anticoagulants|anticoagulants|mesh-ancestor
92839263|NCT00689715|Ethanol|ethanol|mesh-list
92839264|NCT00689715|Paclitaxel|paclitaxel|mesh-list
92839265|NCT00689715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92839266|NCT00689715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839267|NCT00689715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839268|NCT00689715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92839269|NCT00689715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92839270|NCT00689715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92839271|NCT00689715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839273|NCT00689715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839274|NCT00689715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839275|NCT00689715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839276|NCT00689949|Folic Acid|folic acid|mesh-list
92839277|NCT00689949|Hematinics|hematinics|mesh-ancestor
92839278|NCT00689949|Vitamin B Complex|vitamin b complex|mesh-ancestor
92839279|NCT00689949|Vitamins|vitamins|mesh-ancestor
92839280|NCT00689949|Micronutrients|micronutrients|mesh-ancestor
92839281|NCT00689949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839282|NCT04256642|Morphine|morphine|mesh-list
92839283|NCT04256642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92839284|NCT04256642|Narcotics|narcotics|mesh-ancestor
92839285|NCT04256642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839286|NCT04256642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839287|NCT04256642|Analgesics|analgesics|mesh-ancestor
92839288|NCT04256642|Sensory System Agents|sensory system agents|mesh-ancestor
92839289|NCT04256642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839290|NCT00611000|Folic Acid|folic acid|mesh-list
92839291|NCT00611000|Hematinics|hematinics|mesh-ancestor
92839292|NCT00611000|Vitamin B Complex|vitamin b complex|mesh-ancestor
92839293|NCT00611000|Vitamins|vitamins|mesh-ancestor
92839294|NCT00611000|Micronutrients|micronutrients|mesh-ancestor
92839295|NCT00611000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839296|NCT04031157|Antidepressive Agents|antidepressive agents|mesh-list
92839297|NCT04031157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92839298|NCT00690105|Fluticasone|fluticasone|mesh-list
92839299|NCT00690105|Tacrolimus|tacrolimus|mesh-list
92839300|NCT00690105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839301|NCT00690105|Immunologic Factors|immunologic factors|mesh-ancestor
92839302|NCT00690105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839303|NCT00690105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92839304|NCT00690105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839305|NCT00690105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839306|NCT00690105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839308|NCT00690105|Autonomic Agents|autonomic agents|mesh-ancestor
92839309|NCT00690105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839310|NCT00690105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92839311|NCT00690105|Respiratory System Agents|respiratory system agents|mesh-ancestor
92839312|NCT00690105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92839313|NCT00690105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92839314|NCT00694317|Zaleplon|zaleplon|mesh-list
92839315|NCT00694317|Anticonvulsants|anticonvulsants|mesh-ancestor
92839316|NCT00694317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92839317|NCT00694317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839318|NCT00694317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839319|NCT00694317|GABA Modulators|gaba modulators|mesh-ancestor
92839320|NCT00694317|GABA Agents|gaba agents|mesh-ancestor
92839321|NCT00694317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839322|NCT00694317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839323|NCT04136613|Copper|copper|mesh-list
92839324|NCT04136613|Trace Elements|trace elements|mesh-ancestor
92839325|NCT04136613|Micronutrients|micronutrients|mesh-ancestor
92839326|NCT04136613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839327|NCT00978731|Dasatinib|dasatinib|mesh-list
92839328|NCT00978731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839329|NCT00978731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839330|NCT00978731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839331|NCT00978731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839332|NCT04136535|Carboplatin|carboplatin|mesh-list
92839333|NCT04136535|Pemetrexed|pemetrexed|mesh-list
92839334|NCT04136535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839335|NCT04136535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839336|NCT04136535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839337|NCT04136535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92839338|NCT04136535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92839339|NCT00694629|Rifampin|rifampin|mesh-list
92839340|NCT00694629|Rifapentine|rifapentine|mesh-list
92839341|NCT00694629|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92839342|NCT00694629|Antitubercular Agents|antitubercular agents|mesh-ancestor
92839343|NCT00694629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92839344|NCT00694629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839345|NCT00694629|Leprostatic Agents|leprostatic agents|mesh-ancestor
92839346|NCT00694629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92839347|NCT00694629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484402|NCT01921374|Vitamin B 12|vitamin b 12|mesh-list
92839348|NCT00694629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839349|NCT00694629|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92839350|NCT00694629|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92839351|NCT00694629|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92839352|NCT00694629|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92839353|NCT00694629|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92839354|NCT00694629|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92839355|NCT00912639|Paclitaxel|paclitaxel|mesh-list
92839356|NCT00912639|genexol-PM|genexol-pm|mesh-list
92839357|NCT00912639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839358|NCT00912639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839359|NCT00912639|Tubulin Modulators|tubulin modulators|mesh-ancestor
92839360|NCT00912639|Antimitotic Agents|antimitotic agents|mesh-ancestor
92839361|NCT00912639|Mitosis Modulators|mitosis modulators|mesh-ancestor
92839362|NCT00912639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839363|NCT02866409|Dexmedetomidine|dexmedetomidine|mesh-list
92839364|NCT02866409|Bupivacaine|bupivacaine|mesh-list
92839365|NCT02866409|Anesthetics, Local|anesthetics, local|mesh-ancestor
92839366|NCT02866409|Anesthetics|anesthetics|mesh-ancestor
92839367|NCT02866409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839368|NCT02866409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839369|NCT02866409|Sensory System Agents|sensory system agents|mesh-ancestor
92839370|NCT02866409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839371|NCT02866409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92839372|NCT02866409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839373|NCT02866409|Analgesics|analgesics|mesh-ancestor
92839374|NCT02866409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92839375|NCT02866409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92839376|NCT02866409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92839377|NCT02866409|Adrenergic Agents|adrenergic agents|mesh-ancestor
92839378|NCT02866409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839379|NCT02866409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839380|NCT05833984|Tislelizumab|tislelizumab|mesh-list
92839381|NCT05833984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839382|NCT05833984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839383|NCT05833919|Capecitabine|capecitabine|mesh-list
92839384|NCT05833919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839385|NCT05833919|Antimetabolites|antimetabolites|mesh-ancestor
92839386|NCT05833919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839387|NCT05833919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839388|NCT05833815|Everolimus|everolimus|mesh-list
92839389|NCT05833815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92839390|NCT05833815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839391|NCT05833815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839392|NCT05833815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839393|NCT05833815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839394|NCT05833815|Immunologic Factors|immunologic factors|mesh-ancestor
92839395|NCT05833815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839396|NCT05833815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839397|NCT05833802|Antineoplastic Agents|antineoplastic agents|mesh-list
92839398|NCT05833763|Obinutuzumab|obinutuzumab|mesh-list
92839399|NCT05833763|Pirtobrutinib|pirtobrutinib|mesh-list
92839400|NCT05833763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839401|NCT05833763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839402|NCT05833763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839403|NCT05833763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839404|NCT05833763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839405|NCT05833477|Epoetin Alfa|epoetin alfa|mesh-list
92839406|NCT05833477|Hematinics|hematinics|mesh-ancestor
92839407|NCT05833399|Carbamazepine|carbamazepine|mesh-list
92839408|NCT05833399|Amitriptyline|amitriptyline|mesh-list
92839409|NCT05833399|Olanzapine|olanzapine|mesh-list
92839410|NCT05833399|Chlorpromazine|chlorpromazine|mesh-list
92839411|NCT05833399|Risperidone|risperidone|mesh-list
92839412|NCT05833399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92839413|NCT05833399|Mirtazapine|mirtazapine|mesh-list
92839414|NCT05833399|Sertraline|sertraline|mesh-list
92839415|NCT05833399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92839416|NCT05833399|Serotonin Agents|serotonin agents|mesh-ancestor
92839417|NCT05833399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839418|NCT05833399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839419|NCT05833399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839420|NCT05833399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92839421|NCT05833399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92839422|NCT05833399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839423|NCT05833399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92839424|NCT05833399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92839425|NCT05833399|Dopamine Agents|dopamine agents|mesh-ancestor
92839426|NCT05833399|Antiemetics|antiemetics|mesh-ancestor
92839427|NCT05833399|Autonomic Agents|autonomic agents|mesh-ancestor
92839428|NCT05833399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839429|NCT05833399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92839430|NCT05833399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92839431|NCT05833399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92839432|NCT05833399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839433|NCT05833399|Antidepressive Agents|antidepressive agents|mesh-ancestor
92839434|NCT05833399|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92839435|NCT05833399|Histamine Antagonists|histamine antagonists|mesh-ancestor
92839436|NCT05833399|Histamine Agents|histamine agents|mesh-ancestor
92839437|NCT05833399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92839438|NCT05833399|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92839439|NCT05833399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92839440|NCT05833399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92839441|NCT05833399|Adrenergic Agents|adrenergic agents|mesh-ancestor
92839442|NCT05833399|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92839443|NCT05833399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92839444|NCT05833399|Anticonvulsants|anticonvulsants|mesh-ancestor
92839445|NCT05833399|Antimanic Agents|antimanic agents|mesh-ancestor
92839446|NCT05833399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839447|NCT05833399|Analgesics|analgesics|mesh-ancestor
92839448|NCT05833399|Sensory System Agents|sensory system agents|mesh-ancestor
92839449|NCT05833399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92839450|NCT05833399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92839451|NCT05833399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92839452|NCT05833399|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92839453|NCT05833399|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92839454|NCT05832996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92839455|NCT05832996|Lubricant Eye Drops|lubricant eye drops|mesh-list
92839456|NCT05832996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92839457|NCT05832827|Paclitaxel|paclitaxel|mesh-list
92839458|NCT05832827|Carboplatin|carboplatin|mesh-list
92839459|NCT05832827|Pembrolizumab|pembrolizumab|mesh-list
92839460|NCT05832827|Lenvatinib|lenvatinib|mesh-list
92839461|NCT05832827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839462|NCT05832827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839463|NCT05832827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92839464|NCT05832827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92839465|NCT05832827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92839466|NCT05832827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839467|NCT05832827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839468|NCT05832827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92839469|NCT05832827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839470|NCT05832827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839471|NCT05832749|Hyaluronic Acid|hyaluronic acid|mesh-list
92839472|NCT05832749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92839473|NCT05832749|Immunologic Factors|immunologic factors|mesh-ancestor
92839474|NCT05832749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839475|NCT05832749|Viscosupplements|viscosupplements|mesh-ancestor
92839476|NCT05832749|Protective Agents|protective agents|mesh-ancestor
92839477|NCT05832697|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92839478|NCT05832697|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92839479|NCT05832697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92839480|NCT05832619|Serotonin|serotonin|mesh-list
92839481|NCT05832619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92839482|NCT05832619|Serotonin Agents|serotonin agents|mesh-ancestor
92839483|NCT05832619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839484|NCT05832619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839485|NCT05832619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839486|NCT05832580|Etidronic Acid|etidronic acid|mesh-list
92839487|NCT05832580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92839488|NCT05832580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839489|NCT05832515|Fludarabine|fludarabine|mesh-list
92839490|NCT05832515|Fludarabine phosphate|fludarabine phosphate|mesh-list
92839491|NCT05832515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839492|NCT05832515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839493|NCT05832515|Antimetabolites|antimetabolites|mesh-ancestor
92839494|NCT05832515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839495|NCT05832515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839496|NCT05832515|Immunologic Factors|immunologic factors|mesh-ancestor
92839497|NCT05832515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839498|NCT05832489|Methylphenidate|methylphenidate|mesh-list
92839499|NCT05832489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92839500|NCT05832489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839501|NCT05832489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92839502|NCT05832489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92839503|NCT05832489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839504|NCT05832489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839505|NCT05832489|Dopamine Agents|dopamine agents|mesh-ancestor
92839506|NCT05832489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839507|NCT05832333|Vaccines|vaccines|mesh-list
92839508|NCT05832333|Immunologic Factors|immunologic factors|mesh-ancestor
92839509|NCT05832333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839510|NCT05832320|Etoposide|etoposide|mesh-list
92839511|NCT05832320|Daunorubicin|daunorubicin|mesh-list
92839512|NCT05832320|Tretinoin|tretinoin|mesh-list
92839513|NCT05832320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839514|NCT05832320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839515|NCT05832320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92839516|NCT05832320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92839517|NCT05832320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839518|NCT05832320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839519|NCT05832320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92839520|NCT05832320|Keratolytic Agents|keratolytic agents|mesh-ancestor
92839521|NCT05832320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92839522|NCT05832229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92839523|NCT05832229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92839524|NCT05832229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839525|NCT05832229|Antimetabolites|antimetabolites|mesh-ancestor
92839526|NCT05832229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839527|NCT05832229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839528|NCT05832229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92741229|NCT04295551|Ritonavir|ritonavir|mesh-list
92839529|NCT05832229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839530|NCT05832216|Daratumumab|daratumumab|mesh-list
92839531|NCT05832216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839532|NCT05832190|Biotin|biotin|mesh-list
92839533|NCT05832190|Vitamin B Complex|vitamin b complex|mesh-ancestor
92839534|NCT05832190|Vitamins|vitamins|mesh-ancestor
92839535|NCT05832190|Micronutrients|micronutrients|mesh-ancestor
92839536|NCT05832190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839537|NCT05832073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92839538|NCT05832073|Antibodies|antibodies|mesh-list
92839539|NCT05832073|Immunoglobulins|immunoglobulins|mesh-list
92839540|NCT05832073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92839541|NCT05832073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92839542|NCT05832073|Immunologic Factors|immunologic factors|mesh-ancestor
92839543|NCT05832073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839544|NCT05832073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839545|NCT05832034|Immunoglobulins|immunoglobulins|mesh-list
92839546|NCT05832034|Antibodies|antibodies|mesh-list
92839547|NCT05832034|gamma-Globulins|gamma-globulins|mesh-list
92839548|NCT05832034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92839549|NCT05832034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92839550|NCT05832034|Immunologic Factors|immunologic factors|mesh-ancestor
92839551|NCT05832034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839552|NCT05830539|Doxorubicin|doxorubicin|mesh-list
92839553|NCT05830539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92839554|NCT05830539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92839555|NCT05830539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839556|NCT05830539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92839557|NCT05830539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92839558|NCT05830539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839559|NCT05830539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839560|NCT05828940|Losartan|losartan|mesh-list
92839561|NCT05828940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92839562|NCT05828940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92839563|NCT05828940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92839564|NCT05828940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92839565|NCT05828940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839566|NCT05827055|Paclitaxel|paclitaxel|mesh-list
92839567|NCT05827055|Gemcitabine|gemcitabine|mesh-list
92839568|NCT05827055|Proglumide|proglumide|mesh-list
92839569|NCT05827055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839570|NCT05827055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839571|NCT05827055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92839572|NCT05827055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92839573|NCT05827055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92839574|NCT05827055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839575|NCT05827055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839576|NCT05827055|Antimetabolites|antimetabolites|mesh-ancestor
92839577|NCT05827055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92839578|NCT05827055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92839579|NCT05818423|Benzocaine|benzocaine|mesh-list
92839580|NCT05818423|Anesthetics, Local|anesthetics, local|mesh-ancestor
92839581|NCT05818423|Anesthetics|anesthetics|mesh-ancestor
92839582|NCT05818423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839583|NCT05818423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839584|NCT05818423|Sensory System Agents|sensory system agents|mesh-ancestor
92839585|NCT05818423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839586|NCT05816785|Cetuximab|cetuximab|mesh-list
92839587|NCT05816785|Imatinib Mesylate|imatinib mesylate|mesh-list
92839588|NCT05816785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839589|NCT05816785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839590|NCT05816785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839591|NCT05816785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839592|NCT05816785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839593|NCT05813912|Insulin|insulin|mesh-list
92839594|NCT05813912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92839595|NCT05813912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839596|NCT05807399|Moxifloxacin|moxifloxacin|mesh-list
92839597|NCT05807399|Rifampin|rifampin|mesh-list
92839598|NCT05807399|Isoniazid|isoniazid|mesh-list
92839599|NCT05807399|Pyrazinamide|pyrazinamide|mesh-list
92839600|NCT05807399|Bedaquiline|bedaquiline|mesh-list
92839601|NCT05807399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92839602|NCT05807399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839603|NCT05807399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92839604|NCT05807399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92839605|NCT05807399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977210|NCT00545103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839606|NCT05807399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839607|NCT05807399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839608|NCT05807399|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92839609|NCT05807399|Antitubercular Agents|antitubercular agents|mesh-ancestor
92839610|NCT05807399|Leprostatic Agents|leprostatic agents|mesh-ancestor
92839611|NCT05807399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92839612|NCT05807399|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92839613|NCT05807399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92839614|NCT05807399|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92839615|NCT05807399|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92839616|NCT05807399|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92839617|NCT05807399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92839618|NCT05807399|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92839619|NCT05807399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839620|NCT05807399|Antimetabolites|antimetabolites|mesh-ancestor
92839621|NCT05807399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839622|NCT05798390|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92839623|NCT05798390|Ezetimibe|ezetimibe|mesh-list
92839624|NCT05798390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92839625|NCT05798390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839626|NCT05798390|Antimetabolites|antimetabolites|mesh-ancestor
92839627|NCT05798390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839628|NCT05798390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839629|NCT05798390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839630|NCT05798390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92839631|NCT05798390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839632|NCT05796401|Leucovorin|leucovorin|mesh-list
92839633|NCT05796401|Folic Acid|folic acid|mesh-list
92839634|NCT05796401|Vitamin B 12|vitamin b 12|mesh-list
92839635|NCT05796401|Levoleucovorin|levoleucovorin|mesh-list
92839636|NCT05796401|Vitamins|vitamins|mesh-ancestor
92839637|NCT05796401|Micronutrients|micronutrients|mesh-ancestor
92839638|NCT05796401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839639|NCT05796401|Antidotes|antidotes|mesh-ancestor
92839640|NCT05796401|Protective Agents|protective agents|mesh-ancestor
92839641|NCT05796401|Vitamin B Complex|vitamin b complex|mesh-ancestor
92839642|NCT05796401|Hematinics|hematinics|mesh-ancestor
92839643|NCT05771402|Antibodies|antibodies|mesh-list
92839644|NCT05771402|Immunologic Factors|immunologic factors|mesh-ancestor
92839645|NCT05771402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839646|NCT05769816|Antibodies|antibodies|mesh-list
92839647|NCT05769816|Immunologic Factors|immunologic factors|mesh-ancestor
92839648|NCT05769816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839649|NCT05745142|Sunitinib|sunitinib|mesh-list
92839650|NCT05745142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839651|NCT05745142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92839652|NCT05745142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92839653|NCT05745142|Growth Substances|growth substances|mesh-ancestor
92839654|NCT05745142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839655|NCT05745142|Growth Inhibitors|growth inhibitors|mesh-ancestor
92839656|NCT05745142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839657|NCT05745142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839658|NCT05745142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839659|NCT05737069|Ibuprofen|ibuprofen|mesh-list
92839660|NCT05737069|Ibuprofen arginine|ibuprofen arginine|mesh-list
92839661|NCT05737069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92839662|NCT05737069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839663|NCT05737069|Analgesics|analgesics|mesh-ancestor
92839664|NCT05737069|Sensory System Agents|sensory system agents|mesh-ancestor
92839665|NCT05737069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839666|NCT05737069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839667|NCT05737069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839668|NCT05737069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92839669|NCT05737069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92839670|NCT05737069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839671|NCT05737069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839672|NCT05709483|Aspirin|aspirin|mesh-list
92839673|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92839674|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839675|NCT05709483|Analgesics|analgesics|mesh-ancestor
92839676|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
92839677|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839678|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839679|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839680|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92839681|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92839682|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92839683|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839684|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92839685|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92839686|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839688|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
92839689|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92839690|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92839691|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839692|NCT05647057|Polygeline|polygeline|mesh-list
92839693|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
92839694|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
92839695|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92839696|NCT05646082|Dostarlimab|dostarlimab|mesh-list
92839697|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
92839698|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839699|NCT05646082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839700|NCT05643794|Rozanolixizumab|rozanolixizumab|mesh-list
92839701|NCT05643794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92839702|NCT05643794|Immunologic Factors|immunologic factors|mesh-ancestor
92839703|NCT05643794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839704|NCT05641363|Ketorolac|ketorolac|mesh-list
92839705|NCT05641363|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92839706|NCT05641363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92839707|NCT05641363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839708|NCT05641363|Analgesics|analgesics|mesh-ancestor
92839709|NCT05641363|Sensory System Agents|sensory system agents|mesh-ancestor
92839710|NCT05641363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839711|NCT05641363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839712|NCT05641363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92839713|NCT05641363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92839714|NCT05641363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92839715|NCT05641363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839716|NCT05641363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839717|NCT05639322|Ketamine|ketamine|mesh-list
92839718|NCT05639322|Analgesics|analgesics|mesh-ancestor
92839719|NCT05639322|Sensory System Agents|sensory system agents|mesh-ancestor
92839720|NCT05639322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839721|NCT05639322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839722|NCT05639322|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92839723|NCT05639322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92839724|NCT05639322|Anesthetics, General|anesthetics, general|mesh-ancestor
92839725|NCT05639322|Anesthetics|anesthetics|mesh-ancestor
92839726|NCT05639322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839727|NCT05639322|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92839728|NCT05639322|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92839729|NCT05639322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839730|NCT05639322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839731|NCT05629702|Temozolomide|temozolomide|mesh-list
92839732|NCT05629702|Nabiximols|nabiximols|mesh-list
92839733|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92839734|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
92839735|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839736|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839737|NCT05629702|Analgesics|analgesics|mesh-ancestor
92839738|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
92839739|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839740|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839741|NCT05622201|Rituximab|rituximab|mesh-list
92839742|NCT05622201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839743|NCT05622201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839744|NCT05622201|Immunologic Factors|immunologic factors|mesh-ancestor
92839745|NCT05622201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839746|NCT05622201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92839747|NCT05594615|Midazolam|midazolam|mesh-list
92839748|NCT05594615|Caffeine|caffeine|mesh-list
92839749|NCT05594615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92839750|NCT05594615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92839751|NCT05594615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92839752|NCT05594615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839753|NCT05594615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839754|NCT05594615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92839755|NCT05594615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92839756|NCT05594615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92839757|NCT05594615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92839758|NCT05594615|Anesthetics, General|anesthetics, general|mesh-ancestor
92839759|NCT05594615|Anesthetics|anesthetics|mesh-ancestor
92839760|NCT05594615|GABA Modulators|gaba modulators|mesh-ancestor
92839761|NCT05594615|GABA Agents|gaba agents|mesh-ancestor
92839762|NCT05594615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839763|NCT05594615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839764|NCT05594615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92839765|NCT05594615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839766|NCT05594615|Antimetabolites|antimetabolites|mesh-ancestor
92839767|NCT05594615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839768|NCT05594615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92839769|NCT05594615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839770|NCT05594615|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92839771|NCT05594615|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92839772|NCT05594615|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92839773|NCT05594615|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92839774|NCT05594615|Purinergic Agents|purinergic agents|mesh-ancestor
92839775|NCT05594602|Itraconazole|itraconazole|mesh-list
92839776|NCT05594602|Quinidine|quinidine|mesh-list
92839777|NCT05594602|Carbamazepine|carbamazepine|mesh-list
92839778|NCT05594602|Antifungal Agents|antifungal agents|mesh-ancestor
92839779|NCT05594602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839780|NCT05594602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92839781|NCT05594602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92839782|NCT05594602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839783|NCT05594602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839784|NCT05594602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92839785|NCT05594602|Hormone Antagonists|hormone antagonists|mesh-ancestor
92839786|NCT05594602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92839787|NCT05594602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839788|NCT05594602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92839789|NCT05594602|Anticonvulsants|anticonvulsants|mesh-ancestor
92839790|NCT05594602|Antimanic Agents|antimanic agents|mesh-ancestor
92839791|NCT05594602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92839792|NCT05594602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839793|NCT05594602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92839794|NCT05594602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839795|NCT05594602|Analgesics|analgesics|mesh-ancestor
92839796|NCT05594602|Sensory System Agents|sensory system agents|mesh-ancestor
92839797|NCT05594602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839798|NCT05594602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92484855|NCT01931657|Levonorgestrel|levonorgestrel|mesh-list
92839799|NCT05594602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839800|NCT05594602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92839801|NCT05594602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92839802|NCT05594602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92839803|NCT05594602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92839804|NCT05594602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92839805|NCT05594602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839806|NCT05594602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92839807|NCT05594602|Antimalarials|antimalarials|mesh-ancestor
92839808|NCT05594602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92839809|NCT05594602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92839810|NCT05594602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92839811|NCT05594602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92839812|NCT05594602|Cholinergic Agents|cholinergic agents|mesh-ancestor
92839813|NCT05594602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92839814|NCT05594602|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92839815|NCT05590260|Iron|iron|mesh-list
92839816|NCT05590260|Trace Elements|trace elements|mesh-ancestor
92839817|NCT05590260|Micronutrients|micronutrients|mesh-ancestor
92839818|NCT05590260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839819|NCT05589844|Vaccines|vaccines|mesh-list
92839820|NCT05589844|Immunologic Factors|immunologic factors|mesh-ancestor
92148866|NCT04399525|Desloratadine|desloratadine|mesh-list
92839821|NCT05589844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839822|NCT05485519|Midazolam|midazolam|mesh-list
92839823|NCT05485519|Dexmedetomidine|dexmedetomidine|mesh-list
92839824|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92839825|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839826|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839827|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92839829|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
92839830|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839831|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92839832|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92839833|NCT05485519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92839834|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
92839835|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839836|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839837|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92839838|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92839839|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92839840|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92839841|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92839842|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
92839843|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
92839844|NCT05485519|GABA Modulators|gaba modulators|mesh-ancestor
92839845|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
92839846|NCT05411744|Vitamin B 6|vitamin b 6|mesh-list
92839847|NCT05411744|Pyridoxal|pyridoxal|mesh-list
92839848|NCT05411744|Pyridoxine|pyridoxine|mesh-list
92839849|NCT05411744|Isoniazid|isoniazid|mesh-list
92839850|NCT05411744|Rifapentine|rifapentine|mesh-list
92839851|NCT05411744|Vitamins|vitamins|mesh-ancestor
92839852|NCT05411744|Micronutrients|micronutrients|mesh-ancestor
92839853|NCT05411744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839854|NCT05411744|Vitamin B Complex|vitamin b complex|mesh-ancestor
92839855|NCT05411744|Antitubercular Agents|antitubercular agents|mesh-ancestor
92839856|NCT05411744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92839857|NCT05411744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839858|NCT05411744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92839859|NCT05411744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92839860|NCT05411744|Antimetabolites|antimetabolites|mesh-ancestor
92839861|NCT05411744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839862|NCT05411744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92839863|NCT05411744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92839864|NCT05411744|Leprostatic Agents|leprostatic agents|mesh-ancestor
92839865|NCT05400603|Zoledronic Acid|zoledronic acid|mesh-list
92839866|NCT05400603|Irinotecan|irinotecan|mesh-list
92839867|NCT05400603|Temozolomide|temozolomide|mesh-list
92839868|NCT05400603|Dinutuximab|dinutuximab|mesh-list
92839869|NCT05400603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92839870|NCT05400603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92484932|NCT01932229|Afatinib|afatinib|mesh-list
92839871|NCT05400603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839872|NCT05400603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839873|NCT05400603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839874|NCT05400603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92839875|NCT05400603|Alkylating Agents|alkylating agents|mesh-ancestor
92839876|NCT05400603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92839877|NCT05400603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839879|NCT05359627|Polymyxin B|polymyxin b|mesh-list
92839880|NCT05359627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92839881|NCT05359627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839882|NCT05612490|Furosemide|furosemide|mesh-list
92839883|NCT05612490|Diuretics|diuretics|mesh-ancestor
92839884|NCT05612490|Natriuretic Agents|natriuretic agents|mesh-ancestor
92839885|NCT05612490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839886|NCT05612490|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92839887|NCT05612490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839888|NCT05612490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839889|NCT05295784|Caffeine|caffeine|mesh-list
92839890|NCT05295784|Caffeine citrate|caffeine citrate|mesh-list
92839891|NCT05295784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839892|NCT05295784|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92839893|NCT05295784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839894|NCT05295784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92839895|NCT05295784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839896|NCT05295784|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92839897|NCT05295784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92839898|NCT05295784|Purinergic Agents|purinergic agents|mesh-ancestor
92839899|NCT05295784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839900|NCT05246293|Tofacitinib|tofacitinib|mesh-list
92839901|NCT05246293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92839902|NCT05246293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92839903|NCT05246293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839904|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839905|NCT05243147|Polyvinyl alcohol formaldehyde foam|polyvinyl alcohol formaldehyde foam|mesh-list
92839907|NCT05243147|Coagulants|coagulants|mesh-ancestor
92839908|NCT05212610|Vaccines|vaccines|mesh-list
92839909|NCT05212610|Immunologic Factors|immunologic factors|mesh-ancestor
92839910|NCT05212610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839911|NCT05207280|Terlipressin|terlipressin|mesh-list
92839912|NCT05207280|Norepinephrine|norepinephrine|mesh-list
92839913|NCT05207280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92839914|NCT05207280|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92839915|NCT05207280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92839916|NCT05207280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92839917|NCT05207280|Adrenergic Agents|adrenergic agents|mesh-ancestor
92839918|NCT05207280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839919|NCT05207280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839920|NCT05207280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839921|NCT05207280|Sympathomimetics|sympathomimetics|mesh-ancestor
92839922|NCT05207280|Autonomic Agents|autonomic agents|mesh-ancestor
92839923|NCT05207280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839924|NCT05174832|Paclitaxel|paclitaxel|mesh-list
92839925|NCT05174832|Pembrolizumab|pembrolizumab|mesh-list
92839926|NCT05174832|Olaparib|olaparib|mesh-list
92839927|NCT05174832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92839928|NCT05174832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839929|NCT05174832|Tubulin Modulators|tubulin modulators|mesh-ancestor
92839930|NCT05174832|Antimitotic Agents|antimitotic agents|mesh-ancestor
92839931|NCT05174832|Mitosis Modulators|mitosis modulators|mesh-ancestor
92839932|NCT05174832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839933|NCT05174832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92839934|NCT05174832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92839935|NCT05174832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92839936|NCT05174832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839937|NCT05149378|Azacitidine|azacitidine|mesh-list
92839938|NCT05149378|Venetoclax|venetoclax|mesh-list
92839939|NCT05149378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92839940|NCT05149378|Antimetabolites|antimetabolites|mesh-ancestor
92839941|NCT05149378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839942|NCT05149378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839943|NCT05149378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839944|NCT05134857|Zonisamide|zonisamide|mesh-list
92839945|NCT05134857|Anticonvulsants|anticonvulsants|mesh-ancestor
92839946|NCT05134857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92839947|NCT05134857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92839948|NCT05134857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485003|NCT01932502|GABA Agents|gaba agents|mesh-ancestor
92839949|NCT05134857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92839950|NCT05134857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839951|NCT05114590|Insulin Glargine|insulin glargine|mesh-list
92839953|NCT05114590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92839954|NCT05114590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839955|NCT05108935|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92839956|NCT05108935|Buprenorphine|buprenorphine|mesh-list
92839957|NCT05108935|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92839958|NCT05108935|Naloxone|naloxone|mesh-list
92839959|NCT05108935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92839960|NCT05108935|Narcotics|narcotics|mesh-ancestor
92839961|NCT05108935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839962|NCT05108935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839963|NCT05108935|Analgesics|analgesics|mesh-ancestor
92839964|NCT05108935|Sensory System Agents|sensory system agents|mesh-ancestor
92839965|NCT05108935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92839966|NCT05108935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92741665|NCT03219177|Analgesics|analgesics|mesh-ancestor
92839967|NCT05108935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92839968|NCT05108935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92839969|NCT05108935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92839970|NCT05108935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839971|NCT05108935|Antiviral Agents|antiviral agents|mesh-ancestor
92839972|NCT05108935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92839973|NCT05108935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92839974|NCT05108935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92839975|NCT05051527|Silymarin|silymarin|mesh-list
92839976|NCT05051527|Antioxidants|antioxidants|mesh-ancestor
92839977|NCT05051527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839978|NCT05051527|Protective Agents|protective agents|mesh-ancestor
92839979|NCT05051527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839980|NCT04939753|Sevoflurane|sevoflurane|mesh-list
92839981|NCT04939753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92839982|NCT04939753|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92839983|NCT04939753|Anesthetics, General|anesthetics, general|mesh-ancestor
92839984|NCT04939753|Anesthetics|anesthetics|mesh-ancestor
92839985|NCT04939753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92839986|NCT04939753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839987|NCT04924036|Glycopyrrolate|glycopyrrolate|mesh-list
92839988|NCT04924036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92839989|NCT04924036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92839990|NCT04924036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92839991|NCT04924036|Cholinergic Agents|cholinergic agents|mesh-ancestor
92839992|NCT04924036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92839993|NCT04924036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92839994|NCT04924036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92839995|NCT04902885|Carboplatin|carboplatin|mesh-list
92839996|NCT04902885|Etoposide|etoposide|mesh-list
92839997|NCT04902885|Topotecan|topotecan|mesh-list
92839998|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92839999|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840000|NCT04902885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92840001|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840002|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840003|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840004|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92840005|NCT04868058|Ropivacaine|ropivacaine|mesh-list
92840006|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
92840007|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
92840008|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840009|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840010|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
92840011|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840012|NCT04763759|Antibodies|antibodies|mesh-list
92840013|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92840014|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
92840015|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840016|NCT04628988|Prednisone|prednisone|mesh-list
92840017|NCT04628988|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
92840018|NCT04628988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840019|NCT04628988|Glucocorticoids|glucocorticoids|mesh-ancestor
92840020|NCT04628988|Hormones|hormones|mesh-ancestor
92840021|NCT04628988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840022|NCT04628988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840023|NCT04628988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840024|NCT04628988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840025|NCT04628988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840026|NCT04628988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840027|NCT04614363|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92840028|NCT04614363|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92840029|NCT04614363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840030|NCT04567615|Nivolumab|nivolumab|mesh-list
92840031|NCT04567615|Relatlimab|relatlimab|mesh-list
92840032|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840033|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840034|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92840035|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840036|NCT04525274|Dexmedetomidine|dexmedetomidine|mesh-list
92840037|NCT04525274|Ketamine|ketamine|mesh-list
92840038|NCT04525274|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92840039|NCT04525274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840040|NCT04525274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840041|NCT04525274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840042|NCT04525274|Analgesics|analgesics|mesh-ancestor
92840043|NCT04525274|Sensory System Agents|sensory system agents|mesh-ancestor
92840044|NCT04525274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840045|NCT04525274|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92840046|NCT04525274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92840047|NCT04525274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92840048|NCT04525274|Adrenergic Agents|adrenergic agents|mesh-ancestor
92840049|NCT04525274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840050|NCT04525274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840051|NCT04525274|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92840052|NCT04525274|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92840053|NCT04525274|Anesthetics, General|anesthetics, general|mesh-ancestor
92840054|NCT04525274|Anesthetics|anesthetics|mesh-ancestor
92840055|NCT04525274|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92840056|NCT04525274|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92840057|NCT04507503|Futibatinib|futibatinib|mesh-list
92840058|NCT04507503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840059|NCT04503668|Dexamethasone|dexamethasone|mesh-list
92840060|NCT04503668|Ondansetron|ondansetron|mesh-list
92840061|NCT04503668|Olanzapine|olanzapine|mesh-list
92840062|NCT04503668|Fosaprepitant|fosaprepitant|mesh-list
92840063|NCT04503668|Prochlorperazine|prochlorperazine|mesh-list
92840064|NCT04503668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-list
92840065|NCT04503668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840066|NCT04503668|Antiemetics|antiemetics|mesh-ancestor
92840067|NCT04503668|Autonomic Agents|autonomic agents|mesh-ancestor
92840068|NCT04503668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840069|NCT04503668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840070|NCT04503668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840071|NCT04503668|Glucocorticoids|glucocorticoids|mesh-ancestor
92840072|NCT04503668|Hormones|hormones|mesh-ancestor
92840073|NCT04503668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840074|NCT04503668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840075|NCT04503668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840076|NCT04503668|Antipruritics|antipruritics|mesh-ancestor
92840077|NCT04503668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92840078|NCT04503668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92840079|NCT04503668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92840080|NCT04503668|Serotonin Agents|serotonin agents|mesh-ancestor
92840081|NCT04503668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840082|NCT04503668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840083|NCT04503668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92840084|NCT04503668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92840085|NCT04503668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840086|NCT04503668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92840087|NCT04503668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92840088|NCT04503668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92840089|NCT04503668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92840090|NCT04503668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92840091|NCT04503668|Dopamine Agents|dopamine agents|mesh-ancestor
92840092|NCT04481113|Niraparib|niraparib|mesh-list
92840093|NCT04481113|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92840094|NCT04481113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840095|NCT04481113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485157|NCT01933906|Interferons|interferons|mesh-list
92840096|NCT04481113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840098|NCT04472611|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92840099|NCT04472611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92840100|NCT04472611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92840101|NCT04472611|Antimetabolites|antimetabolites|mesh-ancestor
92840102|NCT04472611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840103|NCT04472611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92840104|NCT04472611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92840105|NCT04472611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840106|NCT04472611|Gout Suppressants|gout suppressants|mesh-ancestor
92840107|NCT04472611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840108|NCT04472611|Tubulin Modulators|tubulin modulators|mesh-ancestor
92840109|NCT04472611|Antimitotic Agents|antimitotic agents|mesh-ancestor
92840110|NCT04472611|Mitosis Modulators|mitosis modulators|mesh-ancestor
92840111|NCT04472611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840112|NCT04472598|Navitoclax|navitoclax|mesh-list
92840113|NCT04472598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840114|NCT04423718|Aflibercept|aflibercept|mesh-list
92840115|NCT04423718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92840116|NCT04423718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92840117|NCT04423718|Growth Substances|growth substances|mesh-ancestor
92840118|NCT04423718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840119|NCT04423718|Growth Inhibitors|growth inhibitors|mesh-ancestor
92840120|NCT04423718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840121|NCT04367233|Anesthetics|anesthetics|mesh-list
92840122|NCT04367233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840123|NCT04367233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840124|NCT04341350|Analgesics|analgesics|mesh-list
92840125|NCT04341350|Propofol|propofol|mesh-list
92840126|NCT04341350|Isoflurane|isoflurane|mesh-list
92840127|NCT04341350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92840128|NCT04341350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840129|NCT04341350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840130|NCT04341350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92840131|NCT04341350|Anesthetics, General|anesthetics, general|mesh-ancestor
92840132|NCT04341350|Anesthetics|anesthetics|mesh-ancestor
92840133|NCT04341350|Sensory System Agents|sensory system agents|mesh-ancestor
92840134|NCT04341350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840135|NCT04341350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92840136|NCT04233164|Methylprednisolone|methylprednisolone|mesh-list
92840137|NCT04233164|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92840138|NCT04233164|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92840139|NCT04233164|Prednisolone|prednisolone|mesh-list
92840140|NCT04233164|Prednisolone acetate|prednisolone acetate|mesh-list
92840141|NCT04233164|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92840142|NCT04233164|Prednisolone phosphate|prednisolone phosphate|mesh-list
92840143|NCT04233164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840144|NCT04233164|Antiemetics|antiemetics|mesh-ancestor
92840145|NCT04233164|Autonomic Agents|autonomic agents|mesh-ancestor
92840146|NCT04233164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840147|NCT04233164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840148|NCT04233164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840149|NCT04233164|Glucocorticoids|glucocorticoids|mesh-ancestor
92840150|NCT04233164|Hormones|hormones|mesh-ancestor
92840151|NCT04233164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840152|NCT04233164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92840153|NCT04233164|Protective Agents|protective agents|mesh-ancestor
92840154|NCT04233164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840155|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840156|NCT04193215|Vaccines|vaccines|mesh-list
92840157|NCT04193215|Immunologic Factors|immunologic factors|mesh-ancestor
92840158|NCT04193215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840159|NCT04125563|Capsaicin|capsaicin|mesh-list
92840160|NCT04125563|Antipruritics|antipruritics|mesh-ancestor
92840161|NCT04125563|Dermatologic Agents|dermatologic agents|mesh-ancestor
92840162|NCT04125563|Sensory System Agents|sensory system agents|mesh-ancestor
92840163|NCT04125563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840164|NCT04125563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840165|NCT04101357|Carboplatin|carboplatin|mesh-list
92840166|NCT04101357|Etoposide|etoposide|mesh-list
92840167|NCT04101357|Atezolizumab|atezolizumab|mesh-list
92840168|NCT04101357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840169|NCT04101357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840170|NCT04101357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92741871|NCT01297062|Exenatide|exenatide|mesh-list
92840171|NCT04101357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840172|NCT04101357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840173|NCT04101357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840174|NCT04101357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92840175|NCT04101357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840177|NCT04078295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840178|NCT04078295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840179|NCT04078295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92840180|NCT04078295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840181|NCT04004611|Mirikizumab|mirikizumab|mesh-list
92840182|NCT04004611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92840183|NCT04004611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840184|NCT04004611|Analgesics|analgesics|mesh-ancestor
92840185|NCT04004611|Sensory System Agents|sensory system agents|mesh-ancestor
92840186|NCT04004611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840187|NCT04004611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840188|NCT04004611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840189|NCT04004611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840190|NCT04004611|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92840191|NCT04004611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840192|NCT03974828|Anesthetics|anesthetics|mesh-list
92840193|NCT03974828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840194|NCT03974828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840195|NCT03953677|Dexmedetomidine|dexmedetomidine|mesh-list
92840196|NCT03953677|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92840197|NCT03953677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92433220|NCT01573377|Metformin|metformin|mesh-list
92840198|NCT03953677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840199|NCT03953677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840200|NCT03953677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840201|NCT03953677|Analgesics|analgesics|mesh-ancestor
92840202|NCT03953677|Sensory System Agents|sensory system agents|mesh-ancestor
92840203|NCT03953677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840204|NCT03953677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92840205|NCT03953677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92840206|NCT03953677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92840207|NCT03953677|Adrenergic Agents|adrenergic agents|mesh-ancestor
92840208|NCT03953677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840209|NCT03953677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840210|NCT03937713|Eszopiclone|eszopiclone|mesh-list
92840211|NCT03937713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92840212|NCT03937713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840213|NCT03937713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840214|NCT03934216|Deucravacitinib|deucravacitinib|mesh-list
92840215|NCT03934216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92840216|NCT03934216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92840217|NCT03934216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840218|NCT03934216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840219|NCT03925480|Azithromycin|azithromycin|mesh-list
92840220|NCT03925480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92840221|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840222|NCT03878069|Elapegademase|elapegademase|mesh-list
92840223|NCT03878069|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92840224|NCT03878069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840225|NCT03878069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840226|NCT03876873|Anesthetics|anesthetics|mesh-list
92840227|NCT03876873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840228|NCT03876873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840229|NCT03842696|Cyclosporine|cyclosporine|mesh-list
92840230|NCT03842696|Mycophenolic Acid|mycophenolic acid|mesh-list
92840231|NCT03842696|Cyclophosphamide|cyclophosphamide|mesh-list
92840232|NCT03842696|Methotrexate|methotrexate|mesh-list
92840233|NCT03842696|Vorinostat|vorinostat|mesh-list
92840234|NCT03842696|Tacrolimus|tacrolimus|mesh-list
92840235|NCT03842696|Cyclosporins|cyclosporins|mesh-list
92840236|NCT03842696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840237|NCT03842696|Immunologic Factors|immunologic factors|mesh-ancestor
92840238|NCT03842696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840239|NCT03842696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840240|NCT03842696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92840241|NCT03842696|Alkylating Agents|alkylating agents|mesh-ancestor
92840242|NCT03842696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840243|NCT03842696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840244|NCT03842696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92840245|NCT03842696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92840246|NCT03842696|Abortifacient Agents|abortifacient agents|mesh-ancestor
92840247|NCT03842696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92840248|NCT03842696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92840249|NCT03842696|Antimetabolites|antimetabolites|mesh-ancestor
92840250|NCT03842696|Dermatologic Agents|dermatologic agents|mesh-ancestor
92840251|NCT03842696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840252|NCT03842696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92840253|NCT03842696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92840254|NCT03842696|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92840255|NCT03842696|Antifungal Agents|antifungal agents|mesh-ancestor
92840256|NCT03842696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840257|NCT03842696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92840258|NCT03842696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92840259|NCT03842696|Antitubercular Agents|antitubercular agents|mesh-ancestor
92840260|NCT03842696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92840261|NCT03842696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92840262|NCT03832361|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92840263|NCT03832361|Immunoconjugates|immunoconjugates|mesh-ancestor
92840264|NCT03832361|Immunologic Factors|immunologic factors|mesh-ancestor
92840265|NCT03832361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840266|NCT03762850|Dapagliflozin|dapagliflozin|mesh-list
92840267|NCT03762850|Irbesartan|irbesartan|mesh-list
92840268|NCT03762850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92840269|NCT03762850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840270|NCT03762850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92840271|NCT03762850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840272|NCT03762850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92840273|NCT03762850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92840274|NCT03762850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92840275|NCT03601078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
92840276|NCT03601078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840277|NCT03601078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840278|NCT03479502|Doxycycline|doxycycline|mesh-list
92840279|NCT03479502|Prednisone|prednisone|mesh-list
92840280|NCT03479502|Methylprednisolone|methylprednisolone|mesh-list
92840281|NCT03479502|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92840282|NCT03479502|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92840283|NCT03479502|Prednisolone|prednisolone|mesh-list
92840284|NCT03479502|Prednisolone acetate|prednisolone acetate|mesh-list
92840285|NCT03479502|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92840286|NCT03479502|Prednisolone phosphate|prednisolone phosphate|mesh-list
92840287|NCT03479502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840288|NCT03479502|Glucocorticoids|glucocorticoids|mesh-ancestor
92840289|NCT03479502|Hormones|hormones|mesh-ancestor
92840290|NCT03479502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840291|NCT03479502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840292|NCT03479502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840293|NCT03479502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840294|NCT03479502|Antiemetics|antiemetics|mesh-ancestor
92840295|NCT03479502|Autonomic Agents|autonomic agents|mesh-ancestor
92840296|NCT03479502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840297|NCT03479502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840298|NCT03479502|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92840299|NCT03479502|Protective Agents|protective agents|mesh-ancestor
92840300|NCT03479502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92840301|NCT03479502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840302|NCT03479502|Antimalarials|antimalarials|mesh-ancestor
92840303|NCT03479502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92840304|NCT03479502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92840305|NCT03294460|Ethanol|ethanol|mesh-list
92840306|NCT03294460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92840307|NCT03294460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840308|NCT03294460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840309|NCT03294460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840310|NCT03240016|Pembrolizumab|pembrolizumab|mesh-list
92840311|NCT03240016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92840312|NCT03240016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840313|NCT03240016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840314|NCT03240016|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92840315|NCT03240016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840316|NCT03097796|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
92840317|NCT03097796|Respiratory System Agents|respiratory system agents|mesh-ancestor
92840318|NCT03067051|Verteporfin|verteporfin|mesh-list
92485384|NCT01935310|Imiquimod|imiquimod|mesh-list
92840319|NCT03067051|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92840321|NCT03013998|Cytarabine|cytarabine|mesh-list
92840322|NCT03013998|Azacitidine|azacitidine|mesh-list
92840323|NCT03013998|Decitabine|decitabine|mesh-list
92840324|NCT03013998|Daunorubicin|daunorubicin|mesh-list
92840325|NCT03013998|Venetoclax|venetoclax|mesh-list
92840326|NCT03013998|AZD5991|azd5991|mesh-list
92840327|NCT03013998|Pevonedistat|pevonedistat|mesh-list
92840328|NCT03013998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92840329|NCT03013998|Antimetabolites|antimetabolites|mesh-ancestor
92840330|NCT03013998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840331|NCT03013998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840332|NCT03013998|Antiviral Agents|antiviral agents|mesh-ancestor
92840333|NCT03013998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840334|NCT03013998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840335|NCT03013998|Immunologic Factors|immunologic factors|mesh-ancestor
92840336|NCT03013998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840337|NCT03013998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840338|NCT03013998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92840339|NCT03013998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92840340|NCT03013998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840341|NCT02911142|Prednisone|prednisone|mesh-list
92840342|NCT02911142|Cyclophosphamide|cyclophosphamide|mesh-list
92840343|NCT02911142|Rituximab|rituximab|mesh-list
92840344|NCT02911142|Doxorubicin|doxorubicin|mesh-list
92840345|NCT02911142|Vincristine|vincristine|mesh-list
92840346|NCT02911142|Lenalidomide|lenalidomide|mesh-list
92840347|NCT02911142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840348|NCT02911142|Immunologic Factors|immunologic factors|mesh-ancestor
92840349|NCT02911142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840350|NCT02911142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840351|NCT02911142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92840352|NCT02911142|Alkylating Agents|alkylating agents|mesh-ancestor
92840353|NCT02911142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840354|NCT02911142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840355|NCT02911142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92840356|NCT02911142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840357|NCT02911142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92840358|NCT02911142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92840359|NCT02911142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840360|NCT02911142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840361|NCT02911142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840362|NCT02911142|Glucocorticoids|glucocorticoids|mesh-ancestor
92840363|NCT02911142|Hormones|hormones|mesh-ancestor
92840364|NCT02911142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840365|NCT02911142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840366|NCT02911142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840367|NCT02911142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92840368|NCT02911142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92840369|NCT02911142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92840370|NCT02911142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92840371|NCT02911142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92840372|NCT02911142|Growth Substances|growth substances|mesh-ancestor
92840373|NCT02911142|Growth Inhibitors|growth inhibitors|mesh-ancestor
92840374|NCT02901067|Aspirin|aspirin|mesh-list
92840375|NCT02901067|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92840376|NCT02901067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92840377|NCT02901067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840378|NCT02901067|Analgesics|analgesics|mesh-ancestor
92840379|NCT02901067|Sensory System Agents|sensory system agents|mesh-ancestor
92840380|NCT02901067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840381|NCT02901067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840382|NCT02901067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840383|NCT02901067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840384|NCT02901067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92742084|NCT01285908|Norepinephrine|norepinephrine|mesh-list
92840385|NCT02901067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92840386|NCT02901067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840387|NCT02901067|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92840388|NCT02901067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92840389|NCT02901067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840390|NCT02901067|Antipyretics|antipyretics|mesh-ancestor
92840391|NCT02901067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92840392|NCT02901067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92840393|NCT02901067|Antimetabolites|antimetabolites|mesh-ancestor
92840394|NCT02901067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92485456|NCT01935531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840395|NCT02901067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92840396|NCT02859896|Calcitriol|calcitriol|mesh-list
92840397|NCT02859896|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92840398|NCT02859896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92840399|NCT02859896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840400|NCT02859896|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92840401|NCT02859896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92840402|NCT02859896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840403|NCT02859896|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92840404|NCT02859896|Vitamins|vitamins|mesh-ancestor
92840405|NCT02859896|Micronutrients|micronutrients|mesh-ancestor
92840406|NCT02859896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92840407|NCT02711670|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92840408|NCT02711670|Chlorthalidone|chlorthalidone|mesh-list
92840409|NCT02711670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92840410|NCT02711670|Diuretics|diuretics|mesh-ancestor
92840411|NCT02711670|Natriuretic Agents|natriuretic agents|mesh-ancestor
92840412|NCT02711670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840413|NCT02711670|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92840414|NCT02711670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92840415|NCT02711670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840416|NCT02658097|Pembrolizumab|pembrolizumab|mesh-list
92840417|NCT02658097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840418|NCT02658097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840419|NCT02658097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92977211|NCT00545103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840420|NCT02658097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840421|NCT02581527|Rifampin|rifampin|mesh-list
92840422|NCT02581527|Isoniazid|isoniazid|mesh-list
92840423|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
92840424|NCT02581527|Ethambutol|ethambutol|mesh-list
92840425|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92840426|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
92840427|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92840428|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840429|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
92840430|NCT02581527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92840431|NCT02581527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840432|NCT02581527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840433|NCT02581527|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92840434|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92840435|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92840436|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92840437|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92840438|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92840439|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92840440|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92840441|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
92840442|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92840443|NCT02558010|Morphine|morphine|mesh-list
92840444|NCT02558010|Methadone|methadone|mesh-list
92840445|NCT02558010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92840446|NCT02558010|Narcotics|narcotics|mesh-ancestor
92840447|NCT02558010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840448|NCT02558010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840449|NCT02558010|Analgesics|analgesics|mesh-ancestor
92840450|NCT02558010|Sensory System Agents|sensory system agents|mesh-ancestor
92840451|NCT02558010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840452|NCT02558010|Antitussive Agents|antitussive agents|mesh-ancestor
92840453|NCT02558010|Respiratory System Agents|respiratory system agents|mesh-ancestor
92840454|NCT02473497|Crizotinib|crizotinib|mesh-list
92840455|NCT02473497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840456|NCT02473497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92840457|NCT02473497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840458|NCT02473497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840459|NCT02466074|Acetazolamide|acetazolamide|mesh-list
92840460|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
92840461|NCT02466074|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92840462|NCT02466074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840463|NCT02466074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840464|NCT02466074|Diuretics|diuretics|mesh-ancestor
92840465|NCT02466074|Natriuretic Agents|natriuretic agents|mesh-ancestor
92840466|NCT02466074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485530|NCT01935817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840468|NCT02393794|Romidepsin|romidepsin|mesh-list
92840469|NCT02393794|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92840470|NCT02393794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840471|NCT02393794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840472|NCT02393794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92840473|NCT02393794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840474|NCT02393794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92840475|NCT02393794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840476|NCT02319837|Leuprolide|leuprolide|mesh-list
92840477|NCT02319837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92840478|NCT02319837|Fertility Agents|fertility agents|mesh-ancestor
92840479|NCT02319837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92840480|NCT02319837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840481|NCT02319837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840482|NCT02319837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840483|NCT02159950|Vaccines|vaccines|mesh-list
92840484|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
92840485|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840486|NCT02152137|Paclitaxel|paclitaxel|mesh-list
92840487|NCT02152137|Efatutazone|efatutazone|mesh-list
92840488|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840489|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840490|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92840491|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92840492|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92840493|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840494|NCT02007512|Exemestane|exemestane|mesh-list
92840495|NCT02007512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840496|NCT02007512|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92840497|NCT02007512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92840498|NCT02007512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840499|NCT02007512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840500|NCT02007512|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92840501|NCT02007512|Hormone Antagonists|hormone antagonists|mesh-ancestor
92840502|NCT02007512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840503|NCT02007512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840505|NCT01971489|Gemcitabine|gemcitabine|mesh-list
92840506|NCT01971489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840507|NCT01971489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92840508|NCT01971489|Antimetabolites|antimetabolites|mesh-ancestor
92840509|NCT01971489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840510|NCT01942135|Fulvestrant|fulvestrant|mesh-list
92840511|NCT01942135|Palbociclib|palbociclib|mesh-list
92840512|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840513|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840514|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92840515|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92840516|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
92840517|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840518|NCT01942135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840519|NCT01942135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92840520|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840521|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840522|NCT01838174|Methylprednisolone|methylprednisolone|mesh-list
92840523|NCT01838174|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92840524|NCT01838174|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92840525|NCT01838174|Prednisolone|prednisolone|mesh-list
92840526|NCT01838174|Prednisolone acetate|prednisolone acetate|mesh-list
92840527|NCT01838174|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92840528|NCT01838174|Prednisolone phosphate|prednisolone phosphate|mesh-list
92840529|NCT01838174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840530|NCT01838174|Antiemetics|antiemetics|mesh-ancestor
92840531|NCT01838174|Autonomic Agents|autonomic agents|mesh-ancestor
92840532|NCT01838174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840533|NCT01838174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840534|NCT01838174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840535|NCT01838174|Glucocorticoids|glucocorticoids|mesh-ancestor
92840536|NCT01838174|Hormones|hormones|mesh-ancestor
92840537|NCT01838174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840538|NCT01838174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92840539|NCT01838174|Protective Agents|protective agents|mesh-ancestor
92485611|NCT01936090|Bortezomib|bortezomib|mesh-list
92840540|NCT01838174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92840541|NCT01838174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840543|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92840544|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840545|NCT01743131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840546|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840547|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840548|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
92840549|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840550|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840551|NCT01685814|Lenalidomide|lenalidomide|mesh-list
92840552|NCT01685814|Bortezomib|bortezomib|mesh-list
92840553|NCT01685814|Immunologic Factors|immunologic factors|mesh-ancestor
92840554|NCT01685814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840555|NCT01685814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92840556|NCT01685814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92840557|NCT01685814|Growth Substances|growth substances|mesh-ancestor
92840558|NCT01685814|Growth Inhibitors|growth inhibitors|mesh-ancestor
92840559|NCT01685814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840560|NCT01147016|Paclitaxel|paclitaxel|mesh-list
92840561|NCT01147016|Cyclophosphamide|cyclophosphamide|mesh-list
92840562|NCT01147016|Doxorubicin|doxorubicin|mesh-list
92840563|NCT01147016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92840564|NCT01147016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840565|NCT01147016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840566|NCT01147016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92840567|NCT01147016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92433222|NCT01573377|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92840569|NCT01147016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840570|NCT01147016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840571|NCT01147016|Immunologic Factors|immunologic factors|mesh-ancestor
92840572|NCT01147016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840573|NCT01147016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840574|NCT01147016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92840575|NCT01147016|Alkylating Agents|alkylating agents|mesh-ancestor
92840576|NCT01147016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92840577|NCT01147016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92840578|NCT01147016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92840579|NCT01147016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840580|NCT01147016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840581|NCT00967785|Plerixafor|plerixafor|mesh-list
92840582|NCT00967785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92840583|NCT00967785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92840584|NCT00967785|Antiviral Agents|antiviral agents|mesh-ancestor
92840585|NCT00967785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840586|NCT00200200|Bevacizumab|bevacizumab|mesh-list
92840587|NCT00200200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840588|NCT00200200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840589|NCT00200200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92840590|NCT00200200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92840591|NCT00200200|Growth Substances|growth substances|mesh-ancestor
92742295|NCT04319601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840592|NCT00200200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840593|NCT00200200|Growth Inhibitors|growth inhibitors|mesh-ancestor
92840594|NCT00106587|Paclitaxel|paclitaxel|mesh-list
92840595|NCT00106587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840596|NCT00106587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840597|NCT00106587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92840598|NCT00106587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92840599|NCT00106587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92840600|NCT00106587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840601|NCT00694863|Cosyntropin|cosyntropin|mesh-list
92840602|NCT00694863|Adrenocorticotropin zinc|adrenocorticotropin zinc|mesh-list
92840603|NCT00694863|Hormones|hormones|mesh-ancestor
92840604|NCT00694863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840605|NCT00694863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840606|NCT00629213|Acarbose|acarbose|mesh-list
92840607|NCT00629213|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92840608|NCT00629213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840609|NCT00629213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840610|NCT00629213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92840611|NCT00629213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840612|NCT00978341|Pregabalin|pregabalin|mesh-list
92840613|NCT00978341|Analgesics|analgesics|mesh-ancestor
92840614|NCT00978341|Sensory System Agents|sensory system agents|mesh-ancestor
92840615|NCT00978341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840616|NCT00978341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840617|NCT00978341|Anticonvulsants|anticonvulsants|mesh-ancestor
92840618|NCT00978341|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92840619|NCT00978341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92840620|NCT00978341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840621|NCT00978341|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92840622|NCT00978341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92840623|NCT00978341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92840624|NCT00978341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840625|NCT00978341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92840626|NCT00695331|Misoprostol|misoprostol|mesh-list
92840627|NCT00695331|Oxytocin|oxytocin|mesh-list
92840628|NCT00695331|Oxytocics|oxytocics|mesh-ancestor
92840629|NCT00695331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92840630|NCT00695331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840631|NCT00695331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92840632|NCT00695331|Abortifacient Agents|abortifacient agents|mesh-ancestor
92840633|NCT00695331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92840634|NCT00695331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840635|NCT00695643|Mesalamine|mesalamine|mesh-list
92840636|NCT00695643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92840637|NCT00695643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840638|NCT00695643|Analgesics|analgesics|mesh-ancestor
92840639|NCT00695643|Sensory System Agents|sensory system agents|mesh-ancestor
92840640|NCT00695643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977212|NCT00586157|Methylphenidate|methylphenidate|mesh-list
92840641|NCT00695643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840642|NCT00695643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840643|NCT00695643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840644|NCT02623881|Progesterone|progesterone|mesh-list
92840645|NCT02623881|Progestins|progestins|mesh-ancestor
92840646|NCT02623881|Hormones|hormones|mesh-ancestor
92840647|NCT02623881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840648|NCT02623881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840649|NCT04135833|Itraconazole|itraconazole|mesh-list
92840650|NCT04135833|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92840651|NCT04135833|Rifampin|rifampin|mesh-list
92840652|NCT04135833|Antifungal Agents|antifungal agents|mesh-ancestor
92840653|NCT04135833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840654|NCT04135833|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92840655|NCT04135833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92840656|NCT04135833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840657|NCT04135833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840658|NCT04135833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92840659|NCT04135833|Hormone Antagonists|hormone antagonists|mesh-ancestor
92840660|NCT04135833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840661|NCT04135833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742367|NCT01036594|Hormone Antagonists|hormone antagonists|mesh-ancestor
92840662|NCT04135833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92840663|NCT04135833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92840664|NCT04135833|Antitubercular Agents|antitubercular agents|mesh-ancestor
92840665|NCT04135833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92840666|NCT04135833|Leprostatic Agents|leprostatic agents|mesh-ancestor
92840667|NCT04135833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92840668|NCT04135833|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92840669|NCT04135833|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92840670|NCT04135833|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92840671|NCT04135833|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92840672|NCT04135833|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92840673|NCT04135833|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92840674|NCT00696033|Diazepam|diazepam|mesh-list
92840675|NCT00696033|Lorazepam|lorazepam|mesh-list
92840676|NCT00696033|Anticonvulsants|anticonvulsants|mesh-ancestor
92840677|NCT00696033|Antiemetics|antiemetics|mesh-ancestor
92840678|NCT00696033|Autonomic Agents|autonomic agents|mesh-ancestor
92840679|NCT00696033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840680|NCT00696033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840681|NCT00696033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840682|NCT00696033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92840683|NCT00696033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840684|NCT00696033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92840685|NCT00696033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92840686|NCT00696033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92840687|NCT00696033|GABA Modulators|gaba modulators|mesh-ancestor
92840688|NCT00696033|GABA Agents|gaba agents|mesh-ancestor
92840689|NCT00696033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840690|NCT00696033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840691|NCT00696033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92840692|NCT00696033|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92840693|NCT00696033|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92840694|NCT00696033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92840695|NCT00696033|Anesthetics, General|anesthetics, general|mesh-ancestor
92840696|NCT00696033|Anesthetics|anesthetics|mesh-ancestor
92840698|NCT02623569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92840699|NCT02623569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92840700|NCT02623569|Sympatholytics|sympatholytics|mesh-ancestor
92840701|NCT02623569|Autonomic Agents|autonomic agents|mesh-ancestor
92840702|NCT02623569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840703|NCT02623569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840704|NCT02623569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92840705|NCT02623569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92840706|NCT02623569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92840707|NCT02623569|Adrenergic Agents|adrenergic agents|mesh-ancestor
92840708|NCT02623569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840709|NCT02623569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840710|NCT00977561|Cisplatin|cisplatin|mesh-list
92840711|NCT00977561|Carboplatin|carboplatin|mesh-list
92840712|NCT00977561|Etoposide|etoposide|mesh-list
92840713|NCT00977561|Etoposide phosphate|etoposide phosphate|mesh-list
92840714|NCT00977561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840715|NCT00977561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840716|NCT00977561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92840717|NCT00977561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840718|NCT00977561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840719|NCT00977561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840720|NCT04291313|Vitamin D|vitamin d|mesh-list
92840721|NCT04291313|Ergocalciferols|ergocalciferols|mesh-list
92840722|NCT04291313|Cholecalciferol|cholecalciferol|mesh-list
92840723|NCT04291313|Vitamins|vitamins|mesh-list
92840724|NCT04291313|Micronutrients|micronutrients|mesh-ancestor
92840725|NCT04291313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840726|NCT04291313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92840727|NCT04291313|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92840728|NCT02866253|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92840729|NCT02866253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92840730|NCT02866253|Immunologic Factors|immunologic factors|mesh-ancestor
92840731|NCT02866253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840732|NCT02865785|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92840733|NCT02865785|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92840734|NCT02865785|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92840735|NCT02865785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92840736|NCT04049669|Cyclophosphamide|cyclophosphamide|mesh-list
92840737|NCT04049669|Temozolomide|temozolomide|mesh-list
92840738|NCT04049669|Lomustine|lomustine|mesh-list
92840739|NCT04049669|Etoposide|etoposide|mesh-list
92840740|NCT04049669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840741|NCT04049669|Immunologic Factors|immunologic factors|mesh-ancestor
92840742|NCT04049669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840743|NCT04049669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840744|NCT04049669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92840745|NCT04049669|Alkylating Agents|alkylating agents|mesh-ancestor
92840746|NCT04049669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840747|NCT04049669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840748|NCT04049669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92840749|NCT04049669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92840750|NCT04049669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92840751|NCT04049669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92840752|NCT04049669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840753|NCT00594165|Rotigotine|rotigotine|mesh-list
92840754|NCT00594165|Dopamine Agonists|dopamine agonists|mesh-ancestor
92840755|NCT00594165|Dopamine Agents|dopamine agents|mesh-ancestor
92840756|NCT00594165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840757|NCT00594165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840758|NCT00594165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840759|NCT00928070|Fesoterodine|fesoterodine|mesh-list
92840760|NCT00928070|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92840761|NCT00928070|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92840762|NCT00928070|Cholinergic Agents|cholinergic agents|mesh-ancestor
92840763|NCT00928070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840764|NCT00928070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840765|NCT00928070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840766|NCT00928070|Urological Agents|urological agents|mesh-ancestor
92840767|NCT04012073|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92840768|NCT04012073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92840769|NCT04012073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840770|NCT04012073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840771|NCT04001621|Capecitabine|capecitabine|mesh-list
92840772|NCT04001621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92840773|NCT04001621|Antimetabolites|antimetabolites|mesh-ancestor
92840774|NCT04001621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840775|NCT04001621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840776|NCT00976937|Metformin|metformin|mesh-list
92840777|NCT00976937|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92840778|NCT00976937|Lixisenatide|lixisenatide|mesh-list
92840779|NCT00976937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92840780|NCT00976937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840781|NCT00976937|Incretins|incretins|mesh-ancestor
92840782|NCT00976937|Hormones|hormones|mesh-ancestor
92840783|NCT00976937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840784|NCT00976937|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92840785|NCT00976937|Protease Inhibitors|protease inhibitors|mesh-ancestor
92840786|NCT00976937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840787|NCT00976937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840788|NCT02623023|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92840789|NCT02623023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92840790|NCT02623023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92840791|NCT02623023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92840792|NCT02623023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840793|NCT02623023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840794|NCT02623023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840795|NCT02623023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92840796|NCT02623023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92840797|NCT02623023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92840798|NCT04256252|Rituximab|rituximab|mesh-list
92840799|NCT04256252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92840800|NCT04256252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840801|NCT04256252|Immunologic Factors|immunologic factors|mesh-ancestor
92840802|NCT04256252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840803|NCT04256252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840804|NCT02622555|Mirabegron|mirabegron|mesh-list
92840805|NCT02622555|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92840806|NCT02622555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92840807|NCT02622555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92840808|NCT02622555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92840809|NCT02622555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840810|NCT02622555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840811|NCT02622555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840812|NCT02622555|Urological Agents|urological agents|mesh-ancestor
92840813|NCT05329454|Ibuprofen|ibuprofen|mesh-list
92840814|NCT05329454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92840815|NCT05329454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840816|NCT05329454|Analgesics|analgesics|mesh-ancestor
92840817|NCT05329454|Sensory System Agents|sensory system agents|mesh-ancestor
92840818|NCT05329454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840819|NCT05329454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840820|NCT05329454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840821|NCT05329454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840822|NCT05329454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92840823|NCT05329454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840824|NCT05329454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840825|NCT00629447|Tinzaparin|tinzaparin|mesh-list
92840826|NCT00629447|Anticoagulants|anticoagulants|mesh-ancestor
92840827|NCT00629447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92840828|NCT00629447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92840829|NCT00629447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840830|NCT02622477|Pirfenidone|pirfenidone|mesh-list
92840831|NCT02622477|Analgesics|analgesics|mesh-ancestor
92840832|NCT02622477|Sensory System Agents|sensory system agents|mesh-ancestor
92840833|NCT02622477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840834|NCT02622477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840835|NCT02622477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92840836|NCT02622477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840837|NCT02622477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840838|NCT02622477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840839|NCT02622477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840840|NCT02622243|Glycopyrrolate|glycopyrrolate|mesh-list
92840841|NCT02622243|Tiotropium Bromide|tiotropium bromide|mesh-list
92840842|NCT02622243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92840843|NCT02622243|Autonomic Agents|autonomic agents|mesh-ancestor
92840844|NCT02622243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840845|NCT02622243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840846|NCT02622243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92840847|NCT02622243|Respiratory System Agents|respiratory system agents|mesh-ancestor
92840848|NCT02622243|Parasympatholytics|parasympatholytics|mesh-ancestor
92840849|NCT02622243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92840850|NCT02622243|Cholinergic Agents|cholinergic agents|mesh-ancestor
92840851|NCT02622243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840852|NCT02622243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840853|NCT02622243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92840854|NCT02622243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92840855|NCT04289675|Interferons|interferons|mesh-list
92840856|NCT04289675|Interferon-beta|interferon-beta|mesh-list
92840857|NCT04289675|Teriflunomide|teriflunomide|mesh-list
92840858|NCT04289675|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92840859|NCT04289675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840860|NCT04289675|Antiviral Agents|antiviral agents|mesh-ancestor
92840861|NCT04289675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840862|NCT04289675|Immunologic Factors|immunologic factors|mesh-ancestor
92840863|NCT04289675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840864|NCT04289675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92840865|NCT04289675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840866|NCT04289675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92840867|NCT04289675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840868|NCT04289675|Analgesics|analgesics|mesh-ancestor
92840869|NCT04289675|Sensory System Agents|sensory system agents|mesh-ancestor
92840870|NCT04289675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840871|NCT04289675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92840872|NCT04289675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840873|NCT00696579|Gemcitabine|gemcitabine|mesh-list
92840874|NCT00696579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92840875|NCT00696579|Antimetabolites|antimetabolites|mesh-ancestor
92840876|NCT00696579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840877|NCT00696579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840878|NCT02865629|Acetylcysteine|acetylcysteine|mesh-list
92840879|NCT02865629|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92840880|NCT02865629|Antiviral Agents|antiviral agents|mesh-ancestor
92840881|NCT02865629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840882|NCT02865629|Expectorants|expectorants|mesh-ancestor
92840883|NCT02865629|Respiratory System Agents|respiratory system agents|mesh-ancestor
92840884|NCT02865629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92840885|NCT02865629|Antioxidants|antioxidants|mesh-ancestor
92840886|NCT02865629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840887|NCT02865629|Protective Agents|protective agents|mesh-ancestor
92840888|NCT02865629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840889|NCT02865629|Antidotes|antidotes|mesh-ancestor
92840890|NCT02867345|Cyclophosphamide|cyclophosphamide|mesh-list
92840891|NCT02867345|Interleukin-2|interleukin-2|mesh-list
92840892|NCT02867345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92840893|NCT02867345|Immunologic Factors|immunologic factors|mesh-ancestor
92840894|NCT02867345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840895|NCT02867345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92840896|NCT02867345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92840897|NCT02867345|Alkylating Agents|alkylating agents|mesh-ancestor
92840898|NCT02867345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840899|NCT02867345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840900|NCT02867345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92840901|NCT02867345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92840902|NCT02867345|Analgesics|analgesics|mesh-ancestor
92840903|NCT02867345|Sensory System Agents|sensory system agents|mesh-ancestor
92840904|NCT02867345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92840905|NCT00975689|Acetylcysteine|acetylcysteine|mesh-list
92840906|NCT00975689|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92840907|NCT00975689|Antiviral Agents|antiviral agents|mesh-ancestor
92840908|NCT00975689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840909|NCT00975689|Expectorants|expectorants|mesh-ancestor
92840910|NCT00975689|Respiratory System Agents|respiratory system agents|mesh-ancestor
92840911|NCT00975689|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92840912|NCT00975689|Antioxidants|antioxidants|mesh-ancestor
92840913|NCT00975689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840914|NCT00975689|Protective Agents|protective agents|mesh-ancestor
92840915|NCT00975689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840917|NCT02621385|Midazolam|midazolam|mesh-list
92840918|NCT02621385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92840919|NCT02621385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92840920|NCT02621385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92840921|NCT02621385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840922|NCT02621385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92840923|NCT02621385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92840924|NCT02621385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92840925|NCT02621385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92840926|NCT02621385|Anesthetics, General|anesthetics, general|mesh-ancestor
92840927|NCT02621385|Anesthetics|anesthetics|mesh-ancestor
92840928|NCT02621385|GABA Modulators|gaba modulators|mesh-ancestor
92840929|NCT02621385|GABA Agents|gaba agents|mesh-ancestor
92840930|NCT02621385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840931|NCT02621385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840932|NCT00922766|Dalteparin|dalteparin|mesh-list
92840933|NCT00922766|Tinzaparin|tinzaparin|mesh-list
92840934|NCT00922766|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92840935|NCT00922766|Anticoagulants|anticoagulants|mesh-ancestor
92840936|NCT00922766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92840937|NCT00922766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92840938|NCT00922766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840940|NCT04134897|Oxaliplatin|oxaliplatin|mesh-list
92840941|NCT04134897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92840942|NCT04134897|Antimetabolites|antimetabolites|mesh-ancestor
92840943|NCT04134897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840944|NCT04134897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840945|NCT02620995|Sildenafil Citrate|sildenafil citrate|mesh-list
92840946|NCT02620995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840947|NCT02620995|Vasodilator Agents|vasodilator agents|mesh-ancestor
92840948|NCT02620995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92840949|NCT02620995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92840950|NCT02620995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92840951|NCT02620995|Urological Agents|urological agents|mesh-ancestor
92840952|NCT02620839|Cisplatin|cisplatin|mesh-list
92840953|NCT02620839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840954|NCT02620605|Cabergoline|cabergoline|mesh-list
92840955|NCT02620605|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92840956|NCT02620605|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92840957|NCT02620605|Dopamine Agonists|dopamine agonists|mesh-ancestor
92840958|NCT02620605|Dopamine Agents|dopamine agents|mesh-ancestor
92840959|NCT02620605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92840960|NCT02620605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840961|NCT02620605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840962|NCT00976391|Insulin|insulin|mesh-list
92840963|NCT00976391|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92840964|NCT00976391|Insulin Glargine|insulin glargine|mesh-list
92840965|NCT00976391|Insulin Lispro|insulin lispro|mesh-list
92840966|NCT00976391|rGLP-1 protein|rglp-1 protein|mesh-list
92840967|NCT00976391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92840968|NCT00976391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92840969|NCT00976391|Incretins|incretins|mesh-ancestor
92840970|NCT00976391|Hormones|hormones|mesh-ancestor
92840971|NCT00976391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92840972|NCT04252664|Remdesivir|remdesivir|mesh-list
92840973|NCT04252664|Antimetabolites|antimetabolites|mesh-ancestor
92840974|NCT04252664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92840975|NCT04252664|Antiviral Agents|antiviral agents|mesh-ancestor
92840976|NCT04252664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840977|NCT00696969|Amphotericin B|amphotericin b|mesh-list
92840978|NCT00696969|Paromomycin|paromomycin|mesh-list
92840979|NCT00696969|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92840980|NCT00696969|Miltefosine|miltefosine|mesh-list
92840981|NCT00696969|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92840982|NCT00696969|Deoxycholic Acid|deoxycholic acid|mesh-list
92840983|NCT00696969|Amebicides|amebicides|mesh-ancestor
92840984|NCT00696969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92840985|NCT00696969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92840986|NCT00696969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92840987|NCT00696969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92840988|NCT00696969|Antifungal Agents|antifungal agents|mesh-ancestor
92840989|NCT00696969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92840990|NCT00696969|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92840991|NCT00696969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92840992|NCT04203680|Cardioplegic Solutions|cardioplegic solutions|mesh-list
92840993|NCT04203680|Tryptophan|tryptophan|mesh-list
92840994|NCT04203680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92840995|NCT04203680|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92840996|NCT04203680|Antidepressive Agents|antidepressive agents|mesh-ancestor
92840997|NCT04203680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92840998|NCT02620215|Dinoprostone|dinoprostone|mesh-list
92840999|NCT02620215|Oxytocics|oxytocics|mesh-ancestor
92841000|NCT02620215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92841001|NCT02620215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841002|NCT02620293|Emollients|emollients|mesh-list
92841003|NCT02620293|Dermatologic Agents|dermatologic agents|mesh-ancestor
92841004|NCT02619981|Lidocaine|lidocaine|mesh-list
92841005|NCT02619981|Anesthetics, Local|anesthetics, local|mesh-ancestor
92841006|NCT02619981|Anesthetics|anesthetics|mesh-ancestor
92841007|NCT02619981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841008|NCT02619981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841009|NCT02619981|Sensory System Agents|sensory system agents|mesh-ancestor
92841010|NCT02619981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841011|NCT02619981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92841012|NCT02619981|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92841013|NCT02619981|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92841014|NCT02619981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92841015|NCT02619981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841017|NCT02619669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841018|NCT02619669|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92841019|NCT02619669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92841020|NCT02619669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841021|NCT02619669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841022|NCT02619669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92841023|NCT02619669|Hormone Antagonists|hormone antagonists|mesh-ancestor
92841024|NCT02619669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841025|NCT02619669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841026|NCT03965117|Norepinephrine|norepinephrine|mesh-list
92841027|NCT03965117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92841028|NCT03965117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92841029|NCT03965117|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841030|NCT03965117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841031|NCT03965117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841032|NCT03965117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841033|NCT03965117|Sympathomimetics|sympathomimetics|mesh-ancestor
92841034|NCT03965117|Autonomic Agents|autonomic agents|mesh-ancestor
92841035|NCT03965117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841036|NCT03965117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92841037|NCT00917462|Sorafenib|sorafenib|mesh-list
92841038|NCT00917462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841039|NCT00917462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92841040|NCT00917462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841041|NCT00917462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841042|NCT02619513|Dexmedetomidine|dexmedetomidine|mesh-list
92841043|NCT02619513|Ropivacaine|ropivacaine|mesh-list
92841044|NCT02619513|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92841045|NCT02619513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841046|NCT02619513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841047|NCT02619513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841048|NCT02619513|Analgesics|analgesics|mesh-ancestor
92841049|NCT02619513|Sensory System Agents|sensory system agents|mesh-ancestor
92841050|NCT02619513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841051|NCT02619513|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92841052|NCT02619513|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92841053|NCT02619513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92841054|NCT02619513|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841055|NCT02619513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841056|NCT02619513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841057|NCT02619513|Anesthetics, Local|anesthetics, local|mesh-ancestor
92841058|NCT02619513|Anesthetics|anesthetics|mesh-ancestor
92841059|NCT03947255|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92841060|NCT03947255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92841061|NCT03947255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841062|NCT03947255|Immunotoxins|immunotoxins|mesh-ancestor
92841063|NCT03947255|Immunoconjugates|immunoconjugates|mesh-ancestor
92841064|NCT03947255|Immunologic Factors|immunologic factors|mesh-ancestor
92841065|NCT03947255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841066|NCT02619747|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
92841067|NCT02619747|Antacids|antacids|mesh-ancestor
92841068|NCT02619747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841069|NCT02619747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92841070|NCT00697125|Vaccines|vaccines|mesh-list
92841071|NCT00697125|Immunologic Factors|immunologic factors|mesh-ancestor
92841072|NCT00697125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841073|NCT04134273|Clindamycin|clindamycin|mesh-list
92841074|NCT04134273|Clindamycin palmitate|clindamycin palmitate|mesh-list
92841075|NCT04134273|Clindamycin phosphate|clindamycin phosphate|mesh-list
92841076|NCT04134273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92841077|NCT04134273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841078|NCT04134273|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92841079|NCT04134273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841080|NCT04134273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841081|NCT04134117|Tisagenlecleucel|tisagenlecleucel|mesh-list
92841082|NCT04134117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92841083|NCT04134117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841084|NCT03853187|Durvalumab|durvalumab|mesh-list
92841085|NCT03853187|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92841086|NCT03853187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92841087|NCT03853187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841089|NCT03853187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841090|NCT03849443|Tranexamic Acid|tranexamic acid|mesh-list
92841091|NCT03849443|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92841092|NCT03849443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92841093|NCT03849443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841094|NCT03849443|Hemostatics|hemostatics|mesh-ancestor
92841095|NCT03849443|Coagulants|coagulants|mesh-ancestor
92841096|NCT00697281|Indoleacetic Acids|indoleacetic acids|mesh-list
92841097|NCT00697281|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92841098|NCT00697281|Growth Substances|growth substances|mesh-ancestor
92841099|NCT00697281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841100|NCT00979901|Loratadine|loratadine|mesh-list
92841101|NCT00979901|Montelukast|montelukast|mesh-list
92841102|NCT00979901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92841103|NCT00979901|Respiratory System Agents|respiratory system agents|mesh-ancestor
92841104|NCT00979901|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92841105|NCT00979901|Hormone Antagonists|hormone antagonists|mesh-ancestor
92841106|NCT00979901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841107|NCT00979901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841108|NCT00979901|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92841109|NCT00979901|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92841110|NCT00979901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841111|NCT00979901|Antipruritics|antipruritics|mesh-ancestor
92841112|NCT00979901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92841113|NCT00979901|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92841114|NCT00979901|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92841115|NCT00979901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92841116|NCT00979901|Histamine Antagonists|histamine antagonists|mesh-ancestor
92841117|NCT00979901|Histamine Agents|histamine agents|mesh-ancestor
92841118|NCT00979901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841119|NCT02619201|Ondansetron|ondansetron|mesh-list
92841120|NCT02619201|Metoclopramide|metoclopramide|mesh-list
92841121|NCT02619201|Antiemetics|antiemetics|mesh-ancestor
92841122|NCT02619201|Autonomic Agents|autonomic agents|mesh-ancestor
92841123|NCT02619201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841124|NCT02619201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841125|NCT02619201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92841126|NCT02619201|Antipruritics|antipruritics|mesh-ancestor
92841127|NCT02619201|Dermatologic Agents|dermatologic agents|mesh-ancestor
92841128|NCT02619201|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92841129|NCT02619201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92841130|NCT02619201|Serotonin Agents|serotonin agents|mesh-ancestor
92841131|NCT02619201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841132|NCT02619201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841133|NCT02619201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92841134|NCT02619201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92841135|NCT02619201|Dopamine Agents|dopamine agents|mesh-ancestor
92841136|NCT00975611|Amantadine|amantadine|mesh-list
92486207|NCT01939691|Prednisolone|prednisolone|mesh-list
92841137|NCT00975611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92841138|NCT00975611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92841139|NCT00975611|Antiviral Agents|antiviral agents|mesh-ancestor
92841140|NCT00975611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841141|NCT00975611|Dopamine Agents|dopamine agents|mesh-ancestor
92841142|NCT00975611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841143|NCT00975611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841144|NCT00975611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841145|NCT00975611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841146|NCT00975611|Analgesics|analgesics|mesh-ancestor
92841147|NCT00975611|Sensory System Agents|sensory system agents|mesh-ancestor
92841148|NCT00975611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841149|NCT02865005|Dapsone|dapsone|mesh-list
92841150|NCT02865005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841151|NCT02865005|Antimalarials|antimalarials|mesh-ancestor
92841152|NCT02865005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92841153|NCT02865005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92841154|NCT02865005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92841155|NCT02865005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841156|NCT02865005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841157|NCT02865005|Leprostatic Agents|leprostatic agents|mesh-ancestor
92841158|NCT02865005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92841159|NCT02862977|Ketoprofen|ketoprofen|mesh-list
92841160|NCT02862977|Amitriptyline|amitriptyline|mesh-list
92841161|NCT02862977|Cyclobenzaprine|cyclobenzaprine|mesh-list
92841162|NCT02862977|Caffeine|caffeine|mesh-list
92841163|NCT02862977|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92841164|NCT02862977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841165|NCT02862977|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92841166|NCT02862977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841167|NCT02862977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841168|NCT02862977|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92841169|NCT02862977|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92841170|NCT02862977|Purinergic Agents|purinergic agents|mesh-ancestor
92841171|NCT02862977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841172|NCT02862977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92841173|NCT02862977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841174|NCT02862977|Analgesics|analgesics|mesh-ancestor
92841175|NCT02862977|Sensory System Agents|sensory system agents|mesh-ancestor
92841176|NCT02862977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841177|NCT02862977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841178|NCT02862977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841179|NCT02862977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92841180|NCT02862977|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92841181|NCT02862977|Antidepressive Agents|antidepressive agents|mesh-ancestor
92841182|NCT02862977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92841183|NCT02862977|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92841184|NCT02862977|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92841185|NCT02862977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92841186|NCT02862977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841187|NCT02862977|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92841188|NCT02862977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92841189|NCT02862977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92841190|NCT02862977|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841191|NCT02864927|Vaccines|vaccines|mesh-list
92841192|NCT02864927|Immunologic Factors|immunologic factors|mesh-ancestor
92841193|NCT02864927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841194|NCT02618499|Oxytocin|oxytocin|mesh-list
92841195|NCT02618499|Oxytocics|oxytocics|mesh-ancestor
92841196|NCT02618499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92841197|NCT02618499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841198|NCT04133961|Phenylephrine|phenylephrine|mesh-list
92841199|NCT04133961|Oxymetazoline|oxymetazoline|mesh-list
92841200|NCT04133961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92841201|NCT04133961|Mydriatics|mydriatics|mesh-ancestor
92841202|NCT04133961|Autonomic Agents|autonomic agents|mesh-ancestor
92841203|NCT04133961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841204|NCT04133961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841205|NCT04133961|Sympathomimetics|sympathomimetics|mesh-ancestor
92841206|NCT04133961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92841207|NCT04133961|Nasal Decongestants|nasal decongestants|mesh-ancestor
92841208|NCT04133961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92841209|NCT04133961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92841210|NCT04133961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92486289|NCT01939990|Nebivolol|nebivolol|mesh-list
92841211|NCT04133961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92841212|NCT04133961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841213|NCT04133961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841214|NCT04133961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841215|NCT04133961|Protective Agents|protective agents|mesh-ancestor
92841216|NCT02618733|Clopidogrel|clopidogrel|mesh-list
92841217|NCT02618733|Ticagrelor|ticagrelor|mesh-list
92841218|NCT02618733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92841219|NCT02618733|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92841220|NCT02618733|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92841221|NCT02618733|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92841222|NCT02618733|Purinergic Agents|purinergic agents|mesh-ancestor
92841223|NCT02618733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841224|NCT02618733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841225|NCT02618733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841226|NCT00970307|Vaccines|vaccines|mesh-list
92841227|NCT00970307|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92841228|NCT00970307|Immunologic Factors|immunologic factors|mesh-ancestor
92841229|NCT00970307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841230|NCT00917384|Ramucirumab|ramucirumab|mesh-list
92841231|NCT00917384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841232|NCT04133571|Lidocaine|lidocaine|mesh-list
92841233|NCT04133571|Anesthetics, Local|anesthetics, local|mesh-ancestor
92841234|NCT04133571|Anesthetics|anesthetics|mesh-ancestor
92841235|NCT04133571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841236|NCT04133571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841237|NCT04133571|Sensory System Agents|sensory system agents|mesh-ancestor
92841238|NCT04133571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841239|NCT04133571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92841240|NCT04133571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92841241|NCT04133571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92841242|NCT04133571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92841243|NCT04133571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841244|NCT00629681|Pregabalin|pregabalin|mesh-list
92841245|NCT00629681|Analgesics|analgesics|mesh-ancestor
92841246|NCT00629681|Sensory System Agents|sensory system agents|mesh-ancestor
92841247|NCT00629681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841248|NCT00629681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841249|NCT00629681|Anticonvulsants|anticonvulsants|mesh-ancestor
92841250|NCT00629681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92841251|NCT00629681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92841252|NCT00629681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841253|NCT00629681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92841254|NCT00629681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92841255|NCT00629681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92841256|NCT00629681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841257|NCT00629681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92841258|NCT02617485|Prednisone|prednisone|mesh-list
92841259|NCT02617485|Cyclophosphamide|cyclophosphamide|mesh-list
92841260|NCT02617485|Rituximab|rituximab|mesh-list
92841261|NCT02617485|Doxorubicin|doxorubicin|mesh-list
92841262|NCT02617485|Vincristine|vincristine|mesh-list
92841263|NCT02617485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841264|NCT02617485|Immunologic Factors|immunologic factors|mesh-ancestor
92841265|NCT02617485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841266|NCT02617485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841267|NCT02617485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92841268|NCT02617485|Alkylating Agents|alkylating agents|mesh-ancestor
92841269|NCT02617485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841270|NCT02617485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841271|NCT02617485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92841272|NCT02617485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92841273|NCT02617485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92841274|NCT02617485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92841275|NCT02617485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92841276|NCT02617485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841277|NCT02617485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841278|NCT02617485|Glucocorticoids|glucocorticoids|mesh-ancestor
92841279|NCT02617485|Hormones|hormones|mesh-ancestor
92841280|NCT02617485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841281|NCT02617485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92841282|NCT02617485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92841283|NCT02617485|Tubulin Modulators|tubulin modulators|mesh-ancestor
92841284|NCT02617485|Antimitotic Agents|antimitotic agents|mesh-ancestor
92841285|NCT02617485|Mitosis Modulators|mitosis modulators|mesh-ancestor
92841287|NCT04289207|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92841288|NCT04289207|Hormone Antagonists|hormone antagonists|mesh-ancestor
92841289|NCT04289207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841290|NCT04289207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841291|NCT02863835|Albuterol|albuterol|mesh-list
92841292|NCT02863835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92841293|NCT02863835|Autonomic Agents|autonomic agents|mesh-ancestor
92841294|NCT02863835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841295|NCT02863835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841296|NCT02863835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92841297|NCT02863835|Respiratory System Agents|respiratory system agents|mesh-ancestor
92841298|NCT02863835|Tocolytic Agents|tocolytic agents|mesh-ancestor
92841299|NCT02863835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92841300|NCT02863835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92841301|NCT02863835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92841302|NCT02863835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92841303|NCT02863835|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841304|NCT02863835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977213|NCT00586157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92841305|NCT02863835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841306|NCT00697437|Ketoconazole|ketoconazole|mesh-list
92841307|NCT00697437|Docetaxel|docetaxel|mesh-list
92841308|NCT00697437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841309|NCT00697437|Tubulin Modulators|tubulin modulators|mesh-ancestor
92841310|NCT00697437|Antimitotic Agents|antimitotic agents|mesh-ancestor
92841311|NCT00697437|Mitosis Modulators|mitosis modulators|mesh-ancestor
92841312|NCT00697437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841313|NCT00697437|Antifungal Agents|antifungal agents|mesh-ancestor
92841314|NCT00697437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841315|NCT00697437|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92841316|NCT00697437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92841317|NCT00697437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841318|NCT00697437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92841319|NCT00697437|Hormone Antagonists|hormone antagonists|mesh-ancestor
92841320|NCT00697437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841321|NCT00697437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841322|NCT00697437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92841323|NCT04252274|Darunavir|darunavir|mesh-list
92841324|NCT04252274|Cobicistat|cobicistat|mesh-list
92841325|NCT04252274|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92841326|NCT04252274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92841327|NCT04252274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92841328|NCT04252274|Protease Inhibitors|protease inhibitors|mesh-ancestor
92841329|NCT04252274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841330|NCT04252274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841331|NCT04252274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92841332|NCT04252274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92841333|NCT04252274|Antiviral Agents|antiviral agents|mesh-ancestor
92841334|NCT04252274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841335|NCT04252274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92841336|NCT04252274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92841337|NCT00864513|Pemetrexed|pemetrexed|mesh-list
92841338|NCT00864513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841339|NCT00864513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841340|NCT00864513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841341|NCT00864513|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92841342|NCT00864513|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92841343|NCT04128891|Valsartan|valsartan|mesh-list
92841344|NCT04128891|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92841345|NCT04128891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92841346|NCT04128891|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92841347|NCT04128891|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92841348|NCT04128891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841349|NCT04251962|Fentanyl|fentanyl|mesh-list
92841350|NCT04251962|Bupivacaine|bupivacaine|mesh-list
92841351|NCT04251962|Anesthetics, Local|anesthetics, local|mesh-ancestor
92841352|NCT04251962|Anesthetics|anesthetics|mesh-ancestor
92841353|NCT04251962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841354|NCT04251962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841355|NCT04251962|Sensory System Agents|sensory system agents|mesh-ancestor
92841356|NCT04251962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841357|NCT04251962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92841358|NCT04251962|Narcotics|narcotics|mesh-ancestor
92841359|NCT04251962|Analgesics|analgesics|mesh-ancestor
92841360|NCT04251962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92841361|NCT04251962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92841362|NCT04251962|Anesthetics, General|anesthetics, general|mesh-ancestor
92841363|NCT04255238|Dapagliflozin|dapagliflozin|mesh-list
92841364|NCT04255238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92841365|NCT04255238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841366|NCT04255238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841367|NCT04255238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841368|NCT04250948|Capecitabine|capecitabine|mesh-list
92841369|NCT04250948|Oxaliplatin|oxaliplatin|mesh-list
92841370|NCT04250948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92841371|NCT04250948|Antimetabolites|antimetabolites|mesh-ancestor
92841372|NCT04250948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841373|NCT04250948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841374|NCT05251766|Paclitaxel|paclitaxel|mesh-list
92841375|NCT05251766|Docetaxel|docetaxel|mesh-list
92841376|NCT05251766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92841377|NCT05251766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841378|NCT05251766|Tubulin Modulators|tubulin modulators|mesh-ancestor
92841379|NCT05251766|Antimitotic Agents|antimitotic agents|mesh-ancestor
92841380|NCT05251766|Mitosis Modulators|mitosis modulators|mesh-ancestor
92841381|NCT05251766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841382|NCT04254380|Insulin Lispro|insulin lispro|mesh-list
92841383|NCT04254380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841384|NCT04254380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841385|NCT00631514|Acetaminophen|acetaminophen|mesh-list
92841386|NCT00631514|Ibuprofen|ibuprofen|mesh-list
92841387|NCT00631514|Piroxicam|piroxicam|mesh-list
92841388|NCT00631514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841389|NCT00631514|Analgesics|analgesics|mesh-ancestor
92841390|NCT00631514|Sensory System Agents|sensory system agents|mesh-ancestor
92841391|NCT00631514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841392|NCT00631514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841393|NCT00631514|Antipyretics|antipyretics|mesh-ancestor
92841394|NCT00631514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92841395|NCT00631514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841396|NCT00631514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841397|NCT00631514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92841398|NCT00631514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841399|NCT00631514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841400|NCT04623944|Cytarabine|cytarabine|mesh-list
92841401|NCT04623944|Cyclophosphamide|cyclophosphamide|mesh-list
92841402|NCT04623944|Fludarabine|fludarabine|mesh-list
92841403|NCT04623944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841404|NCT04623944|Immunologic Factors|immunologic factors|mesh-ancestor
92841405|NCT04623944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841406|NCT04623944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841407|NCT04623944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92841408|NCT04623944|Alkylating Agents|alkylating agents|mesh-ancestor
92841409|NCT04623944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841410|NCT04623944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841411|NCT04623944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92841412|NCT04623944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92841413|NCT04623944|Antimetabolites|antimetabolites|mesh-ancestor
92841414|NCT04623944|Antiviral Agents|antiviral agents|mesh-ancestor
92841415|NCT04623944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841416|NCT05253014|Acetaminophen|acetaminophen|mesh-list
92841417|NCT05253014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841418|NCT05253014|Analgesics|analgesics|mesh-ancestor
92841419|NCT05253014|Sensory System Agents|sensory system agents|mesh-ancestor
92841420|NCT05253014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841421|NCT05253014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841422|NCT05253014|Antipyretics|antipyretics|mesh-ancestor
92841423|NCT00659425|Immunotoxin HA22|immunotoxin ha22|mesh-list
92841424|NCT00659425|Immunotoxins|immunotoxins|mesh-ancestor
92841425|NCT00659425|Immunoconjugates|immunoconjugates|mesh-ancestor
92841426|NCT00659425|Immunologic Factors|immunologic factors|mesh-ancestor
92841427|NCT00659425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841428|NCT00659425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841429|NCT00656851|Pioglitazone|pioglitazone|mesh-list
92841430|NCT00656851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841431|NCT00656851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841432|NCT00803335|Estrogens|estrogens|mesh-list
92841433|NCT00803335|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92841435|NCT00803335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841436|NCT00803335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841437|NCT00797953|Cardiotonic Agents|cardiotonic agents|mesh-list
92841438|NCT00656617|Cytarabine|cytarabine|mesh-list
92841439|NCT00656617|Vorinostat|vorinostat|mesh-list
92841440|NCT00656617|Idarubicin|idarubicin|mesh-list
92841441|NCT00656617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92841442|NCT00656617|Antimetabolites|antimetabolites|mesh-ancestor
92841443|NCT00656617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841444|NCT00656617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841445|NCT00656617|Antiviral Agents|antiviral agents|mesh-ancestor
92841446|NCT00656617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841447|NCT00656617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841448|NCT00656617|Immunologic Factors|immunologic factors|mesh-ancestor
92841449|NCT00656617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841450|NCT00656617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92841451|NCT00656617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841452|NCT00656617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92841453|NCT00656617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92841454|NCT00656617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92841456|NCT00798343|Immunologic Factors|immunologic factors|mesh-ancestor
92841457|NCT00798343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841458|NCT00803725|Fentanyl|fentanyl|mesh-list
92841459|NCT00803725|Mepivacaine|mepivacaine|mesh-list
92841460|NCT00803725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92841461|NCT00803725|Narcotics|narcotics|mesh-ancestor
92841462|NCT00803725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841463|NCT00803725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841464|NCT00803725|Analgesics|analgesics|mesh-ancestor
92841465|NCT00803725|Sensory System Agents|sensory system agents|mesh-ancestor
92841466|NCT00803725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841467|NCT00803725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92841468|NCT00803725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92841469|NCT00803725|Anesthetics, General|anesthetics, general|mesh-ancestor
92841470|NCT00803725|Anesthetics|anesthetics|mesh-ancestor
92841471|NCT00803725|Anesthetics, Local|anesthetics, local|mesh-ancestor
92841472|NCT00803803|Pilocarpine|pilocarpine|mesh-list
92841473|NCT00803803|Miotics|miotics|mesh-ancestor
92841474|NCT00803803|Autonomic Agents|autonomic agents|mesh-ancestor
92841475|NCT00803803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841476|NCT00803803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841477|NCT00803803|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92841478|NCT00803803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92841479|NCT00803803|Cholinergic Agents|cholinergic agents|mesh-ancestor
92841480|NCT00803803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841481|NCT00803803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841482|NCT04775329|Rifaximin|rifaximin|mesh-list
92841483|NCT04775329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92841484|NCT04775329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841485|NCT04775329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92841486|NCT00659269|Vitamins|vitamins|mesh-list
92841487|NCT00659269|Vitamin B 12|vitamin b 12|mesh-list
92841488|NCT00659269|Vitamin B 6|vitamin b 6|mesh-list
92841489|NCT00659269|Pyridoxal|pyridoxal|mesh-list
92841490|NCT00659269|Pyridoxine|pyridoxine|mesh-list
92841491|NCT00659269|Vitamin B Complex|vitamin b complex|mesh-list
92841492|NCT00659269|Vincristine|vincristine|mesh-list
92841493|NCT00659269|Vinorelbine|vinorelbine|mesh-list
92841494|NCT00659269|Docetaxel|docetaxel|mesh-list
92841495|NCT00659269|Cisplatin|cisplatin|mesh-list
92841496|NCT00659269|Oxaliplatin|oxaliplatin|mesh-list
92841497|NCT00659269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92841498|NCT00659269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841499|NCT00659269|Tubulin Modulators|tubulin modulators|mesh-ancestor
92841500|NCT00659269|Antimitotic Agents|antimitotic agents|mesh-ancestor
92841501|NCT00659269|Mitosis Modulators|mitosis modulators|mesh-ancestor
92841502|NCT00659269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841503|NCT00659269|Micronutrients|micronutrients|mesh-ancestor
92841504|NCT00659269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841505|NCT00922129|Cyclosporine|cyclosporine|mesh-list
92841506|NCT00922129|Sirolimus|sirolimus|mesh-list
92841507|NCT00922129|Temsirolimus|temsirolimus|mesh-list
92841508|NCT00922129|MTOR Inhibitors|mtor inhibitors|mesh-list
92841509|NCT00922129|Tacrolimus|tacrolimus|mesh-list
92841510|NCT00922129|Cyclosporins|cyclosporins|mesh-list
92841511|NCT00922129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841512|NCT00922129|Immunologic Factors|immunologic factors|mesh-ancestor
92841513|NCT00922129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841514|NCT00922129|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92841515|NCT00922129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841516|NCT00922129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841517|NCT00922129|Antifungal Agents|antifungal agents|mesh-ancestor
92841518|NCT00922129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841519|NCT00922129|Dermatologic Agents|dermatologic agents|mesh-ancestor
92841520|NCT00922129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841521|NCT00922129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92841522|NCT00922129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92841523|NCT00922129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841524|NCT00922129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92841525|NCT00806299|Loperamide|loperamide|mesh-list
92841526|NCT00806299|Antidiarrheals|antidiarrheals|mesh-list
92841527|NCT00806299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92841528|NCT00804115|Timolol|timolol|mesh-list
92841529|NCT00804115|Latanoprost|latanoprost|mesh-list
92841530|NCT00804115|Pilocarpine|pilocarpine|mesh-list
92841531|NCT00804115|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92841532|NCT00804115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92841533|NCT00804115|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841535|NCT00804115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841536|NCT00804115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841537|NCT00804115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92841538|NCT00804115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92841539|NCT00804115|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92841540|NCT00804115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92841541|NCT00804115|Miotics|miotics|mesh-ancestor
92841542|NCT00804115|Autonomic Agents|autonomic agents|mesh-ancestor
92841543|NCT00804115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841544|NCT00804115|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92841545|NCT00804115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92841546|NCT00804115|Cholinergic Agents|cholinergic agents|mesh-ancestor
92841547|NCT02554123|Vitamin E|vitamin e|mesh-list
92841548|NCT02554123|Petrolatum|petrolatum|mesh-list
92841549|NCT02554123|Vitamins|vitamins|mesh-ancestor
92841550|NCT02554123|Micronutrients|micronutrients|mesh-ancestor
92841551|NCT02554123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841552|NCT02554123|Antioxidants|antioxidants|mesh-ancestor
92841553|NCT02554123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841554|NCT02554123|Protective Agents|protective agents|mesh-ancestor
92841555|NCT02554123|Emollients|emollients|mesh-ancestor
92841556|NCT02554123|Dermatologic Agents|dermatologic agents|mesh-ancestor
92841557|NCT00799045|Clopidogrel|clopidogrel|mesh-list
92841558|NCT00799045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92841559|NCT00799045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92841560|NCT00799045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92841561|NCT00799045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92841562|NCT00799045|Purinergic Agents|purinergic agents|mesh-ancestor
92841563|NCT00799045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841564|NCT00799045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841565|NCT00799045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841566|NCT00658333|Mycophenolic Acid|mycophenolic acid|mesh-list
92841567|NCT00658333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92841568|NCT00658333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841569|NCT00658333|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92841570|NCT00658333|Antitubercular Agents|antitubercular agents|mesh-ancestor
92841571|NCT00658333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92841572|NCT00658333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841573|NCT00658333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841574|NCT00658333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841575|NCT00804271|Memantine|memantine|mesh-list
92841576|NCT00804271|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92841577|NCT00804271|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92841578|NCT00804271|Dopamine Agents|dopamine agents|mesh-ancestor
92841579|NCT00804271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841580|NCT00804271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841581|NCT00804271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841582|NCT00804271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92841583|NCT00804271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92841584|NCT00799201|Naloxone|naloxone|mesh-list
92841585|NCT00799201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92841586|NCT00799201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841587|NCT00799201|Sensory System Agents|sensory system agents|mesh-ancestor
92841588|NCT00799201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841589|NCT00806611|Ethanol|ethanol|mesh-list
92841590|NCT00806611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92841591|NCT00806611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841592|NCT00806611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841593|NCT00806611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841594|NCT00799513|Lenalidomide|lenalidomide|mesh-list
92841595|NCT00799513|Immunologic Factors|immunologic factors|mesh-ancestor
92841596|NCT00799513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841597|NCT00799513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92841598|NCT00799513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92841599|NCT00799513|Growth Substances|growth substances|mesh-ancestor
92841600|NCT00799513|Growth Inhibitors|growth inhibitors|mesh-ancestor
92841601|NCT00799513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841602|NCT00806767|Fludarabine|fludarabine|mesh-list
92841603|NCT00806767|Fludarabine phosphate|fludarabine phosphate|mesh-list
92841604|NCT00806767|Busulfan|busulfan|mesh-list
92841605|NCT00806767|Immunoglobulins|immunoglobulins|mesh-list
92841606|NCT00806767|Antibodies|antibodies|mesh-list
92841607|NCT00806767|gamma-Globulins|gamma-globulins|mesh-list
92841608|NCT00806767|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92841609|NCT00806767|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92841610|NCT00806767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841611|NCT00806767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92841612|NCT00806767|Antimetabolites|antimetabolites|mesh-ancestor
92841613|NCT00806767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841614|NCT00806767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841615|NCT00806767|Immunologic Factors|immunologic factors|mesh-ancestor
92841616|NCT00806767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841617|NCT00806767|Alkylating Agents|alkylating agents|mesh-ancestor
92841618|NCT00806767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92841619|NCT00806767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92841620|NCT00863655|Everolimus|everolimus|mesh-list
92841621|NCT00863655|Exemestane|exemestane|mesh-list
92841622|NCT00863655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92841623|NCT00863655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92841624|NCT00863655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841625|NCT00863655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841626|NCT00863655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841627|NCT00863655|Immunologic Factors|immunologic factors|mesh-ancestor
92841628|NCT00863655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841629|NCT00863655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841630|NCT00863655|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92841631|NCT00863655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92841632|NCT00863655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92841633|NCT00863655|Hormone Antagonists|hormone antagonists|mesh-ancestor
92841634|NCT00863655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841635|NCT00806923|Bevacizumab|bevacizumab|mesh-list
92841636|NCT00806923|Gemcitabine|gemcitabine|mesh-list
92841637|NCT00806923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92841638|NCT00806923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841639|NCT00806923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92841640|NCT00806923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92841641|NCT00806923|Growth Substances|growth substances|mesh-ancestor
92841642|NCT00806923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841643|NCT00806923|Growth Inhibitors|growth inhibitors|mesh-ancestor
92841644|NCT00806923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92841645|NCT00806923|Antimetabolites|antimetabolites|mesh-ancestor
92841646|NCT00806923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841647|NCT00698607|Sirolimus|sirolimus|mesh-list
92841648|NCT00698607|Everolimus|everolimus|mesh-list
92841649|NCT00698607|Clopidogrel|clopidogrel|mesh-list
92841650|NCT00698607|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92841651|NCT00698607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92841652|NCT00698607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841653|NCT00698607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841654|NCT00698607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841655|NCT00698607|Immunologic Factors|immunologic factors|mesh-ancestor
92841656|NCT00698607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841657|NCT00698607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841658|NCT00698607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92841659|NCT00698607|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92841660|NCT00698607|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92841661|NCT00698607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92841662|NCT00698607|Purinergic Agents|purinergic agents|mesh-ancestor
92841663|NCT00698607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841664|NCT00698607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92841665|NCT00698607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841666|NCT00698607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92841667|NCT00698607|Antifungal Agents|antifungal agents|mesh-ancestor
92841668|NCT04124757|Rocuronium|rocuronium|mesh-list
92841669|NCT04124757|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92841670|NCT04124757|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92841671|NCT04124757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92841672|NCT04124757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841673|NCT04124757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841674|NCT04123041|Nicotine|nicotine|mesh-list
92841675|NCT04123041|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92841676|NCT04123041|Autonomic Agents|autonomic agents|mesh-ancestor
92841677|NCT04123041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841678|NCT04123041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841679|NCT04123041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92841680|NCT04123041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92841681|NCT04123041|Cholinergic Agents|cholinergic agents|mesh-ancestor
92841682|NCT04123041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841683|NCT04123041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841684|NCT00698763|Simendan|simendan|mesh-list
92841685|NCT00698763|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92841686|NCT00698763|Vasodilator Agents|vasodilator agents|mesh-ancestor
92841687|NCT00698763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92841688|NCT00698763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92841689|NCT00698763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841690|NCT00698763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841691|NCT00698763|Protective Agents|protective agents|mesh-ancestor
92841692|NCT00698763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841693|NCT00804895|Cortivazol|cortivazol|mesh-list
92841694|NCT00804895|Verapamil|verapamil|mesh-list
92841695|NCT00804895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92841696|NCT00804895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92841697|NCT00804895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92841698|NCT00804895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841699|NCT00804895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92841700|NCT00804895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841701|NCT00804895|Vasodilator Agents|vasodilator agents|mesh-ancestor
92841702|NCT00804895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841703|NCT00800137|Heparin|heparin|mesh-list
92841704|NCT00800137|Calcium heparin|calcium heparin|mesh-list
92841705|NCT00800137|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92841706|NCT00800137|Tinzaparin|tinzaparin|mesh-list
92841707|NCT00800137|Dalteparin|dalteparin|mesh-list
92841708|NCT00800137|Warfarin|warfarin|mesh-list
92841709|NCT00800137|Anticoagulants|anticoagulants|mesh-ancestor
92841710|NCT00800137|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92841711|NCT00800137|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92841712|NCT00800137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841713|NCT00807079|Carboplatin|carboplatin|mesh-list
92841714|NCT00807079|Topotecan|topotecan|mesh-list
92841715|NCT00807079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841716|NCT00807079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92841717|NCT00807079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92841718|NCT00807079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841719|NCT00807079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841720|NCT00800293|Betamethasone|betamethasone|mesh-list
92841721|NCT00800293|Betamethasone Valerate|betamethasone valerate|mesh-list
92841722|NCT00800293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92841723|NCT00800293|Betamethasone benzoate|betamethasone benzoate|mesh-list
92841724|NCT00800293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92841725|NCT00800293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841726|NCT00800293|Glucocorticoids|glucocorticoids|mesh-ancestor
92841727|NCT00800293|Hormones|hormones|mesh-ancestor
92841728|NCT00800293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841729|NCT00800293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841730|NCT00800293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92841731|NCT00800293|Respiratory System Agents|respiratory system agents|mesh-ancestor
92841732|NCT00658021|Exenatide|exenatide|mesh-list
92841733|NCT00658021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841734|NCT00658021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841735|NCT00658021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92841736|NCT00658021|Incretins|incretins|mesh-ancestor
92841737|NCT00658021|Hormones|hormones|mesh-ancestor
92841738|NCT00658021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486815|NCT01943240|Ropivacaine|ropivacaine|mesh-list
92841739|NCT00920816|Sorafenib|sorafenib|mesh-list
92841740|NCT00920816|Axitinib|axitinib|mesh-list
92841741|NCT00920816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841742|NCT00920816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92841743|NCT00920816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841744|NCT00920816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841745|NCT00631592|Dolutegravir|dolutegravir|mesh-list
92841746|NCT00631592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92841747|NCT00631592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92841748|NCT00631592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841749|NCT00631592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841750|NCT00631592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92841751|NCT00631592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92841752|NCT00631592|Antiviral Agents|antiviral agents|mesh-ancestor
92841753|NCT00631592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841754|NCT05251610|Propranolol|propranolol|mesh-list
92841755|NCT05251610|Oxytocin|oxytocin|mesh-list
92841756|NCT05251610|Oxytocics|oxytocics|mesh-ancestor
92841757|NCT05251610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92841758|NCT05251610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841759|NCT05251610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92841760|NCT05251610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92841761|NCT05251610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841762|NCT05251610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841763|NCT05251610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841764|NCT05251610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92841765|NCT05251610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92841766|NCT05251610|Vasodilator Agents|vasodilator agents|mesh-ancestor
92841768|NCT00657709|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92841769|NCT00657709|Immunologic Factors|immunologic factors|mesh-ancestor
92841770|NCT00657709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841771|NCT00657553|Bortezomib|bortezomib|mesh-list
92841772|NCT00657553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841773|NCT04253912|Povidone-Iodine|povidone-iodine|mesh-list
92841774|NCT04253912|Povidone|povidone|mesh-list
92841775|NCT04253912|Plasma Substitutes|plasma substitutes|mesh-ancestor
92841776|NCT04253912|Blood Substitutes|blood substitutes|mesh-ancestor
92841777|NCT04253912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92841778|NCT04253912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841779|NCT00800527|Diclofenac|diclofenac|mesh-list
92841780|NCT00800527|Gabapentin|gabapentin|mesh-list
92841781|NCT00800527|Analgesics|analgesics|mesh-ancestor
92841782|NCT00800527|Sensory System Agents|sensory system agents|mesh-ancestor
92841783|NCT00800527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841784|NCT00800527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841785|NCT00800527|Anticonvulsants|anticonvulsants|mesh-ancestor
92841786|NCT00800527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92841787|NCT00800527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92841788|NCT00800527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841789|NCT00800527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92841790|NCT00800527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92841791|NCT00800527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92841792|NCT00800527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841793|NCT00800527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841794|NCT00800527|Antimanic Agents|antimanic agents|mesh-ancestor
92841795|NCT00800527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92841796|NCT00800527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841797|NCT00800527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841798|NCT00800527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841799|NCT00800527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92841800|NCT00800527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841801|NCT00862719|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92841802|NCT00862719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841803|NCT00862719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841804|NCT00862719|Incretins|incretins|mesh-ancestor
92841805|NCT00862719|Hormones|hormones|mesh-ancestor
92841806|NCT00862719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841807|NCT00862719|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92841808|NCT00862719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92841809|NCT00862719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841810|NCT00862719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841811|NCT04120779|Sulfamethazine|sulfamethazine|mesh-list
92841812|NCT04120779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841813|NCT00862641|Regadenoson|regadenoson|mesh-list
92841814|NCT00862641|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92841815|NCT00862641|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92841816|NCT00862641|Purinergic Agonists|purinergic agonists|mesh-ancestor
92841817|NCT00862641|Purinergic Agents|purinergic agents|mesh-ancestor
92841818|NCT00862641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841819|NCT00862641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841820|NCT00862641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841821|NCT04119921|Ketorolac|ketorolac|mesh-list
92841822|NCT04119921|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92841823|NCT04119921|Lubricant Eye Drops|lubricant eye drops|mesh-list
92841824|NCT04119921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92841825|NCT04119921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841826|NCT04119921|Analgesics|analgesics|mesh-ancestor
92841827|NCT04119921|Sensory System Agents|sensory system agents|mesh-ancestor
92841828|NCT04119921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841829|NCT04119921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841830|NCT04119921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841831|NCT04119921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841832|NCT04119921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92841833|NCT04119921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841834|NCT04119921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841835|NCT04119921|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92841836|NCT04119921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92841837|NCT00861471|Docetaxel|docetaxel|mesh-list
92841838|NCT00861471|Imatinib Mesylate|imatinib mesylate|mesh-list
92841839|NCT00861471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841840|NCT00861471|Tubulin Modulators|tubulin modulators|mesh-ancestor
92841841|NCT00861471|Antimitotic Agents|antimitotic agents|mesh-ancestor
92841842|NCT00861471|Mitosis Modulators|mitosis modulators|mesh-ancestor
92841843|NCT00861471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841844|NCT00861471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92841845|NCT00861471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841846|NCT02613585|Permethrin|permethrin|mesh-list
92841847|NCT02613585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841848|NCT02613585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841849|NCT04119297|Heparinoids|heparinoids|mesh-list
92841850|NCT04119297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841851|NCT04119297|Anticoagulants|anticoagulants|mesh-ancestor
92841852|NCT00699387|Benzonidazole|benzonidazole|mesh-list
92841853|NCT00699387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92841854|NCT00699387|Immunologic Factors|immunologic factors|mesh-ancestor
92841855|NCT00699387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841856|NCT00699387|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92841857|NCT00699387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92841858|NCT00699387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92841859|NCT00699387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841860|NCT00699465|Enoxaparin|enoxaparin|mesh-list
92841861|NCT00699465|Enoxaparin sodium|enoxaparin sodium|mesh-list
92841862|NCT00699465|Anticoagulants|anticoagulants|mesh-ancestor
92841863|NCT00699465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92841864|NCT00699465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92841865|NCT00699465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841866|NCT00858117|Rituximab|rituximab|mesh-list
92841867|NCT00858117|Alemtuzumab|alemtuzumab|mesh-list
92841868|NCT00858117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92841869|NCT00858117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841870|NCT00858117|Immunologic Factors|immunologic factors|mesh-ancestor
92841871|NCT00858117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841872|NCT00858117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841873|NCT00700947|Metoprolol|metoprolol|mesh-list
92841874|NCT00700947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92841875|NCT00700947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92841876|NCT00700947|Adrenergic Agents|adrenergic agents|mesh-ancestor
92841877|NCT00700947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841878|NCT00700947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841879|NCT00700947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841880|NCT00700947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92841881|NCT00700947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92841882|NCT00700947|Sympatholytics|sympatholytics|mesh-ancestor
92841883|NCT00700947|Autonomic Agents|autonomic agents|mesh-ancestor
92841884|NCT00700947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841885|NCT00700947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92841886|NCT00652951|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92841887|NCT00652951|Immunologic Factors|immunologic factors|mesh-ancestor
92841888|NCT00652951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841889|NCT04116255|Salicylic Acid|salicylic acid|mesh-list
92841890|NCT04116255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486964|NCT01944215|Caffeine|caffeine|mesh-list
92841891|NCT04116255|Antifungal Agents|antifungal agents|mesh-ancestor
92841892|NCT04116255|Keratolytic Agents|keratolytic agents|mesh-ancestor
92841893|NCT04116255|Dermatologic Agents|dermatologic agents|mesh-ancestor
92841894|NCT00805519|Chloroquine|chloroquine|mesh-list
92841895|NCT00805519|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92841896|NCT00805519|Prednisolone|prednisolone|mesh-list
92841897|NCT00805519|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92841898|NCT00805519|Methylprednisolone|methylprednisolone|mesh-list
92841899|NCT00805519|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92841900|NCT00805519|Prednisolone acetate|prednisolone acetate|mesh-list
92841901|NCT00805519|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92841902|NCT00805519|Prednisolone phosphate|prednisolone phosphate|mesh-list
92841903|NCT00805519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92841904|NCT00805519|Glucocorticoids|glucocorticoids|mesh-ancestor
92841905|NCT00805519|Hormones|hormones|mesh-ancestor
92841906|NCT00805519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841907|NCT00805519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841908|NCT00805519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92841909|NCT00805519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92841910|NCT00805519|Antiemetics|antiemetics|mesh-ancestor
92841911|NCT00805519|Autonomic Agents|autonomic agents|mesh-ancestor
92841912|NCT00805519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92841913|NCT00805519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92841914|NCT00805519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92841915|NCT00805519|Protective Agents|protective agents|mesh-ancestor
92841916|NCT00805519|Amebicides|amebicides|mesh-ancestor
92841917|NCT00805519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92841918|NCT00805519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92841919|NCT00805519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92841920|NCT00805519|Antimalarials|antimalarials|mesh-ancestor
92841921|NCT00805519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92841922|NCT00805519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92841923|NCT00805519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92841924|NCT00805519|Analgesics|analgesics|mesh-ancestor
92841925|NCT00805519|Sensory System Agents|sensory system agents|mesh-ancestor
92841926|NCT00805519|Filaricides|filaricides|mesh-ancestor
92841927|NCT00805519|Antinematodal Agents|antinematodal agents|mesh-ancestor
92841928|NCT00805519|Anthelmintics|anthelmintics|mesh-ancestor
92841929|NCT00592683|Aripiprazole|aripiprazole|mesh-list
92841930|NCT00592683|Antidepressive Agents|antidepressive agents|mesh-ancestor
92841931|NCT00592683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92841932|NCT00592683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92841933|NCT00592683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92841934|NCT00592683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841935|NCT00592683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841936|NCT00592683|Dopamine Agonists|dopamine agonists|mesh-ancestor
92841937|NCT00592683|Dopamine Agents|dopamine agents|mesh-ancestor
92841938|NCT00592683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841939|NCT00592683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841940|NCT00592683|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92841941|NCT00592683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92841942|NCT00592683|Serotonin Agents|serotonin agents|mesh-ancestor
92841943|NCT00592683|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92841944|NCT00592683|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92841945|NCT00592683|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92841946|NCT00592683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92841947|NCT02613039|Contraceptive Agents|contraceptive agents|mesh-list
92841948|NCT02613039|Contraceptives, Oral|contraceptives, oral|mesh-list
92841949|NCT02613039|Estrogens|estrogens|mesh-list
92841950|NCT02613039|Progestins|progestins|mesh-list
92841951|NCT02613039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92841952|NCT02613039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841953|NCT02613039|Hormones|hormones|mesh-ancestor
92841954|NCT02613039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841955|NCT02613039|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92841956|NCT00813475|Insulin|insulin|mesh-list
92841957|NCT00813475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92841958|NCT00813475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841959|NCT00813475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841960|NCT00701259|Lansoprazole|lansoprazole|mesh-list
92841961|NCT00701259|Dexlansoprazole|dexlansoprazole|mesh-list
92841962|NCT00701259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92841963|NCT00701259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92841964|NCT00701259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92841965|NCT00701259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92841966|NCT00701259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841967|NCT00701337|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92841969|NCT00701337|Estradiol|estradiol|mesh-list
92841970|NCT00701337|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92841971|NCT00701337|Estrogens|estrogens|mesh-ancestor
92841972|NCT00701337|Hormones|hormones|mesh-ancestor
92841973|NCT00701337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92841974|NCT00701337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841975|NCT00701337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92841976|NCT00701337|Contraceptive Agents|contraceptive agents|mesh-ancestor
92841977|NCT00701337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92841978|NCT00701337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92841979|NCT00654901|Vaccines|vaccines|mesh-list
92841980|NCT00654901|Immunologic Factors|immunologic factors|mesh-ancestor
92841981|NCT00654901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841983|NCT00701493|Anticonvulsants|anticonvulsants|mesh-ancestor
92841984|NCT00701493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92841985|NCT00701493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841986|NCT04253678|Vortioxetine|vortioxetine|mesh-list
92841987|NCT04253678|Antidepressive Agents|antidepressive agents|mesh-ancestor
92841988|NCT04253678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92841989|NCT04253678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92841990|NCT04253678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92841991|NCT04253678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92841992|NCT04253678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92841993|NCT04253678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92841994|NCT04253678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92841995|NCT04253678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92841996|NCT04253678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92841997|NCT04253678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92841998|NCT04253678|Serotonin Agents|serotonin agents|mesh-ancestor
92841999|NCT04253678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92842000|NCT04253678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92842001|NCT04253678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92842002|NCT04253678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92842003|NCT00813631|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92842004|NCT00813631|Laxatives|laxatives|mesh-ancestor
92842005|NCT00813631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92842006|NCT02551861|Ribavirin|ribavirin|mesh-list
92842007|NCT02551861|Sofosbuvir|sofosbuvir|mesh-list
92842008|NCT02551861|Antimetabolites|antimetabolites|mesh-ancestor
92842009|NCT02551861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842010|NCT02551861|Antiviral Agents|antiviral agents|mesh-ancestor
92842011|NCT02551861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842012|NCT00846495|Topiramate|topiramate|mesh-list
92842013|NCT00846495|Frovatriptan|frovatriptan|mesh-list
92842014|NCT00846495|Anticonvulsants|anticonvulsants|mesh-ancestor
92842015|NCT00846495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92842016|NCT00846495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842017|NCT00846495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92842018|NCT00846495|Serotonin Agents|serotonin agents|mesh-ancestor
92743719|NCT01293968|Promethazine|promethazine|mesh-list
92842019|NCT00846495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842020|NCT00846495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842021|NCT00654745|Amlodipine|amlodipine|mesh-list
92842022|NCT00654745|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92842023|NCT00654745|Olmesartan|olmesartan|mesh-list
92842024|NCT00654745|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92842025|NCT00654745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92842026|NCT00654745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842027|NCT00654745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842028|NCT00654745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842029|NCT00654745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842030|NCT00654745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842031|NCT00654745|Vasodilator Agents|vasodilator agents|mesh-ancestor
92842032|NCT00654745|Diuretics|diuretics|mesh-ancestor
92842033|NCT00654745|Natriuretic Agents|natriuretic agents|mesh-ancestor
92842034|NCT00654745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92842035|NCT00654745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92842036|NCT00654745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92842037|NCT00809887|Micafungin|micafungin|mesh-list
92842038|NCT00809887|Antifungal Agents|antifungal agents|mesh-ancestor
92842039|NCT00809887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842040|NCT00846027|Paclitaxel|paclitaxel|mesh-list
92842041|NCT00846027|Bevacizumab|bevacizumab|mesh-list
92842042|NCT00846027|Gemcitabine|gemcitabine|mesh-list
92842043|NCT00846027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92842044|NCT00846027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842045|NCT00846027|Tubulin Modulators|tubulin modulators|mesh-ancestor
92842046|NCT00846027|Antimitotic Agents|antimitotic agents|mesh-ancestor
92842047|NCT00846027|Mitosis Modulators|mitosis modulators|mesh-ancestor
92842048|NCT00846027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842049|NCT00846027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842050|NCT00846027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92842051|NCT00846027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92842052|NCT00846027|Growth Substances|growth substances|mesh-ancestor
92842053|NCT00846027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842054|NCT00846027|Growth Inhibitors|growth inhibitors|mesh-ancestor
92842055|NCT00846027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92842056|NCT00846027|Antimetabolites|antimetabolites|mesh-ancestor
92842058|NCT00807625|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92842059|NCT00807625|Medroxyprogesterone|medroxyprogesterone|mesh-list
92842060|NCT00807625|Trace Elements|trace elements|mesh-ancestor
92842061|NCT00807625|Micronutrients|micronutrients|mesh-ancestor
92842062|NCT00807625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842063|NCT00807625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92842064|NCT00807625|Contraceptive Agents|contraceptive agents|mesh-ancestor
92842065|NCT00807625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92842066|NCT00807625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92842067|NCT00807625|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92842068|NCT00807625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92842069|NCT00807625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842070|NCT00807625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92842071|NCT00807625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92842072|NCT00807625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92842073|NCT02551549|Rezafungin|rezafungin|mesh-list
92842074|NCT02551549|Antifungal Agents|antifungal agents|mesh-ancestor
92842075|NCT02551549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842076|NCT00810121|Ketoprofen|ketoprofen|mesh-list
92842077|NCT00810121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92842078|NCT00810121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842079|NCT00810121|Analgesics|analgesics|mesh-ancestor
92842080|NCT00810121|Sensory System Agents|sensory system agents|mesh-ancestor
92842081|NCT00810121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842082|NCT00810121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842083|NCT00810121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92842084|NCT00810121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92842085|NCT00810121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92842086|NCT00810121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842087|NCT00810121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842088|NCT00652327|Atorvastatin|atorvastatin|mesh-list
92842089|NCT00652327|Simvastatin|simvastatin|mesh-list
92842090|NCT00652327|Ezetimibe|ezetimibe|mesh-list
92842091|NCT00652327|Pravastatin|pravastatin|mesh-list
92743791|NCT01222533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92842092|NCT00652327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92842093|NCT00652327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92842094|NCT00652327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92842095|NCT00652327|Antimetabolites|antimetabolites|mesh-ancestor
92842096|NCT00652327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842097|NCT00652327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92842098|NCT00652327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842099|NCT00814021|Sunitinib|sunitinib|mesh-list
92842100|NCT00814021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842101|NCT00814021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92842102|NCT00814021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92842103|NCT00814021|Growth Substances|growth substances|mesh-ancestor
92842104|NCT00814021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842105|NCT00814021|Growth Inhibitors|growth inhibitors|mesh-ancestor
92842106|NCT00814021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842107|NCT00814021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842108|NCT00814021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842109|NCT00645853|Warfarin|warfarin|mesh-list
92842110|NCT00645853|Anticoagulants|anticoagulants|mesh-ancestor
92842111|NCT00652093|Acetaminophen|acetaminophen|mesh-list
92842112|NCT00652093|Oxymorphone|oxymorphone|mesh-list
92842113|NCT00652093|Acetaminophen, dextropropoxyphene, drug combination|acetaminophen, dextropropoxyphene, drug combination|mesh-list
92842114|NCT00652093|Dextropropoxyphene|dextropropoxyphene|mesh-list
92842115|NCT00652093|Levopropoxyphene|levopropoxyphene|mesh-list
92842116|NCT00652093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842117|NCT00652093|Analgesics|analgesics|mesh-ancestor
92842118|NCT00652093|Sensory System Agents|sensory system agents|mesh-ancestor
92842119|NCT00652093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842120|NCT00652093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842121|NCT00652093|Antipyretics|antipyretics|mesh-ancestor
92842122|NCT00652093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92842123|NCT00652093|Narcotics|narcotics|mesh-ancestor
92842124|NCT00652093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842125|NCT00652093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92842126|NCT00652093|Antitussive Agents|antitussive agents|mesh-ancestor
92842127|NCT00652093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92842128|NCT00651937|Melphalan|melphalan|mesh-list
92842129|NCT00651937|Lenograstim|lenograstim|mesh-list
92842130|NCT00651937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92842131|NCT00651937|Alkylating Agents|alkylating agents|mesh-ancestor
92842132|NCT00651937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842133|NCT00651937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842134|NCT00651937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92842135|NCT00651937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842136|NCT00651937|Immunologic Factors|immunologic factors|mesh-ancestor
92842137|NCT00651937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842138|NCT00651937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92842140|NCT00654355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842141|NCT00654355|Immunologic Factors|immunologic factors|mesh-ancestor
92842142|NCT00654355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842143|NCT00654355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92842144|NCT00654355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842145|NCT00654355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842146|NCT00651313|Lidocaine|lidocaine|mesh-list
92842147|NCT00651313|Anesthetics, Local|anesthetics, local|mesh-ancestor
92842148|NCT00651313|Anesthetics|anesthetics|mesh-ancestor
92842149|NCT00651313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842150|NCT00651313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842151|NCT00651313|Sensory System Agents|sensory system agents|mesh-ancestor
92842152|NCT00651313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842153|NCT00651313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92842154|NCT00651313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92842155|NCT00651313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92842156|NCT00651313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842157|NCT00651313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842158|NCT00808171|Lidocaine|lidocaine|mesh-list
92842159|NCT00808171|Nitrous Oxide|nitrous oxide|mesh-list
92842160|NCT00808171|Anesthetics, Local|anesthetics, local|mesh-list
92842161|NCT00808171|Prilocaine|prilocaine|mesh-list
92842162|NCT00808171|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92842163|NCT00808171|Anesthetics|anesthetics|mesh-list
92842164|NCT00808171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842165|NCT00808171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842166|NCT00808171|Sensory System Agents|sensory system agents|mesh-ancestor
92842167|NCT00808171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842168|NCT00808171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92842169|NCT00808171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92842170|NCT00808171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92842171|NCT00808171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842172|NCT00808171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842173|NCT00808171|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92842174|NCT00808171|Anesthetics, General|anesthetics, general|mesh-ancestor
92842175|NCT00808171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842176|NCT00808171|Analgesics|analgesics|mesh-ancestor
92842177|NCT00808171|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92842178|NCT04703257|Dipyrone|dipyrone|mesh-list
92842179|NCT04703257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92842180|NCT04703257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842181|NCT04703257|Analgesics|analgesics|mesh-ancestor
92842182|NCT04703257|Sensory System Agents|sensory system agents|mesh-ancestor
92842183|NCT04703257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842184|NCT04703257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842185|NCT04703257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92842186|NCT04703257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92842187|NCT04703257|Antipyretics|antipyretics|mesh-ancestor
92842188|NCT00808327|Fentanyl|fentanyl|mesh-list
92842189|NCT00808327|Bupivacaine|bupivacaine|mesh-list
92842190|NCT00808327|Anesthetics, Local|anesthetics, local|mesh-ancestor
92842191|NCT00808327|Anesthetics|anesthetics|mesh-ancestor
92842192|NCT00808327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842193|NCT00808327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842194|NCT00808327|Sensory System Agents|sensory system agents|mesh-ancestor
92842195|NCT00808327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842197|NCT00808327|Narcotics|narcotics|mesh-ancestor
92842198|NCT00808327|Analgesics|analgesics|mesh-ancestor
92842199|NCT00808327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92842200|NCT00808327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92842201|NCT00808327|Anesthetics, General|anesthetics, general|mesh-ancestor
92842202|NCT00814645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92842203|NCT00814723|Ezetimibe|ezetimibe|mesh-list
92842204|NCT00814723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92842205|NCT00814723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92842206|NCT00814723|Antimetabolites|antimetabolites|mesh-ancestor
92433232|NCT01573377|Estrogens|estrogens|mesh-ancestor
92842207|NCT00814723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842209|NCT00845871|Deferasirox|deferasirox|mesh-list
92842210|NCT00845871|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92842211|NCT00845871|Chelating Agents|chelating agents|mesh-ancestor
92842212|NCT00845871|Sequestering Agents|sequestering agents|mesh-ancestor
92842213|NCT00845871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842214|NCT02864849|Capecitabine|capecitabine|mesh-list
92842215|NCT02864849|Oxaliplatin|oxaliplatin|mesh-list
92842216|NCT02864849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92842217|NCT02864849|Antimetabolites|antimetabolites|mesh-ancestor
92842218|NCT02864849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842219|NCT02864849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842220|NCT00701961|Artesunate|artesunate|mesh-list
92842221|NCT00701961|Mefloquine|mefloquine|mesh-list
92842222|NCT00701961|Antimalarials|antimalarials|mesh-ancestor
92842223|NCT00701961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92842224|NCT00701961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92842225|NCT00701961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842226|NCT00701961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842227|NCT00701961|Antiviral Agents|antiviral agents|mesh-ancestor
92842228|NCT00701961|Schistosomicides|schistosomicides|mesh-ancestor
92842229|NCT00701961|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92842230|NCT00701961|Anthelmintics|anthelmintics|mesh-ancestor
92842231|NCT04286711|Paclitaxel|paclitaxel|mesh-list
92842232|NCT04286711|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92842233|NCT04286711|Apatinib|apatinib|mesh-list
92842234|NCT04286711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92842235|NCT04286711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842236|NCT04286711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92842237|NCT04286711|Antimitotic Agents|antimitotic agents|mesh-ancestor
92842238|NCT04286711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92842239|NCT04286711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842240|NCT04286711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842241|NCT04286711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842242|NCT02863913|Cyclophosphamide|cyclophosphamide|mesh-list
92842243|NCT02863913|Interleukin-2|interleukin-2|mesh-list
92842244|NCT02863913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842245|NCT02863913|Immunologic Factors|immunologic factors|mesh-ancestor
92842246|NCT02863913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842247|NCT02863913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92842248|NCT02863913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92842249|NCT02863913|Alkylating Agents|alkylating agents|mesh-ancestor
92842250|NCT02863913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842251|NCT02863913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842252|NCT02863913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92842253|NCT02863913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842254|NCT02863913|Analgesics|analgesics|mesh-ancestor
92842255|NCT02863913|Sensory System Agents|sensory system agents|mesh-ancestor
92842256|NCT02863913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842257|NCT02612649|Ramosetron|ramosetron|mesh-list
92842258|NCT02612649|Antiemetics|antiemetics|mesh-ancestor
92842259|NCT02612649|Autonomic Agents|autonomic agents|mesh-ancestor
92842260|NCT02612649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842261|NCT02612649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842262|NCT02612649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92842263|NCT02612649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92842264|NCT02612649|Serotonin Agents|serotonin agents|mesh-ancestor
92842265|NCT02612649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842266|NCT02612649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842267|NCT04908800|Itraconazole|itraconazole|mesh-list
92487339|NCT04476979|Hormones|hormones|mesh-ancestor
92842268|NCT04908800|Antifungal Agents|antifungal agents|mesh-ancestor
92842269|NCT04908800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842270|NCT04908800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92842271|NCT04908800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92842272|NCT04908800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842273|NCT04908800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842274|NCT04908800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92842275|NCT04908800|Hormone Antagonists|hormone antagonists|mesh-ancestor
92842276|NCT04908800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842277|NCT04908800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842278|NCT04908800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92842279|NCT00844857|Olanzapine|olanzapine|mesh-list
92842280|NCT00844857|Fluoxetine|fluoxetine|mesh-list
92842282|NCT00844857|Autonomic Agents|autonomic agents|mesh-ancestor
92842283|NCT00844857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842284|NCT00844857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842285|NCT00844857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92842286|NCT00844857|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92842287|NCT00844857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92842288|NCT00844857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842289|NCT00844857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842290|NCT00844857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92842291|NCT00844857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92842292|NCT00844857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842293|NCT00844857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842294|NCT00844857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842295|NCT00844857|Serotonin Agents|serotonin agents|mesh-ancestor
92842296|NCT00844857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92842297|NCT00844857|Antidepressive Agents|antidepressive agents|mesh-ancestor
92842298|NCT00844857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92842299|NCT00844857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92842300|NCT00844857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842301|NCT00702117|Flecainide|flecainide|mesh-list
92842302|NCT00702117|Procainamide|procainamide|mesh-list
92842303|NCT00702117|Ajmaline|ajmaline|mesh-list
92842304|NCT00702117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92842305|NCT00702117|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92842306|NCT00702117|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92842307|NCT00702117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842308|NCT00702117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842309|NCT00913107|Lamotrigine|lamotrigine|mesh-list
92842310|NCT00913107|Carbamazepine|carbamazepine|mesh-list
92842311|NCT00913107|Anticonvulsants|anticonvulsants|mesh-list
92842312|NCT00913107|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842313|NCT00913107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842314|NCT00913107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842315|NCT00913107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842316|NCT00913107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842317|NCT00913107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92842318|NCT00913107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92842319|NCT00913107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842320|NCT00913107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842321|NCT00913107|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92842322|NCT00913107|Antimanic Agents|antimanic agents|mesh-ancestor
92842323|NCT00913107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842324|NCT00913107|Analgesics|analgesics|mesh-ancestor
92842325|NCT00913107|Sensory System Agents|sensory system agents|mesh-ancestor
92842326|NCT00913107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842327|NCT00913107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92842328|NCT00913107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92842329|NCT00569803|Abatacept|abatacept|mesh-list
92842330|NCT00569803|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92842331|NCT00569803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842332|NCT00569803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842333|NCT00569803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842334|NCT00569803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842335|NCT00569803|Immunologic Factors|immunologic factors|mesh-ancestor
92842336|NCT00569803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842337|NCT00569803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92842338|NCT00920426|Cabotegravir|cabotegravir|mesh-list
92842339|NCT00920426|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92842340|NCT00920426|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92842341|NCT00920426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842342|NCT00920426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842343|NCT00920426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92842344|NCT00920426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92842345|NCT00920426|Antiviral Agents|antiviral agents|mesh-ancestor
92842346|NCT00920426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842347|NCT04046185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92842348|NCT04046185|Progesterone|progesterone|mesh-list
92842349|NCT04046185|Progestins|progestins|mesh-ancestor
92842350|NCT04046185|Hormones|hormones|mesh-ancestor
92842351|NCT04046185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842352|NCT04046185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842353|NCT04046185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842354|NCT04046185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842355|NCT04046185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842356|NCT00810589|Insulin|insulin|mesh-list
92842357|NCT00810589|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92842358|NCT00810589|Insulin Lispro|insulin lispro|mesh-list
92842359|NCT00810589|Insulin Detemir|insulin detemir|mesh-list
92842360|NCT00810589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92842361|NCT00810589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842362|NCT00810667|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92842363|NCT00810667|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92842364|NCT00810667|Serotonin Agents|serotonin agents|mesh-ancestor
92842365|NCT00810667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842366|NCT00810667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842367|NCT00810667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842368|NCT04253132|Tolfenamic acid|tolfenamic acid|mesh-list
92842369|NCT04253132|Analgesics|analgesics|mesh-ancestor
92842370|NCT04253132|Sensory System Agents|sensory system agents|mesh-ancestor
92842371|NCT04253132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842372|NCT04253132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842373|NCT04253132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92842374|NCT04253132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842375|NCT04253132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92842376|NCT04253132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92842377|NCT04253132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842378|NCT04253132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842379|NCT04253132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842380|NCT04253132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842381|NCT04253132|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
92842382|NCT04253132|Hormone Antagonists|hormone antagonists|mesh-ancestor
92842383|NCT04253132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842384|NCT04253132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92842385|NCT04253132|Serotonin Agents|serotonin agents|mesh-ancestor
92842386|NCT04253132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842387|NCT00914966|Complement C1s|complement c1s|mesh-list
92842388|NCT00914966|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92842389|NCT00914966|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92842390|NCT00914966|Immunologic Factors|immunologic factors|mesh-ancestor
92842391|NCT00914966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842392|NCT00914966|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92842393|NCT00914966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842394|NCT00815269|Sevoflurane|sevoflurane|mesh-list
92842395|NCT00815269|Desflurane|desflurane|mesh-list
92842396|NCT00815269|Isoflurane|isoflurane|mesh-list
92842397|NCT00815269|Halothane|halothane|mesh-list
92842398|NCT00815269|Enflurane|enflurane|mesh-list
92842399|NCT00815269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92842400|NCT00815269|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92842401|NCT00815269|Anesthetics, General|anesthetics, general|mesh-ancestor
92842402|NCT00815269|Anesthetics|anesthetics|mesh-ancestor
92842403|NCT00815269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842404|NCT00815269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842405|NCT00914810|Vitamin D|vitamin d|mesh-list
92842406|NCT00914810|Cholecalciferol|cholecalciferol|mesh-list
92842407|NCT00914810|Vitamins|vitamins|mesh-ancestor
92842408|NCT00914810|Micronutrients|micronutrients|mesh-ancestor
92842409|NCT00914810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842410|NCT00914810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92842411|NCT00914810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842412|NCT00808717|Atorvastatin|atorvastatin|mesh-list
92842413|NCT00808717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92842414|NCT00808717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92842415|NCT00808717|Antimetabolites|antimetabolites|mesh-ancestor
92842416|NCT00808717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842417|NCT00808717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92842418|NCT00808717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92842419|NCT00808717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842420|NCT00914732|Vaccines|vaccines|mesh-list
92842421|NCT00914732|Immunologic Factors|immunologic factors|mesh-ancestor
92842422|NCT00914732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842423|NCT00844545|Eculizumab|eculizumab|mesh-list
92842424|NCT00844545|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92842425|NCT00844545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842426|NCT00844545|Immunologic Factors|immunologic factors|mesh-ancestor
92842427|NCT00844545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842428|NCT00815503|Ropivacaine|ropivacaine|mesh-list
92842429|NCT00815503|Anesthetics, Local|anesthetics, local|mesh-ancestor
92842430|NCT00815503|Anesthetics|anesthetics|mesh-ancestor
92842431|NCT00815503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842432|NCT00815503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842433|NCT00815503|Sensory System Agents|sensory system agents|mesh-ancestor
92842434|NCT00815503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842435|NCT00702819|Bevacizumab|bevacizumab|mesh-list
92842436|NCT00702819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842437|NCT00702819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842438|NCT00702819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92842439|NCT00702819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92842440|NCT00702819|Growth Substances|growth substances|mesh-ancestor
92842441|NCT00702819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842442|NCT00702819|Growth Inhibitors|growth inhibitors|mesh-ancestor
92842443|NCT00650845|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92842444|NCT00650845|Chelating Agents|chelating agents|mesh-ancestor
92842445|NCT00650845|Sequestering Agents|sequestering agents|mesh-ancestor
92842446|NCT00650845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842447|NCT00842985|Dronabinol|dronabinol|mesh-list
92842448|NCT00842985|Modafinil|modafinil|mesh-list
92842449|NCT00842985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92842450|NCT00842985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842451|NCT00842985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92842452|NCT00842985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92842453|NCT00842985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92842454|NCT00842985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842455|NCT00842985|Hallucinogens|hallucinogens|mesh-ancestor
92842456|NCT00842985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842457|NCT00842985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842458|NCT00842985|Analgesics|analgesics|mesh-ancestor
92842459|NCT00842985|Sensory System Agents|sensory system agents|mesh-ancestor
92842460|NCT00842985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842461|NCT00842985|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92842462|NCT00842985|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92842463|NCT00842985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842464|NCT00842985|Hormones|hormones|mesh-ancestor
92842465|NCT00842985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842466|NCT00808795|Acetylcysteine|acetylcysteine|mesh-list
92842467|NCT00808795|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92842468|NCT00808795|Antiviral Agents|antiviral agents|mesh-ancestor
92842469|NCT00808795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842470|NCT00808795|Expectorants|expectorants|mesh-ancestor
92842471|NCT00808795|Respiratory System Agents|respiratory system agents|mesh-ancestor
92842472|NCT00808795|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92842473|NCT00808795|Antioxidants|antioxidants|mesh-ancestor
92842474|NCT00808795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842475|NCT00808795|Protective Agents|protective agents|mesh-ancestor
92842476|NCT00808795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842477|NCT00808795|Antidotes|antidotes|mesh-ancestor
92842478|NCT00808951|Artesunate|artesunate|mesh-list
92842479|NCT00808951|Lumefantrine|lumefantrine|mesh-list
92842480|NCT00808951|Artemether|artemether|mesh-list
92842481|NCT00808951|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92842482|NCT00808951|Amodiaquine|amodiaquine|mesh-list
92842483|NCT00808951|Antimalarials|antimalarials|mesh-ancestor
92842484|NCT00808951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92842485|NCT00808951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92842486|NCT00808951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487559|NCT05412589|Apatinib|apatinib|mesh-list
92842487|NCT00808951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842488|NCT00808951|Antiviral Agents|antiviral agents|mesh-ancestor
92842489|NCT00808951|Schistosomicides|schistosomicides|mesh-ancestor
92842490|NCT00808951|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92842491|NCT00808951|Anthelmintics|anthelmintics|mesh-ancestor
92842492|NCT00809029|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92842493|NCT00809029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92842494|NCT00809029|Incretins|incretins|mesh-ancestor
92842495|NCT00809029|Hormones|hormones|mesh-ancestor
92842496|NCT00809029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842497|NCT00809029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842498|NCT00842829|Fentanyl|fentanyl|mesh-list
92842499|NCT00842829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92842500|NCT00842829|Narcotics|narcotics|mesh-ancestor
92842501|NCT00842829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842502|NCT00842829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842503|NCT00842829|Analgesics|analgesics|mesh-ancestor
92842504|NCT00842829|Sensory System Agents|sensory system agents|mesh-ancestor
92842505|NCT00842829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842506|NCT00842829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92842507|NCT00842829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92842508|NCT00842829|Anesthetics, General|anesthetics, general|mesh-ancestor
92842509|NCT00842829|Anesthetics|anesthetics|mesh-ancestor
92842510|NCT04045093|Warfarin|warfarin|mesh-list
92842511|NCT04045093|Dabigatran|dabigatran|mesh-list
92842512|NCT04045093|Anticoagulants|anticoagulants|mesh-ancestor
92842513|NCT04045093|Antithrombins|antithrombins|mesh-ancestor
92842514|NCT04045093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92842515|NCT04045093|Protease Inhibitors|protease inhibitors|mesh-ancestor
92842516|NCT04045093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842517|NCT04045093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842518|NCT00811291|Calcium, Dietary|calcium, dietary|mesh-list
92842519|NCT00811291|Folic Acid|folic acid|mesh-list
92842520|NCT00811291|Calcium|calcium|mesh-list
92842521|NCT00811291|Vitamins|vitamins|mesh-ancestor
92842522|NCT00811291|Micronutrients|micronutrients|mesh-ancestor
92842523|NCT00811291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842524|NCT00811291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842525|NCT00811291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92842526|NCT00811291|Hematinics|hematinics|mesh-ancestor
92842527|NCT00811291|Vitamin B Complex|vitamin b complex|mesh-ancestor
92842528|NCT00811369|Fulvestrant|fulvestrant|mesh-list
92842529|NCT00811369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92842530|NCT00811369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842531|NCT00811369|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92842532|NCT00811369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92842533|NCT00811369|Hormone Antagonists|hormone antagonists|mesh-ancestor
92842534|NCT00811369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842535|NCT00811369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842536|NCT00842361|Insulin|insulin|mesh-list
92842537|NCT00842361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92842538|NCT00842361|Insulin Aspart|insulin aspart|mesh-list
92842539|NCT00842361|Insulin, Long-Acting|insulin, long-acting|mesh-list
92842540|NCT00842361|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92842541|NCT00842361|Biphasic Insulins|biphasic insulins|mesh-list
92842542|NCT00842361|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92842543|NCT00842361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92842544|NCT00842361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842545|NCT00811447|Docetaxel|docetaxel|mesh-list
92842546|NCT00811447|Fluorouracil|fluorouracil|mesh-list
92842547|NCT00811447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842548|NCT00811447|Tubulin Modulators|tubulin modulators|mesh-ancestor
92842549|NCT00811447|Antimitotic Agents|antimitotic agents|mesh-ancestor
92842550|NCT00811447|Mitosis Modulators|mitosis modulators|mesh-ancestor
92842551|NCT00811447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842552|NCT00811447|Antimetabolites|antimetabolites|mesh-ancestor
92842553|NCT00811447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92842554|NCT00811447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842555|NCT00811447|Immunologic Factors|immunologic factors|mesh-ancestor
92842556|NCT00811447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842557|NCT00702975|Paclitaxel|paclitaxel|mesh-list
92842558|NCT00702975|Bevacizumab|bevacizumab|mesh-list
92842559|NCT00702975|Carboplatin|carboplatin|mesh-list
92842560|NCT00702975|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92842561|NCT00702975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92842562|NCT00702975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487641|NCT05077800|Losartan|losartan|mesh-list
92842563|NCT00702975|Tubulin Modulators|tubulin modulators|mesh-ancestor
92842564|NCT00702975|Antimitotic Agents|antimitotic agents|mesh-ancestor
92842565|NCT00702975|Mitosis Modulators|mitosis modulators|mesh-ancestor
92842566|NCT00702975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842567|NCT00702975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842568|NCT00702975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92842569|NCT00702975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92842570|NCT00702975|Growth Substances|growth substances|mesh-ancestor
92842571|NCT00702975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842572|NCT00702975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92842574|NCT00702975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842575|NCT00809107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92842576|NCT00809107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92842577|NCT00809107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842578|NCT02612181|Dexmedetomidine|dexmedetomidine|mesh-list
92842579|NCT02612181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92842580|NCT02612181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842581|NCT02612181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842582|NCT02612181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842583|NCT02612181|Analgesics|analgesics|mesh-ancestor
92842584|NCT02612181|Sensory System Agents|sensory system agents|mesh-ancestor
92842585|NCT02612181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842586|NCT02612181|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92842587|NCT02612181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92842588|NCT02612181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92842589|NCT02612181|Adrenergic Agents|adrenergic agents|mesh-ancestor
92842590|NCT02612181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148943|NCT00838695|Nasal Decongestants|nasal decongestants|mesh-ancestor
92842591|NCT02612181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842592|NCT02612259|Tryptophan|tryptophan|mesh-list
92842593|NCT02612259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92842594|NCT02612259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92842595|NCT02612259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842596|NCT00841035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92842597|NCT00841035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842598|NCT00841035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842599|NCT00841035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842600|NCT00841035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842601|NCT00642811|Aspirin|aspirin|mesh-list
92842602|NCT00642811|Clopidogrel|clopidogrel|mesh-list
92842603|NCT00642811|Ticagrelor|ticagrelor|mesh-list
92842604|NCT00642811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92842605|NCT00642811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842606|NCT00642811|Analgesics|analgesics|mesh-ancestor
92842607|NCT00642811|Sensory System Agents|sensory system agents|mesh-ancestor
92842608|NCT00642811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842609|NCT00642811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842610|NCT00642811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92842611|NCT00642811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92842612|NCT00642811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92842613|NCT00642811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92842614|NCT00642811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842615|NCT00642811|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92842616|NCT00642811|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92842617|NCT00642811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842618|NCT00642811|Antipyretics|antipyretics|mesh-ancestor
92842619|NCT00642811|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92842620|NCT00642811|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92842621|NCT00642811|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92842622|NCT00642811|Purinergic Agents|purinergic agents|mesh-ancestor
92842623|NCT00642811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842624|NCT00838929|Vorinostat|vorinostat|mesh-list
92842625|NCT00838929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842626|NCT00838929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92842627|NCT00838929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842628|NCT00838929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842629|NCT00811603|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92842630|NCT00811603|Cefazolin|cefazolin|mesh-list
92842631|NCT00811603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842632|NCT00811681|Pioglitazone|pioglitazone|mesh-list
92842633|NCT00811681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92842634|NCT00811681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842635|NCT00811759|Temozolomide|temozolomide|mesh-list
92842636|NCT00811759|Sorafenib|sorafenib|mesh-list
92842637|NCT00811759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92487706|NCT04725864|Progesterone|progesterone|mesh-list
92842638|NCT00811759|Alkylating Agents|alkylating agents|mesh-ancestor
92842639|NCT00811759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842640|NCT00811759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842641|NCT00811759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842642|NCT00811759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842643|NCT00815893|Dexmedetomidine|dexmedetomidine|mesh-list
92842644|NCT00815893|Propofol|propofol|mesh-list
92842645|NCT00815893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92842646|NCT00815893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842647|NCT00815893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842648|NCT00815893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92842649|NCT00815893|Analgesics|analgesics|mesh-ancestor
92842650|NCT00815893|Sensory System Agents|sensory system agents|mesh-ancestor
92842651|NCT00815893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842652|NCT00815893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92842653|NCT00815893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92842654|NCT00815893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92842655|NCT00815893|Adrenergic Agents|adrenergic agents|mesh-ancestor
92842656|NCT00815893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842657|NCT00815893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842658|NCT00815893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92842659|NCT00815893|Anesthetics, General|anesthetics, general|mesh-ancestor
92842660|NCT00815893|Anesthetics|anesthetics|mesh-ancestor
92842661|NCT00816049|Mercaptopurine|mercaptopurine|mesh-list
92842662|NCT00816049|Antimetabolites|antimetabolites|mesh-ancestor
92842663|NCT00816049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842664|NCT00816049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92842665|NCT00816049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842666|NCT00816049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842667|NCT00816049|Immunologic Factors|immunologic factors|mesh-ancestor
92842668|NCT00816049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842669|NCT00816049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92842670|NCT00816049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842671|NCT04648891|Lidocaine|lidocaine|mesh-list
92842672|NCT04648891|Anesthetics, Local|anesthetics, local|mesh-ancestor
92842673|NCT04648891|Anesthetics|anesthetics|mesh-ancestor
92842674|NCT04648891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842675|NCT04648891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842676|NCT04648891|Sensory System Agents|sensory system agents|mesh-ancestor
92842677|NCT04648891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842678|NCT04648891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92842679|NCT04648891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92842680|NCT04648891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92842681|NCT04648891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842682|NCT04648891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842683|NCT04045015|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92842684|NCT04045015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92842685|NCT00811837|Midazolam|midazolam|mesh-list
92842686|NCT00811837|Remifentanil|remifentanil|mesh-list
92842687|NCT00811837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92842688|NCT00811837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92842689|NCT00811837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842690|NCT00811837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842691|NCT00811837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92842692|NCT00811837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92842693|NCT00811837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842694|NCT00811837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92842695|NCT00811837|Anesthetics, General|anesthetics, general|mesh-ancestor
92842696|NCT00811837|Anesthetics|anesthetics|mesh-ancestor
92842697|NCT00811837|GABA Modulators|gaba modulators|mesh-ancestor
92842698|NCT00811837|GABA Agents|gaba agents|mesh-ancestor
92842699|NCT00811837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842700|NCT00811837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842701|NCT00811837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92842702|NCT00811837|Narcotics|narcotics|mesh-ancestor
92842703|NCT00811837|Analgesics|analgesics|mesh-ancestor
92842704|NCT00811837|Sensory System Agents|sensory system agents|mesh-ancestor
92842705|NCT00811837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842706|NCT00811915|Sirolimus|sirolimus|mesh-list
92842707|NCT00811915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92842708|NCT00811915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842709|NCT00811915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92842710|NCT00811915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842711|NCT00811915|Antifungal Agents|antifungal agents|mesh-ancestor
92842712|NCT00811915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842713|NCT00811915|Immunologic Factors|immunologic factors|mesh-ancestor
92842714|NCT00811915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842715|NCT00816127|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92842716|NCT00816127|Hemostatics|hemostatics|mesh-ancestor
92842717|NCT00816127|Coagulants|coagulants|mesh-ancestor
92842718|NCT00816127|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92842719|NCT00816127|Natriuretic Agents|natriuretic agents|mesh-ancestor
92842720|NCT00816127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842721|NCT00916058|Melphalan|melphalan|mesh-list
92842722|NCT00916058|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92842723|NCT00916058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92842724|NCT00916058|Alkylating Agents|alkylating agents|mesh-ancestor
92842725|NCT00916058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842726|NCT00916058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842727|NCT00916058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92842728|NCT00916058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92842729|NCT00916058|Immunologic Factors|immunologic factors|mesh-ancestor
92842730|NCT00916058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842731|NCT04559906|Ethyl Chloride|ethyl chloride|mesh-list
92842732|NCT04559906|Anesthetics, Local|anesthetics, local|mesh-ancestor
92842733|NCT04559906|Anesthetics|anesthetics|mesh-ancestor
92842734|NCT04559906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842735|NCT04559906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842736|NCT04559906|Sensory System Agents|sensory system agents|mesh-ancestor
92842737|NCT04559906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842738|NCT00912782|Vitamin D|vitamin d|mesh-list
92842739|NCT00912782|Cholecalciferol|cholecalciferol|mesh-list
92842740|NCT00912782|Vitamins|vitamins|mesh-ancestor
92842741|NCT00912782|Micronutrients|micronutrients|mesh-ancestor
92842742|NCT00912782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842743|NCT00912782|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92842744|NCT00912782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842745|NCT04202978|Capecitabine|capecitabine|mesh-list
92842746|NCT04202978|Oxaliplatin|oxaliplatin|mesh-list
92842747|NCT04202978|Apatinib|apatinib|mesh-list
92842748|NCT04202978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92842749|NCT04202978|Antimetabolites|antimetabolites|mesh-ancestor
92842750|NCT04202978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842751|NCT04202978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842752|NCT04202978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842753|NCT04202978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842754|NCT04186442|Botulinum Toxins|botulinum toxins|mesh-list
92842755|NCT04186442|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92842756|NCT04186442|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92842757|NCT04186442|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92842758|NCT04186442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842759|NCT04186442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842760|NCT04186442|Cholinergic Agents|cholinergic agents|mesh-ancestor
92842761|NCT04186442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842762|NCT04186442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842763|NCT04186442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92842764|NCT04186442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842765|NCT04203368|Adenosine|adenosine|mesh-list
92842766|NCT04203368|Verapamil|verapamil|mesh-list
92842767|NCT04203368|Analgesics|analgesics|mesh-ancestor
92842768|NCT04203368|Sensory System Agents|sensory system agents|mesh-ancestor
92842769|NCT04203368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842770|NCT04203368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842771|NCT04203368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92842772|NCT04203368|Vasodilator Agents|vasodilator agents|mesh-ancestor
92842773|NCT04203368|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92842774|NCT04203368|Purinergic Agonists|purinergic agonists|mesh-ancestor
92842775|NCT04203368|Purinergic Agents|purinergic agents|mesh-ancestor
92842776|NCT04203368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842777|NCT04203368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842778|NCT04203368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842779|NCT04203368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842780|NCT04203368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842781|NCT04133948|Nivolumab|nivolumab|mesh-list
92842782|NCT04133948|Ipilimumab|ipilimumab|mesh-list
92744516|NCT02866435|Protective Agents|protective agents|mesh-ancestor
92842783|NCT04133948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842784|NCT04133948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842785|NCT04133948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92842786|NCT04133948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842787|NCT00911534|Rabeprazole|rabeprazole|mesh-list
92842788|NCT00911534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92842789|NCT00911534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92842790|NCT00911534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92842791|NCT00911534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842792|NCT00911534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842794|NCT00911300|Heparin|heparin|mesh-list
92842795|NCT00911300|Calcium heparin|calcium heparin|mesh-list
92842796|NCT00911300|PENTA|penta|mesh-list
92842797|NCT00911300|Fondaparinux|fondaparinux|mesh-list
92842798|NCT00911300|Vitamins|vitamins|mesh-ancestor
92842799|NCT00911300|Micronutrients|micronutrients|mesh-ancestor
92842800|NCT00911300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842801|NCT00911300|Anticoagulants|anticoagulants|mesh-ancestor
92842802|NCT00911300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92842803|NCT00911300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92842804|NCT00911300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842805|NCT00911300|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92842806|NCT00911300|Hemostatics|hemostatics|mesh-ancestor
92842807|NCT00911300|Coagulants|coagulants|mesh-ancestor
92842808|NCT00911300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92842809|NCT00911300|Antithrombins|antithrombins|mesh-ancestor
92842810|NCT00911300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92842811|NCT00911300|Protease Inhibitors|protease inhibitors|mesh-ancestor
92842812|NCT00911300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842813|NCT00911144|Vaccines|vaccines|mesh-list
92842814|NCT00911144|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92842815|NCT00911144|Immunologic Factors|immunologic factors|mesh-ancestor
92842816|NCT00911144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842817|NCT04395248|Anesthetics|anesthetics|mesh-list
92842818|NCT04395248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842819|NCT04395248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842820|NCT00632216|Risedronic Acid|risedronic acid|mesh-list
92842821|NCT00632216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842822|NCT00632216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842823|NCT00632216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842824|NCT00632216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842825|NCT00632216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842826|NCT00632216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92842827|NCT04276298|Metronidazole|metronidazole|mesh-list
92842828|NCT04276298|Lidocaine|lidocaine|mesh-list
92842829|NCT04276298|Diltiazem|diltiazem|mesh-list
92842830|NCT04276298|Anesthetics, Local|anesthetics, local|mesh-ancestor
92842831|NCT04276298|Anesthetics|anesthetics|mesh-ancestor
92842832|NCT04276298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842833|NCT04276298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744568|NCT02863861|Anesthetics|anesthetics|mesh-ancestor
92842834|NCT04276298|Sensory System Agents|sensory system agents|mesh-ancestor
92842835|NCT04276298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842836|NCT04276298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92842837|NCT04276298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92842838|NCT04276298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92842839|NCT04276298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842840|NCT04276298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842841|NCT04276298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842842|NCT04276298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92842843|NCT04276298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92842844|NCT04276298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92842845|NCT04276298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92842846|NCT04276298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842847|NCT04276298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842848|NCT04276298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92842849|NCT04273880|Ascorbic Acid|ascorbic acid|mesh-list
92842850|NCT04273880|Methylphenidate|methylphenidate|mesh-list
92842851|NCT04273880|Vitamins|vitamins|mesh-ancestor
92842852|NCT04273880|Micronutrients|micronutrients|mesh-ancestor
92842853|NCT04273880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842854|NCT04273880|Antioxidants|antioxidants|mesh-ancestor
92842855|NCT04273880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842856|NCT04273880|Protective Agents|protective agents|mesh-ancestor
92842857|NCT04273880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92842858|NCT04273880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92842859|NCT04273880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92842860|NCT04273880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842861|NCT04273880|Dopamine Agents|dopamine agents|mesh-ancestor
92842862|NCT04273880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842863|NCT00910988|Olanzapine|olanzapine|mesh-list
92842864|NCT00910988|Ziprasidone|ziprasidone|mesh-list
92842865|NCT00910988|Antiemetics|antiemetics|mesh-ancestor
92842866|NCT00910988|Autonomic Agents|autonomic agents|mesh-ancestor
92842867|NCT00910988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842868|NCT00910988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842869|NCT00910988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92842870|NCT00910988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92842871|NCT00910988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92842872|NCT00910988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92842873|NCT00910988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92842874|NCT00910988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92842875|NCT00910988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92842876|NCT00910988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842877|NCT00910988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842878|NCT00910988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842879|NCT00910988|Serotonin Agents|serotonin agents|mesh-ancestor
92842880|NCT00910988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92842881|NCT00910988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92842882|NCT00910988|Dopamine Agents|dopamine agents|mesh-ancestor
92842884|NCT00644059|Immunologic Factors|immunologic factors|mesh-ancestor
92842885|NCT00644059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842886|NCT00817687|Mycophenolic Acid|mycophenolic acid|mesh-list
92842887|NCT00817687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92842888|NCT00817687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842889|NCT00817687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92842890|NCT00817687|Antitubercular Agents|antitubercular agents|mesh-ancestor
92842891|NCT00817687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92842892|NCT00817687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842893|NCT00817687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842894|NCT00817687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842895|NCT00811993|Etoposide|etoposide|mesh-list
92842896|NCT00811993|Docetaxel|docetaxel|mesh-list
92842897|NCT00811993|Bevacizumab|bevacizumab|mesh-list
92842898|NCT00811993|Carboplatin|carboplatin|mesh-list
92842899|NCT00811993|Gemcitabine|gemcitabine|mesh-list
92842900|NCT00811993|Capecitabine|capecitabine|mesh-list
92842901|NCT00811993|Trastuzumab|trastuzumab|mesh-list
92842902|NCT00811993|Irinotecan|irinotecan|mesh-list
92842903|NCT00811993|Cetuximab|cetuximab|mesh-list
92842904|NCT00811993|Temozolomide|temozolomide|mesh-list
92842905|NCT00811993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92842906|NCT00811993|Sorafenib|sorafenib|mesh-list
92842907|NCT00811993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92842908|NCT00811993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842909|NCT00811993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92842910|NCT00811993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92842911|NCT00811993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92842912|NCT00811993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842913|NCT00811993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842914|NCT00811993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92842915|NCT00811993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92842916|NCT00811993|Growth Substances|growth substances|mesh-ancestor
92842917|NCT00811993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842918|NCT00811993|Growth Inhibitors|growth inhibitors|mesh-ancestor
92842919|NCT00811993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92842920|NCT00811993|Antimetabolites|antimetabolites|mesh-ancestor
92842921|NCT00811993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92842922|NCT00811993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92842923|NCT00811993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842924|NCT00811993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92842925|NCT00811993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92842926|NCT00811993|Alkylating Agents|alkylating agents|mesh-ancestor
92842927|NCT00811993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842928|NCT00817765|Ritonavir|ritonavir|mesh-list
92842929|NCT00817765|Fosamprenavir|fosamprenavir|mesh-list
92842930|NCT00817765|Posaconazole|posaconazole|mesh-list
92842931|NCT00817765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92842932|NCT00817765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92842933|NCT00817765|Protease Inhibitors|protease inhibitors|mesh-ancestor
92842934|NCT00817765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842935|NCT00817765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842936|NCT00817765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92842937|NCT00817765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92842938|NCT00817765|Antiviral Agents|antiviral agents|mesh-ancestor
92842939|NCT00817765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92842940|NCT00817765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92842941|NCT00817765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92842942|NCT00817765|Antifungal Agents|antifungal agents|mesh-ancestor
92188115|NCT04098250|Analgesics|analgesics|mesh-ancestor
92842943|NCT00817765|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92842944|NCT00817765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92842945|NCT00817765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92842946|NCT00817765|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92842947|NCT00817765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92842948|NCT00817765|Hormone Antagonists|hormone antagonists|mesh-ancestor
92842949|NCT00817765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92842950|NCT00817765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842952|NCT00816205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92842953|NCT00816205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842954|NCT00816205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842955|NCT00816205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92842956|NCT00816205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842957|NCT00816205|Vasodilator Agents|vasodilator agents|mesh-ancestor
92842958|NCT00816205|Tocolytic Agents|tocolytic agents|mesh-ancestor
92842959|NCT00816205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92842960|NCT00816283|Dasatinib|dasatinib|mesh-list
92842961|NCT00816283|Vorinostat|vorinostat|mesh-list
92842962|NCT00816283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842963|NCT00816283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92842964|NCT00816283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92842965|NCT00816283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842966|NCT00816283|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92842967|NCT00910910|Lenalidomide|lenalidomide|mesh-list
92842968|NCT00910910|Chlorambucil|chlorambucil|mesh-list
92842969|NCT00910910|Immunologic Factors|immunologic factors|mesh-ancestor
92842970|NCT00910910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842971|NCT00910910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92842972|NCT00910910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92842973|NCT00910910|Growth Substances|growth substances|mesh-ancestor
92842974|NCT00910910|Growth Inhibitors|growth inhibitors|mesh-ancestor
92842975|NCT00910910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842976|NCT00910910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92842977|NCT00910910|Alkylating Agents|alkylating agents|mesh-ancestor
92842978|NCT00910910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842979|NCT04522544|Durvalumab|durvalumab|mesh-list
92842980|NCT04522544|Tremelimumab|tremelimumab|mesh-list
92842981|NCT04522544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92842982|NCT04522544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92842983|NCT04384562|Methylphenidate|methylphenidate|mesh-list
92842984|NCT04384562|Reboxetine|reboxetine|mesh-list
92842985|NCT04384562|Nicotine|nicotine|mesh-list
92842986|NCT04384562|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92842987|NCT04384562|Autonomic Agents|autonomic agents|mesh-ancestor
92842988|NCT04384562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92842989|NCT04384562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92842990|NCT04384562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92842991|NCT04384562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92842992|NCT04384562|Cholinergic Agents|cholinergic agents|mesh-ancestor
92842993|NCT04384562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92842994|NCT04384562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92842995|NCT04384562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92842996|NCT04384562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92842997|NCT04384562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92842998|NCT04384562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92842999|NCT04384562|Dopamine Agents|dopamine agents|mesh-ancestor
92843000|NCT04384562|Antidepressive Agents|antidepressive agents|mesh-ancestor
92843001|NCT04384562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843002|NCT04384562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92843003|NCT04384562|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843004|NCT04515134|Ubiquinone|ubiquinone|mesh-list
92843005|NCT04515134|Coenzyme Q10|coenzyme q10|mesh-list
92843006|NCT04515134|Micronutrients|micronutrients|mesh-ancestor
92843007|NCT04515134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843008|NCT04515134|Vitamins|vitamins|mesh-ancestor
92843009|NCT04238390|Meropenem|meropenem|mesh-list
92843010|NCT04238390|Tazobactam|tazobactam|mesh-list
92843011|NCT04238390|Ceftolozane|ceftolozane|mesh-list
92843012|NCT04238390|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92843013|NCT04238390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92843014|NCT04238390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488088|NCT05413902|Anticonvulsants|anticonvulsants|mesh-ancestor
92843015|NCT04238390|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92843016|NCT04238390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843017|NCT04238390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843018|NCT04238390|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92843020|NCT04236830|Cariostatic Agents|cariostatic agents|mesh-ancestor
92843021|NCT04236830|Protective Agents|protective agents|mesh-ancestor
92843022|NCT04236830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843023|NCT04203212|Goserelin|goserelin|mesh-list
92843024|NCT04203212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92843025|NCT04203212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843026|NCT00637910|Docetaxel|docetaxel|mesh-list
92843027|NCT00637910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92843028|NCT00637910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843029|NCT00637910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92843030|NCT00637910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92843031|NCT00637910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92843032|NCT00637910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843033|NCT00637910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92843034|NCT00637910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843035|NCT03408236|Botulinum Toxins|botulinum toxins|mesh-list
92843036|NCT03408236|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92843037|NCT03408236|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92843038|NCT03408236|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92843039|NCT03408236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843040|NCT03408236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843041|NCT03408236|Cholinergic Agents|cholinergic agents|mesh-ancestor
92843042|NCT03408236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843043|NCT03408236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843044|NCT03408236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92843045|NCT03408236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843046|NCT04449536|Mesna|mesna|mesh-list
92843047|NCT04449536|Protective Agents|protective agents|mesh-ancestor
92843048|NCT04449536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843049|NCT03960554|Denosumab|denosumab|mesh-list
92843050|NCT03960554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92843051|NCT03960554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843052|NCT04084106|Amoxicillin|amoxicillin|mesh-list
92744759|NCT04294732|Bupivacaine|bupivacaine|mesh-list
92843053|NCT04084106|Clavulanic Acids|clavulanic acids|mesh-list
92843054|NCT04084106|Clavulanic Acid|clavulanic acid|mesh-list
92843055|NCT04084106|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92843056|NCT04084106|Penicillin V|penicillin v|mesh-list
92843057|NCT04084106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92843058|NCT04084106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843059|NCT04084106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843060|NCT04084106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843061|NCT04084106|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92843062|NCT02977052|Nivolumab|nivolumab|mesh-list
92843063|NCT02977052|Ipilimumab|ipilimumab|mesh-list
92843064|NCT02977052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92843065|NCT02977052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843066|NCT02977052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92843067|NCT02977052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843068|NCT02973542|Ethosuximide|ethosuximide|mesh-list
92843069|NCT02973542|Anticonvulsants|anticonvulsants|mesh-ancestor
92843070|NCT02973386|Cisplatin|cisplatin|mesh-list
92843071|NCT02973386|Capecitabine|capecitabine|mesh-list
92843072|NCT02973386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843073|NCT02973386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92843074|NCT02973386|Antimetabolites|antimetabolites|mesh-ancestor
92843075|NCT02973386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843076|NCT00909428|Solifenacin Succinate|solifenacin succinate|mesh-list
92843077|NCT00909428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92843078|NCT00909428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92843079|NCT00909428|Cholinergic Agents|cholinergic agents|mesh-ancestor
92843080|NCT00909428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843081|NCT00909428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843082|NCT00909428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843083|NCT00909428|Urological Agents|urological agents|mesh-ancestor
92843084|NCT03718130|Vaccines|vaccines|mesh-list
92843085|NCT03718130|Immunologic Factors|immunologic factors|mesh-ancestor
92843086|NCT03718130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843087|NCT00908960|Enoxaparin|enoxaparin|mesh-list
92843088|NCT00908960|Anticoagulants|anticoagulants|mesh-ancestor
92843089|NCT00908960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92843090|NCT00908960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92843091|NCT00908960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843093|NCT05332106|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92843094|NCT05332106|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92843096|NCT05332106|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92843097|NCT05332106|Nandrolone|nandrolone|mesh-list
92843098|NCT05332106|Estrogens|estrogens|mesh-ancestor
92843099|NCT05332106|Hormones|hormones|mesh-ancestor
92843100|NCT05332106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843101|NCT05332106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843102|NCT05332106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92843103|NCT05332106|Contraceptive Agents|contraceptive agents|mesh-ancestor
92843104|NCT05332106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92843105|NCT05332106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92843106|NCT05332106|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92843107|NCT05332106|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92843108|NCT05332106|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92843109|NCT05332106|Hormone Antagonists|hormone antagonists|mesh-ancestor
92843110|NCT05332106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92843111|NCT05332106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843112|NCT05332106|Androgens|androgens|mesh-ancestor
92843113|NCT05332106|Anabolic Agents|anabolic agents|mesh-ancestor
92843114|NCT05332028|Fentanyl|fentanyl|mesh-list
92843115|NCT05332028|Bupivacaine|bupivacaine|mesh-list
92843116|NCT05332028|Propofol|propofol|mesh-list
92843117|NCT05332028|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843118|NCT05332028|Anesthetics|anesthetics|mesh-ancestor
92843119|NCT05332028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843120|NCT05332028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843121|NCT05332028|Sensory System Agents|sensory system agents|mesh-ancestor
92843122|NCT05332028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843123|NCT05332028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92843124|NCT05332028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92843125|NCT05332028|Anesthetics, General|anesthetics, general|mesh-ancestor
92843126|NCT05332028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92843127|NCT05332028|Narcotics|narcotics|mesh-ancestor
92843128|NCT05332028|Analgesics|analgesics|mesh-ancestor
92843129|NCT05332028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92843130|NCT00816517|Botulinum Toxins|botulinum toxins|mesh-list
92843131|NCT00816517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92843132|NCT00816517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92843133|NCT00816517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92843134|NCT00816517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843135|NCT00816517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843136|NCT00816517|Cholinergic Agents|cholinergic agents|mesh-ancestor
92843137|NCT00816517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843138|NCT00816517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843139|NCT00816517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92843140|NCT00816517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843141|NCT00643201|Enoxaparin|enoxaparin|mesh-list
92843142|NCT00643201|Warfarin|warfarin|mesh-list
92843143|NCT00643201|Enoxaparin sodium|enoxaparin sodium|mesh-list
92843144|NCT00643201|Apixaban|apixaban|mesh-list
92843145|NCT00643201|Anticoagulants|anticoagulants|mesh-ancestor
92843146|NCT00643201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92843147|NCT00643201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92843148|NCT00643201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843149|NCT00643201|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92843150|NCT00643201|Antithrombins|antithrombins|mesh-ancestor
92843151|NCT00643201|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92843152|NCT00643201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92843153|NCT00643201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843154|NCT00643123|Allopurinol|allopurinol|mesh-list
92843155|NCT00643123|Antimetabolites|antimetabolites|mesh-ancestor
92843156|NCT00643123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843157|NCT00643123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843158|NCT00643123|Gout Suppressants|gout suppressants|mesh-ancestor
92843159|NCT00643123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92843160|NCT00643123|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92843161|NCT00643123|Antioxidants|antioxidants|mesh-ancestor
92843162|NCT00643123|Protective Agents|protective agents|mesh-ancestor
92843163|NCT00643123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843164|NCT00816673|Melatonin|melatonin|mesh-list
92843165|NCT00816673|Antioxidants|antioxidants|mesh-ancestor
92843166|NCT00816673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843167|NCT00816673|Protective Agents|protective agents|mesh-ancestor
92843168|NCT00816673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843169|NCT00816673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843170|NCT00818155|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92843171|NCT00818155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92843172|NCT00818155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92843173|NCT00818155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843174|NCT00818155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843175|NCT00818155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843176|NCT00818155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843177|NCT00818155|Antidepressive Agents|antidepressive agents|mesh-ancestor
92843178|NCT00818155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843179|NCT00641719|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92843180|NCT00641719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92843181|NCT00641719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92843182|NCT00641719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843183|NCT00641719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843184|NCT00641719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843185|NCT00641719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843186|NCT00641719|Analgesics|analgesics|mesh-ancestor
92843187|NCT00641719|Sensory System Agents|sensory system agents|mesh-ancestor
92843188|NCT00641719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843189|NCT00641719|Antidepressive Agents|antidepressive agents|mesh-ancestor
92843190|NCT00641719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843191|NCT00641719|Dopamine Agents|dopamine agents|mesh-ancestor
92843192|NCT02863367|Gemcitabine|gemcitabine|mesh-list
92843193|NCT02863367|Apatinib|apatinib|mesh-list
92843194|NCT02863367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92843195|NCT02863367|Antimetabolites|antimetabolites|mesh-ancestor
92843196|NCT02863367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843197|NCT02863367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843198|NCT02863367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92843199|NCT02863367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843200|NCT00648895|Metoprolol|metoprolol|mesh-list
92843201|NCT00648895|Nebivolol|nebivolol|mesh-list
92843202|NCT00648895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92843203|NCT00648895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92843204|NCT00648895|Sympatholytics|sympatholytics|mesh-ancestor
92843205|NCT00648895|Autonomic Agents|autonomic agents|mesh-ancestor
92843206|NCT00648895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843207|NCT00648895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843208|NCT00648895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92843209|NCT00648895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92843210|NCT00648895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92843211|NCT00648895|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843212|NCT00648895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843213|NCT00648895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843214|NCT00648895|Vasodilator Agents|vasodilator agents|mesh-ancestor
92843215|NCT00648895|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92843216|NCT00648895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92843217|NCT00648895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92843218|NCT00975221|Cinacalcet|cinacalcet|mesh-list
92843219|NCT00975221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92843220|NCT00975221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843221|NCT00975221|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92843222|NCT00975221|Hormone Antagonists|hormone antagonists|mesh-ancestor
92843223|NCT00975221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843224|NCT02863679|Tetracaine|tetracaine|mesh-list
92843225|NCT02863679|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843226|NCT02863679|Anesthetics|anesthetics|mesh-ancestor
92843227|NCT02863679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843228|NCT02863679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843229|NCT02863679|Sensory System Agents|sensory system agents|mesh-ancestor
92843230|NCT02863679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843231|NCT00906698|Vinorelbine|vinorelbine|mesh-list
92843232|NCT00906698|Afatinib|afatinib|mesh-list
92843233|NCT00906698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92843234|NCT00906698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843235|NCT00906698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92843236|NCT00906698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92843237|NCT00906698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92843238|NCT00906698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843239|NCT00906698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92843240|NCT00906698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843241|NCT00972023|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92843242|NCT00972023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92843243|NCT00972023|Immunologic Factors|immunologic factors|mesh-ancestor
92843244|NCT00972023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843245|NCT03396926|Bevacizumab|bevacizumab|mesh-list
92843246|NCT03396926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92843247|NCT03396926|Pembrolizumab|pembrolizumab|mesh-list
92843248|NCT03396926|Capecitabine|capecitabine|mesh-list
92843249|NCT03396926|Endothelial Growth Factors|endothelial growth factors|mesh-list
92843250|NCT03396926|Antibodies|antibodies|mesh-list
92843251|NCT03396926|Immunoglobulins|immunoglobulins|mesh-list
92843252|NCT03396926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92843253|NCT03396926|Immunoglobulin G|immunoglobulin g|mesh-list
92843254|NCT03396926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843255|NCT03396926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92843256|NCT03396926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92843257|NCT03396926|Growth Substances|growth substances|mesh-ancestor
92843258|NCT03396926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843259|NCT03396926|Growth Inhibitors|growth inhibitors|mesh-ancestor
92843260|NCT03396926|Immunologic Factors|immunologic factors|mesh-ancestor
92843261|NCT03396926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92843262|NCT03396926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843263|NCT03396926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92843264|NCT03396926|Antimetabolites|antimetabolites|mesh-ancestor
92843265|NCT00971945|Paclitaxel|paclitaxel|mesh-list
92843266|NCT00971945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92843267|NCT00971945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843268|NCT00971945|Tubulin Modulators|tubulin modulators|mesh-ancestor
92843269|NCT00971945|Antimitotic Agents|antimitotic agents|mesh-ancestor
92843270|NCT00971945|Mitosis Modulators|mitosis modulators|mesh-ancestor
92843271|NCT00971945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843272|NCT03672500|Epinephrine|epinephrine|mesh-list
92843273|NCT03672500|Bupivacaine|bupivacaine|mesh-list
92843274|NCT03672500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843275|NCT03672500|Anesthetics|anesthetics|mesh-ancestor
92843276|NCT03672500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843277|NCT03672500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843278|NCT03672500|Sensory System Agents|sensory system agents|mesh-ancestor
92843279|NCT03672500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843280|NCT03672500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92843281|NCT03672500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92843282|NCT03672500|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843283|NCT03672500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843284|NCT03672500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843285|NCT03672500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92843286|NCT03672500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92843287|NCT03672500|Autonomic Agents|autonomic agents|mesh-ancestor
92843288|NCT03672500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92843289|NCT03672500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92843290|NCT03672500|Mydriatics|mydriatics|mesh-ancestor
92843291|NCT03672500|Sympathomimetics|sympathomimetics|mesh-ancestor
92843292|NCT03672500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92843293|NCT00971867|Paclitaxel|paclitaxel|mesh-list
92843294|NCT00971867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92843295|NCT00971867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843296|NCT00971867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92843297|NCT00971867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92843298|NCT00971867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92843299|NCT00971867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843300|NCT00812851|Dronabinol|dronabinol|mesh-list
92843301|NCT00812851|Hallucinogens|hallucinogens|mesh-ancestor
92843302|NCT00812851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843303|NCT00812851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843304|NCT00812851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92843305|NCT00812851|Analgesics|analgesics|mesh-ancestor
92843306|NCT00812851|Sensory System Agents|sensory system agents|mesh-ancestor
92843307|NCT00812851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843308|NCT00812851|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92843309|NCT00812851|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92843310|NCT00812851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843311|NCT00812851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488419|NCT02900560|Cc-486|cc-486|mesh-list
92843312|NCT00812851|Hormones|hormones|mesh-ancestor
93046916|NCT00350636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843313|NCT00812851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843315|NCT00648037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92843316|NCT00648037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843317|NCT00648037|Immunologic Factors|immunologic factors|mesh-ancestor
92843318|NCT00648037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843319|NCT00648037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92843320|NCT00817375|Milnacipran|milnacipran|mesh-list
92843321|NCT00817375|Mirtazapine|mirtazapine|mesh-list
92843322|NCT00817375|Sertraline|sertraline|mesh-list
92843323|NCT00817375|Fluoxetine|fluoxetine|mesh-list
92843324|NCT00817375|Paroxetine|paroxetine|mesh-list
92843325|NCT00817375|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92843326|NCT00817375|Nortriptyline|nortriptyline|mesh-list
92843327|NCT00817375|Antidepressive Agents|antidepressive agents|mesh-ancestor
92843328|NCT00817375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843329|NCT00817375|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92843330|NCT00817375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92843331|NCT00817375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843332|NCT00817375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843333|NCT00817375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843334|NCT00817375|Serotonin Agents|serotonin agents|mesh-ancestor
92843335|NCT00817375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843336|NCT00817375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92843337|NCT00817375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92843338|NCT00817375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92843339|NCT00817375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843340|NCT00817375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92843341|NCT00817375|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92843342|NCT00817375|Histamine Antagonists|histamine antagonists|mesh-ancestor
92843343|NCT00817375|Histamine Agents|histamine agents|mesh-ancestor
92843344|NCT00817375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92843345|NCT00817375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92843346|NCT00817375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843347|NCT00817375|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92843348|NCT00817375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92843349|NCT00817375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92843350|NCT00817375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843351|NCT00817375|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92843352|NCT00817375|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92843353|NCT00817375|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92843354|NCT00817375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92843355|NCT00817375|Analgesics|analgesics|mesh-ancestor
92843356|NCT00817375|Sensory System Agents|sensory system agents|mesh-ancestor
92843357|NCT00817375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843358|NCT00817375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92843359|NCT00817375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92843360|NCT00818701|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92843361|NCT00818701|Sildenafil Citrate|sildenafil citrate|mesh-list
92843362|NCT00818701|Vasodilator Agents|vasodilator agents|mesh-ancestor
92843363|NCT00818701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92843364|NCT00818701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92843365|NCT00818701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843366|NCT00818701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843367|NCT00818701|Urological Agents|urological agents|mesh-ancestor
92843368|NCT00818701|Natriuretic Agents|natriuretic agents|mesh-ancestor
92843369|NCT00818701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843370|NCT00813241|Celecoxib|celecoxib|mesh-list
92843371|NCT00813241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92843372|NCT00813241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92843373|NCT00813241|Analgesics|analgesics|mesh-ancestor
92843374|NCT00813241|Sensory System Agents|sensory system agents|mesh-ancestor
92843375|NCT00813241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843376|NCT00813241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843377|NCT00813241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843378|NCT00813241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92843379|NCT00813241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92843380|NCT00813241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92843381|NCT00813241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843382|NCT00813241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843383|NCT00640393|Etanercept|etanercept|mesh-list
92843384|NCT00640393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92843385|NCT00640393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92843387|NCT00640393|Sensory System Agents|sensory system agents|mesh-ancestor
92843388|NCT00640393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843389|NCT00640393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843390|NCT00640393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843391|NCT00640393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92843392|NCT00640393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843393|NCT00640393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92843394|NCT00640393|Immunologic Factors|immunologic factors|mesh-ancestor
92843395|NCT00821353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92843396|NCT05315024|Imiquimod|imiquimod|mesh-list
92843397|NCT05315024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92843398|NCT05315024|Immunologic Factors|immunologic factors|mesh-ancestor
92843399|NCT05315024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843400|NCT05315024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843401|NCT05315024|Interferon Inducers|interferon inducers|mesh-ancestor
92843402|NCT00627445|Insulin|insulin|mesh-list
92843403|NCT00627445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92843404|NCT00627445|Metformin|metformin|mesh-list
92843405|NCT00627445|Insulin Aspart|insulin aspart|mesh-list
92843406|NCT00627445|Insulin, Long-Acting|insulin, long-acting|mesh-list
92843407|NCT00627445|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92843408|NCT00627445|Biphasic Insulins|biphasic insulins|mesh-list
92843409|NCT00627445|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92843410|NCT00627445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92843411|NCT00627445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843412|NCT02030990|Fluorometholone|fluorometholone|mesh-list
92843413|NCT02030990|Mitomycins|mitomycins|mesh-list
92843414|NCT02030990|Mitomycin|mitomycin|mesh-list
92843415|NCT02030990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92745121|NCT01306643|Idelalisib|idelalisib|mesh-list
92843416|NCT02030990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843417|NCT02030990|Alkylating Agents|alkylating agents|mesh-ancestor
92843418|NCT02030990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843419|NCT02030990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92843420|NCT02030990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843421|NCT02030990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843422|NCT02030990|Glucocorticoids|glucocorticoids|mesh-ancestor
92843423|NCT02030990|Hormones|hormones|mesh-ancestor
92843424|NCT02030990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843425|NCT02030990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843426|NCT02030990|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92843427|NCT00822055|Timolol|timolol|mesh-list
92843428|NCT00822055|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92843429|NCT00822055|Dorzolamide|dorzolamide|mesh-list
92843430|NCT00822055|Maleic acid|maleic acid|mesh-list
92843431|NCT00822055|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92843432|NCT00822055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843433|NCT00822055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843434|NCT00822055|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92843435|NCT00822055|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92843436|NCT00822055|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843437|NCT00822055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843438|NCT00822055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843439|NCT00822055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92843440|NCT00822055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92843441|NCT00822055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92843442|NCT00822055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92843443|NCT00822055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92843444|NCT00822055|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92843445|NCT00822133|Lidocaine|lidocaine|mesh-list
92843446|NCT00822133|Ketamine|ketamine|mesh-list
92843447|NCT00822133|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843448|NCT00822133|Anesthetics|anesthetics|mesh-ancestor
92843449|NCT00822133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843450|NCT00822133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843451|NCT00822133|Sensory System Agents|sensory system agents|mesh-ancestor
92843452|NCT00822133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843453|NCT00822133|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92843454|NCT00822133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92843455|NCT00822133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92843456|NCT00822133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843457|NCT00822133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843458|NCT00822133|Analgesics|analgesics|mesh-ancestor
93046917|NCT00350636|Urological Agents|urological agents|mesh-ancestor
92843459|NCT00822133|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92843461|NCT00822133|Anesthetics, General|anesthetics, general|mesh-ancestor
92843462|NCT00822133|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92843463|NCT00822133|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92843464|NCT00822133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843465|NCT00822211|Vildagliptin|vildagliptin|mesh-list
92843466|NCT00822211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92843467|NCT00822211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843468|NCT00822211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92843469|NCT00822211|Protease Inhibitors|protease inhibitors|mesh-ancestor
92843470|NCT00822211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843471|NCT00822211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843472|NCT04018417|Amphotericin B|amphotericin b|mesh-list
92843473|NCT04018417|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92843474|NCT04018417|Amebicides|amebicides|mesh-ancestor
92843475|NCT04018417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92843476|NCT04018417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92843477|NCT04018417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843478|NCT04018417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92843479|NCT04018417|Antifungal Agents|antifungal agents|mesh-ancestor
92843480|NCT01791920|Botulinum Toxins|botulinum toxins|mesh-list
92843481|NCT01791920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92843482|NCT01791920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92843483|NCT01791920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92843484|NCT01791920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843485|NCT01791920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843486|NCT01791920|Cholinergic Agents|cholinergic agents|mesh-ancestor
92843487|NCT01791920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843488|NCT01791920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843489|NCT01791920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92843490|NCT01791920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843491|NCT00826657|Vitamin B 12|vitamin b 12|mesh-list
92843492|NCT00826657|Hydroxocobalamin|hydroxocobalamin|mesh-list
92843493|NCT00826657|Vitamins|vitamins|mesh-ancestor
92843494|NCT00826657|Micronutrients|micronutrients|mesh-ancestor
92843495|NCT00826657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843496|NCT00826657|Vitamin B Complex|vitamin b complex|mesh-ancestor
92843497|NCT00826657|Hematinics|hematinics|mesh-ancestor
92843498|NCT02992964|Nivolumab|nivolumab|mesh-list
92843499|NCT02992964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92843500|NCT02992964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843501|NCT02992964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92843502|NCT02992964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843503|NCT03597776|Lidocaine|lidocaine|mesh-list
92843504|NCT03597776|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843505|NCT03597776|Anesthetics|anesthetics|mesh-ancestor
92843506|NCT03597776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843507|NCT03597776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843508|NCT03597776|Sensory System Agents|sensory system agents|mesh-ancestor
92843509|NCT03597776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843510|NCT03597776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92843511|NCT03597776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92843512|NCT03597776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92843513|NCT03597776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843514|NCT03597776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843515|NCT00625183|Selenium|selenium|mesh-list
92843516|NCT00625183|Capecitabine|capecitabine|mesh-list
92843517|NCT00625183|Oxaliplatin|oxaliplatin|mesh-list
92843518|NCT00625183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92843519|NCT00625183|Antimetabolites|antimetabolites|mesh-ancestor
92843520|NCT00625183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843521|NCT00625183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843522|NCT00625183|Antioxidants|antioxidants|mesh-ancestor
92843523|NCT00625183|Protective Agents|protective agents|mesh-ancestor
92843524|NCT00625183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843525|NCT00625183|Trace Elements|trace elements|mesh-ancestor
92843526|NCT00625183|Micronutrients|micronutrients|mesh-ancestor
92843527|NCT00826891|Topotecan|topotecan|mesh-list
92843528|NCT00826891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843529|NCT00826891|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92843530|NCT00826891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92843531|NCT00826891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488613|NCT01946555|Hydromorphone|hydromorphone|mesh-list
92433236|NCT01573377|Hormone Antagonists|hormone antagonists|mesh-ancestor
92843532|NCT00826891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843534|NCT00826969|Glucocorticoids|glucocorticoids|mesh-ancestor
92843535|NCT00826969|Hormones|hormones|mesh-ancestor
92843536|NCT00826969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843537|NCT00826969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843538|NCT00826969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92843539|NCT03560882|Atorvastatin|atorvastatin|mesh-list
92843540|NCT03560882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92843541|NCT03560882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92843542|NCT03560882|Antimetabolites|antimetabolites|mesh-ancestor
92843543|NCT03560882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843544|NCT03560882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92843545|NCT03560882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92843546|NCT03560882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843547|NCT04044547|Rotigotine|rotigotine|mesh-list
92843548|NCT04044547|Dopamine Agonists|dopamine agonists|mesh-ancestor
92843549|NCT04044547|Dopamine Agents|dopamine agents|mesh-ancestor
92843550|NCT04044547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843551|NCT04044547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843552|NCT04044547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843553|NCT02768948|Losartan|losartan|mesh-list
92843554|NCT02768948|Telmisartan|telmisartan|mesh-list
92843555|NCT02768948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92843556|NCT02768948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92745266|NCT01304147|Anesthetics, General|anesthetics, general|mesh-ancestor
92843557|NCT02768948|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92843558|NCT02768948|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92843559|NCT02768948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843560|NCT00640315|Riociguat|riociguat|mesh-list
92843561|NCT00640315|Enzyme Activators|enzyme activators|mesh-ancestor
92843562|NCT00640315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843563|NCT00904748|Sildenafil Citrate|sildenafil citrate|mesh-list
92843564|NCT00904748|Citric Acid|citric acid|mesh-list
92843565|NCT00904748|Sodium Citrate|sodium citrate|mesh-list
92843566|NCT00904748|Anticoagulants|anticoagulants|mesh-ancestor
92843567|NCT00904748|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92843568|NCT00904748|Chelating Agents|chelating agents|mesh-ancestor
92843569|NCT00904748|Sequestering Agents|sequestering agents|mesh-ancestor
92843570|NCT00904748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843571|NCT00904748|Vasodilator Agents|vasodilator agents|mesh-ancestor
92843572|NCT00904748|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92843573|NCT00904748|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92843574|NCT00904748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843575|NCT00904748|Urological Agents|urological agents|mesh-ancestor
92843576|NCT00574405|Insulin|insulin|mesh-list
92843577|NCT00574405|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92843578|NCT00574405|Insulin Lispro|insulin lispro|mesh-list
92843579|NCT00574405|Insulin Aspart|insulin aspart|mesh-list
92843580|NCT00574405|Insulin, Isophane|insulin, isophane|mesh-list
92843581|NCT00574405|Isophane Insulin, Human|isophane insulin, human|mesh-list
92843582|NCT00574405|Isophane insulin, beef|isophane insulin, beef|mesh-list
92843583|NCT00574405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92843584|NCT00574405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843585|NCT00971243|Metformin|metformin|mesh-list
92843586|NCT00971243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92843587|NCT00971243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843588|NCT00822913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92843589|NCT00822913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92843590|NCT00822913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92843591|NCT00822913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843592|NCT00822913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843593|NCT00822913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92843594|NCT00822913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843595|NCT00822913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843596|NCT00822913|Cholinergic Agents|cholinergic agents|mesh-ancestor
92843597|NCT00822913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843598|NCT04400383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92843599|NCT04400383|Antibodies|antibodies|mesh-list
92843600|NCT04400383|Immunoglobulins|immunoglobulins|mesh-list
92843601|NCT04400383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92843602|NCT04400383|Immunologic Factors|immunologic factors|mesh-ancestor
92843603|NCT04400383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843604|NCT04400383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843605|NCT04381429|Insulin Aspart|insulin aspart|mesh-list
92843606|NCT04381429|Insulin, Long-Acting|insulin, long-acting|mesh-list
92843607|NCT04381429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92843609|NCT04381429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843610|NCT00568555|Naltrexone|naltrexone|mesh-list
92843611|NCT00568555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92843612|NCT00568555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92843613|NCT00568555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843614|NCT00568555|Sensory System Agents|sensory system agents|mesh-ancestor
92843615|NCT00568555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843616|NCT00819325|Pioglitazone|pioglitazone|mesh-list
92843617|NCT00819325|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92843618|NCT00819325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843619|NCT00904670|Methylphenidate|methylphenidate|mesh-list
92843620|NCT00904670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92843621|NCT00904670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843622|NCT00904670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92843623|NCT00904670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92843624|NCT00904670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843625|NCT00904670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843626|NCT00904670|Dopamine Agents|dopamine agents|mesh-ancestor
92843627|NCT00904670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843628|NCT00827281|Cycloserine|cycloserine|mesh-list
92843629|NCT00827281|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92843630|NCT00827281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843631|NCT00827281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92843632|NCT00827281|Antitubercular Agents|antitubercular agents|mesh-ancestor
92843633|NCT00827281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92843634|NCT00827281|Antimetabolites|antimetabolites|mesh-ancestor
92843635|NCT00827281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843636|NCT00823381|Resveratrol|resveratrol|mesh-list
92843637|NCT00823381|Antioxidants|antioxidants|mesh-ancestor
92843638|NCT00823381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843639|NCT00823381|Protective Agents|protective agents|mesh-ancestor
92843640|NCT00823381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843641|NCT00823381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843642|NCT00823381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92843643|NCT00638443|Diphenhydramine|diphenhydramine|mesh-list
92843644|NCT00638443|Promethazine|promethazine|mesh-list
92843645|NCT00638443|Pregabalin|pregabalin|mesh-list
92843646|NCT00638443|Analgesics|analgesics|mesh-ancestor
92843647|NCT00638443|Sensory System Agents|sensory system agents|mesh-ancestor
92843648|NCT00638443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843649|NCT00638443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843650|NCT00638443|Anticonvulsants|anticonvulsants|mesh-ancestor
92843651|NCT00638443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92843652|NCT00638443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843653|NCT00638443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843654|NCT00638443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92843655|NCT00638443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92843656|NCT00638443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92843657|NCT00638443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843658|NCT00638443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843659|NCT00638443|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92843660|NCT00638443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92843661|NCT00638443|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843662|NCT00638443|Anesthetics|anesthetics|mesh-ancestor
92843663|NCT00638443|Antiemetics|antiemetics|mesh-ancestor
92843664|NCT00638443|Autonomic Agents|autonomic agents|mesh-ancestor
92843665|NCT00638443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843666|NCT00638443|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92843667|NCT00638443|Histamine Antagonists|histamine antagonists|mesh-ancestor
92843668|NCT00638443|Histamine Agents|histamine agents|mesh-ancestor
92843669|NCT00638443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843670|NCT00638443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92843671|NCT00638443|Antipruritics|antipruritics|mesh-ancestor
92843672|NCT00638443|Dermatologic Agents|dermatologic agents|mesh-ancestor
92843673|NCT00568399|Sodium thiosulfate|sodium thiosulfate|mesh-list
92843674|NCT00568399|Antidotes|antidotes|mesh-ancestor
92843675|NCT00568399|Protective Agents|protective agents|mesh-ancestor
92843676|NCT00568399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843677|NCT00568399|Antioxidants|antioxidants|mesh-ancestor
92843678|NCT00568399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843679|NCT00568399|Antitubercular Agents|antitubercular agents|mesh-ancestor
92843680|NCT00568399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92843681|NCT00568399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843682|NCT00568399|Chelating Agents|chelating agents|mesh-ancestor
92843683|NCT00568399|Sequestering Agents|sequestering agents|mesh-ancestor
92843684|NCT00975143|Isotretinoin|isotretinoin|mesh-list
92843685|NCT00975143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92843686|NCT04286087|Anesthetics|anesthetics|mesh-list
92843687|NCT04286087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843688|NCT04286087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843689|NCT04288349|Epinephrine|epinephrine|mesh-list
92843690|NCT04288349|Racepinephrine|racepinephrine|mesh-list
92843691|NCT04288349|Ropivacaine|ropivacaine|mesh-list
92843692|NCT04288349|Epinephryl borate|epinephryl borate|mesh-list
92843693|NCT04288349|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843694|NCT04288349|Anesthetics|anesthetics|mesh-ancestor
92843695|NCT04288349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843696|NCT04288349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843697|NCT04288349|Sensory System Agents|sensory system agents|mesh-ancestor
92843698|NCT04288349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843699|NCT04288349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92843700|NCT04288349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92843701|NCT04288349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843702|NCT04288349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843703|NCT04288349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843704|NCT04288349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92843705|NCT04288349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92843706|NCT04288349|Autonomic Agents|autonomic agents|mesh-ancestor
92843707|NCT04288349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92843708|NCT04288349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92843709|NCT04288349|Mydriatics|mydriatics|mesh-ancestor
92843710|NCT04288349|Sympathomimetics|sympathomimetics|mesh-ancestor
92843711|NCT04288349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92843712|NCT03667313|Sirolimus|sirolimus|mesh-list
92843713|NCT03667313|Paclitaxel|paclitaxel|mesh-list
92843714|NCT03667313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92843715|NCT03667313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843716|NCT03667313|Tubulin Modulators|tubulin modulators|mesh-ancestor
92843717|NCT03667313|Antimitotic Agents|antimitotic agents|mesh-ancestor
92843718|NCT03667313|Mitosis Modulators|mitosis modulators|mesh-ancestor
92843719|NCT03667313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843720|NCT03667313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92843721|NCT03667313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843722|NCT03667313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92843723|NCT03667313|Antifungal Agents|antifungal agents|mesh-ancestor
92843724|NCT03667313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92843725|NCT03667313|Immunologic Factors|immunologic factors|mesh-ancestor
92843726|NCT03667313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843727|NCT00974675|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92843728|NCT00974675|Immunologic Factors|immunologic factors|mesh-ancestor
92843729|NCT00974675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843730|NCT04925531|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92843731|NCT04925531|Ampicillin|ampicillin|mesh-list
92843732|NCT04925531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843733|NCT00634933|Prednisone|prednisone|mesh-list
92843734|NCT00634933|Methylprednisolone|methylprednisolone|mesh-list
92843735|NCT00634933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92843736|NCT00634933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92843737|NCT00634933|Prednisolone|prednisolone|mesh-list
92843738|NCT00634933|Prednisolone acetate|prednisolone acetate|mesh-list
92843739|NCT00634933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92843740|NCT00634933|Prednisolone phosphate|prednisolone phosphate|mesh-list
92843741|NCT00634933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843742|NCT00634933|Glucocorticoids|glucocorticoids|mesh-ancestor
92843743|NCT00634933|Hormones|hormones|mesh-ancestor
92843744|NCT00634933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843745|NCT00634933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843746|NCT00634933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92843747|NCT00634933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843748|NCT00634933|Antiemetics|antiemetics|mesh-ancestor
92843749|NCT00634933|Autonomic Agents|autonomic agents|mesh-ancestor
92843750|NCT00634933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843751|NCT00634933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843752|NCT00634933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92843753|NCT00634933|Protective Agents|protective agents|mesh-ancestor
92843754|NCT00967499|Ondansetron|ondansetron|mesh-list
92843755|NCT00967499|Palonosetron|palonosetron|mesh-list
92843756|NCT00967499|Antiemetics|antiemetics|mesh-ancestor
92843757|NCT00967499|Autonomic Agents|autonomic agents|mesh-ancestor
92843758|NCT00967499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843759|NCT00967499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843760|NCT00967499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843761|NCT00967499|Antipruritics|antipruritics|mesh-ancestor
92843762|NCT00967499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92843763|NCT00967499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92843764|NCT00967499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92843765|NCT00967499|Serotonin Agents|serotonin agents|mesh-ancestor
92843766|NCT00967499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843767|NCT00967499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843768|NCT04286399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92843769|NCT04286399|Angiotensin II|angiotensin ii|mesh-list
92843770|NCT04286399|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92843771|NCT04286399|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92843772|NCT04286399|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92843773|NCT04286399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92843774|NCT04286399|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843775|NCT04286399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745482|NCT05926804|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92843776|NCT04286399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843777|NCT04286399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843778|NCT04286399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92843779|NCT04286399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92843780|NCT04286399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92843781|NCT04286399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843782|NCT00629837|Factor VIII|factor viii|mesh-list
92843783|NCT00629837|Coagulants|coagulants|mesh-ancestor
92843784|NCT00827671|Cetuximab|cetuximab|mesh-list
92843785|NCT00827671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92843786|NCT00827671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843787|NCT03643133|Mifamurtide|mifamurtide|mesh-list
92843788|NCT03643133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92843789|NCT03643133|Immunologic Factors|immunologic factors|mesh-ancestor
92843790|NCT03643133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843791|NCT00823849|Cilostazol|cilostazol|mesh-list
92843792|NCT00823849|Probucol|probucol|mesh-list
92843793|NCT00823849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92843794|NCT00823849|Autonomic Agents|autonomic agents|mesh-ancestor
92843795|NCT00823849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843796|NCT00823849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843797|NCT00823849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92843798|NCT00823849|Respiratory System Agents|respiratory system agents|mesh-ancestor
92843799|NCT00823849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92843800|NCT00823849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92843801|NCT00823849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843802|NCT00823849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92843803|NCT00823849|Vasodilator Agents|vasodilator agents|mesh-ancestor
92843804|NCT00823849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92843805|NCT00823849|Protective Agents|protective agents|mesh-ancestor
92843806|NCT00823849|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92843807|NCT00823849|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92843808|NCT00823849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843809|NCT00823849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92843810|NCT00823849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92843811|NCT00823849|Antimetabolites|antimetabolites|mesh-ancestor
92843812|NCT00823849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92843813|NCT00823849|Antioxidants|antioxidants|mesh-ancestor
92843814|NCT02550067|Copper|copper|mesh-list
92843815|NCT02550067|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92843816|NCT02550067|Levonorgestrel|levonorgestrel|mesh-list
92843817|NCT02550067|Medroxyprogesterone|medroxyprogesterone|mesh-list
92843818|NCT02550067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92843819|NCT02550067|Contraceptive Agents|contraceptive agents|mesh-ancestor
92843820|NCT02550067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92843821|NCT02550067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843822|NCT02550067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92843823|NCT02550067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92843824|NCT02550067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92843825|NCT02550067|Trace Elements|trace elements|mesh-ancestor
92843826|NCT02550067|Micronutrients|micronutrients|mesh-ancestor
92843827|NCT02550067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92843828|NCT02550067|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92843829|NCT02550067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92843830|NCT02550067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843831|NCT02862509|Budesonide|budesonide|mesh-list
92843832|NCT02862509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843833|NCT02862509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92843834|NCT02862509|Autonomic Agents|autonomic agents|mesh-ancestor
92488914|NCT01948401|Prednisolone|prednisolone|mesh-list
92843835|NCT02862509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843836|NCT02862509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843837|NCT02862509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92843838|NCT02862509|Respiratory System Agents|respiratory system agents|mesh-ancestor
92843839|NCT02862509|Glucocorticoids|glucocorticoids|mesh-ancestor
92843840|NCT02862509|Hormones|hormones|mesh-ancestor
92843841|NCT02862509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843842|NCT04285775|Chrysarobin|chrysarobin|mesh-list
92843843|NCT04285775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92843844|NCT04285775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92843845|NCT04285775|Analgesics|analgesics|mesh-ancestor
92843846|NCT04285775|Sensory System Agents|sensory system agents|mesh-ancestor
92843847|NCT04285775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843848|NCT04285775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843849|NCT04285775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843850|NCT04285775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92843851|NCT00965081|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92843852|NCT00965081|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92843853|NCT00965081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92843854|NCT00965081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843855|NCT00965081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843856|NCT00965081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843857|NCT00965081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843858|NCT00965081|Analgesics|analgesics|mesh-ancestor
92843859|NCT00965081|Sensory System Agents|sensory system agents|mesh-ancestor
92843860|NCT00965081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843861|NCT00965081|Antidepressive Agents|antidepressive agents|mesh-ancestor
92843862|NCT00965081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92843863|NCT00965081|Dopamine Agents|dopamine agents|mesh-ancestor
92843864|NCT00961649|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92843865|NCT00961649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92843866|NCT00961649|Brinzolamide|brinzolamide|mesh-list
92843867|NCT00961649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92843868|NCT00961649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92843869|NCT00961649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92843870|NCT00961649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92843871|NCT00961649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92843872|NCT00961649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92843873|NCT00961649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843874|NCT00961649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843875|NCT00961649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843876|NCT00961649|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92843877|NCT00961649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843878|NCT04267601|Anagliptin|anagliptin|mesh-list
92843879|NCT04267601|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92843880|NCT04267601|Protease Inhibitors|protease inhibitors|mesh-ancestor
92843881|NCT04267601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843882|NCT04267601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843883|NCT04267601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92843884|NCT04267601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843885|NCT02861261|Promethazine|promethazine|mesh-list
92843886|NCT02861261|Diphenhydramine|diphenhydramine|mesh-list
92843887|NCT02861261|Antipruritics|antipruritics|mesh-ancestor
92843888|NCT02861261|Dermatologic Agents|dermatologic agents|mesh-ancestor
92843889|NCT02861261|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92843890|NCT02861261|Histamine Antagonists|histamine antagonists|mesh-ancestor
92843891|NCT02861261|Histamine Agents|histamine agents|mesh-ancestor
92843892|NCT02861261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843893|NCT02861261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843894|NCT02861261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843895|NCT02861261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92843896|NCT02861261|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92843897|NCT02861261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92843898|NCT02861261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843899|NCT02861261|Anesthetics, Local|anesthetics, local|mesh-ancestor
92843900|NCT02861261|Anesthetics|anesthetics|mesh-ancestor
92843901|NCT02861261|Sensory System Agents|sensory system agents|mesh-ancestor
92843902|NCT02861261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843903|NCT02861261|Antiemetics|antiemetics|mesh-ancestor
92843904|NCT02861261|Autonomic Agents|autonomic agents|mesh-ancestor
92843905|NCT02861261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843906|NCT04283435|Sildenafil Citrate|sildenafil citrate|mesh-list
92843907|NCT04283435|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92843908|NCT04283435|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92843909|NCT04283435|Estradiol|estradiol|mesh-list
92843910|NCT04283435|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92843911|NCT04283435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843912|NCT04283435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843913|NCT04283435|Estrogens|estrogens|mesh-ancestor
92843914|NCT04283435|Hormones|hormones|mesh-ancestor
92843915|NCT04283435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843916|NCT04283435|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92843917|NCT04283435|Contraceptive Agents|contraceptive agents|mesh-ancestor
92843918|NCT04283435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92843919|NCT04283435|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92843920|NCT04283435|Vasodilator Agents|vasodilator agents|mesh-ancestor
92843921|NCT04283435|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92843922|NCT04283435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92843923|NCT04283435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843924|NCT04283435|Urological Agents|urological agents|mesh-ancestor
92843925|NCT04284761|Bicalutamide|bicalutamide|mesh-list
92843926|NCT04284761|Androgen Antagonists|androgen antagonists|mesh-ancestor
92843927|NCT04284761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92843928|NCT04284761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843929|NCT04284761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843930|NCT04284761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843931|NCT00632125|Epoetin Alfa|epoetin alfa|mesh-list
92843932|NCT00632125|Hematinics|hematinics|mesh-ancestor
92843933|NCT00903968|Plerixafor|plerixafor|mesh-list
92843934|NCT00903968|Dexamethasone|dexamethasone|mesh-list
92843935|NCT00903968|Bortezomib|bortezomib|mesh-list
92843936|NCT00903968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92843937|NCT00903968|Antiemetics|antiemetics|mesh-ancestor
92843938|NCT00903968|Autonomic Agents|autonomic agents|mesh-ancestor
92843939|NCT00903968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843940|NCT00903968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843941|NCT00903968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843942|NCT00903968|Glucocorticoids|glucocorticoids|mesh-ancestor
92843943|NCT00903968|Hormones|hormones|mesh-ancestor
92843944|NCT00903968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92843945|NCT00903968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92843946|NCT00903968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843947|NCT00903968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92843948|NCT00903968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92843949|NCT00903968|Antiviral Agents|antiviral agents|mesh-ancestor
92843950|NCT00903968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92843951|NCT00632606|Magnesium Sulfate|magnesium sulfate|mesh-list
92843952|NCT00632606|Metoclopramide|metoclopramide|mesh-list
92843953|NCT00632606|Analgesics|analgesics|mesh-ancestor
92843954|NCT00632606|Sensory System Agents|sensory system agents|mesh-ancestor
92843955|NCT00632606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92843956|NCT00632606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843957|NCT00632606|Anesthetics|anesthetics|mesh-ancestor
92843958|NCT00632606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92843959|NCT00632606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92843960|NCT00632606|Anticonvulsants|anticonvulsants|mesh-ancestor
92843961|NCT00632606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92843962|NCT00632606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843963|NCT00632606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843964|NCT00632606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92843965|NCT00632606|Tocolytic Agents|tocolytic agents|mesh-ancestor
92843966|NCT00632606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92843967|NCT00632606|Antiemetics|antiemetics|mesh-ancestor
92843968|NCT00632606|Autonomic Agents|autonomic agents|mesh-ancestor
92843969|NCT00632606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92843970|NCT00632606|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92843971|NCT00632606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92843972|NCT00632606|Dopamine Agents|dopamine agents|mesh-ancestor
92843973|NCT00632606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92843974|NCT00903344|Vitamin D|vitamin d|mesh-list
92843975|NCT00903344|Cholecalciferol|cholecalciferol|mesh-list
92843976|NCT00903344|Vitamins|vitamins|mesh-ancestor
92843977|NCT00903344|Micronutrients|micronutrients|mesh-ancestor
92843978|NCT00903344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843979|NCT00903344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433237|NCT01573377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92843980|NCT00903344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92843981|NCT02847338|Amlodipine|amlodipine|mesh-list
92843982|NCT02847338|Lisinopril|lisinopril|mesh-list
92843983|NCT02847338|Chlorthalidone|chlorthalidone|mesh-list
92843984|NCT02847338|Amiloride|amiloride|mesh-list
92843985|NCT02847338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92843986|NCT02847338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92843987|NCT02847338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92843988|NCT02847338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92843989|NCT02847338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92843990|NCT02847338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92843991|NCT02847338|Vasodilator Agents|vasodilator agents|mesh-ancestor
92843992|NCT02847338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92843993|NCT02847338|Protease Inhibitors|protease inhibitors|mesh-ancestor
92843994|NCT02847338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92843995|NCT02847338|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92843996|NCT02847338|Protective Agents|protective agents|mesh-ancestor
92843997|NCT02847338|Diuretics|diuretics|mesh-ancestor
92843998|NCT02847338|Natriuretic Agents|natriuretic agents|mesh-ancestor
92843999|NCT02847338|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92844000|NCT02847338|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92844001|NCT02847338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92844002|NCT02847338|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92844003|NCT02847338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92844004|NCT02847104|Insulin|insulin|mesh-list
92844005|NCT02847104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92844006|NCT02847104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844007|NCT02847104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844008|NCT02849366|Immunomodulating Agents|immunomodulating agents|mesh-list
92844009|NCT02849366|Immunologic Factors|immunologic factors|mesh-ancestor
92844010|NCT02849366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844011|NCT02849132|Entecavir|entecavir|mesh-list
92844012|NCT02849132|Antiviral Agents|antiviral agents|mesh-ancestor
92844013|NCT02849132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844014|NCT05116826|Nitazoxanide|nitazoxanide|mesh-list
92844015|NCT05116826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92844016|NCT05116826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844017|NCT02848508|Metformin|metformin|mesh-list
92844018|NCT02848508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844019|NCT02848508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844020|NCT00902564|Escitalopram|escitalopram|mesh-list
92844021|NCT00902564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92844022|NCT00902564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92844023|NCT00902564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844024|NCT00902564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844025|NCT00902564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844026|NCT00902564|Serotonin Agents|serotonin agents|mesh-ancestor
92844027|NCT00902564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844028|NCT00626197|Mycophenolic Acid|mycophenolic acid|mesh-list
92844029|NCT00626197|Cyclophosphamide|cyclophosphamide|mesh-list
92844030|NCT00626197|Azathioprine|azathioprine|mesh-list
92844031|NCT00626197|Ocrelizumab|ocrelizumab|mesh-list
92844032|NCT00626197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92844033|NCT00626197|Immunologic Factors|immunologic factors|mesh-ancestor
92844034|NCT00626197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844035|NCT00626197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844036|NCT00626197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92844037|NCT00626197|Alkylating Agents|alkylating agents|mesh-ancestor
92844038|NCT00626197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844039|NCT00626197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844040|NCT00626197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92844041|NCT00626197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92844042|NCT00626197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92844043|NCT00626197|Antitubercular Agents|antitubercular agents|mesh-ancestor
92844044|NCT00626197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844045|NCT00626197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844046|NCT00626197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844047|NCT00626197|Antimetabolites|antimetabolites|mesh-ancestor
92844048|NCT00626197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92844049|NCT00626275|Naproxen|naproxen|mesh-list
92844050|NCT00626275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92844051|NCT00626275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844052|NCT00626275|Analgesics|analgesics|mesh-ancestor
92844053|NCT00626275|Sensory System Agents|sensory system agents|mesh-ancestor
92745765|NCT05601492|Thalidomide|thalidomide|mesh-list
92844054|NCT00626275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844055|NCT00626275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844056|NCT00626275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844057|NCT00626275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844058|NCT00626275|Gout Suppressants|gout suppressants|mesh-ancestor
92844059|NCT00626275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92844060|NCT00626275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844061|NCT00626275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844062|NCT02847884|Infliximab|infliximab|mesh-list
92844063|NCT02847884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92844064|NCT02847884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844065|NCT02847884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92844066|NCT02847884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844067|NCT02847884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844068|NCT00623935|Fludarabine|fludarabine|mesh-list
92844069|NCT00623935|Busulfan|busulfan|mesh-list
92844070|NCT00623935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844071|NCT00623935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844072|NCT00623935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92844073|NCT00623935|Immunologic Factors|immunologic factors|mesh-ancestor
92844074|NCT00623935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844075|NCT00623935|Alkylating Agents|alkylating agents|mesh-ancestor
92844076|NCT00623935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92844077|NCT00623935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92844078|NCT00623779|Aspirin|aspirin|mesh-list
92844079|NCT00623779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92844080|NCT00623779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844081|NCT00623779|Analgesics|analgesics|mesh-ancestor
92844082|NCT00623779|Sensory System Agents|sensory system agents|mesh-ancestor
92844083|NCT00623779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844084|NCT00623779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844085|NCT00623779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844086|NCT00623779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844087|NCT00623779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92844088|NCT00623779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844089|NCT00623779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844090|NCT00623779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92844091|NCT00623779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92844092|NCT00623779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844093|NCT00623779|Antipyretics|antipyretics|mesh-ancestor
92844094|NCT00828373|Lidocaine|lidocaine|mesh-list
92844095|NCT00828373|Anesthetics, Local|anesthetics, local|mesh-ancestor
92844096|NCT00828373|Anesthetics|anesthetics|mesh-ancestor
92844097|NCT00828373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844098|NCT00828373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844099|NCT00828373|Sensory System Agents|sensory system agents|mesh-ancestor
92844100|NCT00828373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844101|NCT00828373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92844102|NCT00828373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92844103|NCT00828373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92844104|NCT00828373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844105|NCT00828373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844106|NCT00824239|Fentanyl|fentanyl|mesh-list
92844107|NCT00824239|Midazolam|midazolam|mesh-list
92844108|NCT00824239|Propofol|propofol|mesh-list
92844109|NCT00824239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92844110|NCT00824239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844111|NCT00824239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844112|NCT00824239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92844113|NCT00824239|Anesthetics, General|anesthetics, general|mesh-ancestor
92844114|NCT00824239|Anesthetics|anesthetics|mesh-ancestor
92844115|NCT00824239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92844116|NCT00824239|Narcotics|narcotics|mesh-ancestor
92844117|NCT00824239|Analgesics|analgesics|mesh-ancestor
92844118|NCT00824239|Sensory System Agents|sensory system agents|mesh-ancestor
92844119|NCT00824239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844120|NCT00824239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92844121|NCT00824239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92844122|NCT00824239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92844123|NCT00824239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92844124|NCT00824239|GABA Modulators|gaba modulators|mesh-ancestor
92844125|NCT00824239|GABA Agents|gaba agents|mesh-ancestor
92844126|NCT00824239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844127|NCT00824239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844128|NCT04777760|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92844129|NCT04777760|Respiratory System Agents|respiratory system agents|mesh-ancestor
92844130|NCT02548975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92844131|NCT02548975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92844132|NCT02548975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92844133|NCT02548975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92844134|NCT02548975|Antimetabolites|antimetabolites|mesh-ancestor
93046918|NCT00350636|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92844135|NCT02548975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844136|NCT02548975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844137|NCT02548975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92844138|NCT02548975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92844139|NCT02548975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92844140|NCT02548975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844141|NCT02548975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844142|NCT04044703|Vancomycin|vancomycin|mesh-list
92844143|NCT04044703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844144|NCT04044703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844145|NCT02848040|Bile Acids and Salts|bile acids and salts|mesh-list
92844146|NCT02848040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844147|NCT00824317|Methylphenidate|methylphenidate|mesh-list
92844148|NCT00824317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92844149|NCT00824317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844150|NCT00824317|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92844151|NCT00824317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92844152|NCT00824317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844153|NCT00824317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844154|NCT00824317|Dopamine Agents|dopamine agents|mesh-ancestor
92844155|NCT00824317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844156|NCT02847806|Insulin|insulin|mesh-list
92844157|NCT02847806|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92844158|NCT02847806|Estradiol|estradiol|mesh-list
92844159|NCT02847806|Testosterone|testosterone|mesh-list
92844160|NCT02847806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844161|NCT02847806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844162|NCT02847806|Estrogens|estrogens|mesh-ancestor
92844163|NCT02847806|Hormones|hormones|mesh-ancestor
92844164|NCT02847806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844165|NCT02847806|Androgens|androgens|mesh-ancestor
92844166|NCT00828529|Bedaquiline|bedaquiline|mesh-list
92844167|NCT00828529|Antitubercular Agents|antitubercular agents|mesh-ancestor
92844168|NCT00828529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844169|NCT00828529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844170|NCT00632762|Amantadine|amantadine|mesh-list
92844171|NCT00632762|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92844172|NCT00632762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92844173|NCT00632762|Antiviral Agents|antiviral agents|mesh-ancestor
92844174|NCT00632762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844175|NCT00632762|Dopamine Agents|dopamine agents|mesh-ancestor
92844176|NCT00632762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844177|NCT00632762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844178|NCT00632762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844179|NCT00632762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844180|NCT00632762|Analgesics|analgesics|mesh-ancestor
92844181|NCT00632762|Sensory System Agents|sensory system agents|mesh-ancestor
92844182|NCT00632762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844183|NCT01351766|Nicotine|nicotine|mesh-list
92844184|NCT01351766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92844185|NCT01351766|Autonomic Agents|autonomic agents|mesh-ancestor
92844186|NCT01351766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844187|NCT01351766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844188|NCT01351766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92844189|NCT01351766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92844190|NCT01351766|Cholinergic Agents|cholinergic agents|mesh-ancestor
92844191|NCT01351766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844192|NCT01351766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844193|NCT02846090|Dexmedetomidine|dexmedetomidine|mesh-list
92844194|NCT02846090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92844195|NCT02846090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844196|NCT02846090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844197|NCT02846090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844198|NCT02846090|Analgesics|analgesics|mesh-ancestor
92844199|NCT02846090|Sensory System Agents|sensory system agents|mesh-ancestor
92844200|NCT02846090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844201|NCT02846090|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92844202|NCT02846090|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92844203|NCT02846090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92844204|NCT02846090|Adrenergic Agents|adrenergic agents|mesh-ancestor
92844205|NCT02846090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844206|NCT02846090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844207|NCT00828763|Dolutegravir|dolutegravir|mesh-list
92844208|NCT00828763|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92844209|NCT00828763|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92844210|NCT00828763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844211|NCT00828763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844212|NCT00828763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92844213|NCT00828763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92844214|NCT00828763|Antiviral Agents|antiviral agents|mesh-ancestor
92844215|NCT00828763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844216|NCT00824707|Entecavir|entecavir|mesh-list
92844217|NCT00824707|Antiviral Agents|antiviral agents|mesh-ancestor
92844218|NCT00824707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844219|NCT00824785|Capecitabine|capecitabine|mesh-list
92844220|NCT00824785|Oxaliplatin|oxaliplatin|mesh-list
92844221|NCT00824785|Epirubicin|epirubicin|mesh-list
92844222|NCT00824785|Panitumumab|panitumumab|mesh-list
92844223|NCT00824785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92844224|NCT00824785|Antimetabolites|antimetabolites|mesh-ancestor
92844225|NCT00824785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844226|NCT00824785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844227|NCT00824785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92844228|NCT00824785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92844229|NCT00824785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92844230|NCT00824785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844231|NCT00824785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844232|NCT00824863|Ketoconazole|ketoconazole|mesh-list
92844233|NCT00824863|Antifungal Agents|antifungal agents|mesh-ancestor
92844234|NCT00824863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844235|NCT00824863|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92844236|NCT00824863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92844237|NCT00824863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844238|NCT00824863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844239|NCT00824863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92844240|NCT00824863|Hormone Antagonists|hormone antagonists|mesh-ancestor
92844241|NCT00824863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844242|NCT00824863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844243|NCT00824863|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92844244|NCT02844530|Epratuzumab|epratuzumab|mesh-list
92844245|NCT02844530|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92844246|NCT02844530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844247|NCT02844530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844248|NCT02844530|Chelating Agents|chelating agents|mesh-ancestor
92844249|NCT02844530|Sequestering Agents|sequestering agents|mesh-ancestor
92844250|NCT02844530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844251|NCT00820417|Cetuximab|cetuximab|mesh-list
92844252|NCT00820417|Gefitinib|gefitinib|mesh-list
92844253|NCT00820417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844254|NCT00820417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844255|NCT00820417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844256|NCT00820417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844257|NCT00820417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844258|NCT04923620|Cetuximab|cetuximab|mesh-list
92844259|NCT04923620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844260|NCT04923620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844261|NCT00828919|Axitinib|axitinib|mesh-list
92844262|NCT00828919|Crizotinib|crizotinib|mesh-list
92844263|NCT00828919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844264|NCT00828919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844265|NCT00828919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844266|NCT00828919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844267|NCT00828997|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92844268|NCT00828997|Immunologic Factors|immunologic factors|mesh-ancestor
92844269|NCT00828997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844270|NCT02548741|Metformin|metformin|mesh-list
92844271|NCT02548741|Calcium Carbonate|calcium carbonate|mesh-list
92844272|NCT02548741|Calcium|calcium|mesh-list
92844273|NCT02548741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844274|NCT02548741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844275|NCT02548741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92844276|NCT02548741|Antacids|antacids|mesh-ancestor
92844277|NCT02548741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844278|NCT02548741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844279|NCT02845856|Cetuximab|cetuximab|mesh-list
92844280|NCT02845856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844281|NCT02845856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844282|NCT00825019|Paroxetine|paroxetine|mesh-list
92844283|NCT00825019|Amibegron|amibegron|mesh-list
92844284|NCT00825019|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92844285|NCT00825019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92844286|NCT00825019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92844287|NCT00825019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844288|NCT00825019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844289|NCT00825019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844290|NCT00825019|Serotonin Agents|serotonin agents|mesh-ancestor
92844291|NCT00825019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844292|NCT00825019|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92844293|NCT00825019|Antidepressive Agents|antidepressive agents|mesh-ancestor
92844294|NCT00825019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92844295|NCT00825019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92844296|NCT00825019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92844297|NCT00825019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844298|NCT00825019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92844299|NCT00825019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92844300|NCT00825019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92844301|NCT00825019|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92844302|NCT00929006|Progesterone|progesterone|mesh-list
92844303|NCT00929006|Progestins|progestins|mesh-ancestor
92844304|NCT00929006|Hormones|hormones|mesh-ancestor
92844305|NCT00929006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844306|NCT00929006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844307|NCT00877214|Rituximab|rituximab|mesh-list
92844308|NCT00877214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844309|NCT00877214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844310|NCT00877214|Immunologic Factors|immunologic factors|mesh-ancestor
92844311|NCT00877214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844312|NCT00877214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844313|NCT00474032|Botulinum Toxins|botulinum toxins|mesh-list
92844314|NCT00474032|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92844315|NCT00474032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844316|NCT00474032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844317|NCT00474032|Cholinergic Agents|cholinergic agents|mesh-ancestor
92844318|NCT00474032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844319|NCT00474032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844320|NCT05242718|Palmidrol|palmidrol|mesh-list
92844321|NCT05242718|Acetylcysteine|acetylcysteine|mesh-list
92844322|NCT05242718|Curcumin|curcumin|mesh-list
92844323|NCT05242718|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92844324|NCT05242718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92844325|NCT05242718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844326|NCT05242718|Analgesics|analgesics|mesh-ancestor
92844327|NCT05242718|Sensory System Agents|sensory system agents|mesh-ancestor
92844328|NCT05242718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844329|NCT05242718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844330|NCT05242718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844331|NCT05242718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844332|NCT05242718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844333|NCT05242718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844334|NCT05242718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844335|NCT05242718|Antiviral Agents|antiviral agents|mesh-ancestor
92844336|NCT05242718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844337|NCT05242718|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92844338|NCT05242718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92844339|NCT05242718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844340|NCT05242718|Hormones|hormones|mesh-ancestor
92844341|NCT05242718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844342|NCT05242718|Expectorants|expectorants|mesh-ancestor
92844343|NCT05242718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92844344|NCT05242718|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92844345|NCT05242718|Antioxidants|antioxidants|mesh-ancestor
92844346|NCT05242718|Protective Agents|protective agents|mesh-ancestor
92844347|NCT05242718|Antidotes|antidotes|mesh-ancestor
92844348|NCT00045968|Immunomodulating Agents|immunomodulating agents|mesh-list
92844349|NCT00045968|Immunologic Factors|immunologic factors|mesh-ancestor
92844350|NCT00045968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844351|NCT02845778|Melatonin|melatonin|mesh-list
92844352|NCT02845778|Antioxidants|antioxidants|mesh-ancestor
92844353|NCT02845778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844354|NCT02845778|Protective Agents|protective agents|mesh-ancestor
92844355|NCT02845778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844356|NCT02845778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844357|NCT05241938|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92844358|NCT05241938|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92844359|NCT05337332|Triamcinolone|triamcinolone|mesh-list
92844360|NCT05337332|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92844361|NCT05337332|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92844362|NCT05337332|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92844363|NCT05337332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844364|NCT05337332|Glucocorticoids|glucocorticoids|mesh-ancestor
92844365|NCT05337332|Hormones|hormones|mesh-ancestor
92844366|NCT05337332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844367|NCT05337332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844368|NCT05337332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92844369|NCT05337332|Immunologic Factors|immunologic factors|mesh-ancestor
92844370|NCT05337332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844371|NCT05337332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844372|NCT00901394|Folic Acid|folic acid|mesh-list
92844373|NCT00901394|Nitrous Oxide|nitrous oxide|mesh-list
92844374|NCT00901394|Hematinics|hematinics|mesh-ancestor
92844375|NCT00901394|Vitamin B Complex|vitamin b complex|mesh-ancestor
92844376|NCT00901394|Vitamins|vitamins|mesh-ancestor
92844377|NCT00901394|Micronutrients|micronutrients|mesh-ancestor
92844378|NCT00901394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844379|NCT00901394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92844380|NCT00901394|Anesthetics, General|anesthetics, general|mesh-ancestor
92844381|NCT00901394|Anesthetics|anesthetics|mesh-ancestor
92844382|NCT00901394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844383|NCT00901394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844384|NCT00901394|Analgesics|analgesics|mesh-ancestor
92844385|NCT00901394|Sensory System Agents|sensory system agents|mesh-ancestor
92844386|NCT00901394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844387|NCT05337254|Dihydroergotamine|dihydroergotamine|mesh-list
92844388|NCT05337254|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92844389|NCT05337254|Dopamine Agonists|dopamine agonists|mesh-ancestor
92844390|NCT05337254|Dopamine Agents|dopamine agents|mesh-ancestor
92844391|NCT05337254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844392|NCT05337254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844393|NCT05337254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844394|NCT05337254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844395|NCT05337254|Analgesics|analgesics|mesh-ancestor
92844396|NCT05337254|Sensory System Agents|sensory system agents|mesh-ancestor
92844397|NCT05337254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844398|NCT00896532|Zoledronic Acid|zoledronic acid|mesh-list
92844399|NCT00896532|Denosumab|denosumab|mesh-list
92844400|NCT00896532|Alendronate|alendronate|mesh-list
92844401|NCT00896532|Teriparatide|teriparatide|mesh-list
92844402|NCT00896532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92844403|NCT00896532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92746119|NCT05038982|Abrocitinib|abrocitinib|mesh-list
92844404|NCT00896532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844405|NCT00896532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92844406|NCT00896532|Immunologic Factors|immunologic factors|mesh-ancestor
92844407|NCT00574873|Imatinib Mesylate|imatinib mesylate|mesh-list
92844408|NCT00574873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844409|NCT00574873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844410|NCT00574873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844411|NCT00574873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844412|NCT02843490|Ranibizumab|ranibizumab|mesh-list
92844413|NCT02843490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92844414|NCT02843490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92844415|NCT02843490|Growth Substances|growth substances|mesh-ancestor
92844416|NCT02843490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844417|NCT02843490|Growth Inhibitors|growth inhibitors|mesh-ancestor
92844418|NCT02843490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844419|NCT00902174|Imatinib Mesylate|imatinib mesylate|mesh-list
92844420|NCT00902174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844421|NCT00902174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844422|NCT00902174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844423|NCT00902174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844424|NCT04201808|Tenofovir|tenofovir|mesh-list
92844425|NCT04201808|Antiviral Agents|antiviral agents|mesh-ancestor
92844426|NCT04201808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844427|NCT04201808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92844428|NCT04201808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92844429|NCT04201808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844430|NCT04201808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844431|NCT04201808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92844432|NCT04201808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92844434|NCT01341600|Clopidogrel|clopidogrel|mesh-list
92844435|NCT01341600|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92844436|NCT01341600|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92844437|NCT01341600|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92844438|NCT01341600|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92844439|NCT01341600|Purinergic Agents|purinergic agents|mesh-ancestor
92844440|NCT01341600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844441|NCT01341600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844442|NCT01341600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844443|NCT01341600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92844444|NCT01341600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844445|NCT01341600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92844446|NCT01341600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844447|NCT02845388|Sildenafil Citrate|sildenafil citrate|mesh-list
92844448|NCT02845388|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92844449|NCT02845388|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92844451|NCT02845388|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92844452|NCT02845388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844453|NCT02845388|Estrogens|estrogens|mesh-ancestor
92844454|NCT02845388|Hormones|hormones|mesh-ancestor
92844455|NCT02845388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844456|NCT02845388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844457|NCT02845388|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92844458|NCT02845388|Contraceptive Agents|contraceptive agents|mesh-ancestor
92844459|NCT02845388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92844460|NCT02845388|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92844461|NCT02845388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92844462|NCT02845388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92844463|NCT02845388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92844464|NCT02845388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844465|NCT02845388|Urological Agents|urological agents|mesh-ancestor
92844466|NCT02845466|Becaplermin|becaplermin|mesh-list
92844467|NCT02845466|Anticoagulants|anticoagulants|mesh-ancestor
92844468|NCT02845466|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92844469|NCT02845466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92844470|NCT02845466|Growth Substances|growth substances|mesh-ancestor
92844471|NCT02845466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844472|NCT00623623|Enoxaparin|enoxaparin|mesh-list
92844473|NCT00623623|Tenecteplase|tenecteplase|mesh-list
92844474|NCT00623623|Clopidogrel|clopidogrel|mesh-list
92844475|NCT00623623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92844476|NCT00623623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92844477|NCT00623623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92844478|NCT00623623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92844479|NCT00623623|Purinergic Agents|purinergic agents|mesh-ancestor
92844480|NCT00623623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844481|NCT00623623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844482|NCT00623623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844483|NCT00623623|Anticoagulants|anticoagulants|mesh-ancestor
92844484|NCT00623623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92844485|NCT00623623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844486|NCT00896454|Denosumab|denosumab|mesh-list
92844487|NCT00896454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92844488|NCT00896454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844489|NCT04224584|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92844490|NCT04224584|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92844491|NCT04224584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92844492|NCT04224584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844493|NCT04224584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844494|NCT04224584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844495|NCT04224584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844496|NCT04224584|Analgesics|analgesics|mesh-ancestor
92844497|NCT04224584|Sensory System Agents|sensory system agents|mesh-ancestor
92844498|NCT04224584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844499|NCT04224584|Antidepressive Agents|antidepressive agents|mesh-ancestor
92844500|NCT04224584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92844501|NCT04224584|Dopamine Agents|dopamine agents|mesh-ancestor
92844502|NCT02993198|Carvedilol|carvedilol|mesh-list
92844503|NCT02993198|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92844504|NCT02993198|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92489588|NCT05876481|Psilocybin|psilocybin|mesh-list
92844505|NCT02993198|Adrenergic Agents|adrenergic agents|mesh-ancestor
92844506|NCT02993198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844507|NCT02993198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844508|NCT02993198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844509|NCT02993198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92844510|NCT02993198|Antioxidants|antioxidants|mesh-ancestor
92844511|NCT02993198|Protective Agents|protective agents|mesh-ancestor
92844512|NCT02993198|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92844513|NCT02993198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844514|NCT02993198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92844515|NCT02993198|Vasodilator Agents|vasodilator agents|mesh-ancestor
92844516|NCT02993198|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92844517|NCT02993198|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92844518|NCT00829231|Sorafenib|sorafenib|mesh-list
92844519|NCT00829231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844520|NCT00829231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844521|NCT00829231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844522|NCT00829231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844523|NCT00901628|Cefuroxime|cefuroxime|mesh-list
92844524|NCT00901628|Cefuroxime axetil|cefuroxime axetil|mesh-list
92844525|NCT00901628|Ketorolac|ketorolac|mesh-list
92844526|NCT00901628|Epinephrine|epinephrine|mesh-list
92844527|NCT00901628|Morphine|morphine|mesh-list
92844528|NCT00901628|Ropivacaine|ropivacaine|mesh-list
92844529|NCT00901628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92844530|NCT00901628|Narcotics|narcotics|mesh-ancestor
92844531|NCT00901628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844532|NCT00901628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844533|NCT00901628|Analgesics|analgesics|mesh-ancestor
92844534|NCT00901628|Sensory System Agents|sensory system agents|mesh-ancestor
92844535|NCT00901628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844536|NCT00901628|Anesthetics, Local|anesthetics, local|mesh-ancestor
92844537|NCT00901628|Anesthetics|anesthetics|mesh-ancestor
92844538|NCT00901628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92844539|NCT00901628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92844540|NCT00901628|Adrenergic Agents|adrenergic agents|mesh-ancestor
92844541|NCT00901628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844542|NCT00901628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844543|NCT00901628|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92844544|NCT00901628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92844545|NCT00901628|Autonomic Agents|autonomic agents|mesh-ancestor
92844546|NCT00901628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92844547|NCT00901628|Respiratory System Agents|respiratory system agents|mesh-ancestor
92844548|NCT00901628|Mydriatics|mydriatics|mesh-ancestor
92844549|NCT00901628|Sympathomimetics|sympathomimetics|mesh-ancestor
92844550|NCT00901628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92844551|NCT00901628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92844552|NCT00901628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844553|NCT00901628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844554|NCT00901628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844555|NCT00901628|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92844556|NCT00901628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844557|NCT00901628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844558|NCT00901628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844559|NCT00623545|Exenatide|exenatide|mesh-list
92844560|NCT00623545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844561|NCT00623545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844562|NCT00623545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92844563|NCT00623545|Incretins|incretins|mesh-ancestor
92844564|NCT00623545|Hormones|hormones|mesh-ancestor
92844565|NCT00623545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844566|NCT00825097|Botulinum Toxins|botulinum toxins|mesh-list
92844567|NCT00825097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92844568|NCT00825097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844569|NCT00825097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844570|NCT00825097|Cholinergic Agents|cholinergic agents|mesh-ancestor
92844571|NCT00825097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844572|NCT00825097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844574|NCT02839668|Lidocaine|lidocaine|mesh-list
92844575|NCT02839668|Atropine|atropine|mesh-list
92844576|NCT02839668|Tramadol|tramadol|mesh-list
92844577|NCT02839668|Sevoflurane|sevoflurane|mesh-list
92844578|NCT02839668|Neostigmine|neostigmine|mesh-list
92844579|NCT02839668|Anesthetics, Local|anesthetics, local|mesh-ancestor
92844580|NCT02839668|Anesthetics|anesthetics|mesh-ancestor
92844581|NCT02839668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844582|NCT02839668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844583|NCT02839668|Sensory System Agents|sensory system agents|mesh-ancestor
92844584|NCT02839668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844585|NCT02839668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92844586|NCT02839668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92844587|NCT02839668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92844588|NCT02839668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844589|NCT02839668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844590|NCT02839668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844591|NCT02839668|Analgesics|analgesics|mesh-ancestor
92844592|NCT02839668|Antipyretics|antipyretics|mesh-ancestor
92844593|NCT02839668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92844594|NCT02839668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92844595|NCT02839668|Anesthetics, General|anesthetics, general|mesh-ancestor
92844596|NCT02839668|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92844597|NCT02839668|Narcotics|narcotics|mesh-ancestor
92844598|NCT02839668|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92844599|NCT02839668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92844600|NCT02839668|Autonomic Agents|autonomic agents|mesh-ancestor
92844601|NCT02839668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92844602|NCT02839668|Respiratory System Agents|respiratory system agents|mesh-ancestor
92844603|NCT02839668|Mydriatics|mydriatics|mesh-ancestor
92844604|NCT02839668|Parasympatholytics|parasympatholytics|mesh-ancestor
92844605|NCT02839668|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92844606|NCT02839668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92844607|NCT02839668|Cholinergic Agents|cholinergic agents|mesh-ancestor
92844608|NCT02839668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844609|NCT02839668|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92844610|NCT02839668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844611|NCT02839668|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92844612|NCT04701788|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92844613|NCT04701788|Immunologic Factors|immunologic factors|mesh-ancestor
92844614|NCT04701788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844615|NCT04700618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92844616|NCT04700618|Immunologic Factors|immunologic factors|mesh-ancestor
92844617|NCT04700618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844618|NCT00829465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92844619|NCT00829465|Immunologic Factors|immunologic factors|mesh-ancestor
92844620|NCT00829465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844621|NCT02839356|Epinephrine|epinephrine|mesh-list
92844622|NCT02839356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92844623|NCT02839356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92844624|NCT02839356|Adrenergic Agents|adrenergic agents|mesh-ancestor
92844625|NCT02839356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844626|NCT02839356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844627|NCT02839356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844628|NCT02839356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92844629|NCT02839356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92844630|NCT02839356|Autonomic Agents|autonomic agents|mesh-ancestor
92844631|NCT02839356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844632|NCT02839356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92844633|NCT02839356|Respiratory System Agents|respiratory system agents|mesh-ancestor
92844634|NCT02839356|Mydriatics|mydriatics|mesh-ancestor
92844635|NCT02839356|Sympathomimetics|sympathomimetics|mesh-ancestor
92844636|NCT02839356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92844637|NCT04674410|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92844638|NCT04674410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844639|NCT02840526|Acetaminophen|acetaminophen|mesh-list
92844640|NCT02840526|Fentanyl|fentanyl|mesh-list
92844641|NCT02840526|Bupivacaine|bupivacaine|mesh-list
92844642|NCT02840526|Propofol|propofol|mesh-list
92844643|NCT02840526|Sevoflurane|sevoflurane|mesh-list
92844644|NCT02840526|Anesthetics, Local|anesthetics, local|mesh-ancestor
92844645|NCT02840526|Anesthetics|anesthetics|mesh-ancestor
92844646|NCT02840526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844647|NCT02840526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844648|NCT02840526|Sensory System Agents|sensory system agents|mesh-ancestor
92189839|NCT00358657|Sirolimus|sirolimus|mesh-list
92844649|NCT02840526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844650|NCT02840526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92844651|NCT02840526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92844652|NCT02840526|Anesthetics, General|anesthetics, general|mesh-ancestor
92844653|NCT02840526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92844654|NCT02840526|Narcotics|narcotics|mesh-ancestor
92844655|NCT02840526|Analgesics|analgesics|mesh-ancestor
92844656|NCT02840526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92844657|NCT02840526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844658|NCT02840526|Antipyretics|antipyretics|mesh-ancestor
92844659|NCT02840526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92844660|NCT02840526|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92844661|NCT02342444|Enoxaparin|enoxaparin|mesh-list
92844662|NCT02342444|Enoxaparin sodium|enoxaparin sodium|mesh-list
92844663|NCT02342444|Anticoagulants|anticoagulants|mesh-ancestor
92844664|NCT02342444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92844665|NCT02342444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844666|NCT02342444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844667|NCT00825253|Insulin|insulin|mesh-list
92844668|NCT00825253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92844669|NCT00825253|Insulin Aspart|insulin aspart|mesh-list
92844670|NCT00825253|Biphasic Insulins|biphasic insulins|mesh-list
92844671|NCT00825253|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92844672|NCT00825253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844673|NCT00825253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844674|NCT00820885|Teduglutide|teduglutide|mesh-list
92844675|NCT00820885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844676|NCT00820885|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92844677|NCT00820885|Protective Agents|protective agents|mesh-ancestor
92844678|NCT00820885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844679|NCT03845582|Vitamin A|vitamin a|mesh-list
92844680|NCT03845582|Retinol acetate|retinol acetate|mesh-list
92844681|NCT03845582|Vitamins|vitamins|mesh-ancestor
92844682|NCT03845582|Micronutrients|micronutrients|mesh-ancestor
92844683|NCT03845582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844684|NCT03845582|Protective Agents|protective agents|mesh-ancestor
92844685|NCT03845582|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92844686|NCT03845582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844687|NCT03845582|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92844688|NCT03845582|Immunologic Factors|immunologic factors|mesh-ancestor
92844689|NCT00820963|Temozolomide|temozolomide|mesh-list
92844690|NCT00820963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92844691|NCT00820963|Alkylating Agents|alkylating agents|mesh-ancestor
92844692|NCT00820963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844693|NCT00820963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844694|NCT02834676|Ethanol|ethanol|mesh-list
92844695|NCT02834676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92844696|NCT02834676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844697|NCT02834676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844698|NCT02834676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844699|NCT00632840|Atorvastatin|atorvastatin|mesh-list
92844700|NCT00632840|Fenofibrate|fenofibrate|mesh-list
92844701|NCT00632840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92844702|NCT00632840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92844703|NCT00632840|Antimetabolites|antimetabolites|mesh-ancestor
92844704|NCT00632840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844705|NCT00632840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92844706|NCT00632840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92844707|NCT00632840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844708|NCT00829699|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92844709|NCT00829699|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92844710|NCT00829699|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92844711|NCT00829699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92844712|NCT00829777|Naloxone|naloxone|mesh-list
92844713|NCT00829777|Lactulose|lactulose|mesh-list
92844714|NCT00829777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92844715|NCT00829777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844716|NCT00829777|Sensory System Agents|sensory system agents|mesh-ancestor
92844717|NCT00829777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844718|NCT00829777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844719|NCT02834754|Vedolizumab|vedolizumab|mesh-list
92844720|NCT02834754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844721|NCT02839122|Tadalafil|tadalafil|mesh-list
92844722|NCT02839122|Dutasteride|dutasteride|mesh-list
92844723|NCT02839122|Vasodilator Agents|vasodilator agents|mesh-ancestor
92844724|NCT02839122|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92844725|NCT02839122|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92844727|NCT02839122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844728|NCT02839122|Urological Agents|urological agents|mesh-ancestor
92844729|NCT02839122|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92844730|NCT02839122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92844731|NCT02839122|Hormone Antagonists|hormone antagonists|mesh-ancestor
93046919|NCT00350636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489829|NCT05874544|Rifabutin|rifabutin|mesh-list
92844732|NCT02839122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844733|NCT02839122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844734|NCT00633282|Pioglitazone|pioglitazone|mesh-list
92844735|NCT00633282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92844736|NCT00633282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844737|NCT00633282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844738|NCT00830089|Levobupivacaine|levobupivacaine|mesh-list
92844739|NCT00830089|Anesthetics, Local|anesthetics, local|mesh-ancestor
92844740|NCT00830089|Anesthetics|anesthetics|mesh-ancestor
92844741|NCT00830089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92844742|NCT00830089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844743|NCT00830089|Sensory System Agents|sensory system agents|mesh-ancestor
92844744|NCT00830089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844745|NCT00830245|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92844746|NCT00830245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844747|NCT00830245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844748|NCT00830245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844749|NCT00830245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844750|NCT02837874|Antidiarrheals|antidiarrheals|mesh-list
92844751|NCT02837874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844752|NCT02838030|Aspirin|aspirin|mesh-list
92844753|NCT02838030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92844754|NCT02838030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844755|NCT02838030|Analgesics|analgesics|mesh-ancestor
92844756|NCT02838030|Sensory System Agents|sensory system agents|mesh-ancestor
92844757|NCT02838030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844758|NCT02838030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844759|NCT02838030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844760|NCT02838030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844761|NCT02838030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92844762|NCT02838030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844763|NCT02838030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844764|NCT02838030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92844765|NCT02838030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92844766|NCT02838030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844767|NCT02838030|Antipyretics|antipyretics|mesh-ancestor
92844768|NCT00825643|Insulin Detemir|insulin detemir|mesh-list
92844769|NCT00825643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844770|NCT00825643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844771|NCT04044079|Misoprostol|misoprostol|mesh-list
92844772|NCT04044079|Dinoprostone|dinoprostone|mesh-list
92844773|NCT04044079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92844774|NCT04044079|Abortifacient Agents|abortifacient agents|mesh-ancestor
92844775|NCT04044079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92844776|NCT04044079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844777|NCT04044079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92844778|NCT04044079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844779|NCT04044079|Oxytocics|oxytocics|mesh-ancestor
92844780|NCT00830323|Oseltamivir|oseltamivir|mesh-list
92844781|NCT00830323|Amantadine|amantadine|mesh-list
92844782|NCT00830323|Zanamivir|zanamivir|mesh-list
92844783|NCT00830323|Antiviral Agents|antiviral agents|mesh-ancestor
92844784|NCT00830323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844785|NCT00830323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844786|NCT00830323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844787|NCT00830323|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92844788|NCT00830323|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92844789|NCT00830323|Dopamine Agents|dopamine agents|mesh-ancestor
92844790|NCT00830323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844791|NCT00830323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844792|NCT00830323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844793|NCT00830323|Analgesics|analgesics|mesh-ancestor
92844794|NCT00830323|Sensory System Agents|sensory system agents|mesh-ancestor
92844795|NCT00830323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844796|NCT00830401|Doxycycline|doxycycline|mesh-list
92844797|NCT00830401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433239|NCT01573468|Capecitabine|capecitabine|mesh-list
92844798|NCT00830401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844799|NCT00830401|Antimalarials|antimalarials|mesh-ancestor
92844800|NCT00830401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92844801|NCT00830401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92844802|NCT04249908|Maleic acid|maleic acid|mesh-list
92844803|NCT04249908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844804|NCT04249908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844805|NCT00825721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92844806|NCT00825721|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92844807|NCT02837640|Levodopa|levodopa|mesh-list
92844808|NCT02837640|Carbidopa|carbidopa|mesh-list
92844809|NCT02837640|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92844810|NCT02837640|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92844811|NCT02837640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92844812|NCT02837640|Dopamine Agents|dopamine agents|mesh-ancestor
92844813|NCT02837640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92844814|NCT02837640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844815|NCT02837640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844816|NCT02837640|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92844817|NCT02837640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844818|NCT02837640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92844819|NCT02837640|Immunologic Factors|immunologic factors|mesh-ancestor
92844820|NCT02837640|Dopamine Agonists|dopamine agonists|mesh-ancestor
92844821|NCT02834286|Dexamethasone|dexamethasone|mesh-list
92844822|NCT02834286|Rituximab|rituximab|mesh-list
92844823|NCT02834286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844824|NCT02834286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844825|NCT02834286|Immunologic Factors|immunologic factors|mesh-ancestor
92844826|NCT02834286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844827|NCT02834286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844828|NCT02834286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844829|NCT02834286|Antiemetics|antiemetics|mesh-ancestor
92844830|NCT02834286|Autonomic Agents|autonomic agents|mesh-ancestor
92844831|NCT02834286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844832|NCT02834286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844833|NCT02834286|Glucocorticoids|glucocorticoids|mesh-ancestor
92844834|NCT02834286|Hormones|hormones|mesh-ancestor
92844835|NCT02834286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844836|NCT02834286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92844837|NCT02839044|Vitamin K 2|vitamin k 2|mesh-list
92844838|NCT02839044|Vitamin K|vitamin k|mesh-list
92844839|NCT02839044|Menaquinone 7|menaquinone 7|mesh-list
92844840|NCT02839044|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92844841|NCT02839044|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844842|NCT02839044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844843|NCT02839044|Hemostatics|hemostatics|mesh-ancestor
92844844|NCT02839044|Coagulants|coagulants|mesh-ancestor
92844845|NCT02839044|Vitamins|vitamins|mesh-ancestor
92844846|NCT02839044|Micronutrients|micronutrients|mesh-ancestor
92844847|NCT02839044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844848|NCT02833506|Sirolimus|sirolimus|mesh-list
92844849|NCT02833506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844850|NCT02833506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844851|NCT02833506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92844852|NCT02833506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844853|NCT02833506|Antifungal Agents|antifungal agents|mesh-ancestor
92844854|NCT02833506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92844855|NCT02833506|Immunologic Factors|immunologic factors|mesh-ancestor
92844856|NCT02833506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844857|NCT02838576|Estrogens|estrogens|mesh-list
92844858|NCT02838576|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92844859|NCT02838576|Hormones|hormones|mesh-ancestor
92844860|NCT02838576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844861|NCT02838576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844862|NCT00838539|Sirolimus|sirolimus|mesh-list
92844863|NCT00838539|Temsirolimus|temsirolimus|mesh-list
92844864|NCT00838539|MTOR Inhibitors|mtor inhibitors|mesh-list
92844865|NCT00838539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844866|NCT00838539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844867|NCT00838539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844868|NCT00838539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92844869|NCT00838539|Immunologic Factors|immunologic factors|mesh-ancestor
92844870|NCT00838539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844871|NCT00838539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844872|NCT00838539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844873|NCT00838539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844874|NCT00838539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92844875|NCT00838539|Antifungal Agents|antifungal agents|mesh-ancestor
92844876|NCT02836548|Vorinostat|vorinostat|mesh-list
92844877|NCT02836548|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92844878|NCT02836548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844879|NCT02836548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844880|NCT02836548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844881|NCT02836704|Metformin|metformin|mesh-list
92844882|NCT02836704|Insulin Glargine|insulin glargine|mesh-list
92844883|NCT02836704|Acarbose|acarbose|mesh-list
92844884|NCT02836704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844885|NCT02836704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844886|NCT02836704|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92844887|NCT02836704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844888|NCT02836704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844889|NCT02833584|Acetaminophen|acetaminophen|mesh-list
92844890|NCT02833584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844891|NCT02833584|Analgesics|analgesics|mesh-ancestor
92844892|NCT02833584|Sensory System Agents|sensory system agents|mesh-ancestor
92844893|NCT02833584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92844894|NCT02833584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844895|NCT02833584|Antipyretics|antipyretics|mesh-ancestor
92844896|NCT00837759|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92844897|NCT00837759|Lansoprazole|lansoprazole|mesh-list
92844898|NCT00837759|Dexlansoprazole|dexlansoprazole|mesh-list
92844899|NCT00837759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92844900|NCT00837759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844901|NCT00837759|Incretins|incretins|mesh-ancestor
92844902|NCT00837759|Hormones|hormones|mesh-ancestor
92844903|NCT00837759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92844904|NCT00837759|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92844905|NCT00837759|Protease Inhibitors|protease inhibitors|mesh-ancestor
92844906|NCT00837759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844907|NCT00837759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844908|NCT00837759|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92844909|NCT00837759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844910|NCT00837759|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92844911|NCT00703365|Gemcitabine|gemcitabine|mesh-list
92844912|NCT00703365|Sorafenib|sorafenib|mesh-list
92844913|NCT00703365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92844914|NCT00703365|Antimetabolites|antimetabolites|mesh-ancestor
92844915|NCT00703365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844916|NCT00703365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844917|NCT00703365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92844918|NCT00703365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844919|NCT05878899|Enoxaparin|enoxaparin|mesh-list
92844920|NCT05878899|Anticoagulants|anticoagulants|mesh-ancestor
92844921|NCT05878899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92844922|NCT05878899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844923|NCT05878899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844924|NCT05878639|Lactulose|lactulose|mesh-list
92844925|NCT05878639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92844926|NCT05878574|Heparin|heparin|mesh-list
92844927|NCT05878574|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92844928|NCT05878574|Tinzaparin|tinzaparin|mesh-list
92844929|NCT05878574|Dalteparin|dalteparin|mesh-list
92844930|NCT05878574|Anticoagulants|anticoagulants|mesh-ancestor
92844931|NCT05878574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92844932|NCT05878574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92844933|NCT05878574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844934|NCT05878561|Indapamide|indapamide|mesh-list
92844935|NCT05878561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92844936|NCT05878561|Diuretics|diuretics|mesh-ancestor
92844937|NCT05878561|Natriuretic Agents|natriuretic agents|mesh-ancestor
92844938|NCT05878561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844939|NCT05878561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92844940|NCT05878561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92844941|NCT05878561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844942|NCT05878379|Iron|iron|mesh-list
92844943|NCT05878379|Trace Elements|trace elements|mesh-ancestor
92844944|NCT05878379|Micronutrients|micronutrients|mesh-ancestor
92844945|NCT05878379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844946|NCT05878353|Doxycycline|doxycycline|mesh-list
92844947|NCT05878353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92844948|NCT05878353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844950|NCT05878353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92844951|NCT05878353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92844952|NCT05878288|Cemiplimab|cemiplimab|mesh-list
92844953|NCT05878288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844954|NCT05878288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844955|NCT05878262|Ibuprofen|ibuprofen|mesh-list
92844956|NCT05878262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92844957|NCT05878262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92844958|NCT05878262|Analgesics|analgesics|mesh-ancestor
92844959|NCT05878262|Sensory System Agents|sensory system agents|mesh-ancestor
92844960|NCT05878262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046920|NCT01051544|Factor VIII|factor viii|mesh-list
92844961|NCT05878262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844962|NCT05878262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92844963|NCT05878262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92844964|NCT05878262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92844965|NCT05878262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844966|NCT05878262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844967|NCT05878249|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92844969|NCT05878249|Edetic Acid|edetic acid|mesh-list
92844970|NCT05878249|Pentetic Acid|pentetic acid|mesh-list
92844971|NCT05878249|Disinfectants|disinfectants|mesh-ancestor
92844972|NCT05878249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92844973|NCT05878249|Anticoagulants|anticoagulants|mesh-ancestor
92844974|NCT05878249|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92844975|NCT05878249|Chelating Agents|chelating agents|mesh-ancestor
92844976|NCT05878249|Sequestering Agents|sequestering agents|mesh-ancestor
92844977|NCT05878249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844978|NCT05878249|Antidotes|antidotes|mesh-ancestor
92844979|NCT05878249|Protective Agents|protective agents|mesh-ancestor
92844980|NCT05878249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92844981|NCT05878249|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92844982|NCT05878158|Simvastatin|simvastatin|mesh-list
92844983|NCT05878158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92844984|NCT05878158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92844985|NCT05878158|Antimetabolites|antimetabolites|mesh-ancestor
92844986|NCT05878158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844987|NCT05878158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92844988|NCT05878158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92844989|NCT05878158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92844990|NCT05878028|Docetaxel|docetaxel|mesh-list
92844991|NCT05878028|Tislelizumab|tislelizumab|mesh-list
92844992|NCT05878028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92844993|NCT05878028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92844994|NCT05878028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92844995|NCT05878028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92844996|NCT05878028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92844997|NCT05878028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92844998|NCT05878015|Acetaminophen|acetaminophen|mesh-list
92844999|NCT05878015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845000|NCT05878015|Analgesics|analgesics|mesh-ancestor
92845001|NCT05878015|Sensory System Agents|sensory system agents|mesh-ancestor
92845002|NCT05878015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845003|NCT05878015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845004|NCT05878015|Antipyretics|antipyretics|mesh-ancestor
92845005|NCT05877911|Sodium sulfate|sodium sulfate|mesh-list
92845006|NCT05877911|Cathartics|cathartics|mesh-ancestor
92845007|NCT05877911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92845008|NCT05877872|Immunomodulating Agents|immunomodulating agents|mesh-list
92845009|NCT05877872|Immunologic Factors|immunologic factors|mesh-ancestor
92845010|NCT05877872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845011|NCT05877846|Vitamin D|vitamin d|mesh-list
92845012|NCT05877846|Ergocalciferols|ergocalciferols|mesh-list
92845013|NCT05877846|Cholecalciferol|cholecalciferol|mesh-list
92845014|NCT05877846|Vitamins|vitamins|mesh-list
92845015|NCT05877846|Micronutrients|micronutrients|mesh-ancestor
92845016|NCT05877846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845017|NCT05877846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92845018|NCT05877846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92845019|NCT05877820|Lenvatinib|lenvatinib|mesh-list
92845020|NCT05877820|Tislelizumab|tislelizumab|mesh-list
92845021|NCT05877820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845022|NCT05877820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845023|NCT05877820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190209|NCT00364819|Rituximab|rituximab|mesh-list
92845024|NCT05877820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845025|NCT05877820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845027|NCT05877807|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92845028|NCT05877807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845029|NCT05877807|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92845030|NCT05877807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845031|NCT05877807|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92845032|NCT05877807|GABA Agonists|gaba agonists|mesh-ancestor
92845033|NCT05877807|GABA Agents|gaba agents|mesh-ancestor
92845034|NCT05877807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845035|NCT05877807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845036|NCT05877781|Palmidrol|palmidrol|mesh-list
92845037|NCT05877781|Analgesics|analgesics|mesh-ancestor
92845038|NCT05877781|Sensory System Agents|sensory system agents|mesh-ancestor
92845039|NCT05877781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845040|NCT05877781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845041|NCT05877781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92845042|NCT05877781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845043|NCT05877781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845044|NCT05877781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845045|NCT05877781|Antiviral Agents|antiviral agents|mesh-ancestor
92845046|NCT05877781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845047|NCT05877781|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92845048|NCT05877781|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92845049|NCT05877781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845050|NCT05877781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845051|NCT05877781|Hormones|hormones|mesh-ancestor
92845052|NCT05877781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845053|NCT05877690|Bupivacaine|bupivacaine|mesh-list
92845054|NCT05877690|Prilocaine|prilocaine|mesh-list
92845055|NCT05877690|Anesthetics, Local|anesthetics, local|mesh-ancestor
92845056|NCT05877690|Anesthetics|anesthetics|mesh-ancestor
92845057|NCT05877690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845058|NCT05877690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845059|NCT05877690|Sensory System Agents|sensory system agents|mesh-ancestor
92845060|NCT05877690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845061|NCT05877638|Sulfadiazine|sulfadiazine|mesh-list
92845062|NCT05877638|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92845063|NCT05877638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92845064|NCT05877638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845065|NCT05877638|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92845066|NCT05877638|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92845067|NCT05877638|Coccidiostats|coccidiostats|mesh-ancestor
92845068|NCT05877638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92845069|NCT05877313|Nitric Oxide|nitric oxide|mesh-list
92845070|NCT05877313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92845071|NCT05877313|Autonomic Agents|autonomic agents|mesh-ancestor
92845072|NCT05877313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845073|NCT05877313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845074|NCT05877313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92845075|NCT05877313|Respiratory System Agents|respiratory system agents|mesh-ancestor
92845076|NCT05877313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92845077|NCT05877313|Antioxidants|antioxidants|mesh-ancestor
92845078|NCT05877313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845079|NCT05877313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845080|NCT05877313|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92845081|NCT05877313|Vasodilator Agents|vasodilator agents|mesh-ancestor
92845082|NCT05877313|Gasotransmitters|gasotransmitters|mesh-ancestor
92845083|NCT05877313|Protective Agents|protective agents|mesh-ancestor
92845084|NCT05877235|Quercetin|quercetin|mesh-list
92845085|NCT05877235|Antioxidants|antioxidants|mesh-ancestor
92845086|NCT05877235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845087|NCT05877235|Protective Agents|protective agents|mesh-ancestor
92845088|NCT05877235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845089|NCT05877131|Ropivacaine|ropivacaine|mesh-list
92845090|NCT05877131|Levobupivacaine|levobupivacaine|mesh-list
92845091|NCT05877131|Anesthetics, Local|anesthetics, local|mesh-ancestor
92845092|NCT05877131|Anesthetics|anesthetics|mesh-ancestor
92845093|NCT05877131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845094|NCT05877131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845095|NCT05877131|Sensory System Agents|sensory system agents|mesh-ancestor
92845096|NCT05877131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845097|NCT05877079|Menthol|menthol|mesh-list
92845098|NCT05877079|Antipruritics|antipruritics|mesh-ancestor
92845099|NCT05877079|Dermatologic Agents|dermatologic agents|mesh-ancestor
92845100|NCT05877040|Rituximab|rituximab|mesh-list
92845101|NCT05877040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845102|NCT05877040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845103|NCT05877040|Immunologic Factors|immunologic factors|mesh-ancestor
92845104|NCT05877040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845105|NCT05877040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845106|NCT05877001|Tislelizumab|tislelizumab|mesh-list
92845107|NCT05877001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845108|NCT05877001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845109|NCT05876949|Denosumab|denosumab|mesh-list
92845110|NCT05876949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92845111|NCT05876949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845112|NCT05876858|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92845113|NCT05876858|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92845114|NCT05876858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845115|NCT05873777|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92845116|NCT05873777|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92845117|NCT05873777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845119|NCT05859009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92845120|NCT05859009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92845121|NCT05859009|Adrenergic Agents|adrenergic agents|mesh-ancestor
92845122|NCT05859009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845123|NCT05859009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845124|NCT05859009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845125|NCT05859009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92845126|NCT05859009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92845127|NCT05859009|Vasodilator Agents|vasodilator agents|mesh-ancestor
92845128|NCT05838560|Dasatinib|dasatinib|mesh-list
92845129|NCT05838560|Quercetin|quercetin|mesh-list
92845130|NCT05838560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845131|NCT05838560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845132|NCT05838560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845133|NCT05838560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845134|NCT05838560|Antioxidants|antioxidants|mesh-ancestor
92845135|NCT05838560|Protective Agents|protective agents|mesh-ancestor
92845136|NCT05838560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845137|NCT05795309|Insulin|insulin|mesh-list
92845138|NCT05795309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92845139|NCT05795309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845140|NCT05790707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92845141|NCT05746572|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92845142|NCT05746572|Hallucinogens|hallucinogens|mesh-ancestor
92845143|NCT05746572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845144|NCT05746572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92845145|NCT05746572|Serotonin Agents|serotonin agents|mesh-ancestor
92845146|NCT05746572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845147|NCT05746572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845148|NCT05746572|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92845149|NCT05746572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92845150|NCT05746572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845151|NCT05746572|Adrenergic Agents|adrenergic agents|mesh-ancestor
92845152|NCT05737121|Lidocaine|lidocaine|mesh-list
92845153|NCT05737121|Heparin|heparin|mesh-list
92845154|NCT05737121|Calcium heparin|calcium heparin|mesh-list
92845155|NCT05737121|Anesthetics, Local|anesthetics, local|mesh-ancestor
92845156|NCT05737121|Anesthetics|anesthetics|mesh-ancestor
92845157|NCT05737121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845158|NCT05737121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845159|NCT05737121|Sensory System Agents|sensory system agents|mesh-ancestor
92845160|NCT05737121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845161|NCT05737121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92845162|NCT05737121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92845163|NCT05737121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92845164|NCT05737121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845165|NCT05737121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845166|NCT05737121|Anticoagulants|anticoagulants|mesh-ancestor
92845167|NCT05737121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92845168|NCT05737121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92845169|NCT05727904|Pembrolizumab|pembrolizumab|mesh-list
92845170|NCT05727904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845171|NCT05727904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845172|NCT05727904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845173|NCT05727904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845174|NCT05721235|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92845175|NCT05721235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92845176|NCT05721235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845177|NCT05721235|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92845178|NCT05721235|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92845179|NCT05721235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845180|NCT05721235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845181|NCT05721235|Dopamine Agents|dopamine agents|mesh-ancestor
92845182|NCT05721235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845183|NCT05675579|Pembrolizumab|pembrolizumab|mesh-list
92845184|NCT05675579|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92845185|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845186|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845187|NCT05675579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845188|NCT05675579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845189|NCT05675579|Immunoconjugates|immunoconjugates|mesh-ancestor
92845190|NCT05675579|Immunologic Factors|immunologic factors|mesh-ancestor
92845191|NCT05675579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845193|NCT05663658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92845194|NCT05663658|Narcotics|narcotics|mesh-ancestor
92845195|NCT05663658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845196|NCT05663658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845197|NCT05663658|Analgesics|analgesics|mesh-ancestor
92845198|NCT05663658|Sensory System Agents|sensory system agents|mesh-ancestor
92845199|NCT05663658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845200|NCT05660135|Amlodipine|amlodipine|mesh-list
92845201|NCT05660135|Olmesartan|olmesartan|mesh-list
92845202|NCT05660135|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92845203|NCT05660135|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92845204|NCT05660135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92845205|NCT05660135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92845206|NCT05660135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845207|NCT05660135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845208|NCT05660135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92845209|NCT05660135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845210|NCT05660135|Vasodilator Agents|vasodilator agents|mesh-ancestor
92845211|NCT05660135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92845212|NCT05660135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92845213|NCT05660135|Antimetabolites|antimetabolites|mesh-ancestor
92845214|NCT05660135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92845215|NCT05660135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92845216|NCT05660135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845217|NCT05660135|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92845218|NCT05660135|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92845219|NCT05653713|Lenograstim|lenograstim|mesh-list
92845220|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92845221|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
92845222|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845223|NCT05635929|Betaine|betaine|mesh-list
92845224|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92845225|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
92845226|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92845227|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
92845228|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845229|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92845230|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
92845231|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845232|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
92845233|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845234|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845235|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845236|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
92845237|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845238|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845239|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92845240|NCT05606263|Nimotuzumab|nimotuzumab|mesh-list
92845241|NCT05606263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845242|NCT05606263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845243|NCT05599451|Pyrithione zinc|pyrithione zinc|mesh-list
92845244|NCT05599451|Keratolytic Agents|keratolytic agents|mesh-ancestor
92845245|NCT05599451|Dermatologic Agents|dermatologic agents|mesh-ancestor
92845246|NCT05597722|Amphetamine|amphetamine|mesh-list
92845248|NCT05597722|Dextroamphetamine|dextroamphetamine|mesh-list
92845249|NCT05597722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92845250|NCT05597722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845251|NCT05597722|Sympathomimetics|sympathomimetics|mesh-ancestor
92845252|NCT05597722|Autonomic Agents|autonomic agents|mesh-ancestor
92845253|NCT05597722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845254|NCT05597722|Dopamine Agents|dopamine agents|mesh-ancestor
92845255|NCT05597722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845256|NCT05597722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845257|NCT05597722|Adrenergic Agents|adrenergic agents|mesh-ancestor
92845258|NCT05597722|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92845259|NCT05597722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92845260|NCT05597722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845261|NCT05597722|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92845262|NCT05574101|Cemiplimab|cemiplimab|mesh-list
92845263|NCT05574101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845264|NCT05574101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845265|NCT05563220|Everolimus|everolimus|mesh-list
92845266|NCT05563220|Palbociclib|palbociclib|mesh-list
92845267|NCT05563220|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92845268|NCT05563220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845269|NCT05563220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845270|NCT05563220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845271|NCT05563220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845272|NCT05563220|Immunologic Factors|immunologic factors|mesh-ancestor
92845273|NCT05563220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845274|NCT05563220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845275|NCT05555667|Propofol|propofol|mesh-list
92845276|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92845277|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845278|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845279|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92845280|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
92845281|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
92845282|NCT05491226|Pembrolizumab|pembrolizumab|mesh-list
92845283|NCT05491226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845284|NCT05491226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845285|NCT05491226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845286|NCT05491226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845287|NCT05474846|Melatonin|melatonin|mesh-list
92845288|NCT05474846|Methylphenidate|methylphenidate|mesh-list
92845289|NCT05474846|Antioxidants|antioxidants|mesh-ancestor
92845290|NCT05474846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845291|NCT05474846|Protective Agents|protective agents|mesh-ancestor
92845292|NCT05474846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845293|NCT05474846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845294|NCT05474846|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92845295|NCT05474846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92845296|NCT05474846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92845297|NCT05474846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845298|NCT05474846|Dopamine Agents|dopamine agents|mesh-ancestor
92845299|NCT05474846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845300|NCT05462613|Aspirin|aspirin|mesh-list
92845301|NCT05462613|Bevacizumab|bevacizumab|mesh-list
92845302|NCT05462613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845303|NCT05462613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845304|NCT05462613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92845305|NCT05462613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92845306|NCT05462613|Growth Substances|growth substances|mesh-ancestor
92845307|NCT05462613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845308|NCT05462613|Growth Inhibitors|growth inhibitors|mesh-ancestor
92845309|NCT05462613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92845310|NCT05462613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845311|NCT05462613|Analgesics|analgesics|mesh-ancestor
92845312|NCT05462613|Sensory System Agents|sensory system agents|mesh-ancestor
92845313|NCT05462613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845314|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845315|NCT05462613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845316|NCT05462613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92845317|NCT05462613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92845318|NCT05462613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845319|NCT05462613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92845320|NCT05462613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92845321|NCT05462613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845323|NCT05411887|Olmesartan|olmesartan|mesh-list
92845324|NCT05411887|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92845325|NCT05411887|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92845326|NCT05411887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92845327|NCT05411887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92845328|NCT05411887|Antimetabolites|antimetabolites|mesh-ancestor
92845329|NCT05411887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845330|NCT05411887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92845331|NCT05411887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92845332|NCT05411887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845333|NCT05411887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92845334|NCT05411887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92845335|NCT05411887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92845336|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
92845337|NCT05398081|Cefuroxime|cefuroxime|mesh-list
92845338|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
92845339|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92845340|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845341|NCT05382299|Paclitaxel|paclitaxel|mesh-list
92845342|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92845343|NCT05382299|Carboplatin|carboplatin|mesh-list
92845344|NCT05382299|Gemcitabine|gemcitabine|mesh-list
92845345|NCT05382299|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92845346|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92845347|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845348|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
92845349|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
92845350|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
92845351|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845352|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845353|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
92845354|NCT05382299|Immunoconjugates|immunoconjugates|mesh-ancestor
92845355|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
92845356|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845357|NCT05364008|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92845358|NCT05364008|Antioxidants|antioxidants|mesh-ancestor
92845359|NCT05364008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845360|NCT05364008|Protective Agents|protective agents|mesh-ancestor
92845361|NCT05364008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845362|NCT05364008|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92845363|NCT05364008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92845364|NCT05364008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845365|NCT05364008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92845366|NCT05357898|Pembrolizumab|pembrolizumab|mesh-list
92845367|NCT05357898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845368|NCT05357898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845369|NCT05357898|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845370|NCT05357898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845371|NCT05318573|Gemcitabine|gemcitabine|mesh-list
92845372|NCT05318573|Pembrolizumab|pembrolizumab|mesh-list
92845373|NCT05318573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845374|NCT05318573|Antimetabolites|antimetabolites|mesh-ancestor
92845375|NCT05318573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845376|NCT05318573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845377|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845378|NCT05318573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845379|NCT05307770|Melatonin|melatonin|mesh-list
92845380|NCT05307770|Antioxidants|antioxidants|mesh-ancestor
92845381|NCT05307770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845382|NCT05307770|Protective Agents|protective agents|mesh-ancestor
92845383|NCT05307770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845384|NCT05307770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845385|NCT05307458|Buprenorphine|buprenorphine|mesh-list
92845386|NCT05307458|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92845387|NCT05307458|Naloxone|naloxone|mesh-list
92845388|NCT05307458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92845389|NCT05307458|Narcotics|narcotics|mesh-ancestor
92845390|NCT05307458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845391|NCT05307458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845392|NCT05307458|Analgesics|analgesics|mesh-ancestor
92845393|NCT05307458|Sensory System Agents|sensory system agents|mesh-ancestor
92845394|NCT05307458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845395|NCT05307458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92845396|NCT05267626|Aldesleukin|aldesleukin|mesh-list
92845397|NCT05267626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845398|NCT05267626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92845399|NCT05267626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92845400|NCT05267626|Antiviral Agents|antiviral agents|mesh-ancestor
92845401|NCT05267626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845402|NCT05199662|Tenecteplase|tenecteplase|mesh-list
92845403|NCT05199662|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92845404|NCT05199662|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92845405|NCT05199662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845406|NCT05198934|Trifluridine|trifluridine|mesh-list
92845407|NCT05198934|Panitumumab|panitumumab|mesh-list
92845408|NCT05198934|Sotorasib|sotorasib|mesh-list
92845409|NCT05198934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845410|NCT05198934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845411|NCT05198934|Antimetabolites|antimetabolites|mesh-ancestor
92845412|NCT05198934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845413|NCT05198934|Antiviral Agents|antiviral agents|mesh-ancestor
92845414|NCT05198934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845415|NCT05198934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845416|NCT05123053|Amifampridine|amifampridine|mesh-list
92845417|NCT05123053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92845418|NCT05123053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845419|NCT05123053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845420|NCT05123053|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92845421|NCT05123053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845422|NCT05123053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845423|NCT05112601|Nivolumab|nivolumab|mesh-list
92845424|NCT05112601|Ipilimumab|ipilimumab|mesh-list
92845425|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845426|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845427|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845428|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845429|NCT05109702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92845430|NCT05109702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92845431|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
92845432|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845433|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845434|NCT05083481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845435|NCT05083481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845436|NCT05060744|Antacids|antacids|mesh-list
92845437|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
92845438|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845439|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92845440|NCT05057117|Botulinum Toxins|botulinum toxins|mesh-list
92845441|NCT05057117|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92845442|NCT05057117|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92845443|NCT05057117|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92845444|NCT05057117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845445|NCT05057117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845446|NCT05057117|Cholinergic Agents|cholinergic agents|mesh-ancestor
92845447|NCT05057117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845448|NCT05057117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845449|NCT05057117|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92845450|NCT05057117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845451|NCT05047939|Propofol|propofol|mesh-list
92845452|NCT05047939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92845453|NCT05047939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845454|NCT05047939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845455|NCT05047939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92845456|NCT05047939|Anesthetics, General|anesthetics, general|mesh-ancestor
92845457|NCT05047939|Anesthetics|anesthetics|mesh-ancestor
92845458|NCT05041127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92845459|NCT05041127|Cetuximab|cetuximab|mesh-list
92845460|NCT05041127|Antibodies|antibodies|mesh-list
92845461|NCT05041127|Immunoglobulins|immunoglobulins|mesh-list
92845462|NCT05041127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92845463|NCT05041127|Immunologic Factors|immunologic factors|mesh-ancestor
92845464|NCT05041127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845465|NCT05041127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845466|NCT05030298|Temozolomide|temozolomide|mesh-list
92845467|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845468|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
92845469|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845470|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845471|NCT04913675|Sotrovimab|sotrovimab|mesh-list
92845472|NCT04913675|Antiviral Agents|antiviral agents|mesh-ancestor
92845473|NCT04913675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845474|NCT04926285|Venetoclax|venetoclax|mesh-list
92845475|NCT04926285|Homoharringtonine|homoharringtonine|mesh-list
92845476|NCT04926285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845477|NCT04926285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92845478|NCT04926285|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92845479|NCT04926285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845480|NCT04926285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845481|NCT04858854|Sulforaphane|sulforaphane|mesh-list
92490570|NCT04084210|Nicotine|nicotine|mesh-list
92845482|NCT04858854|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92845483|NCT04858854|Protective Agents|protective agents|mesh-ancestor
92845484|NCT04858854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845485|NCT04858854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845486|NCT04856566|Ethanol|ethanol|mesh-list
92845487|NCT04856566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92845488|NCT04856566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747203|NCT02004782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845489|NCT04856566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845490|NCT04856566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845491|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
92845492|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92845493|NCT04798482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845494|NCT04798482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845495|NCT04798482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845496|NCT04798482|Analgesics|analgesics|mesh-ancestor
92845497|NCT04798482|Sensory System Agents|sensory system agents|mesh-ancestor
92845498|NCT04798482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845499|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92845500|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92845501|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92845502|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
92845503|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845504|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845505|NCT04774250|Zonisamide|zonisamide|mesh-list
92845506|NCT04774250|Anticonvulsants|anticonvulsants|mesh-ancestor
92845507|NCT04774250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92845508|NCT04774250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845509|NCT04774250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845510|NCT04774250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92845511|NCT04774250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845512|NCT04768569|Zonisamide|zonisamide|mesh-list
92845513|NCT04768569|Anticonvulsants|anticonvulsants|mesh-ancestor
92845514|NCT04768569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92845515|NCT04768569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92845516|NCT04768569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845517|NCT04768569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92845518|NCT04768569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845519|NCT04721132|Bevacizumab|bevacizumab|mesh-list
92845520|NCT04721132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92845521|NCT04721132|Atezolizumab|atezolizumab|mesh-list
92845522|NCT04721132|Endothelial Growth Factors|endothelial growth factors|mesh-list
92845523|NCT04721132|Antibodies|antibodies|mesh-list
92845524|NCT04721132|Immunoglobulins|immunoglobulins|mesh-list
92845525|NCT04721132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92845526|NCT04721132|Immunoglobulin G|immunoglobulin g|mesh-list
92845527|NCT04721132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845528|NCT04721132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92845529|NCT04721132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92845530|NCT04721132|Growth Substances|growth substances|mesh-ancestor
92845531|NCT04721132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845532|NCT04721132|Growth Inhibitors|growth inhibitors|mesh-ancestor
92845533|NCT04721132|Immunologic Factors|immunologic factors|mesh-ancestor
92845534|NCT04721132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845535|NCT04721132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845536|NCT04711837|Propofol|propofol|mesh-list
92845537|NCT04711837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92845538|NCT04711837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845539|NCT04711837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845540|NCT04711837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92845541|NCT04711837|Anesthetics, General|anesthetics, general|mesh-ancestor
92845542|NCT04711837|Anesthetics|anesthetics|mesh-ancestor
92845543|NCT04669457|Midazolam|midazolam|mesh-list
92845544|NCT04669457|Dexmedetomidine|dexmedetomidine|mesh-list
92845545|NCT04669457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92845546|NCT04669457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845547|NCT04669457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845548|NCT04669457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845549|NCT04669457|Analgesics|analgesics|mesh-ancestor
92845550|NCT04669457|Sensory System Agents|sensory system agents|mesh-ancestor
92845551|NCT04669457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845552|NCT04669457|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92845553|NCT04669457|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92845554|NCT04669457|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92845555|NCT04669457|Adrenergic Agents|adrenergic agents|mesh-ancestor
92845556|NCT04669457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845557|NCT04669457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845558|NCT04669457|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92845559|NCT04669457|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92845560|NCT04669457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92845561|NCT04669457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92845562|NCT04669457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92845563|NCT04669457|Anesthetics, General|anesthetics, general|mesh-ancestor
92845564|NCT04669457|Anesthetics|anesthetics|mesh-ancestor
92845565|NCT04669457|GABA Modulators|gaba modulators|mesh-ancestor
92845566|NCT04669457|GABA Agents|gaba agents|mesh-ancestor
92845567|NCT04666649|Venetoclax|venetoclax|mesh-list
92845568|NCT04666649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845569|NCT04642365|Atezolizumab|atezolizumab|mesh-list
92845570|NCT04642365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845571|NCT04642365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845572|NCT04642365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845573|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845574|NCT04626635|Cemiplimab|cemiplimab|mesh-list
92845575|NCT04626635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845576|NCT04626635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845577|NCT04537715|Itraconazole|itraconazole|mesh-list
92845578|NCT04537715|Rifampin|rifampin|mesh-list
92845579|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
92845580|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845581|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92845582|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92845583|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845584|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845585|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92845586|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
92845587|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845588|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845589|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92845590|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92845591|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
92845592|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92845593|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
92845594|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92845595|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92845596|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92845597|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92845598|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92845599|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92845600|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92845601|NCT04532528|Dabigatran|dabigatran|mesh-list
92845602|NCT04532528|Antithrombins|antithrombins|mesh-ancestor
92845603|NCT04532528|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92845604|NCT04532528|Protease Inhibitors|protease inhibitors|mesh-ancestor
92845605|NCT04532528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845606|NCT04532528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845607|NCT04532528|Anticoagulants|anticoagulants|mesh-ancestor
92845608|NCT04427956|Riboflavin|riboflavin|mesh-list
92845609|NCT04427956|Vitamin B Complex|vitamin b complex|mesh-ancestor
92845610|NCT04427956|Vitamins|vitamins|mesh-ancestor
92845611|NCT04427956|Micronutrients|micronutrients|mesh-ancestor
92845612|NCT04427956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845613|NCT04427956|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92845614|NCT04427956|Dermatologic Agents|dermatologic agents|mesh-ancestor
92845615|NCT04427241|Cerebrolysin|cerebrolysin|mesh-list
92845616|NCT04427241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92845617|NCT04427241|Protective Agents|protective agents|mesh-ancestor
92845618|NCT04427241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845619|NCT04427241|Nootropic Agents|nootropic agents|mesh-ancestor
92845621|NCT04385290|Daunorubicin|daunorubicin|mesh-list
92845622|NCT04385290|Gemtuzumab|gemtuzumab|mesh-list
92845623|NCT04385290|Midostaurin|midostaurin|mesh-list
92845624|NCT04385290|Staurosporine|staurosporine|mesh-list
92845625|NCT04385290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845626|NCT04385290|Antimetabolites|antimetabolites|mesh-ancestor
92845627|NCT04385290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845628|NCT04385290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845629|NCT04385290|Antiviral Agents|antiviral agents|mesh-ancestor
92845630|NCT04385290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490720|NCT03354013|Calcium|calcium|mesh-list
92845631|NCT04385290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845632|NCT04385290|Immunologic Factors|immunologic factors|mesh-ancestor
92845633|NCT04385290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845634|NCT04385290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92845635|NCT04385290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92845636|NCT04385290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92845637|NCT04385290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845638|NCT04385290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845639|NCT04385290|Immunotoxins|immunotoxins|mesh-ancestor
92845640|NCT04385290|Immunoconjugates|immunoconjugates|mesh-ancestor
92845641|NCT04385290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845643|NCT04324463|Interferons|interferons|mesh-list
92845644|NCT04324463|Interferon-beta|interferon-beta|mesh-list
92845645|NCT04324463|Colchicine|colchicine|mesh-list
92845646|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
92845647|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845648|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
92845649|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845650|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92845651|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845652|NCT04324463|Analgesics|analgesics|mesh-ancestor
92845653|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
92845654|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845655|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845656|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845657|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845658|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92845659|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92845660|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845661|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92845662|NCT04324463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92845663|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845664|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
92845665|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92845666|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
92845667|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92845668|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
92845669|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
92845670|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
92845671|NCT04324463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92845672|NCT04324463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92845673|NCT04324463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92845674|NCT04324463|Immunologic Factors|immunologic factors|mesh-ancestor
92845675|NCT04315701|Cemiplimab|cemiplimab|mesh-list
92845676|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845677|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845678|NCT04240093|Analgesics, Opioid|analgesics, opioid|mesh-list
92845679|NCT04240093|Narcotics|narcotics|mesh-ancestor
92845680|NCT04240093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845681|NCT04240093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845682|NCT04240093|Analgesics|analgesics|mesh-ancestor
92845683|NCT04240093|Sensory System Agents|sensory system agents|mesh-ancestor
92845684|NCT04240093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845685|NCT04213794|Sodium thiosulfate|sodium thiosulfate|mesh-list
92845686|NCT04213794|Cisplatin|cisplatin|mesh-list
92845687|NCT04213794|Doxorubicin|doxorubicin|mesh-list
92845688|NCT04213794|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92845689|NCT04213794|Daunorubicin|daunorubicin|mesh-list
92845690|NCT04213794|Antidotes|antidotes|mesh-list
92845691|NCT04213794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845692|NCT04213794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92845693|NCT04213794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92845694|NCT04213794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92845695|NCT04213794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845696|NCT04213794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845697|NCT04213794|Protective Agents|protective agents|mesh-ancestor
92845698|NCT04213794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845700|NCT04213794|Antitubercular Agents|antitubercular agents|mesh-ancestor
92845701|NCT04213794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92845702|NCT04213794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845703|NCT04213794|Chelating Agents|chelating agents|mesh-ancestor
92845704|NCT04213794|Sequestering Agents|sequestering agents|mesh-ancestor
92845705|NCT04157335|Benralizumab|benralizumab|mesh-list
92845706|NCT04157335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92845707|NCT04157335|Respiratory System Agents|respiratory system agents|mesh-ancestor
92490792|NCT03150810|Pamiparib|pamiparib|mesh-list
92845708|NCT04115774|Diphosphonates|diphosphonates|mesh-list
92845709|NCT04115774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92845710|NCT04115774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845712|NCT04083170|Cyclophosphamide|cyclophosphamide|mesh-list
92845713|NCT04083170|Thiotepa|thiotepa|mesh-list
92845714|NCT04083170|Fludarabine|fludarabine|mesh-list
92845715|NCT04083170|Fludarabine phosphate|fludarabine phosphate|mesh-list
92845716|NCT04083170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845717|NCT04083170|Immunologic Factors|immunologic factors|mesh-ancestor
92845718|NCT04083170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845719|NCT04083170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845720|NCT04083170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845721|NCT04083170|Alkylating Agents|alkylating agents|mesh-ancestor
92845722|NCT04083170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845723|NCT04083170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845724|NCT04083170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92845725|NCT04083170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845726|NCT04083170|Antimetabolites|antimetabolites|mesh-ancestor
92845727|NCT04083170|Antiviral Agents|antiviral agents|mesh-ancestor
92845728|NCT04083170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845729|NCT04025359|Dronabinol|dronabinol|mesh-list
92845730|NCT04025359|Hallucinogens|hallucinogens|mesh-ancestor
92845731|NCT04025359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845732|NCT04025359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92845733|NCT04025359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845734|NCT04025359|Analgesics|analgesics|mesh-ancestor
92845735|NCT04025359|Sensory System Agents|sensory system agents|mesh-ancestor
92845736|NCT04025359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845737|NCT04025359|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92845738|NCT04025359|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92845739|NCT04025359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92845740|NCT04025359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845741|NCT04025359|Hormones|hormones|mesh-ancestor
92845742|NCT04025359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845743|NCT04005716|Cisplatin|cisplatin|mesh-list
92845744|NCT04005716|Carboplatin|carboplatin|mesh-list
92845745|NCT04005716|Etoposide|etoposide|mesh-list
92845746|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
92845747|NCT04005716|Tislelizumab|tislelizumab|mesh-list
92845748|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845749|NCT04005716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92845750|NCT04005716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92845751|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92845752|NCT04005716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845753|NCT04005716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845754|NCT04005716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845755|NCT03995628|Dexamethasone|dexamethasone|mesh-list
92845756|NCT03995628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845757|NCT03995628|Antiemetics|antiemetics|mesh-ancestor
92845758|NCT03995628|Autonomic Agents|autonomic agents|mesh-ancestor
92845759|NCT03995628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845760|NCT03995628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845761|NCT03995628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92845762|NCT03995628|Glucocorticoids|glucocorticoids|mesh-ancestor
92845763|NCT03995628|Hormones|hormones|mesh-ancestor
92845764|NCT03995628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845765|NCT03995628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92845766|NCT03995628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845767|NCT03972280|Antibodies|antibodies|mesh-list
92845768|NCT03972280|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92845769|NCT03972280|Lenograstim|lenograstim|mesh-list
92845770|NCT03972280|Immunologic Factors|immunologic factors|mesh-ancestor
92845771|NCT03972280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845772|NCT03972280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92845773|NCT03961568|Cenobamate|cenobamate|mesh-list
92845774|NCT03961568|Anticonvulsants|anticonvulsants|mesh-ancestor
92845775|NCT03941886|Aspirin|aspirin|mesh-list
92845776|NCT03941886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92845777|NCT03941886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92845778|NCT03941886|Analgesics|analgesics|mesh-ancestor
92845779|NCT03941886|Sensory System Agents|sensory system agents|mesh-ancestor
92845780|NCT03941886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92845781|NCT03941886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845782|NCT03941886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845783|NCT03941886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845784|NCT03941886|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92845785|NCT03941886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92845786|NCT03941886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845787|NCT03941886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92845788|NCT03941886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92845789|NCT03941886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845790|NCT03941886|Antipyretics|antipyretics|mesh-ancestor
92845791|NCT03921008|Paclitaxel|paclitaxel|mesh-list
92845792|NCT03921008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92845793|NCT03921008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845794|NCT03921008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92845795|NCT03921008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92845796|NCT03921008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92845797|NCT03921008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845798|NCT03845296|Rucaparib|rucaparib|mesh-list
92845799|NCT03845296|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92845800|NCT03845296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845801|NCT03845296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845802|NCT03845296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845803|NCT03813108|Lumefantrine|lumefantrine|mesh-list
92845804|NCT03813108|Artemether|artemether|mesh-list
92845805|NCT03813108|Mefloquine|mefloquine|mesh-list
92845806|NCT03813108|Atovaquone|atovaquone|mesh-list
92845807|NCT03813108|Proguanil|proguanil|mesh-list
92845808|NCT03813108|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92845809|NCT03813108|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92845810|NCT03813108|Antimalarials|antimalarials|mesh-ancestor
92845811|NCT03813108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92845812|NCT03813108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92845813|NCT03813108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845814|NCT03813108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845815|NCT03813108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845816|NCT03813108|Antimetabolites|antimetabolites|mesh-ancestor
92845817|NCT03675737|Pembrolizumab|pembrolizumab|mesh-list
92845818|NCT03675737|Fluorouracil|fluorouracil|mesh-list
92845819|NCT03675737|Capecitabine|capecitabine|mesh-list
92845820|NCT03675737|Oxaliplatin|oxaliplatin|mesh-list
92845821|NCT03675737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845822|NCT03675737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845823|NCT03675737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845824|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845825|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
92845826|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845827|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845828|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
92845829|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845830|NCT03621748|Anesthetics|anesthetics|mesh-list
92845831|NCT03621748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92845832|NCT03621748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845833|NCT03604991|Paclitaxel|paclitaxel|mesh-list
92845834|NCT03604991|Carboplatin|carboplatin|mesh-list
92845835|NCT03604991|Nivolumab|nivolumab|mesh-list
92845836|NCT03604991|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92845837|NCT03604991|Ipilimumab|ipilimumab|mesh-list
92845838|NCT03604991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92845839|NCT03604991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845840|NCT03604991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92845841|NCT03604991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92845842|NCT03604991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92845843|NCT03604991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845844|NCT03604991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845845|NCT03604991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845846|NCT03586453|Osimertinib|osimertinib|mesh-list
92845847|NCT03586453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845848|NCT03586453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845849|NCT03586453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845850|NCT03586453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845851|NCT03467373|Prednisone|prednisone|mesh-list
92845852|NCT03467373|Cyclophosphamide|cyclophosphamide|mesh-list
92845853|NCT03467373|Rituximab|rituximab|mesh-list
92845854|NCT03467373|Doxorubicin|doxorubicin|mesh-list
92845855|NCT03467373|Vincristine|vincristine|mesh-list
92845856|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
92845857|NCT03467373|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92845858|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845859|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
92845860|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845861|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845862|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845863|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
92845864|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845865|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845866|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92845867|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845868|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92845869|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92845870|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92845871|NCT03467373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845872|NCT03467373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92845873|NCT03467373|Glucocorticoids|glucocorticoids|mesh-ancestor
92845874|NCT03467373|Hormones|hormones|mesh-ancestor
92845875|NCT03467373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845876|NCT03467373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92845877|NCT03467373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92845878|NCT03467373|Tubulin Modulators|tubulin modulators|mesh-ancestor
92845879|NCT03467373|Antimitotic Agents|antimitotic agents|mesh-ancestor
92845880|NCT03467373|Mitosis Modulators|mitosis modulators|mesh-ancestor
92845881|NCT03467373|Immunoconjugates|immunoconjugates|mesh-ancestor
92845882|NCT03440450|Gemcitabine|gemcitabine|mesh-list
92845883|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845884|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
92845885|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845886|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845887|NCT03417154|Cyclophosphamide|cyclophosphamide|mesh-list
92845888|NCT03417154|Nivolumab|nivolumab|mesh-list
92845889|NCT03417154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845890|NCT03417154|Immunologic Factors|immunologic factors|mesh-ancestor
92845891|NCT03417154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845892|NCT03417154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845893|NCT03417154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845894|NCT03417154|Alkylating Agents|alkylating agents|mesh-ancestor
92845895|NCT03417154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845896|NCT03417154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845897|NCT03417154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92845898|NCT03417154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845899|NCT03417154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845900|NCT03396315|Zoledronic Acid|zoledronic acid|mesh-list
92845901|NCT03396315|Alendronate|alendronate|mesh-list
92845902|NCT03396315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92845903|NCT03396315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845904|NCT03332017|Obinutuzumab|obinutuzumab|mesh-list
92845905|NCT03332017|Zanubrutinib|zanubrutinib|mesh-list
92845906|NCT03332017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845907|NCT03332017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845908|NCT03332017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845909|NCT03332017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845910|NCT03332017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845911|NCT03221036|Vedolizumab|vedolizumab|mesh-list
92845912|NCT03221036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92845913|NCT03120624|Iodine|iodine|mesh-list
92845914|NCT03120624|Interferons|interferons|mesh-list
92845915|NCT03120624|Interferon-beta|interferon-beta|mesh-list
92845916|NCT03120624|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92845917|NCT03120624|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
92845918|NCT03120624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845919|NCT03120624|Antiviral Agents|antiviral agents|mesh-ancestor
92845920|NCT03120624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845921|NCT03120624|Immunologic Factors|immunologic factors|mesh-ancestor
92845922|NCT03120624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845923|NCT03120624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92845924|NCT03120624|Trace Elements|trace elements|mesh-ancestor
92845925|NCT03120624|Micronutrients|micronutrients|mesh-ancestor
92845926|NCT03120624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845927|NCT03120624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845928|NCT03120624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845929|NCT03120624|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92845930|NCT03032783|Mycophenolic Acid|mycophenolic acid|mesh-list
92845931|NCT03032783|Cyclophosphamide|cyclophosphamide|mesh-list
92845932|NCT03032783|Tacrolimus|tacrolimus|mesh-list
92845933|NCT03032783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845934|NCT03032783|Immunologic Factors|immunologic factors|mesh-ancestor
92845935|NCT03032783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845936|NCT03032783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845937|NCT03032783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845938|NCT03032783|Alkylating Agents|alkylating agents|mesh-ancestor
92845939|NCT03032783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845940|NCT03032783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845941|NCT03032783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92845942|NCT03032783|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92845943|NCT03032783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845944|NCT03032783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92845945|NCT03032783|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92845946|NCT03032783|Antitubercular Agents|antitubercular agents|mesh-ancestor
92845947|NCT03032783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92845948|NCT03032783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845949|NCT02778685|Pembrolizumab|pembrolizumab|mesh-list
92845950|NCT02778685|Letrozole|letrozole|mesh-list
92845951|NCT02778685|Fulvestrant|fulvestrant|mesh-list
92845952|NCT02778685|Palbociclib|palbociclib|mesh-list
92845953|NCT02778685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845954|NCT02778685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845955|NCT02778685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92845956|NCT02778685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845957|NCT02778685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92845958|NCT02778685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92845959|NCT02778685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845960|NCT02778685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92845961|NCT02778685|Hormone Antagonists|hormone antagonists|mesh-ancestor
92845962|NCT02778685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845963|NCT02778685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845964|NCT02778685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92845965|NCT02778685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92845966|NCT02778685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92845967|NCT02740985|Docetaxel|docetaxel|mesh-list
92845968|NCT02740985|Durvalumab|durvalumab|mesh-list
92845969|NCT02740985|Abiraterone Acetate|abiraterone acetate|mesh-list
92845970|NCT02740985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845971|NCT02740985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92845972|NCT02740985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92845973|NCT02740985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92845974|NCT02740985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845975|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845976|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92845977|NCT02740985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92845978|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
92845979|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92845980|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845981|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92845982|NCT02728531|Cytarabine|cytarabine|mesh-list
92845983|NCT02728531|Rituximab|rituximab|mesh-list
92845984|NCT02728531|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92845985|NCT02728531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92845986|NCT02728531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92845987|NCT02728531|Immunologic Factors|immunologic factors|mesh-ancestor
92845988|NCT02728531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92845989|NCT02728531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92845990|NCT02728531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92845991|NCT02728531|Antimetabolites|antimetabolites|mesh-ancestor
92845992|NCT02728531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92845993|NCT02728531|Antiviral Agents|antiviral agents|mesh-ancestor
92845994|NCT02728531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92845995|NCT02728531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92845996|NCT02728531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92845997|NCT02728531|Alkylating Agents|alkylating agents|mesh-ancestor
92845998|NCT02723331|Paclitaxel|paclitaxel|mesh-list
92845999|NCT02723331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92846000|NCT02723331|Gemcitabine|gemcitabine|mesh-list
92846001|NCT02723331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92846002|NCT02723331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846003|NCT02723331|Tubulin Modulators|tubulin modulators|mesh-ancestor
92846004|NCT02723331|Antimitotic Agents|antimitotic agents|mesh-ancestor
92846005|NCT02723331|Mitosis Modulators|mitosis modulators|mesh-ancestor
92846006|NCT02723331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846007|NCT02723331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92846008|NCT02723331|Antimetabolites|antimetabolites|mesh-ancestor
92846009|NCT02593526|Bumetanide|bumetanide|mesh-list
92846010|NCT02593526|Dialysis Solutions|dialysis solutions|mesh-list
92846011|NCT02593526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92846012|NCT02593526|Diuretics|diuretics|mesh-ancestor
92846013|NCT02593526|Natriuretic Agents|natriuretic agents|mesh-ancestor
92846014|NCT02593526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846015|NCT02593526|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92846016|NCT02593526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846017|NCT02593526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846018|NCT02484677|Docetaxel|docetaxel|mesh-list
92846019|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846020|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92846021|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92846022|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92846023|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846024|NCT02476097|Esomeprazole|esomeprazole|mesh-list
92846025|NCT02476097|Omeprazole|omeprazole|mesh-list
92846026|NCT02476097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92846027|NCT02476097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846028|NCT02476097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92846029|NCT02476097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846030|NCT02476097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846031|NCT02456857|Bevacizumab|bevacizumab|mesh-list
92846032|NCT02456857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92846033|NCT02456857|Doxorubicin|doxorubicin|mesh-list
92846034|NCT02456857|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92846035|NCT02456857|Everolimus|everolimus|mesh-list
92846036|NCT02456857|Endothelial Growth Factors|endothelial growth factors|mesh-list
92846037|NCT02456857|Antibodies|antibodies|mesh-list
92846038|NCT02456857|Immunoglobulins|immunoglobulins|mesh-list
92846039|NCT02456857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92846040|NCT02456857|Immunoglobulin G|immunoglobulin g|mesh-list
92846041|NCT02456857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846042|NCT02456857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846043|NCT02456857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846044|NCT02456857|Growth Substances|growth substances|mesh-ancestor
92846045|NCT02456857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846046|NCT02456857|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846047|NCT02456857|Immunologic Factors|immunologic factors|mesh-ancestor
92846048|NCT02456857|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92846049|NCT02456857|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92846050|NCT02456857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92846051|NCT02456857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846052|NCT02456857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846053|NCT02456857|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92846054|NCT02456857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92846055|NCT02456857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846056|NCT03946358|Atezolizumab|atezolizumab|mesh-list
92846057|NCT03946358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92846058|NCT03946358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846059|NCT03946358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846060|NCT03946358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846061|NCT02118584|Etrolizumab|etrolizumab|mesh-list
92846062|NCT02118584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846063|NCT02118584|Immunologic Factors|immunologic factors|mesh-ancestor
92846064|NCT02118584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846066|NCT02115282|Goserelin|goserelin|mesh-list
92846067|NCT02115282|Entinostat|entinostat|mesh-list
92846068|NCT02115282|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92846069|NCT02115282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846070|NCT02115282|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92846071|NCT02115282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92846072|NCT02115282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846073|NCT02115282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846074|NCT02115282|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92846075|NCT02115282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846076|NCT02115282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846077|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846078|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846079|NCT02107963|Cyclophosphamide|cyclophosphamide|mesh-list
92846080|NCT02107963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846081|NCT02107963|Immunologic Factors|immunologic factors|mesh-ancestor
92846082|NCT02107963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846083|NCT02107963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846084|NCT02107963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92846085|NCT02107963|Alkylating Agents|alkylating agents|mesh-ancestor
92846086|NCT02107963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846087|NCT02107963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846088|NCT02107963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92846089|NCT02106507|Everolimus|everolimus|mesh-list
92846090|NCT02106507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92846091|NCT02106507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92846092|NCT02106507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846093|NCT02106507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846094|NCT02106507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846095|NCT02106507|Immunologic Factors|immunologic factors|mesh-ancestor
92846096|NCT02106507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846097|NCT02106507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846098|NCT02051218|Denosumab|denosumab|mesh-list
92846099|NCT02051218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92846100|NCT02051218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846101|NCT01940094|Prednisone|prednisone|mesh-list
92846102|NCT01940094|Glucocorticoids|glucocorticoids|mesh-list
92846103|NCT01940094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846104|NCT01940094|Hormones|hormones|mesh-ancestor
92846105|NCT01940094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846106|NCT01940094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846107|NCT01940094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846108|NCT01940094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846109|NCT01905046|Metformin|metformin|mesh-list
92846110|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92846111|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846112|NCT01786265|Prednisone|prednisone|mesh-list
92846113|NCT01786265|Cortisone|cortisone|mesh-list
92846114|NCT01786265|Leuprolide|leuprolide|mesh-list
92846115|NCT01786265|Goserelin|goserelin|mesh-list
92846116|NCT01786265|Flutamide|flutamide|mesh-list
92846117|NCT01786265|Abiraterone Acetate|abiraterone acetate|mesh-list
92846118|NCT01786265|Bicalutamide|bicalutamide|mesh-list
92846119|NCT01786265|Nilutamide|nilutamide|mesh-list
92846120|NCT01786265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846121|NCT01786265|Glucocorticoids|glucocorticoids|mesh-ancestor
92846122|NCT01786265|Hormones|hormones|mesh-ancestor
92846123|NCT01786265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846124|NCT01786265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846125|NCT01786265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846126|NCT01786265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846127|NCT01786265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92846128|NCT01786265|Fertility Agents|fertility agents|mesh-ancestor
92846129|NCT01786265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92846130|NCT01786265|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92846131|NCT01786265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846132|NCT01786265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846133|NCT01786265|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846134|NCT01786265|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92846135|NCT01786265|Androgen Antagonists|androgen antagonists|mesh-ancestor
92846136|NCT01596621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92846137|NCT01596621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92846139|NCT01596621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846140|NCT01596621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846141|NCT01264315|Lenalidomide|lenalidomide|mesh-list
92846142|NCT01264315|Immunologic Factors|immunologic factors|mesh-ancestor
92846143|NCT01264315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846144|NCT01264315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846145|NCT01264315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846146|NCT01264315|Growth Substances|growth substances|mesh-ancestor
92846147|NCT01264315|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846148|NCT01264315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846149|NCT01108627|Formoterol Fumarate|formoterol fumarate|mesh-list
92846150|NCT01108627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92846151|NCT01108627|Autonomic Agents|autonomic agents|mesh-ancestor
92846152|NCT01108627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846153|NCT01108627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846154|NCT01108627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92846155|NCT01108627|Respiratory System Agents|respiratory system agents|mesh-ancestor
92846156|NCT01108627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92491262|NCT01953744|Fluconazole|fluconazole|mesh-list
92846157|NCT01108627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92846158|NCT01108627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92846159|NCT01108627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92846160|NCT01108627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846161|NCT01108627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846162|NCT00890149|Ondansetron|ondansetron|mesh-list
92846163|NCT00890149|Antiemetics|antiemetics|mesh-ancestor
92846164|NCT00890149|Autonomic Agents|autonomic agents|mesh-ancestor
92846165|NCT00890149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846166|NCT00890149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846167|NCT00890149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846168|NCT00890149|Antipruritics|antipruritics|mesh-ancestor
92846169|NCT00890149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846170|NCT00890149|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92846171|NCT00890149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92846172|NCT00890149|Serotonin Agents|serotonin agents|mesh-ancestor
92846173|NCT00890149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846174|NCT00890149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846175|NCT00566098|Melphalan|melphalan|mesh-list
92846176|NCT00566098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92846177|NCT00566098|Alkylating Agents|alkylating agents|mesh-ancestor
92846178|NCT00566098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846179|NCT00566098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846180|NCT00566098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92846181|NCT00566098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846182|NCT00566098|Immunologic Factors|immunologic factors|mesh-ancestor
92846183|NCT00566098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846184|NCT00248287|Carboplatin|carboplatin|mesh-list
92846185|NCT00248287|Irinotecan|irinotecan|mesh-list
92846186|NCT00248287|Cetuximab|cetuximab|mesh-list
92846187|NCT00248287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846188|NCT00248287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92846189|NCT00248287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92846190|NCT00248287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846191|NCT00248287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846192|NCT00248287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846193|NCT04249284|Deucravacitinib|deucravacitinib|mesh-list
92846194|NCT04249284|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846195|NCT04249284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92846196|NCT04249284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846197|NCT04249284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846198|NCT04474938|Dexamethasone|dexamethasone|mesh-list
92846199|NCT04474938|Bortezomib|bortezomib|mesh-list
92846200|NCT04474938|Daratumumab|daratumumab|mesh-list
92846201|NCT04474938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846202|NCT04474938|Antiemetics|antiemetics|mesh-ancestor
92846203|NCT04474938|Autonomic Agents|autonomic agents|mesh-ancestor
92846204|NCT04474938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846205|NCT04474938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846206|NCT04474938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846207|NCT04474938|Glucocorticoids|glucocorticoids|mesh-ancestor
92846208|NCT04474938|Hormones|hormones|mesh-ancestor
92846209|NCT04474938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846210|NCT04474938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846211|NCT04474938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846213|NCT00837213|Clindamycin|clindamycin|mesh-list
92846214|NCT00837213|Clindamycin palmitate|clindamycin palmitate|mesh-list
92846215|NCT00837213|Clindamycin phosphate|clindamycin phosphate|mesh-list
92846216|NCT00837213|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92846217|NCT00837213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92846218|NCT00837213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846219|NCT00837213|Antimalarials|antimalarials|mesh-ancestor
92846220|NCT00837213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92846221|NCT00837213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92846222|NCT00837213|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92846223|NCT00837213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846224|NCT00837213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846225|NCT00837213|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846226|NCT02833038|Magnesium Sulfate|magnesium sulfate|mesh-list
92846227|NCT02833038|Analgesics|analgesics|mesh-ancestor
92846228|NCT02833038|Sensory System Agents|sensory system agents|mesh-ancestor
92846229|NCT02833038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846230|NCT02833038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846231|NCT02833038|Anesthetics|anesthetics|mesh-ancestor
92846232|NCT02833038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846233|NCT02833038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92846234|NCT02833038|Anticonvulsants|anticonvulsants|mesh-ancestor
92846235|NCT02833038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92846236|NCT02833038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846237|NCT02833038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846238|NCT02833038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92846239|NCT02833038|Tocolytic Agents|tocolytic agents|mesh-ancestor
92846240|NCT02833038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92846241|NCT00703755|Metformin|metformin|mesh-list
92846242|NCT00703755|Fenofibrate|fenofibrate|mesh-list
92846243|NCT00703755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92846244|NCT00703755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846245|NCT00703755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92846246|NCT00703755|Antimetabolites|antimetabolites|mesh-ancestor
92846247|NCT00703755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846248|NCT00703755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92846249|NCT02838342|Interferons|interferons|mesh-list
92846250|NCT02838342|Interferon-alpha|interferon-alpha|mesh-list
92846251|NCT02838342|Cyclophosphamide|cyclophosphamide|mesh-list
92846252|NCT02838342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846253|NCT02838342|Immunologic Factors|immunologic factors|mesh-ancestor
92846254|NCT02838342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846255|NCT02838342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846256|NCT02838342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92846257|NCT02838342|Alkylating Agents|alkylating agents|mesh-ancestor
92846258|NCT02838342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846259|NCT02838342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846260|NCT02838342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92846261|NCT02838342|Antiviral Agents|antiviral agents|mesh-ancestor
92846262|NCT02838342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846263|NCT05333640|Sirolimus|sirolimus|mesh-list
92846264|NCT05333640|Paclitaxel|paclitaxel|mesh-list
92846265|NCT05333640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92846266|NCT05333640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846267|NCT05333640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92846268|NCT05333640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92846269|NCT05333640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92846270|NCT05333640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846271|NCT05333640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92846272|NCT05333640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846273|NCT05333640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92846274|NCT05333640|Antifungal Agents|antifungal agents|mesh-ancestor
92846275|NCT05333640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846276|NCT05333640|Immunologic Factors|immunologic factors|mesh-ancestor
92846277|NCT05333640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846278|NCT02838264|Itraconazole|itraconazole|mesh-list
92846279|NCT02838264|Antifungal Agents|antifungal agents|mesh-ancestor
92846280|NCT02838264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846281|NCT02838264|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92846282|NCT02838264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92846283|NCT02838264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846284|NCT02838264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191491|NCT00405353|Hormones|hormones|mesh-ancestor
92846285|NCT02838264|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92846286|NCT02838264|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846287|NCT02838264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846288|NCT02838264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846289|NCT02838264|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92846291|NCT00633438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92846292|NCT00633438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92846293|NCT00633438|Analgesics|analgesics|mesh-ancestor
92846294|NCT00633438|Sensory System Agents|sensory system agents|mesh-ancestor
92846295|NCT00633438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846296|NCT00633438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846297|NCT00633438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846298|NCT00633438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846299|NCT00633438|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92846300|NCT00633438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92846301|NCT00633438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846302|NCT00633438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846303|NCT02833116|Dexamethasone|dexamethasone|mesh-list
92846304|NCT02833116|Betamethasone|betamethasone|mesh-list
92846305|NCT02833116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846306|NCT02833116|Antiemetics|antiemetics|mesh-ancestor
92846307|NCT02833116|Autonomic Agents|autonomic agents|mesh-ancestor
92846308|NCT02833116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046921|NCT01051544|Coagulants|coagulants|mesh-ancestor
92846309|NCT02833116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846310|NCT02833116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846311|NCT02833116|Glucocorticoids|glucocorticoids|mesh-ancestor
92846312|NCT02833116|Hormones|hormones|mesh-ancestor
92846313|NCT02833116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846314|NCT02833116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846315|NCT02833116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846316|NCT02833116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92846317|NCT02833116|Respiratory System Agents|respiratory system agents|mesh-ancestor
92846318|NCT00703989|Thioctic Acid|thioctic acid|mesh-list
92846319|NCT00703989|Benphothiamine|benphothiamine|mesh-list
92846320|NCT00703989|Antioxidants|antioxidants|mesh-ancestor
92846321|NCT00703989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846322|NCT00703989|Protective Agents|protective agents|mesh-ancestor
92846323|NCT00703989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846324|NCT00703989|Vitamin B Complex|vitamin b complex|mesh-ancestor
92846325|NCT00703989|Vitamins|vitamins|mesh-ancestor
92846326|NCT00703989|Micronutrients|micronutrients|mesh-ancestor
92846327|NCT00703989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92846328|NCT00703989|Immunologic Factors|immunologic factors|mesh-ancestor
92846329|NCT00703989|Chelating Agents|chelating agents|mesh-ancestor
92846330|NCT00703989|Sequestering Agents|sequestering agents|mesh-ancestor
92846331|NCT05335460|Capecitabine|capecitabine|mesh-list
92846332|NCT05335460|Oxaliplatin|oxaliplatin|mesh-list
92846333|NCT05335460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92846334|NCT05335460|Antimetabolites|antimetabolites|mesh-ancestor
92846335|NCT05335460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846336|NCT05335460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846337|NCT02836002|Pyrimethamine|pyrimethamine|mesh-list
92846338|NCT02836002|Piperaquine|piperaquine|mesh-list
92846339|NCT02836002|Sulfadoxine|sulfadoxine|mesh-list
92846340|NCT02836002|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92846341|NCT02836002|Atovaquone|atovaquone|mesh-list
92846342|NCT02836002|Proguanil|proguanil|mesh-list
92846343|NCT02836002|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92846344|NCT02836002|Antimalarials|antimalarials|mesh-ancestor
92846345|NCT02836002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92846346|NCT02836002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92846347|NCT02836002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846348|NCT02836002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92846349|NCT02836002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846350|NCT02836002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846351|NCT02836002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92846352|NCT02836002|Antimetabolites|antimetabolites|mesh-ancestor
92846353|NCT02297516|Botulinum Toxins|botulinum toxins|mesh-list
92846354|NCT02297516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92846355|NCT02297516|Hyaluronic Acid|hyaluronic acid|mesh-list
92846356|NCT02297516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92846357|NCT02297516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846358|NCT02297516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846359|NCT02297516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92846360|NCT02297516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846361|NCT02297516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846362|NCT02297516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92846363|NCT02297516|Immunologic Factors|immunologic factors|mesh-ancestor
92846364|NCT02297516|Viscosupplements|viscosupplements|mesh-ancestor
92846365|NCT02297516|Protective Agents|protective agents|mesh-ancestor
92846366|NCT02842580|Leucovorin|leucovorin|mesh-list
92846367|NCT02842580|Bevacizumab|bevacizumab|mesh-list
92846368|NCT02842580|Capecitabine|capecitabine|mesh-list
92846369|NCT02842580|Oxaliplatin|oxaliplatin|mesh-list
92846370|NCT02842580|Irinotecan|irinotecan|mesh-list
92846371|NCT02842580|Levoleucovorin|levoleucovorin|mesh-list
92846372|NCT02842580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846373|NCT02842580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846374|NCT02842580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846375|NCT02842580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846376|NCT02842580|Growth Substances|growth substances|mesh-ancestor
92846377|NCT02842580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846378|NCT02842580|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846379|NCT02842580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92846380|NCT02842580|Antimetabolites|antimetabolites|mesh-ancestor
92846381|NCT02842580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846382|NCT02842580|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92846383|NCT02842580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92846384|NCT02842580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846385|NCT02842580|Antidotes|antidotes|mesh-ancestor
92846386|NCT02842580|Protective Agents|protective agents|mesh-ancestor
92846387|NCT02842580|Vitamin B Complex|vitamin b complex|mesh-ancestor
92846388|NCT02842580|Vitamins|vitamins|mesh-ancestor
92846389|NCT02842580|Micronutrients|micronutrients|mesh-ancestor
92846390|NCT00836277|Irinotecan|irinotecan|mesh-list
92846391|NCT00836277|Panitumumab|panitumumab|mesh-list
92846392|NCT00836277|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92846393|NCT00836277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92846394|NCT00836277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846395|NCT00836277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846396|NCT00836277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846397|NCT00836277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846398|NCT00831025|Immunomodulating Agents|immunomodulating agents|mesh-list
92846399|NCT00831025|Immunologic Factors|immunologic factors|mesh-ancestor
92846400|NCT00831025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846401|NCT00835731|Vitamin B 12|vitamin b 12|mesh-list
92846402|NCT00835731|Hydroxocobalamin|hydroxocobalamin|mesh-list
92846403|NCT00835731|Misoprostol|misoprostol|mesh-list
92846404|NCT00835731|Vitamins|vitamins|mesh-ancestor
92846405|NCT00835731|Micronutrients|micronutrients|mesh-ancestor
92846406|NCT00835731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846407|NCT00835731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92846408|NCT00835731|Abortifacient Agents|abortifacient agents|mesh-ancestor
92846409|NCT00835731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92846410|NCT00835731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92846411|NCT00835731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846412|NCT00835731|Oxytocics|oxytocics|mesh-ancestor
92846413|NCT00835731|Vitamin B Complex|vitamin b complex|mesh-ancestor
92846414|NCT00835731|Hematinics|hematinics|mesh-ancestor
92846415|NCT03721406|Ropivacaine|ropivacaine|mesh-list
92846416|NCT03721406|Anesthetics, Local|anesthetics, local|mesh-ancestor
92846417|NCT03721406|Anesthetics|anesthetics|mesh-ancestor
92846418|NCT03721406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846419|NCT03721406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846420|NCT03721406|Sensory System Agents|sensory system agents|mesh-ancestor
92846421|NCT03721406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846422|NCT00751166|Cetirizine|cetirizine|mesh-list
92846423|NCT00751166|Desloratadine|desloratadine|mesh-list
92846424|NCT00751166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92846425|NCT00751166|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92846426|NCT00751166|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92846427|NCT00751166|Histamine Antagonists|histamine antagonists|mesh-ancestor
92846428|NCT00751166|Histamine Agents|histamine agents|mesh-ancestor
92846429|NCT00751166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846430|NCT00751166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846431|NCT00751166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846432|NCT00751166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92846433|NCT00751166|Cholinergic Agents|cholinergic agents|mesh-ancestor
92846434|NCT00837343|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92846435|NCT00837343|Antidepressive Agents|antidepressive agents|mesh-ancestor
92846436|NCT00837343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92846437|NCT00837343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92846438|NCT00837343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92846439|NCT00837343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846440|NCT00837343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846441|NCT00732368|Mometasone Furoate|mometasone furoate|mesh-list
92846442|NCT00732368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846443|NCT00732368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846444|NCT00732368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92846445|NCT00704145|Paclitaxel|paclitaxel|mesh-list
92846446|NCT00704145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92846447|NCT00704145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846448|NCT00704145|Tubulin Modulators|tubulin modulators|mesh-ancestor
92846449|NCT00704145|Antimitotic Agents|antimitotic agents|mesh-ancestor
92846450|NCT00704145|Mitosis Modulators|mitosis modulators|mesh-ancestor
92846451|NCT00704145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846452|NCT03508232|Doxycycline|doxycycline|mesh-list
92846453|NCT03508232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92846454|NCT03508232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846455|NCT03508232|Antimalarials|antimalarials|mesh-ancestor
92846456|NCT03508232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92846457|NCT03508232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92846458|NCT00704223|Insulin Aspart|insulin aspart|mesh-list
92846459|NCT00704223|Biphasic Insulins|biphasic insulins|mesh-list
92846460|NCT00704223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92846461|NCT00704223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846462|NCT00704301|Rivastigmine|rivastigmine|mesh-list
92846463|NCT00704301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92846464|NCT00704301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846465|NCT00704301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846466|NCT00704301|Cholinergic Agents|cholinergic agents|mesh-ancestor
92846467|NCT00704301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846468|NCT00704301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846469|NCT00704301|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92846470|NCT00704301|Protective Agents|protective agents|mesh-ancestor
92846471|NCT00831103|Valacyclovir|valacyclovir|mesh-list
92846472|NCT00831103|Antiviral Agents|antiviral agents|mesh-ancestor
92846473|NCT00831103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846474|NCT00704444|Ezetimibe|ezetimibe|mesh-list
92846475|NCT00704444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92846476|NCT00704444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92846477|NCT00704444|Antimetabolites|antimetabolites|mesh-ancestor
92846478|NCT00704444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846479|NCT00704444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92846480|NCT00704691|Lenalidomide|lenalidomide|mesh-list
92846481|NCT00704691|Immunologic Factors|immunologic factors|mesh-ancestor
92846482|NCT00704691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846483|NCT00704691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846484|NCT00704691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846485|NCT00704691|Growth Substances|growth substances|mesh-ancestor
92846486|NCT00704691|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846487|NCT00704691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846488|NCT00704925|Amifampridine|amifampridine|mesh-list
92846489|NCT00704925|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92846490|NCT00704925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846491|NCT00704925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846492|NCT00704925|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92846493|NCT00704925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846494|NCT00704925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846495|NCT00574249|Adalimumab|adalimumab|mesh-list
92846496|NCT00574249|Betamethasone|betamethasone|mesh-list
92846497|NCT00574249|Calcipotriene|calcipotriene|mesh-list
92846498|NCT00574249|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92846499|NCT00574249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846500|NCT00574249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846501|NCT00574249|Glucocorticoids|glucocorticoids|mesh-ancestor
92846502|NCT00574249|Hormones|hormones|mesh-ancestor
92846503|NCT00574249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846504|NCT00574249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846505|NCT00574249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92846506|NCT00574249|Respiratory System Agents|respiratory system agents|mesh-ancestor
92846507|NCT00574249|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846508|NCT00891228|ST 1435|st 1435|mesh-list
92846509|NCT00891228|Testosterone|testosterone|mesh-list
92846510|NCT00891228|Androgens|androgens|mesh-ancestor
92846511|NCT00891228|Hormones|hormones|mesh-ancestor
92977214|NCT00586157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846512|NCT00891228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846513|NCT00891228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846514|NCT00891228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92846515|NCT00891228|Contraceptive Agents|contraceptive agents|mesh-ancestor
92846516|NCT00891228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92846517|NCT00891228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92846518|NCT00896168|Infliximab|infliximab|mesh-list
92846519|NCT00896168|Methotrexate|methotrexate|mesh-list
92846520|NCT00896168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92846521|NCT00896168|Abortifacient Agents|abortifacient agents|mesh-ancestor
92846522|NCT00896168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92846523|NCT00896168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846524|NCT00896168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92846525|NCT00896168|Antimetabolites|antimetabolites|mesh-ancestor
92846526|NCT00896168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846527|NCT00896168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846528|NCT00896168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846529|NCT00896168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846530|NCT00896168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92846531|NCT00896168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846532|NCT00896168|Immunologic Factors|immunologic factors|mesh-ancestor
92846533|NCT00896168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846534|NCT00896168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92846535|NCT00896168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92846536|NCT00896168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846537|NCT00896168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846538|NCT00833703|Clopidogrel|clopidogrel|mesh-list
92846539|NCT00833703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92846540|NCT00833703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92846541|NCT00833703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92846542|NCT00833703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92846543|NCT00833703|Purinergic Agents|purinergic agents|mesh-ancestor
92846544|NCT00833703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846545|NCT00833703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846546|NCT00833703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846547|NCT00833547|Eszopiclone|eszopiclone|mesh-list
92846548|NCT00833547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92846549|NCT00833547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846550|NCT00833547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846551|NCT00833469|Escitalopram|escitalopram|mesh-list
92846552|NCT00833469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92846553|NCT00833469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92846554|NCT00833469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846555|NCT00833469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846556|NCT00833469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846557|NCT00833469|Serotonin Agents|serotonin agents|mesh-ancestor
92846558|NCT00833469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846559|NCT02831478|Sunscreening Agents|sunscreening agents|mesh-list
92846560|NCT02831478|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92846561|NCT02831478|Protective Agents|protective agents|mesh-ancestor
92846562|NCT02831478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846563|NCT02831478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92846564|NCT00837655|Calcium Carbonate|calcium carbonate|mesh-list
92846565|NCT00837655|Calcium|calcium|mesh-list
92846566|NCT00837655|Sevelamer|sevelamer|mesh-list
92846567|NCT00837655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92846568|NCT00837655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846569|NCT00837655|Antacids|antacids|mesh-ancestor
92846570|NCT00837655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846571|NCT00837655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846572|NCT00837655|Chelating Agents|chelating agents|mesh-ancestor
92846573|NCT00837655|Sequestering Agents|sequestering agents|mesh-ancestor
92846574|NCT00843661|Ezetimibe|ezetimibe|mesh-list
92846575|NCT00843661|Pravastatin|pravastatin|mesh-list
92846576|NCT00843661|Fenofibrate|fenofibrate|mesh-list
92846577|NCT00843661|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92846578|NCT00843661|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92846579|NCT00843661|Antimetabolites|antimetabolites|mesh-ancestor
92846580|NCT00843661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846581|NCT00843661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92846582|NCT00843661|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92846583|NCT00843661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846584|NCT00832377|Timolol|timolol|mesh-list
92846585|NCT00832377|Dorzolamide|dorzolamide|mesh-list
92846586|NCT00832377|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92846587|NCT00832377|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92846588|NCT00832377|Adrenergic Agents|adrenergic agents|mesh-ancestor
92846589|NCT00832377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846590|NCT00832377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846591|NCT00832377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846592|NCT00832377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92846593|NCT00832377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92846594|NCT00832377|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92846595|NCT00832377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846596|NCT00843895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92846597|NCT00843895|Immunologic Factors|immunologic factors|mesh-ancestor
92846598|NCT00843895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846599|NCT00705315|Bevacizumab|bevacizumab|mesh-list
92846600|NCT00705315|Docetaxel|docetaxel|mesh-list
92846601|NCT00705315|Epirubicin|epirubicin|mesh-list
92846602|NCT00705315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846603|NCT00705315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846604|NCT00705315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846605|NCT00705315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846606|NCT00705315|Growth Substances|growth substances|mesh-ancestor
92846607|NCT00705315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846608|NCT00705315|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846609|NCT00705315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92846610|NCT00705315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92846611|NCT00705315|Mitosis Modulators|mitosis modulators|mesh-ancestor
93046922|NCT01058720|Vitamin D|vitamin d|mesh-list
92846612|NCT00705315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846613|NCT00705315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92846614|NCT00705315|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92846615|NCT00705315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92846616|NCT00705315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846617|NCT00892008|Pregabalin|pregabalin|mesh-list
92846618|NCT00892008|Analgesics|analgesics|mesh-ancestor
92846619|NCT00892008|Sensory System Agents|sensory system agents|mesh-ancestor
92846620|NCT00892008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846621|NCT00892008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846622|NCT00892008|Anticonvulsants|anticonvulsants|mesh-ancestor
92846623|NCT00892008|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92846624|NCT00892008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846625|NCT00892008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846626|NCT00892008|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92846627|NCT00892008|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92846628|NCT00892008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92846629|NCT00892008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846630|NCT00892008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92846631|NCT00623233|Bevacizumab|bevacizumab|mesh-list
92846632|NCT00623233|Gemcitabine|gemcitabine|mesh-list
92846633|NCT00623233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846634|NCT00623233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846635|NCT00623233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846636|NCT00623233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846637|NCT00623233|Growth Substances|growth substances|mesh-ancestor
92846638|NCT00623233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846639|NCT00623233|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846640|NCT00623233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92846641|NCT00623233|Antimetabolites|antimetabolites|mesh-ancestor
92846642|NCT00623233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846643|NCT00837889|Diuretics|diuretics|mesh-list
92846644|NCT00837889|Natriuretic Agents|natriuretic agents|mesh-ancestor
92846645|NCT00837889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846646|NCT02841488|Fentanyl|fentanyl|mesh-list
92846647|NCT02841488|Ropivacaine|ropivacaine|mesh-list
92846648|NCT02841488|Anesthetics, Local|anesthetics, local|mesh-ancestor
92846649|NCT02841488|Anesthetics|anesthetics|mesh-ancestor
92846650|NCT02841488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846651|NCT02841488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846652|NCT02841488|Sensory System Agents|sensory system agents|mesh-ancestor
92846653|NCT02841488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846654|NCT02841488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92846655|NCT02841488|Narcotics|narcotics|mesh-ancestor
92846656|NCT02841488|Analgesics|analgesics|mesh-ancestor
92846657|NCT02841488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92846658|NCT02841488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92846659|NCT02841488|Anesthetics, General|anesthetics, general|mesh-ancestor
92846661|NCT02832726|Hydroxocobalamin|hydroxocobalamin|mesh-list
92846662|NCT02832726|Vitamins|vitamins|mesh-ancestor
92846663|NCT02832726|Micronutrients|micronutrients|mesh-ancestor
92846664|NCT02832726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846665|NCT02832726|Vitamin B Complex|vitamin b complex|mesh-ancestor
92846666|NCT02832726|Hematinics|hematinics|mesh-ancestor
92846667|NCT00202904|Ezetimibe|ezetimibe|mesh-list
92846668|NCT00202904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92846669|NCT00202904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92846670|NCT00202904|Antimetabolites|antimetabolites|mesh-ancestor
92846671|NCT00202904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846672|NCT00202904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92846673|NCT02690870|Tamoxifen|tamoxifen|mesh-list
92846674|NCT02690870|Clomiphene|clomiphene|mesh-list
92846675|NCT02690870|Enclomiphene|enclomiphene|mesh-list
92846676|NCT02690870|Zuclomiphene|zuclomiphene|mesh-list
92846677|NCT02690870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92846678|NCT02690870|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846679|NCT02690870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846680|NCT02690870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846681|NCT02690870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846682|NCT02690870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846683|NCT02690870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92846684|NCT02690870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92846685|NCT02690870|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92491767|NCT01956487|Propafenone|propafenone|mesh-list
92846686|NCT02690870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92846687|NCT02690870|Fertility Agents|fertility agents|mesh-ancestor
92846688|NCT02690870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92846689|NCT00844207|Azithromycin|azithromycin|mesh-list
92846690|NCT00844207|Chloroquine|chloroquine|mesh-list
92846691|NCT00844207|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92846692|NCT00844207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92846693|NCT00844207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846694|NCT00844207|Amebicides|amebicides|mesh-ancestor
92846695|NCT00844207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92846696|NCT00844207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92846697|NCT00844207|Antimalarials|antimalarials|mesh-ancestor
92846698|NCT00844207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846699|NCT00844207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92846700|NCT00844207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92846701|NCT00844207|Analgesics|analgesics|mesh-ancestor
92846702|NCT00844207|Sensory System Agents|sensory system agents|mesh-ancestor
92846703|NCT00844207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846704|NCT00844207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846705|NCT00844207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846706|NCT00844207|Filaricides|filaricides|mesh-ancestor
92846707|NCT00844207|Antinematodal Agents|antinematodal agents|mesh-ancestor
92846708|NCT00844207|Anthelmintics|anthelmintics|mesh-ancestor
92846709|NCT02841722|Lenograstim|lenograstim|mesh-list
92846710|NCT02841722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92846711|NCT02841722|Immunologic Factors|immunologic factors|mesh-ancestor
92846712|NCT02841722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846713|NCT02548117|Finasteride|finasteride|mesh-list
92846714|NCT02548117|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92846715|NCT02548117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92846716|NCT02548117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846717|NCT02548117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846718|NCT02548117|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846719|NCT02548117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846720|NCT02548117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846721|NCT02548117|Urological Agents|urological agents|mesh-ancestor
92846722|NCT02841800|Phenobarbital|phenobarbital|mesh-list
92846723|NCT02841800|Anticonvulsants|anticonvulsants|mesh-ancestor
92846724|NCT02841800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92846725|NCT02841800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846726|NCT02841800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846727|NCT02841800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92846728|NCT02841800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92846729|NCT02841800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846730|NCT02841800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846731|NCT02841800|GABA Modulators|gaba modulators|mesh-ancestor
92846732|NCT02841800|GABA Agents|gaba agents|mesh-ancestor
92846733|NCT02841800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92846734|NCT02841800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92846735|NCT02841800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92846737|NCT02832336|Caffeine citrate|caffeine citrate|mesh-list
92846738|NCT02832336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846739|NCT02832336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92846740|NCT02832336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846741|NCT02832336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92846742|NCT02832336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846743|NCT02832336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92846744|NCT02832336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92846745|NCT02832336|Purinergic Agents|purinergic agents|mesh-ancestor
92846746|NCT02832336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846747|NCT00621751|Carbamazepine|carbamazepine|mesh-list
92846748|NCT00621751|Anticonvulsants|anticonvulsants|mesh-ancestor
92846749|NCT00621751|Antimanic Agents|antimanic agents|mesh-ancestor
92846750|NCT00621751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92846751|NCT00621751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846752|NCT00621751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846753|NCT00621751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92846754|NCT00621751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92846755|NCT00621751|Analgesics|analgesics|mesh-ancestor
92846756|NCT00621751|Sensory System Agents|sensory system agents|mesh-ancestor
92846757|NCT00621751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846758|NCT00621751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92846759|NCT00621751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846760|NCT00621751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846761|NCT00621751|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92846762|NCT00621751|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92846764|NCT02690792|Vitamins|vitamins|mesh-ancestor
92846765|NCT02690792|Micronutrients|micronutrients|mesh-ancestor
92846766|NCT02690792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846767|NCT02690792|Antioxidants|antioxidants|mesh-ancestor
92846768|NCT02690792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846769|NCT02690792|Protective Agents|protective agents|mesh-ancestor
92846770|NCT00831649|Natalizumab|natalizumab|mesh-list
92846771|NCT00831649|Immunologic Factors|immunologic factors|mesh-ancestor
92846772|NCT00831649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846773|NCT02841332|Misonidazole|misonidazole|mesh-list
92846774|NCT02841332|Bevacizumab|bevacizumab|mesh-list
92846775|NCT02841332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846776|NCT02841332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846777|NCT02841332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92846778|NCT02841332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92846779|NCT02841332|Growth Substances|growth substances|mesh-ancestor
92846780|NCT02841332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846781|NCT02841332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92846782|NCT02841332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92846783|NCT02841332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92846784|NCT02841332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846785|NCT00838357|Plerixafor|plerixafor|mesh-list
92846786|NCT00838357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92846787|NCT00838357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92846788|NCT00838357|Antiviral Agents|antiviral agents|mesh-ancestor
92846789|NCT00838357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846790|NCT00156104|Haloperidol|haloperidol|mesh-list
92846791|NCT00156104|Haloperidol decanoate|haloperidol decanoate|mesh-list
92846792|NCT00156104|Asenapine|asenapine|mesh-list
92846793|NCT00156104|Antiemetics|antiemetics|mesh-ancestor
92846794|NCT00156104|Autonomic Agents|autonomic agents|mesh-ancestor
92846795|NCT00156104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846796|NCT00156104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846797|NCT00156104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92846798|NCT00156104|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92846799|NCT00156104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92846800|NCT00156104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846801|NCT00156104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92846802|NCT00156104|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92846803|NCT00156104|Dopamine Agents|dopamine agents|mesh-ancestor
92846804|NCT00156104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846805|NCT00156104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846806|NCT00156104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92846807|NCT00254462|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92191999|NCT00458237|Trastuzumab|trastuzumab|mesh-list
92846808|NCT00254462|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92846809|NCT00254462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92846810|NCT00254462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92846811|NCT00254462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846812|NCT00254462|Adrenergic Agents|adrenergic agents|mesh-ancestor
92846813|NCT00254462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846814|NCT00254462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846816|NCT00891930|Panitumumab|panitumumab|mesh-list
92846817|NCT00891930|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92846818|NCT00891930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92846819|NCT00891930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846820|NCT00891930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846821|NCT00891930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846822|NCT00891930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92846823|NCT02831088|Salicylates|salicylates|mesh-list
92846824|NCT02831088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92846825|NCT02831088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92846826|NCT02831088|Analgesics|analgesics|mesh-ancestor
92846827|NCT02831088|Sensory System Agents|sensory system agents|mesh-ancestor
92846828|NCT02831088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846829|NCT02831088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846830|NCT02831088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846831|NCT02831088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846832|NCT02831088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92846833|NCT02831088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846834|NCT02831088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846835|NCT02841176|Golimumab|golimumab|mesh-list
92846836|NCT02841176|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92846837|NCT02841176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846838|NCT02841176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846839|NCT02841176|Immunologic Factors|immunologic factors|mesh-ancestor
92846840|NCT02841176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846841|NCT01615874|Prednisone|prednisone|mesh-list
92846842|NCT01615874|Prednisolone|prednisolone|mesh-list
92846843|NCT01615874|Montelukast|montelukast|mesh-list
92846844|NCT01615874|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
92846845|NCT01615874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846846|NCT01615874|Glucocorticoids|glucocorticoids|mesh-ancestor
92846847|NCT01615874|Hormones|hormones|mesh-ancestor
92846848|NCT01615874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846849|NCT01615874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846850|NCT01615874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92846851|NCT01615874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846852|NCT01615874|Autonomic Agents|autonomic agents|mesh-ancestor
92846853|NCT01615874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846854|NCT01615874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92846855|NCT01615874|Respiratory System Agents|respiratory system agents|mesh-ancestor
92846856|NCT01615874|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92846857|NCT01615874|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846858|NCT01615874|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92846859|NCT01615874|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92846860|NCT01615874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846861|NCT01615874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92846862|NCT00891462|Bromides|bromides|mesh-list
92846863|NCT00891462|Anticonvulsants|anticonvulsants|mesh-ancestor
92846864|NCT04248348|Heparin|heparin|mesh-list
92846865|NCT04248348|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92846866|NCT04248348|Tinzaparin|tinzaparin|mesh-list
92846867|NCT04248348|Dalteparin|dalteparin|mesh-list
92846868|NCT04248348|Anticoagulants|anticoagulants|mesh-ancestor
92846869|NCT04248348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92846870|NCT04248348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92846871|NCT04248348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846872|NCT04245774|Bupivacaine|bupivacaine|mesh-list
92846873|NCT04245774|Levobupivacaine|levobupivacaine|mesh-list
92846874|NCT04245774|Anesthetics, Local|anesthetics, local|mesh-ancestor
92846875|NCT04245774|Anesthetics|anesthetics|mesh-ancestor
92846876|NCT04245774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846877|NCT04245774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846878|NCT04245774|Sensory System Agents|sensory system agents|mesh-ancestor
92846879|NCT04245774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846880|NCT04247646|Melatonin|melatonin|mesh-list
92846881|NCT04247646|Antioxidants|antioxidants|mesh-ancestor
92846882|NCT04247646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846883|NCT04247646|Protective Agents|protective agents|mesh-ancestor
92846884|NCT04247646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846885|NCT04247646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846886|NCT00900146|Metformin|metformin|mesh-list
92846887|NCT00900146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92846888|NCT00900146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846889|NCT00140972|Diclofenac|diclofenac|mesh-list
92846890|NCT00140972|Etoricoxib|etoricoxib|mesh-list
92846891|NCT00140972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92846892|NCT00140972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92846893|NCT00140972|Analgesics|analgesics|mesh-ancestor
92846894|NCT00140972|Sensory System Agents|sensory system agents|mesh-ancestor
92846895|NCT00140972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846896|NCT00140972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846897|NCT00140972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846898|NCT00140972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846899|NCT00140972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92846900|NCT00140972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846901|NCT00140972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846902|NCT00140972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92846903|NCT02830932|Vaccines|vaccines|mesh-list
92846904|NCT02830932|Immunologic Factors|immunologic factors|mesh-ancestor
92846905|NCT02830932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846906|NCT00895310|Ketoconazole|ketoconazole|mesh-list
92846907|NCT00895310|Hydrocortisone|hydrocortisone|mesh-list
92846908|NCT00895310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846909|NCT00895310|Antifungal Agents|antifungal agents|mesh-ancestor
92491992|NCT01957995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846910|NCT00895310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846911|NCT00895310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92846912|NCT00895310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92846913|NCT00895310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846914|NCT00895310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846915|NCT00895310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92846916|NCT00895310|Hormone Antagonists|hormone antagonists|mesh-ancestor
92846917|NCT00895310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92846918|NCT00895310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846919|NCT00895310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92846920|NCT04245618|Cisplatin|cisplatin|mesh-list
92846921|NCT04245618|Gemcitabine|gemcitabine|mesh-list
92846922|NCT04245618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846923|NCT04245618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92846924|NCT04245618|Antimetabolites|antimetabolites|mesh-ancestor
92846925|NCT04245618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846926|NCT00092768|Celecoxib|celecoxib|mesh-list
92846927|NCT00092768|Etoricoxib|etoricoxib|mesh-list
92846928|NCT00092768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92846929|NCT00092768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92846930|NCT00092768|Analgesics|analgesics|mesh-ancestor
92846931|NCT00092768|Sensory System Agents|sensory system agents|mesh-ancestor
92846932|NCT00092768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846933|NCT00092768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846934|NCT00092768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92846935|NCT00092768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846936|NCT00092768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92846937|NCT00092768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92846938|NCT00092768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92846939|NCT00092768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846940|NCT02831712|Ferrous fumarate|ferrous fumarate|mesh-list
92846941|NCT02831712|Trace Elements|trace elements|mesh-ancestor
92846942|NCT02831712|Micronutrients|micronutrients|mesh-ancestor
92846943|NCT02831712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846944|NCT02843984|Lactoferrin|lactoferrin|mesh-list
92846945|NCT02843984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846946|NCT02840708|Sargramostim|sargramostim|mesh-list
92846947|NCT02840708|Immunologic Factors|immunologic factors|mesh-ancestor
92846948|NCT02840708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846949|NCT00817076|Desloratadine|desloratadine|mesh-list
92846950|NCT00817076|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92846951|NCT00817076|Cholinergic Agents|cholinergic agents|mesh-ancestor
92846952|NCT00817076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846953|NCT00817076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846954|NCT00817076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846955|NCT00817076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92846956|NCT00817076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92846957|NCT00817076|Histamine Antagonists|histamine antagonists|mesh-ancestor
92846958|NCT00817076|Histamine Agents|histamine agents|mesh-ancestor
92846959|NCT02844062|Cyclophosphamide|cyclophosphamide|mesh-list
92846960|NCT02844062|Fludarabine|fludarabine|mesh-list
92846961|NCT02844062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92846962|NCT02844062|Immunologic Factors|immunologic factors|mesh-ancestor
92846963|NCT02844062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846964|NCT02844062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92846965|NCT02844062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92846966|NCT02844062|Alkylating Agents|alkylating agents|mesh-ancestor
92846967|NCT02844062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846968|NCT02844062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846969|NCT02844062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92846970|NCT02830230|Azithromycin|azithromycin|mesh-list
92846971|NCT02830230|Cefixime|cefixime|mesh-list
92846972|NCT02830230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92846973|NCT02830230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92846974|NCT02840240|Gabapentin|gabapentin|mesh-list
92846975|NCT02840240|Analgesics|analgesics|mesh-ancestor
92846976|NCT02840240|Sensory System Agents|sensory system agents|mesh-ancestor
92846977|NCT02840240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92846978|NCT02840240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846979|NCT02840240|Anticonvulsants|anticonvulsants|mesh-ancestor
92846980|NCT02840240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92846981|NCT02840240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92846982|NCT02840240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846983|NCT02840240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92846984|NCT02840240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92846985|NCT02840240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92846986|NCT02840240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92846987|NCT02840240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92846988|NCT02840240|Antimanic Agents|antimanic agents|mesh-ancestor
92846989|NCT00888654|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92846990|NCT00888654|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92846991|NCT00888654|Protective Agents|protective agents|mesh-ancestor
92846992|NCT00888654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92846993|NCT00888654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92846994|NCT03238430|Morphine|morphine|mesh-list
92846995|NCT03238430|Ropivacaine|ropivacaine|mesh-list
92846996|NCT03238430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92846997|NCT03238430|Narcotics|narcotics|mesh-ancestor
92846998|NCT03238430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92846999|NCT03238430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847000|NCT03238430|Analgesics|analgesics|mesh-ancestor
92847001|NCT03238430|Sensory System Agents|sensory system agents|mesh-ancestor
92847002|NCT03238430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847003|NCT03238430|Anesthetics, Local|anesthetics, local|mesh-ancestor
92847004|NCT03238430|Anesthetics|anesthetics|mesh-ancestor
92847005|NCT02829840|Azacitidine|azacitidine|mesh-list
92847006|NCT02829840|Ponatinib|ponatinib|mesh-list
92847007|NCT02829840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847008|NCT02829840|Antimetabolites|antimetabolites|mesh-ancestor
92847009|NCT02829840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847010|NCT02829840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847011|NCT02829840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847012|NCT02829840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92847013|NCT03223220|Midazolam|midazolam|mesh-list
92847014|NCT03223220|Ketamine|ketamine|mesh-list
92847015|NCT03223220|Analgesics|analgesics|mesh-ancestor
92847016|NCT03223220|Sensory System Agents|sensory system agents|mesh-ancestor
92847017|NCT03223220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847018|NCT03223220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847019|NCT03223220|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92847020|NCT03223220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92847021|NCT03223220|Anesthetics, General|anesthetics, general|mesh-ancestor
92847022|NCT03223220|Anesthetics|anesthetics|mesh-ancestor
92847023|NCT03223220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847024|NCT03223220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92847025|NCT03223220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92847026|NCT03223220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847027|NCT03223220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847028|NCT03223220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92847029|NCT03223220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92847031|NCT03223220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92847032|NCT03223220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92847033|NCT03223220|GABA Modulators|gaba modulators|mesh-ancestor
92847034|NCT03223220|GABA Agents|gaba agents|mesh-ancestor
92847035|NCT02827890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92847036|NCT02827890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92847037|NCT02827890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847038|NCT02827890|Incretins|incretins|mesh-ancestor
92847039|NCT02827890|Hormones|hormones|mesh-ancestor
92847040|NCT02827890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847041|NCT02827890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92847042|NCT02827890|Protease Inhibitors|protease inhibitors|mesh-ancestor
92847043|NCT02827890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847044|NCT02827890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847045|NCT04250792|Naltrexone|naltrexone|mesh-list
92847046|NCT04250792|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92847047|NCT04250792|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92847048|NCT04250792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847049|NCT04250792|Sensory System Agents|sensory system agents|mesh-ancestor
92847050|NCT04250792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847051|NCT02840162|Celecoxib|celecoxib|mesh-list
92847052|NCT02840162|Benzenesulfonamide|benzenesulfonamide|mesh-list
92847053|NCT02840162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92847054|NCT02840162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92847055|NCT02840162|Analgesics|analgesics|mesh-ancestor
92847056|NCT02840162|Sensory System Agents|sensory system agents|mesh-ancestor
92847057|NCT02840162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847058|NCT02840162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847059|NCT02840162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847060|NCT02840162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847061|NCT02840162|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92847062|NCT02840162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92847063|NCT02840162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847064|NCT02840162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847065|NCT02840162|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92847066|NCT02827656|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92847067|NCT02827656|Luteolytic Agents|luteolytic agents|mesh-ancestor
92847068|NCT02827656|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92847069|NCT02827656|Contraceptive Agents|contraceptive agents|mesh-ancestor
92847070|NCT02827656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92847071|NCT02827656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847072|NCT02827656|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92847073|NCT02827656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92847074|NCT02827656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847076|NCT02827578|Solifenacin Succinate|solifenacin succinate|mesh-list
92847077|NCT02827578|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92847078|NCT02827578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92847079|NCT02827578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92847080|NCT02827578|Adrenergic Agents|adrenergic agents|mesh-ancestor
92847081|NCT02827578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847082|NCT02827578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847083|NCT02827578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847084|NCT02827578|Urological Agents|urological agents|mesh-ancestor
92847085|NCT02827578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92847086|NCT02827578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92847087|NCT02827578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92847088|NCT02829372|Antibodies|antibodies|mesh-list
92847089|NCT02829372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92847090|NCT02829372|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92847091|NCT02829372|Immunologic Factors|immunologic factors|mesh-ancestor
92847092|NCT02829372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847093|NCT00899678|Certolizumab Pegol|certolizumab pegol|mesh-list
92847094|NCT00899678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92847095|NCT00899678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847096|NCT00899678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92847097|NCT00899678|Immunologic Factors|immunologic factors|mesh-ancestor
92847098|NCT00899678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847099|NCT00899678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847100|NCT00887484|Clindamycin|clindamycin|mesh-list
92847101|NCT00887484|Clindamycin palmitate|clindamycin palmitate|mesh-list
92847102|NCT00887484|Clindamycin phosphate|clindamycin phosphate|mesh-list
92847103|NCT00887484|Adapalene|adapalene|mesh-list
92847104|NCT00887484|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92847106|NCT00887484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847107|NCT00887484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92847108|NCT00887484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847109|NCT00887484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847110|NCT00887484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847111|NCT00887484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92847112|NCT00887484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92847113|NCT00887484|Analgesics|analgesics|mesh-ancestor
92847114|NCT00887484|Sensory System Agents|sensory system agents|mesh-ancestor
92847115|NCT00887484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847116|NCT00887484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847117|NCT00887484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847118|NCT00887484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847119|NCT00794378|Cetirizine|cetirizine|mesh-list
92847120|NCT00794378|Desloratadine|desloratadine|mesh-list
92847121|NCT00794378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92847122|NCT00794378|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92847123|NCT00794378|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92847124|NCT00794378|Histamine Antagonists|histamine antagonists|mesh-ancestor
92847125|NCT00794378|Histamine Agents|histamine agents|mesh-ancestor
92847126|NCT00794378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847127|NCT00794378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847128|NCT00794378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847129|NCT00794378|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92847130|NCT00794378|Cholinergic Agents|cholinergic agents|mesh-ancestor
92847131|NCT00789152|Levocetirizine|levocetirizine|mesh-list
92847132|NCT00789152|Desloratadine|desloratadine|mesh-list
92847133|NCT00789152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92847134|NCT00789152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92847135|NCT00789152|Histamine Antagonists|histamine antagonists|mesh-ancestor
92847136|NCT00789152|Histamine Agents|histamine agents|mesh-ancestor
92847137|NCT00789152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847138|NCT00789152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847139|NCT00789152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847140|NCT00789152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92847141|NCT00789152|Cholinergic Agents|cholinergic agents|mesh-ancestor
92847142|NCT00783458|Fluticasone|fluticasone|mesh-list
92847143|NCT00783458|Mometasone Furoate|mometasone furoate|mesh-list
92847144|NCT00783458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847145|NCT00783458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92847146|NCT00783458|Autonomic Agents|autonomic agents|mesh-ancestor
92847147|NCT00783458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847148|NCT00783458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847149|NCT00783458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92847150|NCT00783458|Respiratory System Agents|respiratory system agents|mesh-ancestor
92847151|NCT00783458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847152|NCT00783458|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92847153|NCT00620659|Modafinil|modafinil|mesh-list
92847154|NCT00620659|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92847155|NCT00620659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847156|NCT00620659|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92847157|NCT00620659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92847158|NCT00620659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92847159|NCT00620659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847160|NCT02829060|Gentamicins|gentamicins|mesh-list
92847161|NCT02829060|Ampicillin|ampicillin|mesh-list
92847162|NCT02829060|Nitrofurantoin|nitrofurantoin|mesh-list
92847163|NCT02829060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92847164|NCT02829060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847165|NCT02829060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92847166|NCT02829060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847167|NCT02829060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847168|NCT02829060|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92847169|NCT00838669|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92847170|NCT00838669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92847171|NCT00838669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92847172|NCT00838669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847173|NCT00838669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847174|NCT00838669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92847175|NCT00838669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92847176|NCT00838669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92847177|NCT00838669|Serotonin Agents|serotonin agents|mesh-ancestor
92847178|NCT00838669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847179|NCT00838669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847180|NCT00838669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92847181|NCT00838669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92847182|NCT00838669|Dopamine Agents|dopamine agents|mesh-ancestor
92847183|NCT00783146|Fexofenadine|fexofenadine|mesh-list
92847184|NCT00783146|Desloratadine|desloratadine|mesh-list
92847185|NCT00783146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92847186|NCT00783146|Cholinergic Agents|cholinergic agents|mesh-ancestor
92847187|NCT00783146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847188|NCT00783146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847189|NCT00783146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847190|NCT00783146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92847191|NCT00783146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92847192|NCT00783146|Histamine Antagonists|histamine antagonists|mesh-ancestor
92847193|NCT00783146|Histamine Agents|histamine agents|mesh-ancestor
92847194|NCT00783146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92847195|NCT00844675|Rabeprazole|rabeprazole|mesh-list
92847196|NCT00844675|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92847197|NCT00844675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847198|NCT00844675|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92847199|NCT00844675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847200|NCT00844675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847201|NCT02840006|Anesthetics|anesthetics|mesh-list
92847202|NCT02840006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847203|NCT02840006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847204|NCT02826252|Iloprost|iloprost|mesh-list
92847205|NCT02826252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92847206|NCT02826252|Vasodilator Agents|vasodilator agents|mesh-ancestor
92847207|NCT02839928|Ketamine|ketamine|mesh-list
92492295|NCT01960543|Fentanyl|fentanyl|mesh-list
92847208|NCT02839928|Analgesics|analgesics|mesh-list
92847209|NCT02839928|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92847210|NCT02839928|Sensory System Agents|sensory system agents|mesh-ancestor
92847211|NCT02839928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847212|NCT02839928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847213|NCT02839928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92847214|NCT02839928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92847215|NCT02839928|Anesthetics, General|anesthetics, general|mesh-ancestor
92847216|NCT02839928|Anesthetics|anesthetics|mesh-ancestor
92847217|NCT02839928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847218|NCT02839928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92847219|NCT02839928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92847220|NCT02839928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847221|NCT02839928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847222|NCT02839928|Anesthetics, Local|anesthetics, local|mesh-ancestor
92847223|NCT02839928|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92847224|NCT05018520|Prednisone|prednisone|mesh-list
92847225|NCT05018520|Rituximab|rituximab|mesh-list
92847226|NCT05018520|Cyclophosphamide|cyclophosphamide|mesh-list
92847227|NCT05018520|Vincristine|vincristine|mesh-list
92847228|NCT05018520|Doxorubicin|doxorubicin|mesh-list
92847229|NCT05018520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92847230|NCT05018520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847231|NCT05018520|Immunologic Factors|immunologic factors|mesh-ancestor
92847232|NCT05018520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847233|NCT05018520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847234|NCT05018520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748947|NCT01164579|Immunologic Factors|immunologic factors|mesh-ancestor
92847235|NCT05018520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92847236|NCT05018520|Alkylating Agents|alkylating agents|mesh-ancestor
92847237|NCT05018520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847238|NCT05018520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92847239|NCT05018520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847240|NCT05018520|Glucocorticoids|glucocorticoids|mesh-ancestor
92847241|NCT05018520|Hormones|hormones|mesh-ancestor
92847242|NCT05018520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847243|NCT05018520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92847244|NCT05018520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92847245|NCT05018520|Tubulin Modulators|tubulin modulators|mesh-ancestor
92847246|NCT05018520|Antimitotic Agents|antimitotic agents|mesh-ancestor
92847247|NCT05018520|Mitosis Modulators|mitosis modulators|mesh-ancestor
92847248|NCT05018520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92847249|NCT05018520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92847250|NCT05018520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92847251|NCT05018520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847253|NCT04321746|Analgesics|analgesics|mesh-ancestor
92847254|NCT04321746|Sensory System Agents|sensory system agents|mesh-ancestor
92847255|NCT04321746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847256|NCT04321746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847257|NCT04321746|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92847258|NCT04321746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92847259|NCT04321746|Anesthetics, General|anesthetics, general|mesh-ancestor
92847260|NCT04321746|Anesthetics|anesthetics|mesh-ancestor
92847261|NCT04321746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847262|NCT04321746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92847263|NCT04321746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92847264|NCT04321746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847265|NCT04321746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847266|NCT02839694|Celecoxib|celecoxib|mesh-list
92847267|NCT02839694|Decitabine|decitabine|mesh-list
92847268|NCT02839694|Tetrahydrouridine|tetrahydrouridine|mesh-list
92847269|NCT02839694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92847270|NCT02839694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92847271|NCT02839694|Analgesics|analgesics|mesh-ancestor
92847272|NCT02839694|Sensory System Agents|sensory system agents|mesh-ancestor
92847273|NCT02839694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847274|NCT02839694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847275|NCT02839694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847276|NCT02839694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847277|NCT02839694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92847278|NCT02839694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92847279|NCT02839694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847280|NCT02839694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492371|NCT01961193|Silicon|silicon|mesh-list
92847281|NCT02839694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847282|NCT02839694|Antimetabolites|antimetabolites|mesh-ancestor
92847283|NCT02839694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847284|NCT04243434|Prednisone|prednisone|mesh-list
92847285|NCT04243434|Cyclophosphamide|cyclophosphamide|mesh-list
92847286|NCT04243434|Doxorubicin|doxorubicin|mesh-list
92847287|NCT04243434|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92847288|NCT04243434|Vincristine|vincristine|mesh-list
92847289|NCT04243434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749032|NCT00953329|Alefacept|alefacept|mesh-list
92847290|NCT04243434|Immunologic Factors|immunologic factors|mesh-ancestor
92847291|NCT04243434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847292|NCT04243434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847293|NCT04243434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92847294|NCT04243434|Alkylating Agents|alkylating agents|mesh-ancestor
92847295|NCT04243434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847296|NCT04243434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847297|NCT04243434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92847298|NCT04243434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92847299|NCT04243434|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92847300|NCT04243434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92847301|NCT04243434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847302|NCT04243434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847303|NCT04243434|Glucocorticoids|glucocorticoids|mesh-ancestor
92847304|NCT04243434|Hormones|hormones|mesh-ancestor
92847305|NCT04243434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847306|NCT04243434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92847307|NCT04243434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92847308|NCT04243434|Tubulin Modulators|tubulin modulators|mesh-ancestor
92847309|NCT04243434|Antimitotic Agents|antimitotic agents|mesh-ancestor
92847310|NCT04243434|Mitosis Modulators|mitosis modulators|mesh-ancestor
92847311|NCT00832039|Selenious Acid|selenious acid|mesh-list
92847312|NCT00832039|Sodium Selenite|sodium selenite|mesh-list
92847313|NCT00832039|Trace Elements|trace elements|mesh-ancestor
92847314|NCT00832039|Micronutrients|micronutrients|mesh-ancestor
92847315|NCT00832039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847316|NCT02826564|Pembrolizumab|pembrolizumab|mesh-list
92847317|NCT02826564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92847318|NCT02826564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847319|NCT02826564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92847320|NCT02826564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847321|NCT02837978|Methotrexate|methotrexate|mesh-list
92847322|NCT02837978|Tacrolimus|tacrolimus|mesh-list
92847323|NCT02837978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92847324|NCT02837978|Abortifacient Agents|abortifacient agents|mesh-ancestor
92847325|NCT02837978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92847326|NCT02837978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847327|NCT02837978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847328|NCT02837978|Antimetabolites|antimetabolites|mesh-ancestor
92847329|NCT02837978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847330|NCT02837978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847331|NCT02837978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847332|NCT02837978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847333|NCT02837978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92847334|NCT02837978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92847335|NCT02837978|Immunologic Factors|immunologic factors|mesh-ancestor
92847336|NCT02837978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847337|NCT02837978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92847338|NCT02837978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92847339|NCT00839059|Lenalidomide|lenalidomide|mesh-list
92847340|NCT00839059|Immunologic Factors|immunologic factors|mesh-ancestor
92847341|NCT00839059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847342|NCT00839059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92847343|NCT00839059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92847344|NCT00839059|Growth Substances|growth substances|mesh-ancestor
92847345|NCT00839059|Growth Inhibitors|growth inhibitors|mesh-ancestor
92847346|NCT00839059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847347|NCT02839538|Anesthetics|anesthetics|mesh-list
92847348|NCT02839538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847349|NCT02839538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847350|NCT02826174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92847351|NCT02826174|Anesthetics|anesthetics|mesh-list
92847352|NCT02826174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847353|NCT02826174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847354|NCT00621517|Bupropion|bupropion|mesh-list
92847355|NCT00621517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92847356|NCT00621517|Antidepressive Agents|antidepressive agents|mesh-ancestor
92847357|NCT00621517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92847358|NCT00621517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92847359|NCT00621517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92847360|NCT00621517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92847361|NCT00621517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847362|NCT00621517|Dopamine Agents|dopamine agents|mesh-ancestor
92847363|NCT00621517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847364|NCT00621517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847365|NCT00621517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92847366|NCT00621517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92847367|NCT00621517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847368|NCT02827266|Epoetin Alfa|epoetin alfa|mesh-list
92847369|NCT02827266|Hematinics|hematinics|mesh-ancestor
92847370|NCT00845221|Imatinib Mesylate|imatinib mesylate|mesh-list
92847371|NCT00845221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847372|NCT00845221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92847373|NCT00845221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847374|NCT00845221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847375|NCT02546401|Insulin Aspart|insulin aspart|mesh-list
92847376|NCT02546401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92847377|NCT02546401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847378|NCT02826876|Ropivacaine|ropivacaine|mesh-list
92847379|NCT02826876|Anesthetics, Local|anesthetics, local|mesh-ancestor
92847380|NCT02826876|Anesthetics|anesthetics|mesh-ancestor
92847381|NCT02826876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847382|NCT02826876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847383|NCT02826876|Sensory System Agents|sensory system agents|mesh-ancestor
92847384|NCT02826876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847385|NCT04244448|Emtricitabine|emtricitabine|mesh-list
92847386|NCT04244448|Antiviral Agents|antiviral agents|mesh-ancestor
92847387|NCT04244448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847388|NCT04244448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92847389|NCT04244448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92847390|NCT04244448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847391|NCT04244448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847392|NCT04244448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92847393|NCT04244448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92847394|NCT02547025|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92847395|NCT02547025|Amoxicillin|amoxicillin|mesh-list
92847396|NCT02547025|Clarithromycin|clarithromycin|mesh-list
92847397|NCT02547025|Levofloxacin|levofloxacin|mesh-list
92847398|NCT02547025|Ofloxacin|ofloxacin|mesh-list
92847399|NCT02547025|Tetracycline|tetracycline|mesh-list
92847400|NCT02547025|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92847401|NCT02547025|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92847402|NCT02547025|Rabeprazole|rabeprazole|mesh-list
92847403|NCT02547025|Bismuth|bismuth|mesh-list
92847404|NCT02547025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847405|NCT02547025|Antitubercular Agents|antitubercular agents|mesh-ancestor
92847406|NCT02547025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92847407|NCT02547025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847408|NCT02547025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847409|NCT02547025|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92847410|NCT02547025|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92847411|NCT02547025|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92847412|NCT02547025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92847413|NCT02547025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92847414|NCT02547025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847415|NCT02547025|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92847416|NCT02547025|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92847417|NCT02547025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847418|NCT02547025|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92847419|NCT02547025|Antacids|antacids|mesh-ancestor
92847420|NCT00839293|Fenofibric acid|fenofibric acid|mesh-list
92847421|NCT00839293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92847422|NCT00839293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92847423|NCT00839293|Antimetabolites|antimetabolites|mesh-ancestor
92847424|NCT00839293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847425|NCT00839293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92847426|NCT05660382|Miconazole|miconazole|mesh-list
92847427|NCT05660382|Clotrimazole|clotrimazole|mesh-list
92847428|NCT05660382|Mineral Oil|mineral oil|mesh-list
92847429|NCT05660382|Antifungal Agents|antifungal agents|mesh-ancestor
92847430|NCT05660382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92492521|NCT01962376|Antimetabolites|antimetabolites|mesh-ancestor
92847431|NCT05660382|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92847432|NCT05660382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92847433|NCT05660382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847434|NCT05660382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847435|NCT05660382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92847436|NCT05660382|Hormone Antagonists|hormone antagonists|mesh-ancestor
92847437|NCT05660382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847438|NCT05660382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847439|NCT05660382|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92847440|NCT05660382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92847441|NCT05660382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92847442|NCT05660382|Emollients|emollients|mesh-ancestor
92847443|NCT05660382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847444|NCT00839371|Midazolam|midazolam|mesh-list
92847445|NCT00839371|Propofol|propofol|mesh-list
92847446|NCT00839371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92847447|NCT00839371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847448|NCT00839371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847449|NCT00839371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92847450|NCT00839371|Anesthetics, General|anesthetics, general|mesh-ancestor
92847451|NCT00839371|Anesthetics|anesthetics|mesh-ancestor
92847452|NCT00839371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92847453|NCT00839371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92847454|NCT00839371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92847455|NCT00839371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92847456|NCT00839371|GABA Modulators|gaba modulators|mesh-ancestor
92847457|NCT00839371|GABA Agents|gaba agents|mesh-ancestor
92847458|NCT00839371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847459|NCT00839371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847460|NCT02826408|Rabeprazole|rabeprazole|mesh-list
92847461|NCT02826408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92847462|NCT02826408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847463|NCT02826408|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92847464|NCT02826408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847465|NCT02826408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847466|NCT00573937|Morphine|morphine|mesh-list
92847467|NCT00573937|Methadone|methadone|mesh-list
92847468|NCT00573937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92847469|NCT00573937|Narcotics|narcotics|mesh-ancestor
92847470|NCT00573937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847471|NCT00573937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847472|NCT00573937|Analgesics|analgesics|mesh-ancestor
92847473|NCT00573937|Sensory System Agents|sensory system agents|mesh-ancestor
92847474|NCT00573937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847475|NCT00573937|Antitussive Agents|antitussive agents|mesh-ancestor
92847476|NCT00573937|Respiratory System Agents|respiratory system agents|mesh-ancestor
92847477|NCT00845533|Piperaquine|piperaquine|mesh-list
92847478|NCT00845533|Artenimol|artenimol|mesh-list
92847479|NCT00845533|Antimalarials|antimalarials|mesh-ancestor
92847480|NCT00845533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92847481|NCT00845533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92847482|NCT00845533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847483|NCT00839449|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92847484|NCT00839449|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92847485|NCT00839449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92847486|NCT04958538|Methotrexate|methotrexate|mesh-list
92847487|NCT04958538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92847488|NCT04958538|Abortifacient Agents|abortifacient agents|mesh-ancestor
92847489|NCT04958538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92847490|NCT04958538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847491|NCT04958538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847492|NCT04958538|Antimetabolites|antimetabolites|mesh-ancestor
92847493|NCT04958538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847494|NCT04958538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847495|NCT04958538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847496|NCT04958538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847497|NCT04958538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92847498|NCT04958538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92847499|NCT04958538|Immunologic Factors|immunologic factors|mesh-ancestor
92847500|NCT04958538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847501|NCT04958538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92847502|NCT02548195|Gemcitabine|gemcitabine|mesh-list
92847503|NCT02548195|Capecitabine|capecitabine|mesh-list
92847504|NCT02548195|Oxaliplatin|oxaliplatin|mesh-list
92847505|NCT02548195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847506|NCT02548195|Antimetabolites|antimetabolites|mesh-ancestor
92749226|NCT02853799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92847507|NCT02548195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847508|NCT02548195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847509|NCT00573859|Methylphenidate|methylphenidate|mesh-list
92847510|NCT00573859|Amphetamine|amphetamine|mesh-list
92847511|NCT00573859|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92847512|NCT00573859|Dextroamphetamine|dextroamphetamine|mesh-list
92847513|NCT00573859|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92847514|NCT00573859|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92847515|NCT00573859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847516|NCT00573859|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92847517|NCT00573859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92847518|NCT00573859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92847519|NCT00573859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847520|NCT00573859|Dopamine Agents|dopamine agents|mesh-ancestor
92847521|NCT00573859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847522|NCT00573859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92847523|NCT00573859|Adrenergic Agents|adrenergic agents|mesh-ancestor
92847524|NCT00573859|Sympathomimetics|sympathomimetics|mesh-ancestor
92847525|NCT00573859|Autonomic Agents|autonomic agents|mesh-ancestor
92847526|NCT00573859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847527|NCT04043065|Anti-Infective Agents|anti-infective agents|mesh-list
92847528|NCT04043065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92847529|NCT00839605|Dexmedetomidine|dexmedetomidine|mesh-list
92847530|NCT00839605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92847531|NCT00839605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847532|NCT00839605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847533|NCT00839605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92847534|NCT00839605|Analgesics|analgesics|mesh-ancestor
92847535|NCT00839605|Sensory System Agents|sensory system agents|mesh-ancestor
92847536|NCT00839605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847537|NCT00839605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92847538|NCT00839605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92847539|NCT00839605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92847540|NCT00839605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92847541|NCT00839605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847542|NCT00839605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847543|NCT00839683|Dapagliflozin|dapagliflozin|mesh-list
92847544|NCT00839683|Valsartan|valsartan|mesh-list
92847545|NCT00839683|Simvastatin|simvastatin|mesh-list
92847546|NCT00839683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92847548|NCT00839683|Antimetabolites|antimetabolites|mesh-ancestor
92847549|NCT00839683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847550|NCT00839683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92847551|NCT00839683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92847552|NCT00839683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847553|NCT00839683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92847554|NCT00839683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92847555|NCT00839683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847556|NCT00839683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92847557|NCT00839683|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92847558|NCT00839683|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92847559|NCT00839761|Iron|iron|mesh-list
92847560|NCT00839761|Trace Elements|trace elements|mesh-ancestor
92847561|NCT00839761|Micronutrients|micronutrients|mesh-ancestor
92847562|NCT00839761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847563|NCT02825394|Ecarin|ecarin|mesh-list
92847564|NCT02825394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92847565|NCT02825394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92847566|NCT02825394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847567|NCT00845611|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92847568|NCT00845611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92847569|NCT00845611|Immunologic Factors|immunologic factors|mesh-ancestor
92847570|NCT00845611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847571|NCT00845689|Adenosine|adenosine|mesh-list
92847572|NCT00845689|Analgesics|analgesics|mesh-ancestor
92847573|NCT00845689|Sensory System Agents|sensory system agents|mesh-ancestor
92847574|NCT00845689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847575|NCT00845689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847576|NCT00845689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92847577|NCT00845689|Vasodilator Agents|vasodilator agents|mesh-ancestor
92847578|NCT00845689|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92847579|NCT00845689|Purinergic Agonists|purinergic agonists|mesh-ancestor
92847580|NCT00845689|Purinergic Agents|purinergic agents|mesh-ancestor
92847581|NCT00845689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847582|NCT00845689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847583|NCT05660694|Vitamin E|vitamin e|mesh-list
92847584|NCT05660694|Triamcinolone|triamcinolone|mesh-list
92847585|NCT05660694|Pentoxifylline|pentoxifylline|mesh-list
92847586|NCT05660694|Vitamins|vitamins|mesh-ancestor
92847587|NCT05660694|Micronutrients|micronutrients|mesh-ancestor
92847588|NCT05660694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847589|NCT05660694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847590|NCT05660694|Glucocorticoids|glucocorticoids|mesh-ancestor
92847591|NCT05660694|Hormones|hormones|mesh-ancestor
92847592|NCT05660694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847593|NCT05660694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847594|NCT05660694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847595|NCT05660694|Antioxidants|antioxidants|mesh-ancestor
92847596|NCT05660694|Protective Agents|protective agents|mesh-ancestor
92847597|NCT05660694|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92847598|NCT05660694|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92847599|NCT05660694|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92847600|NCT05660694|Vasodilator Agents|vasodilator agents|mesh-ancestor
92847601|NCT05660694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92847602|NCT05113368|Fulvestrant|fulvestrant|mesh-list
92847603|NCT05113368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92847604|NCT05113368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847605|NCT05113368|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92847606|NCT05113368|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92847607|NCT05113368|Hormone Antagonists|hormone antagonists|mesh-ancestor
92847608|NCT05113368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847609|NCT05113368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847610|NCT02824614|Erythritol|erythritol|mesh-list
92847611|NCT02824614|Vasodilator Agents|vasodilator agents|mesh-ancestor
92847612|NCT00840229|Triamcinolone|triamcinolone|mesh-list
92847613|NCT00840229|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92847614|NCT00840229|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92847615|NCT00840229|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92847616|NCT00840229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847617|NCT00840229|Glucocorticoids|glucocorticoids|mesh-ancestor
92847618|NCT00840229|Hormones|hormones|mesh-ancestor
92847619|NCT00840229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847620|NCT00840229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847621|NCT00840229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92847622|NCT00840229|Immunologic Factors|immunologic factors|mesh-ancestor
92847623|NCT00840229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847624|NCT00840229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847625|NCT00831441|Apixaban|apixaban|mesh-list
92847626|NCT00831441|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92847627|NCT00831441|Antithrombins|antithrombins|mesh-ancestor
92847628|NCT00831441|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92847629|NCT00831441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92847630|NCT00831441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847631|NCT00831441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847632|NCT00831441|Anticoagulants|anticoagulants|mesh-ancestor
92847633|NCT00840385|Vidarabine|vidarabine|mesh-list
92847634|NCT00840385|Fludarabine|fludarabine|mesh-list
92847635|NCT00840385|Fludarabine phosphate|fludarabine phosphate|mesh-list
92847636|NCT00840385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847637|NCT00840385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847638|NCT00840385|Antimetabolites|antimetabolites|mesh-ancestor
92847639|NCT00840385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847640|NCT00840385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92847641|NCT00840385|Immunologic Factors|immunologic factors|mesh-ancestor
92847642|NCT00840385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847643|NCT00840385|Antiviral Agents|antiviral agents|mesh-ancestor
92847644|NCT00840385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847645|NCT02824458|Apatinib|apatinib|mesh-list
92847646|NCT02824458|Gefitinib|gefitinib|mesh-list
92847647|NCT02824458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847648|NCT02824458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92847649|NCT02824458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749374|NCT01231620|Zanamivir|zanamivir|mesh-list
92847650|NCT02824458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847651|NCT00840931|Lenalidomide|lenalidomide|mesh-list
92847652|NCT00840931|Immunologic Factors|immunologic factors|mesh-ancestor
92847653|NCT00840931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847654|NCT00840931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93046923|NCT01058720|Cholecalciferol|cholecalciferol|mesh-list
92847655|NCT00840931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92847656|NCT00840931|Growth Substances|growth substances|mesh-ancestor
92847657|NCT00840931|Growth Inhibitors|growth inhibitors|mesh-ancestor
92847658|NCT00840931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847659|NCT05659992|Cytarabine|cytarabine|mesh-list
92847660|NCT05659992|Azacitidine|azacitidine|mesh-list
92847661|NCT05659992|Venetoclax|venetoclax|mesh-list
92847662|NCT05659992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847663|NCT05659992|Antimetabolites|antimetabolites|mesh-ancestor
92847664|NCT05659992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847665|NCT05659992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847666|NCT05659992|Antiviral Agents|antiviral agents|mesh-ancestor
92847667|NCT05659992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847668|NCT05659992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92847669|NCT05659992|Immunologic Factors|immunologic factors|mesh-ancestor
92847670|NCT05659992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847671|NCT05659992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847672|NCT00834379|Pravastatin|pravastatin|mesh-list
92847673|NCT00834379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92847674|NCT00834379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92847675|NCT00834379|Antimetabolites|antimetabolites|mesh-ancestor
92847676|NCT00834379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847677|NCT00834379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92847678|NCT00834379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92847679|NCT00834379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847680|NCT00834457|Ritonavir|ritonavir|mesh-list
92847681|NCT00834457|Lopinavir|lopinavir|mesh-list
92847682|NCT00834457|Zidovudine|zidovudine|mesh-list
92847683|NCT00834457|Lamivudine|lamivudine|mesh-list
92847684|NCT00834457|Abacavir|abacavir|mesh-list
92847685|NCT00834457|Dideoxynucleosides|dideoxynucleosides|mesh-list
92847686|NCT00834457|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92847687|NCT00834457|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92847688|NCT00834457|Protease Inhibitors|protease inhibitors|mesh-ancestor
92847689|NCT00834457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847690|NCT00834457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847691|NCT00834457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92847692|NCT00834457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92847693|NCT00834457|Antiviral Agents|antiviral agents|mesh-ancestor
92847694|NCT00834457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847695|NCT00834457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92847696|NCT00834457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92847697|NCT00834457|Antimetabolites|antimetabolites|mesh-ancestor
92847698|NCT00834457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92847699|NCT00834457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92847700|NCT03851965|Plasminogen|plasminogen|mesh-list
92847701|NCT03851965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92847702|NCT03851965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92847703|NCT03851965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847704|NCT02611635|Warfarin|warfarin|mesh-list
92847705|NCT02611635|Rivaroxaban|rivaroxaban|mesh-list
92847706|NCT02611635|Dabigatran|dabigatran|mesh-list
92847707|NCT02611635|Apixaban|apixaban|mesh-list
92847708|NCT02611635|Edoxaban|edoxaban|mesh-list
92847709|NCT02611635|Anticoagulants|anticoagulants|mesh-ancestor
92847710|NCT02611635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92847711|NCT02611635|Antithrombins|antithrombins|mesh-ancestor
92847712|NCT02611635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92847713|NCT02611635|Protease Inhibitors|protease inhibitors|mesh-ancestor
92847714|NCT02611635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847715|NCT02611635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847716|NCT02824926|Ketoconazole|ketoconazole|mesh-list
92847717|NCT02824926|Antifungal Agents|antifungal agents|mesh-ancestor
92847718|NCT02824926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847719|NCT02824926|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92847720|NCT02824926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92847721|NCT02824926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847722|NCT02824926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847723|NCT02824926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92847724|NCT02824926|Hormone Antagonists|hormone antagonists|mesh-ancestor
92847725|NCT02824926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847726|NCT02824926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847727|NCT02824926|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92847728|NCT00705471|Infliximab|infliximab|mesh-list
92847729|NCT00705471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92847730|NCT00705471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847731|NCT00705471|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847732|NCT00705471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847733|NCT00705471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847734|NCT00705549|Cisplatin|cisplatin|mesh-list
92847735|NCT00705549|Gemcitabine|gemcitabine|mesh-list
92847736|NCT00705549|Docetaxel|docetaxel|mesh-list
92847737|NCT00705549|Vinorelbine|vinorelbine|mesh-list
92847738|NCT00705549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847739|NCT00705549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847740|NCT00705549|Antimetabolites|antimetabolites|mesh-ancestor
92847741|NCT00705549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847742|NCT00705549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92847743|NCT00705549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92847744|NCT00705549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92847745|NCT00705549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92847746|NCT02824770|Tramadol|tramadol|mesh-list
92847747|NCT02824770|Bupivacaine|bupivacaine|mesh-list
92847748|NCT02824770|Anesthetics, Local|anesthetics, local|mesh-ancestor
92847749|NCT02824770|Anesthetics|anesthetics|mesh-ancestor
92847750|NCT02824770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847751|NCT02824770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847752|NCT02824770|Sensory System Agents|sensory system agents|mesh-ancestor
92847753|NCT02824770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847754|NCT02824770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92847755|NCT02824770|Narcotics|narcotics|mesh-ancestor
92847756|NCT02824770|Analgesics|analgesics|mesh-ancestor
92847757|NCT02824536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92847758|NCT02824536|Antibodies|antibodies|mesh-list
92847759|NCT02824536|Immunoglobulins|immunoglobulins|mesh-list
92847760|NCT02824536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92847761|NCT02824536|Immunologic Factors|immunologic factors|mesh-ancestor
92847762|NCT02824536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847763|NCT02824536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847764|NCT00831129|Rosiglitazone|rosiglitazone|mesh-list
92847765|NCT00831129|Simvastatin|simvastatin|mesh-list
92847766|NCT00831129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92847767|NCT00831129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92847768|NCT00831129|Antimetabolites|antimetabolites|mesh-ancestor
92977215|NCT00586157|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92847769|NCT00831129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847770|NCT00831129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92847771|NCT00831129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92847772|NCT00831129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847773|NCT00831129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92847774|NCT00831129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847775|NCT00637962|polysaccharide-K|polysaccharide-k|mesh-list
92847776|NCT00637962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92847777|NCT00637962|Immunologic Factors|immunologic factors|mesh-ancestor
92847778|NCT00637962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847779|NCT00637962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92847780|NCT00637962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847781|NCT00637962|Antiviral Agents|antiviral agents|mesh-ancestor
92847782|NCT00637962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847783|NCT00637962|Interferon Inducers|interferon inducers|mesh-ancestor
92847784|NCT00637962|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92847785|NCT00637962|Protective Agents|protective agents|mesh-ancestor
92847786|NCT00913341|Alprazolam|alprazolam|mesh-list
92847787|NCT00913341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92847788|NCT00913341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847789|NCT00913341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847790|NCT00913341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92847791|NCT00913341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92847792|NCT00913341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92847793|NCT00913341|GABA Modulators|gaba modulators|mesh-ancestor
92847794|NCT00913341|GABA Agents|gaba agents|mesh-ancestor
92847795|NCT00913341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749520|NCT01153971|Immunologic Factors|immunologic factors|mesh-ancestor
92847796|NCT00913341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847797|NCT00620113|Vitamin D|vitamin d|mesh-list
92847798|NCT00620113|Cholecalciferol|cholecalciferol|mesh-list
92847799|NCT00620113|Calcium Carbonate|calcium carbonate|mesh-list
92847800|NCT00620113|Calcium|calcium|mesh-list
92847801|NCT00620113|Vitamins|vitamins|mesh-ancestor
92847802|NCT00620113|Micronutrients|micronutrients|mesh-ancestor
92847803|NCT00620113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847804|NCT00620113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92847805|NCT00620113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92847806|NCT00620113|Antacids|antacids|mesh-ancestor
92847807|NCT00620113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847808|NCT00620113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847809|NCT00830115|Pantoprazole|pantoprazole|mesh-list
92847810|NCT00830115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92847811|NCT00830115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847812|NCT00830115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92847813|NCT00830115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847814|NCT00830115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847815|NCT00633672|Esomeprazole|esomeprazole|mesh-list
92847816|NCT00633672|Ranitidine|ranitidine|mesh-list
92847817|NCT00633672|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92847818|NCT00633672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92847819|NCT00633672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847820|NCT00633672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92847821|NCT00633672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847822|NCT00633672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847823|NCT00633672|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92847824|NCT00633672|Histamine Antagonists|histamine antagonists|mesh-ancestor
92847825|NCT00633672|Histamine Agents|histamine agents|mesh-ancestor
92847826|NCT00633672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847827|NCT00633672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847828|NCT02547103|Chlorhexidine|chlorhexidine|mesh-list
92847829|NCT02547103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92847830|NCT02547103|Mupirocin|mupirocin|mesh-list
92847831|NCT02547103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92847832|NCT02547103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847833|NCT02547103|Disinfectants|disinfectants|mesh-ancestor
92847834|NCT02547103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847835|NCT02547103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92847836|NCT02547103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92847837|NCT02547103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847838|NCT02547103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847839|NCT02822586|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92847840|NCT02822586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92847841|NCT02822586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847842|NCT02822586|Immunotoxins|immunotoxins|mesh-ancestor
92847843|NCT02822586|Immunoconjugates|immunoconjugates|mesh-ancestor
92847844|NCT02822586|Immunologic Factors|immunologic factors|mesh-ancestor
92847845|NCT02822586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847846|NCT00848809|Vancomycin|vancomycin|mesh-list
92847847|NCT00848809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92847848|NCT00848809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92847849|NCT00834847|Pravastatin|pravastatin|mesh-list
92847850|NCT00834847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92847851|NCT00834847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92847852|NCT00834847|Antimetabolites|antimetabolites|mesh-ancestor
92847853|NCT00834847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847854|NCT00834847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92847855|NCT00834847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92847856|NCT00834847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847857|NCT00841477|Vaccines|vaccines|mesh-list
92847858|NCT00841477|Immunologic Factors|immunologic factors|mesh-ancestor
92847859|NCT00841477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847860|NCT00834925|Diltiazem|diltiazem|mesh-list
92847861|NCT00834925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92847862|NCT00834925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92847863|NCT00834925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92847864|NCT00834925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847865|NCT00834925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92847866|NCT00834925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847867|NCT00834925|Vasodilator Agents|vasodilator agents|mesh-ancestor
92847868|NCT00841633|Norepinephrine|norepinephrine|mesh-list
92847869|NCT00841633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92847870|NCT00841633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92847871|NCT00841633|Adrenergic Agents|adrenergic agents|mesh-ancestor
92847872|NCT00841633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847873|NCT00841633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847874|NCT00841633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847875|NCT00841633|Sympathomimetics|sympathomimetics|mesh-ancestor
92847876|NCT00841633|Autonomic Agents|autonomic agents|mesh-ancestor
92847877|NCT00841633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847878|NCT00841633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92847879|NCT02823912|Capsaicin|capsaicin|mesh-list
92847880|NCT02823912|Magnesium Oxide|magnesium oxide|mesh-list
92847881|NCT02823912|Antipruritics|antipruritics|mesh-ancestor
92847882|NCT02823912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847883|NCT02823912|Sensory System Agents|sensory system agents|mesh-ancestor
92847884|NCT02823912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847885|NCT02823912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847887|NCT02823912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847888|NCT02823912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847889|NCT00841945|Prednisone|prednisone|mesh-list
92847890|NCT00841945|Rituximab|rituximab|mesh-list
92847891|NCT00841945|Doxorubicin|doxorubicin|mesh-list
92847892|NCT00841945|Vincristine|vincristine|mesh-list
92847893|NCT00841945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92847894|NCT00841945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847895|NCT00841945|Immunologic Factors|immunologic factors|mesh-ancestor
92847896|NCT00841945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847897|NCT00841945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847898|NCT00841945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92847899|NCT00841945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92847900|NCT00841945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92847901|NCT00841945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847902|NCT00841945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847903|NCT00841945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847904|NCT00841945|Glucocorticoids|glucocorticoids|mesh-ancestor
92847905|NCT00841945|Hormones|hormones|mesh-ancestor
92847906|NCT00841945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92847907|NCT00841945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92847908|NCT00841945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92847909|NCT00841945|Tubulin Modulators|tubulin modulators|mesh-ancestor
92847910|NCT00841945|Antimitotic Agents|antimitotic agents|mesh-ancestor
92847911|NCT00841945|Mitosis Modulators|mitosis modulators|mesh-ancestor
92847912|NCT02822196|Lidocaine|lidocaine|mesh-list
92847913|NCT02822196|Bupivacaine|bupivacaine|mesh-list
92847914|NCT02822196|Anesthetics, Local|anesthetics, local|mesh-ancestor
92847915|NCT02822196|Anesthetics|anesthetics|mesh-ancestor
92847916|NCT02822196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847917|NCT02822196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847918|NCT02822196|Sensory System Agents|sensory system agents|mesh-ancestor
92847919|NCT02822196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92847920|NCT02822196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92847921|NCT02822196|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92847922|NCT02822196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92847923|NCT02822196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92847924|NCT02822196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847925|NCT00706017|Insulin Detemir|insulin detemir|mesh-list
92847926|NCT00706017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92847927|NCT00706017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847929|NCT00829179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92847930|NCT00829179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92847931|NCT00829179|Respiratory System Agents|respiratory system agents|mesh-ancestor
92847932|NCT00849355|Rituximab|rituximab|mesh-list
92847933|NCT00849355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92847934|NCT00849355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847935|NCT00849355|Immunologic Factors|immunologic factors|mesh-ancestor
92847936|NCT00849355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847937|NCT00849355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92847938|NCT00835393|Pantoprazole|pantoprazole|mesh-list
92847939|NCT00835393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92847940|NCT00835393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92847941|NCT00835393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92847942|NCT00835393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847943|NCT00835393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847944|NCT00706173|Hydrocortisone|hydrocortisone|mesh-list
92847945|NCT00706173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92847946|NCT02822742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92847947|NCT02822742|Latanoprost|latanoprost|mesh-list
92847948|NCT02822742|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92847949|NCT00835471|Docetaxel|docetaxel|mesh-list
92847950|NCT00835471|Pemetrexed|pemetrexed|mesh-list
92847951|NCT00835471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92847952|NCT00835471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847953|NCT00835471|Tubulin Modulators|tubulin modulators|mesh-ancestor
92847954|NCT00835471|Antimitotic Agents|antimitotic agents|mesh-ancestor
92847955|NCT00835471|Mitosis Modulators|mitosis modulators|mesh-ancestor
92847956|NCT00835471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847957|NCT00835471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847958|NCT00835471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92847959|NCT00835471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92847960|NCT00835471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92847961|NCT00849511|Melatonin|melatonin|mesh-list
92847962|NCT00849511|Antioxidants|antioxidants|mesh-ancestor
92847963|NCT00849511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847964|NCT00849511|Protective Agents|protective agents|mesh-ancestor
92847965|NCT00849511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847966|NCT00849511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92847967|NCT02546791|Dasatinib|dasatinib|mesh-list
92847968|NCT02546791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847969|NCT02546791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92847970|NCT02546791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92847971|NCT02546791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847972|NCT00966875|Ixekizumab|ixekizumab|mesh-list
92847973|NCT00966875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92847974|NCT00849745|Alemtuzumab|alemtuzumab|mesh-list
92847975|NCT00849745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92847976|NCT00849745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847977|NCT00835627|Sertraline|sertraline|mesh-list
92847978|NCT00835627|Antidepressive Agents|antidepressive agents|mesh-ancestor
92847979|NCT00835627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92847980|NCT00835627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92847981|NCT00835627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92847982|NCT00835627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92847983|NCT00835627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847984|NCT00835627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92847985|NCT00835627|Serotonin Agents|serotonin agents|mesh-ancestor
92847986|NCT00835627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847987|NCT00842491|Cisplatin|cisplatin|mesh-list
92847988|NCT00842491|Capecitabine|capecitabine|mesh-list
92847989|NCT00842491|Endostar protein|endostar protein|mesh-list
92847990|NCT00842491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92847991|NCT00842491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92847992|NCT00842491|Antimetabolites|antimetabolites|mesh-ancestor
92193201|NCT04005170|Paclitaxel|paclitaxel|mesh-list
92847993|NCT00842491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92847994|NCT00842491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92847995|NCT00842491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92847996|NCT00842491|Growth Substances|growth substances|mesh-ancestor
92847997|NCT00842491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92847998|NCT00842491|Growth Inhibitors|growth inhibitors|mesh-ancestor
92848000|NCT05659212|Magnesium Sulfate|magnesium sulfate|mesh-list
92848001|NCT05659212|Dexmedetomidine|dexmedetomidine|mesh-list
92848002|NCT05659212|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848003|NCT05659212|Anesthetics|anesthetics|mesh-ancestor
92848004|NCT05659212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848005|NCT05659212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848006|NCT05659212|Sensory System Agents|sensory system agents|mesh-ancestor
92848007|NCT05659212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848008|NCT05659212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848009|NCT05659212|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848010|NCT05659212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848011|NCT05659212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848012|NCT05659212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848013|NCT05659212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848014|NCT05659212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848015|NCT05659212|Analgesics|analgesics|mesh-ancestor
92848016|NCT05659212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92848017|NCT05659212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92848018|NCT05659212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92848019|NCT05659212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848020|NCT05659212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848021|NCT05659212|Anticonvulsants|anticonvulsants|mesh-ancestor
92848022|NCT05659212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92848023|NCT05659212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92848024|NCT05659212|Tocolytic Agents|tocolytic agents|mesh-ancestor
92848025|NCT05659212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92848026|NCT00835939|Lidocaine|lidocaine|mesh-list
92848027|NCT00835939|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848028|NCT00835939|Anesthetics|anesthetics|mesh-ancestor
92848029|NCT00835939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848030|NCT00835939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848031|NCT00835939|Sensory System Agents|sensory system agents|mesh-ancestor
92848032|NCT00835939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848033|NCT00835939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848034|NCT00835939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848035|NCT00835939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848036|NCT00835939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848037|NCT00835939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848038|NCT05659368|Tirzepatide|tirzepatide|mesh-list
92848039|NCT05659368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92848040|NCT05659368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848041|NCT05659368|Incretins|incretins|mesh-ancestor
92848042|NCT05659368|Hormones|hormones|mesh-ancestor
92848043|NCT05659368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848044|NCT00818649|Bortezomib|bortezomib|mesh-list
92848045|NCT00818649|Vorinostat|vorinostat|mesh-list
92848046|NCT00818649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848047|NCT00818649|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92848048|NCT00818649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848049|NCT00818649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848050|NCT02861105|Enoxaparin|enoxaparin|mesh-list
92848051|NCT02861105|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92848052|NCT02861105|Anticoagulants|anticoagulants|mesh-ancestor
92848053|NCT02861105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92848054|NCT02861105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92848055|NCT02861105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848056|NCT02820558|Substance P|substance p|mesh-list
92848057|NCT02820558|Neurokinin A|neurokinin a|mesh-list
92848058|NCT02820558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848059|NCT02820558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848060|NCT02820558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848061|NCT00961571|Capecitabine|capecitabine|mesh-list
92848062|NCT00961571|Sunitinib|sunitinib|mesh-list
92848063|NCT00961571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92848064|NCT00961571|Antimetabolites|antimetabolites|mesh-ancestor
92848065|NCT00961571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848066|NCT00961571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848067|NCT00961571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92848068|NCT00961571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92848069|NCT00961571|Growth Substances|growth substances|mesh-ancestor
92848070|NCT00961571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848071|NCT00961571|Growth Inhibitors|growth inhibitors|mesh-ancestor
92848072|NCT00961571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92848073|NCT00961571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848075|NCT02820948|Vitamin E|vitamin e|mesh-list
92848076|NCT02820948|Tocopherols|tocopherols|mesh-list
92848077|NCT02820948|Tocotrienols|tocotrienols|mesh-list
92848078|NCT02820948|alpha-Tocopherol|alpha-tocopherol|mesh-list
92848079|NCT02820948|Micronutrients|micronutrients|mesh-ancestor
92848080|NCT02820948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848081|NCT02820948|Antioxidants|antioxidants|mesh-ancestor
92848082|NCT02820948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848083|NCT02820948|Protective Agents|protective agents|mesh-ancestor
92848084|NCT02860949|Ketorolac|ketorolac|mesh-list
92848085|NCT02860949|Epinephrine|epinephrine|mesh-list
92848086|NCT02860949|Morphine|morphine|mesh-list
92848087|NCT02860949|Bupivacaine|bupivacaine|mesh-list
92749799|NCT01147497|Misoprostol|misoprostol|mesh-list
92848088|NCT02860949|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848089|NCT02860949|Anesthetics|anesthetics|mesh-ancestor
92848090|NCT02860949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848091|NCT02860949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848092|NCT02860949|Sensory System Agents|sensory system agents|mesh-ancestor
92848093|NCT02860949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848094|NCT02860949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92848095|NCT02860949|Narcotics|narcotics|mesh-ancestor
92848096|NCT02860949|Analgesics|analgesics|mesh-ancestor
92848097|NCT02860949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92848098|NCT02860949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92848099|NCT02860949|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848100|NCT02860949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848101|NCT02860949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848102|NCT02860949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92848103|NCT02860949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92848104|NCT02860949|Autonomic Agents|autonomic agents|mesh-ancestor
92848105|NCT02860949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92848106|NCT02860949|Respiratory System Agents|respiratory system agents|mesh-ancestor
92848107|NCT02860949|Mydriatics|mydriatics|mesh-ancestor
92848108|NCT02860949|Sympathomimetics|sympathomimetics|mesh-ancestor
92848109|NCT02860949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93046924|NCT01058720|Vitamins|vitamins|mesh-ancestor
92848110|NCT02860949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92848111|NCT02860949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848112|NCT02860949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848113|NCT02860949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848114|NCT02860949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92848115|NCT02860949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848116|NCT03248063|Cefazolin|cefazolin|mesh-list
92848117|NCT03248063|Cloxacillin|cloxacillin|mesh-list
92848118|NCT03248063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848119|NCT03248063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848120|NCT00964223|Clindamycin|clindamycin|mesh-list
92848121|NCT00964223|Clindamycin palmitate|clindamycin palmitate|mesh-list
92848122|NCT00964223|Clindamycin phosphate|clindamycin phosphate|mesh-list
92848123|NCT00964223|Adapalene|adapalene|mesh-list
92848124|NCT00964223|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92848125|NCT00964223|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92848126|NCT00964223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848127|NCT00964223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848128|NCT00964223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92848129|NCT00964223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848130|NCT00964223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848131|NCT00964223|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848132|NCT00964223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92848133|NCT00964223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848134|NCT00964223|Analgesics|analgesics|mesh-ancestor
92848135|NCT00964223|Sensory System Agents|sensory system agents|mesh-ancestor
92848136|NCT00964223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848137|NCT00964223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848138|NCT00964223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848139|NCT00964223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848140|NCT00620815|Vaccines|vaccines|mesh-list
92848141|NCT00620815|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92848143|NCT00620815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848144|NCT00620815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92848145|NCT04238988|Paclitaxel|paclitaxel|mesh-list
92848146|NCT04238988|Carboplatin|carboplatin|mesh-list
92848147|NCT04238988|Pembrolizumab|pembrolizumab|mesh-list
92848148|NCT04238988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92848149|NCT04238988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848150|NCT04238988|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848151|NCT04238988|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848152|NCT04238988|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848153|NCT04238988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848154|NCT04238988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92848155|NCT04238988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92848156|NCT04284215|Paclitaxel|paclitaxel|mesh-list
92848157|NCT04284215|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92848158|NCT04284215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92848159|NCT04284215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848160|NCT04284215|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848161|NCT04284215|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848162|NCT04284215|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848163|NCT04284215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848164|NCT02816970|Vildagliptin|vildagliptin|mesh-list
92848165|NCT02816970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92848166|NCT02816970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848167|NCT02816970|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92848168|NCT02816970|Protease Inhibitors|protease inhibitors|mesh-ancestor
92848169|NCT02816970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848170|NCT02816970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848171|NCT03372941|Dalbavancin|dalbavancin|mesh-list
92848172|NCT03372941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848173|NCT03372941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848174|NCT04238832|Nicotine|nicotine|mesh-list
92848175|NCT04238832|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92848176|NCT04238832|Autonomic Agents|autonomic agents|mesh-ancestor
92848177|NCT04238832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848178|NCT04238832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848179|NCT04238832|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92848180|NCT04238832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92848181|NCT04238832|Cholinergic Agents|cholinergic agents|mesh-ancestor
92848182|NCT04238832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848183|NCT04238832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848184|NCT04622904|Lidocaine|lidocaine|mesh-list
92848185|NCT04622904|Ketamine|ketamine|mesh-list
92848186|NCT04622904|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848187|NCT04622904|Anesthetics|anesthetics|mesh-ancestor
92848188|NCT04622904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848189|NCT04622904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848190|NCT04622904|Sensory System Agents|sensory system agents|mesh-ancestor
92848191|NCT04622904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848192|NCT04622904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848193|NCT04622904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848194|NCT04622904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848195|NCT04622904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848196|NCT04622904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848197|NCT04622904|Analgesics|analgesics|mesh-ancestor
92848198|NCT04622904|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92848199|NCT04622904|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92848200|NCT04622904|Anesthetics, General|anesthetics, general|mesh-ancestor
92848201|NCT04622904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92848202|NCT04622904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92848203|NCT04622904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848204|NCT00634062|Lamotrigine|lamotrigine|mesh-list
92848205|NCT00634062|Anticonvulsants|anticonvulsants|mesh-ancestor
92848206|NCT00634062|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92848207|NCT00634062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848208|NCT00634062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848209|NCT00634062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92848210|NCT00634062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848211|NCT00634062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92848212|NCT00634062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92848213|NCT00634062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848214|NCT00634062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92848215|NCT00634062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848217|NCT00634140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92848218|NCT00634140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92848219|NCT00634140|Antimetabolites|antimetabolites|mesh-ancestor
92848220|NCT00634140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848221|NCT00634140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92848222|NCT02819544|Ropivacaine|ropivacaine|mesh-list
92848223|NCT02819544|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848224|NCT02819544|Anesthetics|anesthetics|mesh-ancestor
92848225|NCT02819544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848226|NCT02819544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848227|NCT02819544|Sensory System Agents|sensory system agents|mesh-ancestor
92848228|NCT02819544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848229|NCT02819388|Contraceptive Agents|contraceptive agents|mesh-list
92848230|NCT02819388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92848231|NCT02819388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848232|NCT02818140|Ropivacaine|ropivacaine|mesh-list
92848233|NCT02818140|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848234|NCT02818140|Anesthetics|anesthetics|mesh-ancestor
92848235|NCT02818140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848236|NCT02818140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848237|NCT02818140|Sensory System Agents|sensory system agents|mesh-ancestor
92848238|NCT02818140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848239|NCT04238208|Lidocaine|lidocaine|mesh-list
92848240|NCT04238208|Capsaicin|capsaicin|mesh-list
92848241|NCT04238208|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848242|NCT04238208|Anesthetics|anesthetics|mesh-ancestor
92848243|NCT04238208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848244|NCT04238208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848245|NCT04238208|Sensory System Agents|sensory system agents|mesh-ancestor
92848246|NCT04238208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848247|NCT04238208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848248|NCT04238208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848249|NCT04238208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848250|NCT04238208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848251|NCT04238208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848252|NCT04238208|Antipruritics|antipruritics|mesh-ancestor
92848253|NCT04238208|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848254|NCT02816112|Ciprofloxacin|ciprofloxacin|mesh-list
92848255|NCT02816112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848256|NCT02816112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848257|NCT02816112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92493341|NCT01967758|Amoxicillin|amoxicillin|mesh-list
92848258|NCT02816112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92848259|NCT02816112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848260|NCT02816112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848261|NCT02816112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848262|NCT02816112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92848263|NCT02816112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92848264|NCT02815722|Simvastatin|simvastatin|mesh-list
92848265|NCT02815722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92848266|NCT02815722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92848267|NCT02815722|Antimetabolites|antimetabolites|mesh-ancestor
92848268|NCT02815722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848269|NCT02815722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92848270|NCT02815722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92848271|NCT02815722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848273|NCT02817750|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92848274|NCT02817750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848275|NCT02817750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848276|NCT02817750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848277|NCT02817750|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92848278|NCT02817750|GABA Agonists|gaba agonists|mesh-ancestor
92848279|NCT02817750|GABA Agents|gaba agents|mesh-ancestor
92848280|NCT02817750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848281|NCT02817750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848282|NCT02815410|Levetiracetam|levetiracetam|mesh-list
92848283|NCT02815410|Anticonvulsants|anticonvulsants|mesh-ancestor
92848284|NCT02815410|Nootropic Agents|nootropic agents|mesh-ancestor
92848285|NCT02814630|Omalizumab|omalizumab|mesh-list
92848286|NCT02814630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92848287|NCT02814630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92848288|NCT02814630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92848289|NCT00619957|Risedronic Acid|risedronic acid|mesh-list
92848291|NCT00619957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848292|NCT00619957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848293|NCT00619957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92848294|NCT00619957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848295|NCT00619957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92848296|NCT04519476|Methylprednisolone|methylprednisolone|mesh-list
92848297|NCT04519476|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92848298|NCT04519476|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92848299|NCT04519476|Prednisolone|prednisolone|mesh-list
92848300|NCT04519476|Prednisolone acetate|prednisolone acetate|mesh-list
92848301|NCT04519476|Lenalidomide|lenalidomide|mesh-list
92848302|NCT04519476|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92848303|NCT04519476|Prednisolone phosphate|prednisolone phosphate|mesh-list
92848304|NCT04519476|Immunologic Factors|immunologic factors|mesh-ancestor
92848305|NCT04519476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848306|NCT04519476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92848307|NCT04519476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92848308|NCT04519476|Growth Substances|growth substances|mesh-ancestor
92848309|NCT04519476|Growth Inhibitors|growth inhibitors|mesh-ancestor
92848310|NCT04519476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848311|NCT04519476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848312|NCT04519476|Antiemetics|antiemetics|mesh-ancestor
92848313|NCT04519476|Autonomic Agents|autonomic agents|mesh-ancestor
92848314|NCT04519476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848315|NCT04519476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848316|NCT04519476|Glucocorticoids|glucocorticoids|mesh-ancestor
92848317|NCT04519476|Hormones|hormones|mesh-ancestor
92848318|NCT04519476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848319|NCT04519476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92848320|NCT04519476|Protective Agents|protective agents|mesh-ancestor
92848321|NCT04519476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848322|NCT00961415|Bevacizumab|bevacizumab|mesh-list
92848323|NCT00961415|Pemetrexed|pemetrexed|mesh-list
92848324|NCT00961415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92848325|NCT00961415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848326|NCT00961415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92848327|NCT00961415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92848328|NCT00961415|Growth Substances|growth substances|mesh-ancestor
92848329|NCT00961415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848330|NCT00961415|Growth Inhibitors|growth inhibitors|mesh-ancestor
92848331|NCT00961415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848332|NCT00961415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848333|NCT00961415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92848334|NCT00961415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92848335|NCT00851227|Conivaptan|conivaptan|mesh-list
92848336|NCT00851227|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92848337|NCT00851227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848338|NCT00851227|Natriuretic Agents|natriuretic agents|mesh-ancestor
92848339|NCT00851227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848340|NCT03365609|Bismuth|bismuth|mesh-list
92848341|NCT03365609|Antacids|antacids|mesh-ancestor
92848342|NCT03365609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848343|NCT03365609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848344|NCT05636904|Minoxidil|minoxidil|mesh-list
92848345|NCT05636904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92848346|NCT05636904|Dinoprost|dinoprost|mesh-list
92848347|NCT05636904|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
92848348|NCT05636904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92848349|NCT05636904|Vasodilator Agents|vasodilator agents|mesh-ancestor
92848350|NCT05636904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92848351|NCT05636904|Abortifacient Agents|abortifacient agents|mesh-ancestor
92848352|NCT05636904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92848353|NCT05636904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848354|NCT05636904|Oxytocics|oxytocics|mesh-ancestor
92848355|NCT00836485|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92848356|NCT00836485|Ketotifen|ketotifen|mesh-list
92848357|NCT00836485|Lubricant Eye Drops|lubricant eye drops|mesh-list
92848358|NCT00836485|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92848359|NCT00836485|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92848360|NCT00836485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92848361|NCT00836485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848362|NCT00836485|Analgesics|analgesics|mesh-ancestor
92848363|NCT00836485|Sensory System Agents|sensory system agents|mesh-ancestor
92848364|NCT00836485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848365|NCT00836485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848367|NCT00836485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848368|NCT00836485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92848369|NCT00836485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92848370|NCT00836485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92848371|NCT00836485|Histamine Antagonists|histamine antagonists|mesh-ancestor
92848372|NCT00836485|Histamine Agents|histamine agents|mesh-ancestor
92848373|NCT00836485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848374|NCT00836485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848375|NCT00836485|Antipruritics|antipruritics|mesh-ancestor
92848376|NCT00836485|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848377|NCT00963599|Loratadine|loratadine|mesh-list
92848378|NCT00963599|Montelukast|montelukast|mesh-list
92848379|NCT00963599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92848380|NCT00963599|Respiratory System Agents|respiratory system agents|mesh-ancestor
92848381|NCT00963599|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92848382|NCT00963599|Hormone Antagonists|hormone antagonists|mesh-ancestor
92848383|NCT00963599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848384|NCT00963599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848385|NCT00963599|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92848386|NCT00963599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92848387|NCT00963599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848388|NCT00963599|Antipruritics|antipruritics|mesh-ancestor
92848389|NCT00963599|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848390|NCT00963599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92848391|NCT00963599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92848392|NCT00963599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92848393|NCT00963599|Histamine Antagonists|histamine antagonists|mesh-ancestor
92848394|NCT00963599|Histamine Agents|histamine agents|mesh-ancestor
92848395|NCT00963599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848396|NCT05636592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92848397|NCT05636592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848398|NCT05636592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92848399|NCT05636592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848400|NCT00851461|Goserelin|goserelin|mesh-list
92848401|NCT00851461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848402|NCT00851461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848403|NCT04205136|Spironolactone|spironolactone|mesh-list
92848404|NCT04205136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92848405|NCT04205136|Hormone Antagonists|hormone antagonists|mesh-ancestor
92848406|NCT04205136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848407|NCT04205136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848408|NCT04205136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92848409|NCT04205136|Diuretics|diuretics|mesh-ancestor
92848410|NCT04205136|Natriuretic Agents|natriuretic agents|mesh-ancestor
92848411|NCT02815332|Minocycline|minocycline|mesh-list
92848412|NCT02815332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848413|NCT02815332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848414|NCT02811354|Osimertinib|osimertinib|mesh-list
92848415|NCT02811354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848416|NCT02811354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92848417|NCT02811354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848418|NCT02811354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848419|NCT02810808|Ranibizumab|ranibizumab|mesh-list
92848420|NCT02810808|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92848421|NCT02810808|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92848422|NCT02810808|Growth Substances|growth substances|mesh-ancestor
92848423|NCT02810808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848424|NCT02810808|Growth Inhibitors|growth inhibitors|mesh-ancestor
92848425|NCT02810808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848426|NCT00619801|Levocetirizine|levocetirizine|mesh-list
92848427|NCT00619801|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92848428|NCT00619801|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92848429|NCT00619801|Histamine Antagonists|histamine antagonists|mesh-ancestor
92848430|NCT00619801|Histamine Agents|histamine agents|mesh-ancestor
92848431|NCT00619801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848432|NCT00619801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848433|NCT00619801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848434|NCT02545777|Diclofenac|diclofenac|mesh-list
92193648|NCT04029350|Osimertinib|osimertinib|mesh-list
92848435|NCT02545777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92848437|NCT02545777|Analgesics|analgesics|mesh-ancestor
92848438|NCT02545777|Sensory System Agents|sensory system agents|mesh-ancestor
92848439|NCT02545777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848440|NCT02545777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848441|NCT02545777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848442|NCT02545777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848443|NCT02545777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92848444|NCT02545777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750151|NCT00938431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848445|NCT02545777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848446|NCT02810886|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92848447|NCT02810886|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92848448|NCT02810886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848449|NCT00962741|Etanercept|etanercept|mesh-list
92848450|NCT00962741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92848451|NCT00962741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848452|NCT00962741|Analgesics|analgesics|mesh-ancestor
92848453|NCT00962741|Sensory System Agents|sensory system agents|mesh-ancestor
92848454|NCT00962741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848455|NCT00962741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848456|NCT00962741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848457|NCT00962741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848458|NCT00962741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848459|NCT00962741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92848460|NCT00962741|Immunologic Factors|immunologic factors|mesh-ancestor
92848461|NCT00851929|Ambrisentan|ambrisentan|mesh-list
92848462|NCT00851929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92848463|NCT02813382|Bupivacaine|bupivacaine|mesh-list
92848464|NCT02813382|Prilocaine|prilocaine|mesh-list
92848465|NCT02813382|Chloroprocaine|chloroprocaine|mesh-list
92848466|NCT02813382|Procaine|procaine|mesh-list
92848467|NCT02813382|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848468|NCT02813382|Anesthetics|anesthetics|mesh-ancestor
92848469|NCT02813382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848470|NCT02813382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848471|NCT02813382|Sensory System Agents|sensory system agents|mesh-ancestor
92848472|NCT02813382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848473|NCT00619645|Cyclosporine|cyclosporine|mesh-list
92848474|NCT00619645|Mycophenolic Acid|mycophenolic acid|mesh-list
92848475|NCT00619645|Fludarabine|fludarabine|mesh-list
92848476|NCT00619645|Fludarabine phosphate|fludarabine phosphate|mesh-list
92848477|NCT00619645|Busulfan|busulfan|mesh-list
92848478|NCT00619645|Cyclosporins|cyclosporins|mesh-list
92848479|NCT00619645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848480|NCT00619645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92848481|NCT00619645|Antimetabolites|antimetabolites|mesh-ancestor
92848482|NCT00619645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848483|NCT00619645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92848484|NCT00619645|Immunologic Factors|immunologic factors|mesh-ancestor
92848485|NCT00619645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848486|NCT00619645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848487|NCT00619645|Antifungal Agents|antifungal agents|mesh-ancestor
92848488|NCT00619645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848489|NCT00619645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848490|NCT00619645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848491|NCT00619645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92848492|NCT00619645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92848493|NCT00619645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92848494|NCT00619645|Antitubercular Agents|antitubercular agents|mesh-ancestor
92848495|NCT00619645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848496|NCT00619645|Alkylating Agents|alkylating agents|mesh-ancestor
92848497|NCT00619645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92848498|NCT00619645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92848499|NCT00852163|Busulfan|busulfan|mesh-list
92848500|NCT00852163|Clofarabine|clofarabine|mesh-list
92848501|NCT00852163|Alkylating Agents|alkylating agents|mesh-ancestor
92848502|NCT00852163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848503|NCT00852163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92848504|NCT00852163|Immunologic Factors|immunologic factors|mesh-ancestor
92848505|NCT00852163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848506|NCT00852163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92848507|NCT00852163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848508|NCT00852163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92848509|NCT00852163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92848511|NCT00855517|Latanoprost|latanoprost|mesh-list
92848512|NCT00855517|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92848513|NCT00855517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92848514|NCT02544919|SMOFlipid|smoflipid|mesh-list
92848515|NCT02544919|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92848516|NCT02544919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92848517|NCT02544919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92848518|NCT00818259|Dexamethasone|dexamethasone|mesh-list
92848519|NCT00818259|Ondansetron|ondansetron|mesh-list
92848520|NCT00818259|Aprepitant|aprepitant|mesh-list
92848521|NCT00818259|Fosaprepitant|fosaprepitant|mesh-list
92848522|NCT00818259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848523|NCT00818259|Antiemetics|antiemetics|mesh-ancestor
92848524|NCT00818259|Autonomic Agents|autonomic agents|mesh-ancestor
92848525|NCT00818259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848526|NCT00818259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848527|NCT00818259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848528|NCT00818259|Glucocorticoids|glucocorticoids|mesh-ancestor
92848529|NCT00818259|Hormones|hormones|mesh-ancestor
92848530|NCT00818259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848531|NCT00818259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848532|NCT00818259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848533|NCT00818259|Antipruritics|antipruritics|mesh-ancestor
92848534|NCT00818259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848535|NCT00818259|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92848536|NCT00818259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92848537|NCT00818259|Serotonin Agents|serotonin agents|mesh-ancestor
92848538|NCT00818259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848539|NCT00818259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848540|NCT00818259|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92848541|NCT05578482|Mometasone Furoate|mometasone furoate|mesh-list
92848542|NCT05578482|Dicloxacillin|dicloxacillin|mesh-list
92848543|NCT05578482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848544|NCT05578482|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848545|NCT05578482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92848546|NCT05578482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92848547|NCT05578482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848548|NCT02809404|Everolimus|everolimus|mesh-list
92848549|NCT02809404|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92848550|NCT02809404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92848551|NCT02809404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848552|NCT02809404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493640|NCT01969617|Naltrexone|naltrexone|mesh-list
92848553|NCT02809404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92848554|NCT02809404|Immunologic Factors|immunologic factors|mesh-ancestor
92848555|NCT02809404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848556|NCT02809404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848557|NCT00619099|Decitabine|decitabine|mesh-list
92848558|NCT00619099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92848559|NCT00619099|Antimetabolites|antimetabolites|mesh-ancestor
92848560|NCT00619099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848561|NCT00619099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848562|NCT00619099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848563|NCT02812992|Paclitaxel|paclitaxel|mesh-list
92848564|NCT02812992|Gemcitabine|gemcitabine|mesh-list
92848565|NCT02812992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92848566|NCT02812992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848567|NCT02812992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848568|NCT02812992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848569|NCT02812992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848570|NCT02812992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848571|NCT02812992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92848572|NCT02812992|Antimetabolites|antimetabolites|mesh-ancestor
92848573|NCT00856063|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92848574|NCT00856063|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92848575|NCT00856063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92848576|NCT00856063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848577|NCT00856063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848578|NCT00856063|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848579|NCT00856063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848580|NCT00856063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848581|NCT02812602|Lidocaine|lidocaine|mesh-list
92848582|NCT02812602|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848583|NCT02812602|Anesthetics|anesthetics|mesh-ancestor
92193799|NCT04021862|Antibodies|antibodies|mesh-list
92848584|NCT02812602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848586|NCT02812602|Sensory System Agents|sensory system agents|mesh-ancestor
92848587|NCT02812602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848588|NCT02812602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848589|NCT02812602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848590|NCT02812602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848591|NCT02812602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848592|NCT02812602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848593|NCT00837187|Dexmedetomidine|dexmedetomidine|mesh-list
92848594|NCT00837187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848595|NCT00837187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848596|NCT00837187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848597|NCT00837187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848598|NCT00837187|Analgesics|analgesics|mesh-ancestor
92848599|NCT00837187|Sensory System Agents|sensory system agents|mesh-ancestor
92848600|NCT00837187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848601|NCT00837187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92848602|NCT00837187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92848603|NCT00837187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92848604|NCT00837187|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848605|NCT00837187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848606|NCT00837187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848607|NCT00962585|Equol|equol|mesh-list
92848608|NCT00962585|Phytoestrogens|phytoestrogens|mesh-ancestor
92848609|NCT00962585|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92848610|NCT00962585|Estrogens|estrogens|mesh-ancestor
92848611|NCT00962585|Hormones|hormones|mesh-ancestor
92848612|NCT00962585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848613|NCT00962585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848614|NCT00621985|Dexamethasone|dexamethasone|mesh-list
92848615|NCT00621985|Hydrocortisone|hydrocortisone|mesh-list
92848616|NCT00621985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848617|NCT00621985|Antiemetics|antiemetics|mesh-ancestor
92848618|NCT00621985|Autonomic Agents|autonomic agents|mesh-ancestor
92848619|NCT00621985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848620|NCT00621985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848621|NCT00621985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848622|NCT00621985|Glucocorticoids|glucocorticoids|mesh-ancestor
92848623|NCT00621985|Hormones|hormones|mesh-ancestor
92848624|NCT00621985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848625|NCT00621985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848626|NCT00621985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848627|NCT02812368|Clonidine|clonidine|mesh-list
92848628|NCT02812368|Analgesics|analgesics|mesh-ancestor
92848629|NCT02812368|Sensory System Agents|sensory system agents|mesh-ancestor
92848630|NCT02812368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848631|NCT02812368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848632|NCT02812368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92848633|NCT02812368|Sympatholytics|sympatholytics|mesh-ancestor
92848634|NCT02812368|Autonomic Agents|autonomic agents|mesh-ancestor
92848635|NCT02812368|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92848636|NCT02812368|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92848637|NCT02812368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92848638|NCT02812368|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848639|NCT02812368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848640|NCT02812368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848641|NCT03312257|Atropine|atropine|mesh-list
92848642|NCT03312257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92848643|NCT03312257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848644|NCT03312257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92848645|NCT03312257|Autonomic Agents|autonomic agents|mesh-ancestor
92848646|NCT03312257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848647|NCT03312257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848648|NCT03312257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92848649|NCT03312257|Respiratory System Agents|respiratory system agents|mesh-ancestor
92848650|NCT03312257|Mydriatics|mydriatics|mesh-ancestor
92848651|NCT03312257|Parasympatholytics|parasympatholytics|mesh-ancestor
92848652|NCT03312257|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92848653|NCT03312257|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92848654|NCT03312257|Cholinergic Agents|cholinergic agents|mesh-ancestor
92848655|NCT03312257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977216|NCT00586157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92848656|NCT03312257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848657|NCT00856687|Montelukast|montelukast|mesh-list
92848658|NCT00856687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92848659|NCT00856687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92848660|NCT00856687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92848661|NCT00856687|Hormone Antagonists|hormone antagonists|mesh-ancestor
92848662|NCT00856687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848663|NCT00856687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848664|NCT00856687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92848665|NCT00856687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92848666|NCT00856687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848667|NCT02862665|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92848668|NCT02862665|Hematinics|hematinics|mesh-ancestor
92848669|NCT02807922|Zopiclone|zopiclone|mesh-list
92848670|NCT02807922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848671|NCT02807922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848672|NCT02807922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848673|NCT00861367|Aspirin|aspirin|mesh-list
92848674|NCT00861367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92848675|NCT00861367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848676|NCT00861367|Analgesics|analgesics|mesh-ancestor
92848677|NCT00861367|Sensory System Agents|sensory system agents|mesh-ancestor
92848678|NCT00861367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848679|NCT00861367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848680|NCT00861367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848681|NCT00861367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848682|NCT00861367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92848683|NCT00861367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92848684|NCT00861367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848685|NCT00861367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92848686|NCT00861367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92848687|NCT00861367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848688|NCT00861367|Antipyretics|antipyretics|mesh-ancestor
92848689|NCT04285073|Paclitaxel|paclitaxel|mesh-list
92848690|NCT04285073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92848691|NCT04285073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848692|NCT04285073|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848693|NCT04285073|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848694|NCT04285073|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848695|NCT04285073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848696|NCT00861445|Lacosamide|lacosamide|mesh-list
92848697|NCT00861445|Anticonvulsants|anticonvulsants|mesh-ancestor
92848698|NCT00861445|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848699|NCT00861445|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848700|NCT00861445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848701|NCT00861445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848702|NCT04284059|Vitamin D|vitamin d|mesh-list
92848703|NCT04284059|Vitamins|vitamins|mesh-list
92848704|NCT04284059|Micronutrients|micronutrients|mesh-ancestor
92848705|NCT04284059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848706|NCT04284059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92848707|NCT00852709|Cyclophosphamide|cyclophosphamide|mesh-list
92848708|NCT00852709|Clofarabine|clofarabine|mesh-list
92848709|NCT00852709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92848710|NCT00852709|Immunologic Factors|immunologic factors|mesh-ancestor
92848711|NCT00852709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848712|NCT00852709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92848713|NCT00852709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92848714|NCT00852709|Alkylating Agents|alkylating agents|mesh-ancestor
92848715|NCT00852709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848716|NCT00852709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848717|NCT00852709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92848718|NCT00852709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92848719|NCT00852709|Antimetabolites|antimetabolites|mesh-ancestor
92848720|NCT00861523|Thiamine|thiamine|mesh-list
92848721|NCT00861523|Promethazine|promethazine|mesh-list
92848722|NCT00861523|Diphenhydramine|diphenhydramine|mesh-list
92848723|NCT00861523|Vitamin B Complex|vitamin b complex|mesh-ancestor
92848724|NCT00861523|Vitamins|vitamins|mesh-ancestor
92848725|NCT00861523|Micronutrients|micronutrients|mesh-ancestor
92848726|NCT00861523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848727|NCT00861523|Antipruritics|antipruritics|mesh-ancestor
92848728|NCT00861523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848729|NCT00861523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92848730|NCT00861523|Histamine Antagonists|histamine antagonists|mesh-ancestor
92848731|NCT00861523|Histamine Agents|histamine agents|mesh-ancestor
92848732|NCT00861523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750439|NCT01266590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848733|NCT00861523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848734|NCT00861523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92848735|NCT00861523|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92848736|NCT00861523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848737|NCT00861523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848738|NCT00861523|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848739|NCT00861523|Anesthetics|anesthetics|mesh-ancestor
92848740|NCT00861523|Sensory System Agents|sensory system agents|mesh-ancestor
92848741|NCT00861523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848742|NCT00861523|Antiemetics|antiemetics|mesh-ancestor
92848743|NCT00861523|Autonomic Agents|autonomic agents|mesh-ancestor
92848744|NCT00861523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848745|NCT02811978|Dexamethasone|dexamethasone|mesh-list
92848746|NCT02811978|Bortezomib|bortezomib|mesh-list
92848747|NCT02811978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848748|NCT02811978|Antiemetics|antiemetics|mesh-ancestor
92848749|NCT02811978|Autonomic Agents|autonomic agents|mesh-ancestor
92848750|NCT02811978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848751|NCT02811978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848752|NCT02811978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848753|NCT02811978|Glucocorticoids|glucocorticoids|mesh-ancestor
92848754|NCT02811978|Hormones|hormones|mesh-ancestor
92848755|NCT02811978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848756|NCT02811978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848757|NCT02811978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848758|NCT00630149|Pemetrexed|pemetrexed|mesh-list
92848759|NCT00630149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848760|NCT00630149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848761|NCT00630149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848762|NCT00630149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92848763|NCT00630149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92848764|NCT04204577|Apatinib|apatinib|mesh-list
92848765|NCT04204577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848766|NCT04204577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92848767|NCT04204577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848768|NCT04204577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848769|NCT00852787|Digoxin|digoxin|mesh-list
92848770|NCT00852787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848771|NCT00852787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92848772|NCT00852787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848773|NCT00852787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848774|NCT00852787|Protective Agents|protective agents|mesh-ancestor
92848775|NCT00852787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848776|NCT02545465|Riociguat|riociguat|mesh-list
92848777|NCT02545465|Enzyme Activators|enzyme activators|mesh-ancestor
92848778|NCT02545465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848779|NCT00961259|Fenofibric acid|fenofibric acid|mesh-list
92848780|NCT00961259|Fenofibrate|fenofibrate|mesh-list
92848781|NCT00961259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92848782|NCT00961259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92848783|NCT00961259|Antimetabolites|antimetabolites|mesh-ancestor
92848784|NCT00961259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848785|NCT00961259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92848786|NCT04283747|Immunoglobulins|immunoglobulins|mesh-list
92848787|NCT04283747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92848788|NCT04283747|Antibodies|antibodies|mesh-list
92848789|NCT04283747|Immunologic Factors|immunologic factors|mesh-ancestor
92848790|NCT04283747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848791|NCT04111926|Dexmedetomidine|dexmedetomidine|mesh-list
92848792|NCT04111926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848793|NCT04111926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848794|NCT04111926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848795|NCT04111926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92848796|NCT04111926|Analgesics|analgesics|mesh-ancestor
92848797|NCT04111926|Sensory System Agents|sensory system agents|mesh-ancestor
92848798|NCT04111926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848799|NCT04111926|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92848800|NCT04111926|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92848801|NCT04111926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92848802|NCT04111926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848803|NCT04111926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848804|NCT04111926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848806|NCT04041349|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848807|NCT04041349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848808|NCT00961181|Paclitaxel|paclitaxel|mesh-list
92848809|NCT00961181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92848810|NCT00961181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848811|NCT00961181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848812|NCT00961181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848813|NCT00961181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848814|NCT00961181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848815|NCT02807610|Propofol|propofol|mesh-list
92848816|NCT02807610|Etomidate|etomidate|mesh-list
92848817|NCT02807610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92848818|NCT02807610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848819|NCT02807610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848820|NCT02807610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92848821|NCT02807610|Anesthetics, General|anesthetics, general|mesh-ancestor
92848822|NCT02807610|Anesthetics|anesthetics|mesh-ancestor
92848823|NCT00857077|Pyrimethamine|pyrimethamine|mesh-list
92848824|NCT00857077|Sulfadoxine|sulfadoxine|mesh-list
92848825|NCT00857077|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92848826|NCT00857077|Antimalarials|antimalarials|mesh-ancestor
92848827|NCT00857077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92848828|NCT00857077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92848829|NCT00857077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848830|NCT00857077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92848831|NCT00857077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848832|NCT00857077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848833|NCT00857077|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92848834|NCT00857155|Clopidogrel|clopidogrel|mesh-list
92848835|NCT00857155|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92848836|NCT00857155|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92848837|NCT00857155|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92848838|NCT00857155|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92848839|NCT00857155|Purinergic Agents|purinergic agents|mesh-ancestor
92848840|NCT00857155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848841|NCT00857155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848842|NCT00857155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848843|NCT00817635|Eplerenone|eplerenone|mesh-list
92848844|NCT00817635|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92848845|NCT00817635|Hormone Antagonists|hormone antagonists|mesh-ancestor
92848846|NCT00817635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848847|NCT00817635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848848|NCT00817635|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92848849|NCT00817635|Diuretics|diuretics|mesh-ancestor
92848850|NCT00817635|Natriuretic Agents|natriuretic agents|mesh-ancestor
92848851|NCT00817635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92848852|NCT00853177|Lidocaine|lidocaine|mesh-list
92848853|NCT00853177|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848854|NCT00853177|Anesthetics|anesthetics|mesh-ancestor
92848855|NCT00853177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848856|NCT00853177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848857|NCT00853177|Sensory System Agents|sensory system agents|mesh-ancestor
92848858|NCT00853177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848859|NCT00853177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848860|NCT00853177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848861|NCT00853177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848862|NCT00853177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848863|NCT00853177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848865|NCT00924079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92848866|NCT00924079|Narcotics|narcotics|mesh-ancestor
92848867|NCT00924079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848868|NCT00924079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848869|NCT00924079|Analgesics|analgesics|mesh-ancestor
92848870|NCT00924079|Sensory System Agents|sensory system agents|mesh-ancestor
92848871|NCT00924079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848872|NCT00817479|Dexamethasone|dexamethasone|mesh-list
92848873|NCT00817479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848874|NCT00817479|Antiemetics|antiemetics|mesh-ancestor
92848875|NCT00817479|Autonomic Agents|autonomic agents|mesh-ancestor
92433257|NCT01573637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92848876|NCT00817479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848877|NCT00817479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848878|NCT00817479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92848879|NCT00817479|Glucocorticoids|glucocorticoids|mesh-ancestor
92848880|NCT00817479|Hormones|hormones|mesh-ancestor
92848881|NCT00817479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848882|NCT00817479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848883|NCT00817479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848884|NCT00853411|Prednisone|prednisone|mesh-list
92848885|NCT00853411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92848886|NCT00853411|Glucocorticoids|glucocorticoids|mesh-ancestor
92848887|NCT00853411|Hormones|hormones|mesh-ancestor
92848888|NCT00853411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92848889|NCT00853411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848890|NCT00853411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92848891|NCT00853411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848892|NCT04030533|Ustekinumab|ustekinumab|mesh-list
92848893|NCT04030533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92848894|NCT04030533|Dermatologic Agents|dermatologic agents|mesh-ancestor
92848895|NCT04030533|Immunologic Factors|immunologic factors|mesh-ancestor
92848896|NCT04030533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848897|NCT02807298|Lidocaine|lidocaine|mesh-list
92848898|NCT02807298|Epinephrine|epinephrine|mesh-list
92848899|NCT02807298|Carticaine|carticaine|mesh-list
92848900|NCT02807298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92848901|NCT02807298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92848902|NCT02807298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92848903|NCT02807298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848904|NCT02807298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848905|NCT02807298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848906|NCT02807298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92848907|NCT02807298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92848908|NCT02807298|Autonomic Agents|autonomic agents|mesh-ancestor
92848909|NCT02807298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848910|NCT02807298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92848911|NCT02807298|Respiratory System Agents|respiratory system agents|mesh-ancestor
92848912|NCT02807298|Mydriatics|mydriatics|mesh-ancestor
92848913|NCT02807298|Sympathomimetics|sympathomimetics|mesh-ancestor
92848914|NCT02807298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92848915|NCT02807298|Anesthetics, Local|anesthetics, local|mesh-ancestor
92848916|NCT02807298|Anesthetics|anesthetics|mesh-ancestor
92848917|NCT02807298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848918|NCT02807298|Sensory System Agents|sensory system agents|mesh-ancestor
92848919|NCT02807298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92848920|NCT02807298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92848921|NCT02807298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92848922|NCT02807298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848923|NCT04041427|Albendazole|albendazole|mesh-list
92848924|NCT04041427|Anthelmintics|anthelmintics|mesh-ancestor
92848925|NCT04041427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92848926|NCT04041427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92848927|NCT04041427|Anticestodal Agents|anticestodal agents|mesh-ancestor
92848928|NCT04041427|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92848929|NCT04041427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92848930|NCT04041427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848931|NCT04041427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848932|NCT04041427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848933|NCT04041427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848934|NCT04041427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848935|NCT00961961|Lithium Carbonate|lithium carbonate|mesh-list
92848936|NCT00961961|Fluoxetine|fluoxetine|mesh-list
92848937|NCT00961961|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92848938|NCT00961961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92848939|NCT00961961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92848940|NCT00961961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848941|NCT00961961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92848942|NCT00961961|Serotonin Agents|serotonin agents|mesh-ancestor
92750658|NCT05938140|Protease Inhibitors|protease inhibitors|mesh-ancestor
92848943|NCT00961961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848944|NCT00961961|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92848945|NCT00961961|Antidepressive Agents|antidepressive agents|mesh-ancestor
92848946|NCT00961961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92848947|NCT00961961|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92848948|NCT00961961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92848949|NCT00961961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848950|NCT00961961|Antimanic Agents|antimanic agents|mesh-ancestor
92848951|NCT00961961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92848952|NCT00961961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92848953|NCT02610933|Vitamin K|vitamin k|mesh-list
92848954|NCT02610933|Vitamin K 2|vitamin k 2|mesh-list
92848955|NCT02610933|Rivaroxaban|rivaroxaban|mesh-list
92848956|NCT02610933|Vitamins|vitamins|mesh-ancestor
92848957|NCT02610933|Micronutrients|micronutrients|mesh-ancestor
92848958|NCT02610933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848959|NCT02610933|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92848960|NCT02610933|Antithrombins|antithrombins|mesh-ancestor
92848961|NCT02610933|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92848962|NCT02610933|Protease Inhibitors|protease inhibitors|mesh-ancestor
92848963|NCT02610933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92848964|NCT02610933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848965|NCT02610933|Anticoagulants|anticoagulants|mesh-ancestor
92848966|NCT02610933|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92848967|NCT02610933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92848968|NCT02610933|Hemostatics|hemostatics|mesh-ancestor
92848969|NCT02610933|Coagulants|coagulants|mesh-ancestor
92848970|NCT04042441|Insulin|insulin|mesh-list
92848971|NCT04042441|Insulin Aspart|insulin aspart|mesh-list
92848972|NCT04042441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92848973|NCT04042441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848974|NCT00817089|Naltrexone|naltrexone|mesh-list
92848975|NCT00817089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92848976|NCT00817089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92848977|NCT00817089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848978|NCT00817089|Sensory System Agents|sensory system agents|mesh-ancestor
92848979|NCT00817089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92848980|NCT03296033|Enoxaparin|enoxaparin|mesh-list
92848981|NCT03296033|Enoxaparin sodium|enoxaparin sodium|mesh-list
92848982|NCT03296033|Anticoagulants|anticoagulants|mesh-ancestor
92848983|NCT03296033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92848984|NCT03296033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92848985|NCT03296033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848986|NCT00857779|Immunomodulating Agents|immunomodulating agents|mesh-list
92848987|NCT00857779|Immunologic Factors|immunologic factors|mesh-ancestor
92848988|NCT00857779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92848989|NCT05758389|Paclitaxel|paclitaxel|mesh-list
92848990|NCT05758389|Tislelizumab|tislelizumab|mesh-list
92848991|NCT05758389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92848992|NCT05758389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92848993|NCT05758389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92848994|NCT05758389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92848995|NCT05758389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92848996|NCT05758389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92848997|NCT05758389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92848998|NCT00857935|Permethrin|permethrin|mesh-list
92848999|NCT00857935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849000|NCT00857935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849001|NCT00853879|Vitamins|vitamins|mesh-list
92849002|NCT00853879|Folic Acid|folic acid|mesh-list
92849003|NCT00853879|Hydroxocobalamin|hydroxocobalamin|mesh-list
92849004|NCT00853879|Vitamin B 12|vitamin b 12|mesh-list
92849005|NCT00853879|Vitamin B 6|vitamin b 6|mesh-list
92849006|NCT00853879|Pyridoxal|pyridoxal|mesh-list
92849007|NCT00853879|Pyridoxine|pyridoxine|mesh-list
92849008|NCT00853879|Vitamin B Complex|vitamin b complex|mesh-list
92849009|NCT00853879|Micronutrients|micronutrients|mesh-ancestor
92849010|NCT00853879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849011|NCT00853879|Hematinics|hematinics|mesh-ancestor
92849012|NCT04171843|Cyclophosphamide|cyclophosphamide|mesh-list
92849013|NCT04171843|Fludarabine|fludarabine|mesh-list
92849014|NCT04171843|Nirogacestat|nirogacestat|mesh-list
92849015|NCT04171843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849016|NCT04171843|Immunologic Factors|immunologic factors|mesh-ancestor
92849017|NCT04171843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849018|NCT04171843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849019|NCT04171843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92849020|NCT04171843|Alkylating Agents|alkylating agents|mesh-ancestor
92849021|NCT04171843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849022|NCT04171843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849023|NCT04171843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92849024|NCT04171843|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92849025|NCT04171843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849026|NCT00815919|Prednisone|prednisone|mesh-list
92849027|NCT00815919|Bortezomib|bortezomib|mesh-list
92849028|NCT00815919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849029|NCT00815919|Glucocorticoids|glucocorticoids|mesh-ancestor
92849030|NCT00815919|Hormones|hormones|mesh-ancestor
92849031|NCT00815919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849032|NCT00815919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849033|NCT00815919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92849034|NCT00815919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849035|NCT02545153|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92849036|NCT02545153|Aprotinin|aprotinin|mesh-list
92849037|NCT02545153|Hemostatics|hemostatics|mesh-ancestor
92849038|NCT02545153|Coagulants|coagulants|mesh-ancestor
92849039|NCT02545153|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92849040|NCT02545153|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92849041|NCT02545153|Protease Inhibitors|protease inhibitors|mesh-ancestor
92849042|NCT02545153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849043|NCT02545153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849044|NCT00913653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92849045|NCT00913653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92849046|NCT00913653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849047|NCT00854035|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92849048|NCT00854035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92849049|NCT00854035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849050|NCT00854035|Incretins|incretins|mesh-ancestor
92849051|NCT00854035|Hormones|hormones|mesh-ancestor
92849052|NCT00854035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849053|NCT00854035|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92849054|NCT00854035|Protease Inhibitors|protease inhibitors|mesh-ancestor
92849055|NCT00854035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849056|NCT00854035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849057|NCT00957905|Calcium, Dietary|calcium, dietary|mesh-list
92849058|NCT00957905|Leucovorin|leucovorin|mesh-list
92849059|NCT00957905|Folic Acid|folic acid|mesh-list
92849060|NCT00957905|Fluorouracil|fluorouracil|mesh-list
92849061|NCT00957905|Oxaliplatin|oxaliplatin|mesh-list
92849062|NCT00957905|Alvocidib|alvocidib|mesh-list
92849063|NCT00957905|Calcium|calcium|mesh-list
92849064|NCT00957905|Levoleucovorin|levoleucovorin|mesh-list
92849065|NCT00957905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92849066|NCT00957905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849067|NCT00957905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92849068|NCT00957905|Antimetabolites|antimetabolites|mesh-ancestor
92849069|NCT00957905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849070|NCT00957905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92849071|NCT00957905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849072|NCT00957905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849073|NCT00957905|Immunologic Factors|immunologic factors|mesh-ancestor
92849074|NCT00957905|Antidotes|antidotes|mesh-ancestor
92849075|NCT00957905|Protective Agents|protective agents|mesh-ancestor
92849076|NCT00957905|Vitamin B Complex|vitamin b complex|mesh-ancestor
92849077|NCT00957905|Vitamins|vitamins|mesh-ancestor
92849078|NCT00957905|Micronutrients|micronutrients|mesh-ancestor
92849079|NCT00957905|Hematinics|hematinics|mesh-ancestor
92849080|NCT00957905|Growth Inhibitors|growth inhibitors|mesh-ancestor
92849081|NCT00957905|Growth Substances|growth substances|mesh-ancestor
92849082|NCT00957905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92849083|NCT00957905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849084|NCT02804646|Carboplatin|carboplatin|mesh-list
92849085|NCT02804646|Pemetrexed|pemetrexed|mesh-list
92849086|NCT02804646|Endostatins|endostatins|mesh-list
92849087|NCT02804646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849088|NCT02804646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849089|NCT02804646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849090|NCT02804646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92849091|NCT02804646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92849092|NCT02804646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92849093|NCT02804646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92849094|NCT02804646|Growth Substances|growth substances|mesh-ancestor
92849095|NCT02804646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849096|NCT02804646|Growth Inhibitors|growth inhibitors|mesh-ancestor
92849097|NCT02858297|Triamcinolone|triamcinolone|mesh-list
92849098|NCT02858297|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92849099|NCT02858297|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92849100|NCT02858297|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92849101|NCT02858297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849102|NCT02858297|Glucocorticoids|glucocorticoids|mesh-ancestor
92849103|NCT02858297|Hormones|hormones|mesh-ancestor
92849104|NCT02858297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849105|NCT02858297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849106|NCT02858297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849107|NCT02858297|Immunologic Factors|immunologic factors|mesh-ancestor
92849108|NCT02858297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849109|NCT02858297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849110|NCT00858325|Daptomycin|daptomycin|mesh-list
92849111|NCT00858325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92849112|NCT00858325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849113|NCT02804490|Vitamin A|vitamin a|mesh-list
92849114|NCT02804490|Beta Carotene|beta carotene|mesh-list
92849115|NCT02804490|Provitamins|provitamins|mesh-list
92849116|NCT02804490|Carotenoids|carotenoids|mesh-list
92849117|NCT02804490|Vitamins|vitamins|mesh-ancestor
92849118|NCT02804490|Micronutrients|micronutrients|mesh-ancestor
92849119|NCT02804490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849120|NCT02804490|Antioxidants|antioxidants|mesh-ancestor
92849121|NCT02804490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849122|NCT02804490|Protective Agents|protective agents|mesh-ancestor
92849123|NCT00960323|Colchicine|colchicine|mesh-list
92849124|NCT00960323|Atorvastatin|atorvastatin|mesh-list
92849125|NCT00960323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92849126|NCT00960323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92849127|NCT00960323|Antimetabolites|antimetabolites|mesh-ancestor
92849128|NCT00960323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849129|NCT00960323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92849130|NCT00960323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92849131|NCT00960323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849132|NCT00960323|Gout Suppressants|gout suppressants|mesh-ancestor
92849133|NCT00960323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849134|NCT00960323|Tubulin Modulators|tubulin modulators|mesh-ancestor
92849135|NCT00960323|Antimitotic Agents|antimitotic agents|mesh-ancestor
92849136|NCT00960323|Mitosis Modulators|mitosis modulators|mesh-ancestor
92849137|NCT00960323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849138|NCT00617929|Rituximab|rituximab|mesh-list
92849139|NCT00617929|Clofarabine|clofarabine|mesh-list
92849140|NCT00617929|Thymoglobulin|thymoglobulin|mesh-list
92849141|NCT00617929|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92849142|NCT00617929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92849143|NCT00617929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849144|NCT00617929|Immunologic Factors|immunologic factors|mesh-ancestor
92849145|NCT00617929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849146|NCT00617929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849147|NCT00617929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849148|NCT00617929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92849149|NCT00617929|Antimetabolites|antimetabolites|mesh-ancestor
92849150|NCT00617929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849151|NCT00862381|Hydrocortisone|hydrocortisone|mesh-list
92849152|NCT00862381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849153|NCT02800590|Abp-700|abp-700|mesh-list
92849154|NCT02800590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92849155|NCT02800590|GABA Agonists|gaba agonists|mesh-ancestor
92849156|NCT02800590|GABA Agents|gaba agents|mesh-ancestor
92849157|NCT02800590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849158|NCT02800590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849159|NCT02800590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849160|NCT00815295|Cetuximab|cetuximab|mesh-list
92849161|NCT00815295|Sorafenib|sorafenib|mesh-list
92849162|NCT00815295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92849163|NCT00815295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849164|NCT00815295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92849165|NCT00815295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849166|NCT00815295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849167|NCT00630383|Histamine|histamine|mesh-list
92849168|NCT00630383|Histamine Agonists|histamine agonists|mesh-ancestor
92849169|NCT00630383|Histamine Agents|histamine agents|mesh-ancestor
92849170|NCT00630383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849171|NCT00630383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849172|NCT00630383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849173|NCT02806752|Triamcinolone|triamcinolone|mesh-list
92849174|NCT02806752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92849175|NCT02806752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92849176|NCT02806752|Ranibizumab|ranibizumab|mesh-list
92849177|NCT02806752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92849178|NCT02806752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92849179|NCT02806752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92849180|NCT02806752|Growth Substances|growth substances|mesh-ancestor
92849181|NCT02806752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849182|NCT02806752|Growth Inhibitors|growth inhibitors|mesh-ancestor
92849183|NCT02806752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849184|NCT02806752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849185|NCT02806752|Glucocorticoids|glucocorticoids|mesh-ancestor
92849186|NCT02806752|Hormones|hormones|mesh-ancestor
92849187|NCT02806752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849188|NCT02806752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849189|NCT02806752|Immunologic Factors|immunologic factors|mesh-ancestor
92849190|NCT02806752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849191|NCT02806752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849192|NCT00854425|Asparaginase|asparaginase|mesh-list
92849193|NCT00854425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849194|NCT02544529|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92849195|NCT02544529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92849196|NCT02544529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92849197|NCT02544529|Echothiophate Iodide|echothiophate iodide|mesh-list
92849198|NCT02544529|Laxatives|laxatives|mesh-ancestor
92849199|NCT02544529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849200|NCT02544529|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92849201|NCT02544529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849202|NCT02544529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849203|NCT02544529|Cholinergic Agents|cholinergic agents|mesh-ancestor
92849204|NCT02544529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849205|NCT02544529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849206|NCT02544529|Miotics|miotics|mesh-ancestor
92849207|NCT02544529|Autonomic Agents|autonomic agents|mesh-ancestor
92849208|NCT02544529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849209|NCT02544529|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92849210|NCT02806596|Sevoflurane|sevoflurane|mesh-list
92849211|NCT02806596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92849212|NCT02806596|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92849213|NCT02806596|Anesthetics, General|anesthetics, general|mesh-ancestor
92849214|NCT02806596|Anesthetics|anesthetics|mesh-ancestor
92849215|NCT02806596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849216|NCT02806596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849217|NCT04282031|Letrozole|letrozole|mesh-list
92849218|NCT04282031|Fulvestrant|fulvestrant|mesh-list
92849219|NCT04282031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849220|NCT04282031|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92849221|NCT04282031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92849222|NCT04282031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849223|NCT04282031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849224|NCT04282031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92849225|NCT04282031|Hormone Antagonists|hormone antagonists|mesh-ancestor
92849226|NCT04282031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849227|NCT04282031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849228|NCT04282031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92849229|NCT04282031|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92849230|NCT00854503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92849231|NCT00854503|Simvastatin|simvastatin|mesh-list
92849232|NCT00854503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92849233|NCT00854503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92849234|NCT00854503|Antimetabolites|antimetabolites|mesh-ancestor
92849235|NCT00854503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849236|NCT00854503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92849237|NCT00854503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92849238|NCT00854503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849239|NCT00858715|Aspirin|aspirin|mesh-list
92849240|NCT00858715|Clopidogrel|clopidogrel|mesh-list
92849241|NCT00858715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92849242|NCT00858715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849243|NCT00858715|Analgesics|analgesics|mesh-ancestor
92849244|NCT00858715|Sensory System Agents|sensory system agents|mesh-ancestor
92849245|NCT00858715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849246|NCT00858715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849247|NCT00858715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849248|NCT00858715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849249|NCT00858715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92849250|NCT00858715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92849251|NCT00858715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849252|NCT00858715|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92849253|NCT00858715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92849254|NCT00858715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849255|NCT00858715|Antipyretics|antipyretics|mesh-ancestor
92849256|NCT00858715|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92849257|NCT00858715|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92849258|NCT00858715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92849259|NCT00858715|Purinergic Agents|purinergic agents|mesh-ancestor
92849260|NCT00858715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849261|NCT02806284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92849262|NCT02806284|Immunologic Factors|immunologic factors|mesh-ancestor
92849263|NCT02806284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849264|NCT00960869|Aspirin|aspirin|mesh-list
92849265|NCT00960869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92849266|NCT00960869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849267|NCT00960869|Analgesics|analgesics|mesh-ancestor
92849268|NCT00960869|Sensory System Agents|sensory system agents|mesh-ancestor
92849269|NCT00960869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849270|NCT00960869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849271|NCT00960869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849272|NCT00960869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849273|NCT00960869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92849274|NCT00960869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92849275|NCT00960869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849276|NCT00960869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92849277|NCT00960869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92849278|NCT00960869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849279|NCT00960869|Antipyretics|antipyretics|mesh-ancestor
92849280|NCT02799888|Cyclosporine|cyclosporine|mesh-list
92849281|NCT02799888|Maraviroc|maraviroc|mesh-list
92849282|NCT02799888|Methotrexate|methotrexate|mesh-list
92849283|NCT02799888|Tacrolimus|tacrolimus|mesh-list
92849284|NCT02799888|Cyclosporins|cyclosporins|mesh-list
92849285|NCT02799888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92849286|NCT02799888|Abortifacient Agents|abortifacient agents|mesh-ancestor
92849287|NCT02799888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92849288|NCT02799888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849289|NCT02799888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92849290|NCT02799888|Antimetabolites|antimetabolites|mesh-ancestor
92849291|NCT02799888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849292|NCT02799888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849293|NCT02799888|Dermatologic Agents|dermatologic agents|mesh-ancestor
92849294|NCT02799888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849295|NCT02799888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92849296|NCT02799888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849297|NCT02799888|Immunologic Factors|immunologic factors|mesh-ancestor
92849298|NCT02799888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849299|NCT02799888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92849300|NCT02799888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92849301|NCT02799888|Antifungal Agents|antifungal agents|mesh-ancestor
92849302|NCT02799888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849303|NCT02799888|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92849304|NCT02799888|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92849305|NCT02799888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92849306|NCT02799888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92849307|NCT02799888|Antiviral Agents|antiviral agents|mesh-ancestor
92849308|NCT02799888|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92849309|NCT00859105|Imiquimod|imiquimod|mesh-list
92849310|NCT00859105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92849311|NCT00859105|Immunologic Factors|immunologic factors|mesh-ancestor
92849312|NCT00859105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849313|NCT00859105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849314|NCT00859105|Interferon Inducers|interferon inducers|mesh-ancestor
92849315|NCT00859183|Sirolimus|sirolimus|mesh-list
92849316|NCT00859183|Temsirolimus|temsirolimus|mesh-list
92849317|NCT00859183|MTOR Inhibitors|mtor inhibitors|mesh-list
92849318|NCT00859183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92849319|NCT00859183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849320|NCT00859183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92849321|NCT00859183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849322|NCT00859183|Antifungal Agents|antifungal agents|mesh-ancestor
92849323|NCT00859183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849324|NCT00859183|Immunologic Factors|immunologic factors|mesh-ancestor
92849325|NCT00859183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849326|NCT00859183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92849327|NCT00859183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849328|NCT00859183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849329|NCT02803944|Azithromycin|azithromycin|mesh-list
92849330|NCT02803944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92849331|NCT02803944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849332|NCT02545231|Pitavastatin|pitavastatin|mesh-list
92849333|NCT02545231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92849334|NCT02545231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92849335|NCT02545231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92849336|NCT02545231|Antimetabolites|antimetabolites|mesh-ancestor
92849337|NCT02545231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849338|NCT02545231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849339|NCT02545231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92849340|NCT02803788|Dexamethasone|dexamethasone|mesh-list
92849341|NCT02803788|Ondansetron|ondansetron|mesh-list
92849342|NCT02803788|Ramosetron|ramosetron|mesh-list
92849343|NCT02803788|Antiemetics|antiemetics|mesh-list
92849344|NCT02803788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849345|NCT02803788|Autonomic Agents|autonomic agents|mesh-ancestor
92849346|NCT02803788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849347|NCT02803788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849348|NCT02803788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849349|NCT02803788|Glucocorticoids|glucocorticoids|mesh-ancestor
92849350|NCT02803788|Hormones|hormones|mesh-ancestor
92849351|NCT02803788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849352|NCT02803788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92849353|NCT02803788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849354|NCT02803788|Antipruritics|antipruritics|mesh-ancestor
92849355|NCT02803788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92849356|NCT02803788|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92849357|NCT02803788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92849358|NCT02803788|Serotonin Agents|serotonin agents|mesh-ancestor
92849359|NCT02803788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849360|NCT02803788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849361|NCT02610153|Vitamin K|vitamin k|mesh-list
92849362|NCT02610153|Vitamins|vitamins|mesh-ancestor
92849363|NCT02610153|Micronutrients|micronutrients|mesh-ancestor
92849364|NCT02610153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849365|NCT02610153|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92849366|NCT02610153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92849367|NCT02610153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849368|NCT02610153|Hemostatics|hemostatics|mesh-ancestor
92849369|NCT02610153|Coagulants|coagulants|mesh-ancestor
92849370|NCT00862693|Calcitriol|calcitriol|mesh-list
92849371|NCT00862693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92849372|NCT00862693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849373|NCT00862693|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92849374|NCT00862693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849375|NCT00862693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849376|NCT00862693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92849377|NCT00862693|Vitamins|vitamins|mesh-ancestor
92849378|NCT00862693|Micronutrients|micronutrients|mesh-ancestor
92849379|NCT00862693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92849380|NCT05757063|Dexmedetomidine|dexmedetomidine|mesh-list
92849381|NCT05757063|Propofol|propofol|mesh-list
92849382|NCT05757063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92849383|NCT05757063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849384|NCT05757063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849385|NCT05757063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849386|NCT05757063|Analgesics|analgesics|mesh-ancestor
92849387|NCT05757063|Sensory System Agents|sensory system agents|mesh-ancestor
92849388|NCT05757063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849389|NCT05757063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92849390|NCT05757063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92849391|NCT05757063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92849392|NCT05757063|Adrenergic Agents|adrenergic agents|mesh-ancestor
92849393|NCT05757063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849394|NCT05757063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849395|NCT05757063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92849396|NCT05757063|Anesthetics, General|anesthetics, general|mesh-ancestor
92849397|NCT05757063|Anesthetics|anesthetics|mesh-ancestor
92849398|NCT02799498|Etanercept|etanercept|mesh-list
92849399|NCT02799498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92849400|NCT02799498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849401|NCT02799498|Analgesics|analgesics|mesh-ancestor
92849402|NCT02799498|Sensory System Agents|sensory system agents|mesh-ancestor
92849403|NCT02799498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849404|NCT02799498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849405|NCT02799498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849406|NCT02799498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849407|NCT02799498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849408|NCT02799498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849409|NCT02799498|Immunologic Factors|immunologic factors|mesh-ancestor
92849410|NCT00617851|Vaccines|vaccines|mesh-list
92849411|NCT00617851|Immunologic Factors|immunologic factors|mesh-ancestor
92849412|NCT00617851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849413|NCT02806440|Naltrexone|naltrexone|mesh-list
92849414|NCT02806440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92849415|NCT02806440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92849416|NCT02806440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849417|NCT02806440|Sensory System Agents|sensory system agents|mesh-ancestor
92849418|NCT02806440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849419|NCT00913809|Desipramine|desipramine|mesh-list
92849420|NCT00913809|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92849421|NCT00913809|Antidepressive Agents|antidepressive agents|mesh-ancestor
92849422|NCT00913809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849423|NCT00913809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849424|NCT00913809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849425|NCT00913809|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92849426|NCT00913809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92849427|NCT00913809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849428|NCT00913809|Adrenergic Agents|adrenergic agents|mesh-ancestor
92849429|NCT00913809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849430|NCT00913809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849431|NCT02806362|Ritonavir|ritonavir|mesh-list
92849432|NCT02806362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92849433|NCT02806362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92849434|NCT02806362|Protease Inhibitors|protease inhibitors|mesh-ancestor
92849435|NCT02806362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849436|NCT02806362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849437|NCT02806362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92849438|NCT02806362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92849439|NCT02806362|Antiviral Agents|antiviral agents|mesh-ancestor
92849440|NCT02806362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849441|NCT02806362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92849442|NCT02806362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92849443|NCT00855049|Acetaminophen|acetaminophen|mesh-list
92849444|NCT00855049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849445|NCT00855049|Analgesics|analgesics|mesh-ancestor
92849446|NCT00855049|Sensory System Agents|sensory system agents|mesh-ancestor
92849447|NCT00855049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849448|NCT00855049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849449|NCT00855049|Antipyretics|antipyretics|mesh-ancestor
92849450|NCT02799030|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92849451|NCT02799030|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92849452|NCT02799030|Dermatologic Agents|dermatologic agents|mesh-ancestor
92849453|NCT00812955|Simvastatin|simvastatin|mesh-list
92849454|NCT00812955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92849455|NCT00812955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92849456|NCT00812955|Antimetabolites|antimetabolites|mesh-ancestor
92849457|NCT00812955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849458|NCT00812955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92849459|NCT00812955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92849460|NCT00812955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849461|NCT04235478|Triamcinolone|triamcinolone|mesh-list
92849462|NCT04235478|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92849463|NCT04235478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849464|NCT04235478|Glucocorticoids|glucocorticoids|mesh-ancestor
92849465|NCT04235478|Hormones|hormones|mesh-ancestor
92849466|NCT04235478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849467|NCT04235478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849468|NCT04235478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849469|NCT04235478|Immunologic Factors|immunologic factors|mesh-ancestor
92849470|NCT00619489|Vedolizumab|vedolizumab|mesh-list
92849471|NCT00619489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849472|NCT02806206|Prucalopride|prucalopride|mesh-list
92849473|NCT02806206|Laxatives|laxatives|mesh-ancestor
92849474|NCT02806206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849475|NCT02806206|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92849476|NCT02806206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92849477|NCT02806206|Serotonin Agents|serotonin agents|mesh-ancestor
92849478|NCT02806206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849479|NCT02806206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849480|NCT02806206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849481|NCT00855205|Rituximab|rituximab|mesh-list
92849482|NCT00855205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92849483|NCT00855205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849484|NCT00855205|Immunologic Factors|immunologic factors|mesh-ancestor
92849485|NCT00855205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849486|NCT00855205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849487|NCT00859807|Amodiaquine|amodiaquine|mesh-list
92849488|NCT00859807|Antimalarials|antimalarials|mesh-ancestor
92849489|NCT00859807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92849490|NCT00859807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92849491|NCT00859807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849492|NCT00859885|Clopidogrel|clopidogrel|mesh-list
92849493|NCT00859885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849494|NCT00859885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849495|NCT00859885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92849496|NCT00859885|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92849497|NCT00859885|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92849498|NCT00859885|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92849499|NCT00859885|Purinergic Agents|purinergic agents|mesh-ancestor
92849500|NCT00859885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849501|NCT02798874|Clopidogrel|clopidogrel|mesh-list
92849502|NCT02798874|Ticagrelor|ticagrelor|mesh-list
92849503|NCT02798874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92849504|NCT02798874|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92849505|NCT02798874|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92849506|NCT02798874|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92849507|NCT02798874|Purinergic Agents|purinergic agents|mesh-ancestor
92849508|NCT02798874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849509|NCT02798874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849510|NCT02798874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849511|NCT02799264|Cabotegravir|cabotegravir|mesh-list
92849512|NCT02799264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92849513|NCT02799264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92849514|NCT02799264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849515|NCT02799264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849516|NCT02799264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92849517|NCT02799264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92849518|NCT02799264|Antiviral Agents|antiviral agents|mesh-ancestor
92849519|NCT02799264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849520|NCT00959699|Interferons|interferons|mesh-list
92849521|NCT00959699|Ribavirin|ribavirin|mesh-list
92849522|NCT00959699|Interferon-alpha|interferon-alpha|mesh-list
92849523|NCT00959699|Interferon alpha-2|interferon alpha-2|mesh-list
92849524|NCT00959699|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92849525|NCT00959699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849526|NCT00959699|Antiviral Agents|antiviral agents|mesh-ancestor
92849527|NCT00959699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849528|NCT00959699|Antimetabolites|antimetabolites|mesh-ancestor
92849529|NCT00959699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849530|NCT00959699|Immunologic Factors|immunologic factors|mesh-ancestor
92849531|NCT00959699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849532|NCT02806128|Kallikreins|kallikreins|mesh-list
92494624|NCT01976676|Folic Acid|folic acid|mesh-list
92849533|NCT02806128|Coagulants|coagulants|mesh-ancestor
92849534|NCT02806128|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92849535|NCT02806128|Fertility Agents|fertility agents|mesh-ancestor
92849536|NCT02806128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92849537|NCT02806128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849538|NCT00860119|Alprazolam|alprazolam|mesh-list
92849539|NCT00860119|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92849540|NCT00860119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849541|NCT00860119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849542|NCT00860119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92849543|NCT00860119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92849544|NCT00860119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849545|NCT00860119|GABA Modulators|gaba modulators|mesh-ancestor
92849546|NCT00860119|GABA Agents|gaba agents|mesh-ancestor
92849547|NCT00860119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849548|NCT00860119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849549|NCT00855283|Glycopyrrolate|glycopyrrolate|mesh-list
92849550|NCT00855283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92849551|NCT00855283|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92849552|NCT00855283|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92849553|NCT00855283|Cholinergic Agents|cholinergic agents|mesh-ancestor
92849554|NCT00855283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849555|NCT00855283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849556|NCT00855283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849557|NCT02805738|Tenofovir|tenofovir|mesh-list
92849558|NCT02805738|Antiviral Agents|antiviral agents|mesh-ancestor
92849559|NCT02805738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849560|NCT02805738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92849561|NCT02805738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92849562|NCT02805738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849563|NCT02805738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849564|NCT02805738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92849565|NCT02805738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92849566|NCT00855361|Rabeprazole|rabeprazole|mesh-list
92849567|NCT00855361|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92849568|NCT00855361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849569|NCT00855361|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92849570|NCT00855361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849571|NCT00855361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849572|NCT02798406|Pembrolizumab|pembrolizumab|mesh-list
92849573|NCT02798406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92849574|NCT02798406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849575|NCT02798406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92849576|NCT02798406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849577|NCT05550636|Midazolam|midazolam|mesh-list
92849578|NCT05550636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92849579|NCT05550636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92849580|NCT05550636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849581|NCT05550636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849582|NCT05550636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92849583|NCT05550636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92849584|NCT05550636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849585|NCT05550636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92849586|NCT05550636|Anesthetics, General|anesthetics, general|mesh-ancestor
92849587|NCT05550636|Anesthetics|anesthetics|mesh-ancestor
92849588|NCT05550636|GABA Modulators|gaba modulators|mesh-ancestor
92849589|NCT05550636|GABA Agents|gaba agents|mesh-ancestor
92849590|NCT05550636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849591|NCT05550636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849592|NCT02857829|Caffeine|caffeine|mesh-list
92849593|NCT02857829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92849594|NCT02857829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849595|NCT02857829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92849596|NCT02857829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751307|NCT04844866|Rituximab|rituximab|mesh-list
92849597|NCT02857829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849598|NCT02857829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92849599|NCT02857829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92849600|NCT02857829|Purinergic Agents|purinergic agents|mesh-ancestor
92849601|NCT02857829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849602|NCT00860275|Fluconazole|fluconazole|mesh-list
92849603|NCT00860275|Ketoconazole|ketoconazole|mesh-list
92849604|NCT00860275|BMS 708163|bms 708163|mesh-list
92849605|NCT00860275|Antifungal Agents|antifungal agents|mesh-ancestor
92849606|NCT00860275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849607|NCT00860275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92849608|NCT00860275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92849609|NCT00860275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849610|NCT00860275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849611|NCT00860275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92849612|NCT00860275|Hormone Antagonists|hormone antagonists|mesh-ancestor
92849613|NCT00860275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849614|NCT00860275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849615|NCT00860275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92849616|NCT00860275|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92849617|NCT00860275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92849618|NCT00860275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92849619|NCT02798250|Insulin|insulin|mesh-list
92849620|NCT02798250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92849621|NCT02798250|Glucagon|glucagon|mesh-list
92849622|NCT02798250|Hormones|hormones|mesh-list
92849623|NCT02798250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92849624|NCT02798250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849625|NCT02798250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849626|NCT02798250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849627|NCT00865111|Bupropion|bupropion|mesh-list
92849628|NCT00865111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92849629|NCT00865111|Antidepressive Agents|antidepressive agents|mesh-ancestor
92849630|NCT00865111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849631|NCT00865111|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92849632|NCT00865111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92849633|NCT00865111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849634|NCT00865111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849635|NCT00865111|Dopamine Agents|dopamine agents|mesh-ancestor
92849636|NCT00865111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849637|NCT00865111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849638|NCT00865111|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92849639|NCT00865111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92849640|NCT00865111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849641|NCT02802696|Furosemide|furosemide|mesh-list
92849642|NCT02802696|Diuretics|diuretics|mesh-ancestor
92849643|NCT02802696|Natriuretic Agents|natriuretic agents|mesh-ancestor
92849644|NCT02802696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849645|NCT02802696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92849646|NCT02802696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849647|NCT02802696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849648|NCT00865267|Halobetasol|halobetasol|mesh-list
92849649|NCT00865267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92849650|NCT02798172|Metformin|metformin|mesh-list
92849651|NCT02798172|Alogliptin|alogliptin|mesh-list
92849652|NCT02798172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92849653|NCT02798172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849654|NCT02798172|Incretins|incretins|mesh-ancestor
92849655|NCT02798172|Hormones|hormones|mesh-ancestor
92849656|NCT02798172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849657|NCT02798172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92849658|NCT02798172|Protease Inhibitors|protease inhibitors|mesh-ancestor
92849659|NCT02798172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751375|NCT04736706|Pembrolizumab|pembrolizumab|mesh-list
92849660|NCT02798172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849661|NCT00865423|Gabapentin|gabapentin|mesh-list
92849662|NCT00865423|Analgesics|analgesics|mesh-ancestor
92849663|NCT00865423|Sensory System Agents|sensory system agents|mesh-ancestor
92849664|NCT00865423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849665|NCT00865423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849666|NCT00865423|Anticonvulsants|anticonvulsants|mesh-ancestor
92849667|NCT00865423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92849668|NCT00865423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92849669|NCT00865423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849670|NCT00865423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849671|NCT00865423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92849672|NCT00865423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92849673|NCT00865423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849674|NCT00865423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849675|NCT00865423|Antimanic Agents|antimanic agents|mesh-ancestor
92849676|NCT00955721|Gemcitabine|gemcitabine|mesh-list
92849677|NCT00955721|Oxaliplatin|oxaliplatin|mesh-list
92849678|NCT00955721|Sorafenib|sorafenib|mesh-list
92849679|NCT00955721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92849680|NCT00955721|Antimetabolites|antimetabolites|mesh-ancestor
92849681|NCT00955721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849682|NCT00955721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849683|NCT00955721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92849684|NCT00955721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849685|NCT02802540|Nabilone|nabilone|mesh-list
92849686|NCT02802540|Antiemetics|antiemetics|mesh-ancestor
92849687|NCT02802540|Autonomic Agents|autonomic agents|mesh-ancestor
92849688|NCT02802540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849689|NCT02802540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849690|NCT02802540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849691|NCT02802540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92849692|NCT02802540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92849693|NCT02802540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849694|NCT02802540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849695|NCT00865501|Spironolactone|spironolactone|mesh-list
92849696|NCT00865501|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92849697|NCT00865501|Hormone Antagonists|hormone antagonists|mesh-ancestor
92849698|NCT00865501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849699|NCT00865501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849700|NCT00865501|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92849701|NCT00865501|Diuretics|diuretics|mesh-ancestor
92849702|NCT00865501|Natriuretic Agents|natriuretic agents|mesh-ancestor
92849703|NCT02797704|Aflibercept|aflibercept|mesh-list
92849704|NCT02797704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92849705|NCT02797704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92849706|NCT02797704|Growth Substances|growth substances|mesh-ancestor
92849707|NCT02797704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849708|NCT02797704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92849709|NCT02797704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849710|NCT04281095|Botulinum Toxins|botulinum toxins|mesh-list
92849711|NCT04281095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92849712|NCT04281095|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92849713|NCT04281095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92849714|NCT04281095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849715|NCT04281095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849716|NCT04281095|Cholinergic Agents|cholinergic agents|mesh-ancestor
92849717|NCT04281095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849718|NCT04281095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849719|NCT04281095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92849720|NCT04281095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849721|NCT00863161|Lesogaberan|lesogaberan|mesh-list
92849722|NCT00863161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849723|NCT00863161|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92849724|NCT00863161|GABA Agonists|gaba agonists|mesh-ancestor
92849725|NCT00863161|GABA Agents|gaba agents|mesh-ancestor
92849726|NCT00863161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849727|NCT00863161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849728|NCT00863161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849729|NCT00863239|Interferons|interferons|mesh-list
92849731|NCT00863239|Interferon-alpha|interferon-alpha|mesh-list
92849732|NCT00863239|Interferon alpha-2|interferon alpha-2|mesh-list
92849733|NCT00863239|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92849734|NCT00863239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849735|NCT00863239|Antiviral Agents|antiviral agents|mesh-ancestor
92849736|NCT00863239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849737|NCT00863239|Antimetabolites|antimetabolites|mesh-ancestor
92849738|NCT00863239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849739|NCT00863239|Immunologic Factors|immunologic factors|mesh-ancestor
92849740|NCT00863239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849741|NCT02802072|Aspirin|aspirin|mesh-list
92849742|NCT02802072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92849743|NCT02802072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849744|NCT02802072|Analgesics|analgesics|mesh-ancestor
92849745|NCT02802072|Sensory System Agents|sensory system agents|mesh-ancestor
92849746|NCT02802072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849747|NCT02802072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849748|NCT02802072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849749|NCT02802072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849750|NCT02802072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92849751|NCT02802072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92849752|NCT02802072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849753|NCT02802072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92494839|NCT01978665|Prednisone|prednisone|mesh-list
92849754|NCT02802072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92849755|NCT02802072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849756|NCT02802072|Antipyretics|antipyretics|mesh-ancestor
92849757|NCT04276883|Dexmedetomidine|dexmedetomidine|mesh-list
92849758|NCT04276883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92849759|NCT04276883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849760|NCT04276883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849761|NCT04276883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92849762|NCT04276883|Analgesics|analgesics|mesh-ancestor
92849763|NCT04276883|Sensory System Agents|sensory system agents|mesh-ancestor
92849764|NCT04276883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849765|NCT04276883|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92849766|NCT04276883|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92849767|NCT04276883|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92849768|NCT04276883|Adrenergic Agents|adrenergic agents|mesh-ancestor
92849769|NCT04276883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849770|NCT04276883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849772|NCT00865657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92849773|NCT00865657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849774|NCT00865657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849775|NCT00865657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92849776|NCT00865657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92849777|NCT00865657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849778|NCT00865657|GABA Modulators|gaba modulators|mesh-ancestor
92849779|NCT00865657|GABA Agents|gaba agents|mesh-ancestor
92849780|NCT00865657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849781|NCT00865657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849782|NCT00863395|Lidocaine|lidocaine|mesh-list
92849783|NCT00863395|Anesthetics, Local|anesthetics, local|mesh-ancestor
92849784|NCT00863395|Anesthetics|anesthetics|mesh-ancestor
92849785|NCT00863395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849786|NCT00863395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849787|NCT00863395|Sensory System Agents|sensory system agents|mesh-ancestor
92849788|NCT00863395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849789|NCT00863395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92849790|NCT00863395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92849791|NCT00863395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92849792|NCT00863395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849793|NCT00863395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849794|NCT02939183|Dexamethasone|dexamethasone|mesh-list
92849795|NCT02939183|Pomalidomide|pomalidomide|mesh-list
92849796|NCT02939183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849797|NCT02939183|Antiemetics|antiemetics|mesh-ancestor
92849798|NCT02939183|Autonomic Agents|autonomic agents|mesh-ancestor
92849799|NCT02939183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849800|NCT02939183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849801|NCT02939183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849802|NCT02939183|Glucocorticoids|glucocorticoids|mesh-ancestor
92849803|NCT02939183|Hormones|hormones|mesh-ancestor
92849804|NCT02939183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849805|NCT02939183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92849806|NCT02939183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849807|NCT02939183|Immunologic Factors|immunologic factors|mesh-ancestor
92849808|NCT02939183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92849809|NCT02939183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92849810|NCT02939183|Growth Substances|growth substances|mesh-ancestor
92849811|NCT02939183|Growth Inhibitors|growth inhibitors|mesh-ancestor
92849812|NCT02801838|Morphine|morphine|mesh-list
92849813|NCT02801838|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92849814|NCT02801838|Narcotics|narcotics|mesh-ancestor
92849815|NCT02801838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849816|NCT02801838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849817|NCT02801838|Analgesics|analgesics|mesh-ancestor
92849818|NCT02801838|Sensory System Agents|sensory system agents|mesh-ancestor
92849819|NCT02801838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849820|NCT04276025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92849821|NCT04276025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92849822|NCT04276025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849823|NCT02797860|Rocuronium|rocuronium|mesh-list
92849824|NCT02797860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92849825|NCT02797860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92849826|NCT02797860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92849827|NCT02797860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849828|NCT02797860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849830|NCT00860899|Levobupivacaine|levobupivacaine|mesh-list
92849831|NCT00860899|Analgesics|analgesics|mesh-ancestor
92849832|NCT00860899|Sensory System Agents|sensory system agents|mesh-ancestor
92849833|NCT00860899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849834|NCT00860899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849835|NCT00860899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92849836|NCT00860899|Sympatholytics|sympatholytics|mesh-ancestor
92849837|NCT00860899|Autonomic Agents|autonomic agents|mesh-ancestor
92849838|NCT00860899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92849839|NCT00860899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92849840|NCT00860899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92849841|NCT00860899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92849842|NCT00860899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849843|NCT00860899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849844|NCT00860899|Anesthetics, Local|anesthetics, local|mesh-ancestor
92849845|NCT00860899|Anesthetics|anesthetics|mesh-ancestor
92849846|NCT00860899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849847|NCT02797782|Antibodies|antibodies|mesh-list
92849848|NCT02797782|Immunologic Factors|immunologic factors|mesh-ancestor
92849849|NCT02797782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849850|NCT00863629|Insulin|insulin|mesh-list
92849851|NCT00863629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92849852|NCT00863629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849853|NCT00860977|Valacyclovir|valacyclovir|mesh-list
92849854|NCT00860977|Antiviral Agents|antiviral agents|mesh-ancestor
92849855|NCT00860977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849856|NCT00865891|Nifedipine|nifedipine|mesh-list
92849857|NCT00865891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92849858|NCT00865891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849859|NCT00865891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849860|NCT00865891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92849861|NCT00865891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849862|NCT00865891|Vasodilator Agents|vasodilator agents|mesh-ancestor
92849863|NCT00865891|Tocolytic Agents|tocolytic agents|mesh-ancestor
92849864|NCT00865891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92849865|NCT02797236|Vaccines|vaccines|mesh-list
92849866|NCT02797236|Immunologic Factors|immunologic factors|mesh-ancestor
92849867|NCT02797236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849868|NCT00863785|Acetylcysteine|acetylcysteine|mesh-list
92849869|NCT00863785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92849870|NCT00863785|Antiviral Agents|antiviral agents|mesh-ancestor
92849871|NCT00863785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849872|NCT00863785|Expectorants|expectorants|mesh-ancestor
92849873|NCT00863785|Respiratory System Agents|respiratory system agents|mesh-ancestor
92849874|NCT00863785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92849875|NCT00863785|Antioxidants|antioxidants|mesh-ancestor
92849876|NCT00863785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849877|NCT00863785|Protective Agents|protective agents|mesh-ancestor
92849878|NCT00863785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849879|NCT00863785|Antidotes|antidotes|mesh-ancestor
92849880|NCT02801526|Amlodipine|amlodipine|mesh-list
92849881|NCT02801526|Candesartan|candesartan|mesh-list
92849882|NCT02801526|Candesartan cilexetil|candesartan cilexetil|mesh-list
92849883|NCT02801526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92849884|NCT02801526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92849885|NCT02801526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849886|NCT02801526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849887|NCT02801526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92849888|NCT02801526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849889|NCT02801526|Vasodilator Agents|vasodilator agents|mesh-ancestor
92849890|NCT02801526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92849891|NCT02801526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92849892|NCT02805426|Misoprostol|misoprostol|mesh-list
92849893|NCT02805426|Tranexamic Acid|tranexamic acid|mesh-list
92849894|NCT02805426|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92849895|NCT02805426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92849896|NCT02805426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849897|NCT02805426|Hemostatics|hemostatics|mesh-ancestor
92849898|NCT02805426|Coagulants|coagulants|mesh-ancestor
92849899|NCT02805426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92849900|NCT02805426|Abortifacient Agents|abortifacient agents|mesh-ancestor
92849901|NCT02805426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92849902|NCT02805426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849903|NCT02805426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92849904|NCT02805426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92849905|NCT02805426|Oxytocics|oxytocics|mesh-ancestor
92849906|NCT02801292|Ketamine|ketamine|mesh-list
92849907|NCT02801292|Analgesics|analgesics|mesh-ancestor
92849908|NCT02801292|Sensory System Agents|sensory system agents|mesh-ancestor
92849909|NCT02801292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92849910|NCT02801292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849911|NCT02801292|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92849912|NCT02801292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92849913|NCT02801292|Anesthetics, General|anesthetics, general|mesh-ancestor
92849914|NCT02801292|Anesthetics|anesthetics|mesh-ancestor
92849915|NCT02801292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92849916|NCT02801292|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92849917|NCT02801292|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92849918|NCT02801292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849919|NCT02801292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849920|NCT02544061|Interleukin-12|interleukin-12|mesh-list
92849921|NCT02544061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92849922|NCT02544061|Immunologic Factors|immunologic factors|mesh-ancestor
92849923|NCT02544061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849924|NCT02544061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92849925|NCT02544061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92849926|NCT02544061|Growth Substances|growth substances|mesh-ancestor
92849927|NCT02544061|Growth Inhibitors|growth inhibitors|mesh-ancestor
92849928|NCT02544061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849929|NCT00863863|Griseofulvin|griseofulvin|mesh-list
92849930|NCT00863863|Antifungal Agents|antifungal agents|mesh-ancestor
92849931|NCT00863863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92849932|NCT03853044|Prednisone|prednisone|mesh-list
92849933|NCT03853044|Cyclophosphamide|cyclophosphamide|mesh-list
92849934|NCT03853044|Doxorubicin|doxorubicin|mesh-list
92849935|NCT03853044|Vincristine|vincristine|mesh-list
92849936|NCT03853044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849937|NCT03853044|Immunologic Factors|immunologic factors|mesh-ancestor
92849938|NCT03853044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849939|NCT03853044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92849940|NCT03853044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92849941|NCT03853044|Alkylating Agents|alkylating agents|mesh-ancestor
92849942|NCT03853044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849943|NCT03853044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849944|NCT03853044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92849945|NCT03853044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92849946|NCT03853044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92849947|NCT03853044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92849948|NCT03853044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849949|NCT03853044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92849950|NCT03853044|Glucocorticoids|glucocorticoids|mesh-ancestor
92849951|NCT03853044|Hormones|hormones|mesh-ancestor
92849952|NCT03853044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849953|NCT03853044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92849954|NCT03853044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92849955|NCT03853044|Tubulin Modulators|tubulin modulators|mesh-ancestor
92849956|NCT03853044|Antimitotic Agents|antimitotic agents|mesh-ancestor
92849957|NCT03853044|Mitosis Modulators|mitosis modulators|mesh-ancestor
92849958|NCT00870337|Everolimus|everolimus|mesh-list
92849959|NCT00870337|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92849960|NCT00870337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92849961|NCT00870337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849962|NCT00870337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849963|NCT00870337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92849964|NCT00870337|Immunologic Factors|immunologic factors|mesh-ancestor
92849965|NCT00870337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849966|NCT00870337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92849967|NCT00866437|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92849968|NCT00866437|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92849969|NCT00866437|Estropipate|estropipate|mesh-list
92849970|NCT00866437|Estradiol|estradiol|mesh-list
92849971|NCT00866437|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92849972|NCT00866437|Estrone|estrone|mesh-list
92849973|NCT00866437|Progesterone|progesterone|mesh-list
92849974|NCT00866437|Estrogens|estrogens|mesh-ancestor
92849975|NCT00866437|Hormones|hormones|mesh-ancestor
92849976|NCT00866437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92849977|NCT00866437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849978|NCT00866437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92849979|NCT00866437|Contraceptive Agents|contraceptive agents|mesh-ancestor
92849980|NCT00866437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92849981|NCT00866437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92849983|NCT00863941|Bupropion|bupropion|mesh-list
92849984|NCT00863941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92849985|NCT00863941|Antidepressive Agents|antidepressive agents|mesh-ancestor
92849986|NCT00863941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92849987|NCT00863941|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92849988|NCT00863941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92849989|NCT00863941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92849990|NCT00863941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92849991|NCT00863941|Dopamine Agents|dopamine agents|mesh-ancestor
92849992|NCT00863941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92849993|NCT00863941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92849994|NCT00863941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92849995|NCT00863941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92849996|NCT00863941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92849997|NCT00812565|gamma-Globulins|gamma-globulins|mesh-list
92849998|NCT00812565|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92849999|NCT00812565|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92850000|NCT00812565|Immunologic Factors|immunologic factors|mesh-ancestor
92850001|NCT00812565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850002|NCT00866515|Ketoconazole|ketoconazole|mesh-list
92850003|NCT00866515|Antifungal Agents|antifungal agents|mesh-ancestor
92850004|NCT00866515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850005|NCT00866515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92850006|NCT00866515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92850007|NCT00866515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850008|NCT00866515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850009|NCT00866515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92850010|NCT00866515|Hormone Antagonists|hormone antagonists|mesh-ancestor
92850011|NCT00866515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850012|NCT00866515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850013|NCT00866515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92850015|NCT02795754|GSK-2838232|gsk-2838232|mesh-list
92850016|NCT02795754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92850017|NCT02795754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92850018|NCT02795754|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850019|NCT02795754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850020|NCT02795754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850021|NCT02795754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92850022|NCT02795754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92850023|NCT02795754|Antiviral Agents|antiviral agents|mesh-ancestor
92850024|NCT02795754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850025|NCT02795754|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92850026|NCT02795754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92850027|NCT00864019|Sertraline|sertraline|mesh-list
92850028|NCT00864019|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850029|NCT00864019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850030|NCT00864019|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92850031|NCT00864019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92850032|NCT00864019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850033|NCT00864019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850034|NCT00864019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850035|NCT00864019|Serotonin Agents|serotonin agents|mesh-ancestor
92850036|NCT00864019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850037|NCT00812487|Insulin|insulin|mesh-list
92850038|NCT00812487|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92850039|NCT00812487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850040|NCT00812487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850041|NCT04235868|Mitogens|mitogens|mesh-list
92850042|NCT04235868|Mitosis Modulators|mitosis modulators|mesh-ancestor
92850043|NCT04235868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850044|NCT02800902|Atorvastatin|atorvastatin|mesh-list
92850045|NCT02800902|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92850046|NCT02800902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92850047|NCT02800902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92850048|NCT02800902|Antimetabolites|antimetabolites|mesh-ancestor
92850049|NCT02800902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850050|NCT02800902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92850051|NCT02800902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92850052|NCT02800902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850053|NCT05756595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92850054|NCT00617461|Gabapentin|gabapentin|mesh-list
92850055|NCT00617461|Analgesics|analgesics|mesh-ancestor
92850056|NCT00617461|Sensory System Agents|sensory system agents|mesh-ancestor
92850057|NCT00617461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850058|NCT00617461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850059|NCT00617461|Anticonvulsants|anticonvulsants|mesh-ancestor
92850060|NCT00617461|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92850061|NCT00617461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850062|NCT00617461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850063|NCT00617461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850064|NCT00617461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92850065|NCT00617461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92850066|NCT00617461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850067|NCT00617461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850068|NCT00617461|Antimanic Agents|antimanic agents|mesh-ancestor
92850069|NCT00812331|Simeprevir|simeprevir|mesh-list
92850070|NCT00812331|Antiviral Agents|antiviral agents|mesh-ancestor
92850071|NCT00812331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850072|NCT00812331|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850073|NCT00812331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850074|NCT00812331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850075|NCT04233996|Meropenem|meropenem|mesh-list
92850076|NCT04233996|Tazobactam|tazobactam|mesh-list
92850077|NCT04233996|Piperacillin|piperacillin|mesh-list
92850078|NCT04233996|Cefepime|cefepime|mesh-list
92850079|NCT04233996|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92850080|NCT04233996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850081|NCT04233996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850082|NCT04233996|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92850083|NCT04233996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850084|NCT04233996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850085|NCT00812253|Insulin|insulin|mesh-list
92850086|NCT00812253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92850087|NCT00812253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850088|NCT00812253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850089|NCT00870571|Amlodipine|amlodipine|mesh-list
92850090|NCT00870571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92850091|NCT00870571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92850092|NCT00870571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850093|NCT00870571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850094|NCT00870571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92850095|NCT00870571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850096|NCT00870571|Vasodilator Agents|vasodilator agents|mesh-ancestor
92850097|NCT05756439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92751817|NCT03712943|Nivolumab|nivolumab|mesh-list
92850098|NCT05756439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850099|NCT05756439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850100|NCT00616759|Propofol|propofol|mesh-list
92850101|NCT00616759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92850102|NCT00616759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850103|NCT00616759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850104|NCT00616759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92850105|NCT00616759|Anesthetics, General|anesthetics, general|mesh-ancestor
92850106|NCT00616759|Anesthetics|anesthetics|mesh-ancestor
92850107|NCT00866593|Dexetimide|dexetimide|mesh-list
92850108|NCT00866593|Citalopram|citalopram|mesh-list
92850109|NCT00866593|Escitalopram|escitalopram|mesh-list
92850110|NCT00866593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92850111|NCT00866593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92850112|NCT00866593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850113|NCT00866593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850114|NCT00866593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850115|NCT00866593|Serotonin Agents|serotonin agents|mesh-ancestor
92850116|NCT00866593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850117|NCT00866593|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92850118|NCT00866593|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92850119|NCT00866593|Parasympatholytics|parasympatholytics|mesh-ancestor
92850120|NCT00866593|Autonomic Agents|autonomic agents|mesh-ancestor
92850121|NCT00866593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850122|NCT00866593|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92850123|NCT00866593|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92850124|NCT00866593|Cholinergic Agents|cholinergic agents|mesh-ancestor
93046925|NCT01058720|Micronutrients|micronutrients|mesh-ancestor
92850125|NCT00866593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92850126|NCT00866593|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850127|NCT00866593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850128|NCT02796378|Ubiquinone|ubiquinone|mesh-list
92850129|NCT02796378|Coenzyme Q10|coenzyme q10|mesh-list
92850130|NCT02796378|Simvastatin|simvastatin|mesh-list
92850131|NCT02796378|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92850132|NCT02796378|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92850133|NCT02796378|Antimetabolites|antimetabolites|mesh-ancestor
92850134|NCT02796378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850135|NCT02796378|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92850136|NCT02796378|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92850137|NCT02796378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850138|NCT02796378|Micronutrients|micronutrients|mesh-ancestor
92850139|NCT02796378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850140|NCT02796378|Vitamins|vitamins|mesh-ancestor
92850141|NCT00864409|Ropivacaine|ropivacaine|mesh-list
92850142|NCT00864409|Anesthetics, Local|anesthetics, local|mesh-ancestor
92850143|NCT00864409|Anesthetics|anesthetics|mesh-ancestor
92850144|NCT00864409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850145|NCT00864409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850146|NCT00864409|Sensory System Agents|sensory system agents|mesh-ancestor
92850147|NCT00864409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850148|NCT00866983|Sildenafil Citrate|sildenafil citrate|mesh-list
92850149|NCT00866983|Vasodilator Agents|vasodilator agents|mesh-ancestor
92850150|NCT00866983|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92850151|NCT00866983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92850152|NCT00866983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850153|NCT00866983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850154|NCT00866983|Urological Agents|urological agents|mesh-ancestor
92850155|NCT05226013|Rasburicase|rasburicase|mesh-list
92850156|NCT05226013|Gout Suppressants|gout suppressants|mesh-ancestor
92850157|NCT05226013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850158|NCT00870883|Acetylcysteine|acetylcysteine|mesh-list
92850159|NCT00870883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92850160|NCT00870883|Deferoxamine|deferoxamine|mesh-list
92850161|NCT00870883|Antiviral Agents|antiviral agents|mesh-ancestor
92850162|NCT00870883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850163|NCT00870883|Expectorants|expectorants|mesh-ancestor
92850164|NCT00870883|Respiratory System Agents|respiratory system agents|mesh-ancestor
92850165|NCT00870883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92850166|NCT00870883|Antioxidants|antioxidants|mesh-ancestor
92850167|NCT00870883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850168|NCT00870883|Protective Agents|protective agents|mesh-ancestor
92850169|NCT00870883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850170|NCT00870883|Antidotes|antidotes|mesh-ancestor
92850171|NCT00870883|Siderophores|siderophores|mesh-ancestor
92850172|NCT00870883|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92850173|NCT00870883|Chelating Agents|chelating agents|mesh-ancestor
92850174|NCT00870883|Sequestering Agents|sequestering agents|mesh-ancestor
92850175|NCT00870961|Cholecalciferol|cholecalciferol|mesh-list
92850176|NCT00870961|Vitamin D|vitamin d|mesh-list
92850177|NCT00870961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92850178|NCT00870961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850179|NCT00870961|Vitamins|vitamins|mesh-ancestor
92850180|NCT00870961|Micronutrients|micronutrients|mesh-ancestor
92850181|NCT00870961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92850182|NCT00811941|Nalmefene|nalmefene|mesh-list
92850183|NCT00811941|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92850184|NCT00811941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850185|NCT00811941|Sensory System Agents|sensory system agents|mesh-ancestor
92850186|NCT00811941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850187|NCT00864565|Fentanyl|fentanyl|mesh-list
92850188|NCT00864565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92850189|NCT00864565|Narcotics|narcotics|mesh-ancestor
92850190|NCT00864565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850191|NCT00864565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850192|NCT00864565|Analgesics|analgesics|mesh-ancestor
92850193|NCT00864565|Sensory System Agents|sensory system agents|mesh-ancestor
92850194|NCT00864565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850195|NCT00864565|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92850196|NCT00864565|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92850197|NCT00864565|Anesthetics, General|anesthetics, general|mesh-ancestor
92850198|NCT00864565|Anesthetics|anesthetics|mesh-ancestor
92850199|NCT00864643|Atorvastatin|atorvastatin|mesh-list
92850200|NCT00864643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92850201|NCT00864643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92850202|NCT00864643|Antimetabolites|antimetabolites|mesh-ancestor
92850203|NCT00864643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850204|NCT00864643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92850205|NCT00864643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92850206|NCT00864643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850208|NCT00871039|Propofol|propofol|mesh-list
92850209|NCT00871039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92850210|NCT00871039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850211|NCT00871039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850212|NCT00871039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92850213|NCT00871039|Anesthetics, General|anesthetics, general|mesh-ancestor
92850214|NCT00871039|Anesthetics|anesthetics|mesh-ancestor
92850215|NCT00871039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92850216|NCT00871039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92850217|NCT00871039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850218|NCT00871039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850219|NCT00871039|GABA Modulators|gaba modulators|mesh-ancestor
92850220|NCT00871039|GABA Agents|gaba agents|mesh-ancestor
92850221|NCT00871039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850222|NCT00871039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850223|NCT00867061|ON 01910|on 01910|mesh-list
92850224|NCT00867061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850225|NCT00867061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92850226|NCT00867061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850227|NCT00867061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850228|NCT00864799|Misoprostol|misoprostol|mesh-list
92850229|NCT00864799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92850230|NCT00864799|Abortifacient Agents|abortifacient agents|mesh-ancestor
92850231|NCT00864799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92850232|NCT00864799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850233|NCT00864799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92850234|NCT00864799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92850235|NCT00864799|Oxytocics|oxytocics|mesh-ancestor
92850236|NCT04234776|Ketamine|ketamine|mesh-list
92850237|NCT04234776|Aripiprazole|aripiprazole|mesh-list
92850238|NCT04234776|Escitalopram|escitalopram|mesh-list
92850239|NCT04234776|Analgesics|analgesics|mesh-ancestor
92850240|NCT04234776|Sensory System Agents|sensory system agents|mesh-ancestor
92850241|NCT04234776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850242|NCT04234776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850243|NCT04234776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92850244|NCT04234776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92850245|NCT04234776|Anesthetics, General|anesthetics, general|mesh-ancestor
92850246|NCT04234776|Anesthetics|anesthetics|mesh-ancestor
92850247|NCT04234776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850248|NCT04234776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92850249|NCT04234776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92850250|NCT04234776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850251|NCT04234776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850252|NCT04234776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92850253|NCT04234776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92850254|NCT04234776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850255|NCT04234776|Serotonin Agents|serotonin agents|mesh-ancestor
92850256|NCT04234776|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850257|NCT04234776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850258|NCT04234776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92850259|NCT04234776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850260|NCT04234776|Dopamine Agonists|dopamine agonists|mesh-ancestor
92850261|NCT04234776|Dopamine Agents|dopamine agents|mesh-ancestor
92850262|NCT04234776|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92850263|NCT04234776|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92850264|NCT04234776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92850265|NCT04234776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92850266|NCT04234776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92850267|NCT04234776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92850268|NCT05756049|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92850269|NCT05756049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850270|NCT00871273|Capecitabine|capecitabine|mesh-list
92850271|NCT00871273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850272|NCT00871273|Antimetabolites|antimetabolites|mesh-ancestor
92850273|NCT00871273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850274|NCT00871273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850275|NCT00867295|Cefazolin|cefazolin|mesh-list
92850276|NCT00867295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850277|NCT00867295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850278|NCT02794506|Propolis|propolis|mesh-list
92850279|NCT02794506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850280|NCT04040491|Gemcitabine|gemcitabine|mesh-list
92850281|NCT04040491|Lenalidomide|lenalidomide|mesh-list
92850282|NCT04040491|Antibodies|antibodies|mesh-list
92850283|NCT04040491|Antibodies, Blocking|antibodies, blocking|mesh-list
92850284|NCT04040491|Immunologic Factors|immunologic factors|mesh-ancestor
92850285|NCT04040491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850286|NCT04040491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850287|NCT04040491|Antimetabolites|antimetabolites|mesh-ancestor
92977217|NCT00586157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850288|NCT04040491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850289|NCT04040491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850290|NCT04040491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92850291|NCT04040491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92850292|NCT04040491|Growth Substances|growth substances|mesh-ancestor
92850293|NCT04040491|Growth Inhibitors|growth inhibitors|mesh-ancestor
92850295|NCT02794584|Dsuvia|dsuvia|mesh-list
92850296|NCT02794584|Anesthetics|anesthetics|mesh-ancestor
92850297|NCT02794584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850298|NCT02794584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850299|NCT02794584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92850300|NCT02794584|Narcotics|narcotics|mesh-ancestor
92850301|NCT02794584|Analgesics|analgesics|mesh-ancestor
92850302|NCT02794584|Sensory System Agents|sensory system agents|mesh-ancestor
92850303|NCT02794584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850304|NCT02794584|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92850305|NCT02794584|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92850306|NCT02794584|Anesthetics, General|anesthetics, general|mesh-ancestor
92850307|NCT00811473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92850308|NCT00811473|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850309|NCT00811473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850310|NCT00811473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92850311|NCT00811473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850312|NCT00811473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850313|NCT00811473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850314|NCT00871507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92850315|NCT00871507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850316|NCT00871507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850317|NCT00871507|Incretins|incretins|mesh-ancestor
92850318|NCT00871507|Hormones|hormones|mesh-ancestor
92850319|NCT00871507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850320|NCT00871507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92850321|NCT00871507|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850322|NCT00871507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850323|NCT00871507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850324|NCT00865033|Metformin|metformin|mesh-list
92850325|NCT00865033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850326|NCT00865033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850327|NCT04234932|Latanoprost|latanoprost|mesh-list
92850328|NCT04234932|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92850329|NCT04234932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92850330|NCT02789592|Clonazepam|clonazepam|mesh-list
92850331|NCT02789592|Melatonin|melatonin|mesh-list
92850332|NCT02789592|Antioxidants|antioxidants|mesh-ancestor
92850333|NCT02789592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850334|NCT02789592|Protective Agents|protective agents|mesh-ancestor
92850335|NCT02789592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850336|NCT02789592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850337|NCT02789592|Anticonvulsants|anticonvulsants|mesh-ancestor
92850338|NCT02789592|GABA Modulators|gaba modulators|mesh-ancestor
92850339|NCT02789592|GABA Agents|gaba agents|mesh-ancestor
92850340|NCT02789592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850341|NCT00876421|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92850342|NCT00876421|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92850343|NCT00876421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92850344|NCT00876421|Cholinergic Agents|cholinergic agents|mesh-ancestor
92850345|NCT00876421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850346|NCT00876421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850347|NCT00876421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850348|NCT00876421|Urological Agents|urological agents|mesh-ancestor
92850349|NCT00872131|Sertraline|sertraline|mesh-list
92850350|NCT00872131|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850351|NCT00872131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850352|NCT00872131|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92850353|NCT00872131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92850354|NCT00872131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850355|NCT00872131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850356|NCT00872131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850357|NCT00872131|Serotonin Agents|serotonin agents|mesh-ancestor
92850358|NCT00872131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850359|NCT04233294|Decitabine|decitabine|mesh-list
92850360|NCT04233294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850361|NCT04233294|Antimetabolites|antimetabolites|mesh-ancestor
92850362|NCT04233294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850363|NCT04233294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850365|NCT00872209|Ciprofloxacin|ciprofloxacin|mesh-list
92850366|NCT00872209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850367|NCT00872209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850368|NCT00872209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92850369|NCT00872209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92850370|NCT00872209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850371|NCT00872209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850372|NCT00872209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850373|NCT00872209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92752087|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92850374|NCT00872209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92850375|NCT00872365|Micronutrients|micronutrients|mesh-list
92850376|NCT00872365|Trace Elements|trace elements|mesh-list
92850377|NCT00872365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850378|NCT03637062|Progesterone|progesterone|mesh-list
92850379|NCT03637062|Progestins|progestins|mesh-ancestor
92850380|NCT03637062|Hormones|hormones|mesh-ancestor
92850381|NCT03637062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850382|NCT03637062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850383|NCT02793648|Vitamins|vitamins|mesh-list
92850384|NCT02793648|Ascorbic Acid|ascorbic acid|mesh-list
92850385|NCT02793648|Vitamin E|vitamin e|mesh-list
92850386|NCT02793648|Tocopherols|tocopherols|mesh-list
92850387|NCT02793648|alpha-Tocopherol|alpha-tocopherol|mesh-list
92850388|NCT02793648|Micronutrients|micronutrients|mesh-ancestor
92850389|NCT02793648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850390|NCT02793648|Antioxidants|antioxidants|mesh-ancestor
92850391|NCT02793648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850392|NCT02793648|Protective Agents|protective agents|mesh-ancestor
92850393|NCT02789358|Adenosine|adenosine|mesh-list
92850394|NCT02789358|Analgesics|analgesics|mesh-ancestor
92850395|NCT02789358|Sensory System Agents|sensory system agents|mesh-ancestor
92850396|NCT02789358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850397|NCT02789358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850398|NCT02789358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92850399|NCT02789358|Vasodilator Agents|vasodilator agents|mesh-ancestor
92850400|NCT02789358|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92850401|NCT02789358|Purinergic Agonists|purinergic agonists|mesh-ancestor
92850402|NCT02789358|Purinergic Agents|purinergic agents|mesh-ancestor
92850403|NCT02789358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850404|NCT02789358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850405|NCT03847506|Amlodipine|amlodipine|mesh-list
92850406|NCT03847506|Candesartan|candesartan|mesh-list
92850407|NCT03847506|Candesartan cilexetil|candesartan cilexetil|mesh-list
92850408|NCT03847506|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92850409|NCT03847506|Ezetimibe|ezetimibe|mesh-list
92850410|NCT03847506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92850411|NCT03847506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92850412|NCT03847506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850413|NCT03847506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850414|NCT03847506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92850415|NCT03847506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850416|NCT03847506|Vasodilator Agents|vasodilator agents|mesh-ancestor
92850417|NCT03847506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92850418|NCT03847506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92850419|NCT03847506|Antimetabolites|antimetabolites|mesh-ancestor
92850420|NCT03847506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92850421|NCT03847506|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92850422|NCT03847506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850423|NCT03847506|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92850424|NCT03847506|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92850425|NCT00617305|Ambrisentan|ambrisentan|mesh-list
92850426|NCT00617305|Sildenafil Citrate|sildenafil citrate|mesh-list
92850427|NCT00617305|Tadalafil|tadalafil|mesh-list
92850428|NCT00617305|Vasodilator Agents|vasodilator agents|mesh-ancestor
92850429|NCT00617305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92850430|NCT00617305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92850431|NCT00617305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850432|NCT00617305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850433|NCT00617305|Urological Agents|urological agents|mesh-ancestor
92850434|NCT00617305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92850436|NCT02792712|Ticagrelor|ticagrelor|mesh-list
92195679|NCT03589040|Darunavir|darunavir|mesh-list
92850437|NCT02792712|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92850438|NCT02792712|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92850439|NCT02792712|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92850440|NCT02792712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92850441|NCT02792712|Purinergic Agents|purinergic agents|mesh-ancestor
92850442|NCT02792712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850443|NCT02792712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850444|NCT02792712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850446|NCT02789202|Sodium Fluoride|sodium fluoride|mesh-list
92850447|NCT02789202|Fluorides, Topical|fluorides, topical|mesh-list
92850448|NCT02789202|Cariostatic Agents|cariostatic agents|mesh-ancestor
92850449|NCT02789202|Protective Agents|protective agents|mesh-ancestor
92850450|NCT02789202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850451|NCT00811395|Interferons|interferons|mesh-list
92850452|NCT00811395|Interferon-beta|interferon-beta|mesh-list
92850453|NCT00811395|Teriflunomide|teriflunomide|mesh-list
92850454|NCT00811395|Glatiramer Acetate|glatiramer acetate|mesh-list
92850455|NCT00811395|Interferon beta-1b|interferon beta-1b|mesh-list
92850456|NCT00811395|(T,G)-A-L|(t,g)-a-l|mesh-list
92850457|NCT00811395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850458|NCT00811395|Antiviral Agents|antiviral agents|mesh-ancestor
92850459|NCT00811395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850460|NCT00811395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92850461|NCT00811395|Immunologic Factors|immunologic factors|mesh-ancestor
92850462|NCT00811395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850463|NCT00811395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92850464|NCT00811395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850465|NCT00811395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92850466|NCT00811395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92850467|NCT00811395|Analgesics|analgesics|mesh-ancestor
92850468|NCT00811395|Sensory System Agents|sensory system agents|mesh-ancestor
92850469|NCT00811395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850470|NCT00811395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92850471|NCT02792946|Ambroxol|ambroxol|mesh-list
92850472|NCT02792946|Expectorants|expectorants|mesh-ancestor
92850473|NCT02792946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92850474|NCT00876577|Moxifloxacin|moxifloxacin|mesh-list
92850475|NCT00876577|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92850476|NCT00876577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850477|NCT00876577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850478|NCT00876577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92850479|NCT00876577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92850480|NCT00876577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850481|NCT00876577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850482|NCT00876577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850483|NCT00876577|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92850484|NCT00876577|Contraceptive Agents|contraceptive agents|mesh-ancestor
92850485|NCT00876577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92850486|NCT00876577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850487|NCT00876577|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92850488|NCT00876577|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92850489|NCT00876577|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92850490|NCT02787798|Valsartan|valsartan|mesh-list
92850491|NCT02787798|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92850492|NCT02787798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92850493|NCT02787798|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92850494|NCT02787798|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92850495|NCT02787798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850496|NCT02609997|Dexamethasone|dexamethasone|mesh-list
92850497|NCT02609997|Proxymetacaine|proxymetacaine|mesh-list
92850498|NCT02609997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92850499|NCT02609997|Antiemetics|antiemetics|mesh-ancestor
92850500|NCT02609997|Autonomic Agents|autonomic agents|mesh-ancestor
92850501|NCT02609997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850502|NCT02609997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850503|NCT02609997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92850505|NCT02609997|Hormones|hormones|mesh-ancestor
92850506|NCT02609997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850507|NCT02609997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92850508|NCT02609997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850509|NCT02609997|Anesthetics, Local|anesthetics, local|mesh-ancestor
92850510|NCT02609997|Anesthetics|anesthetics|mesh-ancestor
92433269|NCT01573715|Cisatracurium|cisatracurium|mesh-list
92850511|NCT02609997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850512|NCT02609997|Sensory System Agents|sensory system agents|mesh-ancestor
92850513|NCT00876655|Tedizolid phosphate|tedizolid phosphate|mesh-list
92850514|NCT00876655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850515|NCT00876655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850516|NCT02609919|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92850518|NCT02609919|Sequestering Agents|sequestering agents|mesh-ancestor
92850519|NCT02609919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850520|NCT04114500|Estradiol|estradiol|mesh-list
92850521|NCT04114500|Progesterone|progesterone|mesh-list
92850522|NCT04114500|Estrogens|estrogens|mesh-ancestor
92850523|NCT04114500|Hormones|hormones|mesh-ancestor
92850524|NCT04114500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850525|NCT04114500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850526|NCT04114500|Progestins|progestins|mesh-ancestor
92850527|NCT05755659|Fosaprepitant|fosaprepitant|mesh-list
92850528|NCT05755659|Aprepitant|aprepitant|mesh-list
92850529|NCT05755659|Antiemetics|antiemetics|mesh-ancestor
92850530|NCT05755659|Autonomic Agents|autonomic agents|mesh-ancestor
92850531|NCT05755659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850532|NCT05755659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850533|NCT05755659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92850534|NCT05755659|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92850535|NCT05755659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850536|NCT05755659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850537|NCT00913887|Diclofenac|diclofenac|mesh-list
92850538|NCT00913887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92850539|NCT00913887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92850540|NCT00913887|Analgesics|analgesics|mesh-ancestor
92850541|NCT00913887|Sensory System Agents|sensory system agents|mesh-ancestor
92850542|NCT00913887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850543|NCT00913887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850544|NCT00913887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92850545|NCT00913887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850546|NCT00913887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92850547|NCT00913887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850548|NCT00913887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850549|NCT02792400|Empagliflozin|empagliflozin|mesh-list
92850550|NCT02792400|Linagliptin|linagliptin|mesh-list
92850551|NCT02792400|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92850552|NCT02792400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850553|NCT02792400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850554|NCT02792400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850555|NCT02792400|Incretins|incretins|mesh-ancestor
92850556|NCT02792400|Hormones|hormones|mesh-ancestor
92850557|NCT02792400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850558|NCT02792400|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92850559|NCT02792400|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850560|NCT02792400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850561|NCT04040023|Vitamins|vitamins|mesh-list
92850562|NCT04040023|Micronutrients|micronutrients|mesh-ancestor
92850563|NCT04040023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850564|NCT05755581|Antineoplastic Agents|antineoplastic agents|mesh-list
92850565|NCT05755581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
92850566|NCT05017155|Mexiletine|mexiletine|mesh-list
92850567|NCT05017155|Lamotrigine|lamotrigine|mesh-list
92850568|NCT05017155|Anticonvulsants|anticonvulsants|mesh-ancestor
92850569|NCT05017155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92850570|NCT05017155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850571|NCT05017155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850572|NCT05017155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92850573|NCT05017155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850574|NCT05017155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92850575|NCT05017155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850576|NCT05017155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850577|NCT05017155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850578|NCT05017155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92850579|NCT05017155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92850580|NCT05017155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92850581|NCT05162131|Ticagrelor|ticagrelor|mesh-list
92433270|NCT01573715|Atracurium|atracurium|mesh-list
92850582|NCT05162131|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92850583|NCT05162131|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92850584|NCT05162131|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92850585|NCT05162131|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92850586|NCT05162131|Purinergic Agents|purinergic agents|mesh-ancestor
92850587|NCT05162131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850588|NCT05162131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850589|NCT05162131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850590|NCT00868153|Levonorgestrel|levonorgestrel|mesh-list
92850591|NCT00868153|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92850592|NCT00868153|Contraceptive Agents|contraceptive agents|mesh-ancestor
92850593|NCT00868153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92850594|NCT00868153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850595|NCT00868153|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92850596|NCT00868153|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92850597|NCT00868153|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92850599|NCT00876889|Anticonvulsants|anticonvulsants|mesh-ancestor
92850600|NCT00876889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92850601|NCT00876889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92850602|NCT00876889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850603|NCT00876889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850604|NCT00876889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850605|NCT00876889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92850606|NCT00876889|Protective Agents|protective agents|mesh-ancestor
92850607|NCT00868465|Lumefantrine|lumefantrine|mesh-list
92850608|NCT00868465|Artemether|artemether|mesh-list
92850609|NCT00868465|Piperaquine|piperaquine|mesh-list
92850610|NCT00868465|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92850611|NCT00868465|Artenimol|artenimol|mesh-list
92850612|NCT00868465|Antimalarials|antimalarials|mesh-ancestor
92850613|NCT00868465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92850614|NCT00868465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92850615|NCT00868465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850616|NCT02689986|Rituximab|rituximab|mesh-list
92850617|NCT02689986|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92850618|NCT02689986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92850619|NCT02689986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850620|NCT02689986|Immunologic Factors|immunologic factors|mesh-ancestor
92850621|NCT02689986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850622|NCT02689986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850623|NCT02689986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92850624|NCT02689986|Alkylating Agents|alkylating agents|mesh-ancestor
92850625|NCT02689986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850626|NCT00876967|Pyrithione zinc|pyrithione zinc|mesh-list
92850627|NCT00876967|Keratolytic Agents|keratolytic agents|mesh-ancestor
92850628|NCT00876967|Dermatologic Agents|dermatologic agents|mesh-ancestor
92850629|NCT00955409|Saponin QA-21V1|saponin qa-21v1|mesh-list
92850630|NCT00955409|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92850631|NCT00955409|Immunologic Factors|immunologic factors|mesh-ancestor
92850632|NCT00955409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850633|NCT00877123|Vitamin D|vitamin d|mesh-list
92850634|NCT00877123|Vitamins|vitamins|mesh-ancestor
92850635|NCT00877123|Micronutrients|micronutrients|mesh-ancestor
92850636|NCT00877123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850637|NCT00877123|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92850638|NCT00873223|Liraglutide|liraglutide|mesh-list
92850639|NCT00873223|Insulin Detemir|insulin detemir|mesh-list
92850640|NCT00873223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850641|NCT00873223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850642|NCT00873223|Incretins|incretins|mesh-ancestor
92850643|NCT00873223|Hormones|hormones|mesh-ancestor
92850644|NCT00873223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850645|NCT00873379|Melatonin|melatonin|mesh-list
92850646|NCT00873379|Antioxidants|antioxidants|mesh-ancestor
92850647|NCT00873379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850648|NCT00873379|Protective Agents|protective agents|mesh-ancestor
92850649|NCT00873379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850650|NCT00873379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850651|NCT00868855|Bradykinin|bradykinin|mesh-list
92850652|NCT00868855|Kininogens|kininogens|mesh-list
92850653|NCT00868855|Vasodilator Agents|vasodilator agents|mesh-ancestor
92850654|NCT00868855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92850655|NCT00868855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850656|NCT00868855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850657|NCT00868855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850659|NCT00615901|Fluorouracil|fluorouracil|mesh-list
92850660|NCT00615901|Methotrexate|methotrexate|mesh-list
92850661|NCT00615901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92850662|NCT00615901|Immunologic Factors|immunologic factors|mesh-ancestor
92850663|NCT00615901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850664|NCT00615901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850665|NCT00615901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92850666|NCT00615901|Alkylating Agents|alkylating agents|mesh-ancestor
92850667|NCT00615901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850668|NCT00615901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850669|NCT00615901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92850670|NCT00615901|Antimetabolites|antimetabolites|mesh-ancestor
92850671|NCT00615901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850672|NCT00615901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92850673|NCT00615901|Abortifacient Agents|abortifacient agents|mesh-ancestor
92850674|NCT00615901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92850675|NCT00615901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92850676|NCT00615901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850677|NCT00615901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92850678|NCT00615901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92850679|NCT00616603|Dexamethasone|dexamethasone|mesh-list
92850680|NCT00616603|Dexamethasone acetate|dexamethasone acetate|mesh-list
92850681|NCT00616603|Ropivacaine|ropivacaine|mesh-list
92850682|NCT00616603|BB 1101|bb 1101|mesh-list
92850683|NCT00616603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92850684|NCT00616603|Antiemetics|antiemetics|mesh-ancestor
92850685|NCT00616603|Autonomic Agents|autonomic agents|mesh-ancestor
92850686|NCT00616603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850687|NCT00616603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850688|NCT00616603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92850689|NCT00616603|Glucocorticoids|glucocorticoids|mesh-ancestor
92850690|NCT00616603|Hormones|hormones|mesh-ancestor
92850691|NCT00616603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850692|NCT00616603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92850693|NCT00616603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850694|NCT00616603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850695|NCT00616603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850696|NCT00616603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850697|NCT00616603|Anesthetics, Local|anesthetics, local|mesh-ancestor
92850698|NCT00616603|Anesthetics|anesthetics|mesh-ancestor
92850699|NCT00616603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850700|NCT00616603|Sensory System Agents|sensory system agents|mesh-ancestor
92850701|NCT00873535|Varenicline|varenicline|mesh-list
92850702|NCT00873535|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92850703|NCT00873535|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92850704|NCT00873535|Cholinergic Agents|cholinergic agents|mesh-ancestor
92850705|NCT00873535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850706|NCT00873535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850707|NCT00873535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850708|NCT02790996|Vancomycin|vancomycin|mesh-list
92850709|NCT02790996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850710|NCT02790996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850711|NCT00810693|Riociguat|riociguat|mesh-list
92850712|NCT00810693|Enzyme Activators|enzyme activators|mesh-ancestor
92850713|NCT00810693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850714|NCT02790840|Omeprazole|omeprazole|mesh-list
92850715|NCT02790840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92850716|NCT02790840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92850717|NCT02790840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92850718|NCT02790840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850719|NCT02790840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850720|NCT02790684|Firuglipel|firuglipel|mesh-list
92850721|NCT02790684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92850722|NCT02790684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850723|NCT02790450|Benzbromarone|benzbromarone|mesh-list
92850724|NCT02790450|Uricosuric Agents|uricosuric agents|mesh-ancestor
92850725|NCT02790450|Gout Suppressants|gout suppressants|mesh-ancestor
92850726|NCT02790450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850728|NCT02790528|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92850729|NCT02790528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92850730|NCT02790528|Antimetabolites|antimetabolites|mesh-ancestor
92850731|NCT02790528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850732|NCT02790528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92850733|NCT02790528|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92850734|NCT02790528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850736|NCT00953615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92850737|NCT00953615|Immunologic Factors|immunologic factors|mesh-ancestor
92850738|NCT00953615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850739|NCT00953615|Leprostatic Agents|leprostatic agents|mesh-ancestor
92850740|NCT00953615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850741|NCT00953615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850742|NCT00953615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92850743|NCT00953615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92850744|NCT00953615|Growth Substances|growth substances|mesh-ancestor
92850745|NCT00953615|Growth Inhibitors|growth inhibitors|mesh-ancestor
92850746|NCT00953615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850747|NCT00873769|Loxapine|loxapine|mesh-list
92850748|NCT00873769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92850749|NCT00873769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850750|NCT00873769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850751|NCT00873769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850752|NCT00873769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850753|NCT00873769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92850754|NCT00873769|Dopamine Agents|dopamine agents|mesh-ancestor
92850755|NCT00873769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850756|NCT00873769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850757|NCT02785614|Trazodone|trazodone|mesh-list
92850758|NCT02785614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92850759|NCT02785614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850760|NCT02785614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850761|NCT02785614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850762|NCT02785614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850763|NCT02785614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92850764|NCT02785614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92850765|NCT02785614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850766|NCT02785614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850767|NCT02785614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850768|NCT02785614|Serotonin Agents|serotonin agents|mesh-ancestor
92850769|NCT02785614|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92850770|NCT02785614|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850771|NCT02787018|Dexamethasone|dexamethasone|mesh-list
92850772|NCT02787018|Dexmedetomidine|dexmedetomidine|mesh-list
92850773|NCT02787018|Ropivacaine|ropivacaine|mesh-list
92850774|NCT02787018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92850775|NCT02787018|Antiemetics|antiemetics|mesh-ancestor
92850776|NCT02787018|Autonomic Agents|autonomic agents|mesh-ancestor
92850777|NCT02787018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850778|NCT02787018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850779|NCT02787018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92850780|NCT02787018|Glucocorticoids|glucocorticoids|mesh-ancestor
92850781|NCT02787018|Hormones|hormones|mesh-ancestor
92850782|NCT02787018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92850783|NCT02787018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92850784|NCT02787018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850785|NCT02787018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92850786|NCT02787018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850787|NCT02787018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92850788|NCT02787018|Analgesics|analgesics|mesh-ancestor
92850789|NCT02787018|Sensory System Agents|sensory system agents|mesh-ancestor
92850790|NCT02787018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92850791|NCT02787018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92850792|NCT02787018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92850793|NCT02787018|Adrenergic Agents|adrenergic agents|mesh-ancestor
92850794|NCT02787018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850795|NCT02787018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850796|NCT02787018|Anesthetics, Local|anesthetics, local|mesh-ancestor
92850797|NCT02787018|Anesthetics|anesthetics|mesh-ancestor
92850798|NCT00873925|Vitamin D|vitamin d|mesh-list
92850799|NCT00873925|Vitamins|vitamins|mesh-ancestor
92850800|NCT00873925|Micronutrients|micronutrients|mesh-ancestor
92850801|NCT00873925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850802|NCT00873925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92850803|NCT03412266|Cytarabine|cytarabine|mesh-list
92850804|NCT03412266|Cyclophosphamide|cyclophosphamide|mesh-list
92850805|NCT03412266|Busulfan|busulfan|mesh-list
92850806|NCT03412266|Semustine|semustine|mesh-list
92850807|NCT03412266|Fludarabine|fludarabine|mesh-list
92850808|NCT03412266|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92850809|NCT03412266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92850810|NCT03412266|Immunologic Factors|immunologic factors|mesh-ancestor
92850811|NCT03412266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850812|NCT03412266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850813|NCT03412266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92850814|NCT03412266|Alkylating Agents|alkylating agents|mesh-ancestor
92850815|NCT03412266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850816|NCT03412266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850817|NCT03412266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92850818|NCT03412266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850819|NCT03412266|Antimetabolites|antimetabolites|mesh-ancestor
92850820|NCT03412266|Antiviral Agents|antiviral agents|mesh-ancestor
92850821|NCT03412266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850822|NCT00877591|Ritonavir|ritonavir|mesh-list
92850823|NCT00877591|Darunavir|darunavir|mesh-list
92850824|NCT00877591|Fosamprenavir|fosamprenavir|mesh-list
92850825|NCT00877591|Rifampin|rifampin|mesh-list
92850826|NCT00877591|Rifabutin|rifabutin|mesh-list
92850827|NCT00877591|Buprenorphine|buprenorphine|mesh-list
92850828|NCT00877591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92850829|NCT00877591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92850830|NCT00877591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92850831|NCT00877591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850832|NCT00877591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850833|NCT00877591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92850834|NCT00877591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92850835|NCT00877591|Antiviral Agents|antiviral agents|mesh-ancestor
92850836|NCT00877591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92850837|NCT00877591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92850838|NCT00877591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92850839|NCT00877591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92850840|NCT00877591|Narcotics|narcotics|mesh-ancestor
92850841|NCT00877591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850842|NCT00877591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850843|NCT00877591|Analgesics|analgesics|mesh-ancestor
92850844|NCT00877591|Sensory System Agents|sensory system agents|mesh-ancestor
92850845|NCT00877591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850846|NCT00877591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92850847|NCT00877591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92850848|NCT00877591|Antitubercular Agents|antitubercular agents|mesh-ancestor
92850849|NCT00877591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850850|NCT00877591|Leprostatic Agents|leprostatic agents|mesh-ancestor
92850851|NCT00877591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92850852|NCT00877591|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92850853|NCT00877591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92850854|NCT00877591|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92850855|NCT00877591|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92850856|NCT00877591|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92850857|NCT00877591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92850858|NCT04200222|Vanadium|vanadium|mesh-list
92850859|NCT04200222|Trace Elements|trace elements|mesh-ancestor
92850860|NCT04200222|Micronutrients|micronutrients|mesh-ancestor
92850861|NCT04200222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850862|NCT00874003|Mirtazapine|mirtazapine|mesh-list
92850863|NCT00874003|Antidepressive Agents|antidepressive agents|mesh-ancestor
92850864|NCT00874003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92850865|NCT00874003|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92850866|NCT00874003|Histamine Antagonists|histamine antagonists|mesh-ancestor
92850867|NCT00874003|Histamine Agents|histamine agents|mesh-ancestor
92850868|NCT00874003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850869|NCT00874003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752580|NCT05935787|Vitamin B Complex|vitamin b complex|mesh-ancestor
92850870|NCT00874003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850871|NCT00874003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92850872|NCT00874003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92850873|NCT00874003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850874|NCT00874003|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92850875|NCT00874003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92850876|NCT00874003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92850877|NCT00874003|Adrenergic Agents|adrenergic agents|mesh-ancestor
92850878|NCT00874003|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92850879|NCT00874003|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92850880|NCT00874003|Serotonin Agents|serotonin agents|mesh-ancestor
92850882|NCT04915365|Acetazolamide|acetazolamide|mesh-list
92850883|NCT04915365|Anticonvulsants|anticonvulsants|mesh-ancestor
92850884|NCT04915365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92850885|NCT04915365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850886|NCT04915365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850887|NCT04915365|Diuretics|diuretics|mesh-ancestor
92850888|NCT04915365|Natriuretic Agents|natriuretic agents|mesh-ancestor
92850889|NCT04915365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850890|NCT02785146|Calcium, Dietary|calcium, dietary|mesh-list
92850891|NCT02785146|Leucovorin|leucovorin|mesh-list
92850892|NCT02785146|Fluorouracil|fluorouracil|mesh-list
92850893|NCT02785146|Oxaliplatin|oxaliplatin|mesh-list
92850894|NCT02785146|Calcium|calcium|mesh-list
92850895|NCT02785146|Levoleucovorin|levoleucovorin|mesh-list
92850896|NCT02785146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92850897|NCT02785146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850898|NCT02785146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92850899|NCT02785146|Antimetabolites|antimetabolites|mesh-ancestor
92850900|NCT02785146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850901|NCT02785146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850902|NCT02785146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850903|NCT02785146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92850904|NCT02785146|Immunologic Factors|immunologic factors|mesh-ancestor
92850905|NCT02785146|Antidotes|antidotes|mesh-ancestor
92850906|NCT02785146|Protective Agents|protective agents|mesh-ancestor
92850907|NCT02785146|Vitamin B Complex|vitamin b complex|mesh-ancestor
92850908|NCT02785146|Vitamins|vitamins|mesh-ancestor
92850909|NCT02785146|Micronutrients|micronutrients|mesh-ancestor
92850910|NCT00913965|Atenolol|atenolol|mesh-list
92850911|NCT00913965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92850912|NCT00913965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92850913|NCT00913965|Sympatholytics|sympatholytics|mesh-ancestor
92850914|NCT00913965|Autonomic Agents|autonomic agents|mesh-ancestor
92850915|NCT00913965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850916|NCT00913965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850917|NCT00913965|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92850918|NCT00913965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92850919|NCT00913965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92850920|NCT00913965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92850921|NCT00913965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850922|NCT00913965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850923|NCT05753865|Paclitaxel|paclitaxel|mesh-list
92850924|NCT05753865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92850925|NCT05753865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850926|NCT05753865|Tubulin Modulators|tubulin modulators|mesh-ancestor
92850927|NCT05753865|Antimitotic Agents|antimitotic agents|mesh-ancestor
92850928|NCT05753865|Mitosis Modulators|mitosis modulators|mesh-ancestor
92850929|NCT05753865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850930|NCT00869869|Melatonin|melatonin|mesh-list
92850931|NCT00869869|Antioxidants|antioxidants|mesh-ancestor
92850932|NCT00869869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850933|NCT00869869|Protective Agents|protective agents|mesh-ancestor
92850934|NCT00869869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850935|NCT00869869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92850936|NCT05753787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92850937|NCT05753787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92850938|NCT00874315|Cyclosporine|cyclosporine|mesh-list
92850939|NCT00874315|Mycophenolic Acid|mycophenolic acid|mesh-list
92850940|NCT00874315|Fludarabine|fludarabine|mesh-list
92850941|NCT00874315|Fludarabine phosphate|fludarabine phosphate|mesh-list
92850942|NCT00874315|Busulfan|busulfan|mesh-list
92850943|NCT00874315|Tacrolimus|tacrolimus|mesh-list
92850944|NCT00874315|Cyclosporins|cyclosporins|mesh-list
92850945|NCT00874315|Thymoglobulin|thymoglobulin|mesh-list
92850946|NCT00874315|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92850947|NCT00874315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92850948|NCT00874315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92850949|NCT00874315|Antimetabolites|antimetabolites|mesh-ancestor
92850950|NCT00874315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850951|NCT00874315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92850952|NCT00874315|Immunologic Factors|immunologic factors|mesh-ancestor
92850953|NCT00874315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850954|NCT00874315|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92850955|NCT00874315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92850956|NCT00874315|Antifungal Agents|antifungal agents|mesh-ancestor
92850958|NCT00874315|Dermatologic Agents|dermatologic agents|mesh-ancestor
92850959|NCT00874315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92850960|NCT00874315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92850961|NCT00874315|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92850962|NCT00874315|Antitubercular Agents|antitubercular agents|mesh-ancestor
92850963|NCT00874315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92850964|NCT00874315|Alkylating Agents|alkylating agents|mesh-ancestor
92850965|NCT00874315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92850966|NCT00874315|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92850967|NCT00874393|Hydrocortisone|hydrocortisone|mesh-list
92850968|NCT00874393|Dopamine|dopamine|mesh-list
92850969|NCT00874393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92850970|NCT00874393|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92850971|NCT00874393|Sympathomimetics|sympathomimetics|mesh-ancestor
92850972|NCT00874393|Autonomic Agents|autonomic agents|mesh-ancestor
92850973|NCT00874393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850974|NCT00874393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850975|NCT00874393|Dopamine Agents|dopamine agents|mesh-ancestor
92850976|NCT00874393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850977|NCT00874393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850978|NCT00874393|Protective Agents|protective agents|mesh-ancestor
92850979|NCT04199364|Poractant alfa|poractant alfa|mesh-list
92850980|NCT04199364|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92850981|NCT04199364|Respiratory System Agents|respiratory system agents|mesh-ancestor
92850982|NCT00870025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92850983|NCT00870025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92850984|NCT00870025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850985|NCT00877981|Parathyroid Hormone|parathyroid hormone|mesh-list
92850986|NCT00877981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92850987|NCT00877981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850988|NCT02786550|Botulinum Toxins|botulinum toxins|mesh-list
92850989|NCT02786550|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92850990|NCT02786550|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92850991|NCT02786550|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92850992|NCT02786550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92850993|NCT02786550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92850994|NCT02786550|Cholinergic Agents|cholinergic agents|mesh-ancestor
92850995|NCT02786550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92850996|NCT02786550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92850997|NCT02786550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92850998|NCT02786550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92850999|NCT02784054|Cyclophosphamide|cyclophosphamide|mesh-list
92851000|NCT02784054|Melphalan|melphalan|mesh-list
92851001|NCT02784054|Thiotepa|thiotepa|mesh-list
92851002|NCT02784054|Carboplatin|carboplatin|mesh-list
92851003|NCT02784054|Etoposide|etoposide|mesh-list
92851004|NCT02784054|Bleomycin|bleomycin|mesh-list
92851005|NCT02784054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851006|NCT02784054|Immunologic Factors|immunologic factors|mesh-ancestor
92851007|NCT02784054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851008|NCT02784054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851009|NCT02784054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851010|NCT02784054|Alkylating Agents|alkylating agents|mesh-ancestor
92851011|NCT02784054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851012|NCT02784054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851013|NCT02784054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92851014|NCT02784054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851015|NCT02784054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851016|NCT02784054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851017|NCT02784054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851018|NCT02784054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92851019|NCT00874861|Poly ICLC|poly iclc|mesh-list
92851020|NCT00874861|Interferon Inducers|interferon inducers|mesh-ancestor
92851021|NCT00874861|Immunologic Factors|immunologic factors|mesh-ancestor
92851022|NCT00874861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851023|NCT04038853|Vitamin D|vitamin d|mesh-list
92851024|NCT04038853|Cholecalciferol|cholecalciferol|mesh-list
92851025|NCT04038853|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92851026|NCT04038853|Calcitriol|calcitriol|mesh-list
92851027|NCT04038853|Vitamins|vitamins|mesh-ancestor
92496124|NCT01987739|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92851028|NCT04038853|Micronutrients|micronutrients|mesh-ancestor
92851029|NCT04038853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851030|NCT04038853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92196264|NCT03155048|Estradiol|estradiol|mesh-list
92851031|NCT04038853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92851032|NCT04038853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92851033|NCT04038853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92851034|NCT04038853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851035|NCT04038853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92851036|NCT02066220|Cyclophosphamide|cyclophosphamide|mesh-list
92851038|NCT02066220|Cisplatin|cisplatin|mesh-list
92851039|NCT02066220|Carboplatin|carboplatin|mesh-list
92851040|NCT02066220|Vincristine|vincristine|mesh-list
92851041|NCT02066220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851042|NCT02066220|Immunologic Factors|immunologic factors|mesh-ancestor
92851043|NCT02066220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851044|NCT02066220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851045|NCT02066220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851046|NCT02066220|Alkylating Agents|alkylating agents|mesh-ancestor
92851047|NCT02066220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851048|NCT02066220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851049|NCT02066220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92851050|NCT02066220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851051|NCT02066220|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851052|NCT02066220|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851053|NCT02066220|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851054|NCT00573391|Thalidomide|thalidomide|mesh-list
92851055|NCT00573391|Dexamethasone|dexamethasone|mesh-list
92851056|NCT00573391|Dexamethasone acetate|dexamethasone acetate|mesh-list
92851057|NCT00573391|Melphalan|melphalan|mesh-list
92851058|NCT00573391|Bortezomib|bortezomib|mesh-list
92851059|NCT00573391|BB 1101|bb 1101|mesh-list
92851060|NCT00573391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851061|NCT00573391|Antiemetics|antiemetics|mesh-ancestor
92851062|NCT00573391|Autonomic Agents|autonomic agents|mesh-ancestor
92851063|NCT00573391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851064|NCT00573391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851065|NCT00573391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851066|NCT00573391|Glucocorticoids|glucocorticoids|mesh-ancestor
92851067|NCT00573391|Hormones|hormones|mesh-ancestor
92851068|NCT00573391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851069|NCT00573391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92851070|NCT00573391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851071|NCT00573391|Protease Inhibitors|protease inhibitors|mesh-ancestor
92851072|NCT00573391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851073|NCT00573391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851074|NCT00573391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851075|NCT00573391|Alkylating Agents|alkylating agents|mesh-ancestor
92851076|NCT00573391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92851077|NCT00573391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851078|NCT00573391|Immunologic Factors|immunologic factors|mesh-ancestor
92851079|NCT00573391|Leprostatic Agents|leprostatic agents|mesh-ancestor
92851080|NCT00573391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851081|NCT00573391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851082|NCT00573391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92851083|NCT00573391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92851084|NCT00573391|Growth Substances|growth substances|mesh-ancestor
92851085|NCT00573391|Growth Inhibitors|growth inhibitors|mesh-ancestor
92851086|NCT00590967|Cisplatin|cisplatin|mesh-list
92851087|NCT00590967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851088|NCT02783976|Sofosbuvir|sofosbuvir|mesh-list
92851089|NCT02783976|Antiviral Agents|antiviral agents|mesh-ancestor
92851090|NCT02783976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851091|NCT00878371|Morphine|morphine|mesh-list
92851092|NCT00878371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92851093|NCT00878371|Narcotics|narcotics|mesh-ancestor
92851094|NCT00878371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851095|NCT00878371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851096|NCT00878371|Analgesics|analgesics|mesh-ancestor
92851097|NCT00878371|Sensory System Agents|sensory system agents|mesh-ancestor
92851098|NCT00878371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851099|NCT04054635|Fluorides|fluorides|mesh-list
92851100|NCT04054635|Cariostatic Agents|cariostatic agents|mesh-ancestor
92851101|NCT04054635|Protective Agents|protective agents|mesh-ancestor
92851102|NCT04054635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851103|NCT00923299|Trastuzumab|trastuzumab|mesh-list
92851104|NCT00923299|Cetuximab|cetuximab|mesh-list
92851105|NCT00923299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92851106|NCT00923299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851107|NCT05753397|Ropivacaine|ropivacaine|mesh-list
92851108|NCT05753397|Anesthetics, Local|anesthetics, local|mesh-ancestor
92851109|NCT05753397|Anesthetics|anesthetics|mesh-ancestor
92851110|NCT05753397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851111|NCT05753397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851112|NCT05753397|Sensory System Agents|sensory system agents|mesh-ancestor
92851113|NCT05753397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851114|NCT00875173|Selenium|selenium|mesh-list
92851115|NCT00875173|Antioxidants|antioxidants|mesh-list
92851116|NCT00875173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851117|NCT00875173|Protective Agents|protective agents|mesh-ancestor
92851118|NCT00875173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851119|NCT00875173|Trace Elements|trace elements|mesh-ancestor
92851120|NCT00875173|Micronutrients|micronutrients|mesh-ancestor
92851121|NCT04029831|Ketamine|ketamine|mesh-list
92851122|NCT04029831|Propofol|propofol|mesh-list
92851123|NCT04029831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851124|NCT04029831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851125|NCT04029831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851126|NCT04029831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92851127|NCT04029831|Anesthetics, General|anesthetics, general|mesh-ancestor
92851128|NCT04029831|Anesthetics|anesthetics|mesh-ancestor
92851129|NCT04029831|Analgesics|analgesics|mesh-ancestor
92851130|NCT04029831|Sensory System Agents|sensory system agents|mesh-ancestor
92851131|NCT04029831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851132|NCT04029831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92851133|NCT04029831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92851134|NCT04029831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92851135|NCT04029831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851136|NCT04029831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851137|NCT00878449|Etoposide|etoposide|mesh-list
92851138|NCT00878449|Navitoclax|navitoclax|mesh-list
92851139|NCT00878449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851140|NCT00878449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851141|NCT00878449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851142|NCT00878449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851143|NCT00878449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851144|NCT00878449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851145|NCT00875407|3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|mesh-list
92851146|NCT00875407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92851147|NCT00875407|Dopamine Agents|dopamine agents|mesh-ancestor
92851148|NCT00875407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851149|NCT00875407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851150|NCT00875407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851151|NCT00875875|Rifaximin|rifaximin|mesh-list
92851152|NCT00875875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851153|NCT00875875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851154|NCT00875875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851155|NCT01716312|Omalizumab|omalizumab|mesh-list
92851156|NCT01716312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92851157|NCT01716312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92851158|NCT01716312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92851159|NCT00880243|Cytarabine|cytarabine|mesh-list
92851160|NCT00880243|Etoposide|etoposide|mesh-list
92851161|NCT00880243|Mitoxantrone|mitoxantrone|mesh-list
92851162|NCT00880243|Daunorubicin|daunorubicin|mesh-list
92851163|NCT00880243|Molgramostim|molgramostim|mesh-list
92851164|NCT00880243|Sargramostim|sargramostim|mesh-list
92851165|NCT00880243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851166|NCT00880243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851167|NCT00880243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851168|NCT00880243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851169|NCT00880243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851170|NCT00880243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851171|NCT00880243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851172|NCT00880243|Antimetabolites|antimetabolites|mesh-ancestor
92851173|NCT00880243|Antiviral Agents|antiviral agents|mesh-ancestor
92851174|NCT00880243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851175|NCT00880243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851176|NCT00880243|Immunologic Factors|immunologic factors|mesh-ancestor
92851177|NCT00880243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851178|NCT00880243|Analgesics|analgesics|mesh-ancestor
92851179|NCT00880243|Sensory System Agents|sensory system agents|mesh-ancestor
92851180|NCT00880243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851181|NCT00880243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92851182|NCT02783586|Bupivacaine|bupivacaine|mesh-list
92851183|NCT02783586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92851185|NCT02783586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851186|NCT02783586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851187|NCT02783586|Sensory System Agents|sensory system agents|mesh-ancestor
92851188|NCT02783586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851189|NCT00590577|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92851190|NCT00590577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92851191|NCT00590577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92851192|NCT00590577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851193|NCT00590577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851194|NCT00590577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92851195|NCT00590577|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92851196|NCT00590577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92851197|NCT00590577|Serotonin Agents|serotonin agents|mesh-ancestor
92851198|NCT00590577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851199|NCT00590577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851200|NCT00590577|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92851201|NCT00590577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92851202|NCT00590577|Dopamine Agents|dopamine agents|mesh-ancestor
92851203|NCT00880321|Dabrafenib|dabrafenib|mesh-list
92851204|NCT00880321|Midazolam|midazolam|mesh-list
92851205|NCT00880321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92851206|NCT00880321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851207|NCT00880321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851208|NCT00880321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851209|NCT00880321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92851210|NCT00880321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92851211|NCT00880321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92851212|NCT00880321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92851213|NCT00880321|Anesthetics, General|anesthetics, general|mesh-ancestor
92851214|NCT00880321|Anesthetics|anesthetics|mesh-ancestor
92851215|NCT00880321|GABA Modulators|gaba modulators|mesh-ancestor
92851216|NCT00880321|GABA Agents|gaba agents|mesh-ancestor
92851217|NCT00880321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851218|NCT00880321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851219|NCT00880321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851220|NCT00880321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92851221|NCT00880321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851222|NCT02608437|Ipilimumab|ipilimumab|mesh-list
92851223|NCT02608437|Guadecitabine|guadecitabine|mesh-list
92851224|NCT02608437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92851225|NCT02608437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851226|NCT02608437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92752897|NCT05705258|Growth Inhibitors|growth inhibitors|mesh-ancestor
92851227|NCT02608437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851228|NCT05753007|Cannabidiol|cannabidiol|mesh-list
92851229|NCT05753007|Anticonvulsants|anticonvulsants|mesh-ancestor
92851230|NCT04230330|Dexamethasone|dexamethasone|mesh-list
92851231|NCT04230330|Gemcitabine|gemcitabine|mesh-list
92851232|NCT04230330|Nivolumab|nivolumab|mesh-list
92851233|NCT04230330|Asparaginase|asparaginase|mesh-list
92851234|NCT04230330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851235|NCT04230330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851236|NCT04230330|Antiemetics|antiemetics|mesh-ancestor
92851237|NCT04230330|Autonomic Agents|autonomic agents|mesh-ancestor
92851238|NCT04230330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851239|NCT04230330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851240|NCT04230330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851241|NCT04230330|Glucocorticoids|glucocorticoids|mesh-ancestor
92851242|NCT04230330|Hormones|hormones|mesh-ancestor
92851243|NCT04230330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851244|NCT04230330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92851245|NCT04230330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851246|NCT04230330|Antimetabolites|antimetabolites|mesh-ancestor
92851247|NCT04230330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851248|NCT04230330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92851249|NCT04230330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92851250|NCT02785068|Leucovorin|leucovorin|mesh-list
92851251|NCT02785068|Fluorouracil|fluorouracil|mesh-list
92851252|NCT02785068|Antimetabolites|antimetabolites|mesh-ancestor
92851253|NCT02785068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851254|NCT02785068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851255|NCT02785068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851256|NCT02785068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851257|NCT02785068|Immunologic Factors|immunologic factors|mesh-ancestor
92851258|NCT02785068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851260|NCT02785068|Protective Agents|protective agents|mesh-ancestor
92851261|NCT02785068|Vitamin B Complex|vitamin b complex|mesh-ancestor
92851262|NCT02785068|Vitamins|vitamins|mesh-ancestor
92851263|NCT02785068|Micronutrients|micronutrients|mesh-ancestor
92851264|NCT05752929|Insulin|insulin|mesh-list
92851265|NCT05752929|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92851266|NCT05752929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92851267|NCT05752929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851268|NCT00880477|Edetic Acid|edetic acid|mesh-list
92851269|NCT00880477|Vaccines|vaccines|mesh-list
92851270|NCT00880477|Pentetic Acid|pentetic acid|mesh-list
92851271|NCT00880477|Immunologic Factors|immunologic factors|mesh-ancestor
92851272|NCT00880477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851273|NCT00880477|Antidotes|antidotes|mesh-ancestor
92851274|NCT00880477|Protective Agents|protective agents|mesh-ancestor
92851275|NCT00880477|Chelating Agents|chelating agents|mesh-ancestor
92851276|NCT00880477|Sequestering Agents|sequestering agents|mesh-ancestor
92851277|NCT00880477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851278|NCT00880477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92851279|NCT00880477|Anticoagulants|anticoagulants|mesh-ancestor
92851280|NCT00880477|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92851281|NCT05293938|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92851282|NCT05293938|Cathartics|cathartics|mesh-ancestor
92851283|NCT05293938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851284|NCT00882739|Clopidogrel|clopidogrel|mesh-list
92851285|NCT00882739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92851286|NCT00882739|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92851287|NCT00882739|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92851288|NCT00882739|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92851289|NCT00882739|Purinergic Agents|purinergic agents|mesh-ancestor
92851290|NCT00882739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851291|NCT00882739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851292|NCT00882739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851293|NCT02783040|Digoxin|digoxin|mesh-list
92851294|NCT02783040|Midazolam|midazolam|mesh-list
92851295|NCT02783040|BI 425809|bi 425809|mesh-list
92851296|NCT02783040|Omeprazole|omeprazole|mesh-list
92851297|NCT02783040|Warfarin|warfarin|mesh-list
92851298|NCT02783040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92851299|NCT02783040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851300|NCT02783040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851301|NCT02783040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851302|NCT02783040|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92851303|NCT02783040|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92851304|NCT02783040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92851305|NCT02783040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92851306|NCT02783040|Anesthetics, General|anesthetics, general|mesh-ancestor
92851307|NCT02783040|Anesthetics|anesthetics|mesh-ancestor
92851308|NCT02783040|GABA Modulators|gaba modulators|mesh-ancestor
92851309|NCT02783040|GABA Agents|gaba agents|mesh-ancestor
92851310|NCT02783040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851311|NCT02783040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851312|NCT02783040|Anticoagulants|anticoagulants|mesh-ancestor
92851313|NCT02783040|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92851314|NCT02783040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851315|NCT02783040|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92851316|NCT02783040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851317|NCT02783040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92851318|NCT02783040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92851319|NCT02783040|Protective Agents|protective agents|mesh-ancestor
92851320|NCT02783040|Nootropic Agents|nootropic agents|mesh-ancestor
92851321|NCT02512926|Cyclophosphamide|cyclophosphamide|mesh-list
92851322|NCT02512926|Etoposide|etoposide|mesh-list
92851323|NCT02512926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851324|NCT02512926|Immunologic Factors|immunologic factors|mesh-ancestor
92851325|NCT02512926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851326|NCT02512926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851327|NCT02512926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851328|NCT02512926|Alkylating Agents|alkylating agents|mesh-ancestor
92851329|NCT02512926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851330|NCT02512926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851331|NCT02512926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92851332|NCT02512926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851333|NCT02512926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851334|NCT02512926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851335|NCT02512926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851336|NCT02786082|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92851337|NCT02786082|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92851338|NCT02786082|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92851339|NCT02786082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851340|NCT05275686|Fluticasone|fluticasone|mesh-list
92851341|NCT05275686|Xhance|xhance|mesh-list
92851342|NCT05275686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851343|NCT05275686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92851344|NCT05275686|Autonomic Agents|autonomic agents|mesh-ancestor
92851345|NCT05275686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851346|NCT05275686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851347|NCT05275686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92851348|NCT05275686|Respiratory System Agents|respiratory system agents|mesh-ancestor
92851349|NCT05275686|Dermatologic Agents|dermatologic agents|mesh-ancestor
92851350|NCT05275686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92851351|NCT01503606|Clarithromycin|clarithromycin|mesh-list
92851352|NCT01503606|Cefazolin|cefazolin|mesh-list
92851353|NCT01503606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851354|NCT01503606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851355|NCT01503606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92851356|NCT01503606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851357|NCT01503606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851358|NCT01503606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92851359|NCT01503606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92851360|NCT00882973|genexol-PM|genexol-pm|mesh-list
92851361|NCT00882973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851362|NCT00882973|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851363|NCT00882973|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851364|NCT00882973|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851365|NCT00882973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851366|NCT00805935|Leuprolide|leuprolide|mesh-list
92851367|NCT00805935|Menotropins|menotropins|mesh-list
92851368|NCT00805935|Progesterone|progesterone|mesh-list
92851369|NCT00805935|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92851370|NCT00805935|Progestins|progestins|mesh-ancestor
92851371|NCT00805935|Hormones|hormones|mesh-ancestor
92851372|NCT00805935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851373|NCT00805935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851374|NCT00805935|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92851375|NCT00805935|Fertility Agents|fertility agents|mesh-ancestor
92851376|NCT00805935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92851377|NCT00805935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92851378|NCT00805935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851379|NCT00878917|Dorzolamide|dorzolamide|mesh-list
92851380|NCT00878917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92851381|NCT00878917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92851382|NCT00878917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92851383|NCT00878917|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92851384|NCT00878917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851385|NCT00878917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851386|NCT00638118|Fexofenadine|fexofenadine|mesh-list
92851387|NCT00638118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92851388|NCT00638118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92851389|NCT00638118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92851390|NCT00638118|Histamine Antagonists|histamine antagonists|mesh-ancestor
92851391|NCT00638118|Histamine Agents|histamine agents|mesh-ancestor
92851392|NCT00638118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851393|NCT00638118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851394|NCT00638118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851395|NCT00805545|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92851396|NCT00805545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92851397|NCT00805545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851398|NCT00805545|Antitubercular Agents|antitubercular agents|mesh-ancestor
92851399|NCT00590031|Irinotecan|irinotecan|mesh-list
92851400|NCT00590031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851401|NCT00590031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92851402|NCT00590031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851403|NCT00590031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851404|NCT00590031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851405|NCT02783196|Liraglutide|liraglutide|mesh-list
92851406|NCT02783196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92851407|NCT02783196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851408|NCT02783196|Incretins|incretins|mesh-ancestor
92851409|NCT02783196|Hormones|hormones|mesh-ancestor
92496500|NCT01990872|Vitamin D|vitamin d|mesh-list
92851410|NCT02783196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851412|NCT05188170|Anticestodal Agents|anticestodal agents|mesh-ancestor
92851413|NCT05188170|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92851414|NCT05188170|Anthelmintics|anthelmintics|mesh-ancestor
92851415|NCT05188170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92851416|NCT05188170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851417|NCT05188170|Antinematodal Agents|antinematodal agents|mesh-ancestor
92851418|NCT02782338|Diclofenac|diclofenac|mesh-list
92851419|NCT02782338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92851420|NCT02782338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92851421|NCT02782338|Analgesics|analgesics|mesh-ancestor
92851422|NCT02782338|Sensory System Agents|sensory system agents|mesh-ancestor
92851423|NCT02782338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851424|NCT02782338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851425|NCT02782338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851426|NCT02782338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851427|NCT02782338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92851428|NCT02782338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851429|NCT02782338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851430|NCT02782260|Dipyridamole|dipyridamole|mesh-list
92851431|NCT02782260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92851432|NCT02782260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851433|NCT02782260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851434|NCT02782260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92851435|NCT02782260|Vasodilator Agents|vasodilator agents|mesh-ancestor
92851436|NCT05031936|Ropivacaine|ropivacaine|mesh-list
92851437|NCT05031936|Anesthetics, Local|anesthetics, local|mesh-ancestor
92851438|NCT05031936|Anesthetics|anesthetics|mesh-ancestor
92851439|NCT05031936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851440|NCT05031936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851441|NCT05031936|Sensory System Agents|sensory system agents|mesh-ancestor
92851442|NCT05031936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851443|NCT03577704|Paclitaxel|paclitaxel|mesh-list
92851444|NCT03577704|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92851445|NCT03577704|Cisplatin|cisplatin|mesh-list
92851446|NCT03577704|Carboplatin|carboplatin|mesh-list
92851447|NCT03577704|Gemcitabine|gemcitabine|mesh-list
92851448|NCT03577704|Oxaliplatin|oxaliplatin|mesh-list
92851449|NCT03577704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92851450|NCT03577704|Antibodies|antibodies|mesh-list
92851451|NCT03577704|Immunoglobulins|immunoglobulins|mesh-list
92851452|NCT03577704|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92851453|NCT03577704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851454|NCT03577704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851455|NCT03577704|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851456|NCT03577704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851457|NCT03577704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851458|NCT03577704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851459|NCT03577704|Immunologic Factors|immunologic factors|mesh-ancestor
92851460|NCT03577704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851461|NCT03577704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851462|NCT03577704|Antimetabolites|antimetabolites|mesh-ancestor
92851463|NCT05176626|Phentermine|phentermine|mesh-list
92851464|NCT05176626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92851465|NCT05176626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851466|NCT05176626|Appetite Depressants|appetite depressants|mesh-ancestor
92851467|NCT05176626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92851468|NCT05176626|Sympathomimetics|sympathomimetics|mesh-ancestor
92851469|NCT05176626|Autonomic Agents|autonomic agents|mesh-ancestor
92851470|NCT05176626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851471|NCT05176626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92851472|NCT05176626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851473|NCT05176626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851474|NCT05030766|Nicotine|nicotine|mesh-list
92851475|NCT05030766|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92851476|NCT05030766|Autonomic Agents|autonomic agents|mesh-ancestor
92851477|NCT05030766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851478|NCT05030766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851479|NCT05030766|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92851480|NCT05030766|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92851481|NCT05030766|Cholinergic Agents|cholinergic agents|mesh-ancestor
92851482|NCT05030766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851483|NCT05030766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851484|NCT00615199|Tofacitinib|tofacitinib|mesh-list
92851485|NCT00615199|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92851486|NCT00615199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92851487|NCT00615199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851488|NCT00615199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851489|NCT05328024|Immunomodulating Agents|immunomodulating agents|mesh-list
92851490|NCT05328024|Immunologic Factors|immunologic factors|mesh-ancestor
92851491|NCT05328024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851492|NCT00879073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92851493|NCT00879073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851494|NCT00879073|Alkylating Agents|alkylating agents|mesh-ancestor
92851495|NCT00879073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851496|NCT00879073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851498|NCT00880867|Interferon Inducers|interferon inducers|mesh-ancestor
92851499|NCT00880867|Immunologic Factors|immunologic factors|mesh-ancestor
92851500|NCT00880867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851501|NCT04228926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92851502|NCT04228926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92851503|NCT02782182|Leucovorin|leucovorin|mesh-list
92851504|NCT02782182|Oxaliplatin|oxaliplatin|mesh-list
92851505|NCT02782182|Irinotecan|irinotecan|mesh-list
92851506|NCT02782182|Folfirinox|folfirinox|mesh-list
92851507|NCT02782182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851508|NCT02782182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92851509|NCT02782182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851510|NCT02782182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753183|NCT05473715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92851511|NCT02782182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851512|NCT02782182|Antidotes|antidotes|mesh-ancestor
92851513|NCT02782182|Protective Agents|protective agents|mesh-ancestor
92851514|NCT02782182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851515|NCT02782182|Vitamin B Complex|vitamin b complex|mesh-ancestor
92851516|NCT02782182|Vitamins|vitamins|mesh-ancestor
92851517|NCT02782182|Micronutrients|micronutrients|mesh-ancestor
92851518|NCT02780778|Docetaxel|docetaxel|mesh-list
92851519|NCT02780778|Apatinib|apatinib|mesh-list
92851520|NCT02780778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851521|NCT02780778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851522|NCT02780778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851523|NCT02780778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851524|NCT02780778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851525|NCT02780778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92851526|NCT02780778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851527|NCT00881101|Paclitaxel|paclitaxel|mesh-list
92851528|NCT00881101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851529|NCT00881101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851530|NCT00881101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851531|NCT00881101|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851532|NCT00881101|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851533|NCT00881101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851534|NCT00883909|Dutasteride|dutasteride|mesh-list
92851535|NCT00883909|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92851536|NCT00883909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92851537|NCT00883909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851538|NCT00883909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851539|NCT00883909|Hormone Antagonists|hormone antagonists|mesh-ancestor
92851540|NCT00883909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851541|NCT00883909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851542|NCT00634686|Vitamin D|vitamin d|mesh-list
92851543|NCT00634686|Calcium|calcium|mesh-list
92851544|NCT00634686|Vitamins|vitamins|mesh-ancestor
92851545|NCT00634686|Micronutrients|micronutrients|mesh-ancestor
92851546|NCT00634686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851547|NCT00634686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92851548|NCT00634686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92851549|NCT05340192|Octreotide|octreotide|mesh-list
92851550|NCT05340192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851551|NCT05340192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92851552|NCT05340192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851553|NCT03955861|Adalimumab|adalimumab|mesh-list
92851554|NCT03955861|Golimumab|golimumab|mesh-list
92851555|NCT03955861|Certolizumab Pegol|certolizumab pegol|mesh-list
92851556|NCT03955861|Etanercept|etanercept|mesh-list
92851557|NCT03955861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92851558|NCT03955861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851559|NCT03955861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851560|NCT03955861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92851561|NCT03955861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92851563|NCT03955861|Sensory System Agents|sensory system agents|mesh-ancestor
92851564|NCT03955861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851565|NCT03955861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851566|NCT03955861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851567|NCT03955861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851568|NCT03955861|Immunologic Factors|immunologic factors|mesh-ancestor
92851570|NCT00881179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851571|NCT00881179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851572|NCT00881179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92851573|NCT00881179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851574|NCT00881179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851575|NCT00881179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92851576|NCT00881179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92851577|NCT02781246|Dexmedetomidine|dexmedetomidine|mesh-list
92851578|NCT02781246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851579|NCT02781246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851580|NCT02781246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851581|NCT02781246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92851582|NCT02781246|Analgesics|analgesics|mesh-ancestor
92851583|NCT02781246|Sensory System Agents|sensory system agents|mesh-ancestor
92753257|NCT05330130|Hormones|hormones|mesh-ancestor
92851584|NCT02781246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851585|NCT02781246|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92851586|NCT02781246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92851587|NCT02781246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92851588|NCT02781246|Adrenergic Agents|adrenergic agents|mesh-ancestor
92851589|NCT02781246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851590|NCT02781246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851591|NCT00613951|Insulin|insulin|mesh-list
92851592|NCT00613951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92851593|NCT00613951|Metformin|metformin|mesh-list
92851594|NCT00613951|Insulin Aspart|insulin aspart|mesh-list
92851595|NCT00613951|Insulin, Long-Acting|insulin, long-acting|mesh-list
92851596|NCT00613951|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92851597|NCT00613951|Biphasic Insulins|biphasic insulins|mesh-list
92851598|NCT00613951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92851599|NCT00613951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851600|NCT00881413|Esomeprazole|esomeprazole|mesh-list
92851601|NCT00881413|Pantoprazole|pantoprazole|mesh-list
92851602|NCT00881413|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92851603|NCT00881413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851604|NCT00881413|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92851605|NCT00881413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851606|NCT00881413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851607|NCT00881491|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92851608|NCT00881491|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92851609|NCT00881491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851610|NCT00881491|Antitubercular Agents|antitubercular agents|mesh-ancestor
92851611|NCT00958841|Pasireotide|pasireotide|mesh-list
92851612|NCT00958841|Hormones|hormones|mesh-ancestor
92851613|NCT00958841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851614|NCT00958841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851615|NCT02937116|Cisplatin|cisplatin|mesh-list
92851616|NCT02937116|Gemcitabine|gemcitabine|mesh-list
92851617|NCT02937116|Capecitabine|capecitabine|mesh-list
92851618|NCT02937116|Oxaliplatin|oxaliplatin|mesh-list
92851619|NCT02937116|Irinotecan|irinotecan|mesh-list
92851620|NCT02937116|Etoposide|etoposide|mesh-list
92851621|NCT02937116|Pemetrexed|pemetrexed|mesh-list
92851622|NCT02937116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851623|NCT02937116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851624|NCT02937116|Antimetabolites|antimetabolites|mesh-ancestor
92851625|NCT02937116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851626|NCT02937116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92851627|NCT02937116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851628|NCT02937116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851629|NCT02937116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92851630|NCT02937116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851631|NCT02937116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92851632|NCT02937116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92851633|NCT03927105|Nivolumab|nivolumab|mesh-list
92851634|NCT03927105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496728|NCT01992588|Insulin Aspart|insulin aspart|mesh-list
92851635|NCT03927105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196866|NCT03152474|Vitamins|vitamins|mesh-ancestor
92851636|NCT03927105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92851637|NCT03927105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851638|NCT00613327|Oxybutynin|oxybutynin|mesh-list
92851639|NCT00613327|Parasympatholytics|parasympatholytics|mesh-ancestor
92851640|NCT00613327|Autonomic Agents|autonomic agents|mesh-ancestor
92851641|NCT00613327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851642|NCT00613327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851643|NCT00613327|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92851644|NCT00613327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92851645|NCT00613327|Cholinergic Agents|cholinergic agents|mesh-ancestor
92851646|NCT00613327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851647|NCT00613327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851648|NCT00613327|Urological Agents|urological agents|mesh-ancestor
92851649|NCT04273997|Metronidazole|metronidazole|mesh-list
92851650|NCT04273997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851651|NCT04273997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851652|NCT04273997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92851653|NCT04273997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92851654|NCT05339802|Linezolid|linezolid|mesh-list
92851655|NCT05339802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851656|NCT05339802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851657|NCT05339802|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92851658|NCT05339802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851659|NCT05339802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851660|NCT04649203|Riboflavin|riboflavin|mesh-list
92851661|NCT04649203|Niacinamide|niacinamide|mesh-list
92851662|NCT04649203|Niacin|niacin|mesh-list
92851663|NCT04649203|Nicotinic Acids|nicotinic acids|mesh-list
92851664|NCT04649203|Vitamin B Complex|vitamin b complex|mesh-ancestor
92851665|NCT04649203|Vitamins|vitamins|mesh-ancestor
92851666|NCT04649203|Micronutrients|micronutrients|mesh-ancestor
92851667|NCT04649203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851668|NCT04649203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92851669|NCT04649203|Dermatologic Agents|dermatologic agents|mesh-ancestor
92851670|NCT04649203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92851671|NCT04649203|Antimetabolites|antimetabolites|mesh-ancestor
92851672|NCT04649203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851673|NCT04649203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92851674|NCT04649203|Vasodilator Agents|vasodilator agents|mesh-ancestor
92851675|NCT00881725|Metformin|metformin|mesh-list
92851676|NCT00881725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92851677|NCT00881725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851678|NCT05086224|Lidocaine|lidocaine|mesh-list
92851679|NCT05086224|Anesthetics, Local|anesthetics, local|mesh-list
92851680|NCT05086224|Anesthetics|anesthetics|mesh-list
92851681|NCT05086224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851682|NCT05086224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851683|NCT05086224|Sensory System Agents|sensory system agents|mesh-ancestor
92851684|NCT05086224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851685|NCT05086224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92851686|NCT05086224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92851687|NCT05086224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92851688|NCT05086224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92851689|NCT05086224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851690|NCT00954941|Ondansetron|ondansetron|mesh-list
92851691|NCT00954941|Aprepitant|aprepitant|mesh-list
92851692|NCT00954941|Antiemetics|antiemetics|mesh-ancestor
92851693|NCT00954941|Autonomic Agents|autonomic agents|mesh-ancestor
92851694|NCT00954941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851695|NCT00954941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851696|NCT00954941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851697|NCT00954941|Antipruritics|antipruritics|mesh-ancestor
92851698|NCT00954941|Dermatologic Agents|dermatologic agents|mesh-ancestor
92851699|NCT00954941|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92851700|NCT00954941|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92851701|NCT00954941|Serotonin Agents|serotonin agents|mesh-ancestor
92851702|NCT00954941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851703|NCT00954941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851704|NCT00954941|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92851705|NCT05339646|Ritonavir|ritonavir|mesh-list
92851706|NCT05339646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92851707|NCT05339646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92851708|NCT05339646|Protease Inhibitors|protease inhibitors|mesh-ancestor
92851709|NCT05339646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851710|NCT05339646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851712|NCT05339646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92851713|NCT05339646|Antiviral Agents|antiviral agents|mesh-ancestor
92851714|NCT05339646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851715|NCT05339646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92851716|NCT05339646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92851717|NCT00630695|Lanreotide|lanreotide|mesh-list
92851718|NCT00630695|Somatostatin|somatostatin|mesh-list
92851719|NCT00630695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851720|NCT00630695|Hormones|hormones|mesh-ancestor
92851721|NCT00630695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851722|NCT00630695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851723|NCT02843438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92851724|NCT00954707|Aspirin|aspirin|mesh-list
92851725|NCT00954707|Clopidogrel|clopidogrel|mesh-list
92851726|NCT00954707|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92851727|NCT00954707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92851728|NCT00954707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92851729|NCT00954707|Analgesics|analgesics|mesh-ancestor
92851730|NCT00954707|Sensory System Agents|sensory system agents|mesh-ancestor
92851731|NCT00954707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851732|NCT00954707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851733|NCT00954707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92851734|NCT00954707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851735|NCT00954707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92851736|NCT00954707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92851737|NCT00954707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851738|NCT00954707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92851739|NCT00954707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92851740|NCT00954707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851741|NCT00954707|Antipyretics|antipyretics|mesh-ancestor
92851742|NCT00954707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92851743|NCT00954707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92851744|NCT00954707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92851745|NCT00954707|Purinergic Agents|purinergic agents|mesh-ancestor
92851746|NCT00954707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851747|NCT00630851|Donepezil|donepezil|mesh-list
92851748|NCT00630851|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92851749|NCT00630851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851750|NCT00630851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851751|NCT00630851|Cholinergic Agents|cholinergic agents|mesh-ancestor
92851752|NCT00630851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851753|NCT00630851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851754|NCT00630851|Nootropic Agents|nootropic agents|mesh-ancestor
92851755|NCT00613171|Imatinib Mesylate|imatinib mesylate|mesh-list
92851756|NCT00613171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851757|NCT00613171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92851758|NCT00613171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851759|NCT00613171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851760|NCT05156892|Tamoxifen|tamoxifen|mesh-list
92851761|NCT05156892|Itraconazole|itraconazole|mesh-list
92851762|NCT05156892|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92851763|NCT05156892|Hormone Antagonists|hormone antagonists|mesh-ancestor
92851764|NCT05156892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92851765|NCT05156892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851766|NCT05156892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92851767|NCT05156892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851768|NCT05156892|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92851769|NCT05156892|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92851770|NCT05156892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92851771|NCT05156892|Antifungal Agents|antifungal agents|mesh-ancestor
92851772|NCT05156892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851773|NCT05156892|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92851774|NCT05156892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92851775|NCT05156892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851776|NCT05156892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851777|NCT05156892|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92851778|NCT05156892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92851779|NCT03894345|Prazosin|prazosin|mesh-list
92851780|NCT03894345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92851781|NCT03894345|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92851782|NCT03894345|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92851783|NCT03894345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92851784|NCT03894345|Adrenergic Agents|adrenergic agents|mesh-ancestor
92851785|NCT03894345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851786|NCT03894345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851787|NCT03894345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851788|NCT02859077|Carboplatin|carboplatin|mesh-list
92851789|NCT02859077|Gemcitabine|gemcitabine|mesh-list
92851790|NCT02859077|Pemetrexed|pemetrexed|mesh-list
92851791|NCT02859077|Gefitinib|gefitinib|mesh-list
92851792|NCT02859077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851793|NCT02859077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851794|NCT02859077|Antimetabolites|antimetabolites|mesh-ancestor
92851795|NCT02859077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851796|NCT02859077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851797|NCT02859077|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92851798|NCT02859077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92851799|NCT02859077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92851800|NCT00879307|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92851801|NCT00879307|Antidepressive Agents|antidepressive agents|mesh-ancestor
92851802|NCT00879307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92851803|NCT00879307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92851804|NCT00879307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92851805|NCT00879307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851806|NCT00879307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851807|NCT03851835|Ondansetron|ondansetron|mesh-list
92851808|NCT03851835|Antiemetics|antiemetics|mesh-ancestor
92851809|NCT03851835|Autonomic Agents|autonomic agents|mesh-ancestor
92851810|NCT03851835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851811|NCT03851835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851812|NCT03851835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92851813|NCT03851835|Antipruritics|antipruritics|mesh-ancestor
92851814|NCT03851835|Dermatologic Agents|dermatologic agents|mesh-ancestor
92851815|NCT03851835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92851816|NCT03851835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92851817|NCT03851835|Serotonin Agents|serotonin agents|mesh-ancestor
92851818|NCT03851835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851819|NCT03851835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851820|NCT00879385|Decitabine|decitabine|mesh-list
92851821|NCT00879385|Panitumumab|panitumumab|mesh-list
92851822|NCT00879385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92851823|NCT00879385|Antimetabolites|antimetabolites|mesh-ancestor
92851824|NCT00879385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851825|NCT00879385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851826|NCT00879385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851827|NCT00879385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92851828|NCT00914121|Moxifloxacin|moxifloxacin|mesh-list
92851829|NCT00914121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92851830|NCT00914121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851831|NCT00914121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851832|NCT00914121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851833|NCT00914121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851834|NCT00914121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851835|NCT00914121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851836|NCT00953225|Vitamin D|vitamin d|mesh-list
92851837|NCT00953225|Cholecalciferol|cholecalciferol|mesh-list
92851838|NCT00953225|Vitamins|vitamins|mesh-ancestor
92851839|NCT00953225|Micronutrients|micronutrients|mesh-ancestor
92851840|NCT00953225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851841|NCT00953225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92851842|NCT00953225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92851843|NCT03819231|Oxytocin|oxytocin|mesh-list
92851844|NCT03819231|Oxytocics|oxytocics|mesh-ancestor
92851845|NCT03819231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92851846|NCT03819231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851847|NCT00613015|Guanfacine|guanfacine|mesh-list
92851848|NCT00613015|Modafinil|modafinil|mesh-list
92851849|NCT00613015|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92851850|NCT00613015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851851|NCT00613015|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92851852|NCT00613015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92851853|NCT00613015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92851854|NCT00613015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851855|NCT00613015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92851856|NCT00613015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92496958|NCT01994668|Lorazepam|lorazepam|mesh-list
92851857|NCT00613015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92851858|NCT00613015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92851859|NCT00613015|Adrenergic Agents|adrenergic agents|mesh-ancestor
92851860|NCT00613015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851862|NCT02779608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851863|NCT02779608|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851864|NCT02779608|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851865|NCT02779608|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851866|NCT02779608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851868|NCT02543671|Cholecalciferol|cholecalciferol|mesh-list
92851869|NCT02543671|Vitamins|vitamins|mesh-ancestor
92851870|NCT02543671|Micronutrients|micronutrients|mesh-ancestor
92851871|NCT02543671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851872|NCT02543671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92851873|NCT02543671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92851874|NCT02838992|Cyclosporine|cyclosporine|mesh-list
92851875|NCT02838992|Cyclophosphamide|cyclophosphamide|mesh-list
92851876|NCT02838992|Cyclosporins|cyclosporins|mesh-list
92851877|NCT02838992|Thymoglobulin|thymoglobulin|mesh-list
92851878|NCT02838992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851879|NCT02838992|Immunologic Factors|immunologic factors|mesh-ancestor
92851880|NCT02838992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851881|NCT02838992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851882|NCT02838992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851883|NCT02838992|Alkylating Agents|alkylating agents|mesh-ancestor
92851884|NCT02838992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851885|NCT02838992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851886|NCT02838992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92851887|NCT02838992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851888|NCT02838992|Antifungal Agents|antifungal agents|mesh-ancestor
92851889|NCT02838992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851890|NCT02838992|Dermatologic Agents|dermatologic agents|mesh-ancestor
92851891|NCT02838992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92851892|NCT00879541|Factor VIII|factor viii|mesh-list
92851893|NCT00879541|Coagulants|coagulants|mesh-ancestor
92851894|NCT00884299|Antioxidants|antioxidants|mesh-list
92851895|NCT00884299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851896|NCT00884299|Protective Agents|protective agents|mesh-ancestor
92851897|NCT00884299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851898|NCT02843126|Trastuzumab|trastuzumab|mesh-list
92851899|NCT02843126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92851900|NCT02843126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851901|NCT04201652|Anesthetics|anesthetics|mesh-list
92851902|NCT04201652|Anesthetics, Local|anesthetics, local|mesh-list
92851903|NCT04201652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851904|NCT04201652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851905|NCT04201652|Sensory System Agents|sensory system agents|mesh-ancestor
92851906|NCT04201652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851907|NCT05338476|Midazolam|midazolam|mesh-list
92851908|NCT05338476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92851909|NCT05338476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851910|NCT05338476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851911|NCT05338476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851912|NCT05338476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92851913|NCT05338476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92851914|NCT05338476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92851915|NCT05338476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92851916|NCT05338476|Anesthetics, General|anesthetics, general|mesh-ancestor
92851917|NCT05338476|Anesthetics|anesthetics|mesh-ancestor
92851918|NCT05338476|GABA Modulators|gaba modulators|mesh-ancestor
92851919|NCT05338476|GABA Agents|gaba agents|mesh-ancestor
92851920|NCT05338476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851921|NCT05338476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851922|NCT02838758|Lidocaine|lidocaine|mesh-list
92851923|NCT02838758|Anesthetics, Local|anesthetics, local|mesh-ancestor
92851924|NCT02838758|Anesthetics|anesthetics|mesh-ancestor
92851925|NCT02838758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851926|NCT02838758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851927|NCT02838758|Sensory System Agents|sensory system agents|mesh-ancestor
92851928|NCT02838758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851929|NCT02838758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92851930|NCT02838758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92851931|NCT02838758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92497031|NCT01995006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851932|NCT02838758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92851933|NCT02838758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851934|NCT00803595|Oseltamivir|oseltamivir|mesh-list
92851935|NCT00803595|Antiviral Agents|antiviral agents|mesh-ancestor
92753614|NCT04854499|Magrolimab|magrolimab|mesh-list
92851936|NCT00803595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851937|NCT00803595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851938|NCT00803595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851939|NCT02843204|Pembrolizumab|pembrolizumab|mesh-list
92851940|NCT02843204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92851941|NCT02843204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851942|NCT02843204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92851943|NCT02843204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851944|NCT02606565|Chlorhexidine|chlorhexidine|mesh-list
92851945|NCT02606565|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92851946|NCT02606565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92851947|NCT02606565|Disinfectants|disinfectants|mesh-ancestor
92851948|NCT04227990|Cyclophosphamide|cyclophosphamide|mesh-list
92851949|NCT04227990|Docetaxel|docetaxel|mesh-list
92851950|NCT04227990|Doxorubicin|doxorubicin|mesh-list
92851951|NCT04227990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92851952|NCT04227990|Immunologic Factors|immunologic factors|mesh-ancestor
92851953|NCT04227990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851954|NCT04227990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92851955|NCT04227990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92851956|NCT04227990|Alkylating Agents|alkylating agents|mesh-ancestor
92851957|NCT04227990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851958|NCT04227990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92851959|NCT04227990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92851960|NCT04227990|Tubulin Modulators|tubulin modulators|mesh-ancestor
92851961|NCT04227990|Antimitotic Agents|antimitotic agents|mesh-ancestor
92851962|NCT04227990|Mitosis Modulators|mitosis modulators|mesh-ancestor
92851963|NCT04227990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92851964|NCT04227990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92851965|NCT04227990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92851966|NCT04227990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92851967|NCT02606409|Dexmedetomidine|dexmedetomidine|mesh-list
92851968|NCT02606409|Propofol|propofol|mesh-list
92851969|NCT02606409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851970|NCT02606409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851971|NCT02606409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851972|NCT02606409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92851973|NCT02606409|Analgesics|analgesics|mesh-ancestor
92851974|NCT02606409|Sensory System Agents|sensory system agents|mesh-ancestor
92851975|NCT02606409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92851976|NCT02606409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92851977|NCT02606409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92851978|NCT02606409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92851979|NCT02606409|Adrenergic Agents|adrenergic agents|mesh-ancestor
92851980|NCT02606409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851981|NCT02606409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851982|NCT02606409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92851983|NCT02606409|Anesthetics, General|anesthetics, general|mesh-ancestor
92851984|NCT02606409|Anesthetics|anesthetics|mesh-ancestor
92851985|NCT00611767|Thiopental|thiopental|mesh-list
92851986|NCT00611767|Anticonvulsants|anticonvulsants|mesh-ancestor
92851987|NCT00611767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92851988|NCT00611767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92851989|NCT00611767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92851990|NCT00611767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92851991|NCT00611767|Anesthetics, General|anesthetics, general|mesh-ancestor
92851992|NCT00611767|Anesthetics|anesthetics|mesh-ancestor
92851993|NCT00611767|GABA Modulators|gaba modulators|mesh-ancestor
92851994|NCT00611767|GABA Agents|gaba agents|mesh-ancestor
92851995|NCT00611767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92851996|NCT00611767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92851997|NCT04967508|Ustekinumab|ustekinumab|mesh-list
92851998|NCT04967508|Dermatologic Agents|dermatologic agents|mesh-ancestor
92851999|NCT00803361|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92852000|NCT00803361|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92852001|NCT00803361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92852002|NCT00803361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852003|NCT00803361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852004|NCT00803361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497105|NCT01995331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852005|NCT00803361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852007|NCT00803361|Sensory System Agents|sensory system agents|mesh-ancestor
92852008|NCT00803361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852009|NCT00803361|Antidepressive Agents|antidepressive agents|mesh-ancestor
92852010|NCT00803361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92852012|NCT02837198|Dotinurad|dotinurad|mesh-list
92852013|NCT02837198|FYX-051|fyx-051|mesh-list
92852014|NCT02837198|Uricosuric Agents|uricosuric agents|mesh-ancestor
92852015|NCT02837198|Gout Suppressants|gout suppressants|mesh-ancestor
92852016|NCT02837198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852017|NCT02837198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852018|NCT02837198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852019|NCT00611533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92852020|NCT00611533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92852021|NCT00611533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92852022|NCT00611533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852023|NCT00611533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852024|NCT00611533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92852025|NCT00611533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852026|NCT00611533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852027|NCT04038307|Acetaminophen|acetaminophen|mesh-list
92852028|NCT04038307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852029|NCT04038307|Analgesics|analgesics|mesh-ancestor
92852030|NCT04038307|Sensory System Agents|sensory system agents|mesh-ancestor
92852031|NCT04038307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852032|NCT04038307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852033|NCT04038307|Antipyretics|antipyretics|mesh-ancestor
92852034|NCT00884533|Moxifloxacin|moxifloxacin|mesh-list
92852035|NCT00884533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92852036|NCT00884533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852037|NCT00884533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92852038|NCT00884533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92852039|NCT00884533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852040|NCT00884533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852041|NCT00884533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852042|NCT02842814|Hydroxychloroquine|hydroxychloroquine|mesh-list
92852043|NCT02842814|Glucocorticoids|glucocorticoids|mesh-list
92852044|NCT02842814|Antimalarials|antimalarials|mesh-ancestor
92852045|NCT02842814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92852046|NCT02842814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92852047|NCT02842814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852048|NCT02842814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852049|NCT02842814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852050|NCT02842814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852051|NCT02842814|Hormones|hormones|mesh-ancestor
92852052|NCT02842814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852053|NCT02842814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852054|NCT00882193|Ribavirin|ribavirin|mesh-list
92852055|NCT00882193|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92852056|NCT00882193|Betaine|betaine|mesh-list
92852057|NCT00882193|Antimetabolites|antimetabolites|mesh-ancestor
92852058|NCT00882193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852059|NCT00882193|Antiviral Agents|antiviral agents|mesh-ancestor
92852060|NCT00882193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852061|NCT00882193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852062|NCT00882193|Lipotropic Agents|lipotropic agents|mesh-ancestor
92852063|NCT00882193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92852064|NCT00882193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92852065|NCT02778360|Methylphenidate|methylphenidate|mesh-list
92852066|NCT02778360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92852067|NCT02778360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852068|NCT02778360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92852069|NCT02778360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92852070|NCT02778360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852071|NCT02778360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852072|NCT02778360|Dopamine Agents|dopamine agents|mesh-ancestor
92852073|NCT02778360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852074|NCT00953147|Ciclesonide|ciclesonide|mesh-list
92852075|NCT00953147|Glucocorticoids|glucocorticoids|mesh-ancestor
92852076|NCT00953147|Hormones|hormones|mesh-ancestor
92852077|NCT00953147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197329|NCT00557193|Prednisolone|prednisolone|mesh-list
92852078|NCT00953147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852079|NCT00953147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92852081|NCT05333744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852082|NCT05333744|Glucocorticoids|glucocorticoids|mesh-ancestor
92852083|NCT05333744|Hormones|hormones|mesh-ancestor
92852084|NCT05333744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852085|NCT05333744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852086|NCT05333744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852087|NCT05333744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852088|NCT04250246|Nivolumab|nivolumab|mesh-list
92852089|NCT04250246|Ipilimumab|ipilimumab|mesh-list
92852090|NCT04250246|Guadecitabine|guadecitabine|mesh-list
92852091|NCT04250246|Azacitidine|azacitidine|mesh-list
92852092|NCT04250246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852093|NCT04250246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852094|NCT04250246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92852095|NCT04250246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852096|NCT04250246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852097|NCT04250246|Antimetabolites|antimetabolites|mesh-ancestor
92852098|NCT04250246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852099|NCT04273529|Thalidomide|thalidomide|mesh-list
92852100|NCT04273529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852101|NCT04273529|Immunologic Factors|immunologic factors|mesh-ancestor
92852102|NCT04273529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852103|NCT04273529|Leprostatic Agents|leprostatic agents|mesh-ancestor
92852104|NCT04273529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92852105|NCT04273529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852106|NCT04273529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92852107|NCT04273529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92852108|NCT04273529|Growth Substances|growth substances|mesh-ancestor
92852109|NCT04273529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92852110|NCT04273529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852111|NCT02858843|Ivacaftor|ivacaftor|mesh-list
92852112|NCT02858843|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92852113|NCT02858843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852114|NCT02858843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852115|NCT02779530|Diclofenac|diclofenac|mesh-list
92852116|NCT02779530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852117|NCT02779530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852118|NCT02779530|Analgesics|analgesics|mesh-ancestor
92852119|NCT02779530|Sensory System Agents|sensory system agents|mesh-ancestor
92852120|NCT02779530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852121|NCT02779530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852122|NCT02779530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852123|NCT02779530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852124|NCT02779530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92852125|NCT02779530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852126|NCT02779530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852127|NCT00952523|Adapalene|adapalene|mesh-list
92852128|NCT00952523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92852129|NCT00952523|Tretinoin|tretinoin|mesh-list
92852130|NCT00952523|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92852131|NCT00952523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92852132|NCT00952523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852133|NCT00952523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852134|NCT00952523|Analgesics|analgesics|mesh-ancestor
92852135|NCT00952523|Sensory System Agents|sensory system agents|mesh-ancestor
92852136|NCT00952523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852137|NCT00952523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852138|NCT00952523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852139|NCT00952523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852140|NCT00952523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852141|NCT00952523|Keratolytic Agents|keratolytic agents|mesh-ancestor
92852142|NCT04249154|Leuprolide|leuprolide|mesh-list
92852143|NCT04249154|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92852144|NCT04249154|Fertility Agents|fertility agents|mesh-ancestor
92852145|NCT04249154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92852146|NCT04249154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852147|NCT04249154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852148|NCT04249154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852149|NCT02857361|Ketamine|ketamine|mesh-list
92852150|NCT02857361|Analgesics|analgesics|mesh-ancestor
92852151|NCT02857361|Sensory System Agents|sensory system agents|mesh-ancestor
92852152|NCT02857361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852153|NCT02857361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852154|NCT02857361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92852156|NCT02857361|Anesthetics, General|anesthetics, general|mesh-ancestor
92852157|NCT02857361|Anesthetics|anesthetics|mesh-ancestor
92852158|NCT02857361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852159|NCT02857361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92852160|NCT02857361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92852161|NCT02857361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852162|NCT02857361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852163|NCT02778126|Prexasertib|prexasertib|mesh-list
92852164|NCT02778126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852165|NCT02778126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852166|NCT02778126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852167|NCT05050500|Dapagliflozin|dapagliflozin|mesh-list
92852168|NCT05050500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92852169|NCT05050500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852170|NCT05050500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92852171|NCT05050500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852172|NCT02232737|Nicotine|nicotine|mesh-list
92852173|NCT02232737|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92852174|NCT02232737|Autonomic Agents|autonomic agents|mesh-ancestor
92852175|NCT02232737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852176|NCT02232737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852177|NCT02232737|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92852178|NCT02232737|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92852179|NCT02232737|Cholinergic Agents|cholinergic agents|mesh-ancestor
92852180|NCT02232737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852181|NCT02232737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852182|NCT04272359|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92852183|NCT04272359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852184|NCT02777814|Entecavir|entecavir|mesh-list
92852185|NCT02777814|Antiviral Agents|antiviral agents|mesh-ancestor
92852186|NCT02777814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852187|NCT04430192|177Lu-PSMA-617|177lu-psma-617|mesh-list
92852188|NCT04430192|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92852189|NCT04430192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852190|NCT02778906|Abatacept|abatacept|mesh-list
92852191|NCT02778906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92852192|NCT02778906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852193|NCT02778906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852194|NCT02778906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852195|NCT02778906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852196|NCT02778906|Immunologic Factors|immunologic factors|mesh-ancestor
92852197|NCT02778906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852198|NCT02778906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852199|NCT00630929|Ibuprofen|ibuprofen|mesh-list
92852200|NCT00630929|Celecoxib|celecoxib|mesh-list
92852201|NCT00630929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852202|NCT00630929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852203|NCT00630929|Analgesics|analgesics|mesh-ancestor
92753893|NCT04002115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852204|NCT00630929|Sensory System Agents|sensory system agents|mesh-ancestor
92852205|NCT00630929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852206|NCT00630929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852207|NCT00630929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852208|NCT00630929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852209|NCT00630929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92852210|NCT00630929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852211|NCT00630929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852212|NCT00630929|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92852213|NCT04204928|Pralsetinib|pralsetinib|mesh-list
92852214|NCT04204928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852215|NCT02834546|Sorafenib|sorafenib|mesh-list
92852216|NCT02834546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852217|NCT02834546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852218|NCT02834546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852219|NCT02834546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852220|NCT00948857|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92852221|NCT00948857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92852222|NCT00948857|Immunologic Factors|immunologic factors|mesh-ancestor
92852223|NCT00948857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852224|NCT04227912|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92852225|NCT04227912|Anesthetics|anesthetics|mesh-list
92852226|NCT04227912|Anesthetics, Local|anesthetics, local|mesh-list
92852227|NCT04227912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852228|NCT04227912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852229|NCT04227912|Sensory System Agents|sensory system agents|mesh-ancestor
92852230|NCT04227912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852231|NCT04227912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852232|NCT04227912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852234|NCT04227912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852235|NCT04227912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852237|NCT02854787|Oxymetazoline|oxymetazoline|mesh-list
92852238|NCT02854787|Norepinephrine|norepinephrine|mesh-list
92852239|NCT02854787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92852240|NCT02854787|Mydriatics|mydriatics|mesh-ancestor
92852241|NCT02854787|Autonomic Agents|autonomic agents|mesh-ancestor
92852242|NCT02854787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852243|NCT02854787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852244|NCT02854787|Sympathomimetics|sympathomimetics|mesh-ancestor
92852245|NCT02854787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92852246|NCT02854787|Nasal Decongestants|nasal decongestants|mesh-ancestor
92852247|NCT02854787|Respiratory System Agents|respiratory system agents|mesh-ancestor
92852248|NCT02854787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92852249|NCT02854787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92852250|NCT02854787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92852251|NCT02854787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92852252|NCT02854787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852253|NCT02854787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852254|NCT02854787|Protective Agents|protective agents|mesh-ancestor
92852255|NCT02778828|Linezolid|linezolid|mesh-list
92852256|NCT02778828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92852257|NCT02778828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852258|NCT02778828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92852259|NCT02778828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852260|NCT02778828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852261|NCT02777736|Methotrexate|methotrexate|mesh-list
92852262|NCT02777736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92852263|NCT02777736|Abortifacient Agents|abortifacient agents|mesh-ancestor
92852264|NCT02777736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92852265|NCT02777736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852266|NCT02777736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852267|NCT02777736|Antimetabolites|antimetabolites|mesh-ancestor
92852268|NCT02777736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852269|NCT02777736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852270|NCT02777736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92852271|NCT02777736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852272|NCT02777736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92852273|NCT02777736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852274|NCT02777736|Immunologic Factors|immunologic factors|mesh-ancestor
92852275|NCT02777736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852276|NCT02777736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92852277|NCT02836184|Niacin|niacin|mesh-list
92852278|NCT02836184|Nicotinic Acids|nicotinic acids|mesh-list
92852279|NCT02836184|Niacinamide|niacinamide|mesh-list
92852280|NCT02836184|Calcium Carbonate|calcium carbonate|mesh-list
92852281|NCT02836184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852282|NCT02836184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92852283|NCT02836184|Antimetabolites|antimetabolites|mesh-ancestor
92852284|NCT02836184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852285|NCT02836184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92852286|NCT02836184|Vasodilator Agents|vasodilator agents|mesh-ancestor
92852287|NCT02836184|Vitamin B Complex|vitamin b complex|mesh-ancestor
92852288|NCT02836184|Vitamins|vitamins|mesh-ancestor
92852289|NCT02836184|Micronutrients|micronutrients|mesh-ancestor
92852290|NCT02836184|Antacids|antacids|mesh-ancestor
92852291|NCT02836184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852292|NCT04824144|Dexmedetomidine|dexmedetomidine|mesh-list
92852293|NCT04824144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92852294|NCT04824144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852295|NCT04824144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852296|NCT04824144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852297|NCT04824144|Analgesics|analgesics|mesh-ancestor
92852298|NCT04824144|Sensory System Agents|sensory system agents|mesh-ancestor
92852299|NCT04824144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852300|NCT04824144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92852301|NCT04824144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92852302|NCT04824144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92852303|NCT04824144|Adrenergic Agents|adrenergic agents|mesh-ancestor
92852304|NCT04824144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852305|NCT04824144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852306|NCT02775474|Fentanyl|fentanyl|mesh-list
92852307|NCT02775474|Methadone|methadone|mesh-list
92852308|NCT02775474|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92852309|NCT02775474|Narcotics|narcotics|mesh-ancestor
92852310|NCT02775474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852311|NCT02775474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852312|NCT02775474|Analgesics|analgesics|mesh-ancestor
92852313|NCT02775474|Sensory System Agents|sensory system agents|mesh-ancestor
92852314|NCT02775474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852315|NCT02775474|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92852316|NCT02775474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92852317|NCT02775474|Anesthetics, General|anesthetics, general|mesh-ancestor
92852318|NCT02775474|Anesthetics|anesthetics|mesh-ancestor
92852319|NCT02775474|Antitussive Agents|antitussive agents|mesh-ancestor
92852320|NCT02775474|Respiratory System Agents|respiratory system agents|mesh-ancestor
92852321|NCT05158686|Paclitaxel|paclitaxel|mesh-list
92852322|NCT05158686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92852323|NCT05158686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852324|NCT05158686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92852325|NCT05158686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92852326|NCT05158686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92852327|NCT05158686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852328|NCT02835794|Azacitidine|azacitidine|mesh-list
92852329|NCT02835794|Homoharringtonine|homoharringtonine|mesh-list
92852330|NCT02835794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852331|NCT02835794|Antimetabolites|antimetabolites|mesh-ancestor
92852332|NCT02835794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852333|NCT02835794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852334|NCT02835794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852335|NCT02835794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92852336|NCT02835794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92852337|NCT02836028|Temozolomide|temozolomide|mesh-list
92852338|NCT02836028|Talazoparib|talazoparib|mesh-list
92852339|NCT02836028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92852340|NCT02836028|Alkylating Agents|alkylating agents|mesh-ancestor
92852341|NCT02836028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852342|NCT02836028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852343|NCT02836028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92852344|NCT02836028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852345|NCT01778946|Nicotine|nicotine|mesh-list
92852346|NCT01778946|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92852347|NCT01778946|Autonomic Agents|autonomic agents|mesh-ancestor
92852348|NCT01778946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852349|NCT01778946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852350|NCT01778946|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92852351|NCT01778946|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92852352|NCT01778946|Cholinergic Agents|cholinergic agents|mesh-ancestor
92852353|NCT01778946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852354|NCT01778946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852355|NCT04227210|Vaccines|vaccines|mesh-list
92852356|NCT04227210|Immunologic Factors|immunologic factors|mesh-ancestor
92852357|NCT04227210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852358|NCT02833766|Doxorubicin|doxorubicin|mesh-list
92852359|NCT02833766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92852360|NCT02833766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852361|NCT02833766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92852362|NCT02833766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92852363|NCT02833766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852364|NCT02833766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852365|NCT04813380|Immunomodulating Agents|immunomodulating agents|mesh-list
92852366|NCT04813380|Immunologic Factors|immunologic factors|mesh-ancestor
92852367|NCT04813380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852368|NCT04951362|Ivermectin|ivermectin|mesh-list
92852369|NCT04951362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92852370|NCT04951362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852371|NCT02833610|Denosumab|denosumab|mesh-list
92852372|NCT02833610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92852373|NCT02833610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852374|NCT04225728|Iron|iron|mesh-list
92433281|NCT01573741|Ketamine|ketamine|mesh-list
92852375|NCT04225728|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92852376|NCT04225728|Teferrol|teferrol|mesh-list
92852377|NCT04225728|Trace Elements|trace elements|mesh-ancestor
92852378|NCT04225728|Micronutrients|micronutrients|mesh-ancestor
92852379|NCT04225728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852380|NCT04225728|Hematinics|hematinics|mesh-ancestor
92852381|NCT02835716|Ustekinumab|ustekinumab|mesh-list
92852382|NCT02835716|Dermatologic Agents|dermatologic agents|mesh-ancestor
92852383|NCT04247984|Bevacizumab|bevacizumab|mesh-list
92852384|NCT04247984|Fluorouracil|fluorouracil|mesh-list
92852385|NCT04247984|Capecitabine|capecitabine|mesh-list
92852386|NCT04247984|Irinotecan|irinotecan|mesh-list
92852387|NCT04247984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852388|NCT04247984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852389|NCT04247984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92852390|NCT04247984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92852391|NCT04247984|Growth Substances|growth substances|mesh-ancestor
92852392|NCT04247984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852393|NCT04247984|Growth Inhibitors|growth inhibitors|mesh-ancestor
92852394|NCT04247984|Antimetabolites|antimetabolites|mesh-ancestor
92852395|NCT04247984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852396|NCT04247984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852397|NCT04247984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852398|NCT04247984|Immunologic Factors|immunologic factors|mesh-ancestor
92852399|NCT04247984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92852400|NCT04247984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92852401|NCT04247984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852402|NCT00948389|Dasatinib|dasatinib|mesh-list
92852403|NCT00948389|Lomustine|lomustine|mesh-list
92852404|NCT00948389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852405|NCT00948389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852406|NCT00948389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852407|NCT00948389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852408|NCT00948389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92852409|NCT00948389|Alkylating Agents|alkylating agents|mesh-ancestor
92852410|NCT02775318|Bupivacaine|bupivacaine|mesh-list
92852411|NCT02775318|Anesthetics, Local|anesthetics, local|mesh-ancestor
92852412|NCT02775318|Anesthetics|anesthetics|mesh-ancestor
92852413|NCT02775318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852414|NCT02775318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852415|NCT02775318|Sensory System Agents|sensory system agents|mesh-ancestor
92852416|NCT02775318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852417|NCT00948155|Varenicline|varenicline|mesh-list
92852418|NCT00948155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92852419|NCT00948155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92852420|NCT00948155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92852421|NCT00948155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852422|NCT00948155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852423|NCT00948155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852424|NCT02776956|Atorvastatin|atorvastatin|mesh-list
92852425|NCT02776956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92852426|NCT02776956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92852427|NCT02776956|Antimetabolites|antimetabolites|mesh-ancestor
92852428|NCT02776956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852429|NCT02776956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92852430|NCT02776956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92852431|NCT02776956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852432|NCT04910178|Empagliflozin|empagliflozin|mesh-list
92852433|NCT04910178|Pentoxifylline|pentoxifylline|mesh-list
92852434|NCT04910178|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92852435|NCT04910178|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92852436|NCT04910178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852437|NCT04910178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92852438|NCT04910178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852439|NCT04910178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92852440|NCT04910178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852441|NCT04910178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92852442|NCT04910178|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92852443|NCT04910178|Protective Agents|protective agents|mesh-ancestor
92852444|NCT04910178|Vasodilator Agents|vasodilator agents|mesh-ancestor
92852445|NCT04910178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92852446|NCT04910178|Antioxidants|antioxidants|mesh-ancestor
92852447|NCT04910178|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92852448|NCT04910178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852449|NCT02778594|Levodopa|levodopa|mesh-list
92852450|NCT02778594|Benserazide|benserazide|mesh-list
92852451|NCT02778594|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92852452|NCT02778594|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92852453|NCT02778594|Dopamine Agents|dopamine agents|mesh-ancestor
92852454|NCT02778594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852455|NCT02778594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852456|NCT02778594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852457|NCT02778594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852458|NCT02775006|Docetaxel|docetaxel|mesh-list
92852459|NCT02775006|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92852460|NCT02775006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852461|NCT02775006|Tubulin Modulators|tubulin modulators|mesh-ancestor
92852462|NCT02775006|Antimitotic Agents|antimitotic agents|mesh-ancestor
92852463|NCT02775006|Mitosis Modulators|mitosis modulators|mesh-ancestor
92852464|NCT02775006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852465|NCT02775006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852466|NCT02775006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852467|NCT04851834|Cisplatin|cisplatin|mesh-list
92852468|NCT04851834|Carboplatin|carboplatin|mesh-list
92852469|NCT04851834|Temozolomide|temozolomide|mesh-list
92852470|NCT04851834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852471|NCT04851834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92852472|NCT04851834|Alkylating Agents|alkylating agents|mesh-ancestor
92852473|NCT04851834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852474|NCT01880567|Rituximab|rituximab|mesh-list
92852475|NCT01880567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92852476|NCT01880567|Antibodies|antibodies|mesh-list
92852477|NCT01880567|Immunoglobulins|immunoglobulins|mesh-list
92852478|NCT01880567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92852479|NCT01880567|Immunologic Factors|immunologic factors|mesh-ancestor
92852480|NCT01880567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852481|NCT01880567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852482|NCT01880567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852483|NCT02776722|Tagatose|tagatose|mesh-list
92852484|NCT02776722|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92852485|NCT02776722|Chelating Agents|chelating agents|mesh-ancestor
92852486|NCT02776722|Sequestering Agents|sequestering agents|mesh-ancestor
92852487|NCT02776722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852488|NCT02776878|Dasatinib|dasatinib|mesh-list
92852489|NCT02776878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852490|NCT02776878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852491|NCT02776878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852492|NCT02776878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852493|NCT02772822|Rituximab|rituximab|mesh-list
92852494|NCT02772822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852495|NCT02772822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852496|NCT02772822|Immunologic Factors|immunologic factors|mesh-ancestor
92852497|NCT02772822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852498|NCT02772822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852499|NCT00635076|Alprazolam|alprazolam|mesh-list
92852500|NCT00635076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92852501|NCT00635076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852502|NCT00635076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852503|NCT00635076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92852504|NCT00635076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92852505|NCT00635076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92852506|NCT00635076|GABA Modulators|gaba modulators|mesh-ancestor
92852507|NCT00635076|GABA Agents|gaba agents|mesh-ancestor
92852508|NCT00635076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852509|NCT00635076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852510|NCT02772744|Ribavirin|ribavirin|mesh-list
92852511|NCT02772744|Sofosbuvir|sofosbuvir|mesh-list
92852512|NCT02772744|Antimetabolites|antimetabolites|mesh-ancestor
92852513|NCT02772744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852514|NCT02772744|Antiviral Agents|antiviral agents|mesh-ancestor
92852515|NCT02772744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852516|NCT02774382|Vancomycin|vancomycin|mesh-list
92852517|NCT02774382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92852518|NCT02774382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852519|NCT02774460|Amlodipine|amlodipine|mesh-list
92852520|NCT02774460|Candesartan|candesartan|mesh-list
92852521|NCT02774460|Candesartan cilexetil|candesartan cilexetil|mesh-list
92852522|NCT02774460|Lisinopril|lisinopril|mesh-list
92852523|NCT02774460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92852524|NCT02774460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92852525|NCT02774460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852526|NCT02774460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852527|NCT02774460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92852528|NCT02774460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852529|NCT02774460|Vasodilator Agents|vasodilator agents|mesh-ancestor
92852530|NCT02774460|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92852531|NCT02774460|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92852532|NCT02774460|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92852533|NCT02774460|Protease Inhibitors|protease inhibitors|mesh-ancestor
92852534|NCT02774460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852535|NCT02774460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92852536|NCT02774460|Protective Agents|protective agents|mesh-ancestor
92852539|NCT02772354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92852540|NCT02772354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92852541|NCT02772354|Sympatholytics|sympatholytics|mesh-ancestor
92852542|NCT02772354|Autonomic Agents|autonomic agents|mesh-ancestor
92852543|NCT02772354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852544|NCT02772354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852545|NCT02772354|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92852546|NCT02772354|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92852547|NCT02772354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92852548|NCT02772354|Adrenergic Agents|adrenergic agents|mesh-ancestor
92852549|NCT02772354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852550|NCT02772354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852551|NCT02772354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92852552|NCT02772354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852553|NCT02772354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92852554|NCT02772354|Vasodilator Agents|vasodilator agents|mesh-ancestor
92852555|NCT00611455|Ofatumumab|ofatumumab|mesh-list
92852556|NCT00611455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852557|NCT02767752|Gemcitabine|gemcitabine|mesh-list
92852558|NCT02767752|Capecitabine|capecitabine|mesh-list
92149019|NCT00868959|Serotonin Agents|serotonin agents|mesh-ancestor
92852559|NCT02767752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852560|NCT02767752|Antimetabolites|antimetabolites|mesh-ancestor
92852561|NCT02767752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852562|NCT02767752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852563|NCT00885625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92852564|NCT00885625|Immunologic Factors|immunologic factors|mesh-ancestor
92852565|NCT00885625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852566|NCT02835404|Nedaplatin|nedaplatin|mesh-list
92852567|NCT02835404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852568|NCT00885781|SMOFlipid|smoflipid|mesh-list
92852569|NCT00885781|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92852570|NCT00885781|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92852571|NCT00885781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92852572|NCT02767674|Prednisone|prednisone|mesh-list
92852573|NCT02767674|Cyclophosphamide|cyclophosphamide|mesh-list
92852574|NCT02767674|Rituximab|rituximab|mesh-list
92852575|NCT02767674|Gemcitabine|gemcitabine|mesh-list
92852576|NCT02767674|Oxaliplatin|oxaliplatin|mesh-list
92852577|NCT02767674|Epirubicin|epirubicin|mesh-list
92852578|NCT02767674|Vindesine|vindesine|mesh-list
92852579|NCT02767674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852580|NCT02767674|Immunologic Factors|immunologic factors|mesh-ancestor
92852581|NCT02767674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852582|NCT02767674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852583|NCT02767674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92852584|NCT02767674|Alkylating Agents|alkylating agents|mesh-ancestor
92852585|NCT02767674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852586|NCT02767674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852587|NCT02767674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92852588|NCT02767674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852589|NCT02767674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852590|NCT02767674|Antimetabolites|antimetabolites|mesh-ancestor
92852591|NCT02767674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852592|NCT02767674|Glucocorticoids|glucocorticoids|mesh-ancestor
92852593|NCT02767674|Hormones|hormones|mesh-ancestor
92852594|NCT02767674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852595|NCT02767674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852596|NCT02767674|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92852597|NCT02767674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92852598|NCT02767674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92852599|NCT02767674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852600|NCT02767674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92433282|NCT01573741|Analgesics|analgesics|mesh-ancestor
92852601|NCT02767674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92852602|NCT02767674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92852603|NCT02767674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92852604|NCT02833688|Dexmedetomidine|dexmedetomidine|mesh-list
92852605|NCT02833688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92852606|NCT02833688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852607|NCT02833688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852608|NCT02833688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852609|NCT02833688|Analgesics|analgesics|mesh-ancestor
92852610|NCT02833688|Sensory System Agents|sensory system agents|mesh-ancestor
92852611|NCT02833688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852612|NCT02833688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92852613|NCT02833688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92852614|NCT02833688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92852615|NCT02833688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92852616|NCT02833688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852617|NCT02833688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852618|NCT00947531|Cerebrolysin|cerebrolysin|mesh-list
92852619|NCT00947531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92852620|NCT00947531|Protective Agents|protective agents|mesh-ancestor
92852621|NCT00947531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852622|NCT00947531|Nootropic Agents|nootropic agents|mesh-ancestor
92852623|NCT00612313|Fluoxetine|fluoxetine|mesh-list
92852624|NCT00612313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92852625|NCT00612313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92852626|NCT00612313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852627|NCT00612313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852628|NCT00612313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852629|NCT00612313|Serotonin Agents|serotonin agents|mesh-ancestor
92852630|NCT00612313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852631|NCT00612313|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92852632|NCT00612313|Antidepressive Agents|antidepressive agents|mesh-ancestor
92852633|NCT00612313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92852634|NCT00612313|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92852635|NCT00612313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92852636|NCT00612313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852637|NCT00890552|Dexamethasone|dexamethasone|mesh-list
92852638|NCT00890552|Dexamethasone acetate|dexamethasone acetate|mesh-list
92852639|NCT00890552|Lenalidomide|lenalidomide|mesh-list
92852640|NCT00890552|Melphalan|melphalan|mesh-list
92852641|NCT00890552|BB 1101|bb 1101|mesh-list
92852642|NCT00890552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852643|NCT00890552|Antiemetics|antiemetics|mesh-ancestor
92852644|NCT00890552|Autonomic Agents|autonomic agents|mesh-ancestor
92852645|NCT00890552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852646|NCT00890552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852647|NCT00890552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852648|NCT00890552|Glucocorticoids|glucocorticoids|mesh-ancestor
92852649|NCT00890552|Hormones|hormones|mesh-ancestor
92852650|NCT00890552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852651|NCT00890552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852652|NCT00890552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852653|NCT00890552|Protease Inhibitors|protease inhibitors|mesh-ancestor
92852654|NCT00890552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852655|NCT00890552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852656|NCT00890552|Immunologic Factors|immunologic factors|mesh-ancestor
92852657|NCT00890552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92852658|NCT00890552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92852659|NCT00890552|Growth Substances|growth substances|mesh-ancestor
92852660|NCT00890552|Growth Inhibitors|growth inhibitors|mesh-ancestor
92852661|NCT00890552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92852662|NCT00890552|Alkylating Agents|alkylating agents|mesh-ancestor
92852663|NCT00890552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92852664|NCT00890552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852665|NCT02856503|Vitamin D|vitamin d|mesh-list
92852666|NCT02856503|Cholecalciferol|cholecalciferol|mesh-list
92852667|NCT02856503|Vitamins|vitamins|mesh-ancestor
92852668|NCT02856503|Micronutrients|micronutrients|mesh-ancestor
92852669|NCT02856503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852670|NCT02856503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92852671|NCT02856503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92852672|NCT02833376|Chlorhexidine|chlorhexidine|mesh-list
92852673|NCT02833376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92852674|NCT02833376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852675|NCT02833376|Disinfectants|disinfectants|mesh-ancestor
92852677|NCT02542813|Oxytocics|oxytocics|mesh-ancestor
92852678|NCT02542813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92497788|NCT01999933|Cisplatin|cisplatin|mesh-list
92852679|NCT02542813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852680|NCT02772120|Progesterone|progesterone|mesh-list
92852681|NCT02772120|Progestins|progestins|mesh-ancestor
92852682|NCT02772120|Hormones|hormones|mesh-ancestor
92852683|NCT02772120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852684|NCT02772120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852685|NCT04248608|Morphine|morphine|mesh-list
92852686|NCT04248608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92852687|NCT04248608|Narcotics|narcotics|mesh-ancestor
92852688|NCT04248608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852689|NCT04248608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852690|NCT04248608|Analgesics|analgesics|mesh-ancestor
92852691|NCT04248608|Sensory System Agents|sensory system agents|mesh-ancestor
92852692|NCT04248608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852693|NCT04783194|Dexamethasone|dexamethasone|mesh-list
92852694|NCT04783194|Bupivacaine|bupivacaine|mesh-list
92852695|NCT04783194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852696|NCT04783194|Antiemetics|antiemetics|mesh-ancestor
92852697|NCT04783194|Autonomic Agents|autonomic agents|mesh-ancestor
92852698|NCT04783194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852699|NCT04783194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852700|NCT04783194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852701|NCT04783194|Glucocorticoids|glucocorticoids|mesh-ancestor
92852702|NCT04783194|Hormones|hormones|mesh-ancestor
92754392|NCT00840853|Anesthetics|anesthetics|mesh-ancestor
92852703|NCT04783194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852704|NCT04783194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852705|NCT04783194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852706|NCT04783194|Anesthetics, Local|anesthetics, local|mesh-ancestor
92852707|NCT04783194|Anesthetics|anesthetics|mesh-ancestor
92852708|NCT04783194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852709|NCT04783194|Sensory System Agents|sensory system agents|mesh-ancestor
92852710|NCT02854241|Liver Extracts|liver extracts|mesh-list
92852711|NCT02854241|Hematinics|hematinics|mesh-ancestor
92852712|NCT02835170|Immunoglobulins|immunoglobulins|mesh-list
92852713|NCT02835170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92852714|NCT02835170|Antibodies|antibodies|mesh-list
92852715|NCT02835170|Immunologic Factors|immunologic factors|mesh-ancestor
92852716|NCT02835170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852717|NCT00946985|Risperidone|risperidone|mesh-list
92852718|NCT00946985|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92852719|NCT00946985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92852720|NCT00946985|Serotonin Agents|serotonin agents|mesh-ancestor
92852721|NCT00946985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852722|NCT00946985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852723|NCT00946985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852724|NCT00946985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92852725|NCT00946985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92852726|NCT00946985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852727|NCT00946985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92852728|NCT00946985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92852729|NCT00946985|Dopamine Agents|dopamine agents|mesh-ancestor
92852730|NCT00946985|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92852731|NCT00946985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92852732|NCT00611923|Flutamide|flutamide|mesh-list
92852733|NCT00611923|Androgen Antagonists|androgen antagonists|mesh-ancestor
92852734|NCT00611923|Hormone Antagonists|hormone antagonists|mesh-ancestor
92852735|NCT00611923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852736|NCT00611923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852737|NCT00611923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852738|NCT00611923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852739|NCT04246502|Capecitabine|capecitabine|mesh-list
92852740|NCT04246502|Trastuzumab|trastuzumab|mesh-list
92852741|NCT04246502|Pertuzumab|pertuzumab|mesh-list
92852742|NCT04246502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852743|NCT04246502|Antimetabolites|antimetabolites|mesh-ancestor
92852744|NCT04246502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852745|NCT04246502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852746|NCT04246502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852747|NCT02767362|Atorvastatin|atorvastatin|mesh-list
92852748|NCT02767362|Ezetimibe|ezetimibe|mesh-list
92852749|NCT02767362|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92852750|NCT02767362|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198014|NCT00684775|Naltrexone|naltrexone|mesh-list
92852751|NCT02767362|Antimetabolites|antimetabolites|mesh-ancestor
92852752|NCT02767362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852753|NCT02767362|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92852754|NCT02767362|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92852755|NCT02767362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852757|NCT00609973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92852758|NCT00609973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852759|NCT00609973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92852760|NCT00609973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92852761|NCT00609973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852762|NCT00609973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852763|NCT00609973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852764|NCT00609973|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92852765|NCT00609973|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92852766|NCT02541643|Elotuzumab|elotuzumab|mesh-list
92852767|NCT02541643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852768|NCT02696694|Progesterone|progesterone|mesh-list
92852769|NCT02696694|Progestins|progestins|mesh-ancestor
92852770|NCT02696694|Hormones|hormones|mesh-ancestor
92852771|NCT02696694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852772|NCT02696694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852773|NCT04038073|Antibodies|antibodies|mesh-list
92852774|NCT04038073|Antistreptolysin|antistreptolysin|mesh-list
92852775|NCT04038073|Immunologic Factors|immunologic factors|mesh-ancestor
92852776|NCT04038073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852777|NCT04739592|Vitamin D|vitamin d|mesh-list
92852778|NCT04739592|Cholecalciferol|cholecalciferol|mesh-list
92852779|NCT04739592|Alendronate|alendronate|mesh-list
92852780|NCT04739592|Vitamins|vitamins|mesh-ancestor
92852781|NCT04739592|Micronutrients|micronutrients|mesh-ancestor
92852782|NCT04739592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852783|NCT04739592|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92852784|NCT04739592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92852785|NCT00633386|Celecoxib|celecoxib|mesh-list
92852786|NCT00633386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852787|NCT00633386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852788|NCT00633386|Analgesics|analgesics|mesh-ancestor
92852789|NCT00633386|Sensory System Agents|sensory system agents|mesh-ancestor
92852790|NCT00633386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852791|NCT00633386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852792|NCT00633386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852793|NCT00633386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852794|NCT00633386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92852795|NCT00633386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92852796|NCT00633386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852797|NCT00633386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852798|NCT02771418|Anesthetics|anesthetics|mesh-list
92852799|NCT02771418|Propofol|propofol|mesh-list
92852800|NCT02771418|Sevoflurane|sevoflurane|mesh-list
92852801|NCT02771418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852802|NCT02771418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852803|NCT02771418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92852804|NCT02771418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92852805|NCT02771418|Anesthetics, General|anesthetics, general|mesh-ancestor
92852806|NCT02771418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92852807|NCT02771418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92852808|NCT00888901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92852809|NCT00888901|Methylprednisolone|methylprednisolone|mesh-list
92852810|NCT00888901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92852811|NCT00888901|Prednisolone|prednisolone|mesh-list
92852812|NCT00888901|Prednisolone acetate|prednisolone acetate|mesh-list
92852813|NCT00888901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92852814|NCT00888901|Prednisolone phosphate|prednisolone phosphate|mesh-list
92852815|NCT00888901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852816|NCT00888901|Antiemetics|antiemetics|mesh-ancestor
92852817|NCT00888901|Autonomic Agents|autonomic agents|mesh-ancestor
92852818|NCT00888901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852819|NCT00888901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852820|NCT00888901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852821|NCT00888901|Glucocorticoids|glucocorticoids|mesh-ancestor
92852822|NCT00888901|Hormones|hormones|mesh-ancestor
92852823|NCT00888901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852824|NCT00888901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92198082|NCT00092833|Ezetimibe|ezetimibe|mesh-list
92852826|NCT00888901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852827|NCT00888901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852828|NCT00803049|Teriflunomide|teriflunomide|mesh-list
92852829|NCT00803049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852830|NCT00803049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852831|NCT00803049|Analgesics|analgesics|mesh-ancestor
92852832|NCT00803049|Sensory System Agents|sensory system agents|mesh-ancestor
92852833|NCT00803049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852834|NCT00803049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852835|NCT00803049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852836|NCT00803049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852837|NCT00803049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852838|NCT00803049|Immunologic Factors|immunologic factors|mesh-ancestor
92852839|NCT00884767|Leucovorin|leucovorin|mesh-list
92852840|NCT00884767|Fluorouracil|fluorouracil|mesh-list
92852841|NCT00884767|Oxaliplatin|oxaliplatin|mesh-list
92852842|NCT00884767|Calcium|calcium|mesh-list
92852843|NCT00884767|Levoleucovorin|levoleucovorin|mesh-list
92852844|NCT00884767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92852845|NCT00884767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852846|NCT00884767|Antimetabolites|antimetabolites|mesh-ancestor
92852847|NCT00884767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852848|NCT00884767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754536|NCT00931255|Sirolimus|sirolimus|mesh-list
92852849|NCT00884767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852850|NCT00884767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92852851|NCT00884767|Immunologic Factors|immunologic factors|mesh-ancestor
92852852|NCT00884767|Antidotes|antidotes|mesh-ancestor
92852853|NCT00884767|Protective Agents|protective agents|mesh-ancestor
92852854|NCT00884767|Vitamin B Complex|vitamin b complex|mesh-ancestor
92852855|NCT00884767|Vitamins|vitamins|mesh-ancestor
92852856|NCT00884767|Micronutrients|micronutrients|mesh-ancestor
92852857|NCT00890084|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92852858|NCT00890084|Telmisartan|telmisartan|mesh-list
92852859|NCT00890084|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92852860|NCT00890084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92852861|NCT00890084|Diuretics|diuretics|mesh-ancestor
92852862|NCT00890084|Natriuretic Agents|natriuretic agents|mesh-ancestor
92852863|NCT00890084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852864|NCT00890084|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92852865|NCT00890084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852866|NCT00890084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852867|NCT00890084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92852868|NCT00890084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92852869|NCT00884845|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92852870|NCT00884845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852871|NCT00884845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852872|NCT00884845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852873|NCT00884845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852874|NCT02773602|Dexamethasone|dexamethasone|mesh-list
92852875|NCT02773602|Clonidine|clonidine|mesh-list
92852876|NCT02773602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852877|NCT02773602|Antiemetics|antiemetics|mesh-ancestor
92852878|NCT02773602|Autonomic Agents|autonomic agents|mesh-ancestor
92852879|NCT02773602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852880|NCT02773602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852881|NCT02773602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92852882|NCT02773602|Glucocorticoids|glucocorticoids|mesh-ancestor
92852883|NCT02773602|Hormones|hormones|mesh-ancestor
92852884|NCT02773602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92852885|NCT02773602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92852886|NCT02773602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852887|NCT02773602|Analgesics|analgesics|mesh-ancestor
92852888|NCT02773602|Sensory System Agents|sensory system agents|mesh-ancestor
92852889|NCT02773602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92852890|NCT02773602|Sympatholytics|sympatholytics|mesh-ancestor
92852891|NCT02773602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92852892|NCT02773602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92852893|NCT02773602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92852894|NCT02773602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92852895|NCT02773602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852896|NCT02773602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852897|NCT02770950|Indomethacin|indomethacin|mesh-list
92852898|NCT02770950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92852899|NCT02770950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92852900|NCT02770950|Analgesics|analgesics|mesh-ancestor
92852901|NCT02770950|Sensory System Agents|sensory system agents|mesh-ancestor
92852902|NCT02770950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852903|NCT02770950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852904|NCT02770950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92852905|NCT02770950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92852906|NCT02770950|Gout Suppressants|gout suppressants|mesh-ancestor
92852907|NCT02770950|Tocolytic Agents|tocolytic agents|mesh-ancestor
92852908|NCT02770950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92852909|NCT02770950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92852910|NCT02770950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852911|NCT02770950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852912|NCT00889057|Sorafenib|sorafenib|mesh-list
92852913|NCT00889057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852914|NCT00889057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92852915|NCT00889057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852916|NCT00889057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852917|NCT05684289|Sildenafil Citrate|sildenafil citrate|mesh-list
92852918|NCT05684289|Vasodilator Agents|vasodilator agents|mesh-ancestor
92852919|NCT05684289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92852920|NCT05684289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92852921|NCT05684289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852922|NCT05684289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852923|NCT05684289|Urological Agents|urological agents|mesh-ancestor
92852924|NCT02829008|Bevacizumab|bevacizumab|mesh-list
92852925|NCT02829008|Pemetrexed|pemetrexed|mesh-list
92852926|NCT02829008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92852927|NCT02829008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852928|NCT02829008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92852929|NCT02829008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92852930|NCT02829008|Growth Substances|growth substances|mesh-ancestor
92852931|NCT02829008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852932|NCT02829008|Growth Inhibitors|growth inhibitors|mesh-ancestor
92852933|NCT02829008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852934|NCT02829008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852935|NCT02829008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92852936|NCT02829008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92852937|NCT00889135|Droxidopa|droxidopa|mesh-list
92852938|NCT00889135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92852939|NCT00889135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92852940|NCT00889213|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92852941|NCT00889213|Hemostatics|hemostatics|mesh-ancestor
92852942|NCT00889213|Coagulants|coagulants|mesh-ancestor
92852943|NCT00382200|Decitabine|decitabine|mesh-list
92852944|NCT00382200|Tretinoin|tretinoin|mesh-list
92852945|NCT00382200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92852946|NCT00382200|Antimetabolites|antimetabolites|mesh-ancestor
92852947|NCT00382200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852948|NCT00382200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92852949|NCT00382200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92852950|NCT00382200|Keratolytic Agents|keratolytic agents|mesh-ancestor
92852951|NCT00382200|Dermatologic Agents|dermatologic agents|mesh-ancestor
92852952|NCT02696928|Lumefantrine|lumefantrine|mesh-list
92852953|NCT02696928|Primaquine|primaquine|mesh-list
92852954|NCT02696928|Antimalarials|antimalarials|mesh-ancestor
92852955|NCT02696928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92852956|NCT02696928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92852957|NCT02696928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92852958|NCT00886405|Nitroglycerin|nitroglycerin|mesh-list
92852959|NCT00886405|Vasodilator Agents|vasodilator agents|mesh-ancestor
92852960|NCT00889369|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92852961|NCT00889369|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92852962|NCT00889369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92852963|NCT00889369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92852964|NCT00889369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852965|NCT00889369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852966|NCT00889369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852967|NCT00889369|Analgesics|analgesics|mesh-ancestor
92852968|NCT00889369|Sensory System Agents|sensory system agents|mesh-ancestor
92852969|NCT00889369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852970|NCT00889369|Antidepressive Agents|antidepressive agents|mesh-ancestor
92852971|NCT00889369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92852972|NCT00889369|Dopamine Agents|dopamine agents|mesh-ancestor
92852974|NCT02766192|Analgesics|analgesics|mesh-ancestor
92852975|NCT02766192|Sensory System Agents|sensory system agents|mesh-ancestor
92852976|NCT02766192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92852977|NCT02766192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852978|NCT02766192|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92852979|NCT02766192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92852980|NCT02766192|Anesthetics, General|anesthetics, general|mesh-ancestor
92498084|NCT02001896|Carboplatin|carboplatin|mesh-list
92852981|NCT02766192|Anesthetics|anesthetics|mesh-ancestor
92852982|NCT02766192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92852983|NCT02766192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92852984|NCT02766192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92852985|NCT02766192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852986|NCT02766192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92852987|NCT05278897|Hyaluronic Acid|hyaluronic acid|mesh-list
92852988|NCT05278897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92852989|NCT05278897|Immunologic Factors|immunologic factors|mesh-ancestor
92852990|NCT05278897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92852991|NCT05278897|Viscosupplements|viscosupplements|mesh-ancestor
92852992|NCT05278897|Protective Agents|protective agents|mesh-ancestor
92852993|NCT00889525|Cabergoline|cabergoline|mesh-list
92852994|NCT00889525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92852995|NCT00889525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92852996|NCT00889525|Dopamine Agonists|dopamine agonists|mesh-ancestor
92852997|NCT00889525|Dopamine Agents|dopamine agents|mesh-ancestor
92852998|NCT00889525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92852999|NCT00889525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853000|NCT00889525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853001|NCT02770794|Infliximab|infliximab|mesh-list
92853002|NCT02770794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92853003|NCT02770794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853004|NCT02770794|Dermatologic Agents|dermatologic agents|mesh-ancestor
92853005|NCT02770794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853006|NCT02770794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853007|NCT04224246|Sodium Oxybate|sodium oxybate|mesh-list
92853008|NCT04224246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92853009|NCT04224246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92853010|NCT04224246|Anesthetics, General|anesthetics, general|mesh-ancestor
92853011|NCT04224246|Anesthetics|anesthetics|mesh-ancestor
92853012|NCT04224246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853013|NCT04224246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853014|NCT02766270|Temozolomide|temozolomide|mesh-list
92853015|NCT02766270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92853016|NCT02766270|Alkylating Agents|alkylating agents|mesh-ancestor
92853017|NCT02766270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853018|NCT02766270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853019|NCT04300010|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92853020|NCT04300010|Dermatologic Agents|dermatologic agents|mesh-ancestor
92853021|NCT02766348|Gemcitabine|gemcitabine|mesh-list
92853022|NCT02766348|Cisplatin|cisplatin|mesh-list
92853023|NCT02766348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92853024|NCT02766348|Antimetabolites|antimetabolites|mesh-ancestor
92853025|NCT02766348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853026|NCT02766348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853027|NCT00608569|Ritonavir|ritonavir|mesh-list
92853028|NCT00608569|Lopinavir|lopinavir|mesh-list
92853029|NCT00608569|Tenofovir|tenofovir|mesh-list
92853030|NCT00608569|Emtricitabine|emtricitabine|mesh-list
92853031|NCT00608569|Zidovudine|zidovudine|mesh-list
92853032|NCT00608569|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92853033|NCT00608569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92853034|NCT00608569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92853035|NCT00608569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853036|NCT00608569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853037|NCT00608569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853038|NCT00608569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92853039|NCT00608569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92853040|NCT00608569|Antiviral Agents|antiviral agents|mesh-ancestor
92853041|NCT00608569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853042|NCT00608569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92853043|NCT00608569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92853044|NCT00608569|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92853045|NCT00608569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92853046|NCT00608569|Antimetabolites|antimetabolites|mesh-ancestor
92853047|NCT04699422|Pirinitramide|pirinitramide|mesh-list
92853048|NCT04699422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92853049|NCT04699422|Narcotics|narcotics|mesh-ancestor
92853050|NCT04699422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853051|NCT04699422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853052|NCT04699422|Analgesics|analgesics|mesh-ancestor
92853053|NCT04699422|Sensory System Agents|sensory system agents|mesh-ancestor
92853054|NCT04699422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853055|NCT02828384|Psyllium|psyllium|mesh-list
92853056|NCT02828384|Cathartics|cathartics|mesh-ancestor
92853057|NCT02828384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853058|NCT00886717|Paclitaxel|paclitaxel|mesh-list
92853059|NCT00886717|genexol-PM|genexol-pm|mesh-list
92853060|NCT00886717|Carboplatin|carboplatin|mesh-list
92853061|NCT00886717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92853062|NCT00886717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853063|NCT00886717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92853064|NCT00886717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92853065|NCT00886717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92853066|NCT00886717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853067|NCT00889837|Loxapine|loxapine|mesh-list
92853068|NCT00889837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92853069|NCT00889837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92853070|NCT00889837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853071|NCT00889837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853072|NCT00889837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92853073|NCT00889837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92853074|NCT00889837|Dopamine Agents|dopamine agents|mesh-ancestor
92853075|NCT00889837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853076|NCT00889837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853077|NCT02770404|Nafithromycin|nafithromycin|mesh-list
92853078|NCT02770404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853079|NCT02770404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853080|NCT02770404|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92853081|NCT02770404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853082|NCT02770404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853083|NCT00886873|Mifepristone|mifepristone|mesh-list
92853084|NCT00886873|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92853085|NCT00886873|Abortifacient Agents|abortifacient agents|mesh-ancestor
92853086|NCT00886873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92853087|NCT00886873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853088|NCT00886873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92853089|NCT00886873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92853090|NCT00886873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92853091|NCT00886873|Contraceptive Agents|contraceptive agents|mesh-ancestor
92853092|NCT00886873|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92853093|NCT00886873|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92853094|NCT00886873|Hormone Antagonists|hormone antagonists|mesh-ancestor
92853095|NCT00886873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853096|NCT00886873|Luteolytic Agents|luteolytic agents|mesh-ancestor
92853097|NCT00886873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92853098|NCT00886873|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92853099|NCT04243850|Empagliflozin|empagliflozin|mesh-list
92853100|NCT04243850|Caffeine|caffeine|mesh-list
92853101|NCT04243850|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92853102|NCT04243850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853103|NCT04243850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92853104|NCT04243850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853105|NCT04243850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853106|NCT04243850|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92853107|NCT04243850|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92853108|NCT04243850|Purinergic Agents|purinergic agents|mesh-ancestor
92853109|NCT04243850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853110|NCT04243850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92853111|NCT04243850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92853112|NCT00892801|Everolimus|everolimus|mesh-list
92853113|NCT00892801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92853114|NCT00892801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92853115|NCT00892801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853116|NCT00892801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853117|NCT00892801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853118|NCT00892801|Immunologic Factors|immunologic factors|mesh-ancestor
92853119|NCT00892801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853120|NCT00892801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853121|NCT04222842|Vorolanib|vorolanib|mesh-list
92853122|NCT04222842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92853123|NCT04222842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853124|NCT04222842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853125|NCT00633542|Interferons|interferons|mesh-list
92853126|NCT00633542|Interferon-alpha|interferon-alpha|mesh-list
92853127|NCT00633542|Thalidomide|thalidomide|mesh-list
92853128|NCT00633542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853129|NCT00633542|Antiviral Agents|antiviral agents|mesh-ancestor
92853130|NCT00633542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853131|NCT00633542|Immunologic Factors|immunologic factors|mesh-ancestor
92853132|NCT00633542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853133|NCT00633542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853134|NCT00633542|Leprostatic Agents|leprostatic agents|mesh-ancestor
92853135|NCT00633542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853136|NCT00633542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92853137|NCT00633542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92853138|NCT00633542|Growth Substances|growth substances|mesh-ancestor
92853139|NCT00633542|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853140|NCT02766036|Propolis|propolis|mesh-list
92853141|NCT02766036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853142|NCT00610675|Mirtazapine|mirtazapine|mesh-list
92853143|NCT00610675|Antidepressive Agents|antidepressive agents|mesh-ancestor
92853144|NCT00610675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92853145|NCT00610675|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92853146|NCT00610675|Histamine Antagonists|histamine antagonists|mesh-ancestor
92853147|NCT00610675|Histamine Agents|histamine agents|mesh-ancestor
92853148|NCT00610675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853149|NCT00610675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853150|NCT00610675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853151|NCT00610675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92853152|NCT00610675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92853153|NCT00610675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853154|NCT00610675|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92853155|NCT00610675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92853156|NCT00610675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92853157|NCT00610675|Adrenergic Agents|adrenergic agents|mesh-ancestor
92853158|NCT00610675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92853159|NCT00610675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92853160|NCT00610675|Serotonin Agents|serotonin agents|mesh-ancestor
92853161|NCT00610675|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92853162|NCT02828228|Vitamin D|vitamin d|mesh-list
92853163|NCT02828228|Cholecalciferol|cholecalciferol|mesh-list
92853164|NCT02828228|Vitamins|vitamins|mesh-ancestor
92853165|NCT02828228|Micronutrients|micronutrients|mesh-ancestor
92853166|NCT02828228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853167|NCT02828228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92853168|NCT02828228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92853169|NCT02769936|Cycloserine|cycloserine|mesh-list
92853170|NCT02769936|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92853171|NCT02769936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853172|NCT02769936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92853173|NCT02769936|Antitubercular Agents|antitubercular agents|mesh-ancestor
92853174|NCT02769936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853175|NCT02769936|Antimetabolites|antimetabolites|mesh-ancestor
92853176|NCT02769936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853177|NCT00887029|Timolol|timolol|mesh-list
92853178|NCT00887029|Travoprost|travoprost|mesh-list
92853179|NCT00887029|Latanoprost|latanoprost|mesh-list
92853180|NCT00887029|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92853181|NCT00887029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92853182|NCT00887029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92853183|NCT00887029|Adrenergic Agents|adrenergic agents|mesh-ancestor
92853184|NCT00887029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853185|NCT00887029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853186|NCT00887029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853187|NCT00887029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92853188|NCT00887029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853189|NCT00887029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92853190|NCT00635310|Liver Extracts|liver extracts|mesh-list
92853191|NCT00635310|Hematinics|hematinics|mesh-ancestor
92853192|NCT02762448|Asunaprevir|asunaprevir|mesh-list
92853193|NCT02762448|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853194|NCT02762448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853195|NCT02762448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853196|NCT00573157|Mycophenolic Acid|mycophenolic acid|mesh-list
92853197|NCT00573157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92853198|NCT00573157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853199|NCT00573157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92853200|NCT00573157|Antitubercular Agents|antitubercular agents|mesh-ancestor
92853201|NCT00573157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853202|NCT00573157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853203|NCT00573157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853204|NCT00573157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853205|NCT00890383|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92853206|NCT00890383|Plasma Substitutes|plasma substitutes|mesh-ancestor
92853207|NCT00890383|Blood Substitutes|blood substitutes|mesh-ancestor
92853209|NCT00887107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853210|NCT00887107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92853211|NCT00887107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853212|NCT00887107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853213|NCT00802737|Ofatumumab|ofatumumab|mesh-list
92853214|NCT00802737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853215|NCT02769390|Clonidine|clonidine|mesh-list
92853216|NCT02769390|Diazepam|diazepam|mesh-list
92853217|NCT02769390|Analgesics|analgesics|mesh-ancestor
92853218|NCT02769390|Sensory System Agents|sensory system agents|mesh-ancestor
92853219|NCT02769390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853220|NCT02769390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853221|NCT02769390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853222|NCT02769390|Sympatholytics|sympatholytics|mesh-ancestor
92853223|NCT02769390|Autonomic Agents|autonomic agents|mesh-ancestor
92853224|NCT02769390|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92853225|NCT02769390|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92853226|NCT02769390|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92853227|NCT02769390|Adrenergic Agents|adrenergic agents|mesh-ancestor
92853228|NCT02769390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853229|NCT02769390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853230|NCT02769390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92853231|NCT02769390|Anticonvulsants|anticonvulsants|mesh-ancestor
92853232|NCT02769390|Antiemetics|antiemetics|mesh-ancestor
92853233|NCT02769390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853234|NCT02769390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92853235|NCT02769390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853236|NCT02769390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92853237|NCT02769390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92853238|NCT02769390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92853239|NCT02769390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92853240|NCT02769390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92853241|NCT02769390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92853242|NCT02769390|Anesthetics, General|anesthetics, general|mesh-ancestor
92853243|NCT02769390|Anesthetics|anesthetics|mesh-ancestor
92853244|NCT02769390|GABA Modulators|gaba modulators|mesh-ancestor
92853245|NCT02769390|GABA Agents|gaba agents|mesh-ancestor
92853246|NCT00890539|Methacholine Chloride|methacholine chloride|mesh-list
92853247|NCT00890539|Miotics|miotics|mesh-ancestor
92853248|NCT00890539|Autonomic Agents|autonomic agents|mesh-ancestor
92853249|NCT00890539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853250|NCT00890539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853251|NCT00890539|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92853252|NCT00890539|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92853253|NCT00890539|Respiratory System Agents|respiratory system agents|mesh-ancestor
92853254|NCT00890539|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92853255|NCT00890539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92853256|NCT00890539|Cholinergic Agents|cholinergic agents|mesh-ancestor
92853257|NCT00890539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853258|NCT00890539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853259|NCT00887263|Budesonide|budesonide|mesh-list
92853260|NCT00887263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853261|NCT00887263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92853262|NCT00887263|Autonomic Agents|autonomic agents|mesh-ancestor
92853263|NCT00887263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853264|NCT00887263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853265|NCT00887263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92853266|NCT00887263|Respiratory System Agents|respiratory system agents|mesh-ancestor
92853267|NCT00887263|Glucocorticoids|glucocorticoids|mesh-ancestor
92853268|NCT00887263|Hormones|hormones|mesh-ancestor
92853269|NCT00887263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853270|NCT00415233|Hormones|hormones|mesh-list
92853271|NCT00415233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853272|NCT00415233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853273|NCT00914667|Warfarin|warfarin|mesh-list
92853274|NCT00914667|Fesoterodine|fesoterodine|mesh-list
92853275|NCT00914667|Anticoagulants|anticoagulants|mesh-ancestor
92853276|NCT00914667|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92853277|NCT00914667|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92853278|NCT00914667|Cholinergic Agents|cholinergic agents|mesh-ancestor
92853279|NCT00914667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853280|NCT00914667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853281|NCT00914667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853282|NCT00914667|Urological Agents|urological agents|mesh-ancestor
92853283|NCT00887978|Treprostinil|treprostinil|mesh-list
92853284|NCT00887978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853285|NCT00608023|Tesamorelin|tesamorelin|mesh-list
92853286|NCT00608023|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92853287|NCT00608023|Growth Substances|growth substances|mesh-ancestor
92853288|NCT00608023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853289|NCT00608023|Hormones|hormones|mesh-ancestor
92853290|NCT00608023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853291|NCT02765022|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92853292|NCT02765022|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92853293|NCT02765022|beta-Endorphin|beta-endorphin|mesh-list
92853294|NCT02765022|Hormones|hormones|mesh-ancestor
92853295|NCT02765022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853296|NCT02765022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853297|NCT02765022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853298|NCT02765022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853299|NCT04224636|Bevacizumab|bevacizumab|mesh-list
92853300|NCT04224636|Atezolizumab|atezolizumab|mesh-list
92853301|NCT04224636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853302|NCT04224636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853303|NCT04224636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92853304|NCT04224636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92853305|NCT04224636|Growth Substances|growth substances|mesh-ancestor
92853306|NCT04224636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853307|NCT04224636|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853308|NCT04224636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92853309|NCT04224636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853310|NCT00607789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92853311|NCT00607789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92853312|NCT00607789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92853313|NCT00607789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92853314|NCT00607789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853315|NCT00607789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853316|NCT00607789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853317|NCT00607789|Analgesics|analgesics|mesh-ancestor
92853318|NCT00607789|Sensory System Agents|sensory system agents|mesh-ancestor
92853319|NCT00607789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853320|NCT00607789|Antidepressive Agents|antidepressive agents|mesh-ancestor
92853321|NCT00607789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92853322|NCT00607789|Dopamine Agents|dopamine agents|mesh-ancestor
92853323|NCT02761512|Lansoprazole|lansoprazole|mesh-list
92853324|NCT02761512|Dexlansoprazole|dexlansoprazole|mesh-list
92853325|NCT02761512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92853326|NCT02761512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853327|NCT02761512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92853328|NCT02761512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755036|NCT04901689|Leronlimab|leronlimab|mesh-list
92853329|NCT02761512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853330|NCT00893269|Zolpidem|zolpidem|mesh-list
92853331|NCT00893269|Eszopiclone|eszopiclone|mesh-list
92853332|NCT00893269|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92853333|NCT00893269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92853334|NCT00893269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853335|NCT00893269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853336|NCT00893269|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92853337|NCT00893269|GABA Agonists|gaba agonists|mesh-ancestor
92853338|NCT00893269|GABA Agents|gaba agents|mesh-ancestor
92853339|NCT00893269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853340|NCT00893269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853341|NCT05672667|Oxytocin|oxytocin|mesh-list
92853342|NCT05672667|Oxytocics|oxytocics|mesh-ancestor
92853343|NCT05672667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92853344|NCT05672667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853345|NCT04115397|Zoledronic Acid|zoledronic acid|mesh-list
92853346|NCT04115397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92853347|NCT04115397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853348|NCT00887822|Bevacizumab|bevacizumab|mesh-list
92853349|NCT00887822|Capecitabine|capecitabine|mesh-list
92853350|NCT00887822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853351|NCT00887822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853352|NCT00887822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92853353|NCT00887822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92498463|NCT02004197|Antacids|antacids|mesh-ancestor
92853354|NCT00887822|Growth Substances|growth substances|mesh-ancestor
92853355|NCT00887822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853356|NCT00887822|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853357|NCT00887822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92853358|NCT00887822|Antimetabolites|antimetabolites|mesh-ancestor
92853359|NCT00887822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853360|NCT04222920|Adalimumab|adalimumab|mesh-list
92853361|NCT04222920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92853362|NCT04222920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853363|NCT04222920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853364|NCT04115163|Paclitaxel|paclitaxel|mesh-list
92853365|NCT04115163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92853366|NCT04115163|Gemcitabine|gemcitabine|mesh-list
92853367|NCT04115163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92853368|NCT04115163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853369|NCT04115163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92853370|NCT04115163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92853371|NCT04115163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92853372|NCT04115163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853373|NCT04115163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92853374|NCT04115163|Antimetabolites|antimetabolites|mesh-ancestor
92853375|NCT02542111|Dexamethasone|dexamethasone|mesh-list
92853376|NCT02542111|Gemcitabine|gemcitabine|mesh-list
92853377|NCT02542111|Bortezomib|bortezomib|mesh-list
92853378|NCT02542111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853379|NCT02542111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853380|NCT02542111|Antiemetics|antiemetics|mesh-ancestor
92853381|NCT02542111|Autonomic Agents|autonomic agents|mesh-ancestor
92853382|NCT02542111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853383|NCT02542111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853384|NCT02542111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853385|NCT02542111|Glucocorticoids|glucocorticoids|mesh-ancestor
92853386|NCT02542111|Hormones|hormones|mesh-ancestor
92853387|NCT02542111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853388|NCT02542111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92853389|NCT02542111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92853390|NCT02542111|Antimetabolites|antimetabolites|mesh-ancestor
92853391|NCT02542111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853392|NCT02768688|Dexmedetomidine|dexmedetomidine|mesh-list
92853393|NCT02768688|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92853394|NCT02768688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853395|NCT02768688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853396|NCT02768688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92853397|NCT02768688|Analgesics|analgesics|mesh-ancestor
92755085|NCT00625209|Fludrocortisone|fludrocortisone|mesh-list
92853398|NCT02768688|Sensory System Agents|sensory system agents|mesh-ancestor
92853399|NCT02768688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853400|NCT02768688|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92853401|NCT02768688|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92853402|NCT02768688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92853403|NCT02768688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92853404|NCT02768688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853405|NCT02768688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853406|NCT00891163|Lidocaine|lidocaine|mesh-list
92853407|NCT00891163|Tetracaine|tetracaine|mesh-list
92853408|NCT00891163|Anesthetics, Local|anesthetics, local|mesh-ancestor
92853409|NCT00891163|Anesthetics|anesthetics|mesh-ancestor
92853410|NCT00891163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853411|NCT00891163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853412|NCT00891163|Sensory System Agents|sensory system agents|mesh-ancestor
92853413|NCT00891163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853414|NCT00891163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92853415|NCT00891163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92853416|NCT00891163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92853418|NCT00891163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853419|NCT02541331|Broncho-Vaxom|broncho-vaxom|mesh-list
92853420|NCT02541331|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92853421|NCT02541331|Immunologic Factors|immunologic factors|mesh-ancestor
92853422|NCT02541331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853423|NCT00893425|Ramipril|ramipril|mesh-list
92853424|NCT00893425|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92853425|NCT00893425|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853426|NCT00893425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853427|NCT00893425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853428|NCT00893425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853429|NCT00951665|Paclitaxel|paclitaxel|mesh-list
92853430|NCT00951665|Maytansine|maytansine|mesh-list
92853431|NCT00951665|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92853432|NCT00951665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92853433|NCT00951665|Trastuzumab|trastuzumab|mesh-list
92853434|NCT00951665|Pertuzumab|pertuzumab|mesh-list
92853435|NCT00951665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92853436|NCT00951665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853437|NCT00951665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92853438|NCT00951665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92853439|NCT00951665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92853440|NCT00951665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853441|NCT00951665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853442|NCT00951665|Immunotoxins|immunotoxins|mesh-ancestor
92853443|NCT00951665|Immunoconjugates|immunoconjugates|mesh-ancestor
92853444|NCT00951665|Immunologic Factors|immunologic factors|mesh-ancestor
92853445|NCT00951665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853446|NCT02769078|Warfarin|warfarin|mesh-list
92853447|NCT02769078|Rivaroxaban|rivaroxaban|mesh-list
92853448|NCT02769078|Dabigatran|dabigatran|mesh-list
92853449|NCT02769078|Apixaban|apixaban|mesh-list
92853450|NCT02769078|Anticoagulants|anticoagulants|mesh-ancestor
92853451|NCT02769078|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92853452|NCT02769078|Antithrombins|antithrombins|mesh-ancestor
92853453|NCT02769078|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92853454|NCT02769078|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853455|NCT02769078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853456|NCT02769078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853457|NCT04036201|Bupivacaine|bupivacaine|mesh-list
92853458|NCT04036201|Hyaluronic Acid|hyaluronic acid|mesh-list
92853459|NCT04036201|Anesthetics, Local|anesthetics, local|mesh-ancestor
92853460|NCT04036201|Anesthetics|anesthetics|mesh-ancestor
92853461|NCT04036201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853462|NCT04036201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853463|NCT04036201|Sensory System Agents|sensory system agents|mesh-ancestor
92853464|NCT04036201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853465|NCT04036201|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92853466|NCT04036201|Immunologic Factors|immunologic factors|mesh-ancestor
92853467|NCT04036201|Viscosupplements|viscosupplements|mesh-ancestor
92853468|NCT04036201|Protective Agents|protective agents|mesh-ancestor
92853469|NCT00801099|Amoxicillin|amoxicillin|mesh-list
92755156|NCT04962841|Antidepressive Agents|antidepressive agents|mesh-ancestor
92853470|NCT00801099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92853471|NCT00801099|Clavulanic Acids|clavulanic acids|mesh-list
92853472|NCT00801099|Clavulanic Acid|clavulanic acid|mesh-list
92853473|NCT00801099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853474|NCT00801099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853475|NCT00801099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92853476|NCT00801099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853477|NCT00801099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853478|NCT02768610|Dexmedetomidine|dexmedetomidine|mesh-list
92853479|NCT02768610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92853480|NCT02768610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853481|NCT02768610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853482|NCT02768610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92853483|NCT02768610|Analgesics|analgesics|mesh-ancestor
92853484|NCT02768610|Sensory System Agents|sensory system agents|mesh-ancestor
92853485|NCT02768610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853486|NCT02768610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92853487|NCT02768610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92853488|NCT02768610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92853489|NCT02768610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92853490|NCT02768610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853491|NCT02768610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853492|NCT02764710|Amoxicillin|amoxicillin|mesh-list
92853493|NCT02764710|Clavulanic Acid|clavulanic acid|mesh-list
92853494|NCT02764710|Clavulanic Acids|clavulanic acids|mesh-list
92853495|NCT02764710|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92853496|NCT02764710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853497|NCT02764710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853498|NCT02764710|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92853499|NCT02764710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853500|NCT02764710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853501|NCT00923169|Mitogens|mitogens|mesh-list
92853502|NCT00923169|Mitosis Modulators|mitosis modulators|mesh-ancestor
92853503|NCT00923169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853504|NCT02541019|Ondansetron|ondansetron|mesh-list
92853505|NCT02541019|Palonosetron|palonosetron|mesh-list
92853506|NCT02541019|Antiemetics|antiemetics|mesh-ancestor
92853507|NCT02541019|Autonomic Agents|autonomic agents|mesh-ancestor
92853508|NCT02541019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853509|NCT02541019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853510|NCT02541019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853511|NCT02541019|Antipruritics|antipruritics|mesh-ancestor
92853512|NCT02541019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92853513|NCT02541019|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92853514|NCT02541019|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92853515|NCT02541019|Serotonin Agents|serotonin agents|mesh-ancestor
92853516|NCT02541019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853517|NCT02541019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853518|NCT00893581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92853519|NCT00893581|Antidepressive Agents|antidepressive agents|mesh-ancestor
92853520|NCT00893581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92853521|NCT00893581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92853522|NCT00893581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92853523|NCT00893581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853524|NCT00893581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853525|NCT04114383|Deuterium Oxide|deuterium oxide|mesh-list
92853526|NCT04114383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853527|NCT04114383|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92853528|NCT04114383|Protective Agents|protective agents|mesh-ancestor
92853529|NCT04114383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853530|NCT04114461|Tofacitinib|tofacitinib|mesh-list
92853531|NCT04114461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853532|NCT04114461|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92853533|NCT04114461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92853534|NCT04114461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853535|NCT02768454|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92853536|NCT02768454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853537|NCT02768376|Fentanyl|fentanyl|mesh-list
92853538|NCT02768376|Bupivacaine|bupivacaine|mesh-list
92853539|NCT02768376|Anesthetics|anesthetics|mesh-list
92853540|NCT02768376|Anesthetics, Local|anesthetics, local|mesh-ancestor
92853541|NCT02768376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853542|NCT02768376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853543|NCT02768376|Sensory System Agents|sensory system agents|mesh-ancestor
92853544|NCT02768376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853545|NCT02768376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92853546|NCT02768376|Narcotics|narcotics|mesh-ancestor
92853547|NCT02768376|Analgesics|analgesics|mesh-ancestor
92853548|NCT02768376|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92853549|NCT02768376|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92853550|NCT02768376|Anesthetics, General|anesthetics, general|mesh-ancestor
92853551|NCT02696460|Lidocaine|lidocaine|mesh-list
92853552|NCT02696460|Prilocaine|prilocaine|mesh-list
92853553|NCT02696460|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92853554|NCT02696460|Anesthetics, Local|anesthetics, local|mesh-ancestor
92853555|NCT02696460|Anesthetics|anesthetics|mesh-ancestor
92853556|NCT02696460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853557|NCT02696460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853558|NCT02696460|Sensory System Agents|sensory system agents|mesh-ancestor
92853559|NCT02696460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853560|NCT02696460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92853561|NCT02696460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92853562|NCT02696460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92853563|NCT02696460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433290|NCT01573741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853564|NCT02696460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853565|NCT02696460|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92853566|NCT00888043|Bevacizumab|bevacizumab|mesh-list
92853567|NCT00888043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853568|NCT00888043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853569|NCT00888043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92853570|NCT00888043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92853571|NCT00888043|Growth Substances|growth substances|mesh-ancestor
92853572|NCT00888043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853573|NCT00888043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853574|NCT02768220|Empagliflozin|empagliflozin|mesh-list
92853575|NCT02768220|Linagliptin|linagliptin|mesh-list
92853576|NCT02768220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92853577|NCT02768220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853578|NCT02768220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92853579|NCT02768220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853581|NCT02768220|Hormones|hormones|mesh-ancestor
92853582|NCT02768220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853583|NCT02768220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92853584|NCT02768220|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853585|NCT02768220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853586|NCT02760888|Diclofenac|diclofenac|mesh-list
92853587|NCT02760888|Tramadol|tramadol|mesh-list
92853588|NCT02760888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92853589|NCT02760888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92853590|NCT02760888|Analgesics|analgesics|mesh-ancestor
92853591|NCT02760888|Sensory System Agents|sensory system agents|mesh-ancestor
92853592|NCT02760888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853593|NCT02760888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853594|NCT02760888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853595|NCT02760888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853596|NCT02760888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92853597|NCT02760888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853598|NCT02760888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853599|NCT02760888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92853600|NCT02760888|Narcotics|narcotics|mesh-ancestor
92853601|NCT02760888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853602|NCT00799617|Methyltestosterone|methyltestosterone|mesh-list
92853603|NCT00799617|Testosterone|testosterone|mesh-list
92853604|NCT00799617|Testosterone undecanoate|testosterone undecanoate|mesh-list
92853605|NCT00799617|Testosterone enanthate|testosterone enanthate|mesh-list
92853606|NCT00799617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92853607|NCT00799617|Androgens|androgens|mesh-ancestor
92853608|NCT00799617|Hormones|hormones|mesh-ancestor
92853609|NCT00799617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853610|NCT00799617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853611|NCT00799617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92853612|NCT00799617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853613|NCT00799617|Anabolic Agents|anabolic agents|mesh-ancestor
92853614|NCT00607087|Insulin|insulin|mesh-list
92853615|NCT00607087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92853616|NCT00607087|Insulin Aspart|insulin aspart|mesh-list
92853617|NCT00607087|Insulin Lispro|insulin lispro|mesh-list
92853618|NCT00607087|Insulin glulisine|insulin glulisine|mesh-list
92853619|NCT00607087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92853620|NCT00607087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853621|NCT00610363|Rilonacept|rilonacept|mesh-list
92853622|NCT00610363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853623|NCT00887588|Valsartan|valsartan|mesh-list
92853624|NCT00887588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92853625|NCT00887588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853626|NCT00887588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92853627|NCT00887588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92853628|NCT00887588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853629|NCT00799383|Vitamin D|vitamin d|mesh-list
92853630|NCT00799383|Calcium|calcium|mesh-list
92853631|NCT00799383|Vitamins|vitamins|mesh-ancestor
92853632|NCT00799383|Micronutrients|micronutrients|mesh-ancestor
92853633|NCT00799383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853634|NCT00799383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92853635|NCT00799383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92853636|NCT02763852|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92853637|NCT02763852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853638|NCT02763852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853639|NCT02763852|Dopamine Agents|dopamine agents|mesh-ancestor
92853640|NCT02763852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853641|NCT02763852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853642|NCT04114149|Analgesics, Opioid|analgesics, opioid|mesh-list
92853643|NCT04114149|Narcotics|narcotics|mesh-ancestor
92853644|NCT04114149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853645|NCT04114149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853646|NCT04114149|Analgesics|analgesics|mesh-ancestor
92853647|NCT04114149|Sensory System Agents|sensory system agents|mesh-ancestor
92853648|NCT04114149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853649|NCT00891397|Pregabalin|pregabalin|mesh-list
92853650|NCT00891397|Analgesics|analgesics|mesh-ancestor
92853651|NCT00891397|Sensory System Agents|sensory system agents|mesh-ancestor
92498769|NCT02006498|Silymarin|silymarin|mesh-list
92853652|NCT00891397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853653|NCT00891397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853654|NCT00891397|Anticonvulsants|anticonvulsants|mesh-ancestor
92853655|NCT00891397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92853656|NCT00891397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92853657|NCT00891397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853658|NCT00891397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92853659|NCT00891397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92853660|NCT00891397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92853661|NCT00891397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853662|NCT00891397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92853664|NCT02767596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92853665|NCT02767596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853666|NCT02826902|Remifentanil|remifentanil|mesh-list
92853667|NCT02826902|Propofol|propofol|mesh-list
92853668|NCT02826902|Desflurane|desflurane|mesh-list
92853669|NCT02826902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92853670|NCT02826902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853671|NCT02826902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853672|NCT02826902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92853673|NCT02826902|Anesthetics, General|anesthetics, general|mesh-ancestor
92853674|NCT02826902|Anesthetics|anesthetics|mesh-ancestor
92853675|NCT02826902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92853676|NCT02826902|Narcotics|narcotics|mesh-ancestor
92853677|NCT02826902|Analgesics|analgesics|mesh-ancestor
92853678|NCT02826902|Sensory System Agents|sensory system agents|mesh-ancestor
92853679|NCT02826902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853680|NCT02826902|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92853681|NCT00798759|Travoprost|travoprost|mesh-list
92853682|NCT00798759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92853683|NCT00798759|Latanoprost|latanoprost|mesh-list
92853684|NCT00798759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92853685|NCT00798759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853686|NCT00891475|Interferons|interferons|mesh-list
92853687|NCT00891475|Interferon-alpha|interferon-alpha|mesh-list
92853688|NCT00891475|Sunitinib|sunitinib|mesh-list
92853689|NCT00891475|Maleic acid|maleic acid|mesh-list
92853690|NCT00891475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853691|NCT00891475|Antiviral Agents|antiviral agents|mesh-ancestor
92853692|NCT00891475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853693|NCT00891475|Immunologic Factors|immunologic factors|mesh-ancestor
92853694|NCT00891475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853695|NCT00891475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92853696|NCT00891475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92853697|NCT00891475|Growth Substances|growth substances|mesh-ancestor
92853698|NCT00891475|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853699|NCT00891475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92853700|NCT00891475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853701|NCT00891475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853702|NCT00887432|Vitamin D|vitamin d|mesh-list
92853703|NCT00887432|Cholecalciferol|cholecalciferol|mesh-list
92853704|NCT00887432|Vitamins|vitamins|mesh-ancestor
92853705|NCT00887432|Micronutrients|micronutrients|mesh-ancestor
92853706|NCT00887432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853707|NCT00887432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92853708|NCT00887432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92853709|NCT04222686|Losartan|losartan|mesh-list
92853710|NCT04222686|Perindopril|perindopril|mesh-list
92853711|NCT04222686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92853712|NCT04222686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92853713|NCT04222686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92853714|NCT04222686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92853715|NCT04222686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853716|NCT04222686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92853717|NCT04222686|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853718|NCT04222686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853719|NCT04113915|Cyclosporine|cyclosporine|mesh-list
92853720|NCT04113915|Dexamethasone|dexamethasone|mesh-list
92853721|NCT04113915|Cyclosporins|cyclosporins|mesh-list
92853722|NCT04113915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853723|NCT04113915|Immunologic Factors|immunologic factors|mesh-ancestor
92853724|NCT04113915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853725|NCT04113915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853726|NCT04113915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853727|NCT04113915|Antiemetics|antiemetics|mesh-ancestor
92853728|NCT04113915|Autonomic Agents|autonomic agents|mesh-ancestor
92853729|NCT04113915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853730|NCT04113915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853731|NCT04113915|Glucocorticoids|glucocorticoids|mesh-ancestor
92853733|NCT04113915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853734|NCT04113915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92853735|NCT04113915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853736|NCT04113915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853737|NCT04113915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853738|NCT04113915|Antifungal Agents|antifungal agents|mesh-ancestor
92853739|NCT04113915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853740|NCT04113915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92853741|NCT04113915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92853742|NCT03590821|Aspirin|aspirin|mesh-list
92853743|NCT03590821|Celecoxib|celecoxib|mesh-list
92853744|NCT03590821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92853745|NCT03590821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92853746|NCT03590821|Analgesics|analgesics|mesh-ancestor
92853747|NCT03590821|Sensory System Agents|sensory system agents|mesh-ancestor
92853748|NCT03590821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755434|NCT01207596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92853749|NCT03590821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853750|NCT03590821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853751|NCT03590821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853752|NCT03590821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92853753|NCT03590821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92853754|NCT03590821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853755|NCT03590821|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92853756|NCT03590821|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92853757|NCT03590821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853758|NCT03590821|Antipyretics|antipyretics|mesh-ancestor
92853759|NCT03590821|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92853760|NCT04113993|Bazedoxifene|bazedoxifene|mesh-list
92853761|NCT04113993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92853762|NCT04113993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92853763|NCT04113993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92853764|NCT04113993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853765|NCT04113993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853766|NCT04113993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92853767|NCT02758470|Acetazolamide|acetazolamide|mesh-list
92853768|NCT02758470|Methazolamide|methazolamide|mesh-list
92853769|NCT02758470|Anticonvulsants|anticonvulsants|mesh-ancestor
92853770|NCT02758470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92853771|NCT02758470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853772|NCT02758470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853773|NCT02758470|Diuretics|diuretics|mesh-ancestor
92853774|NCT02758470|Natriuretic Agents|natriuretic agents|mesh-ancestor
92853775|NCT02758470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853776|NCT04223076|Chlorhexidine|chlorhexidine|mesh-list
92853777|NCT04223076|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92853778|NCT04223076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92853779|NCT04223076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853780|NCT04223076|Disinfectants|disinfectants|mesh-ancestor
92853781|NCT04223076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92853782|NCT00951275|Antirheumatic Agents|antirheumatic agents|mesh-list
92853783|NCT02764008|Bupivacaine|bupivacaine|mesh-list
92853784|NCT02764008|Anesthetics, Local|anesthetics, local|mesh-ancestor
92853785|NCT02764008|Anesthetics|anesthetics|mesh-ancestor
92853786|NCT02764008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853787|NCT02764008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853788|NCT02764008|Sensory System Agents|sensory system agents|mesh-ancestor
92853789|NCT02764008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853790|NCT00798603|Bevacizumab|bevacizumab|mesh-list
92853791|NCT00798603|Carboplatin|carboplatin|mesh-list
92853792|NCT00798603|Pemetrexed|pemetrexed|mesh-list
92853793|NCT00798603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853794|NCT00798603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853795|NCT00798603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92853796|NCT00798603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92853797|NCT00798603|Growth Substances|growth substances|mesh-ancestor
92853798|NCT00798603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853799|NCT00798603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92853800|NCT00798603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853801|NCT00798603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853802|NCT00798603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92853803|NCT00798603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92853804|NCT04036981|Botulinum Toxins|botulinum toxins|mesh-list
92853805|NCT04036981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92853806|NCT04036981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92853807|NCT04036981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92853808|NCT04036981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92853809|NCT04036981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853810|NCT04036981|Cholinergic Agents|cholinergic agents|mesh-ancestor
92853811|NCT04036981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853812|NCT04036981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853813|NCT04036981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92853814|NCT04036981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853816|NCT00887354|Teriparatide|teriparatide|mesh-list
92853817|NCT00887354|Risedronic Acid|risedronic acid|mesh-list
92853818|NCT00887354|Calcium|calcium|mesh-list
92853819|NCT00887354|Vitamins|vitamins|mesh-ancestor
92853820|NCT00887354|Micronutrients|micronutrients|mesh-ancestor
92853821|NCT00887354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853822|NCT00887354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92853823|NCT00887354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92853824|NCT00887354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92853825|NCT00887354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92853826|NCT00887354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853827|NCT00951041|Vaccines|vaccines|mesh-list
92853828|NCT00951041|Immunologic Factors|immunologic factors|mesh-ancestor
92853829|NCT00951041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853830|NCT02832596|Norepinephrine|norepinephrine|mesh-list
92853831|NCT02832596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92853832|NCT02832596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92853833|NCT02832596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92853834|NCT02832596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853835|NCT02832596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853836|NCT02832596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853837|NCT02832596|Sympathomimetics|sympathomimetics|mesh-ancestor
92853838|NCT02832596|Autonomic Agents|autonomic agents|mesh-ancestor
92853839|NCT02832596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853840|NCT02832596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92853841|NCT02760420|Amoxicillin|amoxicillin|mesh-list
92853842|NCT02760420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853843|NCT02760420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853844|NCT04612530|Nivolumab|nivolumab|mesh-list
92853845|NCT04612530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853846|NCT04612530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853847|NCT04612530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92853848|NCT04612530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853849|NCT00945815|Cytarabine|cytarabine|mesh-list
92853850|NCT00945815|Clofarabine|clofarabine|mesh-list
92853851|NCT00945815|Epratuzumab|epratuzumab|mesh-list
92853852|NCT00945815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92853853|NCT00945815|Antimetabolites|antimetabolites|mesh-ancestor
92853854|NCT00945815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853855|NCT00945815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853856|NCT00945815|Antiviral Agents|antiviral agents|mesh-ancestor
92853857|NCT00945815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853858|NCT00945815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853859|NCT00945815|Immunologic Factors|immunologic factors|mesh-ancestor
92853860|NCT00945815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853861|NCT00945815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92853862|NCT00606307|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92853863|NCT00606307|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92853864|NCT00606307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853865|NCT00606307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853866|NCT00798369|Triamcinolone|triamcinolone|mesh-list
92853867|NCT00798369|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92853868|NCT00798369|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92853869|NCT00798369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92853870|NCT00798369|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92853871|NCT00798369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853872|NCT00798369|Glucocorticoids|glucocorticoids|mesh-ancestor
92853873|NCT00798369|Hormones|hormones|mesh-ancestor
92853874|NCT00798369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853875|NCT00798369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853876|NCT00798369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853877|NCT00798369|Immunologic Factors|immunologic factors|mesh-ancestor
92853878|NCT00798369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853879|NCT00798369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853880|NCT00608959|Chlorhexidine|chlorhexidine|mesh-list
92853881|NCT00608959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92853882|NCT00608959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755626|NCT01283009|Hormones|hormones|mesh-ancestor
92853883|NCT00608959|Disinfectants|disinfectants|mesh-ancestor
92853884|NCT02760342|Metformin|metformin|mesh-list
92853885|NCT02760342|Peficitinib|peficitinib|mesh-list
92853886|NCT02760342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92853887|NCT02760342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853888|NCT02760342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853889|NCT02760342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853890|NCT02760342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853891|NCT02760342|Immunologic Factors|immunologic factors|mesh-ancestor
92853892|NCT04221282|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92853893|NCT04221282|Anticonvulsants|anticonvulsants|mesh-ancestor
92853894|NCT04221282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92853895|NCT04221282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92853896|NCT04221282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92853897|NCT04221282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853898|NCT00894283|Enoxaparin|enoxaparin|mesh-list
92853900|NCT00894283|Fondaparinux|fondaparinux|mesh-list
92853901|NCT00894283|Anticoagulants|anticoagulants|mesh-ancestor
92853902|NCT00894283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92853903|NCT00894283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92853904|NCT00894283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853905|NCT00894283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92853906|NCT00894283|Antithrombins|antithrombins|mesh-ancestor
92853907|NCT00894283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92853908|NCT00894283|Protease Inhibitors|protease inhibitors|mesh-ancestor
92853909|NCT00894283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853910|NCT00895609|Neostigmine|neostigmine|mesh-list
92853911|NCT00895609|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92853912|NCT00895609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853913|NCT00895609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853914|NCT00895609|Cholinergic Agents|cholinergic agents|mesh-ancestor
92853915|NCT00895609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92853916|NCT00895609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853917|NCT00895609|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92853918|NCT00895609|Autonomic Agents|autonomic agents|mesh-ancestor
92853919|NCT00895609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853920|NCT00894439|Piperacillin|piperacillin|mesh-list
92853921|NCT00894439|BLI-489|bli-489|mesh-list
92853922|NCT00894439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92853923|NCT00894439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853924|NCT00894439|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92853925|NCT00894439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853926|NCT00894439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853927|NCT04035889|Melatonin|melatonin|mesh-list
92853928|NCT04035889|Antioxidants|antioxidants|mesh-ancestor
92853929|NCT04035889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853930|NCT04035889|Protective Agents|protective agents|mesh-ancestor
92853931|NCT04035889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853932|NCT04035889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92853933|NCT00895687|Bortezomib|bortezomib|mesh-list
92853934|NCT00895687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92853935|NCT00895687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853936|NCT00895687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92853937|NCT00895687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853938|NCT00895687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853939|NCT00798135|Itraconazole|itraconazole|mesh-list
92853940|NCT00798135|Antifungal Agents|antifungal agents|mesh-ancestor
92853941|NCT00798135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92853942|NCT00798135|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92853943|NCT00798135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92853944|NCT00798135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853945|NCT00798135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853946|NCT00798135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92853947|NCT00798135|Hormone Antagonists|hormone antagonists|mesh-ancestor
92853948|NCT00798135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853949|NCT00798135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853950|NCT00798135|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92853952|NCT02762838|Infliximab|infliximab|mesh-list
92853953|NCT02762838|Methotrexate|methotrexate|mesh-list
92853954|NCT02762838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92853955|NCT02762838|Abortifacient Agents|abortifacient agents|mesh-ancestor
92853956|NCT02762838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92853957|NCT02762838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853958|NCT02762838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92853959|NCT02762838|Antimetabolites|antimetabolites|mesh-ancestor
92853960|NCT02762838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92853961|NCT02762838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853962|NCT02762838|Dermatologic Agents|dermatologic agents|mesh-ancestor
92853963|NCT02762838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92853964|NCT02762838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92853965|NCT02762838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853966|NCT02762838|Immunologic Factors|immunologic factors|mesh-ancestor
92853967|NCT02762838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853968|NCT02762838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92853969|NCT02762838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92853970|NCT02762838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853971|NCT02762838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853972|NCT02762838|Hematinics|hematinics|mesh-ancestor
92853973|NCT02762838|Vitamin B Complex|vitamin b complex|mesh-ancestor
92853974|NCT02762838|Vitamins|vitamins|mesh-ancestor
92853975|NCT02762838|Micronutrients|micronutrients|mesh-ancestor
92853976|NCT02753166|Dexamethasone|dexamethasone|mesh-list
92853977|NCT02753166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92853978|NCT02753166|Antiemetics|antiemetics|mesh-ancestor
92853979|NCT02753166|Autonomic Agents|autonomic agents|mesh-ancestor
92853980|NCT02753166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92853981|NCT02753166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853982|NCT02753166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92853983|NCT02753166|Glucocorticoids|glucocorticoids|mesh-ancestor
92853984|NCT02753166|Hormones|hormones|mesh-ancestor
92853985|NCT02753166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92853986|NCT02753166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92853987|NCT02753166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92853988|NCT02753088|Glatiramer Acetate|glatiramer acetate|mesh-list
92853989|NCT02753088|Mannitol|mannitol|mesh-list
92853990|NCT02753088|(T,G)-A-L|(t,g)-a-l|mesh-list
92853991|NCT02753088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92853992|NCT02753088|Diuretics|diuretics|mesh-ancestor
92853993|NCT02753088|Natriuretic Agents|natriuretic agents|mesh-ancestor
92853994|NCT02753088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92853995|NCT02753088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92853996|NCT02753088|Immunologic Factors|immunologic factors|mesh-ancestor
92853997|NCT02753088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92853998|NCT02753088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92853999|NCT02757534|Domperidone|domperidone|mesh-list
92854000|NCT02757534|Antiemetics|antiemetics|mesh-ancestor
92854001|NCT02757534|Autonomic Agents|autonomic agents|mesh-ancestor
92854002|NCT02757534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854003|NCT02757534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854004|NCT02757534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92854005|NCT02757534|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92854006|NCT02757534|Dopamine Agents|dopamine agents|mesh-ancestor
92854007|NCT02757534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854008|NCT02757534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854009|NCT00914901|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92854010|NCT00914901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92854011|NCT00914901|Autonomic Agents|autonomic agents|mesh-ancestor
92854012|NCT00914901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854013|NCT00914901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854014|NCT00914901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92854015|NCT00914901|Respiratory System Agents|respiratory system agents|mesh-ancestor
92854016|NCT00914901|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92854017|NCT00914901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92854018|NCT00914901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92854019|NCT00914901|Adrenergic Agents|adrenergic agents|mesh-ancestor
92854020|NCT00914901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854021|NCT00914901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854022|NCT00797823|Insulin|insulin|mesh-list
92854023|NCT00797823|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92854024|NCT00797823|Glucagon|glucagon|mesh-list
92854025|NCT00797823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92854026|NCT00797823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854027|NCT00797823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499136|NCT02009007|Oxymetazoline|oxymetazoline|mesh-list
92854028|NCT00797823|Hormones|hormones|mesh-ancestor
92854029|NCT00797823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854030|NCT02757144|Esomeprazole|esomeprazole|mesh-list
92854031|NCT02757144|Fexuprazan|fexuprazan|mesh-list
92854032|NCT02757144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92854033|NCT02757144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92854034|NCT02757144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92854035|NCT02757144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854036|NCT02757144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854037|NCT04568616|Letrozole|letrozole|mesh-list
92854038|NCT04568616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854039|NCT04568616|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92854040|NCT04568616|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92854041|NCT04568616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854042|NCT04568616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854043|NCT04568616|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92854044|NCT04568616|Hormone Antagonists|hormone antagonists|mesh-ancestor
92854045|NCT04568616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854046|NCT04568616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854047|NCT00950807|Tiotropium Bromide|tiotropium bromide|mesh-list
92854048|NCT00950807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92854049|NCT00950807|Autonomic Agents|autonomic agents|mesh-ancestor
92854050|NCT00950807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854051|NCT00950807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854052|NCT00950807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92854053|NCT00950807|Respiratory System Agents|respiratory system agents|mesh-ancestor
92854054|NCT00950807|Parasympatholytics|parasympatholytics|mesh-ancestor
92854055|NCT00950807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92854056|NCT00950807|Cholinergic Agents|cholinergic agents|mesh-ancestor
92854057|NCT00950807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854058|NCT00950807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854059|NCT00608881|Ubiquinone|ubiquinone|mesh-list
92854060|NCT00608881|Coenzyme Q10|coenzyme q10|mesh-list
92854061|NCT00608881|Micronutrients|micronutrients|mesh-ancestor
92854062|NCT00608881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854063|NCT00608881|Vitamins|vitamins|mesh-ancestor
92854064|NCT05608395|Carbon-11 methionine|carbon-11 methionine|mesh-list
92854065|NCT05608395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92854066|NCT05608395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854067|NCT04221906|Betamethasone|betamethasone|mesh-list
92854068|NCT04221906|Calcipotriene|calcipotriene|mesh-list
92854069|NCT04221906|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92854070|NCT04221906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854071|NCT04221906|Glucocorticoids|glucocorticoids|mesh-ancestor
92854072|NCT04221906|Hormones|hormones|mesh-ancestor
92854073|NCT04221906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854074|NCT04221906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854075|NCT04221906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92854076|NCT04221906|Respiratory System Agents|respiratory system agents|mesh-ancestor
92854077|NCT04221906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92854078|NCT00945191|Paclitaxel|paclitaxel|mesh-list
92854079|NCT00945191|Carboplatin|carboplatin|mesh-list
92854080|NCT00945191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92854081|NCT00945191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854082|NCT00945191|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854083|NCT00945191|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854084|NCT00945191|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854085|NCT00945191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854086|NCT01082393|Mometasone Furoate|mometasone furoate|mesh-list
92854088|NCT01082393|Tacrolimus|tacrolimus|mesh-list
92854089|NCT01082393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854090|NCT01082393|Immunologic Factors|immunologic factors|mesh-ancestor
92854091|NCT01082393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854092|NCT01082393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92854093|NCT01082393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854094|NCT01082393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854095|NCT01082393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854096|NCT01082393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92854097|NCT01082393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92854098|NCT01082393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854099|NCT01082393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854100|NCT01082393|Analgesics|analgesics|mesh-ancestor
92854101|NCT01082393|Sensory System Agents|sensory system agents|mesh-ancestor
92854102|NCT01082393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854103|NCT01082393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854104|NCT02757066|Melatonin|melatonin|mesh-list
92854105|NCT02757066|Antioxidants|antioxidants|mesh-ancestor
92854106|NCT02757066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854107|NCT02757066|Protective Agents|protective agents|mesh-ancestor
92854108|NCT02757066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854109|NCT02757066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854110|NCT00894673|Heparin|heparin|mesh-list
92854111|NCT00894673|Calcium heparin|calcium heparin|mesh-list
92854112|NCT00894673|Anticoagulants|anticoagulants|mesh-ancestor
92854113|NCT00894673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92854114|NCT00894673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92854115|NCT00894673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854116|NCT00892489|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92854117|NCT00892489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92854118|NCT00892489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92854119|NCT00892489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854120|NCT00892489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854121|NCT00892489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92854122|NCT00892489|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92854123|NCT00892489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92854124|NCT00892489|Serotonin Agents|serotonin agents|mesh-ancestor
92854125|NCT00892489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854126|NCT00892489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854127|NCT00892489|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92854128|NCT00892489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92854129|NCT00892489|Dopamine Agents|dopamine agents|mesh-ancestor
92854130|NCT02752308|Atropine|atropine|mesh-list
92854131|NCT02752308|Epinephrine|epinephrine|mesh-list
92854132|NCT02752308|Fentanyl|fentanyl|mesh-list
92854133|NCT02752308|Bupivacaine|bupivacaine|mesh-list
92854134|NCT02752308|Neostigmine|neostigmine|mesh-list
92854135|NCT02752308|Anesthetics, Local|anesthetics, local|mesh-ancestor
92854136|NCT02752308|Anesthetics|anesthetics|mesh-ancestor
92854137|NCT02752308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854138|NCT02752308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854139|NCT02752308|Sensory System Agents|sensory system agents|mesh-ancestor
92854140|NCT02752308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854141|NCT02752308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92854142|NCT02752308|Narcotics|narcotics|mesh-ancestor
92854143|NCT02752308|Analgesics|analgesics|mesh-ancestor
92854144|NCT02752308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92854145|NCT02752308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92854146|NCT02752308|Anesthetics, General|anesthetics, general|mesh-ancestor
92854147|NCT02752308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92854148|NCT02752308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92854149|NCT02752308|Adrenergic Agents|adrenergic agents|mesh-ancestor
92854150|NCT02752308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854151|NCT02752308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854152|NCT02752308|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92854153|NCT02752308|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92854154|NCT02752308|Autonomic Agents|autonomic agents|mesh-ancestor
92854155|NCT02752308|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92854156|NCT02752308|Respiratory System Agents|respiratory system agents|mesh-ancestor
92854157|NCT02752308|Mydriatics|mydriatics|mesh-ancestor
92854158|NCT02752308|Sympathomimetics|sympathomimetics|mesh-ancestor
92854159|NCT02752308|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92854160|NCT02752308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92854161|NCT02752308|Parasympatholytics|parasympatholytics|mesh-ancestor
92854162|NCT02752308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92854163|NCT02752308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92854164|NCT02752308|Cholinergic Agents|cholinergic agents|mesh-ancestor
92854165|NCT02752308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92854166|NCT02752308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854167|NCT02752308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92854168|NCT00894751|Dexmedetomidine|dexmedetomidine|mesh-list
92854169|NCT00894751|Propofol|propofol|mesh-list
92854170|NCT00894751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92854171|NCT00894751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854172|NCT00894751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854173|NCT00894751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854174|NCT00894751|Analgesics|analgesics|mesh-ancestor
92854175|NCT00894751|Sensory System Agents|sensory system agents|mesh-ancestor
92854176|NCT00894751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854177|NCT00894751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92854178|NCT00894751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92854179|NCT00894751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92854180|NCT00894751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92854181|NCT00894751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854182|NCT00894751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854183|NCT00894751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92854184|NCT00894751|Anesthetics, General|anesthetics, general|mesh-ancestor
92854185|NCT00894751|Anesthetics|anesthetics|mesh-ancestor
92854186|NCT00896077|Lisofylline|lisofylline|mesh-list
92854187|NCT00896077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92854188|NCT00896077|Immunologic Factors|immunologic factors|mesh-ancestor
92854189|NCT00896077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854190|NCT00896077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854191|NCT00896077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854192|NCT00896077|Analgesics|analgesics|mesh-ancestor
92854193|NCT00896077|Sensory System Agents|sensory system agents|mesh-ancestor
92854194|NCT00896077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854195|NCT00896077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854196|NCT00896077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854197|NCT00896077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854199|NCT00792909|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92854200|NCT00792909|Immunologic Factors|immunologic factors|mesh-ancestor
92854201|NCT00792909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854202|NCT00896155|Tamoxifen|tamoxifen|mesh-list
92854203|NCT00896155|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92854204|NCT00896155|Hormone Antagonists|hormone antagonists|mesh-ancestor
92854205|NCT00896155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854206|NCT00896155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854207|NCT00896155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92854208|NCT00896155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854209|NCT00896155|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92854210|NCT00896155|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92854211|NCT00896155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92854212|NCT00896311|Nitroglycerin|nitroglycerin|mesh-list
92854213|NCT00896311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92854214|NCT02751996|Tenofovir|tenofovir|mesh-list
92854215|NCT02751996|Antiviral Agents|antiviral agents|mesh-ancestor
92854216|NCT02751996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854217|NCT02751996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92854218|NCT02751996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92854219|NCT02751996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854220|NCT02751996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854221|NCT02751996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92854222|NCT02751996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92854223|NCT00944645|Niacin|niacin|mesh-list
92854224|NCT00944645|Niacinamide|niacinamide|mesh-list
92854225|NCT00944645|Nicotinic Acids|nicotinic acids|mesh-list
92854226|NCT00944645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92854227|NCT00944645|Antimetabolites|antimetabolites|mesh-ancestor
92854228|NCT00944645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854229|NCT00944645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92854230|NCT00944645|Vasodilator Agents|vasodilator agents|mesh-ancestor
92854231|NCT00944645|Vitamin B Complex|vitamin b complex|mesh-ancestor
92854232|NCT00944645|Vitamins|vitamins|mesh-ancestor
92854233|NCT00944645|Micronutrients|micronutrients|mesh-ancestor
92854234|NCT00944645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854235|NCT02751918|Doxorubicin|doxorubicin|mesh-list
92854236|NCT02751918|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92854237|NCT02751918|Maytansine|maytansine|mesh-list
92854238|NCT02751918|Anetumab ravtansine|anetumab ravtansine|mesh-list
92854239|NCT02751918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92854240|NCT02751918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854241|NCT02751918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92854242|NCT02751918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92854244|NCT02751918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854245|NCT02751918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92854246|NCT02751918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854247|NCT02751918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854248|NCT02751918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854249|NCT02751918|Immunoconjugates|immunoconjugates|mesh-ancestor
92854250|NCT02751918|Immunologic Factors|immunologic factors|mesh-ancestor
92854251|NCT02751918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854252|NCT00901069|Cyclophosphamide|cyclophosphamide|mesh-list
92854253|NCT00901069|Rituximab|rituximab|mesh-list
92854254|NCT00901069|Vincristine|vincristine|mesh-list
92854255|NCT00901069|Azacitidine|azacitidine|mesh-list
92854256|NCT00901069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854257|NCT00901069|Immunologic Factors|immunologic factors|mesh-ancestor
92854258|NCT00901069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854259|NCT00901069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854260|NCT00901069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92854261|NCT00901069|Alkylating Agents|alkylating agents|mesh-ancestor
92854262|NCT00901069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854263|NCT00901069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854264|NCT00901069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92854265|NCT00901069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92854266|NCT00901069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92854267|NCT00901069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854268|NCT00901069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854269|NCT00901069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854270|NCT00901069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854271|NCT00901069|Antimetabolites|antimetabolites|mesh-ancestor
92854272|NCT00901069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854273|NCT02853539|Denosumab|denosumab|mesh-list
92854274|NCT02853539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92854275|NCT02853539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854276|NCT02751840|Caffeine|caffeine|mesh-list
92854277|NCT02751840|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92854278|NCT02751840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854279|NCT02751840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92854280|NCT02751840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854281|NCT02751840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854282|NCT02751840|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92854283|NCT02751840|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92854284|NCT02751840|Purinergic Agents|purinergic agents|mesh-ancestor
92854285|NCT02751840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854286|NCT00894829|Heparin|heparin|mesh-list
92854287|NCT00894829|Calcium heparin|calcium heparin|mesh-list
92854288|NCT00894829|Anticoagulants|anticoagulants|mesh-ancestor
92854289|NCT00894829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92854290|NCT00894829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92854291|NCT00894829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854292|NCT04108845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92854293|NCT04108845|Immunologic Factors|immunologic factors|mesh-ancestor
92854294|NCT04108845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854295|NCT00606229|Aripiprazole|aripiprazole|mesh-list
92854296|NCT00606229|Antidepressive Agents|antidepressive agents|mesh-ancestor
92854297|NCT00606229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92854298|NCT00606229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92854299|NCT00606229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92854300|NCT00606229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854301|NCT00606229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854302|NCT00606229|Dopamine Agonists|dopamine agonists|mesh-ancestor
92854303|NCT00606229|Dopamine Agents|dopamine agents|mesh-ancestor
92854304|NCT00606229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854305|NCT00606229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854306|NCT00606229|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92854307|NCT00606229|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92854308|NCT00606229|Serotonin Agents|serotonin agents|mesh-ancestor
92854309|NCT00606229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92854310|NCT00606229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92854311|NCT00606229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92854312|NCT00606229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92854314|NCT02756598|Dsuvia|dsuvia|mesh-list
92854315|NCT02756598|Propofol|propofol|mesh-list
92854316|NCT02756598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92854317|NCT02756598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854318|NCT02756598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854319|NCT02756598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92854320|NCT02756598|Anesthetics, General|anesthetics, general|mesh-ancestor
92854321|NCT02756598|Anesthetics|anesthetics|mesh-ancestor
92854322|NCT02756598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92854323|NCT02756598|Narcotics|narcotics|mesh-ancestor
92854324|NCT02756598|Analgesics|analgesics|mesh-ancestor
92854325|NCT02756598|Sensory System Agents|sensory system agents|mesh-ancestor
92854326|NCT02756598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854327|NCT02756598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92854328|NCT00950651|Tramadol|tramadol|mesh-list
92854329|NCT00950651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92854330|NCT00950651|Narcotics|narcotics|mesh-ancestor
92854331|NCT00950651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854332|NCT00950651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854333|NCT00950651|Analgesics|analgesics|mesh-ancestor
92854334|NCT00950651|Sensory System Agents|sensory system agents|mesh-ancestor
92854335|NCT00950651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854336|NCT00901147|Bortezomib|bortezomib|mesh-list
92854337|NCT00901147|Panobinostat|panobinostat|mesh-list
92854338|NCT00901147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854339|NCT00901147|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92854340|NCT00901147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854341|NCT00901147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854342|NCT04268537|Antibodies|antibodies|mesh-list
92854343|NCT04268537|Antibodies, Blocking|antibodies, blocking|mesh-list
92854344|NCT04268537|Immunologic Factors|immunologic factors|mesh-ancestor
92854345|NCT04268537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854346|NCT02756130|Carboplatin|carboplatin|mesh-list
92854347|NCT02756130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854348|NCT05598723|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92854349|NCT05598723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92854350|NCT05598723|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92854351|NCT05598723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92854352|NCT05598723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854353|NCT05598723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854354|NCT05598723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92854355|NCT05598723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92854356|NCT05598723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854357|NCT05598723|Cholinergic Agents|cholinergic agents|mesh-ancestor
92854358|NCT05598723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854359|NCT00605293|Epoetin Alfa|epoetin alfa|mesh-list
92854360|NCT00605293|Hematinics|hematinics|mesh-ancestor
92854361|NCT04221126|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92854362|NCT04221126|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92854363|NCT04221126|Dermatologic Agents|dermatologic agents|mesh-ancestor
92854364|NCT05594589|Lemborexant|lemborexant|mesh-list
92854365|NCT05594589|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92854366|NCT05594589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854367|NCT05594589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854368|NCT05594589|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92854369|NCT05594589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92854370|NCT05594589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854371|NCT05594589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854372|NCT00602303|Torsemide|torsemide|mesh-list
92854373|NCT00602303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92854374|NCT00602303|Diuretics|diuretics|mesh-ancestor
92854375|NCT00602303|Natriuretic Agents|natriuretic agents|mesh-ancestor
92854376|NCT00602303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854377|NCT00602303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92854378|NCT00602303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92854379|NCT00602303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854380|NCT00631085|Tocopherols|tocopherols|mesh-list
92854381|NCT00631085|Vitamin E|vitamin e|mesh-list
92854382|NCT00631085|Tocotrienols|tocotrienols|mesh-list
92854383|NCT00631085|alpha-Tocopherol|alpha-tocopherol|mesh-list
92854384|NCT00631085|gamma-Tocopherol|gamma-tocopherol|mesh-list
92854385|NCT00631085|Antioxidants|antioxidants|mesh-ancestor
92854386|NCT00631085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854387|NCT00631085|Protective Agents|protective agents|mesh-ancestor
92854388|NCT00631085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854390|NCT00631085|Micronutrients|micronutrients|mesh-ancestor
92854391|NCT04269863|Aspirin|aspirin|mesh-list
92854392|NCT04269863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854393|NCT04269863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854394|NCT04269863|Analgesics|analgesics|mesh-ancestor
92854395|NCT04269863|Sensory System Agents|sensory system agents|mesh-ancestor
92854396|NCT04269863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854397|NCT04269863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854398|NCT04269863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854399|NCT04269863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854400|NCT04269863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92854401|NCT04269863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92854402|NCT04269863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854403|NCT04269863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92854404|NCT04269863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92854405|NCT04269863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854406|NCT04269863|Antipyretics|antipyretics|mesh-ancestor
92854407|NCT00901381|Lenograstim|lenograstim|mesh-list
92854408|NCT00901381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92854409|NCT00901381|Immunologic Factors|immunologic factors|mesh-ancestor
92854410|NCT00901381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854411|NCT00602381|Lithium Carbonate|lithium carbonate|mesh-list
92854412|NCT00602381|Antidepressive Agents|antidepressive agents|mesh-ancestor
92854413|NCT00602381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92854414|NCT00602381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854415|NCT00602381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854416|NCT00602381|Antimanic Agents|antimanic agents|mesh-ancestor
92854417|NCT00602381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92854418|NCT00602381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854419|NCT00602381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854420|NCT02751528|Vaccines|vaccines|mesh-list
92854421|NCT02751528|Immunologic Factors|immunologic factors|mesh-ancestor
92854422|NCT02751528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854423|NCT00901537|Azacitidine|azacitidine|mesh-list
92854424|NCT00901537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854425|NCT00901537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854426|NCT00901537|Antimetabolites|antimetabolites|mesh-ancestor
92854427|NCT00901537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854428|NCT00901537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854429|NCT00894985|Heparin|heparin|mesh-list
92854430|NCT00894985|Calcium heparin|calcium heparin|mesh-list
92854431|NCT00894985|Anticoagulants|anticoagulants|mesh-ancestor
92854432|NCT00894985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92854433|NCT00894985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92854434|NCT00894985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854435|NCT04585152|Rituximab|rituximab|mesh-list
92854436|NCT04585152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92854437|NCT04585152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854438|NCT04585152|Immunologic Factors|immunologic factors|mesh-ancestor
92854439|NCT04585152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854440|NCT04585152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854441|NCT00943787|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92154388|NCT04361409|Rituximab|rituximab|mesh-list
92854442|NCT00943787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854443|NCT00895063|Botulinum Toxins|botulinum toxins|mesh-list
92854444|NCT00895063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92854445|NCT00895063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92854446|NCT00895063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854447|NCT00895063|Cholinergic Agents|cholinergic agents|mesh-ancestor
92854448|NCT00895063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854449|NCT00895063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854450|NCT02751294|Tafenoquine|tafenoquine|mesh-list
92854451|NCT02751294|Antimalarials|antimalarials|mesh-ancestor
92854452|NCT02751294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92854453|NCT02751294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92854454|NCT02751294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854455|NCT00901615|Lenalidomide|lenalidomide|mesh-list
92854456|NCT00901615|Immunologic Factors|immunologic factors|mesh-ancestor
92854457|NCT00901615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854458|NCT00901615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92854459|NCT00901615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92854460|NCT00901615|Growth Substances|growth substances|mesh-ancestor
92854461|NCT00901615|Growth Inhibitors|growth inhibitors|mesh-ancestor
92854462|NCT00901615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854463|NCT00949325|Sirolimus|sirolimus|mesh-list
92854464|NCT00949325|Doxorubicin|doxorubicin|mesh-list
92854465|NCT00949325|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92854466|NCT00949325|Temsirolimus|temsirolimus|mesh-list
92854467|NCT00949325|MTOR Inhibitors|mtor inhibitors|mesh-list
92854468|NCT00949325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92854469|NCT00949325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854470|NCT00949325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92854471|NCT00949325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92854472|NCT00949325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854473|NCT00949325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854474|NCT00949325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92854475|NCT00949325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854476|NCT00949325|Immunologic Factors|immunologic factors|mesh-ancestor
92854477|NCT00949325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854478|NCT00949325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92854479|NCT00949325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854480|NCT00949325|Antifungal Agents|antifungal agents|mesh-ancestor
92499581|NCT04278833|Dexamethasone|dexamethasone|mesh-list
92854481|NCT02853071|Estramustine|estramustine|mesh-list
92854482|NCT02853071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92854483|NCT02853071|Alkylating Agents|alkylating agents|mesh-ancestor
92854484|NCT02853071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854485|NCT02853071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854486|NCT02853071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92854487|NCT02603757|Vitamin D|vitamin d|mesh-list
92854488|NCT02603757|Cholecalciferol|cholecalciferol|mesh-list
92854489|NCT02603757|Vitamins|vitamins|mesh-ancestor
92854490|NCT02603757|Micronutrients|micronutrients|mesh-ancestor
92854491|NCT02603757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854492|NCT02603757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92854493|NCT02603757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92854494|NCT02758782|Celecoxib|celecoxib|mesh-list
92854495|NCT02758782|Golimumab|golimumab|mesh-list
92854496|NCT02758782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854497|NCT02758782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854498|NCT02758782|Analgesics|analgesics|mesh-ancestor
92854499|NCT02758782|Sensory System Agents|sensory system agents|mesh-ancestor
92854500|NCT02758782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854501|NCT02758782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854502|NCT02758782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854503|NCT02758782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854504|NCT02758782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92854505|NCT02758782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92854506|NCT02758782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854507|NCT02758782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854508|NCT02758782|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92854509|NCT02758782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854510|NCT02758782|Immunologic Factors|immunologic factors|mesh-ancestor
92854511|NCT04221672|Terlipressin|terlipressin|mesh-list
92854512|NCT04221672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92854513|NCT04221672|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92854514|NCT00895297|Dasatinib|dasatinib|mesh-list
92854515|NCT00895297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854516|NCT00895297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92854517|NCT00895297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854518|NCT00895297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854519|NCT00943319|Fludarabine|fludarabine|mesh-list
92854520|NCT00943319|Busulfan|busulfan|mesh-list
92854521|NCT00943319|Alemtuzumab|alemtuzumab|mesh-list
92854522|NCT00943319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854523|NCT00943319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854524|NCT00943319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854525|NCT00943319|Immunologic Factors|immunologic factors|mesh-ancestor
92854526|NCT00943319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854527|NCT00943319|Alkylating Agents|alkylating agents|mesh-ancestor
92854528|NCT00943319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92854529|NCT00943319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92854530|NCT00943319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92854531|NCT02603991|Levetiracetam|levetiracetam|mesh-list
92854532|NCT02603991|Anticonvulsants|anticonvulsants|mesh-ancestor
92854533|NCT02603991|Nootropic Agents|nootropic agents|mesh-ancestor
92854534|NCT02540785|Levofloxacin|levofloxacin|mesh-list
92854535|NCT02540785|Ofloxacin|ofloxacin|mesh-list
92854536|NCT02540785|Tobramycin|tobramycin|mesh-list
92854537|NCT02540785|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92854539|NCT02540785|Dexamethasone acetate|dexamethasone acetate|mesh-list
92854540|NCT02540785|BB 1101|bb 1101|mesh-list
92854541|NCT02540785|Hyaluronic Acid|hyaluronic acid|mesh-list
92854542|NCT02540785|Dipivefrin|dipivefrin|mesh-list
92854543|NCT02540785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854544|NCT02540785|Antiemetics|antiemetics|mesh-ancestor
92854545|NCT02540785|Autonomic Agents|autonomic agents|mesh-ancestor
92854546|NCT02540785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854547|NCT02540785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854548|NCT02540785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92854549|NCT02540785|Glucocorticoids|glucocorticoids|mesh-ancestor
92854550|NCT02540785|Hormones|hormones|mesh-ancestor
92854551|NCT02540785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854552|NCT02540785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92854553|NCT02540785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854554|NCT02540785|Protease Inhibitors|protease inhibitors|mesh-ancestor
92854555|NCT02540785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854556|NCT02540785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854557|NCT02540785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92854558|NCT02540785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854559|NCT02540785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92854560|NCT02540785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92854561|NCT02540785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92854562|NCT02540785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92854563|NCT02540785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92854564|NCT02540785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92854565|NCT02540785|Immunologic Factors|immunologic factors|mesh-ancestor
92854566|NCT02540785|Viscosupplements|viscosupplements|mesh-ancestor
92854567|NCT02540785|Protective Agents|protective agents|mesh-ancestor
92854568|NCT02540785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92854569|NCT02540785|Adrenergic Agents|adrenergic agents|mesh-ancestor
92854570|NCT02540785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854571|NCT02540785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92854572|NCT02540785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92854573|NCT04243278|Aspirin|aspirin|mesh-list
92854574|NCT04243278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92154539|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
92854575|NCT04243278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854576|NCT04243278|Analgesics|analgesics|mesh-ancestor
92854577|NCT04243278|Sensory System Agents|sensory system agents|mesh-ancestor
92854578|NCT04243278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854579|NCT04243278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854580|NCT04243278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854581|NCT04243278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854582|NCT04243278|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92854583|NCT04243278|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92854584|NCT04243278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854585|NCT04243278|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92854586|NCT04243278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92854587|NCT04243278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854588|NCT04243278|Antipyretics|antipyretics|mesh-ancestor
92854589|NCT00915369|Paclitaxel|paclitaxel|mesh-list
92854590|NCT00915369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92854591|NCT00915369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854592|NCT00915369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854593|NCT00915369|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854594|NCT00915369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854595|NCT00915369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854596|NCT00901849|Sirolimus|sirolimus|mesh-list
92854597|NCT00901849|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92854598|NCT00901849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92854599|NCT00901849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854600|NCT00901849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92854601|NCT00901849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854602|NCT00901849|Antifungal Agents|antifungal agents|mesh-ancestor
92854603|NCT00901849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854604|NCT00901849|Immunologic Factors|immunologic factors|mesh-ancestor
92854605|NCT00901849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854606|NCT00901849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92854607|NCT00901849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854608|NCT00901849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854609|NCT04243122|Aspirin|aspirin|mesh-list
92854610|NCT04243122|Apixaban|apixaban|mesh-list
92854611|NCT04243122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854612|NCT04243122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854613|NCT04243122|Analgesics|analgesics|mesh-ancestor
92854614|NCT04243122|Sensory System Agents|sensory system agents|mesh-ancestor
92854615|NCT04243122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854616|NCT04243122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854617|NCT04243122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854618|NCT04243122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854619|NCT04243122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92854620|NCT04243122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92854621|NCT04243122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854622|NCT04243122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92854623|NCT04243122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92854624|NCT04243122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854625|NCT04243122|Antipyretics|antipyretics|mesh-ancestor
92854626|NCT04243122|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92854627|NCT04243122|Antithrombins|antithrombins|mesh-ancestor
92854628|NCT04243122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92854629|NCT04243122|Protease Inhibitors|protease inhibitors|mesh-ancestor
92854630|NCT04243122|Anticoagulants|anticoagulants|mesh-ancestor
92854631|NCT04268927|Letrozole|letrozole|mesh-list
92854632|NCT04268927|LHRH, N-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|lhrh, n-acetyl-(4-chlorophenylalanyl)(1)-(4-chlorophenylalanyl)(2)-tryptophyl(3)-arginyl(6)-alanine(10)-|mesh-list
92854633|NCT04268927|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92854634|NCT04268927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854635|NCT04268927|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92854636|NCT04268927|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92854637|NCT04268927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854638|NCT04268927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854639|NCT04268927|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92854640|NCT04268927|Hormone Antagonists|hormone antagonists|mesh-ancestor
92854641|NCT04268927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854642|NCT04268927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854644|NCT05429580|Tranexamic Acid|tranexamic acid|mesh-list
92854645|NCT05429580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92854646|NCT05429580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92149097|NCT00871689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92854647|NCT05429580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854648|NCT05429580|Hemostatics|hemostatics|mesh-ancestor
92854649|NCT05429580|Coagulants|coagulants|mesh-ancestor
92854650|NCT00790647|Bortezomib|bortezomib|mesh-list
92854651|NCT00790647|Melphalan|melphalan|mesh-list
92854652|NCT00790647|Immunologic Factors|immunologic factors|mesh-ancestor
92854653|NCT00790647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854654|NCT00790647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854655|NCT00790647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92854656|NCT00790647|Alkylating Agents|alkylating agents|mesh-ancestor
92854657|NCT00790647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854658|NCT00790647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92854659|NCT00790647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854660|NCT00286013|Gemcitabine|gemcitabine|mesh-list
92854661|NCT00286013|Oxaliplatin|oxaliplatin|mesh-list
92854662|NCT00286013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854663|NCT00286013|Antimetabolites|antimetabolites|mesh-ancestor
92854664|NCT00286013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854665|NCT00286013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854666|NCT02754882|Paclitaxel|paclitaxel|mesh-list
92854667|NCT02754882|Bevacizumab|bevacizumab|mesh-list
92854668|NCT02754882|Carboplatin|carboplatin|mesh-list
92854669|NCT02754882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92854670|NCT02754882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854671|NCT02754882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854672|NCT02754882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854673|NCT02754882|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854674|NCT02754882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854675|NCT02754882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92854676|NCT02754882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92854677|NCT02754882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92854678|NCT02754882|Growth Substances|growth substances|mesh-ancestor
92854679|NCT02754882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854680|NCT02754882|Growth Inhibitors|growth inhibitors|mesh-ancestor
92854681|NCT00790569|Nicotine|nicotine|mesh-list
92854682|NCT00790569|Varenicline|varenicline|mesh-list
92854683|NCT00790569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92854684|NCT00790569|Autonomic Agents|autonomic agents|mesh-ancestor
92854685|NCT00790569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854686|NCT00790569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854687|NCT00790569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92854688|NCT00790569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92854689|NCT00790569|Cholinergic Agents|cholinergic agents|mesh-ancestor
92854690|NCT00790569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854691|NCT00790569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854693|NCT00939029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92854694|NCT00939029|Autonomic Agents|autonomic agents|mesh-ancestor
92854695|NCT00939029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854696|NCT00939029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854697|NCT00939029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92854698|NCT00939029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92854699|NCT00939029|Cholinergic Agents|cholinergic agents|mesh-ancestor
92854700|NCT00939029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854701|NCT00939029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854702|NCT00602615|Torsemide|torsemide|mesh-list
92854703|NCT00602615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92854704|NCT00602615|Diuretics|diuretics|mesh-ancestor
92854705|NCT00602615|Natriuretic Agents|natriuretic agents|mesh-ancestor
92854706|NCT00602615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433299|NCT01573806|Incretins|incretins|mesh-ancestor
92433428|NCT01575483|Incretins|incretins|mesh-ancestor
92854707|NCT00602615|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92433656|NCT01577095|Rosiglitazone|rosiglitazone|mesh-list
92433948|NCT01578564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158825|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
92434164|NCT01579760|Aflibercept|aflibercept|mesh-list
92854708|NCT00602615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92854709|NCT00602615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854710|NCT00604253|Insulin|insulin|mesh-list
92434543|NCT01590901|Antioxidants|antioxidants|mesh-ancestor
92854711|NCT00604253|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92854712|NCT00604253|Insulin Detemir|insulin detemir|mesh-list
92434685|NCT01591889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92434761|NCT01592201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92854713|NCT00604253|Isophane Insulin, Human|isophane insulin, human|mesh-list
92434836|NCT01592526|Nicotine|nicotine|mesh-list
92854714|NCT00604253|Insulin, Isophane|insulin, isophane|mesh-list
92854715|NCT00604253|Isophane insulin, beef|isophane insulin, beef|mesh-list
92435065|NCT01593826|Antidotes|antidotes|mesh-ancestor
92435140|NCT01594229|Rituximab|rituximab|mesh-list
92435196|NCT01594502|Dutasteride|dutasteride|mesh-list
92854716|NCT00604253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435345|NCT01595633|Tenofovir|tenofovir|mesh-list
92854717|NCT00604253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854718|NCT02754960|Thalidomide|thalidomide|mesh-list
92435545|NCT01596400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435620|NCT01596647|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92435698|NCT01596855|Epoetin Alfa|epoetin alfa|mesh-list
92854719|NCT02754960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854720|NCT02754960|Immunologic Factors|immunologic factors|mesh-ancestor
92854721|NCT02754960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854722|NCT02754960|Leprostatic Agents|leprostatic agents|mesh-ancestor
92854723|NCT02754960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92854724|NCT02754960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435925|NCT01597817|Hemostatics|hemostatics|mesh-ancestor
92854725|NCT02754960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92854726|NCT02754960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92854727|NCT02754960|Growth Substances|growth substances|mesh-ancestor
92854728|NCT02754960|Growth Inhibitors|growth inhibitors|mesh-ancestor
92854729|NCT02754960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436295|NCT05689619|Silybin|silybin|mesh-list
92436594|NCT04690855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436668|NCT04463498|Sympathomimetics|sympathomimetics|mesh-ancestor
92854731|NCT00587847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436960|NCT05703373|Micronutrients|micronutrients|mesh-list
92854732|NCT00587847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437108|NCT04706429|Trientine|trientine|mesh-list
92854733|NCT02540239|Simethicone|simethicone|mesh-list
92437207|NCT03841110|Nivolumab|nivolumab|mesh-list
92854734|NCT02540239|Antifoaming Agents|antifoaming agents|mesh-ancestor
92854735|NCT02540239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854736|NCT02540239|Emollients|emollients|mesh-ancestor
92854737|NCT02540239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92854738|NCT02540395|Mycophenolic Acid|mycophenolic acid|mesh-list
92437864|NCT01859026|Mitogens|mitogens|mesh-list
92854739|NCT02540395|Prednisolone|prednisolone|mesh-list
92854740|NCT02540395|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92854741|NCT02540395|Methylprednisolone|methylprednisolone|mesh-list
92854742|NCT02540395|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92854743|NCT02540395|Prednisolone acetate|prednisolone acetate|mesh-list
92854744|NCT02540395|Tacrolimus|tacrolimus|mesh-list
92854745|NCT02540395|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92854746|NCT02540395|Prednisolone phosphate|prednisolone phosphate|mesh-list
92854747|NCT02540395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854748|NCT02540395|Immunologic Factors|immunologic factors|mesh-ancestor
92854749|NCT02540395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854750|NCT02540395|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92854751|NCT02540395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438229|NCT01610947|Sensory System Agents|sensory system agents|mesh-ancestor
92854752|NCT02540395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438305|NCT01611480|Imiquimod|imiquimod|mesh-list
92854753|NCT02540395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92854754|NCT02540395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438516|NCT01612975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854755|NCT02540395|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92854756|NCT02540395|Antitubercular Agents|antitubercular agents|mesh-ancestor
92438741|NCT01614041|Serotonin Agents|serotonin agents|mesh-ancestor
92438810|NCT01614366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854757|NCT02540395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438957|NCT01615393|Ribavirin|ribavirin|mesh-list
92439175|NCT01616927|Lanreotide|lanreotide|mesh-list
92854758|NCT02540395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854759|NCT02540395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854760|NCT02540395|Glucocorticoids|glucocorticoids|mesh-ancestor
92854761|NCT02540395|Hormones|hormones|mesh-ancestor
92439252|NCT01617226|Azacitidine|azacitidine|mesh-list
92439393|NCT01617928|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92439468|NCT01618591|Rifaximin|rifaximin|mesh-list
92977218|NCT00586157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439692|NCT01619683|Enclomiphene|enclomiphene|mesh-list
92154745|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92854762|NCT02540395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92854763|NCT02540395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92854765|NCT02540395|Autonomic Agents|autonomic agents|mesh-ancestor
92977219|NCT00586157|Dopamine Agents|dopamine agents|mesh-ancestor
92440129|NCT01622283|Histamine Agents|histamine agents|mesh-ancestor
92854766|NCT02540395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854767|NCT02540395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92440287|NCT01623336|Interferon-alpha|interferon-alpha|mesh-list
92854768|NCT02540395|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92854769|NCT02540395|Protective Agents|protective agents|mesh-ancestor
92854770|NCT05565729|Levocetirizine|levocetirizine|mesh-list
92977220|NCT00586157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854771|NCT05565729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92854772|NCT05565729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92854773|NCT05565729|Histamine Antagonists|histamine antagonists|mesh-ancestor
92854774|NCT05565729|Histamine Agents|histamine agents|mesh-ancestor
92854775|NCT05565729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854776|NCT05565729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854777|NCT05565729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854778|NCT04547166|Bevacizumab|bevacizumab|mesh-list
92977221|NCT02552654|Hydrocortisone|hydrocortisone|mesh-list
92854779|NCT04547166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92854780|NCT04547166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854781|NCT04547166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92854782|NCT04547166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92854783|NCT04547166|Growth Substances|growth substances|mesh-ancestor
92441085|NCT01628952|Curare|curare|mesh-list
92441534|NCT01631526|Vitamin D|vitamin d|mesh-list
92854785|NCT04547166|Growth Inhibitors|growth inhibitors|mesh-ancestor
92441684|NCT01633086|Nitric Oxide|nitric oxide|mesh-list
92441758|NCT01633749|Vaccines|vaccines|mesh-list
92854788|NCT00602693|Fludarabine|fludarabine|mesh-list
92854789|NCT00602693|Fludarabine phosphate|fludarabine phosphate|mesh-list
92854790|NCT00602693|Allopurinol|allopurinol|mesh-list
92442056|NCT01635686|Etanercept|etanercept|mesh-list
92854791|NCT00602693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854792|NCT00602693|Immunologic Factors|immunologic factors|mesh-ancestor
92854793|NCT00602693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442350|NCT01635426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854795|NCT00602693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92854796|NCT00602693|Alkylating Agents|alkylating agents|mesh-ancestor
92854797|NCT00602693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854798|NCT00602693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854799|NCT00602693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92854800|NCT00602693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854801|NCT00602693|Antimetabolites|antimetabolites|mesh-ancestor
92854802|NCT00602693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92442648|NCT01638078|Thalidomide|thalidomide|mesh-list
92854803|NCT00602693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854804|NCT00602693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92854805|NCT00602693|Antifungal Agents|antifungal agents|mesh-ancestor
92854806|NCT00602693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854808|NCT00602693|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92854809|NCT00602693|Antioxidants|antioxidants|mesh-ancestor
92854810|NCT00602693|Protective Agents|protective agents|mesh-ancestor
92854811|NCT00902395|Midazolam|midazolam|mesh-list
92854812|NCT00902395|Ketamine|ketamine|mesh-list
92854813|NCT00902395|Analgesics|analgesics|mesh-ancestor
92854814|NCT00902395|Sensory System Agents|sensory system agents|mesh-ancestor
92854815|NCT00902395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854816|NCT00902395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854817|NCT00902395|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92854818|NCT00902395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92854819|NCT00902395|Anesthetics, General|anesthetics, general|mesh-ancestor
92854820|NCT00902395|Anesthetics|anesthetics|mesh-ancestor
92854821|NCT00902395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854822|NCT00902395|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92854823|NCT00902395|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92854824|NCT00902395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854825|NCT00902395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854826|NCT00902395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92854827|NCT00902395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92854828|NCT00902395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92854829|NCT00902395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92443389|NCT01650883|Vitamins|vitamins|mesh-list
92854830|NCT00902395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92854831|NCT00902395|GABA Modulators|gaba modulators|mesh-ancestor
92854832|NCT00902395|GABA Agents|gaba agents|mesh-ancestor
92854833|NCT04213404|Spartalizumab|spartalizumab|mesh-list
92854834|NCT04213404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92854835|NCT04213404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854836|NCT04213404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92854837|NCT04213404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854838|NCT00604409|Capecitabine|capecitabine|mesh-list
92854839|NCT00604409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854840|NCT00604409|Antimetabolites|antimetabolites|mesh-ancestor
92854841|NCT00604409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854842|NCT00604409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854843|NCT00905905|Simvastatin|simvastatin|mesh-list
92854845|NCT00905905|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92854846|NCT00905905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92854847|NCT00905905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92854848|NCT00905905|Antimetabolites|antimetabolites|mesh-ancestor
92854849|NCT00905905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854850|NCT00905905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92854851|NCT00905905|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92854852|NCT00905905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854853|NCT00902473|Topiramate|topiramate|mesh-list
92443467|NCT01651390|Sirolimus|sirolimus|mesh-list
92854854|NCT00902473|Anticonvulsants|anticonvulsants|mesh-ancestor
92443491|NCT01651416|Antimalarials|antimalarials|mesh-ancestor
92854855|NCT00902473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92854856|NCT00902473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443793|NCT01652599|Hormones|hormones|mesh-ancestor
92854857|NCT05177484|Ferric maltol|ferric maltol|mesh-list
92854858|NCT05177484|Hematinics|hematinics|mesh-ancestor
92854859|NCT04104789|Oxymetazoline|oxymetazoline|mesh-list
92854860|NCT04104789|Tetracaine|tetracaine|mesh-list
92854861|NCT04104789|Carticaine|carticaine|mesh-list
92443869|NCT01653067|Antiemetics|antiemetics|mesh-ancestor
92854862|NCT04104789|Anesthetics, Local|anesthetics, local|mesh-ancestor
92854864|NCT04104789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854865|NCT04104789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854866|NCT04104789|Sensory System Agents|sensory system agents|mesh-ancestor
92854867|NCT04104789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854868|NCT04104789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92854869|NCT04104789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92854870|NCT04104789|Adrenergic Agents|adrenergic agents|mesh-ancestor
92854871|NCT04104789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854872|NCT04104789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854873|NCT04104789|Sympathomimetics|sympathomimetics|mesh-ancestor
92854874|NCT04104789|Autonomic Agents|autonomic agents|mesh-ancestor
92854875|NCT04104789|Nasal Decongestants|nasal decongestants|mesh-ancestor
92854876|NCT04104789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92854877|NCT04104789|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444352|NCT01655875|Plerixafor|plerixafor|mesh-list
92854878|NCT00938717|Linaclotide|linaclotide|mesh-list
92854879|NCT00938717|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92854880|NCT00938717|Enzyme Activators|enzyme activators|mesh-ancestor
92854881|NCT00938717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854882|NCT00938717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92854884|NCT00905983|Docetaxel|docetaxel|mesh-list
92854885|NCT00905983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854886|NCT00905983|Antimetabolites|antimetabolites|mesh-ancestor
92444505|NCT01656512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92977222|NCT02552654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977223|NCT00809744|Cholecalciferol|cholecalciferol|mesh-list
92854887|NCT00905983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977224|NCT00809744|Vitamin D|vitamin d|mesh-list
92444847|NCT01658033|Leucovorin|leucovorin|mesh-list
92444925|NCT01658449|Hyaluronic Acid|hyaluronic acid|mesh-list
92854888|NCT00905983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854889|NCT00905983|Tubulin Modulators|tubulin modulators|mesh-ancestor
92854890|NCT00905983|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854891|NCT00905983|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854892|NCT00906061|Gemcitabine|gemcitabine|mesh-list
92854893|NCT00906061|Docetaxel|docetaxel|mesh-list
92854894|NCT00906061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92854895|NCT00906061|Antimetabolites|antimetabolites|mesh-ancestor
92154889|NCT04140461|Amebicides|amebicides|mesh-ancestor
92854896|NCT00906061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854897|NCT00906061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446100|NCT01666249|Antibodies|antibodies|mesh-list
92854898|NCT00906061|Tubulin Modulators|tubulin modulators|mesh-ancestor
92446172|NCT01666678|Analgesics|analgesics|mesh-ancestor
92446395|NCT01668446|Estradiol|estradiol|mesh-list
92446480|NCT01668927|Bismuth|bismuth|mesh-list
92854899|NCT00906061|Antimitotic Agents|antimitotic agents|mesh-ancestor
92854900|NCT00906061|Mitosis Modulators|mitosis modulators|mesh-ancestor
92854902|NCT02602509|Pyrazinamide|pyrazinamide|mesh-list
92854903|NCT02602509|Celecoxib|celecoxib|mesh-list
92854904|NCT02602509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854905|NCT02602509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92854906|NCT02602509|Analgesics|analgesics|mesh-ancestor
92854907|NCT02602509|Sensory System Agents|sensory system agents|mesh-ancestor
92854908|NCT02602509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854909|NCT02602509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854910|NCT02602509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92854911|NCT02602509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854912|NCT02602509|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92854913|NCT02602509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92854914|NCT02602509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854915|NCT02602509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854916|NCT02602509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92854917|NCT02602509|Antitubercular Agents|antitubercular agents|mesh-ancestor
92854918|NCT02602509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92854919|NCT02602509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854920|NCT02602509|Leprostatic Agents|leprostatic agents|mesh-ancestor
92854921|NCT02602509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92854922|NCT02602509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92854923|NCT02602509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92854924|NCT02602509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92854925|NCT02602509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92854926|NCT02602509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92854927|NCT02602509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92854928|NCT02852837|Daratumumab|daratumumab|mesh-list
92854929|NCT02852837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854930|NCT00897871|Cyclophosphamide|cyclophosphamide|mesh-list
92500042|NCT01163357|Sirolimus|sirolimus|mesh-list
92854932|NCT00897871|Etoposide|etoposide|mesh-list
92854933|NCT00897871|Etoposide phosphate|etoposide phosphate|mesh-list
92854934|NCT00897871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92854935|NCT00897871|Immunologic Factors|immunologic factors|mesh-ancestor
92854936|NCT00897871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854937|NCT00897871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92854938|NCT00897871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92854939|NCT00897871|Alkylating Agents|alkylating agents|mesh-ancestor
92854940|NCT00897871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854941|NCT00897871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92854942|NCT00897871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92854943|NCT00897871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92854944|NCT00897871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92854945|NCT00897871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92854946|NCT00897871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92854947|NCT00902707|Phenylpropanolamine|phenylpropanolamine|mesh-list
92854948|NCT00902707|Guaifenesin|guaifenesin|mesh-list
92447368|NCT04231838|Nicotine|nicotine|mesh-list
92447378|NCT04218266|Apixaban|apixaban|mesh-list
92447443|NCT03928093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92447518|NCT03571308|Glucocorticoids|glucocorticoids|mesh-ancestor
92447746|NCT02812862|Cholinergic Agents|cholinergic agents|mesh-ancestor
92447823|NCT05838105|Progesterone|progesterone|mesh-list
92447899|NCT05836545|Anesthetics|anesthetics|mesh-ancestor
92448047|NCT05597254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92448127|NCT05312242|Vitamins|vitamins|mesh-ancestor
92448199|NCT05069935|Immunologic Factors|immunologic factors|mesh-ancestor
92448353|NCT04256317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448648|NCT01684982|Sirolimus|sirolimus|mesh-list
92448742|NCT01688362|Hormones|hormones|mesh-ancestor
92448795|NCT01690247|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92448868|NCT01690403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448942|NCT01690702|Docetaxel|docetaxel|mesh-list
92854949|NCT00902707|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92854950|NCT00902707|Expectorants|expectorants|mesh-ancestor
92854951|NCT00902707|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449238|NCT01693081|Apomorphine|apomorphine|mesh-list
92854952|NCT00902707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92854953|NCT00902707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92449408|NCT05288725|Hormones|hormones|mesh-ancestor
92854954|NCT00902707|Adrenergic Agents|adrenergic agents|mesh-ancestor
92854955|NCT00902707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854956|NCT00902707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449685|NCT05294666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92854957|NCT00902707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854958|NCT00902707|Appetite Depressants|appetite depressants|mesh-ancestor
92854959|NCT00902707|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92854960|NCT00902707|Sympathomimetics|sympathomimetics|mesh-ancestor
92450298|NCT04871425|Narcotics|narcotics|mesh-ancestor
92854961|NCT00902707|Autonomic Agents|autonomic agents|mesh-ancestor
92450740|NCT04096066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92854962|NCT00902707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854963|NCT00902707|Nasal Decongestants|nasal decongestants|mesh-ancestor
92854964|NCT00902707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92854965|NCT00906139|Fentanyl|fentanyl|mesh-list
92854966|NCT00906139|Midazolam|midazolam|mesh-list
92854967|NCT00906139|Propofol|propofol|mesh-list
92854968|NCT00906139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92854969|NCT00906139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92854970|NCT00906139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92854971|NCT00906139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92854972|NCT00906139|Anesthetics, General|anesthetics, general|mesh-ancestor
92854973|NCT00906139|Anesthetics|anesthetics|mesh-ancestor
92854974|NCT00906139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92854975|NCT00906139|Narcotics|narcotics|mesh-ancestor
92854976|NCT00906139|Analgesics|analgesics|mesh-ancestor
92854977|NCT00906139|Sensory System Agents|sensory system agents|mesh-ancestor
92854978|NCT00906139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92854980|NCT00906139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92854981|NCT00906139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92854982|NCT00906139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92451022|NCT05801029|Osimertinib|osimertinib|mesh-list
92854983|NCT00906139|GABA Modulators|gaba modulators|mesh-ancestor
92854984|NCT00906139|GABA Agents|gaba agents|mesh-ancestor
92854985|NCT00906139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92854986|NCT00906139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92854987|NCT00906295|Chrysarobin|chrysarobin|mesh-list
92451549|NCT04732065|Dopamine|dopamine|mesh-list
92854988|NCT00906295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92854990|NCT00906295|Analgesics|analgesics|mesh-ancestor
92451916|NCT02960230|Nivolumab|nivolumab|mesh-list
92854991|NCT00906295|Sensory System Agents|sensory system agents|mesh-ancestor
92854992|NCT00906295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452213|NCT03759184|Obinutuzumab|obinutuzumab|mesh-list
92854993|NCT00906295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452367|NCT03569475|Milnacipran|milnacipran|mesh-list
92854994|NCT00906295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452591|NCT05436964|Analgesics|analgesics|mesh-ancestor
92452737|NCT02203773|Antimetabolites|antimetabolites|mesh-ancestor
92854996|NCT02754102|Sunscreening Agents|sunscreening agents|mesh-list
92854997|NCT02754102|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92854998|NCT02754102|Protective Agents|protective agents|mesh-ancestor
92453041|NCT02512172|Romidepsin|romidepsin|mesh-list
92854999|NCT02754102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855000|NCT02754102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92855002|NCT00134303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855003|NCT00134303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855005|NCT00902941|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92855006|NCT00902941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855007|NCT00902941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855008|NCT00902941|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92855009|NCT00902941|Protective Agents|protective agents|mesh-ancestor
92855010|NCT00902941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855011|NCT02754258|Methylphenidate|methylphenidate|mesh-list
92855012|NCT02754258|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92855013|NCT02754258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855014|NCT02754258|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92149171|NCT02154243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92855015|NCT02754258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92855016|NCT02754258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855017|NCT02754258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855018|NCT02754258|Dopamine Agents|dopamine agents|mesh-ancestor
92855019|NCT02754258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855021|NCT04267991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92855022|NCT04267991|Immunologic Factors|immunologic factors|mesh-ancestor
92453394|NCT01828840|Antitussive Agents|antitussive agents|mesh-ancestor
92855023|NCT04267991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453565|NCT00942877|Cediranib|cediranib|mesh-list
92855024|NCT04267991|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92453632|NCT00066950|Fluorides|fluorides|mesh-list
92855025|NCT04267991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454149|NCT01697722|Hormones|hormones|mesh-ancestor
92454451|NCT01699802|Anesthetics|anesthetics|mesh-list
92454454|NCT01699828|Buspirone|buspirone|mesh-list
92454523|NCT01700322|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92855026|NCT04267991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855027|NCT02852681|Drospirenone|drospirenone|mesh-list
92455055|NCT01703559|Phentolamine|phentolamine|mesh-list
92855028|NCT02852681|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92855030|NCT02852681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455213|NCT01704638|Digoxin|digoxin|mesh-list
92855031|NCT02852681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455430|NCT01705743|Anesthetics, General|anesthetics, general|mesh-ancestor
92855032|NCT02852681|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92855033|NCT02852681|Diuretics|diuretics|mesh-ancestor
92455800|NCT01708369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855036|NCT02754180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855037|NCT02754180|Antimetabolites|antimetabolites|mesh-ancestor
92855038|NCT02754180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456244|NCT01710904|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92456318|NCT01711437|Antifoaming Agents|antifoaming agents|mesh-ancestor
92855039|NCT02754180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855040|NCT00602849|Sertraline|sertraline|mesh-list
92456475|NCT01712100|Irbesartan|irbesartan|mesh-list
92855041|NCT00602849|Antidepressive Agents|antidepressive agents|mesh-ancestor
92456544|NCT01712464|Oxytocin|oxytocin|mesh-list
92855043|NCT00602849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92855044|NCT00602849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92456915|NCT01714297|Dalteparin|dalteparin|mesh-list
92457284|NCT01716624|Oxybutynin|oxybutynin|mesh-list
92457365|NCT01717118|Vaccines|vaccines|mesh-list
92855045|NCT00602849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457447|NCT01717729|Iodine|iodine|mesh-list
92457508|NCT01718054|Amebicides|amebicides|mesh-ancestor
92457583|NCT01718314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92457659|NCT01718626|Docetaxel|docetaxel|mesh-list
92457812|NCT01719601|Sensory System Agents|sensory system agents|mesh-ancestor
92457898|NCT01719835|Hormones|hormones|mesh-ancestor
92458034|NCT01724892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458113|NCT01730157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92855046|NCT00602849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458193|NCT01730664|Ertapenem|ertapenem|mesh-list
92458266|NCT01731132|Copper|copper|mesh-list
92855047|NCT00602849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855048|NCT00602849|Serotonin Agents|serotonin agents|mesh-ancestor
92855049|NCT00602849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855050|NCT00906451|Simvastatin|simvastatin|mesh-list
92855051|NCT00906451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92855052|NCT00906451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92459156|NCT01737294|Capsaicin|capsaicin|mesh-list
92459229|NCT01737671|Micronutrients|micronutrients|mesh-ancestor
92855053|NCT00906451|Antimetabolites|antimetabolites|mesh-ancestor
92459378|NCT01738815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92855054|NCT00906451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459754|NCT01741558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855055|NCT00906451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92855056|NCT00906451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92855057|NCT00906451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855058|NCT00898417|Paclitaxel|paclitaxel|mesh-list
92855059|NCT00898417|Bevacizumab|bevacizumab|mesh-list
92855061|NCT00898417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92460201|NCT01743885|Sympathomimetics|sympathomimetics|mesh-ancestor
92460275|NCT01744249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460432|NCT01745549|Insulin|insulin|mesh-list
92855063|NCT00898417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92855064|NCT00898417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92855065|NCT00898417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92460647|NCT01746771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92460948|NCT01748344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461022|NCT01748630|Analgesics|analgesics|mesh-ancestor
92461051|NCT01748721|Antibodies|antibodies|mesh-list
92461246|NCT01749475|Anesthetics, General|anesthetics, general|mesh-ancestor
92461325|NCT01750099|Adrenergic Agents|adrenergic agents|mesh-ancestor
92461476|NCT01751074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92461547|NCT01751828|Serotonin Agents|serotonin agents|mesh-ancestor
92855066|NCT00898417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855067|NCT00898417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855068|NCT00898417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92855069|NCT00898417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92855070|NCT00898417|Growth Substances|growth substances|mesh-ancestor
92855071|NCT00898417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855072|NCT00898417|Growth Inhibitors|growth inhibitors|mesh-ancestor
92855073|NCT05381363|Interferons|interferons|mesh-list
92855074|NCT05381363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855075|NCT05381363|Antiviral Agents|antiviral agents|mesh-ancestor
92855076|NCT05381363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855077|NCT00906529|Insulin Aspart|insulin aspart|mesh-list
92855078|NCT00906529|Insulin Detemir|insulin detemir|mesh-list
92855079|NCT00906529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855080|NCT00906529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855082|NCT00783705|Vitamin B Complex|vitamin b complex|mesh-ancestor
92855083|NCT00783705|Vitamins|vitamins|mesh-ancestor
92855084|NCT00783705|Micronutrients|micronutrients|mesh-ancestor
92855085|NCT00783705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855086|NCT02755350|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92855087|NCT02755350|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92855088|NCT02755350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92855089|NCT02755350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855090|NCT02755350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855091|NCT02755350|Antiviral Agents|antiviral agents|mesh-ancestor
92855092|NCT02755350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855093|NCT02755350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92855094|NCT02755350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92855095|NCT04103697|Capecitabine|capecitabine|mesh-list
92855096|NCT04103697|Oxaliplatin|oxaliplatin|mesh-list
92855097|NCT04103697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855098|NCT04103697|Antimetabolites|antimetabolites|mesh-ancestor
92855099|NCT04103697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855100|NCT04103697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855101|NCT00898573|Lapatinib|lapatinib|mesh-list
92462264|NCT01756781|Midazolam|midazolam|mesh-list
92855102|NCT00898573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855103|NCT00898573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92855104|NCT00898573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855105|NCT00898573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855106|NCT04321668|Hylan|hylan|mesh-list
92855107|NCT04321668|Viscosupplements|viscosupplements|mesh-ancestor
92855108|NCT04321668|Protective Agents|protective agents|mesh-ancestor
92855109|NCT04321668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855110|NCT02851745|Linagliptin|linagliptin|mesh-list
92855111|NCT02851745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855112|NCT02851745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855113|NCT02851745|Incretins|incretins|mesh-ancestor
92855114|NCT02851745|Hormones|hormones|mesh-ancestor
92855115|NCT02851745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855116|NCT02851745|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92855117|NCT02851745|Protease Inhibitors|protease inhibitors|mesh-ancestor
92855118|NCT02851745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462683|NCT01759394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855119|NCT02851745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855121|NCT02602197|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92855122|NCT02602197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92462895|NCT01760226|Prednisone|prednisone|mesh-list
92463115|NCT01760980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92855125|NCT02602197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855126|NCT02602197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855128|NCT02602197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463713|NCT01764451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92855129|NCT02602197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855130|NCT02602197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855131|NCT02753712|Fluticasone|fluticasone|mesh-list
92855133|NCT02753712|Formoterol Fumarate|formoterol fumarate|mesh-list
92855134|NCT02753712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855136|NCT02753712|Autonomic Agents|autonomic agents|mesh-ancestor
92855137|NCT02753712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855138|NCT02753712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855139|NCT02753712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855140|NCT02753712|Respiratory System Agents|respiratory system agents|mesh-ancestor
92855141|NCT02753712|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464603|NCT01769183|Squalamine|squalamine|mesh-list
92855142|NCT02753712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92464675|NCT01769677|Analgesics|analgesics|mesh-ancestor
92855143|NCT02753712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92855144|NCT02753712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92464844|NCT01770223|Ribavirin|ribavirin|mesh-list
92464903|NCT01770600|Dopamine Agents|dopamine agents|mesh-ancestor
92855145|NCT02753712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92855146|NCT02753712|Adrenergic Agents|adrenergic agents|mesh-ancestor
92465262|NCT01773408|Antimetabolites|antimetabolites|mesh-ancestor
92855148|NCT02753712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855149|NCT04220892|Pembrolizumab|pembrolizumab|mesh-list
92465494|NCT01775618|Factor VIII|factor viii|mesh-list
92465576|NCT01776515|Tramadol|tramadol|mesh-list
92855151|NCT04220892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855152|NCT04220892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855154|NCT04220892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855155|NCT04220892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466009|NCT01779882|Alkylating Agents|alkylating agents|mesh-ancestor
92466164|NCT01780909|Domperidone|domperidone|mesh-list
92466315|NCT01782300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466390|NCT01782846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855156|NCT04220892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92855157|NCT04220892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92855158|NCT02696148|Liraglutide|liraglutide|mesh-list
92855159|NCT02696148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855160|NCT02696148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855161|NCT02696148|Incretins|incretins|mesh-ancestor
92466772|NCT01785446|Analgesics|analgesics|mesh-ancestor
92467073|NCT01787396|Metformin|metformin|mesh-list
92855162|NCT02696148|Hormones|hormones|mesh-ancestor
92192117|NCT00484393|Tetracaine|tetracaine|mesh-list
92467288|NCT01788982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92977225|NCT00809744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92467439|NCT01789879|Contraceptive Agents|contraceptive agents|mesh-ancestor
92977226|NCT00809744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467585|NCT01796132|Citalopram|citalopram|mesh-list
92855163|NCT02696148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855164|NCT00887198|Prednisone|prednisone|mesh-list
92855165|NCT00887198|Abiraterone Acetate|abiraterone acetate|mesh-list
92192701|NCT00490009|Iodine|iodine|mesh-list
92855166|NCT00887198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855167|NCT00887198|Glucocorticoids|glucocorticoids|mesh-ancestor
92977228|NCT00809744|Micronutrients|micronutrients|mesh-ancestor
92977229|NCT00809744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92468322|NCT01804413|Insulin|insulin|mesh-list
92855169|NCT00887198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855170|NCT00887198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855171|NCT00887198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855172|NCT00887198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855173|NCT00887198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92855174|NCT00887198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855175|NCT00887198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855176|NCT00887198|Hormone Antagonists|hormone antagonists|mesh-ancestor
92855177|NCT00887198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92855178|NCT04342585|Progesterone|progesterone|mesh-list
92855179|NCT04342585|Progestins|progestins|mesh-ancestor
92855180|NCT04342585|Hormones|hormones|mesh-ancestor
92855181|NCT04342585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855182|NCT04342585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855183|NCT02831894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92855184|NCT02831894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155253|NCT03067974|Analgesics|analgesics|mesh-ancestor
92468533|NCT01808586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855185|NCT02831894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855187|NCT00782067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469219|NCT01813617|Hormones|hormones|mesh-ancestor
92469377|NCT01814319|Probenecid|probenecid|mesh-list
92855188|NCT00782067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92855189|NCT00782067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977231|NCT00246337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92469587|NCT01815255|Tenofovir|tenofovir|mesh-list
92855190|NCT00782067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855191|NCT05520723|Loperamide|loperamide|mesh-list
92855192|NCT05520723|Antidiarrheals|antidiarrheals|mesh-list
92469811|NCT01817257|Heparin|heparin|mesh-list
92855193|NCT05520723|Lenograstim|lenograstim|mesh-list
92855194|NCT05520723|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92977232|NCT00246337|Serotonin Agents|serotonin agents|mesh-ancestor
92855195|NCT05520723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92855196|NCT05520723|Immunologic Factors|immunologic factors|mesh-ancestor
92470322|NCT01820897|Trimethoprim|trimethoprim|mesh-list
92470396|NCT01821235|Gabapentin|gabapentin|mesh-list
92470549|NCT01822405|Vitamin E|vitamin e|mesh-list
92855197|NCT05520723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470924|NCT01825031|Antimetabolites|antimetabolites|mesh-ancestor
92855198|NCT05520723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855199|NCT05520723|Immunoconjugates|immunoconjugates|mesh-ancestor
92855201|NCT02826746|Analgesics|analgesics|mesh-ancestor
92855202|NCT02826746|Sensory System Agents|sensory system agents|mesh-ancestor
92471382|NCT01828437|Pyridoxine|pyridoxine|mesh-list
92471592|NCT01830270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92855203|NCT02826746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471890|NCT01840800|Ropivacaine|ropivacaine|mesh-list
92472114|NCT01842230|Vitamins|vitamins|mesh-ancestor
92472182|NCT01842893|Narcotics|narcotics|mesh-ancestor
92855204|NCT02826746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855205|NCT02826746|Anesthetics|anesthetics|mesh-ancestor
92472334|NCT01843699|Topiramate|topiramate|mesh-list
92855206|NCT02826746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855207|NCT02826746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92855208|NCT02826746|Anticonvulsants|anticonvulsants|mesh-ancestor
92472930|NCT01847495|Irinotecan|irinotecan|mesh-list
92473123|NCT01848743|Tenofovir|tenofovir|mesh-list
92473157|NCT01848873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92855209|NCT02826746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92473232|NCT01849835|Menthol|menthol|mesh-list
92855210|NCT02826746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855211|NCT02826746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855212|NCT02826746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92855213|NCT02826746|Tocolytic Agents|tocolytic agents|mesh-ancestor
92855214|NCT02826746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92855215|NCT02750904|Nicotine|nicotine|mesh-list
92855216|NCT02750904|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92855217|NCT02750904|Autonomic Agents|autonomic agents|mesh-ancestor
92855218|NCT02750904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855219|NCT02750904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855220|NCT02750904|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92855221|NCT02750904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92855222|NCT02750904|Cholinergic Agents|cholinergic agents|mesh-ancestor
92855223|NCT02750904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855224|NCT02750904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855225|NCT02831972|Itraconazole|itraconazole|mesh-list
92855226|NCT02831972|Antifungal Agents|antifungal agents|mesh-ancestor
92855227|NCT02831972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855228|NCT02831972|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92855229|NCT02831972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92855230|NCT02831972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855231|NCT02831972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855232|NCT02831972|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92855233|NCT02831972|Hormone Antagonists|hormone antagonists|mesh-ancestor
92855234|NCT02831972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855235|NCT02831972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855236|NCT02831972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92855237|NCT02695758|Bupivacaine|bupivacaine|mesh-list
92855238|NCT02695758|Anesthetics, Local|anesthetics, local|mesh-ancestor
92855239|NCT02695758|Anesthetics|anesthetics|mesh-ancestor
92155328|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
92855240|NCT02695758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855241|NCT02695758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855242|NCT02695758|Sensory System Agents|sensory system agents|mesh-ancestor
92855243|NCT02695758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855244|NCT00605215|Interferons|interferons|mesh-list
92855246|NCT00605215|Interferon-beta|interferon-beta|mesh-list
92855247|NCT00605215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855248|NCT00605215|Antiviral Agents|antiviral agents|mesh-ancestor
92855249|NCT00605215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855250|NCT00605215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92855251|NCT00605215|Immunologic Factors|immunologic factors|mesh-ancestor
92855252|NCT00605215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855253|NCT02827682|Anesthetics|anesthetics|mesh-list
92855254|NCT02827682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855255|NCT02827682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855256|NCT02826200|Acenocoumarol|acenocoumarol|mesh-list
92855257|NCT02826200|Anticoagulants|anticoagulants|mesh-ancestor
92855258|NCT04244708|Temozolomide|temozolomide|mesh-list
92473794|NCT01853800|Anticoagulants|anticoagulants|mesh-ancestor
92855259|NCT04244708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92855260|NCT04244708|Alkylating Agents|alkylating agents|mesh-ancestor
92473857|NCT01854411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855261|NCT04244708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855262|NCT04244708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855264|NCT02750748|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92855265|NCT02750748|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92855266|NCT02750748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855267|NCT02750748|Sensory System Agents|sensory system agents|mesh-ancestor
92855268|NCT02750748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855270|NCT00604279|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92855271|NCT00604279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92855272|NCT00604279|Serotonin Agents|serotonin agents|mesh-ancestor
92474084|NCT01855581|Ketamine|ketamine|mesh-list
92855273|NCT00604279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977233|NCT00246337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855274|NCT00604279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855275|NCT00604279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855276|NCT00604279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92855277|NCT00604279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92855278|NCT00604279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855279|NCT00604279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92855280|NCT00604279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92855281|NCT00604279|Dopamine Agents|dopamine agents|mesh-ancestor
92474301|NCT01856959|Magnesium Sulfate|magnesium sulfate|mesh-list
92855282|NCT00604279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92855283|NCT00604279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92855284|NCT00635856|Gefitinib|gefitinib|mesh-list
92474439|NCT01857479|Autonomic Agents|autonomic agents|mesh-ancestor
92474512|NCT01857817|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92855285|NCT00635856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855286|NCT00635856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92855287|NCT00635856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474662|NCT01858090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92855288|NCT00635856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855289|NCT00906685|Bevacizumab|bevacizumab|mesh-list
92855290|NCT00906685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855291|NCT00906685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855292|NCT00906685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92474811|NCT01858831|Atovaquone|atovaquone|mesh-list
92855293|NCT00906685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92855294|NCT00906685|Growth Substances|growth substances|mesh-ancestor
92855295|NCT00906685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855296|NCT00906685|Growth Inhibitors|growth inhibitors|mesh-ancestor
92855297|NCT05660720|Moxifloxacin|moxifloxacin|mesh-list
92855298|NCT05660720|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92855299|NCT05660720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92855300|NCT05660720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855301|NCT05660720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92855302|NCT05660720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474943|NCT01859858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855304|NCT05660720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855305|NCT05660720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475175|NCT01861223|Afatinib|afatinib|mesh-list
92475475|NCT01863485|Vorolanib|vorolanib|mesh-list
92855306|NCT05660720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92855307|NCT05660720|Contraceptive Agents|contraceptive agents|mesh-ancestor
92855308|NCT05660720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92855309|NCT05660720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855310|NCT05660720|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92855311|NCT05660720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92855312|NCT05660720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92855313|NCT02695212|Apremilast|apremilast|mesh-list
92855314|NCT02695212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92855315|NCT02695212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92855316|NCT02695212|Analgesics|analgesics|mesh-ancestor
92855317|NCT02695212|Sensory System Agents|sensory system agents|mesh-ancestor
92855318|NCT02695212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855319|NCT02695212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855320|NCT02695212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855321|NCT02695212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855322|NCT02695212|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92855323|NCT02695212|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92855324|NCT02695212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855325|NCT02695212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855327|NCT05381207|Xhance|xhance|mesh-list
92475816|NCT01865916|Cathartics|cathartics|mesh-ancestor
92475892|NCT01866553|Interferons|interferons|mesh-list
92855328|NCT05381207|Montelukast|montelukast|mesh-list
92855329|NCT05381207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855330|NCT05381207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92855331|NCT05381207|Autonomic Agents|autonomic agents|mesh-ancestor
92855332|NCT05381207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855333|NCT05381207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855334|NCT05381207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855335|NCT05381207|Respiratory System Agents|respiratory system agents|mesh-ancestor
92855336|NCT05381207|Dermatologic Agents|dermatologic agents|mesh-ancestor
92855337|NCT05381207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92855338|NCT05381207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92855339|NCT05381207|Hormone Antagonists|hormone antagonists|mesh-ancestor
92855340|NCT05381207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855341|NCT05381207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92855342|NCT05381207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92855343|NCT05381207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855344|NCT02750670|Dexamethasone|dexamethasone|mesh-list
92855345|NCT02750670|Gemcitabine|gemcitabine|mesh-list
92855346|NCT02750670|Obinutuzumab|obinutuzumab|mesh-list
92855347|NCT02750670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855348|NCT02750670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855349|NCT02750670|Antiemetics|antiemetics|mesh-ancestor
92855350|NCT02750670|Autonomic Agents|autonomic agents|mesh-ancestor
92855351|NCT02750670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855352|NCT02750670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855353|NCT02750670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855354|NCT02750670|Glucocorticoids|glucocorticoids|mesh-ancestor
92476097|NCT01868438|Artesunate|artesunate|mesh-list
92855355|NCT02750670|Hormones|hormones|mesh-ancestor
92855356|NCT02750670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855357|NCT02750670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855358|NCT02750670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855359|NCT02750670|Antimetabolites|antimetabolites|mesh-ancestor
92855360|NCT02750670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476611|NCT01871493|Insulin Lispro|insulin lispro|mesh-list
92476684|NCT01871701|Serotonin Agents|serotonin agents|mesh-ancestor
92855361|NCT02750670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855362|NCT00605891|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92477063|NCT05855629|Analgesics|analgesics|mesh-ancestor
92855363|NCT00605891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92855364|NCT00605891|Autonomic Agents|autonomic agents|mesh-ancestor
92855365|NCT00605891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477433|NCT05531994|Hormone Antagonists|hormone antagonists|mesh-ancestor
92477653|NCT05184842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855366|NCT00605891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855367|NCT00605891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855368|NCT00605891|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477953|NCT04255160|Estradiol|estradiol|mesh-list
92478027|NCT04062656|Fluorouracil|fluorouracil|mesh-list
92855369|NCT00605891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92855370|NCT00605891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92478256|NCT03340220|Itraconazole|itraconazole|mesh-list
92478335|NCT02664935|Docetaxel|docetaxel|mesh-list
92855371|NCT00605891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92478568|NCT01873144|Epinephrine|epinephrine|mesh-list
92478632|NCT01873430|Melatonin|melatonin|mesh-list
92855372|NCT00605891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92855373|NCT00605891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478856|NCT01875172|Dopamine Agents|dopamine agents|mesh-ancestor
92478924|NCT01875757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478997|NCT01876121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479071|NCT01876641|Vemurafenib|vemurafenib|mesh-list
92855374|NCT00605891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855376|NCT05122208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92479216|NCT01878188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479292|NCT01878578|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92855377|NCT05122208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855378|NCT05122208|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92855379|NCT05122208|Histamine Antagonists|histamine antagonists|mesh-ancestor
92855380|NCT05122208|Histamine Agents|histamine agents|mesh-ancestor
92479596|NCT01880931|Remifentanil|remifentanil|mesh-list
92855381|NCT05122208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479664|NCT01881997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855382|NCT05122208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855383|NCT05122208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855384|NCT00781911|Octreotide|octreotide|mesh-list
92855385|NCT00781911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855386|NCT00781911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855387|NCT00781911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855388|NCT00605917|Sertraline|sertraline|mesh-list
92855389|NCT00605917|Antidepressive Agents|antidepressive agents|mesh-ancestor
92855390|NCT00605917|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92855391|NCT00605917|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92855392|NCT00605917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92855393|NCT00605917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855394|NCT00605917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855395|NCT00605917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855396|NCT00605917|Serotonin Agents|serotonin agents|mesh-ancestor
92479981|NCT01884506|Iron|iron|mesh-list
92855397|NCT00605917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855399|NCT04919096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92480101|NCT01885338|Expectorants|expectorants|mesh-ancestor
92855400|NCT04919096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92480328|NCT01886573|Entinostat|entinostat|mesh-list
92855401|NCT04919096|Growth Substances|growth substances|mesh-ancestor
92855402|NCT04919096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855403|NCT04919096|Growth Inhibitors|growth inhibitors|mesh-ancestor
92855404|NCT04919096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480770|NCT01888822|Ciprofloxacin|ciprofloxacin|mesh-list
92855405|NCT02746848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92480917|NCT01889680|Oxaliplatin|oxaliplatin|mesh-list
92480993|NCT01891292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92855406|NCT02746848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92855407|NCT00781599|Varenicline|varenicline|mesh-list
92855408|NCT00781599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92855409|NCT00781599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92481448|NCT01901198|Interferons|interferons|mesh-list
92855410|NCT00781599|Cholinergic Agents|cholinergic agents|mesh-ancestor
92855411|NCT00781599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855412|NCT00781599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481737|NCT01903018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855413|NCT00781599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855414|NCT00904111|Lidocaine|lidocaine|mesh-list
92855415|NCT00904111|Anesthetics, Local|anesthetics, local|mesh-ancestor
92855416|NCT00904111|Anesthetics|anesthetics|mesh-ancestor
92482188|NCT01906411|Dopamine Agents|dopamine agents|mesh-ancestor
92855417|NCT00904111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855418|NCT00904111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482565|NCT01908621|Cytarabine|cytarabine|mesh-list
92855419|NCT00904111|Sensory System Agents|sensory system agents|mesh-ancestor
92482652|NCT01909830|Gemcitabine|gemcitabine|mesh-list
92482729|NCT01910155|Hormones|hormones|mesh-ancestor
92855420|NCT00904111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855421|NCT00904111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92482935|NCT01911234|Immunologic Factors|immunologic factors|mesh-ancestor
92855422|NCT00904111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92483236|NCT01912898|Vitamin D|vitamin d|mesh-list
92855423|NCT00904111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92855424|NCT00904111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483529|NCT01914965|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92483602|NCT01915472|Immunoconjugates|immunoconjugates|mesh-list
92855425|NCT00904111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855426|NCT03240211|Pembrolizumab|pembrolizumab|mesh-list
92855427|NCT03240211|Decitabine|decitabine|mesh-list
92855428|NCT03240211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855429|NCT03240211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855430|NCT03240211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92855431|NCT03240211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855432|NCT03240211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855433|NCT03240211|Antimetabolites|antimetabolites|mesh-ancestor
92855434|NCT03240211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855435|NCT04278144|Nivolumab|nivolumab|mesh-list
92855436|NCT04278144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855437|NCT04278144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855438|NCT04278144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92855439|NCT04278144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855440|NCT00899197|Tamoxifen|tamoxifen|mesh-list
92855441|NCT00899197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92855442|NCT00899197|Hormone Antagonists|hormone antagonists|mesh-ancestor
92484185|NCT01918813|Vancomycin|vancomycin|mesh-list
92977234|NCT00246337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855443|NCT00899197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855444|NCT00899197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500571|NCT02012517|Cefazolin|cefazolin|mesh-list
92855445|NCT00899197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855446|NCT00899197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855447|NCT00899197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92855448|NCT00899197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92855449|NCT00899197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92855450|NCT00603083|Ketorolac|ketorolac|mesh-list
92855451|NCT00603083|Ropivacaine|ropivacaine|mesh-list
92855452|NCT00603083|Anesthetics, Local|anesthetics, local|mesh-ancestor
92855453|NCT00603083|Anesthetics|anesthetics|mesh-ancestor
92484560|NCT01930019|Thiopental|thiopental|mesh-list
92855454|NCT00603083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855455|NCT00603083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855456|NCT00603083|Sensory System Agents|sensory system agents|mesh-ancestor
92484707|NCT01930812|Listerine|listerine|mesh-list
92855457|NCT00603083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855458|NCT00603083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92855459|NCT00603083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92855460|NCT00603083|Analgesics|analgesics|mesh-ancestor
92855461|NCT00603083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855462|NCT00603083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855463|NCT00603083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92855464|NCT00603083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855465|NCT00603083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855466|NCT05379257|Furosemide|furosemide|mesh-list
92855467|NCT05379257|Diuretics|diuretics|mesh-ancestor
92855468|NCT05379257|Natriuretic Agents|natriuretic agents|mesh-ancestor
92977237|NCT05012943|Immunologic Factors|immunologic factors|mesh-ancestor
92855469|NCT05379257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855470|NCT05379257|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92855471|NCT05379257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855472|NCT05379257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855473|NCT04241744|Vancomycin|vancomycin|mesh-list
92485362|NCT01935141|Triiodobenzoic Acids|triiodobenzoic acids|mesh-list
92855474|NCT04241744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92855475|NCT04241744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855477|NCT02824094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485580|NCT01936025|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92855478|NCT02824094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92855479|NCT02824094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855480|NCT02824094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855481|NCT00899587|Enalapril|enalapril|mesh-list
92855482|NCT00899587|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92855483|NCT00899587|Protease Inhibitors|protease inhibitors|mesh-ancestor
92855484|NCT00899587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855485|NCT00899587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855486|NCT00899587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92855487|NCT04268069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92855488|NCT04268069|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92855489|NCT02824406|Acetazolamide|acetazolamide|mesh-list
92855490|NCT02824406|Anticonvulsants|anticonvulsants|mesh-ancestor
92855491|NCT02824406|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92855492|NCT02824406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855493|NCT02824406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855494|NCT02824406|Diuretics|diuretics|mesh-ancestor
92855495|NCT02824406|Natriuretic Agents|natriuretic agents|mesh-ancestor
92855496|NCT02824406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485879|NCT01937767|Fentanyl|fentanyl|mesh-list
92486240|NCT01939743|Diclofenac|diclofenac|mesh-list
92855497|NCT04267679|Cannabidiol|cannabidiol|mesh-list
92855498|NCT04267679|Anticonvulsants|anticonvulsants|mesh-ancestor
92855499|NCT04951388|Somatomedin B|somatomedin b|mesh-list
92855500|NCT04951388|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92855501|NCT04951388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92855502|NCT04951388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92855503|NCT04951388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855504|NCT04951388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855505|NCT04242914|Midazolam|midazolam|mesh-list
92855506|NCT04242914|Ketamine|ketamine|mesh-list
92855507|NCT04242914|Analgesics|analgesics|mesh-ancestor
92855508|NCT04242914|Sensory System Agents|sensory system agents|mesh-ancestor
92855509|NCT04242914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855510|NCT04242914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855511|NCT04242914|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92855512|NCT04242914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92855513|NCT04242914|Anesthetics, General|anesthetics, general|mesh-ancestor
92855514|NCT04242914|Anesthetics|anesthetics|mesh-ancestor
92855515|NCT04242914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855516|NCT04242914|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92855517|NCT04242914|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92855518|NCT04242914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855519|NCT04242914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855520|NCT04242914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92855521|NCT04242914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92855522|NCT04242914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92855523|NCT04242914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92855524|NCT04242914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92855525|NCT04242914|GABA Modulators|gaba modulators|mesh-ancestor
92855527|NCT00780273|Cimetidine|cimetidine|mesh-list
92855528|NCT00780273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92855529|NCT00780273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855530|NCT00780273|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92855531|NCT00780273|Histamine Antagonists|histamine antagonists|mesh-ancestor
92855532|NCT00780273|Histamine Agents|histamine agents|mesh-ancestor
92855533|NCT00780273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486828|NCT01943409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92486878|NCT01943630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855534|NCT00780273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855535|NCT00780273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855536|NCT00780273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92855537|NCT00780273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92855538|NCT00780273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855539|NCT02827136|Lidocaine|lidocaine|mesh-list
92855540|NCT02827136|Anesthetics, Local|anesthetics, local|mesh-ancestor
92855541|NCT02827136|Anesthetics|anesthetics|mesh-ancestor
92855542|NCT02827136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855543|NCT02827136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855544|NCT02827136|Sensory System Agents|sensory system agents|mesh-ancestor
92855545|NCT02827136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855546|NCT02827136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92855547|NCT02827136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92855548|NCT02827136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92855549|NCT02827136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855550|NCT02827136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855551|NCT04102995|Pregnanolone|pregnanolone|mesh-list
92855552|NCT04102995|Anesthetics|anesthetics|mesh-ancestor
92855553|NCT04102995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855554|NCT04102995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855555|NCT00899821|Aldesleukin|aldesleukin|mesh-list
92855556|NCT00899821|Interleukin-12|interleukin-12|mesh-list
92855557|NCT00899821|Sargramostim|sargramostim|mesh-list
92855558|NCT00899821|Immunologic Factors|immunologic factors|mesh-ancestor
92855559|NCT00899821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855560|NCT00899821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487100|NCT01945476|GABA Agents|gaba agents|mesh-ancestor
92855561|NCT00899821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92855562|NCT00899821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92855563|NCT00899821|Antiviral Agents|antiviral agents|mesh-ancestor
92855564|NCT00899821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92855565|NCT00899821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92855566|NCT00899821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92855567|NCT00899821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92855568|NCT00899821|Growth Substances|growth substances|mesh-ancestor
92855569|NCT00899821|Growth Inhibitors|growth inhibitors|mesh-ancestor
92855571|NCT00005112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855572|NCT00005112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855573|NCT04163406|Ferrous fumarate|ferrous fumarate|mesh-list
92855574|NCT04163406|Trace Elements|trace elements|mesh-ancestor
92855575|NCT04163406|Micronutrients|micronutrients|mesh-ancestor
92855576|NCT04163406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855577|NCT04218552|Amlodipine|amlodipine|mesh-list
92855578|NCT04218552|Telmisartan|telmisartan|mesh-list
92855579|NCT04218552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92855580|NCT04218552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92855581|NCT04218552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855582|NCT04218552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855583|NCT04218552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92855584|NCT04218552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855585|NCT04218552|Vasodilator Agents|vasodilator agents|mesh-ancestor
92855586|NCT04218552|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92855587|NCT04218552|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92855588|NCT00904657|Sunitinib|sunitinib|mesh-list
92855589|NCT00904657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855590|NCT00904657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92855591|NCT00904657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92855592|NCT00904657|Growth Substances|growth substances|mesh-ancestor
92855593|NCT00904657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855594|NCT00904657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92855595|NCT00904657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92855596|NCT00904657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855597|NCT00904657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855598|NCT00904735|Imatinib Mesylate|imatinib mesylate|mesh-list
92855599|NCT00904735|Hydroxyurea|hydroxyurea|mesh-list
92855600|NCT00904735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855601|NCT00904735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92855602|NCT00904735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855603|NCT00904735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855604|NCT00904735|Antisickling Agents|antisickling agents|mesh-ancestor
92855605|NCT00904735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92855606|NCT02823626|Spironolactone|spironolactone|mesh-list
92855607|NCT02823626|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92855608|NCT02823626|Hormone Antagonists|hormone antagonists|mesh-ancestor
92855609|NCT02823626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855610|NCT02823626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855611|NCT02823626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92855612|NCT02823626|Diuretics|diuretics|mesh-ancestor
92855613|NCT02823626|Natriuretic Agents|natriuretic agents|mesh-ancestor
92855614|NCT00779259|Quinine|quinine|mesh-list
92855615|NCT00779259|Theophylline|theophylline|mesh-list
92855616|NCT00779259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92855617|NCT00779259|Autonomic Agents|autonomic agents|mesh-ancestor
92855618|NCT00779259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855619|NCT00779259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855620|NCT00779259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855621|NCT00779259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92855622|NCT00779259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92855623|NCT00779259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855624|NCT00779259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855625|NCT00779259|Vasodilator Agents|vasodilator agents|mesh-ancestor
92855626|NCT00779259|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92487696|NCT04898478|Analgesics|analgesics|mesh-ancestor
92487761|NCT04475016|Alkylating Agents|alkylating agents|mesh-ancestor
92487836|NCT03427736|Ketorolac|ketorolac|mesh-list
92855627|NCT00779259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92487989|NCT00323856|Factor VIII|factor viii|mesh-list
92855629|NCT00779259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855630|NCT00779259|Antimalarials|antimalarials|mesh-ancestor
92488511|NCT01945879|Heparin|heparin|mesh-list
92855631|NCT00779259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92488669|NCT01946906|Rifaximin|rifaximin|mesh-list
92855632|NCT00779259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92488840|NCT01947998|Warfarin|warfarin|mesh-list
92855633|NCT00779259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489034|NCT01949168|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92855634|NCT00779259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92855635|NCT00779259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92489256|NCT01950546|Fluorides|fluorides|mesh-list
92855636|NCT00779259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489549|NCT01952756|Cilostazol|cilostazol|mesh-list
92489624|NCT05876039|Narcotics|narcotics|mesh-ancestor
92855638|NCT00779259|Sensory System Agents|sensory system agents|mesh-ancestor
92855640|NCT02746380|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92855641|NCT02746380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855642|NCT02746380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855643|NCT02745990|Epoetin Alfa|epoetin alfa|mesh-list
92855644|NCT02745990|Hematinics|hematinics|mesh-ancestor
92855645|NCT00915915|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92855646|NCT00915915|Gestodene|gestodene|mesh-list
92855647|NCT00915915|Femovan|femovan|mesh-list
92855648|NCT00915915|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92855649|NCT00915915|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92855651|NCT00915915|Contraceptive Agents|contraceptive agents|mesh-ancestor
92490513|NCT04237103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855652|NCT00915915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92855653|NCT00915915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855654|NCT00915915|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92855655|NCT00915915|Estrogens|estrogens|mesh-ancestor
92855656|NCT00915915|Hormones|hormones|mesh-ancestor
92855657|NCT00915915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855658|NCT00915915|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92855659|NCT00915915|Progestins|progestins|mesh-ancestor
92855660|NCT00915915|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92855661|NCT02538367|Prucalopride|prucalopride|mesh-list
92855662|NCT02538367|YH12852|yh12852|mesh-list
92855663|NCT02538367|Laxatives|laxatives|mesh-ancestor
92500797|NCT02013089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490728|NCT03348423|Analgesics|analgesics|mesh-ancestor
92855664|NCT02538367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855665|NCT02538367|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92855666|NCT02538367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92855667|NCT02538367|Serotonin Agents|serotonin agents|mesh-ancestor
92855668|NCT02538367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855669|NCT02538367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491032|NCT02106572|Mitomycins|mitomycins|mesh-list
92491278|NCT01953757|Vitamins|vitamins|mesh-list
92855670|NCT02538367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855672|NCT00900445|Prednisolone|prednisolone|mesh-list
92491700|NCT01955759|Vasodilator Agents|vasodilator agents|mesh-ancestor
92855673|NCT00900445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92855674|NCT00900445|Methylprednisolone|methylprednisolone|mesh-list
92855675|NCT00900445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92855676|NCT00900445|Prednisolone acetate|prednisolone acetate|mesh-list
92855678|NCT00900445|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92855679|NCT00900445|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92855680|NCT00900445|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92855681|NCT00900445|Cortisone|cortisone|mesh-list
92855683|NCT00900445|Daunorubicin|daunorubicin|mesh-list
92492662|NCT01963754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92855684|NCT00900445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92855685|NCT00900445|Prednisolone phosphate|prednisolone phosphate|mesh-list
92855686|NCT00900445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492926|NCT01964846|Curcumin|curcumin|mesh-list
92855687|NCT00900445|Glucocorticoids|glucocorticoids|mesh-ancestor
92855688|NCT00900445|Hormones|hormones|mesh-ancestor
92855689|NCT00900445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855690|NCT00900445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855691|NCT00900445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855692|NCT00900445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855693|NCT00900445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92855694|NCT00900445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92855695|NCT00900445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92855696|NCT00900445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92977238|NCT05012943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855697|NCT00900445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855698|NCT00900445|Antiemetics|antiemetics|mesh-ancestor
92855700|NCT00900445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977239|NCT01581853|Ritonavir|ritonavir|mesh-list
92855701|NCT00900445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855702|NCT00900445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92855703|NCT00900445|Protective Agents|protective agents|mesh-ancestor
92855704|NCT00900445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92855705|NCT00900445|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92855706|NCT00900445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92855707|NCT00900445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855708|NCT03994419|Anesthetics|anesthetics|mesh-list
92494582|NCT01976143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855709|NCT03994419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92855710|NCT03994419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855711|NCT00936065|Etanercept|etanercept|mesh-list
92855712|NCT00936065|Acitretin|acitretin|mesh-list
92855713|NCT00936065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92855714|NCT00936065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92855715|NCT00936065|Analgesics|analgesics|mesh-ancestor
92855716|NCT00936065|Sensory System Agents|sensory system agents|mesh-ancestor
92855717|NCT00936065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855718|NCT00936065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855719|NCT00936065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855720|NCT00936065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494666|NCT01977209|Gossypol|gossypol|mesh-list
92855721|NCT00936065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494867|NCT01978782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92855722|NCT00936065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92855723|NCT00936065|Immunologic Factors|immunologic factors|mesh-ancestor
92855724|NCT00936065|Keratolytic Agents|keratolytic agents|mesh-ancestor
92855725|NCT00936065|Dermatologic Agents|dermatologic agents|mesh-ancestor
92855726|NCT04241276|Paclitaxel|paclitaxel|mesh-list
92855727|NCT04241276|Gemcitabine|gemcitabine|mesh-list
92855728|NCT04241276|Tretinoin|tretinoin|mesh-list
92855729|NCT04241276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92855730|NCT04241276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855731|NCT04241276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92855732|NCT04241276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92855733|NCT04241276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92855734|NCT04241276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494942|NCT01979653|Analgesics|analgesics|mesh-ancestor
92855735|NCT04241276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855736|NCT04241276|Antimetabolites|antimetabolites|mesh-ancestor
92855737|NCT04241276|Keratolytic Agents|keratolytic agents|mesh-ancestor
92855738|NCT04241276|Dermatologic Agents|dermatologic agents|mesh-ancestor
92855739|NCT00905047|Leucovorin|leucovorin|mesh-list
92855740|NCT00905047|Folic Acid|folic acid|mesh-list
92855741|NCT00905047|Tegafur|tegafur|mesh-list
92855742|NCT00905047|Levoleucovorin|levoleucovorin|mesh-list
92495231|NCT01981889|Prednisone|prednisone|mesh-list
92855743|NCT00905047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92855745|NCT00905047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855746|NCT00905047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855747|NCT00905047|Antidotes|antidotes|mesh-ancestor
92855748|NCT00905047|Protective Agents|protective agents|mesh-ancestor
92855749|NCT00905047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855750|NCT00905047|Vitamin B Complex|vitamin b complex|mesh-ancestor
92855752|NCT00905047|Micronutrients|micronutrients|mesh-ancestor
92855753|NCT00905047|Hematinics|hematinics|mesh-ancestor
92855754|NCT04102449|Apremilast|apremilast|mesh-list
92855755|NCT04102449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92855756|NCT04102449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92855757|NCT04102449|Analgesics|analgesics|mesh-ancestor
92855758|NCT04102449|Sensory System Agents|sensory system agents|mesh-ancestor
92855759|NCT04102449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855760|NCT04102449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855761|NCT04102449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855762|NCT04102449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855763|NCT04102449|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92855764|NCT04102449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92855765|NCT04102449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855766|NCT04102449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855767|NCT02823236|Triamcinolone|triamcinolone|mesh-list
92855768|NCT02823236|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92855769|NCT02823236|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92855770|NCT02823236|Pirfenidone|pirfenidone|mesh-list
92855771|NCT02823236|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92855772|NCT02823236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855773|NCT02823236|Glucocorticoids|glucocorticoids|mesh-ancestor
92855774|NCT02823236|Hormones|hormones|mesh-ancestor
92855775|NCT02823236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855776|NCT02823236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855777|NCT02823236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92855778|NCT02823236|Immunologic Factors|immunologic factors|mesh-ancestor
92855779|NCT02823236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855780|NCT02823236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855781|NCT02823236|Analgesics|analgesics|mesh-ancestor
92855782|NCT02823236|Sensory System Agents|sensory system agents|mesh-ancestor
92855783|NCT02823236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855784|NCT02823236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92855785|NCT02823236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92855786|NCT02823236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92855787|NCT02823236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855788|NCT00633698|Niacin|niacin|mesh-list
92855789|NCT00633698|Nicotinic Acids|nicotinic acids|mesh-list
92855790|NCT00633698|Niacinamide|niacinamide|mesh-list
92855791|NCT00633698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92855792|NCT00633698|Antimetabolites|antimetabolites|mesh-ancestor
92855793|NCT00633698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495401|NCT01983449|Hormones|hormones|mesh-ancestor
92855794|NCT00633698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92155929|NCT04765085|Aripiprazole|aripiprazole|mesh-list
92855795|NCT00633698|Vasodilator Agents|vasodilator agents|mesh-ancestor
92855796|NCT00633698|Vitamin B Complex|vitamin b complex|mesh-ancestor
92855797|NCT00633698|Vitamins|vitamins|mesh-ancestor
92855798|NCT00633698|Micronutrients|micronutrients|mesh-ancestor
92495776|NCT01985750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495850|NCT01986036|Calcium|calcium|mesh-list
92855799|NCT00633698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855801|NCT02825342|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92855802|NCT02825342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92855803|NCT02825342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92855804|NCT02825342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496002|NCT01986764|Dopamine Agents|dopamine agents|mesh-ancestor
92496065|NCT01987128|Sensory System Agents|sensory system agents|mesh-ancestor
92855805|NCT02825342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855807|NCT02825342|Serotonin Agents|serotonin agents|mesh-ancestor
92855808|NCT02825342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977242|NCT01581853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92977243|NCT01581853|Protease Inhibitors|protease inhibitors|mesh-ancestor
92977244|NCT01581853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496812|NCT01993290|Ropivacaine|ropivacaine|mesh-list
92496888|NCT01993979|Antimetabolites|antimetabolites|mesh-ancestor
92855809|NCT02825342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92855810|NCT02825342|Antidepressive Agents|antidepressive agents|mesh-ancestor
92855812|NCT02825342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855814|NCT02749890|Lixisenatide|lixisenatide|mesh-list
92855815|NCT02749890|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92855816|NCT02749890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855817|NCT04242758|Dapagliflozin|dapagliflozin|mesh-list
92855818|NCT04242758|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92855819|NCT04242758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92855820|NCT04242758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855822|NCT04242758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497336|NCT01996683|Deferiprone|deferiprone|mesh-list
92855823|NCT04242758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92855824|NCT04242758|Diuretics|diuretics|mesh-ancestor
92855825|NCT04242758|Natriuretic Agents|natriuretic agents|mesh-ancestor
92855826|NCT04242758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92855827|NCT04242758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92855828|NCT02745912|Metformin|metformin|mesh-list
92855829|NCT02745912|Naltrexone|naltrexone|mesh-list
92855830|NCT02745912|Bupropion|bupropion|mesh-list
92855831|NCT02745912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855832|NCT02745912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855833|NCT02745912|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92855834|NCT02745912|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92855835|NCT02745912|Sensory System Agents|sensory system agents|mesh-ancestor
92855836|NCT02745912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855837|NCT02745912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92855838|NCT02745912|Antidepressive Agents|antidepressive agents|mesh-ancestor
92855839|NCT02745912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497627|NCT01998685|Propofol|propofol|mesh-list
92855840|NCT02745912|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92855841|NCT02745912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92497759|NCT01999686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855842|NCT02745912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497906|NCT02000947|Durvalumab|durvalumab|mesh-list
92497983|NCT02001285|Remifentanil|remifentanil|mesh-list
92498057|NCT02001584|GABA Agents|gaba agents|mesh-ancestor
92855843|NCT02745912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855844|NCT02745912|Dopamine Agents|dopamine agents|mesh-ancestor
92855845|NCT02745912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855846|NCT02745912|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92855847|NCT02745912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92855850|NCT02825186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855851|NCT02825186|Antiemetics|antiemetics|mesh-ancestor
92499197|NCT05778227|Eusol|eusol|mesh-list
92499254|NCT05777694|Anesthetics|anesthetics|mesh-list
92499332|NCT05587894|Ritonavir|ritonavir|mesh-list
92855853|NCT02825186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499700|NCT03994731|Antiemetics|antiemetics|mesh-ancestor
92855854|NCT02825186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500081|NCT00863369|Immunologic Factors|immunologic factors|mesh-ancestor
92855855|NCT02825186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855856|NCT02825186|Glucocorticoids|glucocorticoids|mesh-ancestor
92500603|NCT02012920|Seviteronel|seviteronel|mesh-list
92500615|NCT02012946|Simendan|simendan|mesh-list
92500677|NCT02013232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500750|NCT02013856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92500836|NCT02014454|Propranolol|propranolol|mesh-list
92501053|NCT02015650|Mitomycin|mitomycin|mesh-list
92501127|NCT02016209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977245|NCT01581853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977246|NCT01581853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977248|NCT01581853|Antiviral Agents|antiviral agents|mesh-ancestor
92977249|NCT01581853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977250|NCT01581853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92977251|NCT01581853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92977252|NCT01070641|Carvedilol|carvedilol|mesh-list
92502110|NCT02022527|Antipyretics|antipyretics|mesh-ancestor
92855858|NCT02825186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855859|NCT02825186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855860|NCT02825186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855861|NCT00604825|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92855862|NCT00604825|Estrogens|estrogens|mesh-ancestor
92855863|NCT00604825|Hormones|hormones|mesh-ancestor
92855864|NCT00604825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855865|NCT00604825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855866|NCT04239560|Boron|boron|mesh-list
92855867|NCT04239560|Trace Elements|trace elements|mesh-ancestor
92855868|NCT04239560|Micronutrients|micronutrients|mesh-ancestor
92855869|NCT04239560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855870|NCT04218162|Lasmiditan|lasmiditan|mesh-list
92855871|NCT04218162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92855872|NCT04218162|Serotonin Agents|serotonin agents|mesh-ancestor
92855873|NCT04218162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92855874|NCT04218162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855875|NCT04218162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855876|NCT00606125|Sorafenib|sorafenib|mesh-list
92855877|NCT00606125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855878|NCT00606125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92502537|NCT02025023|Triamcinolone|triamcinolone|mesh-list
92855879|NCT00606125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855880|NCT00606125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855881|NCT04242212|Misoprostol|misoprostol|mesh-list
92855882|NCT04242212|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92855883|NCT04242212|Abortifacient Agents|abortifacient agents|mesh-ancestor
92855884|NCT04242212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92855885|NCT04242212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855886|NCT04242212|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92855887|NCT04242212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855888|NCT04242212|Oxytocics|oxytocics|mesh-ancestor
92503053|NCT02028234|Omeprazole|omeprazole|mesh-list
92228180|NCT02463266|Sulfamethazine|sulfamethazine|mesh-list
92855889|NCT02851433|Anesthetics|anesthetics|mesh-list
92855890|NCT02851433|Propofol|propofol|mesh-list
92855891|NCT02851433|Sevoflurane|sevoflurane|mesh-list
92501031|NCT02015507|Ivacaftor|ivacaftor|mesh-list
92855892|NCT02851433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503643|NCT02040597|Autonomic Agents|autonomic agents|mesh-ancestor
92855893|NCT02851433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503817|NCT02041481|Leucovorin|leucovorin|mesh-list
92855894|NCT02851433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92503869|NCT02042222|Hydroxyurea|hydroxyurea|mesh-list
92855895|NCT02851433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92503951|NCT02042742|Antioxidants|antioxidants|mesh-ancestor
92855896|NCT02851433|Anesthetics, General|anesthetics, general|mesh-ancestor
92855897|NCT02851433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92504463|NCT02046538|Vitamins|vitamins|mesh-ancestor
92855898|NCT02851433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92504614|NCT02047175|Niacin|niacin|mesh-list
92504688|NCT00005826|Rubitecan|rubitecan|mesh-list
92855899|NCT05629806|Metformin|metformin|mesh-list
92855900|NCT05629806|Pioglitazone|pioglitazone|mesh-list
92855901|NCT05629806|Acarbose|acarbose|mesh-list
92504990|NCT00005949|Aldesleukin|aldesleukin|mesh-list
92855902|NCT05629806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92855903|NCT05629806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855904|NCT05629806|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92855905|NCT05629806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505440|NCT00386841|Escitalopram|escitalopram|mesh-list
92977253|NCT01070641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92977255|NCT01070641|Adrenergic Agents|adrenergic agents|mesh-ancestor
92855906|NCT05629806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855908|NCT02745756|Immunologic Factors|immunologic factors|mesh-ancestor
92855910|NCT04242368|Fluticasone|fluticasone|mesh-list
92855911|NCT04242368|Xhance|xhance|mesh-list
92855912|NCT04242368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855913|NCT04242368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92855914|NCT04242368|Autonomic Agents|autonomic agents|mesh-ancestor
92855915|NCT04242368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506783|NCT00006348|Serotonin Agents|serotonin agents|mesh-ancestor
92855916|NCT04242368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507086|NCT00006016|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92855917|NCT04242368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92507313|NCT00386815|Pemetrexed|pemetrexed|mesh-list
92507386|NCT00006399|Estrogens|estrogens|mesh-list
92855918|NCT04242368|Respiratory System Agents|respiratory system agents|mesh-ancestor
92855919|NCT04242368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92855920|NCT04242368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92855921|NCT04217148|Dexamethasone|dexamethasone|mesh-list
92507540|NCT05147233|Dexamethasone|dexamethasone|mesh-list
92855922|NCT04217148|Dexamethasone acetate|dexamethasone acetate|mesh-list
92855924|NCT04217148|BB 1101|bb 1101|mesh-list
92855925|NCT04217148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855926|NCT04217148|Antiemetics|antiemetics|mesh-ancestor
92855927|NCT04217148|Autonomic Agents|autonomic agents|mesh-ancestor
92855928|NCT04217148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855929|NCT04217148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855930|NCT04217148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92855931|NCT04217148|Glucocorticoids|glucocorticoids|mesh-ancestor
92855932|NCT04217148|Hormones|hormones|mesh-ancestor
92855933|NCT04217148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92855934|NCT04217148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92855935|NCT04217148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855936|NCT04217148|Protease Inhibitors|protease inhibitors|mesh-ancestor
92855937|NCT04217148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508281|NCT00006154|Stavudine|stavudine|mesh-list
92508365|NCT00006208|Emtricitabine|emtricitabine|mesh-list
92855938|NCT04217148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508430|NCT00006232|Dexamethasone|dexamethasone|mesh-list
92855939|NCT04217148|Keratolytic Agents|keratolytic agents|mesh-ancestor
92855940|NCT04217148|Dermatologic Agents|dermatologic agents|mesh-ancestor
92855941|NCT00900913|Ropivacaine|ropivacaine|mesh-list
92508880|NCT00006394|Hormones|hormones|mesh-list
92855942|NCT00900913|Anesthetics, Local|anesthetics, local|mesh-ancestor
92509177|NCT00006493|Rosiglitazone|rosiglitazone|mesh-list
92855943|NCT00900913|Anesthetics|anesthetics|mesh-ancestor
92509253|NCT00007033|Anticonvulsants|anticonvulsants|mesh-ancestor
92855944|NCT00900913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509335|NCT00007813|Etoposide|etoposide|mesh-list
92509399|NCT00008047|Fluorouracil|fluorouracil|mesh-list
92855945|NCT00900913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855946|NCT00900913|Sensory System Agents|sensory system agents|mesh-ancestor
92855947|NCT00900913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855948|NCT04216836|Magnesium Oxide|magnesium oxide|mesh-list
92855949|NCT04216836|Antacids|antacids|mesh-ancestor
92855950|NCT04216836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855951|NCT04216836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155948|NCT02633046|Hormones|hormones|mesh-ancestor
92855952|NCT00937157|Glatiramer Acetate|glatiramer acetate|mesh-list
92855953|NCT00937157|(T,G)-A-L|(t,g)-a-l|mesh-list
92855954|NCT00937157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92855955|NCT00937157|Immunologic Factors|immunologic factors|mesh-ancestor
92855956|NCT00937157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510072|NCT00000556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92855957|NCT00937157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92855958|NCT00937157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92510600|NCT00000904|Antiviral Agents|antiviral agents|mesh-ancestor
92855959|NCT04034173|Leucovorin|leucovorin|mesh-list
92855960|NCT04034173|Folic Acid|folic acid|mesh-list
92855961|NCT04034173|Irinotecan|irinotecan|mesh-list
92855962|NCT04034173|Panitumumab|panitumumab|mesh-list
92855964|NCT04034173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92855965|NCT04034173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92855966|NCT04034173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92855967|NCT04034173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855968|NCT04034173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92855969|NCT04034173|Antidotes|antidotes|mesh-ancestor
92511130|NCT00388635|Prednisone|prednisone|mesh-list
92855970|NCT04034173|Protective Agents|protective agents|mesh-ancestor
92855971|NCT04034173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511402|NCT00389584|Irinotecan|irinotecan|mesh-list
92855972|NCT04034173|Vitamin B Complex|vitamin b complex|mesh-ancestor
92855973|NCT04034173|Vitamins|vitamins|mesh-ancestor
92511566|NCT05551858|Proglumide|proglumide|mesh-list
92855974|NCT04034173|Micronutrients|micronutrients|mesh-ancestor
92511860|NCT00000534|Calcium|calcium|mesh-list
92855976|NCT04034173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92855977|NCT00606203|Milnacipran|milnacipran|mesh-list
92855978|NCT00606203|Levomilnacipran|levomilnacipran|mesh-list
92512236|NCT00000681|Antimetabolites|antimetabolites|mesh-ancestor
92977256|NCT01070641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512605|NCT03729271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92512682|NCT00000855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512760|NCT03206203|Carboplatin|carboplatin|mesh-list
92512834|NCT00000903|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513133|NCT00005834|Cyclophosphamide|cyclophosphamide|mesh-list
92513287|NCT00005861|Doxorubicin|doxorubicin|mesh-list
92855979|NCT00606203|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92855980|NCT00606203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92855981|NCT00606203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92513363|NCT00001113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513435|NCT00008866|Hydroxyurea|hydroxyurea|mesh-list
92855982|NCT00606203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92855983|NCT00606203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92513672|NCT00010036|Carboplatin|carboplatin|mesh-list
92855984|NCT00606203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92855985|NCT00606203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92855986|NCT00606203|Analgesics|analgesics|mesh-ancestor
92855987|NCT00606203|Sensory System Agents|sensory system agents|mesh-ancestor
92855988|NCT00606203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92855989|NCT00606203|Antidepressive Agents|antidepressive agents|mesh-ancestor
92855990|NCT00606203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92855991|NCT02539849|Adalimumab|adalimumab|mesh-list
92855992|NCT02539849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92855993|NCT02539849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92855994|NCT02539849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514194|NCT00005972|Irinotecan|irinotecan|mesh-list
92514257|NCT00005978|Etoposide|etoposide|mesh-list
92855995|NCT02749578|Atorvastatin|atorvastatin|mesh-list
92855996|NCT02749578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92855997|NCT02749578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92855998|NCT02749578|Antimetabolites|antimetabolites|mesh-ancestor
92514703|NCT00016432|Exemestane|exemestane|mesh-list
92855999|NCT02749578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856000|NCT02749578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92856001|NCT02749578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92856002|NCT02749578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856003|NCT05378867|Bevacizumab|bevacizumab|mesh-list
92515304|NCT00392080|Naproxen|naproxen|mesh-list
92856004|NCT05378867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92856005|NCT05378867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856006|NCT05378867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92856007|NCT05378867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92856008|NCT05378867|Growth Substances|growth substances|mesh-ancestor
92856009|NCT05378867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856010|NCT05378867|Growth Inhibitors|growth inhibitors|mesh-ancestor
92856011|NCT02749656|Desoximetasone|desoximetasone|mesh-list
92856013|NCT02749656|Glucocorticoids|glucocorticoids|mesh-ancestor
92515741|NCT03960151|Hormones|hormones|mesh-ancestor
92856015|NCT02749656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515974|NCT03432091|Melatonin|melatonin|mesh-list
92516189|NCT05605665|Analgesics|analgesics|mesh-ancestor
92516263|NCT02633098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856016|NCT02749656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516559|NCT01466452|Aspirin|aspirin|mesh-list
92856018|NCT00603317|Clavulanic Acids|clavulanic acids|mesh-list
92856019|NCT00603317|Clavulanic Acid|clavulanic acid|mesh-list
92516867|NCT05321160|Ketamine|ketamine|mesh-list
92517235|NCT00276601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92517308|NCT00276133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517608|NCT04712357|Emtricitabine|emtricitabine|mesh-list
92856020|NCT00603317|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92518007|NCT00400114|Irinotecan|irinotecan|mesh-list
92518218|NCT00086359|Ritonavir|ritonavir|mesh-list
92518380|NCT04762953|Vitamins|vitamins|mesh-ancestor
92518519|NCT00088270|Fluorouracil|fluorouracil|mesh-list
92856021|NCT00603317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518598|NCT00088894|Bevacizumab|bevacizumab|mesh-list
92856022|NCT00603317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856023|NCT00603317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856024|NCT00603317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518820|NCT00089440|Aripiprazole|aripiprazole|mesh-list
92518893|NCT00006167|Anabolic Agents|anabolic agents|mesh-ancestor
92856025|NCT00603317|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92856026|NCT02745522|Oxytocin|oxytocin|mesh-list
92856027|NCT02745522|Oxytocics|oxytocics|mesh-ancestor
92856028|NCT02745522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92856029|NCT02745522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856030|NCT02824718|Teriparatide|teriparatide|mesh-list
92856032|NCT02824718|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92856033|NCT02824718|Sodium Channel Blockers|sodium channel blockers|mesh-list
92856035|NCT02824718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
92856036|NCT02824718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92856037|NCT02824718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856038|NCT02824718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92520264|NCT04062708|Durvalumab|durvalumab|mesh-list
92856040|NCT02824718|Vitamins|vitamins|mesh-ancestor
92856041|NCT02824718|Micronutrients|micronutrients|mesh-ancestor
92856042|NCT02824718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92520599|NCT00102622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520749|NCT00006449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520824|NCT00104260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93046926|NCT01058720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501170|NCT02016365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92521051|NCT00106132|Triamcinolone|triamcinolone|mesh-list
92856043|NCT02824718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856044|NCT05378711|Fluoxetine|fluoxetine|mesh-list
92856045|NCT05378711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92856046|NCT05378711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92856047|NCT05378711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92521499|NCT00108979|Escitalopram|escitalopram|mesh-list
92521575|NCT00109408|Antimetabolites|antimetabolites|mesh-ancestor
92521639|NCT00109993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521715|NCT00110695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521866|NCT00111748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92522092|NCT00007670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856048|NCT05378711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856049|NCT05378711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856050|NCT05378711|Serotonin Agents|serotonin agents|mesh-ancestor
92856051|NCT05378711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522317|NCT00007982|Cyclophosphamide|cyclophosphamide|mesh-list
92522471|NCT00008177|Iodine|iodine|mesh-list
92522472|NCT00008177|Cyclosporine|cyclosporine|mesh-list
92522622|NCT00115609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92856052|NCT05378711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92523000|NCT00118066|Vitamins|vitamins|mesh-ancestor
92523231|NCT00120055|Atorvastatin|atorvastatin|mesh-list
92856053|NCT05378711|Antidepressive Agents|antidepressive agents|mesh-ancestor
92856054|NCT05378711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856055|NCT05378711|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92856056|NCT05378711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92856057|NCT05378711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856058|NCT00777153|Cediranib|cediranib|mesh-list
92524301|NCT00020605|Naloxone|naloxone|mesh-list
92856059|NCT00777153|Lomustine|lomustine|mesh-list
92856060|NCT00777153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524511|NCT00010413|Cyclophosphamide|cyclophosphamide|mesh-list
92856061|NCT00777153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92856062|NCT00777153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856063|NCT00777153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856065|NCT00777153|Alkylating Agents|alkylating agents|mesh-ancestor
92856066|NCT02821520|Verteporfin|verteporfin|mesh-list
92856067|NCT02821520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92856068|NCT02821520|Dermatologic Agents|dermatologic agents|mesh-ancestor
92856069|NCT00604955|Paromomycin|paromomycin|mesh-list
92856070|NCT00604955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856071|NCT00604955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856072|NCT00604955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92856073|NCT00604955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92856074|NCT04266509|Rifampin|rifampin|mesh-list
92856075|NCT04266509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92856076|NCT04266509|Antitubercular Agents|antitubercular agents|mesh-ancestor
92856077|NCT04266509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856078|NCT04266509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856079|NCT04266509|Leprostatic Agents|leprostatic agents|mesh-ancestor
92856080|NCT04266509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92856081|NCT04266509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856082|NCT04266509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856083|NCT04266509|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92856084|NCT04266509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92856085|NCT04266509|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92856086|NCT04266509|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92856087|NCT04266509|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92856088|NCT04266509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92856089|NCT02824874|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92856090|NCT02824874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92856091|NCT02824874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856092|NCT02824874|Incretins|incretins|mesh-ancestor
92856093|NCT02824874|Hormones|hormones|mesh-ancestor
92856094|NCT02824874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856095|NCT02824874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92856096|NCT02824874|Protease Inhibitors|protease inhibitors|mesh-ancestor
92856097|NCT02824874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856098|NCT02824874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856099|NCT04204265|Hyaluronic Acid|hyaluronic acid|mesh-list
92856100|NCT04204265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92856101|NCT04204265|Immunologic Factors|immunologic factors|mesh-ancestor
92856102|NCT04204265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856103|NCT04204265|Viscosupplements|viscosupplements|mesh-ancestor
92856104|NCT04204265|Protective Agents|protective agents|mesh-ancestor
92856105|NCT04267913|Dexamethasone|dexamethasone|mesh-list
92856106|NCT04267913|Dexamethasone acetate|dexamethasone acetate|mesh-list
92856107|NCT04267913|Docetaxel|docetaxel|mesh-list
92856108|NCT04267913|Ramucirumab|ramucirumab|mesh-list
92856109|NCT04267913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92856110|NCT04267913|Antibodies|antibodies|mesh-list
92856111|NCT04267913|Immunoglobulins|immunoglobulins|mesh-list
92856112|NCT04267913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92856113|NCT04267913|Lexatumumab|lexatumumab|mesh-list
92856114|NCT04267913|BB 1101|bb 1101|mesh-list
92856115|NCT04267913|Immunologic Factors|immunologic factors|mesh-ancestor
92856116|NCT04267913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856117|NCT04267913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856118|NCT04267913|Antiemetics|antiemetics|mesh-ancestor
92856119|NCT04267913|Autonomic Agents|autonomic agents|mesh-ancestor
92856120|NCT04267913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856121|NCT04267913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92856122|NCT04267913|Glucocorticoids|glucocorticoids|mesh-ancestor
92856123|NCT04267913|Hormones|hormones|mesh-ancestor
92856124|NCT04267913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856125|NCT04267913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856126|NCT04267913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856127|NCT04267913|Protease Inhibitors|protease inhibitors|mesh-ancestor
92856128|NCT04267913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856129|NCT04267913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856130|NCT04267913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92856131|NCT04267913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92856132|NCT04267913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92856133|NCT04216758|Paclitaxel|paclitaxel|mesh-list
92856134|NCT04216758|Gemcitabine|gemcitabine|mesh-list
92856135|NCT04216758|Tegafur|tegafur|mesh-list
92856136|NCT04216758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92856137|NCT04216758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856138|NCT04216758|Tubulin Modulators|tubulin modulators|mesh-ancestor
92856139|NCT04216758|Antimitotic Agents|antimitotic agents|mesh-ancestor
92856140|NCT04216758|Mitosis Modulators|mitosis modulators|mesh-ancestor
92856141|NCT04216758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856142|NCT04216758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856143|NCT04216758|Antimetabolites|antimetabolites|mesh-ancestor
92856144|NCT00606437|Fludarabine|fludarabine|mesh-list
92856145|NCT00606437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856146|NCT02538211|Vaccines|vaccines|mesh-list
92856147|NCT02538211|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92856148|NCT02538211|Immunologic Factors|immunologic factors|mesh-ancestor
92856149|NCT02538211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856150|NCT02821676|Anesthetics|anesthetics|mesh-list
92856151|NCT02821676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856152|NCT02821676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856153|NCT02745054|Anticoagulants|anticoagulants|mesh-list
92856154|NCT00908089|Sulfasalazine|sulfasalazine|mesh-list
92856155|NCT00908089|Hydroxychloroquine|hydroxychloroquine|mesh-list
92856156|NCT00908089|Prednisolone|prednisolone|mesh-list
92856157|NCT00908089|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92856158|NCT00908089|Methylprednisolone|methylprednisolone|mesh-list
92856159|NCT00908089|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92856160|NCT00908089|Prednisolone acetate|prednisolone acetate|mesh-list
92856161|NCT00908089|Infliximab|infliximab|mesh-list
92856162|NCT00908089|Naltrexone|naltrexone|mesh-list
92856163|NCT00908089|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92856164|NCT00908089|Prednisolone phosphate|prednisolone phosphate|mesh-list
92856165|NCT00908089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856166|NCT00908089|Glucocorticoids|glucocorticoids|mesh-ancestor
92856167|NCT00908089|Hormones|hormones|mesh-ancestor
92856168|NCT00908089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856169|NCT00908089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856170|NCT00908089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856171|NCT00908089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856172|NCT00908089|Antiemetics|antiemetics|mesh-ancestor
92856173|NCT00908089|Autonomic Agents|autonomic agents|mesh-ancestor
92856174|NCT00908089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856175|NCT00908089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92856176|NCT00908089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92856177|NCT00908089|Protective Agents|protective agents|mesh-ancestor
92856178|NCT00908089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92856179|NCT00908089|Dermatologic Agents|dermatologic agents|mesh-ancestor
92856180|NCT00908089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856181|NCT00908089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856182|NCT00908089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92856183|NCT00908089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92856184|NCT00908089|Analgesics|analgesics|mesh-ancestor
92856185|NCT00908089|Sensory System Agents|sensory system agents|mesh-ancestor
92856186|NCT00908089|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92856187|NCT00908089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92856188|NCT00908089|Antimalarials|antimalarials|mesh-ancestor
92856189|NCT00908089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92856190|NCT00908089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92856191|NCT00908089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856192|NCT00908089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856193|NCT04758416|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92856194|NCT04758416|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92856195|NCT04758416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856196|NCT05378555|Ketamine|ketamine|mesh-list
92856197|NCT05378555|Analgesics|analgesics|mesh-ancestor
92856198|NCT05378555|Sensory System Agents|sensory system agents|mesh-ancestor
92856199|NCT05378555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856200|NCT05378555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156033|NCT04181736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92856201|NCT05378555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92856202|NCT05378555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92856203|NCT05378555|Anesthetics, General|anesthetics, general|mesh-ancestor
92856204|NCT05378555|Anesthetics|anesthetics|mesh-ancestor
92856205|NCT05378555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856206|NCT05378555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92856207|NCT05378555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92856208|NCT05378555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856209|NCT05378555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856210|NCT03553446|Sevoflurane|sevoflurane|mesh-list
92856211|NCT03553446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92856212|NCT03553446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92856213|NCT03553446|Anesthetics, General|anesthetics, general|mesh-ancestor
92856214|NCT03553446|Anesthetics|anesthetics|mesh-ancestor
92856215|NCT03553446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856216|NCT03553446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856217|NCT00908167|Cytarabine|cytarabine|mesh-list
92856218|NCT00908167|Clofarabine|clofarabine|mesh-list
92856219|NCT00908167|Sorafenib|sorafenib|mesh-list
92856220|NCT00908167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856221|NCT00908167|Antimetabolites|antimetabolites|mesh-ancestor
92856222|NCT00908167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856223|NCT00908167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856224|NCT00908167|Antiviral Agents|antiviral agents|mesh-ancestor
92856225|NCT00908167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856226|NCT00908167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856227|NCT00908167|Immunologic Factors|immunologic factors|mesh-ancestor
92856228|NCT00908167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856229|NCT00908167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92856230|NCT00908167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856231|NCT02821052|Insulin|insulin|mesh-list
92856232|NCT02821052|Insulin Aspart|insulin aspart|mesh-list
92856233|NCT02821052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92856234|NCT02821052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856235|NCT05659628|Tislelizumab|tislelizumab|mesh-list
92856236|NCT05659628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92856237|NCT05659628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856238|NCT00606515|Paclitaxel|paclitaxel|mesh-list
92856239|NCT00606515|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92856240|NCT00606515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92856241|NCT00606515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856242|NCT00606515|Tubulin Modulators|tubulin modulators|mesh-ancestor
92856243|NCT00606515|Antimitotic Agents|antimitotic agents|mesh-ancestor
92856244|NCT00606515|Mitosis Modulators|mitosis modulators|mesh-ancestor
92856245|NCT00606515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856246|NCT00908323|Vaccines|vaccines|mesh-list
92856247|NCT00908323|Immunologic Factors|immunologic factors|mesh-ancestor
92856248|NCT00908323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856249|NCT02749032|Metformin|metformin|mesh-list
92856250|NCT02749032|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92856251|NCT02749032|Vildagliptin|vildagliptin|mesh-list
92856252|NCT02749032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92856253|NCT02749032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856254|NCT02749032|Incretins|incretins|mesh-ancestor
92856255|NCT02749032|Hormones|hormones|mesh-ancestor
92856256|NCT02749032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856257|NCT02749032|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92856258|NCT02749032|Protease Inhibitors|protease inhibitors|mesh-ancestor
92856259|NCT02749032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856260|NCT02749032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856261|NCT00908713|Methylprednisolone|methylprednisolone|mesh-list
92856262|NCT00908713|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92856263|NCT00908713|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92856264|NCT00908713|Prednisolone|prednisolone|mesh-list
92856265|NCT00908713|Prednisolone acetate|prednisolone acetate|mesh-list
92856266|NCT00908713|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92856267|NCT00908713|Prednisolone phosphate|prednisolone phosphate|mesh-list
92856268|NCT00908713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92501399|NCT02018094|Povidone|povidone|mesh-list
92856270|NCT00908713|Autonomic Agents|autonomic agents|mesh-ancestor
92856271|NCT00908713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856272|NCT00908713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856273|NCT00908713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92856274|NCT00908713|Glucocorticoids|glucocorticoids|mesh-ancestor
92856275|NCT00908713|Hormones|hormones|mesh-ancestor
92856276|NCT00908713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856277|NCT00908713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92856278|NCT00908713|Protective Agents|protective agents|mesh-ancestor
92856279|NCT00908713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856280|NCT00908713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856281|NCT00908869|Interferons|interferons|mesh-list
92856282|NCT00908869|Interferon-alpha|interferon-alpha|mesh-list
92856284|NCT00908869|Cyclophosphamide|cyclophosphamide|mesh-list
92856285|NCT00908869|Vinorelbine|vinorelbine|mesh-list
92856286|NCT00908869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856287|NCT00908869|Immunologic Factors|immunologic factors|mesh-ancestor
92856288|NCT00908869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856289|NCT00908869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856290|NCT00908869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92856291|NCT00908869|Alkylating Agents|alkylating agents|mesh-ancestor
92856292|NCT00908869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856293|NCT00908869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856294|NCT00908869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92856295|NCT00908869|Antiviral Agents|antiviral agents|mesh-ancestor
92856296|NCT00908869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856297|NCT00908869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92856298|NCT00908869|Tubulin Modulators|tubulin modulators|mesh-ancestor
92856299|NCT00908869|Antimitotic Agents|antimitotic agents|mesh-ancestor
92856300|NCT00908869|Mitosis Modulators|mitosis modulators|mesh-ancestor
92856301|NCT00605111|Insulin Aspart|insulin aspart|mesh-list
92856302|NCT00605111|Biphasic Insulins|biphasic insulins|mesh-list
92856303|NCT00605111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92856304|NCT00605111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856305|NCT03465774|Doxycycline|doxycycline|mesh-list
92856306|NCT03465774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856307|NCT03465774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856308|NCT03465774|Antimalarials|antimalarials|mesh-ancestor
92856309|NCT03465774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92856310|NCT03465774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92856311|NCT04240496|Clozapine|clozapine|mesh-list
92856312|NCT04240496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92856313|NCT04240496|Serotonin Agents|serotonin agents|mesh-ancestor
92856314|NCT04240496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856315|NCT04240496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856316|NCT04240496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856317|NCT04240496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92856318|NCT04240496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92856319|NCT04240496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856320|NCT04240496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856321|NCT04240496|GABA Antagonists|gaba antagonists|mesh-ancestor
92856322|NCT04240496|GABA Agents|gaba agents|mesh-ancestor
92856323|NCT03450018|Gemcitabine|gemcitabine|mesh-list
92856324|NCT03450018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856325|NCT03450018|Antimetabolites|antimetabolites|mesh-ancestor
92856326|NCT03450018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856327|NCT03450018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856328|NCT00909337|Bosentan|bosentan|mesh-list
92856329|NCT00909337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92856330|NCT00909337|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92856331|NCT00909337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856332|NCT00909571|Tacrolimus|tacrolimus|mesh-list
92856333|NCT00909571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856334|NCT00909571|Immunologic Factors|immunologic factors|mesh-ancestor
92856335|NCT00909571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856336|NCT00909571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92856337|NCT00909571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856338|NCT00909571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856339|NCT04015375|Dapsone|dapsone|mesh-list
92856340|NCT04015375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856341|NCT04015375|Antimalarials|antimalarials|mesh-ancestor
92856342|NCT04015375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92856343|NCT04015375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92856344|NCT04015375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92856345|NCT04015375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856346|NCT04015375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856347|NCT04015375|Leprostatic Agents|leprostatic agents|mesh-ancestor
92856348|NCT04015375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856349|NCT04239794|Propofol|propofol|mesh-list
92856350|NCT04239794|Sevoflurane|sevoflurane|mesh-list
92856351|NCT04239794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92856352|NCT04239794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856353|NCT04239794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856354|NCT04239794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92856355|NCT04239794|Anesthetics, General|anesthetics, general|mesh-ancestor
92856356|NCT04239794|Anesthetics|anesthetics|mesh-ancestor
92856357|NCT04239794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92200844|NCT05688098|Amlodipine|amlodipine|mesh-list
92856358|NCT04239794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92856359|NCT02850887|Anesthetics|anesthetics|mesh-list
92856360|NCT02850887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856361|NCT02850887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856362|NCT00931645|Cytarabine|cytarabine|mesh-list
92856363|NCT00931645|Dexamethasone|dexamethasone|mesh-list
92856364|NCT00931645|Cyclophosphamide|cyclophosphamide|mesh-list
92856365|NCT00931645|Cisplatin|cisplatin|mesh-list
92856366|NCT00931645|Fludarabine|fludarabine|mesh-list
92856367|NCT00931645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856368|NCT00931645|Immunologic Factors|immunologic factors|mesh-ancestor
92856369|NCT00931645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856370|NCT00931645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856371|NCT00931645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92856372|NCT00931645|Alkylating Agents|alkylating agents|mesh-ancestor
92856373|NCT00931645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856374|NCT00931645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856375|NCT00931645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92856376|NCT00931645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856377|NCT00931645|Antiemetics|antiemetics|mesh-ancestor
92856378|NCT00931645|Autonomic Agents|autonomic agents|mesh-ancestor
92856379|NCT00931645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856380|NCT00931645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92856381|NCT00931645|Glucocorticoids|glucocorticoids|mesh-ancestor
92856382|NCT00931645|Hormones|hormones|mesh-ancestor
92856383|NCT00931645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856384|NCT00931645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856385|NCT00931645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856386|NCT00931645|Antimetabolites|antimetabolites|mesh-ancestor
92856387|NCT00931645|Antiviral Agents|antiviral agents|mesh-ancestor
92856388|NCT00931645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856389|NCT05658692|Anti-Infective Agents|anti-infective agents|mesh-list
92856390|NCT05658692|Dexamethasone|dexamethasone|mesh-list
92856391|NCT05658692|Hydrocortisone|hydrocortisone|mesh-list
92856392|NCT05658692|Simendan|simendan|mesh-list
92856393|NCT05658692|Dopamine|dopamine|mesh-list
92856394|NCT05658692|Isoproterenol|isoproterenol|mesh-list
92856395|NCT05658692|Olprinone|olprinone|mesh-list
92856396|NCT05658692|Epinephrine|epinephrine|mesh-list
92856397|NCT05658692|Norepinephrine|norepinephrine|mesh-list
92856398|NCT05658692|Metaraminol|metaraminol|mesh-list
92856399|NCT05658692|Midazolam|midazolam|mesh-list
92856400|NCT05658692|Dexmedetomidine|dexmedetomidine|mesh-list
92856401|NCT05658692|Bromides|bromides|mesh-list
92856402|NCT05658692|Propofol|propofol|mesh-list
92856403|NCT05658692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92856404|NCT05658692|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92856405|NCT05658692|Simvastatin|simvastatin|mesh-list
92856406|NCT05658692|Glucocorticoids|glucocorticoids|mesh-list
92856407|NCT05658692|Succinylcholine|succinylcholine|mesh-list
92856408|NCT05658692|Vecuronium Bromide|vecuronium bromide|mesh-list
92856409|NCT05658692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856410|NCT05658692|Antiemetics|antiemetics|mesh-ancestor
92856411|NCT05658692|Autonomic Agents|autonomic agents|mesh-ancestor
92856412|NCT05658692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856413|NCT05658692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856414|NCT05658692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92856415|NCT05658692|Hormones|hormones|mesh-ancestor
92856416|NCT05658692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856417|NCT05658692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856418|NCT05658692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856419|NCT05658692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856420|NCT05658692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856421|NCT05658692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856422|NCT05658692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92856423|NCT05658692|Analgesics|analgesics|mesh-ancestor
92856424|NCT05658692|Sensory System Agents|sensory system agents|mesh-ancestor
92856425|NCT05658692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92156055|NCT03858491|Cobicistat|cobicistat|mesh-list
92856426|NCT05658692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92856427|NCT05658692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92856428|NCT05658692|Adrenergic Agents|adrenergic agents|mesh-ancestor
92856429|NCT05658692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856430|NCT05658692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92856431|NCT05658692|Anesthetics, General|anesthetics, general|mesh-ancestor
92856432|NCT05658692|Anesthetics|anesthetics|mesh-ancestor
92856433|NCT05658692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92856434|NCT05658692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92856435|NCT05658692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92856436|NCT05658692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856437|NCT05658692|GABA Modulators|gaba modulators|mesh-ancestor
92856439|NCT05658692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92856440|NCT05658692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92856441|NCT05658692|Antimetabolites|antimetabolites|mesh-ancestor
92856442|NCT05658692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92856443|NCT05658692|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92856444|NCT05658692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92856445|NCT05658692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92856446|NCT05658692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92856447|NCT05658692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92856448|NCT05658692|Mydriatics|mydriatics|mesh-ancestor
92856449|NCT05658692|Sympathomimetics|sympathomimetics|mesh-ancestor
92856450|NCT05658692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92856451|NCT05658692|Anticonvulsants|anticonvulsants|mesh-ancestor
92856452|NCT05658692|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92856453|NCT05658692|Vasodilator Agents|vasodilator agents|mesh-ancestor
92856454|NCT05658692|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92856455|NCT05658692|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92856456|NCT05658692|Protective Agents|protective agents|mesh-ancestor
92856457|NCT05658692|Dopamine Agents|dopamine agents|mesh-ancestor
92856458|NCT05658692|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92856459|NCT05658692|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92856460|NCT05658692|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92856461|NCT05658692|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92856462|NCT05658692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92856463|NCT05658692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92856464|NCT05658692|Cholinergic Agents|cholinergic agents|mesh-ancestor
92856465|NCT05658692|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92856466|NCT02744508|Dexamethasone|dexamethasone|mesh-list
92856467|NCT02744508|Palonosetron|palonosetron|mesh-list
92856468|NCT02744508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856469|NCT02744508|Antiemetics|antiemetics|mesh-ancestor
92856470|NCT02744508|Autonomic Agents|autonomic agents|mesh-ancestor
92856471|NCT02744508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856472|NCT02744508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856473|NCT02744508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92856474|NCT02744508|Glucocorticoids|glucocorticoids|mesh-ancestor
92856475|NCT02744508|Hormones|hormones|mesh-ancestor
92856476|NCT02744508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856477|NCT02744508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856478|NCT02744508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856479|NCT02744508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92856480|NCT02744508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92856481|NCT02744508|Serotonin Agents|serotonin agents|mesh-ancestor
92856482|NCT02744508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856483|NCT02744508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856484|NCT00927511|Fulvestrant|fulvestrant|mesh-list
92856485|NCT00927511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856486|NCT00927511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856487|NCT00927511|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92856488|NCT00927511|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92856489|NCT00927511|Hormone Antagonists|hormone antagonists|mesh-ancestor
92856490|NCT00927511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856491|NCT00927511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856492|NCT04637594|Pembrolizumab|pembrolizumab|mesh-list
92856493|NCT04637594|Nivolumab|nivolumab|mesh-list
92856494|NCT04637594|Atezolizumab|atezolizumab|mesh-list
92856495|NCT04637594|Durvalumab|durvalumab|mesh-list
92856496|NCT04637594|Avelumab|avelumab|mesh-list
92856497|NCT04637594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92501626|NCT02019381|Vitamins|vitamins|mesh-list
92856498|NCT04637594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856499|NCT04637594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92856500|NCT04637594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856501|NCT03211338|Progesterone|progesterone|mesh-list
92856502|NCT03211338|Mitogens|mitogens|mesh-list
92856503|NCT03211338|Progestins|progestins|mesh-ancestor
92856504|NCT03211338|Hormones|hormones|mesh-ancestor
92856505|NCT03211338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856506|NCT03211338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856507|NCT03211338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92856508|NCT03211338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856509|NCT00936611|Panobinostat|panobinostat|mesh-list
92856510|NCT00936611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856511|NCT00936611|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92856512|NCT00936611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856513|NCT00936611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856514|NCT02744196|Methotrexate|methotrexate|mesh-list
92856515|NCT02744196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856516|NCT02744196|Immunologic Factors|immunologic factors|mesh-ancestor
92856517|NCT02744196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856518|NCT02744196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856519|NCT02744196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92856520|NCT02744196|Abortifacient Agents|abortifacient agents|mesh-ancestor
92856521|NCT02744196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92856522|NCT02744196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856523|NCT02744196|Antimetabolites|antimetabolites|mesh-ancestor
92856524|NCT02744196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856525|NCT02744196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92856526|NCT02744196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856527|NCT02744196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92856528|NCT02744196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856529|NCT02744196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92856530|NCT02139852|Capsaicin|capsaicin|mesh-list
92856531|NCT02139852|Antipruritics|antipruritics|mesh-ancestor
92856532|NCT02139852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92856533|NCT02139852|Sensory System Agents|sensory system agents|mesh-ancestor
92856534|NCT02139852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856535|NCT02139852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856536|NCT05379647|Cyclophosphamide|cyclophosphamide|mesh-list
92856537|NCT05379647|Rituximab|rituximab|mesh-list
92856538|NCT05379647|Fludarabine|fludarabine|mesh-list
92856539|NCT05379647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856540|NCT05379647|Immunologic Factors|immunologic factors|mesh-ancestor
92856541|NCT05379647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856542|NCT05379647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856543|NCT05379647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92856544|NCT05379647|Alkylating Agents|alkylating agents|mesh-ancestor
92856545|NCT05379647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856546|NCT05379647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856547|NCT05379647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92856548|NCT05379647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92856549|NCT02748330|Aspirin|aspirin|mesh-list
92856550|NCT02748330|Clopidogrel|clopidogrel|mesh-list
92856551|NCT02748330|Ticagrelor|ticagrelor|mesh-list
92856552|NCT02748330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92856553|NCT02748330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92856554|NCT02748330|Analgesics|analgesics|mesh-ancestor
92856555|NCT02748330|Sensory System Agents|sensory system agents|mesh-ancestor
92856556|NCT02748330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856557|NCT02748330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856558|NCT02748330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856559|NCT02748330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856560|NCT02748330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92856561|NCT02748330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92856562|NCT02748330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856563|NCT02748330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92856564|NCT02748330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92856565|NCT02748330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856566|NCT02748330|Antipyretics|antipyretics|mesh-ancestor
92856567|NCT02748330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92856568|NCT02748330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92856569|NCT02748330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92856570|NCT02748330|Purinergic Agents|purinergic agents|mesh-ancestor
92501701|NCT02019810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92856571|NCT02748330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856572|NCT05379569|Cyclophosphamide|cyclophosphamide|mesh-list
92856573|NCT05379569|Fludarabine|fludarabine|mesh-list
92856574|NCT05379569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856575|NCT05379569|Immunologic Factors|immunologic factors|mesh-ancestor
92856576|NCT05379569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856577|NCT05379569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856578|NCT05379569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92856579|NCT05379569|Alkylating Agents|alkylating agents|mesh-ancestor
92856580|NCT05379569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856581|NCT05379569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856582|NCT05379569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92856583|NCT02818556|Hyaluronic Acid|hyaluronic acid|mesh-list
92856584|NCT02818556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92856585|NCT02818556|Immunologic Factors|immunologic factors|mesh-ancestor
92856586|NCT02818556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856587|NCT02818556|Viscosupplements|viscosupplements|mesh-ancestor
92856588|NCT02818556|Protective Agents|protective agents|mesh-ancestor
92856589|NCT04171128|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92856590|NCT04171128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856591|NCT04238936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92856592|NCT04238936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856593|NCT04627142|Irinotecan|irinotecan|mesh-list
92856594|NCT04627142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92856595|NCT04627142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92856596|NCT04627142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856597|NCT04627142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856598|NCT04627142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856599|NCT00936221|Dacarbazine|dacarbazine|mesh-list
92856600|NCT00936221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92856601|NCT00936221|Alkylating Agents|alkylating agents|mesh-ancestor
92856602|NCT00936221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856603|NCT00936221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856604|NCT00776919|Clindamycin|clindamycin|mesh-list
92856605|NCT00776919|Clindamycin palmitate|clindamycin palmitate|mesh-list
92856606|NCT00776919|Clindamycin phosphate|clindamycin phosphate|mesh-list
92856607|NCT00776919|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92856608|NCT00776919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856609|NCT00776919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856610|NCT00776919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92856611|NCT00776919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856612|NCT00776919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856613|NCT00776919|Dermatologic Agents|dermatologic agents|mesh-ancestor
92856614|NCT05657678|Vitamin D|vitamin d|mesh-list
92856615|NCT05657678|Ergocalciferols|ergocalciferols|mesh-list
92856616|NCT05657678|Cholecalciferol|cholecalciferol|mesh-list
92856617|NCT05657678|Vitamins|vitamins|mesh-list
92856618|NCT05657678|Micronutrients|micronutrients|mesh-ancestor
92156086|NCT02705963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856619|NCT05657678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856620|NCT05657678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92856621|NCT05657678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92856622|NCT02747940|Pregabalin|pregabalin|mesh-list
92856623|NCT02747940|Flunarizine|flunarizine|mesh-list
92856624|NCT02747940|Analgesics|analgesics|mesh-ancestor
92856625|NCT02747940|Sensory System Agents|sensory system agents|mesh-ancestor
92856626|NCT02747940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856627|NCT02747940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856628|NCT02747940|Anticonvulsants|anticonvulsants|mesh-ancestor
92856629|NCT02747940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92856630|NCT02747940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856631|NCT02747940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856632|NCT02747940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92856633|NCT02747940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92856634|NCT02747940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92856635|NCT02747940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856636|NCT02747940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856637|NCT02747940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92856638|NCT02747940|Histamine Antagonists|histamine antagonists|mesh-ancestor
92856639|NCT02747940|Histamine Agents|histamine agents|mesh-ancestor
92856640|NCT02747940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856641|NCT02747940|Vasodilator Agents|vasodilator agents|mesh-ancestor
92856642|NCT04238702|Empagliflozin|empagliflozin|mesh-list
92856643|NCT04238702|Losartan|losartan|mesh-list
92856644|NCT04238702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92501781|NCT02020330|Lumefantrine|lumefantrine|mesh-list
92856645|NCT04238702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92856646|NCT04238702|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92856647|NCT04238702|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92856648|NCT04238702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856649|NCT04238702|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92856650|NCT04238702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92856651|NCT04238702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856652|NCT00603785|Omalizumab|omalizumab|mesh-list
92856653|NCT00603785|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92856655|NCT00603785|Respiratory System Agents|respiratory system agents|mesh-ancestor
92856656|NCT00633776|Formoterol Fumarate|formoterol fumarate|mesh-list
92856657|NCT00633776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92856658|NCT00633776|Autonomic Agents|autonomic agents|mesh-ancestor
92856659|NCT00633776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856660|NCT00633776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856661|NCT00633776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92856662|NCT00633776|Respiratory System Agents|respiratory system agents|mesh-ancestor
92856663|NCT00633776|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92856664|NCT00633776|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92856665|NCT00633776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92856666|NCT00633776|Adrenergic Agents|adrenergic agents|mesh-ancestor
92856667|NCT00633776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856668|NCT00633776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856669|NCT05382923|Melatonin|melatonin|mesh-list
92856670|NCT05382923|Antioxidants|antioxidants|mesh-ancestor
92856671|NCT05382923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856672|NCT05382923|Protective Agents|protective agents|mesh-ancestor
92856673|NCT05382923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856674|NCT05382923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856675|NCT02743572|Iron|iron|mesh-list
92856676|NCT02743572|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92856677|NCT02743572|Trace Elements|trace elements|mesh-ancestor
92856678|NCT02743572|Micronutrients|micronutrients|mesh-ancestor
92856679|NCT02743572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856680|NCT02743572|Hematinics|hematinics|mesh-ancestor
92856681|NCT00775593|Sirolimus|sirolimus|mesh-list
92856682|NCT00775593|Temsirolimus|temsirolimus|mesh-list
92856683|NCT00775593|MTOR Inhibitors|mtor inhibitors|mesh-list
92856684|NCT00775593|Clofarabine|clofarabine|mesh-list
92856685|NCT00775593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92856686|NCT00775593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856687|NCT00775593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856688|NCT00775593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856689|NCT00775593|Immunologic Factors|immunologic factors|mesh-ancestor
92856690|NCT00775593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856691|NCT00775593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856692|NCT00775593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856693|NCT00775593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856694|NCT00775593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92856695|NCT00775593|Antifungal Agents|antifungal agents|mesh-ancestor
92856696|NCT00775593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856697|NCT00775593|Antimetabolites|antimetabolites|mesh-ancestor
92856698|NCT00606983|Tamsulosin|tamsulosin|mesh-list
92856699|NCT00606983|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92856700|NCT00606983|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92856701|NCT00606983|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92856702|NCT00606983|Adrenergic Agents|adrenergic agents|mesh-ancestor
92856703|NCT00606983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856704|NCT00606983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856705|NCT00606983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856706|NCT00606983|Urological Agents|urological agents|mesh-ancestor
92856707|NCT02817932|Ranolazine|ranolazine|mesh-list
92856708|NCT02817932|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92856709|NCT02817932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856710|NCT02817932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856711|NCT02743260|Metformin|metformin|mesh-list
92856712|NCT02743260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92856713|NCT02743260|Adefovir|adefovir|mesh-list
92856714|NCT02743260|Digoxin|digoxin|mesh-list
92856715|NCT02743260|Pitavastatin|pitavastatin|mesh-list
92856716|NCT02743260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92856717|NCT02743260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856718|NCT02743260|Incretins|incretins|mesh-ancestor
92856719|NCT02743260|Hormones|hormones|mesh-ancestor
92856720|NCT02743260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856721|NCT02743260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92856722|NCT02743260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92856723|NCT02743260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856724|NCT02743260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856725|NCT02743260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92856726|NCT02743260|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92524896|NCT00000170|Atropine|atropine|mesh-list
92856727|NCT02743260|Protective Agents|protective agents|mesh-ancestor
92856728|NCT02743260|Antiviral Agents|antiviral agents|mesh-ancestor
92856729|NCT02743260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856730|NCT02743260|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92856731|NCT02743260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92856732|NCT02743260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92856733|NCT02743260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92856734|NCT02743260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92856735|NCT02743260|Antimetabolites|antimetabolites|mesh-ancestor
92856736|NCT02743260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92856737|NCT05629260|Cyclophosphamide|cyclophosphamide|mesh-list
92856738|NCT05629260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856739|NCT05629260|Immunologic Factors|immunologic factors|mesh-ancestor
92856740|NCT05629260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856741|NCT05629260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856742|NCT05629260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92856743|NCT05629260|Alkylating Agents|alkylating agents|mesh-ancestor
92156099|NCT03844061|Rituximab|rituximab|mesh-list
92856744|NCT05629260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856745|NCT05629260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856746|NCT05629260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92856747|NCT02819648|Prednisolone|prednisolone|mesh-list
92856748|NCT02819648|Glucocorticoids|glucocorticoids|mesh-list
92856749|NCT02819648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856751|NCT02819648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92856752|NCT02819648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856753|NCT02819648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92856754|NCT02819648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856755|NCT00934661|Morphine|morphine|mesh-list
92856756|NCT00934661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92856757|NCT00934661|Narcotics|narcotics|mesh-ancestor
92856758|NCT00934661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856759|NCT00934661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856760|NCT00934661|Analgesics|analgesics|mesh-ancestor
92856761|NCT00934661|Sensory System Agents|sensory system agents|mesh-ancestor
92856762|NCT00934661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856763|NCT02743182|Interferons|interferons|mesh-list
92856764|NCT02743182|Interferon-alpha|interferon-alpha|mesh-list
92856765|NCT02743182|Interferon alpha-2|interferon alpha-2|mesh-list
92856766|NCT02743182|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92856767|NCT02743182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856768|NCT02743182|Antiviral Agents|antiviral agents|mesh-ancestor
92856769|NCT02743182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856770|NCT02743182|Immunologic Factors|immunologic factors|mesh-ancestor
92856771|NCT02743182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856772|NCT00775437|Adalimumab|adalimumab|mesh-list
92856773|NCT00775437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92856774|NCT00775437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92856775|NCT00775437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92856776|NCT04238078|Contraceptive Agents|contraceptive agents|mesh-list
92856777|NCT04238078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92856778|NCT04238078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856779|NCT02742168|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
92856780|NCT02742168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92856781|NCT02742168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856782|NCT02819414|Acetaminophen|acetaminophen|mesh-list
92856783|NCT02819414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92856784|NCT02819414|Analgesics|analgesics|mesh-ancestor
92856785|NCT02819414|Sensory System Agents|sensory system agents|mesh-ancestor
92856786|NCT02819414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856787|NCT02819414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856788|NCT02819414|Antipyretics|antipyretics|mesh-ancestor
92856789|NCT02743104|Lidocaine|lidocaine|mesh-list
92856790|NCT02743104|Atropine|atropine|mesh-list
92856791|NCT02743104|Midazolam|midazolam|mesh-list
92856792|NCT02743104|Ketamine|ketamine|mesh-list
92856793|NCT02743104|Propofol|propofol|mesh-list
92856794|NCT02743104|Anesthetics, Local|anesthetics, local|mesh-ancestor
92856795|NCT02743104|Anesthetics|anesthetics|mesh-ancestor
92856796|NCT02743104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856797|NCT02743104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856798|NCT02743104|Sensory System Agents|sensory system agents|mesh-ancestor
92856799|NCT02743104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856800|NCT02743104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92856801|NCT02743104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92856802|NCT02743104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92856803|NCT02743104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856804|NCT02743104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856805|NCT02743104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92856806|NCT02743104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92856807|NCT02743104|Anesthetics, General|anesthetics, general|mesh-ancestor
92856808|NCT02743104|Analgesics|analgesics|mesh-ancestor
92856809|NCT02743104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92856810|NCT02743104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92856811|NCT02743104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92856812|NCT02743104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856813|NCT02743104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92856814|NCT02743104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92856815|NCT02743104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92856816|NCT02743104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856817|NCT02743104|GABA Modulators|gaba modulators|mesh-ancestor
92856818|NCT02743104|GABA Agents|gaba agents|mesh-ancestor
92856819|NCT02743104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92856820|NCT02743104|Autonomic Agents|autonomic agents|mesh-ancestor
92856821|NCT02743104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92856822|NCT02743104|Respiratory System Agents|respiratory system agents|mesh-ancestor
92856823|NCT02743104|Mydriatics|mydriatics|mesh-ancestor
92856824|NCT02743104|Parasympatholytics|parasympatholytics|mesh-ancestor
92856825|NCT02743104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92856826|NCT02743104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92856827|NCT02743104|Cholinergic Agents|cholinergic agents|mesh-ancestor
92856828|NCT00775203|Trazodone|trazodone|mesh-list
92856829|NCT00775203|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92856830|NCT00775203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92856831|NCT00775203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856832|NCT00775203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856833|NCT00775203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856834|NCT00775203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92856835|NCT00775203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92856836|NCT00775203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856837|NCT00775203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856838|NCT00775203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856839|NCT00775203|Serotonin Agents|serotonin agents|mesh-ancestor
92856840|NCT00775203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92856841|NCT00775203|Antidepressive Agents|antidepressive agents|mesh-ancestor
92856842|NCT02816684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92856843|NCT02816684|Antiviral Agents|antiviral agents|mesh-ancestor
92856844|NCT02816684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856845|NCT00607217|Vaccines|vaccines|mesh-list
92856846|NCT00607217|Immunologic Factors|immunologic factors|mesh-ancestor
92856847|NCT00607217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856849|NCT02747316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92856850|NCT02747316|Trace Elements|trace elements|mesh-ancestor
92856851|NCT02747316|Micronutrients|micronutrients|mesh-ancestor
92856852|NCT02747316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856853|NCT05648708|Bupivacaine|bupivacaine|mesh-list
92856854|NCT05648708|Prilocaine|prilocaine|mesh-list
92856855|NCT05648708|Anesthetics, Local|anesthetics, local|mesh-ancestor
92856856|NCT05648708|Anesthetics|anesthetics|mesh-ancestor
92856857|NCT05648708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856858|NCT05648708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856859|NCT05648708|Sensory System Agents|sensory system agents|mesh-ancestor
92856860|NCT05648708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856861|NCT02742948|Ceftriaxone|ceftriaxone|mesh-list
92856862|NCT02742948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856863|NCT02742948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856864|NCT00636246|Sertraline|sertraline|mesh-list
92856865|NCT00636246|Reboxetine|reboxetine|mesh-list
92856866|NCT00636246|Antidepressive Agents|antidepressive agents|mesh-ancestor
92856867|NCT00636246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92856868|NCT00636246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92856869|NCT00636246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92856870|NCT00636246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856871|NCT00636246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856872|NCT00636246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501996|NCT02022163|Vaccines|vaccines|mesh-list
92856874|NCT00636246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856875|NCT00636246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92856876|NCT00636246|Adrenergic Agents|adrenergic agents|mesh-ancestor
92856877|NCT02819570|Ampicillin|ampicillin|mesh-list
92856878|NCT02819570|Cefuroxime|cefuroxime|mesh-list
92856879|NCT02819570|Cefuroxime axetil|cefuroxime axetil|mesh-list
92856881|NCT02819570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856882|NCT02819570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856883|NCT04239170|Gemcitabine|gemcitabine|mesh-list
92856884|NCT04239170|Oxaliplatin|oxaliplatin|mesh-list
92856885|NCT04239170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856886|NCT04239170|Antimetabolites|antimetabolites|mesh-ancestor
92856887|NCT04239170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856888|NCT04239170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856889|NCT04480190|Gemcitabine|gemcitabine|mesh-list
92856890|NCT04480190|Fluorouracil|fluorouracil|mesh-list
92856891|NCT04480190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856892|NCT04480190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856893|NCT04480190|Antimetabolites|antimetabolites|mesh-ancestor
92156111|NCT03844061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856894|NCT04480190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856895|NCT04480190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92856896|NCT04480190|Immunologic Factors|immunologic factors|mesh-ancestor
92856897|NCT04480190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856898|NCT02741856|Paclitaxel|paclitaxel|mesh-list
92856899|NCT02741856|Carboplatin|carboplatin|mesh-list
92856900|NCT02741856|Capecitabine|capecitabine|mesh-list
92856901|NCT02741856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92856902|NCT02741856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856903|NCT02741856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92856904|NCT02741856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92856905|NCT02741856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92856906|NCT02741856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856907|NCT02741856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92856908|NCT02741856|Antimetabolites|antimetabolites|mesh-ancestor
92856909|NCT02741232|Lidocaine|lidocaine|mesh-list
92856910|NCT02741232|Epinephrine|epinephrine|mesh-list
92856911|NCT02741232|Racepinephrine|racepinephrine|mesh-list
92856912|NCT02741232|Epinephryl borate|epinephryl borate|mesh-list
92856913|NCT02741232|Anesthetics, Local|anesthetics, local|mesh-ancestor
92856914|NCT02741232|Anesthetics|anesthetics|mesh-ancestor
92856915|NCT02741232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856916|NCT02741232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856917|NCT02741232|Sensory System Agents|sensory system agents|mesh-ancestor
92856918|NCT02741232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856919|NCT02741232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92856920|NCT02741232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92856921|NCT02741232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92856922|NCT02741232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856923|NCT02741232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856924|NCT02741232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92856925|NCT02741232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92856926|NCT02741232|Adrenergic Agents|adrenergic agents|mesh-ancestor
92856927|NCT02741232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856928|NCT02741232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92856929|NCT02741232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92856930|NCT02741232|Autonomic Agents|autonomic agents|mesh-ancestor
92856931|NCT02741232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92856932|NCT02741232|Respiratory System Agents|respiratory system agents|mesh-ancestor
92856933|NCT02741232|Mydriatics|mydriatics|mesh-ancestor
92856934|NCT02741232|Sympathomimetics|sympathomimetics|mesh-ancestor
92856935|NCT02741232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92856936|NCT04239014|Olaparib|olaparib|mesh-list
92856937|NCT04239014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92856938|NCT04239014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856939|NCT04239014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856940|NCT04239014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856941|NCT00568321|Tanezumab|tanezumab|mesh-list
92856942|NCT00568321|Analgesics|analgesics|mesh-ancestor
92856943|NCT00568321|Sensory System Agents|sensory system agents|mesh-ancestor
92856944|NCT00568321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856945|NCT00568321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856946|NCT02742480|Dabigatran|dabigatran|mesh-list
92856947|NCT02742480|Acenocoumarol|acenocoumarol|mesh-list
92856948|NCT02742480|Antithrombins|antithrombins|mesh-ancestor
92502077|NCT02022488|Anesthetics|anesthetics|mesh-ancestor
92856949|NCT02742480|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92856950|NCT02742480|Protease Inhibitors|protease inhibitors|mesh-ancestor
92856951|NCT02742480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856952|NCT02742480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856953|NCT02742480|Anticoagulants|anticoagulants|mesh-ancestor
92856954|NCT00774345|Lenalidomide|lenalidomide|mesh-list
92856955|NCT00774345|Immunologic Factors|immunologic factors|mesh-ancestor
92856956|NCT00774345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856957|NCT00774345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92856958|NCT00774345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92856959|NCT00774345|Growth Substances|growth substances|mesh-ancestor
92856960|NCT00774345|Growth Inhibitors|growth inhibitors|mesh-ancestor
92856961|NCT00774345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92856962|NCT02819102|Berotralstat|berotralstat|mesh-list
92856963|NCT02819102|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92856964|NCT02819102|Protease Inhibitors|protease inhibitors|mesh-ancestor
92856965|NCT02819102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92856966|NCT02819102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856967|NCT04342026|Endocrine Disruptors|endocrine disruptors|mesh-list
92856968|NCT04342026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856970|NCT02819180|Immunologic Factors|immunologic factors|mesh-ancestor
92856971|NCT02819180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856972|NCT04661930|Fenofibrate|fenofibrate|mesh-list
92856973|NCT04661930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92856974|NCT04661930|Antimetabolites|antimetabolites|mesh-ancestor
92856975|NCT04661930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856976|NCT04661930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92856977|NCT02815046|Botulinum Toxins|botulinum toxins|mesh-list
92856978|NCT02815046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92856979|NCT02815046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92856980|NCT02815046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92856981|NCT02815046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92856982|NCT02815046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92856983|NCT02815046|Cholinergic Agents|cholinergic agents|mesh-ancestor
92856984|NCT02815046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92856985|NCT02815046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856986|NCT02815046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92856987|NCT02815046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856988|NCT02601963|Minocycline|minocycline|mesh-list
92856989|NCT02601963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92856990|NCT02601963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92856991|NCT00927979|Ropivacaine|ropivacaine|mesh-list
92856992|NCT00927979|Anesthetics, Local|anesthetics, local|mesh-ancestor
92856993|NCT00927979|Anesthetics|anesthetics|mesh-ancestor
92856994|NCT00927979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92856995|NCT00927979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92856996|NCT00927979|Sensory System Agents|sensory system agents|mesh-ancestor
92856997|NCT00927979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92856998|NCT00931957|Prednisolone|prednisolone|mesh-list
92856999|NCT00931957|Etanercept|etanercept|mesh-list
92857000|NCT00931957|Methotrexate|methotrexate|mesh-list
92857001|NCT00931957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92857002|NCT00931957|Abortifacient Agents|abortifacient agents|mesh-ancestor
92857003|NCT00931957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857004|NCT00931957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857005|NCT00931957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92857006|NCT00931957|Antimetabolites|antimetabolites|mesh-ancestor
92857007|NCT00931957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857008|NCT00931957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857009|NCT00931957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92857010|NCT00931957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857011|NCT00931957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92857012|NCT00931957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857013|NCT00931957|Immunologic Factors|immunologic factors|mesh-ancestor
92857014|NCT00931957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857015|NCT00931957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92857016|NCT00931957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857017|NCT00931957|Glucocorticoids|glucocorticoids|mesh-ancestor
92857018|NCT00931957|Hormones|hormones|mesh-ancestor
92857019|NCT00931957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857020|NCT00931957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857021|NCT00931957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857022|NCT00931957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857023|NCT00931957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92857024|NCT00931957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92857025|NCT00931957|Analgesics|analgesics|mesh-ancestor
92857026|NCT00931957|Sensory System Agents|sensory system agents|mesh-ancestor
92857027|NCT02731950|Magnesium Sulfate|magnesium sulfate|mesh-list
92857028|NCT02731950|Bupivacaine|bupivacaine|mesh-list
92857029|NCT02731950|Anesthetics, Local|anesthetics, local|mesh-ancestor
92857030|NCT02731950|Anesthetics|anesthetics|mesh-ancestor
92857031|NCT02731950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857032|NCT02731950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857033|NCT02731950|Sensory System Agents|sensory system agents|mesh-ancestor
92857034|NCT02731950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857035|NCT02731950|Analgesics|analgesics|mesh-ancestor
92857036|NCT02731950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92857037|NCT02731950|Anticonvulsants|anticonvulsants|mesh-ancestor
92857038|NCT02731950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92857039|NCT02731950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857040|NCT02731950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857041|NCT02731950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92857042|NCT02731950|Tocolytic Agents|tocolytic agents|mesh-ancestor
92857043|NCT02731950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857044|NCT00773253|Botulinum Toxins|botulinum toxins|mesh-list
92857045|NCT00773253|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92857046|NCT00773253|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92857047|NCT00773253|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92857048|NCT00773253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857049|NCT00773253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857050|NCT00773253|Cholinergic Agents|cholinergic agents|mesh-ancestor
92857051|NCT00773253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857052|NCT00773253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857053|NCT00773253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92857054|NCT00773253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857055|NCT00928213|Heparin|heparin|mesh-list
92857056|NCT00928213|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92857057|NCT00928213|Tinzaparin|tinzaparin|mesh-list
92857058|NCT00928213|Dalteparin|dalteparin|mesh-list
92857059|NCT00928213|Progesterone|progesterone|mesh-list
92857060|NCT00928213|Hormones|hormones|mesh-ancestor
92857061|NCT00928213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857062|NCT00928213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857063|NCT00928213|Anticoagulants|anticoagulants|mesh-ancestor
92857064|NCT00928213|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92857065|NCT00928213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92857066|NCT00928213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857067|NCT00928213|Progestins|progestins|mesh-ancestor
92857068|NCT00928291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92857069|NCT00928291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857070|NCT02736240|Vaccines|vaccines|mesh-list
92857071|NCT02736240|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92857072|NCT02736240|Immunologic Factors|immunologic factors|mesh-ancestor
92857073|NCT02736240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857074|NCT02741154|Letrozole|letrozole|mesh-list
92857075|NCT02741154|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92857076|NCT02741154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857077|NCT02741154|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92857078|NCT02741154|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92857079|NCT02741154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857080|NCT02741154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857081|NCT02741154|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92857082|NCT02741154|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857083|NCT02741154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857084|NCT02741154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857085|NCT02741154|Luteolytic Agents|luteolytic agents|mesh-ancestor
92857086|NCT02741154|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92857087|NCT02741154|Contraceptive Agents|contraceptive agents|mesh-ancestor
92857088|NCT02741154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857089|NCT02741154|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92857090|NCT02741154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857091|NCT04287816|Antithrombin III|antithrombin iii|mesh-list
92857092|NCT04287816|Antithrombins|antithrombins|mesh-list
92857093|NCT04287816|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92857094|NCT04287816|Protease Inhibitors|protease inhibitors|mesh-ancestor
92857095|NCT04287816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857096|NCT04287816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857097|NCT04287816|Anticoagulants|anticoagulants|mesh-ancestor
92857098|NCT02735928|Doxorubicin|doxorubicin|mesh-list
92857099|NCT02735928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857100|NCT02735928|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92857102|NCT02735928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92857103|NCT02735928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857104|NCT02735928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857105|NCT02731560|Rituximab|rituximab|mesh-list
92857106|NCT02731560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857107|NCT02731560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857108|NCT02731560|Immunologic Factors|immunologic factors|mesh-ancestor
92857109|NCT02731560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857110|NCT02731560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857111|NCT00773097|Poly ICLC|poly iclc|mesh-list
92857112|NCT00773097|Interferon Inducers|interferon inducers|mesh-ancestor
92857113|NCT00773097|Immunologic Factors|immunologic factors|mesh-ancestor
92857114|NCT00773097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857115|NCT00933335|Tositumomab I-131|tositumomab i-131|mesh-list
92857116|NCT00933335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857117|NCT02814110|Lenograstim|lenograstim|mesh-list
92857118|NCT02814110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92857119|NCT02814110|Immunologic Factors|immunologic factors|mesh-ancestor
92857120|NCT02814110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857121|NCT00928525|Imatinib Mesylate|imatinib mesylate|mesh-list
92857122|NCT00928525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857123|NCT00928525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92857124|NCT00928525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857125|NCT00928525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857126|NCT04264481|Lidocaine|lidocaine|mesh-list
92857127|NCT04264481|Anesthetics, Local|anesthetics, local|mesh-ancestor
92857128|NCT04264481|Anesthetics|anesthetics|mesh-ancestor
92857129|NCT04264481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857130|NCT04264481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857131|NCT04264481|Sensory System Agents|sensory system agents|mesh-ancestor
92857132|NCT04264481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857133|NCT04264481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92857134|NCT04264481|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92857135|NCT04264481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92857136|NCT04264481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857137|NCT04264481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857138|NCT05303909|Gentamicins|gentamicins|mesh-list
92857139|NCT05303909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857140|NCT05303909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857141|NCT05303909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92857142|NCT05303909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857143|NCT05303909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857144|NCT04306692|Inositol|inositol|mesh-list
92857145|NCT04306692|Clomiphene|clomiphene|mesh-list
92857146|NCT04306692|Enclomiphene|enclomiphene|mesh-list
92857147|NCT04306692|Zuclomiphene|zuclomiphene|mesh-list
92857148|NCT04306692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92857149|NCT04306692|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857150|NCT04306692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857151|NCT04306692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857152|NCT04306692|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92857153|NCT04306692|Fertility Agents|fertility agents|mesh-ancestor
92857154|NCT04306692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857155|NCT04306692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92857156|NCT04306692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92857157|NCT04306692|Vitamin B Complex|vitamin b complex|mesh-ancestor
92857158|NCT04306692|Vitamins|vitamins|mesh-ancestor
92857159|NCT04306692|Micronutrients|micronutrients|mesh-ancestor
92857160|NCT00772941|Varenicline|varenicline|mesh-list
92857161|NCT00772941|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92857162|NCT00772941|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92857163|NCT00772941|Cholinergic Agents|cholinergic agents|mesh-ancestor
92857164|NCT00772941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857165|NCT00772941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857166|NCT00772941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857167|NCT02735694|Cycloserine|cycloserine|mesh-list
92857168|NCT02735694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92857169|NCT02735694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857170|NCT02735694|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92857171|NCT02735694|Antitubercular Agents|antitubercular agents|mesh-ancestor
92857172|NCT02735694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857173|NCT02735694|Antimetabolites|antimetabolites|mesh-ancestor
92201657|NCT04388033|Growth Substances|growth substances|mesh-ancestor
92857174|NCT02735694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857175|NCT04237532|Dexmedetomidine|dexmedetomidine|mesh-list
92857176|NCT04237532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92857177|NCT04237532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857178|NCT04237532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857179|NCT04237532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92857180|NCT04237532|Analgesics|analgesics|mesh-ancestor
92857181|NCT04237532|Sensory System Agents|sensory system agents|mesh-ancestor
92857182|NCT04237532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857183|NCT04237532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92857184|NCT04237532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92857185|NCT04237532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92857186|NCT04237532|Adrenergic Agents|adrenergic agents|mesh-ancestor
92857187|NCT04237532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857188|NCT04237532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857189|NCT02731092|Lactoferrin|lactoferrin|mesh-list
92857190|NCT02731092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857191|NCT00928837|Naproxen|naproxen|mesh-list
92857192|NCT00928837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92857193|NCT00928837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92857194|NCT00928837|Analgesics|analgesics|mesh-ancestor
92857195|NCT00928837|Sensory System Agents|sensory system agents|mesh-ancestor
92857196|NCT00928837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857197|NCT00928837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857198|NCT00928837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857199|NCT00928837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857200|NCT00928837|Gout Suppressants|gout suppressants|mesh-ancestor
92857201|NCT00928837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92857202|NCT00928837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857203|NCT00928837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857204|NCT02730936|Anti-Infective Agents|anti-infective agents|mesh-list
92857205|NCT02730936|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92857206|NCT00925093|Vancomycin|vancomycin|mesh-list
92857207|NCT00925093|Linezolid|linezolid|mesh-list
92857208|NCT00925093|Teicoplanin|teicoplanin|mesh-list
92857209|NCT00925093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857210|NCT00925093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857211|NCT00925093|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92857212|NCT00925093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857213|NCT00925093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857214|NCT01562977|Rituximab|rituximab|mesh-list
92857215|NCT01562977|Gemcitabine|gemcitabine|mesh-list
92857216|NCT01562977|Oxaliplatin|oxaliplatin|mesh-list
92857217|NCT01562977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857218|NCT01562977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857219|NCT01562977|Immunologic Factors|immunologic factors|mesh-ancestor
92857220|NCT01562977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857221|NCT01562977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857222|NCT01562977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92857223|NCT01562977|Antimetabolites|antimetabolites|mesh-ancestor
92857224|NCT01562977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857225|NCT00607685|Fluorouracil|fluorouracil|mesh-list
92857226|NCT00607685|Hyaluronic Acid|hyaluronic acid|mesh-list
92857227|NCT00607685|Antimetabolites|antimetabolites|mesh-ancestor
92857228|NCT00607685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857229|NCT00607685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92857230|NCT00607685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857231|NCT00607685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857232|NCT00607685|Immunologic Factors|immunologic factors|mesh-ancestor
92857233|NCT00607685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857234|NCT00607685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92857235|NCT00607685|Viscosupplements|viscosupplements|mesh-ancestor
92857236|NCT00607685|Protective Agents|protective agents|mesh-ancestor
92857237|NCT05450718|Buprenorphine|buprenorphine|mesh-list
92857238|NCT05450718|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92857239|NCT05450718|Naloxone|naloxone|mesh-list
92857240|NCT05450718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92857241|NCT05450718|Narcotics|narcotics|mesh-ancestor
92857242|NCT05450718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857243|NCT05450718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857244|NCT05450718|Analgesics|analgesics|mesh-ancestor
92857245|NCT05450718|Sensory System Agents|sensory system agents|mesh-ancestor
92857246|NCT05450718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857247|NCT05450718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92857249|NCT04265027|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92857250|NCT04265027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857251|NCT04265027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857252|NCT04265027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92857253|NCT04265027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92857254|NCT00607763|Micafungin|micafungin|mesh-list
92857255|NCT00607763|Antifungal Agents|antifungal agents|mesh-ancestor
92857256|NCT00607763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857257|NCT00928915|Thrombin|thrombin|mesh-list
92857258|NCT00928915|Hemostatics|hemostatics|mesh-ancestor
92857259|NCT00928915|Coagulants|coagulants|mesh-ancestor
92857260|NCT02814500|Amlodipine|amlodipine|mesh-list
92857261|NCT02814500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92857262|NCT02814500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92857263|NCT02814500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92857264|NCT02814500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857265|NCT02814500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857266|NCT02814500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92857267|NCT02814500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857268|NCT02814500|Vasodilator Agents|vasodilator agents|mesh-ancestor
92857269|NCT02814500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92857270|NCT02814500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92857271|NCT02814500|Antimetabolites|antimetabolites|mesh-ancestor
92857272|NCT02814500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92857273|NCT02814500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92857274|NCT02814500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857275|NCT00939341|Budesonide|budesonide|mesh-list
92857276|NCT00939341|Formoterol Fumarate|formoterol fumarate|mesh-list
92857277|NCT00939341|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92857278|NCT00939341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857279|NCT00939341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92857280|NCT00939341|Autonomic Agents|autonomic agents|mesh-ancestor
92857281|NCT00939341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857282|NCT00939341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857283|NCT00939341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92857284|NCT00939341|Respiratory System Agents|respiratory system agents|mesh-ancestor
92857285|NCT00939341|Glucocorticoids|glucocorticoids|mesh-ancestor
92857286|NCT00939341|Hormones|hormones|mesh-ancestor
92857287|NCT00939341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857288|NCT00939341|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92857289|NCT00939341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92857290|NCT00939341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92857291|NCT00939341|Adrenergic Agents|adrenergic agents|mesh-ancestor
92857292|NCT00939341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857293|NCT00939341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857294|NCT00925327|Riboflavin|riboflavin|mesh-list
92857295|NCT00925327|Vitamin B Complex|vitamin b complex|mesh-ancestor
92857296|NCT00925327|Vitamins|vitamins|mesh-ancestor
92857297|NCT00925327|Micronutrients|micronutrients|mesh-ancestor
92857298|NCT00925327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857299|NCT00925327|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92857300|NCT00925327|Dermatologic Agents|dermatologic agents|mesh-ancestor
92857301|NCT04237376|Tenofovir|tenofovir|mesh-list
92857302|NCT04237376|Antiviral Agents|antiviral agents|mesh-ancestor
92857303|NCT04237376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857304|NCT04237376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92857305|NCT04237376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92857306|NCT04237376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857307|NCT04237376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857308|NCT04237376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92857309|NCT04237376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92857310|NCT04015687|Lamotrigine|lamotrigine|mesh-list
92857311|NCT04015687|Anticonvulsants|anticonvulsants|mesh-ancestor
92857312|NCT04015687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92857313|NCT04015687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857314|NCT04015687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857315|NCT04015687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92857316|NCT04015687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857317|NCT04015687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92857318|NCT04015687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92857319|NCT04015687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857320|NCT04015687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92857321|NCT04015687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92857322|NCT02739906|Insulin|insulin|mesh-list
92857323|NCT02739906|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92857324|NCT02739906|Insulin Lispro|insulin lispro|mesh-list
92857325|NCT02739906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92156127|NCT03829319|Carboplatin|carboplatin|mesh-list
92857326|NCT02739906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857327|NCT02739672|Amlodipine|amlodipine|mesh-list
92857328|NCT02739672|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92857329|NCT02739672|Telmisartan|telmisartan|mesh-list
92857330|NCT02739672|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92857331|NCT02739672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92857332|NCT02739672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92857333|NCT02739672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857334|NCT02739672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857335|NCT02739672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92857336|NCT02739672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857337|NCT02739672|Vasodilator Agents|vasodilator agents|mesh-ancestor
92857338|NCT02739672|Diuretics|diuretics|mesh-ancestor
92857339|NCT02739672|Natriuretic Agents|natriuretic agents|mesh-ancestor
92857340|NCT02739672|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92857341|NCT02739672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92857342|NCT02739672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92857343|NCT00932971|Tenofovir|tenofovir|mesh-list
92857344|NCT00932971|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92857345|NCT00932971|Interferon-alpha|interferon-alpha|mesh-list
92857346|NCT00932971|Interferon alpha-2|interferon alpha-2|mesh-list
92857347|NCT00932971|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92857348|NCT00932971|Antiviral Agents|antiviral agents|mesh-ancestor
92857349|NCT00932971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857350|NCT00932971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92857351|NCT00932971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92857352|NCT00932971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857353|NCT00932971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857354|NCT00932971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92857355|NCT00932971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92857356|NCT00932971|Immunologic Factors|immunologic factors|mesh-ancestor
92857357|NCT00932971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857358|NCT00932971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857359|NCT05382143|Atosiban|atosiban|mesh-list
92857360|NCT05382143|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857361|NCT05382143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857362|NCT05382143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857363|NCT05382143|Tocolytic Agents|tocolytic agents|mesh-ancestor
92857364|NCT05382143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857365|NCT00933049|Amoxicillin|amoxicillin|mesh-list
92857366|NCT00933049|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92857367|NCT00933049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857368|NCT00933049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857369|NCT00933049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92857370|NCT00933049|Antimalarials|antimalarials|mesh-ancestor
92857371|NCT00933049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92857372|NCT00933049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92857373|NCT05788458|Bupivacaine|bupivacaine|mesh-list
92857374|NCT05788458|Anesthetics, Local|anesthetics, local|mesh-ancestor
92857375|NCT05788458|Anesthetics|anesthetics|mesh-ancestor
92857376|NCT05788458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857377|NCT05788458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857378|NCT05788458|Sensory System Agents|sensory system agents|mesh-ancestor
92857379|NCT05788458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857380|NCT05788393|Lidocaine|lidocaine|mesh-list
92857381|NCT05788393|Dexmedetomidine|dexmedetomidine|mesh-list
92857382|NCT05788393|Anesthetics, Local|anesthetics, local|mesh-ancestor
92857383|NCT05788393|Anesthetics|anesthetics|mesh-ancestor
92857384|NCT05788393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857385|NCT05788393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857386|NCT05788393|Sensory System Agents|sensory system agents|mesh-ancestor
92857387|NCT05788393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857388|NCT05788393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92857389|NCT05788393|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92857390|NCT05788393|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92857391|NCT05788393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201908|NCT03793439|Prednisone|prednisone|mesh-list
92156128|NCT03829319|Pembrolizumab|pembrolizumab|mesh-list
92857392|NCT05788393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857393|NCT05788393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92857394|NCT05788393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92857395|NCT05788393|Analgesics|analgesics|mesh-ancestor
92857396|NCT05788393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92857397|NCT05788393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92857398|NCT05788393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92857399|NCT05788393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92857400|NCT05788393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857401|NCT05788159|Lacosamide|lacosamide|mesh-list
92857402|NCT05788159|Anticonvulsants|anticonvulsants|mesh-ancestor
92857403|NCT05788159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92857404|NCT05788159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92857405|NCT05788159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92857406|NCT05788159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857407|NCT05788094|Chloroquine|chloroquine|mesh-list
92857408|NCT05788094|Piperaquine|piperaquine|mesh-list
92857409|NCT05788094|Artenimol|artenimol|mesh-list
92857410|NCT05788094|Tafenoquine|tafenoquine|mesh-list
92857411|NCT05788094|Amebicides|amebicides|mesh-ancestor
92857412|NCT05788094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92857413|NCT05788094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92857414|NCT05788094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857415|NCT05788094|Antimalarials|antimalarials|mesh-ancestor
92857416|NCT05788094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857417|NCT05787925|Vitamin E|vitamin e|mesh-list
92857418|NCT05787925|Vitamins|vitamins|mesh-ancestor
92857419|NCT05787925|Micronutrients|micronutrients|mesh-ancestor
92857420|NCT05787925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857421|NCT05787925|Antioxidants|antioxidants|mesh-ancestor
92857422|NCT05787925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857423|NCT05787925|Protective Agents|protective agents|mesh-ancestor
92857424|NCT05787912|Hyaluronic Acid|hyaluronic acid|mesh-list
92857425|NCT05787912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92857426|NCT05787912|Immunologic Factors|immunologic factors|mesh-ancestor
92857427|NCT05787912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857428|NCT05787912|Viscosupplements|viscosupplements|mesh-ancestor
92857429|NCT05787912|Protective Agents|protective agents|mesh-ancestor
92857430|NCT05787808|Vitamin D|vitamin d|mesh-list
92857431|NCT05787808|Vitamins|vitamins|mesh-ancestor
92857432|NCT05787808|Micronutrients|micronutrients|mesh-ancestor
92857433|NCT05787808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857434|NCT05787808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92857435|NCT05787743|Tocotrienols|tocotrienols|mesh-list
92857436|NCT05787743|Vitamin E|vitamin e|mesh-list
92857437|NCT05787743|Tocopherols|tocopherols|mesh-list
92857438|NCT05787743|Antioxidants|antioxidants|mesh-ancestor
92857439|NCT05787743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857440|NCT05787743|Protective Agents|protective agents|mesh-ancestor
92857441|NCT05787743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857442|NCT05787743|Vitamins|vitamins|mesh-ancestor
92857443|NCT05787743|Micronutrients|micronutrients|mesh-ancestor
92857444|NCT05787574|Dexamethasone|dexamethasone|mesh-list
92857445|NCT05787574|Fludarabine|fludarabine|mesh-list
92857446|NCT05787574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857447|NCT05787574|Antiemetics|antiemetics|mesh-ancestor
92857448|NCT05787574|Autonomic Agents|autonomic agents|mesh-ancestor
92857449|NCT05787574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857450|NCT05787574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857451|NCT05787574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857452|NCT05787574|Glucocorticoids|glucocorticoids|mesh-ancestor
92857453|NCT05787574|Hormones|hormones|mesh-ancestor
92857454|NCT05787574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857455|NCT05787574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857456|NCT05787574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857457|NCT05787535|Cyclophosphamide|cyclophosphamide|mesh-list
92857458|NCT05787535|Fludarabine|fludarabine|mesh-list
92857459|NCT05787535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857460|NCT05787535|Immunologic Factors|immunologic factors|mesh-ancestor
92857461|NCT05787535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857462|NCT05787535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857463|NCT05787535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92857464|NCT05787535|Alkylating Agents|alkylating agents|mesh-ancestor
92857465|NCT05787535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857466|NCT05787535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157751|NCT04041843|Apixaban|apixaban|mesh-list
92857467|NCT05787535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92857468|NCT05787509|Progesterone|progesterone|mesh-list
92502596|NCT02025361|Lidocaine|lidocaine|mesh-list
92857469|NCT05787509|Progestins|progestins|mesh-ancestor
92857470|NCT05787509|Hormones|hormones|mesh-ancestor
92857471|NCT05787509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857472|NCT05787509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857473|NCT05787002|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92857474|NCT05787002|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92857475|NCT05787002|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92857476|NCT05787002|Antimetabolites|antimetabolites|mesh-ancestor
92857477|NCT05787002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857478|NCT05787002|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92857479|NCT05787002|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92857480|NCT05787002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857481|NCT05786950|Bromides|bromides|mesh-list
92857482|NCT05786950|Albuterol|albuterol|mesh-list
92857483|NCT05786950|Ipratropium|ipratropium|mesh-list
92857484|NCT05786950|Anticonvulsants|anticonvulsants|mesh-ancestor
92857485|NCT05786950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92857486|NCT05786950|Autonomic Agents|autonomic agents|mesh-ancestor
92857487|NCT05786950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857488|NCT05786950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857489|NCT05786950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92857490|NCT05786950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92857491|NCT05786950|Tocolytic Agents|tocolytic agents|mesh-ancestor
92857492|NCT05786950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857493|NCT05786950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92857494|NCT05786950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92857495|NCT05786950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92857496|NCT05786950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92857497|NCT05786950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857498|NCT05786950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857499|NCT05786950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92857500|NCT05786950|Cholinergic Agents|cholinergic agents|mesh-ancestor
92857501|NCT05786885|Vitamins|vitamins|mesh-list
92857502|NCT05786885|Ascorbic Acid|ascorbic acid|mesh-list
92857503|NCT05786885|Micronutrients|micronutrients|mesh-ancestor
92857504|NCT05786885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857505|NCT05786885|Antioxidants|antioxidants|mesh-ancestor
92857506|NCT05786885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857507|NCT05786885|Protective Agents|protective agents|mesh-ancestor
92857508|NCT05786859|Rifaximin|rifaximin|mesh-list
92857509|NCT05786859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857510|NCT05786859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857511|NCT05786859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857512|NCT05786768|Rituximab|rituximab|mesh-list
92857513|NCT05786768|Obinutuzumab|obinutuzumab|mesh-list
92857514|NCT05786768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857515|NCT05786768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857516|NCT05786768|Immunologic Factors|immunologic factors|mesh-ancestor
92857517|NCT05786768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857518|NCT05786768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857519|NCT05786638|Immunomodulating Agents|immunomodulating agents|mesh-list
92857520|NCT05786638|Immunologic Factors|immunologic factors|mesh-ancestor
92857521|NCT05786638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857522|NCT05785897|Sirolimus|sirolimus|mesh-list
92857523|NCT05785897|Ticagrelor|ticagrelor|mesh-list
92857524|NCT05785897|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92857525|NCT05785897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857526|NCT05785897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857527|NCT05785897|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92857528|NCT05785897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857529|NCT05785897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857530|NCT05785897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92857531|NCT05785897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857532|NCT05785897|Antifungal Agents|antifungal agents|mesh-ancestor
92857533|NCT05785897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857534|NCT05785897|Immunologic Factors|immunologic factors|mesh-ancestor
92857535|NCT05785897|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92857536|NCT05785897|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92857537|NCT05785897|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92857538|NCT05785897|Purinergic Agents|purinergic agents|mesh-ancestor
92857539|NCT05785897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857540|NCT05785819|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92202024|NCT03686306|Urological Agents|urological agents|mesh-ancestor
92857541|NCT05785819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857543|NCT05784688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857544|NCT05784688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857545|NCT05784688|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92857546|NCT05784688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857547|NCT05776459|Prednisolone|prednisolone|mesh-list
92857548|NCT05776459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857549|NCT05776459|Glucocorticoids|glucocorticoids|mesh-ancestor
92857550|NCT05776459|Hormones|hormones|mesh-ancestor
92857551|NCT05776459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857552|NCT05776459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857553|NCT05776459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857554|NCT05776459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857555|NCT05764044|Gemcitabine|gemcitabine|mesh-list
92857556|NCT05764044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857557|NCT05764044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92857558|NCT05764044|Antimetabolites|antimetabolites|mesh-ancestor
92857559|NCT05764044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857560|NCT05739136|Norethindrone|norethindrone|mesh-list
92857561|NCT05739136|Norethindrone Acetate|norethindrone acetate|mesh-list
92857562|NCT05739136|Estradiol|estradiol|mesh-list
92857563|NCT05739136|Relugolix|relugolix|mesh-list
92857564|NCT05739136|Estrogens|estrogens|mesh-ancestor
92857565|NCT05739136|Hormones|hormones|mesh-ancestor
92857566|NCT05739136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857567|NCT05739136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857568|NCT05739136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92857569|NCT05739136|Contraceptive Agents|contraceptive agents|mesh-ancestor
92857570|NCT05739136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857571|NCT05739136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92857572|NCT05739136|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92857573|NCT05739136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92857574|NCT05739136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92857575|NCT05739136|Androgen Antagonists|androgen antagonists|mesh-ancestor
92857576|NCT05739136|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857577|NCT05737030|N-Methylaspartate|n-methylaspartate|mesh-list
92857578|NCT05737030|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92857579|NCT05737030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92857580|NCT05737030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857581|NCT05737030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857582|NCT05737030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857583|NCT05716295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92857584|NCT05716295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857585|NCT05716295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857586|NCT05716295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857587|NCT05708625|Doxycycline|doxycycline|mesh-list
92857588|NCT05708625|Voriconazole|voriconazole|mesh-list
92857589|NCT05708625|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92857590|NCT05708625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857591|NCT05708625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857592|NCT05708625|Antimalarials|antimalarials|mesh-ancestor
92857593|NCT05708625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92857594|NCT05708625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92857595|NCT05708625|Antifungal Agents|antifungal agents|mesh-ancestor
92857596|NCT05708625|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92857597|NCT05708625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92857598|NCT05708625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857599|NCT05708625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857600|NCT05708625|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92857601|NCT05708625|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857602|NCT05708625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857603|NCT05708625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857604|NCT05708625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92857605|NCT05708625|Schistosomicides|schistosomicides|mesh-ancestor
92857606|NCT05708625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92857607|NCT05708625|Anthelmintics|anthelmintics|mesh-ancestor
92857608|NCT05706844|Anesthetics|anesthetics|mesh-list
92857609|NCT05706844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156139|NCT03814109|Niacin|niacin|mesh-list
92857610|NCT05706844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857611|NCT05702827|Meloxicam|meloxicam|mesh-list
92857612|NCT05702827|Bupivacaine|bupivacaine|mesh-list
92857613|NCT05702827|Anesthetics, Local|anesthetics, local|mesh-ancestor
92857614|NCT05702827|Anesthetics|anesthetics|mesh-ancestor
92857615|NCT05702827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857616|NCT05702827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857617|NCT05702827|Sensory System Agents|sensory system agents|mesh-ancestor
92857618|NCT05702827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857619|NCT05702827|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92857620|NCT05702827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92857621|NCT05702827|Analgesics|analgesics|mesh-ancestor
92857622|NCT05702827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857623|NCT05702827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857624|NCT05702827|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92857625|NCT05702827|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92857626|NCT05702827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857627|NCT05702827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857628|NCT05685628|Charcoal|charcoal|mesh-list
92857629|NCT05685628|Antidotes|antidotes|mesh-ancestor
92857630|NCT05685628|Protective Agents|protective agents|mesh-ancestor
92857631|NCT05685628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857632|NCT05673889|Dabigatran|dabigatran|mesh-list
92857633|NCT05673889|Antithrombins|antithrombins|mesh-ancestor
92857634|NCT05673889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92857635|NCT05673889|Protease Inhibitors|protease inhibitors|mesh-ancestor
92857636|NCT05673889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857637|NCT05673889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857638|NCT05673889|Anticoagulants|anticoagulants|mesh-ancestor
92857639|NCT05654298|Sumatriptan|sumatriptan|mesh-list
92857640|NCT05654298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92857641|NCT05654298|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92857642|NCT05654298|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92857643|NCT05654298|Serotonin Agents|serotonin agents|mesh-ancestor
92857644|NCT05654298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857645|NCT05654298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857646|NCT05654298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857647|NCT05649293|Vitamin B 6|vitamin b 6|mesh-list
92857648|NCT05649293|Pyridoxal|pyridoxal|mesh-list
92857649|NCT05649293|Pyridoxine|pyridoxine|mesh-list
92857650|NCT05649293|Vitamins|vitamins|mesh-ancestor
92857651|NCT05649293|Micronutrients|micronutrients|mesh-ancestor
92857652|NCT05649293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857653|NCT05649293|Vitamin B Complex|vitamin b complex|mesh-ancestor
92857654|NCT05639972|Aldesleukin|aldesleukin|mesh-list
92857655|NCT05639972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857656|NCT05639972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92857657|NCT05639972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92857658|NCT05639972|Antiviral Agents|antiviral agents|mesh-ancestor
92857659|NCT05639972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857660|NCT05622318|Mycophenolic Acid|mycophenolic acid|mesh-list
92857661|NCT05622318|Cyclophosphamide|cyclophosphamide|mesh-list
92857662|NCT05622318|Tacrolimus|tacrolimus|mesh-list
92857663|NCT05622318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857664|NCT05622318|Immunologic Factors|immunologic factors|mesh-ancestor
92857665|NCT05622318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857666|NCT05622318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857667|NCT05622318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92857668|NCT05622318|Alkylating Agents|alkylating agents|mesh-ancestor
92857669|NCT05622318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857670|NCT05622318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857671|NCT05622318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92857672|NCT05622318|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92857673|NCT05622318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857674|NCT05622318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92857675|NCT05622318|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92857676|NCT05622318|Antitubercular Agents|antitubercular agents|mesh-ancestor
92857677|NCT05622318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857678|NCT05622318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857679|NCT05618613|Onapristone|onapristone|mesh-list
92857680|NCT05618613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857681|NCT05618613|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92857682|NCT05618613|Fertility Agents|fertility agents|mesh-ancestor
92857683|NCT05618613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92156140|NCT03814109|Indapamide|indapamide|mesh-list
92857684|NCT05618613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857685|NCT05618613|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857686|NCT05618613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857688|NCT05617963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857689|NCT05617963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857691|NCT05587036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857692|NCT05587036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857693|NCT05587036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857694|NCT05570305|Dapagliflozin|dapagliflozin|mesh-list
92857695|NCT05570305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92857696|NCT05570305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857697|NCT05570305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92857698|NCT05570305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857699|NCT05567731|Hormones|hormones|mesh-list
92857700|NCT05567731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857701|NCT05567731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857702|NCT05561543|Peppermint oil|peppermint oil|mesh-list
92857703|NCT05561543|Antiemetics|antiemetics|mesh-ancestor
92857704|NCT05561543|Autonomic Agents|autonomic agents|mesh-ancestor
92857705|NCT05561543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857706|NCT05561543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857707|NCT05561543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857708|NCT05561543|Parasympatholytics|parasympatholytics|mesh-ancestor
92857709|NCT05535309|Sulbactam|sulbactam|mesh-list
92857710|NCT05535309|Cefoperazone|cefoperazone|mesh-list
92857711|NCT05535309|Sulperazone|sulperazone|mesh-list
92857712|NCT05535309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857713|NCT05535309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857714|NCT05535309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92857715|NCT05535309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857716|NCT05535309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857717|NCT05535309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92857718|NCT05506046|Nicotine|nicotine|mesh-list
92857719|NCT05506046|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92857720|NCT05506046|Autonomic Agents|autonomic agents|mesh-ancestor
92857721|NCT05506046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857722|NCT05506046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857723|NCT05506046|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92857724|NCT05506046|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92857725|NCT05506046|Cholinergic Agents|cholinergic agents|mesh-ancestor
92857726|NCT05506046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857727|NCT05506046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857728|NCT05503875|Adalimumab|adalimumab|mesh-list
92857729|NCT05503875|Methotrexate|methotrexate|mesh-list
92857730|NCT05503875|Ixekizumab|ixekizumab|mesh-list
92857731|NCT05503875|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92857732|NCT05503875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92857733|NCT05503875|Abortifacient Agents|abortifacient agents|mesh-ancestor
92857734|NCT05503875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857735|NCT05503875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857736|NCT05503875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92857737|NCT05503875|Antimetabolites|antimetabolites|mesh-ancestor
92857738|NCT05503875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857739|NCT05503875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857740|NCT05503875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92857741|NCT05503875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857742|NCT05503875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92857743|NCT05503875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857744|NCT05503875|Immunologic Factors|immunologic factors|mesh-ancestor
92857745|NCT05503875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857746|NCT05503875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92857747|NCT05503875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92857748|NCT05503875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857749|NCT05503875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92857750|NCT05487950|Rivaroxaban|rivaroxaban|mesh-list
92857751|NCT05487950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92857752|NCT05487950|Antithrombins|antithrombins|mesh-ancestor
92857753|NCT05487950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92857754|NCT05487950|Protease Inhibitors|protease inhibitors|mesh-ancestor
92857755|NCT05487950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857756|NCT05487950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857757|NCT05487950|Anticoagulants|anticoagulants|mesh-ancestor
92857758|NCT05477823|Androgens|androgens|mesh-list
92857759|NCT05477823|Hormones|hormones|mesh-ancestor
92857760|NCT05477823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857761|NCT05477823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857763|NCT05452512|Vitamins|vitamins|mesh-list
92857764|NCT05452512|Micronutrients|micronutrients|mesh-ancestor
92857765|NCT05452512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857766|NCT05452512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92857767|NCT05432089|Oxytocin|oxytocin|mesh-list
92857768|NCT05432089|Oxytocics|oxytocics|mesh-ancestor
92857769|NCT05432089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857770|NCT05432089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857771|NCT05428826|Prednisone|prednisone|mesh-list
92857772|NCT05428826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857773|NCT05428826|Glucocorticoids|glucocorticoids|mesh-ancestor
92857774|NCT05428826|Hormones|hormones|mesh-ancestor
92857775|NCT05428826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857776|NCT05428826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857777|NCT05428826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857778|NCT05428826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857779|NCT05427513|Tranexamic Acid|tranexamic acid|mesh-list
92857780|NCT05427513|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92857781|NCT05427513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92857782|NCT05427513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857783|NCT05427513|Hemostatics|hemostatics|mesh-ancestor
92857784|NCT05427513|Coagulants|coagulants|mesh-ancestor
92857785|NCT05411718|Aspirin|aspirin|mesh-list
92857786|NCT05411718|Naproxen|naproxen|mesh-list
92857787|NCT05411718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92857788|NCT05411718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92857789|NCT05411718|Analgesics|analgesics|mesh-ancestor
92857790|NCT05411718|Sensory System Agents|sensory system agents|mesh-ancestor
92857791|NCT05411718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857792|NCT05411718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857793|NCT05411718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857794|NCT05411718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92857795|NCT05411718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92857796|NCT05411718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92857797|NCT05411718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857798|NCT05411718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92857799|NCT05411718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92857800|NCT05411718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857801|NCT05411718|Antipyretics|antipyretics|mesh-ancestor
92857802|NCT05411718|Gout Suppressants|gout suppressants|mesh-ancestor
92857803|NCT05403723|Carboplatin|carboplatin|mesh-list
92857804|NCT05403723|Etoposide|etoposide|mesh-list
92857805|NCT05403723|Durvalumab|durvalumab|mesh-list
92857806|NCT05403723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857807|NCT05403723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92857808|NCT05403723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92857809|NCT05403723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92857810|NCT05403723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857811|NCT05403723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857812|NCT05403723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857813|NCT05386095|Bupivacaine|bupivacaine|mesh-list
92857814|NCT05386095|Anesthetics, Local|anesthetics, local|mesh-ancestor
92857815|NCT05386095|Anesthetics|anesthetics|mesh-ancestor
92857816|NCT05386095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92857817|NCT05386095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857818|NCT05386095|Sensory System Agents|sensory system agents|mesh-ancestor
92857819|NCT05386095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857820|NCT05360264|Decitabine|decitabine|mesh-list
92857821|NCT05360264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92857822|NCT05360264|Antimetabolites|antimetabolites|mesh-ancestor
92857823|NCT05360264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857824|NCT05360264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857825|NCT05360264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857826|NCT05357482|Sirolimus|sirolimus|mesh-list
92857827|NCT05357482|Plerixafor|plerixafor|mesh-list
92857828|NCT05357482|Alemtuzumab|alemtuzumab|mesh-list
92857829|NCT05357482|Hydroxyurea|hydroxyurea|mesh-list
92857830|NCT05357482|Immunologic Factors|immunologic factors|mesh-ancestor
92857831|NCT05357482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857832|NCT05357482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857833|NCT05357482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857834|NCT05357482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92857835|NCT05357482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857836|NCT05357482|Antifungal Agents|antifungal agents|mesh-ancestor
92857837|NCT05357482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92857838|NCT05357482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857839|NCT05357482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857840|NCT05357482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857841|NCT05357482|Antisickling Agents|antisickling agents|mesh-ancestor
92857842|NCT05357482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92857843|NCT05357482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92857844|NCT05357482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92857845|NCT05357482|Antiviral Agents|antiviral agents|mesh-ancestor
92857846|NCT05321524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92857847|NCT05321524|Cathartics|cathartics|mesh-ancestor
92857848|NCT05321524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857849|NCT05280496|Metformin|metformin|mesh-list
92857850|NCT05280496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92857851|NCT05280496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857852|NCT05280457|Nivolumab|nivolumab|mesh-list
92857853|NCT05280457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857854|NCT05280457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857855|NCT05280457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92857856|NCT05280457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857857|NCT05247268|Letrozole|letrozole|mesh-list
92857858|NCT05247268|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92857859|NCT05247268|Megestrol|megestrol|mesh-list
92857860|NCT05247268|Megestrol Acetate|megestrol acetate|mesh-list
92857861|NCT05247268|Medroxyprogesterone|medroxyprogesterone|mesh-list
92857862|NCT05247268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857863|NCT05247268|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92857864|NCT05247268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92857865|NCT05247268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857866|NCT05247268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857867|NCT05247268|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92857868|NCT05247268|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857869|NCT05247268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857870|NCT05247268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857871|NCT05247268|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92857872|NCT05247268|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92857873|NCT05247268|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92857874|NCT05247268|Contraceptive Agents|contraceptive agents|mesh-ancestor
92857875|NCT05247268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92857876|NCT05247268|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92857877|NCT05247268|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92857878|NCT05247268|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92156159|NCT01016769|MTOR Inhibitors|mtor inhibitors|mesh-list
92857879|NCT05247268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857880|NCT05247268|Appetite Stimulants|appetite stimulants|mesh-ancestor
92857881|NCT05247268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92857882|NCT05239546|Dostarlimab|dostarlimab|mesh-list
92857883|NCT05239546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857884|NCT05211804|Ranibizumab|ranibizumab|mesh-list
92857885|NCT05211804|Aflibercept|aflibercept|mesh-list
92857886|NCT05211804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857887|NCT05211804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92857888|NCT05211804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92857889|NCT05211804|Growth Substances|growth substances|mesh-ancestor
92857890|NCT05211804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857891|NCT05211804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92857892|NCT05136560|Dexamethasone|dexamethasone|mesh-list
92857893|NCT05136560|Dexamethasone acetate|dexamethasone acetate|mesh-list
92857894|NCT05136560|BB 1101|bb 1101|mesh-list
92857895|NCT05136560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92857896|NCT05136560|Antiemetics|antiemetics|mesh-ancestor
92857897|NCT05136560|Autonomic Agents|autonomic agents|mesh-ancestor
92857898|NCT05136560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857899|NCT05136560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857900|NCT05136560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92857901|NCT05136560|Glucocorticoids|glucocorticoids|mesh-ancestor
92857902|NCT05136560|Hormones|hormones|mesh-ancestor
92857903|NCT05136560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857904|NCT05136560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92857905|NCT05136560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857906|NCT05136560|Protease Inhibitors|protease inhibitors|mesh-ancestor
92857907|NCT05136560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857908|NCT05136560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857909|NCT05125016|Cemiplimab|cemiplimab|mesh-list
92857910|NCT05125016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857911|NCT05125016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857912|NCT05084586|Epirubicin|epirubicin|mesh-list
92857913|NCT05084586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92857914|NCT05084586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92857915|NCT05084586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857916|NCT05084586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92857917|NCT05084586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92857918|NCT05084586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857919|NCT05084586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857920|NCT05077085|Vancomycin|vancomycin|mesh-list
92857921|NCT05077085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503049|NCT02028078|Insulin|insulin|mesh-list
92857922|NCT05077085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857924|NCT05059626|Simvastatin|simvastatin|mesh-list
92857925|NCT05059626|Estrogens|estrogens|mesh-list
92857926|NCT05059626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92857927|NCT05059626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92857928|NCT05059626|Antimetabolites|antimetabolites|mesh-ancestor
92857929|NCT05059626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857930|NCT05059626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92857931|NCT05059626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92857932|NCT05059626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857933|NCT05059626|Hormones|hormones|mesh-ancestor
92857934|NCT05059626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92857935|NCT05059626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857936|NCT05059626|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92857937|NCT05059626|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92857938|NCT05059626|Hormone Antagonists|hormone antagonists|mesh-ancestor
92857939|NCT05059626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92857940|NCT04975958|Atezolizumab|atezolizumab|mesh-list
92857941|NCT04975958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92857942|NCT04975958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857943|NCT04975958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92857944|NCT04975958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857945|NCT04973930|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92857946|NCT04973930|Escitalopram|escitalopram|mesh-list
92857947|NCT04973930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92857948|NCT04973930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92857949|NCT04973930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156176|NCT03807479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92857950|NCT04973930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857951|NCT04973930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857952|NCT04973930|Serotonin Agents|serotonin agents|mesh-ancestor
92857953|NCT04973930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857954|NCT04973930|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92857955|NCT04973930|Antidepressive Agents|antidepressive agents|mesh-ancestor
92857956|NCT04973930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92857957|NCT04973930|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92857958|NCT04930744|Metformin|metformin|mesh-list
92857959|NCT04930744|Rifampin|rifampin|mesh-list
92857960|NCT04930744|Isoniazid|isoniazid|mesh-list
92857961|NCT04930744|Pyrazinamide|pyrazinamide|mesh-list
92857962|NCT04930744|Ethambutol|ethambutol|mesh-list
92857963|NCT04930744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92857964|NCT04930744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857965|NCT04930744|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92857966|NCT04930744|Antitubercular Agents|antitubercular agents|mesh-ancestor
92857967|NCT04930744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92857968|NCT04930744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92857969|NCT04930744|Leprostatic Agents|leprostatic agents|mesh-ancestor
92857970|NCT04930744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92857971|NCT04930744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92857972|NCT04930744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857973|NCT04930744|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92857974|NCT04930744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92857975|NCT04930744|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92857976|NCT04930744|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92857977|NCT04930744|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92857978|NCT04930744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92857979|NCT04930744|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92857981|NCT04930744|Antimetabolites|antimetabolites|mesh-ancestor
92857982|NCT04930744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92857983|NCT04877093|Clonidine|clonidine|mesh-list
92857984|NCT04877093|Analgesics|analgesics|mesh-ancestor
92857985|NCT04877093|Sensory System Agents|sensory system agents|mesh-ancestor
92857986|NCT04877093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92857987|NCT04877093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92857988|NCT04877093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92857989|NCT04877093|Sympatholytics|sympatholytics|mesh-ancestor
92857990|NCT04877093|Autonomic Agents|autonomic agents|mesh-ancestor
92857991|NCT04877093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92857992|NCT04877093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92503121|NCT02028598|Anticoagulants|anticoagulants|mesh-ancestor
92857993|NCT04877093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92857994|NCT04877093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92857995|NCT04877093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92857996|NCT04877093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92857997|NCT04866017|Durvalumab|durvalumab|mesh-list
92857998|NCT04866017|Tislelizumab|tislelizumab|mesh-list
92857999|NCT04866017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858000|NCT04866017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858001|NCT04850911|Ketamine|ketamine|mesh-list
92858002|NCT04850911|Analgesics|analgesics|mesh-ancestor
92858003|NCT04850911|Sensory System Agents|sensory system agents|mesh-ancestor
92858004|NCT04850911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858005|NCT04850911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858006|NCT04850911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92858007|NCT04850911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92858008|NCT04850911|Anesthetics, General|anesthetics, general|mesh-ancestor
92858009|NCT04850911|Anesthetics|anesthetics|mesh-ancestor
92858010|NCT04850911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858011|NCT04850911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92858012|NCT04850911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92858013|NCT04850911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858014|NCT04850911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858015|NCT04836533|Antidepressive Agents|antidepressive agents|mesh-list
92858016|NCT04836533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92858017|NCT04828694|Naltrexone|naltrexone|mesh-list
92858018|NCT04828694|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92858019|NCT04828694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92858020|NCT04828694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858021|NCT04828694|Sensory System Agents|sensory system agents|mesh-ancestor
92858022|NCT04828694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858023|NCT04827056|Ethanol|ethanol|mesh-list
92858024|NCT04827056|Dexmedetomidine|dexmedetomidine|mesh-list
92858025|NCT04827056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92858026|NCT04827056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858027|NCT04827056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858028|NCT04827056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858029|NCT04827056|Analgesics|analgesics|mesh-ancestor
92858030|NCT04827056|Sensory System Agents|sensory system agents|mesh-ancestor
92858031|NCT04827056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858032|NCT04827056|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92858033|NCT04827056|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92858034|NCT04827056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92858035|NCT04827056|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858036|NCT04827056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858037|NCT04827056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858038|NCT04827056|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92858039|NCT04827056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858040|NCT04807127|Pembrolizumab|pembrolizumab|mesh-list
92858041|NCT04807127|Durvalumab|durvalumab|mesh-list
92858042|NCT04807127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92858043|NCT04807127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858044|NCT04807127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858045|NCT04807127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858046|NCT04807114|Pembrolizumab|pembrolizumab|mesh-list
92858047|NCT04807114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92858048|NCT04807114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858049|NCT04807114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858050|NCT04807114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858052|NCT04759664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858053|NCT04759664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858054|NCT04759664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858055|NCT04642404|Cannabidiol|cannabidiol|mesh-list
92858056|NCT04642404|Anticonvulsants|anticonvulsants|mesh-ancestor
92858057|NCT04642352|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92858058|NCT04642352|Bupivacaine|bupivacaine|mesh-list
92858059|NCT04642352|Anesthetics, Local|anesthetics, local|mesh-ancestor
92858060|NCT04642352|Anesthetics|anesthetics|mesh-ancestor
92858061|NCT04642352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858062|NCT04642352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858063|NCT04642352|Sensory System Agents|sensory system agents|mesh-ancestor
92858064|NCT04642352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858065|NCT04642352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858066|NCT04642352|Glucocorticoids|glucocorticoids|mesh-ancestor
92858067|NCT04642352|Hormones|hormones|mesh-ancestor
92858068|NCT04642352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858069|NCT04642352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858070|NCT04642352|Immunologic Factors|immunologic factors|mesh-ancestor
92858071|NCT04637282|Gemfibrozil|gemfibrozil|mesh-list
92858072|NCT04637282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92858073|NCT04637282|Antimetabolites|antimetabolites|mesh-ancestor
92858074|NCT04637282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858075|NCT04637282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92858076|NCT04637282|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92858077|NCT04637282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92858078|NCT04637282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858079|NCT04598477|Prednisone|prednisone|mesh-list
92858080|NCT04598477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858081|NCT04598477|Glucocorticoids|glucocorticoids|mesh-ancestor
92858082|NCT04598477|Hormones|hormones|mesh-ancestor
92858083|NCT04598477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858084|NCT04598477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858085|NCT04598477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92858086|NCT04598477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858087|NCT04594408|Epinephrine|epinephrine|mesh-list
92858088|NCT04594408|Racepinephrine|racepinephrine|mesh-list
92858089|NCT04594408|Tranexamic Acid|tranexamic acid|mesh-list
92858090|NCT04594408|Epinephryl borate|epinephryl borate|mesh-list
92858091|NCT04594408|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92858092|NCT04594408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92156180|NCT03019809|Plerixafor|plerixafor|mesh-list
92858093|NCT04594408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858094|NCT04594408|Hemostatics|hemostatics|mesh-ancestor
92858095|NCT04594408|Coagulants|coagulants|mesh-ancestor
92858096|NCT04594408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92858097|NCT04594408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92858098|NCT04594408|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858099|NCT04594408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858100|NCT04594408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858101|NCT04594408|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92858102|NCT04594408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92858103|NCT04594408|Autonomic Agents|autonomic agents|mesh-ancestor
92858104|NCT04594408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858105|NCT04594408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92858106|NCT04594408|Respiratory System Agents|respiratory system agents|mesh-ancestor
92858107|NCT04594408|Mydriatics|mydriatics|mesh-ancestor
92858108|NCT04594408|Sympathomimetics|sympathomimetics|mesh-ancestor
92858109|NCT04594408|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92858110|NCT04557215|Acetylcysteine|acetylcysteine|mesh-list
92858111|NCT04557215|Rifaximin|rifaximin|mesh-list
92858112|NCT04557215|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92858113|NCT04557215|Antiviral Agents|antiviral agents|mesh-ancestor
92858114|NCT04557215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858115|NCT04557215|Expectorants|expectorants|mesh-ancestor
92858116|NCT04557215|Respiratory System Agents|respiratory system agents|mesh-ancestor
92858117|NCT04557215|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92858118|NCT04557215|Antioxidants|antioxidants|mesh-ancestor
92858119|NCT04557215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858120|NCT04557215|Protective Agents|protective agents|mesh-ancestor
92858121|NCT04557215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858122|NCT04557215|Antidotes|antidotes|mesh-ancestor
92858123|NCT04557215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858124|NCT04557215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92858125|NCT04498117|Paclitaxel|paclitaxel|mesh-list
92858126|NCT04498117|Carboplatin|carboplatin|mesh-list
92858127|NCT04498117|Oregovomab|oregovomab|mesh-list
92858128|NCT04498117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92858129|NCT04498117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858130|NCT04498117|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858131|NCT04498117|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858132|NCT04498117|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858133|NCT04498117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858134|NCT04498117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858135|NCT04468230|Nicotine|nicotine|mesh-list
92858136|NCT04468230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92858137|NCT04468230|Autonomic Agents|autonomic agents|mesh-ancestor
92858138|NCT04468230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858139|NCT04468230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858140|NCT04468230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92503271|NCT02029573|Temozolomide|temozolomide|mesh-list
92858141|NCT04468230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92858142|NCT04468230|Cholinergic Agents|cholinergic agents|mesh-ancestor
92858143|NCT04468230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858144|NCT04468230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858145|NCT04432857|Pembrolizumab|pembrolizumab|mesh-list
92858146|NCT04432857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858147|NCT04432857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858148|NCT04432857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858149|NCT04432857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858150|NCT04423627|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92858151|NCT04423627|Clonidine|clonidine|mesh-list
92858152|NCT04423627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92858153|NCT04423627|Diuretics|diuretics|mesh-ancestor
92858154|NCT04423627|Natriuretic Agents|natriuretic agents|mesh-ancestor
92858155|NCT04423627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858156|NCT04423627|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92858157|NCT04423627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858158|NCT04423627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858159|NCT04423627|Analgesics|analgesics|mesh-ancestor
92858160|NCT04423627|Sensory System Agents|sensory system agents|mesh-ancestor
92858161|NCT04423627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858162|NCT04423627|Sympatholytics|sympatholytics|mesh-ancestor
92858163|NCT04423627|Autonomic Agents|autonomic agents|mesh-ancestor
92858164|NCT04423627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92858165|NCT04423627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92858166|NCT04423627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92858167|NCT04423627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858168|NCT04423627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858169|NCT04395001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92858170|NCT04395001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92858171|NCT04395001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92858172|NCT04395001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858173|NCT04395001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858174|NCT04395001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858175|NCT04395001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858176|NCT04395001|Analgesics|analgesics|mesh-ancestor
92858177|NCT04395001|Sensory System Agents|sensory system agents|mesh-ancestor
92858178|NCT04395001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858179|NCT04395001|Antidepressive Agents|antidepressive agents|mesh-ancestor
92858180|NCT04395001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92858181|NCT04395001|Dopamine Agents|dopamine agents|mesh-ancestor
92858182|NCT04391764|Naltrexone|naltrexone|mesh-list
92858183|NCT04391764|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92858184|NCT04391764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92858185|NCT04391764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858186|NCT04391764|Sensory System Agents|sensory system agents|mesh-ancestor
92858187|NCT04391764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858188|NCT04339062|Sirolimus|sirolimus|mesh-list
92858189|NCT04339062|Prednisone|prednisone|mesh-list
92858190|NCT04339062|Everolimus|everolimus|mesh-list
92858191|NCT04339062|Cemiplimab|cemiplimab|mesh-list
92858192|NCT04339062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858193|NCT04339062|Glucocorticoids|glucocorticoids|mesh-ancestor
92858194|NCT04339062|Hormones|hormones|mesh-ancestor
92858195|NCT04339062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858196|NCT04339062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524916|NCT02024607|Oxaliplatin|oxaliplatin|mesh-list
92858197|NCT04339062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92858198|NCT04339062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858199|NCT04339062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92858200|NCT04339062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858201|NCT04339062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858202|NCT04339062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858203|NCT04339062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858204|NCT04339062|Immunologic Factors|immunologic factors|mesh-ancestor
92858205|NCT04339062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858206|NCT04339062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858207|NCT04339062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92858208|NCT04339062|Antifungal Agents|antifungal agents|mesh-ancestor
92858209|NCT04339062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858211|NCT04318080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858212|NCT04318080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858213|NCT04305158|Nitrous Oxide|nitrous oxide|mesh-list
92858214|NCT04305158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92858215|NCT04305158|Anesthetics, General|anesthetics, general|mesh-ancestor
92858216|NCT04305158|Anesthetics|anesthetics|mesh-ancestor
92858217|NCT04305158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858218|NCT04305158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858219|NCT04305158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858220|NCT04305158|Analgesics|analgesics|mesh-ancestor
92858221|NCT04305158|Sensory System Agents|sensory system agents|mesh-ancestor
92858222|NCT04305158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858223|NCT04303195|Metopimazine|metopimazine|mesh-list
92858224|NCT04303195|Antiemetics|antiemetics|mesh-ancestor
92858225|NCT04303195|Autonomic Agents|autonomic agents|mesh-ancestor
92858226|NCT04303195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858227|NCT04303195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858228|NCT04303195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92858229|NCT04292470|Amitriptyline|amitriptyline|mesh-list
92858230|NCT04292470|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92858231|NCT04292470|Antidepressive Agents|antidepressive agents|mesh-ancestor
92858232|NCT04292470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92858233|NCT04292470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858234|NCT04292470|Analgesics|analgesics|mesh-ancestor
92858235|NCT04292470|Sensory System Agents|sensory system agents|mesh-ancestor
92858236|NCT04292470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858237|NCT04292470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858238|NCT04292470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92858239|NCT04292470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92858240|NCT04292470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858241|NCT04292470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858242|NCT04292470|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858243|NCT04292470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858244|NCT04208334|Curcumin|curcumin|mesh-list
92858245|NCT04208334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92858246|NCT04208334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858247|NCT04208334|Analgesics|analgesics|mesh-ancestor
92858248|NCT04208334|Sensory System Agents|sensory system agents|mesh-ancestor
92858249|NCT04208334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858250|NCT04208334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858251|NCT04208334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858252|NCT04208334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858253|NCT04208334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858254|NCT04208334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858255|NCT04208334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858256|NCT04158141|Cisplatin|cisplatin|mesh-list
92858257|NCT04158141|Carboplatin|carboplatin|mesh-list
92858258|NCT04158141|Pemetrexed|pemetrexed|mesh-list
92858259|NCT04158141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858260|NCT04158141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858261|NCT04158141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858262|NCT04158141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92858263|NCT04158141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92858264|NCT04080284|Niraparib|niraparib|mesh-list
92858265|NCT04080284|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92858266|NCT04080284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858267|NCT04080284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858268|NCT04080284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858269|NCT04074967|Nivolumab|nivolumab|mesh-list
92858271|NCT04074967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858272|NCT04074967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858273|NCT04074967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858274|NCT04074967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858275|NCT04073797|Colchicine|colchicine|mesh-list
92858276|NCT04073797|Gout Suppressants|gout suppressants|mesh-ancestor
92858277|NCT04073797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858278|NCT04073797|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858279|NCT04073797|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858280|NCT04073797|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858281|NCT04073797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858282|NCT04073797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858283|NCT04060017|Calcium, Dietary|calcium, dietary|mesh-list
92858284|NCT04060017|Leucovorin|leucovorin|mesh-list
92858285|NCT04060017|Calcium|calcium|mesh-list
92858286|NCT04060017|Levoleucovorin|levoleucovorin|mesh-list
92858287|NCT04060017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92858288|NCT04060017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858289|NCT04060017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92858290|NCT04060017|Antidotes|antidotes|mesh-ancestor
92858291|NCT04060017|Protective Agents|protective agents|mesh-ancestor
92858293|NCT04060017|Vitamins|vitamins|mesh-ancestor
92858294|NCT04060017|Micronutrients|micronutrients|mesh-ancestor
92858295|NCT04052334|Cyclophosphamide|cyclophosphamide|mesh-list
92858296|NCT04052334|Fludarabine|fludarabine|mesh-list
92858297|NCT04052334|Interleukin-2|interleukin-2|mesh-list
92858298|NCT04052334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858299|NCT04052334|Immunologic Factors|immunologic factors|mesh-ancestor
92858300|NCT04052334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858301|NCT04052334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858302|NCT04052334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92858303|NCT04052334|Alkylating Agents|alkylating agents|mesh-ancestor
92858304|NCT04052334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858305|NCT04052334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858306|NCT04052334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92858307|NCT04052334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858308|NCT04052334|Analgesics|analgesics|mesh-ancestor
92858309|NCT04052334|Sensory System Agents|sensory system agents|mesh-ancestor
92858310|NCT04052334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858311|NCT04046549|Abatacept|abatacept|mesh-list
92858312|NCT04046549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858313|NCT04046549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858314|NCT04046549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858315|NCT04046549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858316|NCT04046549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858317|NCT04046549|Immunologic Factors|immunologic factors|mesh-ancestor
92858318|NCT04046549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858319|NCT04046549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858320|NCT04042935|Thioctic Acid|thioctic acid|mesh-list
92858321|NCT04042935|Antioxidants|antioxidants|mesh-ancestor
92858322|NCT04042935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858323|NCT04042935|Protective Agents|protective agents|mesh-ancestor
92858324|NCT04042935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858325|NCT04042935|Vitamin B Complex|vitamin b complex|mesh-ancestor
92858326|NCT04042935|Vitamins|vitamins|mesh-ancestor
92858327|NCT04042935|Micronutrients|micronutrients|mesh-ancestor
92858328|NCT04027309|Midostaurin|midostaurin|mesh-list
92858329|NCT04027309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858330|NCT04027309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858331|NCT04027309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858332|NCT04027309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858333|NCT03988933|Rifampin|rifampin|mesh-list
92858334|NCT03988933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92858335|NCT03988933|Antitubercular Agents|antitubercular agents|mesh-ancestor
92858336|NCT03988933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858337|NCT03988933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858338|NCT03988933|Leprostatic Agents|leprostatic agents|mesh-ancestor
92858339|NCT03988933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92858340|NCT03988933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858341|NCT03988933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858342|NCT03988933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92858343|NCT03988933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92858344|NCT03988933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92858345|NCT03988933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92858346|NCT03988933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92858347|NCT03988933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92858348|NCT03958565|Zoledronic Acid|zoledronic acid|mesh-list
92858349|NCT03958565|Denosumab|denosumab|mesh-list
92858350|NCT03958565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92858351|NCT03958565|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92858352|NCT03958565|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92858353|NCT03958565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858354|NCT03958565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858355|NCT03958565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858356|NCT03958565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858357|NCT03785925|Nivolumab|nivolumab|mesh-list
92858358|NCT03785925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858359|NCT03785925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858360|NCT03785925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858361|NCT03785925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858362|NCT03752398|Ipilimumab|ipilimumab|mesh-list
92858363|NCT03752398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858364|NCT03752398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858365|NCT03752398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858366|NCT03752398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858367|NCT03734692|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92858368|NCT03734692|Pembrolizumab|pembrolizumab|mesh-list
92858369|NCT03734692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858370|NCT03734692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858371|NCT03734692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92156199|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858372|NCT03734692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858373|NCT03734692|Antiviral Agents|antiviral agents|mesh-ancestor
92858374|NCT03734692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858375|NCT03700476|Gemcitabine|gemcitabine|mesh-list
92858376|NCT03700476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858377|NCT03700476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92858378|NCT03700476|Antimetabolites|antimetabolites|mesh-ancestor
92858379|NCT03700476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858380|NCT03644667|Mycophenolic Acid|mycophenolic acid|mesh-list
92858381|NCT03644667|Prednisone|prednisone|mesh-list
92858382|NCT03644667|Methylprednisolone|methylprednisolone|mesh-list
92858383|NCT03644667|Tacrolimus|tacrolimus|mesh-list
92858384|NCT03644667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92858385|NCT03644667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858386|NCT03644667|Glucocorticoids|glucocorticoids|mesh-ancestor
92858387|NCT03644667|Hormones|hormones|mesh-ancestor
92858388|NCT03644667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858389|NCT03644667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858390|NCT03644667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92858391|NCT03644667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858392|NCT03644667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858393|NCT03644667|Immunologic Factors|immunologic factors|mesh-ancestor
92858394|NCT03644667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858395|NCT03644667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858396|NCT03644667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92858397|NCT03644667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92858398|NCT03644667|Antitubercular Agents|antitubercular agents|mesh-ancestor
92858399|NCT03644667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858400|NCT03644667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858401|NCT03644667|Antiemetics|antiemetics|mesh-ancestor
92858402|NCT03644667|Autonomic Agents|autonomic agents|mesh-ancestor
92858403|NCT03644667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858404|NCT03644667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92858405|NCT03644667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92858406|NCT03644667|Protective Agents|protective agents|mesh-ancestor
92858407|NCT03638141|Durvalumab|durvalumab|mesh-list
92858408|NCT03638141|Ipilimumab|ipilimumab|mesh-list
92858409|NCT03638141|Tremelimumab|tremelimumab|mesh-list
92858410|NCT03638141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92858411|NCT03638141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858412|NCT03638141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858413|NCT03638141|Immunologic Factors|immunologic factors|mesh-ancestor
92858415|NCT03638141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858416|NCT03638141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858417|NCT03330106|Paclitaxel|paclitaxel|mesh-list
92858418|NCT03330106|Docetaxel|docetaxel|mesh-list
92858419|NCT03330106|Carboplatin|carboplatin|mesh-list
92858420|NCT03330106|Pevonedistat|pevonedistat|mesh-list
92858421|NCT03330106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92858422|NCT03330106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858423|NCT03330106|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858424|NCT03330106|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858425|NCT03330106|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858426|NCT03330106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858427|NCT03330106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858428|NCT03239145|Pembrolizumab|pembrolizumab|mesh-list
92858429|NCT03239145|Trebananib|trebananib|mesh-list
92858430|NCT03239145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858431|NCT03239145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858432|NCT03239145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858433|NCT03239145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858434|NCT03239145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92858435|NCT03239145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92858436|NCT03239145|Growth Substances|growth substances|mesh-ancestor
92858437|NCT03239145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858438|NCT03239145|Growth Inhibitors|growth inhibitors|mesh-ancestor
92858439|NCT03164564|Tenofovir|tenofovir|mesh-list
92858440|NCT03164564|Emtricitabine|emtricitabine|mesh-list
92858441|NCT03164564|Cabotegravir|cabotegravir|mesh-list
92858442|NCT03164564|Antiviral Agents|antiviral agents|mesh-ancestor
92858443|NCT03164564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858444|NCT03164564|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92858445|NCT03164564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92858446|NCT03164564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858447|NCT03164564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858448|NCT03164564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92858449|NCT03164564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92858450|NCT03164564|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92858451|NCT03164564|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92858452|NCT03153410|Cyclophosphamide|cyclophosphamide|mesh-list
92858453|NCT03153410|Pembrolizumab|pembrolizumab|mesh-list
92858454|NCT03153410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858455|NCT03153410|Immunologic Factors|immunologic factors|mesh-ancestor
92858456|NCT03153410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858457|NCT03153410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858458|NCT03153410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92858459|NCT03153410|Alkylating Agents|alkylating agents|mesh-ancestor
92858460|NCT03153410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858461|NCT03153410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858462|NCT03153410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92858463|NCT03153410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858464|NCT03153410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858465|NCT03113422|Venetoclax|venetoclax|mesh-list
92858466|NCT03113422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858467|NCT03070886|Docetaxel|docetaxel|mesh-list
92858468|NCT03070886|Leuprolide|leuprolide|mesh-list
92858469|NCT03070886|Goserelin|goserelin|mesh-list
92858470|NCT03070886|Bicalutamide|bicalutamide|mesh-list
92858471|NCT03070886|Flutamide|flutamide|mesh-list
92858472|NCT03070886|Nilutamide|nilutamide|mesh-list
92858473|NCT03070886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858474|NCT03070886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858475|NCT03070886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858476|NCT03070886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858477|NCT03070886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858478|NCT03070886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92858480|NCT03070886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92858481|NCT03070886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858482|NCT03070886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92858483|NCT03070886|Androgen Antagonists|androgen antagonists|mesh-ancestor
92858484|NCT03070886|Hormone Antagonists|hormone antagonists|mesh-ancestor
92858485|NCT03070886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858486|NCT02987257|Cyclosporine|cyclosporine|mesh-list
92858487|NCT02987257|Etanercept|etanercept|mesh-list
92858488|NCT02987257|Cyclosporins|cyclosporins|mesh-list
92858489|NCT02987257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858490|NCT02987257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858491|NCT02987257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858492|NCT02987257|Immunologic Factors|immunologic factors|mesh-ancestor
92858493|NCT02987257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858494|NCT02987257|Antifungal Agents|antifungal agents|mesh-ancestor
92858495|NCT02987257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858496|NCT02987257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92858497|NCT02987257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858498|NCT02987257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92858499|NCT02987257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92858500|NCT02987257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858501|NCT02987257|Analgesics|analgesics|mesh-ancestor
92858502|NCT02987257|Sensory System Agents|sensory system agents|mesh-ancestor
92858503|NCT02987257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858504|NCT02987257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858505|NCT02987257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92858506|NCT02913274|Paclitaxel|paclitaxel|mesh-list
92858507|NCT02913274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92858508|NCT02913274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858509|NCT02913274|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858510|NCT02913274|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858511|NCT02913274|Mitosis Modulators|mitosis modulators|mesh-ancestor
92156210|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858512|NCT02913274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858513|NCT02896335|Palbociclib|palbociclib|mesh-list
92858514|NCT02896335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858515|NCT02896335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858516|NCT02896335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858517|NCT02896335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858518|NCT02821754|Durvalumab|durvalumab|mesh-list
92858519|NCT02821754|Tremelimumab|tremelimumab|mesh-list
92858520|NCT02821754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858521|NCT02821754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858522|NCT02781883|Decitabine|decitabine|mesh-list
92858523|NCT02781883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92858524|NCT02781883|Antimetabolites|antimetabolites|mesh-ancestor
92858525|NCT02781883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858526|NCT02781883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858527|NCT02781883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858529|NCT02772003|Vaccines|vaccines|mesh-list
92858530|NCT02772003|Immunologic Factors|immunologic factors|mesh-ancestor
92858531|NCT02772003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858532|NCT02772003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92858533|NCT02772003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92858534|NCT02772003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92858535|NCT02772003|Growth Substances|growth substances|mesh-ancestor
92858536|NCT02772003|Growth Inhibitors|growth inhibitors|mesh-ancestor
92858537|NCT02772003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858538|NCT02684162|Guadecitabine|guadecitabine|mesh-list
92858539|NCT02684162|Azacitidine|azacitidine|mesh-list
92858540|NCT02684162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858541|NCT02684162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92858542|NCT02684162|Antimetabolites|antimetabolites|mesh-ancestor
92858543|NCT02684162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858544|NCT02684162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858545|NCT02619682|Lenalidomide|lenalidomide|mesh-list
92858546|NCT02619682|Ixazomib|ixazomib|mesh-list
92858547|NCT02619682|Glycine|glycine|mesh-list
92858548|NCT02619682|Immunologic Factors|immunologic factors|mesh-ancestor
92858549|NCT02619682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858550|NCT02619682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92858551|NCT02619682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92858552|NCT02619682|Growth Substances|growth substances|mesh-ancestor
92858553|NCT02619682|Growth Inhibitors|growth inhibitors|mesh-ancestor
92858554|NCT02619682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858555|NCT02619682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858556|NCT02619682|Protease Inhibitors|protease inhibitors|mesh-ancestor
92858557|NCT02619682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858558|NCT02619682|Glycine Agents|glycine agents|mesh-ancestor
92858559|NCT02619682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858560|NCT02617589|Nivolumab|nivolumab|mesh-list
92858561|NCT02617589|Temozolomide|temozolomide|mesh-list
92858562|NCT02617589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858563|NCT02617589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858564|NCT02617589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858565|NCT02617589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858566|NCT02617589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92858567|NCT02617589|Alkylating Agents|alkylating agents|mesh-ancestor
92858568|NCT02540707|Solifenacin Succinate|solifenacin succinate|mesh-list
92858569|NCT02540707|Mirabegron|mirabegron|mesh-list
92858570|NCT02540707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92858571|NCT02540707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92858572|NCT02540707|Cholinergic Agents|cholinergic agents|mesh-ancestor
92858573|NCT02540707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858574|NCT02540707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858575|NCT02540707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858576|NCT02540707|Urological Agents|urological agents|mesh-ancestor
92858577|NCT02540707|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92858578|NCT02540707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92858579|NCT02540707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92858580|NCT02540707|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858581|NCT02531932|Carboplatin|carboplatin|mesh-list
92858582|NCT02531932|Everolimus|everolimus|mesh-list
92858583|NCT02531932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858584|NCT02531932|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92858585|NCT02531932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858586|NCT02531932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858587|NCT02531932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858588|NCT02531932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858589|NCT02531932|Immunologic Factors|immunologic factors|mesh-ancestor
92858590|NCT02531932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858591|NCT02504346|Osimertinib|osimertinib|mesh-list
92858592|NCT02504346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858593|NCT02504346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858594|NCT02504346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858595|NCT02504346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858596|NCT02345265|Olaparib|olaparib|mesh-list
92858597|NCT02345265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92858598|NCT02345265|Cediranib|cediranib|mesh-list
92858599|NCT02345265|Maleic acid|maleic acid|mesh-list
92858600|NCT02345265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858601|NCT02345265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858602|NCT02345265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858603|NCT02345265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858605|NCT02340169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858606|NCT02340169|Glucocorticoids|glucocorticoids|mesh-ancestor
92858607|NCT02340169|Hormones|hormones|mesh-ancestor
92858608|NCT02340169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858609|NCT02340169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858610|NCT02337829|Acalabrutinib|acalabrutinib|mesh-list
92858611|NCT02337829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858612|NCT02317874|Paclitaxel|paclitaxel|mesh-list
92858613|NCT02317874|Carboplatin|carboplatin|mesh-list
92858614|NCT02317874|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92858615|NCT02317874|Talazoparib|talazoparib|mesh-list
92858616|NCT02317874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92858617|NCT02317874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858618|NCT02317874|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858619|NCT02317874|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858620|NCT02317874|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858621|NCT02317874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858622|NCT02317874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92858623|NCT02317874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858624|NCT02257528|Nivolumab|nivolumab|mesh-list
92858625|NCT02257528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858626|NCT02257528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858627|NCT02257528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858628|NCT02257528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858629|NCT02179086|Temozolomide|temozolomide|mesh-list
92858630|NCT02179086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92858631|NCT02179086|Alkylating Agents|alkylating agents|mesh-ancestor
92858632|NCT02179086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858633|NCT02179086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858634|NCT02160015|Rituximab|rituximab|mesh-list
92858635|NCT02160015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92858636|NCT02160015|Lenalidomide|lenalidomide|mesh-list
92858637|NCT02160015|Antibodies|antibodies|mesh-list
92858638|NCT02160015|Immunoglobulins|immunoglobulins|mesh-list
92858639|NCT02160015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92858640|NCT02160015|Immunologic Factors|immunologic factors|mesh-ancestor
92858641|NCT02160015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858642|NCT02160015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858643|NCT02160015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858644|NCT02160015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92858645|NCT02160015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92858646|NCT02160015|Growth Substances|growth substances|mesh-ancestor
92858647|NCT02160015|Growth Inhibitors|growth inhibitors|mesh-ancestor
92858648|NCT01899326|Desipramine|desipramine|mesh-list
92858649|NCT01899326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858650|NCT01899326|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92858651|NCT01899326|Antidepressive Agents|antidepressive agents|mesh-ancestor
92858652|NCT01899326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92858653|NCT01899326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858654|NCT01899326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858655|NCT01899326|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92858656|NCT01899326|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92858657|NCT01899326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858658|NCT01899326|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858659|NCT01899326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858660|NCT01856192|Prednisone|prednisone|mesh-list
92858661|NCT01856192|Cortisone|cortisone|mesh-list
92858662|NCT01856192|Cyclophosphamide|cyclophosphamide|mesh-list
92858663|NCT01856192|Rituximab|rituximab|mesh-list
92858664|NCT01856192|Doxorubicin|doxorubicin|mesh-list
92858665|NCT01856192|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92503799|NCT02041455|Melatonin|melatonin|mesh-list
92858666|NCT01856192|Vincristine|vincristine|mesh-list
92858668|NCT01856192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92858669|NCT01856192|Antibodies|antibodies|mesh-list
92858670|NCT01856192|Immunoglobulins|immunoglobulins|mesh-list
92858671|NCT01856192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92858672|NCT01856192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858673|NCT01856192|Immunologic Factors|immunologic factors|mesh-ancestor
92858674|NCT01856192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858675|NCT01856192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858676|NCT01856192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92858677|NCT01856192|Alkylating Agents|alkylating agents|mesh-ancestor
92858678|NCT01856192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858679|NCT01856192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858680|NCT01856192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92858681|NCT01856192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92858682|NCT01856192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92858683|NCT01856192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92858684|NCT01856192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858685|NCT01856192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858686|NCT01856192|Glucocorticoids|glucocorticoids|mesh-ancestor
92858688|NCT01856192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858689|NCT01856192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92858690|NCT01856192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92858691|NCT01856192|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858692|NCT01856192|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858693|NCT01856192|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858694|NCT01856192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92858695|NCT01856192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92858696|NCT01856192|Growth Substances|growth substances|mesh-ancestor
92858697|NCT01856192|Growth Inhibitors|growth inhibitors|mesh-ancestor
92858698|NCT01849146|Temozolomide|temozolomide|mesh-list
92858699|NCT01849146|Adavosertib|adavosertib|mesh-list
92858700|NCT01849146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92858701|NCT01849146|Alkylating Agents|alkylating agents|mesh-ancestor
92858702|NCT01849146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858703|NCT01849146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858704|NCT01849146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858705|NCT01572480|Dexamethasone|dexamethasone|mesh-list
92858706|NCT01572480|Lenalidomide|lenalidomide|mesh-list
92858707|NCT01572480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858708|NCT01572480|Antiemetics|antiemetics|mesh-ancestor
92858709|NCT01572480|Autonomic Agents|autonomic agents|mesh-ancestor
92858710|NCT01572480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858711|NCT01572480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858712|NCT01572480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92858713|NCT01572480|Glucocorticoids|glucocorticoids|mesh-ancestor
92858714|NCT01572480|Hormones|hormones|mesh-ancestor
92858715|NCT01572480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858716|NCT01572480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92858717|NCT01572480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858718|NCT01572480|Immunologic Factors|immunologic factors|mesh-ancestor
92858719|NCT01572480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92858720|NCT01572480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92858721|NCT01572480|Growth Substances|growth substances|mesh-ancestor
92858722|NCT01572480|Growth Inhibitors|growth inhibitors|mesh-ancestor
92858723|NCT01515137|Sulindac|sulindac|mesh-list
92858724|NCT01515137|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92858725|NCT01515137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858726|NCT01515137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858727|NCT01515137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858728|NCT01515137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858729|NCT01515137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92858730|NCT01515137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858731|NCT01515137|Analgesics|analgesics|mesh-ancestor
92858732|NCT01515137|Sensory System Agents|sensory system agents|mesh-ancestor
92858733|NCT01515137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858734|NCT01515137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858735|NCT01515137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92858736|NCT01515137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92858737|NCT01515137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92858738|NCT01393509|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
92503875|NCT02042482|Ubiquinone|ubiquinone|mesh-list
92858739|NCT01393509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858740|NCT01375829|Sirolimus|sirolimus|mesh-list
92858741|NCT01375829|Temsirolimus|temsirolimus|mesh-list
92858742|NCT01375829|Epothilone B|epothilone b|mesh-list
92858743|NCT01375829|MTOR Inhibitors|mtor inhibitors|mesh-list
92858744|NCT01375829|Epothilones|epothilones|mesh-list
92858745|NCT01375829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858746|NCT01375829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858747|NCT01375829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92858748|NCT01375829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858749|NCT01375829|Antifungal Agents|antifungal agents|mesh-ancestor
92858750|NCT01375829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858751|NCT01375829|Immunologic Factors|immunologic factors|mesh-ancestor
92858752|NCT01375829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858753|NCT01375829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858754|NCT01375829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858755|NCT01375829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858756|NCT01375829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858757|NCT01375829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858758|NCT01375829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858759|NCT01126190|Docetaxel|docetaxel|mesh-list
92858760|NCT01126190|Doxorubicin|doxorubicin|mesh-list
92858761|NCT01126190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858762|NCT01126190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858763|NCT01126190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858764|NCT01126190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858765|NCT01126190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858766|NCT01126190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92858767|NCT01126190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92858768|NCT01126190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92858769|NCT01126190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858770|NCT00472654|Vitamin D|vitamin d|mesh-list
92858771|NCT00472654|Vitamins|vitamins|mesh-ancestor
92858772|NCT00472654|Micronutrients|micronutrients|mesh-ancestor
92858773|NCT00472654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858774|NCT00472654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92858775|NCT00323037|Carvedilol|carvedilol|mesh-list
92858776|NCT00323037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92858777|NCT00323037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92858778|NCT00323037|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858779|NCT00323037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858780|NCT00323037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858781|NCT00323037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858782|NCT00323037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92858783|NCT00323037|Antioxidants|antioxidants|mesh-ancestor
92858784|NCT00323037|Protective Agents|protective agents|mesh-ancestor
92858785|NCT00323037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92858786|NCT00323037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858787|NCT00323037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92858788|NCT00323037|Vasodilator Agents|vasodilator agents|mesh-ancestor
92858789|NCT00323037|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92858790|NCT00323037|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92858791|NCT00128297|Pamidronate|pamidronate|mesh-list
92858792|NCT00128297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92858793|NCT00128297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858794|NCT00939185|Azithromycin|azithromycin|mesh-list
92858795|NCT00939185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858796|NCT00939185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858797|NCT02808104|Mazindol|mazindol|mesh-list
92858798|NCT02808104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92858799|NCT02808104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858800|NCT02808104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92858801|NCT02808104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92858802|NCT02808104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858803|NCT02808104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858804|NCT02808104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92858805|NCT02808104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858806|NCT02808104|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92858807|NCT02808104|Dopamine Agents|dopamine agents|mesh-ancestor
92858808|NCT05165771|Tofacitinib|tofacitinib|mesh-list
92858809|NCT05165771|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92858810|NCT05165771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858811|NCT05165771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858812|NCT05165771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858813|NCT02730624|Tazobactam|tazobactam|mesh-list
92503966|NCT02043054|Hormones|hormones|mesh-ancestor
92858815|NCT02730624|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92858816|NCT02730624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858817|NCT02730624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858818|NCT02730624|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92858819|NCT02730624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858820|NCT02730624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858822|NCT02807870|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92858823|NCT02807870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858824|NCT02807870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92858825|NCT02807870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92858826|NCT02807870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92858827|NCT02807870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858828|NCT02807870|Dopamine Agents|dopamine agents|mesh-ancestor
92858829|NCT02807870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858830|NCT00925873|Vidarabine|vidarabine|mesh-list
92858831|NCT00925873|Fludarabine|fludarabine|mesh-list
92858832|NCT00925873|Fludarabine phosphate|fludarabine phosphate|mesh-list
92858833|NCT00925873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858834|NCT00925873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92858835|NCT00925873|Antimetabolites|antimetabolites|mesh-ancestor
92858836|NCT00925873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858837|NCT00925873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858838|NCT00925873|Immunologic Factors|immunologic factors|mesh-ancestor
92858839|NCT00925873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858840|NCT00925873|Antiviral Agents|antiviral agents|mesh-ancestor
92858841|NCT00925873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858842|NCT05590598|Azelastine|azelastine|mesh-list
92858843|NCT05590598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92858844|NCT05590598|Autonomic Agents|autonomic agents|mesh-ancestor
92858845|NCT05590598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858846|NCT05590598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858847|NCT05590598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92858848|NCT05590598|Respiratory System Agents|respiratory system agents|mesh-ancestor
92858849|NCT05590598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92858850|NCT05590598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858851|NCT05590598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858852|NCT05590598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92858853|NCT05590598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92858854|NCT05590598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92858855|NCT05590598|Histamine Antagonists|histamine antagonists|mesh-ancestor
92858856|NCT05590598|Histamine Agents|histamine agents|mesh-ancestor
92858857|NCT05590598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858858|NCT00925951|Acetaminophen|acetaminophen|mesh-list
92858859|NCT00925951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92858860|NCT00925951|Analgesics|analgesics|mesh-ancestor
92858861|NCT00925951|Sensory System Agents|sensory system agents|mesh-ancestor
92858862|NCT00925951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858863|NCT00925951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858864|NCT00925951|Antipyretics|antipyretics|mesh-ancestor
92858865|NCT00933205|Tipranavir|tipranavir|mesh-list
92858866|NCT00933205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92858867|NCT00933205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92858868|NCT00933205|Antiviral Agents|antiviral agents|mesh-ancestor
92858869|NCT00933205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858870|NCT02813486|Vaccines|vaccines|mesh-list
92858871|NCT02813486|Immunologic Factors|immunologic factors|mesh-ancestor
92159198|NCT04061512|Hormones|hormones|mesh-ancestor
92858872|NCT02813486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858873|NCT02739516|Letrozole|letrozole|mesh-list
92858874|NCT02739516|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92858875|NCT02739516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858876|NCT02739516|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92858877|NCT02739516|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92858878|NCT02739516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858879|NCT02739516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858880|NCT02739516|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92858881|NCT02739516|Hormone Antagonists|hormone antagonists|mesh-ancestor
92858882|NCT02739516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92858883|NCT02739516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858884|NCT02739516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92858885|NCT00933283|Methadone|methadone|mesh-list
92858886|NCT00933283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92858887|NCT00933283|Narcotics|narcotics|mesh-ancestor
92858888|NCT00933283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858889|NCT00933283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858890|NCT00933283|Analgesics|analgesics|mesh-ancestor
92858891|NCT00933283|Sensory System Agents|sensory system agents|mesh-ancestor
92858892|NCT00933283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858893|NCT00933283|Antitussive Agents|antitussive agents|mesh-ancestor
92858894|NCT00933283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92858895|NCT02813018|Ropivacaine|ropivacaine|mesh-list
92858896|NCT02813018|Anesthetics, Local|anesthetics, local|mesh-ancestor
92858897|NCT02813018|Anesthetics|anesthetics|mesh-ancestor
92858898|NCT02813018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858899|NCT02813018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858900|NCT02813018|Sensory System Agents|sensory system agents|mesh-ancestor
92858901|NCT02813018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858902|NCT04253964|Paclitaxel|paclitaxel|mesh-list
92858903|NCT04253964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92858904|NCT04253964|Carboplatin|carboplatin|mesh-list
92858905|NCT04253964|Pembrolizumab|pembrolizumab|mesh-list
92858906|NCT04253964|Pemetrexed|pemetrexed|mesh-list
92858907|NCT04253964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92858908|NCT04253964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858909|NCT04253964|Tubulin Modulators|tubulin modulators|mesh-ancestor
92858910|NCT04253964|Antimitotic Agents|antimitotic agents|mesh-ancestor
92858911|NCT04253964|Mitosis Modulators|mitosis modulators|mesh-ancestor
92858912|NCT04253964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858913|NCT04253964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92858914|NCT04253964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92858915|NCT04253964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858916|NCT04253964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92858917|NCT04253964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92858918|NCT02810132|Metformin|metformin|mesh-list
92858919|NCT02810132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92858920|NCT02810132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858921|NCT02734524|Carboplatin|carboplatin|mesh-list
92858922|NCT02734524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858923|NCT04173962|Midazolam|midazolam|mesh-list
92858924|NCT04173962|Ketamine|ketamine|mesh-list
92858925|NCT04173962|Analgesics|analgesics|mesh-ancestor
92858926|NCT04173962|Sensory System Agents|sensory system agents|mesh-ancestor
92858927|NCT04173962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92858928|NCT04173962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858929|NCT04173962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92858930|NCT04173962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92858931|NCT04173962|Anesthetics, General|anesthetics, general|mesh-ancestor
92858932|NCT04173962|Anesthetics|anesthetics|mesh-ancestor
92858933|NCT04173962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858934|NCT04173962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92858935|NCT04173962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92858936|NCT04173962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858937|NCT04173962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858938|NCT04173962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92858939|NCT04173962|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92858940|NCT04173962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92858941|NCT04173962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92858942|NCT04173962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92858943|NCT04173962|GABA Modulators|gaba modulators|mesh-ancestor
92858944|NCT04173962|GABA Agents|gaba agents|mesh-ancestor
92858945|NCT00772005|Modafinil|modafinil|mesh-list
92858946|NCT00772005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92858947|NCT00772005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858948|NCT00772005|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92858949|NCT00772005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92858950|NCT00772005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92858951|NCT00772005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858952|NCT03333408|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92858953|NCT03333408|Clindamycin|clindamycin|mesh-list
92858954|NCT03333408|Clindamycin palmitate|clindamycin palmitate|mesh-list
92858955|NCT03333408|Clindamycin phosphate|clindamycin phosphate|mesh-list
92858956|NCT03333408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92858957|NCT03333408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858958|NCT03333408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92858959|NCT03333408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858960|NCT03333408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858961|NCT03333408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92504106|NCT02044250|Aspirin|aspirin|mesh-list
92858962|NCT04262999|Levetiracetam|levetiracetam|mesh-list
92858963|NCT04262999|Valproic Acid|valproic acid|mesh-list
92858964|NCT04262999|Anticonvulsants|anticonvulsants|mesh-ancestor
92858965|NCT04262999|Nootropic Agents|nootropic agents|mesh-ancestor
92858966|NCT04262999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858967|NCT04262999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858968|NCT04262999|GABA Agents|gaba agents|mesh-ancestor
92858969|NCT04262999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92858970|NCT04262999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858971|NCT04262999|Antimanic Agents|antimanic agents|mesh-ancestor
92858972|NCT04262999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92858973|NCT04262999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92858974|NCT04262999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92858975|NCT05582174|Esomeprazole|esomeprazole|mesh-list
92858976|NCT05582174|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92858977|NCT05582174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92858978|NCT05582174|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92858979|NCT05582174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858980|NCT05582174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858981|NCT00926107|Sirolimus|sirolimus|mesh-list
92858982|NCT00926107|Temsirolimus|temsirolimus|mesh-list
92858983|NCT00926107|MTOR Inhibitors|mtor inhibitors|mesh-list
92858984|NCT00926107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92858985|NCT00926107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92858986|NCT00926107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858987|NCT00926107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92858988|NCT00926107|Immunologic Factors|immunologic factors|mesh-ancestor
92858989|NCT00926107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92858990|NCT00926107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92858991|NCT00926107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92858992|NCT00926107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92858993|NCT00926107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92858994|NCT00926107|Antifungal Agents|antifungal agents|mesh-ancestor
92858995|NCT02729766|Empagliflozin|empagliflozin|mesh-list
92858996|NCT02729766|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92858997|NCT02729766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92858998|NCT02729766|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92858999|NCT02729766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859000|NCT02812940|Everolimus|everolimus|mesh-list
92859001|NCT02812940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92859002|NCT02812940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92859003|NCT02812940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859004|NCT02812940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859005|NCT02812940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859006|NCT02812940|Immunologic Factors|immunologic factors|mesh-ancestor
92859007|NCT02812940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859008|NCT02812940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859009|NCT00933439|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92859010|NCT00933439|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92859011|NCT00933439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92859012|NCT00933439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92859013|NCT00933439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859014|NCT00933439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859015|NCT00933439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859016|NCT00933439|Analgesics|analgesics|mesh-ancestor
92859017|NCT00933439|Sensory System Agents|sensory system agents|mesh-ancestor
92859018|NCT00933439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859019|NCT00933439|Antidepressive Agents|antidepressive agents|mesh-ancestor
92859020|NCT00933439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92859021|NCT00933439|Dopamine Agents|dopamine agents|mesh-ancestor
92859022|NCT00608075|Lithium Carbonate|lithium carbonate|mesh-list
92859023|NCT00608075|Antidepressive Agents|antidepressive agents|mesh-ancestor
92859024|NCT00608075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92859025|NCT00608075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859026|NCT00608075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859027|NCT00608075|Antimanic Agents|antimanic agents|mesh-ancestor
92859028|NCT00608075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92859029|NCT00608075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859030|NCT00608075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859031|NCT02809742|Ropivacaine|ropivacaine|mesh-list
92859032|NCT02809742|Anesthetics, Local|anesthetics, local|mesh-ancestor
92859033|NCT02809742|Anesthetics|anesthetics|mesh-ancestor
92859034|NCT02809742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859035|NCT02809742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859036|NCT02809742|Sensory System Agents|sensory system agents|mesh-ancestor
92203529|NCT03618134|Tremelimumab|tremelimumab|mesh-list
92859037|NCT02809742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859038|NCT00929851|Formoterol Fumarate|formoterol fumarate|mesh-list
92859039|NCT00929851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92859040|NCT00929851|Autonomic Agents|autonomic agents|mesh-ancestor
92859041|NCT00929851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859042|NCT00929851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859043|NCT00929851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92859044|NCT00929851|Respiratory System Agents|respiratory system agents|mesh-ancestor
92859045|NCT00929851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92859046|NCT00929851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92859047|NCT00929851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92859048|NCT00929851|Adrenergic Agents|adrenergic agents|mesh-ancestor
92859049|NCT00929851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859050|NCT00929851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859051|NCT02729376|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
92859052|NCT02729376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859053|NCT02729376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859054|NCT00933517|Cyclophosphamide|cyclophosphamide|mesh-list
92859055|NCT00933517|Docetaxel|docetaxel|mesh-list
92859056|NCT00933517|Panitumumab|panitumumab|mesh-list
92859057|NCT00933517|Epirubicin|epirubicin|mesh-list
92859058|NCT00933517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859059|NCT00933517|Immunologic Factors|immunologic factors|mesh-ancestor
92859060|NCT00933517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859061|NCT00933517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859062|NCT00933517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92859063|NCT00933517|Alkylating Agents|alkylating agents|mesh-ancestor
92859064|NCT00933517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859065|NCT00933517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859066|NCT00933517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92859067|NCT00933517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92859068|NCT00933517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92859069|NCT00933517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92859070|NCT00933517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92859071|NCT00933517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92859072|NCT00933517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92859073|NCT00933517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92859074|NCT00933517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859075|NCT00926341|Pioglitazone|pioglitazone|mesh-list
92859076|NCT00926341|Telmisartan|telmisartan|mesh-list
92859077|NCT00926341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92859078|NCT00926341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859079|NCT00926341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92859080|NCT00926341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92859081|NCT00926341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92859082|NCT00926341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859083|NCT00926419|Vaccines|vaccines|mesh-list
92859084|NCT00926419|Immunologic Factors|immunologic factors|mesh-ancestor
92859085|NCT00926419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859086|NCT00608231|Dexmedetomidine|dexmedetomidine|mesh-list
92859087|NCT00608231|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92859088|NCT00608231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859089|NCT00608231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859090|NCT00608231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859091|NCT00608231|Analgesics|analgesics|mesh-ancestor
92859092|NCT00608231|Sensory System Agents|sensory system agents|mesh-ancestor
92859093|NCT00608231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859094|NCT00608231|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92859095|NCT00608231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92859096|NCT00608231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92859097|NCT00608231|Adrenergic Agents|adrenergic agents|mesh-ancestor
92859098|NCT00608231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859099|NCT00608231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859100|NCT02739204|Celecoxib|celecoxib|mesh-list
92859101|NCT02739204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92859102|NCT02739204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859103|NCT02739204|Analgesics|analgesics|mesh-ancestor
92859104|NCT02739204|Sensory System Agents|sensory system agents|mesh-ancestor
92859105|NCT02739204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859106|NCT02739204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859107|NCT02739204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859108|NCT02739204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859110|NCT02739204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92859111|NCT02739204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859112|NCT02739204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859114|NCT00927485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92859115|NCT00927485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859116|NCT00927485|Analgesics|analgesics|mesh-ancestor
92859117|NCT00927485|Sensory System Agents|sensory system agents|mesh-ancestor
92859118|NCT00927485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859119|NCT00927485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859120|NCT00927485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859121|NCT00927485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859122|NCT00927485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859123|NCT00927485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859124|NCT00927485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859125|NCT00926653|Escitalopram|escitalopram|mesh-list
92859126|NCT00926653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92859127|NCT00926653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92859128|NCT00926653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92859129|NCT00926653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859130|NCT00926653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859131|NCT00926653|Serotonin Agents|serotonin agents|mesh-ancestor
92859132|NCT00926653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859133|NCT02733822|Naloxone|naloxone|mesh-list
92859134|NCT02733822|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92859135|NCT02733822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859136|NCT02733822|Sensory System Agents|sensory system agents|mesh-ancestor
92859137|NCT02733822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859138|NCT00930241|Tacrolimus|tacrolimus|mesh-list
92859139|NCT00930241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859140|NCT00930241|Immunologic Factors|immunologic factors|mesh-ancestor
92859141|NCT00930241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859142|NCT00930241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92859143|NCT00930241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859144|NCT00930241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859145|NCT04260269|Trifluridine|trifluridine|mesh-list
92859146|NCT04260269|Fluorouracil|fluorouracil|mesh-list
92859147|NCT04260269|Capecitabine|capecitabine|mesh-list
92859148|NCT04260269|Tegafur|tegafur|mesh-list
92859149|NCT04260269|Antimetabolites|antimetabolites|mesh-ancestor
92859150|NCT04260269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859151|NCT04260269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92859152|NCT04260269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859153|NCT04260269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859154|NCT04260269|Immunologic Factors|immunologic factors|mesh-ancestor
92859155|NCT04260269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859156|NCT04260269|Antiviral Agents|antiviral agents|mesh-ancestor
92859157|NCT04260269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859158|NCT02738970|Trastuzumab|trastuzumab|mesh-list
92859159|NCT02738970|Pertuzumab|pertuzumab|mesh-list
92859160|NCT02738970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92859161|NCT02738970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859162|NCT00926731|Cytarabine|cytarabine|mesh-list
92859163|NCT00926731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92859164|NCT00926731|Antimetabolites|antimetabolites|mesh-ancestor
92859165|NCT00926731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859166|NCT00926731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859167|NCT00926731|Antiviral Agents|antiviral agents|mesh-ancestor
92859168|NCT00926731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859169|NCT00926731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859170|NCT00926731|Immunologic Factors|immunologic factors|mesh-ancestor
92859171|NCT00926731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859172|NCT00926809|Amoxicillin|amoxicillin|mesh-list
92859173|NCT00926809|Clarithromycin|clarithromycin|mesh-list
92859174|NCT00926809|Lansoprazole|lansoprazole|mesh-list
92859175|NCT00926809|Dexlansoprazole|dexlansoprazole|mesh-list
92859176|NCT00926809|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92859177|NCT00926809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859178|NCT00926809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859179|NCT00926809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92859180|NCT00926809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859181|NCT00926809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859182|NCT00926809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92859183|NCT00926809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92859184|NCT00926809|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92859185|NCT00926809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859186|NCT02805920|Bupivacaine|bupivacaine|mesh-list
92859187|NCT02805920|Anesthetics, Local|anesthetics, local|mesh-ancestor
92859188|NCT02805920|Anesthetics|anesthetics|mesh-ancestor
92859189|NCT02805920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859190|NCT02805920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859191|NCT02805920|Sensory System Agents|sensory system agents|mesh-ancestor
92859192|NCT02805920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859193|NCT04262765|Amlodipine|amlodipine|mesh-list
92859194|NCT04262765|Ramipril|ramipril|mesh-list
92859195|NCT04262765|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92859196|NCT04262765|Atorvastatin|atorvastatin|mesh-list
92859197|NCT04262765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92859198|NCT04262765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92859199|NCT04262765|Antimetabolites|antimetabolites|mesh-ancestor
92859200|NCT04262765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859201|NCT04262765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92859202|NCT04262765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92859203|NCT04262765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859204|NCT04262765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92859205|NCT04262765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92859206|NCT04262765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156266|NCT03778073|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92859207|NCT04262765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92859208|NCT04262765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859209|NCT04262765|Vasodilator Agents|vasodilator agents|mesh-ancestor
92859210|NCT04262765|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92859211|NCT04262765|Protease Inhibitors|protease inhibitors|mesh-ancestor
92859212|NCT03112434|Botulinum Toxins|botulinum toxins|mesh-list
92859213|NCT03112434|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92859214|NCT03112434|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92859215|NCT03112434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92859216|NCT03112434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92859217|NCT03112434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859218|NCT03112434|Cholinergic Agents|cholinergic agents|mesh-ancestor
92859219|NCT03112434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859220|NCT03112434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859221|NCT03112434|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92859222|NCT03112434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859223|NCT02738814|Propofol|propofol|mesh-list
92859224|NCT02738814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92859225|NCT02738814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859226|NCT02738814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859227|NCT02738814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92859228|NCT02738814|Anesthetics, General|anesthetics, general|mesh-ancestor
92859229|NCT02738814|Anesthetics|anesthetics|mesh-ancestor
92859230|NCT02805608|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92859231|NCT02805608|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92859232|NCT02805608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859233|NCT02729064|Insulin|insulin|mesh-list
92859234|NCT02729064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92859235|NCT02729064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92859236|NCT02729064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859237|NCT00609401|Sorafenib|sorafenib|mesh-list
92859238|NCT00609401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859239|NCT00609401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92859240|NCT00609401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859241|NCT00609401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859242|NCT02805842|Tacrolimus|tacrolimus|mesh-list
92859243|NCT02805842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859244|NCT02805842|Immunologic Factors|immunologic factors|mesh-ancestor
92859245|NCT02805842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859246|NCT02805842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92859247|NCT02805842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859248|NCT02805842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859249|NCT00926965|Olanzapine|olanzapine|mesh-list
92859250|NCT00926965|Antipsychotic Agents|antipsychotic agents|mesh-list
92859251|NCT00926965|Amisulpride|amisulpride|mesh-list
92859252|NCT00926965|Antiemetics|antiemetics|mesh-ancestor
92859253|NCT00926965|Autonomic Agents|autonomic agents|mesh-ancestor
92859254|NCT00926965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859255|NCT00926965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504393|NCT02046421|Luteolytic Agents|luteolytic agents|mesh-ancestor
92859256|NCT00926965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859257|NCT00926965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92859258|NCT00926965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859259|NCT00926965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92859260|NCT00926965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92859261|NCT00926965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92859262|NCT00926965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92859263|NCT00926965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859264|NCT00926965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859265|NCT00926965|Serotonin Agents|serotonin agents|mesh-ancestor
92859266|NCT00926965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92859267|NCT00926965|Dopamine Agents|dopamine agents|mesh-ancestor
92859268|NCT00926965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92859269|NCT00926965|Antidepressive Agents|antidepressive agents|mesh-ancestor
92859270|NCT04260113|Apatinib|apatinib|mesh-list
92859271|NCT04260113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859272|NCT04260113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92859273|NCT04260113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859274|NCT04260113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859275|NCT02738658|Everolimus|everolimus|mesh-list
92859276|NCT02738658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92859277|NCT02738658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92859278|NCT02738658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859279|NCT02738658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859280|NCT02738658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859281|NCT02738658|Immunologic Factors|immunologic factors|mesh-ancestor
92859282|NCT02738658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859283|NCT02738658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859284|NCT02733510|Methylprednisolone|methylprednisolone|mesh-list
92859285|NCT02733510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92859286|NCT02733510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92859287|NCT02733510|Prednisolone|prednisolone|mesh-list
92859288|NCT02733510|Prednisolone acetate|prednisolone acetate|mesh-list
92859289|NCT02733510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92859290|NCT02733510|Prednisolone phosphate|prednisolone phosphate|mesh-list
92859291|NCT02733510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859292|NCT02733510|Antiemetics|antiemetics|mesh-ancestor
92859293|NCT02733510|Autonomic Agents|autonomic agents|mesh-ancestor
92859294|NCT02733510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859295|NCT02733510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859296|NCT02733510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859297|NCT02733510|Glucocorticoids|glucocorticoids|mesh-ancestor
92859298|NCT02733510|Hormones|hormones|mesh-ancestor
92859299|NCT02733510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859300|NCT02733510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92859301|NCT02733510|Protective Agents|protective agents|mesh-ancestor
92859302|NCT02733510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92859303|NCT02733510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859304|NCT00927095|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92859305|NCT00927095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92859306|NCT00927095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859307|NCT00933985|Doxorubicin|doxorubicin|mesh-list
92859308|NCT00933985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92859309|NCT00933985|Dexrazoxane|dexrazoxane|mesh-list
92859310|NCT00933985|Vincristine|vincristine|mesh-list
92859311|NCT00933985|Razoxane|razoxane|mesh-list
92859312|NCT00933985|Obatoclax|obatoclax|mesh-list
92859313|NCT00933985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92859314|NCT00933985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859315|NCT00933985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92859316|NCT00933985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92859317|NCT00933985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859318|NCT00933985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859319|NCT00933985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92859320|NCT00933985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92859321|NCT00933985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92859322|NCT00933985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92859323|NCT00933985|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92859325|NCT00933985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859326|NCT02812394|Levodopa|levodopa|mesh-list
92859327|NCT02812394|Carbidopa|carbidopa|mesh-list
92859328|NCT02812394|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92859329|NCT02812394|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92859330|NCT02812394|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92859331|NCT02812394|Dopamine Agents|dopamine agents|mesh-ancestor
92859332|NCT02812394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156286|NCT00971295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92859333|NCT02812394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859334|NCT02812394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859335|NCT02812394|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92859336|NCT02812394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859337|NCT02812394|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92859338|NCT02812394|Immunologic Factors|immunologic factors|mesh-ancestor
92859339|NCT02812394|Dopamine Agonists|dopamine agonists|mesh-ancestor
92859340|NCT00930475|Carboplatin|carboplatin|mesh-list
92859341|NCT00930475|Everolimus|everolimus|mesh-list
92859342|NCT00930475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859343|NCT00930475|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92859344|NCT00930475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92859345|NCT00930475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859346|NCT00930475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859347|NCT00930475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859348|NCT00930475|Immunologic Factors|immunologic factors|mesh-ancestor
92859349|NCT00930475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859350|NCT05623592|Methotrexate|methotrexate|mesh-list
92859351|NCT05623592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92859352|NCT05623592|Abortifacient Agents|abortifacient agents|mesh-ancestor
92859353|NCT05623592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92859354|NCT05623592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859355|NCT05623592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92859356|NCT05623592|Antimetabolites|antimetabolites|mesh-ancestor
92859357|NCT05623592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859358|NCT05623592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859359|NCT05623592|Dermatologic Agents|dermatologic agents|mesh-ancestor
92859360|NCT05623592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859361|NCT05623592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92859362|NCT05623592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859363|NCT05623592|Immunologic Factors|immunologic factors|mesh-ancestor
92859364|NCT05623592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859365|NCT05623592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92859366|NCT02728518|Amikacin|amikacin|mesh-list
92859367|NCT02728518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859368|NCT02728518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859369|NCT00634400|Candesartan|candesartan|mesh-list
92859370|NCT00634400|Candesartan cilexetil|candesartan cilexetil|mesh-list
92859371|NCT00634400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92859372|NCT00634400|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92859373|NCT00634400|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92859374|NCT00634400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859375|NCT04262375|Durvalumab|durvalumab|mesh-list
92859376|NCT04262375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92859377|NCT04262375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859378|NCT00936793|Ritonavir|ritonavir|mesh-list
92859379|NCT00936793|Darunavir|darunavir|mesh-list
92859380|NCT00936793|Beclomethasone|beclomethasone|mesh-list
92859381|NCT00936793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92859382|NCT00936793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92859383|NCT00936793|Protease Inhibitors|protease inhibitors|mesh-ancestor
92859384|NCT00936793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859385|NCT00936793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859386|NCT00936793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92859387|NCT00936793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92859388|NCT00936793|Antiviral Agents|antiviral agents|mesh-ancestor
92859389|NCT00936793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859390|NCT00936793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92859391|NCT00936793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92859392|NCT00936793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859393|NCT00936793|Glucocorticoids|glucocorticoids|mesh-ancestor
92859394|NCT00936793|Hormones|hormones|mesh-ancestor
92859395|NCT00936793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859396|NCT00936793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859397|NCT00936793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92859398|NCT00936793|Respiratory System Agents|respiratory system agents|mesh-ancestor
92859399|NCT02805452|Solifenacin Succinate|solifenacin succinate|mesh-list
92859400|NCT02805452|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92859401|NCT02805452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92859402|NCT02805452|Cholinergic Agents|cholinergic agents|mesh-ancestor
92859403|NCT02805452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859404|NCT02805452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859405|NCT02805452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859406|NCT02805452|Urological Agents|urological agents|mesh-ancestor
92859407|NCT00937027|Aminopterin|aminopterin|mesh-list
92859408|NCT00937027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92859409|NCT00937027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859410|NCT00937027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859411|NCT02738502|Ritonavir|ritonavir|mesh-list
92859412|NCT02738502|Darunavir|darunavir|mesh-list
92859413|NCT02738502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92859414|NCT02738502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92859415|NCT02738502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92859416|NCT02738502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859417|NCT02738502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859418|NCT02738502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92859419|NCT02738502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92859420|NCT02738502|Antiviral Agents|antiviral agents|mesh-ancestor
92859421|NCT02738502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859422|NCT02738502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92859423|NCT02738502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92859424|NCT04261907|Ritonavir|ritonavir|mesh-list
92859425|NCT04261907|Lopinavir|lopinavir|mesh-list
92859426|NCT04261907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92859427|NCT04261907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92859428|NCT04261907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92859429|NCT04261907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859430|NCT04261907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859431|NCT04261907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92859432|NCT04261907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92859433|NCT04261907|Antiviral Agents|antiviral agents|mesh-ancestor
92859434|NCT04261907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859435|NCT04261907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92859436|NCT04261907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92859437|NCT00930709|Botulinum Toxins|botulinum toxins|mesh-list
92859438|NCT00930709|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92859439|NCT00930709|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92859440|NCT00930709|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92859441|NCT00930709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92859442|NCT00930709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859443|NCT00930709|Cholinergic Agents|cholinergic agents|mesh-ancestor
92859444|NCT00930709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859445|NCT00930709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859446|NCT00930709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92859447|NCT00930709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859448|NCT02738346|Carboplatin|carboplatin|mesh-list
92859449|NCT02738346|Etoposide|etoposide|mesh-list
92859450|NCT02738346|Topotecan|topotecan|mesh-list
92859451|NCT02738346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859452|NCT02738346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92859453|NCT02738346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92859454|NCT02738346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92859455|NCT02738346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859456|NCT02738346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859457|NCT02738346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92859458|NCT00932165|Exemestane|exemestane|mesh-list
92859459|NCT00932165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859460|NCT00932165|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92859461|NCT00932165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92859462|NCT00932165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859463|NCT00932165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859464|NCT00932165|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92859465|NCT00932165|Hormone Antagonists|hormone antagonists|mesh-ancestor
92859466|NCT00932165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859467|NCT00932165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859468|NCT00937183|Vaccines|vaccines|mesh-list
92859469|NCT00937183|Immunologic Factors|immunologic factors|mesh-ancestor
92859470|NCT00937183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859471|NCT00937261|Risperidone|risperidone|mesh-list
92859472|NCT00937261|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92859473|NCT00937261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92859474|NCT00937261|Serotonin Agents|serotonin agents|mesh-ancestor
92859475|NCT00937261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859476|NCT00937261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859477|NCT00937261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859478|NCT00937261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92859479|NCT00937261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92859480|NCT00937261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859481|NCT00937261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92859482|NCT00937261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92859483|NCT00937261|Dopamine Agents|dopamine agents|mesh-ancestor
92859484|NCT00937261|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92859485|NCT00937261|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92859486|NCT05906433|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92859487|NCT05906433|Triamcinolone|triamcinolone|mesh-list
92859488|NCT05906433|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92859489|NCT05906433|Bupivacaine|bupivacaine|mesh-list
92859490|NCT05906433|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92859491|NCT05906433|Anesthetics, Local|anesthetics, local|mesh-ancestor
92859492|NCT05906433|Anesthetics|anesthetics|mesh-ancestor
92859493|NCT05906433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859494|NCT05906433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859495|NCT05906433|Sensory System Agents|sensory system agents|mesh-ancestor
92859496|NCT05906433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859497|NCT05906433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859498|NCT05906433|Glucocorticoids|glucocorticoids|mesh-ancestor
92859499|NCT05906433|Hormones|hormones|mesh-ancestor
92859500|NCT05906433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859501|NCT05906433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859502|NCT05906433|Immunologic Factors|immunologic factors|mesh-ancestor
92859503|NCT05906433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859504|NCT05906433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859505|NCT05906225|Anesthetics|anesthetics|mesh-list
92859506|NCT05906225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859507|NCT05906225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859508|NCT05906199|Aspirin|aspirin|mesh-list
92859509|NCT05906199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92859510|NCT05906199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859511|NCT05906199|Analgesics|analgesics|mesh-ancestor
92859512|NCT05906199|Sensory System Agents|sensory system agents|mesh-ancestor
92859513|NCT05906199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859514|NCT05906199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859515|NCT05906199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859516|NCT05906199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859517|NCT05906199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92859518|NCT05906199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92859519|NCT05906199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859520|NCT05906199|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92859521|NCT05906199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92859522|NCT05906199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859523|NCT05906199|Antipyretics|antipyretics|mesh-ancestor
92859524|NCT05905965|Empagliflozin|empagliflozin|mesh-list
92859525|NCT05905965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92859526|NCT05905965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859527|NCT05905965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92859528|NCT05905965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859529|NCT05905913|Meropenem|meropenem|mesh-list
92859530|NCT05905913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859531|NCT05905913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859532|NCT05905887|Paclitaxel|paclitaxel|mesh-list
92859533|NCT05905887|Apatinib|apatinib|mesh-list
92859534|NCT05905887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92859535|NCT05905887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859536|NCT05905887|Tubulin Modulators|tubulin modulators|mesh-ancestor
92859537|NCT05905887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92859538|NCT05905887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92859539|NCT05905887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859540|NCT05905887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92859541|NCT05905887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859542|NCT05905757|Tramadol|tramadol|mesh-list
92859543|NCT05905757|Dexmedetomidine|dexmedetomidine|mesh-list
92859544|NCT05905757|Bupivacaine|bupivacaine|mesh-list
92859545|NCT05905757|Anesthetics, Local|anesthetics, local|mesh-ancestor
92859546|NCT05905757|Anesthetics|anesthetics|mesh-ancestor
92859547|NCT05905757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859548|NCT05905757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859549|NCT05905757|Sensory System Agents|sensory system agents|mesh-ancestor
92859550|NCT05905757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859551|NCT05905757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92859552|NCT05905757|Narcotics|narcotics|mesh-ancestor
92859553|NCT05905757|Analgesics|analgesics|mesh-ancestor
92859554|NCT05905757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92859555|NCT05905757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859556|NCT05905757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92859557|NCT05905757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92859558|NCT05905757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92859559|NCT05905757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92859560|NCT05905757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859561|NCT05905757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859562|NCT05905653|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92859563|NCT05905653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92859564|NCT05905484|Moxifloxacin|moxifloxacin|mesh-list
92859565|NCT05905484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859566|NCT05905484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859567|NCT05905484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92859568|NCT05905484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92859569|NCT05905484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859570|NCT05905484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859571|NCT05905484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859572|NCT05905419|Analgesics, Opioid|analgesics, opioid|mesh-list
92859573|NCT05905419|Narcotics|narcotics|mesh-ancestor
92859574|NCT05905419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859575|NCT05905419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859576|NCT05905419|Analgesics|analgesics|mesh-ancestor
92859577|NCT05905419|Sensory System Agents|sensory system agents|mesh-ancestor
92859578|NCT05905419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859579|NCT05905367|Fentanyl|fentanyl|mesh-list
92859580|NCT05905367|Morphine|morphine|mesh-list
92859581|NCT05905367|Methadone|methadone|mesh-list
92859582|NCT05905367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92859583|NCT05905367|Narcotics|narcotics|mesh-ancestor
92859584|NCT05905367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859585|NCT05905367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859586|NCT05905367|Analgesics|analgesics|mesh-ancestor
92859587|NCT05905367|Sensory System Agents|sensory system agents|mesh-ancestor
92859588|NCT05905367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859589|NCT05905367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92859590|NCT05905367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92859591|NCT05905367|Anesthetics, General|anesthetics, general|mesh-ancestor
92859592|NCT05905367|Anesthetics|anesthetics|mesh-ancestor
92859593|NCT05905367|Antitussive Agents|antitussive agents|mesh-ancestor
92859594|NCT05905367|Respiratory System Agents|respiratory system agents|mesh-ancestor
92859595|NCT05905341|Fulvestrant|fulvestrant|mesh-list
92859596|NCT05905341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92859597|NCT05905341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859598|NCT05905341|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92859599|NCT05905341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92859600|NCT05905341|Hormone Antagonists|hormone antagonists|mesh-ancestor
92859601|NCT05905341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859602|NCT05905341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859603|NCT05905315|Paclitaxel|paclitaxel|mesh-list
92859604|NCT05905315|Carboplatin|carboplatin|mesh-list
92859605|NCT05905315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92859606|NCT05905315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859607|NCT05905315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92859608|NCT05905315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92859609|NCT05905315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92859610|NCT05905315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859611|NCT05905185|Vitamin E|vitamin e|mesh-list
92859612|NCT05905185|Tocopherols|tocopherols|mesh-list
92859613|NCT05905185|Tocotrienols|tocotrienols|mesh-list
92859614|NCT05905185|Vitamins|vitamins|mesh-ancestor
92859615|NCT05905185|Micronutrients|micronutrients|mesh-ancestor
92859616|NCT05905185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859617|NCT05905185|Antioxidants|antioxidants|mesh-ancestor
92524986|NCT00023374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92859618|NCT05905185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859619|NCT05905185|Protective Agents|protective agents|mesh-ancestor
92859621|NCT05905055|Aztreonam|aztreonam|mesh-list
92859622|NCT05905055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859623|NCT05905055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859624|NCT05904912|Bupivacaine|bupivacaine|mesh-list
92859625|NCT05904912|Anesthetics, Local|anesthetics, local|mesh-ancestor
92859626|NCT05904912|Anesthetics|anesthetics|mesh-ancestor
92859627|NCT05904912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859628|NCT05904912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859629|NCT05904912|Sensory System Agents|sensory system agents|mesh-ancestor
92859630|NCT05904912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859631|NCT05898841|Tenofovir|tenofovir|mesh-list
92859632|NCT05898841|Emtricitabine|emtricitabine|mesh-list
92859633|NCT05898841|Dolutegravir|dolutegravir|mesh-list
92859634|NCT05898841|Rilpivirine|rilpivirine|mesh-list
92859635|NCT05898841|Antiviral Agents|antiviral agents|mesh-ancestor
92859636|NCT05898841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859637|NCT05898841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92859638|NCT05898841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92859639|NCT05898841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859640|NCT05898841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859641|NCT05898841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92859642|NCT05898841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92859643|NCT05898841|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92859644|NCT05898841|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92859645|NCT05893069|Oxandrolone|oxandrolone|mesh-list
92859646|NCT05893069|Androgens|androgens|mesh-ancestor
92859647|NCT05893069|Hormones|hormones|mesh-ancestor
92859648|NCT05893069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859649|NCT05893069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859650|NCT05893069|Anabolic Agents|anabolic agents|mesh-ancestor
92859651|NCT05887492|Pembrolizumab|pembrolizumab|mesh-list
92859652|NCT05887492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92859653|NCT05887492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859654|NCT05887492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92859655|NCT05887492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859656|NCT05882877|KHK4083|khk4083|mesh-list
92859657|NCT05882877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92859658|NCT05881811|Probenecid|probenecid|mesh-list
92859659|NCT05881811|Cimetidine|cimetidine|mesh-list
92859660|NCT05881811|Uricosuric Agents|uricosuric agents|mesh-ancestor
92859661|NCT05881811|Gout Suppressants|gout suppressants|mesh-ancestor
92859662|NCT05881811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859663|NCT05881811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92859664|NCT05881811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859665|NCT05881811|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92859666|NCT05881811|Histamine Antagonists|histamine antagonists|mesh-ancestor
92859667|NCT05881811|Histamine Agents|histamine agents|mesh-ancestor
92859668|NCT05881811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859669|NCT05881811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859670|NCT05881811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859671|NCT05881811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92859672|NCT05881811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92859673|NCT05881811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859674|NCT05867654|Amoxicillin|amoxicillin|mesh-list
92859675|NCT05867654|Levofloxacin|levofloxacin|mesh-list
92859676|NCT05867654|Clindamycin|clindamycin|mesh-list
92859677|NCT05867654|Clindamycin palmitate|clindamycin palmitate|mesh-list
92859678|NCT05867654|Clindamycin phosphate|clindamycin phosphate|mesh-list
92859679|NCT05867654|Clavulanic Acid|clavulanic acid|mesh-list
92859680|NCT05867654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92859681|NCT05867654|Ampicillin|ampicillin|mesh-list
92859682|NCT05867654|Sulbactam|sulbactam|mesh-list
92859683|NCT05867654|Sultamicillin|sultamicillin|mesh-list
92859684|NCT05867654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859685|NCT05867654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859686|NCT05867654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92859687|NCT05867654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92859688|NCT05867654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92859689|NCT05867654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859690|NCT05867654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859691|NCT05867654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859692|NCT05867654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92859693|NCT05867654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92859694|NCT05867654|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92859695|NCT05867654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92859697|NCT05843565|Trace Elements|trace elements|mesh-ancestor
92859698|NCT05843565|Micronutrients|micronutrients|mesh-ancestor
92859699|NCT05843565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859700|NCT05838703|Bromides|bromides|mesh-list
92859701|NCT05838703|Tiotropium Bromide|tiotropium bromide|mesh-list
92859702|NCT05838703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92859703|NCT05838703|Autonomic Agents|autonomic agents|mesh-ancestor
92859704|NCT05838703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859705|NCT05838703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859706|NCT05838703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92504870|NCT00005898|Hormones|hormones|mesh-ancestor
92859707|NCT05838703|Respiratory System Agents|respiratory system agents|mesh-ancestor
92859708|NCT05838703|Parasympatholytics|parasympatholytics|mesh-ancestor
92859709|NCT05838703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92859710|NCT05838703|Cholinergic Agents|cholinergic agents|mesh-ancestor
92859711|NCT05838703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859712|NCT05838703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859713|NCT05838703|Anticonvulsants|anticonvulsants|mesh-ancestor
92859714|NCT05831683|Anesthetics|anesthetics|mesh-list
92859715|NCT05831683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859716|NCT05831683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859717|NCT05831358|Myeloma Proteins|myeloma proteins|mesh-list
92859718|NCT05831358|Paraproteins|paraproteins|mesh-list
92859719|NCT05831358|Immunologic Factors|immunologic factors|mesh-ancestor
92859720|NCT05831358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859721|NCT05825924|Nicotine|nicotine|mesh-list
92859722|NCT05825924|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92859723|NCT05825924|Autonomic Agents|autonomic agents|mesh-ancestor
92859724|NCT05825924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859725|NCT05825924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859726|NCT05825924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92859727|NCT05825924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92859728|NCT05825924|Cholinergic Agents|cholinergic agents|mesh-ancestor
92859729|NCT05825924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859730|NCT05825924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859731|NCT05807048|Daratumumab|daratumumab|mesh-list
92859732|NCT05807048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859733|NCT05789992|Remifentanil|remifentanil|mesh-list
92859734|NCT05789992|Propofol|propofol|mesh-list
92859735|NCT05789992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92859736|NCT05789992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859737|NCT05789992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859738|NCT05789992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92859739|NCT05789992|Anesthetics, General|anesthetics, general|mesh-ancestor
92859740|NCT05789992|Anesthetics|anesthetics|mesh-ancestor
92859741|NCT05789992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92859742|NCT05789992|Narcotics|narcotics|mesh-ancestor
92859743|NCT05789992|Analgesics|analgesics|mesh-ancestor
92859744|NCT05789992|Sensory System Agents|sensory system agents|mesh-ancestor
92859745|NCT05789992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859746|NCT05765266|Methylprednisolone|methylprednisolone|mesh-list
92859747|NCT05765266|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92859748|NCT05765266|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92859749|NCT05765266|Prednisolone|prednisolone|mesh-list
92859750|NCT05765266|Prednisolone acetate|prednisolone acetate|mesh-list
92859751|NCT05765266|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92859752|NCT05765266|Prednisolone phosphate|prednisolone phosphate|mesh-list
92859753|NCT05765266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859754|NCT05765266|Antiemetics|antiemetics|mesh-ancestor
92859755|NCT05765266|Autonomic Agents|autonomic agents|mesh-ancestor
92859756|NCT05765266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859757|NCT05765266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859758|NCT05765266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859759|NCT05765266|Glucocorticoids|glucocorticoids|mesh-ancestor
92859760|NCT05765266|Hormones|hormones|mesh-ancestor
92204265|NCT00638456|Glucocorticoids|glucocorticoids|mesh-ancestor
93026455|NCT00402285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859761|NCT05765266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859762|NCT05765266|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92859763|NCT05765266|Protective Agents|protective agents|mesh-ancestor
92859764|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92859765|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859766|NCT05764993|Immunoglobulins|immunoglobulins|mesh-list
92859767|NCT05764993|gamma-Globulins|gamma-globulins|mesh-list
92859768|NCT05764993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92859769|NCT05764993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92859770|NCT05764993|Immunologic Factors|immunologic factors|mesh-ancestor
92859771|NCT05764993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859772|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92859773|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859775|NCT05727176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859776|NCT05720325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92859777|NCT05720325|Immunologic Factors|immunologic factors|mesh-ancestor
92859778|NCT05720325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859779|NCT05701501|Pantothenic Acid|pantothenic acid|mesh-list
92859780|NCT05701501|Vitamins|vitamins|mesh-ancestor
92859781|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
92859782|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859783|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
92859784|NCT05700812|Levonorgestrel|levonorgestrel|mesh-list
92859785|NCT05700812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92859786|NCT05700812|Contraceptive Agents|contraceptive agents|mesh-ancestor
92859787|NCT05700812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92859788|NCT05700812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859789|NCT05700812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92859790|NCT05700812|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92859791|NCT05700812|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92859792|NCT05681273|Empagliflozin|empagliflozin|mesh-list
92859793|NCT05681273|Valsartan|valsartan|mesh-list
92859794|NCT05681273|Atorvastatin|atorvastatin|mesh-list
92859795|NCT05681273|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92859796|NCT05681273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92859797|NCT05681273|Antimetabolites|antimetabolites|mesh-ancestor
92859798|NCT05681273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859799|NCT05681273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92859800|NCT05681273|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92859801|NCT05681273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859802|NCT05681273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92859803|NCT05681273|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92859804|NCT05681273|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92859805|NCT05681273|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92859806|NCT05681273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92859807|NCT05681273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859808|NCT05656742|Vitamin D|vitamin d|mesh-list
92859809|NCT05656742|Vitamins|vitamins|mesh-ancestor
92859810|NCT05656742|Micronutrients|micronutrients|mesh-ancestor
92859811|NCT05656742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859812|NCT05656742|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92859813|NCT05592223|Rifampin|rifampin|mesh-list
92859814|NCT05592223|Isoniazid|isoniazid|mesh-list
92859815|NCT05592223|BCG Vaccine|bcg vaccine|mesh-list
92859816|NCT05592223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92859817|NCT05592223|Antitubercular Agents|antitubercular agents|mesh-ancestor
92859818|NCT05592223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859819|NCT05592223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859820|NCT05592223|Leprostatic Agents|leprostatic agents|mesh-ancestor
92859821|NCT05592223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92859822|NCT05592223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859823|NCT05592223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859824|NCT05592223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92859825|NCT05592223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92859826|NCT05592223|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92859827|NCT05592223|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92859828|NCT05592223|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92859829|NCT05592223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92859830|NCT05592223|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92859831|NCT05592223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92859832|NCT05592223|Antimetabolites|antimetabolites|mesh-ancestor
92859833|NCT05592223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92859834|NCT05592223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92859835|NCT05592223|Immunologic Factors|immunologic factors|mesh-ancestor
92859836|NCT05592223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859837|NCT05549505|Anastrozole|anastrozole|mesh-list
92859838|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92859839|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859840|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92859841|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92859842|NCT05549505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859843|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859844|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92859845|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92859846|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859847|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859848|NCT05538767|Albendazole|albendazole|mesh-list
92859849|NCT05538767|Emodepside|emodepside|mesh-list
92859850|NCT05538767|Anthelmintics|anthelmintics|mesh-ancestor
92859851|NCT05538767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92859852|NCT05538767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859853|NCT05538767|Anticestodal Agents|anticestodal agents|mesh-ancestor
92859854|NCT05538767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92859855|NCT05538767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92859856|NCT05538767|Tubulin Modulators|tubulin modulators|mesh-ancestor
92859857|NCT05538767|Antimitotic Agents|antimitotic agents|mesh-ancestor
92859858|NCT05538767|Mitosis Modulators|mitosis modulators|mesh-ancestor
92859859|NCT05538767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859860|NCT05538767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859861|NCT05524168|Gemcitabine|gemcitabine|mesh-list
92859862|NCT05524168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859863|NCT05524168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92859864|NCT05524168|Antimetabolites|antimetabolites|mesh-ancestor
92859865|NCT05524168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859866|NCT05488847|Acetaminophen|acetaminophen|mesh-list
92859867|NCT05488847|Dexamethasone|dexamethasone|mesh-list
92859868|NCT05488847|Ibuprofen|ibuprofen|mesh-list
92859869|NCT05488847|Celecoxib|celecoxib|mesh-list
92859870|NCT05488847|Ketorolac|ketorolac|mesh-list
92859871|NCT05488847|Pregabalin|pregabalin|mesh-list
92859872|NCT05488847|Epinephrine|epinephrine|mesh-list
92859873|NCT05488847|Oxycodone|oxycodone|mesh-list
92859874|NCT05488847|Tramadol|tramadol|mesh-list
92859875|NCT05488847|Tizanidine|tizanidine|mesh-list
92859876|NCT05488847|Magnesium Oxide|magnesium oxide|mesh-list
92859877|NCT05488847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859878|NCT05488847|Antiemetics|antiemetics|mesh-ancestor
92859879|NCT05488847|Autonomic Agents|autonomic agents|mesh-ancestor
92859880|NCT05488847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859881|NCT05488847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859882|NCT05488847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859883|NCT05488847|Glucocorticoids|glucocorticoids|mesh-ancestor
92859884|NCT05488847|Hormones|hormones|mesh-ancestor
92859885|NCT05488847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859886|NCT05488847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92859887|NCT05488847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859888|NCT05488847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859889|NCT05488847|Analgesics|analgesics|mesh-ancestor
92859890|NCT05488847|Sensory System Agents|sensory system agents|mesh-ancestor
92859891|NCT05488847|Antipyretics|antipyretics|mesh-ancestor
92859892|NCT05488847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92859893|NCT05488847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859894|NCT05488847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92859895|NCT05488847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859896|NCT05488847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859897|NCT05488847|Anticonvulsants|anticonvulsants|mesh-ancestor
92859898|NCT05488847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92859899|NCT05488847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92859900|NCT05488847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524995|NCT00023413|Efavirenz|efavirenz|mesh-list
92859901|NCT05488847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92859902|NCT05488847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92859903|NCT05488847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92859904|NCT05488847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92859905|NCT05488847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92859906|NCT05488847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92859907|NCT05488847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92859908|NCT05488847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859909|NCT05488847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92859910|NCT05488847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92859911|NCT05488847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92859912|NCT05488847|Respiratory System Agents|respiratory system agents|mesh-ancestor
92859913|NCT05488847|Mydriatics|mydriatics|mesh-ancestor
92859914|NCT05488847|Sympathomimetics|sympathomimetics|mesh-ancestor
92859915|NCT05488847|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92859916|NCT05488847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92859917|NCT05488847|Narcotics|narcotics|mesh-ancestor
92859918|NCT05488847|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92859919|NCT05488847|Antacids|antacids|mesh-ancestor
92859920|NCT05488847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92859921|NCT05488847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92859922|NCT05488847|Parasympatholytics|parasympatholytics|mesh-ancestor
92859923|NCT05488847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92859924|NCT05487599|Sirolimus|sirolimus|mesh-list
92859925|NCT05487599|Prednisone|prednisone|mesh-list
92859926|NCT05487599|Methylprednisolone|methylprednisolone|mesh-list
92859927|NCT05487599|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92859928|NCT05487599|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92859929|NCT05487599|Prednisolone|prednisolone|mesh-list
92859930|NCT05487599|Prednisolone acetate|prednisolone acetate|mesh-list
92859931|NCT05487599|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92859932|NCT05487599|Prednisolone phosphate|prednisolone phosphate|mesh-list
92859933|NCT05487599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859934|NCT05487599|Glucocorticoids|glucocorticoids|mesh-ancestor
92859935|NCT05487599|Hormones|hormones|mesh-ancestor
92859936|NCT05487599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92859937|NCT05487599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859938|NCT05487599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92859939|NCT05487599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859940|NCT05487599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92859941|NCT05487599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92859942|NCT05487599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92859943|NCT05487599|Antifungal Agents|antifungal agents|mesh-ancestor
92859944|NCT05487599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92859945|NCT05487599|Immunologic Factors|immunologic factors|mesh-ancestor
92859946|NCT05487599|Antiemetics|antiemetics|mesh-ancestor
92859947|NCT05487599|Autonomic Agents|autonomic agents|mesh-ancestor
92859948|NCT05487599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859949|NCT05487599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92859950|NCT05487599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92859951|NCT05487599|Protective Agents|protective agents|mesh-ancestor
92859952|NCT05464420|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92859953|NCT05464420|Immunologic Factors|immunologic factors|mesh-ancestor
92859954|NCT05464420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859955|NCT05431582|Bevacizumab|bevacizumab|mesh-list
92859956|NCT05431582|Pembrolizumab|pembrolizumab|mesh-list
92859957|NCT05431582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92859958|NCT05431582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92859959|NCT05431582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92859960|NCT05431582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92859961|NCT05431582|Growth Substances|growth substances|mesh-ancestor
92859962|NCT05431582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859963|NCT05431582|Growth Inhibitors|growth inhibitors|mesh-ancestor
92859964|NCT05431582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92859965|NCT05431582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859966|NCT05418556|Aspirin|aspirin|mesh-list
92859967|NCT05418556|Clopidogrel|clopidogrel|mesh-list
92859968|NCT05418556|Ticagrelor|ticagrelor|mesh-list
92859969|NCT05418556|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92859970|NCT05418556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92859971|NCT05418556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92859972|NCT05418556|Analgesics|analgesics|mesh-ancestor
92859973|NCT05418556|Sensory System Agents|sensory system agents|mesh-ancestor
92859974|NCT05418556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92859975|NCT05418556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859976|NCT05418556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92859977|NCT05418556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92859978|NCT05418556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92859979|NCT05418556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92859980|NCT05418556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92859981|NCT05418556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92859982|NCT05418556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92859983|NCT05418556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92859985|NCT05418556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92859986|NCT05418556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92859987|NCT05418556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92859988|NCT05418556|Purinergic Agents|purinergic agents|mesh-ancestor
92859989|NCT05418556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92859990|NCT05412030|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92859991|NCT05412030|Immunologic Factors|immunologic factors|mesh-ancestor
92859992|NCT05412030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92859993|NCT05384756|Sirolimus|sirolimus|mesh-list
92859994|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92859995|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
92859996|NCT05384756|Antibodies|antibodies|mesh-list
92859997|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
92859998|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92859999|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
92860000|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860001|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860002|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860003|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860004|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92860005|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
92860006|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860007|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92860008|NCT05362760|Fulvestrant|fulvestrant|mesh-list
92860009|NCT05362760|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92860010|NCT05362760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505149|NCT00005985|Antimetabolites|antimetabolites|mesh-ancestor
92860011|NCT05362760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860012|NCT05362760|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92860013|NCT05362760|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92860014|NCT05362760|Hormone Antagonists|hormone antagonists|mesh-ancestor
92860015|NCT05362760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860016|NCT05362760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860017|NCT05362760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92860018|NCT05362760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860019|NCT05362760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860020|NCT05349188|Melatonin|melatonin|mesh-list
92860021|NCT05349188|Antioxidants|antioxidants|mesh-ancestor
92860022|NCT05349188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860023|NCT05349188|Protective Agents|protective agents|mesh-ancestor
92860024|NCT05349188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860025|NCT05349188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92860026|NCT05331027|Sevoflurane|sevoflurane|mesh-list
92860027|NCT05331027|Desflurane|desflurane|mesh-list
92860028|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92860029|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92860030|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
92860031|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
92860032|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92860033|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860034|NCT05299242|Adalimumab|adalimumab|mesh-list
92860035|NCT05299242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92860036|NCT05299242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860037|NCT05299242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860038|NCT05299125|Pemetrexed|pemetrexed|mesh-list
92860039|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92860040|NCT05299125|Lazertinib|lazertinib|mesh-list
92860041|NCT05299125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860042|NCT05299125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860043|NCT05299125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860044|NCT05299125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92860045|NCT05299125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92860046|NCT05299125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92204549|NCT00724009|Clofarabine|clofarabine|mesh-list
92860047|NCT05299125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860048|NCT05290727|Hyaluronic Acid|hyaluronic acid|mesh-list
92860049|NCT05290727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92860050|NCT05290727|Immunologic Factors|immunologic factors|mesh-ancestor
92860051|NCT05290727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860052|NCT05290727|Viscosupplements|viscosupplements|mesh-ancestor
92860053|NCT05290727|Protective Agents|protective agents|mesh-ancestor
92860054|NCT05282706|Peppermint oil|peppermint oil|mesh-list
92860055|NCT05282706|Antiemetics|antiemetics|mesh-ancestor
92860056|NCT05282706|Autonomic Agents|autonomic agents|mesh-ancestor
92860057|NCT05282706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860058|NCT05282706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860059|NCT05282706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860060|NCT05282706|Parasympatholytics|parasympatholytics|mesh-ancestor
92860061|NCT05222984|Decitabine|decitabine|mesh-list
92860062|NCT05222984|Venetoclax|venetoclax|mesh-list
92860063|NCT05222984|Navitoclax|navitoclax|mesh-list
92860064|NCT05222984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860065|NCT05222984|Antimetabolites|antimetabolites|mesh-ancestor
92860066|NCT05222984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860067|NCT05222984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860068|NCT05222984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860069|NCT05221840|Durvalumab|durvalumab|mesh-list
92860070|NCT05221840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860071|NCT05221840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860072|NCT05177848|Nicotine|nicotine|mesh-list
92860073|NCT05177848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92860074|NCT05177848|Autonomic Agents|autonomic agents|mesh-ancestor
92860075|NCT05177848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860076|NCT05177848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860077|NCT05177848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92860078|NCT05177848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92860079|NCT05177848|Cholinergic Agents|cholinergic agents|mesh-ancestor
92860080|NCT05177848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860081|NCT05177848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860082|NCT05169008|Vaccines|vaccines|mesh-list
92860083|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
92860084|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860085|NCT05159453|Insulin|insulin|mesh-list
92860086|NCT05159453|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92860087|NCT05159453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92860088|NCT05159453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860089|NCT05096195|Calcium, Dietary|calcium, dietary|mesh-list
92860090|NCT05096195|Vitamin D|vitamin d|mesh-list
92860091|NCT05096195|Denosumab|denosumab|mesh-list
92860092|NCT05096195|Calcium|calcium|mesh-list
92860093|NCT05096195|Vitamins|vitamins|mesh-ancestor
92860094|NCT05096195|Micronutrients|micronutrients|mesh-ancestor
92860095|NCT05096195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860096|NCT05096195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92860097|NCT05096195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92860098|NCT05067933|Vaccines|vaccines|mesh-list
92860099|NCT05067933|Immunologic Factors|immunologic factors|mesh-ancestor
92860100|NCT05067933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860101|NCT05059860|Insulin|insulin|mesh-list
92860102|NCT05059860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92860103|NCT05059860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860104|NCT05022524|Acetic Acid|acetic acid|mesh-list
92860105|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860106|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860107|NCT04852068|Vaccines|vaccines|mesh-list
92860108|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
92860109|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860110|NCT04839042|Cloricromen|cloricromen|mesh-list
92860111|NCT04839042|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92860112|NCT04835441|ALPN-101|alpn-101|mesh-list
92860113|NCT04835441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860114|NCT04835441|Immunologic Factors|immunologic factors|mesh-ancestor
92860115|NCT04835441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860116|NCT04825223|Vaccines|vaccines|mesh-list
92860117|NCT04825223|Immunologic Factors|immunologic factors|mesh-ancestor
92860118|NCT04825223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860119|NCT04806100|Carbon Fiber|carbon fiber|mesh-list
92860120|NCT04806100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92860121|NCT04806100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860122|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
92860123|NCT04789096|Trastuzumab|trastuzumab|mesh-list
92860124|NCT04789096|Capecitabine|capecitabine|mesh-list
92860125|NCT04789096|Tucatinib|tucatinib|mesh-list
92860126|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860127|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860128|NCT04789096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860129|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860130|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860131|NCT04789096|Antimetabolites|antimetabolites|mesh-ancestor
92860132|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92860133|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860134|NCT04774094|Ceftazidime|ceftazidime|mesh-list
92860135|NCT04774094|Avibactam|avibactam|mesh-list
92860136|NCT04774094|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92860137|NCT04774094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860138|NCT04774094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860139|NCT04774094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92860140|NCT04774094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860141|NCT04774094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860142|NCT04761822|Vaccines|vaccines|mesh-list
92860143|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
92860144|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860145|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92860146|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92860147|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860148|NCT04707235|Hydroxyurea|hydroxyurea|mesh-list
92860149|NCT04707235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860150|NCT04707235|Antisickling Agents|antisickling agents|mesh-ancestor
92860151|NCT04707235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860152|NCT04707235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860153|NCT04707235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92860154|NCT04702893|Nintedanib|nintedanib|mesh-list
92860155|NCT04702893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860156|NCT04702893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92860157|NCT04702893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860158|NCT04702893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860159|NCT04668157|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92860160|NCT04668157|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92860161|NCT04668157|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92505298|NCT00006021|Ascorbic Acid|ascorbic acid|mesh-list
93046927|NCT01058720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92860162|NCT04668157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860163|NCT04665037|Posaconazole|posaconazole|mesh-list
92860164|NCT04665037|Antifungal Agents|antifungal agents|mesh-ancestor
92860165|NCT04665037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860166|NCT04665037|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92860167|NCT04665037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92860168|NCT04665037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92860169|NCT04665037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92860170|NCT04665037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92860171|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860172|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860173|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92860174|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
92860175|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860176|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860177|NCT04639466|Vaccines|vaccines|mesh-list
92860178|NCT04639466|Immunologic Factors|immunologic factors|mesh-ancestor
92860179|NCT04639466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860180|NCT04609046|Rituximab|rituximab|mesh-list
92860181|NCT04609046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92860182|NCT04609046|Nivolumab|nivolumab|mesh-list
92860183|NCT04609046|Methotrexate|methotrexate|mesh-list
92860184|NCT04609046|Lenalidomide|lenalidomide|mesh-list
92860185|NCT04609046|Antibodies|antibodies|mesh-list
92860186|NCT04609046|Immunoglobulins|immunoglobulins|mesh-list
92860187|NCT04609046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92860188|NCT04609046|Immunologic Factors|immunologic factors|mesh-ancestor
92860189|NCT04609046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860190|NCT04609046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860191|NCT04609046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860192|NCT04609046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860193|NCT04609046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860194|NCT04609046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92860195|NCT04609046|Abortifacient Agents|abortifacient agents|mesh-ancestor
92860196|NCT04609046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92860197|NCT04609046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860198|NCT04609046|Antimetabolites|antimetabolites|mesh-ancestor
92860199|NCT04609046|Dermatologic Agents|dermatologic agents|mesh-ancestor
92860200|NCT04609046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860201|NCT04609046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92860202|NCT04609046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860203|NCT04609046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92860204|NCT04609046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92860205|NCT04609046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92860206|NCT04609046|Growth Substances|growth substances|mesh-ancestor
92860207|NCT04609046|Growth Inhibitors|growth inhibitors|mesh-ancestor
92860208|NCT04548999|Methylprednisolone|methylprednisolone|mesh-list
92860209|NCT04548999|Ocrelizumab|ocrelizumab|mesh-list
92860210|NCT04548999|Histamine Antagonists|histamine antagonists|mesh-list
92860211|NCT04548999|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92860212|NCT04548999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860213|NCT04548999|Antiemetics|antiemetics|mesh-ancestor
92860214|NCT04548999|Autonomic Agents|autonomic agents|mesh-ancestor
92860215|NCT04548999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860216|NCT04548999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860217|NCT04548999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860218|NCT04548999|Glucocorticoids|glucocorticoids|mesh-ancestor
92860220|NCT04548999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860221|NCT04548999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92860222|NCT04548999|Protective Agents|protective agents|mesh-ancestor
92860223|NCT04548999|Immunologic Factors|immunologic factors|mesh-ancestor
92860224|NCT04548999|Histamine Agents|histamine agents|mesh-ancestor
92860225|NCT04548999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860226|NCT04548999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860227|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
92860228|NCT04548661|Povidone|povidone|mesh-list
92860229|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
92860230|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
92860231|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92860232|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860233|NCT04544436|Methylprednisolone|methylprednisolone|mesh-list
92860234|NCT04544436|Ocrelizumab|ocrelizumab|mesh-list
92860235|NCT04544436|Histamine Antagonists|histamine antagonists|mesh-list
92860236|NCT04544436|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92860237|NCT04544436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860238|NCT04544436|Antiemetics|antiemetics|mesh-ancestor
92860239|NCT04544436|Autonomic Agents|autonomic agents|mesh-ancestor
92860240|NCT04544436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860241|NCT04544436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860242|NCT04544436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860243|NCT04544436|Glucocorticoids|glucocorticoids|mesh-ancestor
92860244|NCT04544436|Hormones|hormones|mesh-ancestor
92860245|NCT04544436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860246|NCT04544436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92860247|NCT04544436|Protective Agents|protective agents|mesh-ancestor
92860248|NCT04544436|Immunologic Factors|immunologic factors|mesh-ancestor
92860249|NCT04544436|Histamine Agents|histamine agents|mesh-ancestor
92860250|NCT04544436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860251|NCT04544436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860252|NCT04537156|Vaccines|vaccines|mesh-list
92860253|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
92860254|NCT04537156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860255|NCT04536298|Vitamin D|vitamin d|mesh-list
92860256|NCT04536298|Ergocalciferols|ergocalciferols|mesh-list
92860257|NCT04536298|Cholecalciferol|cholecalciferol|mesh-list
92860258|NCT04536298|Vitamins|vitamins|mesh-list
92860259|NCT04536298|Micronutrients|micronutrients|mesh-ancestor
92860260|NCT04536298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860261|NCT04536298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92860262|NCT04536298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92860263|NCT04465318|Nicotine|nicotine|mesh-list
92860264|NCT04465318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92860265|NCT04465318|Autonomic Agents|autonomic agents|mesh-ancestor
92860266|NCT04465318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860267|NCT04465318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860268|NCT04465318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92860269|NCT04465318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92860270|NCT04465318|Cholinergic Agents|cholinergic agents|mesh-ancestor
92860271|NCT04465318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860272|NCT04465318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860273|NCT04462523|Prednisolone|prednisolone|mesh-list
92860274|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860275|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
92860276|NCT04462523|Hormones|hormones|mesh-ancestor
92860277|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860278|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860279|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860280|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860281|NCT04437108|Solifenacin Succinate|solifenacin succinate|mesh-list
92860282|NCT04437108|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92860283|NCT04437108|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92860284|NCT04437108|Cholinergic Agents|cholinergic agents|mesh-ancestor
92860285|NCT04437108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860286|NCT04437108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860287|NCT04437108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860288|NCT04437108|Urological Agents|urological agents|mesh-ancestor
92860289|NCT04401761|Aspirin|aspirin|mesh-list
92860290|NCT04401761|Rivaroxaban|rivaroxaban|mesh-list
92860291|NCT04401761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92860292|NCT04401761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92860293|NCT04401761|Analgesics|analgesics|mesh-ancestor
92860294|NCT04401761|Sensory System Agents|sensory system agents|mesh-ancestor
92860295|NCT04401761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860296|NCT04401761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860297|NCT04401761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860298|NCT04401761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860299|NCT04401761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92860300|NCT04401761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92860301|NCT04401761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860302|NCT04401761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92860303|NCT04401761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92860304|NCT04401761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860305|NCT04401761|Antipyretics|antipyretics|mesh-ancestor
92860306|NCT04401761|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92860307|NCT04401761|Antithrombins|antithrombins|mesh-ancestor
92860308|NCT04401761|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92860309|NCT04401761|Protease Inhibitors|protease inhibitors|mesh-ancestor
92860310|NCT04401761|Anticoagulants|anticoagulants|mesh-ancestor
92860311|NCT04395079|Durvalumab|durvalumab|mesh-list
92860312|NCT04395079|Ipilimumab|ipilimumab|mesh-list
92860313|NCT04395079|Tremelimumab|tremelimumab|mesh-list
92860314|NCT04395079|Immunoglobulins|immunoglobulins|mesh-list
92860315|NCT04395079|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92860316|NCT04395079|Immunoglobulin G|immunoglobulin g|mesh-list
92860317|NCT04395079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860318|NCT04395079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860319|NCT04395079|Immunologic Factors|immunologic factors|mesh-ancestor
92860320|NCT04395079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860321|NCT04395079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860322|NCT04395079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860323|NCT04391309|Remdesivir|remdesivir|mesh-list
92860324|NCT04391309|Antimetabolites|antimetabolites|mesh-ancestor
92860325|NCT04391309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860326|NCT04391309|Antiviral Agents|antiviral agents|mesh-ancestor
92860327|NCT04391309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860328|NCT04381897|Acetylcysteine|acetylcysteine|mesh-list
92860329|NCT04381897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92860330|NCT04381897|Antiviral Agents|antiviral agents|mesh-ancestor
92860331|NCT04381897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860332|NCT04381897|Expectorants|expectorants|mesh-ancestor
92860333|NCT04381897|Respiratory System Agents|respiratory system agents|mesh-ancestor
92860334|NCT04381897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92860335|NCT04381897|Antioxidants|antioxidants|mesh-ancestor
92860336|NCT04381897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860337|NCT04381897|Protective Agents|protective agents|mesh-ancestor
92860338|NCT04381897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860339|NCT04381897|Antidotes|antidotes|mesh-ancestor
92860340|NCT04356690|Etoposide|etoposide|mesh-list
93026456|NCT00402285|Protective Agents|protective agents|mesh-ancestor
92860341|NCT04356690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860342|NCT04356690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860343|NCT04356690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92860344|NCT04356690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92860345|NCT04356690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860346|NCT04356690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860347|NCT04353661|Azithromycin|azithromycin|mesh-list
92860348|NCT04353661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860349|NCT04353661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860351|NCT04352205|Dexamethasone|dexamethasone|mesh-list
92860352|NCT04352205|Dexamethasone acetate|dexamethasone acetate|mesh-list
92860353|NCT04352205|Lenalidomide|lenalidomide|mesh-list
92860354|NCT04352205|Bortezomib|bortezomib|mesh-list
92860355|NCT04352205|Daratumumab|daratumumab|mesh-list
92860356|NCT04352205|Ichthammol|ichthammol|mesh-list
92860357|NCT04352205|BB 1101|bb 1101|mesh-list
92860358|NCT04352205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860359|NCT04352205|Antiemetics|antiemetics|mesh-ancestor
92860360|NCT04352205|Autonomic Agents|autonomic agents|mesh-ancestor
92860361|NCT04352205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860362|NCT04352205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860363|NCT04352205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860364|NCT04352205|Glucocorticoids|glucocorticoids|mesh-ancestor
92860365|NCT04352205|Hormones|hormones|mesh-ancestor
92860366|NCT04352205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860367|NCT04352205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860368|NCT04352205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860369|NCT04352205|Protease Inhibitors|protease inhibitors|mesh-ancestor
92860370|NCT04352205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860371|NCT04352205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860372|NCT04352205|Immunologic Factors|immunologic factors|mesh-ancestor
92860373|NCT04352205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92860374|NCT04352205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92860375|NCT04352205|Growth Substances|growth substances|mesh-ancestor
92860376|NCT04352205|Growth Inhibitors|growth inhibitors|mesh-ancestor
92860377|NCT04352205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860378|NCT04352205|Leprostatic Agents|leprostatic agents|mesh-ancestor
92860379|NCT04352205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860380|NCT04352205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860381|NCT04352205|Dermatologic Agents|dermatologic agents|mesh-ancestor
92860382|NCT04339140|Zafirlukast|zafirlukast|mesh-list
92860383|NCT04339140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92860384|NCT04339140|Respiratory System Agents|respiratory system agents|mesh-ancestor
92860385|NCT04339140|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92860386|NCT04339140|Hormone Antagonists|hormone antagonists|mesh-ancestor
92860387|NCT04339140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860388|NCT04339140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860389|NCT04337827|Rituximab|rituximab|mesh-list
92860390|NCT04337827|Acalabrutinib|acalabrutinib|mesh-list
92860391|NCT04337827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860392|NCT04337827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860393|NCT04337827|Immunologic Factors|immunologic factors|mesh-ancestor
92860394|NCT04337827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860395|NCT04337827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860396|NCT04308785|Atezolizumab|atezolizumab|mesh-list
92860397|NCT04308785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860398|NCT04308785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860399|NCT04308785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860400|NCT04308785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860401|NCT04266301|Azacitidine|azacitidine|mesh-list
92860402|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860403|NCT04266301|Antimetabolites|antimetabolites|mesh-ancestor
92860404|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860405|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860406|NCT04266301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860407|NCT04263922|Valsartan|valsartan|mesh-list
92860408|NCT04263922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92860409|NCT04263922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92860410|NCT04263922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92860411|NCT04263922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860412|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
92860413|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860414|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860415|NCT04251117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860416|NCT04251117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860417|NCT04249622|Rifaximin|rifaximin|mesh-list
92860418|NCT04249622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860419|NCT04249622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860420|NCT04249622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860422|NCT04246047|Bortezomib|bortezomib|mesh-list
92860423|NCT04246047|Daratumumab|daratumumab|mesh-list
92860424|NCT04246047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860425|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
92860426|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
92860427|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860428|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860429|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860430|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
92860431|NCT04246047|Hormones|hormones|mesh-ancestor
92860432|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860433|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860434|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860435|NCT04222062|Carmustine|carmustine|mesh-list
92860436|NCT04222062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860437|NCT04222062|Alkylating Agents|alkylating agents|mesh-ancestor
92860438|NCT04222062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860439|NCT04222062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860440|NCT04221529|Atezolizumab|atezolizumab|mesh-list
92860441|NCT04221529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860442|NCT04221529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860443|NCT04221529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860444|NCT04221529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860445|NCT04219774|Aspirin|aspirin|mesh-list
92860446|NCT04219774|Clopidogrel|clopidogrel|mesh-list
92860447|NCT04219774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92860448|NCT04219774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92860449|NCT04219774|Analgesics|analgesics|mesh-ancestor
92860450|NCT04219774|Sensory System Agents|sensory system agents|mesh-ancestor
92860451|NCT04219774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860452|NCT04219774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860453|NCT04219774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860454|NCT04219774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860455|NCT04219774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92860456|NCT04219774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92860457|NCT04219774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860458|NCT04219774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92860459|NCT04219774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92860460|NCT04219774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860461|NCT04219774|Antipyretics|antipyretics|mesh-ancestor
92860462|NCT04219774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92505603|NCT03834909|Tenofovir|tenofovir|mesh-list
92860463|NCT04219774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92860464|NCT04219774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92860465|NCT04219774|Purinergic Agents|purinergic agents|mesh-ancestor
92860466|NCT04219774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860467|NCT04218539|Psilocybin|psilocybin|mesh-list
92860468|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
92860469|NCT04218539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860470|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92860471|NCT04195139|Nivolumab|nivolumab|mesh-list
92860472|NCT04195139|Temozolomide|temozolomide|mesh-list
92860473|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860474|NCT04195139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860475|NCT04195139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860476|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860477|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860478|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
92860479|NCT04174352|Tamoxifen|tamoxifen|mesh-list
92860480|NCT04174352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92860481|NCT04174352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92860482|NCT04174352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860483|NCT04174352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860484|NCT04174352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860485|NCT04174352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860486|NCT04174352|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92860487|NCT04174352|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92860488|NCT04174352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92860489|NCT04150289|Panobinostat|panobinostat|mesh-list
92860490|NCT04150289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860491|NCT04150289|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92860492|NCT04150289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860493|NCT04150289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860494|NCT04136756|Rituximab|rituximab|mesh-list
92860495|NCT04136756|Daratumumab|daratumumab|mesh-list
92860496|NCT04136756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860497|NCT04136756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860498|NCT04136756|Immunologic Factors|immunologic factors|mesh-ancestor
92860499|NCT04136756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860500|NCT04136756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860501|NCT04123366|Pembrolizumab|pembrolizumab|mesh-list
92860502|NCT04123366|Olaparib|olaparib|mesh-list
92860503|NCT04123366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860504|NCT04123366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860505|NCT04123366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860506|NCT04123366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860507|NCT04123366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92860508|NCT04123366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860509|NCT04092270|Doxorubicin|doxorubicin|mesh-list
92860510|NCT04092270|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92860511|NCT04092270|Peposertib|peposertib|mesh-list
92860512|NCT04092270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92860513|NCT04092270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860514|NCT04092270|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92860515|NCT04092270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92860516|NCT04092270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860517|NCT04092270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860518|NCT04092270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92860519|NCT04056624|Carotenoids|carotenoids|mesh-list
92860520|NCT04056624|Antioxidants|antioxidants|mesh-ancestor
92860521|NCT04056624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860522|NCT04056624|Protective Agents|protective agents|mesh-ancestor
92860523|NCT04056624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860524|NCT04052880|Dexamethasone|dexamethasone|mesh-list
92860525|NCT04052880|Lenalidomide|lenalidomide|mesh-list
92860526|NCT04052880|Bortezomib|bortezomib|mesh-list
92860527|NCT04052880|Daratumumab|daratumumab|mesh-list
92860528|NCT04052880|Ixazomib|ixazomib|mesh-list
92860529|NCT04052880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860530|NCT04052880|Antiemetics|antiemetics|mesh-ancestor
92860531|NCT04052880|Autonomic Agents|autonomic agents|mesh-ancestor
92860532|NCT04052880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860533|NCT04052880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860534|NCT04052880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860535|NCT04052880|Glucocorticoids|glucocorticoids|mesh-ancestor
92860536|NCT04052880|Hormones|hormones|mesh-ancestor
92860537|NCT04052880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860538|NCT04052880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860539|NCT04052880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860540|NCT04052880|Immunologic Factors|immunologic factors|mesh-ancestor
92860541|NCT04052880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92860542|NCT04052880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92860543|NCT04052880|Growth Substances|growth substances|mesh-ancestor
92860544|NCT04052880|Growth Inhibitors|growth inhibitors|mesh-ancestor
92860545|NCT04052880|Protease Inhibitors|protease inhibitors|mesh-ancestor
92860546|NCT04052880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860547|NCT04052880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860548|NCT04007276|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92860549|NCT04007276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92860550|NCT04007276|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92860551|NCT04007276|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92860552|NCT04007276|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92860553|NCT04007276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92860554|NCT04007276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92860555|NCT04007276|Adrenergic Agents|adrenergic agents|mesh-ancestor
92860556|NCT04007276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860557|NCT04007276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860558|NCT04007276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860559|NCT03969446|Pembrolizumab|pembrolizumab|mesh-list
92860560|NCT03969446|Decitabine|decitabine|mesh-list
92860561|NCT03969446|Venetoclax|venetoclax|mesh-list
92860562|NCT03969446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860563|NCT03969446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860564|NCT03969446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860565|NCT03969446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860566|NCT03969446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860567|NCT03969446|Antimetabolites|antimetabolites|mesh-ancestor
92860568|NCT03969446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860569|NCT03927690|Ranibizumab|ranibizumab|mesh-list
92860570|NCT03927690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92860571|NCT03927690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92860572|NCT03927690|Growth Substances|growth substances|mesh-ancestor
92860573|NCT03927690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860574|NCT03927690|Growth Inhibitors|growth inhibitors|mesh-ancestor
92860575|NCT03927690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860576|NCT03900715|Luspatercept|luspatercept|mesh-list
92860577|NCT03900715|Hematinics|hematinics|mesh-ancestor
92860578|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92860579|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
92860580|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860581|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
92860582|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860583|NCT03858231|Acetaminophen|acetaminophen|mesh-list
92860584|NCT03858231|Ibuprofen|ibuprofen|mesh-list
92860585|NCT03858231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92860586|NCT03858231|Analgesics|analgesics|mesh-ancestor
92860587|NCT03858231|Sensory System Agents|sensory system agents|mesh-ancestor
92860588|NCT03858231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860589|NCT03858231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860590|NCT03858231|Antipyretics|antipyretics|mesh-ancestor
92860591|NCT03858231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92860592|NCT03858231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860593|NCT03858231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860594|NCT03858231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92860595|NCT03858231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860596|NCT03858231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860597|NCT03856515|Nicotine|nicotine|mesh-list
92860598|NCT03856515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92860599|NCT03856515|Autonomic Agents|autonomic agents|mesh-ancestor
92860600|NCT03856515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860601|NCT03856515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860602|NCT03856515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92860603|NCT03856515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92860604|NCT03856515|Cholinergic Agents|cholinergic agents|mesh-ancestor
92860605|NCT03856515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860606|NCT03856515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860607|NCT03853954|Methoxyflurane|methoxyflurane|mesh-list
92860608|NCT03853954|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92860609|NCT03853954|Anesthetics, General|anesthetics, general|mesh-ancestor
92860610|NCT03853954|Anesthetics|anesthetics|mesh-ancestor
92860611|NCT03853954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92860612|NCT03853954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860613|NCT03806985|Psilocybin|psilocybin|mesh-list
92860614|NCT03806985|Hallucinogens|hallucinogens|mesh-ancestor
92860615|NCT03806985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860616|NCT03806985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92860617|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
92860618|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860619|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
92860620|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860621|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860622|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92860623|NCT03742414|Fluticasone|fluticasone|mesh-list
92860624|NCT03742414|Xhance|xhance|mesh-list
92860625|NCT03742414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860626|NCT03742414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92860627|NCT03742414|Autonomic Agents|autonomic agents|mesh-ancestor
92860628|NCT03742414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860629|NCT03742414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525012|NCT00023530|Thalidomide|thalidomide|mesh-list
92860630|NCT03742414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92860631|NCT03742414|Respiratory System Agents|respiratory system agents|mesh-ancestor
92860632|NCT03742414|Dermatologic Agents|dermatologic agents|mesh-ancestor
92860633|NCT03742414|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92860634|NCT03728556|Antibodies|antibodies|mesh-list
92860635|NCT03728556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92860636|NCT03728556|Immunologic Factors|immunologic factors|mesh-ancestor
92860637|NCT03728556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860638|NCT03634228|Cytarabine|cytarabine|mesh-list
92860639|NCT03634228|Venetoclax|venetoclax|mesh-list
92860640|NCT03634228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860641|NCT03634228|Antimetabolites|antimetabolites|mesh-ancestor
92860642|NCT03634228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860643|NCT03634228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860644|NCT03634228|Antiviral Agents|antiviral agents|mesh-ancestor
92860645|NCT03634228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860646|NCT03634228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860647|NCT03634228|Immunologic Factors|immunologic factors|mesh-ancestor
92860648|NCT03634228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860649|NCT03612973|Insulin|insulin|mesh-list
92860650|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92860651|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860652|NCT03603223|Pembrolizumab|pembrolizumab|mesh-list
92860653|NCT03603223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860654|NCT03603223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860655|NCT03603223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860656|NCT03603223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860657|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
92860658|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
92860659|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860660|NCT03587142|Buspirone|buspirone|mesh-list
92860661|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92860662|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92860663|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92860664|NCT03587142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860665|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92860666|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92860667|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
92860668|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860669|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860670|NCT03535688|Cycloserine|cycloserine|mesh-list
92860671|NCT03535688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92860672|NCT03535688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860673|NCT03535688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92860674|NCT03535688|Antitubercular Agents|antitubercular agents|mesh-ancestor
92860675|NCT03535688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92860676|NCT03535688|Antimetabolites|antimetabolites|mesh-ancestor
92860677|NCT03535688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860678|NCT03532139|Enoxaparin|enoxaparin|mesh-list
92860679|NCT03532139|Enoxaparin sodium|enoxaparin sodium|mesh-list
92860680|NCT03532139|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92860681|NCT03532139|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92860682|NCT03532139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92860683|NCT03532139|Antimetabolites|antimetabolites|mesh-ancestor
92860684|NCT03532139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860685|NCT03532139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92860686|NCT03532139|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92860687|NCT03532139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505823|NCT02373813|Vitamins|vitamins|mesh-ancestor
92860688|NCT03532139|Anticoagulants|anticoagulants|mesh-ancestor
92860689|NCT03532139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92860690|NCT03532139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92860691|NCT03509584|Nivolumab|nivolumab|mesh-list
92860692|NCT03509584|Ipilimumab|ipilimumab|mesh-list
92860693|NCT03509584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860694|NCT03509584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860695|NCT03509584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860696|NCT03509584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860697|NCT03493854|Paclitaxel|paclitaxel|mesh-list
92860698|NCT03493854|Docetaxel|docetaxel|mesh-list
92860699|NCT03493854|Cyclophosphamide|cyclophosphamide|mesh-list
92860700|NCT03493854|Doxorubicin|doxorubicin|mesh-list
92860701|NCT03493854|Trastuzumab|trastuzumab|mesh-list
92860702|NCT03493854|Pertuzumab|pertuzumab|mesh-list
92860703|NCT03493854|Hormones|hormones|mesh-list
92860704|NCT03493854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860705|NCT03493854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860706|NCT03493854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92860707|NCT03493854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92860708|NCT03493854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92860709|NCT03493854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860710|NCT03493854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860711|NCT03493854|Immunologic Factors|immunologic factors|mesh-ancestor
92860712|NCT03493854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860713|NCT03493854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860714|NCT03493854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860715|NCT03493854|Alkylating Agents|alkylating agents|mesh-ancestor
92860716|NCT03493854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92860717|NCT03493854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92860718|NCT03493854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92860719|NCT03493854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92860720|NCT03493854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860721|NCT03493854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860722|NCT03493854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860723|NCT03390686|Paclitaxel|paclitaxel|mesh-list
92860724|NCT03390686|Bevacizumab|bevacizumab|mesh-list
92860725|NCT03390686|Carboplatin|carboplatin|mesh-list
92860726|NCT03390686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860727|NCT03390686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860728|NCT03390686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92860729|NCT03390686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92860730|NCT03390686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92860731|NCT03390686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860732|NCT03390686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860733|NCT03390686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92860734|NCT03390686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92860735|NCT03390686|Growth Substances|growth substances|mesh-ancestor
92860736|NCT03390686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860737|NCT03390686|Growth Inhibitors|growth inhibitors|mesh-ancestor
92860738|NCT03384277|Cyclophosphamide|cyclophosphamide|mesh-list
92860739|NCT03384277|Rituximab|rituximab|mesh-list
92860740|NCT03384277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860741|NCT03384277|Immunologic Factors|immunologic factors|mesh-ancestor
92860742|NCT03384277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860743|NCT03384277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860744|NCT03384277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860745|NCT03384277|Alkylating Agents|alkylating agents|mesh-ancestor
92860746|NCT03384277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860747|NCT03384277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860748|NCT03384277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92860749|NCT03384277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860750|NCT03370367|Tretinoin|tretinoin|mesh-list
92860751|NCT03370367|Isotretinoin|isotretinoin|mesh-list
92860752|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860753|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
92860754|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
92860755|NCT03341689|Psilocybin|psilocybin|mesh-list
92860756|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
92860757|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860758|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92860759|NCT03324425|Simvastatin|simvastatin|mesh-list
92860760|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92860761|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92860762|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
92860763|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860764|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92860765|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92860767|NCT03317457|Doxorubicin|doxorubicin|mesh-list
92860768|NCT03317457|Durvalumab|durvalumab|mesh-list
92860769|NCT03317457|Tremelimumab|tremelimumab|mesh-list
92860770|NCT03317457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92860771|NCT03317457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860772|NCT03317457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92860773|NCT03317457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92860774|NCT03317457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860775|NCT03317457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860776|NCT03317457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860778|NCT03267836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860779|NCT03267836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860780|NCT03197506|Pembrolizumab|pembrolizumab|mesh-list
92860781|NCT03197506|Temozolomide|temozolomide|mesh-list
92860782|NCT03197506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860783|NCT03197506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860784|NCT03197506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860785|NCT03197506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860786|NCT03197506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860787|NCT03197506|Alkylating Agents|alkylating agents|mesh-ancestor
92860788|NCT03188705|Aspirin|aspirin|mesh-list
92860789|NCT03188705|Clopidogrel|clopidogrel|mesh-list
92860790|NCT03188705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92860791|NCT03188705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92860792|NCT03188705|Analgesics|analgesics|mesh-ancestor
92860793|NCT03188705|Sensory System Agents|sensory system agents|mesh-ancestor
92860794|NCT03188705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92860795|NCT03188705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860796|NCT03188705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860797|NCT03188705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860798|NCT03188705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92860799|NCT03188705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92860800|NCT03188705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860801|NCT03188705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92860802|NCT03188705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92860803|NCT03188705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860804|NCT03188705|Antipyretics|antipyretics|mesh-ancestor
92860805|NCT03188705|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92860806|NCT03188705|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92860807|NCT03188705|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92860808|NCT03188705|Purinergic Agents|purinergic agents|mesh-ancestor
92860809|NCT03188705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92860810|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
92860811|NCT03113487|Vaccines|vaccines|mesh-list
92860812|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
92860813|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860814|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860815|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860816|NCT03113487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860817|NCT03113487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860818|NCT03072238|Prednisone|prednisone|mesh-list
92860819|NCT03072238|Prednisolone|prednisolone|mesh-list
92860820|NCT03072238|Ipatasertib|ipatasertib|mesh-list
92860821|NCT03072238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860822|NCT03072238|Glucocorticoids|glucocorticoids|mesh-ancestor
92860823|NCT03072238|Hormones|hormones|mesh-ancestor
92860824|NCT03072238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860825|NCT03072238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860826|NCT03072238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860827|NCT03072238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860828|NCT03072238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92860829|NCT03072238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860830|NCT03072238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860831|NCT03032484|Bevacizumab|bevacizumab|mesh-list
92860832|NCT03032484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860833|NCT03032484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860834|NCT03032484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92860835|NCT03032484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92860836|NCT03032484|Growth Substances|growth substances|mesh-ancestor
92860837|NCT03032484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860838|NCT03032484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92860839|NCT03003546|Paclitaxel|paclitaxel|mesh-list
92860840|NCT03003546|Rituximab|rituximab|mesh-list
92860841|NCT03003546|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92860842|NCT03003546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860843|NCT03003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860844|NCT03003546|Tubulin Modulators|tubulin modulators|mesh-ancestor
92860845|NCT03003546|Antimitotic Agents|antimitotic agents|mesh-ancestor
92860846|NCT03003546|Mitosis Modulators|mitosis modulators|mesh-ancestor
92860847|NCT03003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860848|NCT03003546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860849|NCT03003546|Immunologic Factors|immunologic factors|mesh-ancestor
92860850|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860851|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860852|NCT02996825|Gemcitabine|gemcitabine|mesh-list
92860853|NCT02996825|Maytansine|maytansine|mesh-list
92860854|NCT02996825|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92860855|NCT02996825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92860856|NCT02996825|Antimetabolites|antimetabolites|mesh-ancestor
92860857|NCT02996825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860858|NCT02996825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860859|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860860|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92860861|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92860862|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92860863|NCT02996825|Immunoconjugates|immunoconjugates|mesh-ancestor
92860864|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
92860865|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860866|NCT02981173|Psilocybin|psilocybin|mesh-list
92860867|NCT02981173|Hallucinogens|hallucinogens|mesh-ancestor
92860868|NCT02981173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860869|NCT02981173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92860870|NCT02975349|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92860871|NCT02975349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92860872|NCT02975349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860873|NCT02975349|Immunologic Factors|immunologic factors|mesh-ancestor
92860874|NCT02975349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860875|NCT02955394|Fulvestrant|fulvestrant|mesh-list
92860876|NCT02955394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92860877|NCT02955394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860878|NCT02955394|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92860879|NCT02955394|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92860880|NCT02955394|Hormone Antagonists|hormone antagonists|mesh-ancestor
92860881|NCT02955394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92860882|NCT02955394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860883|NCT02864953|Glyburide|glyburide|mesh-list
92860884|NCT02864953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92860885|NCT02864953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860886|NCT02780583|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92860887|NCT02780583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860888|NCT02768532|Vedolizumab|vedolizumab|mesh-list
92860889|NCT02768532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860890|NCT02710851|Vaccines|vaccines|mesh-list
92860891|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
92860892|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860893|NCT02675829|Trastuzumab|trastuzumab|mesh-list
92860894|NCT02675829|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92860895|NCT02675829|Maytansine|maytansine|mesh-list
92860896|NCT02675829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860897|NCT02675829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860898|NCT02675829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860899|NCT02675829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92860900|NCT02675829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92860901|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92860902|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860903|NCT02675829|Immunotoxins|immunotoxins|mesh-ancestor
92860904|NCT02675829|Immunoconjugates|immunoconjugates|mesh-ancestor
92860905|NCT02675829|Immunologic Factors|immunologic factors|mesh-ancestor
92860906|NCT02675829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860907|NCT02588651|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92860908|NCT02588651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860909|NCT02588651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860910|NCT02588651|Immunotoxins|immunotoxins|mesh-ancestor
92506051|NCT00006126|Busulfan|busulfan|mesh-list
92860911|NCT02588651|Immunoconjugates|immunoconjugates|mesh-ancestor
92860912|NCT02588651|Immunologic Factors|immunologic factors|mesh-ancestor
92860913|NCT02588651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860915|NCT02554851|Mitosis Modulators|mitosis modulators|mesh-ancestor
92860916|NCT02554851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860917|NCT02520141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92860918|NCT02520141|Ramucirumab|ramucirumab|mesh-list
92860919|NCT02520141|Antibodies|antibodies|mesh-list
92860920|NCT02520141|Immunoglobulins|immunoglobulins|mesh-list
92860921|NCT02520141|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92860922|NCT02520141|Lexatumumab|lexatumumab|mesh-list
92860923|NCT02520141|Immunologic Factors|immunologic factors|mesh-ancestor
92860924|NCT02520141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860925|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860926|NCT02513875|Vitamin D|vitamin d|mesh-list
92860927|NCT02513875|Vitamins|vitamins|mesh-ancestor
92860928|NCT02513875|Micronutrients|micronutrients|mesh-ancestor
92860929|NCT02513875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860930|NCT02513875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92860931|NCT02513394|Palbociclib|palbociclib|mesh-list
92860932|NCT02513394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860933|NCT02513394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92860934|NCT02513394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860935|NCT02513394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860936|NCT02329847|Nivolumab|nivolumab|mesh-list
92860937|NCT02329847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860938|NCT02329847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860939|NCT02329847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860940|NCT02329847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860941|NCT02287428|Pembrolizumab|pembrolizumab|mesh-list
92860942|NCT02287428|Temozolomide|temozolomide|mesh-list
92860943|NCT02287428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92860944|NCT02287428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860945|NCT02287428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92860946|NCT02287428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860947|NCT02287428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860948|NCT02287428|Alkylating Agents|alkylating agents|mesh-ancestor
92860949|NCT02286687|Talazoparib|talazoparib|mesh-list
92860950|NCT02286687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92860951|NCT02286687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860952|NCT02286687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860953|NCT02286687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860954|NCT02255227|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92860955|NCT02255227|Immunologic Factors|immunologic factors|mesh-ancestor
92860956|NCT02255227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860957|NCT02192359|Irinotecan|irinotecan|mesh-list
92860958|NCT02192359|Camptothecin|camptothecin|mesh-list
92860959|NCT02192359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92860960|NCT02192359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92860961|NCT02192359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860962|NCT02192359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860963|NCT02192359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860964|NCT02192359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92860965|NCT02145143|Vemurafenib|vemurafenib|mesh-list
92860966|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860967|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92860968|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92860969|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860970|NCT02133196|Aldesleukin|aldesleukin|mesh-list
92860971|NCT02133196|Cyclophosphamide|cyclophosphamide|mesh-list
92860972|NCT02133196|Fludarabine|fludarabine|mesh-list
92860973|NCT02133196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92860974|NCT02133196|Immunologic Factors|immunologic factors|mesh-ancestor
92860975|NCT02133196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860976|NCT02133196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92860977|NCT02133196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92860978|NCT02133196|Alkylating Agents|alkylating agents|mesh-ancestor
92860979|NCT02133196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92860980|NCT02133196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92860981|NCT02133196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92860983|NCT02133196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92860984|NCT02133196|Antiviral Agents|antiviral agents|mesh-ancestor
92860985|NCT02133196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92860987|NCT02119468|Pomalidomide|pomalidomide|mesh-list
92860988|NCT02119468|Ixazomib|ixazomib|mesh-list
92860989|NCT02119468|Glycine|glycine|mesh-list
92860990|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92860991|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92860992|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
92860993|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
92860994|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161425|NCT01679795|Tibolone|tibolone|mesh-list
92860995|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92860996|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92860997|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
92860998|NCT02119468|Hormones|hormones|mesh-ancestor
92860999|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861000|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861001|NCT02119468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861002|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861003|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
92861004|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861005|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861006|NCT02119468|Growth Substances|growth substances|mesh-ancestor
92861007|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861008|NCT02119468|Protease Inhibitors|protease inhibitors|mesh-ancestor
92861009|NCT02119468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861010|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
92861011|NCT02119468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861012|NCT02017717|Bevacizumab|bevacizumab|mesh-list
92861013|NCT02017717|Nivolumab|nivolumab|mesh-list
92861014|NCT02017717|Ipilimumab|ipilimumab|mesh-list
92861015|NCT02017717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92861016|NCT02017717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861017|NCT02017717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861018|NCT02017717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861019|NCT02017717|Growth Substances|growth substances|mesh-ancestor
92861020|NCT02017717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861021|NCT02017717|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861022|NCT02017717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92861023|NCT02017717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861024|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92861025|NCT01935921|Cetuximab|cetuximab|mesh-list
92861026|NCT01935921|Ipilimumab|ipilimumab|mesh-list
92861027|NCT01935921|Antibodies|antibodies|mesh-list
92861028|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
92861029|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92861030|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
92861031|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861032|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861033|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92861034|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861035|NCT01863550|Dexamethasone|dexamethasone|mesh-list
92861036|NCT01863550|Dexamethasone acetate|dexamethasone acetate|mesh-list
92861037|NCT01863550|Lenalidomide|lenalidomide|mesh-list
92861038|NCT01863550|Bortezomib|bortezomib|mesh-list
92861039|NCT01863550|Ichthammol|ichthammol|mesh-list
92861040|NCT01863550|BB 1101|bb 1101|mesh-list
92861041|NCT01863550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861042|NCT01863550|Antiemetics|antiemetics|mesh-ancestor
92861043|NCT01863550|Autonomic Agents|autonomic agents|mesh-ancestor
92861044|NCT01863550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861045|NCT01863550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861046|NCT01863550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92861047|NCT01863550|Glucocorticoids|glucocorticoids|mesh-ancestor
92861048|NCT01863550|Hormones|hormones|mesh-ancestor
92525046|NCT00000176|Progesterone|progesterone|mesh-list
92861049|NCT01863550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861050|NCT01863550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861051|NCT01863550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861052|NCT01863550|Immunologic Factors|immunologic factors|mesh-ancestor
92861053|NCT01863550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861054|NCT01863550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861055|NCT01863550|Growth Substances|growth substances|mesh-ancestor
92861056|NCT01863550|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861057|NCT01863550|Protease Inhibitors|protease inhibitors|mesh-ancestor
92861058|NCT01863550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861059|NCT01863550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861060|NCT01863550|Dermatologic Agents|dermatologic agents|mesh-ancestor
92861061|NCT01824836|Anastrozole|anastrozole|mesh-list
92861062|NCT01824836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861063|NCT01824836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861064|NCT01824836|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92861065|NCT01824836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92861066|NCT01824836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861067|NCT01824836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861068|NCT01824836|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92861069|NCT01824836|Hormone Antagonists|hormone antagonists|mesh-ancestor
92861070|NCT01824836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861071|NCT01824836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861072|NCT01552434|Sirolimus|sirolimus|mesh-list
92861073|NCT01552434|Bevacizumab|bevacizumab|mesh-list
92861074|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92861075|NCT01552434|Cetuximab|cetuximab|mesh-list
92861076|NCT01552434|Temsirolimus|temsirolimus|mesh-list
92861077|NCT01552434|MTOR Inhibitors|mtor inhibitors|mesh-list
92861078|NCT01552434|Valproic Acid|valproic acid|mesh-list
92861079|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
92861080|NCT01552434|Antibodies|antibodies|mesh-list
92861081|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
92861082|NCT01552434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92861083|NCT01552434|Immunoglobulin G|immunoglobulin g|mesh-list
92861084|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861085|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861086|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861087|NCT01552434|Growth Substances|growth substances|mesh-ancestor
92861088|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861089|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861090|NCT01552434|Immunologic Factors|immunologic factors|mesh-ancestor
92861091|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92861092|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861093|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92861094|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
92861095|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861096|NCT01552434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92861097|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861098|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861099|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
92861100|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
92861101|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861102|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
92861103|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92861104|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861105|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92861106|NCT01415752|Rituximab|rituximab|mesh-list
92861107|NCT01415752|Lenalidomide|lenalidomide|mesh-list
92861108|NCT01415752|Bortezomib|bortezomib|mesh-list
92861109|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92861110|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92861111|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861112|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
92861113|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861114|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861115|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861116|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861117|NCT01415752|Growth Substances|growth substances|mesh-ancestor
92861118|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861119|NCT01415752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861120|NCT01415752|Alkylating Agents|alkylating agents|mesh-ancestor
92861121|NCT01415752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861122|NCT01164228|Gemcitabine|gemcitabine|mesh-list
92861123|NCT01164228|Sunitinib|sunitinib|mesh-list
92861124|NCT01164228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861125|NCT01164228|Antimetabolites|antimetabolites|mesh-ancestor
92861126|NCT01164228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861127|NCT01164228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861128|NCT01164228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861129|NCT01164228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861130|NCT01164228|Growth Substances|growth substances|mesh-ancestor
92861131|NCT01164228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861132|NCT01164228|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861133|NCT01164228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92861134|NCT01164228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861135|NCT00950846|Cyclophosphamide|cyclophosphamide|mesh-list
92861136|NCT00950846|Busulfan|busulfan|mesh-list
92861137|NCT00950846|Fludarabine|fludarabine|mesh-list
92861138|NCT00950846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506276|NCT00006249|Antiviral Agents|antiviral agents|mesh-ancestor
92156373|NCT02083679|Paclitaxel|paclitaxel|mesh-list
92861139|NCT00950846|Immunologic Factors|immunologic factors|mesh-ancestor
92861140|NCT00950846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861141|NCT00950846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861142|NCT00950846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861143|NCT00950846|Alkylating Agents|alkylating agents|mesh-ancestor
92861144|NCT00950846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861145|NCT00950846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861146|NCT00950846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92861147|NCT00923013|Rituximab|rituximab|mesh-list
92861148|NCT00923013|Cladribine|cladribine|mesh-list
92861149|NCT00923013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92861150|NCT00923013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861151|NCT00923013|Immunologic Factors|immunologic factors|mesh-ancestor
92861152|NCT00923013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861153|NCT00923013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861154|NCT00923013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861155|NCT00641030|Melphalan|melphalan|mesh-list
92861156|NCT00641030|Clofarabine|clofarabine|mesh-list
92861157|NCT00641030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861158|NCT00641030|Alkylating Agents|alkylating agents|mesh-ancestor
92861159|NCT00641030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861160|NCT00641030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861161|NCT00641030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92861162|NCT00641030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861163|NCT00641030|Immunologic Factors|immunologic factors|mesh-ancestor
92861164|NCT00641030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861165|NCT00641030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861166|NCT00641030|Antimetabolites|antimetabolites|mesh-ancestor
92861167|NCT00554515|Aldesleukin|aldesleukin|mesh-list
92861168|NCT00554515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861169|NCT00554515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92861170|NCT00554515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92861171|NCT00554515|Antiviral Agents|antiviral agents|mesh-ancestor
92861172|NCT00554515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861173|NCT00329043|Sunitinib|sunitinib|mesh-list
92861174|NCT00329043|Leuprolide|leuprolide|mesh-list
92861175|NCT00329043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861176|NCT00329043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861177|NCT00329043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861178|NCT00329043|Growth Substances|growth substances|mesh-ancestor
92861179|NCT00329043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861180|NCT00329043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861181|NCT00329043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92861182|NCT00329043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861183|NCT00329043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861184|NCT00329043|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92861185|NCT00329043|Fertility Agents|fertility agents|mesh-ancestor
92861186|NCT00329043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861187|NCT00329043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861188|NCT00209586|Fospropofol|fospropofol|mesh-list
92861189|NCT00209586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92861190|NCT00209586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861191|NCT00209586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861192|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92861193|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861194|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861195|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861196|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92861198|NCT00082797|Methotrexate|methotrexate|mesh-list
92861199|NCT00082797|Calcium|calcium|mesh-list
92861200|NCT00082797|Levoleucovorin|levoleucovorin|mesh-list
92861201|NCT00082797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92861202|NCT00082797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861203|NCT00082797|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92861204|NCT00082797|Abortifacient Agents|abortifacient agents|mesh-ancestor
92861205|NCT00082797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861206|NCT00082797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861207|NCT00082797|Antimetabolites|antimetabolites|mesh-ancestor
92861208|NCT00082797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861209|NCT00082797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861210|NCT00082797|Dermatologic Agents|dermatologic agents|mesh-ancestor
92861211|NCT00082797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861212|NCT00082797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92861213|NCT00082797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861214|NCT00082797|Immunologic Factors|immunologic factors|mesh-ancestor
92861215|NCT00082797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861216|NCT00082797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92861217|NCT00082797|Antidotes|antidotes|mesh-ancestor
92861218|NCT00082797|Protective Agents|protective agents|mesh-ancestor
92861219|NCT00082797|Vitamin B Complex|vitamin b complex|mesh-ancestor
92861220|NCT00082797|Vitamins|vitamins|mesh-ancestor
92861221|NCT00082797|Micronutrients|micronutrients|mesh-ancestor
92861222|NCT00060398|Dexamethasone|dexamethasone|mesh-list
92861223|NCT00060398|Epoetin Alfa|epoetin alfa|mesh-list
92861224|NCT00060398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861225|NCT00060398|Antiemetics|antiemetics|mesh-ancestor
92861226|NCT00060398|Autonomic Agents|autonomic agents|mesh-ancestor
92861227|NCT00060398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861228|NCT00060398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861229|NCT00060398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92861230|NCT00060398|Glucocorticoids|glucocorticoids|mesh-ancestor
92861231|NCT00060398|Hormones|hormones|mesh-ancestor
92861232|NCT00060398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861233|NCT00060398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861234|NCT00060398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861235|NCT00060398|Hematinics|hematinics|mesh-ancestor
92861236|NCT00054561|Vitamin E|vitamin e|mesh-list
92861237|NCT00054561|Interferons|interferons|mesh-list
92861238|NCT00054561|Interferon-alpha|interferon-alpha|mesh-list
92861239|NCT00054561|Isotretinoin|isotretinoin|mesh-list
92861240|NCT00054561|Vitamins|vitamins|mesh-ancestor
92861241|NCT00054561|Micronutrients|micronutrients|mesh-ancestor
92861242|NCT00054561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861243|NCT00054561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861244|NCT00054561|Antiviral Agents|antiviral agents|mesh-ancestor
92861245|NCT00054561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861246|NCT00054561|Immunologic Factors|immunologic factors|mesh-ancestor
92861247|NCT00054561|Antioxidants|antioxidants|mesh-ancestor
92861248|NCT00054561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861249|NCT00054561|Protective Agents|protective agents|mesh-ancestor
92861250|NCT00054561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92861251|NCT00049517|Cytarabine|cytarabine|mesh-list
92861252|NCT00049517|Cyclophosphamide|cyclophosphamide|mesh-list
92861253|NCT00049517|Busulfan|busulfan|mesh-list
92861254|NCT00049517|Daunorubicin|daunorubicin|mesh-list
92861255|NCT00049517|Gemtuzumab|gemtuzumab|mesh-list
92861256|NCT00049517|Sargramostim|sargramostim|mesh-list
92861257|NCT00049517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861258|NCT00049517|Immunologic Factors|immunologic factors|mesh-ancestor
92861259|NCT00049517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861260|NCT00049517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861261|NCT00049517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861262|NCT00049517|Alkylating Agents|alkylating agents|mesh-ancestor
92861263|NCT00049517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861264|NCT00049517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861265|NCT00049517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92861266|NCT00049517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861267|NCT00049517|Antimetabolites|antimetabolites|mesh-ancestor
92861268|NCT00049517|Antiviral Agents|antiviral agents|mesh-ancestor
92861269|NCT00049517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861270|NCT00049517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92861271|NCT00049517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92861272|NCT00049517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92861273|NCT00049517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861274|NCT00049517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92861275|NCT00049517|Immunotoxins|immunotoxins|mesh-ancestor
92861276|NCT00049517|Immunoconjugates|immunoconjugates|mesh-ancestor
92861277|NCT00041314|Sulindac sulfone|sulindac sulfone|mesh-list
92861278|NCT00041314|Carboplatin|carboplatin|mesh-list
92861279|NCT00041314|Gemcitabine|gemcitabine|mesh-list
92861280|NCT00041314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861281|NCT00041314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861282|NCT00041314|Antimetabolites|antimetabolites|mesh-ancestor
92861283|NCT00041314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861284|NCT00041314|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92861285|NCT00041314|Protective Agents|protective agents|mesh-ancestor
92861286|NCT00041314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861287|NCT00041314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92861288|NCT00041314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861289|NCT00041314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92861290|NCT00041314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92861291|NCT00041314|Analgesics|analgesics|mesh-ancestor
92861292|NCT00041314|Sensory System Agents|sensory system agents|mesh-ancestor
92861293|NCT00041314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861294|NCT00041314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861295|NCT00041314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861296|NCT00028990|Paclitaxel|paclitaxel|mesh-list
92861297|NCT00028990|Bevacizumab|bevacizumab|mesh-list
92861298|NCT00028990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861299|NCT00028990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861300|NCT00028990|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861301|NCT00028990|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861302|NCT00028990|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861303|NCT00028990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861304|NCT00028990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92861305|NCT00028990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861306|NCT00028990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861307|NCT00028990|Growth Substances|growth substances|mesh-ancestor
92861308|NCT00028990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861309|NCT00028990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861310|NCT00027859|Ketoconazole|ketoconazole|mesh-list
92861311|NCT00027859|Hydrocortisone|hydrocortisone|mesh-list
92861312|NCT00027859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92861313|NCT00027859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92861314|NCT00027859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92861315|NCT00027859|Docetaxel|docetaxel|mesh-list
92861316|NCT00027859|Estramustine|estramustine|mesh-list
92861317|NCT00027859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861318|NCT00027859|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861319|NCT00027859|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861320|NCT00027859|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861321|NCT00027859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861322|NCT00027859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861323|NCT00027859|Antifungal Agents|antifungal agents|mesh-ancestor
92861324|NCT00027859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861325|NCT00027859|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92861326|NCT00027859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92861327|NCT00027859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861328|NCT00027859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92861329|NCT00027859|Hormone Antagonists|hormone antagonists|mesh-ancestor
92861330|NCT00027859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861331|NCT00027859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861332|NCT00027859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92861333|NCT00027859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861334|NCT00027859|Alkylating Agents|alkylating agents|mesh-ancestor
92861335|NCT00027859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861336|NCT00026286|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92861337|NCT00026286|Medroxyprogesterone|medroxyprogesterone|mesh-list
92861339|NCT00026286|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92861340|NCT00026286|Hormones|hormones|mesh-ancestor
92861341|NCT00026286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861342|NCT00026286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861343|NCT00026286|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92861344|NCT00026286|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92861345|NCT00026286|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92861346|NCT00026286|Contraceptive Agents|contraceptive agents|mesh-ancestor
92861347|NCT00026286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861348|NCT00026286|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92861349|NCT00026286|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92861350|NCT00026286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92861351|NCT00026286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861352|NCT00026286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861353|NCT00014118|Paclitaxel|paclitaxel|mesh-list
92861354|NCT00014118|Carboplatin|carboplatin|mesh-list
92861355|NCT00014118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861356|NCT00014118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861357|NCT00014118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861358|NCT00014118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861359|NCT00014118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861360|NCT00014118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861361|NCT00006004|Paclitaxel|paclitaxel|mesh-list
92861362|NCT00006004|Carboplatin|carboplatin|mesh-list
92861363|NCT00006004|Gemcitabine|gemcitabine|mesh-list
92861364|NCT00006004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861365|NCT00006004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861366|NCT00006004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861367|NCT00006004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861368|NCT00006004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861369|NCT00006004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861370|NCT00006004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861371|NCT00006004|Antimetabolites|antimetabolites|mesh-ancestor
92861372|NCT00004860|Leucovorin|leucovorin|mesh-list
92861373|NCT00004860|Tegafur|tegafur|mesh-list
92861374|NCT00004860|Calcium|calcium|mesh-list
92861375|NCT00004860|Levoleucovorin|levoleucovorin|mesh-list
92861376|NCT00004860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92861377|NCT00004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861378|NCT00004860|Antidotes|antidotes|mesh-ancestor
92861379|NCT00004860|Protective Agents|protective agents|mesh-ancestor
92861380|NCT00004860|Vitamin B Complex|vitamin b complex|mesh-ancestor
92861381|NCT00004860|Vitamins|vitamins|mesh-ancestor
92861382|NCT00004860|Micronutrients|micronutrients|mesh-ancestor
92861383|NCT00004860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861384|NCT00004860|Antimetabolites|antimetabolites|mesh-ancestor
92861385|NCT00004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861386|NCT00004860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861387|NCT00003864|Carboplatin|carboplatin|mesh-list
92861388|NCT00003864|Docetaxel|docetaxel|mesh-list
92861389|NCT00003864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861390|NCT00003864|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861391|NCT00003864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861392|NCT00003864|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861393|NCT00003864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861394|NCT00003810|Gemcitabine|gemcitabine|mesh-list
92861395|NCT00003810|Docetaxel|docetaxel|mesh-list
92861396|NCT00003810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861397|NCT00003810|Antimetabolites|antimetabolites|mesh-ancestor
92861398|NCT00003810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861399|NCT00003810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861400|NCT00003810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861401|NCT00003810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861402|NCT00003810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861403|NCT00003701|Paclitaxel|paclitaxel|mesh-list
92861404|NCT00003701|Vinblastine|vinblastine|mesh-list
92861405|NCT00003701|Carboplatin|carboplatin|mesh-list
92861406|NCT00003701|Doxorubicin|doxorubicin|mesh-list
92861407|NCT00003701|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92861408|NCT00003701|Methotrexate|methotrexate|mesh-list
92861409|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861410|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861411|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861412|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861413|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861414|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861415|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92861416|NCT00003701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92861417|NCT00003701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92861418|NCT00003701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861419|NCT00003701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92861420|NCT00003701|Abortifacient Agents|abortifacient agents|mesh-ancestor
92861421|NCT00003701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861422|NCT00003701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861423|NCT00003701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92861424|NCT00003701|Antimetabolites|antimetabolites|mesh-ancestor
92861425|NCT00003701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92861426|NCT00003701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92861427|NCT00003701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861428|NCT00003701|Immunologic Factors|immunologic factors|mesh-ancestor
92861429|NCT00003701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861430|NCT00003701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92861431|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
92861432|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861433|NCT00003614|Paclitaxel|paclitaxel|mesh-list
92861434|NCT00003614|Estramustine|estramustine|mesh-list
92861435|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861436|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861437|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861438|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861439|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861440|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861441|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861442|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
92861443|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861445|NCT00003519|Docetaxel|docetaxel|mesh-list
92861446|NCT00003519|Doxorubicin|doxorubicin|mesh-list
92861447|NCT00003519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92861448|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861449|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
92861450|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861451|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861452|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92861453|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
92861454|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861455|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861456|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92861457|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861458|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861459|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861460|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92861461|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92861462|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92861463|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861464|NCT00003283|Prednisone|prednisone|mesh-list
92861465|NCT00003283|Octreotide|octreotide|mesh-list
92861466|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861467|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
92861468|NCT00003283|Hormones|hormones|mesh-ancestor
92861469|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861470|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861471|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861472|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861473|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92861474|NCT00003235|Paclitaxel|paclitaxel|mesh-list
92861475|NCT00003235|Carboplatin|carboplatin|mesh-list
92861476|NCT00003235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861477|NCT00003235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861478|NCT00003235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861479|NCT00003235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861480|NCT00003235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861481|NCT00003235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861482|NCT00003206|Paclitaxel|paclitaxel|mesh-list
92861483|NCT00003206|Carboplatin|carboplatin|mesh-list
92861484|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861485|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861486|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861487|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861488|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861489|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861490|NCT00003010|Marimastat|marimastat|mesh-list
92861491|NCT00003010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861492|NCT00003010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861493|NCT00003008|Ritonavir|ritonavir|mesh-list
92861494|NCT00003008|Nelfinavir|nelfinavir|mesh-list
92861495|NCT00003008|Indinavir|indinavir|mesh-list
92861496|NCT00003008|Saquinavir|saquinavir|mesh-list
92861497|NCT00003008|Paclitaxel|paclitaxel|mesh-list
92861498|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861499|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861500|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861501|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861502|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861503|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861504|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92861505|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92861506|NCT00003008|Protease Inhibitors|protease inhibitors|mesh-ancestor
92861507|NCT00003008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861508|NCT00003008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92861509|NCT00003008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92861510|NCT00003008|Antiviral Agents|antiviral agents|mesh-ancestor
92861511|NCT00003008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861512|NCT00003008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92861513|NCT00003008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92861514|NCT00002996|Flecainide|flecainide|mesh-list
92861515|NCT00002996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92861516|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92861517|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92506654|NCT00005878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861518|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92861519|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861520|NCT00002878|Dexamethasone|dexamethasone|mesh-list
92861521|NCT00002878|Doxorubicin|doxorubicin|mesh-list
92861522|NCT00002878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92861523|NCT00002878|Vincristine|vincristine|mesh-list
92861524|NCT00002878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861525|NCT00002878|Antiemetics|antiemetics|mesh-ancestor
92861526|NCT00002878|Autonomic Agents|autonomic agents|mesh-ancestor
92861527|NCT00002878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861528|NCT00002878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861529|NCT00002878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92861530|NCT00002878|Glucocorticoids|glucocorticoids|mesh-ancestor
92861531|NCT00002878|Hormones|hormones|mesh-ancestor
92861532|NCT00002878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525086|NCT00391404|Alendronate|alendronate|mesh-list
92861533|NCT00002878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861534|NCT00002878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861535|NCT00002878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92861536|NCT00002878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92861537|NCT00002878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92861538|NCT00002878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861539|NCT00002878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861540|NCT00002878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861541|NCT00002878|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861542|NCT00002878|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861543|NCT00002878|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861544|NCT00002632|Paclitaxel|paclitaxel|mesh-list
92861545|NCT00002632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92861546|NCT00002632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861547|NCT00002632|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861548|NCT00002632|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861549|NCT00002632|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861550|NCT00002632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861551|NCT00002520|Nicotine|nicotine|mesh-list
92861552|NCT00002520|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92861553|NCT00002520|Autonomic Agents|autonomic agents|mesh-ancestor
92861554|NCT00002520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861555|NCT00002520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861556|NCT00002520|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92861557|NCT00002520|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92861558|NCT00002520|Cholinergic Agents|cholinergic agents|mesh-ancestor
92861559|NCT00002520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861560|NCT00002520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861561|NCT00609557|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92861562|NCT00609557|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92861563|NCT00609557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92861564|NCT00609557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92861565|NCT00609557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861566|NCT00609557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861567|NCT00609557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861568|NCT00609557|Analgesics|analgesics|mesh-ancestor
92861569|NCT00609557|Sensory System Agents|sensory system agents|mesh-ancestor
92861570|NCT00609557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861571|NCT00609557|Antidepressive Agents|antidepressive agents|mesh-ancestor
92861572|NCT00609557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92861573|NCT00609557|Dopamine Agents|dopamine agents|mesh-ancestor
92861574|NCT05122481|Ascorbic Acid|ascorbic acid|mesh-list
92861575|NCT05122481|Vitamins|vitamins|mesh-ancestor
92861576|NCT05122481|Micronutrients|micronutrients|mesh-ancestor
92861577|NCT05122481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861578|NCT05122481|Antioxidants|antioxidants|mesh-ancestor
92156387|NCT02083679|Antimetabolites|antimetabolites|mesh-ancestor
92861579|NCT05122481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861580|NCT05122481|Protective Agents|protective agents|mesh-ancestor
92861581|NCT00937417|Docetaxel|docetaxel|mesh-list
92861582|NCT00937417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861583|NCT00937417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92861584|NCT00937417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92861585|NCT00937417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92861586|NCT00937417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861587|NCT02728440|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92861588|NCT02728440|Menotropins|menotropins|mesh-list
92861589|NCT02728440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861590|NCT02728440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861591|NCT02728440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92506739|NCT00006345|Hormones|hormones|mesh-ancestor
92861592|NCT02728440|Fertility Agents|fertility agents|mesh-ancestor
92861593|NCT05358912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92861594|NCT04261517|Hydroxychloroquine|hydroxychloroquine|mesh-list
92861595|NCT04261517|Antimalarials|antimalarials|mesh-ancestor
92861596|NCT04261517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92861597|NCT04261517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92861598|NCT04261517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861599|NCT04261517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861600|NCT04261517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861601|NCT04261517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861602|NCT00930865|Dapagliflozin|dapagliflozin|mesh-list
92861604|NCT00930865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92206115|NCT02062359|Aldesleukin|aldesleukin|mesh-list
92861605|NCT00930865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861606|NCT00930865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92861607|NCT00930865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861608|NCT00930865|Diuretics|diuretics|mesh-ancestor
92861609|NCT00930865|Natriuretic Agents|natriuretic agents|mesh-ancestor
92861610|NCT00930865|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92861611|NCT00930865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92861612|NCT02737800|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92861613|NCT02737800|Luteolytic Agents|luteolytic agents|mesh-ancestor
92861614|NCT02737800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92861615|NCT02737800|Contraceptive Agents|contraceptive agents|mesh-ancestor
92861616|NCT02737800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861617|NCT02737800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861618|NCT02737800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92861619|NCT02737800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861620|NCT02737800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861621|NCT00934531|Donepezil|donepezil|mesh-list
92861622|NCT00934531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92861623|NCT00934531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861624|NCT00934531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861625|NCT00934531|Cholinergic Agents|cholinergic agents|mesh-ancestor
92861626|NCT00934531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861627|NCT00934531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861628|NCT00934531|Nootropic Agents|nootropic agents|mesh-ancestor
92861629|NCT00931021|Nicotine|nicotine|mesh-list
92861630|NCT00931021|Varenicline|varenicline|mesh-list
92861631|NCT00931021|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92861632|NCT00931021|Autonomic Agents|autonomic agents|mesh-ancestor
92861633|NCT00931021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861634|NCT00931021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861635|NCT00931021|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92861636|NCT00931021|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92861637|NCT00931021|Cholinergic Agents|cholinergic agents|mesh-ancestor
92861638|NCT00931021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861639|NCT00931021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861640|NCT00937807|Sevoflurane|sevoflurane|mesh-list
92861641|NCT00937807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92861642|NCT00937807|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92861643|NCT00937807|Anesthetics, General|anesthetics, general|mesh-ancestor
92861644|NCT00937807|Anesthetics|anesthetics|mesh-ancestor
92861645|NCT00937807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861646|NCT00937807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861647|NCT00934687|Botulinum Toxins|botulinum toxins|mesh-list
92861648|NCT00934687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92861649|NCT00934687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92861650|NCT00934687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92861651|NCT00934687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92861652|NCT00934687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861653|NCT00934687|Cholinergic Agents|cholinergic agents|mesh-ancestor
92861654|NCT00934687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861655|NCT00934687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861656|NCT00934687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92861657|NCT00934687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861658|NCT02808728|Bupivacaine|bupivacaine|mesh-list
92861659|NCT02808728|Ropivacaine|ropivacaine|mesh-list
92861660|NCT02808728|Anesthetics, Local|anesthetics, local|mesh-ancestor
92861661|NCT02808728|Anesthetics|anesthetics|mesh-ancestor
92861662|NCT02808728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861663|NCT02808728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861664|NCT02808728|Sensory System Agents|sensory system agents|mesh-ancestor
92861665|NCT02808728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861666|NCT05331053|Atorvastatin|atorvastatin|mesh-list
92861667|NCT05331053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92861668|NCT05331053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92861669|NCT05331053|Antimetabolites|antimetabolites|mesh-ancestor
92861670|NCT05331053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861671|NCT05331053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92861672|NCT05331053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92861673|NCT05331053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861674|NCT02732730|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92861675|NCT02732730|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92861676|NCT02732730|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92861677|NCT02732730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861678|NCT02732730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861679|NCT02732730|Antiviral Agents|antiviral agents|mesh-ancestor
92861680|NCT02732730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861681|NCT02732730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92861682|NCT02732730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92861683|NCT02808650|Prexasertib|prexasertib|mesh-list
92861684|NCT02808650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92861685|NCT02808650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861686|NCT02808650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861687|NCT04996667|Nitric Oxide|nitric oxide|mesh-list
92861688|NCT04996667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92861689|NCT04996667|Autonomic Agents|autonomic agents|mesh-ancestor
92861690|NCT04996667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861691|NCT04996667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861692|NCT04996667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92861693|NCT04996667|Respiratory System Agents|respiratory system agents|mesh-ancestor
92861694|NCT04996667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92861695|NCT04996667|Antioxidants|antioxidants|mesh-ancestor
92861696|NCT04996667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861697|NCT04996667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861698|NCT04996667|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92861699|NCT04996667|Vasodilator Agents|vasodilator agents|mesh-ancestor
92861700|NCT04996667|Gasotransmitters|gasotransmitters|mesh-ancestor
92861701|NCT04996667|Protective Agents|protective agents|mesh-ancestor
92861702|NCT00929669|Pasireotide|pasireotide|mesh-list
92861703|NCT00929669|Hormones|hormones|mesh-ancestor
92861704|NCT00929669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861705|NCT00929669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861706|NCT02804360|Dexamethasone|dexamethasone|mesh-list
92861707|NCT02804360|Dexamethasone acetate|dexamethasone acetate|mesh-list
92861708|NCT02804360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861709|NCT02804360|Antiemetics|antiemetics|mesh-ancestor
92861710|NCT02804360|Autonomic Agents|autonomic agents|mesh-ancestor
92861711|NCT02804360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861712|NCT02804360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861713|NCT02804360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92861714|NCT02804360|Glucocorticoids|glucocorticoids|mesh-ancestor
92861715|NCT02804360|Hormones|hormones|mesh-ancestor
92861716|NCT02804360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861717|NCT02804360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861718|NCT02804360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861719|NCT02727738|Selenium|selenium|mesh-list
92861720|NCT02727738|Methimazole|methimazole|mesh-list
92861721|NCT02727738|Antioxidants|antioxidants|mesh-ancestor
92861722|NCT02727738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861723|NCT02727738|Protective Agents|protective agents|mesh-ancestor
92861724|NCT02727738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861725|NCT02727738|Trace Elements|trace elements|mesh-ancestor
92861726|NCT02727738|Micronutrients|micronutrients|mesh-ancestor
92861727|NCT02727738|Antithyroid Agents|antithyroid agents|mesh-ancestor
92861728|NCT02727738|Hormone Antagonists|hormone antagonists|mesh-ancestor
92861729|NCT02727738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861730|NCT02732418|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92861731|NCT02732418|Contraceptive Agents|contraceptive agents|mesh-list
92861732|NCT02732418|Medroxyprogesterone|medroxyprogesterone|mesh-list
92861733|NCT02732418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861734|NCT02732418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861735|NCT02732418|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92861736|NCT02732418|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92861737|NCT02732418|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92506881|NCT00387738|Histamine Agonists|histamine agonists|mesh-ancestor
92861738|NCT02732418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92861739|NCT02732418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861740|NCT02732418|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92861741|NCT02732418|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92861742|NCT02732418|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92861743|NCT02811692|Aflibercept|aflibercept|mesh-list
92861744|NCT02811692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92861745|NCT02811692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92861746|NCT02811692|Growth Substances|growth substances|mesh-ancestor
92861747|NCT02811692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861748|NCT02811692|Growth Inhibitors|growth inhibitors|mesh-ancestor
92861749|NCT02811692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861750|NCT04004078|Antifungal Agents|antifungal agents|mesh-list
92861751|NCT04004078|Clotrimazole|clotrimazole|mesh-list
92861753|NCT04004078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861754|NCT04004078|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92861755|NCT04004078|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92861756|NCT04004078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92861757|NCT04004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861758|NCT04004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861759|NCT04004078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92861760|NCT04004078|Hormone Antagonists|hormone antagonists|mesh-ancestor
92861761|NCT04004078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861762|NCT04004078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861763|NCT04004078|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92861764|NCT04004078|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92861765|NCT02732262|Oxycodone|oxycodone|mesh-list
92861766|NCT02732262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92861767|NCT02732262|Narcotics|narcotics|mesh-ancestor
92861768|NCT02732262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861769|NCT02732262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861770|NCT02732262|Analgesics|analgesics|mesh-ancestor
92861771|NCT02732262|Sensory System Agents|sensory system agents|mesh-ancestor
92861772|NCT02732262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861773|NCT00926393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92861774|NCT00926393|Antidepressive Agents|antidepressive agents|mesh-ancestor
92861775|NCT00926393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92861776|NCT00926393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92861777|NCT00926393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92861778|NCT00926393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861779|NCT00926393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861780|NCT02737254|Oxytocin|oxytocin|mesh-list
92861781|NCT02737254|Oxytocics|oxytocics|mesh-ancestor
92861782|NCT02737254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92861783|NCT02737254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861784|NCT00938197|Amlodipine|amlodipine|mesh-list
92861785|NCT00938197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92861786|NCT00938197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92861787|NCT00938197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92861788|NCT00938197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861789|NCT00938197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92861790|NCT00938197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861791|NCT00938197|Vasodilator Agents|vasodilator agents|mesh-ancestor
92861792|NCT02727504|Dobutamine|dobutamine|mesh-list
92861793|NCT02727504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92861794|NCT02727504|Sympathomimetics|sympathomimetics|mesh-ancestor
92861795|NCT02727504|Autonomic Agents|autonomic agents|mesh-ancestor
92861796|NCT02727504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861797|NCT02727504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861798|NCT02727504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92861799|NCT02727504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92861800|NCT02727504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92861801|NCT02727504|Adrenergic Agents|adrenergic agents|mesh-ancestor
92861802|NCT02727504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861803|NCT02727504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861804|NCT02727504|Protective Agents|protective agents|mesh-ancestor
92861805|NCT02727348|Anesthetics|anesthetics|mesh-list
92861806|NCT02727348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861807|NCT02727348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861808|NCT02804126|Acetaminophen|acetaminophen|mesh-list
92861809|NCT02804126|Dipyrone|dipyrone|mesh-list
92861810|NCT02804126|Ketoprofen|ketoprofen|mesh-list
92861811|NCT02804126|Morphine|morphine|mesh-list
92861812|NCT02804126|Bupivacaine|bupivacaine|mesh-list
92861813|NCT02804126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92861814|NCT02804126|Anesthetics|anesthetics|mesh-ancestor
92861815|NCT02804126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861816|NCT02804126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861817|NCT02804126|Sensory System Agents|sensory system agents|mesh-ancestor
92861818|NCT02804126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861819|NCT02804126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92861820|NCT02804126|Narcotics|narcotics|mesh-ancestor
92861821|NCT02804126|Analgesics|analgesics|mesh-ancestor
92861822|NCT02804126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92861823|NCT02804126|Antipyretics|antipyretics|mesh-ancestor
92861824|NCT02804126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92861825|NCT02804126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861826|NCT02804126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861827|NCT02804126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92861828|NCT02804126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861829|NCT02804126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861830|NCT04013815|Ropivacaine|ropivacaine|mesh-list
92861831|NCT04013815|Anesthetics, Local|anesthetics, local|mesh-ancestor
92861832|NCT04013815|Anesthetics|anesthetics|mesh-ancestor
92861833|NCT04013815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861834|NCT04013815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861835|NCT04013815|Sensory System Agents|sensory system agents|mesh-ancestor
92861836|NCT04013815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861837|NCT00610103|Apomorphine|apomorphine|mesh-list
92861838|NCT00610103|Emetics|emetics|mesh-ancestor
92861839|NCT00610103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861840|NCT00610103|Autonomic Agents|autonomic agents|mesh-ancestor
92861841|NCT00610103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861842|NCT00610103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92861843|NCT00610103|Dopamine Agonists|dopamine agonists|mesh-ancestor
92861844|NCT00610103|Dopamine Agents|dopamine agents|mesh-ancestor
92861845|NCT00610103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92861846|NCT00610103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861847|NCT05624190|Plasminogen|plasminogen|mesh-list
92861848|NCT05624190|Tenecteplase|tenecteplase|mesh-list
92861849|NCT05624190|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92861850|NCT05624190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92861851|NCT05624190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92861852|NCT05624190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861853|NCT00938353|Beclomethasone|beclomethasone|mesh-list
92861854|NCT00938353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861855|NCT00938353|Glucocorticoids|glucocorticoids|mesh-ancestor
92861856|NCT00938353|Hormones|hormones|mesh-ancestor
92861857|NCT00938353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861858|NCT00938353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861859|NCT00938353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92861860|NCT00938353|Respiratory System Agents|respiratory system agents|mesh-ancestor
92861861|NCT04259333|Acetaminophen|acetaminophen|mesh-list
92861862|NCT04259333|Celecoxib|celecoxib|mesh-list
92861863|NCT04259333|Codeine|codeine|mesh-list
92861864|NCT04259333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92861865|NCT04259333|Analgesics|analgesics|mesh-ancestor
92861866|NCT04259333|Sensory System Agents|sensory system agents|mesh-ancestor
92861867|NCT04259333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92861868|NCT04259333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861869|NCT04259333|Antipyretics|antipyretics|mesh-ancestor
92861870|NCT04259333|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92861871|NCT04259333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861872|NCT04259333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92861873|NCT04259333|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92861874|NCT04259333|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92861875|NCT04259333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861876|NCT04259333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861877|NCT04259333|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92861878|NCT04259333|Narcotics|narcotics|mesh-ancestor
92861879|NCT04259333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92861880|NCT04259333|Antitussive Agents|antitussive agents|mesh-ancestor
92861881|NCT04259333|Respiratory System Agents|respiratory system agents|mesh-ancestor
92861882|NCT02721420|Piperaquine|piperaquine|mesh-list
92861883|NCT02721420|Artenimol|artenimol|mesh-list
92861884|NCT02721420|Antimalarials|antimalarials|mesh-ancestor
92861885|NCT02721420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92861886|NCT02721420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92861887|NCT02721420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861888|NCT00608699|Niacin|niacin|mesh-list
92861889|NCT00608699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92861890|NCT00608699|Antimetabolites|antimetabolites|mesh-ancestor
92861891|NCT00608699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861892|NCT00608699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92861893|NCT00608699|Vasodilator Agents|vasodilator agents|mesh-ancestor
92861894|NCT00608699|Vitamin B Complex|vitamin b complex|mesh-ancestor
92861895|NCT00608699|Vitamins|vitamins|mesh-ancestor
92861896|NCT00608699|Micronutrients|micronutrients|mesh-ancestor
92861897|NCT00608699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861898|NCT05193396|Hydrocortisone|hydrocortisone|mesh-list
92861899|NCT05193396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92861900|NCT02726490|Metformin|metformin|mesh-list
92861901|NCT02726490|Glyburide|glyburide|mesh-list
92861902|NCT02726490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92861903|NCT02726490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861904|NCT02726646|Doxycycline|doxycycline|mesh-list
92861905|NCT02726646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92861906|NCT02726646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861907|NCT02726646|Antimalarials|antimalarials|mesh-ancestor
92861908|NCT02726646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92861909|NCT02726646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92861910|NCT02803892|Vildagliptin|vildagliptin|mesh-list
92861911|NCT02803892|Sirolimus|sirolimus|mesh-list
92861912|NCT02803892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92861913|NCT02803892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861914|NCT02803892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92861915|NCT02803892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861916|NCT02803892|Antifungal Agents|antifungal agents|mesh-ancestor
92861917|NCT02803892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92861918|NCT02803892|Immunologic Factors|immunologic factors|mesh-ancestor
92861919|NCT02803892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861920|NCT02803892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861921|NCT02803892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861922|NCT02803892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92861923|NCT02803892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92861924|NCT02803892|Protease Inhibitors|protease inhibitors|mesh-ancestor
92861925|NCT02803502|Thrombin|thrombin|mesh-list
92861926|NCT02803502|Hemostatics|hemostatics|mesh-ancestor
92861927|NCT02803502|Coagulants|coagulants|mesh-ancestor
92861928|NCT02721186|Primaquine|primaquine|mesh-list
92861929|NCT02721186|Piperaquine|piperaquine|mesh-list
92861930|NCT02721186|Artenimol|artenimol|mesh-list
92861931|NCT02721186|Antimalarials|antimalarials|mesh-ancestor
92861932|NCT02721186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92861933|NCT02721186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92861934|NCT02721186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861935|NCT02716428|Ribavirin|ribavirin|mesh-list
92861936|NCT02716428|Antimetabolites|antimetabolites|mesh-ancestor
92861937|NCT02716428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861938|NCT02716428|Antiviral Agents|antiviral agents|mesh-ancestor
92861939|NCT02716428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861940|NCT05511428|Daratumumab|daratumumab|mesh-list
92861941|NCT05511428|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92861942|NCT05511428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861943|NCT05511428|Immunologic Factors|immunologic factors|mesh-ancestor
92861944|NCT05511428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861945|NCT00931463|Ritonavir|ritonavir|mesh-list
92861946|NCT00931463|Lopinavir|lopinavir|mesh-list
92861947|NCT00931463|Raltegravir Potassium|raltegravir potassium|mesh-list
92861948|NCT00931463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92861949|NCT00931463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92861950|NCT00931463|Protease Inhibitors|protease inhibitors|mesh-ancestor
92861951|NCT00931463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861952|NCT00931463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861953|NCT00931463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92861954|NCT00931463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92861955|NCT00931463|Antiviral Agents|antiviral agents|mesh-ancestor
92861956|NCT00931463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861957|NCT00931463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92861958|NCT00931463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92861959|NCT00931463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92861960|NCT00931463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92861961|NCT03974594|Trifluridine|trifluridine|mesh-list
92861962|NCT03974594|Antimetabolites|antimetabolites|mesh-ancestor
92861963|NCT03974594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861964|NCT03974594|Antiviral Agents|antiviral agents|mesh-ancestor
92861965|NCT03974594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861966|NCT03964688|Ascorbic Acid|ascorbic acid|mesh-list
92861967|NCT03964688|Vitamins|vitamins|mesh-ancestor
92861968|NCT03964688|Micronutrients|micronutrients|mesh-ancestor
92861969|NCT03964688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861970|NCT03964688|Antioxidants|antioxidants|mesh-ancestor
92861971|NCT03964688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861972|NCT03964688|Protective Agents|protective agents|mesh-ancestor
92861973|NCT00929201|Metformin|metformin|mesh-list
92861974|NCT00929201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92861975|NCT00929201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92861976|NCT00929201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861977|NCT00929201|Incretins|incretins|mesh-ancestor
92861978|NCT00929201|Hormones|hormones|mesh-ancestor
92861979|NCT00929201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92861980|NCT00929201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92861981|NCT00929201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92861982|NCT00929201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92861983|NCT00929201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92861985|NCT02800772|Retinol acetate|retinol acetate|mesh-list
92861986|NCT02800772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92861987|NCT02800772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92861988|NCT02800772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92861989|NCT02800772|Immunologic Factors|immunologic factors|mesh-ancestor
92861990|NCT02800772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861991|NCT02800772|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92861992|NCT02800772|Protective Agents|protective agents|mesh-ancestor
92861993|NCT02800772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92861994|NCT02773212|Amphetamine|amphetamine|mesh-list
92861995|NCT02773212|Dextroamphetamine|dextroamphetamine|mesh-list
92861996|NCT02773212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92861997|NCT02773212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92861998|NCT02773212|Sympathomimetics|sympathomimetics|mesh-ancestor
92861999|NCT02773212|Autonomic Agents|autonomic agents|mesh-ancestor
92862000|NCT02773212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862001|NCT02773212|Dopamine Agents|dopamine agents|mesh-ancestor
92862002|NCT02773212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862003|NCT02773212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862004|NCT02773212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862005|NCT02773212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92862006|NCT02773212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92862007|NCT02773212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92862008|NCT02773212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92862009|NCT00610493|Sirolimus|sirolimus|mesh-list
92862010|NCT00610493|Bevacizumab|bevacizumab|mesh-list
92862011|NCT00610493|Temsirolimus|temsirolimus|mesh-list
92862012|NCT00610493|MTOR Inhibitors|mtor inhibitors|mesh-list
92862013|NCT00610493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862014|NCT00610493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862015|NCT00610493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92862016|NCT00610493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92862017|NCT00610493|Growth Substances|growth substances|mesh-ancestor
92862018|NCT00610493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862019|NCT00610493|Growth Inhibitors|growth inhibitors|mesh-ancestor
92862020|NCT00610493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92862021|NCT00610493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862022|NCT00610493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862023|NCT00610493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862024|NCT00610493|Immunologic Factors|immunologic factors|mesh-ancestor
92862025|NCT00610493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862026|NCT00610493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862027|NCT00610493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92862028|NCT00610493|Antifungal Agents|antifungal agents|mesh-ancestor
92862029|NCT02716272|Nivolumab|nivolumab|mesh-list
92862030|NCT02716272|Ipilimumab|ipilimumab|mesh-list
92862031|NCT02716272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862032|NCT02716272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862033|NCT02716272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92862034|NCT02716272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862035|NCT02720406|Ketamine|ketamine|mesh-list
92862036|NCT02720406|Analgesics|analgesics|mesh-ancestor
92862037|NCT02720406|Sensory System Agents|sensory system agents|mesh-ancestor
92862038|NCT02720406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862039|NCT02720406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862040|NCT02720406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92862041|NCT02720406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92862042|NCT02720406|Anesthetics, General|anesthetics, general|mesh-ancestor
92862043|NCT02720406|Anesthetics|anesthetics|mesh-ancestor
92862044|NCT02720406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862045|NCT02720406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92862046|NCT02720406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92862047|NCT02720406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862048|NCT02720406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862050|NCT05504876|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92206558|NCT02413203|Celecoxib|celecoxib|mesh-list
92862052|NCT05504876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862053|NCT05504876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862054|NCT05504876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92862055|NCT05504876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92862056|NCT05504876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92862057|NCT05504876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92862058|NCT05504876|Anesthetics, General|anesthetics, general|mesh-ancestor
92862059|NCT05504876|Anesthetics|anesthetics|mesh-ancestor
92862060|NCT05504876|GABA Modulators|gaba modulators|mesh-ancestor
92862061|NCT05504876|GABA Agents|gaba agents|mesh-ancestor
92862062|NCT05504876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862063|NCT05504876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862064|NCT02802722|Vitamin D|vitamin d|mesh-list
92862065|NCT02802722|Cholecalciferol|cholecalciferol|mesh-list
92862066|NCT02802722|Vitamins|vitamins|mesh-ancestor
92862067|NCT02802722|Micronutrients|micronutrients|mesh-ancestor
92862068|NCT02802722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862069|NCT02802722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92862070|NCT02802722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92862071|NCT02802644|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92862072|NCT02802644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92156422|NCT04790448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862073|NCT02802644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862074|NCT02802644|Incretins|incretins|mesh-ancestor
92862075|NCT02802644|Hormones|hormones|mesh-ancestor
92862076|NCT02802644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862077|NCT02802644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92862078|NCT02802644|Protease Inhibitors|protease inhibitors|mesh-ancestor
92862079|NCT02802644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862080|NCT02802644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862081|NCT02744976|Metformin|metformin|mesh-list
92862082|NCT02744976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862083|NCT02744976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862084|NCT00928889|Acarbose|acarbose|mesh-list
92862085|NCT00928889|Nateglinide|nateglinide|mesh-list
92862086|NCT00928889|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92862087|NCT00928889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862088|NCT00928889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862089|NCT00928889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862090|NCT00928889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862091|NCT02725398|Scopolamine|scopolamine|mesh-list
92862092|NCT02725398|Bromides|bromides|mesh-list
92862093|NCT02725398|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92862094|NCT02725398|Anticonvulsants|anticonvulsants|mesh-ancestor
92862095|NCT02725398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92862096|NCT02725398|Antiemetics|antiemetics|mesh-ancestor
92862097|NCT02725398|Autonomic Agents|autonomic agents|mesh-ancestor
92862098|NCT02725398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862099|NCT02725398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862100|NCT02725398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92862101|NCT02725398|Mydriatics|mydriatics|mesh-ancestor
92862102|NCT02725398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92862103|NCT02725398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862104|NCT02725398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862105|NCT02725398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862106|NCT02725398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92862107|NCT02725398|Parasympatholytics|parasympatholytics|mesh-ancestor
92862108|NCT02795546|Alendronate|alendronate|mesh-list
92862109|NCT02795546|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92862110|NCT02795546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862111|NCT03978091|Ceftazidime|ceftazidime|mesh-list
92862112|NCT03978091|Avibactam|avibactam|mesh-list
92862113|NCT03978091|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92862114|NCT03978091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862115|NCT03978091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862116|NCT03978091|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92862117|NCT03978091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507259|NCT05680792|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92862118|NCT03978091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862119|NCT00610571|Temozolomide|temozolomide|mesh-list
92862120|NCT00610571|Topotecan|topotecan|mesh-list
92862121|NCT00610571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92862122|NCT00610571|Alkylating Agents|alkylating agents|mesh-ancestor
92862123|NCT00610571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862124|NCT00610571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862125|NCT00610571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92862126|NCT00610571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92862127|NCT00610571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862128|NCT02725242|Budesonide|budesonide|mesh-list
92862129|NCT02725242|Formoterol Fumarate|formoterol fumarate|mesh-list
92862130|NCT02725242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862131|NCT02725242|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92862132|NCT02725242|Autonomic Agents|autonomic agents|mesh-ancestor
92862133|NCT02725242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862134|NCT02725242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862135|NCT02725242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92862136|NCT02725242|Respiratory System Agents|respiratory system agents|mesh-ancestor
92862137|NCT02725242|Glucocorticoids|glucocorticoids|mesh-ancestor
92862138|NCT02725242|Hormones|hormones|mesh-ancestor
92862139|NCT02725242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862140|NCT02725242|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92862141|NCT02725242|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92862142|NCT02725242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862143|NCT02725242|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862144|NCT02725242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026457|NCT00402285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862145|NCT02725242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862146|NCT00564733|Paclitaxel|paclitaxel|mesh-list
92862147|NCT00564733|Docetaxel|docetaxel|mesh-list
92862148|NCT00564733|Carboplatin|carboplatin|mesh-list
92862149|NCT00564733|Gemcitabine|gemcitabine|mesh-list
92862150|NCT00564733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92862151|NCT00564733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92862152|NCT00564733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862153|NCT00564733|Tubulin Modulators|tubulin modulators|mesh-ancestor
92862154|NCT00564733|Antimitotic Agents|antimitotic agents|mesh-ancestor
92862155|NCT00564733|Mitosis Modulators|mitosis modulators|mesh-ancestor
92862156|NCT00564733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862157|NCT00564733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92862158|NCT00564733|Antimetabolites|antimetabolites|mesh-ancestor
92862159|NCT00564733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92862160|NCT02725164|Nitrous Oxide|nitrous oxide|mesh-list
92862161|NCT02725164|Sevoflurane|sevoflurane|mesh-list
92862162|NCT02725164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92862163|NCT02725164|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92862164|NCT02725164|Anesthetics, General|anesthetics, general|mesh-ancestor
92862165|NCT02725164|Anesthetics|anesthetics|mesh-ancestor
92862166|NCT02725164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862167|NCT02725164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862168|NCT02725164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862169|NCT02725164|Analgesics|analgesics|mesh-ancestor
92862170|NCT02725164|Sensory System Agents|sensory system agents|mesh-ancestor
92862171|NCT02725164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862172|NCT02800694|Fentanyl|fentanyl|mesh-list
92862173|NCT02800694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92862174|NCT02800694|Narcotics|narcotics|mesh-ancestor
92862175|NCT02800694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862176|NCT02800694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862177|NCT02800694|Analgesics|analgesics|mesh-ancestor
92862178|NCT02800694|Sensory System Agents|sensory system agents|mesh-ancestor
92862179|NCT02800694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862180|NCT02800694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92862181|NCT02800694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92862182|NCT02800694|Anesthetics, General|anesthetics, general|mesh-ancestor
92862183|NCT02800694|Anesthetics|anesthetics|mesh-ancestor
92862184|NCT00931385|Formoterol Fumarate|formoterol fumarate|mesh-list
92862185|NCT00931385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92862186|NCT00931385|Autonomic Agents|autonomic agents|mesh-ancestor
92862187|NCT00931385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862188|NCT00931385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862189|NCT00931385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92862190|NCT00931385|Respiratory System Agents|respiratory system agents|mesh-ancestor
92862191|NCT00931385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92862192|NCT00931385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92507341|NCT05678296|Analgesics|analgesics|mesh-list
92862193|NCT00931385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862194|NCT00931385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862195|NCT00931385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862196|NCT00931385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862197|NCT00938509|Ibuprofen|ibuprofen|mesh-list
92862198|NCT00938509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92862199|NCT00938509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862200|NCT00938509|Analgesics|analgesics|mesh-ancestor
92862201|NCT00938509|Sensory System Agents|sensory system agents|mesh-ancestor
92862202|NCT00938509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862203|NCT00938509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862204|NCT00938509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862205|NCT00938509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92862206|NCT00938509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92862207|NCT00938509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862208|NCT00938509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862210|NCT02724618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92862211|NCT02724618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862212|NCT02724618|Analgesics|analgesics|mesh-ancestor
92862213|NCT02724618|Sensory System Agents|sensory system agents|mesh-ancestor
92862214|NCT02724618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862215|NCT02724618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862216|NCT02724618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162660|NCT03924635|Hormones|hormones|mesh-ancestor
92862217|NCT02724618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92862218|NCT02724618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862219|NCT02724618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862220|NCT02724618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862221|NCT02801786|Tamoxifen|tamoxifen|mesh-list
92862222|NCT02801786|Lidocaine|lidocaine|mesh-list
92862223|NCT02801786|Anesthetics, Local|anesthetics, local|mesh-ancestor
92862224|NCT02801786|Anesthetics|anesthetics|mesh-ancestor
92862225|NCT02801786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862226|NCT02801786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862227|NCT02801786|Sensory System Agents|sensory system agents|mesh-ancestor
92862228|NCT02801786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862229|NCT02801786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92862230|NCT02801786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92862231|NCT02801786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92862232|NCT02801786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92862233|NCT02801786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862234|NCT02801786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92862235|NCT02801786|Hormone Antagonists|hormone antagonists|mesh-ancestor
92862236|NCT02801786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862237|NCT02801786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92862238|NCT02801786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862239|NCT02801786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92862240|NCT02801786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92862241|NCT02801786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92862242|NCT04258553|Antioxidants|antioxidants|mesh-list
92862243|NCT04258553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862244|NCT04258553|Protective Agents|protective agents|mesh-ancestor
92862245|NCT04258553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862246|NCT00938743|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92862247|NCT00938743|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92862248|NCT00938743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92862249|NCT00938743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92862250|NCT00938743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862251|NCT00938743|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862252|NCT00938743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862253|NCT00938743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862254|NCT02719392|Acetylcysteine|acetylcysteine|mesh-list
92862255|NCT02719392|Minocycline|minocycline|mesh-list
92862256|NCT02719392|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92862257|NCT02719392|Antiviral Agents|antiviral agents|mesh-ancestor
92862258|NCT02719392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862259|NCT02719392|Expectorants|expectorants|mesh-ancestor
92862260|NCT02719392|Respiratory System Agents|respiratory system agents|mesh-ancestor
92862261|NCT02719392|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92862262|NCT02719392|Antioxidants|antioxidants|mesh-ancestor
92862263|NCT02719392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507410|NCT05552404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862264|NCT02719392|Protective Agents|protective agents|mesh-ancestor
92862265|NCT02719392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862267|NCT02719392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862268|NCT02802098|Bevacizumab|bevacizumab|mesh-list
92862269|NCT02802098|Durvalumab|durvalumab|mesh-list
92862270|NCT02802098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862271|NCT02802098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862272|NCT02802098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92862273|NCT02802098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92862274|NCT02802098|Growth Substances|growth substances|mesh-ancestor
92862275|NCT02802098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862276|NCT02802098|Growth Inhibitors|growth inhibitors|mesh-ancestor
92862278|NCT00938821|Bupivacaine|bupivacaine|mesh-list
92862279|NCT00938821|Anesthetics, Local|anesthetics, local|mesh-ancestor
92862280|NCT00938821|Anesthetics|anesthetics|mesh-ancestor
92862281|NCT00938821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862282|NCT00938821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862283|NCT00938821|Sensory System Agents|sensory system agents|mesh-ancestor
92862284|NCT00938821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862285|NCT00938821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92862286|NCT00938821|Narcotics|narcotics|mesh-ancestor
92862287|NCT00938821|Analgesics|analgesics|mesh-ancestor
92862288|NCT04013581|Empagliflozin|empagliflozin|mesh-list
92862289|NCT04013581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92862290|NCT04013581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862291|NCT04013581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862292|NCT04013581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862293|NCT02715960|Vitamin A|vitamin a|mesh-list
92862294|NCT02715960|Tretinoin|tretinoin|mesh-list
92862295|NCT02715960|Acitretin|acitretin|mesh-list
92862296|NCT02715960|Vitamins|vitamins|mesh-ancestor
92862297|NCT02715960|Micronutrients|micronutrients|mesh-ancestor
92862298|NCT02715960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862299|NCT02715960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862300|NCT02715960|Keratolytic Agents|keratolytic agents|mesh-ancestor
92862301|NCT02715960|Dermatologic Agents|dermatologic agents|mesh-ancestor
92862302|NCT03983018|Rituximab|rituximab|mesh-list
92862303|NCT03983018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862304|NCT03983018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862305|NCT03983018|Immunologic Factors|immunologic factors|mesh-ancestor
92862306|NCT03983018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862307|NCT03983018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92862308|NCT02794922|Vitamin B Complex|vitamin b complex|mesh-list
92862309|NCT02794922|Vitamins|vitamins|mesh-ancestor
92862310|NCT02794922|Micronutrients|micronutrients|mesh-ancestor
92862311|NCT02794922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862312|NCT00935467|Saxagliptin|saxagliptin|mesh-list
92862313|NCT00935467|Incretins|incretins|mesh-ancestor
92862314|NCT00935467|Hormones|hormones|mesh-ancestor
92862315|NCT00935467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862316|NCT00935467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862317|NCT00935467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92862318|NCT00935467|Protease Inhibitors|protease inhibitors|mesh-ancestor
92862319|NCT00935467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862320|NCT00935467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862321|NCT00935467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862322|NCT00935545|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92862323|NCT00935545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92862324|NCT00935545|Immunologic Factors|immunologic factors|mesh-ancestor
92862325|NCT00935545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862326|NCT04235816|Azithromycin|azithromycin|mesh-list
92862327|NCT04235816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862328|NCT04235816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862329|NCT00936013|Oseltamivir|oseltamivir|mesh-list
92862330|NCT00936013|Antiviral Agents|antiviral agents|mesh-ancestor
92862331|NCT00936013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862332|NCT00936013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862333|NCT00936013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862334|NCT00936091|Vitamin A|vitamin a|mesh-list
92862335|NCT00936091|Vitamins|vitamins|mesh-ancestor
92862336|NCT00936091|Micronutrients|micronutrients|mesh-ancestor
92862337|NCT00936091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862338|NCT00563797|Mecamylamine|mecamylamine|mesh-list
92862339|NCT00563797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92862340|NCT00563797|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92862341|NCT00563797|Autonomic Agents|autonomic agents|mesh-ancestor
92862342|NCT00563797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862343|NCT00563797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862344|NCT00563797|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92862345|NCT00563797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92862347|NCT00563797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862348|NCT00563797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862349|NCT01192698|Interferons|interferons|mesh-list
92862350|NCT01192698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862351|NCT01192698|Antiviral Agents|antiviral agents|mesh-ancestor
92862352|NCT01192698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862353|NCT04014361|Itraconazole|itraconazole|mesh-list
92862354|NCT04014361|Antifungal Agents|antifungal agents|mesh-ancestor
92862355|NCT04014361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862356|NCT04014361|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92862357|NCT04014361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92862358|NCT04014361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862359|NCT04014361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862360|NCT04014361|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92156442|NCT05319756|Gabapentin|gabapentin|mesh-list
92862361|NCT04014361|Hormone Antagonists|hormone antagonists|mesh-ancestor
92862362|NCT04014361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862363|NCT04014361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862364|NCT04014361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92862365|NCT00771927|Lacosamide|lacosamide|mesh-list
92862366|NCT00771927|Anticonvulsants|anticonvulsants|mesh-ancestor
92862367|NCT00771927|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92862368|NCT00771927|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92862369|NCT00771927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92862370|NCT00771927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862371|NCT02715492|Enoxaparin|enoxaparin|mesh-list
92862372|NCT02715492|Anticoagulants|anticoagulants|mesh-ancestor
92862373|NCT02715492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92862374|NCT02715492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92862375|NCT02715492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862376|NCT03940196|Paclitaxel|paclitaxel|mesh-list
92862377|NCT03940196|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92862378|NCT03940196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92862379|NCT03940196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862380|NCT03940196|Tubulin Modulators|tubulin modulators|mesh-ancestor
92862381|NCT03940196|Antimitotic Agents|antimitotic agents|mesh-ancestor
92862382|NCT03940196|Mitosis Modulators|mitosis modulators|mesh-ancestor
92862383|NCT03940196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862384|NCT03988179|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92862385|NCT03988179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862386|NCT03988179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862387|NCT03988179|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862388|NCT03988179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862389|NCT03988179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862390|NCT02724150|Omeprazole|omeprazole|mesh-list
92862391|NCT02724150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92862392|NCT02724150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92862393|NCT02724150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92862394|NCT02724150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862395|NCT02724150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862396|NCT00936247|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92862397|NCT02715336|Leuprolide|leuprolide|mesh-list
92862398|NCT02715336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92862399|NCT02715336|Fertility Agents|fertility agents|mesh-ancestor
92862400|NCT02715336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92862401|NCT02715336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862402|NCT02715336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92862403|NCT02715336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862404|NCT02794610|Tacrolimus|tacrolimus|mesh-list
92862405|NCT02794610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862406|NCT02794610|Immunologic Factors|immunologic factors|mesh-ancestor
92862407|NCT02794610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862408|NCT02794610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92862409|NCT02794610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862410|NCT02794610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862411|NCT02799758|Pitavastatin|pitavastatin|mesh-list
92862412|NCT02799758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92862413|NCT02799758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92862414|NCT02799758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92862415|NCT02799758|Antimetabolites|antimetabolites|mesh-ancestor
92525104|NCT00000191|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92862416|NCT02799758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862417|NCT02799758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862418|NCT02799758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92862419|NCT00938899|Simeprevir|simeprevir|mesh-list
92862420|NCT00938899|Antiviral Agents|antiviral agents|mesh-ancestor
92862421|NCT00938899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862422|NCT00938899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92862423|NCT00938899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862424|NCT00938899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862425|NCT03259165|Diuretics|diuretics|mesh-list
92862426|NCT03259165|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92862427|NCT03259165|Natriuretic Agents|natriuretic agents|mesh-ancestor
92862428|NCT03259165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862429|NCT03259165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026458|NCT00402285|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92862430|NCT03259165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862431|NCT04013659|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92862432|NCT04013659|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92862433|NCT04013659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862434|NCT00939133|Tretinoin|tretinoin|mesh-list
92862435|NCT00939133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862436|NCT00939133|Keratolytic Agents|keratolytic agents|mesh-ancestor
92862437|NCT00939133|Dermatologic Agents|dermatologic agents|mesh-ancestor
92862438|NCT02799446|Reslizumab|reslizumab|mesh-list
92862439|NCT02799446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92862440|NCT02799446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92862441|NCT00564889|Dexamethasone|dexamethasone|mesh-list
92862442|NCT00564889|Cyclophosphamide|cyclophosphamide|mesh-list
92862443|NCT00564889|Lenalidomide|lenalidomide|mesh-list
92862444|NCT00564889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862445|NCT00564889|Immunologic Factors|immunologic factors|mesh-ancestor
92862446|NCT00564889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862447|NCT00564889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92862448|NCT00564889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92862449|NCT00564889|Alkylating Agents|alkylating agents|mesh-ancestor
92862450|NCT00564889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862451|NCT00564889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862452|NCT00564889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92862453|NCT00564889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862454|NCT00564889|Antiemetics|antiemetics|mesh-ancestor
92862455|NCT00564889|Autonomic Agents|autonomic agents|mesh-ancestor
92862456|NCT00564889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862457|NCT00564889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92862458|NCT00564889|Glucocorticoids|glucocorticoids|mesh-ancestor
92862459|NCT00564889|Hormones|hormones|mesh-ancestor
92862460|NCT00564889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862461|NCT00564889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92862462|NCT00564889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92862463|NCT00564889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92862464|NCT00564889|Growth Substances|growth substances|mesh-ancestor
92862465|NCT00564889|Growth Inhibitors|growth inhibitors|mesh-ancestor
92862466|NCT02790164|Rocuronium|rocuronium|mesh-list
92862467|NCT02790164|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92862468|NCT02790164|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92862469|NCT02790164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92862470|NCT02790164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862471|NCT02790164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862472|NCT00939757|Mirabegron|mirabegron|mesh-list
92862473|NCT00939757|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92862474|NCT00939757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92862475|NCT00939757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862476|NCT00939757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862477|NCT00939757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862478|NCT00939757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862479|NCT00939757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862480|NCT00939757|Urological Agents|urological agents|mesh-ancestor
92862481|NCT05415644|Metformin|metformin|mesh-list
92862482|NCT05415644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862483|NCT05415644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862484|NCT00939835|Dexetimide|dexetimide|mesh-list
92862485|NCT00939835|Citalopram|citalopram|mesh-list
92862486|NCT00939835|Escitalopram|escitalopram|mesh-list
92862487|NCT00939835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92862488|NCT00939835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92525106|NCT00023842|Mitomycin|mitomycin|mesh-list
92862490|NCT00939835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862491|NCT00939835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862492|NCT00939835|Serotonin Agents|serotonin agents|mesh-ancestor
92862493|NCT00939835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862494|NCT00939835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92862495|NCT00939835|Antidepressive Agents|antidepressive agents|mesh-ancestor
92862496|NCT00939835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92862497|NCT00939835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92862498|NCT00939835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92862499|NCT00939835|Parasympatholytics|parasympatholytics|mesh-ancestor
92862500|NCT00939835|Autonomic Agents|autonomic agents|mesh-ancestor
92862501|NCT00939835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862502|NCT00939835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92862503|NCT00939835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92862504|NCT00939835|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862505|NCT02690012|Magnesium citrate|magnesium citrate|mesh-list
92862506|NCT02690012|Magnesium Oxide|magnesium oxide|mesh-list
92862507|NCT02690012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862508|NCT02690012|Cathartics|cathartics|mesh-ancestor
92862509|NCT02690012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92862510|NCT02690012|Antacids|antacids|mesh-ancestor
92862511|NCT02793986|Dexmedetomidine|dexmedetomidine|mesh-list
92862512|NCT02793986|Propofol|propofol|mesh-list
92862513|NCT02793986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92862514|NCT02793986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862515|NCT02793986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862516|NCT02793986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862517|NCT02793986|Analgesics|analgesics|mesh-ancestor
92862518|NCT02793986|Sensory System Agents|sensory system agents|mesh-ancestor
92862519|NCT02793986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862520|NCT02793986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92862521|NCT02793986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92862522|NCT02793986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862523|NCT02793986|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862524|NCT02793986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862525|NCT02793986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862526|NCT02793986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92862527|NCT02793986|Anesthetics, General|anesthetics, general|mesh-ancestor
92862528|NCT02793986|Anesthetics|anesthetics|mesh-ancestor
92862529|NCT00940069|Pemetrexed|pemetrexed|mesh-list
92862530|NCT00940069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862531|NCT00940069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862532|NCT00940069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862533|NCT00940069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92862534|NCT00940069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92862535|NCT00940303|Leucovorin|leucovorin|mesh-list
92862536|NCT00940303|Bevacizumab|bevacizumab|mesh-list
92862537|NCT00940303|Oxaliplatin|oxaliplatin|mesh-list
92862538|NCT00940303|Irinotecan|irinotecan|mesh-list
92862539|NCT00940303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862540|NCT00940303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862541|NCT00940303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92862542|NCT00940303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92862543|NCT00940303|Growth Substances|growth substances|mesh-ancestor
92862544|NCT00940303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862545|NCT00940303|Growth Inhibitors|growth inhibitors|mesh-ancestor
92862546|NCT00940303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92862547|NCT00940303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92862548|NCT00940303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862549|NCT00940303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862550|NCT00940303|Antidotes|antidotes|mesh-ancestor
92862551|NCT00940303|Protective Agents|protective agents|mesh-ancestor
92862552|NCT00940303|Vitamin B Complex|vitamin b complex|mesh-ancestor
92862553|NCT00940303|Vitamins|vitamins|mesh-ancestor
92862554|NCT00940303|Micronutrients|micronutrients|mesh-ancestor
92862555|NCT02794220|Nicotine|nicotine|mesh-list
92862556|NCT02794220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92862557|NCT02794220|Autonomic Agents|autonomic agents|mesh-ancestor
92862558|NCT02794220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862559|NCT02794220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862560|NCT02794220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92862561|NCT02794220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92862562|NCT02794220|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862563|NCT02794220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862564|NCT02794220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862565|NCT00941083|Raltegravir Potassium|raltegravir potassium|mesh-list
92862566|NCT00941083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92862567|NCT00941083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92862568|NCT00941083|Antiviral Agents|antiviral agents|mesh-ancestor
92862569|NCT00941083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862570|NCT00941083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92862571|NCT00941083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92862572|NCT00941083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156449|NCT05319756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862573|NCT00941083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862574|NCT04405999|Bromhexine|bromhexine|mesh-list
92862575|NCT04405999|Expectorants|expectorants|mesh-ancestor
92862576|NCT04405999|Respiratory System Agents|respiratory system agents|mesh-ancestor
92862577|NCT02793908|Progesterone|progesterone|mesh-list
92862578|NCT02793908|Progestins|progestins|mesh-ancestor
92862579|NCT02793908|Hormones|hormones|mesh-ancestor
92862580|NCT02793908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862581|NCT02793908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862582|NCT02789930|Anesthetics|anesthetics|mesh-list
92862583|NCT02789930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862584|NCT02789930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862585|NCT00560833|Mirtazapine|mirtazapine|mesh-list
92862586|NCT00560833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862587|NCT00560833|Antidepressive Agents|antidepressive agents|mesh-ancestor
92862588|NCT00560833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92862589|NCT00560833|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92862590|NCT00560833|Histamine Antagonists|histamine antagonists|mesh-ancestor
92862591|NCT00560833|Histamine Agents|histamine agents|mesh-ancestor
92862592|NCT00560833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862593|NCT00560833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862594|NCT00560833|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92862595|NCT00560833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92862596|NCT00560833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862597|NCT00560833|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92862598|NCT00560833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92862599|NCT00560833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92862600|NCT00560833|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862601|NCT00560833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92862602|NCT00560833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92862603|NCT00560833|Serotonin Agents|serotonin agents|mesh-ancestor
92862604|NCT00560833|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92862605|NCT02723760|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
92862606|NCT02723760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92862607|NCT02723760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862608|NCT00941161|Metformin|metformin|mesh-list
92862609|NCT00941161|Glimepiride|glimepiride|mesh-list
92862610|NCT00941161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862611|NCT00941161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862612|NCT00941161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92862613|NCT00941161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862614|NCT00941161|Immunologic Factors|immunologic factors|mesh-ancestor
92862615|NCT00944515|Azithromycin|azithromycin|mesh-list
92862616|NCT00944515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862617|NCT00944515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862618|NCT00771654|Phentermine|phentermine|mesh-list
92862619|NCT00771654|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92862620|NCT00771654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862621|NCT00771654|Appetite Depressants|appetite depressants|mesh-ancestor
92862622|NCT00771654|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92862623|NCT00771654|Sympathomimetics|sympathomimetics|mesh-ancestor
92862624|NCT00771654|Autonomic Agents|autonomic agents|mesh-ancestor
92862625|NCT00771654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862626|NCT00771654|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862627|NCT00771654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862628|NCT00771654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862629|NCT00941239|Metformin|metformin|mesh-list
92862630|NCT00941239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862631|NCT00941239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862632|NCT04235426|Vitamin B 12|vitamin b 12|mesh-list
92862633|NCT04235426|Hydroxocobalamin|hydroxocobalamin|mesh-list
92862634|NCT04235426|Diclofenac|diclofenac|mesh-list
92862635|NCT04235426|Vitamins|vitamins|mesh-ancestor
92862636|NCT04235426|Micronutrients|micronutrients|mesh-ancestor
92862637|NCT04235426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156452|NCT05319756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92862638|NCT04235426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92862639|NCT04235426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862640|NCT04235426|Analgesics|analgesics|mesh-ancestor
92862641|NCT04235426|Sensory System Agents|sensory system agents|mesh-ancestor
92862642|NCT04235426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862643|NCT04235426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862644|NCT04235426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92862645|NCT04235426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92862646|NCT04235426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862647|NCT04235426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862648|NCT04235426|Vitamin B Complex|vitamin b complex|mesh-ancestor
92862649|NCT04235426|Hematinics|hematinics|mesh-ancestor
92862650|NCT02793440|Cortivazol|cortivazol|mesh-list
92862651|NCT02793440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862652|NCT02723838|Gemcitabine|gemcitabine|mesh-list
92862653|NCT02723838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862654|NCT02723838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92862655|NCT02723838|Antimetabolites|antimetabolites|mesh-ancestor
92862656|NCT02723838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862657|NCT02789150|Norepinephrine|norepinephrine|mesh-list
92862658|NCT02789150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92862659|NCT02789150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862660|NCT02789150|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862661|NCT02789150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862662|NCT02789150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862663|NCT02789150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862664|NCT02789150|Sympathomimetics|sympathomimetics|mesh-ancestor
92862665|NCT02789150|Autonomic Agents|autonomic agents|mesh-ancestor
92862666|NCT02789150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862667|NCT02789150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92862668|NCT02715024|Tamsulosin|tamsulosin|mesh-list
92862669|NCT02715024|Solifenacin Succinate|solifenacin succinate|mesh-list
92862670|NCT02715024|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92862671|NCT02715024|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92862672|NCT02715024|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92862673|NCT02715024|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862674|NCT02715024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862675|NCT02715024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862676|NCT02715024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862677|NCT02715024|Urological Agents|urological agents|mesh-ancestor
92862678|NCT02715024|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92862679|NCT02715024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92862680|NCT02715024|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862681|NCT02798744|Empagliflozin|empagliflozin|mesh-list
92862682|NCT02798744|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92862683|NCT02798744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862684|NCT02798744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862685|NCT02798744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862686|NCT00925769|Bevacizumab|bevacizumab|mesh-list
92862687|NCT00925769|Capecitabine|capecitabine|mesh-list
92862688|NCT00925769|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92862689|NCT00925769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862690|NCT00925769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862691|NCT00925769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92862692|NCT00925769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92862693|NCT00925769|Growth Substances|growth substances|mesh-ancestor
92862694|NCT00925769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862695|NCT00925769|Growth Inhibitors|growth inhibitors|mesh-ancestor
92862696|NCT00925769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92862697|NCT00925769|Antimetabolites|antimetabolites|mesh-ancestor
92862698|NCT00925769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862699|NCT00925769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92862700|NCT00925769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862701|NCT00770913|Rabeprazole|rabeprazole|mesh-list
92862702|NCT00770913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92862703|NCT00770913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92862704|NCT00770913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92156462|NCT04410588|Fentanyl|fentanyl|mesh-list
92862705|NCT00770913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862706|NCT00770913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862707|NCT00562861|Lamotrigine|lamotrigine|mesh-list
92862708|NCT00562861|Carbamazepine|carbamazepine|mesh-list
92862709|NCT00562861|Valproic Acid|valproic acid|mesh-list
92862710|NCT00562861|Citalopram|citalopram|mesh-list
92862711|NCT00562861|Anticonvulsants|anticonvulsants|mesh-ancestor
92862712|NCT00562861|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92862713|NCT00562861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92507861|NCT00006630|Antibodies|antibodies|mesh-list
92862714|NCT00562861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862715|NCT00562861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92862716|NCT00562861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862717|NCT00562861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92862718|NCT00562861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92862719|NCT00562861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862720|NCT00562861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92862721|NCT00562861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92862722|NCT00562861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92862723|NCT00562861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92862724|NCT00562861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862725|NCT00562861|Serotonin Agents|serotonin agents|mesh-ancestor
92862726|NCT00562861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92862727|NCT00562861|Antidepressive Agents|antidepressive agents|mesh-ancestor
92862728|NCT00562861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862729|NCT00562861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862730|NCT00562861|GABA Agents|gaba agents|mesh-ancestor
92862731|NCT00562861|Antimanic Agents|antimanic agents|mesh-ancestor
92862732|NCT00562861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862733|NCT00562861|Analgesics|analgesics|mesh-ancestor
92862734|NCT00562861|Sensory System Agents|sensory system agents|mesh-ancestor
92862735|NCT00562861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92862736|NCT00562861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92862737|NCT02723448|Aclarubicin|aclarubicin|mesh-list
92862738|NCT02723448|Aclacinomycins|aclacinomycins|mesh-list
92862739|NCT02723448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92862740|NCT02723448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862741|NCT02723448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92862742|NCT02723448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92862743|NCT02723448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862744|NCT02723448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862745|NCT02723448|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92862746|NCT02723448|Immunologic Factors|immunologic factors|mesh-ancestor
92862747|NCT02723448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862748|NCT02798510|Gemcitabine|gemcitabine|mesh-list
92862749|NCT02798510|Capecitabine|capecitabine|mesh-list
92862750|NCT02798510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92862751|NCT02798510|Antimetabolites|antimetabolites|mesh-ancestor
92862752|NCT02798510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862753|NCT02798510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862754|NCT00941473|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92862755|NCT00941473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862756|NCT00941473|Glucocorticoids|glucocorticoids|mesh-ancestor
92862757|NCT00941473|Hormones|hormones|mesh-ancestor
92862758|NCT00941473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862759|NCT00941473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862760|NCT00941473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862761|NCT00941473|Immunologic Factors|immunologic factors|mesh-ancestor
92862762|NCT04258475|Raltegravir Potassium|raltegravir potassium|mesh-list
92862763|NCT04258475|Calcium|calcium|mesh-list
92862764|NCT04258475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92862765|NCT04258475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862766|NCT04258475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92862767|NCT04258475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92862768|NCT04258475|Antiviral Agents|antiviral agents|mesh-ancestor
92862769|NCT04258475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862770|NCT04258475|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92862771|NCT04258475|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92862772|NCT04258475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026459|NCT00402285|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92862773|NCT04258475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862774|NCT00609011|Temozolomide|temozolomide|mesh-list
92862775|NCT00609011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92862776|NCT00609011|Alkylating Agents|alkylating agents|mesh-ancestor
92862777|NCT00609011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862778|NCT00609011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862779|NCT00770679|Atorvastatin|atorvastatin|mesh-list
92862780|NCT00770679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92862781|NCT00770679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92862782|NCT00770679|Antimetabolites|antimetabolites|mesh-ancestor
92862783|NCT00770679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862784|NCT00770679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92862785|NCT00770679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92507945|NCT00006786|Leucovorin|leucovorin|mesh-list
92862786|NCT00770679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862788|NCT04042116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862789|NCT04042116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862790|NCT04042116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92862791|NCT04042116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862792|NCT04260581|Amantadine|amantadine|mesh-list
92862793|NCT04260581|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92862794|NCT04260581|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92862795|NCT04260581|Antiviral Agents|antiviral agents|mesh-ancestor
92862796|NCT04260581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862797|NCT04260581|Dopamine Agents|dopamine agents|mesh-ancestor
92862798|NCT04260581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862799|NCT04260581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862800|NCT04260581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862801|NCT04260581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862802|NCT04260581|Analgesics|analgesics|mesh-ancestor
92862803|NCT04260581|Sensory System Agents|sensory system agents|mesh-ancestor
92862804|NCT04260581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862805|NCT00770367|Pioglitazone|pioglitazone|mesh-list
92862806|NCT00770367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862807|NCT00770367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862808|NCT00941785|Amodiaquine|amodiaquine|mesh-list
92862809|NCT00941785|Antimalarials|antimalarials|mesh-ancestor
92862810|NCT00941785|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92862811|NCT00941785|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92862812|NCT00941785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862813|NCT02793050|Trabectedin|trabectedin|mesh-list
92862814|NCT02793050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92862815|NCT02793050|Alkylating Agents|alkylating agents|mesh-ancestor
92862816|NCT02793050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862817|NCT02793050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862818|NCT00944905|MDX-1203|mdx-1203|mesh-list
92862819|NCT00944905|Immunoconjugates|immunoconjugates|mesh-ancestor
92862820|NCT00944905|Immunologic Factors|immunologic factors|mesh-ancestor
92862821|NCT00944905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862822|NCT00942253|Dopamine|dopamine|mesh-list
92862823|NCT00942253|Dopamine Agonists|dopamine agonists|mesh-list
92862824|NCT00942253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92862825|NCT00942253|Sympathomimetics|sympathomimetics|mesh-ancestor
92862826|NCT00942253|Autonomic Agents|autonomic agents|mesh-ancestor
92862827|NCT00942253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862828|NCT00942253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862829|NCT00942253|Dopamine Agents|dopamine agents|mesh-ancestor
92862830|NCT00942253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862831|NCT00942253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862832|NCT00942253|Protective Agents|protective agents|mesh-ancestor
92862833|NCT02792816|Artesunate|artesunate|mesh-list
92862834|NCT02792816|Artemether|artemether|mesh-list
92862835|NCT02792816|Piperaquine|piperaquine|mesh-list
92862836|NCT02792816|Artenimol|artenimol|mesh-list
92862837|NCT02792816|Mefloquine|mefloquine|mesh-list
92862838|NCT02792816|Antimalarials|antimalarials|mesh-list
92862839|NCT02792816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92862840|NCT02792816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92862841|NCT02792816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862842|NCT02792816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862843|NCT02792816|Antiviral Agents|antiviral agents|mesh-ancestor
92862844|NCT02792816|Schistosomicides|schistosomicides|mesh-ancestor
92862845|NCT02792816|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92862846|NCT02792816|Anthelmintics|anthelmintics|mesh-ancestor
92862847|NCT00940381|Sirolimus|sirolimus|mesh-list
92862848|NCT00940381|Cetuximab|cetuximab|mesh-list
92862849|NCT00940381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92862850|NCT00940381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862851|NCT00940381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862852|NCT00940381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862853|NCT00940381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92862854|NCT00940381|Antifungal Agents|antifungal agents|mesh-ancestor
92207377|NCT02394951|Pregabalin|pregabalin|mesh-list
92862855|NCT00940381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862856|NCT00940381|Immunologic Factors|immunologic factors|mesh-ancestor
92862857|NCT00940381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862858|NCT00637988|Aspirin|aspirin|mesh-list
92862859|NCT00637988|Rofecoxib|rofecoxib|mesh-list
92862860|NCT00637988|Esomeprazole|esomeprazole|mesh-list
92862861|NCT00637988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92508036|NCT00006049|Paclitaxel|paclitaxel|mesh-list
92862862|NCT00637988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862863|NCT00637988|Analgesics|analgesics|mesh-ancestor
92862865|NCT00637988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862866|NCT00637988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862867|NCT00637988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92862868|NCT00637988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92862869|NCT00637988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92862870|NCT00637988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92862871|NCT00637988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862872|NCT00637988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92862873|NCT00637988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92862874|NCT00637988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862875|NCT00637988|Antipyretics|antipyretics|mesh-ancestor
92862876|NCT00637988|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92862877|NCT00637988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92862878|NCT00637988|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92862879|NCT00637988|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92862880|NCT04258163|Gemcitabine|gemcitabine|mesh-list
92862881|NCT04258163|Capecitabine|capecitabine|mesh-list
92862882|NCT04258163|Doxorubicin|doxorubicin|mesh-list
92862883|NCT04258163|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92862884|NCT04258163|Letrozole|letrozole|mesh-list
92862885|NCT04258163|Fulvestrant|fulvestrant|mesh-list
92862886|NCT04258163|Anastrozole|anastrozole|mesh-list
92862887|NCT04258163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92862888|NCT04258163|Antimetabolites|antimetabolites|mesh-ancestor
92862889|NCT04258163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862890|NCT04258163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862891|NCT04258163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92862892|NCT04258163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92862893|NCT04258163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92862894|NCT04258163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862895|NCT04258163|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92862896|NCT04258163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92862897|NCT04258163|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92862898|NCT04258163|Hormone Antagonists|hormone antagonists|mesh-ancestor
92862899|NCT04258163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862900|NCT04258163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862901|NCT04258163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92862902|NCT04258163|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92862903|NCT00942487|Nebivolol|nebivolol|mesh-list
92862904|NCT00942487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92862905|NCT00942487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92862906|NCT00942487|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92862907|NCT00942487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92862908|NCT00942487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92862909|NCT00942487|Adrenergic Agents|adrenergic agents|mesh-ancestor
92862910|NCT00942487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862911|NCT00942487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862912|NCT00942487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862913|NCT00611039|Ritonavir|ritonavir|mesh-list
92862914|NCT00611039|Darunavir|darunavir|mesh-list
92862915|NCT00611039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92862916|NCT00611039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92862917|NCT00611039|Protease Inhibitors|protease inhibitors|mesh-ancestor
92862918|NCT00611039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862919|NCT00611039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862920|NCT00611039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92862921|NCT00611039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92862922|NCT00611039|Antiviral Agents|antiviral agents|mesh-ancestor
92862923|NCT00611039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862924|NCT00611039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92862925|NCT00611039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92862926|NCT00942565|Acetaminophen|acetaminophen|mesh-list
92862927|NCT00942565|Tramadol|tramadol|mesh-list
92862928|NCT00942565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92862929|NCT00942565|Analgesics|analgesics|mesh-ancestor
92862930|NCT00942565|Sensory System Agents|sensory system agents|mesh-ancestor
92862931|NCT00942565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862932|NCT00942565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862933|NCT00942565|Antipyretics|antipyretics|mesh-ancestor
92862934|NCT00942565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92862935|NCT00942565|Narcotics|narcotics|mesh-ancestor
92862936|NCT00942565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92862937|NCT00945373|Calcium Dobesilate|calcium dobesilate|mesh-list
92862938|NCT00945373|Calcium|calcium|mesh-list
92862939|NCT00945373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92862940|NCT00945373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862941|NCT00945373|Hemostatics|hemostatics|mesh-ancestor
92862942|NCT00945373|Coagulants|coagulants|mesh-ancestor
92862943|NCT04100655|Molgramostim|molgramostim|mesh-list
92862944|NCT04100655|Estradiol|estradiol|mesh-list
92862945|NCT04100655|Sargramostim|sargramostim|mesh-list
92862946|NCT04100655|Estrogens|estrogens|mesh-ancestor
92862947|NCT04100655|Hormones|hormones|mesh-ancestor
92862948|NCT04100655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92862949|NCT04100655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862950|NCT04100655|Immunologic Factors|immunologic factors|mesh-ancestor
92862951|NCT04100655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862952|NCT00556933|Mycophenolic Acid|mycophenolic acid|mesh-list
92862953|NCT00556933|Sirolimus|sirolimus|mesh-list
92862954|NCT00556933|Tacrolimus|tacrolimus|mesh-list
92862955|NCT00556933|Thymoglobulin|thymoglobulin|mesh-list
92862956|NCT00556933|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92862957|NCT00556933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92862958|NCT00556933|Immunologic Factors|immunologic factors|mesh-ancestor
92862959|NCT00556933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862960|NCT00556933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92862961|NCT00556933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92862962|NCT00556933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862963|NCT00556933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92862964|NCT00556933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862965|NCT00556933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92862966|NCT00556933|Antitubercular Agents|antitubercular agents|mesh-ancestor
92862967|NCT00556933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92862968|NCT00556933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92862969|NCT00556933|Antifungal Agents|antifungal agents|mesh-ancestor
92862970|NCT02792426|Nicotine|nicotine|mesh-list
92862971|NCT02792426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92862972|NCT02792426|Autonomic Agents|autonomic agents|mesh-ancestor
92862973|NCT02792426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862974|NCT02792426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862975|NCT02792426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92862976|NCT02792426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92862977|NCT02792426|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862978|NCT02792426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862979|NCT02792426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862980|NCT00770211|Botulinum Toxins|botulinum toxins|mesh-list
92862981|NCT00770211|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92862982|NCT00770211|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92862983|NCT00770211|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92862984|NCT00770211|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92862985|NCT00770211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92862986|NCT00770211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92862987|NCT00770211|Cholinergic Agents|cholinergic agents|mesh-ancestor
92862988|NCT00770211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92862989|NCT00770211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862990|NCT00770211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92862991|NCT00770211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92862992|NCT02792036|Carboplatin|carboplatin|mesh-list
92862993|NCT02792036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92862994|NCT02797340|Metformin|metformin|mesh-list
92862995|NCT02797340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92862996|NCT02797340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92862997|NCT00928187|Ritonavir|ritonavir|mesh-list
92862998|NCT00928187|Lopinavir|lopinavir|mesh-list
92862999|NCT00928187|Darunavir|darunavir|mesh-list
92863000|NCT00928187|Tenofovir|tenofovir|mesh-list
92863001|NCT00928187|Emtricitabine|emtricitabine|mesh-list
92863002|NCT00928187|Abacavir|abacavir|mesh-list
92863003|NCT00928187|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92863004|NCT00928187|Didanosine|didanosine|mesh-list
92863005|NCT00928187|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92863006|NCT00928187|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92863007|NCT00928187|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863008|NCT00928187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863009|NCT00928187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863010|NCT00928187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92863011|NCT00928187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92863012|NCT00928187|Antiviral Agents|antiviral agents|mesh-ancestor
92863013|NCT00928187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863014|NCT00928187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92863015|NCT00928187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92863016|NCT00928187|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92863017|NCT00928187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92863018|NCT00928187|Antimetabolites|antimetabolites|mesh-ancestor
92863019|NCT04235270|Tadalafil|tadalafil|mesh-list
92863020|NCT04235270|Macitentan|macitentan|mesh-list
92863021|NCT04235270|Vasodilator Agents|vasodilator agents|mesh-ancestor
92863022|NCT04235270|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92863023|NCT04235270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92863024|NCT04235270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863025|NCT04235270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863026|NCT04235270|Urological Agents|urological agents|mesh-ancestor
92863027|NCT04235270|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92863028|NCT04235270|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92863029|NCT04235270|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92863030|NCT04256525|Aspirin|aspirin|mesh-list
92863031|NCT04256525|Heparin|heparin|mesh-list
92863032|NCT04256525|Rivaroxaban|rivaroxaban|mesh-list
92863033|NCT04256525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92863034|NCT04256525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863035|NCT04256525|Analgesics|analgesics|mesh-ancestor
92863036|NCT04256525|Sensory System Agents|sensory system agents|mesh-ancestor
92863037|NCT04256525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863038|NCT04256525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863039|NCT04256525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863040|NCT04256525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863041|NCT04256525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92863042|NCT04256525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92863043|NCT04256525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863044|NCT04256525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92863045|NCT04256525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92863046|NCT04256525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863047|NCT04256525|Antipyretics|antipyretics|mesh-ancestor
92863048|NCT04256525|Anticoagulants|anticoagulants|mesh-ancestor
92863049|NCT04256525|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92863050|NCT04256525|Antithrombins|antithrombins|mesh-ancestor
92863051|NCT04256525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92863052|NCT04256525|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863053|NCT02791958|Ramipril|ramipril|mesh-list
92863054|NCT02791958|Atorvastatin|atorvastatin|mesh-list
92863055|NCT02791958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92863056|NCT02791958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92863057|NCT02791958|Antimetabolites|antimetabolites|mesh-ancestor
92863058|NCT02791958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863059|NCT02791958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92863060|NCT02791958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92863061|NCT02791958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863062|NCT02791958|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92863063|NCT02791958|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863064|NCT02791958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92863065|NCT02601651|Lidocaine|lidocaine|mesh-list
92863067|NCT02601651|Anesthetics|anesthetics|mesh-ancestor
92863068|NCT02601651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863069|NCT02601651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863070|NCT02601651|Sensory System Agents|sensory system agents|mesh-ancestor
92863071|NCT02601651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863072|NCT02601651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92863073|NCT02601651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92863074|NCT02601651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92863075|NCT02601651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863076|NCT02601651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863077|NCT00943267|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92863078|NCT00943267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863079|NCT00945919|Oxymorphone|oxymorphone|mesh-list
92863080|NCT00945919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92863081|NCT00945919|Narcotics|narcotics|mesh-ancestor
92863082|NCT00945919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863083|NCT00945919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863084|NCT00945919|Analgesics|analgesics|mesh-ancestor
92863085|NCT00945919|Sensory System Agents|sensory system agents|mesh-ancestor
92863086|NCT00945919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863087|NCT00945919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92863088|NCT00945997|Misoprostol|misoprostol|mesh-list
92863089|NCT00945997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92863091|NCT00945997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863092|NCT00945997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863093|NCT00945997|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92863094|NCT00945997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863095|NCT00945997|Oxytocics|oxytocics|mesh-ancestor
92863096|NCT00943345|Indomethacin|indomethacin|mesh-list
92863097|NCT00943345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92863098|NCT00943345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863099|NCT00943345|Analgesics|analgesics|mesh-ancestor
92863100|NCT00943345|Sensory System Agents|sensory system agents|mesh-ancestor
92863101|NCT00943345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863102|NCT00943345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863103|NCT00943345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863104|NCT00943345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863105|NCT00943345|Gout Suppressants|gout suppressants|mesh-ancestor
92863106|NCT00943345|Tocolytic Agents|tocolytic agents|mesh-ancestor
92863107|NCT00943345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863108|NCT00943345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92863109|NCT00943345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863110|NCT00943345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863111|NCT02797028|Allopurinol|allopurinol|mesh-list
92863112|NCT02797028|Antimetabolites|antimetabolites|mesh-ancestor
92863113|NCT02797028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863114|NCT02797028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863115|NCT02797028|Gout Suppressants|gout suppressants|mesh-ancestor
92863116|NCT02797028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863117|NCT02797028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92863118|NCT02797028|Antioxidants|antioxidants|mesh-ancestor
92863119|NCT02797028|Protective Agents|protective agents|mesh-ancestor
92863120|NCT02797028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863121|NCT00916461|Minocycline|minocycline|mesh-list
92863122|NCT00916461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92863123|NCT00916461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863124|NCT04260035|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92863125|NCT04260035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863126|NCT04260035|Vasodilator Agents|vasodilator agents|mesh-ancestor
92863127|NCT04260035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92863128|NCT04260035|Protective Agents|protective agents|mesh-ancestor
92863129|NCT04260035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863130|NCT00768651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92863131|NCT00768651|Pantoprazole|pantoprazole|mesh-list
92863132|NCT00768651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92863133|NCT00768651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863134|NCT00768651|Incretins|incretins|mesh-ancestor
92863135|NCT00768651|Hormones|hormones|mesh-ancestor
93026460|NCT00402285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863136|NCT00768651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863137|NCT00768651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92863138|NCT00768651|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863139|NCT00768651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207660|NCT00799643|Sodium Salicylate|sodium salicylate|mesh-list
92863140|NCT00768651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863141|NCT00768651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92863142|NCT00768651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863143|NCT00768651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92863144|NCT00943501|Liraglutide|liraglutide|mesh-list
92863145|NCT00943501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92863146|NCT00943501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863147|NCT00943501|Incretins|incretins|mesh-ancestor
92863148|NCT00943501|Hormones|hormones|mesh-ancestor
92863149|NCT00943501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863150|NCT04258241|Bupivacaine|bupivacaine|mesh-list
92863151|NCT04258241|Anesthetics, Local|anesthetics, local|mesh-list
92863152|NCT04258241|Anesthetics|anesthetics|mesh-list
92863153|NCT04258241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92863154|NCT04258241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863155|NCT04258241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863156|NCT04258241|Sensory System Agents|sensory system agents|mesh-ancestor
92863157|NCT04258241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863158|NCT02796794|Genistein|genistein|mesh-list
92863159|NCT02796794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92863160|NCT02796794|Protective Agents|protective agents|mesh-ancestor
92863161|NCT02796794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863162|NCT02796794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863163|NCT02796794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92863164|NCT02796794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863165|NCT02796794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863166|NCT02796794|Phytoestrogens|phytoestrogens|mesh-ancestor
92863167|NCT02796794|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92863168|NCT02796794|Estrogens|estrogens|mesh-ancestor
92863169|NCT02796794|Hormones|hormones|mesh-ancestor
92863170|NCT02796794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863171|NCT04097613|Povidone-Iodine|povidone-iodine|mesh-list
92863172|NCT04097613|Budesonide|budesonide|mesh-list
92863173|NCT04097613|Povidone|povidone|mesh-list
92863174|NCT04097613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863175|NCT04097613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92863176|NCT04097613|Autonomic Agents|autonomic agents|mesh-ancestor
92863177|NCT04097613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863178|NCT04097613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863179|NCT04097613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92863180|NCT04097613|Respiratory System Agents|respiratory system agents|mesh-ancestor
92863181|NCT04097613|Glucocorticoids|glucocorticoids|mesh-ancestor
92863182|NCT04097613|Hormones|hormones|mesh-ancestor
92863183|NCT04097613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863184|NCT04097613|Plasma Substitutes|plasma substitutes|mesh-ancestor
92863185|NCT04097613|Blood Substitutes|blood substitutes|mesh-ancestor
92863186|NCT04097613|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92863187|NCT04097613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863188|NCT00946387|Ondansetron|ondansetron|mesh-list
92863189|NCT00946387|Antiemetics|antiemetics|mesh-ancestor
92863190|NCT00946387|Autonomic Agents|autonomic agents|mesh-ancestor
92863191|NCT00946387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863192|NCT00946387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863193|NCT00946387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863194|NCT00946387|Antipruritics|antipruritics|mesh-ancestor
92863195|NCT00946387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92863196|NCT00946387|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92863197|NCT00946387|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92863198|NCT00946387|Serotonin Agents|serotonin agents|mesh-ancestor
92863199|NCT00946387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863200|NCT00946387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863201|NCT00916695|Everolimus|everolimus|mesh-list
92863202|NCT00916695|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92863203|NCT00916695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92863204|NCT00916695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863205|NCT00916695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863206|NCT00916695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92863207|NCT00916695|Immunologic Factors|immunologic factors|mesh-ancestor
92863208|NCT00916695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863209|NCT00916695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863210|NCT00946465|Ramipril|ramipril|mesh-list
92863211|NCT00946465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92863212|NCT00946465|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863213|NCT00946465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863214|NCT00946465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863215|NCT00946465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92863216|NCT00756717|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92863217|NCT00756717|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92863218|NCT00756717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863219|NCT00756717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863221|NCT00946621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92863222|NCT00946621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863223|NCT00946621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863224|NCT00946621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863225|NCT00946621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92863226|NCT02600793|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92863227|NCT02600793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92863228|NCT02600793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863229|NCT04235894|Propofol|propofol|mesh-list
92863230|NCT04235894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92863231|NCT04235894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863232|NCT04235894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863233|NCT04235894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92863234|NCT04235894|Anesthetics, General|anesthetics, general|mesh-ancestor
92863235|NCT04235894|Anesthetics|anesthetics|mesh-ancestor
92863236|NCT04096599|Fluorides|fluorides|mesh-list
92863237|NCT04096599|Cariostatic Agents|cariostatic agents|mesh-ancestor
92863238|NCT04096599|Protective Agents|protective agents|mesh-ancestor
92863239|NCT04096599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863240|NCT00923351|Vaccines|vaccines|mesh-list
92863241|NCT00923351|Immunologic Factors|immunologic factors|mesh-ancestor
92863242|NCT00923351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863243|NCT02788292|Acetylcysteine|acetylcysteine|mesh-list
92863244|NCT02788292|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92863245|NCT02788292|Antiviral Agents|antiviral agents|mesh-ancestor
92863246|NCT02788292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863247|NCT02788292|Expectorants|expectorants|mesh-ancestor
92863248|NCT02788292|Respiratory System Agents|respiratory system agents|mesh-ancestor
92863249|NCT02788292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92863250|NCT02788292|Antioxidants|antioxidants|mesh-ancestor
92863251|NCT02788292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863252|NCT02788292|Protective Agents|protective agents|mesh-ancestor
92863253|NCT02788292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863254|NCT02788292|Antidotes|antidotes|mesh-ancestor
92863255|NCT00944359|Zinc|zinc|mesh-list
92863256|NCT00944359|Trace Elements|trace elements|mesh-ancestor
92863257|NCT00944359|Micronutrients|micronutrients|mesh-ancestor
92863258|NCT00944359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863259|NCT02791256|Ribavirin|ribavirin|mesh-list
92863260|NCT02791256|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92863261|NCT02791256|Antimetabolites|antimetabolites|mesh-ancestor
92863262|NCT02791256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863263|NCT02791256|Antiviral Agents|antiviral agents|mesh-ancestor
92863264|NCT02791256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863265|NCT04258007|Neostigmine|neostigmine|mesh-list
92863266|NCT04258007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92863267|NCT04258007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863268|NCT04258007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863269|NCT04258007|Cholinergic Agents|cholinergic agents|mesh-ancestor
92863270|NCT04258007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863271|NCT04258007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863272|NCT04258007|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92863273|NCT04258007|Autonomic Agents|autonomic agents|mesh-ancestor
92863274|NCT04258007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863275|NCT02787824|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92863276|NCT02787824|Hematinics|hematinics|mesh-ancestor
92863277|NCT02796950|Acipimox|acipimox|mesh-list
92863278|NCT02796950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92863279|NCT02796950|Antimetabolites|antimetabolites|mesh-ancestor
92863280|NCT02796950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863281|NCT02796950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92863282|NCT00755079|Adrenergic Agents|adrenergic agents|mesh-list
92863283|NCT00755079|Adrenergic Agonists|adrenergic agonists|mesh-list
92863284|NCT00755079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863285|NCT00755079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863286|NCT00755079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863287|NCT00950209|Heparin|heparin|mesh-list
92863288|NCT00950209|Anticoagulants|anticoagulants|mesh-ancestor
92863289|NCT00950209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92863290|NCT00950209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92863291|NCT00950209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863292|NCT05370326|Analgesics, Opioid|analgesics, opioid|mesh-list
92863293|NCT05370326|Narcotics|narcotics|mesh-ancestor
92863294|NCT05370326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863295|NCT05370326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863296|NCT05370326|Analgesics|analgesics|mesh-ancestor
92863297|NCT05370326|Sensory System Agents|sensory system agents|mesh-ancestor
92863298|NCT05370326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863299|NCT00947323|Simvastatin|simvastatin|mesh-list
92863300|NCT00947323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92863301|NCT00947323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92863302|NCT00947323|Antimetabolites|antimetabolites|mesh-ancestor
92863303|NCT00947323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863304|NCT00947323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92863305|NCT00947323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92863306|NCT00947323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863307|NCT04236050|Rocuronium|rocuronium|mesh-list
92863308|NCT04236050|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92863309|NCT04236050|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92863310|NCT04236050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92863311|NCT04236050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863312|NCT04236050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863313|NCT02790632|Nimodipine|nimodipine|mesh-list
92863314|NCT02790632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92863315|NCT02790632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92863316|NCT02790632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863317|NCT02790632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863318|NCT02790632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92863319|NCT02790632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863320|NCT02790632|Vasodilator Agents|vasodilator agents|mesh-ancestor
92863321|NCT03633110|Pembrolizumab|pembrolizumab|mesh-list
92863322|NCT03633110|Nivolumab|nivolumab|mesh-list
92863323|NCT03633110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92863324|NCT03633110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863325|NCT03633110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92863326|NCT03633110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863327|NCT02788136|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92863328|NCT02788136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863329|NCT02788136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863330|NCT02788058|Gefitinib|gefitinib|mesh-list
92863331|NCT02788058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863332|NCT02788058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92863333|NCT02788058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863334|NCT02788058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863335|NCT04200092|Granisetron|granisetron|mesh-list
92863336|NCT04200092|Antiemetics|antiemetics|mesh-ancestor
92863337|NCT04200092|Autonomic Agents|autonomic agents|mesh-ancestor
92863338|NCT04200092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863339|NCT04200092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863340|NCT04200092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863341|NCT04200092|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92863342|NCT04200092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92863343|NCT04200092|Serotonin Agents|serotonin agents|mesh-ancestor
92863344|NCT04200092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863345|NCT04200092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863346|NCT00754065|Moxifloxacin|moxifloxacin|mesh-list
92863348|NCT00754065|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92863349|NCT00754065|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92863350|NCT00754065|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92863351|NCT00754065|Estradiol|estradiol|mesh-list
92863352|NCT00754065|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92863353|NCT00754065|Estrogens|estrogens|mesh-ancestor
92863354|NCT00754065|Hormones|hormones|mesh-ancestor
92863355|NCT00754065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863356|NCT00754065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863357|NCT00754065|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92863358|NCT00754065|Contraceptive Agents|contraceptive agents|mesh-ancestor
92863359|NCT00754065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863360|NCT00754065|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92863361|NCT00754065|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92863362|NCT00754065|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92863363|NCT00754065|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92863364|NCT00754065|Hormone Antagonists|hormone antagonists|mesh-ancestor
92863365|NCT00754065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92863366|NCT00754065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863367|NCT00754065|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92863368|NCT00754065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92863369|NCT00754065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863370|NCT00754065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92863371|NCT00754065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92863372|NCT00754065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863373|NCT00754065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863374|NCT02787746|Donepezil|donepezil|mesh-list
92863375|NCT02787746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92863376|NCT02787746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863377|NCT02787746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863378|NCT02787746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92863379|NCT02787746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863380|NCT02787746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863381|NCT02787746|Nootropic Agents|nootropic agents|mesh-ancestor
92863382|NCT03254654|Apatinib|apatinib|mesh-list
92863383|NCT03254654|Vinorelbine|vinorelbine|mesh-list
92863384|NCT03254654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863385|NCT03254654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92863386|NCT03254654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863387|NCT03254654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863388|NCT03254654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92863389|NCT03254654|Tubulin Modulators|tubulin modulators|mesh-ancestor
92863390|NCT03254654|Antimitotic Agents|antimitotic agents|mesh-ancestor
92863391|NCT03254654|Mitosis Modulators|mitosis modulators|mesh-ancestor
92863392|NCT02785718|Hemostatics|hemostatics|mesh-list
92863393|NCT02785718|Coagulants|coagulants|mesh-ancestor
92863394|NCT04094805|Calcitriol|calcitriol|mesh-list
92863395|NCT04094805|Dexamethasone|dexamethasone|mesh-list
92863396|NCT04094805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863397|NCT04094805|Antiemetics|antiemetics|mesh-ancestor
92863398|NCT04094805|Autonomic Agents|autonomic agents|mesh-ancestor
92863399|NCT04094805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863400|NCT04094805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863401|NCT04094805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863402|NCT04094805|Glucocorticoids|glucocorticoids|mesh-ancestor
92863403|NCT04094805|Hormones|hormones|mesh-ancestor
92863404|NCT04094805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863405|NCT04094805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92863406|NCT04094805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863407|NCT04094805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92863408|NCT04094805|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92863409|NCT04094805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863410|NCT04094805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863411|NCT04094805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92863412|NCT04094805|Vitamins|vitamins|mesh-ancestor
92863413|NCT04094805|Micronutrients|micronutrients|mesh-ancestor
92863414|NCT04094805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92863415|NCT04094727|Lumefantrine|lumefantrine|mesh-list
92863416|NCT04094727|Artemether|artemether|mesh-list
92863417|NCT04094727|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92863418|NCT04094727|Antimalarials|antimalarials|mesh-ancestor
92863419|NCT04094727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92863420|NCT04094727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92863421|NCT04094727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863422|NCT00638066|Botulinum Toxins|botulinum toxins|mesh-list
92863423|NCT00638066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92863424|NCT00638066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92863425|NCT00638066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92863426|NCT00638066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863427|NCT00638066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863428|NCT00638066|Cholinergic Agents|cholinergic agents|mesh-ancestor
92863429|NCT00638066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863430|NCT00638066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863431|NCT00638066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92863432|NCT00638066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863433|NCT02786732|Ustekinumab|ustekinumab|mesh-list
92863434|NCT02786732|Brodalumab|brodalumab|mesh-list
92863435|NCT02786732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92863436|NCT02786732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92863437|NCT02786732|Immunologic Factors|immunologic factors|mesh-ancestor
92863438|NCT02786732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863439|NCT02785250|Cyclophosphamide|cyclophosphamide|mesh-list
92863440|NCT02785250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92863441|NCT02785250|Immunologic Factors|immunologic factors|mesh-ancestor
92863442|NCT02785250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863443|NCT02785250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863444|NCT02785250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92863445|NCT02785250|Alkylating Agents|alkylating agents|mesh-ancestor
92863446|NCT02785250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863447|NCT02785250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863448|NCT02785250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92863449|NCT03110822|Methylprednisolone|methylprednisolone|mesh-list
92863450|NCT03110822|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92863451|NCT03110822|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92863452|NCT03110822|Prednisolone|prednisolone|mesh-list
92863453|NCT03110822|Prednisolone acetate|prednisolone acetate|mesh-list
92863454|NCT03110822|Lenalidomide|lenalidomide|mesh-list
92863455|NCT03110822|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92863456|NCT03110822|Prednisolone phosphate|prednisolone phosphate|mesh-list
92863457|NCT03110822|Immunologic Factors|immunologic factors|mesh-ancestor
92863458|NCT03110822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863459|NCT03110822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92863460|NCT03110822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92863461|NCT03110822|Growth Substances|growth substances|mesh-ancestor
92863462|NCT03110822|Growth Inhibitors|growth inhibitors|mesh-ancestor
92863463|NCT03110822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863464|NCT03110822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863466|NCT03110822|Autonomic Agents|autonomic agents|mesh-ancestor
92863467|NCT03110822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863468|NCT03110822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863469|NCT03110822|Glucocorticoids|glucocorticoids|mesh-ancestor
92863470|NCT03110822|Hormones|hormones|mesh-ancestor
92863471|NCT03110822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863472|NCT03110822|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92863473|NCT03110822|Protective Agents|protective agents|mesh-ancestor
92863474|NCT03110822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92863475|NCT02787356|Lidocaine|lidocaine|mesh-list
92863476|NCT02787356|Anesthetics, Local|anesthetics, local|mesh-ancestor
92863477|NCT02787356|Anesthetics|anesthetics|mesh-ancestor
92863478|NCT02787356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863479|NCT02787356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863480|NCT02787356|Sensory System Agents|sensory system agents|mesh-ancestor
92863481|NCT02787356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863482|NCT02787356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92863483|NCT02787356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92863484|NCT02787356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92863485|NCT02787356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863486|NCT02787356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863487|NCT02787278|Otaplimastat|otaplimastat|mesh-list
92863488|NCT02787278|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92863489|NCT02787278|Protective Agents|protective agents|mesh-ancestor
92863490|NCT02787278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863491|NCT03083678|Afatinib|afatinib|mesh-list
92863492|NCT03083678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863493|NCT03083678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92863494|NCT03083678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863495|NCT03083678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863496|NCT04232150|Midazolam|midazolam|mesh-list
92863497|NCT04232150|Anesthetics|anesthetics|mesh-list
92863498|NCT04232150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863499|NCT04232150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863500|NCT04232150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92863501|NCT04232150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92863502|NCT04232150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92863503|NCT04232150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92863504|NCT04232150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92863505|NCT04232150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92863506|NCT04232150|Anesthetics, General|anesthetics, general|mesh-ancestor
92863507|NCT04232150|GABA Modulators|gaba modulators|mesh-ancestor
92863508|NCT04232150|GABA Agents|gaba agents|mesh-ancestor
92863509|NCT04232150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863510|NCT04232150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863511|NCT04197752|Anesthetics|anesthetics|mesh-list
92863512|NCT04197752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863513|NCT04197752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863514|NCT02336750|Aprepitant|aprepitant|mesh-list
92863515|NCT02336750|Fosaprepitant|fosaprepitant|mesh-list
92863516|NCT02336750|Mirtazapine|mirtazapine|mesh-list
92863517|NCT02336750|Antiemetics|antiemetics|mesh-ancestor
92863518|NCT02336750|Autonomic Agents|autonomic agents|mesh-ancestor
92863519|NCT02336750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863520|NCT02336750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863521|NCT02336750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863522|NCT02336750|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92863523|NCT02336750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863524|NCT02336750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863525|NCT02336750|Antidepressive Agents|antidepressive agents|mesh-ancestor
92863526|NCT02336750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92863527|NCT02336750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92863528|NCT02336750|Histamine Antagonists|histamine antagonists|mesh-ancestor
92863529|NCT02336750|Histamine Agents|histamine agents|mesh-ancestor
92863530|NCT02336750|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92863531|NCT02336750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92863532|NCT02336750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863533|NCT02336750|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92863534|NCT02336750|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92863535|NCT02336750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92863536|NCT02336750|Adrenergic Agents|adrenergic agents|mesh-ancestor
92863537|NCT02336750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92863538|NCT02336750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92863539|NCT02336750|Serotonin Agents|serotonin agents|mesh-ancestor
92863540|NCT02336750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92863541|NCT02784392|Metoclopramide|metoclopramide|mesh-list
92863542|NCT02784392|Antiemetics|antiemetics|mesh-ancestor
92863543|NCT02784392|Autonomic Agents|autonomic agents|mesh-ancestor
92863544|NCT02784392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863545|NCT02784392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863546|NCT02784392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863547|NCT02784392|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92863548|NCT02784392|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92863549|NCT02784392|Dopamine Agents|dopamine agents|mesh-ancestor
92863550|NCT02784392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863551|NCT02784392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863552|NCT00634556|Levodopa|levodopa|mesh-list
92863553|NCT00634556|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92863554|NCT00634556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92863555|NCT00634556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92863556|NCT00634556|Dopamine Agents|dopamine agents|mesh-ancestor
92863557|NCT00634556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863558|NCT00634556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863559|NCT00634556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863560|NCT02784080|Isoantibodies|isoantibodies|mesh-list
92863561|NCT02784080|Immunologic Factors|immunologic factors|mesh-ancestor
92863562|NCT02784080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863563|NCT02784860|Lidocaine|lidocaine|mesh-list
92863564|NCT02784860|Anesthetics, Local|anesthetics, local|mesh-ancestor
92863565|NCT02784860|Anesthetics|anesthetics|mesh-ancestor
92863566|NCT02784860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863567|NCT02784860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863568|NCT02784860|Sensory System Agents|sensory system agents|mesh-ancestor
92863569|NCT02784860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863570|NCT02784860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92863571|NCT02784860|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92863572|NCT02784860|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92863573|NCT02784860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863574|NCT02784860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863576|NCT02783924|Vitamin D|vitamin d|mesh-list
92863577|NCT02783924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92863578|NCT02783924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863579|NCT02783924|Vitamins|vitamins|mesh-ancestor
92863580|NCT02783924|Micronutrients|micronutrients|mesh-ancestor
92863581|NCT02783924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92863582|NCT02783846|Dexmedetomidine|dexmedetomidine|mesh-list
92863583|NCT02783846|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92863584|NCT02783846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863585|NCT02783846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863586|NCT02783846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863587|NCT02783846|Analgesics|analgesics|mesh-ancestor
92863588|NCT02783846|Sensory System Agents|sensory system agents|mesh-ancestor
92863589|NCT02783846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863590|NCT02783846|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92863591|NCT02783846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92863592|NCT02783846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92863593|NCT02783846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92863594|NCT02783846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863595|NCT02783846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863596|NCT02783378|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
92863597|NCT02783378|Antacids|antacids|mesh-ancestor
92863598|NCT02783378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863599|NCT02783378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863600|NCT05237726|Heparin|heparin|mesh-list
92863601|NCT05237726|Enoxaparin|enoxaparin|mesh-list
92863602|NCT05237726|Calcium heparin|calcium heparin|mesh-list
92863603|NCT05237726|Enoxaparin sodium|enoxaparin sodium|mesh-list
92863604|NCT05237726|Anticoagulants|anticoagulants|mesh-ancestor
92863605|NCT05237726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92863606|NCT05237726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92863607|NCT05237726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863608|NCT02783144|Dexamethasone|dexamethasone|mesh-list
92863609|NCT02783144|Dexamethasone acetate|dexamethasone acetate|mesh-list
92863610|NCT02783144|BB 1101|bb 1101|mesh-list
92863611|NCT02783144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863612|NCT02783144|Antiemetics|antiemetics|mesh-ancestor
92863613|NCT02783144|Autonomic Agents|autonomic agents|mesh-ancestor
92863614|NCT02783144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863615|NCT02783144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863616|NCT02783144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863617|NCT02783144|Glucocorticoids|glucocorticoids|mesh-ancestor
92863618|NCT02783144|Hormones|hormones|mesh-ancestor
92863619|NCT02783144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863620|NCT02783144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92863621|NCT02783144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863622|NCT02783144|Protease Inhibitors|protease inhibitors|mesh-ancestor
92863623|NCT02783144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863624|NCT02783144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863625|NCT05260320|Anesthetics|anesthetics|mesh-list
92863626|NCT05260320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863627|NCT05260320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863628|NCT02783222|Paclitaxel|paclitaxel|mesh-list
92863629|NCT02783222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92863630|NCT02783222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863631|NCT02783222|Tubulin Modulators|tubulin modulators|mesh-ancestor
92863632|NCT02783222|Antimitotic Agents|antimitotic agents|mesh-ancestor
92863633|NCT02783222|Mitosis Modulators|mitosis modulators|mesh-ancestor
92863634|NCT02783222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863635|NCT02689856|Hydrocortisone|hydrocortisone|mesh-list
92863636|NCT02689856|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92863638|NCT02689856|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92863639|NCT02689856|Lidocaine|lidocaine|mesh-list
92863640|NCT02689856|Anesthetics, Local|anesthetics, local|mesh-ancestor
92863641|NCT02689856|Anesthetics|anesthetics|mesh-ancestor
92863642|NCT02689856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863643|NCT02689856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863644|NCT02689856|Sensory System Agents|sensory system agents|mesh-ancestor
92863645|NCT02689856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863646|NCT02689856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92863647|NCT02689856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92863648|NCT02689856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92863649|NCT02689856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863650|NCT02689856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863651|NCT02689856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863652|NCT02722902|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92863653|NCT02722902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92863654|NCT02722902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92863655|NCT02722902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92863656|NCT05206448|Letrozole|letrozole|mesh-list
92863657|NCT05206448|Clomiphene|clomiphene|mesh-list
92863658|NCT05206448|Enclomiphene|enclomiphene|mesh-list
92863659|NCT05206448|Zuclomiphene|zuclomiphene|mesh-list
92863660|NCT05206448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863661|NCT05206448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863662|NCT05206448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92863663|NCT05206448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92863664|NCT05206448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863665|NCT05206448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92863666|NCT05206448|Hormone Antagonists|hormone antagonists|mesh-ancestor
92863667|NCT05206448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863668|NCT05206448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863669|NCT05206448|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92863670|NCT05206448|Fertility Agents|fertility agents|mesh-ancestor
92863671|NCT05206448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863672|NCT05206448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92863673|NCT05206448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92863674|NCT02722746|Epinephrine|epinephrine|mesh-list
92863675|NCT02722746|Ropivacaine|ropivacaine|mesh-list
92863676|NCT02722746|Anesthetics, Local|anesthetics, local|mesh-ancestor
92863677|NCT02722746|Anesthetics|anesthetics|mesh-ancestor
92863678|NCT02722746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863679|NCT02722746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863680|NCT02722746|Sensory System Agents|sensory system agents|mesh-ancestor
92863681|NCT02722746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863682|NCT02722746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92863683|NCT02722746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92863684|NCT02722746|Adrenergic Agents|adrenergic agents|mesh-ancestor
92863685|NCT02722746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863686|NCT02722746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863687|NCT02722746|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92863688|NCT02722746|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92863689|NCT02722746|Autonomic Agents|autonomic agents|mesh-ancestor
92863690|NCT02722746|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92863691|NCT02722746|Respiratory System Agents|respiratory system agents|mesh-ancestor
92863692|NCT02722746|Mydriatics|mydriatics|mesh-ancestor
92863693|NCT02722746|Sympathomimetics|sympathomimetics|mesh-ancestor
92863694|NCT02722746|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92863695|NCT02784626|Dexmedetomidine|dexmedetomidine|mesh-list
92863696|NCT02784626|Propofol|propofol|mesh-list
93026461|NCT03747159|Belimumab|belimumab|mesh-list
92863697|NCT02784626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92863698|NCT02784626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863699|NCT02784626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863700|NCT02784626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863701|NCT02784626|Analgesics|analgesics|mesh-ancestor
92863702|NCT02784626|Sensory System Agents|sensory system agents|mesh-ancestor
92863703|NCT02784626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863704|NCT02784626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92863705|NCT02784626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92863706|NCT02784626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92863707|NCT02784626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92863708|NCT02784626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863709|NCT02784626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863710|NCT02784626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92863711|NCT02784626|Anesthetics, General|anesthetics, general|mesh-ancestor
92863712|NCT02784626|Anesthetics|anesthetics|mesh-ancestor
92863713|NCT02782754|Cyclophosphamide|cyclophosphamide|mesh-list
92863714|NCT02782754|Carboplatin|carboplatin|mesh-list
92863715|NCT02782754|Etoposide|etoposide|mesh-list
92863716|NCT02782754|Bleomycin|bleomycin|mesh-list
92863717|NCT02782754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92863718|NCT02782754|Immunologic Factors|immunologic factors|mesh-ancestor
92863719|NCT02782754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863720|NCT02782754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863721|NCT02782754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92863722|NCT02782754|Alkylating Agents|alkylating agents|mesh-ancestor
92863723|NCT02782754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863724|NCT02782754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863725|NCT02782754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92863726|NCT02782754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92863727|NCT02782754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92863728|NCT02782754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92863729|NCT02782754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863730|NCT02782754|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92863731|NCT05341076|Oxytocin|oxytocin|mesh-list
92863732|NCT05341076|Oxytocics|oxytocics|mesh-ancestor
92863733|NCT05341076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863734|NCT05341076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863735|NCT05133518|Midazolam|midazolam|mesh-list
92863736|NCT05133518|Ketamine|ketamine|mesh-list
92863737|NCT05133518|Analgesics|analgesics|mesh-ancestor
92863738|NCT05133518|Sensory System Agents|sensory system agents|mesh-ancestor
92863739|NCT05133518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863740|NCT05133518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863741|NCT05133518|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92863742|NCT05133518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92863743|NCT05133518|Anesthetics, General|anesthetics, general|mesh-ancestor
92863744|NCT05133518|Anesthetics|anesthetics|mesh-ancestor
92863745|NCT05133518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863746|NCT05133518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92863747|NCT05133518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92863748|NCT05133518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863749|NCT05133518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863750|NCT05133518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92863751|NCT05133518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92863752|NCT05133518|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92863753|NCT05133518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92863754|NCT05133518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92863755|NCT05133518|GABA Modulators|gaba modulators|mesh-ancestor
92863756|NCT05133518|GABA Agents|gaba agents|mesh-ancestor
92863757|NCT02714712|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92863758|NCT02714712|Antiviral Agents|antiviral agents|mesh-ancestor
92863759|NCT02714712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863760|NCT02714166|Sunscreening Agents|sunscreening agents|mesh-list
92863761|NCT02714166|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92863762|NCT02714166|Protective Agents|protective agents|mesh-ancestor
92863763|NCT02714166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863764|NCT02714166|Dermatologic Agents|dermatologic agents|mesh-ancestor
92863765|NCT04231682|Denosumab|denosumab|mesh-list
92863766|NCT04231682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92863767|NCT04231682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863768|NCT02722356|Oxytocin|oxytocin|mesh-list
92863769|NCT02722356|Oxytocics|oxytocics|mesh-ancestor
92863770|NCT02722356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863771|NCT02722356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863772|NCT00753675|Gemcitabine|gemcitabine|mesh-list
92863773|NCT00753675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92863774|NCT00753675|Antimetabolites|antimetabolites|mesh-ancestor
92863775|NCT00753675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863776|NCT00753675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863777|NCT05131178|Bupivacaine|bupivacaine|mesh-list
92863778|NCT05131178|Anesthetics, Local|anesthetics, local|mesh-ancestor
92863779|NCT05131178|Anesthetics|anesthetics|mesh-ancestor
92863780|NCT05131178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863781|NCT05131178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863782|NCT05131178|Sensory System Agents|sensory system agents|mesh-ancestor
92863783|NCT05131178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863784|NCT02546934|Cisplatin|cisplatin|mesh-list
92863786|NCT02546934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863787|NCT02546934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92863788|NCT02546934|Antimetabolites|antimetabolites|mesh-ancestor
92863789|NCT02546934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863790|NCT00586521|Factor VIII|factor viii|mesh-list
92863791|NCT00586521|Coagulants|coagulants|mesh-ancestor
92863792|NCT02782286|Ketorolac|ketorolac|mesh-list
92863793|NCT02782286|Morphine|morphine|mesh-list
92863794|NCT02782286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92863795|NCT02782286|Narcotics|narcotics|mesh-ancestor
92863796|NCT02782286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863797|NCT02782286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863798|NCT02782286|Analgesics|analgesics|mesh-ancestor
92863799|NCT02782286|Sensory System Agents|sensory system agents|mesh-ancestor
92863800|NCT02782286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863801|NCT02782286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92863802|NCT02782286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863803|NCT02782286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863804|NCT02782286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863805|NCT02782286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92863806|NCT02782286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863807|NCT02782286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863808|NCT04231448|Prednisone|prednisone|mesh-list
92863809|NCT04231448|Cyclophosphamide|cyclophosphamide|mesh-list
92863810|NCT04231448|Rituximab|rituximab|mesh-list
92863811|NCT04231448|Doxorubicin|doxorubicin|mesh-list
92863812|NCT04231448|Vincristine|vincristine|mesh-list
92863813|NCT04231448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92863814|NCT04231448|Immunologic Factors|immunologic factors|mesh-ancestor
92863815|NCT04231448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863816|NCT04231448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863817|NCT04231448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92863818|NCT04231448|Alkylating Agents|alkylating agents|mesh-ancestor
92863819|NCT04231448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863820|NCT04231448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863821|NCT04231448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92863822|NCT04231448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92863823|NCT04231448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92863824|NCT04231448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92863825|NCT04231448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92863826|NCT04231448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863827|NCT04231448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863828|NCT04231448|Glucocorticoids|glucocorticoids|mesh-ancestor
92863829|NCT04231448|Hormones|hormones|mesh-ancestor
92863830|NCT04231448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863831|NCT04231448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92863832|NCT04231448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92863833|NCT04231448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92863834|NCT04231448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92863835|NCT04231448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92863836|NCT02600247|Acetaminophen|acetaminophen|mesh-list
92863837|NCT02600247|Celecoxib|celecoxib|mesh-list
92863838|NCT02600247|Pregabalin|pregabalin|mesh-list
92863839|NCT02600247|Oxycodone|oxycodone|mesh-list
92863840|NCT02600247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92863841|NCT02600247|Tramadol|tramadol|mesh-list
92863842|NCT02600247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863843|NCT02600247|Analgesics|analgesics|mesh-ancestor
92863844|NCT02600247|Sensory System Agents|sensory system agents|mesh-ancestor
92863845|NCT02600247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863846|NCT02600247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863847|NCT02600247|Antipyretics|antipyretics|mesh-ancestor
92863848|NCT02600247|Anticonvulsants|anticonvulsants|mesh-ancestor
92863849|NCT02600247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92863850|NCT02600247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863851|NCT02600247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863852|NCT02600247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92863853|NCT02600247|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92863854|NCT02600247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92863855|NCT02600247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863856|NCT02600247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92863857|NCT02600247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92863858|NCT02600247|Narcotics|narcotics|mesh-ancestor
92863859|NCT02600247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92208385|NCT00821795|Coagulants|coagulants|mesh-ancestor
92863860|NCT02600247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863861|NCT02600247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863862|NCT02600247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92863863|NCT02600247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92863864|NCT02600247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863865|NCT02600247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92863866|NCT02600247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92863867|NCT02600247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863868|NCT02600247|Antidepressive Agents|antidepressive agents|mesh-ancestor
92863869|NCT02600247|Dopamine Agents|dopamine agents|mesh-ancestor
92863870|NCT05453253|Vaccines|vaccines|mesh-list
92863871|NCT05453253|Immunologic Factors|immunologic factors|mesh-ancestor
92863872|NCT05453253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863873|NCT04229498|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92863874|NCT04229498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863875|NCT02717052|Ketamine|ketamine|mesh-list
92863876|NCT02717052|Esketamine|esketamine|mesh-list
92863877|NCT02717052|Analgesics|analgesics|mesh-ancestor
92863878|NCT02717052|Sensory System Agents|sensory system agents|mesh-ancestor
92863879|NCT02717052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863880|NCT02717052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863881|NCT02717052|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92863882|NCT02717052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92863883|NCT02717052|Anesthetics, General|anesthetics, general|mesh-ancestor
92863884|NCT02717052|Anesthetics|anesthetics|mesh-ancestor
92863885|NCT02717052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863886|NCT02717052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92863887|NCT02717052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92863888|NCT02717052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92863889|NCT02717052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863890|NCT02717052|Antidepressive Agents|antidepressive agents|mesh-ancestor
92863891|NCT02717052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92863892|NCT05342558|Fluticasone|fluticasone|mesh-list
92863893|NCT05342558|Xhance|xhance|mesh-list
92863894|NCT05342558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863895|NCT05342558|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92863896|NCT05342558|Autonomic Agents|autonomic agents|mesh-ancestor
92863897|NCT05342558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863898|NCT05342558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863899|NCT05342558|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92863900|NCT05342558|Respiratory System Agents|respiratory system agents|mesh-ancestor
92863901|NCT05342558|Dermatologic Agents|dermatologic agents|mesh-ancestor
92863902|NCT05342558|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92863903|NCT00923273|Folic Acid|folic acid|mesh-list
92863904|NCT00923273|Vitamin B 12|vitamin b 12|mesh-list
92863905|NCT00923273|Sirolimus|sirolimus|mesh-list
92863906|NCT00923273|Dexamethasone|dexamethasone|mesh-list
92863907|NCT00923273|Pemetrexed|pemetrexed|mesh-list
92863908|NCT00923273|Vitamins|vitamins|mesh-ancestor
92863909|NCT00923273|Micronutrients|micronutrients|mesh-ancestor
92863910|NCT00923273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863911|NCT00923273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92863912|NCT00923273|Antiemetics|antiemetics|mesh-ancestor
92863913|NCT00923273|Autonomic Agents|autonomic agents|mesh-ancestor
92863914|NCT00923273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156532|NCT02630472|Quinine|quinine|mesh-list
92863915|NCT00923273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92863916|NCT00923273|Glucocorticoids|glucocorticoids|mesh-ancestor
92863917|NCT00923273|Hormones|hormones|mesh-ancestor
92863918|NCT00923273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863919|NCT00923273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92863920|NCT00923273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863921|NCT00923273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863922|NCT00923273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863923|NCT00923273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92863924|NCT00923273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92863925|NCT00923273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92863926|NCT00923273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863927|NCT00923273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92863928|NCT00923273|Antifungal Agents|antifungal agents|mesh-ancestor
92863929|NCT00923273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92863930|NCT00923273|Immunologic Factors|immunologic factors|mesh-ancestor
92863931|NCT00923273|Hematinics|hematinics|mesh-ancestor
92863932|NCT00923273|Vitamin B Complex|vitamin b complex|mesh-ancestor
92863933|NCT04231370|Lenalidomide|lenalidomide|mesh-list
92863934|NCT04231370|Immunologic Factors|immunologic factors|mesh-ancestor
92863936|NCT04231370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92863937|NCT04231370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92863938|NCT04231370|Growth Substances|growth substances|mesh-ancestor
92863939|NCT04231370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92863940|NCT04231370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863941|NCT05340530|Meropenem|meropenem|mesh-list
92863942|NCT05340530|Avibactam|avibactam|mesh-list
92863943|NCT05340530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92863944|NCT05340530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863945|NCT05340530|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92863946|NCT05340530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92863947|NCT05340530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863948|NCT00634712|Candesartan|candesartan|mesh-list
92863949|NCT00634712|Candesartan cilexetil|candesartan cilexetil|mesh-list
92863950|NCT00634712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92863951|NCT00634712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92863952|NCT00634712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92863953|NCT00634712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863954|NCT00923195|Aldesleukin|aldesleukin|mesh-list
92863955|NCT00923195|Cyclophosphamide|cyclophosphamide|mesh-list
92863956|NCT00923195|Fludarabine|fludarabine|mesh-list
92863957|NCT00923195|Interleukin-2|interleukin-2|mesh-list
92863958|NCT00923195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92863959|NCT00923195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92863960|NCT00923195|Immunologic Factors|immunologic factors|mesh-ancestor
92863961|NCT00923195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863962|NCT00923195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92863963|NCT00923195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92863964|NCT00923195|Alkylating Agents|alkylating agents|mesh-ancestor
92863965|NCT00923195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863966|NCT00923195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92863967|NCT00923195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92863968|NCT00923195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92863969|NCT00923195|Analgesics|analgesics|mesh-ancestor
92863970|NCT00923195|Sensory System Agents|sensory system agents|mesh-ancestor
92863971|NCT00923195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863972|NCT00923195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92863973|NCT00923195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92863974|NCT00923195|Antiviral Agents|antiviral agents|mesh-ancestor
92863975|NCT00923195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92863976|NCT00923195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92863977|NCT02721888|Liraglutide|liraglutide|mesh-list
92863978|NCT02721888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92863979|NCT02721888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863980|NCT02721888|Incretins|incretins|mesh-ancestor
92863981|NCT02721888|Hormones|hormones|mesh-ancestor
92863982|NCT02721888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92863983|NCT04256057|Magnesium Sulfate|magnesium sulfate|mesh-list
92863984|NCT04256057|Analgesics|analgesics|mesh-ancestor
92863985|NCT04256057|Sensory System Agents|sensory system agents|mesh-ancestor
92863986|NCT04256057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92863987|NCT04256057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92863988|NCT04256057|Anesthetics|anesthetics|mesh-ancestor
92863989|NCT04256057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92863991|NCT04256057|Anticonvulsants|anticonvulsants|mesh-ancestor
92863992|NCT04256057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92863993|NCT04256057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92863994|NCT04256057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92863995|NCT04256057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92863996|NCT04256057|Tocolytic Agents|tocolytic agents|mesh-ancestor
92863997|NCT04256057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92863998|NCT04189302|Pyrithione zinc|pyrithione zinc|mesh-list
92863999|NCT04189302|Keratolytic Agents|keratolytic agents|mesh-ancestor
92864000|NCT04189302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864001|NCT02714010|Gefitinib|gefitinib|mesh-list
92864002|NCT02714010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864003|NCT02714010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864004|NCT02714010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864005|NCT02714010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864006|NCT00917241|Dexamethasone|dexamethasone|mesh-list
92864007|NCT00917241|Methimazole|methimazole|mesh-list
92864008|NCT00917241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864009|NCT00917241|Antiemetics|antiemetics|mesh-ancestor
92864010|NCT00917241|Autonomic Agents|autonomic agents|mesh-ancestor
92864011|NCT00917241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864012|NCT00917241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864013|NCT00917241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864014|NCT00917241|Glucocorticoids|glucocorticoids|mesh-ancestor
92864015|NCT00917241|Hormones|hormones|mesh-ancestor
92864016|NCT00917241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864017|NCT00917241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92864018|NCT00917241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864019|NCT00917241|Antithyroid Agents|antithyroid agents|mesh-ancestor
92864020|NCT00917241|Hormone Antagonists|hormone antagonists|mesh-ancestor
92864021|NCT00919061|Gemcitabine|gemcitabine|mesh-list
92864022|NCT00919061|Sorafenib|sorafenib|mesh-list
92864023|NCT00919061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864024|NCT00919061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864025|NCT00919061|Antimetabolites|antimetabolites|mesh-ancestor
92864026|NCT00919061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864027|NCT00919061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864028|NCT00919061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864029|NCT05106296|Cyclophosphamide|cyclophosphamide|mesh-list
92864030|NCT05106296|Etoposide|etoposide|mesh-list
92864031|NCT05106296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864032|NCT05106296|Immunologic Factors|immunologic factors|mesh-ancestor
92864033|NCT05106296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864034|NCT05106296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864035|NCT05106296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92864036|NCT05106296|Alkylating Agents|alkylating agents|mesh-ancestor
92864037|NCT05106296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864038|NCT05106296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864039|NCT05106296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92864040|NCT05106296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92864041|NCT05106296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92864042|NCT05106296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92864043|NCT05106296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864044|NCT02598687|Paclitaxel|paclitaxel|mesh-list
92864045|NCT02598687|Carboplatin|carboplatin|mesh-list
92864046|NCT02598687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92864047|NCT02598687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864048|NCT02598687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92864049|NCT02598687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92864050|NCT02598687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92864051|NCT02598687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864052|NCT05338190|Rituximab|rituximab|mesh-list
92864053|NCT05338190|Belimumab|belimumab|mesh-list
92864054|NCT05338190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92864055|NCT05338190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864056|NCT05338190|Immunologic Factors|immunologic factors|mesh-ancestor
92864057|NCT05338190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864058|NCT05338190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864059|NCT05338190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864060|NCT04908605|Melatonin|melatonin|mesh-list
92864061|NCT04908605|Mirtazapine|mirtazapine|mesh-list
92864062|NCT04908605|Antioxidants|antioxidants|mesh-ancestor
92864063|NCT04908605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864064|NCT04908605|Protective Agents|protective agents|mesh-ancestor
92864065|NCT04908605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864066|NCT04908605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864067|NCT04908605|Antidepressive Agents|antidepressive agents|mesh-ancestor
92864068|NCT04908605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864069|NCT04908605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92864070|NCT04908605|Histamine Antagonists|histamine antagonists|mesh-ancestor
92864072|NCT04908605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864073|NCT04908605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92864074|NCT04908605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92864075|NCT04908605|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92864076|NCT04908605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92864077|NCT04908605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92864078|NCT04908605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92864079|NCT04908605|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92864080|NCT04908605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92864081|NCT04908605|Serotonin Agents|serotonin agents|mesh-ancestor
92864082|NCT04908605|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92864083|NCT02782208|Acipimox|acipimox|mesh-list
92864084|NCT02782208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92864085|NCT02782208|Antimetabolites|antimetabolites|mesh-ancestor
92864086|NCT02782208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864087|NCT02782208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92864088|NCT02598453|Ibandronic Acid|ibandronic acid|mesh-list
92864089|NCT02598453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92864090|NCT02598453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864091|NCT00611286|Sirolimus|sirolimus|mesh-list
92864092|NCT00611286|Paclitaxel|paclitaxel|mesh-list
92864093|NCT00611286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92864094|NCT00611286|Everolimus|everolimus|mesh-list
92864095|NCT00611286|Clopidogrel|clopidogrel|mesh-list
92864096|NCT00611286|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
92864097|NCT00611286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92864098|NCT00611286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864099|NCT00611286|Tubulin Modulators|tubulin modulators|mesh-ancestor
92864100|NCT00611286|Antimitotic Agents|antimitotic agents|mesh-ancestor
92864101|NCT00611286|Mitosis Modulators|mitosis modulators|mesh-ancestor
92864102|NCT00611286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864103|NCT00611286|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92864104|NCT00611286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864105|NCT00611286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864106|NCT00611286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864107|NCT00611286|Immunologic Factors|immunologic factors|mesh-ancestor
92864108|NCT00611286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864109|NCT00611286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92864110|NCT00611286|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92864111|NCT00611286|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92864112|NCT00611286|Purinergic Agents|purinergic agents|mesh-ancestor
92864113|NCT00611286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864114|NCT00611286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92864115|NCT00611286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864116|NCT00611286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92864117|NCT00611286|Antifungal Agents|antifungal agents|mesh-ancestor
92864118|NCT04257851|Sumatriptan|sumatriptan|mesh-list
92864119|NCT04257851|Theophylline|theophylline|mesh-list
92864120|NCT04257851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92864121|NCT04257851|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92864122|NCT04257851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92864123|NCT04257851|Serotonin Agents|serotonin agents|mesh-ancestor
92864124|NCT04257851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864125|NCT04257851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864126|NCT04257851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864127|NCT04257851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92864128|NCT04257851|Autonomic Agents|autonomic agents|mesh-ancestor
92864129|NCT04257851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864130|NCT04257851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92864131|NCT04257851|Respiratory System Agents|respiratory system agents|mesh-ancestor
92864132|NCT04257851|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92864133|NCT04257851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864134|NCT04257851|Vasodilator Agents|vasodilator agents|mesh-ancestor
92864135|NCT04257851|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92864136|NCT04257851|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92864137|NCT04257851|Purinergic Agents|purinergic agents|mesh-ancestor
92864138|NCT02780102|Methylphenidate|methylphenidate|mesh-list
92864139|NCT02780102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92864140|NCT02780102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864141|NCT02780102|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92864142|NCT02780102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92864143|NCT02780102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864144|NCT02780102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864145|NCT02780102|Dopamine Agents|dopamine agents|mesh-ancestor
92864146|NCT02780102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864147|NCT04197050|Valsartan|valsartan|mesh-list
92864148|NCT04197050|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92864149|NCT04197050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92864150|NCT04197050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92864151|NCT04197050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92864152|NCT04197050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864153|NCT04090047|Itraconazole|itraconazole|mesh-list
92864154|NCT04090047|PF-06700841|pf-06700841|mesh-list
92864155|NCT04090047|Antifungal Agents|antifungal agents|mesh-ancestor
92864156|NCT04090047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864157|NCT04090047|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92864158|NCT04090047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92864159|NCT04090047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864160|NCT04090047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864161|NCT04090047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92864162|NCT04090047|Hormone Antagonists|hormone antagonists|mesh-ancestor
92864163|NCT04090047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864164|NCT04090047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864165|NCT04090047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92864166|NCT04090047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864167|NCT02782052|Bromides|bromides|mesh-list
92864168|NCT02782052|Albuterol|albuterol|mesh-list
92864169|NCT02782052|Ipratropium|ipratropium|mesh-list
92864170|NCT02782052|Anticonvulsants|anticonvulsants|mesh-ancestor
92864171|NCT02782052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92864172|NCT02782052|Autonomic Agents|autonomic agents|mesh-ancestor
92864173|NCT02782052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864174|NCT02782052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864175|NCT02782052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92864176|NCT02782052|Respiratory System Agents|respiratory system agents|mesh-ancestor
92864177|NCT02782052|Tocolytic Agents|tocolytic agents|mesh-ancestor
92864178|NCT02782052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864179|NCT02782052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92864180|NCT02782052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92864181|NCT02782052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92864182|NCT02782052|Adrenergic Agents|adrenergic agents|mesh-ancestor
92864183|NCT02782052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864184|NCT02782052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864185|NCT02782052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92864186|NCT02782052|Cholinergic Agents|cholinergic agents|mesh-ancestor
92864187|NCT02708628|Heparin|heparin|mesh-list
92864188|NCT02708628|Allantoin|allantoin|mesh-list
92864189|NCT02708628|Anticoagulants|anticoagulants|mesh-ancestor
92864190|NCT02708628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92864191|NCT02708628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92864192|NCT02708628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864193|NCT02708628|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864194|NCT00746733|Amphetamine|amphetamine|mesh-list
92864195|NCT00746733|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92864196|NCT00746733|Adderall|adderall|mesh-list
92864197|NCT00746733|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92864198|NCT00746733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864199|NCT00746733|Sympathomimetics|sympathomimetics|mesh-ancestor
92864200|NCT00746733|Autonomic Agents|autonomic agents|mesh-ancestor
92864201|NCT00746733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864202|NCT00746733|Dopamine Agents|dopamine agents|mesh-ancestor
92156544|NCT03729011|Propofol|propofol|mesh-list
92864203|NCT00746733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864204|NCT00746733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864205|NCT00746733|Adrenergic Agents|adrenergic agents|mesh-ancestor
92864206|NCT00746733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92864207|NCT00746733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92864208|NCT00746733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864209|NCT00746733|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92864210|NCT00636870|Fexofenadine|fexofenadine|mesh-list
92864211|NCT00636870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92864212|NCT00636870|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92864213|NCT00636870|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92864214|NCT00636870|Histamine Antagonists|histamine antagonists|mesh-ancestor
92864215|NCT00636870|Histamine Agents|histamine agents|mesh-ancestor
92864216|NCT00636870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864217|NCT00636870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864218|NCT00636870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864219|NCT00634790|Alprazolam|alprazolam|mesh-list
92864220|NCT00634790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92864221|NCT00634790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864222|NCT00634790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864223|NCT00634790|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92864224|NCT00634790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92864225|NCT00634790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864226|NCT00634790|GABA Modulators|gaba modulators|mesh-ancestor
92864227|NCT00634790|GABA Agents|gaba agents|mesh-ancestor
92864228|NCT00634790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864229|NCT00634790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864230|NCT04831151|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
92864231|NCT04831151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864232|NCT04831151|Androgen Antagonists|androgen antagonists|mesh-ancestor
92864233|NCT04831151|Hormone Antagonists|hormone antagonists|mesh-ancestor
92864234|NCT04831151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864235|NCT00917397|Sertraline|sertraline|mesh-list
92864236|NCT00917397|Antidepressive Agents|antidepressive agents|mesh-ancestor
92864237|NCT00917397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864238|NCT00917397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92864239|NCT00917397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92864240|NCT00917397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864241|NCT00917397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864242|NCT00917397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864243|NCT00917397|Serotonin Agents|serotonin agents|mesh-ancestor
92864244|NCT00917397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864245|NCT02708160|Fluorides|fluorides|mesh-list
92864246|NCT02708160|Cariostatic Agents|cariostatic agents|mesh-ancestor
92864247|NCT02708160|Protective Agents|protective agents|mesh-ancestor
92864248|NCT02708160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864249|NCT04257461|Capecitabine|capecitabine|mesh-list
92864250|NCT04257461|Oxaliplatin|oxaliplatin|mesh-list
92864251|NCT04257461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864252|NCT04257461|Antimetabolites|antimetabolites|mesh-ancestor
92864253|NCT04257461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864254|NCT04257461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864255|NCT02712528|Sufentanil|sufentanil|mesh-list
92864256|NCT02712528|Remifentanil|remifentanil|mesh-list
92864257|NCT02712528|Sevoflurane|sevoflurane|mesh-list
92864258|NCT02712528|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92864259|NCT02712528|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92864260|NCT02712528|Anesthetics, General|anesthetics, general|mesh-ancestor
92864261|NCT02712528|Anesthetics|anesthetics|mesh-ancestor
92864262|NCT02712528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864263|NCT02712528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864264|NCT02712528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92864265|NCT02712528|Narcotics|narcotics|mesh-ancestor
92864266|NCT02712528|Analgesics|analgesics|mesh-ancestor
92864267|NCT02712528|Sensory System Agents|sensory system agents|mesh-ancestor
92864268|NCT02712528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864269|NCT02712528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92864270|NCT02712528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92864271|NCT04089657|Apatinib|apatinib|mesh-list
92864272|NCT04089657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864273|NCT04089657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864274|NCT04089657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026462|NCT03747159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864275|NCT04089657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864276|NCT02713074|Povidone-Iodine|povidone-iodine|mesh-list
92864277|NCT02713074|Povidone|povidone|mesh-list
92864278|NCT02713074|Plasma Substitutes|plasma substitutes|mesh-ancestor
92864279|NCT02713074|Blood Substitutes|blood substitutes|mesh-ancestor
92864280|NCT02713074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92864281|NCT02713074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864282|NCT00637793|(S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|(s)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro(4.5)decan-3-one|mesh-list
92864283|NCT00637793|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92864284|NCT00637793|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92864285|NCT00637793|Cholinergic Agents|cholinergic agents|mesh-ancestor
92864286|NCT00637793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864287|NCT00637793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864288|NCT00637793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864289|NCT00745875|Pemetrexed|pemetrexed|mesh-list
92864290|NCT00745875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864291|NCT00745875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864292|NCT00745875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864293|NCT00745875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92864294|NCT00745875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92864295|NCT04089813|Metformin|metformin|mesh-list
92864296|NCT04089813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92864297|NCT04089813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864298|NCT00555217|Losartan|losartan|mesh-list
92864299|NCT00555217|Lisinopril|lisinopril|mesh-list
92864300|NCT00555217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92864302|NCT00555217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92864303|NCT00555217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92864304|NCT00555217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864305|NCT00555217|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92864306|NCT00555217|Protease Inhibitors|protease inhibitors|mesh-ancestor
92864307|NCT00555217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864308|NCT00555217|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92864309|NCT00555217|Protective Agents|protective agents|mesh-ancestor
92864310|NCT00555217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864311|NCT02711904|Remifentanil|remifentanil|mesh-list
92864312|NCT02711904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92864313|NCT02711904|Narcotics|narcotics|mesh-ancestor
92864314|NCT02711904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864315|NCT02711904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864316|NCT02711904|Analgesics|analgesics|mesh-ancestor
92864317|NCT02711904|Sensory System Agents|sensory system agents|mesh-ancestor
92864318|NCT02711904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864319|NCT05326490|Metformin|metformin|mesh-list
92864320|NCT05326490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92864321|NCT05326490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864322|NCT02693808|Hyaluronic Acid|hyaluronic acid|mesh-list
92864323|NCT02693808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92864324|NCT02693808|Immunologic Factors|immunologic factors|mesh-ancestor
92864325|NCT02693808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864326|NCT02693808|Viscosupplements|viscosupplements|mesh-ancestor
92864327|NCT02693808|Protective Agents|protective agents|mesh-ancestor
92864328|NCT02711982|Methylprednisolone|methylprednisolone|mesh-list
92864329|NCT02711982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92864330|NCT02711982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92864331|NCT02711982|Prednisolone|prednisolone|mesh-list
92864332|NCT02711982|Prednisolone acetate|prednisolone acetate|mesh-list
92864333|NCT02711982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92864334|NCT02711982|Prednisolone phosphate|prednisolone phosphate|mesh-list
92864335|NCT02711982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864336|NCT02711982|Antiemetics|antiemetics|mesh-ancestor
92864337|NCT02711982|Autonomic Agents|autonomic agents|mesh-ancestor
92864338|NCT02711982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864339|NCT02711982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864340|NCT02711982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864341|NCT02711982|Glucocorticoids|glucocorticoids|mesh-ancestor
92864342|NCT02711982|Hormones|hormones|mesh-ancestor
92864343|NCT02711982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864344|NCT02711982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92864345|NCT02711982|Protective Agents|protective agents|mesh-ancestor
92864346|NCT02711982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92864347|NCT02711982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864348|NCT00745095|Neostigmine|neostigmine|mesh-list
92864349|NCT00745095|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92864350|NCT00745095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864351|NCT00745095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864352|NCT00745095|Cholinergic Agents|cholinergic agents|mesh-ancestor
92864353|NCT00745095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864354|NCT00745095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864355|NCT00745095|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92864356|NCT00745095|Autonomic Agents|autonomic agents|mesh-ancestor
92864357|NCT00745095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509531|NCT00008515|Glucocorticoids|glucocorticoids|mesh-ancestor
92864358|NCT05181462|Carboplatin|carboplatin|mesh-list
92864359|NCT05181462|Gemcitabine|gemcitabine|mesh-list
92864360|NCT05181462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864361|NCT05181462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864362|NCT05181462|Antimetabolites|antimetabolites|mesh-ancestor
92864363|NCT05181462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864364|NCT00612612|Rituximab|rituximab|mesh-list
92864365|NCT00612612|Fludarabine|fludarabine|mesh-list
92864366|NCT00612612|Fludarabine phosphate|fludarabine phosphate|mesh-list
92864367|NCT00612612|Obatoclax|obatoclax|mesh-list
92864368|NCT00612612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92864369|NCT00612612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864370|NCT00612612|Immunologic Factors|immunologic factors|mesh-ancestor
92864371|NCT00612612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864372|NCT00612612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864373|NCT00612612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864374|NCT00612612|Antimetabolites|antimetabolites|mesh-ancestor
92864375|NCT00612612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864376|NCT00612612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864377|NCT00612612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864378|NCT00947713|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92864379|NCT00947713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864380|NCT00947713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864381|NCT00940693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92864382|NCT00940693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92864383|NCT00940693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92864384|NCT00940693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864385|NCT00940693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864386|NCT00940693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864387|NCT00940693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864389|NCT00940693|Sensory System Agents|sensory system agents|mesh-ancestor
92864390|NCT00940693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864391|NCT00940693|Antidepressive Agents|antidepressive agents|mesh-ancestor
92864392|NCT00940693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864393|NCT00940693|Dopamine Agents|dopamine agents|mesh-ancestor
92864394|NCT02598063|Lamivudine|lamivudine|mesh-list
92864395|NCT02598063|Adefovir|adefovir|mesh-list
92864396|NCT02598063|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92864397|NCT02598063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92864398|NCT02598063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92864399|NCT02598063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92864400|NCT02598063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864401|NCT02598063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864402|NCT02598063|Antiviral Agents|antiviral agents|mesh-ancestor
92864403|NCT02598063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864404|NCT02598063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92864405|NCT02598063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92864406|NCT02707458|Probucol|probucol|mesh-list
92864407|NCT02707458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92864408|NCT02707458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92864409|NCT02707458|Antimetabolites|antimetabolites|mesh-ancestor
92864410|NCT02707458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864411|NCT02707458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92864412|NCT02707458|Antioxidants|antioxidants|mesh-ancestor
92864413|NCT02707458|Protective Agents|protective agents|mesh-ancestor
92864414|NCT02707458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864415|NCT00950677|Exenatide|exenatide|mesh-list
92864416|NCT00950677|Pramlintide|pramlintide|mesh-list
92864417|NCT00950677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92864418|NCT00950677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864419|NCT00950677|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92864420|NCT00950677|Incretins|incretins|mesh-ancestor
92864421|NCT00950677|Hormones|hormones|mesh-ancestor
92864422|NCT00950677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864423|NCT05174598|Calcitriol|calcitriol|mesh-list
92864424|NCT05174598|Calcipotriene|calcipotriene|mesh-list
92864425|NCT05174598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864426|NCT05174598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92864427|NCT05174598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864428|NCT05174598|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92864429|NCT05174598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864430|NCT05174598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864431|NCT05174598|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92864432|NCT05174598|Vitamins|vitamins|mesh-ancestor
92509607|NCT05638087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864433|NCT05174598|Micronutrients|micronutrients|mesh-ancestor
92864434|NCT05174598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92864435|NCT05341856|Isosorbide|isosorbide|mesh-list
92864436|NCT05341856|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92864437|NCT05341856|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92864438|NCT05341856|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92864439|NCT05341856|Diuretics|diuretics|mesh-ancestor
92864440|NCT05341856|Natriuretic Agents|natriuretic agents|mesh-ancestor
92864441|NCT05341856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864442|NCT05341856|Vasodilator Agents|vasodilator agents|mesh-ancestor
92864443|NCT05341856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92864444|NCT05341856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864445|NCT00951223|Interferons|interferons|mesh-list
92864446|NCT00951223|Interferon alfacon-1|interferon alfacon-1|mesh-list
92864447|NCT00951223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864449|NCT00951223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864450|NCT02711592|Analgesics|analgesics|mesh-list
92864451|NCT02711592|Sensory System Agents|sensory system agents|mesh-ancestor
92864452|NCT02711592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864453|NCT02711592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864454|NCT00948103|Nitrous Oxide|nitrous oxide|mesh-list
92864455|NCT00948103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92864456|NCT00948103|Anesthetics, General|anesthetics, general|mesh-ancestor
92864457|NCT00948103|Anesthetics|anesthetics|mesh-ancestor
92864458|NCT00948103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864459|NCT00948103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864460|NCT00948103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92864461|NCT00948103|Analgesics|analgesics|mesh-ancestor
92864462|NCT00948103|Sensory System Agents|sensory system agents|mesh-ancestor
92864463|NCT00948103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864464|NCT02012114|Cysteamine|cysteamine|mesh-list
92864465|NCT02012114|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92864466|NCT02012114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864467|NCT05301205|Gabapentin|gabapentin|mesh-list
92864468|NCT05301205|Analgesics|analgesics|mesh-ancestor
92864469|NCT05301205|Sensory System Agents|sensory system agents|mesh-ancestor
92864470|NCT05301205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864471|NCT05301205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864472|NCT05301205|Anticonvulsants|anticonvulsants|mesh-ancestor
92864473|NCT05301205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92864474|NCT05301205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92864475|NCT05301205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864476|NCT05301205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864477|NCT05301205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92864478|NCT05301205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92864479|NCT05301205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864480|NCT05301205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864481|NCT05301205|Antimanic Agents|antimanic agents|mesh-ancestor
92864482|NCT02707224|Candesartan|candesartan|mesh-list
92864483|NCT02707224|Candesartan cilexetil|candesartan cilexetil|mesh-list
92864484|NCT02707224|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92864485|NCT02707224|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92864486|NCT02707224|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92864487|NCT02707224|Antimetabolites|antimetabolites|mesh-ancestor
92864488|NCT02707224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864489|NCT02707224|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92864490|NCT02707224|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92864491|NCT02707224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864492|NCT02707224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92864493|NCT02707224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92864494|NCT02707224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92864495|NCT04229264|Apixaban|apixaban|mesh-list
92864496|NCT04229264|Clopidogrel|clopidogrel|mesh-list
92864497|NCT04229264|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92864498|NCT04229264|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92864499|NCT04229264|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92864500|NCT04229264|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92864501|NCT04229264|Purinergic Agents|purinergic agents|mesh-ancestor
92864502|NCT04229264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864503|NCT04229264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864504|NCT04229264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864505|NCT04229264|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92864506|NCT04229264|Antithrombins|antithrombins|mesh-ancestor
92509695|NCT00000145|Zinc|zinc|mesh-list
92864507|NCT04229264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92864508|NCT04229264|Protease Inhibitors|protease inhibitors|mesh-ancestor
92864509|NCT04229264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864510|NCT04229264|Anticoagulants|anticoagulants|mesh-ancestor
92864511|NCT02597829|Certolizumab Pegol|certolizumab pegol|mesh-list
92864512|NCT02597829|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92864513|NCT02597829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864514|NCT02597829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864515|NCT02597829|Immunologic Factors|immunologic factors|mesh-ancestor
92864516|NCT02597829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864517|NCT02597829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864518|NCT02711202|Sirolimus|sirolimus|mesh-list
92864519|NCT02711202|Infliximab|infliximab|mesh-list
92864520|NCT02711202|Alemtuzumab|alemtuzumab|mesh-list
92864521|NCT02711202|Tacrolimus|tacrolimus|mesh-list
92864522|NCT02711202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864523|NCT02711202|Immunologic Factors|immunologic factors|mesh-ancestor
92864524|NCT02711202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864525|NCT02711202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92864526|NCT02711202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864527|NCT02711202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864528|NCT02711202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92864529|NCT02711202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864530|NCT02711202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92864531|NCT02711202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864532|NCT02711202|Antifungal Agents|antifungal agents|mesh-ancestor
92864533|NCT02711202|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92864534|NCT02711202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864535|NCT02711202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864536|NCT02711202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864537|NCT02711202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864538|NCT02711202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92864539|NCT04227938|ALPN-101|alpn-101|mesh-list
92864540|NCT04227938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864541|NCT04227938|Immunologic Factors|immunologic factors|mesh-ancestor
92864542|NCT04227938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864543|NCT02711358|Indomethacin|indomethacin|mesh-list
92864544|NCT02711358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92864545|NCT02711358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92864546|NCT02711358|Analgesics|analgesics|mesh-ancestor
92864547|NCT02711358|Sensory System Agents|sensory system agents|mesh-ancestor
92864548|NCT02711358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864549|NCT02711358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864550|NCT02711358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864551|NCT02711358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864552|NCT02711358|Gout Suppressants|gout suppressants|mesh-ancestor
92864553|NCT02711358|Tocolytic Agents|tocolytic agents|mesh-ancestor
92864554|NCT02711358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864555|NCT02711358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92864556|NCT02711358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864557|NCT02711358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864558|NCT04962152|Nalbuphine|nalbuphine|mesh-list
92864559|NCT04962152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92864560|NCT04962152|Narcotics|narcotics|mesh-ancestor
92864561|NCT04962152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864562|NCT04962152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156559|NCT00977769|Oxytocin|oxytocin|mesh-list
92864563|NCT04962152|Analgesics|analgesics|mesh-ancestor
92864564|NCT04962152|Sensory System Agents|sensory system agents|mesh-ancestor
92864565|NCT04962152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864566|NCT00744627|Vortioxetine|vortioxetine|mesh-list
92864567|NCT00744627|Antidepressive Agents|antidepressive agents|mesh-ancestor
92864568|NCT00744627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864569|NCT00744627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92864570|NCT00744627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92864571|NCT00744627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864572|NCT00744627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864573|NCT00744627|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92864574|NCT00744627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92864575|NCT00744627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864576|NCT00744627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864577|NCT00744627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864578|NCT00744627|Serotonin Agents|serotonin agents|mesh-ancestor
92864579|NCT00744627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92864580|NCT00744627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92864581|NCT00744627|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92864582|NCT00744627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92864583|NCT04942886|Entecavir|entecavir|mesh-list
92864584|NCT04942886|Antiviral Agents|antiviral agents|mesh-ancestor
92864585|NCT04942886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864586|NCT00951847|Oxcarbazepine|oxcarbazepine|mesh-list
92864587|NCT00951847|Anticonvulsants|anticonvulsants|mesh-ancestor
92864588|NCT00951847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92864589|NCT00951847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92864590|NCT00951847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864591|NCT00951847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864592|NCT00951847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92864593|NCT00951847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92864594|NCT02711280|Propofol|propofol|mesh-list
92864595|NCT02711280|Sevoflurane|sevoflurane|mesh-list
92864596|NCT02711280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92864597|NCT02711280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864598|NCT02711280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864599|NCT02711280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92864600|NCT02711280|Anesthetics, General|anesthetics, general|mesh-ancestor
92864601|NCT02711280|Anesthetics|anesthetics|mesh-ancestor
92864602|NCT02711280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92864603|NCT02711280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92864604|NCT00948493|Insulin|insulin|mesh-list
92864605|NCT00948493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92864606|NCT00948493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92864607|NCT00948493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864608|NCT00952003|Bevacizumab|bevacizumab|mesh-list
92864609|NCT00952003|Docetaxel|docetaxel|mesh-list
92864610|NCT00952003|Oxaliplatin|oxaliplatin|mesh-list
92864611|NCT00952003|Irinotecan|irinotecan|mesh-list
92864612|NCT00952003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92864613|NCT00952003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864614|NCT00952003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92864615|NCT00952003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92864616|NCT00952003|Growth Substances|growth substances|mesh-ancestor
92864617|NCT00952003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864618|NCT00952003|Growth Inhibitors|growth inhibitors|mesh-ancestor
92864619|NCT00952003|Tubulin Modulators|tubulin modulators|mesh-ancestor
92864620|NCT00952003|Antimitotic Agents|antimitotic agents|mesh-ancestor
92864621|NCT00952003|Mitosis Modulators|mitosis modulators|mesh-ancestor
92864622|NCT00952003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864623|NCT00952003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92864624|NCT00952003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92864625|NCT00952003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864626|NCT00612144|Metformin|metformin|mesh-list
92864627|NCT00612144|Glimepiride|glimepiride|mesh-list
92864628|NCT00612144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92864629|NCT00612144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864630|NCT00612144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92864631|NCT00612144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864632|NCT00612144|Immunologic Factors|immunologic factors|mesh-ancestor
92864633|NCT02597361|Irbesartan|irbesartan|mesh-list
92864634|NCT02597361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026463|NCT03747159|Immunologic Factors|immunologic factors|mesh-ancestor
92864635|NCT02597361|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92864636|NCT02597361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92864637|NCT02597361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864638|NCT00562627|Ketorolac|ketorolac|mesh-list
92864639|NCT00562627|Epinephrine|epinephrine|mesh-list
92864640|NCT00562627|Racepinephrine|racepinephrine|mesh-list
92864641|NCT00562627|Fentanyl|fentanyl|mesh-list
92864642|NCT00562627|Morphine|morphine|mesh-list
92864643|NCT00562627|Bupivacaine|bupivacaine|mesh-list
92864644|NCT00562627|Ropivacaine|ropivacaine|mesh-list
92864645|NCT00562627|Epinephryl borate|epinephryl borate|mesh-list
92864646|NCT00562627|Anesthetics, Local|anesthetics, local|mesh-ancestor
92864647|NCT00562627|Anesthetics|anesthetics|mesh-ancestor
92864648|NCT00562627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864649|NCT00562627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864650|NCT00562627|Sensory System Agents|sensory system agents|mesh-ancestor
92864651|NCT00562627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864652|NCT00562627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92864653|NCT00562627|Narcotics|narcotics|mesh-ancestor
92864654|NCT00562627|Analgesics|analgesics|mesh-ancestor
92864655|NCT00562627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92864656|NCT00562627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92864657|NCT00562627|Anesthetics, General|anesthetics, general|mesh-ancestor
92864658|NCT00562627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92864659|NCT00562627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92864660|NCT00562627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92864661|NCT00562627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864662|NCT00562627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864663|NCT00562627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92864664|NCT00562627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92864665|NCT00562627|Autonomic Agents|autonomic agents|mesh-ancestor
92864666|NCT00562627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92864667|NCT00562627|Respiratory System Agents|respiratory system agents|mesh-ancestor
92864668|NCT00562627|Mydriatics|mydriatics|mesh-ancestor
92864669|NCT00562627|Sympathomimetics|sympathomimetics|mesh-ancestor
92864670|NCT00562627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92864671|NCT00562627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92864672|NCT00562627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92864673|NCT00562627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864674|NCT00562627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864675|NCT00562627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92864676|NCT00562627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864677|NCT02597283|Sirolimus|sirolimus|mesh-list
92864678|NCT02597283|Temsirolimus|temsirolimus|mesh-list
92864679|NCT02597283|MTOR Inhibitors|mtor inhibitors|mesh-list
92864680|NCT02597283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92864681|NCT02597283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864682|NCT02597283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92864683|NCT02597283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864684|NCT02597283|Antifungal Agents|antifungal agents|mesh-ancestor
92864685|NCT02597283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864686|NCT02597283|Immunologic Factors|immunologic factors|mesh-ancestor
92864687|NCT02597283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864688|NCT02597283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864689|NCT02597283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864690|NCT02597283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864691|NCT00948649|Varenicline|varenicline|mesh-list
92864692|NCT00948649|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92864693|NCT00948649|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92864694|NCT00948649|Cholinergic Agents|cholinergic agents|mesh-ancestor
92864695|NCT00948649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864696|NCT00948649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864697|NCT00948649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864698|NCT00952159|Tramadol|tramadol|mesh-list
92864699|NCT00952159|O-demethyltramadol|o-demethyltramadol|mesh-list
92864700|NCT00952159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92864701|NCT00952159|Narcotics|narcotics|mesh-ancestor
92864702|NCT00952159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864703|NCT00952159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864704|NCT00952159|Analgesics|analgesics|mesh-ancestor
92864705|NCT00952159|Sensory System Agents|sensory system agents|mesh-ancestor
92864706|NCT00952159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864707|NCT00948727|Cyclosporine|cyclosporine|mesh-list
92864708|NCT00948727|Cyclosporins|cyclosporins|mesh-list
92156564|NCT03725501|Ranibizumab|ranibizumab|mesh-list
92864709|NCT00948727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864710|NCT00948727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864711|NCT00948727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864712|NCT00948727|Immunologic Factors|immunologic factors|mesh-ancestor
92864713|NCT00948727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864714|NCT00948727|Antifungal Agents|antifungal agents|mesh-ancestor
92864715|NCT00948727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864716|NCT00948727|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864717|NCT00948727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864718|NCT00948727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92864719|NCT02778776|Metformin|metformin|mesh-list
92864720|NCT02778776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92864721|NCT02778776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864722|NCT00948805|Goserelin|goserelin|mesh-list
92864723|NCT00948805|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92864724|NCT00948805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92864725|NCT00948805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864726|NCT00948805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864727|NCT00948805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864728|NCT02710656|Paclitaxel|paclitaxel|mesh-list
92864729|NCT02710656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92864730|NCT02710656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864731|NCT02710656|Tubulin Modulators|tubulin modulators|mesh-ancestor
92864732|NCT02710656|Antimitotic Agents|antimitotic agents|mesh-ancestor
92864733|NCT02710656|Mitosis Modulators|mitosis modulators|mesh-ancestor
92864734|NCT02710656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509925|NCT00388999|Lectins|lectins|mesh-list
92864735|NCT02780882|Pasireotide|pasireotide|mesh-list
92864736|NCT02780882|Hormones|hormones|mesh-ancestor
92864737|NCT02780882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864738|NCT02780882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864739|NCT02710266|Gabexate|gabexate|mesh-list
92864740|NCT02710266|Anticoagulants|anticoagulants|mesh-ancestor
92864741|NCT02710266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92864742|NCT02710266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92864743|NCT02710266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864744|NCT02710266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864745|NCT00562159|Fluticasone|fluticasone|mesh-list
92864746|NCT00562159|Xhance|xhance|mesh-list
92864747|NCT00562159|Mometasone Furoate|mometasone furoate|mesh-list
92864748|NCT00562159|Loratadine|loratadine|mesh-list
92864749|NCT00562159|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92864750|NCT00562159|Prednisone|prednisone|mesh-list
92864751|NCT00562159|Albuterol|albuterol|mesh-list
92864752|NCT00562159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864753|NCT00562159|Glucocorticoids|glucocorticoids|mesh-ancestor
92864754|NCT00562159|Hormones|hormones|mesh-ancestor
92864755|NCT00562159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864756|NCT00562159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864757|NCT00562159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92864758|NCT00562159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864759|NCT00562159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92864760|NCT00562159|Autonomic Agents|autonomic agents|mesh-ancestor
92864761|NCT00562159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864762|NCT00562159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92864763|NCT00562159|Respiratory System Agents|respiratory system agents|mesh-ancestor
92864764|NCT00562159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864765|NCT00562159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92864766|NCT00562159|Tocolytic Agents|tocolytic agents|mesh-ancestor
92864767|NCT00562159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864768|NCT00562159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92864769|NCT00562159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92864770|NCT00562159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92864771|NCT00562159|Adrenergic Agents|adrenergic agents|mesh-ancestor
92864772|NCT00562159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864773|NCT00562159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864774|NCT00562159|Antipruritics|antipruritics|mesh-ancestor
92864775|NCT00562159|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92864776|NCT00562159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92864777|NCT00562159|Histamine Antagonists|histamine antagonists|mesh-ancestor
92864778|NCT00562159|Histamine Agents|histamine agents|mesh-ancestor
92864779|NCT00562159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92864780|NCT00562159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92864781|NCT00562159|Analgesics|analgesics|mesh-ancestor
92864782|NCT00562159|Sensory System Agents|sensory system agents|mesh-ancestor
92864783|NCT00562159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92864784|NCT02710110|Capsaicin|capsaicin|mesh-list
92864785|NCT02710110|Antipruritics|antipruritics|mesh-ancestor
92864786|NCT02710110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92864787|NCT02710110|Sensory System Agents|sensory system agents|mesh-ancestor
92864788|NCT02710110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864789|NCT02710110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864790|NCT00952627|Pycnogenols|pycnogenols|mesh-list
92864791|NCT00952627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92864792|NCT00952627|Immunologic Factors|immunologic factors|mesh-ancestor
92864793|NCT00952627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864794|NCT00952627|Antioxidants|antioxidants|mesh-ancestor
92864795|NCT00952627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864796|NCT00952627|Protective Agents|protective agents|mesh-ancestor
92864797|NCT00952627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92864798|NCT00611676|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92864799|NCT00611676|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92864800|NCT00611676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92864801|NCT00611676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92864802|NCT00611676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864803|NCT00611676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92864804|NCT00611676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864805|NCT00611676|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92864806|NCT00611676|Antidepressive Agents|antidepressive agents|mesh-ancestor
92864807|NCT00611676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92864808|NCT04848714|Antivenins|antivenins|mesh-list
92864809|NCT04848714|Immunologic Factors|immunologic factors|mesh-ancestor
92864810|NCT04848714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864811|NCT00952861|Doxycycline|doxycycline|mesh-list
92864812|NCT00952861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92864813|NCT00952861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864814|NCT00952861|Antimalarials|antimalarials|mesh-ancestor
92864815|NCT00952861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92864816|NCT00952861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92864817|NCT05137730|Parathyroid Hormone|parathyroid hormone|mesh-list
92864818|NCT05137730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864819|NCT05137730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92864820|NCT04889066|Durvalumab|durvalumab|mesh-list
92864821|NCT04889066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92864822|NCT04889066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864823|NCT04223778|Islatravir|islatravir|mesh-list
92864824|NCT04223778|Antiviral Agents|antiviral agents|mesh-ancestor
92864825|NCT04223778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864826|NCT04223778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864827|NCT04223778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864828|NCT04223778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92864829|NCT04223778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92864830|NCT04223778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92864831|NCT05109416|Bupivacaine|bupivacaine|mesh-list
92864832|NCT05109416|Anesthetics, Local|anesthetics, local|mesh-ancestor
92864833|NCT05109416|Anesthetics|anesthetics|mesh-ancestor
92864834|NCT05109416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864835|NCT05109416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864836|NCT05109416|Sensory System Agents|sensory system agents|mesh-ancestor
92864837|NCT05109416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864838|NCT04074564|Apatinib|apatinib|mesh-list
92864839|NCT04074564|Antibodies|antibodies|mesh-list
92864840|NCT04074564|Immunologic Factors|immunologic factors|mesh-ancestor
92864841|NCT04074564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864842|NCT04074564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864843|NCT04074564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864844|NCT04074564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864845|NCT04074564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864846|NCT02778308|Gemcitabine|gemcitabine|mesh-list
92864847|NCT02778308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864848|NCT02778308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864849|NCT02778308|Antimetabolites|antimetabolites|mesh-ancestor
92864850|NCT02778308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864851|NCT02776202|Mycophenolic Acid|mycophenolic acid|mesh-list
92864852|NCT02776202|Sirolimus|sirolimus|mesh-list
92864853|NCT02776202|Fludarabine|fludarabine|mesh-list
92864854|NCT02776202|Fludarabine phosphate|fludarabine phosphate|mesh-list
92864855|NCT02776202|Melphalan|melphalan|mesh-list
92864856|NCT02776202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864857|NCT02776202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864858|NCT02776202|Antimetabolites|antimetabolites|mesh-ancestor
92864859|NCT02776202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864860|NCT02776202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864861|NCT02776202|Immunologic Factors|immunologic factors|mesh-ancestor
92864862|NCT02776202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864863|NCT02776202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92864864|NCT02776202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92864865|NCT02776202|Antitubercular Agents|antitubercular agents|mesh-ancestor
92864866|NCT02776202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92864867|NCT02776202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864868|NCT02776202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864869|NCT02776202|Antifungal Agents|antifungal agents|mesh-ancestor
92864870|NCT02776202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92864871|NCT02776202|Alkylating Agents|alkylating agents|mesh-ancestor
92864872|NCT02776202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92864873|NCT00921557|Vitamin D|vitamin d|mesh-list
92864874|NCT00921557|Alendronate|alendronate|mesh-list
92864875|NCT00921557|Calcium Carbonate|calcium carbonate|mesh-list
92864876|NCT00921557|Calcium|calcium|mesh-list
92864877|NCT00921557|Vitamins|vitamins|mesh-ancestor
92864878|NCT00921557|Micronutrients|micronutrients|mesh-ancestor
92864879|NCT00921557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864880|NCT00921557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92864881|NCT00921557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92864882|NCT00921557|Antacids|antacids|mesh-ancestor
92864883|NCT00921557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864884|NCT00921557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864885|NCT00611754|Fluorouracil|fluorouracil|mesh-list
92864886|NCT00611754|Oxaliplatin|oxaliplatin|mesh-list
92864887|NCT00611754|Antimetabolites|antimetabolites|mesh-ancestor
92864888|NCT00611754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864889|NCT00611754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92864890|NCT00611754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864891|NCT00611754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92864892|NCT00611754|Immunologic Factors|immunologic factors|mesh-ancestor
92864893|NCT00611754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864894|NCT00550615|Dasatinib|dasatinib|mesh-list
92864895|NCT00550615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864896|NCT00550615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92864897|NCT00550615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864898|NCT00550615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864899|NCT02709720|Cisplatin|cisplatin|mesh-list
92864900|NCT02709720|Vinorelbine|vinorelbine|mesh-list
92864901|NCT02709720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864902|NCT02709720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92864903|NCT02709720|Tubulin Modulators|tubulin modulators|mesh-ancestor
92864904|NCT02709720|Antimitotic Agents|antimitotic agents|mesh-ancestor
92864905|NCT02709720|Mitosis Modulators|mitosis modulators|mesh-ancestor
92864906|NCT02709720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864907|NCT02779634|Coenzyme Q10|coenzyme q10|mesh-list
92864908|NCT02779634|Micronutrients|micronutrients|mesh-ancestor
92864909|NCT02779634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864910|NCT02779634|Vitamins|vitamins|mesh-ancestor
92864911|NCT04255589|Ethanol|ethanol|mesh-list
92864912|NCT04255589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92864913|NCT04255589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864914|NCT04255589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864915|NCT04255589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864916|NCT00744471|Tanezumab|tanezumab|mesh-list
92864917|NCT00744471|Analgesics|analgesics|mesh-ancestor
92864918|NCT00744471|Sensory System Agents|sensory system agents|mesh-ancestor
92864919|NCT00744471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864920|NCT00744471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864921|NCT02776436|Dexamethasone|dexamethasone|mesh-list
92864922|NCT02776436|Prednisone|prednisone|mesh-list
92864923|NCT02776436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92864924|NCT02776436|Antiemetics|antiemetics|mesh-ancestor
92156572|NCT00979017|Irinotecan|irinotecan|mesh-list
92864925|NCT02776436|Autonomic Agents|autonomic agents|mesh-ancestor
92864926|NCT02776436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864927|NCT02776436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864928|NCT02776436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864929|NCT02776436|Glucocorticoids|glucocorticoids|mesh-ancestor
92864930|NCT02776436|Hormones|hormones|mesh-ancestor
92864931|NCT02776436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864932|NCT02776436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92864933|NCT02776436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92864934|NCT02775968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92864935|NCT02775968|Azithromycin|azithromycin|mesh-list
92864936|NCT02775968|Ceftriaxone|ceftriaxone|mesh-list
92864937|NCT02775968|Erythromycin|erythromycin|mesh-list
92864938|NCT02775968|Cephalosporins|cephalosporins|mesh-list
92864939|NCT02775968|Cefamandole|cefamandole|mesh-list
92864940|NCT02775968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92864941|NCT02775968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864942|NCT02775968|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92864943|NCT02775968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92864944|NCT02775968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864945|NCT02775734|Acetylcysteine|acetylcysteine|mesh-list
92864946|NCT02775734|Clomiphene|clomiphene|mesh-list
92864947|NCT02775734|Enclomiphene|enclomiphene|mesh-list
92864948|NCT02775734|Zuclomiphene|zuclomiphene|mesh-list
92864949|NCT02775734|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92864950|NCT02775734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864951|NCT02775734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92864952|NCT02775734|Hormone Antagonists|hormone antagonists|mesh-ancestor
92864953|NCT02775734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92864954|NCT02775734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864955|NCT02775734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92864956|NCT02775734|Fertility Agents|fertility agents|mesh-ancestor
92864957|NCT02775734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864958|NCT02775734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92864959|NCT02775734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92864960|NCT02775734|Antiviral Agents|antiviral agents|mesh-ancestor
92864961|NCT02775734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510143|NCT00000601|Hormones|hormones|mesh-list
92864962|NCT02775734|Expectorants|expectorants|mesh-ancestor
92864963|NCT02775734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92864964|NCT02775734|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92864965|NCT02775734|Antioxidants|antioxidants|mesh-ancestor
92864966|NCT02775734|Protective Agents|protective agents|mesh-ancestor
92864967|NCT02775734|Antidotes|antidotes|mesh-ancestor
92864968|NCT02772926|Benphothiamine|benphothiamine|mesh-list
92864969|NCT02772926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92864970|NCT02772926|Immunologic Factors|immunologic factors|mesh-ancestor
92864971|NCT02772926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864972|NCT02772926|Chelating Agents|chelating agents|mesh-ancestor
92864973|NCT02772926|Sequestering Agents|sequestering agents|mesh-ancestor
92864974|NCT02772926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92864975|NCT02709564|Misoprostol|misoprostol|mesh-list
92864976|NCT02709564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92864977|NCT02709564|Abortifacient Agents|abortifacient agents|mesh-ancestor
92864978|NCT02709564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92864979|NCT02709564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864980|NCT02709564|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92864981|NCT02709564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92864982|NCT02709564|Oxytocics|oxytocics|mesh-ancestor
92864983|NCT04688814|Morphine|morphine|mesh-list
92864984|NCT04688814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92864985|NCT04688814|Narcotics|narcotics|mesh-ancestor
92864986|NCT04688814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92864987|NCT04688814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864988|NCT04688814|Analgesics|analgesics|mesh-ancestor
92864989|NCT04688814|Sensory System Agents|sensory system agents|mesh-ancestor
92864990|NCT04688814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864991|NCT00744237|Metoprolol|metoprolol|mesh-list
92864992|NCT00744237|Nebivolol|nebivolol|mesh-list
92864993|NCT00744237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92864994|NCT00744237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92864995|NCT00744237|Sympatholytics|sympatholytics|mesh-ancestor
92864996|NCT00744237|Autonomic Agents|autonomic agents|mesh-ancestor
92864997|NCT00744237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92864998|NCT00744237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92864999|NCT00744237|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92865000|NCT00744237|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92865001|NCT00744237|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92865002|NCT00744237|Adrenergic Agents|adrenergic agents|mesh-ancestor
92865003|NCT00744237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865004|NCT00744237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865005|NCT00744237|Vasodilator Agents|vasodilator agents|mesh-ancestor
92865006|NCT00744237|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92865007|NCT00744237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92865008|NCT00744237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92865009|NCT04821284|Leucovorin|leucovorin|mesh-list
92865010|NCT04821284|Paclitaxel|paclitaxel|mesh-list
92865011|NCT04821284|Gemcitabine|gemcitabine|mesh-list
92865012|NCT04821284|Fluorouracil|fluorouracil|mesh-list
92865013|NCT04821284|Oxaliplatin|oxaliplatin|mesh-list
92865014|NCT04821284|Irinotecan|irinotecan|mesh-list
92865015|NCT04821284|Calcium|calcium|mesh-list
92865016|NCT04821284|Levoleucovorin|levoleucovorin|mesh-list
92865017|NCT04821284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92865018|NCT04821284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865019|NCT04821284|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865020|NCT04821284|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865021|NCT04821284|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865022|NCT04821284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865023|NCT04821284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92865024|NCT04821284|Antimetabolites|antimetabolites|mesh-ancestor
92865025|NCT04821284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92865026|NCT04821284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865027|NCT04821284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865028|NCT04821284|Immunologic Factors|immunologic factors|mesh-ancestor
92865029|NCT04821284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92865030|NCT04821284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92865031|NCT04821284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865032|NCT04821284|Antidotes|antidotes|mesh-ancestor
92865033|NCT04821284|Protective Agents|protective agents|mesh-ancestor
92865034|NCT04821284|Vitamin B Complex|vitamin b complex|mesh-ancestor
92865035|NCT04821284|Vitamins|vitamins|mesh-ancestor
92865036|NCT04821284|Micronutrients|micronutrients|mesh-ancestor
92865037|NCT05260554|Fosfomycin|fosfomycin|mesh-list
92865038|NCT05260554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865039|NCT05260554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865040|NCT04089345|Ustekinumab|ustekinumab|mesh-list
92865041|NCT04089345|Dermatologic Agents|dermatologic agents|mesh-ancestor
92865042|NCT02693574|Amoxicillin|amoxicillin|mesh-list
92865043|NCT02693574|Clarithromycin|clarithromycin|mesh-list
92865044|NCT02693574|Levofloxacin|levofloxacin|mesh-list
92865045|NCT02693574|Esomeprazole|esomeprazole|mesh-list
92865046|NCT02693574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865047|NCT02693574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865048|NCT02693574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92865049|NCT02693574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865050|NCT02693574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92865051|NCT02693574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865052|NCT02693574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865053|NCT02693574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92865054|NCT02693574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92865055|NCT02693574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92865056|NCT02693574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92865057|NCT02693574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92865058|NCT02693574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92865059|NCT02693574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865060|NCT02693574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92865061|NCT04179266|Ketamine|ketamine|mesh-list
92865062|NCT04179266|Analgesics|analgesics|mesh-ancestor
92865063|NCT04179266|Sensory System Agents|sensory system agents|mesh-ancestor
92865064|NCT04179266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865065|NCT04179266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865066|NCT04179266|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92865067|NCT04179266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92865068|NCT04179266|Anesthetics, General|anesthetics, general|mesh-ancestor
92865069|NCT04179266|Anesthetics|anesthetics|mesh-ancestor
92865070|NCT04179266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865071|NCT04179266|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92865072|NCT04179266|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92865073|NCT04179266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865074|NCT04179266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865075|NCT00743145|Naltrexone|naltrexone|mesh-list
92865076|NCT00743145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92865077|NCT00743145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92865078|NCT00743145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865079|NCT00743145|Sensory System Agents|sensory system agents|mesh-ancestor
92865080|NCT00743145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865081|NCT04875728|Cefazolin|cefazolin|mesh-list
92865082|NCT04875728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865083|NCT04875728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865084|NCT00611910|Sirolimus|sirolimus|mesh-list
92865085|NCT00611910|Paclitaxel|paclitaxel|mesh-list
92865086|NCT00611910|Temsirolimus|temsirolimus|mesh-list
92865087|NCT00611910|MTOR Inhibitors|mtor inhibitors|mesh-list
92865088|NCT00611910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92865089|NCT00611910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865090|NCT00611910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865091|NCT00611910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865092|NCT00611910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865093|NCT00611910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865094|NCT00611910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865095|NCT00611910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865096|NCT00611910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92865097|NCT00611910|Antifungal Agents|antifungal agents|mesh-ancestor
92865098|NCT00611910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865099|NCT00611910|Immunologic Factors|immunologic factors|mesh-ancestor
92865100|NCT00611910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865101|NCT00611910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92865102|NCT00611910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865103|NCT00920855|Bortezomib|bortezomib|mesh-list
92865104|NCT00920855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92865105|NCT00920855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865106|NCT00920855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92865107|NCT00920855|Alkylating Agents|alkylating agents|mesh-ancestor
92865108|NCT00920855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865109|NCT04251845|Melatonin|melatonin|mesh-list
92865110|NCT04251845|Antioxidants|antioxidants|mesh-ancestor
92865111|NCT04251845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865112|NCT04251845|Protective Agents|protective agents|mesh-ancestor
92865113|NCT04251845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865114|NCT04251845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92510283|NCT00000712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865116|NCT05207358|Cyclophosphamide|cyclophosphamide|mesh-list
92865117|NCT05207358|Rituximab|rituximab|mesh-list
92865118|NCT05207358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865119|NCT05207358|Immunologic Factors|immunologic factors|mesh-ancestor
92865120|NCT05207358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865121|NCT05207358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865122|NCT05207358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92865123|NCT05207358|Alkylating Agents|alkylating agents|mesh-ancestor
92865124|NCT05207358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865125|NCT05207358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865126|NCT05207358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92865127|NCT05207358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92865128|NCT05207358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92865129|NCT05207358|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92865130|NCT05207358|Antitubercular Agents|antitubercular agents|mesh-ancestor
92865131|NCT05207358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865132|NCT05207358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865133|NCT05207358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865134|NCT04256993|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92865135|NCT04256993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865136|NCT05387031|Ustekinumab|ustekinumab|mesh-list
92865137|NCT05387031|Dermatologic Agents|dermatologic agents|mesh-ancestor
92865138|NCT04570644|Cromolyn Sodium|cromolyn sodium|mesh-list
92865139|NCT04570644|Ibuprofen|ibuprofen|mesh-list
92865140|NCT04570644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92865141|NCT04570644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865142|NCT04570644|Analgesics|analgesics|mesh-ancestor
92865143|NCT04570644|Sensory System Agents|sensory system agents|mesh-ancestor
92865144|NCT04570644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865145|NCT04570644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865146|NCT04570644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865147|NCT04570644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865148|NCT04570644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92865149|NCT04570644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865150|NCT04570644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865151|NCT04570644|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92865152|NCT04570644|Immunologic Factors|immunologic factors|mesh-ancestor
92865153|NCT04570644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92865154|NCT04570644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92865155|NCT04570644|Respiratory System Agents|respiratory system agents|mesh-ancestor
92865156|NCT02775110|Natalizumab|natalizumab|mesh-list
92865157|NCT02775110|Immunologic Factors|immunologic factors|mesh-ancestor
92865158|NCT02775110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865159|NCT02775266|Thioctic Acid|thioctic acid|mesh-list
92865160|NCT02775266|Antioxidants|antioxidants|mesh-ancestor
92865161|NCT02775266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865162|NCT02775266|Protective Agents|protective agents|mesh-ancestor
92865163|NCT02775266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865164|NCT02775266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92865165|NCT02775266|Vitamins|vitamins|mesh-ancestor
92865166|NCT02775266|Micronutrients|micronutrients|mesh-ancestor
92865167|NCT01524926|Crizotinib|crizotinib|mesh-list
92865168|NCT01524926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865169|NCT01524926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92865170|NCT01524926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865171|NCT01524926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865172|NCT03738228|Cisplatin|cisplatin|mesh-list
92865173|NCT03738228|Atezolizumab|atezolizumab|mesh-list
92865174|NCT03738228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92865175|NCT03738228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865176|NCT03738228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92865177|NCT03738228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865178|NCT03738228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92865179|NCT03738228|Immunologic Factors|immunologic factors|mesh-ancestor
92865180|NCT03738228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865181|NCT04756232|Mecamylamine|mecamylamine|mesh-list
92865182|NCT04756232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92865183|NCT04756232|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92865184|NCT04756232|Autonomic Agents|autonomic agents|mesh-ancestor
92865185|NCT04756232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865186|NCT04756232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865187|NCT04756232|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92865188|NCT04756232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92865189|NCT04756232|Cholinergic Agents|cholinergic agents|mesh-ancestor
92525176|NCT00023998|Methotrexate|methotrexate|mesh-list
92865190|NCT04756232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865191|NCT04756232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865193|NCT02774876|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92865194|NCT02774876|Hormones|hormones|mesh-list
92865195|NCT02774876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92865196|NCT02774876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865197|NCT02774876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865198|NCT04225364|Paclitaxel|paclitaxel|mesh-list
92865199|NCT04225364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92865200|NCT04225364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92865201|NCT04225364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865202|NCT04225364|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865203|NCT04225364|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865204|NCT04225364|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865205|NCT04225364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865206|NCT02771834|Vitamin D|vitamin d|mesh-list
92865207|NCT02771834|Vitamins|vitamins|mesh-ancestor
92865208|NCT02771834|Micronutrients|micronutrients|mesh-ancestor
92865209|NCT02771834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865210|NCT02771834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92865211|NCT02774564|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92865212|NCT02774564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92865213|NCT02774564|Immunologic Factors|immunologic factors|mesh-ancestor
92865214|NCT02774564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865215|NCT02774564|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92865216|NCT02774564|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92865217|NCT02774564|Dopamine Agonists|dopamine agonists|mesh-ancestor
92865218|NCT02774564|Dopamine Agents|dopamine agents|mesh-ancestor
92865219|NCT02774564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865220|NCT02774564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865221|NCT00613470|Citalopram|citalopram|mesh-list
92865222|NCT00613470|Escitalopram|escitalopram|mesh-list
92865223|NCT00613470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92865224|NCT00613470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92865225|NCT00613470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865226|NCT00613470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865227|NCT00613470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865228|NCT00613470|Serotonin Agents|serotonin agents|mesh-ancestor
92865229|NCT00613470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865230|NCT00613470|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92865231|NCT00613470|Antidepressive Agents|antidepressive agents|mesh-ancestor
92865232|NCT00613470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92865233|NCT02771912|Propofol|propofol|mesh-list
92865234|NCT02771912|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92865235|NCT02771912|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92865236|NCT02771912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865237|NCT02771912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865238|NCT02771912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92865239|NCT02771912|Anesthetics, General|anesthetics, general|mesh-ancestor
92865240|NCT02771912|Anesthetics|anesthetics|mesh-ancestor
92865241|NCT02771912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92865242|NCT02771912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92865243|NCT02771912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92865244|NCT00741819|Treprostinil|treprostinil|mesh-list
92865245|NCT00741819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92865246|NCT04457466|Mitogens|mitogens|mesh-list
92865247|NCT04457466|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865248|NCT04457466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865249|NCT04954742|Riociguat|riociguat|mesh-list
92865250|NCT04954742|Enzyme Activators|enzyme activators|mesh-ancestor
92865251|NCT04954742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865252|NCT04193696|Immunomodulating Agents|immunomodulating agents|mesh-list
92865253|NCT04193696|Immunologic Factors|immunologic factors|mesh-ancestor
92865254|NCT04193696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865255|NCT02774096|Xenon|xenon|mesh-list
92865256|NCT02774096|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92865257|NCT02774096|Anesthetics, General|anesthetics, general|mesh-ancestor
92865258|NCT02774096|Anesthetics|anesthetics|mesh-ancestor
92865259|NCT02774096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865260|NCT02774096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865261|NCT04181385|Bromocriptine|bromocriptine|mesh-list
92865262|NCT04181385|Olanzapine|olanzapine|mesh-list
92865263|NCT04181385|Antiemetics|antiemetics|mesh-ancestor
92865264|NCT04181385|Autonomic Agents|autonomic agents|mesh-ancestor
92865265|NCT04181385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865266|NCT04181385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865267|NCT04181385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865268|NCT04181385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92865269|NCT04181385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92865270|NCT04181385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865271|NCT04181385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92865272|NCT04181385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92865273|NCT04181385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92865274|NCT04181385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865275|NCT04181385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865276|NCT04181385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865277|NCT04181385|Serotonin Agents|serotonin agents|mesh-ancestor
92865278|NCT04181385|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92865279|NCT04181385|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92865280|NCT04181385|Hormone Antagonists|hormone antagonists|mesh-ancestor
92865281|NCT04181385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865282|NCT04181385|Dopamine Agonists|dopamine agonists|mesh-ancestor
92865283|NCT04181385|Dopamine Agents|dopamine agents|mesh-ancestor
92865285|NCT00924443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92865286|NCT00924443|Antimetabolites|antimetabolites|mesh-ancestor
92865287|NCT00924443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865288|NCT00924443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865289|NCT02677155|Rituximab|rituximab|mesh-list
92865290|NCT02677155|Pembrolizumab|pembrolizumab|mesh-list
92865291|NCT02677155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92865292|NCT02677155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865293|NCT02677155|Immunologic Factors|immunologic factors|mesh-ancestor
92865294|NCT02677155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865295|NCT02677155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865296|NCT02677155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92865297|NCT02677155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865298|NCT02537691|Theophylline|theophylline|mesh-list
92865299|NCT02537691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92865300|NCT02537691|Autonomic Agents|autonomic agents|mesh-ancestor
92865301|NCT02537691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865302|NCT02537691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865303|NCT02537691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92865304|NCT02537691|Respiratory System Agents|respiratory system agents|mesh-ancestor
92865305|NCT02537691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92865306|NCT02537691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865307|NCT02537691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865308|NCT02537691|Vasodilator Agents|vasodilator agents|mesh-ancestor
92865309|NCT02537691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92865310|NCT02537691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92865311|NCT02537691|Purinergic Agents|purinergic agents|mesh-ancestor
92865312|NCT02537691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865313|NCT04225052|Varenicline|varenicline|mesh-list
92865314|NCT04225052|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92865315|NCT04225052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92865316|NCT04225052|Cholinergic Agents|cholinergic agents|mesh-ancestor
92865317|NCT04225052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865318|NCT04225052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865319|NCT04225052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865320|NCT04255121|Lidocaine|lidocaine|mesh-list
92865321|NCT04255121|Epinephrine|epinephrine|mesh-list
92865322|NCT04255121|Racepinephrine|racepinephrine|mesh-list
92865323|NCT04255121|Epinephryl borate|epinephryl borate|mesh-list
92865325|NCT04255121|Anesthetics|anesthetics|mesh-ancestor
92865326|NCT04255121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865327|NCT04255121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865328|NCT04255121|Sensory System Agents|sensory system agents|mesh-ancestor
92865329|NCT04255121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865330|NCT04255121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92865331|NCT04255121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92865332|NCT04255121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92865333|NCT04255121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865334|NCT04255121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865335|NCT04255121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92865336|NCT04255121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92865338|NCT04255121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865339|NCT04255121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92865340|NCT04255121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92865341|NCT04255121|Autonomic Agents|autonomic agents|mesh-ancestor
92865342|NCT04255121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92865343|NCT04255121|Respiratory System Agents|respiratory system agents|mesh-ancestor
92865344|NCT04255121|Mydriatics|mydriatics|mesh-ancestor
92865345|NCT04255121|Sympathomimetics|sympathomimetics|mesh-ancestor
92865346|NCT04255121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92865347|NCT03521232|Niclosamide|niclosamide|mesh-list
92865348|NCT03521232|Anticestodal Agents|anticestodal agents|mesh-ancestor
92865349|NCT03521232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92865350|NCT03521232|Anthelmintics|anthelmintics|mesh-ancestor
92865351|NCT03521232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92865352|NCT03521232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865353|NCT03521232|Antinematodal Agents|antinematodal agents|mesh-ancestor
92865354|NCT00924287|Aldesleukin|aldesleukin|mesh-list
92865355|NCT00924287|Cyclophosphamide|cyclophosphamide|mesh-list
92865356|NCT00924287|Fludarabine|fludarabine|mesh-list
92865357|NCT00924287|Interleukin-2|interleukin-2|mesh-list
92865358|NCT00924287|Mesna|mesna|mesh-list
92865359|NCT00924287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865360|NCT00924287|Immunologic Factors|immunologic factors|mesh-ancestor
92865361|NCT00924287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865362|NCT00924287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865363|NCT00924287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92865364|NCT00924287|Alkylating Agents|alkylating agents|mesh-ancestor
92865365|NCT00924287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865366|NCT00924287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865367|NCT00924287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92865368|NCT00924287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865369|NCT00924287|Analgesics|analgesics|mesh-ancestor
92865370|NCT00924287|Sensory System Agents|sensory system agents|mesh-ancestor
92865371|NCT00924287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865372|NCT00924287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92865373|NCT00924287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92865374|NCT00924287|Antiviral Agents|antiviral agents|mesh-ancestor
92865375|NCT00924287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865376|NCT00924287|Protective Agents|protective agents|mesh-ancestor
92865377|NCT02696954|Lumefantrine|lumefantrine|mesh-list
92865378|NCT02696954|Artemether|artemether|mesh-list
92865379|NCT02696954|Primaquine|primaquine|mesh-list
92865380|NCT02696954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92865381|NCT02696954|Amodiaquine|amodiaquine|mesh-list
92865382|NCT02696954|Antimalarials|antimalarials|mesh-ancestor
92865383|NCT02696954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92865384|NCT02696954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92865385|NCT02696954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865386|NCT02677077|Natalizumab|natalizumab|mesh-list
92865387|NCT02677077|Immunologic Factors|immunologic factors|mesh-ancestor
92865388|NCT02677077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865389|NCT02771600|Anesthetics|anesthetics|mesh-list
92865390|NCT02771600|Anesthetics, Local|anesthetics, local|mesh-list
92865391|NCT02771600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865392|NCT02771600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865393|NCT02771600|Sensory System Agents|sensory system agents|mesh-ancestor
92865394|NCT02771600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865395|NCT02773316|Morphine|morphine|mesh-list
92865396|NCT02773316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92865397|NCT02773316|Narcotics|narcotics|mesh-ancestor
92865398|NCT02773316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865399|NCT02773316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865400|NCT02773316|Analgesics|analgesics|mesh-ancestor
92865401|NCT02773316|Sensory System Agents|sensory system agents|mesh-ancestor
92865402|NCT02773316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865403|NCT00642681|Insulin|insulin|mesh-list
92865404|NCT00642681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92865405|NCT00642681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865406|NCT02773550|Prednisone|prednisone|mesh-list
92865407|NCT02773550|Bortezomib|bortezomib|mesh-list
92865408|NCT02773550|Melphalan|melphalan|mesh-list
92865409|NCT02773550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865410|NCT02773550|Glucocorticoids|glucocorticoids|mesh-ancestor
92865411|NCT02773550|Hormones|hormones|mesh-ancestor
92865412|NCT02773550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865413|NCT02773550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865414|NCT02773550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92510584|NCT00389233|Ascorbic Acid|ascorbic acid|mesh-list
92865415|NCT02773550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865416|NCT02773550|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92865417|NCT02773550|Alkylating Agents|alkylating agents|mesh-ancestor
92865418|NCT02773550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865419|NCT02773550|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92865420|NCT02773550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865421|NCT02773550|Immunologic Factors|immunologic factors|mesh-ancestor
92865422|NCT02773472|Morphine|morphine|mesh-list
92865423|NCT02773472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92865424|NCT02773472|Narcotics|narcotics|mesh-ancestor
92865425|NCT02773472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865426|NCT02773472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865427|NCT02773472|Analgesics|analgesics|mesh-ancestor
92865428|NCT02773472|Sensory System Agents|sensory system agents|mesh-ancestor
92865429|NCT02773472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865430|NCT00637871|Tamoxifen|tamoxifen|mesh-list
92865431|NCT00637871|Bicalutamide|bicalutamide|mesh-list
92865432|NCT00637871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92865433|NCT00637871|Hormone Antagonists|hormone antagonists|mesh-ancestor
92865434|NCT00637871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865435|NCT00637871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865436|NCT00637871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92865437|NCT00637871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865438|NCT00637871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92865439|NCT00637871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92865440|NCT00637871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92865441|NCT00637871|Androgen Antagonists|androgen antagonists|mesh-ancestor
92865442|NCT00635258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92865443|NCT00635258|Ganirelix|ganirelix|mesh-list
92865444|NCT00635258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865445|NCT00635258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865446|NCT00635258|Luteolytic Agents|luteolytic agents|mesh-ancestor
92865447|NCT00635258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92865448|NCT00635258|Contraceptive Agents|contraceptive agents|mesh-ancestor
92865449|NCT00635258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92865450|NCT00635258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92865451|NCT00635258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92865452|NCT00635258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865453|NCT00635258|Hormone Antagonists|hormone antagonists|mesh-ancestor
92865454|NCT00642837|Acetaminophen|acetaminophen|mesh-list
92865455|NCT00642837|Tramadol|tramadol|mesh-list
92865456|NCT00642837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865457|NCT00642837|Analgesics|analgesics|mesh-ancestor
92865458|NCT00642837|Sensory System Agents|sensory system agents|mesh-ancestor
92865459|NCT00642837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865460|NCT00642837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865461|NCT00642837|Antipyretics|antipyretics|mesh-ancestor
92865462|NCT00642837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92865463|NCT00642837|Narcotics|narcotics|mesh-ancestor
92865464|NCT00642837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865465|NCT02776748|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92865466|NCT02776748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92865467|NCT02776748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92865468|NCT02776748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865469|NCT02776748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865470|NCT02776748|Antiviral Agents|antiviral agents|mesh-ancestor
92865471|NCT02776748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865472|NCT02776748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92865473|NCT02776748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92865475|NCT02676609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92865476|NCT02676609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865477|NCT00642915|Insulin Glargine|insulin glargine|mesh-list
92865478|NCT00642915|Glimepiride|glimepiride|mesh-list
92865479|NCT00642915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92865480|NCT00642915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865481|NCT00642915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92865482|NCT00642915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865483|NCT00642915|Immunologic Factors|immunologic factors|mesh-ancestor
92865484|NCT02676297|Tiotropium Bromide|tiotropium bromide|mesh-list
92865485|NCT02676297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92865486|NCT02676297|Autonomic Agents|autonomic agents|mesh-ancestor
92865487|NCT02676297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865488|NCT02676297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865489|NCT02676297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92865490|NCT02676297|Respiratory System Agents|respiratory system agents|mesh-ancestor
92865491|NCT02676297|Parasympatholytics|parasympatholytics|mesh-ancestor
92865492|NCT02676297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92865493|NCT02676297|Cholinergic Agents|cholinergic agents|mesh-ancestor
92865494|NCT02676297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865495|NCT02676297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865496|NCT02696720|Lidocaine|lidocaine|mesh-list
92865497|NCT02696720|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865498|NCT02696720|Anesthetics|anesthetics|mesh-ancestor
92865499|NCT02696720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865500|NCT02696720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865501|NCT02696720|Sensory System Agents|sensory system agents|mesh-ancestor
92865502|NCT02696720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865503|NCT02696720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92865504|NCT02696720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92865505|NCT02696720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92865506|NCT02696720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865507|NCT02696720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865508|NCT00643071|Tacrolimus|tacrolimus|mesh-list
92865509|NCT00643071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865510|NCT00643071|Immunologic Factors|immunologic factors|mesh-ancestor
92865511|NCT00643071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865512|NCT00643071|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92865513|NCT00643071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865514|NCT00643071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865515|NCT03728634|Vitamin A|vitamin a|mesh-list
92865516|NCT03728634|Vitamins|vitamins|mesh-ancestor
92865517|NCT03728634|Micronutrients|micronutrients|mesh-ancestor
92865518|NCT03728634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865519|NCT02767310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92865520|NCT02767310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92865521|NCT02767310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92865522|NCT02767310|Antimetabolites|antimetabolites|mesh-ancestor
92865523|NCT02767310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865524|NCT02767310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92865525|NCT02767310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92865526|NCT02767310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865527|NCT04353414|Bupivacaine|bupivacaine|mesh-list
92865528|NCT04353414|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865529|NCT04353414|Anesthetics|anesthetics|mesh-ancestor
92865530|NCT04353414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865531|NCT04353414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865532|NCT04353414|Sensory System Agents|sensory system agents|mesh-ancestor
92865533|NCT04353414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865534|NCT00643149|Amoxicillin|amoxicillin|mesh-list
92865535|NCT00643149|Azithromycin|azithromycin|mesh-list
92865536|NCT00643149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865537|NCT00643149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865538|NCT05141682|Azacitidine|azacitidine|mesh-list
92865539|NCT05141682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92865540|NCT05141682|Antimetabolites|antimetabolites|mesh-ancestor
92865541|NCT05141682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865542|NCT05141682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865543|NCT05141682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865544|NCT00643227|Azithromycin|azithromycin|mesh-list
92865545|NCT00643227|Clarithromycin|clarithromycin|mesh-list
92865546|NCT00643227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865547|NCT00643227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865548|NCT00643227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92865549|NCT00643227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865550|NCT00643227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865551|NCT00643227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92865552|NCT00643227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92865553|NCT00613392|Antioxidants|antioxidants|mesh-list
92865554|NCT00613392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865555|NCT00613392|Protective Agents|protective agents|mesh-ancestor
92865556|NCT00613392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865557|NCT02537457|Rivaroxaban|rivaroxaban|mesh-list
92865558|NCT02537457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92865559|NCT02537457|Antithrombins|antithrombins|mesh-ancestor
92865560|NCT02537457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92865561|NCT02537457|Protease Inhibitors|protease inhibitors|mesh-ancestor
92865562|NCT02537457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865563|NCT02537457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865564|NCT02537457|Anticoagulants|anticoagulants|mesh-ancestor
92865565|NCT02762864|Clopidogrel|clopidogrel|mesh-list
92865566|NCT02762864|Ticagrelor|ticagrelor|mesh-list
92865567|NCT02762864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865568|NCT02762864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865569|NCT02762864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92865570|NCT02762864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92865571|NCT02762864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92865572|NCT02762864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92865573|NCT02762864|Purinergic Agents|purinergic agents|mesh-ancestor
92865574|NCT02762864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865575|NCT02767154|Mannitol|mannitol|mesh-list
92865576|NCT02767154|Dextrans|dextrans|mesh-list
92865577|NCT02767154|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92865578|NCT02767154|Diuretics|diuretics|mesh-ancestor
92865579|NCT02767154|Natriuretic Agents|natriuretic agents|mesh-ancestor
92865580|NCT02767154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865581|NCT02767154|Anticoagulants|anticoagulants|mesh-ancestor
92865582|NCT02767154|Plasma Substitutes|plasma substitutes|mesh-ancestor
92865583|NCT02767154|Blood Substitutes|blood substitutes|mesh-ancestor
92865584|NCT02767232|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92865585|NCT02767232|Plasminogen|plasminogen|mesh-list
92865586|NCT02767232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92865587|NCT02767232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92865588|NCT02767232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865589|NCT02767076|Anesthetics|anesthetics|mesh-list
92865590|NCT02767076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865591|NCT02767076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865592|NCT02766764|Hormones|hormones|mesh-list
92865593|NCT02766764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865594|NCT02766764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865595|NCT04658654|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
92865596|NCT04658654|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92865597|NCT04658654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865598|NCT04658654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865599|NCT02770508|Ritonavir|ritonavir|mesh-list
92865600|NCT02770508|Darunavir|darunavir|mesh-list
92865601|NCT02770508|Tenofovir|tenofovir|mesh-list
92865602|NCT02770508|Lamivudine|lamivudine|mesh-list
92865603|NCT02770508|Emtricitabine|emtricitabine|mesh-list
92865604|NCT02770508|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92865605|NCT02770508|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92865606|NCT02770508|Protease Inhibitors|protease inhibitors|mesh-ancestor
92865607|NCT02770508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865608|NCT02770508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865609|NCT02770508|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92865610|NCT02770508|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92865611|NCT02770508|Antiviral Agents|antiviral agents|mesh-ancestor
92865612|NCT02770508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865613|NCT02770508|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92865614|NCT02770508|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92865615|NCT02770508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92865616|NCT02770508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92865617|NCT02762942|Misoprostol|misoprostol|mesh-list
92865618|NCT02762942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92865619|NCT02762942|Abortifacient Agents|abortifacient agents|mesh-ancestor
92865620|NCT02762942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92865621|NCT02762942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865623|NCT02762942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865624|NCT02762942|Oxytocics|oxytocics|mesh-ancestor
92865625|NCT02770430|Infliximab|infliximab|mesh-list
92865626|NCT02770430|Basiliximab|basiliximab|mesh-list
92865627|NCT02770430|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92865628|NCT02770430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865629|NCT02770430|Dermatologic Agents|dermatologic agents|mesh-ancestor
92865630|NCT02770430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865631|NCT02770430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865632|NCT02770430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865633|NCT02770430|Immunologic Factors|immunologic factors|mesh-ancestor
92865634|NCT02770430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865635|NCT00918203|Paclitaxel|paclitaxel|mesh-list
92865636|NCT00918203|Carboplatin|carboplatin|mesh-list
92865637|NCT00918203|Olaratumab|olaratumab|mesh-list
92865638|NCT00918203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92865639|NCT00918203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865640|NCT00918203|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865641|NCT00918203|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865642|NCT00918203|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865643|NCT00918203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865645|NCT00644319|Morphine|morphine|mesh-list
92865646|NCT00644319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92865647|NCT00644319|Narcotics|narcotics|mesh-ancestor
92865648|NCT00644319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865649|NCT00644319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865650|NCT00644319|Analgesics|analgesics|mesh-ancestor
92865651|NCT00644319|Sensory System Agents|sensory system agents|mesh-ancestor
92865652|NCT00644319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865653|NCT00644319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92865654|NCT00644319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865655|NCT00644319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865656|NCT00644319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865657|NCT00644319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92865658|NCT00644319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865659|NCT00644319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865660|NCT04224116|Tranexamic Acid|tranexamic acid|mesh-list
92865661|NCT04224116|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92865662|NCT04224116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92865663|NCT04224116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865664|NCT04224116|Hemostatics|hemostatics|mesh-ancestor
92865665|NCT04224116|Coagulants|coagulants|mesh-ancestor
92865666|NCT02672709|Apixaban|apixaban|mesh-list
92865667|NCT02672709|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92865668|NCT02672709|Antithrombins|antithrombins|mesh-ancestor
92865669|NCT02672709|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92865670|NCT02672709|Protease Inhibitors|protease inhibitors|mesh-ancestor
92865671|NCT02672709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865672|NCT02672709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865673|NCT02672709|Anticoagulants|anticoagulants|mesh-ancestor
92865674|NCT02770274|Aspirin|aspirin|mesh-list
92865675|NCT02770274|Cilostazol|cilostazol|mesh-list
92865676|NCT02770274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92865677|NCT02770274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865678|NCT02770274|Analgesics|analgesics|mesh-ancestor
92865679|NCT02770274|Sensory System Agents|sensory system agents|mesh-ancestor
92865680|NCT02770274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865681|NCT02770274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865682|NCT02770274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865683|NCT02770274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865684|NCT02770274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92865685|NCT02770274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92865686|NCT02770274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865687|NCT02770274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92865688|NCT02770274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92865689|NCT02770274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865690|NCT02770274|Antipyretics|antipyretics|mesh-ancestor
92865691|NCT02770274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92865692|NCT02770274|Autonomic Agents|autonomic agents|mesh-ancestor
92865693|NCT02770274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92865694|NCT02770274|Respiratory System Agents|respiratory system agents|mesh-ancestor
92865695|NCT02770274|Vasodilator Agents|vasodilator agents|mesh-ancestor
92865696|NCT02770274|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92865697|NCT02770274|Protective Agents|protective agents|mesh-ancestor
92865698|NCT02770274|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92865699|NCT02770274|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92865700|NCT00910221|Atorvastatin|atorvastatin|mesh-list
92865701|NCT00910221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92865702|NCT00910221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92865703|NCT00910221|Antimetabolites|antimetabolites|mesh-ancestor
92865704|NCT00910221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865705|NCT00910221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92865706|NCT00910221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92865707|NCT00910221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865708|NCT04657562|Tacrolimus|tacrolimus|mesh-list
92865709|NCT04657562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865710|NCT04657562|Immunologic Factors|immunologic factors|mesh-ancestor
92865711|NCT04657562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865712|NCT04657562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92510897|NCT00001066|Lamivudine|lamivudine|mesh-list
92865713|NCT04657562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865714|NCT04657562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865715|NCT05252117|Carticaine|carticaine|mesh-list
92865716|NCT05252117|Mepivacaine|mepivacaine|mesh-list
92865717|NCT05252117|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865718|NCT05252117|Anesthetics|anesthetics|mesh-ancestor
92865719|NCT05252117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865720|NCT05252117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865721|NCT05252117|Sensory System Agents|sensory system agents|mesh-ancestor
92865722|NCT05252117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865723|NCT04224350|Tacrolimus|tacrolimus|mesh-list
92865724|NCT04224350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865725|NCT04224350|Immunologic Factors|immunologic factors|mesh-ancestor
92865726|NCT04224350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865727|NCT04224350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92865728|NCT04224350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865729|NCT04224350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865730|NCT02770716|Terlipressin|terlipressin|mesh-list
92865731|NCT02770716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92865732|NCT02770716|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92865733|NCT04846829|Citalopram|citalopram|mesh-list
92865734|NCT04846829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92865735|NCT04846829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92865736|NCT04846829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865737|NCT04846829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865738|NCT04846829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865739|NCT04846829|Serotonin Agents|serotonin agents|mesh-ancestor
92865740|NCT04846829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865741|NCT04846829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92865742|NCT04846829|Antidepressive Agents|antidepressive agents|mesh-ancestor
92865743|NCT04846829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92865744|NCT02672241|Temozolomide|temozolomide|mesh-list
92865745|NCT02672241|Nimotuzumab|nimotuzumab|mesh-list
92865746|NCT02672241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92865747|NCT02672241|Alkylating Agents|alkylating agents|mesh-ancestor
92865748|NCT02672241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865749|NCT02672241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865750|NCT02672241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92865751|NCT04177875|Paclitaxel|paclitaxel|mesh-list
92865752|NCT04177875|Docetaxel|docetaxel|mesh-list
92865753|NCT04177875|Cisplatin|cisplatin|mesh-list
92865754|NCT04177875|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92865755|NCT04177875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92865756|NCT04177875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865757|NCT04177875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865758|NCT04177875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865759|NCT04177875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865760|NCT04177875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865761|NCT00917579|Atorvastatin|atorvastatin|mesh-list
92865762|NCT00917579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92865763|NCT00917579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92865764|NCT00917579|Antimetabolites|antimetabolites|mesh-ancestor
92865765|NCT00917579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865766|NCT00917579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92865767|NCT00917579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92865768|NCT00917579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865769|NCT03808740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92865770|NCT03808740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92865771|NCT03808740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92865772|NCT03808740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865773|NCT03808740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865774|NCT03808740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92865775|NCT03808740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865776|NCT03808740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865778|NCT02766140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865779|NCT02766140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865780|NCT02766140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865781|NCT02766140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865782|NCT02766140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865783|NCT04177641|Antioxidants|antioxidants|mesh-list
92865784|NCT04177641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510972|NCT00001105|Antibodies|antibodies|mesh-list
92865785|NCT04177641|Protective Agents|protective agents|mesh-ancestor
92865786|NCT04177641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865787|NCT04178109|Acetaminophen|acetaminophen|mesh-list
92865788|NCT04178109|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92865789|NCT04178109|Tramadol|tramadol|mesh-list
92865790|NCT04178109|Ropivacaine|ropivacaine|mesh-list
92865791|NCT04178109|Levobupivacaine|levobupivacaine|mesh-list
92865792|NCT04178109|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865793|NCT04178109|Anesthetics|anesthetics|mesh-ancestor
92865794|NCT04178109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865795|NCT04178109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865796|NCT04178109|Sensory System Agents|sensory system agents|mesh-ancestor
92865797|NCT04178109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865798|NCT04178109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865799|NCT04178109|Analgesics|analgesics|mesh-ancestor
92865800|NCT04178109|Antipyretics|antipyretics|mesh-ancestor
92865801|NCT04178109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92865802|NCT04178109|Narcotics|narcotics|mesh-ancestor
92865803|NCT04178109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92865804|NCT04178109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865805|NCT04178109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865806|NCT00644475|Candesartan|candesartan|mesh-list
92865807|NCT00644475|Candesartan cilexetil|candesartan cilexetil|mesh-list
92865808|NCT00644475|Imidapril|imidapril|mesh-list
92865809|NCT00644475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92865810|NCT00644475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92865811|NCT00644475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92865812|NCT00644475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865813|NCT00644475|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92865814|NCT00644475|Protease Inhibitors|protease inhibitors|mesh-ancestor
92865815|NCT00644475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865816|NCT04177719|Oxytocin|oxytocin|mesh-list
92865817|NCT04177719|Oxytocics|oxytocics|mesh-ancestor
92865818|NCT04177719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92865819|NCT04177719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865820|NCT00644553|Amoxicillin|amoxicillin|mesh-list
92865821|NCT00644553|Clarithromycin|clarithromycin|mesh-list
92865822|NCT00644553|Clavulanic Acid|clavulanic acid|mesh-list
92865823|NCT00644553|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92865824|NCT00644553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865825|NCT00644553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865826|NCT00644553|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92865827|NCT00644553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865828|NCT00644553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865829|NCT00644553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92865830|NCT00644553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92865831|NCT00644553|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92865832|NCT02762474|Paclitaxel|paclitaxel|mesh-list
92865833|NCT02762474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92865834|NCT02762474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865835|NCT02762474|Tubulin Modulators|tubulin modulators|mesh-ancestor
92865836|NCT02762474|Antimitotic Agents|antimitotic agents|mesh-ancestor
92865837|NCT02762474|Mitosis Modulators|mitosis modulators|mesh-ancestor
92865838|NCT02762474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865839|NCT00915473|Methylprednisolone|methylprednisolone|mesh-list
92865840|NCT00915473|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92865841|NCT00915473|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92865842|NCT00915473|Prednisolone|prednisolone|mesh-list
92865843|NCT00915473|Prednisolone acetate|prednisolone acetate|mesh-list
92865844|NCT00915473|Lidocaine|lidocaine|mesh-list
92865845|NCT00915473|Bupivacaine|bupivacaine|mesh-list
92865846|NCT00915473|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92865847|NCT00915473|Prednisolone phosphate|prednisolone phosphate|mesh-list
92865848|NCT00915473|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865849|NCT00915473|Anesthetics|anesthetics|mesh-ancestor
92865850|NCT00915473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865851|NCT00915473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865852|NCT00915473|Sensory System Agents|sensory system agents|mesh-ancestor
92865853|NCT00915473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865854|NCT00915473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92865855|NCT00915473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92865856|NCT00915473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92865857|NCT00915473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156614|NCT05386953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92865858|NCT00915473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865859|NCT00915473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865860|NCT00915473|Antiemetics|antiemetics|mesh-ancestor
92865861|NCT00915473|Autonomic Agents|autonomic agents|mesh-ancestor
92865862|NCT00915473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865863|NCT00915473|Glucocorticoids|glucocorticoids|mesh-ancestor
92865864|NCT00915473|Hormones|hormones|mesh-ancestor
92865865|NCT00915473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865866|NCT00915473|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92865867|NCT00915473|Protective Agents|protective agents|mesh-ancestor
92865868|NCT00915473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92865869|NCT00915473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865870|NCT04691726|Dipyrone|dipyrone|mesh-list
92865871|NCT04691726|Lidocaine|lidocaine|mesh-list
92865872|NCT04691726|Morphine|morphine|mesh-list
92865873|NCT04691726|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865874|NCT04691726|Anesthetics|anesthetics|mesh-ancestor
92865875|NCT04691726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865876|NCT04691726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865877|NCT04691726|Sensory System Agents|sensory system agents|mesh-ancestor
92865878|NCT04691726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865879|NCT04691726|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92865880|NCT04691726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92865881|NCT04691726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92865882|NCT04691726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92865883|NCT04691726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865884|NCT04691726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92865885|NCT04691726|Narcotics|narcotics|mesh-ancestor
92865886|NCT04691726|Analgesics|analgesics|mesh-ancestor
92865887|NCT04691726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92865888|NCT04691726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865889|NCT04691726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92865890|NCT04691726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865891|NCT04691726|Antipyretics|antipyretics|mesh-ancestor
92865892|NCT00614328|Naltrexone|naltrexone|mesh-list
92865893|NCT00614328|Baclofen|baclofen|mesh-list
92865894|NCT00614328|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92865895|NCT00614328|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92865896|NCT00614328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865897|NCT00614328|Sensory System Agents|sensory system agents|mesh-ancestor
92865898|NCT00614328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865899|NCT00614328|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92865900|NCT00614328|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92865901|NCT00614328|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92865902|NCT00614328|GABA Agonists|gaba agonists|mesh-ancestor
92865903|NCT00614328|GABA Agents|gaba agents|mesh-ancestor
92865904|NCT00614328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92865905|NCT00614328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865906|NCT04177173|Methotrexate|methotrexate|mesh-list
92865907|NCT04177173|Simvastatin|simvastatin|mesh-list
92865908|NCT04177173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92865909|NCT04177173|Abortifacient Agents|abortifacient agents|mesh-ancestor
92865910|NCT04177173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92865911|NCT04177173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865912|NCT04177173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92865913|NCT04177173|Antimetabolites|antimetabolites|mesh-ancestor
92865914|NCT04177173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865915|NCT04177173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865916|NCT04177173|Dermatologic Agents|dermatologic agents|mesh-ancestor
92865917|NCT04177173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865918|NCT04177173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92865919|NCT04177173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92865920|NCT04177173|Immunologic Factors|immunologic factors|mesh-ancestor
92865921|NCT04177173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865922|NCT04177173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92865923|NCT04177173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92865924|NCT04177173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92865925|NCT04177173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92865926|NCT04177173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92865927|NCT04224818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92156616|NCT05176548|Myeloma Proteins|myeloma proteins|mesh-list
92865928|NCT04224818|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92865929|NCT04224818|Luteolytic Agents|luteolytic agents|mesh-ancestor
92865930|NCT04224818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92865931|NCT04224818|Contraceptive Agents|contraceptive agents|mesh-ancestor
92865932|NCT04224818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92865933|NCT04224818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865934|NCT04224818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92865935|NCT04224818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92865936|NCT04224818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865937|NCT03651804|Acetaminophen|acetaminophen|mesh-list
92865938|NCT03651804|Diphosphonates|diphosphonates|mesh-list
92865939|NCT03651804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92865940|NCT03651804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92865941|NCT03651804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92865942|NCT03651804|Analgesics|analgesics|mesh-ancestor
92865943|NCT03651804|Sensory System Agents|sensory system agents|mesh-ancestor
92865944|NCT03651804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865945|NCT03651804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865946|NCT03651804|Antipyretics|antipyretics|mesh-ancestor
92865947|NCT03651804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92865948|NCT03651804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92865949|NCT00917267|Exenatide|exenatide|mesh-list
92865950|NCT00917267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92865951|NCT00917267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865952|NCT00917267|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92865953|NCT00917267|Incretins|incretins|mesh-ancestor
92865954|NCT00917267|Hormones|hormones|mesh-ancestor
92865955|NCT00917267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865956|NCT02670759|Bupivacaine|bupivacaine|mesh-list
92865957|NCT02670759|Anesthetics, Local|anesthetics, local|mesh-ancestor
92865958|NCT02670759|Anesthetics|anesthetics|mesh-ancestor
92865959|NCT02670759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92865960|NCT02670759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865961|NCT02670759|Sensory System Agents|sensory system agents|mesh-ancestor
92865962|NCT02670759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92865963|NCT00644943|Amoxicillin|amoxicillin|mesh-list
92865964|NCT00644943|Cefdinir|cefdinir|mesh-list
92865965|NCT00644943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865966|NCT00644943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865967|NCT02762006|Durvalumab|durvalumab|mesh-list
92865968|NCT02762006|Tremelimumab|tremelimumab|mesh-list
92865969|NCT02762006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92865970|NCT02762006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865971|NCT02769884|Pancrelipase|pancrelipase|mesh-list
92865972|NCT02769884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92865973|NCT05213507|Amikacin|amikacin|mesh-list
92865974|NCT05213507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92865975|NCT05213507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865976|NCT02670603|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92865977|NCT04253873|Temozolomide|temozolomide|mesh-list
92865978|NCT04253873|Apatinib|apatinib|mesh-list
92865979|NCT04253873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92865980|NCT04253873|Alkylating Agents|alkylating agents|mesh-ancestor
92865981|NCT04253873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865982|NCT04253873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92865983|NCT04253873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92865984|NCT04253873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865985|NCT05147727|Fluconazole|fluconazole|mesh-list
92865986|NCT05147727|Antifungal Agents|antifungal agents|mesh-ancestor
92865987|NCT05147727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92865988|NCT05147727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92865989|NCT05147727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92865990|NCT05147727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92865991|NCT05147727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92865992|NCT05147727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92865993|NCT05147727|Hormone Antagonists|hormone antagonists|mesh-ancestor
92865994|NCT05147727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92865995|NCT05147727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92865996|NCT05147727|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92865997|NCT05147727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92865998|NCT02765594|Hydroxychloroquine|hydroxychloroquine|mesh-list
92865999|NCT02765594|Valsartan|valsartan|mesh-list
92866000|NCT02765594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866001|NCT02765594|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92866002|NCT02765594|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92866003|NCT02765594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866004|NCT02765594|Antimalarials|antimalarials|mesh-ancestor
92866005|NCT02765594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92866006|NCT02765594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92866007|NCT02765594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866008|NCT02765594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866009|NCT02765594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866010|NCT00920699|Ubiquinone|ubiquinone|mesh-list
92866011|NCT00920699|Coenzyme Q10|coenzyme q10|mesh-list
92866012|NCT00920699|Micronutrients|micronutrients|mesh-ancestor
92866013|NCT00920699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866014|NCT00920699|Vitamins|vitamins|mesh-ancestor
92866015|NCT02670135|Triclosan|triclosan|mesh-list
92866016|NCT02670135|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92866017|NCT02670135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866018|NCT02670135|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92866019|NCT02670135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92866020|NCT02670135|Antimetabolites|antimetabolites|mesh-ancestor
92866021|NCT02670135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866022|NCT02670135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92866023|NCT02769494|Riboflavin|riboflavin|mesh-list
92866024|NCT02769494|Flavin Mononucleotide|flavin mononucleotide|mesh-list
92866025|NCT02769494|Mesalamine|mesalamine|mesh-list
92866026|NCT02769494|Vitamin B Complex|vitamin b complex|mesh-ancestor
92866027|NCT02769494|Vitamins|vitamins|mesh-ancestor
92866028|NCT02769494|Micronutrients|micronutrients|mesh-ancestor
92866029|NCT02769494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866030|NCT02769494|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92866031|NCT02769494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92866032|NCT02769494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92866033|NCT02769494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92866034|NCT02769494|Analgesics|analgesics|mesh-ancestor
92866035|NCT02769494|Sensory System Agents|sensory system agents|mesh-ancestor
92866036|NCT02769494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866037|NCT02769494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866038|NCT02769494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866039|NCT02769572|Diclofenac|diclofenac|mesh-list
92866040|NCT02769572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92866041|NCT02769572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92866042|NCT02769572|Analgesics|analgesics|mesh-ancestor
92866043|NCT02769572|Sensory System Agents|sensory system agents|mesh-ancestor
92866044|NCT02769572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866045|NCT02769572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866046|NCT02769572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866047|NCT02769572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866048|NCT02769572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92866049|NCT02769572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866050|NCT02769572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866051|NCT02669589|Heparin|heparin|mesh-list
92866052|NCT02669589|Anticoagulants|anticoagulants|mesh-ancestor
92866053|NCT02669589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866054|NCT02669589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92866055|NCT02669589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92866056|NCT02765204|Dapagliflozin|dapagliflozin|mesh-list
92866057|NCT02765204|Saxagliptin|saxagliptin|mesh-list
92866058|NCT02765204|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92866059|NCT02765204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866060|NCT02765204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92525202|NCT00023998|Antidotes|antidotes|mesh-ancestor
92866061|NCT02765204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866062|NCT02765204|Incretins|incretins|mesh-ancestor
92866063|NCT02765204|Hormones|hormones|mesh-ancestor
92866064|NCT02765204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866065|NCT02765204|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92866066|NCT02765204|Protease Inhibitors|protease inhibitors|mesh-ancestor
92866067|NCT02765204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866068|NCT03342456|Amoxicillin|amoxicillin|mesh-list
92866069|NCT03342456|Doxycycline|doxycycline|mesh-list
92866070|NCT03342456|Furazolidone|furazolidone|mesh-list
92156626|NCT03719105|Etoposide|etoposide|mesh-list
92866071|NCT03342456|Potassium Citrate|potassium citrate|mesh-list
92866072|NCT03342456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866073|NCT03342456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866074|NCT03342456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866075|NCT03342456|Antimalarials|antimalarials|mesh-ancestor
92866076|NCT03342456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92866077|NCT03342456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92866078|NCT03342456|Diuretics|diuretics|mesh-ancestor
92866079|NCT03342456|Natriuretic Agents|natriuretic agents|mesh-ancestor
92866080|NCT03342456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866081|NCT03342456|Expectorants|expectorants|mesh-ancestor
92866082|NCT03342456|Respiratory System Agents|respiratory system agents|mesh-ancestor
92866083|NCT03342456|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92866084|NCT03342456|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92866085|NCT03342456|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92866086|NCT03342456|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92866087|NCT03342456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866088|NCT02669277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92866089|NCT02669277|gamma-Globulins|gamma-globulins|mesh-list
92866090|NCT02669277|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92866091|NCT02669277|Immunologic Factors|immunologic factors|mesh-ancestor
92866092|NCT02669277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866093|NCT02769104|Docetaxel|docetaxel|mesh-list
92866094|NCT02769104|Letrozole|letrozole|mesh-list
92866095|NCT02769104|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92866096|NCT02769104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866097|NCT02769104|Tubulin Modulators|tubulin modulators|mesh-ancestor
92866098|NCT02769104|Antimitotic Agents|antimitotic agents|mesh-ancestor
92866099|NCT02769104|Mitosis Modulators|mitosis modulators|mesh-ancestor
92866100|NCT02769104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866101|NCT02769104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92866102|NCT02769104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866103|NCT02769104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92866104|NCT02769104|Hormone Antagonists|hormone antagonists|mesh-ancestor
92866105|NCT02769104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866106|NCT02769104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866107|NCT02545842|Insulin Glargine|insulin glargine|mesh-list
92866108|NCT02545842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92866109|NCT02545842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866110|NCT00645255|Sibutramine|sibutramine|mesh-list
92866111|NCT00645255|Antidepressive Agents|antidepressive agents|mesh-ancestor
92866112|NCT00645255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92866113|NCT00645255|Appetite Depressants|appetite depressants|mesh-ancestor
92866114|NCT00645255|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92866115|NCT04679012|Prednisone|prednisone|mesh-list
92866116|NCT04679012|Cyclophosphamide|cyclophosphamide|mesh-list
92866117|NCT04679012|Rituximab|rituximab|mesh-list
92866118|NCT04679012|Doxorubicin|doxorubicin|mesh-list
92866119|NCT04679012|Etoposide|etoposide|mesh-list
92866120|NCT04679012|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92866121|NCT04679012|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92866122|NCT04679012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92866123|NCT04679012|Immunologic Factors|immunologic factors|mesh-ancestor
92866124|NCT04679012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866125|NCT04679012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866126|NCT04679012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92866127|NCT04679012|Alkylating Agents|alkylating agents|mesh-ancestor
92866128|NCT04679012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866129|NCT04679012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866130|NCT04679012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92866131|NCT04679012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866132|NCT04679012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92866133|NCT04679012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92866134|NCT04679012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92866135|NCT04679012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866136|NCT04679012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866137|NCT04679012|Glucocorticoids|glucocorticoids|mesh-ancestor
92866138|NCT04679012|Hormones|hormones|mesh-ancestor
92866139|NCT04679012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866140|NCT04679012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92866141|NCT04679012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92866142|NCT04679012|Immunoconjugates|immunoconjugates|mesh-ancestor
92866143|NCT00910455|SRX246|srx246|mesh-list
92866144|NCT00910455|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92866145|NCT00910455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866146|NCT00910455|Natriuretic Agents|natriuretic agents|mesh-ancestor
92866147|NCT00910455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866148|NCT02765126|Vaccines|vaccines|mesh-list
92866149|NCT02765126|Immunologic Factors|immunologic factors|mesh-ancestor
92866150|NCT02765126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866151|NCT02668965|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92866152|NCT02668965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866153|NCT02668965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866154|NCT00916721|Propranolol|propranolol|mesh-list
92866155|NCT00916721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92866156|NCT00916721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92866157|NCT00916721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866158|NCT00916721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866159|NCT00916721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866160|NCT00916721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866161|NCT00916721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866162|NCT00916721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866163|NCT00916721|Vasodilator Agents|vasodilator agents|mesh-ancestor
92866164|NCT00613782|Methyltestosterone|methyltestosterone|mesh-list
92866165|NCT00613782|Testosterone|testosterone|mesh-list
92866166|NCT00613782|Testosterone undecanoate|testosterone undecanoate|mesh-list
92866167|NCT00613782|Testosterone enanthate|testosterone enanthate|mesh-list
92866168|NCT00613782|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92866169|NCT00613782|Androgens|androgens|mesh-ancestor
92866170|NCT00613782|Hormones|hormones|mesh-ancestor
92866171|NCT00613782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866172|NCT00613782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866173|NCT00613782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92866174|NCT00613782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866175|NCT00613782|Anabolic Agents|anabolic agents|mesh-ancestor
92866176|NCT02764736|Atorvastatin|atorvastatin|mesh-list
92866177|NCT02764736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92866178|NCT02764736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92866179|NCT02764736|Antimetabolites|antimetabolites|mesh-ancestor
92866180|NCT02764736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866181|NCT02764736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92866182|NCT02764736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92866183|NCT02764736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866184|NCT00646737|Mycophenolic Acid|mycophenolic acid|mesh-list
92866185|NCT00646737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92866186|NCT00646737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866187|NCT00646737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92866188|NCT00646737|Antitubercular Agents|antitubercular agents|mesh-ancestor
92866189|NCT00646737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866190|NCT00646737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866191|NCT00646737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866192|NCT00646737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866193|NCT00646815|Hormones|hormones|mesh-list
92866194|NCT00646815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866195|NCT00646815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866196|NCT00915005|Paclitaxel|paclitaxel|mesh-list
92866197|NCT00915005|Carboplatin|carboplatin|mesh-list
92866198|NCT00915005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92866199|NCT00915005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866200|NCT00915005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92866201|NCT00915005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92866202|NCT00915005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92866203|NCT00915005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866204|NCT00910533|Ceftriaxone|ceftriaxone|mesh-list
92866205|NCT00910533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866206|NCT00910533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866207|NCT02696642|Maytansine|maytansine|mesh-list
92866208|NCT02696642|Anetumab ravtansine|anetumab ravtansine|mesh-list
92866209|NCT02696642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92866210|NCT02696642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866211|NCT02696642|Tubulin Modulators|tubulin modulators|mesh-ancestor
92866212|NCT02696642|Antimitotic Agents|antimitotic agents|mesh-ancestor
92866213|NCT02696642|Mitosis Modulators|mitosis modulators|mesh-ancestor
92866214|NCT02696642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866215|NCT02696642|Immunoconjugates|immunoconjugates|mesh-ancestor
92866216|NCT02696642|Immunologic Factors|immunologic factors|mesh-ancestor
92866217|NCT02696642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866218|NCT00647049|Cytarabine|cytarabine|mesh-list
92866219|NCT00647049|Rituximab|rituximab|mesh-list
92866220|NCT00647049|Methotrexate|methotrexate|mesh-list
92866221|NCT00647049|Thiotepa|thiotepa|mesh-list
92866222|NCT00647049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866223|NCT00647049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866224|NCT00647049|Immunologic Factors|immunologic factors|mesh-ancestor
92866225|NCT00647049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866226|NCT00647049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866227|NCT00647049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92866228|NCT00647049|Abortifacient Agents|abortifacient agents|mesh-ancestor
92866229|NCT00647049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866230|NCT00647049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92866231|NCT00647049|Antimetabolites|antimetabolites|mesh-ancestor
92866232|NCT00647049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866233|NCT00647049|Dermatologic Agents|dermatologic agents|mesh-ancestor
92866234|NCT00647049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866235|NCT00647049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92866236|NCT00647049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92866237|NCT00647049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92866238|NCT00647049|Antiviral Agents|antiviral agents|mesh-ancestor
92866239|NCT00647049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866240|NCT00647049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92866241|NCT00647049|Alkylating Agents|alkylating agents|mesh-ancestor
92866242|NCT00647049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92866243|NCT02696330|Enoxaparin|enoxaparin|mesh-list
92866244|NCT02696330|Clopidogrel|clopidogrel|mesh-list
92866245|NCT02696330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92866246|NCT02696330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92866247|NCT02696330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92866248|NCT02696330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92866249|NCT02696330|Purinergic Agents|purinergic agents|mesh-ancestor
92866250|NCT02696330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866251|NCT02696330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866252|NCT02696330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866253|NCT02696330|Anticoagulants|anticoagulants|mesh-ancestor
92866254|NCT02696330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92866255|NCT02696330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92866256|NCT04172727|Bupivacaine|bupivacaine|mesh-list
92866257|NCT04172727|Anesthetics, Local|anesthetics, local|mesh-ancestor
92866258|NCT04172727|Anesthetics|anesthetics|mesh-ancestor
92866259|NCT04172727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866260|NCT04172727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866261|NCT04172727|Sensory System Agents|sensory system agents|mesh-ancestor
92866262|NCT04172727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866263|NCT04648319|Nivolumab|nivolumab|mesh-list
92866264|NCT04648319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866265|NCT04648319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866266|NCT04648319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92866267|NCT04648319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866268|NCT00647127|Fentanyl|fentanyl|mesh-list
92866269|NCT00647127|Buprenorphine|buprenorphine|mesh-list
92866270|NCT00647127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92866271|NCT00647127|Narcotics|narcotics|mesh-ancestor
92866272|NCT00647127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866273|NCT00647127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866274|NCT00647127|Analgesics|analgesics|mesh-ancestor
92866275|NCT00647127|Sensory System Agents|sensory system agents|mesh-ancestor
92866276|NCT00647127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866277|NCT00647127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92866278|NCT00647127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92866279|NCT00647127|Anesthetics, General|anesthetics, general|mesh-ancestor
92866280|NCT00647127|Anesthetics|anesthetics|mesh-ancestor
92866282|NCT04750070|Dopamine|dopamine|mesh-list
92866283|NCT04750070|Epinephrine|epinephrine|mesh-list
92866284|NCT04750070|Racepinephrine|racepinephrine|mesh-list
92866285|NCT04750070|Epinephryl borate|epinephryl borate|mesh-list
92866286|NCT04750070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92866287|NCT04750070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92866288|NCT04750070|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866289|NCT04750070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866290|NCT04750070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866291|NCT04750070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866292|NCT04750070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92866293|NCT04750070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92866294|NCT04750070|Autonomic Agents|autonomic agents|mesh-ancestor
92866295|NCT04750070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866296|NCT04750070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92866297|NCT04750070|Respiratory System Agents|respiratory system agents|mesh-ancestor
92866298|NCT04750070|Mydriatics|mydriatics|mesh-ancestor
92866299|NCT04750070|Sympathomimetics|sympathomimetics|mesh-ancestor
92866300|NCT04750070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92866301|NCT04750070|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92866302|NCT04750070|Dopamine Agents|dopamine agents|mesh-ancestor
92866303|NCT04750070|Protective Agents|protective agents|mesh-ancestor
92866304|NCT02763722|Emollients|emollients|mesh-list
92866305|NCT02763722|Dermatologic Agents|dermatologic agents|mesh-ancestor
92866306|NCT01143246|Terlipressin|terlipressin|mesh-list
92866307|NCT01143246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866308|NCT01143246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92866309|NCT00647673|Verapamil|verapamil|mesh-list
92511502|NCT05626621|Azelastine|azelastine|mesh-list
92866310|NCT00647673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866311|NCT00647673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92866312|NCT00647673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866313|NCT00647673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866314|NCT00647673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92866315|NCT00647673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866316|NCT00647673|Vasodilator Agents|vasodilator agents|mesh-ancestor
92866318|NCT00561925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92866319|NCT00561925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92866320|NCT00561925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866321|NCT00561925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866322|NCT00561925|Antiviral Agents|antiviral agents|mesh-ancestor
92866323|NCT00561925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866324|NCT00561925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92866325|NCT00561925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92866326|NCT00561925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92866327|NCT00561925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92866328|NCT02760992|Baclofen|baclofen|mesh-list
92866329|NCT02760992|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92866330|NCT02760992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866331|NCT02760992|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92866332|NCT02760992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866333|NCT02760992|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92866334|NCT02760992|GABA Agonists|gaba agonists|mesh-ancestor
92866335|NCT02760992|GABA Agents|gaba agents|mesh-ancestor
92866336|NCT02760992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866337|NCT02760992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866338|NCT04172259|Cyclophosphamide|cyclophosphamide|mesh-list
92866339|NCT04172259|Docetaxel|docetaxel|mesh-list
92866340|NCT04172259|Doxorubicin|doxorubicin|mesh-list
92866341|NCT04172259|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92866342|NCT04172259|Trastuzumab|trastuzumab|mesh-list
92866343|NCT04172259|Epirubicin|epirubicin|mesh-list
92866344|NCT04172259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92866345|NCT04172259|Immunologic Factors|immunologic factors|mesh-ancestor
92866346|NCT04172259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866347|NCT04172259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866348|NCT04172259|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92866349|NCT04172259|Alkylating Agents|alkylating agents|mesh-ancestor
92866350|NCT04172259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866351|NCT04172259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866352|NCT04172259|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92866353|NCT04172259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92866354|NCT04172259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92866355|NCT04172259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92866356|NCT04172259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92866357|NCT04172259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92866358|NCT04172259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92866359|NCT04172259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866360|NCT04172259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866361|NCT00647751|Lamotrigine|lamotrigine|mesh-list
92866362|NCT00647751|Anticonvulsants|anticonvulsants|mesh-ancestor
92866363|NCT00647751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92866364|NCT00647751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866365|NCT00647751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866366|NCT00647751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92866367|NCT00647751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866368|NCT00647751|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92866369|NCT00647751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92866370|NCT00647751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866371|NCT00647751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92866372|NCT00647751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92866373|NCT02536989|Omeprazole|omeprazole|mesh-list
92866374|NCT02536989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92866375|NCT02536989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866376|NCT02536989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92866377|NCT02536989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866378|NCT02536989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866379|NCT00647829|Valdecoxib|valdecoxib|mesh-list
92866380|NCT00647829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92866381|NCT00647829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92866382|NCT00647829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866383|NCT00647829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866384|NCT00647829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92866385|NCT00647829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92866386|NCT00647829|Analgesics|analgesics|mesh-ancestor
92866387|NCT00647829|Sensory System Agents|sensory system agents|mesh-ancestor
92866388|NCT00647829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866389|NCT00647829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866390|NCT00647829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866391|NCT00647829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866392|NCT02517918|Zoledronic Acid|zoledronic acid|mesh-list
92866393|NCT02517918|Sirolimus|sirolimus|mesh-list
92866394|NCT02517918|Methotrexate|methotrexate|mesh-list
92866395|NCT02517918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92866396|NCT02517918|Abortifacient Agents|abortifacient agents|mesh-ancestor
92866397|NCT02517918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866398|NCT02517918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866399|NCT02517918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92866400|NCT02517918|Antimetabolites|antimetabolites|mesh-ancestor
92866401|NCT02517918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866402|NCT02517918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866403|NCT02517918|Dermatologic Agents|dermatologic agents|mesh-ancestor
92866404|NCT02517918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866405|NCT02517918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92866406|NCT02517918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92866407|NCT02517918|Immunologic Factors|immunologic factors|mesh-ancestor
92866408|NCT02517918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866409|NCT02517918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92866410|NCT02517918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866411|NCT02517918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866412|NCT02517918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92866413|NCT02517918|Antifungal Agents|antifungal agents|mesh-ancestor
92866414|NCT02517918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92866415|NCT00647907|Voriconazole|voriconazole|mesh-list
92866416|NCT00647907|Antifungal Agents|antifungal agents|mesh-ancestor
92866417|NCT00647907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866418|NCT00647907|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92866419|NCT00647907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92866420|NCT00647907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866421|NCT00647907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866422|NCT00647907|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92866423|NCT00647907|Hormone Antagonists|hormone antagonists|mesh-ancestor
92866424|NCT00647907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866425|NCT00647907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866426|NCT00647907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92866427|NCT04017546|Venetoclax|venetoclax|mesh-list
92866428|NCT04017546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866429|NCT04171791|Venetoclax|venetoclax|mesh-list
92866430|NCT04171791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866431|NCT04003818|Teicoplanin|teicoplanin|mesh-list
92866432|NCT04003818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866433|NCT04003818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866434|NCT00949663|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92866435|NCT00949663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866436|NCT00949663|Incretins|incretins|mesh-ancestor
92866437|NCT00949663|Hormones|hormones|mesh-ancestor
92866438|NCT00949663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866439|NCT00949663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866440|NCT00647985|Fexofenadine|fexofenadine|mesh-list
92866441|NCT00647985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92866442|NCT00647985|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92866443|NCT00647985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92866444|NCT00647985|Histamine Antagonists|histamine antagonists|mesh-ancestor
92866445|NCT00647985|Histamine Agents|histamine agents|mesh-ancestor
92866446|NCT00647985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866447|NCT00647985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866448|NCT00647985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866449|NCT02664051|Cromolyn Sodium|cromolyn sodium|mesh-list
92866450|NCT02664051|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92866451|NCT02664051|Immunologic Factors|immunologic factors|mesh-ancestor
92866452|NCT02664051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866453|NCT02664051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92866454|NCT02664051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866455|NCT02664051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92866456|NCT02664051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92866457|NCT00648063|Letrozole|letrozole|mesh-list
92866458|NCT00648063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866459|NCT00648063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92866460|NCT00648063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92866461|NCT00648063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866462|NCT00648063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866463|NCT00648063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92866464|NCT00648063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92866465|NCT00648063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866466|NCT00648063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866467|NCT00648141|Celecoxib|celecoxib|mesh-list
92866468|NCT00648141|Diclofenac|diclofenac|mesh-list
92866469|NCT00648141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92866470|NCT00648141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92866471|NCT00648141|Analgesics|analgesics|mesh-ancestor
92866472|NCT00648141|Sensory System Agents|sensory system agents|mesh-ancestor
92866473|NCT00648141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866474|NCT00648141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866475|NCT00648141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866476|NCT00648141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866477|NCT00648141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92866478|NCT00648141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92866479|NCT00648141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866480|NCT00648141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866481|NCT00953641|Misoprostol|misoprostol|mesh-list
92866482|NCT00953641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92866483|NCT00953641|Abortifacient Agents|abortifacient agents|mesh-ancestor
92866484|NCT00953641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866485|NCT00953641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866486|NCT00953641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92866487|NCT00953641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866488|NCT00953641|Oxytocics|oxytocics|mesh-ancestor
92866489|NCT02763098|Remifentanil|remifentanil|mesh-list
92866490|NCT02763098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92866491|NCT02763098|Narcotics|narcotics|mesh-ancestor
92866492|NCT02763098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866493|NCT02763098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866494|NCT02763098|Analgesics|analgesics|mesh-ancestor
92866495|NCT02763098|Sensory System Agents|sensory system agents|mesh-ancestor
92866496|NCT02763098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866497|NCT00648219|Olmesartan|olmesartan|mesh-list
92866498|NCT00648219|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92866499|NCT00648219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866500|NCT00648219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92866501|NCT00648219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92866502|NCT00648219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866503|NCT00648297|Nadolol|nadolol|mesh-list
92866504|NCT00648297|Bendroflumethiazide|bendroflumethiazide|mesh-list
92866505|NCT00648297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92866506|NCT00648297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92866507|NCT00648297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866508|NCT00648297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866509|NCT00648297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866510|NCT00648297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866511|NCT00648297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866512|NCT00648297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866513|NCT00648297|Sympatholytics|sympatholytics|mesh-ancestor
92866514|NCT00648297|Autonomic Agents|autonomic agents|mesh-ancestor
92866515|NCT00648297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866516|NCT00648297|Diuretics|diuretics|mesh-ancestor
92866517|NCT00648297|Natriuretic Agents|natriuretic agents|mesh-ancestor
92866518|NCT00648297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92866519|NCT00648297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866520|NCT00648453|Clopidogrel|clopidogrel|mesh-list
92866521|NCT00648453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92866522|NCT00648453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92866523|NCT00648453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92866524|NCT00648453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92866525|NCT00648453|Purinergic Agents|purinergic agents|mesh-ancestor
92866526|NCT00648453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866527|NCT00648453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866528|NCT00648453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866529|NCT00549445|Azithromycin|azithromycin|mesh-list
92866530|NCT00549445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866531|NCT00549445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511739|NCT05116930|Atropine|atropine|mesh-list
92866533|NCT00637026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866534|NCT00637026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92866535|NCT00637026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866536|NCT00637026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866537|NCT00649155|Ciprofloxacin|ciprofloxacin|mesh-list
92866538|NCT00649155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866539|NCT00649155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866540|NCT00649155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92866541|NCT00649155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92866542|NCT00649155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866543|NCT00649155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866544|NCT00649155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866545|NCT00649155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92866546|NCT00649155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92866547|NCT02758340|Misoprostol|misoprostol|mesh-list
92866548|NCT02758340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92866549|NCT02758340|Abortifacient Agents|abortifacient agents|mesh-ancestor
92866550|NCT02758340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866551|NCT02758340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866552|NCT02758340|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92866553|NCT02758340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866554|NCT02758340|Oxytocics|oxytocics|mesh-ancestor
92866555|NCT02768168|Dezocine|dezocine|mesh-list
92866556|NCT02768168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92866557|NCT02768168|Narcotics|narcotics|mesh-ancestor
92866558|NCT02768168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866559|NCT02768168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866560|NCT02768168|Analgesics|analgesics|mesh-ancestor
92866561|NCT02768168|Sensory System Agents|sensory system agents|mesh-ancestor
92866562|NCT02768168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866563|NCT03739554|Venetoclax|venetoclax|mesh-list
92866564|NCT03739554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866565|NCT02659683|Esomeprazole|esomeprazole|mesh-list
92866566|NCT02659683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92866567|NCT02659683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866568|NCT02659683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92866569|NCT02659683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866570|NCT02659683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866571|NCT04701476|Pembrolizumab|pembrolizumab|mesh-list
92866572|NCT04701476|Tirapazamine|tirapazamine|mesh-list
92866573|NCT04701476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866574|NCT04701476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866575|NCT04701476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92866576|NCT04701476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866578|NCT05343702|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92866579|NCT05343702|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92866580|NCT05343702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92866581|NCT05343702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866582|NCT05343702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866583|NCT02659761|Lamivudine|lamivudine|mesh-list
92866584|NCT02659761|Abacavir|abacavir|mesh-list
92866585|NCT02659761|Dolutegravir|dolutegravir|mesh-list
92866586|NCT02659761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92866587|NCT02659761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92866588|NCT02659761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866589|NCT02659761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866590|NCT02659761|Antiviral Agents|antiviral agents|mesh-ancestor
92866591|NCT02659761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866592|NCT02659761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92866593|NCT02659761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92866594|NCT02659761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92866595|NCT02659761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92866596|NCT05343546|Copper|copper|mesh-list
92866597|NCT05343546|Levonorgestrel|levonorgestrel|mesh-list
92866598|NCT05343546|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92866599|NCT05343546|Contraceptive Agents|contraceptive agents|mesh-ancestor
92866600|NCT05343546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866601|NCT05343546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866602|NCT05343546|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92866603|NCT05343546|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92866604|NCT05343546|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92866605|NCT05343546|Trace Elements|trace elements|mesh-ancestor
92866606|NCT05343546|Micronutrients|micronutrients|mesh-ancestor
92866608|NCT02659917|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92866609|NCT02659917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866610|NCT02659917|Sympathomimetics|sympathomimetics|mesh-ancestor
92866611|NCT02659917|Autonomic Agents|autonomic agents|mesh-ancestor
92866612|NCT02659917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866613|NCT02659917|Dopamine Agents|dopamine agents|mesh-ancestor
92866614|NCT02659917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866615|NCT02659917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866616|NCT02659917|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866617|NCT02659917|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92866618|NCT02659917|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92866619|NCT02659917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866620|NCT02659917|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92866621|NCT00954265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92866622|NCT00954265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866623|NCT00954265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866624|NCT04500236|Anesthetics|anesthetics|mesh-list
92866625|NCT04500236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866626|NCT04500236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866627|NCT02658825|Moxifloxacin|moxifloxacin|mesh-list
92866628|NCT02658825|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92866629|NCT02658825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92866630|NCT02658825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866631|NCT02658825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92866632|NCT02658825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92866633|NCT02658825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866634|NCT02658825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866635|NCT02658825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866636|NCT02658825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92866637|NCT02658825|Contraceptive Agents|contraceptive agents|mesh-ancestor
92866638|NCT02658825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866639|NCT02658825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866640|NCT02658825|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92866641|NCT02658825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92866642|NCT02658825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92866643|NCT00649233|Metoprolol|metoprolol|mesh-list
92866644|NCT00649233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92866645|NCT00649233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866646|NCT00649233|Diuretics|diuretics|mesh-ancestor
92866647|NCT00649233|Natriuretic Agents|natriuretic agents|mesh-ancestor
92866648|NCT00649233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866649|NCT00649233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92866650|NCT00649233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866651|NCT00649233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866652|NCT00649233|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866653|NCT00649233|Sympatholytics|sympatholytics|mesh-ancestor
92866654|NCT00649233|Autonomic Agents|autonomic agents|mesh-ancestor
92866655|NCT00649233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866656|NCT00649233|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92866657|NCT00649233|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92866658|NCT00649233|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92866659|NCT00649233|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866660|NCT00649233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866662|NCT00954811|Progestins|progestins|mesh-ancestor
92866663|NCT00954811|Hormones|hormones|mesh-ancestor
92866664|NCT00954811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866665|NCT00954811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866666|NCT00954889|Tamsulosin|tamsulosin|mesh-list
92866667|NCT00954889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92866668|NCT00954889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92866669|NCT00954889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92866670|NCT00954889|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866671|NCT00954889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866672|NCT00954889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866673|NCT00954889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866674|NCT00954889|Urological Agents|urological agents|mesh-ancestor
92866675|NCT03666000|Cyclophosphamide|cyclophosphamide|mesh-list
92866676|NCT03666000|Fludarabine|fludarabine|mesh-list
92866677|NCT03666000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511863|NCT04935814|Vasopressins|vasopressins|mesh-list
92866679|NCT03666000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866680|NCT03666000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866681|NCT03666000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92866682|NCT03666000|Alkylating Agents|alkylating agents|mesh-ancestor
92866683|NCT03666000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866684|NCT03666000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866685|NCT03666000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92866686|NCT02692248|Dexamethasone|dexamethasone|mesh-list
92866687|NCT02692248|Rituximab|rituximab|mesh-list
92866688|NCT02692248|Gemcitabine|gemcitabine|mesh-list
92866689|NCT02692248|Oxaliplatin|oxaliplatin|mesh-list
92866690|NCT02692248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866691|NCT02692248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866692|NCT02692248|Immunologic Factors|immunologic factors|mesh-ancestor
92866693|NCT02692248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866694|NCT02692248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866695|NCT02692248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866696|NCT02692248|Antiemetics|antiemetics|mesh-ancestor
92866697|NCT02692248|Autonomic Agents|autonomic agents|mesh-ancestor
92866698|NCT02692248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866699|NCT02692248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866700|NCT02692248|Glucocorticoids|glucocorticoids|mesh-ancestor
92866701|NCT02692248|Hormones|hormones|mesh-ancestor
92866702|NCT02692248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866703|NCT02692248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92866704|NCT02692248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92866705|NCT02692248|Antimetabolites|antimetabolites|mesh-ancestor
92866706|NCT02692248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866707|NCT04477772|Antibodies|antibodies|mesh-list
92866708|NCT04477772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92866709|NCT04477772|Immunologic Factors|immunologic factors|mesh-ancestor
92866710|NCT04477772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866711|NCT02851290|Anesthetics|anesthetics|mesh-list
92866712|NCT02851290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866713|NCT02851290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866714|NCT02757404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92866715|NCT02757404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92866716|NCT02757404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866717|NCT02757404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866718|NCT02757404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92866719|NCT02757404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866720|NCT02757404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866721|NCT02757404|Cholinergic Agents|cholinergic agents|mesh-ancestor
92866722|NCT02757404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866723|NCT00955045|Istradefylline|istradefylline|mesh-list
92866724|NCT00955045|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92866725|NCT00955045|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92866726|NCT00955045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92866727|NCT00955045|Purinergic Agents|purinergic agents|mesh-ancestor
92866728|NCT00955045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866729|NCT00955045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866730|NCT00955045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866731|NCT00601107|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92866732|NCT00601107|Vitamins|vitamins|mesh-ancestor
92866733|NCT00601107|Micronutrients|micronutrients|mesh-ancestor
92866734|NCT00601107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866735|NCT00601107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92866736|NCT00957385|Lenalidomide|lenalidomide|mesh-list
92866737|NCT00957385|Immunologic Factors|immunologic factors|mesh-ancestor
92866738|NCT00957385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866739|NCT00957385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92866740|NCT00957385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92866741|NCT00957385|Growth Substances|growth substances|mesh-ancestor
92866742|NCT00957385|Growth Inhibitors|growth inhibitors|mesh-ancestor
92866743|NCT00957385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866744|NCT04169841|Durvalumab|durvalumab|mesh-list
92866745|NCT04169841|Olaparib|olaparib|mesh-list
92866746|NCT04169841|Tremelimumab|tremelimumab|mesh-list
92866747|NCT04169841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866748|NCT04169841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866749|NCT04169841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92866750|NCT04169841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866751|NCT04169841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866753|NCT02462538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92866754|NCT02462538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866755|NCT02462538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92866756|NCT02462538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866757|NCT02462538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866758|NCT02462538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92866759|NCT02462538|Immunotoxins|immunotoxins|mesh-ancestor
92866760|NCT02462538|Immunoconjugates|immunoconjugates|mesh-ancestor
92866761|NCT02462538|Immunologic Factors|immunologic factors|mesh-ancestor
92866762|NCT02462538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866763|NCT02752646|Ketorolac|ketorolac|mesh-list
92866764|NCT02752646|Nepafenac|nepafenac|mesh-list
92866765|NCT02752646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92866766|NCT02752646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92866767|NCT02752646|Analgesics|analgesics|mesh-ancestor
92866768|NCT02752646|Sensory System Agents|sensory system agents|mesh-ancestor
92866769|NCT02752646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866770|NCT02752646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866771|NCT02752646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866772|NCT02752646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866773|NCT02752646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92866774|NCT02752646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866775|NCT02752646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866776|NCT04169919|Povidone-Iodine|povidone-iodine|mesh-list
92866777|NCT04169919|Povidone|povidone|mesh-list
92866778|NCT04169919|Plasma Substitutes|plasma substitutes|mesh-ancestor
92866779|NCT04169919|Blood Substitutes|blood substitutes|mesh-ancestor
92866780|NCT04169919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92866781|NCT04169919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866782|NCT02757248|Romidepsin|romidepsin|mesh-list
92866783|NCT02757248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92866784|NCT02757248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866785|NCT02757248|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92866786|NCT02757248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866787|NCT02757248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866788|NCT00649311|Losartan|losartan|mesh-list
92866789|NCT00649311|Eplerenone|eplerenone|mesh-list
92866790|NCT00649311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866791|NCT00649311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866792|NCT00649311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92866793|NCT00649311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92866794|NCT00649311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866795|NCT00649311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92866796|NCT00649311|Hormone Antagonists|hormone antagonists|mesh-ancestor
92866797|NCT00649311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92866798|NCT00649311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866799|NCT00649311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92866801|NCT00649311|Natriuretic Agents|natriuretic agents|mesh-ancestor
92866802|NCT02704494|Losartan|losartan|mesh-list
92866803|NCT02704494|Resveratrol|resveratrol|mesh-list
92866804|NCT02704494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866805|NCT02704494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866806|NCT02704494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92866807|NCT02704494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92866808|NCT02704494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866809|NCT02704494|Antioxidants|antioxidants|mesh-ancestor
92866810|NCT02704494|Protective Agents|protective agents|mesh-ancestor
92866811|NCT02704494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866812|NCT02704494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866813|NCT02704494|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92866814|NCT00649467|Topiramate|topiramate|mesh-list
92866815|NCT00649467|Anticonvulsants|anticonvulsants|mesh-ancestor
92866816|NCT00649467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92866817|NCT00649467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866818|NCT00649545|Adalimumab|adalimumab|mesh-list
92866819|NCT00649545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92866820|NCT00649545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866821|NCT00649545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866822|NCT04169763|Nelfinavir|nelfinavir|mesh-list
92866823|NCT04169763|Cisplatin|cisplatin|mesh-list
92866824|NCT04169763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866825|NCT04169763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92866826|NCT04169763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92866827|NCT04169763|Protease Inhibitors|protease inhibitors|mesh-ancestor
92866828|NCT04169763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866829|NCT04169763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866830|NCT04169763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92866831|NCT04169763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92866832|NCT04169763|Antiviral Agents|antiviral agents|mesh-ancestor
92866833|NCT04169763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866834|NCT00635414|Esomeprazole|esomeprazole|mesh-list
92866835|NCT00635414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92866836|NCT00635414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92866837|NCT00635414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92866838|NCT00635414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866839|NCT00635414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866840|NCT02658435|Tafenoquine|tafenoquine|mesh-list
92866841|NCT02658435|Antimalarials|antimalarials|mesh-ancestor
92866842|NCT02658435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92866843|NCT02658435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92866844|NCT02658435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866845|NCT02756546|Hydroxychloroquine|hydroxychloroquine|mesh-list
92866846|NCT02756546|Hydrocortisone|hydrocortisone|mesh-list
92866847|NCT02756546|Cyclophosphamide|cyclophosphamide|mesh-list
92866848|NCT02756546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92866849|NCT02756546|Immunologic Factors|immunologic factors|mesh-ancestor
92866850|NCT02756546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866851|NCT02756546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92866852|NCT02756546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92866853|NCT02756546|Alkylating Agents|alkylating agents|mesh-ancestor
92866854|NCT02756546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866855|NCT02756546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866856|NCT02756546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92866857|NCT02756546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92866858|NCT02756546|Antimalarials|antimalarials|mesh-ancestor
92866859|NCT02756546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92866860|NCT02756546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92866861|NCT02756546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866862|NCT02756546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866863|NCT02759666|Fluzoparib|fluzoparib|mesh-list
92866864|NCT02759666|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92866865|NCT02759666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866866|NCT02759666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866867|NCT02759666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866868|NCT02752724|Ketamine|ketamine|mesh-list
92866869|NCT02752724|Methohexital|methohexital|mesh-list
92866870|NCT02752724|Analgesics|analgesics|mesh-ancestor
92866871|NCT02752724|Sensory System Agents|sensory system agents|mesh-ancestor
92866872|NCT02752724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866873|NCT02752724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866874|NCT02752724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92866875|NCT02752724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92866876|NCT02752724|Anesthetics, General|anesthetics, general|mesh-ancestor
92866877|NCT02752724|Anesthetics|anesthetics|mesh-ancestor
92866878|NCT02752724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866879|NCT02752724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92866880|NCT02752724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92866881|NCT02752724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866882|NCT02752724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866883|NCT00649623|Olmesartan|olmesartan|mesh-list
92866884|NCT00649623|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92866885|NCT00649623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92866886|NCT00649623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92866887|NCT00649623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92866888|NCT00649623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866889|NCT02756312|Anesthetics|anesthetics|mesh-list
92866890|NCT02756312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866891|NCT02756312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866892|NCT02657187|Rocuronium|rocuronium|mesh-list
92866893|NCT02657187|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92866894|NCT02657187|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92866895|NCT02657187|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92866896|NCT02657187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866897|NCT02657187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866898|NCT00649779|Albuterol|albuterol|mesh-list
92512083|NCT00000645|Hypericin|hypericin|mesh-list
92866899|NCT00649779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92866900|NCT00649779|Autonomic Agents|autonomic agents|mesh-ancestor
92866901|NCT00649779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866902|NCT00649779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866903|NCT00649779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92866904|NCT00649779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92866905|NCT00649779|Tocolytic Agents|tocolytic agents|mesh-ancestor
92866906|NCT00649779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866907|NCT00649779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92866908|NCT00649779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92866909|NCT00649779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92866910|NCT00649779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866911|NCT00649779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866912|NCT00649779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866913|NCT00615186|Temozolomide|temozolomide|mesh-list
92866914|NCT00615186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92866915|NCT00615186|Alkylating Agents|alkylating agents|mesh-ancestor
92866916|NCT00615186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866917|NCT00615186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866918|NCT00616044|Anesthetics|anesthetics|mesh-list
92866919|NCT00616044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866920|NCT00616044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866921|NCT02536911|Eliglustat|eliglustat|mesh-list
92866922|NCT02536911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866923|NCT02536911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866924|NCT04221152|Empagliflozin|empagliflozin|mesh-list
92866925|NCT04221152|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92866926|NCT04221152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866927|NCT04221152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92866928|NCT04221152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866929|NCT02656563|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92866930|NCT02656563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866931|NCT02759510|Phenylephrine|phenylephrine|mesh-list
92866932|NCT02759510|Oxymetazoline|oxymetazoline|mesh-list
92866933|NCT02759510|Norepinephrine|norepinephrine|mesh-list
92866934|NCT02759510|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92866935|NCT02759510|Mydriatics|mydriatics|mesh-ancestor
92866936|NCT02759510|Autonomic Agents|autonomic agents|mesh-ancestor
92866937|NCT02759510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866938|NCT02759510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866939|NCT02759510|Sympathomimetics|sympathomimetics|mesh-ancestor
92866940|NCT02759510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92866941|NCT02759510|Nasal Decongestants|nasal decongestants|mesh-ancestor
92866942|NCT02759510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92866943|NCT02759510|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92866944|NCT02759510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92866946|NCT02759510|Adrenergic Agents|adrenergic agents|mesh-ancestor
92866947|NCT02759510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92866948|NCT02759510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866949|NCT02759510|Protective Agents|protective agents|mesh-ancestor
92866950|NCT04220528|Capecitabine|capecitabine|mesh-list
92866951|NCT04220528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92866952|NCT04220528|Antimetabolites|antimetabolites|mesh-ancestor
92866953|NCT04220528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866954|NCT04220528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92866955|NCT02759042|Leronlimab|leronlimab|mesh-list
92866956|NCT02759042|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92866957|NCT02759042|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92866958|NCT02759042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866959|NCT02759042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92866960|NCT02759042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92866961|NCT02759042|Antiviral Agents|antiviral agents|mesh-ancestor
92866962|NCT02759042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92866963|NCT02755532|Bupivacaine|bupivacaine|mesh-list
92866964|NCT02755532|Anesthetics, Local|anesthetics, local|mesh-ancestor
92866965|NCT02755532|Anesthetics|anesthetics|mesh-ancestor
92866966|NCT02755532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866967|NCT02755532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866968|NCT02755532|Sensory System Agents|sensory system agents|mesh-ancestor
92866969|NCT02755532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866970|NCT02755376|Hyaluronic Acid|hyaluronic acid|mesh-list
92866971|NCT02755376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92512160|NCT00000666|Pyrimethamine|pyrimethamine|mesh-list
92866972|NCT02755376|Immunologic Factors|immunologic factors|mesh-ancestor
92866973|NCT02755376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866974|NCT02755376|Viscosupplements|viscosupplements|mesh-ancestor
92866975|NCT02755376|Protective Agents|protective agents|mesh-ancestor
92866976|NCT02752334|Magnesium Sulfate|magnesium sulfate|mesh-list
92866977|NCT02752334|Bupivacaine|bupivacaine|mesh-list
92866978|NCT02752334|Anesthetics, Local|anesthetics, local|mesh-ancestor
92866979|NCT02752334|Anesthetics|anesthetics|mesh-ancestor
92866980|NCT02752334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92866981|NCT02752334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92866982|NCT02752334|Sensory System Agents|sensory system agents|mesh-ancestor
92866983|NCT02752334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92866984|NCT02752334|Analgesics|analgesics|mesh-ancestor
92866985|NCT02752334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92866986|NCT02752334|Anticonvulsants|anticonvulsants|mesh-ancestor
92866987|NCT02752334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92866988|NCT02752334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92866989|NCT02752334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866990|NCT02752334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92866991|NCT02752334|Tocolytic Agents|tocolytic agents|mesh-ancestor
92866992|NCT02752334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92866993|NCT02755298|Acetazolamide|acetazolamide|mesh-list
92866994|NCT02755298|Anticonvulsants|anticonvulsants|mesh-ancestor
92866995|NCT02755298|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92866996|NCT02755298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92866997|NCT02755298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92866998|NCT02755298|Diuretics|diuretics|mesh-ancestor
92866999|NCT02755298|Natriuretic Agents|natriuretic agents|mesh-ancestor
92867000|NCT02755298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867001|NCT02755142|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92867002|NCT02755142|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92867003|NCT02755142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92867005|NCT02759198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92867006|NCT02759198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92867007|NCT02759198|Analgesics|analgesics|mesh-ancestor
92867008|NCT02759198|Sensory System Agents|sensory system agents|mesh-ancestor
92867009|NCT02759198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867010|NCT02759198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867011|NCT02759198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92867012|NCT02759198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92867013|NCT02759198|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92867014|NCT02759198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92867015|NCT02759198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867016|NCT02759198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867017|NCT04220606|Nitroglycerin|nitroglycerin|mesh-list
92867018|NCT04220606|Vasodilator Agents|vasodilator agents|mesh-ancestor
92867019|NCT02755064|Erythromycin|erythromycin|mesh-list
92867020|NCT02755064|Erythromycin Estolate|erythromycin estolate|mesh-list
92867021|NCT02755064|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92867022|NCT02755064|Erythromycin stearate|erythromycin stearate|mesh-list
92867023|NCT02755064|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
92867024|NCT02755064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92867025|NCT02755064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867026|NCT02755064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92867027|NCT02755064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92867028|NCT02755064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867029|NCT02755064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867030|NCT02705976|Warfarin|warfarin|mesh-list
92867031|NCT02705976|Anticoagulants|anticoagulants|mesh-ancestor
92867032|NCT02752412|Insulin|insulin|mesh-list
92867033|NCT02752412|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92867034|NCT02752412|Metformin|metformin|mesh-list
92867035|NCT02752412|Insulin Glargine|insulin glargine|mesh-list
92867036|NCT02752412|Lixisenatide|lixisenatide|mesh-list
92867037|NCT02752412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92867038|NCT02752412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867039|NCT02705820|Pembrolizumab|pembrolizumab|mesh-list
92867040|NCT02705820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867041|NCT02705820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867042|NCT02705820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92867043|NCT02705820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867044|NCT02703090|Remifentanil|remifentanil|mesh-list
92867045|NCT02703090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92867046|NCT02703090|Narcotics|narcotics|mesh-ancestor
92512234|NCT00000681|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867047|NCT02703090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867048|NCT02703090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867049|NCT02703090|Analgesics|analgesics|mesh-ancestor
92867050|NCT02703090|Sensory System Agents|sensory system agents|mesh-ancestor
92867051|NCT02703090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867052|NCT02754362|Bevacizumab|bevacizumab|mesh-list
92867053|NCT02754362|Poly ICLC|poly iclc|mesh-list
92867054|NCT02754362|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92867055|NCT02754362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92867056|NCT02754362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867057|NCT02754362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867058|NCT02754362|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867059|NCT02754362|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867060|NCT02754362|Growth Substances|growth substances|mesh-ancestor
92867061|NCT02754362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867062|NCT02754362|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867063|NCT02754362|Interferon Inducers|interferon inducers|mesh-ancestor
92867064|NCT02754362|Immunologic Factors|immunologic factors|mesh-ancestor
92867065|NCT03373188|Nivolumab|nivolumab|mesh-list
92867066|NCT03373188|Ipilimumab|ipilimumab|mesh-list
92867067|NCT03373188|Antibodies|antibodies|mesh-list
92867068|NCT03373188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92867069|NCT03373188|Immunologic Factors|immunologic factors|mesh-ancestor
92867070|NCT03373188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867071|NCT03373188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867072|NCT03373188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867073|NCT03373188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92867074|NCT03373188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867075|NCT02698098|Methadone|methadone|mesh-list
92867076|NCT02698098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92867077|NCT02698098|Narcotics|narcotics|mesh-ancestor
92867078|NCT02698098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867079|NCT02698098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867080|NCT02698098|Analgesics|analgesics|mesh-ancestor
92867081|NCT02698098|Sensory System Agents|sensory system agents|mesh-ancestor
92867082|NCT02698098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867083|NCT02698098|Antitussive Agents|antitussive agents|mesh-ancestor
92867084|NCT02698098|Respiratory System Agents|respiratory system agents|mesh-ancestor
92867085|NCT04220996|Vortioxetine|vortioxetine|mesh-list
92867086|NCT04220996|Antidepressive Agents|antidepressive agents|mesh-ancestor
92867087|NCT04220996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867088|NCT04220996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92867089|NCT04220996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92867090|NCT04220996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867091|NCT04220996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867092|NCT04220996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92867093|NCT04220996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92867094|NCT04220996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867095|NCT04220996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867096|NCT04220996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867097|NCT04220996|Serotonin Agents|serotonin agents|mesh-ancestor
92867098|NCT04220996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92867099|NCT04220996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92867100|NCT04220996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92867101|NCT04220996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92867102|NCT02702700|Verteporfin|verteporfin|mesh-list
92867103|NCT02702700|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92867104|NCT02702700|Dermatologic Agents|dermatologic agents|mesh-ancestor
92867105|NCT02702622|Provitamins|provitamins|mesh-list
92867106|NCT02702622|Beta Carotene|beta carotene|mesh-list
92867107|NCT02702622|Vitamins|vitamins|mesh-ancestor
92867108|NCT02702622|Micronutrients|micronutrients|mesh-ancestor
92867109|NCT02702622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867110|NCT04214808|Dutasteride|dutasteride|mesh-list
92867111|NCT04214808|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92867112|NCT04214808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92867113|NCT04214808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867114|NCT04214808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867115|NCT04214808|Hormone Antagonists|hormone antagonists|mesh-ancestor
92867116|NCT04214808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867117|NCT04214808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867118|NCT02702778|Prednisone|prednisone|mesh-list
92867119|NCT02702778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92867120|NCT02702778|Glucocorticoids|glucocorticoids|mesh-ancestor
92867121|NCT02702778|Hormones|hormones|mesh-ancestor
92867122|NCT02702778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867123|NCT02702778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867124|NCT02702778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92867125|NCT02702778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867126|NCT02753738|Escitalopram|escitalopram|mesh-list
92867127|NCT02753738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92867128|NCT02753738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92867129|NCT02753738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867130|NCT02753738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867131|NCT02753738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867132|NCT02753738|Serotonin Agents|serotonin agents|mesh-ancestor
92867133|NCT02753738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867134|NCT02751632|Fluoxetine|fluoxetine|mesh-list
92867135|NCT02751632|Antidepressive Agents|antidepressive agents|mesh-list
92867136|NCT02751632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92867137|NCT02751632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92867138|NCT02751632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867139|NCT02751632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867140|NCT02751632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867141|NCT02751632|Serotonin Agents|serotonin agents|mesh-ancestor
92867142|NCT02751632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867143|NCT02751632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92867144|NCT02751632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867145|NCT02751632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92867146|NCT02751632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92867147|NCT02751632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867148|NCT04805268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92867149|NCT04805268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92867150|NCT04805268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867151|NCT02751476|Disinfectants|disinfectants|mesh-list
92867152|NCT02751476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867153|NCT02705664|Amorolfine|amorolfine|mesh-list
92867154|NCT02705664|Bifonazole|bifonazole|mesh-list
92867155|NCT02705664|Antifungal Agents|antifungal agents|mesh-ancestor
92867156|NCT02705664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867157|NCT02753426|Doxycycline|doxycycline|mesh-list
92867158|NCT02753426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92867159|NCT02753426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867160|NCT02753426|Antimalarials|antimalarials|mesh-ancestor
92867161|NCT02753426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92867162|NCT02753426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92867164|NCT04219124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92867165|NCT04219124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867166|NCT04219124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92867167|NCT04219124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867168|NCT02702076|Apomorphine|apomorphine|mesh-list
92867169|NCT02702076|Emetics|emetics|mesh-ancestor
92867170|NCT02702076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867171|NCT02702076|Autonomic Agents|autonomic agents|mesh-ancestor
92867172|NCT02702076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867173|NCT02702076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92867174|NCT02702076|Dopamine Agonists|dopamine agonists|mesh-ancestor
92867175|NCT02702076|Dopamine Agents|dopamine agents|mesh-ancestor
92867176|NCT02702076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867177|NCT02702076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867178|NCT02751398|Dapagliflozin|dapagliflozin|mesh-list
92867179|NCT02751398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92867180|NCT02751398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867181|NCT02751398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92867182|NCT02751398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867183|NCT02753114|Ketamine|ketamine|mesh-list
92867184|NCT02753114|Analgesics|analgesics|mesh-ancestor
92867185|NCT02753114|Sensory System Agents|sensory system agents|mesh-ancestor
92867186|NCT02753114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867187|NCT02753114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867188|NCT02753114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92867189|NCT02753114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92867190|NCT02753114|Anesthetics, General|anesthetics, general|mesh-ancestor
92867191|NCT02753114|Anesthetics|anesthetics|mesh-ancestor
92867192|NCT02753114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867193|NCT02753114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92867194|NCT02753114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92867195|NCT02753114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867196|NCT02753114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867197|NCT03288324|Tofacitinib|tofacitinib|mesh-list
92867198|NCT03288324|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92867199|NCT03288324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867200|NCT03288324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867201|NCT03288324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867202|NCT05324748|Methylprednisolone|methylprednisolone|mesh-list
92867203|NCT05324748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92867204|NCT05324748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92867205|NCT05324748|Prednisolone|prednisolone|mesh-list
92867206|NCT05324748|Prednisolone acetate|prednisolone acetate|mesh-list
92867207|NCT05324748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92867208|NCT05324748|Prednisolone phosphate|prednisolone phosphate|mesh-list
92867209|NCT05324748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92867210|NCT05324748|Antiemetics|antiemetics|mesh-ancestor
92867211|NCT05324748|Autonomic Agents|autonomic agents|mesh-ancestor
92867212|NCT05324748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867213|NCT05324748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867214|NCT05324748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92867215|NCT05324748|Glucocorticoids|glucocorticoids|mesh-ancestor
92867216|NCT05324748|Hormones|hormones|mesh-ancestor
92867217|NCT05324748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867218|NCT05324748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92867219|NCT05324748|Protective Agents|protective agents|mesh-ancestor
92867220|NCT05324748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92867221|NCT05324748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867222|NCT02705274|Bevacizumab|bevacizumab|mesh-list
92867223|NCT02705274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867224|NCT02705274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867225|NCT02705274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867226|NCT02705274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867227|NCT02705274|Growth Substances|growth substances|mesh-ancestor
92867228|NCT02705274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867229|NCT02705274|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867230|NCT00914849|Plerixafor|plerixafor|mesh-list
92867231|NCT00914849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92867232|NCT00914849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92867233|NCT00914849|Antiviral Agents|antiviral agents|mesh-ancestor
92867234|NCT00914849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867235|NCT02704962|Olanzapine|olanzapine|mesh-list
92867237|NCT02704962|Autonomic Agents|autonomic agents|mesh-ancestor
92867238|NCT02704962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867239|NCT02704962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867240|NCT02704962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92867241|NCT02704962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92867242|NCT02704962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92867243|NCT02704962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867244|NCT02704962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867245|NCT02704962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92867246|NCT02704962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92867247|NCT02704962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867248|NCT02704962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867249|NCT02704962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867250|NCT02704962|Serotonin Agents|serotonin agents|mesh-ancestor
92867251|NCT00631943|Pregabalin|pregabalin|mesh-list
92867252|NCT00631943|Analgesics|analgesics|mesh-ancestor
92867253|NCT00631943|Sensory System Agents|sensory system agents|mesh-ancestor
92867254|NCT00631943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867255|NCT00631943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867256|NCT00631943|Anticonvulsants|anticonvulsants|mesh-ancestor
92867257|NCT00631943|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92867258|NCT00631943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867259|NCT00631943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867260|NCT00631943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92867261|NCT00631943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92867262|NCT00631943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92867263|NCT00631943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867264|NCT00631943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867265|NCT05429684|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92867266|NCT05429684|Capecitabine|capecitabine|mesh-list
92867267|NCT05429684|Trastuzumab|trastuzumab|mesh-list
92867268|NCT05429684|Everolimus|everolimus|mesh-list
92867269|NCT05429684|Letrozole|letrozole|mesh-list
92867270|NCT05429684|Palbociclib|palbociclib|mesh-list
92867271|NCT05429684|Pertuzumab|pertuzumab|mesh-list
92867272|NCT05429684|Antibodies|antibodies|mesh-list
92867273|NCT05429684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92867274|NCT05429684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867275|NCT05429684|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867276|NCT05429684|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867277|NCT05429684|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867278|NCT05429684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867279|NCT05429684|Immunologic Factors|immunologic factors|mesh-ancestor
92867280|NCT05429684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867281|NCT05429684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92867282|NCT05429684|Antimetabolites|antimetabolites|mesh-ancestor
92867283|NCT05429684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867284|NCT05429684|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92867285|NCT05429684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867286|NCT05429684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867287|NCT05429684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92867288|NCT05429684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92867289|NCT05429684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92867290|NCT05429684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92867291|NCT05429684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92867292|NCT05429684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867293|NCT05429684|Immunotoxins|immunotoxins|mesh-ancestor
92867294|NCT05429684|Immunoconjugates|immunoconjugates|mesh-ancestor
92867295|NCT05324592|Aflibercept|aflibercept|mesh-list
92867296|NCT05324592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867297|NCT05324592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867298|NCT05324592|Growth Substances|growth substances|mesh-ancestor
92867299|NCT05324592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867300|NCT05324592|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867301|NCT05324592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867302|NCT04433858|Psilocybin|psilocybin|mesh-list
92867303|NCT04433858|Hallucinogens|hallucinogens|mesh-ancestor
92867304|NCT04433858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867305|NCT04433858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867306|NCT02750696|Acetaminophen|acetaminophen|mesh-list
92867307|NCT02750696|Tramadol|tramadol|mesh-list
92867308|NCT02750696|Codeine|codeine|mesh-list
92867309|NCT02750696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92867310|NCT02750696|Analgesics|analgesics|mesh-ancestor
92867311|NCT02750696|Sensory System Agents|sensory system agents|mesh-ancestor
92867312|NCT02750696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867313|NCT02750696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867314|NCT02750696|Antipyretics|antipyretics|mesh-ancestor
92867315|NCT02750696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92867316|NCT02750696|Narcotics|narcotics|mesh-ancestor
92867317|NCT02750696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867318|NCT02750696|Antitussive Agents|antitussive agents|mesh-ancestor
92867319|NCT02750696|Respiratory System Agents|respiratory system agents|mesh-ancestor
92867320|NCT02695550|Conteltinib|conteltinib|mesh-list
92867321|NCT02695550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867322|NCT02695550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867323|NCT02695550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867324|NCT00912743|Olaparib|olaparib|mesh-list
92867325|NCT00912743|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92867326|NCT00912743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867327|NCT00912743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867328|NCT00912743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867329|NCT04432610|Nebivolol|nebivolol|mesh-list
92867330|NCT04432610|Bisoprolol|bisoprolol|mesh-list
92867331|NCT04432610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92867332|NCT04432610|Vasodilator Agents|vasodilator agents|mesh-ancestor
92867333|NCT04432610|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92867334|NCT04432610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92867335|NCT04432610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92867336|NCT04432610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92867337|NCT04432610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867338|NCT04432610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867339|NCT04432610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867340|NCT04432610|Sympatholytics|sympatholytics|mesh-ancestor
92867341|NCT04432610|Autonomic Agents|autonomic agents|mesh-ancestor
92867342|NCT04432610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867343|NCT04432610|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92867344|NCT04432610|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92867345|NCT04432610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92867346|NCT04643093|Ezetimibe|ezetimibe|mesh-list
92867347|NCT04643093|Pitavastatin|pitavastatin|mesh-list
92867348|NCT04643093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92867349|NCT04643093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92867350|NCT04643093|Antimetabolites|antimetabolites|mesh-ancestor
92867351|NCT04643093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867352|NCT04643093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92867353|NCT04643093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92867354|NCT04643093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867355|NCT00914459|Factor VIII|factor viii|mesh-list
92867356|NCT00914459|Coagulants|coagulants|mesh-ancestor
92867357|NCT02701608|Levofloxacin|levofloxacin|mesh-list
92867358|NCT02701608|Rifampin|rifampin|mesh-list
92867359|NCT02701608|Fluoroquinolones|fluoroquinolones|mesh-list
92867360|NCT02701608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92867361|NCT02701608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867362|NCT02701608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92867363|NCT02701608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867364|NCT02701608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867365|NCT02701608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867366|NCT02701608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867367|NCT02701608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867368|NCT02701608|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92867369|NCT02701608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92867370|NCT02701608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92867371|NCT02701608|Antitubercular Agents|antitubercular agents|mesh-ancestor
92867372|NCT02701608|Leprostatic Agents|leprostatic agents|mesh-ancestor
92867373|NCT02701608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92867374|NCT02701608|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92867375|NCT02701608|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92867376|NCT02701608|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92867377|NCT02701608|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92867378|NCT02701608|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92867379|NCT02701608|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92867380|NCT00635960|Hormones|hormones|mesh-list
92867381|NCT00635960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867382|NCT00635960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867383|NCT05429294|Paclitaxel|paclitaxel|mesh-list
92867384|NCT05429294|Trastuzumab|trastuzumab|mesh-list
92867385|NCT05429294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867386|NCT05429294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867387|NCT05429294|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867388|NCT05429294|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867389|NCT05429294|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867390|NCT05429294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867391|NCT05429294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867392|NCT04219046|Naloxegol|naloxegol|mesh-list
92867393|NCT04219046|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92867394|NCT04219046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867395|NCT04219046|Sensory System Agents|sensory system agents|mesh-ancestor
92867396|NCT04219046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867397|NCT00912509|Riboflavin|riboflavin|mesh-list
92867398|NCT00912509|Vitamin B Complex|vitamin b complex|mesh-ancestor
92867399|NCT00912509|Vitamins|vitamins|mesh-ancestor
92867400|NCT00912509|Micronutrients|micronutrients|mesh-ancestor
92867401|NCT00912509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867402|NCT00912509|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92867403|NCT00912509|Dermatologic Agents|dermatologic agents|mesh-ancestor
92867404|NCT02873598|Paclitaxel|paclitaxel|mesh-list
92867405|NCT02873598|Gemcitabine|gemcitabine|mesh-list
92867406|NCT02873598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92867407|NCT02873598|Folfirinox|folfirinox|mesh-list
92867408|NCT02873598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867409|NCT02873598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867410|NCT02873598|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867411|NCT02873598|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867412|NCT02873598|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867413|NCT02873598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867414|NCT02873598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92867415|NCT02873598|Antimetabolites|antimetabolites|mesh-ancestor
92867416|NCT02749994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92867417|NCT02749994|Ezetimibe|ezetimibe|mesh-list
92867418|NCT02749994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92867419|NCT02749994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92867420|NCT02749994|Antimetabolites|antimetabolites|mesh-ancestor
92867421|NCT02749994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867422|NCT02749994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92867423|NCT02749994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92867425|NCT04417049|Pentoxifylline|pentoxifylline|mesh-list
92867426|NCT04417049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92867427|NCT04417049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867428|NCT04417049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867429|NCT04417049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92867430|NCT04417049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92867431|NCT04417049|Protective Agents|protective agents|mesh-ancestor
92867432|NCT04417049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867433|NCT04417049|Vasodilator Agents|vasodilator agents|mesh-ancestor
92867434|NCT04417049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92867435|NCT04417049|Antioxidants|antioxidants|mesh-ancestor
92867436|NCT02862210|Lithium Carbonate|lithium carbonate|mesh-list
92867437|NCT02862210|Antidepressive Agents|antidepressive agents|mesh-ancestor
92867438|NCT02862210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867439|NCT02862210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867440|NCT02862210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867441|NCT02862210|Antimanic Agents|antimanic agents|mesh-ancestor
92867442|NCT02862210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92867443|NCT02862210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867444|NCT02862210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867445|NCT05323422|Ketamine|ketamine|mesh-list
92867446|NCT05323422|Analgesics|analgesics|mesh-ancestor
92867447|NCT05323422|Sensory System Agents|sensory system agents|mesh-ancestor
92867448|NCT05323422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867449|NCT05323422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867450|NCT05323422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92867451|NCT05323422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92867452|NCT05323422|Anesthetics, General|anesthetics, general|mesh-ancestor
92867453|NCT05323422|Anesthetics|anesthetics|mesh-ancestor
92867454|NCT05323422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867455|NCT05323422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92867456|NCT05323422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92867457|NCT05323422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867458|NCT05323422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867460|NCT02700906|Anesthetics, Local|anesthetics, local|mesh-ancestor
92867461|NCT02700906|Anesthetics|anesthetics|mesh-ancestor
92867462|NCT02700906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867463|NCT02700906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867464|NCT02700906|Sensory System Agents|sensory system agents|mesh-ancestor
92867465|NCT02700906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867466|NCT02700906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92867467|NCT02700906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92867468|NCT02700906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92867469|NCT02700906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867470|NCT02700906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867471|NCT00636038|Beta Carotene|beta carotene|mesh-list
92867472|NCT00636038|Carotenoids|carotenoids|mesh-list
92867473|NCT00636038|Antioxidants|antioxidants|mesh-ancestor
92867474|NCT00636038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867475|NCT00636038|Protective Agents|protective agents|mesh-ancestor
92867476|NCT00636038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867477|NCT00636038|Provitamins|provitamins|mesh-ancestor
92867478|NCT00636038|Vitamins|vitamins|mesh-ancestor
92867479|NCT00636038|Micronutrients|micronutrients|mesh-ancestor
92867480|NCT04723004|Bevacizumab|bevacizumab|mesh-list
92867481|NCT04723004|Sorafenib|sorafenib|mesh-list
92867482|NCT04723004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867483|NCT04723004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867484|NCT04723004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867485|NCT04723004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867486|NCT04723004|Growth Substances|growth substances|mesh-ancestor
92867487|NCT04723004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867488|NCT04723004|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867489|NCT04723004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867490|NCT04723004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867491|NCT04723004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867492|NCT04213716|Calcium, Dietary|calcium, dietary|mesh-list
92867493|NCT04213716|Calcium|calcium|mesh-list
92867494|NCT04213716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92867495|NCT04213716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867496|NCT04213716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92867497|NCT04218890|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
92867498|NCT04218890|Thromboplastin|thromboplastin|mesh-list
92867499|NCT04218890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92867500|NCT04218890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92867501|NCT04218890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867502|NCT04218890|Hemostatics|hemostatics|mesh-ancestor
92867503|NCT04218890|Coagulants|coagulants|mesh-ancestor
92867504|NCT04218890|Anticoagulants|anticoagulants|mesh-ancestor
92867505|NCT04218890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92867506|NCT04218890|Protease Inhibitors|protease inhibitors|mesh-ancestor
92867507|NCT04218890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867508|NCT04218890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92867509|NCT04218890|Antithrombins|antithrombins|mesh-ancestor
92867510|NCT00636116|Antivenins|antivenins|mesh-list
92867511|NCT00636116|Immunologic Factors|immunologic factors|mesh-ancestor
92867512|NCT00636116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867513|NCT04772196|Vitamin D|vitamin d|mesh-list
92867514|NCT04772196|Cholecalciferol|cholecalciferol|mesh-list
92867515|NCT04772196|Vitamins|vitamins|mesh-ancestor
92867516|NCT04772196|Micronutrients|micronutrients|mesh-ancestor
92867517|NCT04772196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867518|NCT04772196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92867519|NCT04772196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92867520|NCT05428670|Rituximab|rituximab|mesh-list
92867521|NCT05428670|Lenalidomide|lenalidomide|mesh-list
92867522|NCT05428670|Zanubrutinib|zanubrutinib|mesh-list
92867523|NCT05428670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867524|NCT05428670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867525|NCT05428670|Immunologic Factors|immunologic factors|mesh-ancestor
92867526|NCT05428670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867527|NCT05428670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92867528|NCT05428670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867529|NCT05428670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867530|NCT05428670|Growth Substances|growth substances|mesh-ancestor
92867531|NCT05428670|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867532|NCT05428670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867534|NCT05428670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867535|NCT00635726|Cisplatin|cisplatin|mesh-list
92867536|NCT00635726|Gemcitabine|gemcitabine|mesh-list
92867537|NCT00635726|Doxorubicin|doxorubicin|mesh-list
92867538|NCT00635726|Methotrexate|methotrexate|mesh-list
92867539|NCT00635726|Vinblastine|vinblastine|mesh-list
92867540|NCT00635726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867541|NCT00635726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92867542|NCT00635726|Antimetabolites|antimetabolites|mesh-ancestor
92867543|NCT00635726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867544|NCT00635726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92867545|NCT00635726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867546|NCT00635726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867547|NCT00635726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867548|NCT00635726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92867549|NCT00635726|Abortifacient Agents|abortifacient agents|mesh-ancestor
92867550|NCT00635726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92867551|NCT00635726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867552|NCT00635726|Dermatologic Agents|dermatologic agents|mesh-ancestor
92867553|NCT00635726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92867554|NCT00635726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92867555|NCT00635726|Immunologic Factors|immunologic factors|mesh-ancestor
92867556|NCT00635726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92867557|NCT00635726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92867558|NCT00635726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867559|NCT00635726|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867560|NCT00635726|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867561|NCT00635726|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867562|NCT04219982|Scopolamine|scopolamine|mesh-list
92867563|NCT04219982|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92867564|NCT04219982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92867565|NCT04219982|Antiemetics|antiemetics|mesh-ancestor
92867566|NCT04219982|Autonomic Agents|autonomic agents|mesh-ancestor
92867567|NCT04219982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867568|NCT04219982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867569|NCT04219982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92867570|NCT04219982|Mydriatics|mydriatics|mesh-ancestor
92867571|NCT04219982|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92867572|NCT04219982|Cholinergic Agents|cholinergic agents|mesh-ancestor
92867573|NCT04219982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867574|NCT04219982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867575|NCT04219982|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92867576|NCT04219982|Parasympatholytics|parasympatholytics|mesh-ancestor
92867577|NCT02700438|Nitroglycerin|nitroglycerin|mesh-list
92867578|NCT02700438|Vasodilator Agents|vasodilator agents|mesh-ancestor
92867579|NCT04216706|Calcium Channel Blockers|calcium channel blockers|mesh-list
92867580|NCT04216706|Sympatholytics|sympatholytics|mesh-list
92867581|NCT04216706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92867582|NCT04216706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867583|NCT04216706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867584|NCT04216706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867585|NCT04216706|Autonomic Agents|autonomic agents|mesh-ancestor
92867586|NCT04216706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867587|NCT00913835|Doxorubicin|doxorubicin|mesh-list
92867588|NCT00913835|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92867589|NCT00913835|Olaratumab|olaratumab|mesh-list
92867590|NCT00913835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92867591|NCT00913835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867592|NCT00913835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867593|NCT00913835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867594|NCT00913835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867595|NCT00913835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867596|NCT05322720|Paclitaxel|paclitaxel|mesh-list
92867597|NCT05322720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92867598|NCT05322720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867599|NCT05322720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867600|NCT05322720|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867601|NCT05322720|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867602|NCT05322720|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867603|NCT05322720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867604|NCT04213170|Bevacizumab|bevacizumab|mesh-list
92867605|NCT04213170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867606|NCT04213170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867607|NCT04213170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867608|NCT04213170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867609|NCT04213170|Growth Substances|growth substances|mesh-ancestor
92867610|NCT04213170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867611|NCT04213170|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867612|NCT05322564|Opiate Alkaloids|opiate alkaloids|mesh-list
92867613|NCT05322564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92867614|NCT05322564|Narcotics|narcotics|mesh-ancestor
92867615|NCT05322564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867616|NCT05322564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867617|NCT05322564|Analgesics|analgesics|mesh-ancestor
92867618|NCT05322564|Sensory System Agents|sensory system agents|mesh-ancestor
92867619|NCT05322564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867620|NCT02749136|Gemcitabine|gemcitabine|mesh-list
92867621|NCT02749136|Folfirinox|folfirinox|mesh-list
92867622|NCT02749136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92867623|NCT02749136|Antimetabolites|antimetabolites|mesh-ancestor
92867624|NCT02749136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867625|NCT02749136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867626|NCT00631631|Mifamurtide|mifamurtide|mesh-list
92867627|NCT00631631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92867628|NCT00631631|Immunologic Factors|immunologic factors|mesh-ancestor
92867629|NCT00631631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867630|NCT04238741|Anesthetics|anesthetics|mesh-list
92867631|NCT04238741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867632|NCT04238741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867633|NCT02691858|Hydrocortisone|hydrocortisone|mesh-list
92867634|NCT02691858|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92867635|NCT02691858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92867636|NCT04218500|Niacinamide|niacinamide|mesh-list
92867637|NCT04218500|Niacin|niacin|mesh-list
92867638|NCT04218500|Nicotinic Acids|nicotinic acids|mesh-list
92867639|NCT04218500|Vitamin B Complex|vitamin b complex|mesh-ancestor
92867640|NCT04218500|Vitamins|vitamins|mesh-ancestor
92867641|NCT04218500|Micronutrients|micronutrients|mesh-ancestor
92867642|NCT04218500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867643|NCT04218500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92867644|NCT04218500|Antimetabolites|antimetabolites|mesh-ancestor
92867645|NCT04218500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867646|NCT04218500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92867647|NCT04218500|Vasodilator Agents|vasodilator agents|mesh-ancestor
92867648|NCT04264208|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92867649|NCT04264208|Bombesin|bombesin|mesh-list
92867650|NCT04264208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92867651|NCT04264208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867652|NCT04264208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867653|NCT04264208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867654|NCT05412056|Metformin|metformin|mesh-list
92867655|NCT05412056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92867656|NCT05412056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867657|NCT04453046|Pembrolizumab|pembrolizumab|mesh-list
92867658|NCT04453046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92867659|NCT04453046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867660|NCT04453046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93026464|NCT03747159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867661|NCT04453046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867662|NCT04216628|Oxytocin|oxytocin|mesh-list
92867663|NCT04216628|Oxytocics|oxytocics|mesh-ancestor
92867664|NCT04216628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92867665|NCT04216628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867666|NCT04217096|Paclitaxel|paclitaxel|mesh-list
92867667|NCT04217096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867668|NCT04217096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867669|NCT04217096|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867670|NCT04217096|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867671|NCT04217096|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867672|NCT04217096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867673|NCT05411978|Ubiquinone|ubiquinone|mesh-list
92867674|NCT05411978|Idebenone|idebenone|mesh-list
92867675|NCT05411978|Antioxidants|antioxidants|mesh-ancestor
92867676|NCT05411978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867677|NCT05411978|Protective Agents|protective agents|mesh-ancestor
92867678|NCT05411978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867679|NCT05411978|Micronutrients|micronutrients|mesh-ancestor
92867680|NCT00617370|Paclitaxel|paclitaxel|mesh-list
92867681|NCT00617370|Cyclophosphamide|cyclophosphamide|mesh-list
92867682|NCT00617370|Epirubicin|epirubicin|mesh-list
92867683|NCT00617370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867684|NCT00617370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867685|NCT00617370|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867686|NCT00617370|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867687|NCT00617370|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867688|NCT00617370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867689|NCT00617370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92867690|NCT00617370|Immunologic Factors|immunologic factors|mesh-ancestor
92867691|NCT00617370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867692|NCT00617370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92867693|NCT00617370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92867694|NCT00617370|Alkylating Agents|alkylating agents|mesh-ancestor
92867695|NCT00617370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92867696|NCT00617370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92867697|NCT00617370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867698|NCT00617370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867699|NCT00617370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867700|NCT02699658|Levofloxacin|levofloxacin|mesh-list
92867701|NCT02699658|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92867702|NCT02699658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867703|NCT02699658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92867704|NCT02699658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867705|NCT02699658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867706|NCT02699658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867707|NCT02699658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867708|NCT02699658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867709|NCT02699658|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92867710|NCT02699658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92867711|NCT04218734|Metformin|metformin|mesh-list
92867712|NCT04218734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92867713|NCT04218734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867714|NCT04066478|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92867715|NCT04066478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92867716|NCT04066478|Immunologic Factors|immunologic factors|mesh-ancestor
92867717|NCT04066478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867718|NCT04496063|Ustekinumab|ustekinumab|mesh-list
92867719|NCT04496063|Dermatologic Agents|dermatologic agents|mesh-ancestor
92867720|NCT04032626|Lenalidomide|lenalidomide|mesh-list
92867721|NCT04032626|Immunologic Factors|immunologic factors|mesh-ancestor
92867722|NCT04032626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867723|NCT04032626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92867724|NCT04032626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92867725|NCT04032626|Growth Substances|growth substances|mesh-ancestor
92867726|NCT04032626|Growth Inhibitors|growth inhibitors|mesh-ancestor
92867727|NCT04032626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867728|NCT04214106|Thiamine|thiamine|mesh-list
92867729|NCT04214106|Vitamin B Complex|vitamin b complex|mesh-ancestor
92867730|NCT04214106|Vitamins|vitamins|mesh-ancestor
92867731|NCT04214106|Micronutrients|micronutrients|mesh-ancestor
92867732|NCT04214106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867733|NCT02747732|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92867734|NCT02747732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168274|NCT05321251|Insulin|insulin|mesh-list
92867735|NCT02747732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92867736|NCT02747732|Alkylating Agents|alkylating agents|mesh-ancestor
92867737|NCT02747732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867738|NCT02695862|Terlipressin|terlipressin|mesh-list
92867739|NCT02695862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92867740|NCT02695862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92867741|NCT00617448|Anesthetics|anesthetics|mesh-list
92867742|NCT00617448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867743|NCT00617448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867744|NCT04308863|Chitosan|chitosan|mesh-list
92867745|NCT04308863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867746|NCT04308863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92867747|NCT04308863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92867748|NCT04308863|Antimetabolites|antimetabolites|mesh-ancestor
92867749|NCT04308863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92867750|NCT04308863|Chelating Agents|chelating agents|mesh-ancestor
92867751|NCT04308863|Sequestering Agents|sequestering agents|mesh-ancestor
92867752|NCT04308863|Hemostatics|hemostatics|mesh-ancestor
92867753|NCT04308863|Coagulants|coagulants|mesh-ancestor
92867754|NCT00615810|Efavirenz|efavirenz|mesh-list
92867755|NCT00615810|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92867756|NCT00615810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92867757|NCT00615810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92867759|NCT00615810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867760|NCT00615810|Antiviral Agents|antiviral agents|mesh-ancestor
92867761|NCT00615810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867762|NCT00615810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92867763|NCT00615810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92867764|NCT00615810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92867765|NCT00615810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92867766|NCT00615810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92867767|NCT00615810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92867768|NCT00615810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92867769|NCT00615810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92867770|NCT03355157|Tamoxifen|tamoxifen|mesh-list
92867771|NCT03355157|Paclitaxel|paclitaxel|mesh-list
92867772|NCT03355157|Vinorelbine|vinorelbine|mesh-list
92867773|NCT03355157|Capecitabine|capecitabine|mesh-list
92867774|NCT03355157|Letrozole|letrozole|mesh-list
92867775|NCT03355157|Epirubicin|epirubicin|mesh-list
92867776|NCT03355157|Fulvestrant|fulvestrant|mesh-list
92867777|NCT03355157|Palbociclib|palbociclib|mesh-list
92867778|NCT03355157|Exemestane|exemestane|mesh-list
92867779|NCT03355157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867780|NCT03355157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867781|NCT03355157|Tubulin Modulators|tubulin modulators|mesh-ancestor
92867782|NCT03355157|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867783|NCT03355157|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867784|NCT03355157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867785|NCT03355157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92867786|NCT03355157|Antimetabolites|antimetabolites|mesh-ancestor
92867787|NCT03355157|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92867788|NCT03355157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92867789|NCT03355157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867790|NCT03355157|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92867791|NCT03355157|Hormone Antagonists|hormone antagonists|mesh-ancestor
92867792|NCT03355157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867793|NCT03355157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867794|NCT03355157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92867795|NCT03355157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867796|NCT03355157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867797|NCT03355157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92867798|NCT03355157|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92867799|NCT03355157|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92867800|NCT03355157|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92867801|NCT03355157|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92867802|NCT03355157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867803|NCT04215432|Propolis|propolis|mesh-list
92867804|NCT04215432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867805|NCT02747342|Fluzoparib|fluzoparib|mesh-list
92867806|NCT02747342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92867807|NCT02747342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867808|NCT02747342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867809|NCT02747342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867810|NCT03324035|Tramadol|tramadol|mesh-list
92867811|NCT03324035|Amitriptyline|amitriptyline|mesh-list
92867812|NCT03324035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92867813|NCT03324035|Narcotics|narcotics|mesh-ancestor
92867814|NCT03324035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867815|NCT03324035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867816|NCT03324035|Analgesics|analgesics|mesh-ancestor
92867817|NCT03324035|Sensory System Agents|sensory system agents|mesh-ancestor
92867818|NCT03324035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867819|NCT03324035|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92867820|NCT03324035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92867821|NCT03324035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867822|NCT03324035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92867823|NCT03324035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92867824|NCT03324035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92867825|NCT03324035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867826|NCT03324035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867827|NCT03324035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92867828|NCT03324035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867829|NCT00616746|Ethanol|ethanol|mesh-list
92867830|NCT00616746|Nicotine|nicotine|mesh-list
92867831|NCT00616746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92867832|NCT00616746|Autonomic Agents|autonomic agents|mesh-ancestor
92867833|NCT00616746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867834|NCT00616746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867835|NCT00616746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92867836|NCT00616746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92867837|NCT00616746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92867838|NCT00616746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867839|NCT00616746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867840|NCT00616746|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92867841|NCT00616746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92867842|NCT00616746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867843|NCT00777582|Olaparib|olaparib|mesh-list
92867844|NCT00777582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92867845|NCT00777582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867846|NCT00777582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867847|NCT00777582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867848|NCT00632255|Imatinib Mesylate|imatinib mesylate|mesh-list
92867849|NCT00632255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867850|NCT00632255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867851|NCT00632255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867852|NCT00632255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867853|NCT05271578|Nicotine|nicotine|mesh-list
92867854|NCT05271578|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92867855|NCT05271578|Autonomic Agents|autonomic agents|mesh-ancestor
92867856|NCT05271578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867857|NCT05271578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867858|NCT05271578|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92867859|NCT05271578|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92867860|NCT05271578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92867861|NCT05271578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867862|NCT05271578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867863|NCT04203485|Paclitaxel|paclitaxel|mesh-list
92867864|NCT04203485|Carboplatin|carboplatin|mesh-list
92867865|NCT04203485|Pemetrexed|pemetrexed|mesh-list
92867866|NCT04203485|Apatinib|apatinib|mesh-list
92867867|NCT04203485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867868|NCT04203485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867869|NCT04203485|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513065|NCT00005825|Tretinoin|tretinoin|mesh-list
92867870|NCT04203485|Antimitotic Agents|antimitotic agents|mesh-ancestor
92867871|NCT04203485|Mitosis Modulators|mitosis modulators|mesh-ancestor
92867872|NCT04203485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867873|NCT04203485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867874|NCT04203485|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92867875|NCT04203485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92867876|NCT04203485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867877|NCT03851627|Methyltestosterone|methyltestosterone|mesh-list
92867878|NCT03851627|Testosterone|testosterone|mesh-list
92867879|NCT03851627|Testosterone undecanoate|testosterone undecanoate|mesh-list
92867880|NCT03851627|Testosterone enanthate|testosterone enanthate|mesh-list
92867881|NCT03851627|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92867882|NCT03851627|Androgens|androgens|mesh-ancestor
92867883|NCT03851627|Hormones|hormones|mesh-ancestor
92867884|NCT03851627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867885|NCT03851627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867886|NCT03851627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92867887|NCT03851627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867888|NCT03851627|Anabolic Agents|anabolic agents|mesh-ancestor
92867889|NCT03116126|Guanfacine|guanfacine|mesh-list
92867890|NCT03116126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92867891|NCT03116126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92867892|NCT03116126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92867893|NCT03116126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92867894|NCT03116126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92867895|NCT03116126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867896|NCT03116126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867897|NCT03116126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867898|NCT02983682|Lidocaine|lidocaine|mesh-list
92867899|NCT02983682|Anesthetics, Local|anesthetics, local|mesh-ancestor
92867900|NCT02983682|Anesthetics|anesthetics|mesh-ancestor
92867901|NCT02983682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92867902|NCT02983682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867903|NCT02983682|Sensory System Agents|sensory system agents|mesh-ancestor
92867904|NCT02983682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867905|NCT02983682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92867906|NCT02983682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92867907|NCT02983682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92867908|NCT02983682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867909|NCT02983682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867910|NCT00910247|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92867911|NCT00910247|Anticonvulsants|anticonvulsants|mesh-ancestor
92867912|NCT00910247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92867913|NCT00910247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92867914|NCT00910247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867915|NCT00910247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867916|NCT04217798|Etoposide|etoposide|mesh-list
92867917|NCT04217798|Niraparib|niraparib|mesh-list
92867918|NCT04217798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92867919|NCT04217798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867920|NCT04217798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92867921|NCT04217798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92867922|NCT04217798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867923|NCT04217798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867924|NCT04217798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92867925|NCT02742038|Fluorides|fluorides|mesh-list
92867926|NCT02742038|Fluorides, Topical|fluorides, topical|mesh-list
92867927|NCT02742038|Cariostatic Agents|cariostatic agents|mesh-ancestor
92867928|NCT02742038|Protective Agents|protective agents|mesh-ancestor
92867929|NCT02742038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867930|NCT02022098|Cisplatin|cisplatin|mesh-list
92867931|NCT02022098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867932|NCT02746250|Amitriptyline|amitriptyline|mesh-list
92867933|NCT02746250|Antidepressive Agents|antidepressive agents|mesh-list
92867934|NCT02746250|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
92867935|NCT02746250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92867936|NCT02746250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92867937|NCT02746250|Analgesics|analgesics|mesh-ancestor
92867938|NCT02746250|Sensory System Agents|sensory system agents|mesh-ancestor
92867939|NCT02746250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92867940|NCT02746250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867941|NCT02746250|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92867942|NCT02746250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92867943|NCT02746250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92867944|NCT02746250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867945|NCT02746250|Adrenergic Agents|adrenergic agents|mesh-ancestor
92867946|NCT02746250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92867947|NCT02741960|Metformin|metformin|mesh-list
92867948|NCT02741960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92867949|NCT02741960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867950|NCT00910091|Megestrol|megestrol|mesh-list
92867951|NCT00910091|Megestrol Acetate|megestrol acetate|mesh-list
92867952|NCT00910091|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92867953|NCT00910091|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92867954|NCT00910091|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92867955|NCT00910091|Contraceptive Agents|contraceptive agents|mesh-ancestor
92867956|NCT00910091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92867957|NCT00910091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867958|NCT00910091|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92867959|NCT00910091|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92867960|NCT00910091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92867961|NCT00910091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867962|NCT00910091|Appetite Stimulants|appetite stimulants|mesh-ancestor
92867963|NCT00910091|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92867964|NCT04216550|Apatinib|apatinib|mesh-list
92867965|NCT04216550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867966|NCT04216550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92867967|NCT04216550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867968|NCT04216550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867969|NCT01442792|Rivaroxaban|rivaroxaban|mesh-list
92867970|NCT01442792|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92867971|NCT01442792|Antithrombins|antithrombins|mesh-ancestor
92867972|NCT01442792|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92867973|NCT01442792|Protease Inhibitors|protease inhibitors|mesh-ancestor
92867974|NCT01442792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92867975|NCT01442792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92867977|NCT00909857|Dienogest|dienogest|mesh-list
92867978|NCT00909857|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92867979|NCT00909857|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92867980|NCT00909857|Levonorgestrel|levonorgestrel|mesh-list
92867981|NCT00909857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92867982|NCT00909857|Estradiol|estradiol|mesh-list
92867983|NCT00909857|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92867984|NCT00909857|Estrogens|estrogens|mesh-ancestor
92867985|NCT00909857|Hormones|hormones|mesh-ancestor
92867986|NCT00909857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92867987|NCT00909857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92867988|NCT00909857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92867989|NCT00909857|Contraceptive Agents|contraceptive agents|mesh-ancestor
92867990|NCT00909857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92867991|NCT00909857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92867992|NCT00909857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92867993|NCT00909857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92867994|NCT00909857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92867995|NCT00909857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92867996|NCT00909857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92867997|NCT00909857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92867998|NCT00909857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92867999|NCT00911807|Cerebrolysin|cerebrolysin|mesh-list
92868000|NCT00911807|Donepezil|donepezil|mesh-list
92868001|NCT00911807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92868002|NCT00911807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868003|NCT00911807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868004|NCT00911807|Cholinergic Agents|cholinergic agents|mesh-ancestor
92868005|NCT00911807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868006|NCT00911807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868007|NCT00911807|Nootropic Agents|nootropic agents|mesh-ancestor
92868008|NCT00911807|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92868009|NCT00911807|Protective Agents|protective agents|mesh-ancestor
92868010|NCT04127981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92868011|NCT04127981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92868012|NCT04127981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868013|NCT04117451|Propolis|propolis|mesh-list
92868014|NCT04117451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868015|NCT03690089|Atropine|atropine|mesh-list
92868016|NCT03690089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92868017|NCT03690089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92868018|NCT03690089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92868019|NCT03690089|Autonomic Agents|autonomic agents|mesh-ancestor
92868020|NCT03690089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168586|NCT04402073|Vincristine|vincristine|mesh-list
92868021|NCT03690089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868022|NCT03690089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92868023|NCT03690089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92868024|NCT03690089|Mydriatics|mydriatics|mesh-ancestor
92868025|NCT03690089|Parasympatholytics|parasympatholytics|mesh-ancestor
92868026|NCT03690089|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92868027|NCT03690089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92868028|NCT03690089|Cholinergic Agents|cholinergic agents|mesh-ancestor
92868029|NCT03690089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868030|NCT03690089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868031|NCT03812588|Escitalopram|escitalopram|mesh-list
92868032|NCT03812588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92868033|NCT03812588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92868034|NCT03812588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868035|NCT03812588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868036|NCT03812588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868037|NCT03812588|Serotonin Agents|serotonin agents|mesh-ancestor
92868038|NCT03812588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868039|NCT02387099|Everolimus|everolimus|mesh-list
92868040|NCT02387099|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92868041|NCT02387099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92868042|NCT02387099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868043|NCT02387099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868044|NCT02387099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868045|NCT02387099|Immunologic Factors|immunologic factors|mesh-ancestor
92868046|NCT02387099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212615|NCT03404791|Antimetabolites|antimetabolites|mesh-ancestor
92868047|NCT02387099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868048|NCT02745860|Selexipag|selexipag|mesh-list
92868049|NCT02745860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92868050|NCT04788641|Cyclosporine|cyclosporine|mesh-list
92868051|NCT04788641|Tacrolimus|tacrolimus|mesh-list
92868052|NCT04788641|Cyclosporins|cyclosporins|mesh-list
92868053|NCT04788641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868054|NCT04788641|Immunologic Factors|immunologic factors|mesh-ancestor
92868055|NCT04788641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868056|NCT04788641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92868057|NCT04788641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868058|NCT04788641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868059|NCT04788641|Antifungal Agents|antifungal agents|mesh-ancestor
92868060|NCT04788641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868061|NCT04788641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92868062|NCT04788641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868063|NCT04331288|Ethanol|ethanol|mesh-list
92868064|NCT04331288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92868065|NCT04331288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868066|NCT04331288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868067|NCT04331288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868068|NCT02745470|Lixisenatide|lixisenatide|mesh-list
92868069|NCT02745470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868070|NCT02745470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868071|NCT02741414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92868072|NCT02741414|Amoxicillin|amoxicillin|mesh-list
92868073|NCT02741414|Metronidazole|metronidazole|mesh-list
92868074|NCT02741414|Clarithromycin|clarithromycin|mesh-list
92868075|NCT02741414|Levofloxacin|levofloxacin|mesh-list
92868076|NCT02741414|Tetracycline|tetracycline|mesh-list
92868077|NCT02741414|Furazolidone|furazolidone|mesh-list
92868078|NCT02741414|Esomeprazole|esomeprazole|mesh-list
92868079|NCT02741414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868080|NCT02741414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92868081|NCT02741414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92868082|NCT02741414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92868083|NCT02741414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868084|NCT02741414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92868085|NCT02741414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868086|NCT02741414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868087|NCT02741414|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92868088|NCT02741414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92868089|NCT02741414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92868090|NCT02741414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92868091|NCT02741414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92868092|NCT02741414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513295|NCT00001083|Ritonavir|ritonavir|mesh-list
92868093|NCT02741414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868094|NCT02741414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92868095|NCT02741414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92868096|NCT02741414|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92868097|NCT02741414|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92868098|NCT02736500|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92868099|NCT02736500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92868100|NCT02736500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868101|NCT05629598|Epoetin Alfa|epoetin alfa|mesh-list
92868102|NCT05629598|Hematinics|hematinics|mesh-ancestor
92868103|NCT02744690|Mitomycins|mitomycins|mesh-list
92868104|NCT02744690|Mitomycin|mitomycin|mesh-list
92868105|NCT02744690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92868106|NCT02744690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868107|NCT02744690|Alkylating Agents|alkylating agents|mesh-ancestor
92868108|NCT02744690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868109|NCT02744690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92868110|NCT02744690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868111|NCT02736032|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92868112|NCT02736032|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92868113|NCT02736032|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92868114|NCT02736032|Estradiol|estradiol|mesh-list
92868115|NCT02736032|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92868116|NCT02736032|Progesterone|progesterone|mesh-list
92868117|NCT02736032|Estrogens|estrogens|mesh-ancestor
92868118|NCT02736032|Hormones|hormones|mesh-ancestor
92868119|NCT02736032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868120|NCT02736032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868121|NCT02736032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92212689|NCT00892697|Ribavirin|ribavirin|mesh-list
92868122|NCT02736032|Contraceptive Agents|contraceptive agents|mesh-ancestor
92868123|NCT02736032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92868124|NCT02736032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92868125|NCT02736032|Progestins|progestins|mesh-ancestor
92868126|NCT02736032|Luteolytic Agents|luteolytic agents|mesh-ancestor
92868127|NCT02736032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868128|NCT02736032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868129|NCT02744768|Dasatinib|dasatinib|mesh-list
92868130|NCT02744768|Blinatumomab|blinatumomab|mesh-list
92868131|NCT02744768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868132|NCT02744768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92868133|NCT02744768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868134|NCT02744768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868135|NCT00909779|Formoterol Fumarate|formoterol fumarate|mesh-list
92868136|NCT00909779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92868137|NCT00909779|Autonomic Agents|autonomic agents|mesh-ancestor
92868138|NCT00909779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868139|NCT00909779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868140|NCT00909779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92868141|NCT00909779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92868142|NCT00909779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92868143|NCT00909779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92868144|NCT00909779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92868145|NCT00909779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92868146|NCT00909779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868147|NCT00909779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868148|NCT04096391|Analgesics|analgesics|mesh-list
92868149|NCT04096391|Sensory System Agents|sensory system agents|mesh-ancestor
92868150|NCT04096391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868151|NCT04096391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868152|NCT02744378|Clobetasol|clobetasol|mesh-list
92868153|NCT02744378|Tacrolimus|tacrolimus|mesh-list
92868154|NCT02744378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868155|NCT02744378|Immunologic Factors|immunologic factors|mesh-ancestor
92868156|NCT02744378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868157|NCT02744378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92868158|NCT02744378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868159|NCT02744378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868160|NCT02744378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868161|NCT02744378|Glucocorticoids|glucocorticoids|mesh-ancestor
92868162|NCT02744378|Hormones|hormones|mesh-ancestor
93026465|NCT00413283|Carboplatin|carboplatin|mesh-list
93026466|NCT00413283|Gemcitabine|gemcitabine|mesh-list
92868163|NCT02744378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868164|NCT04318730|Apatinib|apatinib|mesh-list
92868165|NCT04318730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868166|NCT04318730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92868167|NCT04318730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868168|NCT04318730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868169|NCT00632333|Fluorouracil|fluorouracil|mesh-list
92868170|NCT00632333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868171|NCT00632333|Antimetabolites|antimetabolites|mesh-ancestor
92868172|NCT00632333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868173|NCT00632333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92868174|NCT00632333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868175|NCT00632333|Immunologic Factors|immunologic factors|mesh-ancestor
92868176|NCT00632333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868177|NCT02744456|Losartan|losartan|mesh-list
92868178|NCT02744456|Amlodipine|amlodipine|mesh-list
92868179|NCT02744456|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92868180|NCT02744456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92868181|NCT02744456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92868182|NCT02744456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868183|NCT02744456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868184|NCT02744456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92868185|NCT02744456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868186|NCT02744456|Vasodilator Agents|vasodilator agents|mesh-ancestor
92868187|NCT02744456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92868188|NCT02744456|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92868189|NCT02744456|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92868190|NCT02744456|Diuretics|diuretics|mesh-ancestor
92868191|NCT02744456|Natriuretic Agents|natriuretic agents|mesh-ancestor
92868192|NCT02744456|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92868193|NCT02744222|Interferons|interferons|mesh-list
92868194|NCT02744222|Interferon-beta|interferon-beta|mesh-list
92868195|NCT02744222|Interferon beta-1a|interferon beta-1a|mesh-list
92868196|NCT02744222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868197|NCT02744222|Antiviral Agents|antiviral agents|mesh-ancestor
92868198|NCT02744222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868199|NCT02744222|Immunologic Factors|immunologic factors|mesh-ancestor
92868200|NCT02744222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868201|NCT02744222|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92868203|NCT02741024|Lumefantrine|lumefantrine|mesh-list
92868204|NCT02741024|Artemether|artemether|mesh-list
92868205|NCT02741024|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92868206|NCT02741024|Amodiaquine|amodiaquine|mesh-list
92868207|NCT02741024|Antimalarials|antimalarials|mesh-ancestor
92868208|NCT02741024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92868209|NCT02741024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92868210|NCT02741024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868211|NCT02741024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868212|NCT02741024|Antiviral Agents|antiviral agents|mesh-ancestor
92868213|NCT02741024|Schistosomicides|schistosomicides|mesh-ancestor
92868214|NCT02741024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92868215|NCT02741024|Anthelmintics|anthelmintics|mesh-ancestor
92868216|NCT02735876|Rituximab|rituximab|mesh-list
92868217|NCT02735876|Acalabrutinib|acalabrutinib|mesh-list
92868218|NCT02735876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868219|NCT02735876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868220|NCT02735876|Immunologic Factors|immunologic factors|mesh-ancestor
92868221|NCT02735876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868222|NCT02735876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868223|NCT00910871|Bedaquiline|bedaquiline|mesh-list
92868224|NCT00910871|Antitubercular Agents|antitubercular agents|mesh-ancestor
92868225|NCT00910871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868226|NCT00910871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868227|NCT04230707|Melatonin|melatonin|mesh-list
92868228|NCT04230707|Antioxidants|antioxidants|mesh-ancestor
92868229|NCT04230707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868230|NCT04230707|Protective Agents|protective agents|mesh-ancestor
92868231|NCT04230707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868232|NCT04230707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868233|NCT03943667|Paclitaxel|paclitaxel|mesh-list
92868234|NCT03943667|Gemcitabine|gemcitabine|mesh-list
92868235|NCT03943667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92868236|NCT03943667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868237|NCT03943667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92868238|NCT03943667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92868239|NCT03943667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92868240|NCT03943667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513449|NCT00001119|Amprenavir|amprenavir|mesh-list
92868241|NCT03943667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92868242|NCT03943667|Antimetabolites|antimetabolites|mesh-ancestor
92868243|NCT02735798|Trastuzumab|trastuzumab|mesh-list
92868244|NCT02735798|Gancotamab|gancotamab|mesh-list
92868245|NCT02735798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868246|NCT02735798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868247|NCT02735798|Immunoconjugates|immunoconjugates|mesh-ancestor
92868248|NCT02735798|Immunologic Factors|immunologic factors|mesh-ancestor
92868249|NCT02735798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868250|NCT03760718|Chloroprocaine|chloroprocaine|mesh-list
92868251|NCT03760718|Procaine|procaine|mesh-list
92868252|NCT03760718|Anesthetics, Local|anesthetics, local|mesh-ancestor
92868253|NCT03760718|Anesthetics|anesthetics|mesh-ancestor
92868254|NCT03760718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868255|NCT03760718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868256|NCT03760718|Sensory System Agents|sensory system agents|mesh-ancestor
92868257|NCT03760718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868258|NCT05590286|Amoxicillin|amoxicillin|mesh-list
92868259|NCT05590286|Esomeprazole|esomeprazole|mesh-list
92868260|NCT05590286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868261|NCT05590286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868262|NCT05590286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92868263|NCT05590286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868264|NCT05590286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92868265|NCT05590286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868266|NCT05590286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868267|NCT05580029|Triamcinolone|triamcinolone|mesh-list
92868268|NCT05580029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868269|NCT05580029|Glucocorticoids|glucocorticoids|mesh-ancestor
92868270|NCT05580029|Hormones|hormones|mesh-ancestor
92868271|NCT05580029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868272|NCT05580029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868273|NCT03724994|Paclitaxel|paclitaxel|mesh-list
92868274|NCT03724994|Gemcitabine|gemcitabine|mesh-list
92868275|NCT03724994|Fluorouracil|fluorouracil|mesh-list
92868276|NCT03724994|Folfirinox|folfirinox|mesh-list
92868277|NCT03724994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92868278|NCT03724994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868279|NCT03724994|Tubulin Modulators|tubulin modulators|mesh-ancestor
92868280|NCT03724994|Antimitotic Agents|antimitotic agents|mesh-ancestor
92868281|NCT03724994|Mitosis Modulators|mitosis modulators|mesh-ancestor
92868282|NCT03724994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868283|NCT03724994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92868284|NCT03724994|Antimetabolites|antimetabolites|mesh-ancestor
92868285|NCT03724994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868286|NCT03724994|Immunologic Factors|immunologic factors|mesh-ancestor
92868287|NCT03724994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868288|NCT02735330|Ethanol|ethanol|mesh-list
92868289|NCT02735330|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92868290|NCT02735330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868291|NCT02735330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868292|NCT02735330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868293|NCT02631941|Budesonide|budesonide|mesh-list
92868294|NCT02631941|Formoterol Fumarate|formoterol fumarate|mesh-list
92868295|NCT02631941|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92868296|NCT02631941|Charcoal|charcoal|mesh-list
92868297|NCT02631941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868298|NCT02631941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92868299|NCT02631941|Autonomic Agents|autonomic agents|mesh-ancestor
92868300|NCT02631941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868301|NCT02631941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868302|NCT02631941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92868303|NCT02631941|Respiratory System Agents|respiratory system agents|mesh-ancestor
92868304|NCT02631941|Glucocorticoids|glucocorticoids|mesh-ancestor
92868305|NCT02631941|Hormones|hormones|mesh-ancestor
92868306|NCT02631941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868307|NCT02631941|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92868308|NCT02631941|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92868309|NCT02631941|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92868310|NCT02631941|Adrenergic Agents|adrenergic agents|mesh-ancestor
92868311|NCT02631941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868312|NCT02631941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868313|NCT02631941|Antidotes|antidotes|mesh-ancestor
92868314|NCT02631941|Protective Agents|protective agents|mesh-ancestor
92868315|NCT02690987|Exenatide|exenatide|mesh-list
92868316|NCT02690987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868317|NCT02690987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868318|NCT02690987|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92868319|NCT02690987|Incretins|incretins|mesh-ancestor
92868320|NCT02690987|Hormones|hormones|mesh-ancestor
92868321|NCT02690987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868322|NCT02740166|Propranolol|propranolol|mesh-list
92868323|NCT02740166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92868324|NCT02740166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92868325|NCT02740166|Adrenergic Agents|adrenergic agents|mesh-ancestor
92868326|NCT02740166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868327|NCT02740166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868328|NCT02740166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868329|NCT02740166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92868330|NCT02740166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92868331|NCT02740166|Vasodilator Agents|vasodilator agents|mesh-ancestor
92868332|NCT02735018|Epinephrine|epinephrine|mesh-list
92868333|NCT02735018|Racepinephrine|racepinephrine|mesh-list
92868334|NCT02735018|Epinephryl borate|epinephryl borate|mesh-list
92868335|NCT02735018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92868336|NCT02735018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92868337|NCT02735018|Adrenergic Agents|adrenergic agents|mesh-ancestor
92868338|NCT02735018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868339|NCT02735018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868340|NCT02735018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868341|NCT02735018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92868342|NCT02735018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92868343|NCT02735018|Autonomic Agents|autonomic agents|mesh-ancestor
92868344|NCT02735018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868345|NCT02735018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92868346|NCT02735018|Respiratory System Agents|respiratory system agents|mesh-ancestor
92868347|NCT02735018|Mydriatics|mydriatics|mesh-ancestor
92868348|NCT02735018|Sympathomimetics|sympathomimetics|mesh-ancestor
92868349|NCT02735018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92868350|NCT00908375|Pregabalin|pregabalin|mesh-list
92868351|NCT00908375|Analgesics|analgesics|mesh-ancestor
92868352|NCT00908375|Sensory System Agents|sensory system agents|mesh-ancestor
92868353|NCT00908375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868354|NCT00908375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868355|NCT00908375|Anticonvulsants|anticonvulsants|mesh-ancestor
92868356|NCT00908375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92868357|NCT00908375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868358|NCT00908375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868359|NCT00908375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92868360|NCT00908375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92868361|NCT00908375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92868362|NCT00908375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868363|NCT00908375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92868364|NCT04247867|Psyllium|psyllium|mesh-list
92868365|NCT04247867|Cathartics|cathartics|mesh-ancestor
92868366|NCT04247867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868367|NCT02731664|Glucagon|glucagon|mesh-list
92868368|NCT02731664|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92868369|NCT02731664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868370|NCT02731664|Hormones|hormones|mesh-ancestor
92868371|NCT02731664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868372|NCT02731664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868373|NCT02731664|Incretins|incretins|mesh-ancestor
92868374|NCT02543255|Prednisone|prednisone|mesh-list
92868375|NCT02543255|Leuprolide|leuprolide|mesh-list
92868376|NCT02543255|Abiraterone Acetate|abiraterone acetate|mesh-list
92868377|NCT02543255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868378|NCT02543255|Glucocorticoids|glucocorticoids|mesh-ancestor
92868379|NCT02543255|Hormones|hormones|mesh-ancestor
92868380|NCT02543255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156711|NCT03707951|Antiviral Agents|antiviral agents|mesh-ancestor
92868381|NCT02543255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868382|NCT02543255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868383|NCT02543255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868384|NCT02543255|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92868385|NCT02543255|Fertility Agents|fertility agents|mesh-ancestor
92868386|NCT02543255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92868387|NCT02543255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92868388|NCT02543255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868389|NCT02543255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868390|NCT02543255|Hormone Antagonists|hormone antagonists|mesh-ancestor
92868391|NCT02543255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92868392|NCT02695004|Donepezil|donepezil|mesh-list
92868393|NCT02695004|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92868394|NCT02695004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868395|NCT02695004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868396|NCT02695004|Cholinergic Agents|cholinergic agents|mesh-ancestor
92868397|NCT02695004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868398|NCT02695004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868399|NCT02695004|Nootropic Agents|nootropic agents|mesh-ancestor
92868400|NCT00909389|Simvastatin|simvastatin|mesh-list
92868401|NCT00909389|Ezetimibe|ezetimibe|mesh-list
92868402|NCT00909389|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92868403|NCT00909389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92868404|NCT00909389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92868405|NCT00909389|Antimetabolites|antimetabolites|mesh-ancestor
92868406|NCT00909389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868407|NCT00909389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92868408|NCT00909389|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92868409|NCT00909389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868410|NCT00910715|Doxycycline|doxycycline|mesh-list
92868411|NCT00910715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868412|NCT00910715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868413|NCT00910715|Antimalarials|antimalarials|mesh-ancestor
92868414|NCT00910715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92868415|NCT00910715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92868416|NCT02731430|Morphine|morphine|mesh-list
92868417|NCT02731430|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92868418|NCT02731430|Narcotics|narcotics|mesh-ancestor
92868419|NCT02731430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868420|NCT02731430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868421|NCT02731430|Analgesics|analgesics|mesh-ancestor
92868422|NCT02731430|Sensory System Agents|sensory system agents|mesh-ancestor
92868423|NCT02731430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868424|NCT04232969|Exenatide|exenatide|mesh-list
92868425|NCT04232969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868426|NCT04232969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868427|NCT04232969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92868428|NCT04232969|Incretins|incretins|mesh-ancestor
92868429|NCT04232969|Hormones|hormones|mesh-ancestor
92868430|NCT04232969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868431|NCT03364868|Insulin|insulin|mesh-list
92868432|NCT03364868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868433|NCT03364868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868434|NCT03695510|Pembrolizumab|pembrolizumab|mesh-list
92868435|NCT03695510|Afatinib|afatinib|mesh-list
92868436|NCT03695510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868437|NCT03695510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868438|NCT03695510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92868439|NCT03695510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868440|NCT03695510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92868441|NCT03695510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868442|NCT02731040|Ibandronic Acid|ibandronic acid|mesh-list
92868443|NCT02731040|Zoledronic Acid|zoledronic acid|mesh-list
92868444|NCT02731040|Diphosphonates|diphosphonates|mesh-list
92868445|NCT02731040|Etidronic Acid|etidronic acid|mesh-list
92868446|NCT02731040|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92868447|NCT02731040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868448|NCT02734160|Durvalumab|durvalumab|mesh-list
92868449|NCT02734160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868450|NCT02734160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868451|NCT02730572|Methylphenidate|methylphenidate|mesh-list
92868452|NCT02730572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92868453|NCT02730572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868454|NCT02730572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92868455|NCT02730572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92868456|NCT02730572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868457|NCT02730572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868458|NCT02730572|Dopamine Agents|dopamine agents|mesh-ancestor
92868459|NCT02730572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868460|NCT04225988|Tacrolimus|tacrolimus|mesh-list
92868461|NCT04225988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868462|NCT04225988|Immunologic Factors|immunologic factors|mesh-ancestor
92868463|NCT04225988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868464|NCT04225988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92868465|NCT04225988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868466|NCT04225988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868467|NCT02730026|Ketoprofen|ketoprofen|mesh-list
92868468|NCT02730026|Omeprazole|omeprazole|mesh-list
92868469|NCT02730026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92868470|NCT02730026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868471|NCT02730026|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92868472|NCT02730026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868473|NCT02730026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868474|NCT02730026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92868475|NCT02730026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92868476|NCT02730026|Analgesics|analgesics|mesh-ancestor
92868477|NCT02730026|Sensory System Agents|sensory system agents|mesh-ancestor
92868478|NCT02730026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868479|NCT02730026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868480|NCT02730026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868481|NCT02730026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868482|NCT02730026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92868483|NCT02738918|Abatacept|abatacept|mesh-list
92868484|NCT02738918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92868485|NCT02738918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868486|NCT02738918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868487|NCT02738918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868488|NCT02738918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868489|NCT02738918|Immunologic Factors|immunologic factors|mesh-ancestor
92868490|NCT02738918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868491|NCT02738918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868492|NCT03195374|Analgesics, Opioid|analgesics, opioid|mesh-list
92868493|NCT03195374|Narcotics|narcotics|mesh-ancestor
92868494|NCT03195374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868495|NCT03195374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868496|NCT03195374|Analgesics|analgesics|mesh-ancestor
92868497|NCT03195374|Sensory System Agents|sensory system agents|mesh-ancestor
92868498|NCT03195374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868499|NCT02739386|Ipilimumab|ipilimumab|mesh-list
92868500|NCT02739386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868501|NCT02739386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868502|NCT02739386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92868503|NCT02739386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868504|NCT00636428|Midazolam|midazolam|mesh-list
92868505|NCT00636428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92868506|NCT00636428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92868507|NCT00636428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868508|NCT00636428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868509|NCT00636428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92868510|NCT00636428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92868511|NCT00636428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92868512|NCT00636428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92868513|NCT00636428|Anesthetics, General|anesthetics, general|mesh-ancestor
92868514|NCT00636428|Anesthetics|anesthetics|mesh-ancestor
92868515|NCT00636428|GABA Modulators|gaba modulators|mesh-ancestor
92868516|NCT00636428|GABA Agents|gaba agents|mesh-ancestor
92868517|NCT00636428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868518|NCT00636428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868519|NCT02729870|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92868520|NCT02729870|Laxatives|laxatives|mesh-ancestor
92868521|NCT02729870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868522|NCT05628662|Insulin|insulin|mesh-list
92868523|NCT05628662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868524|NCT05628662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868525|NCT02694848|Aspirin|aspirin|mesh-list
92868526|NCT02694848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92868527|NCT02694848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92868528|NCT02694848|Analgesics|analgesics|mesh-ancestor
92868529|NCT02694848|Sensory System Agents|sensory system agents|mesh-ancestor
92868530|NCT02694848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868531|NCT02694848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868532|NCT02694848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868533|NCT02694848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868534|NCT02694848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92868535|NCT02694848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92868536|NCT02694848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868537|NCT02694848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92868538|NCT02694848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92868539|NCT02694848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868540|NCT02694848|Antipyretics|antipyretics|mesh-ancestor
92868541|NCT02729324|Protective Agents|protective agents|mesh-list
92868542|NCT02729324|Radiation-Protective Agents|radiation-protective agents|mesh-list
92868543|NCT02729324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868544|NCT02733458|Dexamethasone|dexamethasone|mesh-list
92868545|NCT02733458|Gemcitabine|gemcitabine|mesh-list
92868546|NCT02733458|Etoposide|etoposide|mesh-list
92868547|NCT02733458|Pegaspargase|pegaspargase|mesh-list
92868548|NCT02733458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868549|NCT02733458|Antiemetics|antiemetics|mesh-ancestor
92868550|NCT02733458|Autonomic Agents|autonomic agents|mesh-ancestor
92868551|NCT02733458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868552|NCT02733458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868553|NCT02733458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868554|NCT02733458|Glucocorticoids|glucocorticoids|mesh-ancestor
92868555|NCT02733458|Hormones|hormones|mesh-ancestor
92868556|NCT02733458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868557|NCT02733458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868558|NCT02733458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868559|NCT02733458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868560|NCT02733458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868561|NCT02733458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92868562|NCT02733458|Antimetabolites|antimetabolites|mesh-ancestor
92868563|NCT02733458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92868564|NCT02733458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525232|NCT00000248|Pergolide|pergolide|mesh-list
92868565|NCT02733458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92868566|NCT03658772|Pembrolizumab|pembrolizumab|mesh-list
92868567|NCT03658772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868568|NCT03658772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868569|NCT03658772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92868570|NCT03658772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868571|NCT02729012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92868572|NCT02728856|Sunscreening Agents|sunscreening agents|mesh-list
92868573|NCT02728856|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92868574|NCT02728856|Protective Agents|protective agents|mesh-ancestor
92868575|NCT02728856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868576|NCT02728856|Dermatologic Agents|dermatologic agents|mesh-ancestor
92868577|NCT02728934|Infliximab|infliximab|mesh-list
92868578|NCT02728934|Golimumab|golimumab|mesh-list
92868579|NCT02728934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92868580|NCT02728934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868581|NCT02728934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92868582|NCT02728934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868583|NCT02728934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868584|NCT02728934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868585|NCT02728934|Immunologic Factors|immunologic factors|mesh-ancestor
92868586|NCT02728934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868587|NCT04179500|Moxifloxacin|moxifloxacin|mesh-list
92868588|NCT04179500|Pyrazinamide|pyrazinamide|mesh-list
92868589|NCT04179500|Bedaquiline|bedaquiline|mesh-list
92868590|NCT04179500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868591|NCT04179500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868592|NCT04179500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92868593|NCT04179500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92868594|NCT04179500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868595|NCT04179500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868596|NCT04179500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868597|NCT04179500|Antitubercular Agents|antitubercular agents|mesh-ancestor
92868598|NCT02728700|Mycophenolic Acid|mycophenolic acid|mesh-list
92868599|NCT02728700|Sirolimus|sirolimus|mesh-list
92868600|NCT02728700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92868601|NCT02728700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868602|NCT02728700|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92868603|NCT02728700|Antitubercular Agents|antitubercular agents|mesh-ancestor
92868604|NCT02728700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868605|NCT02728700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868606|NCT02728700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868607|NCT02728700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868608|NCT02728700|Antifungal Agents|antifungal agents|mesh-ancestor
92868609|NCT02728700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868610|NCT02728700|Immunologic Factors|immunologic factors|mesh-ancestor
92868611|NCT02728700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868612|NCT02728622|Tamoxifen|tamoxifen|mesh-list
92868613|NCT02728622|Paclitaxel|paclitaxel|mesh-list
92868614|NCT02728622|Doxorubicin|doxorubicin|mesh-list
92868615|NCT02728622|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92868616|NCT02728622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92868617|NCT02728622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868618|NCT02728622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92868619|NCT02728622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92868620|NCT02728622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92868621|NCT02728622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868622|NCT02728622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92868623|NCT02728622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92868624|NCT02728622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92868626|NCT02728622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92868627|NCT02728622|Hormone Antagonists|hormone antagonists|mesh-ancestor
92868628|NCT02728622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868629|NCT02728622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868630|NCT02728622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868631|NCT02728622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92868632|NCT02728622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92868633|NCT02728622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92868634|NCT02728466|Proanthocyanidin|proanthocyanidin|mesh-list
92868635|NCT02728466|Procyanidin|procyanidin|mesh-list
92868636|NCT02728466|Antioxidants|antioxidants|mesh-ancestor
92868637|NCT02728466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868638|NCT02728466|Protective Agents|protective agents|mesh-ancestor
92868639|NCT02728466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868641|NCT02728466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92868642|NCT02728466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868643|NCT02733380|Thalidomide|thalidomide|mesh-list
92868644|NCT02733380|Dexamethasone|dexamethasone|mesh-list
92868645|NCT02733380|Doxorubicin|doxorubicin|mesh-list
92868646|NCT02733380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92868647|NCT02733380|Vinorelbine|vinorelbine|mesh-list
92868648|NCT02733380|Mitoxantrone|mitoxantrone|mesh-list
92868649|NCT02733380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868650|NCT02733380|Antiemetics|antiemetics|mesh-ancestor
92868651|NCT02733380|Autonomic Agents|autonomic agents|mesh-ancestor
92868652|NCT02733380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868653|NCT02733380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868654|NCT02733380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868655|NCT02733380|Glucocorticoids|glucocorticoids|mesh-ancestor
92868656|NCT02733380|Hormones|hormones|mesh-ancestor
92868657|NCT02733380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868658|NCT02733380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868659|NCT02733380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868660|NCT02733380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92868661|NCT02733380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92868662|NCT02733380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92868663|NCT02733380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868664|NCT02733380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868665|NCT02733380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92868666|NCT02733380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92868667|NCT02733380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92868668|NCT02733380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92868669|NCT02733380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868670|NCT02733380|Immunologic Factors|immunologic factors|mesh-ancestor
92868671|NCT02733380|Leprostatic Agents|leprostatic agents|mesh-ancestor
92868672|NCT02733380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868673|NCT02733380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868674|NCT02733380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92868675|NCT02733380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92868676|NCT02733380|Growth Substances|growth substances|mesh-ancestor
92868677|NCT02733380|Growth Inhibitors|growth inhibitors|mesh-ancestor
92868678|NCT02733380|Analgesics|analgesics|mesh-ancestor
92868679|NCT02733380|Sensory System Agents|sensory system agents|mesh-ancestor
92868680|NCT02737670|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92868681|NCT02737670|Anticoagulants|anticoagulants|mesh-ancestor
92868682|NCT02737670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92868683|NCT02737670|Antimetabolites|antimetabolites|mesh-ancestor
92868684|NCT02737670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868685|NCT02737670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92868686|NCT02737670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92868687|NCT02737670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92868688|NCT02737670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868689|NCT02737670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868690|NCT02728310|Levobupivacaine|levobupivacaine|mesh-list
92868691|NCT02728310|Anesthetics, Local|anesthetics, local|mesh-ancestor
92868692|NCT02728310|Anesthetics|anesthetics|mesh-ancestor
92868693|NCT02728310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92513902|NCT00005942|Daunorubicin|daunorubicin|mesh-list
92868694|NCT02728310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868695|NCT02728310|Sensory System Agents|sensory system agents|mesh-ancestor
92868696|NCT02728310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868697|NCT00636584|Nitroprusside|nitroprusside|mesh-list
92868698|NCT00636584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92868699|NCT00636584|Vasodilator Agents|vasodilator agents|mesh-ancestor
92868700|NCT00636584|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92868701|NCT00636584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868702|NCT02732756|Oxymetazoline|oxymetazoline|mesh-list
92868703|NCT02732756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92868704|NCT02732756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92868705|NCT02732756|Adrenergic Agents|adrenergic agents|mesh-ancestor
92868706|NCT02732756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868707|NCT02732756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868708|NCT02732756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868709|NCT02732756|Sympathomimetics|sympathomimetics|mesh-ancestor
92868710|NCT02732756|Autonomic Agents|autonomic agents|mesh-ancestor
92868711|NCT02732756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868712|NCT02732756|Nasal Decongestants|nasal decongestants|mesh-ancestor
92868713|NCT02732756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92868714|NCT02732756|Respiratory System Agents|respiratory system agents|mesh-ancestor
92868715|NCT02732522|Misoprostol|misoprostol|mesh-list
92868716|NCT02732522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92868717|NCT02732522|Abortifacient Agents|abortifacient agents|mesh-ancestor
92868718|NCT02732522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92868719|NCT02732522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868720|NCT02732522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92868721|NCT02732522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868722|NCT02732522|Oxytocics|oxytocics|mesh-ancestor
92868723|NCT02732678|Propranolol|propranolol|mesh-list
92868724|NCT02732678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92868725|NCT02732678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92868726|NCT02732678|Adrenergic Agents|adrenergic agents|mesh-ancestor
92868727|NCT02732678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868728|NCT02732678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868729|NCT02732678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868730|NCT02732678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92868731|NCT02732678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92868732|NCT02732678|Vasodilator Agents|vasodilator agents|mesh-ancestor
92868733|NCT02727608|Eculizumab|eculizumab|mesh-list
92868734|NCT02727608|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92868735|NCT02727608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868736|NCT02727608|Immunologic Factors|immunologic factors|mesh-ancestor
92868737|NCT02727608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868738|NCT02727296|Propofol|propofol|mesh-list
92868739|NCT02727296|Sevoflurane|sevoflurane|mesh-list
92868740|NCT02727296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92868741|NCT02727296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868742|NCT02727296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868743|NCT02727296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92868744|NCT02727296|Anesthetics, General|anesthetics, general|mesh-ancestor
92868745|NCT02727296|Anesthetics|anesthetics|mesh-ancestor
92868746|NCT02727296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92868747|NCT02727296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92868748|NCT02732132|Fentanyl|fentanyl|mesh-list
92868749|NCT02732132|Midazolam|midazolam|mesh-list
92868750|NCT02732132|Ketamine|ketamine|mesh-list
92868751|NCT02732132|Propofol|propofol|mesh-list
92868752|NCT02732132|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92868753|NCT02732132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868754|NCT02732132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868755|NCT02732132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92868756|NCT02732132|Anesthetics, General|anesthetics, general|mesh-ancestor
92868757|NCT02732132|Anesthetics|anesthetics|mesh-ancestor
92868758|NCT02732132|Analgesics|analgesics|mesh-ancestor
92868759|NCT02732132|Sensory System Agents|sensory system agents|mesh-ancestor
92868760|NCT02732132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868761|NCT02732132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92868762|NCT02732132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92868763|NCT02732132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92868764|NCT02732132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868765|NCT02732132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868766|NCT02732132|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92868767|NCT02732132|Narcotics|narcotics|mesh-ancestor
92868768|NCT02732132|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92868769|NCT02732132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92868770|NCT02732132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92868771|NCT02732132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92868772|NCT02732132|GABA Modulators|gaba modulators|mesh-ancestor
92868773|NCT02732132|GABA Agents|gaba agents|mesh-ancestor
92868774|NCT02737202|Saracatinib|saracatinib|mesh-list
92868775|NCT02737202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868776|NCT02737202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868777|NCT02737202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868778|NCT02721368|Lidocaine|lidocaine|mesh-list
92868779|NCT02721368|Anesthetics, Local|anesthetics, local|mesh-ancestor
92868780|NCT02721368|Anesthetics|anesthetics|mesh-ancestor
92868781|NCT02721368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868782|NCT02721368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868783|NCT02721368|Sensory System Agents|sensory system agents|mesh-ancestor
92868784|NCT02721368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868785|NCT02721368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92868786|NCT02721368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92868787|NCT02721368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92868788|NCT02721368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868789|NCT02721368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868791|NCT02737124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92868792|NCT02737124|Analgesics|analgesics|mesh-ancestor
92868793|NCT02737124|Sensory System Agents|sensory system agents|mesh-ancestor
92868794|NCT02737124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868795|NCT02737124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868796|NCT02737124|Antipyretics|antipyretics|mesh-ancestor
92868797|NCT02721290|Ropivacaine|ropivacaine|mesh-list
92868798|NCT02721290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92868799|NCT02721290|Anesthetics|anesthetics|mesh-ancestor
92868800|NCT02721290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868801|NCT02721290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156740|NCT03692663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868802|NCT02721290|Sensory System Agents|sensory system agents|mesh-ancestor
92868803|NCT02721290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868804|NCT02720978|Oxytocin|oxytocin|mesh-list
92868805|NCT02720978|Oxytocics|oxytocics|mesh-ancestor
92868806|NCT02720978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92868807|NCT02720978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868808|NCT02726984|Listerine|listerine|mesh-list
92868809|NCT02726984|Fluorides|fluorides|mesh-list
92868810|NCT02726984|Sodium Fluoride|sodium fluoride|mesh-list
92868811|NCT02726984|Cariostatic Agents|cariostatic agents|mesh-ancestor
92868812|NCT02726984|Protective Agents|protective agents|mesh-ancestor
92868813|NCT02726984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868814|NCT02726984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92868815|NCT02726984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868816|NCT02726828|Ketamine|ketamine|mesh-list
92868817|NCT02726828|Morphine|morphine|mesh-list
92868818|NCT02726828|Analgesics|analgesics|mesh-ancestor
92868819|NCT02726828|Sensory System Agents|sensory system agents|mesh-ancestor
92868820|NCT02726828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868821|NCT02726828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868822|NCT02726828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92868823|NCT02726828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92868824|NCT02726828|Anesthetics, General|anesthetics, general|mesh-ancestor
92868825|NCT02726828|Anesthetics|anesthetics|mesh-ancestor
92868826|NCT02726828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868827|NCT02726828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92868828|NCT02726828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92868829|NCT02726828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868830|NCT02726828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868831|NCT02726828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92868832|NCT02726828|Narcotics|narcotics|mesh-ancestor
92868833|NCT02799134|Dexamethasone|dexamethasone|mesh-list
92868834|NCT02799134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868835|NCT02799134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868836|NCT02799134|Antiemetics|antiemetics|mesh-ancestor
92868837|NCT02799134|Autonomic Agents|autonomic agents|mesh-ancestor
92868838|NCT02799134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868839|NCT02799134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868840|NCT02799134|Glucocorticoids|glucocorticoids|mesh-ancestor
92868841|NCT02799134|Hormones|hormones|mesh-ancestor
92868842|NCT02799134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868843|NCT02799134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868844|NCT02799134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868845|NCT02720822|Morphine|morphine|mesh-list
92868846|NCT02720822|Laxatives|laxatives|mesh-list
92868848|NCT02720822|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92868849|NCT02720822|Narcotics|narcotics|mesh-ancestor
92868850|NCT02720822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868851|NCT02720822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868852|NCT02720822|Analgesics|analgesics|mesh-ancestor
92868853|NCT02720822|Sensory System Agents|sensory system agents|mesh-ancestor
92868854|NCT02720822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868855|NCT02720822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868856|NCT02757872|Vitamin D|vitamin d|mesh-list
92868857|NCT02757872|Ergocalciferols|ergocalciferols|mesh-list
92868858|NCT02757872|Cholecalciferol|cholecalciferol|mesh-list
92868859|NCT02757872|Vitamins|vitamins|mesh-list
92868860|NCT02757872|Micronutrients|micronutrients|mesh-ancestor
92868861|NCT02757872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868862|NCT02757872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92868863|NCT02757872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92868865|NCT02746796|Tegafur|tegafur|mesh-list
92868866|NCT02746796|Oxaliplatin|oxaliplatin|mesh-list
92868867|NCT02746796|Nivolumab|nivolumab|mesh-list
92868868|NCT02746796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92868869|NCT02746796|Antimetabolites|antimetabolites|mesh-ancestor
92868870|NCT02746796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868871|NCT02746796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868872|NCT02746796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92868873|NCT02746796|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92868874|NCT04167176|Lidocaine|lidocaine|mesh-list
92868875|NCT04167176|Bupivacaine|bupivacaine|mesh-list
92868876|NCT04167176|Anesthetics, Local|anesthetics, local|mesh-ancestor
92868877|NCT04167176|Anesthetics|anesthetics|mesh-ancestor
92868878|NCT04167176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868879|NCT04167176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868880|NCT04167176|Sensory System Agents|sensory system agents|mesh-ancestor
92868881|NCT04167176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868882|NCT04167176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92868883|NCT04167176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92868884|NCT04167176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92868885|NCT04167176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868886|NCT04167176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868887|NCT02720120|Ocrelizumab|ocrelizumab|mesh-list
92868888|NCT02720120|Immunologic Factors|immunologic factors|mesh-ancestor
92868889|NCT02720120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868890|NCT04189250|Carbon Monoxide|carbon monoxide|mesh-list
92868891|NCT04189250|Antimetabolites|antimetabolites|mesh-ancestor
92868892|NCT04189250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868893|NCT04189250|Gasotransmitters|gasotransmitters|mesh-ancestor
92868894|NCT04189250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92868895|NCT04189250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868896|NCT02726126|Fentanyl|fentanyl|mesh-list
92868897|NCT02726126|Melatonin|melatonin|mesh-list
92868898|NCT02726126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92868899|NCT02726126|Narcotics|narcotics|mesh-ancestor
92868900|NCT02726126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868901|NCT02726126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868902|NCT02726126|Analgesics|analgesics|mesh-ancestor
92868903|NCT02726126|Sensory System Agents|sensory system agents|mesh-ancestor
92868904|NCT02726126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92868905|NCT02726126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92868906|NCT02726126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92868907|NCT02726126|Anesthetics, General|anesthetics, general|mesh-ancestor
92868908|NCT02726126|Anesthetics|anesthetics|mesh-ancestor
92868909|NCT02726126|Antioxidants|antioxidants|mesh-ancestor
92868910|NCT02726126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868911|NCT02726126|Protective Agents|protective agents|mesh-ancestor
92868912|NCT02694458|Vancomycin|vancomycin|mesh-list
92868913|NCT02694458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868914|NCT02694458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868915|NCT02719808|Tenofovir|tenofovir|mesh-list
92868916|NCT02719808|Antiviral Agents|antiviral agents|mesh-ancestor
92868917|NCT02719808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868918|NCT02719808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92868919|NCT02719808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92868920|NCT02719808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868921|NCT02719808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868922|NCT02719808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92868923|NCT02719808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92868924|NCT02719418|Tinzaparin|tinzaparin|mesh-list
92868925|NCT02719418|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92868926|NCT02719418|Dalteparin|dalteparin|mesh-list
92868927|NCT02719418|Anticoagulants|anticoagulants|mesh-ancestor
92868928|NCT02719418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92868929|NCT02719418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92868930|NCT02719418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868931|NCT02129348|Lithium Carbonate|lithium carbonate|mesh-list
92868932|NCT02129348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92868933|NCT02129348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92868934|NCT02129348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868935|NCT02129348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868936|NCT02129348|Antimanic Agents|antimanic agents|mesh-ancestor
92868937|NCT02129348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92868938|NCT02129348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92868940|NCT02725736|Nifedipine|nifedipine|mesh-list
92868941|NCT02725736|Atosiban|atosiban|mesh-list
92868942|NCT02725736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92868943|NCT02725736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92868944|NCT02725736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868945|NCT02725736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92868946|NCT02725736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868947|NCT02725736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92868948|NCT02725736|Tocolytic Agents|tocolytic agents|mesh-ancestor
92868949|NCT02725736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92868950|NCT02725736|Hormone Antagonists|hormone antagonists|mesh-ancestor
92868951|NCT02725736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868952|NCT02716142|Misoprostol|misoprostol|mesh-list
92868953|NCT02716142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92868954|NCT02716142|Abortifacient Agents|abortifacient agents|mesh-ancestor
92868955|NCT02716142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92868956|NCT02716142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868957|NCT02716142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92868958|NCT02716142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92868959|NCT02716142|Oxytocics|oxytocics|mesh-ancestor
92868960|NCT03015974|Mycophenolic Acid|mycophenolic acid|mesh-list
92868961|NCT03015974|Prednisone|prednisone|mesh-list
92868962|NCT03015974|Prednisolone|prednisolone|mesh-list
92868963|NCT03015974|Deflazacort|deflazacort|mesh-list
92868964|NCT03015974|Cyclophosphamide|cyclophosphamide|mesh-list
92868965|NCT03015974|Dipyridamole|dipyridamole|mesh-list
92868966|NCT03015974|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92868967|NCT03015974|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92868968|NCT03015974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92868969|NCT03015974|Immunologic Factors|immunologic factors|mesh-ancestor
92868970|NCT03015974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868971|NCT03015974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92868972|NCT03015974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92868973|NCT03015974|Alkylating Agents|alkylating agents|mesh-ancestor
92868974|NCT03015974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92868975|NCT03015974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92868976|NCT03015974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92868977|NCT03015974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92868978|NCT03015974|Glucocorticoids|glucocorticoids|mesh-ancestor
92868979|NCT03015974|Hormones|hormones|mesh-ancestor
92868980|NCT03015974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868981|NCT03015974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92868982|NCT03015974|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92868983|NCT03015974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92868984|NCT03015974|Antitubercular Agents|antitubercular agents|mesh-ancestor
92868985|NCT03015974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92868986|NCT03015974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92868987|NCT03015974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92868988|NCT03015974|Protease Inhibitors|protease inhibitors|mesh-ancestor
92868989|NCT03015974|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92868990|NCT03015974|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92868991|NCT03015974|Vasodilator Agents|vasodilator agents|mesh-ancestor
92868992|NCT02718950|Liraglutide|liraglutide|mesh-list
92868993|NCT02718950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92868994|NCT02718950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92868995|NCT02718950|Incretins|incretins|mesh-ancestor
92868996|NCT02718950|Hormones|hormones|mesh-ancestor
92514207|NCT00014209|Dexamethasone|dexamethasone|mesh-list
92868997|NCT02718950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92868999|NCT02725502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869000|NCT02725502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869001|NCT02725502|Incretins|incretins|mesh-ancestor
92869002|NCT02725502|Hormones|hormones|mesh-ancestor
92869003|NCT02725502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869004|NCT02725502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92869005|NCT02725502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92869006|NCT02725502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869007|NCT02725502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869008|NCT02718716|Rozanolixizumab|rozanolixizumab|mesh-list
92869009|NCT02718716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869010|NCT02718716|Immunologic Factors|immunologic factors|mesh-ancestor
92869011|NCT02718716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869013|NCT01959464|Progestins|progestins|mesh-ancestor
92869015|NCT01959464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869016|NCT01959464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869017|NCT02718482|Gemcitabine|gemcitabine|mesh-list
92869018|NCT02718482|Docetaxel|docetaxel|mesh-list
92869019|NCT02718482|Ifosfamide|ifosfamide|mesh-list
92869020|NCT02718482|Isophosphamide mustard|isophosphamide mustard|mesh-list
92869021|NCT02718482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869022|NCT02718482|Antimetabolites|antimetabolites|mesh-ancestor
92869023|NCT02718482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869024|NCT02718482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869025|NCT02718482|Tubulin Modulators|tubulin modulators|mesh-ancestor
92869026|NCT02718482|Antimitotic Agents|antimitotic agents|mesh-ancestor
92869027|NCT02718482|Mitosis Modulators|mitosis modulators|mesh-ancestor
92869028|NCT02718482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869029|NCT02718482|Alkylating Agents|alkylating agents|mesh-ancestor
92869030|NCT01921166|Leuprolide|leuprolide|mesh-list
92869031|NCT01921166|Clomiphene|clomiphene|mesh-list
92869032|NCT01921166|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92869033|NCT01921166|Fertility Agents|fertility agents|mesh-ancestor
92869034|NCT01921166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92869035|NCT01921166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869036|NCT01921166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92869037|NCT01921166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869038|NCT01921166|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92869039|NCT01921166|Hormone Antagonists|hormone antagonists|mesh-ancestor
92869040|NCT01921166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869041|NCT01921166|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92869042|NCT01921166|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92869043|NCT05087030|Denosumab|denosumab|mesh-list
92869044|NCT05087030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92869045|NCT05087030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869046|NCT02717858|Liraglutide|liraglutide|mesh-list
92869047|NCT02717858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869048|NCT02717858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869049|NCT02717858|Incretins|incretins|mesh-ancestor
92869050|NCT02717858|Hormones|hormones|mesh-ancestor
92869051|NCT02717858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869052|NCT02725112|Pregabalin|pregabalin|mesh-list
92869053|NCT02725112|Analgesics|analgesics|mesh-ancestor
92869054|NCT02725112|Sensory System Agents|sensory system agents|mesh-ancestor
92869055|NCT02725112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869056|NCT02725112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869057|NCT02725112|Anticonvulsants|anticonvulsants|mesh-ancestor
92869058|NCT02725112|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92869059|NCT02725112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869060|NCT02725112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869061|NCT02725112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92869062|NCT02725112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92869063|NCT02725112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92869064|NCT02725112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869065|NCT02725112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92869066|NCT02724332|Sirolimus|sirolimus|mesh-list
92869067|NCT02724332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92869068|NCT02724332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869069|NCT02724332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514286|NCT00001332|Cisplatin|cisplatin|mesh-list
92869070|NCT02724332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869071|NCT02724332|Antifungal Agents|antifungal agents|mesh-ancestor
92869072|NCT02724332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869073|NCT02724332|Immunologic Factors|immunologic factors|mesh-ancestor
92869074|NCT02724332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869076|NCT02717780|Remifentanil|remifentanil|mesh-list
92869077|NCT02717780|Sevoflurane|sevoflurane|mesh-list
92869078|NCT02717780|Desflurane|desflurane|mesh-list
92869079|NCT02717780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92869080|NCT02717780|Narcotics|narcotics|mesh-ancestor
92869081|NCT02717780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869082|NCT02717780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869083|NCT02717780|Analgesics|analgesics|mesh-ancestor
92869084|NCT02717780|Sensory System Agents|sensory system agents|mesh-ancestor
92869085|NCT02717780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869086|NCT02717780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92869087|NCT02717780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92869088|NCT02717780|Anesthetics, General|anesthetics, general|mesh-ancestor
92869089|NCT02717780|Anesthetics|anesthetics|mesh-ancestor
92869090|NCT02717780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92869091|NCT02717780|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92869092|NCT02724098|Dexmedetomidine|dexmedetomidine|mesh-list
92869093|NCT02724098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92869094|NCT02724098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869095|NCT02724098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869096|NCT02724098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869097|NCT02724098|Analgesics|analgesics|mesh-ancestor
92869098|NCT02724098|Sensory System Agents|sensory system agents|mesh-ancestor
92869099|NCT02724098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869100|NCT02724098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92869101|NCT02724098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92869102|NCT02724098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92869103|NCT02724098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92869104|NCT02724098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869105|NCT02724098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869106|NCT02723942|Immunomodulating Agents|immunomodulating agents|mesh-list
92869107|NCT02723942|Immunologic Factors|immunologic factors|mesh-ancestor
92869108|NCT02723942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869109|NCT04138316|Candesartan|candesartan|mesh-list
92869110|NCT04138316|Candesartan cilexetil|candesartan cilexetil|mesh-list
92869111|NCT04138316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92869112|NCT04138316|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92869113|NCT04138316|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92869114|NCT04138316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869115|NCT05291390|Pyronaridine|pyronaridine|mesh-list
92869116|NCT05291390|Antimalarials|antimalarials|mesh-ancestor
92869117|NCT05291390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92869118|NCT05291390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92869119|NCT05291390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869120|NCT04189484|Evolocumab|evolocumab|mesh-list
92869121|NCT04189484|Alirocumab|alirocumab|mesh-list
92869122|NCT04189484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92869123|NCT04189484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92869124|NCT04189484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92869125|NCT04189484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92869126|NCT04189484|Antimetabolites|antimetabolites|mesh-ancestor
92869127|NCT04189484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869128|NCT04189484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92869129|NCT04189484|Protease Inhibitors|protease inhibitors|mesh-ancestor
92869130|NCT04189484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869131|NCT04189484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92869132|NCT04189484|Immunologic Factors|immunologic factors|mesh-ancestor
92869133|NCT04189484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869134|NCT00636740|Zoledronic Acid|zoledronic acid|mesh-list
92869135|NCT00636740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92869136|NCT00636740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869137|NCT02716766|Capecitabine|capecitabine|mesh-list
92869138|NCT02716766|Oxaliplatin|oxaliplatin|mesh-list
92869139|NCT02716766|Sorafenib|sorafenib|mesh-list
92869140|NCT02716766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869141|NCT02716766|Antimetabolites|antimetabolites|mesh-ancestor
92869142|NCT02716766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869143|NCT02716766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514351|NCT00391690|Zoledronic Acid|zoledronic acid|mesh-list
92869144|NCT02716766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92869145|NCT02716766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869146|NCT02716610|Insulin Lispro|insulin lispro|mesh-list
92869147|NCT02716610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869148|NCT02716610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869150|NCT02694224|Cyclophosphamide|cyclophosphamide|mesh-list
92869151|NCT02694224|Epirubicin|epirubicin|mesh-list
92869152|NCT02694224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92869153|NCT02694224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869154|NCT02694224|Tubulin Modulators|tubulin modulators|mesh-ancestor
92869155|NCT02694224|Antimitotic Agents|antimitotic agents|mesh-ancestor
92869156|NCT02694224|Mitosis Modulators|mitosis modulators|mesh-ancestor
92869157|NCT02694224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869158|NCT02694224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869159|NCT02694224|Immunologic Factors|immunologic factors|mesh-ancestor
92869160|NCT02694224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869161|NCT02694224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869162|NCT02694224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869163|NCT02694224|Alkylating Agents|alkylating agents|mesh-ancestor
92869164|NCT02694224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92869165|NCT02694224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92869166|NCT02694224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92869167|NCT02694224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92869168|NCT02694224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869169|NCT00782288|Digitoxin|digitoxin|mesh-list
92869170|NCT00782288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92869171|NCT00782288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92869172|NCT00782288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156755|NCT03685331|Olaparib|olaparib|mesh-list
92869173|NCT00782288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869174|NCT00782288|Protective Agents|protective agents|mesh-ancestor
92869175|NCT00782288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869176|NCT04189094|Etoposide|etoposide|mesh-list
92869177|NCT04189094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869178|NCT04189094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92869179|NCT04189094|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92869180|NCT04189094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92869181|NCT04189094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869182|NCT04189094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869183|NCT02712944|Testosterone|testosterone|mesh-list
92869184|NCT02712944|Androgens|androgens|mesh-ancestor
92869185|NCT02712944|Hormones|hormones|mesh-ancestor
92869186|NCT02712944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869187|NCT02712944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869188|NCT02712866|Vedolizumab|vedolizumab|mesh-list
92869189|NCT02712866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869190|NCT00600483|Gentamicins|gentamicins|mesh-list
92869191|NCT00600483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92869192|NCT00600483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869193|NCT00600483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92869194|NCT00600483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869195|NCT00600483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869196|NCT04132232|Carbon Monoxide|carbon monoxide|mesh-list
92869197|NCT04132232|Antimetabolites|antimetabolites|mesh-ancestor
92869198|NCT04132232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869199|NCT04132232|Gasotransmitters|gasotransmitters|mesh-ancestor
92869200|NCT04132232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869201|NCT04132232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869202|NCT00649857|Cetirizine|cetirizine|mesh-list
92869203|NCT00649857|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92869204|NCT00649857|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92869205|NCT00649857|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92869206|NCT00649857|Histamine Antagonists|histamine antagonists|mesh-ancestor
92869207|NCT00649857|Histamine Agents|histamine agents|mesh-ancestor
92869208|NCT00649857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869209|NCT00649857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869210|NCT00649857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869211|NCT00764270|Thioctic Acid|thioctic acid|mesh-list
92869212|NCT00764270|Antioxidants|antioxidants|mesh-ancestor
92869213|NCT00764270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869214|NCT00764270|Protective Agents|protective agents|mesh-ancestor
92869215|NCT00764270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869216|NCT00764270|Vitamin B Complex|vitamin b complex|mesh-ancestor
92869217|NCT00764270|Vitamins|vitamins|mesh-ancestor
92869218|NCT00764270|Micronutrients|micronutrients|mesh-ancestor
92869219|NCT00650481|Oxybutynin|oxybutynin|mesh-list
92869220|NCT00650481|Parasympatholytics|parasympatholytics|mesh-ancestor
92869221|NCT00650481|Autonomic Agents|autonomic agents|mesh-ancestor
92869222|NCT00650481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869223|NCT00650481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869224|NCT00650481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92869225|NCT00650481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92869226|NCT00650481|Cholinergic Agents|cholinergic agents|mesh-ancestor
92869227|NCT00650481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869228|NCT00650481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869229|NCT00650481|Urological Agents|urological agents|mesh-ancestor
92869230|NCT02712476|Furosemide|furosemide|mesh-list
92869231|NCT02712476|Mannitol|mannitol|mesh-list
92869232|NCT02712476|Diuretics|diuretics|mesh-ancestor
92869233|NCT02712476|Natriuretic Agents|natriuretic agents|mesh-ancestor
92869234|NCT02712476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869235|NCT02712476|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92869236|NCT02712476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869237|NCT02712476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869238|NCT02712476|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92869239|NCT02722538|Gemcitabine|gemcitabine|mesh-list
92869240|NCT02722538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869241|NCT02722538|Antimetabolites|antimetabolites|mesh-ancestor
92869242|NCT02722538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869243|NCT02722538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869244|NCT02651727|Paclitaxel|paclitaxel|mesh-list
92869245|NCT02651727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92869246|NCT02651727|Gemcitabine|gemcitabine|mesh-list
92869247|NCT02651727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92869248|NCT02651727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869249|NCT02651727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92869250|NCT02651727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92869251|NCT02651727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92869252|NCT02651727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869253|NCT02651727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869254|NCT02651727|Antimetabolites|antimetabolites|mesh-ancestor
92869255|NCT02650791|Tranexamic Acid|tranexamic acid|mesh-list
92869256|NCT02650791|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92869257|NCT02650791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92869258|NCT02650791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869259|NCT02650791|Hemostatics|hemostatics|mesh-ancestor
92869260|NCT02650791|Coagulants|coagulants|mesh-ancestor
92869261|NCT04035668|Remibrutinib|remibrutinib|mesh-list
92869262|NCT04035668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92869263|NCT04035668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869264|NCT04035668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869265|NCT02650713|Atezolizumab|atezolizumab|mesh-list
92869266|NCT02650713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92869267|NCT02650713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869268|NCT02650713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92869269|NCT02650713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869270|NCT02650635|Cyclophosphamide|cyclophosphamide|mesh-list
92869271|NCT02650635|Lenograstim|lenograstim|mesh-list
92869272|NCT02650635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869273|NCT02650635|Immunologic Factors|immunologic factors|mesh-ancestor
92869274|NCT02650635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869275|NCT02650635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869276|NCT02650635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869277|NCT02650635|Alkylating Agents|alkylating agents|mesh-ancestor
92869278|NCT02650635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869279|NCT02650635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869280|NCT02650635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92869281|NCT02650635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92869282|NCT00650637|Calcium, Dietary|calcium, dietary|mesh-list
92869283|NCT00650637|Lamivudine|lamivudine|mesh-list
92869284|NCT00650637|Zidovudine|zidovudine|mesh-list
92869285|NCT00650637|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92869286|NCT00650637|Nelfinavir|nelfinavir|mesh-list
92869287|NCT00650637|Calcium Carbonate|calcium carbonate|mesh-list
92869288|NCT00650637|Loperamide|loperamide|mesh-list
92869289|NCT00650637|Antidiarrheals|antidiarrheals|mesh-list
92869290|NCT00650637|Calcium|calcium|mesh-list
92869291|NCT00650637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92869292|NCT00650637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869293|NCT00650637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92869294|NCT00650637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92869295|NCT00650637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92869296|NCT00650637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869297|NCT00650637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869298|NCT00650637|Antiviral Agents|antiviral agents|mesh-ancestor
92869299|NCT00650637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869300|NCT00650637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92869301|NCT00650637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92869302|NCT00650637|Antimetabolites|antimetabolites|mesh-ancestor
92869303|NCT00650637|Antacids|antacids|mesh-ancestor
92869304|NCT00650637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869305|NCT00650637|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92869306|NCT00650637|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92869308|NCT02650479|Exenatide|exenatide|mesh-list
92869309|NCT02650479|Moxifloxacin|moxifloxacin|mesh-list
92869310|NCT02650479|Palonosetron|palonosetron|mesh-list
92869311|NCT02650479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92869312|NCT02650479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869313|NCT02650479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92869314|NCT02650479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92869315|NCT02650479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869316|NCT02650479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869317|NCT02650479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869318|NCT02650479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869319|NCT02650479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869320|NCT02650479|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92869321|NCT02650479|Incretins|incretins|mesh-ancestor
92869322|NCT02650479|Hormones|hormones|mesh-ancestor
92869323|NCT02650479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869324|NCT02650479|Antiemetics|antiemetics|mesh-ancestor
92869325|NCT02650479|Autonomic Agents|autonomic agents|mesh-ancestor
92869326|NCT02650479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869327|NCT02650479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869328|NCT02650479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92869329|NCT02650479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92869330|NCT02650479|Serotonin Agents|serotonin agents|mesh-ancestor
92869331|NCT02650479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869332|NCT02722772|Etanercept|etanercept|mesh-list
92869333|NCT02722772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92869334|NCT02722772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869335|NCT02722772|Analgesics|analgesics|mesh-ancestor
92869336|NCT02722772|Sensory System Agents|sensory system agents|mesh-ancestor
92869337|NCT02722772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869338|NCT02722772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869339|NCT02722772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869340|NCT02722772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869341|NCT02722772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869342|NCT02722772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869343|NCT02722772|Immunologic Factors|immunologic factors|mesh-ancestor
92869344|NCT02650245|Lactulose|lactulose|mesh-list
92869345|NCT02650245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869346|NCT00650793|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92869347|NCT00650793|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92869348|NCT00650793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92869349|NCT00650793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869350|NCT00650793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869351|NCT00650793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92869352|NCT00650793|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92869353|NCT00650793|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92869354|NCT00650793|Serotonin Agents|serotonin agents|mesh-ancestor
92869355|NCT00650793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869356|NCT00650793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869357|NCT00650793|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92869358|NCT00650793|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92869359|NCT00650793|Dopamine Agents|dopamine agents|mesh-ancestor
92869360|NCT00910767|Insulin|insulin|mesh-list
92869361|NCT00910767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869362|NCT00910767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869363|NCT02722694|Methotrexate|methotrexate|mesh-list
92869364|NCT02722694|Abatacept|abatacept|mesh-list
92869365|NCT02722694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92869366|NCT02722694|Abortifacient Agents|abortifacient agents|mesh-ancestor
92869367|NCT02722694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92869368|NCT02722694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869369|NCT02722694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869370|NCT02722694|Antimetabolites|antimetabolites|mesh-ancestor
92869371|NCT02722694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869372|NCT02722694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869373|NCT02722694|Dermatologic Agents|dermatologic agents|mesh-ancestor
92869374|NCT02722694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869375|NCT02722694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92869376|NCT02722694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869377|NCT02722694|Immunologic Factors|immunologic factors|mesh-ancestor
92869378|NCT02722694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869379|NCT02722694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92869380|NCT02722694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92213944|NCT01721525|Ribavirin|ribavirin|mesh-list
92869381|NCT02722694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92869382|NCT00650871|Casopitant|casopitant|mesh-list
92869383|NCT00650871|Antiemetics|antiemetics|mesh-ancestor
92869384|NCT00650871|Autonomic Agents|autonomic agents|mesh-ancestor
92869385|NCT00650871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869386|NCT00650871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869387|NCT00650871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869388|NCT00650871|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92869389|NCT00650871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869390|NCT00650871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869391|NCT02649621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92869392|NCT02649621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92869393|NCT02649465|Glimepiride|glimepiride|mesh-list
92869394|NCT02649465|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
92869395|NCT02649465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92869396|NCT02649465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869397|NCT02649465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869398|NCT02649465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869399|NCT02649465|Immunologic Factors|immunologic factors|mesh-ancestor
92869400|NCT02649465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92869401|NCT02649465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869402|NCT00651105|Vildagliptin|vildagliptin|mesh-list
92869403|NCT00651105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869404|NCT00651105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869405|NCT00651105|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92869406|NCT00651105|Protease Inhibitors|protease inhibitors|mesh-ancestor
92869407|NCT00651105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869408|NCT00651105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869410|NCT02694146|Viscosupplements|viscosupplements|mesh-ancestor
92869411|NCT02694146|Protective Agents|protective agents|mesh-ancestor
92869412|NCT02694146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869413|NCT04167267|Fexuprazan|fexuprazan|mesh-list
92869414|NCT04167267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869415|NCT02649075|Immunoglobulins|immunoglobulins|mesh-list
92869416|NCT02649075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92869417|NCT02649075|Antibodies|antibodies|mesh-list
92869418|NCT02649075|Immunologic Factors|immunologic factors|mesh-ancestor
92869419|NCT02649075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869420|NCT02644785|Protamines|protamines|mesh-list
92869421|NCT02644785|Heparin Antagonists|heparin antagonists|mesh-ancestor
92869422|NCT02644785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869423|NCT02644785|Coagulants|coagulants|mesh-ancestor
92869424|NCT02644707|Selenium|selenium|mesh-list
92869425|NCT02644707|Antioxidants|antioxidants|mesh-ancestor
92869426|NCT02644707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869427|NCT02644707|Protective Agents|protective agents|mesh-ancestor
92869428|NCT02644707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869429|NCT02644707|Trace Elements|trace elements|mesh-ancestor
92869430|NCT02644707|Micronutrients|micronutrients|mesh-ancestor
92869431|NCT02711228|Immunoglobulins|immunoglobulins|mesh-list
92869432|NCT02711228|Antibodies|antibodies|mesh-list
92869433|NCT02711228|gamma-Globulins|gamma-globulins|mesh-list
92869434|NCT02711228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92869435|NCT02711228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92869436|NCT02711228|Immunologic Factors|immunologic factors|mesh-ancestor
92869437|NCT02711228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869438|NCT02644863|Paclitaxel|paclitaxel|mesh-list
92869439|NCT02644863|Cisplatin|cisplatin|mesh-list
92869440|NCT02644863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92869441|NCT02644863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869442|NCT02644863|Tubulin Modulators|tubulin modulators|mesh-ancestor
92869443|NCT02644863|Antimitotic Agents|antimitotic agents|mesh-ancestor
92869444|NCT02644863|Mitosis Modulators|mitosis modulators|mesh-ancestor
92869445|NCT02644863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869446|NCT00302744|Niacin|niacin|mesh-list
92869447|NCT00302744|Psilocybin|psilocybin|mesh-list
92869448|NCT00302744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92869449|NCT00302744|Antimetabolites|antimetabolites|mesh-ancestor
92156770|NCT04626024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869450|NCT00302744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869451|NCT00302744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92869452|NCT00302744|Vasodilator Agents|vasodilator agents|mesh-ancestor
92869453|NCT00302744|Vitamin B Complex|vitamin b complex|mesh-ancestor
92869454|NCT00302744|Vitamins|vitamins|mesh-ancestor
92869455|NCT00302744|Micronutrients|micronutrients|mesh-ancestor
92869456|NCT00302744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869457|NCT00302744|Hallucinogens|hallucinogens|mesh-ancestor
92869458|NCT00302744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92869459|NCT02644629|Ketamine|ketamine|mesh-list
92869460|NCT02644629|Analgesics|analgesics|mesh-ancestor
92869461|NCT02644629|Sensory System Agents|sensory system agents|mesh-ancestor
92869462|NCT02644629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869463|NCT02644629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869464|NCT02644629|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92869465|NCT02644629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92869466|NCT02644629|Anesthetics, General|anesthetics, general|mesh-ancestor
92869467|NCT02644629|Anesthetics|anesthetics|mesh-ancestor
92156780|NCT00981435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869468|NCT02644629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869469|NCT02644629|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92869470|NCT02644629|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92869471|NCT02644629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869472|NCT02644629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869473|NCT00652665|Leflunomide|leflunomide|mesh-list
92869474|NCT00652665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869475|NCT00652665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869476|NCT00652665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869477|NCT00652665|Immunologic Factors|immunologic factors|mesh-ancestor
92869478|NCT00652665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869479|NCT02644551|Ciclopirox|ciclopirox|mesh-list
92869480|NCT02644551|Antifungal Agents|antifungal agents|mesh-ancestor
92869481|NCT02644551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869482|NCT02644395|Amlodipine|amlodipine|mesh-list
92869483|NCT02644395|Chlorthalidone|chlorthalidone|mesh-list
92869484|NCT02644395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92869485|NCT02644395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92869486|NCT02644395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869487|NCT02644395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869488|NCT02644395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92869489|NCT02644395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869490|NCT02644395|Vasodilator Agents|vasodilator agents|mesh-ancestor
92869491|NCT02644395|Diuretics|diuretics|mesh-ancestor
92869492|NCT02644395|Natriuretic Agents|natriuretic agents|mesh-ancestor
92869493|NCT02644395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92869494|NCT04166565|Dexamethasone|dexamethasone|mesh-list
92869495|NCT04166565|Cyclophosphamide|cyclophosphamide|mesh-list
92869496|NCT04166565|Bortezomib|bortezomib|mesh-list
92869497|NCT04166565|Daratumumab|daratumumab|mesh-list
92869498|NCT04166565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869499|NCT04166565|Immunologic Factors|immunologic factors|mesh-ancestor
92869500|NCT04166565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869501|NCT04166565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869502|NCT04166565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869503|NCT04166565|Alkylating Agents|alkylating agents|mesh-ancestor
92869504|NCT04166565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869505|NCT04166565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869506|NCT04166565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92869507|NCT04166565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869508|NCT04166565|Antiemetics|antiemetics|mesh-ancestor
92869509|NCT04166565|Autonomic Agents|autonomic agents|mesh-ancestor
92869510|NCT04166565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869511|NCT04166565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92869512|NCT04166565|Glucocorticoids|glucocorticoids|mesh-ancestor
92869513|NCT04166565|Hormones|hormones|mesh-ancestor
92869514|NCT04166565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869515|NCT04166565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92869516|NCT02644473|Tranexamic Acid|tranexamic acid|mesh-list
92869517|NCT02644473|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92869518|NCT02644473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92869519|NCT02644473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869520|NCT02644473|Hemostatics|hemostatics|mesh-ancestor
92869521|NCT02644473|Coagulants|coagulants|mesh-ancestor
92869522|NCT02644083|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92869523|NCT02644083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92869524|NCT02644083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869525|NCT02644083|Immunologic Factors|immunologic factors|mesh-ancestor
92869526|NCT02644083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869528|NCT04005872|Fluorides|fluorides|mesh-list
92869529|NCT04005872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92869530|NCT04005872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869531|NCT04005872|Cariostatic Agents|cariostatic agents|mesh-ancestor
92869532|NCT04005872|Protective Agents|protective agents|mesh-ancestor
92869533|NCT00652821|Tramadol|tramadol|mesh-list
92869534|NCT00652821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92869535|NCT00652821|Narcotics|narcotics|mesh-ancestor
92869536|NCT00652821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869537|NCT00652821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869538|NCT00652821|Analgesics|analgesics|mesh-ancestor
92869539|NCT00652821|Sensory System Agents|sensory system agents|mesh-ancestor
92869540|NCT00652821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869541|NCT02644161|Antidepressive Agents|antidepressive agents|mesh-list
92869542|NCT02644161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92869543|NCT02535975|Metformin|metformin|mesh-list
92869544|NCT02535975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869545|NCT02535975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869546|NCT02714036|Ibudilast|ibudilast|mesh-list
92869547|NCT02714036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92869548|NCT02714036|Autonomic Agents|autonomic agents|mesh-ancestor
92869549|NCT02714036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869550|NCT02714036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869551|NCT02714036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92869552|NCT02714036|Respiratory System Agents|respiratory system agents|mesh-ancestor
92869553|NCT02714036|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92869554|NCT02714036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869555|NCT02714036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869556|NCT02714036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92157016|NCT03614741|Tinzaparin|tinzaparin|mesh-list
92869557|NCT02714036|Vasodilator Agents|vasodilator agents|mesh-ancestor
92869558|NCT02710448|Metformin|metformin|mesh-list
92869559|NCT02710448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869560|NCT02710448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869561|NCT04602026|Coal Tar|coal tar|mesh-list
92869562|NCT04602026|Keratolytic Agents|keratolytic agents|mesh-ancestor
92869563|NCT04602026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92869564|NCT04166253|Vitamin D|vitamin d|mesh-list
92869565|NCT04166253|Alfacalcidol|alfacalcidol|mesh-list
92869566|NCT04166253|Vitamins|vitamins|mesh-ancestor
92869567|NCT04166253|Micronutrients|micronutrients|mesh-ancestor
92869568|NCT04166253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869569|NCT04166253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92869570|NCT00653055|Cabergoline|cabergoline|mesh-list
92869571|NCT00653055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92869572|NCT00653055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92869573|NCT00653055|Dopamine Agonists|dopamine agonists|mesh-ancestor
92869574|NCT00653055|Dopamine Agents|dopamine agents|mesh-ancestor
92869575|NCT00653055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869576|NCT00653055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869577|NCT00653055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869578|NCT02643147|Furosemide|furosemide|mesh-list
92869579|NCT02643147|Diuretics|diuretics|mesh-list
92869580|NCT02643147|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92869581|NCT02643147|Natriuretic Agents|natriuretic agents|mesh-ancestor
92869582|NCT02643147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869583|NCT02643147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869584|NCT02643147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869585|NCT02642913|Sorafenib|sorafenib|mesh-list
92869586|NCT02642913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869587|NCT02642913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92869588|NCT02642913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869589|NCT02642913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869590|NCT04165629|Aspirin|aspirin|mesh-list
92869591|NCT04165629|Clopidogrel|clopidogrel|mesh-list
92157052|NCT01363661|Molsidomine|molsidomine|mesh-list
92869592|NCT04165629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92869593|NCT04165629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869594|NCT04165629|Analgesics|analgesics|mesh-ancestor
92869595|NCT04165629|Sensory System Agents|sensory system agents|mesh-ancestor
92869596|NCT04165629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869597|NCT04165629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869598|NCT04165629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869599|NCT04165629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869600|NCT04165629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92869601|NCT04165629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92869602|NCT04165629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869603|NCT04165629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92869604|NCT04165629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92869605|NCT04165629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869606|NCT04165629|Antipyretics|antipyretics|mesh-ancestor
92869607|NCT04165629|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92869608|NCT04165629|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92869609|NCT04165629|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92869610|NCT04165629|Purinergic Agents|purinergic agents|mesh-ancestor
92869611|NCT04165629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869612|NCT02642523|Insulin|insulin|mesh-list
92869613|NCT02642523|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92869614|NCT02642523|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92869615|NCT02642523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869616|NCT02642523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869617|NCT02642523|Natriuretic Agents|natriuretic agents|mesh-ancestor
92869618|NCT02713802|Propofol|propofol|mesh-list
92869619|NCT02713802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92869620|NCT02713802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869621|NCT02713802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869622|NCT02713802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92869623|NCT02713802|Anesthetics, General|anesthetics, general|mesh-ancestor
92869624|NCT02713802|Anesthetics|anesthetics|mesh-ancestor
92869625|NCT02642601|Indomethacin|indomethacin|mesh-list
92869626|NCT02642601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92869627|NCT02642601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869628|NCT02642601|Analgesics|analgesics|mesh-ancestor
92869629|NCT02642601|Sensory System Agents|sensory system agents|mesh-ancestor
92869630|NCT02642601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869631|NCT02642601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869632|NCT02642601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869633|NCT02642601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869634|NCT02642601|Gout Suppressants|gout suppressants|mesh-ancestor
92869635|NCT02642601|Tocolytic Agents|tocolytic agents|mesh-ancestor
92869636|NCT02642601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92869637|NCT02642601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92869638|NCT02642601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869639|NCT02642601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869640|NCT02709902|Adapalene|adapalene|mesh-list
92869641|NCT02709902|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92869642|NCT02709902|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92869643|NCT02709902|Dermatologic Agents|dermatologic agents|mesh-ancestor
92869644|NCT02709902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92869645|NCT02709902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869646|NCT02709902|Analgesics|analgesics|mesh-ancestor
92869647|NCT02709902|Sensory System Agents|sensory system agents|mesh-ancestor
92869648|NCT02709902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869649|NCT02709902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869650|NCT02709902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869651|NCT02709902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869652|NCT02710604|Tenofovir|tenofovir|mesh-list
92869653|NCT02710604|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
92869654|NCT02710604|Antiviral Agents|antiviral agents|mesh-ancestor
92157145|NCT04436250|Ketamine|ketamine|mesh-list
92869655|NCT02710604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869656|NCT02710604|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92869657|NCT02710604|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92869658|NCT02710604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869659|NCT02710604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869660|NCT02710604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92869661|NCT02710604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92869662|NCT02709824|Chlorhexidine|chlorhexidine|mesh-list
92869663|NCT02709824|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92869664|NCT02709824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92869665|NCT02709824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869666|NCT02709824|Disinfectants|disinfectants|mesh-ancestor
92869667|NCT02709824|Dermatologic Agents|dermatologic agents|mesh-ancestor
92869668|NCT02642367|Rocuronium|rocuronium|mesh-list
92869669|NCT02642367|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92869670|NCT02642367|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92869671|NCT02642367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92869672|NCT02642367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869673|NCT02642367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869674|NCT00653445|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92869675|NCT00653445|Ezetimibe|ezetimibe|mesh-list
92869676|NCT00653445|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92869677|NCT00653445|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92869678|NCT00653445|Antimetabolites|antimetabolites|mesh-ancestor
92869679|NCT00653445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869680|NCT00653445|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92869681|NCT00653445|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92869682|NCT00653445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869683|NCT02641899|Acetaminophen|acetaminophen|mesh-list
92869684|NCT02641899|Exenatide|exenatide|mesh-list
92869685|NCT02641899|Digoxin|digoxin|mesh-list
92869686|NCT02641899|Lisinopril|lisinopril|mesh-list
92869687|NCT02641899|Warfarin|warfarin|mesh-list
92869688|NCT02641899|Atorvastatin|atorvastatin|mesh-list
92869689|NCT02641899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92869690|NCT02641899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92869691|NCT02641899|Antimetabolites|antimetabolites|mesh-ancestor
92869692|NCT02641899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869693|NCT02641899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92869694|NCT02641899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92869695|NCT02641899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869696|NCT02641899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869697|NCT02641899|Analgesics|analgesics|mesh-ancestor
92869698|NCT02641899|Sensory System Agents|sensory system agents|mesh-ancestor
92869699|NCT02641899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869700|NCT02641899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869701|NCT02641899|Antipyretics|antipyretics|mesh-ancestor
92869702|NCT02641899|Anticoagulants|anticoagulants|mesh-ancestor
92869703|NCT02641899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92869704|NCT02641899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92869705|NCT02641899|Protective Agents|protective agents|mesh-ancestor
92869706|NCT02641899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92869707|NCT02641899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92869708|NCT02641899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92869709|NCT02641899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92869710|NCT02641899|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92869711|NCT02641899|Incretins|incretins|mesh-ancestor
92869712|NCT02641899|Hormones|hormones|mesh-ancestor
92869713|NCT02641899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92869714|NCT02641821|Nifedipine|nifedipine|mesh-list
92869715|NCT02641821|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92157227|NCT00997113|Anesthetics, General|anesthetics, general|mesh-ancestor
92869716|NCT02641821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869717|NCT02641821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869718|NCT02641821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92869719|NCT02641821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869720|NCT02641821|Vasodilator Agents|vasodilator agents|mesh-ancestor
92869721|NCT02641821|Tocolytic Agents|tocolytic agents|mesh-ancestor
92869722|NCT02641821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92869723|NCT01320345|Fenofibrate|fenofibrate|mesh-list
92869724|NCT01320345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92869725|NCT01320345|Antimetabolites|antimetabolites|mesh-ancestor
92869726|NCT01320345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869727|NCT01320345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92869728|NCT04164615|Capecitabine|capecitabine|mesh-list
92869729|NCT04164615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869730|NCT04164615|Antimetabolites|antimetabolites|mesh-ancestor
92869731|NCT04164615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869732|NCT04164615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869733|NCT04164459|Latanoprost|latanoprost|mesh-list
92869734|NCT04164459|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92869735|NCT04164459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92869736|NCT04164693|Heparin|heparin|mesh-list
92869737|NCT04164693|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92869738|NCT04164693|Tinzaparin|tinzaparin|mesh-list
92869739|NCT04164693|Dalteparin|dalteparin|mesh-list
92869740|NCT04164693|Warfarin|warfarin|mesh-list
92869741|NCT04164693|Anticoagulants|anticoagulants|mesh-ancestor
92869742|NCT04164693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92869743|NCT04164693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92869744|NCT04164693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869745|NCT00655785|Gemcitabine|gemcitabine|mesh-list
92869746|NCT00655785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514954|NCT00006038|Leucovorin|leucovorin|mesh-list
92869748|NCT00655785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869749|NCT00655785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869750|NCT00885495|Ritonavir|ritonavir|mesh-list
92869751|NCT00885495|Darunavir|darunavir|mesh-list
92869752|NCT00885495|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92869753|NCT00885495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92869754|NCT00885495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92869755|NCT00885495|Protease Inhibitors|protease inhibitors|mesh-ancestor
92869756|NCT00885495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869757|NCT00885495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869758|NCT00885495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92869759|NCT00885495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92869760|NCT00885495|Antiviral Agents|antiviral agents|mesh-ancestor
92869761|NCT00885495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869762|NCT00885495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92869763|NCT00885495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92869764|NCT00885495|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92869765|NCT00885495|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92869766|NCT00885495|Antimetabolites|antimetabolites|mesh-ancestor
92869767|NCT00885495|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92869768|NCT00885495|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92869769|NCT02637375|Paclitaxel|paclitaxel|mesh-list
92869770|NCT02637375|Cyclophosphamide|cyclophosphamide|mesh-list
92869771|NCT02637375|Doxorubicin|doxorubicin|mesh-list
92869772|NCT02637375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92869773|NCT02637375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869774|NCT02637375|Tubulin Modulators|tubulin modulators|mesh-ancestor
92869775|NCT02637375|Antimitotic Agents|antimitotic agents|mesh-ancestor
92869776|NCT02637375|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026467|NCT00413283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869777|NCT02637375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869778|NCT02637375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869779|NCT02637375|Immunologic Factors|immunologic factors|mesh-ancestor
92869780|NCT02637375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869781|NCT02637375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869782|NCT02637375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869783|NCT02637375|Alkylating Agents|alkylating agents|mesh-ancestor
92869784|NCT02637375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92869785|NCT02637375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92869786|NCT02637375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92869787|NCT02637375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92869788|NCT02637375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869789|NCT04163523|Zanubrutinib|zanubrutinib|mesh-list
92869790|NCT04163523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869791|NCT04163523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92869792|NCT04163523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869793|NCT04163523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869794|NCT00885105|Vaccines|vaccines|mesh-list
92869795|NCT00885105|Immunologic Factors|immunologic factors|mesh-ancestor
92869796|NCT00885105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869797|NCT02709668|Vitamin B Complex|vitamin b complex|mesh-list
92869798|NCT02709668|Vitamins|vitamins|mesh-ancestor
92869799|NCT02709668|Micronutrients|micronutrients|mesh-ancestor
92869800|NCT02709668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869801|NCT04188782|Sevoflurane|sevoflurane|mesh-list
92869802|NCT04188782|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92869803|NCT04188782|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92869804|NCT04188782|Anesthetics, General|anesthetics, general|mesh-ancestor
92869805|NCT04188782|Anesthetics|anesthetics|mesh-ancestor
92869806|NCT04188782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869807|NCT04188782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869808|NCT02709590|Diclofenac|diclofenac|mesh-list
92869809|NCT02709590|Lidocaine|lidocaine|mesh-list
92869810|NCT02709590|Anesthetics, Local|anesthetics, local|mesh-ancestor
92869811|NCT02709590|Anesthetics|anesthetics|mesh-ancestor
92869812|NCT02709590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869813|NCT02709590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869814|NCT02709590|Sensory System Agents|sensory system agents|mesh-ancestor
92869815|NCT02709590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869816|NCT02709590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92869817|NCT02709590|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92869818|NCT02709590|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92869819|NCT02709590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869820|NCT02709590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869821|NCT02709590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92869822|NCT02709590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869823|NCT02709590|Analgesics|analgesics|mesh-ancestor
92869824|NCT02709590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869826|NCT02709590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92869827|NCT02709590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869828|NCT02707874|Ropivacaine|ropivacaine|mesh-list
92869829|NCT02707874|Anesthetics, Local|anesthetics, local|mesh-ancestor
92869830|NCT02707874|Anesthetics|anesthetics|mesh-ancestor
92869831|NCT02707874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869832|NCT02707874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869833|NCT02707874|Sensory System Agents|sensory system agents|mesh-ancestor
92869834|NCT02707874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869835|NCT02709200|Dexmedetomidine|dexmedetomidine|mesh-list
92869836|NCT02709200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92869837|NCT02709200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869838|NCT02709200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869839|NCT02709200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869840|NCT02709200|Analgesics|analgesics|mesh-ancestor
92157409|NCT01001559|Sympathomimetics|sympathomimetics|mesh-ancestor
92869841|NCT02709200|Sensory System Agents|sensory system agents|mesh-ancestor
92869842|NCT02709200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869843|NCT02709200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92869844|NCT02709200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92869845|NCT02709200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92869846|NCT02709200|Adrenergic Agents|adrenergic agents|mesh-ancestor
92869847|NCT02709200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869848|NCT02709200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869849|NCT00611936|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92869850|NCT00611936|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92869851|NCT00611936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92869852|NCT00611936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869853|NCT00611936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869854|NCT00611936|Adrenergic Agents|adrenergic agents|mesh-ancestor
92869855|NCT00611936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92869856|NCT00611936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869857|NCT02707328|Paclitaxel|paclitaxel|mesh-list
92869858|NCT02707328|Gemcitabine|gemcitabine|mesh-list
92869859|NCT02707328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92869860|NCT02707328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869861|NCT02707328|Tubulin Modulators|tubulin modulators|mesh-ancestor
92869862|NCT02707328|Antimitotic Agents|antimitotic agents|mesh-ancestor
92869863|NCT02707328|Mitosis Modulators|mitosis modulators|mesh-ancestor
92869864|NCT02707328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869865|NCT02707328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92157446|NCT01004991|Rituximab|rituximab|mesh-list
92869866|NCT02707328|Antimetabolites|antimetabolites|mesh-ancestor
92869867|NCT00612638|Irinotecan|irinotecan|mesh-list
92869868|NCT00612638|Temozolomide|temozolomide|mesh-list
92869869|NCT00612638|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92869870|NCT00612638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92869871|NCT00612638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92869872|NCT00612638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869873|NCT00612638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869874|NCT00612638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869875|NCT00612638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869876|NCT00612638|Alkylating Agents|alkylating agents|mesh-ancestor
92869877|NCT05151848|Adalimumab|adalimumab|mesh-list
92869878|NCT05151848|Tofacitinib|tofacitinib|mesh-list
92869879|NCT05151848|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92869880|NCT05151848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869881|NCT05151848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869882|NCT05151848|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92869883|NCT05151848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92869884|NCT05151848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869885|NCT05151848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869886|NCT05134688|Magnesium Sulfate|magnesium sulfate|mesh-list
92869887|NCT05134688|Analgesics|analgesics|mesh-ancestor
92869888|NCT05134688|Sensory System Agents|sensory system agents|mesh-ancestor
92869889|NCT05134688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157498|NCT03115047|Narcotics|narcotics|mesh-ancestor
92869890|NCT05134688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869891|NCT05134688|Anesthetics|anesthetics|mesh-ancestor
92515108|NCT00017719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869892|NCT05134688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869893|NCT05134688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92869894|NCT05134688|Anticonvulsants|anticonvulsants|mesh-ancestor
92869895|NCT05134688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92869896|NCT05134688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92869897|NCT05134688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869898|NCT05134688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92869899|NCT05134688|Tocolytic Agents|tocolytic agents|mesh-ancestor
92869900|NCT05134688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92869901|NCT02693288|Anesthetics|anesthetics|mesh-list
92869902|NCT02693288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869903|NCT02693288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869904|NCT02693210|Cyclophosphamide|cyclophosphamide|mesh-list
92869905|NCT02693210|Rituximab|rituximab|mesh-list
92869906|NCT02693210|Methotrexate|methotrexate|mesh-list
92869907|NCT02693210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92869908|NCT02693210|Immunologic Factors|immunologic factors|mesh-ancestor
92869909|NCT02693210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869910|NCT02693210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869911|NCT02693210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92869912|NCT02693210|Alkylating Agents|alkylating agents|mesh-ancestor
92869913|NCT02693210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869914|NCT02693210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869915|NCT02693210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92869916|NCT02693210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92869917|NCT02693210|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92869918|NCT02693210|Abortifacient Agents|abortifacient agents|mesh-ancestor
92869919|NCT02693210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92869920|NCT02693210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92869921|NCT02693210|Antimetabolites|antimetabolites|mesh-ancestor
92869922|NCT02693210|Dermatologic Agents|dermatologic agents|mesh-ancestor
92869923|NCT02693210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869924|NCT02693210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92869925|NCT02693210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92869926|NCT05024006|Interferons|interferons|mesh-list
92869927|NCT05024006|Ritonavir|ritonavir|mesh-list
92869928|NCT05024006|Lopinavir|lopinavir|mesh-list
92869929|NCT05024006|Interferon-beta|interferon-beta|mesh-list
92869930|NCT05024006|Interferon beta-1a|interferon beta-1a|mesh-list
92869931|NCT05024006|Remdesivir|remdesivir|mesh-list
92869932|NCT05024006|Hydroxychloroquine|hydroxychloroquine|mesh-list
92869933|NCT05024006|Acalabrutinib|acalabrutinib|mesh-list
92869934|NCT05024006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869935|NCT05024006|Antiviral Agents|antiviral agents|mesh-ancestor
92869936|NCT05024006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92869937|NCT05024006|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92869938|NCT05024006|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92869939|NCT05024006|Protease Inhibitors|protease inhibitors|mesh-ancestor
92869940|NCT05024006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869941|NCT05024006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869942|NCT05024006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92869943|NCT05024006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92869944|NCT05024006|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92869945|NCT05024006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92869946|NCT05024006|Antimalarials|antimalarials|mesh-ancestor
92869947|NCT05024006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92869948|NCT05024006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92869949|NCT05024006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869950|NCT05024006|Immunologic Factors|immunologic factors|mesh-ancestor
92869951|NCT05024006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869952|NCT05024006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92869953|NCT05024006|Antimetabolites|antimetabolites|mesh-ancestor
92869954|NCT02707250|Meperidine|meperidine|mesh-list
92869955|NCT02707250|Bupivacaine|bupivacaine|mesh-list
92869956|NCT02707250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92869957|NCT02707250|Anesthetics|anesthetics|mesh-ancestor
92869958|NCT02707250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869959|NCT02707250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869960|NCT02707250|Sensory System Agents|sensory system agents|mesh-ancestor
92157587|NCT01053507|Sumatriptan|sumatriptan|mesh-list
92869961|NCT02707250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869962|NCT02707250|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92869963|NCT02707250|Narcotics|narcotics|mesh-ancestor
92869964|NCT02707250|Analgesics|analgesics|mesh-ancestor
92869965|NCT02707250|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92869966|NCT03781544|Acetaminophen|acetaminophen|mesh-list
92869967|NCT03781544|Diclofenac|diclofenac|mesh-list
92869968|NCT03781544|Tramadol|tramadol|mesh-list
92515182|NCT05680805|Metformin|metformin|mesh-list
92869969|NCT03781544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92869970|NCT03781544|Analgesics|analgesics|mesh-ancestor
92869971|NCT03781544|Sensory System Agents|sensory system agents|mesh-ancestor
92869972|NCT03781544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92869973|NCT03781544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869975|NCT03781544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92869976|NCT03781544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92869977|NCT03781544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92869978|NCT03781544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92869979|NCT03781544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869980|NCT03781544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92869981|NCT03781544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92869982|NCT03781544|Narcotics|narcotics|mesh-ancestor
92869983|NCT03781544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869984|NCT02707094|Immunologic Factors|immunologic factors|mesh-list
92869985|NCT02707094|Immunomodulating Agents|immunomodulating agents|mesh-list
92869986|NCT02707094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869987|NCT02707016|Sevoflurane|sevoflurane|mesh-list
92869988|NCT02707016|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92869989|NCT02707016|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92869990|NCT02707016|Anesthetics, General|anesthetics, general|mesh-ancestor
92869991|NCT02707016|Anesthetics|anesthetics|mesh-ancestor
92869992|NCT02707016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92869993|NCT02707016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92869994|NCT04956146|Carboplatin|carboplatin|mesh-list
92869995|NCT04956146|Pemetrexed|pemetrexed|mesh-list
92869996|NCT04956146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92869997|NCT04956146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92869998|NCT04956146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157628|NCT01055223|Amiloride|amiloride|mesh-list
92869999|NCT04956146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92870000|NCT04956146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92870001|NCT00612794|Exenatide|exenatide|mesh-list
92870002|NCT00612794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92870003|NCT00612794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870004|NCT00612794|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92870005|NCT00612794|Incretins|incretins|mesh-ancestor
92870006|NCT00612794|Hormones|hormones|mesh-ancestor
92870007|NCT00612794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870008|NCT03773276|Norepinephrine|norepinephrine|mesh-list
92870009|NCT03773276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92870010|NCT03773276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92870011|NCT03773276|Adrenergic Agents|adrenergic agents|mesh-ancestor
92870012|NCT03773276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870013|NCT03773276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870014|NCT03773276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870015|NCT03773276|Sympathomimetics|sympathomimetics|mesh-ancestor
92870016|NCT03773276|Autonomic Agents|autonomic agents|mesh-ancestor
92870017|NCT03773276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870018|NCT03773276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92870019|NCT02706860|Atorvastatin|atorvastatin|mesh-list
92870020|NCT02706860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92870021|NCT02706860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92870022|NCT02706860|Antimetabolites|antimetabolites|mesh-ancestor
92870023|NCT02706860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870024|NCT02706860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92870025|NCT02706860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92870026|NCT02706860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870027|NCT02706470|Cyclosporine|cyclosporine|mesh-list
92870028|NCT02706470|Cyclosporins|cyclosporins|mesh-list
92870029|NCT02706470|Dydrogesterone|dydrogesterone|mesh-list
92870030|NCT02706470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870031|NCT02706470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870032|NCT02706470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870033|NCT02706470|Immunologic Factors|immunologic factors|mesh-ancestor
92870034|NCT02706470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870035|NCT02706470|Antifungal Agents|antifungal agents|mesh-ancestor
92870036|NCT02706470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870037|NCT02706470|Dermatologic Agents|dermatologic agents|mesh-ancestor
92870038|NCT02706470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870039|NCT02706470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92870040|NCT02706470|Progestins|progestins|mesh-ancestor
92870041|NCT02706470|Hormones|hormones|mesh-ancestor
92870042|NCT02706470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870043|NCT03769766|Curcumin|curcumin|mesh-list
92870044|NCT03769766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92515256|NCT00386750|Lumefantrine|lumefantrine|mesh-list
92870047|NCT03769766|Sensory System Agents|sensory system agents|mesh-ancestor
92870048|NCT03769766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870049|NCT03769766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870050|NCT03769766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870051|NCT03769766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870052|NCT03769766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870053|NCT03769766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870054|NCT03769766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870055|NCT03764540|Prednisone|prednisone|mesh-list
92870056|NCT03764540|Docetaxel|docetaxel|mesh-list
92870057|NCT03764540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870058|NCT03764540|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870059|NCT03764540|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870060|NCT03764540|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870061|NCT03764540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870062|NCT03764540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870063|NCT03764540|Glucocorticoids|glucocorticoids|mesh-ancestor
92870064|NCT03764540|Hormones|hormones|mesh-ancestor
92870065|NCT03764540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870066|NCT03764540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870067|NCT03764540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870068|NCT03763370|Immunoconjugates|immunoconjugates|mesh-list
92870069|NCT03763370|Immunologic Factors|immunologic factors|mesh-ancestor
92870070|NCT03763370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870071|NCT02706236|Pancrelipase|pancrelipase|mesh-list
92870072|NCT02706236|Pancreatin|pancreatin|mesh-list
92870073|NCT02706236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870074|NCT00613496|Irbesartan|irbesartan|mesh-list
92870075|NCT00613496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92870076|NCT00613496|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92870077|NCT00613496|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92870078|NCT00613496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870079|NCT00612950|Glucagon|glucagon|mesh-list
92870080|NCT00612950|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92870081|NCT00612950|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92870082|NCT00612950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870083|NCT00612950|Hormones|hormones|mesh-ancestor
92870084|NCT00612950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870085|NCT00612950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870086|NCT00612950|Incretins|incretins|mesh-ancestor
92870087|NCT00884793|Ritonavir|ritonavir|mesh-list
92870088|NCT00884793|Lopinavir|lopinavir|mesh-list
92870089|NCT00884793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92870090|NCT00884793|Fosamprenavir|fosamprenavir|mesh-list
92870091|NCT00884793|Raltegravir Potassium|raltegravir potassium|mesh-list
92870092|NCT00884793|Efavirenz|efavirenz|mesh-list
92870093|NCT00884793|Etravirine|etravirine|mesh-list
92870094|NCT00884793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92870095|NCT00884793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92870096|NCT00884793|Protease Inhibitors|protease inhibitors|mesh-ancestor
92870097|NCT00884793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870098|NCT00884793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870099|NCT00884793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92870100|NCT00884793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92870101|NCT00884793|Antiviral Agents|antiviral agents|mesh-ancestor
92870102|NCT00884793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870103|NCT00884793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92870104|NCT00884793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92870105|NCT00884793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92870106|NCT00884793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92870107|NCT00884793|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92870108|NCT00884793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92870109|NCT00884793|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92870110|NCT00884793|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92870111|NCT00884793|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92870112|NCT00884793|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92870113|NCT00884793|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92870114|NCT02636829|Calcium|calcium|mesh-list
92870115|NCT02636829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92870116|NCT02636829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870117|NCT00884325|Levocetirizine|levocetirizine|mesh-list
92870119|NCT00884325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92870120|NCT00884325|Histamine Antagonists|histamine antagonists|mesh-ancestor
92870121|NCT00884325|Histamine Agents|histamine agents|mesh-ancestor
92870122|NCT00884325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870123|NCT00884325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870124|NCT00884325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870125|NCT00656409|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92870126|NCT00656409|Immunologic Factors|immunologic factors|mesh-ancestor
92870127|NCT00656409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870128|NCT05264558|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92870129|NCT05264558|Antiviral Agents|antiviral agents|mesh-ancestor
92870130|NCT05264558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870131|NCT04705844|Adalimumab|adalimumab|mesh-list
92870132|NCT04705844|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92870133|NCT04705844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870134|NCT04705844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870135|NCT00636896|Olanzapine|olanzapine|mesh-list
92870136|NCT00636896|Modafinil|modafinil|mesh-list
92870137|NCT00636896|Antiemetics|antiemetics|mesh-ancestor
92870138|NCT00636896|Autonomic Agents|autonomic agents|mesh-ancestor
92870139|NCT00636896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870140|NCT00636896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870141|NCT00636896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870142|NCT00636896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92870143|NCT00636896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870144|NCT00636896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870145|NCT00636896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870146|NCT00636896|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92870147|NCT00636896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92870148|NCT00636896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870149|NCT00636896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157852|NCT05539911|Fentanyl|fentanyl|mesh-list
92870150|NCT00636896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870151|NCT00636896|Serotonin Agents|serotonin agents|mesh-ancestor
92870152|NCT00636896|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92870153|NCT00636896|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92870154|NCT00636896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92870155|NCT00636896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92870156|NCT04470674|Carboplatin|carboplatin|mesh-list
92870157|NCT04470674|Pemetrexed|pemetrexed|mesh-list
92870158|NCT04470674|Durvalumab|durvalumab|mesh-list
92870159|NCT04470674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870160|NCT04470674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870161|NCT04470674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870162|NCT04470674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92870163|NCT04470674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92870164|NCT04470674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870165|NCT00883779|Carboplatin|carboplatin|mesh-list
92870166|NCT00883779|Gemcitabine|gemcitabine|mesh-list
92870167|NCT00883779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92870168|NCT00883779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870169|NCT00883779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870170|NCT00883779|Antimetabolites|antimetabolites|mesh-ancestor
92870171|NCT00883779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870172|NCT00883779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870173|NCT00883779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870174|NCT05263778|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92870175|NCT05263778|Ezetimibe|ezetimibe|mesh-list
92870176|NCT05263778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92870177|NCT05263778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92870178|NCT05263778|Antimetabolites|antimetabolites|mesh-ancestor
92870179|NCT05263778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870180|NCT05263778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92870181|NCT05263778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870182|NCT05263778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92870183|NCT05263778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870184|NCT02693444|Lidocaine|lidocaine|mesh-list
92870185|NCT02693444|Anesthetics, Local|anesthetics, local|mesh-ancestor
92870186|NCT02693444|Anesthetics|anesthetics|mesh-ancestor
92870187|NCT02693444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870188|NCT02693444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870189|NCT02693444|Sensory System Agents|sensory system agents|mesh-ancestor
92870191|NCT02693444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92870192|NCT02693444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92870193|NCT02693444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92870194|NCT02693444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870195|NCT02693444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870196|NCT04162743|Trazodone|trazodone|mesh-list
92870197|NCT04162743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92870198|NCT04162743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870199|NCT04162743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870200|NCT04162743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870201|NCT04162743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870202|NCT04162743|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92870203|NCT04162743|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92870204|NCT04162743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870205|NCT04162743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870206|NCT04162743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870207|NCT04162743|Serotonin Agents|serotonin agents|mesh-ancestor
92870208|NCT04162743|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92870209|NCT04162743|Antidepressive Agents|antidepressive agents|mesh-ancestor
92870210|NCT03813992|Nitroglycerin|nitroglycerin|mesh-list
92870211|NCT03813992|Vasodilator Agents|vasodilator agents|mesh-ancestor
92870212|NCT04302896|Tenofovir|tenofovir|mesh-list
92870213|NCT04302896|Lamivudine|lamivudine|mesh-list
92870214|NCT04302896|Emtricitabine|emtricitabine|mesh-list
92870215|NCT04302896|Dolutegravir|dolutegravir|mesh-list
92870216|NCT04302896|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92870217|NCT04302896|Antiviral Agents|antiviral agents|mesh-ancestor
92870218|NCT04302896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870219|NCT04302896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92870220|NCT04302896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92870221|NCT04302896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870222|NCT04302896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870223|NCT04302896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92870224|NCT04302896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92870225|NCT04302896|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92870226|NCT04302896|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92870227|NCT00656643|Sirolimus|sirolimus|mesh-list
92870228|NCT00656643|Temsirolimus|temsirolimus|mesh-list
92870229|NCT00656643|MTOR Inhibitors|mtor inhibitors|mesh-list
92870230|NCT00656643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92870231|NCT00656643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870232|NCT00656643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92870233|NCT00656643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870234|NCT00656643|Antifungal Agents|antifungal agents|mesh-ancestor
92870235|NCT00656643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870236|NCT00656643|Immunologic Factors|immunologic factors|mesh-ancestor
92870237|NCT00656643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870238|NCT00656643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870239|NCT00656643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870240|NCT00656643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870241|NCT03712202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92870242|NCT03712202|Nivolumab|nivolumab|mesh-list
92870243|NCT03712202|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92870244|NCT03712202|Doxorubicin|doxorubicin|mesh-list
92870245|NCT03712202|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92870246|NCT03712202|Daunorubicin|daunorubicin|mesh-list
92870247|NCT03712202|Bleomycin|bleomycin|mesh-list
92870248|NCT03712202|Dacarbazine|dacarbazine|mesh-list
92870249|NCT03712202|Vinblastine|vinblastine|mesh-list
92870250|NCT03712202|Antibodies|antibodies|mesh-list
92870251|NCT03712202|Immunoglobulins|immunoglobulins|mesh-list
92870252|NCT03712202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92870253|NCT03712202|Imidazole|imidazole|mesh-list
92870254|NCT03712202|Immunoconjugates|immunoconjugates|mesh-list
92870255|NCT03712202|Immunologic Factors|immunologic factors|mesh-ancestor
92870256|NCT03712202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870257|NCT03712202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870258|NCT03712202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92870259|NCT03712202|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92870260|NCT03712202|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92870261|NCT03712202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870262|NCT03712202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870263|NCT03712202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92870264|NCT03712202|Immunotoxins|immunotoxins|mesh-ancestor
92870265|NCT03712202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92870267|NCT03712202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92870268|NCT03712202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870269|NCT03712202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870270|NCT03712202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870271|NCT02635971|Gemcitabine|gemcitabine|mesh-list
92870272|NCT02635971|Oxaliplatin|oxaliplatin|mesh-list
92870273|NCT02635971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870274|NCT02635971|Antimetabolites|antimetabolites|mesh-ancestor
92870275|NCT02635971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870276|NCT02635971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870277|NCT00657423|Cisplatin|cisplatin|mesh-list
92870278|NCT00657423|Docetaxel|docetaxel|mesh-list
92870279|NCT00657423|Endostar protein|endostar protein|mesh-list
92870280|NCT00657423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870281|NCT00657423|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870282|NCT00657423|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870283|NCT00657423|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870284|NCT00657423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870285|NCT00657423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92870286|NCT00657423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870287|NCT00657423|Growth Substances|growth substances|mesh-ancestor
92870288|NCT00657423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870289|NCT00657423|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870290|NCT00911235|Fluconazole|fluconazole|mesh-list
92870291|NCT00911235|Fesoterodine|fesoterodine|mesh-list
92870292|NCT00911235|Antifungal Agents|antifungal agents|mesh-ancestor
92870293|NCT00911235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870294|NCT00911235|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92870295|NCT00911235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92870296|NCT00911235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870297|NCT00911235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870298|NCT00911235|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92870299|NCT00911235|Hormone Antagonists|hormone antagonists|mesh-ancestor
92870300|NCT00911235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870301|NCT00911235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870302|NCT00911235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92870303|NCT00911235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92870304|NCT00911235|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92870305|NCT00911235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92870306|NCT00911235|Cholinergic Agents|cholinergic agents|mesh-ancestor
92870307|NCT00911235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870308|NCT00911235|Urological Agents|urological agents|mesh-ancestor
92870309|NCT00636974|Anesthetics|anesthetics|mesh-list
92870310|NCT00636974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870311|NCT00636974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870312|NCT02535351|Sunitinib|sunitinib|mesh-list
92870313|NCT02535351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870314|NCT02535351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92870315|NCT02535351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870316|NCT02535351|Growth Substances|growth substances|mesh-ancestor
92870317|NCT02535351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870318|NCT02535351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870319|NCT02535351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870320|NCT02535351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870321|NCT02535351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870322|NCT00613964|Diuretics|diuretics|mesh-list
92870323|NCT00613964|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92870324|NCT00613964|Natriuretic Agents|natriuretic agents|mesh-ancestor
92870325|NCT00613964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870326|NCT00613964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870327|NCT00613964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870328|NCT05342870|Dexmedetomidine|dexmedetomidine|mesh-list
92870329|NCT05342870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92870330|NCT05342870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870331|NCT05342870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870332|NCT05342870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92870333|NCT05342870|Analgesics|analgesics|mesh-ancestor
92870334|NCT05342870|Sensory System Agents|sensory system agents|mesh-ancestor
92870335|NCT05342870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870336|NCT05342870|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92870338|NCT05342870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92870339|NCT05342870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92870340|NCT05342870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870341|NCT05342870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870342|NCT00657579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92870343|NCT00657579|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92870345|NCT05342792|Tislelizumab|tislelizumab|mesh-list
92870346|NCT05342792|Antibodies|antibodies|mesh-list
92870347|NCT05342792|Immunologic Factors|immunologic factors|mesh-ancestor
92870348|NCT05342792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870349|NCT05342792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870350|NCT05342792|Antimetabolites|antimetabolites|mesh-ancestor
92870351|NCT05342792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158097|NCT05852847|Danazol|danazol|mesh-list
92870352|NCT05342792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870353|NCT05342792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870354|NCT00657891|Omalizumab|omalizumab|mesh-list
92870355|NCT00657891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92870356|NCT00657891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92870357|NCT00657891|Respiratory System Agents|respiratory system agents|mesh-ancestor
92870358|NCT05162300|Botulinum Toxins|botulinum toxins|mesh-list
92870359|NCT05162300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92870360|NCT05162300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870361|NCT05162300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870362|NCT05162300|Cholinergic Agents|cholinergic agents|mesh-ancestor
92870363|NCT05162300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870364|NCT05162300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870365|NCT04159077|Tamsulosin|tamsulosin|mesh-list
92870366|NCT04159077|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92870367|NCT04159077|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92870368|NCT04159077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92870369|NCT04159077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92870370|NCT04159077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870371|NCT04159077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870372|NCT04159077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870373|NCT04159077|Urological Agents|urological agents|mesh-ancestor
92870374|NCT02690480|Fulvestrant|fulvestrant|mesh-list
92870375|NCT02690480|Palbociclib|palbociclib|mesh-list
92870376|NCT02690480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870377|NCT02690480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870378|NCT02690480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92870379|NCT02690480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92870380|NCT02690480|Hormone Antagonists|hormone antagonists|mesh-ancestor
92870381|NCT02690480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870382|NCT02690480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870383|NCT02690480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870384|NCT02690480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870385|NCT02690480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870386|NCT00658593|Gemcitabine|gemcitabine|mesh-list
92870387|NCT00658593|Capecitabine|capecitabine|mesh-list
92870388|NCT00658593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870389|NCT00658593|Antimetabolites|antimetabolites|mesh-ancestor
92870390|NCT00658593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870391|NCT00658593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870392|NCT00880269|Panobinostat|panobinostat|mesh-list
92870393|NCT00880269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870394|NCT00880269|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92870395|NCT00880269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870396|NCT00880269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870397|NCT00880191|Dexamethasone|dexamethasone|mesh-list
92870398|NCT00880191|Gabapentin|gabapentin|mesh-list
92870399|NCT00880191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870400|NCT00880191|Antiemetics|antiemetics|mesh-ancestor
92870401|NCT00880191|Autonomic Agents|autonomic agents|mesh-ancestor
92870402|NCT00880191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870403|NCT00880191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870404|NCT00880191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870405|NCT00880191|Glucocorticoids|glucocorticoids|mesh-ancestor
92870406|NCT00880191|Hormones|hormones|mesh-ancestor
93026468|NCT00413283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870407|NCT00880191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525255|NCT00024193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92870408|NCT00880191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870409|NCT00880191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870410|NCT00880191|Analgesics|analgesics|mesh-ancestor
92870411|NCT00880191|Sensory System Agents|sensory system agents|mesh-ancestor
92870412|NCT00880191|Anticonvulsants|anticonvulsants|mesh-ancestor
92515629|NCT05641623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870413|NCT00880191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92870414|NCT00880191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870415|NCT00880191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870416|NCT00880191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870417|NCT00880191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92870418|NCT00880191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92870419|NCT00880191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870420|NCT00880191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870421|NCT00880191|Antimanic Agents|antimanic agents|mesh-ancestor
92870422|NCT00659451|Losartan|losartan|mesh-list
92870423|NCT00659451|Amlodipine|amlodipine|mesh-list
92870424|NCT00659451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92870425|NCT00659451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92870426|NCT00659451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870427|NCT00659451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870428|NCT00659451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92870429|NCT00659451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870430|NCT00659451|Vasodilator Agents|vasodilator agents|mesh-ancestor
92870431|NCT00659451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92870432|NCT00659451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92870433|NCT00659451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92870434|NCT00911313|Metformin|metformin|mesh-list
92870435|NCT00911313|Letrozole|letrozole|mesh-list
92870436|NCT00911313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92870437|NCT00911313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870438|NCT00911313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870439|NCT00911313|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92870440|NCT00911313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92870441|NCT00911313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870442|NCT00911313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870443|NCT00911313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92870444|NCT00911313|Hormone Antagonists|hormone antagonists|mesh-ancestor
92870445|NCT00911313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870446|NCT00659685|Ondansetron|ondansetron|mesh-list
92870447|NCT00659685|Antiemetics|antiemetics|mesh-ancestor
92870448|NCT00659685|Autonomic Agents|autonomic agents|mesh-ancestor
92870449|NCT00659685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870450|NCT00659685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870451|NCT00659685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870452|NCT00659685|Antipruritics|antipruritics|mesh-ancestor
92870453|NCT00659685|Dermatologic Agents|dermatologic agents|mesh-ancestor
92870454|NCT00659685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92870455|NCT00659685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92870456|NCT00659685|Serotonin Agents|serotonin agents|mesh-ancestor
92870457|NCT00659685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870458|NCT00659685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870459|NCT00659841|Ciclesonide|ciclesonide|mesh-list
92870460|NCT00659841|Glucocorticoids|glucocorticoids|mesh-ancestor
92870461|NCT00659841|Hormones|hormones|mesh-ancestor
92870462|NCT00659841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870463|NCT00659841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870464|NCT00659841|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92870465|NCT00659919|Trazodone|trazodone|mesh-list
92870466|NCT00659919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92870467|NCT00659919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870468|NCT00659919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870469|NCT00659919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870470|NCT00659919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870471|NCT00659919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92870472|NCT00659919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92870473|NCT00659919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870474|NCT00659919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870475|NCT00659919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870476|NCT00659919|Serotonin Agents|serotonin agents|mesh-ancestor
92870477|NCT00659919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92870478|NCT00659919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92870479|NCT00659997|Albendazole|albendazole|mesh-list
92870481|NCT00659997|Anthelmintics|anthelmintics|mesh-ancestor
92870482|NCT00659997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92870483|NCT00659997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870484|NCT00659997|Anticestodal Agents|anticestodal agents|mesh-ancestor
92870485|NCT00659997|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92870486|NCT00659997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92870487|NCT00659997|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870488|NCT00659997|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870489|NCT00659997|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870490|NCT00659997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870491|NCT00659997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870492|NCT00659997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92870493|NCT00659997|Immunologic Factors|immunologic factors|mesh-ancestor
92870494|NCT00659997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870495|NCT00659997|Antinematodal Agents|antinematodal agents|mesh-ancestor
92870496|NCT00659997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870497|NCT00660153|Tivozanib|tivozanib|mesh-list
92870498|NCT00660153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870499|NCT00660153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870500|NCT00660153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870501|NCT00660231|Gemcitabine|gemcitabine|mesh-list
92870502|NCT00660231|Bexarotene|bexarotene|mesh-list
92870503|NCT00660231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870504|NCT00660231|Antimetabolites|antimetabolites|mesh-ancestor
92870505|NCT00660231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870506|NCT00660231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870507|NCT00597519|Cyclophosphamide|cyclophosphamide|mesh-list
92870508|NCT00597519|Fludarabine|fludarabine|mesh-list
92870509|NCT00597519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870510|NCT00597519|Immunologic Factors|immunologic factors|mesh-ancestor
92870511|NCT00597519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158309|NCT05711641|Lidocaine|lidocaine|mesh-list
92870512|NCT00597519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870513|NCT00597519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92870514|NCT00597519|Alkylating Agents|alkylating agents|mesh-ancestor
92870515|NCT00597519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870516|NCT00597519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870517|NCT00597519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92870518|NCT00660621|Bevacizumab|bevacizumab|mesh-list
92870519|NCT00660621|Temozolomide|temozolomide|mesh-list
92870520|NCT00660621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870521|NCT00660621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870522|NCT00660621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92870523|NCT00660621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870524|NCT00660621|Growth Substances|growth substances|mesh-ancestor
92870525|NCT00660621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870526|NCT00660621|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870527|NCT00660621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92870528|NCT00660621|Alkylating Agents|alkylating agents|mesh-ancestor
92870529|NCT00660621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870530|NCT02632305|Paclitaxel|paclitaxel|mesh-list
92870531|NCT02632305|Gemcitabine|gemcitabine|mesh-list
92870532|NCT02632305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92870533|NCT02632305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870534|NCT02632305|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870535|NCT02632305|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870536|NCT02632305|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870537|NCT02632305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870538|NCT02632305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92870539|NCT02632305|Antimetabolites|antimetabolites|mesh-ancestor
92870540|NCT02631993|Furocoumarins|furocoumarins|mesh-list
92870541|NCT02631993|Dermatologic Agents|dermatologic agents|mesh-ancestor
92870542|NCT02631993|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92870543|NCT00660855|Parecoxib|parecoxib|mesh-list
92870544|NCT00660855|Valdecoxib|valdecoxib|mesh-list
92870545|NCT00660855|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92870546|NCT00660855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92870547|NCT00660855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870548|NCT00660855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870549|NCT00660855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92870550|NCT00660855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92870551|NCT00660855|Analgesics|analgesics|mesh-ancestor
92870552|NCT00660855|Sensory System Agents|sensory system agents|mesh-ancestor
92215128|NCT04359511|Prednisone|prednisone|mesh-list
92870553|NCT00660855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870554|NCT00660855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870555|NCT00660855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870556|NCT00660855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870557|NCT00660933|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92870559|NCT02632071|Paclitaxel|paclitaxel|mesh-list
92515779|NCT03959761|Nivolumab|nivolumab|mesh-list
92870560|NCT02632071|Ricolinostat|ricolinostat|mesh-list
92870561|NCT02632071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92870562|NCT02632071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870563|NCT02632071|Tubulin Modulators|tubulin modulators|mesh-ancestor
92158404|NCT05572255|Cenobamate|cenobamate|mesh-list
92870564|NCT02632071|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870565|NCT02632071|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870566|NCT02632071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870567|NCT02632071|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92870568|NCT02632071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870569|NCT00879333|Everolimus|everolimus|mesh-list
92870570|NCT00879333|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92870571|NCT00879333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870572|NCT00879333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870573|NCT00879333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870574|NCT00879333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870575|NCT00879333|Immunologic Factors|immunologic factors|mesh-ancestor
92870576|NCT00879333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870577|NCT00879333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870578|NCT02630823|Paclitaxel|paclitaxel|mesh-list
92870579|NCT02630823|Carboplatin|carboplatin|mesh-list
92870580|NCT02630823|Pembrolizumab|pembrolizumab|mesh-list
92870581|NCT02630823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92870582|NCT02630823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870583|NCT02630823|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870584|NCT02630823|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870585|NCT02630823|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870586|NCT02630823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870587|NCT02630823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870588|NCT02630823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92870589|NCT02630511|Mannitol|mannitol|mesh-list
92870590|NCT02630511|Methacholine Chloride|methacholine chloride|mesh-list
92870591|NCT02630511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92870592|NCT02630511|Diuretics|diuretics|mesh-ancestor
92870593|NCT02630511|Natriuretic Agents|natriuretic agents|mesh-ancestor
92870594|NCT02630511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870595|NCT02630511|Miotics|miotics|mesh-ancestor
92870596|NCT02630511|Autonomic Agents|autonomic agents|mesh-ancestor
92870597|NCT02630511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870598|NCT02630511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92870599|NCT02630511|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92870600|NCT02630511|Respiratory System Agents|respiratory system agents|mesh-ancestor
92870601|NCT02630511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92870602|NCT02630511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92870603|NCT02630511|Cholinergic Agents|cholinergic agents|mesh-ancestor
92870604|NCT02630511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870605|NCT02630511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870606|NCT00666159|Pimecrolimus|pimecrolimus|mesh-list
92870607|NCT00666159|Tacrolimus|tacrolimus|mesh-list
92870608|NCT00666159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870609|NCT00666159|Immunologic Factors|immunologic factors|mesh-ancestor
92870610|NCT00666159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870611|NCT00666159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92870612|NCT00666159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870613|NCT00666159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870614|NCT00666159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92870615|NCT00666159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92870616|NCT00666159|Analgesics|analgesics|mesh-ancestor
92870617|NCT00666159|Sensory System Agents|sensory system agents|mesh-ancestor
92870618|NCT00666159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870619|NCT00666159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870620|NCT00666159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870621|NCT00666159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92870622|NCT00666393|Fentanyl|fentanyl|mesh-list
92870623|NCT00666393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92870624|NCT00666393|Narcotics|narcotics|mesh-ancestor
92870625|NCT00666393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870626|NCT00666393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870627|NCT00666393|Analgesics|analgesics|mesh-ancestor
92158500|NCT05442463|Captopril|captopril|mesh-list
92870628|NCT00666393|Sensory System Agents|sensory system agents|mesh-ancestor
92870629|NCT00666393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870630|NCT00666393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92870631|NCT00666393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92870632|NCT00666393|Anesthetics, General|anesthetics, general|mesh-ancestor
92870633|NCT00666393|Anesthetics|anesthetics|mesh-ancestor
92515856|NCT03958708|Rifaximin|rifaximin|mesh-list
92870634|NCT00666627|Alendronate|alendronate|mesh-list
92870635|NCT00666627|Risedronic Acid|risedronic acid|mesh-list
92870636|NCT00666627|Ibandronic Acid|ibandronic acid|mesh-list
92870637|NCT00666627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92870638|NCT00666627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870639|NCT00666627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92870640|NCT00666627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870641|NCT00666627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870642|NCT00666627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92870643|NCT00666783|Palonosetron|palonosetron|mesh-list
92870644|NCT00666783|Granisetron|granisetron|mesh-list
92870645|NCT00666783|Antiemetics|antiemetics|mesh-ancestor
92870646|NCT00666783|Autonomic Agents|autonomic agents|mesh-ancestor
92870647|NCT00666783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870648|NCT00666783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870649|NCT00666783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870650|NCT00666783|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92870651|NCT00666783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92870652|NCT00666783|Serotonin Agents|serotonin agents|mesh-ancestor
92870653|NCT00666783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870654|NCT00666783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870655|NCT00666939|Gabapentin|gabapentin|mesh-list
92870656|NCT00666939|Analgesics|analgesics|mesh-ancestor
92870657|NCT00666939|Sensory System Agents|sensory system agents|mesh-ancestor
92870658|NCT00666939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870659|NCT00666939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870660|NCT00666939|Anticonvulsants|anticonvulsants|mesh-ancestor
92870661|NCT00666939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92870662|NCT00666939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870663|NCT00666939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870664|NCT00666939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870665|NCT00666939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92870666|NCT00666939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92870667|NCT00666939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870668|NCT00666939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870669|NCT00666939|Antimanic Agents|antimanic agents|mesh-ancestor
92870670|NCT00667407|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92870671|NCT00667407|Albuterol|albuterol|mesh-list
92870672|NCT00667407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92870673|NCT00667407|Autonomic Agents|autonomic agents|mesh-ancestor
92870674|NCT00667407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870675|NCT00667407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870676|NCT00667407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92870677|NCT00667407|Respiratory System Agents|respiratory system agents|mesh-ancestor
92870678|NCT00667407|Tocolytic Agents|tocolytic agents|mesh-ancestor
92870679|NCT00667407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92870680|NCT00667407|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92870681|NCT00667407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92870682|NCT00667407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92870683|NCT00667407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92870684|NCT00667407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870685|NCT00667407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870686|NCT00667485|Sirolimus|sirolimus|mesh-list
92870687|NCT00667485|Bevacizumab|bevacizumab|mesh-list
92870688|NCT00667485|Temsirolimus|temsirolimus|mesh-list
92870689|NCT00667485|MTOR Inhibitors|mtor inhibitors|mesh-list
92870690|NCT00667485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870691|NCT00667485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870692|NCT00667485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92870693|NCT00667485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870694|NCT00667485|Growth Substances|growth substances|mesh-ancestor
92870695|NCT00667485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870696|NCT00667485|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870697|NCT00667485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92870698|NCT00667485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870699|NCT00667485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92870700|NCT00667485|Antifungal Agents|antifungal agents|mesh-ancestor
92870701|NCT00667485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870702|NCT00667485|Immunologic Factors|immunologic factors|mesh-ancestor
92870703|NCT00667485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92870704|NCT00667485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870705|NCT00667485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870706|NCT00667641|Paclitaxel|paclitaxel|mesh-list
92870707|NCT00667641|Bortezomib|bortezomib|mesh-list
92870708|NCT00667641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92515926|NCT05206175|Methamphetamine|methamphetamine|mesh-list
92870709|NCT00667641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870710|NCT00667641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870711|NCT00667641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870712|NCT00667641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870713|NCT00667641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870714|NCT00667797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92870715|NCT00667797|Albuterol|albuterol|mesh-list
92870716|NCT00667797|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92870717|NCT00667797|Autonomic Agents|autonomic agents|mesh-ancestor
92870718|NCT00667797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870719|NCT00667797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870720|NCT00667797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92870721|NCT00667797|Respiratory System Agents|respiratory system agents|mesh-ancestor
92870722|NCT00667797|Tocolytic Agents|tocolytic agents|mesh-ancestor
92870723|NCT00667797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92870724|NCT00667797|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92870725|NCT00667797|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92870726|NCT00667797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92870727|NCT00667797|Adrenergic Agents|adrenergic agents|mesh-ancestor
92870728|NCT00667797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870729|NCT00667797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870730|NCT03481556|Dexamethasone|dexamethasone|mesh-list
92870731|NCT03481556|Dexamethasone acetate|dexamethasone acetate|mesh-list
92870732|NCT03481556|Bortezomib|bortezomib|mesh-list
92870733|NCT03481556|Melphalan|melphalan|mesh-list
92870734|NCT03481556|Daratumumab|daratumumab|mesh-list
92870735|NCT03481556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870736|NCT03481556|Antiemetics|antiemetics|mesh-ancestor
92870737|NCT03481556|Autonomic Agents|autonomic agents|mesh-ancestor
92870738|NCT03481556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870739|NCT03481556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870740|NCT03481556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870741|NCT03481556|Glucocorticoids|glucocorticoids|mesh-ancestor
92870742|NCT03481556|Hormones|hormones|mesh-ancestor
92870743|NCT03481556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870744|NCT03481556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870745|NCT03481556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870746|NCT03481556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92870747|NCT03481556|Alkylating Agents|alkylating agents|mesh-ancestor
92870748|NCT03481556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870749|NCT03481556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92870750|NCT03481556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870751|NCT03481556|Immunologic Factors|immunologic factors|mesh-ancestor
92870752|NCT00668031|Aprotinin|aprotinin|mesh-list
92870753|NCT00668031|Hemostatics|hemostatics|mesh-ancestor
92870754|NCT00668031|Coagulants|coagulants|mesh-ancestor
92870755|NCT00668031|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92870756|NCT00668031|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92870757|NCT00668031|Protease Inhibitors|protease inhibitors|mesh-ancestor
92870758|NCT00668031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870759|NCT00668031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870760|NCT03480776|Aspirin|aspirin|mesh-list
92870761|NCT03480776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92870762|NCT03480776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92870763|NCT03480776|Analgesics|analgesics|mesh-ancestor
92870764|NCT03480776|Sensory System Agents|sensory system agents|mesh-ancestor
92870765|NCT03480776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870766|NCT03480776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870767|NCT03480776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870768|NCT03480776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92870769|NCT03480776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92870770|NCT03480776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92870771|NCT03480776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870772|NCT03480776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92870773|NCT03480776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92870774|NCT03480776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870775|NCT03480776|Antipyretics|antipyretics|mesh-ancestor
92870776|NCT00668109|Tadalafil|tadalafil|mesh-list
92870777|NCT00668109|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92870778|NCT00668109|Vasodilator Agents|vasodilator agents|mesh-ancestor
92870779|NCT00668109|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92870780|NCT00668109|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92870781|NCT00668109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870782|NCT00668109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516014|NCT05633472|Vitamin D|vitamin d|mesh-list
92870783|NCT00668109|Urological Agents|urological agents|mesh-ancestor
92870784|NCT00668343|Simvastatin|simvastatin|mesh-list
92870785|NCT00668343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92870786|NCT00668343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92870787|NCT00668343|Antimetabolites|antimetabolites|mesh-ancestor
92870788|NCT00668343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870789|NCT00668343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92870790|NCT00668343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92870791|NCT00668343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870792|NCT04717700|Dexamethasone|dexamethasone|mesh-list
92870793|NCT04717700|Lenalidomide|lenalidomide|mesh-list
92870795|NCT04717700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870796|NCT04717700|Antiemetics|antiemetics|mesh-ancestor
92870797|NCT04717700|Autonomic Agents|autonomic agents|mesh-ancestor
92870798|NCT04717700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870799|NCT04717700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870800|NCT04717700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870801|NCT04717700|Glucocorticoids|glucocorticoids|mesh-ancestor
92870802|NCT04717700|Hormones|hormones|mesh-ancestor
92870803|NCT04717700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870804|NCT04717700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870805|NCT04717700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870806|NCT04717700|Immunologic Factors|immunologic factors|mesh-ancestor
92870807|NCT04717700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92870808|NCT04717700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870809|NCT04717700|Growth Substances|growth substances|mesh-ancestor
92870810|NCT04717700|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870811|NCT02630277|Aflibercept|aflibercept|mesh-list
92870812|NCT02630277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92870813|NCT02630277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870814|NCT02630277|Growth Substances|growth substances|mesh-ancestor
92870815|NCT02630277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870816|NCT02630277|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870817|NCT02630277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870818|NCT00668499|Pemetrexed|pemetrexed|mesh-list
92870819|NCT00668499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870820|NCT00668499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870821|NCT00668499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870822|NCT00668499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92870823|NCT00668499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92870824|NCT05201846|Insulin|insulin|mesh-list
92870825|NCT05201846|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92870826|NCT05201846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92870827|NCT05201846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870828|NCT00668967|Verapamil|verapamil|mesh-list
92870829|NCT00668967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92870830|NCT00668967|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92870831|NCT00668967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870832|NCT00668967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870833|NCT00668967|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92870834|NCT00668967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870835|NCT00668967|Vasodilator Agents|vasodilator agents|mesh-ancestor
92870836|NCT03583658|Ambroxol|ambroxol|mesh-list
92870837|NCT03583658|Expectorants|expectorants|mesh-ancestor
92870838|NCT03583658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92870839|NCT03555968|Dronabinol|dronabinol|mesh-list
92870840|NCT03555968|Hallucinogens|hallucinogens|mesh-ancestor
92870841|NCT03555968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870842|NCT03555968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870843|NCT03555968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92870844|NCT03555968|Analgesics|analgesics|mesh-ancestor
92870845|NCT03555968|Sensory System Agents|sensory system agents|mesh-ancestor
92870846|NCT03555968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870847|NCT03555968|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92870848|NCT03555968|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92870849|NCT03555968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870850|NCT03555968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870852|NCT03555968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870853|NCT04593680|Tenofovir|tenofovir|mesh-list
92870854|NCT04593680|Emtricitabine|emtricitabine|mesh-list
92870855|NCT04593680|Antiviral Agents|antiviral agents|mesh-ancestor
92870856|NCT04593680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870857|NCT04593680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92870858|NCT04593680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92870860|NCT04593680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870861|NCT04593680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92870862|NCT04593680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92870863|NCT00669435|Losartan|losartan|mesh-list
92870864|NCT00669435|Amlodipine|amlodipine|mesh-list
92870865|NCT00669435|Simvastatin|simvastatin|mesh-list
92870866|NCT00669435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92870867|NCT00669435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92870868|NCT00669435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870869|NCT00669435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870870|NCT00669435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92870871|NCT00669435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870872|NCT00669435|Vasodilator Agents|vasodilator agents|mesh-ancestor
92870873|NCT00669435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92870874|NCT00669435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92870875|NCT00669435|Antimetabolites|antimetabolites|mesh-ancestor
92870876|NCT00669435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92870877|NCT00669435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92870878|NCT00669435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870879|NCT00669435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92870880|NCT00669435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92870881|NCT00669435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92870882|NCT00669591|Bavituximab|bavituximab|mesh-list
92870883|NCT00669591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870884|NCT00669591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870885|NCT00669747|Carboplatin|carboplatin|mesh-list
92870886|NCT00669747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870887|NCT00596427|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92870888|NCT00596427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92870889|NCT00596427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92870890|NCT00596427|Antimetabolites|antimetabolites|mesh-ancestor
92870891|NCT00596427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870892|NCT00596427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92870893|NCT00670215|Ciprofloxacin|ciprofloxacin|mesh-list
92870894|NCT00670215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92870895|NCT00670215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870896|NCT00670215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92870897|NCT00670215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92870898|NCT00670215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870899|NCT00670215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870900|NCT00670215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870901|NCT00670215|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92870902|NCT00670215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92870903|NCT00670293|Raclopride|raclopride|mesh-list
92870904|NCT00670293|Methylphenidate|methylphenidate|mesh-list
92870905|NCT00670293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92870906|NCT00670293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870907|NCT00670293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92870908|NCT00670293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92870909|NCT00670293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92870910|NCT00670293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870911|NCT00670293|Dopamine Agents|dopamine agents|mesh-ancestor
92870912|NCT00670293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870913|NCT00670293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92870914|NCT00670293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92870915|NCT00670293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870916|NCT00670293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92870917|NCT00670293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92525262|NCT00024232|Antibodies|antibodies|mesh-list
92870919|NCT00670683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92870920|NCT00670683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870921|NCT00670761|Misoprostol|misoprostol|mesh-list
92870922|NCT00670761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92870923|NCT00670761|Abortifacient Agents|abortifacient agents|mesh-ancestor
92870924|NCT00670761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92870925|NCT00670761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870926|NCT00670761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93026469|NCT00413283|Antimetabolites|antimetabolites|mesh-ancestor
92870927|NCT00670761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870928|NCT00670761|Oxytocics|oxytocics|mesh-ancestor
92870929|NCT00680433|Ketamine|ketamine|mesh-list
92870930|NCT00680433|Analgesics|analgesics|mesh-ancestor
92870931|NCT00680433|Sensory System Agents|sensory system agents|mesh-ancestor
92870932|NCT00680433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870933|NCT00680433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870934|NCT00680433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92870935|NCT00680433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92870936|NCT00680433|Anesthetics, General|anesthetics, general|mesh-ancestor
92870938|NCT00680433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870939|NCT00680433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92870940|NCT00680433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92870941|NCT00680433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92870942|NCT00680433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870943|NCT03322280|Chlorotrianisene|chlorotrianisene|mesh-list
92870944|NCT03322280|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92870945|NCT03322280|Estrogens|estrogens|mesh-ancestor
92870946|NCT03322280|Hormones|hormones|mesh-ancestor
92870947|NCT03322280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870948|NCT03322280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870949|NCT03322280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870950|NCT03322280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870951|NCT04150965|Thalidomide|thalidomide|mesh-list
92870952|NCT04150965|Dexamethasone|dexamethasone|mesh-list
92870953|NCT04150965|Dexamethasone acetate|dexamethasone acetate|mesh-list
92870954|NCT04150965|Pomalidomide|pomalidomide|mesh-list
92870955|NCT04150965|Relatlimab|relatlimab|mesh-list
92870956|NCT04150965|Elotuzumab|elotuzumab|mesh-list
92870957|NCT04150965|BB 1101|bb 1101|mesh-list
92870958|NCT04150965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92870959|NCT04150965|Antiemetics|antiemetics|mesh-ancestor
92870960|NCT04150965|Autonomic Agents|autonomic agents|mesh-ancestor
92870961|NCT04150965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870962|NCT04150965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870963|NCT04150965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92870964|NCT04150965|Glucocorticoids|glucocorticoids|mesh-ancestor
92870965|NCT04150965|Hormones|hormones|mesh-ancestor
92870966|NCT04150965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92870967|NCT04150965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92870968|NCT04150965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870969|NCT04150965|Protease Inhibitors|protease inhibitors|mesh-ancestor
92870970|NCT04150965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92870971|NCT04150965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870972|NCT04150965|Immunologic Factors|immunologic factors|mesh-ancestor
92870973|NCT04150965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92158937|NCT04704063|Vitamin E|vitamin e|mesh-list
92870974|NCT04150965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92870975|NCT04150965|Growth Substances|growth substances|mesh-ancestor
92870976|NCT04150965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92870977|NCT04150965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92870978|NCT04150965|Leprostatic Agents|leprostatic agents|mesh-ancestor
92870979|NCT04150965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92870980|NCT04150965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92870981|NCT04150965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92870982|NCT04150965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92870983|NCT04150575|Paclitaxel|paclitaxel|mesh-list
92870984|NCT04150575|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92870985|NCT04150575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92870986|NCT04150575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92870987|NCT04150575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92870988|NCT04150575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92870989|NCT04150575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92870990|NCT04150575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92870991|NCT05345132|Magnesium Sulfate|magnesium sulfate|mesh-list
92870992|NCT05345132|Nifedipine|nifedipine|mesh-list
92870994|NCT05345132|Sensory System Agents|sensory system agents|mesh-ancestor
92870995|NCT05345132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92870996|NCT05345132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92870997|NCT05345132|Anesthetics|anesthetics|mesh-ancestor
92870998|NCT05345132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92870999|NCT05345132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92871000|NCT05345132|Anticonvulsants|anticonvulsants|mesh-ancestor
92871001|NCT05345132|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92871002|NCT05345132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871003|NCT05345132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871004|NCT05345132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92871006|NCT05345132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92871007|NCT05345132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92871008|NCT04349306|Rasburicase|rasburicase|mesh-list
92871009|NCT04349306|Gout Suppressants|gout suppressants|mesh-ancestor
92871010|NCT04349306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871011|NCT00614588|Anesthetics|anesthetics|mesh-list
92871012|NCT00614588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871013|NCT00614588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871014|NCT03421652|Nivolumab|nivolumab|mesh-list
92871015|NCT03421652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871016|NCT03421652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871017|NCT03421652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92871018|NCT03421652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871019|NCT02699840|Vaccines|vaccines|mesh-list
92871020|NCT02699840|Immunologic Factors|immunologic factors|mesh-ancestor
92871021|NCT02699840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871022|NCT00613808|Nitric Oxide|nitric oxide|mesh-list
92871023|NCT00613808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92871024|NCT00613808|Autonomic Agents|autonomic agents|mesh-ancestor
92158962|NCT04636255|Calcium|calcium|mesh-list
92871025|NCT00613808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871026|NCT00613808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871027|NCT00613808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92871028|NCT00613808|Respiratory System Agents|respiratory system agents|mesh-ancestor
92871029|NCT00613808|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92871030|NCT00613808|Antioxidants|antioxidants|mesh-ancestor
92871031|NCT00613808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871032|NCT00613808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871033|NCT00613808|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92871034|NCT00613808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92871035|NCT00613808|Gasotransmitters|gasotransmitters|mesh-ancestor
92871036|NCT00613808|Protective Agents|protective agents|mesh-ancestor
92871037|NCT05344742|Paclitaxel|paclitaxel|mesh-list
92871038|NCT05344742|Capecitabine|capecitabine|mesh-list
92871039|NCT05344742|Mitoxantrone|mitoxantrone|mesh-list
92871040|NCT05344742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92871041|NCT05344742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871042|NCT05344742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92871043|NCT05344742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92871044|NCT05344742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92871045|NCT05344742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871046|NCT05344742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871047|NCT05344742|Antimetabolites|antimetabolites|mesh-ancestor
92871048|NCT05344742|Analgesics|analgesics|mesh-ancestor
92871049|NCT05344742|Sensory System Agents|sensory system agents|mesh-ancestor
92871050|NCT05344742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871051|NCT05344742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871052|NCT05344742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92871053|NCT05344742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92871054|NCT05344742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871055|NCT02046434|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92871056|NCT02046434|Glycerol|glycerol|mesh-list
92871057|NCT02046434|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92871058|NCT02046434|Protective Agents|protective agents|mesh-ancestor
92871059|NCT02046434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871060|NCT02046434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871061|NCT03930446|Ethanol|ethanol|mesh-list
92871062|NCT03930446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92871063|NCT03930446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871064|NCT03930446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871065|NCT03930446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871066|NCT00614666|Nikkomycin|nikkomycin|mesh-list
92871067|NCT00614666|Antifungal Agents|antifungal agents|mesh-ancestor
92871068|NCT00614666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871069|NCT00614666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871070|NCT00614666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871071|NCT03794336|Aspirin|aspirin|mesh-list
92871072|NCT03794336|Metformin|metformin|mesh-list
92871073|NCT03794336|Alogliptin|alogliptin|mesh-list
92871074|NCT03794336|Acarbose|acarbose|mesh-list
92871075|NCT03794336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871076|NCT03794336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871077|NCT03794336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92871078|NCT03794336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871079|NCT03794336|Analgesics|analgesics|mesh-ancestor
92871080|NCT03794336|Sensory System Agents|sensory system agents|mesh-ancestor
92871081|NCT03794336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871082|NCT03794336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871083|NCT03794336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871084|NCT03794336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92871085|NCT03794336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92871086|NCT03794336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871087|NCT03794336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92871088|NCT03794336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92871089|NCT03794336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871090|NCT03794336|Antipyretics|antipyretics|mesh-ancestor
92871091|NCT03794336|Incretins|incretins|mesh-ancestor
92871092|NCT03794336|Hormones|hormones|mesh-ancestor
92871093|NCT03794336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871094|NCT03794336|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92871095|NCT03794336|Protease Inhibitors|protease inhibitors|mesh-ancestor
92871096|NCT03794336|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92871097|NCT03774914|Alemtuzumab|alemtuzumab|mesh-list
92871098|NCT03774914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871099|NCT03774914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871100|NCT03687554|Venglustat|venglustat|mesh-list
92871101|NCT03687554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871102|NCT03687554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871103|NCT03681158|Valproic Acid|valproic acid|mesh-list
92871104|NCT03681158|Anticonvulsants|anticonvulsants|mesh-ancestor
92871105|NCT03681158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871106|NCT03681158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871107|NCT03681158|GABA Agents|gaba agents|mesh-ancestor
92871108|NCT03681158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871109|NCT03681158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871110|NCT03681158|Antimanic Agents|antimanic agents|mesh-ancestor
92871111|NCT03681158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92871112|NCT03681158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871113|NCT03681158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92871114|NCT05343806|Magnesium Sulfate|magnesium sulfate|mesh-list
92871115|NCT05343806|Nifedipine|nifedipine|mesh-list
92871116|NCT05343806|Analgesics|analgesics|mesh-ancestor
92871117|NCT05343806|Sensory System Agents|sensory system agents|mesh-ancestor
92871118|NCT05343806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871119|NCT05343806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871120|NCT05343806|Anesthetics|anesthetics|mesh-ancestor
92871121|NCT05343806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871122|NCT05343806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92871123|NCT05343806|Anticonvulsants|anticonvulsants|mesh-ancestor
92871124|NCT05343806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92871125|NCT05343806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871126|NCT05343806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871127|NCT05343806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92871128|NCT05343806|Tocolytic Agents|tocolytic agents|mesh-ancestor
92871129|NCT05343806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92871130|NCT05343806|Vasodilator Agents|vasodilator agents|mesh-ancestor
92871131|NCT05343728|Hemostatics|hemostatics|mesh-list
92871132|NCT05343728|Coagulants|coagulants|mesh-ancestor
92871133|NCT00436748|Darbepoetin alfa|darbepoetin alfa|mesh-list
92871134|NCT00436748|Hematinics|hematinics|mesh-ancestor
92871135|NCT02704598|Warfarin|warfarin|mesh-list
92871136|NCT02704598|Rivaroxaban|rivaroxaban|mesh-list
92871137|NCT02704598|Anticoagulants|anticoagulants|mesh-ancestor
92871138|NCT02704598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92871139|NCT02704598|Antithrombins|antithrombins|mesh-ancestor
92171921|NCT02397720|Nivolumab|nivolumab|mesh-list
92871140|NCT02704598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92871141|NCT02704598|Protease Inhibitors|protease inhibitors|mesh-ancestor
92871142|NCT02704598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871143|NCT02704598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871144|NCT03342404|Luspatercept|luspatercept|mesh-list
92871145|NCT03342404|Hematinics|hematinics|mesh-ancestor
92871146|NCT03094052|Trastuzumab|trastuzumab|mesh-list
92871147|NCT03094052|Atropine|atropine|mesh-list
92871148|NCT03094052|Diphenoxylate|diphenoxylate|mesh-list
92871149|NCT03094052|Loperamide|loperamide|mesh-list
92871150|NCT03094052|Antidiarrheals|antidiarrheals|mesh-list
92871151|NCT03094052|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
92871152|NCT03094052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871153|NCT03094052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871154|NCT03094052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92871155|NCT03094052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92871156|NCT03094052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92871157|NCT03094052|Autonomic Agents|autonomic agents|mesh-ancestor
92871158|NCT03094052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871159|NCT03094052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871160|NCT03094052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92871161|NCT03094052|Respiratory System Agents|respiratory system agents|mesh-ancestor
92871162|NCT03094052|Mydriatics|mydriatics|mesh-ancestor
92871163|NCT03094052|Parasympatholytics|parasympatholytics|mesh-ancestor
92871164|NCT03094052|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92871165|NCT03094052|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92871166|NCT03094052|Cholinergic Agents|cholinergic agents|mesh-ancestor
92871167|NCT03094052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871168|NCT03094052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871169|NCT03094052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871170|NCT03094052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92871171|NCT03094052|Narcotics|narcotics|mesh-ancestor
92871172|NCT03094052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871173|NCT03094052|Analgesics|analgesics|mesh-ancestor
92871174|NCT03094052|Sensory System Agents|sensory system agents|mesh-ancestor
92871175|NCT05343338|Sivelestat|sivelestat|mesh-list
92871176|NCT05343338|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92871177|NCT05343338|Protease Inhibitors|protease inhibitors|mesh-ancestor
92871178|NCT05343338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871179|NCT05343338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871180|NCT02704520|Leucovorin|leucovorin|mesh-list
92871181|NCT02704520|Folic Acid|folic acid|mesh-list
92871182|NCT02704520|Fluorouracil|fluorouracil|mesh-list
92871183|NCT02704520|Capecitabine|capecitabine|mesh-list
92871184|NCT02704520|Oxaliplatin|oxaliplatin|mesh-list
92871185|NCT02704520|Levoleucovorin|levoleucovorin|mesh-list
92871186|NCT02704520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871187|NCT02704520|Antimetabolites|antimetabolites|mesh-ancestor
92871188|NCT02704520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871189|NCT02704520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871190|NCT02704520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871191|NCT02704520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871192|NCT02704520|Immunologic Factors|immunologic factors|mesh-ancestor
92871193|NCT02704520|Antidotes|antidotes|mesh-ancestor
92871194|NCT02704520|Protective Agents|protective agents|mesh-ancestor
92871195|NCT02704520|Vitamin B Complex|vitamin b complex|mesh-ancestor
92871196|NCT02704520|Vitamins|vitamins|mesh-ancestor
92871197|NCT02704520|Micronutrients|micronutrients|mesh-ancestor
92871198|NCT02704520|Hematinics|hematinics|mesh-ancestor
92871199|NCT02704052|Enoxaparin|enoxaparin|mesh-list
92871200|NCT02704052|Enoxaparin sodium|enoxaparin sodium|mesh-list
92871201|NCT02704052|Anticoagulants|anticoagulants|mesh-ancestor
92871202|NCT02704052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92871203|NCT02704052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92871204|NCT02704052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871205|NCT02703896|Esomeprazole|esomeprazole|mesh-list
92871206|NCT02703896|Omeprazole|omeprazole|mesh-list
92871207|NCT02703896|Pantoprazole|pantoprazole|mesh-list
92871208|NCT02703896|Lansoprazole|lansoprazole|mesh-list
92871209|NCT02703896|Famotidine|famotidine|mesh-list
92871210|NCT02703896|Ranitidine|ranitidine|mesh-list
92871211|NCT02703896|Cimetidine|cimetidine|mesh-list
92871212|NCT02703896|Nizatidine|nizatidine|mesh-list
92871213|NCT02703896|Lafutidine|lafutidine|mesh-list
92871214|NCT02703896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92871215|NCT02703896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871216|NCT02703896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92871217|NCT02703896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871218|NCT02703896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871219|NCT02703896|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92871220|NCT02703896|Histamine Antagonists|histamine antagonists|mesh-ancestor
92871221|NCT02703896|Histamine Agents|histamine agents|mesh-ancestor
92871222|NCT02703896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871223|NCT02703896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159070|NCT04540666|Propofol|propofol|mesh-list
92871224|NCT02703896|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92871225|NCT02703896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92871226|NCT02737436|Oxytocin|oxytocin|mesh-list
92871227|NCT02737436|Oxytocics|oxytocics|mesh-ancestor
92871228|NCT02737436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92871229|NCT02737436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871230|NCT00614978|Temozolomide|temozolomide|mesh-list
92871231|NCT00614978|Lapatinib|lapatinib|mesh-list
92871232|NCT00614978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92871233|NCT00614978|Alkylating Agents|alkylating agents|mesh-ancestor
92871234|NCT00614978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871235|NCT00614978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871236|NCT00614978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92871237|NCT00614978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871238|NCT03188354|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92871239|NCT03188354|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92871240|NCT03188354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871241|NCT02703740|Lidocaine|lidocaine|mesh-list
92871242|NCT02703740|Hyaluronic Acid|hyaluronic acid|mesh-list
92871243|NCT02703740|Anesthetics, Local|anesthetics, local|mesh-ancestor
92871244|NCT02703740|Anesthetics|anesthetics|mesh-ancestor
92871245|NCT02703740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871246|NCT02703740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871247|NCT02703740|Sensory System Agents|sensory system agents|mesh-ancestor
92871248|NCT02703740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871249|NCT02703740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92871250|NCT02703740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92871251|NCT02703740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92871252|NCT02703740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871253|NCT02703740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871254|NCT02703740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92871255|NCT02703740|Immunologic Factors|immunologic factors|mesh-ancestor
92871256|NCT02703740|Viscosupplements|viscosupplements|mesh-ancestor
92871257|NCT02703740|Protective Agents|protective agents|mesh-ancestor
92871258|NCT00615368|Epoetin Alfa|epoetin alfa|mesh-list
92871259|NCT00615368|Hematinics|hematinics|mesh-ancestor
92871260|NCT00615446|Gemcitabine|gemcitabine|mesh-list
92871261|NCT00615446|Sunitinib|sunitinib|mesh-list
92871262|NCT00615446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871263|NCT00615446|Antimetabolites|antimetabolites|mesh-ancestor
92871264|NCT00615446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871265|NCT00615446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871266|NCT00615446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92871267|NCT00615446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92871268|NCT00615446|Growth Substances|growth substances|mesh-ancestor
92871269|NCT00615446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871270|NCT00615446|Growth Inhibitors|growth inhibitors|mesh-ancestor
92871271|NCT00615446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92871272|NCT00615446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871273|NCT02703272|Dexamethasone|dexamethasone|mesh-list
92871274|NCT02703272|Rituximab|rituximab|mesh-list
92871275|NCT02703272|Carboplatin|carboplatin|mesh-list
92871276|NCT02703272|Etoposide|etoposide|mesh-list
92871277|NCT02703272|Vincristine|vincristine|mesh-list
92871278|NCT02703272|Ifosfamide|ifosfamide|mesh-list
92871279|NCT02703272|Idarubicin|idarubicin|mesh-list
92871280|NCT02703272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871281|NCT02703272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871282|NCT02703272|Immunologic Factors|immunologic factors|mesh-ancestor
92871283|NCT02703272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871284|NCT02703272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871285|NCT02703272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871286|NCT02703272|Antiemetics|antiemetics|mesh-ancestor
92871287|NCT02703272|Autonomic Agents|autonomic agents|mesh-ancestor
92871288|NCT02703272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871289|NCT02703272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871290|NCT02703272|Glucocorticoids|glucocorticoids|mesh-ancestor
92871291|NCT02703272|Hormones|hormones|mesh-ancestor
92871292|NCT02703272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871293|NCT02703272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92871294|NCT02703272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92871295|NCT02703272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92871296|NCT02703272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92871297|NCT02703272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871298|NCT02703272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871299|NCT02703272|Tubulin Modulators|tubulin modulators|mesh-ancestor
92871300|NCT02703272|Antimitotic Agents|antimitotic agents|mesh-ancestor
92871301|NCT02703272|Mitosis Modulators|mitosis modulators|mesh-ancestor
92871302|NCT02703272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92871303|NCT02703272|Alkylating Agents|alkylating agents|mesh-ancestor
92871304|NCT02703272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92871306|NCT02703194|Prednisolone|prednisolone|mesh-list
92871307|NCT02703194|Leflunomide|leflunomide|mesh-list
92871308|NCT02703194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871309|NCT02703194|Glucocorticoids|glucocorticoids|mesh-ancestor
92871310|NCT02703194|Hormones|hormones|mesh-ancestor
92516525|NCT01805596|Ticagrelor|ticagrelor|mesh-list
92159123|NCT04303780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92871311|NCT02703194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871312|NCT02703194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871313|NCT02703194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92871314|NCT02703194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871315|NCT02703194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871316|NCT02703194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871317|NCT02703194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871318|NCT02703194|Immunologic Factors|immunologic factors|mesh-ancestor
92871319|NCT02402660|Vitamin A|vitamin a|mesh-list
92871320|NCT02402660|Retinol acetate|retinol acetate|mesh-list
92871321|NCT02402660|Vitamins|vitamins|mesh-ancestor
92871322|NCT02402660|Micronutrients|micronutrients|mesh-ancestor
92871323|NCT02402660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871324|NCT02402660|Protective Agents|protective agents|mesh-ancestor
92871325|NCT02402660|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92871326|NCT02402660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871327|NCT02402660|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92871328|NCT02402660|Immunologic Factors|immunologic factors|mesh-ancestor
92871329|NCT02702960|Mycophenolic Acid|mycophenolic acid|mesh-list
92871330|NCT02702960|Prednisone|prednisone|mesh-list
92871331|NCT02702960|Cyclophosphamide|cyclophosphamide|mesh-list
92871332|NCT02702960|Fludarabine|fludarabine|mesh-list
92871333|NCT02702960|Tacrolimus|tacrolimus|mesh-list
92871334|NCT02702960|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92871335|NCT02702960|Mesna|mesna|mesh-list
92871336|NCT02702960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871337|NCT02702960|Immunologic Factors|immunologic factors|mesh-ancestor
92871338|NCT02702960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871339|NCT02702960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871340|NCT02702960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92871341|NCT02702960|Alkylating Agents|alkylating agents|mesh-ancestor
92871342|NCT02702960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871343|NCT02702960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871344|NCT02702960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92871345|NCT02702960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871346|NCT02702960|Glucocorticoids|glucocorticoids|mesh-ancestor
92871347|NCT02702960|Hormones|hormones|mesh-ancestor
92871348|NCT02702960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871349|NCT02702960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92871350|NCT02702960|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92871351|NCT02702960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871352|NCT02702960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92871353|NCT02702960|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92871354|NCT02702960|Antitubercular Agents|antitubercular agents|mesh-ancestor
92871355|NCT02702960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92871356|NCT02702960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871357|NCT02702960|Protective Agents|protective agents|mesh-ancestor
92871358|NCT02699528|Methylphenidate|methylphenidate|mesh-list
92871359|NCT02699528|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92871360|NCT02699528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871361|NCT02699528|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92871362|NCT02699528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92871363|NCT02699528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871364|NCT02699528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871365|NCT02699528|Dopamine Agents|dopamine agents|mesh-ancestor
92871366|NCT02699528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871367|NCT04215770|Penicillins|penicillins|mesh-list
92871368|NCT04215770|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92871369|NCT04215770|Penicillin G|penicillin g|mesh-list
92871370|NCT04215770|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92871371|NCT04215770|Penicillin G Procaine|penicillin g procaine|mesh-list
92871372|NCT04215770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92871373|NCT04215770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871374|NCT04215770|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92871375|NCT04215770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871376|NCT04215770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871377|NCT02702882|Fenugreek seed meal|fenugreek seed meal|mesh-list
92871378|NCT02702882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871379|NCT02702882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871380|NCT02699138|Trazodone|trazodone|mesh-list
92871381|NCT02699138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92871382|NCT02699138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92871383|NCT02699138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871384|NCT02699138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871385|NCT02699138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92871386|NCT02699138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92516604|NCT01465906|Bromides|bromides|mesh-list
92871387|NCT02699138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92871388|NCT02699138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871389|NCT02699138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871390|NCT02699138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871391|NCT02699138|Serotonin Agents|serotonin agents|mesh-ancestor
92871392|NCT02699138|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92871393|NCT02699138|Antidepressive Agents|antidepressive agents|mesh-ancestor
92871394|NCT00615134|Enfuvirtide|enfuvirtide|mesh-list
92871395|NCT00615134|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92871396|NCT00615134|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92871397|NCT00615134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871398|NCT00615134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92871399|NCT00615134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92871400|NCT00615134|Antiviral Agents|antiviral agents|mesh-ancestor
92871401|NCT00615134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871402|NCT01831076|Tamoxifen|tamoxifen|mesh-list
92871403|NCT01831076|Exemestane|exemestane|mesh-list
92871404|NCT01831076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92871405|NCT01831076|Hormone Antagonists|hormone antagonists|mesh-ancestor
92871406|NCT01831076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871407|NCT01831076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871408|NCT01831076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92871409|NCT01831076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871410|NCT01831076|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92871411|NCT01831076|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92871412|NCT01831076|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92871413|NCT01831076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92871414|NCT01831076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92871415|NCT01831076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871416|NCT01831076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871417|NCT02698982|Anesthetics|anesthetics|mesh-list
92871418|NCT02698982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871419|NCT02698982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871420|NCT00615524|Exemestane|exemestane|mesh-list
92871421|NCT00615524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871422|NCT00615524|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92871423|NCT00615524|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92871424|NCT00615524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871425|NCT00615524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871426|NCT00615524|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92871427|NCT00615524|Hormone Antagonists|hormone antagonists|mesh-ancestor
92871428|NCT00615524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871429|NCT00615524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871430|NCT00908141|Sargramostim|sargramostim|mesh-list
92871431|NCT00908141|Immunologic Factors|immunologic factors|mesh-ancestor
92871432|NCT00908141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871433|NCT01246310|Inositol|inositol|mesh-list
92871434|NCT01246310|Vitamin B Complex|vitamin b complex|mesh-ancestor
92871435|NCT01246310|Vitamins|vitamins|mesh-ancestor
92871436|NCT01246310|Micronutrients|micronutrients|mesh-ancestor
92525273|NCT00024271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871437|NCT01246310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871438|NCT00700076|Ketamine|ketamine|mesh-list
92871439|NCT00700076|Analgesics|analgesics|mesh-ancestor
92871440|NCT00700076|Sensory System Agents|sensory system agents|mesh-ancestor
92871441|NCT00700076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871442|NCT00700076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871443|NCT00700076|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92871444|NCT00700076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92871445|NCT00700076|Anesthetics, General|anesthetics, general|mesh-ancestor
92871446|NCT00700076|Anesthetics|anesthetics|mesh-ancestor
92871447|NCT00700076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871448|NCT00700076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92871449|NCT00700076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92871450|NCT00700076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871451|NCT00700076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871452|NCT02698514|Sevoflurane|sevoflurane|mesh-list
92871453|NCT02698514|Desflurane|desflurane|mesh-list
92871454|NCT02698514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92871455|NCT02698514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92871456|NCT02698514|Anesthetics, General|anesthetics, general|mesh-ancestor
92871457|NCT02698514|Anesthetics|anesthetics|mesh-ancestor
92871458|NCT02698514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516680|NCT04201457|Antioxidants|antioxidants|mesh-ancestor
92871459|NCT02698514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871460|NCT02706158|Vitamin D|vitamin d|mesh-list
92871461|NCT02706158|Calcium|calcium|mesh-list
92871462|NCT02706158|Vitamins|vitamins|mesh-ancestor
92871463|NCT02706158|Micronutrients|micronutrients|mesh-ancestor
92871464|NCT02706158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871465|NCT02706158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92871466|NCT02706158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92871467|NCT03739853|Sulfasalazine|sulfasalazine|mesh-list
92871468|NCT03739853|Adalimumab|adalimumab|mesh-list
92871469|NCT03739853|Methotrexate|methotrexate|mesh-list
92871470|NCT03739853|Leflunomide|leflunomide|mesh-list
92871471|NCT03739853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92871472|NCT03739853|Abortifacient Agents|abortifacient agents|mesh-ancestor
92871473|NCT03739853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92871474|NCT03739853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871475|NCT03739853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871476|NCT03739853|Antimetabolites|antimetabolites|mesh-ancestor
92871477|NCT03739853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871478|NCT03739853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871479|NCT03739853|Dermatologic Agents|dermatologic agents|mesh-ancestor
92871480|NCT03739853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871481|NCT03739853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92871482|NCT03739853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871483|NCT03739853|Immunologic Factors|immunologic factors|mesh-ancestor
92871484|NCT03739853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871485|NCT03739853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92871486|NCT03739853|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92871487|NCT03739853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871488|NCT03739853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871489|NCT03739853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92871490|NCT03739853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871491|NCT03739853|Analgesics|analgesics|mesh-ancestor
92871492|NCT03739853|Sensory System Agents|sensory system agents|mesh-ancestor
92871493|NCT03739853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871494|NCT03739853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871495|NCT00615602|Cyclophosphamide|cyclophosphamide|mesh-list
92871496|NCT00615602|Docetaxel|docetaxel|mesh-list
92871497|NCT00615602|Trastuzumab|trastuzumab|mesh-list
92871498|NCT00615602|Epirubicin|epirubicin|mesh-list
92871499|NCT00615602|Fluorouracil|fluorouracil|mesh-list
92871500|NCT00615602|Lenograstim|lenograstim|mesh-list
92871501|NCT00615602|Mitogens|mitogens|mesh-list
92871502|NCT00615602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871503|NCT00615602|Immunologic Factors|immunologic factors|mesh-ancestor
92871504|NCT00615602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871505|NCT00615602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871506|NCT00615602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92871507|NCT00615602|Alkylating Agents|alkylating agents|mesh-ancestor
92871508|NCT00615602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871509|NCT00615602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871510|NCT00615602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92871511|NCT00615602|Tubulin Modulators|tubulin modulators|mesh-ancestor
92871512|NCT00615602|Antimitotic Agents|antimitotic agents|mesh-ancestor
92871513|NCT00615602|Mitosis Modulators|mitosis modulators|mesh-ancestor
92871514|NCT00615602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871515|NCT00615602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92871516|NCT00615602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92871517|NCT00615602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92871518|NCT00615602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871520|NCT00615602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871521|NCT00615602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92871522|NCT02698748|Chloroquine|chloroquine|mesh-list
92871523|NCT02698748|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92871524|NCT02698748|Amebicides|amebicides|mesh-ancestor
92871525|NCT02698748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92871526|NCT02698748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92871527|NCT02698748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871528|NCT02698748|Antimalarials|antimalarials|mesh-ancestor
92871529|NCT02698748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871530|NCT02698748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92871531|NCT02698748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871532|NCT02698748|Analgesics|analgesics|mesh-ancestor
92871533|NCT02698748|Sensory System Agents|sensory system agents|mesh-ancestor
92871534|NCT02698748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871535|NCT02698748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871536|NCT02698748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871538|NCT02698748|Antinematodal Agents|antinematodal agents|mesh-ancestor
92871539|NCT02698748|Anthelmintics|anthelmintics|mesh-ancestor
92871540|NCT04750343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92871541|NCT04214990|Aspirin|aspirin|mesh-list
92871542|NCT04214990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92871543|NCT04214990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871544|NCT04214990|Analgesics|analgesics|mesh-ancestor
92871545|NCT04214990|Sensory System Agents|sensory system agents|mesh-ancestor
92871546|NCT04214990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871547|NCT04214990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871548|NCT04214990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871549|NCT04214990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871550|NCT04214990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92871551|NCT04214990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92871552|NCT04214990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871553|NCT04214990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92871554|NCT04214990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92871555|NCT04214990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871556|NCT04214990|Antipyretics|antipyretics|mesh-ancestor
92871557|NCT00615212|Rosiglitazone|rosiglitazone|mesh-list
92871558|NCT00615212|Flurbiprofen|flurbiprofen|mesh-list
92871559|NCT00615212|Midazolam|midazolam|mesh-list
92871560|NCT00615212|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92871561|NCT00615212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92871562|NCT00615212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871563|NCT00615212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871564|NCT00615212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92871565|NCT00615212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92871566|NCT00615212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92871567|NCT00615212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92871568|NCT00615212|Anesthetics, General|anesthetics, general|mesh-ancestor
92871569|NCT00615212|Anesthetics|anesthetics|mesh-ancestor
92871570|NCT00615212|GABA Modulators|gaba modulators|mesh-ancestor
92871571|NCT00615212|GABA Agents|gaba agents|mesh-ancestor
92871572|NCT00615212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871573|NCT00615212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871574|NCT00615212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871575|NCT00615212|Analgesics|analgesics|mesh-ancestor
92871576|NCT00615212|Sensory System Agents|sensory system agents|mesh-ancestor
92871577|NCT00615212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871578|NCT00615212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92871579|NCT00615212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871580|NCT00615212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871581|NCT00615212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871582|NCT00615212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92871583|NCT00615212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871584|NCT02701478|Nitrous Oxide|nitrous oxide|mesh-list
92871585|NCT02701478|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92871586|NCT02701478|Anesthetics, General|anesthetics, general|mesh-ancestor
92871588|NCT02701478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871589|NCT02701478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871590|NCT02701478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871591|NCT02701478|Analgesics|analgesics|mesh-ancestor
92871592|NCT02701478|Sensory System Agents|sensory system agents|mesh-ancestor
92871593|NCT02701478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871594|NCT03314363|Trace Elements|trace elements|mesh-list
92871595|NCT03314363|Micronutrients|micronutrients|mesh-list
92871596|NCT03314363|Citric Acid|citric acid|mesh-list
92871597|NCT03314363|Sodium Citrate|sodium citrate|mesh-list
92871598|NCT03314363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871599|NCT03314363|Anticoagulants|anticoagulants|mesh-ancestor
92871600|NCT03314363|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92871601|NCT03314363|Chelating Agents|chelating agents|mesh-ancestor
92871602|NCT03314363|Sequestering Agents|sequestering agents|mesh-ancestor
92871603|NCT03314363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871604|NCT00906347|Misoprostol|misoprostol|mesh-list
92871605|NCT00906347|Oxytocin|oxytocin|mesh-list
92871606|NCT00906347|Oxytocics|oxytocics|mesh-ancestor
92871607|NCT00906347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92871608|NCT00906347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871609|NCT00906347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92871610|NCT00906347|Abortifacient Agents|abortifacient agents|mesh-ancestor
92871611|NCT00906347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92516823|NCT00847678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92871612|NCT00906347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871614|NCT02705768|Oxcarbazepine|oxcarbazepine|mesh-list
92871615|NCT02705768|Anticonvulsants|anticonvulsants|mesh-ancestor
92871616|NCT02705768|Antimanic Agents|antimanic agents|mesh-ancestor
92871617|NCT02705768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92871618|NCT02705768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871619|NCT02705768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871620|NCT02705768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92871621|NCT02705768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871622|NCT02705768|Analgesics|analgesics|mesh-ancestor
92871623|NCT02705768|Sensory System Agents|sensory system agents|mesh-ancestor
92871624|NCT02705768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871625|NCT02705768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92871626|NCT02705768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871627|NCT02705768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871628|NCT02705768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92871629|NCT02705768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92871630|NCT02705768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92871631|NCT00616070|Difluprednate|difluprednate|mesh-list
92871632|NCT00616070|Glucocorticoids|glucocorticoids|mesh-ancestor
92871633|NCT00616070|Hormones|hormones|mesh-ancestor
92871634|NCT00616070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871635|NCT00616070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871636|NCT03153527|Prednisone|prednisone|mesh-list
92871637|NCT03153527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871638|NCT03153527|Glucocorticoids|glucocorticoids|mesh-ancestor
92871639|NCT03153527|Hormones|hormones|mesh-ancestor
92871640|NCT03153527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871641|NCT03153527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871642|NCT03153527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92871643|NCT03153527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871644|NCT02705534|Ribavirin|ribavirin|mesh-list
92871645|NCT02705534|Sofosbuvir|sofosbuvir|mesh-list
92871646|NCT02705534|Ledipasvir|ledipasvir|mesh-list
92871647|NCT02705534|Antimetabolites|antimetabolites|mesh-ancestor
92871648|NCT02705534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871649|NCT02705534|Antiviral Agents|antiviral agents|mesh-ancestor
92871650|NCT02705534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871651|NCT02701166|Bezafibrate|bezafibrate|mesh-list
92871652|NCT02701166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92871653|NCT02701166|Antimetabolites|antimetabolites|mesh-ancestor
92871654|NCT02701166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871655|NCT02701166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92871656|NCT03141203|Romidepsin|romidepsin|mesh-list
92871657|NCT03141203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92871658|NCT03141203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871659|NCT03141203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92216239|NCT04361513|Hormones|hormones|mesh-ancestor
92871661|NCT03141203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871662|NCT05320991|Ketamine|ketamine|mesh-list
92871663|NCT05320991|Analgesics|analgesics|mesh-ancestor
92871664|NCT05320991|Sensory System Agents|sensory system agents|mesh-ancestor
92871665|NCT05320991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871666|NCT05320991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871667|NCT05320991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92871668|NCT05320991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92871669|NCT05320991|Anesthetics, General|anesthetics, general|mesh-ancestor
92871670|NCT05320991|Anesthetics|anesthetics|mesh-ancestor
92871671|NCT05320991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871672|NCT05320991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92871673|NCT05320991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92871674|NCT05320991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871675|NCT05320991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871676|NCT04215614|Lidocaine|lidocaine|mesh-list
92871677|NCT04215614|Bupivacaine|bupivacaine|mesh-list
92871678|NCT04215614|Anesthetics, Local|anesthetics, local|mesh-ancestor
92871679|NCT04215614|Anesthetics|anesthetics|mesh-ancestor
92871680|NCT04215614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871681|NCT04215614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871682|NCT04215614|Sensory System Agents|sensory system agents|mesh-ancestor
92871683|NCT04215614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871684|NCT04215614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92516898|NCT03969641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159376|NCT03649633|Vitamins|vitamins|mesh-list
92871685|NCT04215614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92871686|NCT04215614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92871687|NCT04215614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871688|NCT04215614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871690|NCT00906035|Dipyridamole|dipyridamole|mesh-list
92871691|NCT00906035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92871692|NCT00906035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92871693|NCT00906035|Analgesics|analgesics|mesh-ancestor
92871694|NCT00906035|Sensory System Agents|sensory system agents|mesh-ancestor
92871695|NCT00906035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871696|NCT00906035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871697|NCT00906035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871698|NCT00906035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871699|NCT00906035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92871700|NCT00906035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92871701|NCT00906035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871702|NCT00906035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92871703|NCT00906035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92871704|NCT00906035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871705|NCT00906035|Antipyretics|antipyretics|mesh-ancestor
92871706|NCT00906035|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92871707|NCT00906035|Vasodilator Agents|vasodilator agents|mesh-ancestor
92871708|NCT02698280|Bevacizumab|bevacizumab|mesh-list
92871709|NCT02698280|Nimustine|nimustine|mesh-list
92871710|NCT02698280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871711|NCT02698280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871712|NCT02698280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92871713|NCT02698280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92871714|NCT02698280|Growth Substances|growth substances|mesh-ancestor
92871715|NCT02698280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871716|NCT02698280|Growth Inhibitors|growth inhibitors|mesh-ancestor
92871717|NCT03087773|Empagliflozin|empagliflozin|mesh-list
92871718|NCT03087773|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92871719|NCT03087773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871720|NCT03087773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871721|NCT03087773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871722|NCT02705612|Nimotuzumab|nimotuzumab|mesh-list
92871723|NCT02705612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871724|NCT02705612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871725|NCT05333159|Dapagliflozin|dapagliflozin|mesh-list
92871726|NCT05333159|Empagliflozin|empagliflozin|mesh-list
92871727|NCT05333159|Canagliflozin|canagliflozin|mesh-list
92871728|NCT05333159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92871729|NCT05333159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871730|NCT05333159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871731|NCT05333159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871732|NCT02698124|Decitabine|decitabine|mesh-list
92871733|NCT02698124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871734|NCT02698124|Antimetabolites|antimetabolites|mesh-ancestor
92871735|NCT02698124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871736|NCT02698124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871737|NCT02698124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871738|NCT00905489|Nevirapine|nevirapine|mesh-list
92871739|NCT00905489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92871740|NCT00905489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92871741|NCT00905489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871742|NCT00905489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871743|NCT00905489|Antiviral Agents|antiviral agents|mesh-ancestor
92871744|NCT00905489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871745|NCT00905489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92871746|NCT00905489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92871747|NCT00905489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92871748|NCT00905489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92871749|NCT02705378|Naloxegol|naloxegol|mesh-list
92871750|NCT02705378|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92871751|NCT02705378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871752|NCT02705378|Sensory System Agents|sensory system agents|mesh-ancestor
92871753|NCT02705378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871754|NCT03059147|Nivolumab|nivolumab|mesh-list
92871755|NCT03059147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92871756|NCT03059147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516992|NCT03772964|Metformin|metformin|mesh-list
92871757|NCT03059147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92871758|NCT03059147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871759|NCT03356834|Tenofovir|tenofovir|mesh-list
92871760|NCT03356834|Antiviral Agents|antiviral agents|mesh-ancestor
92871761|NCT03356834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871762|NCT03356834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92871763|NCT03356834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92871764|NCT03356834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871765|NCT03356834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871766|NCT03356834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92871767|NCT03356834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92871768|NCT02705066|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92871769|NCT02705066|Nootropic Agents|nootropic agents|mesh-ancestor
92871770|NCT00615758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92871771|NCT00615758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871772|NCT00615758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92871773|NCT00615758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871774|NCT00615758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871775|NCT02704988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92871776|NCT02704754|Suvorexant|suvorexant|mesh-list
92871777|NCT02704754|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92871778|NCT02704754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92871779|NCT02704754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871780|NCT02704754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871781|NCT02704754|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92871782|NCT02704754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871783|NCT02704754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871784|NCT05182658|Empagliflozin|empagliflozin|mesh-list
92871785|NCT05182658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92871786|NCT05182658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871787|NCT05182658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871788|NCT05182658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871789|NCT04214054|Calcium|calcium|mesh-list
92871790|NCT04214054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92871791|NCT04214054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871792|NCT02909036|Melphalan|melphalan|mesh-list
92871793|NCT02909036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92871794|NCT02909036|Alkylating Agents|alkylating agents|mesh-ancestor
92871795|NCT02909036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871796|NCT02909036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871797|NCT02909036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92871798|NCT02909036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871799|NCT02909036|Immunologic Factors|immunologic factors|mesh-ancestor
92871800|NCT02909036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871801|NCT04213898|Paclitaxel|paclitaxel|mesh-list
92871802|NCT04213898|Epirubicin|epirubicin|mesh-list
92871803|NCT04213898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92871804|NCT04213898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92871805|NCT04213898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871806|NCT04213898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92871807|NCT04213898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92871808|NCT04213898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92871809|NCT04213898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871810|NCT04213898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92871811|NCT04213898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92871812|NCT04213898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92871813|NCT04213898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871814|NCT03170882|Dexamethasone|dexamethasone|mesh-list
92871815|NCT03170882|Pomalidomide|pomalidomide|mesh-list
92871816|NCT03170882|Ixazomib|ixazomib|mesh-list
92871817|NCT03170882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871818|NCT03170882|Antiemetics|antiemetics|mesh-ancestor
92871819|NCT03170882|Autonomic Agents|autonomic agents|mesh-ancestor
92871820|NCT03170882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871821|NCT03170882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871822|NCT03170882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871823|NCT03170882|Glucocorticoids|glucocorticoids|mesh-ancestor
92871824|NCT03170882|Hormones|hormones|mesh-ancestor
92871825|NCT03170882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871826|NCT03170882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92871827|NCT03170882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871828|NCT03170882|Immunologic Factors|immunologic factors|mesh-ancestor
92871829|NCT03170882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92871830|NCT03170882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92871831|NCT03170882|Growth Substances|growth substances|mesh-ancestor
92871832|NCT03170882|Growth Inhibitors|growth inhibitors|mesh-ancestor
92871833|NCT03170882|Protease Inhibitors|protease inhibitors|mesh-ancestor
92871834|NCT03170882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871835|NCT03170882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871836|NCT00616850|Lidocaine|lidocaine|mesh-list
92871837|NCT00616850|Anesthetics, Local|anesthetics, local|mesh-ancestor
92871838|NCT00616850|Anesthetics|anesthetics|mesh-ancestor
92871839|NCT00616850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871840|NCT00616850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871841|NCT00616850|Sensory System Agents|sensory system agents|mesh-ancestor
92871842|NCT00616850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871843|NCT00616850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92871844|NCT00616850|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92871845|NCT00616850|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92871846|NCT00616850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871847|NCT00616850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871848|NCT00618644|Ranibizumab|ranibizumab|mesh-list
92871849|NCT00618644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92871850|NCT00618644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92871851|NCT00618644|Growth Substances|growth substances|mesh-ancestor
92871852|NCT00618644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871853|NCT00618644|Growth Inhibitors|growth inhibitors|mesh-ancestor
92871854|NCT00618644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871855|NCT05324774|Aflibercept|aflibercept|mesh-list
92871856|NCT05324774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92871857|NCT05324774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92871858|NCT05324774|Growth Substances|growth substances|mesh-ancestor
92871859|NCT05324774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871860|NCT05324774|Growth Inhibitors|growth inhibitors|mesh-ancestor
92871861|NCT05324774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871862|NCT05324618|Hydrocortisone|hydrocortisone|mesh-list
92871863|NCT05324618|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92871864|NCT05324618|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92871865|NCT05324618|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92871866|NCT05324618|Tacrolimus|tacrolimus|mesh-list
92871867|NCT05324618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871868|NCT05324618|Immunologic Factors|immunologic factors|mesh-ancestor
92159496|NCT03229538|Hormones|hormones|mesh-ancestor
92871869|NCT05324618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871870|NCT05324618|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92871871|NCT05324618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871872|NCT05324618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871873|NCT05324618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92871874|NCT03654989|Treprostinil|treprostinil|mesh-list
92871875|NCT03654989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92871877|NCT05300594|Micronutrients|micronutrients|mesh-ancestor
92871878|NCT05300594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871879|NCT00907517|Cytarabine|cytarabine|mesh-list
92871880|NCT00907517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92871881|NCT00907517|Antimetabolites|antimetabolites|mesh-ancestor
92871882|NCT00907517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871883|NCT00907517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871884|NCT00907517|Antiviral Agents|antiviral agents|mesh-ancestor
92871885|NCT00907517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871886|NCT00907517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92871887|NCT00907517|Immunologic Factors|immunologic factors|mesh-ancestor
92871888|NCT00907517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871889|NCT03043547|Leucovorin|leucovorin|mesh-list
92871890|NCT03043547|Antidotes|antidotes|mesh-ancestor
92871891|NCT03043547|Protective Agents|protective agents|mesh-ancestor
92871892|NCT03043547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871893|NCT03043547|Vitamin B Complex|vitamin b complex|mesh-ancestor
92871894|NCT03043547|Vitamins|vitamins|mesh-ancestor
92871895|NCT03043547|Micronutrients|micronutrients|mesh-ancestor
92871896|NCT00905255|Lixisenatide|lixisenatide|mesh-list
92871897|NCT00905255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871898|NCT00905255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871899|NCT00905021|Sunitinib|sunitinib|mesh-list
92871900|NCT00905021|Exemestane|exemestane|mesh-list
92871901|NCT00905021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871902|NCT00905021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92871903|NCT00905021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92871904|NCT00905021|Growth Substances|growth substances|mesh-ancestor
92871905|NCT00905021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871906|NCT00905021|Growth Inhibitors|growth inhibitors|mesh-ancestor
92871907|NCT00905021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92871908|NCT00905021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871909|NCT00905021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871910|NCT00905021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92871911|NCT00905021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92871912|NCT00905021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92871913|NCT00905021|Hormone Antagonists|hormone antagonists|mesh-ancestor
92871914|NCT00905021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92871916|NCT03537131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92871917|NCT03537131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871918|NCT03537131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92871919|NCT03537131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871920|NCT02677805|Botulinum Toxins|botulinum toxins|mesh-list
92871921|NCT02677805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92871922|NCT02677805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92871923|NCT02677805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92871924|NCT02677805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871925|NCT02677805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871926|NCT02677805|Cholinergic Agents|cholinergic agents|mesh-ancestor
92871927|NCT02677805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871928|NCT02677805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871929|NCT02677805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92871930|NCT02677805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871931|NCT04202861|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92871932|NCT04202861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871933|NCT04202471|Chlorhexidine|chlorhexidine|mesh-list
92871934|NCT04202471|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92871935|NCT04202471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92871936|NCT04202471|Disinfectants|disinfectants|mesh-ancestor
92871937|NCT02395601|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|(r)-n-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1h-indole-3-carboxamide|mesh-list
92871938|NCT02395601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871939|NCT02395601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871940|NCT00632645|Olanzapine|olanzapine|mesh-list
92871941|NCT00632645|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
92871942|NCT00632645|Tetrabenazine|tetrabenazine|mesh-list
92871943|NCT00632645|Antiemetics|antiemetics|mesh-ancestor
92871944|NCT00632645|Autonomic Agents|autonomic agents|mesh-ancestor
92871945|NCT00632645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871946|NCT00632645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871947|NCT00632645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871948|NCT00632645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92871949|NCT00632645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92871950|NCT00632645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92871951|NCT00632645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92871952|NCT00632645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92871953|NCT00632645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92871954|NCT00632645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92871955|NCT00632645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871956|NCT00632645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871957|NCT00632645|Serotonin Agents|serotonin agents|mesh-ancestor
92871958|NCT00632645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92871959|NCT00632645|Adrenergic Agents|adrenergic agents|mesh-ancestor
92871960|NCT00632645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92871961|NCT00632645|Dopamine Agents|dopamine agents|mesh-ancestor
92871963|NCT02849873|Dermatologic Agents|dermatologic agents|mesh-ancestor
92871964|NCT02849873|Keratolytic Agents|keratolytic agents|mesh-ancestor
92871965|NCT02304809|Vemurafenib|vemurafenib|mesh-list
92871966|NCT02304809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871967|NCT02304809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92871968|NCT02304809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871969|NCT02304809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871970|NCT02849483|Ramosetron|ramosetron|mesh-list
92871971|NCT02849483|Antiemetics|antiemetics|mesh-ancestor
92871972|NCT02849483|Autonomic Agents|autonomic agents|mesh-ancestor
92871973|NCT02849483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92871974|NCT02849483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871975|NCT02849483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92871976|NCT02849483|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92871977|NCT02849483|Serotonin Agents|serotonin agents|mesh-ancestor
92871978|NCT02849483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92871979|NCT02849483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871981|NCT04500665|Gout Suppressants|gout suppressants|mesh-ancestor
92871982|NCT04500665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92871983|NCT04500665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92871984|NCT04500665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92871985|NCT04500665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92871986|NCT04500665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871987|NCT04500665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871988|NCT05116007|Carboplatin|carboplatin|mesh-list
92871989|NCT05116007|Etoposide|etoposide|mesh-list
92871990|NCT05116007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92871991|NCT05116007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92871992|NCT05116007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92871993|NCT05116007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92871994|NCT05116007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92871995|NCT05116007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92871996|NCT02849327|Immunomodulating Agents|immunomodulating agents|mesh-list
92871997|NCT02849327|Immunologic Factors|immunologic factors|mesh-ancestor
92871998|NCT02849327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92871999|NCT00618696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92872000|NCT00618696|Antibodies|antibodies|mesh-list
92872001|NCT00618696|Immunoglobulins|immunoglobulins|mesh-list
92872002|NCT00618696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92872003|NCT00618696|Immunologic Factors|immunologic factors|mesh-ancestor
92872004|NCT00618696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872005|NCT00618696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872006|NCT00618852|Furosemide|furosemide|mesh-list
92872007|NCT00618852|Diuretics|diuretics|mesh-ancestor
92872008|NCT00618852|Natriuretic Agents|natriuretic agents|mesh-ancestor
92872009|NCT00618852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872010|NCT00618852|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92872011|NCT00618852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92872012|NCT00618852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872013|NCT02073474|Nabiximols|nabiximols|mesh-list
92872014|NCT02073474|Analgesics|analgesics|mesh-ancestor
92872015|NCT02073474|Sensory System Agents|sensory system agents|mesh-ancestor
92872016|NCT02073474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872017|NCT02073474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872018|NCT00637104|Chromium|chromium|mesh-list
92872019|NCT00637104|Trace Elements|trace elements|mesh-ancestor
92872020|NCT00637104|Micronutrients|micronutrients|mesh-ancestor
92872021|NCT00637104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872022|NCT00617760|Vaccines|vaccines|mesh-list
92216630|NCT04360031|Tacrolimus|tacrolimus|mesh-list
92872023|NCT00617760|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92872024|NCT00617760|Immunologic Factors|immunologic factors|mesh-ancestor
92872025|NCT00617760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872026|NCT00620490|Ropivacaine|ropivacaine|mesh-list
92872027|NCT00620490|Anesthetics, Local|anesthetics, local|mesh-ancestor
92872028|NCT00620490|Anesthetics|anesthetics|mesh-ancestor
92872029|NCT00620490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872030|NCT00620490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872031|NCT00620490|Sensory System Agents|sensory system agents|mesh-ancestor
92872032|NCT00620490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872033|NCT04212078|Levofloxacin|levofloxacin|mesh-list
92872034|NCT04212078|Cefuroxime|cefuroxime|mesh-list
92872035|NCT04212078|Cefuroxime axetil|cefuroxime axetil|mesh-list
92872036|NCT04212078|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92872037|NCT04212078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872038|NCT04212078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872039|NCT04212078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92872040|NCT04212078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92872041|NCT04212078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872042|NCT04212078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872043|NCT04212078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872044|NCT04212078|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92872045|NCT04212078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92872046|NCT01898520|Nabiximols|nabiximols|mesh-list
92872047|NCT01898520|Analgesics|analgesics|mesh-ancestor
92872048|NCT01898520|Sensory System Agents|sensory system agents|mesh-ancestor
92872049|NCT01898520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872050|NCT01898520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872051|NCT00903617|Niacin|niacin|mesh-list
92872052|NCT00903617|Nicotinic Acids|nicotinic acids|mesh-list
92872053|NCT00903617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872054|NCT00903617|Antimetabolites|antimetabolites|mesh-ancestor
92872055|NCT00903617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872056|NCT00903617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872057|NCT00903617|Vasodilator Agents|vasodilator agents|mesh-ancestor
92872058|NCT00903617|Vitamin B Complex|vitamin b complex|mesh-ancestor
92872059|NCT00903617|Vitamins|vitamins|mesh-ancestor
92872060|NCT00903617|Micronutrients|micronutrients|mesh-ancestor
92872061|NCT00903617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872062|NCT02848937|Citric Acid|citric acid|mesh-list
92872063|NCT02848937|Sodium Citrate|sodium citrate|mesh-list
92872064|NCT02848937|Anticoagulants|anticoagulants|mesh-ancestor
92872065|NCT02848937|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92872066|NCT02848937|Chelating Agents|chelating agents|mesh-ancestor
92872067|NCT02848937|Sequestering Agents|sequestering agents|mesh-ancestor
92872068|NCT02848937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872069|NCT00343824|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92872070|NCT00343824|Laxatives|laxatives|mesh-ancestor
92872071|NCT00343824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872072|NCT02849015|Immunomodulating Agents|immunomodulating agents|mesh-list
92872073|NCT02849015|Immunologic Factors|immunologic factors|mesh-ancestor
92872074|NCT02849015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872075|NCT01428089|Progesterone|progesterone|mesh-list
92872076|NCT01428089|Progestins|progestins|mesh-ancestor
92872077|NCT01428089|Hormones|hormones|mesh-ancestor
92872078|NCT01428089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872079|NCT01428089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872080|NCT04212000|Ketoconazole|ketoconazole|mesh-list
92872081|NCT04212000|Antifungal Agents|antifungal agents|mesh-ancestor
92872082|NCT04212000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872083|NCT04212000|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92872084|NCT04212000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92872085|NCT04212000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872086|NCT04212000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872087|NCT04212000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92872088|NCT04212000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92872089|NCT04212000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872090|NCT04212000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872091|NCT04212000|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92872092|NCT00619398|Tacrolimus|tacrolimus|mesh-list
92872093|NCT00619398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92872094|NCT00619398|Immunologic Factors|immunologic factors|mesh-ancestor
92872095|NCT00619398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872096|NCT00619398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92872097|NCT00619398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872098|NCT00619398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872099|NCT00620646|Aspirin|aspirin|mesh-list
92872100|NCT00620646|Cilostazol|cilostazol|mesh-list
92872101|NCT00620646|Clopidogrel|clopidogrel|mesh-list
92872102|NCT00620646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872103|NCT00620646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872104|NCT00620646|Analgesics|analgesics|mesh-ancestor
92872105|NCT00620646|Sensory System Agents|sensory system agents|mesh-ancestor
92872106|NCT00620646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872107|NCT00620646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872108|NCT00620646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872109|NCT00620646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872110|NCT00620646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92872111|NCT00620646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92872112|NCT00620646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872113|NCT00620646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92872114|NCT00620646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92872115|NCT00620646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872116|NCT00620646|Antipyretics|antipyretics|mesh-ancestor
92872117|NCT00620646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92872118|NCT00620646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92872119|NCT00620646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92872120|NCT00620646|Purinergic Agents|purinergic agents|mesh-ancestor
92872121|NCT00620646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872122|NCT00620646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92872123|NCT00620646|Autonomic Agents|autonomic agents|mesh-ancestor
92872124|NCT00620646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92872125|NCT00620646|Respiratory System Agents|respiratory system agents|mesh-ancestor
92517354|NCT00275548|Ribavirin|ribavirin|mesh-list
92872126|NCT00620646|Vasodilator Agents|vasodilator agents|mesh-ancestor
92872127|NCT00620646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92872128|NCT00620646|Protective Agents|protective agents|mesh-ancestor
92872129|NCT00620646|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92872130|NCT00620646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92872131|NCT00810017|Trastuzumab|trastuzumab|mesh-list
92872132|NCT00810017|Etoposide|etoposide|mesh-list
92872133|NCT00810017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92872134|NCT00810017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872135|NCT00810017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92872136|NCT00810017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92872137|NCT00810017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92872138|NCT00810017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872139|NCT00810017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872140|NCT00620724|Nifedipine|nifedipine|mesh-list
92872141|NCT00620724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92872142|NCT00620724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92872143|NCT00620724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872144|NCT00620724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92872145|NCT00620724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872146|NCT00620724|Vasodilator Agents|vasodilator agents|mesh-ancestor
92872147|NCT00620724|Tocolytic Agents|tocolytic agents|mesh-ancestor
92872148|NCT00620724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92872149|NCT04209426|Tacrine|tacrine|mesh-list
92872150|NCT04209426|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92872151|NCT04209426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872152|NCT04209426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872153|NCT04209426|Cholinergic Agents|cholinergic agents|mesh-ancestor
92872154|NCT04209426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872155|NCT04209426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872156|NCT04209426|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92872157|NCT04209426|Autonomic Agents|autonomic agents|mesh-ancestor
92872158|NCT04209426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872159|NCT04209426|Nootropic Agents|nootropic agents|mesh-ancestor
92872160|NCT00620802|Clopidogrel|clopidogrel|mesh-list
92872161|NCT00620802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92872162|NCT00620802|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92872163|NCT00620802|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92872164|NCT00620802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92872165|NCT00620802|Purinergic Agents|purinergic agents|mesh-ancestor
92525286|NCT00024310|Paclitaxel|paclitaxel|mesh-list
92872166|NCT00620802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872167|NCT00620802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872168|NCT00620802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872170|NCT02848157|Ropivacaine|ropivacaine|mesh-list
92872171|NCT02848157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92872172|NCT02848157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872173|NCT02848157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872174|NCT02848157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872175|NCT02848157|Analgesics|analgesics|mesh-ancestor
92872176|NCT02848157|Sensory System Agents|sensory system agents|mesh-ancestor
92872177|NCT02848157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872178|NCT02848157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92872179|NCT02848157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92872180|NCT02848157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92159558|NCT02962414|Everolimus|everolimus|mesh-list
92872181|NCT02848157|Adrenergic Agents|adrenergic agents|mesh-ancestor
92872182|NCT02848157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872183|NCT02848157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872184|NCT02848157|Anesthetics, Local|anesthetics, local|mesh-ancestor
92872185|NCT02848157|Anesthetics|anesthetics|mesh-ancestor
92872186|NCT04211844|Sofosbuvir|sofosbuvir|mesh-list
92872187|NCT04211844|Ledipasvir|ledipasvir|mesh-list
92872188|NCT04211844|Antiviral Agents|antiviral agents|mesh-ancestor
92872189|NCT04211844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872190|NCT00619710|Meropenem|meropenem|mesh-list
92872191|NCT00619710|Imipenem|imipenem|mesh-list
92872192|NCT00619710|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92872193|NCT00619710|Cilastatin|cilastatin|mesh-list
92872194|NCT00619710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872195|NCT00619710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872196|NCT00619710|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872197|NCT00619710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872198|NCT00619710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517421|NCT02921555|Autonomic Agents|autonomic agents|mesh-ancestor
92872200|NCT03929627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872201|NCT04019015|Thrombin|thrombin|mesh-list
92872202|NCT04019015|Hemostatics|hemostatics|mesh-ancestor
92872203|NCT04019015|Coagulants|coagulants|mesh-ancestor
92872204|NCT02846909|Progesterone|progesterone|mesh-list
92872205|NCT02846909|Progestins|progestins|mesh-ancestor
92872206|NCT02846909|Hormones|hormones|mesh-ancestor
92872207|NCT02846909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872208|NCT02846909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872209|NCT00632723|Gefitinib|gefitinib|mesh-list
92872210|NCT00632723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872211|NCT00632723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872212|NCT00632723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872213|NCT00632723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872214|NCT02847143|Oxytocin|oxytocin|mesh-list
92872215|NCT02847143|Oxytocics|oxytocics|mesh-ancestor
92872216|NCT02847143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92872217|NCT02847143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872218|NCT02847455|Rabeprazole|rabeprazole|mesh-list
92872219|NCT02847455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92872220|NCT02847455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872221|NCT02847455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92872222|NCT02847455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872223|NCT02847455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872224|NCT03897335|Aminophylline|aminophylline|mesh-list
92872225|NCT03897335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92872226|NCT03897335|Autonomic Agents|autonomic agents|mesh-ancestor
92872227|NCT03897335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872228|NCT03897335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872229|NCT03897335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92872230|NCT03897335|Respiratory System Agents|respiratory system agents|mesh-ancestor
92872231|NCT03897335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92872232|NCT03897335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92872233|NCT03897335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872234|NCT03897335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872235|NCT03897335|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92872236|NCT03897335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92872237|NCT03897335|Purinergic Agents|purinergic agents|mesh-ancestor
92872238|NCT03897335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872239|NCT03897335|Protective Agents|protective agents|mesh-ancestor
92872240|NCT01617096|Dapivirine|dapivirine|mesh-list
92872241|NCT01617096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92872242|NCT01617096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92872243|NCT01617096|Antiviral Agents|antiviral agents|mesh-ancestor
92872244|NCT01617096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872245|NCT00619944|Ritonavir|ritonavir|mesh-list
92872246|NCT00619944|Lopinavir|lopinavir|mesh-list
92872247|NCT00619944|Lumefantrine|lumefantrine|mesh-list
92872248|NCT00619944|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92872249|NCT00619944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92872250|NCT00619944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92872251|NCT00619944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872252|NCT00619944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872253|NCT00619944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872254|NCT00619944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92872255|NCT00619944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92872256|NCT00619944|Antiviral Agents|antiviral agents|mesh-ancestor
92872257|NCT00619944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872258|NCT00619944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92872259|NCT00619944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92872260|NCT00619944|Antimalarials|antimalarials|mesh-ancestor
92872261|NCT00619944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92872262|NCT00619944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92872263|NCT00621036|Methotrexate|methotrexate|mesh-list
92872264|NCT00621036|Thiotepa|thiotepa|mesh-list
92872265|NCT00621036|Immunoglobulins|immunoglobulins|mesh-list
92872266|NCT00621036|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92872267|NCT00621036|Antibodies|antibodies|mesh-list
92872268|NCT00621036|Sargramostim|sargramostim|mesh-list
92872269|NCT00621036|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92872270|NCT00621036|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92872271|NCT00621036|Abortifacient Agents|abortifacient agents|mesh-ancestor
92872272|NCT00621036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92872273|NCT00621036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872274|NCT00621036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92872275|NCT00621036|Antimetabolites|antimetabolites|mesh-ancestor
92872276|NCT00621036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872277|NCT00621036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872278|NCT00621036|Dermatologic Agents|dermatologic agents|mesh-ancestor
92872279|NCT00621036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872280|NCT00621036|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92872281|NCT00621036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92872282|NCT00621036|Immunologic Factors|immunologic factors|mesh-ancestor
92872283|NCT00621036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872284|NCT00621036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92872285|NCT00621036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92872286|NCT00621036|Alkylating Agents|alkylating agents|mesh-ancestor
92872287|NCT00621036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92872289|NCT02846831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92872290|NCT02846831|Hormones|hormones|mesh-list
92872291|NCT02846831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92872292|NCT02846831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872293|NCT02846831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872294|NCT01497509|Epinephrine|epinephrine|mesh-list
92872295|NCT01497509|Racepinephrine|racepinephrine|mesh-list
92872296|NCT01497509|Fentanyl|fentanyl|mesh-list
92872297|NCT01497509|Bupivacaine|bupivacaine|mesh-list
92872298|NCT01497509|Epinephryl borate|epinephryl borate|mesh-list
92872299|NCT01497509|Anesthetics, Local|anesthetics, local|mesh-ancestor
92872300|NCT01497509|Anesthetics|anesthetics|mesh-ancestor
92872301|NCT01497509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872302|NCT01497509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872303|NCT01497509|Sensory System Agents|sensory system agents|mesh-ancestor
92872304|NCT01497509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872305|NCT01497509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92872306|NCT01497509|Narcotics|narcotics|mesh-ancestor
92872307|NCT01497509|Analgesics|analgesics|mesh-ancestor
92872308|NCT01497509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92872309|NCT01497509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92872310|NCT01497509|Anesthetics, General|anesthetics, general|mesh-ancestor
92872311|NCT01497509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92872312|NCT01497509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92872313|NCT01497509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92872314|NCT01497509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872315|NCT01497509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872316|NCT01497509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92872317|NCT01497509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92872318|NCT01497509|Autonomic Agents|autonomic agents|mesh-ancestor
92872319|NCT01497509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92872320|NCT01497509|Respiratory System Agents|respiratory system agents|mesh-ancestor
92872321|NCT01497509|Mydriatics|mydriatics|mesh-ancestor
92872322|NCT01497509|Sympathomimetics|sympathomimetics|mesh-ancestor
92872323|NCT01497509|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92872324|NCT02844881|Apatinib|apatinib|mesh-list
92872325|NCT02844881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872326|NCT02844881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872327|NCT02844881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872328|NCT02844881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872329|NCT02846519|Rifampin|rifampin|mesh-list
92872330|NCT02846519|Esketamine|esketamine|mesh-list
92872331|NCT02846519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92872332|NCT02846519|Antitubercular Agents|antitubercular agents|mesh-ancestor
92872333|NCT02846519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872334|NCT02846519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872335|NCT02846519|Leprostatic Agents|leprostatic agents|mesh-ancestor
92872336|NCT02846519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92872337|NCT02846519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872338|NCT02846519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872339|NCT02846519|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92872340|NCT02846519|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92872341|NCT02846519|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92872342|NCT02846519|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92872343|NCT02846519|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92872344|NCT02846519|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92872345|NCT02846519|Antidepressive Agents|antidepressive agents|mesh-ancestor
92872346|NCT02846519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92872347|NCT00618228|Balsalazide|balsalazide|mesh-list
92872348|NCT00618228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872349|NCT00618228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872350|NCT00618228|Analgesics|analgesics|mesh-ancestor
92872351|NCT00618228|Sensory System Agents|sensory system agents|mesh-ancestor
92872352|NCT00618228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872353|NCT00618228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872354|NCT00618228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872355|NCT00618228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872356|NCT00618228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872357|NCT03711305|Carboplatin|carboplatin|mesh-list
92872358|NCT03711305|Etoposide|etoposide|mesh-list
92872359|NCT03711305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872360|NCT03711305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92872361|NCT03711305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92872362|NCT03711305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92872363|NCT03711305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872364|NCT03711305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872365|NCT00618384|Sorafenib|sorafenib|mesh-list
92872366|NCT00618384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872367|NCT00618384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872368|NCT00618384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872369|NCT00618384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872370|NCT03608657|Apremilast|apremilast|mesh-list
92872371|NCT03608657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872372|NCT03608657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872373|NCT03608657|Analgesics|analgesics|mesh-ancestor
92872374|NCT03608657|Sensory System Agents|sensory system agents|mesh-ancestor
92872375|NCT03608657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872376|NCT03608657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872377|NCT03608657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872378|NCT03608657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872379|NCT03608657|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92872380|NCT03608657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92872381|NCT03608657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872382|NCT03608657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872383|NCT05000658|Dexamethasone|dexamethasone|mesh-list
92872384|NCT05000658|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92872385|NCT05000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872386|NCT05000658|Antiemetics|antiemetics|mesh-ancestor
92872387|NCT05000658|Autonomic Agents|autonomic agents|mesh-ancestor
92872388|NCT05000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872389|NCT05000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872390|NCT05000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872392|NCT05000658|Hormones|hormones|mesh-ancestor
92872393|NCT05000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872394|NCT05000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92872395|NCT05000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872396|NCT02844803|Metformin|metformin|mesh-list
92872397|NCT02844803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92872398|NCT02844803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872399|NCT04211298|Dexmedetomidine|dexmedetomidine|mesh-list
92872400|NCT04211298|Propofol|propofol|mesh-list
92872401|NCT04211298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92872402|NCT04211298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872403|NCT04211298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872404|NCT04211298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872405|NCT04211298|Analgesics|analgesics|mesh-ancestor
92872406|NCT04211298|Sensory System Agents|sensory system agents|mesh-ancestor
92872407|NCT04211298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872408|NCT04211298|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92872409|NCT04211298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92872410|NCT04211298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92872411|NCT04211298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92872412|NCT04211298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872413|NCT04211298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872414|NCT04211298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92872415|NCT04211298|Anesthetics, General|anesthetics, general|mesh-ancestor
92872416|NCT04211298|Anesthetics|anesthetics|mesh-ancestor
92872417|NCT04212702|Everolimus|everolimus|mesh-list
92872418|NCT04212702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92872419|NCT04212702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872420|NCT04212702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872421|NCT04212702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872422|NCT04212702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92872423|NCT04212702|Immunologic Factors|immunologic factors|mesh-ancestor
92872424|NCT04212702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872425|NCT04212702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872426|NCT02691780|Sorafenib|sorafenib|mesh-list
92872427|NCT02691780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872428|NCT02691780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872429|NCT02691780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872430|NCT02691780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872431|NCT02845661|Dexmedetomidine|dexmedetomidine|mesh-list
92872432|NCT02845661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92872433|NCT02845661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872434|NCT02845661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872435|NCT02845661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872436|NCT02845661|Analgesics|analgesics|mesh-ancestor
92872437|NCT02845661|Sensory System Agents|sensory system agents|mesh-ancestor
92872438|NCT02845661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872439|NCT02845661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92872440|NCT02845661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92872441|NCT02845661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92872442|NCT02845661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92872443|NCT02845661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872444|NCT02845661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872445|NCT02844335|Immunomodulating Agents|immunomodulating agents|mesh-list
92872446|NCT02844335|Immunologic Factors|immunologic factors|mesh-ancestor
92872447|NCT02844335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872448|NCT00880074|Alovudine|alovudine|mesh-list
92872449|NCT00880074|Antiviral Agents|antiviral agents|mesh-ancestor
92872450|NCT00880074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872451|NCT04375787|Atorvastatin|atorvastatin|mesh-list
92872452|NCT04375787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92872453|NCT04375787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872454|NCT04375787|Antimetabolites|antimetabolites|mesh-ancestor
92872455|NCT04375787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872456|NCT04375787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872457|NCT04375787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92872458|NCT04375787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872459|NCT00825630|Esomeprazole|esomeprazole|mesh-list
92872460|NCT00825630|Pantoprazole|pantoprazole|mesh-list
92872461|NCT00825630|Lansoprazole|lansoprazole|mesh-list
92872462|NCT00825630|Dexlansoprazole|dexlansoprazole|mesh-list
92872463|NCT00825630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92872465|NCT00825630|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92872466|NCT00825630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872467|NCT00825630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872468|NCT00620100|Docetaxel|docetaxel|mesh-list
92872469|NCT00620100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872470|NCT00620100|Tubulin Modulators|tubulin modulators|mesh-ancestor
92872471|NCT00620100|Antimitotic Agents|antimitotic agents|mesh-ancestor
92872472|NCT00620100|Mitosis Modulators|mitosis modulators|mesh-ancestor
92872473|NCT00620100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872474|NCT02845349|Vortioxetine|vortioxetine|mesh-list
92872475|NCT02845349|Antidepressive Agents|antidepressive agents|mesh-ancestor
92872476|NCT02845349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92872477|NCT02845349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92872478|NCT02845349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92872479|NCT02845349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872480|NCT02845349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872481|NCT02845349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92872482|NCT02845349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92872483|NCT02845349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92872484|NCT02845349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872485|NCT02845349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872486|NCT02845349|Serotonin Agents|serotonin agents|mesh-ancestor
92872487|NCT02845349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92872488|NCT02845349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92872489|NCT02845349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92872490|NCT02845349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92872491|NCT03852251|Capecitabine|capecitabine|mesh-list
92872492|NCT03852251|Oxaliplatin|oxaliplatin|mesh-list
92872493|NCT03852251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92872494|NCT03852251|Antimetabolites|antimetabolites|mesh-ancestor
92872495|NCT03852251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872496|NCT03852251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872497|NCT00620178|Losartan|losartan|mesh-list
92872498|NCT00620178|Candesartan|candesartan|mesh-list
92872499|NCT00620178|Candesartan cilexetil|candesartan cilexetil|mesh-list
92872500|NCT00620178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92872501|NCT00620178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92872502|NCT00620178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92872503|NCT00620178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92872504|NCT00620178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872505|NCT04349982|Fibrin fragment D|fibrin fragment d|mesh-list
92872506|NCT04349982|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92872507|NCT04349982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92872508|NCT04349982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872509|NCT04349982|Hemostatics|hemostatics|mesh-ancestor
92872510|NCT04349982|Coagulants|coagulants|mesh-ancestor
92872511|NCT04315350|Prednisolone|prednisolone|mesh-list
92872512|NCT04315350|Curcumin|curcumin|mesh-list
92872513|NCT04315350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872514|NCT04315350|Glucocorticoids|glucocorticoids|mesh-ancestor
92872515|NCT04315350|Hormones|hormones|mesh-ancestor
92872516|NCT04315350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872517|NCT04315350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872518|NCT04315350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92872519|NCT04315350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872520|NCT04315350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872521|NCT04315350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872522|NCT04315350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872523|NCT04315350|Analgesics|analgesics|mesh-ancestor
92872524|NCT04315350|Sensory System Agents|sensory system agents|mesh-ancestor
92872525|NCT04315350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872526|NCT04315350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872527|NCT04315350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872528|NCT04288206|Cefazolin|cefazolin|mesh-list
92872529|NCT04288206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872530|NCT04288206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872531|NCT04958772|Lenograstim|lenograstim|mesh-list
92872532|NCT04958772|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92872533|NCT04958772|Immunologic Factors|immunologic factors|mesh-ancestor
92872534|NCT04958772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872535|NCT02771249|Pyridoxine|pyridoxine|mesh-list
92872536|NCT02771249|Isoniazid|isoniazid|mesh-list
92872538|NCT02771249|Cobicistat|cobicistat|mesh-list
92872539|NCT02771249|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92872540|NCT02771249|Antitubercular Agents|antitubercular agents|mesh-ancestor
92872541|NCT02771249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872542|NCT02771249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872543|NCT02771249|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92872544|NCT02771249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872545|NCT02771249|Antimetabolites|antimetabolites|mesh-ancestor
92872546|NCT02771249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872547|NCT02771249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872548|NCT02771249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92872549|NCT02771249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92872550|NCT02771249|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872551|NCT02771249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872552|NCT02771249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92872553|NCT02771249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92872554|NCT02771249|Antiviral Agents|antiviral agents|mesh-ancestor
92872555|NCT02771249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92872556|NCT02771249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92872557|NCT02771249|Vitamin B Complex|vitamin b complex|mesh-ancestor
92872558|NCT02771249|Vitamins|vitamins|mesh-ancestor
92872559|NCT02771249|Micronutrients|micronutrients|mesh-ancestor
92872560|NCT02771249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872561|NCT04208958|Vancomycin|vancomycin|mesh-list
92872562|NCT04208958|Nivolumab|nivolumab|mesh-list
92872563|NCT04208958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92872564|NCT04208958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872565|NCT04208958|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92872566|NCT04208958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872567|NCT04208958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872568|NCT04208958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872569|NCT04048278|Lidocaine|lidocaine|mesh-list
92872570|NCT04048278|Anesthetics, Local|anesthetics, local|mesh-ancestor
92872571|NCT04048278|Anesthetics|anesthetics|mesh-ancestor
92872572|NCT04048278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517799|NCT00084019|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872573|NCT04048278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872574|NCT04048278|Sensory System Agents|sensory system agents|mesh-ancestor
92872575|NCT04048278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872576|NCT04048278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92872577|NCT04048278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92872578|NCT04048278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92872579|NCT04048278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92872580|NCT04048278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872581|NCT02697318|Timolol|timolol|mesh-list
92872582|NCT02697318|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92872583|NCT02697318|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92872584|NCT02697318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872585|NCT02697318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92872586|NCT02697318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92872587|NCT02697318|Adrenergic Agents|adrenergic agents|mesh-ancestor
92872588|NCT02697318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872589|NCT02697318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872590|NCT02697318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92872591|NCT02697318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92872592|NCT05242133|Interferons|interferons|mesh-list
92872593|NCT05242133|Interferon-beta|interferon-beta|mesh-list
92872594|NCT05242133|Interferon beta-1a|interferon beta-1a|mesh-list
92872595|NCT05242133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872596|NCT05242133|Antiviral Agents|antiviral agents|mesh-ancestor
92872597|NCT05242133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872598|NCT05242133|Immunologic Factors|immunologic factors|mesh-ancestor
92872599|NCT05242133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872600|NCT05242133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92872601|NCT00621816|Nitroprusside|nitroprusside|mesh-list
92872602|NCT00621816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92872603|NCT00621816|Vasodilator Agents|vasodilator agents|mesh-ancestor
92872604|NCT00621816|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92872605|NCT00621816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872606|NCT05368974|Antiviral Agents|antiviral agents|mesh-list
92872607|NCT05368974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872608|NCT04186026|Glucagon|glucagon|mesh-list
92872609|NCT04186026|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92872610|NCT04186026|Incretins|incretins|mesh-ancestor
92872611|NCT04186026|Hormones|hormones|mesh-ancestor
92872612|NCT04186026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872613|NCT04186026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872614|NCT04186026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872615|NCT00900731|Tiotropium Bromide|tiotropium bromide|mesh-list
92872616|NCT00900731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92872617|NCT00900731|Autonomic Agents|autonomic agents|mesh-ancestor
92872618|NCT00900731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872619|NCT00900731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872620|NCT00900731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92872621|NCT00900731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92872622|NCT00900731|Parasympatholytics|parasympatholytics|mesh-ancestor
92872623|NCT00900731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92872624|NCT00900731|Cholinergic Agents|cholinergic agents|mesh-ancestor
92872625|NCT00900731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872626|NCT00900731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872627|NCT02687490|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92872628|NCT02687490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872629|NCT05241821|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92872630|NCT05241821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92872631|NCT05241821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872632|NCT00650819|Simvastatin|simvastatin|mesh-list
92872633|NCT00650819|Ezetimibe|ezetimibe|mesh-list
92872634|NCT00650819|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92872635|NCT00650819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872636|NCT00650819|Antimetabolites|antimetabolites|mesh-ancestor
92872637|NCT00650819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872638|NCT00650819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872639|NCT00650819|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92872640|NCT00650819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872641|NCT05662410|Aflibercept|aflibercept|mesh-list
92872642|NCT05662410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92872643|NCT05662410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92872644|NCT05662410|Growth Substances|growth substances|mesh-ancestor
92872645|NCT05662410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872646|NCT05662410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92872647|NCT05662410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872648|NCT02689362|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92872649|NCT02689362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92872650|NCT02689362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872651|NCT02689362|Incretins|incretins|mesh-ancestor
92872652|NCT02689362|Hormones|hormones|mesh-ancestor
92872653|NCT02689362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872654|NCT02689362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92872655|NCT02689362|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872656|NCT02689362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872657|NCT02689362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872658|NCT02687256|Heparin|heparin|mesh-list
92872659|NCT02687256|Anticoagulants|anticoagulants|mesh-ancestor
92872660|NCT02687256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92872661|NCT02687256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92872662|NCT02687256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872663|NCT00622206|Ritonavir|ritonavir|mesh-list
92872664|NCT00622206|Saquinavir|saquinavir|mesh-list
92872665|NCT00622206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92872666|NCT00622206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92872667|NCT00622206|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872668|NCT00622206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872669|NCT00622206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872670|NCT00622206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92872671|NCT00622206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92872672|NCT00622206|Antiviral Agents|antiviral agents|mesh-ancestor
92872673|NCT00622206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872674|NCT00622206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92872675|NCT00622206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92872676|NCT03582293|Tranexamic Acid|tranexamic acid|mesh-list
92872677|NCT03582293|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92872678|NCT03582293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92159583|NCT02895750|Metformin|metformin|mesh-list
92872679|NCT03582293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872680|NCT03582293|Hemostatics|hemostatics|mesh-ancestor
92872681|NCT03582293|Coagulants|coagulants|mesh-ancestor
92872682|NCT03574337|Neostigmine|neostigmine|mesh-list
92872683|NCT03574337|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92872684|NCT03574337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872685|NCT03574337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872686|NCT03574337|Cholinergic Agents|cholinergic agents|mesh-ancestor
92872687|NCT03574337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872688|NCT03574337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872689|NCT03574337|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92872690|NCT03574337|Autonomic Agents|autonomic agents|mesh-ancestor
92872691|NCT03574337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872692|NCT02689596|Oxytocin|oxytocin|mesh-list
92872693|NCT02689596|Oxytocics|oxytocics|mesh-ancestor
92872694|NCT02689596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92872695|NCT02689596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872696|NCT04574856|Temozolomide|temozolomide|mesh-list
92872697|NCT04574856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92872698|NCT04574856|Alkylating Agents|alkylating agents|mesh-ancestor
92872699|NCT04574856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872700|NCT04574856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872701|NCT00423995|Loratadine|loratadine|mesh-list
92872702|NCT00423995|Montelukast|montelukast|mesh-list
92872703|NCT00423995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92872704|NCT00423995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92872705|NCT00423995|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92872706|NCT00423995|Hormone Antagonists|hormone antagonists|mesh-ancestor
92872707|NCT00423995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872708|NCT00423995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872709|NCT00423995|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92872710|NCT00423995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92872711|NCT00423995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872712|NCT00423995|Antipruritics|antipruritics|mesh-ancestor
92872713|NCT00423995|Dermatologic Agents|dermatologic agents|mesh-ancestor
92872714|NCT00423995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92872715|NCT00423995|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92872716|NCT00423995|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92872717|NCT00423995|Histamine Antagonists|histamine antagonists|mesh-ancestor
92872718|NCT00423995|Histamine Agents|histamine agents|mesh-ancestor
92872719|NCT00423995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872720|NCT00380627|Etoricoxib|etoricoxib|mesh-list
92872721|NCT00380627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872722|NCT00380627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872723|NCT00380627|Analgesics|analgesics|mesh-ancestor
92872724|NCT00380627|Sensory System Agents|sensory system agents|mesh-ancestor
92872725|NCT00380627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872726|NCT00380627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872727|NCT00380627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872728|NCT00380627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872729|NCT00380627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92872730|NCT00380627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92872731|NCT00380627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872732|NCT00380627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872733|NCT00212771|Olanzapine|olanzapine|mesh-list
92872734|NCT00212771|Asenapine|asenapine|mesh-list
92872735|NCT00212771|Antiemetics|antiemetics|mesh-ancestor
92872736|NCT00212771|Autonomic Agents|autonomic agents|mesh-ancestor
92872737|NCT00212771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872738|NCT00212771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872739|NCT00212771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92872740|NCT00212771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92872741|NCT00212771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92872742|NCT00212771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872743|NCT00212771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92872744|NCT00212771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92872745|NCT00212771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92872746|NCT00212771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92872747|NCT00212771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872748|NCT00212771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872749|NCT00212771|Serotonin Agents|serotonin agents|mesh-ancestor
92872750|NCT03842436|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92872751|NCT03842436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92872752|NCT03842436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92872753|NCT03842436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872754|NCT03842436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872755|NCT03842436|Antiviral Agents|antiviral agents|mesh-ancestor
92872756|NCT03842436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872757|NCT03842436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92872758|NCT03842436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92872759|NCT03829722|Paclitaxel|paclitaxel|mesh-list
92872760|NCT03829722|Carboplatin|carboplatin|mesh-list
92872761|NCT03829722|Nivolumab|nivolumab|mesh-list
92872762|NCT03829722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92872763|NCT03829722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872764|NCT03829722|Tubulin Modulators|tubulin modulators|mesh-ancestor
92872765|NCT03829722|Antimitotic Agents|antimitotic agents|mesh-ancestor
92872766|NCT03829722|Mitosis Modulators|mitosis modulators|mesh-ancestor
92872767|NCT03829722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872768|NCT03829722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92872769|NCT03829722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92872770|NCT03822312|Tobramycin|tobramycin|mesh-list
92872771|NCT03822312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872772|NCT03822312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872773|NCT02687178|Canrenone|canrenone|mesh-list
92872774|NCT02687178|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92872775|NCT02687178|Hormone Antagonists|hormone antagonists|mesh-ancestor
92872776|NCT02687178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872777|NCT02687178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872778|NCT02687178|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92872779|NCT02687178|Diuretics|diuretics|mesh-ancestor
92872780|NCT02687178|Natriuretic Agents|natriuretic agents|mesh-ancestor
92872781|NCT03711318|Buprenorphine|buprenorphine|mesh-list
92872782|NCT03711318|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92872783|NCT03711318|Naloxone|naloxone|mesh-list
92872784|NCT03711318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92872785|NCT03711318|Narcotics|narcotics|mesh-ancestor
92872786|NCT03711318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872787|NCT03711318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872788|NCT03711318|Analgesics|analgesics|mesh-ancestor
92872789|NCT03711318|Sensory System Agents|sensory system agents|mesh-ancestor
92872790|NCT03711318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872791|NCT03711318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92872792|NCT03535116|Ketorolac|ketorolac|mesh-list
92872793|NCT03535116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872794|NCT03535116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872795|NCT03535116|Analgesics|analgesics|mesh-ancestor
92872796|NCT03535116|Sensory System Agents|sensory system agents|mesh-ancestor
92872797|NCT03535116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872798|NCT03535116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872799|NCT03535116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872800|NCT03535116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872801|NCT03535116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92872802|NCT03535116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872803|NCT03535116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872804|NCT03704298|Cyclophosphamide|cyclophosphamide|mesh-list
92872805|NCT03704298|Fludarabine|fludarabine|mesh-list
92872806|NCT03704298|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92872807|NCT03704298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92872808|NCT03704298|Immunologic Factors|immunologic factors|mesh-ancestor
92872809|NCT03704298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872810|NCT03704298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872811|NCT03704298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92872812|NCT03704298|Alkylating Agents|alkylating agents|mesh-ancestor
92872813|NCT03704298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872814|NCT03704298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872815|NCT03704298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92872816|NCT03704298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92872817|NCT02687100|Beclomethasone|beclomethasone|mesh-list
92872818|NCT02687100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872819|NCT02687100|Glucocorticoids|glucocorticoids|mesh-ancestor
92872820|NCT02687100|Hormones|hormones|mesh-ancestor
92872821|NCT02687100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92872822|NCT02687100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872823|NCT02687100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92872824|NCT02687100|Respiratory System Agents|respiratory system agents|mesh-ancestor
92872825|NCT05662098|Hydroxyurea|hydroxyurea|mesh-list
92872826|NCT05662098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872827|NCT05662098|Antisickling Agents|antisickling agents|mesh-ancestor
92872828|NCT05662098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872829|NCT05662098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872830|NCT05662098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92872831|NCT02153645|Amantadine|amantadine|mesh-list
92872832|NCT02153645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92872833|NCT02153645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92872834|NCT02153645|Antiviral Agents|antiviral agents|mesh-ancestor
92872835|NCT02153645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872836|NCT02153645|Dopamine Agents|dopamine agents|mesh-ancestor
92872837|NCT02153645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92872838|NCT02153645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872839|NCT02153645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872840|NCT02153645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872841|NCT02153645|Analgesics|analgesics|mesh-ancestor
92872842|NCT02153645|Sensory System Agents|sensory system agents|mesh-ancestor
92872843|NCT02153645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872844|NCT02688738|Doxycycline|doxycycline|mesh-list
92872845|NCT02688738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872846|NCT02688738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872847|NCT02688738|Antimalarials|antimalarials|mesh-ancestor
92872848|NCT02688738|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92872849|NCT02688738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92872850|NCT00639366|Trastuzumab|trastuzumab|mesh-list
92872851|NCT00639366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92872852|NCT00639366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872853|NCT02686788|Tarenflurbil|tarenflurbil|mesh-list
92872854|NCT02686788|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92872855|NCT02686788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872856|NCT02686788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872857|NCT02686710|Propofol|propofol|mesh-list
92872858|NCT02686710|Sevoflurane|sevoflurane|mesh-list
92872859|NCT02686710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92872860|NCT02686710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92872861|NCT02686710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872862|NCT02686710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92872863|NCT02686710|Anesthetics, General|anesthetics, general|mesh-ancestor
92872864|NCT02686710|Anesthetics|anesthetics|mesh-ancestor
92872865|NCT02686710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92872866|NCT02686710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92872867|NCT01818167|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92872868|NCT01818167|Dermatologic Agents|dermatologic agents|mesh-ancestor
92872869|NCT01773083|Heparin|heparin|mesh-list
92872870|NCT01773083|Calcium heparin|calcium heparin|mesh-list
92872871|NCT01773083|Anticoagulants|anticoagulants|mesh-ancestor
92872872|NCT01773083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92872873|NCT01773083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92872874|NCT01773083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872875|NCT02354898|Sorafenib|sorafenib|mesh-list
92872876|NCT02354898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872877|NCT02354898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872878|NCT02354898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872879|NCT02354898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872880|NCT00110435|Atorvastatin|atorvastatin|mesh-list
92872881|NCT00110435|Simvastatin|simvastatin|mesh-list
92872882|NCT00110435|Ezetimibe|ezetimibe|mesh-list
92872883|NCT00110435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92872884|NCT00110435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872885|NCT00110435|Antimetabolites|antimetabolites|mesh-ancestor
92872886|NCT00110435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872887|NCT00110435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872888|NCT00110435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92872889|NCT00110435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872890|NCT00093899|Simvastatin|simvastatin|mesh-list
92872891|NCT00093899|Ezetimibe|ezetimibe|mesh-list
92872892|NCT00093899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92872893|NCT00093899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872894|NCT00093899|Antimetabolites|antimetabolites|mesh-ancestor
92872895|NCT00093899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872896|NCT00093899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872897|NCT00093899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92872898|NCT00093899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872899|NCT00092807|Ezetimibe|ezetimibe|mesh-list
92872900|NCT00092807|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92872901|NCT00092807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92872902|NCT00092807|Antimetabolites|antimetabolites|mesh-ancestor
92872903|NCT00092807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872904|NCT00092807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92872905|NCT00092729|Naproxen|naproxen|mesh-list
92872906|NCT00092729|Etoricoxib|etoricoxib|mesh-list
92872907|NCT00092729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872908|NCT00092729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872909|NCT00092729|Analgesics|analgesics|mesh-ancestor
92872910|NCT00092729|Sensory System Agents|sensory system agents|mesh-ancestor
92872911|NCT00092729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872912|NCT00092729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872913|NCT00092729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872914|NCT00092729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872915|NCT00092729|Gout Suppressants|gout suppressants|mesh-ancestor
92872916|NCT00092729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92872917|NCT00092729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872918|NCT00092729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872919|NCT00092729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92872920|NCT02686476|Empagliflozin|empagliflozin|mesh-list
92872921|NCT02686476|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92872922|NCT02686476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872923|NCT02686476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92872924|NCT02686476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872925|NCT04972175|Insulin Lispro|insulin lispro|mesh-list
92872926|NCT04972175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92872927|NCT04972175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872928|NCT00616382|Indomethacin|indomethacin|mesh-list
92872929|NCT00616382|Pentoxifylline|pentoxifylline|mesh-list
92872930|NCT00616382|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92872931|NCT00616382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872932|NCT00616382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872933|NCT00616382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92872934|NCT00616382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92872935|NCT00616382|Protective Agents|protective agents|mesh-ancestor
92872936|NCT00616382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872937|NCT00616382|Vasodilator Agents|vasodilator agents|mesh-ancestor
92872938|NCT00616382|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92872939|NCT00616382|Antioxidants|antioxidants|mesh-ancestor
92872940|NCT00616382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872941|NCT00616382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872942|NCT00616382|Analgesics|analgesics|mesh-ancestor
92872943|NCT00616382|Sensory System Agents|sensory system agents|mesh-ancestor
92872944|NCT00616382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872945|NCT00616382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872946|NCT00616382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92872947|NCT00616382|Gout Suppressants|gout suppressants|mesh-ancestor
92872948|NCT00616382|Tocolytic Agents|tocolytic agents|mesh-ancestor
92872949|NCT00616382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92872950|NCT00616382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92872951|NCT01864746|Palbociclib|palbociclib|mesh-list
92872952|NCT01864746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872953|NCT01864746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92872954|NCT01864746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872955|NCT01864746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872956|NCT04967573|Rivaroxaban|rivaroxaban|mesh-list
92872957|NCT04967573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92872958|NCT04967573|Antithrombins|antithrombins|mesh-ancestor
92872959|NCT04967573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92872960|NCT04967573|Protease Inhibitors|protease inhibitors|mesh-ancestor
92872961|NCT04967573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872962|NCT04967573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872963|NCT04967573|Anticoagulants|anticoagulants|mesh-ancestor
92872964|NCT04212650|Losartan|losartan|mesh-list
92872965|NCT04212650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92872966|NCT04212650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92872967|NCT04212650|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92872968|NCT04212650|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92872969|NCT04212650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872970|NCT02574728|Sirolimus|sirolimus|mesh-list
92872971|NCT02574728|Celecoxib|celecoxib|mesh-list
92872972|NCT02574728|Cyclophosphamide|cyclophosphamide|mesh-list
92872973|NCT02574728|Etoposide|etoposide|mesh-list
92872974|NCT02574728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92872975|NCT02574728|Immunologic Factors|immunologic factors|mesh-ancestor
92872976|NCT02574728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92872978|NCT02574728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92872979|NCT02574728|Alkylating Agents|alkylating agents|mesh-ancestor
92872980|NCT02574728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92872981|NCT02574728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92872982|NCT02574728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92872983|NCT02574728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92872984|NCT02574728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92872985|NCT02574728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92872986|NCT02574728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92872987|NCT02574728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92872988|NCT02574728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92872989|NCT02574728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92872990|NCT02574728|Antifungal Agents|antifungal agents|mesh-ancestor
92872991|NCT02574728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92872992|NCT02574728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92872993|NCT02574728|Analgesics|analgesics|mesh-ancestor
92872994|NCT02574728|Sensory System Agents|sensory system agents|mesh-ancestor
92872995|NCT02574728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92872996|NCT02574728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92872997|NCT02574728|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92872998|NCT02574728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92872999|NCT00617474|Epoetin Alfa|epoetin alfa|mesh-list
92873000|NCT00617474|Hematinics|hematinics|mesh-ancestor
92873001|NCT00619034|Diclofenac|diclofenac|mesh-list
92873002|NCT00619034|Dorzolamide|dorzolamide|mesh-list
92873003|NCT00619034|Latanoprost|latanoprost|mesh-list
92873004|NCT00619034|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92873005|NCT00619034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92873006|NCT00619034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92873007|NCT00619034|Analgesics|analgesics|mesh-ancestor
92873008|NCT00619034|Sensory System Agents|sensory system agents|mesh-ancestor
92873009|NCT00619034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873010|NCT00619034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873011|NCT00619034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873012|NCT00619034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873013|NCT00619034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92873014|NCT00619034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873015|NCT00619034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873016|NCT00619034|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92873017|NCT00619034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92873018|NCT00619034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92518256|NCT04784637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873019|NCT01614912|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92873020|NCT01614912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92873021|NCT01614912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92873022|NCT01614912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873023|NCT01614912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873024|NCT01614912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92873025|NCT01614912|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92873026|NCT01614912|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92873027|NCT01614912|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92873028|NCT01614912|Adrenergic Agents|adrenergic agents|mesh-ancestor
92873029|NCT01614912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873030|NCT01614912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873031|NCT01614912|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92873032|NCT01614912|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92873033|NCT01614912|Serotonin Agents|serotonin agents|mesh-ancestor
92873034|NCT01614912|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92873035|NCT01614912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92873036|NCT01614912|Dopamine Agents|dopamine agents|mesh-ancestor
92873037|NCT00638742|Latanoprost|latanoprost|mesh-list
92873038|NCT00638742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92173791|NCT04430556|Sertraline|sertraline|mesh-list
92873039|NCT00638742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92873040|NCT03512418|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92873041|NCT03512418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92873042|NCT03512418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92873043|NCT03512418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873044|NCT03512418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873045|NCT03512418|Antiviral Agents|antiviral agents|mesh-ancestor
92217636|NCT03168022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92873047|NCT03512418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92873048|NCT03512418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92873049|NCT02686242|Anesthetics|anesthetics|mesh-list
92873050|NCT02686242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873051|NCT02686242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873052|NCT05661786|Antiviral Agents|antiviral agents|mesh-list
92873053|NCT05661786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873054|NCT00639522|Paclitaxel|paclitaxel|mesh-list
92873055|NCT00639522|Capecitabine|capecitabine|mesh-list
92873056|NCT00639522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92873057|NCT00639522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873058|NCT00639522|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873059|NCT00639522|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873060|NCT00639522|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873061|NCT00639522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873062|NCT00639522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92873063|NCT00639522|Antimetabolites|antimetabolites|mesh-ancestor
92873064|NCT00411138|Paclitaxel|paclitaxel|mesh-list
92873065|NCT00411138|Carboplatin|carboplatin|mesh-list
92873066|NCT00411138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92873067|NCT00411138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873068|NCT00411138|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873069|NCT00411138|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873070|NCT00411138|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873071|NCT00411138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873072|NCT02686086|Albuterol|albuterol|mesh-list
92873073|NCT02686086|Ipratropium|ipratropium|mesh-list
92873074|NCT02686086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92873075|NCT02686086|Autonomic Agents|autonomic agents|mesh-ancestor
92873076|NCT02686086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873077|NCT02686086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873078|NCT02686086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92873079|NCT02686086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92873080|NCT02686086|Tocolytic Agents|tocolytic agents|mesh-ancestor
92873081|NCT02686086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92873082|NCT02686086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92873083|NCT02686086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92873084|NCT02686086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92873085|NCT02686086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92873086|NCT02686086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873087|NCT02686086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873088|NCT02686086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92873089|NCT02686086|Cholinergic Agents|cholinergic agents|mesh-ancestor
92873090|NCT03460158|Hyaluronic Acid|hyaluronic acid|mesh-list
92873091|NCT03460158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92873092|NCT03460158|Immunologic Factors|immunologic factors|mesh-ancestor
92873093|NCT03460158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873094|NCT03460158|Viscosupplements|viscosupplements|mesh-ancestor
92873095|NCT03460158|Protective Agents|protective agents|mesh-ancestor
92873096|NCT02697630|Pembrolizumab|pembrolizumab|mesh-list
92873097|NCT02697630|Entinostat|entinostat|mesh-list
92873098|NCT02697630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92873099|NCT02697630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873100|NCT02697630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92873101|NCT02697630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873102|NCT02697630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92873103|NCT02697630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873104|NCT02685852|Exenatide|exenatide|mesh-list
92873105|NCT02685852|Acarbose|acarbose|mesh-list
92159596|NCT02863809|Riboflavin|riboflavin|mesh-list
92873106|NCT02685852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873107|NCT02685852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873108|NCT02685852|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92873109|NCT02685852|Incretins|incretins|mesh-ancestor
92873110|NCT02685852|Hormones|hormones|mesh-ancestor
92873111|NCT02685852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873112|NCT02685852|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92873113|NCT02685852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873114|NCT02685852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873115|NCT02697162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92873116|NCT02697162|Octenidine|octenidine|mesh-list
92873117|NCT02697162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873118|NCT02685930|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92873119|NCT02685930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92873120|NCT02685930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873121|NCT02685930|Antitubercular Agents|antitubercular agents|mesh-ancestor
92873123|NCT00622674|Bortezomib|bortezomib|mesh-list
92873124|NCT00622674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92873125|NCT00622674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873126|NCT02687724|Golimumab|golimumab|mesh-list
92873127|NCT02687724|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92873128|NCT02687724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873129|NCT02687724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92873130|NCT02687724|Immunologic Factors|immunologic factors|mesh-ancestor
92873131|NCT02687724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873132|NCT02685774|Metformin|metformin|mesh-list
92873133|NCT02685774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873134|NCT02685774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873135|NCT00638976|Eptifibatide|eptifibatide|mesh-list
92873136|NCT00638976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92873137|NCT05661708|Chitosan|chitosan|mesh-list
92873138|NCT05661708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92873139|NCT05661708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92873140|NCT05661708|Antimetabolites|antimetabolites|mesh-ancestor
92873141|NCT05661708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873142|NCT05661708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92873143|NCT05661708|Chelating Agents|chelating agents|mesh-ancestor
92873144|NCT05661708|Sequestering Agents|sequestering agents|mesh-ancestor
92873145|NCT05661708|Hemostatics|hemostatics|mesh-ancestor
92873146|NCT05661708|Coagulants|coagulants|mesh-ancestor
92873147|NCT00639756|Allopurinol|allopurinol|mesh-list
92873148|NCT00639756|Antimetabolites|antimetabolites|mesh-ancestor
92873149|NCT00639756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873150|NCT00639756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873151|NCT00639756|Gout Suppressants|gout suppressants|mesh-ancestor
92873152|NCT00639756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873153|NCT00639756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92873154|NCT00639756|Antioxidants|antioxidants|mesh-ancestor
92873155|NCT00639756|Protective Agents|protective agents|mesh-ancestor
92873156|NCT00639756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873157|NCT00622752|Nicotine|nicotine|mesh-list
92873158|NCT00622752|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92873159|NCT00622752|Autonomic Agents|autonomic agents|mesh-ancestor
92873160|NCT00622752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873161|NCT00622752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873162|NCT00622752|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92873163|NCT00622752|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92873164|NCT00622752|Cholinergic Agents|cholinergic agents|mesh-ancestor
92873165|NCT00622752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873166|NCT00622752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873167|NCT03451578|alpha-MSH|alpha-msh|mesh-list
92873168|NCT03451578|Hormones|hormones|mesh-ancestor
92873169|NCT03451578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873170|NCT03451578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873171|NCT02686008|Olaparib|olaparib|mesh-list
92873172|NCT02686008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92873173|NCT02686008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873174|NCT02686008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873175|NCT02686008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873176|NCT02685618|Iloprost|iloprost|mesh-list
92873177|NCT02685618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92873178|NCT02685618|Vasodilator Agents|vasodilator agents|mesh-ancestor
92873179|NCT00602472|Linagliptin|linagliptin|mesh-list
92873180|NCT00602472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873181|NCT00602472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873182|NCT00602472|Incretins|incretins|mesh-ancestor
92873183|NCT00602472|Hormones|hormones|mesh-ancestor
92873184|NCT00602472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873185|NCT00602472|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92873186|NCT00602472|Protease Inhibitors|protease inhibitors|mesh-ancestor
92873187|NCT00602472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873188|NCT00602472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873189|NCT03384654|Cytarabine|cytarabine|mesh-list
92873190|NCT03384654|Prednisone|prednisone|mesh-list
92873191|NCT03384654|Cyclophosphamide|cyclophosphamide|mesh-list
92873192|NCT03384654|Doxorubicin|doxorubicin|mesh-list
92873193|NCT03384654|Methotrexate|methotrexate|mesh-list
92873194|NCT03384654|Vincristine|vincristine|mesh-list
92873195|NCT03384654|Asparaginase|asparaginase|mesh-list
92873196|NCT03384654|Mercaptopurine|mercaptopurine|mesh-list
92873197|NCT03384654|Daratumumab|daratumumab|mesh-list
92873198|NCT03384654|Pegaspargase|pegaspargase|mesh-list
92873199|NCT03384654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92873200|NCT03384654|Immunologic Factors|immunologic factors|mesh-ancestor
92873201|NCT03384654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873202|NCT03384654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873203|NCT03384654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92873204|NCT03384654|Alkylating Agents|alkylating agents|mesh-ancestor
92873205|NCT03384654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873206|NCT03384654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873207|NCT03384654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92873208|NCT03384654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92873209|NCT03384654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92873210|NCT03384654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92873211|NCT03384654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873212|NCT03384654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873213|NCT03384654|Glucocorticoids|glucocorticoids|mesh-ancestor
92873214|NCT03384654|Hormones|hormones|mesh-ancestor
92873215|NCT03384654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873216|NCT03384654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92873217|NCT03384654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92873218|NCT03384654|Abortifacient Agents|abortifacient agents|mesh-ancestor
92873219|NCT03384654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92873220|NCT03384654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92873221|NCT03384654|Antimetabolites|antimetabolites|mesh-ancestor
92873222|NCT03384654|Dermatologic Agents|dermatologic agents|mesh-ancestor
92873223|NCT03384654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92873224|NCT03384654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92873225|NCT03384654|Antiviral Agents|antiviral agents|mesh-ancestor
92873226|NCT03384654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873227|NCT03384654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92873228|NCT03384654|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873229|NCT03384654|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873230|NCT03384654|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873231|NCT02685462|Digoxin|digoxin|mesh-list
92873232|NCT02685462|Caffeine|caffeine|mesh-list
92873233|NCT02685462|Atorvastatin|atorvastatin|mesh-list
92873234|NCT02685462|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92873235|NCT02685462|Simvastatin|simvastatin|mesh-list
92873236|NCT02685462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92873237|NCT02685462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92873238|NCT02685462|Antimetabolites|antimetabolites|mesh-ancestor
92873239|NCT02685462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873240|NCT02685462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92873241|NCT02685462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92873242|NCT02685462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873243|NCT02685462|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92873244|NCT02685462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873245|NCT02685462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92873246|NCT02685462|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92873247|NCT02685462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92873248|NCT02685462|Purinergic Agents|purinergic agents|mesh-ancestor
92873249|NCT02685462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873250|NCT02685462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92873251|NCT02685462|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92873252|NCT02685462|Protective Agents|protective agents|mesh-ancestor
92873254|NCT02685306|Taxane|taxane|mesh-list
92873255|NCT02685306|Bavituximab|bavituximab|mesh-list
92873256|NCT02685306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92873257|NCT02685306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873258|NCT02685306|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873259|NCT02685306|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873260|NCT02685306|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873261|NCT02685306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873262|NCT02685306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92873263|NCT02680938|Oxytocin|oxytocin|mesh-list
92873264|NCT02680938|Oxytocics|oxytocics|mesh-ancestor
92873265|NCT02680938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92873266|NCT02680938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873267|NCT05663892|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92873268|NCT05663892|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92873269|NCT05663892|Estradiol|estradiol|mesh-list
92873270|NCT05663892|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92873271|NCT05663892|Estrogens|estrogens|mesh-ancestor
92873272|NCT05663892|Hormones|hormones|mesh-ancestor
92873273|NCT05663892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873274|NCT05663892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873275|NCT05663892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92873276|NCT05663892|Contraceptive Agents|contraceptive agents|mesh-ancestor
92873277|NCT05663892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92873278|NCT05663892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92873279|NCT02685228|Gemcitabine|gemcitabine|mesh-list
92873280|NCT02685228|Decitabine|decitabine|mesh-list
92873281|NCT02685228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92873282|NCT02685228|Antimetabolites|antimetabolites|mesh-ancestor
92873283|NCT02685228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873284|NCT02685228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873285|NCT02685228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873286|NCT00616460|Bivalirudin|bivalirudin|mesh-list
92873287|NCT00616460|Antithrombins|antithrombins|mesh-ancestor
92873288|NCT00616460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92873289|NCT00616460|Protease Inhibitors|protease inhibitors|mesh-ancestor
92873290|NCT00616460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873291|NCT00616460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873292|NCT00616460|Anticoagulants|anticoagulants|mesh-ancestor
92873293|NCT00616538|Fluticasone|fluticasone|mesh-list
92873295|NCT00616538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873296|NCT00616538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92873297|NCT00616538|Autonomic Agents|autonomic agents|mesh-ancestor
92873298|NCT00616538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873299|NCT00616538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873300|NCT00616538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92873301|NCT00616538|Respiratory System Agents|respiratory system agents|mesh-ancestor
92873302|NCT00616538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92873303|NCT00616538|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92873304|NCT02680548|Methylprednisolone|methylprednisolone|mesh-list
92873305|NCT02680548|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92873306|NCT02680548|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92873307|NCT02680548|Prednisolone|prednisolone|mesh-list
92873308|NCT02680548|Prednisolone acetate|prednisolone acetate|mesh-list
92873309|NCT02680548|Bupivacaine|bupivacaine|mesh-list
92873310|NCT02680548|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92873311|NCT02680548|Prednisolone phosphate|prednisolone phosphate|mesh-list
92873312|NCT02680548|Anesthetics, Local|anesthetics, local|mesh-ancestor
92873313|NCT02680548|Anesthetics|anesthetics|mesh-ancestor
92873314|NCT02680548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873315|NCT02680548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873316|NCT02680548|Sensory System Agents|sensory system agents|mesh-ancestor
92873317|NCT02680548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873318|NCT02680548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873319|NCT02680548|Antiemetics|antiemetics|mesh-ancestor
92873320|NCT02680548|Autonomic Agents|autonomic agents|mesh-ancestor
92518561|NCT00088543|Thymoglobulin|thymoglobulin|mesh-list
92873321|NCT02680548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873322|NCT02680548|Glucocorticoids|glucocorticoids|mesh-ancestor
92873323|NCT02680548|Hormones|hormones|mesh-ancestor
92873324|NCT02680548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873325|NCT02680548|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92873326|NCT02680548|Protective Agents|protective agents|mesh-ancestor
92873327|NCT02680548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92873328|NCT02680548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873329|NCT05663736|Glimepiride|glimepiride|mesh-list
92873330|NCT05663736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92873331|NCT05663736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873332|NCT05663736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873333|NCT05663736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92873334|NCT05663736|Immunologic Factors|immunologic factors|mesh-ancestor
92873335|NCT02685150|Omeprazole|omeprazole|mesh-list
92873336|NCT02685150|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92873337|NCT02685150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92873338|NCT02685150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873339|NCT02685150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873340|NCT02685150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873341|NCT02682186|Ropivacaine|ropivacaine|mesh-list
92873342|NCT02682186|Anesthetics, Local|anesthetics, local|mesh-ancestor
92873343|NCT02682186|Anesthetics|anesthetics|mesh-ancestor
92873344|NCT02682186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873345|NCT02682186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873346|NCT02682186|Sensory System Agents|sensory system agents|mesh-ancestor
92873347|NCT02682186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873348|NCT00619268|Interferons|interferons|mesh-list
92873349|NCT00619268|Interferon-alpha|interferon-alpha|mesh-list
92873350|NCT00619268|Interferon alpha-2|interferon alpha-2|mesh-list
92873351|NCT00619268|Sirolimus|sirolimus|mesh-list
92873352|NCT00619268|Bevacizumab|bevacizumab|mesh-list
92873353|NCT00619268|Sunitinib|sunitinib|mesh-list
92873354|NCT00619268|Temsirolimus|temsirolimus|mesh-list
92873355|NCT00619268|MTOR Inhibitors|mtor inhibitors|mesh-list
92873356|NCT00619268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92873357|NCT00619268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873358|NCT00619268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92873359|NCT00619268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92873360|NCT00619268|Growth Substances|growth substances|mesh-ancestor
92873361|NCT00619268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873362|NCT00619268|Growth Inhibitors|growth inhibitors|mesh-ancestor
92873363|NCT00619268|Antiviral Agents|antiviral agents|mesh-ancestor
92873364|NCT00619268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873365|NCT00619268|Immunologic Factors|immunologic factors|mesh-ancestor
92873366|NCT00619268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92873367|NCT00619268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873368|NCT00619268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873369|NCT00619268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92873370|NCT00619268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92873371|NCT00619268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92873372|NCT00619268|Antifungal Agents|antifungal agents|mesh-ancestor
92873373|NCT00619346|Pafuramidine|pafuramidine|mesh-list
92873374|NCT00619346|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92873375|NCT00619346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92873376|NCT00619346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92873377|NCT00619346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873378|NCT04182828|Lidocaine|lidocaine|mesh-list
92873379|NCT04182828|Anesthetics, Local|anesthetics, local|mesh-ancestor
92873380|NCT04182828|Anesthetics|anesthetics|mesh-ancestor
92873381|NCT04182828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873382|NCT04182828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873383|NCT04182828|Sensory System Agents|sensory system agents|mesh-ancestor
92873384|NCT04182828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873385|NCT04182828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92873386|NCT04182828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92873387|NCT04182828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92873388|NCT04182828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159622|NCT02823028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92873389|NCT04182828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873390|NCT00619424|Pemetrexed|pemetrexed|mesh-list
92873391|NCT00619424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92873392|NCT00619424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873393|NCT00619424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873394|NCT00619424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873395|NCT00619424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92873396|NCT00619424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92873397|NCT00619424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92873398|NCT00641004|Esomeprazole|esomeprazole|mesh-list
92873399|NCT00641004|Rebamipide|rebamipide|mesh-list
92873400|NCT00641004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92873401|NCT00641004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873402|NCT00641004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92873403|NCT00641004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873404|NCT00641004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873405|NCT00641004|Antioxidants|antioxidants|mesh-ancestor
92873406|NCT00641004|Protective Agents|protective agents|mesh-ancestor
92873407|NCT00641004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873408|NCT02680080|Moxifloxacin|moxifloxacin|mesh-list
92873409|NCT02680080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92873410|NCT02680080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873411|NCT02680080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92873412|NCT02680080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92873413|NCT02680080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873414|NCT02680080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873415|NCT02680080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873416|NCT01009788|Temozolomide|temozolomide|mesh-list
92873417|NCT01009788|Veliparib|veliparib|mesh-list
92873418|NCT01009788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525304|NCT00024349|Mitomycins|mitomycins|mesh-list
92873419|NCT01009788|Alkylating Agents|alkylating agents|mesh-ancestor
92873420|NCT01009788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873421|NCT01009788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873422|NCT01009788|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92873423|NCT01009788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873425|NCT04183608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92873426|NCT04183608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873427|NCT04183608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873428|NCT00641082|Adefovir|adefovir|mesh-list
92873429|NCT00641082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92873430|NCT00641082|Clevudine|clevudine|mesh-list
92873431|NCT00641082|Antiviral Agents|antiviral agents|mesh-ancestor
92873432|NCT00641082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873433|NCT00641082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92873434|NCT00641082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92873435|NCT00641082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873436|NCT00641082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873437|NCT00641160|Vinorelbine|vinorelbine|mesh-list
92873438|NCT00641160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92873439|NCT00641160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873440|NCT00641160|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873441|NCT00641160|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873442|NCT00641160|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873443|NCT00641160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873444|NCT02679924|Hyaluronic Acid|hyaluronic acid|mesh-list
92873445|NCT02679924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92873446|NCT02679924|Immunologic Factors|immunologic factors|mesh-ancestor
92873447|NCT02679924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873448|NCT02679924|Viscosupplements|viscosupplements|mesh-ancestor
92873449|NCT02679924|Protective Agents|protective agents|mesh-ancestor
92873450|NCT00618176|Lamivudine|lamivudine|mesh-list
92873451|NCT00618176|Zidovudine|zidovudine|mesh-list
92873452|NCT00618176|Nevirapine|nevirapine|mesh-list
92873453|NCT00618176|Didanosine|didanosine|mesh-list
92873454|NCT00618176|Stavudine|stavudine|mesh-list
92873455|NCT00618176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92873456|NCT00618176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92873457|NCT00618176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873458|NCT00618176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873459|NCT00618176|Antiviral Agents|antiviral agents|mesh-ancestor
92873460|NCT00618176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873461|NCT00618176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92873462|NCT00618176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92873463|NCT00618176|Antimetabolites|antimetabolites|mesh-ancestor
92873464|NCT00618176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92873465|NCT00618176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92873466|NCT04211558|Ozanimod|ozanimod|mesh-list
92873467|NCT04211558|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92873468|NCT04211558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873469|NCT04211558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92873470|NCT04211558|Immunologic Factors|immunologic factors|mesh-ancestor
92873471|NCT04211558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873472|NCT05048498|Azacitidine|azacitidine|mesh-list
92873473|NCT05048498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92873474|NCT05048498|Antimetabolites|antimetabolites|mesh-ancestor
92873475|NCT05048498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873476|NCT05048498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873477|NCT05048498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873478|NCT00901901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92873479|NCT00901901|Sorafenib|sorafenib|mesh-list
92873480|NCT00901901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873481|NCT00901901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92873482|NCT00901901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873483|NCT00901901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873484|NCT00618254|Granisetron|granisetron|mesh-list
92873485|NCT00618254|Antiemetics|antiemetics|mesh-ancestor
92873486|NCT00618254|Autonomic Agents|autonomic agents|mesh-ancestor
92873487|NCT00618254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873488|NCT00618254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873489|NCT00618254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873490|NCT00618254|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92873491|NCT00618254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92873492|NCT00618254|Serotonin Agents|serotonin agents|mesh-ancestor
92525306|NCT00024349|Antimetabolites|antimetabolites|mesh-ancestor
92873494|NCT00618254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873495|NCT04184466|Insulin|insulin|mesh-list
92873496|NCT04184466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92873497|NCT04184466|Insulin Aspart|insulin aspart|mesh-list
92873498|NCT04184466|Insulin, Long-Acting|insulin, long-acting|mesh-list
92873499|NCT04184466|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92873500|NCT04184466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873501|NCT04184466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873502|NCT03620201|Atezolizumab|atezolizumab|mesh-list
92873503|NCT03620201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92873504|NCT03620201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873505|NCT03620201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92873506|NCT03620201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873507|NCT04201769|Dexamethasone|dexamethasone|mesh-list
92873508|NCT04201769|Palonosetron|palonosetron|mesh-list
92873509|NCT04201769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873510|NCT04201769|Antiemetics|antiemetics|mesh-ancestor
92873511|NCT04201769|Autonomic Agents|autonomic agents|mesh-ancestor
92873512|NCT04201769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873513|NCT04201769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873514|NCT04201769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873515|NCT04201769|Glucocorticoids|glucocorticoids|mesh-ancestor
92873516|NCT04201769|Hormones|hormones|mesh-ancestor
92873517|NCT04201769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873518|NCT04201769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92873519|NCT04201769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873520|NCT04201769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92873521|NCT04201769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92873522|NCT04201769|Serotonin Agents|serotonin agents|mesh-ancestor
92873523|NCT04201769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873524|NCT04201769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873525|NCT05336825|Lidocaine|lidocaine|mesh-list
92873526|NCT05336825|Anesthetics, Local|anesthetics, local|mesh-ancestor
92873527|NCT05336825|Anesthetics|anesthetics|mesh-ancestor
92873528|NCT05336825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159630|NCT02785224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92873529|NCT05336825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873530|NCT05336825|Sensory System Agents|sensory system agents|mesh-ancestor
92873531|NCT05336825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873532|NCT05336825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92873533|NCT05336825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92873534|NCT05336825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92873535|NCT05336825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92873536|NCT05336825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873537|NCT04748783|Listerine|listerine|mesh-list
92873538|NCT04748783|Chlorhexidine|chlorhexidine|mesh-list
92873539|NCT04748783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92873540|NCT04748783|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92873541|NCT04748783|Sodium Fluoride|sodium fluoride|mesh-list
92873542|NCT04748783|Cariostatic Agents|cariostatic agents|mesh-ancestor
92873543|NCT04748783|Protective Agents|protective agents|mesh-ancestor
92873544|NCT04748783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873545|NCT04748783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92873546|NCT04748783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518793|NCT00390156|Bevacizumab|bevacizumab|mesh-list
92873547|NCT04748783|Disinfectants|disinfectants|mesh-ancestor
92873548|NCT04748783|Dermatologic Agents|dermatologic agents|mesh-ancestor
92873549|NCT02777580|Tenecteplase|tenecteplase|mesh-list
92873550|NCT02777580|Clopidogrel|clopidogrel|mesh-list
92873551|NCT02777580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92873552|NCT02777580|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92873553|NCT02777580|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92873554|NCT02777580|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92873555|NCT02777580|Purinergic Agents|purinergic agents|mesh-ancestor
92873556|NCT02777580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873557|NCT02777580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873558|NCT02777580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873559|NCT02777580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92873560|NCT02777580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92873561|NCT04628663|Dexmedetomidine|dexmedetomidine|mesh-list
92873562|NCT04628663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92873563|NCT04628663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873564|NCT04628663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873565|NCT04628663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92873567|NCT04628663|Sensory System Agents|sensory system agents|mesh-ancestor
92873568|NCT04628663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873569|NCT04628663|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92873570|NCT04628663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92873571|NCT04628663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92873572|NCT04628663|Adrenergic Agents|adrenergic agents|mesh-ancestor
92873573|NCT04628663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873574|NCT04628663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873575|NCT05663268|Infliximab|infliximab|mesh-list
92873576|NCT05663268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92873577|NCT05663268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873578|NCT05663268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92873579|NCT05663268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873580|NCT05663268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873581|NCT02822027|gamma-Globulins|gamma-globulins|mesh-list
92873582|NCT02822027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92873583|NCT02822027|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92873584|NCT02822027|Immunologic Factors|immunologic factors|mesh-ancestor
92873585|NCT02822027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873586|NCT00642096|Metoprolol|metoprolol|mesh-list
92873587|NCT00642096|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92873588|NCT00642096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92873589|NCT00642096|Diuretics|diuretics|mesh-ancestor
92873590|NCT00642096|Natriuretic Agents|natriuretic agents|mesh-ancestor
92873591|NCT00642096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873592|NCT00642096|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92873593|NCT00642096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92873594|NCT00642096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873595|NCT00642096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92873596|NCT00642096|Sympatholytics|sympatholytics|mesh-ancestor
92873597|NCT00642096|Autonomic Agents|autonomic agents|mesh-ancestor
92873598|NCT00642096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873599|NCT00642096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92873600|NCT00642096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92873601|NCT00642096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92873602|NCT00642096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92873603|NCT00642096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873604|NCT05336513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92873605|NCT02679456|Fluconazole|fluconazole|mesh-list
92873606|NCT02679456|Ibrexafungerp|ibrexafungerp|mesh-list
92873607|NCT02679456|Antifungal Agents|antifungal agents|mesh-ancestor
92873608|NCT02679456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873609|NCT02679456|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92873610|NCT02679456|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92873611|NCT02679456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873612|NCT02679456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873613|NCT02679456|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92873614|NCT02679456|Hormone Antagonists|hormone antagonists|mesh-ancestor
92873615|NCT02679456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873616|NCT02679456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873617|NCT02679456|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92873618|NCT02679456|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92518858|NCT00089830|Squalamine|squalamine|mesh-list
92873619|NCT00640458|Sildenafil Citrate|sildenafil citrate|mesh-list
92873620|NCT00640458|Vasodilator Agents|vasodilator agents|mesh-ancestor
92873621|NCT00640458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92873622|NCT00640458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92873623|NCT00640458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873624|NCT00640458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873625|NCT00640458|Urological Agents|urological agents|mesh-ancestor
92873626|NCT00909948|Fludarabine|fludarabine|mesh-list
92873627|NCT00909948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873628|NCT02681562|Olaparib|olaparib|mesh-list
92873629|NCT02681562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92873630|NCT02681562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873631|NCT02681562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873632|NCT02681562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873633|NCT00633035|Esomeprazole|esomeprazole|mesh-list
92873634|NCT00633035|Famotidine|famotidine|mesh-list
92873635|NCT00633035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92873636|NCT00633035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873637|NCT00633035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92873638|NCT00633035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873639|NCT00633035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873640|NCT00633035|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92873641|NCT00633035|Histamine Antagonists|histamine antagonists|mesh-ancestor
92873642|NCT00633035|Histamine Agents|histamine agents|mesh-ancestor
92873643|NCT00633035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873644|NCT00633035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873646|NCT02511132|Docetaxel|docetaxel|mesh-list
92873647|NCT02511132|Irinotecan|irinotecan|mesh-list
92873648|NCT02511132|Temozolomide|temozolomide|mesh-list
92873649|NCT02511132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92873650|NCT02511132|Antimetabolites|antimetabolites|mesh-ancestor
92873651|NCT02511132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873652|NCT02511132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873653|NCT02511132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873654|NCT02511132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873655|NCT02511132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873656|NCT02511132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92873657|NCT02511132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92873658|NCT02511132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873659|NCT02511132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92873660|NCT02511132|Alkylating Agents|alkylating agents|mesh-ancestor
92873661|NCT02678520|Goserelin|goserelin|mesh-list
92873662|NCT02678520|Bicalutamide|bicalutamide|mesh-list
92873663|NCT02678520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873664|NCT02678520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873665|NCT02678520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92873666|NCT02678520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873667|NCT02678520|Androgen Antagonists|androgen antagonists|mesh-ancestor
92873668|NCT02678520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92873669|NCT00642252|Fluorides|fluorides|mesh-list
92873670|NCT00642252|Cariostatic Agents|cariostatic agents|mesh-ancestor
92873671|NCT00642252|Protective Agents|protective agents|mesh-ancestor
92873672|NCT00642252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873673|NCT00642330|Ibuprofen|ibuprofen|mesh-list
92873674|NCT00642330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92873675|NCT00642330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92873676|NCT00642330|Analgesics|analgesics|mesh-ancestor
92873677|NCT00642330|Sensory System Agents|sensory system agents|mesh-ancestor
92873678|NCT00642330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873679|NCT00642330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873680|NCT00642330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873681|NCT00642330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873682|NCT00642330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92873683|NCT00642330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873684|NCT00642330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873685|NCT02681796|Bupivacaine|bupivacaine|mesh-list
92873686|NCT02681796|Anesthetics, Local|anesthetics, local|mesh-ancestor
92873687|NCT02681796|Anesthetics|anesthetics|mesh-ancestor
92873688|NCT02681796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873689|NCT02681796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873690|NCT02681796|Sensory System Agents|sensory system agents|mesh-ancestor
92873691|NCT02681796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873692|NCT02842931|Prednisone|prednisone|mesh-list
92873693|NCT02842931|Cyclophosphamide|cyclophosphamide|mesh-list
92873694|NCT02842931|Doxorubicin|doxorubicin|mesh-list
92873695|NCT02842931|Etoposide|etoposide|mesh-list
92873696|NCT02842931|Vincristine|vincristine|mesh-list
92873697|NCT02842931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92873698|NCT02842931|Immunologic Factors|immunologic factors|mesh-ancestor
92873699|NCT02842931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873700|NCT02842931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873701|NCT02842931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92873702|NCT02842931|Alkylating Agents|alkylating agents|mesh-ancestor
92873703|NCT02842931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873704|NCT02842931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873705|NCT02842931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92873706|NCT02842931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92873707|NCT02842931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92873708|NCT02842931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92873709|NCT02842931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873710|NCT02842931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92873711|NCT02842931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873712|NCT02842931|Glucocorticoids|glucocorticoids|mesh-ancestor
92873713|NCT02842931|Hormones|hormones|mesh-ancestor
92873714|NCT02842931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873715|NCT02842931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92873716|NCT02842931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92873717|NCT02842931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92873718|NCT02842931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92873719|NCT04183296|Propofol|propofol|mesh-list
92873720|NCT04183296|Sevoflurane|sevoflurane|mesh-list
92873721|NCT04183296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92873722|NCT04183296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873723|NCT04183296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873724|NCT04183296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92873725|NCT04183296|Anesthetics, General|anesthetics, general|mesh-ancestor
92873726|NCT04183296|Anesthetics|anesthetics|mesh-ancestor
92873727|NCT04183296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92873728|NCT04183296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92873729|NCT00642408|Micronutrients|micronutrients|mesh-list
92873730|NCT00642408|Trace Elements|trace elements|mesh-list
92873731|NCT00642408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873732|NCT02678598|Micafungin|micafungin|mesh-list
92873733|NCT02678598|Antifungal Agents|antifungal agents|mesh-ancestor
92873734|NCT02678598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873735|NCT02359019|Pembrolizumab|pembrolizumab|mesh-list
92873736|NCT02359019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92873737|NCT02359019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873738|NCT02359019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92873739|NCT02359019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873740|NCT02678364|Vitamin D|vitamin d|mesh-list
92873741|NCT02678364|Cholecalciferol|cholecalciferol|mesh-list
92873742|NCT02678364|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92873743|NCT02678364|Calcifediol|calcifediol|mesh-list
92873744|NCT02678364|Vitamins|vitamins|mesh-ancestor
92873745|NCT02678364|Micronutrients|micronutrients|mesh-ancestor
92873746|NCT02678364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873747|NCT02678364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92873748|NCT02678364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92873749|NCT02678208|Tranexamic Acid|tranexamic acid|mesh-list
92873750|NCT02678208|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92873751|NCT02678208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92873752|NCT02678208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873753|NCT02678208|Hemostatics|hemostatics|mesh-ancestor
92873754|NCT02678208|Coagulants|coagulants|mesh-ancestor
92873755|NCT05551182|Nicergoline|nicergoline|mesh-list
92873756|NCT05551182|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92873757|NCT05551182|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92873758|NCT05551182|Adrenergic Agents|adrenergic agents|mesh-ancestor
92873759|NCT05551182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873760|NCT05551182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873761|NCT05551182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873762|NCT05551182|Vasodilator Agents|vasodilator agents|mesh-ancestor
92873763|NCT05551182|Nootropic Agents|nootropic agents|mesh-ancestor
92873764|NCT02677584|Caffeine|caffeine|mesh-list
92873765|NCT02677584|Caffeine citrate|caffeine citrate|mesh-list
92873766|NCT02677584|Citric Acid|citric acid|mesh-list
92873767|NCT02677584|Sodium Citrate|sodium citrate|mesh-list
92873768|NCT02677584|Anticoagulants|anticoagulants|mesh-ancestor
92873769|NCT02677584|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92873770|NCT02677584|Chelating Agents|chelating agents|mesh-ancestor
92873771|NCT02677584|Sequestering Agents|sequestering agents|mesh-ancestor
92873772|NCT02677584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873773|NCT02677584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92873774|NCT02677584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873775|NCT02677584|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92873777|NCT02677584|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92873778|NCT02677584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92873779|NCT02677584|Purinergic Agents|purinergic agents|mesh-ancestor
92873780|NCT02677584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873781|NCT05662956|Azacitidine|azacitidine|mesh-list
92873782|NCT05662956|Venetoclax|venetoclax|mesh-list
92873783|NCT05662956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92873785|NCT05662956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873786|NCT05662956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873787|NCT05662956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873788|NCT02838173|Ropivacaine|ropivacaine|mesh-list
92873789|NCT02838173|Anesthetics, Local|anesthetics, local|mesh-ancestor
92873790|NCT02838173|Anesthetics|anesthetics|mesh-ancestor
92873791|NCT02838173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873792|NCT02838173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873793|NCT02838173|Sensory System Agents|sensory system agents|mesh-ancestor
92873794|NCT02838173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873795|NCT00641472|Budesonide|budesonide|mesh-list
92873796|NCT00641472|Montelukast|montelukast|mesh-list
92873797|NCT00641472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873798|NCT00641472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92873799|NCT00641472|Autonomic Agents|autonomic agents|mesh-ancestor
92873800|NCT00641472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873801|NCT00641472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873802|NCT00641472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92873803|NCT00641472|Respiratory System Agents|respiratory system agents|mesh-ancestor
92873804|NCT00641472|Glucocorticoids|glucocorticoids|mesh-ancestor
92873805|NCT00641472|Hormones|hormones|mesh-ancestor
92873806|NCT00641472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873807|NCT00641472|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92873808|NCT00641472|Hormone Antagonists|hormone antagonists|mesh-ancestor
92873809|NCT00641472|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92873810|NCT00641472|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92873811|NCT00641472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873812|NCT00896051|Ritonavir|ritonavir|mesh-list
92873813|NCT00896051|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92873814|NCT00896051|Tenofovir|tenofovir|mesh-list
92873815|NCT00896051|Etravirine|etravirine|mesh-list
92873816|NCT00896051|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92873817|NCT00896051|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92873818|NCT00896051|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92873819|NCT00896051|Protease Inhibitors|protease inhibitors|mesh-ancestor
92873820|NCT00896051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873821|NCT00896051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873822|NCT00896051|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92873823|NCT00896051|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92873824|NCT00896051|Antiviral Agents|antiviral agents|mesh-ancestor
92873825|NCT00896051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873826|NCT00896051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92873827|NCT00896051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92873828|NCT00896051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92873829|NCT02673606|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92873830|NCT02673606|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92873831|NCT02673606|Estradiol|estradiol|mesh-list
92873832|NCT02673606|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92873833|NCT02673606|Estrogens|estrogens|mesh-ancestor
92873834|NCT02673606|Hormones|hormones|mesh-ancestor
92873835|NCT02673606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873836|NCT02673606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873837|NCT02673606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92873838|NCT02673606|Contraceptive Agents|contraceptive agents|mesh-ancestor
92873839|NCT02673606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92873840|NCT02673606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92873841|NCT02675400|Methylphenidate|methylphenidate|mesh-list
92873842|NCT02675400|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92873843|NCT02675400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92873844|NCT02675400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873845|NCT02675400|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92873846|NCT02675400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92873847|NCT02675400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92873848|NCT02675400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873849|NCT02675400|Dopamine Agents|dopamine agents|mesh-ancestor
92873850|NCT02675400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873851|NCT05501886|Fulvestrant|fulvestrant|mesh-list
92873852|NCT05501886|Palbociclib|palbociclib|mesh-list
92873853|NCT05501886|Gedatolisib|gedatolisib|mesh-list
92873854|NCT05501886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92873855|NCT05501886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873856|NCT05501886|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92873858|NCT05501886|Hormone Antagonists|hormone antagonists|mesh-ancestor
92873859|NCT05501886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873860|NCT05501886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873861|NCT05501886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92873862|NCT05501886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873863|NCT05501886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873864|NCT00894647|Imiquimod|imiquimod|mesh-list
92873865|NCT00894647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92873866|NCT00894647|Immunologic Factors|immunologic factors|mesh-ancestor
92873867|NCT00894647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873868|NCT00894647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873869|NCT00894647|Interferon Inducers|interferon inducers|mesh-ancestor
92873870|NCT02839421|Moxifloxacin|moxifloxacin|mesh-list
92873871|NCT02839421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92873872|NCT02839421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873873|NCT02839421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92873874|NCT02839421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92873875|NCT02839421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873876|NCT02839421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873877|NCT02839421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873878|NCT02841839|Fluorides|fluorides|mesh-list
92873879|NCT02841839|Tin Fluorides|tin fluorides|mesh-list
92873880|NCT02841839|Cariostatic Agents|cariostatic agents|mesh-ancestor
92873881|NCT02841839|Protective Agents|protective agents|mesh-ancestor
92873882|NCT02841839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873883|NCT04179942|Nitric Oxide|nitric oxide|mesh-list
92873884|NCT04179942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92873885|NCT04179942|Autonomic Agents|autonomic agents|mesh-ancestor
92873886|NCT04179942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873887|NCT04179942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873888|NCT04179942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92873889|NCT04179942|Respiratory System Agents|respiratory system agents|mesh-ancestor
92873890|NCT04179942|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92873891|NCT04179942|Antioxidants|antioxidants|mesh-ancestor
92873892|NCT04179942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873893|NCT04179942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92873894|NCT04179942|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92873895|NCT04179942|Vasodilator Agents|vasodilator agents|mesh-ancestor
92873896|NCT04179942|Gasotransmitters|gasotransmitters|mesh-ancestor
92873897|NCT04179942|Protective Agents|protective agents|mesh-ancestor
92873898|NCT04250831|Chromium|chromium|mesh-list
92873899|NCT04250831|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92873900|NCT04250831|Trace Elements|trace elements|mesh-ancestor
92873901|NCT04250831|Micronutrients|micronutrients|mesh-ancestor
92873902|NCT04250831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873903|NCT04250831|Cathartics|cathartics|mesh-ancestor
92873904|NCT04250831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873905|NCT00633191|Immunomodulating Agents|immunomodulating agents|mesh-list
92873906|NCT00633191|Immunologic Factors|immunologic factors|mesh-ancestor
92873907|NCT00633191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873908|NCT00643500|Levetiracetam|levetiracetam|mesh-list
92873909|NCT00643500|Anticonvulsants|anticonvulsants|mesh-ancestor
92873910|NCT00643500|Nootropic Agents|nootropic agents|mesh-ancestor
92873911|NCT02837081|Anti-Infective Agents|anti-infective agents|mesh-list
92873912|NCT02837081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92873913|NCT00633269|Olaparib|olaparib|mesh-list
92873914|NCT00633269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92873915|NCT00633269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873916|NCT00633269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873917|NCT00633269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873918|NCT04181346|Pregabalin|pregabalin|mesh-list
92873919|NCT04181346|Analgesics|analgesics|mesh-ancestor
92873920|NCT04181346|Sensory System Agents|sensory system agents|mesh-ancestor
92873921|NCT04181346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873922|NCT04181346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873924|NCT04181346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92873925|NCT04181346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92873926|NCT04181346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873927|NCT04181346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92873928|NCT04181346|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92873929|NCT04181346|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92873930|NCT04181346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92873931|NCT04181346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92873932|NCT00642798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92873933|NCT00642798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92873934|NCT00642798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873935|NCT00642798|Incretins|incretins|mesh-ancestor
92873936|NCT00642798|Hormones|hormones|mesh-ancestor
92873937|NCT00642798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92873938|NCT00642798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92873939|NCT00642798|Protease Inhibitors|protease inhibitors|mesh-ancestor
92873940|NCT00642798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873941|NCT00642798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873942|NCT05364996|Dimercaprol|dimercaprol|mesh-list
92873943|NCT05364996|Chelating Agents|chelating agents|mesh-ancestor
92873944|NCT05364996|Sequestering Agents|sequestering agents|mesh-ancestor
92873945|NCT05364996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873946|NCT00643734|Azithromycin|azithromycin|mesh-list
92873947|NCT00643734|Levofloxacin|levofloxacin|mesh-list
92873948|NCT00643734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92873949|NCT00643734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873950|NCT00643734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92873951|NCT00643734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92873952|NCT00643734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92873953|NCT00643734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873954|NCT00643734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873955|NCT00643734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873956|NCT00643734|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92873957|NCT00643734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92873958|NCT02674308|Vedolizumab|vedolizumab|mesh-list
92873959|NCT02674308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873960|NCT04179006|Antidepressive Agents|antidepressive agents|mesh-list
92873961|NCT04179006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92873962|NCT02672592|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92873963|NCT02672592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873964|NCT04178850|Folic Acid|folic acid|mesh-list
92873965|NCT04178850|Vitamin B Complex|vitamin b complex|mesh-list
92873966|NCT04178850|Infliximab|infliximab|mesh-list
92873967|NCT04178850|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92873968|NCT04178850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92873969|NCT04178850|Dermatologic Agents|dermatologic agents|mesh-ancestor
92873970|NCT04178850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92873971|NCT04178850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92873972|NCT04178850|Hematinics|hematinics|mesh-ancestor
92873973|NCT04178850|Vitamins|vitamins|mesh-ancestor
92873974|NCT04178850|Micronutrients|micronutrients|mesh-ancestor
92873975|NCT04178850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873976|NCT02676336|Iodine|iodine|mesh-list
92873977|NCT02676336|Cadexomer iodine|cadexomer iodine|mesh-list
92873978|NCT02676336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92873979|NCT02676336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92873980|NCT02676336|Trace Elements|trace elements|mesh-ancestor
92873981|NCT02676336|Micronutrients|micronutrients|mesh-ancestor
92873982|NCT02676336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873983|NCT02672358|Trametinib|trametinib|mesh-list
92873984|NCT02672358|Dabrafenib|dabrafenib|mesh-list
92873985|NCT02672358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92873986|NCT02672358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92873987|NCT02672358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92873988|NCT02672358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92873989|NCT02675868|Phenylephrine|phenylephrine|mesh-list
92873990|NCT02675868|Vasopressins|vasopressins|mesh-list
92873991|NCT02675868|Arginine Vasopressin|arginine vasopressin|mesh-list
92873992|NCT02675868|Oxymetazoline|oxymetazoline|mesh-list
92873993|NCT02675868|Norepinephrine|norepinephrine|mesh-list
92873994|NCT02675868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92873995|NCT02675868|Mydriatics|mydriatics|mesh-ancestor
92873996|NCT02675868|Autonomic Agents|autonomic agents|mesh-ancestor
92873997|NCT02675868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92873998|NCT02675868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92873999|NCT02675868|Sympathomimetics|sympathomimetics|mesh-ancestor
92874000|NCT02675868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92874001|NCT02675868|Nasal Decongestants|nasal decongestants|mesh-ancestor
92874002|NCT02675868|Respiratory System Agents|respiratory system agents|mesh-ancestor
92874003|NCT02675868|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92874004|NCT02675868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92874005|NCT02675868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92874006|NCT02675868|Adrenergic Agents|adrenergic agents|mesh-ancestor
92874007|NCT02675868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874008|NCT02675868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874010|NCT02675868|Hemostatics|hemostatics|mesh-ancestor
92874011|NCT02675868|Coagulants|coagulants|mesh-ancestor
92874012|NCT02675868|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92874013|NCT02675868|Natriuretic Agents|natriuretic agents|mesh-ancestor
92874014|NCT05279742|Valsartan|valsartan|mesh-list
92874015|NCT05279742|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92874016|NCT05279742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92874017|NCT05279742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92874018|NCT05279742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92874019|NCT05279742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874020|NCT02673840|Ketotifen|ketotifen|mesh-list
92874021|NCT02673840|Antipruritics|antipruritics|mesh-ancestor
92874022|NCT02673840|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874023|NCT02673840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92874024|NCT02673840|Histamine Antagonists|histamine antagonists|mesh-ancestor
92874025|NCT02673840|Histamine Agents|histamine agents|mesh-ancestor
92874026|NCT02673840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874027|NCT02673840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874028|NCT02673840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874029|NCT02673840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92874030|NCT00644124|Aflibercept|aflibercept|mesh-list
92874031|NCT00644124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92874032|NCT00644124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92874033|NCT00644124|Growth Substances|growth substances|mesh-ancestor
92874034|NCT00644124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874035|NCT00644124|Growth Inhibitors|growth inhibitors|mesh-ancestor
92874036|NCT00644124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874037|NCT02670954|Flurbiprofen|flurbiprofen|mesh-list
92874038|NCT02670954|Dexmedetomidine|dexmedetomidine|mesh-list
92874039|NCT02670954|Tramadol|tramadol|mesh-list
92874040|NCT02670954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92874041|NCT02670954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874042|NCT02670954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874043|NCT02670954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92874044|NCT02670954|Analgesics|analgesics|mesh-ancestor
92874045|NCT02670954|Sensory System Agents|sensory system agents|mesh-ancestor
92874046|NCT02670954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874047|NCT02670954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92874048|NCT02670954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92874049|NCT02670954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92874050|NCT02670954|Adrenergic Agents|adrenergic agents|mesh-ancestor
92874051|NCT02670954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874052|NCT02670954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874053|NCT02670954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92874054|NCT02670954|Narcotics|narcotics|mesh-ancestor
92874055|NCT02670954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92874056|NCT02670954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874057|NCT02670954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874058|NCT02670954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92874059|NCT02670954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874060|NCT00644904|Vitamin D|vitamin d|mesh-list
92874061|NCT00644904|Ergocalciferols|ergocalciferols|mesh-list
92874062|NCT00644904|Cholecalciferol|cholecalciferol|mesh-list
92874063|NCT00644904|Vitamins|vitamins|mesh-list
92874064|NCT00644904|Micronutrients|micronutrients|mesh-ancestor
92874065|NCT00644904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874066|NCT00644904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92874067|NCT00644904|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92874068|NCT02670564|Busulfan|busulfan|mesh-list
92874069|NCT02670564|Alkylating Agents|alkylating agents|mesh-ancestor
92874070|NCT02670564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519338|NCT00006239|Tretinoin|tretinoin|mesh-list
92874071|NCT02670564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874072|NCT02670564|Immunologic Factors|immunologic factors|mesh-ancestor
92874073|NCT02670564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874074|NCT02670564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92874075|NCT02670564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874076|NCT02670564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92874077|NCT02672202|Pregabalin|pregabalin|mesh-list
92874078|NCT02672202|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92874079|NCT02672202|Analgesics|analgesics|mesh-ancestor
92874080|NCT02672202|Sensory System Agents|sensory system agents|mesh-ancestor
92874081|NCT02672202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525314|NCT00024349|Alkylating Agents|alkylating agents|mesh-ancestor
92874082|NCT02672202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159681|NCT02521311|Clemastine|clemastine|mesh-list
92874083|NCT02672202|Anticonvulsants|anticonvulsants|mesh-ancestor
92874084|NCT02672202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92874085|NCT02672202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874086|NCT02672202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874087|NCT02672202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92874088|NCT02672202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92874089|NCT02672202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874090|NCT02672202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874091|NCT02672202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874092|NCT02672202|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92874093|NCT02672202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92874094|NCT02672202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874095|NCT02672202|Antidepressive Agents|antidepressive agents|mesh-ancestor
92874096|NCT02672202|Dopamine Agents|dopamine agents|mesh-ancestor
92874097|NCT02671578|Nitrous Oxide|nitrous oxide|mesh-list
92874098|NCT02671578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92874099|NCT02671578|Anesthetics, General|anesthetics, general|mesh-ancestor
92874100|NCT02671578|Anesthetics|anesthetics|mesh-ancestor
92874101|NCT02671578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874102|NCT02671578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874103|NCT02671578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92874104|NCT02671578|Analgesics|analgesics|mesh-ancestor
92874105|NCT02671578|Sensory System Agents|sensory system agents|mesh-ancestor
92874106|NCT02671578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874108|NCT00644982|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92874109|NCT00644982|Antidepressive Agents|antidepressive agents|mesh-ancestor
92874110|NCT00644982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874111|NCT00644982|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92874112|NCT00644982|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92874113|NCT00644982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874114|NCT00644982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874115|NCT00644982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874116|NCT00644982|Serotonin Agents|serotonin agents|mesh-ancestor
92874117|NCT00644982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874118|NCT00644982|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92874119|NCT00644982|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92874120|NCT02670642|Esomeprazole|esomeprazole|mesh-list
92874121|NCT02670642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92874122|NCT02670642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874123|NCT02670642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92874124|NCT02670642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874125|NCT02670642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874126|NCT04175496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92874127|NCT02670018|Metformin|metformin|mesh-list
92874128|NCT02670018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92874129|NCT02670018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874130|NCT02670096|Acetazolamide|acetazolamide|mesh-list
92874131|NCT02670096|Anticonvulsants|anticonvulsants|mesh-ancestor
92874132|NCT02670096|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92874133|NCT02670096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874134|NCT02670096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874135|NCT02670096|Diuretics|diuretics|mesh-ancestor
92874136|NCT02670096|Natriuretic Agents|natriuretic agents|mesh-ancestor
92874137|NCT02670096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874138|NCT00645060|Antibodies|antibodies|mesh-list
92874139|NCT00645060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92874140|NCT00645060|Immunologic Factors|immunologic factors|mesh-ancestor
92874141|NCT00645060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874142|NCT04176978|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92874143|NCT04176978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92874144|NCT04176978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92874145|NCT04176978|Antimetabolites|antimetabolites|mesh-ancestor
92874146|NCT04176978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874147|NCT04176978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92874148|NCT04176978|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92874149|NCT04176978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874150|NCT00644670|Atorvastatin|atorvastatin|mesh-list
92874151|NCT00644670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92874152|NCT00644670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92874154|NCT00644670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874155|NCT00644670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92874156|NCT00644670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92874157|NCT00644670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874158|NCT02669706|Pentamidine|pentamidine|mesh-list
92874159|NCT02669706|Antifungal Agents|antifungal agents|mesh-ancestor
92874160|NCT02669706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874161|NCT02669706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92874162|NCT02669706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92874163|NCT02669706|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92874164|NCT00645138|Anesthetics|anesthetics|mesh-list
92874165|NCT00645138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874166|NCT00645138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874167|NCT00895895|Donepezil|donepezil|mesh-list
92874168|NCT00895895|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92874169|NCT00895895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874170|NCT00895895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874171|NCT00895895|Cholinergic Agents|cholinergic agents|mesh-ancestor
92874172|NCT00895895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874173|NCT00895895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874174|NCT00895895|Nootropic Agents|nootropic agents|mesh-ancestor
92874175|NCT00644748|Gabapentin|gabapentin|mesh-list
92874176|NCT00644748|Analgesics|analgesics|mesh-ancestor
92874177|NCT00644748|Sensory System Agents|sensory system agents|mesh-ancestor
92874178|NCT00644748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874179|NCT00644748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874180|NCT00644748|Anticonvulsants|anticonvulsants|mesh-ancestor
92874181|NCT00644748|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92874182|NCT00644748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874183|NCT00644748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874184|NCT00644748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874185|NCT00644748|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92874186|NCT00644748|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92874187|NCT00644748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874188|NCT00644748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874189|NCT00644748|Antimanic Agents|antimanic agents|mesh-ancestor
92874190|NCT00910416|Remifentanil|remifentanil|mesh-list
92874191|NCT00910416|Propofol|propofol|mesh-list
92874192|NCT00910416|Sevoflurane|sevoflurane|mesh-list
92874193|NCT00910416|Atracurium|atracurium|mesh-list
92874194|NCT00910416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92874195|NCT00910416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874196|NCT00910416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874197|NCT00910416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92874198|NCT00910416|Anesthetics, General|anesthetics, general|mesh-ancestor
92874199|NCT00910416|Anesthetics|anesthetics|mesh-ancestor
92874200|NCT00910416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92874201|NCT00910416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92874202|NCT00910416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92874203|NCT00910416|Narcotics|narcotics|mesh-ancestor
92874204|NCT00910416|Analgesics|analgesics|mesh-ancestor
92874205|NCT00910416|Sensory System Agents|sensory system agents|mesh-ancestor
92874206|NCT00910416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874207|NCT00910416|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92874208|NCT00910416|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92874209|NCT00910416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92874210|NCT00910416|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92874211|NCT00910416|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92874212|NCT00910416|Cholinergic Agents|cholinergic agents|mesh-ancestor
92874213|NCT00910416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874214|NCT00910416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874215|NCT02669238|Etonogestrel|etonogestrel|mesh-list
92874216|NCT02669238|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92874217|NCT02669238|Contraceptive Agents|contraceptive agents|mesh-ancestor
92874218|NCT02669238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92874219|NCT02669238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874220|NCT02669238|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92874221|NCT02669004|Morphine|morphine|mesh-list
92874222|NCT02669004|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92874223|NCT02669004|Narcotics|narcotics|mesh-ancestor
92874224|NCT02669004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874225|NCT02669004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874226|NCT02669004|Analgesics|analgesics|mesh-ancestor
92874227|NCT02669004|Sensory System Agents|sensory system agents|mesh-ancestor
92874228|NCT02669004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874230|NCT00895661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874231|NCT00895661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874232|NCT00895661|Immunologic Factors|immunologic factors|mesh-ancestor
92874233|NCT00895661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874234|NCT00895661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874235|NCT00645294|Adefovir|adefovir|mesh-list
92874236|NCT00645294|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92874237|NCT00645294|Antiviral Agents|antiviral agents|mesh-ancestor
92874238|NCT00645294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874239|NCT00645294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92874240|NCT00645294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92874241|NCT00645294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874242|NCT00645294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874243|NCT02837003|Aspirin|aspirin|mesh-list
92874244|NCT02837003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92874245|NCT02837003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92874246|NCT02837003|Analgesics|analgesics|mesh-ancestor
92874247|NCT02837003|Sensory System Agents|sensory system agents|mesh-ancestor
92874248|NCT02837003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874249|NCT02837003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874250|NCT02837003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874251|NCT02837003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874252|NCT02837003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92874253|NCT02837003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92874254|NCT02837003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874255|NCT02837003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92874256|NCT02837003|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92874257|NCT02837003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874258|NCT02837003|Antipyretics|antipyretics|mesh-ancestor
92874259|NCT02668926|Amphetamine|amphetamine|mesh-list
92874260|NCT02668926|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92874261|NCT02668926|Dextroamphetamine|dextroamphetamine|mesh-list
92874262|NCT02668926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92874263|NCT02668926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874264|NCT02668926|Sympathomimetics|sympathomimetics|mesh-ancestor
92874265|NCT02668926|Autonomic Agents|autonomic agents|mesh-ancestor
92874266|NCT02668926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874267|NCT02668926|Dopamine Agents|dopamine agents|mesh-ancestor
92874268|NCT02668926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874269|NCT02668926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874270|NCT02668926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92874271|NCT02668926|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92874272|NCT02668926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92874273|NCT02668926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874274|NCT02668926|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92874275|NCT02668536|Sunscreening Agents|sunscreening agents|mesh-list
92874276|NCT02668536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92874277|NCT02668536|Protective Agents|protective agents|mesh-ancestor
92874278|NCT02668536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874279|NCT02668536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874280|NCT00645372|Risperidone|risperidone|mesh-list
92874281|NCT00645372|Ziprasidone|ziprasidone|mesh-list
92874282|NCT00645372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92874283|NCT00645372|Serotonin Agents|serotonin agents|mesh-ancestor
92874284|NCT00645372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874285|NCT00645372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874286|NCT00645372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874287|NCT00645372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92874288|NCT00645372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874289|NCT00645372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874290|NCT00645372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874291|NCT00645372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92874292|NCT00645372|Dopamine Agents|dopamine agents|mesh-ancestor
92874293|NCT00645918|Clopidogrel|clopidogrel|mesh-list
92874294|NCT00645918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92874295|NCT00645918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92874296|NCT00645918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92874297|NCT00645918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92874298|NCT00645918|Purinergic Agents|purinergic agents|mesh-ancestor
92874299|NCT00645918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874300|NCT00645918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874301|NCT00645918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874302|NCT00646854|Cyclophosphamide|cyclophosphamide|mesh-list
92874304|NCT00646854|Doxorubicin|doxorubicin|mesh-list
92874305|NCT00646854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92874306|NCT00646854|Vincristine|vincristine|mesh-list
92874307|NCT00646854|Lenograstim|lenograstim|mesh-list
92874308|NCT00646854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874309|NCT00646854|Immunologic Factors|immunologic factors|mesh-ancestor
92874310|NCT00646854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874311|NCT00646854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874312|NCT00646854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92874313|NCT00646854|Alkylating Agents|alkylating agents|mesh-ancestor
92874314|NCT00646854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874315|NCT00646854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874316|NCT00646854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92874317|NCT00646854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92874318|NCT00646854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874319|NCT00646854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92874320|NCT00646854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92874321|NCT00646854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92874322|NCT00646854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874323|NCT00646854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92874324|NCT00646854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92874325|NCT00646854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92874326|NCT00646854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92874327|NCT04173858|Naloxegol|naloxegol|mesh-list
92874328|NCT04173858|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92874329|NCT04173858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874330|NCT04173858|Sensory System Agents|sensory system agents|mesh-ancestor
92874331|NCT04173858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874332|NCT00646932|Ergocalciferols|ergocalciferols|mesh-list
92874333|NCT00646932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92874334|NCT00646932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874335|NCT00646932|Vitamins|vitamins|mesh-ancestor
92874336|NCT00646932|Micronutrients|micronutrients|mesh-ancestor
92874337|NCT00646932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92874338|NCT00646152|Poly ICLC|poly iclc|mesh-list
92874339|NCT00646152|Interferon Inducers|interferon inducers|mesh-ancestor
92874340|NCT00646152|Immunologic Factors|immunologic factors|mesh-ancestor
92874341|NCT00646152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874342|NCT00647166|Azathioprine|azathioprine|mesh-list
92874343|NCT00647166|Antimetabolites|antimetabolites|mesh-ancestor
92874344|NCT00647166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874345|NCT00647166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92874346|NCT00647166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874347|NCT00647166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874348|NCT00647166|Immunologic Factors|immunologic factors|mesh-ancestor
92874349|NCT00647166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874350|NCT00647166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874351|NCT00647244|Tenofovir|tenofovir|mesh-list
92874352|NCT00647244|Abacavir|abacavir|mesh-list
92874353|NCT00647244|Antiviral Agents|antiviral agents|mesh-ancestor
92874354|NCT00647244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874355|NCT00647244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92874356|NCT00647244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92874357|NCT00647244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874358|NCT00647244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874359|NCT00647244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92874360|NCT00647244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92874361|NCT00895583|Sirolimus|sirolimus|mesh-list
92874362|NCT00895583|Tacrolimus|tacrolimus|mesh-list
92874363|NCT00895583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874364|NCT00895583|Immunologic Factors|immunologic factors|mesh-ancestor
92874365|NCT00895583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874366|NCT00895583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92874367|NCT00895583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874368|NCT00895583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874369|NCT00895583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874370|NCT00895583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874371|NCT00895583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92874372|NCT00895583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874373|NCT00895583|Antifungal Agents|antifungal agents|mesh-ancestor
92874374|NCT00647322|Anticonvulsants|anticonvulsants|mesh-list
92874375|NCT04174872|Midazolam|midazolam|mesh-list
92218981|NCT01057381|Morphine|morphine|mesh-list
92874377|NCT04174872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92874378|NCT04174872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874379|NCT04174872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874380|NCT04174872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92874381|NCT04174872|Analgesics|analgesics|mesh-ancestor
92874382|NCT04174872|Sensory System Agents|sensory system agents|mesh-ancestor
92874383|NCT04174872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874384|NCT04174872|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92874385|NCT04174872|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92874386|NCT04174872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92874387|NCT04174872|Adrenergic Agents|adrenergic agents|mesh-ancestor
92874388|NCT04174872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874389|NCT04174872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874390|NCT04174872|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92874391|NCT04174872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92874392|NCT04174872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874393|NCT04174872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874394|NCT04174872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92874395|NCT04174872|Anesthetics, General|anesthetics, general|mesh-ancestor
92874396|NCT04174872|Anesthetics|anesthetics|mesh-ancestor
92874397|NCT04174872|GABA Modulators|gaba modulators|mesh-ancestor
92874398|NCT04174872|GABA Agents|gaba agents|mesh-ancestor
92874399|NCT02841137|Progesterone|progesterone|mesh-list
92874400|NCT02841137|Progestins|progestins|mesh-ancestor
92874401|NCT02841137|Hormones|hormones|mesh-ancestor
92874402|NCT02841137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874403|NCT02841137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874404|NCT00645606|Rituximab|rituximab|mesh-list
92874405|NCT00645606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874406|NCT00645606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874407|NCT00645606|Immunologic Factors|immunologic factors|mesh-ancestor
92874408|NCT00645606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874409|NCT00645606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874410|NCT02836847|Trastuzumab|trastuzumab|mesh-list
92874411|NCT02836847|Cetuximab|cetuximab|mesh-list
92874412|NCT02836847|Everolimus|everolimus|mesh-list
92874413|NCT02836847|Sorafenib|sorafenib|mesh-list
92874414|NCT02836847|Lapatinib|lapatinib|mesh-list
92874415|NCT02836847|Gefitinib|gefitinib|mesh-list
92874416|NCT02836847|Crizotinib|crizotinib|mesh-list
92874417|NCT02836847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874418|NCT02836847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874419|NCT02836847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92874420|NCT02836847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92874421|NCT02836847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874422|NCT02836847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874423|NCT02836847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874424|NCT02836847|Immunologic Factors|immunologic factors|mesh-ancestor
92874425|NCT02836847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874426|NCT02666040|Anesthetics|anesthetics|mesh-list
92874427|NCT02666040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874428|NCT02666040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874429|NCT00894413|Tadalafil|tadalafil|mesh-list
92874430|NCT00894413|Vasodilator Agents|vasodilator agents|mesh-ancestor
92874431|NCT00894413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92874432|NCT00894413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92874433|NCT00894413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874434|NCT00894413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874435|NCT00894413|Urological Agents|urological agents|mesh-ancestor
92874436|NCT04250519|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92874437|NCT04250519|Eusol|eusol|mesh-list
92874438|NCT04250519|Disinfectants|disinfectants|mesh-ancestor
92874439|NCT04250519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874440|NCT04172220|Midazolam|midazolam|mesh-list
92874441|NCT04172220|Anesthetics|anesthetics|mesh-list
92874442|NCT04172220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874443|NCT04172220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874444|NCT04172220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92874445|NCT04172220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92874446|NCT04172220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92874447|NCT04172220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92159695|NCT02494258|Cc-486|cc-486|mesh-list
92874448|NCT04172220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874449|NCT04172220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92874450|NCT04172220|Anesthetics, General|anesthetics, general|mesh-ancestor
92874451|NCT04172220|GABA Modulators|gaba modulators|mesh-ancestor
92874452|NCT04172220|GABA Agents|gaba agents|mesh-ancestor
92874453|NCT04172220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874454|NCT04172220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874455|NCT02665806|Fluticasone|fluticasone|mesh-list
92874456|NCT02665806|Ciclesonide|ciclesonide|mesh-list
92874457|NCT02665806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874458|NCT02665806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92874459|NCT02665806|Autonomic Agents|autonomic agents|mesh-ancestor
92874460|NCT02665806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874461|NCT02665806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874462|NCT02665806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92874463|NCT02665806|Respiratory System Agents|respiratory system agents|mesh-ancestor
92874464|NCT02665806|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874465|NCT02665806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92874466|NCT02665806|Glucocorticoids|glucocorticoids|mesh-ancestor
92874467|NCT02665806|Hormones|hormones|mesh-ancestor
92874468|NCT02665806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874469|NCT00646386|Adalimumab|adalimumab|mesh-list
92874470|NCT00646386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92874471|NCT00646386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874472|NCT00646386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874473|NCT00647634|Alprazolam|alprazolam|mesh-list
92874474|NCT00647634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92874475|NCT00647634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874476|NCT00647634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874477|NCT00647634|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92874478|NCT00647634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874479|NCT00647634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874480|NCT00647634|GABA Modulators|gaba modulators|mesh-ancestor
92874481|NCT00647634|GABA Agents|gaba agents|mesh-ancestor
92874482|NCT00647634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874483|NCT00647634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874484|NCT04172064|Dobutamine|dobutamine|mesh-list
92874485|NCT04172064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92874486|NCT04172064|Sympathomimetics|sympathomimetics|mesh-ancestor
92874487|NCT04172064|Autonomic Agents|autonomic agents|mesh-ancestor
92874488|NCT04172064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874489|NCT04172064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874490|NCT04172064|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92874491|NCT04172064|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92874492|NCT04172064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92874493|NCT04172064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92874494|NCT04172064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874495|NCT04172064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874496|NCT04172064|Protective Agents|protective agents|mesh-ancestor
92874497|NCT00647712|Valproic Acid|valproic acid|mesh-list
92874498|NCT00647712|Anticonvulsants|anticonvulsants|mesh-ancestor
92874499|NCT00647712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874500|NCT00647712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874501|NCT00647712|GABA Agents|gaba agents|mesh-ancestor
92874502|NCT00647712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874503|NCT00647712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874504|NCT00647712|Antimanic Agents|antimanic agents|mesh-ancestor
92874505|NCT00647712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874506|NCT00647712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874507|NCT00647712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874508|NCT04173390|Pregabalin|pregabalin|mesh-list
92874509|NCT04173390|Analgesics|analgesics|mesh-ancestor
92874510|NCT04173390|Sensory System Agents|sensory system agents|mesh-ancestor
92874511|NCT04173390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874512|NCT04173390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874513|NCT04173390|Anticonvulsants|anticonvulsants|mesh-ancestor
92874514|NCT04173390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92874515|NCT04173390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874516|NCT04173390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874517|NCT04173390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92874518|NCT04173390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92874519|NCT04173390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92874520|NCT04173390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874521|NCT04173390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874522|NCT04895202|Siponimod|siponimod|mesh-list
92874523|NCT04895202|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92874524|NCT04895202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874525|NCT04895202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874526|NCT04895202|Immunologic Factors|immunologic factors|mesh-ancestor
92874527|NCT04895202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874528|NCT02665650|Pembrolizumab|pembrolizumab|mesh-list
92874529|NCT02665650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874530|NCT02665650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874531|NCT02665650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92874532|NCT02665650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874533|NCT00647868|Testosterone|testosterone|mesh-list
92874534|NCT00647868|Androgens|androgens|mesh-ancestor
92874535|NCT00647868|Hormones|hormones|mesh-ancestor
92874536|NCT00647868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874537|NCT00647868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874538|NCT00647946|Tenofovir|tenofovir|mesh-list
92874539|NCT00647946|Abacavir|abacavir|mesh-list
92874540|NCT00647946|Antiviral Agents|antiviral agents|mesh-ancestor
92874541|NCT00647946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874542|NCT00647946|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92874543|NCT00647946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92874544|NCT00647946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874545|NCT00647946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874546|NCT00647946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92874547|NCT00647946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92874548|NCT00648024|Anagrelide|anagrelide|mesh-list
92874549|NCT00648024|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92874550|NCT00648024|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92874551|NCT00648024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874552|NCT00648024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92874553|NCT02665416|Bevacizumab|bevacizumab|mesh-list
92874554|NCT02665416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874555|NCT02665416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874556|NCT02665416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92874557|NCT02665416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92874558|NCT02665416|Growth Substances|growth substances|mesh-ancestor
92874559|NCT02665416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874560|NCT02665416|Growth Inhibitors|growth inhibitors|mesh-ancestor
92874561|NCT00646620|Fluticasone|fluticasone|mesh-list
92874562|NCT00646620|Budesonide|budesonide|mesh-list
92874563|NCT00646620|Albuterol|albuterol|mesh-list
92874564|NCT00646620|Formoterol Fumarate|formoterol fumarate|mesh-list
92874565|NCT00646620|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92874566|NCT00646620|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92874567|NCT00646620|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92874568|NCT00646620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874569|NCT00646620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92874570|NCT00646620|Autonomic Agents|autonomic agents|mesh-ancestor
92874571|NCT00646620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874572|NCT00646620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874573|NCT00646620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92874574|NCT00646620|Respiratory System Agents|respiratory system agents|mesh-ancestor
92874575|NCT00646620|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874576|NCT00646620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92874577|NCT00646620|Glucocorticoids|glucocorticoids|mesh-ancestor
92874578|NCT00646620|Hormones|hormones|mesh-ancestor
92874579|NCT00646620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874580|NCT00646620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92874581|NCT00646620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92874582|NCT00646620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92874583|NCT00646620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92874584|NCT00646620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874585|NCT00646620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874586|NCT00646620|Tocolytic Agents|tocolytic agents|mesh-ancestor
92874587|NCT00646620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92874588|NCT00646620|Sympathomimetics|sympathomimetics|mesh-ancestor
92874589|NCT00648180|Doxycycline|doxycycline|mesh-list
92874590|NCT00648180|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874591|NCT00648180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874592|NCT00648180|Antimalarials|antimalarials|mesh-ancestor
92874593|NCT00648180|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92874594|NCT00648180|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92874595|NCT02664168|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92874596|NCT02664168|Laxatives|laxatives|mesh-ancestor
92874597|NCT02664168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874598|NCT00648492|Metformin|metformin|mesh-list
92874599|NCT00648492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92874600|NCT00648492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874602|NCT00648570|Citalopram|citalopram|mesh-list
92874603|NCT00648570|Escitalopram|escitalopram|mesh-list
92874604|NCT00648570|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92874605|NCT00648570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92874606|NCT00648570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874607|NCT00648570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874608|NCT00648570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874609|NCT00648570|Serotonin Agents|serotonin agents|mesh-ancestor
92874610|NCT00648570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874611|NCT00648570|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92874612|NCT00648570|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92874613|NCT00648570|Parasympatholytics|parasympatholytics|mesh-ancestor
92874614|NCT00648570|Autonomic Agents|autonomic agents|mesh-ancestor
92874615|NCT00648570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874616|NCT00648570|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92874617|NCT00648570|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92874618|NCT00648570|Cholinergic Agents|cholinergic agents|mesh-ancestor
92874619|NCT00648570|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92874620|NCT00648570|Antidepressive Agents|antidepressive agents|mesh-ancestor
92874621|NCT00648570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92874622|NCT00648258|Naproxen|naproxen|mesh-list
92874623|NCT00648258|Valdecoxib|valdecoxib|mesh-list
92874624|NCT00648258|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92874625|NCT00648258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92874626|NCT00648258|Analgesics|analgesics|mesh-ancestor
92874627|NCT00648258|Sensory System Agents|sensory system agents|mesh-ancestor
92874628|NCT00648258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874629|NCT00648258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874630|NCT00648258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874631|NCT00648258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874632|NCT00648258|Gout Suppressants|gout suppressants|mesh-ancestor
92874633|NCT00648258|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92874634|NCT00648258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874635|NCT00648258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874636|NCT00648258|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92874637|NCT00648336|Mercaptopurine|mercaptopurine|mesh-list
92874638|NCT00648336|Antimetabolites|antimetabolites|mesh-ancestor
92874639|NCT00648336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874640|NCT00648336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92874641|NCT00648336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874642|NCT00648336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874643|NCT00648336|Immunologic Factors|immunologic factors|mesh-ancestor
92874644|NCT00648336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874645|NCT00648336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92874646|NCT00648336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874647|NCT04650984|Doxorubicin|doxorubicin|mesh-list
92874648|NCT04650984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92874649|NCT04650984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874650|NCT04650984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92874651|NCT04650984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92874652|NCT04650984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874653|NCT04650984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874654|NCT00648414|Fentanyl|fentanyl|mesh-list
92874655|NCT00648414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92874656|NCT00648414|Narcotics|narcotics|mesh-ancestor
92874657|NCT00648414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874658|NCT00648414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874659|NCT00648414|Analgesics|analgesics|mesh-ancestor
92874660|NCT00648414|Sensory System Agents|sensory system agents|mesh-ancestor
92874661|NCT00648414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874662|NCT00648414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92874663|NCT00648414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92874664|NCT00648414|Anesthetics, General|anesthetics, general|mesh-ancestor
92874665|NCT00648414|Anesthetics|anesthetics|mesh-ancestor
92874666|NCT02663700|Artesunate|artesunate|mesh-list
92874667|NCT02663700|Antimalarials|antimalarials|mesh-ancestor
92874668|NCT02663700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92874669|NCT02663700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92874670|NCT02663700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874671|NCT02663700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874672|NCT02663700|Antiviral Agents|antiviral agents|mesh-ancestor
92874673|NCT02663700|Schistosomicides|schistosomicides|mesh-ancestor
92874674|NCT02663700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92874675|NCT02663700|Anthelmintics|anthelmintics|mesh-ancestor
92874676|NCT00648726|Azithromycin|azithromycin|mesh-list
92874677|NCT00648726|Erythromycin|erythromycin|mesh-list
92874678|NCT00648726|Erythromycin Estolate|erythromycin estolate|mesh-list
92874679|NCT00648726|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92874680|NCT00648726|Erythromycin stearate|erythromycin stearate|mesh-list
92874682|NCT00648726|Cefuroxime axetil|cefuroxime axetil|mesh-list
92874683|NCT00648726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874684|NCT00648726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874685|NCT00648726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874686|NCT00648726|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92874687|NCT00648726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874688|NCT00648726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874689|NCT04171674|Ceftobiprole|ceftobiprole|mesh-list
92874690|NCT04171674|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92874691|NCT04171674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874692|NCT04171674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874693|NCT00648804|Ondansetron|ondansetron|mesh-list
92874694|NCT00648804|Antiemetics|antiemetics|mesh-ancestor
92874695|NCT00648804|Autonomic Agents|autonomic agents|mesh-ancestor
92874696|NCT00648804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874697|NCT00648804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874698|NCT00648804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874699|NCT00648804|Antipruritics|antipruritics|mesh-ancestor
92874700|NCT00648804|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874701|NCT00648804|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92874702|NCT00648804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92874703|NCT00648804|Serotonin Agents|serotonin agents|mesh-ancestor
92874704|NCT00648804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874705|NCT00648804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874706|NCT02664012|Menthol|menthol|mesh-list
92874707|NCT02664012|Nicotine|nicotine|mesh-list
92874708|NCT02664012|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92874709|NCT02664012|Autonomic Agents|autonomic agents|mesh-ancestor
92874710|NCT02664012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874711|NCT02664012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874712|NCT02664012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92874713|NCT02664012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92874714|NCT02664012|Cholinergic Agents|cholinergic agents|mesh-ancestor
92874715|NCT02664012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874716|NCT02664012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874717|NCT02664012|Antipruritics|antipruritics|mesh-ancestor
92874718|NCT02664012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874719|NCT00895037|Factor VIII|factor viii|mesh-list
92874720|NCT00895037|Coagulants|coagulants|mesh-ancestor
92874721|NCT04170504|Methotrexate|methotrexate|mesh-list
92874722|NCT04170504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92874723|NCT04170504|Abortifacient Agents|abortifacient agents|mesh-ancestor
92874724|NCT04170504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92874725|NCT04170504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874726|NCT04170504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92874727|NCT04170504|Antimetabolites|antimetabolites|mesh-ancestor
92874728|NCT04170504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874729|NCT04170504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874730|NCT04170504|Dermatologic Agents|dermatologic agents|mesh-ancestor
92874731|NCT04170504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874732|NCT04170504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92874733|NCT04170504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874734|NCT04170504|Immunologic Factors|immunologic factors|mesh-ancestor
92874735|NCT04170504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874736|NCT04170504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92874737|NCT04170270|Omeprazole|omeprazole|mesh-list
92874738|NCT04170270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92874739|NCT04170270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874740|NCT04170270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92874741|NCT04170270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874742|NCT04170270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874743|NCT00633347|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92874744|NCT00633347|Cetrorelix|cetrorelix|mesh-list
92874745|NCT00633347|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92874746|NCT00633347|Hormones|hormones|mesh-ancestor
92874747|NCT00633347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874748|NCT00633347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874749|NCT00633347|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92874750|NCT00633347|Fertility Agents|fertility agents|mesh-ancestor
92874751|NCT00633347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92874752|NCT00633347|Hormone Antagonists|hormone antagonists|mesh-ancestor
92874753|NCT00633347|Luteolytic Agents|luteolytic agents|mesh-ancestor
92874754|NCT00633347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92874755|NCT00633347|Contraceptive Agents|contraceptive agents|mesh-ancestor
92874756|NCT00633347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92874757|NCT00633347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92874758|NCT00633347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874759|NCT02838719|Dexamethasone|dexamethasone|mesh-list
92874760|NCT02838719|Dexamethasone acetate|dexamethasone acetate|mesh-list
92874762|NCT02838719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874763|NCT02838719|Antiemetics|antiemetics|mesh-ancestor
92874764|NCT02838719|Autonomic Agents|autonomic agents|mesh-ancestor
92874765|NCT02838719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874766|NCT02838719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874767|NCT02838719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874768|NCT02838719|Glucocorticoids|glucocorticoids|mesh-ancestor
92874769|NCT02838719|Hormones|hormones|mesh-ancestor
92874770|NCT02838719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874771|NCT02838719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92874772|NCT02838719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874773|NCT02838719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92874774|NCT02838719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874775|NCT02838719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874776|NCT02659488|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92874777|NCT02659488|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92874778|NCT02659488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874779|NCT02659488|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92874780|NCT02659488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92874781|NCT02659488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874782|NCT02659488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874783|NCT02659488|Dopamine Agents|dopamine agents|mesh-ancestor
92874784|NCT02659488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874785|NCT00649194|Rabeprazole|rabeprazole|mesh-list
92874786|NCT00649194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92874787|NCT00649194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874788|NCT00649194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92874789|NCT00649194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874790|NCT00649194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874791|NCT02659254|Sirolimus|sirolimus|mesh-list
92874792|NCT02659254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874793|NCT02659254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874794|NCT02659254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92874795|NCT02659254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874796|NCT02659254|Antifungal Agents|antifungal agents|mesh-ancestor
92874797|NCT02659254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874798|NCT02659254|Immunologic Factors|immunologic factors|mesh-ancestor
92874799|NCT02659254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874800|NCT02658864|Lafutidine|lafutidine|mesh-list
92874801|NCT02658864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92874802|NCT02658864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874803|NCT02658864|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92874804|NCT02658864|Histamine Antagonists|histamine antagonists|mesh-ancestor
92874805|NCT02658864|Histamine Agents|histamine agents|mesh-ancestor
92874806|NCT02658864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874807|NCT02658864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874808|NCT02658864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874809|NCT02835833|Bevacizumab|bevacizumab|mesh-list
92874810|NCT02835833|Nintedanib|nintedanib|mesh-list
92874811|NCT02835833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874812|NCT02835833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874813|NCT02835833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92874814|NCT02835833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92874815|NCT02835833|Growth Substances|growth substances|mesh-ancestor
92874816|NCT02835833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874817|NCT02835833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92874818|NCT02835833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92874819|NCT02835833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874820|NCT02835833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874821|NCT04171284|Docetaxel|docetaxel|mesh-list
92520072|NCT02888067|Bromides|bromides|mesh-list
92874822|NCT04171284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874823|NCT04171284|Tubulin Modulators|tubulin modulators|mesh-ancestor
92874824|NCT04171284|Antimitotic Agents|antimitotic agents|mesh-ancestor
92874825|NCT04171284|Mitosis Modulators|mitosis modulators|mesh-ancestor
92874826|NCT04171284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874827|NCT02838329|Ropivacaine|ropivacaine|mesh-list
92874828|NCT02838329|Anesthetics, Local|anesthetics, local|mesh-ancestor
92874829|NCT02838329|Anesthetics|anesthetics|mesh-ancestor
92874830|NCT02838329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874831|NCT02838329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874832|NCT02838329|Sensory System Agents|sensory system agents|mesh-ancestor
92874833|NCT02838329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874834|NCT02662530|Botulinum Toxins|botulinum toxins|mesh-list
92874835|NCT02662530|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92874836|NCT02662530|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92874837|NCT02662530|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92874838|NCT02662530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874839|NCT02662530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874840|NCT02662530|Cholinergic Agents|cholinergic agents|mesh-ancestor
92874841|NCT02662530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874842|NCT02662530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874843|NCT02662530|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92874844|NCT02662530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874845|NCT02835521|Triamcinolone|triamcinolone|mesh-list
92874846|NCT02835521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92874847|NCT02835521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92874848|NCT02835521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92874849|NCT02835521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92874850|NCT02835521|Glucocorticoids|glucocorticoids|mesh-ancestor
92874851|NCT02835521|Hormones|hormones|mesh-ancestor
92874852|NCT02835521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92874853|NCT02835521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874854|NCT02835521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874855|NCT02835521|Immunologic Factors|immunologic factors|mesh-ancestor
92874856|NCT02835521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874857|NCT02835521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874858|NCT00649272|Oxybutynin|oxybutynin|mesh-list
92874859|NCT00649272|Parasympatholytics|parasympatholytics|mesh-ancestor
92874860|NCT00649272|Autonomic Agents|autonomic agents|mesh-ancestor
92874861|NCT00649272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874862|NCT00649272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874863|NCT00649272|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92874864|NCT00649272|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92874865|NCT00649272|Cholinergic Agents|cholinergic agents|mesh-ancestor
92874866|NCT00649272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874867|NCT00649272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874868|NCT00649272|Urological Agents|urological agents|mesh-ancestor
92874869|NCT02666898|Cyclophosphamide|cyclophosphamide|mesh-list
92874870|NCT02666898|Fludarabine|fludarabine|mesh-list
92874871|NCT02666898|Obinutuzumab|obinutuzumab|mesh-list
92874872|NCT02666898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874873|NCT02666898|Immunologic Factors|immunologic factors|mesh-ancestor
92874874|NCT02666898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874875|NCT02666898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92874876|NCT02666898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92874877|NCT02666898|Alkylating Agents|alkylating agents|mesh-ancestor
92874878|NCT02666898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874879|NCT02666898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874880|NCT02666898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92874881|NCT02666898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92874882|NCT00633425|Glimepiride|glimepiride|mesh-list
92874883|NCT00633425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92874884|NCT00633425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92874885|NCT00633425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874886|NCT00633425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874887|NCT00633425|Immunologic Factors|immunologic factors|mesh-ancestor
92874888|NCT02840279|BPN14770|bpn14770|mesh-list
92874889|NCT02840279|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92874890|NCT02840279|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92874891|NCT02840279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874892|NCT02840279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874893|NCT00648960|Clarithromycin|clarithromycin|mesh-list
92874894|NCT00648960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874895|NCT00648960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874896|NCT00648960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92874897|NCT00648960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874898|NCT00648960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874899|NCT00648960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92874900|NCT00648960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92874902|NCT04437329|Docetaxel|docetaxel|mesh-list
92874903|NCT04437329|Fluorouracil|fluorouracil|mesh-list
92874904|NCT04437329|Nedaplatin|nedaplatin|mesh-list
92874905|NCT04437329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874906|NCT04437329|Tubulin Modulators|tubulin modulators|mesh-ancestor
92874907|NCT04437329|Antimitotic Agents|antimitotic agents|mesh-ancestor
92874908|NCT04437329|Mitosis Modulators|mitosis modulators|mesh-ancestor
92874909|NCT04437329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874910|NCT04437329|Antimetabolites|antimetabolites|mesh-ancestor
92874911|NCT04437329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92874912|NCT04437329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92874913|NCT04437329|Immunologic Factors|immunologic factors|mesh-ancestor
92874914|NCT04437329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874915|NCT02834507|Levodopa|levodopa|mesh-list
92874916|NCT02834507|Carbidopa|carbidopa|mesh-list
92874917|NCT02834507|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92874918|NCT02834507|Entacapone|entacapone|mesh-list
92874919|NCT02834507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92874920|NCT02834507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92874921|NCT02834507|Dopamine Agents|dopamine agents|mesh-ancestor
92874922|NCT02834507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874923|NCT02834507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874924|NCT02834507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874925|NCT02834507|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92874926|NCT02834507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874927|NCT02834507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92874928|NCT02834507|Immunologic Factors|immunologic factors|mesh-ancestor
92874929|NCT02834507|Dopamine Agonists|dopamine agonists|mesh-ancestor
92874930|NCT02834507|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92874931|NCT02831543|Mosapride|mosapride|mesh-list
92874932|NCT02831543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874933|NCT02831543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92874934|NCT02831543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92874935|NCT02831543|Serotonin Agents|serotonin agents|mesh-ancestor
92874936|NCT02831543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92874937|NCT02831543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874938|NCT02840591|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92874939|NCT02840591|Nootropic Agents|nootropic agents|mesh-ancestor
92874940|NCT02667054|Anesthetics|anesthetics|mesh-list
92874941|NCT02667054|Anesthetics, Local|anesthetics, local|mesh-list
92874942|NCT02667054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874943|NCT02667054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874944|NCT02667054|Sensory System Agents|sensory system agents|mesh-ancestor
92159722|NCT02308527|Topotecan|topotecan|mesh-list
92874945|NCT02667054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874946|NCT02662296|Idelalisib|idelalisib|mesh-list
92874947|NCT02662296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874948|NCT02662296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874949|NCT02662296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874950|NCT02662374|Nystatin|nystatin|mesh-list
92874951|NCT02662374|Calcium|calcium|mesh-list
92874952|NCT02662374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92874953|NCT02662374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525323|NCT00024388|Paclitaxel|paclitaxel|mesh-list
92874954|NCT02662374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874955|NCT02662374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874956|NCT02662374|Antifungal Agents|antifungal agents|mesh-ancestor
92874957|NCT02662374|Ionophores|ionophores|mesh-ancestor
92874958|NCT02662374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874959|NCT02662374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874960|NCT05334251|Anesthetics|anesthetics|mesh-list
92874961|NCT05334251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874962|NCT05334251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874963|NCT00649350|Metformin|metformin|mesh-list
92874964|NCT00649350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92874965|NCT00649350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874966|NCT00649506|Nitrofurantoin|nitrofurantoin|mesh-list
92874967|NCT00649506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92874968|NCT00649506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874969|NCT00649506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874970|NCT00649038|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92874971|NCT00649038|Benazepril|benazepril|mesh-list
92874972|NCT00649038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92874973|NCT00649038|Diuretics|diuretics|mesh-ancestor
92874974|NCT00649038|Natriuretic Agents|natriuretic agents|mesh-ancestor
92874975|NCT00649038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874976|NCT00649038|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92874977|NCT00649038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92874978|NCT00649038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874979|NCT00649038|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92874980|NCT00649038|Protease Inhibitors|protease inhibitors|mesh-ancestor
92874981|NCT00649038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874982|NCT04169256|Bupivacaine|bupivacaine|mesh-list
92874983|NCT04169256|Anesthetics, Local|anesthetics, local|mesh-ancestor
92874984|NCT04169256|Anesthetics|anesthetics|mesh-ancestor
92874985|NCT04169256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92874986|NCT04169256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92874987|NCT04169256|Sensory System Agents|sensory system agents|mesh-ancestor
92874988|NCT04169256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92874989|NCT02658396|Bortezomib|bortezomib|mesh-list
92874990|NCT02658396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874991|NCT02661438|Ciprofloxacin|ciprofloxacin|mesh-list
92874992|NCT02661438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92874993|NCT02661438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92874994|NCT02661438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92874995|NCT02661438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92874996|NCT02661438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92874997|NCT02661438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92874998|NCT02661438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92874999|NCT02661438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92875000|NCT02661438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92875001|NCT00894803|Eptifibatide|eptifibatide|mesh-list
92875002|NCT00894803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92875003|NCT00601458|Naproxen|naproxen|mesh-list
92875004|NCT00601458|Pregabalin|pregabalin|mesh-list
92875005|NCT00601458|Analgesics|analgesics|mesh-ancestor
92875006|NCT00601458|Sensory System Agents|sensory system agents|mesh-ancestor
92875007|NCT00601458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875008|NCT00601458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875009|NCT00601458|Anticonvulsants|anticonvulsants|mesh-ancestor
92875010|NCT00601458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92875011|NCT00601458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875012|NCT00601458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875013|NCT00601458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92875014|NCT00601458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92875015|NCT00601458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875016|NCT00601458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875017|NCT00601458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875018|NCT00601458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92875019|NCT00601458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875020|NCT00601458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875021|NCT00601458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875022|NCT00601458|Gout Suppressants|gout suppressants|mesh-ancestor
92875023|NCT00601458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92875024|NCT00601458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875025|NCT02660736|rGLP-1 protein|rglp-1 protein|mesh-list
92875026|NCT02660736|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92875027|NCT02660736|Incretins|incretins|mesh-ancestor
92875028|NCT02660736|Hormones|hormones|mesh-ancestor
92875029|NCT02660736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875030|NCT02660736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875031|NCT00649584|Gemcitabine|gemcitabine|mesh-list
92875032|NCT00649584|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92875033|NCT00649584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92875034|NCT00649584|Antimetabolites|antimetabolites|mesh-ancestor
92875035|NCT00649584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875036|NCT00649584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875037|NCT00649584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875038|NCT00649584|Immunotoxins|immunotoxins|mesh-ancestor
92875039|NCT00649584|Immunoconjugates|immunoconjugates|mesh-ancestor
92875040|NCT00649584|Immunologic Factors|immunologic factors|mesh-ancestor
92875041|NCT00649584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875042|NCT02141282|Venetoclax|venetoclax|mesh-list
92875043|NCT02141282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875044|NCT02657616|Vitamin K|vitamin k|mesh-list
92875045|NCT02657616|Anticoagulants|anticoagulants|mesh-list
92875046|NCT02657616|Vitamins|vitamins|mesh-ancestor
92875047|NCT02657616|Micronutrients|micronutrients|mesh-ancestor
92875048|NCT02657616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875049|NCT02657616|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92875050|NCT02657616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92875051|NCT02657616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875052|NCT02657616|Hemostatics|hemostatics|mesh-ancestor
92875053|NCT02657616|Coagulants|coagulants|mesh-ancestor
92875054|NCT02657694|Sofosbuvir|sofosbuvir|mesh-list
92875055|NCT02657694|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92875056|NCT02657694|Ledipasvir|ledipasvir|mesh-list
92875057|NCT02657694|Velpatasvir|velpatasvir|mesh-list
92875058|NCT02657694|Antiviral Agents|antiviral agents|mesh-ancestor
92875059|NCT02657694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875060|NCT02657460|Cisplatin|cisplatin|mesh-list
92875061|NCT02657460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875062|NCT00649896|Estradiol|estradiol|mesh-list
92875063|NCT00649896|Estrogens|estrogens|mesh-ancestor
92875064|NCT00649896|Hormones|hormones|mesh-ancestor
92875065|NCT00649896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875066|NCT00649896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875067|NCT00649662|Ciprofloxacin|ciprofloxacin|mesh-list
92875068|NCT00649662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92875069|NCT00649662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875070|NCT00649662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92875071|NCT00649662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92875072|NCT00649662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875073|NCT00649662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875074|NCT00649662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875075|NCT00649662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92875076|NCT00649662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92875077|NCT04188158|Capecitabine|capecitabine|mesh-list
92875078|NCT04188158|Oxaliplatin|oxaliplatin|mesh-list
92875079|NCT04188158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92875080|NCT04188158|Antimetabolites|antimetabolites|mesh-ancestor
92875081|NCT04188158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875082|NCT04188158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875083|NCT02831231|Xanomeline|xanomeline|mesh-list
92875084|NCT02831231|Trospium chloride|trospium chloride|mesh-list
92875085|NCT02831231|Parasympatholytics|parasympatholytics|mesh-ancestor
92875086|NCT02831231|Autonomic Agents|autonomic agents|mesh-ancestor
92875087|NCT02831231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875088|NCT02831231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875089|NCT02831231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92875090|NCT02831231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92875091|NCT02831231|Cholinergic Agents|cholinergic agents|mesh-ancestor
92875092|NCT02831231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875093|NCT02831231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875094|NCT02831231|Urological Agents|urological agents|mesh-ancestor
92875095|NCT02831231|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92875096|NCT02831231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875097|NCT02831231|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92875098|NCT02831231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92875099|NCT05234606|Pembrolizumab|pembrolizumab|mesh-list
92875100|NCT05234606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875101|NCT05234606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875102|NCT05234606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92875103|NCT05234606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875104|NCT00649740|Topiramate|topiramate|mesh-list
92875105|NCT00649740|Anticonvulsants|anticonvulsants|mesh-ancestor
92875106|NCT00649740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92875107|NCT00649740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875108|NCT04209920|Chromium|chromium|mesh-list
92875109|NCT04209920|Nickel|nickel|mesh-list
92875110|NCT04209920|Trace Elements|trace elements|mesh-ancestor
92875111|NCT04209920|Micronutrients|micronutrients|mesh-ancestor
92875112|NCT04209920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875113|NCT00616694|Risedronic Acid|risedronic acid|mesh-list
92875114|NCT00616694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92875115|NCT00616694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875116|NCT00616694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520361|NCT00006383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875117|NCT00616694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92875118|NCT00616694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875119|NCT00616694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92875120|NCT02660658|Dexmedetomidine|dexmedetomidine|mesh-list
92875121|NCT02660658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92875122|NCT02660658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875123|NCT02660658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875124|NCT02660658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875125|NCT02660658|Analgesics|analgesics|mesh-ancestor
92875126|NCT02660658|Sensory System Agents|sensory system agents|mesh-ancestor
92875127|NCT02660658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875128|NCT02660658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92875129|NCT02660658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92875130|NCT02660658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92875131|NCT02660658|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875132|NCT02660658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875133|NCT02660658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875134|NCT02660502|Insulin|insulin|mesh-list
92875135|NCT02660502|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92875136|NCT02660502|Insulin Lispro|insulin lispro|mesh-list
92875137|NCT02660502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92875138|NCT02660502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875139|NCT02660346|Vancomycin|vancomycin|mesh-list
92875140|NCT02660346|Daptomycin|daptomycin|mesh-list
92875141|NCT02660346|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92875142|NCT02660346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92875143|NCT02660346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875144|NCT00620438|Efavirenz|efavirenz|mesh-list
92875145|NCT00620438|Nevirapine|nevirapine|mesh-list
92875146|NCT00620438|Rifampin|rifampin|mesh-list
92875147|NCT00620438|Lumefantrine|lumefantrine|mesh-list
92875148|NCT00620438|Artemether|artemether|mesh-list
92875149|NCT00620438|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92875150|NCT00620438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92875151|NCT00620438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92875152|NCT00620438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875153|NCT00620438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875154|NCT00620438|Antiviral Agents|antiviral agents|mesh-ancestor
92875155|NCT00620438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875156|NCT00620438|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92875157|NCT00620438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92875158|NCT00620438|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92875159|NCT00620438|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92875160|NCT00620438|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92875161|NCT00620438|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92875162|NCT00620438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92875163|NCT00620438|Antitubercular Agents|antitubercular agents|mesh-ancestor
92875164|NCT00620438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525349|NCT00024466|Vaccines|vaccines|mesh-list
92875165|NCT00620438|Leprostatic Agents|leprostatic agents|mesh-ancestor
92875166|NCT00620438|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92875167|NCT00620438|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92875168|NCT00620438|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92875169|NCT00620438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92875170|NCT00620438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92875171|NCT00620438|Antimalarials|antimalarials|mesh-ancestor
92875172|NCT00620438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92875173|NCT00620438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92875174|NCT00891839|Rituximab|rituximab|mesh-list
92875175|NCT00891839|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92875176|NCT00891839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875177|NCT00891839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875178|NCT00891839|Immunologic Factors|immunologic factors|mesh-ancestor
92875179|NCT00891839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875180|NCT00891839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875181|NCT00891839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92875182|NCT00891839|Alkylating Agents|alkylating agents|mesh-ancestor
92875183|NCT00891839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875184|NCT00600756|Risperidone|risperidone|mesh-list
92875185|NCT00600756|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92875186|NCT00600756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92875187|NCT00600756|Serotonin Agents|serotonin agents|mesh-ancestor
92875188|NCT00600756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159755|NCT02131753|Cladribine|cladribine|mesh-list
92875189|NCT00600756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875190|NCT00600756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875191|NCT00600756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92875192|NCT00600756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875193|NCT00600756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875194|NCT00600756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875195|NCT00600756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92875196|NCT00600756|Dopamine Agents|dopamine agents|mesh-ancestor
92875197|NCT00600756|Antidepressive Agents|antidepressive agents|mesh-ancestor
92875198|NCT02657148|Contraceptive Agents|contraceptive agents|mesh-list
92875199|NCT02657148|Etonogestrel|etonogestrel|mesh-list
92875200|NCT02657148|Desogestrel|desogestrel|mesh-list
92875201|NCT02657148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92875202|NCT02657148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875203|NCT02657148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92875204|NCT02657148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92875205|NCT02657148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92875206|NCT02657148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92875207|NCT02657148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92875208|NCT02657148|Progestins|progestins|mesh-ancestor
92875210|NCT02657148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875211|NCT04247087|Vitamin K|vitamin k|mesh-list
92875212|NCT04247087|Vitamin K 1|vitamin k 1|mesh-list
92875213|NCT04247087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92875214|NCT04247087|Vitamins|vitamins|mesh-ancestor
92875215|NCT04247087|Micronutrients|micronutrients|mesh-ancestor
92875216|NCT04247087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875217|NCT04247087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92875218|NCT04247087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92875219|NCT04247087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875220|NCT04247087|Hemostatics|hemostatics|mesh-ancestor
92875221|NCT04247087|Coagulants|coagulants|mesh-ancestor
92875222|NCT00649116|Metoprolol|metoprolol|mesh-list
92875223|NCT00649116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92875224|NCT00649116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92875225|NCT00649116|Sympatholytics|sympatholytics|mesh-ancestor
92875226|NCT00649116|Autonomic Agents|autonomic agents|mesh-ancestor
92875227|NCT00649116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875228|NCT00649116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875229|NCT00649116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92875230|NCT00649116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92875231|NCT00649116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92875232|NCT00649116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875233|NCT00649116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875234|NCT00649116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875235|NCT04459416|Analgesics, Opioid|analgesics, opioid|mesh-list
92875236|NCT04459416|Narcotics|narcotics|mesh-ancestor
92875237|NCT04459416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875238|NCT04459416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875239|NCT04459416|Analgesics|analgesics|mesh-ancestor
92875240|NCT04459416|Sensory System Agents|sensory system agents|mesh-ancestor
92875241|NCT04459416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875242|NCT02652234|Endostar protein|endostar protein|mesh-list
92875243|NCT02652234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92875244|NCT02652234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92875245|NCT02652234|Growth Substances|growth substances|mesh-ancestor
92875246|NCT02652234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875247|NCT02652234|Growth Inhibitors|growth inhibitors|mesh-ancestor
92875248|NCT02652234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875249|NCT04211012|Paclitaxel|paclitaxel|mesh-list
92875250|NCT04211012|Cisplatin|cisplatin|mesh-list
92875251|NCT04211012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92875252|NCT04211012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875253|NCT04211012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92875254|NCT04211012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92875255|NCT04211012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92875256|NCT04211012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875257|NCT00649974|Valacyclovir|valacyclovir|mesh-list
92875258|NCT00649974|Antiviral Agents|antiviral agents|mesh-ancestor
92875259|NCT00649974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875260|NCT02536872|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92875261|NCT02536872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875262|NCT00620594|Dactolisib|dactolisib|mesh-list
92875263|NCT00620594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875264|NCT02655822|Atezolizumab|atezolizumab|mesh-list
92875265|NCT02655822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92875266|NCT02655822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875267|NCT02655822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875268|NCT02655822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875269|NCT00650442|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92875270|NCT00650442|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92875271|NCT00650442|Estradiol|estradiol|mesh-list
92875272|NCT00650442|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92875273|NCT00650442|Estrogens|estrogens|mesh-ancestor
92875274|NCT00650442|Hormones|hormones|mesh-ancestor
92875275|NCT00650442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875276|NCT00650442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875277|NCT00650442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92875278|NCT00650442|Contraceptive Agents|contraceptive agents|mesh-ancestor
92875279|NCT00650442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92875280|NCT00650442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92875281|NCT00890825|Docetaxel|docetaxel|mesh-list
92875282|NCT00890825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875283|NCT00890825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92875284|NCT00890825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92875285|NCT00890825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92875286|NCT00890825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875287|NCT04760132|Vaccines|vaccines|mesh-list
92875288|NCT04760132|Immunologic Factors|immunologic factors|mesh-ancestor
92875289|NCT04760132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875290|NCT04248101|Silver Nitrate|silver nitrate|mesh-list
92875291|NCT04248101|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92875292|NCT04248101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875293|NCT00649818|Lorazepam|lorazepam|mesh-list
92875294|NCT00649818|Anticonvulsants|anticonvulsants|mesh-ancestor
92875295|NCT00649818|Antiemetics|antiemetics|mesh-ancestor
92875296|NCT00649818|Autonomic Agents|autonomic agents|mesh-ancestor
92875297|NCT00649818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875298|NCT00649818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875299|NCT00649818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875300|NCT00649818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92875301|NCT00649818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875302|NCT00649818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92875303|NCT00649818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875304|NCT00649818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875305|NCT00649818|GABA Modulators|gaba modulators|mesh-ancestor
92875306|NCT00649818|GABA Agents|gaba agents|mesh-ancestor
92875307|NCT00649818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875308|NCT00649818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875309|NCT04246697|Acetaminophen|acetaminophen|mesh-list
92875310|NCT04246697|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92875311|NCT04246697|Morphine|morphine|mesh-list
92875312|NCT04246697|Oxycodone|oxycodone|mesh-list
92875313|NCT04246697|Gabapentin|gabapentin|mesh-list
92875314|NCT04246697|Bupivacaine|bupivacaine|mesh-list
92875315|NCT04246697|Anesthetics, Local|anesthetics, local|mesh-ancestor
92875316|NCT04246697|Anesthetics|anesthetics|mesh-ancestor
92875317|NCT04246697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875318|NCT04246697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875319|NCT04246697|Sensory System Agents|sensory system agents|mesh-ancestor
92875320|NCT04246697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875321|NCT04246697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92875322|NCT04246697|Narcotics|narcotics|mesh-ancestor
92875323|NCT04246697|Analgesics|analgesics|mesh-ancestor
92875324|NCT04246697|Anticonvulsants|anticonvulsants|mesh-ancestor
92875325|NCT04246697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92875326|NCT04246697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875327|NCT04246697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875328|NCT04246697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92875329|NCT04246697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92875330|NCT04246697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875331|NCT04246697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875332|NCT04246697|Antimanic Agents|antimanic agents|mesh-ancestor
92875333|NCT04246697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875334|NCT04246697|Antipyretics|antipyretics|mesh-ancestor
92875335|NCT04246697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92875336|NCT04246697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875337|NCT04246697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875338|NCT04246697|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92875339|NCT04246697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875340|NCT02830139|Capecitabine|capecitabine|mesh-list
92875341|NCT02830139|Oxaliplatin|oxaliplatin|mesh-list
92875342|NCT02830139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875343|NCT02830139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92875344|NCT02830139|Antimetabolites|antimetabolites|mesh-ancestor
92875345|NCT02830139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875347|NCT02833025|Hemostatics|hemostatics|mesh-ancestor
92875348|NCT02833025|Coagulants|coagulants|mesh-ancestor
92875349|NCT02651610|Paclitaxel|paclitaxel|mesh-list
92875350|NCT02651610|Docetaxel|docetaxel|mesh-list
92875351|NCT02651610|Taxane|taxane|mesh-list
92875352|NCT02651610|Bavituximab|bavituximab|mesh-list
92875353|NCT02651610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92875354|NCT02651610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875355|NCT02651610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92875356|NCT02651610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92875357|NCT02651610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92875358|NCT02651610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875359|NCT02651610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875360|NCT04208594|Propranolol|propranolol|mesh-list
92875361|NCT04208594|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92875362|NCT04208594|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92875363|NCT04208594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875364|NCT04208594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875365|NCT04208594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875366|NCT04208594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875367|NCT04208594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92875368|NCT04208594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92875369|NCT04208594|Vasodilator Agents|vasodilator agents|mesh-ancestor
92875370|NCT04733144|Dexamethasone|dexamethasone|mesh-list
92875371|NCT04733144|Prednisolone|prednisolone|mesh-list
92875372|NCT04733144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875373|NCT04733144|Antiemetics|antiemetics|mesh-ancestor
92875374|NCT04733144|Autonomic Agents|autonomic agents|mesh-ancestor
92875375|NCT04733144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875376|NCT04733144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875377|NCT04733144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875378|NCT04733144|Glucocorticoids|glucocorticoids|mesh-ancestor
92875379|NCT04733144|Hormones|hormones|mesh-ancestor
92875380|NCT04733144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875381|NCT04733144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92875382|NCT04733144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875383|NCT04724720|Famotidine|famotidine|mesh-list
92875384|NCT04724720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92875385|NCT04724720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875386|NCT04724720|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92875387|NCT04724720|Histamine Antagonists|histamine antagonists|mesh-ancestor
92875388|NCT04724720|Histamine Agents|histamine agents|mesh-ancestor
92875389|NCT04724720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875390|NCT04724720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525350|NCT00024466|Immunologic Factors|immunologic factors|mesh-ancestor
92875391|NCT04724720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875392|NCT02833103|Pinaverium|pinaverium|mesh-list
92875393|NCT02833103|Bromides|bromides|mesh-list
92875394|NCT02833103|Anticonvulsants|anticonvulsants|mesh-ancestor
92875395|NCT02833103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92875396|NCT02833103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875397|NCT02833103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875398|NCT02833103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92875399|NCT02833103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875400|NCT02833103|Parasympatholytics|parasympatholytics|mesh-ancestor
92875401|NCT02833103|Autonomic Agents|autonomic agents|mesh-ancestor
92875402|NCT02833103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875403|NCT02648490|Acetaminophen|acetaminophen|mesh-list
92875404|NCT02648490|Diphenhydramine|diphenhydramine|mesh-list
92875405|NCT02648490|Promethazine|promethazine|mesh-list
92875406|NCT02648490|Dexamethasone|dexamethasone|mesh-list
92875407|NCT02648490|Ondansetron|ondansetron|mesh-list
92875408|NCT02648490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875409|NCT02648490|Antiemetics|antiemetics|mesh-ancestor
92875410|NCT02648490|Autonomic Agents|autonomic agents|mesh-ancestor
92875411|NCT02648490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875412|NCT02648490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875413|NCT02648490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875414|NCT02648490|Glucocorticoids|glucocorticoids|mesh-ancestor
92875415|NCT02648490|Hormones|hormones|mesh-ancestor
92875416|NCT02648490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875417|NCT02648490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92875418|NCT02648490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875419|NCT02648490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875420|NCT02648490|Analgesics|analgesics|mesh-ancestor
92875421|NCT02648490|Sensory System Agents|sensory system agents|mesh-ancestor
92875422|NCT02648490|Antipyretics|antipyretics|mesh-ancestor
92875423|NCT02648490|Antipruritics|antipruritics|mesh-ancestor
92875424|NCT02648490|Dermatologic Agents|dermatologic agents|mesh-ancestor
92875425|NCT02648490|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92875426|NCT02648490|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92875427|NCT02648490|Serotonin Agents|serotonin agents|mesh-ancestor
92875428|NCT02648490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875429|NCT02648490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875430|NCT02648490|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92875431|NCT02648490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92875432|NCT02648490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875433|NCT02648490|Anesthetics, Local|anesthetics, local|mesh-ancestor
92875434|NCT02648490|Anesthetics|anesthetics|mesh-ancestor
92875435|NCT02648490|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92875436|NCT02648490|Histamine Antagonists|histamine antagonists|mesh-ancestor
92875437|NCT02648490|Histamine Agents|histamine agents|mesh-ancestor
92875438|NCT02648490|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92875439|NCT04965272|Cariprazine|cariprazine|mesh-list
92875440|NCT04965272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92875441|NCT04965272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875442|NCT04965272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875443|NCT04965272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875444|NCT04965272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875445|NCT02648412|Ketamine|ketamine|mesh-list
92875446|NCT02648412|Analgesics|analgesics|mesh-ancestor
92875447|NCT02648412|Sensory System Agents|sensory system agents|mesh-ancestor
92875448|NCT02648412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875449|NCT02648412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875450|NCT02648412|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92875451|NCT02648412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92875452|NCT02648412|Anesthetics, General|anesthetics, general|mesh-ancestor
92875453|NCT02648412|Anesthetics|anesthetics|mesh-ancestor
92875454|NCT02648412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875455|NCT02648412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92875456|NCT02648412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92875457|NCT02648412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875458|NCT02648412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875459|NCT00650520|Bromocriptine|bromocriptine|mesh-list
92875460|NCT00650520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92875461|NCT00650520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92875462|NCT00650520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92525351|NCT00024466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875463|NCT00650520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875464|NCT00650520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875465|NCT00650520|Dopamine Agonists|dopamine agonists|mesh-ancestor
92875466|NCT00650520|Dopamine Agents|dopamine agents|mesh-ancestor
92875467|NCT00650520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875468|NCT00650520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875469|NCT04244981|Thrombin|thrombin|mesh-list
92875470|NCT04244981|Hemostatics|hemostatics|mesh-ancestor
92875471|NCT04244981|Coagulants|coagulants|mesh-ancestor
92875472|NCT00621218|Tretinoin|tretinoin|mesh-list
92875473|NCT00621218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875474|NCT00621218|Keratolytic Agents|keratolytic agents|mesh-ancestor
92875475|NCT00621218|Dermatologic Agents|dermatologic agents|mesh-ancestor
92875476|NCT02655276|Glycine|glycine|mesh-list
92875477|NCT02655276|Glycine Agents|glycine agents|mesh-ancestor
92875478|NCT02655276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875479|NCT02655276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875480|NCT02655276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875481|NCT02832947|Rivaroxaban|rivaroxaban|mesh-list
92875482|NCT02832947|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92875483|NCT02832947|Antithrombins|antithrombins|mesh-ancestor
92875484|NCT02832947|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92875485|NCT02832947|Protease Inhibitors|protease inhibitors|mesh-ancestor
92875486|NCT02832947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875487|NCT02832947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875488|NCT02832947|Anticoagulants|anticoagulants|mesh-ancestor
92875489|NCT00651300|Parecoxib|parecoxib|mesh-list
92875490|NCT00651300|Valdecoxib|valdecoxib|mesh-list
92875491|NCT00651300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92875492|NCT00651300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92875493|NCT00651300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875494|NCT00651300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875495|NCT00651300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92875496|NCT00651300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875497|NCT00651300|Analgesics|analgesics|mesh-ancestor
92875498|NCT00651300|Sensory System Agents|sensory system agents|mesh-ancestor
92875499|NCT00651300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875500|NCT00651300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875501|NCT00651300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875502|NCT00651300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875503|NCT02828033|Rilonacept|rilonacept|mesh-list
92875504|NCT02828033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875505|NCT00621998|Olanzapine|olanzapine|mesh-list
92875506|NCT00621998|Risperidone|risperidone|mesh-list
92875507|NCT00621998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92875508|NCT00621998|Serotonin Agents|serotonin agents|mesh-ancestor
92875509|NCT00621998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875510|NCT00621998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875511|NCT00621998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875512|NCT00621998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92875513|NCT00621998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875514|NCT00621998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875515|NCT00621998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875516|NCT00621998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92875517|NCT00621998|Dopamine Agents|dopamine agents|mesh-ancestor
92875518|NCT00621998|Antiemetics|antiemetics|mesh-ancestor
92875519|NCT00621998|Autonomic Agents|autonomic agents|mesh-ancestor
92875520|NCT00621998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875521|NCT00621998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875522|NCT00621998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92875523|NCT00621998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92875524|NCT00621998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875525|NCT02655198|Fenfluramine|fenfluramine|mesh-list
92875526|NCT02655198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92875527|NCT02655198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92875528|NCT02655198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875529|NCT02655198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875530|NCT02655198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875531|NCT02655198|Serotonin Agents|serotonin agents|mesh-ancestor
92875532|NCT02655198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875533|NCT00650052|Zonisamide|zonisamide|mesh-list
92875534|NCT00650052|Anticonvulsants|anticonvulsants|mesh-ancestor
92875535|NCT00650052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92875536|NCT00650052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875537|NCT00650052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875538|NCT00650052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92875539|NCT00650052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875540|NCT00891527|Bevacizumab|bevacizumab|mesh-list
92875541|NCT00891527|Imatinib Mesylate|imatinib mesylate|mesh-list
92875542|NCT00891527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875543|NCT00891527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875544|NCT00891527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92875545|NCT00891527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92159794|NCT02101788|Antioxidants|antioxidants|mesh-ancestor
92875546|NCT00891527|Growth Substances|growth substances|mesh-ancestor
92875547|NCT00891527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875548|NCT00891527|Growth Inhibitors|growth inhibitors|mesh-ancestor
92875549|NCT00891527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92875550|NCT00891527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875551|NCT00891527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875552|NCT03861078|Nicotine|nicotine|mesh-list
92875553|NCT03861078|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92875554|NCT03861078|Autonomic Agents|autonomic agents|mesh-ancestor
92875555|NCT03861078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875556|NCT03861078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875557|NCT03861078|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92875558|NCT03861078|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92875559|NCT03861078|Cholinergic Agents|cholinergic agents|mesh-ancestor
92875560|NCT03861078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875561|NCT03861078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875562|NCT02829359|Entecavir|entecavir|mesh-list
92875563|NCT02829359|Antiviral Agents|antiviral agents|mesh-ancestor
92875564|NCT02829359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875565|NCT02650752|Capecitabine|capecitabine|mesh-list
92875566|NCT02650752|Lapatinib|lapatinib|mesh-list
92875567|NCT02650752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92875568|NCT02650752|Antimetabolites|antimetabolites|mesh-ancestor
92875569|NCT02650752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875570|NCT02650752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875571|NCT02650752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92875572|NCT02650752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520815|NCT00104182|Insulin|insulin|mesh-list
92875573|NCT02832713|Botulinum Toxins|botulinum toxins|mesh-list
92875574|NCT02832713|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92875575|NCT02832713|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92875576|NCT02832713|Hyaluronic Acid|hyaluronic acid|mesh-list
92875577|NCT02832713|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92875578|NCT02832713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875579|NCT02832713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875580|NCT02832713|Cholinergic Agents|cholinergic agents|mesh-ancestor
92875581|NCT02832713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875582|NCT02832713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875583|NCT02832713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92875584|NCT02832713|Immunologic Factors|immunologic factors|mesh-ancestor
92875585|NCT02832713|Viscosupplements|viscosupplements|mesh-ancestor
92875586|NCT02832713|Protective Agents|protective agents|mesh-ancestor
92875587|NCT02832713|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92875588|NCT02832713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875589|NCT02832635|Temozolomide|temozolomide|mesh-list
92875590|NCT02832635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92875591|NCT02832635|Alkylating Agents|alkylating agents|mesh-ancestor
92875592|NCT02832635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875593|NCT02832635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875594|NCT00650598|Diclofenac|diclofenac|mesh-list
92875595|NCT00650598|Valdecoxib|valdecoxib|mesh-list
92875596|NCT00650598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92875597|NCT00650598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875598|NCT00650598|Analgesics|analgesics|mesh-ancestor
92875599|NCT00650598|Sensory System Agents|sensory system agents|mesh-ancestor
92875600|NCT00650598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875601|NCT00650598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875602|NCT00650598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875603|NCT00650598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875604|NCT00650598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92875605|NCT00650598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875606|NCT00650598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875607|NCT00650598|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92875608|NCT00620204|Atorvastatin|atorvastatin|mesh-list
92875609|NCT00620204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92875610|NCT00620204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92875612|NCT00620204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875613|NCT00620204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92875614|NCT00620204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92875615|NCT00620204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875616|NCT02650596|Liraglutide|liraglutide|mesh-list
92875617|NCT02650596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92875618|NCT02650596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875619|NCT02650596|Incretins|incretins|mesh-ancestor
92875620|NCT02650596|Hormones|hormones|mesh-ancestor
92875621|NCT02650596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875622|NCT02650518|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92875623|NCT02650518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875624|NCT02832089|Carvedilol|carvedilol|mesh-list
92875625|NCT02832089|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92875626|NCT02832089|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92875627|NCT02832089|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875628|NCT02832089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875629|NCT02832089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875630|NCT02832089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875631|NCT02832089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92875632|NCT02832089|Antioxidants|antioxidants|mesh-ancestor
92875633|NCT02832089|Protective Agents|protective agents|mesh-ancestor
92875634|NCT02832089|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92875635|NCT02832089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875636|NCT02832089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92875637|NCT02832089|Vasodilator Agents|vasodilator agents|mesh-ancestor
92875638|NCT02832089|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92875639|NCT02832089|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92875640|NCT04247633|Palbociclib|palbociclib|mesh-list
92875641|NCT04247633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875642|NCT04247633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92875643|NCT04247633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875644|NCT04247633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875645|NCT00891371|Lanreotide|lanreotide|mesh-list
92875646|NCT00891371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875648|NCT04324229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92875649|NCT04324229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875650|NCT04324229|Incretins|incretins|mesh-ancestor
92875651|NCT04324229|Hormones|hormones|mesh-ancestor
92875652|NCT04324229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875653|NCT04430894|Dexamethasone|dexamethasone|mesh-list
92875654|NCT04430894|Lenalidomide|lenalidomide|mesh-list
92875655|NCT04430894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875656|NCT04430894|Antiemetics|antiemetics|mesh-ancestor
92875657|NCT04430894|Autonomic Agents|autonomic agents|mesh-ancestor
92875658|NCT04430894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875659|NCT04430894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875660|NCT04430894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875661|NCT04430894|Glucocorticoids|glucocorticoids|mesh-ancestor
92875662|NCT04430894|Hormones|hormones|mesh-ancestor
92875663|NCT04430894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875664|NCT04430894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92875665|NCT04430894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875666|NCT04430894|Immunologic Factors|immunologic factors|mesh-ancestor
92875667|NCT04430894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92875668|NCT04430894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92875669|NCT04430894|Growth Substances|growth substances|mesh-ancestor
92875670|NCT04430894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92875671|NCT04200456|Rozanolixizumab|rozanolixizumab|mesh-list
92875672|NCT04200456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92875673|NCT04200456|Immunologic Factors|immunologic factors|mesh-ancestor
92875674|NCT04200456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875675|NCT02829281|Triamcinolone|triamcinolone|mesh-list
92875676|NCT02829281|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92875677|NCT02829281|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92875678|NCT02829281|Botulinum Toxins|botulinum toxins|mesh-list
92875679|NCT02829281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92875680|NCT02829281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92875681|NCT02829281|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92875682|NCT02829281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92875683|NCT02829281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875684|NCT02829281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875685|NCT02829281|Cholinergic Agents|cholinergic agents|mesh-ancestor
92875686|NCT02829281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875687|NCT02829281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875688|NCT02829281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875690|NCT02829281|Hormones|hormones|mesh-ancestor
92875691|NCT02829281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875692|NCT02829281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92875693|NCT02829281|Immunologic Factors|immunologic factors|mesh-ancestor
92875694|NCT02829281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875695|NCT02829281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92875696|NCT02829281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875697|NCT04210544|Caseins|caseins|mesh-list
92875698|NCT04210544|Chelating Agents|chelating agents|mesh-ancestor
92875699|NCT04210544|Sequestering Agents|sequestering agents|mesh-ancestor
92875700|NCT04210544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875701|NCT04168944|Lenvatinib|lenvatinib|mesh-list
92875702|NCT04168944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92875703|NCT04168944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875704|NCT04168944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92875705|NCT04168944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875706|NCT04168944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875707|NCT04168944|Immunologic Factors|immunologic factors|mesh-ancestor
92875708|NCT04168944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875709|NCT02697032|Bicalutamide|bicalutamide|mesh-list
92875710|NCT02697032|Androgen Antagonists|androgen antagonists|mesh-ancestor
92875711|NCT02697032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92875712|NCT02697032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875713|NCT02697032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875714|NCT02697032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875715|NCT04409834|Heparin|heparin|mesh-list
92875716|NCT04409834|Calcium heparin|calcium heparin|mesh-list
92875717|NCT04409834|Enoxaparin|enoxaparin|mesh-list
92875718|NCT04409834|Enoxaparin sodium|enoxaparin sodium|mesh-list
92875719|NCT04409834|Clopidogrel|clopidogrel|mesh-list
92875720|NCT04409834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92875721|NCT04409834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92875722|NCT04409834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92875723|NCT04409834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92875724|NCT04409834|Purinergic Agents|purinergic agents|mesh-ancestor
92875725|NCT04409834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875726|NCT04409834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875727|NCT04409834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875728|NCT04409834|Anticoagulants|anticoagulants|mesh-ancestor
92875729|NCT04409834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92875730|NCT04409834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92875731|NCT02647632|Ribavirin|ribavirin|mesh-list
92875732|NCT02647632|Sofosbuvir|sofosbuvir|mesh-list
92875733|NCT02647632|Grazoprevir|grazoprevir|mesh-list
92875734|NCT02647632|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92875735|NCT02647632|Antimetabolites|antimetabolites|mesh-ancestor
92875736|NCT02647632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875737|NCT02647632|Antiviral Agents|antiviral agents|mesh-ancestor
92875738|NCT02647632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875739|NCT00621452|Aldesleukin|aldesleukin|mesh-list
92875740|NCT00621452|Cyclophosphamide|cyclophosphamide|mesh-list
92875741|NCT00621452|Interleukin-2|interleukin-2|mesh-list
92875742|NCT00621452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92875743|NCT00621452|Immunologic Factors|immunologic factors|mesh-ancestor
92875744|NCT00621452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875745|NCT00621452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875746|NCT00621452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92875747|NCT00621452|Alkylating Agents|alkylating agents|mesh-ancestor
92875748|NCT00621452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875749|NCT00621452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875750|NCT00621452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92875751|NCT00621452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875752|NCT00621452|Analgesics|analgesics|mesh-ancestor
92875753|NCT00621452|Sensory System Agents|sensory system agents|mesh-ancestor
92875754|NCT00621452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875755|NCT00621452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92875756|NCT00621452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92875757|NCT00621452|Antiviral Agents|antiviral agents|mesh-ancestor
92875758|NCT00621452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875759|NCT04336748|Hydroxychloroquine|hydroxychloroquine|mesh-list
92875760|NCT04336748|Antimalarials|antimalarials|mesh-ancestor
92875761|NCT04336748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92875762|NCT04336748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92875763|NCT04336748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875764|NCT04336748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875765|NCT04336748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875766|NCT04336748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875767|NCT00651612|Timolol|timolol|mesh-list
92875768|NCT00651612|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92875769|NCT00651612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92875770|NCT00651612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92875771|NCT00651612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92875772|NCT00651612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92875773|NCT00651612|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875774|NCT00651612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875775|NCT00651612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875776|NCT00651612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875777|NCT00651612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92875778|NCT00651612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92875779|NCT00651612|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92875780|NCT00651612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92875781|NCT00651612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92875782|NCT00650754|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92875783|NCT00650754|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92875784|NCT00650754|Immunologic Factors|immunologic factors|mesh-ancestor
92875785|NCT00650754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875786|NCT02831933|Valacyclovir|valacyclovir|mesh-list
92875787|NCT02831933|Nivolumab|nivolumab|mesh-list
92875788|NCT02831933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92875789|NCT02831933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875790|NCT02831933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92875791|NCT02831933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875792|NCT02831933|Antiviral Agents|antiviral agents|mesh-ancestor
92875793|NCT02831933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875794|NCT02650206|Liraglutide|liraglutide|mesh-list
92875795|NCT02650206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92875796|NCT02650206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875797|NCT02650206|Incretins|incretins|mesh-ancestor
92875798|NCT02650206|Hormones|hormones|mesh-ancestor
92875799|NCT02650206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875800|NCT05368766|Diuretics|diuretics|mesh-list
92875801|NCT05368766|Natriuretic Agents|natriuretic agents|mesh-ancestor
92875802|NCT05368766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875803|NCT00891293|Fenofibrate|fenofibrate|mesh-list
92875804|NCT00891293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92875805|NCT00891293|Antimetabolites|antimetabolites|mesh-ancestor
92875806|NCT00891293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875807|NCT00891293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92875808|NCT05368142|Cell Wall Skeleton|cell wall skeleton|mesh-list
92875809|NCT05368142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92875810|NCT05368142|Immunologic Factors|immunologic factors|mesh-ancestor
92875811|NCT05368142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875812|NCT00889421|Apremilast|apremilast|mesh-list
92875813|NCT00889421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92875814|NCT00889421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875815|NCT00889421|Analgesics|analgesics|mesh-ancestor
92875816|NCT00889421|Sensory System Agents|sensory system agents|mesh-ancestor
92875817|NCT00889421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875818|NCT00889421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875819|NCT00889421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875820|NCT00889421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875821|NCT00889421|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92875822|NCT00889421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92875823|NCT00889421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875824|NCT00889421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875825|NCT02827643|Vitamin D|vitamin d|mesh-list
92875826|NCT02827643|Ergocalciferols|ergocalciferols|mesh-list
92875827|NCT02827643|Lamivudine|lamivudine|mesh-list
92875828|NCT02827643|Calcium|calcium|mesh-list
92875829|NCT02827643|Vitamins|vitamins|mesh-ancestor
92875830|NCT02827643|Micronutrients|micronutrients|mesh-ancestor
92875831|NCT02827643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875832|NCT02827643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92875833|NCT02827643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92875834|NCT02827643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92875835|NCT02827643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92875836|NCT02827643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875837|NCT02827643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875838|NCT02827643|Antiviral Agents|antiviral agents|mesh-ancestor
92875839|NCT02827643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875840|NCT02827643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92875841|NCT02827643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92875842|NCT02646774|Micafungin|micafungin|mesh-list
92875843|NCT02646774|Antifungal Agents|antifungal agents|mesh-ancestor
92875844|NCT02646774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92875845|NCT02647086|Metoprolol|metoprolol|mesh-list
92875846|NCT02647086|Midazolam|midazolam|mesh-list
92875847|NCT02647086|Caffeine|caffeine|mesh-list
92875848|NCT02647086|Omeprazole|omeprazole|mesh-list
92875849|NCT02647086|Warfarin|warfarin|mesh-list
92875850|NCT02647086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92875851|NCT02647086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92875852|NCT02647086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92875853|NCT02647086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875854|NCT02647086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92875855|NCT02647086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92875856|NCT02647086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875857|NCT02647086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92875858|NCT02647086|Anesthetics, General|anesthetics, general|mesh-ancestor
92875859|NCT02647086|Anesthetics|anesthetics|mesh-ancestor
92875860|NCT02647086|GABA Modulators|gaba modulators|mesh-ancestor
92875861|NCT02647086|GABA Agents|gaba agents|mesh-ancestor
92875862|NCT02647086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875863|NCT02647086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875864|NCT02647086|Anticoagulants|anticoagulants|mesh-ancestor
92875865|NCT02647086|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92875866|NCT02647086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92875867|NCT02647086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875868|NCT02647086|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92875869|NCT02647086|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92875870|NCT02647086|Purinergic Agents|purinergic agents|mesh-ancestor
92875871|NCT02647086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92875872|NCT02647086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875873|NCT02647086|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92875874|NCT02647086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92875875|NCT02647086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92875876|NCT02647086|Sympatholytics|sympatholytics|mesh-ancestor
92875877|NCT02647086|Autonomic Agents|autonomic agents|mesh-ancestor
92875878|NCT02647086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875879|NCT02647086|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92875880|NCT02647086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92875881|NCT02647086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92875882|NCT02647086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875883|NCT00651690|Botulinum Toxins|botulinum toxins|mesh-list
92875884|NCT00651690|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92875885|NCT00651690|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92875886|NCT00651690|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92875887|NCT00651690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875888|NCT00651690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875889|NCT00651690|Cholinergic Agents|cholinergic agents|mesh-ancestor
92875890|NCT00651690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875891|NCT00651690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875892|NCT00651690|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92875893|NCT00651690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875894|NCT00651768|Budesonide|budesonide|mesh-list
92875895|NCT00651768|Formoterol Fumarate|formoterol fumarate|mesh-list
92875896|NCT00651768|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92875897|NCT00651768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875898|NCT00651768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92875899|NCT00651768|Autonomic Agents|autonomic agents|mesh-ancestor
92875900|NCT00651768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875901|NCT00651768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875902|NCT00651768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92875903|NCT00651768|Respiratory System Agents|respiratory system agents|mesh-ancestor
92875904|NCT00651768|Glucocorticoids|glucocorticoids|mesh-ancestor
92875905|NCT00651768|Hormones|hormones|mesh-ancestor
92875906|NCT00651768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875907|NCT00651768|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92875908|NCT00651768|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92875909|NCT00651768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92875910|NCT00651768|Adrenergic Agents|adrenergic agents|mesh-ancestor
92875911|NCT00651768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875912|NCT00651768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875913|NCT00651846|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92875914|NCT00651846|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92875915|NCT00651846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92875916|NCT00651846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875917|NCT00651846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92875918|NCT00651846|Contraceptive Agents|contraceptive agents|mesh-ancestor
92875919|NCT00651846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92875920|NCT00651846|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92875921|NCT00651846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92875922|NCT00651846|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92875923|NCT00651846|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92875924|NCT00651846|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92875925|NCT00651846|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92875926|NCT00651846|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92875927|NCT04167306|Bupropion|bupropion|mesh-list
92875928|NCT04167306|Varenicline|varenicline|mesh-list
92875929|NCT04167306|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92875930|NCT04167306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92875931|NCT04167306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92875932|NCT04167306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92875933|NCT04167306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92875934|NCT04167306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92875935|NCT04167306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875936|NCT04167306|Dopamine Agents|dopamine agents|mesh-ancestor
92875937|NCT04167306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92875938|NCT04167306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875939|NCT04167306|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92875940|NCT04167306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92875941|NCT04167306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875942|NCT04167306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92875943|NCT04167306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92875944|NCT04167306|Cholinergic Agents|cholinergic agents|mesh-ancestor
92875945|NCT04244591|Methylprednisolone|methylprednisolone|mesh-list
92875946|NCT04244591|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92875947|NCT04244591|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92875948|NCT04244591|Prednisolone|prednisolone|mesh-list
92875949|NCT04244591|Prednisolone acetate|prednisolone acetate|mesh-list
92875950|NCT04244591|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92875951|NCT04244591|Prednisolone phosphate|prednisolone phosphate|mesh-list
92875952|NCT04244591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875953|NCT04244591|Antiemetics|antiemetics|mesh-ancestor
92875954|NCT04244591|Autonomic Agents|autonomic agents|mesh-ancestor
92875955|NCT04244591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875956|NCT04244591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875957|NCT04244591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92875958|NCT04244591|Glucocorticoids|glucocorticoids|mesh-ancestor
92875959|NCT04244591|Hormones|hormones|mesh-ancestor
92875960|NCT04244591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92875961|NCT04244591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92875962|NCT04244591|Protective Agents|protective agents|mesh-ancestor
92875963|NCT04244591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92875964|NCT04244591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875965|NCT02649582|Temozolomide|temozolomide|mesh-list
92875966|NCT02649582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92875967|NCT02649582|Alkylating Agents|alkylating agents|mesh-ancestor
92875968|NCT02649582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875969|NCT02649582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875970|NCT04167696|Cyclophosphamide|cyclophosphamide|mesh-list
92875971|NCT04167696|Fludarabine|fludarabine|mesh-list
92875972|NCT04167696|Fludarabine phosphate|fludarabine phosphate|mesh-list
92875973|NCT04167696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92875974|NCT04167696|Immunologic Factors|immunologic factors|mesh-ancestor
92875975|NCT04167696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875976|NCT04167696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875977|NCT04167696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92875978|NCT04167696|Alkylating Agents|alkylating agents|mesh-ancestor
92875979|NCT04167696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875980|NCT04167696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92875981|NCT04167696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92875982|NCT04167696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92875983|NCT04167696|Antimetabolites|antimetabolites|mesh-ancestor
92875984|NCT02827487|Celecoxib|celecoxib|mesh-list
92875985|NCT02827487|Tramadol|tramadol|mesh-list
92875986|NCT02827487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92875987|NCT02827487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92875988|NCT02827487|Analgesics|analgesics|mesh-ancestor
92875989|NCT02827487|Sensory System Agents|sensory system agents|mesh-ancestor
92875990|NCT02827487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92875991|NCT02827487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92875992|NCT02827487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92875993|NCT02827487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92875994|NCT02827487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92875995|NCT02827487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92875996|NCT02827487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92875997|NCT02827487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92875998|NCT02827487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92875999|NCT02827487|Narcotics|narcotics|mesh-ancestor
92876000|NCT02827487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876001|NCT02649504|Mycophenolic Acid|mycophenolic acid|mesh-list
92876002|NCT02649504|Dexamethasone|dexamethasone|mesh-list
92876003|NCT02649504|Rituximab|rituximab|mesh-list
92876004|NCT02649504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92876005|NCT02649504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876006|NCT02649504|Immunologic Factors|immunologic factors|mesh-ancestor
92876007|NCT02649504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876008|NCT02649504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876009|NCT02649504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876010|NCT02649504|Antiemetics|antiemetics|mesh-ancestor
92876011|NCT02649504|Autonomic Agents|autonomic agents|mesh-ancestor
92876012|NCT02649504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876013|NCT02649504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876014|NCT02649504|Glucocorticoids|glucocorticoids|mesh-ancestor
92876015|NCT02649504|Hormones|hormones|mesh-ancestor
92876016|NCT02649504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876017|NCT02649504|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92876018|NCT02649504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92876019|NCT02649504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92876020|NCT02649504|Antitubercular Agents|antitubercular agents|mesh-ancestor
92876021|NCT02649504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876022|NCT02649504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876023|NCT02649504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876024|NCT02649504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876026|NCT03703856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92876027|NCT03703856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92876028|NCT03703856|Dopamine Agents|dopamine agents|mesh-ancestor
92876029|NCT03703856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876030|NCT03703856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876031|NCT03703856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876032|NCT03703856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92876033|NCT03703856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92876034|NCT00650910|Lapatinib|lapatinib|mesh-list
92876035|NCT00650910|Digoxin|digoxin|mesh-list
92876036|NCT00650910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876037|NCT00650910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92876038|NCT00650910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876039|NCT00650910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876040|NCT00650910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92876041|NCT00650910|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92876042|NCT00650910|Protective Agents|protective agents|mesh-ancestor
92876043|NCT00650910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876044|NCT02654730|Primaquine|primaquine|mesh-list
92876045|NCT02654730|Piperaquine|piperaquine|mesh-list
92876046|NCT02654730|Artenimol|artenimol|mesh-list
92876047|NCT02654730|Artemisinins|artemisinins|mesh-list
92876048|NCT02654730|Antimalarials|antimalarials|mesh-ancestor
92876049|NCT02654730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92876050|NCT02654730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92876051|NCT02654730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876052|NCT00888329|Aprepitant|aprepitant|mesh-list
92876053|NCT00888329|Antiemetics|antiemetics|mesh-ancestor
92876054|NCT00888329|Autonomic Agents|autonomic agents|mesh-ancestor
92876055|NCT00888329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876056|NCT00888329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876057|NCT00888329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876058|NCT00888329|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92876059|NCT00888329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876060|NCT00888329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876061|NCT00652002|Budesonide|budesonide|mesh-list
92876062|NCT00652002|Formoterol Fumarate|formoterol fumarate|mesh-list
92876063|NCT00652002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876064|NCT00652002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92876065|NCT00652002|Autonomic Agents|autonomic agents|mesh-ancestor
92876066|NCT00652002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876067|NCT00652002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876068|NCT00652002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92876069|NCT00652002|Respiratory System Agents|respiratory system agents|mesh-ancestor
92876070|NCT00652002|Glucocorticoids|glucocorticoids|mesh-ancestor
92876071|NCT00652002|Hormones|hormones|mesh-ancestor
92876072|NCT00652002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876073|NCT00652002|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92876074|NCT00652002|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92876075|NCT00652002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876076|NCT00652002|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876077|NCT00652002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876078|NCT00652002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876079|NCT02646540|Metolazone|metolazone|mesh-list
92876080|NCT02646540|Furosemide|furosemide|mesh-list
92876081|NCT02646540|Tolvaptan|tolvaptan|mesh-list
92876082|NCT02646540|Diuretics|diuretics|mesh-list
92876083|NCT02646540|Natriuretic Agents|natriuretic agents|mesh-ancestor
92876084|NCT02646540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876085|NCT02646540|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92876086|NCT02646540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876087|NCT02646540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876088|NCT02646540|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92876089|NCT02646540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92876090|NCT02646540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92876091|NCT00651066|Ritonavir|ritonavir|mesh-list
92876092|NCT00651066|Lopinavir|lopinavir|mesh-list
92876093|NCT00651066|Rifabutin|rifabutin|mesh-list
92876094|NCT00651066|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92876095|NCT00651066|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92876096|NCT00651066|Protease Inhibitors|protease inhibitors|mesh-ancestor
92876097|NCT00651066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876098|NCT00651066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876099|NCT00651066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92876100|NCT00651066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92876101|NCT00651066|Antiviral Agents|antiviral agents|mesh-ancestor
92876102|NCT00651066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876103|NCT00651066|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92876104|NCT00651066|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92876105|NCT00651066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876106|NCT00651066|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92876107|NCT00651066|Antitubercular Agents|antitubercular agents|mesh-ancestor
92876108|NCT02646072|Ketorolac|ketorolac|mesh-list
92876109|NCT02646072|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92876110|NCT02646072|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92876111|NCT02646072|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92876112|NCT02646072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876113|NCT02646072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876114|NCT02646072|Analgesics|analgesics|mesh-ancestor
92876115|NCT02646072|Sensory System Agents|sensory system agents|mesh-ancestor
92876116|NCT02646072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876117|NCT02646072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876118|NCT02646072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876119|NCT02646072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876120|NCT02646072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876121|NCT02646072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876122|NCT02646072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876123|NCT02654106|Temozolomide|temozolomide|mesh-list
92876124|NCT02654106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92876125|NCT02654106|Alkylating Agents|alkylating agents|mesh-ancestor
92876126|NCT02654106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876127|NCT02654106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876128|NCT04243733|Pemetrexed|pemetrexed|mesh-list
92876129|NCT04243733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876130|NCT04243733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876131|NCT04243733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876132|NCT04243733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92876133|NCT04243733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92876134|NCT03434366|Dexmedetomidine|dexmedetomidine|mesh-list
92876135|NCT03434366|Ketamine|ketamine|mesh-list
92876136|NCT03434366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876137|NCT03434366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876138|NCT03434366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876139|NCT03434366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876140|NCT03434366|Analgesics|analgesics|mesh-ancestor
92876141|NCT03434366|Sensory System Agents|sensory system agents|mesh-ancestor
92876142|NCT03434366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876143|NCT03434366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92876144|NCT03434366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876145|NCT03434366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876146|NCT03434366|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876147|NCT03434366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876148|NCT03434366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876149|NCT03434366|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92876150|NCT03434366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92876151|NCT03434366|Anesthetics, General|anesthetics, general|mesh-ancestor
92876152|NCT03434366|Anesthetics|anesthetics|mesh-ancestor
92876153|NCT03434366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92876154|NCT03434366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92876155|NCT04167228|Ceftazidime|ceftazidime|mesh-list
92876156|NCT04167228|Avibactam|avibactam|mesh-list
92876157|NCT04167228|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92876158|NCT04167228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876159|NCT04167228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876160|NCT04167228|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92876161|NCT04167228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876162|NCT04167228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876163|NCT02687438|Mometasone Furoate|mometasone furoate|mesh-list
92876164|NCT02687438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876165|NCT02687438|Dermatologic Agents|dermatologic agents|mesh-ancestor
92876166|NCT02687438|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92521414|NCT03625323|Pembrolizumab|pembrolizumab|mesh-list
93046928|NCT01058720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876167|NCT02537834|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
92876168|NCT02537834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92876169|NCT02537834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876170|NCT02537834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92876171|NCT02537834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876172|NCT02648958|Dexmedetomidine|dexmedetomidine|mesh-list
92876173|NCT02648958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876174|NCT02648958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876175|NCT02648958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876176|NCT02648958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876177|NCT02648958|Analgesics|analgesics|mesh-ancestor
92876178|NCT02648958|Sensory System Agents|sensory system agents|mesh-ancestor
92876179|NCT02648958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876180|NCT02648958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92876181|NCT02648958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876182|NCT02648958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876183|NCT02648958|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876184|NCT02648958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876185|NCT02648958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876186|NCT00887549|Pemetrexed|pemetrexed|mesh-list
92876187|NCT00887549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876188|NCT00887549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876189|NCT00887549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876190|NCT00887549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92876191|NCT00887549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92876192|NCT04243811|Anesthetics|anesthetics|mesh-list
92220817|NCT05506488|Dasatinib|dasatinib|mesh-list
92876193|NCT04243811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876194|NCT04243811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876195|NCT00638300|Dialysis Solutions|dialysis solutions|mesh-list
92876196|NCT00638300|Calcium|calcium|mesh-list
92876197|NCT00638300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876198|NCT00638300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876199|NCT00638300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92876200|NCT00887315|Cisplatin|cisplatin|mesh-list
92876201|NCT00887315|Docetaxel|docetaxel|mesh-list
92876202|NCT00887315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876203|NCT00887315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92876204|NCT00887315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92876205|NCT00887315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92876206|NCT00887315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876207|NCT02645994|Anesthetics|anesthetics|mesh-list
92876208|NCT02645994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876209|NCT02645994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876210|NCT03014648|Atezolizumab|atezolizumab|mesh-list
92876211|NCT03014648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92876212|NCT03014648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876213|NCT03014648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92876214|NCT03014648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876215|NCT02645058|Analgesics|analgesics|mesh-list
92876216|NCT02645058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876217|NCT02645058|Sensory System Agents|sensory system agents|mesh-ancestor
92876218|NCT02645058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876219|NCT02644980|Anesthetics|anesthetics|mesh-list
92876220|NCT02644980|Propofol|propofol|mesh-list
92876221|NCT02644980|Etomidate|etomidate|mesh-list
92876222|NCT02644980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876223|NCT02644980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876224|NCT02644980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876225|NCT02644980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92876226|NCT02644980|Anesthetics, General|anesthetics, general|mesh-ancestor
92876227|NCT04187456|Midazolam|midazolam|mesh-list
92876228|NCT04187456|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92876229|NCT04187456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876230|NCT04187456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876231|NCT04187456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876232|NCT04187456|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92876233|NCT04187456|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876234|NCT04187456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876235|NCT04187456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92876236|NCT04187456|Anesthetics, General|anesthetics, general|mesh-ancestor
92876237|NCT04187456|Anesthetics|anesthetics|mesh-ancestor
92876238|NCT04187456|GABA Modulators|gaba modulators|mesh-ancestor
92876239|NCT04187456|GABA Agents|gaba agents|mesh-ancestor
92876240|NCT04187456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876241|NCT04187456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876242|NCT02827331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92876243|NCT02827331|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
92876244|NCT02827331|Antidepressive Agents|antidepressive agents|mesh-list
92876245|NCT02827331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876246|NCT02827331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876247|NCT02827331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876248|NCT02827331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876249|NCT02687204|Enoxaparin|enoxaparin|mesh-list
92876250|NCT02687204|Enoxaparin sodium|enoxaparin sodium|mesh-list
92876251|NCT02687204|Anticoagulants|anticoagulants|mesh-ancestor
92876252|NCT02687204|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92876253|NCT02687204|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92876254|NCT02687204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876255|NCT00650208|Lamotrigine|lamotrigine|mesh-list
92876256|NCT00650208|Anticonvulsants|anticonvulsants|mesh-ancestor
92876257|NCT00650208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92876258|NCT00650208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876259|NCT00650208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876260|NCT00650208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876261|NCT00650208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876262|NCT00650208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92876263|NCT00650208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876264|NCT00650208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876265|NCT00650208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876266|NCT00650208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92876267|NCT02645370|Topiramate|topiramate|mesh-list
92876268|NCT02645370|Anticonvulsants|anticonvulsants|mesh-ancestor
92876269|NCT02645370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92876270|NCT02645370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876271|NCT00652392|Budesonide|budesonide|mesh-list
92876272|NCT00652392|Formoterol Fumarate|formoterol fumarate|mesh-list
92876273|NCT00652392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876274|NCT00652392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92876275|NCT00652392|Autonomic Agents|autonomic agents|mesh-ancestor
92876276|NCT00652392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876277|NCT00652392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876278|NCT00652392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92876279|NCT00652392|Respiratory System Agents|respiratory system agents|mesh-ancestor
92876280|NCT00652392|Glucocorticoids|glucocorticoids|mesh-ancestor
92876281|NCT00652392|Hormones|hormones|mesh-ancestor
92876282|NCT00652392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876283|NCT00652392|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92876284|NCT00652392|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92876285|NCT00652392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876286|NCT00652392|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876287|NCT00652392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876288|NCT00652392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876289|NCT02645214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92876290|NCT02645214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876291|NCT02653638|Indomethacin|indomethacin|mesh-list
92876292|NCT02653638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876293|NCT02653638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876294|NCT02653638|Analgesics|analgesics|mesh-ancestor
92876295|NCT02653638|Sensory System Agents|sensory system agents|mesh-ancestor
92876296|NCT02653638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876297|NCT02653638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876298|NCT02653638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876299|NCT02653638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876300|NCT02653638|Gout Suppressants|gout suppressants|mesh-ancestor
92876301|NCT02653638|Tocolytic Agents|tocolytic agents|mesh-ancestor
92876302|NCT02653638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92876303|NCT02653638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876304|NCT02653638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876305|NCT02653638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876306|NCT02644590|Melatonin|melatonin|mesh-list
92876307|NCT02644590|Antioxidants|antioxidants|mesh-ancestor
92876308|NCT02644590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876309|NCT02644590|Protective Agents|protective agents|mesh-ancestor
92876310|NCT02644590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876311|NCT02644590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521569|NCT00109408|Methotrexate|methotrexate|mesh-list
92876313|NCT00910806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92876314|NCT00910806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92876315|NCT00910806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876316|NCT00910806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876317|NCT00910806|Antiviral Agents|antiviral agents|mesh-ancestor
92876318|NCT00910806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876319|NCT00910806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92876320|NCT00910806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92876321|NCT00910806|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92876322|NCT00910806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92876323|NCT00652704|Doxycycline|doxycycline|mesh-list
92876324|NCT00652704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876325|NCT00652704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876326|NCT00652704|Antimalarials|antimalarials|mesh-ancestor
92876327|NCT00652704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92876328|NCT00652704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92876329|NCT00652782|Rolofylline|rolofylline|mesh-list
92876330|NCT00652782|Diuretics|diuretics|mesh-ancestor
92876331|NCT00652782|Natriuretic Agents|natriuretic agents|mesh-ancestor
92876332|NCT00652782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876333|NCT00653562|Zolpidem|zolpidem|mesh-list
92876334|NCT00653562|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92876335|NCT00653562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876336|NCT00653562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876337|NCT00653562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876338|NCT00653562|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92876339|NCT00653562|GABA Agonists|gaba agonists|mesh-ancestor
92876340|NCT00653562|GABA Agents|gaba agents|mesh-ancestor
92876341|NCT00653562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876342|NCT00653562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876343|NCT00887159|Cisplatin|cisplatin|mesh-list
92876344|NCT00887159|Etoposide|etoposide|mesh-list
92876345|NCT00887159|Etoposide phosphate|etoposide phosphate|mesh-list
92876346|NCT00887159|Podophyllotoxin|podophyllotoxin|mesh-list
92876347|NCT00887159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92876348|NCT00887159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876349|NCT00887159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92876350|NCT00887159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92876351|NCT00887159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92876352|NCT00887159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876353|NCT00887159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876354|NCT00887159|Keratolytic Agents|keratolytic agents|mesh-ancestor
92876355|NCT00887159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92876356|NCT00887159|Tubulin Modulators|tubulin modulators|mesh-ancestor
92876357|NCT00887159|Antimitotic Agents|antimitotic agents|mesh-ancestor
92876358|NCT00887159|Mitosis Modulators|mitosis modulators|mesh-ancestor
92876359|NCT00887159|Immunologic Factors|immunologic factors|mesh-ancestor
92876360|NCT00887159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876361|NCT00650286|Modafinil|modafinil|mesh-list
92876362|NCT00650286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92876363|NCT00650286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876364|NCT00650286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92876365|NCT00650286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92876366|NCT00650286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92876367|NCT00650286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876368|NCT02640846|Simendan|simendan|mesh-list
92876369|NCT02640846|Milrinone|milrinone|mesh-list
92876370|NCT02640846|Norepinephrine|norepinephrine|mesh-list
92876371|NCT02640846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876372|NCT02640846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876373|NCT02640846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876374|NCT02640846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876375|NCT02640846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876376|NCT02640846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876377|NCT02640846|Sympathomimetics|sympathomimetics|mesh-ancestor
92876378|NCT02640846|Autonomic Agents|autonomic agents|mesh-ancestor
92876379|NCT02640846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876380|NCT02640846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92876381|NCT02640846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92876382|NCT02640846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92876383|NCT02640846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92876384|NCT02640846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92876385|NCT02640846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521631|NCT00109993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876386|NCT02640846|Protective Agents|protective agents|mesh-ancestor
92876387|NCT02640846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92876388|NCT02644044|Methotrexate|methotrexate|mesh-list
92876389|NCT02644044|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92876390|NCT02644044|Abortifacient Agents|abortifacient agents|mesh-ancestor
92876391|NCT02644044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92876392|NCT02644044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876393|NCT02644044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92876394|NCT02644044|Antimetabolites|antimetabolites|mesh-ancestor
92876395|NCT02644044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876396|NCT02644044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876397|NCT02644044|Dermatologic Agents|dermatologic agents|mesh-ancestor
92876398|NCT02644044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876399|NCT02644044|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92876400|NCT02644044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92876401|NCT02644044|Immunologic Factors|immunologic factors|mesh-ancestor
92876402|NCT02644044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876403|NCT02644044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92876404|NCT00652860|Doxorubicin|doxorubicin|mesh-list
92876405|NCT00652860|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92876406|NCT00652860|Ifosfamide|ifosfamide|mesh-list
92876407|NCT00652860|Molgramostim|molgramostim|mesh-list
92876408|NCT00652860|Mitomycins|mitomycins|mesh-list
92876409|NCT00652860|Mitomycin|mitomycin|mesh-list
92876410|NCT00652860|Sargramostim|sargramostim|mesh-list
92876411|NCT00652860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876412|NCT00652860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92876413|NCT00652860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92876414|NCT00652860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92876415|NCT00652860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876416|NCT00652860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876417|NCT00652860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92876418|NCT00652860|Alkylating Agents|alkylating agents|mesh-ancestor
92876419|NCT00652860|Immunologic Factors|immunologic factors|mesh-ancestor
92876420|NCT00652860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876421|NCT00652860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92876423|NCT02536014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876424|NCT02536014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876425|NCT02536014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876426|NCT02536014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876427|NCT02536014|Analgesics|analgesics|mesh-ancestor
92876428|NCT02536014|Sensory System Agents|sensory system agents|mesh-ancestor
92876429|NCT02536014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876430|NCT02536014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92876431|NCT02536014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876432|NCT02536014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876433|NCT02536014|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876434|NCT02536014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876435|NCT02536014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876436|NCT02653014|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92876437|NCT02653014|Mineralocorticoids|mineralocorticoids|mesh-list
92876438|NCT02653014|Hormone Antagonists|hormone antagonists|mesh-ancestor
92876439|NCT02653014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876440|NCT02653014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876441|NCT02653014|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92876442|NCT02653014|Diuretics|diuretics|mesh-ancestor
92876443|NCT02653014|Natriuretic Agents|natriuretic agents|mesh-ancestor
92876444|NCT02653014|Hormones|hormones|mesh-ancestor
92876445|NCT00886613|Vaccines|vaccines|mesh-list
92876446|NCT00886613|Immunologic Factors|immunologic factors|mesh-ancestor
92876447|NCT00886613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876448|NCT00653016|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92876449|NCT00653016|Norelgestromin|norelgestromin|mesh-list
92876450|NCT00653016|Estradiol|estradiol|mesh-list
92876451|NCT00653016|Estrogens|estrogens|mesh-ancestor
92876452|NCT00653016|Hormones|hormones|mesh-ancestor
92876453|NCT00653016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876454|NCT00653016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876455|NCT00653016|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92876456|NCT00653016|Contraceptive Agents|contraceptive agents|mesh-ancestor
92876457|NCT00653016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92876458|NCT00653016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92876459|NCT00653016|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92876460|NCT00653016|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92876461|NCT00886379|Vitamin D|vitamin d|mesh-list
92876462|NCT00886379|Ergocalciferols|ergocalciferols|mesh-list
92876463|NCT00886379|Cholecalciferol|cholecalciferol|mesh-list
92876464|NCT00886379|Vitamins|vitamins|mesh-list
92876465|NCT00886379|Micronutrients|micronutrients|mesh-ancestor
92876466|NCT00886379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876467|NCT00886379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92876468|NCT00886379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876469|NCT00633581|Ascorbic Acid|ascorbic acid|mesh-list
92876470|NCT00633581|Vitamins|vitamins|mesh-ancestor
92876471|NCT00633581|Micronutrients|micronutrients|mesh-ancestor
92876472|NCT00633581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876473|NCT00633581|Antioxidants|antioxidants|mesh-ancestor
92876474|NCT00633581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876475|NCT00633581|Protective Agents|protective agents|mesh-ancestor
92876476|NCT02825147|Dexamethasone|dexamethasone|mesh-list
92876477|NCT02825147|Methotrexate|methotrexate|mesh-list
92876478|NCT02825147|Etoposide|etoposide|mesh-list
92876479|NCT02825147|Pegaspargase|pegaspargase|mesh-list
92876480|NCT02825147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876481|NCT02825147|Antiemetics|antiemetics|mesh-ancestor
92876482|NCT02825147|Autonomic Agents|autonomic agents|mesh-ancestor
92876483|NCT02825147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876484|NCT02825147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876485|NCT02825147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876486|NCT02825147|Glucocorticoids|glucocorticoids|mesh-ancestor
92876487|NCT02825147|Hormones|hormones|mesh-ancestor
92876488|NCT02825147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876489|NCT02825147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92876490|NCT02825147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876491|NCT02825147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92876492|NCT02825147|Abortifacient Agents|abortifacient agents|mesh-ancestor
92876493|NCT02825147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92876494|NCT02825147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92876495|NCT02825147|Antimetabolites|antimetabolites|mesh-ancestor
92876496|NCT02825147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876497|NCT02825147|Dermatologic Agents|dermatologic agents|mesh-ancestor
92876498|NCT02825147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876499|NCT02825147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92876500|NCT02825147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92876501|NCT02825147|Immunologic Factors|immunologic factors|mesh-ancestor
92876502|NCT02825147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876503|NCT02825147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92876504|NCT02825147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92876505|NCT02825147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92876506|NCT02825147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92876507|NCT02825225|Anesthetics|anesthetics|mesh-list
92876508|NCT02825225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876509|NCT02825225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876510|NCT00637949|Rofecoxib|rofecoxib|mesh-list
92876511|NCT00637949|Lumiracoxib|lumiracoxib|mesh-list
92876512|NCT00637949|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92876513|NCT00637949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876514|NCT00637949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876515|NCT00637949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876516|NCT00637949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876517|NCT00637949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876518|NCT00637949|Analgesics|analgesics|mesh-ancestor
92876519|NCT00637949|Sensory System Agents|sensory system agents|mesh-ancestor
92876520|NCT00637949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159852|NCT01407263|Coagulants|coagulants|mesh-ancestor
92876521|NCT00637949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876522|NCT00637949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876523|NCT00637949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876524|NCT04242017|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92876525|NCT04242017|Luteolytic Agents|luteolytic agents|mesh-ancestor
92876526|NCT04242017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92876527|NCT04242017|Contraceptive Agents|contraceptive agents|mesh-ancestor
92876528|NCT04242017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92876529|NCT04242017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876530|NCT04242017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92876531|NCT04242017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92876532|NCT04242017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876533|NCT00599196|Rotigotine|rotigotine|mesh-list
92876534|NCT00599196|Dopamine Agonists|dopamine agonists|mesh-ancestor
92876535|NCT00599196|Dopamine Agents|dopamine agents|mesh-ancestor
92521781|NCT00111124|Etanercept|etanercept|mesh-list
92876536|NCT00599196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876537|NCT00599196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876538|NCT00599196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876539|NCT04201145|Pembrolizumab|pembrolizumab|mesh-list
92876540|NCT04201145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92876541|NCT04201145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876542|NCT04201145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92876543|NCT04201145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876544|NCT02824601|Calcium|calcium|mesh-list
92876545|NCT02824601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876546|NCT02824601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876547|NCT02643732|Methylphenidate|methylphenidate|mesh-list
92876548|NCT02643732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92876549|NCT02643732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876550|NCT02643732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92876551|NCT02643732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92876552|NCT02643732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876553|NCT02643732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876554|NCT02643732|Dopamine Agents|dopamine agents|mesh-ancestor
92876555|NCT02643732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876556|NCT04876937|Dexmedetomidine|dexmedetomidine|mesh-list
92876557|NCT04876937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876558|NCT04876937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876559|NCT04876937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876560|NCT04876937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876561|NCT04876937|Analgesics|analgesics|mesh-ancestor
92876562|NCT04876937|Sensory System Agents|sensory system agents|mesh-ancestor
92876563|NCT04876937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876564|NCT04876937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92876565|NCT04876937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876566|NCT04876937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876567|NCT04876937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876568|NCT04876937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876569|NCT04876937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876570|NCT04165590|Immunomodulating Agents|immunomodulating agents|mesh-list
92876571|NCT04165590|Immunologic Factors|immunologic factors|mesh-ancestor
92876572|NCT04165590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876573|NCT05660993|Nivolumab|nivolumab|mesh-list
92876574|NCT05660993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92876575|NCT05660993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876576|NCT05660993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92876577|NCT05660993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876578|NCT00633659|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92876579|NCT00633659|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92876580|NCT00633659|Plasma Substitutes|plasma substitutes|mesh-ancestor
92876581|NCT00633659|Blood Substitutes|blood substitutes|mesh-ancestor
92876582|NCT04241705|Lumefantrine|lumefantrine|mesh-list
92876583|NCT04241705|Artemether|artemether|mesh-list
92876584|NCT04241705|Primaquine|primaquine|mesh-list
92876585|NCT04241705|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92876586|NCT04241705|Antimalarials|antimalarials|mesh-ancestor
92876587|NCT04241705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92876588|NCT04241705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92876589|NCT04241705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876590|NCT04243109|Dexamethasone|dexamethasone|mesh-list
92876591|NCT04243109|Cyclophosphamide|cyclophosphamide|mesh-list
92876592|NCT04243109|Pomalidomide|pomalidomide|mesh-list
92876593|NCT04243109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92876594|NCT04243109|Immunologic Factors|immunologic factors|mesh-ancestor
92876595|NCT04243109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876596|NCT04243109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876597|NCT04243109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92876598|NCT04243109|Alkylating Agents|alkylating agents|mesh-ancestor
92876599|NCT04243109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876600|NCT04243109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876601|NCT04243109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92876602|NCT04243109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876603|NCT04243109|Antiemetics|antiemetics|mesh-ancestor
92876604|NCT04243109|Autonomic Agents|autonomic agents|mesh-ancestor
92876605|NCT04243109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876606|NCT04243109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876607|NCT04243109|Glucocorticoids|glucocorticoids|mesh-ancestor
92521857|NCT00111748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876608|NCT04243109|Hormones|hormones|mesh-ancestor
92876609|NCT04243109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876610|NCT04243109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92876611|NCT04243109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92876612|NCT04243109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92876613|NCT04243109|Growth Substances|growth substances|mesh-ancestor
92876614|NCT04243109|Growth Inhibitors|growth inhibitors|mesh-ancestor
92876615|NCT04861181|Niraparib|niraparib|mesh-list
92876616|NCT04861181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92876617|NCT04861181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876618|NCT04861181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876619|NCT04861181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876620|NCT00603512|Tofacitinib|tofacitinib|mesh-list
92876621|NCT00603512|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92876622|NCT00603512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92876623|NCT00603512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876624|NCT00603512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876625|NCT04167774|Paclitaxel|paclitaxel|mesh-list
92876626|NCT04167774|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92876627|NCT04167774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92876628|NCT04167774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876629|NCT04167774|Tubulin Modulators|tubulin modulators|mesh-ancestor
92876630|NCT04167774|Antimitotic Agents|antimitotic agents|mesh-ancestor
92876631|NCT04167774|Mitosis Modulators|mitosis modulators|mesh-ancestor
92876632|NCT04167774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876633|NCT02640300|Clozapine|clozapine|mesh-list
92876634|NCT02640300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92876635|NCT02640300|Serotonin Agents|serotonin agents|mesh-ancestor
92876636|NCT02640300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876637|NCT02640300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876638|NCT02640300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876639|NCT02640300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92876640|NCT02640300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876641|NCT02640300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876642|NCT02640300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876643|NCT02640300|GABA Antagonists|gaba antagonists|mesh-ancestor
92876644|NCT02640300|GABA Agents|gaba agents|mesh-ancestor
92876645|NCT02640144|Hyaluronic Acid|hyaluronic acid|mesh-list
92876646|NCT02640144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92876647|NCT02640144|Immunologic Factors|immunologic factors|mesh-ancestor
92876648|NCT02640144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876649|NCT02640144|Viscosupplements|viscosupplements|mesh-ancestor
92876650|NCT02640144|Protective Agents|protective agents|mesh-ancestor
92876651|NCT02643186|Misoprostol|misoprostol|mesh-list
92876652|NCT02643186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92876653|NCT02643186|Abortifacient Agents|abortifacient agents|mesh-ancestor
92876654|NCT02643186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92876655|NCT02643186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876656|NCT02643186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92876657|NCT02643186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876658|NCT02643186|Oxytocics|oxytocics|mesh-ancestor
92876659|NCT02652312|Diclofenac|diclofenac|mesh-list
92876660|NCT02652312|Fentanyl|fentanyl|mesh-list
92876661|NCT02652312|Dexmedetomidine|dexmedetomidine|mesh-list
92876662|NCT02652312|Ondansetron|ondansetron|mesh-list
92876663|NCT02652312|Propofol|propofol|mesh-list
92876664|NCT02652312|Desflurane|desflurane|mesh-list
92876665|NCT02652312|Atracurium|atracurium|mesh-list
92876666|NCT02652312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92876667|NCT02652312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876668|NCT02652312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876669|NCT02652312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876670|NCT02652312|Analgesics|analgesics|mesh-ancestor
92876671|NCT02652312|Sensory System Agents|sensory system agents|mesh-ancestor
92876672|NCT02652312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876673|NCT02652312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92876674|NCT02652312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876675|NCT02652312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876676|NCT02652312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876677|NCT02652312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876678|NCT02652312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876679|NCT02652312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92876680|NCT02652312|Anesthetics, General|anesthetics, general|mesh-ancestor
92876681|NCT02652312|Anesthetics|anesthetics|mesh-ancestor
92876682|NCT02652312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92876683|NCT02652312|Narcotics|narcotics|mesh-ancestor
92876684|NCT02652312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92876685|NCT02652312|Antiemetics|antiemetics|mesh-ancestor
92876686|NCT02652312|Autonomic Agents|autonomic agents|mesh-ancestor
92876687|NCT02652312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876688|NCT02652312|Antipruritics|antipruritics|mesh-ancestor
92876689|NCT02652312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92876690|NCT02652312|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92876691|NCT02652312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92876692|NCT02652312|Serotonin Agents|serotonin agents|mesh-ancestor
92876693|NCT02652312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876694|NCT02652312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876695|NCT02652312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876696|NCT02652312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876697|NCT02652312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876698|NCT02652312|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92876699|NCT02652312|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92876700|NCT02652312|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92876701|NCT02652312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92876702|NCT02652312|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92876703|NCT02652312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92876704|NCT02652312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92876705|NCT04165512|Triamcinolone|triamcinolone|mesh-list
92876706|NCT04165512|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92876707|NCT04165512|Bupivacaine|bupivacaine|mesh-list
92876708|NCT04165512|Anesthetics, Local|anesthetics, local|mesh-ancestor
92876709|NCT04165512|Anesthetics|anesthetics|mesh-ancestor
92876710|NCT04165512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876711|NCT04165512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876712|NCT04165512|Sensory System Agents|sensory system agents|mesh-ancestor
92876713|NCT04165512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876714|NCT04165512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876715|NCT04165512|Glucocorticoids|glucocorticoids|mesh-ancestor
92876716|NCT04165512|Hormones|hormones|mesh-ancestor
92876717|NCT04165512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876718|NCT04165512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92876719|NCT04165512|Immunologic Factors|immunologic factors|mesh-ancestor
92876720|NCT02642874|Methocarbamol|methocarbamol|mesh-list
92876721|NCT02642874|Calcium Carbonate|calcium carbonate|mesh-list
92876722|NCT02642874|Calcium|calcium|mesh-list
92876723|NCT02642874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876724|NCT02642874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876725|NCT02642874|Antacids|antacids|mesh-ancestor
92876726|NCT02642874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876727|NCT02642874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876728|NCT02642874|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92876729|NCT02642874|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92159872|NCT01397929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876730|NCT02642874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876731|NCT00653874|Bilirubin|bilirubin|mesh-list
92876732|NCT00653874|Antioxidants|antioxidants|mesh-ancestor
92876733|NCT00653874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876734|NCT00653874|Protective Agents|protective agents|mesh-ancestor
92876735|NCT00653874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876736|NCT04224701|Vaccines|vaccines|mesh-list
92876737|NCT04224701|Immunologic Factors|immunologic factors|mesh-ancestor
92876738|NCT04224701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876739|NCT00653952|Paclitaxel|paclitaxel|mesh-list
92876740|NCT00653952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92876741|NCT00653952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876742|NCT00653952|Tubulin Modulators|tubulin modulators|mesh-ancestor
92876743|NCT00653952|Antimitotic Agents|antimitotic agents|mesh-ancestor
92876744|NCT00653952|Mitosis Modulators|mitosis modulators|mesh-ancestor
92876745|NCT00653952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876746|NCT00650364|Midodrine|midodrine|mesh-list
92876747|NCT00650364|Sympathomimetics|sympathomimetics|mesh-ancestor
92876748|NCT00650364|Autonomic Agents|autonomic agents|mesh-ancestor
92876749|NCT00650364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876750|NCT00650364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876751|NCT00650364|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92876752|NCT00650364|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92876753|NCT00650364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92876754|NCT00650364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92876755|NCT00650364|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876756|NCT00650364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876757|NCT00650364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876758|NCT04909697|Sivelestat|sivelestat|mesh-list
92522011|NCT00007631|Tretinoin|tretinoin|mesh-list
92876759|NCT04909697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92876760|NCT04909697|Protease Inhibitors|protease inhibitors|mesh-ancestor
92876761|NCT04909697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876762|NCT04909697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876763|NCT00654108|Ascorbic Acid|ascorbic acid|mesh-list
92876764|NCT00654108|Ciprofloxacin|ciprofloxacin|mesh-list
92876765|NCT00654108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876766|NCT00654108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876767|NCT00654108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92876768|NCT00654108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92876769|NCT00654108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876770|NCT00654108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876771|NCT00654108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876772|NCT00654108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92876773|NCT00654108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92876774|NCT00654108|Antioxidants|antioxidants|mesh-ancestor
92876775|NCT00654108|Protective Agents|protective agents|mesh-ancestor
92876776|NCT00654108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876777|NCT00654108|Vitamins|vitamins|mesh-ancestor
92876778|NCT00654108|Micronutrients|micronutrients|mesh-ancestor
92876779|NCT04165902|Hyaluronic Acid|hyaluronic acid|mesh-list
92876780|NCT04165902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92876781|NCT04165902|Immunologic Factors|immunologic factors|mesh-ancestor
92159875|NCT01370330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876782|NCT04165902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876783|NCT04165902|Viscosupplements|viscosupplements|mesh-ancestor
92876784|NCT04165902|Protective Agents|protective agents|mesh-ancestor
92876785|NCT02639598|Topiramate|topiramate|mesh-list
92876786|NCT02639598|Flunarizine|flunarizine|mesh-list
92876787|NCT02639598|Anticonvulsants|anticonvulsants|mesh-ancestor
92876788|NCT02639598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92876789|NCT02639598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876790|NCT02639598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92876791|NCT02639598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876792|NCT02639598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876793|NCT02639598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876794|NCT02639598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92876795|NCT02639598|Histamine Antagonists|histamine antagonists|mesh-ancestor
92876796|NCT02639598|Histamine Agents|histamine agents|mesh-ancestor
92876797|NCT02639598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876798|NCT02639598|Vasodilator Agents|vasodilator agents|mesh-ancestor
92876799|NCT04907279|Aripiprazole|aripiprazole|mesh-list
92876800|NCT04907279|Antidepressive Agents|antidepressive agents|mesh-ancestor
92876801|NCT04907279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876802|NCT04907279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92876803|NCT04907279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876804|NCT04907279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876805|NCT04907279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876806|NCT04907279|Dopamine Agonists|dopamine agonists|mesh-ancestor
92876807|NCT04907279|Dopamine Agents|dopamine agents|mesh-ancestor
92876808|NCT04907279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876809|NCT04907279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876810|NCT04907279|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92876811|NCT04907279|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92876812|NCT04907279|Serotonin Agents|serotonin agents|mesh-ancestor
92876813|NCT04907279|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92876814|NCT04907279|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92876815|NCT04907279|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92876816|NCT04907279|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92876817|NCT02642718|Ketorolac|ketorolac|mesh-list
92876818|NCT02642718|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92876819|NCT02642718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876820|NCT02642718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876821|NCT02642718|Analgesics|analgesics|mesh-ancestor
92876822|NCT02642718|Sensory System Agents|sensory system agents|mesh-ancestor
92876823|NCT02642718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876824|NCT02642718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876825|NCT02642718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876826|NCT02642718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876827|NCT02642718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876828|NCT02642718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876829|NCT02642718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876830|NCT02642484|Gabapentin|gabapentin|mesh-list
92876831|NCT02642484|Calcium Carbonate|calcium carbonate|mesh-list
92876832|NCT02642484|Calcium|calcium|mesh-list
92522090|NCT00007670|Antimanic Agents|antimanic agents|mesh-ancestor
92876833|NCT02642484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92876834|NCT02642484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876835|NCT02642484|Analgesics|analgesics|mesh-ancestor
92876836|NCT02642484|Sensory System Agents|sensory system agents|mesh-ancestor
92876837|NCT02642484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876838|NCT02642484|Anticonvulsants|anticonvulsants|mesh-ancestor
92876839|NCT02642484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92876840|NCT02642484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876841|NCT02642484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876842|NCT02642484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876843|NCT02642484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92876844|NCT02642484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92876845|NCT02642484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876846|NCT02642484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876847|NCT02642484|Antimanic Agents|antimanic agents|mesh-ancestor
92876849|NCT02642484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876850|NCT00639392|Zoledronic Acid|zoledronic acid|mesh-list
92876851|NCT00639392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92876852|NCT00639392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876853|NCT04185350|Exenatide|exenatide|mesh-list
92876854|NCT04185350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92876855|NCT04185350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876856|NCT04185350|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92876857|NCT04185350|Incretins|incretins|mesh-ancestor
92876858|NCT04185350|Hormones|hormones|mesh-ancestor
92876859|NCT04185350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92876860|NCT00653172|Streptogramin A|streptogramin a|mesh-list
92876861|NCT00653172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876862|NCT00653172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876863|NCT02639520|Fosfomycin|fosfomycin|mesh-list
92876864|NCT02639520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876865|NCT02639520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876866|NCT02822729|Timolol|timolol|mesh-list
92876867|NCT02822729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92876868|NCT02822729|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92876869|NCT02822729|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92876870|NCT02822729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92876871|NCT02822729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92876872|NCT02822729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876873|NCT02822729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876874|NCT02822729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876875|NCT02822729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92876876|NCT02822729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92876877|NCT02642250|Metronidazole|metronidazole|mesh-list
92876878|NCT02642250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876879|NCT02642250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876880|NCT02642250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92876881|NCT02642250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92876882|NCT00653250|Celecoxib|celecoxib|mesh-list
92876883|NCT00653250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876884|NCT00653250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876885|NCT00653250|Analgesics|analgesics|mesh-ancestor
92876886|NCT00653250|Sensory System Agents|sensory system agents|mesh-ancestor
92876887|NCT00653250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876888|NCT00653250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876889|NCT00653250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876890|NCT00653250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876891|NCT00653250|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92876892|NCT00653250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876893|NCT00653250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876894|NCT00653250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876895|NCT00638534|Telithromycin|telithromycin|mesh-list
92876896|NCT00638534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876897|NCT00638534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876898|NCT04240535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92876899|NCT04240535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92876900|NCT04240535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92876901|NCT04240535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876902|NCT04240535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876903|NCT04240535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92876904|NCT04240535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876905|NCT04240535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876906|NCT04240535|Cholinergic Agents|cholinergic agents|mesh-ancestor
92876907|NCT04240535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876908|NCT02638896|Sulfasalazine|sulfasalazine|mesh-list
92876909|NCT02638896|Celecoxib|celecoxib|mesh-list
92876910|NCT02638896|Etanercept|etanercept|mesh-list
92876911|NCT02638896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876912|NCT02638896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876913|NCT02638896|Analgesics|analgesics|mesh-ancestor
92876914|NCT02638896|Sensory System Agents|sensory system agents|mesh-ancestor
92876915|NCT02638896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876916|NCT02638896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876917|NCT02638896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876918|NCT02638896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876919|NCT02638896|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92876920|NCT02638896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876921|NCT02638896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876922|NCT02638896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876923|NCT02638896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92876924|NCT02638896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92876925|NCT02638896|Immunologic Factors|immunologic factors|mesh-ancestor
92876927|NCT04240223|Brilacidin|brilacidin|mesh-list
92876928|NCT04240223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876929|NCT00653406|Risperidone|risperidone|mesh-list
92876930|NCT00653406|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92876931|NCT00653406|Serotonin Agents|serotonin agents|mesh-ancestor
92876932|NCT00653406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876933|NCT00653406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876934|NCT00653406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876935|NCT00653406|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92876936|NCT00653406|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92876937|NCT00653406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876938|NCT00653406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92876939|NCT00653406|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92876940|NCT00653406|Dopamine Agents|dopamine agents|mesh-ancestor
92876941|NCT00638612|Valacyclovir|valacyclovir|mesh-list
92876942|NCT00638612|Antiviral Agents|antiviral agents|mesh-ancestor
92876943|NCT00638612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876944|NCT00655200|Insulin Detemir|insulin detemir|mesh-list
92876945|NCT00655200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92876946|NCT00655200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876947|NCT04239755|Doxycycline|doxycycline|mesh-list
92876948|NCT04239755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92876949|NCT04239755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92876950|NCT04239755|Antimalarials|antimalarials|mesh-ancestor
92876951|NCT04239755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92876952|NCT04239755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92876953|NCT04185194|Lidocaine|lidocaine|mesh-list
92876954|NCT04185194|Anesthetics, Local|anesthetics, local|mesh-ancestor
92876955|NCT04185194|Anesthetics|anesthetics|mesh-ancestor
92876956|NCT04185194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92876957|NCT04185194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876958|NCT04185194|Sensory System Agents|sensory system agents|mesh-ancestor
92876959|NCT04185194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876960|NCT04185194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92876961|NCT04185194|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92876962|NCT04185194|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92876963|NCT04185194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876964|NCT04185194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876965|NCT00876447|Botulinum Toxins|botulinum toxins|mesh-list
92876966|NCT00876447|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92876967|NCT00876447|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92876968|NCT00876447|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92876969|NCT00876447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92876970|NCT00876447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876971|NCT00876447|Cholinergic Agents|cholinergic agents|mesh-ancestor
92876972|NCT00876447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92876973|NCT00876447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876974|NCT00876447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92876975|NCT00876447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876976|NCT04239833|Gefitinib|gefitinib|mesh-list
92876977|NCT04239833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876978|NCT04239833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92876979|NCT04239833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876980|NCT04239833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522236|NCT00113737|Fluoxetine|fluoxetine|mesh-list
92876982|NCT03513770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92876983|NCT03513770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92876984|NCT03513770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92876985|NCT03513770|Analgesics|analgesics|mesh-ancestor
92876986|NCT03513770|Sensory System Agents|sensory system agents|mesh-ancestor
92876987|NCT03513770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92876988|NCT03513770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92876989|NCT03513770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92876990|NCT03513770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92876991|NCT03513770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92876992|NCT03513770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92876993|NCT03513770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92876994|NCT02638740|Mechlorethamine|mechlorethamine|mesh-list
92876995|NCT02638740|Alkylating Agents|alkylating agents|mesh-ancestor
92876996|NCT02638740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525368|NCT00395239|Autonomic Agents|autonomic agents|mesh-ancestor
92876997|NCT02638740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92876998|NCT02638740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92876999|NCT02823977|Dexmedetomidine|dexmedetomidine|mesh-list
92877000|NCT02823977|Ketamine|ketamine|mesh-list
92877001|NCT02823977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92877002|NCT02823977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877003|NCT02823977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877004|NCT02823977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877005|NCT02823977|Analgesics|analgesics|mesh-ancestor
92877006|NCT02823977|Sensory System Agents|sensory system agents|mesh-ancestor
92877007|NCT02823977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877008|NCT02823977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92877009|NCT02823977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92877010|NCT02823977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877011|NCT02823977|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877012|NCT02823977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877013|NCT02823977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877014|NCT02823977|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92877015|NCT02823977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92877016|NCT02823977|Anesthetics, General|anesthetics, general|mesh-ancestor
92877017|NCT02823977|Anesthetics|anesthetics|mesh-ancestor
92877018|NCT02823977|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92877019|NCT02823977|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92877020|NCT00680511|Methamphetamine|methamphetamine|mesh-list
92877021|NCT00680511|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92877022|NCT00680511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877023|NCT00680511|Sympathomimetics|sympathomimetics|mesh-ancestor
92877024|NCT00680511|Autonomic Agents|autonomic agents|mesh-ancestor
92877025|NCT00680511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877026|NCT00680511|Dopamine Agents|dopamine agents|mesh-ancestor
92877027|NCT00680511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877028|NCT00680511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877029|NCT00680511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877030|NCT00680511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92877031|NCT00680511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92877032|NCT00680511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877033|NCT00680511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92877034|NCT00654576|Olanzapine|olanzapine|mesh-list
92877035|NCT00654576|Chlorpromazine|chlorpromazine|mesh-list
92877036|NCT00654576|Risperidone|risperidone|mesh-list
92877037|NCT00654576|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92877038|NCT00654576|Clozapine|clozapine|mesh-list
92877039|NCT00654576|Sulpiride|sulpiride|mesh-list
92877040|NCT00654576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92877041|NCT00654576|Serotonin Agents|serotonin agents|mesh-ancestor
92877042|NCT00654576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877043|NCT00654576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877044|NCT00654576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877045|NCT00654576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92877046|NCT00654576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92877047|NCT00654576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877048|NCT00654576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92877049|NCT00654576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92877050|NCT00654576|Dopamine Agents|dopamine agents|mesh-ancestor
92877051|NCT00654576|Antiemetics|antiemetics|mesh-ancestor
92877052|NCT00654576|Autonomic Agents|autonomic agents|mesh-ancestor
92877053|NCT00654576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877054|NCT00654576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877055|NCT00654576|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92877056|NCT00654576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92877057|NCT00654576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877058|NCT00654576|Antidepressive Agents|antidepressive agents|mesh-ancestor
92877059|NCT00654576|GABA Antagonists|gaba antagonists|mesh-ancestor
92877060|NCT00654576|GABA Agents|gaba agents|mesh-ancestor
92877061|NCT00654576|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92877062|NCT00622622|Gemcitabine|gemcitabine|mesh-list
92877063|NCT00622622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877064|NCT00622622|Antimetabolites|antimetabolites|mesh-ancestor
92877065|NCT00622622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877066|NCT00622622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877067|NCT00598650|Donepezil|donepezil|mesh-list
92877068|NCT00598650|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92877069|NCT00598650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877070|NCT00598650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877071|NCT00598650|Cholinergic Agents|cholinergic agents|mesh-ancestor
92877072|NCT00598650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877073|NCT00598650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877074|NCT00598650|Nootropic Agents|nootropic agents|mesh-ancestor
92877075|NCT04150731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92877076|NCT04150731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92877077|NCT04150731|Estradiol|estradiol|mesh-list
92877078|NCT04150731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92877079|NCT04150731|Estrogens|estrogens|mesh-ancestor
92877080|NCT04150731|Hormones|hormones|mesh-ancestor
92877081|NCT04150731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877082|NCT04150731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877083|NCT04150731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92877084|NCT04150731|Contraceptive Agents|contraceptive agents|mesh-ancestor
92877085|NCT04150731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877086|NCT04150731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92877087|NCT02641938|Dexmedetomidine|dexmedetomidine|mesh-list
92877088|NCT02641938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92877089|NCT02641938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877090|NCT02641938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877091|NCT02641938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877092|NCT02641938|Analgesics|analgesics|mesh-ancestor
92877093|NCT02641938|Sensory System Agents|sensory system agents|mesh-ancestor
92877094|NCT02641938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877095|NCT02641938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92877096|NCT02641938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92877097|NCT02641938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877098|NCT02641938|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877099|NCT02641938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877100|NCT02641938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877101|NCT04249076|Clobetasol|clobetasol|mesh-list
92877102|NCT04249076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877103|NCT04249076|Glucocorticoids|glucocorticoids|mesh-ancestor
92877104|NCT04249076|Hormones|hormones|mesh-ancestor
92877105|NCT04249076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877106|NCT04249076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877107|NCT00681135|Olaflur|olaflur|mesh-list
92877108|NCT00681135|Cariostatic Agents|cariostatic agents|mesh-ancestor
92877109|NCT00681135|Protective Agents|protective agents|mesh-ancestor
92877110|NCT00681135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877111|NCT02821559|Bevacizumab|bevacizumab|mesh-list
92877112|NCT02821559|Oxaliplatin|oxaliplatin|mesh-list
92877113|NCT02821559|Raltitrexed|raltitrexed|mesh-list
92877114|NCT02821559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877115|NCT02821559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877116|NCT02821559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92877117|NCT02821559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92877118|NCT02821559|Growth Substances|growth substances|mesh-ancestor
92877119|NCT02821559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877120|NCT02821559|Growth Inhibitors|growth inhibitors|mesh-ancestor
92877121|NCT02821559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877122|NCT02821559|Antimetabolites|antimetabolites|mesh-ancestor
92877123|NCT02821559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877124|NCT02821559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92877125|NCT02821559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877126|NCT00681213|Sirolimus|sirolimus|mesh-list
92877127|NCT00681213|Temsirolimus|temsirolimus|mesh-list
92877128|NCT00681213|MTOR Inhibitors|mtor inhibitors|mesh-list
92877129|NCT00681213|Tacrolimus|tacrolimus|mesh-list
92877130|NCT00681213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877131|NCT00681213|Immunologic Factors|immunologic factors|mesh-ancestor
92877132|NCT00681213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877133|NCT00681213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92877134|NCT00681213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877135|NCT00681213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877136|NCT00681213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92877137|NCT00681213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877138|NCT00681213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92877139|NCT00681213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877140|NCT00681213|Antifungal Agents|antifungal agents|mesh-ancestor
92877141|NCT00681213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92877143|NCT02638506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92877144|NCT02638506|Narcotics|narcotics|mesh-ancestor
92877145|NCT02638506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877146|NCT02638506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877147|NCT02638506|Analgesics|analgesics|mesh-ancestor
92877148|NCT02638506|Sensory System Agents|sensory system agents|mesh-ancestor
92877149|NCT02638506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877150|NCT02638506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92877151|NCT02638506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92877152|NCT02638506|Anesthetics, General|anesthetics, general|mesh-ancestor
92877153|NCT02638506|Anesthetics|anesthetics|mesh-ancestor
92877154|NCT04745975|Paclitaxel|paclitaxel|mesh-list
92877155|NCT04745975|Vinorelbine|vinorelbine|mesh-list
92877156|NCT04745975|Gemcitabine|gemcitabine|mesh-list
92877157|NCT04745975|Capecitabine|capecitabine|mesh-list
92877158|NCT04745975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877159|NCT04745975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877160|NCT04745975|Tubulin Modulators|tubulin modulators|mesh-ancestor
92877161|NCT04745975|Antimitotic Agents|antimitotic agents|mesh-ancestor
92877162|NCT04745975|Mitosis Modulators|mitosis modulators|mesh-ancestor
92877163|NCT04745975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877164|NCT04745975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877165|NCT04745975|Antimetabolites|antimetabolites|mesh-ancestor
92877166|NCT04150107|Insulin|insulin|mesh-list
92877167|NCT04150107|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92877168|NCT04150107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92877169|NCT04150107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877170|NCT02638428|Cytarabine|cytarabine|mesh-list
92877171|NCT02638428|Carboplatin|carboplatin|mesh-list
92877172|NCT02638428|Trastuzumab|trastuzumab|mesh-list
92877173|NCT02638428|Fludarabine|fludarabine|mesh-list
92877174|NCT02638428|Etoposide|etoposide|mesh-list
92877175|NCT02638428|Everolimus|everolimus|mesh-list
92877176|NCT02638428|Sorafenib|sorafenib|mesh-list
92877177|NCT02638428|Dasatinib|dasatinib|mesh-list
92877178|NCT02638428|Ifosfamide|ifosfamide|mesh-list
92877179|NCT02638428|Axitinib|axitinib|mesh-list
92877180|NCT02638428|Vemurafenib|vemurafenib|mesh-list
92877181|NCT02638428|Crizotinib|crizotinib|mesh-list
92877182|NCT02638428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877183|NCT02638428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877184|NCT02638428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877185|NCT02638428|Antimetabolites|antimetabolites|mesh-ancestor
92877186|NCT02638428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877187|NCT02638428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877188|NCT02638428|Immunologic Factors|immunologic factors|mesh-ancestor
92877189|NCT02638428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877190|NCT02638428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877191|NCT02638428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877192|NCT02638428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877193|NCT02638428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877194|NCT02638428|Antiviral Agents|antiviral agents|mesh-ancestor
92877195|NCT02638428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877196|NCT02638428|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92877197|NCT02638428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92877198|NCT02638428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92877199|NCT02638428|Alkylating Agents|alkylating agents|mesh-ancestor
92877200|NCT01003964|Cisplatin|cisplatin|mesh-list
92877201|NCT01003964|Gemcitabine|gemcitabine|mesh-list
92877202|NCT01003964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877203|NCT01003964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877204|NCT01003964|Antimetabolites|antimetabolites|mesh-ancestor
92877205|NCT01003964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522466|NCT00115024|Estradiol|estradiol|mesh-list
92877206|NCT02823743|Aspirin|aspirin|mesh-list
92877207|NCT02823743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92877208|NCT02823743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877209|NCT02823743|Analgesics|analgesics|mesh-ancestor
92877210|NCT02823743|Sensory System Agents|sensory system agents|mesh-ancestor
92877211|NCT02823743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877212|NCT02823743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877213|NCT02823743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877214|NCT02823743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221842|NCT03797872|Glucocorticoids|glucocorticoids|mesh-ancestor
92877216|NCT02823743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92877217|NCT02823743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159910|NCT00678327|Alkylating Agents|alkylating agents|mesh-ancestor
92877218|NCT02823743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92877219|NCT02823743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92877220|NCT02823743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877221|NCT02823743|Antipyretics|antipyretics|mesh-ancestor
92877222|NCT00654888|Mitomycins|mitomycins|mesh-list
92877223|NCT00654888|Mitomycin|mitomycin|mesh-list
92877224|NCT00654888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92877225|NCT00654888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877226|NCT00654888|Alkylating Agents|alkylating agents|mesh-ancestor
92877227|NCT00654888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877228|NCT00654888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92877229|NCT00654888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877230|NCT05299203|Verapamil|verapamil|mesh-list
92877231|NCT05299203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92877232|NCT05299203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92877233|NCT05299203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877234|NCT05299203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877235|NCT05299203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92877236|NCT05299203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877237|NCT05299203|Vasodilator Agents|vasodilator agents|mesh-ancestor
92877238|NCT02638584|Rabeprazole|rabeprazole|mesh-list
92877239|NCT02638584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92877240|NCT02638584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877241|NCT02638584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92877242|NCT02638584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877243|NCT02638584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877244|NCT04208516|Dexamethasone|dexamethasone|mesh-list
92877245|NCT04208516|Lidocaine|lidocaine|mesh-list
92877246|NCT04208516|Dexmedetomidine|dexmedetomidine|mesh-list
92877247|NCT04208516|Ropivacaine|ropivacaine|mesh-list
92877248|NCT04208516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877249|NCT04208516|Antiemetics|antiemetics|mesh-ancestor
92877250|NCT04208516|Autonomic Agents|autonomic agents|mesh-ancestor
92877251|NCT04208516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877252|NCT04208516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877253|NCT04208516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877254|NCT04208516|Glucocorticoids|glucocorticoids|mesh-ancestor
92877255|NCT04208516|Hormones|hormones|mesh-ancestor
92877256|NCT04208516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877257|NCT04208516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92877258|NCT04208516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877259|NCT04208516|Anesthetics, Local|anesthetics, local|mesh-ancestor
92877260|NCT04208516|Anesthetics|anesthetics|mesh-ancestor
92877261|NCT04208516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877262|NCT04208516|Sensory System Agents|sensory system agents|mesh-ancestor
92877263|NCT04208516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92877264|NCT04208516|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92877265|NCT04208516|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92877266|NCT04208516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877267|NCT04208516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877268|NCT04208516|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92877269|NCT04208516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877270|NCT04208516|Analgesics|analgesics|mesh-ancestor
92877271|NCT04208516|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92877272|NCT04208516|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92877273|NCT04208516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877274|NCT04208516|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877275|NCT04208516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877276|NCT02821169|Ropivacaine|ropivacaine|mesh-list
92877277|NCT02821169|Anesthetics, Local|anesthetics, local|mesh-ancestor
92877278|NCT02821169|Anesthetics|anesthetics|mesh-ancestor
92877279|NCT02821169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877280|NCT02821169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877281|NCT02821169|Sensory System Agents|sensory system agents|mesh-ancestor
92877282|NCT02821169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877283|NCT02820935|Itraconazole|itraconazole|mesh-list
92877284|NCT02820935|Rifampin|rifampin|mesh-list
92877285|NCT02820935|Antifungal Agents|antifungal agents|mesh-ancestor
92877286|NCT02820935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877287|NCT02820935|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92877288|NCT02820935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92877289|NCT02820935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877290|NCT02820935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877291|NCT02820935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92877292|NCT02820935|Hormone Antagonists|hormone antagonists|mesh-ancestor
92877293|NCT02820935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877294|NCT02820935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877295|NCT02820935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92877296|NCT02820935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92877297|NCT02820935|Antitubercular Agents|antitubercular agents|mesh-ancestor
92877298|NCT02820935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92877299|NCT02820935|Leprostatic Agents|leprostatic agents|mesh-ancestor
92877300|NCT02820935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92877301|NCT02820935|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92877302|NCT02820935|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92877303|NCT02820935|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92877304|NCT02820935|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92877305|NCT02820935|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92877306|NCT02820935|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92877307|NCT02626845|Rituximab|rituximab|mesh-list
92877308|NCT02626845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877309|NCT02626845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877310|NCT02626845|Immunologic Factors|immunologic factors|mesh-ancestor
92877311|NCT02626845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877312|NCT02626845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877313|NCT02821247|Aflibercept|aflibercept|mesh-list
92877314|NCT02821247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92877315|NCT02821247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92877316|NCT02821247|Growth Substances|growth substances|mesh-ancestor
92877317|NCT02821247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877318|NCT02821247|Growth Inhibitors|growth inhibitors|mesh-ancestor
92877319|NCT02821247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877320|NCT00681525|Atorvastatin|atorvastatin|mesh-list
92877321|NCT00681525|Ezetimibe|ezetimibe|mesh-list
92877322|NCT00681525|Fenofibric acid|fenofibric acid|mesh-list
92877323|NCT00681525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92877324|NCT00681525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92877325|NCT00681525|Antimetabolites|antimetabolites|mesh-ancestor
92877326|NCT00681525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877327|NCT00681525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92877328|NCT00681525|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92877329|NCT00681525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877330|NCT00681603|Bevacizumab|bevacizumab|mesh-list
92877331|NCT00681603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877332|NCT00681603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877333|NCT00681603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92877334|NCT00681603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92877335|NCT00681603|Growth Substances|growth substances|mesh-ancestor
92877336|NCT00681603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877337|NCT00681603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92877338|NCT04239443|Apatinib|apatinib|mesh-list
92877339|NCT04239443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92877340|NCT04239443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877341|NCT04239443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92877342|NCT04239443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877343|NCT04239443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877344|NCT04239443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877345|NCT04200599|Oxytocin|oxytocin|mesh-list
92877346|NCT04200599|Oxytocics|oxytocics|mesh-ancestor
92877347|NCT04200599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877348|NCT04200599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877349|NCT02820077|Hemostatics|hemostatics|mesh-list
92877350|NCT02820077|Coagulants|coagulants|mesh-ancestor
92877351|NCT00681993|Cyclophosphamide|cyclophosphamide|mesh-list
92877352|NCT00681993|Carboplatin|carboplatin|mesh-list
92877353|NCT00681993|Docetaxel|docetaxel|mesh-list
92877354|NCT00681993|Trastuzumab|trastuzumab|mesh-list
92877355|NCT00681993|Doxorubicin|doxorubicin|mesh-list
92877356|NCT00681993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92877357|NCT00681993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877358|NCT00681993|Immunologic Factors|immunologic factors|mesh-ancestor
92877359|NCT00681993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877360|NCT00681993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877361|NCT00681993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92877362|NCT00681993|Alkylating Agents|alkylating agents|mesh-ancestor
92877363|NCT00681993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877364|NCT00681993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877365|NCT00681993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92877366|NCT00681993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92877367|NCT00681993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92877368|NCT00681993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92877369|NCT00681993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877370|NCT00681993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92877371|NCT00681993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877372|NCT00681993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877373|NCT00681993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877374|NCT02819999|Etoposide|etoposide|mesh-list
92877375|NCT02819999|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92877376|NCT02819999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877377|NCT02819999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877378|NCT02819999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877379|NCT02819999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877380|NCT02819999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877381|NCT02819999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877382|NCT02819999|Immunoconjugates|immunoconjugates|mesh-ancestor
92877383|NCT02819999|Immunologic Factors|immunologic factors|mesh-ancestor
92877384|NCT02819999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877385|NCT04173494|Danazol|danazol|mesh-list
92877386|NCT04173494|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92877387|NCT04173494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92877388|NCT04173494|Hormone Antagonists|hormone antagonists|mesh-ancestor
92877389|NCT04173494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877390|NCT04173494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877391|NCT04173494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92877392|NCT04173494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877393|NCT04173494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877394|NCT02819921|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92877395|NCT02819921|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92877396|NCT02819921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92877397|NCT02819921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877398|NCT02819921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877399|NCT02819921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877400|NCT02819921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877401|NCT02819921|Antidepressive Agents|antidepressive agents|mesh-ancestor
92877402|NCT02819921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92877403|NCT00875979|Trastuzumab|trastuzumab|mesh-list
92877404|NCT00875979|Pertuzumab|pertuzumab|mesh-list
92877405|NCT00875979|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92877406|NCT00875979|Maytansine|maytansine|mesh-list
92877407|NCT00875979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92877408|NCT00875979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877409|NCT00875979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877410|NCT00875979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92877411|NCT00875979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92877412|NCT00875979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92877413|NCT00875979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877414|NCT00875979|Immunotoxins|immunotoxins|mesh-ancestor
92877415|NCT00875979|Immunoconjugates|immunoconjugates|mesh-ancestor
92877416|NCT00875979|Immunologic Factors|immunologic factors|mesh-ancestor
92877417|NCT00875979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877418|NCT02818751|Escitalopram|escitalopram|mesh-list
92877419|NCT02818751|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92877420|NCT02818751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92877421|NCT02818751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877422|NCT02818751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877423|NCT02818751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877424|NCT02818751|Serotonin Agents|serotonin agents|mesh-ancestor
92877425|NCT02818751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877426|NCT04238975|Vaccines|vaccines|mesh-list
92877427|NCT04238975|Immunologic Factors|immunologic factors|mesh-ancestor
92877428|NCT04238975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877430|NCT00602420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92877431|NCT00602420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877432|NCT00602420|Analgesics|analgesics|mesh-ancestor
92877433|NCT00602420|Sensory System Agents|sensory system agents|mesh-ancestor
92877434|NCT00602420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877435|NCT00602420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877436|NCT00602420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877437|NCT00602420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877438|NCT00602420|Gout Suppressants|gout suppressants|mesh-ancestor
92877439|NCT00602420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92877440|NCT00602420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877441|NCT00602420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877442|NCT04635605|Methylene Blue|methylene blue|mesh-list
92877443|NCT04635605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877444|NCT04635605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877445|NCT02688374|Nicotine|nicotine|mesh-list
92877446|NCT02688374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92877447|NCT02688374|Autonomic Agents|autonomic agents|mesh-ancestor
92877448|NCT02688374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877449|NCT02688374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877450|NCT02688374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92877451|NCT02688374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92877452|NCT02688374|Cholinergic Agents|cholinergic agents|mesh-ancestor
92877453|NCT02688374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877454|NCT02688374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877455|NCT02819375|Ketamine|ketamine|mesh-list
92877456|NCT02819375|Remifentanil|remifentanil|mesh-list
92877457|NCT02819375|Propofol|propofol|mesh-list
92877458|NCT02819375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92877459|NCT02819375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877460|NCT02819375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877461|NCT02819375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92877462|NCT02819375|Anesthetics, General|anesthetics, general|mesh-ancestor
92877463|NCT02819375|Anesthetics|anesthetics|mesh-ancestor
92877464|NCT02819375|Analgesics|analgesics|mesh-ancestor
92877465|NCT02819375|Sensory System Agents|sensory system agents|mesh-ancestor
92877466|NCT02819375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877467|NCT02819375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92877468|NCT02819375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92877469|NCT02819375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92877470|NCT02819375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877471|NCT02819375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877472|NCT02819375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92877473|NCT02819375|Narcotics|narcotics|mesh-ancestor
92877474|NCT02818985|Dexamethasone|dexamethasone|mesh-list
92877475|NCT02818985|Dexmedetomidine|dexmedetomidine|mesh-list
92877476|NCT02818985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877477|NCT02818985|Antiemetics|antiemetics|mesh-ancestor
92877478|NCT02818985|Autonomic Agents|autonomic agents|mesh-ancestor
92877479|NCT02818985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877480|NCT02818985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877481|NCT02818985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877482|NCT02818985|Glucocorticoids|glucocorticoids|mesh-ancestor
92877483|NCT02818985|Hormones|hormones|mesh-ancestor
92877484|NCT02818985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877485|NCT02818985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92877486|NCT02818985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877487|NCT02818985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92877488|NCT02818985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877489|NCT02818985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877490|NCT02818985|Analgesics|analgesics|mesh-ancestor
92877491|NCT02818985|Sensory System Agents|sensory system agents|mesh-ancestor
92877492|NCT02818985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92877493|NCT02818985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92877494|NCT02818985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877495|NCT02818985|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877496|NCT02818985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877497|NCT02818985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877498|NCT03362060|Pembrolizumab|pembrolizumab|mesh-list
92877499|NCT03362060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522772|NCT00008528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92877500|NCT03362060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877501|NCT03362060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92877502|NCT03362060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877504|NCT02815787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92877505|NCT02815787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877506|NCT00639938|Nevirapine|nevirapine|mesh-list
92877507|NCT00639938|Immunoglobulins|immunoglobulins|mesh-list
92877508|NCT00639938|Antibodies|antibodies|mesh-list
92877509|NCT00639938|gamma-Globulins|gamma-globulins|mesh-list
92877510|NCT00639938|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92877511|NCT00639938|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92877512|NCT00639938|Immunologic Factors|immunologic factors|mesh-ancestor
92877513|NCT00639938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877514|NCT00639938|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92877515|NCT00639938|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92877516|NCT00639938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877517|NCT00639938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877518|NCT00639938|Antiviral Agents|antiviral agents|mesh-ancestor
92877519|NCT00639938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877520|NCT00639938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92877521|NCT00639938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92877522|NCT00639938|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92877523|NCT00639938|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92877524|NCT02815319|Dexamethasone|dexamethasone|mesh-list
92877525|NCT02815319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877526|NCT02815319|Antiemetics|antiemetics|mesh-ancestor
92877527|NCT02815319|Autonomic Agents|autonomic agents|mesh-ancestor
92877528|NCT02815319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877529|NCT02815319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877530|NCT02815319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877531|NCT02815319|Glucocorticoids|glucocorticoids|mesh-ancestor
92877532|NCT02815319|Hormones|hormones|mesh-ancestor
92877533|NCT02815319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877534|NCT02815319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92877535|NCT02815319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877536|NCT02815475|Curcumin|curcumin|mesh-list
92877537|NCT02815475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92877538|NCT02815475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877539|NCT02815475|Analgesics|analgesics|mesh-ancestor
92877540|NCT02815475|Sensory System Agents|sensory system agents|mesh-ancestor
92877541|NCT02815475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877542|NCT02815475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877543|NCT02815475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877544|NCT02815475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877545|NCT02815475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877546|NCT02815475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877547|NCT02815475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877548|NCT00640796|Aldesleukin|aldesleukin|mesh-list
92877549|NCT00640796|Cyclophosphamide|cyclophosphamide|mesh-list
92877550|NCT00640796|Fludarabine|fludarabine|mesh-list
92877551|NCT00640796|Interleukin-2|interleukin-2|mesh-list
92877552|NCT00640796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877553|NCT00640796|Immunologic Factors|immunologic factors|mesh-ancestor
92877554|NCT00640796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877555|NCT00640796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877556|NCT00640796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92877557|NCT00640796|Alkylating Agents|alkylating agents|mesh-ancestor
92877558|NCT00640796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877559|NCT00640796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877560|NCT00640796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92877561|NCT00640796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877562|NCT00640796|Analgesics|analgesics|mesh-ancestor
92877563|NCT00640796|Sensory System Agents|sensory system agents|mesh-ancestor
92877564|NCT00640796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877565|NCT00640796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92877566|NCT00640796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92877567|NCT00640796|Antiviral Agents|antiviral agents|mesh-ancestor
92877568|NCT00640796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877569|NCT02687984|Risperidone|risperidone|mesh-list
92877570|NCT02687984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92877571|NCT02687984|Serotonin Agents|serotonin agents|mesh-ancestor
92877572|NCT02687984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877573|NCT02687984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877574|NCT02687984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877575|NCT02687984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92877577|NCT02687984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877578|NCT02687984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92877579|NCT02687984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92877580|NCT02687984|Dopamine Agents|dopamine agents|mesh-ancestor
92877581|NCT05657873|Immunomodulating Agents|immunomodulating agents|mesh-list
92877582|NCT05657873|Immunologic Factors|immunologic factors|mesh-ancestor
92877583|NCT05657873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877584|NCT02683148|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92877585|NCT02683148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92877586|NCT02683148|Immunologic Factors|immunologic factors|mesh-ancestor
92877587|NCT02683148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877589|NCT02684786|Reserpine|reserpine|mesh-list
92877590|NCT02684786|Anesthetics, Local|anesthetics, local|mesh-ancestor
92877591|NCT02684786|Anesthetics|anesthetics|mesh-ancestor
92877592|NCT02684786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877593|NCT02684786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877594|NCT02684786|Sensory System Agents|sensory system agents|mesh-ancestor
92877595|NCT02684786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877596|NCT02684786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92877597|NCT02684786|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92877598|NCT02684786|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92877599|NCT02684786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877600|NCT02684786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877601|NCT02684786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92877602|NCT02684786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92877603|NCT02684786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92877604|NCT02684786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92877605|NCT02684786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92877606|NCT02684786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92877607|NCT02684786|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877608|NCT02684786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877609|NCT02683070|Tramadol|tramadol|mesh-list
92877610|NCT02683070|Ropivacaine|ropivacaine|mesh-list
92877611|NCT02683070|Anesthetics, Local|anesthetics, local|mesh-ancestor
92877612|NCT02683070|Anesthetics|anesthetics|mesh-ancestor
92877613|NCT02683070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877614|NCT02683070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877615|NCT02683070|Sensory System Agents|sensory system agents|mesh-ancestor
92877616|NCT02683070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877617|NCT02683070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92877618|NCT02683070|Narcotics|narcotics|mesh-ancestor
92877619|NCT02683070|Analgesics|analgesics|mesh-ancestor
92877620|NCT02685176|Charcoal|charcoal|mesh-list
92877621|NCT02685176|Antidotes|antidotes|mesh-ancestor
92877622|NCT02685176|Protective Agents|protective agents|mesh-ancestor
92877623|NCT02685176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877624|NCT05664074|Ketorolac|ketorolac|mesh-list
92877625|NCT05664074|Indomethacin|indomethacin|mesh-list
92877626|NCT05664074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92877627|NCT05664074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877628|NCT05664074|Analgesics|analgesics|mesh-ancestor
92877629|NCT05664074|Sensory System Agents|sensory system agents|mesh-ancestor
92877630|NCT05664074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877631|NCT05664074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877632|NCT05664074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877633|NCT05664074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877634|NCT05664074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92877635|NCT05664074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877636|NCT05664074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877637|NCT05664074|Gout Suppressants|gout suppressants|mesh-ancestor
92877638|NCT05664074|Tocolytic Agents|tocolytic agents|mesh-ancestor
92877639|NCT05664074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877640|NCT00634205|Doxorubicin|doxorubicin|mesh-list
92877641|NCT00634205|Valproic Acid|valproic acid|mesh-list
92877642|NCT00634205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92877643|NCT00634205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877644|NCT00634205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877645|NCT00634205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877646|NCT00634205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877647|NCT00634205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877648|NCT00634205|Anticonvulsants|anticonvulsants|mesh-ancestor
92877649|NCT00634205|GABA Agents|gaba agents|mesh-ancestor
92877650|NCT00634205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877651|NCT00634205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877652|NCT00634205|Antimanic Agents|antimanic agents|mesh-ancestor
92877653|NCT00634205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92877654|NCT00634205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877655|NCT00634205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92877656|NCT04238195|Moxifloxacin|moxifloxacin|mesh-list
92877657|NCT04238195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92877658|NCT04238195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877659|NCT04238195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877660|NCT04238195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877661|NCT04238195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877662|NCT04238195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877663|NCT04238195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877664|NCT02818049|Dimercaprol|dimercaprol|mesh-list
92877665|NCT02818049|Chelating Agents|chelating agents|mesh-ancestor
92877666|NCT02818049|Sequestering Agents|sequestering agents|mesh-ancestor
92877667|NCT02818049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877668|NCT02684708|Prednisone|prednisone|mesh-list
92877669|NCT02684708|Cyclophosphamide|cyclophosphamide|mesh-list
92877670|NCT02684708|Dacarbazine|dacarbazine|mesh-list
92877671|NCT02684708|Vincristine|vincristine|mesh-list
92877672|NCT02684708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877673|NCT02684708|Immunologic Factors|immunologic factors|mesh-ancestor
92877674|NCT02684708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877675|NCT02684708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877676|NCT02684708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92877677|NCT02684708|Alkylating Agents|alkylating agents|mesh-ancestor
92877678|NCT02684708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877679|NCT02684708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877680|NCT02684708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92877681|NCT02684708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877682|NCT02684708|Glucocorticoids|glucocorticoids|mesh-ancestor
92877683|NCT02684708|Hormones|hormones|mesh-ancestor
92877684|NCT02684708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877685|NCT02684708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92877686|NCT02684708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877687|NCT02684708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92877688|NCT02684708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92877689|NCT02684708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92877690|NCT02817503|Folic Acid|folic acid|mesh-list
92877691|NCT02817503|Vitamin B Complex|vitamin b complex|mesh-list
92877692|NCT02817503|Amlodipine|amlodipine|mesh-list
92877693|NCT02817503|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92877694|NCT02817503|Enalapril|enalapril|mesh-list
92877695|NCT02817503|Enalaprilat|enalaprilat|mesh-list
92877696|NCT02817503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92877697|NCT02817503|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92877698|NCT02817503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877699|NCT02817503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877700|NCT02817503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92877701|NCT02817503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877702|NCT02817503|Vasodilator Agents|vasodilator agents|mesh-ancestor
92877703|NCT02817503|Hematinics|hematinics|mesh-ancestor
92877704|NCT02817503|Vitamins|vitamins|mesh-ancestor
92877705|NCT02817503|Micronutrients|micronutrients|mesh-ancestor
92877706|NCT02817503|Diuretics|diuretics|mesh-ancestor
92877707|NCT02817503|Natriuretic Agents|natriuretic agents|mesh-ancestor
92877708|NCT02817503|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92877709|NCT02817503|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92877710|NCT02817503|Protease Inhibitors|protease inhibitors|mesh-ancestor
92877711|NCT02817503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877712|NCT02814461|Axitinib|axitinib|mesh-list
92877713|NCT02814461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877714|NCT02814461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92877715|NCT02814461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877716|NCT02814461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877717|NCT00875667|Fludarabine|fludarabine|mesh-list
92877718|NCT00875667|Fludarabine phosphate|fludarabine phosphate|mesh-list
92877719|NCT00875667|Lenalidomide|lenalidomide|mesh-list
92877720|NCT00875667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877721|NCT00875667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877722|NCT00875667|Antimetabolites|antimetabolites|mesh-ancestor
92877723|NCT00875667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877724|NCT00875667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877725|NCT00875667|Immunologic Factors|immunologic factors|mesh-ancestor
92877726|NCT00875667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877727|NCT00875667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92877728|NCT00875667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92877729|NCT00875667|Growth Substances|growth substances|mesh-ancestor
92877730|NCT00875667|Growth Inhibitors|growth inhibitors|mesh-ancestor
92877731|NCT02811185|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92877732|NCT02811185|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92877733|NCT02811185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877734|NCT02811341|Scopolamine|scopolamine|mesh-list
92877735|NCT02811341|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92877736|NCT02811341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92877737|NCT02811341|Antiemetics|antiemetics|mesh-ancestor
92877738|NCT02811341|Autonomic Agents|autonomic agents|mesh-ancestor
92877739|NCT02811341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877740|NCT02811341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877741|NCT02811341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877742|NCT02811341|Mydriatics|mydriatics|mesh-ancestor
92877743|NCT02811341|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92877744|NCT02811341|Cholinergic Agents|cholinergic agents|mesh-ancestor
92877745|NCT02811341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877746|NCT02811341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877747|NCT02811341|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92877748|NCT02811341|Parasympatholytics|parasympatholytics|mesh-ancestor
92877749|NCT00682383|Docetaxel|docetaxel|mesh-list
92877750|NCT00682383|Etoposide|etoposide|mesh-list
92877751|NCT00682383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877752|NCT00682383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92877753|NCT00682383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92877754|NCT00682383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92877755|NCT00682383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877756|NCT00682383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877757|NCT00682383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877758|NCT00682383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877759|NCT00682383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877760|NCT04237493|Insulin|insulin|mesh-list
92877761|NCT04237493|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92877762|NCT04237493|Metformin|metformin|mesh-list
92877763|NCT04237493|Insulin Glargine|insulin glargine|mesh-list
92877764|NCT04237493|Glimepiride|glimepiride|mesh-list
92877765|NCT04237493|Vildagliptin|vildagliptin|mesh-list
92877766|NCT04237493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92877767|NCT04237493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877768|NCT04237493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92877769|NCT04237493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877770|NCT04237493|Immunologic Factors|immunologic factors|mesh-ancestor
92877771|NCT04237493|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92877772|NCT04237493|Protease Inhibitors|protease inhibitors|mesh-ancestor
92877773|NCT04237493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877774|NCT04237493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877775|NCT00683319|Cyclophosphamide|cyclophosphamide|mesh-list
92877776|NCT00683319|Carboplatin|carboplatin|mesh-list
92877777|NCT00683319|Methotrexate|methotrexate|mesh-list
92877778|NCT00683319|Vincristine|vincristine|mesh-list
92877779|NCT00683319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877780|NCT00683319|Immunologic Factors|immunologic factors|mesh-ancestor
92877781|NCT00683319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877782|NCT00683319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877783|NCT00683319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92877784|NCT00683319|Alkylating Agents|alkylating agents|mesh-ancestor
92877785|NCT00683319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877786|NCT00683319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877787|NCT00683319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92877788|NCT00683319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92877789|NCT00683319|Abortifacient Agents|abortifacient agents|mesh-ancestor
92159935|NCT00602667|Topotecan|topotecan|mesh-list
92877790|NCT00683319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877791|NCT00683319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92877792|NCT00683319|Antimetabolites|antimetabolites|mesh-ancestor
92877793|NCT00683319|Dermatologic Agents|dermatologic agents|mesh-ancestor
92877794|NCT00683319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877795|NCT00683319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92877796|NCT00683319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92877797|NCT00683319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92877798|NCT00683319|Tubulin Modulators|tubulin modulators|mesh-ancestor
92877799|NCT00683319|Antimitotic Agents|antimitotic agents|mesh-ancestor
92877800|NCT00683319|Mitosis Modulators|mitosis modulators|mesh-ancestor
92877801|NCT00634361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92877802|NCT00634361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92877803|NCT00634361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92877805|NCT02810483|Anticonvulsants|anticonvulsants|mesh-ancestor
92877806|NCT02810483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92877807|NCT02810483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877808|NCT00683865|Moxifloxacin|moxifloxacin|mesh-list
92877809|NCT00683865|Ofloxacin|ofloxacin|mesh-list
92877810|NCT00683865|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92877811|NCT00683865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92877812|NCT00683865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877813|NCT00683865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92877814|NCT00683865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92877815|NCT00683865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877816|NCT00683865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877817|NCT00683865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877818|NCT00683865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92877819|NCT00683865|Contraceptive Agents|contraceptive agents|mesh-ancestor
92877820|NCT00683865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877821|NCT00683865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877822|NCT00683865|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92877823|NCT00683865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92877824|NCT00683865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92877825|NCT00683865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92877826|NCT00683865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92877827|NCT00683865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92877828|NCT02813369|Naloxegol|naloxegol|mesh-list
92877829|NCT02813369|Laxatives|laxatives|mesh-list
92877830|NCT02813369|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92877831|NCT02813369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877832|NCT02813369|Sensory System Agents|sensory system agents|mesh-ancestor
92877833|NCT02813369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877834|NCT02813369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877835|NCT00683943|Lithium Carbonate|lithium carbonate|mesh-list
92877836|NCT00683943|Antidepressive Agents|antidepressive agents|mesh-ancestor
92877837|NCT00683943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92877838|NCT00683943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877839|NCT00683943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877840|NCT00683943|Antimanic Agents|antimanic agents|mesh-ancestor
92877841|NCT00683943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92877842|NCT00683943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877843|NCT00683943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877844|NCT02810015|Botulinum Toxins|botulinum toxins|mesh-list
92877845|NCT02810015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92877846|NCT02810015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92877847|NCT02810015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92877848|NCT02810015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877849|NCT02810015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877850|NCT02810015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92877851|NCT02810015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877852|NCT02810015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877853|NCT02810015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92877854|NCT02810015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877855|NCT02809781|Etanercept|etanercept|mesh-list
92877856|NCT02809781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92877857|NCT02809781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877858|NCT02809781|Analgesics|analgesics|mesh-ancestor
92877859|NCT02809781|Sensory System Agents|sensory system agents|mesh-ancestor
92877860|NCT02809781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877861|NCT02809781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877862|NCT02809781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877863|NCT02809781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877864|NCT02809781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92877865|NCT02809781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92877866|NCT02809781|Immunologic Factors|immunologic factors|mesh-ancestor
92877867|NCT02809937|Dexmedetomidine|dexmedetomidine|mesh-list
92877868|NCT02809937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92877869|NCT02809937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877870|NCT02809937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877871|NCT02809937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92877872|NCT02809937|Analgesics|analgesics|mesh-ancestor
92877873|NCT02809937|Sensory System Agents|sensory system agents|mesh-ancestor
92222526|NCT05604638|Tirofiban|tirofiban|mesh-list
92877874|NCT02809937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877875|NCT02809937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92877876|NCT02809937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92877877|NCT02809937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877878|NCT02809937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877879|NCT02809937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877880|NCT02809937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877881|NCT02812979|Albuterol|albuterol|mesh-list
92877882|NCT02812979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92877883|NCT02812979|Autonomic Agents|autonomic agents|mesh-ancestor
92877884|NCT02812979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877885|NCT02812979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877886|NCT02812979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92877887|NCT02812979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92877888|NCT02812979|Tocolytic Agents|tocolytic agents|mesh-ancestor
92877889|NCT02812979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877890|NCT02812979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92877891|NCT02812979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92877892|NCT02812979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877893|NCT02812979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877894|NCT02812979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877895|NCT02812979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877896|NCT02809469|Apixaban|apixaban|mesh-list
92877897|NCT02809469|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92877898|NCT02809469|Antithrombins|antithrombins|mesh-ancestor
92877899|NCT02809469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92877900|NCT02809469|Protease Inhibitors|protease inhibitors|mesh-ancestor
92877901|NCT02809469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877902|NCT02809469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877903|NCT02809469|Anticoagulants|anticoagulants|mesh-ancestor
92877904|NCT02809079|Mycophenolic Acid|mycophenolic acid|mesh-list
92877905|NCT02809079|Prednisone|prednisone|mesh-list
92877906|NCT02809079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877907|NCT02809079|Glucocorticoids|glucocorticoids|mesh-ancestor
92877908|NCT02809079|Hormones|hormones|mesh-ancestor
92877909|NCT02809079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877910|NCT02809079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877911|NCT02809079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92877912|NCT02809079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877913|NCT02809079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92877914|NCT02809079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92877915|NCT02809079|Antitubercular Agents|antitubercular agents|mesh-ancestor
92877916|NCT02809079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92877917|NCT02809079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877918|NCT02809079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92877919|NCT02809079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877920|NCT02812199|Lidocaine|lidocaine|mesh-list
92877921|NCT02812199|Epinephrine|epinephrine|mesh-list
92877922|NCT02812199|Racepinephrine|racepinephrine|mesh-list
92877923|NCT02812199|Epinephryl borate|epinephryl borate|mesh-list
92877924|NCT02812199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92877925|NCT02812199|Anesthetics|anesthetics|mesh-ancestor
92877926|NCT02812199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92877927|NCT02812199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877928|NCT02812199|Sensory System Agents|sensory system agents|mesh-ancestor
92877929|NCT02812199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877930|NCT02812199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92877931|NCT02812199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92877932|NCT02812199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92877933|NCT02812199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159940|NCT00602667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92877934|NCT02812199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877935|NCT02812199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92877936|NCT02812199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877937|NCT02812199|Adrenergic Agents|adrenergic agents|mesh-ancestor
92877938|NCT02812199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877939|NCT02812199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92877940|NCT02812199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92877941|NCT02812199|Autonomic Agents|autonomic agents|mesh-ancestor
92877942|NCT02812199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92877943|NCT02812199|Respiratory System Agents|respiratory system agents|mesh-ancestor
92877944|NCT02812199|Mydriatics|mydriatics|mesh-ancestor
92877945|NCT02812199|Sympathomimetics|sympathomimetics|mesh-ancestor
92525382|NCT00025051|Analgesics|analgesics|mesh-ancestor
92877946|NCT02812199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92877947|NCT02812043|Amorolfine|amorolfine|mesh-list
92877948|NCT02812043|Antifungal Agents|antifungal agents|mesh-ancestor
92877949|NCT02812043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92877950|NCT02808767|Ticagrelor|ticagrelor|mesh-list
92877951|NCT02808767|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92877952|NCT02808767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92877953|NCT02808767|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92877954|NCT02808767|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92877955|NCT02808767|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92877956|NCT02808767|Purinergic Agents|purinergic agents|mesh-ancestor
92877957|NCT02808767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92877958|NCT02808767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877959|NCT02808767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877961|NCT02812355|Anticoagulants|anticoagulants|mesh-ancestor
92877962|NCT02812355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92877963|NCT02812355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92877964|NCT02812355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877965|NCT02811731|Amlodipine|amlodipine|mesh-list
92877966|NCT02811731|Candesartan|candesartan|mesh-list
92877967|NCT02811731|Candesartan cilexetil|candesartan cilexetil|mesh-list
92877968|NCT02811731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92877969|NCT02811731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92877970|NCT02811731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92877971|NCT02811731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92877972|NCT02811731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92877973|NCT02811731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877974|NCT02811731|Vasodilator Agents|vasodilator agents|mesh-ancestor
92877975|NCT02811731|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92877976|NCT02811731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92877977|NCT02811809|Leuprolide|leuprolide|mesh-list
92877978|NCT02811809|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92877979|NCT02811809|Fertility Agents|fertility agents|mesh-ancestor
92877980|NCT02811809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92877981|NCT02811809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877982|NCT02811809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92877983|NCT02811809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92877984|NCT05569421|Budesonide|budesonide|mesh-list
92877985|NCT05569421|Formoterol Fumarate|formoterol fumarate|mesh-list
92877986|NCT05569421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92877987|NCT05569421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92877988|NCT05569421|Autonomic Agents|autonomic agents|mesh-ancestor
92877989|NCT05569421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92877990|NCT05569421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92877991|NCT05569421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92877992|NCT05569421|Respiratory System Agents|respiratory system agents|mesh-ancestor
92877993|NCT05569421|Glucocorticoids|glucocorticoids|mesh-ancestor
92877994|NCT05569421|Hormones|hormones|mesh-ancestor
92877995|NCT05569421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92877996|NCT05569421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92877997|NCT05569421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92877998|NCT05569421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92877999|NCT05569421|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878000|NCT05569421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878001|NCT05569421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878002|NCT02808611|Propranolol|propranolol|mesh-list
92878003|NCT02808611|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92878004|NCT02808611|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92878005|NCT02808611|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878006|NCT02808611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878007|NCT02808611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878008|NCT02808611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878009|NCT02808611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92878010|NCT02808611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878011|NCT02808611|Vasodilator Agents|vasodilator agents|mesh-ancestor
92878012|NCT02808533|Topiramate|topiramate|mesh-list
92878013|NCT02808533|Anticonvulsants|anticonvulsants|mesh-ancestor
92878014|NCT02808533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92878015|NCT02808533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878016|NCT02811497|Azacitidine|azacitidine|mesh-list
92878017|NCT02811497|Durvalumab|durvalumab|mesh-list
92878018|NCT02811497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92878019|NCT02811497|Antimetabolites|antimetabolites|mesh-ancestor
92878020|NCT02811497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878021|NCT02811497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878022|NCT02811497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878023|NCT02811497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878024|NCT00634439|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92878025|NCT00634439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92878026|NCT00634439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92878027|NCT00634439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878028|NCT00634439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878029|NCT00634439|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878030|NCT00634439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878031|NCT00634439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878033|NCT02807909|Diltiazem|diltiazem|mesh-list
92878034|NCT02807909|Antifungal Agents|antifungal agents|mesh-ancestor
92878035|NCT02807909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878036|NCT02807909|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92878037|NCT02807909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92878038|NCT02807909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878039|NCT02807909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878040|NCT02807909|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92878041|NCT02807909|Hormone Antagonists|hormone antagonists|mesh-ancestor
92878042|NCT02807909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878043|NCT02807909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878044|NCT02807909|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92878045|NCT02807909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878046|NCT02807909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92878047|NCT02807909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878048|NCT02807909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92878049|NCT02807909|Vasodilator Agents|vasodilator agents|mesh-ancestor
92878050|NCT02808065|Mycophenolic Acid|mycophenolic acid|mesh-list
92878051|NCT02808065|Tacrolimus|tacrolimus|mesh-list
92878052|NCT02808065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92878053|NCT02808065|Immunologic Factors|immunologic factors|mesh-ancestor
92878054|NCT02808065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878055|NCT02808065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92878056|NCT02808065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878057|NCT02808065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878058|NCT02808065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92878059|NCT02808065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878060|NCT02808065|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92878061|NCT02808065|Antitubercular Agents|antitubercular agents|mesh-ancestor
92878062|NCT02808065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92878063|NCT02808065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878064|NCT00602030|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92878065|NCT00602030|Entinostat|entinostat|mesh-list
92878066|NCT00602030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878067|NCT00602030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92878068|NCT00602030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878069|NCT00602030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878070|NCT00602030|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92878071|NCT02804711|Vaccines|vaccines|mesh-list
92878072|NCT02804711|Immunologic Factors|immunologic factors|mesh-ancestor
92878073|NCT02804711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878074|NCT00640094|Melatonin|melatonin|mesh-list
92878075|NCT00640094|Antioxidants|antioxidants|mesh-ancestor
92878076|NCT00640094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878077|NCT00640094|Protective Agents|protective agents|mesh-ancestor
92878078|NCT00640094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878079|NCT00640094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878080|NCT04183634|Rotigotine|rotigotine|mesh-list
92878081|NCT04183634|Dopamine Agonists|dopamine agonists|mesh-ancestor
92878082|NCT04183634|Dopamine Agents|dopamine agents|mesh-ancestor
92878083|NCT04183634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878084|NCT04183634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878085|NCT04183634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878086|NCT02804633|Acetaminophen|acetaminophen|mesh-list
92878087|NCT02804633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878088|NCT02804633|Analgesics|analgesics|mesh-ancestor
92878089|NCT02804633|Sensory System Agents|sensory system agents|mesh-ancestor
92878090|NCT02804633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878091|NCT02804633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878092|NCT02804633|Antipyretics|antipyretics|mesh-ancestor
92878093|NCT02807441|Aspirin|aspirin|mesh-list
92878094|NCT02807441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92878095|NCT02807441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878096|NCT02807441|Analgesics|analgesics|mesh-ancestor
92878097|NCT02807441|Sensory System Agents|sensory system agents|mesh-ancestor
92878098|NCT02807441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878099|NCT02807441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878100|NCT02807441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878101|NCT02807441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878102|NCT02807441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92878103|NCT02807441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92878104|NCT02807441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878105|NCT02807441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92878106|NCT02807441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92878107|NCT02807441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878108|NCT02807441|Antipyretics|antipyretics|mesh-ancestor
92878109|NCT02807285|Ocrelizumab|ocrelizumab|mesh-list
92878110|NCT02807285|Immunologic Factors|immunologic factors|mesh-ancestor
92878111|NCT02807285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878112|NCT02682680|Ezetimibe|ezetimibe|mesh-list
92878113|NCT02682680|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92878114|NCT02682680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92878115|NCT02682680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92878116|NCT02682680|Antimetabolites|antimetabolites|mesh-ancestor
92878117|NCT02682680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878118|NCT02682680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92878119|NCT02807207|Moxifloxacin|moxifloxacin|mesh-list
92878120|NCT02807207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92878121|NCT02807207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878122|NCT02807207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92878123|NCT02807207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92878124|NCT02807207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878125|NCT02807207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878126|NCT02807207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878127|NCT02682758|Xenon|xenon|mesh-list
92878128|NCT02682758|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92878129|NCT02682758|Anesthetics, General|anesthetics, general|mesh-ancestor
92878130|NCT02682758|Anesthetics|anesthetics|mesh-ancestor
92878131|NCT02682758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878132|NCT02682758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878133|NCT02682524|Aceclofenac|aceclofenac|mesh-list
92878134|NCT02682524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92878135|NCT02682524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878136|NCT02682524|Analgesics|analgesics|mesh-ancestor
92878137|NCT02682524|Sensory System Agents|sensory system agents|mesh-ancestor
92878138|NCT02682524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878139|NCT02682524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878140|NCT02682524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878141|NCT02682524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878142|NCT04183556|Naproxen|naproxen|mesh-list
92878143|NCT04183556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92878144|NCT04183556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92878145|NCT04183556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878146|NCT04183556|Analgesics|analgesics|mesh-ancestor
92878147|NCT04183556|Sensory System Agents|sensory system agents|mesh-ancestor
92878148|NCT04183556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878149|NCT04183556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878150|NCT04183556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878151|NCT04183556|Gout Suppressants|gout suppressants|mesh-ancestor
92878152|NCT04183556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92878153|NCT04183556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878154|NCT04183556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878155|NCT00640952|Acamprosate|acamprosate|mesh-list
92878156|NCT00640952|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92878157|NCT02684240|Nitazoxanide|nitazoxanide|mesh-list
92878158|NCT02684240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92878159|NCT02684240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878160|NCT02807051|Clarithromycin|clarithromycin|mesh-list
92878161|NCT02807051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92878162|NCT02807051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878163|NCT02807051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92878164|NCT02807051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222805|NCT00955487|Nitric Oxide|nitric oxide|mesh-list
92878165|NCT02807051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878166|NCT02807051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92878167|NCT02807051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92878168|NCT02684084|Dexamethasone|dexamethasone|mesh-list
92878169|NCT02684084|Ranibizumab|ranibizumab|mesh-list
92878170|NCT02684084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878171|NCT02684084|Antiemetics|antiemetics|mesh-ancestor
92878172|NCT02684084|Autonomic Agents|autonomic agents|mesh-ancestor
92878173|NCT02684084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878174|NCT02684084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878175|NCT02684084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878176|NCT02684084|Glucocorticoids|glucocorticoids|mesh-ancestor
92878177|NCT02684084|Hormones|hormones|mesh-ancestor
92878178|NCT02684084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878179|NCT02684084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878180|NCT02684084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878181|NCT02684084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92878182|NCT02684084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92878183|NCT02684084|Growth Substances|growth substances|mesh-ancestor
92878184|NCT02684084|Growth Inhibitors|growth inhibitors|mesh-ancestor
92878185|NCT02684318|Olaparib|olaparib|mesh-list
92878186|NCT02684318|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92878187|NCT02684318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878188|NCT02684318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878189|NCT02684318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878190|NCT02806817|Bevacizumab|bevacizumab|mesh-list
92878191|NCT02806817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878192|NCT02806817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878193|NCT02806817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92878194|NCT02806817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92878195|NCT02806817|Growth Substances|growth substances|mesh-ancestor
92878196|NCT02806817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878197|NCT02806817|Growth Inhibitors|growth inhibitors|mesh-ancestor
92878198|NCT04182854|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92878199|NCT04182854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878200|NCT04182854|Diuretics|diuretics|mesh-ancestor
92878201|NCT04182854|Natriuretic Agents|natriuretic agents|mesh-ancestor
92878202|NCT04182854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878203|NCT04182854|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92878204|NCT04182854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878205|NCT04182854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878206|NCT02680808|Olorofim|olorofim|mesh-list
92878207|NCT02680808|Midazolam|midazolam|mesh-list
92878208|NCT02680808|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92878209|NCT02680808|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92878210|NCT02680808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878211|NCT02680808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878212|NCT02680808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92878213|NCT02680808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92878214|NCT02680808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92878215|NCT02680808|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92878216|NCT02680808|Anesthetics, General|anesthetics, general|mesh-ancestor
92878217|NCT02680808|Anesthetics|anesthetics|mesh-ancestor
92878218|NCT02680808|GABA Modulators|gaba modulators|mesh-ancestor
92878219|NCT02680808|GABA Agents|gaba agents|mesh-ancestor
92878220|NCT02680808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878221|NCT02680808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878222|NCT02680808|Antifungal Agents|antifungal agents|mesh-ancestor
92878223|NCT02680808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878224|NCT05663684|Proxymetacaine|proxymetacaine|mesh-list
92878225|NCT05663684|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92878226|NCT05663684|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92878227|NCT05663684|Anesthetics, Local|anesthetics, local|mesh-ancestor
92878228|NCT05663684|Anesthetics|anesthetics|mesh-ancestor
92878229|NCT05663684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878230|NCT05663684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878231|NCT05663684|Sensory System Agents|sensory system agents|mesh-ancestor
92878232|NCT05663684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878233|NCT04004819|Rituximab|rituximab|mesh-list
92878234|NCT04004819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878235|NCT04004819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878236|NCT04004819|Immunologic Factors|immunologic factors|mesh-ancestor
92222882|NCT04129112|Propofol|propofol|mesh-list
92878237|NCT04004819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878239|NCT00641654|Interferons|interferons|mesh-list
92878240|NCT00641654|Ribavirin|ribavirin|mesh-list
92878241|NCT00641654|Interferon-alpha|interferon-alpha|mesh-list
92878242|NCT00641654|Interferon alpha-2|interferon alpha-2|mesh-list
92878243|NCT00641654|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92878244|NCT00641654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878245|NCT00641654|Antiviral Agents|antiviral agents|mesh-ancestor
92878246|NCT00641654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878247|NCT00641654|Antimetabolites|antimetabolites|mesh-ancestor
92878248|NCT00641654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878249|NCT00641654|Immunologic Factors|immunologic factors|mesh-ancestor
92878250|NCT00641654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878251|NCT02826434|Durvalumab|durvalumab|mesh-list
92878252|NCT02826434|Poly ICLC|poly iclc|mesh-list
92878253|NCT02826434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878254|NCT02826434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878255|NCT02826434|Interferon Inducers|interferon inducers|mesh-ancestor
92878256|NCT02826434|Immunologic Factors|immunologic factors|mesh-ancestor
92878257|NCT02826434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878258|NCT00549601|Rivastigmine|rivastigmine|mesh-list
92878259|NCT00549601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92878260|NCT00549601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878261|NCT00549601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878262|NCT00549601|Cholinergic Agents|cholinergic agents|mesh-ancestor
92878263|NCT00549601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878264|NCT00549601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878265|NCT00549601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92878266|NCT00549601|Protective Agents|protective agents|mesh-ancestor
92878267|NCT02806349|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92878268|NCT02806349|Cathartics|cathartics|mesh-ancestor
92878269|NCT02806349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878270|NCT04184492|Insulin|insulin|mesh-list
92878271|NCT04184492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92878272|NCT04184492|Insulin Aspart|insulin aspart|mesh-list
92878273|NCT04184492|Insulin, Long-Acting|insulin, long-acting|mesh-list
92878274|NCT04184492|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92878275|NCT04184492|Biphasic Insulins|biphasic insulins|mesh-list
92878276|NCT04184492|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92878277|NCT04184492|Insulin, Isophane|insulin, isophane|mesh-list
92878278|NCT04184492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159992|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92878279|NCT04184492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878280|NCT02806115|Acetic Acid|acetic acid|mesh-list
92878281|NCT02806115|Retinol acetate|retinol acetate|mesh-list
92878282|NCT02806115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92878283|NCT02806115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878284|NCT02806115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92878285|NCT02806115|Immunologic Factors|immunologic factors|mesh-ancestor
92878286|NCT02806115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878287|NCT02806115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92878288|NCT02806115|Protective Agents|protective agents|mesh-ancestor
92878289|NCT02806115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878290|NCT02682134|Dexamethasone|dexamethasone|mesh-list
92878291|NCT02682134|Dexamethasone acetate|dexamethasone acetate|mesh-list
92878292|NCT02682134|Lidocaine|lidocaine|mesh-list
92878293|NCT02682134|BB 1101|bb 1101|mesh-list
92878294|NCT02682134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878295|NCT02682134|Antiemetics|antiemetics|mesh-ancestor
92878296|NCT02682134|Autonomic Agents|autonomic agents|mesh-ancestor
92878297|NCT02682134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878298|NCT02682134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878299|NCT02682134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878300|NCT02682134|Glucocorticoids|glucocorticoids|mesh-ancestor
92878301|NCT02682134|Hormones|hormones|mesh-ancestor
92878302|NCT02682134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878303|NCT02682134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878304|NCT02682134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878305|NCT02682134|Protease Inhibitors|protease inhibitors|mesh-ancestor
92878306|NCT02682134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878307|NCT02682134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878308|NCT02682134|Anesthetics, Local|anesthetics, local|mesh-ancestor
92878309|NCT02682134|Anesthetics|anesthetics|mesh-ancestor
92878310|NCT02682134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878311|NCT02682134|Sensory System Agents|sensory system agents|mesh-ancestor
92878312|NCT02682134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92878313|NCT02682134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92878314|NCT02682134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92878315|NCT02682134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878316|NCT04236323|Remifentanil|remifentanil|mesh-list
92878317|NCT04236323|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92878318|NCT04236323|Narcotics|narcotics|mesh-ancestor
92878319|NCT04236323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878320|NCT04236323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878321|NCT04236323|Analgesics|analgesics|mesh-ancestor
92878322|NCT04236323|Sensory System Agents|sensory system agents|mesh-ancestor
92878323|NCT04236323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878324|NCT04206163|Edotreotide|edotreotide|mesh-list
92878325|NCT04206163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92878326|NCT04206163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878327|NCT00909974|Micronutrients|micronutrients|mesh-list
92878328|NCT00909974|Trace Elements|trace elements|mesh-list
92878329|NCT00909974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878331|NCT05300347|Analgesics|analgesics|mesh-ancestor
92878332|NCT05300347|Sensory System Agents|sensory system agents|mesh-ancestor
92878333|NCT05300347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878334|NCT05300347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878335|NCT05300347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92878336|NCT05300347|Vasodilator Agents|vasodilator agents|mesh-ancestor
92878337|NCT05300347|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92878338|NCT05300347|Purinergic Agonists|purinergic agonists|mesh-ancestor
92878339|NCT05300347|Purinergic Agents|purinergic agents|mesh-ancestor
92878340|NCT05300347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878341|NCT05300347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878342|NCT04011241|Itraconazole|itraconazole|mesh-list
92878343|NCT04011241|Antifungal Agents|antifungal agents|mesh-ancestor
92878344|NCT04011241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878345|NCT04011241|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92878346|NCT04011241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92878347|NCT04011241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878348|NCT04011241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878349|NCT04011241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92878350|NCT04011241|Hormone Antagonists|hormone antagonists|mesh-ancestor
92159996|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
92878351|NCT04011241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878352|NCT04011241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878353|NCT04011241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92878354|NCT00956059|Prednisone|prednisone|mesh-list
92878355|NCT00956059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878356|NCT00956059|Glucocorticoids|glucocorticoids|mesh-ancestor
92878357|NCT00956059|Hormones|hormones|mesh-ancestor
92878358|NCT00956059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878359|NCT00956059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878360|NCT00956059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878361|NCT00956059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878362|NCT04010929|Pemetrexed|pemetrexed|mesh-list
92878363|NCT04010929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878364|NCT04010929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878365|NCT04010929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878366|NCT04010929|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92878367|NCT04010929|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92878368|NCT00956215|Aprepitant|aprepitant|mesh-list
92878369|NCT00956215|Fosaprepitant|fosaprepitant|mesh-list
92878370|NCT00956215|Antiemetics|antiemetics|mesh-ancestor
92878371|NCT00956215|Autonomic Agents|autonomic agents|mesh-ancestor
92878372|NCT00956215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878373|NCT00956215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878374|NCT00956215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878375|NCT00956215|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92878376|NCT00956215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878377|NCT00956215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878378|NCT00640640|Bevacizumab|bevacizumab|mesh-list
92878379|NCT00640640|Ranibizumab|ranibizumab|mesh-list
92878380|NCT00640640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878381|NCT00640640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878382|NCT00640640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92878383|NCT00640640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92878384|NCT00640640|Growth Substances|growth substances|mesh-ancestor
92223028|NCT05505006|Vitamins|vitamins|mesh-ancestor
92878385|NCT00640640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878386|NCT00640640|Growth Inhibitors|growth inhibitors|mesh-ancestor
92878387|NCT03973177|Phenol|phenol|mesh-list
92878388|NCT03973177|Methylprednisolone|methylprednisolone|mesh-list
92878389|NCT03973177|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92878390|NCT03973177|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92878391|NCT03973177|Prednisolone|prednisolone|mesh-list
92878392|NCT03973177|Prednisolone acetate|prednisolone acetate|mesh-list
92878393|NCT03973177|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92878394|NCT03973177|Prednisolone phosphate|prednisolone phosphate|mesh-list
92878395|NCT03973177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878396|NCT03973177|Antiemetics|antiemetics|mesh-ancestor
92878397|NCT03973177|Autonomic Agents|autonomic agents|mesh-ancestor
92878398|NCT03973177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878399|NCT03973177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878400|NCT03973177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878401|NCT03973177|Glucocorticoids|glucocorticoids|mesh-ancestor
92878402|NCT03973177|Hormones|hormones|mesh-ancestor
92878403|NCT03973177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878404|NCT03973177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92878405|NCT03973177|Protective Agents|protective agents|mesh-ancestor
92878406|NCT03973177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878407|NCT03973177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878408|NCT03973177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92878409|NCT03973177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878410|NCT03973177|Disinfectants|disinfectants|mesh-ancestor
92878411|NCT03973177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92878412|NCT03973177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92878413|NCT03951493|Zoledronic Acid|zoledronic acid|mesh-list
92878414|NCT03951493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92878415|NCT03951493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878416|NCT00961909|Metformin|metformin|mesh-list
92878417|NCT00961909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92878418|NCT00961909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878419|NCT04115189|Sunitinib|sunitinib|mesh-list
92878420|NCT04115189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878421|NCT04115189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92878422|NCT04115189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92878423|NCT04115189|Growth Substances|growth substances|mesh-ancestor
92878424|NCT04115189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878425|NCT04115189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92878426|NCT04115189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92878427|NCT04115189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878428|NCT04115189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878429|NCT03940729|Chlorhexidine|chlorhexidine|mesh-list
92878430|NCT03940729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92878431|NCT03940729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878432|NCT03940729|Disinfectants|disinfectants|mesh-ancestor
92878433|NCT02678234|Acetaminophen|acetaminophen|mesh-list
92878434|NCT02678234|Phenylephrine|phenylephrine|mesh-list
92878435|NCT02678234|Oxymetazoline|oxymetazoline|mesh-list
92878436|NCT02678234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878437|NCT02678234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878438|NCT02678234|Analgesics|analgesics|mesh-ancestor
92878439|NCT02678234|Sensory System Agents|sensory system agents|mesh-ancestor
92878440|NCT02678234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878441|NCT02678234|Antipyretics|antipyretics|mesh-ancestor
92878442|NCT02678234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878443|NCT02678234|Protective Agents|protective agents|mesh-ancestor
92878444|NCT02678234|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92878445|NCT02678234|Mydriatics|mydriatics|mesh-ancestor
92878446|NCT02678234|Autonomic Agents|autonomic agents|mesh-ancestor
92878447|NCT02678234|Sympathomimetics|sympathomimetics|mesh-ancestor
92878448|NCT02678234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92878449|NCT02678234|Nasal Decongestants|nasal decongestants|mesh-ancestor
92878450|NCT02678234|Respiratory System Agents|respiratory system agents|mesh-ancestor
92878451|NCT02678234|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92878452|NCT02678234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92878453|NCT02678234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92878454|NCT02678234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878455|NCT02678234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878456|NCT00601640|Eflornithine|eflornithine|mesh-list
92878457|NCT00601640|Diclofenac|diclofenac|mesh-list
92878458|NCT00601640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92878459|NCT00601640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878460|NCT00601640|Analgesics|analgesics|mesh-ancestor
92878461|NCT00601640|Sensory System Agents|sensory system agents|mesh-ancestor
92878462|NCT00601640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878463|NCT00601640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878464|NCT00601640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878465|NCT00601640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878466|NCT00601640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92878467|NCT00601640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878468|NCT00601640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878469|NCT00601640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878470|NCT00601640|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92878471|NCT00601640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92878472|NCT00601640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92878473|NCT00601640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878474|NCT00601640|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92878475|NCT02805725|Cyclophosphamide|cyclophosphamide|mesh-list
92878476|NCT02805725|Trabectedin|trabectedin|mesh-list
92878477|NCT02805725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92878478|NCT02805725|Immunologic Factors|immunologic factors|mesh-ancestor
92878479|NCT02805725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878480|NCT02805725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878481|NCT02805725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92878482|NCT02805725|Alkylating Agents|alkylating agents|mesh-ancestor
92878483|NCT02805725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878484|NCT02805725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878485|NCT02805725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92878486|NCT05300191|Dialysis Solutions|dialysis solutions|mesh-list
92878487|NCT05300191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92878488|NCT03549715|Durvalumab|durvalumab|mesh-list
92878489|NCT03549715|Tremelimumab|tremelimumab|mesh-list
92878490|NCT03549715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878491|NCT03549715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878492|NCT02803385|Analgesics, Opioid|analgesics, opioid|mesh-list
92878493|NCT02803385|Anesthetics|anesthetics|mesh-list
92878494|NCT02803385|Anesthetics, Local|anesthetics, local|mesh-list
92878495|NCT02803385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878496|NCT02803385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878497|NCT02803385|Narcotics|narcotics|mesh-ancestor
92878498|NCT02803385|Analgesics|analgesics|mesh-ancestor
92878499|NCT02803385|Sensory System Agents|sensory system agents|mesh-ancestor
92878500|NCT02803385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878501|NCT00958321|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92878502|NCT00958321|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92878503|NCT00958321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878504|NCT00642434|Metoprolol|metoprolol|mesh-list
92878505|NCT00642434|Carvedilol|carvedilol|mesh-list
92878506|NCT00642434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92878507|NCT00642434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878508|NCT00642434|Sympatholytics|sympatholytics|mesh-ancestor
92878509|NCT00642434|Autonomic Agents|autonomic agents|mesh-ancestor
92878510|NCT00642434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878511|NCT00642434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878512|NCT00642434|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92878513|NCT00642434|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92878514|NCT00642434|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92878515|NCT00642434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878516|NCT00642434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878517|NCT00642434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878518|NCT00642434|Antioxidants|antioxidants|mesh-ancestor
92878519|NCT00642434|Protective Agents|protective agents|mesh-ancestor
92878520|NCT00642434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92878521|NCT00642434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878522|NCT00642434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92878523|NCT00642434|Vasodilator Agents|vasodilator agents|mesh-ancestor
92878524|NCT00642434|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92878525|NCT00642434|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92878526|NCT05352373|Calcium|calcium|mesh-list
92878527|NCT05352373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92878528|NCT05352373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878529|NCT02677532|Acetaminophen|acetaminophen|mesh-list
92878530|NCT02677532|Sufentanil|sufentanil|mesh-list
92878531|NCT02677532|Morphine|morphine|mesh-list
92878532|NCT02677532|Dsuvia|dsuvia|mesh-list
92878533|NCT02677532|Levobupivacaine|levobupivacaine|mesh-list
92878534|NCT02677532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92878535|NCT02677532|Narcotics|narcotics|mesh-ancestor
92878536|NCT02677532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878537|NCT02677532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878538|NCT02677532|Analgesics|analgesics|mesh-ancestor
92878539|NCT02677532|Sensory System Agents|sensory system agents|mesh-ancestor
92878540|NCT02677532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878541|NCT02677532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878542|NCT02677532|Antipyretics|antipyretics|mesh-ancestor
92878543|NCT02677532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92878544|NCT02677532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92878545|NCT02677532|Anesthetics, General|anesthetics, general|mesh-ancestor
92878546|NCT02677532|Anesthetics|anesthetics|mesh-ancestor
92878547|NCT02677532|Anesthetics, Local|anesthetics, local|mesh-ancestor
92878548|NCT00641810|Caffeine|caffeine|mesh-list
92878549|NCT00641810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92878550|NCT00641810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878551|NCT00641810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92878552|NCT00641810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878553|NCT00641810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878554|NCT00641810|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92878555|NCT00641810|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92878556|NCT00641810|Purinergic Agents|purinergic agents|mesh-ancestor
92878557|NCT00641810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878558|NCT02802995|Thrombin|thrombin|mesh-list
92878559|NCT02802995|Hemostatics|hemostatics|mesh-ancestor
92878560|NCT02802995|Coagulants|coagulants|mesh-ancestor
92878561|NCT00910052|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92878562|NCT00910052|Hemostatics|hemostatics|mesh-ancestor
92878563|NCT00910052|Coagulants|coagulants|mesh-ancestor
92878564|NCT02677376|Listerine|listerine|mesh-list
92878565|NCT02677376|Fluorides|fluorides|mesh-list
92878566|NCT02677376|Sodium Fluoride|sodium fluoride|mesh-list
92878567|NCT02677376|Cariostatic Agents|cariostatic agents|mesh-ancestor
92878568|NCT02677376|Protective Agents|protective agents|mesh-ancestor
92878569|NCT02677376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878570|NCT02677376|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92878571|NCT02677376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878572|NCT02800889|Pixantrone|pixantrone|mesh-list
92878573|NCT02800889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92878574|NCT02800889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92878575|NCT02800889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878576|NCT02800889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878577|NCT02800889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878578|NCT02803073|Methyltestosterone|methyltestosterone|mesh-list
92878579|NCT02803073|Testosterone|testosterone|mesh-list
92878580|NCT02803073|Testosterone undecanoate|testosterone undecanoate|mesh-list
92878581|NCT02803073|Testosterone enanthate|testosterone enanthate|mesh-list
92878582|NCT02803073|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92878583|NCT02803073|Androgens|androgens|mesh-ancestor
92878584|NCT02803073|Hormones|hormones|mesh-ancestor
92878585|NCT02803073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878586|NCT02803073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878587|NCT02803073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878588|NCT02803073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878589|NCT02803073|Anabolic Agents|anabolic agents|mesh-ancestor
92878590|NCT00922532|Nitric Oxide|nitric oxide|mesh-list
92878591|NCT00922532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92878592|NCT00922532|Autonomic Agents|autonomic agents|mesh-ancestor
92878593|NCT00922532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878594|NCT00922532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878595|NCT00922532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92878596|NCT00922532|Respiratory System Agents|respiratory system agents|mesh-ancestor
92878597|NCT00922532|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92878598|NCT00922532|Antioxidants|antioxidants|mesh-ancestor
92878599|NCT00922532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878600|NCT00922532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878601|NCT00922532|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92878602|NCT00922532|Vasodilator Agents|vasodilator agents|mesh-ancestor
92878603|NCT00922532|Gasotransmitters|gasotransmitters|mesh-ancestor
92878604|NCT00922532|Protective Agents|protective agents|mesh-ancestor
92878605|NCT05662904|Gemtuzumab|gemtuzumab|mesh-list
92878606|NCT05662904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878607|NCT05662904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878608|NCT05662904|Immunotoxins|immunotoxins|mesh-ancestor
92878609|NCT05662904|Immunoconjugates|immunoconjugates|mesh-ancestor
92878610|NCT05662904|Immunologic Factors|immunologic factors|mesh-ancestor
92878611|NCT05662904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878612|NCT00642512|Dronabinol|dronabinol|mesh-list
92878613|NCT00642512|Ondansetron|ondansetron|mesh-list
92878614|NCT00642512|Antiemetics|antiemetics|mesh-ancestor
92878615|NCT00642512|Autonomic Agents|autonomic agents|mesh-ancestor
92878616|NCT00642512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878617|NCT00642512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878618|NCT00642512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878619|NCT00642512|Antipruritics|antipruritics|mesh-ancestor
92878620|NCT00642512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92878621|NCT00642512|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92878622|NCT00642512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92878623|NCT00642512|Serotonin Agents|serotonin agents|mesh-ancestor
92878624|NCT00642512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878625|NCT00642512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878627|NCT00642512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92878628|NCT00642512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92878629|NCT00642512|Analgesics|analgesics|mesh-ancestor
92878630|NCT00642512|Sensory System Agents|sensory system agents|mesh-ancestor
92878631|NCT00642512|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92878632|NCT00642512|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92878633|NCT00642512|Hormones|hormones|mesh-ancestor
92878634|NCT00642512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878635|NCT02802683|Phenylephrine|phenylephrine|mesh-list
92878636|NCT02802683|Oxymetazoline|oxymetazoline|mesh-list
92878637|NCT02802683|Bupivacaine|bupivacaine|mesh-list
92878638|NCT02802683|Levobupivacaine|levobupivacaine|mesh-list
92878639|NCT02802683|Anesthetics, Local|anesthetics, local|mesh-ancestor
92878640|NCT02802683|Anesthetics|anesthetics|mesh-ancestor
92878641|NCT02802683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878642|NCT02802683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878643|NCT02802683|Sensory System Agents|sensory system agents|mesh-ancestor
92878644|NCT02802683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878645|NCT02802683|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92878646|NCT02802683|Mydriatics|mydriatics|mesh-ancestor
92878647|NCT02802683|Autonomic Agents|autonomic agents|mesh-ancestor
92878648|NCT02802683|Sympathomimetics|sympathomimetics|mesh-ancestor
92878649|NCT02802683|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92878650|NCT02802683|Nasal Decongestants|nasal decongestants|mesh-ancestor
92878651|NCT02802683|Respiratory System Agents|respiratory system agents|mesh-ancestor
92878652|NCT02802683|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92878653|NCT02802683|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92878654|NCT02802683|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92878655|NCT02802683|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878656|NCT02802683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878657|NCT02802683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878658|NCT02802683|Protective Agents|protective agents|mesh-ancestor
92878659|NCT00641264|Omeprazole|omeprazole|mesh-list
92878660|NCT00641264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92878661|NCT00641264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878662|NCT00641264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92878663|NCT00641264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878664|NCT00641264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878665|NCT05484167|Methyltestosterone|methyltestosterone|mesh-list
92878666|NCT05484167|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92878667|NCT05484167|Testosterone|testosterone|mesh-list
92878668|NCT05484167|Testosterone undecanoate|testosterone undecanoate|mesh-list
92878669|NCT05484167|Testosterone enanthate|testosterone enanthate|mesh-list
92878670|NCT05484167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878671|NCT05484167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878672|NCT05484167|Anabolic Agents|anabolic agents|mesh-ancestor
92878673|NCT05484167|Hormones|hormones|mesh-ancestor
92878674|NCT05484167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878675|NCT05484167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878676|NCT05484167|Androgens|androgens|mesh-ancestor
92878677|NCT04183322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92878678|NCT04183322|Immunologic Factors|immunologic factors|mesh-ancestor
92878679|NCT04183322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878680|NCT04180982|Febuxostat|febuxostat|mesh-list
92878681|NCT04180982|Gout Suppressants|gout suppressants|mesh-ancestor
92878682|NCT04180982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92878683|NCT02802605|Bemiparin|bemiparin|mesh-list
92878684|NCT02802605|Anticoagulants|anticoagulants|mesh-ancestor
92878685|NCT02800265|Sulforaphane|sulforaphane|mesh-list
92878686|NCT02800265|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92878687|NCT02800265|Protective Agents|protective agents|mesh-ancestor
92878688|NCT02800265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878689|NCT02800265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878690|NCT02676986|Exemestane|exemestane|mesh-list
92878691|NCT02676986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878692|NCT02676986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92878693|NCT02676986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92878694|NCT02676986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878695|NCT02676986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878696|NCT02676986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92878697|NCT02676986|Hormone Antagonists|hormone antagonists|mesh-ancestor
92878698|NCT02676986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878699|NCT02676986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878700|NCT02802215|Folic Acid|folic acid|mesh-list
92878701|NCT02802215|Metformin|metformin|mesh-list
92878702|NCT02802215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92878703|NCT02802215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878704|NCT02802215|Hematinics|hematinics|mesh-ancestor
92878705|NCT02802215|Vitamin B Complex|vitamin b complex|mesh-ancestor
92878706|NCT02802215|Vitamins|vitamins|mesh-ancestor
92878707|NCT02802215|Micronutrients|micronutrients|mesh-ancestor
92878708|NCT02799797|Sufentanil|sufentanil|mesh-list
92878709|NCT02799797|Dsuvia|dsuvia|mesh-list
92878710|NCT02799797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92878711|NCT02799797|Narcotics|narcotics|mesh-ancestor
92878712|NCT02799797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878713|NCT02799797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878714|NCT02799797|Analgesics|analgesics|mesh-ancestor
92878715|NCT02799797|Sensory System Agents|sensory system agents|mesh-ancestor
92878716|NCT02799797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878717|NCT02799797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92878718|NCT02799797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92878719|NCT02799797|Anesthetics, General|anesthetics, general|mesh-ancestor
92878720|NCT02799797|Anesthetics|anesthetics|mesh-ancestor
92878721|NCT05663372|Eplerenone|eplerenone|mesh-list
92878722|NCT05663372|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92878723|NCT05663372|Hormone Antagonists|hormone antagonists|mesh-ancestor
92878724|NCT05663372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878725|NCT05663372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878726|NCT05663372|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92878727|NCT05663372|Diuretics|diuretics|mesh-ancestor
92878728|NCT05663372|Natriuretic Agents|natriuretic agents|mesh-ancestor
92878729|NCT05663372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878730|NCT02802137|Timolol|timolol|mesh-list
92878731|NCT02802137|Dorzolamide|dorzolamide|mesh-list
92878732|NCT02802137|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92878733|NCT02802137|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92878734|NCT02802137|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878735|NCT02802137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878736|NCT02802137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878737|NCT02802137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878738|NCT02802137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92878739|NCT02802137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878740|NCT02802137|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92878741|NCT02802137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878742|NCT04033562|Lidocaine|lidocaine|mesh-list
92878743|NCT04033562|Bupivacaine|bupivacaine|mesh-list
92878744|NCT04033562|Anesthetics, Local|anesthetics, local|mesh-ancestor
92878745|NCT04033562|Anesthetics|anesthetics|mesh-ancestor
92878746|NCT04033562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878747|NCT04033562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878748|NCT04033562|Sensory System Agents|sensory system agents|mesh-ancestor
92878749|NCT04033562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878750|NCT04033562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92878751|NCT04033562|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92878752|NCT04033562|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92878753|NCT04033562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878754|NCT04033562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878755|NCT04032834|Budesonide|budesonide|mesh-list
92878756|NCT04032834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878757|NCT04032834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92878758|NCT04032834|Autonomic Agents|autonomic agents|mesh-ancestor
92878759|NCT04032834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878760|NCT04032834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878761|NCT04032834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92878762|NCT04032834|Respiratory System Agents|respiratory system agents|mesh-ancestor
92878763|NCT04032834|Glucocorticoids|glucocorticoids|mesh-ancestor
92878764|NCT04032834|Hormones|hormones|mesh-ancestor
92223402|NCT04694586|Antimetabolites|antimetabolites|mesh-ancestor
92878765|NCT04032834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878767|NCT02817191|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92878768|NCT02817191|Dexamethasone|dexamethasone|mesh-list
92878769|NCT02817191|Dexamethasone acetate|dexamethasone acetate|mesh-list
92878770|NCT02817191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92878771|NCT02817191|BB 1101|bb 1101|mesh-list
92878772|NCT02817191|Dipivefrin|dipivefrin|mesh-list
92878773|NCT02817191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878774|NCT02817191|Antiemetics|antiemetics|mesh-ancestor
92878775|NCT02817191|Autonomic Agents|autonomic agents|mesh-ancestor
92878776|NCT02817191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524056|NCT00019513|Vitamin B Complex|vitamin b complex|mesh-ancestor
92878777|NCT02817191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878778|NCT02817191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878779|NCT02817191|Glucocorticoids|glucocorticoids|mesh-ancestor
92878780|NCT02817191|Hormones|hormones|mesh-ancestor
92878781|NCT02817191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878782|NCT02817191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92878783|NCT02817191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878784|NCT02817191|Protease Inhibitors|protease inhibitors|mesh-ancestor
92878785|NCT02817191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878786|NCT02817191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878787|NCT02817191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92878788|NCT02817191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92878789|NCT02817191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878790|NCT02817191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92878791|NCT02817191|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878792|NCT02817191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878793|NCT02636010|Pembrolizumab|pembrolizumab|mesh-list
92878794|NCT02636010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878795|NCT02636010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878796|NCT02636010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92878797|NCT02636010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878798|NCT05474027|Antihypertensive Agents|antihypertensive agents|mesh-list
92878799|NCT05474027|Tranexamic Acid|tranexamic acid|mesh-list
92878800|NCT05474027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92878801|NCT05474027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92878802|NCT05474027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878803|NCT05474027|Hemostatics|hemostatics|mesh-ancestor
92878804|NCT05474027|Coagulants|coagulants|mesh-ancestor
92878805|NCT00642824|Bevacizumab|bevacizumab|mesh-list
92878806|NCT00642824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878807|NCT00642824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878808|NCT00642824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92878809|NCT00642824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92878810|NCT00642824|Growth Substances|growth substances|mesh-ancestor
92878811|NCT00642824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878812|NCT00642824|Growth Inhibitors|growth inhibitors|mesh-ancestor
92878813|NCT02679014|Petesicatib|petesicatib|mesh-list
92878814|NCT02679014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878815|NCT02679014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878816|NCT02801357|Lofexidine|lofexidine|mesh-list
92878817|NCT02801357|Buprenorphine|buprenorphine|mesh-list
92878818|NCT02801357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92878819|NCT02801357|Narcotics|narcotics|mesh-ancestor
92878820|NCT02801357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878821|NCT02801357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878822|NCT02801357|Analgesics|analgesics|mesh-ancestor
92878823|NCT02801357|Sensory System Agents|sensory system agents|mesh-ancestor
92878824|NCT02801357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878825|NCT02801357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92878826|NCT02801357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878827|NCT02801357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92878828|NCT02801357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92878829|NCT02801357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92878830|NCT02801357|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878831|NCT02801357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878832|NCT02801357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878833|NCT02676674|Vitamin D|vitamin d|mesh-list
92878834|NCT02676674|Cholecalciferol|cholecalciferol|mesh-list
92878835|NCT02676674|Vitamins|vitamins|mesh-ancestor
92878836|NCT02676674|Micronutrients|micronutrients|mesh-ancestor
92878837|NCT02676674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878838|NCT02676674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92878839|NCT02676674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92878841|NCT00962299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878842|NCT00962299|Glucocorticoids|glucocorticoids|mesh-ancestor
92878843|NCT00962299|Hormones|hormones|mesh-ancestor
92878844|NCT00962299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878845|NCT00962299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878846|NCT00962299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92878847|NCT00962299|Respiratory System Agents|respiratory system agents|mesh-ancestor
92878848|NCT02679092|Misoprostol|misoprostol|mesh-list
92878849|NCT02679092|Mifepristone|mifepristone|mesh-list
92878850|NCT02679092|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92878851|NCT02679092|Abortifacient Agents|abortifacient agents|mesh-ancestor
93046929|NCT00346268|Parecoxib|parecoxib|mesh-list
92878852|NCT02679092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92878853|NCT02679092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878854|NCT02679092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92878855|NCT02679092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92878856|NCT02679092|Oxytocics|oxytocics|mesh-ancestor
92878857|NCT02679092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92878858|NCT02679092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92878859|NCT02679092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92878860|NCT02679092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92878861|NCT02679092|Contraceptive Agents|contraceptive agents|mesh-ancestor
92878862|NCT02679092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92878863|NCT02679092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92878864|NCT02679092|Hormone Antagonists|hormone antagonists|mesh-ancestor
92878865|NCT02679092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878866|NCT02679092|Luteolytic Agents|luteolytic agents|mesh-ancestor
92878867|NCT02679092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92878868|NCT02679092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92878869|NCT04183088|Tislelizumab|tislelizumab|mesh-list
92878870|NCT04183088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878871|NCT04183088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878872|NCT00642122|Budesonide|budesonide|mesh-list
92878873|NCT00642122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92878874|NCT00642122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92878875|NCT00642122|Autonomic Agents|autonomic agents|mesh-ancestor
92878876|NCT00642122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878877|NCT00642122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878878|NCT00642122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92878879|NCT00642122|Respiratory System Agents|respiratory system agents|mesh-ancestor
92878880|NCT00642122|Glucocorticoids|glucocorticoids|mesh-ancestor
92878881|NCT00642122|Hormones|hormones|mesh-ancestor
92878882|NCT00642122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92878883|NCT00546871|Immunoglobulins|immunoglobulins|mesh-list
92878884|NCT00546871|Antibodies|antibodies|mesh-list
92878885|NCT00546871|gamma-Globulins|gamma-globulins|mesh-list
92878886|NCT00546871|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92878887|NCT00546871|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92878888|NCT00546871|Immunologic Factors|immunologic factors|mesh-ancestor
92878889|NCT00546871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878890|NCT02817113|Fluorouracil|fluorouracil|mesh-list
92878891|NCT02817113|Cetuximab|cetuximab|mesh-list
92878892|NCT02817113|Antimetabolites|antimetabolites|mesh-ancestor
92878893|NCT02817113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878894|NCT02817113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92878895|NCT02817113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878896|NCT02817113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92878897|NCT02817113|Immunologic Factors|immunologic factors|mesh-ancestor
92878898|NCT02817113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878899|NCT02817113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878900|NCT02801201|Midazolam|midazolam|mesh-list
92878901|NCT02801201|Bupivacaine|bupivacaine|mesh-list
92878902|NCT02801201|Anesthetics, Local|anesthetics, local|mesh-ancestor
92878903|NCT02801201|Anesthetics|anesthetics|mesh-ancestor
92878904|NCT02801201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92878905|NCT02801201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878906|NCT02801201|Sensory System Agents|sensory system agents|mesh-ancestor
92878907|NCT02801201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878908|NCT02801201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92878909|NCT02801201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92878911|NCT02801201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92878912|NCT02801201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92878913|NCT02801201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92878914|NCT02801201|Anesthetics, General|anesthetics, general|mesh-ancestor
92878915|NCT02801201|GABA Modulators|gaba modulators|mesh-ancestor
92878916|NCT02801201|GABA Agents|gaba agents|mesh-ancestor
92878917|NCT02801201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878918|NCT02801201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878919|NCT04182932|Vaccines|vaccines|mesh-list
92878920|NCT04182932|Immunologic Factors|immunologic factors|mesh-ancestor
92878921|NCT04182932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878922|NCT03951805|Insulin|insulin|mesh-list
92878923|NCT03951805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92878924|NCT03951805|Insulin Glargine|insulin glargine|mesh-list
92878925|NCT03951805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92878926|NCT03951805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878927|NCT02681198|Lofexidine|lofexidine|mesh-list
92878929|NCT02681198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92878930|NCT02681198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92878931|NCT02681198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878932|NCT02681198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878933|NCT02681198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92878934|NCT02681198|Serotonin Agents|serotonin agents|mesh-ancestor
92878935|NCT02681198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878936|NCT02681198|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92878937|NCT02681198|Antidepressive Agents|antidepressive agents|mesh-ancestor
92878938|NCT02681198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92878939|NCT02681198|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92878940|NCT02681198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92878941|NCT02681198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878942|NCT02681198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878943|NCT02681198|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92878944|NCT02681198|Sensory System Agents|sensory system agents|mesh-ancestor
92878945|NCT02681198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878946|NCT02681198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92878947|NCT02681198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92878948|NCT02681198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92878949|NCT02681198|Adrenergic Agents|adrenergic agents|mesh-ancestor
92878950|NCT05597306|Venetoclax|venetoclax|mesh-list
92878951|NCT05597306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878952|NCT00962533|Telbivudine|telbivudine|mesh-list
92878953|NCT00962533|Antiviral Agents|antiviral agents|mesh-ancestor
92878954|NCT00962533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878955|NCT00962533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92878956|NCT00962533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878957|NCT00962533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878958|NCT00642980|Clindamycin|clindamycin|mesh-list
92878959|NCT00642980|Clindamycin palmitate|clindamycin palmitate|mesh-list
92878960|NCT00642980|Clindamycin phosphate|clindamycin phosphate|mesh-list
92878961|NCT00642980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92878962|NCT00642980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92878963|NCT00642980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92878964|NCT00642980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878965|NCT00642980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878966|NCT02798159|Sildenafil Citrate|sildenafil citrate|mesh-list
92878967|NCT02798159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878968|NCT02798159|Vasodilator Agents|vasodilator agents|mesh-ancestor
92878969|NCT02798159|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92878970|NCT02798159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92878971|NCT02798159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878972|NCT02798159|Urological Agents|urological agents|mesh-ancestor
92878973|NCT00962767|Gemtuzumab|gemtuzumab|mesh-list
92878974|NCT00962767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92878975|NCT00962767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878976|NCT00962767|Immunotoxins|immunotoxins|mesh-ancestor
92878977|NCT00962767|Immunoconjugates|immunoconjugates|mesh-ancestor
92878978|NCT00962767|Immunologic Factors|immunologic factors|mesh-ancestor
92878979|NCT00962767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878980|NCT02678780|Lenvatinib|lenvatinib|mesh-list
92878981|NCT02678780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92878982|NCT02678780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92878983|NCT02678780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525390|NCT00025051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92878984|NCT02678780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878986|NCT00963001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92878987|NCT00643136|Pregabalin|pregabalin|mesh-list
92878988|NCT00643136|Analgesics|analgesics|mesh-ancestor
92878989|NCT00643136|Sensory System Agents|sensory system agents|mesh-ancestor
92878990|NCT00643136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92878991|NCT00643136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92878992|NCT00643136|Anticonvulsants|anticonvulsants|mesh-ancestor
92878993|NCT00643136|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92878994|NCT00643136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92878995|NCT00643136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92878996|NCT00643136|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92878997|NCT00643136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92878998|NCT00643136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92878999|NCT00643136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92524293|NCT00010062|Fluorouracil|fluorouracil|mesh-list
92879000|NCT00643136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92879001|NCT01563367|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92879002|NCT01563367|Hematinics|hematinics|mesh-ancestor
92879003|NCT00963313|Adalimumab|adalimumab|mesh-list
92879004|NCT00963313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92879005|NCT00963313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879006|NCT00963313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879007|NCT02797145|Digoxin|digoxin|mesh-list
92879008|NCT02797145|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92879009|NCT02797145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92879010|NCT02797145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879011|NCT02797145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879012|NCT02797145|Protective Agents|protective agents|mesh-ancestor
92879013|NCT02797145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879014|NCT02690129|Progesterone|progesterone|mesh-list
92879015|NCT02690129|Progestins|progestins|mesh-ancestor
92879016|NCT02690129|Hormones|hormones|mesh-ancestor
92879017|NCT02690129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879018|NCT02690129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879019|NCT00883116|Paclitaxel|paclitaxel|mesh-list
92879020|NCT00883116|Doxorubicin|doxorubicin|mesh-list
92879021|NCT00883116|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92879022|NCT00883116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92879023|NCT00883116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879024|NCT00883116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92879025|NCT00883116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92879026|NCT00883116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92879027|NCT00883116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879028|NCT00883116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92879029|NCT00883116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879030|NCT00883116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879031|NCT00883116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879032|NCT02139397|Eflornithine|eflornithine|mesh-list
92879033|NCT02139397|Bortezomib|bortezomib|mesh-list
92879034|NCT02139397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879035|NCT02139397|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92879036|NCT02139397|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92879037|NCT02139397|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92879038|NCT02139397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879039|NCT02139397|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92879040|NCT02139397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879041|NCT02139397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879042|NCT00643292|Amoxicillin|amoxicillin|mesh-list
92879043|NCT00643292|Azithromycin|azithromycin|mesh-list
92879044|NCT00643292|Clavulanic Acid|clavulanic acid|mesh-list
92879045|NCT00643292|Clavulanic Acids|clavulanic acids|mesh-list
92879046|NCT00643292|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92879047|NCT00643292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92879048|NCT00643292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879049|NCT00643292|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92879050|NCT00643292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879051|NCT00643292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879052|NCT02797067|Indomethacin|indomethacin|mesh-list
92879053|NCT02797067|Glycerol|glycerol|mesh-list
92879054|NCT02797067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879055|NCT02797067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879056|NCT02797067|Analgesics|analgesics|mesh-ancestor
92879057|NCT02797067|Sensory System Agents|sensory system agents|mesh-ancestor
92879058|NCT02797067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879059|NCT02797067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879060|NCT02797067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879061|NCT02797067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879062|NCT02797067|Gout Suppressants|gout suppressants|mesh-ancestor
92879063|NCT02797067|Tocolytic Agents|tocolytic agents|mesh-ancestor
92879064|NCT02797067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92879065|NCT02797067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92879066|NCT02797067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879067|NCT02797067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879068|NCT02797067|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92879069|NCT02797067|Protective Agents|protective agents|mesh-ancestor
92879070|NCT00655044|Insulin Detemir|insulin detemir|mesh-list
92879071|NCT00655044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879072|NCT00655044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879073|NCT00963703|Rituximab|rituximab|mesh-list
92879074|NCT00963703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92879075|NCT00963703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879076|NCT00963703|Immunologic Factors|immunologic factors|mesh-ancestor
92879077|NCT00963703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879078|NCT00963703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879079|NCT00655122|Dalteparin|dalteparin|mesh-list
92879080|NCT00655122|Tinzaparin|tinzaparin|mesh-list
92879081|NCT00655122|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92879082|NCT00655122|Anticoagulants|anticoagulants|mesh-ancestor
92879083|NCT00655122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92879084|NCT00655122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92879085|NCT00655122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879086|NCT02638116|Omeprazole|omeprazole|mesh-list
92879087|NCT02638116|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92879088|NCT02638116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92879089|NCT02638116|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92879090|NCT02638116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879091|NCT02638116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879092|NCT04164264|Propofol|propofol|mesh-list
92879093|NCT04164264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879094|NCT04164264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879095|NCT04164264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879096|NCT04164264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879097|NCT04164264|Anesthetics, General|anesthetics, general|mesh-ancestor
92879098|NCT04164264|Anesthetics|anesthetics|mesh-ancestor
92879099|NCT02795039|Fulvestrant|fulvestrant|mesh-list
92879100|NCT02795039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92879101|NCT02795039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879102|NCT02795039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92879103|NCT02795039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92879104|NCT02795039|Hormone Antagonists|hormone antagonists|mesh-ancestor
92879105|NCT02795039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879106|NCT02795039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879107|NCT02796833|SMOFlipid|smoflipid|mesh-list
92879108|NCT02796833|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92879109|NCT02796833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92879110|NCT02796833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92879111|NCT04009603|Metformin|metformin|mesh-list
92879112|NCT04009603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879113|NCT04009603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879114|NCT02635230|Aspirin|aspirin|mesh-list
92879115|NCT02635230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879116|NCT02635230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879117|NCT02635230|Analgesics|analgesics|mesh-ancestor
92879118|NCT02635230|Sensory System Agents|sensory system agents|mesh-ancestor
92879119|NCT02635230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879120|NCT02635230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879121|NCT02635230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879122|NCT02635230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879123|NCT02635230|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92879124|NCT02635230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92879125|NCT02635230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879126|NCT02635230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92879127|NCT02635230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92879128|NCT02635230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879129|NCT02635230|Antipyretics|antipyretics|mesh-ancestor
92879130|NCT00964015|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92879131|NCT00964015|Plasma Substitutes|plasma substitutes|mesh-ancestor
92879132|NCT00964015|Blood Substitutes|blood substitutes|mesh-ancestor
92879133|NCT02673632|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92879134|NCT02673632|Luteolytic Agents|luteolytic agents|mesh-ancestor
92879135|NCT02673632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92879136|NCT02673632|Contraceptive Agents|contraceptive agents|mesh-ancestor
92879137|NCT02673632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92879138|NCT02673632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879139|NCT02673632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92879140|NCT02673632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92879141|NCT02673632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879142|NCT04009525|Cyclosporine|cyclosporine|mesh-list
92879143|NCT04009525|Mycophenolic Acid|mycophenolic acid|mesh-list
92879144|NCT04009525|Cyclophosphamide|cyclophosphamide|mesh-list
92879146|NCT04009525|Methotrexate|methotrexate|mesh-list
92879147|NCT04009525|Fludarabine|fludarabine|mesh-list
92879148|NCT04009525|Tacrolimus|tacrolimus|mesh-list
92879149|NCT04009525|Cyclosporins|cyclosporins|mesh-list
92879150|NCT04009525|Thymoglobulin|thymoglobulin|mesh-list
92524441|NCT00021151|Alemtuzumab|alemtuzumab|mesh-list
92879151|NCT04009525|Basiliximab|basiliximab|mesh-list
92879152|NCT04009525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92879153|NCT04009525|Immunologic Factors|immunologic factors|mesh-ancestor
92879154|NCT04009525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879155|NCT04009525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879156|NCT04009525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92879157|NCT04009525|Alkylating Agents|alkylating agents|mesh-ancestor
92879158|NCT04009525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879159|NCT04009525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879160|NCT04009525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92879161|NCT04009525|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92879162|NCT04009525|Abortifacient Agents|abortifacient agents|mesh-ancestor
92879163|NCT04009525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92879164|NCT04009525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879165|NCT04009525|Antimetabolites|antimetabolites|mesh-ancestor
92879166|NCT04009525|Dermatologic Agents|dermatologic agents|mesh-ancestor
92879167|NCT04009525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879168|NCT04009525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92879169|NCT04009525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92879170|NCT04009525|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92879171|NCT04009525|Antifungal Agents|antifungal agents|mesh-ancestor
92879172|NCT04009525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879173|NCT04009525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92879174|NCT04009525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92879175|NCT04009525|Antitubercular Agents|antitubercular agents|mesh-ancestor
92879176|NCT04009525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92879177|NCT04032366|Nitric Oxide|nitric oxide|mesh-list
92879178|NCT04032366|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92879179|NCT04032366|Autonomic Agents|autonomic agents|mesh-ancestor
92879180|NCT04032366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879181|NCT04032366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879182|NCT04032366|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92879183|NCT04032366|Respiratory System Agents|respiratory system agents|mesh-ancestor
92879184|NCT04032366|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92879185|NCT04032366|Antioxidants|antioxidants|mesh-ancestor
92879186|NCT04032366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879187|NCT04032366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879188|NCT04032366|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92879189|NCT04032366|Vasodilator Agents|vasodilator agents|mesh-ancestor
92879190|NCT04032366|Gasotransmitters|gasotransmitters|mesh-ancestor
92879191|NCT04032366|Protective Agents|protective agents|mesh-ancestor
92879192|NCT02537600|Vemurafenib|vemurafenib|mesh-list
92879193|NCT02537600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879194|NCT02537600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92879195|NCT02537600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879196|NCT02537600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879197|NCT00684099|Docetaxel|docetaxel|mesh-list
92879198|NCT00684099|Pemetrexed|pemetrexed|mesh-list
92879199|NCT00684099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879200|NCT00684099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92879201|NCT00684099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92879202|NCT00684099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92879203|NCT00684099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879204|NCT00684099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879206|NCT00684099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92879207|NCT04159896|Nivolumab|nivolumab|mesh-list
92879208|NCT04159896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92879209|NCT04159896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92879210|NCT04159896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879211|NCT04159896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92879212|NCT04159896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879213|NCT04159896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92879214|NCT04159896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879215|NCT02635074|Cytarabine|cytarabine|mesh-list
92879216|NCT02635074|Idarubicin|idarubicin|mesh-list
92879217|NCT02635074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879218|NCT02635074|Antimetabolites|antimetabolites|mesh-ancestor
92879219|NCT02635074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879220|NCT02635074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879221|NCT02635074|Antiviral Agents|antiviral agents|mesh-ancestor
92879222|NCT02635074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879223|NCT02635074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92879224|NCT02635074|Immunologic Factors|immunologic factors|mesh-ancestor
92879225|NCT02635074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879226|NCT02635074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92879227|NCT02635074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879228|NCT02635074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879229|NCT02635074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879230|NCT02537366|Dexmedetomidine|dexmedetomidine|mesh-list
92879231|NCT02537366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879232|NCT02537366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879233|NCT02537366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879234|NCT02537366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879235|NCT02537366|Analgesics|analgesics|mesh-ancestor
92879236|NCT02537366|Sensory System Agents|sensory system agents|mesh-ancestor
92879237|NCT02537366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879238|NCT02537366|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92879239|NCT02537366|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92879240|NCT02537366|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92879241|NCT02537366|Adrenergic Agents|adrenergic agents|mesh-ancestor
92879242|NCT02537366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879243|NCT02537366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879244|NCT00690417|Vitamin D|vitamin d|mesh-list
92879245|NCT00690417|Cholecalciferol|cholecalciferol|mesh-list
92879246|NCT00690417|Vitamins|vitamins|mesh-ancestor
92879247|NCT00690417|Micronutrients|micronutrients|mesh-ancestor
92879248|NCT00690417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879249|NCT00690417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92879250|NCT00690417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92879251|NCT05434559|Insulin|insulin|mesh-list
92879252|NCT05434559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879253|NCT05434559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879254|NCT00546637|Fesoterodine|fesoterodine|mesh-list
92879255|NCT00546637|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92879256|NCT00546637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92879257|NCT00546637|Cholinergic Agents|cholinergic agents|mesh-ancestor
92879258|NCT00546637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879259|NCT00546637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879260|NCT00546637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879261|NCT00546637|Urological Agents|urological agents|mesh-ancestor
92879262|NCT00690885|Interferons|interferons|mesh-list
92879263|NCT00690885|Interferon-alpha|interferon-alpha|mesh-list
92879264|NCT00690885|Interferon alpha-2|interferon alpha-2|mesh-list
92879265|NCT00690885|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92879266|NCT00690885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879267|NCT00690885|Antiviral Agents|antiviral agents|mesh-ancestor
92879268|NCT00690885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879269|NCT00690885|Immunologic Factors|immunologic factors|mesh-ancestor
92879270|NCT00690885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879271|NCT04138719|Paclitaxel|paclitaxel|mesh-list
92879272|NCT04138719|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92879273|NCT04138719|Carboplatin|carboplatin|mesh-list
92879274|NCT04138719|Epirubicin|epirubicin|mesh-list
92879275|NCT04138719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92879276|NCT04138719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879277|NCT04138719|Tubulin Modulators|tubulin modulators|mesh-ancestor
92879278|NCT04138719|Antimitotic Agents|antimitotic agents|mesh-ancestor
92879279|NCT04138719|Mitosis Modulators|mitosis modulators|mesh-ancestor
92879280|NCT04138719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879281|NCT04138719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92879282|NCT04138719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879283|NCT04138719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879284|NCT04138719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879285|NCT02790203|Celecoxib|celecoxib|mesh-list
92879286|NCT02790203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879287|NCT02790203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879288|NCT02790203|Analgesics|analgesics|mesh-ancestor
92879289|NCT02790203|Sensory System Agents|sensory system agents|mesh-ancestor
92879290|NCT02790203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879291|NCT02790203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879292|NCT02790203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879293|NCT02790203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879294|NCT02790203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92879295|NCT02790203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92879296|NCT02790203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879297|NCT02790203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879298|NCT02816567|Sufentanil|sufentanil|mesh-list
92879299|NCT02816567|Propofol|propofol|mesh-list
92879300|NCT02816567|Cisatracurium|cisatracurium|mesh-list
92879301|NCT02816567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879302|NCT02816567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879303|NCT02816567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879304|NCT02816567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879305|NCT02816567|Anesthetics, General|anesthetics, general|mesh-ancestor
92879306|NCT02816567|Anesthetics|anesthetics|mesh-ancestor
92879307|NCT02816567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92879308|NCT02816567|Narcotics|narcotics|mesh-ancestor
92879309|NCT02816567|Analgesics|analgesics|mesh-ancestor
92879310|NCT02816567|Sensory System Agents|sensory system agents|mesh-ancestor
92879311|NCT02816567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879312|NCT02816567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92879313|NCT02816567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92879314|NCT02816567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92879315|NCT00657774|Prednisone|prednisone|mesh-list
92879316|NCT00657774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879317|NCT00657774|Glucocorticoids|glucocorticoids|mesh-ancestor
92879318|NCT00657774|Hormones|hormones|mesh-ancestor
92879319|NCT00657774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879320|NCT00657774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879321|NCT00657774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92879322|NCT00657774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879323|NCT04138485|Immunoglobulins|immunoglobulins|mesh-list
92879324|NCT04138485|Immunologic Factors|immunologic factors|mesh-ancestor
92879325|NCT04138485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879326|NCT02789969|Fentanyl|fentanyl|mesh-list
92879327|NCT02789969|Hydromorphone|hydromorphone|mesh-list
92879328|NCT02789969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92879329|NCT02789969|Narcotics|narcotics|mesh-ancestor
92879330|NCT02789969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879331|NCT02789969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879332|NCT02789969|Analgesics|analgesics|mesh-ancestor
92879333|NCT02789969|Sensory System Agents|sensory system agents|mesh-ancestor
92879334|NCT02789969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879335|NCT02789969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92879336|NCT02789969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879337|NCT02789969|Anesthetics, General|anesthetics, general|mesh-ancestor
92879338|NCT02789969|Anesthetics|anesthetics|mesh-ancestor
92879339|NCT00657852|Pamidronate|pamidronate|mesh-list
92879340|NCT00657852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92879341|NCT00657852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879342|NCT00691275|Ondansetron|ondansetron|mesh-list
92879343|NCT00691275|Antiemetics|antiemetics|mesh-ancestor
92879344|NCT00691275|Autonomic Agents|autonomic agents|mesh-ancestor
92879345|NCT00691275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879346|NCT00691275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879347|NCT00691275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92879348|NCT00691275|Antipruritics|antipruritics|mesh-ancestor
92879349|NCT00691275|Dermatologic Agents|dermatologic agents|mesh-ancestor
92879350|NCT00691275|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92879351|NCT00691275|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92879352|NCT00691275|Serotonin Agents|serotonin agents|mesh-ancestor
92879353|NCT00691275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879354|NCT00691275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879355|NCT00657930|Insulin Detemir|insulin detemir|mesh-list
92879356|NCT00657930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879357|NCT00657930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879358|NCT00655512|Clobetasol|clobetasol|mesh-list
92879359|NCT00655512|Pimecrolimus|pimecrolimus|mesh-list
92879360|NCT00655512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879361|NCT00655512|Glucocorticoids|glucocorticoids|mesh-ancestor
92879362|NCT00655512|Hormones|hormones|mesh-ancestor
92879363|NCT00655512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879364|NCT00655512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879365|NCT00655512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879366|NCT00655512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879367|NCT00655512|Analgesics|analgesics|mesh-ancestor
92879368|NCT00655512|Sensory System Agents|sensory system agents|mesh-ancestor
92879369|NCT00655512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879370|NCT00655512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879371|NCT00655512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92879372|NCT00655512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92879373|NCT00655512|Immunologic Factors|immunologic factors|mesh-ancestor
92879374|NCT00655512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92879375|NCT00655512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879376|NCT00655512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879377|NCT00644306|Thalidomide|thalidomide|mesh-list
92879378|NCT00644306|Prednisone|prednisone|mesh-list
92879379|NCT00644306|Melphalan|melphalan|mesh-list
92879380|NCT00644306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879381|NCT00644306|Glucocorticoids|glucocorticoids|mesh-ancestor
92879382|NCT00644306|Hormones|hormones|mesh-ancestor
92879383|NCT00644306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879384|NCT00644306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879385|NCT00644306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92879386|NCT00644306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879387|NCT00644306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92879388|NCT00644306|Alkylating Agents|alkylating agents|mesh-ancestor
92879389|NCT00644306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879390|NCT00644306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92879391|NCT00644306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92879392|NCT00644306|Immunologic Factors|immunologic factors|mesh-ancestor
92879393|NCT00644306|Leprostatic Agents|leprostatic agents|mesh-ancestor
92879394|NCT00644306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92879395|NCT00644306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879396|NCT00644306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92879397|NCT00644306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92879398|NCT00644306|Growth Substances|growth substances|mesh-ancestor
92879399|NCT00644306|Growth Inhibitors|growth inhibitors|mesh-ancestor
92879400|NCT02634528|Insulin|insulin|mesh-list
92879401|NCT02634528|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92879402|NCT02634528|Insulin, Isophane|insulin, isophane|mesh-list
92879403|NCT02634528|Isophane Insulin, Human|isophane insulin, human|mesh-list
92879404|NCT02634528|Isophane insulin, beef|isophane insulin, beef|mesh-list
92879405|NCT02634528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879406|NCT02634528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879407|NCT02816411|Caseins|caseins|mesh-list
92879408|NCT02816411|Chelating Agents|chelating agents|mesh-ancestor
92879409|NCT02816411|Sequestering Agents|sequestering agents|mesh-ancestor
92879410|NCT02816411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879411|NCT00655590|Sildenafil Citrate|sildenafil citrate|mesh-list
92879412|NCT00655590|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92879413|NCT00655590|Vasodilator Agents|vasodilator agents|mesh-ancestor
92879414|NCT00655590|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92879415|NCT00655590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92879416|NCT00655590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879417|NCT00655590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879418|NCT00655590|Urological Agents|urological agents|mesh-ancestor
92879419|NCT02794025|Esmolol|esmolol|mesh-list
92879420|NCT02794025|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92879421|NCT02794025|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92879422|NCT02794025|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92879423|NCT02794025|Adrenergic Agents|adrenergic agents|mesh-ancestor
92879424|NCT02794025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879425|NCT02794025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879426|NCT02794025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879427|NCT00546481|Epoetin Alfa|epoetin alfa|mesh-list
92879428|NCT00546481|Hematinics|hematinics|mesh-ancestor
92879429|NCT02789813|Valproic Acid|valproic acid|mesh-list
92879431|NCT02789813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879432|NCT02789813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879433|NCT02789813|GABA Agents|gaba agents|mesh-ancestor
92879434|NCT02789813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879435|NCT02789813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879436|NCT02789813|Antimanic Agents|antimanic agents|mesh-ancestor
92879437|NCT02789813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92879438|NCT02789813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879439|NCT02789813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92879440|NCT02632578|Vaccines|vaccines|mesh-list
92879441|NCT02632578|Immunologic Factors|immunologic factors|mesh-ancestor
92879442|NCT02632578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879443|NCT04138251|Empagliflozin|empagliflozin|mesh-list
92879444|NCT04138251|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92879445|NCT04138251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879446|NCT04138251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879447|NCT04138251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879448|NCT00964171|Efavirenz|efavirenz|mesh-list
92879449|NCT00964171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92879450|NCT00964171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92879451|NCT00964171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046930|NCT00346268|Morphine|morphine|mesh-list
92879452|NCT00964171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879453|NCT00964171|Antiviral Agents|antiviral agents|mesh-ancestor
92879454|NCT00964171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879455|NCT00964171|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92879456|NCT00964171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92879457|NCT00964171|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92879458|NCT00964171|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92879459|NCT00964171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92879460|NCT00964171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92879461|NCT04016246|Propofol|propofol|mesh-list
92879462|NCT04016246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879463|NCT04016246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879464|NCT04016246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879465|NCT04016246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879466|NCT04016246|Anesthetics, General|anesthetics, general|mesh-ancestor
92879467|NCT04016246|Anesthetics|anesthetics|mesh-ancestor
92879468|NCT02789501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92879469|NCT04178876|Ethanol|ethanol|mesh-list
92879470|NCT04178876|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92879471|NCT04178876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879472|NCT04178876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879473|NCT04178876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879474|NCT02789579|Levofloxacin|levofloxacin|mesh-list
92879475|NCT02789579|Nitrofurantoin|nitrofurantoin|mesh-list
92879476|NCT02789579|Cefuroxime|cefuroxime|mesh-list
92879477|NCT02789579|Cefuroxime axetil|cefuroxime axetil|mesh-list
92879478|NCT02789579|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92879479|NCT02789579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879480|NCT02789579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92879481|NCT02789579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879482|NCT02789579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879483|NCT02789579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879484|NCT02789579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879485|NCT02789579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879486|NCT02789579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92879487|NCT02789579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92879488|NCT04233203|Insulin|insulin|mesh-list
92879489|NCT04233203|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92879490|NCT04233203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879491|NCT04233203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879492|NCT00959101|Metformin|metformin|mesh-list
92879493|NCT00959101|Repaglinide|repaglinide|mesh-list
92879494|NCT00959101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879495|NCT00959101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879496|NCT04233359|Anesthetics|anesthetics|mesh-list
92879497|NCT04233359|Anesthetics, Local|anesthetics, local|mesh-list
92879498|NCT04233359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879499|NCT04233359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879500|NCT04233359|Sensory System Agents|sensory system agents|mesh-ancestor
92879501|NCT04233359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879502|NCT00964327|Darunavir|darunavir|mesh-list
92879503|NCT00964327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92879504|NCT00964327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92879505|NCT00964327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92879506|NCT00964327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879507|NCT00964327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879508|NCT00964327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92879509|NCT00964327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92879510|NCT00964327|Antiviral Agents|antiviral agents|mesh-ancestor
92879511|NCT00964327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879513|NCT05252546|Antidiarrheals|antidiarrheals|mesh-list
92879514|NCT05252546|Bentonite|bentonite|mesh-list
92879515|NCT05252546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92879516|NCT05252546|Antidotes|antidotes|mesh-ancestor
92879517|NCT05252546|Protective Agents|protective agents|mesh-ancestor
92879518|NCT05252546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879519|NCT00644384|Acitretin|acitretin|mesh-list
92879520|NCT00644384|Keratolytic Agents|keratolytic agents|mesh-ancestor
92879521|NCT00644384|Dermatologic Agents|dermatologic agents|mesh-ancestor
92879522|NCT02637648|Sodium Oxybate|sodium oxybate|mesh-list
92879523|NCT02637648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92879524|NCT02637648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879525|NCT02637648|Anesthetics, General|anesthetics, general|mesh-ancestor
92879526|NCT02637648|Anesthetics|anesthetics|mesh-ancestor
92879527|NCT02637648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879528|NCT02637648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879529|NCT02815865|Oxytocin|oxytocin|mesh-list
92879530|NCT02815865|Dinoprostone|dinoprostone|mesh-list
92879531|NCT02815865|Oxytocics|oxytocics|mesh-ancestor
92879532|NCT02815865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92879533|NCT02815865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879534|NCT02673866|Pregabalin|pregabalin|mesh-list
92879535|NCT02673866|DS-1971a|ds-1971a|mesh-list
92879536|NCT02673866|Analgesics|analgesics|mesh-ancestor
92879537|NCT02673866|Sensory System Agents|sensory system agents|mesh-ancestor
92879538|NCT02673866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879539|NCT02673866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879540|NCT02673866|Anticonvulsants|anticonvulsants|mesh-ancestor
92879541|NCT02673866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92879542|NCT02673866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92879543|NCT02673866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879544|NCT02673866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92879545|NCT02673866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92879546|NCT02673866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92879547|NCT02673866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879548|NCT02673866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92879549|NCT02673866|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92879550|NCT02673866|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92879551|NCT00964561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92879552|NCT00964561|Ciprofloxacin|ciprofloxacin|mesh-list
92879553|NCT00964561|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92879554|NCT00964561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879555|NCT00964561|Antitubercular Agents|antitubercular agents|mesh-ancestor
92879556|NCT00964561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879557|NCT00964561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879558|NCT00964561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879559|NCT00964561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879560|NCT00964561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879561|NCT00964561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92879562|NCT00964561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92879563|NCT02793323|Anesthetics|anesthetics|mesh-list
92879564|NCT02793323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879565|NCT02793323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879566|NCT00964639|Ropivacaine|ropivacaine|mesh-list
92879567|NCT00964639|Anesthetics, Local|anesthetics, local|mesh-ancestor
92879568|NCT00964639|Anesthetics|anesthetics|mesh-ancestor
92879569|NCT00964639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879570|NCT00964639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879571|NCT00964639|Sensory System Agents|sensory system agents|mesh-ancestor
92879572|NCT00964639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879573|NCT00880620|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92879574|NCT00880620|Carbidopa|carbidopa|mesh-list
92879575|NCT00880620|Levodopa|levodopa|mesh-list
92879576|NCT00880620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92879577|NCT00880620|Immunologic Factors|immunologic factors|mesh-ancestor
92879578|NCT00880620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879579|NCT00880620|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92879580|NCT00880620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92879581|NCT00880620|Dopamine Agonists|dopamine agonists|mesh-ancestor
92879583|NCT00880620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879584|NCT00880620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879585|NCT00880620|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92879586|NCT00880620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879587|NCT00959335|Bicalutamide|bicalutamide|mesh-list
92879588|NCT00959335|Androgen Antagonists|androgen antagonists|mesh-ancestor
92879589|NCT00959335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92879590|NCT00959335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879591|NCT00959335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879592|NCT00959335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879593|NCT00644618|Gemcitabine|gemcitabine|mesh-list
92879594|NCT00644618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879595|NCT00644618|Antimetabolites|antimetabolites|mesh-ancestor
92879596|NCT00644618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879597|NCT00644618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879598|NCT03967847|Ketorolac|ketorolac|mesh-list
92879599|NCT03967847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879600|NCT03967847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879601|NCT03967847|Analgesics|analgesics|mesh-ancestor
92879602|NCT03967847|Sensory System Agents|sensory system agents|mesh-ancestor
92879603|NCT03967847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879604|NCT03967847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879605|NCT03967847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879606|NCT03967847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879607|NCT03967847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92879608|NCT03967847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879609|NCT03967847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879610|NCT04175990|Dydrogesterone|dydrogesterone|mesh-list
92879611|NCT04175990|Progestins|progestins|mesh-ancestor
92879612|NCT04175990|Hormones|hormones|mesh-ancestor
92879613|NCT04175990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879614|NCT04175990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879615|NCT00959569|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92879616|NCT00959569|Esmolol|esmolol|mesh-list
92879617|NCT00959569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92879618|NCT00959569|Adrenergic Agents|adrenergic agents|mesh-ancestor
92879619|NCT00959569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879620|NCT00959569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879621|NCT00959569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879622|NCT00959569|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92879623|NCT00881868|Clobetasol|clobetasol|mesh-list
92879624|NCT00881868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879625|NCT00881868|Glucocorticoids|glucocorticoids|mesh-ancestor
92879626|NCT00881868|Hormones|hormones|mesh-ancestor
92879627|NCT00881868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879628|NCT00881868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879629|NCT04176068|Calcium|calcium|mesh-list
92879630|NCT04176068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92879631|NCT04176068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879632|NCT00959725|Infliximab|infliximab|mesh-list
92879633|NCT00959725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92879634|NCT00959725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879635|NCT00959725|Dermatologic Agents|dermatologic agents|mesh-ancestor
92879636|NCT00959725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92879637|NCT00959725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879638|NCT02789189|Gemcitabine|gemcitabine|mesh-list
92879639|NCT02789189|Nedaplatin|nedaplatin|mesh-list
92879640|NCT02789189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879641|NCT02789189|Antimetabolites|antimetabolites|mesh-ancestor
92879642|NCT02789189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879643|NCT02789189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879644|NCT04234607|Carboplatin|carboplatin|mesh-list
92879645|NCT04234607|Etoposide|etoposide|mesh-list
92879646|NCT04234607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879647|NCT04234607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92879648|NCT04234607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879649|NCT04234607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879651|NCT04234607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879652|NCT03955471|Niraparib|niraparib|mesh-list
92879653|NCT03955471|Dostarlimab|dostarlimab|mesh-list
92879654|NCT03955471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92879655|NCT03955471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879656|NCT03955471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879657|NCT03955471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879658|NCT02637726|Remifentanil|remifentanil|mesh-list
92879659|NCT02637726|Propofol|propofol|mesh-list
92879660|NCT02637726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879661|NCT02637726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879662|NCT02637726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879663|NCT02637726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879664|NCT02637726|Anesthetics, General|anesthetics, general|mesh-ancestor
92879665|NCT02637726|Anesthetics|anesthetics|mesh-ancestor
92879666|NCT02637726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92879667|NCT02637726|Narcotics|narcotics|mesh-ancestor
92879668|NCT02637726|Analgesics|analgesics|mesh-ancestor
92879669|NCT02637726|Sensory System Agents|sensory system agents|mesh-ancestor
92879670|NCT02637726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879671|NCT04161768|Norfloxacin|norfloxacin|mesh-list
92879672|NCT04161768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92879673|NCT04161768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879674|NCT04161768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524978|NCT00023374|Rifampin|rifampin|mesh-list
92879675|NCT04161768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879676|NCT04161768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879677|NCT04161768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879678|NCT04161768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879679|NCT04161768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92879680|NCT04161768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92879681|NCT05300282|Gemcitabine|gemcitabine|mesh-list
92879682|NCT05300282|Atezolizumab|atezolizumab|mesh-list
92879683|NCT05300282|Vinorelbine|vinorelbine|mesh-list
92879684|NCT05300282|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92879685|NCT05300282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879686|NCT05300282|Antimetabolites|antimetabolites|mesh-ancestor
92879687|NCT05300282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879688|NCT05300282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879689|NCT05300282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92879690|NCT05300282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92879691|NCT05300282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92879692|NCT05300282|Tubulin Modulators|tubulin modulators|mesh-ancestor
92879693|NCT05300282|Antimitotic Agents|antimitotic agents|mesh-ancestor
92879694|NCT05300282|Mitosis Modulators|mitosis modulators|mesh-ancestor
92879695|NCT05300282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92879696|NCT05300282|Alkylating Agents|alkylating agents|mesh-ancestor
92879697|NCT02793011|Dexamethasone|dexamethasone|mesh-list
92879698|NCT02793011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879699|NCT02793011|Antiemetics|antiemetics|mesh-ancestor
92879700|NCT02793011|Autonomic Agents|autonomic agents|mesh-ancestor
92879701|NCT02793011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879702|NCT02793011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879703|NCT02793011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92879704|NCT02793011|Glucocorticoids|glucocorticoids|mesh-ancestor
92879705|NCT02793011|Hormones|hormones|mesh-ancestor
92879706|NCT02793011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879707|NCT02793011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92879708|NCT02793011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879709|NCT00965107|Thiopental|thiopental|mesh-list
92879710|NCT00965107|Propofol|propofol|mesh-list
92879711|NCT00965107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879712|NCT00965107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879713|NCT00965107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879714|NCT00965107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92879715|NCT00965107|Anesthetics, General|anesthetics, general|mesh-ancestor
92879716|NCT00965107|Anesthetics|anesthetics|mesh-ancestor
92879717|NCT00965107|Anticonvulsants|anticonvulsants|mesh-ancestor
92879718|NCT00965107|GABA Modulators|gaba modulators|mesh-ancestor
92879719|NCT00965107|GABA Agents|gaba agents|mesh-ancestor
92879720|NCT00965107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879721|NCT00965107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879722|NCT02788877|Aflibercept|aflibercept|mesh-list
92879723|NCT02788877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92879724|NCT02788877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92879725|NCT02788877|Growth Substances|growth substances|mesh-ancestor
92160102|NCT00112931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879726|NCT02788877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879727|NCT02788877|Growth Inhibitors|growth inhibitors|mesh-ancestor
92879728|NCT02788877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879729|NCT00959881|Donepezil|donepezil|mesh-list
92879730|NCT00959881|Begacestat|begacestat|mesh-list
92879731|NCT00959881|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92879732|NCT00959881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879733|NCT00959881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879734|NCT00959881|Cholinergic Agents|cholinergic agents|mesh-ancestor
92879735|NCT00959881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879736|NCT00959881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879737|NCT00959881|Nootropic Agents|nootropic agents|mesh-ancestor
92879738|NCT00959881|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92879739|NCT00959959|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
92879740|NCT00959959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879741|NCT00959959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879742|NCT03651011|Aflibercept|aflibercept|mesh-list
92879743|NCT03651011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92879744|NCT03651011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92879745|NCT03651011|Growth Substances|growth substances|mesh-ancestor
92879746|NCT03651011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879747|NCT03651011|Growth Inhibitors|growth inhibitors|mesh-ancestor
92879748|NCT03651011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525047|NCT00000176|Estrogens|estrogens|mesh-list
92879749|NCT00880542|Sorafenib|sorafenib|mesh-list
92879750|NCT00880542|Ifosfamide|ifosfamide|mesh-list
92879751|NCT00880542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879752|NCT00880542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92879753|NCT00880542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879754|NCT00880542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879755|NCT00880542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92879756|NCT00880542|Alkylating Agents|alkylating agents|mesh-ancestor
92879757|NCT00960037|Vitamin D|vitamin d|mesh-list
92879758|NCT00960037|Cholecalciferol|cholecalciferol|mesh-list
92879759|NCT00960037|Vitamins|vitamins|mesh-ancestor
92879760|NCT00960037|Micronutrients|micronutrients|mesh-ancestor
92879761|NCT00960037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879762|NCT00960037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92879763|NCT00960037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92879764|NCT04161690|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92879765|NCT04161690|Ropivacaine|ropivacaine|mesh-list
92879766|NCT04161690|Anesthetics, Local|anesthetics, local|mesh-ancestor
92879767|NCT04161690|Anesthetics|anesthetics|mesh-ancestor
92879768|NCT04161690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879769|NCT04161690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879770|NCT04161690|Sensory System Agents|sensory system agents|mesh-ancestor
92879771|NCT04161690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879772|NCT04161690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879773|NCT04161690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879774|NCT04161690|Analgesics|analgesics|mesh-ancestor
92879775|NCT04161690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879776|NCT04161690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879777|NCT00885534|Temozolomide|temozolomide|mesh-list
92879778|NCT00885534|Vinblastine|vinblastine|mesh-list
92879779|NCT00885534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879780|NCT00885534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92879781|NCT00885534|Alkylating Agents|alkylating agents|mesh-ancestor
92879782|NCT00885534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879783|NCT00885534|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92879784|NCT00885534|Tubulin Modulators|tubulin modulators|mesh-ancestor
92879785|NCT00885534|Antimitotic Agents|antimitotic agents|mesh-ancestor
92879786|NCT00885534|Mitosis Modulators|mitosis modulators|mesh-ancestor
92879787|NCT05277038|Clonidine|clonidine|mesh-list
92879788|NCT05277038|Zopiclone|zopiclone|mesh-list
92879789|NCT05277038|Analgesics|analgesics|mesh-ancestor
92879790|NCT05277038|Sensory System Agents|sensory system agents|mesh-ancestor
92879791|NCT05277038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879792|NCT05277038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879793|NCT05277038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92879794|NCT05277038|Sympatholytics|sympatholytics|mesh-ancestor
92879795|NCT05277038|Autonomic Agents|autonomic agents|mesh-ancestor
92879796|NCT05277038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92879797|NCT05277038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92879798|NCT05277038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92879799|NCT05277038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92879800|NCT05277038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879801|NCT05277038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879802|NCT05277038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92879803|NCT05277038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879804|NCT00960349|Cisplatin|cisplatin|mesh-list
92879805|NCT00960349|Capecitabine|capecitabine|mesh-list
92879806|NCT00960349|Cediranib|cediranib|mesh-list
92879807|NCT00960349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879808|NCT00960349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879809|NCT00960349|Antimetabolites|antimetabolites|mesh-ancestor
92879810|NCT00960349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879811|NCT00960349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92879812|NCT00960349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879813|NCT02670434|Pitavastatin|pitavastatin|mesh-list
92879814|NCT02670434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92879815|NCT02670434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92879816|NCT02670434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92879817|NCT02670434|Antimetabolites|antimetabolites|mesh-ancestor
92879818|NCT02670434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879819|NCT02670434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879820|NCT02670434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92879821|NCT00965653|Folic Acid|folic acid|mesh-list
92879822|NCT00965653|Methotrexate|methotrexate|mesh-list
92879823|NCT00965653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92525122|NCT00000221|Analgesics|analgesics|mesh-ancestor
92879824|NCT00965653|Abortifacient Agents|abortifacient agents|mesh-ancestor
92879825|NCT00965653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92879826|NCT00965653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879827|NCT00965653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879828|NCT00965653|Antimetabolites|antimetabolites|mesh-ancestor
92879829|NCT00965653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879830|NCT00965653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879831|NCT00965653|Dermatologic Agents|dermatologic agents|mesh-ancestor
92879832|NCT00965653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879833|NCT00965653|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92879834|NCT00965653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92879835|NCT00965653|Immunologic Factors|immunologic factors|mesh-ancestor
92879836|NCT00965653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879837|NCT00965653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92879838|NCT00965653|Hematinics|hematinics|mesh-ancestor
92879839|NCT00965653|Vitamin B Complex|vitamin b complex|mesh-ancestor
92879840|NCT00965653|Vitamins|vitamins|mesh-ancestor
92879841|NCT00965653|Micronutrients|micronutrients|mesh-ancestor
92879842|NCT00644696|Cefixime|cefixime|mesh-list
92879843|NCT00644696|Cefpodoxime|cefpodoxime|mesh-list
92879844|NCT00644696|Irinotecan|irinotecan|mesh-list
92879845|NCT00644696|Bortezomib|bortezomib|mesh-list
92879846|NCT00644696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92879847|NCT00644696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879848|NCT00644696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879849|NCT00644696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879850|NCT00644696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879851|NCT00644696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92879852|NCT00644696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92879853|NCT00960739|Topotecan|topotecan|mesh-list
92879854|NCT00960739|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92879855|NCT00960739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92879856|NCT00960739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879857|NCT00960739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879858|NCT00960739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879859|NCT00960739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879860|NCT00960739|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92879861|NCT00659022|Bevacizumab|bevacizumab|mesh-list
92879862|NCT00659022|Capecitabine|capecitabine|mesh-list
92879863|NCT00659022|Oxaliplatin|oxaliplatin|mesh-list
92879864|NCT00659022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92879865|NCT00659022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879866|NCT00659022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92879867|NCT00659022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92879868|NCT00659022|Growth Substances|growth substances|mesh-ancestor
92879869|NCT00659022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879870|NCT00659022|Growth Inhibitors|growth inhibitors|mesh-ancestor
92879871|NCT00659022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92879872|NCT00659022|Antimetabolites|antimetabolites|mesh-ancestor
92879873|NCT00659022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879874|NCT02788643|Dimercaprol|dimercaprol|mesh-list
92879875|NCT02788643|Chelating Agents|chelating agents|mesh-ancestor
92879876|NCT02788643|Sequestering Agents|sequestering agents|mesh-ancestor
92879877|NCT02788643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879878|NCT04175522|Immunoglobulins|immunoglobulins|mesh-list
92879879|NCT04175522|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92879880|NCT04175522|Antibodies|antibodies|mesh-list
92879881|NCT04175522|Immunoglobulin G|immunoglobulin g|mesh-list
92879882|NCT04175522|Immunologic Factors|immunologic factors|mesh-ancestor
92879883|NCT04175522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879884|NCT00960817|Aspirin|aspirin|mesh-list
92879885|NCT00960817|Dipyridamole|dipyridamole|mesh-list
92879886|NCT00960817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879887|NCT00960817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879888|NCT00960817|Analgesics|analgesics|mesh-ancestor
92879889|NCT00960817|Sensory System Agents|sensory system agents|mesh-ancestor
92879890|NCT00960817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879891|NCT00960817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879892|NCT00960817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879893|NCT00960817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879894|NCT00960817|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92879895|NCT00960817|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92879896|NCT00960817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879897|NCT00960817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92879898|NCT00960817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92525197|NCT00023998|Immunologic Factors|immunologic factors|mesh-ancestor
92879899|NCT00960817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879901|NCT00960817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92879902|NCT00960817|Vasodilator Agents|vasodilator agents|mesh-ancestor
92879903|NCT00965809|Dronabinol|dronabinol|mesh-list
92879904|NCT00965809|Hallucinogens|hallucinogens|mesh-ancestor
92879905|NCT00965809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879906|NCT00965809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92879907|NCT00965809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879908|NCT00965809|Analgesics|analgesics|mesh-ancestor
92879909|NCT00965809|Sensory System Agents|sensory system agents|mesh-ancestor
92879910|NCT00965809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879911|NCT00965809|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92879912|NCT00965809|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92879913|NCT00965809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879914|NCT00965809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879915|NCT00965809|Hormones|hormones|mesh-ancestor
92879916|NCT00965809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879917|NCT00885378|Metformin|metformin|mesh-list
92879918|NCT00885378|Saxagliptin|saxagliptin|mesh-list
92879919|NCT00885378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92879920|NCT00885378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879921|NCT00885378|Incretins|incretins|mesh-ancestor
92879922|NCT00885378|Hormones|hormones|mesh-ancestor
92879923|NCT00885378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92879924|NCT00885378|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92879925|NCT00885378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92879926|NCT00885378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879927|NCT00885378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879928|NCT04095494|Nitrous Oxide|nitrous oxide|mesh-list
92879929|NCT04095494|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92879930|NCT04095494|Anesthetics, General|anesthetics, general|mesh-ancestor
92879931|NCT04095494|Anesthetics|anesthetics|mesh-ancestor
92879932|NCT04095494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879933|NCT04095494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879934|NCT04095494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879935|NCT04095494|Analgesics|analgesics|mesh-ancestor
92879936|NCT04095494|Sensory System Agents|sensory system agents|mesh-ancestor
92879937|NCT04095494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879938|NCT02537210|Mesalamine|mesalamine|mesh-list
92879939|NCT02537210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879940|NCT02537210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879941|NCT02537210|Analgesics|analgesics|mesh-ancestor
92879942|NCT02537210|Sensory System Agents|sensory system agents|mesh-ancestor
92879943|NCT02537210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879944|NCT02537210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879946|NCT02537210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879947|NCT01563289|Ibuprofen|ibuprofen|mesh-list
92879948|NCT01563289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92879949|NCT01563289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92879950|NCT01563289|Analgesics|analgesics|mesh-ancestor
92879951|NCT01563289|Sensory System Agents|sensory system agents|mesh-ancestor
92879952|NCT01563289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879953|NCT01563289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879954|NCT01563289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92879955|NCT01563289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92879956|NCT01563289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92879957|NCT01563289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879958|NCT01563289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879959|NCT00960973|Menatetrenone|menatetrenone|mesh-list
92879960|NCT00960973|Hemostatics|hemostatics|mesh-ancestor
92879961|NCT00960973|Coagulants|coagulants|mesh-ancestor
92879962|NCT04099849|Zinc|zinc|mesh-list
92879963|NCT04099849|Trace Elements|trace elements|mesh-ancestor
92879964|NCT04099849|Micronutrients|micronutrients|mesh-ancestor
92879965|NCT04099849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879966|NCT00659100|Gabapentin|gabapentin|mesh-list
92879967|NCT00659100|Analgesics|analgesics|mesh-ancestor
92879968|NCT00659100|Sensory System Agents|sensory system agents|mesh-ancestor
92879969|NCT00659100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879970|NCT00659100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92879971|NCT00659100|Anticonvulsants|anticonvulsants|mesh-ancestor
92879972|NCT00659100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92879973|NCT00659100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92525275|NCT00024271|Antimetabolites|antimetabolites|mesh-ancestor
92879974|NCT00659100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92879975|NCT00659100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92879976|NCT00659100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92879977|NCT00659100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92879978|NCT00659100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92879979|NCT00659100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879980|NCT00659100|Antimanic Agents|antimanic agents|mesh-ancestor
92879981|NCT00659178|Doxorubicin|doxorubicin|mesh-list
92879982|NCT00659178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92879983|NCT00659178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92879984|NCT00659178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92879985|NCT00659178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92879986|NCT00659178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92879987|NCT00659178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92879988|NCT00659178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879989|NCT02792621|Acipimox|acipimox|mesh-list
92879990|NCT02792621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92879991|NCT02792621|Antimetabolites|antimetabolites|mesh-ancestor
92879992|NCT02792621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92879993|NCT02792621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92879994|NCT04009759|Ketamine|ketamine|mesh-list
92879995|NCT04009759|Morphine|morphine|mesh-list
92879996|NCT04009759|Analgesics|analgesics|mesh-ancestor
92879997|NCT04009759|Sensory System Agents|sensory system agents|mesh-ancestor
92879998|NCT04009759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92879999|NCT04009759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880000|NCT04009759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92880001|NCT04009759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92880002|NCT04009759|Anesthetics, General|anesthetics, general|mesh-ancestor
92880003|NCT04009759|Anesthetics|anesthetics|mesh-ancestor
92880004|NCT04009759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880005|NCT04009759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92880006|NCT04009759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92880007|NCT04009759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880008|NCT04009759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880009|NCT04009759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92880010|NCT04009759|Narcotics|narcotics|mesh-ancestor
92880011|NCT00645086|Clarithromycin|clarithromycin|mesh-list
92880012|NCT00645086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92880013|NCT00645086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880014|NCT00645086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92880015|NCT00645086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880016|NCT00645086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880017|NCT00645086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92880018|NCT00645086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92880019|NCT05238649|Vaccines|vaccines|mesh-list
92880020|NCT05238649|Immunologic Factors|immunologic factors|mesh-ancestor
92880021|NCT05238649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880022|NCT02792153|Estradiol|estradiol|mesh-list
92880023|NCT02792153|Estrogens|estrogens|mesh-ancestor
92880024|NCT02792153|Hormones|hormones|mesh-ancestor
92880025|NCT02792153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880026|NCT02792153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880027|NCT00644540|Vaccines|vaccines|mesh-list
92880028|NCT00644540|Immunologic Factors|immunologic factors|mesh-ancestor
92880029|NCT00644540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880030|NCT02669732|Firuglipel|firuglipel|mesh-list
92880031|NCT02669732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92880032|NCT02669732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880033|NCT05003245|Ranibizumab|ranibizumab|mesh-list
92880034|NCT05003245|Antibodies|antibodies|mesh-list
92880035|NCT05003245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92880036|NCT05003245|Mitogens|mitogens|mesh-list
92880037|NCT05003245|Endothelial Growth Factors|endothelial growth factors|mesh-list
92880038|NCT05003245|Immunologic Factors|immunologic factors|mesh-ancestor
92880039|NCT05003245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880040|NCT05003245|Mitosis Modulators|mitosis modulators|mesh-ancestor
92880041|NCT05003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880042|NCT05003245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92880043|NCT05003245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92880044|NCT05003245|Growth Substances|growth substances|mesh-ancestor
92880045|NCT05003245|Growth Inhibitors|growth inhibitors|mesh-ancestor
92880046|NCT05003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880047|NCT05367089|Fluconazole|fluconazole|mesh-list
92880048|NCT05367089|Antifungal Agents|antifungal agents|mesh-ancestor
92880049|NCT05367089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880050|NCT05367089|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92880051|NCT05367089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92880052|NCT05367089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880053|NCT05367089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880054|NCT05367089|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92880055|NCT05367089|Hormone Antagonists|hormone antagonists|mesh-ancestor
92880056|NCT05367089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880057|NCT05367089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880058|NCT05367089|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92880059|NCT05367089|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92880061|NCT02671058|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92880062|NCT02671058|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92880063|NCT02671058|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92880064|NCT02671058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880065|NCT02791919|Cytarabine|cytarabine|mesh-list
92880066|NCT02791919|Fludarabine|fludarabine|mesh-list
92880067|NCT02791919|Fludarabine phosphate|fludarabine phosphate|mesh-list
92880068|NCT02791919|Lenograstim|lenograstim|mesh-list
92880069|NCT02791919|Adavosertib|adavosertib|mesh-list
92880070|NCT02791919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880071|NCT02791919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880072|NCT02791919|Antimetabolites|antimetabolites|mesh-ancestor
92880073|NCT02791919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880074|NCT02791919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880075|NCT02791919|Immunologic Factors|immunologic factors|mesh-ancestor
92880076|NCT02791919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880077|NCT02791919|Antiviral Agents|antiviral agents|mesh-ancestor
92880078|NCT02791919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880079|NCT02791919|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92880080|NCT02791919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880081|NCT00966121|Propranolol|propranolol|mesh-list
92880082|NCT00966121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92880083|NCT00966121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92880084|NCT00966121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92880085|NCT00966121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880086|NCT00966121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880087|NCT00966121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880088|NCT00966121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92880089|NCT00966121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92880090|NCT00966121|Vasodilator Agents|vasodilator agents|mesh-ancestor
92880091|NCT02537288|Moxifloxacin|moxifloxacin|mesh-list
92880092|NCT02537288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92880093|NCT02537288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880094|NCT02537288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92880095|NCT02537288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92880096|NCT02537288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880097|NCT02537288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880098|NCT02537288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880099|NCT00659412|Methotrexate|methotrexate|mesh-list
92880100|NCT00659412|Alefacept|alefacept|mesh-list
92880101|NCT00659412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92880102|NCT00659412|Abortifacient Agents|abortifacient agents|mesh-ancestor
92880103|NCT00659412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92880104|NCT00659412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880105|NCT00659412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880106|NCT00659412|Antimetabolites|antimetabolites|mesh-ancestor
92880107|NCT00659412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880108|NCT00659412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880109|NCT00659412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92880110|NCT00659412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880111|NCT00659412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92880112|NCT00659412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880113|NCT00659412|Immunologic Factors|immunologic factors|mesh-ancestor
92880114|NCT00659412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880115|NCT00659412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880116|NCT04176224|Edaravone|edaravone|mesh-list
92880117|NCT04176224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92880118|NCT04176224|Antioxidants|antioxidants|mesh-ancestor
92880119|NCT04176224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880120|NCT04176224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92880121|NCT04176224|Protective Agents|protective agents|mesh-ancestor
92880122|NCT04176224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880123|NCT00966199|Antihypertensive Agents|antihypertensive agents|mesh-list
92880124|NCT04158102|Bupivacaine|bupivacaine|mesh-list
92880125|NCT04158102|Anesthetics, Local|anesthetics, local|mesh-ancestor
92880126|NCT04158102|Anesthetics|anesthetics|mesh-ancestor
92880127|NCT04158102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880128|NCT04158102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880129|NCT04158102|Sensory System Agents|sensory system agents|mesh-ancestor
92880130|NCT04158102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880131|NCT02689895|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92880132|NCT02689895|Antiviral Agents|antiviral agents|mesh-ancestor
92880133|NCT02689895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880134|NCT00961363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92880135|NCT00961363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92880136|NCT00961363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880137|NCT00961363|Incretins|incretins|mesh-ancestor
92880138|NCT00961363|Hormones|hormones|mesh-ancestor
92880139|NCT00961363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880140|NCT00961363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92880141|NCT00961363|Protease Inhibitors|protease inhibitors|mesh-ancestor
92880142|NCT00961363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880143|NCT00961363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880144|NCT02633202|Cisplatin|cisplatin|mesh-list
92880145|NCT02633202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880146|NCT00645242|Fluconazole|fluconazole|mesh-list
92880147|NCT00645242|Antifungal Agents|antifungal agents|mesh-ancestor
92880148|NCT00645242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880149|NCT00645242|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92880150|NCT00645242|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92880151|NCT00645242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880152|NCT00645242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880153|NCT00645242|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92880154|NCT00645242|Hormone Antagonists|hormone antagonists|mesh-ancestor
92880155|NCT00645242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880156|NCT00645242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880157|NCT00645242|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92880158|NCT00645242|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92880159|NCT00659568|Metformin|metformin|mesh-list
92880160|NCT00659568|Sirolimus|sirolimus|mesh-list
92880161|NCT00659568|Temsirolimus|temsirolimus|mesh-list
92880162|NCT00659568|MTOR Inhibitors|mtor inhibitors|mesh-list
92880163|NCT00659568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92880164|NCT00659568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880165|NCT00659568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92880166|NCT00659568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880167|NCT00659568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880168|NCT00659568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880169|NCT00659568|Immunologic Factors|immunologic factors|mesh-ancestor
92880170|NCT00659568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880171|NCT00659568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92880172|NCT00659568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880173|NCT00659568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92880174|NCT00659568|Antifungal Agents|antifungal agents|mesh-ancestor
92880175|NCT00961753|Ibuprofen|ibuprofen|mesh-list
92880176|NCT00961753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92880177|NCT00961753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92880178|NCT00961753|Analgesics|analgesics|mesh-ancestor
92880179|NCT00961753|Sensory System Agents|sensory system agents|mesh-ancestor
92880180|NCT00961753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880181|NCT00961753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880182|NCT00961753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880183|NCT00961753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880184|NCT00961753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92880185|NCT00961753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880186|NCT00961753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880187|NCT04232813|Estradiol|estradiol|mesh-list
92880188|NCT04232813|Estrogens|estrogens|mesh-ancestor
92880189|NCT04232813|Hormones|hormones|mesh-ancestor
92880190|NCT04232813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880191|NCT04232813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880192|NCT00659958|Zonisamide|zonisamide|mesh-list
92880193|NCT00659958|Anticonvulsants|anticonvulsants|mesh-ancestor
92880194|NCT00659958|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92880195|NCT00659958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880196|NCT00659958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880197|NCT00659958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92880198|NCT00659958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880199|NCT00644774|Azithromycin|azithromycin|mesh-list
92880200|NCT00644774|Cefdinir|cefdinir|mesh-list
92880201|NCT00644774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92880202|NCT00644774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880203|NCT00545779|Ibandronic Acid|ibandronic acid|mesh-list
92880204|NCT00545779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92880205|NCT00545779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880206|NCT00910442|Acetylcysteine|acetylcysteine|mesh-list
92880207|NCT00910442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92880208|NCT00910442|Antiviral Agents|antiviral agents|mesh-ancestor
92880209|NCT00910442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880210|NCT00910442|Expectorants|expectorants|mesh-ancestor
92880211|NCT00910442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92880212|NCT00910442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92880213|NCT00910442|Antioxidants|antioxidants|mesh-ancestor
92880214|NCT00910442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880215|NCT00910442|Protective Agents|protective agents|mesh-ancestor
92880216|NCT00910442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880217|NCT00910442|Antidotes|antidotes|mesh-ancestor
92880218|NCT00660036|Etoposide|etoposide|mesh-list
92880219|NCT00660036|Mitoxantrone|mitoxantrone|mesh-list
92880220|NCT00660036|Gemtuzumab|gemtuzumab|mesh-list
92880221|NCT00660036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92880222|NCT00660036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880223|NCT00660036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92880224|NCT00660036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92880225|NCT00660036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880226|NCT00660036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880227|NCT00660036|Analgesics|analgesics|mesh-ancestor
92880228|NCT00660036|Sensory System Agents|sensory system agents|mesh-ancestor
92880229|NCT00660036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880230|NCT00660036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880231|NCT00660036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92880232|NCT00660036|Immunotoxins|immunotoxins|mesh-ancestor
92880233|NCT00660036|Immunoconjugates|immunoconjugates|mesh-ancestor
92880234|NCT00660036|Immunologic Factors|immunologic factors|mesh-ancestor
92880235|NCT02791373|Gemcitabine|gemcitabine|mesh-list
92880236|NCT02791373|Vinorelbine|vinorelbine|mesh-list
92880237|NCT02791373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880238|NCT02791373|Antimetabolites|antimetabolites|mesh-ancestor
92880239|NCT02791373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880240|NCT02791373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880241|NCT02791373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92880242|NCT02791373|Tubulin Modulators|tubulin modulators|mesh-ancestor
92880243|NCT02791373|Antimitotic Agents|antimitotic agents|mesh-ancestor
92880244|NCT02791373|Mitosis Modulators|mitosis modulators|mesh-ancestor
92880246|NCT03102047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92880247|NCT03102047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880248|NCT00966745|Milrinone|milrinone|mesh-list
92880249|NCT00966745|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92880250|NCT00966745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92880251|NCT00966745|Vasodilator Agents|vasodilator agents|mesh-ancestor
92880252|NCT00966745|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92880253|NCT00966745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92880254|NCT00966745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880255|NCT00966745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880256|NCT00966745|Protective Agents|protective agents|mesh-ancestor
92880257|NCT00966745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880258|NCT02669030|Suvorexant|suvorexant|mesh-list
92880259|NCT02669030|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92880260|NCT02669030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92880261|NCT02669030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880262|NCT02669030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880263|NCT02669030|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92880264|NCT02669030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880265|NCT02669030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880266|NCT02668796|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92880267|NCT02668796|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92880268|NCT02668796|Estradiol|estradiol|mesh-list
92880269|NCT02668796|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92880270|NCT02668796|Estrogens|estrogens|mesh-ancestor
92880271|NCT02668796|Hormones|hormones|mesh-ancestor
92880272|NCT02668796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880273|NCT02668796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880274|NCT02668796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92880275|NCT02668796|Contraceptive Agents|contraceptive agents|mesh-ancestor
92880276|NCT02668796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92880277|NCT02668796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92880278|NCT00645320|Ziprasidone|ziprasidone|mesh-list
92880279|NCT00645320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92880280|NCT00645320|Serotonin Agents|serotonin agents|mesh-ancestor
92880281|NCT00645320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880282|NCT00645320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880283|NCT00645320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880284|NCT00645320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92880285|NCT00645320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92880286|NCT00645320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880287|NCT00645320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880288|NCT00645320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92880289|NCT00645320|Dopamine Agents|dopamine agents|mesh-ancestor
92880290|NCT03938857|Fentanyl|fentanyl|mesh-list
92880291|NCT03938857|Dexmedetomidine|dexmedetomidine|mesh-list
92880292|NCT03938857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92880293|NCT03938857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880294|NCT03938857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880295|NCT03938857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92880296|NCT03938857|Analgesics|analgesics|mesh-ancestor
92880297|NCT03938857|Sensory System Agents|sensory system agents|mesh-ancestor
92880298|NCT03938857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880299|NCT03938857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92880300|NCT03938857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92880301|NCT03938857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92880302|NCT03938857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92880303|NCT03938857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880304|NCT03938857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880305|NCT03938857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92880306|NCT03938857|Narcotics|narcotics|mesh-ancestor
92880307|NCT03938857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92880308|NCT03938857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92880310|NCT03938857|Anesthetics|anesthetics|mesh-ancestor
92880311|NCT04160598|Fentanyl|fentanyl|mesh-list
92880312|NCT04160598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92880313|NCT04160598|Narcotics|narcotics|mesh-ancestor
92880314|NCT04160598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880315|NCT04160598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880316|NCT04160598|Analgesics|analgesics|mesh-ancestor
92880317|NCT04160598|Sensory System Agents|sensory system agents|mesh-ancestor
92880318|NCT04160598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880319|NCT04160598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92880320|NCT04160598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92880321|NCT04160598|Anesthetics, General|anesthetics, general|mesh-ancestor
92880322|NCT04160598|Anesthetics|anesthetics|mesh-ancestor
92880323|NCT00967837|Insulin|insulin|mesh-list
92880324|NCT00967837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92880325|NCT00967837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92880326|NCT00967837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880327|NCT02668016|Atorvastatin|atorvastatin|mesh-list
92880328|NCT02668016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92880329|NCT02668016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92880330|NCT02668016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92880331|NCT02668016|Antimetabolites|antimetabolites|mesh-ancestor
92880332|NCT02668016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880333|NCT02668016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92880334|NCT02668016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880335|NCT03012971|Dexmedetomidine|dexmedetomidine|mesh-list
92880336|NCT03012971|Morphine|morphine|mesh-list
92880337|NCT03012971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92880338|NCT03012971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880339|NCT03012971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880340|NCT03012971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92880341|NCT03012971|Analgesics|analgesics|mesh-ancestor
92880342|NCT03012971|Sensory System Agents|sensory system agents|mesh-ancestor
92880343|NCT03012971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880344|NCT03012971|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92880345|NCT03012971|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92880346|NCT03012971|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92880347|NCT03012971|Adrenergic Agents|adrenergic agents|mesh-ancestor
92880348|NCT03012971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880349|NCT03012971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880350|NCT03012971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92880351|NCT03012971|Narcotics|narcotics|mesh-ancestor
92880352|NCT00966901|Nicotine|nicotine|mesh-list
92880353|NCT00966901|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92880354|NCT00966901|Autonomic Agents|autonomic agents|mesh-ancestor
92880355|NCT00966901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880356|NCT00966901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880357|NCT00966901|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92880358|NCT00966901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92880359|NCT00966901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92880360|NCT00966901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880361|NCT00966901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880362|NCT02668172|Pasireotide|pasireotide|mesh-list
92880363|NCT02668172|Hormones|hormones|mesh-ancestor
92880364|NCT02668172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880365|NCT02668172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880366|NCT00660270|Interferons|interferons|mesh-list
92880367|NCT00660270|Interferon-alpha|interferon-alpha|mesh-list
92880368|NCT00660270|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92880369|NCT00660270|Gemcitabine|gemcitabine|mesh-list
92880370|NCT00660270|Fluorouracil|fluorouracil|mesh-list
92880371|NCT00660270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880372|NCT00660270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880373|NCT00660270|Antimetabolites|antimetabolites|mesh-ancestor
92880374|NCT00660270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160128|NCT05307003|Trazodone|trazodone|mesh-list
92880375|NCT00660270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880376|NCT00660270|Immunologic Factors|immunologic factors|mesh-ancestor
92880377|NCT00660270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880378|NCT00660270|Antiviral Agents|antiviral agents|mesh-ancestor
92880379|NCT00660270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880380|NCT04032132|Curcumin|curcumin|mesh-list
92880381|NCT04032132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92880382|NCT04032132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92880383|NCT04032132|Analgesics|analgesics|mesh-ancestor
92880384|NCT04032132|Sensory System Agents|sensory system agents|mesh-ancestor
92880385|NCT04032132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880386|NCT04032132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880387|NCT04032132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880388|NCT04032132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880389|NCT04032132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880390|NCT04032132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880391|NCT04032132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880392|NCT00967057|Dexamethasone|dexamethasone|mesh-list
92880393|NCT00967057|Methotrexate|methotrexate|mesh-list
92880394|NCT00967057|Vincristine|vincristine|mesh-list
92880395|NCT00967057|Asparaginase|asparaginase|mesh-list
92880396|NCT00967057|Mitoxantrone|mitoxantrone|mesh-list
92880397|NCT00967057|Idarubicin|idarubicin|mesh-list
92880398|NCT00967057|Pegaspargase|pegaspargase|mesh-list
92880399|NCT00967057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880400|NCT00967057|Antiemetics|antiemetics|mesh-ancestor
92880401|NCT00967057|Autonomic Agents|autonomic agents|mesh-ancestor
92880402|NCT00967057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880403|NCT00967057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880404|NCT00967057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92880405|NCT00967057|Glucocorticoids|glucocorticoids|mesh-ancestor
92880406|NCT00967057|Hormones|hormones|mesh-ancestor
92880407|NCT00967057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880408|NCT00967057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92880409|NCT00967057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880410|NCT00967057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92880411|NCT00967057|Abortifacient Agents|abortifacient agents|mesh-ancestor
92880412|NCT00967057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92880413|NCT00967057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880414|NCT00967057|Antimetabolites|antimetabolites|mesh-ancestor
92880415|NCT00967057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880416|NCT00967057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92880417|NCT00967057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880418|NCT00967057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92880419|NCT00967057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880420|NCT00967057|Immunologic Factors|immunologic factors|mesh-ancestor
92880421|NCT00967057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880422|NCT00967057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880423|NCT00967057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92880424|NCT00967057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92880425|NCT00967057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92880426|NCT00967057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92880427|NCT00967057|Analgesics|analgesics|mesh-ancestor
92880428|NCT00967057|Sensory System Agents|sensory system agents|mesh-ancestor
92880429|NCT00967057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92880430|NCT00967057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92880431|NCT00967057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92880432|NCT02633514|Etoposide|etoposide|mesh-list
92880433|NCT02633514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880434|NCT02633514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92880435|NCT02633514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92880436|NCT02633514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92880437|NCT02633514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880438|NCT02633514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880439|NCT00656214|Lycopene|lycopene|mesh-list
92880440|NCT00656214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880441|NCT00656214|Antioxidants|antioxidants|mesh-ancestor
92880442|NCT00656214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880443|NCT00656214|Protective Agents|protective agents|mesh-ancestor
92880444|NCT00656214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880445|NCT00656214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92880446|NCT00656214|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92880447|NCT00656214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880448|NCT02790671|Firuglipel|firuglipel|mesh-list
92880449|NCT02790671|Itraconazole|itraconazole|mesh-list
92880450|NCT02790671|Antifungal Agents|antifungal agents|mesh-ancestor
92880451|NCT02790671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880452|NCT02790671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92880453|NCT02790671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92880454|NCT02790671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880455|NCT02790671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880456|NCT02790671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92880457|NCT02790671|Hormone Antagonists|hormone antagonists|mesh-ancestor
92880458|NCT02790671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880459|NCT02790671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880460|NCT02790671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92880461|NCT02790671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92880463|NCT02668094|Pregabalin|pregabalin|mesh-list
92880464|NCT02668094|Propofol|propofol|mesh-list
92880465|NCT02668094|Anesthetics, Local|anesthetics, local|mesh-ancestor
92880466|NCT02668094|Anesthetics|anesthetics|mesh-ancestor
92880467|NCT02668094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880468|NCT02668094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880469|NCT02668094|Sensory System Agents|sensory system agents|mesh-ancestor
92880470|NCT02668094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880471|NCT02668094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92880472|NCT02668094|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92880473|NCT02668094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92880474|NCT02668094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880475|NCT02668094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880476|NCT02668094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92880477|NCT02668094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92880478|NCT02668094|Anesthetics, General|anesthetics, general|mesh-ancestor
92880479|NCT02668094|Analgesics|analgesics|mesh-ancestor
92880480|NCT02668094|Anticonvulsants|anticonvulsants|mesh-ancestor
92880481|NCT02668094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92880482|NCT02668094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92880483|NCT02668094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92880484|NCT02668094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92880485|NCT02668094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880486|NCT00967135|Pregabalin|pregabalin|mesh-list
92880487|NCT00967135|Analgesics|analgesics|mesh-ancestor
92880488|NCT00967135|Sensory System Agents|sensory system agents|mesh-ancestor
92880489|NCT00967135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880490|NCT00967135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880491|NCT00967135|Anticonvulsants|anticonvulsants|mesh-ancestor
92880492|NCT00967135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92880493|NCT00967135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880494|NCT00967135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046931|NCT00346268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92880495|NCT00967135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92880496|NCT00967135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92880497|NCT00967135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92880498|NCT00967135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880499|NCT00967135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880500|NCT02666768|Interferons|interferons|mesh-list
92880501|NCT02666768|Interferon-gamma|interferon-gamma|mesh-list
92880502|NCT02666768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880503|NCT02666768|Antiviral Agents|antiviral agents|mesh-ancestor
92880504|NCT02666768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880505|NCT00967213|Ranibizumab|ranibizumab|mesh-list
92880506|NCT00967213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92880507|NCT00967213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92880508|NCT00967213|Growth Substances|growth substances|mesh-ancestor
92880509|NCT00967213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880510|NCT00967213|Growth Inhibitors|growth inhibitors|mesh-ancestor
92880511|NCT00967213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880512|NCT04160676|Ascorbic Acid|ascorbic acid|mesh-list
92880513|NCT04160676|Thiamine|thiamine|mesh-list
92880514|NCT04160676|Hydrocortisone|hydrocortisone|mesh-list
92880515|NCT04160676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880516|NCT04160676|Antioxidants|antioxidants|mesh-ancestor
92880517|NCT04160676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880518|NCT04160676|Protective Agents|protective agents|mesh-ancestor
92880519|NCT04160676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880520|NCT04160676|Vitamins|vitamins|mesh-ancestor
92880521|NCT04160676|Micronutrients|micronutrients|mesh-ancestor
92880522|NCT04160676|Vitamin B Complex|vitamin b complex|mesh-ancestor
92880523|NCT00660426|Gemcitabine|gemcitabine|mesh-list
92880524|NCT00660426|Capecitabine|capecitabine|mesh-list
92880525|NCT00660426|Oxaliplatin|oxaliplatin|mesh-list
92880526|NCT00660426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880527|NCT00660426|Antimetabolites|antimetabolites|mesh-ancestor
92880528|NCT00660426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880529|NCT00660426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880530|NCT00967291|Ifosfamide|ifosfamide|mesh-list
92880531|NCT00967291|Mitomycins|mitomycins|mesh-list
92880532|NCT00967291|Mitomycin|mitomycin|mesh-list
92880533|NCT00967291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92880534|NCT00967291|Alkylating Agents|alkylating agents|mesh-ancestor
92880535|NCT00967291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880536|NCT00967291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880537|NCT00967291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92880538|NCT00967291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880539|NCT00967291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880540|NCT00645398|Pregabalin|pregabalin|mesh-list
92880541|NCT00645398|Analgesics|analgesics|mesh-ancestor
92880542|NCT00645398|Sensory System Agents|sensory system agents|mesh-ancestor
92880543|NCT00645398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880544|NCT00645398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880545|NCT00645398|Anticonvulsants|anticonvulsants|mesh-ancestor
92880546|NCT00645398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92880547|NCT00645398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880548|NCT00645398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880549|NCT00645398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92880550|NCT00645398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92880551|NCT00645398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92880552|NCT00645398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880553|NCT00645398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880554|NCT00884832|Clonidine|clonidine|mesh-list
92880555|NCT00884832|Analgesics|analgesics|mesh-ancestor
92880556|NCT00884832|Sensory System Agents|sensory system agents|mesh-ancestor
92880557|NCT00884832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880558|NCT00884832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880559|NCT00884832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92880560|NCT00884832|Sympatholytics|sympatholytics|mesh-ancestor
92880561|NCT00884832|Autonomic Agents|autonomic agents|mesh-ancestor
92880562|NCT00884832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92880563|NCT00884832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92880564|NCT00884832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92880565|NCT00884832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92880566|NCT00884832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880567|NCT00884832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880568|NCT00660582|Leucovorin|leucovorin|mesh-list
92880569|NCT00660582|Folic Acid|folic acid|mesh-list
92880570|NCT00660582|Fluorouracil|fluorouracil|mesh-list
92880571|NCT00660582|Oxaliplatin|oxaliplatin|mesh-list
92880573|NCT00660582|Levoleucovorin|levoleucovorin|mesh-list
92880574|NCT00660582|Antimetabolites|antimetabolites|mesh-ancestor
92880575|NCT00660582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880576|NCT00660582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880577|NCT00660582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880578|NCT00660582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880579|NCT00660582|Immunologic Factors|immunologic factors|mesh-ancestor
92880580|NCT00660582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880581|NCT00660582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92880582|NCT00660582|Antidotes|antidotes|mesh-ancestor
92880583|NCT00660582|Protective Agents|protective agents|mesh-ancestor
92880584|NCT00660582|Vitamin B Complex|vitamin b complex|mesh-ancestor
92880585|NCT00660582|Vitamins|vitamins|mesh-ancestor
92880586|NCT00660582|Micronutrients|micronutrients|mesh-ancestor
92880587|NCT00660582|Hematinics|hematinics|mesh-ancestor
92880588|NCT00646802|Progesterone|progesterone|mesh-list
92880589|NCT00646802|Progestins|progestins|mesh-ancestor
92880590|NCT00646802|Hormones|hormones|mesh-ancestor
92880591|NCT00646802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880592|NCT00646802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880593|NCT00968383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92880594|NCT00968383|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92880595|NCT00968383|Adrenergic Agents|adrenergic agents|mesh-list
92880596|NCT00968383|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92880597|NCT00968383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92880598|NCT00968383|Protease Inhibitors|protease inhibitors|mesh-ancestor
92880599|NCT00968383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880600|NCT00968383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880601|NCT00968383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880602|NCT00968383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880603|NCT00657228|Heparin|heparin|mesh-list
92880604|NCT00657228|Anticoagulants|anticoagulants|mesh-ancestor
92880605|NCT00657228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92880606|NCT00657228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92880607|NCT00657228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880608|NCT02666534|Lidocaine|lidocaine|mesh-list
92880609|NCT02666534|Prilocaine|prilocaine|mesh-list
92880610|NCT02666534|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92880611|NCT02666534|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92880612|NCT02666534|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92880613|NCT02666534|Anesthetics, Local|anesthetics, local|mesh-ancestor
92880614|NCT02666534|Anesthetics|anesthetics|mesh-ancestor
92880615|NCT02666534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880616|NCT02666534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880617|NCT02666534|Sensory System Agents|sensory system agents|mesh-ancestor
92880618|NCT02666534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880619|NCT02666534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92880620|NCT02666534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92880621|NCT02666534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92880622|NCT02666534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880623|NCT02666534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880624|NCT02666534|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92880625|NCT02666534|Dermatologic Agents|dermatologic agents|mesh-ancestor
92880626|NCT02666534|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92880627|NCT02787473|Docetaxel|docetaxel|mesh-list
92880628|NCT02787473|Pemetrexed|pemetrexed|mesh-list
92880629|NCT02787473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880630|NCT02787473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92880631|NCT02787473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92880632|NCT02787473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92880633|NCT02787473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880634|NCT02787473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880635|NCT02787473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92880636|NCT02787473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880637|NCT00657306|Hydrocortisone|hydrocortisone|mesh-list
92880638|NCT00657306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880639|NCT00967603|Sunitinib|sunitinib|mesh-list
92880640|NCT00967603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880641|NCT00967603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92880642|NCT00967603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92880643|NCT00967603|Growth Substances|growth substances|mesh-ancestor
92880644|NCT00967603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880645|NCT00967603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92880646|NCT00967603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92880647|NCT00967603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880648|NCT00967603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880649|NCT00657384|Tranexamic Acid|tranexamic acid|mesh-list
92880650|NCT00657384|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92880651|NCT00657384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92880652|NCT00657384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880653|NCT00657384|Hemostatics|hemostatics|mesh-ancestor
92880654|NCT00657384|Coagulants|coagulants|mesh-ancestor
92880655|NCT00973453|Immunomodulating Agents|immunomodulating agents|mesh-list
92880656|NCT00973453|Immunologic Factors|immunologic factors|mesh-list
92880657|NCT00973453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880658|NCT00646880|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92880659|NCT00646880|Propiverine|propiverine|mesh-list
92880660|NCT00646880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92880661|NCT00646880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92880662|NCT00646880|Cholinergic Agents|cholinergic agents|mesh-ancestor
92880663|NCT00646880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880664|NCT00646880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880665|NCT00646880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880666|NCT00646880|Urological Agents|urological agents|mesh-ancestor
92880667|NCT00646880|Parasympatholytics|parasympatholytics|mesh-ancestor
92880668|NCT00646880|Autonomic Agents|autonomic agents|mesh-ancestor
92880669|NCT00646880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880670|NCT00910598|Glatiramer Acetate|glatiramer acetate|mesh-list
92880671|NCT00910598|(T,G)-A-L|(t,g)-a-l|mesh-list
92880672|NCT00910598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92880673|NCT00910598|Immunologic Factors|immunologic factors|mesh-ancestor
92880674|NCT00910598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880675|NCT00910598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880676|NCT00910598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880677|NCT00968461|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
92880678|NCT00968461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880679|NCT00968461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880680|NCT00968461|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92880681|NCT00968461|Protective Agents|protective agents|mesh-ancestor
92880682|NCT00968461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880683|NCT00968461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880684|NCT04157010|Methotrexate|methotrexate|mesh-list
92880685|NCT04157010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92880686|NCT04157010|Abortifacient Agents|abortifacient agents|mesh-ancestor
92880687|NCT04157010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92880688|NCT04157010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880689|NCT04157010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880690|NCT04157010|Antimetabolites|antimetabolites|mesh-ancestor
92880691|NCT04157010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880692|NCT04157010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880693|NCT04157010|Dermatologic Agents|dermatologic agents|mesh-ancestor
92880694|NCT04157010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880695|NCT04157010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92880696|NCT04157010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880697|NCT04157010|Immunologic Factors|immunologic factors|mesh-ancestor
92880698|NCT04157010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880699|NCT04157010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880700|NCT02632032|Insulin|insulin|mesh-list
92880701|NCT02632032|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92880702|NCT02632032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92880703|NCT02632032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880704|NCT00973609|Folic Acid|folic acid|mesh-list
92880705|NCT00973609|Vitamin B Complex|vitamin b complex|mesh-list
92880706|NCT00973609|Bevacizumab|bevacizumab|mesh-list
92880707|NCT00973609|Fluorouracil|fluorouracil|mesh-list
92880708|NCT00973609|Capecitabine|capecitabine|mesh-list
92880709|NCT00973609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92880710|NCT00973609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880711|NCT00973609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92880712|NCT00973609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92880713|NCT00973609|Growth Substances|growth substances|mesh-ancestor
92880714|NCT00973609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880715|NCT00973609|Growth Inhibitors|growth inhibitors|mesh-ancestor
92880716|NCT00973609|Antimetabolites|antimetabolites|mesh-ancestor
92880717|NCT00973609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880718|NCT00973609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880719|NCT00973609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880720|NCT00973609|Immunologic Factors|immunologic factors|mesh-ancestor
92880721|NCT00973609|Hematinics|hematinics|mesh-ancestor
92880723|NCT00973609|Micronutrients|micronutrients|mesh-ancestor
92880724|NCT02537054|Aflibercept|aflibercept|mesh-list
92880725|NCT02537054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92880726|NCT02537054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92880727|NCT02537054|Growth Substances|growth substances|mesh-ancestor
92880728|NCT02537054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880729|NCT02537054|Growth Inhibitors|growth inhibitors|mesh-ancestor
92880730|NCT02537054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880731|NCT00973687|Dexamethasone|dexamethasone|mesh-list
92880732|NCT00973687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880733|NCT00973687|Antiemetics|antiemetics|mesh-ancestor
92880734|NCT00973687|Autonomic Agents|autonomic agents|mesh-ancestor
92880735|NCT00973687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880736|NCT00973687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880737|NCT00973687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92880738|NCT00973687|Glucocorticoids|glucocorticoids|mesh-ancestor
92880739|NCT00973687|Hormones|hormones|mesh-ancestor
92880740|NCT00973687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160140|NCT05307003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880741|NCT00973687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92880742|NCT00973687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880743|NCT02785757|Thrombin|thrombin|mesh-list
92880744|NCT02785757|Hemostatics|hemostatics|mesh-ancestor
92880745|NCT02785757|Coagulants|coagulants|mesh-ancestor
92880746|NCT00645554|Galantamine|galantamine|mesh-list
92880747|NCT00645554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92880748|NCT00645554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880749|NCT00645554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880750|NCT00645554|Cholinergic Agents|cholinergic agents|mesh-ancestor
92880751|NCT00645554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880752|NCT00645554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880753|NCT00645554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92880754|NCT00645554|Autonomic Agents|autonomic agents|mesh-ancestor
92880755|NCT00645554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880756|NCT00645554|Nootropic Agents|nootropic agents|mesh-ancestor
92880758|NCT02785601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92880759|NCT02785601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92880760|NCT02785601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880761|NCT02785601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880762|NCT02785601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880763|NCT02785601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92880764|NCT02785601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92880765|NCT02785601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880766|NCT02785601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880767|NCT02785601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880768|NCT02785601|Serotonin Agents|serotonin agents|mesh-ancestor
92880769|NCT02785601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92880770|NCT02785601|Antidepressive Agents|antidepressive agents|mesh-ancestor
92880771|NCT05299567|Azithromycin|azithromycin|mesh-list
92880772|NCT05299567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92880773|NCT05299567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880774|NCT00660894|Leucovorin|leucovorin|mesh-list
92880775|NCT00660894|Tegafur|tegafur|mesh-list
92880776|NCT00660894|Calcium|calcium|mesh-list
92880777|NCT00660894|Levoleucovorin|levoleucovorin|mesh-list
92880778|NCT00660894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92880779|NCT00660894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880780|NCT00660894|Antidotes|antidotes|mesh-ancestor
92880781|NCT00660894|Protective Agents|protective agents|mesh-ancestor
92880782|NCT00660894|Vitamin B Complex|vitamin b complex|mesh-ancestor
92880783|NCT00660894|Vitamins|vitamins|mesh-ancestor
92880784|NCT00660894|Micronutrients|micronutrients|mesh-ancestor
92880785|NCT00660894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880786|NCT00660894|Antimetabolites|antimetabolites|mesh-ancestor
92880787|NCT00660894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880788|NCT00660894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880789|NCT00660972|Tenofovir|tenofovir|mesh-list
92880790|NCT00660972|Emtricitabine|emtricitabine|mesh-list
92880791|NCT00660972|Raltegravir Potassium|raltegravir potassium|mesh-list
92880792|NCT00660972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92880793|NCT00660972|Antiviral Agents|antiviral agents|mesh-ancestor
92880794|NCT00660972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92880795|NCT00660972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92880796|NCT00660972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880797|NCT00660972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880798|NCT00660972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880799|NCT00660972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92880800|NCT00660972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92880801|NCT00660972|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92880802|NCT00660972|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92880803|NCT02667470|Solifenacin Succinate|solifenacin succinate|mesh-list
92880804|NCT02667470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92880805|NCT02667470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92880806|NCT02667470|Cholinergic Agents|cholinergic agents|mesh-ancestor
92880807|NCT02667470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880808|NCT02667470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880809|NCT02667470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880810|NCT02667470|Urological Agents|urological agents|mesh-ancestor
92880811|NCT05327699|Ketamine|ketamine|mesh-list
92880812|NCT05327699|Analgesics|analgesics|mesh-ancestor
92880813|NCT05327699|Sensory System Agents|sensory system agents|mesh-ancestor
92880814|NCT05327699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160141|NCT05307003|Serotonin Agents|serotonin agents|mesh-ancestor
92880815|NCT05327699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880816|NCT05327699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92880817|NCT05327699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92880818|NCT05327699|Anesthetics, General|anesthetics, general|mesh-ancestor
92880819|NCT05327699|Anesthetics|anesthetics|mesh-ancestor
92880820|NCT05327699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880821|NCT05327699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92880822|NCT05327699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92880823|NCT05327699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880824|NCT05327699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880825|NCT04157478|Temozolomide|temozolomide|mesh-list
92880826|NCT04157478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92880828|NCT04157478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880829|NCT04157478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880830|NCT00647192|Eplerenone|eplerenone|mesh-list
92880831|NCT00647192|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92880832|NCT00647192|Hormone Antagonists|hormone antagonists|mesh-ancestor
92880833|NCT00647192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880834|NCT00647192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880835|NCT00647192|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92880836|NCT00647192|Diuretics|diuretics|mesh-ancestor
92880837|NCT00647192|Natriuretic Agents|natriuretic agents|mesh-ancestor
92880838|NCT00647192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92880839|NCT00661206|Clopidogrel|clopidogrel|mesh-list
92880840|NCT00661206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92880841|NCT00661206|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92880842|NCT00661206|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92880843|NCT00661206|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92880844|NCT00661206|Purinergic Agents|purinergic agents|mesh-ancestor
92880845|NCT00661206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880846|NCT00661206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880847|NCT00661206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880848|NCT05276960|Cholecalciferol|cholecalciferol|mesh-list
92880849|NCT05276960|Vitamin D|vitamin d|mesh-list
92880850|NCT05276960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92880851|NCT05276960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880852|NCT05276960|Vitamins|vitamins|mesh-ancestor
92880853|NCT05276960|Micronutrients|micronutrients|mesh-ancestor
92880854|NCT05276960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92880855|NCT02787317|Heparin|heparin|mesh-list
92880856|NCT02787317|Bivalirudin|bivalirudin|mesh-list
92880857|NCT02787317|Anticoagulants|anticoagulants|mesh-ancestor
92880858|NCT02787317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92880859|NCT02787317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92880860|NCT02787317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880861|NCT02787317|Antithrombins|antithrombins|mesh-ancestor
92880862|NCT02787317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92880863|NCT02787317|Protease Inhibitors|protease inhibitors|mesh-ancestor
92880864|NCT02787317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880865|NCT00645632|Doxorubicin|doxorubicin|mesh-list
92880866|NCT00645632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92880867|NCT00645632|Methotrexate|methotrexate|mesh-list
92880868|NCT00645632|Ifosfamide|ifosfamide|mesh-list
92880869|NCT00645632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880870|NCT00645632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92880871|NCT00645632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92880872|NCT00645632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92880873|NCT00645632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880874|NCT00645632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880875|NCT00645632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92880876|NCT00645632|Abortifacient Agents|abortifacient agents|mesh-ancestor
92880877|NCT00645632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92880878|NCT00645632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880879|NCT00645632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92880880|NCT00645632|Antimetabolites|antimetabolites|mesh-ancestor
92880881|NCT00645632|Dermatologic Agents|dermatologic agents|mesh-ancestor
92880882|NCT00645632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92880883|NCT00645632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92880884|NCT00645632|Immunologic Factors|immunologic factors|mesh-ancestor
92880885|NCT00645632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880886|NCT00645632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92880887|NCT00645632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92880888|NCT00645632|Alkylating Agents|alkylating agents|mesh-ancestor
92880889|NCT04156464|Lorazepam|lorazepam|mesh-list
92880890|NCT04156464|Phenobarbital|phenobarbital|mesh-list
92880891|NCT04156464|Anticonvulsants|anticonvulsants|mesh-ancestor
92880892|NCT04156464|Antiemetics|antiemetics|mesh-ancestor
92880893|NCT04156464|Autonomic Agents|autonomic agents|mesh-ancestor
92880894|NCT04156464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880895|NCT04156464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880896|NCT04156464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92880897|NCT04156464|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92225555|NCT04549116|Progestins|progestins|mesh-ancestor
92880898|NCT04156464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880899|NCT04156464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92880900|NCT04156464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92880901|NCT04156464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880902|NCT04156464|GABA Modulators|gaba modulators|mesh-ancestor
92880903|NCT04156464|GABA Agents|gaba agents|mesh-ancestor
92880904|NCT04156464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880905|NCT04156464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880906|NCT04156464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92880907|NCT04156464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92880908|NCT04156464|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92880909|NCT04156464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92880910|NCT04156464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92880911|NCT02607215|Vinorelbine|vinorelbine|mesh-list
92880912|NCT02607215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92880913|NCT02607215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880914|NCT02607215|Tubulin Modulators|tubulin modulators|mesh-ancestor
92880915|NCT02607215|Antimitotic Agents|antimitotic agents|mesh-ancestor
92880916|NCT02607215|Mitosis Modulators|mitosis modulators|mesh-ancestor
92880917|NCT02607215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880918|NCT00973999|Botulinum Toxins|botulinum toxins|mesh-list
92880919|NCT00973999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92880920|NCT00973999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880921|NCT00973999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880922|NCT00973999|Cholinergic Agents|cholinergic agents|mesh-ancestor
92880923|NCT00973999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880924|NCT00973999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880925|NCT00968929|Streptokinase|streptokinase|mesh-list
92880926|NCT00968929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92880927|NCT00968929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92880928|NCT00968929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880929|NCT00661596|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92880930|NCT00661596|Vasodilator Agents|vasodilator agents|mesh-ancestor
92880931|NCT00661596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92880932|NCT00661596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92880933|NCT00661596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880934|NCT00661596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880935|NCT00661596|Urological Agents|urological agents|mesh-ancestor
92880936|NCT00969085|Curcumin|curcumin|mesh-list
92880937|NCT00969085|Turmeric extract|turmeric extract|mesh-list
92880938|NCT00969085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92880939|NCT00969085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92880940|NCT00969085|Analgesics|analgesics|mesh-ancestor
92880941|NCT00969085|Sensory System Agents|sensory system agents|mesh-ancestor
92880942|NCT00969085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880943|NCT00969085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526284|NCT00012129|Annamycin|annamycin|mesh-list
92880944|NCT00969085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92880945|NCT00969085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92880946|NCT00969085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92880947|NCT00969085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92880948|NCT00969085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880949|NCT00969085|Antioxidants|antioxidants|mesh-ancestor
92880950|NCT00969085|Protective Agents|protective agents|mesh-ancestor
92880951|NCT00974155|Dexetimide|dexetimide|mesh-list
92880952|NCT00974155|Citalopram|citalopram|mesh-list
92880953|NCT00974155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92880954|NCT00974155|Escitalopram|escitalopram|mesh-list
92160143|NCT03153917|Hydrocortisone|hydrocortisone|mesh-list
92880955|NCT00974155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92880956|NCT00974155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92880957|NCT00974155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92880958|NCT00974155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92880959|NCT00974155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92880960|NCT00974155|Serotonin Agents|serotonin agents|mesh-ancestor
92880961|NCT00974155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880962|NCT00974155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92880963|NCT00974155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92880964|NCT00974155|Parasympatholytics|parasympatholytics|mesh-ancestor
92880965|NCT00974155|Autonomic Agents|autonomic agents|mesh-ancestor
92880966|NCT00974155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880967|NCT00974155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92880968|NCT00974155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92880969|NCT00974155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92880970|NCT00974155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92880971|NCT00974155|Antidepressive Agents|antidepressive agents|mesh-ancestor
92880972|NCT00974155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92880973|NCT00974155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92880974|NCT00879996|Buprenorphine|buprenorphine|mesh-list
92880975|NCT00879996|Methadone|methadone|mesh-list
92880976|NCT00879996|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92880977|NCT00879996|Naloxone|naloxone|mesh-list
92880978|NCT00879996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92880979|NCT00879996|Narcotics|narcotics|mesh-ancestor
92880980|NCT00879996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92880981|NCT00879996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880982|NCT00879996|Analgesics|analgesics|mesh-ancestor
92880983|NCT00879996|Sensory System Agents|sensory system agents|mesh-ancestor
92880984|NCT00879996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92880985|NCT00879996|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92880986|NCT00879996|Antitussive Agents|antitussive agents|mesh-ancestor
92880987|NCT00879996|Respiratory System Agents|respiratory system agents|mesh-ancestor
92880988|NCT00969163|Testosterone|testosterone|mesh-list
92880989|NCT00969163|Androgens|androgens|mesh-ancestor
92880990|NCT00969163|Hormones|hormones|mesh-ancestor
92880991|NCT00969163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92880992|NCT00969163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92880993|NCT00873093|Leucovorin|leucovorin|mesh-list
92880994|NCT00873093|Cytarabine|cytarabine|mesh-list
92880995|NCT00873093|Prednisone|prednisone|mesh-list
92880996|NCT00873093|Hydrocortisone|hydrocortisone|mesh-list
92880997|NCT00873093|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92880998|NCT00873093|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92880999|NCT00873093|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92881000|NCT00873093|Cyclophosphamide|cyclophosphamide|mesh-list
92881001|NCT00873093|Doxorubicin|doxorubicin|mesh-list
92881002|NCT00873093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92881003|NCT00873093|Methotrexate|methotrexate|mesh-list
92881004|NCT00873093|Etoposide|etoposide|mesh-list
92881005|NCT00873093|Vincristine|vincristine|mesh-list
92881006|NCT00873093|Bortezomib|bortezomib|mesh-list
92881007|NCT00873093|Asparaginase|asparaginase|mesh-list
92881008|NCT00873093|Pegaspargase|pegaspargase|mesh-list
92881009|NCT00873093|Etoposide phosphate|etoposide phosphate|mesh-list
92881010|NCT00873093|Levoleucovorin|levoleucovorin|mesh-list
92881011|NCT00873093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881012|NCT00873093|Immunologic Factors|immunologic factors|mesh-ancestor
92881013|NCT00873093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881014|NCT00873093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881015|NCT00873093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92881016|NCT00873093|Alkylating Agents|alkylating agents|mesh-ancestor
92881017|NCT00873093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881018|NCT00873093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881019|NCT00873093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92881020|NCT00873093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526349|NCT00028405|Talaporfin|talaporfin|mesh-list
92881021|NCT00873093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92881022|NCT00873093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92881023|NCT00873093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881024|NCT00873093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881025|NCT00873093|Glucocorticoids|glucocorticoids|mesh-ancestor
92881026|NCT00873093|Hormones|hormones|mesh-ancestor
92881027|NCT00873093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149172|NCT02154243|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881028|NCT00873093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92881029|NCT00873093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92881030|NCT00873093|Abortifacient Agents|abortifacient agents|mesh-ancestor
92881031|NCT00873093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92881032|NCT00873093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92881033|NCT00873093|Antimetabolites|antimetabolites|mesh-ancestor
92881034|NCT00873093|Dermatologic Agents|dermatologic agents|mesh-ancestor
92881035|NCT00873093|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92881036|NCT00873093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92881037|NCT00873093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92881038|NCT00873093|Antiviral Agents|antiviral agents|mesh-ancestor
92881039|NCT00873093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881040|NCT00873093|Antidotes|antidotes|mesh-ancestor
92881041|NCT00873093|Protective Agents|protective agents|mesh-ancestor
92881042|NCT00873093|Vitamin B Complex|vitamin b complex|mesh-ancestor
92881043|NCT00873093|Vitamins|vitamins|mesh-ancestor
92881044|NCT00873093|Micronutrients|micronutrients|mesh-ancestor
92881045|NCT00873093|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881046|NCT00873093|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881047|NCT00873093|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881048|NCT00969319|Factor VIII|factor viii|mesh-list
92881049|NCT00969319|Coagulants|coagulants|mesh-ancestor
92881050|NCT02784899|Iloprost|iloprost|mesh-list
92881051|NCT02784899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92881052|NCT02784899|Vasodilator Agents|vasodilator agents|mesh-ancestor
92881053|NCT00974389|Bevacizumab|bevacizumab|mesh-list
92881054|NCT00974389|Tegafur|tegafur|mesh-list
92881055|NCT00974389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881056|NCT00974389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881057|NCT00974389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92881058|NCT00974389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92881059|NCT00974389|Growth Substances|growth substances|mesh-ancestor
92881060|NCT00974389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881061|NCT00974389|Growth Inhibitors|growth inhibitors|mesh-ancestor
92881062|NCT00974389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92881063|NCT00974389|Antimetabolites|antimetabolites|mesh-ancestor
92881064|NCT00974389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881065|NCT00969397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92881066|NCT00969397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92881067|NCT00969397|Growth Substances|growth substances|mesh-ancestor
92881068|NCT00969397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881069|NCT00969397|Growth Inhibitors|growth inhibitors|mesh-ancestor
92881070|NCT00969397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881071|NCT02783885|Immunomodulating Agents|immunomodulating agents|mesh-list
92881072|NCT02783885|Immunologic Factors|immunologic factors|mesh-ancestor
92881073|NCT02783885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881074|NCT00647660|Nadolol|nadolol|mesh-list
92881075|NCT00647660|Bendroflumethiazide|bendroflumethiazide|mesh-list
92881076|NCT00647660|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92881077|NCT00647660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92881078|NCT00647660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881079|NCT00647660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881080|NCT00647660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881081|NCT00647660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881082|NCT00647660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92881083|NCT00647660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92881084|NCT00647660|Sympatholytics|sympatholytics|mesh-ancestor
92881085|NCT00647660|Autonomic Agents|autonomic agents|mesh-ancestor
92881086|NCT00647660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881087|NCT00647660|Diuretics|diuretics|mesh-ancestor
92881088|NCT00647660|Natriuretic Agents|natriuretic agents|mesh-ancestor
92881089|NCT00647660|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92881090|NCT00647660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881091|NCT00634595|Paclitaxel|paclitaxel|mesh-list
92881092|NCT00634595|Cisplatin|cisplatin|mesh-list
92881093|NCT00634595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92881094|NCT00634595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526416|NCT00028600|Alkylating Agents|alkylating agents|mesh-ancestor
92881095|NCT00634595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881096|NCT00634595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881097|NCT00634595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881098|NCT00634595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881099|NCT00647738|Baclofen|baclofen|mesh-list
92160151|NCT01096875|Atorvastatin|atorvastatin|mesh-list
92881100|NCT00647738|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92881101|NCT00647738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881102|NCT00647738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92881103|NCT00647738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881104|NCT00647738|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92881105|NCT00647738|GABA Agonists|gaba agonists|mesh-ancestor
92881106|NCT00647738|GABA Agents|gaba agents|mesh-ancestor
92881107|NCT00647738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881108|NCT00647738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881109|NCT04008511|Capecitabine|capecitabine|mesh-list
92881110|NCT04008511|Oxaliplatin|oxaliplatin|mesh-list
92881111|NCT04008511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92881112|NCT04008511|Antimetabolites|antimetabolites|mesh-ancestor
92881113|NCT04008511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881114|NCT04008511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881115|NCT00979537|Nisoldipine|nisoldipine|mesh-list
92881116|NCT00979537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92881117|NCT00979537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92881118|NCT00979537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881119|NCT00979537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881120|NCT00979537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92881121|NCT00979537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881122|NCT00979537|Vasodilator Agents|vasodilator agents|mesh-ancestor
92881123|NCT00692055|Naproxen|naproxen|mesh-list
92881124|NCT00692055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92881125|NCT00692055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881126|NCT00692055|Analgesics|analgesics|mesh-ancestor
92881127|NCT00692055|Sensory System Agents|sensory system agents|mesh-ancestor
92881128|NCT00692055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881129|NCT00692055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881130|NCT00692055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881131|NCT00692055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881132|NCT00692055|Gout Suppressants|gout suppressants|mesh-ancestor
92881133|NCT00692055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92881134|NCT00692055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881135|NCT00692055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881136|NCT04033250|Bisacodyl|bisacodyl|mesh-list
92881137|NCT04033250|Picosulfate sodium|picosulfate sodium|mesh-list
92881138|NCT04033250|Magnesium Oxide|magnesium oxide|mesh-list
92881139|NCT04033250|Sodium Citrate|sodium citrate|mesh-list
92881140|NCT04033250|Citric Acid|citric acid|mesh-list
92881141|NCT04033250|Cathartics|cathartics|mesh-ancestor
92881142|NCT04033250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881143|NCT04033250|Laxatives|laxatives|mesh-ancestor
92881144|NCT04033250|Anticoagulants|anticoagulants|mesh-ancestor
92881145|NCT04033250|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92881146|NCT04033250|Chelating Agents|chelating agents|mesh-ancestor
92881147|NCT04033250|Sequestering Agents|sequestering agents|mesh-ancestor
92881148|NCT04033250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881149|NCT04033250|Antacids|antacids|mesh-ancestor
92881150|NCT02624973|Tamoxifen|tamoxifen|mesh-list
92881151|NCT02624973|Cyclophosphamide|cyclophosphamide|mesh-list
92881152|NCT02624973|Docetaxel|docetaxel|mesh-list
92881153|NCT02624973|Trastuzumab|trastuzumab|mesh-list
92881154|NCT02624973|Letrozole|letrozole|mesh-list
92881155|NCT02624973|Epirubicin|epirubicin|mesh-list
92881156|NCT02624973|Olaparib|olaparib|mesh-list
92881157|NCT02624973|Palbociclib|palbociclib|mesh-list
92881158|NCT02624973|Pertuzumab|pertuzumab|mesh-list
92881159|NCT02624973|Goserelin|goserelin|mesh-list
92881160|NCT02624973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881161|NCT02624973|Immunologic Factors|immunologic factors|mesh-ancestor
92881162|NCT02624973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881163|NCT02624973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881164|NCT02624973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92881165|NCT02624973|Alkylating Agents|alkylating agents|mesh-ancestor
92881166|NCT02624973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881167|NCT02624973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881168|NCT02624973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92881169|NCT02624973|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881170|NCT02624973|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881171|NCT02624973|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881172|NCT02624973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881173|NCT02624973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92881174|NCT02624973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92881175|NCT02624973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881176|NCT02624973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92881177|NCT02624973|Hormone Antagonists|hormone antagonists|mesh-ancestor
92881178|NCT02624973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881179|NCT02624973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92881180|NCT02624973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92881181|NCT02624973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92881182|NCT02624973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92881183|NCT02624973|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92881184|NCT02624973|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92881185|NCT02624973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92881186|NCT02624973|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92881187|NCT02624973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92881189|NCT00647816|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92881190|NCT00647816|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92881191|NCT00647816|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881192|NCT00647816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881193|NCT00647816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881194|NCT00647816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881195|NCT00647816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92881196|NCT00647816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92881197|NCT00647816|Vasodilator Agents|vasodilator agents|mesh-ancestor
92881198|NCT00647894|Alprazolam|alprazolam|mesh-list
92881199|NCT00647894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92881200|NCT00647894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881201|NCT00647894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881202|NCT00647894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92881203|NCT00647894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881204|NCT00647894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881205|NCT00647894|GABA Modulators|gaba modulators|mesh-ancestor
92881206|NCT00647894|GABA Agents|gaba agents|mesh-ancestor
92881207|NCT00647894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881208|NCT00647894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881209|NCT02782559|Sildenafil Citrate|sildenafil citrate|mesh-list
92881210|NCT02782559|Vasodilator Agents|vasodilator agents|mesh-ancestor
92881211|NCT02782559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92881212|NCT02782559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92881213|NCT02782559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881214|NCT02782559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881215|NCT02782559|Urological Agents|urological agents|mesh-ancestor
92881216|NCT00647972|Olanzapine|olanzapine|mesh-list
92881217|NCT00647972|Antiemetics|antiemetics|mesh-ancestor
92881218|NCT00647972|Autonomic Agents|autonomic agents|mesh-ancestor
92881219|NCT00647972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881220|NCT00647972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881221|NCT00647972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881222|NCT00647972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92881223|NCT00647972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881224|NCT00647972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881225|NCT00647972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881226|NCT00647972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92881227|NCT00647972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92881228|NCT00647972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881229|NCT00647972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881230|NCT00647972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881231|NCT00647972|Serotonin Agents|serotonin agents|mesh-ancestor
92881232|NCT02782403|Axitinib|axitinib|mesh-list
92881233|NCT02782403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881234|NCT02782403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92881235|NCT02782403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881236|NCT02782403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881237|NCT00646178|Adalimumab|adalimumab|mesh-list
92881238|NCT00646178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92881239|NCT00646178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881240|NCT00646178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881241|NCT02624817|Glyburide|glyburide|mesh-list
92881242|NCT02624817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881243|NCT02624817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881244|NCT02664116|Diclofenac|diclofenac|mesh-list
92881245|NCT02664116|Ketorolac|ketorolac|mesh-list
92526568|NCT01803555|Glucocorticoids|glucocorticoids|mesh-ancestor
92881246|NCT02664116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92881247|NCT02664116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92881248|NCT02664116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881249|NCT02664116|Analgesics|analgesics|mesh-ancestor
92881250|NCT02664116|Sensory System Agents|sensory system agents|mesh-ancestor
92881251|NCT02664116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881252|NCT02664116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881253|NCT02664116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881254|NCT02664116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881255|NCT02664116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92881256|NCT02664116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881257|NCT02664116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881258|NCT00692601|Capsaicin|capsaicin|mesh-list
92881259|NCT00692601|Antipruritics|antipruritics|mesh-ancestor
92881260|NCT00692601|Dermatologic Agents|dermatologic agents|mesh-ancestor
92881261|NCT00692601|Sensory System Agents|sensory system agents|mesh-ancestor
92881262|NCT00692601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881263|NCT00692601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881264|NCT02785055|Hydromorphone|hydromorphone|mesh-list
92881265|NCT02785055|Bupivacaine|bupivacaine|mesh-list
92881266|NCT02785055|Anesthetics, Local|anesthetics, local|mesh-ancestor
92881267|NCT02785055|Anesthetics|anesthetics|mesh-ancestor
92881268|NCT02785055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881269|NCT02785055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881270|NCT02785055|Sensory System Agents|sensory system agents|mesh-ancestor
92881271|NCT02785055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881272|NCT02785055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92881273|NCT02785055|Narcotics|narcotics|mesh-ancestor
92881274|NCT02785055|Analgesics|analgesics|mesh-ancestor
92881275|NCT02624661|Glycerol|glycerol|mesh-list
92881276|NCT02624661|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92881277|NCT02624661|Protective Agents|protective agents|mesh-ancestor
92881278|NCT02624661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881279|NCT00648050|Verapamil|verapamil|mesh-list
92881280|NCT00648050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92881281|NCT00648050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92881282|NCT00648050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881283|NCT00648050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881284|NCT00648050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92881285|NCT00648050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881286|NCT00648050|Vasodilator Agents|vasodilator agents|mesh-ancestor
92881287|NCT00692757|Povidone-Iodine|povidone-iodine|mesh-list
92881288|NCT00692757|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92881289|NCT00692757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881290|NCT02624505|Albuterol|albuterol|mesh-list
92881291|NCT02624505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92881292|NCT02624505|Autonomic Agents|autonomic agents|mesh-ancestor
92881293|NCT02624505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881294|NCT02624505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881295|NCT02624505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92881296|NCT02624505|Respiratory System Agents|respiratory system agents|mesh-ancestor
92881297|NCT02624505|Tocolytic Agents|tocolytic agents|mesh-ancestor
92881298|NCT02624505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92881299|NCT02624505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92881300|NCT02624505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92881301|NCT02624505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92881302|NCT02624505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881303|NCT02624505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881304|NCT02624505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881305|NCT00969631|Metformin|metformin|mesh-list
92881306|NCT00969631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881307|NCT00969631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881308|NCT02782481|Levodopa|levodopa|mesh-list
92881309|NCT02782481|Carbidopa|carbidopa|mesh-list
92881310|NCT02782481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92881311|NCT02782481|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92881312|NCT02782481|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92881313|NCT02782481|Dopamine Agents|dopamine agents|mesh-ancestor
92881314|NCT02782481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881315|NCT02782481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881316|NCT02782481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881317|NCT02782481|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92881318|NCT02782481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881319|NCT00648128|Clarithromycin|clarithromycin|mesh-list
92881320|NCT00648128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92881321|NCT00648128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881322|NCT00648128|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92881323|NCT00648128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881324|NCT00648128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881325|NCT00648128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92881326|NCT00648128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92881328|NCT05342597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92881329|NCT05342597|Antioxidants|antioxidants|mesh-ancestor
92881330|NCT05342597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881331|NCT05342597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92881332|NCT05342597|Protective Agents|protective agents|mesh-ancestor
92881333|NCT05342597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881334|NCT02784821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92881335|NCT02784821|Gentamicins|gentamicins|mesh-list
92881336|NCT02784821|Ampicillin|ampicillin|mesh-list
92881337|NCT02784821|Cefotaxime|cefotaxime|mesh-list
92881338|NCT02784821|Cefoxitin|cefoxitin|mesh-list
92881339|NCT02784821|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92881340|NCT02784821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881341|NCT02784821|Antitubercular Agents|antitubercular agents|mesh-ancestor
92881342|NCT02784821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92881344|NCT02784821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881345|NCT00693069|Clopidogrel|clopidogrel|mesh-list
92881346|NCT00693069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92881347|NCT00693069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92881348|NCT00693069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92881349|NCT00693069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92881350|NCT00693069|Purinergic Agents|purinergic agents|mesh-ancestor
92881351|NCT00693069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881352|NCT00693069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881353|NCT00693069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881354|NCT04949282|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92881355|NCT04949282|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92881356|NCT04949282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881357|NCT00974935|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92881358|NCT00974935|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92881359|NCT00974935|Immunologic Factors|immunologic factors|mesh-ancestor
92881360|NCT00974935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881361|NCT00974935|Antacids|antacids|mesh-ancestor
92881362|NCT00974935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881363|NCT00974935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881364|NCT00665808|Insulin|insulin|mesh-list
92881365|NCT00665808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92881366|NCT00665808|Insulin Detemir|insulin detemir|mesh-list
92881367|NCT00665808|Isophane Insulin, Human|isophane insulin, human|mesh-list
92881368|NCT00665808|Insulin, Isophane|insulin, isophane|mesh-list
92881369|NCT00665808|Isophane insulin, beef|isophane insulin, beef|mesh-list
92881370|NCT00665808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881371|NCT00665808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881372|NCT04230083|Dienogest|dienogest|mesh-list
92881373|NCT04230083|Nandrolone|nandrolone|mesh-list
92881374|NCT04230083|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92881375|NCT04230083|Contraceptive Agents|contraceptive agents|mesh-ancestor
92881376|NCT04230083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92881377|NCT04230083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881378|NCT04230083|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92881379|NCT04230083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92881380|NCT04230083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92881381|NCT04230083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92881382|NCT04230083|Hormone Antagonists|hormone antagonists|mesh-ancestor
92881383|NCT04230083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881384|NCT04230083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92881385|NCT04230083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881386|NCT04230083|Androgens|androgens|mesh-ancestor
92881387|NCT04230083|Hormones|hormones|mesh-ancestor
92881388|NCT04230083|Anabolic Agents|anabolic agents|mesh-ancestor
92881389|NCT00645866|Docetaxel|docetaxel|mesh-list
92881390|NCT00645866|Capecitabine|capecitabine|mesh-list
92881391|NCT00645866|Epirubicin|epirubicin|mesh-list
92881392|NCT00645866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881393|NCT00645866|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881394|NCT00645866|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881395|NCT00645866|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881396|NCT00645866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881397|NCT00645866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92881398|NCT00645866|Antimetabolites|antimetabolites|mesh-ancestor
92881399|NCT00645866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92881400|NCT00645866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92881401|NCT00645866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92881402|NCT00645866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881403|NCT05221151|Pregabalin|pregabalin|mesh-list
92881404|NCT05221151|Ondansetron|ondansetron|mesh-list
92881405|NCT05221151|Melatonin|melatonin|mesh-list
92881406|NCT05221151|Analgesics|analgesics|mesh-ancestor
92881407|NCT05221151|Sensory System Agents|sensory system agents|mesh-ancestor
92881408|NCT05221151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881409|NCT05221151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881410|NCT05221151|Anticonvulsants|anticonvulsants|mesh-ancestor
92881411|NCT05221151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92881412|NCT05221151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92525420|NCT00000368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881413|NCT05221151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881414|NCT05221151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92881415|NCT05221151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92881416|NCT05221151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881417|NCT05221151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881418|NCT05221151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881419|NCT05221151|Antioxidants|antioxidants|mesh-ancestor
92881420|NCT05221151|Protective Agents|protective agents|mesh-ancestor
92881421|NCT05221151|Antiemetics|antiemetics|mesh-ancestor
92881422|NCT05221151|Autonomic Agents|autonomic agents|mesh-ancestor
92881423|NCT05221151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881424|NCT05221151|Antipruritics|antipruritics|mesh-ancestor
92881425|NCT05221151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92881426|NCT05221151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92881427|NCT05221151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92881428|NCT05221151|Serotonin Agents|serotonin agents|mesh-ancestor
92881429|NCT05221151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881430|NCT04008043|Acetaminophen|acetaminophen|mesh-list
92881431|NCT04008043|Dexamethasone|dexamethasone|mesh-list
92881432|NCT04008043|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92881433|NCT04008043|Hydrocodone|hydrocodone|mesh-list
92881434|NCT04008043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881435|NCT04008043|Antiemetics|antiemetics|mesh-ancestor
92881436|NCT04008043|Autonomic Agents|autonomic agents|mesh-ancestor
92881437|NCT04008043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881438|NCT04008043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881439|NCT04008043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881440|NCT04008043|Glucocorticoids|glucocorticoids|mesh-ancestor
92881441|NCT04008043|Hormones|hormones|mesh-ancestor
92881442|NCT04008043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881443|NCT04008043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92881444|NCT04008043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881445|NCT04008043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881446|NCT04008043|Analgesics|analgesics|mesh-ancestor
92881447|NCT04008043|Sensory System Agents|sensory system agents|mesh-ancestor
92881448|NCT04008043|Antipyretics|antipyretics|mesh-ancestor
92881449|NCT04008043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92881450|NCT04008043|Narcotics|narcotics|mesh-ancestor
92881451|NCT04008043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881452|NCT04008043|Antitussive Agents|antitussive agents|mesh-ancestor
92881453|NCT04008043|Respiratory System Agents|respiratory system agents|mesh-ancestor
92881454|NCT04008043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92881455|NCT04008043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881456|NCT02783183|Pregabalin|pregabalin|mesh-list
92881457|NCT02783183|Analgesics|analgesics|mesh-ancestor
92881458|NCT02783183|Sensory System Agents|sensory system agents|mesh-ancestor
92881459|NCT02783183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881460|NCT02783183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881461|NCT02783183|Anticonvulsants|anticonvulsants|mesh-ancestor
92881462|NCT02783183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92881463|NCT02783183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881464|NCT02783183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881465|NCT02783183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92881466|NCT02783183|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92881467|NCT02783183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881468|NCT02783183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881469|NCT02783183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881470|NCT00693381|Mycophenolic Acid|mycophenolic acid|mesh-list
92881471|NCT00693381|Prednisone|prednisone|mesh-list
92881472|NCT00693381|Methylprednisolone|methylprednisolone|mesh-list
92881473|NCT00693381|Tacrolimus|tacrolimus|mesh-list
92881474|NCT00693381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881475|NCT00693381|Glucocorticoids|glucocorticoids|mesh-ancestor
92881476|NCT00693381|Hormones|hormones|mesh-ancestor
92881477|NCT00693381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881478|NCT00693381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881479|NCT00693381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92881480|NCT00693381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881481|NCT00693381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881482|NCT00693381|Immunologic Factors|immunologic factors|mesh-ancestor
92881483|NCT00693381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92881484|NCT00693381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881485|NCT00693381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881486|NCT00693381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92881487|NCT00693381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92881488|NCT00693381|Antitubercular Agents|antitubercular agents|mesh-ancestor
92881489|NCT00693381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92881490|NCT00693381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881491|NCT00693381|Antiemetics|antiemetics|mesh-ancestor
92881492|NCT00693381|Autonomic Agents|autonomic agents|mesh-ancestor
92881493|NCT00693381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881494|NCT00693381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881495|NCT00693381|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92881496|NCT00693381|Protective Agents|protective agents|mesh-ancestor
92881497|NCT05285891|Ocrelizumab|ocrelizumab|mesh-list
92881498|NCT05285891|Immunologic Factors|immunologic factors|mesh-ancestor
92881499|NCT05285891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881500|NCT00693615|Vaccines|vaccines|mesh-list
92881501|NCT00693615|Immunologic Factors|immunologic factors|mesh-ancestor
92881502|NCT00693615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881503|NCT02663960|Citric Acid|citric acid|mesh-list
92881504|NCT02663960|Sodium Citrate|sodium citrate|mesh-list
92881505|NCT02663960|Anticoagulants|anticoagulants|mesh-ancestor
92881506|NCT02663960|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92881507|NCT02663960|Chelating Agents|chelating agents|mesh-ancestor
92881508|NCT02663960|Sequestering Agents|sequestering agents|mesh-ancestor
92881509|NCT02663960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881510|NCT00693771|Insulin Glargine|insulin glargine|mesh-list
92881511|NCT00693771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881512|NCT00693771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881513|NCT00693849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92881514|NCT00693849|Sertraline|sertraline|mesh-list
92881515|NCT00693849|Escitalopram|escitalopram|mesh-list
92881516|NCT00693849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92881517|NCT00693849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92881518|NCT00693849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881519|NCT00693849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881520|NCT00693849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881521|NCT00693849|Serotonin Agents|serotonin agents|mesh-ancestor
92881522|NCT00693849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881523|NCT00693849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92881524|NCT00693849|Antidepressive Agents|antidepressive agents|mesh-ancestor
92881525|NCT00693849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881526|NCT00693849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92881527|NCT00693927|Fludarabine|fludarabine|mesh-list
92881528|NCT00693927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881529|NCT00648362|Glimepiride|glimepiride|mesh-list
92881530|NCT00648362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92881531|NCT00648362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881532|NCT00648362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881533|NCT00648362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881534|NCT00648362|Immunologic Factors|immunologic factors|mesh-ancestor
92881535|NCT00648440|Midodrine|midodrine|mesh-list
92881536|NCT00648440|Sympathomimetics|sympathomimetics|mesh-ancestor
92881537|NCT00648440|Autonomic Agents|autonomic agents|mesh-ancestor
92881538|NCT00648440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881539|NCT00648440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881540|NCT00648440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92881541|NCT00648440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92881542|NCT00648440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92881543|NCT00648440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92881544|NCT00648440|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881545|NCT00648440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881546|NCT00648440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881547|NCT00694005|Sirolimus|sirolimus|mesh-list
92881548|NCT00694005|Paclitaxel|paclitaxel|mesh-list
92881549|NCT00694005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92881550|NCT00694005|Everolimus|everolimus|mesh-list
92881551|NCT00694005|Temsirolimus|temsirolimus|mesh-list
92881552|NCT00694005|MTOR Inhibitors|mtor inhibitors|mesh-list
92881553|NCT00694005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92881554|NCT00694005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881555|NCT00694005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881556|NCT00694005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881557|NCT00694005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881558|NCT00694005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881559|NCT00694005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92881560|NCT00694005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881561|NCT00694005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881562|NCT00694005|Immunologic Factors|immunologic factors|mesh-ancestor
92881563|NCT00694005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881564|NCT00694005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92881565|NCT00694005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881566|NCT00694005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92881567|NCT00694005|Antifungal Agents|antifungal agents|mesh-ancestor
92881568|NCT00975325|Yohimbine|yohimbine|mesh-list
92881569|NCT00975325|Mydriatics|mydriatics|mesh-ancestor
92881570|NCT00975325|Autonomic Agents|autonomic agents|mesh-ancestor
92881571|NCT00975325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881572|NCT00975325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881573|NCT00975325|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92881574|NCT00975325|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92881575|NCT00975325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92881576|NCT00975325|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881577|NCT00975325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881578|NCT00975325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881579|NCT00975325|Urological Agents|urological agents|mesh-ancestor
92881580|NCT00910676|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92881581|NCT00910676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881582|NCT00648518|Metformin|metformin|mesh-list
92881583|NCT00648518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881584|NCT00648518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881585|NCT00648596|Sildenafil Citrate|sildenafil citrate|mesh-list
92881586|NCT00648596|Vasodilator Agents|vasodilator agents|mesh-ancestor
92881587|NCT00648596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92881588|NCT00648596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92881589|NCT00648596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881590|NCT00648596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881591|NCT00648596|Urological Agents|urological agents|mesh-ancestor
92881592|NCT03921151|Mirtazapine|mirtazapine|mesh-list
92881593|NCT03921151|Antidepressive Agents|antidepressive agents|mesh-ancestor
92881594|NCT03921151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881595|NCT03921151|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92881596|NCT03921151|Histamine Antagonists|histamine antagonists|mesh-ancestor
92881597|NCT03921151|Histamine Agents|histamine agents|mesh-ancestor
92881598|NCT03921151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881599|NCT03921151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881600|NCT03921151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881601|NCT03921151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92881602|NCT03921151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881603|NCT03921151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160168|NCT03580187|Morphine|morphine|mesh-list
92881604|NCT03921151|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92881605|NCT03921151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92881606|NCT03921151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92881607|NCT03921151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881608|NCT03921151|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92881609|NCT03921151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92881610|NCT03921151|Serotonin Agents|serotonin agents|mesh-ancestor
92881611|NCT03921151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92881612|NCT04570436|Diazepam|diazepam|mesh-list
92881613|NCT04570436|Gabapentin|gabapentin|mesh-list
92881614|NCT04570436|Analgesics|analgesics|mesh-ancestor
92881615|NCT04570436|Sensory System Agents|sensory system agents|mesh-ancestor
92881616|NCT04570436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881617|NCT04570436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881618|NCT04570436|Anticonvulsants|anticonvulsants|mesh-ancestor
92881619|NCT04570436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92881620|NCT04570436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881621|NCT04570436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881622|NCT04570436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881623|NCT04570436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92881624|NCT04570436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92881625|NCT04570436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525431|NCT00025207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881626|NCT04570436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881627|NCT04570436|Antimanic Agents|antimanic agents|mesh-ancestor
92881628|NCT04570436|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92881629|NCT04570436|Antiemetics|antiemetics|mesh-ancestor
92881630|NCT04570436|Autonomic Agents|autonomic agents|mesh-ancestor
92881631|NCT04570436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881632|NCT04570436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92881633|NCT04570436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92881634|NCT04570436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92881635|NCT04570436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92881636|NCT04570436|Anesthetics, General|anesthetics, general|mesh-ancestor
92881637|NCT04570436|Anesthetics|anesthetics|mesh-ancestor
92881638|NCT04570436|GABA Modulators|gaba modulators|mesh-ancestor
92881639|NCT04570436|GABA Agents|gaba agents|mesh-ancestor
92881640|NCT05195645|Abatacept|abatacept|mesh-list
92881641|NCT05195645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92881642|NCT05195645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881643|NCT05195645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881644|NCT05195645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881645|NCT05195645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881646|NCT05195645|Immunologic Factors|immunologic factors|mesh-ancestor
92881647|NCT05195645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881648|NCT05195645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881649|NCT04171388|Micronutrients|micronutrients|mesh-list
92881650|NCT04171388|Trace Elements|trace elements|mesh-list
92881651|NCT04171388|Azithromycin|azithromycin|mesh-list
92881652|NCT04171388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92881653|NCT04171388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881654|NCT04171388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881655|NCT00970411|Tivozanib|tivozanib|mesh-list
92881656|NCT00970411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92881657|NCT00970411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881658|NCT00970411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881659|NCT05341193|Bevacizumab|bevacizumab|mesh-list
92881660|NCT05341193|Gemcitabine|gemcitabine|mesh-list
92881661|NCT05341193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881662|NCT05341193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881663|NCT05341193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92881664|NCT05341193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92881665|NCT05341193|Growth Substances|growth substances|mesh-ancestor
92881666|NCT05341193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881667|NCT05341193|Growth Inhibitors|growth inhibitors|mesh-ancestor
92881668|NCT05341193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92881669|NCT05341193|Antimetabolites|antimetabolites|mesh-ancestor
92881670|NCT05341193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881671|NCT04229459|Nivolumab|nivolumab|mesh-list
92881672|NCT04229459|Cetuximab|cetuximab|mesh-list
92881673|NCT04229459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881674|NCT04229459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881675|NCT04229459|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92881676|NCT04229459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881677|NCT00980239|Bevacizumab|bevacizumab|mesh-list
92881678|NCT00980239|Cetuximab|cetuximab|mesh-list
92881679|NCT00980239|Oxaliplatin|oxaliplatin|mesh-list
92881680|NCT00980239|Irinotecan|irinotecan|mesh-list
92881681|NCT00980239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881682|NCT00980239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881683|NCT00980239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92881684|NCT00980239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92881685|NCT00980239|Growth Substances|growth substances|mesh-ancestor
92881686|NCT00980239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881687|NCT00980239|Growth Inhibitors|growth inhibitors|mesh-ancestor
92881688|NCT00980239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92881689|NCT00980239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92881690|NCT00980239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881691|NCT00980239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881692|NCT02665832|Amlodipine|amlodipine|mesh-list
92881693|NCT02665832|Olmesartan|olmesartan|mesh-list
92881694|NCT02665832|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92527015|NCT00000554|Sympathomimetics|sympathomimetics|mesh-ancestor
92881695|NCT02665832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92881696|NCT02665832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92881697|NCT02665832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881698|NCT02665832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881699|NCT02665832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92881700|NCT02665832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881702|NCT02665832|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92881703|NCT02665832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92881704|NCT02665832|Antimetabolites|antimetabolites|mesh-ancestor
92881705|NCT02665832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92881706|NCT02665832|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92881707|NCT02665832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881708|NCT02665832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92881709|NCT02665832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92881710|NCT02781467|Cyclophosphamide|cyclophosphamide|mesh-list
92881711|NCT02781467|Fludarabine|fludarabine|mesh-list
92881712|NCT02781467|Interleukin-2|interleukin-2|mesh-list
92881713|NCT02781467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92881714|NCT02781467|Immunologic Factors|immunologic factors|mesh-ancestor
92881715|NCT02781467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881716|NCT02781467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881717|NCT02781467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92881718|NCT02781467|Alkylating Agents|alkylating agents|mesh-ancestor
92881719|NCT02781467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881720|NCT02781467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881721|NCT02781467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92881722|NCT02781467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881723|NCT02781467|Analgesics|analgesics|mesh-ancestor
92881724|NCT02781467|Sensory System Agents|sensory system agents|mesh-ancestor
92881725|NCT02781467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881726|NCT00648830|Clarithromycin|clarithromycin|mesh-list
92881727|NCT00648830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92881728|NCT00648830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881729|NCT00648830|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92881730|NCT00648830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881731|NCT00648830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881732|NCT00648830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92881733|NCT00648830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92881734|NCT00970567|Insulin|insulin|mesh-list
92881735|NCT00970567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881736|NCT00970567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881737|NCT05341817|Letrozole|letrozole|mesh-list
92881738|NCT05341817|Mifepristone|mifepristone|mesh-list
92881739|NCT05341817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881740|NCT05341817|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92881741|NCT05341817|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92881742|NCT05341817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881743|NCT05341817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881744|NCT05341817|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92881745|NCT05341817|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026470|NCT00413283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881746|NCT05341817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881747|NCT05341817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881748|NCT05341817|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92881749|NCT05341817|Abortifacient Agents|abortifacient agents|mesh-ancestor
92881750|NCT05341817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92881751|NCT05341817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92881752|NCT05341817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92881753|NCT05341817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92881754|NCT05341817|Contraceptive Agents|contraceptive agents|mesh-ancestor
92881755|NCT05341817|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92881756|NCT05341817|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92881757|NCT05341817|Luteolytic Agents|luteolytic agents|mesh-ancestor
92881758|NCT05341817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92881759|NCT05341817|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92881760|NCT02663570|Melatonin|melatonin|mesh-list
92881761|NCT02663570|Antioxidants|antioxidants|mesh-ancestor
92881762|NCT02663570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881763|NCT02663570|Protective Agents|protective agents|mesh-ancestor
92881764|NCT02663570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881765|NCT02663570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881766|NCT00980473|Timolol|timolol|mesh-list
92881767|NCT00980473|Travoprost|travoprost|mesh-list
93046932|NCT00346268|Narcotics|narcotics|mesh-ancestor
92527089|NCT00031564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92881768|NCT00980473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92881769|NCT00980473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92881770|NCT00980473|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881771|NCT00980473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881772|NCT00980473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881773|NCT00980473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881774|NCT00980473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92881775|NCT00980473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92881777|NCT02784743|Albendazole|albendazole|mesh-list
92881778|NCT02784743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92881779|NCT02784743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881780|NCT02784743|Anthelmintics|anthelmintics|mesh-ancestor
92881781|NCT02784743|Anticestodal Agents|anticestodal agents|mesh-ancestor
92881782|NCT02784743|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92881783|NCT02784743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92881784|NCT02784743|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881785|NCT02784743|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881786|NCT02784743|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881787|NCT02784743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881788|NCT02784743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881789|NCT00980551|Carboplatin|carboplatin|mesh-list
92881790|NCT00980551|Vincristine|vincristine|mesh-list
92881791|NCT00980551|Topotecan|topotecan|mesh-list
92881792|NCT00980551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881793|NCT00980551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92881794|NCT00980551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92881795|NCT00980551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92881796|NCT00980551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92881797|NCT00980551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881798|NCT00980551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92881799|NCT00980551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92881800|NCT00980551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881801|NCT02660060|Pramipexole|pramipexole|mesh-list
92881802|NCT02660060|Antioxidants|antioxidants|mesh-ancestor
92881803|NCT02660060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881804|NCT02660060|Protective Agents|protective agents|mesh-ancestor
92881805|NCT02660060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881806|NCT02660060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92881807|NCT02660060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92881808|NCT02660060|Dopamine Agonists|dopamine agonists|mesh-ancestor
92881809|NCT02660060|Dopamine Agents|dopamine agents|mesh-ancestor
92881810|NCT02660060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881811|NCT04008979|Aspirin|aspirin|mesh-list
92881812|NCT04008979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92881813|NCT04008979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881814|NCT04008979|Analgesics|analgesics|mesh-ancestor
92881815|NCT04008979|Sensory System Agents|sensory system agents|mesh-ancestor
92881816|NCT04008979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881817|NCT04008979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881818|NCT04008979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881819|NCT04008979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881820|NCT04008979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92881821|NCT04008979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92881822|NCT04008979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881823|NCT04008979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92881824|NCT04008979|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92881825|NCT04008979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881826|NCT04008979|Antipyretics|antipyretics|mesh-ancestor
92881827|NCT05263583|Bromides|bromides|mesh-list
92881828|NCT05263583|Anticonvulsants|anticonvulsants|mesh-ancestor
92881829|NCT00970879|Mefloquine|mefloquine|mesh-list
92881830|NCT00970879|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92881831|NCT00970879|Antimalarials|antimalarials|mesh-ancestor
92881832|NCT00970879|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92881833|NCT00970879|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92881834|NCT00970879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881835|NCT00970879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92881836|NCT00970879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92881837|NCT05340803|Magnesium Sulfate|magnesium sulfate|mesh-list
92881838|NCT05340803|Midazolam|midazolam|mesh-list
92881839|NCT05340803|Dexmedetomidine|dexmedetomidine|mesh-list
92881840|NCT05340803|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92881841|NCT05340803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881842|NCT05340803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881843|NCT05340803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881844|NCT05340803|Analgesics|analgesics|mesh-ancestor
92881845|NCT05340803|Sensory System Agents|sensory system agents|mesh-ancestor
92881846|NCT05340803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881847|NCT05340803|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92881848|NCT05340803|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92881849|NCT05340803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92881850|NCT05340803|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881851|NCT05340803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881852|NCT05340803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881853|NCT05340803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92881854|NCT05340803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92881855|NCT05340803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92881856|NCT05340803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92881857|NCT05340803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92881858|NCT05340803|Anesthetics, General|anesthetics, general|mesh-ancestor
92881859|NCT05340803|Anesthetics|anesthetics|mesh-ancestor
92881860|NCT05340803|GABA Modulators|gaba modulators|mesh-ancestor
92881861|NCT05340803|GABA Agents|gaba agents|mesh-ancestor
92881862|NCT05340803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92881863|NCT05340803|Anticonvulsants|anticonvulsants|mesh-ancestor
92881864|NCT05340803|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92881865|NCT05340803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881866|NCT05340803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92881867|NCT05340803|Tocolytic Agents|tocolytic agents|mesh-ancestor
92881868|NCT05340803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92881869|NCT02663258|Pembrolizumab|pembrolizumab|mesh-list
92881870|NCT02663258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881871|NCT02663258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881872|NCT02663258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92881873|NCT02663258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881874|NCT04033172|Fulvestrant|fulvestrant|mesh-list
92881875|NCT04033172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92881876|NCT04033172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881877|NCT04033172|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92881878|NCT04033172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92881879|NCT04033172|Hormone Antagonists|hormone antagonists|mesh-ancestor
92881880|NCT04033172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881881|NCT04033172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881882|NCT00980707|Fluticasone|fluticasone|mesh-list
92881883|NCT00980707|Xhance|xhance|mesh-list
92881884|NCT00980707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881885|NCT00980707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92881886|NCT00980707|Autonomic Agents|autonomic agents|mesh-ancestor
92881887|NCT00980707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881888|NCT00980707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881889|NCT00980707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92881890|NCT00980707|Respiratory System Agents|respiratory system agents|mesh-ancestor
92881891|NCT00980707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92881892|NCT00980707|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92881893|NCT05340725|Dexmedetomidine|dexmedetomidine|mesh-list
92881894|NCT05340725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92881895|NCT05340725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881896|NCT05340725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881897|NCT05340725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881898|NCT05340725|Analgesics|analgesics|mesh-ancestor
92881899|NCT05340725|Sensory System Agents|sensory system agents|mesh-ancestor
92881900|NCT05340725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881901|NCT05340725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92881902|NCT05340725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92881903|NCT05340725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92881904|NCT05340725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92881905|NCT05340725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881906|NCT05340725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881907|NCT00970957|Bevacizumab|bevacizumab|mesh-list
92881908|NCT00970957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92881909|NCT00970957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92881910|NCT00970957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92881911|NCT00970957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92881912|NCT00970957|Growth Substances|growth substances|mesh-ancestor
92226584|NCT02627846|Anesthetics, Local|anesthetics, local|mesh-ancestor
92881913|NCT00970957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881914|NCT00970957|Growth Inhibitors|growth inhibitors|mesh-ancestor
92881915|NCT00976105|Zolpidem|zolpidem|mesh-list
92881916|NCT00976105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92881917|NCT00976105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92881918|NCT00976105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881919|NCT00976105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881920|NCT00976105|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92881921|NCT00976105|GABA Agonists|gaba agonists|mesh-ancestor
92881923|NCT00976105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881924|NCT00976105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881925|NCT00976261|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92881926|NCT00976261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881927|NCT00976261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881928|NCT00976261|Incretins|incretins|mesh-ancestor
92881929|NCT00976261|Hormones|hormones|mesh-ancestor
92881930|NCT00976261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881931|NCT00976261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92881932|NCT00976261|Protease Inhibitors|protease inhibitors|mesh-ancestor
92881933|NCT00976261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881934|NCT00976261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881935|NCT02662712|JNJ-56136379|jnj-56136379|mesh-list
92881936|NCT02662712|Antiviral Agents|antiviral agents|mesh-ancestor
92881937|NCT02662712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92881938|NCT00976651|Menotropins|menotropins|mesh-list
92881939|NCT00976651|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92881940|NCT00976651|Fertility Agents|fertility agents|mesh-ancestor
92881941|NCT00976651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92881942|NCT00976651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881943|NCT00971581|Ketoprofen|ketoprofen|mesh-list
92881944|NCT00971581|Omeprazole|omeprazole|mesh-list
92881945|NCT00971581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92881946|NCT00971581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92881947|NCT00971581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92881948|NCT00971581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881949|NCT00971581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881950|NCT00971581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92881951|NCT00971581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92881952|NCT00971581|Analgesics|analgesics|mesh-ancestor
92881953|NCT00971581|Sensory System Agents|sensory system agents|mesh-ancestor
92881954|NCT00971581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881955|NCT00971581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881956|NCT00971581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92881957|NCT00971581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92881958|NCT00971581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92881959|NCT02662322|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92881960|NCT02662322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92881961|NCT02662322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881962|NCT00971659|Insulin|insulin|mesh-list
92881963|NCT00971659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92881964|NCT00971659|Metformin|metformin|mesh-list
92881965|NCT00971659|Insulin Glargine|insulin glargine|mesh-list
92881966|NCT00971659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92881967|NCT00971659|Exenatide|exenatide|mesh-list
92881968|NCT00971659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92881969|NCT00971659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92881970|NCT00971659|Incretins|incretins|mesh-ancestor
92881971|NCT00971659|Hormones|hormones|mesh-ancestor
92881972|NCT00971659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92881973|NCT00971659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92881974|NCT00971659|Protease Inhibitors|protease inhibitors|mesh-ancestor
92881975|NCT00971659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92881976|NCT00971659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881977|NCT00971659|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92881978|NCT00648986|Tazarotene|tazarotene|mesh-list
92881979|NCT00648986|Dermatologic Agents|dermatologic agents|mesh-ancestor
92881980|NCT00648986|Keratolytic Agents|keratolytic agents|mesh-ancestor
92881981|NCT00971815|Dexetimide|dexetimide|mesh-list
92881982|NCT00971815|Citalopram|citalopram|mesh-list
92881983|NCT00971815|Escitalopram|escitalopram|mesh-list
92881984|NCT00971815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92881985|NCT00971815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92881986|NCT00971815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92881987|NCT00971815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92881988|NCT00971815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92881989|NCT00971815|Serotonin Agents|serotonin agents|mesh-ancestor
92881990|NCT00971815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527320|NCT00032734|Satavaptan|satavaptan|mesh-list
92881991|NCT00971815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92881992|NCT00971815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92881993|NCT00971815|Parasympatholytics|parasympatholytics|mesh-ancestor
92881994|NCT00971815|Autonomic Agents|autonomic agents|mesh-ancestor
92881995|NCT00971815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92881996|NCT00971815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92881997|NCT00971815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92881998|NCT00971815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92881999|NCT00971815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92882000|NCT00971815|Antidepressive Agents|antidepressive agents|mesh-ancestor
92882001|NCT00971815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882002|NCT00981487|Ondansetron|ondansetron|mesh-list
92882003|NCT00981487|Antiemetics|antiemetics|mesh-ancestor
92882004|NCT00981487|Autonomic Agents|autonomic agents|mesh-ancestor
92882005|NCT00981487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882006|NCT00981487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882007|NCT00981487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882008|NCT00981487|Antipruritics|antipruritics|mesh-ancestor
92882009|NCT00981487|Dermatologic Agents|dermatologic agents|mesh-ancestor
92882010|NCT00981487|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92882011|NCT00981487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92882012|NCT00981487|Serotonin Agents|serotonin agents|mesh-ancestor
92882013|NCT00981487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882014|NCT00981487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882015|NCT00646568|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92882016|NCT00646568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882017|NCT00646568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882018|NCT00971893|Methylprednisolone|methylprednisolone|mesh-list
92882019|NCT00971893|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92882020|NCT00971893|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92882021|NCT00971893|Prednisolone|prednisolone|mesh-list
92882022|NCT00971893|Prednisolone acetate|prednisolone acetate|mesh-list
92882023|NCT00971893|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92882024|NCT00971893|Prednisolone phosphate|prednisolone phosphate|mesh-list
92882025|NCT00971893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92882026|NCT00971893|Antiemetics|antiemetics|mesh-ancestor
92882027|NCT00971893|Autonomic Agents|autonomic agents|mesh-ancestor
92882028|NCT00971893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882029|NCT00971893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882030|NCT00971893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882031|NCT00971893|Glucocorticoids|glucocorticoids|mesh-ancestor
92882032|NCT00971893|Hormones|hormones|mesh-ancestor
92882033|NCT00971893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882034|NCT00971893|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92882035|NCT00971893|Protective Agents|protective agents|mesh-ancestor
92882036|NCT00971893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92882037|NCT00971893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882038|NCT02665208|Nicotine|nicotine|mesh-list
92882039|NCT02665208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92882040|NCT02665208|Autonomic Agents|autonomic agents|mesh-ancestor
92882041|NCT02665208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882042|NCT02665208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882043|NCT02665208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92882044|NCT02665208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92882045|NCT02665208|Cholinergic Agents|cholinergic agents|mesh-ancestor
92882046|NCT02665208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882047|NCT02665208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882048|NCT00977353|Citalopram|citalopram|mesh-list
92882049|NCT00977353|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92882050|NCT00977353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92882051|NCT00977353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882052|NCT00977353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882053|NCT00977353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882054|NCT00977353|Serotonin Agents|serotonin agents|mesh-ancestor
92882055|NCT00977353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882056|NCT00977353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92525440|NCT00025285|Thalidomide|thalidomide|mesh-list
92882057|NCT00977353|Antidepressive Agents|antidepressive agents|mesh-ancestor
92882058|NCT00977353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882059|NCT00871923|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92882060|NCT00871923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882061|NCT00871923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92882062|NCT00871923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882063|NCT00871923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882064|NCT04170530|Oxaliplatin|oxaliplatin|mesh-list
92882065|NCT04170530|Irinotecan|irinotecan|mesh-list
92882066|NCT04170530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882067|NCT04170530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92882068|NCT04170530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882069|NCT04170530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882070|NCT04170530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882071|NCT02617017|Buspirone|buspirone|mesh-list
92882072|NCT02617017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92882073|NCT02617017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92882074|NCT02617017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882075|NCT02617017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882076|NCT02617017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882077|NCT02617017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92882078|NCT02617017|Serotonin Agents|serotonin agents|mesh-ancestor
92882079|NCT02617017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882080|NCT02617017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882081|NCT02616861|Praliciguat|praliciguat|mesh-list
92882082|NCT02616861|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92882083|NCT02616861|Enzyme Activators|enzyme activators|mesh-ancestor
92882084|NCT02616861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882085|NCT02616861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882086|NCT00981721|Cediranib|cediranib|mesh-list
92882087|NCT00981721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882088|NCT00981721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92882089|NCT00981721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882090|NCT00981721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882091|NCT04133337|Apatinib|apatinib|mesh-list
92882092|NCT04133337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882093|NCT04133337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92882094|NCT04133337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882095|NCT04133337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882096|NCT04133259|Tenofovir|tenofovir|mesh-list
92882097|NCT04133259|Entecavir|entecavir|mesh-list
92882098|NCT04133259|Antibodies|antibodies|mesh-list
92882099|NCT04133259|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92882100|NCT04133259|Immunologic Factors|immunologic factors|mesh-ancestor
92882101|NCT04133259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882102|NCT04133259|Antiviral Agents|antiviral agents|mesh-ancestor
92882103|NCT04133259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882104|NCT04133259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92882105|NCT04133259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92882106|NCT04133259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882107|NCT04133259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882108|NCT04133259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92882109|NCT04133259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92882110|NCT02616315|Naltrexone|naltrexone|mesh-list
92882111|NCT02616315|Bupropion|bupropion|mesh-list
92882112|NCT02616315|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92882113|NCT02616315|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92882114|NCT02616315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882115|NCT02616315|Sensory System Agents|sensory system agents|mesh-ancestor
92882116|NCT02616315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882117|NCT02616315|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92882118|NCT02616315|Antidepressive Agents|antidepressive agents|mesh-ancestor
92882119|NCT02616315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882120|NCT02616315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92882121|NCT02616315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92882122|NCT02616315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882123|NCT02616315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882124|NCT02616315|Dopamine Agents|dopamine agents|mesh-ancestor
92882125|NCT02616315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882126|NCT02616315|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92882127|NCT02616315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92882128|NCT02616315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882129|NCT02779283|Calcium, Dietary|calcium, dietary|mesh-list
92882130|NCT02779283|Leucovorin|leucovorin|mesh-list
92882131|NCT02779283|Folic Acid|folic acid|mesh-list
92882132|NCT02779283|Cytarabine|cytarabine|mesh-list
92882133|NCT02779283|Dexamethasone|dexamethasone|mesh-list
92882134|NCT02779283|Methylprednisolone|methylprednisolone|mesh-list
92882135|NCT02779283|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92882136|NCT02779283|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92882137|NCT02779283|Prednisolone|prednisolone|mesh-list
92882138|NCT02779283|Prednisolone acetate|prednisolone acetate|mesh-list
92882139|NCT02779283|Dexamethasone acetate|dexamethasone acetate|mesh-list
92882140|NCT02779283|Cyclophosphamide|cyclophosphamide|mesh-list
92882141|NCT02779283|Rituximab|rituximab|mesh-list
92882142|NCT02779283|Doxorubicin|doxorubicin|mesh-list
92882143|NCT02779283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92882144|NCT02779283|Methotrexate|methotrexate|mesh-list
92882145|NCT02779283|Vincristine|vincristine|mesh-list
92882147|NCT02779283|Sunitinib|sunitinib|mesh-list
92882148|NCT02779283|Dasatinib|dasatinib|mesh-list
92882149|NCT02779283|Idarubicin|idarubicin|mesh-list
92882150|NCT02779283|Ponatinib|ponatinib|mesh-list
92882151|NCT02779283|Idelalisib|idelalisib|mesh-list
92882152|NCT02779283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92882153|NCT02779283|Antibodies|antibodies|mesh-list
92882154|NCT02779283|Immunoglobulins|immunoglobulins|mesh-list
92882155|NCT02779283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92882156|NCT02779283|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92882157|NCT02779283|Prednisolone phosphate|prednisolone phosphate|mesh-list
92882158|NCT02779283|BB 1101|bb 1101|mesh-list
92882159|NCT02779283|Calcium|calcium|mesh-list
92882160|NCT02779283|Levoleucovorin|levoleucovorin|mesh-list
92882161|NCT02779283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882162|NCT02779283|Immunologic Factors|immunologic factors|mesh-ancestor
92882163|NCT02779283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882164|NCT02779283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882165|NCT02779283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92882166|NCT02779283|Alkylating Agents|alkylating agents|mesh-ancestor
92882167|NCT02779283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183036|NCT00245557|Sertraline|sertraline|mesh-list
92882168|NCT02779283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882169|NCT02779283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92882170|NCT02779283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92882171|NCT02779283|Antiemetics|antiemetics|mesh-ancestor
92882172|NCT02779283|Autonomic Agents|autonomic agents|mesh-ancestor
92882173|NCT02779283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882174|NCT02779283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882175|NCT02779283|Glucocorticoids|glucocorticoids|mesh-ancestor
92882176|NCT02779283|Hormones|hormones|mesh-ancestor
92882177|NCT02779283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882178|NCT02779283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92882179|NCT02779283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92882180|NCT02779283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92882181|NCT02779283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882182|NCT02779283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882183|NCT02779283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92882184|NCT02779283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92882185|NCT02779283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92882186|NCT02779283|Abortifacient Agents|abortifacient agents|mesh-ancestor
92882187|NCT02779283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882188|NCT02779283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882189|NCT02779283|Antimetabolites|antimetabolites|mesh-ancestor
92882190|NCT02779283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92882191|NCT02779283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92882192|NCT02779283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92882193|NCT02779283|Antiviral Agents|antiviral agents|mesh-ancestor
92882194|NCT02779283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882195|NCT02779283|Antidotes|antidotes|mesh-ancestor
92882196|NCT02779283|Protective Agents|protective agents|mesh-ancestor
92882197|NCT02779283|Vitamin B Complex|vitamin b complex|mesh-ancestor
92882198|NCT02779283|Vitamins|vitamins|mesh-ancestor
92882199|NCT02779283|Micronutrients|micronutrients|mesh-ancestor
92882200|NCT02779283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92882201|NCT02779283|Tubulin Modulators|tubulin modulators|mesh-ancestor
92882202|NCT02779283|Antimitotic Agents|antimitotic agents|mesh-ancestor
92882203|NCT02779283|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882204|NCT02779283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92882205|NCT02779283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92882206|NCT02779283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92882207|NCT02779283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92882208|NCT02779283|Growth Substances|growth substances|mesh-ancestor
92882209|NCT02779283|Growth Inhibitors|growth inhibitors|mesh-ancestor
92882211|NCT02779283|Protease Inhibitors|protease inhibitors|mesh-ancestor
92882212|NCT02616003|Liraglutide|liraglutide|mesh-list
92882213|NCT02616003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882214|NCT02616003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882215|NCT02616003|Incretins|incretins|mesh-ancestor
92882216|NCT02616003|Hormones|hormones|mesh-ancestor
92882217|NCT02616003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527557|NCT00033436|Niacin|niacin|mesh-list
92882218|NCT02661152|Nimorazole|nimorazole|mesh-list
92882219|NCT02661152|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92882220|NCT02661152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92882221|NCT02661152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92882222|NCT02661152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882223|NCT00697671|Cyclophosphamide|cyclophosphamide|mesh-list
92882224|NCT00697671|Etoposide|etoposide|mesh-list
92882225|NCT00697671|Interleukin-2|interleukin-2|mesh-list
92882226|NCT00697671|Clofarabine|clofarabine|mesh-list
92882227|NCT00697671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882228|NCT00697671|Immunologic Factors|immunologic factors|mesh-ancestor
92882229|NCT00697671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882230|NCT00697671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882231|NCT00697671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92882232|NCT00697671|Alkylating Agents|alkylating agents|mesh-ancestor
92882233|NCT00697671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882234|NCT00697671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882235|NCT00697671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92882236|NCT00697671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92882237|NCT00697671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92882238|NCT00697671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882239|NCT00697671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882240|NCT00697671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92882241|NCT00697671|Analgesics|analgesics|mesh-ancestor
92882242|NCT00697671|Sensory System Agents|sensory system agents|mesh-ancestor
92882243|NCT00697671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882244|NCT00697671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882245|NCT00697671|Antimetabolites|antimetabolites|mesh-ancestor
92882246|NCT03922945|Topiramate|topiramate|mesh-list
92882247|NCT03922945|Phentermine|phentermine|mesh-list
92882248|NCT03922945|Anticonvulsants|anticonvulsants|mesh-ancestor
92882249|NCT03922945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882250|NCT03922945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882251|NCT03922945|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92882252|NCT03922945|Appetite Depressants|appetite depressants|mesh-ancestor
92882253|NCT03922945|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92882254|NCT03922945|Sympathomimetics|sympathomimetics|mesh-ancestor
92882255|NCT03922945|Autonomic Agents|autonomic agents|mesh-ancestor
92882256|NCT03922945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882257|NCT03922945|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882258|NCT03922945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882259|NCT03922945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882260|NCT04973345|Terbutaline|terbutaline|mesh-list
92882261|NCT04973345|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92882262|NCT04973345|Autonomic Agents|autonomic agents|mesh-ancestor
92882263|NCT04973345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882264|NCT04973345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882265|NCT04973345|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92882266|NCT04973345|Respiratory System Agents|respiratory system agents|mesh-ancestor
92882267|NCT04973345|Sympathomimetics|sympathomimetics|mesh-ancestor
92882268|NCT04973345|Tocolytic Agents|tocolytic agents|mesh-ancestor
92882269|NCT04973345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882270|NCT04973345|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92882271|NCT04973345|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92882272|NCT04973345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92882273|NCT04973345|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882274|NCT04973345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882275|NCT04973345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882276|NCT05236985|Oxytocin|oxytocin|mesh-list
92882277|NCT05236985|Oxytocics|oxytocics|mesh-ancestor
92882278|NCT05236985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882279|NCT05236985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882280|NCT03922477|Atezolizumab|atezolizumab|mesh-list
92882281|NCT03922477|Magrolimab|magrolimab|mesh-list
92882282|NCT03922477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92882283|NCT03922477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882284|NCT03922477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882285|NCT03922477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882286|NCT00978211|Octreotide|octreotide|mesh-list
92882287|NCT00978211|Somatostatin|somatostatin|mesh-list
92882288|NCT00978211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882289|NCT00978211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92882290|NCT00978211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882291|NCT00978211|Hormones|hormones|mesh-ancestor
92882292|NCT00978211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882293|NCT00978211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882294|NCT00867165|Ezetimibe|ezetimibe|mesh-list
92882295|NCT00867165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92882297|NCT00867165|Antimetabolites|antimetabolites|mesh-ancestor
92882298|NCT00867165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882299|NCT00867165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92882300|NCT00981955|Caffeine|caffeine|mesh-list
92882301|NCT00981955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92882302|NCT00981955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882303|NCT00981955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92882304|NCT00981955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882305|NCT00981955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882306|NCT00981955|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92882307|NCT00981955|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92882308|NCT00981955|Purinergic Agents|purinergic agents|mesh-ancestor
92882309|NCT00981955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882310|NCT00972829|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92882311|NCT00972829|Ezetimibe|ezetimibe|mesh-list
92882312|NCT00972829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92882313|NCT00972829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92882314|NCT00972829|Antimetabolites|antimetabolites|mesh-ancestor
93026471|NCT00402051|Carboplatin|carboplatin|mesh-list
92882315|NCT00972829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882316|NCT00972829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92882317|NCT00972829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92882318|NCT00972829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882319|NCT05037617|Oxytocin|oxytocin|mesh-list
92882320|NCT05037617|Oxytocics|oxytocics|mesh-ancestor
92882321|NCT05037617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882322|NCT05037617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882323|NCT00972907|Nifedipine|nifedipine|mesh-list
92882324|NCT00972907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92882325|NCT00972907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882326|NCT00972907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882327|NCT00972907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92882328|NCT00972907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882329|NCT00972907|Vasodilator Agents|vasodilator agents|mesh-ancestor
92882330|NCT00972907|Tocolytic Agents|tocolytic agents|mesh-ancestor
92882331|NCT00972907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882332|NCT04008433|Lidocaine|lidocaine|mesh-list
92882333|NCT04008433|Anesthetics, Local|anesthetics, local|mesh-ancestor
92882334|NCT04008433|Anesthetics|anesthetics|mesh-ancestor
92882335|NCT04008433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882336|NCT04008433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882337|NCT04008433|Sensory System Agents|sensory system agents|mesh-ancestor
92882338|NCT04008433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882339|NCT04008433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92882340|NCT04008433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92882341|NCT04008433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92882342|NCT04008433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882343|NCT04008433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882344|NCT04132479|Amoxicillin|amoxicillin|mesh-list
92882345|NCT04132479|Clarithromycin|clarithromycin|mesh-list
92882346|NCT04132479|Tinidazole|tinidazole|mesh-list
92882347|NCT04132479|Rabeprazole|rabeprazole|mesh-list
92882348|NCT04132479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92882349|NCT04132479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882350|NCT04132479|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92882351|NCT04132479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882352|NCT04132479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882353|NCT04132479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92882354|NCT04132479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92882355|NCT04132479|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92882356|NCT04132479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882357|NCT04132479|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92882359|NCT04132479|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92882360|NCT04132479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92882361|NCT04132479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92882362|NCT00972985|Lorazepam|lorazepam|mesh-list
92882363|NCT00972985|Methylphenidate|methylphenidate|mesh-list
92882364|NCT00972985|Modafinil|modafinil|mesh-list
92882365|NCT00972985|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92882366|NCT00972985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882367|NCT00972985|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92527692|NCT00389051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882368|NCT00972985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92882369|NCT00972985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882370|NCT00972985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882371|NCT00972985|Dopamine Agents|dopamine agents|mesh-ancestor
92882372|NCT00972985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882373|NCT00972985|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92882374|NCT00972985|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92882375|NCT00972985|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92882376|NCT00972985|Anticonvulsants|anticonvulsants|mesh-ancestor
92882377|NCT00972985|Antiemetics|antiemetics|mesh-ancestor
92882378|NCT00972985|Autonomic Agents|autonomic agents|mesh-ancestor
92882379|NCT00972985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882380|NCT00972985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882381|NCT00972985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92882382|NCT00972985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882383|NCT00972985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92882384|NCT00972985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92882385|NCT00972985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882386|NCT00972985|GABA Modulators|gaba modulators|mesh-ancestor
92882387|NCT00972985|GABA Agents|gaba agents|mesh-ancestor
92882388|NCT00867087|Rituximab|rituximab|mesh-list
92882389|NCT00867087|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92882390|NCT00867087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882391|NCT00867087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882392|NCT00867087|Immunologic Factors|immunologic factors|mesh-ancestor
92882393|NCT00867087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882394|NCT00867087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882395|NCT00867087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92882396|NCT00867087|Immunotoxins|immunotoxins|mesh-ancestor
92882397|NCT00867087|Immunoconjugates|immunoconjugates|mesh-ancestor
92882398|NCT02778425|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92882399|NCT02778425|Somatostatin|somatostatin|mesh-list
92882400|NCT02778425|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92882401|NCT02778425|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882402|NCT02778425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882403|NCT02778425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882404|NCT02778425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882405|NCT02778425|Hormones|hormones|mesh-ancestor
92882406|NCT02778425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882407|NCT04228757|Phytoestrogens|phytoestrogens|mesh-list
92882408|NCT04228757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92882409|NCT04228757|Estrogens|estrogens|mesh-ancestor
92882410|NCT04228757|Hormones|hormones|mesh-ancestor
92882411|NCT04228757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882412|NCT04228757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882413|NCT04227431|Insulin|insulin|mesh-list
92882414|NCT04227431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882415|NCT04227431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882416|NCT04227041|Capecitabine|capecitabine|mesh-list
92882417|NCT04227041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882418|NCT04227041|Antimetabolites|antimetabolites|mesh-ancestor
92882419|NCT04227041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882420|NCT04227041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882421|NCT04226963|Ketamine|ketamine|mesh-list
92882422|NCT04226963|Analgesics|analgesics|mesh-ancestor
92882423|NCT04226963|Sensory System Agents|sensory system agents|mesh-ancestor
92882424|NCT04226963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882425|NCT04226963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882426|NCT04226963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92882427|NCT04226963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92882428|NCT04226963|Anesthetics, General|anesthetics, general|mesh-ancestor
92882429|NCT04226963|Anesthetics|anesthetics|mesh-ancestor
92882430|NCT04226963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227106|NCT00001054|Antiviral Agents|antiviral agents|mesh-ancestor
92882431|NCT04226963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92882432|NCT04226963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92882433|NCT04226963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882434|NCT04226963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882435|NCT00545233|Pioglitazone|pioglitazone|mesh-list
92882436|NCT00545233|Ribavirin|ribavirin|mesh-list
92882437|NCT00545233|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92882438|NCT00545233|Antimetabolites|antimetabolites|mesh-ancestor
92882439|NCT00545233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882440|NCT00545233|Antiviral Agents|antiviral agents|mesh-ancestor
92882441|NCT00545233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882442|NCT00545233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882443|NCT00545233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882445|NCT02393248|Docetaxel|docetaxel|mesh-list
92882446|NCT02393248|Pembrolizumab|pembrolizumab|mesh-list
92882447|NCT02393248|Trastuzumab|trastuzumab|mesh-list
92882448|NCT02393248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882449|NCT02393248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882450|NCT02393248|Antimetabolites|antimetabolites|mesh-ancestor
92882451|NCT02393248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882452|NCT02393248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92882453|NCT02393248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92882454|NCT02393248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882455|NCT02393248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882456|NCT02393248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92882457|NCT00601484|Tanezumab|tanezumab|mesh-list
92882458|NCT00601484|Analgesics|analgesics|mesh-ancestor
92882459|NCT00601484|Sensory System Agents|sensory system agents|mesh-ancestor
92882460|NCT00601484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882461|NCT00601484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882462|NCT04228601|Fluzoparib|fluzoparib|mesh-list
92882463|NCT04228601|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92882464|NCT04228601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882465|NCT04228601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882466|NCT04228601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882467|NCT00978601|Analgesics|analgesics|mesh-list
92882468|NCT00978601|Sensory System Agents|sensory system agents|mesh-ancestor
92882469|NCT00978601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882470|NCT00978601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882471|NCT00883896|Fezakinumab|fezakinumab|mesh-list
92882472|NCT00883896|Dermatologic Agents|dermatologic agents|mesh-ancestor
92882473|NCT02778191|Carboplatin|carboplatin|mesh-list
92882474|NCT02778191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882475|NCT05170685|Nivolumab|nivolumab|mesh-list
92882476|NCT05170685|Relatlimab|relatlimab|mesh-list
92882477|NCT05170685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882478|NCT05170685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882479|NCT05170685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92882480|NCT05170685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882481|NCT02778893|Thalidomide|thalidomide|mesh-list
92882482|NCT02778893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882483|NCT02778893|Immunologic Factors|immunologic factors|mesh-ancestor
92882484|NCT02778893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882485|NCT02778893|Leprostatic Agents|leprostatic agents|mesh-ancestor
92882486|NCT02778893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92882487|NCT02778893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882488|NCT02778893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92882489|NCT02778893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92882490|NCT02778893|Growth Substances|growth substances|mesh-ancestor
92882491|NCT02778893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92882492|NCT02778893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882493|NCT03920293|Ravulizumab|ravulizumab|mesh-list
92882494|NCT03920293|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92882495|NCT03920293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882496|NCT03920293|Immunologic Factors|immunologic factors|mesh-ancestor
92882497|NCT03920293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882498|NCT02671864|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92882499|NCT02671864|Incretins|incretins|mesh-list
92882500|NCT02671864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882501|NCT02671864|Hormones|hormones|mesh-ancestor
92882502|NCT02671864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882503|NCT00867009|Pemetrexed|pemetrexed|mesh-list
92882504|NCT00867009|Cetuximab|cetuximab|mesh-list
92882505|NCT00867009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882506|NCT00867009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882507|NCT00867009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882508|NCT00867009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92882509|NCT00867009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92882510|NCT00867009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882511|NCT00666042|Moxifloxacin|moxifloxacin|mesh-list
92882512|NCT00666042|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92882513|NCT00666042|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92882514|NCT00666042|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92882515|NCT00666042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92882516|NCT00666042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882517|NCT00666042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92882518|NCT00666042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882519|NCT00666042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882520|NCT00666042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882521|NCT00666042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882522|NCT00666042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92882523|NCT00666042|Contraceptive Agents|contraceptive agents|mesh-ancestor
92882524|NCT00666042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882525|NCT00666042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882526|NCT00666042|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92882527|NCT00666042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92882528|NCT00666042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92882529|NCT02660840|Flupenthixol|flupenthixol|mesh-list
92882530|NCT02660840|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92882531|NCT02660840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92882532|NCT02660840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92882533|NCT02660840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882534|NCT02660840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882535|NCT02660840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882536|NCT02660840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92882537|NCT02660840|Dopamine Agents|dopamine agents|mesh-ancestor
92882538|NCT02660840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882539|NCT02660840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882541|NCT02777801|Antiviral Agents|antiviral agents|mesh-ancestor
92882542|NCT02777801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882543|NCT00649064|Ziprasidone|ziprasidone|mesh-list
92882544|NCT00649064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92882545|NCT00649064|Serotonin Agents|serotonin agents|mesh-ancestor
92882546|NCT00649064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882547|NCT00649064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882548|NCT00649064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882549|NCT00649064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92882550|NCT00649064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92882551|NCT00649064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882552|NCT00649064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882553|NCT00649064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92882554|NCT00649064|Dopamine Agents|dopamine agents|mesh-ancestor
92882555|NCT04132713|Capecitabine|capecitabine|mesh-list
92882556|NCT04132713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882557|NCT04132713|Antimetabolites|antimetabolites|mesh-ancestor
92882558|NCT04132713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882559|NCT04132713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882560|NCT04007341|Dexmedetomidine|dexmedetomidine|mesh-list
92882561|NCT04007341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92882562|NCT04007341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882563|NCT04007341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882564|NCT04007341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92882565|NCT04007341|Analgesics|analgesics|mesh-ancestor
92882566|NCT04007341|Sensory System Agents|sensory system agents|mesh-ancestor
92882567|NCT04007341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882568|NCT04007341|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92882569|NCT04007341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92882570|NCT04007341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92882571|NCT04007341|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882572|NCT04007341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882573|NCT04007341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882574|NCT02656082|Etanercept|etanercept|mesh-list
92882575|NCT02656082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92882576|NCT02656082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92882577|NCT02656082|Analgesics|analgesics|mesh-ancestor
92882578|NCT02656082|Sensory System Agents|sensory system agents|mesh-ancestor
92882579|NCT02656082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882580|NCT02656082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882582|NCT02656082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882583|NCT02656082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882584|NCT02656082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882585|NCT02656082|Immunologic Factors|immunologic factors|mesh-ancestor
92882586|NCT04132635|Mitogens|mitogens|mesh-list
92882587|NCT04132635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882588|NCT04132635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882589|NCT02623504|Carbamazepine|carbamazepine|mesh-list
92882590|NCT02623504|Anticonvulsants|anticonvulsants|mesh-ancestor
92882591|NCT02623504|Antimanic Agents|antimanic agents|mesh-ancestor
92882592|NCT02623504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92882593|NCT02623504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882594|NCT02623504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882595|NCT02623504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882596|NCT02623504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92882597|NCT02623504|Analgesics|analgesics|mesh-ancestor
92882598|NCT02623504|Sensory System Agents|sensory system agents|mesh-ancestor
92882599|NCT02623504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882600|NCT02623504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92882601|NCT02623504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882602|NCT02623504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882603|NCT02623504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92882604|NCT02623504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92882605|NCT02777723|Hyaluronic Acid|hyaluronic acid|mesh-list
92882606|NCT02777723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92882607|NCT02777723|Immunologic Factors|immunologic factors|mesh-ancestor
92882608|NCT02777723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882609|NCT02777723|Viscosupplements|viscosupplements|mesh-ancestor
92882610|NCT02777723|Protective Agents|protective agents|mesh-ancestor
92882611|NCT00601250|Linagliptin|linagliptin|mesh-list
92882612|NCT00601250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882613|NCT00601250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882614|NCT00601250|Incretins|incretins|mesh-ancestor
92882615|NCT00601250|Hormones|hormones|mesh-ancestor
92882616|NCT00601250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882617|NCT00601250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92882618|NCT00601250|Protease Inhibitors|protease inhibitors|mesh-ancestor
92882619|NCT00601250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882620|NCT00601250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882621|NCT04226885|Fentanyl|fentanyl|mesh-list
92882622|NCT04226885|Midazolam|midazolam|mesh-list
92882623|NCT04226885|Dexmedetomidine|dexmedetomidine|mesh-list
92882624|NCT04226885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92882625|NCT04226885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882626|NCT04226885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882627|NCT04226885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92882628|NCT04226885|Analgesics|analgesics|mesh-ancestor
92882629|NCT04226885|Sensory System Agents|sensory system agents|mesh-ancestor
92882630|NCT04226885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882631|NCT04226885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92882632|NCT04226885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92882633|NCT04226885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92882634|NCT04226885|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882635|NCT04226885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882636|NCT04226885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882637|NCT04226885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92882638|NCT04226885|Narcotics|narcotics|mesh-ancestor
92882639|NCT04226885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92882640|NCT04226885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92882641|NCT04226885|Anesthetics, General|anesthetics, general|mesh-ancestor
92882642|NCT04226885|Anesthetics|anesthetics|mesh-ancestor
92882643|NCT04226885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92882644|NCT04226885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92882645|NCT04226885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92882646|NCT04226885|GABA Modulators|gaba modulators|mesh-ancestor
92882647|NCT04226885|GABA Agents|gaba agents|mesh-ancestor
92882648|NCT00866775|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92882649|NCT00866775|Anticonvulsants|anticonvulsants|mesh-ancestor
92882650|NCT00866775|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92882651|NCT00866775|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92882652|NCT00866775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882653|NCT00866775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882654|NCT02777411|Vaccines|vaccines|mesh-list
92882655|NCT02777411|Immunologic Factors|immunologic factors|mesh-ancestor
92882656|NCT02777411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882657|NCT02777489|Perindopril|perindopril|mesh-list
92882658|NCT02777489|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92882659|NCT02777489|Protease Inhibitors|protease inhibitors|mesh-ancestor
92882660|NCT02777489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882661|NCT02777489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882662|NCT02777489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92882663|NCT02660762|Cytarabine|cytarabine|mesh-list
92882664|NCT02660762|Dexamethasone|dexamethasone|mesh-list
92882665|NCT02660762|Dexamethasone acetate|dexamethasone acetate|mesh-list
92527992|NCT00000689|Leucovorin|leucovorin|mesh-list
92882667|NCT02660762|Cyclophosphamide|cyclophosphamide|mesh-list
92882668|NCT02660762|Methotrexate|methotrexate|mesh-list
92882669|NCT02660762|Etoposide|etoposide|mesh-list
92882670|NCT02660762|Vincristine|vincristine|mesh-list
92882671|NCT02660762|Daunorubicin|daunorubicin|mesh-list
92882672|NCT02660762|Mercaptopurine|mercaptopurine|mesh-list
92882673|NCT02660762|Pegaspargase|pegaspargase|mesh-list
92882674|NCT02660762|Thioguanine|thioguanine|mesh-list
92882675|NCT02660762|BB 1101|bb 1101|mesh-list
92882676|NCT02660762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882677|NCT02660762|Immunologic Factors|immunologic factors|mesh-ancestor
92882678|NCT02660762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882679|NCT02660762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882680|NCT02660762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92882681|NCT02660762|Alkylating Agents|alkylating agents|mesh-ancestor
92882682|NCT02660762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882683|NCT02660762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882684|NCT02660762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92882685|NCT02660762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92882686|NCT02660762|Antiemetics|antiemetics|mesh-ancestor
92882687|NCT02660762|Autonomic Agents|autonomic agents|mesh-ancestor
92882688|NCT02660762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882689|NCT02660762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882690|NCT02660762|Glucocorticoids|glucocorticoids|mesh-ancestor
92882691|NCT02660762|Hormones|hormones|mesh-ancestor
92882692|NCT02660762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882693|NCT02660762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92882694|NCT02660762|Protease Inhibitors|protease inhibitors|mesh-ancestor
92882695|NCT02660762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882696|NCT02660762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92882697|NCT02660762|Abortifacient Agents|abortifacient agents|mesh-ancestor
92882698|NCT02660762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882699|NCT02660762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882700|NCT02660762|Antimetabolites|antimetabolites|mesh-ancestor
92882701|NCT02660762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92882702|NCT02660762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92882703|NCT02660762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92882704|NCT02660762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92882705|NCT02660762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92882706|NCT02660762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882707|NCT02660762|Antiviral Agents|antiviral agents|mesh-ancestor
92882708|NCT02660762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882709|NCT02660762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92882710|NCT02660762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92882711|NCT02660762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882712|NCT02660762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92882713|NCT02660684|Cyclosporine|cyclosporine|mesh-list
92882714|NCT02660684|Methotrexate|methotrexate|mesh-list
92882715|NCT02660684|Tacrolimus|tacrolimus|mesh-list
92882716|NCT02660684|Cyclosporins|cyclosporins|mesh-list
92882717|NCT02660684|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92882718|NCT02660684|Abortifacient Agents|abortifacient agents|mesh-ancestor
92882719|NCT02660684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882720|NCT02660684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882721|NCT02660684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92882722|NCT02660684|Antimetabolites|antimetabolites|mesh-ancestor
92882723|NCT02660684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882724|NCT02660684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882725|NCT02660684|Dermatologic Agents|dermatologic agents|mesh-ancestor
92882726|NCT02660684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882727|NCT02660684|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92882728|NCT02660684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882729|NCT02660684|Immunologic Factors|immunologic factors|mesh-ancestor
92882730|NCT02660684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882731|NCT02660684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92882732|NCT02660684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92882733|NCT02660684|Antifungal Agents|antifungal agents|mesh-ancestor
92882734|NCT02660684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882735|NCT00982891|Morphine|morphine|mesh-list
92882736|NCT00982891|Hydromorphone|hydromorphone|mesh-list
92882737|NCT00982891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92882738|NCT00982891|Narcotics|narcotics|mesh-ancestor
92882739|NCT00982891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882740|NCT00982891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882741|NCT00982891|Analgesics|analgesics|mesh-ancestor
92882742|NCT00982891|Sensory System Agents|sensory system agents|mesh-ancestor
92882743|NCT00982891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882744|NCT02615223|Bicalutamide|bicalutamide|mesh-list
92882745|NCT02615223|Hormones|hormones|mesh-list
92882746|NCT02615223|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92882747|NCT02615223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92882748|NCT02615223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882749|NCT02615223|Androgen Antagonists|androgen antagonists|mesh-ancestor
92882750|NCT02615223|Hormone Antagonists|hormone antagonists|mesh-ancestor
92882751|NCT02615223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882752|NCT04132557|Methylphenidate|methylphenidate|mesh-list
92882753|NCT04132557|Amphetamine|amphetamine|mesh-list
92882754|NCT04132557|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92882755|NCT04132557|Dextroamphetamine|dextroamphetamine|mesh-list
92882756|NCT04132557|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92882757|NCT04132557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92882758|NCT04132557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882759|NCT04132557|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92882760|NCT04132557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92882761|NCT04132557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882762|NCT04132557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882763|NCT04132557|Dopamine Agents|dopamine agents|mesh-ancestor
92882764|NCT04132557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882765|NCT04132557|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92882766|NCT04132557|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882767|NCT04132557|Sympathomimetics|sympathomimetics|mesh-ancestor
92882768|NCT04132557|Autonomic Agents|autonomic agents|mesh-ancestor
92882769|NCT04132557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882770|NCT00978913|Cyclophosphamide|cyclophosphamide|mesh-list
92882771|NCT00978913|Vaccines|vaccines|mesh-list
92882772|NCT00978913|Immunologic Factors|immunologic factors|mesh-ancestor
92882773|NCT00978913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882774|NCT00978913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882775|NCT00978913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882776|NCT00978913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92882777|NCT00978913|Alkylating Agents|alkylating agents|mesh-ancestor
92882778|NCT00978913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882779|NCT00978913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882780|NCT00978913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92882781|NCT04227509|Pembrolizumab|pembrolizumab|mesh-list
92882782|NCT04227509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882783|NCT04227509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882784|NCT04227509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92882785|NCT04227509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882786|NCT02778659|Zolpidem|zolpidem|mesh-list
92882787|NCT02778659|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92882788|NCT02778659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92882789|NCT02778659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882790|NCT02778659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882791|NCT02778659|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92882792|NCT02778659|GABA Agonists|gaba agonists|mesh-ancestor
92882793|NCT02778659|GABA Agents|gaba agents|mesh-ancestor
92882794|NCT02778659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882795|NCT02778659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882796|NCT04072900|Imiquimod|imiquimod|mesh-list
92882797|NCT04072900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92882798|NCT04072900|Immunologic Factors|immunologic factors|mesh-ancestor
92882799|NCT04072900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882800|NCT04072900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882801|NCT04072900|Interferon Inducers|interferon inducers|mesh-ancestor
92882802|NCT00984763|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92882803|NCT00984763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92882804|NCT00984763|Immunologic Factors|immunologic factors|mesh-ancestor
92882805|NCT00984763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882806|NCT00984763|Antacids|antacids|mesh-ancestor
92882807|NCT00984763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882808|NCT00984763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92882809|NCT02578108|Lidocaine|lidocaine|mesh-list
92882810|NCT02578108|Anesthetics, Local|anesthetics, local|mesh-list
92882811|NCT02578108|Anesthetics|anesthetics|mesh-list
92882812|NCT02578108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92882813|NCT02578108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882814|NCT02578108|Sensory System Agents|sensory system agents|mesh-ancestor
92882815|NCT02578108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882816|NCT02578108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92882817|NCT02578108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92882819|NCT02578108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92882820|NCT02578108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882821|NCT02776163|Docetaxel|docetaxel|mesh-list
92882822|NCT02776163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882823|NCT02776163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92882824|NCT02776163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92882825|NCT02776163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882826|NCT02776163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882827|NCT05325346|Argatroban|argatroban|mesh-list
92882828|NCT05325346|Antithrombins|antithrombins|mesh-ancestor
92882829|NCT05325346|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92882830|NCT05325346|Protease Inhibitors|protease inhibitors|mesh-ancestor
92882831|NCT05325346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882832|NCT05325346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882833|NCT05325346|Anticoagulants|anticoagulants|mesh-ancestor
92882834|NCT05325346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92882835|NCT00984997|Etoposide|etoposide|mesh-list
92882836|NCT00984997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882837|NCT00984997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92882838|NCT00984997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92882839|NCT00984997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882840|NCT00984997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882841|NCT00984997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882842|NCT00973219|Interferons|interferons|mesh-list
92882843|NCT00973219|Tenofovir|tenofovir|mesh-list
92882844|NCT00973219|Interferon-alpha|interferon-alpha|mesh-list
92882845|NCT00973219|Interferon alpha-2|interferon alpha-2|mesh-list
92882846|NCT00973219|Adefovir|adefovir|mesh-list
92882847|NCT00973219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92882848|NCT00973219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92882849|NCT00973219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882850|NCT00973219|Antiviral Agents|antiviral agents|mesh-ancestor
92882851|NCT00973219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882852|NCT00973219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92882853|NCT00973219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92882854|NCT00973219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882855|NCT00973219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882856|NCT00973219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92882857|NCT00973219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92882858|NCT00973219|Immunologic Factors|immunologic factors|mesh-ancestor
92882859|NCT00973219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882860|NCT04194125|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
92882861|NCT04194125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92882862|NCT04194125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882863|NCT04973891|Metformin|metformin|mesh-list
92882864|NCT04973891|Canagliflozin|canagliflozin|mesh-list
92882865|NCT04973891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882866|NCT04973891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882867|NCT04973891|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92882868|NCT04973891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882869|NCT00983047|Docetaxel|docetaxel|mesh-list
92882870|NCT00983047|Nimotuzumab|nimotuzumab|mesh-list
92882871|NCT00983047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882872|NCT00983047|Tubulin Modulators|tubulin modulators|mesh-ancestor
92882873|NCT00983047|Antimitotic Agents|antimitotic agents|mesh-ancestor
92882874|NCT00983047|Mitosis Modulators|mitosis modulators|mesh-ancestor
92882875|NCT00983047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882876|NCT00983047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92882877|NCT00983125|Clonidine|clonidine|mesh-list
92882878|NCT00983125|Analgesics|analgesics|mesh-ancestor
92882879|NCT00983125|Sensory System Agents|sensory system agents|mesh-ancestor
92882880|NCT00983125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882881|NCT00983125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882882|NCT00983125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92882883|NCT00983125|Sympatholytics|sympatholytics|mesh-ancestor
92882884|NCT00983125|Autonomic Agents|autonomic agents|mesh-ancestor
92882885|NCT00983125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92882886|NCT00983125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92882887|NCT00983125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92882888|NCT00983125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92882889|NCT00983125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528222|NCT00035191|Nootropic Agents|nootropic agents|mesh-ancestor
92882890|NCT00983125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882891|NCT00988039|Raltegravir Potassium|raltegravir potassium|mesh-list
92882893|NCT00988039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92882894|NCT00988039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92882895|NCT00988039|Antiviral Agents|antiviral agents|mesh-ancestor
92882896|NCT00988039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882897|NCT00988039|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92882898|NCT00988039|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92882899|NCT00988039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882900|NCT00988039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882901|NCT00988039|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92882902|NCT00988039|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92882903|NCT00988039|Protease Inhibitors|protease inhibitors|mesh-ancestor
92882904|NCT00988039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92882905|NCT00988039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92882906|NCT04855513|Metformin|metformin|mesh-list
92882907|NCT04855513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92882908|NCT04855513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882909|NCT02775773|Tranexamic Acid|tranexamic acid|mesh-list
92882910|NCT02775773|Oxytocin|oxytocin|mesh-list
92882911|NCT02775773|Oxytocics|oxytocics|mesh-ancestor
92882912|NCT02775773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882913|NCT02775773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882914|NCT02775773|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92882915|NCT02775773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92882916|NCT02775773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882917|NCT02775773|Hemostatics|hemostatics|mesh-ancestor
92882918|NCT02775773|Coagulants|coagulants|mesh-ancestor
92882919|NCT00983203|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92882920|NCT00983203|Lubricant Eye Drops|lubricant eye drops|mesh-list
92882921|NCT00983203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92882922|NCT00988195|Doxorubicin|doxorubicin|mesh-list
92882923|NCT00988195|BCT-100|bct-100|mesh-list
92882924|NCT00988195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92882925|NCT00988195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882926|NCT00988195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92882927|NCT00988195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92882928|NCT00988195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882929|NCT00988195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882930|NCT00634985|Eletriptan|eletriptan|mesh-list
92882931|NCT00634985|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92882932|NCT00634985|Serotonin Agents|serotonin agents|mesh-ancestor
92882933|NCT00634985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882934|NCT00634985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882935|NCT00634985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882936|NCT00985387|Solifenacin Succinate|solifenacin succinate|mesh-list
92882937|NCT00985387|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92882938|NCT00985387|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92882939|NCT00985387|Cholinergic Agents|cholinergic agents|mesh-ancestor
92882940|NCT00985387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92882941|NCT00985387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882942|NCT00985387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882943|NCT00985387|Urological Agents|urological agents|mesh-ancestor
92882944|NCT02776943|Hyaluronic Acid|hyaluronic acid|mesh-list
92882945|NCT02776943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92882946|NCT02776943|Immunologic Factors|immunologic factors|mesh-ancestor
92882947|NCT02776943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882948|NCT02776943|Viscosupplements|viscosupplements|mesh-ancestor
92882949|NCT02776943|Protective Agents|protective agents|mesh-ancestor
92882950|NCT04005781|Hydroxychloroquine|hydroxychloroquine|mesh-list
92882951|NCT04005781|Antimalarials|antimalarials|mesh-ancestor
92882952|NCT04005781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92882953|NCT04005781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92882954|NCT04005781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92882955|NCT04005781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92882956|NCT04005781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882957|NCT04005781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882958|NCT04654351|Icatibant|icatibant|mesh-list
92882959|NCT04654351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92882960|NCT04654351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92882961|NCT04654351|Analgesics|analgesics|mesh-ancestor
92882962|NCT04654351|Sensory System Agents|sensory system agents|mesh-ancestor
92882963|NCT04654351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92882964|NCT04654351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882965|NCT04654351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92882966|NCT04654351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92882967|NCT04654351|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92882968|NCT04654351|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92882969|NCT04654351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882970|NCT04654351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92882971|NCT04654351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92882972|NCT04654351|Immunologic Factors|immunologic factors|mesh-ancestor
92882973|NCT00582556|Zoledronic Acid|zoledronic acid|mesh-list
92882974|NCT00582556|Leuprolide|leuprolide|mesh-list
92882975|NCT00582556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92882976|NCT00582556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882977|NCT00582556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92882978|NCT00582556|Fertility Agents|fertility agents|mesh-ancestor
92882979|NCT00582556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92882980|NCT00582556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92882981|NCT00582556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92882982|NCT02776397|Vitamin E|vitamin e|mesh-list
92882983|NCT02776397|Tocopherols|tocopherols|mesh-list
92882984|NCT02776397|alpha-Tocopherol|alpha-tocopherol|mesh-list
92882985|NCT02776397|Vitamins|vitamins|mesh-ancestor
92882986|NCT02776397|Micronutrients|micronutrients|mesh-ancestor
92882987|NCT02776397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882988|NCT02776397|Antioxidants|antioxidants|mesh-ancestor
92882989|NCT02776397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882990|NCT02776397|Protective Agents|protective agents|mesh-ancestor
92882991|NCT00985777|Vitamin E|vitamin e|mesh-list
92882992|NCT00985777|Tocopherols|tocopherols|mesh-list
92882993|NCT00985777|Tocotrienols|tocotrienols|mesh-list
92882994|NCT00985777|Vitamins|vitamins|mesh-ancestor
92882995|NCT00985777|Micronutrients|micronutrients|mesh-ancestor
92882996|NCT00985777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92882997|NCT00985777|Antioxidants|antioxidants|mesh-ancestor
92882998|NCT00985777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92882999|NCT00985777|Protective Agents|protective agents|mesh-ancestor
92883000|NCT01563601|Carboplatin|carboplatin|mesh-list
92883001|NCT01563601|Etoposide|etoposide|mesh-list
92883002|NCT01563601|Etoposide phosphate|etoposide phosphate|mesh-list
92883003|NCT01563601|Obatoclax|obatoclax|mesh-list
92883004|NCT01563601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883005|NCT01563601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92883006|NCT01563601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92883007|NCT01563601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92883008|NCT01563601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883009|NCT01563601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883010|NCT00988507|Artesunate|artesunate|mesh-list
92883011|NCT00988507|Ferroquine|ferroquine|mesh-list
92883012|NCT00988507|Antimalarials|antimalarials|mesh-ancestor
92883013|NCT00988507|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92883014|NCT00988507|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92883015|NCT00988507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883016|NCT00988507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883017|NCT00988507|Antiviral Agents|antiviral agents|mesh-ancestor
92883018|NCT00988507|Schistosomicides|schistosomicides|mesh-ancestor
92883019|NCT00988507|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92883020|NCT00988507|Anthelmintics|anthelmintics|mesh-ancestor
92883021|NCT00985855|Etoposide|etoposide|mesh-list
92883022|NCT00985855|Cetuximab|cetuximab|mesh-list
92883023|NCT00985855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883024|NCT00985855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92883025|NCT00985855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92883026|NCT00985855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92883027|NCT00985855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883028|NCT00985855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883029|NCT00985855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883031|NCT04226105|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92883032|NCT04226105|Insulin Aspart|insulin aspart|mesh-list
92883033|NCT04226105|Insulin, Long-Acting|insulin, long-acting|mesh-list
92883034|NCT04226105|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92883035|NCT04226105|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92883036|NCT04226105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92883037|NCT04226105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883038|NCT02776865|Lidocaine|lidocaine|mesh-list
92883039|NCT02776865|Anesthetics, Local|anesthetics, local|mesh-ancestor
92883040|NCT02776865|Anesthetics|anesthetics|mesh-ancestor
92883041|NCT02776865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883042|NCT02776865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883043|NCT02776865|Sensory System Agents|sensory system agents|mesh-ancestor
92883044|NCT02776865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883045|NCT02776865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92883046|NCT02776865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92883047|NCT02776865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92883048|NCT02776865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92883049|NCT02776865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883050|NCT02772653|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92883051|NCT02772653|Natriuretic Agents|natriuretic agents|mesh-ancestor
92883052|NCT02772653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883053|NCT00542269|Amlodipine|amlodipine|mesh-list
92883054|NCT00542269|Ramipril|ramipril|mesh-list
92883055|NCT00542269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92883056|NCT00542269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92883057|NCT00542269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92883058|NCT00542269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883059|NCT00542269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92883060|NCT00542269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883061|NCT00542269|Vasodilator Agents|vasodilator agents|mesh-ancestor
92883062|NCT00542269|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92883063|NCT00542269|Protease Inhibitors|protease inhibitors|mesh-ancestor
92883064|NCT00542269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883065|NCT02579434|Midazolam|midazolam|mesh-list
92883066|NCT02579434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92883067|NCT02579434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92883068|NCT02579434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883069|NCT02579434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883070|NCT02579434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92883071|NCT02579434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92883072|NCT02579434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92883073|NCT02579434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92883074|NCT02579434|Anesthetics, General|anesthetics, general|mesh-ancestor
92883075|NCT02579434|Anesthetics|anesthetics|mesh-ancestor
92883076|NCT02579434|GABA Modulators|gaba modulators|mesh-ancestor
92883077|NCT02579434|GABA Agents|gaba agents|mesh-ancestor
92883078|NCT02579434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883079|NCT02579434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883080|NCT00542191|Paclitaxel|paclitaxel|mesh-list
92883081|NCT00542191|Cyclophosphamide|cyclophosphamide|mesh-list
92883082|NCT00542191|Carboplatin|carboplatin|mesh-list
92883083|NCT00542191|Doxorubicin|doxorubicin|mesh-list
92883084|NCT00542191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92883085|NCT00542191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883086|NCT00542191|Tubulin Modulators|tubulin modulators|mesh-ancestor
92883087|NCT00542191|Antimitotic Agents|antimitotic agents|mesh-ancestor
92883088|NCT00542191|Mitosis Modulators|mitosis modulators|mesh-ancestor
92883089|NCT00542191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883090|NCT00542191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883091|NCT00542191|Immunologic Factors|immunologic factors|mesh-ancestor
92883092|NCT00542191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883093|NCT00542191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883094|NCT00542191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92883095|NCT00542191|Alkylating Agents|alkylating agents|mesh-ancestor
92883096|NCT00542191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92883097|NCT00542191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92883098|NCT00542191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92883099|NCT00542191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92883100|NCT00542191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883101|NCT00600938|Deferasirox|deferasirox|mesh-list
92883102|NCT00600938|Deferoxamine|deferoxamine|mesh-list
92883103|NCT00600938|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92883104|NCT00600938|Chelating Agents|chelating agents|mesh-ancestor
92883105|NCT00600938|Sequestering Agents|sequestering agents|mesh-ancestor
92883106|NCT00600938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883107|NCT00600938|Siderophores|siderophores|mesh-ancestor
92883108|NCT03061474|Niacinamide|niacinamide|mesh-list
92883110|NCT03061474|Nicotinic Acids|nicotinic acids|mesh-list
92883111|NCT03061474|Vitamin B Complex|vitamin b complex|mesh-ancestor
92883112|NCT03061474|Vitamins|vitamins|mesh-ancestor
92883113|NCT03061474|Micronutrients|micronutrients|mesh-ancestor
93026472|NCT00402051|Pemetrexed|pemetrexed|mesh-list
92883114|NCT03061474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883115|NCT03061474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92883116|NCT03061474|Antimetabolites|antimetabolites|mesh-ancestor
93046933|NCT00346268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883117|NCT03061474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883118|NCT03061474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92883119|NCT03061474|Vasodilator Agents|vasodilator agents|mesh-ancestor
92883120|NCT00988663|Memantine|memantine|mesh-list
92883121|NCT00988663|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92883122|NCT00988663|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92883123|NCT00988663|Dopamine Agents|dopamine agents|mesh-ancestor
92883124|NCT00988663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883125|NCT00988663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883126|NCT00988663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883127|NCT00988663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92883128|NCT00988663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92883129|NCT04072198|Leucovorin|leucovorin|mesh-list
92883130|NCT04072198|Bevacizumab|bevacizumab|mesh-list
92883131|NCT04072198|Nivolumab|nivolumab|mesh-list
92883132|NCT04072198|Oxaliplatin|oxaliplatin|mesh-list
92883133|NCT04072198|Irinotecan|irinotecan|mesh-list
92883134|NCT04072198|Fluorouracil|fluorouracil|mesh-list
92883135|NCT04072198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883136|NCT04072198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883137|NCT04072198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92883138|NCT04072198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92883139|NCT04072198|Growth Substances|growth substances|mesh-ancestor
92883140|NCT04072198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883141|NCT04072198|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883142|NCT04072198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92883143|NCT04072198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883144|NCT04072198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92883145|NCT04072198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92883146|NCT04072198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883147|NCT04072198|Antidotes|antidotes|mesh-ancestor
92883148|NCT04072198|Protective Agents|protective agents|mesh-ancestor
92883149|NCT04072198|Vitamin B Complex|vitamin b complex|mesh-ancestor
92883150|NCT04072198|Vitamins|vitamins|mesh-ancestor
92883151|NCT04072198|Micronutrients|micronutrients|mesh-ancestor
92883152|NCT04072198|Antimetabolites|antimetabolites|mesh-ancestor
92883153|NCT04072198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92883154|NCT04072198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883155|NCT04072198|Immunologic Factors|immunologic factors|mesh-ancestor
92883156|NCT02772419|Benralizumab|benralizumab|mesh-list
92883157|NCT02772419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92883158|NCT02772419|Respiratory System Agents|respiratory system agents|mesh-ancestor
92883159|NCT00543439|Factor VIII|factor viii|mesh-list
92883160|NCT00543439|Coagulants|coagulants|mesh-ancestor
92883161|NCT02772497|Aflibercept|aflibercept|mesh-list
92883162|NCT02772497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92883163|NCT02772497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92883164|NCT02772497|Growth Substances|growth substances|mesh-ancestor
92883165|NCT02772497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883166|NCT02772497|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883167|NCT02772497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883168|NCT00582166|Rituximab|rituximab|mesh-list
92883169|NCT00582166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92883170|NCT00582166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883171|NCT00582166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883172|NCT00582166|Immunologic Factors|immunologic factors|mesh-ancestor
92883173|NCT00582166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883174|NCT00582166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883175|NCT02775539|Mirabegron|mirabegron|mesh-list
92883176|NCT02775539|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92883177|NCT02775539|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92883178|NCT02775539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92883179|NCT02775539|Adrenergic Agents|adrenergic agents|mesh-ancestor
92883180|NCT02775539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883181|NCT02775539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883182|NCT02775539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883183|NCT02775539|Urological Agents|urological agents|mesh-ancestor
92883184|NCT04840459|Bamlanivimab|bamlanivimab|mesh-list
92883185|NCT04840459|Antiviral Agents|antiviral agents|mesh-ancestor
92883186|NCT04840459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883187|NCT04666961|Tamoxifen|tamoxifen|mesh-list
92883188|NCT04666961|Anastrozole|anastrozole|mesh-list
92883189|NCT04666961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92883190|NCT04666961|Hormone Antagonists|hormone antagonists|mesh-ancestor
92883191|NCT04666961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883192|NCT04666961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883193|NCT04666961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92883194|NCT04666961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883195|NCT04666961|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92883196|NCT04666961|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92883197|NCT04666961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92883198|NCT04666961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92883199|NCT04666961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92883200|NCT04666961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883201|NCT04666961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883203|NCT04006639|Sensory System Agents|sensory system agents|mesh-ancestor
92883204|NCT04006639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883205|NCT04006639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883206|NCT00601172|Dexamethasone|dexamethasone|mesh-list
92883207|NCT00601172|Ondansetron|ondansetron|mesh-list
92883208|NCT00601172|Casopitant|casopitant|mesh-list
92883209|NCT00601172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883210|NCT00601172|Antiemetics|antiemetics|mesh-ancestor
92883211|NCT00601172|Autonomic Agents|autonomic agents|mesh-ancestor
92883212|NCT00601172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883213|NCT00601172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883214|NCT00601172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92883215|NCT00601172|Glucocorticoids|glucocorticoids|mesh-ancestor
92883216|NCT00601172|Hormones|hormones|mesh-ancestor
92883217|NCT00601172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883218|NCT00601172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92883219|NCT00601172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883220|NCT00601172|Antipruritics|antipruritics|mesh-ancestor
92883221|NCT00601172|Dermatologic Agents|dermatologic agents|mesh-ancestor
92883222|NCT00601172|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92883223|NCT00601172|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92883224|NCT00601172|Serotonin Agents|serotonin agents|mesh-ancestor
92883225|NCT00601172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883226|NCT00601172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883227|NCT00601172|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92883228|NCT02772107|Temozolomide|temozolomide|mesh-list
92883229|NCT02772107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92883230|NCT02772107|Alkylating Agents|alkylating agents|mesh-ancestor
92883231|NCT02772107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883232|NCT02772107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883233|NCT00986167|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92883234|NCT00986167|Antidepressive Agents|antidepressive agents|mesh-ancestor
92883235|NCT00986167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92883236|NCT00986167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92883237|NCT00986167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92883238|NCT00986167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883239|NCT00986167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883240|NCT00988897|Leucovorin|leucovorin|mesh-list
92883241|NCT00988897|Bevacizumab|bevacizumab|mesh-list
92883242|NCT00988897|Fluorouracil|fluorouracil|mesh-list
92883243|NCT00988897|Oxaliplatin|oxaliplatin|mesh-list
92525457|NCT00025285|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883244|NCT00988897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883245|NCT00988897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883246|NCT00988897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92883247|NCT00988897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92883248|NCT00988897|Growth Substances|growth substances|mesh-ancestor
92883249|NCT00988897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883250|NCT00988897|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883251|NCT00988897|Antimetabolites|antimetabolites|mesh-ancestor
92883252|NCT00988897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883253|NCT00988897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92883254|NCT00988897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883255|NCT00988897|Immunologic Factors|immunologic factors|mesh-ancestor
92883256|NCT00988897|Antidotes|antidotes|mesh-ancestor
92883257|NCT00988897|Protective Agents|protective agents|mesh-ancestor
92883258|NCT00988897|Vitamin B Complex|vitamin b complex|mesh-ancestor
92883259|NCT00988897|Vitamins|vitamins|mesh-ancestor
92883260|NCT00988897|Micronutrients|micronutrients|mesh-ancestor
92883261|NCT02775227|Hydrocortisone|hydrocortisone|mesh-list
92883262|NCT02775227|Pasireotide|pasireotide|mesh-list
92883263|NCT02775227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883264|NCT02775227|Hormones|hormones|mesh-ancestor
92883265|NCT02775227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883266|NCT02775227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883267|NCT02875132|Pembrolizumab|pembrolizumab|mesh-list
92528602|NCT00036556|Atrasentan|atrasentan|mesh-list
92883268|NCT02875132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883269|NCT02875132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883270|NCT02875132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92883271|NCT02875132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883272|NCT00984217|Panitumumab|panitumumab|mesh-list
92883273|NCT00984217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883274|NCT00984217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883275|NCT00989053|Escitalopram|escitalopram|mesh-list
92883276|NCT00989053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92883277|NCT00989053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92883278|NCT00989053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92883279|NCT00989053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883280|NCT00989053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883281|NCT00989053|Serotonin Agents|serotonin agents|mesh-ancestor
92883282|NCT00989053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883283|NCT04614493|Temozolomide|temozolomide|mesh-list
92883284|NCT04614493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92883285|NCT04614493|Alkylating Agents|alkylating agents|mesh-ancestor
92883286|NCT04614493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883287|NCT04614493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883288|NCT02841748|Pembrolizumab|pembrolizumab|mesh-list
92883289|NCT02841748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883290|NCT02841748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883291|NCT02841748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92883292|NCT02841748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883293|NCT04033094|Morphine|morphine|mesh-list
92883294|NCT04033094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92883295|NCT04033094|Narcotics|narcotics|mesh-ancestor
92883296|NCT04033094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883297|NCT04033094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883298|NCT04033094|Analgesics|analgesics|mesh-ancestor
92883299|NCT04033094|Sensory System Agents|sensory system agents|mesh-ancestor
92883300|NCT04033094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883301|NCT04073758|Dexmedetomidine|dexmedetomidine|mesh-list
92883302|NCT04073758|Remifentanil|remifentanil|mesh-list
92883303|NCT04073758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92883304|NCT04073758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883305|NCT04073758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883306|NCT04073758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883307|NCT04073758|Analgesics|analgesics|mesh-ancestor
92883308|NCT04073758|Sensory System Agents|sensory system agents|mesh-ancestor
92883309|NCT04073758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883310|NCT04073758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92883311|NCT04073758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92883312|NCT04073758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92883313|NCT04073758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92883314|NCT04073758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525459|NCT00025324|Thiotepa|thiotepa|mesh-list
92883315|NCT04073758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883316|NCT04073758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92883317|NCT04073758|Narcotics|narcotics|mesh-ancestor
92883318|NCT02660606|Analgesics, Opioid|analgesics, opioid|mesh-list
92883319|NCT02660606|Narcotics|narcotics|mesh-ancestor
92883320|NCT02660606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883321|NCT02660606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883322|NCT02660606|Analgesics|analgesics|mesh-ancestor
92883323|NCT02660606|Sensory System Agents|sensory system agents|mesh-ancestor
92883324|NCT02660606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883325|NCT00582010|Nitric Oxide|nitric oxide|mesh-list
92883326|NCT00582010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92883327|NCT00582010|Autonomic Agents|autonomic agents|mesh-ancestor
92883328|NCT00582010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883329|NCT00582010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883330|NCT00582010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92883331|NCT00582010|Respiratory System Agents|respiratory system agents|mesh-ancestor
92883332|NCT00582010|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92883333|NCT00582010|Antioxidants|antioxidants|mesh-ancestor
92883334|NCT00582010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883335|NCT00582010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883336|NCT00582010|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92883337|NCT00582010|Vasodilator Agents|vasodilator agents|mesh-ancestor
92883338|NCT00582010|Gasotransmitters|gasotransmitters|mesh-ancestor
92883339|NCT00582010|Protective Agents|protective agents|mesh-ancestor
92883340|NCT00989209|Botulinum Toxins|botulinum toxins|mesh-list
92883341|NCT00989209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92883342|NCT00989209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92883343|NCT00989209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92883344|NCT00989209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92883345|NCT00989209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883346|NCT00989209|Cholinergic Agents|cholinergic agents|mesh-ancestor
92883347|NCT00989209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883348|NCT00989209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883349|NCT00989209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92883350|NCT00989209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883351|NCT00649922|Adalimumab|adalimumab|mesh-list
92883352|NCT00649922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92883353|NCT00649922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883354|NCT00649922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883355|NCT00986557|Ganciclovir|ganciclovir|mesh-list
92883356|NCT00986557|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92883357|NCT00986557|Foscarnet|foscarnet|mesh-list
92883358|NCT00986557|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92883359|NCT00986557|Alemtuzumab|alemtuzumab|mesh-list
92883360|NCT00986557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883361|NCT00986557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883362|NCT00986557|Antiviral Agents|antiviral agents|mesh-ancestor
92883363|NCT00986557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883364|NCT00986557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92883365|NCT00986557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883366|NCT00986557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883367|NCT00986557|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92883368|NCT00910754|Prednisone|prednisone|mesh-list
92883369|NCT00910754|Abiraterone Acetate|abiraterone acetate|mesh-list
92883370|NCT00910754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883371|NCT00910754|Glucocorticoids|glucocorticoids|mesh-ancestor
92883372|NCT00910754|Hormones|hormones|mesh-ancestor
92883373|NCT00910754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883374|NCT00910754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883375|NCT00910754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92883376|NCT00910754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883377|NCT00910754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92883378|NCT00910754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883379|NCT00910754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883380|NCT00910754|Hormone Antagonists|hormone antagonists|mesh-ancestor
92883381|NCT00910754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92883382|NCT00649376|Fexofenadine|fexofenadine|mesh-list
92883383|NCT00649376|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92883384|NCT00649376|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92883385|NCT00649376|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92883386|NCT00649376|Histamine Antagonists|histamine antagonists|mesh-ancestor
92883387|NCT00649376|Histamine Agents|histamine agents|mesh-ancestor
92883388|NCT00649376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883389|NCT00649376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883390|NCT00649376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883391|NCT02340676|Interleukin-2|interleukin-2|mesh-list
92160248|NCT04728971|Caspofungin|caspofungin|mesh-list
92883392|NCT02340676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883393|NCT02340676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883394|NCT02340676|Analgesics|analgesics|mesh-ancestor
92883395|NCT02340676|Sensory System Agents|sensory system agents|mesh-ancestor
92883396|NCT02340676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883397|NCT02340676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883398|NCT00649454|Metformin|metformin|mesh-list
92883399|NCT00649454|Glipizide|glipizide|mesh-list
92883400|NCT00649454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92883401|NCT00649454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883402|NCT03920215|Varenicline|varenicline|mesh-list
92883403|NCT03920215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92883404|NCT03920215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92883405|NCT03920215|Cholinergic Agents|cholinergic agents|mesh-ancestor
92883406|NCT03920215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883407|NCT03920215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883408|NCT03920215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883409|NCT02655770|Liraglutide|liraglutide|mesh-list
92883410|NCT02655770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92883411|NCT02655770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883412|NCT02655770|Incretins|incretins|mesh-ancestor
92883413|NCT02655770|Hormones|hormones|mesh-ancestor
92883414|NCT02655770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883415|NCT00986713|Amphotericin B|amphotericin b|mesh-list
92883416|NCT00986713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92883417|NCT00986713|Amebicides|amebicides|mesh-ancestor
92883418|NCT00986713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92883419|NCT00986713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92883420|NCT00986713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883421|NCT00986713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92883422|NCT00986713|Antifungal Agents|antifungal agents|mesh-ancestor
92883423|NCT02651870|Amlodipine|amlodipine|mesh-list
92883424|NCT02651870|Candesartan|candesartan|mesh-list
92883425|NCT02651870|Candesartan cilexetil|candesartan cilexetil|mesh-list
92883426|NCT02651870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92883427|NCT02651870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92883428|NCT02651870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92883429|NCT02651870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883430|NCT02651870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92883431|NCT02651870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883432|NCT02651870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92883433|NCT02651870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92883434|NCT02651870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92883435|NCT02766803|Resveratrol|resveratrol|mesh-list
92883436|NCT02766803|Simvastatin|simvastatin|mesh-list
92883437|NCT02766803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92883438|NCT02766803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92883439|NCT02766803|Antimetabolites|antimetabolites|mesh-ancestor
92883440|NCT02766803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883441|NCT02766803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92883442|NCT02766803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92883443|NCT02766803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883444|NCT02766803|Antioxidants|antioxidants|mesh-ancestor
92883445|NCT02766803|Protective Agents|protective agents|mesh-ancestor
92883446|NCT02766803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883447|NCT02766803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92883448|NCT00650468|Mycophenolic Acid|mycophenolic acid|mesh-list
92883449|NCT00650468|Prednisone|prednisone|mesh-list
92883450|NCT00650468|Tacrolimus|tacrolimus|mesh-list
92883451|NCT00650468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883452|NCT00650468|Glucocorticoids|glucocorticoids|mesh-ancestor
92883453|NCT00650468|Hormones|hormones|mesh-ancestor
92883454|NCT00650468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883455|NCT00650468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883456|NCT00650468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92883457|NCT00650468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883458|NCT00650468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883459|NCT00650468|Immunologic Factors|immunologic factors|mesh-ancestor
92883460|NCT00650468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92883461|NCT00650468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883462|NCT00650468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883463|NCT00650468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92883464|NCT00650468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92883465|NCT00650468|Antitubercular Agents|antitubercular agents|mesh-ancestor
92883466|NCT00650468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92883467|NCT00650468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883468|NCT02576080|Imatinib Mesylate|imatinib mesylate|mesh-list
92883469|NCT02576080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883470|NCT02576080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92883471|NCT02576080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883472|NCT02576080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883473|NCT04006483|Fluorides|fluorides|mesh-list
92883474|NCT04006483|Tin Fluorides|tin fluorides|mesh-list
92883475|NCT04006483|Cariostatic Agents|cariostatic agents|mesh-ancestor
92883476|NCT04006483|Protective Agents|protective agents|mesh-ancestor
92883477|NCT04006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883478|NCT02651792|Meperidine|meperidine|mesh-list
92883479|NCT02651792|Ketamine|ketamine|mesh-list
92883480|NCT02651792|Propofol|propofol|mesh-list
92883481|NCT02651792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92883482|NCT02651792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883483|NCT02651792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883484|NCT02651792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92883485|NCT02651792|Anesthetics, General|anesthetics, general|mesh-ancestor
92883486|NCT02651792|Anesthetics|anesthetics|mesh-ancestor
92883487|NCT02651792|Analgesics|analgesics|mesh-ancestor
92883488|NCT02651792|Sensory System Agents|sensory system agents|mesh-ancestor
92883489|NCT02651792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528825|NCT00000899|Lamivudine|lamivudine|mesh-list
92883490|NCT02651792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92883491|NCT02651792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92883492|NCT02651792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92883493|NCT02651792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883494|NCT02651792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883495|NCT02651792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92883496|NCT02651792|Narcotics|narcotics|mesh-ancestor
92883497|NCT02651792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92883498|NCT04754815|Paclitaxel|paclitaxel|mesh-list
92883499|NCT04754815|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92883500|NCT04754815|Pembrolizumab|pembrolizumab|mesh-list
92883501|NCT04754815|Pemetrexed|pemetrexed|mesh-list
92883502|NCT04754815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92883503|NCT04754815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883504|NCT04754815|Tubulin Modulators|tubulin modulators|mesh-ancestor
92883505|NCT04754815|Antimitotic Agents|antimitotic agents|mesh-ancestor
92883506|NCT04754815|Mitosis Modulators|mitosis modulators|mesh-ancestor
92883507|NCT04754815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883508|NCT04754815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883509|NCT04754815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92883510|NCT04754815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883511|NCT04754815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92883512|NCT04754815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92883513|NCT00649532|Ondansetron|ondansetron|mesh-list
92883514|NCT00649532|Antiemetics|antiemetics|mesh-ancestor
92883515|NCT00649532|Autonomic Agents|autonomic agents|mesh-ancestor
92883516|NCT00649532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883517|NCT00649532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883518|NCT00649532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92883519|NCT00649532|Antipruritics|antipruritics|mesh-ancestor
92883520|NCT00649532|Dermatologic Agents|dermatologic agents|mesh-ancestor
92883521|NCT00649532|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92883522|NCT00649532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92883523|NCT00649532|Serotonin Agents|serotonin agents|mesh-ancestor
92883524|NCT00649532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883525|NCT00649532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883526|NCT02655614|Midazolam|midazolam|mesh-list
92883527|NCT02655614|Caffeine|caffeine|mesh-list
92883528|NCT02655614|Rabeprazole|rabeprazole|mesh-list
92883529|NCT02655614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92883530|NCT02655614|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92883531|NCT02655614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883532|NCT02655614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883533|NCT02655614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92883534|NCT02655614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92883535|NCT02655614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92883536|NCT02655614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92883537|NCT02655614|Anesthetics, General|anesthetics, general|mesh-ancestor
92883538|NCT02655614|Anesthetics|anesthetics|mesh-ancestor
92883539|NCT02655614|GABA Modulators|gaba modulators|mesh-ancestor
92883541|NCT02655614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883542|NCT02655614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883543|NCT02655614|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92883544|NCT02655614|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92883545|NCT02655614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883546|NCT02655614|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92883547|NCT02655614|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92883548|NCT02655614|Purinergic Agents|purinergic agents|mesh-ancestor
92883549|NCT02655614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92883550|NCT02655614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92883551|NCT02655614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92883552|NCT02772029|Apatinib|apatinib|mesh-list
92883553|NCT02772029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883554|NCT02772029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92883555|NCT02772029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883556|NCT02772029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883557|NCT02766725|Sildenafil Citrate|sildenafil citrate|mesh-list
92883558|NCT02766725|Vasodilator Agents|vasodilator agents|mesh-ancestor
92883559|NCT02766725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92883560|NCT02766725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92883561|NCT02766725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883562|NCT02766725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883563|NCT02766725|Urological Agents|urological agents|mesh-ancestor
92883564|NCT02658422|Montelukast|montelukast|mesh-list
92883566|NCT02658422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92883567|NCT02658422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92883568|NCT02658422|Hormone Antagonists|hormone antagonists|mesh-ancestor
92883569|NCT02658422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883570|NCT02658422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883571|NCT02658422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92883572|NCT02658422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92883573|NCT02658422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883574|NCT02771795|Trastuzumab|trastuzumab|mesh-list
92883575|NCT02771795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883576|NCT02771795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883577|NCT02655536|Bevacizumab|bevacizumab|mesh-list
92883578|NCT02655536|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92883579|NCT02655536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883580|NCT02655536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883581|NCT02655536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92883582|NCT02655536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92883583|NCT02655536|Growth Substances|growth substances|mesh-ancestor
92883584|NCT02655536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883585|NCT02655536|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883586|NCT02655536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92883587|NCT02655536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883588|NCT02655536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883589|NCT02766647|Lenograstim|lenograstim|mesh-list
92883590|NCT02766647|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92883591|NCT02766647|Immunologic Factors|immunologic factors|mesh-ancestor
92883592|NCT02766647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883593|NCT02651636|Folic Acid|folic acid|mesh-list
92883594|NCT02651636|Thioctic Acid|thioctic acid|mesh-list
92883595|NCT02651636|Inositol|inositol|mesh-list
92883596|NCT02651636|Hematinics|hematinics|mesh-ancestor
92883597|NCT02651636|Vitamin B Complex|vitamin b complex|mesh-ancestor
92883598|NCT02651636|Vitamins|vitamins|mesh-ancestor
92883599|NCT02651636|Micronutrients|micronutrients|mesh-ancestor
92883600|NCT02651636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883601|NCT02651636|Antioxidants|antioxidants|mesh-ancestor
92883602|NCT02651636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883603|NCT02651636|Protective Agents|protective agents|mesh-ancestor
92883604|NCT02774993|Doxycycline|doxycycline|mesh-list
92883605|NCT02774993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92883606|NCT02774993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883607|NCT02774993|Antimalarials|antimalarials|mesh-ancestor
92883608|NCT02774993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92883609|NCT02774993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92883610|NCT02774837|Tenofovir|tenofovir|mesh-list
92883611|NCT02774837|Telbivudine|telbivudine|mesh-list
92883612|NCT02774837|Antiviral Agents|antiviral agents|mesh-ancestor
92883613|NCT02774837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228324|NCT00002122|Rifabutin|rifabutin|mesh-list
92883614|NCT02774837|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92883615|NCT02774837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92883616|NCT02774837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883617|NCT02774837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883618|NCT02774837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92883619|NCT02774837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92883620|NCT02658188|Gabapentin|gabapentin|mesh-list
92883621|NCT02658188|Analgesics|analgesics|mesh-ancestor
92883622|NCT02658188|Sensory System Agents|sensory system agents|mesh-ancestor
92883623|NCT02658188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883624|NCT02658188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883625|NCT02658188|Anticonvulsants|anticonvulsants|mesh-ancestor
92883626|NCT02658188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92883627|NCT02658188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92883628|NCT02658188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883629|NCT02658188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92883630|NCT02658188|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92883631|NCT02658188|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92883632|NCT02658188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883633|NCT02658188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883634|NCT02658188|Antimanic Agents|antimanic agents|mesh-ancestor
92883635|NCT02771717|Budesonide|budesonide|mesh-list
92883636|NCT02771717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883637|NCT02771717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92883638|NCT02771717|Autonomic Agents|autonomic agents|mesh-ancestor
92528975|NCT00014937|Ritonavir|ritonavir|mesh-list
92883639|NCT02771717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883640|NCT02771717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883641|NCT02771717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92883642|NCT02771717|Respiratory System Agents|respiratory system agents|mesh-ancestor
92883643|NCT02771717|Glucocorticoids|glucocorticoids|mesh-ancestor
92883644|NCT02771717|Hormones|hormones|mesh-ancestor
92883645|NCT02771717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883646|NCT02655380|Ketamine|ketamine|mesh-list
92883647|NCT02655380|Remifentanil|remifentanil|mesh-list
92883648|NCT02655380|Analgesics|analgesics|mesh-ancestor
92883649|NCT02655380|Sensory System Agents|sensory system agents|mesh-ancestor
92883650|NCT02655380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883651|NCT02655380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883652|NCT02655380|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92883653|NCT02655380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92883654|NCT02655380|Anesthetics, General|anesthetics, general|mesh-ancestor
92883655|NCT02655380|Anesthetics|anesthetics|mesh-ancestor
92883656|NCT02655380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883657|NCT02655380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92883658|NCT02655380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92883659|NCT02655380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883660|NCT02655380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883661|NCT02655380|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92883662|NCT02655380|Narcotics|narcotics|mesh-ancestor
92883663|NCT00580840|Certolizumab Pegol|certolizumab pegol|mesh-list
92883664|NCT00580840|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92883665|NCT00580840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883666|NCT00580840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883667|NCT00580840|Immunologic Factors|immunologic factors|mesh-ancestor
92883668|NCT00580840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883669|NCT00580840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883670|NCT00987103|Tacrolimus|tacrolimus|mesh-list
92883671|NCT00987103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883672|NCT00987103|Immunologic Factors|immunologic factors|mesh-ancestor
92883673|NCT00987103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883674|NCT00987103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92883675|NCT00987103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883676|NCT00987103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883677|NCT02655458|Lenalidomide|lenalidomide|mesh-list
92883678|NCT02655458|Elotuzumab|elotuzumab|mesh-list
92883679|NCT02655458|Immunologic Factors|immunologic factors|mesh-ancestor
92883680|NCT02655458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883681|NCT02655458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92883682|NCT02655458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92883683|NCT02655458|Growth Substances|growth substances|mesh-ancestor
92883684|NCT02655458|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883685|NCT02655458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883686|NCT04006093|Apixaban|apixaban|mesh-list
92883687|NCT04006093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92883688|NCT04006093|Antithrombins|antithrombins|mesh-ancestor
92883689|NCT04006093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92883690|NCT04006093|Protease Inhibitors|protease inhibitors|mesh-ancestor
92883691|NCT04006093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883692|NCT04006093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883693|NCT04006093|Anticoagulants|anticoagulants|mesh-ancestor
92883694|NCT02766257|Anesthetics|anesthetics|mesh-list
92883695|NCT02766257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883696|NCT02766257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883697|NCT04005469|Treprostinil|treprostinil|mesh-list
92883698|NCT04005469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92883699|NCT02651324|Ketamine|ketamine|mesh-list
92883700|NCT02651324|Analgesics|analgesics|mesh-ancestor
92883701|NCT02651324|Sensory System Agents|sensory system agents|mesh-ancestor
92883702|NCT02651324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883703|NCT02651324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883704|NCT02651324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92883705|NCT02651324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92883706|NCT02651324|Anesthetics, General|anesthetics, general|mesh-ancestor
92883707|NCT02651324|Anesthetics|anesthetics|mesh-ancestor
92883708|NCT02651324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883709|NCT02651324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92883710|NCT02651324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92883711|NCT02651324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883712|NCT02651324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883713|NCT00662220|Ribavirin|ribavirin|mesh-list
92883715|NCT00662220|Interferon-alpha|interferon-alpha|mesh-list
92883716|NCT00662220|Antimetabolites|antimetabolites|mesh-ancestor
92883717|NCT00662220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883718|NCT00662220|Antiviral Agents|antiviral agents|mesh-ancestor
92883719|NCT00662220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883720|NCT00662220|Immunologic Factors|immunologic factors|mesh-ancestor
92883721|NCT00662220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883722|NCT02575924|Imidacloprid|imidacloprid|mesh-list
92883723|NCT02575924|Cholinergic Agents|cholinergic agents|mesh-ancestor
92883724|NCT02575924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883725|NCT02575924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883726|NCT02575924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883727|NCT02651168|Aflibercept|aflibercept|mesh-list
92883728|NCT02651168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92883729|NCT02651168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92883730|NCT02651168|Growth Substances|growth substances|mesh-ancestor
92883731|NCT02651168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883732|NCT02651168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92883733|NCT02651168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883734|NCT04073602|Trastuzumab|trastuzumab|mesh-list
92883735|NCT04073602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883736|NCT04073602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883737|NCT00650000|Modafinil|modafinil|mesh-list
92883738|NCT00650000|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92883739|NCT00650000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883740|NCT00650000|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92883741|NCT00650000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92883742|NCT00650000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92883743|NCT00650000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883744|NCT02630862|Aspirin|aspirin|mesh-list
92883745|NCT02630862|Dipyridamole|dipyridamole|mesh-list
92883746|NCT02630862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92883747|NCT02630862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883748|NCT02630862|Analgesics|analgesics|mesh-ancestor
92883749|NCT02630862|Sensory System Agents|sensory system agents|mesh-ancestor
92883750|NCT02630862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883751|NCT02630862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883752|NCT02630862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883753|NCT02630862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883754|NCT02630862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92883755|NCT02630862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92883756|NCT02630862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883757|NCT02630862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92883758|NCT02630862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92883759|NCT02630862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883760|NCT02630862|Antipyretics|antipyretics|mesh-ancestor
92883761|NCT02630862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92883762|NCT02630862|Vasodilator Agents|vasodilator agents|mesh-ancestor
92883763|NCT02536430|Ketorolac|ketorolac|mesh-list
92883764|NCT02536430|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92883765|NCT02536430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92883766|NCT02536430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883767|NCT02536430|Analgesics|analgesics|mesh-ancestor
92883768|NCT02536430|Sensory System Agents|sensory system agents|mesh-ancestor
92883769|NCT02536430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883770|NCT02536430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883771|NCT02536430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883772|NCT02536430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883773|NCT02536430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92883774|NCT02536430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883775|NCT02536430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883776|NCT02631174|Antithrombins|antithrombins|mesh-list
92883777|NCT02631174|Antithrombin III|antithrombin iii|mesh-list
92883778|NCT02631174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92883779|NCT02631174|Protease Inhibitors|protease inhibitors|mesh-ancestor
92883780|NCT02631174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883781|NCT02631174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883782|NCT02631174|Anticoagulants|anticoagulants|mesh-ancestor
92883783|NCT04686929|Abatacept|abatacept|mesh-list
92883784|NCT04686929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92883785|NCT04686929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529124|NCT00015210|Serotonin Agents|serotonin agents|mesh-ancestor
92883786|NCT04686929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883787|NCT04686929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883788|NCT04686929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883789|NCT04686929|Immunologic Factors|immunologic factors|mesh-ancestor
92883790|NCT04686929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883791|NCT04686929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883792|NCT02765633|Cangrelor|cangrelor|mesh-list
92883793|NCT02765633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92883794|NCT02765633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92883795|NCT02765633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92883796|NCT02765633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92883797|NCT02765633|Purinergic Agents|purinergic agents|mesh-ancestor
92883798|NCT02765633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92883799|NCT02765633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883800|NCT02765633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883801|NCT00581776|Dexamethasone|dexamethasone|mesh-list
92883802|NCT00581776|Cyclophosphamide|cyclophosphamide|mesh-list
92883803|NCT00581776|Rituximab|rituximab|mesh-list
92883804|NCT00581776|Doxorubicin|doxorubicin|mesh-list
92883805|NCT00581776|Vincristine|vincristine|mesh-list
92883806|NCT00581776|Bortezomib|bortezomib|mesh-list
92883807|NCT00581776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883808|NCT00581776|Immunologic Factors|immunologic factors|mesh-ancestor
92883809|NCT00581776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883810|NCT00581776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883811|NCT00581776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92883812|NCT00581776|Alkylating Agents|alkylating agents|mesh-ancestor
92883813|NCT00581776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883814|NCT00581776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883815|NCT00581776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92883816|NCT00581776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92883817|NCT00581776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883818|NCT00581776|Antiemetics|antiemetics|mesh-ancestor
92883819|NCT00581776|Autonomic Agents|autonomic agents|mesh-ancestor
92883820|NCT00581776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883821|NCT00581776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92883822|NCT00581776|Glucocorticoids|glucocorticoids|mesh-ancestor
92883823|NCT00581776|Hormones|hormones|mesh-ancestor
92883824|NCT00581776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883825|NCT00581776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92883826|NCT00581776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92883827|NCT00581776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92883828|NCT00581776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92883829|NCT00581776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883830|NCT00581776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92883831|NCT00581776|Tubulin Modulators|tubulin modulators|mesh-ancestor
92883832|NCT00581776|Antimitotic Agents|antimitotic agents|mesh-ancestor
92883833|NCT00581776|Mitosis Modulators|mitosis modulators|mesh-ancestor
92883834|NCT00662454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92883835|NCT00662454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92883836|NCT00662454|Levonorgestrel|levonorgestrel|mesh-list
92883837|NCT00662454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92883838|NCT00662454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92883839|NCT00662454|Estradiol|estradiol|mesh-list
92883840|NCT00662454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92883841|NCT00662454|Estrogens|estrogens|mesh-ancestor
92883842|NCT00662454|Hormones|hormones|mesh-ancestor
92883843|NCT00662454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883844|NCT00662454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883845|NCT00662454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92883846|NCT00662454|Contraceptive Agents|contraceptive agents|mesh-ancestor
92883847|NCT00662454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92883848|NCT00662454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92883849|NCT00662454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92883850|NCT00662454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92883851|NCT00662454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92883852|NCT00662454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92883853|NCT04156152|Listerine|listerine|mesh-list
92883854|NCT04156152|Fluorides|fluorides|mesh-list
92883855|NCT04156152|Sodium Fluoride|sodium fluoride|mesh-list
92883856|NCT04156152|Cariostatic Agents|cariostatic agents|mesh-ancestor
92883857|NCT04156152|Protective Agents|protective agents|mesh-ancestor
92883858|NCT04156152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883859|NCT04156152|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92883860|NCT04156152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883861|NCT00662610|Naproxen|naproxen|mesh-list
92883862|NCT00662610|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92883863|NCT00662610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92883864|NCT00662610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883865|NCT00662610|Analgesics|analgesics|mesh-ancestor
92883866|NCT00662610|Sensory System Agents|sensory system agents|mesh-ancestor
92883867|NCT00662610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883868|NCT00662610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883869|NCT00662610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883870|NCT00662610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883871|NCT00662610|Gout Suppressants|gout suppressants|mesh-ancestor
92883872|NCT00662610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92883873|NCT00662610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883874|NCT00662610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883875|NCT00662610|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92883876|NCT04225325|Dolutegravir|dolutegravir|mesh-list
92883877|NCT04225325|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92883878|NCT04225325|Emtricitabine|emtricitabine|mesh-list
92883879|NCT04225325|Darunavir|darunavir|mesh-list
92883880|NCT04225325|Cobicistat|cobicistat|mesh-list
92883881|NCT04225325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92883882|NCT04225325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92883883|NCT04225325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883884|NCT04225325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883885|NCT04225325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92883886|NCT04225325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92883887|NCT04225325|Antiviral Agents|antiviral agents|mesh-ancestor
92883888|NCT04225325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883889|NCT04225325|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92883890|NCT04225325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92883891|NCT04225325|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92883892|NCT04225325|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92883893|NCT04225325|Protease Inhibitors|protease inhibitors|mesh-ancestor
92883894|NCT04225325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92883895|NCT04225325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92883896|NCT00649610|Diclofenac|diclofenac|mesh-list
92883897|NCT00649610|Valdecoxib|valdecoxib|mesh-list
92883898|NCT00649610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92883899|NCT00649610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883900|NCT00649610|Analgesics|analgesics|mesh-ancestor
92883901|NCT00649610|Sensory System Agents|sensory system agents|mesh-ancestor
92883902|NCT00649610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883903|NCT00649610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883904|NCT00649610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883905|NCT00649610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883906|NCT00649610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92883907|NCT00649610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883908|NCT00649610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883909|NCT00649610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92883910|NCT02655146|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92883912|NCT02655146|Estradiol|estradiol|mesh-list
92883913|NCT02655146|Progestins|progestins|mesh-ancestor
92883914|NCT02655146|Hormones|hormones|mesh-ancestor
92883915|NCT02655146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92883916|NCT02655146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883917|NCT02655146|Luteolytic Agents|luteolytic agents|mesh-ancestor
92883918|NCT02655146|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92883919|NCT02655146|Contraceptive Agents|contraceptive agents|mesh-ancestor
92883920|NCT02655146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92883921|NCT02655146|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92883922|NCT02655146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92883923|NCT02655146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883924|NCT02655146|Estrogens|estrogens|mesh-ancestor
92883925|NCT02774525|Ethanol|ethanol|mesh-list
92883926|NCT02774525|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92883927|NCT02774525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883928|NCT02774525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92883929|NCT02774525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883930|NCT04167566|Artemisinins|artemisinins|mesh-list
92883931|NCT04167566|Artemisinin|artemisinin|mesh-list
92883932|NCT04167566|Antimalarials|antimalarials|mesh-ancestor
92883933|NCT04167566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92883934|NCT04167566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92883935|NCT04167566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883936|NCT00650624|Valdecoxib|valdecoxib|mesh-list
92883937|NCT00650624|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92883938|NCT00650624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92883939|NCT00650624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883940|NCT00650624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883941|NCT00650624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92883942|NCT00650624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883943|NCT00650624|Analgesics|analgesics|mesh-ancestor
92883944|NCT00650624|Sensory System Agents|sensory system agents|mesh-ancestor
92883945|NCT00650624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883946|NCT00650624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883947|NCT00650624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92883948|NCT00650624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883949|NCT00666354|Methotrexate|methotrexate|mesh-list
92883950|NCT00666354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92883951|NCT00666354|Abortifacient Agents|abortifacient agents|mesh-ancestor
92883952|NCT00666354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92883953|NCT00666354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883954|NCT00666354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92883955|NCT00666354|Antimetabolites|antimetabolites|mesh-ancestor
92883956|NCT00666354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883957|NCT00666354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883958|NCT00666354|Dermatologic Agents|dermatologic agents|mesh-ancestor
92883959|NCT00666354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92883960|NCT00666354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92883961|NCT00666354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883962|NCT00666354|Immunologic Factors|immunologic factors|mesh-ancestor
92883963|NCT00666354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883964|NCT00666354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92883965|NCT02774291|Aldesleukin|aldesleukin|mesh-list
92883966|NCT02774291|Cyclophosphamide|cyclophosphamide|mesh-list
92883967|NCT02774291|Fludarabine|fludarabine|mesh-list
92883968|NCT02774291|Fludarabine phosphate|fludarabine phosphate|mesh-list
92883969|NCT02774291|Interleukin-2|interleukin-2|mesh-list
92883970|NCT02774291|Lenograstim|lenograstim|mesh-list
92883971|NCT02774291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92883972|NCT02774291|Immunologic Factors|immunologic factors|mesh-ancestor
92883973|NCT02774291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883974|NCT02774291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92883975|NCT02774291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92883976|NCT02774291|Alkylating Agents|alkylating agents|mesh-ancestor
92883977|NCT02774291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92883978|NCT02774291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92883979|NCT02774291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92883980|NCT02774291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92883981|NCT02774291|Antimetabolites|antimetabolites|mesh-ancestor
92883982|NCT02774291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92883983|NCT02774291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92883984|NCT02774291|Analgesics|analgesics|mesh-ancestor
92883985|NCT02774291|Sensory System Agents|sensory system agents|mesh-ancestor
92883986|NCT02774291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92883987|NCT02774291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92883988|NCT02774291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92883989|NCT02774291|Antiviral Agents|antiviral agents|mesh-ancestor
92883990|NCT02774291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92883991|NCT02536352|Vitamins|vitamins|mesh-list
92883992|NCT02536352|Fluorides|fluorides|mesh-list
92883993|NCT02536352|Micronutrients|micronutrients|mesh-ancestor
92883994|NCT02536352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92883995|NCT02536352|Cariostatic Agents|cariostatic agents|mesh-ancestor
92883996|NCT02536352|Protective Agents|protective agents|mesh-ancestor
92883997|NCT02773979|Chloroquine|chloroquine|mesh-list
92883998|NCT02773979|Amebicides|amebicides|mesh-ancestor
92883999|NCT02773979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92884000|NCT02773979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92884001|NCT02773979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884002|NCT02773979|Antimalarials|antimalarials|mesh-ancestor
92884003|NCT02773979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884004|NCT00662844|Vitamin D|vitamin d|mesh-list
92884005|NCT00662844|Cholecalciferol|cholecalciferol|mesh-list
92884006|NCT00662844|Vitamins|vitamins|mesh-ancestor
92884007|NCT00662844|Micronutrients|micronutrients|mesh-ancestor
92884008|NCT00662844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884009|NCT00662844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884010|NCT00662844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92884011|NCT02650544|Mirtazapine|mirtazapine|mesh-list
92884012|NCT02650544|Antidepressive Agents|antidepressive agents|mesh-ancestor
92884013|NCT02650544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884014|NCT02650544|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92884015|NCT02650544|Histamine Antagonists|histamine antagonists|mesh-ancestor
92884016|NCT02650544|Histamine Agents|histamine agents|mesh-ancestor
92884017|NCT02650544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884018|NCT02650544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884019|NCT02650544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884020|NCT02650544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92884021|NCT02650544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884022|NCT02650544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884023|NCT02650544|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92884024|NCT02650544|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92884025|NCT02650544|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92884026|NCT02650544|Adrenergic Agents|adrenergic agents|mesh-ancestor
92884027|NCT02650544|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92884028|NCT02650544|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92884029|NCT02650544|Serotonin Agents|serotonin agents|mesh-ancestor
92884030|NCT02650544|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92884031|NCT02650388|Chrysarobin|chrysarobin|mesh-list
92884032|NCT02650388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92884033|NCT02650388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92884034|NCT02650388|Analgesics|analgesics|mesh-ancestor
92884035|NCT02650388|Sensory System Agents|sensory system agents|mesh-ancestor
92884036|NCT02650388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884037|NCT02650388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884038|NCT02650388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884039|NCT02650388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884040|NCT00883740|Pregabalin|pregabalin|mesh-list
92884041|NCT00883740|Analgesics|analgesics|mesh-ancestor
92884042|NCT00883740|Sensory System Agents|sensory system agents|mesh-ancestor
92884043|NCT00883740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884044|NCT00883740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884045|NCT00883740|Anticonvulsants|anticonvulsants|mesh-ancestor
92884046|NCT00883740|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92884047|NCT00883740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884048|NCT00883740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884049|NCT00883740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884050|NCT00883740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92884051|NCT00883740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884052|NCT00883740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884053|NCT00883740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884054|NCT04183712|Gemcitabine|gemcitabine|mesh-list
92884055|NCT04183712|Oxaliplatin|oxaliplatin|mesh-list
92884056|NCT04183712|Afatinib|afatinib|mesh-list
92884057|NCT04183712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92884058|NCT04183712|Antimetabolites|antimetabolites|mesh-ancestor
92884059|NCT04183712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884060|NCT04183712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884061|NCT04183712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92884062|NCT04183712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884063|NCT02773199|Bupivacaine|bupivacaine|mesh-list
92884064|NCT02773199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92884065|NCT02773199|Anesthetics|anesthetics|mesh-ancestor
92884066|NCT02773199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884067|NCT02773199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884068|NCT02773199|Sensory System Agents|sensory system agents|mesh-ancestor
92884069|NCT02773199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884070|NCT02654834|Nitrous Oxide|nitrous oxide|mesh-list
92884071|NCT02654834|Anesthetics|anesthetics|mesh-list
92884072|NCT02654834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884073|NCT02654834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884074|NCT02654834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92884075|NCT02654834|Anesthetics, General|anesthetics, general|mesh-ancestor
92884076|NCT02654834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92884077|NCT02654834|Analgesics|analgesics|mesh-ancestor
92884078|NCT02654834|Sensory System Agents|sensory system agents|mesh-ancestor
92884079|NCT02654834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884080|NCT00656526|Lidocaine|lidocaine|mesh-list
92884081|NCT00656526|Anesthetics, Local|anesthetics, local|mesh-ancestor
92884082|NCT00656526|Anesthetics|anesthetics|mesh-ancestor
92884083|NCT00656526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884084|NCT00656526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884085|NCT00656526|Sensory System Agents|sensory system agents|mesh-ancestor
92884086|NCT00656526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884087|NCT00656526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884088|NCT00656526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92884089|NCT00656526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92884090|NCT00656526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884091|NCT00656526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884092|NCT02765009|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92884093|NCT02765009|Furosemide|furosemide|mesh-list
92884094|NCT02765009|Bumetanide|bumetanide|mesh-list
92884095|NCT02765009|Diuretics|diuretics|mesh-list
92884096|NCT02765009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884097|NCT02765009|Natriuretic Agents|natriuretic agents|mesh-ancestor
92884098|NCT02765009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884099|NCT02765009|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92884100|NCT02765009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884101|NCT02765009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884102|NCT02765009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92884103|NCT02649920|Dinoprostone|dinoprostone|mesh-list
92884104|NCT02649920|Oxytocics|oxytocics|mesh-ancestor
92884105|NCT02649920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884106|NCT02649920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884107|NCT00649688|Metoprolol|metoprolol|mesh-list
92884108|NCT00649688|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92884109|NCT00649688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884110|NCT00649688|Diuretics|diuretics|mesh-ancestor
92884111|NCT00649688|Natriuretic Agents|natriuretic agents|mesh-ancestor
92884112|NCT00649688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884113|NCT00649688|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92884114|NCT00649688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884115|NCT00649688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884116|NCT00649688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884117|NCT00649688|Sympatholytics|sympatholytics|mesh-ancestor
92884118|NCT00649688|Autonomic Agents|autonomic agents|mesh-ancestor
92884119|NCT00649688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884120|NCT00649688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92884121|NCT00649688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92884122|NCT00649688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92884123|NCT00649688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92884124|NCT00649688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884125|NCT00667056|Tacrolimus|tacrolimus|mesh-list
92884126|NCT00667056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92884127|NCT00667056|Immunologic Factors|immunologic factors|mesh-ancestor
92884128|NCT00667056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884129|NCT00667056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92884130|NCT00667056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884131|NCT00667056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884132|NCT02764619|Spironolactone|spironolactone|mesh-list
92884133|NCT02764619|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92884134|NCT02764619|Hormone Antagonists|hormone antagonists|mesh-ancestor
92884135|NCT02764619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884136|NCT02764619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884137|NCT02764619|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92884138|NCT02764619|Diuretics|diuretics|mesh-ancestor
92884139|NCT02764619|Natriuretic Agents|natriuretic agents|mesh-ancestor
92884140|NCT04032210|Zinc|zinc|mesh-list
92884141|NCT04032210|Fluorides|fluorides|mesh-list
92884142|NCT04032210|Cariostatic Agents|cariostatic agents|mesh-ancestor
92884143|NCT04032210|Protective Agents|protective agents|mesh-ancestor
92884144|NCT04032210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884145|NCT04032210|Trace Elements|trace elements|mesh-ancestor
92884146|NCT04032210|Micronutrients|micronutrients|mesh-ancestor
92884147|NCT04223219|Magnesium Sulfate|magnesium sulfate|mesh-list
92884148|NCT04223219|Fentanyl|fentanyl|mesh-list
92884149|NCT04223219|Dexmedetomidine|dexmedetomidine|mesh-list
92884150|NCT04223219|Ketamine|ketamine|mesh-list
92884151|NCT04223219|Propofol|propofol|mesh-list
92884152|NCT04223219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92884153|NCT04223219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884154|NCT04223219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884155|NCT04223219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92884156|NCT04223219|Analgesics|analgesics|mesh-ancestor
92884157|NCT04223219|Sensory System Agents|sensory system agents|mesh-ancestor
92884158|NCT04223219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884159|NCT04223219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92884160|NCT04223219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92884161|NCT04223219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92884162|NCT04223219|Adrenergic Agents|adrenergic agents|mesh-ancestor
92884164|NCT04223219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884165|NCT04223219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92884166|NCT04223219|Anesthetics, General|anesthetics, general|mesh-ancestor
92884167|NCT04223219|Anesthetics|anesthetics|mesh-ancestor
92884168|NCT04223219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92884169|NCT04223219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92884170|NCT04223219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92884171|NCT04223219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92884172|NCT04223219|Narcotics|narcotics|mesh-ancestor
92884173|NCT04223219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92884174|NCT04223219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884175|NCT04223219|Anticonvulsants|anticonvulsants|mesh-ancestor
92884176|NCT04223219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92884177|NCT04223219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884178|NCT04223219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884179|NCT04223219|Tocolytic Agents|tocolytic agents|mesh-ancestor
92884180|NCT04223219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884181|NCT02631252|Hydroxychloroquine|hydroxychloroquine|mesh-list
92884182|NCT02631252|Etoposide|etoposide|mesh-list
92884183|NCT02631252|Mitoxantrone|mitoxantrone|mesh-list
92884184|NCT02631252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92884185|NCT02631252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884186|NCT02631252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884187|NCT02631252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884188|NCT02631252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884189|NCT02631252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884190|NCT02631252|Antimalarials|antimalarials|mesh-ancestor
92884191|NCT02631252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92884192|NCT02631252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92884193|NCT02631252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884194|NCT02631252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884195|NCT02631252|Analgesics|analgesics|mesh-ancestor
92884196|NCT02631252|Sensory System Agents|sensory system agents|mesh-ancestor
92884197|NCT02631252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884198|NCT02631252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884199|NCT02631408|Vancomycin|vancomycin|mesh-list
92884200|NCT02631408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884201|NCT02631408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884202|NCT02630394|Azithromycin|azithromycin|mesh-list
92884203|NCT02630394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884204|NCT02630394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884205|NCT02771405|Ribavirin|ribavirin|mesh-list
92884206|NCT02771405|Sofosbuvir|sofosbuvir|mesh-list
92884207|NCT02771405|Simeprevir|simeprevir|mesh-list
92884208|NCT02771405|Ledipasvir|ledipasvir|mesh-list
92884209|NCT02771405|Antimetabolites|antimetabolites|mesh-ancestor
92884210|NCT02771405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884211|NCT02771405|Antiviral Agents|antiviral agents|mesh-ancestor
92884212|NCT02771405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884213|NCT02771405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92884214|NCT02771405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884215|NCT00667758|Cetrorelix|cetrorelix|mesh-list
92884216|NCT00667758|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92884217|NCT00667758|Fertility Agents|fertility agents|mesh-ancestor
92884218|NCT00667758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884219|NCT00667758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884220|NCT00667758|Hormone Antagonists|hormone antagonists|mesh-ancestor
92884221|NCT00667758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884222|NCT00542815|Sevelamer|sevelamer|mesh-list
92884223|NCT00542815|Chelating Agents|chelating agents|mesh-ancestor
92884224|NCT00542815|Sequestering Agents|sequestering agents|mesh-ancestor
92884225|NCT00542815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884226|NCT02762591|Pimavanserin|pimavanserin|mesh-list
92884227|NCT02762591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92884228|NCT02762591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92884229|NCT02762591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92884230|NCT02762591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884231|NCT02762591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884232|NCT02762591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884233|NCT02762591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884234|NCT02762591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92884235|NCT02762591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92884236|NCT02762591|Serotonin Agents|serotonin agents|mesh-ancestor
92884237|NCT02762591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529586|NCT00016263|Oblimersen|oblimersen|mesh-list
92884238|NCT02762591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884240|NCT02696369|Epinephrine|epinephrine|mesh-list
92884241|NCT02696369|Racepinephrine|racepinephrine|mesh-list
92884242|NCT02696369|Epinephryl borate|epinephryl borate|mesh-list
92884243|NCT02696369|Anesthetics, Local|anesthetics, local|mesh-ancestor
92884244|NCT02696369|Anesthetics|anesthetics|mesh-ancestor
92884245|NCT02696369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884246|NCT02696369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884247|NCT02696369|Sensory System Agents|sensory system agents|mesh-ancestor
92884248|NCT02696369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884249|NCT02696369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884250|NCT02696369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92884251|NCT02696369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92884252|NCT02696369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884253|NCT02696369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884254|NCT02696369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92884255|NCT02696369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92884256|NCT02696369|Adrenergic Agents|adrenergic agents|mesh-ancestor
92884257|NCT02696369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884258|NCT02696369|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92884259|NCT02696369|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92884260|NCT02696369|Autonomic Agents|autonomic agents|mesh-ancestor
92884261|NCT02696369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92884262|NCT02696369|Respiratory System Agents|respiratory system agents|mesh-ancestor
92884263|NCT02696369|Mydriatics|mydriatics|mesh-ancestor
92884264|NCT02696369|Sympathomimetics|sympathomimetics|mesh-ancestor
92884265|NCT02696369|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92884266|NCT00663312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92884267|NCT00663312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884268|NCT00663312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884269|NCT02636088|Cetuximab|cetuximab|mesh-list
92884270|NCT02636088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92884271|NCT02636088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884272|NCT02630160|Epinephrine|epinephrine|mesh-list
92884273|NCT02630160|Bupivacaine|bupivacaine|mesh-list
92884274|NCT02630160|Anesthetics, Local|anesthetics, local|mesh-ancestor
92884275|NCT02630160|Anesthetics|anesthetics|mesh-ancestor
92884276|NCT02630160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884277|NCT02630160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884278|NCT02630160|Sensory System Agents|sensory system agents|mesh-ancestor
92884279|NCT02630160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884280|NCT02630160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92884282|NCT02630160|Adrenergic Agents|adrenergic agents|mesh-ancestor
92884283|NCT02630160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884284|NCT02630160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884285|NCT02630160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92884286|NCT02630160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92884287|NCT02630160|Autonomic Agents|autonomic agents|mesh-ancestor
92884288|NCT02630160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92884289|NCT02630160|Respiratory System Agents|respiratory system agents|mesh-ancestor
92884290|NCT02630160|Mydriatics|mydriatics|mesh-ancestor
92884291|NCT02630160|Sympathomimetics|sympathomimetics|mesh-ancestor
92884292|NCT02630160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92884293|NCT00668304|Moxifloxacin|moxifloxacin|mesh-list
92884294|NCT00668304|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92884295|NCT00668304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884296|NCT00668304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884297|NCT00668304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884298|NCT00668304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884299|NCT00668304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884300|NCT00668304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884301|NCT00668304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884302|NCT00668304|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92884303|NCT00668304|Contraceptive Agents|contraceptive agents|mesh-ancestor
92884304|NCT00668304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884305|NCT00668304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884306|NCT00668304|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92884307|NCT00668304|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92884308|NCT00668304|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92884309|NCT00542425|Teriparatide|teriparatide|mesh-list
92884310|NCT00542425|Abaloparatide|abaloparatide|mesh-list
92529656|NCT00016341|Megestrol|megestrol|mesh-list
92884311|NCT00542425|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92884312|NCT00542425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884313|NCT00542425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884314|NCT00542425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92884315|NCT00668538|Miconazole|miconazole|mesh-list
92884316|NCT00668538|Clotrimazole|clotrimazole|mesh-list
92884317|NCT00668538|Antifungal Agents|antifungal agents|mesh-ancestor
92884318|NCT00668538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884319|NCT00668538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92884320|NCT00668538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92884321|NCT00668538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884322|NCT00668538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884323|NCT00668538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92884324|NCT00668538|Hormone Antagonists|hormone antagonists|mesh-ancestor
92884325|NCT00668538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884326|NCT00668538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884327|NCT00668538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92884328|NCT00668538|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92884329|NCT00668538|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92884330|NCT00668616|Paclitaxel|paclitaxel|mesh-list
92884331|NCT00668616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92884332|NCT00668616|Cyclophosphamide|cyclophosphamide|mesh-list
92884333|NCT00668616|Epirubicin|epirubicin|mesh-list
92884334|NCT00668616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92884335|NCT00668616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884336|NCT00668616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92884337|NCT00668616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92884338|NCT00668616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92884339|NCT00668616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884340|NCT00668616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92884341|NCT00668616|Immunologic Factors|immunologic factors|mesh-ancestor
92884342|NCT00668616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884343|NCT00668616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884344|NCT00668616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92884345|NCT00668616|Alkylating Agents|alkylating agents|mesh-ancestor
92884346|NCT00668616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92884347|NCT00668616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92884348|NCT00668616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884349|NCT00668616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884351|NCT02763761|Prednisone|prednisone|mesh-list
92884352|NCT02763761|Methylprednisolone|methylprednisolone|mesh-list
92884353|NCT02763761|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92884354|NCT02763761|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92884355|NCT02763761|Prednisolone|prednisolone|mesh-list
92884356|NCT02763761|Prednisolone acetate|prednisolone acetate|mesh-list
92884357|NCT02763761|Infliximab|infliximab|mesh-list
92884358|NCT02763761|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92884359|NCT02763761|Prednisolone phosphate|prednisolone phosphate|mesh-list
92884360|NCT02763761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884361|NCT02763761|Glucocorticoids|glucocorticoids|mesh-ancestor
92884362|NCT02763761|Hormones|hormones|mesh-ancestor
92884363|NCT02763761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884364|NCT02763761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884365|NCT02763761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92884366|NCT02763761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884367|NCT02763761|Antiemetics|antiemetics|mesh-ancestor
92884368|NCT02763761|Autonomic Agents|autonomic agents|mesh-ancestor
92884369|NCT02763761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884370|NCT02763761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92884371|NCT02763761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92884372|NCT02763761|Protective Agents|protective agents|mesh-ancestor
92884373|NCT02763761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92884374|NCT02763761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92884375|NCT02763761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884376|NCT04155918|Allopurinol|allopurinol|mesh-list
92884377|NCT04155918|Febuxostat|febuxostat|mesh-list
92884378|NCT04155918|Antimetabolites|antimetabolites|mesh-ancestor
92884379|NCT04155918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884380|NCT04155918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884381|NCT04155918|Gout Suppressants|gout suppressants|mesh-ancestor
92884382|NCT04155918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884383|NCT04155918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92884384|NCT04155918|Antioxidants|antioxidants|mesh-ancestor
92884385|NCT04155918|Protective Agents|protective agents|mesh-ancestor
92884386|NCT04155918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884387|NCT02763839|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92884388|NCT02763839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92884389|NCT02763839|Immunologic Factors|immunologic factors|mesh-ancestor
92884390|NCT02763839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884391|NCT02763839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92884392|NCT02763839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92884393|NCT02763839|Dopamine Agonists|dopamine agonists|mesh-ancestor
92884394|NCT02763839|Dopamine Agents|dopamine agents|mesh-ancestor
92884395|NCT02763839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884396|NCT02763839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884397|NCT00541099|Bevacizumab|bevacizumab|mesh-list
92884398|NCT00541099|Docetaxel|docetaxel|mesh-list
92884399|NCT00541099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92884400|NCT00541099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884401|NCT00541099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92884402|NCT00541099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92884403|NCT00541099|Growth Substances|growth substances|mesh-ancestor
92884404|NCT00541099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884405|NCT00541099|Growth Inhibitors|growth inhibitors|mesh-ancestor
92884406|NCT00541099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92884407|NCT00541099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92884408|NCT00541099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92884409|NCT00541099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884410|NCT00580606|Glycerol|glycerol|mesh-list
92884411|NCT00580606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92884412|NCT00580606|Protective Agents|protective agents|mesh-ancestor
92884413|NCT00580606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884414|NCT02575768|Adenosine|adenosine|mesh-list
92884415|NCT02575768|Analgesics|analgesics|mesh-ancestor
92884416|NCT02575768|Sensory System Agents|sensory system agents|mesh-ancestor
92884417|NCT02575768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884418|NCT02575768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884419|NCT02575768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884420|NCT02575768|Vasodilator Agents|vasodilator agents|mesh-ancestor
92884421|NCT02575768|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92884422|NCT02575768|Purinergic Agonists|purinergic agonists|mesh-ancestor
92884423|NCT02575768|Purinergic Agents|purinergic agents|mesh-ancestor
92884424|NCT02575768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525469|NCT00025324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884425|NCT02575768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884426|NCT00987493|Rituximab|rituximab|mesh-list
92884427|NCT00987493|Lenalidomide|lenalidomide|mesh-list
92884428|NCT00987493|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92884429|NCT00987493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92884430|NCT00987493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884431|NCT00987493|Immunologic Factors|immunologic factors|mesh-ancestor
92884432|NCT00987493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884433|NCT00987493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884434|NCT00987493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92884435|NCT00987493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92884436|NCT00987493|Growth Substances|growth substances|mesh-ancestor
92884437|NCT00987493|Growth Inhibitors|growth inhibitors|mesh-ancestor
92884438|NCT00987493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92884439|NCT00987493|Alkylating Agents|alkylating agents|mesh-ancestor
92884440|NCT00987493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884441|NCT02579356|Telmisartan|telmisartan|mesh-list
92884442|NCT02579356|Atorvastatin|atorvastatin|mesh-list
92884443|NCT02579356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92884444|NCT02579356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92884445|NCT02579356|Antimetabolites|antimetabolites|mesh-ancestor
92884446|NCT02579356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884447|NCT02579356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92884448|NCT02579356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92884449|NCT02579356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884450|NCT02579356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884451|NCT02579356|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92884452|NCT02579356|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92884453|NCT03914170|Cetuximab|cetuximab|mesh-list
92884454|NCT03914170|Folfirinox|folfirinox|mesh-list
92884455|NCT03914170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92884456|NCT03914170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884457|NCT00663624|Insulin Aspart|insulin aspart|mesh-list
92884458|NCT00663624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92884459|NCT00663624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884460|NCT02577250|Ketamine|ketamine|mesh-list
92884461|NCT02577250|Analgesics|analgesics|mesh-ancestor
92884462|NCT02577250|Sensory System Agents|sensory system agents|mesh-ancestor
92884463|NCT02577250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884464|NCT02577250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884465|NCT02577250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92884466|NCT02577250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92884467|NCT02577250|Anesthetics, General|anesthetics, general|mesh-ancestor
92884468|NCT02577250|Anesthetics|anesthetics|mesh-ancestor
92884469|NCT02577250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884470|NCT02577250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92884471|NCT02577250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92884472|NCT02577250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884473|NCT02577250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884474|NCT00668850|Insulin|insulin|mesh-list
92884475|NCT00668850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92884476|NCT00668850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92884477|NCT00668850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884478|NCT02762123|Flurbiprofen|flurbiprofen|mesh-list
92884479|NCT02762123|Digoxin|digoxin|mesh-list
92884480|NCT02762123|Midazolam|midazolam|mesh-list
92884481|NCT02762123|Omeprazole|omeprazole|mesh-list
92884482|NCT02762123|Montelukast|montelukast|mesh-list
92884483|NCT02762123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92884484|NCT02762123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92884485|NCT02762123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884486|NCT02762123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884487|NCT02762123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92884488|NCT02762123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884489|NCT02762123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884490|NCT02762123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92884491|NCT02762123|Anesthetics, General|anesthetics, general|mesh-ancestor
92884492|NCT02762123|Anesthetics|anesthetics|mesh-ancestor
92884493|NCT02762123|GABA Modulators|gaba modulators|mesh-ancestor
92884494|NCT02762123|GABA Agents|gaba agents|mesh-ancestor
92884495|NCT02762123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884496|NCT02762123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884497|NCT02762123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92884498|NCT02762123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92884499|NCT02762123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92884500|NCT02762123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884501|NCT02762123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92884502|NCT02762123|Respiratory System Agents|respiratory system agents|mesh-ancestor
92884503|NCT02762123|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92884504|NCT02762123|Hormone Antagonists|hormone antagonists|mesh-ancestor
92884505|NCT02762123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884506|NCT02762123|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92884507|NCT02762123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92884508|NCT02762123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884509|NCT02762123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92884510|NCT02762123|Protective Agents|protective agents|mesh-ancestor
92884511|NCT02762123|Analgesics|analgesics|mesh-ancestor
92884512|NCT02762123|Sensory System Agents|sensory system agents|mesh-ancestor
92884513|NCT02762123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884514|NCT02762123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92884515|NCT02762123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92884516|NCT02762123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884517|NCT02762123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884518|NCT02762123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92884519|NCT04153734|Paclitaxel|paclitaxel|mesh-list
92884520|NCT04153734|Carboplatin|carboplatin|mesh-list
92884521|NCT04153734|Pembrolizumab|pembrolizumab|mesh-list
92884522|NCT04153734|Pemetrexed|pemetrexed|mesh-list
92884523|NCT04153734|Cisplatin|cisplatin|mesh-list
92884524|NCT04153734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92884525|NCT04153734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884526|NCT04153734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92884527|NCT04153734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92884528|NCT04153734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92884529|NCT04153734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884530|NCT04153734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92884531|NCT04153734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92884532|NCT04153734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884533|NCT04153734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92884534|NCT04153734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92884535|NCT04073680|Canagliflozin|canagliflozin|mesh-list
92884536|NCT04073680|Serabelisib|serabelisib|mesh-list
92884537|NCT04073680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92884538|NCT04073680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884539|NCT04073680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92884540|NCT04073680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884541|NCT04073680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884542|NCT02761577|Acetylcysteine|acetylcysteine|mesh-list
92884543|NCT02761577|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92884544|NCT02761577|Antiviral Agents|antiviral agents|mesh-ancestor
92884545|NCT02761577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884546|NCT02761577|Expectorants|expectorants|mesh-ancestor
92884547|NCT02761577|Respiratory System Agents|respiratory system agents|mesh-ancestor
92884548|NCT02761577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92884549|NCT02761577|Antioxidants|antioxidants|mesh-ancestor
92884550|NCT02761577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884551|NCT02761577|Protective Agents|protective agents|mesh-ancestor
92884552|NCT02761577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884553|NCT02761577|Antidotes|antidotes|mesh-ancestor
92884554|NCT00579982|Lamotrigine|lamotrigine|mesh-list
92884555|NCT00579982|Anticonvulsants|anticonvulsants|mesh-ancestor
92884556|NCT00579982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92884557|NCT00579982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884558|NCT00579982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884559|NCT00579982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884560|NCT00579982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884561|NCT00579982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92884562|NCT00579982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884563|NCT00579982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884564|NCT00579982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884565|NCT00579982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92884566|NCT00596466|Pregabalin|pregabalin|mesh-list
92884567|NCT00596466|Analgesics|analgesics|mesh-ancestor
92884568|NCT00596466|Sensory System Agents|sensory system agents|mesh-ancestor
92884569|NCT00596466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884570|NCT00596466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884571|NCT00596466|Anticonvulsants|anticonvulsants|mesh-ancestor
92884572|NCT00596466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92884573|NCT00596466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884574|NCT00596466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884575|NCT00596466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884576|NCT00596466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92884577|NCT00596466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884578|NCT00596466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884579|NCT00596466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884580|NCT02763059|Acetaminophen|acetaminophen|mesh-list
92884581|NCT02763059|Dexamethasone|dexamethasone|mesh-list
92884582|NCT02763059|Ibuprofen|ibuprofen|mesh-list
92884583|NCT02763059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884584|NCT02763059|Antiemetics|antiemetics|mesh-ancestor
92884585|NCT02763059|Autonomic Agents|autonomic agents|mesh-ancestor
92884586|NCT02763059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884587|NCT02763059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884588|NCT02763059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92884589|NCT02763059|Glucocorticoids|glucocorticoids|mesh-ancestor
92884590|NCT02763059|Hormones|hormones|mesh-ancestor
92884591|NCT02763059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884592|NCT02763059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92884593|NCT02763059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884594|NCT02763059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92884595|NCT02763059|Analgesics|analgesics|mesh-ancestor
92884596|NCT02763059|Sensory System Agents|sensory system agents|mesh-ancestor
92884597|NCT02763059|Antipyretics|antipyretics|mesh-ancestor
92884598|NCT02763059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92884599|NCT02763059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884600|NCT02763059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92884601|NCT02763059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884602|NCT02763059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884603|NCT04222517|Hemostatics|hemostatics|mesh-list
92884604|NCT04222517|Coagulants|coagulants|mesh-ancestor
92884605|NCT00671112|Everolimus|everolimus|mesh-list
92884606|NCT00671112|Bortezomib|bortezomib|mesh-list
92884607|NCT00671112|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92884608|NCT00671112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92884609|NCT00671112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884610|NCT00671112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884611|NCT00671112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92884612|NCT00671112|Immunologic Factors|immunologic factors|mesh-ancestor
92884613|NCT00671112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884614|NCT00671112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884616|NCT04857385|Coagulants|coagulants|mesh-ancestor
92884617|NCT00664014|Tolvaptan|tolvaptan|mesh-list
92884618|NCT00664014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92884619|NCT00664014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884620|NCT00664014|Natriuretic Agents|natriuretic agents|mesh-ancestor
92884621|NCT00664014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884622|NCT02696915|Fentanyl|fentanyl|mesh-list
92884623|NCT02696915|Bupivacaine|bupivacaine|mesh-list
92884624|NCT02696915|Anesthetics, Local|anesthetics, local|mesh-ancestor
92884625|NCT02696915|Anesthetics|anesthetics|mesh-ancestor
92884626|NCT02696915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884627|NCT02696915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884628|NCT02696915|Sensory System Agents|sensory system agents|mesh-ancestor
92884629|NCT02696915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884630|NCT02696915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92884631|NCT02696915|Narcotics|narcotics|mesh-ancestor
92884632|NCT02696915|Analgesics|analgesics|mesh-ancestor
92884633|NCT02696915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92884634|NCT02696915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92884635|NCT02696915|Anesthetics, General|anesthetics, general|mesh-ancestor
92884636|NCT00911664|Vitamin D|vitamin d|mesh-list
92884637|NCT00911664|Ergocalciferols|ergocalciferols|mesh-list
92884638|NCT00911664|Cholecalciferol|cholecalciferol|mesh-list
92884639|NCT00911664|Vitamins|vitamins|mesh-list
92884640|NCT00911664|Micronutrients|micronutrients|mesh-ancestor
92884641|NCT00911664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884642|NCT00911664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92884643|NCT00911664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92884644|NCT04821817|Rocuronium|rocuronium|mesh-list
92884645|NCT04821817|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92884646|NCT04821817|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92884647|NCT04821817|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92884648|NCT04821817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884649|NCT04821817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884650|NCT00664170|Docetaxel|docetaxel|mesh-list
92884651|NCT00664170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884652|NCT00664170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92884653|NCT00664170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92884654|NCT00664170|Mitosis Modulators|mitosis modulators|mesh-ancestor
92884655|NCT00664170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884656|NCT02758067|Risperidone|risperidone|mesh-list
92884657|NCT02758067|Brexpiprazole|brexpiprazole|mesh-list
92884658|NCT02758067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92884659|NCT02758067|Serotonin Agents|serotonin agents|mesh-ancestor
92884660|NCT02758067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884661|NCT02758067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884662|NCT02758067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884663|NCT02758067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92884664|NCT02758067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884665|NCT02758067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884666|NCT02758067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884667|NCT02758067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92884668|NCT02758067|Dopamine Agents|dopamine agents|mesh-ancestor
92884669|NCT02758067|Dopamine Agonists|dopamine agonists|mesh-ancestor
92884670|NCT00664248|Clindamycin|clindamycin|mesh-list
92884671|NCT00664248|Clindamycin palmitate|clindamycin palmitate|mesh-list
92884672|NCT00664248|Clindamycin phosphate|clindamycin phosphate|mesh-list
92884673|NCT00664248|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92884674|NCT00664248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884675|NCT00664248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884676|NCT00664248|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92160319|NCT04814355|Celecoxib|celecoxib|mesh-list
92884677|NCT00664248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884678|NCT00664248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884679|NCT00664248|Dermatologic Agents|dermatologic agents|mesh-ancestor
92884680|NCT00579670|Ziprasidone|ziprasidone|mesh-list
92884681|NCT00579670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92884682|NCT00579670|Serotonin Agents|serotonin agents|mesh-ancestor
92884683|NCT00579670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884684|NCT00579670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884685|NCT00579670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884686|NCT00579670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92884687|NCT00579670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92884688|NCT00579670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884689|NCT00579670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92884690|NCT00579670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92884691|NCT00579670|Dopamine Agents|dopamine agents|mesh-ancestor
92884692|NCT00669786|Menotropins|menotropins|mesh-list
92884693|NCT00669786|Hormones|hormones|mesh-list
92884694|NCT00669786|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92884695|NCT00669786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884696|NCT00669786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884697|NCT00669786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92884698|NCT00669786|Fertility Agents|fertility agents|mesh-ancestor
92884699|NCT00669786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884700|NCT02760953|Epirubicin|epirubicin|mesh-list
92884701|NCT02760953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92884702|NCT02760953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884703|NCT02760953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884704|NCT02760953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884705|NCT02760953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884706|NCT02760953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884707|NCT02630004|Melatonin|melatonin|mesh-list
92884708|NCT02630004|Antioxidants|antioxidants|mesh-ancestor
92884709|NCT02630004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884710|NCT02630004|Protective Agents|protective agents|mesh-ancestor
92884711|NCT02630004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884712|NCT02630004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884713|NCT00129922|Paclitaxel|paclitaxel|mesh-list
92884714|NCT00129922|Cyclophosphamide|cyclophosphamide|mesh-list
92884715|NCT00129922|Fluorouracil|fluorouracil|mesh-list
92884716|NCT00129922|Epirubicin|epirubicin|mesh-list
92884717|NCT00129922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92884718|NCT00129922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884719|NCT00129922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92884720|NCT00129922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92884721|NCT00129922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92884722|NCT00129922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884723|NCT00129922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92884724|NCT00129922|Immunologic Factors|immunologic factors|mesh-ancestor
92884725|NCT00129922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884726|NCT00129922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884727|NCT00129922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92884728|NCT00129922|Alkylating Agents|alkylating agents|mesh-ancestor
92884729|NCT00129922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92884730|NCT00129922|Antimetabolites|antimetabolites|mesh-ancestor
92884731|NCT00129922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92884732|NCT00129922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92884733|NCT00129922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884734|NCT00129922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884735|NCT00129922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884737|NCT03909295|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92884738|NCT03909295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884739|NCT03909295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92884740|NCT03909295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92884741|NCT03909295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884742|NCT04153968|Retinol acetate|retinol acetate|mesh-list
92884743|NCT04153968|Protective Agents|protective agents|mesh-ancestor
92884744|NCT04153968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884745|NCT04153968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92884746|NCT04153968|Immunologic Factors|immunologic factors|mesh-ancestor
92884747|NCT04153968|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92884748|NCT04153968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160322|NCT04814355|Analgesics|analgesics|mesh-ancestor
92884749|NCT00671424|Remogliflozin etabonate|remogliflozin etabonate|mesh-list
92884750|NCT00671424|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92884751|NCT00671424|Furosemide|furosemide|mesh-list
92884752|NCT00671424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884753|NCT00671424|Diuretics|diuretics|mesh-ancestor
92884754|NCT00671424|Natriuretic Agents|natriuretic agents|mesh-ancestor
92884755|NCT00671424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884756|NCT00671424|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92884757|NCT00671424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884758|NCT00671424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046934|NCT00346268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530107|NCT00017160|Ifosfamide|ifosfamide|mesh-list
92884759|NCT00671424|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92884760|NCT00671424|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92884761|NCT00671424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92884763|NCT00599924|Sunitinib|sunitinib|mesh-list
92884764|NCT00599924|Fluorouracil|fluorouracil|mesh-list
92884765|NCT00599924|Oxaliplatin|oxaliplatin|mesh-list
92884766|NCT00599924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884767|NCT00599924|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92884768|NCT00599924|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92884769|NCT00599924|Growth Substances|growth substances|mesh-ancestor
92884770|NCT00599924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884771|NCT00599924|Growth Inhibitors|growth inhibitors|mesh-ancestor
92884772|NCT00599924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92884773|NCT00599924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884774|NCT00599924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884775|NCT00599924|Antimetabolites|antimetabolites|mesh-ancestor
92884776|NCT00599924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92884777|NCT00599924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92884778|NCT00599924|Immunologic Factors|immunologic factors|mesh-ancestor
92884779|NCT00599924|Antidotes|antidotes|mesh-ancestor
92884780|NCT00599924|Protective Agents|protective agents|mesh-ancestor
92884781|NCT00599924|Vitamin B Complex|vitamin b complex|mesh-ancestor
92884782|NCT00599924|Vitamins|vitamins|mesh-ancestor
92884783|NCT00599924|Micronutrients|micronutrients|mesh-ancestor
92884784|NCT02757209|Fluticasone|fluticasone|mesh-list
92884785|NCT02757209|Xhance|xhance|mesh-list
92884786|NCT02757209|Budesonide|budesonide|mesh-list
92884787|NCT02757209|Formoterol Fumarate|formoterol fumarate|mesh-list
92884788|NCT02757209|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92884789|NCT02757209|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92884790|NCT02757209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884791|NCT02757209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92884792|NCT02757209|Autonomic Agents|autonomic agents|mesh-ancestor
92884793|NCT02757209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884794|NCT02757209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884795|NCT02757209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92884796|NCT02757209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92884797|NCT02757209|Dermatologic Agents|dermatologic agents|mesh-ancestor
92884798|NCT02757209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92884799|NCT02757209|Glucocorticoids|glucocorticoids|mesh-ancestor
92884800|NCT02757209|Hormones|hormones|mesh-ancestor
92884801|NCT02757209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884802|NCT02757209|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92884803|NCT02757209|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92884804|NCT02757209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92884805|NCT02757209|Adrenergic Agents|adrenergic agents|mesh-ancestor
92884806|NCT02757209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92884807|NCT02757209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884808|NCT00670254|Hydrocortisone|hydrocortisone|mesh-list
92884809|NCT00670254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884810|NCT00581542|Moxifloxacin|moxifloxacin|mesh-list
92884811|NCT00581542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884812|NCT00581542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884813|NCT00581542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884814|NCT00581542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884815|NCT00581542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884816|NCT00581542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884817|NCT00581542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884818|NCT05338801|Menthol|menthol|mesh-list
92884819|NCT05338801|Antipruritics|antipruritics|mesh-ancestor
92884820|NCT05338801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92884821|NCT02757287|Desogestrel|desogestrel|mesh-list
92884822|NCT02757287|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92884823|NCT02757287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92884824|NCT02757287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92884825|NCT02757287|Contraceptive Agents|contraceptive agents|mesh-ancestor
92884826|NCT02757287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92884827|NCT02757287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884828|NCT02757287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92884829|NCT02757287|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92884830|NCT02757287|Progestins|progestins|mesh-ancestor
92884831|NCT02757287|Hormones|hormones|mesh-ancestor
92884832|NCT02757287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884833|NCT02649686|Trastuzumab|trastuzumab|mesh-list
92884834|NCT02649686|Durvalumab|durvalumab|mesh-list
92884835|NCT02649686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92884836|NCT02649686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884837|NCT02757365|Aspirin|aspirin|mesh-list
92884838|NCT02757365|Levofloxacin|levofloxacin|mesh-list
92884839|NCT02757365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92884840|NCT02757365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92884841|NCT02757365|Analgesics|analgesics|mesh-ancestor
92884842|NCT02757365|Sensory System Agents|sensory system agents|mesh-ancestor
92884843|NCT02757365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884844|NCT02757365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884845|NCT02757365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884846|NCT02757365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884847|NCT02757365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92884848|NCT02757365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92884849|NCT02757365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884850|NCT02757365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92884851|NCT02757365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92884852|NCT02757365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884853|NCT02757365|Antipyretics|antipyretics|mesh-ancestor
92884854|NCT02757365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92884855|NCT02757365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884856|NCT02757365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884857|NCT02757365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92884858|NCT02757365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92884859|NCT02757365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884860|NCT02757365|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92884861|NCT02757365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92884862|NCT02649530|LGK974|lgk974|mesh-list
92884863|NCT02649530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884864|NCT02649530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884866|NCT02575534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92884867|NCT02575534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92884868|NCT02575534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92884869|NCT02575534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884870|NCT02575534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884871|NCT02757443|Phosphocreatine|phosphocreatine|mesh-list
92884872|NCT02757443|Anesthetics|anesthetics|mesh-list
92884873|NCT02757443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92884874|NCT02757443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884875|NCT02757443|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92884876|NCT02757443|Protective Agents|protective agents|mesh-ancestor
92884877|NCT04071262|Prednisolone|prednisolone|mesh-list
92884878|NCT04071262|Abiraterone Acetate|abiraterone acetate|mesh-list
92884879|NCT04071262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884880|NCT04071262|Glucocorticoids|glucocorticoids|mesh-ancestor
92884881|NCT04071262|Hormones|hormones|mesh-ancestor
92884882|NCT04071262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884883|NCT04071262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884884|NCT04071262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92884885|NCT04071262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884886|NCT04071262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92884887|NCT04071262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884888|NCT04071262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884889|NCT04071262|Hormone Antagonists|hormone antagonists|mesh-ancestor
92884890|NCT04071262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92884891|NCT04154982|Acetylcysteine|acetylcysteine|mesh-list
92884892|NCT04154982|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92884893|NCT04154982|Antiviral Agents|antiviral agents|mesh-ancestor
92884894|NCT04154982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884895|NCT04154982|Expectorants|expectorants|mesh-ancestor
92884896|NCT04154982|Respiratory System Agents|respiratory system agents|mesh-ancestor
92884897|NCT04154982|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92884898|NCT04154982|Antioxidants|antioxidants|mesh-ancestor
92884899|NCT04154982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884900|NCT04154982|Protective Agents|protective agents|mesh-ancestor
92884901|NCT04154982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884902|NCT04154982|Antidotes|antidotes|mesh-ancestor
92884903|NCT04154748|Omeprazole|omeprazole|mesh-list
92884904|NCT04154748|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92884905|NCT04154748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92884906|NCT04154748|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92884907|NCT04154748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046935|NCT00346268|Analgesics|analgesics|mesh-ancestor
92884908|NCT04154748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884909|NCT02657096|Hybenx|hybenx|mesh-list
92884910|NCT02657096|Dental Disinfectants|dental disinfectants|mesh-ancestor
92884911|NCT02657096|Disinfectants|disinfectants|mesh-ancestor
92884912|NCT02657096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884913|NCT02536742|Fulvestrant|fulvestrant|mesh-list
92884914|NCT02536742|Palbociclib|palbociclib|mesh-list
92884915|NCT02536742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92884916|NCT02536742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884917|NCT02536742|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92884918|NCT02536742|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92884919|NCT02536742|Hormone Antagonists|hormone antagonists|mesh-ancestor
92884920|NCT02536742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884921|NCT02536742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884922|NCT02536742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92884923|NCT02536742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884924|NCT02536742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884925|NCT00670410|Fludarabine|fludarabine|mesh-list
92884926|NCT00670410|Busulfan|busulfan|mesh-list
92884927|NCT00670410|Thymoglobulin|thymoglobulin|mesh-list
92884928|NCT00670410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884929|NCT00670410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884930|NCT00670410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92884931|NCT00670410|Immunologic Factors|immunologic factors|mesh-ancestor
92884932|NCT00670410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884933|NCT00670410|Alkylating Agents|alkylating agents|mesh-ancestor
92884934|NCT00670410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92884935|NCT00670410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92884936|NCT02756663|Dexamethasone|dexamethasone|mesh-list
92884937|NCT02756663|Panobinostat|panobinostat|mesh-list
92884938|NCT02756663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884939|NCT02756663|Antiemetics|antiemetics|mesh-ancestor
92884940|NCT02756663|Autonomic Agents|autonomic agents|mesh-ancestor
92884941|NCT02756663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884942|NCT02756663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884943|NCT02756663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92884944|NCT02756663|Glucocorticoids|glucocorticoids|mesh-ancestor
92884946|NCT02756663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92884947|NCT02756663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92884948|NCT02756663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884949|NCT02756663|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92884950|NCT02756663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884951|NCT02756663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884952|NCT02654678|Enalapril|enalapril|mesh-list
92884953|NCT02654678|Enalaprilat|enalaprilat|mesh-list
92884954|NCT02654678|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92884955|NCT02654678|Protease Inhibitors|protease inhibitors|mesh-ancestor
92884956|NCT02654678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92884957|NCT02654678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884958|NCT02654678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884959|NCT05288023|Azithromycin|azithromycin|mesh-list
92884960|NCT05288023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92884961|NCT05288023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92884962|NCT00670566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92884963|NCT00670566|Irbesartan|irbesartan|mesh-list
92884964|NCT00670566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92884965|NCT00670566|Diuretics|diuretics|mesh-ancestor
92884966|NCT00670566|Natriuretic Agents|natriuretic agents|mesh-ancestor
92884967|NCT00670566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884968|NCT00670566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92884969|NCT00670566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92884970|NCT00670566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884971|NCT00670566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92884972|NCT00670566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92884973|NCT02629848|Paclitaxel|paclitaxel|mesh-list
92884974|NCT02629848|Carboplatin|carboplatin|mesh-list
92884975|NCT02629848|Motesanib diphosphate|motesanib diphosphate|mesh-list
92884976|NCT02629848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92884977|NCT02629848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92884978|NCT02629848|Tubulin Modulators|tubulin modulators|mesh-ancestor
92884979|NCT02629848|Antimitotic Agents|antimitotic agents|mesh-ancestor
92884980|NCT02629848|Mitosis Modulators|mitosis modulators|mesh-ancestor
92884981|NCT02629848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884982|NCT02629848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92884984|NCT03912337|Erenumab|erenumab|mesh-list
92884985|NCT03912337|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92884986|NCT03912337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92884987|NCT03912337|Analgesics|analgesics|mesh-ancestor
92884988|NCT03912337|Sensory System Agents|sensory system agents|mesh-ancestor
92884989|NCT03912337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92884990|NCT03912337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92884991|NCT00650156|Adalimumab|adalimumab|mesh-list
92884992|NCT00650156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92884993|NCT00650156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92884994|NCT00650156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92884995|NCT02576782|Dexamethasone|dexamethasone|mesh-list
92884996|NCT02576782|Dexamethasone acetate|dexamethasone acetate|mesh-list
92884997|NCT02576782|Bupivacaine|bupivacaine|mesh-list
92884998|NCT02576782|BB 1101|bb 1101|mesh-list
92884999|NCT02576782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885000|NCT02576782|Antiemetics|antiemetics|mesh-ancestor
92885001|NCT02576782|Autonomic Agents|autonomic agents|mesh-ancestor
92885002|NCT02576782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885003|NCT02576782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885004|NCT02576782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885005|NCT02576782|Glucocorticoids|glucocorticoids|mesh-ancestor
92885006|NCT02576782|Hormones|hormones|mesh-ancestor
92885007|NCT02576782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885008|NCT02576782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92885009|NCT02576782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885010|NCT02576782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92885011|NCT02576782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885012|NCT02576782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885013|NCT02576782|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885014|NCT02576782|Anesthetics|anesthetics|mesh-ancestor
92885015|NCT02576782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885016|NCT02576782|Sensory System Agents|sensory system agents|mesh-ancestor
92885017|NCT02629770|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92885018|NCT02629770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885019|NCT02577094|Fludarabine|fludarabine|mesh-list
92885020|NCT02577094|Busulfan|busulfan|mesh-list
92885021|NCT02577094|Epratuzumab|epratuzumab|mesh-list
92885022|NCT02577094|Thymoglobulin|thymoglobulin|mesh-list
92885023|NCT02577094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885024|NCT02577094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885025|NCT02577094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885026|NCT02577094|Immunologic Factors|immunologic factors|mesh-ancestor
92885027|NCT02577094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885028|NCT02577094|Alkylating Agents|alkylating agents|mesh-ancestor
92885029|NCT02577094|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92885030|NCT02577094|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92885031|NCT02577094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885032|NCT00649844|Ziprasidone|ziprasidone|mesh-list
92885033|NCT00649844|Clozapine|clozapine|mesh-list
92885034|NCT00649844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92885035|NCT00649844|Serotonin Agents|serotonin agents|mesh-ancestor
92885036|NCT00649844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885037|NCT00649844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885038|NCT00649844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885039|NCT00649844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92885040|NCT00649844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92885041|NCT00649844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885042|NCT00649844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92885043|NCT00649844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92885044|NCT00649844|Dopamine Agents|dopamine agents|mesh-ancestor
92885045|NCT00649844|GABA Antagonists|gaba antagonists|mesh-ancestor
92885046|NCT00649844|GABA Agents|gaba agents|mesh-ancestor
92885047|NCT03912259|Emollients|emollients|mesh-list
92885048|NCT03912259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885049|NCT02656472|Tranexamic Acid|tranexamic acid|mesh-list
92885050|NCT02656472|Aminocaproic Acid|aminocaproic acid|mesh-list
92885051|NCT02656472|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92885052|NCT02656472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92885053|NCT02656472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885054|NCT02656472|Hemostatics|hemostatics|mesh-ancestor
92885055|NCT02656472|Coagulants|coagulants|mesh-ancestor
92885056|NCT00665340|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92885057|NCT00665340|Vasodilator Agents|vasodilator agents|mesh-ancestor
92885058|NCT00665340|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92885059|NCT00665340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92885060|NCT00665340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885061|NCT00665340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885062|NCT00665340|Urological Agents|urological agents|mesh-ancestor
92885064|NCT00665418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92885065|NCT00665418|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92885066|NCT00665418|Anesthetics, General|anesthetics, general|mesh-ancestor
92885067|NCT00665418|Anesthetics|anesthetics|mesh-ancestor
92885068|NCT00665418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885069|NCT00665418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885070|NCT04058990|Paclitaxel|paclitaxel|mesh-list
92885071|NCT04058990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92885072|NCT04058990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92885073|NCT04058990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885074|NCT04058990|Tubulin Modulators|tubulin modulators|mesh-ancestor
92885075|NCT04058990|Antimitotic Agents|antimitotic agents|mesh-ancestor
92885076|NCT04058990|Mitosis Modulators|mitosis modulators|mesh-ancestor
92885077|NCT04058990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885078|NCT00595920|Vaccines|vaccines|mesh-list
92885079|NCT00595920|Immunologic Factors|immunologic factors|mesh-ancestor
92885080|NCT00595920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885081|NCT02654288|Gemcitabine|gemcitabine|mesh-list
92885082|NCT02654288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92885083|NCT02654288|Antimetabolites|antimetabolites|mesh-ancestor
92885084|NCT02654288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885085|NCT02654288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885087|NCT02649140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885088|NCT02649140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885089|NCT00665496|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92885090|NCT00665496|Vasodilator Agents|vasodilator agents|mesh-ancestor
92885091|NCT00665496|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92885092|NCT00665496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92885093|NCT00665496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885094|NCT00665496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885095|NCT00665496|Urological Agents|urological agents|mesh-ancestor
92885096|NCT02653898|Artesunate|artesunate|mesh-list
92885097|NCT02653898|Primaquine|primaquine|mesh-list
92885098|NCT02653898|Piperaquine|piperaquine|mesh-list
92885099|NCT02653898|Artenimol|artenimol|mesh-list
92885100|NCT02653898|Mefloquine|mefloquine|mesh-list
92885101|NCT02653898|Permethrin|permethrin|mesh-list
92885102|NCT02653898|Antimalarials|antimalarials|mesh-ancestor
92885103|NCT02653898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92885104|NCT02653898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92885105|NCT02653898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885106|NCT02653898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885107|NCT02653898|Antiviral Agents|antiviral agents|mesh-ancestor
92885108|NCT02653898|Schistosomicides|schistosomicides|mesh-ancestor
92885109|NCT02653898|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92885110|NCT02653898|Anthelmintics|anthelmintics|mesh-ancestor
92885111|NCT02653898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885112|NCT02653898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885113|NCT02629536|Acetylcysteine|acetylcysteine|mesh-list
92885114|NCT02629536|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92885115|NCT02629536|Antiviral Agents|antiviral agents|mesh-ancestor
92885116|NCT02629536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885117|NCT02629536|Expectorants|expectorants|mesh-ancestor
92885118|NCT02629536|Respiratory System Agents|respiratory system agents|mesh-ancestor
92885119|NCT02629536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92885120|NCT02629536|Antioxidants|antioxidants|mesh-ancestor
92885121|NCT02629536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885122|NCT02629536|Protective Agents|protective agents|mesh-ancestor
92885123|NCT02629536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885124|NCT02629536|Antidotes|antidotes|mesh-ancestor
92885125|NCT04071106|Betamethasone|betamethasone|mesh-list
92885126|NCT04071106|Calcipotriene|calcipotriene|mesh-list
92885127|NCT04071106|Petrolatum|petrolatum|mesh-list
92885128|NCT04071106|Turmeric extract|turmeric extract|mesh-list
92885129|NCT04071106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885130|NCT04071106|Glucocorticoids|glucocorticoids|mesh-ancestor
92885131|NCT04071106|Hormones|hormones|mesh-ancestor
92885132|NCT04071106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885133|NCT04071106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885134|NCT04071106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92885135|NCT04071106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92885137|NCT04071106|Antioxidants|antioxidants|mesh-ancestor
92885138|NCT04071106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885139|NCT04071106|Protective Agents|protective agents|mesh-ancestor
92885140|NCT04071106|Emollients|emollients|mesh-ancestor
92885141|NCT00670722|Insulin|insulin|mesh-list
92885142|NCT00670722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92885143|NCT00670722|Insulin Aspart|insulin aspart|mesh-list
92885144|NCT00670722|Insulin, Long-Acting|insulin, long-acting|mesh-list
92885145|NCT00670722|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92885146|NCT00670722|Insulin Detemir|insulin detemir|mesh-list
92885147|NCT00670722|Biphasic Insulins|biphasic insulins|mesh-list
92885148|NCT00670722|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92885149|NCT00670722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92885150|NCT00670722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885151|NCT02648906|Choline|choline|mesh-list
92885152|NCT02648906|Lipotropic Agents|lipotropic agents|mesh-ancestor
92885153|NCT02648906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92885154|NCT02648906|Antimetabolites|antimetabolites|mesh-ancestor
92885155|NCT02648906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885156|NCT02648906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885157|NCT02648906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92885158|NCT02648906|Nootropic Agents|nootropic agents|mesh-ancestor
92885159|NCT00670878|Gemcitabine|gemcitabine|mesh-list
92885160|NCT00670878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92885161|NCT00670878|Antimetabolites|antimetabolites|mesh-ancestor
92885162|NCT00670878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885163|NCT00670878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885165|NCT02760095|Acetic Acid|acetic acid|mesh-list
92885166|NCT02760095|Retinol acetate|retinol acetate|mesh-list
92885167|NCT02760095|Zinc Sulfate|zinc sulfate|mesh-list
92885168|NCT02760095|Vitamins|vitamins|mesh-ancestor
92885169|NCT02760095|Micronutrients|micronutrients|mesh-ancestor
92885170|NCT02760095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885171|NCT02760095|Protective Agents|protective agents|mesh-ancestor
92885172|NCT02760095|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92885173|NCT02760095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885174|NCT02760095|Astringents|astringents|mesh-ancestor
92885175|NCT02760095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885176|NCT02760095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92885177|NCT02760095|Immunologic Factors|immunologic factors|mesh-ancestor
92885178|NCT02760095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885179|NCT02760095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885180|NCT04418167|Dabrafenib|dabrafenib|mesh-list
92885181|NCT04418167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885182|NCT04418167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92885183|NCT04418167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885184|NCT04418167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885185|NCT02576626|Glycopyrrolate|glycopyrrolate|mesh-list
92885186|NCT02576626|Albuterol|albuterol|mesh-list
92885187|NCT02576626|Ipratropium|ipratropium|mesh-list
92885188|NCT02576626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92885189|NCT02576626|Autonomic Agents|autonomic agents|mesh-ancestor
92885190|NCT02576626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885191|NCT02576626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885192|NCT02576626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92885193|NCT02576626|Respiratory System Agents|respiratory system agents|mesh-ancestor
92885194|NCT02576626|Tocolytic Agents|tocolytic agents|mesh-ancestor
92885195|NCT02576626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92885196|NCT02576626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92885197|NCT02576626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92885198|NCT02576626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92885199|NCT02576626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92885200|NCT02576626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885201|NCT02576626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885202|NCT02576626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92885203|NCT02576626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92885204|NCT02576626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92885205|NCT02576626|Cholinergic Agents|cholinergic agents|mesh-ancestor
92885206|NCT00877890|Exenatide|exenatide|mesh-list
92885207|NCT00877890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92885208|NCT00877890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885209|NCT00877890|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92885210|NCT00877890|Incretins|incretins|mesh-ancestor
92885211|NCT00877890|Hormones|hormones|mesh-ancestor
92885212|NCT00877890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885214|NCT02648672|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92885215|NCT02648672|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92885216|NCT02648672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885217|NCT02648672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885218|NCT04221971|Cyclophosphamide|cyclophosphamide|mesh-list
92885219|NCT04221971|Fludarabine|fludarabine|mesh-list
92885220|NCT04221971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885221|NCT04221971|Immunologic Factors|immunologic factors|mesh-ancestor
92885222|NCT04221971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885223|NCT04221971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885224|NCT04221971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92885225|NCT04221971|Alkylating Agents|alkylating agents|mesh-ancestor
92885226|NCT04221971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885227|NCT04221971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885228|NCT04221971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92885229|NCT02644694|Dexamethasone|dexamethasone|mesh-list
92885230|NCT02644694|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92885231|NCT02644694|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92885232|NCT02644694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885233|NCT02644694|Antiemetics|antiemetics|mesh-ancestor
92885234|NCT02644694|Autonomic Agents|autonomic agents|mesh-ancestor
92885235|NCT02644694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885236|NCT02644694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885237|NCT02644694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885238|NCT02644694|Glucocorticoids|glucocorticoids|mesh-ancestor
92885239|NCT02644694|Hormones|hormones|mesh-ancestor
92977257|NCT01070641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885240|NCT02644694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885241|NCT02644694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92885242|NCT02644694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885243|NCT02644694|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92885244|NCT02653742|Ketorolac|ketorolac|mesh-list
92885245|NCT02653742|Fentanyl|fentanyl|mesh-list
92885246|NCT02653742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92885247|NCT02653742|Narcotics|narcotics|mesh-ancestor
92885248|NCT02653742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885249|NCT02653742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885250|NCT02653742|Analgesics|analgesics|mesh-ancestor
92885251|NCT02653742|Sensory System Agents|sensory system agents|mesh-ancestor
92885252|NCT02653742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885253|NCT02653742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92885254|NCT02653742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92885255|NCT02653742|Anesthetics, General|anesthetics, general|mesh-ancestor
92885256|NCT02653742|Anesthetics|anesthetics|mesh-ancestor
92885257|NCT02653742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92885258|NCT02653742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92885259|NCT02653742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885260|NCT02653742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885261|NCT02653742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92885262|NCT02653742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885263|NCT02653742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885264|NCT02755259|Acetazolamide|acetazolamide|mesh-list
92885265|NCT02755259|Anticonvulsants|anticonvulsants|mesh-ancestor
92885266|NCT02755259|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92885267|NCT02755259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885268|NCT02755259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885269|NCT02755259|Diuretics|diuretics|mesh-ancestor
92885270|NCT02755259|Natriuretic Agents|natriuretic agents|mesh-ancestor
92885271|NCT02755259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885272|NCT02575222|Nivolumab|nivolumab|mesh-list
92885273|NCT02575222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885274|NCT02575222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885275|NCT02575222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92885276|NCT02575222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885277|NCT00680394|Misoprostol|misoprostol|mesh-list
92885278|NCT00680394|Mifepristone|mifepristone|mesh-list
92885279|NCT00680394|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92885280|NCT00680394|Abortifacient Agents|abortifacient agents|mesh-ancestor
92885281|NCT00680394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92885282|NCT00680394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885283|NCT00680394|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92885284|NCT00680394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885285|NCT00680394|Oxytocics|oxytocics|mesh-ancestor
92885286|NCT00680394|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92885287|NCT00680394|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92885288|NCT00680394|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92885289|NCT00680394|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92885290|NCT00680394|Contraceptive Agents|contraceptive agents|mesh-ancestor
92885291|NCT00680394|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92885292|NCT00680394|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92885293|NCT00680394|Hormone Antagonists|hormone antagonists|mesh-ancestor
92885294|NCT00680394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885295|NCT00680394|Luteolytic Agents|luteolytic agents|mesh-ancestor
92885296|NCT00680394|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92885297|NCT00680394|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92885298|NCT04724044|Moxifloxacin|moxifloxacin|mesh-list
92885299|NCT04724044|Clarithromycin|clarithromycin|mesh-list
92885300|NCT04724044|Ceftriaxone|ceftriaxone|mesh-list
92885301|NCT04724044|Lactams|lactams|mesh-list
92885302|NCT04724044|beta-Lactams|beta-lactams|mesh-list
92885303|NCT04724044|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92885304|NCT04724044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885305|NCT04724044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885306|NCT04724044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92885307|NCT04724044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92885308|NCT04724044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885309|NCT04724044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885310|NCT04724044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525488|NCT00025363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885311|NCT04724044|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92885312|NCT04724044|Contraceptive Agents|contraceptive agents|mesh-ancestor
92885313|NCT04724044|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92885314|NCT04724044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885315|NCT04724044|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92885316|NCT04724044|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92885317|NCT04724044|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92885318|NCT04724044|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92885319|NCT04724044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92885320|NCT04724044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92885321|NCT02768519|OTS167|ots167|mesh-list
92885322|NCT02768519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92885323|NCT02768519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885324|NCT02768519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885325|NCT00671814|Linezolid|linezolid|mesh-list
92885326|NCT00671814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885327|NCT00671814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885328|NCT00671814|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92885329|NCT00671814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160344|NCT01110135|Etoposide|etoposide|mesh-list
92885330|NCT00671814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885331|NCT02627430|Talazoparib|talazoparib|mesh-list
92885332|NCT02627430|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92885333|NCT02627430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885334|NCT02627430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885335|NCT02627430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885336|NCT02759393|Lansoprazole|lansoprazole|mesh-list
92885337|NCT02759393|Dexlansoprazole|dexlansoprazole|mesh-list
92885338|NCT02759393|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92885339|NCT02759393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885340|NCT02759393|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92885341|NCT02759393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885342|NCT02759393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885343|NCT02576548|MEDI4276|medi4276|mesh-list
92885344|NCT02576548|Immunoconjugates|immunoconjugates|mesh-ancestor
92885345|NCT02576548|Immunologic Factors|immunologic factors|mesh-ancestor
92885346|NCT02576548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885347|NCT02758925|Cytarabine|cytarabine|mesh-list
92885348|NCT02758925|Rituximab|rituximab|mesh-list
92885349|NCT02758925|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92885350|NCT02758925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885351|NCT02758925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885352|NCT02758925|Immunologic Factors|immunologic factors|mesh-ancestor
92885353|NCT02758925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885354|NCT02758925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885355|NCT02758925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92885356|NCT02758925|Antimetabolites|antimetabolites|mesh-ancestor
92885357|NCT02758925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885358|NCT02758925|Antiviral Agents|antiviral agents|mesh-ancestor
92885359|NCT02758925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885360|NCT02758925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885361|NCT02758925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92885362|NCT02758925|Alkylating Agents|alkylating agents|mesh-ancestor
92885363|NCT00676260|Pioglitazone|pioglitazone|mesh-list
92885364|NCT00676260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92885365|NCT00676260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885367|NCT00652652|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92885368|NCT00652652|Diuretics|diuretics|mesh-ancestor
92885369|NCT00652652|Natriuretic Agents|natriuretic agents|mesh-ancestor
92885370|NCT00652652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885371|NCT00652652|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92885372|NCT00652652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885373|NCT00652652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885374|NCT02768441|Dextroamphetamine|dextroamphetamine|mesh-list
92885375|NCT02768441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92885376|NCT02768441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885377|NCT02768441|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92885378|NCT02768441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92885379|NCT02768441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885380|NCT02768441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885381|NCT02768441|Dopamine Agents|dopamine agents|mesh-ancestor
92885382|NCT02768441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885383|NCT02644616|Torsemide|torsemide|mesh-list
92885384|NCT02644616|Tolvaptan|tolvaptan|mesh-list
92885385|NCT02644616|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92885386|NCT02644616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885387|NCT02644616|Natriuretic Agents|natriuretic agents|mesh-ancestor
92885388|NCT02644616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885389|NCT02644616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92885390|NCT02644616|Diuretics|diuretics|mesh-ancestor
92885391|NCT02644616|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92885392|NCT02644616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885393|NCT02648048|Pirfenidone|pirfenidone|mesh-list
92885394|NCT02648048|Analgesics|analgesics|mesh-ancestor
92885395|NCT02648048|Sensory System Agents|sensory system agents|mesh-ancestor
92885396|NCT02648048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885397|NCT02648048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885398|NCT02648048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92885399|NCT02648048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92885400|NCT02648048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885401|NCT02648048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885402|NCT02648048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885403|NCT00676416|Propofol|propofol|mesh-list
92885404|NCT00676416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92885405|NCT00676416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885406|NCT00676416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885407|NCT00676416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92885408|NCT00676416|Anesthetics, General|anesthetics, general|mesh-ancestor
92885409|NCT00676416|Anesthetics|anesthetics|mesh-ancestor
92885410|NCT00651326|Docetaxel|docetaxel|mesh-list
92885411|NCT00651326|Leuprolide|leuprolide|mesh-list
92885412|NCT00651326|Goserelin|goserelin|mesh-list
92885413|NCT00651326|Bicalutamide|bicalutamide|mesh-list
92885414|NCT00651326|Flutamide|flutamide|mesh-list
92885415|NCT00651326|Buserelin|buserelin|mesh-list
92885416|NCT00651326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885417|NCT00651326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92885418|NCT00651326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92885419|NCT00651326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92885420|NCT00651326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885421|NCT00651326|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92885422|NCT00651326|Fertility Agents|fertility agents|mesh-ancestor
92885423|NCT00651326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92885424|NCT00651326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885425|NCT00651326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92885426|NCT00651326|Androgen Antagonists|androgen antagonists|mesh-ancestor
92885427|NCT00651326|Hormone Antagonists|hormone antagonists|mesh-ancestor
92885428|NCT00651326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885429|NCT04150536|Lidocaine|lidocaine|mesh-list
92885430|NCT04150536|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885431|NCT04150536|Anesthetics|anesthetics|mesh-ancestor
92885432|NCT04150536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885433|NCT04150536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885435|NCT04150536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885436|NCT04150536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92885437|NCT04150536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92885438|NCT04150536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92885439|NCT04150536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885440|NCT04150536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885441|NCT05167123|Calcium|calcium|mesh-list
92885442|NCT05167123|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92885443|NCT05167123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885444|NCT02644538|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92885445|NCT02644538|Antiviral Agents|antiviral agents|mesh-ancestor
92885446|NCT02644538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885447|NCT02576314|Sofosbuvir|sofosbuvir|mesh-list
92885448|NCT02576314|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92885449|NCT02576314|Ledipasvir|ledipasvir|mesh-list
92885450|NCT02576314|Antiviral Agents|antiviral agents|mesh-ancestor
92885451|NCT02576314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885452|NCT00650234|Metformin|metformin|mesh-list
92885453|NCT00650234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92885454|NCT00650234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885455|NCT00680940|Paclitaxel|paclitaxel|mesh-list
92885456|NCT00680940|Cisplatin|cisplatin|mesh-list
92885457|NCT00680940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92885458|NCT00680940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885459|NCT00680940|Tubulin Modulators|tubulin modulators|mesh-ancestor
92885460|NCT00680940|Antimitotic Agents|antimitotic agents|mesh-ancestor
92885461|NCT00680940|Mitosis Modulators|mitosis modulators|mesh-ancestor
92885462|NCT00680940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885463|NCT03472885|Eculizumab|eculizumab|mesh-list
92885464|NCT03472885|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92885465|NCT03472885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885466|NCT03472885|Immunologic Factors|immunologic factors|mesh-ancestor
92885467|NCT03472885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885468|NCT02644304|Cabergoline|cabergoline|mesh-list
92885469|NCT02644304|Clomiphene|clomiphene|mesh-list
92885470|NCT02644304|Enclomiphene|enclomiphene|mesh-list
92885471|NCT02644304|Zuclomiphene|zuclomiphene|mesh-list
92885472|NCT02644304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885473|NCT02644304|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92885474|NCT02644304|Hormone Antagonists|hormone antagonists|mesh-ancestor
92885475|NCT02644304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885476|NCT02644304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885477|NCT02644304|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92885478|NCT02644304|Fertility Agents|fertility agents|mesh-ancestor
92885479|NCT02644304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92885480|NCT02644304|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92885481|NCT02644304|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92885482|NCT02644304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92885483|NCT02644304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92885484|NCT02644304|Dopamine Agonists|dopamine agonists|mesh-ancestor
92885485|NCT02644304|Dopamine Agents|dopamine agents|mesh-ancestor
92885486|NCT02644304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885487|NCT00681174|Acetaminophen|acetaminophen|mesh-list
92885488|NCT00681174|Morphine|morphine|mesh-list
92885489|NCT00681174|Remifentanil|remifentanil|mesh-list
92885490|NCT00681174|Oxycodone|oxycodone|mesh-list
92885491|NCT00681174|Propofol|propofol|mesh-list
92885492|NCT00681174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92885493|NCT00681174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885494|NCT00681174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885495|NCT00681174|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92885496|NCT00681174|Anesthetics, General|anesthetics, general|mesh-ancestor
92885497|NCT00681174|Anesthetics|anesthetics|mesh-ancestor
92885498|NCT00681174|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92885499|NCT00681174|Narcotics|narcotics|mesh-ancestor
92885500|NCT00681174|Analgesics|analgesics|mesh-ancestor
92885501|NCT00681174|Sensory System Agents|sensory system agents|mesh-ancestor
92885502|NCT00681174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885503|NCT00681174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92885504|NCT00681174|Antipyretics|antipyretics|mesh-ancestor
92885505|NCT02758769|Abatacept|abatacept|mesh-list
92885506|NCT02758769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92530855|NCT00001586|Antimetabolites|antimetabolites|mesh-ancestor
92885507|NCT02758769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885508|NCT02758769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885509|NCT02758769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885510|NCT02758769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885511|NCT02758769|Immunologic Factors|immunologic factors|mesh-ancestor
92885512|NCT02758769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885513|NCT02758769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885515|NCT04150146|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92885516|NCT04150146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885517|NCT04150146|Antioxidants|antioxidants|mesh-ancestor
92885518|NCT04150146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885519|NCT04150146|Protective Agents|protective agents|mesh-ancestor
92885520|NCT04150146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885521|NCT04150146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885522|NCT00652730|Buspirone|buspirone|mesh-list
92885523|NCT00652730|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92885524|NCT00652730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92885525|NCT00652730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885526|NCT00652730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885527|NCT00652730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92885528|NCT00652730|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92885529|NCT00652730|Serotonin Agents|serotonin agents|mesh-ancestor
92885530|NCT00652730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885531|NCT00652730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885532|NCT00652808|Naproxen|naproxen|mesh-list
92885533|NCT00652808|Valdecoxib|valdecoxib|mesh-list
92885534|NCT00652808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92885535|NCT00652808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92885536|NCT00652808|Analgesics|analgesics|mesh-ancestor
92885537|NCT00652808|Sensory System Agents|sensory system agents|mesh-ancestor
92885538|NCT00652808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885539|NCT00652808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885540|NCT00652808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885541|NCT00652808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885542|NCT00652808|Gout Suppressants|gout suppressants|mesh-ancestor
92885543|NCT00652808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92885544|NCT00652808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885545|NCT00652808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885546|NCT00652808|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92885547|NCT00635531|Alprazolam|alprazolam|mesh-list
92885548|NCT00635531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92885549|NCT00635531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885550|NCT00635531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885551|NCT00635531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92885552|NCT00635531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92885553|NCT00635531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92885554|NCT00635531|GABA Modulators|gaba modulators|mesh-ancestor
92885555|NCT00635531|GABA Agents|gaba agents|mesh-ancestor
92885556|NCT00635531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885557|NCT00635531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885558|NCT02535156|Risperidone|risperidone|mesh-list
92885559|NCT02535156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92885560|NCT02535156|Serotonin Agents|serotonin agents|mesh-ancestor
92885561|NCT02535156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885562|NCT02535156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885563|NCT02535156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885564|NCT02535156|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92885565|NCT02535156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92885566|NCT02535156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885567|NCT02535156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92885568|NCT02535156|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92885569|NCT02535156|Dopamine Agents|dopamine agents|mesh-ancestor
92885570|NCT03417895|Apatinib|apatinib|mesh-list
92885571|NCT03417895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885572|NCT03417895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92885573|NCT03417895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885574|NCT03417895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885575|NCT05299164|Rituximab|rituximab|mesh-list
92885576|NCT05299164|Gemcitabine|gemcitabine|mesh-list
92885577|NCT05299164|Vinorelbine|vinorelbine|mesh-list
92885578|NCT05299164|Mitoxantrone|mitoxantrone|mesh-list
92885579|NCT05299164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885580|NCT05299164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885581|NCT05299164|Immunologic Factors|immunologic factors|mesh-ancestor
92885582|NCT05299164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885584|NCT05299164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92885585|NCT05299164|Antimetabolites|antimetabolites|mesh-ancestor
92885586|NCT05299164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885587|NCT05299164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92885588|NCT05299164|Tubulin Modulators|tubulin modulators|mesh-ancestor
92885589|NCT05299164|Antimitotic Agents|antimitotic agents|mesh-ancestor
92885590|NCT05299164|Mitosis Modulators|mitosis modulators|mesh-ancestor
92885591|NCT05299164|Analgesics|analgesics|mesh-ancestor
92885592|NCT05299164|Sensory System Agents|sensory system agents|mesh-ancestor
92885593|NCT05299164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885594|NCT05299164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92885595|NCT05299164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92885596|NCT05299164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885597|NCT01563835|Fentanyl|fentanyl|mesh-list
92885598|NCT01563835|Bupivacaine|bupivacaine|mesh-list
92885599|NCT01563835|Citric Acid|citric acid|mesh-list
92885600|NCT01563835|Sodium Citrate|sodium citrate|mesh-list
92885601|NCT01563835|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885602|NCT01563835|Anesthetics|anesthetics|mesh-ancestor
92885603|NCT01563835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885604|NCT01563835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885605|NCT01563835|Sensory System Agents|sensory system agents|mesh-ancestor
92885606|NCT01563835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885607|NCT01563835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92885608|NCT01563835|Narcotics|narcotics|mesh-ancestor
92885609|NCT01563835|Analgesics|analgesics|mesh-ancestor
92885610|NCT01563835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92885611|NCT01563835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92885612|NCT01563835|Anesthetics, General|anesthetics, general|mesh-ancestor
92885613|NCT01563835|Anticoagulants|anticoagulants|mesh-ancestor
92885614|NCT01563835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92885615|NCT01563835|Chelating Agents|chelating agents|mesh-ancestor
92885616|NCT01563835|Sequestering Agents|sequestering agents|mesh-ancestor
92885617|NCT01563835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885618|NCT02768207|Vemurafenib|vemurafenib|mesh-list
92885619|NCT02768207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885620|NCT02768207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92885621|NCT02768207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885622|NCT02768207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885623|NCT02653196|Cyclosporine|cyclosporine|mesh-list
92885624|NCT02653196|Mycophenolic Acid|mycophenolic acid|mesh-list
92885625|NCT02653196|Fludarabine|fludarabine|mesh-list
92885626|NCT02653196|Etoposide|etoposide|mesh-list
92885627|NCT02653196|Melphalan|melphalan|mesh-list
92885628|NCT02653196|Alemtuzumab|alemtuzumab|mesh-list
92885629|NCT02653196|Thiotepa|thiotepa|mesh-list
92885630|NCT02653196|Tacrolimus|tacrolimus|mesh-list
92885631|NCT02653196|Cyclosporins|cyclosporins|mesh-list
92885632|NCT02653196|Mitogens|mitogens|mesh-list
92885633|NCT02653196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885634|NCT02653196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885635|NCT02653196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885636|NCT02653196|Immunologic Factors|immunologic factors|mesh-ancestor
92885637|NCT02653196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885638|NCT02653196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92885639|NCT02653196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92885640|NCT02653196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92885641|NCT02653196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885642|NCT02653196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92885643|NCT02653196|Antifungal Agents|antifungal agents|mesh-ancestor
92885644|NCT02653196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885645|NCT02653196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885646|NCT02653196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885647|NCT02653196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92885648|NCT02653196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92885649|NCT02653196|Antitubercular Agents|antitubercular agents|mesh-ancestor
92885650|NCT02653196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885651|NCT02653196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92885652|NCT02653196|Alkylating Agents|alkylating agents|mesh-ancestor
92885653|NCT02653196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92885654|NCT02653196|Mitosis Modulators|mitosis modulators|mesh-ancestor
92885655|NCT02653196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885656|NCT05135845|Spartalizumab|spartalizumab|mesh-list
92531022|NCT00018174|Fluoxetine|fluoxetine|mesh-list
92885657|NCT05135845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92885658|NCT05135845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885659|NCT05135845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885660|NCT05135845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885661|NCT04479436|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92885662|NCT04479436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885663|NCT04479436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885664|NCT00677118|Cisplatin|cisplatin|mesh-list
92885665|NCT00677118|Fluorouracil|fluorouracil|mesh-list
92885666|NCT00677118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885667|NCT00677118|Antimetabolites|antimetabolites|mesh-ancestor
92885668|NCT00677118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885669|NCT00677118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92885670|NCT00677118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885671|NCT00677118|Immunologic Factors|immunologic factors|mesh-ancestor
92885672|NCT00677118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885673|NCT02644226|Sevoflurane|sevoflurane|mesh-list
92885674|NCT02644226|Desflurane|desflurane|mesh-list
92885675|NCT02644226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92885676|NCT02644226|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92885677|NCT02644226|Anesthetics, General|anesthetics, general|mesh-ancestor
92885678|NCT02644226|Anesthetics|anesthetics|mesh-ancestor
92885679|NCT02644226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885680|NCT02644226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885681|NCT02753855|Telavancin|telavancin|mesh-list
92885682|NCT02753855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885683|NCT02753855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885685|NCT02758691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92885686|NCT02758691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885687|NCT00714376|Docetaxel|docetaxel|mesh-list
92885688|NCT00714376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885689|NCT00714376|Tubulin Modulators|tubulin modulators|mesh-ancestor
92885690|NCT00714376|Antimitotic Agents|antimitotic agents|mesh-ancestor
92885691|NCT00714376|Mitosis Modulators|mitosis modulators|mesh-ancestor
92885692|NCT00714376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885693|NCT04068766|Bupivacaine|bupivacaine|mesh-list
92885694|NCT04068766|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885695|NCT04068766|Anesthetics|anesthetics|mesh-ancestor
92885696|NCT04068766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885697|NCT04068766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885698|NCT04068766|Sensory System Agents|sensory system agents|mesh-ancestor
92885699|NCT04068766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885700|NCT03267199|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92885701|NCT03267199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92885702|NCT03267199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885703|NCT04725695|Lidocaine|lidocaine|mesh-list
92885704|NCT04725695|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885705|NCT04725695|Anesthetics|anesthetics|mesh-ancestor
92885706|NCT04725695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885707|NCT04725695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885708|NCT04725695|Sensory System Agents|sensory system agents|mesh-ancestor
92885709|NCT04725695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885710|NCT04725695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92885711|NCT04725695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92885712|NCT04725695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92885713|NCT04725695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885714|NCT04725695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885715|NCT04151472|Ubiquinone|ubiquinone|mesh-list
92885716|NCT04151472|Idebenone|idebenone|mesh-list
92885717|NCT04151472|Antioxidants|antioxidants|mesh-ancestor
92885718|NCT04151472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885719|NCT04151472|Protective Agents|protective agents|mesh-ancestor
92885720|NCT04151472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885721|NCT04151472|Micronutrients|micronutrients|mesh-ancestor
92885722|NCT04070794|Metformin|metformin|mesh-list
92885723|NCT04070794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92885724|NCT04070794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885725|NCT02695901|Chlorhexidine|chlorhexidine|mesh-list
92885726|NCT02695901|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92885727|NCT02695901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92885728|NCT02695901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885729|NCT02695901|Disinfectants|disinfectants|mesh-ancestor
92885730|NCT02695901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885731|NCT00677664|Glatiramer Acetate|glatiramer acetate|mesh-list
92885732|NCT00677664|Mannitol|mannitol|mesh-list
92885733|NCT00677664|(T,G)-A-L|(t,g)-a-l|mesh-list
92885734|NCT00677664|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92531077|NCT00044785|Vitamins|vitamins|mesh-ancestor
92885735|NCT00677664|Diuretics|diuretics|mesh-ancestor
92885736|NCT00677664|Natriuretic Agents|natriuretic agents|mesh-ancestor
92885737|NCT00677664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885738|NCT00677664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92885739|NCT00677664|Immunologic Factors|immunologic factors|mesh-ancestor
92885740|NCT00677664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885741|NCT00677664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885742|NCT02572492|Dexamethasone|dexamethasone|mesh-list
92885743|NCT02572492|Dexamethasone acetate|dexamethasone acetate|mesh-list
92885744|NCT02572492|Melphalan|melphalan|mesh-list
92885745|NCT02572492|BB 1101|bb 1101|mesh-list
92885746|NCT02572492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885747|NCT02572492|Antiemetics|antiemetics|mesh-ancestor
92885748|NCT02572492|Autonomic Agents|autonomic agents|mesh-ancestor
92885749|NCT02572492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885750|NCT02572492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885751|NCT02572492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885752|NCT02572492|Glucocorticoids|glucocorticoids|mesh-ancestor
92885753|NCT02572492|Hormones|hormones|mesh-ancestor
92885754|NCT02572492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885755|NCT02572492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92885756|NCT02572492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885757|NCT02572492|Protease Inhibitors|protease inhibitors|mesh-ancestor
92885758|NCT02572492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885759|NCT02572492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885760|NCT02572492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92885761|NCT02572492|Alkylating Agents|alkylating agents|mesh-ancestor
92885762|NCT02572492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92885763|NCT02572492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885764|NCT02572492|Immunologic Factors|immunologic factors|mesh-ancestor
92885765|NCT02753387|Chlorhexidine|chlorhexidine|mesh-list
92885766|NCT02753387|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92885767|NCT02753387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885768|NCT02753387|Disinfectants|disinfectants|mesh-ancestor
92885769|NCT00672282|Bicalutamide|bicalutamide|mesh-list
92885770|NCT00672282|Androgen Antagonists|androgen antagonists|mesh-ancestor
92885771|NCT00672282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92885772|NCT00672282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885773|NCT00672282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885774|NCT00672282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885775|NCT02753309|Sirolimus|sirolimus|mesh-list
92885776|NCT02753309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885777|NCT02753309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885778|NCT02753309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92885779|NCT02753309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885780|NCT02753309|Antifungal Agents|antifungal agents|mesh-ancestor
92885781|NCT02753309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92885782|NCT02753309|Immunologic Factors|immunologic factors|mesh-ancestor
92885783|NCT02753309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885784|NCT04147728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92885785|NCT04147728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92885786|NCT04147728|Growth Substances|growth substances|mesh-ancestor
92885787|NCT04147728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885788|NCT04147728|Growth Inhibitors|growth inhibitors|mesh-ancestor
92885789|NCT04147728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885790|NCT04330690|Artesunate|artesunate|mesh-list
92885791|NCT04330690|Dexamethasone|dexamethasone|mesh-list
92885792|NCT04330690|Infliximab|infliximab|mesh-list
92885793|NCT04330690|Imatinib Mesylate|imatinib mesylate|mesh-list
92885794|NCT04330690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885795|NCT04330690|Antiemetics|antiemetics|mesh-ancestor
92885796|NCT04330690|Autonomic Agents|autonomic agents|mesh-ancestor
92885797|NCT04330690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885798|NCT04330690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885799|NCT04330690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92885800|NCT04330690|Glucocorticoids|glucocorticoids|mesh-ancestor
92885801|NCT04330690|Hormones|hormones|mesh-ancestor
92885802|NCT04330690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885803|NCT04330690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92885804|NCT04330690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885805|NCT04330690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92885806|NCT04330690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885807|NCT04330690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885808|NCT04330690|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92885809|NCT04330690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885810|NCT04330690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885812|NCT04330690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92885813|NCT04330690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92885814|NCT04330690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885815|NCT04330690|Antiviral Agents|antiviral agents|mesh-ancestor
92885816|NCT04330690|Schistosomicides|schistosomicides|mesh-ancestor
92885817|NCT04330690|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92885818|NCT04330690|Anthelmintics|anthelmintics|mesh-ancestor
92885819|NCT03083041|Apatinib|apatinib|mesh-list
92885820|NCT03083041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885821|NCT03083041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92885822|NCT03083041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885823|NCT03083041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885824|NCT00672360|Folic Acid|folic acid|mesh-list
92885825|NCT00672360|Hematinics|hematinics|mesh-ancestor
92885826|NCT00672360|Vitamin B Complex|vitamin b complex|mesh-ancestor
92885827|NCT00672360|Vitamins|vitamins|mesh-ancestor
92885828|NCT00672360|Micronutrients|micronutrients|mesh-ancestor
92885829|NCT00672360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885830|NCT02628522|Lidocaine|lidocaine|mesh-list
92885831|NCT02628522|Epinephrine|epinephrine|mesh-list
92885832|NCT02628522|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885833|NCT02628522|Anesthetics|anesthetics|mesh-ancestor
92885834|NCT02628522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885835|NCT02628522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885836|NCT02628522|Sensory System Agents|sensory system agents|mesh-ancestor
92885837|NCT02628522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885838|NCT02628522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92885839|NCT02628522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92885840|NCT02628522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92885841|NCT02628522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885842|NCT02628522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885843|NCT02628522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92885844|NCT02628522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92885845|NCT02628522|Adrenergic Agents|adrenergic agents|mesh-ancestor
92885846|NCT02628522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885847|NCT02628522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92885848|NCT02628522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92885849|NCT02628522|Autonomic Agents|autonomic agents|mesh-ancestor
92885850|NCT02628522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92885851|NCT02628522|Respiratory System Agents|respiratory system agents|mesh-ancestor
92885852|NCT02628522|Mydriatics|mydriatics|mesh-ancestor
92885853|NCT02628522|Sympathomimetics|sympathomimetics|mesh-ancestor
92885854|NCT02628522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92885855|NCT02572336|Plasminogen|plasminogen|mesh-list
92885856|NCT02572336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92885857|NCT02572336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92885858|NCT02572336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92885859|NCT02572336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885860|NCT02750969|Lidocaine|lidocaine|mesh-list
92885861|NCT02750969|Anesthetics, Local|anesthetics, local|mesh-ancestor
92885862|NCT02750969|Anesthetics|anesthetics|mesh-ancestor
92885863|NCT02750969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885864|NCT02750969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885865|NCT02750969|Sensory System Agents|sensory system agents|mesh-ancestor
92885866|NCT02750969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885867|NCT02750969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92885868|NCT02750969|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92885869|NCT02750969|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92885870|NCT02750969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885871|NCT02750969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885872|NCT04067011|Doxycycline|doxycycline|mesh-list
92885873|NCT04067011|Ciprofloxacin|ciprofloxacin|mesh-list
92885874|NCT04067011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885875|NCT04067011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885876|NCT04067011|Antimalarials|antimalarials|mesh-ancestor
92885877|NCT04067011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92885878|NCT04067011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92885879|NCT04067011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92885880|NCT04067011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92885881|NCT04067011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885882|NCT04067011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885883|NCT04067011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885884|NCT04067011|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92531228|NCT00045721|Alkylating Agents|alkylating agents|mesh-ancestor
92885885|NCT04067011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92885886|NCT04044859|Pembrolizumab|pembrolizumab|mesh-list
92885887|NCT04044859|Nivolumab|nivolumab|mesh-list
92885888|NCT04044859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885889|NCT04044859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885890|NCT04044859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92885891|NCT04044859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885892|NCT00719056|Ciprofloxacin|ciprofloxacin|mesh-list
92885893|NCT00719056|Lactams|lactams|mesh-list
92885894|NCT00719056|Cephalosporins|cephalosporins|mesh-list
92885895|NCT00719056|Teicoplanin|teicoplanin|mesh-list
92885896|NCT00719056|beta-Lactams|beta-lactams|mesh-list
92885897|NCT00719056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92885898|NCT00719056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885899|NCT00719056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92885900|NCT00719056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92885901|NCT00719056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885902|NCT00719056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885903|NCT00719056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885904|NCT00719056|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92885905|NCT00719056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92885906|NCT04469699|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92885907|NCT04469699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92885908|NCT04469699|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885909|NCT03475004|Bevacizumab|bevacizumab|mesh-list
92885910|NCT03475004|Pembrolizumab|pembrolizumab|mesh-list
92885911|NCT03475004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92885912|NCT03475004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885913|NCT03475004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92885914|NCT03475004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92885915|NCT03475004|Growth Substances|growth substances|mesh-ancestor
92885916|NCT03475004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885917|NCT03475004|Growth Inhibitors|growth inhibitors|mesh-ancestor
92885918|NCT03475004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92885919|NCT03475004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885920|NCT02695745|Celecoxib|celecoxib|mesh-list
92885921|NCT02695745|Capsaicin|capsaicin|mesh-list
92885922|NCT02695745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92885923|NCT02695745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92885924|NCT02695745|Analgesics|analgesics|mesh-ancestor
92885925|NCT02695745|Sensory System Agents|sensory system agents|mesh-ancestor
92885926|NCT02695745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885927|NCT02695745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885928|NCT02695745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92885929|NCT02695745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92885930|NCT02695745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92885931|NCT02695745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92885932|NCT02695745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92885933|NCT02695745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885934|NCT02695745|Antipruritics|antipruritics|mesh-ancestor
92885935|NCT02695745|Dermatologic Agents|dermatologic agents|mesh-ancestor
92885936|NCT00990067|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92885937|NCT00990067|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92885938|NCT00990067|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92885939|NCT00990067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92885940|NCT00990067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92885941|NCT00990067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885942|NCT00990067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885943|NCT00990067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885944|NCT00990067|Analgesics|analgesics|mesh-ancestor
92885945|NCT00990067|Sensory System Agents|sensory system agents|mesh-ancestor
92885946|NCT00990067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885947|NCT00990067|Antidepressive Agents|antidepressive agents|mesh-ancestor
92885948|NCT00990067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92885949|NCT00990067|Dopamine Agents|dopamine agents|mesh-ancestor
92885950|NCT00990067|Hallucinogens|hallucinogens|mesh-ancestor
92885951|NCT00990067|Serotonin Agents|serotonin agents|mesh-ancestor
92885952|NCT00990067|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92885953|NCT00990067|Adrenergic Agents|adrenergic agents|mesh-ancestor
92885954|NCT00719290|Hyaluronic Acid|hyaluronic acid|mesh-list
92885955|NCT00719290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92885956|NCT00719290|Immunologic Factors|immunologic factors|mesh-ancestor
92885957|NCT00719290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885958|NCT00719290|Viscosupplements|viscosupplements|mesh-ancestor
92885959|NCT00719290|Protective Agents|protective agents|mesh-ancestor
92885960|NCT00635921|Ziprasidone|ziprasidone|mesh-list
92885961|NCT00635921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92885962|NCT00635921|Serotonin Agents|serotonin agents|mesh-ancestor
92885963|NCT00635921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92885964|NCT00635921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92885965|NCT00635921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885966|NCT00635921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92885967|NCT00635921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92885968|NCT00635921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885969|NCT00635921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92885970|NCT00635921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92885971|NCT00635921|Dopamine Agents|dopamine agents|mesh-ancestor
92885972|NCT04166006|Interleukin-2|interleukin-2|mesh-list
92885973|NCT04166006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92885974|NCT04166006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92885975|NCT04166006|Analgesics|analgesics|mesh-ancestor
92885977|NCT04166006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885978|NCT04166006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885979|NCT04069858|Entecavir|entecavir|mesh-list
92885980|NCT04069858|Antiviral Agents|antiviral agents|mesh-ancestor
92885981|NCT04069858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92885982|NCT00710086|Remifentanil|remifentanil|mesh-list
92885983|NCT00710086|Hydromorphone|hydromorphone|mesh-list
92885984|NCT00710086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92885985|NCT00710086|Narcotics|narcotics|mesh-ancestor
92885986|NCT00710086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92885987|NCT00710086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885988|NCT00710086|Analgesics|analgesics|mesh-ancestor
92885989|NCT00710086|Sensory System Agents|sensory system agents|mesh-ancestor
92885990|NCT00710086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92885991|NCT00652886|Oxandrolone|oxandrolone|mesh-list
92885992|NCT00652886|Androgens|androgens|mesh-ancestor
92885993|NCT00652886|Hormones|hormones|mesh-ancestor
92885994|NCT00652886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92885995|NCT00652886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92885996|NCT00652886|Anabolic Agents|anabolic agents|mesh-ancestor
92885997|NCT00539305|Methyltestosterone|methyltestosterone|mesh-list
92885998|NCT00539305|Testosterone|testosterone|mesh-list
92885999|NCT00539305|Testosterone undecanoate|testosterone undecanoate|mesh-list
92886000|NCT00539305|Testosterone enanthate|testosterone enanthate|mesh-list
92886001|NCT00539305|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92886002|NCT00539305|Androgens|androgens|mesh-ancestor
92886003|NCT00539305|Hormones|hormones|mesh-ancestor
92886004|NCT00539305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886005|NCT00539305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886006|NCT00539305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92886007|NCT00539305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886008|NCT00539305|Anabolic Agents|anabolic agents|mesh-ancestor
92886009|NCT02643914|Nicotine|nicotine|mesh-list
92886010|NCT02643914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92886011|NCT02643914|Autonomic Agents|autonomic agents|mesh-ancestor
92886012|NCT02643914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886013|NCT02643914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886014|NCT02643914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92886015|NCT02643914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92886016|NCT02643914|Cholinergic Agents|cholinergic agents|mesh-ancestor
92886017|NCT02643914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886018|NCT02643914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886019|NCT00715702|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92886020|NCT00715702|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92886021|NCT00715702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886022|NCT00715702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92886023|NCT00715702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92886024|NCT00715702|Antiviral Agents|antiviral agents|mesh-ancestor
92886025|NCT00715702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886026|NCT04808999|Pembrolizumab|pembrolizumab|mesh-list
92886027|NCT04808999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92886028|NCT04808999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886029|NCT04808999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92886030|NCT04808999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886031|NCT00990223|Eplerenone|eplerenone|mesh-list
92531379|NCT04369560|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92886032|NCT00990223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92886033|NCT00990223|Hormone Antagonists|hormone antagonists|mesh-ancestor
92886034|NCT00990223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886035|NCT00990223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886036|NCT00990223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92886037|NCT00990223|Diuretics|diuretics|mesh-ancestor
92886038|NCT00990223|Natriuretic Agents|natriuretic agents|mesh-ancestor
92886039|NCT00990223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886040|NCT00715780|Insulin|insulin|mesh-list
92886041|NCT00715780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92886042|NCT00715780|Insulin Aspart|insulin aspart|mesh-list
92886043|NCT00715780|Insulin, Long-Acting|insulin, long-acting|mesh-list
92886044|NCT00715780|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92886045|NCT00715780|Insulin Detemir|insulin detemir|mesh-list
92886047|NCT00715780|Isophane Insulin, Human|isophane insulin, human|mesh-list
92886048|NCT00715780|Insulin, Isophane|insulin, isophane|mesh-list
92886049|NCT00715780|Isophane insulin, beef|isophane insulin, beef|mesh-list
92886050|NCT00715780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92886051|NCT00715780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886052|NCT02652884|Betamethasone|betamethasone|mesh-list
92886053|NCT02652884|Betamethasone acetate|betamethasone acetate|mesh-list
92886054|NCT02652884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886055|NCT02652884|Glucocorticoids|glucocorticoids|mesh-ancestor
92886056|NCT02652884|Hormones|hormones|mesh-ancestor
92886057|NCT02652884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886058|NCT02652884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886059|NCT02652884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92886060|NCT02652884|Respiratory System Agents|respiratory system agents|mesh-ancestor
92886061|NCT00990301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92886062|NCT00990301|Moexipril|moexipril|mesh-list
92886063|NCT00990301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886064|NCT00990301|Diuretics|diuretics|mesh-ancestor
92886065|NCT00990301|Natriuretic Agents|natriuretic agents|mesh-ancestor
92886066|NCT00990301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886067|NCT00990301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92886068|NCT00990301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886069|NCT00990301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886070|NCT00990301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92886071|NCT00990301|Protease Inhibitors|protease inhibitors|mesh-ancestor
92886072|NCT00990301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886073|NCT00715858|Doxycycline|doxycycline|mesh-list
92886074|NCT00715858|Rifampin|rifampin|mesh-list
92886075|NCT00715858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886076|NCT00715858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886077|NCT00715858|Antimalarials|antimalarials|mesh-ancestor
92886078|NCT00715858|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92886079|NCT00715858|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92886080|NCT00715858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92886081|NCT00715858|Antitubercular Agents|antitubercular agents|mesh-ancestor
92886082|NCT00715858|Leprostatic Agents|leprostatic agents|mesh-ancestor
92886083|NCT00715858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92886084|NCT00715858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886085|NCT00715858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886086|NCT00715858|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92886087|NCT00715858|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92886088|NCT00715858|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92886089|NCT00715858|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92886090|NCT00715858|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92886091|NCT00715858|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92886092|NCT02643680|Chlorhexidine|chlorhexidine|mesh-list
92886093|NCT02643680|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92886094|NCT02643680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886095|NCT02643680|Disinfectants|disinfectants|mesh-ancestor
92886096|NCT04696445|Morphine|morphine|mesh-list
92886097|NCT04696445|Oxycodone|oxycodone|mesh-list
92886098|NCT04696445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886099|NCT04696445|Narcotics|narcotics|mesh-ancestor
92886100|NCT04696445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886101|NCT04696445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886102|NCT04696445|Analgesics|analgesics|mesh-ancestor
92886103|NCT04696445|Sensory System Agents|sensory system agents|mesh-ancestor
92886104|NCT04696445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886105|NCT05360953|Clonidine|clonidine|mesh-list
92886106|NCT05360953|Doxazosin|doxazosin|mesh-list
92531481|NCT04258410|Quercetin|quercetin|mesh-list
92886107|NCT05360953|Analgesics|analgesics|mesh-ancestor
92886108|NCT05360953|Sensory System Agents|sensory system agents|mesh-ancestor
92886109|NCT05360953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886110|NCT05360953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886111|NCT05360953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886112|NCT05360953|Sympatholytics|sympatholytics|mesh-ancestor
92886113|NCT05360953|Autonomic Agents|autonomic agents|mesh-ancestor
92886114|NCT05360953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92886115|NCT05360953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92886116|NCT05360953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92886117|NCT05360953|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886118|NCT05360953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886119|NCT05360953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886120|NCT05360953|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92886121|NCT05360953|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92886122|NCT05360953|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92886125|NCT02647424|Enclomiphene|enclomiphene|mesh-list
92886126|NCT02647424|Zuclomiphene|zuclomiphene|mesh-list
92886127|NCT02647424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886128|NCT02647424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92886129|NCT02647424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92886130|NCT02647424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886131|NCT02647424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886132|NCT02647424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92886133|NCT02647424|Hormone Antagonists|hormone antagonists|mesh-ancestor
92886134|NCT02647424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886135|NCT02647424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886136|NCT02647424|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92886137|NCT02647424|Fertility Agents|fertility agents|mesh-ancestor
92886138|NCT02647424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92886139|NCT02647424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92886140|NCT02647424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92886141|NCT02574754|Warfarin|warfarin|mesh-list
92886142|NCT02574754|Anticoagulants|anticoagulants|mesh-ancestor
92886143|NCT00719602|Ritonavir|ritonavir|mesh-list
92886144|NCT00719602|Lopinavir|lopinavir|mesh-list
92886145|NCT00719602|Lamivudine|lamivudine|mesh-list
92886146|NCT00719602|Zidovudine|zidovudine|mesh-list
92886147|NCT00719602|Nevirapine|nevirapine|mesh-list
92886148|NCT00719602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92886149|NCT00719602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92886150|NCT00719602|Protease Inhibitors|protease inhibitors|mesh-ancestor
92886151|NCT00719602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886152|NCT00719602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886153|NCT00719602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92886154|NCT00719602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92886155|NCT00719602|Antiviral Agents|antiviral agents|mesh-ancestor
92886156|NCT00719602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886157|NCT00719602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92886158|NCT00719602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92886159|NCT00719602|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92886160|NCT00719602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92886161|NCT00719602|Antimetabolites|antimetabolites|mesh-ancestor
92886162|NCT00719602|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92886163|NCT00719602|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92886164|NCT02652650|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92886165|NCT02652650|Norethindrone|norethindrone|mesh-list
92886166|NCT02652650|Norethindrone Acetate|norethindrone acetate|mesh-list
92886167|NCT02652650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92886168|NCT02652650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92886169|NCT02652650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92886170|NCT02652650|Contraceptive Agents|contraceptive agents|mesh-ancestor
92886171|NCT02652650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92886172|NCT02652650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886173|NCT02652650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92886174|NCT02652650|Estrogens|estrogens|mesh-ancestor
92886175|NCT02652650|Hormones|hormones|mesh-ancestor
92886176|NCT02652650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886177|NCT02652650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92886178|NCT02643602|Theophylline|theophylline|mesh-list
92886179|NCT02643602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92886180|NCT02643602|Autonomic Agents|autonomic agents|mesh-ancestor
92531528|NCT00046735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886181|NCT02643602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886182|NCT02643602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886184|NCT02643602|Respiratory System Agents|respiratory system agents|mesh-ancestor
92886185|NCT02643602|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92886186|NCT02643602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886187|NCT02643602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886188|NCT02643602|Vasodilator Agents|vasodilator agents|mesh-ancestor
92886189|NCT02643602|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92886190|NCT02643602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92886191|NCT02643602|Purinergic Agents|purinergic agents|mesh-ancestor
92886192|NCT02643602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886193|NCT00710320|Anesthetics|anesthetics|mesh-list
92886194|NCT00710320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886196|NCT00716170|Glucagon|glucagon|mesh-list
92886197|NCT00716170|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92886198|NCT00716170|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92886199|NCT00716170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92886200|NCT00716170|Hormones|hormones|mesh-ancestor
92886201|NCT00716170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886202|NCT00716170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886203|NCT00716170|Incretins|incretins|mesh-ancestor
92886204|NCT02652806|Epoetin Alfa|epoetin alfa|mesh-list
92886205|NCT02652806|Hematinics|hematinics|mesh-ancestor
92886206|NCT04529135|Dexmedetomidine|dexmedetomidine|mesh-list
92886207|NCT04529135|Remifentanil|remifentanil|mesh-list
92886208|NCT04529135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92886209|NCT04529135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886210|NCT04529135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886211|NCT04529135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886212|NCT04529135|Analgesics|analgesics|mesh-ancestor
92886213|NCT04529135|Sensory System Agents|sensory system agents|mesh-ancestor
92886214|NCT04529135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886215|NCT04529135|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92886216|NCT04529135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92886217|NCT04529135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92886218|NCT04529135|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886219|NCT04529135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886220|NCT04529135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886221|NCT04529135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886222|NCT04529135|Narcotics|narcotics|mesh-ancestor
92886223|NCT02647190|Asparaginase|asparaginase|mesh-list
92886224|NCT02647190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886225|NCT00653042|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92886226|NCT00653042|Natriuretic Agents|natriuretic agents|mesh-ancestor
92886227|NCT00653042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886228|NCT04165850|Ciprofloxacin|ciprofloxacin|mesh-list
92886229|NCT04165850|Celecoxib|celecoxib|mesh-list
92886230|NCT04165850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92886231|NCT04165850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886232|NCT04165850|Analgesics|analgesics|mesh-ancestor
92886233|NCT04165850|Sensory System Agents|sensory system agents|mesh-ancestor
92886234|NCT04165850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886235|NCT04165850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886236|NCT04165850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886237|NCT04165850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886238|NCT04165850|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92886239|NCT04165850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92886240|NCT04165850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886241|NCT04165850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886242|NCT04165850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886243|NCT04165850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886244|NCT04165850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92886245|NCT04165850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92886246|NCT04165850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886247|NCT04165850|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92886248|NCT04165850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92886249|NCT00719758|Beraprost|beraprost|mesh-list
92886250|NCT00719758|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92886251|NCT00719758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92886252|NCT02647268|Magnesium Sulfate|magnesium sulfate|mesh-list
92886253|NCT02647268|Oxytocin|oxytocin|mesh-list
92886254|NCT02647268|Oxytocics|oxytocics|mesh-ancestor
92886255|NCT02647268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92886256|NCT02647268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886257|NCT02647268|Analgesics|analgesics|mesh-ancestor
92886258|NCT02647268|Sensory System Agents|sensory system agents|mesh-ancestor
92886259|NCT02647268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886260|NCT02647268|Anesthetics|anesthetics|mesh-ancestor
92886261|NCT02647268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886262|NCT02647268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92886263|NCT02647268|Anticonvulsants|anticonvulsants|mesh-ancestor
92886264|NCT02647268|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92886265|NCT02647268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886266|NCT02647268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026473|NCT00402051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886267|NCT02647268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92886268|NCT02647268|Tocolytic Agents|tocolytic agents|mesh-ancestor
92886269|NCT04218149|Bupivacaine|bupivacaine|mesh-list
92886270|NCT04218149|Anesthetics, Local|anesthetics, local|mesh-ancestor
92886271|NCT04218149|Anesthetics|anesthetics|mesh-ancestor
92886272|NCT04218149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886273|NCT04218149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886274|NCT04218149|Sensory System Agents|sensory system agents|mesh-ancestor
92886275|NCT04218149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886276|NCT04032860|Tenofovir|tenofovir|mesh-list
92886277|NCT04032860|Entecavir|entecavir|mesh-list
92886278|NCT04032860|Antiviral Agents|antiviral agents|mesh-ancestor
92886279|NCT04032860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886280|NCT04032860|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92886281|NCT04032860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92886282|NCT04032860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886283|NCT04032860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886284|NCT04032860|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92886285|NCT04032860|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92886286|NCT00716248|Bucillamine|bucillamine|mesh-list
92886287|NCT00716248|Methotrexate|methotrexate|mesh-list
92886288|NCT00716248|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92886289|NCT00716248|Abortifacient Agents|abortifacient agents|mesh-ancestor
92886290|NCT00716248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92886291|NCT00716248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886292|NCT00716248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886293|NCT00716248|Antimetabolites|antimetabolites|mesh-ancestor
92886294|NCT00716248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886295|NCT00716248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886296|NCT00716248|Dermatologic Agents|dermatologic agents|mesh-ancestor
92886297|NCT00716248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886298|NCT00716248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92886299|NCT00716248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886300|NCT00716248|Immunologic Factors|immunologic factors|mesh-ancestor
92886301|NCT00716248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886302|NCT00716248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92886303|NCT00716248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92886304|NCT00716248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886305|NCT00716248|Analgesics|analgesics|mesh-ancestor
92886306|NCT00716248|Sensory System Agents|sensory system agents|mesh-ancestor
92886307|NCT00716248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886308|NCT00716248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886309|NCT00716248|Antioxidants|antioxidants|mesh-ancestor
92886310|NCT00716248|Protective Agents|protective agents|mesh-ancestor
92886311|NCT02643212|Rivaroxaban|rivaroxaban|mesh-list
92886312|NCT02643212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92886313|NCT02643212|Antithrombins|antithrombins|mesh-ancestor
92886314|NCT02643212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92886315|NCT02643212|Protease Inhibitors|protease inhibitors|mesh-ancestor
92886316|NCT02643212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886317|NCT02643212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886318|NCT02643212|Anticoagulants|anticoagulants|mesh-ancestor
92886319|NCT02642900|Nystatin|nystatin|mesh-list
92886320|NCT02642900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886321|NCT02642900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886322|NCT02642900|Antifungal Agents|antifungal agents|mesh-ancestor
92886323|NCT02642900|Ionophores|ionophores|mesh-ancestor
92886324|NCT02642900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886325|NCT02642900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886326|NCT02652728|Enalapril|enalapril|mesh-list
92886327|NCT02652728|Enalaprilat|enalaprilat|mesh-list
92886328|NCT02652728|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92886329|NCT02652728|Protease Inhibitors|protease inhibitors|mesh-ancestor
92886331|NCT02652728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886332|NCT02652728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886333|NCT00720148|Bortezomib|bortezomib|mesh-list
92886334|NCT00720148|Sunitinib|sunitinib|mesh-list
92886335|NCT00720148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886336|NCT00720148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886337|NCT00720148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92886338|NCT00720148|Growth Substances|growth substances|mesh-ancestor
92886339|NCT00720148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886340|NCT00720148|Growth Inhibitors|growth inhibitors|mesh-ancestor
92886341|NCT00720148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92886342|NCT00720148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886343|NCT00720148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886344|NCT00710788|Calcium Carbonate|calcium carbonate|mesh-list
92886345|NCT00710788|Calcium|calcium|mesh-list
92886346|NCT00710788|Sevelamer|sevelamer|mesh-list
92886347|NCT00710788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92886348|NCT00710788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886349|NCT00710788|Antacids|antacids|mesh-ancestor
92886350|NCT00710788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886351|NCT00710788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92886352|NCT00710788|Chelating Agents|chelating agents|mesh-ancestor
92886353|NCT00710788|Sequestering Agents|sequestering agents|mesh-ancestor
92886354|NCT03530189|Insulin|insulin|mesh-list
92886355|NCT03530189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92886356|NCT03530189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886357|NCT02646800|Micafungin|micafungin|mesh-list
92886358|NCT02646800|Antifungal Agents|antifungal agents|mesh-ancestor
92886359|NCT02646800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886360|NCT02749409|Parecoxib|parecoxib|mesh-list
92886361|NCT02749409|Morphine|morphine|mesh-list
92886362|NCT02749409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886363|NCT02749409|Narcotics|narcotics|mesh-ancestor
92886364|NCT02749409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886365|NCT02749409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886366|NCT02749409|Analgesics|analgesics|mesh-ancestor
92886367|NCT02749409|Sensory System Agents|sensory system agents|mesh-ancestor
92886368|NCT02749409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886369|NCT02749409|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92886370|NCT02749409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92886371|NCT02749409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886372|NCT02749409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886373|NCT02749409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92886374|NCT02749409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886375|NCT02749409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886376|NCT02749409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886377|NCT03454529|Simvastatin|simvastatin|mesh-list
92886378|NCT03454529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92886379|NCT03454529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92886380|NCT03454529|Antimetabolites|antimetabolites|mesh-ancestor
92886381|NCT03454529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886382|NCT03454529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92886383|NCT03454529|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92886384|NCT03454529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886385|NCT03449459|Amikacin|amikacin|mesh-list
92886386|NCT03449459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886387|NCT03449459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886388|NCT00653120|Propranolol|propranolol|mesh-list
92886389|NCT00653120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92886390|NCT00653120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92886391|NCT00653120|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886392|NCT00653120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886393|NCT00653120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886394|NCT00653120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886395|NCT00653120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92886396|NCT00653120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886397|NCT00653120|Vasodilator Agents|vasodilator agents|mesh-ancestor
92886398|NCT00678132|Gemcitabine|gemcitabine|mesh-list
92886399|NCT00678132|Olaparib|olaparib|mesh-list
92886400|NCT00678132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886401|NCT00678132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886402|NCT00678132|Antimetabolites|antimetabolites|mesh-ancestor
92531749|NCT05641337|Insulin Aspart|insulin aspart|mesh-list
92886403|NCT00678132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886404|NCT00678132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92886405|NCT00678132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886406|NCT02789345|Osimertinib|osimertinib|mesh-list
92886407|NCT02789345|Ramucirumab|ramucirumab|mesh-list
92886408|NCT02789345|Necitumumab|necitumumab|mesh-list
92886409|NCT02789345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886410|NCT02789345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92886411|NCT02789345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026474|NCT00402051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886412|NCT02789345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886413|NCT02789345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92886414|NCT02772965|Methotrexate|methotrexate|mesh-list
92886415|NCT02772965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92886416|NCT02772965|Abortifacient Agents|abortifacient agents|mesh-ancestor
92886417|NCT02772965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92886418|NCT02772965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886419|NCT02772965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886420|NCT02772965|Antimetabolites|antimetabolites|mesh-ancestor
92886421|NCT02772965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886422|NCT02772965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886423|NCT02772965|Dermatologic Agents|dermatologic agents|mesh-ancestor
92886424|NCT02772965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886425|NCT02772965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92886426|NCT02772965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886427|NCT02772965|Immunologic Factors|immunologic factors|mesh-ancestor
92886428|NCT02772965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886429|NCT02772965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92886430|NCT00681720|Flumazenil|flumazenil|mesh-list
92886431|NCT00681720|Antidotes|antidotes|mesh-ancestor
92886432|NCT00681720|Protective Agents|protective agents|mesh-ancestor
92886433|NCT00681720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886434|NCT00681720|GABA Modulators|gaba modulators|mesh-ancestor
92886435|NCT00681720|GABA Agents|gaba agents|mesh-ancestor
92886436|NCT00681720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886437|NCT00681720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886438|NCT00650312|Metformin|metformin|mesh-list
92886439|NCT00650312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92886440|NCT00650312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886441|NCT00538681|Pemetrexed|pemetrexed|mesh-list
92886442|NCT00538681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886443|NCT00538681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886444|NCT00538681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886445|NCT00538681|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92886446|NCT00538681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92886447|NCT00650390|Adalimumab|adalimumab|mesh-list
92886448|NCT00650390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92886449|NCT00650390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886450|NCT00650390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886451|NCT00681876|Bevacizumab|bevacizumab|mesh-list
92886452|NCT00681876|Cetuximab|cetuximab|mesh-list
92886453|NCT00681876|Irinotecan|irinotecan|mesh-list
92886454|NCT00681876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92886455|NCT00681876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886456|NCT00681876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886457|NCT00681876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92886458|NCT00681876|Growth Substances|growth substances|mesh-ancestor
92886459|NCT00681876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886460|NCT00681876|Growth Inhibitors|growth inhibitors|mesh-ancestor
92886461|NCT00681876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92886462|NCT00681876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92886463|NCT00681876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886464|NCT00681876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886465|NCT02226367|Prazosin|prazosin|mesh-list
92886466|NCT02226367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886467|NCT02226367|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92886468|NCT02226367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92886469|NCT02226367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92886470|NCT02226367|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886471|NCT02226367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886472|NCT02226367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886473|NCT02226367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886474|NCT03885934|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92886475|NCT03885934|Immunologic Factors|immunologic factors|mesh-ancestor
92886476|NCT03885934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886477|NCT02159989|Aflibercept|aflibercept|mesh-list
92886478|NCT02159989|Endothelial Growth Factors|endothelial growth factors|mesh-list
92886479|NCT02159989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886480|NCT02159989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92886481|NCT02159989|Growth Substances|growth substances|mesh-ancestor
92886482|NCT02159989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886483|NCT02159989|Growth Inhibitors|growth inhibitors|mesh-ancestor
92886484|NCT02159989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886485|NCT02628132|Paclitaxel|paclitaxel|mesh-list
92886486|NCT02628132|Durvalumab|durvalumab|mesh-list
92886487|NCT02628132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92886488|NCT02628132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886489|NCT02628132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92886490|NCT02628132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92886491|NCT02628132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92886492|NCT02628132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886493|NCT02628132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92886494|NCT02695355|Methylphenidate|methylphenidate|mesh-list
92886495|NCT02695355|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92886496|NCT02695355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886497|NCT02695355|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92886498|NCT02695355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92886499|NCT02695355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886500|NCT02695355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886501|NCT02695355|Dopamine Agents|dopamine agents|mesh-ancestor
92886502|NCT02695355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886503|NCT02573038|Aflibercept|aflibercept|mesh-list
92886504|NCT02573038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886505|NCT02573038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92886506|NCT02573038|Growth Substances|growth substances|mesh-ancestor
92886507|NCT02573038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886508|NCT02573038|Growth Inhibitors|growth inhibitors|mesh-ancestor
92886509|NCT02573038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886510|NCT02159755|Palbociclib|palbociclib|mesh-list
92886511|NCT02159755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886512|NCT02159755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92886513|NCT02159755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886514|NCT02159755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886515|NCT01822015|Cytarabine|cytarabine|mesh-list
92886516|NCT01822015|Sirolimus|sirolimus|mesh-list
92886517|NCT01822015|Idarubicin|idarubicin|mesh-list
92886518|NCT01822015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886519|NCT01822015|Antimetabolites|antimetabolites|mesh-ancestor
92886520|NCT01822015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886521|NCT01822015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886522|NCT01822015|Antiviral Agents|antiviral agents|mesh-ancestor
92886523|NCT01822015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886524|NCT01822015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886525|NCT01822015|Immunologic Factors|immunologic factors|mesh-ancestor
92886526|NCT01822015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886527|NCT01822015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886528|NCT01822015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92886529|NCT01822015|Antifungal Agents|antifungal agents|mesh-ancestor
92886530|NCT01822015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886531|NCT01822015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92886532|NCT01822015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92886533|NCT00990535|Octreotide|octreotide|mesh-list
92886534|NCT00990535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92886535|NCT00990535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92886536|NCT00990535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886537|NCT05590897|Anti-Infective Agents|anti-infective agents|mesh-list
92886538|NCT05590897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92886539|NCT00720304|Docetaxel|docetaxel|mesh-list
92886540|NCT00720304|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92886541|NCT00720304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886542|NCT00720304|Tubulin Modulators|tubulin modulators|mesh-ancestor
92886543|NCT00720304|Antimitotic Agents|antimitotic agents|mesh-ancestor
92886544|NCT00720304|Mitosis Modulators|mitosis modulators|mesh-ancestor
92886545|NCT00720304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886546|NCT00720304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92886547|NCT00720304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886548|NCT00682344|Levobupivacaine|levobupivacaine|mesh-list
92886549|NCT00682344|Anesthetics, Local|anesthetics, local|mesh-ancestor
92886550|NCT00682344|Anesthetics|anesthetics|mesh-ancestor
92886551|NCT00682344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886552|NCT00682344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886553|NCT00682344|Sensory System Agents|sensory system agents|mesh-ancestor
92886554|NCT00682344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886556|NCT00990691|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92886557|NCT00990691|Antidepressive Agents|antidepressive agents|mesh-ancestor
92886558|NCT00990691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92886559|NCT00990691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886560|NCT00990691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886561|NCT00990691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92525505|NCT00025402|Interferon-alpha|interferon-alpha|mesh-list
92886562|NCT00990691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92886563|NCT00990691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886564|NCT00990691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886565|NCT00990691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886566|NCT00990691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886568|NCT00678522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92886569|NCT00678522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92886570|NCT00678522|Antimetabolites|antimetabolites|mesh-ancestor
92886571|NCT00678522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886572|NCT00678522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92886573|NCT00678522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92886574|NCT00678522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886575|NCT04391855|Dexmedetomidine|dexmedetomidine|mesh-list
92886576|NCT04391855|Tramadol|tramadol|mesh-list
92886577|NCT04391855|Ropivacaine|ropivacaine|mesh-list
92886578|NCT04391855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92886579|NCT04391855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886580|NCT04391855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886581|NCT04391855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886582|NCT04391855|Analgesics|analgesics|mesh-ancestor
92886583|NCT04391855|Sensory System Agents|sensory system agents|mesh-ancestor
92886584|NCT04391855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886585|NCT04391855|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92886586|NCT04391855|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92886587|NCT04391855|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92886588|NCT04391855|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886589|NCT04391855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886590|NCT04391855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886591|NCT04391855|Anesthetics, Local|anesthetics, local|mesh-ancestor
92886592|NCT04391855|Anesthetics|anesthetics|mesh-ancestor
92886593|NCT04391855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886594|NCT04391855|Narcotics|narcotics|mesh-ancestor
92886595|NCT00716950|Losartan|losartan|mesh-list
92886596|NCT00716950|Valsartan|valsartan|mesh-list
92886597|NCT00716950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886598|NCT00716950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92886599|NCT00716950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92886600|NCT00716950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886601|NCT00716950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92886602|NCT00711178|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92886603|NCT00711178|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92886604|NCT00711178|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92886605|NCT00711178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92886606|NCT00678756|Ketoconazole|ketoconazole|mesh-list
92886607|NCT00678756|Antifungal Agents|antifungal agents|mesh-ancestor
92886608|NCT00678756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886609|NCT00678756|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92886610|NCT00678756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92886611|NCT00678756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886612|NCT00678756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886613|NCT00678756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92886614|NCT00678756|Hormone Antagonists|hormone antagonists|mesh-ancestor
92886615|NCT00678756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886616|NCT00678756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886617|NCT00678756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92886618|NCT02748395|Triamcinolone|triamcinolone|mesh-list
92886619|NCT02748395|Lidocaine|lidocaine|mesh-list
92886620|NCT02748395|Anesthetics, Local|anesthetics, local|mesh-ancestor
92886621|NCT02748395|Anesthetics|anesthetics|mesh-ancestor
92886622|NCT02748395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886623|NCT02748395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886624|NCT02748395|Sensory System Agents|sensory system agents|mesh-ancestor
92531979|NCT00389558|Amikacin|amikacin|mesh-list
92886625|NCT02748395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886626|NCT02748395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92886627|NCT02748395|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92886628|NCT02748395|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92886629|NCT02748395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886630|NCT02748395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886631|NCT02748395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886632|NCT02748395|Glucocorticoids|glucocorticoids|mesh-ancestor
92886633|NCT02748395|Hormones|hormones|mesh-ancestor
92886634|NCT02748395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886635|NCT02629224|Gabapentin|gabapentin|mesh-list
92886636|NCT02629224|Analgesics|analgesics|mesh-ancestor
92886637|NCT02629224|Sensory System Agents|sensory system agents|mesh-ancestor
92886638|NCT02629224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886639|NCT02629224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886640|NCT02629224|Anticonvulsants|anticonvulsants|mesh-ancestor
92886641|NCT02629224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92886642|NCT02629224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92886643|NCT02629224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886644|NCT02629224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92886645|NCT02629224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92886646|NCT02629224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92886647|NCT02629224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886648|NCT02629224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886649|NCT02629224|Antimanic Agents|antimanic agents|mesh-ancestor
92886650|NCT00711256|Sunscreening Agents|sunscreening agents|mesh-list
92886651|NCT00711256|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92886652|NCT00711256|Protective Agents|protective agents|mesh-ancestor
92886653|NCT00711256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886654|NCT00711256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92886655|NCT04069234|Clopidogrel|clopidogrel|mesh-list
92886656|NCT04069234|Ticagrelor|ticagrelor|mesh-list
92886657|NCT04069234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92886658|NCT04069234|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92886659|NCT04069234|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92886660|NCT04069234|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92886661|NCT04069234|Purinergic Agents|purinergic agents|mesh-ancestor
92886662|NCT04069234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886663|NCT04069234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886664|NCT04069234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886665|NCT04374773|Dronabinol|dronabinol|mesh-list
92886666|NCT04374773|Hallucinogens|hallucinogens|mesh-ancestor
92886667|NCT04374773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886668|NCT04374773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92886669|NCT04374773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886670|NCT04374773|Analgesics|analgesics|mesh-ancestor
92886671|NCT04374773|Sensory System Agents|sensory system agents|mesh-ancestor
92886672|NCT04374773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886673|NCT04374773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92886674|NCT04374773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92886675|NCT04374773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886676|NCT04374773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886677|NCT04374773|Hormones|hormones|mesh-ancestor
92886678|NCT04374773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92886679|NCT00720538|Thalidomide|thalidomide|mesh-list
92886680|NCT00720538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886681|NCT00720538|Immunologic Factors|immunologic factors|mesh-ancestor
92886682|NCT00720538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886683|NCT00720538|Leprostatic Agents|leprostatic agents|mesh-ancestor
92886684|NCT00720538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886685|NCT00720538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886686|NCT00720538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886687|NCT00720538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92886688|NCT00720538|Growth Substances|growth substances|mesh-ancestor
92886689|NCT00720538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92886690|NCT00720538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886691|NCT00678990|Heparin|heparin|mesh-list
92886692|NCT00678990|Anticoagulants|anticoagulants|mesh-ancestor
92886693|NCT00678990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92886694|NCT00678990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92886695|NCT00678990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886696|NCT00679068|Bosentan|bosentan|mesh-list
92886697|NCT00679068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886698|NCT00679068|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92886699|NCT00679068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886700|NCT00679146|Ketoprofen|ketoprofen|mesh-list
92886701|NCT00679146|Colchicine|colchicine|mesh-list
92886702|NCT00679146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92886703|NCT00679146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886704|NCT00679146|Analgesics|analgesics|mesh-ancestor
92886705|NCT00679146|Sensory System Agents|sensory system agents|mesh-ancestor
92886706|NCT00679146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886707|NCT00679146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886708|NCT00679146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886709|NCT00679146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886710|NCT00679146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92886711|NCT00679146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886712|NCT00679146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886713|NCT00679146|Gout Suppressants|gout suppressants|mesh-ancestor
92886714|NCT00679146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92886715|NCT00679146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92886716|NCT00679146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92886717|NCT00679146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886718|NCT00679224|Ambrisentan|ambrisentan|mesh-list
92886719|NCT00679224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886720|NCT02748005|Fenugreek seed meal|fenugreek seed meal|mesh-list
92886721|NCT02748005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92886722|NCT02748005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886723|NCT00990847|Procaterol|procaterol|mesh-list
92886724|NCT00990847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92886725|NCT00990847|Autonomic Agents|autonomic agents|mesh-ancestor
92886726|NCT00990847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886727|NCT00990847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886728|NCT00990847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92886729|NCT00990847|Respiratory System Agents|respiratory system agents|mesh-ancestor
92886730|NCT00990847|Sympathomimetics|sympathomimetics|mesh-ancestor
92886731|NCT00990847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92886732|NCT00990847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92886733|NCT00990847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92886734|NCT00990847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886735|NCT00990847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886736|NCT00990847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886737|NCT00594516|Tapentadol|tapentadol|mesh-list
92886738|NCT00594516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886739|NCT00594516|Narcotics|narcotics|mesh-ancestor
92886740|NCT00594516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886741|NCT00594516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886742|NCT00594516|Analgesics|analgesics|mesh-ancestor
92886743|NCT00594516|Sensory System Agents|sensory system agents|mesh-ancestor
92886744|NCT00594516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886745|NCT00594516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92886746|NCT00594516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92886747|NCT00594516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886748|NCT00594516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886749|NCT00594516|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886750|NCT00594516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886751|NCT00682500|Calfactant|calfactant|mesh-list
92886752|NCT00682500|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92886753|NCT00682500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92886754|NCT00538291|Capecitabine|capecitabine|mesh-list
92886755|NCT00538291|Cetuximab|cetuximab|mesh-list
92886756|NCT00538291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886757|NCT00538291|Antimetabolites|antimetabolites|mesh-ancestor
92886758|NCT00538291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886759|NCT00538291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886760|NCT00538291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92886761|NCT00682578|Artesunate|artesunate|mesh-list
92886762|NCT00682578|Chloroquine|chloroquine|mesh-list
92886763|NCT00682578|Pyrimethamine|pyrimethamine|mesh-list
92886764|NCT00682578|Piperaquine|piperaquine|mesh-list
92886765|NCT00682578|Artenimol|artenimol|mesh-list
92886766|NCT00682578|Antimalarials|antimalarials|mesh-ancestor
92886767|NCT00682578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92886768|NCT00682578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92886769|NCT00682578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886770|NCT00682578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532124|NCT00051142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92886771|NCT00682578|Antiviral Agents|antiviral agents|mesh-ancestor
92886772|NCT00682578|Schistosomicides|schistosomicides|mesh-ancestor
92886773|NCT00682578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92886774|NCT00682578|Anthelmintics|anthelmintics|mesh-ancestor
92886776|NCT00682578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886777|NCT00682578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92886778|NCT00682578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886779|NCT00682578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886780|NCT00594906|Teriparatide|teriparatide|mesh-list
92886781|NCT00594906|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92886782|NCT00594906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886783|NCT00594906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92886784|NCT02745431|Oxytocin|oxytocin|mesh-list
92886785|NCT02745431|Oxytocics|oxytocics|mesh-ancestor
92886786|NCT02745431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92886787|NCT02745431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886788|NCT00682656|Azithromycin|azithromycin|mesh-list
92886789|NCT00682656|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92886790|NCT00682656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92886791|NCT00682656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886792|NCT00682656|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92886793|NCT00682656|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92886794|NCT05590117|Leucovorin|leucovorin|mesh-list
92886795|NCT05590117|Fluorouracil|fluorouracil|mesh-list
92886796|NCT05590117|Oxaliplatin|oxaliplatin|mesh-list
92886797|NCT05590117|Pentoxifylline|pentoxifylline|mesh-list
92886798|NCT05590117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886799|NCT05590117|Antimetabolites|antimetabolites|mesh-ancestor
92886800|NCT05590117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886801|NCT05590117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886802|NCT05590117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886803|NCT05590117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886804|NCT05590117|Immunologic Factors|immunologic factors|mesh-ancestor
92886805|NCT05590117|Antidotes|antidotes|mesh-ancestor
92886806|NCT05590117|Protective Agents|protective agents|mesh-ancestor
92886807|NCT05590117|Vitamin B Complex|vitamin b complex|mesh-ancestor
92886808|NCT05590117|Vitamins|vitamins|mesh-ancestor
92886809|NCT05590117|Micronutrients|micronutrients|mesh-ancestor
92886810|NCT05590117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92886811|NCT05590117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886812|NCT05590117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92886813|NCT05590117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92886814|NCT05590117|Vasodilator Agents|vasodilator agents|mesh-ancestor
92886815|NCT05590117|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92886816|NCT05590117|Antioxidants|antioxidants|mesh-ancestor
92886817|NCT00636311|Gemcitabine|gemcitabine|mesh-list
92886818|NCT00636311|Bortezomib|bortezomib|mesh-list
92886819|NCT00636311|Vinorelbine|vinorelbine|mesh-list
92886820|NCT00636311|Ifosfamide|ifosfamide|mesh-list
92886821|NCT00636311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886822|NCT00636311|Antimetabolites|antimetabolites|mesh-ancestor
92886823|NCT00636311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886824|NCT00636311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886825|NCT00636311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92886826|NCT00636311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92886827|NCT00636311|Antimitotic Agents|antimitotic agents|mesh-ancestor
92886828|NCT00636311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92886829|NCT00636311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92886830|NCT00636311|Alkylating Agents|alkylating agents|mesh-ancestor
92886831|NCT00679458|Buprenorphine|buprenorphine|mesh-list
92886832|NCT00679458|Naloxone|naloxone|mesh-list
92886833|NCT00679458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886834|NCT00679458|Narcotics|narcotics|mesh-ancestor
92886835|NCT00679458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886836|NCT00679458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886837|NCT00679458|Analgesics|analgesics|mesh-ancestor
92886838|NCT00679458|Sensory System Agents|sensory system agents|mesh-ancestor
92886839|NCT00679458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886840|NCT00679458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92886841|NCT04216511|Autoantibodies|autoantibodies|mesh-list
92886842|NCT04216511|Immunologic Factors|immunologic factors|mesh-ancestor
92886843|NCT04216511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886844|NCT02747537|Irinotecan|irinotecan|mesh-list
92886845|NCT02747537|Sorafenib|sorafenib|mesh-list
92886846|NCT02747537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92886847|NCT02747537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92886848|NCT02747537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886849|NCT02747537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886850|NCT02747537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886851|NCT02747537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92886852|NCT02747381|Alfacalcidol|alfacalcidol|mesh-list
92886853|NCT02747381|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92886854|NCT02747381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92886855|NCT02747381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886857|NCT02747381|Micronutrients|micronutrients|mesh-ancestor
92886858|NCT00673218|Omalizumab|omalizumab|mesh-list
92886859|NCT00673218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92886860|NCT00673218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92886861|NCT00673218|Respiratory System Agents|respiratory system agents|mesh-ancestor
92886862|NCT00673296|Bevacizumab|bevacizumab|mesh-list
92886863|NCT00673296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92886864|NCT00673296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886865|NCT00673296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92886866|NCT00673296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92886867|NCT00673296|Growth Substances|growth substances|mesh-ancestor
92886868|NCT00673296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886869|NCT00673296|Growth Inhibitors|growth inhibitors|mesh-ancestor
92886870|NCT04216355|Azacitidine|azacitidine|mesh-list
92886871|NCT04216355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92886872|NCT04216355|Antimetabolites|antimetabolites|mesh-ancestor
92886873|NCT04216355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886874|NCT04216355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886875|NCT04216355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886876|NCT00683124|Losartan|losartan|mesh-list
92886877|NCT00683124|Nebivolol|nebivolol|mesh-list
92886878|NCT00683124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92886879|NCT00683124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92886880|NCT00683124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92886881|NCT00683124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92886882|NCT00683124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886883|NCT00683124|Vasodilator Agents|vasodilator agents|mesh-ancestor
92886884|NCT00683124|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92886885|NCT00683124|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92886886|NCT00683124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92886887|NCT00683124|Adrenergic Agents|adrenergic agents|mesh-ancestor
92886888|NCT00683124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886889|NCT00683124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886890|NCT02744729|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
92886891|NCT02744729|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92886892|NCT02744729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886893|NCT00683202|Aspirin|aspirin|mesh-list
92886894|NCT00683202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92886895|NCT00683202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886896|NCT00683202|Analgesics|analgesics|mesh-ancestor
92886897|NCT00683202|Sensory System Agents|sensory system agents|mesh-ancestor
92886898|NCT00683202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886899|NCT00683202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886900|NCT00683202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886901|NCT00683202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92886902|NCT00683202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92886903|NCT00683202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92886904|NCT00683202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886905|NCT00683202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92886906|NCT00683202|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92886907|NCT00683202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886908|NCT00683202|Antipyretics|antipyretics|mesh-ancestor
92886909|NCT00679536|Fludarabine|fludarabine|mesh-list
92886910|NCT00679536|Busulfan|busulfan|mesh-list
92886911|NCT00679536|Thymoglobulin|thymoglobulin|mesh-list
92886912|NCT00679536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92886913|NCT00679536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886914|NCT00679536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92886915|NCT00679536|Immunologic Factors|immunologic factors|mesh-ancestor
92886916|NCT00679536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886917|NCT00679536|Alkylating Agents|alkylating agents|mesh-ancestor
92886918|NCT00679536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92886919|NCT00679536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92886920|NCT00537979|Ergocalciferols|ergocalciferols|mesh-list
92886921|NCT00537979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92886922|NCT00537979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886924|NCT00537979|Micronutrients|micronutrients|mesh-ancestor
92886925|NCT00537979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92886926|NCT00679614|Acetaminophen|acetaminophen|mesh-list
92886927|NCT00679614|Tramadol|tramadol|mesh-list
92886928|NCT00679614|Naloxone|naloxone|mesh-list
92886929|NCT00679614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92886930|NCT00679614|Analgesics|analgesics|mesh-ancestor
92886931|NCT00679614|Sensory System Agents|sensory system agents|mesh-ancestor
92886932|NCT00679614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886933|NCT00679614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886934|NCT00679614|Antipyretics|antipyretics|mesh-ancestor
92886935|NCT00679614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886936|NCT00679614|Narcotics|narcotics|mesh-ancestor
92886937|NCT00679614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886938|NCT00679614|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92886939|NCT02744417|Bupropion|bupropion|mesh-list
92886940|NCT02744417|Nicotine|nicotine|mesh-list
92886941|NCT02744417|Varenicline|varenicline|mesh-list
92886942|NCT02744417|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92886943|NCT02744417|Autonomic Agents|autonomic agents|mesh-ancestor
92886944|NCT02744417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886945|NCT02744417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886946|NCT02744417|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92886947|NCT02744417|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92886948|NCT02744417|Cholinergic Agents|cholinergic agents|mesh-ancestor
92886949|NCT02744417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886950|NCT02744417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886951|NCT02744417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92886952|NCT02744417|Antidepressive Agents|antidepressive agents|mesh-ancestor
92886953|NCT02744417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92886954|NCT02744417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92886955|NCT02744417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92886956|NCT02744417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92886957|NCT02744417|Dopamine Agents|dopamine agents|mesh-ancestor
92886958|NCT02744417|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92886959|NCT02744417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92886960|NCT02744417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92886961|NCT02629146|Fentanyl|fentanyl|mesh-list
92886962|NCT02629146|Midazolam|midazolam|mesh-list
92886963|NCT02629146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92886964|NCT02629146|Narcotics|narcotics|mesh-ancestor
92886965|NCT02629146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92886966|NCT02629146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92886967|NCT02629146|Analgesics|analgesics|mesh-ancestor
92886968|NCT02629146|Sensory System Agents|sensory system agents|mesh-ancestor
92886969|NCT02629146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92886970|NCT02629146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92886971|NCT02629146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92886972|NCT02629146|Anesthetics, General|anesthetics, general|mesh-ancestor
92886973|NCT02629146|Anesthetics|anesthetics|mesh-ancestor
92886974|NCT02629146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92886975|NCT02629146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92886976|NCT02629146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92886977|NCT02629146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92886978|NCT02629146|GABA Modulators|gaba modulators|mesh-ancestor
92886979|NCT02629146|GABA Agents|gaba agents|mesh-ancestor
92886980|NCT02629146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92886981|NCT02629146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886982|NCT02744339|Riociguat|riociguat|mesh-list
92886983|NCT02744339|Enzyme Activators|enzyme activators|mesh-ancestor
92886984|NCT02744339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886985|NCT00991159|Bococizumab|bococizumab|mesh-list
92886986|NCT00991159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92886987|NCT00991159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92886988|NCT00991159|Antimetabolites|antimetabolites|mesh-ancestor
92886989|NCT00991159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92886990|NCT00991159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92886991|NCT00679770|Tavaborole|tavaborole|mesh-list
92886992|NCT00679770|Antifungal Agents|antifungal agents|mesh-ancestor
92886993|NCT00679770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92886995|NCT02744495|Droperidol|droperidol|mesh-list
92886996|NCT02744495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92886997|NCT02744495|Glucocorticoids|glucocorticoids|mesh-ancestor
92886998|NCT02744495|Hormones|hormones|mesh-ancestor
92886999|NCT02744495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887000|NCT02744495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532366|NCT00052585|Vitamins|vitamins|mesh-ancestor
92887001|NCT02744495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92887002|NCT02744495|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887003|NCT02744495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92887004|NCT02744495|Antiemetics|antiemetics|mesh-ancestor
92887005|NCT02744495|Autonomic Agents|autonomic agents|mesh-ancestor
92887006|NCT02744495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887007|NCT02744495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887008|NCT02744495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92887009|NCT02744495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92887010|NCT02744495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887011|NCT02744495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92887012|NCT02744495|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92887013|NCT02744495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92887014|NCT02744495|Dopamine Agents|dopamine agents|mesh-ancestor
92887015|NCT02744495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887016|NCT02744495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887017|NCT00683358|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92887018|NCT00683358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92887019|NCT00683358|Immunologic Factors|immunologic factors|mesh-ancestor
92887020|NCT00683358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887021|NCT00683436|Adipiplon|adipiplon|mesh-list
92887022|NCT00683436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887023|NCT00683436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887024|NCT00683436|GABA Agonists|gaba agonists|mesh-ancestor
92887025|NCT00683436|GABA Agents|gaba agents|mesh-ancestor
92887026|NCT00683436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887027|NCT00683436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887028|NCT00683436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92887029|NCT00683436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92887030|NCT00683436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92887031|NCT00989443|Cidofovir|cidofovir|mesh-list
92887032|NCT00989443|Antiviral Agents|antiviral agents|mesh-ancestor
92887033|NCT00989443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887034|NCT00989443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887035|NCT00989443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887036|NCT00683514|Cisplatin|cisplatin|mesh-list
92887037|NCT00683514|Vinorelbine|vinorelbine|mesh-list
92887038|NCT00683514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887039|NCT00683514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887040|NCT00683514|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887041|NCT00683514|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887042|NCT00683514|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887043|NCT00683514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887044|NCT00683670|Cyclophosphamide|cyclophosphamide|mesh-list
92887045|NCT00683670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92887046|NCT00683670|Immunologic Factors|immunologic factors|mesh-ancestor
92887047|NCT00683670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887048|NCT00683670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92887049|NCT00683670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92887050|NCT00683670|Alkylating Agents|alkylating agents|mesh-ancestor
92887051|NCT00683670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887052|NCT00683670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887053|NCT00683670|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92887054|NCT05629325|Buspirone|buspirone|mesh-list
92887055|NCT05629325|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92887056|NCT05629325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92887057|NCT05629325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887058|NCT05629325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887059|NCT05629325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92887060|NCT05629325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92887061|NCT05629325|Serotonin Agents|serotonin agents|mesh-ancestor
92887062|NCT05629325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887063|NCT05629325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887064|NCT02629380|Hyaluronic Acid|hyaluronic acid|mesh-list
92887065|NCT02629380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92887066|NCT02629380|Immunologic Factors|immunologic factors|mesh-ancestor
92525527|NCT00025402|Antimetabolites|antimetabolites|mesh-ancestor
92887067|NCT02629380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887068|NCT02629380|Viscosupplements|viscosupplements|mesh-ancestor
92887069|NCT02629380|Protective Agents|protective agents|mesh-ancestor
92887070|NCT02743247|Mycophenolic Acid|mycophenolic acid|mesh-list
92887071|NCT02743247|Tacrolimus|tacrolimus|mesh-list
92887072|NCT02743247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92887073|NCT02743247|Immunologic Factors|immunologic factors|mesh-ancestor
92887074|NCT02743247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887075|NCT02743247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92887076|NCT02743247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887077|NCT02743247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887078|NCT02743247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92887079|NCT02743247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887080|NCT02743247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92887081|NCT02743247|Antitubercular Agents|antitubercular agents|mesh-ancestor
92887082|NCT02743247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887083|NCT02743247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887084|NCT00680160|Tavaborole|tavaborole|mesh-list
92887085|NCT00680160|Antifungal Agents|antifungal agents|mesh-ancestor
92887086|NCT00680160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887087|NCT00683982|Nitazoxanide|nitazoxanide|mesh-list
92887088|NCT00683982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92887089|NCT00683982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887090|NCT02742623|Rivaroxaban|rivaroxaban|mesh-list
92887091|NCT02742623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92887092|NCT02742623|Antithrombins|antithrombins|mesh-ancestor
92887093|NCT02742623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92887094|NCT02742623|Protease Inhibitors|protease inhibitors|mesh-ancestor
92887095|NCT02742623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887096|NCT02742623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887097|NCT02742623|Anticoagulants|anticoagulants|mesh-ancestor
92887098|NCT00537823|Leucovorin|leucovorin|mesh-list
92887099|NCT00537823|Bevacizumab|bevacizumab|mesh-list
92887100|NCT00537823|Cetuximab|cetuximab|mesh-list
92887101|NCT00537823|Fluorouracil|fluorouracil|mesh-list
92887102|NCT00537823|Oxaliplatin|oxaliplatin|mesh-list
92887103|NCT00537823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92887104|NCT00537823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887105|NCT00537823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92887106|NCT00537823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92887107|NCT00537823|Growth Substances|growth substances|mesh-ancestor
92887108|NCT00537823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887109|NCT00537823|Growth Inhibitors|growth inhibitors|mesh-ancestor
92887110|NCT00537823|Antimetabolites|antimetabolites|mesh-ancestor
92887111|NCT00537823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887112|NCT00537823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92887113|NCT00537823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92887114|NCT00537823|Immunologic Factors|immunologic factors|mesh-ancestor
92887115|NCT00537823|Antidotes|antidotes|mesh-ancestor
92887116|NCT00537823|Protective Agents|protective agents|mesh-ancestor
92887117|NCT00537823|Vitamin B Complex|vitamin b complex|mesh-ancestor
92887118|NCT00537823|Vitamins|vitamins|mesh-ancestor
92887119|NCT00537823|Micronutrients|micronutrients|mesh-ancestor
92887120|NCT04139928|Magnesium citrate|magnesium citrate|mesh-list
92887121|NCT04139928|Magnesium Oxide|magnesium oxide|mesh-list
92887122|NCT04139928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887123|NCT04139928|Cathartics|cathartics|mesh-ancestor
92887124|NCT04139928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887125|NCT04139928|Antacids|antacids|mesh-ancestor
92887126|NCT05589025|Eugenol|eugenol|mesh-list
92887127|NCT05589025|Zinc Oxide|zinc oxide|mesh-list
92887128|NCT05589025|Dermatologic Agents|dermatologic agents|mesh-ancestor
92887129|NCT05589025|Sunscreening Agents|sunscreening agents|mesh-ancestor
92887130|NCT05589025|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92887131|NCT05589025|Protective Agents|protective agents|mesh-ancestor
92887132|NCT05589025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887133|NCT05589025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887134|NCT02742233|Saxagliptin|saxagliptin|mesh-list
92887135|NCT02742233|Incretins|incretins|mesh-ancestor
92887136|NCT02742233|Hormones|hormones|mesh-ancestor
92887137|NCT02742233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887138|NCT02742233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887139|NCT02742233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92887140|NCT02742233|Protease Inhibitors|protease inhibitors|mesh-ancestor
92887141|NCT02742233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887142|NCT02742233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887143|NCT02742233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887144|NCT00673608|Deferasirox|deferasirox|mesh-list
92887145|NCT00673608|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92887146|NCT00673608|Chelating Agents|chelating agents|mesh-ancestor
92887147|NCT00673608|Sequestering Agents|sequestering agents|mesh-ancestor
92887148|NCT00673608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887149|NCT00537277|Insulin Aspart|insulin aspart|mesh-list
92887150|NCT00537277|Biphasic Insulins|biphasic insulins|mesh-list
92887151|NCT00537277|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92887152|NCT00537277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887153|NCT00537277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887154|NCT02742467|Amlodipine|amlodipine|mesh-list
92887155|NCT02742467|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92887156|NCT02742467|Perindopril|perindopril|mesh-list
92887157|NCT02742467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92887158|NCT02742467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92887159|NCT02742467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92887160|NCT02742467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887161|NCT02742467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92887162|NCT02742467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887163|NCT02742467|Vasodilator Agents|vasodilator agents|mesh-ancestor
92887164|NCT02742467|Diuretics|diuretics|mesh-ancestor
92887165|NCT02742467|Natriuretic Agents|natriuretic agents|mesh-ancestor
92887166|NCT02742467|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92887167|NCT02742467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92887168|NCT02742467|Protease Inhibitors|protease inhibitors|mesh-ancestor
92887169|NCT02742467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887171|NCT00684216|Capecitabine|capecitabine|mesh-list
92887172|NCT00684216|Letrozole|letrozole|mesh-list
92887173|NCT00684216|Anastrozole|anastrozole|mesh-list
92887174|NCT00684216|Exemestane|exemestane|mesh-list
92887175|NCT00684216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92887176|NCT00684216|Antimetabolites|antimetabolites|mesh-ancestor
92887177|NCT00684216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887178|NCT00684216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887179|NCT00684216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92887180|NCT00684216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92887181|NCT00684216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887182|NCT00684216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92887183|NCT00684216|Hormone Antagonists|hormone antagonists|mesh-ancestor
92887184|NCT00684216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887185|NCT00684216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887186|NCT00684216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92887187|NCT00684216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92887188|NCT00684216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92887189|NCT00684216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92887190|NCT00684450|Protamines|protamines|mesh-list
92887191|NCT00684450|Heparin Antagonists|heparin antagonists|mesh-ancestor
92887192|NCT00684450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887193|NCT00684450|Coagulants|coagulants|mesh-ancestor
92887194|NCT00684528|Metformin|metformin|mesh-list
92887195|NCT00684528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887196|NCT00684528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887197|NCT00684606|Oxytocin|oxytocin|mesh-list
92887198|NCT00684606|Oxytocics|oxytocics|mesh-ancestor
92887199|NCT00684606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92887200|NCT00684606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887201|NCT00684372|Leflunomide|leflunomide|mesh-list
92887202|NCT00684372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887203|NCT00684372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887204|NCT00684372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92887205|NCT00684372|Immunologic Factors|immunologic factors|mesh-ancestor
92887206|NCT00684372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887207|NCT00673686|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92887208|NCT00673686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92887209|NCT00673686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887210|NCT04334915|Cenicriviroc|cenicriviroc|mesh-list
92887211|NCT04334915|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92887212|NCT04334915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887213|NCT04334915|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92887214|NCT04334915|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92887215|NCT04334915|Antiviral Agents|antiviral agents|mesh-ancestor
92887216|NCT04334915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887217|NCT00991627|Atropine|atropine|mesh-list
92887218|NCT00991627|Ephedrine|ephedrine|mesh-list
92887219|NCT00991627|Pseudoephedrine|pseudoephedrine|mesh-list
92887220|NCT00991627|Morphine|morphine|mesh-list
92887221|NCT00991627|Bupivacaine|bupivacaine|mesh-list
92887222|NCT00991627|Anesthetics, Local|anesthetics, local|mesh-list
92887223|NCT00991627|Anesthetics|anesthetics|mesh-list
92887224|NCT00991627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887225|NCT00991627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887226|NCT00991627|Sensory System Agents|sensory system agents|mesh-ancestor
92887227|NCT00991627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887228|NCT00991627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92887229|NCT00991627|Narcotics|narcotics|mesh-ancestor
92532580|NCT00054106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887230|NCT00991627|Analgesics|analgesics|mesh-ancestor
92887231|NCT00991627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92887232|NCT00991627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92887233|NCT00991627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92887234|NCT00991627|Autonomic Agents|autonomic agents|mesh-ancestor
92887235|NCT00991627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92887236|NCT00991627|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887237|NCT00991627|Mydriatics|mydriatics|mesh-ancestor
92887238|NCT00991627|Parasympatholytics|parasympatholytics|mesh-ancestor
92887239|NCT00991627|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92887240|NCT00991627|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92887241|NCT00991627|Cholinergic Agents|cholinergic agents|mesh-ancestor
92887242|NCT00991627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887243|NCT00991627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887244|NCT00991627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92887245|NCT00991627|Sympathomimetics|sympathomimetics|mesh-ancestor
92887246|NCT00991627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92887247|NCT00991627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92887248|NCT00991627|Nasal Decongestants|nasal decongestants|mesh-ancestor
92887249|NCT03562871|Carboplatin|carboplatin|mesh-list
92887250|NCT03562871|Pembrolizumab|pembrolizumab|mesh-list
92887251|NCT03562871|Pemetrexed|pemetrexed|mesh-list
92887252|NCT03562871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887253|NCT03562871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92887254|NCT03562871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92887255|NCT03562871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887256|NCT03562871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887257|NCT03562871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92887258|NCT03562871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92887259|NCT00690222|Mydriatics|mydriatics|mesh-list
92887260|NCT00690222|Autonomic Agents|autonomic agents|mesh-ancestor
92887261|NCT00690222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887262|NCT00690222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887263|NCT02736071|Celecoxib|celecoxib|mesh-list
92887264|NCT02736071|Tramadol|tramadol|mesh-list
92887265|NCT02736071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92887266|NCT02736071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92887267|NCT02736071|Analgesics|analgesics|mesh-ancestor
92887268|NCT02736071|Sensory System Agents|sensory system agents|mesh-ancestor
92887269|NCT02736071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887270|NCT02736071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887271|NCT02736071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887272|NCT02736071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92887273|NCT02736071|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92887274|NCT02736071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92887275|NCT02736071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887276|NCT02736071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887277|NCT02736071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92887278|NCT02736071|Narcotics|narcotics|mesh-ancestor
92887279|NCT02736071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887280|NCT00690300|Docetaxel|docetaxel|mesh-list
92887281|NCT00690300|Oxaliplatin|oxaliplatin|mesh-list
92887282|NCT00690300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887283|NCT00690300|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887284|NCT00690300|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887285|NCT00690300|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887286|NCT00690300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887287|NCT02741219|Sufentanil|sufentanil|mesh-list
92887288|NCT02741219|Dexmedetomidine|dexmedetomidine|mesh-list
92887289|NCT02741219|Dsuvia|dsuvia|mesh-list
92887290|NCT02741219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92525531|NCT00025441|Dactinomycin|dactinomycin|mesh-list
92887291|NCT02741219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887292|NCT02741219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887293|NCT02741219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92887294|NCT02741219|Analgesics|analgesics|mesh-ancestor
92887295|NCT02741219|Sensory System Agents|sensory system agents|mesh-ancestor
92887296|NCT02741219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887297|NCT02741219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92887298|NCT02741219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92887299|NCT02741219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92887300|NCT02741219|Adrenergic Agents|adrenergic agents|mesh-ancestor
92887301|NCT02741219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887302|NCT02741219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887303|NCT02741219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92887304|NCT02741219|Narcotics|narcotics|mesh-ancestor
92887305|NCT02741219|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92887306|NCT02741219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92887307|NCT02741219|Anesthetics, General|anesthetics, general|mesh-ancestor
92887308|NCT02741219|Anesthetics|anesthetics|mesh-ancestor
92887309|NCT00690534|Insulin|insulin|mesh-list
92887310|NCT00690534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92887311|NCT00690534|Nitroprusside|nitroprusside|mesh-list
92887312|NCT00690534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887313|NCT00690534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887314|NCT00690534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92887315|NCT00690534|Vasodilator Agents|vasodilator agents|mesh-ancestor
92887316|NCT00690534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92887317|NCT00690534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887318|NCT00991705|Atorvastatin|atorvastatin|mesh-list
92887319|NCT00991705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92887320|NCT00991705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92887321|NCT00991705|Antimetabolites|antimetabolites|mesh-ancestor
92887322|NCT00991705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887323|NCT00991705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92887324|NCT00991705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92887325|NCT00991705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887326|NCT02735837|Doxycycline|doxycycline|mesh-list
92887327|NCT02735837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887328|NCT02735837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887329|NCT02735837|Antimalarials|antimalarials|mesh-ancestor
92887330|NCT02735837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92887331|NCT02735837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92887332|NCT02625558|Riociguat|riociguat|mesh-list
92887333|NCT02625558|Enzyme Activators|enzyme activators|mesh-ancestor
92887334|NCT02625558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887335|NCT00685230|Antivenins|antivenins|mesh-list
92887336|NCT00685230|Immunologic Factors|immunologic factors|mesh-ancestor
92887337|NCT00685230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887338|NCT05455879|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92887339|NCT05455879|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887340|NCT00991783|Digoxin|digoxin|mesh-list
92887341|NCT00991783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92887342|NCT00991783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92887343|NCT00991783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887344|NCT00991783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887345|NCT00991783|Protective Agents|protective agents|mesh-ancestor
92887346|NCT00991783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887347|NCT00690768|Bevacizumab|bevacizumab|mesh-list
92887348|NCT00690768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92887349|NCT00690768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887350|NCT00690768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92887351|NCT00690768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92887352|NCT00690768|Growth Substances|growth substances|mesh-ancestor
92887353|NCT00690768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887354|NCT00690768|Growth Inhibitors|growth inhibitors|mesh-ancestor
92887355|NCT00690846|Adalimumab|adalimumab|mesh-list
92887356|NCT00690846|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92887357|NCT00690846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887358|NCT00690846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92887359|NCT04683679|Pembrolizumab|pembrolizumab|mesh-list
92887360|NCT04683679|Olaparib|olaparib|mesh-list
92887361|NCT04683679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92887362|NCT04683679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887363|NCT04683679|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92525533|NCT00025441|Ifosfamide|ifosfamide|mesh-list
92887364|NCT04683679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887365|NCT04683679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92887366|NCT04683679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887367|NCT00685464|Abciximab|abciximab|mesh-list
92887368|NCT00685464|Anticoagulants|anticoagulants|mesh-ancestor
92887369|NCT00685464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92887370|NCT02740829|Glucagon|glucagon|mesh-list
92887371|NCT02740829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887372|NCT02740829|Hormones|hormones|mesh-ancestor
92887373|NCT02740829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887374|NCT02740829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887375|NCT00685542|Diacerein|diacerein|mesh-list
92887376|NCT00685542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887377|NCT02741063|Oxytocin|oxytocin|mesh-list
92532730|NCT00055120|Lopinavir|lopinavir|mesh-list
92887378|NCT02741063|Oxytocics|oxytocics|mesh-ancestor
92887379|NCT02741063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92887380|NCT02741063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887381|NCT04138836|Itraconazole|itraconazole|mesh-list
92887382|NCT04138836|Midazolam|midazolam|mesh-list
92887383|NCT04138836|Esomeprazole|esomeprazole|mesh-list
92887384|NCT04138836|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92887385|NCT04138836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92887386|NCT04138836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887387|NCT04138836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887388|NCT04138836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92887389|NCT04138836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92887390|NCT04138836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92887391|NCT04138836|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92887392|NCT04138836|Anesthetics, General|anesthetics, general|mesh-ancestor
92887393|NCT04138836|Anesthetics|anesthetics|mesh-ancestor
92887394|NCT04138836|GABA Modulators|gaba modulators|mesh-ancestor
92887395|NCT04138836|GABA Agents|gaba agents|mesh-ancestor
92887396|NCT04138836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887397|NCT04138836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887398|NCT04138836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92887399|NCT04138836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887400|NCT04138836|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92887401|NCT04138836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887402|NCT04138836|Antifungal Agents|antifungal agents|mesh-ancestor
92887403|NCT04138836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887404|NCT04138836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92887405|NCT04138836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92887406|NCT04138836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92887407|NCT04138836|Hormone Antagonists|hormone antagonists|mesh-ancestor
92887408|NCT04138836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887409|NCT04138836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92887410|NCT00922584|Sorafenib|sorafenib|mesh-list
92887411|NCT00922584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887412|NCT00922584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92887413|NCT00922584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887414|NCT00922584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887415|NCT02735603|Moxifloxacin|moxifloxacin|mesh-list
92887416|NCT02735603|Naltrexone|naltrexone|mesh-list
92887417|NCT02735603|Bupropion|bupropion|mesh-list
92887418|NCT02735603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887419|NCT02735603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887420|NCT02735603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92887421|NCT02735603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92887422|NCT02735603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887423|NCT02735603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887424|NCT02735603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887425|NCT02735603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887426|NCT02735603|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92887427|NCT02735603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92887428|NCT02735603|Sensory System Agents|sensory system agents|mesh-ancestor
92887429|NCT02735603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160419|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
92887430|NCT02735603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92887431|NCT02735603|Antidepressive Agents|antidepressive agents|mesh-ancestor
92887432|NCT02735603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92887433|NCT02735603|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92887434|NCT02735603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92887435|NCT02735603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92887437|NCT02735603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887438|NCT02735603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92887439|NCT02735603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92887440|NCT00685776|Anacetrapib|anacetrapib|mesh-list
92887441|NCT00685776|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92887442|NCT00685776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92887443|NCT00685776|Antimetabolites|antimetabolites|mesh-ancestor
92887444|NCT00685776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887445|NCT00685776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92887446|NCT00685854|Ranibizumab|ranibizumab|mesh-list
92887447|NCT00685854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92887448|NCT00685854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92887449|NCT00685854|Growth Substances|growth substances|mesh-ancestor
92887450|NCT00685854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887451|NCT00685854|Growth Inhibitors|growth inhibitors|mesh-ancestor
92887452|NCT00685854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887453|NCT04138368|Psychotropic Drugs|psychotropic drugs|mesh-list
92887454|NCT04138290|Antidepressive Agents|antidepressive agents|mesh-list
92532803|NCT00055549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92887455|NCT04138290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92887457|NCT04003207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887458|NCT04003207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887459|NCT04582435|Insulin|insulin|mesh-list
92887460|NCT04582435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887461|NCT04582435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887462|NCT05295355|Bromides|bromides|mesh-list
92887463|NCT05295355|Tiotropium Bromide|tiotropium bromide|mesh-list
92887464|NCT05295355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92887465|NCT05295355|Autonomic Agents|autonomic agents|mesh-ancestor
92887466|NCT05295355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887467|NCT05295355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887468|NCT05295355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92887469|NCT05295355|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887470|NCT05295355|Parasympatholytics|parasympatholytics|mesh-ancestor
92887471|NCT05295355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92887472|NCT05295355|Cholinergic Agents|cholinergic agents|mesh-ancestor
92887473|NCT05295355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887474|NCT05295355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887475|NCT05295355|Anticonvulsants|anticonvulsants|mesh-ancestor
92887476|NCT01564303|Acetylcysteine|acetylcysteine|mesh-list
92887477|NCT01564303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92887478|NCT01564303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92887479|NCT01564303|Antiviral Agents|antiviral agents|mesh-ancestor
92887480|NCT01564303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887481|NCT01564303|Expectorants|expectorants|mesh-ancestor
92887482|NCT01564303|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887483|NCT01564303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92887484|NCT01564303|Antioxidants|antioxidants|mesh-ancestor
92887485|NCT01564303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887486|NCT01564303|Protective Agents|protective agents|mesh-ancestor
92887487|NCT01564303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887488|NCT01564303|Antidotes|antidotes|mesh-ancestor
92887489|NCT01564303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92887490|NCT01564303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887491|NCT00674232|Misoprostol|misoprostol|mesh-list
92887492|NCT00674232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92887493|NCT00674232|Abortifacient Agents|abortifacient agents|mesh-ancestor
92887494|NCT00674232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92887495|NCT00674232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887496|NCT00674232|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92887497|NCT00674232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887498|NCT00674232|Oxytocics|oxytocics|mesh-ancestor
92887499|NCT00674310|Ropinirole|ropinirole|mesh-list
92887500|NCT00674310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92887501|NCT00674310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92887502|NCT00674310|Dopamine Agonists|dopamine agonists|mesh-ancestor
92887503|NCT00674310|Dopamine Agents|dopamine agents|mesh-ancestor
92887504|NCT00674310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887505|NCT00674310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887506|NCT00674310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887507|NCT00686010|Dalcetrapib|dalcetrapib|mesh-list
92887508|NCT00686010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92887509|NCT00686010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92887511|NCT00686010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887512|NCT00686010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92887513|NCT05265247|Esomeprazole|esomeprazole|mesh-list
92887514|NCT05265247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92887515|NCT05265247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887516|NCT05265247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92887517|NCT05265247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887518|NCT05265247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887519|NCT03823300|Aflibercept|aflibercept|mesh-list
92887520|NCT03823300|Faricimab|faricimab|mesh-list
92887521|NCT03823300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92887522|NCT03823300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92887523|NCT03823300|Growth Substances|growth substances|mesh-ancestor
92887524|NCT03823300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887525|NCT03823300|Growth Inhibitors|growth inhibitors|mesh-ancestor
92887526|NCT03823300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887527|NCT00537745|Naltrexone|naltrexone|mesh-list
92887528|NCT00537745|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92887529|NCT00537745|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92887530|NCT00537745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887531|NCT00537745|Sensory System Agents|sensory system agents|mesh-ancestor
92887532|NCT00537745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887533|NCT00686322|Paclitaxel|paclitaxel|mesh-list
92887534|NCT00686322|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92887535|NCT00686322|Cisplatin|cisplatin|mesh-list
92887536|NCT00686322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887537|NCT00686322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887538|NCT00686322|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887539|NCT00686322|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887540|NCT00686322|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887541|NCT00686322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887542|NCT02734511|Propofol|propofol|mesh-list
92887543|NCT02734511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92887544|NCT02734511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887545|NCT02734511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887546|NCT02734511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92887547|NCT02734511|Anesthetics, General|anesthetics, general|mesh-ancestor
92887548|NCT02734511|Anesthetics|anesthetics|mesh-ancestor
92887549|NCT04003441|Fexuprazan|fexuprazan|mesh-list
92887550|NCT04003441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887551|NCT02739815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92887552|NCT02739815|Tranexamic Acid|tranexamic acid|mesh-list
92887553|NCT02739815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887554|NCT02739815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92887555|NCT02739815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92887556|NCT02739815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887557|NCT02739815|Hemostatics|hemostatics|mesh-ancestor
92887558|NCT02739815|Coagulants|coagulants|mesh-ancestor
92887559|NCT00720616|Insulin|insulin|mesh-list
92887560|NCT00720616|Hormones|hormones|mesh-list
92887561|NCT00720616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887562|NCT00720616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887563|NCT00720616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887564|NCT00720772|Sodium thiosulfate|sodium thiosulfate|mesh-list
92887565|NCT00720772|Antidotes|antidotes|mesh-ancestor
92887566|NCT00720772|Protective Agents|protective agents|mesh-ancestor
92887567|NCT00720772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887568|NCT00720772|Antioxidants|antioxidants|mesh-ancestor
92887569|NCT00720772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887570|NCT00720772|Antitubercular Agents|antitubercular agents|mesh-ancestor
92887571|NCT00720772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887572|NCT00720772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887573|NCT00720772|Chelating Agents|chelating agents|mesh-ancestor
92887574|NCT00720772|Sequestering Agents|sequestering agents|mesh-ancestor
92887575|NCT00720850|Lenalidomide|lenalidomide|mesh-list
92887576|NCT00720850|Immunologic Factors|immunologic factors|mesh-ancestor
92887577|NCT00720850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887578|NCT00720850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92887579|NCT00720850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92887580|NCT00720850|Growth Substances|growth substances|mesh-ancestor
92887581|NCT00720850|Growth Inhibitors|growth inhibitors|mesh-ancestor
92887582|NCT00720850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887583|NCT03785158|Melatonin|melatonin|mesh-list
92887584|NCT03785158|Antioxidants|antioxidants|mesh-ancestor
92887585|NCT03785158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887587|NCT03785158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887588|NCT03785158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887589|NCT02739581|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92887590|NCT02739581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92887591|NCT02739581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92887592|NCT02739581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887593|NCT02739581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887594|NCT02739581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887595|NCT02733809|Sorafenib|sorafenib|mesh-list
92887596|NCT02733809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887597|NCT02733809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92887598|NCT02733809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887599|NCT02733809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887600|NCT00717340|Paclitaxel|paclitaxel|mesh-list
92887601|NCT00717340|Tivozanib|tivozanib|mesh-list
92887602|NCT00717340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887603|NCT00717340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887604|NCT00717340|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887605|NCT00717340|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887606|NCT00717340|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887607|NCT00717340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887609|NCT00717340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887610|NCT02733887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92887611|NCT02733887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92887612|NCT02733887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887613|NCT00874848|Paclitaxel|paclitaxel|mesh-list
92887614|NCT00874848|Carboplatin|carboplatin|mesh-list
92887615|NCT00874848|Cetuximab|cetuximab|mesh-list
92887616|NCT00874848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92887617|NCT00874848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887618|NCT00874848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887619|NCT00874848|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887620|NCT00874848|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887621|NCT00874848|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887622|NCT00874848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887623|NCT00874848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92887624|NCT00691236|Zoledronic Acid|zoledronic acid|mesh-list
92887625|NCT00691236|Doxorubicin|doxorubicin|mesh-list
92887626|NCT00691236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92887627|NCT00691236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887628|NCT00691236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92887629|NCT00691236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92887630|NCT00691236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887631|NCT00691236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887632|NCT00691236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92887633|NCT00691236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887634|NCT04137978|Potassium Citrate|potassium citrate|mesh-list
92887635|NCT04137978|Diuretics|diuretics|mesh-ancestor
92887636|NCT04137978|Natriuretic Agents|natriuretic agents|mesh-ancestor
92887637|NCT04137978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887638|NCT04137978|Expectorants|expectorants|mesh-ancestor
92887639|NCT04137978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887640|NCT00691392|Linezolid|linezolid|mesh-list
92887641|NCT00691392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887642|NCT00691392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887643|NCT00691392|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92887644|NCT00691392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887645|NCT00691392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887646|NCT02625168|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92887647|NCT02625168|Afatinib|afatinib|mesh-list
92887648|NCT02625168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887649|NCT02625168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92887650|NCT02625168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887651|NCT02625168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887652|NCT00717730|Vitamins|vitamins|mesh-list
92887653|NCT00717730|Folic Acid|folic acid|mesh-list
92887654|NCT00717730|Hydroxocobalamin|hydroxocobalamin|mesh-list
92887655|NCT00717730|Vitamin B 12|vitamin b 12|mesh-list
92887656|NCT00717730|Vitamin B Complex|vitamin b complex|mesh-list
92887657|NCT00717730|Micronutrients|micronutrients|mesh-ancestor
92887658|NCT00717730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887659|NCT00717730|Hematinics|hematinics|mesh-ancestor
92887660|NCT00691470|Warfarin|warfarin|mesh-list
92887661|NCT00691470|Anticoagulants|anticoagulants|mesh-ancestor
92887663|NCT05407597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92887664|NCT05407597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92887665|NCT05407597|Analgesics|analgesics|mesh-ancestor
92887666|NCT05407597|Sensory System Agents|sensory system agents|mesh-ancestor
92887667|NCT05407597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887668|NCT05407597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887669|NCT05407597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887670|NCT05407597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92887671|NCT05407597|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92887672|NCT05407597|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92887673|NCT05407597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887674|NCT05407597|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92887675|NCT05407597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92887676|NCT05407597|Immunologic Factors|immunologic factors|mesh-ancestor
92887677|NCT05407207|Immunologic Factors|immunologic factors|mesh-list
92887678|NCT05407207|Immunomodulating Agents|immunomodulating agents|mesh-list
92887679|NCT05407207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887680|NCT05493995|Paclitaxel|paclitaxel|mesh-list
92887681|NCT05493995|Gemcitabine|gemcitabine|mesh-list
92887682|NCT05493995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887683|NCT05493995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887684|NCT05493995|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887685|NCT05493995|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887686|NCT05493995|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887687|NCT05493995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887688|NCT05493995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92887689|NCT05493995|Antimetabolites|antimetabolites|mesh-ancestor
92887690|NCT00717808|Tranilast|tranilast|mesh-list
92887691|NCT00717808|Anthranilic acid|anthranilic acid|mesh-list
92887692|NCT00717808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92887693|NCT00717808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92887694|NCT00717808|Analgesics|analgesics|mesh-ancestor
92887695|NCT00717808|Sensory System Agents|sensory system agents|mesh-ancestor
92887696|NCT00717808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887697|NCT00717808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887698|NCT00717808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887699|NCT00717808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92887700|NCT00717808|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92887701|NCT00717808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92887702|NCT00717808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887703|NCT00717808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92887704|NCT00717808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92887705|NCT00717808|Histamine Antagonists|histamine antagonists|mesh-ancestor
92887706|NCT00717808|Histamine Agents|histamine agents|mesh-ancestor
92887707|NCT00717808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887708|NCT00717808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92887709|NCT00717808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92887710|NCT00717808|Anticonvulsants|anticonvulsants|mesh-ancestor
92887711|NCT02738177|Isosorbide|isosorbide|mesh-list
92887712|NCT02738177|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92887713|NCT02738177|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92887714|NCT02738177|Misoprostol|misoprostol|mesh-list
92887715|NCT02738177|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92887716|NCT02738177|Abortifacient Agents|abortifacient agents|mesh-ancestor
92887717|NCT02738177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92887718|NCT02738177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887719|NCT02738177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92887720|NCT02738177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887721|NCT02738177|Oxytocics|oxytocics|mesh-ancestor
92887722|NCT02738177|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92887723|NCT02738177|Diuretics|diuretics|mesh-ancestor
92887724|NCT02738177|Natriuretic Agents|natriuretic agents|mesh-ancestor
92887725|NCT02738177|Vasodilator Agents|vasodilator agents|mesh-ancestor
92887726|NCT02738177|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92887727|NCT02738177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887728|NCT04043806|Ivacaftor|ivacaftor|mesh-list
92887729|NCT04043806|Elexacaftor|elexacaftor|mesh-list
92887730|NCT04043806|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92887731|NCT04043806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92887732|NCT04043806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887733|NCT02737943|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92887734|NCT02737943|Analgesics|analgesics|mesh-list
92887735|NCT02737943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887737|NCT02737943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887738|NCT02737943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887739|NCT05290753|Erythromycin|erythromycin|mesh-list
92887740|NCT05290753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887741|NCT05290753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887742|NCT05290753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887743|NCT05290753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92887744|NCT05290753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887745|NCT05290753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887746|NCT02737709|Paclitaxel|paclitaxel|mesh-list
92887747|NCT02737709|Carboplatin|carboplatin|mesh-list
92887748|NCT02737709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887749|NCT02737709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887750|NCT02737709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887751|NCT02737709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887752|NCT02737709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887753|NCT02737709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887754|NCT02572960|Vitamin D|vitamin d|mesh-list
92887755|NCT02572960|Cholecalciferol|cholecalciferol|mesh-list
92533109|NCT00057928|Antimetabolites|antimetabolites|mesh-ancestor
92887757|NCT02572960|Vitamins|vitamins|mesh-ancestor
92887758|NCT02572960|Micronutrients|micronutrients|mesh-ancestor
92887759|NCT02572960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887760|NCT02572960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92887761|NCT02572960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92887762|NCT02572960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92887763|NCT02572960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92887764|NCT02572960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92887765|NCT02572960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887766|NCT04001959|Fluorides|fluorides|mesh-list
92887767|NCT04001959|Cariostatic Agents|cariostatic agents|mesh-ancestor
92887768|NCT04001959|Protective Agents|protective agents|mesh-ancestor
92887769|NCT04001959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887770|NCT00721240|Montelukast|montelukast|mesh-list
92887771|NCT00721240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92887772|NCT00721240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887773|NCT00721240|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92887774|NCT00721240|Hormone Antagonists|hormone antagonists|mesh-ancestor
92887775|NCT00721240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887776|NCT00721240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887777|NCT00721240|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92887778|NCT00721240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92887779|NCT00721240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887780|NCT02737319|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92887781|NCT02737319|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92887782|NCT02737319|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92887783|NCT02737319|Antimetabolites|antimetabolites|mesh-ancestor
92887784|NCT02737319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887785|NCT02737319|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92887786|NCT02737319|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92887787|NCT02737319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887788|NCT00721552|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92887789|NCT00721552|Prednisolone|prednisolone|mesh-list
92887790|NCT00721552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92887791|NCT00721552|Methylprednisolone|methylprednisolone|mesh-list
92887792|NCT00721552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92887793|NCT00721552|Prednisolone acetate|prednisolone acetate|mesh-list
92887794|NCT00721552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92887795|NCT00721552|Prednisolone phosphate|prednisolone phosphate|mesh-list
92887796|NCT00721552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887797|NCT00721552|Glucocorticoids|glucocorticoids|mesh-ancestor
92887798|NCT00721552|Hormones|hormones|mesh-ancestor
92887799|NCT00721552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887800|NCT00721552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887801|NCT00721552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92887802|NCT00721552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887803|NCT00721552|Antiemetics|antiemetics|mesh-ancestor
92887804|NCT00721552|Autonomic Agents|autonomic agents|mesh-ancestor
92887805|NCT00721552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887806|NCT00721552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887807|NCT00721552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92887808|NCT00721552|Protective Agents|protective agents|mesh-ancestor
92887809|NCT00721552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92887810|NCT00721552|Incretins|incretins|mesh-ancestor
92887811|NCT00721552|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92887812|NCT00721552|Protease Inhibitors|protease inhibitors|mesh-ancestor
92887813|NCT00721552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887814|NCT00721552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887815|NCT04069078|Scopolamine|scopolamine|mesh-list
92887816|NCT04069078|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92887817|NCT04069078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92887818|NCT04069078|Antiemetics|antiemetics|mesh-ancestor
92887819|NCT04069078|Autonomic Agents|autonomic agents|mesh-ancestor
92887820|NCT04069078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887821|NCT04069078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887822|NCT04069078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887823|NCT04069078|Mydriatics|mydriatics|mesh-ancestor
92887824|NCT04069078|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92887825|NCT04069078|Cholinergic Agents|cholinergic agents|mesh-ancestor
92887826|NCT04069078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887827|NCT04069078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533182|NCT00058201|Vitamins|vitamins|mesh-ancestor
92887828|NCT04069078|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92887829|NCT04069078|Parasympatholytics|parasympatholytics|mesh-ancestor
92887830|NCT02732249|Metronidazole|metronidazole|mesh-list
92887831|NCT02732249|Clarithromycin|clarithromycin|mesh-list
92887832|NCT02732249|Potassium Citrate|potassium citrate|mesh-list
92887833|NCT02732249|Esomeprazole|esomeprazole|mesh-list
92887834|NCT02732249|Bismuth|bismuth|mesh-list
92887835|NCT02732249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887836|NCT02732249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887837|NCT02732249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92887838|NCT02732249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92887839|NCT02732249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92887840|NCT02732249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92887841|NCT02732249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887842|NCT02732249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92887843|NCT02732249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887844|NCT02732249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92887845|NCT02732249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92887846|NCT02732249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92887847|NCT02732249|Antacids|antacids|mesh-ancestor
92887848|NCT02732249|Diuretics|diuretics|mesh-ancestor
92887849|NCT02732249|Natriuretic Agents|natriuretic agents|mesh-ancestor
92887850|NCT02732249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887851|NCT02732249|Expectorants|expectorants|mesh-ancestor
92887852|NCT02732249|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887853|NCT04561063|Sofosbuvir|sofosbuvir|mesh-list
92887854|NCT04561063|Nitazoxanide|nitazoxanide|mesh-list
92887855|NCT04561063|Antiviral Agents|antiviral agents|mesh-ancestor
92887856|NCT04561063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92887857|NCT04561063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92887858|NCT02732093|Lidocaine|lidocaine|mesh-list
92887859|NCT02732093|Anesthetics, Local|anesthetics, local|mesh-ancestor
92887860|NCT02732093|Anesthetics|anesthetics|mesh-ancestor
92887861|NCT02732093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887862|NCT02732093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887863|NCT02732093|Sensory System Agents|sensory system agents|mesh-ancestor
92887864|NCT02732093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887865|NCT02732093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92887866|NCT02732093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92887867|NCT02732093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92887868|NCT02732093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92887869|NCT02732093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887870|NCT00718276|Vitamin D|vitamin d|mesh-list
92887871|NCT00718276|Cholecalciferol|cholecalciferol|mesh-list
92887872|NCT00718276|Vitamins|vitamins|mesh-ancestor
92887873|NCT00718276|Micronutrients|micronutrients|mesh-ancestor
92887874|NCT00718276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887875|NCT00718276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92887876|NCT00718276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92887877|NCT00718354|Cisplatin|cisplatin|mesh-list
92887878|NCT00718354|Carboplatin|carboplatin|mesh-list
92887879|NCT00718354|Fluorouracil|fluorouracil|mesh-list
92887880|NCT00718354|Capecitabine|capecitabine|mesh-list
92887881|NCT00718354|Oxaliplatin|oxaliplatin|mesh-list
92887882|NCT00718354|Epirubicin|epirubicin|mesh-list
92887883|NCT00718354|Enoxaparin|enoxaparin|mesh-list
92887884|NCT00718354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887885|NCT00718354|Antimetabolites|antimetabolites|mesh-ancestor
92887886|NCT00718354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887887|NCT00718354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92887888|NCT00718354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92887889|NCT00718354|Immunologic Factors|immunologic factors|mesh-ancestor
92887890|NCT00718354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887891|NCT00718354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92887892|NCT00718354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92887893|NCT00718354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92887894|NCT00718354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887895|NCT00718354|Anticoagulants|anticoagulants|mesh-ancestor
92887896|NCT00718354|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92887897|NCT00718354|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92887898|NCT00536809|Capecitabine|capecitabine|mesh-list
92887899|NCT00536809|Oxaliplatin|oxaliplatin|mesh-list
92887900|NCT00536809|Lapatinib|lapatinib|mesh-list
92887901|NCT00536809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92887902|NCT00536809|Antimetabolites|antimetabolites|mesh-ancestor
92887903|NCT00536809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887904|NCT00536809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887905|NCT00536809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92887906|NCT00536809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887907|NCT04189601|Complement System Proteins|complement system proteins|mesh-list
92887908|NCT04189601|Immunologic Factors|immunologic factors|mesh-ancestor
92887909|NCT04189601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887910|NCT04067986|Apatinib|apatinib|mesh-list
92887911|NCT04067986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887912|NCT04067986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92887913|NCT04067986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887914|NCT04067986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887915|NCT00536731|Budesonide|budesonide|mesh-list
92887916|NCT00536731|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92887917|NCT00536731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92887918|NCT00536731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92887919|NCT00536731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92887920|NCT00536731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92887921|NCT00536731|Autonomic Agents|autonomic agents|mesh-ancestor
92887922|NCT00536731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92887923|NCT00536731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887924|NCT00536731|Glucocorticoids|glucocorticoids|mesh-ancestor
92887925|NCT00536731|Hormones|hormones|mesh-ancestor
92887926|NCT00536731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92887927|NCT02571712|Timolol|timolol|mesh-list
92887928|NCT02571712|Bimatoprost|bimatoprost|mesh-list
92887929|NCT02571712|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92887930|NCT02571712|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92887931|NCT02571712|Adrenergic Agents|adrenergic agents|mesh-ancestor
92887932|NCT02571712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887933|NCT02571712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887934|NCT02571712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887935|NCT02571712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92887936|NCT02571712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92887937|NCT02730845|Dexmedetomidine|dexmedetomidine|mesh-list
92887938|NCT02730845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92887939|NCT02730845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92887940|NCT02730845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887941|NCT02730845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92887942|NCT02730845|Analgesics|analgesics|mesh-ancestor
92887943|NCT02730845|Sensory System Agents|sensory system agents|mesh-ancestor
92887944|NCT02730845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160439|NCT01114581|Guaifenesin|guaifenesin|mesh-list
92887945|NCT02730845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92887946|NCT02730845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92887947|NCT02730845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92887948|NCT02730845|Adrenergic Agents|adrenergic agents|mesh-ancestor
92887949|NCT02730845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92887950|NCT02730845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887951|NCT02730689|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92887952|NCT02730689|Ezetimibe|ezetimibe|mesh-list
92887953|NCT02730689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92887954|NCT02730689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92887955|NCT02730689|Antimetabolites|antimetabolites|mesh-ancestor
92887956|NCT02730689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887957|NCT02730689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92887958|NCT02730689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92887959|NCT02730689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887960|NCT03579316|Olaparib|olaparib|mesh-list
92887961|NCT03579316|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92887962|NCT03579316|Adavosertib|adavosertib|mesh-list
92887963|NCT03579316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887964|NCT03579316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887965|NCT03579316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887966|NCT02730533|Esomeprazole|esomeprazole|mesh-list
92887967|NCT02730533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92887968|NCT02730533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92887969|NCT02730533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92887970|NCT02730533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887971|NCT02730533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887972|NCT00536575|Bortezomib|bortezomib|mesh-list
92887973|NCT00536575|Sorafenib|sorafenib|mesh-list
92887974|NCT00536575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887975|NCT00536575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92887976|NCT00536575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92887977|NCT00536575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887978|NCT00712114|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92533333|NCT00059800|Boron|boron|mesh-list
92887979|NCT00712114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92887980|NCT00712114|Immunologic Factors|immunologic factors|mesh-ancestor
92887981|NCT00712114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887982|NCT03214250|Paclitaxel|paclitaxel|mesh-list
92887983|NCT03214250|Gemcitabine|gemcitabine|mesh-list
92887984|NCT03214250|Nivolumab|nivolumab|mesh-list
92887985|NCT03214250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92887986|NCT03214250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92887987|NCT03214250|Tubulin Modulators|tubulin modulators|mesh-ancestor
92887988|NCT03214250|Antimitotic Agents|antimitotic agents|mesh-ancestor
92887989|NCT03214250|Mitosis Modulators|mitosis modulators|mesh-ancestor
92887990|NCT03214250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92887991|NCT03214250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92887992|NCT03214250|Antimetabolites|antimetabolites|mesh-ancestor
92887993|NCT03214250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92887994|NCT03214250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92887995|NCT00722098|Cyclophosphamide|cyclophosphamide|mesh-list
92887996|NCT00722098|Vaccines|vaccines|mesh-list
92887997|NCT00722098|Immunologic Factors|immunologic factors|mesh-ancestor
92887998|NCT00722098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92887999|NCT00722098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888000|NCT00722098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888001|NCT00722098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92888002|NCT00722098|Alkylating Agents|alkylating agents|mesh-ancestor
92888003|NCT00722098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888004|NCT00722098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888005|NCT00722098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92888006|NCT04186871|Abatacept|abatacept|mesh-list
92888007|NCT04186871|Branebrutinib|branebrutinib|mesh-list
92888008|NCT04186871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92888009|NCT04186871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888010|NCT04186871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888011|NCT04186871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888012|NCT04186871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888013|NCT04186871|Immunologic Factors|immunologic factors|mesh-ancestor
92888014|NCT04186871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888015|NCT04186871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888016|NCT04186871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92888017|NCT04186871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888018|NCT05245591|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
92888019|NCT05245591|Anticoagulants|anticoagulants|mesh-ancestor
92888020|NCT00992095|Buprenorphine|buprenorphine|mesh-list
92888021|NCT00992095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92888022|NCT00992095|Narcotics|narcotics|mesh-ancestor
92888023|NCT00992095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888024|NCT00992095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888025|NCT00992095|Analgesics|analgesics|mesh-ancestor
92888026|NCT00992095|Sensory System Agents|sensory system agents|mesh-ancestor
92888027|NCT00992095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888028|NCT00992095|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92888029|NCT00653354|Valdecoxib|valdecoxib|mesh-list
92888030|NCT00653354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92888031|NCT00653354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92888032|NCT00653354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888033|NCT00653354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888034|NCT00653354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92888035|NCT00653354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888036|NCT00653354|Analgesics|analgesics|mesh-ancestor
92888037|NCT00653354|Sensory System Agents|sensory system agents|mesh-ancestor
92888038|NCT00653354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888039|NCT00653354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888040|NCT00653354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888041|NCT00653354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888042|NCT00712504|Docetaxel|docetaxel|mesh-list
92888043|NCT00712504|Sunitinib|sunitinib|mesh-list
92888044|NCT00712504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888045|NCT00712504|Tubulin Modulators|tubulin modulators|mesh-ancestor
92888046|NCT00712504|Antimitotic Agents|antimitotic agents|mesh-ancestor
92888047|NCT00712504|Mitosis Modulators|mitosis modulators|mesh-ancestor
92888048|NCT00712504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888049|NCT00712504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92888050|NCT00712504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92888051|NCT00712504|Growth Substances|growth substances|mesh-ancestor
92888052|NCT00712504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888053|NCT00712504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92888054|NCT00712504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92888055|NCT00712504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888057|NCT00653510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92888058|NCT00653510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92888059|NCT00653510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888060|NCT02694653|Acetaminophen|acetaminophen|mesh-list
92888061|NCT02694653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888062|NCT02694653|Analgesics|analgesics|mesh-ancestor
92888063|NCT02694653|Sensory System Agents|sensory system agents|mesh-ancestor
92888064|NCT02694653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888065|NCT02694653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888066|NCT02694653|Antipyretics|antipyretics|mesh-ancestor
92888067|NCT00722956|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92888068|NCT00722956|Atorvastatin|atorvastatin|mesh-list
92888069|NCT00722956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92888070|NCT00722956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92888071|NCT00722956|Antimetabolites|antimetabolites|mesh-ancestor
92888072|NCT00722956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888073|NCT00722956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92888074|NCT00722956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92888075|NCT00722956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888076|NCT00722956|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92888077|NCT00722956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92888078|NCT00722956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92888079|NCT00722956|Antiviral Agents|antiviral agents|mesh-ancestor
92888080|NCT00722956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888081|NCT00992173|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92888082|NCT00992173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888083|NCT00992173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888084|NCT00992173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888085|NCT00992173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92888086|NCT02729285|Ketorolac|ketorolac|mesh-list
92888087|NCT02729285|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92888088|NCT02729285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92888089|NCT02729285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888090|NCT02729285|Analgesics|analgesics|mesh-ancestor
92888091|NCT02729285|Sensory System Agents|sensory system agents|mesh-ancestor
92888092|NCT02729285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888093|NCT02729285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888094|NCT02729285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888095|NCT02729285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888096|NCT02729285|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92888097|NCT02729285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888098|NCT02729285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888099|NCT00722176|Risperidone|risperidone|mesh-list
92888100|NCT00722176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92888101|NCT00722176|Serotonin Agents|serotonin agents|mesh-ancestor
92888102|NCT00722176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888103|NCT00722176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888104|NCT00722176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888105|NCT00722176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92888106|NCT00722176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92888107|NCT00722176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888108|NCT00722176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92888109|NCT00722176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92888110|NCT00722176|Dopamine Agents|dopamine agents|mesh-ancestor
92888111|NCT02729441|Ramipril|ramipril|mesh-list
92888112|NCT02729441|Perindopril|perindopril|mesh-list
92888113|NCT02729441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92888114|NCT02729441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92888115|NCT02729441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888116|NCT02729441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888117|NCT02729441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92888118|NCT04181333|Trastuzumab|trastuzumab|mesh-list
92888119|NCT04181333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888120|NCT04181333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888121|NCT00712660|Antipsychotic Agents|antipsychotic agents|mesh-list
92888122|NCT00712660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92888123|NCT00712660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888124|NCT00712660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888125|NCT00712660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92888126|NCT00636545|Oblimersen|oblimersen|mesh-list
92888127|NCT00636545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888128|NCT00722488|Pevonedistat|pevonedistat|mesh-list
92888129|NCT00722488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888130|NCT00722488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888131|NCT00652106|Timolol|timolol|mesh-list
92888132|NCT00652106|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92888133|NCT00652106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92888134|NCT00652106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92888135|NCT00652106|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92888136|NCT00652106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92888137|NCT00652106|Adrenergic Agents|adrenergic agents|mesh-ancestor
92888138|NCT00652106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888139|NCT00652106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888140|NCT00652106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888141|NCT00652106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92888142|NCT00652106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92888143|NCT00652106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92888144|NCT00652106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92888145|NCT00652106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92888146|NCT00723268|Prednisolone|prednisolone|mesh-list
92888147|NCT00723268|Colchicine|colchicine|mesh-list
92888148|NCT00723268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888149|NCT00723268|Glucocorticoids|glucocorticoids|mesh-ancestor
92888150|NCT00723268|Hormones|hormones|mesh-ancestor
92888151|NCT00723268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888152|NCT00723268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888153|NCT00723268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888154|NCT00723268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888155|NCT00723268|Gout Suppressants|gout suppressants|mesh-ancestor
92888156|NCT00723268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888157|NCT00723268|Tubulin Modulators|tubulin modulators|mesh-ancestor
92888158|NCT00723268|Antimitotic Agents|antimitotic agents|mesh-ancestor
92888159|NCT00723268|Mitosis Modulators|mitosis modulators|mesh-ancestor
92888160|NCT00723268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888161|NCT00874770|Ribavirin|ribavirin|mesh-list
92888162|NCT00874770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92888163|NCT00874770|Antimetabolites|antimetabolites|mesh-ancestor
92888164|NCT00874770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888165|NCT00874770|Antiviral Agents|antiviral agents|mesh-ancestor
92888166|NCT00874770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888167|NCT00536263|Interferons|interferons|mesh-list
92888168|NCT00536263|Interferon-alpha|interferon-alpha|mesh-list
92888169|NCT00536263|Interferon alpha-2|interferon alpha-2|mesh-list
92888170|NCT00536263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92888171|NCT00536263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888172|NCT00536263|Antiviral Agents|antiviral agents|mesh-ancestor
92888173|NCT00536263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888174|NCT00536263|Immunologic Factors|immunologic factors|mesh-ancestor
92888175|NCT00536263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888176|NCT00578344|Cyclophosphamide|cyclophosphamide|mesh-list
92888177|NCT00578344|Busulfan|busulfan|mesh-list
92888178|NCT00578344|Alemtuzumab|alemtuzumab|mesh-list
92888179|NCT00578344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888180|NCT00578344|Immunologic Factors|immunologic factors|mesh-ancestor
92888181|NCT00578344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888182|NCT00578344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888183|NCT00578344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92888184|NCT00578344|Alkylating Agents|alkylating agents|mesh-ancestor
92888185|NCT00578344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888186|NCT00578344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888187|NCT00578344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92888188|NCT00578344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888189|NCT00653588|Atorvastatin|atorvastatin|mesh-list
92888190|NCT00653588|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92888191|NCT00653588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92888192|NCT00653588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92888193|NCT00653588|Antimetabolites|antimetabolites|mesh-ancestor
92888194|NCT00653588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888195|NCT00653588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92888196|NCT00653588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92888197|NCT00653588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888198|NCT00723346|Asparaginase|asparaginase|mesh-list
92888199|NCT00723346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888200|NCT02571400|Analgesics, Opioid|analgesics, opioid|mesh-list
92888201|NCT02571400|Analgesics|analgesics|mesh-list
92888202|NCT02571400|Narcotics|narcotics|mesh-ancestor
92888203|NCT02571400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888204|NCT02571400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888205|NCT02571400|Sensory System Agents|sensory system agents|mesh-ancestor
92888206|NCT02571400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888208|NCT02641652|Antidepressive Agents|antidepressive agents|mesh-ancestor
92888209|NCT02641652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92888210|NCT02641652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92888211|NCT02641652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92888212|NCT02641652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92888213|NCT02641652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888214|NCT02641652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888215|NCT02641652|Serotonin Agents|serotonin agents|mesh-ancestor
92888216|NCT02641652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888217|NCT02626104|Lactoferrin|lactoferrin|mesh-list
92888218|NCT02626104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888219|NCT02571166|Valacyclovir|valacyclovir|mesh-list
92888220|NCT02571166|Antiviral Agents|antiviral agents|mesh-ancestor
92888221|NCT02571166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888222|NCT00686478|Interferons|interferons|mesh-list
92888223|NCT00686478|Interferon-alpha|interferon-alpha|mesh-list
92888224|NCT00686478|Interferon alpha-2|interferon alpha-2|mesh-list
92888225|NCT00686478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888226|NCT00686478|Antiviral Agents|antiviral agents|mesh-ancestor
92888227|NCT00686478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888228|NCT00686478|Immunologic Factors|immunologic factors|mesh-ancestor
92888229|NCT00686478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888230|NCT00723424|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92888231|NCT00723424|Digoxin|digoxin|mesh-list
92888232|NCT00723424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92888233|NCT00723424|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92888234|NCT00723424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888235|NCT00723424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888236|NCT00723424|Protective Agents|protective agents|mesh-ancestor
92888237|NCT00723424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888238|NCT00723424|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92888239|NCT00723424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92888240|NCT00723424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92888241|NCT00723424|Antiviral Agents|antiviral agents|mesh-ancestor
92888242|NCT00723424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888243|NCT02641340|Fentanyl|fentanyl|mesh-list
92888244|NCT02641340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92888245|NCT02641340|Narcotics|narcotics|mesh-ancestor
92888246|NCT02641340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888247|NCT02641340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888248|NCT02641340|Analgesics|analgesics|mesh-ancestor
92888249|NCT02641340|Sensory System Agents|sensory system agents|mesh-ancestor
92888250|NCT02641340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888251|NCT02641340|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92888252|NCT02641340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92888253|NCT02641340|Anesthetics, General|anesthetics, general|mesh-ancestor
92888254|NCT02641340|Anesthetics|anesthetics|mesh-ancestor
92888255|NCT02625948|Tranexamic Acid|tranexamic acid|mesh-list
92888256|NCT02625948|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92888257|NCT02625948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92888258|NCT02625948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888259|NCT02625948|Hemostatics|hemostatics|mesh-ancestor
92888260|NCT02625948|Coagulants|coagulants|mesh-ancestor
92888261|NCT02571556|Dexamethasone|dexamethasone|mesh-list
92888262|NCT02571556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92888263|NCT02571556|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92888264|NCT02571556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888265|NCT02571556|Antiemetics|antiemetics|mesh-ancestor
92888266|NCT02571556|Autonomic Agents|autonomic agents|mesh-ancestor
92888267|NCT02571556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888268|NCT02571556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888269|NCT02571556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888270|NCT02571556|Glucocorticoids|glucocorticoids|mesh-ancestor
92888271|NCT02571556|Hormones|hormones|mesh-ancestor
92888272|NCT02571556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888273|NCT02571556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888274|NCT02571556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888275|NCT02571556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92888276|NCT03752216|Niraparib|niraparib|mesh-list
92888277|NCT03752216|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92888279|NCT03752216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888280|NCT03752216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888281|NCT00691548|Cetuximab|cetuximab|mesh-list
92888282|NCT00691548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888283|NCT00691548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888284|NCT00712738|Nifedipine|nifedipine|mesh-list
92888285|NCT00712738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92888286|NCT00712738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92888287|NCT00712738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888288|NCT00712738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92888289|NCT00712738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888290|NCT00712738|Vasodilator Agents|vasodilator agents|mesh-ancestor
92888291|NCT00712738|Tocolytic Agents|tocolytic agents|mesh-ancestor
92888292|NCT00712738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92888294|NCT00686556|Mycophenolic Acid|mycophenolic acid|mesh-list
92888295|NCT00686556|Cyclophosphamide|cyclophosphamide|mesh-list
92888296|NCT00686556|Fludarabine|fludarabine|mesh-list
92888297|NCT00686556|Cyclosporins|cyclosporins|mesh-list
92888298|NCT00686556|Lenograstim|lenograstim|mesh-list
92888299|NCT00686556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888300|NCT00686556|Immunologic Factors|immunologic factors|mesh-ancestor
92888301|NCT00686556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888302|NCT00686556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888303|NCT00686556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92888304|NCT00686556|Alkylating Agents|alkylating agents|mesh-ancestor
92888305|NCT00686556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888306|NCT00686556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888307|NCT00686556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92888308|NCT00686556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888309|NCT00686556|Antifungal Agents|antifungal agents|mesh-ancestor
92888310|NCT00686556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888311|NCT00686556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92888312|NCT00686556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92888313|NCT00686556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92888314|NCT00686556|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92888315|NCT00686556|Antitubercular Agents|antitubercular agents|mesh-ancestor
92888316|NCT00686556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888317|NCT00686556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92888318|NCT04070482|Tenofovir|tenofovir|mesh-list
92888319|NCT04070482|Antiviral Agents|antiviral agents|mesh-ancestor
92888320|NCT04070482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888321|NCT04070482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92888322|NCT04070482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92888323|NCT04070482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888324|NCT04070482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888325|NCT04070482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92888326|NCT04070482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92888327|NCT04166786|Ethanol|ethanol|mesh-list
92888328|NCT04166786|Methyltestosterone|methyltestosterone|mesh-list
92888329|NCT04166786|Petrolatum|petrolatum|mesh-list
92888330|NCT04166786|Testosterone|testosterone|mesh-list
92888331|NCT04166786|Testosterone undecanoate|testosterone undecanoate|mesh-list
92888332|NCT04166786|Testosterone enanthate|testosterone enanthate|mesh-list
92888333|NCT04166786|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92888334|NCT04166786|Androgens|androgens|mesh-ancestor
92888335|NCT04166786|Hormones|hormones|mesh-ancestor
92888336|NCT04166786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888337|NCT04166786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888338|NCT04166786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888339|NCT04166786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888340|NCT04166786|Anabolic Agents|anabolic agents|mesh-ancestor
92888341|NCT04166786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92888342|NCT04166786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888343|NCT04166786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888344|NCT04166786|Emollients|emollients|mesh-ancestor
92888345|NCT04166786|Dermatologic Agents|dermatologic agents|mesh-ancestor
92888346|NCT02727647|Factor VIII|factor viii|mesh-list
92888347|NCT02727647|Coagulants|coagulants|mesh-ancestor
92888348|NCT00723502|Amoxicillin|amoxicillin|mesh-list
92888349|NCT00723502|Finafloxacin|finafloxacin|mesh-list
92888350|NCT00723502|Fluoroquinolones|fluoroquinolones|mesh-list
92888351|NCT00723502|Esomeprazole|esomeprazole|mesh-list
92888352|NCT00723502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888353|NCT00723502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888354|NCT00723502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92888355|NCT00723502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888356|NCT00723502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92888357|NCT00723502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888358|NCT00723502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888359|NCT00723502|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92888360|NCT00723502|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92888361|NCT00723502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92888362|NCT00723502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888363|NCT00723502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92888364|NCT02727881|Squalamine|squalamine|mesh-list
92888365|NCT02727881|Ranibizumab|ranibizumab|mesh-list
92888366|NCT02727881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92888367|NCT02727881|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92888368|NCT02727881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92888369|NCT02727881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92888370|NCT02727881|Growth Substances|growth substances|mesh-ancestor
92888371|NCT02727881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888372|NCT02727881|Growth Inhibitors|growth inhibitors|mesh-ancestor
92888373|NCT02727881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888374|NCT02727881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888375|NCT02727881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888376|NCT02727881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92888377|NCT02727881|Protective Agents|protective agents|mesh-ancestor
92888378|NCT01564381|Resveratrol|resveratrol|mesh-list
92888379|NCT01564381|Antioxidants|antioxidants|mesh-ancestor
92160451|NCT01114581|Sympathomimetics|sympathomimetics|mesh-ancestor
92888380|NCT01564381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888381|NCT01564381|Protective Agents|protective agents|mesh-ancestor
92888382|NCT01564381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888383|NCT01564381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888384|NCT01564381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92888385|NCT04164524|Gentamicins|gentamicins|mesh-list
92888386|NCT04164524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888387|NCT04164524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888388|NCT04164524|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92888389|NCT04164524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888390|NCT04164524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888391|NCT00723658|Cytarabine|cytarabine|mesh-list
92888392|NCT00723658|Thalidomide|thalidomide|mesh-list
92888393|NCT00723658|Dexamethasone|dexamethasone|mesh-list
92888394|NCT00723658|Cyclophosphamide|cyclophosphamide|mesh-list
92888395|NCT00723658|Melphalan|melphalan|mesh-list
92888396|NCT00723658|Carmustine|carmustine|mesh-list
92888397|NCT00723658|Rituximab|rituximab|mesh-list
92888398|NCT00723658|Doxorubicin|doxorubicin|mesh-list
92888399|NCT00723658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92888400|NCT00723658|Etoposide|etoposide|mesh-list
92888401|NCT00723658|Bortezomib|bortezomib|mesh-list
92888402|NCT00723658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888403|NCT00723658|Immunologic Factors|immunologic factors|mesh-ancestor
92888404|NCT00723658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888405|NCT00723658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888406|NCT00723658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92888407|NCT00723658|Alkylating Agents|alkylating agents|mesh-ancestor
92888408|NCT00723658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888409|NCT00723658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888410|NCT00723658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92888411|NCT00723658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888412|NCT00723658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888413|NCT00723658|Antiemetics|antiemetics|mesh-ancestor
92888414|NCT00723658|Autonomic Agents|autonomic agents|mesh-ancestor
92888415|NCT00723658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888416|NCT00723658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888417|NCT00723658|Glucocorticoids|glucocorticoids|mesh-ancestor
92888418|NCT00723658|Hormones|hormones|mesh-ancestor
92888419|NCT00723658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888420|NCT00723658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888421|NCT00723658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92888422|NCT00723658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92888423|NCT00723658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92888424|NCT00723658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888425|NCT00723658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92888426|NCT00723658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92888427|NCT00723658|Antimetabolites|antimetabolites|mesh-ancestor
92888428|NCT00723658|Antiviral Agents|antiviral agents|mesh-ancestor
92888429|NCT00723658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888430|NCT00723658|Leprostatic Agents|leprostatic agents|mesh-ancestor
92888431|NCT00723658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888432|NCT00723658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92888433|NCT00723658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92888434|NCT00723658|Growth Substances|growth substances|mesh-ancestor
92888435|NCT00723658|Growth Inhibitors|growth inhibitors|mesh-ancestor
92888436|NCT04139850|Antiviral Agents|antiviral agents|mesh-list
92888437|NCT04139850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888438|NCT02638142|Furosemide|furosemide|mesh-list
92888439|NCT02638142|Diuretics|diuretics|mesh-ancestor
92888440|NCT02638142|Natriuretic Agents|natriuretic agents|mesh-ancestor
92888441|NCT02638142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888442|NCT02638142|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92525582|NCT00000395|Vitamins|vitamins|mesh-ancestor
92888443|NCT02638142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92888444|NCT02638142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888445|NCT02727491|Dextromethorphan|dextromethorphan|mesh-list
92888446|NCT02727491|Antitussive Agents|antitussive agents|mesh-ancestor
92888447|NCT02727491|Respiratory System Agents|respiratory system agents|mesh-ancestor
92888448|NCT02727491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92888449|NCT02727491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92888450|NCT02727491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888451|NCT02727491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888452|NCT02727491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888454|NCT03562195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92888455|NCT03562195|Autonomic Agents|autonomic agents|mesh-ancestor
92888456|NCT03562195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888457|NCT03562195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888458|NCT03562195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92888459|NCT03562195|Respiratory System Agents|respiratory system agents|mesh-ancestor
92888460|NCT03562195|Tocolytic Agents|tocolytic agents|mesh-ancestor
92888461|NCT03562195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92888462|NCT03562195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92888463|NCT03562195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92888464|NCT03562195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92888465|NCT03562195|Adrenergic Agents|adrenergic agents|mesh-ancestor
92888466|NCT03562195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888467|NCT03562195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888468|NCT00686868|Ofatumumab|ofatumumab|mesh-list
92888469|NCT00686868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888470|NCT00992329|Ciprofloxacin|ciprofloxacin|mesh-list
92888471|NCT00992329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888472|NCT00992329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888473|NCT00992329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92888474|NCT00992329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92888475|NCT00992329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888476|NCT00992329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888477|NCT00992329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888478|NCT00992329|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92888479|NCT00992329|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92888480|NCT02645864|Irinotecan|irinotecan|mesh-list
92888481|NCT02645864|Apatinib|apatinib|mesh-list
92888482|NCT02645864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92888483|NCT02645864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92888484|NCT02645864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888485|NCT02645864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888486|NCT02645864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888487|NCT02645864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92888488|NCT00674856|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92888489|NCT00674856|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92888490|NCT00674856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888491|NCT02574130|Amikacin|amikacin|mesh-list
92888492|NCT02574130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92888493|NCT02574130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888494|NCT00652184|Valacyclovir|valacyclovir|mesh-list
92888495|NCT00652184|Sorivudine|sorivudine|mesh-list
92888496|NCT00652184|Antiviral Agents|antiviral agents|mesh-ancestor
92888497|NCT00652184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888498|NCT00652184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888499|NCT00652184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888500|NCT02726867|Lacosamide|lacosamide|mesh-list
92888501|NCT02726867|Ketamine|ketamine|mesh-list
92888502|NCT02726867|Levetiracetam|levetiracetam|mesh-list
92888503|NCT02726867|Phenobarbital|phenobarbital|mesh-list
92888504|NCT02726867|Analgesics|analgesics|mesh-ancestor
92888505|NCT02726867|Sensory System Agents|sensory system agents|mesh-ancestor
92888506|NCT02726867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888507|NCT02726867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888508|NCT02726867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92888509|NCT02726867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92888510|NCT02726867|Anesthetics, General|anesthetics, general|mesh-ancestor
92888511|NCT02726867|Anesthetics|anesthetics|mesh-ancestor
92888512|NCT02726867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888513|NCT02726867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92888514|NCT02726867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92525586|NCT00025480|Paclitaxel|paclitaxel|mesh-list
92888515|NCT02726867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888516|NCT02726867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888517|NCT02726867|Anticonvulsants|anticonvulsants|mesh-ancestor
92888518|NCT02726867|Nootropic Agents|nootropic agents|mesh-ancestor
92888519|NCT02726867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92888520|NCT02726867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92888521|NCT02726867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92888522|NCT02726867|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92888523|NCT02726867|GABA Modulators|gaba modulators|mesh-ancestor
92888524|NCT02726867|GABA Agents|gaba agents|mesh-ancestor
92888525|NCT02726867|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92888526|NCT02726867|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92888527|NCT02726867|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92888528|NCT00723970|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92888529|NCT00723970|Antidepressive Agents|antidepressive agents|mesh-ancestor
92888530|NCT00723970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92888531|NCT00723970|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92888532|NCT00723970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92888533|NCT00723970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888534|NCT00723970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888535|NCT00873366|Tamoxifen|tamoxifen|mesh-list
92888536|NCT00873366|Dextromethorphan|dextromethorphan|mesh-list
92888537|NCT00873366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888538|NCT00873366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92888539|NCT00873366|Hormone Antagonists|hormone antagonists|mesh-ancestor
92888540|NCT00873366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888541|NCT00873366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888542|NCT00873366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888543|NCT00873366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888544|NCT00873366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92888545|NCT00873366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92888546|NCT00873366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92888547|NCT00873366|Antitussive Agents|antitussive agents|mesh-ancestor
92888548|NCT00873366|Respiratory System Agents|respiratory system agents|mesh-ancestor
92888549|NCT00873366|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92888550|NCT00873366|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92888551|NCT00873366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888552|NCT00712894|Verapamil|verapamil|mesh-list
92888553|NCT00712894|Diltiazem|diltiazem|mesh-list
92888554|NCT00712894|Nitroglycerin|nitroglycerin|mesh-list
92888555|NCT00712894|Vasodilator Agents|vasodilator agents|mesh-ancestor
92888556|NCT00712894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92888557|NCT00712894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92888558|NCT00712894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92888559|NCT00712894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888560|NCT00712894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92888561|NCT00712894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888562|NCT00712894|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92888563|NCT04164368|Lenalidomide|lenalidomide|mesh-list
92888564|NCT04164368|Immunologic Factors|immunologic factors|mesh-ancestor
92888565|NCT04164368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888566|NCT04164368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92888567|NCT04164368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92888568|NCT04164368|Growth Substances|growth substances|mesh-ancestor
92888569|NCT04164368|Growth Inhibitors|growth inhibitors|mesh-ancestor
92888570|NCT04164368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888571|NCT02726555|Atorvastatin|atorvastatin|mesh-list
92888572|NCT02726555|Red yeast rice|red yeast rice|mesh-list
92888573|NCT02726555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92888574|NCT02726555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92888575|NCT02726555|Antimetabolites|antimetabolites|mesh-ancestor
92888576|NCT02726555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888577|NCT02726555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92888578|NCT02726555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92888579|NCT02726555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888580|NCT00536107|Docetaxel|docetaxel|mesh-list
92888581|NCT00536107|Gefitinib|gefitinib|mesh-list
92888582|NCT00536107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888583|NCT00536107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92160528|NCT01044771|Tenofovir|tenofovir|mesh-list
92888584|NCT00536107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92888585|NCT00536107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525588|NCT00025480|Tipifarnib|tipifarnib|mesh-list
92888586|NCT00536107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888587|NCT00536107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92888588|NCT00536107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888589|NCT01022138|Cyclophosphamide|cyclophosphamide|mesh-list
92888590|NCT01022138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888591|NCT01022138|Immunologic Factors|immunologic factors|mesh-ancestor
92888592|NCT01022138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888593|NCT01022138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888594|NCT01022138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92888595|NCT01022138|Alkylating Agents|alkylating agents|mesh-ancestor
92888596|NCT01022138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888597|NCT01022138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888598|NCT01022138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92888599|NCT00724360|Trastuzumab|trastuzumab|mesh-list
92888600|NCT00724360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888601|NCT00724360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888602|NCT02637830|Fluorides|fluorides|mesh-list
92888603|NCT02637830|Fluorides, Topical|fluorides, topical|mesh-list
92888604|NCT02637830|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92888605|NCT02637830|Cariostatic Agents|cariostatic agents|mesh-ancestor
92888606|NCT02637830|Protective Agents|protective agents|mesh-ancestor
92888607|NCT02637830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888608|NCT00687258|Vitamin E|vitamin e|mesh-list
92888609|NCT00687258|Vitamins|vitamins|mesh-ancestor
92888610|NCT00687258|Micronutrients|micronutrients|mesh-ancestor
92888611|NCT00687258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888612|NCT00687258|Antioxidants|antioxidants|mesh-ancestor
92888613|NCT00687258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888614|NCT00687258|Protective Agents|protective agents|mesh-ancestor
92888615|NCT04001569|Paclitaxel|paclitaxel|mesh-list
92888616|NCT04001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92888617|NCT04001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888618|NCT04001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92888619|NCT04001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92888620|NCT04001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92888621|NCT04001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888622|NCT00692016|Naproxen|naproxen|mesh-list
92888623|NCT00692016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92888624|NCT00692016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888625|NCT00692016|Analgesics|analgesics|mesh-ancestor
92888626|NCT00692016|Sensory System Agents|sensory system agents|mesh-ancestor
92888627|NCT00692016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888628|NCT00692016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888629|NCT00692016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888630|NCT00692016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888631|NCT00692016|Gout Suppressants|gout suppressants|mesh-ancestor
92888632|NCT00692016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92888633|NCT00692016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888634|NCT00692016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888635|NCT03295981|Zoledronic Acid|zoledronic acid|mesh-list
92888636|NCT03295981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92888637|NCT03295981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888638|NCT02733107|Etoposide|etoposide|mesh-list
92888639|NCT02733107|Apatinib|apatinib|mesh-list
92888640|NCT02733107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92888641|NCT02733107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888642|NCT02733107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92888643|NCT02733107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92888644|NCT02733107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888645|NCT02733107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888646|NCT02733107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92888647|NCT00675012|Capecitabine|capecitabine|mesh-list
92888648|NCT00675012|Oxaliplatin|oxaliplatin|mesh-list
92888649|NCT00675012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92888650|NCT00675012|Antimetabolites|antimetabolites|mesh-ancestor
92888651|NCT00675012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888652|NCT00675012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888653|NCT00652262|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92888654|NCT00652262|Vasodilator Agents|vasodilator agents|mesh-ancestor
92888655|NCT00652262|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92888656|NCT00652262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92888657|NCT00652262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888658|NCT00652262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888659|NCT00652262|Urological Agents|urological agents|mesh-ancestor
92888660|NCT02640794|Aspirin|aspirin|mesh-list
92888661|NCT02640794|Clopidogrel|clopidogrel|mesh-list
92888662|NCT02640794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92888663|NCT02640794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888664|NCT02640794|Analgesics|analgesics|mesh-ancestor
92888665|NCT02640794|Sensory System Agents|sensory system agents|mesh-ancestor
92888666|NCT02640794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888667|NCT02640794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888668|NCT02640794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888669|NCT02640794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888670|NCT02640794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92888671|NCT02640794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92888672|NCT02640794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888673|NCT02640794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92888674|NCT02640794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92888675|NCT02640794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888676|NCT02640794|Antipyretics|antipyretics|mesh-ancestor
92888677|NCT02640794|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92888678|NCT02640794|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92888679|NCT02640794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92888680|NCT02640794|Purinergic Agents|purinergic agents|mesh-ancestor
92888681|NCT02640794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888682|NCT00724672|Adalimumab|adalimumab|mesh-list
92888683|NCT00724672|Infliximab|infliximab|mesh-list
92888684|NCT00724672|Etanercept|etanercept|mesh-list
92888685|NCT00724672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92888686|NCT00724672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888687|NCT00724672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888688|NCT00724672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92888689|NCT00724672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888690|NCT00724672|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92888691|NCT00724672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888692|NCT00724672|Analgesics|analgesics|mesh-ancestor
92888693|NCT00724672|Sensory System Agents|sensory system agents|mesh-ancestor
92888694|NCT00724672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888695|NCT00724672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888696|NCT00724672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888697|NCT00724672|Immunologic Factors|immunologic factors|mesh-ancestor
92888698|NCT02624856|Dexamethasone|dexamethasone|mesh-list
92888699|NCT02624856|Bupivacaine|bupivacaine|mesh-list
92888700|NCT02624856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888701|NCT02624856|Antiemetics|antiemetics|mesh-ancestor
92888702|NCT02624856|Autonomic Agents|autonomic agents|mesh-ancestor
92888703|NCT02624856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888704|NCT02624856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888705|NCT02624856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888706|NCT02624856|Glucocorticoids|glucocorticoids|mesh-ancestor
92888707|NCT02624856|Hormones|hormones|mesh-ancestor
92888708|NCT02624856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888709|NCT02624856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888710|NCT02624856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888711|NCT02624856|Anesthetics, Local|anesthetics, local|mesh-ancestor
92888712|NCT02624856|Anesthetics|anesthetics|mesh-ancestor
92888713|NCT02624856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888714|NCT02624856|Sensory System Agents|sensory system agents|mesh-ancestor
92888715|NCT02646020|Loratadine|loratadine|mesh-list
92888716|NCT02646020|Aprepitant|aprepitant|mesh-list
92888717|NCT02646020|Fosaprepitant|fosaprepitant|mesh-list
92888718|NCT02646020|Desloratadine|desloratadine|mesh-list
92888719|NCT02646020|Antiemetics|antiemetics|mesh-ancestor
92888720|NCT02646020|Autonomic Agents|autonomic agents|mesh-ancestor
92888721|NCT02646020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888722|NCT02646020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888723|NCT02646020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888724|NCT02646020|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92888725|NCT02646020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888726|NCT02646020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888727|NCT02646020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92888728|NCT02646020|Cholinergic Agents|cholinergic agents|mesh-ancestor
92888729|NCT02646020|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92888730|NCT02646020|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92888731|NCT02646020|Histamine Antagonists|histamine antagonists|mesh-ancestor
92888733|NCT02646020|Antipruritics|antipruritics|mesh-ancestor
92888735|NCT02646020|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92888736|NCT02733419|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92888737|NCT02733419|Enfuvirtide|enfuvirtide|mesh-list
92888738|NCT02733419|Antiviral Agents|antiviral agents|mesh-ancestor
92888739|NCT02733419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888740|NCT02733419|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92888741|NCT02733419|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92888742|NCT02733419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888743|NCT02733419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92888744|NCT00992797|Vitamin D|vitamin d|mesh-list
92888745|NCT00992797|Cholecalciferol|cholecalciferol|mesh-list
92888746|NCT00992797|Vitamins|vitamins|mesh-ancestor
92888747|NCT00992797|Micronutrients|micronutrients|mesh-ancestor
92888748|NCT00992797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888749|NCT00992797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92888750|NCT00992797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92888751|NCT02725541|Trastuzumab|trastuzumab|mesh-list
92888752|NCT02725541|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92888753|NCT02725541|Maytansine|maytansine|mesh-list
92888754|NCT02725541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92888755|NCT02725541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888756|NCT02725541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92888757|NCT02725541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92888758|NCT02725541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92888759|NCT02725541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92888760|NCT02725541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888761|NCT02725541|Immunotoxins|immunotoxins|mesh-ancestor
92888762|NCT02725541|Immunoconjugates|immunoconjugates|mesh-ancestor
92888763|NCT02725541|Immunologic Factors|immunologic factors|mesh-ancestor
92888764|NCT02725541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888765|NCT00911066|Azacitidine|azacitidine|mesh-list
92888766|NCT00911066|Pevonedistat|pevonedistat|mesh-list
92888767|NCT00911066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92888768|NCT00911066|Antimetabolites|antimetabolites|mesh-ancestor
92888769|NCT00911066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888770|NCT00911066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888771|NCT00911066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888772|NCT02733341|Ticagrelor|ticagrelor|mesh-list
92888773|NCT02733341|Cangrelor|cangrelor|mesh-list
92888774|NCT02733341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92888775|NCT02733341|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92888776|NCT02733341|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92888777|NCT02733341|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92888778|NCT02733341|Purinergic Agents|purinergic agents|mesh-ancestor
92888779|NCT02733341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888780|NCT02733341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888781|NCT02733341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888782|NCT00692172|Alefacept|alefacept|mesh-list
92888783|NCT00692172|Dermatologic Agents|dermatologic agents|mesh-ancestor
92888784|NCT00692172|Immunologic Factors|immunologic factors|mesh-ancestor
92888785|NCT00692172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888786|NCT00692250|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92888787|NCT00692250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92888788|NCT00692250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92888789|NCT00692250|Antimetabolites|antimetabolites|mesh-ancestor
92888790|NCT00692250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888791|NCT00692250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92888792|NCT03675139|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92888793|NCT03675139|Medroxyprogesterone|medroxyprogesterone|mesh-list
92888794|NCT03675139|Dydrogesterone|dydrogesterone|mesh-list
92888795|NCT03675139|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92888796|NCT03675139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92888797|NCT03675139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92888798|NCT03675139|Contraceptive Agents|contraceptive agents|mesh-ancestor
92888799|NCT03675139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92888800|NCT03675139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888801|NCT03675139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92534155|NCT00065923|Topiramate|topiramate|mesh-list
92888802|NCT03675139|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92888803|NCT03675139|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92525591|NCT00025480|Tubulin Modulators|tubulin modulators|mesh-ancestor
92888804|NCT03675139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888805|NCT03675139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888806|NCT03675139|Progestins|progestins|mesh-ancestor
92888808|NCT03675139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888809|NCT02645552|Tranexamic Acid|tranexamic acid|mesh-list
92888810|NCT02645552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92888811|NCT02645552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92888812|NCT02645552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888813|NCT02645552|Hemostatics|hemostatics|mesh-ancestor
92888814|NCT02645552|Coagulants|coagulants|mesh-ancestor
92888816|NCT00692328|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92888817|NCT00692328|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92888818|NCT00692328|Dopamine Agents|dopamine agents|mesh-ancestor
92888819|NCT00692328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888820|NCT00692328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888821|NCT00692328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888822|NCT03415828|Ethanol|ethanol|mesh-list
92888823|NCT03415828|Prednisolone|prednisolone|mesh-list
92888824|NCT03415828|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92888825|NCT03415828|Methylprednisolone|methylprednisolone|mesh-list
92888826|NCT03415828|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92888827|NCT03415828|Prednisolone acetate|prednisolone acetate|mesh-list
92888828|NCT03415828|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92888829|NCT03415828|Prednisolone phosphate|prednisolone phosphate|mesh-list
92888830|NCT03415828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888831|NCT03415828|Glucocorticoids|glucocorticoids|mesh-ancestor
92888832|NCT03415828|Hormones|hormones|mesh-ancestor
92888833|NCT03415828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888834|NCT03415828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888835|NCT03415828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888836|NCT03415828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888837|NCT03415828|Antiemetics|antiemetics|mesh-ancestor
92888838|NCT03415828|Autonomic Agents|autonomic agents|mesh-ancestor
92888839|NCT03415828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888840|NCT03415828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888841|NCT03415828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92888842|NCT03415828|Protective Agents|protective agents|mesh-ancestor
92888843|NCT03415828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92888844|NCT03415828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888845|NCT03415828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888846|NCT00687648|Prednisolone|prednisolone|mesh-list
92888847|NCT00687648|Cyclophosphamide|cyclophosphamide|mesh-list
92888848|NCT00687648|Methotrexate|methotrexate|mesh-list
92888849|NCT00687648|Letrozole|letrozole|mesh-list
92888850|NCT00687648|Anastrozole|anastrozole|mesh-list
92888851|NCT00687648|Exemestane|exemestane|mesh-list
92888852|NCT00687648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92888853|NCT00687648|Immunologic Factors|immunologic factors|mesh-ancestor
92888854|NCT00687648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888855|NCT00687648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888856|NCT00687648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92888857|NCT00687648|Alkylating Agents|alkylating agents|mesh-ancestor
92888858|NCT00687648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888859|NCT00687648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888860|NCT00687648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92888861|NCT00687648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92888862|NCT00687648|Abortifacient Agents|abortifacient agents|mesh-ancestor
92888863|NCT00687648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92888864|NCT00687648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92888865|NCT00687648|Antimetabolites|antimetabolites|mesh-ancestor
92888866|NCT00687648|Dermatologic Agents|dermatologic agents|mesh-ancestor
92888867|NCT00687648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888868|NCT00687648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92888869|NCT00687648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92888870|NCT00687648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888871|NCT00687648|Glucocorticoids|glucocorticoids|mesh-ancestor
92888872|NCT00687648|Hormones|hormones|mesh-ancestor
92888873|NCT00687648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888874|NCT00687648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888875|NCT00687648|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92888876|NCT00687648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92888877|NCT00687648|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92888878|NCT00687648|Hormone Antagonists|hormone antagonists|mesh-ancestor
92888879|NCT00725218|Flurbiprofen|flurbiprofen|mesh-list
92888880|NCT00725218|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92888881|NCT00725218|Analgesics|analgesics|mesh-ancestor
92888882|NCT00725218|Sensory System Agents|sensory system agents|mesh-ancestor
92888883|NCT00725218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888884|NCT00725218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888885|NCT00725218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92888886|NCT00725218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92888887|NCT00725218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888888|NCT00725218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92888889|NCT00725218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92888890|NCT00725218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888891|NCT00725218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888893|NCT02732795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92888894|NCT02732795|Narcotics|narcotics|mesh-ancestor
92888895|NCT02732795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888896|NCT02732795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888897|NCT02732795|Analgesics|analgesics|mesh-ancestor
92888898|NCT02732795|Sensory System Agents|sensory system agents|mesh-ancestor
92888899|NCT02732795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888900|NCT05373004|Empagliflozin|empagliflozin|mesh-list
92888901|NCT05373004|Enalapril|enalapril|mesh-list
92888902|NCT05373004|Enalaprilat|enalaprilat|mesh-list
92888903|NCT05373004|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92888904|NCT05373004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888905|NCT05373004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92888906|NCT05373004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888907|NCT05373004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92888908|NCT05373004|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92888909|NCT05373004|Protease Inhibitors|protease inhibitors|mesh-ancestor
92888910|NCT05373004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92888911|NCT00655616|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92888912|NCT00655616|Montelukast|montelukast|mesh-list
92888913|NCT00655616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92888914|NCT00655616|Autonomic Agents|autonomic agents|mesh-ancestor
92888915|NCT00655616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888916|NCT00655616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888917|NCT00655616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92888918|NCT00655616|Respiratory System Agents|respiratory system agents|mesh-ancestor
92888919|NCT00655616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92888920|NCT00655616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92888921|NCT00655616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92888922|NCT00655616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92888923|NCT00655616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92888924|NCT00655616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888925|NCT00655616|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92888926|NCT00655616|Hormone Antagonists|hormone antagonists|mesh-ancestor
92888927|NCT00655616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888928|NCT00655616|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92888929|NCT00655616|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92888930|NCT00713440|Acetaminophen|acetaminophen|mesh-list
92888931|NCT00713440|Prednisolone|prednisolone|mesh-list
92888932|NCT00713440|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92888933|NCT00713440|Methylprednisolone|methylprednisolone|mesh-list
92888934|NCT00713440|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92888935|NCT00713440|Prednisolone acetate|prednisolone acetate|mesh-list
92888936|NCT00713440|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92888937|NCT00713440|Prednisolone phosphate|prednisolone phosphate|mesh-list
92888938|NCT00713440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888939|NCT00713440|Glucocorticoids|glucocorticoids|mesh-ancestor
92888940|NCT00713440|Hormones|hormones|mesh-ancestor
92888941|NCT00713440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888942|NCT00713440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888943|NCT00713440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92888944|NCT00713440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92888945|NCT00713440|Antiemetics|antiemetics|mesh-ancestor
92888946|NCT00713440|Autonomic Agents|autonomic agents|mesh-ancestor
92888947|NCT00713440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888948|NCT00713440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92888949|NCT00713440|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92525596|NCT00025519|Thalidomide|thalidomide|mesh-list
92888950|NCT00713440|Protective Agents|protective agents|mesh-ancestor
92888952|NCT00713440|Analgesics|analgesics|mesh-ancestor
92888953|NCT00713440|Sensory System Agents|sensory system agents|mesh-ancestor
92888954|NCT00713440|Antipyretics|antipyretics|mesh-ancestor
92888956|NCT00993109|Nifedipine|nifedipine|mesh-list
92888957|NCT00993109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92888958|NCT00993109|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92888959|NCT00993109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92888960|NCT00993109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92888961|NCT00993109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92888962|NCT00993109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92888963|NCT00993109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92888964|NCT00993109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888965|NCT00993109|Vasodilator Agents|vasodilator agents|mesh-ancestor
92888966|NCT00993109|Tocolytic Agents|tocolytic agents|mesh-ancestor
92888967|NCT00993109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92888968|NCT02725229|Levobupivacaine|levobupivacaine|mesh-list
92888969|NCT02725229|Anesthetics, Local|anesthetics, local|mesh-ancestor
92888970|NCT02725229|Anesthetics|anesthetics|mesh-ancestor
92888971|NCT02725229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92888972|NCT02725229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888973|NCT02725229|Sensory System Agents|sensory system agents|mesh-ancestor
92888974|NCT02725229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888975|NCT00655772|Chlorine dioxide|chlorine dioxide|mesh-list
92888976|NCT00655772|Dental Disinfectants|dental disinfectants|mesh-ancestor
92888977|NCT00655772|Disinfectants|disinfectants|mesh-ancestor
92888978|NCT00655772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888979|NCT00675246|Betamethasone|betamethasone|mesh-list
92888980|NCT00675246|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
92888981|NCT00675246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888982|NCT00675246|Glucocorticoids|glucocorticoids|mesh-ancestor
92888983|NCT00675246|Hormones|hormones|mesh-ancestor
92888984|NCT00675246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92888985|NCT00675246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92888986|NCT00675246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92888987|NCT00675246|Respiratory System Agents|respiratory system agents|mesh-ancestor
92888988|NCT00675246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92888989|NCT00675246|Autonomic Agents|autonomic agents|mesh-ancestor
92888990|NCT00675246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92888991|NCT02732405|Grazoprevir|grazoprevir|mesh-list
92888992|NCT02732405|Antiviral Agents|antiviral agents|mesh-ancestor
92888993|NCT02732405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92888994|NCT04001725|Metformin|metformin|mesh-list
92888995|NCT04001725|Dexamethasone|dexamethasone|mesh-list
92888996|NCT04001725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92888997|NCT04001725|Antiemetics|antiemetics|mesh-ancestor
92888998|NCT04001725|Autonomic Agents|autonomic agents|mesh-ancestor
92888999|NCT04001725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889000|NCT04001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889001|NCT04001725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92889002|NCT04001725|Glucocorticoids|glucocorticoids|mesh-ancestor
92889003|NCT04001725|Hormones|hormones|mesh-ancestor
92889004|NCT04001725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889005|NCT04001725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92889006|NCT04001725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889007|NCT04001725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92889008|NCT00713674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92889009|NCT00713674|Mupirocin|mupirocin|mesh-list
92889010|NCT00713674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889011|NCT00713674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92889012|NCT00713674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889013|NCT00713674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889014|NCT00885482|Ritonavir|ritonavir|mesh-list
92889015|NCT00885482|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92889016|NCT00885482|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92889017|NCT00885482|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92889018|NCT00885482|Protease Inhibitors|protease inhibitors|mesh-ancestor
92889019|NCT00885482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889020|NCT00885482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889021|NCT00885482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92889022|NCT00885482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92889023|NCT00885482|Antiviral Agents|antiviral agents|mesh-ancestor
92525599|NCT00025519|Tacrolimus|tacrolimus|mesh-list
92889024|NCT00885482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889025|NCT00885482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92889026|NCT00885482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92889027|NCT04139226|CC-11050|cc-11050|mesh-list
92889028|NCT04139226|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92889029|NCT04139226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92889030|NCT04139226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889031|NCT04139226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889032|NCT05366062|Cyclophosphamide|cyclophosphamide|mesh-list
92889033|NCT05366062|Pembrolizumab|pembrolizumab|mesh-list
92889034|NCT05366062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889035|NCT05366062|Immunologic Factors|immunologic factors|mesh-ancestor
92889036|NCT05366062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889037|NCT05366062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889038|NCT05366062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92889039|NCT05366062|Alkylating Agents|alkylating agents|mesh-ancestor
92889040|NCT05366062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889041|NCT05366062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889042|NCT05366062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92889043|NCT05366062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889044|NCT05366062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92889045|NCT02645240|Heparin|heparin|mesh-list
92889046|NCT02645240|Calcium heparin|calcium heparin|mesh-list
92889047|NCT02645240|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92889048|NCT02645240|Tinzaparin|tinzaparin|mesh-list
92889049|NCT02645240|Dalteparin|dalteparin|mesh-list
92889050|NCT02645240|Anticoagulants|anticoagulants|mesh-ancestor
92889051|NCT02645240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92889052|NCT02645240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92889053|NCT02645240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889054|NCT00688194|Letrozole|letrozole|mesh-list
92889055|NCT00688194|Fulvestrant|fulvestrant|mesh-list
92889056|NCT00688194|Lapatinib|lapatinib|mesh-list
92889057|NCT00688194|Anastrozole|anastrozole|mesh-list
92889058|NCT00688194|Exemestane|exemestane|mesh-list
92889059|NCT00688194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889060|NCT00688194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92889061|NCT00688194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92889062|NCT00688194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889063|NCT00688194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889064|NCT00688194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92889065|NCT00688194|Hormone Antagonists|hormone antagonists|mesh-ancestor
92889066|NCT00688194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889067|NCT00688194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889068|NCT00688194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92889069|NCT00688194|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92889070|NCT00688194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889071|NCT00653744|Atorvastatin|atorvastatin|mesh-list
92889072|NCT00653744|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92889073|NCT00653744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92889074|NCT00653744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92889075|NCT00653744|Antimetabolites|antimetabolites|mesh-ancestor
92889076|NCT00653744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889077|NCT00653744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92889078|NCT00653744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92889079|NCT00653744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889080|NCT03322267|Cisplatin|cisplatin|mesh-list
92889081|NCT03322267|Pembrolizumab|pembrolizumab|mesh-list
92889082|NCT03322267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889083|NCT03322267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160623|NCT01162551|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92889084|NCT03322267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92889085|NCT03322267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889086|NCT00652496|Bimatoprost|bimatoprost|mesh-list
92889087|NCT00652496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92889088|NCT00652496|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92889089|NCT00652496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92889090|NCT00688272|Ciprofloxacin|ciprofloxacin|mesh-list
92889091|NCT00688272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92889092|NCT00688272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889093|NCT00688272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92889094|NCT00688272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92889095|NCT00688272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525602|NCT00025519|Antimetabolites|antimetabolites|mesh-ancestor
92889096|NCT00688272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889097|NCT00688272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889098|NCT00688272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92889099|NCT00688272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92889101|NCT00993343|Sirolimus|sirolimus|mesh-list
92889102|NCT00993343|Methotrexate|methotrexate|mesh-list
92889103|NCT00993343|Tacrolimus|tacrolimus|mesh-list
92889104|NCT00993343|Cyclosporins|cyclosporins|mesh-list
92889105|NCT00993343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92889106|NCT00993343|Abortifacient Agents|abortifacient agents|mesh-ancestor
92889107|NCT00993343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92889108|NCT00993343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889109|NCT00993343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92889110|NCT00993343|Antimetabolites|antimetabolites|mesh-ancestor
92889111|NCT00993343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889112|NCT00993343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889113|NCT00993343|Dermatologic Agents|dermatologic agents|mesh-ancestor
92889114|NCT00993343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889115|NCT00993343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92889116|NCT00993343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889117|NCT00993343|Immunologic Factors|immunologic factors|mesh-ancestor
92889118|NCT00993343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889119|NCT00993343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92889120|NCT00993343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92889121|NCT00993343|Antifungal Agents|antifungal agents|mesh-ancestor
92889122|NCT00993343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889123|NCT00993343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92889124|NCT00993343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92889125|NCT02974049|Ivermectin|ivermectin|mesh-list
92889126|NCT02974049|Albendazole|albendazole|mesh-list
92889127|NCT02974049|Diethylcarbamazine|diethylcarbamazine|mesh-list
92889128|NCT02974049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92889129|NCT02974049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889130|NCT02974049|Anthelmintics|anthelmintics|mesh-ancestor
92889131|NCT02974049|Anticestodal Agents|anticestodal agents|mesh-ancestor
92889132|NCT02974049|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92889133|NCT02974049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92889134|NCT02974049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889135|NCT02974049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889136|NCT02974049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889137|NCT02974049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889138|NCT02974049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889139|NCT02974049|Filaricides|filaricides|mesh-ancestor
92889140|NCT02974049|Antinematodal Agents|antinematodal agents|mesh-ancestor
92889141|NCT02974049|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92889142|NCT02974049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889143|NCT02637284|BPC 157|bpc 157|mesh-list
92889144|NCT02637284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92889145|NCT02637284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92889146|NCT04138992|Bevacizumab|bevacizumab|mesh-list
92889147|NCT04138992|Cisplatin|cisplatin|mesh-list
92889148|NCT04138992|Docetaxel|docetaxel|mesh-list
92889149|NCT04138992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889150|NCT04138992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889151|NCT04138992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92889152|NCT04138992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92889153|NCT04138992|Growth Substances|growth substances|mesh-ancestor
92889154|NCT04138992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889155|NCT04138992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92889156|NCT04138992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889157|NCT04138992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889158|NCT04138992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889159|NCT04138992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889160|NCT04137588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92889161|NCT04137588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92889162|NCT04137588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889163|NCT04137588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889164|NCT04137588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889165|NCT04137588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92889166|NCT04137588|Growth Substances|growth substances|mesh-ancestor
92889167|NCT04137588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889168|NCT04137588|Growth Inhibitors|growth inhibitors|mesh-ancestor
92889169|NCT02721329|Acetaminophen|acetaminophen|mesh-list
92889170|NCT02721329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92889171|NCT02721329|Analgesics|analgesics|mesh-ancestor
92889172|NCT02721329|Sensory System Agents|sensory system agents|mesh-ancestor
92889173|NCT02721329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889174|NCT02721329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889175|NCT02721329|Antipyretics|antipyretics|mesh-ancestor
92534524|NCT02966587|Durvalumab|durvalumab|mesh-list
92889176|NCT02637128|Artesunate|artesunate|mesh-list
92889177|NCT02637128|Lumefantrine|lumefantrine|mesh-list
92889178|NCT02637128|Artemether|artemether|mesh-list
92889179|NCT02637128|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92889180|NCT02637128|Amodiaquine|amodiaquine|mesh-list
92889181|NCT02637128|Antimalarials|antimalarials|mesh-ancestor
92889182|NCT02637128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92889183|NCT02637128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92889184|NCT02637128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889185|NCT02637128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889186|NCT02637128|Antiviral Agents|antiviral agents|mesh-ancestor
92889187|NCT02637128|Schistosomicides|schistosomicides|mesh-ancestor
92889188|NCT02637128|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92889189|NCT02637128|Anthelmintics|anthelmintics|mesh-ancestor
92889190|NCT02624622|Chlorhexidine|chlorhexidine|mesh-list
92889191|NCT02624622|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92889192|NCT02624622|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92889193|NCT02624622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889194|NCT02624622|Disinfectants|disinfectants|mesh-ancestor
92889195|NCT02624622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92889196|NCT00585247|Imiquimod|imiquimod|mesh-list
92889197|NCT00585247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92889198|NCT00585247|Immunologic Factors|immunologic factors|mesh-ancestor
92889199|NCT00585247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889200|NCT00585247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889201|NCT00585247|Interferon Inducers|interferon inducers|mesh-ancestor
92889202|NCT04002349|Budesonide|budesonide|mesh-list
92889203|NCT04002349|Levocabastine|levocabastine|mesh-list
92889204|NCT04002349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889205|NCT04002349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92889206|NCT04002349|Autonomic Agents|autonomic agents|mesh-ancestor
92889207|NCT04002349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889208|NCT04002349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889209|NCT04002349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92889210|NCT04002349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92889211|NCT04002349|Glucocorticoids|glucocorticoids|mesh-ancestor
92889212|NCT04002349|Hormones|hormones|mesh-ancestor
92889213|NCT04002349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889214|NCT04002349|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92889215|NCT04002349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92889216|NCT04002349|Histamine Antagonists|histamine antagonists|mesh-ancestor
92889217|NCT04002349|Histamine Agents|histamine agents|mesh-ancestor
92889218|NCT04002349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889219|NCT04002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889220|NCT00688428|Aspirin|aspirin|mesh-list
92889221|NCT00688428|Esomeprazole|esomeprazole|mesh-list
92889222|NCT00688428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92889223|NCT00688428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92889224|NCT00688428|Analgesics|analgesics|mesh-ancestor
92889225|NCT00688428|Sensory System Agents|sensory system agents|mesh-ancestor
92889226|NCT00688428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889227|NCT00688428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889228|NCT00688428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889229|NCT00688428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889230|NCT00688428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92889231|NCT00688428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92889232|NCT00688428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889233|NCT00688428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92889234|NCT00688428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92889235|NCT00688428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889236|NCT00688428|Antipyretics|antipyretics|mesh-ancestor
92889237|NCT00688428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92889238|NCT00688428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92889239|NCT00688428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92889240|NCT02724761|Epinephrine|epinephrine|mesh-list
92889241|NCT02724761|Racepinephrine|racepinephrine|mesh-list
92889242|NCT02724761|Epinephryl borate|epinephryl borate|mesh-list
92889243|NCT02724761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92889244|NCT02724761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92889245|NCT02724761|Adrenergic Agents|adrenergic agents|mesh-ancestor
92889246|NCT02724761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889247|NCT02724761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889248|NCT02724761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889249|NCT02724761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92889250|NCT02724761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92889251|NCT02724761|Autonomic Agents|autonomic agents|mesh-ancestor
92889252|NCT02724761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889253|NCT02724761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92889254|NCT02724761|Respiratory System Agents|respiratory system agents|mesh-ancestor
92889255|NCT02724761|Mydriatics|mydriatics|mesh-ancestor
92889256|NCT02724761|Sympathomimetics|sympathomimetics|mesh-ancestor
92889257|NCT02724761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92889258|NCT04350190|Apatinib|apatinib|mesh-list
92889259|NCT04350190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889260|NCT04350190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889261|NCT04350190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889262|NCT04350190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889263|NCT02721173|Clindamycin|clindamycin|mesh-list
92889264|NCT02721173|Clindamycin palmitate|clindamycin palmitate|mesh-list
92889265|NCT02721173|Clindamycin phosphate|clindamycin phosphate|mesh-list
92889266|NCT02721173|Adapalene|adapalene|mesh-list
92889267|NCT02721173|Tazarotene|tazarotene|mesh-list
92889268|NCT02721173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92889269|NCT02721173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889270|NCT02721173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92889271|NCT02721173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889272|NCT02721173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889273|NCT02721173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92889274|NCT02721173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92889275|NCT02721173|Analgesics|analgesics|mesh-ancestor
92889276|NCT02721173|Sensory System Agents|sensory system agents|mesh-ancestor
92889277|NCT02721173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889278|NCT02721173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889279|NCT02721173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889280|NCT02721173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889281|NCT02721173|Dermatologic Agents|dermatologic agents|mesh-ancestor
92889282|NCT02721173|Keratolytic Agents|keratolytic agents|mesh-ancestor
92889283|NCT00713986|Tin Fluorides|tin fluorides|mesh-list
92889284|NCT00713986|Cariostatic Agents|cariostatic agents|mesh-ancestor
92889285|NCT00713986|Protective Agents|protective agents|mesh-ancestor
92889286|NCT00713986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889287|NCT00993733|Dialysis Solutions|dialysis solutions|mesh-list
92889288|NCT00993733|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92889289|NCT00692640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92889290|NCT00692640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889291|NCT00692640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889292|NCT00692640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889293|NCT00692640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889294|NCT04137432|Oxytocin|oxytocin|mesh-list
92889295|NCT04137432|Oxytocics|oxytocics|mesh-ancestor
92889296|NCT04137432|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92889297|NCT04137432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889298|NCT00885170|Vitamin D|vitamin d|mesh-list
92889299|NCT00885170|Cholecalciferol|cholecalciferol|mesh-list
92889300|NCT00885170|Calcium|calcium|mesh-list
92889301|NCT00885170|Vitamins|vitamins|mesh-ancestor
92889302|NCT00885170|Micronutrients|micronutrients|mesh-ancestor
92889303|NCT00885170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889304|NCT00885170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92889305|NCT00885170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92889306|NCT05342467|Dinoprostone|dinoprostone|mesh-list
92889307|NCT05342467|Gemeprost|gemeprost|mesh-list
92889308|NCT05342467|Oxytocics|oxytocics|mesh-ancestor
92889309|NCT05342467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92889310|NCT05342467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889311|NCT05342467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92889312|NCT05342467|Abortifacient Agents|abortifacient agents|mesh-ancestor
92889313|NCT02720783|Econazole|econazole|mesh-list
92889314|NCT02720783|Benzydamine|benzydamine|mesh-list
92889315|NCT02720783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889316|NCT02720783|Antifungal Agents|antifungal agents|mesh-ancestor
92889317|NCT02720783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889318|NCT02720783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92889319|NCT02720783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92889320|NCT02720783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889321|NCT02720783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889322|NCT02720783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92889323|NCT02720783|Hormone Antagonists|hormone antagonists|mesh-ancestor
92889324|NCT02720783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889325|NCT02720783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889326|NCT00714064|Edetic Acid|edetic acid|mesh-list
92889327|NCT00714064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92889328|NCT00714064|Pentetic Acid|pentetic acid|mesh-list
92889329|NCT00714064|Immunologic Factors|immunologic factors|mesh-ancestor
92889330|NCT00714064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889332|NCT00714064|Protective Agents|protective agents|mesh-ancestor
92889333|NCT00714064|Chelating Agents|chelating agents|mesh-ancestor
92889334|NCT00714064|Sequestering Agents|sequestering agents|mesh-ancestor
92889335|NCT00714064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889336|NCT00714064|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92889337|NCT00714064|Anticoagulants|anticoagulants|mesh-ancestor
92889338|NCT00714064|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92889339|NCT02720705|Dexmedetomidine|dexmedetomidine|mesh-list
92889340|NCT02720705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92889341|NCT02720705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889342|NCT02720705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889343|NCT02720705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92889344|NCT02720705|Analgesics|analgesics|mesh-ancestor
92889345|NCT02720705|Sensory System Agents|sensory system agents|mesh-ancestor
92889346|NCT02720705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889347|NCT02720705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92889348|NCT02720705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92889349|NCT02720705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92889350|NCT02720705|Adrenergic Agents|adrenergic agents|mesh-ancestor
92889351|NCT02720705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889352|NCT02720705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889353|NCT02720471|Anesthetics|anesthetics|mesh-list
92889354|NCT02720471|Anesthetics, Local|anesthetics, local|mesh-list
92889355|NCT02720471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889356|NCT02720471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889357|NCT02720471|Sensory System Agents|sensory system agents|mesh-ancestor
92889358|NCT02720471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889359|NCT00688818|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92889360|NCT00688818|Antidepressive Agents|antidepressive agents|mesh-ancestor
92889361|NCT00688818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92889362|NCT00688818|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92889363|NCT00688818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92889364|NCT00688818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889365|NCT00688818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889366|NCT00656006|Ribavirin|ribavirin|mesh-list
92889367|NCT00656006|Antimetabolites|antimetabolites|mesh-ancestor
92889368|NCT00656006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889369|NCT00656006|Antiviral Agents|antiviral agents|mesh-ancestor
92889370|NCT00656006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889371|NCT00688896|Pravastatin|pravastatin|mesh-list
92889372|NCT00688896|Dalcetrapib|dalcetrapib|mesh-list
92889373|NCT00688896|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92889374|NCT00688896|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92889375|NCT00688896|Antimetabolites|antimetabolites|mesh-ancestor
92889376|NCT00688896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889377|NCT00688896|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92889378|NCT00688896|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92889379|NCT00688896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889380|NCT02724293|Pregabalin|pregabalin|mesh-list
92889381|NCT02724293|Analgesics|analgesics|mesh-ancestor
92889382|NCT02724293|Sensory System Agents|sensory system agents|mesh-ancestor
92889383|NCT02724293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889384|NCT02724293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889385|NCT02724293|Anticonvulsants|anticonvulsants|mesh-ancestor
92889386|NCT02724293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92889387|NCT02724293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92889388|NCT02724293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889389|NCT02724293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92889390|NCT02724293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92889391|NCT02724293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92889392|NCT02724293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889393|NCT02724293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92889394|NCT05092828|Morphine|morphine|mesh-list
92889395|NCT05092828|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92889396|NCT05092828|Narcotics|narcotics|mesh-ancestor
92889397|NCT05092828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889398|NCT05092828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889399|NCT05092828|Analgesics|analgesics|mesh-ancestor
92889400|NCT05092828|Sensory System Agents|sensory system agents|mesh-ancestor
92889401|NCT05092828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889402|NCT04137198|Sufentanil|sufentanil|mesh-list
92889404|NCT04137198|Narcotics|narcotics|mesh-ancestor
92889405|NCT04137198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889406|NCT04137198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889407|NCT04137198|Analgesics|analgesics|mesh-ancestor
92889408|NCT04137198|Sensory System Agents|sensory system agents|mesh-ancestor
92889409|NCT04137198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889410|NCT04137198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92889411|NCT04137198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92889412|NCT04137198|Anesthetics, General|anesthetics, general|mesh-ancestor
92889413|NCT04137198|Anesthetics|anesthetics|mesh-ancestor
92889414|NCT00995293|Docetaxel|docetaxel|mesh-list
92889415|NCT00995293|Fluorouracil|fluorouracil|mesh-list
92889416|NCT00995293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889417|NCT00995293|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889418|NCT00995293|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889419|NCT00995293|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889420|NCT00995293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889421|NCT00995293|Antimetabolites|antimetabolites|mesh-ancestor
92889422|NCT00995293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92889423|NCT00995293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889424|NCT00995293|Immunologic Factors|immunologic factors|mesh-ancestor
92889425|NCT00995293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889426|NCT00692952|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92889427|NCT00692952|Contraceptive Agents|contraceptive agents|mesh-list
92889428|NCT00692952|Nonoxynol|nonoxynol|mesh-list
92889429|NCT00692952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92889430|NCT00692952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889431|NCT00692952|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92889432|NCT00692952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889433|NCT00692952|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92889434|NCT00692952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92889435|NCT00692952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92889436|NCT00692952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92889437|NCT02639858|Docetaxel|docetaxel|mesh-list
92889438|NCT02639858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889439|NCT02639858|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889440|NCT02639858|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889441|NCT02639858|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889442|NCT02639858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889443|NCT00689208|Atropine|atropine|mesh-list
92889444|NCT00689208|Physostigmine|physostigmine|mesh-list
92889445|NCT00689208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92889446|NCT00689208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92889447|NCT00689208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92889448|NCT00689208|Autonomic Agents|autonomic agents|mesh-ancestor
92889449|NCT00689208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889450|NCT00689208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889451|NCT00689208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92889452|NCT00689208|Respiratory System Agents|respiratory system agents|mesh-ancestor
92889453|NCT00689208|Mydriatics|mydriatics|mesh-ancestor
92889454|NCT00689208|Parasympatholytics|parasympatholytics|mesh-ancestor
92889455|NCT00689208|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92889456|NCT00689208|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92889457|NCT00689208|Cholinergic Agents|cholinergic agents|mesh-ancestor
92889458|NCT00689208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889459|NCT00689208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889460|NCT00689208|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92889461|NCT00689208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889462|NCT00689208|Miotics|miotics|mesh-ancestor
92889463|NCT00726466|Ranibizumab|ranibizumab|mesh-list
92889464|NCT00726466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92889465|NCT00726466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92889466|NCT00726466|Growth Substances|growth substances|mesh-ancestor
92889467|NCT00726466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889468|NCT00726466|Growth Inhibitors|growth inhibitors|mesh-ancestor
92889469|NCT00726466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889470|NCT02694263|Pioglitazone|pioglitazone|mesh-list
92889471|NCT02694263|Glimepiride|glimepiride|mesh-list
92889472|NCT02694263|Canagliflozin|canagliflozin|mesh-list
92889473|NCT02694263|Repaglinide|repaglinide|mesh-list
92889474|NCT02694263|Gliclazide|gliclazide|mesh-list
92889475|NCT02694263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92889476|NCT02694263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889477|NCT02694263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92889478|NCT02694263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889479|NCT02694263|Immunologic Factors|immunologic factors|mesh-ancestor
92889480|NCT02694263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92889481|NCT02694263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889482|NCT04139070|Bleomycin|bleomycin|mesh-list
92889483|NCT04139070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92889484|NCT04139070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889485|NCT00693030|Sirolimus|sirolimus|mesh-list
92889486|NCT00693030|Paclitaxel|paclitaxel|mesh-list
92889487|NCT00693030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92889488|NCT00693030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889489|NCT00693030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889490|NCT00693030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889491|NCT00693030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889492|NCT00693030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889493|NCT00693030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92889494|NCT00693030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889495|NCT00693030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92889496|NCT00693030|Antifungal Agents|antifungal agents|mesh-ancestor
92889497|NCT00693030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889498|NCT00693030|Immunologic Factors|immunologic factors|mesh-ancestor
92889499|NCT00693030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889500|NCT00653822|Alefacept|alefacept|mesh-list
92889501|NCT00653822|Dermatologic Agents|dermatologic agents|mesh-ancestor
92889502|NCT00653822|Immunologic Factors|immunologic factors|mesh-ancestor
92889503|NCT00653822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889504|NCT04137276|Vitamins|vitamins|mesh-list
92889505|NCT04137276|Thiamine|thiamine|mesh-list
92889506|NCT04137276|Vitamin B Complex|vitamin b complex|mesh-list
92889507|NCT04137276|Micronutrients|micronutrients|mesh-ancestor
92889508|NCT04137276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889509|NCT02723981|Vitamins|vitamins|mesh-list
92889510|NCT02723981|Vitamin K|vitamin k|mesh-list
92889511|NCT02723981|Rivaroxaban|rivaroxaban|mesh-list
92889512|NCT02723981|Dabigatran|dabigatran|mesh-list
92889513|NCT02723981|Anticoagulants|anticoagulants|mesh-list
92889514|NCT02723981|Clopidogrel|clopidogrel|mesh-list
92889515|NCT02723981|Micronutrients|micronutrients|mesh-ancestor
92889516|NCT02723981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889517|NCT02723981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92889518|NCT02723981|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92889519|NCT02723981|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92889520|NCT02723981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92889521|NCT02723981|Purinergic Agents|purinergic agents|mesh-ancestor
92889522|NCT02723981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889523|NCT02723981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889524|NCT02723981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92889525|NCT02723981|Antithrombins|antithrombins|mesh-ancestor
92889526|NCT02723981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92889527|NCT02723981|Protease Inhibitors|protease inhibitors|mesh-ancestor
92889528|NCT02723981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889529|NCT02723981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92889530|NCT02723981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92889531|NCT02723981|Hemostatics|hemostatics|mesh-ancestor
92889532|NCT02723981|Coagulants|coagulants|mesh-ancestor
92889533|NCT00912444|Cyclophosphamide|cyclophosphamide|mesh-list
92889534|NCT00912444|Docetaxel|docetaxel|mesh-list
92889535|NCT00912444|Doxorubicin|doxorubicin|mesh-list
92889536|NCT00912444|Epirubicin|epirubicin|mesh-list
92889537|NCT00912444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889538|NCT00912444|Immunologic Factors|immunologic factors|mesh-ancestor
92889539|NCT00912444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889540|NCT00912444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889541|NCT00912444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92889542|NCT00912444|Alkylating Agents|alkylating agents|mesh-ancestor
92889543|NCT00912444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889544|NCT00912444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889545|NCT00912444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92889546|NCT00912444|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889547|NCT00912444|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889548|NCT00912444|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889549|NCT00912444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92889550|NCT00912444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92889551|NCT00912444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92889552|NCT00912444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889553|NCT02644525|Imatinib Mesylate|imatinib mesylate|mesh-list
92889554|NCT02644525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889555|NCT02644525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889556|NCT02644525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046936|NCT00346268|Sensory System Agents|sensory system agents|mesh-ancestor
92889557|NCT02644525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889559|NCT00726700|Cyclophosphamide|cyclophosphamide|mesh-list
92889560|NCT00726700|Rituximab|rituximab|mesh-list
92889561|NCT00726700|Doxorubicin|doxorubicin|mesh-list
92889562|NCT00726700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92889563|NCT00726700|Vincristine|vincristine|mesh-list
92889564|NCT00726700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889565|NCT00726700|Immunologic Factors|immunologic factors|mesh-ancestor
92889566|NCT00726700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889567|NCT00726700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889568|NCT00726700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92889569|NCT00726700|Alkylating Agents|alkylating agents|mesh-ancestor
92889570|NCT00726700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889571|NCT00726700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889572|NCT00726700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92889573|NCT00726700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889574|NCT00726700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92889575|NCT00726700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92889576|NCT00726700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92889577|NCT00726700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889578|NCT00726700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889579|NCT00726700|Glucocorticoids|glucocorticoids|mesh-ancestor
92889580|NCT00726700|Hormones|hormones|mesh-ancestor
92889581|NCT00726700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889582|NCT00726700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92889583|NCT00726700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92889584|NCT00726700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889585|NCT00726700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889586|NCT00726700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889587|NCT02723903|Fluoxetine|fluoxetine|mesh-list
92889588|NCT02723903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92889589|NCT02723903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92889590|NCT02723903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92889591|NCT02723903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889592|NCT02723903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889593|NCT02723903|Serotonin Agents|serotonin agents|mesh-ancestor
92889594|NCT02723903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889595|NCT02723903|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92889596|NCT02723903|Antidepressive Agents|antidepressive agents|mesh-ancestor
92889597|NCT02723903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92889598|NCT02723903|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92889599|NCT02723903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92889600|NCT02723903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889601|NCT00675714|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92889602|NCT00675714|Itraconazole|itraconazole|mesh-list
92889603|NCT00675714|Fluconazole|fluconazole|mesh-list
92889604|NCT00675714|Ketoconazole|ketoconazole|mesh-list
92889605|NCT00675714|Methyltestosterone|methyltestosterone|mesh-list
92889606|NCT00675714|Propranolol|propranolol|mesh-list
92889607|NCT00675714|Metoprolol|metoprolol|mesh-list
92889608|NCT00675714|Hormones|hormones|mesh-list
92889609|NCT00675714|Testosterone|testosterone|mesh-list
92889610|NCT00675714|Testosterone undecanoate|testosterone undecanoate|mesh-list
92889611|NCT00675714|Testosterone enanthate|testosterone enanthate|mesh-list
92889612|NCT00675714|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92889613|NCT00675714|Oxandrolone|oxandrolone|mesh-list
92889614|NCT00675714|Nandrolone|nandrolone|mesh-list
92889615|NCT00675714|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92889616|NCT00675714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889617|NCT00675714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889618|NCT00675714|Androgens|androgens|mesh-ancestor
92889619|NCT00675714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92889620|NCT00675714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889621|NCT00675714|Anabolic Agents|anabolic agents|mesh-ancestor
92889622|NCT00675714|Antifungal Agents|antifungal agents|mesh-ancestor
92889623|NCT00675714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889624|NCT00675714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92889625|NCT00675714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92889626|NCT00675714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889627|NCT00675714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889628|NCT00675714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92889629|NCT00675714|Hormone Antagonists|hormone antagonists|mesh-ancestor
92889630|NCT00675714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92889631|NCT00675714|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92889632|NCT00675714|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92889633|NCT00675714|Adrenergic Agents|adrenergic agents|mesh-ancestor
92889634|NCT00675714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889635|NCT00675714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92889636|NCT00675714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92889637|NCT00675714|Vasodilator Agents|vasodilator agents|mesh-ancestor
92889639|NCT00675714|Autonomic Agents|autonomic agents|mesh-ancestor
92889640|NCT00675714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889641|NCT00675714|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92889642|NCT00675714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92889643|NCT00675714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92889644|NCT00675714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92889645|NCT00656240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92889646|NCT00656240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92889647|NCT00729976|Ibuprofen|ibuprofen|mesh-list
92889648|NCT00729976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92889649|NCT00729976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92889650|NCT00729976|Analgesics|analgesics|mesh-ancestor
92889651|NCT00729976|Sensory System Agents|sensory system agents|mesh-ancestor
92889652|NCT00729976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889653|NCT00729976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889654|NCT00729976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889655|NCT00729976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889656|NCT00729976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92889657|NCT00729976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889658|NCT00729976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889659|NCT00656318|Contraceptive Agents|contraceptive agents|mesh-list
92889660|NCT00656318|Contraceptives, Oral|contraceptives, oral|mesh-list
92889661|NCT00656318|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92889662|NCT00656318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92889663|NCT00656318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889664|NCT00656318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92889665|NCT02451553|Capecitabine|capecitabine|mesh-list
92889666|NCT02451553|Afatinib|afatinib|mesh-list
92889667|NCT02451553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92889668|NCT02451553|Antimetabolites|antimetabolites|mesh-ancestor
92889669|NCT02451553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889670|NCT02451553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889671|NCT02451553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889672|NCT02451553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889673|NCT02636816|Carbetocin|carbetocin|mesh-list
92889674|NCT02636816|Oxytocics|oxytocics|mesh-ancestor
92889675|NCT02636816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92889676|NCT02636816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889677|NCT00730054|Clonidine|clonidine|mesh-list
92889678|NCT00730054|Remifentanil|remifentanil|mesh-list
92889679|NCT00730054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92889680|NCT00730054|Narcotics|narcotics|mesh-ancestor
92889681|NCT00730054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889682|NCT00730054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889683|NCT00730054|Analgesics|analgesics|mesh-ancestor
92889684|NCT00730054|Sensory System Agents|sensory system agents|mesh-ancestor
92889685|NCT00730054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889686|NCT00730054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92889687|NCT00730054|Sympatholytics|sympatholytics|mesh-ancestor
92889688|NCT00730054|Autonomic Agents|autonomic agents|mesh-ancestor
92889689|NCT00730054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92889690|NCT00730054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92889691|NCT00730054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92889692|NCT00730054|Adrenergic Agents|adrenergic agents|mesh-ancestor
92889693|NCT00730054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889694|NCT00730054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889695|NCT00866619|Vaccines|vaccines|mesh-list
92889696|NCT00866619|Immunologic Factors|immunologic factors|mesh-ancestor
92889697|NCT00866619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889698|NCT00693108|Testosterone|testosterone|mesh-list
92889699|NCT00693108|Androgens|androgens|mesh-ancestor
92889700|NCT00693108|Hormones|hormones|mesh-ancestor
92889701|NCT00693108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889702|NCT00693108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889703|NCT00884390|Factor VIII|factor viii|mesh-list
92889704|NCT00884390|Coagulants|coagulants|mesh-ancestor
92889705|NCT02723669|Acetylcysteine|acetylcysteine|mesh-list
92889706|NCT02723669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92889707|NCT02723669|Antiviral Agents|antiviral agents|mesh-ancestor
92889708|NCT02723669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889710|NCT02723669|Respiratory System Agents|respiratory system agents|mesh-ancestor
92889711|NCT02723669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92889712|NCT02723669|Antioxidants|antioxidants|mesh-ancestor
92889713|NCT02723669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889714|NCT02723669|Protective Agents|protective agents|mesh-ancestor
92889715|NCT02723669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889716|NCT02723669|Antidotes|antidotes|mesh-ancestor
92889717|NCT02719379|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92889718|NCT02719379|Immunologic Factors|immunologic factors|mesh-ancestor
92889719|NCT02719379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889720|NCT00689442|Atorvastatin|atorvastatin|mesh-list
92889721|NCT00689442|Dalcetrapib|dalcetrapib|mesh-list
92889722|NCT00689442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92889723|NCT00689442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92889724|NCT00689442|Antimetabolites|antimetabolites|mesh-ancestor
92889725|NCT00689442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889726|NCT00689442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92889727|NCT00689442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92889728|NCT00689442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889729|NCT02625636|Glucagon|glucagon|mesh-list
92889730|NCT02625636|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92889731|NCT02625636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92889732|NCT02625636|Hormones|hormones|mesh-ancestor
92889733|NCT02625636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889734|NCT02625636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889735|NCT02625636|Incretins|incretins|mesh-ancestor
92889736|NCT03012100|Cyclophosphamide|cyclophosphamide|mesh-list
92889737|NCT03012100|Vaccines|vaccines|mesh-list
92889738|NCT03012100|Sargramostim|sargramostim|mesh-list
92889739|NCT03012100|Immunologic Factors|immunologic factors|mesh-ancestor
92889740|NCT03012100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889741|NCT03012100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889742|NCT03012100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889743|NCT03012100|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92889744|NCT03012100|Alkylating Agents|alkylating agents|mesh-ancestor
92889745|NCT03012100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889746|NCT03012100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889747|NCT03012100|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92889748|NCT02379247|Paclitaxel|paclitaxel|mesh-list
92889749|NCT02379247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92889750|NCT02379247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889751|NCT02379247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889752|NCT02379247|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889753|NCT02379247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92889754|NCT02379247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889755|NCT00689520|Vitamin K|vitamin k|mesh-list
92889756|NCT00689520|Tinzaparin|tinzaparin|mesh-list
92889757|NCT00689520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92889758|NCT00689520|Dalteparin|dalteparin|mesh-list
92889759|NCT00689520|Acenocoumarol|acenocoumarol|mesh-list
92889760|NCT00689520|Vitamins|vitamins|mesh-ancestor
92889761|NCT00689520|Micronutrients|micronutrients|mesh-ancestor
92889762|NCT00689520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889763|NCT00689520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92889764|NCT00689520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92889765|NCT00689520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889766|NCT00689520|Hemostatics|hemostatics|mesh-ancestor
92889767|NCT00689520|Coagulants|coagulants|mesh-ancestor
92889768|NCT00689520|Anticoagulants|anticoagulants|mesh-ancestor
92889769|NCT00689520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92889770|NCT02723279|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92889771|NCT02723279|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92889772|NCT02723279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92889773|NCT02723279|Cholinergic Agents|cholinergic agents|mesh-ancestor
92889774|NCT02723279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889775|NCT02723279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889776|NCT02723279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889777|NCT02723279|Urological Agents|urological agents|mesh-ancestor
92889778|NCT02615301|Vitamin D|vitamin d|mesh-list
92889779|NCT02615301|Ergocalciferols|ergocalciferols|mesh-list
92889780|NCT02615301|Cholecalciferol|cholecalciferol|mesh-list
92535156|NCT00073840|Albuterol|albuterol|mesh-list
92889781|NCT02615301|Vitamins|vitamins|mesh-list
92889782|NCT02615301|Micronutrients|micronutrients|mesh-ancestor
92889783|NCT02615301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889784|NCT02615301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92889785|NCT02615301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92889786|NCT02570230|Ketamine|ketamine|mesh-list
92889787|NCT02570230|Analgesics|analgesics|mesh-ancestor
92889788|NCT02570230|Sensory System Agents|sensory system agents|mesh-ancestor
92889789|NCT02570230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889790|NCT02570230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889791|NCT02570230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92889792|NCT02570230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92889793|NCT02570230|Anesthetics, General|anesthetics, general|mesh-ancestor
92889794|NCT02570230|Anesthetics|anesthetics|mesh-ancestor
92889795|NCT02570230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889796|NCT02570230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92889797|NCT02570230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92889798|NCT02570230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190751|NCT03025958|Nimotuzumab|nimotuzumab|mesh-list
92889799|NCT02570230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889800|NCT00693342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92889801|NCT00693342|Immunologic Factors|immunologic factors|mesh-ancestor
92889802|NCT00693342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889803|NCT02718911|Durvalumab|durvalumab|mesh-list
92889804|NCT02718911|Tremelimumab|tremelimumab|mesh-list
92889805|NCT02718911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889806|NCT02718911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889807|NCT00697905|Carboplatin|carboplatin|mesh-list
92889808|NCT00697905|Gemcitabine|gemcitabine|mesh-list
92889809|NCT00697905|Fluorouracil|fluorouracil|mesh-list
92889810|NCT00697905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889811|NCT00697905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92889812|NCT00697905|Antimetabolites|antimetabolites|mesh-ancestor
92889813|NCT00697905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889814|NCT00697905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889815|NCT00697905|Immunologic Factors|immunologic factors|mesh-ancestor
92889816|NCT00697905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889817|NCT02718755|Cytarabine|cytarabine|mesh-list
92889818|NCT02718755|Fludarabine|fludarabine|mesh-list
92889819|NCT02718755|Fludarabine phosphate|fludarabine phosphate|mesh-list
92889820|NCT02718755|Asparaginase|asparaginase|mesh-list
92889821|NCT02718755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889822|NCT02718755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92889823|NCT02718755|Antimetabolites|antimetabolites|mesh-ancestor
92889824|NCT02718755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889825|NCT02718755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889826|NCT02718755|Immunologic Factors|immunologic factors|mesh-ancestor
92889827|NCT02718755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889828|NCT02718755|Antiviral Agents|antiviral agents|mesh-ancestor
92889829|NCT02718755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889830|NCT00730210|Parathyroid Hormone|parathyroid hormone|mesh-list
92889831|NCT00730210|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92889832|NCT00730210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889833|NCT00730288|Vaccines|vaccines|mesh-list
92889834|NCT00730288|Immunologic Factors|immunologic factors|mesh-ancestor
92889835|NCT00730288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889836|NCT00872898|Memantine|memantine|mesh-list
92889837|NCT00872898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92889838|NCT00872898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92889840|NCT00872898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889841|NCT00872898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889842|NCT00872898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889843|NCT00872898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92889844|NCT00872898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92889845|NCT02723435|Midostaurin|midostaurin|mesh-list
92889846|NCT02723435|Staurosporine|staurosporine|mesh-list
92889847|NCT02723435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889848|NCT02723435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889849|NCT02723435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889850|NCT02723435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889851|NCT02718677|Factor VIII|factor viii|mesh-list
92889852|NCT02718677|Coagulants|coagulants|mesh-ancestor
92889853|NCT04132011|Morphine|morphine|mesh-list
92889854|NCT04132011|Oxycodone|oxycodone|mesh-list
92889855|NCT04132011|Analgesics, Opioid|analgesics, opioid|mesh-list
92535204|NCT00074191|Antiemetics|antiemetics|mesh-ancestor
92889856|NCT04132011|Hydromorphone|hydromorphone|mesh-list
92889857|NCT04132011|Narcotics|narcotics|mesh-ancestor
92889858|NCT04132011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92889859|NCT04132011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889860|NCT04132011|Analgesics|analgesics|mesh-ancestor
92889861|NCT04132011|Sensory System Agents|sensory system agents|mesh-ancestor
92889862|NCT04132011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889863|NCT00693576|Simvastatin|simvastatin|mesh-list
92889864|NCT00693576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92889865|NCT00693576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92889866|NCT00693576|Antimetabolites|antimetabolites|mesh-ancestor
92889867|NCT00693576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889868|NCT00693576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92889869|NCT00693576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92889870|NCT00693576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889871|NCT04116047|Durvalumab|durvalumab|mesh-list
92889872|NCT04116047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889873|NCT04116047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889874|NCT00693732|Escitalopram|escitalopram|mesh-list
92889875|NCT00693732|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92889876|NCT00693732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92889877|NCT00693732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92889878|NCT00693732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889879|NCT00693732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889880|NCT00693732|Serotonin Agents|serotonin agents|mesh-ancestor
92889881|NCT00693732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889882|NCT00689598|Spironolactone|spironolactone|mesh-list
92889883|NCT00689598|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92889884|NCT00689598|Hormone Antagonists|hormone antagonists|mesh-ancestor
92889885|NCT00689598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92889886|NCT00689598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889887|NCT00689598|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92889888|NCT00689598|Diuretics|diuretics|mesh-ancestor
92889889|NCT00689598|Natriuretic Agents|natriuretic agents|mesh-ancestor
92889890|NCT04163354|Listerine|listerine|mesh-list
92889891|NCT04163354|Fluorides|fluorides|mesh-list
92889892|NCT04163354|Sodium Fluoride|sodium fluoride|mesh-list
92889893|NCT04163354|Fluorides, Topical|fluorides, topical|mesh-list
92889894|NCT04163354|Cariostatic Agents|cariostatic agents|mesh-ancestor
92889895|NCT04163354|Protective Agents|protective agents|mesh-ancestor
92889896|NCT04163354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889897|NCT04163354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92889898|NCT04163354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889899|NCT04131621|Nivolumab|nivolumab|mesh-list
92889900|NCT04131621|Ipilimumab|ipilimumab|mesh-list
92889901|NCT04131621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889902|NCT04131621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889903|NCT04131621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92889904|NCT04131621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889905|NCT00689832|Fluticasone|fluticasone|mesh-list
92889906|NCT00689832|Tacrolimus|tacrolimus|mesh-list
92889907|NCT00689832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889908|NCT00689832|Immunologic Factors|immunologic factors|mesh-ancestor
92889909|NCT00689832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889910|NCT00689832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92889911|NCT00689832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889912|NCT00689832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889913|NCT00689832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889914|NCT00689832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92889915|NCT00689832|Autonomic Agents|autonomic agents|mesh-ancestor
92889916|NCT00689832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889917|NCT00689832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92889918|NCT00689832|Respiratory System Agents|respiratory system agents|mesh-ancestor
92889919|NCT00689832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92889920|NCT00689832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92889922|NCT02718521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92889923|NCT02718521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92889924|NCT02718521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92889925|NCT02718521|Diuretics|diuretics|mesh-ancestor
92889926|NCT02718521|Natriuretic Agents|natriuretic agents|mesh-ancestor
92889927|NCT02718521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889928|NCT02718521|Vasodilator Agents|vasodilator agents|mesh-ancestor
92889929|NCT02718521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92889930|NCT02718521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889931|NCT02718599|Terlipressin|terlipressin|mesh-list
92889932|NCT02718599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92889933|NCT02718599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92889934|NCT00693966|Vaccines|vaccines|mesh-list
92889935|NCT00693966|Immunologic Factors|immunologic factors|mesh-ancestor
92889936|NCT00693966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889937|NCT00694044|Varenicline|varenicline|mesh-list
92889938|NCT00694044|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92889939|NCT00694044|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92889940|NCT00694044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92889941|NCT00694044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92889942|NCT00694044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889943|NCT00694044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889944|NCT02722811|Etanercept|etanercept|mesh-list
92889945|NCT02722811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92889946|NCT02722811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92889947|NCT02722811|Analgesics|analgesics|mesh-ancestor
92889948|NCT02722811|Sensory System Agents|sensory system agents|mesh-ancestor
92889949|NCT02722811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92889950|NCT02722811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889951|NCT02722811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92889952|NCT02722811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889953|NCT02722811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92889954|NCT02722811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889955|NCT02722811|Immunologic Factors|immunologic factors|mesh-ancestor
92889956|NCT04136886|Cisplatin|cisplatin|mesh-list
92889957|NCT04136886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889958|NCT04103645|Vactosertib|vactosertib|mesh-list
92889959|NCT04103645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92889960|NCT04103645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92889961|NCT04103645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889962|NCT00534313|Abatacept|abatacept|mesh-list
92889963|NCT00534313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92889964|NCT00534313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889965|NCT00534313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889966|NCT00534313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889967|NCT00534313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889968|NCT00534313|Immunologic Factors|immunologic factors|mesh-ancestor
92889969|NCT00534313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889970|NCT00534313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92889971|NCT00694200|Bevacizumab|bevacizumab|mesh-list
92889972|NCT00694200|Vinorelbine|vinorelbine|mesh-list
92889973|NCT00694200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92889974|NCT00694200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889975|NCT00694200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92889976|NCT00694200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92889977|NCT00694200|Growth Substances|growth substances|mesh-ancestor
92889978|NCT00694200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889979|NCT00694200|Growth Inhibitors|growth inhibitors|mesh-ancestor
92889980|NCT00694200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92889981|NCT00694200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92889982|NCT00694200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92889983|NCT00694200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525621|NCT00025558|Thiotepa|thiotepa|mesh-list
92889984|NCT00694200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889986|NCT02722733|Lenograstim|lenograstim|mesh-list
92889987|NCT02722733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92889988|NCT02722733|Immunologic Factors|immunologic factors|mesh-ancestor
92889989|NCT02722733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92889990|NCT02722733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92889991|NCT02722733|Antimetabolites|antimetabolites|mesh-ancestor
92889992|NCT02722733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92889993|NCT02722733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92889994|NCT02722733|Antiviral Agents|antiviral agents|mesh-ancestor
92889995|NCT02722733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92889996|NCT02722733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92889997|NCT02722421|Efavirenz|efavirenz|mesh-list
92889998|NCT02722421|Levonorgestrel|levonorgestrel|mesh-list
92889999|NCT02722421|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92890000|NCT02722421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890001|NCT02722421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890002|NCT02722421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890003|NCT02722421|Antiviral Agents|antiviral agents|mesh-ancestor
92890004|NCT02722421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890005|NCT02722421|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92535353|NCT00075439|Gefitinib|gefitinib|mesh-list
92890006|NCT02722421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92890007|NCT02722421|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92890008|NCT02722421|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92890009|NCT02722421|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92890010|NCT02722421|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92890011|NCT02722421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92890012|NCT02722421|Contraceptive Agents|contraceptive agents|mesh-ancestor
92890013|NCT02722421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92890014|NCT02722421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890015|NCT02722421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92890016|NCT02722421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92890017|NCT02722421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92890018|NCT02617290|Clopidogrel|clopidogrel|mesh-list
92890019|NCT02617290|Ticagrelor|ticagrelor|mesh-list
92890020|NCT02617290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890021|NCT02617290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92890022|NCT02617290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92890023|NCT02617290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92890024|NCT02617290|Purinergic Agents|purinergic agents|mesh-ancestor
92890025|NCT02617290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890026|NCT02617290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890027|NCT02617290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890028|NCT02717819|Vitamin D|vitamin d|mesh-list
92890029|NCT02717819|Vitamins|vitamins|mesh-ancestor
92890030|NCT02717819|Micronutrients|micronutrients|mesh-ancestor
92890031|NCT02717819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890032|NCT02717819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92890033|NCT02007655|Apixaban|apixaban|mesh-list
92890034|NCT02007655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92890035|NCT02007655|Antithrombins|antithrombins|mesh-ancestor
92890036|NCT02007655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92890037|NCT02007655|Protease Inhibitors|protease inhibitors|mesh-ancestor
92890038|NCT02007655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890039|NCT02007655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890040|NCT02007655|Anticoagulants|anticoagulants|mesh-ancestor
92890041|NCT05298462|Antibodies|antibodies|mesh-list
92890042|NCT05298462|Immunologic Factors|immunologic factors|mesh-ancestor
92890043|NCT05298462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890044|NCT00730366|Chloroquine|chloroquine|mesh-list
92890045|NCT00730366|Pyrimethamine|pyrimethamine|mesh-list
92890046|NCT00730366|Sulfadoxine|sulfadoxine|mesh-list
92890047|NCT00730366|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92890048|NCT00730366|Amebicides|amebicides|mesh-ancestor
92890049|NCT00730366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92890050|NCT00730366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92890051|NCT00730366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890052|NCT00730366|Antimalarials|antimalarials|mesh-ancestor
92890053|NCT00730366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890054|NCT00730366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92890055|NCT00730366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890056|NCT00730366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890057|NCT00730366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92890058|NCT02722343|Tenofovir|tenofovir|mesh-list
92890059|NCT02722343|Emtricitabine|emtricitabine|mesh-list
92890060|NCT02722343|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92890061|NCT02722343|Antiviral Agents|antiviral agents|mesh-ancestor
92890062|NCT02722343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890063|NCT02722343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92890064|NCT02722343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890065|NCT02722343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890066|NCT02722343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890067|NCT02722343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92890068|NCT02722343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92890069|NCT00694590|Plerixafor|plerixafor|mesh-list
92890070|NCT00694590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92890071|NCT00694590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92890072|NCT00694590|Antiviral Agents|antiviral agents|mesh-ancestor
92890073|NCT00694590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890074|NCT00730444|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92890075|NCT00730444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890076|NCT00730444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890077|NCT00730444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535427|NCT00075673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890078|NCT00730444|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92890079|NCT03903406|Dexamethasone|dexamethasone|mesh-list
92890080|NCT03903406|Lenalidomide|lenalidomide|mesh-list
92890081|NCT03903406|Ixazomib|ixazomib|mesh-list
92890082|NCT03903406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890083|NCT03903406|Antiemetics|antiemetics|mesh-ancestor
92890084|NCT03903406|Autonomic Agents|autonomic agents|mesh-ancestor
92890085|NCT03903406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890086|NCT03903406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890087|NCT03903406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890088|NCT03903406|Glucocorticoids|glucocorticoids|mesh-ancestor
92890089|NCT03903406|Hormones|hormones|mesh-ancestor
92890090|NCT03903406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890091|NCT03903406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92890092|NCT03903406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890093|NCT03903406|Immunologic Factors|immunologic factors|mesh-ancestor
92890094|NCT03903406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92890095|NCT03903406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92890096|NCT03903406|Growth Substances|growth substances|mesh-ancestor
92890097|NCT03903406|Growth Inhibitors|growth inhibitors|mesh-ancestor
92890098|NCT03903406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92890099|NCT03903406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890100|NCT03903406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890101|NCT00594204|Varenicline|varenicline|mesh-list
92890102|NCT00594204|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92890103|NCT00594204|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92890104|NCT00594204|Cholinergic Agents|cholinergic agents|mesh-ancestor
92890105|NCT00594204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890106|NCT00594204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890107|NCT00594204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890108|NCT04733092|Ethiodized Oil|ethiodized oil|mesh-list
92890109|NCT04733092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890110|NCT00999271|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92890111|NCT00999271|Hormones|hormones|mesh-list
92890112|NCT00999271|Incretins|incretins|mesh-list
92890113|NCT00999271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890114|NCT00999271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890115|NCT00999271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890116|NCT02716961|Gemcitabine|gemcitabine|mesh-list
92890117|NCT02716961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890118|NCT02716961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890119|NCT02716961|Antimetabolites|antimetabolites|mesh-ancestor
92890120|NCT02716961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890121|NCT02704156|Gemcitabine|gemcitabine|mesh-list
92890122|NCT02704156|Pembrolizumab|pembrolizumab|mesh-list
92890123|NCT02704156|Trametinib|trametinib|mesh-list
92890124|NCT02704156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890125|NCT02704156|Antimetabolites|antimetabolites|mesh-ancestor
92890126|NCT02704156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890127|NCT02704156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890128|NCT02704156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890129|NCT02704156|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92890130|NCT02704156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92890131|NCT02704156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890132|NCT00912678|Mycophenolic Acid|mycophenolic acid|mesh-list
92890133|NCT00912678|Tacrolimus|tacrolimus|mesh-list
92890134|NCT00912678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890135|NCT00912678|Immunologic Factors|immunologic factors|mesh-ancestor
92890136|NCT00912678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890137|NCT00912678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92890138|NCT00912678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890139|NCT00912678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890140|NCT00912678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92890141|NCT00912678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890142|NCT00912678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92890143|NCT00912678|Antitubercular Agents|antitubercular agents|mesh-ancestor
92890144|NCT00912678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92890145|NCT00912678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890146|NCT00995839|Terlipressin|terlipressin|mesh-list
92890147|NCT00995839|Vasopressins|vasopressins|mesh-list
92890148|NCT00995839|Arginine Vasopressin|arginine vasopressin|mesh-list
92890149|NCT00995839|Hemostatics|hemostatics|mesh-ancestor
92890150|NCT00995839|Coagulants|coagulants|mesh-ancestor
92890151|NCT00995839|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92890152|NCT00995839|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92890153|NCT00995839|Natriuretic Agents|natriuretic agents|mesh-ancestor
92890154|NCT00995839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890155|NCT00995839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92890156|NCT00994513|Thioctic Acid|thioctic acid|mesh-list
92890157|NCT00994513|Antioxidants|antioxidants|mesh-ancestor
92890158|NCT00994513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890159|NCT00994513|Protective Agents|protective agents|mesh-ancestor
92890160|NCT00994513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890161|NCT00994513|Vitamin B Complex|vitamin b complex|mesh-ancestor
92890162|NCT00994513|Vitamins|vitamins|mesh-ancestor
92890163|NCT00994513|Micronutrients|micronutrients|mesh-ancestor
92890164|NCT02616744|Ibandronic Acid|ibandronic acid|mesh-list
92890165|NCT02616744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92890166|NCT02616744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890167|NCT00995917|Vitamin K|vitamin k|mesh-list
92890168|NCT00995917|Vitamins|vitamins|mesh-ancestor
92890169|NCT00995917|Micronutrients|micronutrients|mesh-ancestor
92890170|NCT00995917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890171|NCT00995917|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92160756|NCT01182675|Antiviral Agents|antiviral agents|mesh-ancestor
92890172|NCT00995917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92890173|NCT00995917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890174|NCT00995917|Hemostatics|hemostatics|mesh-ancestor
92890175|NCT00995917|Coagulants|coagulants|mesh-ancestor
92890176|NCT02616822|Resveratrol|resveratrol|mesh-list
92890177|NCT02616822|Antioxidants|antioxidants|mesh-ancestor
92890178|NCT02616822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890179|NCT02616822|Protective Agents|protective agents|mesh-ancestor
92890180|NCT02616822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890181|NCT02616822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890182|NCT02616822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890183|NCT00912756|Cilostazol|cilostazol|mesh-list
92890184|NCT00912756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92890185|NCT00912756|Autonomic Agents|autonomic agents|mesh-ancestor
92890186|NCT00912756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890187|NCT00912756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890188|NCT00912756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92890189|NCT00912756|Respiratory System Agents|respiratory system agents|mesh-ancestor
92890190|NCT00912756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92890191|NCT00912756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92890192|NCT00912756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890193|NCT00912756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890194|NCT00912756|Vasodilator Agents|vasodilator agents|mesh-ancestor
92890195|NCT00912756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92890196|NCT00912756|Protective Agents|protective agents|mesh-ancestor
92890197|NCT00912756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92890198|NCT00912756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92890199|NCT00912756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890200|NCT04426240|Cyclosporine|cyclosporine|mesh-list
92890201|NCT04426240|Cyclosporins|cyclosporins|mesh-list
92890202|NCT04426240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890203|NCT04426240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890204|NCT04426240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890205|NCT04426240|Immunologic Factors|immunologic factors|mesh-ancestor
92890206|NCT04426240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890207|NCT04426240|Antifungal Agents|antifungal agents|mesh-ancestor
92890208|NCT04426240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890209|NCT04426240|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890210|NCT04426240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890211|NCT04426240|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92890212|NCT00995995|Rosiglitazone|rosiglitazone|mesh-list
92890213|NCT00995995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92890214|NCT00995995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890215|NCT00999349|Silymarin|silymarin|mesh-list
92890216|NCT00999349|Antioxidants|antioxidants|mesh-ancestor
92890217|NCT00999349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890218|NCT00999349|Protective Agents|protective agents|mesh-ancestor
92890219|NCT00999349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890220|NCT02621112|Imiquimod|imiquimod|mesh-list
92890221|NCT02621112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92890222|NCT02621112|Immunologic Factors|immunologic factors|mesh-ancestor
92890223|NCT02621112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890224|NCT02621112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890225|NCT02621112|Interferon Inducers|interferon inducers|mesh-ancestor
92890226|NCT04000789|Vitamins|vitamins|mesh-list
92890227|NCT04000789|Vitamin E|vitamin e|mesh-list
92890228|NCT04000789|Vitamin A|vitamin a|mesh-list
92890229|NCT04000789|Hyaluronic Acid|hyaluronic acid|mesh-list
92890230|NCT04000789|Micronutrients|micronutrients|mesh-ancestor
92535578|NCT03951207|Antimetabolites|antimetabolites|mesh-ancestor
92890231|NCT04000789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890232|NCT04000789|Antioxidants|antioxidants|mesh-ancestor
92890233|NCT04000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890234|NCT04000789|Protective Agents|protective agents|mesh-ancestor
92890235|NCT04000789|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92890236|NCT04000789|Immunologic Factors|immunologic factors|mesh-ancestor
92890238|NCT00697554|Vaccines|vaccines|mesh-list
92890239|NCT00697554|Immunologic Factors|immunologic factors|mesh-ancestor
92890240|NCT00697554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890241|NCT00731068|Mitogens|mitogens|mesh-list
92890242|NCT00731068|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890243|NCT00731068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890244|NCT00866307|Cytarabine|cytarabine|mesh-list
92890245|NCT00866307|Dexamethasone|dexamethasone|mesh-list
92890246|NCT00866307|Dexamethasone acetate|dexamethasone acetate|mesh-list
92890247|NCT00866307|Prednisone|prednisone|mesh-list
92890248|NCT00866307|Cortisone|cortisone|mesh-list
92890249|NCT00866307|Cyclophosphamide|cyclophosphamide|mesh-list
92890250|NCT00866307|Doxorubicin|doxorubicin|mesh-list
92890251|NCT00866307|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92890252|NCT00866307|Methotrexate|methotrexate|mesh-list
92890253|NCT00866307|Vincristine|vincristine|mesh-list
92890254|NCT00866307|Daunorubicin|daunorubicin|mesh-list
92890255|NCT00866307|Asparaginase|asparaginase|mesh-list
92890256|NCT00866307|Mercaptopurine|mercaptopurine|mesh-list
92890257|NCT00866307|Pegaspargase|pegaspargase|mesh-list
92890258|NCT00866307|Thioguanine|thioguanine|mesh-list
92890259|NCT00866307|BB 1101|bb 1101|mesh-list
92890260|NCT00866307|2-Aminopurine|2-aminopurine|mesh-list
92890261|NCT00866307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890262|NCT00866307|Immunologic Factors|immunologic factors|mesh-ancestor
92890263|NCT00866307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890264|NCT00866307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890265|NCT00866307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92890266|NCT00866307|Alkylating Agents|alkylating agents|mesh-ancestor
92890267|NCT00866307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890268|NCT00866307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890269|NCT00866307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92890270|NCT00866307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890271|NCT00866307|Antiemetics|antiemetics|mesh-ancestor
92890272|NCT00866307|Autonomic Agents|autonomic agents|mesh-ancestor
92890273|NCT00866307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890274|NCT00866307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890275|NCT00866307|Glucocorticoids|glucocorticoids|mesh-ancestor
92890276|NCT00866307|Hormones|hormones|mesh-ancestor
92890277|NCT00866307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890278|NCT00866307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92890279|NCT00866307|Protease Inhibitors|protease inhibitors|mesh-ancestor
92890280|NCT00866307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890281|NCT00866307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92890282|NCT00866307|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92890283|NCT00866307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92890284|NCT00866307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92890285|NCT00866307|Abortifacient Agents|abortifacient agents|mesh-ancestor
92890286|NCT00866307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92890287|NCT00866307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890288|NCT00866307|Antimetabolites|antimetabolites|mesh-ancestor
92890289|NCT00866307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890290|NCT00866307|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92890291|NCT00866307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890292|NCT00866307|Antiviral Agents|antiviral agents|mesh-ancestor
92890293|NCT00866307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890294|NCT00866307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92890295|NCT00866307|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890296|NCT00866307|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890297|NCT00866307|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890298|NCT00731146|Anesthetics|anesthetics|mesh-list
92890299|NCT00731146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890300|NCT00731146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890301|NCT02716415|Menthol|menthol|mesh-list
92890302|NCT02716415|Petrolatum|petrolatum|mesh-list
92890303|NCT02716415|Zinc Oxide|zinc oxide|mesh-list
92890304|NCT02716415|Antipruritics|antipruritics|mesh-ancestor
92890305|NCT02716415|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890306|NCT02716415|Emollients|emollients|mesh-ancestor
92890307|NCT02716415|Sunscreening Agents|sunscreening agents|mesh-ancestor
92890308|NCT02716415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92890309|NCT02716415|Protective Agents|protective agents|mesh-ancestor
92890310|NCT02716415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890311|NCT02616354|Imipenem|imipenem|mesh-list
92890312|NCT02616354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92890313|NCT02616354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890314|NCT00731224|Rivastigmine|rivastigmine|mesh-list
92890315|NCT00731224|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92890316|NCT00731224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890317|NCT00731224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890318|NCT00731224|Cholinergic Agents|cholinergic agents|mesh-ancestor
92890319|NCT00731224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890320|NCT00731224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890321|NCT00731224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92890322|NCT00731224|Protective Agents|protective agents|mesh-ancestor
92890323|NCT00531427|Buprenorphine|buprenorphine|mesh-list
92890324|NCT00531427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92890325|NCT00531427|Narcotics|narcotics|mesh-ancestor
92890326|NCT00531427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890327|NCT00531427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890328|NCT00531427|Analgesics|analgesics|mesh-ancestor
92890329|NCT00531427|Sensory System Agents|sensory system agents|mesh-ancestor
92890330|NCT00531427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890331|NCT00531427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92890332|NCT00731302|Aspirin|aspirin|mesh-list
92890333|NCT00731302|Meloxicam|meloxicam|mesh-list
92890334|NCT00731302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92890335|NCT00731302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890336|NCT00731302|Analgesics|analgesics|mesh-ancestor
92890337|NCT00731302|Sensory System Agents|sensory system agents|mesh-ancestor
92890338|NCT00731302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890339|NCT00731302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890340|NCT00731302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890341|NCT00731302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890342|NCT00731302|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92890343|NCT00731302|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92890344|NCT00731302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890345|NCT00731302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890346|NCT00731302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92890347|NCT00731302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890348|NCT00731302|Antipyretics|antipyretics|mesh-ancestor
92890349|NCT00731302|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92890350|NCT00871728|Itraconazole|itraconazole|mesh-list
92890351|NCT00871728|Antifungal Agents|antifungal agents|mesh-ancestor
92890352|NCT00871728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890353|NCT00871728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92525628|NCT00025558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92890354|NCT00871728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92890355|NCT00871728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890356|NCT00871728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890357|NCT00871728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92890358|NCT00871728|Hormone Antagonists|hormone antagonists|mesh-ancestor
92890359|NCT00871728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890360|NCT00871728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890361|NCT00871728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92890362|NCT00731380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92890363|NCT00731380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890364|NCT00999427|Povidone-Iodine|povidone-iodine|mesh-list
92890366|NCT00999427|Plasma Substitutes|plasma substitutes|mesh-ancestor
92890367|NCT00999427|Blood Substitutes|blood substitutes|mesh-ancestor
92890368|NCT00999427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92890369|NCT00999427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890370|NCT04189211|Trastuzumab|trastuzumab|mesh-list
92890371|NCT04189211|Maytansine|maytansine|mesh-list
92890372|NCT04189211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890373|NCT04189211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160776|NCT01187355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92890374|NCT04189211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92890375|NCT04189211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890376|NCT04189211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890377|NCT04189211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890378|NCT04189211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890379|NCT00364780|XL647|xl647|mesh-list
92890380|NCT00364780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890381|NCT00364780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92890382|NCT00364780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890383|NCT00364780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890384|NCT00868998|Gemcitabine|gemcitabine|mesh-list
92890385|NCT00868998|Capecitabine|capecitabine|mesh-list
92890386|NCT00868998|Docetaxel|docetaxel|mesh-list
92890387|NCT00868998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890388|NCT00868998|Antimetabolites|antimetabolites|mesh-ancestor
92890389|NCT00868998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890390|NCT00868998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890391|NCT00868998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890392|NCT00868998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890393|NCT00868998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890394|NCT00996151|Testosterone|testosterone|mesh-list
92890395|NCT00996151|Androgens|androgens|mesh-ancestor
92890396|NCT00996151|Hormones|hormones|mesh-ancestor
92890397|NCT00996151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890398|NCT00996151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890399|NCT04131231|Aldesleukin|aldesleukin|mesh-list
92890400|NCT04131231|Methotrexate|methotrexate|mesh-list
92890401|NCT04131231|Interleukin-2|interleukin-2|mesh-list
92890402|NCT04131231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92890403|NCT04131231|Abortifacient Agents|abortifacient agents|mesh-ancestor
92890404|NCT04131231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92890405|NCT04131231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890406|NCT04131231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890407|NCT04131231|Antimetabolites|antimetabolites|mesh-ancestor
92890408|NCT04131231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890409|NCT04131231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890410|NCT04131231|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890411|NCT04131231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890412|NCT04131231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92890413|NCT04131231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890414|NCT04131231|Immunologic Factors|immunologic factors|mesh-ancestor
92890415|NCT04131231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890416|NCT04131231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890417|NCT04131231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890418|NCT04131231|Analgesics|analgesics|mesh-ancestor
92890419|NCT04131231|Sensory System Agents|sensory system agents|mesh-ancestor
92890420|NCT04131231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890421|NCT04131231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92890422|NCT04131231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92890423|NCT04131231|Antiviral Agents|antiviral agents|mesh-ancestor
92890424|NCT04131231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890425|NCT02716259|Fluorides|fluorides|mesh-list
92890426|NCT02716259|Sodium Fluoride|sodium fluoride|mesh-list
92525630|NCT00025597|Cyclophosphamide|cyclophosphamide|mesh-list
92890427|NCT02716259|Cariostatic Agents|cariostatic agents|mesh-ancestor
92890428|NCT02716259|Protective Agents|protective agents|mesh-ancestor
92890429|NCT02716259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890431|NCT00996229|Antioxidants|antioxidants|mesh-ancestor
92890432|NCT00996229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890433|NCT00996229|Protective Agents|protective agents|mesh-ancestor
92890434|NCT00996229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890435|NCT00996229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890436|NCT00996229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890437|NCT02712671|Interferons|interferons|mesh-list
92890438|NCT02712671|Interferon-gamma|interferon-gamma|mesh-list
92890439|NCT02712671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890440|NCT02712671|Antiviral Agents|antiviral agents|mesh-ancestor
92890441|NCT02712671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890442|NCT02614833|Paclitaxel|paclitaxel|mesh-list
92890443|NCT02614833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92890444|NCT02614833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890445|NCT02614833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890446|NCT02614833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890447|NCT02614833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890448|NCT02614833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890449|NCT05260957|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92890450|NCT05260957|Immunoconjugates|immunoconjugates|mesh-ancestor
92890451|NCT05260957|Immunologic Factors|immunologic factors|mesh-ancestor
92890452|NCT05260957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890453|NCT00999505|Amantadine|amantadine|mesh-list
92890454|NCT00999505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92890455|NCT00999505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92890456|NCT00999505|Antiviral Agents|antiviral agents|mesh-ancestor
92890457|NCT00999505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890458|NCT00999505|Dopamine Agents|dopamine agents|mesh-ancestor
92890459|NCT00999505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890460|NCT00999505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890461|NCT00999505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890462|NCT00999505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890464|NCT00999505|Sensory System Agents|sensory system agents|mesh-ancestor
92890465|NCT00999505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890466|NCT00996385|Oxaliplatin|oxaliplatin|mesh-list
92890467|NCT00996385|Bortezomib|bortezomib|mesh-list
92890468|NCT00996385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890469|NCT00533845|Bupivacaine|bupivacaine|mesh-list
92890470|NCT00533845|Anesthetics, Local|anesthetics, local|mesh-ancestor
92890471|NCT00533845|Anesthetics|anesthetics|mesh-ancestor
92890472|NCT00533845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890473|NCT00533845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890474|NCT00533845|Sensory System Agents|sensory system agents|mesh-ancestor
92890475|NCT00533845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890476|NCT02752763|Dextrans|dextrans|mesh-list
92890477|NCT02752763|Povidone|povidone|mesh-list
92890478|NCT02752763|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92890479|NCT02752763|Lubricant Eye Drops|lubricant eye drops|mesh-list
92890480|NCT02752763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92890481|NCT02752763|Plasma Substitutes|plasma substitutes|mesh-ancestor
92890482|NCT02752763|Blood Substitutes|blood substitutes|mesh-ancestor
92890483|NCT02752763|Anticoagulants|anticoagulants|mesh-ancestor
92890484|NCT00857649|Memantine|memantine|mesh-list
92890485|NCT00857649|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92890486|NCT00857649|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92890487|NCT00857649|Dopamine Agents|dopamine agents|mesh-ancestor
92890488|NCT00857649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890489|NCT00857649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890490|NCT00857649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890491|NCT00857649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92890492|NCT00857649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92890493|NCT02752841|Vitamin D|vitamin d|mesh-list
92890494|NCT02752841|Vitamins|vitamins|mesh-ancestor
92890495|NCT02752841|Micronutrients|micronutrients|mesh-ancestor
92890496|NCT02752841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890497|NCT02752841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92890498|NCT03971669|Vaccines|vaccines|mesh-list
92890499|NCT03971669|Immunologic Factors|immunologic factors|mesh-ancestor
92890500|NCT03971669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890501|NCT02715869|Sevoflurane|sevoflurane|mesh-list
92890502|NCT02715869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890503|NCT02715869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92890504|NCT02715869|Anesthetics, General|anesthetics, general|mesh-ancestor
92890505|NCT02715869|Anesthetics|anesthetics|mesh-ancestor
92890506|NCT02715869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890507|NCT02715869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890508|NCT00532441|Docetaxel|docetaxel|mesh-list
92890509|NCT00532441|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92890510|NCT00532441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890511|NCT00532441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890512|NCT00532441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890513|NCT00532441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890514|NCT00532441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890515|NCT00532441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92890516|NCT00532441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890517|NCT00999739|Vaccines|vaccines|mesh-list
92890518|NCT00999739|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92890519|NCT00999739|Immunologic Factors|immunologic factors|mesh-ancestor
92890520|NCT00999739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890521|NCT00996463|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92890522|NCT00996463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92890523|NCT00996463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92890524|NCT00996463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890525|NCT00996463|Schistosomicides|schistosomicides|mesh-ancestor
92890526|NCT00996463|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92890527|NCT00996463|Anthelmintics|anthelmintics|mesh-ancestor
92890528|NCT00999817|Dextromethorphan|dextromethorphan|mesh-list
92890529|NCT00999817|Antitussive Agents|antitussive agents|mesh-ancestor
92890530|NCT00999817|Respiratory System Agents|respiratory system agents|mesh-ancestor
92890531|NCT00999817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92890532|NCT00999817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92890533|NCT00999817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890534|NCT00999817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890535|NCT00999817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890536|NCT00857259|Everolimus|everolimus|mesh-list
92890537|NCT00857259|Ranibizumab|ranibizumab|mesh-list
92890538|NCT00857259|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92890539|NCT00857259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92890540|NCT00857259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890541|NCT00857259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890542|NCT00857259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890543|NCT00857259|Immunologic Factors|immunologic factors|mesh-ancestor
92890544|NCT00857259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890545|NCT00857259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890546|NCT00857259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92890547|NCT00857259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92890548|NCT00857259|Growth Substances|growth substances|mesh-ancestor
92890549|NCT00857259|Growth Inhibitors|growth inhibitors|mesh-ancestor
92890550|NCT00868608|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92890551|NCT00868608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890552|NCT00868608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890553|NCT00868608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92890554|NCT00868608|Immunotoxins|immunotoxins|mesh-ancestor
92890555|NCT00868608|Immunoconjugates|immunoconjugates|mesh-ancestor
92890556|NCT00868608|Immunologic Factors|immunologic factors|mesh-ancestor
92890557|NCT00868608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890558|NCT04000633|Lidocaine|lidocaine|mesh-list
92890559|NCT04000633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92890560|NCT04000633|Anesthetics|anesthetics|mesh-ancestor
92890561|NCT04000633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890562|NCT04000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890563|NCT04000633|Sensory System Agents|sensory system agents|mesh-ancestor
92890564|NCT04000633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890565|NCT04000633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92890566|NCT04000633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92890567|NCT04000633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92890568|NCT04000633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92890569|NCT04000633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890570|NCT00994825|Simendan|simendan|mesh-list
92890571|NCT00994825|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92890572|NCT00994825|Vasodilator Agents|vasodilator agents|mesh-ancestor
92890573|NCT00994825|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92890574|NCT00994825|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92890575|NCT00994825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890576|NCT00994825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890577|NCT00994825|Protective Agents|protective agents|mesh-ancestor
92890578|NCT00994825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890579|NCT02752529|Tacrolimus|tacrolimus|mesh-list
92890580|NCT02752529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890581|NCT02752529|Immunologic Factors|immunologic factors|mesh-ancestor
92890582|NCT02752529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890583|NCT02752529|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92890584|NCT02752529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890585|NCT02752529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890586|NCT00856635|Glatiramer Acetate|glatiramer acetate|mesh-list
92890587|NCT00856635|(T,G)-A-L|(t,g)-a-l|mesh-list
92890588|NCT00856635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92890589|NCT00856635|Immunologic Factors|immunologic factors|mesh-ancestor
92890590|NCT00856635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890591|NCT00856635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890592|NCT00856635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890593|NCT02620800|Leucovorin|leucovorin|mesh-list
92890594|NCT02620800|Paclitaxel|paclitaxel|mesh-list
92890595|NCT02620800|Bevacizumab|bevacizumab|mesh-list
92890596|NCT02620800|Oxaliplatin|oxaliplatin|mesh-list
92890597|NCT02620800|Calcium|calcium|mesh-list
92890598|NCT02620800|Levoleucovorin|levoleucovorin|mesh-list
92890599|NCT02620800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92890600|NCT02620800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890601|NCT02620800|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890602|NCT02620800|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890603|NCT02620800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890604|NCT02620800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890605|NCT02620800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890606|NCT02620800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92890607|NCT02620800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92890608|NCT02620800|Growth Substances|growth substances|mesh-ancestor
92890609|NCT02620800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890610|NCT02620800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92890611|NCT02620800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92890612|NCT02620800|Antidotes|antidotes|mesh-ancestor
92535957|NCT00079456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890613|NCT02620800|Protective Agents|protective agents|mesh-ancestor
92890614|NCT02620800|Vitamin B Complex|vitamin b complex|mesh-ancestor
92890616|NCT02620800|Micronutrients|micronutrients|mesh-ancestor
92890617|NCT04135014|Midazolam|midazolam|mesh-list
92890618|NCT04135014|Dexmedetomidine|dexmedetomidine|mesh-list
92890619|NCT04135014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92890620|NCT04135014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890621|NCT04135014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890622|NCT04135014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890623|NCT04135014|Analgesics|analgesics|mesh-ancestor
92890624|NCT04135014|Sensory System Agents|sensory system agents|mesh-ancestor
92890625|NCT04135014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890626|NCT04135014|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92890627|NCT04135014|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92890628|NCT04135014|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92890629|NCT04135014|Adrenergic Agents|adrenergic agents|mesh-ancestor
92890630|NCT04135014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890631|NCT04135014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890632|NCT04135014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92890633|NCT04135014|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92890634|NCT04135014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92890635|NCT04135014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92890636|NCT04135014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92890637|NCT04135014|Anesthetics, General|anesthetics, general|mesh-ancestor
92890638|NCT04135014|Anesthetics|anesthetics|mesh-ancestor
92890639|NCT04135014|GABA Modulators|gaba modulators|mesh-ancestor
92890640|NCT04135014|GABA Agents|gaba agents|mesh-ancestor
92890641|NCT00996697|Budesonide|budesonide|mesh-list
92890642|NCT00996697|Formoterol Fumarate|formoterol fumarate|mesh-list
92890643|NCT00996697|Tiotropium Bromide|tiotropium bromide|mesh-list
92890644|NCT00996697|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92890645|NCT00996697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890646|NCT00996697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92890647|NCT00996697|Autonomic Agents|autonomic agents|mesh-ancestor
92890648|NCT00996697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890649|NCT00996697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890650|NCT00996697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92525634|NCT00025597|Etoposide|etoposide|mesh-list
92890652|NCT00996697|Glucocorticoids|glucocorticoids|mesh-ancestor
92890653|NCT00996697|Hormones|hormones|mesh-ancestor
92890654|NCT00996697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890655|NCT00996697|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92890656|NCT00996697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92890657|NCT00996697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92890658|NCT00996697|Adrenergic Agents|adrenergic agents|mesh-ancestor
92890659|NCT00996697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890660|NCT00996697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890661|NCT00996697|Parasympatholytics|parasympatholytics|mesh-ancestor
92890662|NCT00996697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92890663|NCT00996697|Cholinergic Agents|cholinergic agents|mesh-ancestor
92890664|NCT00999973|Mitomycins|mitomycins|mesh-list
92890665|NCT00999973|Mitomycin|mitomycin|mesh-list
92890666|NCT00999973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92890667|NCT00999973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890668|NCT00999973|Alkylating Agents|alkylating agents|mesh-ancestor
92890669|NCT00999973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890670|NCT00999973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890671|NCT00999973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890672|NCT02715947|Methotrexate|methotrexate|mesh-list
92890673|NCT02715947|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92890674|NCT02715947|Abortifacient Agents|abortifacient agents|mesh-ancestor
92890675|NCT02715947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92890676|NCT02715947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890677|NCT02715947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890678|NCT02715947|Antimetabolites|antimetabolites|mesh-ancestor
92890679|NCT02715947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890680|NCT02715947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890681|NCT02715947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890682|NCT02715947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890683|NCT02715947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92890684|NCT02715947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890685|NCT02715947|Immunologic Factors|immunologic factors|mesh-ancestor
92890686|NCT02715947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890687|NCT02715947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890688|NCT00856323|Tenofovir|tenofovir|mesh-list
92890689|NCT00856323|Emtricitabine|emtricitabine|mesh-list
92890690|NCT00856323|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92890691|NCT00856323|Antiviral Agents|antiviral agents|mesh-ancestor
92890692|NCT00856323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890693|NCT00856323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92890694|NCT00856323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92890695|NCT00856323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890696|NCT00856323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890697|NCT00856323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92890698|NCT00856323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92890699|NCT00856245|Rituximab|rituximab|mesh-list
92890700|NCT00856245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890701|NCT00856245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890702|NCT00856245|Immunologic Factors|immunologic factors|mesh-ancestor
92160848|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890703|NCT00856245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890704|NCT00856245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890705|NCT00855933|Cetylpyridinium|cetylpyridinium|mesh-list
92890706|NCT00855933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92890707|NCT00855933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890708|NCT00994903|Simvastatin|simvastatin|mesh-list
92890709|NCT00994903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92890710|NCT00994903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92890711|NCT00994903|Antimetabolites|antimetabolites|mesh-ancestor
92890712|NCT00994903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890713|NCT00994903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92890714|NCT00994903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92890715|NCT00994903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890716|NCT00699777|Risedronic Acid|risedronic acid|mesh-list
92890717|NCT00699777|Etidronic Acid|etidronic acid|mesh-list
92890718|NCT00699777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92890719|NCT00699777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92890720|NCT00699777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890721|NCT00699777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92890722|NCT00699777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890723|NCT00699777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92890724|NCT00997009|Paclitaxel|paclitaxel|mesh-list
92890725|NCT00997009|Carboplatin|carboplatin|mesh-list
92890726|NCT00997009|Cetuximab|cetuximab|mesh-list
92890727|NCT00997009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92890728|NCT00997009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890729|NCT00997009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92890730|NCT00997009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92890731|NCT00997009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92890732|NCT00997009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890733|NCT00997009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890734|NCT02712125|Isosorbide|isosorbide|mesh-list
92890735|NCT02712125|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92890736|NCT02712125|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92890737|NCT02712125|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92890738|NCT02712125|Diuretics|diuretics|mesh-ancestor
92890739|NCT02712125|Natriuretic Agents|natriuretic agents|mesh-ancestor
92890740|NCT02712125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890741|NCT02712125|Vasodilator Agents|vasodilator agents|mesh-ancestor
92890742|NCT02712125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92890743|NCT02712125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890744|NCT00994981|Magnesium Sulfate|magnesium sulfate|mesh-list
92890745|NCT00994981|Analgesics|analgesics|mesh-ancestor
92890746|NCT00994981|Sensory System Agents|sensory system agents|mesh-ancestor
92890747|NCT00994981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890748|NCT00994981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890749|NCT00994981|Anesthetics|anesthetics|mesh-ancestor
92890750|NCT00994981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890751|NCT00994981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92890752|NCT00994981|Anticonvulsants|anticonvulsants|mesh-ancestor
92890753|NCT00994981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92890754|NCT00994981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92890755|NCT00994981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890756|NCT00994981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92890757|NCT00994981|Tocolytic Agents|tocolytic agents|mesh-ancestor
92890758|NCT00994981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92890759|NCT02715479|Dolutegravir|dolutegravir|mesh-list
92890760|NCT02715479|BMS-955176|bms-955176|mesh-list
92890761|NCT02715479|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92890762|NCT02715479|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92890763|NCT02715479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890764|NCT02715479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160854|NCT01624259|Metformin|metformin|mesh-list
92890765|NCT02715479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92890766|NCT02715479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92890767|NCT02715479|Antiviral Agents|antiviral agents|mesh-ancestor
92890768|NCT02715479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890769|NCT01000441|Adalimumab|adalimumab|mesh-list
92890770|NCT01000441|Infliximab|infliximab|mesh-list
92890771|NCT01000441|Etanercept|etanercept|mesh-list
92890772|NCT01000441|Rituximab|rituximab|mesh-list
92890773|NCT01000441|Abatacept|abatacept|mesh-list
92890774|NCT01000441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890775|NCT01000441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890776|NCT01000441|Immunologic Factors|immunologic factors|mesh-ancestor
92890777|NCT01000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890778|NCT01000441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890779|NCT01000441|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92890780|NCT01000441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890781|NCT01000441|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890782|NCT01000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890783|NCT01000441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92890784|NCT01000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890785|NCT01000441|Analgesics|analgesics|mesh-ancestor
92890786|NCT01000441|Sensory System Agents|sensory system agents|mesh-ancestor
92890787|NCT01000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890788|NCT01000441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890789|NCT01000441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92890790|NCT01000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890791|NCT00997087|Flumazenil|flumazenil|mesh-list
92890792|NCT00997087|Antidotes|antidotes|mesh-ancestor
92890793|NCT00997087|Protective Agents|protective agents|mesh-ancestor
92890794|NCT00997087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890795|NCT00997087|GABA Modulators|gaba modulators|mesh-ancestor
92890796|NCT00997087|GABA Agents|gaba agents|mesh-ancestor
92890797|NCT00997087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890798|NCT00997087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890799|NCT01000597|Fluticasone|fluticasone|mesh-list
92890801|NCT01000597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890802|NCT01000597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92890803|NCT01000597|Autonomic Agents|autonomic agents|mesh-ancestor
92890804|NCT01000597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890805|NCT01000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890806|NCT01000597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92890807|NCT01000597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92890808|NCT01000597|Dermatologic Agents|dermatologic agents|mesh-ancestor
92890809|NCT01000597|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92890810|NCT02751593|Dexamethasone|dexamethasone|mesh-list
92890811|NCT02751593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890812|NCT02751593|Antiemetics|antiemetics|mesh-ancestor
92890813|NCT02751593|Autonomic Agents|autonomic agents|mesh-ancestor
92890814|NCT02751593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890815|NCT02751593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890816|NCT02751593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890817|NCT02751593|Glucocorticoids|glucocorticoids|mesh-ancestor
92890818|NCT02751593|Hormones|hormones|mesh-ancestor
92890819|NCT02751593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890820|NCT02751593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92890821|NCT02751593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890822|NCT00997399|Panobinostat|panobinostat|mesh-list
92890823|NCT00997399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890824|NCT00997399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92890825|NCT00997399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890826|NCT00997399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890827|NCT00997477|Budesonide|budesonide|mesh-list
92890828|NCT00997477|Formoterol Fumarate|formoterol fumarate|mesh-list
92890829|NCT00997477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890830|NCT00997477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92890831|NCT00997477|Autonomic Agents|autonomic agents|mesh-ancestor
92890832|NCT00997477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890833|NCT00997477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890834|NCT00997477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92890835|NCT00997477|Respiratory System Agents|respiratory system agents|mesh-ancestor
92890836|NCT00997477|Glucocorticoids|glucocorticoids|mesh-ancestor
92890837|NCT00997477|Hormones|hormones|mesh-ancestor
92890838|NCT00997477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890839|NCT00997477|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92890840|NCT00997477|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92890841|NCT00997477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92890842|NCT00997477|Adrenergic Agents|adrenergic agents|mesh-ancestor
92890843|NCT00997477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890844|NCT00997477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890845|NCT01000831|Vaccines|vaccines|mesh-list
92890846|NCT01000831|Immunologic Factors|immunologic factors|mesh-ancestor
92890847|NCT01000831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890848|NCT05170789|Dexamethasone|dexamethasone|mesh-list
92890849|NCT05170789|Elotuzumab|elotuzumab|mesh-list
92890850|NCT05170789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890851|NCT05170789|Antiemetics|antiemetics|mesh-ancestor
92890852|NCT05170789|Autonomic Agents|autonomic agents|mesh-ancestor
92890853|NCT05170789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890854|NCT05170789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890855|NCT05170789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890856|NCT05170789|Glucocorticoids|glucocorticoids|mesh-ancestor
92890857|NCT05170789|Hormones|hormones|mesh-ancestor
92890858|NCT05170789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890859|NCT05170789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92890860|NCT05170789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890861|NCT02693951|Cefotiam|cefotiam|mesh-list
92890862|NCT02693951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92890863|NCT02693951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890864|NCT00997711|Sirolimus|sirolimus|mesh-list
92890865|NCT00997711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92890866|NCT00997711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890867|NCT00997711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92890868|NCT00997711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890869|NCT00997711|Antifungal Agents|antifungal agents|mesh-ancestor
92890870|NCT00997711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92890871|NCT00997711|Immunologic Factors|immunologic factors|mesh-ancestor
92890872|NCT00997711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890873|NCT01001143|Decitabine|decitabine|mesh-list
92890874|NCT01001143|Bexarotene|bexarotene|mesh-list
92890875|NCT01001143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92890876|NCT01001143|Antimetabolites|antimetabolites|mesh-ancestor
92890877|NCT01001143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890878|NCT01001143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890879|NCT01001143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890880|NCT02715167|Budesonide|budesonide|mesh-list
92890881|NCT02715167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890882|NCT02715167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92890883|NCT02715167|Autonomic Agents|autonomic agents|mesh-ancestor
92890884|NCT02715167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890885|NCT02715167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890886|NCT02715167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92890887|NCT02715167|Respiratory System Agents|respiratory system agents|mesh-ancestor
92890888|NCT02715167|Glucocorticoids|glucocorticoids|mesh-ancestor
92890889|NCT02715167|Hormones|hormones|mesh-ancestor
92890890|NCT02715167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890891|NCT03885661|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92890892|NCT03885661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92890893|NCT03885661|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92890894|NCT02620566|Bupivacaine|bupivacaine|mesh-list
92890895|NCT02620566|Anesthetics, Local|anesthetics, local|mesh-ancestor
92890896|NCT02620566|Anesthetics|anesthetics|mesh-ancestor
92890897|NCT02620566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92890898|NCT02620566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890899|NCT02620566|Sensory System Agents|sensory system agents|mesh-ancestor
92890900|NCT02620566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890901|NCT00855465|Riociguat|riociguat|mesh-list
92890902|NCT00855465|Enzyme Activators|enzyme activators|mesh-ancestor
92160872|NCT02081183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890903|NCT00855465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890904|NCT02714699|Diclofenac|diclofenac|mesh-list
92890905|NCT02714699|Scopolamine|scopolamine|mesh-list
92890906|NCT02714699|Bromides|bromides|mesh-list
92890907|NCT02714699|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92890908|NCT02714699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92890909|NCT02714699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890910|NCT02714699|Analgesics|analgesics|mesh-ancestor
92890911|NCT02714699|Sensory System Agents|sensory system agents|mesh-ancestor
92890912|NCT02714699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890913|NCT02714699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890914|NCT02714699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890915|NCT02714699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890916|NCT02714699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92890917|NCT02714699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890918|NCT02714699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890920|NCT02714699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92890921|NCT02714699|Antiemetics|antiemetics|mesh-ancestor
92890922|NCT02714699|Autonomic Agents|autonomic agents|mesh-ancestor
92890923|NCT02714699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890924|NCT02714699|Mydriatics|mydriatics|mesh-ancestor
92890925|NCT02714699|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92890926|NCT02714699|Cholinergic Agents|cholinergic agents|mesh-ancestor
92890927|NCT02714699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890928|NCT02714699|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92890929|NCT02714699|Parasympatholytics|parasympatholytics|mesh-ancestor
92890930|NCT01004419|Fulvestrant|fulvestrant|mesh-list
92890931|NCT01004419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92890932|NCT01004419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890933|NCT01004419|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92890934|NCT01004419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92890935|NCT01004419|Hormone Antagonists|hormone antagonists|mesh-ancestor
92890936|NCT01004419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92890937|NCT01004419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890938|NCT02714855|Apixaban|apixaban|mesh-list
92890939|NCT02714855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92890940|NCT02714855|Antithrombins|antithrombins|mesh-ancestor
92890941|NCT02714855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92890942|NCT02714855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92890943|NCT02714855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890944|NCT02714855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890945|NCT02714855|Anticoagulants|anticoagulants|mesh-ancestor
92890946|NCT02712203|Vaccines|vaccines|mesh-list
92890948|NCT02712203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890949|NCT00696930|Edotreotide|edotreotide|mesh-list
92890950|NCT00696930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92890951|NCT00696930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890952|NCT00598442|Darbepoetin alfa|darbepoetin alfa|mesh-list
92890953|NCT00598442|Hematinics|hematinics|mesh-ancestor
92890954|NCT02714543|Hydrocortisone|hydrocortisone|mesh-list
92890955|NCT02714543|Hyaluronic Acid|hyaluronic acid|mesh-list
92890956|NCT02714543|Antioxidants|antioxidants|mesh-list
92890957|NCT02714543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890958|NCT02714543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92890959|NCT02714543|Immunologic Factors|immunologic factors|mesh-ancestor
92890960|NCT02714543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890961|NCT02714543|Viscosupplements|viscosupplements|mesh-ancestor
92890962|NCT02714543|Protective Agents|protective agents|mesh-ancestor
92890963|NCT02714543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890964|NCT02714231|Diclofenac|diclofenac|mesh-list
92890965|NCT02714231|Scopolamine|scopolamine|mesh-list
92890966|NCT02714231|Bromides|bromides|mesh-list
92890967|NCT02714231|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92890968|NCT02714231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92890969|NCT02714231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92890970|NCT02714231|Analgesics|analgesics|mesh-ancestor
92890971|NCT02714231|Sensory System Agents|sensory system agents|mesh-ancestor
92890972|NCT02714231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92890973|NCT02714231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890974|NCT02714231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92890975|NCT02714231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92890976|NCT02714231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92890977|NCT02714231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92890978|NCT02714231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92890979|NCT02714231|Anticonvulsants|anticonvulsants|mesh-ancestor
92890980|NCT02714231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92890981|NCT02714231|Antiemetics|antiemetics|mesh-ancestor
92890982|NCT02714231|Autonomic Agents|autonomic agents|mesh-ancestor
92890983|NCT02714231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92890984|NCT02714231|Mydriatics|mydriatics|mesh-ancestor
92890985|NCT02714231|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92890986|NCT02714231|Cholinergic Agents|cholinergic agents|mesh-ancestor
92890987|NCT02714231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92890988|NCT02714231|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92890989|NCT02714231|Parasympatholytics|parasympatholytics|mesh-ancestor
92890990|NCT00855309|Acyclovir|acyclovir|mesh-list
92890991|NCT00855309|Antiviral Agents|antiviral agents|mesh-ancestor
92890992|NCT00855309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92890993|NCT00532129|Rituximab|rituximab|mesh-list
92890994|NCT00532129|Chlorambucil|chlorambucil|mesh-list
92890995|NCT00532129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92890996|NCT00532129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92890997|NCT00532129|Immunologic Factors|immunologic factors|mesh-ancestor
92890998|NCT00532129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92890999|NCT00532129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891000|NCT00532129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92891001|NCT00532129|Alkylating Agents|alkylating agents|mesh-ancestor
92891002|NCT00532129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891003|NCT04163276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92891004|NCT04163276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92891005|NCT04163276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891006|NCT04163588|Metolazone|metolazone|mesh-list
92891007|NCT04163588|Diuretics|diuretics|mesh-list
92891008|NCT04163588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92891009|NCT04163588|Natriuretic Agents|natriuretic agents|mesh-ancestor
92891010|NCT04163588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891011|NCT04163588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891012|NCT04163588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891013|NCT04163588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92891014|NCT04163588|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92891015|NCT05167513|Metformin|metformin|mesh-list
92891016|NCT05167513|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92891017|NCT05167513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891018|NCT05167513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891019|NCT05167513|Incretins|incretins|mesh-ancestor
92891020|NCT05167513|Hormones|hormones|mesh-ancestor
92977258|NCT01070641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891021|NCT05167513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891022|NCT05167513|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92891024|NCT05167513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891025|NCT05167513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891026|NCT00654056|Insulin|insulin|mesh-list
92891027|NCT00654056|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92891028|NCT00654056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891029|NCT00654056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891030|NCT00854373|Hormones|hormones|mesh-list
92891031|NCT00854373|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92891032|NCT00854373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891033|NCT00854373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891034|NCT00611507|Fluorouracil|fluorouracil|mesh-list
92891035|NCT00611507|Oxaliplatin|oxaliplatin|mesh-list
92891036|NCT00611507|Antimetabolites|antimetabolites|mesh-ancestor
92891037|NCT00611507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891038|NCT00611507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92891039|NCT00611507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891040|NCT00611507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92891041|NCT00611507|Immunologic Factors|immunologic factors|mesh-ancestor
92891042|NCT00611507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891043|NCT01001845|Vitamin E|vitamin e|mesh-list
92891044|NCT01001845|alpha-Tocopherol|alpha-tocopherol|mesh-list
92891045|NCT01001845|Tocopherols|tocopherols|mesh-list
92891046|NCT01001845|Antioxidants|antioxidants|mesh-ancestor
92891047|NCT01001845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891048|NCT01001845|Protective Agents|protective agents|mesh-ancestor
92891049|NCT01001845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891050|NCT01001845|Vitamins|vitamins|mesh-ancestor
92891051|NCT01001845|Micronutrients|micronutrients|mesh-ancestor
92891052|NCT02635334|Montelukast|montelukast|mesh-list
92891053|NCT02635334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92891054|NCT02635334|Respiratory System Agents|respiratory system agents|mesh-ancestor
92891055|NCT02635334|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92891056|NCT02635334|Hormone Antagonists|hormone antagonists|mesh-ancestor
92891057|NCT02635334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891058|NCT02635334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891059|NCT02635334|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92891060|NCT02635334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92891061|NCT02635334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891062|NCT00853905|Triamcinolone|triamcinolone|mesh-list
92891063|NCT00853905|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92891064|NCT00853905|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92891065|NCT00853905|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92891066|NCT00853905|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92891067|NCT00853905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891068|NCT00853905|Glucocorticoids|glucocorticoids|mesh-ancestor
92891069|NCT00853905|Hormones|hormones|mesh-ancestor
92891070|NCT00853905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891071|NCT00853905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891072|NCT00853905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92891073|NCT00853905|Immunologic Factors|immunologic factors|mesh-ancestor
92891074|NCT00853905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891075|NCT00853905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891076|NCT00998101|Carboplatin|carboplatin|mesh-list
92891077|NCT00998101|Cetuximab|cetuximab|mesh-list
92891078|NCT00998101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891079|NCT00998101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92891080|NCT04234217|Niacin|niacin|mesh-list
92891081|NCT04234217|Niacinamide|niacinamide|mesh-list
92891082|NCT04234217|Nicotinic Acids|nicotinic acids|mesh-list
92891083|NCT04234217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92891084|NCT04234217|Antimetabolites|antimetabolites|mesh-ancestor
92891085|NCT04234217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891086|NCT04234217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92891087|NCT04234217|Vasodilator Agents|vasodilator agents|mesh-ancestor
92891088|NCT04234217|Vitamin B Complex|vitamin b complex|mesh-ancestor
92891089|NCT04234217|Vitamins|vitamins|mesh-ancestor
92891090|NCT04234217|Micronutrients|micronutrients|mesh-ancestor
92891091|NCT04234217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891092|NCT01002079|Rifampin|rifampin|mesh-list
92891093|NCT01002079|BMS 708163|bms 708163|mesh-list
92891094|NCT01002079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92891095|NCT01002079|Antitubercular Agents|antitubercular agents|mesh-ancestor
92891096|NCT01002079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92891097|NCT01002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891098|NCT01002079|Leprostatic Agents|leprostatic agents|mesh-ancestor
92891099|NCT01002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92891100|NCT01002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891101|NCT01002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891102|NCT01002079|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92891103|NCT01002079|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92891104|NCT01002079|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92891105|NCT01002079|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92891106|NCT01002079|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92891107|NCT01002079|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92891108|NCT01002079|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92891109|NCT02639624|Dialysis Solutions|dialysis solutions|mesh-list
92891110|NCT02639624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92891111|NCT05429567|Fentanyl|fentanyl|mesh-list
92891112|NCT05429567|Bupivacaine|bupivacaine|mesh-list
92891113|NCT05429567|Anesthetics, Local|anesthetics, local|mesh-ancestor
92891114|NCT05429567|Anesthetics|anesthetics|mesh-ancestor
92891115|NCT05429567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891116|NCT05429567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891117|NCT05429567|Sensory System Agents|sensory system agents|mesh-ancestor
92891118|NCT05429567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891119|NCT05429567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891120|NCT05429567|Narcotics|narcotics|mesh-ancestor
92891121|NCT05429567|Analgesics|analgesics|mesh-ancestor
92891122|NCT05429567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92891123|NCT05429567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92891124|NCT05429567|Anesthetics, General|anesthetics, general|mesh-ancestor
92891125|NCT00868296|Pantoprazole|pantoprazole|mesh-list
92891126|NCT00868296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92891127|NCT00868296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891128|NCT00868296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92891129|NCT00868296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891130|NCT00868296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891131|NCT01002157|Vitamin K|vitamin k|mesh-list
92891132|NCT01002157|Vitamin K 2|vitamin k 2|mesh-list
92891133|NCT01002157|Menaquinone 7|menaquinone 7|mesh-list
92891134|NCT01002157|Vitamins|vitamins|mesh-ancestor
92891135|NCT01002157|Micronutrients|micronutrients|mesh-ancestor
92891136|NCT01002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891137|NCT01002157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92536479|NCT00083161|Etoposide|etoposide|mesh-list
92891138|NCT01002157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92891139|NCT01002157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891140|NCT01002157|Hemostatics|hemostatics|mesh-ancestor
92891141|NCT01002157|Coagulants|coagulants|mesh-ancestor
92891142|NCT01004497|Cytarabine|cytarabine|mesh-list
92891143|NCT01004497|Dexamethasone|dexamethasone|mesh-list
92891144|NCT01004497|Dexamethasone acetate|dexamethasone acetate|mesh-list
92891145|NCT01004497|Cyclophosphamide|cyclophosphamide|mesh-list
92891146|NCT01004497|Vincristine|vincristine|mesh-list
92891147|NCT01004497|Daunorubicin|daunorubicin|mesh-list
92891148|NCT01004497|Dasatinib|dasatinib|mesh-list
92891149|NCT01004497|Mitoxantrone|mitoxantrone|mesh-list
92891150|NCT01004497|BB 1101|bb 1101|mesh-list
92891151|NCT01004497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92891152|NCT01004497|Immunologic Factors|immunologic factors|mesh-ancestor
92891153|NCT01004497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891154|NCT01004497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891155|NCT01004497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92891156|NCT01004497|Alkylating Agents|alkylating agents|mesh-ancestor
92891157|NCT01004497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891158|NCT01004497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891159|NCT01004497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92891160|NCT01004497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891161|NCT01004497|Antiemetics|antiemetics|mesh-ancestor
92891162|NCT01004497|Autonomic Agents|autonomic agents|mesh-ancestor
92891163|NCT01004497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891164|NCT01004497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891165|NCT01004497|Glucocorticoids|glucocorticoids|mesh-ancestor
92891166|NCT01004497|Hormones|hormones|mesh-ancestor
92891167|NCT01004497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891168|NCT01004497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92891169|NCT01004497|Protease Inhibitors|protease inhibitors|mesh-ancestor
92891170|NCT01004497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891171|NCT01004497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92891172|NCT01004497|Antimetabolites|antimetabolites|mesh-ancestor
92891173|NCT01004497|Antiviral Agents|antiviral agents|mesh-ancestor
92891174|NCT01004497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891175|NCT01004497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92891176|NCT01004497|Tubulin Modulators|tubulin modulators|mesh-ancestor
92891177|NCT01004497|Antimitotic Agents|antimitotic agents|mesh-ancestor
92891178|NCT01004497|Mitosis Modulators|mitosis modulators|mesh-ancestor
92891179|NCT01004497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92891180|NCT01004497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92891181|NCT01004497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92891182|NCT01004497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891183|NCT01004497|Analgesics|analgesics|mesh-ancestor
92891184|NCT01004497|Sensory System Agents|sensory system agents|mesh-ancestor
92891185|NCT02713841|Insulin|insulin|mesh-list
92891186|NCT02713841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92891187|NCT02713841|Insulin Lispro|insulin lispro|mesh-list
92891188|NCT02713841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891189|NCT02713841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891191|NCT01004575|Chromium|chromium|mesh-list
92891192|NCT01004575|Trace Elements|trace elements|mesh-ancestor
92891193|NCT01004575|Micronutrients|micronutrients|mesh-ancestor
92891194|NCT01004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891195|NCT02615730|Paclitaxel|paclitaxel|mesh-list
92891196|NCT02615730|GSK2636771|gsk2636771|mesh-list
92891197|NCT02615730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92891198|NCT02615730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891199|NCT02615730|Tubulin Modulators|tubulin modulators|mesh-ancestor
92891200|NCT02615730|Antimitotic Agents|antimitotic agents|mesh-ancestor
92891201|NCT02615730|Mitosis Modulators|mitosis modulators|mesh-ancestor
92891202|NCT02615730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891203|NCT02615730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891204|NCT02615730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891205|NCT02711891|Loperamide|loperamide|mesh-list
92891206|NCT02711891|Antidiarrheals|antidiarrheals|mesh-list
92891207|NCT02711891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891208|NCT02615496|Aflibercept|aflibercept|mesh-list
92891209|NCT02615496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92891210|NCT02615496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92891211|NCT02615496|Growth Substances|growth substances|mesh-ancestor
92891212|NCT02615496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891213|NCT02615496|Growth Inhibitors|growth inhibitors|mesh-ancestor
92891214|NCT02615496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891215|NCT02714075|Zinc|zinc|mesh-list
92891216|NCT02714075|Iron|iron|mesh-list
92891217|NCT02714075|Zinc Sulfate|zinc sulfate|mesh-list
92891218|NCT02714075|Zinc Oxide|zinc oxide|mesh-list
92891219|NCT02714075|Citric Acid|citric acid|mesh-list
92891220|NCT02714075|Sodium Citrate|sodium citrate|mesh-list
92891221|NCT02714075|Anticoagulants|anticoagulants|mesh-ancestor
92891222|NCT02714075|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92891223|NCT02714075|Chelating Agents|chelating agents|mesh-ancestor
92891224|NCT02714075|Sequestering Agents|sequestering agents|mesh-ancestor
92891225|NCT02714075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891226|NCT02714075|Trace Elements|trace elements|mesh-ancestor
92891227|NCT02714075|Micronutrients|micronutrients|mesh-ancestor
92891228|NCT02714075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891229|NCT02714075|Astringents|astringents|mesh-ancestor
92891230|NCT02714075|Dermatologic Agents|dermatologic agents|mesh-ancestor
92891231|NCT02714075|Sunscreening Agents|sunscreening agents|mesh-ancestor
92891232|NCT02714075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92891233|NCT02714075|Protective Agents|protective agents|mesh-ancestor
92891234|NCT02636426|Sorafenib|sorafenib|mesh-list
92891235|NCT02636426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891236|NCT02636426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891237|NCT02636426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891238|NCT02636426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891239|NCT02713763|Sunitinib|sunitinib|mesh-list
92891240|NCT02713763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891241|NCT02713763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92891242|NCT02713763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92891243|NCT02713763|Growth Substances|growth substances|mesh-ancestor
92891244|NCT02713763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891245|NCT02713763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92891246|NCT02713763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891247|NCT02713763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891248|NCT02713763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891249|NCT00867360|Mifepristone|mifepristone|mesh-list
92891250|NCT00867360|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92891251|NCT00867360|Abortifacient Agents|abortifacient agents|mesh-ancestor
92891252|NCT00867360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92891253|NCT00867360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160890|NCT02080403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92891254|NCT00867360|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92891255|NCT00867360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92891256|NCT00867360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92891257|NCT00867360|Contraceptive Agents|contraceptive agents|mesh-ancestor
92891258|NCT00867360|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92891259|NCT00867360|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92891260|NCT00867360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92891261|NCT00867360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891262|NCT00867360|Luteolytic Agents|luteolytic agents|mesh-ancestor
92891263|NCT00867360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92891264|NCT00867360|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92891265|NCT00656552|Escitalopram|escitalopram|mesh-list
92891266|NCT00656552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92891267|NCT00656552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92891268|NCT00656552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891269|NCT00656552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891270|NCT00656552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891271|NCT00656552|Serotonin Agents|serotonin agents|mesh-ancestor
92891272|NCT00656552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891273|NCT01004809|Dutasteride|dutasteride|mesh-list
92891274|NCT01004809|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92891275|NCT01004809|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92891276|NCT01004809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891277|NCT01004809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891278|NCT01004809|Hormone Antagonists|hormone antagonists|mesh-ancestor
92891279|NCT01004809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891280|NCT01004809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891281|NCT00883688|Bevacizumab|bevacizumab|mesh-list
92891282|NCT00883688|Lapatinib|lapatinib|mesh-list
92891283|NCT00883688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92891284|NCT00883688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891285|NCT00883688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92891286|NCT00883688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92891287|NCT00883688|Growth Substances|growth substances|mesh-ancestor
92891288|NCT00883688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891289|NCT00883688|Growth Inhibitors|growth inhibitors|mesh-ancestor
92891290|NCT00883688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891291|NCT00883688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891292|NCT00883688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891293|NCT04191863|Valproic Acid|valproic acid|mesh-list
92891294|NCT04191863|Anticonvulsants|anticonvulsants|mesh-ancestor
92891295|NCT04191863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891296|NCT04191863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891297|NCT04191863|GABA Agents|gaba agents|mesh-ancestor
92891298|NCT04191863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891299|NCT04191863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891300|NCT04191863|Antimanic Agents|antimanic agents|mesh-ancestor
92891301|NCT04191863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92891302|NCT04191863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891303|NCT04191863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92891305|NCT02636348|Calcium|calcium|mesh-list
92891306|NCT02636348|Vitamins|vitamins|mesh-ancestor
92891307|NCT02636348|Micronutrients|micronutrients|mesh-ancestor
92891308|NCT02636348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891309|NCT02636348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92891310|NCT02636348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92891311|NCT04219865|Edaravone|edaravone|mesh-list
92891312|NCT04219865|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92891313|NCT04219865|Antioxidants|antioxidants|mesh-ancestor
92891314|NCT04219865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891315|NCT04219865|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92891316|NCT04219865|Protective Agents|protective agents|mesh-ancestor
92891317|NCT04219865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891318|NCT01002703|Prednisone|prednisone|mesh-list
92891320|NCT01002703|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92891321|NCT01002703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891322|NCT01002703|Glucocorticoids|glucocorticoids|mesh-ancestor
92891323|NCT01002703|Hormones|hormones|mesh-ancestor
92891324|NCT01002703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891325|NCT01002703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891326|NCT01002703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92891327|NCT01002703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891328|NCT01002703|Immunologic Factors|immunologic factors|mesh-ancestor
92891329|NCT01002703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92891330|NCT01002703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92891331|NCT01002703|Growth Substances|growth substances|mesh-ancestor
92891332|NCT01002703|Growth Inhibitors|growth inhibitors|mesh-ancestor
92891333|NCT01002703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92891334|NCT01002703|Alkylating Agents|alkylating agents|mesh-ancestor
92891335|NCT01002703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891336|NCT02639234|Nivolumab|nivolumab|mesh-list
92891337|NCT02639234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92891338|NCT02639234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891339|NCT02639234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92891340|NCT02639234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891341|NCT00654290|Propranolol|propranolol|mesh-list
92891342|NCT00654290|Amiodarone|amiodarone|mesh-list
92891343|NCT00654290|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92891344|NCT00654290|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92891345|NCT00654290|Adrenergic Agents|adrenergic agents|mesh-ancestor
92891346|NCT00654290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891347|NCT00654290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891348|NCT00654290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891349|NCT00654290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92891350|NCT00654290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92891351|NCT00654290|Vasodilator Agents|vasodilator agents|mesh-ancestor
92891352|NCT00654290|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92891353|NCT00654290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891354|NCT00654290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92891355|NCT00654290|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92891356|NCT00654290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92891357|NCT00654290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891358|NCT00654290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92891359|NCT00654290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92891360|NCT00654290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92891361|NCT02713139|Metronidazole|metronidazole|mesh-list
92891362|NCT02713139|Clotrimazole|clotrimazole|mesh-list
92891363|NCT02713139|Miconazole|miconazole|mesh-list
92891364|NCT02713139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891365|NCT02713139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92891366|NCT02713139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92891367|NCT02713139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92891368|NCT02713139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92891369|NCT02713139|Antifungal Agents|antifungal agents|mesh-ancestor
92891370|NCT02713139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92891371|NCT02713139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92891372|NCT02713139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891373|NCT02713139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891374|NCT02713139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92891375|NCT02713139|Hormone Antagonists|hormone antagonists|mesh-ancestor
92891376|NCT02713139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891377|NCT02713139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891378|NCT02713139|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92891379|NCT02713139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92891380|NCT01005121|Colchicine|colchicine|mesh-list
92891381|NCT01005121|Gout Suppressants|gout suppressants|mesh-ancestor
92891382|NCT01005121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891383|NCT01005121|Tubulin Modulators|tubulin modulators|mesh-ancestor
92891384|NCT01005121|Antimitotic Agents|antimitotic agents|mesh-ancestor
92891385|NCT01005121|Mitosis Modulators|mitosis modulators|mesh-ancestor
92891386|NCT01005121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891387|NCT01005121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891388|NCT02711579|Celecoxib|celecoxib|mesh-list
92891389|NCT02711579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92891390|NCT02711579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92891392|NCT02711579|Sensory System Agents|sensory system agents|mesh-ancestor
92160906|NCT02079077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891393|NCT02711579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891394|NCT02711579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891395|NCT02711579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891396|NCT02711579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891397|NCT02711579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92891398|NCT02711579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92891399|NCT02711579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891400|NCT02711579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891401|NCT00611195|Remifentanil|remifentanil|mesh-list
92891402|NCT00611195|Propofol|propofol|mesh-list
92891403|NCT00611195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92891404|NCT00611195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891405|NCT00611195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891406|NCT00611195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92891407|NCT00611195|Anesthetics, General|anesthetics, general|mesh-ancestor
92891408|NCT00611195|Anesthetics|anesthetics|mesh-ancestor
92891409|NCT00611195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891410|NCT00611195|Narcotics|narcotics|mesh-ancestor
92891411|NCT00611195|Analgesics|analgesics|mesh-ancestor
92891412|NCT00611195|Sensory System Agents|sensory system agents|mesh-ancestor
92891413|NCT00611195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891414|NCT01008709|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92891415|NCT01008709|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92891416|NCT01008709|beta-Endorphin|beta-endorphin|mesh-list
92891417|NCT01008709|Hormones|hormones|mesh-ancestor
92891418|NCT01008709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891419|NCT01008709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891420|NCT01008709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891421|NCT01008709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891422|NCT02615574|Interferons|interferons|mesh-list
92891423|NCT02615574|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92891424|NCT02615574|Celecoxib|celecoxib|mesh-list
92891425|NCT02615574|Vaccines|vaccines|mesh-list
92891426|NCT02615574|Immunologic Factors|immunologic factors|mesh-ancestor
92891427|NCT02615574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891428|NCT02615574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891429|NCT02615574|Antiviral Agents|antiviral agents|mesh-ancestor
92891430|NCT02615574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891431|NCT02615574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92891432|NCT02615574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92891433|NCT02615574|Analgesics|analgesics|mesh-ancestor
92891434|NCT02615574|Sensory System Agents|sensory system agents|mesh-ancestor
92891435|NCT02615574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891436|NCT02615574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891437|NCT02615574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891438|NCT02615574|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92891439|NCT02615574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92536780|NCT00404053|Purinergic Agents|purinergic agents|mesh-ancestor
92891440|NCT02615574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891441|NCT02615574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891442|NCT02708693|Triamcinolone|triamcinolone|mesh-list
92891443|NCT02708693|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92891444|NCT02708693|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92891445|NCT02708693|Lidocaine|lidocaine|mesh-list
92891446|NCT02708693|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92891447|NCT02708693|Anesthetics, Local|anesthetics, local|mesh-ancestor
92891448|NCT02708693|Anesthetics|anesthetics|mesh-ancestor
92891449|NCT02708693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891450|NCT02708693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891451|NCT02708693|Sensory System Agents|sensory system agents|mesh-ancestor
92891452|NCT02708693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891453|NCT02708693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92891454|NCT02708693|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92891455|NCT02708693|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92891456|NCT02708693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891457|NCT02708693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891458|NCT02708693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891459|NCT02708693|Glucocorticoids|glucocorticoids|mesh-ancestor
92891460|NCT02708693|Hormones|hormones|mesh-ancestor
92891461|NCT02708693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236220|NCT00004216|Cefixime|cefixime|mesh-list
92891462|NCT02708693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160911|NCT02079077|Antipyretics|antipyretics|mesh-ancestor
92891463|NCT02708693|Immunologic Factors|immunologic factors|mesh-ancestor
92891464|NCT02708693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891465|NCT02638922|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92891466|NCT02638922|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92891467|NCT02638922|Trisequens|trisequens|mesh-list
92891468|NCT02638922|Norethindrone|norethindrone|mesh-list
92891469|NCT02638922|Estradiol|estradiol|mesh-list
92891470|NCT02638922|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92891471|NCT02638922|Estrogens|estrogens|mesh-ancestor
92891472|NCT02638922|Hormones|hormones|mesh-ancestor
92891473|NCT02638922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891474|NCT02638922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891475|NCT02638922|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92891476|NCT02638922|Contraceptive Agents|contraceptive agents|mesh-ancestor
92891477|NCT02638922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92891478|NCT02638922|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92891479|NCT02638922|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92891480|NCT02638922|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92891481|NCT02638922|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92891482|NCT01005199|Everolimus|everolimus|mesh-list
92891483|NCT01005199|Sorafenib|sorafenib|mesh-list
92891484|NCT01005199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92891485|NCT01005199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891486|NCT01005199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891487|NCT01005199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891488|NCT01005199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92891489|NCT01005199|Immunologic Factors|immunologic factors|mesh-ancestor
92891490|NCT01005199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891491|NCT01005199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891492|NCT02711189|Oxytocin|oxytocin|mesh-list
92891493|NCT02711189|Oxytocics|oxytocics|mesh-ancestor
92891494|NCT02711189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92891495|NCT02711189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891496|NCT02635802|Lidocaine|lidocaine|mesh-list
92891497|NCT02635802|Midazolam|midazolam|mesh-list
92891498|NCT02635802|Remifentanil|remifentanil|mesh-list
92891499|NCT02635802|Anesthetics, Local|anesthetics, local|mesh-ancestor
92891500|NCT02635802|Anesthetics|anesthetics|mesh-ancestor
92891501|NCT02635802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891502|NCT02635802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891503|NCT02635802|Sensory System Agents|sensory system agents|mesh-ancestor
92891504|NCT02635802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891505|NCT02635802|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92891506|NCT02635802|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92891507|NCT02635802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92891508|NCT02635802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891509|NCT02635802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891510|NCT02635802|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92891511|NCT02635802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92891512|NCT02635802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92891513|NCT02635802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92891514|NCT02635802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92891515|NCT02635802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92891516|NCT02635802|Anesthetics, General|anesthetics, general|mesh-ancestor
92891517|NCT02635802|GABA Modulators|gaba modulators|mesh-ancestor
92891518|NCT02635802|GABA Agents|gaba agents|mesh-ancestor
92891519|NCT02635802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891520|NCT02635802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891521|NCT02635802|Narcotics|narcotics|mesh-ancestor
92891522|NCT02635802|Analgesics|analgesics|mesh-ancestor
92891523|NCT00853749|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92891524|NCT00853749|Immunologic Factors|immunologic factors|mesh-ancestor
92891525|NCT00853749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891526|NCT00657410|Dexamethasone|dexamethasone|mesh-list
92891527|NCT00657410|Prednisone|prednisone|mesh-list
92891528|NCT00657410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891529|NCT00657410|Antiemetics|antiemetics|mesh-ancestor
92891530|NCT00657410|Autonomic Agents|autonomic agents|mesh-ancestor
92891531|NCT00657410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891532|NCT00657410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891533|NCT00657410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891534|NCT00657410|Glucocorticoids|glucocorticoids|mesh-ancestor
92891535|NCT00657410|Hormones|hormones|mesh-ancestor
92891536|NCT00657410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236306|NCT00005578|Hormones|hormones|mesh-ancestor
92160912|NCT03547271|Vaccines|vaccines|mesh-list
92891537|NCT00657410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92891538|NCT00657410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891539|NCT01009021|Diclofenac|diclofenac|mesh-list
92891540|NCT01009021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92891541|NCT01009021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92891542|NCT01009021|Analgesics|analgesics|mesh-ancestor
92891543|NCT01009021|Sensory System Agents|sensory system agents|mesh-ancestor
92891544|NCT01009021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891545|NCT01009021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891546|NCT01009021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891547|NCT01009021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891548|NCT01009021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92891549|NCT01009021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891550|NCT01009021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891551|NCT01005433|Dexmedetomidine|dexmedetomidine|mesh-list
92891552|NCT01005433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92891553|NCT01005433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891554|NCT01005433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891555|NCT01005433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92891556|NCT01005433|Analgesics|analgesics|mesh-ancestor
92891557|NCT01005433|Sensory System Agents|sensory system agents|mesh-ancestor
92891558|NCT01005433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891559|NCT01005433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92891560|NCT01005433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92891561|NCT01005433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92891562|NCT01005433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92891563|NCT01005433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891564|NCT01005433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891565|NCT00654446|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92891566|NCT00654446|Simvastatin|simvastatin|mesh-list
92891567|NCT00654446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92891568|NCT00654446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92891569|NCT00654446|Antimetabolites|antimetabolites|mesh-ancestor
92891570|NCT00654446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891571|NCT00654446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92891572|NCT00654446|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92891573|NCT00654446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891574|NCT01003483|Orlistat|orlistat|mesh-list
92891575|NCT01003483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891576|NCT01003483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891577|NCT01003483|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92891578|NCT01003483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92891579|NCT00592839|Estrogens|estrogens|mesh-list
92891580|NCT00592839|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92891581|NCT00592839|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
92891582|NCT00592839|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
92891583|NCT00592839|Hormones|hormones|mesh-ancestor
92891584|NCT00592839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891585|NCT00592839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891586|NCT01009177|Bosentan|bosentan|mesh-list
92891587|NCT01009177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92891588|NCT01009177|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92891589|NCT01009177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891590|NCT00598832|Adapalene|adapalene|mesh-list
92891591|NCT00598832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92891592|NCT00598832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92891593|NCT00598832|Analgesics|analgesics|mesh-ancestor
92891594|NCT00598832|Sensory System Agents|sensory system agents|mesh-ancestor
92891595|NCT00598832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891596|NCT00598832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891597|NCT00598832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891598|NCT00598832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891599|NCT00598832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92891600|NCT01003561|Anesthetics|anesthetics|mesh-list
92891601|NCT01003561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891602|NCT01003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891603|NCT02711267|Acyclovir|acyclovir|mesh-list
92891604|NCT02711267|Antiviral Agents|antiviral agents|mesh-ancestor
92891605|NCT02711267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891606|NCT04219553|Anti-Infective Agents|anti-infective agents|mesh-list
92891607|NCT04219553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92891609|NCT04459871|Hemostatics|hemostatics|mesh-ancestor
92891610|NCT04459871|Coagulants|coagulants|mesh-ancestor
92891611|NCT02708459|Morphine|morphine|mesh-list
92891612|NCT02708459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891613|NCT02708459|Narcotics|narcotics|mesh-ancestor
92891614|NCT02708459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891615|NCT02708459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891616|NCT02708459|Analgesics|analgesics|mesh-ancestor
92891617|NCT02708459|Sensory System Agents|sensory system agents|mesh-ancestor
92891618|NCT02708459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891619|NCT01005979|Cyclophosphamide|cyclophosphamide|mesh-list
92891620|NCT01005979|Rituximab|rituximab|mesh-list
92891621|NCT01005979|Lenalidomide|lenalidomide|mesh-list
92891622|NCT01005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92891623|NCT01005979|Immunologic Factors|immunologic factors|mesh-ancestor
92891624|NCT01005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891625|NCT01005979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891626|NCT01005979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92891627|NCT01005979|Alkylating Agents|alkylating agents|mesh-ancestor
92891628|NCT01005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891629|NCT01005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891630|NCT01005979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92891631|NCT01005979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92891632|NCT01005979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92891633|NCT01005979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92891634|NCT01005979|Growth Substances|growth substances|mesh-ancestor
92891635|NCT01005979|Growth Inhibitors|growth inhibitors|mesh-ancestor
92891636|NCT00913029|Timolol|timolol|mesh-list
92891637|NCT00913029|Latanoprost|latanoprost|mesh-list
92891638|NCT00913029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92891639|NCT00913029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92891640|NCT00913029|Adrenergic Agents|adrenergic agents|mesh-ancestor
92891641|NCT00913029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891642|NCT00913029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891643|NCT00913029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891644|NCT00913029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92891645|NCT00913029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92891646|NCT00913029|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92891647|NCT00913029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92891648|NCT01006057|Insulin|insulin|mesh-list
92891649|NCT01006057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92891650|NCT01006057|Insulin, Long-Acting|insulin, long-acting|mesh-list
92891651|NCT01006057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891652|NCT01006057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891653|NCT00853125|Sunitinib|sunitinib|mesh-list
92891654|NCT00853125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891655|NCT00853125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92891656|NCT00853125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92891657|NCT00853125|Growth Substances|growth substances|mesh-ancestor
92891658|NCT00853125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891659|NCT00853125|Growth Inhibitors|growth inhibitors|mesh-ancestor
92891660|NCT00853125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891661|NCT00853125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891662|NCT00853125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891663|NCT02707913|Amlodipine|amlodipine|mesh-list
92891664|NCT02707913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92891665|NCT02707913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92891666|NCT02707913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891667|NCT02707913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891668|NCT02707913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92891669|NCT02707913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891670|NCT02707913|Vasodilator Agents|vasodilator agents|mesh-ancestor
92891672|NCT02710877|Dsuvia|dsuvia|mesh-list
92891673|NCT02710877|Levobupivacaine|levobupivacaine|mesh-list
92891674|NCT02710877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891675|NCT02710877|Narcotics|narcotics|mesh-ancestor
92891676|NCT02710877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891677|NCT02710877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891678|NCT02710877|Analgesics|analgesics|mesh-ancestor
92891679|NCT02710877|Sensory System Agents|sensory system agents|mesh-ancestor
92891680|NCT02710877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891681|NCT02710877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92891682|NCT02710877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92891683|NCT02710877|Anesthetics, General|anesthetics, general|mesh-ancestor
92891684|NCT02710877|Anesthetics|anesthetics|mesh-ancestor
92891685|NCT02710877|Anesthetics, Local|anesthetics, local|mesh-ancestor
92891686|NCT00530023|Insulin|insulin|mesh-list
92891687|NCT00530023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891688|NCT00530023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891689|NCT02707445|Clopidogrel|clopidogrel|mesh-list
92891690|NCT02707445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92891691|NCT02707445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92891692|NCT02707445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92891693|NCT02707445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92891694|NCT02707445|Purinergic Agents|purinergic agents|mesh-ancestor
92891695|NCT02707445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891696|NCT02707445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891697|NCT02707445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891698|NCT03999775|Calcium, Dietary|calcium, dietary|mesh-list
92891699|NCT03999775|Vitamin D|vitamin d|mesh-list
92891700|NCT03999775|Ergocalciferols|ergocalciferols|mesh-list
92891701|NCT03999775|Cholecalciferol|cholecalciferol|mesh-list
92891702|NCT03999775|Vitamins|vitamins|mesh-list
92891703|NCT03999775|Calcium|calcium|mesh-list
92891704|NCT03999775|Micronutrients|micronutrients|mesh-ancestor
92891705|NCT03999775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891706|NCT03999775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92891707|NCT03999775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92891708|NCT02706977|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92891709|NCT02706977|Carbidopa|carbidopa|mesh-list
92891710|NCT02706977|Levodopa|levodopa|mesh-list
92891711|NCT02706977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92891712|NCT02706977|Immunologic Factors|immunologic factors|mesh-ancestor
92891713|NCT02706977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891714|NCT02706977|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92891715|NCT02706977|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92891716|NCT02706977|Dopamine Agonists|dopamine agonists|mesh-ancestor
92891717|NCT02706977|Dopamine Agents|dopamine agents|mesh-ancestor
92891718|NCT02706977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891719|NCT02706977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891720|NCT02706977|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92891721|NCT02706977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891722|NCT02707211|Antibodies|antibodies|mesh-list
92891723|NCT02707211|Immunoglobulin M|immunoglobulin m|mesh-list
92891724|NCT02707211|Immunologic Factors|immunologic factors|mesh-ancestor
92891725|NCT02707211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891726|NCT01006525|Zolpidem|zolpidem|mesh-list
92891727|NCT01006525|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92891728|NCT01006525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92891729|NCT01006525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891730|NCT01006525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891731|NCT01006525|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92891732|NCT01006525|GABA Agonists|gaba agonists|mesh-ancestor
92891733|NCT01006525|GABA Agents|gaba agents|mesh-ancestor
92891734|NCT01006525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891735|NCT01006525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891736|NCT01006681|Vaccines|vaccines|mesh-list
92891737|NCT01006681|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92891738|NCT01006681|Immunologic Factors|immunologic factors|mesh-ancestor
92891739|NCT01006681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891740|NCT01006681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92891741|NCT05733403|Norepinephrine|norepinephrine|mesh-list
92891742|NCT05733403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92891743|NCT05733403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92891744|NCT05733403|Adrenergic Agents|adrenergic agents|mesh-ancestor
92891745|NCT05733403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891746|NCT05733403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891747|NCT05733403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891748|NCT05733403|Sympathomimetics|sympathomimetics|mesh-ancestor
92891749|NCT05733403|Autonomic Agents|autonomic agents|mesh-ancestor
92891750|NCT05733403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891751|NCT05733403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92891752|NCT03893903|Avelumab|avelumab|mesh-list
92891753|NCT03893903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92891754|NCT03893903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891755|NCT02706509|Tramadol|tramadol|mesh-list
92891756|NCT02706509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891757|NCT02706509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891758|NCT02706509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891760|NCT02706509|Analgesics|analgesics|mesh-ancestor
92891761|NCT02706509|Sensory System Agents|sensory system agents|mesh-ancestor
92891762|NCT02706509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891763|NCT02710409|Vaccines|vaccines|mesh-list
92891764|NCT02710409|Immunologic Factors|immunologic factors|mesh-ancestor
92891765|NCT02710409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891766|NCT00529087|Bromides|bromides|mesh-list
92891767|NCT00529087|Methylnaltrexone|methylnaltrexone|mesh-list
92891768|NCT00529087|Anticonvulsants|anticonvulsants|mesh-ancestor
92891769|NCT00529087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92891770|NCT00529087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891771|NCT00529087|Sensory System Agents|sensory system agents|mesh-ancestor
92891772|NCT00529087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891773|NCT04318210|Tenofovir|tenofovir|mesh-list
92891774|NCT04318210|Emtricitabine|emtricitabine|mesh-list
92891775|NCT04318210|Antiviral Agents|antiviral agents|mesh-ancestor
92891776|NCT04318210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891777|NCT04318210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92891778|NCT04318210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92891779|NCT04318210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891780|NCT04318210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891781|NCT04318210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92891782|NCT04318210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92891783|NCT00611663|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92891784|NCT00611663|Immunologic Factors|immunologic factors|mesh-ancestor
92891785|NCT00611663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891786|NCT00870870|Carboplatin|carboplatin|mesh-list
92891787|NCT00870870|Gemcitabine|gemcitabine|mesh-list
92891788|NCT00870870|Cetuximab|cetuximab|mesh-list
92891789|NCT00870870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92891790|NCT00870870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891791|NCT00870870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92891792|NCT00870870|Antimetabolites|antimetabolites|mesh-ancestor
92891793|NCT00870870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891794|NCT00870870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92891795|NCT00870870|Immunologic Factors|immunologic factors|mesh-ancestor
92891796|NCT00870870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891797|NCT04120636|Celecoxib|celecoxib|mesh-list
92891798|NCT04120636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92891799|NCT04120636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92891800|NCT04120636|Analgesics|analgesics|mesh-ancestor
92891801|NCT04120636|Sensory System Agents|sensory system agents|mesh-ancestor
92891802|NCT04120636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891803|NCT04120636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891804|NCT04120636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891805|NCT04120636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891806|NCT04120636|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92891807|NCT04120636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92891808|NCT04120636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891809|NCT04120636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891810|NCT00731926|Vitamins|vitamins|mesh-list
92891811|NCT00731926|Vitamin E|vitamin e|mesh-list
92891812|NCT00731926|Micronutrients|micronutrients|mesh-ancestor
92891813|NCT00731926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891814|NCT00731926|Antioxidants|antioxidants|mesh-ancestor
92891815|NCT00731926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891816|NCT00731926|Protective Agents|protective agents|mesh-ancestor
92891817|NCT00732082|Gemcitabine|gemcitabine|mesh-list
92537154|NCT03890666|Albuterol|albuterol|mesh-list
92891818|NCT00732082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92891819|NCT00732082|Antimetabolites|antimetabolites|mesh-ancestor
92891820|NCT00732082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891821|NCT00732082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891822|NCT00611741|Furosemide|furosemide|mesh-list
92891823|NCT00611741|Diuretics|diuretics|mesh-ancestor
92891824|NCT00611741|Natriuretic Agents|natriuretic agents|mesh-ancestor
92891825|NCT00611741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891826|NCT00611741|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92891827|NCT00611741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891828|NCT00611741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891829|NCT04134468|Gemcitabine|gemcitabine|mesh-list
92891830|NCT04134468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92891831|NCT04134468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92891832|NCT04134468|Antimetabolites|antimetabolites|mesh-ancestor
92891833|NCT04134468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891834|NCT04134468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891835|NCT02709863|Propofol|propofol|mesh-list
92891836|NCT02709863|Sevoflurane|sevoflurane|mesh-list
92891837|NCT02709863|Desflurane|desflurane|mesh-list
92891838|NCT02709863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92891839|NCT02709863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891840|NCT02709863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891841|NCT02709863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92891842|NCT02709863|Anesthetics, General|anesthetics, general|mesh-ancestor
92891843|NCT02709863|Anesthetics|anesthetics|mesh-ancestor
92891844|NCT02709863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92891845|NCT02709863|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92891846|NCT03877237|Dapagliflozin|dapagliflozin|mesh-list
92891847|NCT03877237|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92891848|NCT03877237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891849|NCT03877237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891850|NCT03877237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891851|NCT02619786|Colistin|colistin|mesh-list
92891852|NCT02619786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92891853|NCT02619786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891854|NCT00697086|Dronedarone|dronedarone|mesh-list
92891855|NCT00697086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92891856|NCT04066660|Fucoidan|fucoidan|mesh-list
92891857|NCT04066660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92891858|NCT04066660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891859|NCT04066660|Anticoagulants|anticoagulants|mesh-ancestor
92891860|NCT04066660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891861|NCT00697164|Epoetin Alfa|epoetin alfa|mesh-list
92891862|NCT00697164|Hematinics|hematinics|mesh-ancestor
92891863|NCT00694980|Etrolizumab|etrolizumab|mesh-list
92891864|NCT00694980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891865|NCT00694980|Immunologic Factors|immunologic factors|mesh-ancestor
92891866|NCT00694980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891867|NCT00612755|Ribavirin|ribavirin|mesh-list
92891868|NCT00612755|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92891869|NCT00612755|Antimetabolites|antimetabolites|mesh-ancestor
92891870|NCT00612755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891871|NCT00612755|Antiviral Agents|antiviral agents|mesh-ancestor
92891872|NCT00612755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891873|NCT04132674|Tenofovir|tenofovir|mesh-list
92891874|NCT04132674|Emtricitabine|emtricitabine|mesh-list
92891875|NCT04132674|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92891876|NCT04132674|Antiviral Agents|antiviral agents|mesh-ancestor
92891877|NCT04132674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891878|NCT04132674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92891879|NCT04132674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92891880|NCT04132674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891881|NCT04132674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891882|NCT04132674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92891883|NCT04132674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92891884|NCT00612287|Buprenorphine|buprenorphine|mesh-list
92891885|NCT00612287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92891886|NCT00612287|Narcotics|narcotics|mesh-ancestor
92891887|NCT00612287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891888|NCT00612287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891889|NCT00612287|Analgesics|analgesics|mesh-ancestor
92891890|NCT00612287|Sensory System Agents|sensory system agents|mesh-ancestor
92891891|NCT00612287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891892|NCT00612287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92891893|NCT00732784|Imatinib Mesylate|imatinib mesylate|mesh-list
92891894|NCT00732784|Calcium Carbonate|calcium carbonate|mesh-list
92891895|NCT00732784|Calcium|calcium|mesh-list
92891896|NCT00732784|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92891897|NCT00732784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891898|NCT00732784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891899|NCT00732784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891900|NCT00732784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92891901|NCT00732784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891902|NCT00732784|Antacids|antacids|mesh-ancestor
92891903|NCT00732784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891904|NCT04496219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92891905|NCT04496219|BCG Vaccine|bcg vaccine|mesh-list
92891906|NCT04496219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92891907|NCT04496219|Immunologic Factors|immunologic factors|mesh-ancestor
92891908|NCT04496219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891909|NCT02947126|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92891910|NCT02947126|Pentetic Acid|pentetic acid|mesh-list
92891911|NCT02947126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92891912|NCT02947126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891913|NCT02947126|Antidotes|antidotes|mesh-ancestor
92891914|NCT02947126|Protective Agents|protective agents|mesh-ancestor
92891915|NCT02947126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891916|NCT02947126|Chelating Agents|chelating agents|mesh-ancestor
92891917|NCT02947126|Sequestering Agents|sequestering agents|mesh-ancestor
92891918|NCT02947126|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92891919|NCT04492553|Testosterone|testosterone|mesh-list
92891920|NCT04492553|Androgens|androgens|mesh-ancestor
92891921|NCT04492553|Hormones|hormones|mesh-ancestor
92891922|NCT04492553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891923|NCT04492553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891924|NCT00871494|Azithromycin|azithromycin|mesh-list
92891925|NCT00871494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92891926|NCT00871494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891927|NCT01007539|Choline|choline|mesh-list
92891928|NCT01007539|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92891929|NCT01007539|Lipotropic Agents|lipotropic agents|mesh-ancestor
92891930|NCT01007539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92891931|NCT01007539|Antimetabolites|antimetabolites|mesh-ancestor
92891932|NCT01007539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891933|NCT01007539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92891934|NCT01007539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92891935|NCT01007539|Nootropic Agents|nootropic agents|mesh-ancestor
92891936|NCT04951817|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92891937|NCT04951817|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92891938|NCT04951817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891939|NCT04137185|Hormones|hormones|mesh-list
92891940|NCT04137185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891941|NCT04137185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891942|NCT00733174|Rosiglitazone|rosiglitazone|mesh-list
92891943|NCT00733174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92891944|NCT00733174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891945|NCT00529789|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92891946|NCT00529789|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92891947|NCT00529789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92891948|NCT00529789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92891949|NCT00529789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891950|NCT00529789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92891951|NCT00529789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891952|NCT00529789|Analgesics|analgesics|mesh-ancestor
92891953|NCT00529789|Sensory System Agents|sensory system agents|mesh-ancestor
92891954|NCT00529789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891955|NCT00529789|Antidepressive Agents|antidepressive agents|mesh-ancestor
92891956|NCT00529789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92891957|NCT00529789|Dopamine Agents|dopamine agents|mesh-ancestor
92891958|NCT04136028|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92891959|NCT04136028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92891960|NCT00611819|Interferons|interferons|mesh-list
92891961|NCT00611819|Ribavirin|ribavirin|mesh-list
92891962|NCT00611819|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92891963|NCT00611819|Interferon-alpha|interferon-alpha|mesh-list
92891964|NCT00611819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891965|NCT00611819|Antiviral Agents|antiviral agents|mesh-ancestor
92891966|NCT00611819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92891967|NCT00611819|Antimetabolites|antimetabolites|mesh-ancestor
93046937|NCT00346268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891968|NCT00611819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891969|NCT00611819|Immunologic Factors|immunologic factors|mesh-ancestor
92891970|NCT00611819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891971|NCT00577642|Zoledronic Acid|zoledronic acid|mesh-list
92891972|NCT00577642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92891973|NCT00577642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891974|NCT02619162|Letrozole|letrozole|mesh-list
92891975|NCT02619162|Nintedanib|nintedanib|mesh-list
92891976|NCT02619162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92891977|NCT02619162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92891978|NCT02619162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92891979|NCT02619162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525653|NCT00025636|Cytarabine|cytarabine|mesh-list
92891980|NCT02619162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92891981|NCT02619162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92891982|NCT02619162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92891983|NCT02619162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891984|NCT02619162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891985|NCT02619162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92891986|NCT04018690|Triamcinolone|triamcinolone|mesh-list
92891987|NCT04018690|Ropivacaine|ropivacaine|mesh-list
92891988|NCT04018690|Anesthetics, Local|anesthetics, local|mesh-ancestor
92891989|NCT04018690|Anesthetics|anesthetics|mesh-ancestor
92891990|NCT04018690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92891991|NCT04018690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92891992|NCT04018690|Sensory System Agents|sensory system agents|mesh-ancestor
92891993|NCT04018690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92891994|NCT04018690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92891995|NCT04018690|Glucocorticoids|glucocorticoids|mesh-ancestor
92891996|NCT04018690|Hormones|hormones|mesh-ancestor
92891997|NCT04018690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92891998|NCT00697866|Vaccines|vaccines|mesh-list
92891999|NCT00697866|Immunologic Factors|immunologic factors|mesh-ancestor
92892000|NCT00697866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892001|NCT00733564|Lidocaine|lidocaine|mesh-list
92892002|NCT00733564|Propofol|propofol|mesh-list
92892003|NCT00733564|Sevoflurane|sevoflurane|mesh-list
92892004|NCT00733564|Anesthetics, Local|anesthetics, local|mesh-ancestor
92892005|NCT00733564|Anesthetics|anesthetics|mesh-ancestor
92892006|NCT00733564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892007|NCT00733564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892008|NCT00733564|Sensory System Agents|sensory system agents|mesh-ancestor
92892009|NCT00733564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892010|NCT00733564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92892011|NCT00733564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92892012|NCT00733564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92892013|NCT00733564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892014|NCT00733564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892015|NCT00733564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92892016|NCT00733564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92892017|NCT00733564|Anesthetics, General|anesthetics, general|mesh-ancestor
92892018|NCT00733564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92892019|NCT00733564|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92892020|NCT00727870|Glycerol|glycerol|mesh-list
92892021|NCT00727870|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92892022|NCT00727870|Protective Agents|protective agents|mesh-ancestor
92892023|NCT00727870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892024|NCT01007695|Valproic Acid|valproic acid|mesh-list
92892025|NCT01007695|Anticonvulsants|anticonvulsants|mesh-ancestor
92892026|NCT01007695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892027|NCT01007695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892028|NCT01007695|GABA Agents|gaba agents|mesh-ancestor
92892029|NCT01007695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892030|NCT01007695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892031|NCT01007695|Antimanic Agents|antimanic agents|mesh-ancestor
92892032|NCT01007695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92892033|NCT01007695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892034|NCT01007695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92892035|NCT02709473|Remifentanil|remifentanil|mesh-list
92892036|NCT02709473|Propofol|propofol|mesh-list
92892037|NCT02709473|Rocuronium|rocuronium|mesh-list
92892038|NCT02709473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92892039|NCT02709473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892040|NCT02709473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892041|NCT02709473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92537383|NCT00140257|Escitalopram|escitalopram|mesh-list
92892043|NCT02709473|Anesthetics|anesthetics|mesh-ancestor
92892044|NCT02709473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92892045|NCT02709473|Narcotics|narcotics|mesh-ancestor
92892046|NCT02709473|Analgesics|analgesics|mesh-ancestor
92892047|NCT02709473|Sensory System Agents|sensory system agents|mesh-ancestor
92892048|NCT02709473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892049|NCT02709473|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92892050|NCT02709473|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92892051|NCT02709473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92892052|NCT00866658|Lixisenatide|lixisenatide|mesh-list
92892053|NCT00866658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92892054|NCT00866658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892055|NCT04942067|Dexamethasone|dexamethasone|mesh-list
92892056|NCT04942067|Dexamethasone acetate|dexamethasone acetate|mesh-list
92892057|NCT04942067|Lenalidomide|lenalidomide|mesh-list
92892058|NCT04942067|Daratumumab|daratumumab|mesh-list
92892059|NCT04942067|Pomalidomide|pomalidomide|mesh-list
92892060|NCT04942067|BB 1101|bb 1101|mesh-list
92892061|NCT04942067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892062|NCT04942067|Antiemetics|antiemetics|mesh-ancestor
92892063|NCT04942067|Autonomic Agents|autonomic agents|mesh-ancestor
92892064|NCT04942067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892065|NCT04942067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892066|NCT04942067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892067|NCT04942067|Glucocorticoids|glucocorticoids|mesh-ancestor
92892068|NCT04942067|Hormones|hormones|mesh-ancestor
92892069|NCT04942067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892070|NCT04942067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892071|NCT04942067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892072|NCT04942067|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892073|NCT04942067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892074|NCT04942067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892075|NCT04942067|Immunologic Factors|immunologic factors|mesh-ancestor
92892076|NCT04942067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892077|NCT04942067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892078|NCT04942067|Growth Substances|growth substances|mesh-ancestor
92892079|NCT04942067|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892080|NCT01007773|Fentanyl|fentanyl|mesh-list
92892081|NCT01007773|Dexmedetomidine|dexmedetomidine|mesh-list
92892082|NCT01007773|Propofol|propofol|mesh-list
92892083|NCT01007773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92892084|NCT01007773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892085|NCT01007773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892086|NCT01007773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92892087|NCT01007773|Analgesics|analgesics|mesh-ancestor
92892088|NCT01007773|Sensory System Agents|sensory system agents|mesh-ancestor
92892089|NCT01007773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892090|NCT01007773|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92892091|NCT01007773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92892092|NCT01007773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92892093|NCT01007773|Adrenergic Agents|adrenergic agents|mesh-ancestor
92892094|NCT01007773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892095|NCT01007773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892096|NCT01007773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92892097|NCT01007773|Anesthetics, General|anesthetics, general|mesh-ancestor
92892098|NCT01007773|Anesthetics|anesthetics|mesh-ancestor
92892099|NCT01007773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92892100|NCT01007773|Narcotics|narcotics|mesh-ancestor
92892101|NCT01007773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92892102|NCT02615340|Melatonin|melatonin|mesh-list
92892103|NCT02615340|Antioxidants|antioxidants|mesh-ancestor
92892104|NCT02615340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892105|NCT02615340|Protective Agents|protective agents|mesh-ancestor
92892106|NCT02615340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892107|NCT02615340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892108|NCT04899791|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92892109|NCT04899791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892110|NCT04899791|Antioxidants|antioxidants|mesh-ancestor
92892111|NCT04899791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892112|NCT04899791|Protective Agents|protective agents|mesh-ancestor
92892113|NCT04899791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892114|NCT04899791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92892115|NCT02615106|Endostar protein|endostar protein|mesh-list
92892116|NCT02615106|Endostatins|endostatins|mesh-list
92892117|NCT02615106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892118|NCT02615106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892119|NCT02615106|Growth Substances|growth substances|mesh-ancestor
92892120|NCT02615106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892121|NCT02615106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892122|NCT02615106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892123|NCT04930237|Methylnaltrexone|methylnaltrexone|mesh-list
92892124|NCT04930237|Bisacodyl|bisacodyl|mesh-list
92892125|NCT04930237|Magnesium citrate|magnesium citrate|mesh-list
92892126|NCT04930237|Magnesium Oxide|magnesium oxide|mesh-list
92892127|NCT04930237|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92525658|NCT00025636|Methotrexate|methotrexate|mesh-list
92892128|NCT04930237|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92892129|NCT04930237|Calcium|calcium|mesh-list
92892130|NCT04930237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92892131|NCT04930237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892132|NCT04930237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892133|NCT04930237|Cathartics|cathartics|mesh-ancestor
92892134|NCT04930237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892135|NCT04930237|Laxatives|laxatives|mesh-ancestor
92892136|NCT04930237|Antacids|antacids|mesh-ancestor
92892137|NCT04930237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92892138|NCT04930237|Sensory System Agents|sensory system agents|mesh-ancestor
92892139|NCT04930237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892140|NCT04930237|Antidiarrheals|antidiarrheals|mesh-ancestor
92892141|NCT02615262|Dexamethasone|dexamethasone|mesh-list
92892142|NCT02615262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892143|NCT02615262|Antiemetics|antiemetics|mesh-ancestor
92892144|NCT02615262|Autonomic Agents|autonomic agents|mesh-ancestor
92892145|NCT02615262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892146|NCT02615262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892147|NCT02615262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892148|NCT02615262|Glucocorticoids|glucocorticoids|mesh-ancestor
92892149|NCT02615262|Hormones|hormones|mesh-ancestor
92892150|NCT02615262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892151|NCT02615262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892152|NCT02615262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892153|NCT00733720|Naltrexone|naltrexone|mesh-list
92892154|NCT00733720|Buprenorphine|buprenorphine|mesh-list
92892155|NCT00733720|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92892156|NCT00733720|Naloxone|naloxone|mesh-list
92892157|NCT00733720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92892158|NCT00733720|Narcotics|narcotics|mesh-ancestor
92892159|NCT00733720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892160|NCT00733720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892161|NCT00733720|Analgesics|analgesics|mesh-ancestor
92892162|NCT00733720|Sensory System Agents|sensory system agents|mesh-ancestor
92892163|NCT00733720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892164|NCT00733720|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92892165|NCT00733720|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92892166|NCT04134312|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92892167|NCT04134312|Antiviral Agents|antiviral agents|mesh-ancestor
92892168|NCT04134312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892169|NCT05732389|Nivolumab|nivolumab|mesh-list
92892170|NCT05732389|Ipilimumab|ipilimumab|mesh-list
92892171|NCT05732389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92892172|NCT05732389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892173|NCT05732389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92892174|NCT05732389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892175|NCT02624388|Genistein|genistein|mesh-list
92892176|NCT02624388|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92892177|NCT02624388|Protective Agents|protective agents|mesh-ancestor
92892178|NCT02624388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892179|NCT02624388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892180|NCT02624388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92892181|NCT02624388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892182|NCT02624388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892183|NCT02624388|Phytoestrogens|phytoestrogens|mesh-ancestor
92892184|NCT02624388|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92892185|NCT02624388|Estrogens|estrogens|mesh-ancestor
92892186|NCT02624388|Hormones|hormones|mesh-ancestor
92892187|NCT02624388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892188|NCT00727948|Aspirin|aspirin|mesh-list
92892189|NCT00727948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92892190|NCT00727948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92892191|NCT00727948|Analgesics|analgesics|mesh-ancestor
92892192|NCT00727948|Sensory System Agents|sensory system agents|mesh-ancestor
92892193|NCT00727948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892194|NCT00727948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892195|NCT00727948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892196|NCT00727948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92892197|NCT00727948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92892198|NCT00727948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92892199|NCT00727948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892200|NCT00727948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92892201|NCT00727948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92892202|NCT00727948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892203|NCT00727948|Antipyretics|antipyretics|mesh-ancestor
92892204|NCT01007851|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92892205|NCT01007851|Luteolytic Agents|luteolytic agents|mesh-ancestor
92892206|NCT01007851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92892207|NCT01007851|Contraceptive Agents|contraceptive agents|mesh-ancestor
92892208|NCT01007851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92892209|NCT01007851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892210|NCT01007851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92892211|NCT01007851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892212|NCT01007851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892213|NCT05580016|Plasminogen|plasminogen|mesh-list
92892214|NCT05580016|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92892215|NCT05580016|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92892216|NCT05580016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892217|NCT05730673|Leronlimab|leronlimab|mesh-list
92892218|NCT05730673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92892219|NCT05730673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92892220|NCT05730673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892221|NCT05730673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92892222|NCT05730673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92892223|NCT05730673|Antiviral Agents|antiviral agents|mesh-ancestor
92892224|NCT05730673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892225|NCT04134078|Nitric Oxide|nitric oxide|mesh-list
92892226|NCT04134078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92892227|NCT04134078|Autonomic Agents|autonomic agents|mesh-ancestor
92892228|NCT04134078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892229|NCT04134078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892230|NCT04134078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92892231|NCT04134078|Respiratory System Agents|respiratory system agents|mesh-ancestor
92892232|NCT04134078|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92892233|NCT04134078|Antioxidants|antioxidants|mesh-ancestor
92892234|NCT04134078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892235|NCT04134078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892236|NCT04134078|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92892237|NCT04134078|Vasodilator Agents|vasodilator agents|mesh-ancestor
92892238|NCT04134078|Gasotransmitters|gasotransmitters|mesh-ancestor
92892239|NCT04134078|Protective Agents|protective agents|mesh-ancestor
92892240|NCT03871829|Dexamethasone|dexamethasone|mesh-list
92892241|NCT03871829|Dexamethasone acetate|dexamethasone acetate|mesh-list
92892242|NCT03871829|BB 1101|bb 1101|mesh-list
92892243|NCT03871829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892244|NCT03871829|Antiemetics|antiemetics|mesh-ancestor
92892245|NCT03871829|Autonomic Agents|autonomic agents|mesh-ancestor
92892246|NCT03871829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892247|NCT03871829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892248|NCT03871829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892249|NCT03871829|Glucocorticoids|glucocorticoids|mesh-ancestor
92892250|NCT03871829|Hormones|hormones|mesh-ancestor
92892251|NCT03871829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892252|NCT03871829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892253|NCT03871829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892254|NCT03871829|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892255|NCT03871829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892256|NCT03871829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892257|NCT00738556|Sirolimus|sirolimus|mesh-list
92892258|NCT00738556|Paclitaxel|paclitaxel|mesh-list
92892259|NCT00738556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892260|NCT00738556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892261|NCT00738556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892262|NCT00738556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892263|NCT00738556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892264|NCT00738556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892265|NCT00738556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92892266|NCT00738556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892267|NCT00738556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92892268|NCT00738556|Antifungal Agents|antifungal agents|mesh-ancestor
92892269|NCT00738556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92892270|NCT00738556|Immunologic Factors|immunologic factors|mesh-ancestor
92892271|NCT00738556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892273|NCT00597584|Hematinics|hematinics|mesh-ancestor
92237033|NCT00004690|Monolaurin|monolaurin|mesh-list
92892274|NCT00529633|Thalidomide|thalidomide|mesh-list
92892275|NCT00529633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92892276|NCT00529633|Immunologic Factors|immunologic factors|mesh-ancestor
92892277|NCT00529633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892278|NCT00529633|Leprostatic Agents|leprostatic agents|mesh-ancestor
92892279|NCT00529633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92892280|NCT00529633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892281|NCT00529633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892282|NCT00529633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892283|NCT00529633|Growth Substances|growth substances|mesh-ancestor
92892284|NCT00529633|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892285|NCT00529633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892286|NCT01366144|Paclitaxel|paclitaxel|mesh-list
92892287|NCT01366144|Carboplatin|carboplatin|mesh-list
92892288|NCT01366144|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92892289|NCT01366144|Veliparib|veliparib|mesh-list
92892290|NCT01366144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892291|NCT01366144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892292|NCT01366144|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892293|NCT01366144|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892294|NCT01366144|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892295|NCT01366144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892296|NCT01366144|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92892297|NCT01366144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892298|NCT00697944|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92892299|NCT00697944|Antifungal Agents|antifungal agents|mesh-ancestor
92892300|NCT00697944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892301|NCT00697944|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92892302|NCT00697944|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92892303|NCT00657488|Thalidomide|thalidomide|mesh-list
92892304|NCT00657488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92892305|NCT00657488|Immunologic Factors|immunologic factors|mesh-ancestor
92892306|NCT00657488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892307|NCT00657488|Leprostatic Agents|leprostatic agents|mesh-ancestor
92892308|NCT00657488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92892309|NCT00657488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892310|NCT00657488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892311|NCT00657488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892312|NCT00657488|Growth Substances|growth substances|mesh-ancestor
92892313|NCT00657488|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892314|NCT00657488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892315|NCT00530335|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92892316|NCT00530335|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92892317|NCT00530335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92892318|NCT00530335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892319|NCT00530335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892320|NCT00530335|Adrenergic Agents|adrenergic agents|mesh-ancestor
92892321|NCT00530335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892322|NCT00530335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892323|NCT00712270|Risperidone|risperidone|mesh-list
92892324|NCT00712270|Aripiprazole|aripiprazole|mesh-list
92892325|NCT00712270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92892326|NCT00712270|Serotonin Agents|serotonin agents|mesh-ancestor
92892327|NCT00712270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892328|NCT00712270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892329|NCT00712270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892330|NCT00712270|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92892331|NCT00712270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92892332|NCT00712270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892333|NCT00712270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92892334|NCT00712270|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92892335|NCT00712270|Dopamine Agents|dopamine agents|mesh-ancestor
92892336|NCT00712270|Antidepressive Agents|antidepressive agents|mesh-ancestor
92892337|NCT00712270|Dopamine Agonists|dopamine agonists|mesh-ancestor
92892338|NCT00712270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92892339|NCT00712270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92892340|NCT00712270|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92892341|NCT00712270|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92892342|NCT03860597|Memantine|memantine|mesh-list
92892344|NCT03860597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92892345|NCT03860597|Dopamine Agents|dopamine agents|mesh-ancestor
92892346|NCT03860597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892347|NCT03860597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892348|NCT03860597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892349|NCT03860597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92892350|NCT03860597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92892351|NCT02614872|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92892352|NCT02614872|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92892353|NCT02614872|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92892354|NCT02614872|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892355|NCT02614872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892356|NCT02614872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892357|NCT00695604|Fluticasone|fluticasone|mesh-list
92892358|NCT00695604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892359|NCT00695604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92892360|NCT00695604|Autonomic Agents|autonomic agents|mesh-ancestor
92892361|NCT00695604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892362|NCT00695604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892363|NCT00695604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92892364|NCT00695604|Respiratory System Agents|respiratory system agents|mesh-ancestor
92892365|NCT00695604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92892366|NCT00695604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92892367|NCT00654524|Vitamin D|vitamin d|mesh-list
92892368|NCT00654524|Goserelin|goserelin|mesh-list
92892369|NCT00654524|Hormones|hormones|mesh-list
92892370|NCT00654524|Vitamins|vitamins|mesh-ancestor
92892371|NCT00654524|Micronutrients|micronutrients|mesh-ancestor
92892372|NCT00654524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892373|NCT00654524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92892374|NCT00654524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892375|NCT00654524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892376|NCT00654524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892377|NCT05260619|Lenalidomide|lenalidomide|mesh-list
92892378|NCT05260619|Immunologic Factors|immunologic factors|mesh-ancestor
92892379|NCT05260619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892380|NCT05260619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892381|NCT05260619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892382|NCT05260619|Growth Substances|growth substances|mesh-ancestor
92892383|NCT05260619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892384|NCT05260619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892385|NCT00695682|Infliximab|infliximab|mesh-list
92892386|NCT00695682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92892387|NCT00695682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892388|NCT00695682|Dermatologic Agents|dermatologic agents|mesh-ancestor
92892389|NCT00695682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892390|NCT00695682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92892391|NCT00657566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92892392|NCT00657566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92892393|NCT00657566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892394|NCT00657566|Antitubercular Agents|antitubercular agents|mesh-ancestor
92892395|NCT03828773|Fluconazole|fluconazole|mesh-list
92892396|NCT03828773|Posaconazole|posaconazole|mesh-list
92892397|NCT03828773|Antifungal Agents|antifungal agents|mesh-ancestor
92892398|NCT03828773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892399|NCT03828773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92892400|NCT03828773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92892401|NCT03828773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892402|NCT03828773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892403|NCT03828773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92892404|NCT03828773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92892405|NCT03828773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892406|NCT03828773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892407|NCT03828773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92892408|NCT03828773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92892409|NCT03828773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92892410|NCT03828773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92892411|NCT03828773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92892412|NCT00530257|Methylphenidate|methylphenidate|mesh-list
92892413|NCT00530257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92892414|NCT00530257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892415|NCT00530257|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92892416|NCT00530257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92892417|NCT00530257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892418|NCT00530257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892419|NCT00530257|Dopamine Agents|dopamine agents|mesh-ancestor
92237182|NCT00103376|Bortezomib|bortezomib|mesh-list
92892420|NCT00530257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892421|NCT00738868|Cetuximab|cetuximab|mesh-list
92892422|NCT00738868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92892423|NCT00738868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892424|NCT00657644|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92892425|NCT00657644|Vasodilator Agents|vasodilator agents|mesh-ancestor
92892426|NCT00657644|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92892427|NCT00657644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92892428|NCT00657644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892429|NCT00657644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892430|NCT00657644|Urological Agents|urological agents|mesh-ancestor
92892431|NCT00869778|Vaccines|vaccines|mesh-list
92892432|NCT00869778|Immunologic Factors|immunologic factors|mesh-ancestor
92892433|NCT00869778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892434|NCT04159610|Glycopyrrolate|glycopyrrolate|mesh-list
92892435|NCT04159610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92892436|NCT04159610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92892437|NCT04159610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92892438|NCT04159610|Cholinergic Agents|cholinergic agents|mesh-ancestor
92892439|NCT04159610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892440|NCT04159610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892441|NCT04159610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892442|NCT04162028|Ketamine|ketamine|mesh-list
92892443|NCT04162028|Analgesics|analgesics|mesh-ancestor
92892444|NCT04162028|Sensory System Agents|sensory system agents|mesh-ancestor
92892445|NCT04162028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892446|NCT04162028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892447|NCT04162028|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92892448|NCT04162028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92892449|NCT04162028|Anesthetics, General|anesthetics, general|mesh-ancestor
92892450|NCT04162028|Anesthetics|anesthetics|mesh-ancestor
92892451|NCT04162028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892452|NCT04162028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92892453|NCT04162028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92892454|NCT04162028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892455|NCT04162028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892456|NCT00656786|Vitamin K 3|vitamin k 3|mesh-list
92892457|NCT00656786|Vitamin K|vitamin k|mesh-list
92892458|NCT00656786|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92892459|NCT00656786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92892460|NCT00656786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892461|NCT00656786|Hemostatics|hemostatics|mesh-ancestor
92892462|NCT00656786|Coagulants|coagulants|mesh-ancestor
92892463|NCT00656786|Vitamins|vitamins|mesh-ancestor
92892464|NCT00656786|Micronutrients|micronutrients|mesh-ancestor
92892465|NCT00656786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892466|NCT01008631|Sodium thiosulfate|sodium thiosulfate|mesh-list
92892467|NCT01008631|Antidotes|antidotes|mesh-ancestor
92892468|NCT01008631|Protective Agents|protective agents|mesh-ancestor
92892469|NCT01008631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892470|NCT01008631|Antioxidants|antioxidants|mesh-ancestor
92892471|NCT01008631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892472|NCT01008631|Antitubercular Agents|antitubercular agents|mesh-ancestor
92892473|NCT01008631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92892474|NCT01008631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892475|NCT01008631|Chelating Agents|chelating agents|mesh-ancestor
92892476|NCT01008631|Sequestering Agents|sequestering agents|mesh-ancestor
92892477|NCT00734890|Bevacizumab|bevacizumab|mesh-list
92892478|NCT00734890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92892479|NCT00734890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892480|NCT00734890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892481|NCT00734890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892482|NCT00734890|Growth Substances|growth substances|mesh-ancestor
92892483|NCT00734890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892484|NCT00734890|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892485|NCT05325190|Granisetron|granisetron|mesh-list
92892486|NCT05325190|Antiemetics|antiemetics|mesh-ancestor
92892487|NCT05325190|Autonomic Agents|autonomic agents|mesh-ancestor
92892488|NCT05325190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892489|NCT05325190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892490|NCT05325190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892491|NCT05325190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92892492|NCT05325190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92892493|NCT05325190|Serotonin Agents|serotonin agents|mesh-ancestor
92892494|NCT05325190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892495|NCT05325190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892497|NCT02624310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92892498|NCT02624310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92892499|NCT00612521|Adenosine|adenosine|mesh-list
92892500|NCT00612521|Analgesics|analgesics|mesh-ancestor
92892501|NCT00612521|Sensory System Agents|sensory system agents|mesh-ancestor
92892502|NCT00612521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892503|NCT00612521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892504|NCT00612521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92892505|NCT00612521|Vasodilator Agents|vasodilator agents|mesh-ancestor
92892506|NCT00612521|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92892507|NCT00612521|Purinergic Agonists|purinergic agonists|mesh-ancestor
92892508|NCT00612521|Purinergic Agents|purinergic agents|mesh-ancestor
92892509|NCT00612521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892510|NCT00612521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892511|NCT00735124|Gabapentin|gabapentin|mesh-list
92892512|NCT00735124|Analgesics|analgesics|mesh-ancestor
92892513|NCT00735124|Sensory System Agents|sensory system agents|mesh-ancestor
92892514|NCT00735124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892515|NCT00735124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892516|NCT00735124|Anticonvulsants|anticonvulsants|mesh-ancestor
92892517|NCT00735124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92892518|NCT00735124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92892519|NCT00735124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892520|NCT00735124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92892521|NCT00735124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92892522|NCT00735124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92892523|NCT00735124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892524|NCT00735124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892525|NCT00735124|Antimanic Agents|antimanic agents|mesh-ancestor
92892526|NCT04131348|Botulinum Toxins|botulinum toxins|mesh-list
92892527|NCT04131348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92892528|NCT04131348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92892529|NCT04131348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92892530|NCT04131348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892531|NCT04131348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892532|NCT04131348|Cholinergic Agents|cholinergic agents|mesh-ancestor
92892533|NCT04131348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892534|NCT04131348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892535|NCT04131348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92892536|NCT04131348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892537|NCT04246541|Acetaminophen|acetaminophen|mesh-list
92892538|NCT04246541|Ketorolac|ketorolac|mesh-list
92892539|NCT04246541|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92892540|NCT04246541|Oxycodone|oxycodone|mesh-list
92892541|NCT04246541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92892542|NCT04246541|Analgesics|analgesics|mesh-ancestor
92892543|NCT04246541|Sensory System Agents|sensory system agents|mesh-ancestor
92892544|NCT04246541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892545|NCT04246541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892546|NCT04246541|Antipyretics|antipyretics|mesh-ancestor
92892547|NCT04246541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92892548|NCT04246541|Narcotics|narcotics|mesh-ancestor
92892549|NCT04246541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892550|NCT04246541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92892551|NCT04246541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892552|NCT04246541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92892553|NCT04246541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92892554|NCT04246541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892555|NCT04246541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892556|NCT04902859|Clonidine|clonidine|mesh-list
92892557|NCT04902859|Analgesics|analgesics|mesh-ancestor
92892558|NCT04902859|Sensory System Agents|sensory system agents|mesh-ancestor
92892559|NCT04902859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892560|NCT04902859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892561|NCT04902859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92892562|NCT04902859|Sympatholytics|sympatholytics|mesh-ancestor
92892563|NCT04902859|Autonomic Agents|autonomic agents|mesh-ancestor
92892564|NCT04902859|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92892565|NCT04902859|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92892566|NCT04902859|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92892567|NCT04902859|Adrenergic Agents|adrenergic agents|mesh-ancestor
92892568|NCT04902859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892569|NCT04902859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892570|NCT05227313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92892571|NCT00711958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92892572|NCT04180943|Bupivacaine|bupivacaine|mesh-list
92892573|NCT04180943|Anesthetics, Local|anesthetics, local|mesh-ancestor
92892574|NCT04180943|Anesthetics|anesthetics|mesh-ancestor
92892575|NCT04180943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892576|NCT04180943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892577|NCT04180943|Sensory System Agents|sensory system agents|mesh-ancestor
92892578|NCT04180943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892579|NCT05011357|Phenylephrine|phenylephrine|mesh-list
92892580|NCT05011357|Oxymetazoline|oxymetazoline|mesh-list
92892581|NCT05011357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92892582|NCT05011357|Mydriatics|mydriatics|mesh-ancestor
92892583|NCT05011357|Autonomic Agents|autonomic agents|mesh-ancestor
92892584|NCT05011357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892585|NCT05011357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892586|NCT05011357|Sympathomimetics|sympathomimetics|mesh-ancestor
92892587|NCT05011357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92892588|NCT05011357|Nasal Decongestants|nasal decongestants|mesh-ancestor
92892589|NCT05011357|Respiratory System Agents|respiratory system agents|mesh-ancestor
92892590|NCT05011357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92892591|NCT05011357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92892592|NCT05011357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92892593|NCT05011357|Adrenergic Agents|adrenergic agents|mesh-ancestor
92892594|NCT05011357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892595|NCT05011357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892596|NCT05011357|Protective Agents|protective agents|mesh-ancestor
92892597|NCT00711880|Nabiximols|nabiximols|mesh-list
92892598|NCT00711880|Analgesics|analgesics|mesh-ancestor
92892599|NCT00711880|Sensory System Agents|sensory system agents|mesh-ancestor
92892600|NCT00711880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892601|NCT00711880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892602|NCT02693483|Povidone-Iodine|povidone-iodine|mesh-list
92892603|NCT02693483|Povidone|povidone|mesh-list
92892604|NCT02693483|Plasma Substitutes|plasma substitutes|mesh-ancestor
92892605|NCT02693483|Blood Substitutes|blood substitutes|mesh-ancestor
92892606|NCT02693483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92892607|NCT02693483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892608|NCT04873063|Beclomethasone|beclomethasone|mesh-list
92892609|NCT04873063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892610|NCT04873063|Glucocorticoids|glucocorticoids|mesh-ancestor
92892611|NCT04873063|Hormones|hormones|mesh-ancestor
92892612|NCT04873063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892613|NCT04873063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892614|NCT04873063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92892615|NCT04873063|Respiratory System Agents|respiratory system agents|mesh-ancestor
92892616|NCT00739414|Panobinostat|panobinostat|mesh-list
92892617|NCT00739414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892618|NCT00739414|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92892619|NCT00739414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892620|NCT00739414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892621|NCT00612599|Insulin Aspart|insulin aspart|mesh-list
92892622|NCT00612599|Biphasic Insulins|biphasic insulins|mesh-list
92892623|NCT00612599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92892624|NCT00612599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892625|NCT00735280|Heparin|heparin|mesh-list
92892626|NCT00735280|Calcium heparin|calcium heparin|mesh-list
92892627|NCT00735280|Anticoagulants|anticoagulants|mesh-ancestor
92892628|NCT00735280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92892629|NCT00735280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92892630|NCT00735280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892631|NCT00612989|Temozolomide|temozolomide|mesh-list
92892632|NCT00612989|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92892633|NCT00612989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92892634|NCT00612989|Alkylating Agents|alkylating agents|mesh-ancestor
92892635|NCT00612989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892636|NCT00612989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892637|NCT00612989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892638|NCT04929067|Immunomodulating Agents|immunomodulating agents|mesh-list
92892639|NCT04929067|Immunologic Factors|immunologic factors|mesh-ancestor
92892640|NCT04929067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892642|NCT05215405|Navitoclax|navitoclax|mesh-list
92892643|NCT05215405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892644|NCT00613067|Escitalopram|escitalopram|mesh-list
92892645|NCT00613067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92892646|NCT00613067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92892647|NCT00613067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892648|NCT00613067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892649|NCT00613067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892650|NCT00613067|Serotonin Agents|serotonin agents|mesh-ancestor
92892651|NCT00613067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892652|NCT04649489|Bevacizumab|bevacizumab|mesh-list
92892653|NCT04649489|Atezolizumab|atezolizumab|mesh-list
92892654|NCT04649489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92892655|NCT04649489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92892656|NCT04649489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892657|NCT04649489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892658|NCT04649489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892659|NCT04649489|Growth Substances|growth substances|mesh-ancestor
92892660|NCT04649489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892661|NCT04649489|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892662|NCT04649489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92892663|NCT04649489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892664|NCT04649489|Immunologic Factors|immunologic factors|mesh-ancestor
92892665|NCT00613145|Capecitabine|capecitabine|mesh-list
92892666|NCT00613145|Sorafenib|sorafenib|mesh-list
92892667|NCT00613145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92892668|NCT00613145|Antimetabolites|antimetabolites|mesh-ancestor
92892669|NCT00613145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892670|NCT00613145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892671|NCT00613145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92892672|NCT00613145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892673|NCT04570085|Caffeine|caffeine|mesh-list
92892674|NCT04570085|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92892675|NCT04570085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892676|NCT04570085|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92892677|NCT04570085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892678|NCT04570085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892679|NCT04570085|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92892680|NCT04570085|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92892681|NCT04570085|Purinergic Agents|purinergic agents|mesh-ancestor
92892682|NCT04570085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892683|NCT00529399|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92892684|NCT00529399|Aluminum sulfate|aluminum sulfate|mesh-list
92892685|NCT00529399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92892686|NCT00529399|Immunologic Factors|immunologic factors|mesh-ancestor
92892687|NCT00529399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892688|NCT00529399|Antacids|antacids|mesh-ancestor
92892689|NCT00529399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892690|NCT00529399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892691|NCT05268419|Ethanol|ethanol|mesh-list
92892692|NCT05268419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92892693|NCT05268419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892694|NCT05268419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892695|NCT05268419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892697|NCT00852969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92892698|NCT00852969|Antimetabolites|antimetabolites|mesh-ancestor
92892699|NCT00852969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892700|NCT00852969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92892701|NCT00852969|Vasodilator Agents|vasodilator agents|mesh-ancestor
92892702|NCT00852969|Vitamin B Complex|vitamin b complex|mesh-ancestor
92892703|NCT00852969|Vitamins|vitamins|mesh-ancestor
92892704|NCT00852969|Micronutrients|micronutrients|mesh-ancestor
92892705|NCT00852969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892706|NCT00613457|Cytarabine|cytarabine|mesh-list
92892707|NCT00613457|Dexamethasone|dexamethasone|mesh-list
92892708|NCT00613457|Prednisone|prednisone|mesh-list
92892709|NCT00613457|Cyclophosphamide|cyclophosphamide|mesh-list
92892710|NCT00613457|Ifosfamide|ifosfamide|mesh-list
92892711|NCT00613457|Doxorubicin|doxorubicin|mesh-list
92892712|NCT00613457|Methotrexate|methotrexate|mesh-list
92892713|NCT00613457|Etoposide|etoposide|mesh-list
92892714|NCT00613457|Vincristine|vincristine|mesh-list
92892715|NCT00613457|Daunorubicin|daunorubicin|mesh-list
92892716|NCT00613457|Asparaginase|asparaginase|mesh-list
92538051|NCT00404716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892717|NCT00613457|Mercaptopurine|mercaptopurine|mesh-list
92892718|NCT00613457|Thioguanine|thioguanine|mesh-list
92892719|NCT00613457|Vindesine|vindesine|mesh-list
92892720|NCT00613457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92892721|NCT00613457|Immunologic Factors|immunologic factors|mesh-ancestor
92892722|NCT00613457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892723|NCT00613457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92892724|NCT00613457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92892725|NCT00613457|Alkylating Agents|alkylating agents|mesh-ancestor
92892726|NCT00613457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892727|NCT00613457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892728|NCT00613457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92892729|NCT00613457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892730|NCT00613457|Antiemetics|antiemetics|mesh-ancestor
92892731|NCT00613457|Autonomic Agents|autonomic agents|mesh-ancestor
92892732|NCT00613457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892733|NCT00613457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892734|NCT00613457|Glucocorticoids|glucocorticoids|mesh-ancestor
92892735|NCT00613457|Hormones|hormones|mesh-ancestor
92892736|NCT00613457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892737|NCT00613457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892738|NCT00613457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92892739|NCT00613457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92892740|NCT00613457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92892741|NCT00613457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892742|NCT00613457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92892743|NCT00613457|Abortifacient Agents|abortifacient agents|mesh-ancestor
92892744|NCT00613457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92892745|NCT00613457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92892746|NCT00613457|Antimetabolites|antimetabolites|mesh-ancestor
92892747|NCT00613457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92892748|NCT00613457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92892749|NCT00613457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92892750|NCT00613457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892751|NCT00613457|Antiviral Agents|antiviral agents|mesh-ancestor
92892752|NCT00613457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892753|NCT00613457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892754|NCT00613457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892755|NCT00613457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892756|NCT04131582|Metformin|metformin|mesh-list
92892757|NCT04131582|Empagliflozin|empagliflozin|mesh-list
92892758|NCT04131582|Linagliptin|linagliptin|mesh-list
92892759|NCT04131582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92892760|NCT04131582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892761|NCT04131582|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92892762|NCT04131582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892763|NCT04131582|Incretins|incretins|mesh-ancestor
92892764|NCT04131582|Hormones|hormones|mesh-ancestor
92892765|NCT04131582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892766|NCT04131582|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92892767|NCT04131582|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892768|NCT04131582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892769|NCT00521365|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92892770|NCT00521365|Antidepressive Agents|antidepressive agents|mesh-ancestor
92892771|NCT00521365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92892772|NCT00521365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92892773|NCT00521365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92892774|NCT00521365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892775|NCT00521365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892776|NCT00695994|Carboplatin|carboplatin|mesh-list
92892777|NCT00695994|Gemcitabine|gemcitabine|mesh-list
92892778|NCT00695994|Docetaxel|docetaxel|mesh-list
92892779|NCT00695994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892780|NCT00695994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92892781|NCT00695994|Antimetabolites|antimetabolites|mesh-ancestor
92892782|NCT00695994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892783|NCT00695994|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892784|NCT00695994|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892785|NCT00695994|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892786|NCT00711802|Daptomycin|daptomycin|mesh-list
92892787|NCT00711802|Cloxacillin|cloxacillin|mesh-list
92538124|NCT03128021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92892788|NCT00711802|Oxacillin|oxacillin|mesh-list
92892789|NCT00711802|Nafcillin|nafcillin|mesh-list
92892790|NCT00711802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92892791|NCT00711802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892792|NCT00851877|Paclitaxel|paclitaxel|mesh-list
92892794|NCT00851877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892795|NCT00851877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892796|NCT00851877|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892797|NCT00851877|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892798|NCT00851877|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892799|NCT00851877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892800|NCT00851877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92892801|NCT00613223|Etoposide|etoposide|mesh-list
92892802|NCT00613223|Etoposide phosphate|etoposide phosphate|mesh-list
92892803|NCT00613223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892804|NCT00613223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892805|NCT00613223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92892806|NCT00613223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92892807|NCT00613223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892808|NCT00613223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892809|NCT00882908|Ribavirin|ribavirin|mesh-list
92892810|NCT00882908|Simeprevir|simeprevir|mesh-list
92892811|NCT00882908|Antimetabolites|antimetabolites|mesh-ancestor
92892812|NCT00882908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892813|NCT00882908|Antiviral Agents|antiviral agents|mesh-ancestor
92892814|NCT00882908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892815|NCT00882908|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892816|NCT00882908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892817|NCT03580967|Vortioxetine|vortioxetine|mesh-list
92892818|NCT03580967|Antidepressive Agents|antidepressive agents|mesh-ancestor
92892819|NCT03580967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92892820|NCT03580967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92892821|NCT03580967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92892822|NCT03580967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892823|NCT03580967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892824|NCT03580967|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92892825|NCT03580967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92892826|NCT03580967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892827|NCT03580967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892828|NCT03580967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892829|NCT03580967|Serotonin Agents|serotonin agents|mesh-ancestor
92892830|NCT03580967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92892831|NCT03580967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92892832|NCT03580967|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92892833|NCT03580967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92892834|NCT00851799|Ritonavir|ritonavir|mesh-list
92892835|NCT00851799|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92892836|NCT00851799|Darunavir|darunavir|mesh-list
92892837|NCT00851799|Tenofovir|tenofovir|mesh-list
92892838|NCT00851799|Emtricitabine|emtricitabine|mesh-list
92892839|NCT00851799|Raltegravir Potassium|raltegravir potassium|mesh-list
92892840|NCT00851799|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92892841|NCT00851799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92892842|NCT00851799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92892843|NCT00851799|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892844|NCT00851799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892845|NCT00851799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892846|NCT00851799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92892847|NCT00851799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92892848|NCT00851799|Antiviral Agents|antiviral agents|mesh-ancestor
92892849|NCT00851799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892850|NCT00851799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92892851|NCT00851799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92892852|NCT00851799|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92892853|NCT00851799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92892854|NCT00851799|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92892855|NCT00851799|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92892856|NCT00853047|Octreotide|octreotide|mesh-list
92892857|NCT00853047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92892858|NCT00853047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92892859|NCT00853047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892860|NCT04117191|Tryptophan|tryptophan|mesh-list
92892861|NCT04117191|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92892862|NCT04117191|Antidepressive Agents|antidepressive agents|mesh-ancestor
92892863|NCT04117191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92892864|NCT00520975|Paclitaxel|paclitaxel|mesh-list
92892866|NCT00520975|Carboplatin|carboplatin|mesh-list
92892867|NCT00520975|Trastuzumab|trastuzumab|mesh-list
92892868|NCT00520975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92892869|NCT00520975|Antibodies|antibodies|mesh-list
92892870|NCT00520975|Immunoglobulins|immunoglobulins|mesh-list
92892871|NCT00520975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92892872|NCT00520975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892873|NCT00520975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892874|NCT00520975|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892875|NCT00520975|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892876|NCT00520975|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892877|NCT00520975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892878|NCT00520975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892879|NCT00520975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892880|NCT00520975|Growth Substances|growth substances|mesh-ancestor
92892881|NCT00520975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892882|NCT00520975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892883|NCT00520975|Immunologic Factors|immunologic factors|mesh-ancestor
92892884|NCT00614159|Ketamine|ketamine|mesh-list
92892885|NCT00614159|Propofol|propofol|mesh-list
92892886|NCT00614159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92892887|NCT00614159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892888|NCT00614159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892889|NCT00614159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92892890|NCT00614159|Anesthetics, General|anesthetics, general|mesh-ancestor
92892891|NCT00614159|Anesthetics|anesthetics|mesh-ancestor
92892892|NCT00614159|Analgesics|analgesics|mesh-ancestor
92892893|NCT00614159|Sensory System Agents|sensory system agents|mesh-ancestor
92892894|NCT00614159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892895|NCT00614159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92892896|NCT00614159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92892897|NCT00614159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92892898|NCT00614159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892899|NCT00614159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892900|NCT05042531|Azacitidine|azacitidine|mesh-list
92892901|NCT05042531|Dasatinib|dasatinib|mesh-list
92892902|NCT05042531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92892903|NCT05042531|Antimetabolites|antimetabolites|mesh-ancestor
92892904|NCT05042531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892905|NCT05042531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892906|NCT05042531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892907|NCT05042531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92892908|NCT00851721|Factor VIII|factor viii|mesh-list
92892909|NCT00851721|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92892910|NCT00851721|Coagulants|coagulants|mesh-ancestor
92892911|NCT04071119|Oxytocin|oxytocin|mesh-list
92892912|NCT04071119|Oxytocics|oxytocics|mesh-ancestor
92892913|NCT04071119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92892914|NCT04071119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892915|NCT02634476|Ethanol|ethanol|mesh-list
92892916|NCT02634476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92892917|NCT02634476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92892918|NCT02634476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92892919|NCT02634476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892920|NCT04385303|Lorecivivint|lorecivivint|mesh-list
92892921|NCT04385303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892922|NCT00654602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92892923|NCT00654602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92892924|NCT00654602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92892925|NCT00654602|Antimetabolites|antimetabolites|mesh-ancestor
92892926|NCT00654602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892927|NCT00654602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92892928|NCT00654602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92892929|NCT00654602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892930|NCT00740194|Estradiol|estradiol|mesh-list
92892931|NCT00740194|Estrogens|estrogens|mesh-ancestor
92892932|NCT00740194|Hormones|hormones|mesh-ancestor
92892933|NCT00740194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92892934|NCT00740194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892935|NCT04159142|Paclitaxel|paclitaxel|mesh-list
92892936|NCT04159142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92892937|NCT04159142|Carboplatin|carboplatin|mesh-list
92892938|NCT04159142|Capecitabine|capecitabine|mesh-list
92525670|NCT00025636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92892939|NCT04159142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92892940|NCT04159142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892941|NCT04159142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92892942|NCT04159142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92892943|NCT04159142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92892944|NCT04159142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892945|NCT04159142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92892946|NCT04159142|Antimetabolites|antimetabolites|mesh-ancestor
92892947|NCT00654680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92892948|NCT00654680|Vasodilator Agents|vasodilator agents|mesh-ancestor
92892949|NCT00654680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92892950|NCT00654680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92892951|NCT00654680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892952|NCT00654680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892953|NCT00654680|Urological Agents|urological agents|mesh-ancestor
92892954|NCT00520741|Lacosamide|lacosamide|mesh-list
92892955|NCT00520741|Anticonvulsants|anticonvulsants|mesh-ancestor
92892956|NCT00520741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92892957|NCT00520741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92892958|NCT00520741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92892959|NCT00520741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892960|NCT03682289|Durvalumab|durvalumab|mesh-list
92892961|NCT03682289|Olaparib|olaparib|mesh-list
92892962|NCT03682289|Adenosine|adenosine|mesh-list
92892963|NCT03682289|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92892964|NCT03682289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92892965|NCT03682289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892966|NCT03682289|Immunologic Factors|immunologic factors|mesh-ancestor
92892967|NCT03682289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892968|NCT03682289|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92892969|NCT03682289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892970|NCT03682289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892971|NCT03682289|Analgesics|analgesics|mesh-ancestor
92892972|NCT03682289|Sensory System Agents|sensory system agents|mesh-ancestor
92892973|NCT03682289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92892974|NCT03682289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92892975|NCT03682289|Vasodilator Agents|vasodilator agents|mesh-ancestor
92892976|NCT03682289|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92892977|NCT03682289|Purinergic Agonists|purinergic agonists|mesh-ancestor
92892978|NCT03682289|Purinergic Agents|purinergic agents|mesh-ancestor
92892979|NCT03682289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92892980|NCT00729118|Lenalidomide|lenalidomide|mesh-list
92892981|NCT00729118|Vorinostat|vorinostat|mesh-list
92892982|NCT00729118|Immunologic Factors|immunologic factors|mesh-ancestor
92892983|NCT00729118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92892984|NCT00729118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92892985|NCT00729118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92892986|NCT00729118|Growth Substances|growth substances|mesh-ancestor
92892987|NCT00729118|Growth Inhibitors|growth inhibitors|mesh-ancestor
92892988|NCT00729118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92892989|NCT00729118|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92892990|NCT00729118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92892991|NCT00729118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92892992|NCT04064632|Darunavir|darunavir|mesh-list
92892993|NCT04064632|Cobicistat|cobicistat|mesh-list
92892994|NCT04064632|Rilpivirine|rilpivirine|mesh-list
92892995|NCT04064632|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92892996|NCT04064632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92892997|NCT04064632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92892998|NCT04064632|Protease Inhibitors|protease inhibitors|mesh-ancestor
92892999|NCT04064632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893000|NCT04064632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893001|NCT04064632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92893002|NCT04064632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92893003|NCT04064632|Antiviral Agents|antiviral agents|mesh-ancestor
92893004|NCT04064632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893005|NCT04064632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92893006|NCT04064632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92893007|NCT04064632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92893008|NCT04064632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92893009|NCT00882518|Chlorpromazine|chlorpromazine|mesh-list
92893010|NCT00882518|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92893011|NCT00882518|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893012|NCT00882518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893013|NCT00882518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92893014|NCT00882518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92893015|NCT00882518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893016|NCT00882518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893017|NCT00882518|Antiemetics|antiemetics|mesh-ancestor
92893018|NCT00882518|Autonomic Agents|autonomic agents|mesh-ancestor
92893019|NCT00882518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893020|NCT00882518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893021|NCT00882518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92893022|NCT00882518|Dopamine Agents|dopamine agents|mesh-ancestor
92893023|NCT00882518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893024|NCT00882518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893025|NCT00882362|Aripiprazole|aripiprazole|mesh-list
92893026|NCT00882362|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893027|NCT00882362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893028|NCT00882362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92893029|NCT00882362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92893030|NCT00882362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893031|NCT00882362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893032|NCT00882362|Dopamine Agonists|dopamine agonists|mesh-ancestor
92893033|NCT00882362|Dopamine Agents|dopamine agents|mesh-ancestor
92893034|NCT00882362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893035|NCT00882362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893036|NCT00882362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92893037|NCT00882362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92893038|NCT00882362|Serotonin Agents|serotonin agents|mesh-ancestor
92893039|NCT00882362|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92893040|NCT00882362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92893041|NCT00882362|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92893042|NCT00882362|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92893043|NCT00529243|Raltegravir Potassium|raltegravir potassium|mesh-list
92893044|NCT00529243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92893045|NCT00529243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92893046|NCT00529243|Antiviral Agents|antiviral agents|mesh-ancestor
92893047|NCT00529243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893048|NCT00529243|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92893049|NCT00529243|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92893050|NCT00529243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893051|NCT00529243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893052|NCT00636935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92893053|NCT00636935|Clindamycin|clindamycin|mesh-list
92893054|NCT00636935|Clindamycin palmitate|clindamycin palmitate|mesh-list
92893055|NCT00636935|Clindamycin phosphate|clindamycin phosphate|mesh-list
92893056|NCT00636935|Dapsone|dapsone|mesh-list
92893057|NCT00636935|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92893058|NCT00636935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92893059|NCT00636935|Primaquine|primaquine|mesh-list
92893060|NCT00636935|Trimethoprim|trimethoprim|mesh-list
92893061|NCT00636935|Atovaquone|atovaquone|mesh-list
92893062|NCT00636935|Pentamidine|pentamidine|mesh-list
92893063|NCT00636935|Prednisone|prednisone|mesh-list
92893064|NCT00636935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893065|NCT00636935|Glucocorticoids|glucocorticoids|mesh-ancestor
92893066|NCT00636935|Hormones|hormones|mesh-ancestor
92893067|NCT00636935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893068|NCT00636935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893069|NCT00636935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92893070|NCT00636935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893071|NCT00636935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893072|NCT00636935|Antitubercular Agents|antitubercular agents|mesh-ancestor
92893073|NCT00636935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92893074|NCT00636935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893075|NCT00636935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893076|NCT00636935|Antimalarials|antimalarials|mesh-ancestor
92893077|NCT00636935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92893078|NCT00636935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92893079|NCT00636935|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92893080|NCT00636935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92893081|NCT00636935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92893082|NCT00636935|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92893083|NCT00636935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92893084|NCT00636935|Leprostatic Agents|leprostatic agents|mesh-ancestor
92893085|NCT00636935|Antifungal Agents|antifungal agents|mesh-ancestor
92525672|NCT00025636|Autonomic Agents|autonomic agents|mesh-ancestor
92893086|NCT00636935|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92893087|NCT00654758|Paclitaxel|paclitaxel|mesh-list
92893088|NCT00654758|Carboplatin|carboplatin|mesh-list
92893089|NCT00654758|Volociximab|volociximab|mesh-list
92893090|NCT00654758|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92538430|NCT04958044|Calcium|calcium|mesh-list
92893091|NCT00654758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92893092|NCT00654758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893093|NCT00654758|Tubulin Modulators|tubulin modulators|mesh-ancestor
92893094|NCT00654758|Antimitotic Agents|antimitotic agents|mesh-ancestor
92893095|NCT00654758|Mitosis Modulators|mitosis modulators|mesh-ancestor
92893096|NCT00654758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893097|NCT00654758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92893098|NCT00654758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92893099|NCT00654758|Growth Substances|growth substances|mesh-ancestor
92893100|NCT00654758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893101|NCT00654758|Growth Inhibitors|growth inhibitors|mesh-ancestor
92893102|NCT00654758|Immunologic Factors|immunologic factors|mesh-ancestor
92893103|NCT00656864|Pioglitazone|pioglitazone|mesh-list
92893104|NCT00656864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893105|NCT00656864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893106|NCT00658268|Clodronic Acid|clodronic acid|mesh-list
92893107|NCT00658268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92893108|NCT00658268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893109|NCT00613613|Fenofibrate|fenofibrate|mesh-list
92893110|NCT00613613|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92893111|NCT00613613|Antimetabolites|antimetabolites|mesh-ancestor
92893112|NCT00613613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893113|NCT00613613|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92893114|NCT04298099|Ropivacaine|ropivacaine|mesh-list
92893115|NCT04298099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92893116|NCT04298099|Anesthetics|anesthetics|mesh-ancestor
92893117|NCT04298099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893118|NCT04298099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893119|NCT04298099|Sensory System Agents|sensory system agents|mesh-ancestor
92893120|NCT04298099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893121|NCT02613195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92893122|NCT00850395|Maraviroc|maraviroc|mesh-list
92893123|NCT00850395|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92893124|NCT00850395|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92893125|NCT00850395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893126|NCT00850395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92893127|NCT00850395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92893128|NCT00850395|Antiviral Agents|antiviral agents|mesh-ancestor
92893129|NCT00850395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893130|NCT00850395|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92893131|NCT04188431|Dexamethasone|dexamethasone|mesh-list
92893132|NCT04188431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893133|NCT04188431|Antiemetics|antiemetics|mesh-ancestor
92893134|NCT04188431|Autonomic Agents|autonomic agents|mesh-ancestor
92893135|NCT04188431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893136|NCT04188431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893137|NCT04188431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893138|NCT04188431|Glucocorticoids|glucocorticoids|mesh-ancestor
92893139|NCT04188431|Hormones|hormones|mesh-ancestor
92893140|NCT04188431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893141|NCT04188431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92893142|NCT04188431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893143|NCT03630809|Vaccines|vaccines|mesh-list
92893144|NCT03630809|Immunologic Factors|immunologic factors|mesh-ancestor
92893145|NCT03630809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893146|NCT00577720|Risedronic Acid|risedronic acid|mesh-list
92893147|NCT00577720|Etidronic Acid|etidronic acid|mesh-list
92893148|NCT00577720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92893149|NCT00577720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893150|NCT00577720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893151|NCT00577720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92893152|NCT00577720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893153|NCT00577720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92893154|NCT00736294|Ramipril|ramipril|mesh-list
92893155|NCT00736294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92893156|NCT00736294|Protease Inhibitors|protease inhibitors|mesh-ancestor
92893157|NCT00736294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893158|NCT00736294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893160|NCT00512707|Sildenafil Citrate|sildenafil citrate|mesh-list
92893161|NCT00512707|Testosterone|testosterone|mesh-list
92893162|NCT00512707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893163|NCT00512707|Androgens|androgens|mesh-ancestor
92893164|NCT00512707|Hormones|hormones|mesh-ancestor
92893165|NCT00512707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893166|NCT00512707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893167|NCT00512707|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893168|NCT00512707|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92893169|NCT00512707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92893170|NCT00512707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893171|NCT00512707|Urological Agents|urological agents|mesh-ancestor
92893172|NCT00729274|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92893173|NCT03471767|Dextromethorphan|dextromethorphan|mesh-list
92893174|NCT03471767|Bupropion|bupropion|mesh-list
92893175|NCT03471767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92893176|NCT03471767|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893177|NCT03471767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893178|NCT03471767|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92893179|NCT03471767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92893180|NCT03471767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893181|NCT03471767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893182|NCT03471767|Dopamine Agents|dopamine agents|mesh-ancestor
92893183|NCT03471767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893184|NCT03471767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893185|NCT03471767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92893186|NCT03471767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92893187|NCT03471767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893188|NCT03471767|Antitussive Agents|antitussive agents|mesh-ancestor
92893189|NCT03471767|Respiratory System Agents|respiratory system agents|mesh-ancestor
92893190|NCT03471767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92893191|NCT03471767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92893192|NCT00849693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92893193|NCT00849693|Fluoxetine|fluoxetine|mesh-list
92893194|NCT00849693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92893195|NCT00849693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92893196|NCT00849693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893197|NCT00849693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893198|NCT00849693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893199|NCT00849693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893200|NCT00849693|Analgesics|analgesics|mesh-ancestor
92893201|NCT00849693|Sensory System Agents|sensory system agents|mesh-ancestor
92893202|NCT00849693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893203|NCT00849693|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893204|NCT00849693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893205|NCT00849693|Dopamine Agents|dopamine agents|mesh-ancestor
92893206|NCT00849693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92893207|NCT00849693|Serotonin Agents|serotonin agents|mesh-ancestor
92893208|NCT00849693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92893209|NCT00849693|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92893210|NCT00849693|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92893211|NCT00849693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893212|NCT00736606|Simvastatin|simvastatin|mesh-list
92893213|NCT00736606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92893214|NCT00736606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92893215|NCT00736606|Antimetabolites|antimetabolites|mesh-ancestor
92893216|NCT00736606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893217|NCT00736606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92893218|NCT00736606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92893219|NCT00736606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893220|NCT00527605|Dutasteride|dutasteride|mesh-list
92893221|NCT00527605|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92893222|NCT00527605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92893223|NCT00527605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893224|NCT00527605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893225|NCT00527605|Hormone Antagonists|hormone antagonists|mesh-ancestor
92893226|NCT00527605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893227|NCT00527605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893228|NCT04865939|Gemcitabine|gemcitabine|mesh-list
92893229|NCT04865939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92893230|NCT04865939|Antimetabolites|antimetabolites|mesh-ancestor
92893231|NCT04865939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893232|NCT04865939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893233|NCT00741052|Azithromycin|azithromycin|mesh-list
92893234|NCT00741052|Ciprofloxacin|ciprofloxacin|mesh-list
92893235|NCT00741052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538568|NCT02505893|Sirolimus|sirolimus|mesh-list
92893236|NCT00741052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893237|NCT00741052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92893238|NCT00741052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92893239|NCT00741052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893240|NCT00741052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893241|NCT00741052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893242|NCT00741052|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92893243|NCT00741052|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92893245|NCT04116411|Temozolomide|temozolomide|mesh-list
92893246|NCT04116411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92893247|NCT04116411|Alkylating Agents|alkylating agents|mesh-ancestor
92893248|NCT04116411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893249|NCT04116411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893250|NCT04116411|Antiviral Agents|antiviral agents|mesh-ancestor
92893251|NCT04116411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893252|NCT00706953|Doxorubicin|doxorubicin|mesh-list
92160989|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
92893253|NCT00706953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92893254|NCT00706953|Bortezomib|bortezomib|mesh-list
92893255|NCT00706953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92893256|NCT00706953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893257|NCT00706953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92893258|NCT00706953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92893259|NCT00706953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893260|NCT00706953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893261|NCT03462017|Sildenafil Citrate|sildenafil citrate|mesh-list
92893262|NCT03462017|Acetylcholine|acetylcholine|mesh-list
92893263|NCT03462017|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893264|NCT03462017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92893265|NCT03462017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92893266|NCT03462017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893267|NCT03462017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893268|NCT03462017|Urological Agents|urological agents|mesh-ancestor
92893269|NCT03462017|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92893270|NCT03462017|Cholinergic Agents|cholinergic agents|mesh-ancestor
92893271|NCT03462017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893272|NCT03462017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893273|NCT00913419|Amitriptyline|amitriptyline|mesh-list
92893274|NCT00913419|Cyclobenzaprine|cyclobenzaprine|mesh-list
92893275|NCT00913419|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92893276|NCT00913419|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893277|NCT00913419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893278|NCT00913419|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92893279|NCT00913419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893280|NCT00913419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92893281|NCT00913419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893282|NCT00913419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92893283|NCT00913419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893284|NCT00913419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92893285|NCT00913419|Analgesics|analgesics|mesh-ancestor
92893286|NCT00913419|Sensory System Agents|sensory system agents|mesh-ancestor
92893287|NCT00913419|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92893288|NCT00913419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92893289|NCT00913419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893290|NCT00913419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893291|NCT00913419|Adrenergic Agents|adrenergic agents|mesh-ancestor
92893292|NCT00913419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893293|NCT00711412|Capecitabine|capecitabine|mesh-list
92893294|NCT00711412|Oxaliplatin|oxaliplatin|mesh-list
92893295|NCT00711412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92893296|NCT00711412|Antimetabolites|antimetabolites|mesh-ancestor
92893297|NCT00711412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893298|NCT00711412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893299|NCT01840007|Metformin|metformin|mesh-list
92893300|NCT01840007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893301|NCT01840007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893302|NCT03896659|Hydrocortisone|hydrocortisone|mesh-list
92893303|NCT03896659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893304|NCT03746951|Ropivacaine|ropivacaine|mesh-list
92893305|NCT03746951|Anesthetics, Local|anesthetics, local|mesh-ancestor
92893306|NCT03746951|Anesthetics|anesthetics|mesh-ancestor
92893307|NCT03746951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893308|NCT03746951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538661|NCT00405418|Insulin|insulin|mesh-list
92893309|NCT03746951|Sensory System Agents|sensory system agents|mesh-ancestor
92893310|NCT03746951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893311|NCT00577408|Naltrexone|naltrexone|mesh-list
92893312|NCT00577408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92893313|NCT00577408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92893314|NCT00577408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893315|NCT00577408|Sensory System Agents|sensory system agents|mesh-ancestor
92893316|NCT00577408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893317|NCT03391193|Vaccines|vaccines|mesh-list
92893318|NCT03391193|Immunologic Factors|immunologic factors|mesh-ancestor
92893319|NCT03391193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893320|NCT00741364|Vitamin D|vitamin d|mesh-list
92893321|NCT00741364|Cholecalciferol|cholecalciferol|mesh-list
92893322|NCT00741364|Vitamins|vitamins|mesh-ancestor
92893323|NCT00741364|Micronutrients|micronutrients|mesh-ancestor
92893324|NCT00741364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893325|NCT00741364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92893326|NCT00741364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92893327|NCT03332303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92893328|NCT03332303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92893329|NCT03332303|Estradiol|estradiol|mesh-list
92893330|NCT03332303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92893331|NCT03332303|Estrogens|estrogens|mesh-ancestor
92893332|NCT03332303|Hormones|hormones|mesh-ancestor
92893333|NCT03332303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893334|NCT03332303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893335|NCT03332303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92893336|NCT03332303|Contraceptive Agents|contraceptive agents|mesh-ancestor
92893337|NCT03332303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92893338|NCT03332303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92893339|NCT00614471|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92893340|NCT00614471|Interferon-alpha|interferon-alpha|mesh-list
92893341|NCT00614471|Entecavir|entecavir|mesh-list
92893342|NCT00614471|Antiviral Agents|antiviral agents|mesh-ancestor
92893343|NCT00614471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893344|NCT00614471|Immunologic Factors|immunologic factors|mesh-ancestor
92893345|NCT00614471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893346|NCT05742256|Sufentanil|sufentanil|mesh-list
92893347|NCT05742256|Oxycodone|oxycodone|mesh-list
92893348|NCT05742256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92893349|NCT05742256|Narcotics|narcotics|mesh-ancestor
92893350|NCT05742256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893351|NCT05742256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893352|NCT05742256|Analgesics|analgesics|mesh-ancestor
92893353|NCT05742256|Sensory System Agents|sensory system agents|mesh-ancestor
92893354|NCT05742256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893355|NCT05742256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92893356|NCT05742256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92893357|NCT05742256|Anesthetics, General|anesthetics, general|mesh-ancestor
92893358|NCT05742256|Anesthetics|anesthetics|mesh-ancestor
92893359|NCT00713596|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92893360|NCT00713596|Hemostatics|hemostatics|mesh-ancestor
92893361|NCT00713596|Coagulants|coagulants|mesh-ancestor
92893362|NCT00729664|Atezolizumab|atezolizumab|mesh-list
92893363|NCT00729664|BMS-936559|bms-936559|mesh-list
92893364|NCT00729664|Antibodies|antibodies|mesh-list
92893365|NCT00729664|Immunoglobulins|immunoglobulins|mesh-list
92893366|NCT00729664|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92893367|NCT00729664|Immunologic Factors|immunologic factors|mesh-ancestor
92893368|NCT00729664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893369|NCT00729664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92893370|NCT00729664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893371|NCT00729664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893372|NCT00729664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893373|NCT04229615|Apatinib|apatinib|mesh-list
92893374|NCT04229615|Fluzoparib|fluzoparib|mesh-list
92893375|NCT04229615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893376|NCT04229615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92893377|NCT04229615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893378|NCT04229615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893379|NCT04229615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92893381|NCT00881894|Dopamine Agonists|dopamine agonists|mesh-ancestor
92893382|NCT00881894|Dopamine Agents|dopamine agents|mesh-ancestor
92893383|NCT00881894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893384|NCT00881894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893385|NCT00881894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538721|NCT01805544|Rivaroxaban|rivaroxaban|mesh-list
92893387|NCT02638376|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92893388|NCT02638376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92893389|NCT02638376|Vitamin B Complex|vitamin b complex|mesh-ancestor
92893390|NCT02638376|Vitamins|vitamins|mesh-ancestor
92893391|NCT02638376|Micronutrients|micronutrients|mesh-ancestor
92893392|NCT02638376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893393|NCT02638376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92893394|NCT02638376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92893395|NCT00827931|Tranexamic Acid|tranexamic acid|mesh-list
92893396|NCT00827931|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92893397|NCT00827931|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92893398|NCT00827931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893399|NCT00827931|Hemostatics|hemostatics|mesh-ancestor
92893400|NCT00827931|Coagulants|coagulants|mesh-ancestor
92893401|NCT04158674|Simendan|simendan|mesh-list
92893402|NCT04158674|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92893403|NCT04158674|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893404|NCT04158674|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92893405|NCT04158674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92893406|NCT04158674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893407|NCT04158674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893408|NCT04158674|Protective Agents|protective agents|mesh-ancestor
92893409|NCT04158674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893410|NCT00526669|Capecitabine|capecitabine|mesh-list
92893411|NCT00526669|Lapatinib|lapatinib|mesh-list
92893412|NCT00526669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92893413|NCT00526669|Antimetabolites|antimetabolites|mesh-ancestor
92893414|NCT00526669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893415|NCT00526669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893416|NCT00526669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92893417|NCT00526669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893418|NCT03640949|Methylprednisolone|methylprednisolone|mesh-list
92893419|NCT03640949|Vasopressins|vasopressins|mesh-list
92893420|NCT03640949|Arginine Vasopressin|arginine vasopressin|mesh-list
92893421|NCT03640949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893422|NCT03640949|Antiemetics|antiemetics|mesh-ancestor
92893423|NCT03640949|Autonomic Agents|autonomic agents|mesh-ancestor
92893424|NCT03640949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893425|NCT03640949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893426|NCT03640949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893427|NCT03640949|Glucocorticoids|glucocorticoids|mesh-ancestor
92893428|NCT03640949|Hormones|hormones|mesh-ancestor
92893429|NCT03640949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893430|NCT03640949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92893431|NCT03640949|Protective Agents|protective agents|mesh-ancestor
92893432|NCT03640949|Hemostatics|hemostatics|mesh-ancestor
92893433|NCT03640949|Coagulants|coagulants|mesh-ancestor
92893434|NCT03640949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92893435|NCT03640949|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92893436|NCT03640949|Natriuretic Agents|natriuretic agents|mesh-ancestor
92893437|NCT00827775|Carvedilol|carvedilol|mesh-list
92893438|NCT00827775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92893439|NCT00827775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92893440|NCT00827775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92893441|NCT00827775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893442|NCT00827775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893443|NCT00827775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893444|NCT00827775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92893445|NCT00827775|Antioxidants|antioxidants|mesh-ancestor
92893446|NCT00827775|Protective Agents|protective agents|mesh-ancestor
92893447|NCT00827775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92893448|NCT00827775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893449|NCT00827775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92893450|NCT00827775|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893451|NCT00827775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92893453|NCT02544308|Dexamethasone|dexamethasone|mesh-list
92893454|NCT02544308|Lenalidomide|lenalidomide|mesh-list
92893455|NCT02544308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893456|NCT02544308|Antiemetics|antiemetics|mesh-ancestor
92893457|NCT02544308|Autonomic Agents|autonomic agents|mesh-ancestor
92893458|NCT02544308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893459|NCT02544308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893460|NCT02544308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893461|NCT02544308|Glucocorticoids|glucocorticoids|mesh-ancestor
92893462|NCT02544308|Hormones|hormones|mesh-ancestor
92893463|NCT02544308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893464|NCT02544308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92893465|NCT02544308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893466|NCT02544308|Immunologic Factors|immunologic factors|mesh-ancestor
92893467|NCT02544308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92893468|NCT02544308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92893469|NCT02544308|Growth Substances|growth substances|mesh-ancestor
92893470|NCT02544308|Growth Inhibitors|growth inhibitors|mesh-ancestor
92893471|NCT00707187|Tadalafil|tadalafil|mesh-list
92893472|NCT00707187|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893473|NCT00707187|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92160999|NCT03527147|Magrolimab|magrolimab|mesh-list
92893474|NCT00707187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92893475|NCT00707187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893476|NCT00707187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893477|NCT00707187|Urological Agents|urological agents|mesh-ancestor
92893478|NCT03998761|Progesterone|progesterone|mesh-list
92893479|NCT03998761|Dydrogesterone|dydrogesterone|mesh-list
92893480|NCT03998761|Progestins|progestins|mesh-ancestor
92893481|NCT03998761|Hormones|hormones|mesh-ancestor
92893482|NCT03998761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893483|NCT03998761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893484|NCT00658580|Etoposide|etoposide|mesh-list
92893485|NCT00658580|Etoposide phosphate|etoposide phosphate|mesh-list
92893486|NCT00658580|Epirubicin|epirubicin|mesh-list
92893487|NCT00658580|Ifosfamide|ifosfamide|mesh-list
92893488|NCT00658580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893489|NCT00658580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92893490|NCT00658580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92893491|NCT00658580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92893492|NCT00658580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893493|NCT00658580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893494|NCT00658580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92893495|NCT00658580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92893496|NCT00658580|Alkylating Agents|alkylating agents|mesh-ancestor
92893497|NCT00729742|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92893498|NCT00729742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893499|NCT00729742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92893500|NCT00729742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893501|NCT00729742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893502|NCT03435107|Durvalumab|durvalumab|mesh-list
92893503|NCT03435107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893504|NCT03435107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893505|NCT03612791|Atezolizumab|atezolizumab|mesh-list
92893506|NCT03612791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893507|NCT03612791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92893508|NCT03612791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893509|NCT03612791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893510|NCT00827541|Tigecycline|tigecycline|mesh-list
92893511|NCT00827541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92893512|NCT00827541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893513|NCT00827541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92893514|NCT00827541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893515|NCT00827541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893516|NCT05741866|Chlorhexidine|chlorhexidine|mesh-list
92893517|NCT05741866|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92893518|NCT05741866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92893519|NCT05741866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893520|NCT05741866|Disinfectants|disinfectants|mesh-ancestor
92893521|NCT05741866|Dermatologic Agents|dermatologic agents|mesh-ancestor
92893522|NCT03916601|Insulin|insulin|mesh-list
92893523|NCT03916601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92893524|NCT03916601|Insulin Aspart|insulin aspart|mesh-list
92893525|NCT03916601|Insulin, Long-Acting|insulin, long-acting|mesh-list
92238303|NCT01080677|Propranolol|propranolol|mesh-list
92893526|NCT03916601|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92893528|NCT03916601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893529|NCT00518323|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92893530|NCT00518323|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92893531|NCT00518323|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92893532|NCT00518323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893533|NCT00518323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893534|NCT00518323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893535|NCT00518323|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92893536|NCT00518323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92893537|NCT00518323|Serotonin Agents|serotonin agents|mesh-ancestor
92893538|NCT00518323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893539|NCT00518323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893540|NCT00518323|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92893541|NCT00518323|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92893542|NCT00518323|Dopamine Agents|dopamine agents|mesh-ancestor
92893543|NCT00707421|Fluorometholone|fluorometholone|mesh-list
92893544|NCT00707421|Ketorolac|ketorolac|mesh-list
92893545|NCT00707421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92893546|NCT00707421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92893547|NCT00707421|Analgesics|analgesics|mesh-ancestor
92893548|NCT00707421|Sensory System Agents|sensory system agents|mesh-ancestor
92893549|NCT00707421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893550|NCT00707421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893551|NCT00707421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893552|NCT00707421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92893553|NCT00707421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92893554|NCT00707421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893555|NCT00707421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893556|NCT00707421|Glucocorticoids|glucocorticoids|mesh-ancestor
92893557|NCT00707421|Hormones|hormones|mesh-ancestor
92893558|NCT00707421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893559|NCT00707421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92893560|NCT03570437|Paclitaxel|paclitaxel|mesh-list
92893561|NCT03570437|Olaparib|olaparib|mesh-list
92893562|NCT03570437|Cediranib|cediranib|mesh-list
92893563|NCT03570437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92893564|NCT03570437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893565|NCT03570437|Tubulin Modulators|tubulin modulators|mesh-ancestor
92893566|NCT03570437|Antimitotic Agents|antimitotic agents|mesh-ancestor
92893567|NCT03570437|Mitosis Modulators|mitosis modulators|mesh-ancestor
92893568|NCT03570437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893569|NCT03570437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92893570|NCT03570437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893571|NCT03570437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92893572|NCT00826449|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92893573|NCT00826449|Dasatinib|dasatinib|mesh-list
92893574|NCT00826449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893575|NCT00826449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92893576|NCT00826449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893577|NCT00826449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893578|NCT03632213|Losartan|losartan|mesh-list
92893579|NCT03632213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92893580|NCT03632213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92893581|NCT03632213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92893582|NCT03632213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92893583|NCT03632213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893584|NCT00825825|Citalopram|citalopram|mesh-list
92893585|NCT00825825|Escitalopram|escitalopram|mesh-list
92893586|NCT00825825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92893587|NCT00825825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92893588|NCT00825825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893589|NCT00825825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893590|NCT00825825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893591|NCT00825825|Serotonin Agents|serotonin agents|mesh-ancestor
92893592|NCT00825825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893593|NCT00825825|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92893594|NCT00825825|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893595|NCT00825825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977259|NCT01070641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92977260|NCT01070641|Antioxidants|antioxidants|mesh-ancestor
92893596|NCT03802487|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92893597|NCT03802487|Charcoal|charcoal|mesh-list
92893598|NCT03802487|Antidotes|antidotes|mesh-ancestor
92893599|NCT03802487|Protective Agents|protective agents|mesh-ancestor
92893600|NCT03802487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893601|NCT03802487|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92893602|NCT03802487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893603|NCT03802487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893604|NCT00880334|Docetaxel|docetaxel|mesh-list
92893605|NCT00880334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893606|NCT00880334|Tubulin Modulators|tubulin modulators|mesh-ancestor
92893607|NCT00880334|Antimitotic Agents|antimitotic agents|mesh-ancestor
92893608|NCT00880334|Mitosis Modulators|mitosis modulators|mesh-ancestor
92893609|NCT00880334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893610|NCT01033565|Melatonin|melatonin|mesh-list
92893611|NCT01033565|Antioxidants|antioxidants|mesh-ancestor
92893612|NCT01033565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893613|NCT01033565|Protective Agents|protective agents|mesh-ancestor
92893614|NCT01033565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893615|NCT01033565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893616|NCT00658892|Antibodies|antibodies|mesh-list
92893617|NCT00658892|Immunologic Factors|immunologic factors|mesh-ancestor
92893618|NCT00658892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893619|NCT00654914|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92893620|NCT00654914|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893621|NCT00654914|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92893622|NCT00654914|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92893623|NCT00654914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893624|NCT00654914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893625|NCT00654914|Urological Agents|urological agents|mesh-ancestor
92893626|NCT00865566|Vaccines|vaccines|mesh-list
92893627|NCT00865566|Immunologic Factors|immunologic factors|mesh-ancestor
92893628|NCT00865566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893629|NCT00658970|Tirbanibulin|tirbanibulin|mesh-list
92893630|NCT00658970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893631|NCT00658970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893632|NCT00659048|Ciclesonide|ciclesonide|mesh-list
92893633|NCT00659048|Glucocorticoids|glucocorticoids|mesh-ancestor
92893634|NCT00659048|Hormones|hormones|mesh-ancestor
92893635|NCT00659048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893636|NCT00659048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893637|NCT00659048|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92893638|NCT02623920|Rituximab|rituximab|mesh-list
92893639|NCT02623920|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92893640|NCT02623920|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92893641|NCT02623920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893642|NCT02623920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893643|NCT02623920|Immunologic Factors|immunologic factors|mesh-ancestor
92893644|NCT02623920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893645|NCT02623920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92893646|NCT02623920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92893647|NCT02623920|Alkylating Agents|alkylating agents|mesh-ancestor
92893648|NCT02623920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893649|NCT02623920|Immunotoxins|immunotoxins|mesh-ancestor
92893650|NCT02623920|Immunoconjugates|immunoconjugates|mesh-ancestor
92893651|NCT00525499|Androgens|androgens|mesh-list
92893652|NCT00525499|Hormones|hormones|mesh-ancestor
92893653|NCT00525499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893654|NCT00525499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893655|NCT04576546|Inositol|inositol|mesh-list
92893656|NCT04576546|Vitamin B Complex|vitamin b complex|mesh-ancestor
92893657|NCT04576546|Vitamins|vitamins|mesh-ancestor
92893658|NCT04576546|Micronutrients|micronutrients|mesh-ancestor
92893659|NCT04576546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893660|NCT02617680|Nitric Oxide|nitric oxide|mesh-list
92893661|NCT02617680|Desflurane|desflurane|mesh-list
92893662|NCT02617680|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92893663|NCT02617680|Autonomic Agents|autonomic agents|mesh-ancestor
92893664|NCT02617680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893665|NCT02617680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893666|NCT02617680|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92893667|NCT02617680|Respiratory System Agents|respiratory system agents|mesh-ancestor
92893668|NCT02617680|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92893669|NCT02617680|Antioxidants|antioxidants|mesh-ancestor
92893670|NCT02617680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893671|NCT02617680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893672|NCT02617680|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92893673|NCT02617680|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893674|NCT02617680|Gasotransmitters|gasotransmitters|mesh-ancestor
92893675|NCT02617680|Protective Agents|protective agents|mesh-ancestor
92893676|NCT02617680|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92893677|NCT02617680|Anesthetics, General|anesthetics, general|mesh-ancestor
92893678|NCT02617680|Anesthetics|anesthetics|mesh-ancestor
92893679|NCT02617680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893680|NCT02568280|Insulin|insulin|mesh-list
92893681|NCT02568280|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92893682|NCT02568280|Insulin Aspart|insulin aspart|mesh-list
92893683|NCT02568280|Insulin, Long-Acting|insulin, long-acting|mesh-list
92539025|NCT00009776|Cyclosporine|cyclosporine|mesh-list
92893684|NCT02568280|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92893685|NCT02568280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893686|NCT02568280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893687|NCT00525265|Tolvaptan|tolvaptan|mesh-list
92893688|NCT00525265|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92893689|NCT00525265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893690|NCT00525265|Natriuretic Agents|natriuretic agents|mesh-ancestor
92893691|NCT00525265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893692|NCT04158830|Aspirin|aspirin|mesh-list
92893693|NCT04158830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92893694|NCT04158830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92893695|NCT04158830|Analgesics|analgesics|mesh-ancestor
92893696|NCT04158830|Sensory System Agents|sensory system agents|mesh-ancestor
92893697|NCT04158830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893698|NCT04158830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893699|NCT04158830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893700|NCT04158830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92893701|NCT04158830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92893702|NCT04158830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92893703|NCT04158830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893704|NCT04158830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92893705|NCT04158830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92893706|NCT04158830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893707|NCT04158830|Antipyretics|antipyretics|mesh-ancestor
92893708|NCT00659282|Insulin Aspart|insulin aspart|mesh-list
92893709|NCT00659282|Biphasic Insulins|biphasic insulins|mesh-list
92893710|NCT00659282|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92893711|NCT00659282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893712|NCT00659282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893713|NCT02617758|Fentanyl|fentanyl|mesh-list
92893714|NCT02617758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92893715|NCT02617758|Narcotics|narcotics|mesh-ancestor
92893716|NCT02617758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893717|NCT02617758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893718|NCT02617758|Analgesics|analgesics|mesh-ancestor
92893719|NCT02617758|Sensory System Agents|sensory system agents|mesh-ancestor
92893720|NCT02617758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893721|NCT02617758|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92893722|NCT02617758|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92893723|NCT02617758|Anesthetics, General|anesthetics, general|mesh-ancestor
92893724|NCT02617758|Anesthetics|anesthetics|mesh-ancestor
92893725|NCT00737542|Lidocaine|lidocaine|mesh-list
92893726|NCT00737542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92893727|NCT00737542|Anesthetics|anesthetics|mesh-ancestor
92893728|NCT00737542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92893729|NCT00737542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893730|NCT00737542|Sensory System Agents|sensory system agents|mesh-ancestor
92893731|NCT00737542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893732|NCT00737542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92893733|NCT00737542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92893734|NCT00737542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92893735|NCT00737542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893736|NCT00737542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893737|NCT00865098|Cetuximab|cetuximab|mesh-list
92893738|NCT00865098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893739|NCT00865098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893740|NCT00880100|Pancrelipase|pancrelipase|mesh-list
92893741|NCT00880100|Pancreatin|pancreatin|mesh-list
92893742|NCT00880100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893743|NCT00729898|Insulin Aspart|insulin aspart|mesh-list
92893744|NCT00729898|Biphasic Insulins|biphasic insulins|mesh-list
92893745|NCT00729898|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92893746|NCT00729898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893747|NCT00729898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893748|NCT00659594|Ciclesonide|ciclesonide|mesh-list
92893749|NCT00659594|Glucocorticoids|glucocorticoids|mesh-ancestor
92893750|NCT00659594|Hormones|hormones|mesh-ancestor
92893751|NCT00659594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893752|NCT00659594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893753|NCT00659594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92893754|NCT05541016|Cisplatin|cisplatin|mesh-list
92893755|NCT05541016|Docetaxel|docetaxel|mesh-list
92893756|NCT05541016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893757|NCT05541016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92893758|NCT05541016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92893759|NCT05541016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92893760|NCT05541016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893761|NCT04158050|Omalizumab|omalizumab|mesh-list
92893762|NCT04158050|Antibodies|antibodies|mesh-list
92893763|NCT04158050|Immunologic Factors|immunologic factors|mesh-ancestor
92893764|NCT04158050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893765|NCT04158050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92893766|NCT04158050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92893767|NCT04158050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92893768|NCT00659750|Ciclesonide|ciclesonide|mesh-list
92893769|NCT00659750|Glucocorticoids|glucocorticoids|mesh-ancestor
92893770|NCT00659750|Hormones|hormones|mesh-ancestor
92893771|NCT00659750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893772|NCT00659750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893773|NCT00659750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92893774|NCT00697476|Topotecan|topotecan|mesh-list
92893775|NCT00697476|Vorinostat|vorinostat|mesh-list
92893776|NCT00697476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92893777|NCT00697476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92893778|NCT00697476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893779|NCT00697476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893780|NCT00697476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893781|NCT00697476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92893782|NCT00660062|Dexetimide|dexetimide|mesh-list
92893783|NCT00660062|Citalopram|citalopram|mesh-list
92893784|NCT00660062|Nortriptyline|nortriptyline|mesh-list
92893785|NCT00660062|Escitalopram|escitalopram|mesh-list
92893786|NCT00660062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92893787|NCT00660062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92893788|NCT00660062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893789|NCT00660062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893790|NCT00660062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92893791|NCT00660062|Serotonin Agents|serotonin agents|mesh-ancestor
92893792|NCT00660062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893793|NCT00660062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92893794|NCT00660062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92893795|NCT00660062|Parasympatholytics|parasympatholytics|mesh-ancestor
92893796|NCT00660062|Autonomic Agents|autonomic agents|mesh-ancestor
92893797|NCT00660062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893798|NCT00660062|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92893799|NCT00660062|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92893800|NCT00660062|Cholinergic Agents|cholinergic agents|mesh-ancestor
92893801|NCT00660062|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92893802|NCT00660062|Antidepressive Agents|antidepressive agents|mesh-ancestor
92893803|NCT00660062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92893804|NCT00660062|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92893805|NCT00660062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92893806|NCT00660062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92893807|NCT04063540|Amiloride|amiloride|mesh-list
92893808|NCT04063540|Diuretics|diuretics|mesh-ancestor
92893809|NCT04063540|Natriuretic Agents|natriuretic agents|mesh-ancestor
92893810|NCT04063540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893811|NCT04063540|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92893812|NCT04063540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92893813|NCT04063540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893814|NCT04063540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893815|NCT04063540|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92893816|NCT04063540|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92893817|NCT04161560|Cetuximab|cetuximab|mesh-list
92893818|NCT04161560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893819|NCT04161560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893820|NCT00518011|Gemcitabine|gemcitabine|mesh-list
92893821|NCT00518011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92893822|NCT00518011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92893823|NCT00518011|Antimetabolites|antimetabolites|mesh-ancestor
92893824|NCT00518011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893825|NCT00518011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893826|NCT00518011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92893827|NCT00518011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893828|NCT00737776|Insulin Aspart|insulin aspart|mesh-list
92893829|NCT00737776|Biphasic Insulins|biphasic insulins|mesh-list
92893830|NCT00737776|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92893831|NCT00737776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893832|NCT00737776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893833|NCT02633930|Amoxicillin|amoxicillin|mesh-list
92893834|NCT02633930|Clarithromycin|clarithromycin|mesh-list
92893835|NCT02633930|Lansoprazole|lansoprazole|mesh-list
92893836|NCT02633930|Dexlansoprazole|dexlansoprazole|mesh-list
92893837|NCT02633930|Bismuth|bismuth|mesh-list
92893838|NCT02633930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92893839|NCT02633930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893840|NCT02633930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92893841|NCT02633930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893842|NCT02633930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893843|NCT02633930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92893844|NCT02633930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92893845|NCT02633930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92893846|NCT02633930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893847|NCT02633930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92893848|NCT02633930|Antacids|antacids|mesh-ancestor
92893849|NCT00698334|Rifampin|rifampin|mesh-list
92893850|NCT00698334|Pyrazinamide|pyrazinamide|mesh-list
92893851|NCT00698334|Ethambutol|ethambutol|mesh-list
92893852|NCT00698334|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92893853|NCT00698334|Antitubercular Agents|antitubercular agents|mesh-ancestor
92893854|NCT00698334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92893855|NCT00698334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893856|NCT00698334|Leprostatic Agents|leprostatic agents|mesh-ancestor
92893857|NCT00698334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92893858|NCT00698334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893859|NCT00698334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893860|NCT00698334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92893861|NCT00698334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92893862|NCT00698334|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92893863|NCT00698334|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92893864|NCT00698334|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92893865|NCT00698334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92893866|NCT04161482|Furosemide|furosemide|mesh-list
92893867|NCT04161482|Diuretics|diuretics|mesh-ancestor
92893868|NCT04161482|Natriuretic Agents|natriuretic agents|mesh-ancestor
92893869|NCT04161482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893870|NCT04161482|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92893871|NCT04161482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893872|NCT04161482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893873|NCT02623452|Insulin Lispro|insulin lispro|mesh-list
92893874|NCT02623452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893875|NCT02623452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893876|NCT02633696|Silybin|silybin|mesh-list
92893877|NCT02633696|Silymarin|silymarin|mesh-list
92893878|NCT02633696|Antioxidants|antioxidants|mesh-ancestor
92893879|NCT02633696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893880|NCT02633696|Protective Agents|protective agents|mesh-ancestor
92893881|NCT02633696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893882|NCT02633696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92893883|NCT02633696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893884|NCT02633852|Aflibercept|aflibercept|mesh-list
92893885|NCT02633852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92893886|NCT02633852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92893887|NCT02633852|Growth Substances|growth substances|mesh-ancestor
92893888|NCT02633852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893889|NCT02633852|Growth Inhibitors|growth inhibitors|mesh-ancestor
92893890|NCT02633852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893891|NCT02633774|Propafenone|propafenone|mesh-list
92893892|NCT02633774|Apixaban|apixaban|mesh-list
92893893|NCT02633774|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92893894|NCT02633774|Antithrombins|antithrombins|mesh-ancestor
92893895|NCT02633774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92893896|NCT02633774|Protease Inhibitors|protease inhibitors|mesh-ancestor
92893897|NCT02633774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893898|NCT02633774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893899|NCT02633774|Anticoagulants|anticoagulants|mesh-ancestor
92893900|NCT02633774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92893901|NCT02633774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92893902|NCT02633774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92893903|NCT02633774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92893904|NCT02633618|Neurotropin|neurotropin|mesh-list
92893905|NCT02633618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92893906|NCT02633618|Immunologic Factors|immunologic factors|mesh-ancestor
92893907|NCT02633618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893909|NCT02633618|Sensory System Agents|sensory system agents|mesh-ancestor
92893910|NCT02633618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893911|NCT02633618|Anticonvulsants|anticonvulsants|mesh-ancestor
92893912|NCT00865020|Telmisartan|telmisartan|mesh-list
92893913|NCT00865020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92893914|NCT00865020|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92893915|NCT00865020|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92893916|NCT00865020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893917|NCT00517933|Sildenafil Citrate|sildenafil citrate|mesh-list
92893918|NCT00517933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893919|NCT00517933|Vasodilator Agents|vasodilator agents|mesh-ancestor
92893920|NCT00517933|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92893921|NCT00517933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92893922|NCT00517933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893923|NCT00517933|Urological Agents|urological agents|mesh-ancestor
92893924|NCT02633384|Sorbitol|sorbitol|mesh-list
92893925|NCT02633384|SMOFlipid|smoflipid|mesh-list
92893926|NCT02633384|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92893927|NCT02633384|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92893928|NCT02633384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92893929|NCT02633384|Cathartics|cathartics|mesh-ancestor
92893930|NCT02633384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893931|NCT02633462|Inositol|inositol|mesh-list
92893932|NCT02633462|Vitamin B Complex|vitamin b complex|mesh-ancestor
92893933|NCT02633462|Vitamins|vitamins|mesh-ancestor
92893934|NCT02633462|Micronutrients|micronutrients|mesh-ancestor
92893935|NCT02633462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893936|NCT02638064|Surgiflo|surgiflo|mesh-list
92893937|NCT02638064|Hemostatics|hemostatics|mesh-ancestor
92893938|NCT02638064|Coagulants|coagulants|mesh-ancestor
92893939|NCT04119336|Dexamethasone|dexamethasone|mesh-list
92893940|NCT04119336|Cyclophosphamide|cyclophosphamide|mesh-list
92893941|NCT04119336|Nivolumab|nivolumab|mesh-list
92893942|NCT04119336|Ixazomib|ixazomib|mesh-list
92893943|NCT04119336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92893944|NCT04119336|Immunologic Factors|immunologic factors|mesh-ancestor
92893945|NCT04119336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893946|NCT04119336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92893947|NCT04119336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92893948|NCT04119336|Alkylating Agents|alkylating agents|mesh-ancestor
92893949|NCT04119336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92893950|NCT04119336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92893951|NCT04119336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92893952|NCT04119336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893953|NCT04119336|Antiemetics|antiemetics|mesh-ancestor
92893954|NCT04119336|Autonomic Agents|autonomic agents|mesh-ancestor
92893955|NCT04119336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893956|NCT04119336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92893957|NCT04119336|Glucocorticoids|glucocorticoids|mesh-ancestor
92893958|NCT04119336|Hormones|hormones|mesh-ancestor
92893959|NCT04119336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893960|NCT04119336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92893961|NCT04119336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893962|NCT04119336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92893963|NCT04119336|Protease Inhibitors|protease inhibitors|mesh-ancestor
92893964|NCT04119336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92893965|NCT00655148|Vaccines|vaccines|mesh-list
92893966|NCT00655148|Immunologic Factors|immunologic factors|mesh-ancestor
92893967|NCT00655148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893968|NCT00857766|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92893969|NCT00857766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92893970|NCT00857766|Autonomic Agents|autonomic agents|mesh-ancestor
92893971|NCT00857766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893972|NCT00857766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893973|NCT00857766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92893974|NCT00857766|Respiratory System Agents|respiratory system agents|mesh-ancestor
92893975|NCT00857766|Glucocorticoids|glucocorticoids|mesh-ancestor
92893976|NCT00857766|Hormones|hormones|mesh-ancestor
92893977|NCT00857766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92893978|NCT00857766|Sympathomimetics|sympathomimetics|mesh-ancestor
92893979|NCT04161404|Metformin|metformin|mesh-list
92893980|NCT04161404|Andrographolide|andrographolide|mesh-list
92893981|NCT04161404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92893982|NCT04161404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92893983|NCT04161404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92893984|NCT04161404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92893985|NCT04161404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92893986|NCT04161404|Analgesics|analgesics|mesh-ancestor
92893987|NCT04161404|Sensory System Agents|sensory system agents|mesh-ancestor
92893988|NCT04161404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92893989|NCT04161404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92893990|NCT04161404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92893991|NCT04161404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92893992|NCT04161404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92893993|NCT04161404|Antiviral Agents|antiviral agents|mesh-ancestor
92893994|NCT04161404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92893995|NCT00517699|Cytarabine|cytarabine|mesh-list
92893996|NCT00517699|Rituximab|rituximab|mesh-list
92893997|NCT00517699|Methotrexate|methotrexate|mesh-list
92893998|NCT00517699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92893999|NCT00517699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894000|NCT00517699|Immunologic Factors|immunologic factors|mesh-ancestor
92894001|NCT00517699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894002|NCT00517699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894003|NCT00517699|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92894004|NCT00517699|Abortifacient Agents|abortifacient agents|mesh-ancestor
92894005|NCT00517699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92894006|NCT00517699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894007|NCT00517699|Antimetabolites|antimetabolites|mesh-ancestor
92894008|NCT00517699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894009|NCT00517699|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894010|NCT00517699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894011|NCT00517699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92894012|NCT00517699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894013|NCT00517699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92894014|NCT00517699|Antiviral Agents|antiviral agents|mesh-ancestor
92894015|NCT00517699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894016|NCT03096275|Glucocorticoids|glucocorticoids|mesh-list
92894017|NCT03096275|Hormones|hormones|mesh-ancestor
92894018|NCT03096275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894019|NCT03096275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894020|NCT04161014|Nintedanib|nintedanib|mesh-list
92894021|NCT04161014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894022|NCT04161014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894023|NCT04161014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894024|NCT04161014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894025|NCT04491643|Megestrol|megestrol|mesh-list
92894026|NCT04491643|Megestrol Acetate|megestrol acetate|mesh-list
92894027|NCT04491643|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92894028|NCT04491643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92894029|NCT04491643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92894030|NCT04491643|Antimetabolites|antimetabolites|mesh-ancestor
92894031|NCT04491643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894032|NCT04491643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92894033|NCT04491643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92894034|NCT04491643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894035|NCT04491643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92894036|NCT04491643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92894037|NCT04491643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92894038|NCT04491643|Contraceptive Agents|contraceptive agents|mesh-ancestor
92894039|NCT04491643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92894040|NCT04491643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894041|NCT04491643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92894042|NCT04491643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92894043|NCT04491643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92894044|NCT04491643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894045|NCT04491643|Appetite Stimulants|appetite stimulants|mesh-ancestor
92894046|NCT04491643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92894047|NCT00699504|Moxifloxacin|moxifloxacin|mesh-list
92894048|NCT00699504|Cangrelor|cangrelor|mesh-list
92894049|NCT00699504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92894050|NCT00699504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894051|NCT00699504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92894052|NCT00699504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92894053|NCT00699504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894054|NCT00699504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894055|NCT00699504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894056|NCT00699504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894057|NCT00699504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92894058|NCT00699504|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92894059|NCT00699504|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92894060|NCT00699504|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92894061|NCT00699504|Purinergic Agents|purinergic agents|mesh-ancestor
92894062|NCT00699504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894063|NCT02997605|Prednisone|prednisone|mesh-list
92894064|NCT02997605|Hydrocortisone|hydrocortisone|mesh-list
92894065|NCT02997605|Glucocorticoids|glucocorticoids|mesh-list
92894066|NCT02997605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92894067|NCT02997605|Hormones|hormones|mesh-ancestor
92894068|NCT02997605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894069|NCT02997605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894070|NCT02997605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92894071|NCT02997605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894072|NCT03767543|Insulin Glargine|insulin glargine|mesh-list
92894073|NCT03767543|Lixisenatide|lixisenatide|mesh-list
92894074|NCT03767543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894075|NCT03767543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894076|NCT00857454|Testosterone|testosterone|mesh-list
92894077|NCT00857454|Androgens|androgens|mesh-ancestor
92894078|NCT00857454|Hormones|hormones|mesh-ancestor
92894079|NCT00857454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894080|NCT00857454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894081|NCT00660140|Carboplatin|carboplatin|mesh-list
92894082|NCT00660140|Gemcitabine|gemcitabine|mesh-list
92894083|NCT00660140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894084|NCT00660140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894085|NCT00660140|Antimetabolites|antimetabolites|mesh-ancestor
92894086|NCT00660140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894087|NCT03760991|Insulin Glargine|insulin glargine|mesh-list
92894088|NCT03760991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894089|NCT03760991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894090|NCT00525031|Interferons|interferons|mesh-list
92894091|NCT00525031|Interferon-alpha|interferon-alpha|mesh-list
92894092|NCT00525031|Interferon alpha-2|interferon alpha-2|mesh-list
92894093|NCT00525031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92894094|NCT00525031|Temozolomide|temozolomide|mesh-list
92894095|NCT00525031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894096|NCT00525031|Antiviral Agents|antiviral agents|mesh-ancestor
92894097|NCT00525031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894098|NCT00525031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894099|NCT00525031|Alkylating Agents|alkylating agents|mesh-ancestor
92894100|NCT00525031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894101|NCT00525031|Immunologic Factors|immunologic factors|mesh-ancestor
92894102|NCT00525031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894103|NCT00660374|Isophane Insulin, Human|isophane insulin, human|mesh-list
92894104|NCT00660374|Insulin, Isophane|insulin, isophane|mesh-list
92894105|NCT00660374|Isophane insulin, beef|isophane insulin, beef|mesh-list
92894106|NCT00660374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894107|NCT00660374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894108|NCT00524485|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92894109|NCT00524485|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92894110|NCT00524485|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894111|NCT00857220|Eszopiclone|eszopiclone|mesh-list
92894112|NCT00857220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92894113|NCT00857220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894114|NCT00857220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894115|NCT00524173|Tenofovir|tenofovir|mesh-list
92894116|NCT00524173|Emtricitabine|emtricitabine|mesh-list
92894117|NCT00524173|Antiviral Agents|antiviral agents|mesh-ancestor
92894118|NCT00524173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894119|NCT00524173|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92894120|NCT00524173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92894121|NCT00524173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894122|NCT00524173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894123|NCT00524173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92894124|NCT00524173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92894125|NCT02704481|Misoprostol|misoprostol|mesh-list
92894126|NCT02704481|Mifepristone|mifepristone|mesh-list
92894127|NCT02704481|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92894128|NCT02704481|Abortifacient Agents|abortifacient agents|mesh-ancestor
92894129|NCT02704481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92894130|NCT02704481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539476|NCT00847119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894131|NCT02704481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92894132|NCT02704481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92894133|NCT02704481|Oxytocics|oxytocics|mesh-ancestor
92894134|NCT02704481|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92894135|NCT02704481|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92894136|NCT02704481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92894137|NCT02704481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92894138|NCT02704481|Contraceptive Agents|contraceptive agents|mesh-ancestor
92894139|NCT02704481|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92894140|NCT02704481|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92894141|NCT02704481|Hormone Antagonists|hormone antagonists|mesh-ancestor
92894142|NCT02704481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894143|NCT02704481|Luteolytic Agents|luteolytic agents|mesh-ancestor
92894144|NCT02704481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92894145|NCT02704481|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92894146|NCT02614482|Fesoterodine|fesoterodine|mesh-list
92894147|NCT02614482|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92894148|NCT02614482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92894149|NCT02614482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92894150|NCT02614482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894151|NCT02614482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894152|NCT02614482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894153|NCT02614482|Urological Agents|urological agents|mesh-ancestor
92894154|NCT04713709|Naloxone|naloxone|mesh-list
92894155|NCT04713709|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92894156|NCT04713709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894157|NCT04713709|Sensory System Agents|sensory system agents|mesh-ancestor
92894158|NCT04713709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894159|NCT00879710|Simvastatin|simvastatin|mesh-list
92894160|NCT00879710|Ezetimibe|ezetimibe|mesh-list
92894161|NCT00879710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92894162|NCT00879710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92894163|NCT00879710|Antimetabolites|antimetabolites|mesh-ancestor
92894164|NCT00879710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894165|NCT00879710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92894166|NCT00879710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92894167|NCT00879710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894168|NCT02703857|Cefoxitin|cefoxitin|mesh-list
92894169|NCT02703857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92894170|NCT02703857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894171|NCT02623062|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
92894172|NCT02623062|Antacids|antacids|mesh-ancestor
92894173|NCT02623062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894174|NCT02623062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92894175|NCT00597506|Bevacizumab|bevacizumab|mesh-list
92894176|NCT00597506|Everolimus|everolimus|mesh-list
92894177|NCT00597506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894178|NCT00597506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894179|NCT00597506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894180|NCT00597506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894181|NCT00597506|Growth Substances|growth substances|mesh-ancestor
92894182|NCT00597506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894183|NCT00597506|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894184|NCT00597506|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92161028|NCT01191723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894185|NCT00597506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894186|NCT00597506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894187|NCT00597506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894188|NCT00597506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894189|NCT00597506|Immunologic Factors|immunologic factors|mesh-ancestor
92894191|NCT03393611|Fludarabine|fludarabine|mesh-list
92894192|NCT03393611|Melphalan|melphalan|mesh-list
92894193|NCT03393611|Daunorubicin|daunorubicin|mesh-list
92894194|NCT03393611|Thymoglobulin|thymoglobulin|mesh-list
92894195|NCT03393611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894196|NCT03393611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894197|NCT03393611|Antimetabolites|antimetabolites|mesh-ancestor
92894198|NCT03393611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894199|NCT03393611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894200|NCT03393611|Immunologic Factors|immunologic factors|mesh-ancestor
92894201|NCT03393611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894202|NCT03393611|Antiviral Agents|antiviral agents|mesh-ancestor
92894203|NCT03393611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894204|NCT03393611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894205|NCT03393611|Alkylating Agents|alkylating agents|mesh-ancestor
92894206|NCT03393611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92894207|NCT03393611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92894208|NCT03393611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92894209|NCT03393611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92894210|NCT03393611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894211|NCT04032548|Chlorhexidine|chlorhexidine|mesh-list
92894212|NCT04032548|Propolis|propolis|mesh-list
92894213|NCT04032548|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92894214|NCT04032548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894215|NCT04032548|Disinfectants|disinfectants|mesh-ancestor
92894216|NCT04032236|Caffeine|caffeine|mesh-list
92894217|NCT04032236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92894218|NCT04032236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894219|NCT04032236|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92894220|NCT04032236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894221|NCT04032236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894222|NCT04032236|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92894223|NCT04032236|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92894224|NCT04032236|Purinergic Agents|purinergic agents|mesh-ancestor
92894225|NCT04032236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894226|NCT02313389|Rituximab|rituximab|mesh-list
92894227|NCT02313389|Methotrexate|methotrexate|mesh-list
92894228|NCT02313389|Temozolomide|temozolomide|mesh-list
92894229|NCT02313389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894230|NCT02313389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894231|NCT02313389|Immunologic Factors|immunologic factors|mesh-ancestor
92894232|NCT02313389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894233|NCT02313389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894234|NCT02313389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92894235|NCT02313389|Abortifacient Agents|abortifacient agents|mesh-ancestor
92894236|NCT02313389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92894237|NCT02313389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894238|NCT02313389|Antimetabolites|antimetabolites|mesh-ancestor
92894239|NCT02313389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894240|NCT02313389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894241|NCT02313389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894242|NCT02313389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92894243|NCT02313389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894244|NCT02313389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92894245|NCT02313389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894246|NCT02313389|Alkylating Agents|alkylating agents|mesh-ancestor
92894247|NCT00708682|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92894248|NCT00708682|Immunologic Factors|immunologic factors|mesh-ancestor
92894249|NCT00708682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894250|NCT02632916|Zoledronic Acid|zoledronic acid|mesh-list
92894251|NCT02632916|Denosumab|denosumab|mesh-list
92894252|NCT02632916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92894253|NCT02632916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894254|NCT00881504|Bevacizumab|bevacizumab|mesh-list
92894255|NCT00881504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894256|NCT00881504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894257|NCT00881504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894258|NCT00881504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894259|NCT00881504|Growth Substances|growth substances|mesh-ancestor
92894260|NCT00881504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894261|NCT00881504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894262|NCT00660764|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92894263|NCT00660764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92894264|NCT00660764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92894265|NCT00660764|Antimetabolites|antimetabolites|mesh-ancestor
92894266|NCT00660764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894267|NCT00660764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92894268|NCT00660764|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92894269|NCT00660764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894270|NCT02131493|Gemcitabine|gemcitabine|mesh-list
92894271|NCT02131493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894272|NCT02131493|Antimetabolites|antimetabolites|mesh-ancestor
92894273|NCT02131493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894274|NCT02131493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894275|NCT02096159|Trimethoprim|trimethoprim|mesh-list
92894276|NCT02096159|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92894277|NCT02096159|Sulfamethoxazole|sulfamethoxazole|mesh-list
92894278|NCT02096159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92539623|NCT00846690|Benzocaine|benzocaine|mesh-list
92894279|NCT02096159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894280|NCT02096159|Antimalarials|antimalarials|mesh-ancestor
92894281|NCT02096159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92894282|NCT02096159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92894283|NCT02096159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92894284|NCT02096159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894285|NCT02096159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894286|NCT02096159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92894287|NCT02096159|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92894288|NCT02096159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92894289|NCT02096159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92894290|NCT02632136|Bupivacaine|bupivacaine|mesh-list
92894291|NCT02632136|Anesthetics, Local|anesthetics, local|mesh-ancestor
92894292|NCT02632136|Anesthetics|anesthetics|mesh-ancestor
92894293|NCT02632136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894294|NCT02632136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894295|NCT02632136|Sensory System Agents|sensory system agents|mesh-ancestor
92894296|NCT02632136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894297|NCT00660920|Ponatinib|ponatinib|mesh-list
92894298|NCT00660920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894299|NCT00660920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894300|NCT00660920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894301|NCT00660920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894302|NCT01936831|Vitamin B 6|vitamin b 6|mesh-list
92894303|NCT01936831|Pyridoxal|pyridoxal|mesh-list
92894304|NCT01936831|Pyridoxine|pyridoxine|mesh-list
92894305|NCT01936831|Isoniazid|isoniazid|mesh-list
92894306|NCT01936831|Vitamins|vitamins|mesh-ancestor
92894307|NCT01936831|Micronutrients|micronutrients|mesh-ancestor
92894308|NCT01936831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894309|NCT01936831|Vitamin B Complex|vitamin b complex|mesh-ancestor
92894310|NCT01936831|Antitubercular Agents|antitubercular agents|mesh-ancestor
92894311|NCT01936831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92894312|NCT01936831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894313|NCT01936831|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92894314|NCT01936831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92894315|NCT01936831|Antimetabolites|antimetabolites|mesh-ancestor
92894316|NCT01936831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894317|NCT01936831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92894318|NCT00615173|Cyclophosphamide|cyclophosphamide|mesh-list
92894319|NCT00615173|Azathioprine|azathioprine|mesh-list
92894320|NCT00615173|Tacrolimus|tacrolimus|mesh-list
92894321|NCT00615173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894322|NCT00615173|Immunologic Factors|immunologic factors|mesh-ancestor
92894323|NCT00615173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894324|NCT00615173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161039|NCT01679951|Methotrexate|methotrexate|mesh-list
92894325|NCT00615173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894326|NCT00615173|Alkylating Agents|alkylating agents|mesh-ancestor
92894327|NCT00615173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894328|NCT00615173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894329|NCT00615173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92894330|NCT00615173|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92894331|NCT00615173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894332|NCT00615173|Antimetabolites|antimetabolites|mesh-ancestor
92894333|NCT00615173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894334|NCT00660998|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92894335|NCT00660998|Vasodilator Agents|vasodilator agents|mesh-ancestor
92894336|NCT00660998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92894337|NCT00660998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92894338|NCT00660998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894339|NCT00660998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894340|NCT00660998|Urological Agents|urological agents|mesh-ancestor
92894342|NCT00657254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894343|NCT00657254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894344|NCT00657254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894345|NCT00657254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894346|NCT01455389|Diphenhydramine|diphenhydramine|mesh-list
92894347|NCT01455389|Promethazine|promethazine|mesh-list
92894348|NCT01455389|Dexamethasone|dexamethasone|mesh-list
92894349|NCT01455389|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92894350|NCT01455389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92894351|NCT01455389|Antiemetics|antiemetics|mesh-ancestor
92894352|NCT01455389|Autonomic Agents|autonomic agents|mesh-ancestor
92894353|NCT01455389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894354|NCT01455389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894355|NCT01455389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92894356|NCT01455389|Glucocorticoids|glucocorticoids|mesh-ancestor
92894357|NCT01455389|Hormones|hormones|mesh-ancestor
92894358|NCT01455389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894359|NCT01455389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92894360|NCT01455389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894361|NCT01455389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894362|NCT01455389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894363|NCT01455389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894364|NCT01455389|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92894365|NCT01455389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92894366|NCT01455389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894367|NCT01455389|Anesthetics, Local|anesthetics, local|mesh-ancestor
92894368|NCT01455389|Anesthetics|anesthetics|mesh-ancestor
92894369|NCT01455389|Sensory System Agents|sensory system agents|mesh-ancestor
92894370|NCT01455389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92894371|NCT01455389|Histamine Antagonists|histamine antagonists|mesh-ancestor
92894372|NCT01455389|Histamine Agents|histamine agents|mesh-ancestor
92894373|NCT01455389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894374|NCT01455389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92894375|NCT01455389|Antipruritics|antipruritics|mesh-ancestor
92894376|NCT01455389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894377|NCT00661076|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92894378|NCT00661076|Adefovir|adefovir|mesh-list
92894379|NCT00661076|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92894380|NCT00661076|Antiviral Agents|antiviral agents|mesh-ancestor
92894381|NCT00661076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894382|NCT00661076|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92894383|NCT00661076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92894384|NCT00661076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894385|NCT00661076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894386|NCT04215965|Dialysis Solutions|dialysis solutions|mesh-list
92894387|NCT04215965|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92894388|NCT00661700|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92894389|NCT00661700|Vasodilator Agents|vasodilator agents|mesh-ancestor
92894390|NCT00661700|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92894391|NCT00661700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92894392|NCT00661700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894393|NCT00661700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894394|NCT00661700|Urological Agents|urological agents|mesh-ancestor
92894395|NCT00613769|Metronidazole|metronidazole|mesh-list
92894396|NCT00613769|Trimethoprim|trimethoprim|mesh-list
92894397|NCT00613769|Sulfamethoxazole|sulfamethoxazole|mesh-list
92894398|NCT00613769|Cefuroxime|cefuroxime|mesh-list
92894399|NCT00613769|Cefuroxime axetil|cefuroxime axetil|mesh-list
92894400|NCT00613769|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92894401|NCT00613769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894402|NCT00613769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92894403|NCT00613769|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92894404|NCT00613769|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92894405|NCT00613769|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92894406|NCT00613769|Antimalarials|antimalarials|mesh-ancestor
92894407|NCT00613769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92894408|NCT00613769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894409|NCT00613769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894410|NCT00613769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92894411|NCT00613769|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92894412|NCT00613769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92894413|NCT00661154|Bevacizumab|bevacizumab|mesh-list
92894414|NCT00661154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894415|NCT00661154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894416|NCT00661154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894417|NCT00661154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894418|NCT00661154|Growth Substances|growth substances|mesh-ancestor
92894419|NCT00661154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894420|NCT00661154|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894421|NCT00523705|Escitalopram|escitalopram|mesh-list
92894422|NCT00523705|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92894423|NCT00523705|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92894424|NCT00523705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894425|NCT00523705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894426|NCT00523705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894427|NCT00523705|Serotonin Agents|serotonin agents|mesh-ancestor
92539771|NCT00013520|Zidovudine|zidovudine|mesh-list
92894428|NCT00523705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894429|NCT00193427|Carboplatin|carboplatin|mesh-list
92894430|NCT00193427|Gemcitabine|gemcitabine|mesh-list
92894431|NCT00193427|Docetaxel|docetaxel|mesh-list
92894432|NCT00193427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894433|NCT00193427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894434|NCT00193427|Antimetabolites|antimetabolites|mesh-ancestor
92894435|NCT00193427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894436|NCT00193427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92894437|NCT00193427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92894438|NCT00193427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92894439|NCT00665678|Paroxetine|paroxetine|mesh-list
92894440|NCT00665678|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92894441|NCT00665678|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92894442|NCT00665678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894443|NCT00665678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894444|NCT00665678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894445|NCT00665678|Serotonin Agents|serotonin agents|mesh-ancestor
92894446|NCT00665678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894447|NCT00665678|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92894448|NCT00665678|Antidepressive Agents|antidepressive agents|mesh-ancestor
92894449|NCT00665678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92894450|NCT00665678|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92894451|NCT00665678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92894452|NCT00665678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894453|NCT05345327|Metformin|metformin|mesh-list
92894454|NCT05345327|Dapagliflozin|dapagliflozin|mesh-list
92894455|NCT05345327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894456|NCT05345327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894457|NCT05345327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92894458|NCT05345327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894459|NCT00523549|Amlodipine|amlodipine|mesh-list
92894460|NCT00523549|Valsartan|valsartan|mesh-list
92894461|NCT00523549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92894462|NCT00523549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92894463|NCT00523549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894464|NCT00523549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894465|NCT00523549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92894466|NCT00523549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894467|NCT00523549|Vasodilator Agents|vasodilator agents|mesh-ancestor
92894468|NCT00523549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92894469|NCT00523549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92894470|NCT04215653|Rabeprazole|rabeprazole|mesh-list
92894471|NCT04215653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92894472|NCT04215653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92894473|NCT04215653|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92894474|NCT04215653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894475|NCT04215653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894476|NCT02706119|Insulin|insulin|mesh-list
92894477|NCT02706119|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92894478|NCT02706119|Insulin Glargine|insulin glargine|mesh-list
92894479|NCT02706119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894480|NCT02706119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894481|NCT02631668|Ferrous succinate|ferrous succinate|mesh-list
92894482|NCT02631668|Hematinics|hematinics|mesh-ancestor
92894483|NCT00665756|Mitomycins|mitomycins|mesh-list
92894484|NCT00665756|Mitomycin|mitomycin|mesh-list
92894485|NCT00665756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92894486|NCT00665756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894487|NCT00665756|Alkylating Agents|alkylating agents|mesh-ancestor
92894488|NCT00665756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894489|NCT00665756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92894490|NCT00665756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894491|NCT00661856|Genistein|genistein|mesh-list
92894492|NCT00661856|Daidzein|daidzein|mesh-list
92894493|NCT00661856|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92894494|NCT00661856|Protective Agents|protective agents|mesh-ancestor
92894495|NCT00661856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894496|NCT00661856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894497|NCT00661856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894498|NCT00661856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894499|NCT00661856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894500|NCT00661856|Phytoestrogens|phytoestrogens|mesh-ancestor
92894501|NCT00661856|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92894503|NCT00661856|Hormones|hormones|mesh-ancestor
92894504|NCT00661856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894505|NCT04215731|Leucovorin|leucovorin|mesh-list
92894506|NCT04215731|Bevacizumab|bevacizumab|mesh-list
92894507|NCT04215731|Fluorouracil|fluorouracil|mesh-list
92894508|NCT04215731|Oxaliplatin|oxaliplatin|mesh-list
92894509|NCT04215731|Irinotecan|irinotecan|mesh-list
92894510|NCT04215731|Levoleucovorin|levoleucovorin|mesh-list
92894511|NCT04215731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894512|NCT04215731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894513|NCT04215731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894514|NCT04215731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894515|NCT04215731|Growth Substances|growth substances|mesh-ancestor
92894516|NCT04215731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894517|NCT04215731|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894518|NCT04215731|Antimetabolites|antimetabolites|mesh-ancestor
92894519|NCT04215731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894520|NCT04215731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894521|NCT04215731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894522|NCT04215731|Immunologic Factors|immunologic factors|mesh-ancestor
92894523|NCT04215731|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92894524|NCT04215731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92894525|NCT04215731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894526|NCT04215731|Antidotes|antidotes|mesh-ancestor
92894527|NCT04215731|Protective Agents|protective agents|mesh-ancestor
92894528|NCT04215731|Vitamin B Complex|vitamin b complex|mesh-ancestor
92894529|NCT04215731|Vitamins|vitamins|mesh-ancestor
92894530|NCT04215731|Micronutrients|micronutrients|mesh-ancestor
92894531|NCT00665834|Atorvastatin|atorvastatin|mesh-list
92894532|NCT00665834|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92894533|NCT00665834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92894534|NCT00665834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92894535|NCT00665834|Antimetabolites|antimetabolites|mesh-ancestor
92894536|NCT00665834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894537|NCT00665834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92894538|NCT00665834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92894539|NCT00665834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894540|NCT02704013|Oxybutynin|oxybutynin|mesh-list
92894541|NCT02704013|Parasympatholytics|parasympatholytics|mesh-ancestor
92894542|NCT02704013|Autonomic Agents|autonomic agents|mesh-ancestor
92894543|NCT02704013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894544|NCT02704013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894545|NCT02704013|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92894546|NCT02704013|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92894547|NCT02704013|Cholinergic Agents|cholinergic agents|mesh-ancestor
92894548|NCT02704013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894549|NCT02704013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894550|NCT02704013|Urological Agents|urological agents|mesh-ancestor
92894551|NCT00665990|Cyclophosphamide|cyclophosphamide|mesh-list
92894552|NCT00665990|Bevacizumab|bevacizumab|mesh-list
92894553|NCT00665990|Sorafenib|sorafenib|mesh-list
92894554|NCT00665990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894555|NCT00665990|Immunologic Factors|immunologic factors|mesh-ancestor
92894556|NCT00665990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894557|NCT00665990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894558|NCT00665990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894559|NCT00665990|Alkylating Agents|alkylating agents|mesh-ancestor
92894560|NCT00665990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894561|NCT00665990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894562|NCT00665990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92894563|NCT00665990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894564|NCT00665990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894565|NCT00665990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894566|NCT00665990|Growth Substances|growth substances|mesh-ancestor
92894567|NCT00665990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894568|NCT00665990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894569|NCT00665990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894570|NCT00666068|Hormones|hormones|mesh-list
92894571|NCT00666068|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92894572|NCT00666068|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92894573|NCT00666068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894574|NCT00666068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894575|NCT00700102|Bevacizumab|bevacizumab|mesh-list
92894576|NCT00700102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894577|NCT00700102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894578|NCT00700102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894579|NCT00700102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894580|NCT00700102|Growth Substances|growth substances|mesh-ancestor
92894581|NCT00700102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894582|NCT00700102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894583|NCT02705729|Methamphetamine|methamphetamine|mesh-list
92894584|NCT02705729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92894585|NCT02705729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894586|NCT02705729|Sympathomimetics|sympathomimetics|mesh-ancestor
92894587|NCT02705729|Autonomic Agents|autonomic agents|mesh-ancestor
92894588|NCT02705729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894589|NCT02705729|Dopamine Agents|dopamine agents|mesh-ancestor
92894590|NCT02705729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894591|NCT02705729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894592|NCT02705729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92894593|NCT02705729|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92894594|NCT02705729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92894595|NCT02705729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894596|NCT02705729|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92894597|NCT02705573|Mannitol|mannitol|mesh-list
92894598|NCT02705573|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92894599|NCT02705573|Diuretics|diuretics|mesh-ancestor
92894600|NCT02705573|Natriuretic Agents|natriuretic agents|mesh-ancestor
92894601|NCT02705573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894602|NCT00613847|Trastuzumab|trastuzumab|mesh-list
92894603|NCT00613847|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92894604|NCT00613847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894605|NCT00613847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894606|NCT00613847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894607|NCT00516295|Cyclophosphamide|cyclophosphamide|mesh-list
92894608|NCT00516295|Bevacizumab|bevacizumab|mesh-list
92894609|NCT00516295|Vincristine|vincristine|mesh-list
92894610|NCT00516295|Topotecan|topotecan|mesh-list
92894611|NCT00516295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92894612|NCT00516295|Antibodies|antibodies|mesh-list
92894613|NCT00516295|Immunoglobulins|immunoglobulins|mesh-list
92894614|NCT00516295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92894615|NCT00516295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894616|NCT00516295|Immunologic Factors|immunologic factors|mesh-ancestor
92894617|NCT00516295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894618|NCT00516295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894619|NCT00516295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894620|NCT00516295|Alkylating Agents|alkylating agents|mesh-ancestor
92894621|NCT00516295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894622|NCT00516295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894623|NCT00516295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92894624|NCT00516295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894625|NCT00516295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894626|NCT00516295|Growth Substances|growth substances|mesh-ancestor
92894627|NCT00516295|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894628|NCT00516295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92894629|NCT00516295|Tubulin Modulators|tubulin modulators|mesh-ancestor
92894630|NCT00516295|Antimitotic Agents|antimitotic agents|mesh-ancestor
92894631|NCT00516295|Mitosis Modulators|mitosis modulators|mesh-ancestor
92894632|NCT00516295|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92894633|NCT00516295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92894634|NCT00516295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894636|NCT03362099|Varenicline|varenicline|mesh-list
92894637|NCT03362099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92894638|NCT03362099|Antidepressive Agents|antidepressive agents|mesh-ancestor
92894639|NCT03362099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92894640|NCT03362099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92894641|NCT03362099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92894642|NCT03362099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894643|NCT03362099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894644|NCT03362099|Dopamine Agents|dopamine agents|mesh-ancestor
92894645|NCT03362099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894646|NCT03362099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894647|NCT03362099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92894648|NCT03362099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92894649|NCT03362099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894650|NCT03362099|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92894651|NCT03362099|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92894652|NCT03362099|Cholinergic Agents|cholinergic agents|mesh-ancestor
92894653|NCT03861559|Mometasone Furoate|mometasone furoate|mesh-list
92894654|NCT03861559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92894655|NCT03861559|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894656|NCT03861559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92894657|NCT02705651|Somatostatin|somatostatin|mesh-list
92894658|NCT02705651|Hormones|hormones|mesh-ancestor
92894659|NCT02705651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894660|NCT02705651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894661|NCT00738088|Gliclazide|gliclazide|mesh-list
92894662|NCT00738088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894663|NCT00738088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894664|NCT02703233|Nitrous Oxide|nitrous oxide|mesh-list
92894665|NCT02703233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92894666|NCT02703233|Anesthetics, General|anesthetics, general|mesh-ancestor
92894667|NCT02703233|Anesthetics|anesthetics|mesh-ancestor
92894668|NCT02703233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894669|NCT02703233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894670|NCT02703233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92894671|NCT02703233|Analgesics|analgesics|mesh-ancestor
92894672|NCT02703233|Sensory System Agents|sensory system agents|mesh-ancestor
92894673|NCT02703233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894674|NCT04152941|Olaparib|olaparib|mesh-list
92894675|NCT04152941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92894676|NCT04152941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894677|NCT04152941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894678|NCT04152941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894679|NCT04062760|Diuretics|diuretics|mesh-list
92894680|NCT04062760|Natriuretic Agents|natriuretic agents|mesh-ancestor
92894681|NCT04062760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894683|NCT02702843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92894684|NCT02702843|Anesthetics, General|anesthetics, general|mesh-ancestor
92894685|NCT02702843|Anesthetics|anesthetics|mesh-ancestor
92894686|NCT02702843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894687|NCT02702843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894688|NCT00516139|Lamotrigine|lamotrigine|mesh-list
92894689|NCT00516139|Anticonvulsants|anticonvulsants|mesh-ancestor
92894690|NCT00516139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92894691|NCT00516139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894692|NCT00516139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894693|NCT00516139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92894694|NCT00516139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894695|NCT00516139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92894696|NCT00516139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92894697|NCT00516139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894698|NCT00516139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92894699|NCT00516139|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92894700|NCT02704715|Anesthetics|anesthetics|mesh-list
92894701|NCT02704715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894702|NCT02704715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894703|NCT00515827|Raltegravir Potassium|raltegravir potassium|mesh-list
92894704|NCT00515827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92894705|NCT00515827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92894706|NCT00515827|Antiviral Agents|antiviral agents|mesh-ancestor
92894707|NCT00515827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894708|NCT00515827|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92894709|NCT00515827|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92894710|NCT00515827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894711|NCT00515827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894712|NCT00615875|Naproxen|naproxen|mesh-list
92894713|NCT00615875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92894714|NCT00615875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92894715|NCT00615875|Analgesics|analgesics|mesh-ancestor
92894716|NCT00615875|Sensory System Agents|sensory system agents|mesh-ancestor
92894717|NCT00615875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894718|NCT00615875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894719|NCT00615875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92894720|NCT00615875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894721|NCT00615875|Gout Suppressants|gout suppressants|mesh-ancestor
92894722|NCT00615875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92894723|NCT00615875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894724|NCT00615875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894725|NCT02630888|Memantine|memantine|mesh-list
92894726|NCT02630888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92894727|NCT02630888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92894728|NCT02630888|Dopamine Agents|dopamine agents|mesh-ancestor
92894729|NCT02630888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894730|NCT02630888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894731|NCT02630888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894732|NCT02630888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92894733|NCT02630888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92894734|NCT00666302|Pimecrolimus|pimecrolimus|mesh-list
92894735|NCT00666302|Tacrolimus|tacrolimus|mesh-list
92894736|NCT00666302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894737|NCT00666302|Immunologic Factors|immunologic factors|mesh-ancestor
92894738|NCT00666302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894739|NCT00666302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92894740|NCT00666302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894741|NCT00666302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894742|NCT00666302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92894743|NCT00666302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92894744|NCT00666302|Analgesics|analgesics|mesh-ancestor
92894745|NCT00666302|Sensory System Agents|sensory system agents|mesh-ancestor
92894746|NCT00666302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894747|NCT00666302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92894748|NCT00666302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894749|NCT00666302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894750|NCT00671372|Bevacizumab|bevacizumab|mesh-list
92894751|NCT00671372|Cetuximab|cetuximab|mesh-list
92894752|NCT00671372|Irinotecan|irinotecan|mesh-list
92894753|NCT00671372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894754|NCT00671372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894755|NCT00671372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894756|NCT00671372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894757|NCT00671372|Growth Substances|growth substances|mesh-ancestor
92894758|NCT00671372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894759|NCT00671372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894760|NCT00671372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92894761|NCT00671372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92894762|NCT00671372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894763|NCT00671372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894764|NCT00856986|Metformin|metformin|mesh-list
92894765|NCT00856986|Liraglutide|liraglutide|mesh-list
92894766|NCT00856986|Insulin Detemir|insulin detemir|mesh-list
92894767|NCT00856986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894768|NCT00856986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894769|NCT00856986|Incretins|incretins|mesh-ancestor
92894770|NCT00856986|Hormones|hormones|mesh-ancestor
92894771|NCT00856986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92894772|NCT00666692|Paclitaxel|paclitaxel|mesh-list
92894773|NCT00666692|Bevacizumab|bevacizumab|mesh-list
92894774|NCT00666692|Carboplatin|carboplatin|mesh-list
92894775|NCT00666692|Volociximab|volociximab|mesh-list
92894776|NCT00666692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92894777|NCT00666692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92894778|NCT00666692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894779|NCT00666692|Tubulin Modulators|tubulin modulators|mesh-ancestor
92894780|NCT00666692|Antimitotic Agents|antimitotic agents|mesh-ancestor
92894781|NCT00666692|Mitosis Modulators|mitosis modulators|mesh-ancestor
92894782|NCT00666692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894783|NCT00666692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894784|NCT00666692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894785|NCT00666692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894786|NCT00666692|Growth Substances|growth substances|mesh-ancestor
92894787|NCT00666692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894788|NCT00666692|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894789|NCT00666692|Immunologic Factors|immunologic factors|mesh-ancestor
92894790|NCT00707746|Mipomersen|mipomersen|mesh-list
92894791|NCT00707746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92894792|NCT00707746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92894793|NCT00707746|Antimetabolites|antimetabolites|mesh-ancestor
92894794|NCT00707746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894795|NCT00707746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92894796|NCT00666770|Gabapentin|gabapentin|mesh-list
92894797|NCT00666770|Analgesics|analgesics|mesh-ancestor
92894798|NCT00666770|Sensory System Agents|sensory system agents|mesh-ancestor
92894799|NCT00666770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894800|NCT00666770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540147|NCT00275652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894801|NCT00666770|Anticonvulsants|anticonvulsants|mesh-ancestor
92894802|NCT00666770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92894803|NCT00666770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92894804|NCT00666770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894805|NCT00666770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92894806|NCT00666770|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92894807|NCT00666770|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92894808|NCT00666770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894809|NCT00666770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894810|NCT00666770|Antimanic Agents|antimanic agents|mesh-ancestor
92894811|NCT04188353|Mannitol|mannitol|mesh-list
92894812|NCT04188353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92894813|NCT04188353|Diuretics|diuretics|mesh-ancestor
92894814|NCT04188353|Natriuretic Agents|natriuretic agents|mesh-ancestor
92894815|NCT04188353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894816|NCT03583697|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
92894817|NCT03583697|Natriuretic Agents|natriuretic agents|mesh-ancestor
92894818|NCT03583697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894819|NCT02630420|Cetuximab|cetuximab|mesh-list
92894820|NCT02630420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92894821|NCT02630420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894822|NCT00667082|Vorinostat|vorinostat|mesh-list
92894823|NCT00667082|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92894824|NCT00667082|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92894825|NCT00667082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894826|NCT00667082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894827|NCT00667082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894828|NCT00667082|Protease Inhibitors|protease inhibitors|mesh-ancestor
92894829|NCT05343299|Lidocaine|lidocaine|mesh-list
92894830|NCT05343299|Ropivacaine|ropivacaine|mesh-list
92894831|NCT05343299|Anesthetics|anesthetics|mesh-list
92894832|NCT05343299|Anesthetics, Local|anesthetics, local|mesh-ancestor
92894833|NCT05343299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894834|NCT05343299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894835|NCT05343299|Sensory System Agents|sensory system agents|mesh-ancestor
92894836|NCT05343299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894837|NCT05343299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92894838|NCT05343299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92894839|NCT05343299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92894840|NCT05343299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92894841|NCT05343299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894842|NCT00667160|Pimecrolimus|pimecrolimus|mesh-list
92894843|NCT00667160|Tacrolimus|tacrolimus|mesh-list
92894844|NCT00667160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894845|NCT00667160|Immunologic Factors|immunologic factors|mesh-ancestor
92894846|NCT00667160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894847|NCT00667160|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92894848|NCT00667160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894849|NCT00667160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894850|NCT00667160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92894851|NCT00667160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92894852|NCT00667160|Analgesics|analgesics|mesh-ancestor
92894853|NCT00667160|Sensory System Agents|sensory system agents|mesh-ancestor
92894854|NCT00667160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894855|NCT00667160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92894856|NCT00667160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92894857|NCT00667160|Dermatologic Agents|dermatologic agents|mesh-ancestor
92894858|NCT02701673|Pyridoxine|pyridoxine|mesh-list
92894859|NCT02701673|Gemcitabine|gemcitabine|mesh-list
92894860|NCT02701673|Azacitidine|azacitidine|mesh-list
92894861|NCT02701673|Melphalan|melphalan|mesh-list
92894862|NCT02701673|Busulfan|busulfan|mesh-list
92894863|NCT02701673|Belinostat|belinostat|mesh-list
92894864|NCT02701673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92894865|NCT02701673|Antimetabolites|antimetabolites|mesh-ancestor
92894866|NCT02701673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894867|NCT02701673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894868|NCT02701673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894869|NCT02701673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894870|NCT02701673|Alkylating Agents|alkylating agents|mesh-ancestor
92894871|NCT02701673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92894872|NCT02701673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92894873|NCT02701673|Immunologic Factors|immunologic factors|mesh-ancestor
92894874|NCT02701673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894875|NCT02701673|Vitamin B Complex|vitamin b complex|mesh-ancestor
92894876|NCT02701673|Vitamins|vitamins|mesh-ancestor
92894877|NCT02701673|Micronutrients|micronutrients|mesh-ancestor
92894878|NCT02701673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92894879|NCT00522379|Rotigotine|rotigotine|mesh-list
92894880|NCT00522379|Dopamine Agonists|dopamine agonists|mesh-ancestor
92894881|NCT00522379|Dopamine Agents|dopamine agents|mesh-ancestor
92894882|NCT00522379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894883|NCT00522379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894884|NCT00522379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894885|NCT00856830|Carboplatin|carboplatin|mesh-list
92894886|NCT00856830|Irinotecan|irinotecan|mesh-list
92894887|NCT00856830|Etoposide|etoposide|mesh-list
92894888|NCT00856830|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92894889|NCT00856830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894890|NCT00856830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92894891|NCT00856830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92894892|NCT00856830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894893|NCT00856830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894894|NCT00856830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92894895|NCT00856830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92894896|NCT00856830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92894897|NCT00856830|Alkylating Agents|alkylating agents|mesh-ancestor
92894898|NCT02614404|Piperaquine|piperaquine|mesh-list
92894899|NCT02614404|Artenimol|artenimol|mesh-list
92894900|NCT02614404|Imatinib Mesylate|imatinib mesylate|mesh-list
92894901|NCT02614404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894902|NCT02614404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894903|NCT02614404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894904|NCT02614404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894905|NCT02614404|Antimalarials|antimalarials|mesh-ancestor
92894906|NCT02614404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92894907|NCT02614404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92894908|NCT02614404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92894909|NCT00522301|Sorafenib|sorafenib|mesh-list
92894910|NCT00522301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894911|NCT00522301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894912|NCT00522301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977261|NCT01070641|Protective Agents|protective agents|mesh-ancestor
92894913|NCT00522301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894914|NCT00662636|Dasatinib|dasatinib|mesh-list
92894915|NCT00662636|Lapatinib|lapatinib|mesh-list
92894916|NCT00662636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894917|NCT00662636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92894918|NCT00662636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894919|NCT00662636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894920|NCT05726344|Lactulose|lactulose|mesh-list
92894921|NCT05726344|Bisacodyl|bisacodyl|mesh-list
92894922|NCT05726344|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92894923|NCT05726344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92894924|NCT05726344|Cathartics|cathartics|mesh-ancestor
92894925|NCT05726344|Laxatives|laxatives|mesh-ancestor
92894926|NCT00506389|Mirtazapine|mirtazapine|mesh-list
92894927|NCT00506389|Antidepressive Agents|antidepressive agents|mesh-ancestor
92894928|NCT00506389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92894929|NCT00506389|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92894930|NCT00506389|Histamine Antagonists|histamine antagonists|mesh-ancestor
92894931|NCT00506389|Histamine Agents|histamine agents|mesh-ancestor
92894932|NCT00506389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894933|NCT00506389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894934|NCT00506389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894935|NCT00506389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92894936|NCT00506389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92894937|NCT00506389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894938|NCT00506389|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92894939|NCT00506389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92894940|NCT00506389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92894941|NCT00506389|Adrenergic Agents|adrenergic agents|mesh-ancestor
92894942|NCT00506389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92894943|NCT00506389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92894944|NCT00506389|Serotonin Agents|serotonin agents|mesh-ancestor
92894945|NCT00506389|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92894946|NCT00667472|Ranibizumab|ranibizumab|mesh-list
92894947|NCT00667472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92894948|NCT00667472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92894949|NCT00667472|Growth Substances|growth substances|mesh-ancestor
92894950|NCT00667472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894951|NCT00667472|Growth Inhibitors|growth inhibitors|mesh-ancestor
92894952|NCT00667472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894953|NCT05705128|Dexmedetomidine|dexmedetomidine|mesh-list
92894954|NCT05705128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92894955|NCT05705128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92894956|NCT05705128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894957|NCT05705128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92894958|NCT05705128|Analgesics|analgesics|mesh-ancestor
92894959|NCT05705128|Sensory System Agents|sensory system agents|mesh-ancestor
92894960|NCT05705128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92894961|NCT05705128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92894962|NCT05705128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92894963|NCT05705128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92894964|NCT05705128|Adrenergic Agents|adrenergic agents|mesh-ancestor
92894965|NCT05705128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92894966|NCT05705128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894967|NCT00662714|Insulin|insulin|mesh-list
92894968|NCT00662714|Repaglinide|repaglinide|mesh-list
92894969|NCT00662714|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92894970|NCT00662714|Insulin, Short-Acting|insulin, short-acting|mesh-list
92894971|NCT00662714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92894972|NCT00662714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894973|NCT00668018|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92894974|NCT00668018|Vasodilator Agents|vasodilator agents|mesh-ancestor
92894975|NCT00668018|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92894976|NCT00668018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92894977|NCT00668018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92894978|NCT00668018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894979|NCT00668018|Urological Agents|urological agents|mesh-ancestor
92894980|NCT00871338|Vaccines|vaccines|mesh-list
92894981|NCT00871338|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92894982|NCT00871338|Immunologic Factors|immunologic factors|mesh-ancestor
92894983|NCT00871338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894984|NCT04130100|Hyaluronic Acid|hyaluronic acid|mesh-list
92894985|NCT04130100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92894986|NCT04130100|Immunologic Factors|immunologic factors|mesh-ancestor
92894987|NCT04130100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92894988|NCT04130100|Viscosupplements|viscosupplements|mesh-ancestor
92894989|NCT04130100|Protective Agents|protective agents|mesh-ancestor
92894990|NCT00597116|Vinorelbine|vinorelbine|mesh-list
92894991|NCT00597116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92894992|NCT00597116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92894993|NCT00597116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92894994|NCT00597116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92894995|NCT00597116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92894996|NCT00597116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92894997|NCT00668096|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92894998|NCT00668096|Vasodilator Agents|vasodilator agents|mesh-ancestor
92894999|NCT00668096|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92895000|NCT00668096|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92895001|NCT00668096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895002|NCT00668096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895003|NCT00668096|Urological Agents|urological agents|mesh-ancestor
92895004|NCT00514735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92895005|NCT03252587|Deucravacitinib|deucravacitinib|mesh-list
92895006|NCT03252587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895007|NCT03252587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92895008|NCT03252587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895009|NCT03252587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895010|NCT02630264|Paclitaxel|paclitaxel|mesh-list
92895011|NCT02630264|Endostatins|endostatins|mesh-list
92895012|NCT02630264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895013|NCT02630264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895014|NCT02630264|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895015|NCT02630264|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895016|NCT02630264|Mitosis Modulators|mitosis modulators|mesh-ancestor
92895017|NCT02630264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895018|NCT02630264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92895019|NCT02630264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92895020|NCT02630264|Growth Substances|growth substances|mesh-ancestor
92895021|NCT02630264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895022|NCT02630264|Growth Inhibitors|growth inhibitors|mesh-ancestor
92895023|NCT00668330|Calcium, Dietary|calcium, dietary|mesh-list
92895024|NCT00668330|Ibandronic Acid|ibandronic acid|mesh-list
92895025|NCT00668330|Alfacalcidol|alfacalcidol|mesh-list
92895026|NCT00668330|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92895027|NCT00668330|Calcium|calcium|mesh-list
92161083|NCT01194453|Hematinics|hematinics|mesh-ancestor
92895028|NCT00668330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92895029|NCT00668330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895030|NCT00668330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92895031|NCT00668330|Vitamins|vitamins|mesh-ancestor
92895032|NCT00668330|Micronutrients|micronutrients|mesh-ancestor
92895033|NCT01012687|Perindopril|perindopril|mesh-list
92895034|NCT01012687|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92895035|NCT01012687|Protease Inhibitors|protease inhibitors|mesh-ancestor
92895036|NCT01012687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895037|NCT01012687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895038|NCT01012687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92895039|NCT00662948|Rituximab|rituximab|mesh-list
92895040|NCT00662948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92895041|NCT00662948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895042|NCT00662948|Immunologic Factors|immunologic factors|mesh-ancestor
92895043|NCT00662948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895044|NCT00662948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895045|NCT00511147|Immunoglobulins|immunoglobulins|mesh-list
92895046|NCT00511147|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92895047|NCT00511147|gamma-Globulins|gamma-globulins|mesh-list
92895048|NCT00511147|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92895049|NCT00511147|Immunologic Factors|immunologic factors|mesh-ancestor
92895050|NCT00511147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895051|NCT00672464|Metformin|metformin|mesh-list
92895052|NCT00672464|Olanzapine|olanzapine|mesh-list
92895053|NCT00672464|Simvastatin|simvastatin|mesh-list
92895054|NCT00672464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92895055|NCT00672464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895056|NCT00672464|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92895057|NCT00672464|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92895058|NCT00672464|Antimetabolites|antimetabolites|mesh-ancestor
92895059|NCT00672464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895060|NCT00672464|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92895061|NCT00672464|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92895062|NCT00672464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895063|NCT00672464|Antiemetics|antiemetics|mesh-ancestor
92895064|NCT00672464|Autonomic Agents|autonomic agents|mesh-ancestor
92895065|NCT00672464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895066|NCT00672464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895067|NCT00672464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92895068|NCT00672464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92895069|NCT00672464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895070|NCT00672464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92895071|NCT00672464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92895072|NCT00672464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92895073|NCT00672464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92895074|NCT00672464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895075|NCT00672464|Serotonin Agents|serotonin agents|mesh-ancestor
92895076|NCT02701595|Amoxicillin|amoxicillin|mesh-list
92895077|NCT02701595|Vancomycin|vancomycin|mesh-list
92895078|NCT02701595|Gentamicins|gentamicins|mesh-list
92895079|NCT02701595|Ceftriaxone|ceftriaxone|mesh-list
92895080|NCT02701595|Penicillins|penicillins|mesh-list
92895081|NCT02701595|Penicillin G|penicillin g|mesh-list
92895082|NCT02701595|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92895083|NCT02701595|Penicillin G Procaine|penicillin g procaine|mesh-list
92895084|NCT02701595|Netilmicin|netilmicin|mesh-list
92895085|NCT02701595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895086|NCT02701595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895087|NCT02701595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92895088|NCT02701595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895089|NCT02701595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895090|NCT00668642|Dutasteride|dutasteride|mesh-list
92895091|NCT00668642|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92895092|NCT00668642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92895093|NCT00668642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895094|NCT00668642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895095|NCT00668642|Hormone Antagonists|hormone antagonists|mesh-ancestor
92895096|NCT00668642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895097|NCT00668642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895098|NCT02698553|Bupropion|bupropion|mesh-list
92895099|NCT02698553|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92895100|NCT02698553|Antidepressive Agents|antidepressive agents|mesh-ancestor
92895101|NCT02698553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92895102|NCT02698553|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92895103|NCT02698553|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92895104|NCT02698553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92895105|NCT02698553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895106|NCT02698553|Dopamine Agents|dopamine agents|mesh-ancestor
92895107|NCT02698553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895108|NCT02698553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895109|NCT02698553|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92895110|NCT02698553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92895111|NCT02698553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895112|NCT00663182|Entecavir|entecavir|mesh-list
92895113|NCT00663182|Antiviral Agents|antiviral agents|mesh-ancestor
92895114|NCT00663182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895115|NCT00616031|Paclitaxel|paclitaxel|mesh-list
92895116|NCT00616031|Carboplatin|carboplatin|mesh-list
92895117|NCT00616031|Nitroglycerin|nitroglycerin|mesh-list
92895118|NCT00616031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895119|NCT00616031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895120|NCT00616031|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895121|NCT00616031|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895122|NCT00616031|Mitosis Modulators|mitosis modulators|mesh-ancestor
92895123|NCT00616031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895124|NCT00616031|Vasodilator Agents|vasodilator agents|mesh-ancestor
92895125|NCT04213937|Paclitaxel|paclitaxel|mesh-list
92895126|NCT04213937|Topotecan|topotecan|mesh-list
92895127|NCT04213937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895128|NCT04213937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895129|NCT04213937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895130|NCT04213937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895131|NCT04213937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92895132|NCT04213937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895133|NCT04213937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92895134|NCT04213937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895135|NCT04213937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895137|NCT02701517|Methotrexate|methotrexate|mesh-list
92895138|NCT02701517|Alemtuzumab|alemtuzumab|mesh-list
92895139|NCT02701517|Cyclosporins|cyclosporins|mesh-list
92895140|NCT02701517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92895141|NCT02701517|Abortifacient Agents|abortifacient agents|mesh-ancestor
92895142|NCT02701517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92895143|NCT02701517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895144|NCT02701517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895145|NCT02701517|Antimetabolites|antimetabolites|mesh-ancestor
92895146|NCT02701517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895147|NCT02701517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895148|NCT02701517|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895149|NCT02701517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895150|NCT02701517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92895151|NCT02701517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895152|NCT02701517|Immunologic Factors|immunologic factors|mesh-ancestor
92895153|NCT02701517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895154|NCT02701517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92895155|NCT02701517|Antifungal Agents|antifungal agents|mesh-ancestor
92895156|NCT02701517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895157|NCT02701517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92895158|NCT02701517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92895159|NCT02630108|Epirubicin|epirubicin|mesh-list
92895160|NCT02630108|Ethiodized Oil|ethiodized oil|mesh-list
92895161|NCT02630108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92895162|NCT02630108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895163|NCT02630108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92895164|NCT02630108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895165|NCT02630108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895166|NCT02630108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895167|NCT00505921|Cytarabine|cytarabine|mesh-list
92895168|NCT00505921|Cyclophosphamide|cyclophosphamide|mesh-list
92895169|NCT00505921|Melphalan|melphalan|mesh-list
92895170|NCT00505921|Carmustine|carmustine|mesh-list
92895171|NCT00505921|Fludarabine|fludarabine|mesh-list
92895172|NCT00505921|Fludarabine phosphate|fludarabine phosphate|mesh-list
92895173|NCT00505921|Etoposide|etoposide|mesh-list
92895174|NCT00505921|Etoposide phosphate|etoposide phosphate|mesh-list
92895175|NCT00505921|Molgramostim|molgramostim|mesh-list
92895176|NCT00505921|Alemtuzumab|alemtuzumab|mesh-list
92895177|NCT00505921|Sargramostim|sargramostim|mesh-list
92895178|NCT00505921|Lenograstim|lenograstim|mesh-list
92895179|NCT00505921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895180|NCT00505921|Immunologic Factors|immunologic factors|mesh-ancestor
92895181|NCT00505921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895182|NCT00505921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895183|NCT00505921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92895184|NCT00505921|Alkylating Agents|alkylating agents|mesh-ancestor
92895185|NCT00505921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895186|NCT00505921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895187|NCT00505921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92895188|NCT00505921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895189|NCT00505921|Antimetabolites|antimetabolites|mesh-ancestor
92895190|NCT00505921|Antiviral Agents|antiviral agents|mesh-ancestor
92895191|NCT00505921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895192|NCT00505921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895193|NCT00505921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92895194|NCT00505921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895195|NCT00505921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895196|NCT00505921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92895197|NCT00505921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92895198|NCT04729205|Mitomycins|mitomycins|mesh-list
92895199|NCT04729205|Mitomycin|mitomycin|mesh-list
92895200|NCT04729205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92895201|NCT04729205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895202|NCT04729205|Alkylating Agents|alkylating agents|mesh-ancestor
92895203|NCT04729205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895204|NCT04729205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92895205|NCT04729205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895206|NCT00669344|Rivastigmine|rivastigmine|mesh-list
92895207|NCT00669344|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92895208|NCT00669344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895209|NCT00669344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895210|NCT00669344|Cholinergic Agents|cholinergic agents|mesh-ancestor
92895211|NCT00669344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895212|NCT00669344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895213|NCT00669344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92895214|NCT00669344|Protective Agents|protective agents|mesh-ancestor
92895215|NCT02701127|Niacinamide|niacinamide|mesh-list
92895216|NCT02701127|Niacin|niacin|mesh-list
92895217|NCT02701127|Nicotinic Acids|nicotinic acids|mesh-list
92895218|NCT02701127|Vitamin B Complex|vitamin b complex|mesh-ancestor
92895219|NCT02701127|Vitamins|vitamins|mesh-ancestor
92895220|NCT02701127|Micronutrients|micronutrients|mesh-ancestor
92895221|NCT02701127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895222|NCT02701127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92895223|NCT02701127|Antimetabolites|antimetabolites|mesh-ancestor
92895224|NCT02701127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895225|NCT02701127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92895226|NCT02701127|Vasodilator Agents|vasodilator agents|mesh-ancestor
92895227|NCT02700893|Atropine|atropine|mesh-list
92895228|NCT02700893|Sufentanil|sufentanil|mesh-list
92895229|NCT02700893|Propofol|propofol|mesh-list
92895230|NCT02700893|Atracurium|atracurium|mesh-list
92895231|NCT02700893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92895232|NCT02700893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895233|NCT02700893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895234|NCT02700893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92895235|NCT02700893|Anesthetics, General|anesthetics, general|mesh-ancestor
92895236|NCT02700893|Anesthetics|anesthetics|mesh-ancestor
92895237|NCT02700893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92895238|NCT02700893|Narcotics|narcotics|mesh-ancestor
92895239|NCT02700893|Analgesics|analgesics|mesh-ancestor
92895240|NCT02700893|Sensory System Agents|sensory system agents|mesh-ancestor
92895241|NCT02700893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895242|NCT02700893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92895243|NCT02700893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92895244|NCT02700893|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92895245|NCT02700893|Autonomic Agents|autonomic agents|mesh-ancestor
92895246|NCT02700893|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92895247|NCT02700893|Respiratory System Agents|respiratory system agents|mesh-ancestor
92895248|NCT02700893|Mydriatics|mydriatics|mesh-ancestor
92895249|NCT02700893|Parasympatholytics|parasympatholytics|mesh-ancestor
92895250|NCT02700893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92895251|NCT02700893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92895252|NCT02700893|Cholinergic Agents|cholinergic agents|mesh-ancestor
92895253|NCT02700893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895254|NCT02700893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895255|NCT02700893|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92895256|NCT02700893|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92895257|NCT02700893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92895258|NCT02700893|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92895259|NCT04213781|Sufentanil|sufentanil|mesh-list
92895260|NCT04213781|Propofol|propofol|mesh-list
92895261|NCT04213781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92895262|NCT04213781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895263|NCT04213781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895264|NCT04213781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92895265|NCT04213781|Anesthetics, General|anesthetics, general|mesh-ancestor
92895266|NCT04213781|Anesthetics|anesthetics|mesh-ancestor
92895267|NCT04213781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92895268|NCT04213781|Narcotics|narcotics|mesh-ancestor
92895269|NCT04213781|Analgesics|analgesics|mesh-ancestor
92895270|NCT04213781|Sensory System Agents|sensory system agents|mesh-ancestor
92895271|NCT04213781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895272|NCT04213781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92895273|NCT00505687|Rotigotine|rotigotine|mesh-list
92895274|NCT00505687|Dopamine Agonists|dopamine agonists|mesh-ancestor
92895276|NCT00505687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895277|NCT00505687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895278|NCT00505687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895279|NCT00669656|Vitamin D|vitamin d|mesh-list
92895280|NCT00669656|Cholecalciferol|cholecalciferol|mesh-list
92895281|NCT00669656|Vitamins|vitamins|mesh-list
92895282|NCT00669656|Vitamin E|vitamin e|mesh-list
92895283|NCT00669656|Tocopherols|tocopherols|mesh-list
92895284|NCT00669656|alpha-Tocopherol|alpha-tocopherol|mesh-list
92895285|NCT00669656|Selenium|selenium|mesh-list
92895286|NCT00669656|Lycopene|lycopene|mesh-list
92895287|NCT00669656|Daidzein|daidzein|mesh-list
92895288|NCT00669656|Micronutrients|micronutrients|mesh-ancestor
92895289|NCT00669656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895290|NCT00669656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92895291|NCT00669656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92895292|NCT00669656|Antioxidants|antioxidants|mesh-ancestor
92895293|NCT00669656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895294|NCT00669656|Protective Agents|protective agents|mesh-ancestor
92895295|NCT00669656|Trace Elements|trace elements|mesh-ancestor
92895296|NCT00669656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895297|NCT00669656|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92895298|NCT00669656|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92895299|NCT00669656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895300|NCT00669656|Phytoestrogens|phytoestrogens|mesh-ancestor
92895301|NCT00669656|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92895302|NCT00669656|Estrogens|estrogens|mesh-ancestor
92895303|NCT00669656|Hormones|hormones|mesh-ancestor
92895304|NCT00669656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895305|NCT00672776|Paroxetine|paroxetine|mesh-list
92895306|NCT00672776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92895307|NCT00672776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92895308|NCT00672776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92895309|NCT00672776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895310|NCT00672776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895311|NCT00672776|Serotonin Agents|serotonin agents|mesh-ancestor
92895312|NCT00672776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895313|NCT00672776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92895314|NCT00672776|Antidepressive Agents|antidepressive agents|mesh-ancestor
92895315|NCT00672776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92895316|NCT00672776|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92895317|NCT00672776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92895318|NCT00672776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895319|NCT00616187|Interferons|interferons|mesh-list
92895320|NCT00616187|Interferon-beta|interferon-beta|mesh-list
92895321|NCT00616187|Atorvastatin|atorvastatin|mesh-list
92895322|NCT00616187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895323|NCT00616187|Antiviral Agents|antiviral agents|mesh-ancestor
92895324|NCT00616187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895325|NCT00616187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92895326|NCT00616187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92895327|NCT00616187|Antimetabolites|antimetabolites|mesh-ancestor
92895328|NCT00616187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895329|NCT00616187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92895330|NCT00616187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92895331|NCT00616187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895332|NCT00616187|Immunologic Factors|immunologic factors|mesh-ancestor
92895333|NCT00616187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895334|NCT00663338|Rotigotine|rotigotine|mesh-list
92895335|NCT00663338|Dopamine Agonists|dopamine agonists|mesh-ancestor
92895336|NCT00663338|Dopamine Agents|dopamine agents|mesh-ancestor
92895337|NCT00663338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895338|NCT00663338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895339|NCT00663338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895340|NCT02992015|Gemcitabine|gemcitabine|mesh-list
92895341|NCT02992015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895342|NCT02992015|Antimetabolites|antimetabolites|mesh-ancestor
92895343|NCT02992015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895344|NCT02992015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895345|NCT01009567|Cabergoline|cabergoline|mesh-list
92895346|NCT01009567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92895347|NCT01009567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92895348|NCT01009567|Dopamine Agonists|dopamine agonists|mesh-ancestor
92895349|NCT01009567|Dopamine Agents|dopamine agents|mesh-ancestor
92895351|NCT01009567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895352|NCT01009567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895353|NCT00669812|Cytarabine|cytarabine|mesh-list
92895354|NCT00669812|Prednisolone|prednisolone|mesh-list
92895355|NCT00669812|Cyclophosphamide|cyclophosphamide|mesh-list
92895356|NCT00669812|Melphalan|melphalan|mesh-list
92895357|NCT00669812|Ifosfamide|ifosfamide|mesh-list
92895358|NCT00669812|Carmustine|carmustine|mesh-list
92895359|NCT00669812|Doxorubicin|doxorubicin|mesh-list
92895360|NCT00669812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92895361|NCT00669812|Methotrexate|methotrexate|mesh-list
92895362|NCT00669812|Etoposide|etoposide|mesh-list
92895363|NCT00669812|Vincristine|vincristine|mesh-list
92895364|NCT00669812|Epirubicin|epirubicin|mesh-list
92895365|NCT00669812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895366|NCT00669812|Immunologic Factors|immunologic factors|mesh-ancestor
92895367|NCT00669812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895368|NCT00669812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895369|NCT00669812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92895370|NCT00669812|Alkylating Agents|alkylating agents|mesh-ancestor
92895371|NCT00669812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895372|NCT00669812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895373|NCT00669812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92895374|NCT00669812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92895375|NCT00669812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92895376|NCT00669812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895377|NCT00669812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895378|NCT00669812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92895379|NCT00669812|Abortifacient Agents|abortifacient agents|mesh-ancestor
92895380|NCT00669812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92895381|NCT00669812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895382|NCT00669812|Antimetabolites|antimetabolites|mesh-ancestor
92895383|NCT00669812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895384|NCT00669812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92895385|NCT00669812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92895386|NCT00669812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895387|NCT00669812|Antiviral Agents|antiviral agents|mesh-ancestor
92895388|NCT00669812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895389|NCT00669812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895390|NCT00669812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895391|NCT00669812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92895392|NCT00669812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895393|NCT00669812|Glucocorticoids|glucocorticoids|mesh-ancestor
92895394|NCT00669812|Hormones|hormones|mesh-ancestor
92895395|NCT00669812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895396|NCT00669812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92895397|NCT02697851|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92895398|NCT02697851|Cobicistat|cobicistat|mesh-list
92895399|NCT02697851|Levonorgestrel|levonorgestrel|mesh-list
92895400|NCT02697851|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92895401|NCT02697851|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92895402|NCT02697851|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92895403|NCT02697851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92895404|NCT02697851|Contraceptive Agents|contraceptive agents|mesh-ancestor
92895405|NCT02697851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92895406|NCT02697851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895407|NCT02697851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92895408|NCT02697851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92895409|NCT02697851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92895410|NCT02697851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92895411|NCT02697851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92895412|NCT02697851|Protease Inhibitors|protease inhibitors|mesh-ancestor
92895413|NCT02697851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895414|NCT02697851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895415|NCT02697851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92895416|NCT02697851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92895417|NCT02697851|Antiviral Agents|antiviral agents|mesh-ancestor
92895418|NCT02697851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895419|NCT02697851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92895420|NCT02697851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92895421|NCT02697851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92895422|NCT02697851|Estrogens|estrogens|mesh-ancestor
92895423|NCT02697851|Hormones|hormones|mesh-ancestor
92977262|NCT01070641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92895424|NCT02697851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895426|NCT02697851|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92895427|NCT02697851|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92895428|NCT02697851|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92895429|NCT01012843|Amoxicillin|amoxicillin|mesh-list
92895430|NCT01012843|Clavulanic Acid|clavulanic acid|mesh-list
92895431|NCT01012843|Clavulanic Acids|clavulanic acids|mesh-list
92895432|NCT01012843|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92895433|NCT01012843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895434|NCT01012843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895435|NCT01012843|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92895436|NCT01012843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895437|NCT01012843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895438|NCT00669890|Mycophenolic Acid|mycophenolic acid|mesh-list
92895439|NCT00669890|Cyclophosphamide|cyclophosphamide|mesh-list
92895440|NCT00669890|Busulfan|busulfan|mesh-list
92895441|NCT00669890|Methotrexate|methotrexate|mesh-list
92895442|NCT00669890|Gemtuzumab|gemtuzumab|mesh-list
92895443|NCT00669890|Tacrolimus|tacrolimus|mesh-list
92895444|NCT00669890|Thymoglobulin|thymoglobulin|mesh-list
92895445|NCT00669890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895446|NCT00669890|Immunologic Factors|immunologic factors|mesh-ancestor
92895447|NCT00669890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895448|NCT00669890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895449|NCT00669890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92895450|NCT00669890|Alkylating Agents|alkylating agents|mesh-ancestor
92895451|NCT00669890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895452|NCT00669890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895453|NCT00669890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92895454|NCT00669890|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92895455|NCT00669890|Abortifacient Agents|abortifacient agents|mesh-ancestor
92895456|NCT00669890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92895457|NCT00669890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895458|NCT00669890|Antimetabolites|antimetabolites|mesh-ancestor
92895459|NCT00669890|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895460|NCT00669890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895461|NCT00669890|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92895462|NCT00669890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92895463|NCT00669890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92895464|NCT00669890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92895465|NCT00669890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92895466|NCT00669890|Antitubercular Agents|antitubercular agents|mesh-ancestor
92895467|NCT00669890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895468|NCT00669890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895469|NCT00669890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92895470|NCT00669890|Immunotoxins|immunotoxins|mesh-ancestor
92895471|NCT00669890|Immunoconjugates|immunoconjugates|mesh-ancestor
92895472|NCT02697929|Neostigmine|neostigmine|mesh-list
92895473|NCT02697929|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92895474|NCT02697929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895475|NCT02697929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895476|NCT02697929|Cholinergic Agents|cholinergic agents|mesh-ancestor
92895477|NCT02697929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895478|NCT02697929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895479|NCT02697929|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92895480|NCT02697929|Autonomic Agents|autonomic agents|mesh-ancestor
92895481|NCT02697929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895482|NCT00505375|Abatacept|abatacept|mesh-list
92895483|NCT00505375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92895484|NCT00505375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895485|NCT00505375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92895486|NCT00505375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895487|NCT00505375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895488|NCT00505375|Immunologic Factors|immunologic factors|mesh-ancestor
92895489|NCT00505375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895490|NCT00505375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895491|NCT02700347|Pyrazinamide|pyrazinamide|mesh-list
92895492|NCT02700347|Allopurinol|allopurinol|mesh-list
92895493|NCT02700347|Antimetabolites|antimetabolites|mesh-ancestor
92895494|NCT02700347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895495|NCT02700347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895496|NCT02700347|Gout Suppressants|gout suppressants|mesh-ancestor
92895498|NCT02700347|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92895499|NCT02700347|Antioxidants|antioxidants|mesh-ancestor
92895500|NCT02700347|Protective Agents|protective agents|mesh-ancestor
92895501|NCT02700347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895502|NCT02700347|Antitubercular Agents|antitubercular agents|mesh-ancestor
92895503|NCT02700347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895504|NCT02700347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895505|NCT00594932|Mycophenolic Acid|mycophenolic acid|mesh-list
92895506|NCT00594932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92895507|NCT00594932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895508|NCT00594932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92895509|NCT00594932|Antitubercular Agents|antitubercular agents|mesh-ancestor
92895510|NCT00594932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895511|NCT00594932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895512|NCT00594932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895513|NCT00594932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895514|NCT00616889|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92895515|NCT00616889|Antidepressive Agents|antidepressive agents|mesh-ancestor
92895516|NCT00616889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92895517|NCT00616889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92895518|NCT00616889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92895519|NCT00616889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895520|NCT00616889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895521|NCT00673088|Ropinirole|ropinirole|mesh-list
92895522|NCT00673088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92895523|NCT00673088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92895524|NCT00673088|Dopamine Agonists|dopamine agonists|mesh-ancestor
92895525|NCT00673088|Dopamine Agents|dopamine agents|mesh-ancestor
92895526|NCT00673088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895527|NCT00673088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895528|NCT00673088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895529|NCT00504829|Atorvastatin|atorvastatin|mesh-list
92895530|NCT00504829|Fenofibrate|fenofibrate|mesh-list
92895531|NCT00504829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92895532|NCT00504829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92895533|NCT00504829|Antimetabolites|antimetabolites|mesh-ancestor
92895534|NCT00504829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895535|NCT00504829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92895536|NCT00504829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92895537|NCT00504829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895538|NCT02701205|Etanercept|etanercept|mesh-list
92895539|NCT02701205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92895540|NCT02701205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92895541|NCT02701205|Analgesics|analgesics|mesh-ancestor
92149249|NCT04398589|Adrenergic Agents|adrenergic agents|mesh-ancestor
92895542|NCT02701205|Sensory System Agents|sensory system agents|mesh-ancestor
92895543|NCT02701205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895544|NCT02701205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895545|NCT02701205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895546|NCT02701205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895547|NCT02701205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895548|NCT02701205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895549|NCT02701205|Immunologic Factors|immunologic factors|mesh-ancestor
92895550|NCT00670436|Paclitaxel|paclitaxel|mesh-list
92895551|NCT00670436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92895552|NCT00670436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895553|NCT00670436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895554|NCT00670436|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895555|NCT00670436|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895556|NCT00670436|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540903|NCT00128934|Estradiol|estradiol|mesh-list
92895557|NCT00670436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895559|NCT02699879|Analgesics|analgesics|mesh-ancestor
92895560|NCT02699879|Sensory System Agents|sensory system agents|mesh-ancestor
92895561|NCT02699879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895562|NCT02699879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895563|NCT02699879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92895564|NCT02699879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92895565|NCT02699879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895566|NCT02699879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895567|NCT02699879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895568|NCT02699723|Itraconazole|itraconazole|mesh-list
92895569|NCT02699723|Arsenic Trioxide|arsenic trioxide|mesh-list
92895570|NCT02699723|Antifungal Agents|antifungal agents|mesh-ancestor
92895571|NCT02699723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895572|NCT02699723|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92895573|NCT02699723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92895574|NCT02699723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895575|NCT02699723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895576|NCT02699723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92895577|NCT02699723|Hormone Antagonists|hormone antagonists|mesh-ancestor
92895578|NCT02699723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895579|NCT02699723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895580|NCT02699723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92895581|NCT02699723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895582|NCT02699645|Amlodipine|amlodipine|mesh-list
92895583|NCT02699645|Telmisartan|telmisartan|mesh-list
92895584|NCT02699645|Indapamide|indapamide|mesh-list
92895585|NCT02699645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92895586|NCT02699645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92895587|NCT02699645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92895588|NCT02699645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895589|NCT02699645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92895590|NCT02699645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895591|NCT02699645|Vasodilator Agents|vasodilator agents|mesh-ancestor
92895592|NCT02699645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92895593|NCT02699645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92895594|NCT02699645|Diuretics|diuretics|mesh-ancestor
92895595|NCT02699645|Natriuretic Agents|natriuretic agents|mesh-ancestor
92895596|NCT02699645|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92895597|NCT04152434|Erenumab|erenumab|mesh-list
92895598|NCT04152434|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92895599|NCT04152434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895600|NCT04152434|Analgesics|analgesics|mesh-ancestor
92895601|NCT04152434|Sensory System Agents|sensory system agents|mesh-ancestor
92895602|NCT04152434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895603|NCT04152434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895604|NCT00615797|Penicillins|penicillins|mesh-list
92895605|NCT00615797|Penicillin V|penicillin v|mesh-list
92895606|NCT00615797|Haloperidol|haloperidol|mesh-list
92895607|NCT00615797|Haloperidol decanoate|haloperidol decanoate|mesh-list
92895608|NCT00615797|Immunoglobulins|immunoglobulins|mesh-list
92895609|NCT00615797|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92895610|NCT00615797|Antibodies|antibodies|mesh-list
92895611|NCT00615797|gamma-Globulins|gamma-globulins|mesh-list
92895612|NCT00615797|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92895613|NCT00615797|Immunologic Factors|immunologic factors|mesh-ancestor
92895614|NCT00615797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895615|NCT00615797|Antiemetics|antiemetics|mesh-ancestor
92895616|NCT00615797|Autonomic Agents|autonomic agents|mesh-ancestor
92895617|NCT00615797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895618|NCT00615797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895619|NCT00615797|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92895620|NCT00615797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92895621|NCT00615797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895622|NCT00615797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92895623|NCT00615797|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92895624|NCT00615797|Dopamine Agents|dopamine agents|mesh-ancestor
92895625|NCT00615797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895626|NCT00615797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895627|NCT00615797|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92895628|NCT00615797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895629|NCT00615797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895630|NCT00705016|Fluorouracil|fluorouracil|mesh-list
92895631|NCT00705016|Cetuximab|cetuximab|mesh-list
92895632|NCT00705016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895633|NCT00705016|Antimetabolites|antimetabolites|mesh-ancestor
92895634|NCT00705016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895635|NCT00705016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895636|NCT00705016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895637|NCT00705016|Immunologic Factors|immunologic factors|mesh-ancestor
92895638|NCT00705016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895639|NCT00705016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92895640|NCT00595868|Varenicline|varenicline|mesh-list
92895641|NCT00595868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92895642|NCT00595868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92895643|NCT00595868|Cholinergic Agents|cholinergic agents|mesh-ancestor
92895644|NCT00595868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895645|NCT00595868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895646|NCT00595868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895647|NCT02699801|Dexmedetomidine|dexmedetomidine|mesh-list
92895648|NCT02699801|Propofol|propofol|mesh-list
92895649|NCT02699801|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92895650|NCT02699801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895651|NCT02699801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895652|NCT02699801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92895653|NCT02699801|Analgesics|analgesics|mesh-ancestor
92895654|NCT02699801|Sensory System Agents|sensory system agents|mesh-ancestor
92895655|NCT02699801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895656|NCT02699801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92895657|NCT02699801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92895658|NCT02699801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92895659|NCT02699801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92895660|NCT02699801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895661|NCT02699801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895662|NCT02699801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92895663|NCT02699801|Anesthetics, General|anesthetics, general|mesh-ancestor
92895664|NCT02699801|Anesthetics|anesthetics|mesh-ancestor
92895665|NCT02727907|Interferons|interferons|mesh-list
92895666|NCT02727907|Interferon-beta|interferon-beta|mesh-list
92895667|NCT02727907|Interferon beta-1a|interferon beta-1a|mesh-list
92895668|NCT02727907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895669|NCT02727907|Antiviral Agents|antiviral agents|mesh-ancestor
92895670|NCT02727907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895671|NCT02727907|Immunologic Factors|immunologic factors|mesh-ancestor
92895672|NCT02727907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895673|NCT02727907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92895674|NCT00663728|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92895675|NCT00663728|Vasodilator Agents|vasodilator agents|mesh-ancestor
92895676|NCT00663728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92895677|NCT00663728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92895678|NCT00663728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895679|NCT00663728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895680|NCT00663728|Urological Agents|urological agents|mesh-ancestor
92895681|NCT01009801|Doxorubicin|doxorubicin|mesh-list
92895682|NCT01009801|Everolimus|everolimus|mesh-list
92895683|NCT01009801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92895684|NCT01009801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895685|NCT01009801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92895686|NCT01009801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895687|NCT01009801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895688|NCT01009801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895689|NCT01009801|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92895690|NCT01009801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92895691|NCT01009801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895692|NCT01009801|Immunologic Factors|immunologic factors|mesh-ancestor
92895693|NCT01009801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895694|NCT00617045|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92895695|NCT00617045|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92895696|NCT00617045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92895697|NCT00617045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92895698|NCT00617045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895699|NCT00617045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895700|NCT00617045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895701|NCT00617045|Analgesics|analgesics|mesh-ancestor
92895702|NCT00617045|Sensory System Agents|sensory system agents|mesh-ancestor
92895703|NCT00617045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895704|NCT00617045|Antidepressive Agents|antidepressive agents|mesh-ancestor
92895706|NCT00617045|Dopamine Agents|dopamine agents|mesh-ancestor
92895707|NCT02629718|Paclitaxel|paclitaxel|mesh-list
92895708|NCT02629718|Carboplatin|carboplatin|mesh-list
92895709|NCT02629718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895710|NCT02629718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895711|NCT02629718|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895712|NCT02629718|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895713|NCT02629718|Mitosis Modulators|mitosis modulators|mesh-ancestor
92895714|NCT02629718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895715|NCT01009879|Etanercept|etanercept|mesh-list
92895716|NCT01009879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92895717|NCT01009879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92895718|NCT01009879|Analgesics|analgesics|mesh-ancestor
92895719|NCT01009879|Sensory System Agents|sensory system agents|mesh-ancestor
92895720|NCT01009879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895721|NCT01009879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895722|NCT01009879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895723|NCT01009879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92895724|NCT01009879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895725|NCT01009879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895726|NCT01009879|Immunologic Factors|immunologic factors|mesh-ancestor
92895727|NCT01009957|Everolimus|everolimus|mesh-list
92895728|NCT01009957|MTOR Inhibitors|mtor inhibitors|mesh-list
92895729|NCT01009957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92895730|NCT01009957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895731|NCT01009957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895732|NCT01009957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92895733|NCT01009957|Immunologic Factors|immunologic factors|mesh-ancestor
92895734|NCT01009957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895735|NCT01009957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895736|NCT04062370|Ranibizumab|ranibizumab|mesh-list
92895737|NCT04062370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92895738|NCT04062370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92895739|NCT04062370|Growth Substances|growth substances|mesh-ancestor
92895740|NCT04062370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895741|NCT04062370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92895742|NCT04062370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895743|NCT01015183|Zinc Sulfate|zinc sulfate|mesh-list
92895744|NCT01015183|Astringents|astringents|mesh-ancestor
92895745|NCT01015183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895746|NCT01015183|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895747|NCT00856284|Metformin|metformin|mesh-list
92895748|NCT00856284|Alogliptin|alogliptin|mesh-list
92895749|NCT00856284|Glipizide|glipizide|mesh-list
92895750|NCT00856284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92895751|NCT00856284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895752|NCT00856284|Incretins|incretins|mesh-ancestor
92895753|NCT00856284|Hormones|hormones|mesh-ancestor
92895754|NCT00856284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895755|NCT00856284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92895756|NCT00856284|Protease Inhibitors|protease inhibitors|mesh-ancestor
92895757|NCT00856284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895758|NCT00856284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895759|NCT00510289|Sorafenib|sorafenib|mesh-list
92895760|NCT00510289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895761|NCT00510289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92895762|NCT00510289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895763|NCT00510289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895764|NCT01013155|Perindopril|perindopril|mesh-list
92895765|NCT01013155|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92895766|NCT01013155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92895767|NCT01013155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895768|NCT01013155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895769|NCT01013155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92895770|NCT00663806|Ciprofloxacin|ciprofloxacin|mesh-list
92895771|NCT00663806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895772|NCT00663806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895773|NCT00663806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92895774|NCT00663806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895775|NCT00663806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541129|NCT00018083|Efavirenz|efavirenz|mesh-list
92895776|NCT00663806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895777|NCT00663806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895778|NCT00663806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92895779|NCT00663806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92895780|NCT01015339|Paclitaxel|paclitaxel|mesh-list
92895781|NCT01015339|Capecitabine|capecitabine|mesh-list
92895782|NCT01015339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92895783|NCT01015339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895784|NCT01015339|Tubulin Modulators|tubulin modulators|mesh-ancestor
92895785|NCT01015339|Antimitotic Agents|antimitotic agents|mesh-ancestor
92895786|NCT01015339|Mitosis Modulators|mitosis modulators|mesh-ancestor
92895787|NCT01015339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895788|NCT01015339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92895789|NCT01015339|Antimetabolites|antimetabolites|mesh-ancestor
92895790|NCT05110313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92895791|NCT05110313|Immunologic Factors|immunologic factors|mesh-ancestor
92895792|NCT05110313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895793|NCT02622906|Pasireotide|pasireotide|mesh-list
92895794|NCT02622906|Hormones|hormones|mesh-ancestor
92895795|NCT02622906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895796|NCT02622906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895797|NCT00673556|Alefacept|alefacept|mesh-list
92895798|NCT00673556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895799|NCT00673556|Immunologic Factors|immunologic factors|mesh-ancestor
92895800|NCT00673556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895801|NCT00675896|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92895802|NCT00675896|Antidepressive Agents|antidepressive agents|mesh-ancestor
92895803|NCT00675896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92895804|NCT00675896|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92895805|NCT00675896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92895806|NCT00675896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895807|NCT00675896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895808|NCT01015417|Amoxicillin|amoxicillin|mesh-list
92895809|NCT01015417|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92895810|NCT01015417|Clavulanic Acids|clavulanic acids|mesh-list
92895811|NCT01015417|Clavulanic Acid|clavulanic acid|mesh-list
92895812|NCT01015417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895813|NCT01015417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895814|NCT01015417|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92895815|NCT01015417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895816|NCT01015417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895817|NCT04061824|Olmesartan|olmesartan|mesh-list
92895818|NCT04061824|Angiotensin II|angiotensin ii|mesh-list
92895819|NCT04061824|Giapreza|giapreza|mesh-list
92895820|NCT04061824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92895821|NCT04061824|Angiotensinogen|angiotensinogen|mesh-list
92895822|NCT04061824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92895823|NCT04061824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92895824|NCT04061824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92895825|NCT04061824|Antimetabolites|antimetabolites|mesh-ancestor
92895826|NCT04061824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895827|NCT04061824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92161111|NCT03492437|Tepotinib|tepotinib|mesh-list
92161112|NCT03492437|Dabigatran|dabigatran|mesh-list
92895828|NCT04061824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92895829|NCT04061824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895830|NCT04061824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92895831|NCT04061824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92895832|NCT04061824|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92895833|NCT04061824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92895834|NCT04061824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92895835|NCT04212533|Vitamin D|vitamin d|mesh-list
92895836|NCT04212533|Vitamins|vitamins|mesh-ancestor
92895837|NCT04212533|Micronutrients|micronutrients|mesh-ancestor
92895838|NCT04212533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895839|NCT04212533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92895840|NCT04155554|Tenofovir|tenofovir|mesh-list
92895841|NCT04155554|Lamivudine|lamivudine|mesh-list
92895842|NCT04155554|Emtricitabine|emtricitabine|mesh-list
92895843|NCT04155554|Dolutegravir|dolutegravir|mesh-list
92895844|NCT04155554|Abacavir|abacavir|mesh-list
92895845|NCT04155554|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92895846|NCT04155554|Antiviral Agents|antiviral agents|mesh-ancestor
92895847|NCT04155554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895848|NCT04155554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92895849|NCT04155554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92895850|NCT04155554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895851|NCT04155554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895852|NCT04155554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92895853|NCT04155554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92895854|NCT04155554|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92895855|NCT04155554|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92895856|NCT00663884|Voglibose|voglibose|mesh-list
92895857|NCT00663884|Mitiglinide|mitiglinide|mesh-list
92895858|NCT00663884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92895859|NCT00663884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895860|NCT00663884|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92895861|NCT00663884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895862|NCT00663884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895864|NCT00856206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895865|NCT03997279|Amoxicillin|amoxicillin|mesh-list
92895866|NCT03997279|Metronidazole|metronidazole|mesh-list
92895867|NCT03997279|Clarithromycin|clarithromycin|mesh-list
92895868|NCT03997279|Rabeprazole|rabeprazole|mesh-list
92895869|NCT03997279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895870|NCT03997279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895871|NCT03997279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92895872|NCT03997279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92895873|NCT03997279|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92895874|NCT03997279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895875|NCT03997279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895876|NCT03997279|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92895877|NCT03997279|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92895878|NCT03997279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92895879|NCT03997279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895880|NCT03997279|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92895882|NCT00920998|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92895883|NCT00920998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895884|NCT00920998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895885|NCT00920998|Cholinergic Agents|cholinergic agents|mesh-ancestor
92895886|NCT00920998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895887|NCT00920998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895888|NCT00920998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895889|NCT00593112|Methylphenidate|methylphenidate|mesh-list
92895890|NCT00593112|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92895891|NCT00593112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895892|NCT00593112|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92895893|NCT00593112|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92895894|NCT00593112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92895895|NCT00593112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895896|NCT00593112|Dopamine Agents|dopamine agents|mesh-ancestor
92895897|NCT00593112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895898|NCT05323565|Dexamethasone|dexamethasone|mesh-list
92895899|NCT05323565|Dexmedetomidine|dexmedetomidine|mesh-list
92895900|NCT05323565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92895901|NCT05323565|Antiemetics|antiemetics|mesh-ancestor
92895902|NCT05323565|Autonomic Agents|autonomic agents|mesh-ancestor
92895903|NCT05323565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895904|NCT05323565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895905|NCT05323565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895906|NCT05323565|Glucocorticoids|glucocorticoids|mesh-ancestor
92895907|NCT05323565|Hormones|hormones|mesh-ancestor
92895908|NCT05323565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895909|NCT05323565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92895910|NCT05323565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895911|NCT05323565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895912|NCT05323565|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92895913|NCT05323565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92895914|NCT05323565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92895915|NCT05323565|Analgesics|analgesics|mesh-ancestor
92895916|NCT05323565|Sensory System Agents|sensory system agents|mesh-ancestor
92895917|NCT05323565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92895918|NCT05323565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92895919|NCT05323565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92895920|NCT05323565|Adrenergic Agents|adrenergic agents|mesh-ancestor
92895921|NCT05323565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895922|NCT01015495|Ranibizumab|ranibizumab|mesh-list
92895923|NCT01015495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92895924|NCT01015495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92895925|NCT01015495|Growth Substances|growth substances|mesh-ancestor
92895926|NCT01015495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895927|NCT01015495|Growth Inhibitors|growth inhibitors|mesh-ancestor
92895928|NCT01015495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895930|NCT00676286|Lipotropic Agents|lipotropic agents|mesh-ancestor
92895931|NCT00676286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92895932|NCT00676286|Antimetabolites|antimetabolites|mesh-ancestor
92895933|NCT00676286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895934|NCT00676286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895935|NCT00676286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92895936|NCT00676286|Nootropic Agents|nootropic agents|mesh-ancestor
92895937|NCT00699894|Ondansetron|ondansetron|mesh-list
92895938|NCT00699894|Aprepitant|aprepitant|mesh-list
92895939|NCT00699894|Antiemetics|antiemetics|mesh-ancestor
92895940|NCT00699894|Autonomic Agents|autonomic agents|mesh-ancestor
92895941|NCT00699894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92895942|NCT00699894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895943|NCT00699894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92895944|NCT00699894|Antipruritics|antipruritics|mesh-ancestor
92895945|NCT00699894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92895946|NCT00699894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92895947|NCT00699894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92895948|NCT00699894|Serotonin Agents|serotonin agents|mesh-ancestor
92895949|NCT00699894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92895950|NCT00699894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895951|NCT00699894|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92895952|NCT00664196|Hormones|hormones|mesh-list
92895953|NCT00664196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92895954|NCT00664196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895955|NCT00616499|Gefitinib|gefitinib|mesh-list
92895956|NCT00616499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895957|NCT00616499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92895958|NCT00616499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895959|NCT00616499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895960|NCT05317936|Venetoclax|venetoclax|mesh-list
92895961|NCT05317936|Pirtobrutinib|pirtobrutinib|mesh-list
92895962|NCT05317936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895963|NCT05317936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92895964|NCT05317936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895965|NCT05317936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895966|NCT02614248|Protective Agents|protective agents|mesh-list
92895967|NCT02614248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895968|NCT00491179|Interferons|interferons|mesh-list
92895969|NCT00491179|Ribavirin|ribavirin|mesh-list
92895970|NCT00491179|Interferon-alpha|interferon-alpha|mesh-list
92895971|NCT00491179|Interferon alpha-2|interferon alpha-2|mesh-list
92895972|NCT00491179|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92895973|NCT00491179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895974|NCT00491179|Antiviral Agents|antiviral agents|mesh-ancestor
92895975|NCT00491179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182566|NCT01680549|Gabapentin|gabapentin|mesh-list
92895976|NCT00491179|Antimetabolites|antimetabolites|mesh-ancestor
92895977|NCT00491179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895978|NCT00491179|Immunologic Factors|immunologic factors|mesh-ancestor
92895979|NCT00491179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92895980|NCT04155476|Nitroglycerin|nitroglycerin|mesh-list
92895981|NCT04155476|Vasodilator Agents|vasodilator agents|mesh-ancestor
92895982|NCT04502095|Levofloxacin|levofloxacin|mesh-list
92895983|NCT04502095|Ofloxacin|ofloxacin|mesh-list
92895984|NCT04502095|Trimethoprim|trimethoprim|mesh-list
92895985|NCT04502095|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92895986|NCT04502095|Nitrofurantoin|nitrofurantoin|mesh-list
92895987|NCT04502095|Clindamycin|clindamycin|mesh-list
92895988|NCT04502095|Ertapenem|ertapenem|mesh-list
92895989|NCT04502095|Sulfamethoxazole|sulfamethoxazole|mesh-list
92895990|NCT04502095|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92895991|NCT04502095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92895992|NCT04502095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92895993|NCT04502095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92895994|NCT04502095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92895995|NCT04502095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92895996|NCT04502095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92895997|NCT04502095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92895998|NCT04502095|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92895999|NCT04502095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92896000|NCT04502095|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92896001|NCT04502095|Antimalarials|antimalarials|mesh-ancestor
92896002|NCT04502095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92896003|NCT04502095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92896004|NCT04502095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92896005|NCT04502095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92896006|NCT04502095|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92896008|NCT00674102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896009|NCT00503581|Megestrol|megestrol|mesh-list
92896010|NCT00503581|Megestrol Acetate|megestrol acetate|mesh-list
92896011|NCT00503581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92896012|NCT00503581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92896013|NCT00503581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92896014|NCT00503581|Contraceptive Agents|contraceptive agents|mesh-ancestor
92896015|NCT00503581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896016|NCT00503581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896017|NCT00503581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92896018|NCT00503581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92896019|NCT00503581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92896020|NCT00503581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896021|NCT00503581|Appetite Stimulants|appetite stimulants|mesh-ancestor
92896022|NCT00503581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92896023|NCT00677144|Capecitabine|capecitabine|mesh-list
92896024|NCT00677144|Oxaliplatin|oxaliplatin|mesh-list
92896025|NCT00677144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92896026|NCT00677144|Antimetabolites|antimetabolites|mesh-ancestor
92896027|NCT00677144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896028|NCT00677144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896029|NCT00703534|Lesogaberan|lesogaberan|mesh-list
92896030|NCT00703534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896031|NCT00703534|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92896032|NCT00703534|GABA Agonists|gaba agonists|mesh-ancestor
92896033|NCT00703534|GABA Agents|gaba agents|mesh-ancestor
92896034|NCT00703534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896035|NCT00703534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896036|NCT00703534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896037|NCT00503425|Rituximab|rituximab|mesh-list
92896038|NCT00503425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896039|NCT00503425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896040|NCT00503425|Immunologic Factors|immunologic factors|mesh-ancestor
92896041|NCT00503425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896042|NCT00503425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896043|NCT00863772|Tanezumab|tanezumab|mesh-list
92896044|NCT00863772|Analgesics|analgesics|mesh-ancestor
92896045|NCT00863772|Sensory System Agents|sensory system agents|mesh-ancestor
92896046|NCT00863772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896047|NCT00863772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896048|NCT01010425|Hormones|hormones|mesh-list
92197064|NCT04345783|Apatinib|apatinib|mesh-list
92896049|NCT01010425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896050|NCT01010425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896051|NCT04914676|Cytarabine|cytarabine|mesh-list
92896052|NCT04914676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92896053|NCT04914676|Antimetabolites|antimetabolites|mesh-ancestor
92896054|NCT04914676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896055|NCT04914676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896056|NCT04914676|Antiviral Agents|antiviral agents|mesh-ancestor
92896057|NCT04914676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896058|NCT04914676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896059|NCT04914676|Immunologic Factors|immunologic factors|mesh-ancestor
92896060|NCT04914676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896061|NCT00677300|Ritonavir|ritonavir|mesh-list
92896062|NCT00677300|Darunavir|darunavir|mesh-list
92896063|NCT00677300|Tenofovir|tenofovir|mesh-list
92896064|NCT00677300|Emtricitabine|emtricitabine|mesh-list
92896065|NCT00677300|Raltegravir Potassium|raltegravir potassium|mesh-list
92896066|NCT00677300|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92896067|NCT00677300|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92896068|NCT00677300|Protease Inhibitors|protease inhibitors|mesh-ancestor
92896069|NCT00677300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896070|NCT00677300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896071|NCT00677300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92896072|NCT00677300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92896073|NCT00677300|Antiviral Agents|antiviral agents|mesh-ancestor
92896074|NCT00677300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896075|NCT00677300|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92896076|NCT00677300|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92896077|NCT00677300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92896078|NCT00677300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92896079|NCT00677300|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92896080|NCT00677300|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92896081|NCT02628392|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92896082|NCT02628392|Firuglipel|firuglipel|mesh-list
92896083|NCT02628392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896084|NCT02628392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896085|NCT02628392|Incretins|incretins|mesh-ancestor
92896086|NCT02628392|Hormones|hormones|mesh-ancestor
92896087|NCT02628392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896088|NCT02628392|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92896089|NCT02628392|Protease Inhibitors|protease inhibitors|mesh-ancestor
92896090|NCT02628392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896091|NCT02628392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896092|NCT00664586|Masoprocol|masoprocol|mesh-list
92896093|NCT00664586|Antioxidants|antioxidants|mesh-ancestor
92896094|NCT00664586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896095|NCT00664586|Protective Agents|protective agents|mesh-ancestor
92896096|NCT00664586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896097|NCT00664586|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92896098|NCT00664586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896099|NCT00664586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92896100|NCT00664586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92896101|NCT00664586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92896102|NCT00664586|Analgesics|analgesics|mesh-ancestor
92896103|NCT00664586|Sensory System Agents|sensory system agents|mesh-ancestor
92896104|NCT00664586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896105|NCT00664586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896106|NCT00664586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896107|NCT00502801|Doripenem|doripenem|mesh-list
92896108|NCT00502801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92896109|NCT00502801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896110|NCT04154852|Folic Acid|folic acid|mesh-list
92896111|NCT04154852|Adalimumab|adalimumab|mesh-list
92896112|NCT04154852|Methotrexate|methotrexate|mesh-list
92896113|NCT04154852|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92896114|NCT04154852|Abortifacient Agents|abortifacient agents|mesh-ancestor
92896115|NCT04154852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896116|NCT04154852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896117|NCT04154852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92896118|NCT04154852|Antimetabolites|antimetabolites|mesh-ancestor
92896119|NCT04154852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896120|NCT04154852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896121|NCT04154852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92896122|NCT04154852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896123|NCT04154852|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92896124|NCT04154852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896125|NCT04154852|Immunologic Factors|immunologic factors|mesh-ancestor
92896126|NCT04154852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896127|NCT04154852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92896128|NCT04154852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92896129|NCT04154852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896130|NCT04154852|Hematinics|hematinics|mesh-ancestor
92896131|NCT04154852|Vitamin B Complex|vitamin b complex|mesh-ancestor
92896132|NCT04154852|Vitamins|vitamins|mesh-ancestor
92896133|NCT04154852|Micronutrients|micronutrients|mesh-ancestor
92896134|NCT00921154|Ivermectin|ivermectin|mesh-list
92896135|NCT00921154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92896136|NCT00921154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896137|NCT01015651|Remifentanil|remifentanil|mesh-list
92896138|NCT01015651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92896139|NCT01015651|Narcotics|narcotics|mesh-ancestor
92896140|NCT01015651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896141|NCT01015651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896142|NCT01015651|Analgesics|analgesics|mesh-ancestor
92896143|NCT01015651|Sensory System Agents|sensory system agents|mesh-ancestor
92896144|NCT01015651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896145|NCT00674414|Trastuzumab|trastuzumab|mesh-list
92896146|NCT00674414|Everolimus|everolimus|mesh-list
92896147|NCT00674414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896148|NCT00674414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896149|NCT00674414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92896150|NCT00674414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92896151|NCT00674414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525729|NCT00026104|Tipifarnib|tipifarnib|mesh-list
92896152|NCT00674414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896153|NCT00674414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896154|NCT00674414|Immunologic Factors|immunologic factors|mesh-ancestor
92896155|NCT00674414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896156|NCT05570422|Cisplatin|cisplatin|mesh-list
92896157|NCT05570422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896158|NCT05272930|Dienogest|dienogest|mesh-list
92896159|NCT05272930|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92896160|NCT05272930|Contraceptive Agents|contraceptive agents|mesh-ancestor
92896161|NCT05272930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896162|NCT05272930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896163|NCT05272930|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92896164|NCT05272930|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92896165|NCT05272930|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92896166|NCT05272930|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92896167|NCT05272930|Hormone Antagonists|hormone antagonists|mesh-ancestor
92896168|NCT05272930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896169|NCT05272930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92896170|NCT05272930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896171|NCT00855894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92896172|NCT00855894|Pertuzumab|pertuzumab|mesh-list
92896173|NCT00855894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896174|NCT00855894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92896175|NCT00855894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896176|NCT00855894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896177|NCT00855894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896178|NCT02566096|Morphine|morphine|mesh-list
92896179|NCT02566096|Bupivacaine|bupivacaine|mesh-list
92896180|NCT02566096|Anesthetics, Local|anesthetics, local|mesh-list
92896181|NCT02566096|Anesthetics|anesthetics|mesh-list
92896182|NCT02566096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896183|NCT02566096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896184|NCT02566096|Sensory System Agents|sensory system agents|mesh-ancestor
92896185|NCT02566096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896186|NCT02566096|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92896187|NCT02566096|Narcotics|narcotics|mesh-ancestor
92896188|NCT02566096|Analgesics|analgesics|mesh-ancestor
92896189|NCT04482244|Cannabidiol|cannabidiol|mesh-list
92896190|NCT04482244|Anticonvulsants|anticonvulsants|mesh-ancestor
92161123|NCT02405585|Leucovorin|leucovorin|mesh-list
92896191|NCT02622594|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92896192|NCT02622594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92896193|NCT02622594|Dermatologic Agents|dermatologic agents|mesh-ancestor
92896194|NCT02628860|Ferric Compounds|ferric compounds|mesh-list
92896195|NCT02628860|Hematinics|hematinics|mesh-ancestor
92896196|NCT00708357|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92896197|NCT00708357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896198|NCT00708357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896199|NCT00855738|Topiramate|topiramate|mesh-list
92896200|NCT00855738|Pregabalin|pregabalin|mesh-list
92896201|NCT00855738|Lamotrigine|lamotrigine|mesh-list
92896202|NCT00855738|Zonisamide|zonisamide|mesh-list
92896203|NCT00855738|Gabapentin|gabapentin|mesh-list
92896204|NCT00855738|Levetiracetam|levetiracetam|mesh-list
92896205|NCT00855738|Tiagabine|tiagabine|mesh-list
92896206|NCT00855738|Analgesics|analgesics|mesh-ancestor
92896207|NCT00855738|Sensory System Agents|sensory system agents|mesh-ancestor
92896208|NCT00855738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896209|NCT00855738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896210|NCT00855738|Anticonvulsants|anticonvulsants|mesh-ancestor
92896211|NCT00855738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92896212|NCT00855738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92896213|NCT00855738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896214|NCT00855738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92896215|NCT00855738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92896216|NCT00855738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92896217|NCT00855738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896218|NCT00855738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92896219|NCT00855738|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92896220|NCT00855738|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92896221|NCT00855738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896222|NCT00855738|Antimanic Agents|antimanic agents|mesh-ancestor
92896223|NCT00855738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896224|NCT00855738|Nootropic Agents|nootropic agents|mesh-ancestor
92896225|NCT00855738|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92896226|NCT00855738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92896227|NCT00855738|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92896228|NCT00855738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92896230|NCT02628002|Regadenoson|regadenoson|mesh-list
92896231|NCT02628002|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92896232|NCT02628002|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92896233|NCT02628002|Purinergic Agonists|purinergic agonists|mesh-ancestor
92896234|NCT02628002|Purinergic Agents|purinergic agents|mesh-ancestor
92896235|NCT02628002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896236|NCT02628002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896237|NCT02628002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896238|NCT00665054|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92896239|NCT00665054|Vasodilator Agents|vasodilator agents|mesh-ancestor
92896240|NCT00665054|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92896241|NCT00665054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92896242|NCT00665054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896243|NCT00665054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896244|NCT00665054|Urological Agents|urological agents|mesh-ancestor
92896245|NCT02622672|Coenzyme Q10|coenzyme q10|mesh-list
92896246|NCT02622672|Micronutrients|micronutrients|mesh-ancestor
92896247|NCT02622672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896248|NCT02622672|Vitamins|vitamins|mesh-ancestor
92896249|NCT04152356|Sorafenib|sorafenib|mesh-list
92896250|NCT04152356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896251|NCT04152356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92896252|NCT04152356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896253|NCT04152356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896254|NCT04271956|Tislelizumab|tislelizumab|mesh-list
92896255|NCT04271956|Zanubrutinib|zanubrutinib|mesh-list
92896256|NCT04271956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896257|NCT04271956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896258|NCT04271956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92896259|NCT04271956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896260|NCT04271956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896261|NCT02628080|Atovaquone|atovaquone|mesh-list
92896262|NCT02628080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896263|NCT02628080|Antimalarials|antimalarials|mesh-ancestor
92896264|NCT02628080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92896265|NCT02628080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92896266|NCT02628080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896267|NCT02628080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896268|NCT00678236|Gentamicins|gentamicins|mesh-list
92896269|NCT00678236|Cimetidine|cimetidine|mesh-list
92896270|NCT00678236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92896271|NCT00678236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896272|NCT00678236|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92896273|NCT00678236|Histamine Antagonists|histamine antagonists|mesh-ancestor
92896274|NCT00678236|Histamine Agents|histamine agents|mesh-ancestor
92896275|NCT00678236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896276|NCT00678236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896277|NCT00678236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896278|NCT00678236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92896279|NCT00678236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92896280|NCT00678236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896281|NCT00678236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92896282|NCT00678236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896283|NCT00678236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92896284|NCT00678314|Ropivacaine|ropivacaine|mesh-list
92896285|NCT00678314|Anesthetics, Local|anesthetics, local|mesh-ancestor
92896286|NCT00678314|Anesthetics|anesthetics|mesh-ancestor
92896287|NCT00678314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896288|NCT00678314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896289|NCT00678314|Sensory System Agents|sensory system agents|mesh-ancestor
92896290|NCT00678314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896291|NCT02566720|Amantadine|amantadine|mesh-list
92896292|NCT02566720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92896293|NCT02566720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92896294|NCT02566720|Antiviral Agents|antiviral agents|mesh-ancestor
92896295|NCT02566720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896296|NCT02566720|Dopamine Agents|dopamine agents|mesh-ancestor
92896297|NCT02566720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896298|NCT02566720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525731|NCT00026104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896299|NCT02566720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896300|NCT02566720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92896302|NCT02566720|Sensory System Agents|sensory system agents|mesh-ancestor
92896303|NCT02566720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896304|NCT00675194|Capecitabine|capecitabine|mesh-list
92896305|NCT00675194|Irinotecan|irinotecan|mesh-list
92896306|NCT00675194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896307|NCT00675194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92896308|NCT00675194|Antimetabolites|antimetabolites|mesh-ancestor
92896309|NCT00675194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896310|NCT00675194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92896311|NCT00675194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92896312|NCT00675194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896314|NCT00665522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92896315|NCT00665522|Narcotics|narcotics|mesh-ancestor
92896316|NCT00665522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896317|NCT00665522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896318|NCT00665522|Analgesics|analgesics|mesh-ancestor
92896319|NCT00665522|Sensory System Agents|sensory system agents|mesh-ancestor
92896320|NCT00665522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896321|NCT00665522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92896322|NCT00665522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92896323|NCT00665522|Anesthetics, General|anesthetics, general|mesh-ancestor
92896324|NCT00665522|Anesthetics|anesthetics|mesh-ancestor
92896325|NCT00675272|Hydrocortisone|hydrocortisone|mesh-list
92896326|NCT00675272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896327|NCT00678626|Docetaxel|docetaxel|mesh-list
92896328|NCT00678626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896329|NCT00678626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92896330|NCT00678626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92896331|NCT00678626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92896332|NCT00678626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896333|NCT00678704|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92896334|NCT00678704|Vasodilator Agents|vasodilator agents|mesh-ancestor
92896335|NCT00678704|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92896336|NCT00678704|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92896337|NCT00678704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896338|NCT00678704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896339|NCT00678704|Urological Agents|urological agents|mesh-ancestor
92896340|NCT00678782|Etanercept|etanercept|mesh-list
92896341|NCT00678782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92896342|NCT00678782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92896343|NCT00678782|Analgesics|analgesics|mesh-ancestor
92896344|NCT00678782|Sensory System Agents|sensory system agents|mesh-ancestor
92896345|NCT00678782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896346|NCT00678782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896347|NCT00678782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896348|NCT00678782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896349|NCT00678782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896350|NCT00678782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896351|NCT00678782|Immunologic Factors|immunologic factors|mesh-ancestor
92896352|NCT04707352|Dapagliflozin|dapagliflozin|mesh-list
92896353|NCT04707352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92896354|NCT04707352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896355|NCT04707352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896356|NCT04707352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896357|NCT04061200|Empagliflozin|empagliflozin|mesh-list
92896358|NCT04061200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92896359|NCT04061200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896360|NCT04061200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896361|NCT04061200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896362|NCT00675350|Homoharringtonine|homoharringtonine|mesh-list
92896363|NCT00675350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92896364|NCT00675350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896365|NCT00675350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92896366|NCT00675350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896367|NCT00675350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896368|NCT02565862|Metformin|metformin|mesh-list
92896369|NCT02565862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896370|NCT02565862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896371|NCT04060888|Ustekinumab|ustekinumab|mesh-list
92896372|NCT04060888|Dermatologic Agents|dermatologic agents|mesh-ancestor
92896373|NCT00879398|Fesoterodine|fesoterodine|mesh-list
92896374|NCT00879398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92896375|NCT00879398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92896376|NCT00879398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92896377|NCT00879398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896378|NCT00879398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896379|NCT00879398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896380|NCT00879398|Urological Agents|urological agents|mesh-ancestor
92896381|NCT00679250|Cetirizine|cetirizine|mesh-list
92896382|NCT00679250|Levocetirizine|levocetirizine|mesh-list
92896383|NCT00679250|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92896384|NCT00679250|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92896385|NCT00679250|Histamine Antagonists|histamine antagonists|mesh-ancestor
92896386|NCT00679250|Histamine Agents|histamine agents|mesh-ancestor
92896387|NCT00679250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896388|NCT00679250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896389|NCT00679250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896390|NCT00679250|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92896391|NCT00696436|Valsartan|valsartan|mesh-list
92896392|NCT00696436|Olmesartan|olmesartan|mesh-list
92896393|NCT00696436|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92896394|NCT00696436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92896395|NCT00696436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92896396|NCT00696436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92896397|NCT00696436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896398|NCT00878072|Famciclovir|famciclovir|mesh-list
92896399|NCT00878072|Antiviral Agents|antiviral agents|mesh-ancestor
92896400|NCT00878072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896401|NCT00878072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92896402|NCT00878072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896403|NCT00878072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896404|NCT00675740|Rosiglitazone|rosiglitazone|mesh-list
92161138|NCT02405585|Antidotes|antidotes|mesh-ancestor
92896405|NCT00675740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896406|NCT00675740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896407|NCT03045341|Naltrexone|naltrexone|mesh-list
92896408|NCT03045341|Bupropion|bupropion|mesh-list
92896409|NCT03045341|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92896410|NCT03045341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92896411|NCT03045341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896412|NCT03045341|Sensory System Agents|sensory system agents|mesh-ancestor
92896413|NCT03045341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896414|NCT03045341|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92896415|NCT03045341|Antidepressive Agents|antidepressive agents|mesh-ancestor
92896416|NCT03045341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92896417|NCT03045341|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92896418|NCT03045341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92896419|NCT03045341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92896420|NCT03045341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896421|NCT03045341|Dopamine Agents|dopamine agents|mesh-ancestor
92896422|NCT03045341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896423|NCT03045341|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92896424|NCT03045341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92896425|NCT03045341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896426|NCT00679484|Candesartan|candesartan|mesh-list
92896427|NCT00679484|Candesartan cilexetil|candesartan cilexetil|mesh-list
92896428|NCT00679484|Olmesartan|olmesartan|mesh-list
92896429|NCT00679484|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92896430|NCT00679484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92896431|NCT00679484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92896432|NCT00679484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92896433|NCT00679484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896434|NCT00679640|Candesartan|candesartan|mesh-list
92896435|NCT00679640|Candesartan cilexetil|candesartan cilexetil|mesh-list
92896436|NCT00679640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92896437|NCT00679640|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92896438|NCT00679640|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92896439|NCT00679640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896440|NCT00921388|Varenicline|varenicline|mesh-list
92896441|NCT00921388|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92896442|NCT00921388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92896443|NCT00921388|Cholinergic Agents|cholinergic agents|mesh-ancestor
92896444|NCT00921388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896445|NCT00921388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896446|NCT00921388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896447|NCT04212065|Buprenorphine|buprenorphine|mesh-list
92896448|NCT04212065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92896449|NCT04212065|Narcotics|narcotics|mesh-ancestor
92896450|NCT04212065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896451|NCT04212065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896452|NCT04212065|Analgesics|analgesics|mesh-ancestor
92896453|NCT04212065|Sensory System Agents|sensory system agents|mesh-ancestor
92896454|NCT04212065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896455|NCT04212065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92896456|NCT02627534|Anti-Infective Agents|anti-infective agents|mesh-list
92896457|NCT02627534|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92896458|NCT02627456|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92896459|NCT02627456|Antimalarials|antimalarials|mesh-ancestor
92896460|NCT02627456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92896461|NCT02627456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92896462|NCT02627456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896463|NCT00617513|Prucalopride|prucalopride|mesh-list
92896464|NCT00617513|Laxatives|laxatives|mesh-ancestor
92896465|NCT00617513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896466|NCT00617513|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92896467|NCT00617513|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92896468|NCT00617513|Serotonin Agents|serotonin agents|mesh-ancestor
92896469|NCT00617513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896470|NCT00617513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896471|NCT00617513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896472|NCT02627222|Vitamin A|vitamin a|mesh-list
92896473|NCT02627222|Provitamins|provitamins|mesh-list
92896474|NCT02627222|Vitamins|vitamins|mesh-ancestor
92896475|NCT02627222|Micronutrients|micronutrients|mesh-ancestor
92896476|NCT02627222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896477|NCT00684476|Immunomodulating Agents|immunomodulating agents|mesh-list
92896478|NCT00684476|Immunologic Factors|immunologic factors|mesh-ancestor
92896479|NCT00684476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896480|NCT00594854|Diclofenac|diclofenac|mesh-list
92896481|NCT00594854|Arthrotec|arthrotec|mesh-list
92896482|NCT00594854|Misoprostol|misoprostol|mesh-list
92896483|NCT00594854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92896484|NCT00594854|Abortifacient Agents|abortifacient agents|mesh-ancestor
92896485|NCT00594854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896486|NCT00594854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896487|NCT00594854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92896488|NCT00594854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896489|NCT00594854|Oxytocics|oxytocics|mesh-ancestor
92896490|NCT00594854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92896491|NCT00594854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92896492|NCT00594854|Analgesics|analgesics|mesh-ancestor
92896493|NCT00594854|Sensory System Agents|sensory system agents|mesh-ancestor
92896494|NCT00594854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896495|NCT00594854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896496|NCT00594854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896497|NCT00594854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92896498|NCT00594854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896499|NCT00594854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896500|NCT00679718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92896501|NCT00679718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92896502|NCT00684632|Fentanyl|fentanyl|mesh-list
92896503|NCT00684632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92896504|NCT00684632|Narcotics|narcotics|mesh-ancestor
92896505|NCT00684632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896506|NCT00684632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896507|NCT00684632|Analgesics|analgesics|mesh-ancestor
92896508|NCT00684632|Sensory System Agents|sensory system agents|mesh-ancestor
92896509|NCT00684632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896510|NCT00684632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92896511|NCT00684632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92896512|NCT00684632|Anesthetics, General|anesthetics, general|mesh-ancestor
92896513|NCT00684632|Anesthetics|anesthetics|mesh-ancestor
92896514|NCT00855582|Tadalafil|tadalafil|mesh-list
92896515|NCT00855582|Vasodilator Agents|vasodilator agents|mesh-ancestor
92896516|NCT00855582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92896517|NCT00855582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92896518|NCT00855582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896519|NCT00855582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896521|NCT00619541|Fluorouracil|fluorouracil|mesh-list
92896522|NCT00619541|Sorafenib|sorafenib|mesh-list
92896523|NCT00619541|Antimetabolites|antimetabolites|mesh-ancestor
92896524|NCT00619541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896525|NCT00619541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92896526|NCT00619541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896527|NCT00619541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896528|NCT00619541|Immunologic Factors|immunologic factors|mesh-ancestor
92896529|NCT00619541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896530|NCT00619541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92896531|NCT00619541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896532|NCT00680498|Ranibizumab|ranibizumab|mesh-list
92896533|NCT00680498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92896534|NCT00680498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92896535|NCT00680498|Growth Substances|growth substances|mesh-ancestor
92896536|NCT00680498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896537|NCT00680498|Growth Inhibitors|growth inhibitors|mesh-ancestor
92896538|NCT00680498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896540|NCT00684866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92896541|NCT00684866|Autonomic Agents|autonomic agents|mesh-ancestor
92896542|NCT00684866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896543|NCT00684866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896544|NCT00684866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92896545|NCT00684866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92896546|NCT00684866|Tocolytic Agents|tocolytic agents|mesh-ancestor
92896547|NCT00684866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896548|NCT00684866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92161146|NCT00089999|Lapatinib|lapatinib|mesh-list
92896549|NCT00684866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92896550|NCT00684866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92896551|NCT00684866|Adrenergic Agents|adrenergic agents|mesh-ancestor
92896552|NCT00684866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896553|NCT00684866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896554|NCT00854724|Puerarin|puerarin|mesh-list
92896555|NCT00854724|Vasodilator Agents|vasodilator agents|mesh-ancestor
92896556|NCT00619697|Insulin|insulin|mesh-list
92896557|NCT00619697|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92896558|NCT00619697|Metformin|metformin|mesh-list
92896559|NCT00619697|Insulin Glargine|insulin glargine|mesh-list
92896560|NCT00619697|Insulin Aspart|insulin aspart|mesh-list
92896561|NCT00619697|Glimepiride|glimepiride|mesh-list
92896562|NCT00619697|Biphasic Insulins|biphasic insulins|mesh-list
92896563|NCT00619697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92896564|NCT00619697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896565|NCT00619697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896566|NCT00619697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92896567|NCT00619697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896568|NCT00619697|Immunologic Factors|immunologic factors|mesh-ancestor
92896569|NCT00680654|Riociguat|riociguat|mesh-list
92896570|NCT00680654|Enzyme Activators|enzyme activators|mesh-ancestor
92896571|NCT00680654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896572|NCT00680108|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92896573|NCT00680108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92896574|NCT00680732|Folic Acid|folic acid|mesh-list
92896575|NCT00680732|Micronutrients|micronutrients|mesh-list
92896576|NCT00680732|Trace Elements|trace elements|mesh-list
92896577|NCT00680732|Chloroquine|chloroquine|mesh-list
92896578|NCT00680732|Pyrimethamine|pyrimethamine|mesh-list
92896579|NCT00680732|Hematinics|hematinics|mesh-ancestor
92896580|NCT00680732|Vitamin B Complex|vitamin b complex|mesh-ancestor
92896581|NCT00680732|Vitamins|vitamins|mesh-ancestor
92896582|NCT00680732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896583|NCT00680732|Amebicides|amebicides|mesh-ancestor
92896584|NCT00680732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92896585|NCT00680732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92896586|NCT00680732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896587|NCT00680732|Antimalarials|antimalarials|mesh-ancestor
92896588|NCT00680732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896589|NCT00680732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92896590|NCT00680732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896591|NCT00680732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896592|NCT00698932|Saxagliptin|saxagliptin|mesh-list
92896593|NCT00698932|Incretins|incretins|mesh-ancestor
92896594|NCT00698932|Hormones|hormones|mesh-ancestor
92896595|NCT00698932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896596|NCT00698932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896597|NCT00698932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92896598|NCT00698932|Protease Inhibitors|protease inhibitors|mesh-ancestor
92896599|NCT00698932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896600|NCT00698932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896601|NCT00698932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92896602|NCT02566252|Cromolyn Sodium|cromolyn sodium|mesh-list
92896604|NCT02566252|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
92896605|NCT02566252|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92896606|NCT02566252|Autonomic Agents|autonomic agents|mesh-ancestor
92896607|NCT02566252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541958|NCT00022737|Mercaptopurine|mercaptopurine|mesh-list
92896608|NCT02566252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896609|NCT02566252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92896610|NCT02566252|Respiratory System Agents|respiratory system agents|mesh-ancestor
92896611|NCT02566252|Tocolytic Agents|tocolytic agents|mesh-ancestor
92896612|NCT02566252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896613|NCT02566252|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92896614|NCT02566252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92896615|NCT02566252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92896616|NCT02566252|Adrenergic Agents|adrenergic agents|mesh-ancestor
92896617|NCT02566252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896618|NCT02566252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896619|NCT02566252|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92896620|NCT02566252|Immunologic Factors|immunologic factors|mesh-ancestor
92896621|NCT02566252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92896622|NCT02566252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896623|NCT00823719|Ofatumumab|ofatumumab|mesh-list
92896624|NCT00823719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92896625|NCT00823719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896626|NCT00823719|Immunologic Factors|immunologic factors|mesh-ancestor
92896627|NCT00823719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896628|NCT03953170|Teduglutide|teduglutide|mesh-list
92896629|NCT03953170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896630|NCT03953170|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92896631|NCT03953170|Protective Agents|protective agents|mesh-ancestor
92896632|NCT03953170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896633|NCT00708591|Sirolimus|sirolimus|mesh-list
92896634|NCT00708591|Ketoconazole|ketoconazole|mesh-list
92896635|NCT00708591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92896636|NCT00708591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896637|NCT00708591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92896638|NCT00708591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896639|NCT00708591|Antifungal Agents|antifungal agents|mesh-ancestor
92896640|NCT00708591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896641|NCT00708591|Immunologic Factors|immunologic factors|mesh-ancestor
92896642|NCT00708591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896643|NCT00708591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896644|NCT00708591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896645|NCT00708591|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92896646|NCT00708591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92896647|NCT00708591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92896648|NCT00708591|Hormone Antagonists|hormone antagonists|mesh-ancestor
92896649|NCT00708591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896650|NCT00708591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92896651|NCT04595266|Leucovorin|leucovorin|mesh-list
92896652|NCT04595266|Bevacizumab|bevacizumab|mesh-list
92896653|NCT04595266|Fluorouracil|fluorouracil|mesh-list
92896654|NCT04595266|Oxaliplatin|oxaliplatin|mesh-list
92896655|NCT04595266|Irinotecan|irinotecan|mesh-list
92896656|NCT04595266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896657|NCT04595266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896658|NCT04595266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92896659|NCT04595266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92896660|NCT04595266|Growth Substances|growth substances|mesh-ancestor
92896661|NCT04595266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896662|NCT04595266|Growth Inhibitors|growth inhibitors|mesh-ancestor
92896663|NCT04595266|Antimetabolites|antimetabolites|mesh-ancestor
92896664|NCT04595266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896665|NCT04595266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92896666|NCT04595266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896667|NCT04595266|Immunologic Factors|immunologic factors|mesh-ancestor
92896668|NCT04595266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92896669|NCT04595266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92896670|NCT04595266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896672|NCT04595266|Protective Agents|protective agents|mesh-ancestor
92896673|NCT04595266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92896674|NCT04595266|Vitamins|vitamins|mesh-ancestor
92896675|NCT04595266|Micronutrients|micronutrients|mesh-ancestor
92896676|NCT00708747|Immunoglobulins|immunoglobulins|mesh-list
92896677|NCT00708747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92896678|NCT00708747|Antibodies|antibodies|mesh-list
92896679|NCT00708747|Immunologic Factors|immunologic factors|mesh-ancestor
92896680|NCT00708747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896681|NCT00685022|Albuterol|albuterol|mesh-list
92896682|NCT00685022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92896683|NCT00685022|Autonomic Agents|autonomic agents|mesh-ancestor
92896684|NCT00685022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896685|NCT00685022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896686|NCT00685022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92896687|NCT00685022|Respiratory System Agents|respiratory system agents|mesh-ancestor
92896688|NCT00685022|Tocolytic Agents|tocolytic agents|mesh-ancestor
92896689|NCT00685022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896690|NCT00685022|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92896691|NCT00685022|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92896692|NCT00685022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92896693|NCT00685022|Adrenergic Agents|adrenergic agents|mesh-ancestor
92896694|NCT00685022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896695|NCT00685022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896696|NCT03787264|Venetoclax|venetoclax|mesh-list
92896697|NCT03787264|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92896698|NCT03787264|Obinutuzumab|obinutuzumab|mesh-list
92896699|NCT03787264|Acalabrutinib|acalabrutinib|mesh-list
92896700|NCT03787264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896701|NCT03787264|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92896702|NCT03787264|Alkylating Agents|alkylating agents|mesh-ancestor
92896703|NCT03787264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896704|NCT03787264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896705|NCT00822237|Vaccines|vaccines|mesh-list
92896706|NCT00822237|Immunologic Factors|immunologic factors|mesh-ancestor
92896707|NCT00822237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896708|NCT00617747|Zolmitriptan|zolmitriptan|mesh-list
92896709|NCT00617747|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92896710|NCT00617747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92896711|NCT00617747|Serotonin Agents|serotonin agents|mesh-ancestor
92896712|NCT00617747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896713|NCT00617747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896714|NCT00617747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896715|NCT00685100|Triamcinolone|triamcinolone|mesh-list
92896716|NCT00685100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896717|NCT00685100|Glucocorticoids|glucocorticoids|mesh-ancestor
92896718|NCT00685100|Hormones|hormones|mesh-ancestor
92896719|NCT00685100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896720|NCT00685100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896721|NCT00708903|Moxifloxacin|moxifloxacin|mesh-list
92896722|NCT00708903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92896723|NCT00708903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896724|NCT00708903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92896725|NCT00708903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92896726|NCT00708903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896727|NCT00708903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896728|NCT00708903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896729|NCT00637091|Irinotecan|irinotecan|mesh-list
92896730|NCT00637091|Cetuximab|cetuximab|mesh-list
92896731|NCT00637091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92896732|NCT00637091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92896733|NCT00637091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896734|NCT00637091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896735|NCT00637091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896736|NCT00637091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896737|NCT04213391|Sulforaphane|sulforaphane|mesh-list
92896738|NCT04213391|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92896739|NCT04213391|Protective Agents|protective agents|mesh-ancestor
92896740|NCT04213391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896741|NCT04213391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896742|NCT00709137|Amiloride|amiloride|mesh-list
92896743|NCT00709137|Spironolactone|spironolactone|mesh-list
92896744|NCT00709137|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92896745|NCT00709137|Hormone Antagonists|hormone antagonists|mesh-ancestor
92896746|NCT00709137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896747|NCT00709137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896748|NCT00709137|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92896749|NCT00709137|Diuretics|diuretics|mesh-ancestor
92896750|NCT00709137|Natriuretic Agents|natriuretic agents|mesh-ancestor
92896751|NCT00709137|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92896752|NCT00709137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92896753|NCT00709137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92896754|NCT00709137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896755|NCT00709137|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92896756|NCT04150172|Rebamipide|rebamipide|mesh-list
92896757|NCT04150172|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92896758|NCT04150172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896760|NCT04150172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896761|NCT04150172|Protective Agents|protective agents|mesh-ancestor
92896762|NCT04150172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896763|NCT04150172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896764|NCT02325011|Fluconazole|fluconazole|mesh-list
92896765|NCT02325011|Nabiximols|nabiximols|mesh-list
92896766|NCT02325011|Dronabinol|dronabinol|mesh-list
92896767|NCT02325011|Cannabidiol|cannabidiol|mesh-list
92896768|NCT02325011|Antifungal Agents|antifungal agents|mesh-ancestor
92896769|NCT02325011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896770|NCT02325011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92896771|NCT02325011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92896772|NCT02325011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896773|NCT02325011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896774|NCT02325011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92896775|NCT02325011|Hormone Antagonists|hormone antagonists|mesh-ancestor
92896776|NCT02325011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896777|NCT02325011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896778|NCT02325011|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92896779|NCT02325011|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92896780|NCT02325011|Analgesics|analgesics|mesh-ancestor
92896781|NCT02325011|Sensory System Agents|sensory system agents|mesh-ancestor
92896782|NCT02325011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896783|NCT02325011|Anticonvulsants|anticonvulsants|mesh-ancestor
92896784|NCT02325011|Hallucinogens|hallucinogens|mesh-ancestor
92896785|NCT02325011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92896786|NCT02325011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92896787|NCT02325011|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92896788|NCT02325011|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92896789|NCT02325011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896790|NCT02325011|Hormones|hormones|mesh-ancestor
92896791|NCT00577096|Thalidomide|thalidomide|mesh-list
92896792|NCT00577096|Dexamethasone|dexamethasone|mesh-list
92896793|NCT00577096|Cyclophosphamide|cyclophosphamide|mesh-list
92896794|NCT00577096|Melphalan|melphalan|mesh-list
92896795|NCT00577096|Cisplatin|cisplatin|mesh-list
92896796|NCT00577096|Doxorubicin|doxorubicin|mesh-list
92896797|NCT00577096|Etoposide|etoposide|mesh-list
92896798|NCT00577096|Vincristine|vincristine|mesh-list
92896799|NCT00577096|Heparin|heparin|mesh-list
92896800|NCT00577096|Calcium heparin|calcium heparin|mesh-list
92896801|NCT00577096|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92896802|NCT00577096|Tinzaparin|tinzaparin|mesh-list
92896803|NCT00577096|Dalteparin|dalteparin|mesh-list
92896804|NCT00577096|Epoetin Alfa|epoetin alfa|mesh-list
92896805|NCT00577096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896806|NCT00577096|Immunologic Factors|immunologic factors|mesh-ancestor
92896807|NCT00577096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896808|NCT00577096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896809|NCT00577096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92896810|NCT00577096|Alkylating Agents|alkylating agents|mesh-ancestor
92896811|NCT00577096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896812|NCT00577096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896813|NCT00577096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92896814|NCT00577096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896815|NCT00577096|Antiemetics|antiemetics|mesh-ancestor
92896816|NCT00577096|Autonomic Agents|autonomic agents|mesh-ancestor
92896817|NCT00577096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896818|NCT00577096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92896819|NCT00577096|Glucocorticoids|glucocorticoids|mesh-ancestor
92896820|NCT00577096|Hormones|hormones|mesh-ancestor
92896821|NCT00577096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896822|NCT00577096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92896824|NCT00577096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92896825|NCT00577096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92896826|NCT00577096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92896827|NCT00577096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92896828|NCT00577096|Tubulin Modulators|tubulin modulators|mesh-ancestor
92896829|NCT00577096|Antimitotic Agents|antimitotic agents|mesh-ancestor
92896830|NCT00577096|Mitosis Modulators|mitosis modulators|mesh-ancestor
92896831|NCT00577096|Anticoagulants|anticoagulants|mesh-ancestor
92896832|NCT00577096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92896833|NCT00577096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92896834|NCT00577096|Hematinics|hematinics|mesh-ancestor
92896835|NCT00577096|Leprostatic Agents|leprostatic agents|mesh-ancestor
92896836|NCT00577096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92896837|NCT00577096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896838|NCT00577096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92896839|NCT00577096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92896840|NCT00577096|Growth Substances|growth substances|mesh-ancestor
92896841|NCT00577096|Growth Inhibitors|growth inhibitors|mesh-ancestor
92896842|NCT02625506|Tramadol|tramadol|mesh-list
92896843|NCT02625506|Levobupivacaine|levobupivacaine|mesh-list
92896844|NCT02625506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92896845|NCT02625506|Narcotics|narcotics|mesh-ancestor
92896846|NCT02625506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896847|NCT02625506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896848|NCT02625506|Analgesics|analgesics|mesh-ancestor
92896849|NCT02625506|Sensory System Agents|sensory system agents|mesh-ancestor
92896850|NCT02625506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896851|NCT02625506|Anesthetics, Local|anesthetics, local|mesh-ancestor
92896852|NCT02625506|Anesthetics|anesthetics|mesh-ancestor
92896853|NCT04209959|Nifekalant|nifekalant|mesh-list
92896854|NCT04209959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92896855|NCT04209803|Minoxidil|minoxidil|mesh-list
92896856|NCT04209803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92896857|NCT04209803|Vasodilator Agents|vasodilator agents|mesh-ancestor
92896858|NCT02567032|Oxytocin|oxytocin|mesh-list
92896859|NCT02567032|Oxytocics|oxytocics|mesh-ancestor
92896860|NCT02567032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92896861|NCT02567032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896862|NCT00618059|Pilocarpine|pilocarpine|mesh-list
92896863|NCT00618059|Miotics|miotics|mesh-ancestor
92896864|NCT00618059|Autonomic Agents|autonomic agents|mesh-ancestor
92896865|NCT00618059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896866|NCT00618059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896867|NCT00618059|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92896868|NCT00618059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92896869|NCT00618059|Cholinergic Agents|cholinergic agents|mesh-ancestor
92896870|NCT00618059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896871|NCT00618059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896872|NCT00863304|Naproxen|naproxen|mesh-list
92896873|NCT00863304|Tanezumab|tanezumab|mesh-list
92896874|NCT00863304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92896875|NCT00863304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92896876|NCT00863304|Analgesics|analgesics|mesh-ancestor
92896877|NCT00863304|Sensory System Agents|sensory system agents|mesh-ancestor
92896878|NCT00863304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896879|NCT00863304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896880|NCT00863304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896881|NCT00863304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896882|NCT00863304|Gout Suppressants|gout suppressants|mesh-ancestor
92896883|NCT00863304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92896884|NCT00863304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896885|NCT00863304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896886|NCT00695110|Methyltestosterone|methyltestosterone|mesh-list
92896887|NCT00695110|Testosterone|testosterone|mesh-list
92896888|NCT00695110|Testosterone undecanoate|testosterone undecanoate|mesh-list
92896889|NCT00695110|Testosterone enanthate|testosterone enanthate|mesh-list
92896890|NCT00695110|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92896891|NCT00695110|Androgens|androgens|mesh-ancestor
92896892|NCT00695110|Hormones|hormones|mesh-ancestor
92896893|NCT00695110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896894|NCT00695110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896895|NCT00695110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92896896|NCT00695110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896897|NCT00695110|Anabolic Agents|anabolic agents|mesh-ancestor
92896898|NCT03374332|Gemtuzumab|gemtuzumab|mesh-list
92896899|NCT03374332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896900|NCT03374332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896901|NCT03374332|Immunotoxins|immunotoxins|mesh-ancestor
92896902|NCT03374332|Immunoconjugates|immunoconjugates|mesh-ancestor
92896903|NCT03374332|Immunologic Factors|immunologic factors|mesh-ancestor
92896904|NCT03374332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896905|NCT03264352|Amlodipine|amlodipine|mesh-list
92896906|NCT03264352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92896907|NCT03264352|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92896908|NCT03264352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92896909|NCT03264352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896910|NCT03264352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92896911|NCT03264352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896912|NCT03264352|Vasodilator Agents|vasodilator agents|mesh-ancestor
92896913|NCT04897919|Lumefantrine|lumefantrine|mesh-list
92896914|NCT04897919|Artemether|artemether|mesh-list
92896915|NCT04897919|Piperaquine|piperaquine|mesh-list
92896916|NCT04897919|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92896917|NCT04897919|Artenimol|artenimol|mesh-list
92896918|NCT04897919|Antimalarials|antimalarials|mesh-ancestor
92896919|NCT04897919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92896920|NCT04897919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92896921|NCT04897919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92896922|NCT00594386|Rotigotine|rotigotine|mesh-list
92896923|NCT00594386|Dopamine Agonists|dopamine agonists|mesh-ancestor
92896924|NCT00594386|Dopamine Agents|dopamine agents|mesh-ancestor
92896925|NCT00594386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896926|NCT00594386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896927|NCT00594386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896928|NCT04857671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92896929|NCT04857671|Botulinum Toxins|botulinum toxins|mesh-list
92896930|NCT04857671|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92896931|NCT04857671|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92896932|NCT04857671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92896933|NCT04857671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92896934|NCT04857671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896935|NCT04857671|Cholinergic Agents|cholinergic agents|mesh-ancestor
92896936|NCT04857671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92896937|NCT04857671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896938|NCT04857671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92896939|NCT04857671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92896940|NCT03466450|Temozolomide|temozolomide|mesh-list
92896941|NCT03466450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92896942|NCT03466450|Alkylating Agents|alkylating agents|mesh-ancestor
92896943|NCT03466450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896944|NCT03466450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896945|NCT00690560|Prednisone|prednisone|mesh-list
92896946|NCT00690560|Cyclophosphamide|cyclophosphamide|mesh-list
92896947|NCT00690560|Rituximab|rituximab|mesh-list
92896948|NCT00690560|Doxorubicin|doxorubicin|mesh-list
92896949|NCT00690560|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92896950|NCT00690560|Vincristine|vincristine|mesh-list
92896951|NCT00690560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92896952|NCT00690560|Immunologic Factors|immunologic factors|mesh-ancestor
92896953|NCT00690560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896954|NCT00690560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92896955|NCT00690560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92896956|NCT00690560|Alkylating Agents|alkylating agents|mesh-ancestor
92896957|NCT00690560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896958|NCT00690560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92896959|NCT00690560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92896960|NCT00690560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92896961|NCT00690560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92896962|NCT00690560|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92896963|NCT00690560|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92896964|NCT00690560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92896965|NCT00690560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92896966|NCT00690560|Glucocorticoids|glucocorticoids|mesh-ancestor
92896967|NCT00690560|Hormones|hormones|mesh-ancestor
92896968|NCT00690560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92896969|NCT00690560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92525740|NCT00026143|Interferon alpha-2|interferon alpha-2|mesh-list
92896970|NCT00690560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92896971|NCT00690560|Tubulin Modulators|tubulin modulators|mesh-ancestor
92896972|NCT00690560|Antimitotic Agents|antimitotic agents|mesh-ancestor
92896973|NCT00690560|Mitosis Modulators|mitosis modulators|mesh-ancestor
92896974|NCT00742690|Terlipressin|terlipressin|mesh-list
92896975|NCT00742690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92896976|NCT00742690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92896977|NCT00742768|Vitamins|vitamins|mesh-list
92896978|NCT00742768|Vitamin K|vitamin k|mesh-list
92896979|NCT00742768|Vitamin K 2|vitamin k 2|mesh-list
92896980|NCT00742768|Micronutrients|micronutrients|mesh-ancestor
92896981|NCT00742768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896982|NCT00742768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92896983|NCT00742768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92896984|NCT00742768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92896985|NCT00742768|Hemostatics|hemostatics|mesh-ancestor
92896986|NCT00742768|Coagulants|coagulants|mesh-ancestor
92896987|NCT00862992|Cariprazine|cariprazine|mesh-list
92896988|NCT00862992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92896989|NCT00862992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92896990|NCT00862992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92896991|NCT00862992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92896992|NCT00862992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92896993|NCT02565316|Sertraline|sertraline|mesh-list
92896994|NCT02565316|Antidepressive Agents|antidepressive agents|mesh-ancestor
92896995|NCT02565316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92896996|NCT02565316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92896997|NCT02565316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92896998|NCT02565316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92896999|NCT02565316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897000|NCT02565316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897001|NCT02565316|Serotonin Agents|serotonin agents|mesh-ancestor
92897002|NCT02565316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897003|NCT00742846|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92897004|NCT00742846|Triamcinolone|triamcinolone|mesh-list
92897005|NCT00742846|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92897006|NCT00742846|Lidocaine|lidocaine|mesh-list
92897007|NCT00742846|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92897008|NCT00742846|Anesthetics, Local|anesthetics, local|mesh-ancestor
92897009|NCT00742846|Anesthetics|anesthetics|mesh-ancestor
92897010|NCT00742846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897011|NCT00742846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897012|NCT00742846|Sensory System Agents|sensory system agents|mesh-ancestor
92897013|NCT00742846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897014|NCT00742846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92897015|NCT00742846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92897016|NCT00742846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92897017|NCT00742846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897018|NCT00742846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897019|NCT00742846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897020|NCT00742846|Glucocorticoids|glucocorticoids|mesh-ancestor
92897021|NCT00742846|Hormones|hormones|mesh-ancestor
92897022|NCT00742846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897023|NCT00742846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897024|NCT00742846|Immunologic Factors|immunologic factors|mesh-ancestor
92897025|NCT00742846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897026|NCT00690872|Carboplatin|carboplatin|mesh-list
92897027|NCT00690872|Gemcitabine|gemcitabine|mesh-list
92897028|NCT00690872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897029|NCT00690872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92897030|NCT00690872|Antimetabolites|antimetabolites|mesh-ancestor
92897031|NCT00690872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897032|NCT00694096|Sunitinib|sunitinib|mesh-list
92897033|NCT00694096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897034|NCT00694096|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92897035|NCT00694096|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92897036|NCT00694096|Growth Substances|growth substances|mesh-ancestor
92897037|NCT00694096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897038|NCT00694096|Growth Inhibitors|growth inhibitors|mesh-ancestor
92897039|NCT00694096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897040|NCT00694096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897041|NCT00694096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897042|NCT04808531|Oxycodone|oxycodone|mesh-list
92897043|NCT04808531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92897044|NCT04808531|Narcotics|narcotics|mesh-ancestor
92897045|NCT04808531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897046|NCT04808531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897047|NCT04808531|Analgesics|analgesics|mesh-ancestor
92897048|NCT04808531|Sensory System Agents|sensory system agents|mesh-ancestor
92897049|NCT04808531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897050|NCT00690950|Dutasteride|dutasteride|mesh-list
92897051|NCT00690950|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92897052|NCT00690950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92897053|NCT00690950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897054|NCT00690950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897055|NCT00690950|Hormone Antagonists|hormone antagonists|mesh-ancestor
92897056|NCT00690950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897057|NCT00690950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897058|NCT02622126|Atropine|atropine|mesh-list
92897059|NCT02622126|Ephedrine|ephedrine|mesh-list
92897060|NCT02622126|Morphine|morphine|mesh-list
92897061|NCT02622126|Bupivacaine|bupivacaine|mesh-list
92897062|NCT02622126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92897063|NCT02622126|Anesthetics|anesthetics|mesh-ancestor
92897064|NCT02622126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897065|NCT02622126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897066|NCT02622126|Sensory System Agents|sensory system agents|mesh-ancestor
92897067|NCT02622126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897068|NCT02622126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92897069|NCT02622126|Narcotics|narcotics|mesh-ancestor
92897070|NCT02622126|Analgesics|analgesics|mesh-ancestor
92897071|NCT02622126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92897072|NCT02622126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92897073|NCT02622126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92897074|NCT02622126|Autonomic Agents|autonomic agents|mesh-ancestor
92897075|NCT02622126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92897076|NCT02622126|Respiratory System Agents|respiratory system agents|mesh-ancestor
92897077|NCT02622126|Mydriatics|mydriatics|mesh-ancestor
92897078|NCT02622126|Parasympatholytics|parasympatholytics|mesh-ancestor
92897079|NCT02622126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92897080|NCT02622126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92897081|NCT02622126|Cholinergic Agents|cholinergic agents|mesh-ancestor
92897082|NCT02622126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897083|NCT02622126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897084|NCT02622126|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92897085|NCT02622126|Sympathomimetics|sympathomimetics|mesh-ancestor
92897086|NCT02622126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92897087|NCT02622126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897088|NCT04140188|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
92897089|NCT04140188|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92897090|NCT04140188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897092|NCT00685568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92897093|NCT00685568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92897094|NCT00685568|Analgesics|analgesics|mesh-ancestor
92897095|NCT00685568|Sensory System Agents|sensory system agents|mesh-ancestor
92897096|NCT00685568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897097|NCT00685568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897098|NCT00685568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897099|NCT00685568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897100|NCT00685568|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92897101|NCT00685568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92897102|NCT00685568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897103|NCT00685568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897104|NCT02626208|ST 1435|st 1435|mesh-list
92897105|NCT02626208|Contraceptive Agents|contraceptive agents|mesh-list
92897106|NCT02626208|Estradiol|estradiol|mesh-list
92897107|NCT02626208|Estrogens|estrogens|mesh-ancestor
92897108|NCT02626208|Hormones|hormones|mesh-ancestor
92897109|NCT02626208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897110|NCT02626208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897111|NCT02626208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92897112|NCT02626208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92897113|NCT02626208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92897114|NCT04210739|Betamethasone|betamethasone|mesh-list
92897115|NCT04210739|Betamethasone Valerate|betamethasone valerate|mesh-list
92897116|NCT04210739|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92897117|NCT04210739|Betamethasone benzoate|betamethasone benzoate|mesh-list
92897118|NCT04210739|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92897119|NCT04210739|Glucocorticoids|glucocorticoids|mesh-ancestor
92897120|NCT04210739|Hormones|hormones|mesh-ancestor
92897121|NCT04210739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897122|NCT04210739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897123|NCT04210739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897124|NCT04210739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92897125|NCT04210739|Respiratory System Agents|respiratory system agents|mesh-ancestor
92897126|NCT00696540|Albuterol|albuterol|mesh-list
92897127|NCT00696540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92897128|NCT00696540|Autonomic Agents|autonomic agents|mesh-ancestor
92897129|NCT00696540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897130|NCT00696540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897131|NCT00696540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92897132|NCT00696540|Respiratory System Agents|respiratory system agents|mesh-ancestor
92897133|NCT00696540|Tocolytic Agents|tocolytic agents|mesh-ancestor
92897134|NCT00696540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92897135|NCT00696540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92897136|NCT00696540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92897137|NCT00696540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92897138|NCT00696540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897139|NCT00696540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897140|NCT00696540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897141|NCT04212845|Dexamethasone|dexamethasone|mesh-list
92897142|NCT04212845|Bupivacaine|bupivacaine|mesh-list
92897143|NCT04212845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897144|NCT04212845|Antiemetics|antiemetics|mesh-ancestor
92897145|NCT04212845|Autonomic Agents|autonomic agents|mesh-ancestor
92897146|NCT04212845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897147|NCT04212845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897148|NCT04212845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897149|NCT04212845|Glucocorticoids|glucocorticoids|mesh-ancestor
92897150|NCT04212845|Hormones|hormones|mesh-ancestor
92897151|NCT04212845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897152|NCT04212845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92897153|NCT04212845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897154|NCT04212845|Anesthetics, Local|anesthetics, local|mesh-ancestor
92897155|NCT04212845|Anesthetics|anesthetics|mesh-ancestor
92897156|NCT04212845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897157|NCT04212845|Sensory System Agents|sensory system agents|mesh-ancestor
92897158|NCT00620165|Levetiracetam|levetiracetam|mesh-list
92897159|NCT00620165|Anticonvulsants|anticonvulsants|mesh-ancestor
92897160|NCT00620165|Nootropic Agents|nootropic agents|mesh-ancestor
92897161|NCT00685646|Zoledronic Acid|zoledronic acid|mesh-list
92897162|NCT00685646|Androgen Antagonists|androgen antagonists|mesh-list
92897163|NCT00685646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92897164|NCT00685646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897165|NCT00685646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92897166|NCT00685646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897167|NCT00685958|Enoxaparin|enoxaparin|mesh-list
92897168|NCT00685958|Anticoagulants|anticoagulants|mesh-ancestor
92897169|NCT00685958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92897170|NCT00685958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92897171|NCT00685958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897172|NCT04138472|Lidocaine|lidocaine|mesh-list
92897173|NCT04138472|Fentanyl|fentanyl|mesh-list
92897174|NCT04138472|Dexmedetomidine|dexmedetomidine|mesh-list
92897175|NCT04138472|Anesthetics, Local|anesthetics, local|mesh-ancestor
92897176|NCT04138472|Anesthetics|anesthetics|mesh-ancestor
92897177|NCT04138472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897178|NCT04138472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897179|NCT04138472|Sensory System Agents|sensory system agents|mesh-ancestor
92897180|NCT04138472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897181|NCT04138472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92897182|NCT04138472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92897183|NCT04138472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92897184|NCT04138472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897185|NCT04138472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897186|NCT04138472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92897187|NCT04138472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92897188|NCT04138472|Analgesics|analgesics|mesh-ancestor
92897189|NCT04138472|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92897190|NCT04138472|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92897191|NCT04138472|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92897192|NCT04138472|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897193|NCT04138472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897194|NCT04138472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92897195|NCT04138472|Narcotics|narcotics|mesh-ancestor
92897196|NCT04138472|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92897197|NCT04138472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92897198|NCT04138472|Anesthetics, General|anesthetics, general|mesh-ancestor
92897199|NCT00620789|Dexetimide|dexetimide|mesh-list
92897200|NCT00620789|Citalopram|citalopram|mesh-list
92897201|NCT00620789|Antidepressive Agents|antidepressive agents|mesh-list
92897202|NCT00620789|Escitalopram|escitalopram|mesh-list
92897203|NCT00620789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92897204|NCT00620789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92897205|NCT00620789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897206|NCT00620789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897207|NCT00620789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897208|NCT00620789|Serotonin Agents|serotonin agents|mesh-ancestor
92897209|NCT00620789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897210|NCT00620789|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92897211|NCT00620789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92897212|NCT00620789|Parasympatholytics|parasympatholytics|mesh-ancestor
92897213|NCT00620789|Autonomic Agents|autonomic agents|mesh-ancestor
92897214|NCT00620789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897215|NCT00620789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92897216|NCT00620789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92897217|NCT00620789|Cholinergic Agents|cholinergic agents|mesh-ancestor
92897218|NCT00620789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92897219|NCT00620789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92897220|NCT00691184|Terbinafine|terbinafine|mesh-list
92897221|NCT00691184|Antifungal Agents|antifungal agents|mesh-ancestor
92897222|NCT00691184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897223|NCT00691184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897224|NCT00691184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897225|NCT00854100|Cariprazine|cariprazine|mesh-list
92897226|NCT00854100|Antidepressive Agents|antidepressive agents|mesh-list
92897227|NCT00854100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92897228|NCT00854100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92897229|NCT00854100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92897230|NCT00854100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897231|NCT00854100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897232|NCT00691262|Tacrolimus|tacrolimus|mesh-list
92897233|NCT00691262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897234|NCT00691262|Immunologic Factors|immunologic factors|mesh-ancestor
92897235|NCT00691262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897236|NCT00691262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92897237|NCT00691262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897238|NCT00691262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897239|NCT00620867|Ibuprofen|ibuprofen|mesh-list
92897240|NCT00620867|Celecoxib|celecoxib|mesh-list
92897241|NCT00620867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92897242|NCT00620867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92897243|NCT00620867|Analgesics|analgesics|mesh-ancestor
92897244|NCT00620867|Sensory System Agents|sensory system agents|mesh-ancestor
92897245|NCT00620867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897246|NCT00620867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897247|NCT00620867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897248|NCT00620867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897249|NCT00620867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92897250|NCT00620867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897251|NCT00620867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897252|NCT00620867|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92897253|NCT04271917|Acetaminophen|acetaminophen|mesh-list
92897254|NCT04271917|Ibuprofen|ibuprofen|mesh-list
92897255|NCT04271917|Cannabidiol|cannabidiol|mesh-list
92897256|NCT04271917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92897257|NCT04271917|Analgesics|analgesics|mesh-ancestor
92897258|NCT04271917|Sensory System Agents|sensory system agents|mesh-ancestor
92897259|NCT04271917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897260|NCT04271917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897261|NCT04271917|Antipyretics|antipyretics|mesh-ancestor
92897262|NCT04271917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92897263|NCT04271917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897264|NCT04271917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897265|NCT04271917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92897266|NCT04271917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897267|NCT04271917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897268|NCT04271917|Anticonvulsants|anticonvulsants|mesh-ancestor
92897269|NCT04122222|Vaccines|vaccines|mesh-list
92897270|NCT04122222|Immunologic Factors|immunologic factors|mesh-ancestor
92897271|NCT04122222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897272|NCT00686114|Paclitaxel|paclitaxel|mesh-list
92897273|NCT00686114|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92897274|NCT00686114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92897275|NCT00686114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897276|NCT00686114|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897277|NCT00686114|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897278|NCT00686114|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897279|NCT00686114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897280|NCT00686114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897281|NCT00686114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897282|NCT01015729|Esomeprazole|esomeprazole|mesh-list
92897283|NCT01015729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897284|NCT01015729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897285|NCT01015729|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92897286|NCT01015729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897287|NCT01015729|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92897288|NCT00698724|Prednisolone acetate|prednisolone acetate|mesh-list
92897289|NCT00698724|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92897290|NCT00698724|Methylprednisolone|methylprednisolone|mesh-list
92897291|NCT00698724|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92897292|NCT00698724|Prednisolone|prednisolone|mesh-list
92897294|NCT00698724|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92897295|NCT00698724|Prednisolone phosphate|prednisolone phosphate|mesh-list
92897296|NCT00698724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897297|NCT00698724|Antiemetics|antiemetics|mesh-ancestor
92897298|NCT00698724|Autonomic Agents|autonomic agents|mesh-ancestor
92897299|NCT00698724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897300|NCT00698724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897301|NCT00698724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897302|NCT00698724|Glucocorticoids|glucocorticoids|mesh-ancestor
92897303|NCT00698724|Hormones|hormones|mesh-ancestor
92897304|NCT00698724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897305|NCT00698724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92897306|NCT00698724|Protective Agents|protective agents|mesh-ancestor
92897307|NCT00698724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92897308|NCT00698724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897309|NCT00698724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92897310|NCT00698724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92897311|NCT00698724|Analgesics|analgesics|mesh-ancestor
92897312|NCT00698724|Sensory System Agents|sensory system agents|mesh-ancestor
92897313|NCT00698724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897314|NCT00686192|Calcium Carbonate|calcium carbonate|mesh-list
92897315|NCT00686192|Calcium|calcium|mesh-list
92897316|NCT00686192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92897317|NCT00686192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897318|NCT00686192|Antacids|antacids|mesh-ancestor
92897319|NCT00686192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897320|NCT00686192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897321|NCT04117776|Chlorhexidine|chlorhexidine|mesh-list
92897322|NCT04117776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92897323|NCT04117776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92897324|NCT04117776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897325|NCT04117776|Disinfectants|disinfectants|mesh-ancestor
92897326|NCT04117776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92897327|NCT00922610|Epoetin Alfa|epoetin alfa|mesh-list
92897328|NCT00922610|Hematinics|hematinics|mesh-ancestor
92897329|NCT04117698|Ethambutol|ethambutol|mesh-list
92897330|NCT04117698|Antitubercular Agents|antitubercular agents|mesh-ancestor
92897331|NCT04117698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92897332|NCT04117698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897333|NCT04118322|Peppermint oil|peppermint oil|mesh-list
92897334|NCT04118322|Antiemetics|antiemetics|mesh-ancestor
92897335|NCT04118322|Autonomic Agents|autonomic agents|mesh-ancestor
92897336|NCT04118322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897337|NCT04118322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897338|NCT04118322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897339|NCT04118322|Parasympatholytics|parasympatholytics|mesh-ancestor
92897340|NCT00698802|Insulin|insulin|mesh-list
92897341|NCT00698802|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92897342|NCT00698802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92897343|NCT00698802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897344|NCT00621647|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92897345|NCT00621647|Antidepressive Agents|antidepressive agents|mesh-ancestor
92897346|NCT00621647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92897347|NCT00621647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92897348|NCT00621647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92897349|NCT00621647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897350|NCT00621647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897351|NCT02621970|Cisplatin|cisplatin|mesh-list
92897352|NCT02621970|Docetaxel|docetaxel|mesh-list
92897353|NCT02621970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897354|NCT02621970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897355|NCT02621970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897356|NCT02621970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897357|NCT02621970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897358|NCT00820755|Cetuximab|cetuximab|mesh-list
92897359|NCT00820755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92897360|NCT00820755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542719|NCT00026637|Sertraline|sertraline|mesh-list
92897361|NCT00700128|Frovatriptan|frovatriptan|mesh-list
92897362|NCT00700128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92897363|NCT00700128|Serotonin Agents|serotonin agents|mesh-ancestor
92897364|NCT00700128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897365|NCT00700128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897366|NCT00700128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897367|NCT04662515|Warfarin|warfarin|mesh-list
92897368|NCT04662515|Rivaroxaban|rivaroxaban|mesh-list
92897369|NCT04662515|Dabigatran|dabigatran|mesh-list
92897370|NCT04662515|Apixaban|apixaban|mesh-list
92897371|NCT04662515|Edoxaban|edoxaban|mesh-list
92897372|NCT04662515|Anticoagulants|anticoagulants|mesh-ancestor
92897373|NCT04662515|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92897374|NCT04662515|Antithrombins|antithrombins|mesh-ancestor
92897375|NCT04662515|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92897376|NCT04662515|Protease Inhibitors|protease inhibitors|mesh-ancestor
92897377|NCT04662515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897378|NCT04662515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897379|NCT04660097|Etoposide|etoposide|mesh-list
92897380|NCT04660097|Etoposide phosphate|etoposide phosphate|mesh-list
92897381|NCT04660097|Durvalumab|durvalumab|mesh-list
92897382|NCT04660097|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92897383|NCT04660097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92897384|NCT04660097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897385|NCT04660097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92897386|NCT04660097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92897387|NCT04660097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897388|NCT04660097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897389|NCT04660097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92897390|NCT04660097|Immunologic Factors|immunologic factors|mesh-ancestor
92897391|NCT04660097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897392|NCT00621101|Sirolimus|sirolimus|mesh-list
92897393|NCT00621101|Temsirolimus|temsirolimus|mesh-list
92897394|NCT00621101|MTOR Inhibitors|mtor inhibitors|mesh-list
92897395|NCT00621101|Ezetimibe|ezetimibe|mesh-list
92897396|NCT00621101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92897397|NCT00621101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897398|NCT00621101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92897399|NCT00621101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897400|NCT00621101|Antifungal Agents|antifungal agents|mesh-ancestor
92897401|NCT00621101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897402|NCT00621101|Immunologic Factors|immunologic factors|mesh-ancestor
92897403|NCT00621101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897404|NCT00621101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897405|NCT00621101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897406|NCT00621101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897407|NCT00621101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92897408|NCT00621101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92897409|NCT00621101|Antimetabolites|antimetabolites|mesh-ancestor
92897410|NCT00621101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92897411|NCT00709215|Cordycepin|cordycepin|mesh-list
92897412|NCT00709215|Pentostatin|pentostatin|mesh-list
92897413|NCT00709215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897414|NCT00709215|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92897415|NCT00709215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897416|NCT00709215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897417|NCT00709215|Antifungal Agents|antifungal agents|mesh-ancestor
92897418|NCT00709215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897419|NCT00699036|Metformin|metformin|mesh-list
92897420|NCT00699036|Rosiglitazone|rosiglitazone|mesh-list
92897421|NCT00699036|Losartan|losartan|mesh-list
92897422|NCT00699036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92897423|NCT00699036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897424|NCT00699036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92897425|NCT00699036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92897426|NCT00699036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92897427|NCT00699036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92897428|NCT00699036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897429|NCT00709293|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92897430|NCT00709293|Immunologic Factors|immunologic factors|mesh-ancestor
92897431|NCT00709293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897432|NCT00709293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897433|NCT00913497|Insulin|insulin|mesh-list
92897434|NCT00913497|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92897435|NCT00913497|Insulin Aspart|insulin aspart|mesh-list
92897436|NCT00913497|Insulin glulisine|insulin glulisine|mesh-list
92897437|NCT00913497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92897438|NCT00913497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542798|NCT04206488|Digoxin|digoxin|mesh-list
92897439|NCT00819741|Metformin|metformin|mesh-list
92897440|NCT00819741|Repaglinide|repaglinide|mesh-list
92897441|NCT00819741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92897442|NCT00819741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897443|NCT04208555|Terconazole|terconazole|mesh-list
92897444|NCT04208555|Antifungal Agents|antifungal agents|mesh-ancestor
92897445|NCT04208555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897446|NCT00621725|Cediranib|cediranib|mesh-list
92897447|NCT00621725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897448|NCT00621725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897449|NCT00621725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897450|NCT00621725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897451|NCT00862134|Docetaxel|docetaxel|mesh-list
92897452|NCT00862134|Lenograstim|lenograstim|mesh-list
92897453|NCT00862134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897454|NCT00862134|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897455|NCT00862134|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897456|NCT00862134|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897457|NCT00862134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897458|NCT00862134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92897459|NCT00862134|Immunologic Factors|immunologic factors|mesh-ancestor
92897460|NCT00862134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897461|NCT00700284|Dapivirine|dapivirine|mesh-list
92897462|NCT00700284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92897463|NCT00700284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92897464|NCT00700284|Antiviral Agents|antiviral agents|mesh-ancestor
92897465|NCT00700284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897466|NCT00618527|Interferons|interferons|mesh-list
92897467|NCT00618527|Interferon-beta|interferon-beta|mesh-list
92897468|NCT00618527|Interferon beta-1a|interferon beta-1a|mesh-list
92897469|NCT00618527|Mycophenolic Acid|mycophenolic acid|mesh-list
92897470|NCT00618527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897471|NCT00618527|Antiviral Agents|antiviral agents|mesh-ancestor
92897472|NCT00618527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897473|NCT00618527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92897474|NCT00618527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92897475|NCT00618527|Antitubercular Agents|antitubercular agents|mesh-ancestor
92897476|NCT00618527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92897477|NCT00618527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897478|NCT00618527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897479|NCT00618527|Immunologic Factors|immunologic factors|mesh-ancestor
92897480|NCT00618527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897481|NCT00618527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92897482|NCT02691533|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92897483|NCT02691533|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92897484|NCT02691533|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92897485|NCT02691533|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92897486|NCT00621881|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92897487|NCT00621881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92897488|NCT00621881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897489|NCT04115982|Cholecalciferol|cholecalciferol|mesh-list
92897490|NCT04115982|Vitamin D|vitamin d|mesh-list
92897491|NCT04115982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92897492|NCT04115982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897494|NCT04115982|Micronutrients|micronutrients|mesh-ancestor
92897495|NCT04115982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92897496|NCT00622037|Lubricant Eye Drops|lubricant eye drops|mesh-list
92897497|NCT00622037|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92897498|NCT00622037|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92897499|NCT01010581|Folic Acid|folic acid|mesh-list
92897500|NCT01010581|Methotrexate|methotrexate|mesh-list
92897501|NCT01010581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92897502|NCT01010581|Abortifacient Agents|abortifacient agents|mesh-ancestor
92897503|NCT01010581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92897504|NCT01010581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897505|NCT01010581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92897506|NCT01010581|Antimetabolites|antimetabolites|mesh-ancestor
92897507|NCT01010581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897508|NCT01010581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897509|NCT01010581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92897510|NCT01010581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897511|NCT01010581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92897512|NCT01010581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897513|NCT01010581|Immunologic Factors|immunologic factors|mesh-ancestor
92897514|NCT01010581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897515|NCT01010581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92897516|NCT01010581|Hematinics|hematinics|mesh-ancestor
92897517|NCT01010581|Vitamin B Complex|vitamin b complex|mesh-ancestor
92897518|NCT01010581|Vitamins|vitamins|mesh-ancestor
92897519|NCT01010581|Micronutrients|micronutrients|mesh-ancestor
92897520|NCT04382885|Cariprazine|cariprazine|mesh-list
92897521|NCT04382885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92897522|NCT04382885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92897523|NCT04382885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897524|NCT04382885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897525|NCT04382885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92897526|NCT04208945|Colistin|colistin|mesh-list
92897527|NCT04208945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92897528|NCT04208945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897529|NCT01016041|Paclitaxel|paclitaxel|mesh-list
92897530|NCT01016041|Everolimus|everolimus|mesh-list
92897531|NCT01016041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92897532|NCT01016041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897533|NCT01016041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897534|NCT01016041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897535|NCT01016041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897536|NCT01016041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897537|NCT01016041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92897538|NCT01016041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897539|NCT01016041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897540|NCT01016041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897541|NCT01016041|Immunologic Factors|immunologic factors|mesh-ancestor
92897542|NCT01016041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897543|NCT00622115|Enoxaparin|enoxaparin|mesh-list
92897544|NCT00622115|Anticoagulants|anticoagulants|mesh-ancestor
92897545|NCT00622115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92897546|NCT00622115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92897547|NCT00622115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897548|NCT02696837|Rocuronium|rocuronium|mesh-list
92897549|NCT02696837|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92897550|NCT02696837|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92897551|NCT02696837|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92897552|NCT02696837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897553|NCT02696837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897554|NCT00490555|Methyltestosterone|methyltestosterone|mesh-list
92897555|NCT00490555|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92897556|NCT00490555|Medroxyprogesterone|medroxyprogesterone|mesh-list
92897557|NCT00490555|Testosterone|testosterone|mesh-list
92897558|NCT00490555|Testosterone undecanoate|testosterone undecanoate|mesh-list
92897559|NCT00490555|Testosterone enanthate|testosterone enanthate|mesh-list
92897560|NCT00490555|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92897561|NCT00490555|Dutasteride|dutasteride|mesh-list
92897562|NCT00490555|Androgens|androgens|mesh-ancestor
92897563|NCT00490555|Hormones|hormones|mesh-ancestor
92897564|NCT00490555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897565|NCT00490555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525750|NCT00026143|Growth Substances|growth substances|mesh-ancestor
92897566|NCT00490555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92897567|NCT00490555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897569|NCT00490555|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92897570|NCT00490555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92897571|NCT00490555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897572|NCT00490555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897573|NCT00490555|Hormone Antagonists|hormone antagonists|mesh-ancestor
92897574|NCT00490555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92897575|NCT00490555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92897576|NCT00490555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92897577|NCT00490555|Contraceptive Agents|contraceptive agents|mesh-ancestor
92897578|NCT00490555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92897579|NCT00490555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92897580|NCT00490555|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92897581|NCT00490555|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92897582|NCT01014247|Moxifloxacin|moxifloxacin|mesh-list
92897583|NCT01014247|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92897584|NCT01014247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92897585|NCT01014247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897586|NCT01014247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92897587|NCT01014247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92897588|NCT01014247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897589|NCT01014247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897590|NCT01014247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542945|NCT00027963|Gabapentin|gabapentin|mesh-list
92897591|NCT01014247|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92897592|NCT01014247|Contraceptive Agents|contraceptive agents|mesh-ancestor
92897593|NCT01014247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92897594|NCT01014247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897595|NCT01014247|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92897596|NCT01014247|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92897597|NCT01014247|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92897598|NCT00049595|Prednisone|prednisone|mesh-list
92897599|NCT00049595|Cyclophosphamide|cyclophosphamide|mesh-list
92897600|NCT00049595|Dacarbazine|dacarbazine|mesh-list
92897601|NCT00049595|Doxorubicin|doxorubicin|mesh-list
92897602|NCT00049595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92897603|NCT00049595|Etoposide|etoposide|mesh-list
92897604|NCT00049595|Vincristine|vincristine|mesh-list
92897605|NCT00049595|Bleomycin|bleomycin|mesh-list
92897606|NCT00049595|Vinblastine|vinblastine|mesh-list
92897607|NCT00049595|Procarbazine|procarbazine|mesh-list
92897608|NCT00049595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897609|NCT00049595|Immunologic Factors|immunologic factors|mesh-ancestor
92897610|NCT00049595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897611|NCT00049595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897612|NCT00049595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92897613|NCT00049595|Alkylating Agents|alkylating agents|mesh-ancestor
92897614|NCT00049595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897615|NCT00049595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897616|NCT00049595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92897617|NCT00049595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92897618|NCT00049595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92897619|NCT00049595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92897620|NCT00049595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897621|NCT00049595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897622|NCT00049595|Glucocorticoids|glucocorticoids|mesh-ancestor
92897623|NCT00049595|Hormones|hormones|mesh-ancestor
92897624|NCT00049595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897625|NCT00049595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92897626|NCT00049595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92897627|NCT00049595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897628|NCT00049595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897629|NCT00049595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897630|NCT00873860|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92897631|NCT00873860|Immunologic Factors|immunologic factors|mesh-ancestor
92897632|NCT00873860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897633|NCT03854227|Docetaxel|docetaxel|mesh-list
92897634|NCT03854227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897635|NCT03854227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897636|NCT03854227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897637|NCT03854227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525752|NCT00026182|Rituximab|rituximab|mesh-list
92897638|NCT03854227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897639|NCT05368961|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
92897640|NCT05368961|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92897641|NCT05368961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897642|NCT05368961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897643|NCT05368961|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92897645|NCT02626754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897646|NCT02626754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92897647|NCT02626754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92897648|NCT02626754|Growth Substances|growth substances|mesh-ancestor
92897649|NCT02626754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897650|NCT02626754|Growth Inhibitors|growth inhibitors|mesh-ancestor
92897651|NCT02626754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897652|NCT02626754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897653|NCT02626754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897654|NCT00691886|Dexmedetomidine|dexmedetomidine|mesh-list
92897655|NCT00691886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92897656|NCT00691886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897657|NCT00691886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897658|NCT00691886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92897659|NCT00691886|Analgesics|analgesics|mesh-ancestor
92897660|NCT00691886|Sensory System Agents|sensory system agents|mesh-ancestor
92897661|NCT00691886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897662|NCT00691886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92897663|NCT00691886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92897664|NCT00691886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92543030|NCT00028314|Ritonavir|ritonavir|mesh-list
92897665|NCT00691886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897666|NCT00691886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897667|NCT00691886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897668|NCT04138004|Lubiprostone|lubiprostone|mesh-list
92897669|NCT04138004|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92897670|NCT04138004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897671|NCT04138004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897672|NCT00621491|Warfarin|warfarin|mesh-list
92897673|NCT00621491|Anticoagulants|anticoagulants|mesh-list
92897674|NCT00622349|Cisplatin|cisplatin|mesh-list
92897675|NCT00622349|Gemcitabine|gemcitabine|mesh-list
92897676|NCT00622349|Docetaxel|docetaxel|mesh-list
92897677|NCT00622349|Ifosfamide|ifosfamide|mesh-list
92897678|NCT00622349|Isophosphamide mustard|isophosphamide mustard|mesh-list
92897679|NCT00622349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897680|NCT00622349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92897681|NCT00622349|Antimetabolites|antimetabolites|mesh-ancestor
92897682|NCT00622349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897683|NCT00622349|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897684|NCT00622349|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897685|NCT00622349|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897686|NCT00622349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92897687|NCT00622349|Alkylating Agents|alkylating agents|mesh-ancestor
92897688|NCT00686816|Sucrose polyester|sucrose polyester|mesh-list
92897689|NCT00686816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92897690|NCT00686816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92897691|NCT00686816|Antimetabolites|antimetabolites|mesh-ancestor
92897692|NCT00686816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897693|NCT00686816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92897694|NCT05368181|Methylprednisolone|methylprednisolone|mesh-list
92897695|NCT05368181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92161206|NCT03482297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897696|NCT05368181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92897697|NCT05368181|Prednisolone|prednisolone|mesh-list
92897698|NCT05368181|Prednisolone acetate|prednisolone acetate|mesh-list
92897699|NCT05368181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92897700|NCT05368181|Prednisolone phosphate|prednisolone phosphate|mesh-list
92897701|NCT05368181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92897702|NCT05368181|Antiemetics|antiemetics|mesh-ancestor
92897703|NCT05368181|Autonomic Agents|autonomic agents|mesh-ancestor
92897704|NCT05368181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897705|NCT05368181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897706|NCT05368181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897707|NCT05368181|Glucocorticoids|glucocorticoids|mesh-ancestor
92897708|NCT05368181|Hormones|hormones|mesh-ancestor
92897709|NCT05368181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897710|NCT05368181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92897711|NCT05368181|Protective Agents|protective agents|mesh-ancestor
92897712|NCT05368181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92897713|NCT05368181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897715|NCT05662163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897716|NCT05662163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897717|NCT02666105|Exemestane|exemestane|mesh-list
92897718|NCT02666105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897719|NCT02666105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92897720|NCT02666105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92897721|NCT02666105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897722|NCT02666105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897723|NCT02666105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92897724|NCT02666105|Hormone Antagonists|hormone antagonists|mesh-ancestor
92897725|NCT02666105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92897726|NCT02666105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897727|NCT04138238|Sirolimus|sirolimus|mesh-list
92897728|NCT04138238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92897729|NCT04138238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897730|NCT04138238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92897731|NCT04138238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897732|NCT04138238|Antifungal Agents|antifungal agents|mesh-ancestor
92897733|NCT04138238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897734|NCT04138238|Immunologic Factors|immunologic factors|mesh-ancestor
92897735|NCT04138238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897736|NCT00622817|Epinephrine|epinephrine|mesh-list
92897737|NCT00622817|Xylometazoline|xylometazoline|mesh-list
92897738|NCT00622817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92897739|NCT00622817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92897740|NCT00622817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897741|NCT00622817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897742|NCT00622817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897743|NCT00622817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897744|NCT00622817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92897745|NCT00622817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92897746|NCT00622817|Autonomic Agents|autonomic agents|mesh-ancestor
92897747|NCT00622817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897748|NCT00622817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92897749|NCT00622817|Respiratory System Agents|respiratory system agents|mesh-ancestor
92897750|NCT00622817|Mydriatics|mydriatics|mesh-ancestor
92897751|NCT00622817|Sympathomimetics|sympathomimetics|mesh-ancestor
92897752|NCT00622817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92897753|NCT00622817|Nasal Decongestants|nasal decongestants|mesh-ancestor
92897754|NCT02432417|Chloroquine|chloroquine|mesh-list
92897755|NCT02432417|Amebicides|amebicides|mesh-ancestor
92897756|NCT02432417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92897757|NCT02432417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92897758|NCT02432417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897759|NCT02432417|Antimalarials|antimalarials|mesh-ancestor
92897760|NCT02432417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897761|NCT00692120|Vitamin D|vitamin d|mesh-list
92897762|NCT00692120|Ergocalciferols|ergocalciferols|mesh-list
92897763|NCT00692120|Cholecalciferol|cholecalciferol|mesh-list
92897764|NCT00692120|Vitamins|vitamins|mesh-list
92897765|NCT00692120|Micronutrients|micronutrients|mesh-ancestor
92897766|NCT00692120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897767|NCT00692120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92897768|NCT00692120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92897769|NCT00819585|Colchicine|colchicine|mesh-list
92897770|NCT00819585|Allopurinol|allopurinol|mesh-list
92897771|NCT00819585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92897772|NCT00819585|Gout Suppressants|gout suppressants|mesh-ancestor
92897773|NCT00819585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92897774|NCT00819585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92897775|NCT00819585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92897776|NCT00819585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92897777|NCT00819585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897778|NCT00819585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897779|NCT00819585|Antimetabolites|antimetabolites|mesh-ancestor
92897780|NCT00819585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897781|NCT00819585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92897782|NCT00819585|Antioxidants|antioxidants|mesh-ancestor
92897783|NCT00819585|Protective Agents|protective agents|mesh-ancestor
92897784|NCT00819585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897785|NCT00819585|Immunologic Factors|immunologic factors|mesh-ancestor
92897786|NCT00687206|Valsartan|valsartan|mesh-list
92897787|NCT00687206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92897788|NCT00687206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92897789|NCT00687206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92897790|NCT00687206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897791|NCT00687284|Insulin Detemir|insulin detemir|mesh-list
92897792|NCT00687284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92897793|NCT00687284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897794|NCT02358395|Sorafenib|sorafenib|mesh-list
92897795|NCT02358395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897796|NCT02358395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92897797|NCT02358395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897798|NCT02358395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897799|NCT00692354|Tosedostat|tosedostat|mesh-list
92897800|NCT00692354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897801|NCT00692354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897802|NCT03928847|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92897803|NCT03928847|Antioxidants|antioxidants|mesh-ancestor
92897804|NCT03928847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897805|NCT03928847|Protective Agents|protective agents|mesh-ancestor
92897806|NCT03928847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897807|NCT03928847|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92897808|NCT03928847|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92897809|NCT03928847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897810|NCT03928847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92897811|NCT02624726|Leucovorin|leucovorin|mesh-list
92897812|NCT02624726|Fluorouracil|fluorouracil|mesh-list
92897813|NCT02624726|Irinotecan|irinotecan|mesh-list
92897814|NCT02624726|Aflibercept|aflibercept|mesh-list
92897815|NCT02624726|Levoleucovorin|levoleucovorin|mesh-list
92897816|NCT02624726|Antimetabolites|antimetabolites|mesh-ancestor
92897817|NCT02624726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897818|NCT02624726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92897819|NCT02624726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92897820|NCT02624726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92897821|NCT02624726|Immunologic Factors|immunologic factors|mesh-ancestor
92897822|NCT02624726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897823|NCT02624726|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92897824|NCT02624726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92897825|NCT02624726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897826|NCT02624726|Antidotes|antidotes|mesh-ancestor
92897827|NCT02624726|Protective Agents|protective agents|mesh-ancestor
92897828|NCT02624726|Vitamin B Complex|vitamin b complex|mesh-ancestor
92897829|NCT02624726|Vitamins|vitamins|mesh-ancestor
92897830|NCT02624726|Micronutrients|micronutrients|mesh-ancestor
92897831|NCT02624726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92897832|NCT02624726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92897833|NCT02624726|Growth Substances|growth substances|mesh-ancestor
92897834|NCT02624726|Growth Inhibitors|growth inhibitors|mesh-ancestor
92897835|NCT00681746|Flumazenil|flumazenil|mesh-list
92897836|NCT00681746|Antidotes|antidotes|mesh-ancestor
92897837|NCT00681746|Protective Agents|protective agents|mesh-ancestor
92897838|NCT00681746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897839|NCT00681746|GABA Modulators|gaba modulators|mesh-ancestor
92897840|NCT00681746|GABA Agents|gaba agents|mesh-ancestor
92897841|NCT00681746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897842|NCT00681746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897843|NCT04265911|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92897844|NCT04265911|Immunologic Factors|immunologic factors|mesh-ancestor
92897845|NCT04265911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897846|NCT00819039|Ondansetron|ondansetron|mesh-list
92897847|NCT00819039|Aprepitant|aprepitant|mesh-list
92897848|NCT00819039|Antiemetics|antiemetics|mesh-ancestor
92897849|NCT00819039|Autonomic Agents|autonomic agents|mesh-ancestor
92897850|NCT00819039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897851|NCT00819039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897852|NCT00819039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897853|NCT00819039|Antipruritics|antipruritics|mesh-ancestor
92897854|NCT00819039|Dermatologic Agents|dermatologic agents|mesh-ancestor
92897855|NCT00819039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92897856|NCT00819039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92897857|NCT00819039|Serotonin Agents|serotonin agents|mesh-ancestor
92897858|NCT00819039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897859|NCT00819039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897860|NCT00819039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92897861|NCT00692510|Rosiglitazone|rosiglitazone|mesh-list
92897862|NCT00692510|Midazolam|midazolam|mesh-list
92897863|NCT00692510|Caffeine|caffeine|mesh-list
92897864|NCT00692510|Bupropion|bupropion|mesh-list
92897865|NCT00692510|Omeprazole|omeprazole|mesh-list
92897866|NCT00692510|Bilirubin|bilirubin|mesh-list
92897867|NCT00692510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92897868|NCT00692510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92897869|NCT00692510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897870|NCT00692510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897871|NCT00692510|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92897872|NCT00692510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92897873|NCT00692510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92897874|NCT00692510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92897875|NCT00692510|Anesthetics, General|anesthetics, general|mesh-ancestor
92897876|NCT00692510|Anesthetics|anesthetics|mesh-ancestor
92897877|NCT00692510|GABA Modulators|gaba modulators|mesh-ancestor
92897878|NCT00692510|GABA Agents|gaba agents|mesh-ancestor
92897879|NCT00692510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897880|NCT00692510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897881|NCT00692510|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92897882|NCT00692510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92897883|NCT00692510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897884|NCT00692510|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92897885|NCT00692510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92897886|NCT00692510|Purinergic Agents|purinergic agents|mesh-ancestor
92897887|NCT00692510|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92897888|NCT00692510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92897889|NCT00692510|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92897890|NCT00692510|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92897891|NCT00692510|Antidepressive Agents|antidepressive agents|mesh-ancestor
92897892|NCT00692510|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92897893|NCT00692510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92897894|NCT00692510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897895|NCT00692510|Dopamine Agents|dopamine agents|mesh-ancestor
92897896|NCT00692510|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92897897|NCT00692510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92897898|NCT00692510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92897900|NCT00692510|Protective Agents|protective agents|mesh-ancestor
92897901|NCT00500539|Omalizumab|omalizumab|mesh-list
92897902|NCT00500539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92897903|NCT00500539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92897904|NCT00500539|Respiratory System Agents|respiratory system agents|mesh-ancestor
92897905|NCT00687518|Epoetin Alfa|epoetin alfa|mesh-list
92897906|NCT00687518|Hematinics|hematinics|mesh-ancestor
92897907|NCT02303795|Warfarin|warfarin|mesh-list
92897908|NCT02303795|Rivaroxaban|rivaroxaban|mesh-list
92897909|NCT02303795|Anticoagulants|anticoagulants|mesh-ancestor
92897910|NCT02303795|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92897911|NCT02303795|Antithrombins|antithrombins|mesh-ancestor
92897912|NCT02303795|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92897913|NCT02303795|Protease Inhibitors|protease inhibitors|mesh-ancestor
92897914|NCT02303795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897915|NCT02303795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897916|NCT04187417|Tetracaine|tetracaine|mesh-list
92897917|NCT04187417|Anesthetics, Local|anesthetics, local|mesh-ancestor
92897918|NCT04187417|Anesthetics|anesthetics|mesh-ancestor
92897919|NCT04187417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897920|NCT04187417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897921|NCT04187417|Sensory System Agents|sensory system agents|mesh-ancestor
92897922|NCT04187417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92897923|NCT00818883|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92897924|NCT00818883|Chlorthalidone|chlorthalidone|mesh-list
92897925|NCT00818883|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92897926|NCT00818883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92897927|NCT00818883|Diuretics|diuretics|mesh-ancestor
92897928|NCT00818883|Natriuretic Agents|natriuretic agents|mesh-ancestor
92897929|NCT00818883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897930|NCT00818883|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92897931|NCT00818883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897932|NCT00818883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897933|NCT00818883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92897934|NCT00818883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92897935|NCT01014481|Tenofovir|tenofovir|mesh-list
92897936|NCT01014481|Lamivudine|lamivudine|mesh-list
92897937|NCT01014481|Efavirenz|efavirenz|mesh-list
92897938|NCT01014481|Antiviral Agents|antiviral agents|mesh-ancestor
92897939|NCT01014481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92897940|NCT01014481|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92897941|NCT01014481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92897942|NCT01014481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897943|NCT01014481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897944|NCT01014481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92897945|NCT01014481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92897946|NCT01014481|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92897947|NCT01014481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92897948|NCT01014481|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92897949|NCT01014481|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92897950|NCT01014481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92897951|NCT01014481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92897952|NCT02167763|Copper|copper|mesh-list
92897953|NCT02167763|Contraceptive Agents|contraceptive agents|mesh-list
92897954|NCT02167763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92897955|NCT02167763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897956|NCT02167763|Trace Elements|trace elements|mesh-ancestor
92897957|NCT02167763|Micronutrients|micronutrients|mesh-ancestor
92897958|NCT00508027|Simvastatin|simvastatin|mesh-list
92897959|NCT00508027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92897960|NCT00508027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92897961|NCT00508027|Antimetabolites|antimetabolites|mesh-ancestor
92897962|NCT00508027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897963|NCT00508027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92897964|NCT00508027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92897965|NCT00508027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92897966|NCT01986101|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92897967|NCT01986101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92897968|NCT01986101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92897969|NCT01986101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543324|NCT00030069|Calcitriol|calcitriol|mesh-list
92897970|NCT01986101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897972|NCT01986101|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92897973|NCT01986101|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92897974|NCT01986101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92897975|NCT01986101|Adrenergic Agents|adrenergic agents|mesh-ancestor
92897976|NCT01986101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897977|NCT01986101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897978|NCT01986101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92897979|NCT01986101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92897980|NCT01986101|Serotonin Agents|serotonin agents|mesh-ancestor
92897981|NCT01986101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92897982|NCT01986101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92897983|NCT01986101|Dopamine Agents|dopamine agents|mesh-ancestor
92897984|NCT00500149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92897985|NCT00500149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92161218|NCT00088829|Paclitaxel|paclitaxel|mesh-list
92897986|NCT00500149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897987|NCT00500149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92897988|NCT00500149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92897989|NCT00500149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92897990|NCT00500149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92897991|NCT00500149|Dopamine Agents|dopamine agents|mesh-ancestor
92897992|NCT00500149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92897993|NCT00681902|Lidocaine|lidocaine|mesh-list
92897994|NCT00681902|Anesthetics, Local|anesthetics, local|mesh-ancestor
92897995|NCT00681902|Anesthetics|anesthetics|mesh-ancestor
92897996|NCT00681902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92897997|NCT00681902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92897998|NCT00681902|Sensory System Agents|sensory system agents|mesh-ancestor
92897999|NCT00681902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898000|NCT00681902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92898001|NCT00681902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92898002|NCT00681902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92898003|NCT00681902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898004|NCT00681902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898005|NCT04185857|Olmesartan|olmesartan|mesh-list
92898006|NCT04185857|Canrenone|canrenone|mesh-list
92242781|NCT00777036|Dasatinib|dasatinib|mesh-list
92898007|NCT04185857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92898008|NCT04185857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92898009|NCT04185857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92898010|NCT04185857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898011|NCT04185857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92898012|NCT04185857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92898013|NCT04185857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898014|NCT04185857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898015|NCT04185857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92898016|NCT04185857|Diuretics|diuretics|mesh-ancestor
92898017|NCT04185857|Natriuretic Agents|natriuretic agents|mesh-ancestor
92898018|NCT01016509|Insulin|insulin|mesh-list
92898019|NCT01016509|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92898020|NCT01016509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92898021|NCT01016509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898022|NCT00639119|Ropinirole|ropinirole|mesh-list
92898023|NCT00639119|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92898024|NCT00639119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92898025|NCT00639119|Dopamine Agonists|dopamine agonists|mesh-ancestor
92898026|NCT00639119|Dopamine Agents|dopamine agents|mesh-ancestor
92898027|NCT00639119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898028|NCT00639119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898029|NCT00639119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898030|NCT01010893|Vaccines|vaccines|mesh-list
92898031|NCT01010893|Immunologic Factors|immunologic factors|mesh-ancestor
92898032|NCT01010893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898033|NCT01011127|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92898034|NCT01011127|Pravastatin|pravastatin|mesh-list
92898035|NCT01011127|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92898036|NCT01011127|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92898037|NCT01011127|Antimetabolites|antimetabolites|mesh-ancestor
92898038|NCT01011127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898039|NCT01011127|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92543398|NCT00030498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898040|NCT01011127|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92898041|NCT01011127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898042|NCT00912548|Tamoxifen|tamoxifen|mesh-list
92898043|NCT00912548|Goserelin|goserelin|mesh-list
92898044|NCT00912548|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92898045|NCT00912548|Hormone Antagonists|hormone antagonists|mesh-ancestor
92898046|NCT00912548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898047|NCT00912548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898048|NCT00912548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92898049|NCT00912548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898050|NCT00912548|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92898051|NCT00912548|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92898052|NCT00912548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92898053|NCT01016665|Anastrozole|anastrozole|mesh-list
92898054|NCT01016665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92898055|NCT01016665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898056|NCT01016665|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92898057|NCT01016665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92898058|NCT01016665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898059|NCT01016665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898060|NCT01016665|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92898061|NCT01016665|Hormone Antagonists|hormone antagonists|mesh-ancestor
92898062|NCT01016665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898063|NCT01016665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898064|NCT00681980|Valproic Acid|valproic acid|mesh-list
92898065|NCT00681980|Anticonvulsants|anticonvulsants|mesh-ancestor
92898066|NCT00681980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898067|NCT00681980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898068|NCT00681980|GABA Agents|gaba agents|mesh-ancestor
92898069|NCT00681980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898070|NCT00681980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898071|NCT00681980|Antimanic Agents|antimanic agents|mesh-ancestor
92898072|NCT00681980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92898073|NCT00681980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898074|NCT00681980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898075|NCT00692900|Docetaxel|docetaxel|mesh-list
92898076|NCT00692900|Oxaliplatin|oxaliplatin|mesh-list
92898077|NCT00692900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898078|NCT00692900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898079|NCT00692900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898080|NCT00692900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898081|NCT00692900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898082|NCT03800381|Rifampin|rifampin|mesh-list
92898083|NCT03800381|Isoniazid|isoniazid|mesh-list
92898084|NCT03800381|Pyrazinamide|pyrazinamide|mesh-list
92898085|NCT03800381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92898086|NCT03800381|Antitubercular Agents|antitubercular agents|mesh-ancestor
92898087|NCT03800381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898088|NCT03800381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898089|NCT03800381|Leprostatic Agents|leprostatic agents|mesh-ancestor
92898090|NCT03800381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92898091|NCT03800381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898092|NCT03800381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898093|NCT03800381|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92898094|NCT03800381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92898095|NCT03800381|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92898096|NCT03800381|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92898097|NCT03800381|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92898098|NCT03800381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92898099|NCT03800381|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92898100|NCT03800381|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92898101|NCT03800381|Antimetabolites|antimetabolites|mesh-ancestor
92898102|NCT03800381|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92898103|NCT00489853|Budesonide|budesonide|mesh-list
92898104|NCT00489853|Formoterol Fumarate|formoterol fumarate|mesh-list
92898105|NCT00489853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898106|NCT00489853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92898107|NCT00489853|Autonomic Agents|autonomic agents|mesh-ancestor
92898108|NCT00489853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898109|NCT00489853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898110|NCT00489853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92898111|NCT00489853|Respiratory System Agents|respiratory system agents|mesh-ancestor
92898112|NCT00489853|Glucocorticoids|glucocorticoids|mesh-ancestor
92898113|NCT00489853|Hormones|hormones|mesh-ancestor
92898114|NCT00489853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898115|NCT00489853|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92898116|NCT00489853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92898117|NCT00489853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92898118|NCT00489853|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898119|NCT00489853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898120|NCT00489853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898121|NCT00682136|Ropivacaine|ropivacaine|mesh-list
92898122|NCT00682136|Anesthetics, Local|anesthetics, local|mesh-ancestor
92898123|NCT00682136|Anesthetics|anesthetics|mesh-ancestor
92898124|NCT00682136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898125|NCT00682136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898126|NCT00682136|Sensory System Agents|sensory system agents|mesh-ancestor
92898127|NCT00682136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898128|NCT00693056|beta-Lactams|beta-lactams|mesh-list
92898129|NCT00693056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898130|NCT00693056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898131|NCT04137302|Hydrocortisone|hydrocortisone|mesh-list
92898132|NCT04137302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898133|NCT04145336|Indomethacin|indomethacin|mesh-list
92898134|NCT04145336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92898135|NCT04145336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92898136|NCT04145336|Analgesics|analgesics|mesh-ancestor
92898137|NCT04145336|Sensory System Agents|sensory system agents|mesh-ancestor
92898138|NCT04145336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898139|NCT04145336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898140|NCT04145336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898141|NCT04145336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92898142|NCT04145336|Gout Suppressants|gout suppressants|mesh-ancestor
92898143|NCT04145336|Tocolytic Agents|tocolytic agents|mesh-ancestor
92898144|NCT04145336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92898145|NCT04145336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92898146|NCT04145336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898147|NCT04145336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898149|NCT00499681|Lapatinib|lapatinib|mesh-list
92898150|NCT00499681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898151|NCT00499681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92898152|NCT00499681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92898153|NCT00499681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898154|NCT00499681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898155|NCT00499681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92898156|NCT00499681|Hormone Antagonists|hormone antagonists|mesh-ancestor
92898157|NCT00499681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898158|NCT00499681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898159|NCT00499681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898160|NCT02687009|Niclosamide|niclosamide|mesh-list
92898161|NCT02687009|Anticestodal Agents|anticestodal agents|mesh-ancestor
92898162|NCT02687009|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92898163|NCT02687009|Anthelmintics|anthelmintics|mesh-ancestor
92898164|NCT02687009|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92898165|NCT02687009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898166|NCT02687009|Antinematodal Agents|antinematodal agents|mesh-ancestor
92898167|NCT00693212|Methylphenidate|methylphenidate|mesh-list
92898168|NCT00693212|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92898169|NCT00693212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898170|NCT00693212|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92898171|NCT00693212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92898172|NCT00693212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898173|NCT00693212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898174|NCT00693212|Dopamine Agents|dopamine agents|mesh-ancestor
92898175|NCT00693212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898176|NCT00688298|Imidacloprid|imidacloprid|mesh-list
92898177|NCT00688298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92898178|NCT00688298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898179|NCT00688298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898180|NCT00688298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898181|NCT00499603|Paclitaxel|paclitaxel|mesh-list
92898182|NCT00499603|Cyclophosphamide|cyclophosphamide|mesh-list
92898183|NCT00499603|Fluorouracil|fluorouracil|mesh-list
92898184|NCT00499603|Epirubicin|epirubicin|mesh-list
92898185|NCT00499603|Everolimus|everolimus|mesh-list
92898186|NCT00499603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543593|NCT00392912|Hormones|hormones|mesh-ancestor
92898187|NCT00499603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898188|NCT00499603|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898189|NCT00499603|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898190|NCT00499603|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898191|NCT00499603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898192|NCT00499603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898193|NCT00499603|Immunologic Factors|immunologic factors|mesh-ancestor
92898194|NCT00499603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898195|NCT00499603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92898196|NCT00499603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92898197|NCT00499603|Alkylating Agents|alkylating agents|mesh-ancestor
92898198|NCT00499603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92898199|NCT00499603|Antimetabolites|antimetabolites|mesh-ancestor
92898200|NCT00499603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92898201|NCT00499603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92898202|NCT00499603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92898203|NCT00499603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92898204|NCT00499603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898205|NCT00499603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92898206|NCT00499603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898207|NCT01946711|Budesonide|budesonide|mesh-list
92898208|NCT01946711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898209|NCT01946711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92898210|NCT01946711|Autonomic Agents|autonomic agents|mesh-ancestor
92898211|NCT01946711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898212|NCT01946711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898213|NCT01946711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92898214|NCT01946711|Respiratory System Agents|respiratory system agents|mesh-ancestor
92898215|NCT01946711|Glucocorticoids|glucocorticoids|mesh-ancestor
92898216|NCT01946711|Hormones|hormones|mesh-ancestor
92898217|NCT01946711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898218|NCT00693446|Sirolimus|sirolimus|mesh-list
92898219|NCT00693446|Tacrolimus|tacrolimus|mesh-list
92898220|NCT00693446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898221|NCT00693446|Immunologic Factors|immunologic factors|mesh-ancestor
92898222|NCT00693446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898223|NCT00693446|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92898224|NCT00693446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898225|NCT00693446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898226|NCT00693446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898227|NCT00693446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898228|NCT00693446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92898229|NCT00693446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898230|NCT00693446|Antifungal Agents|antifungal agents|mesh-ancestor
92898232|NCT00693524|Prednisone|prednisone|mesh-list
92898233|NCT00693524|Tacrolimus|tacrolimus|mesh-list
92898234|NCT00693524|Daclizumab|daclizumab|mesh-list
92898235|NCT00693524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898236|NCT00693524|Glucocorticoids|glucocorticoids|mesh-ancestor
92898237|NCT00693524|Hormones|hormones|mesh-ancestor
92898238|NCT00693524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898239|NCT00693524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898240|NCT00693524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92898241|NCT00693524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898242|NCT00693524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898243|NCT00693524|Immunologic Factors|immunologic factors|mesh-ancestor
92898244|NCT00693524|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92898245|NCT00693524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898246|NCT00693524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898247|NCT00693524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92898248|NCT00693524|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92898249|NCT00693524|Antitubercular Agents|antitubercular agents|mesh-ancestor
92898250|NCT00693524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898251|NCT00693524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898252|NCT00693602|Asparaginase|asparaginase|mesh-list
92898253|NCT00693602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898254|NCT00682214|Vitamin D|vitamin d|mesh-list
92898255|NCT00682214|Cholecalciferol|cholecalciferol|mesh-list
92898256|NCT00682214|Vitamins|vitamins|mesh-ancestor
92898257|NCT00682214|Micronutrients|micronutrients|mesh-ancestor
92898258|NCT00682214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898259|NCT00682214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92898260|NCT00682214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92898261|NCT04137380|Mirikizumab|mirikizumab|mesh-list
93046938|NCT00346268|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92898262|NCT04137380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92898263|NCT04137380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92898264|NCT04137380|Analgesics|analgesics|mesh-ancestor
92898265|NCT04137380|Sensory System Agents|sensory system agents|mesh-ancestor
92161234|NCT03450707|Vitamin B Complex|vitamin b complex|mesh-ancestor
92898266|NCT04137380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898267|NCT04137380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898268|NCT04137380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898269|NCT04137380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92898270|NCT04137380|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92898271|NCT04137380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92898272|NCT00693680|Imipramine|imipramine|mesh-list
92898273|NCT00693680|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92898274|NCT00693680|Antidepressive Agents|antidepressive agents|mesh-ancestor
92898275|NCT00693680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898276|NCT00693680|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92898277|NCT00693680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92898278|NCT00693680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898279|NCT00693680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898280|NCT00693680|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898281|NCT00693680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898282|NCT00693680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898283|NCT00682292|Thymoglobulin|thymoglobulin|mesh-list
92898284|NCT00682292|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92898285|NCT00682292|Daclizumab|daclizumab|mesh-list
92898286|NCT00682292|Immunologic Factors|immunologic factors|mesh-ancestor
92898287|NCT00682292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898288|NCT00682292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898289|NCT00810069|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92898290|NCT00810069|Escitalopram|escitalopram|mesh-list
92898291|NCT00810069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92898292|NCT00810069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92898293|NCT00810069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977263|NCT01070641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898294|NCT00810069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898295|NCT00810069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898296|NCT00810069|Serotonin Agents|serotonin agents|mesh-ancestor
92898297|NCT00810069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898298|NCT00810069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898299|NCT00810069|Antidepressive Agents|antidepressive agents|mesh-ancestor
92898300|NCT00810069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898301|NCT00810069|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92898302|NCT00810069|Analgesics|analgesics|mesh-ancestor
92898303|NCT00810069|Sensory System Agents|sensory system agents|mesh-ancestor
92898304|NCT00810069|Dopamine Agents|dopamine agents|mesh-ancestor
92898305|NCT00693758|Adenosine|adenosine|mesh-list
92898306|NCT00693758|Analgesics|analgesics|mesh-ancestor
92898307|NCT00693758|Sensory System Agents|sensory system agents|mesh-ancestor
92898308|NCT00693758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898309|NCT00693758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898310|NCT00693758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92898311|NCT00693758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92898312|NCT00693758|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92898313|NCT00693758|Purinergic Agonists|purinergic agonists|mesh-ancestor
92898314|NCT00693758|Purinergic Agents|purinergic agents|mesh-ancestor
92898315|NCT00693758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898316|NCT00693758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898317|NCT02625740|Paclitaxel|paclitaxel|mesh-list
92898318|NCT02625740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92898319|NCT02625740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898320|NCT02625740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898321|NCT02625740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898322|NCT02625740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898323|NCT02625740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898324|NCT00688922|Pravastatin|pravastatin|mesh-list
92898325|NCT00688922|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92898326|NCT00688922|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92898327|NCT00688922|Antimetabolites|antimetabolites|mesh-ancestor
92898328|NCT00688922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898329|NCT00688922|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92898330|NCT00688922|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92898331|NCT00688922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898332|NCT00694148|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92898333|NCT00694148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92898334|NCT00694148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898335|NCT00694148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161236|NCT01678079|Calcium|calcium|mesh-list
92898336|NCT00694148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92898337|NCT00694148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898338|NCT00694148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898339|NCT00694148|Cholinergic Agents|cholinergic agents|mesh-ancestor
92898340|NCT00694148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898341|NCT02626364|Crenolanib|crenolanib|mesh-list
92898342|NCT02626364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898343|NCT00694460|Vaccines|vaccines|mesh-list
92898344|NCT00694460|Immunologic Factors|immunologic factors|mesh-ancestor
92898345|NCT00694460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898346|NCT04776525|Doxorubicin|doxorubicin|mesh-list
92898347|NCT04776525|Ifosfamide|ifosfamide|mesh-list
92898348|NCT04776525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92898349|NCT04776525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898350|NCT04776525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92898351|NCT04776525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92898352|NCT04776525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898353|NCT04776525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898354|NCT04776525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92898355|NCT04776525|Alkylating Agents|alkylating agents|mesh-ancestor
92898356|NCT00689000|Tosedostat|tosedostat|mesh-list
92898357|NCT00689000|Glycine|glycine|mesh-list
92898358|NCT00689000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898359|NCT00689000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898360|NCT00689000|Glycine Agents|glycine agents|mesh-ancestor
92898361|NCT00689000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898362|NCT00689000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898363|NCT00489541|Paclitaxel|paclitaxel|mesh-list
92898364|NCT00489541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92898365|NCT00489541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898366|NCT00489541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898367|NCT00489541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898368|NCT00489541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898369|NCT00489541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898370|NCT00689156|Cyclophosphamide|cyclophosphamide|mesh-list
92898371|NCT00689156|Docetaxel|docetaxel|mesh-list
92898372|NCT00689156|Epirubicin|epirubicin|mesh-list
92898373|NCT00689156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898374|NCT00689156|Immunologic Factors|immunologic factors|mesh-ancestor
92898375|NCT00689156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898376|NCT00689156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92898377|NCT00689156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92898378|NCT00689156|Alkylating Agents|alkylating agents|mesh-ancestor
92898379|NCT00689156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898380|NCT00689156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898381|NCT00689156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92898382|NCT00689156|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898383|NCT00689156|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898384|NCT00689156|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898385|NCT00689156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92898386|NCT00689156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92898387|NCT00689156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92898388|NCT00689156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898389|NCT04773873|Lithium Carbonate|lithium carbonate|mesh-list
92898390|NCT04773873|Antidepressive Agents|antidepressive agents|mesh-ancestor
92898391|NCT04773873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898392|NCT04773873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898393|NCT04773873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898394|NCT04773873|Antimanic Agents|antimanic agents|mesh-ancestor
92898395|NCT04773873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92898396|NCT04773873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898397|NCT04773873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898398|NCT01016821|Oxycodone|oxycodone|mesh-list
92898399|NCT01016821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92898400|NCT01016821|Narcotics|narcotics|mesh-ancestor
92898401|NCT01016821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898402|NCT01016821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898403|NCT01016821|Analgesics|analgesics|mesh-ancestor
92898404|NCT01016821|Sensory System Agents|sensory system agents|mesh-ancestor
92898405|NCT01016821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898406|NCT01011205|Mycophenolic Acid|mycophenolic acid|mesh-list
92898407|NCT01011205|Methylprednisolone|methylprednisolone|mesh-list
92898408|NCT01011205|Tacrolimus|tacrolimus|mesh-list
92898409|NCT01011205|Basiliximab|basiliximab|mesh-list
92898410|NCT01011205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898411|NCT01011205|Immunologic Factors|immunologic factors|mesh-ancestor
92898412|NCT01011205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898413|NCT01011205|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92898414|NCT01011205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898415|NCT01011205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898416|NCT01011205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92898417|NCT01011205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898418|NCT01011205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92898419|NCT01011205|Antitubercular Agents|antitubercular agents|mesh-ancestor
92898420|NCT01011205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898421|NCT01011205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898422|NCT01011205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898423|NCT01011205|Antiemetics|antiemetics|mesh-ancestor
92898424|NCT01011205|Autonomic Agents|autonomic agents|mesh-ancestor
92898425|NCT01011205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898426|NCT01011205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92898427|NCT01011205|Glucocorticoids|glucocorticoids|mesh-ancestor
92898428|NCT01011205|Hormones|hormones|mesh-ancestor
92898429|NCT01011205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898430|NCT01011205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92898431|NCT01011205|Protective Agents|protective agents|mesh-ancestor
92898432|NCT00809835|Galantamine|galantamine|mesh-list
92898433|NCT00809835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92898434|NCT00809835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898435|NCT00809835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898436|NCT00809835|Cholinergic Agents|cholinergic agents|mesh-ancestor
92898437|NCT00809835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898438|NCT00809835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898439|NCT00809835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92898440|NCT00809835|Autonomic Agents|autonomic agents|mesh-ancestor
92898441|NCT00809835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898442|NCT00809835|Nootropic Agents|nootropic agents|mesh-ancestor
92898443|NCT01014559|Oxycodone|oxycodone|mesh-list
92898444|NCT01014559|Naloxone|naloxone|mesh-list
92898445|NCT01014559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92898446|NCT01014559|Narcotics|narcotics|mesh-ancestor
92898447|NCT01014559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898448|NCT01014559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898449|NCT01014559|Analgesics|analgesics|mesh-ancestor
92898450|NCT01014559|Sensory System Agents|sensory system agents|mesh-ancestor
92898451|NCT01014559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898452|NCT01014559|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92898453|NCT00853242|Sevelamer|sevelamer|mesh-list
92898454|NCT00853242|Chelating Agents|chelating agents|mesh-ancestor
92898455|NCT00853242|Sequestering Agents|sequestering agents|mesh-ancestor
92898456|NCT00853242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898457|NCT02609061|Alendronate|alendronate|mesh-list
92898458|NCT02609061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92898459|NCT02609061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898460|NCT00848250|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92898461|NCT00848250|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92898462|NCT00848250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898463|NCT00848250|Protease Inhibitors|protease inhibitors|mesh-ancestor
92898464|NCT00694694|Azithromycin|azithromycin|mesh-list
92898465|NCT00694694|Artesunate|artesunate|mesh-list
92898466|NCT00694694|Lumefantrine|lumefantrine|mesh-list
92898467|NCT00694694|Artemether|artemether|mesh-list
92898468|NCT00694694|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92898469|NCT00694694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898470|NCT00694694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898471|NCT00694694|Antimalarials|antimalarials|mesh-ancestor
92898472|NCT00694694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92898473|NCT00694694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92898474|NCT00694694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898475|NCT00694694|Antiviral Agents|antiviral agents|mesh-ancestor
92898476|NCT00694694|Schistosomicides|schistosomicides|mesh-ancestor
92898477|NCT00694694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92898478|NCT00694694|Anthelmintics|anthelmintics|mesh-ancestor
92898479|NCT00700362|Insulin|insulin|mesh-list
92898480|NCT00700362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92898481|NCT00700362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898482|NCT04136600|Antibodies|antibodies|mesh-list
92898483|NCT04136600|Immunologic Factors|immunologic factors|mesh-ancestor
92898484|NCT04136600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898485|NCT00809757|Albuterol|albuterol|mesh-list
92898486|NCT00809757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92898487|NCT00809757|Autonomic Agents|autonomic agents|mesh-ancestor
92898488|NCT00809757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898489|NCT00809757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898490|NCT00809757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92898491|NCT00809757|Respiratory System Agents|respiratory system agents|mesh-ancestor
92898492|NCT00809757|Tocolytic Agents|tocolytic agents|mesh-ancestor
92898493|NCT00809757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92898494|NCT00809757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92898495|NCT00809757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92898496|NCT00809757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92898497|NCT00809757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898498|NCT00809757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898499|NCT00809757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898500|NCT00594464|Rotigotine|rotigotine|mesh-list
92898501|NCT00594464|Dopamine Agonists|dopamine agonists|mesh-ancestor
92898502|NCT00594464|Dopamine Agents|dopamine agents|mesh-ancestor
92898503|NCT00594464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898504|NCT00594464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898505|NCT00594464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898506|NCT00682760|Botulinum Toxins|botulinum toxins|mesh-list
92898507|NCT00682760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92898508|NCT00682760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92898509|NCT00682760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92898510|NCT00682760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898511|NCT00682760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898512|NCT00682760|Cholinergic Agents|cholinergic agents|mesh-ancestor
92898513|NCT00682760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898514|NCT00682760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898515|NCT00682760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92898516|NCT00682760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898517|NCT05326269|Terbutaline|terbutaline|mesh-list
92898518|NCT05326269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92898519|NCT05326269|Autonomic Agents|autonomic agents|mesh-ancestor
92898520|NCT05326269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898521|NCT05326269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898522|NCT05326269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92898523|NCT05326269|Respiratory System Agents|respiratory system agents|mesh-ancestor
92898524|NCT05326269|Sympathomimetics|sympathomimetics|mesh-ancestor
92898525|NCT05326269|Tocolytic Agents|tocolytic agents|mesh-ancestor
92898526|NCT05326269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92898527|NCT05326269|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92898528|NCT05326269|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92898529|NCT05326269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92898530|NCT05326269|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898531|NCT05326269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898532|NCT05326269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898533|NCT02624570|Midostaurin|midostaurin|mesh-list
92898534|NCT02624570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898535|NCT02624570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898536|NCT02624570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898537|NCT02624570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898538|NCT04665453|Dexmedetomidine|dexmedetomidine|mesh-list
92898539|NCT04665453|Melatonin|melatonin|mesh-list
92898540|NCT04665453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92898541|NCT04665453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898542|NCT04665453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898543|NCT04665453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92898544|NCT04665453|Analgesics|analgesics|mesh-ancestor
92898545|NCT04665453|Sensory System Agents|sensory system agents|mesh-ancestor
92898546|NCT04665453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898547|NCT04665453|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92898548|NCT04665453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92898549|NCT04665453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92898550|NCT04665453|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898551|NCT04665453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898552|NCT04665453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898553|NCT04665453|Antioxidants|antioxidants|mesh-ancestor
92898554|NCT04665453|Protective Agents|protective agents|mesh-ancestor
92898555|NCT00695240|Bupivacaine|bupivacaine|mesh-list
92898556|NCT00695240|Anesthetics, Local|anesthetics, local|mesh-ancestor
92898557|NCT00695240|Anesthetics|anesthetics|mesh-ancestor
92898558|NCT00695240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898559|NCT00695240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898560|NCT00695240|Sensory System Agents|sensory system agents|mesh-ancestor
92898561|NCT00695240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898562|NCT00689702|Capecitabine|capecitabine|mesh-list
92898563|NCT00689702|Cetuximab|cetuximab|mesh-list
92898564|NCT00689702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92898565|NCT00689702|Antimetabolites|antimetabolites|mesh-ancestor
92898566|NCT00689702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898567|NCT00689702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898568|NCT00689702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92898569|NCT00689780|Midazolam|midazolam|mesh-list
92898570|NCT00689780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92898571|NCT00689780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92898572|NCT00689780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898573|NCT00689780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898574|NCT00689780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92898575|NCT00689780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92898576|NCT00689780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898577|NCT00689780|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92898578|NCT00689780|Anesthetics, General|anesthetics, general|mesh-ancestor
92898579|NCT00689780|Anesthetics|anesthetics|mesh-ancestor
92898580|NCT00689780|GABA Modulators|gaba modulators|mesh-ancestor
92898581|NCT00689780|GABA Agents|gaba agents|mesh-ancestor
92898582|NCT00689780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898583|NCT00689780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898584|NCT00689858|Cilostazol|cilostazol|mesh-list
92898585|NCT00689858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92898586|NCT00689858|Autonomic Agents|autonomic agents|mesh-ancestor
92898587|NCT00689858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898588|NCT00689858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898590|NCT00689858|Respiratory System Agents|respiratory system agents|mesh-ancestor
92898591|NCT00689858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92898592|NCT00689858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92898593|NCT00689858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898594|NCT00689858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92898595|NCT00689858|Vasodilator Agents|vasodilator agents|mesh-ancestor
92898596|NCT00689858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92898597|NCT00689858|Protective Agents|protective agents|mesh-ancestor
92898598|NCT00689858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92898599|NCT00689858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92898600|NCT00689858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898601|NCT00695630|Flumazenil|flumazenil|mesh-list
92898602|NCT00695630|Antidotes|antidotes|mesh-ancestor
92898603|NCT00695630|Protective Agents|protective agents|mesh-ancestor
92898604|NCT00695630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898605|NCT00695630|GABA Modulators|gaba modulators|mesh-ancestor
92898606|NCT00695630|GABA Agents|gaba agents|mesh-ancestor
92898607|NCT00695630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898608|NCT00695630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898609|NCT01614899|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92898610|NCT01614899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92898611|NCT01614899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92898612|NCT01614899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898613|NCT01614899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898614|NCT01614899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898615|NCT01614899|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92898616|NCT01614899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92898617|NCT01614899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92898618|NCT01614899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898619|NCT01614899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161244|NCT01678235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92898620|NCT01614899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898621|NCT01614899|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92898622|NCT01614899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92898623|NCT01614899|Serotonin Agents|serotonin agents|mesh-ancestor
92898624|NCT01614899|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92898625|NCT01614899|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92898626|NCT01614899|Dopamine Agents|dopamine agents|mesh-ancestor
92898627|NCT00690014|Probenecid|probenecid|mesh-list
92898628|NCT00690014|Uricosuric Agents|uricosuric agents|mesh-ancestor
92898629|NCT00690014|Gout Suppressants|gout suppressants|mesh-ancestor
92898630|NCT00690014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92898631|NCT00683306|Gefitinib|gefitinib|mesh-list
92898632|NCT00683306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898633|NCT00683306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898634|NCT00683306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898635|NCT00683306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898636|NCT01475123|Nicorandil|nicorandil|mesh-list
92898637|NCT01475123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92898638|NCT01475123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92898639|NCT01475123|Vasodilator Agents|vasodilator agents|mesh-ancestor
92898640|NCT01475123|Vitamin B Complex|vitamin b complex|mesh-ancestor
92898641|NCT01475123|Vitamins|vitamins|mesh-ancestor
92898642|NCT01475123|Micronutrients|micronutrients|mesh-ancestor
92898643|NCT01475123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898644|NCT04135898|Bevacizumab|bevacizumab|mesh-list
92898645|NCT04135898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92898646|NCT04135898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898647|NCT04135898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92898648|NCT04135898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92898649|NCT04135898|Growth Substances|growth substances|mesh-ancestor
92898650|NCT04135898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898651|NCT04135898|Growth Inhibitors|growth inhibitors|mesh-ancestor
92898652|NCT04208399|JNJ-56136379|jnj-56136379|mesh-list
92898653|NCT04208399|Antiviral Agents|antiviral agents|mesh-ancestor
92898654|NCT04208399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898655|NCT00912392|Carboplatin|carboplatin|mesh-list
92898656|NCT00912392|Etoposide|etoposide|mesh-list
92898657|NCT00912392|Endostar protein|endostar protein|mesh-list
92898658|NCT00912392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898659|NCT00912392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92898660|NCT00912392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92898661|NCT00912392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92898662|NCT00912392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898663|NCT00912392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898664|NCT00912392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92898665|NCT00912392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92898666|NCT00912392|Growth Substances|growth substances|mesh-ancestor
92898667|NCT00912392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898668|NCT00912392|Growth Inhibitors|growth inhibitors|mesh-ancestor
92898670|NCT00690170|Nicotine|nicotine|mesh-list
92898671|NCT00690170|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92898672|NCT00690170|Autonomic Agents|autonomic agents|mesh-ancestor
92898673|NCT00690170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898674|NCT00690170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898675|NCT00690170|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92898676|NCT00690170|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92898677|NCT00690170|Cholinergic Agents|cholinergic agents|mesh-ancestor
92898678|NCT00690170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898679|NCT00690170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898680|NCT00690170|Analgesics|analgesics|mesh-ancestor
92898681|NCT00690170|Sensory System Agents|sensory system agents|mesh-ancestor
92898682|NCT00690170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92898683|NCT00690170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92898684|NCT00690170|Anesthetics, General|anesthetics, general|mesh-ancestor
92898685|NCT00690170|Anesthetics|anesthetics|mesh-ancestor
92898686|NCT00690170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898687|NCT00690170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92898688|NCT00690170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92898689|NCT00689624|Leucovorin|leucovorin|mesh-list
92898690|NCT00689624|Fluorouracil|fluorouracil|mesh-list
92898691|NCT00689624|Oxaliplatin|oxaliplatin|mesh-list
92898692|NCT00689624|Irinotecan|irinotecan|mesh-list
92898693|NCT00689624|Cetuximab|cetuximab|mesh-list
92898694|NCT00689624|Antimetabolites|antimetabolites|mesh-ancestor
92898695|NCT00689624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898696|NCT00689624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92898697|NCT00689624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898698|NCT00689624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898699|NCT00689624|Immunologic Factors|immunologic factors|mesh-ancestor
92898700|NCT00689624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898701|NCT00689624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92898702|NCT00689624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92898703|NCT00689624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898704|NCT00689624|Antidotes|antidotes|mesh-ancestor
92898705|NCT00689624|Protective Agents|protective agents|mesh-ancestor
92898706|NCT00689624|Vitamin B Complex|vitamin b complex|mesh-ancestor
92898707|NCT00689624|Vitamins|vitamins|mesh-ancestor
92898708|NCT00689624|Micronutrients|micronutrients|mesh-ancestor
92898709|NCT00689624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92898710|NCT00696098|Butyric Acid|butyric acid|mesh-list
92898711|NCT00696098|Histamine Antagonists|histamine antagonists|mesh-ancestor
92898712|NCT00696098|Histamine Agents|histamine agents|mesh-ancestor
92898713|NCT00696098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898714|NCT00696098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898715|NCT00696098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898717|NCT02623478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92898718|NCT02623478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898719|NCT00684164|Conivaptan|conivaptan|mesh-list
92898720|NCT00684164|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92898721|NCT00684164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898722|NCT00684164|Natriuretic Agents|natriuretic agents|mesh-ancestor
92898723|NCT00684164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898724|NCT04135508|Adalimumab|adalimumab|mesh-list
92898725|NCT04135508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92898726|NCT04135508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92898727|NCT04135508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92898728|NCT02622854|Insulin|insulin|mesh-list
92898729|NCT02622854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92898730|NCT02622854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898731|NCT02616770|Perflubron|perflubron|mesh-list
92898732|NCT02616770|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92898733|NCT00499369|Leucovorin|leucovorin|mesh-list
92898734|NCT00499369|Bevacizumab|bevacizumab|mesh-list
92898735|NCT00499369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92898736|NCT00499369|Cetuximab|cetuximab|mesh-list
92898737|NCT00499369|Fluorouracil|fluorouracil|mesh-list
92898738|NCT00499369|Irinotecan|irinotecan|mesh-list
92898739|NCT00499369|Antibodies|antibodies|mesh-list
92898740|NCT00499369|Immunoglobulins|immunoglobulins|mesh-list
92898741|NCT00499369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92898742|NCT00499369|Levoleucovorin|levoleucovorin|mesh-list
92898743|NCT00499369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898744|NCT00499369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92898745|NCT00499369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92898746|NCT00499369|Growth Substances|growth substances|mesh-ancestor
92898747|NCT00499369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898748|NCT00499369|Growth Inhibitors|growth inhibitors|mesh-ancestor
92898749|NCT00499369|Immunologic Factors|immunologic factors|mesh-ancestor
92898750|NCT00499369|Antimetabolites|antimetabolites|mesh-ancestor
92898751|NCT00499369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898752|NCT00499369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92898753|NCT00499369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898754|NCT00499369|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92898755|NCT00499369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92898756|NCT00499369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898757|NCT00499369|Antidotes|antidotes|mesh-ancestor
92898758|NCT00499369|Protective Agents|protective agents|mesh-ancestor
92898759|NCT00499369|Vitamin B Complex|vitamin b complex|mesh-ancestor
92898760|NCT00499369|Vitamins|vitamins|mesh-ancestor
92898761|NCT00499369|Micronutrients|micronutrients|mesh-ancestor
92898762|NCT02616692|Sorafenib|sorafenib|mesh-list
92898763|NCT02616692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898764|NCT02616692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898765|NCT02616692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898766|NCT02616692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898767|NCT01014637|Antifungal Agents|antifungal agents|mesh-list
92898768|NCT01014637|Clotrimazole|clotrimazole|mesh-list
92898769|NCT01014637|Miconazole|miconazole|mesh-list
92898770|NCT01014637|Amorolfine|amorolfine|mesh-list
92898771|NCT01014637|Ciclopirox|ciclopirox|mesh-list
92898772|NCT01014637|Keratolytic Agents|keratolytic agents|mesh-list
92898773|NCT01014637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898774|NCT01014637|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92898775|NCT01014637|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92898776|NCT01014637|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92898777|NCT01014637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898778|NCT01014637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898779|NCT01014637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92898780|NCT01014637|Hormone Antagonists|hormone antagonists|mesh-ancestor
92898781|NCT01014637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898782|NCT01014637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898783|NCT01014637|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92898784|NCT01014637|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92898785|NCT01014637|Dermatologic Agents|dermatologic agents|mesh-ancestor
92898786|NCT00696566|Rifampin|rifampin|mesh-list
92898787|NCT00696566|Clopidogrel|clopidogrel|mesh-list
92898788|NCT00696566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92898789|NCT00696566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92898790|NCT00696566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92898791|NCT00696566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92898792|NCT00696566|Purinergic Agents|purinergic agents|mesh-ancestor
92898793|NCT00696566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898794|NCT00696566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898795|NCT00696566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898796|NCT00696566|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92898797|NCT00696566|Antitubercular Agents|antitubercular agents|mesh-ancestor
92898798|NCT00696566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92898799|NCT00696566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898800|NCT00696566|Leprostatic Agents|leprostatic agents|mesh-ancestor
92898801|NCT00696566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92898802|NCT00696566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898803|NCT00696566|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92898804|NCT00696566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92898805|NCT00696566|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92898806|NCT00696566|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92898807|NCT00696566|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92898808|NCT00696566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92898809|NCT01017133|Deoxyglucose|deoxyglucose|mesh-list
92898810|NCT01017133|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92898811|NCT01017133|Fluorides|fluorides|mesh-list
92898812|NCT01017133|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92898813|NCT01017133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898814|NCT01017133|Cariostatic Agents|cariostatic agents|mesh-ancestor
92898815|NCT01017133|Protective Agents|protective agents|mesh-ancestor
92898816|NCT01017133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898817|NCT01017133|Antimetabolites|antimetabolites|mesh-ancestor
92898818|NCT01017133|Antiviral Agents|antiviral agents|mesh-ancestor
92898819|NCT01017133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898820|NCT00869258|Gemcitabine|gemcitabine|mesh-list
92898821|NCT00869258|Capecitabine|capecitabine|mesh-list
92898822|NCT00869258|Docetaxel|docetaxel|mesh-list
92898823|NCT00869258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92898824|NCT00869258|Antimetabolites|antimetabolites|mesh-ancestor
92898825|NCT00869258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898826|NCT00869258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898827|NCT00869258|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898828|NCT00869258|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898829|NCT00869258|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898830|NCT00696644|Teriparatide|teriparatide|mesh-list
92898831|NCT00696644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92898832|NCT00696644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898833|NCT00696644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92898834|NCT01017367|Antibodies|antibodies|mesh-list
92898835|NCT01017367|Immunologic Factors|immunologic factors|mesh-ancestor
92898836|NCT01017367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898837|NCT00696722|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92898838|NCT00696722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92898839|NCT00696722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92898840|NCT00696722|Protease Inhibitors|protease inhibitors|mesh-ancestor
92898841|NCT00696722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898842|NCT00696722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898843|NCT00696722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92898844|NCT00696722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92898845|NCT00696722|Antiviral Agents|antiviral agents|mesh-ancestor
92898846|NCT00696722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898847|NCT00696956|Paclitaxel|paclitaxel|mesh-list
92898848|NCT00696956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92898849|NCT00696956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898850|NCT00696956|Tubulin Modulators|tubulin modulators|mesh-ancestor
92898851|NCT00696956|Antimitotic Agents|antimitotic agents|mesh-ancestor
92898852|NCT00696956|Mitosis Modulators|mitosis modulators|mesh-ancestor
92898853|NCT00696956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898854|NCT02616848|Everolimus|everolimus|mesh-list
92898855|NCT02616848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92898856|NCT02616848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92898857|NCT02616848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898858|NCT02616848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898859|NCT02616848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92898860|NCT02616848|Immunologic Factors|immunologic factors|mesh-ancestor
92898861|NCT02616848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898862|NCT02616848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898863|NCT02620124|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92898864|NCT02620124|Hormones|hormones|mesh-list
92898865|NCT02620124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898866|NCT02620124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898867|NCT02620124|Luteolytic Agents|luteolytic agents|mesh-ancestor
92898868|NCT02620124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92898869|NCT02620124|Contraceptive Agents|contraceptive agents|mesh-ancestor
92898870|NCT02620124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92898871|NCT02620124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92898872|NCT02620124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92898873|NCT02620124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898874|NCT04134650|Metformin|metformin|mesh-list
92898875|NCT04134650|Linagliptin|linagliptin|mesh-list
92898876|NCT04134650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92898877|NCT04134650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898878|NCT04134650|Incretins|incretins|mesh-ancestor
92898879|NCT04134650|Hormones|hormones|mesh-ancestor
92898880|NCT04134650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92898881|NCT04134650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92898882|NCT04134650|Protease Inhibitors|protease inhibitors|mesh-ancestor
92898883|NCT04134650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898884|NCT04134650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898885|NCT00488683|Vaccines|vaccines|mesh-list
92898886|NCT00488683|Immunologic Factors|immunologic factors|mesh-ancestor
92898887|NCT00488683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898888|NCT02563288|Dexmedetomidine|dexmedetomidine|mesh-list
92898889|NCT02563288|Esmolol|esmolol|mesh-list
92898890|NCT02563288|Adrenergic Agents|adrenergic agents|mesh-list
92898891|NCT02563288|Adrenergic Agonists|adrenergic agonists|mesh-list
92898892|NCT02563288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-list
92898893|NCT02563288|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92898894|NCT02563288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92898895|NCT02563288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898896|NCT02563288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898897|NCT02563288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92898898|NCT02563288|Analgesics|analgesics|mesh-ancestor
92898899|NCT02563288|Sensory System Agents|sensory system agents|mesh-ancestor
92898900|NCT02563288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898901|NCT02563288|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92898902|NCT02563288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898903|NCT02563288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898904|NCT02563288|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92898905|NCT02563288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92898906|NCT00711269|Risperidone|risperidone|mesh-list
92898907|NCT00711269|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92898908|NCT00711269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92898909|NCT00711269|Serotonin Agents|serotonin agents|mesh-ancestor
92898910|NCT00711269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898911|NCT00711269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898912|NCT00711269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898913|NCT00711269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92898914|NCT00711269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92898915|NCT00711269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898916|NCT00711269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898917|NCT00711269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92898918|NCT00711269|Dopamine Agents|dopamine agents|mesh-ancestor
92898919|NCT00711269|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92898920|NCT00711269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92898921|NCT00711269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92898922|NCT00711269|Adrenergic Agents|adrenergic agents|mesh-ancestor
92898923|NCT00711269|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92898924|NCT00711269|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92898925|NCT01014793|Cabergoline|cabergoline|mesh-list
92898926|NCT01014793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92898927|NCT01014793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92898928|NCT01014793|Dopamine Agonists|dopamine agonists|mesh-ancestor
92898929|NCT01014793|Dopamine Agents|dopamine agents|mesh-ancestor
92898930|NCT01014793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898931|NCT01014793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898932|NCT01014793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898933|NCT00286169|Amrubicin|amrubicin|mesh-list
92898934|NCT00286169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898935|NCT00693472|Propranolol|propranolol|mesh-list
92898936|NCT00693472|Haloperidol|haloperidol|mesh-list
92544299|NCT00034125|Tamoxifen|tamoxifen|mesh-list
92898937|NCT00693472|Haloperidol decanoate|haloperidol decanoate|mesh-list
92898938|NCT00693472|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92898939|NCT00693472|Antiemetics|antiemetics|mesh-ancestor
92898940|NCT00693472|Autonomic Agents|autonomic agents|mesh-ancestor
92898941|NCT00693472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92898942|NCT00693472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898943|NCT00693472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92898944|NCT00693472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92898945|NCT00693472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92898946|NCT00693472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92898947|NCT00693472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92898948|NCT00693472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92898949|NCT00693472|Dopamine Agents|dopamine agents|mesh-ancestor
92898950|NCT00693472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92898951|NCT00693472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898952|NCT00693472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92898953|NCT00693472|Cholinergic Agents|cholinergic agents|mesh-ancestor
92898954|NCT00693472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92898955|NCT00693472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92898956|NCT00693472|Adrenergic Agents|adrenergic agents|mesh-ancestor
92525775|NCT00026299|Gefitinib|gefitinib|mesh-list
92898957|NCT00693472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92898958|NCT00693472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92898959|NCT00693472|Vasodilator Agents|vasodilator agents|mesh-ancestor
92898960|NCT00498433|Amlodipine|amlodipine|mesh-list
92898961|NCT00498433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92898962|NCT00498433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92898963|NCT00498433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92898964|NCT00498433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898965|NCT00498433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92898966|NCT00498433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898967|NCT00498433|Vasodilator Agents|vasodilator agents|mesh-ancestor
92898968|NCT02689583|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92898969|NCT02689583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92898970|NCT02689583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898971|NCT02689583|Antitubercular Agents|antitubercular agents|mesh-ancestor
92898972|NCT00746746|Interferons|interferons|mesh-list
92898973|NCT00746746|Interferon-alpha|interferon-alpha|mesh-list
92898974|NCT00746746|Interferon alpha-2|interferon alpha-2|mesh-list
92898975|NCT00746746|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92898976|NCT00746746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898977|NCT00746746|Antiviral Agents|antiviral agents|mesh-ancestor
92898978|NCT00746746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92898979|NCT00746746|Immunologic Factors|immunologic factors|mesh-ancestor
92898980|NCT00746746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898981|NCT00498355|Ranibizumab|ranibizumab|mesh-list
92898982|NCT00498355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92898983|NCT00498355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92898984|NCT00498355|Growth Substances|growth substances|mesh-ancestor
92898985|NCT00498355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92898986|NCT00498355|Growth Inhibitors|growth inhibitors|mesh-ancestor
92898987|NCT00498355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92898988|NCT04539223|Evolocumab|evolocumab|mesh-list
92898989|NCT04539223|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92898990|NCT04539223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92898991|NCT04539223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92898992|NCT04539223|Antimetabolites|antimetabolites|mesh-ancestor
92898993|NCT04539223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92898994|NCT04539223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92898995|NCT04539223|Protease Inhibitors|protease inhibitors|mesh-ancestor
92898996|NCT04539223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92898997|NCT04539223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92898998|NCT01011751|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92898999|NCT01011751|Leuprolide|leuprolide|mesh-list
92899000|NCT01011751|Flutamide|flutamide|mesh-list
92899001|NCT01011751|Cyproterone Acetate|cyproterone acetate|mesh-list
92899002|NCT01011751|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92899003|NCT01011751|Medroxyprogesterone|medroxyprogesterone|mesh-list
92899004|NCT01011751|Cyproterone|cyproterone|mesh-list
92899005|NCT01011751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92899006|NCT01011751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92899007|NCT01011751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544367|NCT00034632|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92899008|NCT01011751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899009|NCT01011751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899010|NCT01011751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899011|NCT01011751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92899012|NCT01011751|Antidepressive Agents|antidepressive agents|mesh-ancestor
92899013|NCT01011751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92899014|NCT01011751|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92899015|NCT01011751|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92899016|NCT01011751|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92899017|NCT01011751|Contraceptive Agents|contraceptive agents|mesh-ancestor
92899018|NCT01011751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92899019|NCT01011751|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92899020|NCT01011751|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92899021|NCT01011751|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92899022|NCT01011751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92899023|NCT01011751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899024|NCT01011751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92899025|NCT01011751|Fertility Agents|fertility agents|mesh-ancestor
92899026|NCT01011751|Androgen Antagonists|androgen antagonists|mesh-ancestor
92899027|NCT01011751|Hormone Antagonists|hormone antagonists|mesh-ancestor
92525778|NCT00026299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899028|NCT01011751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899030|NCT02686619|Sirolimus|sirolimus|mesh-list
92899031|NCT02686619|Prednisolone|prednisolone|mesh-list
92899032|NCT02686619|Cyclosporins|cyclosporins|mesh-list
92899033|NCT02686619|Daclizumab|daclizumab|mesh-list
92899034|NCT02686619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899035|NCT02686619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899036|NCT02686619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899037|NCT02686619|Immunologic Factors|immunologic factors|mesh-ancestor
92899038|NCT02686619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899039|NCT02686619|Antifungal Agents|antifungal agents|mesh-ancestor
92899040|NCT02686619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899041|NCT02686619|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899042|NCT02686619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899043|NCT02686619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92899044|NCT02686619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92899045|NCT02686619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92899046|NCT02686619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899047|NCT02686619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899048|NCT02686619|Glucocorticoids|glucocorticoids|mesh-ancestor
92899049|NCT02686619|Hormones|hormones|mesh-ancestor
92899050|NCT02686619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899051|NCT02686619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92899052|NCT00688636|Infliximab|infliximab|mesh-list
92899053|NCT00688636|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92899054|NCT00688636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899055|NCT00688636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899056|NCT00688636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899057|NCT00688636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899058|NCT00870740|Daclizumab|daclizumab|mesh-list
92899059|NCT00870740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899060|NCT00870740|Immunologic Factors|immunologic factors|mesh-ancestor
92899061|NCT00870740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899062|NCT02686853|Amphotericin B|amphotericin b|mesh-list
92899063|NCT02686853|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92899064|NCT02686853|Amebicides|amebicides|mesh-ancestor
92899065|NCT02686853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92899066|NCT02686853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92899067|NCT02686853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899068|NCT02686853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92899069|NCT02686853|Antifungal Agents|antifungal agents|mesh-ancestor
92899070|NCT01017679|Gefitinib|gefitinib|mesh-list
92899071|NCT01017679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899072|NCT01017679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899073|NCT01017679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899074|NCT01017679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899075|NCT04130672|Hemostatics|hemostatics|mesh-list
92899076|NCT04130672|Coagulants|coagulants|mesh-ancestor
92899077|NCT00743314|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92899078|NCT00743314|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92899079|NCT00743314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899080|NCT02685449|Insulin|insulin|mesh-list
92899081|NCT02685449|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92899082|NCT02685449|Insulin Aspart|insulin aspart|mesh-list
92899083|NCT02685449|Insulin Lispro|insulin lispro|mesh-list
92899084|NCT02685449|Insulin glulisine|insulin glulisine|mesh-list
92899085|NCT02685449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92899086|NCT02685449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899087|NCT00697034|Capsaicin|capsaicin|mesh-list
92899088|NCT00697034|Antipruritics|antipruritics|mesh-ancestor
92899089|NCT00697034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899090|NCT00697034|Sensory System Agents|sensory system agents|mesh-ancestor
92899091|NCT00697034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899092|NCT00697034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899093|NCT00506779|Paclitaxel|paclitaxel|mesh-list
92899094|NCT00506779|Imatinib Mesylate|imatinib mesylate|mesh-list
92899095|NCT00506779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92899096|NCT00506779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899097|NCT00506779|Tubulin Modulators|tubulin modulators|mesh-ancestor
92899098|NCT00506779|Antimitotic Agents|antimitotic agents|mesh-ancestor
92899099|NCT00506779|Mitosis Modulators|mitosis modulators|mesh-ancestor
92899100|NCT00506779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899101|NCT00506779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899102|NCT00506779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899103|NCT04185233|Nitrous Oxide|nitrous oxide|mesh-list
92899104|NCT04185233|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92899105|NCT04185233|Anesthetics, General|anesthetics, general|mesh-ancestor
92899106|NCT04185233|Anesthetics|anesthetics|mesh-ancestor
92899107|NCT04185233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899108|NCT04185233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899109|NCT04185233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899110|NCT04185233|Analgesics|analgesics|mesh-ancestor
92899111|NCT04185233|Sensory System Agents|sensory system agents|mesh-ancestor
92899112|NCT04185233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899114|NCT04185077|Calcium heparin|calcium heparin|mesh-list
92899115|NCT04185077|Bivalirudin|bivalirudin|mesh-list
92899116|NCT04185077|Antithrombins|antithrombins|mesh-list
92899117|NCT04185077|Thrombin|thrombin|mesh-list
92899118|NCT04185077|Anticoagulants|anticoagulants|mesh-ancestor
92899119|NCT04185077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92899120|NCT04185077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92899121|NCT04185077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899122|NCT04185077|Hemostatics|hemostatics|mesh-ancestor
92899123|NCT04185077|Coagulants|coagulants|mesh-ancestor
92899124|NCT04185077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92899125|NCT04185077|Protease Inhibitors|protease inhibitors|mesh-ancestor
92899126|NCT04185077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899127|NCT02686385|Acetylcysteine|acetylcysteine|mesh-list
92899128|NCT02686385|Prednisolone|prednisolone|mesh-list
92899129|NCT02686385|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92899130|NCT02686385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899131|NCT02686385|Glucocorticoids|glucocorticoids|mesh-ancestor
92899132|NCT02686385|Hormones|hormones|mesh-ancestor
92899133|NCT02686385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899134|NCT02686385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899135|NCT02686385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92899136|NCT02686385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899137|NCT02686385|Protective Agents|protective agents|mesh-ancestor
92899138|NCT02686385|Antiviral Agents|antiviral agents|mesh-ancestor
92899139|NCT02686385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899140|NCT02686385|Expectorants|expectorants|mesh-ancestor
92899141|NCT02686385|Respiratory System Agents|respiratory system agents|mesh-ancestor
92899142|NCT02686385|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92899143|NCT02686385|Antioxidants|antioxidants|mesh-ancestor
92899144|NCT02686385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899145|NCT02686385|Antidotes|antidotes|mesh-ancestor
92899146|NCT02686151|Dexamethasone|dexamethasone|mesh-list
92899147|NCT02686151|Letrozole|letrozole|mesh-list
92899148|NCT02686151|Polygeline|polygeline|mesh-list
92899149|NCT02686151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899150|NCT02686151|Antiemetics|antiemetics|mesh-ancestor
92899151|NCT02686151|Autonomic Agents|autonomic agents|mesh-ancestor
92899152|NCT02686151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899153|NCT02686151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899154|NCT02686151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899155|NCT02686151|Glucocorticoids|glucocorticoids|mesh-ancestor
92899156|NCT02686151|Hormones|hormones|mesh-ancestor
92899157|NCT02686151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899158|NCT02686151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92899159|NCT02686151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899160|NCT02686151|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92544514|NCT00035061|Pemetrexed|pemetrexed|mesh-list
92899161|NCT02686151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92899162|NCT02686151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899163|NCT02686151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899164|NCT02686151|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92899165|NCT02686151|Hormone Antagonists|hormone antagonists|mesh-ancestor
92899166|NCT02686151|Plasma Substitutes|plasma substitutes|mesh-ancestor
92899167|NCT02686151|Blood Substitutes|blood substitutes|mesh-ancestor
92899168|NCT00868790|Metformin|metformin|mesh-list
92899169|NCT00868790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92161285|NCT00085709|Daunorubicin|daunorubicin|mesh-list
92899170|NCT00868790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899171|NCT00496483|Tacrolimus|tacrolimus|mesh-list
92899172|NCT00496483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899173|NCT00496483|Immunologic Factors|immunologic factors|mesh-ancestor
92899174|NCT00496483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899175|NCT00496483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92899176|NCT00496483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899177|NCT00496483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899178|NCT02614352|Candesartan|candesartan|mesh-list
92899179|NCT02614352|Candesartan cilexetil|candesartan cilexetil|mesh-list
92899180|NCT02614352|Atorvastatin|atorvastatin|mesh-list
92899181|NCT02614352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92899182|NCT02614352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92899183|NCT02614352|Antimetabolites|antimetabolites|mesh-ancestor
92899184|NCT02614352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899185|NCT02614352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92899186|NCT02614352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92899187|NCT02614352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899188|NCT02614352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92899189|NCT02614352|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92899190|NCT02614352|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92899191|NCT01018225|Darifenacin|darifenacin|mesh-list
92899192|NCT01018225|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92899193|NCT01018225|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92899194|NCT01018225|Cholinergic Agents|cholinergic agents|mesh-ancestor
92899195|NCT01018225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899196|NCT01018225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899197|NCT01018225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899198|NCT01018225|Urological Agents|urological agents|mesh-ancestor
92899199|NCT03528551|Factor VIII|factor viii|mesh-list
92899200|NCT03528551|Coagulants|coagulants|mesh-ancestor
92899201|NCT02685137|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92899202|NCT02685137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899203|NCT02685137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899204|NCT01012063|Epoetin Alfa|epoetin alfa|mesh-list
92899205|NCT01012063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92899206|NCT01012063|Hematinics|hematinics|mesh-ancestor
92899207|NCT03242915|Carboplatin|carboplatin|mesh-list
92899208|NCT03242915|Pembrolizumab|pembrolizumab|mesh-list
92899209|NCT03242915|Pemetrexed|pemetrexed|mesh-list
92899210|NCT03242915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899211|NCT03242915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92899212|NCT03242915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92899213|NCT03242915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899214|NCT03242915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899215|NCT03242915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92899216|NCT03242915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92899217|NCT00861744|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92899218|NCT00861744|Immunologic Factors|immunologic factors|mesh-ancestor
92899219|NCT00861744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899220|NCT02685059|Paclitaxel|paclitaxel|mesh-list
92899221|NCT02685059|Cyclophosphamide|cyclophosphamide|mesh-list
92899222|NCT02685059|Durvalumab|durvalumab|mesh-list
92899223|NCT02685059|Epirubicin|epirubicin|mesh-list
92899224|NCT02685059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92899225|NCT02685059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899226|NCT02685059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92899227|NCT02685059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92899228|NCT02685059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92899229|NCT02685059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899230|NCT02685059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899231|NCT02685059|Immunologic Factors|immunologic factors|mesh-ancestor
92899232|NCT02685059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899233|NCT02685059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899234|NCT02685059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92899235|NCT02685059|Alkylating Agents|alkylating agents|mesh-ancestor
92899236|NCT02685059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92899237|NCT02685059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92899238|NCT02685059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92899239|NCT02685059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92899240|NCT02685059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92899241|NCT02685059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899243|NCT00603239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92899244|NCT00603239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899245|NCT00603239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92899246|NCT00603239|Incretins|incretins|mesh-ancestor
92899247|NCT00603239|Hormones|hormones|mesh-ancestor
92899248|NCT00603239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899249|NCT00699114|Acetaminophen|acetaminophen|mesh-list
92899250|NCT00699114|Ibuprofen|ibuprofen|mesh-list
92899251|NCT00699114|Codeine|codeine|mesh-list
92899252|NCT00699114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899253|NCT00699114|Analgesics|analgesics|mesh-ancestor
92899254|NCT00699114|Sensory System Agents|sensory system agents|mesh-ancestor
92899255|NCT00699114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899256|NCT00699114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899257|NCT00699114|Antipyretics|antipyretics|mesh-ancestor
92899258|NCT00699114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899259|NCT00699114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899260|NCT00699114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899261|NCT00699114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92899262|NCT00699114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899263|NCT00699114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899264|NCT00699114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92899265|NCT00699114|Narcotics|narcotics|mesh-ancestor
92899266|NCT00699114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899267|NCT00699114|Antitussive Agents|antitussive agents|mesh-ancestor
92899268|NCT00699114|Respiratory System Agents|respiratory system agents|mesh-ancestor
92899269|NCT00639587|Cetirizine|cetirizine|mesh-list
92899270|NCT00639587|Ketotifen|ketotifen|mesh-list
92899271|NCT00639587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92899272|NCT00639587|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92899273|NCT00639587|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92899274|NCT00639587|Histamine Antagonists|histamine antagonists|mesh-ancestor
92899275|NCT00639587|Histamine Agents|histamine agents|mesh-ancestor
92899276|NCT00639587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899277|NCT00639587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899278|NCT00639587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899279|NCT00639587|Antipruritics|antipruritics|mesh-ancestor
92899280|NCT00639587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899281|NCT00700518|Nitroglycerin|nitroglycerin|mesh-list
92899282|NCT00700518|Vasodilator Agents|vasodilator agents|mesh-ancestor
92899283|NCT00852540|Linezolid|linezolid|mesh-list
92899284|NCT00852540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92899285|NCT00852540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899286|NCT00852540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92899287|NCT00852540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899288|NCT00852540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899289|NCT00701298|Interferons|interferons|mesh-list
92899290|NCT00701298|Interferon-alpha|interferon-alpha|mesh-list
92899291|NCT00701298|Interferon alpha-2|interferon alpha-2|mesh-list
92899292|NCT00701298|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92899293|NCT00701298|Decitabine|decitabine|mesh-list
92899294|NCT00701298|Azacitidine|azacitidine|mesh-list
92899295|NCT00701298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899296|NCT00701298|Antiviral Agents|antiviral agents|mesh-ancestor
92899297|NCT00701298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899298|NCT00701298|Immunologic Factors|immunologic factors|mesh-ancestor
92899299|NCT00701298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899300|NCT00701298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92899301|NCT00701298|Antimetabolites|antimetabolites|mesh-ancestor
92899302|NCT00701298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899303|NCT00701298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899304|NCT00860574|Methotrexate|methotrexate|mesh-list
92899305|NCT00860574|Fludarabine phosphate|fludarabine phosphate|mesh-list
92899306|NCT00860574|Fludarabine|fludarabine|mesh-list
92899307|NCT00860574|Treosulfan|treosulfan|mesh-list
92899308|NCT00860574|Tacrolimus|tacrolimus|mesh-list
92899309|NCT00860574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92899310|NCT00860574|Abortifacient Agents|abortifacient agents|mesh-ancestor
92899311|NCT00860574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92544661|NCT01805726|Anesthetics|anesthetics|mesh-ancestor
92899312|NCT00860574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899313|NCT00860574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92899314|NCT00860574|Antimetabolites|antimetabolites|mesh-ancestor
92161312|NCT01678703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92899315|NCT00860574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899316|NCT00860574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899317|NCT00860574|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899318|NCT00860574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899319|NCT00860574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92899320|NCT00860574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899321|NCT00860574|Immunologic Factors|immunologic factors|mesh-ancestor
92899322|NCT00860574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899323|NCT00860574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92899324|NCT00860574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92899325|NCT00860574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92899326|NCT00860574|Alkylating Agents|alkylating agents|mesh-ancestor
92899327|NCT00496015|Acetaminophen|acetaminophen|mesh-list
92899328|NCT00496015|Vaccines|vaccines|mesh-list
92899329|NCT00496015|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92899330|NCT00496015|Immunologic Factors|immunologic factors|mesh-ancestor
92899331|NCT00496015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899332|NCT00496015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899333|NCT00496015|Analgesics|analgesics|mesh-ancestor
92899334|NCT00496015|Sensory System Agents|sensory system agents|mesh-ancestor
92899335|NCT00496015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899336|NCT00496015|Antipyretics|antipyretics|mesh-ancestor
92899337|NCT01018381|Ethanol|ethanol|mesh-list
92899338|NCT01018381|Entecavir|entecavir|mesh-list
92899339|NCT01018381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92899340|NCT01018381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899341|NCT01018381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899342|NCT01018381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899343|NCT01018381|Antiviral Agents|antiviral agents|mesh-ancestor
92899344|NCT00487825|Methotrexate|methotrexate|mesh-list
92899345|NCT00487825|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92899346|NCT00487825|Abortifacient Agents|abortifacient agents|mesh-ancestor
92899347|NCT00487825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92899348|NCT00487825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899349|NCT00487825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92899350|NCT00487825|Antimetabolites|antimetabolites|mesh-ancestor
92899351|NCT00487825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899352|NCT00487825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899353|NCT00487825|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899354|NCT00487825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899355|NCT00487825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92899356|NCT00487825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899357|NCT00487825|Immunologic Factors|immunologic factors|mesh-ancestor
92899358|NCT00487825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899359|NCT00487825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92899360|NCT00487747|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92899361|NCT00487747|Antiviral Agents|antiviral agents|mesh-ancestor
92899362|NCT00487747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899363|NCT01012141|Docetaxel|docetaxel|mesh-list
92899364|NCT01012141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899365|NCT01012141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92899366|NCT01012141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92899367|NCT01012141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92899368|NCT01012141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899369|NCT00487435|Tapentadol|tapentadol|mesh-list
92899370|NCT00487435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92899371|NCT00487435|Narcotics|narcotics|mesh-ancestor
92899372|NCT00487435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899373|NCT00487435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899374|NCT00487435|Analgesics|analgesics|mesh-ancestor
92899375|NCT00487435|Sensory System Agents|sensory system agents|mesh-ancestor
92899376|NCT00487435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899377|NCT00487435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92899378|NCT00487435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92899379|NCT00487435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92899380|NCT00487435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899381|NCT00487435|Adrenergic Agents|adrenergic agents|mesh-ancestor
92899382|NCT00487435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899383|NCT00495625|Sunitinib|sunitinib|mesh-list
92899384|NCT00495625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899385|NCT00495625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92899386|NCT00495625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92899387|NCT00495625|Growth Substances|growth substances|mesh-ancestor
92899388|NCT00495625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899389|NCT00495625|Growth Inhibitors|growth inhibitors|mesh-ancestor
92899390|NCT00495625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899391|NCT00495625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899392|NCT00495625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899393|NCT00847626|Chlorthalidone|chlorthalidone|mesh-list
92899394|NCT00847626|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92899395|NCT00847626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92899396|NCT00847626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92899397|NCT00847626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899398|NCT00847626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92899399|NCT00847626|Diuretics|diuretics|mesh-ancestor
92899400|NCT00847626|Natriuretic Agents|natriuretic agents|mesh-ancestor
92899401|NCT00847626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899402|NCT00847626|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92899403|NCT00847626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92899405|NCT04115904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899406|NCT04115904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899408|NCT04115904|Sensory System Agents|sensory system agents|mesh-ancestor
92899409|NCT04115904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899410|NCT04115904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899411|NCT04115904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899412|NCT04115904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899413|NCT04115904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92899414|NCT04115904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899415|NCT04115904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899416|NCT05297994|Vaccines|vaccines|mesh-list
92899417|NCT05297994|Immunologic Factors|immunologic factors|mesh-ancestor
92899418|NCT05297994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899419|NCT04116138|Antisecretory factor|antisecretory factor|mesh-list
92899420|NCT04116138|Antidiarrheals|antidiarrheals|mesh-ancestor
92899421|NCT04116138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899422|NCT00860262|Amlodipine|amlodipine|mesh-list
92899423|NCT00860262|Telmisartan|telmisartan|mesh-list
92899424|NCT00860262|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92899425|NCT00860262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92899426|NCT00860262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92899427|NCT00860262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92899428|NCT00860262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899429|NCT00860262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92899430|NCT00860262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899431|NCT00860262|Vasodilator Agents|vasodilator agents|mesh-ancestor
92899432|NCT00860262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92899433|NCT00860262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92899434|NCT00700830|Insulin Detemir|insulin detemir|mesh-list
92899435|NCT00700830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92899436|NCT00700830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899437|NCT00860028|Varenicline|varenicline|mesh-list
92899438|NCT00860028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92899439|NCT00860028|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92899440|NCT00860028|Cholinergic Agents|cholinergic agents|mesh-ancestor
92899441|NCT00860028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899442|NCT00860028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899443|NCT00860028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899444|NCT00701532|Modafinil|modafinil|mesh-list
92899445|NCT00701532|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92899446|NCT00701532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899447|NCT00701532|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92899448|NCT00701532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92899449|NCT00701532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92899450|NCT00701532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899451|NCT00846768|Olodaterol|olodaterol|mesh-list
92899452|NCT00846768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92899453|NCT00846768|Autonomic Agents|autonomic agents|mesh-ancestor
92899454|NCT00846768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899455|NCT00846768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899456|NCT00846768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92899457|NCT00846768|Respiratory System Agents|respiratory system agents|mesh-ancestor
92899458|NCT00863798|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92899459|NCT00863798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92899460|NCT00863798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92899461|NCT00863798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92899462|NCT00863798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899463|NCT00863798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899464|NCT00863798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899465|NCT00863798|Antidepressive Agents|antidepressive agents|mesh-ancestor
92899466|NCT00863798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92899467|NCT00697658|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92899468|NCT00697658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92899469|NCT00697658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92899470|NCT00697658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899471|NCT00697658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899472|NCT00697658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92525780|NCT00026338|Gemcitabine|gemcitabine|mesh-list
92899473|NCT00697658|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92899474|NCT00697658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92899475|NCT00697658|Serotonin Agents|serotonin agents|mesh-ancestor
92899476|NCT00697658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899477|NCT00697658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899478|NCT00697658|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92899479|NCT00697658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92899480|NCT00697658|Dopamine Agents|dopamine agents|mesh-ancestor
92899481|NCT00699426|Esomeprazole|esomeprazole|mesh-list
92899482|NCT00699426|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92899483|NCT00699426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899484|NCT00699426|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92899485|NCT00699426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899486|NCT00699426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899488|NCT00593606|Dopamine Agonists|dopamine agonists|mesh-ancestor
92899489|NCT00593606|Dopamine Agents|dopamine agents|mesh-ancestor
92899490|NCT00593606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899491|NCT00593606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899492|NCT00593606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899493|NCT02614118|Acetaminophen|acetaminophen|mesh-list
92899494|NCT02614118|Ketorolac|ketorolac|mesh-list
92899495|NCT02614118|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92899496|NCT02614118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899497|NCT02614118|Analgesics|analgesics|mesh-ancestor
92899498|NCT02614118|Sensory System Agents|sensory system agents|mesh-ancestor
92899499|NCT02614118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899500|NCT02614118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899501|NCT02614118|Antipyretics|antipyretics|mesh-ancestor
92899502|NCT02614118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899503|NCT02614118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899504|NCT02614118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899505|NCT02614118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92899506|NCT02614118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899507|NCT02614118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899508|NCT04134416|Donepezil|donepezil|mesh-list
92899509|NCT04134416|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92899510|NCT04134416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899511|NCT04134416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899512|NCT04134416|Cholinergic Agents|cholinergic agents|mesh-ancestor
92899513|NCT04134416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899514|NCT04134416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899515|NCT04134416|Nootropic Agents|nootropic agents|mesh-ancestor
92899516|NCT04134182|Nivolumab|nivolumab|mesh-list
92899517|NCT04134182|Ipilimumab|ipilimumab|mesh-list
92899518|NCT04134182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92899519|NCT04134182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899520|NCT04134182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92899521|NCT04134182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899522|NCT00870584|Omalizumab|omalizumab|mesh-list
92899523|NCT00870584|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92899524|NCT00870584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92899525|NCT00870584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92899526|NCT02614508|Ofatumumab|ofatumumab|mesh-list
92899527|NCT02614508|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92899528|NCT02614508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899529|NCT02614508|Immunologic Factors|immunologic factors|mesh-ancestor
92899530|NCT02614508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899531|NCT02616068|Loxoprofen|loxoprofen|mesh-list
92899532|NCT02616068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899533|NCT02616068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899534|NCT02616068|Analgesics|analgesics|mesh-ancestor
92899535|NCT02616068|Sensory System Agents|sensory system agents|mesh-ancestor
92544883|NCT01465919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92899536|NCT02616068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899537|NCT02616068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899538|NCT02616068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899539|NCT02616068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899541|NCT04127084|Canagliflozin|canagliflozin|mesh-list
92899542|NCT04127084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92899543|NCT04127084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899544|NCT04127084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92899545|NCT04127084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899546|NCT00870194|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92899547|NCT00870194|Exenatide|exenatide|mesh-list
92899548|NCT00870194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92899549|NCT00870194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899550|NCT00870194|Incretins|incretins|mesh-ancestor
92899551|NCT00870194|Hormones|hormones|mesh-ancestor
92899552|NCT00870194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899553|NCT00870194|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92899554|NCT00870194|Protease Inhibitors|protease inhibitors|mesh-ancestor
92899555|NCT00870194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899556|NCT00870194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899557|NCT00870194|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92899558|NCT00690430|Octreotide|octreotide|mesh-list
92899559|NCT00690430|Pasireotide|pasireotide|mesh-list
92899560|NCT00690430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899561|NCT00690430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92899562|NCT00690430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899563|NCT00690430|Hormones|hormones|mesh-ancestor
92899564|NCT00690430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899565|NCT00690430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899566|NCT04126304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92899567|NCT04126304|Azithromycin|azithromycin|mesh-list
92899568|NCT04126304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899569|NCT02563054|Fluorouracil|fluorouracil|mesh-list
92899570|NCT02563054|Capecitabine|capecitabine|mesh-list
92899571|NCT02563054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899572|NCT02563054|Antimetabolites|antimetabolites|mesh-ancestor
92899573|NCT02563054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899574|NCT02563054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92899575|NCT02563054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899576|NCT02563054|Immunologic Factors|immunologic factors|mesh-ancestor
92899577|NCT02563054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899578|NCT02614040|Plasma-lyte 148|plasma-lyte 148|mesh-list
92899579|NCT02614040|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92899580|NCT02614040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92899581|NCT00743470|Ritonavir|ritonavir|mesh-list
92899582|NCT00743470|Lopinavir|lopinavir|mesh-list
92899583|NCT00743470|Rifabutin|rifabutin|mesh-list
92899584|NCT00743470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92899585|NCT00743470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92899586|NCT00743470|Protease Inhibitors|protease inhibitors|mesh-ancestor
92899587|NCT00743470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899588|NCT00743470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899589|NCT00743470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92899590|NCT00743470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92899591|NCT00743470|Antiviral Agents|antiviral agents|mesh-ancestor
92899592|NCT00743470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899593|NCT00743470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92161327|NCT01141569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899594|NCT00743470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92899595|NCT00743470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92899596|NCT00743470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92899597|NCT00743470|Antitubercular Agents|antitubercular agents|mesh-ancestor
92899598|NCT00688324|Acamprosate|acamprosate|mesh-list
92899599|NCT00688324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92899600|NCT02619578|Remifentanil|remifentanil|mesh-list
92899601|NCT02619578|Propofol|propofol|mesh-list
92899602|NCT02619578|Vecuronium Bromide|vecuronium bromide|mesh-list
92899603|NCT02619578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92899604|NCT02619578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899605|NCT02619578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899606|NCT02619578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92899607|NCT02619578|Anesthetics, General|anesthetics, general|mesh-ancestor
92899608|NCT02619578|Anesthetics|anesthetics|mesh-ancestor
92899609|NCT02619578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92899610|NCT02619578|Narcotics|narcotics|mesh-ancestor
92899611|NCT02619578|Analgesics|analgesics|mesh-ancestor
92899612|NCT02619578|Sensory System Agents|sensory system agents|mesh-ancestor
92899613|NCT02619578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899614|NCT02619578|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92899615|NCT02619578|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92899616|NCT02619578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92899617|NCT02619578|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92899618|NCT02619578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92899619|NCT02619578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92899620|NCT02619578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899621|NCT02619578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899622|NCT02615912|Castor Oil|castor oil|mesh-list
92899623|NCT02615912|Cathartics|cathartics|mesh-ancestor
92899624|NCT02615912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899625|NCT04123652|Lidocaine|lidocaine|mesh-list
92899626|NCT04123652|Ketamine|ketamine|mesh-list
92899627|NCT04123652|Anesthetics, Local|anesthetics, local|mesh-ancestor
92899628|NCT04123652|Anesthetics|anesthetics|mesh-ancestor
92899629|NCT04123652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899630|NCT04123652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899631|NCT04123652|Sensory System Agents|sensory system agents|mesh-ancestor
92899632|NCT04123652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899633|NCT04123652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92899634|NCT04123652|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92899635|NCT04123652|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92899636|NCT04123652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92899637|NCT04123652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899638|NCT04123652|Analgesics|analgesics|mesh-ancestor
92899639|NCT04123652|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92899640|NCT04123652|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92899641|NCT04123652|Anesthetics, General|anesthetics, general|mesh-ancestor
92899642|NCT04123652|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92899643|NCT04123652|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92899644|NCT04123652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899645|NCT00862940|Memantine|memantine|mesh-list
92899646|NCT00862940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92899647|NCT00862940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92899648|NCT00862940|Dopamine Agents|dopamine agents|mesh-ancestor
92899649|NCT00862940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899650|NCT00862940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899651|NCT00862940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899652|NCT00862940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92899653|NCT00862940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92899654|NCT04122716|Liraglutide|liraglutide|mesh-list
92899655|NCT04122716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92899656|NCT04122716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899657|NCT04122716|Incretins|incretins|mesh-ancestor
92899658|NCT04122716|Hormones|hormones|mesh-ancestor
92899659|NCT04122716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899660|NCT00868166|Riluzole|riluzole|mesh-list
92899661|NCT00868166|Anticonvulsants|anticonvulsants|mesh-ancestor
92899662|NCT00868166|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92899663|NCT00868166|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92899664|NCT00868166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899665|NCT00868166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899666|NCT00868166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899667|NCT00868166|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92899668|NCT00868166|Protective Agents|protective agents|mesh-ancestor
92899669|NCT00858780|Etanercept|etanercept|mesh-list
92899670|NCT00858780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899671|NCT00858780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899672|NCT00858780|Analgesics|analgesics|mesh-ancestor
92899673|NCT00858780|Sensory System Agents|sensory system agents|mesh-ancestor
92899674|NCT00858780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899675|NCT00858780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899676|NCT00858780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899677|NCT00858780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899678|NCT00858780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899679|NCT00858780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899680|NCT00858780|Immunologic Factors|immunologic factors|mesh-ancestor
92899681|NCT02619266|Megestrol|megestrol|mesh-list
92899682|NCT02619266|Megestrol Acetate|megestrol acetate|mesh-list
92899683|NCT02619266|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92899684|NCT02619266|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92899685|NCT02619266|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92899686|NCT02619266|Contraceptive Agents|contraceptive agents|mesh-ancestor
92899687|NCT02619266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92899688|NCT02619266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899689|NCT02619266|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92899690|NCT02619266|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92899691|NCT02619266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92899693|NCT02619266|Appetite Stimulants|appetite stimulants|mesh-ancestor
92899694|NCT02619266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92899695|NCT00699062|Montelukast|montelukast|mesh-list
92899696|NCT00699062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92899697|NCT00699062|Respiratory System Agents|respiratory system agents|mesh-ancestor
92899698|NCT00699062|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92899699|NCT00699062|Hormone Antagonists|hormone antagonists|mesh-ancestor
92899700|NCT00699062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899701|NCT00699062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899702|NCT00699062|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92899703|NCT00699062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92899704|NCT00699062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899705|NCT02619032|Fentanyl|fentanyl|mesh-list
92899706|NCT02619032|Remifentanil|remifentanil|mesh-list
92899707|NCT02619032|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92899708|NCT02619032|Narcotics|narcotics|mesh-ancestor
92899709|NCT02619032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899710|NCT02619032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899711|NCT02619032|Analgesics|analgesics|mesh-ancestor
92899712|NCT02619032|Sensory System Agents|sensory system agents|mesh-ancestor
92899713|NCT02619032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899714|NCT02619032|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92899715|NCT02619032|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92899716|NCT02619032|Anesthetics, General|anesthetics, general|mesh-ancestor
92899717|NCT02619032|Anesthetics|anesthetics|mesh-ancestor
92899718|NCT00858234|Bortezomib|bortezomib|mesh-list
92899719|NCT00858234|Vorinostat|vorinostat|mesh-list
92899720|NCT00858234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899721|NCT00858234|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92899722|NCT00858234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899723|NCT00858234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899724|NCT00697814|Clomiphene|clomiphene|mesh-list
92899725|NCT00697814|Enclomiphene|enclomiphene|mesh-list
92899726|NCT00697814|Zuclomiphene|zuclomiphene|mesh-list
92899727|NCT00697814|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92899728|NCT00697814|Hormone Antagonists|hormone antagonists|mesh-ancestor
92899729|NCT00697814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92899730|NCT00697814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899731|NCT00697814|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92899732|NCT00697814|Fertility Agents|fertility agents|mesh-ancestor
92899733|NCT00697814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92899734|NCT00697814|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92899735|NCT00697814|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92899736|NCT00862082|Sorafenib|sorafenib|mesh-list
92899737|NCT00862082|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92899738|NCT00862082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899739|NCT00862082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899740|NCT00862082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899741|NCT00862082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899742|NCT00862082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92899743|NCT00862082|Alkylating Agents|alkylating agents|mesh-ancestor
92899744|NCT00849186|Sunitinib|sunitinib|mesh-list
92899745|NCT00849186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899746|NCT00849186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92899747|NCT00849186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92899748|NCT00849186|Growth Substances|growth substances|mesh-ancestor
92899749|NCT00849186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899750|NCT00849186|Growth Inhibitors|growth inhibitors|mesh-ancestor
92899751|NCT00849186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899752|NCT00849186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899753|NCT00849186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899754|NCT00692770|Sorafenib|sorafenib|mesh-list
92899755|NCT00692770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899756|NCT00692770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899757|NCT00692770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899758|NCT00692770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899759|NCT00867308|Lenalidomide|lenalidomide|mesh-list
92899760|NCT00867308|Immunologic Factors|immunologic factors|mesh-ancestor
92899761|NCT00867308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899762|NCT00867308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92899763|NCT00867308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92899765|NCT00867308|Growth Inhibitors|growth inhibitors|mesh-ancestor
92899766|NCT00867308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899767|NCT02618876|Nalbuphine|nalbuphine|mesh-list
92899768|NCT02618876|Bupivacaine|bupivacaine|mesh-list
92899769|NCT02618876|Anesthetics, Local|anesthetics, local|mesh-ancestor
92899770|NCT02618876|Anesthetics|anesthetics|mesh-ancestor
92899771|NCT02618876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899772|NCT02618876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899773|NCT02618876|Sensory System Agents|sensory system agents|mesh-ancestor
92899774|NCT02618876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899775|NCT02618876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92899776|NCT02618876|Narcotics|narcotics|mesh-ancestor
92899777|NCT02618876|Analgesics|analgesics|mesh-ancestor
92899778|NCT04119752|Curcumin|curcumin|mesh-list
92899779|NCT04119752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899780|NCT04119752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899781|NCT04119752|Analgesics|analgesics|mesh-ancestor
92899782|NCT04119752|Sensory System Agents|sensory system agents|mesh-ancestor
92899783|NCT04119752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899784|NCT04119752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899785|NCT04119752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899786|NCT04119752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899787|NCT04119752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899788|NCT04119752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899789|NCT04119752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899790|NCT00866918|Vitamins|vitamins|mesh-list
92899791|NCT00866918|Vitamin A|vitamin a|mesh-list
92899792|NCT00866918|Cytarabine|cytarabine|mesh-list
92899793|NCT00866918|Methotrexate|methotrexate|mesh-list
92899794|NCT00866918|Mercaptopurine|mercaptopurine|mesh-list
92899795|NCT00866918|Mitoxantrone|mitoxantrone|mesh-list
92899796|NCT00866918|Idarubicin|idarubicin|mesh-list
92899797|NCT00866918|Tretinoin|tretinoin|mesh-list
92899798|NCT00866918|Retinol palmitate|retinol palmitate|mesh-list
92899799|NCT00866918|Arsenic Trioxide|arsenic trioxide|mesh-list
92899800|NCT00866918|Micronutrients|micronutrients|mesh-ancestor
92899801|NCT00866918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899802|NCT00866918|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92899803|NCT00866918|Abortifacient Agents|abortifacient agents|mesh-ancestor
92899804|NCT00866918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92899805|NCT00866918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92899806|NCT00866918|Antimetabolites|antimetabolites|mesh-ancestor
92899807|NCT00866918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899808|NCT00866918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899809|NCT00866918|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899810|NCT00866918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899811|NCT00866918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92899812|NCT00866918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899813|NCT00866918|Immunologic Factors|immunologic factors|mesh-ancestor
92899814|NCT00866918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899815|NCT00866918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92899816|NCT00866918|Antiviral Agents|antiviral agents|mesh-ancestor
92899817|NCT00866918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899818|NCT00866918|Analgesics|analgesics|mesh-ancestor
92899819|NCT00866918|Sensory System Agents|sensory system agents|mesh-ancestor
92899820|NCT00866918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899821|NCT00866918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92899822|NCT00866918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92899823|NCT00866918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92899824|NCT00866918|Keratolytic Agents|keratolytic agents|mesh-ancestor
92899825|NCT00866918|Antioxidants|antioxidants|mesh-ancestor
92899826|NCT00866918|Protective Agents|protective agents|mesh-ancestor
92899827|NCT00866918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92899828|NCT00861692|Argatroban|argatroban|mesh-list
92899829|NCT00861692|Antithrombins|antithrombins|mesh-ancestor
92899830|NCT00861692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92899831|NCT00861692|Protease Inhibitors|protease inhibitors|mesh-ancestor
92899832|NCT00861692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899833|NCT00861692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899834|NCT00861692|Anticoagulants|anticoagulants|mesh-ancestor
92899835|NCT00861692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92899836|NCT03131765|Poly I-C|poly i-c|mesh-list
92899837|NCT03131765|Antiviral Agents|antiviral agents|mesh-ancestor
92899838|NCT03131765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899839|NCT03131765|Interferon Inducers|interferon inducers|mesh-ancestor
92899840|NCT03131765|Immunologic Factors|immunologic factors|mesh-ancestor
92899841|NCT03131765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899842|NCT02689037|Aspirin|aspirin|mesh-list
92899843|NCT02689037|Clopidogrel|clopidogrel|mesh-list
92899844|NCT02689037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899845|NCT02689037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899846|NCT02689037|Analgesics|analgesics|mesh-ancestor
92899847|NCT02689037|Sensory System Agents|sensory system agents|mesh-ancestor
92899848|NCT02689037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899849|NCT02689037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899850|NCT02689037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899851|NCT02689037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899852|NCT02689037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92899853|NCT02689037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92899854|NCT02689037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899855|NCT02689037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92899856|NCT02689037|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92899857|NCT02689037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899858|NCT02689037|Antipyretics|antipyretics|mesh-ancestor
92899859|NCT02689037|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92899860|NCT02689037|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92899861|NCT02689037|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92899862|NCT02689037|Purinergic Agents|purinergic agents|mesh-ancestor
92899863|NCT02689037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899864|NCT04184921|Aspirin|aspirin|mesh-list
92899865|NCT04184921|Osimertinib|osimertinib|mesh-list
92899866|NCT04184921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899867|NCT04184921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899868|NCT04184921|Analgesics|analgesics|mesh-ancestor
92899869|NCT04184921|Sensory System Agents|sensory system agents|mesh-ancestor
92899870|NCT04184921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899871|NCT04184921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899872|NCT04184921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899873|NCT04184921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899874|NCT04184921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92899875|NCT04184921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92899876|NCT04184921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899877|NCT04184921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92899878|NCT04184921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92899879|NCT04184921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899880|NCT04184921|Antipyretics|antipyretics|mesh-ancestor
92899881|NCT04184921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899882|NCT04184921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899883|NCT00602927|Varenicline|varenicline|mesh-list
92899884|NCT00602927|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92899885|NCT00602927|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92899886|NCT00602927|Cholinergic Agents|cholinergic agents|mesh-ancestor
92899887|NCT00602927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92899888|NCT00602927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899889|NCT00602927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899890|NCT00639743|Tenecteplase|tenecteplase|mesh-list
92899891|NCT00639743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92899892|NCT00639743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92899893|NCT00639743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899894|NCT04186559|Pentoxifylline|pentoxifylline|mesh-list
92899895|NCT04186559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92899896|NCT04186559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899897|NCT04186559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899898|NCT04186559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92899899|NCT04186559|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92899900|NCT04186559|Protective Agents|protective agents|mesh-ancestor
92899901|NCT04186559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899902|NCT04186559|Vasodilator Agents|vasodilator agents|mesh-ancestor
92899903|NCT04186559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92899904|NCT04186559|Antioxidants|antioxidants|mesh-ancestor
92899905|NCT00602537|Lithium Carbonate|lithium carbonate|mesh-list
92899906|NCT00602537|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92899907|NCT00602537|Antidepressive Agents|antidepressive agents|mesh-ancestor
92899908|NCT00602537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92899909|NCT00602537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899910|NCT00602537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899911|NCT00602537|Antimanic Agents|antimanic agents|mesh-ancestor
92899912|NCT00602537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92899913|NCT00602537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899914|NCT00602537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899915|NCT00602537|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92899916|NCT00602537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92899917|NCT00602537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92899919|NCT00602537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92899920|NCT02688803|Paclitaxel|paclitaxel|mesh-list
92899921|NCT02688803|Docetaxel|docetaxel|mesh-list
92899922|NCT02688803|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92899923|NCT02688803|Cyclophosphamide|cyclophosphamide|mesh-list
92899924|NCT02688803|Doxorubicin|doxorubicin|mesh-list
92899925|NCT02688803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92899926|NCT02688803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92899927|NCT02688803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899928|NCT02688803|Tubulin Modulators|tubulin modulators|mesh-ancestor
92899929|NCT02688803|Antimitotic Agents|antimitotic agents|mesh-ancestor
92899930|NCT02688803|Mitosis Modulators|mitosis modulators|mesh-ancestor
92899931|NCT02688803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899932|NCT02688803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899933|NCT02688803|Immunologic Factors|immunologic factors|mesh-ancestor
92899934|NCT02688803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899935|NCT02688803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899936|NCT02688803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92899937|NCT02688803|Alkylating Agents|alkylating agents|mesh-ancestor
92899938|NCT02688803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92899939|NCT02688803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92899940|NCT02688803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92899941|NCT02688803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92899942|NCT02688803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899943|NCT02684669|Naloxone|naloxone|mesh-list
92899944|NCT02684669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92899945|NCT02684669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899946|NCT02684669|Sensory System Agents|sensory system agents|mesh-ancestor
92899947|NCT02684669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899948|NCT02976935|Xenon|xenon|mesh-list
92899949|NCT02976935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92899950|NCT02976935|Anesthetics, General|anesthetics, general|mesh-ancestor
92899951|NCT02976935|Anesthetics|anesthetics|mesh-ancestor
92899952|NCT02976935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92899953|NCT02976935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899954|NCT00861614|Ipilimumab|ipilimumab|mesh-list
92899955|NCT00861614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92899956|NCT00861614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92899957|NCT00861614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92899958|NCT00861614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899959|NCT00861380|Vaccines|vaccines|mesh-list
92161338|NCT01141725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899960|NCT00861380|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92899961|NCT00861380|Immunologic Factors|immunologic factors|mesh-ancestor
92899962|NCT00861380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899963|NCT00495391|Ribavirin|ribavirin|mesh-list
92899964|NCT00495391|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92899965|NCT00495391|Nitazoxanide|nitazoxanide|mesh-list
92899966|NCT00495391|Antimetabolites|antimetabolites|mesh-ancestor
92899967|NCT00495391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899968|NCT00495391|Antiviral Agents|antiviral agents|mesh-ancestor
92899969|NCT00495391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92899970|NCT00495391|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92899971|NCT04378621|Adalimumab|adalimumab|mesh-list
92899972|NCT04378621|Infliximab|infliximab|mesh-list
92899973|NCT04378621|Golimumab|golimumab|mesh-list
92899974|NCT04378621|Certolizumab Pegol|certolizumab pegol|mesh-list
92899975|NCT04378621|Etanercept|etanercept|mesh-list
92899976|NCT04378621|Tofacitinib|tofacitinib|mesh-list
92899977|NCT04378621|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92899978|NCT04378621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92899979|NCT04378621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92899980|NCT04378621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92899981|NCT04378621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92899982|NCT04378621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92899983|NCT04378621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92899984|NCT04378621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92899985|NCT04378621|Analgesics|analgesics|mesh-ancestor
92899986|NCT04378621|Sensory System Agents|sensory system agents|mesh-ancestor
92899987|NCT04378621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92899988|NCT04378621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92899989|NCT04378621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92899990|NCT04378621|Immunologic Factors|immunologic factors|mesh-ancestor
92899991|NCT04378621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92899992|NCT04378621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92899993|NCT04378621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92899994|NCT00869960|Ritonavir|ritonavir|mesh-list
92899995|NCT00869960|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92899996|NCT00869960|Tenofovir|tenofovir|mesh-list
92899997|NCT00869960|Emtricitabine|emtricitabine|mesh-list
92899998|NCT00869960|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92899999|NCT00869960|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92900000|NCT00869960|Protease Inhibitors|protease inhibitors|mesh-ancestor
92900001|NCT00869960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900002|NCT00869960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900003|NCT00869960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92900004|NCT00869960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92900005|NCT00869960|Antiviral Agents|antiviral agents|mesh-ancestor
92900006|NCT00869960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900007|NCT00869960|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92900008|NCT00869960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92900009|NCT00869960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92900010|NCT00869960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92900011|NCT02618564|Sennosides|sennosides|mesh-list
92900012|NCT02618564|Laxatives|laxatives|mesh-ancestor
92900013|NCT02618564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92900014|NCT02615366|Tranexamic Acid|tranexamic acid|mesh-list
92900015|NCT02615366|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92900016|NCT02615366|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92900017|NCT02615366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900018|NCT02615366|Hemostatics|hemostatics|mesh-ancestor
92900019|NCT02615366|Coagulants|coagulants|mesh-ancestor
92900020|NCT00699296|Panobinostat|panobinostat|mesh-list
92900021|NCT00699296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900022|NCT00699296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92900023|NCT00699296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900024|NCT00699296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900025|NCT04119674|Temozolomide|temozolomide|mesh-list
92900026|NCT04119674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92900027|NCT04119674|Alkylating Agents|alkylating agents|mesh-ancestor
92900028|NCT04119674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900029|NCT04119674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900030|NCT00494299|Sorafenib|sorafenib|mesh-list
92900031|NCT00494299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900032|NCT00494299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900033|NCT00494299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900034|NCT00494299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900035|NCT05298176|Carboplatin|carboplatin|mesh-list
92900036|NCT05298176|Pemetrexed|pemetrexed|mesh-list
92900037|NCT05298176|Osimertinib|osimertinib|mesh-list
92900038|NCT05298176|Afatinib|afatinib|mesh-list
92900039|NCT05298176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900040|NCT05298176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900041|NCT05298176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900042|NCT05298176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92900043|NCT05298176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92900044|NCT05298176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900045|NCT02615288|Vitamin D|vitamin d|mesh-list
92900046|NCT02615288|Cholecalciferol|cholecalciferol|mesh-list
92900047|NCT02615288|Vitamins|vitamins|mesh-ancestor
92900048|NCT02615288|Micronutrients|micronutrients|mesh-ancestor
92900049|NCT02615288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900050|NCT02615288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92900051|NCT02615288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92900052|NCT02618096|Oxytocin|oxytocin|mesh-list
92900053|NCT02618096|Dinoprostone|dinoprostone|mesh-list
92900054|NCT02618096|Oxytocics|oxytocics|mesh-ancestor
92900055|NCT02618096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92900056|NCT02618096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900057|NCT04134026|Epoetin Alfa|epoetin alfa|mesh-list
92900058|NCT04134026|Hematinics|hematinics|mesh-ancestor
92900059|NCT02963831|Cyclophosphamide|cyclophosphamide|mesh-list
92900060|NCT02963831|Durvalumab|durvalumab|mesh-list
92900061|NCT02963831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92900062|NCT02963831|Immunologic Factors|immunologic factors|mesh-ancestor
92900063|NCT02963831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900064|NCT02963831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900065|NCT02963831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92900066|NCT02963831|Alkylating Agents|alkylating agents|mesh-ancestor
92900067|NCT02963831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900068|NCT02963831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900069|NCT02963831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92900070|NCT02963831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92900072|NCT00859898|Dapagliflozin|dapagliflozin|mesh-list
92900073|NCT00859898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92900074|NCT00859898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900075|NCT00859898|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92900076|NCT00859898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900077|NCT02684123|Apremilast|apremilast|mesh-list
92900078|NCT02684123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92900079|NCT02684123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900080|NCT02684123|Analgesics|analgesics|mesh-ancestor
92900081|NCT02684123|Sensory System Agents|sensory system agents|mesh-ancestor
92900082|NCT02684123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900083|NCT02684123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900084|NCT02684123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900085|NCT02684123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900086|NCT02684123|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92900087|NCT02684123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92900088|NCT02684123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900089|NCT02684123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900090|NCT00638729|Clonidine|clonidine|mesh-list
92900091|NCT00638729|Midazolam|midazolam|mesh-list
92900092|NCT00638729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92900093|NCT00638729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92900094|NCT00638729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900095|NCT00638729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900096|NCT00638729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92900097|NCT00638729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92900098|NCT00638729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92900099|NCT00638729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92900100|NCT00638729|Anesthetics, General|anesthetics, general|mesh-ancestor
92900101|NCT00638729|Anesthetics|anesthetics|mesh-ancestor
92900102|NCT00638729|GABA Modulators|gaba modulators|mesh-ancestor
92900103|NCT00638729|GABA Agents|gaba agents|mesh-ancestor
92900104|NCT00638729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900105|NCT00638729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900106|NCT00638729|Analgesics|analgesics|mesh-ancestor
92900107|NCT00638729|Sensory System Agents|sensory system agents|mesh-ancestor
92900108|NCT00638729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900109|NCT00638729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92900110|NCT00638729|Sympatholytics|sympatholytics|mesh-ancestor
92900111|NCT00638729|Autonomic Agents|autonomic agents|mesh-ancestor
92900112|NCT00638729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92900113|NCT00638729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92900114|NCT00638729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92900115|NCT00638729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92900116|NCT00697892|Ritonavir|ritonavir|mesh-list
92900117|NCT00697892|Lopinavir|lopinavir|mesh-list
92900118|NCT00697892|Efavirenz|efavirenz|mesh-list
92900119|NCT00697892|Lumefantrine|lumefantrine|mesh-list
92900120|NCT00697892|Artemether|artemether|mesh-list
92900121|NCT00697892|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92900122|NCT00697892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92900123|NCT00697892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92900124|NCT00697892|Protease Inhibitors|protease inhibitors|mesh-ancestor
92900125|NCT00697892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900126|NCT00697892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900127|NCT00697892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92900128|NCT00697892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92900129|NCT00697892|Antiviral Agents|antiviral agents|mesh-ancestor
92900130|NCT00697892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900131|NCT00697892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92900132|NCT00697892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92900133|NCT00697892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92900134|NCT00697892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92900135|NCT00697892|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92900136|NCT00697892|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92900137|NCT00697892|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92900138|NCT00697892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92900139|NCT00697892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92900140|NCT00697892|Antimalarials|antimalarials|mesh-ancestor
92900141|NCT00697892|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92900142|NCT00697892|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92900143|NCT00699452|Candesartan|candesartan|mesh-list
92900144|NCT00699452|Candesartan cilexetil|candesartan cilexetil|mesh-list
92900145|NCT00699452|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92900146|NCT00699452|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92900147|NCT00699452|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92900148|NCT00699452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900149|NCT02683733|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92900150|NCT02683733|Curcumin|curcumin|mesh-list
92900151|NCT02683733|Mesalamine|mesalamine|mesh-list
92900152|NCT02683733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92900153|NCT02683733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900154|NCT02683733|Analgesics|analgesics|mesh-ancestor
92900155|NCT02683733|Sensory System Agents|sensory system agents|mesh-ancestor
92900156|NCT02683733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900157|NCT02683733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900158|NCT02683733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900159|NCT02683733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900160|NCT02683733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900161|NCT02683733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900162|NCT02683733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900163|NCT02683733|Antitubercular Agents|antitubercular agents|mesh-ancestor
92900164|NCT02683733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92900165|NCT02683733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900166|NCT02683655|Apatinib|apatinib|mesh-list
92900167|NCT02683655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900168|NCT02683655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900169|NCT02683655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900170|NCT02683655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900171|NCT00494221|Leucovorin|leucovorin|mesh-list
92900172|NCT00494221|Fluorouracil|fluorouracil|mesh-list
92900173|NCT00494221|Oxaliplatin|oxaliplatin|mesh-list
92900174|NCT00494221|Cediranib|cediranib|mesh-list
92900175|NCT00494221|Levoleucovorin|levoleucovorin|mesh-list
92900176|NCT00494221|Antimetabolites|antimetabolites|mesh-ancestor
92900177|NCT00494221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900178|NCT00494221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900179|NCT00494221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900180|NCT00494221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92900181|NCT00494221|Immunologic Factors|immunologic factors|mesh-ancestor
92900182|NCT00494221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900183|NCT00494221|Antidotes|antidotes|mesh-ancestor
92900184|NCT00494221|Protective Agents|protective agents|mesh-ancestor
92900185|NCT00494221|Vitamin B Complex|vitamin b complex|mesh-ancestor
92900186|NCT00494221|Vitamins|vitamins|mesh-ancestor
92900187|NCT00494221|Micronutrients|micronutrients|mesh-ancestor
92900188|NCT00494221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900189|NCT00494221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900190|NCT00909935|Dexmedetomidine|dexmedetomidine|mesh-list
92900191|NCT00909935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92900192|NCT00909935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900193|NCT00909935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900194|NCT00909935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900195|NCT00909935|Analgesics|analgesics|mesh-ancestor
92900196|NCT00909935|Sensory System Agents|sensory system agents|mesh-ancestor
92900197|NCT00909935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900198|NCT00909935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92900199|NCT00909935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92900200|NCT00909935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92900201|NCT00909935|Adrenergic Agents|adrenergic agents|mesh-ancestor
92900202|NCT00909935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900203|NCT00909935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900204|NCT00857948|Ivermectin|ivermectin|mesh-list
92900205|NCT00857948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92900206|NCT00857948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900207|NCT02688491|Sunitinib|sunitinib|mesh-list
92900208|NCT02688491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900209|NCT02688491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92545567|NCT00276146|Dipyridamole|dipyridamole|mesh-list
92900210|NCT02688491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900211|NCT02688491|Growth Substances|growth substances|mesh-ancestor
92900212|NCT02688491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900213|NCT02688491|Growth Inhibitors|growth inhibitors|mesh-ancestor
92900214|NCT02688491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900215|NCT02688491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900216|NCT02688491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900217|NCT00857792|Regadenoson|regadenoson|mesh-list
92900218|NCT00857792|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92900219|NCT00857792|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92900220|NCT00857792|Purinergic Agonists|purinergic agonists|mesh-ancestor
92900221|NCT00857792|Purinergic Agents|purinergic agents|mesh-ancestor
92900222|NCT00857792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900223|NCT00857792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900224|NCT00857792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900225|NCT02613494|Glycopyrrolate|glycopyrrolate|mesh-list
92900226|NCT02613494|Scopolamine|scopolamine|mesh-list
92900227|NCT02613494|Bromides|bromides|mesh-list
92900228|NCT02613494|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92900229|NCT02613494|Anticonvulsants|anticonvulsants|mesh-ancestor
92900230|NCT02613494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92900231|NCT02613494|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92900232|NCT02613494|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92900233|NCT02613494|Cholinergic Agents|cholinergic agents|mesh-ancestor
92900234|NCT02613494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900235|NCT02613494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900236|NCT02613494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900237|NCT02613494|Antiemetics|antiemetics|mesh-ancestor
92900238|NCT02613494|Autonomic Agents|autonomic agents|mesh-ancestor
92900239|NCT02613494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900240|NCT02613494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92900241|NCT02613494|Mydriatics|mydriatics|mesh-ancestor
92900242|NCT02613494|Parasympatholytics|parasympatholytics|mesh-ancestor
92900243|NCT00699530|Cabergoline|cabergoline|mesh-list
92900244|NCT00699530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92900245|NCT00699530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92900246|NCT00699530|Dopamine Agonists|dopamine agonists|mesh-ancestor
92900247|NCT00699530|Dopamine Agents|dopamine agents|mesh-ancestor
92900248|NCT00699530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900249|NCT00699530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900250|NCT00699530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900251|NCT02617862|Anesthetics|anesthetics|mesh-list
92900252|NCT02617862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900253|NCT02617862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900254|NCT00601835|Vaccines|vaccines|mesh-list
92900255|NCT00601835|Immunologic Factors|immunologic factors|mesh-ancestor
92900256|NCT00601835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900257|NCT00640367|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92900258|NCT00640367|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92900259|NCT00640367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92900260|NCT00640367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900261|NCT00697502|Capecitabine|capecitabine|mesh-list
92900262|NCT00697502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900264|NCT00697502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900265|NCT00697502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900266|NCT00857246|Irinotecan|irinotecan|mesh-list
92900267|NCT00857246|Cetuximab|cetuximab|mesh-list
92900268|NCT00857246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900269|NCT00857246|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92900270|NCT00857246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92900271|NCT00857246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900272|NCT00857246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900273|NCT00857246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92900274|NCT00699686|Insulin Glargine|insulin glargine|mesh-list
92900275|NCT00699686|Insulin Detemir|insulin detemir|mesh-list
92900276|NCT00699686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92900277|NCT00699686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900278|NCT00640679|Clopidogrel|clopidogrel|mesh-list
92900279|NCT00640679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92900280|NCT00640679|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92900281|NCT00640679|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92900282|NCT00640679|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92900283|NCT00640679|Purinergic Agents|purinergic agents|mesh-ancestor
92900284|NCT00640679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900285|NCT00640679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900286|NCT00640679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900287|NCT02682953|Plerixafor|plerixafor|mesh-list
92900288|NCT02682953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92900289|NCT02682953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92900290|NCT02682953|Antiviral Agents|antiviral agents|mesh-ancestor
92900291|NCT02682953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900292|NCT02683031|Ionophores|ionophores|mesh-list
92900293|NCT02683031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900294|NCT02683031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900295|NCT04184141|Alprazolam|alprazolam|mesh-list
92900296|NCT04184141|Hydroxyzine|hydroxyzine|mesh-list
92900297|NCT04184141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92900298|NCT04184141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900299|NCT04184141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900300|NCT04184141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92900301|NCT04184141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92900302|NCT04184141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92900303|NCT04184141|GABA Modulators|gaba modulators|mesh-ancestor
92900304|NCT04184141|GABA Agents|gaba agents|mesh-ancestor
92900305|NCT04184141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900306|NCT04184141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900307|NCT04184141|Antipruritics|antipruritics|mesh-ancestor
92900308|NCT04184141|Dermatologic Agents|dermatologic agents|mesh-ancestor
92900309|NCT04184141|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92900310|NCT04184141|Histamine Antagonists|histamine antagonists|mesh-ancestor
92900311|NCT04184141|Histamine Agents|histamine agents|mesh-ancestor
92900312|NCT02682329|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92900313|NCT02682329|Carbamide Peroxide|carbamide peroxide|mesh-list
92900314|NCT02682329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92900315|NCT02682329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900316|NCT00640991|Insulin|insulin|mesh-list
92900317|NCT00640991|Insulin Glargine|insulin glargine|mesh-list
92900318|NCT00640991|Insulin glulisine|insulin glulisine|mesh-list
92900319|NCT00640991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92900320|NCT00640991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900321|NCT00638807|Celecoxib|celecoxib|mesh-list
92900322|NCT00638807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92900323|NCT00638807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900324|NCT00638807|Analgesics|analgesics|mesh-ancestor
92900325|NCT00638807|Sensory System Agents|sensory system agents|mesh-ancestor
92900326|NCT00638807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900327|NCT00638807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900328|NCT00638807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900329|NCT00638807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900330|NCT00638807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92900331|NCT00638807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92900332|NCT00638807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900333|NCT00638807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900334|NCT00856856|Everolimus|everolimus|mesh-list
92900335|NCT00856856|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92900336|NCT00856856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900338|NCT00856856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900339|NCT00856856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92900340|NCT00856856|Immunologic Factors|immunologic factors|mesh-ancestor
92900341|NCT00856856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900342|NCT00856856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900343|NCT00782327|Losartan|losartan|mesh-list
92900344|NCT00782327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900345|NCT00782327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92900346|NCT00782327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92900347|NCT00782327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92900348|NCT00782327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900349|NCT00559091|Ribavirin|ribavirin|mesh-list
92900350|NCT00559091|Antimetabolites|antimetabolites|mesh-ancestor
92900351|NCT00559091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900352|NCT00559091|Antiviral Agents|antiviral agents|mesh-ancestor
92900353|NCT00559091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900354|NCT02682017|Fucoidan|fucoidan|mesh-list
92900355|NCT02682017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92900356|NCT02682017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92900357|NCT02682017|Anticoagulants|anticoagulants|mesh-ancestor
92900358|NCT02682017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900359|NCT04076579|Olaparib|olaparib|mesh-list
92900360|NCT04076579|Trabectedin|trabectedin|mesh-list
92545703|NCT00275522|Sirolimus|sirolimus|mesh-list
92900361|NCT04076579|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92900362|NCT04076579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900363|NCT04076579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900364|NCT04076579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900365|NCT04076579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92900366|NCT04076579|Alkylating Agents|alkylating agents|mesh-ancestor
92900367|NCT00603473|Gabapentin|gabapentin|mesh-list
92900368|NCT00603473|Analgesics|analgesics|mesh-ancestor
92900369|NCT00603473|Sensory System Agents|sensory system agents|mesh-ancestor
92900370|NCT00603473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900371|NCT00603473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900372|NCT00603473|Anticonvulsants|anticonvulsants|mesh-ancestor
92900373|NCT00603473|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92900374|NCT00603473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92900375|NCT00603473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900376|NCT00603473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92900377|NCT00603473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92900378|NCT00603473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92900379|NCT00603473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900380|NCT00603473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900381|NCT00603473|Antimanic Agents|antimanic agents|mesh-ancestor
92900382|NCT02688023|Leucovorin|leucovorin|mesh-list
92900383|NCT02688023|Fluorouracil|fluorouracil|mesh-list
92900384|NCT02688023|Capecitabine|capecitabine|mesh-list
92900385|NCT02688023|Oxaliplatin|oxaliplatin|mesh-list
92900386|NCT02688023|Irinotecan|irinotecan|mesh-list
92900387|NCT02688023|Antimetabolites|antimetabolites|mesh-ancestor
92900388|NCT02688023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900389|NCT02688023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900390|NCT02688023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900391|NCT02688023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92900392|NCT02688023|Immunologic Factors|immunologic factors|mesh-ancestor
92900393|NCT02688023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900394|NCT02688023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92900395|NCT02688023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92900396|NCT02688023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900397|NCT02688023|Antidotes|antidotes|mesh-ancestor
92900398|NCT02688023|Protective Agents|protective agents|mesh-ancestor
92900399|NCT02688023|Vitamin B Complex|vitamin b complex|mesh-ancestor
92900400|NCT02688023|Vitamins|vitamins|mesh-ancestor
92900401|NCT02688023|Micronutrients|micronutrients|mesh-ancestor
92900402|NCT00910013|Ropivacaine|ropivacaine|mesh-list
92900403|NCT00910013|Anesthetics, Local|anesthetics, local|mesh-ancestor
92900404|NCT00910013|Anesthetics|anesthetics|mesh-ancestor
92900405|NCT00910013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900406|NCT00910013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900407|NCT00910013|Sensory System Agents|sensory system agents|mesh-ancestor
92900408|NCT00910013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900409|NCT04182191|Tenoxicam|tenoxicam|mesh-list
92245209|NCT04421742|Glucocorticoids|glucocorticoids|mesh-ancestor
92900411|NCT04182191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900412|NCT04182191|Analgesics|analgesics|mesh-ancestor
92900413|NCT04182191|Sensory System Agents|sensory system agents|mesh-ancestor
92900414|NCT04182191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900415|NCT04182191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900416|NCT04182191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900417|NCT04182191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900418|NCT04182191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92900419|NCT04182191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900420|NCT04182191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900421|NCT02680379|Minocycline|minocycline|mesh-list
92900422|NCT02680379|Lovastatin|lovastatin|mesh-list
92900423|NCT02680379|L 647318|l 647318|mesh-list
92900424|NCT02680379|Dihydromevinolin|dihydromevinolin|mesh-list
92900425|NCT02680379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92900426|NCT02680379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900427|NCT02680379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92900428|NCT02680379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92900429|NCT02680379|Antimetabolites|antimetabolites|mesh-ancestor
92900430|NCT02680379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900431|NCT02680379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92900432|NCT02680379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92900433|NCT02680379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900434|NCT03996421|Ferrous fumarate|ferrous fumarate|mesh-list
92900435|NCT03996421|Trace Elements|trace elements|mesh-ancestor
92900436|NCT03996421|Micronutrients|micronutrients|mesh-ancestor
92900437|NCT03996421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900439|NCT00641693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900440|NCT00641693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92900441|NCT00641693|Autonomic Agents|autonomic agents|mesh-ancestor
92900442|NCT00641693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900443|NCT00641693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900444|NCT00641693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92900445|NCT00641693|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900446|NCT00641693|Glucocorticoids|glucocorticoids|mesh-ancestor
92900447|NCT00641693|Hormones|hormones|mesh-ancestor
92900448|NCT00641693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92900449|NCT04183361|Cortisone|cortisone|mesh-list
92900450|NCT04183361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900451|NCT02687867|Vitamin K|vitamin k|mesh-list
92900452|NCT02687867|Dabigatran|dabigatran|mesh-list
92900453|NCT02687867|Vitamins|vitamins|mesh-ancestor
92900454|NCT02687867|Micronutrients|micronutrients|mesh-ancestor
92900455|NCT02687867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900456|NCT02687867|Antithrombins|antithrombins|mesh-ancestor
92900457|NCT02687867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92900458|NCT02687867|Protease Inhibitors|protease inhibitors|mesh-ancestor
92900459|NCT02687867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900460|NCT02687867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900461|NCT02687867|Anticoagulants|anticoagulants|mesh-ancestor
92900462|NCT02687867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92900463|NCT02687867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92900464|NCT02687867|Hemostatics|hemostatics|mesh-ancestor
92900465|NCT02687867|Coagulants|coagulants|mesh-ancestor
92900466|NCT02681783|Aflibercept|aflibercept|mesh-list
92900467|NCT02681783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92900468|NCT02681783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900469|NCT02681783|Growth Substances|growth substances|mesh-ancestor
92900470|NCT02681783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900471|NCT02681783|Growth Inhibitors|growth inhibitors|mesh-ancestor
92900472|NCT02681783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900473|NCT00486811|Oxycodone|oxycodone|mesh-list
92900474|NCT00486811|Tapentadol|tapentadol|mesh-list
92900475|NCT00486811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92900476|NCT00486811|Narcotics|narcotics|mesh-ancestor
92900477|NCT00486811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900478|NCT00486811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900479|NCT00486811|Analgesics|analgesics|mesh-ancestor
92900480|NCT00486811|Sensory System Agents|sensory system agents|mesh-ancestor
92900481|NCT00486811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900482|NCT00486811|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92900483|NCT00486811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92900484|NCT00486811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900485|NCT00486811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900486|NCT00486811|Adrenergic Agents|adrenergic agents|mesh-ancestor
92900487|NCT00486811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900489|NCT00921700|Ibuprofen|ibuprofen|mesh-list
92900490|NCT00921700|Codeine|codeine|mesh-list
92900491|NCT00921700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900492|NCT00921700|Analgesics|analgesics|mesh-ancestor
92900493|NCT00921700|Sensory System Agents|sensory system agents|mesh-ancestor
92900494|NCT00921700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900495|NCT00921700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900496|NCT00921700|Antipyretics|antipyretics|mesh-ancestor
92900497|NCT00921700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92900498|NCT00921700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900499|NCT00921700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900500|NCT00921700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92900501|NCT00921700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900502|NCT00921700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900503|NCT00921700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92900504|NCT00921700|Narcotics|narcotics|mesh-ancestor
92900505|NCT00921700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900506|NCT00921700|Antitussive Agents|antitussive agents|mesh-ancestor
92900507|NCT00921700|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900508|NCT02678195|Amoxicillin|amoxicillin|mesh-list
92900509|NCT02678195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92900510|NCT02678195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900511|NCT03996577|Lidocaine|lidocaine|mesh-list
92900512|NCT03996577|Anesthetics, Local|anesthetics, local|mesh-ancestor
92900513|NCT03996577|Anesthetics|anesthetics|mesh-ancestor
92900514|NCT03996577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900515|NCT03996577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900516|NCT03996577|Sensory System Agents|sensory system agents|mesh-ancestor
92900517|NCT03996577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900518|NCT03996577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900519|NCT03996577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92900520|NCT03996577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92900521|NCT03996577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900522|NCT03996577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900523|NCT02681705|Temozolomide|temozolomide|mesh-list
92900524|NCT02681705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92900525|NCT02681705|Alkylating Agents|alkylating agents|mesh-ancestor
92900526|NCT02681705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900527|NCT02681705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900528|NCT00921622|Vitamin D|vitamin d|mesh-list
92900529|NCT00921622|Vitamins|vitamins|mesh-list
92900530|NCT00921622|Micronutrients|micronutrients|mesh-ancestor
92900531|NCT00921622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900532|NCT00921622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92900533|NCT02681471|Mannitol|mannitol|mesh-list
92900534|NCT02681471|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92900535|NCT02681471|Diuretics|diuretics|mesh-ancestor
92900536|NCT02681471|Natriuretic Agents|natriuretic agents|mesh-ancestor
92900537|NCT02681471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900538|NCT00642395|Bortezomib|bortezomib|mesh-list
92900539|NCT00642395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900540|NCT01018615|Silymarin|silymarin|mesh-list
92900541|NCT01018615|Antioxidants|antioxidants|mesh-ancestor
92900542|NCT01018615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900543|NCT01018615|Protective Agents|protective agents|mesh-ancestor
92900544|NCT01018615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900545|NCT00743782|Hormones|hormones|mesh-list
92900546|NCT00743782|Parathyroid Hormone|parathyroid hormone|mesh-list
92900547|NCT00743782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92900548|NCT00743782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900549|NCT00743782|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92900550|NCT02678117|Magnesium Sulfate|magnesium sulfate|mesh-list
92900551|NCT02678117|Pregabalin|pregabalin|mesh-list
92900552|NCT02678117|Analgesics|analgesics|mesh-ancestor
92900553|NCT02678117|Sensory System Agents|sensory system agents|mesh-ancestor
92900554|NCT02678117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900555|NCT02678117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900556|NCT02678117|Anticonvulsants|anticonvulsants|mesh-ancestor
92900557|NCT02678117|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92900558|NCT02678117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900559|NCT02678117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245350|NCT04214886|Fludarabine|fludarabine|mesh-list
92900560|NCT02678117|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92900561|NCT02678117|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92900562|NCT02678117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92900563|NCT02678117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900564|NCT02678117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92900565|NCT02678117|Anesthetics|anesthetics|mesh-ancestor
92900566|NCT02678117|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900567|NCT02678117|Tocolytic Agents|tocolytic agents|mesh-ancestor
92900568|NCT02678117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92900569|NCT01018849|Vitamin D|vitamin d|mesh-list
92900570|NCT01018849|Cholecalciferol|cholecalciferol|mesh-list
92900571|NCT01018849|Vitamins|vitamins|mesh-ancestor
92900572|NCT01018849|Micronutrients|micronutrients|mesh-ancestor
92900573|NCT01018849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900574|NCT01018849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92900575|NCT01018849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92900576|NCT04102319|Hepcidins|hepcidins|mesh-list
92900577|NCT04102319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900578|NCT00743860|Darapladib|darapladib|mesh-list
92900579|NCT00743860|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92900580|NCT00743860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900581|NCT00743860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900582|NCT00747526|Rabeprazole|rabeprazole|mesh-list
92900583|NCT00747526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92900584|NCT00747526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92900585|NCT00747526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92900586|NCT00747526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545928|NCT00394394|Natriuretic Agents|natriuretic agents|mesh-ancestor
92900587|NCT00747526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900588|NCT00747604|Mecasermin|mecasermin|mesh-list
92900589|NCT00747604|Growth Substances|growth substances|mesh-ancestor
92900590|NCT00747604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900592|NCT02151604|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92900593|NCT02151604|Anesthetics, General|anesthetics, general|mesh-ancestor
92900594|NCT02151604|Anesthetics|anesthetics|mesh-ancestor
92900595|NCT02151604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900596|NCT02151604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900597|NCT00466921|Lenalidomide|lenalidomide|mesh-list
92900598|NCT00466921|Immunologic Factors|immunologic factors|mesh-ancestor
92900599|NCT00466921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900600|NCT00466921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92900601|NCT00466921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900602|NCT00466921|Growth Substances|growth substances|mesh-ancestor
92900603|NCT00466921|Growth Inhibitors|growth inhibitors|mesh-ancestor
92900604|NCT00466921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900605|NCT00601523|Pramipexole|pramipexole|mesh-list
92900606|NCT00601523|Antioxidants|antioxidants|mesh-ancestor
92900607|NCT00601523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900608|NCT00601523|Protective Agents|protective agents|mesh-ancestor
92900609|NCT00601523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900610|NCT00601523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92900611|NCT00601523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92900612|NCT00601523|Dopamine Agonists|dopamine agonists|mesh-ancestor
92900613|NCT00601523|Dopamine Agents|dopamine agents|mesh-ancestor
92900614|NCT00601523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900615|NCT00466687|Bevacizumab|bevacizumab|mesh-list
92900616|NCT00466687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92900617|NCT00466687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92900618|NCT00466687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900619|NCT00466687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92900620|NCT00466687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900621|NCT00466687|Growth Substances|growth substances|mesh-ancestor
92900622|NCT00466687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900623|NCT00466687|Growth Inhibitors|growth inhibitors|mesh-ancestor
92900624|NCT00466687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900625|NCT00466687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900626|NCT00466687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900627|NCT01522768|Paclitaxel|paclitaxel|mesh-list
92900628|NCT01522768|Afatinib|afatinib|mesh-list
92900629|NCT01522768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92900630|NCT01522768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900631|NCT01522768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92900632|NCT01522768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92900633|NCT01522768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92900634|NCT01522768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900635|NCT01522768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900636|NCT01522768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900638|NCT01759459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92900639|NCT01759459|Anesthetics|anesthetics|mesh-ancestor
92900640|NCT01759459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900641|NCT01759459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900642|NCT01759459|Sensory System Agents|sensory system agents|mesh-ancestor
92900643|NCT01759459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900644|NCT01759459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900645|NCT01759459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92900646|NCT01759459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92900647|NCT01759459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900648|NCT01759459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900649|NCT02562742|Ribavirin|ribavirin|mesh-list
92900650|NCT02562742|Antimetabolites|antimetabolites|mesh-ancestor
92900651|NCT02562742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900652|NCT02562742|Antiviral Agents|antiviral agents|mesh-ancestor
92900653|NCT02562742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900654|NCT00744016|Mesalamine|mesalamine|mesh-list
92900655|NCT00744016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92900656|NCT00744016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92900657|NCT00744016|Analgesics|analgesics|mesh-ancestor
92900658|NCT00744016|Sensory System Agents|sensory system agents|mesh-ancestor
92900659|NCT00744016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900660|NCT00744016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900661|NCT00744016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900662|NCT00744016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900663|NCT04182737|Immunoglobulins|immunoglobulins|mesh-list
92900664|NCT04182737|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92900665|NCT04182737|Antibodies|antibodies|mesh-list
92900666|NCT04182737|Immunoglobulin M|immunoglobulin m|mesh-list
92900667|NCT04182737|Immunoglobulin A|immunoglobulin a|mesh-list
92900668|NCT04182737|Immunologic Factors|immunologic factors|mesh-ancestor
92900669|NCT04182737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900670|NCT04181645|Paclitaxel|paclitaxel|mesh-list
92900671|NCT04181645|Gemcitabine|gemcitabine|mesh-list
92900672|NCT04181645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92900673|NCT04181645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900674|NCT04181645|Tubulin Modulators|tubulin modulators|mesh-ancestor
92900675|NCT04181645|Antimitotic Agents|antimitotic agents|mesh-ancestor
92900676|NCT04181645|Mitosis Modulators|mitosis modulators|mesh-ancestor
92900677|NCT04181645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900678|NCT04181645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900679|NCT04181645|Antimetabolites|antimetabolites|mesh-ancestor
92900680|NCT02679833|Vitamin B 12|vitamin b 12|mesh-list
92900681|NCT02679833|Hydroxocobalamin|hydroxocobalamin|mesh-list
92900682|NCT02679833|Vitamin B Complex|vitamin b complex|mesh-ancestor
92900683|NCT02679833|Vitamins|vitamins|mesh-ancestor
92900684|NCT02679833|Micronutrients|micronutrients|mesh-ancestor
92900685|NCT02679833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900686|NCT02679833|Hematinics|hematinics|mesh-ancestor
92900687|NCT00641927|Lithium Carbonate|lithium carbonate|mesh-list
92900688|NCT00641927|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92900689|NCT00641927|Antidepressive Agents|antidepressive agents|mesh-ancestor
92200832|NCT02285283|Itraconazole|itraconazole|mesh-list
92900690|NCT00641927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92900691|NCT00641927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900692|NCT00641927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900693|NCT00641927|Antimanic Agents|antimanic agents|mesh-ancestor
92900694|NCT00641927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92900695|NCT00641927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900696|NCT00641927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900697|NCT00641927|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92900698|NCT00641927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92900699|NCT00641927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900700|NCT00641927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525821|NCT00026416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900701|NCT00641927|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92900703|NCT02677571|Levobupivacaine|levobupivacaine|mesh-list
92900704|NCT02677571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92900705|NCT02677571|Narcotics|narcotics|mesh-ancestor
92900706|NCT02677571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900707|NCT02677571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900708|NCT02677571|Analgesics|analgesics|mesh-ancestor
92900709|NCT02677571|Sensory System Agents|sensory system agents|mesh-ancestor
92900710|NCT02677571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900711|NCT02677571|Anesthetics, Local|anesthetics, local|mesh-ancestor
92900712|NCT02677571|Anesthetics|anesthetics|mesh-ancestor
92900713|NCT04181567|Agomelatine|agomelatine|mesh-list
92900714|NCT04181567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92900715|NCT04181567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900716|NCT04181567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900717|NCT05664191|Simendan|simendan|mesh-list
92900718|NCT05664191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92900719|NCT05664191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92900720|NCT05664191|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92900721|NCT05664191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92900722|NCT05664191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900723|NCT05664191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900724|NCT05664191|Protective Agents|protective agents|mesh-ancestor
92900725|NCT05664191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900726|NCT02676011|Atropine|atropine|mesh-list
92900727|NCT02676011|Succinylcholine|succinylcholine|mesh-list
92900728|NCT02676011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92900729|NCT02676011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900730|NCT02676011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92900731|NCT02676011|Autonomic Agents|autonomic agents|mesh-ancestor
92900732|NCT02676011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900733|NCT02676011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900734|NCT02676011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92900735|NCT02676011|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900736|NCT02676011|Mydriatics|mydriatics|mesh-ancestor
92900737|NCT02676011|Parasympatholytics|parasympatholytics|mesh-ancestor
92900738|NCT02676011|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92900739|NCT02676011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92900740|NCT02676011|Cholinergic Agents|cholinergic agents|mesh-ancestor
92900741|NCT02676011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900742|NCT02676011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900743|NCT02676011|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92900744|NCT02676011|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92900745|NCT02676011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92900746|NCT05662943|Aflibercept|aflibercept|mesh-list
92900747|NCT05662943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92900748|NCT05662943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900749|NCT05662943|Growth Substances|growth substances|mesh-ancestor
92900750|NCT05662943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900751|NCT05662943|Growth Inhibitors|growth inhibitors|mesh-ancestor
92900752|NCT05662943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900753|NCT05663255|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92900754|NCT05663255|Azithromycin|azithromycin|mesh-list
92900755|NCT05663255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900756|NCT02678975|Copper|copper|mesh-list
92900757|NCT02678975|Temozolomide|temozolomide|mesh-list
92900758|NCT02678975|Lomustine|lomustine|mesh-list
92900759|NCT02678975|Disulfiram|disulfiram|mesh-list
92900760|NCT02678975|Alkylating Agents|alkylating agents|mesh-list
92900761|NCT02678975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92900762|NCT02678975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900763|NCT02678975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900764|NCT02678975|Trace Elements|trace elements|mesh-ancestor
92900765|NCT02678975|Micronutrients|micronutrients|mesh-ancestor
92900766|NCT02678975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900767|NCT02678975|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92900768|NCT02678975|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92900769|NCT02678975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900770|NCT02677415|Anesthetics|anesthetics|mesh-list
92900771|NCT02677415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92900772|NCT02677415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900773|NCT02677415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900774|NCT02677415|Anesthetics, General|anesthetics, general|mesh-ancestor
92900775|NCT00454051|Omalizumab|omalizumab|mesh-list
92900776|NCT00454051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92900777|NCT00454051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92900778|NCT00454051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900779|NCT04181489|Prednisolone|prednisolone|mesh-list
92900780|NCT04181489|Cyclophosphamide|cyclophosphamide|mesh-list
92900781|NCT04181489|Rituximab|rituximab|mesh-list
92900782|NCT04181489|Doxorubicin|doxorubicin|mesh-list
92900783|NCT04181489|Vincristine|vincristine|mesh-list
92900784|NCT04181489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92900785|NCT04181489|Immunologic Factors|immunologic factors|mesh-ancestor
92900786|NCT04181489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900787|NCT04181489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92900788|NCT04181489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92900789|NCT04181489|Alkylating Agents|alkylating agents|mesh-ancestor
92900790|NCT04181489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900791|NCT04181489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900792|NCT04181489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92900793|NCT04181489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92900794|NCT04181489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92900795|NCT04181489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92900796|NCT04181489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92900797|NCT04181489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900798|NCT04181489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92900799|NCT04181489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92900800|NCT04181489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92900801|NCT04181489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92900802|NCT04181489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900803|NCT04181489|Glucocorticoids|glucocorticoids|mesh-ancestor
92900804|NCT04181489|Hormones|hormones|mesh-ancestor
92900805|NCT04181489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92900806|NCT04181489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92900807|NCT02537561|Cisplatin|cisplatin|mesh-list
92900808|NCT02537561|Gemcitabine|gemcitabine|mesh-list
92900809|NCT02537561|Talazoparib|talazoparib|mesh-list
92900810|NCT02537561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900811|NCT02537561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900812|NCT02537561|Antimetabolites|antimetabolites|mesh-ancestor
92900813|NCT02537561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900814|NCT02537561|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92900815|NCT02537561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900816|NCT02676089|Tiotropium Bromide|tiotropium bromide|mesh-list
92900817|NCT02676089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92900818|NCT02676089|Autonomic Agents|autonomic agents|mesh-ancestor
92900819|NCT02676089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900820|NCT02676089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900821|NCT02676089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92900822|NCT02676089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900823|NCT02676089|Parasympatholytics|parasympatholytics|mesh-ancestor
92900824|NCT02676089|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92900825|NCT02676089|Cholinergic Agents|cholinergic agents|mesh-ancestor
92900826|NCT02676089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900827|NCT02676089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900828|NCT02679131|Belinostat|belinostat|mesh-list
92900829|NCT02679131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900830|NCT02679131|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92900831|NCT02679131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900832|NCT02679131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900833|NCT00484939|Bevacizumab|bevacizumab|mesh-list
92900834|NCT00484939|Capecitabine|capecitabine|mesh-list
92900835|NCT00484939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92900836|NCT00484939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900837|NCT00484939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92900838|NCT00484939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92900839|NCT00484939|Growth Substances|growth substances|mesh-ancestor
92900840|NCT00484939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900841|NCT00484939|Growth Inhibitors|growth inhibitors|mesh-ancestor
92900842|NCT00484939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92900843|NCT00484939|Antimetabolites|antimetabolites|mesh-ancestor
92900844|NCT00484939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900845|NCT00642161|Budesonide|budesonide|mesh-list
92900846|NCT00642161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92900847|NCT00642161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92900848|NCT00642161|Autonomic Agents|autonomic agents|mesh-ancestor
92900849|NCT00642161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900850|NCT00642161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900851|NCT00642161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92900852|NCT00642161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92900853|NCT00642161|Glucocorticoids|glucocorticoids|mesh-ancestor
92900854|NCT00642161|Hormones|hormones|mesh-ancestor
92900855|NCT00642161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92900856|NCT05663177|Vinorelbine|vinorelbine|mesh-list
92900857|NCT05663177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92900858|NCT05663177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900859|NCT05663177|Tubulin Modulators|tubulin modulators|mesh-ancestor
92900860|NCT05663177|Antimitotic Agents|antimitotic agents|mesh-ancestor
92900861|NCT05663177|Mitosis Modulators|mitosis modulators|mesh-ancestor
92900862|NCT05663177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900863|NCT00642551|Vitamin K 2|vitamin k 2|mesh-list
92900864|NCT00642551|Vitamin K|vitamin k|mesh-list
92900865|NCT00642551|Menaquinone 7|menaquinone 7|mesh-list
92900866|NCT00642551|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92900867|NCT00642551|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92900868|NCT00642551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900869|NCT00642551|Hemostatics|hemostatics|mesh-ancestor
92900870|NCT00642551|Coagulants|coagulants|mesh-ancestor
92900871|NCT00642551|Vitamins|vitamins|mesh-ancestor
92900872|NCT00642551|Micronutrients|micronutrients|mesh-ancestor
92900873|NCT00642551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900874|NCT04181957|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92900875|NCT04181957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92900876|NCT04181957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900877|NCT04181957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92900878|NCT04181957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92900879|NCT04181957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900880|NCT04181957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900881|NCT04181957|Dopamine Agents|dopamine agents|mesh-ancestor
92900882|NCT04181957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900883|NCT00643409|Azithromycin|azithromycin|mesh-list
92900884|NCT00643409|Levofloxacin|levofloxacin|mesh-list
92900885|NCT00643409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92900886|NCT00643409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900887|NCT00643409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92900888|NCT00643409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92900889|NCT00643409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92900890|NCT00643409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900891|NCT00643409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900892|NCT00643409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900893|NCT00643409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92900894|NCT00643409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92900895|NCT04180007|Apatinib|apatinib|mesh-list
92900896|NCT04180007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900897|NCT04180007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92900898|NCT04180007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900899|NCT04180007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900900|NCT02675309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92900901|NCT02675309|Simvastatin|simvastatin|mesh-list
92900902|NCT02675309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92900903|NCT02675309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92900904|NCT02675309|Antimetabolites|antimetabolites|mesh-ancestor
92900905|NCT02675309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900906|NCT02675309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92900907|NCT02675309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92900908|NCT02675309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900909|NCT01025245|Remifentanil|remifentanil|mesh-list
92900910|NCT01025245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92900911|NCT01025245|Narcotics|narcotics|mesh-ancestor
92900912|NCT01025245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900913|NCT01025245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900914|NCT01025245|Analgesics|analgesics|mesh-ancestor
92900915|NCT01025245|Sensory System Agents|sensory system agents|mesh-ancestor
92900916|NCT01025245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900917|NCT02677259|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92900918|NCT02677259|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92900919|NCT02677259|Estradiol|estradiol|mesh-list
92900920|NCT02677259|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92900921|NCT02677259|Progesterone|progesterone|mesh-list
92900922|NCT02677259|Estrogens|estrogens|mesh-ancestor
92900923|NCT02677259|Hormones|hormones|mesh-ancestor
92900924|NCT02677259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92900925|NCT02677259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900926|NCT02677259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92900927|NCT02677259|Contraceptive Agents|contraceptive agents|mesh-ancestor
92900928|NCT02677259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92900929|NCT02677259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92900930|NCT02677259|Progestins|progestins|mesh-ancestor
92900931|NCT02675387|Lidocaine|lidocaine|mesh-list
92900932|NCT02675387|Anesthetics, Local|anesthetics, local|mesh-ancestor
92900933|NCT02675387|Anesthetics|anesthetics|mesh-ancestor
92900934|NCT02675387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900935|NCT02675387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900936|NCT02675387|Sensory System Agents|sensory system agents|mesh-ancestor
92900937|NCT02675387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900938|NCT02675387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900939|NCT02675387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92900940|NCT02675387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92900941|NCT02675387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900942|NCT02675387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900943|NCT02678507|Analgesics, Opioid|analgesics, opioid|mesh-list
92900944|NCT02678507|Narcotics|narcotics|mesh-ancestor
92900945|NCT02678507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900946|NCT02678507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900947|NCT02678507|Analgesics|analgesics|mesh-ancestor
92900948|NCT02678507|Sensory System Agents|sensory system agents|mesh-ancestor
92900949|NCT02678507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900950|NCT00464737|Rotigotine|rotigotine|mesh-list
92900951|NCT00464737|Dopamine Agonists|dopamine agonists|mesh-ancestor
92900952|NCT00464737|Dopamine Agents|dopamine agents|mesh-ancestor
92900953|NCT00464737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92900954|NCT00464737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900955|NCT00464737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900956|NCT02678585|Lidocaine|lidocaine|mesh-list
92900957|NCT02678585|Nalbuphine|nalbuphine|mesh-list
92900958|NCT02678585|Anesthetics, Local|anesthetics, local|mesh-ancestor
92900959|NCT02678585|Anesthetics|anesthetics|mesh-ancestor
92900960|NCT02678585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92900961|NCT02678585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900962|NCT02678585|Sensory System Agents|sensory system agents|mesh-ancestor
92900963|NCT02678585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92900964|NCT02678585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92900965|NCT02678585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92900966|NCT02678585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92900967|NCT02678585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92900968|NCT02678585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900969|NCT02678585|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92900971|NCT02678585|Analgesics|analgesics|mesh-ancestor
92900972|NCT00453349|Moxifloxacin|moxifloxacin|mesh-list
92900973|NCT00453349|Metronidazole|metronidazole|mesh-list
92900974|NCT00453349|Levofloxacin|levofloxacin|mesh-list
92900975|NCT00453349|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92900976|NCT00453349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92900977|NCT00453349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900978|NCT00453349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92900979|NCT00453349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92900980|NCT00453349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92900981|NCT00453349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92900982|NCT00453349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92900983|NCT00453349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92900984|NCT00453349|Contraceptive Agents|contraceptive agents|mesh-ancestor
92900985|NCT00453349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92900986|NCT00453349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92900987|NCT00453349|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92900988|NCT00453349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92900989|NCT00453349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92900990|NCT00453349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92900991|NCT00453349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92900992|NCT00453349|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92245751|NCT03095612|Docetaxel|docetaxel|mesh-list
92900993|NCT00453349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92900994|NCT00453349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92900996|NCT02675153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92900997|NCT02675153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92900998|NCT02675153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92900999|NCT02675153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901000|NCT02675153|Antifungal Agents|antifungal agents|mesh-ancestor
92901001|NCT02675153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901002|NCT02675153|Immunologic Factors|immunologic factors|mesh-ancestor
92901003|NCT02675153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901004|NCT04179617|Nicotine|nicotine|mesh-list
92901005|NCT04179617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92901006|NCT04179617|Autonomic Agents|autonomic agents|mesh-ancestor
92901007|NCT04179617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901008|NCT04179617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901009|NCT04179617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92901010|NCT04179617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92901011|NCT04179617|Cholinergic Agents|cholinergic agents|mesh-ancestor
92901012|NCT04179617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901013|NCT04179617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901014|NCT00464269|Brivaracetam|brivaracetam|mesh-list
92901015|NCT00464269|Anticonvulsants|anticonvulsants|mesh-ancestor
92901016|NCT00642863|Vitamin D|vitamin d|mesh-list
92901017|NCT00642863|Vitamins|vitamins|mesh-list
92901018|NCT00642863|Vitamin A|vitamin a|mesh-list
92901019|NCT00642863|Retinol palmitate|retinol palmitate|mesh-list
92901020|NCT00642863|Micronutrients|micronutrients|mesh-ancestor
92901021|NCT00642863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901022|NCT00642863|Antioxidants|antioxidants|mesh-ancestor
92901023|NCT00642863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901024|NCT00642863|Protective Agents|protective agents|mesh-ancestor
92901025|NCT00642863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92901026|NCT00642863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901027|NCT00642863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92901028|NCT02674997|Factor VIII|factor viii|mesh-list
92901029|NCT02674997|Coagulants|coagulants|mesh-ancestor
92901030|NCT04178291|Erythritol|erythritol|mesh-list
92901031|NCT04178291|Vasodilator Agents|vasodilator agents|mesh-ancestor
92901032|NCT05372315|Dexamethasone|dexamethasone|mesh-list
92901033|NCT05372315|Dexamethasone acetate|dexamethasone acetate|mesh-list
92901034|NCT05372315|BB 1101|bb 1101|mesh-list
92901035|NCT05372315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901036|NCT05372315|Antiemetics|antiemetics|mesh-ancestor
92901037|NCT05372315|Autonomic Agents|autonomic agents|mesh-ancestor
92901038|NCT05372315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901039|NCT05372315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901040|NCT05372315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92901041|NCT05372315|Glucocorticoids|glucocorticoids|mesh-ancestor
92901042|NCT05372315|Hormones|hormones|mesh-ancestor
92901043|NCT05372315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901044|NCT05372315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92901045|NCT05372315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901046|NCT05372315|Protease Inhibitors|protease inhibitors|mesh-ancestor
92901047|NCT05372315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901048|NCT05372315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901049|NCT00643643|Maraviroc|maraviroc|mesh-list
92901050|NCT00643643|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92901051|NCT00643643|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92901052|NCT00643643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901053|NCT00643643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92901054|NCT00643643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92901055|NCT00643643|Antiviral Agents|antiviral agents|mesh-ancestor
92901056|NCT00643643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901057|NCT00643643|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92901058|NCT02676869|Pembrolizumab|pembrolizumab|mesh-list
92901059|NCT02676869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901060|NCT02676869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901061|NCT02676869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92901062|NCT02676869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901063|NCT02673047|Botulinum Toxins|botulinum toxins|mesh-list
92901064|NCT02673047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92901065|NCT02673047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92901066|NCT02673047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92901067|NCT02673047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901068|NCT02673047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901069|NCT02673047|Cholinergic Agents|cholinergic agents|mesh-ancestor
92901070|NCT02673047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901071|NCT02673047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901072|NCT02673047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92901073|NCT02673047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901074|NCT05584319|Empagliflozin|empagliflozin|mesh-list
92901075|NCT05584319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92901076|NCT05584319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901077|NCT05584319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92901078|NCT05584319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901079|NCT02676323|Leucovorin|leucovorin|mesh-list
92901080|NCT02676323|Cytarabine|cytarabine|mesh-list
92901081|NCT02676323|Hydrocortisone|hydrocortisone|mesh-list
92901082|NCT02676323|Methotrexate|methotrexate|mesh-list
92901083|NCT02676323|Fludarabine phosphate|fludarabine phosphate|mesh-list
92901084|NCT02676323|Fludarabine|fludarabine|mesh-list
92901085|NCT02676323|Panobinostat|panobinostat|mesh-list
92901086|NCT02676323|Levoleucovorin|levoleucovorin|mesh-list
92901087|NCT02676323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901088|NCT02676323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92901089|NCT02676323|Abortifacient Agents|abortifacient agents|mesh-ancestor
92901090|NCT02676323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92901091|NCT02676323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92901092|NCT02676323|Antimetabolites|antimetabolites|mesh-ancestor
92901093|NCT02676323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901094|NCT02676323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901095|NCT02676323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92901096|NCT02676323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901097|NCT02676323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92901098|NCT02676323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901099|NCT02676323|Immunologic Factors|immunologic factors|mesh-ancestor
92901100|NCT02676323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901101|NCT02676323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92901102|NCT02676323|Antiviral Agents|antiviral agents|mesh-ancestor
92901103|NCT02676323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901104|NCT02676323|Antidotes|antidotes|mesh-ancestor
92901105|NCT02676323|Protective Agents|protective agents|mesh-ancestor
92901106|NCT02676323|Vitamin B Complex|vitamin b complex|mesh-ancestor
92901107|NCT02676323|Vitamins|vitamins|mesh-ancestor
92901108|NCT02676323|Micronutrients|micronutrients|mesh-ancestor
92901109|NCT02676323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901110|NCT02676323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92901111|NCT00643799|Celecoxib|celecoxib|mesh-list
92901112|NCT00643799|Naproxen|naproxen|mesh-list
92901113|NCT00643799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92901114|NCT00643799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92901115|NCT00643799|Analgesics|analgesics|mesh-ancestor
92901116|NCT00643799|Sensory System Agents|sensory system agents|mesh-ancestor
92901117|NCT00643799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901118|NCT00643799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901119|NCT00643799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901120|NCT00643799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901121|NCT00643799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92901122|NCT00643799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92901123|NCT00643799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901124|NCT00643799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901125|NCT00643799|Gout Suppressants|gout suppressants|mesh-ancestor
92901126|NCT05348213|Decitabine|decitabine|mesh-list
92901127|NCT05348213|Pomalidomide|pomalidomide|mesh-list
92901128|NCT05348213|Zanubrutinib|zanubrutinib|mesh-list
92901129|NCT05348213|Tofacitinib|tofacitinib|mesh-list
92901130|NCT05348213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92901131|NCT05348213|Antimetabolites|antimetabolites|mesh-ancestor
92901132|NCT05348213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901133|NCT05348213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901134|NCT05348213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901135|NCT05348213|Immunologic Factors|immunologic factors|mesh-ancestor
92901136|NCT05348213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901137|NCT05348213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92901138|NCT05348213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92901139|NCT05348213|Growth Substances|growth substances|mesh-ancestor
92901140|NCT05348213|Growth Inhibitors|growth inhibitors|mesh-ancestor
92901141|NCT05348213|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92901142|NCT05348213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92901143|NCT00643877|Oxaliplatin|oxaliplatin|mesh-list
92901144|NCT00643877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901145|NCT02674295|Esketamine|esketamine|mesh-list
92901146|NCT02674295|Antidepressive Agents|antidepressive agents|mesh-ancestor
92901147|NCT02674295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901148|NCT04179071|Famotidine|famotidine|mesh-list
92901149|NCT04179071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92901150|NCT04179071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92901151|NCT04179071|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92901152|NCT04179071|Histamine Antagonists|histamine antagonists|mesh-ancestor
92901153|NCT04179071|Histamine Agents|histamine agents|mesh-ancestor
92901154|NCT04179071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901155|NCT04179071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901156|NCT04179071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901157|NCT02674139|Copper|copper|mesh-list
92901158|NCT02674139|Trace Elements|trace elements|mesh-ancestor
92901159|NCT02674139|Micronutrients|micronutrients|mesh-ancestor
92901160|NCT02674139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901161|NCT00644033|Frovatriptan|frovatriptan|mesh-list
92901162|NCT00644033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92901163|NCT00644033|Serotonin Agents|serotonin agents|mesh-ancestor
92901164|NCT00644033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901165|NCT00644033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901166|NCT00644033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901167|NCT00484315|Paclitaxel|paclitaxel|mesh-list
92901168|NCT00484315|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92901169|NCT00484315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92901170|NCT00484315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901171|NCT00484315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92901172|NCT00484315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92901173|NCT00484315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92901174|NCT00484315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901175|NCT01019083|Zinc|zinc|mesh-list
92901176|NCT01019083|Albendazole|albendazole|mesh-list
92901177|NCT01019083|Secnidazole|secnidazole|mesh-list
92901178|NCT01019083|Zinc Sulfate|zinc sulfate|mesh-list
92901179|NCT01019083|Trace Elements|trace elements|mesh-ancestor
92901180|NCT01019083|Micronutrients|micronutrients|mesh-ancestor
92901181|NCT01019083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901182|NCT01019083|Anthelmintics|anthelmintics|mesh-ancestor
92901183|NCT01019083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92901184|NCT01019083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901185|NCT01019083|Anticestodal Agents|anticestodal agents|mesh-ancestor
92901186|NCT01019083|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92901187|NCT01019083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92901188|NCT01019083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92901189|NCT01019083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92901190|NCT01019083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92901191|NCT01019083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901192|NCT01019083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901193|NCT01019083|Astringents|astringents|mesh-ancestor
92901194|NCT01019083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92901195|NCT00463801|Daptomycin|daptomycin|mesh-list
92901196|NCT00463801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92901197|NCT00463801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901198|NCT02672345|Sevoflurane|sevoflurane|mesh-list
92901199|NCT02672345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92161381|NCT01679327|Leucovorin|leucovorin|mesh-list
92901200|NCT02672345|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92901201|NCT02672345|Anesthetics, General|anesthetics, general|mesh-ancestor
92901202|NCT02672345|Anesthetics|anesthetics|mesh-ancestor
92901203|NCT02672345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901204|NCT02672345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901205|NCT02537249|Dexmedetomidine|dexmedetomidine|mesh-list
92901206|NCT02537249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92901207|NCT02537249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901208|NCT02537249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901209|NCT02537249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92901210|NCT02537249|Analgesics|analgesics|mesh-ancestor
92901211|NCT02537249|Sensory System Agents|sensory system agents|mesh-ancestor
92901212|NCT02537249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901213|NCT02537249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92901214|NCT02537249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92901215|NCT02537249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92901216|NCT02537249|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901217|NCT02537249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901218|NCT02537249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901219|NCT00644111|Hydromorphone|hydromorphone|mesh-list
92901220|NCT00644111|Bupivacaine|bupivacaine|mesh-list
92901221|NCT00644111|Anesthetics, Local|anesthetics, local|mesh-ancestor
92901222|NCT00644111|Anesthetics|anesthetics|mesh-ancestor
92901223|NCT00644111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901224|NCT00644111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901225|NCT00644111|Sensory System Agents|sensory system agents|mesh-ancestor
92901226|NCT00644111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901227|NCT00644111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92901228|NCT00644111|Narcotics|narcotics|mesh-ancestor
92901229|NCT00644111|Analgesics|analgesics|mesh-ancestor
92901230|NCT00644891|Amoxicillin|amoxicillin|mesh-list
92901231|NCT00644891|Cefdinir|cefdinir|mesh-list
92901232|NCT00644891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92901233|NCT00644891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901234|NCT05203445|Pembrolizumab|pembrolizumab|mesh-list
92901235|NCT05203445|Olaparib|olaparib|mesh-list
92901236|NCT05203445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901237|NCT05203445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901238|NCT05203445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92901239|NCT05203445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901240|NCT05203445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92901241|NCT05203445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901242|NCT04178057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92901243|NCT04178057|Antibodies|antibodies|mesh-list
92901244|NCT04178057|Immunoglobulins|immunoglobulins|mesh-list
92901245|NCT04178057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92901246|NCT04178057|Mitogens|mitogens|mesh-list
92901247|NCT04178057|Endothelial Growth Factors|endothelial growth factors|mesh-list
92901248|NCT04178057|Immunologic Factors|immunologic factors|mesh-ancestor
92901249|NCT04178057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901250|NCT04178057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901251|NCT04178057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92901252|NCT04178057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901253|NCT04178057|Growth Substances|growth substances|mesh-ancestor
92901254|NCT04177043|Antibodies|antibodies|mesh-list
92901255|NCT04177043|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92901256|NCT04177043|Immunologic Factors|immunologic factors|mesh-ancestor
92901257|NCT04177043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901258|NCT02670785|Estradiol|estradiol|mesh-list
92901259|NCT02670785|Estrogens|estrogens|mesh-ancestor
92901260|NCT02670785|Hormones|hormones|mesh-ancestor
92901261|NCT02670785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901262|NCT02670785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901263|NCT02670317|Prednisone|prednisone|mesh-list
92901264|NCT02670317|Cyclophosphamide|cyclophosphamide|mesh-list
92901265|NCT02670317|Doxorubicin|doxorubicin|mesh-list
92901266|NCT02670317|Vincristine|vincristine|mesh-list
92901267|NCT02670317|Obinutuzumab|obinutuzumab|mesh-list
92901268|NCT02670317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901269|NCT02670317|Immunologic Factors|immunologic factors|mesh-ancestor
92901270|NCT02670317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901271|NCT02670317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901272|NCT02670317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92901273|NCT02670317|Alkylating Agents|alkylating agents|mesh-ancestor
92901274|NCT02670317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901275|NCT02670317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901276|NCT02670317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92901277|NCT02670317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92901278|NCT02670317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92901279|NCT02670317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92901280|NCT02670317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901281|NCT02670317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901282|NCT02670317|Glucocorticoids|glucocorticoids|mesh-ancestor
92901283|NCT02670317|Hormones|hormones|mesh-ancestor
92901284|NCT02670317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901285|NCT02670317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92901286|NCT02670317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92901287|NCT02670317|Tubulin Modulators|tubulin modulators|mesh-ancestor
92901288|NCT02670317|Antimitotic Agents|antimitotic agents|mesh-ancestor
92901289|NCT02670317|Mitosis Modulators|mitosis modulators|mesh-ancestor
92901290|NCT02670317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901291|NCT02671565|Hyaluronic Acid|hyaluronic acid|mesh-list
92901292|NCT02671565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92901293|NCT02671565|Immunologic Factors|immunologic factors|mesh-ancestor
92901294|NCT02671565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901295|NCT02671565|Viscosupplements|viscosupplements|mesh-ancestor
92901296|NCT02671565|Protective Agents|protective agents|mesh-ancestor
92901297|NCT02537405|Rivaroxaban|rivaroxaban|mesh-list
92901298|NCT02537405|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92901299|NCT02537405|Antithrombins|antithrombins|mesh-ancestor
92901300|NCT02537405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92901301|NCT02537405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92901302|NCT02537405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901303|NCT02537405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901304|NCT02537405|Anticoagulants|anticoagulants|mesh-ancestor
92901305|NCT04175171|Trastuzumab|trastuzumab|mesh-list
92901306|NCT04175171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901307|NCT04175171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901308|NCT04175093|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
92901309|NCT04175093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901310|NCT04175093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901311|NCT00645125|Amoxicillin|amoxicillin|mesh-list
92901313|NCT00645125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92901314|NCT00645125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901315|NCT02669459|Imiquimod|imiquimod|mesh-list
92901316|NCT02669459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92901317|NCT02669459|Immunologic Factors|immunologic factors|mesh-ancestor
92901318|NCT02669459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901319|NCT02669459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901320|NCT02669459|Interferon Inducers|interferon inducers|mesh-ancestor
92901321|NCT04176887|Phenytoin|phenytoin|mesh-list
92901322|NCT04176887|Levetiracetam|levetiracetam|mesh-list
92901323|NCT04176887|Anticonvulsants|anticonvulsants|mesh-ancestor
92901324|NCT04176887|Nootropic Agents|nootropic agents|mesh-ancestor
92901325|NCT04176887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92901326|NCT04176887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92901327|NCT04176887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901328|NCT04176887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901329|NCT04176887|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92901330|NCT04176887|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92901331|NCT04174937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92901332|NCT04174937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901333|NCT00645203|Cefdinir|cefdinir|mesh-list
92901334|NCT00645203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92901335|NCT00645203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901336|NCT02669303|Methylprednisolone|methylprednisolone|mesh-list
92901337|NCT02669303|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92901338|NCT02669303|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92901339|NCT02669303|Prednisolone|prednisolone|mesh-list
92901340|NCT02669303|Prednisolone acetate|prednisolone acetate|mesh-list
92901341|NCT02669303|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92901342|NCT02669303|Prednisolone phosphate|prednisolone phosphate|mesh-list
92901343|NCT02669303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901344|NCT02669303|Antiemetics|antiemetics|mesh-ancestor
92901345|NCT02669303|Autonomic Agents|autonomic agents|mesh-ancestor
92901346|NCT02669303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901347|NCT02669303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901348|NCT02669303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92901349|NCT02669303|Glucocorticoids|glucocorticoids|mesh-ancestor
92901350|NCT02669303|Hormones|hormones|mesh-ancestor
92901351|NCT02669303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901352|NCT02669303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92901353|NCT02669303|Protective Agents|protective agents|mesh-ancestor
92901354|NCT02669303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92901355|NCT02669303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901356|NCT00645281|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92901357|NCT00645281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92901358|NCT00645281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92901359|NCT00645281|Cholinergic Agents|cholinergic agents|mesh-ancestor
92901360|NCT00645281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525845|NCT00027040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901361|NCT00645281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901362|NCT00645281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901363|NCT00645281|Urological Agents|urological agents|mesh-ancestor
92901364|NCT02668679|Hormones|hormones|mesh-list
92901365|NCT02668679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901366|NCT02668679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901367|NCT00645437|Levofloxacin|levofloxacin|mesh-list
92901368|NCT00645437|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92901369|NCT00645437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901370|NCT00645437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92901371|NCT00645437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92901372|NCT00645437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92901373|NCT00645437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901374|NCT00645437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901375|NCT00645437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901376|NCT00645437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92901377|NCT00645437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92901378|NCT02537171|Apatinib|apatinib|mesh-list
92901379|NCT02537171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901380|NCT02537171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92901381|NCT02537171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901382|NCT02537171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901383|NCT00645515|Risperidone|risperidone|mesh-list
92901384|NCT00645515|Ziprasidone|ziprasidone|mesh-list
92901385|NCT00645515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92901386|NCT00645515|Serotonin Agents|serotonin agents|mesh-ancestor
92901387|NCT00645515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901388|NCT00645515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901389|NCT00645515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901390|NCT00645515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92901391|NCT00645515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92901392|NCT00645515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901393|NCT00645515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901394|NCT00645515|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92901395|NCT00645515|Dopamine Agents|dopamine agents|mesh-ancestor
92901396|NCT00644735|Esomeprazole|esomeprazole|mesh-list
92901397|NCT00644735|Lansoprazole|lansoprazole|mesh-list
92901398|NCT00644735|Dexlansoprazole|dexlansoprazole|mesh-list
92901399|NCT00644735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92901400|NCT00644735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92901401|NCT00644735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92901402|NCT00644735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901403|NCT00644735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901404|NCT02667743|Paclitaxel|paclitaxel|mesh-list
92901405|NCT02667743|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92901406|NCT02667743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92901407|NCT02667743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901408|NCT02667743|Tubulin Modulators|tubulin modulators|mesh-ancestor
92901409|NCT02667743|Antimitotic Agents|antimitotic agents|mesh-ancestor
92901410|NCT02667743|Mitosis Modulators|mitosis modulators|mesh-ancestor
92901411|NCT02667743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901412|NCT02666651|Tolvaptan|tolvaptan|mesh-list
92901413|NCT02666651|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92901414|NCT02666651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901415|NCT02666651|Natriuretic Agents|natriuretic agents|mesh-ancestor
92901416|NCT02666651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901417|NCT02671175|Piperaquine|piperaquine|mesh-list
92901418|NCT02671175|Artenimol|artenimol|mesh-list
92901419|NCT02671175|Artemisinins|artemisinins|mesh-list
92901420|NCT02671175|Antimalarials|antimalarials|mesh-ancestor
92901421|NCT02671175|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92901422|NCT02671175|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92901423|NCT02671175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901424|NCT02671097|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92901425|NCT02671097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92901426|NCT02671097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92901427|NCT02671097|Antimetabolites|antimetabolites|mesh-ancestor
92901428|NCT02671097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901429|NCT02671097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92901430|NCT02671097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92901431|NCT02671097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901432|NCT02667197|Analgesics, Opioid|analgesics, opioid|mesh-list
92901433|NCT02667197|Narcotics|narcotics|mesh-ancestor
92901434|NCT02667197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901435|NCT02667197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901437|NCT02667197|Sensory System Agents|sensory system agents|mesh-ancestor
92901438|NCT02667197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901439|NCT00463567|Formoterol Fumarate|formoterol fumarate|mesh-list
92901440|NCT00463567|Tiotropium Bromide|tiotropium bromide|mesh-list
92901441|NCT00463567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92901442|NCT00463567|Autonomic Agents|autonomic agents|mesh-ancestor
92901443|NCT00463567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901444|NCT00463567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901445|NCT00463567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92901446|NCT00463567|Respiratory System Agents|respiratory system agents|mesh-ancestor
92901447|NCT00463567|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92901448|NCT00463567|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92901449|NCT00463567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92901450|NCT00463567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901451|NCT00463567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901452|NCT00463567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901453|NCT00463567|Parasympatholytics|parasympatholytics|mesh-ancestor
92901454|NCT00463567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92901455|NCT00463567|Cholinergic Agents|cholinergic agents|mesh-ancestor
92901456|NCT00646061|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92901457|NCT00646061|Parasympatholytics|parasympatholytics|mesh-ancestor
92901458|NCT00646061|Autonomic Agents|autonomic agents|mesh-ancestor
92901459|NCT00646061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901460|NCT00646061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901461|NCT00646061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92901462|NCT00646061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92901463|NCT00646061|Cholinergic Agents|cholinergic agents|mesh-ancestor
92901464|NCT00646061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901465|NCT00646061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901466|NCT00646841|Doxazosin|doxazosin|mesh-list
92901467|NCT00646841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901468|NCT00646841|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92901469|NCT00646841|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92901470|NCT00646841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92901471|NCT00646841|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901472|NCT00646841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901473|NCT00646841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901474|NCT00646841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901475|NCT04786067|Abatacept|abatacept|mesh-list
92901476|NCT04786067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92901477|NCT04786067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901478|NCT04786067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901479|NCT04786067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901480|NCT04786067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901481|NCT04786067|Immunologic Factors|immunologic factors|mesh-ancestor
92901482|NCT04786067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901483|NCT04786067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901484|NCT00646139|Tirbanibulin|tirbanibulin|mesh-list
92901485|NCT00646139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901486|NCT00646139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901487|NCT00484159|Lidocaine|lidocaine|mesh-list
92901488|NCT00484159|Bupivacaine|bupivacaine|mesh-list
92901489|NCT00484159|Anesthetics, Local|anesthetics, local|mesh-ancestor
92901490|NCT00484159|Anesthetics|anesthetics|mesh-ancestor
92901491|NCT00484159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901492|NCT00484159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901493|NCT00484159|Sensory System Agents|sensory system agents|mesh-ancestor
92901494|NCT00484159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901495|NCT00484159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92901496|NCT00484159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92901497|NCT00484159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92901498|NCT00484159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901499|NCT00484159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901500|NCT02666417|Iron|iron|mesh-list
92901501|NCT02666417|Trace Elements|trace elements|mesh-ancestor
92901502|NCT02666417|Micronutrients|micronutrients|mesh-ancestor
92901503|NCT02666417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901504|NCT00910637|Gestodene|gestodene|mesh-list
92901505|NCT00910637|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92901507|NCT00910637|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92901508|NCT00910637|Contraceptive Agents|contraceptive agents|mesh-ancestor
92901509|NCT00910637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92901510|NCT00910637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901511|NCT00910637|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92901512|NCT00910637|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92901513|NCT00910637|Progestins|progestins|mesh-ancestor
92901514|NCT00910637|Hormones|hormones|mesh-ancestor
92901515|NCT00910637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901516|NCT00462865|Bevacizumab|bevacizumab|mesh-list
92901517|NCT00462865|Gemcitabine|gemcitabine|mesh-list
92901518|NCT00462865|Capecitabine|capecitabine|mesh-list
92901519|NCT00462865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901520|NCT00462865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901521|NCT00462865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92901522|NCT00462865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92901523|NCT00462865|Growth Substances|growth substances|mesh-ancestor
92901524|NCT00462865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901525|NCT00462865|Growth Inhibitors|growth inhibitors|mesh-ancestor
92901526|NCT00462865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92901527|NCT00462865|Antimetabolites|antimetabolites|mesh-ancestor
92901528|NCT00462865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901529|NCT02667353|Anesthetics|anesthetics|mesh-list
92901530|NCT02667353|Etomidate|etomidate|mesh-list
92901531|NCT02667353|Succinylcholine|succinylcholine|mesh-list
92901532|NCT02667353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901533|NCT02667353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901534|NCT02667353|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92901535|NCT02667353|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92901536|NCT02667353|Anesthetics, General|anesthetics, general|mesh-ancestor
92901537|NCT02667353|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92901538|NCT02667353|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92901539|NCT02667353|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92901540|NCT02667353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901541|NCT00462709|Complement C1s|complement c1s|mesh-list
92901542|NCT00462709|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92901543|NCT00462709|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92901544|NCT00462709|Immunologic Factors|immunologic factors|mesh-ancestor
92901545|NCT00462709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901546|NCT00462709|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92901547|NCT00462709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901548|NCT02664857|Vitamin D|vitamin d|mesh-list
92901549|NCT02664857|Ergocalciferols|ergocalciferols|mesh-list
92901550|NCT02664857|Cholecalciferol|cholecalciferol|mesh-list
92901551|NCT02664857|Vitamins|vitamins|mesh-list
92901552|NCT02664857|Micronutrients|micronutrients|mesh-ancestor
92901553|NCT02664857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901554|NCT02664857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92901555|NCT02664857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92901556|NCT02665871|Vaccines|vaccines|mesh-list
92901557|NCT02665871|Immunologic Factors|immunologic factors|mesh-ancestor
92901558|NCT02665871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901559|NCT00647543|Atorvastatin|atorvastatin|mesh-list
92901560|NCT00647543|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92901561|NCT00647543|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92901562|NCT00647543|Antimetabolites|antimetabolites|mesh-ancestor
92901563|NCT00647543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901564|NCT00647543|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92901565|NCT00647543|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92901566|NCT00647543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901567|NCT00647621|Phenytoin|phenytoin|mesh-list
92901568|NCT00647621|Anticonvulsants|anticonvulsants|mesh-ancestor
92901569|NCT00647621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92901570|NCT00647621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92901571|NCT00647621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901572|NCT00647621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901573|NCT00647621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92901574|NCT00647621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92901575|NCT00461305|Drospirenone|drospirenone|mesh-list
92901576|NCT00461305|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92901577|NCT00461305|Hormone Antagonists|hormone antagonists|mesh-ancestor
92901578|NCT00461305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901579|NCT00461305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901580|NCT00461305|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92901581|NCT00461305|Diuretics|diuretics|mesh-ancestor
92901582|NCT00461305|Natriuretic Agents|natriuretic agents|mesh-ancestor
92901583|NCT01022671|Belotecan|belotecan|mesh-list
92901584|NCT01022671|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92901585|NCT01022671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92901586|NCT01022671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901587|NCT01022671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901588|NCT01022671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901589|NCT01022749|Vaccines|vaccines|mesh-list
92901590|NCT01022749|Immunologic Factors|immunologic factors|mesh-ancestor
92901591|NCT01022749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901592|NCT00645905|Adalimumab|adalimumab|mesh-list
92901593|NCT00645905|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92901594|NCT00645905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901595|NCT00645905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901596|NCT00647777|Olanzapine|olanzapine|mesh-list
92901597|NCT00647777|Antiemetics|antiemetics|mesh-ancestor
92901598|NCT00647777|Autonomic Agents|autonomic agents|mesh-ancestor
92901599|NCT00647777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901600|NCT00647777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901601|NCT00647777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92901602|NCT00647777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92901603|NCT00647777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92901604|NCT00647777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901605|NCT00647777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901606|NCT00647777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92901607|NCT00647777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92901608|NCT00647777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901609|NCT00647777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901610|NCT00647777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901611|NCT00647777|Serotonin Agents|serotonin agents|mesh-ancestor
92901612|NCT04173611|Bupivacaine|bupivacaine|mesh-list
92901613|NCT04173611|Anesthetics, Local|anesthetics, local|mesh-ancestor
92901614|NCT04173611|Anesthetics|anesthetics|mesh-ancestor
92901615|NCT04173611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901616|NCT04173611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901617|NCT04173611|Sensory System Agents|sensory system agents|mesh-ancestor
92901618|NCT04173611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901619|NCT02665637|Trastuzumab|trastuzumab|mesh-list
92901620|NCT02665637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901621|NCT02665637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901622|NCT04733183|Dacarbazine|dacarbazine|mesh-list
92901623|NCT04733183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92901624|NCT04733183|Alkylating Agents|alkylating agents|mesh-ancestor
92901625|NCT04733183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901626|NCT04733183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901627|NCT00648011|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92901628|NCT00648011|Quinapril|quinapril|mesh-list
92901629|NCT00648011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901630|NCT00648011|Diuretics|diuretics|mesh-ancestor
92901631|NCT00648011|Natriuretic Agents|natriuretic agents|mesh-ancestor
92901632|NCT00648011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901633|NCT00648011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92161395|NCT01679327|Antidotes|antidotes|mesh-ancestor
92901634|NCT00648011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901635|NCT00648011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901636|NCT00648011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92901637|NCT00648011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92901638|NCT00648011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901639|NCT00646529|Budesonide|budesonide|mesh-list
92901640|NCT00646529|Formoterol Fumarate|formoterol fumarate|mesh-list
92901641|NCT00646529|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92901642|NCT00646529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901643|NCT00646529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92901644|NCT00646529|Autonomic Agents|autonomic agents|mesh-ancestor
92901645|NCT00646529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901646|NCT00646529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901647|NCT00646529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92901648|NCT00646529|Respiratory System Agents|respiratory system agents|mesh-ancestor
92901651|NCT00646529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901652|NCT00646529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92901653|NCT00646529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92901654|NCT00646529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92901655|NCT00646529|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901656|NCT00646529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901657|NCT00646529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901658|NCT00646607|Leucovorin|leucovorin|mesh-list
92901659|NCT00646607|Fluorouracil|fluorouracil|mesh-list
92901660|NCT00646607|Oxaliplatin|oxaliplatin|mesh-list
92901661|NCT00646607|Levoleucovorin|levoleucovorin|mesh-list
92901662|NCT00646607|Antimetabolites|antimetabolites|mesh-ancestor
92901663|NCT00646607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901664|NCT00646607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92901665|NCT00646607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901666|NCT00646607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901667|NCT00646607|Immunologic Factors|immunologic factors|mesh-ancestor
92901668|NCT00646607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901669|NCT00646607|Antidotes|antidotes|mesh-ancestor
92901670|NCT00646607|Protective Agents|protective agents|mesh-ancestor
92901671|NCT00646607|Vitamin B Complex|vitamin b complex|mesh-ancestor
92901672|NCT00646607|Vitamins|vitamins|mesh-ancestor
92901673|NCT00646607|Micronutrients|micronutrients|mesh-ancestor
92901674|NCT00856544|Tofacitinib|tofacitinib|mesh-list
92901675|NCT00856544|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92901676|NCT00856544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92901677|NCT00856544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901678|NCT00856544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901679|NCT00648245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92901680|NCT00648323|Doxazosin|doxazosin|mesh-list
92901681|NCT00648323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901682|NCT00648323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92901683|NCT00648323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92901684|NCT00648323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92901685|NCT00648323|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901686|NCT00648323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901687|NCT00648323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901688|NCT00648323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901689|NCT00856388|Fludarabine|fludarabine|mesh-list
92901690|NCT00856388|Fludarabine phosphate|fludarabine phosphate|mesh-list
92901691|NCT00856388|Melphalan|melphalan|mesh-list
92901692|NCT00856388|Thymoglobulin|thymoglobulin|mesh-list
92901693|NCT00856388|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92901694|NCT00856388|Immunoglobulins|immunoglobulins|mesh-list
92901695|NCT00856388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901696|NCT00856388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92901697|NCT00856388|Antimetabolites|antimetabolites|mesh-ancestor
92901698|NCT00856388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901699|NCT00856388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92901700|NCT00856388|Immunologic Factors|immunologic factors|mesh-ancestor
92901701|NCT00856388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901702|NCT00856388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92901703|NCT00856388|Alkylating Agents|alkylating agents|mesh-ancestor
92901704|NCT00856388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92901705|NCT00648401|Verapamil|verapamil|mesh-list
92901706|NCT00648401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92901707|NCT00648401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92901708|NCT00648401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901709|NCT00648401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901710|NCT00648401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92901711|NCT00648401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901712|NCT00648401|Vasodilator Agents|vasodilator agents|mesh-ancestor
92901713|NCT02663999|Diazepam|diazepam|mesh-list
92901715|NCT02663999|Anticonvulsants|anticonvulsants|mesh-ancestor
92901716|NCT02663999|Antiemetics|antiemetics|mesh-ancestor
92901717|NCT02663999|Autonomic Agents|autonomic agents|mesh-ancestor
92901718|NCT02663999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901719|NCT02663999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901720|NCT02663999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92901721|NCT02663999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92901722|NCT02663999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901723|NCT02663999|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92901724|NCT02663999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92901725|NCT02663999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92901726|NCT02663999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92901727|NCT02663999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901728|NCT02663999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92901729|NCT02663999|Anesthetics, General|anesthetics, general|mesh-ancestor
92901730|NCT02663999|Anesthetics|anesthetics|mesh-ancestor
92901731|NCT02663999|GABA Modulators|gaba modulators|mesh-ancestor
92901732|NCT02663999|GABA Agents|gaba agents|mesh-ancestor
92901733|NCT02663999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901734|NCT02663999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901735|NCT04171427|Lithium Carbonate|lithium carbonate|mesh-list
92901736|NCT04171427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92901737|NCT04171427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901738|NCT04171427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901739|NCT04171427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901740|NCT04171427|Antimanic Agents|antimanic agents|mesh-ancestor
92901741|NCT04171427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92901742|NCT04171427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901743|NCT04171427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901744|NCT04171739|Itraconazole|itraconazole|mesh-list
92901745|NCT04171739|Olorofim|olorofim|mesh-list
92901746|NCT04171739|Rifampin|rifampin|mesh-list
92901747|NCT04171739|Antifungal Agents|antifungal agents|mesh-ancestor
92901748|NCT04171739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901749|NCT04171739|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92901750|NCT04171739|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92901751|NCT04171739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901752|NCT04171739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901753|NCT04171739|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92901754|NCT04171739|Hormone Antagonists|hormone antagonists|mesh-ancestor
92901755|NCT04171739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901756|NCT04171739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901757|NCT04171739|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92901758|NCT04171739|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92901759|NCT04171739|Antitubercular Agents|antitubercular agents|mesh-ancestor
92901760|NCT04171739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92901761|NCT04171739|Leprostatic Agents|leprostatic agents|mesh-ancestor
92901762|NCT04171739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92901763|NCT04171739|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92901764|NCT04171739|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92901765|NCT04171739|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92901766|NCT04171739|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92901767|NCT04171739|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92901768|NCT04171739|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92901769|NCT02656121|Vitamin D|vitamin d|mesh-list
92901770|NCT02656121|Clomiphene|clomiphene|mesh-list
92901771|NCT02656121|Vitamins|vitamins|mesh-ancestor
92901772|NCT02656121|Micronutrients|micronutrients|mesh-ancestor
92901773|NCT02656121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901774|NCT02656121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92901775|NCT02656121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92901776|NCT02656121|Hormone Antagonists|hormone antagonists|mesh-ancestor
92161402|NCT01206387|Glucocorticoids|glucocorticoids|mesh-ancestor
92901777|NCT02656121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901778|NCT02656121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92901779|NCT02656121|Fertility Agents|fertility agents|mesh-ancestor
92901780|NCT02656121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92901781|NCT02656121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92901782|NCT02656121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92901783|NCT00648713|Terbinafine|terbinafine|mesh-list
92901784|NCT00648713|Antifungal Agents|antifungal agents|mesh-ancestor
92901785|NCT00648713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92901786|NCT00648713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901787|NCT00648713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901788|NCT00649883|Vaccines|vaccines|mesh-list
92901789|NCT00649883|Immunologic Factors|immunologic factors|mesh-ancestor
92901790|NCT00649883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901791|NCT00648791|Finasteride|finasteride|mesh-list
92901792|NCT00648791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92901793|NCT00648791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92901794|NCT00648791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901795|NCT00648791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901796|NCT00648791|Hormone Antagonists|hormone antagonists|mesh-ancestor
92901797|NCT00648791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92901798|NCT00648791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901799|NCT00648791|Urological Agents|urological agents|mesh-ancestor
92901801|NCT00649181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901802|NCT00649181|Diuretics|diuretics|mesh-ancestor
92901803|NCT00649181|Natriuretic Agents|natriuretic agents|mesh-ancestor
92901804|NCT00649181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901805|NCT00649181|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92901806|NCT00649181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901807|NCT00649181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901808|NCT02655965|Clonidine|clonidine|mesh-list
92901809|NCT02655965|Ropivacaine|ropivacaine|mesh-list
92901810|NCT02655965|Anesthetics, Local|anesthetics, local|mesh-ancestor
92901811|NCT02655965|Anesthetics|anesthetics|mesh-ancestor
92901812|NCT02655965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901813|NCT02655965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901814|NCT02655965|Sensory System Agents|sensory system agents|mesh-ancestor
92901815|NCT02655965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901816|NCT02655965|Analgesics|analgesics|mesh-ancestor
92901817|NCT02655965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901818|NCT02655965|Sympatholytics|sympatholytics|mesh-ancestor
92901819|NCT02655965|Autonomic Agents|autonomic agents|mesh-ancestor
92901820|NCT02655965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92901821|NCT02655965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92901822|NCT02655965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92901823|NCT02655965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901824|NCT02655965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901825|NCT02655965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901826|NCT04170179|Lenvatinib|lenvatinib|mesh-list
92901827|NCT04170179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901828|NCT04170179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92901829|NCT04170179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901830|NCT04170179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901831|NCT02659085|Ketamine|ketamine|mesh-list
92901832|NCT02659085|Analgesics|analgesics|mesh-ancestor
92901833|NCT02659085|Sensory System Agents|sensory system agents|mesh-ancestor
92901834|NCT02659085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901835|NCT02659085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901836|NCT02659085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92901837|NCT02659085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92901838|NCT02659085|Anesthetics, General|anesthetics, general|mesh-ancestor
92901839|NCT02659085|Anesthetics|anesthetics|mesh-ancestor
92901840|NCT02659085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901841|NCT02659085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92901842|NCT02659085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92901843|NCT02659085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901844|NCT02659085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901845|NCT04171193|Isoflurane|isoflurane|mesh-list
92901846|NCT04171193|Sertraline|sertraline|mesh-list
92901847|NCT04171193|Antidepressive Agents|antidepressive agents|mesh-ancestor
92901848|NCT04171193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92901849|NCT04171193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92901850|NCT04171193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92901851|NCT04171193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901852|NCT04171193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901853|NCT04171193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901854|NCT04171193|Serotonin Agents|serotonin agents|mesh-ancestor
92901855|NCT04171193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901856|NCT04171193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92901857|NCT04171193|Anesthetics, General|anesthetics, general|mesh-ancestor
92901858|NCT04171193|Anesthetics|anesthetics|mesh-ancestor
92901859|NCT04171193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901861|NCT02663141|Losartan|losartan|mesh-list
92901862|NCT02663141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901863|NCT02663141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901864|NCT02663141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92901865|NCT02663141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92901866|NCT02663141|Growth Substances|growth substances|mesh-ancestor
92901867|NCT02663141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901868|NCT02663141|Growth Inhibitors|growth inhibitors|mesh-ancestor
92901869|NCT02663141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92901870|NCT02663141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901871|NCT02663141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92901872|NCT02663141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92901873|NCT02663141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901874|NCT04171349|Dexmedetomidine|dexmedetomidine|mesh-list
92901875|NCT04171349|Carticaine|carticaine|mesh-list
92901876|NCT04171349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92901877|NCT04171349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901878|NCT04171349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901879|NCT04171349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92901880|NCT04171349|Analgesics|analgesics|mesh-ancestor
92901881|NCT04171349|Sensory System Agents|sensory system agents|mesh-ancestor
92901882|NCT04171349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901883|NCT04171349|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92901884|NCT04171349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92901885|NCT04171349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92901886|NCT04171349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92901887|NCT04171349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901888|NCT04171349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901889|NCT04171349|Anesthetics, Local|anesthetics, local|mesh-ancestor
92901890|NCT04171349|Anesthetics|anesthetics|mesh-ancestor
92901891|NCT00650039|Valdecoxib|valdecoxib|mesh-list
92901892|NCT00650039|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92901893|NCT00650039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92901894|NCT00650039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901895|NCT00650039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901896|NCT00650039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92901897|NCT00650039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92901898|NCT00650039|Analgesics|analgesics|mesh-ancestor
92901899|NCT00650039|Sensory System Agents|sensory system agents|mesh-ancestor
92901900|NCT00650039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901901|NCT00650039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901902|NCT00650039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901903|NCT00650039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901904|NCT00649259|Oxybutynin|oxybutynin|mesh-list
92901905|NCT00649259|Parasympatholytics|parasympatholytics|mesh-ancestor
92901906|NCT00649259|Autonomic Agents|autonomic agents|mesh-ancestor
92901907|NCT00649259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901908|NCT00649259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901909|NCT00649259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92901910|NCT00649259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92901911|NCT00649259|Cholinergic Agents|cholinergic agents|mesh-ancestor
92901912|NCT00649259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901913|NCT00649259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901914|NCT00649259|Urological Agents|urological agents|mesh-ancestor
92901915|NCT04401059|Gefitinib|gefitinib|mesh-list
92901916|NCT04401059|Osimertinib|osimertinib|mesh-list
92901917|NCT04401059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901918|NCT04401059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92901919|NCT04401059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901920|NCT04401059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901921|NCT02658773|Lidocaine|lidocaine|mesh-list
92901922|NCT02658773|Prilocaine|prilocaine|mesh-list
92901923|NCT02658773|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92901924|NCT02658773|Anesthetics, Local|anesthetics, local|mesh-ancestor
92901925|NCT02658773|Anesthetics|anesthetics|mesh-ancestor
92901926|NCT02658773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92901927|NCT02658773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901928|NCT02658773|Sensory System Agents|sensory system agents|mesh-ancestor
92901929|NCT02658773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901930|NCT02658773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92901931|NCT02658773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92901932|NCT02658773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92901933|NCT02658773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901934|NCT02658773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901935|NCT02658773|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92901936|NCT00648869|Metformin|metformin|mesh-list
92901937|NCT00648869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92901938|NCT00648869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901939|NCT04169945|Erythritol|erythritol|mesh-list
92901940|NCT04169945|Vasodilator Agents|vasodilator agents|mesh-ancestor
92901941|NCT04169867|Nivolumab|nivolumab|mesh-list
92901942|NCT04169867|Ipilimumab|ipilimumab|mesh-list
92901943|NCT04169867|Atezolizumab|atezolizumab|mesh-list
92901944|NCT04169867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92901945|NCT04169867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92901946|NCT04169867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92901947|NCT04169867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901948|NCT02655029|Amlodipine|amlodipine|mesh-list
92901949|NCT02655029|Perindopril|perindopril|mesh-list
92901950|NCT02655029|Indapamide|indapamide|mesh-list
92901951|NCT02655029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92901952|NCT02655029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92901953|NCT02655029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92901954|NCT02655029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901955|NCT02655029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92901956|NCT02655029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901957|NCT02655029|Vasodilator Agents|vasodilator agents|mesh-ancestor
92901958|NCT02655029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92901959|NCT02655029|Protease Inhibitors|protease inhibitors|mesh-ancestor
92901960|NCT02655029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901961|NCT02655029|Diuretics|diuretics|mesh-ancestor
92901962|NCT02655029|Natriuretic Agents|natriuretic agents|mesh-ancestor
92901963|NCT02655029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92901964|NCT02536859|Insulin|insulin|mesh-list
92901965|NCT02536859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92901966|NCT02536859|Insulin Glargine|insulin glargine|mesh-list
92901967|NCT02536859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92901968|NCT02536859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901969|NCT02536937|Eliglustat|eliglustat|mesh-list
92901970|NCT02536937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901971|NCT02536937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901972|NCT02654561|Heparin|heparin|mesh-list
92901973|NCT02654561|Calcium heparin|calcium heparin|mesh-list
92901974|NCT02654561|Anticoagulants|anticoagulants|mesh-ancestor
92901975|NCT02654561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92901976|NCT02654561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92901977|NCT02654561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901978|NCT02654405|Butyric Acid|butyric acid|mesh-list
92901979|NCT02654405|Histamine Antagonists|histamine antagonists|mesh-ancestor
92901980|NCT02654405|Histamine Agents|histamine agents|mesh-ancestor
92901981|NCT02654405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92901982|NCT02654405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901983|NCT02654405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901984|NCT00649415|Valdecoxib|valdecoxib|mesh-list
92901985|NCT00649415|Piroxicam|piroxicam|mesh-list
92901986|NCT00649415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92901987|NCT00649415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92901988|NCT00649415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92901989|NCT00649415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92901990|NCT00649415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92901991|NCT00649415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92901992|NCT00649415|Analgesics|analgesics|mesh-ancestor
92901993|NCT00649415|Sensory System Agents|sensory system agents|mesh-ancestor
92901994|NCT00649415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92901995|NCT00649415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92901996|NCT00649415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92901997|NCT00649415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92901998|NCT00650117|Fentanyl|fentanyl|mesh-list
92901999|NCT00650117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92902000|NCT00650117|Narcotics|narcotics|mesh-ancestor
92902001|NCT00650117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902002|NCT00650117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902003|NCT00650117|Analgesics|analgesics|mesh-ancestor
92902004|NCT00650117|Sensory System Agents|sensory system agents|mesh-ancestor
92902005|NCT00650117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902006|NCT00650117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92902007|NCT00650117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92902008|NCT00650117|Anesthetics, General|anesthetics, general|mesh-ancestor
92902009|NCT00650117|Anesthetics|anesthetics|mesh-ancestor
92902010|NCT00648947|Clopidogrel|clopidogrel|mesh-list
92902011|NCT00648947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92902012|NCT00648947|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92902013|NCT00648947|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92902014|NCT00648947|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92902015|NCT00648947|Purinergic Agents|purinergic agents|mesh-ancestor
92902016|NCT00648947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902017|NCT00648947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902018|NCT00648947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902019|NCT00649493|Rabeprazole|rabeprazole|mesh-list
92902020|NCT00649493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92902021|NCT00649493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92902022|NCT00649493|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92902023|NCT00649493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902024|NCT00649493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902025|NCT02654093|Cholecalciferol|cholecalciferol|mesh-list
92902026|NCT02654093|Vitamin D|vitamin d|mesh-list
92902027|NCT02654093|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92902028|NCT02654093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92902029|NCT02654093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902030|NCT02654093|Vitamins|vitamins|mesh-ancestor
92902031|NCT02654093|Micronutrients|micronutrients|mesh-ancestor
92902032|NCT02654093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92902033|NCT02654093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92902034|NCT02654093|Hormone Antagonists|hormone antagonists|mesh-ancestor
92902035|NCT02654093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902036|NCT02654093|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92902037|NCT02654093|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92902038|NCT04168619|Methotrexate|methotrexate|mesh-list
92902039|NCT04168619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92902040|NCT04168619|Abortifacient Agents|abortifacient agents|mesh-ancestor
92902041|NCT04168619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902042|NCT04168619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902043|NCT04168619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902044|NCT04168619|Antimetabolites|antimetabolites|mesh-ancestor
92902045|NCT04168619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902046|NCT04168619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902047|NCT04168619|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902048|NCT04168619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902049|NCT04168619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92902050|NCT04168619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902051|NCT04168619|Immunologic Factors|immunologic factors|mesh-ancestor
92902052|NCT04168619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902053|NCT04168619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92902054|NCT02654171|Ziresovir|ziresovir|mesh-list
92902055|NCT02654171|Antiviral Agents|antiviral agents|mesh-ancestor
92902056|NCT02654171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902057|NCT00650195|Metolazone|metolazone|mesh-list
92902058|NCT00650195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92902059|NCT00650195|Diuretics|diuretics|mesh-ancestor
92902060|NCT00650195|Natriuretic Agents|natriuretic agents|mesh-ancestor
92902061|NCT00650195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902062|NCT00650195|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92902063|NCT00650195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902064|NCT00650195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902065|NCT04170959|Metformin|metformin|mesh-list
92902066|NCT04170959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902067|NCT04170959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902068|NCT00848354|Etanercept|etanercept|mesh-list
92902069|NCT00848354|Methotrexate|methotrexate|mesh-list
92902070|NCT00848354|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92902071|NCT00848354|Abortifacient Agents|abortifacient agents|mesh-ancestor
92902072|NCT00848354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902073|NCT00848354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902074|NCT00848354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902075|NCT00848354|Antimetabolites|antimetabolites|mesh-ancestor
92902076|NCT00848354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902077|NCT00848354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902078|NCT00848354|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902079|NCT00848354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902080|NCT00848354|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92902081|NCT00848354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902082|NCT00848354|Immunologic Factors|immunologic factors|mesh-ancestor
92902083|NCT00848354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246834|NCT00585182|Enoxaparin|enoxaparin|mesh-list
92902084|NCT00848354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92902085|NCT00848354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902088|NCT00848354|Sensory System Agents|sensory system agents|mesh-ancestor
92902089|NCT00848354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902090|NCT00848354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902091|NCT00848354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92902092|NCT00600821|Paclitaxel|paclitaxel|mesh-list
92902093|NCT00600821|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92902094|NCT00600821|Bevacizumab|bevacizumab|mesh-list
92902095|NCT00600821|Carboplatin|carboplatin|mesh-list
92902096|NCT00600821|Axitinib|axitinib|mesh-list
92902097|NCT00600821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92902098|NCT00600821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902099|NCT00600821|Tubulin Modulators|tubulin modulators|mesh-ancestor
92902100|NCT00600821|Antimitotic Agents|antimitotic agents|mesh-ancestor
92902101|NCT00600821|Mitosis Modulators|mitosis modulators|mesh-ancestor
92902102|NCT00600821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902103|NCT00600821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902104|NCT00600821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902105|NCT00600821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902106|NCT00600821|Growth Substances|growth substances|mesh-ancestor
92902107|NCT00600821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902108|NCT00600821|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902109|NCT00600821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92902110|NCT00600821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902111|NCT00699764|Vaccines|vaccines|mesh-list
92902112|NCT00699764|Immunologic Factors|immunologic factors|mesh-ancestor
92902113|NCT00699764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902114|NCT02653703|Ethanol|ethanol|mesh-list
92902115|NCT02653703|Menthol|menthol|mesh-list
92902116|NCT02653703|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92902117|NCT02653703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902118|NCT02653703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902119|NCT02653703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902120|NCT02653703|Antipruritics|antipruritics|mesh-ancestor
92902121|NCT02653703|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902122|NCT00649571|Doxycycline|doxycycline|mesh-list
92902123|NCT00649571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902124|NCT00649571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902125|NCT00649571|Antimalarials|antimalarials|mesh-ancestor
92902126|NCT00649571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92902127|NCT00649571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92902128|NCT02662283|Acteoside|acteoside|mesh-list
92902129|NCT02662283|Prednisolone|prednisolone|mesh-list
92902130|NCT02662283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902131|NCT02662283|Glucocorticoids|glucocorticoids|mesh-ancestor
92902132|NCT02662283|Hormones|hormones|mesh-ancestor
92902133|NCT02662283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902134|NCT02662283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902135|NCT02662283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92902136|NCT02662283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902137|NCT02662283|Protective Agents|protective agents|mesh-ancestor
92902138|NCT02662283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902139|NCT02662283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92902140|NCT02662283|Antioxidants|antioxidants|mesh-ancestor
92902141|NCT02662283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902142|NCT02662283|Chelating Agents|chelating agents|mesh-ancestor
92902143|NCT02662283|Sequestering Agents|sequestering agents|mesh-ancestor
92902144|NCT02662283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902145|NCT02662283|Immunologic Factors|immunologic factors|mesh-ancestor
92902146|NCT02657603|Lidocaine|lidocaine|mesh-list
92902147|NCT02657603|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902148|NCT02657603|Anesthetics|anesthetics|mesh-ancestor
92902149|NCT02657603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902150|NCT02657603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902151|NCT02657603|Sensory System Agents|sensory system agents|mesh-ancestor
92902152|NCT02657603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902153|NCT02657603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92902154|NCT02657603|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92902155|NCT02657603|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92902156|NCT02657603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902157|NCT02657603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977264|NCT01070641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92902158|NCT02657447|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92902160|NCT02657447|Sequestering Agents|sequestering agents|mesh-ancestor
92902161|NCT02657447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046939|NCT00346268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93046940|NCT00346268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046941|NCT00346268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046942|NCT00346268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93046943|NCT00346268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93046944|NCT00346268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046945|NCT00346268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046946|NCT00327444|Aflibercept|aflibercept|mesh-list
93046947|NCT00327444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93046948|NCT00327444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93046949|NCT00327444|Growth Substances|growth substances|mesh-ancestor
93046950|NCT00327444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046951|NCT00327444|Growth Inhibitors|growth inhibitors|mesh-ancestor
93046952|NCT00327444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046953|NCT01051622|Technetium Tc 99m Exametazime|technetium tc 99m exametazime|mesh-list
93046954|NCT01051622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93046955|NCT01051622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046956|NCT03982134|Panobinostat|panobinostat|mesh-list
93046957|NCT03982134|Spartalizumab|spartalizumab|mesh-list
93046958|NCT03982134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046959|NCT03982134|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93046960|NCT03982134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046961|NCT03982134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046962|NCT03982134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93046963|NCT03982134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046964|NCT00337610|Metformin|metformin|mesh-list
93046965|NCT00337610|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93046966|NCT00337610|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046967|NCT00337610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046968|NCT00337610|Incretins|incretins|mesh-ancestor
93046969|NCT00337610|Hormones|hormones|mesh-ancestor
93046970|NCT00337610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046971|NCT00337610|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93046972|NCT00337610|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046973|NCT00337610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046974|NCT00337610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046975|NCT01062204|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93046976|NCT01062204|Laxatives|laxatives|mesh-ancestor
93046977|NCT01062204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93046978|NCT01062282|Iloprost|iloprost|mesh-list
93046979|NCT01062282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93046980|NCT01062282|Vasodilator Agents|vasodilator agents|mesh-ancestor
93046981|NCT03985280|Anesthetics|anesthetics|mesh-list
93046982|NCT03985280|Anesthetics, Local|anesthetics, local|mesh-list
93046983|NCT03985280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93046984|NCT03985280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046985|NCT03985280|Sensory System Agents|sensory system agents|mesh-ancestor
93046986|NCT03985280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046987|NCT01058876|Nicotine|nicotine|mesh-list
93046988|NCT01058876|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93046989|NCT01058876|Autonomic Agents|autonomic agents|mesh-ancestor
93046990|NCT01058876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046991|NCT01058876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046992|NCT01058876|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93046993|NCT01058876|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93046994|NCT01058876|Cholinergic Agents|cholinergic agents|mesh-ancestor
93046995|NCT01058876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046996|NCT01058876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046997|NCT03986762|Clavulanic Acids|clavulanic acids|mesh-list
93046998|NCT03986762|Clavulanic Acid|clavulanic acid|mesh-list
93046999|NCT03986762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93047000|NCT03986762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047001|NCT03986762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047002|NCT03986762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047003|NCT03986762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93047004|NCT01051934|Paclitaxel|paclitaxel|mesh-list
93047005|NCT01051934|Bevacizumab|bevacizumab|mesh-list
93047006|NCT01051934|Carboplatin|carboplatin|mesh-list
92547599|NCT05772832|Remifentanil|remifentanil|mesh-list
92902162|NCT00649649|Quinapril|quinapril|mesh-list
92902163|NCT00649649|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92902164|NCT00649649|Protease Inhibitors|protease inhibitors|mesh-ancestor
92902165|NCT00649649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902166|NCT00649649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902167|NCT00649649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92902168|NCT02657291|Ropivacaine|ropivacaine|mesh-list
92902169|NCT02657291|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902170|NCT02657291|Anesthetics|anesthetics|mesh-ancestor
92902171|NCT02657291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902172|NCT02657291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902173|NCT02657291|Sensory System Agents|sensory system agents|mesh-ancestor
92902174|NCT02657291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902175|NCT00699920|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92902176|NCT00699920|Antimalarials|antimalarials|mesh-ancestor
92902177|NCT00699920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92902178|NCT00699920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92902179|NCT00699920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902180|NCT02661893|Rifampin|rifampin|mesh-list
92902181|NCT02661893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92902182|NCT02661893|Antitubercular Agents|antitubercular agents|mesh-ancestor
92902183|NCT02661893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902184|NCT02661893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902185|NCT02661893|Leprostatic Agents|leprostatic agents|mesh-ancestor
92902186|NCT02661893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92902187|NCT02661893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902188|NCT02661893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902189|NCT02661893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92902190|NCT02661893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92902191|NCT02661893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92902192|NCT02661893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92902193|NCT02661893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92902194|NCT02661893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92902195|NCT00855920|Indomethacin|indomethacin|mesh-list
92902196|NCT00855920|Rilonacept|rilonacept|mesh-list
92902197|NCT00855920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902198|NCT00855920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902199|NCT00855920|Analgesics|analgesics|mesh-ancestor
92902200|NCT00855920|Sensory System Agents|sensory system agents|mesh-ancestor
92902201|NCT00855920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902202|NCT00855920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902203|NCT00855920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902204|NCT00855920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902205|NCT00855920|Gout Suppressants|gout suppressants|mesh-ancestor
92902206|NCT00855920|Tocolytic Agents|tocolytic agents|mesh-ancestor
92902207|NCT00855920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902208|NCT00855920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92902209|NCT00855920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902210|NCT00855920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902211|NCT02657213|Insulin|insulin|mesh-list
92902212|NCT02657213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92902213|NCT02657213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902214|NCT02657213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902215|NCT00649727|Oxybutynin|oxybutynin|mesh-list
92902216|NCT00649727|Parasympatholytics|parasympatholytics|mesh-ancestor
92902217|NCT00649727|Autonomic Agents|autonomic agents|mesh-ancestor
92902218|NCT00649727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902219|NCT00649727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902220|NCT00649727|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92902221|NCT00649727|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92902222|NCT00649727|Cholinergic Agents|cholinergic agents|mesh-ancestor
92902223|NCT00649727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902224|NCT00649727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902225|NCT00649727|Urological Agents|urological agents|mesh-ancestor
92902226|NCT00650273|Azithromycin|azithromycin|mesh-list
92902227|NCT00650273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902228|NCT00650273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902229|NCT00698126|Insulin|insulin|mesh-list
92902230|NCT00698126|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92902231|NCT00698126|Insulin Aspart|insulin aspart|mesh-list
92902232|NCT00698126|Biphasic Insulins|biphasic insulins|mesh-list
92902233|NCT00698126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902234|NCT00698126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902235|NCT02661425|Immunoglobulins|immunoglobulins|mesh-list
92902236|NCT02661425|Immunologic Factors|immunologic factors|mesh-ancestor
92902237|NCT02661425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902238|NCT02656901|Anesthetics|anesthetics|mesh-list
92902239|NCT02656901|Sevoflurane|sevoflurane|mesh-list
92902240|NCT02656901|Desflurane|desflurane|mesh-list
92902241|NCT02656901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902242|NCT02656901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902243|NCT02656901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92902244|NCT02656901|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92902245|NCT02656901|Anesthetics, General|anesthetics, general|mesh-ancestor
92902246|NCT00847886|Methotrexate|methotrexate|mesh-list
92902247|NCT00847886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92902248|NCT00847886|Abortifacient Agents|abortifacient agents|mesh-ancestor
92902249|NCT00847886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902250|NCT00847886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902251|NCT00847886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902252|NCT00847886|Antimetabolites|antimetabolites|mesh-ancestor
92902253|NCT00847886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902254|NCT00847886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902255|NCT00847886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902256|NCT00847886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902257|NCT00847886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92902258|NCT00847886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902259|NCT00847886|Immunologic Factors|immunologic factors|mesh-ancestor
92902260|NCT00847886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902261|NCT00847886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92902262|NCT00847808|Dexlansoprazole|dexlansoprazole|mesh-list
92902263|NCT00847808|Lansoprazole|lansoprazole|mesh-list
92902264|NCT00847808|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92902265|NCT00847808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92902266|NCT00847808|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92902267|NCT00847808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902268|NCT00847808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902269|NCT02656979|Latanoprost|latanoprost|mesh-list
92902270|NCT02656979|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92902271|NCT02656979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92902272|NCT04017455|Bevacizumab|bevacizumab|mesh-list
92902273|NCT04017455|Atezolizumab|atezolizumab|mesh-list
92902274|NCT04017455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902275|NCT04017455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902276|NCT04017455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902277|NCT04017455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902278|NCT04017455|Growth Substances|growth substances|mesh-ancestor
92902279|NCT04017455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902280|NCT04017455|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902281|NCT04017455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92902282|NCT04017455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902283|NCT05298020|Paclitaxel|paclitaxel|mesh-list
92902284|NCT05298020|Gemcitabine|gemcitabine|mesh-list
92902285|NCT05298020|Endostar protein|endostar protein|mesh-list
92902286|NCT05298020|Endostatins|endostatins|mesh-list
92902287|NCT05298020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92902288|NCT05298020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902289|NCT05298020|Tubulin Modulators|tubulin modulators|mesh-ancestor
92902290|NCT05298020|Antimitotic Agents|antimitotic agents|mesh-ancestor
92902291|NCT05298020|Mitosis Modulators|mitosis modulators|mesh-ancestor
92902292|NCT05298020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902293|NCT05298020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902294|NCT05298020|Antimetabolites|antimetabolites|mesh-ancestor
92902295|NCT05298020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902296|NCT05298020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902297|NCT05298020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902298|NCT05298020|Growth Substances|growth substances|mesh-ancestor
92902299|NCT05298020|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902300|NCT04170647|Plasminogen|plasminogen|mesh-list
92902301|NCT04170647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92902302|NCT04170647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92902303|NCT04170647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902304|NCT02661347|Risperidone|risperidone|mesh-list
92902305|NCT02661347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92902306|NCT02661347|Serotonin Agents|serotonin agents|mesh-ancestor
92902307|NCT02661347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902308|NCT02661347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902309|NCT02661347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902310|NCT02661347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92902311|NCT02661347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92902312|NCT02661347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902313|NCT02661347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902314|NCT02661347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92902315|NCT02661347|Dopamine Agents|dopamine agents|mesh-ancestor
92902316|NCT00649805|Verapamil|verapamil|mesh-list
92902317|NCT00649805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92902318|NCT00649805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92902319|NCT00649805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902320|NCT00649805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902321|NCT00649805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92902322|NCT00649805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902323|NCT00649805|Vasodilator Agents|vasodilator agents|mesh-ancestor
92902324|NCT02656589|Capecitabine|capecitabine|mesh-list
92902325|NCT02656589|Trastuzumab|trastuzumab|mesh-list
92902326|NCT02656589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902327|NCT02656589|Antimetabolites|antimetabolites|mesh-ancestor
92902328|NCT02656589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902329|NCT02656589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902330|NCT02656589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902331|NCT00600353|Dexamethasone|dexamethasone|mesh-list
92902332|NCT00600353|Aprepitant|aprepitant|mesh-list
92902333|NCT00600353|Palonosetron|palonosetron|mesh-list
92902334|NCT00600353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902335|NCT00600353|Antiemetics|antiemetics|mesh-ancestor
92902336|NCT00600353|Autonomic Agents|autonomic agents|mesh-ancestor
92902337|NCT00600353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902338|NCT00600353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902339|NCT00600353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92902340|NCT00600353|Glucocorticoids|glucocorticoids|mesh-ancestor
92902341|NCT00600353|Hormones|hormones|mesh-ancestor
92902342|NCT00600353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902343|NCT00600353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92902344|NCT00600353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902345|NCT00600353|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92902346|NCT00600353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161429|NCT01679795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902347|NCT00600353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902348|NCT00600353|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92902349|NCT00600353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92902350|NCT00600353|Serotonin Agents|serotonin agents|mesh-ancestor
92902351|NCT02661191|Cholecalciferol|cholecalciferol|mesh-list
92902352|NCT02661191|Vitamin D|vitamin d|mesh-list
92902353|NCT02661191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92902354|NCT02661191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902355|NCT02661191|Vitamins|vitamins|mesh-ancestor
92902356|NCT02661191|Micronutrients|micronutrients|mesh-ancestor
92902357|NCT02661191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92902358|NCT00691210|Niacinamide|niacinamide|mesh-list
92902360|NCT00691210|Nicotinic Acids|nicotinic acids|mesh-list
92902361|NCT00691210|Etoposide|etoposide|mesh-list
92902362|NCT00691210|Vorinostat|vorinostat|mesh-list
92902363|NCT00691210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92902364|NCT00691210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902365|NCT00691210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92902366|NCT00691210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92902367|NCT00691210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902368|NCT00691210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902369|NCT00691210|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92902370|NCT00691210|Vitamin B Complex|vitamin b complex|mesh-ancestor
92902371|NCT00691210|Vitamins|vitamins|mesh-ancestor
92902372|NCT00691210|Micronutrients|micronutrients|mesh-ancestor
92902373|NCT00691210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902374|NCT00691210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92902375|NCT00691210|Antimetabolites|antimetabolites|mesh-ancestor
92902376|NCT00691210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92902377|NCT00691210|Vasodilator Agents|vasodilator agents|mesh-ancestor
92902378|NCT02652065|Acetylcholine|acetylcholine|mesh-list
92902379|NCT02652065|Vasodilator Agents|vasodilator agents|mesh-ancestor
92902380|NCT02652065|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92902381|NCT02652065|Cholinergic Agents|cholinergic agents|mesh-ancestor
92902382|NCT02652065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977265|NCT01070641|Vasodilator Agents|vasodilator agents|mesh-ancestor
92902383|NCT02652065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902384|NCT02652065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902385|NCT00650429|Ziprasidone|ziprasidone|mesh-list
92547820|NCT05680584|Antipruritics|antipruritics|mesh-ancestor
92902386|NCT00650429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92902387|NCT00650429|Serotonin Agents|serotonin agents|mesh-ancestor
92902388|NCT00650429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902389|NCT00650429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902390|NCT00650429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902391|NCT00650429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92902392|NCT00650429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92902393|NCT00650429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902394|NCT00650429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902395|NCT00650429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92902396|NCT00650429|Dopamine Agents|dopamine agents|mesh-ancestor
92902397|NCT00691132|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
92902398|NCT00691132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902399|NCT00691132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902400|NCT00691132|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92902401|NCT00691132|Protective Agents|protective agents|mesh-ancestor
92902402|NCT00691132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902403|NCT00691132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902404|NCT02651753|Calcium, Dietary|calcium, dietary|mesh-list
92902405|NCT02651753|Atorvastatin|atorvastatin|mesh-list
92902406|NCT02651753|Fenofibrate|fenofibrate|mesh-list
92902407|NCT02651753|Calcium|calcium|mesh-list
92902408|NCT02651753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92902409|NCT02651753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902410|NCT02651753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92902411|NCT02651753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92902412|NCT02651753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92902413|NCT02651753|Antimetabolites|antimetabolites|mesh-ancestor
92902414|NCT02651753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902415|NCT02651753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92902416|NCT02651753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92902417|NCT02651753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902418|NCT00855218|Sorafenib|sorafenib|mesh-list
92902419|NCT00855218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902420|NCT00855218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92902421|NCT00855218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902422|NCT00855218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902423|NCT00748150|Vaccines|vaccines|mesh-list
92902424|NCT00748150|Immunologic Factors|immunologic factors|mesh-ancestor
92902425|NCT00748150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902426|NCT02651519|Ropivacaine|ropivacaine|mesh-list
92902427|NCT02651519|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902428|NCT02651519|Anesthetics|anesthetics|mesh-ancestor
92902429|NCT02651519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902430|NCT02651519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902431|NCT02651519|Sensory System Agents|sensory system agents|mesh-ancestor
92902432|NCT02651519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902433|NCT02651441|Gemcitabine|gemcitabine|mesh-list
92902434|NCT02651441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902435|NCT02651441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902436|NCT02651441|Antimetabolites|antimetabolites|mesh-ancestor
92902437|NCT02651441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902438|NCT01063348|Acetylcysteine|acetylcysteine|mesh-list
92902439|NCT01063348|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92902440|NCT01063348|Antiviral Agents|antiviral agents|mesh-ancestor
92902441|NCT01063348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902442|NCT01063348|Expectorants|expectorants|mesh-ancestor
92902443|NCT01063348|Respiratory System Agents|respiratory system agents|mesh-ancestor
92902444|NCT01063348|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92902445|NCT01063348|Antioxidants|antioxidants|mesh-ancestor
92902446|NCT01063348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902447|NCT01063348|Protective Agents|protective agents|mesh-ancestor
92902448|NCT01063348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902449|NCT01063348|Antidotes|antidotes|mesh-ancestor
92902450|NCT00855062|Minocycline|minocycline|mesh-list
92902451|NCT00855062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902452|NCT00855062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902453|NCT00744250|Pancrelipase|pancrelipase|mesh-list
92902454|NCT00744250|Pancreatin|pancreatin|mesh-list
92902455|NCT00744250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92902456|NCT02651207|Lidocaine|lidocaine|mesh-list
92902457|NCT02651207|Ethyl Chloride|ethyl chloride|mesh-list
92902458|NCT02651207|Contraceptive Agents|contraceptive agents|mesh-list
92902459|NCT02651207|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902460|NCT02651207|Anesthetics|anesthetics|mesh-ancestor
92902461|NCT02651207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902462|NCT02651207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902463|NCT02651207|Sensory System Agents|sensory system agents|mesh-ancestor
92902464|NCT02651207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902465|NCT02651207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92902466|NCT02651207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92902467|NCT02651207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92902468|NCT02651207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902469|NCT02651207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902470|NCT02651207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902471|NCT02564536|Decitabine|decitabine|mesh-list
92902472|NCT02564536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902473|NCT02564536|Antimetabolites|antimetabolites|mesh-ancestor
92902474|NCT02564536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902475|NCT02564536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902476|NCT02564536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902477|NCT00600119|Naloxegol|naloxegol|mesh-list
92902478|NCT00600119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92902479|NCT00600119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902480|NCT00600119|Sensory System Agents|sensory system agents|mesh-ancestor
92902481|NCT00600119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902482|NCT00866294|Paroxetine|paroxetine|mesh-list
92902483|NCT00866294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92902484|NCT00866294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92902485|NCT00866294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902486|NCT00866294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902487|NCT00866294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902488|NCT00866294|Serotonin Agents|serotonin agents|mesh-ancestor
92902489|NCT00866294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902490|NCT00866294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92902491|NCT00866294|Antidepressive Agents|antidepressive agents|mesh-ancestor
92902492|NCT00866294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902493|NCT00866294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92902494|NCT00866294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92902495|NCT00866294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902496|NCT02660255|Cannabidiol|cannabidiol|mesh-list
92902497|NCT02660255|Anticonvulsants|anticonvulsants|mesh-ancestor
92902498|NCT00649103|Quinapril|quinapril|mesh-list
92902499|NCT00649103|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92902500|NCT00649103|Protease Inhibitors|protease inhibitors|mesh-ancestor
92902501|NCT00649103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902502|NCT00649103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902503|NCT00649103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92902504|NCT02660177|Dipyrone|dipyrone|mesh-list
92902505|NCT02660177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902506|NCT02660177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902507|NCT02660177|Analgesics|analgesics|mesh-ancestor
92902508|NCT02660177|Sensory System Agents|sensory system agents|mesh-ancestor
92902509|NCT02660177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902510|NCT02660177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902511|NCT02660177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902512|NCT02660177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902513|NCT02660177|Antipyretics|antipyretics|mesh-ancestor
92902514|NCT00701246|Folic Acid|folic acid|mesh-list
92902515|NCT00701246|Vitamin B Complex|vitamin b complex|mesh-list
92902516|NCT00701246|Hematinics|hematinics|mesh-ancestor
92902517|NCT00701246|Vitamins|vitamins|mesh-ancestor
92902518|NCT00701246|Micronutrients|micronutrients|mesh-ancestor
92902519|NCT00701246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902520|NCT02648711|Leucovorin|leucovorin|mesh-list
92902521|NCT02648711|Bevacizumab|bevacizumab|mesh-list
92902522|NCT02648711|Oxaliplatin|oxaliplatin|mesh-list
92902523|NCT02648711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902524|NCT02648711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902525|NCT02648711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902526|NCT02648711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902527|NCT02648711|Growth Substances|growth substances|mesh-ancestor
92902528|NCT02648711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902529|NCT02648711|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902530|NCT02648711|Antidotes|antidotes|mesh-ancestor
92902531|NCT02648711|Protective Agents|protective agents|mesh-ancestor
92902532|NCT02648711|Vitamin B Complex|vitamin b complex|mesh-ancestor
92902534|NCT02648711|Micronutrients|micronutrients|mesh-ancestor
92902535|NCT00854360|Beclomethasone|beclomethasone|mesh-list
92902536|NCT00854360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902537|NCT00854360|Glucocorticoids|glucocorticoids|mesh-ancestor
92902538|NCT00854360|Hormones|hormones|mesh-ancestor
92902539|NCT00854360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902540|NCT00854360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902542|NCT00854360|Respiratory System Agents|respiratory system agents|mesh-ancestor
92902543|NCT00650351|Ciprofloxacin|ciprofloxacin|mesh-list
92902544|NCT00650351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902545|NCT00650351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902546|NCT00650351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92902547|NCT00650351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92902548|NCT00650351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902549|NCT00650351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902550|NCT00650351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902551|NCT00650351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92902552|NCT00650351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92902553|NCT02648633|Nivolumab|nivolumab|mesh-list
92902554|NCT02648633|Valproic Acid|valproic acid|mesh-list
92902555|NCT02648633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902556|NCT02648633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902557|NCT02648633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92902558|NCT02648633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902559|NCT02648633|Anticonvulsants|anticonvulsants|mesh-ancestor
92902560|NCT02648633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902561|NCT02648633|GABA Agents|gaba agents|mesh-ancestor
92902562|NCT02648633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902563|NCT02648633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902564|NCT02648633|Antimanic Agents|antimanic agents|mesh-ancestor
92902565|NCT02648633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92902566|NCT02648633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902567|NCT02648633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902568|NCT00853970|Bromfenac|bromfenac|mesh-list
92902569|NCT00853970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92902570|NCT00853970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92902571|NCT00853970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902572|NCT00853970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902573|NCT00853970|Analgesics|analgesics|mesh-ancestor
92902574|NCT00853970|Sensory System Agents|sensory system agents|mesh-ancestor
92902575|NCT00853970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902576|NCT00853970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902577|NCT00853970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902578|NCT00853970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902579|NCT00651287|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92902580|NCT00651287|Quinapril|quinapril|mesh-list
92902581|NCT00651287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92902582|NCT00651287|Diuretics|diuretics|mesh-ancestor
92902583|NCT00651287|Natriuretic Agents|natriuretic agents|mesh-ancestor
92902584|NCT00651287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902585|NCT00651287|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92902586|NCT00651287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902587|NCT00651287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902588|NCT00651287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92902589|NCT00651287|Protease Inhibitors|protease inhibitors|mesh-ancestor
92902590|NCT00651287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902591|NCT02650427|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92902592|NCT02650427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902593|NCT02650427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902594|NCT02650427|Incretins|incretins|mesh-ancestor
92902595|NCT02650427|Hormones|hormones|mesh-ancestor
92902596|NCT02650427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902597|NCT02650427|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92902598|NCT02650427|Protease Inhibitors|protease inhibitors|mesh-ancestor
92902599|NCT02650427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902600|NCT02650427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902601|NCT02644811|Anesthetics|anesthetics|mesh-list
92902602|NCT02644811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902603|NCT02644811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902604|NCT00651443|Galiximab|galiximab|mesh-list
92902605|NCT00651443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902606|NCT00651443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902607|NCT00650897|Escitalopram|escitalopram|mesh-list
92902608|NCT00650897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92902609|NCT00650897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92902610|NCT00650897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902611|NCT00650897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902612|NCT00650897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902613|NCT00650897|Serotonin Agents|serotonin agents|mesh-ancestor
92902614|NCT00650897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902615|NCT02644499|Folic Acid|folic acid|mesh-list
92902616|NCT02644499|Hydroxychloroquine|hydroxychloroquine|mesh-list
92902617|NCT02644499|Prednisolone|prednisolone|mesh-list
92902618|NCT02644499|Methotrexate|methotrexate|mesh-list
92902619|NCT02644499|Leflunomide|leflunomide|mesh-list
92902620|NCT02644499|Glucocorticoids|glucocorticoids|mesh-list
92902621|NCT02644499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92902622|NCT02644499|Abortifacient Agents|abortifacient agents|mesh-ancestor
92902623|NCT02644499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902624|NCT02644499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902625|NCT02644499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92902626|NCT02644499|Antimetabolites|antimetabolites|mesh-ancestor
92902627|NCT02644499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902628|NCT02644499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902629|NCT02644499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902630|NCT02644499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902631|NCT02644499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92902632|NCT02644499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902633|NCT02644499|Immunologic Factors|immunologic factors|mesh-ancestor
92902634|NCT02644499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902635|NCT02644499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92902636|NCT02644499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902637|NCT02644499|Hormones|hormones|mesh-ancestor
92902638|NCT02644499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902639|NCT02644499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92902640|NCT02644499|Antimalarials|antimalarials|mesh-ancestor
92902641|NCT02644499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92902642|NCT02644499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92902643|NCT02644499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902644|NCT02644499|Hematinics|hematinics|mesh-ancestor
92902645|NCT02644499|Vitamin B Complex|vitamin b complex|mesh-ancestor
92902646|NCT02644499|Vitamins|vitamins|mesh-ancestor
92902647|NCT02644499|Micronutrients|micronutrients|mesh-ancestor
92902648|NCT00652691|Cyclophosphamide|cyclophosphamide|mesh-list
92902649|NCT00652691|Carboplatin|carboplatin|mesh-list
92902650|NCT00652691|Topotecan|topotecan|mesh-list
92902651|NCT00652691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902652|NCT00652691|Immunologic Factors|immunologic factors|mesh-ancestor
92902653|NCT00652691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902654|NCT00652691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902655|NCT00652691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92902656|NCT00652691|Alkylating Agents|alkylating agents|mesh-ancestor
92902657|NCT00652691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902658|NCT00652691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902659|NCT00652691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92902660|NCT00652691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92902661|NCT00652691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92902662|NCT00652691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902663|NCT02649179|Ropivacaine|ropivacaine|mesh-list
92902664|NCT02649179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902665|NCT02649179|Anesthetics|anesthetics|mesh-ancestor
92902666|NCT02649179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902667|NCT02649179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902668|NCT02649179|Sensory System Agents|sensory system agents|mesh-ancestor
92902669|NCT02649179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902670|NCT02644577|Metformin|metformin|mesh-list
92902671|NCT02644577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902672|NCT02644577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902673|NCT02644421|Lidocaine|lidocaine|mesh-list
92902674|NCT02644421|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902675|NCT02644421|Anesthetics|anesthetics|mesh-ancestor
92902676|NCT02644421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902677|NCT02644421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902678|NCT02644421|Sensory System Agents|sensory system agents|mesh-ancestor
92902679|NCT02644421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902680|NCT02644421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92902681|NCT02644421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92902682|NCT02644421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92902683|NCT02644421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902684|NCT02644421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548130|NCT04702256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902685|NCT00651599|Drospirenone|drospirenone|mesh-list
92902686|NCT00651599|Estradiol|estradiol|mesh-list
92902687|NCT00651599|Estrogens|estrogens|mesh-ancestor
92902688|NCT00651599|Hormones|hormones|mesh-ancestor
92902689|NCT00651599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902690|NCT00651599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902691|NCT00651599|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92902692|NCT00651599|Hormone Antagonists|hormone antagonists|mesh-ancestor
92902693|NCT00651599|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92902694|NCT00651599|Diuretics|diuretics|mesh-ancestor
92902695|NCT00651599|Natriuretic Agents|natriuretic agents|mesh-ancestor
92902696|NCT02647151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92902697|NCT02647151|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92902698|NCT02647151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92902699|NCT02647151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902700|NCT02536391|Ipatasertib|ipatasertib|mesh-list
92902701|NCT02536391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902702|NCT02536391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92902703|NCT02536391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902704|NCT02536391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902705|NCT02644187|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92902706|NCT02644187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92902707|NCT02644187|Dermatologic Agents|dermatologic agents|mesh-ancestor
92902708|NCT00651131|Daptomycin|daptomycin|mesh-list
92902709|NCT00651131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902710|NCT00651131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902711|NCT04167137|Atezolizumab|atezolizumab|mesh-list
92902712|NCT04167137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92902713|NCT04167137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902714|NCT04167137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902715|NCT04167137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902716|NCT02649413|Prednisone|prednisone|mesh-list
92902717|NCT02649413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902718|NCT02649413|Glucocorticoids|glucocorticoids|mesh-ancestor
92902719|NCT02649413|Hormones|hormones|mesh-ancestor
92902720|NCT02649413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902721|NCT02649413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902722|NCT02649413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92902723|NCT02649413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902724|NCT02643563|Epinephrine|epinephrine|mesh-list
92902725|NCT02643563|Bupivacaine|bupivacaine|mesh-list
92902726|NCT02643563|Ropivacaine|ropivacaine|mesh-list
92902727|NCT02643563|Anesthetics, Local|anesthetics, local|mesh-ancestor
92902728|NCT02643563|Anesthetics|anesthetics|mesh-ancestor
92902729|NCT02643563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902730|NCT02643563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902731|NCT02643563|Sensory System Agents|sensory system agents|mesh-ancestor
92902732|NCT02643563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902733|NCT02643563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92902734|NCT02643563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92902735|NCT02643563|Adrenergic Agents|adrenergic agents|mesh-ancestor
92902736|NCT02643563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902737|NCT02643563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902738|NCT02643563|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92902739|NCT02643563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92902740|NCT02643563|Autonomic Agents|autonomic agents|mesh-ancestor
92902741|NCT02643563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92902742|NCT02643563|Respiratory System Agents|respiratory system agents|mesh-ancestor
92902743|NCT02643563|Mydriatics|mydriatics|mesh-ancestor
92902744|NCT02643563|Sympathomimetics|sympathomimetics|mesh-ancestor
92902745|NCT02643563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92902746|NCT00651209|Tenofovir|tenofovir|mesh-list
92902747|NCT00651209|Antiviral Agents|antiviral agents|mesh-ancestor
92902748|NCT00651209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902749|NCT00651209|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92902750|NCT00651209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92902751|NCT00651209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902752|NCT00651209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902753|NCT00651209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92902754|NCT00651209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92902755|NCT00652925|Celecoxib|celecoxib|mesh-list
92902756|NCT00652925|Naproxen|naproxen|mesh-list
92902757|NCT00652925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902758|NCT00652925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902759|NCT00652925|Analgesics|analgesics|mesh-ancestor
92902760|NCT00652925|Sensory System Agents|sensory system agents|mesh-ancestor
92902761|NCT00652925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902762|NCT00652925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902763|NCT00652925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902764|NCT00652925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902765|NCT00652925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92902766|NCT00652925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92902767|NCT00652925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902768|NCT00652925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902769|NCT00652925|Gout Suppressants|gout suppressants|mesh-ancestor
92902770|NCT00653003|Leflunomide|leflunomide|mesh-list
92902771|NCT00653003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902772|NCT00653003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202994|NCT01973205|Antipyretics|antipyretics|mesh-ancestor
92902773|NCT00653003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902774|NCT00653003|Immunologic Factors|immunologic factors|mesh-ancestor
92902775|NCT00653003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902777|NCT02643719|Naproxen|naproxen|mesh-list
92902778|NCT02643719|Sumatriptan|sumatriptan|mesh-list
92902779|NCT02643719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902780|NCT02643719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902781|NCT02643719|Analgesics|analgesics|mesh-ancestor
92902782|NCT02643719|Sensory System Agents|sensory system agents|mesh-ancestor
92902783|NCT02643719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902784|NCT02643719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902785|NCT02643719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902786|NCT02643719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902787|NCT02643719|Gout Suppressants|gout suppressants|mesh-ancestor
92902788|NCT02643719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92902789|NCT02643719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902790|NCT02643719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902791|NCT02643719|Anticonvulsants|anticonvulsants|mesh-ancestor
92902792|NCT02643719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902793|NCT02643719|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92902794|NCT02643719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92902795|NCT02643719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92902796|NCT02643719|Serotonin Agents|serotonin agents|mesh-ancestor
92902797|NCT02643719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902798|NCT02649101|Thalidomide|thalidomide|mesh-list
92902799|NCT02649101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92902800|NCT02649101|Immunologic Factors|immunologic factors|mesh-ancestor
92902801|NCT02649101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902802|NCT02649101|Leprostatic Agents|leprostatic agents|mesh-ancestor
92902803|NCT02649101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92902804|NCT02649101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902805|NCT02649101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902806|NCT02649101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902807|NCT02649101|Growth Substances|growth substances|mesh-ancestor
92902808|NCT02649101|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902809|NCT02649101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902810|NCT00700154|Insulin|insulin|mesh-list
92902811|NCT00700154|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92902812|NCT00700154|Insulin Aspart|insulin aspart|mesh-list
92902813|NCT00700154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902814|NCT00700154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902815|NCT00651911|Rasburicase|rasburicase|mesh-list
92902816|NCT00651911|Gout Suppressants|gout suppressants|mesh-ancestor
92902817|NCT00651911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902818|NCT02643407|Docetaxel|docetaxel|mesh-list
92902819|NCT02643407|Nedaplatin|nedaplatin|mesh-list
92902820|NCT02643407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902821|NCT02643407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92902822|NCT02643407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92902823|NCT02643407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92902824|NCT02643407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902825|NCT02643329|Gliclazide|gliclazide|mesh-list
92902826|NCT02643329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92902827|NCT02643329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902828|NCT03245489|Aspirin|aspirin|mesh-list
92902829|NCT03245489|Pembrolizumab|pembrolizumab|mesh-list
92902830|NCT03245489|Clopidogrel|clopidogrel|mesh-list
92902831|NCT03245489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92902832|NCT03245489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902833|NCT03245489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92902834|NCT03245489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902835|NCT03245489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92902836|NCT03245489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902837|NCT03245489|Analgesics|analgesics|mesh-ancestor
92902838|NCT03245489|Sensory System Agents|sensory system agents|mesh-ancestor
92902839|NCT03245489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902840|NCT03245489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902841|NCT03245489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92902842|NCT03245489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92902843|NCT03245489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92902844|NCT03245489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92902845|NCT03245489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92902846|NCT03245489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92902847|NCT03245489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902849|NCT03245489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92902850|NCT03245489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92902851|NCT03245489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92902852|NCT03245489|Purinergic Agents|purinergic agents|mesh-ancestor
92902853|NCT03245489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902854|NCT02643017|Dexmedetomidine|dexmedetomidine|mesh-list
92902855|NCT02643017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92902856|NCT02643017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902857|NCT02643017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902858|NCT02643017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92902859|NCT02643017|Analgesics|analgesics|mesh-ancestor
92902860|NCT02643017|Sensory System Agents|sensory system agents|mesh-ancestor
92902861|NCT02643017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902862|NCT02643017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92902863|NCT02643017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92902864|NCT02643017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92902865|NCT02643017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92902866|NCT02643017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92902867|NCT02643017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902868|NCT02643173|Anesthetics|anesthetics|mesh-list
92902869|NCT02643173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92902870|NCT02643173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902871|NCT02643173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902872|NCT02643173|Anesthetics, General|anesthetics, general|mesh-ancestor
92902873|NCT02646137|Chlorotrianisene|chlorotrianisene|mesh-list
92902874|NCT02646137|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92902875|NCT02646137|Estrogens|estrogens|mesh-ancestor
92902876|NCT02646137|Hormones|hormones|mesh-ancestor
92902877|NCT02646137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902878|NCT02646137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902879|NCT02646137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92902880|NCT02646137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902881|NCT00653549|Torsemide|torsemide|mesh-list
92902882|NCT00653549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92902883|NCT00653549|Diuretics|diuretics|mesh-ancestor
92902884|NCT00653549|Natriuretic Agents|natriuretic agents|mesh-ancestor
92902885|NCT00653549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902886|NCT00653549|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92902887|NCT00653549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92902888|NCT00653549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902889|NCT02642861|Cyclobenzaprine|cyclobenzaprine|mesh-list
92902890|NCT02642861|Calcium Carbonate|calcium carbonate|mesh-list
92902891|NCT02642861|Calcium|calcium|mesh-list
92902892|NCT02642861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92902893|NCT02642861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902894|NCT02642861|Antacids|antacids|mesh-ancestor
92902895|NCT02642861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902896|NCT02642861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92902897|NCT02642861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92902898|NCT02642861|Antidepressive Agents|antidepressive agents|mesh-ancestor
92902899|NCT02642861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902900|NCT02642861|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92902901|NCT02642861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92902902|NCT02642861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902903|NCT02642861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92902904|NCT02642861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902905|NCT02641457|Ranibizumab|ranibizumab|mesh-list
92902906|NCT02641457|Aflibercept|aflibercept|mesh-list
92902907|NCT02641457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902908|NCT02641457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902909|NCT02641457|Growth Substances|growth substances|mesh-ancestor
92548348|NCT04240106|Niraparib|niraparib|mesh-list
92902910|NCT02641457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902911|NCT02641457|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902912|NCT02641457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902913|NCT02642939|Mifepristone|mifepristone|mesh-list
92902914|NCT02642939|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92902915|NCT02642939|Abortifacient Agents|abortifacient agents|mesh-ancestor
92902916|NCT02642939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92902917|NCT02642939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161458|NCT04761731|Immunologic Factors|immunologic factors|mesh-ancestor
92902918|NCT02642939|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92902919|NCT02642939|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92902920|NCT02642939|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92902921|NCT02642939|Contraceptive Agents|contraceptive agents|mesh-ancestor
92902922|NCT02642939|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92902923|NCT02642939|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92902924|NCT02642939|Hormone Antagonists|hormone antagonists|mesh-ancestor
92902925|NCT02642939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92902926|NCT02642939|Luteolytic Agents|luteolytic agents|mesh-ancestor
92902927|NCT02642939|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92902928|NCT02642939|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92902929|NCT02641301|Morphine|morphine|mesh-list
92902930|NCT02641301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92902931|NCT02641301|Narcotics|narcotics|mesh-ancestor
92902932|NCT02641301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902933|NCT02641301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902934|NCT02641301|Analgesics|analgesics|mesh-ancestor
92902935|NCT02641301|Sensory System Agents|sensory system agents|mesh-ancestor
92902936|NCT02641301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902937|NCT03679949|Oxycodone|oxycodone|mesh-list
92902938|NCT03679949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92902939|NCT03679949|Narcotics|narcotics|mesh-ancestor
92902940|NCT03679949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902941|NCT03679949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902942|NCT03679949|Analgesics|analgesics|mesh-ancestor
92902943|NCT03679949|Sensory System Agents|sensory system agents|mesh-ancestor
92902944|NCT03679949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902945|NCT02640989|Vaccines|vaccines|mesh-list
92902946|NCT02640989|Immunologic Factors|immunologic factors|mesh-ancestor
92902947|NCT02640989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902948|NCT02645747|Aflibercept|aflibercept|mesh-list
92902949|NCT02645747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92902950|NCT02645747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92902951|NCT02645747|Growth Substances|growth substances|mesh-ancestor
92902952|NCT02645747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902953|NCT02645747|Growth Inhibitors|growth inhibitors|mesh-ancestor
92902954|NCT02645747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902955|NCT00653237|Chlorhexidine|chlorhexidine|mesh-list
92902956|NCT00653237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92902957|NCT00653237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902958|NCT00653237|Disinfectants|disinfectants|mesh-ancestor
92902959|NCT00653315|Tramadol|tramadol|mesh-list
92902960|NCT00653315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92902961|NCT00653315|Narcotics|narcotics|mesh-ancestor
92902962|NCT00653315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902963|NCT00653315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902964|NCT00653315|Analgesics|analgesics|mesh-ancestor
92902965|NCT00653315|Sensory System Agents|sensory system agents|mesh-ancestor
92902966|NCT00653315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902967|NCT02640833|Venetoclax|venetoclax|mesh-list
92902968|NCT02640833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902969|NCT00653393|Tranylcypromine|tranylcypromine|mesh-list
92902970|NCT00653393|Antidepressive Agents|antidepressive agents|mesh-ancestor
92902971|NCT00653393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92902972|NCT00653393|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92902973|NCT00653393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247812|NCT00631358|Hormones|hormones|mesh-ancestor
92902974|NCT00653393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902975|NCT00653393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92902976|NCT00653393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92902977|NCT00653393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902978|NCT00653393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902980|NCT02645903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92902981|NCT02645903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92902982|NCT02645903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92548420|NCT03872388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902983|NCT02645903|Narcotics|narcotics|mesh-ancestor
92902984|NCT02645903|Analgesics|analgesics|mesh-ancestor
92902985|NCT02645903|Sensory System Agents|sensory system agents|mesh-ancestor
92902986|NCT02645903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92902987|NCT02645981|Sorafenib|sorafenib|mesh-list
92902988|NCT02645981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92902989|NCT02645981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92902990|NCT02645981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92902991|NCT02645981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92902992|NCT02535767|Primaquine|primaquine|mesh-list
92902993|NCT02535767|Antimalarials|antimalarials|mesh-ancestor
92902994|NCT02535767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92902995|NCT02535767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92902996|NCT02535767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902997|NCT02640443|Sulfamethoxazole|sulfamethoxazole|mesh-list
92902998|NCT02640443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92902999|NCT02640365|Leucovorin|leucovorin|mesh-list
92903000|NCT02640365|Bevacizumab|bevacizumab|mesh-list
92903001|NCT02640365|Irinotecan|irinotecan|mesh-list
92903002|NCT02640365|Camptothecin|camptothecin|mesh-list
92903003|NCT02640365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903004|NCT02640365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903005|NCT02640365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903006|NCT02640365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903007|NCT02640365|Growth Substances|growth substances|mesh-ancestor
92903008|NCT02640365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903009|NCT02640365|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903010|NCT02640365|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92903011|NCT02640365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92903012|NCT02640365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903013|NCT02640365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903014|NCT02640365|Antidotes|antidotes|mesh-ancestor
92903015|NCT02640365|Protective Agents|protective agents|mesh-ancestor
92903016|NCT02640365|Vitamin B Complex|vitamin b complex|mesh-ancestor
92903017|NCT02640365|Vitamins|vitamins|mesh-ancestor
92903018|NCT02640365|Micronutrients|micronutrients|mesh-ancestor
92903019|NCT02640365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92903020|NCT02642003|Lenograstim|lenograstim|mesh-list
92903021|NCT02642003|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92903022|NCT02642003|Immunologic Factors|immunologic factors|mesh-ancestor
92903023|NCT02642003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903024|NCT02641847|Cyclophosphamide|cyclophosphamide|mesh-list
92903025|NCT02641847|Gemcitabine|gemcitabine|mesh-list
92903026|NCT02641847|Docetaxel|docetaxel|mesh-list
92903027|NCT02641847|Doxorubicin|doxorubicin|mesh-list
92903028|NCT02641847|Epirubicin|epirubicin|mesh-list
92903029|NCT02641847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903030|NCT02641847|Immunologic Factors|immunologic factors|mesh-ancestor
92903031|NCT02641847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903032|NCT02641847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903033|NCT02641847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92903034|NCT02641847|Alkylating Agents|alkylating agents|mesh-ancestor
92903035|NCT02641847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903036|NCT02641847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903037|NCT02641847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92903038|NCT02641847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92903039|NCT02641847|Antimetabolites|antimetabolites|mesh-ancestor
92903040|NCT02641847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92903041|NCT02641847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92903042|NCT02641847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92903043|NCT02641847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92903044|NCT02641847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92903045|NCT02641847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92903046|NCT02641847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903047|NCT00599027|Mometasone Furoate|mometasone furoate|mesh-list
92903048|NCT00599027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903049|NCT00599027|Dermatologic Agents|dermatologic agents|mesh-ancestor
92903050|NCT00599027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92903051|NCT00652379|Octreotide|octreotide|mesh-list
92903052|NCT00652379|Lanreotide|lanreotide|mesh-list
92903053|NCT00652379|Somatostatin|somatostatin|mesh-list
92903054|NCT00652379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903055|NCT00652379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92903056|NCT00652379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903057|NCT00652379|Hormones|hormones|mesh-ancestor
92903058|NCT00652379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92903059|NCT00652379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548491|NCT03589729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903060|NCT04164797|Endostar protein|endostar protein|mesh-list
92903061|NCT04164797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903062|NCT04164797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903063|NCT04164797|Growth Substances|growth substances|mesh-ancestor
92903064|NCT04164797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903065|NCT04164797|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903066|NCT04164797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903067|NCT00654017|Sildenafil Citrate|sildenafil citrate|mesh-list
92903068|NCT00654017|Vasodilator Agents|vasodilator agents|mesh-ancestor
92903069|NCT00654017|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92903070|NCT00654017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92903071|NCT00654017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903072|NCT00654017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903073|NCT00654017|Urological Agents|urological agents|mesh-ancestor
92903074|NCT02639819|Aminocaproic Acid|aminocaproic acid|mesh-list
92903075|NCT02639819|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92903076|NCT02639819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92903077|NCT02639819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903079|NCT02639819|Coagulants|coagulants|mesh-ancestor
92903080|NCT02639741|Vitamins|vitamins|mesh-list
92903081|NCT02639741|Ascorbic Acid|ascorbic acid|mesh-list
92903082|NCT02639741|Melatonin|melatonin|mesh-list
92903083|NCT02639741|Micronutrients|micronutrients|mesh-ancestor
92903084|NCT02639741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903085|NCT02639741|Antioxidants|antioxidants|mesh-ancestor
92903086|NCT02639741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903087|NCT02639741|Protective Agents|protective agents|mesh-ancestor
92903088|NCT02639741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903089|NCT04164719|Cyclobenzaprine|cyclobenzaprine|mesh-list
92903090|NCT04164719|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92903091|NCT04164719|Antidepressive Agents|antidepressive agents|mesh-ancestor
92903092|NCT04164719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903093|NCT04164719|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92903094|NCT04164719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903095|NCT04164719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92903096|NCT04164719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903097|NCT04164719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92903098|NCT04164719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903099|NCT01149083|Carboplatin|carboplatin|mesh-list
92903100|NCT01149083|Veliparib|veliparib|mesh-list
92903101|NCT01149083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903102|NCT01149083|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92903103|NCT01149083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903104|NCT01149083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903105|NCT00654173|Atorvastatin|atorvastatin|mesh-list
92903106|NCT00654173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92903107|NCT00654173|Simvastatin|simvastatin|mesh-list
92903108|NCT00654173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903109|NCT00654173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903110|NCT00654173|Antimetabolites|antimetabolites|mesh-ancestor
92903111|NCT00654173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903112|NCT00654173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903113|NCT00654173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92903114|NCT00654173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903115|NCT02645279|Midazolam|midazolam|mesh-list
92903116|NCT02645279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92903117|NCT02645279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92903118|NCT02645279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903119|NCT02645279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903120|NCT02645279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92903121|NCT02645279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92903122|NCT02645279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903123|NCT02645279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92903125|NCT02645279|Anesthetics|anesthetics|mesh-ancestor
92903126|NCT02645279|GABA Modulators|gaba modulators|mesh-ancestor
92903127|NCT02645279|GABA Agents|gaba agents|mesh-ancestor
92903128|NCT02645279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903129|NCT02645279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903130|NCT04164329|Anesthetics|anesthetics|mesh-list
92903131|NCT04164329|Anesthetics, General|anesthetics, general|mesh-list
92903132|NCT04164329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903133|NCT04164329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903134|NCT02639039|Cortisone|cortisone|mesh-list
92903135|NCT02639039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903136|NCT00655265|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92903137|NCT00655265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903138|NCT00655265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903139|NCT00655265|Antimetabolites|antimetabolites|mesh-ancestor
92903140|NCT00655265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903141|NCT00655265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903143|NCT02562664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92903144|NCT02562664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903145|NCT00654407|Atorvastatin|atorvastatin|mesh-list
92903146|NCT00654407|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92903147|NCT00654407|Simvastatin|simvastatin|mesh-list
92903148|NCT00654407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903149|NCT00654407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903150|NCT00654407|Antimetabolites|antimetabolites|mesh-ancestor
92903151|NCT00654407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903152|NCT00654407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903153|NCT00654407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92903154|NCT00654407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903155|NCT00691054|Paclitaxel|paclitaxel|mesh-list
92903156|NCT00691054|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92903157|NCT00691054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92903158|NCT00691054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903159|NCT00691054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92903160|NCT00691054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92903161|NCT00691054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92903162|NCT00691054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903163|NCT00598871|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92903164|NCT00598871|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92903165|NCT00744406|Sertraline|sertraline|mesh-list
92903166|NCT00744406|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92903167|NCT00744406|Antidepressive Agents|antidepressive agents|mesh-list
92903168|NCT00744406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903169|NCT00744406|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92903170|NCT00744406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92903171|NCT00744406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903172|NCT00744406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903173|NCT00744406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903174|NCT00744406|Serotonin Agents|serotonin agents|mesh-ancestor
92903175|NCT00744406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903176|NCT00744406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92903177|NCT00744406|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92903178|NCT00690820|Pancrelipase|pancrelipase|mesh-list
92903179|NCT00690820|Pancreatin|pancreatin|mesh-list
92903180|NCT00690820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903181|NCT02562508|Vaccines|vaccines|mesh-list
92903182|NCT02562508|Immunologic Factors|immunologic factors|mesh-ancestor
92903183|NCT02562508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903184|NCT00689338|Fluconazole|fluconazole|mesh-list
92903185|NCT00689338|Voriconazole|voriconazole|mesh-list
92903186|NCT00689338|Anidulafungin|anidulafungin|mesh-list
92903187|NCT00689338|Antifungal Agents|antifungal agents|mesh-ancestor
92903188|NCT00689338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903189|NCT00689338|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92903190|NCT00689338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92903191|NCT00689338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903192|NCT00689338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903193|NCT00689338|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92903194|NCT00689338|Hormone Antagonists|hormone antagonists|mesh-ancestor
92903195|NCT00689338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92903196|NCT00689338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903197|NCT00689338|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92903198|NCT00689338|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92903199|NCT00689338|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92903201|NCT00686998|Antiemetics|antiemetics|mesh-ancestor
92903202|NCT00686998|Autonomic Agents|autonomic agents|mesh-ancestor
92903203|NCT00686998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903204|NCT00686998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903205|NCT00686998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903206|NCT00686998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92903207|NCT00686998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92903208|NCT00686998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903209|NCT00686998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903210|NCT00686998|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92161474|NCT03086681|Cisplatin|cisplatin|mesh-list
92903211|NCT00686998|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92903212|NCT00686998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903213|NCT00686998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903214|NCT00686998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903215|NCT00686998|Serotonin Agents|serotonin agents|mesh-ancestor
92903216|NCT00744640|Gemcitabine|gemcitabine|mesh-list
92903217|NCT00744640|Capecitabine|capecitabine|mesh-list
92903218|NCT00744640|Oxaliplatin|oxaliplatin|mesh-list
92903219|NCT00744640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92903220|NCT00744640|Antimetabolites|antimetabolites|mesh-ancestor
92903221|NCT00744640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903222|NCT00744640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903223|NCT00848718|Paclitaxel|paclitaxel|mesh-list
92903224|NCT00848718|Docetaxel|docetaxel|mesh-list
92903225|NCT00848718|Carboplatin|carboplatin|mesh-list
92903226|NCT00848718|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92903227|NCT00848718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92903228|NCT00848718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903229|NCT00848718|Tubulin Modulators|tubulin modulators|mesh-ancestor
92903230|NCT00848718|Antimitotic Agents|antimitotic agents|mesh-ancestor
92903231|NCT00848718|Mitosis Modulators|mitosis modulators|mesh-ancestor
92903232|NCT00848718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903233|NCT00848718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903234|NCT00848718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903235|NCT02612844|Insulin Aspart|insulin aspart|mesh-list
92903236|NCT02612844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92903237|NCT02612844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903238|NCT00883337|Interferons|interferons|mesh-list
92903239|NCT00883337|Interferon-beta|interferon-beta|mesh-list
92903240|NCT00883337|Interferon beta-1a|interferon beta-1a|mesh-list
92903241|NCT00883337|Teriflunomide|teriflunomide|mesh-list
92903242|NCT00883337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903243|NCT00883337|Antiviral Agents|antiviral agents|mesh-ancestor
92903244|NCT00883337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903245|NCT00883337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92903246|NCT00883337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903247|NCT00883337|Analgesics|analgesics|mesh-ancestor
92903248|NCT00883337|Sensory System Agents|sensory system agents|mesh-ancestor
92903249|NCT00883337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903250|NCT00883337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903251|NCT00883337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903252|NCT00883337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903253|NCT00883337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903254|NCT00883337|Immunologic Factors|immunologic factors|mesh-ancestor
92903255|NCT00883337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92903256|NCT04163783|Zanubrutinib|zanubrutinib|mesh-list
92903257|NCT04163783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903258|NCT04163783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903259|NCT04163783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903260|NCT04163783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903261|NCT00654485|Atorvastatin|atorvastatin|mesh-list
92903262|NCT00654485|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92903263|NCT00654485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903264|NCT00654485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903265|NCT00654485|Antimetabolites|antimetabolites|mesh-ancestor
92903266|NCT00654485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903267|NCT00654485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903268|NCT00654485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92903269|NCT00654485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903270|NCT00837876|Sorafenib|sorafenib|mesh-list
92903271|NCT00837876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248076|NCT00595556|Anticonvulsants|anticonvulsants|mesh-ancestor
92903272|NCT00837876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903274|NCT00837876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903275|NCT00655421|Tolonium Chloride|tolonium chloride|mesh-list
92903276|NCT00655421|Hemostatics|hemostatics|mesh-ancestor
92903277|NCT00655421|Coagulants|coagulants|mesh-ancestor
92903278|NCT00655421|Heparin Antagonists|heparin antagonists|mesh-ancestor
92903279|NCT00655421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903280|NCT00707070|Acitretin|acitretin|mesh-list
92903281|NCT00707070|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92903282|NCT00707070|Immunologic Factors|immunologic factors|mesh-ancestor
92903283|NCT00707070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903284|NCT00707070|Keratolytic Agents|keratolytic agents|mesh-ancestor
92903285|NCT00707070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92903286|NCT00686920|Rifaximin|rifaximin|mesh-list
92903287|NCT00686920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92903288|NCT00686920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903289|NCT00686920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903290|NCT02562118|Letrozole|letrozole|mesh-list
92903291|NCT02562118|Lenvatinib|lenvatinib|mesh-list
92903292|NCT02562118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903293|NCT02562118|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92903294|NCT02562118|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92903295|NCT02562118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903296|NCT02562118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903297|NCT02562118|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92903298|NCT02562118|Hormone Antagonists|hormone antagonists|mesh-ancestor
92903299|NCT02562118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92903300|NCT02562118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903301|NCT02562118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903302|NCT00744718|Bevacizumab|bevacizumab|mesh-list
92903303|NCT00744718|Carboplatin|carboplatin|mesh-list
92903304|NCT00744718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903305|NCT00744718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903306|NCT00744718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903307|NCT00744718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903308|NCT00744718|Growth Substances|growth substances|mesh-ancestor
92903309|NCT00744718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903310|NCT00744718|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903311|NCT00741910|Semapimod|semapimod|mesh-list
92903312|NCT00741910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92903313|NCT00741910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903314|NCT00741910|Analgesics|analgesics|mesh-ancestor
92903315|NCT00741910|Sensory System Agents|sensory system agents|mesh-ancestor
92903316|NCT00741910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903317|NCT00741910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903318|NCT00741910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903319|NCT00741910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903320|NCT00741910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903321|NCT00741910|Immunologic Factors|immunologic factors|mesh-ancestor
92903322|NCT00845832|Rituximab|rituximab|mesh-list
92903323|NCT00845832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903324|NCT00845832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903325|NCT00845832|Immunologic Factors|immunologic factors|mesh-ancestor
92903326|NCT00845832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903327|NCT00845832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903328|NCT00703482|Coenzyme Q10|coenzyme q10|mesh-list
92903329|NCT00703482|Ubiquinone|ubiquinone|mesh-list
92903330|NCT00703482|Fenofibrate|fenofibrate|mesh-list
92903331|NCT00703482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903332|NCT00703482|Antimetabolites|antimetabolites|mesh-ancestor
92903333|NCT00703482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903334|NCT00703482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903335|NCT00703482|Vitamins|vitamins|mesh-ancestor
92903336|NCT00703482|Micronutrients|micronutrients|mesh-ancestor
92903337|NCT00703482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903338|NCT00885755|Capecitabine|capecitabine|mesh-list
92903339|NCT00885755|Trastuzumab|trastuzumab|mesh-list
92903340|NCT00885755|Taxane|taxane|mesh-list
92903341|NCT00885755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92903342|NCT00885755|Antimetabolites|antimetabolites|mesh-ancestor
92903343|NCT00885755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903344|NCT00885755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903345|NCT00885755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903346|NCT00749710|Clopidogrel|clopidogrel|mesh-list
92903347|NCT00749710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92903348|NCT00749710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92903349|NCT00749710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92903350|NCT00749710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92903351|NCT00749710|Purinergic Agents|purinergic agents|mesh-ancestor
92903352|NCT00749710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903353|NCT00749710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161480|NCT03086681|Growth Substances|growth substances|mesh-ancestor
92903354|NCT00749710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903355|NCT00749866|Gentamicins|gentamicins|mesh-list
92903356|NCT00749866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92903357|NCT00749866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903358|NCT00749866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92903359|NCT00749866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903360|NCT00749866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903361|NCT04058236|Polygeline|polygeline|mesh-list
92903362|NCT04058236|Plasma Substitutes|plasma substitutes|mesh-ancestor
92903363|NCT04058236|Blood Substitutes|blood substitutes|mesh-ancestor
92903364|NCT00742066|Felodipine|felodipine|mesh-list
92903365|NCT00742066|Irbesartan|irbesartan|mesh-list
92903366|NCT00742066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92903367|NCT00742066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92903368|NCT00742066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92903369|NCT00742066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903370|NCT00742066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92903371|NCT00742066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92903372|NCT00742066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903373|NCT00742066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92903374|NCT00742066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903375|NCT00742066|Vasodilator Agents|vasodilator agents|mesh-ancestor
92903376|NCT00742144|Ofatumumab|ofatumumab|mesh-list
92903377|NCT00742144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903378|NCT00845676|Interferons|interferons|mesh-list
92903379|NCT00845676|Ribavirin|ribavirin|mesh-list
92903380|NCT00845676|Interferon-alpha|interferon-alpha|mesh-list
92903381|NCT00845676|Interferon alpha-2|interferon alpha-2|mesh-list
92903382|NCT00845676|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92903383|NCT00845676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903384|NCT00845676|Antiviral Agents|antiviral agents|mesh-ancestor
92903385|NCT00845676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903386|NCT00845676|Antimetabolites|antimetabolites|mesh-ancestor
92903387|NCT00845676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903388|NCT00845676|Immunologic Factors|immunologic factors|mesh-ancestor
92903389|NCT00845676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903390|NCT00742300|Cyclophosphamide|cyclophosphamide|mesh-list
92903391|NCT00742300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903392|NCT00742300|Immunologic Factors|immunologic factors|mesh-ancestor
92903393|NCT00742300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903394|NCT00742300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903395|NCT00742300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92903396|NCT00742300|Alkylating Agents|alkylating agents|mesh-ancestor
92903397|NCT00742300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903398|NCT00742300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903399|NCT00742300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92903400|NCT02611908|Obinutuzumab|obinutuzumab|mesh-list
92903401|NCT02611908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903402|NCT02611908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903403|NCT02561884|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92903404|NCT02561884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92903405|NCT02561884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903406|NCT02561884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903407|NCT02561884|Antimetabolites|antimetabolites|mesh-ancestor
92903408|NCT02561884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903409|NCT02561884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903410|NCT02561884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92903411|NCT02561884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903412|NCT02561884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92903413|NCT02561884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92903414|NCT02561884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92903415|NCT00655655|Everolimus|everolimus|mesh-list
92903416|NCT00655655|Vatalanib|vatalanib|mesh-list
92903417|NCT00655655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92903418|NCT00655655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903419|NCT00655655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248225|NCT00603044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903420|NCT00655655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903422|NCT00655655|Immunologic Factors|immunologic factors|mesh-ancestor
92903423|NCT00655655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161483|NCT03086759|Triamcinolone|triamcinolone|mesh-list
92903424|NCT00655655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903425|NCT00844896|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
92903426|NCT00844896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903427|NCT00844896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903428|NCT05483400|Atezolizumab|atezolizumab|mesh-list
92903429|NCT05483400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92903430|NCT05483400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903431|NCT05483400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903432|NCT05483400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903433|NCT00837330|Ranibizumab|ranibizumab|mesh-list
92903434|NCT00837330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903435|NCT00837330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903436|NCT00837330|Growth Substances|growth substances|mesh-ancestor
92903437|NCT00837330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903438|NCT00837330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903439|NCT00837330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903440|NCT00703638|Pemetrexed|pemetrexed|mesh-list
92903441|NCT00703638|Sorafenib|sorafenib|mesh-list
92903442|NCT00703638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903443|NCT00703638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903444|NCT00703638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903445|NCT00703638|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92903446|NCT00703638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92903447|NCT00703638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903448|NCT02637479|Deoxyglucose|deoxyglucose|mesh-list
92903449|NCT02637479|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92903450|NCT02637479|Antimetabolites|antimetabolites|mesh-ancestor
92903451|NCT02637479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903452|NCT02637479|Antiviral Agents|antiviral agents|mesh-ancestor
92903453|NCT02637479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903454|NCT02637479|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92903455|NCT00885365|Tobramycin|tobramycin|mesh-list
92903456|NCT00885365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92903457|NCT00885365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903458|NCT00827112|Ritonavir|ritonavir|mesh-list
92903459|NCT00827112|Lopinavir|lopinavir|mesh-list
92903460|NCT00827112|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92903461|NCT00827112|Darunavir|darunavir|mesh-list
92903462|NCT00827112|Tenofovir|tenofovir|mesh-list
92903463|NCT00827112|Emtricitabine|emtricitabine|mesh-list
92903464|NCT00827112|Maraviroc|maraviroc|mesh-list
92903465|NCT00827112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92903466|NCT00827112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92903467|NCT00827112|Protease Inhibitors|protease inhibitors|mesh-ancestor
92903468|NCT00827112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903469|NCT00827112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903470|NCT00827112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92903471|NCT00827112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92903472|NCT00827112|Antiviral Agents|antiviral agents|mesh-ancestor
92903473|NCT00827112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903474|NCT00827112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92903475|NCT00827112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92903476|NCT00827112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92903477|NCT00827112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92903478|NCT00827112|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92903479|NCT00827112|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92903480|NCT00827112|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92903481|NCT00689104|Mirabegron|mirabegron|mesh-list
92903482|NCT00689104|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92903483|NCT00689104|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92903484|NCT00689104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92903485|NCT00689104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92903486|NCT00689104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92903487|NCT00689104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903488|NCT00689104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903489|NCT00689104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903490|NCT00689104|Urological Agents|urological agents|mesh-ancestor
92903491|NCT00689104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92903492|NCT00689104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92903493|NCT00689104|Cholinergic Agents|cholinergic agents|mesh-ancestor
92903494|NCT02118467|Phenylephrine|phenylephrine|mesh-list
92903495|NCT02118467|Vasopressins|vasopressins|mesh-list
92903496|NCT02118467|Arginine Vasopressin|arginine vasopressin|mesh-list
92903497|NCT02118467|Epinephrine|epinephrine|mesh-list
92903498|NCT02118467|Oxymetazoline|oxymetazoline|mesh-list
92903499|NCT02118467|Norepinephrine|norepinephrine|mesh-list
92903501|NCT02118467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92903502|NCT02118467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92903503|NCT02118467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92903504|NCT02118467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903505|NCT02118467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903506|NCT02118467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903507|NCT02118467|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92903508|NCT02118467|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92903509|NCT02118467|Autonomic Agents|autonomic agents|mesh-ancestor
92903510|NCT02118467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903511|NCT02118467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92903512|NCT02118467|Respiratory System Agents|respiratory system agents|mesh-ancestor
92903513|NCT02118467|Mydriatics|mydriatics|mesh-ancestor
92903514|NCT02118467|Sympathomimetics|sympathomimetics|mesh-ancestor
92903515|NCT02118467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92903516|NCT02118467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92903517|NCT02118467|Nasal Decongestants|nasal decongestants|mesh-ancestor
92903518|NCT02118467|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92903519|NCT02118467|Protective Agents|protective agents|mesh-ancestor
92903520|NCT02118467|Hemostatics|hemostatics|mesh-ancestor
92903521|NCT02118467|Coagulants|coagulants|mesh-ancestor
92903522|NCT02118467|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92903523|NCT02118467|Natriuretic Agents|natriuretic agents|mesh-ancestor
92903525|NCT00702156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92903526|NCT00702156|Sympatholytics|sympatholytics|mesh-ancestor
92903527|NCT00702156|Autonomic Agents|autonomic agents|mesh-ancestor
92903528|NCT00702156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903529|NCT00702156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903530|NCT00702156|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92903531|NCT00702156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92903532|NCT00702156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92903533|NCT00702156|Adrenergic Agents|adrenergic agents|mesh-ancestor
92903534|NCT00702156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903535|NCT00702156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903536|NCT02638415|Carvedilol|carvedilol|mesh-list
92903537|NCT02638415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92903538|NCT02638415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92903539|NCT02638415|Adrenergic Agents|adrenergic agents|mesh-ancestor
92903540|NCT02638415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903541|NCT02638415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903542|NCT02638415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903543|NCT02638415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92903544|NCT02638415|Antioxidants|antioxidants|mesh-ancestor
92903545|NCT02638415|Protective Agents|protective agents|mesh-ancestor
92903546|NCT02638415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92903547|NCT02638415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903548|NCT02638415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92903549|NCT02638415|Vasodilator Agents|vasodilator agents|mesh-ancestor
92903550|NCT02638415|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92903551|NCT02638415|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92903552|NCT00703872|Interferons|interferons|mesh-list
92903553|NCT00703872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903554|NCT00703872|Antiviral Agents|antiviral agents|mesh-ancestor
92903555|NCT00703872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903556|NCT00689026|Lubiprostone|lubiprostone|mesh-list
92903557|NCT00689026|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92903558|NCT00689026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903559|NCT00689026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903560|NCT00598559|Acetaminophen|acetaminophen|mesh-list
92903561|NCT00598559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903562|NCT00598559|Analgesics|analgesics|mesh-ancestor
92903563|NCT00598559|Sensory System Agents|sensory system agents|mesh-ancestor
92903564|NCT00598559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903565|NCT00598559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903566|NCT00598559|Antipyretics|antipyretics|mesh-ancestor
92903567|NCT00686686|Infliximab|infliximab|mesh-list
92525873|NCT00000425|Acetaminophen|acetaminophen|mesh-list
92903568|NCT00686686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92903569|NCT00686686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903570|NCT00686686|Dermatologic Agents|dermatologic agents|mesh-ancestor
92903571|NCT00686686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903572|NCT00686686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903574|NCT02637167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92903575|NCT02637167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903576|NCT02637167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903577|NCT04057300|Aspirin|aspirin|mesh-list
92903578|NCT04057300|Clopidogrel|clopidogrel|mesh-list
92903579|NCT04057300|Ticagrelor|ticagrelor|mesh-list
92903580|NCT04057300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92903581|NCT04057300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903582|NCT04057300|Analgesics|analgesics|mesh-ancestor
92903583|NCT04057300|Sensory System Agents|sensory system agents|mesh-ancestor
92903584|NCT04057300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903585|NCT04057300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903586|NCT04057300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903587|NCT04057300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903588|NCT04057300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92903589|NCT04057300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92903590|NCT04057300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903591|NCT04057300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92903592|NCT04057300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92903593|NCT04057300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903594|NCT04057300|Antipyretics|antipyretics|mesh-ancestor
92903595|NCT04057300|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92903596|NCT04057300|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92903597|NCT04057300|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92903598|NCT04057300|Purinergic Agents|purinergic agents|mesh-ancestor
92903599|NCT04057300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903600|NCT00655967|Acamprosate|acamprosate|mesh-list
92903601|NCT00655967|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92903602|NCT00750100|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92903603|NCT00750100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92903604|NCT00750100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903605|NCT00655109|Fluticasone|fluticasone|mesh-list
92903606|NCT00655109|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92903607|NCT00655109|Lubricant Eye Drops|lubricant eye drops|mesh-list
92903608|NCT00655109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903609|NCT00655109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92903610|NCT00655109|Autonomic Agents|autonomic agents|mesh-ancestor
92903611|NCT00655109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903612|NCT00655109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903613|NCT00655109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92903614|NCT00655109|Respiratory System Agents|respiratory system agents|mesh-ancestor
92903615|NCT00655109|Dermatologic Agents|dermatologic agents|mesh-ancestor
92903616|NCT00655109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92903617|NCT00655109|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92903618|NCT00655109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92903619|NCT00655109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92903620|NCT00655109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903621|NCT00655109|Analgesics|analgesics|mesh-ancestor
92903622|NCT00655109|Sensory System Agents|sensory system agents|mesh-ancestor
92903623|NCT00655109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903624|NCT00655109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92903625|NCT00655109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92903626|NCT00655109|Histamine Antagonists|histamine antagonists|mesh-ancestor
92903627|NCT00655109|Histamine Agents|histamine agents|mesh-ancestor
92903628|NCT00655109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903629|NCT00655109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903630|NCT02632877|Pirfenidone|pirfenidone|mesh-list
92903631|NCT02632877|Ketanserin|ketanserin|mesh-list
92903632|NCT02632877|Analgesics|analgesics|mesh-ancestor
92903633|NCT02632877|Sensory System Agents|sensory system agents|mesh-ancestor
92903634|NCT02632877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903635|NCT02632877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903636|NCT02632877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92903637|NCT02632877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903638|NCT02632877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903639|NCT02632877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903640|NCT02632877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903641|NCT02632877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92903642|NCT02632877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92903643|NCT02632877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92903644|NCT02632877|Serotonin Agents|serotonin agents|mesh-ancestor
92903645|NCT02632877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903646|NCT02632877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903647|NCT00656123|Cyclophosphamide|cyclophosphamide|mesh-list
92903649|NCT00656123|Sargramostim|sargramostim|mesh-list
92903650|NCT00656123|Immunologic Factors|immunologic factors|mesh-ancestor
92903651|NCT00656123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903652|NCT00656123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903653|NCT00656123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903654|NCT00656123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92903655|NCT00656123|Alkylating Agents|alkylating agents|mesh-ancestor
92903656|NCT00656123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903657|NCT00656123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903658|NCT00656123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92903659|NCT04163471|Hemostatics|hemostatics|mesh-list
92903660|NCT04163471|Coagulants|coagulants|mesh-ancestor
92903661|NCT00657449|Valdecoxib|valdecoxib|mesh-list
92549099|NCT00039351|Prednisone|prednisone|mesh-list
92903662|NCT00657449|Rofecoxib|rofecoxib|mesh-list
92903663|NCT00657449|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92903664|NCT00657449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92903665|NCT00657449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903666|NCT00657449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903667|NCT00657449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92903668|NCT00657449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92903669|NCT00657449|Analgesics|analgesics|mesh-ancestor
92903670|NCT00657449|Sensory System Agents|sensory system agents|mesh-ancestor
92903671|NCT00657449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903672|NCT00657449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903673|NCT00657449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903674|NCT00657449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903675|NCT04160195|Cyclophosphamide|cyclophosphamide|mesh-list
92903676|NCT04160195|Fludarabine|fludarabine|mesh-list
92903677|NCT04160195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903678|NCT04160195|Immunologic Factors|immunologic factors|mesh-ancestor
92903679|NCT04160195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903680|NCT04160195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903681|NCT04160195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92903682|NCT04160195|Alkylating Agents|alkylating agents|mesh-ancestor
92903683|NCT04160195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903684|NCT04160195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903685|NCT04160195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92903686|NCT00911261|Oxymorphone|oxymorphone|mesh-list
92903687|NCT00911261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92903688|NCT00911261|Narcotics|narcotics|mesh-ancestor
92903689|NCT00911261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903690|NCT00911261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903691|NCT00911261|Analgesics|analgesics|mesh-ancestor
92903692|NCT00911261|Sensory System Agents|sensory system agents|mesh-ancestor
92903693|NCT00911261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903694|NCT00911261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92903695|NCT00686374|Adalimumab|adalimumab|mesh-list
92903696|NCT00686374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92903697|NCT00686374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903698|NCT00686374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903699|NCT00750178|Vorinostat|vorinostat|mesh-list
92903700|NCT00750178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903701|NCT00750178|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92903702|NCT00750178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903703|NCT00750178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903704|NCT00750334|Clofarabine|clofarabine|mesh-list
92903705|NCT00750334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92903706|NCT00750334|Antimetabolites|antimetabolites|mesh-ancestor
92903707|NCT00750334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903708|NCT00750334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903709|NCT00745186|Glucagon|glucagon|mesh-list
92903710|NCT00745186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903711|NCT00745186|Hormones|hormones|mesh-ancestor
92161501|NCT03086291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903712|NCT00745186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92903713|NCT00745186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903714|NCT00750724|Hyaluronic Acid|hyaluronic acid|mesh-list
92903715|NCT00750724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92903716|NCT00750724|Immunologic Factors|immunologic factors|mesh-ancestor
92903717|NCT00750724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903718|NCT00750724|Viscosupplements|viscosupplements|mesh-ancestor
92903719|NCT00750724|Protective Agents|protective agents|mesh-ancestor
92903720|NCT00752518|Bortezomib|bortezomib|mesh-list
92903721|NCT00752518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903722|NCT00752596|Azimilide|azimilide|mesh-list
92903723|NCT00752596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92903724|NCT00752596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92903725|NCT00752596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903726|NCT00752596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903727|NCT00752596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92903728|NCT00752596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903729|NCT00750802|Lorazepam|lorazepam|mesh-list
92903730|NCT00750802|Anticonvulsants|anticonvulsants|mesh-ancestor
92903731|NCT00750802|Antiemetics|antiemetics|mesh-ancestor
92903732|NCT00750802|Autonomic Agents|autonomic agents|mesh-ancestor
92903733|NCT00750802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903734|NCT00750802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903735|NCT00750802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903736|NCT00750802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92903737|NCT00750802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903738|NCT00750802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92903739|NCT00750802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92903740|NCT00750802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903741|NCT00750802|GABA Modulators|gaba modulators|mesh-ancestor
92903742|NCT00750802|GABA Agents|gaba agents|mesh-ancestor
92903743|NCT00750802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903744|NCT00750802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903745|NCT00751270|Valacyclovir|valacyclovir|mesh-list
92903746|NCT00751270|Antiviral Agents|antiviral agents|mesh-ancestor
92903747|NCT00751270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903748|NCT00751504|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92903749|NCT00751504|Antidepressive Agents|antidepressive agents|mesh-ancestor
92903750|NCT00751504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903751|NCT00751504|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92903752|NCT00751504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92903753|NCT00751504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903754|NCT00751504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903755|NCT00576628|Epoetin Alfa|epoetin alfa|mesh-list
92903756|NCT00576628|Hematinics|hematinics|mesh-ancestor
92903757|NCT00683878|Pioglitazone|pioglitazone|mesh-list
92903758|NCT00683878|Dapagliflozin|dapagliflozin|mesh-list
92903759|NCT00683878|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92903760|NCT00683878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92903761|NCT00683878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903762|NCT00683878|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92903763|NCT00683878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903764|NCT00884741|Bevacizumab|bevacizumab|mesh-list
92903765|NCT00884741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92903766|NCT00884741|Temozolomide|temozolomide|mesh-list
92903767|NCT00884741|Endothelial Growth Factors|endothelial growth factors|mesh-list
92903768|NCT00884741|Antibodies|antibodies|mesh-list
92903769|NCT00884741|Immunoglobulins|immunoglobulins|mesh-list
92903770|NCT00884741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92903771|NCT00884741|Immunoglobulin G|immunoglobulin g|mesh-list
92903772|NCT00884741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903773|NCT00884741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903774|NCT00884741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903775|NCT00884741|Growth Substances|growth substances|mesh-ancestor
92903776|NCT00884741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903777|NCT00884741|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903778|NCT00884741|Immunologic Factors|immunologic factors|mesh-ancestor
92903779|NCT00884741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92903780|NCT00884741|Alkylating Agents|alkylating agents|mesh-ancestor
92903781|NCT00884741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903782|NCT00657527|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92903783|NCT00657527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903784|NCT00657527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903785|NCT00657527|Antimetabolites|antimetabolites|mesh-ancestor
92903786|NCT00657527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903787|NCT00657527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903788|NCT00657527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92903789|NCT00657527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903790|NCT00598481|Busulfan|busulfan|mesh-list
92903791|NCT00598481|Alkylating Agents|alkylating agents|mesh-ancestor
92903792|NCT00598481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903793|NCT00598481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903794|NCT00598481|Immunologic Factors|immunologic factors|mesh-ancestor
92903795|NCT00598481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903796|NCT00598481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92903797|NCT00598481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903798|NCT00598481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92903799|NCT04159649|Letrozole|letrozole|mesh-list
92903800|NCT04159649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903801|NCT04159649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92903802|NCT04159649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92903803|NCT04159649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903804|NCT04159649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903805|NCT04159649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92903806|NCT04159649|Hormone Antagonists|hormone antagonists|mesh-ancestor
92903807|NCT04159649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92903808|NCT04159649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903809|NCT00880763|Interferons|interferons|mesh-list
92903810|NCT00880763|Ribavirin|ribavirin|mesh-list
92903811|NCT00880763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903812|NCT00880763|Antiviral Agents|antiviral agents|mesh-ancestor
92903813|NCT00880763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903814|NCT00880763|Antimetabolites|antimetabolites|mesh-ancestor
92903815|NCT00880763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903817|NCT00884273|Bicalutamide|bicalutamide|mesh-list
92903818|NCT00884273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92903819|NCT00884273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903820|NCT00884273|Androgen Antagonists|androgen antagonists|mesh-ancestor
92903821|NCT00884273|Hormone Antagonists|hormone antagonists|mesh-ancestor
92903822|NCT00884273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92903823|NCT00884273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903824|NCT00657761|Enfuvirtide|enfuvirtide|mesh-list
92903825|NCT00657761|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92903826|NCT00657761|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92903827|NCT00657761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903828|NCT00657761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92903829|NCT00657761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92903830|NCT00657761|Antiviral Agents|antiviral agents|mesh-ancestor
92903831|NCT00657761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903832|NCT00657839|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92903833|NCT00657839|Vasodilator Agents|vasodilator agents|mesh-ancestor
92903834|NCT00657839|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92903835|NCT00657839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92903836|NCT00657839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903837|NCT00657839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903838|NCT00657839|Urological Agents|urological agents|mesh-ancestor
92903839|NCT00884117|Oseltamivir|oseltamivir|mesh-list
92903840|NCT00884117|Antiviral Agents|antiviral agents|mesh-ancestor
92903841|NCT00884117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92903842|NCT00884117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903843|NCT00884117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903844|NCT04159181|Lactulose|lactulose|mesh-list
92903845|NCT04159181|Picosulfate sodium|picosulfate sodium|mesh-list
92903846|NCT04159181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903847|NCT04159181|Cathartics|cathartics|mesh-ancestor
92903848|NCT00884039|Hydrocortisone|hydrocortisone|mesh-list
92903849|NCT00884039|Anecortave|anecortave|mesh-list
92903850|NCT00884039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903851|NCT00884039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903852|NCT00884039|Growth Substances|growth substances|mesh-ancestor
92903853|NCT00884039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903854|NCT00884039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903855|NCT00884039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903856|NCT00884039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92903857|NCT00657995|Pancrelipase|pancrelipase|mesh-list
92903858|NCT00657995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92903859|NCT02632565|Lidocaine|lidocaine|mesh-list
92903860|NCT02632565|Anesthetics, Local|anesthetics, local|mesh-ancestor
92903861|NCT02632565|Anesthetics|anesthetics|mesh-ancestor
92903862|NCT02632565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903863|NCT02632565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903864|NCT02632565|Sensory System Agents|sensory system agents|mesh-ancestor
92903865|NCT02632565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903866|NCT02632565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92903867|NCT02632565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92903868|NCT02632565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92903869|NCT02632565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903870|NCT02632565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903871|NCT04158947|Trastuzumab|trastuzumab|mesh-list
92903872|NCT04158947|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92903874|NCT04158947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903875|NCT04158947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903876|NCT04158947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903877|NCT04158947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903878|NCT04158947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903879|NCT04158947|Tubulin Modulators|tubulin modulators|mesh-ancestor
92903880|NCT04158947|Antimitotic Agents|antimitotic agents|mesh-ancestor
92903881|NCT04158947|Mitosis Modulators|mitosis modulators|mesh-ancestor
92903882|NCT04158947|Immunotoxins|immunotoxins|mesh-ancestor
92903883|NCT04158947|Immunoconjugates|immunoconjugates|mesh-ancestor
92903884|NCT04158947|Immunologic Factors|immunologic factors|mesh-ancestor
92903885|NCT04158947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903886|NCT00835770|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92903887|NCT00835770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92903888|NCT00835770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903889|NCT00835770|Immunologic Factors|immunologic factors|mesh-ancestor
92903890|NCT00835770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903891|NCT04163237|Sorafenib|sorafenib|mesh-list
92903892|NCT04163237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903893|NCT04163237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903894|NCT04163237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903895|NCT04163237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903896|NCT00880685|Memantine|memantine|mesh-list
92903897|NCT00880685|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92903898|NCT00880685|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92903899|NCT00880685|Dopamine Agents|dopamine agents|mesh-ancestor
92903900|NCT00880685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903901|NCT00880685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903902|NCT00880685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903903|NCT00880685|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92903904|NCT00880685|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92903905|NCT02612298|Metoprolol|metoprolol|mesh-list
92903906|NCT02612298|Arotinolol|arotinolol|mesh-list
92903907|NCT02612298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92903908|NCT02612298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92903909|NCT02612298|Sympatholytics|sympatholytics|mesh-ancestor
92903910|NCT02612298|Autonomic Agents|autonomic agents|mesh-ancestor
92903911|NCT02612298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903912|NCT02612298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903913|NCT02612298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92903914|NCT02612298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92903915|NCT02612298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92903916|NCT02612298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92903917|NCT02612298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903918|NCT02612298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903919|NCT02612298|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92903920|NCT00880607|Morphine|morphine|mesh-list
92903921|NCT00880607|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92903922|NCT00880607|Narcotics|narcotics|mesh-ancestor
92903923|NCT00880607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903924|NCT00880607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903925|NCT00880607|Analgesics|analgesics|mesh-ancestor
92903926|NCT00880607|Sensory System Agents|sensory system agents|mesh-ancestor
92903927|NCT00880607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903928|NCT00656435|Bevacizumab|bevacizumab|mesh-list
92903929|NCT00656435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92903930|NCT00656435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903931|NCT00656435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903932|NCT00656435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903933|NCT00656435|Growth Substances|growth substances|mesh-ancestor
92903934|NCT00656435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903935|NCT00656435|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903936|NCT02636231|Endostatins|endostatins|mesh-list
92903937|NCT02636231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92903938|NCT02636231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92903939|NCT02636231|Growth Substances|growth substances|mesh-ancestor
92903940|NCT02636231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903941|NCT02636231|Growth Inhibitors|growth inhibitors|mesh-ancestor
92903942|NCT02636231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903943|NCT00658463|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92903944|NCT00658463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92903945|NCT00658463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92903946|NCT00658463|Antimetabolites|antimetabolites|mesh-ancestor
92903947|NCT00658463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903948|NCT00658463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92903949|NCT00658463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92903950|NCT00658463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903951|NCT00656591|Methotrexate|methotrexate|mesh-list
92903952|NCT00656591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92903953|NCT00656591|Abortifacient Agents|abortifacient agents|mesh-ancestor
92903954|NCT00656591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92903955|NCT00656591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903956|NCT00656591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92903957|NCT00656591|Antimetabolites|antimetabolites|mesh-ancestor
92903958|NCT00656591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903959|NCT00656591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92903960|NCT00656591|Dermatologic Agents|dermatologic agents|mesh-ancestor
92903961|NCT00656591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903962|NCT00656591|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92903963|NCT00656591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92903964|NCT00656591|Immunologic Factors|immunologic factors|mesh-ancestor
92903965|NCT00656591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92903966|NCT00656591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92903967|NCT00658931|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92903968|NCT00658931|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92903969|NCT00658931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92903970|NCT00658931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92903971|NCT00658931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903972|NCT00658931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92903973|NCT00658931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903974|NCT00658931|Analgesics|analgesics|mesh-ancestor
92903975|NCT00658931|Sensory System Agents|sensory system agents|mesh-ancestor
92903976|NCT00658931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903977|NCT00658931|Antidepressive Agents|antidepressive agents|mesh-ancestor
92903978|NCT00658931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92903979|NCT00658931|Dopamine Agents|dopamine agents|mesh-ancestor
92903980|NCT00834912|Tramadol|tramadol|mesh-list
92903981|NCT00834912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92903982|NCT00834912|Narcotics|narcotics|mesh-ancestor
92903983|NCT00834912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92903984|NCT00834912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903985|NCT00834912|Analgesics|analgesics|mesh-ancestor
92903986|NCT00834912|Sensory System Agents|sensory system agents|mesh-ancestor
92903987|NCT00834912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903988|NCT02535689|Tofacitinib|tofacitinib|mesh-list
92903989|NCT02535689|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92903990|NCT02535689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92903991|NCT02535689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92903992|NCT02535689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92903993|NCT02632331|Gabapentin|gabapentin|mesh-list
92903994|NCT02632331|Analgesics|analgesics|mesh-ancestor
92903995|NCT02632331|Sensory System Agents|sensory system agents|mesh-ancestor
92903996|NCT02632331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92903997|NCT02632331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92903998|NCT02632331|Anticonvulsants|anticonvulsants|mesh-ancestor
92903999|NCT02632331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92904000|NCT02632331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92904001|NCT02632331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904002|NCT02632331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904003|NCT02632331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92904004|NCT02632331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92904005|NCT02632331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904006|NCT02632331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904007|NCT02632331|Antimanic Agents|antimanic agents|mesh-ancestor
92904008|NCT04162535|Lidocaine|lidocaine|mesh-list
92904009|NCT04162535|Propofol|propofol|mesh-list
92904010|NCT04162535|Anesthetics|anesthetics|mesh-list
92904011|NCT04162535|Sevoflurane|sevoflurane|mesh-list
92904012|NCT04162535|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92904013|NCT04162535|Anesthetics, Local|anesthetics, local|mesh-ancestor
92904014|NCT04162535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904015|NCT04162535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904016|NCT04162535|Sensory System Agents|sensory system agents|mesh-ancestor
92904017|NCT04162535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904018|NCT04162535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92904019|NCT04162535|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92904020|NCT04162535|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92904021|NCT04162535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92904022|NCT04162535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904023|NCT04162535|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92904024|NCT04162535|Anesthetics, General|anesthetics, general|mesh-ancestor
92904025|NCT04162535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92904026|NCT04162535|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92904027|NCT02632019|Gemcitabine|gemcitabine|mesh-list
92904028|NCT02632019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92904029|NCT02632019|Antimetabolites|antimetabolites|mesh-ancestor
92904030|NCT02632019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904031|NCT02632019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904032|NCT00883493|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92904033|NCT00883493|Lithium Carbonate|lithium carbonate|mesh-list
92904034|NCT00883493|Antidepressive Agents|antidepressive agents|mesh-ancestor
92904035|NCT00883493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904036|NCT00883493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92904037|NCT00883493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92904038|NCT00883493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904039|NCT00883493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904040|NCT00883493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904041|NCT00883493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904042|NCT00883493|Antimanic Agents|antimanic agents|mesh-ancestor
92904043|NCT04158713|Piperaquine|piperaquine|mesh-list
92904044|NCT04158713|Artenimol|artenimol|mesh-list
92904045|NCT04158713|Antimalarials|antimalarials|mesh-ancestor
92904046|NCT04158713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92904047|NCT04158713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92904048|NCT04158713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904049|NCT00659321|Nicotine|nicotine|mesh-list
92904050|NCT00659321|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92904051|NCT00659321|Autonomic Agents|autonomic agents|mesh-ancestor
92904052|NCT00659321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904053|NCT00659321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904054|NCT00659321|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92904055|NCT00659321|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92904056|NCT00659321|Cholinergic Agents|cholinergic agents|mesh-ancestor
92904057|NCT00659321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904058|NCT00659321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904059|NCT00659399|PENTA|penta|mesh-list
92904060|NCT00659399|Fondaparinux|fondaparinux|mesh-list
92904061|NCT00659399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92904062|NCT00659399|Antithrombins|antithrombins|mesh-ancestor
92904063|NCT00659399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92904064|NCT00659399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92904065|NCT00659399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904066|NCT00659399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904067|NCT00659399|Anticoagulants|anticoagulants|mesh-ancestor
92904068|NCT00659399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92904069|NCT00659399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92904070|NCT00659477|Insulin Glargine|insulin glargine|mesh-list
92904071|NCT00659477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92149402|NCT03457896|Trastuzumab|trastuzumab|mesh-list
92904072|NCT00659477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904073|NCT00911339|Atorvastatin|atorvastatin|mesh-list
92904074|NCT00911339|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92904075|NCT00911339|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92904076|NCT00911339|Antimetabolites|antimetabolites|mesh-ancestor
92904077|NCT00911339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904078|NCT00911339|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92904079|NCT00911339|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92904080|NCT00911339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904082|NCT05863195|Bevacizumab|bevacizumab|mesh-list
92904083|NCT05863195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92904084|NCT05863195|Cetuximab|cetuximab|mesh-list
92904085|NCT05863195|Panitumumab|panitumumab|mesh-list
92904086|NCT05863195|Fluorouracil|fluorouracil|mesh-list
92904087|NCT05863195|Oxaliplatin|oxaliplatin|mesh-list
92904088|NCT05863195|Irinotecan|irinotecan|mesh-list
92904089|NCT05863195|Floxuridine|floxuridine|mesh-list
92904090|NCT05863195|Endothelial Growth Factors|endothelial growth factors|mesh-list
92904091|NCT05863195|Antibodies|antibodies|mesh-list
92904092|NCT05863195|Immunoglobulins|immunoglobulins|mesh-list
92904093|NCT05863195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92904094|NCT05863195|Immunoglobulin G|immunoglobulin g|mesh-list
92904095|NCT05863195|Deoxyuridine|deoxyuridine|mesh-list
92904096|NCT05863195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904097|NCT05863195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92904098|NCT05863195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92904099|NCT05863195|Growth Substances|growth substances|mesh-ancestor
92904100|NCT05863195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904101|NCT05863195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92904102|NCT05863195|Immunologic Factors|immunologic factors|mesh-ancestor
92904103|NCT05863195|Antimetabolites|antimetabolites|mesh-ancestor
92904104|NCT05863195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904105|NCT05863195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92904106|NCT05863195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904107|NCT05863195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92904108|NCT05863195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92904109|NCT05863195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904110|NCT05863195|Antidotes|antidotes|mesh-ancestor
92904111|NCT05863195|Protective Agents|protective agents|mesh-ancestor
92904112|NCT05863195|Vitamin B Complex|vitamin b complex|mesh-ancestor
92904113|NCT05863195|Vitamins|vitamins|mesh-ancestor
92904114|NCT05863195|Micronutrients|micronutrients|mesh-ancestor
92904115|NCT05863104|Glycopyrrolate|glycopyrrolate|mesh-list
92904116|NCT05863104|Bromides|bromides|mesh-list
92904117|NCT05863104|Anticonvulsants|anticonvulsants|mesh-ancestor
92904118|NCT05863104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92904119|NCT05863104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92904120|NCT05863104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92904121|NCT05863104|Cholinergic Agents|cholinergic agents|mesh-ancestor
92904122|NCT05863104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904123|NCT05863104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904124|NCT05863104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904125|NCT05863052|Immunomodulating Agents|immunomodulating agents|mesh-list
92904126|NCT05863052|Immunologic Factors|immunologic factors|mesh-ancestor
92904127|NCT05863052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904128|NCT05862792|Bupivacaine|bupivacaine|mesh-list
92904129|NCT05862792|Anesthetics, Local|anesthetics, local|mesh-ancestor
92904130|NCT05862792|Anesthetics|anesthetics|mesh-ancestor
92904131|NCT05862792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904132|NCT05862792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904133|NCT05862792|Sensory System Agents|sensory system agents|mesh-ancestor
92904134|NCT05862792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904135|NCT05862753|Etomidate|etomidate|mesh-list
92904136|NCT05862753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92904137|NCT05862753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904138|NCT05862753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904139|NCT05862753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92904140|NCT05862753|Anesthetics, General|anesthetics, general|mesh-ancestor
92904141|NCT05862753|Anesthetics|anesthetics|mesh-ancestor
92904142|NCT05862714|Itraconazole|itraconazole|mesh-list
92904143|NCT05862714|Fluconazole|fluconazole|mesh-list
92904144|NCT05862714|Antifungal Agents|antifungal agents|mesh-ancestor
92904145|NCT05862714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904146|NCT05862714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92904147|NCT05862714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92904148|NCT05862714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904149|NCT05862714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904150|NCT05862714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92904151|NCT05862714|Hormone Antagonists|hormone antagonists|mesh-ancestor
92904152|NCT05862714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904153|NCT05862714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904154|NCT05862714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92904155|NCT05862714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92904156|NCT05862714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92904157|NCT05862701|Permethrin|permethrin|mesh-list
92904158|NCT05862701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904159|NCT05862701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904160|NCT05862688|Anti-Infective Agents|anti-infective agents|mesh-list
92904161|NCT05862688|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92904162|NCT05862519|Testosterone|testosterone|mesh-list
92904163|NCT05862519|Androgens|androgens|mesh-ancestor
92904164|NCT05862519|Hormones|hormones|mesh-ancestor
92904165|NCT05862519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904166|NCT05862519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904167|NCT05862428|Misoprostol|misoprostol|mesh-list
92904168|NCT05862428|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92904169|NCT05862428|Abortifacient Agents|abortifacient agents|mesh-ancestor
92904170|NCT05862428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92904171|NCT05862428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904172|NCT05862428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92904173|NCT05862428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92904174|NCT05862428|Oxytocics|oxytocics|mesh-ancestor
92904175|NCT05862402|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92904176|NCT05862402|Gentamicins|gentamicins|mesh-list
92904177|NCT05862402|Meropenem|meropenem|mesh-list
92904178|NCT05862402|Imipenem|imipenem|mesh-list
92904179|NCT05862402|Amikacin|amikacin|mesh-list
92904180|NCT05862402|Colistin|colistin|mesh-list
92904181|NCT05862402|Ceftazidime|ceftazidime|mesh-list
92904182|NCT05862402|Tigecycline|tigecycline|mesh-list
92904183|NCT05862402|Avibactam|avibactam|mesh-list
92904184|NCT05862402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92904185|NCT05862402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904186|NCT05862402|Antitubercular Agents|antitubercular agents|mesh-ancestor
92904187|NCT05862402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92904188|NCT05862402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904189|NCT05862402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904190|NCT05862402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92904191|NCT05862220|Fibrin fragment D|fibrin fragment d|mesh-list
92904192|NCT05862220|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92904193|NCT05862220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92904194|NCT05862220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904195|NCT05862220|Hemostatics|hemostatics|mesh-ancestor
92904196|NCT05862220|Coagulants|coagulants|mesh-ancestor
92904197|NCT05862194|Lazertinib|lazertinib|mesh-list
92904198|NCT05862194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904199|NCT05862194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904200|NCT05862194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904201|NCT05862064|Paclitaxel|paclitaxel|mesh-list
92904202|NCT05862064|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92904203|NCT05862064|Cyclophosphamide|cyclophosphamide|mesh-list
92904204|NCT05862064|Epirubicin|epirubicin|mesh-list
92904205|NCT05862064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92904206|NCT05862064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904207|NCT05862064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92904208|NCT05862064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92904209|NCT05862064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92904210|NCT05862064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904211|NCT05862064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904212|NCT05862064|Immunologic Factors|immunologic factors|mesh-ancestor
92904213|NCT05862064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904214|NCT05862064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92904215|NCT05862064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92904216|NCT05862064|Alkylating Agents|alkylating agents|mesh-ancestor
92904217|NCT05862064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92904218|NCT05862064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92904219|NCT05862064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92904220|NCT05862064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92904221|NCT05862064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904222|NCT05861921|Lithium Carbonate|lithium carbonate|mesh-list
92904223|NCT05861921|Antidepressive Agents|antidepressive agents|mesh-ancestor
92904224|NCT05861921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904225|NCT05861921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904226|NCT05861921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904227|NCT05861921|Antimanic Agents|antimanic agents|mesh-ancestor
92904228|NCT05861921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92904229|NCT05861921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904230|NCT05861921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904232|NCT05861791|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92904233|NCT05861791|Fentanyl|fentanyl|mesh-list
92904234|NCT05861791|Nefopam|nefopam|mesh-list
92904235|NCT05861791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92904236|NCT05861791|Narcotics|narcotics|mesh-ancestor
92904237|NCT05861791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904238|NCT05861791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904239|NCT05861791|Analgesics|analgesics|mesh-ancestor
92904240|NCT05861791|Sensory System Agents|sensory system agents|mesh-ancestor
92904241|NCT05861791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904242|NCT05861791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92904243|NCT05861791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92904244|NCT05861791|Anesthetics, General|anesthetics, general|mesh-ancestor
92904245|NCT05861791|Anesthetics|anesthetics|mesh-ancestor
92904246|NCT05861791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92904247|NCT05861791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92904248|NCT05861791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92904249|NCT05861791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92904250|NCT05861791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92904251|NCT05861791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904252|NCT05861791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904253|NCT05861713|Dimenhydrinate|dimenhydrinate|mesh-list
92904254|NCT05861713|Antiemetics|antiemetics|mesh-ancestor
92904255|NCT05861713|Autonomic Agents|autonomic agents|mesh-ancestor
92904256|NCT05861713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904257|NCT05861713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904258|NCT05861713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92904259|NCT05861713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92904260|NCT05861713|Histamine Antagonists|histamine antagonists|mesh-ancestor
92904261|NCT05861713|Histamine Agents|histamine agents|mesh-ancestor
92904262|NCT05861713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904263|NCT05861713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904264|NCT05861687|Amoxicillin|amoxicillin|mesh-list
92904265|NCT05861687|Clarithromycin|clarithromycin|mesh-list
92904266|NCT05861687|Esomeprazole|esomeprazole|mesh-list
92904267|NCT05861687|Lansoprazole|lansoprazole|mesh-list
92904268|NCT05861687|Dexlansoprazole|dexlansoprazole|mesh-list
92904269|NCT05861687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904270|NCT05861687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904271|NCT05861687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92904272|NCT05861687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92904273|NCT05861687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92904274|NCT05861687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904275|NCT05861687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904276|NCT05861687|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92904277|NCT05861687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92904278|NCT05861687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92904279|NCT05861648|Folic Acid|folic acid|mesh-list
92904280|NCT05861648|Hematinics|hematinics|mesh-ancestor
92904281|NCT05861648|Vitamin B Complex|vitamin b complex|mesh-ancestor
92904282|NCT05861648|Vitamins|vitamins|mesh-ancestor
92904283|NCT05861648|Micronutrients|micronutrients|mesh-ancestor
92904284|NCT05861648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904285|NCT05861635|Tislelizumab|tislelizumab|mesh-list
92904286|NCT05861635|Disitamab vedotin|disitamab vedotin|mesh-list
92904287|NCT05861635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904288|NCT05861635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904289|NCT05861635|Immunoconjugates|immunoconjugates|mesh-ancestor
92904290|NCT05861635|Immunologic Factors|immunologic factors|mesh-ancestor
92904291|NCT05861635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904292|NCT05861609|Analgesics|analgesics|mesh-list
92904293|NCT05861609|Sensory System Agents|sensory system agents|mesh-ancestor
92904294|NCT05861609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904295|NCT05861609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904296|NCT05857384|Acetazolamide|acetazolamide|mesh-list
92904297|NCT05857384|Dronabinol|dronabinol|mesh-list
92904298|NCT05857384|Anticonvulsants|anticonvulsants|mesh-ancestor
92904299|NCT05857384|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92904300|NCT05857384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904301|NCT05857384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904302|NCT05857384|Diuretics|diuretics|mesh-ancestor
92904303|NCT05857384|Natriuretic Agents|natriuretic agents|mesh-ancestor
92904304|NCT05857384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904305|NCT05857384|Hallucinogens|hallucinogens|mesh-ancestor
92904306|NCT05857384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904307|NCT05857384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92904308|NCT05857384|Analgesics|analgesics|mesh-ancestor
92904309|NCT05857384|Sensory System Agents|sensory system agents|mesh-ancestor
92904310|NCT05857384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904311|NCT05857384|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92904312|NCT05857384|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92904313|NCT05857384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904314|NCT05857384|Hormones|hormones|mesh-ancestor
92904315|NCT05857384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904316|NCT05817461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92904317|NCT05773326|Sirolimus|sirolimus|mesh-list
92904318|NCT05773326|Temsirolimus|temsirolimus|mesh-list
92904319|NCT05773326|MTOR Inhibitors|mtor inhibitors|mesh-list
92904320|NCT05773326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904321|NCT05773326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904322|NCT05773326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904323|NCT05773326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904324|NCT05773326|Immunologic Factors|immunologic factors|mesh-ancestor
92904325|NCT05773326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904326|NCT05773326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904327|NCT05773326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904328|NCT05773326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904329|NCT05773326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92904330|NCT05773326|Antifungal Agents|antifungal agents|mesh-ancestor
92904331|NCT05765071|Botulinum Toxins|botulinum toxins|mesh-list
92904332|NCT05765071|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92904333|NCT05765071|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92904334|NCT05765071|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92904335|NCT05765071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92904336|NCT05765071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904337|NCT05765071|Cholinergic Agents|cholinergic agents|mesh-ancestor
92904338|NCT05765071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904339|NCT05765071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904340|NCT05765071|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92549789|NCT00049296|Growth Substances|growth substances|mesh-ancestor
92904341|NCT05765071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904342|NCT05750745|Fluorides|fluorides|mesh-list
92904343|NCT05750745|Cariostatic Agents|cariostatic agents|mesh-ancestor
92904344|NCT05750745|Protective Agents|protective agents|mesh-ancestor
92904345|NCT05750745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904346|NCT05746897|Pembrolizumab|pembrolizumab|mesh-list
92904347|NCT05746897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904348|NCT05746897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904349|NCT05746897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92904350|NCT05746897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904351|NCT05725382|Remifentanil|remifentanil|mesh-list
92904352|NCT05725382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92904353|NCT05725382|Narcotics|narcotics|mesh-ancestor
92904354|NCT05725382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904355|NCT05725382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904356|NCT05725382|Analgesics|analgesics|mesh-ancestor
92904357|NCT05725382|Sensory System Agents|sensory system agents|mesh-ancestor
92904358|NCT05725382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904359|NCT05710406|Cetuximab|cetuximab|mesh-list
92904360|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904361|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904362|NCT05686564|Choline|choline|mesh-list
92904363|NCT05686564|Lipotropic Agents|lipotropic agents|mesh-ancestor
92904364|NCT05686564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92904365|NCT05686564|Antimetabolites|antimetabolites|mesh-ancestor
92904366|NCT05686564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904367|NCT05686564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92904368|NCT05686564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92904369|NCT05686564|Nootropic Agents|nootropic agents|mesh-ancestor
92904370|NCT05672355|Vaccines|vaccines|mesh-list
92904371|NCT05672355|Immunologic Factors|immunologic factors|mesh-ancestor
92904372|NCT05672355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904373|NCT05671900|Gemcitabine|gemcitabine|mesh-list
92904374|NCT05671900|Docetaxel|docetaxel|mesh-list
92904375|NCT05671900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92904376|NCT05671900|Antimetabolites|antimetabolites|mesh-ancestor
92249171|NCT01270724|Paclitaxel|paclitaxel|mesh-list
92904377|NCT05671900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904378|NCT05671900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904379|NCT05671900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92904380|NCT05671900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92904381|NCT05671900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92904382|NCT05594147|Sorafenib|sorafenib|mesh-list
92904383|NCT05594147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904384|NCT05594147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904385|NCT05594147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904386|NCT05594147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904387|NCT05533242|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
92904388|NCT05533242|Immunologic Factors|immunologic factors|mesh-ancestor
92904389|NCT05533242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904390|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
92904391|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92904392|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92904393|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904394|NCT05489185|Hemostatics|hemostatics|mesh-ancestor
92904395|NCT05489185|Coagulants|coagulants|mesh-ancestor
92904396|NCT05487586|Ceftazidime|ceftazidime|mesh-list
92904397|NCT05487586|Avibactam|avibactam|mesh-list
92904398|NCT05487586|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92904399|NCT05487586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904400|NCT05487586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904401|NCT05487586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92904402|NCT05487586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904403|NCT05487586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904404|NCT05465304|Azithromycin|azithromycin|mesh-list
92904405|NCT05465304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904406|NCT05465304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904407|NCT05458024|Vitamin D|vitamin d|mesh-list
92904408|NCT05458024|Ergocalciferols|ergocalciferols|mesh-list
92904409|NCT05458024|Cholecalciferol|cholecalciferol|mesh-list
92904410|NCT05458024|Vitamins|vitamins|mesh-list
92904411|NCT05458024|Micronutrients|micronutrients|mesh-ancestor
92904412|NCT05458024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904413|NCT05458024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92904414|NCT05458024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92904415|NCT05456685|Carboplatin|carboplatin|mesh-list
92904416|NCT05456685|Maytansine|maytansine|mesh-list
92549862|NCT00022139|Antimetabolites|antimetabolites|mesh-ancestor
92904417|NCT05456685|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92904418|NCT05456685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904419|NCT05456685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92904420|NCT05456685|Tubulin Modulators|tubulin modulators|mesh-ancestor
92904421|NCT05456685|Antimitotic Agents|antimitotic agents|mesh-ancestor
92904422|NCT05456685|Mitosis Modulators|mitosis modulators|mesh-ancestor
92904423|NCT05456685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904424|NCT05456685|Immunoconjugates|immunoconjugates|mesh-ancestor
92904425|NCT05456685|Immunologic Factors|immunologic factors|mesh-ancestor
92904426|NCT05456685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904427|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
92904428|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92904429|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904430|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92904431|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904432|NCT05370313|Nicotine|nicotine|mesh-list
92904433|NCT05370313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92904434|NCT05370313|Autonomic Agents|autonomic agents|mesh-ancestor
92904435|NCT05370313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904436|NCT05370313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904437|NCT05370313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92904438|NCT05370313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92904439|NCT05370313|Cholinergic Agents|cholinergic agents|mesh-ancestor
92904440|NCT05370313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904441|NCT05370313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904442|NCT05368623|Mydriatics|mydriatics|mesh-list
92904443|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
92904444|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904445|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904446|NCT05357768|Formaldehyde|formaldehyde|mesh-list
92904447|NCT05357768|Disinfectants|disinfectants|mesh-ancestor
92904448|NCT05357768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904450|NCT05329766|Fluorouracil|fluorouracil|mesh-list
92904451|NCT05329766|Oxaliplatin|oxaliplatin|mesh-list
92904452|NCT05329766|Quemliclustat|quemliclustat|mesh-list
92904453|NCT05329766|Antimetabolites|antimetabolites|mesh-ancestor
92904454|NCT05329766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904455|NCT05329766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92904456|NCT05329766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904457|NCT05329766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904458|NCT05329766|Immunologic Factors|immunologic factors|mesh-ancestor
92904459|NCT05329766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904460|NCT05329766|Antidotes|antidotes|mesh-ancestor
92904461|NCT05329766|Protective Agents|protective agents|mesh-ancestor
92904462|NCT05329766|Vitamin B Complex|vitamin b complex|mesh-ancestor
92904463|NCT05329766|Vitamins|vitamins|mesh-ancestor
92904464|NCT05329766|Micronutrients|micronutrients|mesh-ancestor
92904465|NCT05329766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92904466|NCT05329766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904467|NCT05324449|Cannabidiol|cannabidiol|mesh-list
92904468|NCT05324449|Anticonvulsants|anticonvulsants|mesh-ancestor
92904469|NCT05316233|Hyaluronic Acid|hyaluronic acid|mesh-list
92904470|NCT05316233|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92904471|NCT05316233|Immunologic Factors|immunologic factors|mesh-ancestor
92904472|NCT05316233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904473|NCT05316233|Viscosupplements|viscosupplements|mesh-ancestor
92904474|NCT05316233|Protective Agents|protective agents|mesh-ancestor
92904475|NCT05304871|Cefazolin|cefazolin|mesh-list
92904476|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904477|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904478|NCT05281406|Carboplatin|carboplatin|mesh-list
92904479|NCT05281406|Pemetrexed|pemetrexed|mesh-list
92904480|NCT05281406|Osimertinib|osimertinib|mesh-list
92904481|NCT05281406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904482|NCT05281406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904483|NCT05281406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904484|NCT05281406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92904485|NCT05281406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92904486|NCT05281406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904487|NCT05265299|Aspirin|aspirin|mesh-list
92904488|NCT05265299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92904489|NCT05265299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92904490|NCT05265299|Analgesics|analgesics|mesh-ancestor
92904491|NCT05265299|Sensory System Agents|sensory system agents|mesh-ancestor
92904492|NCT05265299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904493|NCT05265299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904494|NCT05265299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92904495|NCT05265299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161546|NCT01144143|Hormones|hormones|mesh-ancestor
92904496|NCT05265299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92904497|NCT05265299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92904498|NCT05265299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904499|NCT05265299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92904500|NCT05265299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92904501|NCT05265299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904502|NCT05265299|Antipyretics|antipyretics|mesh-ancestor
92904503|NCT05246514|Trastuzumab|trastuzumab|mesh-list
92904504|NCT05246514|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92904505|NCT05246514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904506|NCT05246514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904507|NCT05246514|Immunoconjugates|immunoconjugates|mesh-ancestor
92904508|NCT05246514|Immunologic Factors|immunologic factors|mesh-ancestor
92904509|NCT05246514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904510|NCT05233722|Sirolimus|sirolimus|mesh-list
92904511|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904512|NCT05233722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904513|NCT05233722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904514|NCT05233722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92904515|NCT05233722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904516|NCT05233722|Antifungal Agents|antifungal agents|mesh-ancestor
92904517|NCT05233722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904518|NCT05233722|Immunologic Factors|immunologic factors|mesh-ancestor
92904519|NCT05221892|Thiamine|thiamine|mesh-list
92904520|NCT05221892|Pyridoxine|pyridoxine|mesh-list
92904521|NCT05221892|Vitamin B 12|vitamin b 12|mesh-list
92904522|NCT05221892|Hydroxocobalamin|hydroxocobalamin|mesh-list
92904523|NCT05221892|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92904524|NCT05221892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904525|NCT05221892|Vitamin B Complex|vitamin b complex|mesh-ancestor
92904526|NCT05221892|Vitamins|vitamins|mesh-ancestor
92904527|NCT05221892|Micronutrients|micronutrients|mesh-ancestor
92904529|NCT05221892|GABA Agents|gaba agents|mesh-ancestor
92904530|NCT05221892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904531|NCT05221892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904532|NCT05161338|Estradiol|estradiol|mesh-list
92904533|NCT05161338|Progesterone|progesterone|mesh-list
92904534|NCT05161338|Estrogens|estrogens|mesh-ancestor
92904535|NCT05161338|Hormones|hormones|mesh-ancestor
92904536|NCT05161338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904537|NCT05161338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904538|NCT05161338|Progestins|progestins|mesh-ancestor
92904539|NCT05147805|Treprostinil|treprostinil|mesh-list
92904540|NCT05147805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92904541|NCT05108428|Capecitabine|capecitabine|mesh-list
92904542|NCT05108428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92904543|NCT05108428|Antimetabolites|antimetabolites|mesh-ancestor
92904544|NCT05108428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904545|NCT05108428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904546|NCT05045794|Liver Extracts|liver extracts|mesh-list
92904547|NCT05045794|Hematinics|hematinics|mesh-ancestor
92904548|NCT05044936|Cannabidiol|cannabidiol|mesh-list
92904549|NCT05044936|Anticonvulsants|anticonvulsants|mesh-ancestor
92904550|NCT05036408|Coal Tar|coal tar|mesh-list
92904551|NCT05036408|Keratolytic Agents|keratolytic agents|mesh-ancestor
92904552|NCT05036408|Dermatologic Agents|dermatologic agents|mesh-ancestor
92904553|NCT05033743|Secnidazole|secnidazole|mesh-list
92904554|NCT05033743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92904555|NCT05033743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92904556|NCT05033743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904557|NCT05021900|Tenalisib|tenalisib|mesh-list
92904558|NCT05021900|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92904559|NCT05021900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904560|NCT05021900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904561|NCT05014646|Cholestyramine Resin|cholestyramine resin|mesh-list
92904562|NCT05014646|Leflunomide|leflunomide|mesh-list
92904563|NCT05014646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904564|NCT05014646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904565|NCT05014646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904566|NCT05014646|Immunologic Factors|immunologic factors|mesh-ancestor
92904567|NCT05014646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904568|NCT05014646|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92904569|NCT05014646|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92904570|NCT05014646|Antimetabolites|antimetabolites|mesh-ancestor
92904571|NCT05014646|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92904572|NCT04979806|Meropenem|meropenem|mesh-list
92904573|NCT04979806|Cefepime|cefepime|mesh-list
92904574|NCT04979806|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
92904575|NCT04979806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904576|NCT04979806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904577|NCT04971954|Nicotine|nicotine|mesh-list
92904578|NCT04971954|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92904579|NCT04971954|Autonomic Agents|autonomic agents|mesh-ancestor
92904580|NCT04971954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904581|NCT04971954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904582|NCT04971954|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92904583|NCT04971954|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92904584|NCT04971954|Cholinergic Agents|cholinergic agents|mesh-ancestor
92904585|NCT04971954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904586|NCT04971954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904587|NCT04942340|Dexmedetomidine|dexmedetomidine|mesh-list
92904588|NCT04942340|Caffeine|caffeine|mesh-list
92904589|NCT04942340|Atipamezole|atipamezole|mesh-list
92904590|NCT04942340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92904591|NCT04942340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904592|NCT04942340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904593|NCT04942340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92904594|NCT04942340|Analgesics|analgesics|mesh-ancestor
92904595|NCT04942340|Sensory System Agents|sensory system agents|mesh-ancestor
92904596|NCT04942340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904597|NCT04942340|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92904598|NCT04942340|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92904599|NCT04942340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92904600|NCT04942340|Adrenergic Agents|adrenergic agents|mesh-ancestor
92904601|NCT04942340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904602|NCT04942340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904603|NCT04942340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92904604|NCT04942340|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92904605|NCT04942340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904606|NCT04942340|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92904607|NCT04942340|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92904608|NCT04942340|Purinergic Agents|purinergic agents|mesh-ancestor
92904609|NCT04942340|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92904610|NCT04942340|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92904611|NCT04942340|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92904612|NCT04905654|Cromakalim|cromakalim|mesh-list
92904613|NCT04905654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92904614|NCT04905654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92904615|NCT04905654|Autonomic Agents|autonomic agents|mesh-ancestor
92904616|NCT04905654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904617|NCT04905654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904618|NCT04905654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92904619|NCT04905654|Respiratory System Agents|respiratory system agents|mesh-ancestor
92904620|NCT04905654|Parasympatholytics|parasympatholytics|mesh-ancestor
92904621|NCT04905654|Vasodilator Agents|vasodilator agents|mesh-ancestor
92904622|NCT04870034|Palbociclib|palbociclib|mesh-list
92904623|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904624|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904625|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904626|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904627|NCT04857398|Insulin|insulin|mesh-list
92904628|NCT04857398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92904629|NCT04857398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904630|NCT04826432|Pasireotide|pasireotide|mesh-list
92904631|NCT04826432|Hormones|hormones|mesh-ancestor
92904632|NCT04826432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904633|NCT04826432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904634|NCT04812548|Azacitidine|azacitidine|mesh-list
92904635|NCT04812548|Venetoclax|venetoclax|mesh-list
92904636|NCT04812548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92904637|NCT04812548|Antimetabolites|antimetabolites|mesh-ancestor
92904638|NCT04812548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904639|NCT04812548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904640|NCT04812548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904641|NCT04702022|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92904642|NCT04702022|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92161559|NCT01212471|Bromfenac|bromfenac|mesh-list
92904643|NCT04702022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904644|NCT04698525|Valproic Acid|valproic acid|mesh-list
92904645|NCT04698525|Memantine|memantine|mesh-list
92904646|NCT04698525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92904647|NCT04698525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92904648|NCT04698525|Dopamine Agents|dopamine agents|mesh-ancestor
92904649|NCT04698525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904650|NCT04698525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904651|NCT04698525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904652|NCT04698525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92904653|NCT04698525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92904654|NCT04698525|Anticonvulsants|anticonvulsants|mesh-ancestor
92904655|NCT04698525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904656|NCT04698525|GABA Agents|gaba agents|mesh-ancestor
92904657|NCT04698525|Antimanic Agents|antimanic agents|mesh-ancestor
92904658|NCT04698525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92904659|NCT04698525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904660|NCT04698525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904661|NCT04667104|Tenofovir|tenofovir|mesh-list
92904662|NCT04667104|Entecavir|entecavir|mesh-list
92904663|NCT04667104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92904664|NCT04667104|Antiviral Agents|antiviral agents|mesh-ancestor
92904665|NCT04667104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904666|NCT04667104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92904667|NCT04667104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92904668|NCT04667104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904669|NCT04667104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904670|NCT04667104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92904671|NCT04667104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92904672|NCT04660812|Bevacizumab|bevacizumab|mesh-list
92904673|NCT04660812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904674|NCT04660812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904675|NCT04660812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92904676|NCT04660812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92904677|NCT04660812|Growth Substances|growth substances|mesh-ancestor
92904678|NCT04660812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904679|NCT04660812|Growth Inhibitors|growth inhibitors|mesh-ancestor
92904680|NCT04659369|Nivolumab|nivolumab|mesh-list
92904681|NCT04659369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904682|NCT04659369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904683|NCT04659369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92904684|NCT04659369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904685|NCT04651439|Lenograstim|lenograstim|mesh-list
92904686|NCT04651439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92904687|NCT04651439|Immunologic Factors|immunologic factors|mesh-ancestor
92904688|NCT04651439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904689|NCT04635774|Insulin|insulin|mesh-list
92904690|NCT04635774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92904691|NCT04635774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904692|NCT04634799|Plasminogen|plasminogen|mesh-list
92904693|NCT04634799|Plasminogen Activator Inhibitor 1|plasminogen activator inhibitor 1|mesh-list
92904694|NCT04634799|Plasminogen Inactivators|plasminogen inactivators|mesh-list
92904695|NCT04634799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92904696|NCT04634799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92904697|NCT04634799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904698|NCT04634799|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92904699|NCT04634799|Protease Inhibitors|protease inhibitors|mesh-ancestor
92904700|NCT04634799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904701|NCT04603365|Temozolomide|temozolomide|mesh-list
92904702|NCT04603365|Pamiparib|pamiparib|mesh-list
92904703|NCT04603365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92904704|NCT04603365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92904705|NCT04603365|Alkylating Agents|alkylating agents|mesh-ancestor
92904706|NCT04603365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904707|NCT04603365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904708|NCT04603365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904709|NCT04565015|Immunoglobulins|immunoglobulins|mesh-list
92904710|NCT04565015|gamma-Globulins|gamma-globulins|mesh-list
92904711|NCT04565015|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92904712|NCT04565015|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92904713|NCT04565015|Immunologic Factors|immunologic factors|mesh-ancestor
92904714|NCT04565015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904715|NCT04560660|Midazolam|midazolam|mesh-list
92904716|NCT04560660|Ketamine|ketamine|mesh-list
92904717|NCT04560660|Analgesics|analgesics|mesh-ancestor
92904718|NCT04560660|Sensory System Agents|sensory system agents|mesh-ancestor
92904719|NCT04560660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904720|NCT04560660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904721|NCT04560660|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92904722|NCT04560660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92904723|NCT04560660|Anesthetics, General|anesthetics, general|mesh-ancestor
92904724|NCT04560660|Anesthetics|anesthetics|mesh-ancestor
92904725|NCT04560660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904726|NCT04560660|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92904727|NCT04560660|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92904728|NCT04560660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904729|NCT04560660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904730|NCT04560660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92904731|NCT04560660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92904732|NCT04560660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92904733|NCT04560660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92904734|NCT04560660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904735|NCT04560660|GABA Modulators|gaba modulators|mesh-ancestor
92904736|NCT04560660|GABA Agents|gaba agents|mesh-ancestor
92904737|NCT04556526|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92904738|NCT04556526|Antiviral Agents|antiviral agents|mesh-ancestor
92904739|NCT04556526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904740|NCT04517435|Prednisone|prednisone|mesh-list
92904741|NCT04517435|Cyclophosphamide|cyclophosphamide|mesh-list
92904742|NCT04517435|Rituximab|rituximab|mesh-list
92904743|NCT04517435|Doxorubicin|doxorubicin|mesh-list
92904744|NCT04517435|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92904745|NCT04517435|Vincristine|vincristine|mesh-list
92904746|NCT04517435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904747|NCT04517435|Immunologic Factors|immunologic factors|mesh-ancestor
92904748|NCT04517435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904749|NCT04517435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92904750|NCT04517435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92904751|NCT04517435|Alkylating Agents|alkylating agents|mesh-ancestor
92904752|NCT04517435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904753|NCT04517435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904754|NCT04517435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92904755|NCT04517435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904756|NCT04517435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92904757|NCT04517435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92904758|NCT04517435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92904759|NCT04517435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904760|NCT04517435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92904761|NCT04517435|Glucocorticoids|glucocorticoids|mesh-ancestor
92904762|NCT04517435|Hormones|hormones|mesh-ancestor
92904763|NCT04517435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904764|NCT04517435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92904765|NCT04517435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92904766|NCT04517435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92904767|NCT04517435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92904768|NCT04517435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92904769|NCT04478617|Metronidazole|metronidazole|mesh-list
92904770|NCT04478617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904771|NCT04478617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904772|NCT04478617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92904773|NCT04478617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92904774|NCT04439357|Trametinib|trametinib|mesh-list
92904775|NCT04439357|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92904776|NCT04439357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904777|NCT04439357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904778|NCT04439357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904779|NCT04439357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904780|NCT04439357|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92904781|NCT04439357|Protective Agents|protective agents|mesh-ancestor
92904782|NCT04439357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904783|NCT04439357|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92904784|NCT04439357|Antioxidants|antioxidants|mesh-ancestor
92904785|NCT04439318|Trametinib|trametinib|mesh-list
92904786|NCT04439318|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92904787|NCT04439318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904788|NCT04439318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904789|NCT04439318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904790|NCT04439318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904791|NCT04439318|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92904792|NCT04439318|Protective Agents|protective agents|mesh-ancestor
92904793|NCT04439318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904794|NCT04439318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92904795|NCT04439318|Antioxidants|antioxidants|mesh-ancestor
92904796|NCT04431518|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
92904797|NCT04431518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92904798|NCT04431518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92904799|NCT04431518|Antiviral Agents|antiviral agents|mesh-ancestor
92904800|NCT04431518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904802|NCT04424966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904803|NCT04344873|Abatacept|abatacept|mesh-list
92904804|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92904805|NCT04344873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904806|NCT04344873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904807|NCT04344873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904808|NCT04344873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92904809|NCT04344873|Immunologic Factors|immunologic factors|mesh-ancestor
92904810|NCT04344873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904811|NCT04344873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92904812|NCT04340258|Pembrolizumab|pembrolizumab|mesh-list
92904813|NCT04340258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904814|NCT04340258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904815|NCT04340258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92904816|NCT04340258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904817|NCT04301271|Simvastatin|simvastatin|mesh-list
92904818|NCT04301271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92904819|NCT04301271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92904820|NCT04301271|Antimetabolites|antimetabolites|mesh-ancestor
92904821|NCT04301271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904822|NCT04301271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92904823|NCT04301271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92904824|NCT04301271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904825|NCT04228783|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92904826|NCT04228783|Antiviral Agents|antiviral agents|mesh-ancestor
92904827|NCT04228783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904828|NCT04188119|Aspirin|aspirin|mesh-list
92904829|NCT04188119|Avelumab|avelumab|mesh-list
92904830|NCT04188119|Lansoprazole|lansoprazole|mesh-list
92904831|NCT04188119|Dexlansoprazole|dexlansoprazole|mesh-list
92904832|NCT04188119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92904833|NCT04188119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92904834|NCT04188119|Analgesics|analgesics|mesh-ancestor
92904835|NCT04188119|Sensory System Agents|sensory system agents|mesh-ancestor
92904836|NCT04188119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904837|NCT04188119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904838|NCT04188119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92904839|NCT04188119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92904840|NCT04188119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92904841|NCT04188119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92904842|NCT04188119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904843|NCT04188119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92904844|NCT04188119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92904845|NCT04188119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904846|NCT04188119|Antipyretics|antipyretics|mesh-ancestor
92904847|NCT04188119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904848|NCT04188119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904849|NCT04188119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92904850|NCT04188119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92904851|NCT04188119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92904852|NCT04174170|Sertraline|sertraline|mesh-list
92904853|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
92904854|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
92904855|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92161617|NCT00083915|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92904856|NCT04174170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92904857|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92904858|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92904859|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904860|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904861|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
92904862|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904863|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
92904864|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
92904865|NCT04142658|Warfarin|warfarin|mesh-list
92904866|NCT04142658|Apixaban|apixaban|mesh-list
92904867|NCT04142658|Anticoagulants|anticoagulants|mesh-ancestor
92904868|NCT04142658|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92904869|NCT04142658|Antithrombins|antithrombins|mesh-ancestor
92904870|NCT04142658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92904871|NCT04142658|Protease Inhibitors|protease inhibitors|mesh-ancestor
92904872|NCT04142658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904873|NCT04142658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904874|NCT04138394|Ascorbic Acid|ascorbic acid|mesh-list
92904875|NCT04138394|Vitamins|vitamins|mesh-ancestor
92904876|NCT04138394|Micronutrients|micronutrients|mesh-ancestor
92904877|NCT04138394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904878|NCT04138394|Antioxidants|antioxidants|mesh-ancestor
92904879|NCT04138394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904880|NCT04138394|Protective Agents|protective agents|mesh-ancestor
92904881|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
92904882|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
92904883|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904884|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904885|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904886|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904887|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92904888|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
92904889|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904890|NCT04124614|Sertraline|sertraline|mesh-list
92904891|NCT04124614|Brexpiprazole|brexpiprazole|mesh-list
92904892|NCT04124614|Antidepressive Agents|antidepressive agents|mesh-ancestor
92904893|NCT04124614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92904894|NCT04124614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92904895|NCT04124614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92904896|NCT04124614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92904897|NCT04124614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904898|NCT04124614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92904899|NCT04124614|Serotonin Agents|serotonin agents|mesh-ancestor
92904900|NCT04124614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904901|NCT04124614|Dopamine Agonists|dopamine agonists|mesh-ancestor
92904902|NCT04124614|Dopamine Agents|dopamine agents|mesh-ancestor
92904903|NCT04095442|Benzocaine|benzocaine|mesh-list
92904904|NCT04095442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92904905|NCT04095442|Anesthetics|anesthetics|mesh-ancestor
92904906|NCT04095442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904907|NCT04095442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904908|NCT04095442|Sensory System Agents|sensory system agents|mesh-ancestor
92904909|NCT04095442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904910|NCT04082780|Rifamycins|rifamycins|mesh-list
92904911|NCT04082780|Rifamycin SV|rifamycin sv|mesh-list
92904912|NCT04082780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92904913|NCT04082780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904914|NCT04082780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92904915|NCT03977363|Anticoagulants|anticoagulants|mesh-list
92904916|NCT03950674|Folic Acid|folic acid|mesh-list
92904917|NCT03950674|Vitamin B 12|vitamin b 12|mesh-list
92904918|NCT03950674|Dexamethasone|dexamethasone|mesh-list
92904919|NCT03950674|Carboplatin|carboplatin|mesh-list
92904920|NCT03950674|Pembrolizumab|pembrolizumab|mesh-list
92904921|NCT03950674|Pemetrexed|pemetrexed|mesh-list
92904922|NCT03950674|Vitamins|vitamins|mesh-ancestor
92904923|NCT03950674|Micronutrients|micronutrients|mesh-ancestor
92904924|NCT03950674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904925|NCT03950674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904926|NCT03950674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92904927|NCT03950674|Antiemetics|antiemetics|mesh-ancestor
92904928|NCT03950674|Autonomic Agents|autonomic agents|mesh-ancestor
92904929|NCT03950674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904930|NCT03950674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92904931|NCT03950674|Glucocorticoids|glucocorticoids|mesh-ancestor
92904932|NCT03950674|Hormones|hormones|mesh-ancestor
92904933|NCT03950674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92904934|NCT03950674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92904935|NCT03950674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904936|NCT03950674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92904937|NCT03950674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904938|NCT03950674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904939|NCT03950674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92904940|NCT03950674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92904941|NCT03950674|Hematinics|hematinics|mesh-ancestor
92904942|NCT03950674|Vitamin B Complex|vitamin b complex|mesh-ancestor
92904943|NCT03911661|Warfarin|warfarin|mesh-list
92904944|NCT03911661|Anticoagulants|anticoagulants|mesh-ancestor
92904945|NCT03909477|Xenon|xenon|mesh-list
92904946|NCT03909477|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92904947|NCT03909477|Anesthetics, General|anesthetics, general|mesh-ancestor
92904948|NCT03909477|Anesthetics|anesthetics|mesh-ancestor
92904949|NCT03909477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904950|NCT03909477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904951|NCT03874052|Venetoclax|venetoclax|mesh-list
92904952|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92904953|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92904954|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904955|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904956|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904957|NCT03851159|Mannitol|mannitol|mesh-list
92904958|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92904959|NCT03851159|Diuretics|diuretics|mesh-ancestor
92904960|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
92904961|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904962|NCT04491877|Vaccines|vaccines|mesh-list
92904963|NCT04491877|Immunologic Factors|immunologic factors|mesh-ancestor
92904964|NCT04491877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904965|NCT03829410|Bevacizumab|bevacizumab|mesh-list
92904966|NCT03829410|Onvansertib|onvansertib|mesh-list
92904967|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92904968|NCT03829410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161683|NCT01145001|Nicotine|nicotine|mesh-list
92904969|NCT03829410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92904970|NCT03829410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92904971|NCT03829410|Growth Substances|growth substances|mesh-ancestor
92904972|NCT03829410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904973|NCT03829410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92904974|NCT03829410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92904975|NCT03829410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904976|NCT03829410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904978|NCT03711604|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92904979|NCT03711604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92904980|NCT03711604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92904981|NCT03708627|Bimatoprost|bimatoprost|mesh-list
92904982|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92904983|NCT03702621|Bupivacaine|bupivacaine|mesh-list
92904984|NCT03702621|Anesthetics, Local|anesthetics, local|mesh-ancestor
92904985|NCT03702621|Anesthetics|anesthetics|mesh-ancestor
92904986|NCT03702621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92904987|NCT03702621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904988|NCT03702621|Sensory System Agents|sensory system agents|mesh-ancestor
92904989|NCT03702621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92904990|NCT03688295|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92904991|NCT03688295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92904992|NCT03688295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92904993|NCT03688295|Antitubercular Agents|antitubercular agents|mesh-ancestor
92904994|NCT03684876|Diuretics|diuretics|mesh-list
92904995|NCT03684876|Natriuretic Agents|natriuretic agents|mesh-ancestor
92904996|NCT03684876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92904997|NCT03655665|Ofloxacin|ofloxacin|mesh-list
92904998|NCT03655665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92904999|NCT03655665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905000|NCT03655665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92905001|NCT03655665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92905002|NCT03655665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92905003|NCT03655665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905004|NCT03655665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905005|NCT03655665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905006|NCT03655665|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92905007|NCT03655665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905008|NCT03641690|Anti-Infective Agents|anti-infective agents|mesh-list
92905009|NCT03641690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92905010|NCT03604627|Calcium|calcium|mesh-list
92905011|NCT03604627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92905012|NCT03604627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905013|NCT03593317|Spironolactone|spironolactone|mesh-list
92905014|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92905015|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
92905016|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905017|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905018|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92905019|NCT03593317|Diuretics|diuretics|mesh-ancestor
92905020|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
92905021|NCT03516656|Heparin|heparin|mesh-list
92905022|NCT03516656|Calcium heparin|calcium heparin|mesh-list
92905023|NCT03516656|Anticoagulants|anticoagulants|mesh-ancestor
92905024|NCT03516656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92905026|NCT03516656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905027|NCT03479268|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92905028|NCT03479268|Pevonedistat|pevonedistat|mesh-list
92905029|NCT03479268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905030|NCT03459092|Botulinum Toxins|botulinum toxins|mesh-list
92905031|NCT03459092|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92905032|NCT03459092|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92905033|NCT03459092|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92905034|NCT03459092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905035|NCT03459092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905036|NCT03459092|Cholinergic Agents|cholinergic agents|mesh-ancestor
92905037|NCT03459092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905038|NCT03459092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905039|NCT03459092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92905040|NCT03459092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905041|NCT03437421|Vitamin D|vitamin d|mesh-list
92905042|NCT03437421|Cholecalciferol|cholecalciferol|mesh-list
92905043|NCT03437421|Vitamins|vitamins|mesh-ancestor
92905044|NCT03437421|Micronutrients|micronutrients|mesh-ancestor
92905045|NCT03437421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905046|NCT03437421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92905047|NCT03437421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92905048|NCT03416270|Ertugliflozin|ertugliflozin|mesh-list
92905049|NCT03416270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92905050|NCT03416270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905051|NCT03416270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92905052|NCT03416270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905054|NCT03414034|Onvansertib|onvansertib|mesh-list
92905055|NCT03414034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905056|NCT03414034|Glucocorticoids|glucocorticoids|mesh-ancestor
92905057|NCT03414034|Hormones|hormones|mesh-ancestor
92905058|NCT03414034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905059|NCT03414034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905060|NCT03414034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905061|NCT03414034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905062|NCT03414034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92905063|NCT03414034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905064|NCT03414034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905065|NCT03361436|Halichondrin B|halichondrin b|mesh-list
92905066|NCT03361436|Tubulin Modulators|tubulin modulators|mesh-ancestor
92905067|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
92905068|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
92905069|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905070|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905071|NCT03284866|Vaccines|vaccines|mesh-list
92905072|NCT03284866|Immunologic Factors|immunologic factors|mesh-ancestor
92905073|NCT03284866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905074|NCT03260894|Pembrolizumab|pembrolizumab|mesh-list
92905075|NCT03260894|Sunitinib|sunitinib|mesh-list
92905076|NCT03260894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905077|NCT03260894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905078|NCT03260894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905079|NCT03260894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905080|NCT03260894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92905081|NCT03260894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92905082|NCT03260894|Growth Substances|growth substances|mesh-ancestor
92905083|NCT03260894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905084|NCT03260894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92905085|NCT03260894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92905086|NCT03260894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905087|NCT03245008|Fasinumab|fasinumab|mesh-list
92905088|NCT03245008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92905089|NCT03245008|Analgesics|analgesics|mesh-ancestor
92905090|NCT03245008|Sensory System Agents|sensory system agents|mesh-ancestor
92905091|NCT03245008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161694|NCT03011463|Ranitidine|ranitidine|mesh-list
92905092|NCT03245008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905093|NCT03220893|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92905094|NCT03220893|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92905095|NCT03220893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905096|NCT03203473|Nivolumab|nivolumab|mesh-list
92905097|NCT03203473|Ipilimumab|ipilimumab|mesh-list
92905098|NCT03203473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905099|NCT03203473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905100|NCT03203473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905101|NCT03203473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905102|NCT03191786|Gemcitabine|gemcitabine|mesh-list
92905103|NCT03191786|Atezolizumab|atezolizumab|mesh-list
92905104|NCT03191786|Vinorelbine|vinorelbine|mesh-list
92905105|NCT03191786|Antibodies|antibodies|mesh-list
92905106|NCT03191786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92905107|NCT03191786|Immunologic Factors|immunologic factors|mesh-ancestor
92905108|NCT03191786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905109|NCT03191786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92905110|NCT03191786|Antimetabolites|antimetabolites|mesh-ancestor
92905111|NCT03191786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905112|NCT03191786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905113|NCT03191786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905114|NCT03191786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905115|NCT03191786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92905116|NCT03191786|Tubulin Modulators|tubulin modulators|mesh-ancestor
92905117|NCT03191786|Antimitotic Agents|antimitotic agents|mesh-ancestor
92905118|NCT03191786|Mitosis Modulators|mitosis modulators|mesh-ancestor
92905119|NCT03185208|Lithium Carbonate|lithium carbonate|mesh-list
92905120|NCT03185208|Antidepressive Agents|antidepressive agents|mesh-ancestor
92905121|NCT03185208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92905122|NCT03185208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905123|NCT03185208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905124|NCT03185208|Antimanic Agents|antimanic agents|mesh-ancestor
92905125|NCT03185208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92905126|NCT03185208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905127|NCT03185208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905128|NCT03142568|Sildenafil Citrate|sildenafil citrate|mesh-list
92905129|NCT03142568|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905130|NCT03142568|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905131|NCT03142568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905132|NCT03142568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905133|NCT03142568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905134|NCT03142568|Urological Agents|urological agents|mesh-ancestor
92905135|NCT03115567|Triamcinolone|triamcinolone|mesh-list
92905136|NCT03115567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905137|NCT03115567|Glucocorticoids|glucocorticoids|mesh-ancestor
92905138|NCT03115567|Hormones|hormones|mesh-ancestor
92905139|NCT03115567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905140|NCT03115567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905141|NCT03051659|Pembrolizumab|pembrolizumab|mesh-list
92905142|NCT03051659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905143|NCT03051659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905144|NCT03051659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905145|NCT03051659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905146|NCT02982902|Immunomodulating Agents|immunomodulating agents|mesh-list
92905147|NCT02982902|Immunologic Factors|immunologic factors|mesh-ancestor
92905148|NCT02982902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905149|NCT02971761|Pembrolizumab|pembrolizumab|mesh-list
92905150|NCT02971761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905151|NCT02971761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905152|NCT02971761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905153|NCT02971761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905154|NCT02964559|Pembrolizumab|pembrolizumab|mesh-list
92905155|NCT02964559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905156|NCT02964559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905157|NCT02964559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905158|NCT02964559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905159|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92905160|NCT02893293|Hematinics|hematinics|mesh-ancestor
92905161|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92905162|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92905163|NCT02860000|Fulvestrant|fulvestrant|mesh-list
92905164|NCT02860000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905165|NCT02860000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905166|NCT02860000|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92905167|NCT02860000|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92905168|NCT02860000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92905169|NCT02860000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905170|NCT02860000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905171|NCT02724878|Bevacizumab|bevacizumab|mesh-list
92905172|NCT02724878|Atezolizumab|atezolizumab|mesh-list
92905173|NCT02724878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905174|NCT02724878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905175|NCT02724878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92905176|NCT02724878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92905177|NCT02724878|Growth Substances|growth substances|mesh-ancestor
92905178|NCT02724878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905179|NCT02724878|Growth Inhibitors|growth inhibitors|mesh-ancestor
92905180|NCT02724878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905181|NCT02724878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905182|NCT02691923|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92905183|NCT02691923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92905184|NCT02691923|Dermatologic Agents|dermatologic agents|mesh-ancestor
92905185|NCT02672475|Paclitaxel|paclitaxel|mesh-list
92905186|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92905187|NCT02672475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92161739|NCT05688449|Fentanyl|fentanyl|mesh-list
92905188|NCT02672475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905189|NCT02672475|Tubulin Modulators|tubulin modulators|mesh-ancestor
92905190|NCT02672475|Antimitotic Agents|antimitotic agents|mesh-ancestor
92905191|NCT02672475|Mitosis Modulators|mitosis modulators|mesh-ancestor
92905192|NCT02672475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905193|NCT02578680|Folic Acid|folic acid|mesh-list
92905194|NCT02578680|Vitamin B 12|vitamin b 12|mesh-list
92905195|NCT02578680|Dexamethasone|dexamethasone|mesh-list
92905196|NCT02578680|Carboplatin|carboplatin|mesh-list
92905197|NCT02578680|Pembrolizumab|pembrolizumab|mesh-list
92905198|NCT02578680|Pemetrexed|pemetrexed|mesh-list
92905199|NCT02578680|Vitamins|vitamins|mesh-ancestor
92905200|NCT02578680|Micronutrients|micronutrients|mesh-ancestor
92905201|NCT02578680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905202|NCT02578680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905203|NCT02578680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905204|NCT02578680|Antiemetics|antiemetics|mesh-ancestor
92905205|NCT02578680|Autonomic Agents|autonomic agents|mesh-ancestor
92905206|NCT02578680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905207|NCT02578680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92905208|NCT02578680|Glucocorticoids|glucocorticoids|mesh-ancestor
92905209|NCT02578680|Hormones|hormones|mesh-ancestor
92905210|NCT02578680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905211|NCT02578680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905212|NCT02578680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905213|NCT02578680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92905214|NCT02578680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905215|NCT02578680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905216|NCT02578680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92905217|NCT02578680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92905218|NCT02578680|Hematinics|hematinics|mesh-ancestor
92905219|NCT02578680|Vitamin B Complex|vitamin b complex|mesh-ancestor
92905220|NCT02385266|Cycloserine|cycloserine|mesh-list
92905221|NCT02385266|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92905222|NCT02385266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905223|NCT02385266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92905224|NCT02385266|Antitubercular Agents|antitubercular agents|mesh-ancestor
92905225|NCT02385266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92905226|NCT02385266|Antimetabolites|antimetabolites|mesh-ancestor
92905227|NCT02385266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905228|NCT02351765|Cisplatin|cisplatin|mesh-list
92905229|NCT02351765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905230|NCT02251431|Exenatide|exenatide|mesh-list
92905231|NCT02251431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92905232|NCT02251431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905233|NCT02251431|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92905234|NCT02251431|Incretins|incretins|mesh-ancestor
92905235|NCT02251431|Hormones|hormones|mesh-ancestor
92905236|NCT02251431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905237|NCT02191488|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92905238|NCT02191488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92905239|NCT02191488|Dermatologic Agents|dermatologic agents|mesh-ancestor
92905240|NCT02000089|Secretin|secretin|mesh-list
92905241|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92905242|NCT02000089|Hormones|hormones|mesh-ancestor
92905243|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905244|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905245|NCT01494441|Calcium, Dietary|calcium, dietary|mesh-list
92905246|NCT01494441|Calcium|calcium|mesh-list
92905247|NCT01494441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92905248|NCT01494441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905249|NCT01494441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92905250|NCT01367002|Paclitaxel|paclitaxel|mesh-list
92905251|NCT01367002|Carboplatin|carboplatin|mesh-list
92905252|NCT01367002|Trastuzumab|trastuzumab|mesh-list
92905253|NCT01367002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92905254|NCT01367002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905255|NCT01367002|Tubulin Modulators|tubulin modulators|mesh-ancestor
92905256|NCT01367002|Antimitotic Agents|antimitotic agents|mesh-ancestor
92905257|NCT01367002|Mitosis Modulators|mitosis modulators|mesh-ancestor
92905258|NCT01367002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905259|NCT01367002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92905260|NCT00858273|Insulin|insulin|mesh-list
92905261|NCT00858273|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92905262|NCT00858273|Antioxidants|antioxidants|mesh-list
92905263|NCT00858273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92905264|NCT00858273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905265|NCT00858273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905266|NCT00858273|Protective Agents|protective agents|mesh-ancestor
92905267|NCT04158167|Oxytocin|oxytocin|mesh-list
92905268|NCT04158167|Oxytocics|oxytocics|mesh-ancestor
92905269|NCT04158167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92905270|NCT04158167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905271|NCT00659555|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92905272|NCT00659555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92905273|NCT02635607|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92905274|NCT02635607|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92905275|NCT02635607|Ganirelix|ganirelix|mesh-list
92905276|NCT02635607|Luteolytic Agents|luteolytic agents|mesh-ancestor
92905277|NCT02635607|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92905278|NCT02635607|Contraceptive Agents|contraceptive agents|mesh-ancestor
92905279|NCT02635607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92905280|NCT02635607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905281|NCT02635607|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92905282|NCT02635607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905283|NCT02635607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905284|NCT02635607|Hormones|hormones|mesh-ancestor
92905285|NCT02635607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905286|NCT02635607|Hormone Antagonists|hormone antagonists|mesh-ancestor
92905287|NCT00660257|Vaccines|vaccines|mesh-list
92905288|NCT00660257|Immunologic Factors|immunologic factors|mesh-ancestor
92905289|NCT00660257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905290|NCT00844428|Eculizumab|eculizumab|mesh-list
92905291|NCT00844428|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92905292|NCT00844428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92905293|NCT00844428|Immunologic Factors|immunologic factors|mesh-ancestor
92905294|NCT00844428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905295|NCT00660335|Secretin|secretin|mesh-list
92905296|NCT00660335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92905297|NCT00660335|Hormones|hormones|mesh-ancestor
92905298|NCT00660335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905299|NCT00660335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905300|NCT00707772|Ribavirin|ribavirin|mesh-list
92905301|NCT00707772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92905302|NCT00707772|Interferon-alpha|interferon-alpha|mesh-list
92905303|NCT00707772|Antimetabolites|antimetabolites|mesh-ancestor
92905304|NCT00707772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905305|NCT00707772|Antiviral Agents|antiviral agents|mesh-ancestor
92905306|NCT00707772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905307|NCT00707772|Immunologic Factors|immunologic factors|mesh-ancestor
92905308|NCT00707772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905309|NCT00834834|Fluoxetine|fluoxetine|mesh-list
92905310|NCT00834834|Citalopram|citalopram|mesh-list
92905311|NCT00834834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92905312|NCT00834834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92905313|NCT00834834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905314|NCT00834834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905315|NCT00834834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905316|NCT00834834|Serotonin Agents|serotonin agents|mesh-ancestor
92905317|NCT00834834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905318|NCT00834834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92905319|NCT00834834|Antidepressive Agents|antidepressive agents|mesh-ancestor
92550770|NCT00025064|Ifosfamide|ifosfamide|mesh-list
92905320|NCT00834834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92905321|NCT00834834|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92905322|NCT00834834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905323|NCT00834834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905324|NCT00834366|Tramadol|tramadol|mesh-list
92905325|NCT00834366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92905326|NCT00834366|Narcotics|narcotics|mesh-ancestor
92905327|NCT00834366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905328|NCT00834366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905329|NCT00834366|Analgesics|analgesics|mesh-ancestor
92905330|NCT00834366|Sensory System Agents|sensory system agents|mesh-ancestor
92525901|NCT00027391|Autonomic Agents|autonomic agents|mesh-ancestor
92205576|NCT03809767|Antibodies|antibodies|mesh-list
92905331|NCT00834366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905332|NCT00704574|Insulin Detemir|insulin detemir|mesh-list
92905333|NCT00704574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92905334|NCT00704574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905335|NCT00660647|Adalimumab|adalimumab|mesh-list
92905336|NCT00660647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92905337|NCT00660647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905338|NCT00660647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92905339|NCT04156451|Furosemide|furosemide|mesh-list
92905340|NCT04156451|Diuretics|diuretics|mesh-ancestor
92905341|NCT04156451|Natriuretic Agents|natriuretic agents|mesh-ancestor
92905342|NCT04156451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905343|NCT04156451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92905344|NCT04156451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905345|NCT04156451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905346|NCT00660725|Gemcitabine|gemcitabine|mesh-list
92905347|NCT00660725|Oxaliplatin|oxaliplatin|mesh-list
92905348|NCT00660725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92905349|NCT00660725|Antimetabolites|antimetabolites|mesh-ancestor
92905350|NCT00660725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905351|NCT00660725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905352|NCT00844194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92905353|NCT00844194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92905354|NCT00844194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92905355|NCT00844194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905356|NCT00844194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905357|NCT00844194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905358|NCT00844194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905359|NCT00844194|Analgesics|analgesics|mesh-ancestor
92905360|NCT00844194|Sensory System Agents|sensory system agents|mesh-ancestor
92905361|NCT00844194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905362|NCT00844194|Antidepressive Agents|antidepressive agents|mesh-ancestor
92905363|NCT00844194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92905364|NCT00844194|Dopamine Agents|dopamine agents|mesh-ancestor
92905365|NCT00660803|Fulvestrant|fulvestrant|mesh-list
92905366|NCT00660803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905367|NCT00660803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905368|NCT00660803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92905369|NCT00660803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92905370|NCT00660803|Hormone Antagonists|hormone antagonists|mesh-ancestor
92905371|NCT00660803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905372|NCT00660803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905373|NCT00661115|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905374|NCT00661115|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905375|NCT00661115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905376|NCT00661115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905377|NCT00661115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905378|NCT00661115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905379|NCT00661115|Urological Agents|urological agents|mesh-ancestor
92905380|NCT04157699|Tenofovir|tenofovir|mesh-list
92905381|NCT04157699|Antiviral Agents|antiviral agents|mesh-ancestor
92905382|NCT04157699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905383|NCT04157699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92905384|NCT04157699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525914|NCT00027391|Androgens|androgens|mesh-ancestor
92905385|NCT04157699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905386|NCT04157699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905387|NCT04157699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92905388|NCT04157699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92905389|NCT00665717|Raltegravir Potassium|raltegravir potassium|mesh-list
92905390|NCT00665717|Pravastatin|pravastatin|mesh-list
92905391|NCT00665717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92905392|NCT00665717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92905393|NCT00665717|Antiviral Agents|antiviral agents|mesh-ancestor
92905394|NCT00665717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905395|NCT00665717|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92905396|NCT00665717|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92905397|NCT00665717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905398|NCT00665717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905399|NCT00665717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92905400|NCT00665717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92905401|NCT00665717|Antimetabolites|antimetabolites|mesh-ancestor
92905402|NCT00665717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92905403|NCT00665717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92905405|NCT02611596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92905406|NCT02611596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905407|NCT02611596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905408|NCT00661349|Ritonavir|ritonavir|mesh-list
92905409|NCT00661349|Lopinavir|lopinavir|mesh-list
92905410|NCT00661349|Nevirapine|nevirapine|mesh-list
92905411|NCT00661349|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92905412|NCT00661349|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92905413|NCT00661349|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905414|NCT00661349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905415|NCT00661349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905416|NCT00661349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92905417|NCT00661349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92905418|NCT00661349|Antiviral Agents|antiviral agents|mesh-ancestor
92905419|NCT00661349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905420|NCT00661349|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92905421|NCT00661349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905422|NCT00661349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92905423|NCT00661349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92905424|NCT00661349|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92905425|NCT00661349|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92905426|NCT00665873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92905427|NCT00665873|Amoxicillin|amoxicillin|mesh-list
92905428|NCT00665873|Clavulanic Acids|clavulanic acids|mesh-list
92905429|NCT00665873|Clavulanic Acid|clavulanic acid|mesh-list
92905430|NCT00665873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92905431|NCT00665873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905432|NCT00665873|Antitubercular Agents|antitubercular agents|mesh-ancestor
92905433|NCT00665873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905434|NCT00665873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905435|NCT00665873|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92905436|NCT00707850|Ribavirin|ribavirin|mesh-list
92905437|NCT00707850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92905438|NCT00707850|Interferon-alpha|interferon-alpha|mesh-list
92905439|NCT00707850|Antimetabolites|antimetabolites|mesh-ancestor
92905440|NCT00707850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905441|NCT00707850|Antiviral Agents|antiviral agents|mesh-ancestor
92905442|NCT00707850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905443|NCT00707850|Immunologic Factors|immunologic factors|mesh-ancestor
92905444|NCT00707850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905445|NCT00665951|Ritonavir|ritonavir|mesh-list
92905446|NCT00665951|Lopinavir|lopinavir|mesh-list
92905447|NCT00665951|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92905448|NCT00665951|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92905449|NCT00665951|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905450|NCT00665951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905451|NCT00665951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905452|NCT00665951|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92905453|NCT00665951|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92905454|NCT00665951|Antiviral Agents|antiviral agents|mesh-ancestor
92905455|NCT00665951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905456|NCT00665951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92161782|NCT05687981|Hormones|hormones|mesh-ancestor
92905457|NCT00665951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905458|NCT00661739|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92905459|NCT00661739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92905460|NCT00661739|Alkylating Agents|alkylating agents|mesh-ancestor
92905461|NCT00661739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905462|NCT00661739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905463|NCT00878969|Valsartan|valsartan|mesh-list
92905464|NCT00878969|Ramipril|ramipril|mesh-list
92905465|NCT00878969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92905466|NCT00878969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92905467|NCT00878969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92905468|NCT00878969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92905469|NCT00878969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905470|NCT00878969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905471|NCT00878969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905472|NCT00843492|PENTA|penta|mesh-list
92905473|NCT00843492|Nadroparin|nadroparin|mesh-list
92905474|NCT00843492|Fondaparinux|fondaparinux|mesh-list
92905475|NCT00843492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92905476|NCT00843492|Antithrombins|antithrombins|mesh-ancestor
92905477|NCT00843492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92905478|NCT00843492|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905479|NCT00843492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905480|NCT00843492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905481|NCT00843492|Anticoagulants|anticoagulants|mesh-ancestor
92905482|NCT00843492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92905483|NCT00843492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92905484|NCT00666107|Vaccines|vaccines|mesh-list
92905485|NCT00666107|Immunologic Factors|immunologic factors|mesh-ancestor
92905486|NCT00666107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905487|NCT00666185|Fluconazole|fluconazole|mesh-list
92905488|NCT00666185|Micafungin|micafungin|mesh-list
92905489|NCT00666185|Antifungal Agents|antifungal agents|mesh-ancestor
92905490|NCT00666185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905491|NCT00666185|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92905492|NCT00666185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905493|NCT00666185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905494|NCT00666185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905495|NCT00666185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92905496|NCT00666185|Hormone Antagonists|hormone antagonists|mesh-ancestor
92905497|NCT00666185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905498|NCT00666185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905499|NCT00666185|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92905500|NCT00666185|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92905501|NCT00913224|Diclofenac|diclofenac|mesh-list
92905502|NCT00913224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92905503|NCT00913224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92905504|NCT00913224|Analgesics|analgesics|mesh-ancestor
92905505|NCT00913224|Sensory System Agents|sensory system agents|mesh-ancestor
92905506|NCT00913224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905507|NCT00913224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905508|NCT00913224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905509|NCT00913224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92905510|NCT00913224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92905511|NCT00913224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905512|NCT00913224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905513|NCT00666341|Immunomodulating Agents|immunomodulating agents|mesh-list
92905514|NCT00666341|Immunologic Factors|immunologic factors|mesh-list
92905515|NCT00666341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905516|NCT00661973|Budesonide|budesonide|mesh-list
92905517|NCT00661973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905518|NCT00661973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92905519|NCT00661973|Autonomic Agents|autonomic agents|mesh-ancestor
92905520|NCT00661973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905521|NCT00661973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905522|NCT00661973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92905523|NCT00661973|Respiratory System Agents|respiratory system agents|mesh-ancestor
92905524|NCT00661973|Glucocorticoids|glucocorticoids|mesh-ancestor
92905525|NCT00661973|Hormones|hormones|mesh-ancestor
92905526|NCT00661973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905527|NCT00666575|Gabapentin|gabapentin|mesh-list
92905528|NCT00666575|Analgesics|analgesics|mesh-ancestor
92905529|NCT00666575|Sensory System Agents|sensory system agents|mesh-ancestor
92905530|NCT00666575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905531|NCT00666575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905532|NCT00666575|Anticonvulsants|anticonvulsants|mesh-ancestor
92905533|NCT00666575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92905534|NCT00666575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92905535|NCT00666575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905536|NCT00666575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92905537|NCT00666575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92905538|NCT00666575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92905539|NCT00666575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047007|NCT01051934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92905540|NCT00666575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905541|NCT00666575|Antimanic Agents|antimanic agents|mesh-ancestor
92905542|NCT00666653|Pramipexole|pramipexole|mesh-list
92905543|NCT00666653|Antioxidants|antioxidants|mesh-ancestor
92905544|NCT00666653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905545|NCT00666653|Protective Agents|protective agents|mesh-ancestor
92905546|NCT00666653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905547|NCT00666653|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92905548|NCT00666653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92905549|NCT00666653|Dopamine Agonists|dopamine agonists|mesh-ancestor
92905550|NCT00666653|Dopamine Agents|dopamine agents|mesh-ancestor
92905551|NCT00666653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905552|NCT00707928|Nitroglycerin|nitroglycerin|mesh-list
92905553|NCT00707928|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905554|NCT00666809|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905555|NCT00666809|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905556|NCT00666809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905557|NCT00666809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905558|NCT00666809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905559|NCT00666809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905560|NCT00666809|Urological Agents|urological agents|mesh-ancestor
92905561|NCT00666887|Minocycline|minocycline|mesh-list
92905562|NCT00666887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92905563|NCT00666887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905564|NCT00667043|Fentanyl|fentanyl|mesh-list
92905565|NCT00667043|Midazolam|midazolam|mesh-list
92905566|NCT00667043|Remifentanil|remifentanil|mesh-list
92905567|NCT00667043|Propofol|propofol|mesh-list
92905568|NCT00667043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92905569|NCT00667043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905570|NCT00667043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905571|NCT00667043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92905572|NCT00667043|Anesthetics, General|anesthetics, general|mesh-ancestor
92905573|NCT00667043|Anesthetics|anesthetics|mesh-ancestor
92905574|NCT00667043|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92905575|NCT00667043|Narcotics|narcotics|mesh-ancestor
92905576|NCT00667043|Analgesics|analgesics|mesh-ancestor
92905577|NCT00667043|Sensory System Agents|sensory system agents|mesh-ancestor
92905578|NCT00667043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905579|NCT00667043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92905580|NCT00667043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92905581|NCT00667043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92905582|NCT00667043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92905583|NCT00667043|GABA Modulators|gaba modulators|mesh-ancestor
92905584|NCT00667043|GABA Agents|gaba agents|mesh-ancestor
92905585|NCT00667043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905586|NCT00667043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905587|NCT02631473|Ritonavir|ritonavir|mesh-list
92905588|NCT02631473|Lopinavir|lopinavir|mesh-list
92905589|NCT02631473|Efavirenz|efavirenz|mesh-list
92905590|NCT02631473|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92905591|NCT02631473|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92905592|NCT02631473|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905593|NCT02631473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905594|NCT02631473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905595|NCT02631473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92905596|NCT02631473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92905597|NCT02631473|Antiviral Agents|antiviral agents|mesh-ancestor
92905598|NCT02631473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905599|NCT02631473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92905600|NCT02631473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905601|NCT02631473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92905602|NCT02631473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92905603|NCT02631473|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92905604|NCT02631473|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92905605|NCT02631473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92905606|NCT02631473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92905607|NCT02631473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92905609|NCT00825162|Immunologic Factors|immunologic factors|mesh-ancestor
92905610|NCT00825162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905611|NCT00662441|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905612|NCT00662441|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905613|NCT00662441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905614|NCT00662441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905615|NCT00662441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905616|NCT00662441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905617|NCT00662441|Urological Agents|urological agents|mesh-ancestor
92905618|NCT00911573|Vancomycin|vancomycin|mesh-list
92905619|NCT00911573|Clindamycin|clindamycin|mesh-list
92905620|NCT00911573|Clindamycin palmitate|clindamycin palmitate|mesh-list
92905621|NCT00911573|Clindamycin phosphate|clindamycin phosphate|mesh-list
92905622|NCT00911573|Tigecycline|tigecycline|mesh-list
92905623|NCT00911573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92905624|NCT00911573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905625|NCT00911573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92905626|NCT00911573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905627|NCT00911573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905628|NCT00667433|Tenofovir|tenofovir|mesh-list
92905629|NCT00667433|Emtricitabine|emtricitabine|mesh-list
92905630|NCT00667433|Raltegravir Potassium|raltegravir potassium|mesh-list
92905631|NCT00667433|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92905632|NCT00667433|Antiviral Agents|antiviral agents|mesh-ancestor
92905633|NCT00667433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905634|NCT00667433|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92905635|NCT00667433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92905636|NCT00667433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905637|NCT00667433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905638|NCT00667433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92905639|NCT00667433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92905640|NCT00667433|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92905641|NCT00667433|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92905642|NCT00662519|Lenograstim|lenograstim|mesh-list
92905643|NCT00662519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92905644|NCT00662519|Immunologic Factors|immunologic factors|mesh-ancestor
92905645|NCT00662519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905646|NCT00667901|Riluzole|riluzole|mesh-list
92905647|NCT00667901|Anticonvulsants|anticonvulsants|mesh-ancestor
92905648|NCT00667901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92905649|NCT00667901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92905650|NCT00667901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905651|NCT00667901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905652|NCT00667901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905653|NCT00667901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92905654|NCT00667901|Protective Agents|protective agents|mesh-ancestor
92905655|NCT00667979|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905656|NCT00667979|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905657|NCT00667979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905658|NCT00667979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905659|NCT00667979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905660|NCT00667979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905661|NCT00667979|Urological Agents|urological agents|mesh-ancestor
92905662|NCT00668057|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905663|NCT00668057|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905664|NCT00668057|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905665|NCT00668057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905666|NCT00668057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905667|NCT00668057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905668|NCT00668057|Urological Agents|urological agents|mesh-ancestor
92905669|NCT00668135|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905670|NCT00668135|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905671|NCT00668135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905672|NCT00668135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905673|NCT00668135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905674|NCT00668135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905675|NCT00668135|Urological Agents|urological agents|mesh-ancestor
92905676|NCT02630303|Coal Tar|coal tar|mesh-list
92905677|NCT02630303|Keratolytic Agents|keratolytic agents|mesh-ancestor
92905678|NCT02630303|Dermatologic Agents|dermatologic agents|mesh-ancestor
92905679|NCT04155983|Ropivacaine|ropivacaine|mesh-list
92905680|NCT04155983|Anesthetics, Local|anesthetics, local|mesh-ancestor
92905681|NCT04155983|Anesthetics|anesthetics|mesh-ancestor
92905682|NCT04155983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905683|NCT04155983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905684|NCT04155983|Sensory System Agents|sensory system agents|mesh-ancestor
92905685|NCT04155983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905686|NCT00668603|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92905687|NCT00668603|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92905688|NCT00668603|Estradiol|estradiol|mesh-list
92905689|NCT00668603|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92905690|NCT00668603|Estrogens|estrogens|mesh-ancestor
92905691|NCT00668603|Hormones|hormones|mesh-ancestor
92905692|NCT00668603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905693|NCT00668603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905694|NCT00668603|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92905695|NCT00668603|Contraceptive Agents|contraceptive agents|mesh-ancestor
92905696|NCT00668603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92905697|NCT00668603|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92905698|NCT00662987|Amoxicillin|amoxicillin|mesh-list
92905699|NCT00662987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92905700|NCT00662987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905701|NCT00668759|Amiodarone|amiodarone|mesh-list
92905702|NCT00668759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92905703|NCT00668759|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905704|NCT00668759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92905705|NCT00668759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905706|NCT00668759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905707|NCT00668759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92905708|NCT00668759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92905709|NCT00668759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92905710|NCT00668759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905711|NCT00668759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92905712|NCT00668759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92905713|NCT00668759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92905714|NCT00668837|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92905715|NCT00668837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92905716|NCT00668837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92905717|NCT00668837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905718|NCT00668837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905719|NCT00668837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92905720|NCT00668837|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92905721|NCT00668837|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92905722|NCT00668837|Serotonin Agents|serotonin agents|mesh-ancestor
92905723|NCT00668837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161877|NCT01150461|Angiotensin II|angiotensin ii|mesh-list
92905724|NCT00668837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905725|NCT00668837|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92905726|NCT00668837|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92905727|NCT00668837|Dopamine Agents|dopamine agents|mesh-ancestor
92905728|NCT00663221|Vitamin D|vitamin d|mesh-list
92905729|NCT00663221|Calcium|calcium|mesh-list
92905730|NCT00663221|Vitamins|vitamins|mesh-ancestor
92905731|NCT00663221|Micronutrients|micronutrients|mesh-ancestor
92905732|NCT00663221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905733|NCT00663221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92905734|NCT00663221|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92905735|NCT00824850|Vaccines|vaccines|mesh-list
92905736|NCT00824850|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92905737|NCT00824850|Immunologic Factors|immunologic factors|mesh-ancestor
92905738|NCT00824850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905739|NCT00596687|Insulin|insulin|mesh-list
92905740|NCT00596687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92905741|NCT00596687|Insulin Glargine|insulin glargine|mesh-list
92905742|NCT00596687|Insulin glulisine|insulin glulisine|mesh-list
92905743|NCT00596687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92905744|NCT00596687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905745|NCT02631239|Dexamethasone|dexamethasone|mesh-list
92905746|NCT02631239|Methotrexate|methotrexate|mesh-list
92905747|NCT02631239|Etoposide|etoposide|mesh-list
92905748|NCT02631239|Pegaspargase|pegaspargase|mesh-list
92905749|NCT02631239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905750|NCT02631239|Antiemetics|antiemetics|mesh-ancestor
92905751|NCT02631239|Autonomic Agents|autonomic agents|mesh-ancestor
92905752|NCT02631239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905753|NCT02631239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905754|NCT02631239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92905755|NCT02631239|Glucocorticoids|glucocorticoids|mesh-ancestor
92905756|NCT02631239|Hormones|hormones|mesh-ancestor
92905757|NCT02631239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905758|NCT02631239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905759|NCT02631239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905760|NCT02631239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92905761|NCT02631239|Abortifacient Agents|abortifacient agents|mesh-ancestor
92905762|NCT02631239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92905763|NCT02631239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551234|NCT00054405|Analgesics|analgesics|mesh-ancestor
92905764|NCT02631239|Antimetabolites|antimetabolites|mesh-ancestor
92905765|NCT02631239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905766|NCT02631239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92905767|NCT02631239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905768|NCT02631239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92905769|NCT02631239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92905770|NCT02631239|Immunologic Factors|immunologic factors|mesh-ancestor
92905771|NCT02631239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92905772|NCT02631239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92905773|NCT02631239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92905774|NCT02631239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92905775|NCT02631239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92905776|NCT00663377|Losartan|losartan|mesh-list
92905777|NCT00663377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92905778|NCT00663377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92905779|NCT00663377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92905780|NCT00663377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92905781|NCT00663377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905782|NCT00669149|Aspirin|aspirin|mesh-list
92905783|NCT00669149|Heparin|heparin|mesh-list
92905784|NCT00669149|Enoxaparin|enoxaparin|mesh-list
92905785|NCT00669149|Bivalirudin|bivalirudin|mesh-list
92905786|NCT00669149|Clopidogrel|clopidogrel|mesh-list
92905787|NCT00669149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92905788|NCT00669149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92905789|NCT00669149|Analgesics|analgesics|mesh-ancestor
92905790|NCT00669149|Sensory System Agents|sensory system agents|mesh-ancestor
92905791|NCT00669149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905792|NCT00669149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905793|NCT00669149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905794|NCT00669149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92905795|NCT00669149|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92905796|NCT00669149|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92905797|NCT00669149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905798|NCT00669149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92905799|NCT00669149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92905800|NCT00669149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905801|NCT00669149|Antipyretics|antipyretics|mesh-ancestor
92905802|NCT00669149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92905803|NCT00669149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92905804|NCT00669149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92905805|NCT00669149|Purinergic Agents|purinergic agents|mesh-ancestor
92905806|NCT00669149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905807|NCT00669149|Anticoagulants|anticoagulants|mesh-ancestor
92905808|NCT00669149|Antithrombins|antithrombins|mesh-ancestor
92905809|NCT00669149|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92905810|NCT00669149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905811|NCT00663455|Cyclosporine|cyclosporine|mesh-list
92905812|NCT00663455|Cyclosporins|cyclosporins|mesh-list
92905813|NCT00663455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905814|NCT00663455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905815|NCT00663455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92905816|NCT00663455|Immunologic Factors|immunologic factors|mesh-ancestor
92905817|NCT00663455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905818|NCT00663455|Antifungal Agents|antifungal agents|mesh-ancestor
92905819|NCT00663455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905820|NCT00663455|Dermatologic Agents|dermatologic agents|mesh-ancestor
92905821|NCT00663455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92905822|NCT00663455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92905823|NCT00669695|Atorvastatin|atorvastatin|mesh-list
92905824|NCT00669695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92905825|NCT00669695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92905826|NCT00669695|Antimetabolites|antimetabolites|mesh-ancestor
92905827|NCT00669695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905828|NCT00669695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92905829|NCT00669695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92905830|NCT00669695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905831|NCT00663689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92905832|NCT00663689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905833|NCT00663689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92905834|NCT00663689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905835|NCT00663689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905836|NCT00669773|Docetaxel|docetaxel|mesh-list
92905837|NCT00669773|Doxorubicin|doxorubicin|mesh-list
92905838|NCT00669773|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92905839|NCT00669773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905841|NCT00669773|Antimitotic Agents|antimitotic agents|mesh-ancestor
92905842|NCT00669773|Mitosis Modulators|mitosis modulators|mesh-ancestor
92905843|NCT00669773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905844|NCT00669773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92905845|NCT00669773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92905846|NCT00669773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92905847|NCT00669773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905848|NCT00824616|Insulin|insulin|mesh-list
92905849|NCT00824616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92905850|NCT00824616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905851|NCT00663845|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92905852|NCT00663845|Vasodilator Agents|vasodilator agents|mesh-ancestor
92905853|NCT00663845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92905854|NCT00663845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92905855|NCT00663845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905856|NCT00663845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905857|NCT00663845|Urological Agents|urological agents|mesh-ancestor
92905858|NCT00708240|Escitalopram|escitalopram|mesh-list
92905859|NCT00708240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92905860|NCT00708240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92905861|NCT00708240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92905862|NCT00708240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905863|NCT00708240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905864|NCT00708240|Serotonin Agents|serotonin agents|mesh-ancestor
92905865|NCT00708240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905866|NCT04155515|Ribavirin|ribavirin|mesh-list
92905867|NCT04155515|Yimitasvir|yimitasvir|mesh-list
92905868|NCT04155515|Antimetabolites|antimetabolites|mesh-ancestor
92905869|NCT04155515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905871|NCT04155515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905872|NCT00664001|Antioxidants|antioxidants|mesh-list
92905873|NCT00664001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905874|NCT00664001|Protective Agents|protective agents|mesh-ancestor
92905875|NCT00664001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905876|NCT00824382|Olodaterol|olodaterol|mesh-list
92905877|NCT00824382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92905878|NCT00824382|Autonomic Agents|autonomic agents|mesh-ancestor
92905879|NCT00824382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905880|NCT00824382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905881|NCT00824382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92905882|NCT00824382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92905883|NCT00670319|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92905884|NCT00670319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92905885|NCT00670319|Hormone Antagonists|hormone antagonists|mesh-ancestor
92905886|NCT00670319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905887|NCT00670319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905888|NCT00670319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92905889|NCT00670319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92905890|NCT00670319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92905891|NCT00708318|Fentanyl|fentanyl|mesh-list
92905892|NCT00708318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92905893|NCT00708318|Narcotics|narcotics|mesh-ancestor
92905894|NCT00708318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905895|NCT00708318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905896|NCT00708318|Analgesics|analgesics|mesh-ancestor
92905897|NCT00708318|Sensory System Agents|sensory system agents|mesh-ancestor
92905898|NCT00708318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905899|NCT00708318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92905900|NCT00708318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92905901|NCT00708318|Anesthetics, General|anesthetics, general|mesh-ancestor
92905902|NCT00708318|Anesthetics|anesthetics|mesh-ancestor
92905903|NCT00670475|Piroxicam|piroxicam|mesh-list
92905904|NCT00670475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92905905|NCT00670475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92905906|NCT00670475|Analgesics|analgesics|mesh-ancestor
92905907|NCT00670475|Sensory System Agents|sensory system agents|mesh-ancestor
92905908|NCT00670475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905909|NCT00670475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905910|NCT00670475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905911|NCT00670475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92905912|NCT00670475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92905913|NCT00670475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905914|NCT00670475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905915|NCT04154033|Naltrexone|naltrexone|mesh-list
92905916|NCT04154033|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92905917|NCT04154033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92905918|NCT04154033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905919|NCT04154033|Sensory System Agents|sensory system agents|mesh-ancestor
92905920|NCT04154033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905921|NCT05530356|Dextrans|dextrans|mesh-list
92905922|NCT05530356|Anticoagulants|anticoagulants|mesh-ancestor
92905923|NCT05530356|Plasma Substitutes|plasma substitutes|mesh-ancestor
92905924|NCT05530356|Blood Substitutes|blood substitutes|mesh-ancestor
92905925|NCT00664313|Linezolid|linezolid|mesh-list
92905926|NCT00664313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92905927|NCT00664313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92905928|NCT00664313|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92905929|NCT00664313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905930|NCT00664313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905931|NCT00670553|Panobinostat|panobinostat|mesh-list
92905932|NCT00670553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905933|NCT00670553|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92905934|NCT00670553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905935|NCT00670553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905936|NCT00833040|Sufentanil|sufentanil|mesh-list
92905937|NCT00833040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92905938|NCT00833040|Narcotics|narcotics|mesh-ancestor
92905939|NCT00833040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92905940|NCT00833040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905941|NCT00833040|Analgesics|analgesics|mesh-ancestor
92905942|NCT00833040|Sensory System Agents|sensory system agents|mesh-ancestor
92905943|NCT00833040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905944|NCT00833040|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92905945|NCT00833040|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92905946|NCT00833040|Anesthetics, General|anesthetics, general|mesh-ancestor
92905947|NCT00833040|Anesthetics|anesthetics|mesh-ancestor
92905948|NCT02629835|Dexamethasone|dexamethasone|mesh-list
92905949|NCT02629835|Dexamethasone acetate|dexamethasone acetate|mesh-list
92905950|NCT02629835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92905952|NCT02629835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905953|NCT02629835|Antiemetics|antiemetics|mesh-ancestor
92905954|NCT02629835|Autonomic Agents|autonomic agents|mesh-ancestor
92905955|NCT02629835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92905956|NCT02629835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905957|NCT02629835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92905958|NCT02629835|Glucocorticoids|glucocorticoids|mesh-ancestor
92905959|NCT02629835|Hormones|hormones|mesh-ancestor
92905960|NCT02629835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92905961|NCT02629835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92905962|NCT02629835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92905963|NCT02629835|Protease Inhibitors|protease inhibitors|mesh-ancestor
92905964|NCT02629835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905965|NCT02629835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905966|NCT00664469|Atorvastatin|atorvastatin|mesh-list
92905967|NCT00664469|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92905968|NCT00664469|Simvastatin|simvastatin|mesh-list
92905969|NCT00664469|Ezetimibe|ezetimibe|mesh-list
92905970|NCT00664469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92905971|NCT00664469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92905972|NCT00664469|Antimetabolites|antimetabolites|mesh-ancestor
92905973|NCT00664469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905974|NCT00664469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92905975|NCT00664469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92905976|NCT00664469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905977|NCT00843024|Naproxen|naproxen|mesh-list
92905978|NCT00843024|Sumatriptan|sumatriptan|mesh-list
92905979|NCT00843024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92905980|NCT00843024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92905981|NCT00843024|Analgesics|analgesics|mesh-ancestor
92905982|NCT00843024|Sensory System Agents|sensory system agents|mesh-ancestor
92905983|NCT00843024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161918|NCT01220973|Analgesics|analgesics|mesh-ancestor
92905984|NCT00843024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92905985|NCT00843024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92905986|NCT00843024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551456|NCT00055653|Methylprednisolone|methylprednisolone|mesh-list
92905987|NCT00843024|Gout Suppressants|gout suppressants|mesh-ancestor
92905988|NCT00843024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92905989|NCT00843024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92905990|NCT00843024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92905991|NCT00843024|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92905992|NCT00843024|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92905993|NCT00843024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92905994|NCT00843024|Serotonin Agents|serotonin agents|mesh-ancestor
92905995|NCT00843024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92905996|NCT04154813|Topiramate|topiramate|mesh-list
92905997|NCT04154813|Fluoxetine|fluoxetine|mesh-list
92905998|NCT04154813|Anticonvulsants|anticonvulsants|mesh-ancestor
92905999|NCT04154813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906000|NCT04154813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906001|NCT04154813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92906002|NCT04154813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906003|NCT04154813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906004|NCT04154813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906005|NCT04154813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906006|NCT04154813|Serotonin Agents|serotonin agents|mesh-ancestor
92906007|NCT04154813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92906008|NCT04154813|Antidepressive Agents|antidepressive agents|mesh-ancestor
92906009|NCT04154813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92906010|NCT04154813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92906011|NCT04154813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92906012|NCT04154813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906013|NCT00664703|Methylphenidate|methylphenidate|mesh-list
92906014|NCT00664703|Lobeline|lobeline|mesh-list
92250815|NCT02199041|Tacrolimus|tacrolimus|mesh-list
92906015|NCT00664703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92906016|NCT00664703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906017|NCT00664703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92906018|NCT00664703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906019|NCT00664703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906020|NCT00664703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906021|NCT00664703|Dopamine Agents|dopamine agents|mesh-ancestor
92906022|NCT00664703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906023|NCT00664703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92906024|NCT00664703|Autonomic Agents|autonomic agents|mesh-ancestor
92906025|NCT00664703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906026|NCT00664703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92906027|NCT00664703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92906028|NCT00664703|Cholinergic Agents|cholinergic agents|mesh-ancestor
92906029|NCT00664703|Respiratory System Agents|respiratory system agents|mesh-ancestor
92906030|NCT00670787|Losartan|losartan|mesh-list
92906031|NCT00670787|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92906032|NCT00670787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92906033|NCT00670787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92906034|NCT00670787|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92906035|NCT00670787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92906036|NCT00670787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906037|NCT00670787|Diuretics|diuretics|mesh-ancestor
92906038|NCT00670787|Natriuretic Agents|natriuretic agents|mesh-ancestor
92906039|NCT00670787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906040|NCT00670787|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92906041|NCT00670787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906042|NCT00664781|Rucaparib|rucaparib|mesh-list
92906043|NCT00664781|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92906044|NCT00664781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906045|NCT00664781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906046|NCT00664781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906047|NCT00832650|Solifenacin Succinate|solifenacin succinate|mesh-list
92906048|NCT00832650|Fesoterodine|fesoterodine|mesh-list
92906049|NCT00832650|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92906050|NCT00832650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92906051|NCT00832650|Cholinergic Agents|cholinergic agents|mesh-ancestor
92906052|NCT00832650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906053|NCT00832650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906054|NCT00832650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906055|NCT00832650|Urological Agents|urological agents|mesh-ancestor
92906056|NCT00708396|Escitalopram|escitalopram|mesh-list
92906057|NCT00708396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92906058|NCT00708396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906059|NCT00708396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906060|NCT00708396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906061|NCT00708396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906062|NCT00708396|Serotonin Agents|serotonin agents|mesh-ancestor
92906063|NCT00708396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906064|NCT00665093|Insulin|insulin|mesh-list
92906065|NCT00665093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92906066|NCT00665093|Insulin Aspart|insulin aspart|mesh-list
92906067|NCT00665093|Insulin Detemir|insulin detemir|mesh-list
92906068|NCT00665093|Biphasic Insulins|biphasic insulins|mesh-list
92906069|NCT00665093|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92906070|NCT00665093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906071|NCT00665093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906072|NCT00595517|Esomeprazole|esomeprazole|mesh-list
92906073|NCT00595517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92906074|NCT00595517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92906075|NCT00595517|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92906076|NCT00595517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906077|NCT00595517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906078|NCT00911651|Bromides|bromides|mesh-list
92906079|NCT00911651|Albuterol|albuterol|mesh-list
92906080|NCT00911651|Ipratropium|ipratropium|mesh-list
92906081|NCT00911651|Anticonvulsants|anticonvulsants|mesh-ancestor
92906082|NCT00911651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92906083|NCT00911651|Autonomic Agents|autonomic agents|mesh-ancestor
92161951|NCT03289949|Psilocybin|psilocybin|mesh-list
92906084|NCT00911651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906085|NCT00911651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906086|NCT00911651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92906087|NCT00911651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92906088|NCT00911651|Tocolytic Agents|tocolytic agents|mesh-ancestor
92906089|NCT00911651|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906090|NCT00911651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92906091|NCT00911651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92906092|NCT00911651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92906093|NCT00911651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906094|NCT00911651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906095|NCT00911651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906096|NCT00911651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92906097|NCT00911651|Cholinergic Agents|cholinergic agents|mesh-ancestor
92906098|NCT00665327|Moxifloxacin|moxifloxacin|mesh-list
92906099|NCT00665327|Levofloxacin|levofloxacin|mesh-list
92906100|NCT00665327|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92906101|NCT00665327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906102|NCT00665327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906103|NCT00665327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92906104|NCT00665327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92906105|NCT00665327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906106|NCT00665327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906107|NCT00665327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906108|NCT00665327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92906109|NCT00665327|Contraceptive Agents|contraceptive agents|mesh-ancestor
92906110|NCT00665327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906111|NCT00665327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906112|NCT00665327|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92906113|NCT00665327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92906114|NCT00665327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92906115|NCT00665327|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92906116|NCT00665327|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92906117|NCT00665327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92906118|NCT00823836|Ropinirole|ropinirole|mesh-list
92906119|NCT00823836|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92906120|NCT00823836|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92906121|NCT00823836|Dopamine Agonists|dopamine agonists|mesh-ancestor
92906122|NCT00823836|Dopamine Agents|dopamine agents|mesh-ancestor
92906123|NCT00823836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906124|NCT00823836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906125|NCT00823836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906126|NCT04154735|Rifaximin|rifaximin|mesh-list
92906127|NCT04154735|Cyclophosphamide|cyclophosphamide|mesh-list
92906128|NCT04154735|Fludarabine|fludarabine|mesh-list
92906129|NCT04154735|Alemtuzumab|alemtuzumab|mesh-list
92906130|NCT04154735|Tacrolimus|tacrolimus|mesh-list
92906131|NCT04154735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906132|NCT04154735|Immunologic Factors|immunologic factors|mesh-ancestor
92906133|NCT04154735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906134|NCT04154735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906135|NCT04154735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92906136|NCT04154735|Alkylating Agents|alkylating agents|mesh-ancestor
92906137|NCT04154735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906138|NCT04154735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906139|NCT04154735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92906140|NCT04154735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92906141|NCT04154735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906142|NCT04154735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906143|NCT04154735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906144|NCT04154735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906145|NCT04154735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92906147|NCT00705042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92906148|NCT00705042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92906149|NCT00705042|Analgesics|analgesics|mesh-ancestor
92906150|NCT00705042|Sensory System Agents|sensory system agents|mesh-ancestor
92906151|NCT00705042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906152|NCT00705042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906153|NCT00705042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92906154|NCT00705042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906155|NCT00705042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92906156|NCT00705042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906157|NCT00705042|Immunologic Factors|immunologic factors|mesh-ancestor
92906158|NCT00879437|Bevacizumab|bevacizumab|mesh-list
92906159|NCT00879437|Valproic Acid|valproic acid|mesh-list
92906160|NCT00879437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906161|NCT00879437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906162|NCT00879437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906163|NCT00879437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906164|NCT00879437|Growth Substances|growth substances|mesh-ancestor
92906165|NCT00879437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906166|NCT00879437|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906167|NCT00879437|Anticonvulsants|anticonvulsants|mesh-ancestor
92906168|NCT00879437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906169|NCT00879437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906170|NCT00879437|GABA Agents|gaba agents|mesh-ancestor
92906171|NCT00879437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906172|NCT00879437|Antimanic Agents|antimanic agents|mesh-ancestor
92906173|NCT00879437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92906174|NCT00879437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906175|NCT00879437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92906176|NCT00665639|Caspofungin|caspofungin|mesh-list
92906177|NCT00665639|Micafungin|micafungin|mesh-list
92906178|NCT00665639|Antifungal Agents|antifungal agents|mesh-ancestor
92906179|NCT00665639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906180|NCT00665639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906181|NCT00665639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906182|NCT04153253|Aflibercept|aflibercept|mesh-list
92906183|NCT04153253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906184|NCT04153253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906185|NCT04153253|Growth Substances|growth substances|mesh-ancestor
92906186|NCT04153253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906187|NCT04153253|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906188|NCT04153253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906189|NCT00671645|Bevacizumab|bevacizumab|mesh-list
92906190|NCT00671645|Capecitabine|capecitabine|mesh-list
92906191|NCT00671645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906192|NCT00671645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906193|NCT00671645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906194|NCT00671645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906195|NCT00671645|Growth Substances|growth substances|mesh-ancestor
92906196|NCT00671645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906197|NCT00671645|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906198|NCT00671645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906199|NCT00671645|Antimetabolites|antimetabolites|mesh-ancestor
92906200|NCT00671645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906201|NCT02629523|Afatinib|afatinib|mesh-list
92906202|NCT02629523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906203|NCT02629523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92906204|NCT02629523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906205|NCT02629523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906206|NCT00671801|Irinotecan|irinotecan|mesh-list
92551684|NCT00028496|Vaccines|vaccines|mesh-list
92906207|NCT00671801|Lenalidomide|lenalidomide|mesh-list
92906208|NCT00671801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92906209|NCT00671801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92906210|NCT00671801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906211|NCT00671801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906212|NCT00671801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906213|NCT00671801|Immunologic Factors|immunologic factors|mesh-ancestor
92906214|NCT00671801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906215|NCT00671801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906216|NCT00671801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906217|NCT00671801|Growth Substances|growth substances|mesh-ancestor
92906218|NCT00671801|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906220|NCT04152161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92906221|NCT04152161|Immunologic Factors|immunologic factors|mesh-ancestor
92906222|NCT04152161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906223|NCT00676559|Ranibizumab|ranibizumab|mesh-list
92906224|NCT00676559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906225|NCT00676559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906226|NCT00676559|Growth Substances|growth substances|mesh-ancestor
92906227|NCT00676559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906228|NCT00676559|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906229|NCT00676559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906230|NCT00672113|Nifedipine|nifedipine|mesh-list
92906231|NCT00672113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92906232|NCT00672113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906233|NCT00672113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906234|NCT00672113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92906235|NCT00672113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906236|NCT00672113|Vasodilator Agents|vasodilator agents|mesh-ancestor
92906237|NCT00672113|Tocolytic Agents|tocolytic agents|mesh-ancestor
92906238|NCT00672113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906239|NCT00676637|Timolol|timolol|mesh-list
92906240|NCT00676637|Travoprost|travoprost|mesh-list
92906241|NCT00676637|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92906242|NCT00676637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92906243|NCT00676637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92906244|NCT00676637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92906245|NCT00676637|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906246|NCT00676637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906247|NCT00676637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906248|NCT00676637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906249|NCT00676637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92906250|NCT00676637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92906251|NCT00672347|Clonidine|clonidine|mesh-list
92906252|NCT00672347|Morphine|morphine|mesh-list
92906253|NCT00672347|Bupivacaine|bupivacaine|mesh-list
92906254|NCT00672347|Anesthetics, Local|anesthetics, local|mesh-ancestor
92906255|NCT00672347|Anesthetics|anesthetics|mesh-ancestor
92906256|NCT00672347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906257|NCT00672347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906258|NCT00672347|Sensory System Agents|sensory system agents|mesh-ancestor
92906259|NCT00672347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906260|NCT00672347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92906261|NCT00672347|Narcotics|narcotics|mesh-ancestor
92906262|NCT00672347|Analgesics|analgesics|mesh-ancestor
92906263|NCT00672347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92906264|NCT00672347|Sympatholytics|sympatholytics|mesh-ancestor
92906265|NCT00672347|Autonomic Agents|autonomic agents|mesh-ancestor
92906266|NCT00672347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92906267|NCT00672347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92906268|NCT00672347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92906269|NCT00672347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906270|NCT00672347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906271|NCT00672347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906272|NCT00676871|Blinatumomab|blinatumomab|mesh-list
92906273|NCT00676871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906274|NCT00677027|Lentinan|lentinan|mesh-list
92906275|NCT00677027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92906276|NCT00677027|Immunologic Factors|immunologic factors|mesh-ancestor
92906277|NCT00677027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906278|NCT00677027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906279|NCT00595127|Cyclophosphamide|cyclophosphamide|mesh-list
92906280|NCT00595127|Fludarabine|fludarabine|mesh-list
92906281|NCT00595127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906282|NCT00595127|Immunologic Factors|immunologic factors|mesh-ancestor
92551769|NCT00028730|Thiotepa|thiotepa|mesh-list
92906283|NCT00595127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906284|NCT00595127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906285|NCT00595127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92906286|NCT00595127|Alkylating Agents|alkylating agents|mesh-ancestor
92906287|NCT00595127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906288|NCT00595127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906289|NCT00595127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92906290|NCT00672659|Dexetimide|dexetimide|mesh-list
92906291|NCT00672659|Pipamperone|pipamperone|mesh-list
92906292|NCT00672659|Citalopram|citalopram|mesh-list
92906293|NCT00672659|Escitalopram|escitalopram|mesh-list
92906294|NCT00672659|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92906295|NCT00672659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906296|NCT00672659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906297|NCT00672659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906298|NCT00672659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906299|NCT00672659|Serotonin Agents|serotonin agents|mesh-ancestor
92906300|NCT00672659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906301|NCT00672659|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92906302|NCT00672659|Antidepressive Agents|antidepressive agents|mesh-ancestor
92906303|NCT00672659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92906304|NCT00672659|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92906305|NCT00672659|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92906306|NCT00672659|Parasympatholytics|parasympatholytics|mesh-ancestor
92906307|NCT00672659|Autonomic Agents|autonomic agents|mesh-ancestor
92906308|NCT00672659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906309|NCT00672659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92906310|NCT00672659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92906311|NCT00672659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92906312|NCT00672659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92906313|NCT00672659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92906314|NCT00672659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92906315|NCT00672659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906316|NCT00877487|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92906317|NCT00877487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92906318|NCT00877487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906319|NCT00877487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92906320|NCT00877487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906321|NCT00877487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906322|NCT00877487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906323|NCT00877487|Dopamine Agents|dopamine agents|mesh-ancestor
92906324|NCT00877487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906325|NCT00677261|Anesthetics|anesthetics|mesh-list
92906326|NCT00677261|Anesthetics, Local|anesthetics, local|mesh-list
92906327|NCT00677261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906328|NCT00677261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906329|NCT00677261|Sensory System Agents|sensory system agents|mesh-ancestor
92906330|NCT00677261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906331|NCT00912119|Aminocaproic Acid|aminocaproic acid|mesh-list
92906332|NCT00912119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92906333|NCT00912119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92906334|NCT00912119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906335|NCT00912119|Hemostatics|hemostatics|mesh-ancestor
92906336|NCT00912119|Coagulants|coagulants|mesh-ancestor
92906337|NCT00677339|Vitamin D|vitamin d|mesh-list
92906338|NCT00677339|Ergocalciferols|ergocalciferols|mesh-list
92906339|NCT00677339|Cholecalciferol|cholecalciferol|mesh-list
92906340|NCT00677339|Vitamins|vitamins|mesh-list
92906341|NCT00677339|Micronutrients|micronutrients|mesh-ancestor
92906342|NCT00677339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906343|NCT00677339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92906344|NCT00677339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92906345|NCT00672971|Permethrin|permethrin|mesh-list
92906346|NCT00672971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906347|NCT00672971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906348|NCT00673205|Bicalutamide|bicalutamide|mesh-list
92906349|NCT00673205|Androgen Antagonists|androgen antagonists|mesh-ancestor
92906350|NCT00673205|Hormone Antagonists|hormone antagonists|mesh-ancestor
92906351|NCT00673205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92906352|NCT00673205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906353|NCT00673205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906354|NCT00677729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92551834|NCT00028886|Leprostatic Agents|leprostatic agents|mesh-ancestor
92906355|NCT00677729|Albuterol|albuterol|mesh-list
92906356|NCT00677729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92906357|NCT00677729|Autonomic Agents|autonomic agents|mesh-ancestor
92906358|NCT00677729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906359|NCT00677729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906360|NCT00677729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92906361|NCT00677729|Respiratory System Agents|respiratory system agents|mesh-ancestor
92906362|NCT00677729|Tocolytic Agents|tocolytic agents|mesh-ancestor
92906363|NCT00677729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906364|NCT00677729|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92906365|NCT00677729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92906366|NCT00677729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92906367|NCT00677729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906368|NCT00677729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906369|NCT00677729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906370|NCT02628197|Vitamin D|vitamin d|mesh-list
92906371|NCT02628197|Calcium|calcium|mesh-list
92906372|NCT02628197|Vitamins|vitamins|mesh-ancestor
92906373|NCT02628197|Micronutrients|micronutrients|mesh-ancestor
92906374|NCT02628197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906375|NCT02628197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92906376|NCT02628197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92906377|NCT00673829|Interleukin-2|interleukin-2|mesh-list
92906378|NCT00673829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906379|NCT00673829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92906380|NCT00673829|Analgesics|analgesics|mesh-ancestor
92906381|NCT00673829|Sensory System Agents|sensory system agents|mesh-ancestor
92906382|NCT00673829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906383|NCT00673829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906384|NCT04152629|Methylphenidate|methylphenidate|mesh-list
92906385|NCT04152629|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92906386|NCT04152629|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92906387|NCT04152629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906388|NCT04152629|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92906389|NCT04152629|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906390|NCT04152629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906391|NCT04152629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906392|NCT04152629|Dopamine Agents|dopamine agents|mesh-ancestor
92906393|NCT04152629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906394|NCT02535299|Metformin|metformin|mesh-list
92906395|NCT02535299|Liraglutide|liraglutide|mesh-list
92906396|NCT02535299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906397|NCT02535299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906398|NCT02535299|Incretins|incretins|mesh-ancestor
92906399|NCT02535299|Hormones|hormones|mesh-ancestor
92906400|NCT02535299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92906401|NCT00674063|Alefacept|alefacept|mesh-list
92906402|NCT00674063|Dermatologic Agents|dermatologic agents|mesh-ancestor
92906403|NCT00674063|Immunologic Factors|immunologic factors|mesh-ancestor
92906404|NCT00674063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906405|NCT04151459|Metformin|metformin|mesh-list
92906406|NCT04151459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906407|NCT04151459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906408|NCT00674141|Dexamethasone|dexamethasone|mesh-list
92906409|NCT00674141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92906410|NCT00674141|Antiemetics|antiemetics|mesh-ancestor
92906411|NCT00674141|Autonomic Agents|autonomic agents|mesh-ancestor
92906412|NCT00674141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906413|NCT00674141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906414|NCT00674141|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92906415|NCT00674141|Glucocorticoids|glucocorticoids|mesh-ancestor
92906416|NCT00674141|Hormones|hormones|mesh-ancestor
92906417|NCT00674141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92906418|NCT00674141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92906419|NCT00674141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906420|NCT00678275|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92906421|NCT00678275|Immunologic Factors|immunologic factors|mesh-ancestor
92906422|NCT00678275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906423|NCT00678275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906424|NCT02627807|Cisplatin|cisplatin|mesh-list
92906425|NCT02627807|Gemcitabine|gemcitabine|mesh-list
92906426|NCT02627807|Docetaxel|docetaxel|mesh-list
92906427|NCT02627807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906428|NCT02627807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906429|NCT02627807|Antimetabolites|antimetabolites|mesh-ancestor
92906430|NCT02627807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906431|NCT02627807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906432|NCT02627807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906433|NCT02627807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906435|NCT00678431|Antioxidants|antioxidants|mesh-ancestor
92906436|NCT00678431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906437|NCT00678431|Protective Agents|protective agents|mesh-ancestor
92906438|NCT00678431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906439|NCT00678431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906440|NCT00678431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92906441|NCT00678509|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92906442|NCT00678509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92906443|NCT00678509|Immunologic Factors|immunologic factors|mesh-ancestor
92906444|NCT00678509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906445|NCT00674687|Gabapentin|gabapentin|mesh-list
92906446|NCT00674687|Analgesics|analgesics|mesh-ancestor
92906447|NCT00674687|Sensory System Agents|sensory system agents|mesh-ancestor
92906448|NCT00674687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906449|NCT00674687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906450|NCT00674687|Anticonvulsants|anticonvulsants|mesh-ancestor
92906451|NCT00674687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92906452|NCT00674687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92906453|NCT00674687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906454|NCT00674687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92906455|NCT00674687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92906456|NCT00674687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92906457|NCT00674687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906458|NCT00674687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906459|NCT00674687|Antimanic Agents|antimanic agents|mesh-ancestor
92906460|NCT00656747|Amoxicillin|amoxicillin|mesh-list
92906461|NCT00656747|Moxifloxacin|moxifloxacin|mesh-list
92906462|NCT00656747|Clavulanic Acids|clavulanic acids|mesh-list
92906463|NCT00656747|Clavulanic Acid|clavulanic acid|mesh-list
92906464|NCT00656747|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92906465|NCT00656747|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92906466|NCT00656747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906467|NCT00656747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906468|NCT00656747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92906469|NCT00656747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92906470|NCT00656747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906471|NCT00656747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906472|NCT00656747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906473|NCT00656747|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92906474|NCT00656747|Contraceptive Agents|contraceptive agents|mesh-ancestor
92906475|NCT00656747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906476|NCT00656747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906477|NCT00656747|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92906478|NCT00656747|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92906479|NCT00656747|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92906480|NCT00656747|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92906481|NCT00678743|Simvastatin|simvastatin|mesh-list
92906482|NCT00678743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92906483|NCT00678743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92906484|NCT00678743|Antimetabolites|antimetabolites|mesh-ancestor
92906485|NCT00678743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906486|NCT00678743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92906487|NCT00678743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92906488|NCT00678743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906489|NCT04152317|Misoprostol|misoprostol|mesh-list
92906490|NCT04152317|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92906491|NCT04152317|Abortifacient Agents|abortifacient agents|mesh-ancestor
92906492|NCT04152317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906493|NCT04152317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906494|NCT04152317|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92906495|NCT04152317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92906496|NCT04152317|Oxytocics|oxytocics|mesh-ancestor
92906497|NCT02628665|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92906498|NCT02628665|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92906499|NCT02628665|Trioxsalen|trioxsalen|mesh-list
92906500|NCT02628665|Photosensitizing Agents|photosensitizing agents|mesh-list
92906501|NCT02628665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906502|NCT02628665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551984|NCT00029822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92906503|NCT00678977|Gemcitabine|gemcitabine|mesh-list
92906504|NCT00678977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906505|NCT00678977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906506|NCT00678977|Antimetabolites|antimetabolites|mesh-ancestor
92906507|NCT00678977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906508|NCT00674921|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92906509|NCT00674921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92906510|NCT00674921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906511|NCT00674921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906512|NCT00674921|Antimalarials|antimalarials|mesh-ancestor
92906513|NCT00674921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92906514|NCT00674921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92906515|NCT00674999|Bacitracin|bacitracin|mesh-list
92906516|NCT00674999|Nystatin|nystatin|mesh-list
92906517|NCT00674999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92906518|NCT00674999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906519|NCT00674999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906520|NCT00674999|Antifungal Agents|antifungal agents|mesh-ancestor
92906521|NCT00674999|Ionophores|ionophores|mesh-ancestor
92906522|NCT00674999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906523|NCT00674999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906524|NCT00882713|Epoetin Alfa|epoetin alfa|mesh-list
92906525|NCT00882713|Hematinics|hematinics|mesh-ancestor
92906526|NCT04151381|Aminophylline|aminophylline|mesh-list
92906527|NCT04151381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92906528|NCT04151381|Autonomic Agents|autonomic agents|mesh-ancestor
92906529|NCT04151381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906530|NCT04151381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906531|NCT04151381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92906532|NCT04151381|Respiratory System Agents|respiratory system agents|mesh-ancestor
92906533|NCT04151381|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92906534|NCT04151381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92906535|NCT04151381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906536|NCT04151381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906537|NCT04151381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92906538|NCT04151381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92906539|NCT04151381|Purinergic Agents|purinergic agents|mesh-ancestor
92906540|NCT04151381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906541|NCT04151381|Protective Agents|protective agents|mesh-ancestor
92906542|NCT00809133|Paclitaxel|paclitaxel|mesh-list
92906543|NCT00809133|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92906544|NCT00809133|Bevacizumab|bevacizumab|mesh-list
92906545|NCT00809133|Carboplatin|carboplatin|mesh-list
92906546|NCT00809133|Afatinib|afatinib|mesh-list
92906547|NCT00809133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92906548|NCT00809133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906549|NCT00809133|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906550|NCT00809133|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906551|NCT00809133|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906552|NCT00809133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906553|NCT00809133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906554|NCT00809133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906555|NCT00809133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906556|NCT00809133|Growth Substances|growth substances|mesh-ancestor
92906557|NCT00809133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906558|NCT00809133|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906559|NCT00809133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92906560|NCT00809133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906561|NCT00912275|Vinorelbine|vinorelbine|mesh-list
92906562|NCT00912275|Lapatinib|lapatinib|mesh-list
92906563|NCT00912275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92906564|NCT00912275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906565|NCT00912275|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906566|NCT00912275|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906567|NCT00912275|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906568|NCT00912275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906569|NCT00912275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92906570|NCT00912275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906571|NCT00882557|Daptomycin|daptomycin|mesh-list
92906572|NCT00882557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906573|NCT00882557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906574|NCT02627573|Mycophenolic Acid|mycophenolic acid|mesh-list
92906575|NCT02627573|Cyclophosphamide|cyclophosphamide|mesh-list
92906576|NCT02627573|Busulfan|busulfan|mesh-list
92906577|NCT02627573|Fludarabine|fludarabine|mesh-list
92906578|NCT02627573|Fludarabine phosphate|fludarabine phosphate|mesh-list
92906579|NCT02627573|Tacrolimus|tacrolimus|mesh-list
92906580|NCT02627573|Thymoglobulin|thymoglobulin|mesh-list
92906581|NCT02627573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906582|NCT02627573|Immunologic Factors|immunologic factors|mesh-ancestor
92906583|NCT02627573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906584|NCT02627573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906585|NCT02627573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92906586|NCT02627573|Alkylating Agents|alkylating agents|mesh-ancestor
92906587|NCT02627573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906588|NCT02627573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906589|NCT02627573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92906590|NCT02627573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906591|NCT02627573|Antimetabolites|antimetabolites|mesh-ancestor
92906592|NCT02627573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92906593|NCT02627573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906594|NCT02627573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92906595|NCT02627573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92906596|NCT02627573|Antitubercular Agents|antitubercular agents|mesh-ancestor
92906597|NCT02627573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906598|NCT02627573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906599|NCT00675545|Carboplatin|carboplatin|mesh-list
92906600|NCT00675545|Docetaxel|docetaxel|mesh-list
92906601|NCT00675545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906602|NCT00675545|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906603|NCT00675545|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906604|NCT00675545|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906605|NCT00675545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906606|NCT00679523|Tavaborole|tavaborole|mesh-list
92906607|NCT00679523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92906608|NCT00679523|Antifungal Agents|antifungal agents|mesh-ancestor
92906609|NCT00679523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906610|NCT00675701|Moxifloxacin|moxifloxacin|mesh-list
92906611|NCT00675701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906612|NCT00675701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906613|NCT00675701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92906614|NCT00675701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92906615|NCT00675701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906616|NCT00675701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906617|NCT00675701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906618|NCT00808899|Cyclophosphamide|cyclophosphamide|mesh-list
92906619|NCT00808899|Doxorubicin|doxorubicin|mesh-list
92906620|NCT00808899|Irinotecan|irinotecan|mesh-list
92906621|NCT00808899|Etoposide|etoposide|mesh-list
92906622|NCT00808899|Topotecan|topotecan|mesh-list
92906623|NCT00808899|Temsirolimus|temsirolimus|mesh-list
92906624|NCT00808899|Tretinoin|tretinoin|mesh-list
92906625|NCT00808899|Isotretinoin|isotretinoin|mesh-list
92906626|NCT00808899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906627|NCT00808899|Immunologic Factors|immunologic factors|mesh-ancestor
92906628|NCT00808899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906629|NCT00808899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906630|NCT00808899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92906631|NCT00808899|Alkylating Agents|alkylating agents|mesh-ancestor
92906632|NCT00808899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906633|NCT00808899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906634|NCT00808899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92906635|NCT00808899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92906636|NCT00808899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92906637|NCT00808899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92906638|NCT00808899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906639|NCT00808899|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92906640|NCT00808899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92906641|NCT00808899|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92906642|NCT00808899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92906643|NCT00808899|Keratolytic Agents|keratolytic agents|mesh-ancestor
92906644|NCT00808899|Dermatologic Agents|dermatologic agents|mesh-ancestor
92906645|NCT00808665|Dexmedetomidine|dexmedetomidine|mesh-list
92906646|NCT00808665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92906647|NCT00808665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906648|NCT00808665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906649|NCT00808665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92906650|NCT00808665|Analgesics|analgesics|mesh-ancestor
92906651|NCT00808665|Sensory System Agents|sensory system agents|mesh-ancestor
92906652|NCT00808665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906653|NCT00808665|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92906654|NCT00808665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92906655|NCT00808665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92906656|NCT00808665|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906657|NCT00808665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906658|NCT00808665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906659|NCT00808509|Adalimumab|adalimumab|mesh-list
92906660|NCT00808509|Methotrexate|methotrexate|mesh-list
92906661|NCT00808509|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92906662|NCT00808509|Abortifacient Agents|abortifacient agents|mesh-ancestor
92906663|NCT00808509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906664|NCT00808509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906665|NCT00808509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906666|NCT00808509|Antimetabolites|antimetabolites|mesh-ancestor
92906667|NCT00808509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906668|NCT00808509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906669|NCT00808509|Dermatologic Agents|dermatologic agents|mesh-ancestor
92906670|NCT00808509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906671|NCT00808509|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92906672|NCT00808509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906673|NCT00808509|Immunologic Factors|immunologic factors|mesh-ancestor
92906674|NCT00808509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906675|NCT00808509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92906676|NCT00808509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92906677|NCT00808509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92906678|NCT04444869|Cisplatin|cisplatin|mesh-list
92906679|NCT04444869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906680|NCT04276857|Leucovorin|leucovorin|mesh-list
92906681|NCT04276857|Paclitaxel|paclitaxel|mesh-list
92906682|NCT04276857|Gemcitabine|gemcitabine|mesh-list
92906683|NCT04276857|Oxaliplatin|oxaliplatin|mesh-list
92906684|NCT04276857|Irinotecan|irinotecan|mesh-list
92906685|NCT04276857|Folfirinox|folfirinox|mesh-list
92906686|NCT04276857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92906687|NCT04276857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906688|NCT04276857|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906689|NCT04276857|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906690|NCT04276857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906691|NCT04276857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906692|NCT04276857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906693|NCT04276857|Antimetabolites|antimetabolites|mesh-ancestor
92906694|NCT04276857|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92906695|NCT04276857|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92906696|NCT04276857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906697|NCT04276857|Antidotes|antidotes|mesh-ancestor
92906698|NCT04276857|Protective Agents|protective agents|mesh-ancestor
92906699|NCT04276857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906700|NCT04276857|Vitamin B Complex|vitamin b complex|mesh-ancestor
92906701|NCT04276857|Vitamins|vitamins|mesh-ancestor
92906702|NCT04276857|Micronutrients|micronutrients|mesh-ancestor
92906703|NCT00807573|Paclitaxel|paclitaxel|mesh-list
92906704|NCT00807573|Bevacizumab|bevacizumab|mesh-list
92906705|NCT00807573|Pemetrexed|pemetrexed|mesh-list
92906706|NCT00807573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92906707|NCT00807573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906708|NCT00807573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906709|NCT00807573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906710|NCT00807573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906711|NCT00807573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906712|NCT00807573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906713|NCT00807573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92906714|NCT00807573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92906715|NCT00807573|Growth Substances|growth substances|mesh-ancestor
92906716|NCT00807573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906717|NCT00807573|Growth Inhibitors|growth inhibitors|mesh-ancestor
92906718|NCT00807573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906719|NCT00807573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92906720|NCT00807573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92906721|NCT00842712|Cisplatin|cisplatin|mesh-list
92906722|NCT00842712|Gemcitabine|gemcitabine|mesh-list
92906723|NCT00842712|Cetuximab|cetuximab|mesh-list
92906724|NCT00842712|Vinorelbine|vinorelbine|mesh-list
92906725|NCT00842712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906726|NCT00842712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906727|NCT00842712|Antimetabolites|antimetabolites|mesh-ancestor
92906728|NCT00842712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906729|NCT00842712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906730|NCT00842712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92906731|NCT00842712|Tubulin Modulators|tubulin modulators|mesh-ancestor
92906732|NCT00842712|Antimitotic Agents|antimitotic agents|mesh-ancestor
92906733|NCT00842712|Mitosis Modulators|mitosis modulators|mesh-ancestor
92906734|NCT00705120|Cyclosporine|cyclosporine|mesh-list
92906735|NCT00705120|Cyclophosphamide|cyclophosphamide|mesh-list
92906736|NCT00705120|Busulfan|busulfan|mesh-list
92906737|NCT00705120|Cyclosporins|cyclosporins|mesh-list
92906738|NCT00705120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906739|NCT00705120|Immunologic Factors|immunologic factors|mesh-ancestor
92906740|NCT00705120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906741|NCT00705120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906742|NCT00705120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92906743|NCT00705120|Alkylating Agents|alkylating agents|mesh-ancestor
92906744|NCT00705120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906745|NCT00705120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906746|NCT00705120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92906747|NCT00705120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906748|NCT00705120|Antifungal Agents|antifungal agents|mesh-ancestor
92906749|NCT00705120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906750|NCT00705120|Dermatologic Agents|dermatologic agents|mesh-ancestor
92906751|NCT00705120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92906752|NCT00842244|Capecitabine|capecitabine|mesh-list
92906753|NCT00842244|Axitinib|axitinib|mesh-list
92906754|NCT00842244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906755|NCT00842244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92906756|NCT00842244|Antimetabolites|antimetabolites|mesh-ancestor
92906757|NCT00842244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906758|NCT00842244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92906759|NCT00842244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906760|NCT00832416|Tramadol|tramadol|mesh-list
92906761|NCT00832416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92906762|NCT00832416|Narcotics|narcotics|mesh-ancestor
92906763|NCT00832416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906764|NCT00832416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906765|NCT00832416|Analgesics|analgesics|mesh-ancestor
92906766|NCT00832416|Sensory System Agents|sensory system agents|mesh-ancestor
92906767|NCT00832416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906768|NCT00705198|Temozolomide|temozolomide|mesh-list
92906769|NCT00705198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92906770|NCT00705198|Alkylating Agents|alkylating agents|mesh-ancestor
92906771|NCT00705198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906772|NCT00705198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906773|NCT00702936|Telmisartan|telmisartan|mesh-list
92906774|NCT00702936|Ramipril|ramipril|mesh-list
92906775|NCT00702936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92906776|NCT00702936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92906777|NCT00702936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92906778|NCT00702936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906779|NCT00702936|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92906780|NCT00702936|Protease Inhibitors|protease inhibitors|mesh-ancestor
92906781|NCT00702936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906782|NCT00683800|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92906783|NCT00683800|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92906784|NCT00683800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906785|NCT00683800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906786|NCT00683800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906787|NCT00683800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906788|NCT00683800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906789|NCT00683800|Antidepressive Agents|antidepressive agents|mesh-ancestor
92906790|NCT00683800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92906791|NCT00683644|Zinc|zinc|mesh-list
92906792|NCT00683644|Zinc Sulfate|zinc sulfate|mesh-list
92906793|NCT00683644|Trace Elements|trace elements|mesh-ancestor
92906794|NCT00683644|Micronutrients|micronutrients|mesh-ancestor
92906795|NCT00683644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906796|NCT00683644|Astringents|astringents|mesh-ancestor
92906797|NCT00683644|Dermatologic Agents|dermatologic agents|mesh-ancestor
92906798|NCT00753064|Prazosin|prazosin|mesh-list
92906799|NCT00753064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92906800|NCT00753064|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92906801|NCT00753064|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92906802|NCT00753064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92906803|NCT00753064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906804|NCT00753064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525999|NCT00000464|Mexiletine|mexiletine|mesh-list
92906805|NCT00753064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906806|NCT00753064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906807|NCT00751738|Azimilide|azimilide|mesh-list
92906808|NCT00751738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92906809|NCT00751738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92906810|NCT00751738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906811|NCT00751738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906812|NCT00751738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92906813|NCT00751738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906815|NCT04060264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92906816|NCT04060264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92906817|NCT04060264|Immunologic Factors|immunologic factors|mesh-ancestor
92906818|NCT04060264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906819|NCT00684814|Zolpidem|zolpidem|mesh-list
92906820|NCT00684814|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92906821|NCT00684814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92906822|NCT00684814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906823|NCT00684814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906824|NCT00684814|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92906825|NCT00684814|GABA Agonists|gaba agonists|mesh-ancestor
92906826|NCT00684814|GABA Agents|gaba agents|mesh-ancestor
92906827|NCT00684814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906828|NCT00684814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906829|NCT00576472|Methylphenidate|methylphenidate|mesh-list
92906830|NCT00576472|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92906831|NCT00576472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906832|NCT00576472|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92906833|NCT00576472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92906834|NCT00576472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906835|NCT00576472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906836|NCT00576472|Dopamine Agents|dopamine agents|mesh-ancestor
92906837|NCT00576472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906838|NCT00823212|Aspirin|aspirin|mesh-list
92906839|NCT00823212|Ticlopidine|ticlopidine|mesh-list
92906840|NCT00823212|Clopidogrel|clopidogrel|mesh-list
92906841|NCT00823212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92906842|NCT00823212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92906843|NCT00823212|Analgesics|analgesics|mesh-ancestor
92906844|NCT00823212|Sensory System Agents|sensory system agents|mesh-ancestor
92906845|NCT00823212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906846|NCT00823212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906847|NCT00823212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92906848|NCT00823212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92906849|NCT00823212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92906850|NCT00823212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92906851|NCT00823212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906852|NCT00823212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92906853|NCT00823212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92906854|NCT00823212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906855|NCT00823212|Antipyretics|antipyretics|mesh-ancestor
92906856|NCT00823212|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92906857|NCT00823212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92906858|NCT00823212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92906859|NCT00823212|Purinergic Agents|purinergic agents|mesh-ancestor
92906860|NCT00823212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906861|NCT00823212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92906862|NCT00823212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92906863|NCT02561494|Nefopam|nefopam|mesh-list
92906864|NCT02561494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92906865|NCT02561494|Analgesics|analgesics|mesh-ancestor
92906866|NCT02561494|Sensory System Agents|sensory system agents|mesh-ancestor
92906867|NCT02561494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906868|NCT02561494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906869|NCT05958693|Lumefantrine|lumefantrine|mesh-list
92906870|NCT05958693|Artemether|artemether|mesh-list
92906871|NCT05958693|Primaquine|primaquine|mesh-list
92906872|NCT05958693|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92906873|NCT05958693|Antimalarials|antimalarials|mesh-ancestor
92906874|NCT05958693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92906875|NCT05958693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92906876|NCT05958693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906877|NCT05958589|Levobupivacaine|levobupivacaine|mesh-list
92906878|NCT05958589|Anesthetics|anesthetics|mesh-ancestor
92906879|NCT05958589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92906880|NCT05958589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906881|NCT05958589|Anesthetics, Local|anesthetics, local|mesh-ancestor
92906882|NCT05958589|Sensory System Agents|sensory system agents|mesh-ancestor
92906883|NCT05958589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906885|NCT05958342|Arginine Vasopressin|arginine vasopressin|mesh-list
92906886|NCT05958342|Calcium|calcium|mesh-list
92906887|NCT05958342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92906888|NCT05958342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906889|NCT05958342|Hemostatics|hemostatics|mesh-ancestor
92906890|NCT05958342|Coagulants|coagulants|mesh-ancestor
92906891|NCT05958342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92906892|NCT05958342|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92906893|NCT05958342|Natriuretic Agents|natriuretic agents|mesh-ancestor
92906894|NCT05958303|Antioxidants|antioxidants|mesh-list
92906895|NCT05958303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906896|NCT05958303|Protective Agents|protective agents|mesh-ancestor
92906897|NCT05958303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906898|NCT05958277|Vitamins|vitamins|mesh-list
92906899|NCT05958277|Vitamin B 12|vitamin b 12|mesh-list
92906900|NCT05958277|Niacinamide|niacinamide|mesh-list
92906901|NCT05958277|Vitamin B Complex|vitamin b complex|mesh-list
92906902|NCT05958277|Micronutrients|micronutrients|mesh-ancestor
92906903|NCT05958277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906904|NCT05958173|Capsaicin|capsaicin|mesh-list
92906905|NCT05958173|Piperine|piperine|mesh-list
92906906|NCT05958173|Antipruritics|antipruritics|mesh-ancestor
92906907|NCT05958173|Dermatologic Agents|dermatologic agents|mesh-ancestor
92906908|NCT05958173|Sensory System Agents|sensory system agents|mesh-ancestor
92906909|NCT05958173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906910|NCT05958173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162103|NCT02192541|Aflibercept|aflibercept|mesh-list
92906911|NCT05958173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92906912|NCT05958173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906913|NCT05958173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906914|NCT05958160|Topiramate|topiramate|mesh-list
92906915|NCT05958160|Anticonvulsants|anticonvulsants|mesh-ancestor
92906916|NCT05958160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906917|NCT05958160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906918|NCT05958069|Minocycline|minocycline|mesh-list
92906919|NCT05958069|Anticonvulsants|anticonvulsants|mesh-list
92906920|NCT05958069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906921|NCT05958069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906922|NCT05957991|Metformin|metformin|mesh-list
92906923|NCT05957991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906924|NCT05957991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906925|NCT05957978|Paromomycin|paromomycin|mesh-list
92906926|NCT05957978|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92906927|NCT05957978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92906928|NCT05957978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906929|NCT05957978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92906930|NCT05957978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92906931|NCT05957978|Schistosomicides|schistosomicides|mesh-ancestor
92906932|NCT05957978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92906933|NCT05957978|Anthelmintics|anthelmintics|mesh-ancestor
92906934|NCT05957913|Tenofovir|tenofovir|mesh-list
92906935|NCT05957913|Emtricitabine|emtricitabine|mesh-list
92906936|NCT05957913|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92906937|NCT05957913|Antiviral Agents|antiviral agents|mesh-ancestor
92906938|NCT05957913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92906939|NCT05957913|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92906940|NCT05957913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92906941|NCT05957913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92906942|NCT05957913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906943|NCT05957913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92906944|NCT05957913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92906945|NCT05957887|Dapagliflozin|dapagliflozin|mesh-list
92906946|NCT05957887|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92906947|NCT05957887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906948|NCT05957887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92906949|NCT05957887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906950|NCT05957848|Guanfacine|guanfacine|mesh-list
92906951|NCT05957848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92906952|NCT05957848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92906953|NCT05957848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92906954|NCT05957848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92906955|NCT05957848|Adrenergic Agents|adrenergic agents|mesh-ancestor
92906956|NCT05957848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92906957|NCT05957848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906958|NCT05957848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906959|NCT05957822|Tranexamic Acid|tranexamic acid|mesh-list
92906960|NCT05957822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92906961|NCT05957822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92906962|NCT05957822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906963|NCT05957822|Hemostatics|hemostatics|mesh-ancestor
92906964|NCT05957822|Coagulants|coagulants|mesh-ancestor
92906965|NCT05957757|Tislelizumab|tislelizumab|mesh-list
92906966|NCT05957757|Disitamab vedotin|disitamab vedotin|mesh-list
92906967|NCT05957757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92906968|NCT05957757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92906969|NCT05957757|Immunoconjugates|immunoconjugates|mesh-ancestor
92906970|NCT05957757|Immunologic Factors|immunologic factors|mesh-ancestor
92906971|NCT05957757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906972|NCT05957666|Misoprostol|misoprostol|mesh-list
92906973|NCT05957666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92906974|NCT05957666|Abortifacient Agents|abortifacient agents|mesh-ancestor
92906975|NCT05957666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92906976|NCT05957666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906977|NCT05957666|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92906978|NCT05957666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92906979|NCT05957666|Oxytocics|oxytocics|mesh-ancestor
92906980|NCT05957653|Lidocaine|lidocaine|mesh-list
92906981|NCT05957653|Sufentanil|sufentanil|mesh-list
92906982|NCT05957653|Anesthetics, Local|anesthetics, local|mesh-ancestor
92906983|NCT05957653|Anesthetics|anesthetics|mesh-ancestor
92906984|NCT05957653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149403|NCT03457896|Cetuximab|cetuximab|mesh-list
92906985|NCT05957653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92906986|NCT05957653|Sensory System Agents|sensory system agents|mesh-ancestor
92906987|NCT05957653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92906988|NCT05957653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92906989|NCT05957653|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92906990|NCT05957653|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92906991|NCT05957653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92906992|NCT05957653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92906993|NCT05957653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92906994|NCT05957653|Narcotics|narcotics|mesh-ancestor
92906995|NCT05957653|Analgesics|analgesics|mesh-ancestor
92906996|NCT05957653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92906997|NCT05957653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92906998|NCT05957653|Anesthetics, General|anesthetics, general|mesh-ancestor
92906999|NCT05957510|Carboplatin|carboplatin|mesh-list
92907000|NCT05957510|Etoposide|etoposide|mesh-list
92907001|NCT05957510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907002|NCT05957510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907003|NCT05957510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92907004|NCT05957510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92907005|NCT05957510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907006|NCT05957510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907007|NCT05957432|Amoxicillin|amoxicillin|mesh-list
92907008|NCT05957432|Clarithromycin|clarithromycin|mesh-list
92907009|NCT05957432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92907010|NCT05957432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907011|NCT05957432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92907012|NCT05957432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907013|NCT05957432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907014|NCT05957432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92907015|NCT05957432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92907016|NCT05957367|Cetuximab|cetuximab|mesh-list
92907017|NCT05957367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907018|NCT05957367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907019|NCT05957328|Ascorbic Acid|ascorbic acid|mesh-list
92907020|NCT05957328|Antioxidants|antioxidants|mesh-ancestor
92907021|NCT05957328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907022|NCT05957328|Protective Agents|protective agents|mesh-ancestor
92907023|NCT05957328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907024|NCT05957328|Vitamins|vitamins|mesh-ancestor
92907025|NCT05957328|Micronutrients|micronutrients|mesh-ancestor
92907026|NCT05957302|Fentanyl|fentanyl|mesh-list
92907027|NCT05957302|Ketamine|ketamine|mesh-list
92907028|NCT05957302|Analgesics|analgesics|mesh-ancestor
92907029|NCT05957302|Sensory System Agents|sensory system agents|mesh-ancestor
92907030|NCT05957302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907031|NCT05957302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907032|NCT05957302|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92907033|NCT05957302|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92907034|NCT05957302|Anesthetics, General|anesthetics, general|mesh-ancestor
92907035|NCT05957302|Anesthetics|anesthetics|mesh-ancestor
92907036|NCT05957302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907037|NCT05957302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92907038|NCT05957302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92907039|NCT05957302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907040|NCT05957302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907041|NCT05957302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92907042|NCT05957302|Narcotics|narcotics|mesh-ancestor
92907043|NCT05957302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92907044|NCT05957250|FAPI-46|fapi-46|mesh-list
92907045|NCT05957250|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92907046|NCT05957250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907047|NCT05957211|Cyclosporine|cyclosporine|mesh-list
92907048|NCT05957211|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92907049|NCT05957211|Cyclosporins|cyclosporins|mesh-list
92907050|NCT05957211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907051|NCT05957211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907052|NCT05957211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92907053|NCT05957211|Immunologic Factors|immunologic factors|mesh-ancestor
92907054|NCT05957211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907055|NCT05957211|Antifungal Agents|antifungal agents|mesh-ancestor
92907056|NCT05957211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907057|NCT05957211|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907058|NCT05957211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92907059|NCT05957211|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92907060|NCT05957211|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92907061|NCT05957107|Antibodies|antibodies|mesh-list
92907062|NCT05957107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92907063|NCT05957107|Immunologic Factors|immunologic factors|mesh-ancestor
92907064|NCT05957107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907065|NCT05957094|Citalopram|citalopram|mesh-list
92907066|NCT05957094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92907067|NCT05957094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92907068|NCT05957094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907069|NCT05957094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907070|NCT05957094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907071|NCT05957094|Serotonin Agents|serotonin agents|mesh-ancestor
92907072|NCT05957094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907073|NCT05957094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92907074|NCT05957094|Antidepressive Agents|antidepressive agents|mesh-ancestor
92907075|NCT05957094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92907076|NCT05957081|Pembrolizumab|pembrolizumab|mesh-list
92907077|NCT05957081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907078|NCT05957081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907079|NCT05957081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907080|NCT05957081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907081|NCT05957055|Methylphenidate|methylphenidate|mesh-list
92907082|NCT05957055|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92907083|NCT05957055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92907084|NCT05957055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907085|NCT05957055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92907086|NCT05957055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92907087|NCT05957055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907088|NCT05957055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907089|NCT05957055|Dopamine Agents|dopamine agents|mesh-ancestor
92907090|NCT05957055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907091|NCT05956899|Ondansetron|ondansetron|mesh-list
92907092|NCT05956899|Palonosetron|palonosetron|mesh-list
92907093|NCT05956899|Antiemetics|antiemetics|mesh-ancestor
92907094|NCT05956899|Autonomic Agents|autonomic agents|mesh-ancestor
92907095|NCT05956899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907096|NCT05956899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907097|NCT05956899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907098|NCT05956899|Antipruritics|antipruritics|mesh-ancestor
92907099|NCT05956899|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907100|NCT05956899|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92907101|NCT05956899|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92907102|NCT05956899|Serotonin Agents|serotonin agents|mesh-ancestor
92907103|NCT05956899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907104|NCT05956899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907105|NCT05955261|Cytarabine|cytarabine|mesh-list
92907106|NCT05955261|Fludarabine|fludarabine|mesh-list
92907107|NCT05955261|Fludarabine phosphate|fludarabine phosphate|mesh-list
92907108|NCT05955261|Etoposide|etoposide|mesh-list
92907109|NCT05955261|Azacitidine|azacitidine|mesh-list
92907110|NCT05955261|Daunorubicin|daunorubicin|mesh-list
92907111|NCT05955261|Venetoclax|venetoclax|mesh-list
92907112|NCT05955261|Mitoxantrone|mitoxantrone|mesh-list
92907113|NCT05955261|Idarubicin|idarubicin|mesh-list
92907114|NCT05955261|Gemtuzumab|gemtuzumab|mesh-list
92907115|NCT05955261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907116|NCT05955261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907117|NCT05955261|Antimetabolites|antimetabolites|mesh-ancestor
92907118|NCT05955261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907119|NCT05955261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92907120|NCT05955261|Immunologic Factors|immunologic factors|mesh-ancestor
92907121|NCT05955261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907122|NCT05955261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907123|NCT05955261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92907124|NCT05955261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92907125|NCT05955261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907126|NCT05955261|Antiviral Agents|antiviral agents|mesh-ancestor
92907127|NCT05955261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907128|NCT05955261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92907129|NCT05955261|Analgesics|analgesics|mesh-ancestor
92907130|NCT05955261|Sensory System Agents|sensory system agents|mesh-ancestor
92907131|NCT05955261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907132|NCT05955261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907133|NCT05955261|Immunotoxins|immunotoxins|mesh-ancestor
92907134|NCT05955261|Immunoconjugates|immunoconjugates|mesh-ancestor
92907135|NCT05954104|Calcipotriene|calcipotriene|mesh-list
92907136|NCT05954104|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907137|NCT05951712|Acetylcysteine|acetylcysteine|mesh-list
92907138|NCT05951712|Simethicone|simethicone|mesh-list
92907139|NCT05951712|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92907140|NCT05951712|Antiviral Agents|antiviral agents|mesh-ancestor
92907141|NCT05951712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907142|NCT05951712|Expectorants|expectorants|mesh-ancestor
92907143|NCT05951712|Respiratory System Agents|respiratory system agents|mesh-ancestor
92907144|NCT05951712|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92907145|NCT05951712|Antioxidants|antioxidants|mesh-ancestor
92907146|NCT05951712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907147|NCT05951712|Protective Agents|protective agents|mesh-ancestor
92907148|NCT05951712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907149|NCT05951712|Antidotes|antidotes|mesh-ancestor
92907150|NCT05951712|Antifoaming Agents|antifoaming agents|mesh-ancestor
92907151|NCT05951712|Emollients|emollients|mesh-ancestor
92907152|NCT05951712|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907153|NCT05951595|Artesunate|artesunate|mesh-list
92907154|NCT05951595|Lumefantrine|lumefantrine|mesh-list
92907155|NCT05951595|Artemether|artemether|mesh-list
92907156|NCT05951595|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92907157|NCT05951595|Amodiaquine|amodiaquine|mesh-list
92907158|NCT05951595|Antimalarials|antimalarials|mesh-ancestor
92907159|NCT05951595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92907160|NCT05951595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92907161|NCT05951595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907162|NCT05951595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907163|NCT05951595|Antiviral Agents|antiviral agents|mesh-ancestor
92907164|NCT05951595|Schistosomicides|schistosomicides|mesh-ancestor
92907165|NCT05951595|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92907166|NCT05951595|Anthelmintics|anthelmintics|mesh-ancestor
92907167|NCT05947851|Rituximab|rituximab|mesh-list
92907168|NCT05947851|Venetoclax|venetoclax|mesh-list
92907169|NCT05947851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907170|NCT05947851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907171|NCT05947851|Immunologic Factors|immunologic factors|mesh-ancestor
92907172|NCT05947851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907173|NCT05947851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92907174|NCT05947448|Nifedipine|nifedipine|mesh-list
92907175|NCT05947448|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92907176|NCT05947448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907177|NCT05947448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92907178|NCT05947448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907179|NCT05947448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92907180|NCT05947448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907181|NCT05947448|Vasodilator Agents|vasodilator agents|mesh-ancestor
92907182|NCT05947448|Tocolytic Agents|tocolytic agents|mesh-ancestor
92907183|NCT05947448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92907184|NCT05947448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92907185|NCT05947448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92907186|NCT05945485|Vaccines|vaccines|mesh-list
92907187|NCT05945485|Immunologic Factors|immunologic factors|mesh-ancestor
92907188|NCT05945485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907189|NCT05941715|Aflibercept|aflibercept|mesh-list
92907190|NCT05941715|Faricimab|faricimab|mesh-list
92907191|NCT05941715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92907192|NCT05941715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92907193|NCT05941715|Growth Substances|growth substances|mesh-ancestor
92907194|NCT05941715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907195|NCT05941715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92907196|NCT05941715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907197|NCT05936203|Insulin|insulin|mesh-list
92907198|NCT05936203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92907199|NCT05936203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907200|NCT05929157|Artesunate|artesunate|mesh-list
92907201|NCT05929157|Pyronaridine|pyronaridine|mesh-list
92907202|NCT05929157|Antimalarials|antimalarials|mesh-ancestor
92907203|NCT05929157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92907204|NCT05929157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92907205|NCT05929157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907206|NCT05929157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907207|NCT05929157|Antiviral Agents|antiviral agents|mesh-ancestor
92907208|NCT05929157|Schistosomicides|schistosomicides|mesh-ancestor
92907209|NCT05929157|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92907210|NCT05929157|Anthelmintics|anthelmintics|mesh-ancestor
92907211|NCT05904743|Insulin|insulin|mesh-list
92907212|NCT05904743|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92907213|NCT05904743|Insulin, Short-Acting|insulin, short-acting|mesh-list
92907214|NCT05904743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92907215|NCT05904743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907216|NCT05886582|Rotigotine|rotigotine|mesh-list
92907217|NCT05886582|Dopamine Agonists|dopamine agonists|mesh-ancestor
92907218|NCT05886582|Dopamine Agents|dopamine agents|mesh-ancestor
92907219|NCT05886582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907220|NCT05886582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907221|NCT05886582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907222|NCT05884528|Botulinum Toxins|botulinum toxins|mesh-list
92907223|NCT05884528|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92907224|NCT05884528|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92907225|NCT05884528|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92907226|NCT05884528|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92907227|NCT05884528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907228|NCT05884528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907229|NCT05884528|Cholinergic Agents|cholinergic agents|mesh-ancestor
92907230|NCT05884528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907231|NCT05884528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907232|NCT05884528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92907233|NCT05884528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907234|NCT05868577|Anesthetics|anesthetics|mesh-list
92907235|NCT05868577|Anesthetics, Local|anesthetics, local|mesh-list
92907236|NCT05868577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907237|NCT05868577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907238|NCT05868577|Sensory System Agents|sensory system agents|mesh-ancestor
92907239|NCT05868577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907240|NCT05861167|Ustekinumab|ustekinumab|mesh-list
92907241|NCT05861167|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907242|NCT05840211|Paclitaxel|paclitaxel|mesh-list
92907243|NCT05840211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92907244|NCT05840211|Capecitabine|capecitabine|mesh-list
92907245|NCT05840211|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92907246|NCT05840211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907247|NCT05840211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907248|NCT05840211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92907249|NCT05840211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92907250|NCT05840211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907251|NCT05840211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907252|NCT05840211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907254|NCT05840211|Immunoconjugates|immunoconjugates|mesh-ancestor
92907255|NCT05840211|Immunologic Factors|immunologic factors|mesh-ancestor
92907256|NCT05840211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907257|NCT05828459|Paclitaxel|paclitaxel|mesh-list
92907258|NCT05828459|Bevacizumab|bevacizumab|mesh-list
92907259|NCT05828459|Lenalidomide|lenalidomide|mesh-list
92907260|NCT05828459|Pomalidomide|pomalidomide|mesh-list
92907261|NCT05828459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907262|NCT05828459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907263|NCT05828459|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552731|NCT00060255|Cyclophosphamide|cyclophosphamide|mesh-list
92907264|NCT05828459|Antimitotic Agents|antimitotic agents|mesh-ancestor
92907265|NCT05828459|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907266|NCT05828459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907267|NCT05828459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907268|NCT05828459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92907269|NCT05828459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92907270|NCT05828459|Growth Substances|growth substances|mesh-ancestor
92907271|NCT05828459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907272|NCT05828459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92907273|NCT05828459|Immunologic Factors|immunologic factors|mesh-ancestor
92907274|NCT05820763|Dexamethasone|dexamethasone|mesh-list
92907275|NCT05820763|Lenalidomide|lenalidomide|mesh-list
92907276|NCT05820763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907277|NCT05820763|Antiemetics|antiemetics|mesh-ancestor
92907278|NCT05820763|Autonomic Agents|autonomic agents|mesh-ancestor
92907279|NCT05820763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907280|NCT05820763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907281|NCT05820763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907282|NCT05820763|Glucocorticoids|glucocorticoids|mesh-ancestor
92907283|NCT05820763|Hormones|hormones|mesh-ancestor
92907284|NCT05820763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907285|NCT05820763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907286|NCT05820763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907287|NCT05820763|Immunologic Factors|immunologic factors|mesh-ancestor
92907288|NCT05820763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92907289|NCT05820763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92907290|NCT05820763|Growth Substances|growth substances|mesh-ancestor
92907291|NCT05820763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92907292|NCT05819619|Ibuprofen|ibuprofen|mesh-list
92907293|NCT05819619|Ondansetron|ondansetron|mesh-list
92907294|NCT05819619|Misoprostol|misoprostol|mesh-list
92907295|NCT05819619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92907296|NCT05819619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92907297|NCT05819619|Analgesics|analgesics|mesh-ancestor
92907298|NCT05819619|Sensory System Agents|sensory system agents|mesh-ancestor
92907299|NCT05819619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907300|NCT05819619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907301|NCT05819619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907302|NCT05819619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92907303|NCT05819619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92907304|NCT05819619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907305|NCT05819619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907306|NCT05819619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92907307|NCT05819619|Abortifacient Agents|abortifacient agents|mesh-ancestor
92907308|NCT05819619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92907309|NCT05819619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92907310|NCT05819619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907311|NCT05819619|Oxytocics|oxytocics|mesh-ancestor
92907312|NCT05819619|Antiemetics|antiemetics|mesh-ancestor
92907313|NCT05819619|Autonomic Agents|autonomic agents|mesh-ancestor
92907314|NCT05819619|Antipruritics|antipruritics|mesh-ancestor
92907315|NCT05819619|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907316|NCT05819619|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92907317|NCT05819619|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92907318|NCT05819619|Serotonin Agents|serotonin agents|mesh-ancestor
92907319|NCT05819619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907320|NCT05809895|Paclitaxel|paclitaxel|mesh-list
92907321|NCT05809895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92907322|NCT05809895|Carboplatin|carboplatin|mesh-list
92907323|NCT05809895|Gemcitabine|gemcitabine|mesh-list
92907324|NCT05809895|Pembrolizumab|pembrolizumab|mesh-list
92907325|NCT05809895|Tislelizumab|tislelizumab|mesh-list
92907326|NCT05809895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907327|NCT05809895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907328|NCT05809895|Tubulin Modulators|tubulin modulators|mesh-ancestor
92907329|NCT05809895|Antimitotic Agents|antimitotic agents|mesh-ancestor
92907330|NCT05809895|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907331|NCT05809895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907332|NCT05809895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907333|NCT05809895|Antimetabolites|antimetabolites|mesh-ancestor
92907334|NCT05809895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907335|NCT05809895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907336|NCT05803382|Capecitabine|capecitabine|mesh-list
92907337|NCT05803382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907338|NCT05803382|Antimetabolites|antimetabolites|mesh-ancestor
92907339|NCT05803382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907340|NCT05803382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907341|NCT05791097|Paclitaxel|paclitaxel|mesh-list
92907342|NCT05791097|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92907343|NCT05791097|Carboplatin|carboplatin|mesh-list
92907344|NCT05791097|Pembrolizumab|pembrolizumab|mesh-list
92907345|NCT05791097|Pemetrexed|pemetrexed|mesh-list
92907346|NCT05791097|Tislelizumab|tislelizumab|mesh-list
92907347|NCT05791097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907348|NCT05791097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907349|NCT05791097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92907350|NCT05791097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92907351|NCT05791097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907352|NCT05791097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907353|NCT05791097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907354|NCT05791097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907355|NCT05791097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907356|NCT05791097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92907357|NCT05791097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92907358|NCT05766501|Islatravir|islatravir|mesh-list
92907359|NCT05766501|Antiviral Agents|antiviral agents|mesh-ancestor
92907360|NCT05766501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907361|NCT05766501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907362|NCT05766501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907363|NCT05766501|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92907364|NCT05766501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92907365|NCT05766501|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92907366|NCT05763823|Letermovir|letermovir|mesh-list
92907367|NCT05763823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92907368|NCT05763823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907369|NCT05763823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907370|NCT05763823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907371|NCT05763823|Antiviral Agents|antiviral agents|mesh-ancestor
92907372|NCT05763823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907373|NCT05745038|Zaleplon|zaleplon|mesh-list
92907374|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
92907375|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92907376|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907377|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907378|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
92907379|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
92907380|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907381|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907382|NCT05740982|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92907383|NCT05740982|Antiviral Agents|antiviral agents|mesh-ancestor
92907384|NCT05740982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907385|NCT05715281|Atezolizumab|atezolizumab|mesh-list
92907386|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92907387|NCT05715281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907388|NCT05715281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907389|NCT05715281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907390|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907391|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
92907392|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907393|NCT05705349|Islatravir|islatravir|mesh-list
92907394|NCT05705349|Antiviral Agents|antiviral agents|mesh-ancestor
92907395|NCT05705349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907397|NCT05705349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907398|NCT05705349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92907399|NCT05705349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92907400|NCT05705349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92907401|NCT05704985|Paclitaxel|paclitaxel|mesh-list
92907402|NCT05704985|Carboplatin|carboplatin|mesh-list
92907403|NCT05704985|Pembrolizumab|pembrolizumab|mesh-list
92907404|NCT05704985|Fluorouracil|fluorouracil|mesh-list
92907405|NCT05704985|Capecitabine|capecitabine|mesh-list
92907406|NCT05704985|Oxaliplatin|oxaliplatin|mesh-list
92907407|NCT05704985|Nivolumab|nivolumab|mesh-list
92907408|NCT05704985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92907409|NCT05704985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907410|NCT05704985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907411|NCT05704985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92907412|NCT05704985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552883|NCT00060684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907413|NCT05704985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907414|NCT05704985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907415|NCT05704985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907416|NCT05704985|Antimetabolites|antimetabolites|mesh-ancestor
92907417|NCT05704985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907418|NCT05704985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162147|NCT01158651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92907419|NCT05704985|Immunologic Factors|immunologic factors|mesh-ancestor
92907420|NCT05704985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907421|NCT05689021|Prednisone|prednisone|mesh-list
92907422|NCT05689021|Cortisone|cortisone|mesh-list
92907423|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
92907424|NCT05689021|Niraparib|niraparib|mesh-list
92907425|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907426|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
92907427|NCT05689021|Hormones|hormones|mesh-ancestor
92907428|NCT05689021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907429|NCT05689021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907430|NCT05689021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907431|NCT05689021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907432|NCT05689021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92907433|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907434|NCT05689021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907435|NCT05689021|Hormone Antagonists|hormone antagonists|mesh-ancestor
92907436|NCT05689021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92907437|NCT05689021|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92907438|NCT05671081|Magnesium Sulfate|magnesium sulfate|mesh-list
92907439|NCT05671081|Dexmedetomidine|dexmedetomidine|mesh-list
92907440|NCT05671081|Analgesics|analgesics|mesh-list
92907441|NCT05671081|Narcotics|narcotics|mesh-list
92907442|NCT05671081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92907443|NCT05671081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907444|NCT05671081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907445|NCT05671081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92907446|NCT05671081|Sensory System Agents|sensory system agents|mesh-ancestor
92907447|NCT05671081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907448|NCT05671081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92907449|NCT05671081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92907450|NCT05671081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92907451|NCT05671081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92907452|NCT05671081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907453|NCT05671081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907454|NCT05671081|Anesthetics|anesthetics|mesh-ancestor
92907455|NCT05671081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92907456|NCT05671081|Anticonvulsants|anticonvulsants|mesh-ancestor
92907457|NCT05671081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92907458|NCT05671081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907459|NCT05671081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92907460|NCT05671081|Tocolytic Agents|tocolytic agents|mesh-ancestor
92907461|NCT05671081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92907462|NCT05664659|Misoprostol|misoprostol|mesh-list
92907463|NCT05664659|Oxytocin|oxytocin|mesh-list
92907464|NCT05664659|Carbetocin|carbetocin|mesh-list
92907465|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
92907466|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92907467|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907468|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92907469|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
92907470|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92907471|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907472|NCT05654623|Fulvestrant|fulvestrant|mesh-list
92907473|NCT05654623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907474|NCT05654623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907475|NCT05654623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92907476|NCT05654623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92907477|NCT05654623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92907478|NCT05654623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907479|NCT05654623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907480|NCT05647551|Lidocaine|lidocaine|mesh-list
92907481|NCT05647551|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92907482|NCT05647551|Anesthetics, Local|anesthetics, local|mesh-ancestor
92907483|NCT05647551|Anesthetics|anesthetics|mesh-ancestor
92907484|NCT05647551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907485|NCT05647551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907486|NCT05647551|Sensory System Agents|sensory system agents|mesh-ancestor
92907487|NCT05647551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907488|NCT05647551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92907489|NCT05647551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92907490|NCT05647551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92907491|NCT05647551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907492|NCT05647551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907493|NCT05647551|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92907494|NCT05647551|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92907495|NCT05647551|Cholinergic Agents|cholinergic agents|mesh-ancestor
92907496|NCT05647551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907497|NCT05631093|Islatravir|islatravir|mesh-list
92907498|NCT05631093|Antiviral Agents|antiviral agents|mesh-ancestor
92907499|NCT05631093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907500|NCT05631093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907501|NCT05631093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907502|NCT05631093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92907503|NCT05631093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92907504|NCT05631093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92907505|NCT05627479|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92907506|NCT05626478|Dexamethasone|dexamethasone|mesh-list
92907507|NCT05626478|Prednisolone|prednisolone|mesh-list
92907508|NCT05626478|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92907509|NCT05626478|Methylprednisolone|methylprednisolone|mesh-list
92907510|NCT05626478|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92907511|NCT05626478|Prednisolone acetate|prednisolone acetate|mesh-list
92907512|NCT05626478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92907513|NCT05626478|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92907514|NCT05626478|Prednisolone phosphate|prednisolone phosphate|mesh-list
92907515|NCT05626478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907516|NCT05626478|Antiemetics|antiemetics|mesh-ancestor
92907517|NCT05626478|Autonomic Agents|autonomic agents|mesh-ancestor
92907518|NCT05626478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907519|NCT05626478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907520|NCT05626478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907521|NCT05626478|Glucocorticoids|glucocorticoids|mesh-ancestor
92907522|NCT05626478|Hormones|hormones|mesh-ancestor
92907523|NCT05626478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907524|NCT05626478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907525|NCT05626478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907526|NCT05626478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92907527|NCT05626478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92907528|NCT05626478|Protective Agents|protective agents|mesh-ancestor
92907529|NCT05619172|Cetuximab|cetuximab|mesh-list
92907530|NCT05619172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907531|NCT05619172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907532|NCT05600309|Pembrolizumab|pembrolizumab|mesh-list
92907533|NCT05600309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907534|NCT05600309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907535|NCT05600309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907536|NCT05600309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907537|NCT05591144|Prednisone|prednisone|mesh-list
92907538|NCT05591144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907539|NCT05591144|Glucocorticoids|glucocorticoids|mesh-ancestor
92907540|NCT05591144|Hormones|hormones|mesh-ancestor
92907541|NCT05591144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907542|NCT05591144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907543|NCT05591144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907544|NCT05591144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907545|NCT05589597|Nivolumab|nivolumab|mesh-list
92907546|NCT05589597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907547|NCT05589597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907548|NCT05589597|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907549|NCT05589597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907550|NCT05556265|Deucravacitinib|deucravacitinib|mesh-list
92907551|NCT05556265|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907552|NCT05556265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92907553|NCT05556265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907554|NCT05556265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907555|NCT05554380|Paclitaxel|paclitaxel|mesh-list
92907556|NCT05554380|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92907557|NCT05554380|Ipatasertib|ipatasertib|mesh-list
92907558|NCT05554380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907559|NCT05554380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907560|NCT05554380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553041|NCT00033449|Gefitinib|gefitinib|mesh-list
92907562|NCT05554380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907563|NCT05554380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907564|NCT05554380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92907565|NCT05554380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907566|NCT05554354|Fulvestrant|fulvestrant|mesh-list
92907567|NCT05554354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907568|NCT05554354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907569|NCT05554354|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92907570|NCT05554354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92907571|NCT05554354|Hormone Antagonists|hormone antagonists|mesh-ancestor
92907572|NCT05554354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907573|NCT05554354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907574|NCT05554328|Olaparib|olaparib|mesh-list
92907575|NCT05554328|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92907576|NCT05554328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907577|NCT05554328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907578|NCT05554328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907579|NCT05538897|Megestrol|megestrol|mesh-list
92907580|NCT05538897|Megestrol Acetate|megestrol acetate|mesh-list
92907581|NCT05538897|Ipatasertib|ipatasertib|mesh-list
92907582|NCT05538897|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92907583|NCT05538897|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92907584|NCT05538897|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92907585|NCT05538897|Contraceptive Agents|contraceptive agents|mesh-ancestor
92907586|NCT05538897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92907587|NCT05538897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907588|NCT05538897|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92907589|NCT05538897|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92907590|NCT05538897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907591|NCT05538897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907592|NCT05538897|Appetite Stimulants|appetite stimulants|mesh-ancestor
92907593|NCT05538897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92907594|NCT05538897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92907595|NCT05538897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907596|NCT05538897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907597|NCT05493371|Empagliflozin|empagliflozin|mesh-list
92907598|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92907599|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907600|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92907601|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907602|NCT05490680|Sildenafil Citrate|sildenafil citrate|mesh-list
92907603|NCT05490680|Vasodilator Agents|vasodilator agents|mesh-ancestor
92907604|NCT05490680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92907605|NCT05490680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92907606|NCT05490680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907607|NCT05490680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907608|NCT05490680|Urological Agents|urological agents|mesh-ancestor
92907609|NCT05487755|Tadalafil|tadalafil|mesh-list
92907610|NCT05487755|Pentoxifylline|pentoxifylline|mesh-list
92907611|NCT05487755|Vasodilator Agents|vasodilator agents|mesh-ancestor
92907612|NCT05487755|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92907613|NCT05487755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92907614|NCT05487755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907615|NCT05487755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907616|NCT05487755|Urological Agents|urological agents|mesh-ancestor
92907617|NCT05487755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92907618|NCT05487755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92907619|NCT05487755|Protective Agents|protective agents|mesh-ancestor
92907620|NCT05487755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907621|NCT05487755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92907622|NCT05487755|Antioxidants|antioxidants|mesh-ancestor
92907623|NCT05481645|Paclitaxel|paclitaxel|mesh-list
92907624|NCT05481645|Docetaxel|docetaxel|mesh-list
92907625|NCT05481645|Carboplatin|carboplatin|mesh-list
92907626|NCT05481645|Gemcitabine|gemcitabine|mesh-list
92907627|NCT05481645|Doxorubicin|doxorubicin|mesh-list
92907628|NCT05481645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92907629|NCT05481645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907630|NCT05481645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907631|NCT05481645|Tubulin Modulators|tubulin modulators|mesh-ancestor
92907632|NCT05481645|Antimitotic Agents|antimitotic agents|mesh-ancestor
92907633|NCT05481645|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907634|NCT05481645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907635|NCT05481645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907636|NCT05481645|Antimetabolites|antimetabolites|mesh-ancestor
92907637|NCT05481645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92907638|NCT05481645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92907639|NCT05481645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92907640|NCT05481645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907641|NCT05480800|Vaccines|vaccines|mesh-list
92907642|NCT05480800|Immunologic Factors|immunologic factors|mesh-ancestor
92907643|NCT05480800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907644|NCT05478837|Cyclophosphamide|cyclophosphamide|mesh-list
92907645|NCT05478837|Fludarabine|fludarabine|mesh-list
92907646|NCT05478837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92907647|NCT05478837|Immunologic Factors|immunologic factors|mesh-ancestor
92907648|NCT05478837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907649|NCT05478837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92907650|NCT05478837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92907651|NCT05478837|Alkylating Agents|alkylating agents|mesh-ancestor
92907652|NCT05478837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907653|NCT05478837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907654|NCT05478837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92907655|NCT05461053|Lidocaine|lidocaine|mesh-list
92907656|NCT05461053|Anesthetics, Local|anesthetics, local|mesh-ancestor
92907657|NCT05461053|Anesthetics|anesthetics|mesh-ancestor
92907658|NCT05461053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907659|NCT05461053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907660|NCT05461053|Sensory System Agents|sensory system agents|mesh-ancestor
92907661|NCT05461053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907662|NCT05461053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92907663|NCT05461053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92907664|NCT05461053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92907665|NCT05461053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907666|NCT05461053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907667|NCT05413018|Azacitidine|azacitidine|mesh-list
92907669|NCT05413018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907670|NCT05413018|Antimetabolites|antimetabolites|mesh-ancestor
92907671|NCT05413018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907672|NCT05413018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907673|NCT05413018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907674|NCT05397652|Tranexamic Acid|tranexamic acid|mesh-list
92907675|NCT05397652|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92907676|NCT05397652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92907677|NCT05397652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907678|NCT05397652|Hemostatics|hemostatics|mesh-ancestor
92907679|NCT05397652|Coagulants|coagulants|mesh-ancestor
92907680|NCT05397405|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92907681|NCT05397405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92907682|NCT05397405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92907683|NCT05397405|Antimetabolites|antimetabolites|mesh-ancestor
92907684|NCT05397405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907685|NCT05397405|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92907686|NCT05397405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92907687|NCT05397405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907688|NCT05397405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92907689|NCT05371600|Midazolam|midazolam|mesh-list
92907690|NCT05371600|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92907691|NCT05371600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92907692|NCT05371600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907693|NCT05371600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907694|NCT05371600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92907695|NCT05371600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92907696|NCT05371600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92907697|NCT05371600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92907698|NCT05371600|Anesthetics, General|anesthetics, general|mesh-ancestor
92907699|NCT05371600|Anesthetics|anesthetics|mesh-ancestor
92907700|NCT05371600|GABA Modulators|gaba modulators|mesh-ancestor
92907701|NCT05371600|GABA Agents|gaba agents|mesh-ancestor
92907702|NCT05371600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907703|NCT05371600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907704|NCT05370911|Psilocybin|psilocybin|mesh-list
92907705|NCT05370911|Hallucinogens|hallucinogens|mesh-ancestor
92907706|NCT05370911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907707|NCT05370911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553183|NCT00034229|Felbamate|felbamate|mesh-list
92907708|NCT05345522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92907709|NCT05345522|Antibodies|antibodies|mesh-list
92907710|NCT05345522|Immunoglobulins|immunoglobulins|mesh-list
92907711|NCT05345522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92907712|NCT05345522|Immunologic Factors|immunologic factors|mesh-ancestor
92907713|NCT05345522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907714|NCT05345522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907715|NCT05342584|Cytarabine|cytarabine|mesh-list
92907716|NCT05342584|Daunorubicin|daunorubicin|mesh-list
92907717|NCT05342584|Venetoclax|venetoclax|mesh-list
92907718|NCT05342584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92907719|NCT05342584|Antimetabolites|antimetabolites|mesh-ancestor
92907720|NCT05342584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907721|NCT05342584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907722|NCT05342584|Antiviral Agents|antiviral agents|mesh-ancestor
92907723|NCT05342584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907724|NCT05342584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92907725|NCT05342584|Immunologic Factors|immunologic factors|mesh-ancestor
92907726|NCT05342584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907727|NCT05342584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92907728|NCT05342584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92907729|NCT05342584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92907730|NCT05342584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907731|NCT05340504|Acetylcysteine|acetylcysteine|mesh-list
92907732|NCT05340504|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92907733|NCT05340504|Antiviral Agents|antiviral agents|mesh-ancestor
92907734|NCT05340504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907735|NCT05340504|Expectorants|expectorants|mesh-ancestor
92907736|NCT05340504|Respiratory System Agents|respiratory system agents|mesh-ancestor
92907737|NCT05340504|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92907738|NCT05340504|Antioxidants|antioxidants|mesh-ancestor
92907739|NCT05340504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907740|NCT05340504|Protective Agents|protective agents|mesh-ancestor
92907741|NCT05340504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907742|NCT05340504|Antidotes|antidotes|mesh-ancestor
92907743|NCT05338658|Pembrolizumab|pembrolizumab|mesh-list
92907744|NCT05338658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907745|NCT05338658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907746|NCT05338658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907747|NCT05338658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907748|NCT05333549|Istradefylline|istradefylline|mesh-list
92907749|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92907750|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92907751|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92907752|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
92907753|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907754|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907755|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907756|NCT05333458|Atezolizumab|atezolizumab|mesh-list
92907757|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92526019|NCT00000464|Sympatholytics|sympatholytics|mesh-ancestor
92907758|NCT05333458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907759|NCT05333458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907760|NCT05333458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907761|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907762|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
92907763|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907764|NCT05323656|Pembrolizumab|pembrolizumab|mesh-list
92907765|NCT05323656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907766|NCT05323656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907767|NCT05323656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907768|NCT05323656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907769|NCT05308446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92907770|NCT05308446|Nivolumab|nivolumab|mesh-list
92907771|NCT05308446|Cetuximab|cetuximab|mesh-list
92907772|NCT05308446|Antibodies|antibodies|mesh-list
92907773|NCT05308446|Immunoglobulins|immunoglobulins|mesh-list
92907774|NCT05308446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92907775|NCT05308446|Immunologic Factors|immunologic factors|mesh-ancestor
92907776|NCT05308446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907777|NCT05308446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907778|NCT05308446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907779|NCT05308446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907780|NCT05278715|Carboplatin|carboplatin|mesh-list
92907781|NCT05278715|Vincristine|vincristine|mesh-list
92553263|NCT00034580|Olanzapine|olanzapine|mesh-list
92907782|NCT05278715|Endostatins|endostatins|mesh-list
92907783|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907784|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92907785|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92907786|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92907787|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92907788|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907789|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92907790|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92907791|NCT05278715|Growth Substances|growth substances|mesh-ancestor
92907792|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907793|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92907794|NCT05262738|Misoprostol|misoprostol|mesh-list
92907795|NCT05262738|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92907796|NCT05262738|Abortifacient Agents|abortifacient agents|mesh-ancestor
92907797|NCT05262738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92907798|NCT05262738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907799|NCT05262738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92907800|NCT05262738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907801|NCT05262738|Oxytocics|oxytocics|mesh-ancestor
92907802|NCT05256719|Abatacept|abatacept|mesh-list
92907803|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907804|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907805|NCT05256719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907806|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907807|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92907808|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
92907809|NCT05256719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907810|NCT05256719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92907811|NCT05244226|Fentanyl|fentanyl|mesh-list
92907812|NCT05244226|Methadone|methadone|mesh-list
92907813|NCT05244226|Hydromorphone|hydromorphone|mesh-list
92907814|NCT05244226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92907815|NCT05244226|Narcotics|narcotics|mesh-ancestor
92907816|NCT05244226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907817|NCT05244226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907818|NCT05244226|Analgesics|analgesics|mesh-ancestor
92907819|NCT05244226|Sensory System Agents|sensory system agents|mesh-ancestor
92907820|NCT05244226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907821|NCT05244226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92907822|NCT05244226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92907823|NCT05244226|Anesthetics, General|anesthetics, general|mesh-ancestor
92907824|NCT05244226|Anesthetics|anesthetics|mesh-ancestor
92907825|NCT05244226|Antitussive Agents|antitussive agents|mesh-ancestor
92907826|NCT05244226|Respiratory System Agents|respiratory system agents|mesh-ancestor
92907827|NCT05232851|Pembrolizumab|pembrolizumab|mesh-list
92907828|NCT05232851|Vaccines|vaccines|mesh-list
92907829|NCT05232851|Immunologic Factors|immunologic factors|mesh-ancestor
92907830|NCT05232851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907831|NCT05232851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907832|NCT05232851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907833|NCT05232851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92907834|NCT05232851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907835|NCT05193019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92907836|NCT05176223|Edetic Acid|edetic acid|mesh-list
92907837|NCT05176223|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92907838|NCT05176223|Chelating Agents|chelating agents|mesh-ancestor
92907839|NCT05176223|Sequestering Agents|sequestering agents|mesh-ancestor
92907840|NCT05176223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907841|NCT05176223|Anticoagulants|anticoagulants|mesh-ancestor
92907842|NCT05176223|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92907843|NCT05176223|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92907844|NCT05157464|Losartan|losartan|mesh-list
92907845|NCT05157464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92907846|NCT05157464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92907847|NCT05157464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92907848|NCT05157464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92907849|NCT05157464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907850|NCT05156385|Antihypertensive Agents|antihypertensive agents|mesh-list
92907851|NCT05152901|Epinephrine|epinephrine|mesh-list
92907852|NCT05152901|Racepinephrine|racepinephrine|mesh-list
92907853|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
92907854|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92553336|NCT00034697|Temozolomide|temozolomide|mesh-list
92907855|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92907856|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
92907857|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907858|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907859|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907860|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92907861|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92907862|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
92907863|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907864|NCT05152901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92907865|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
92907866|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
92907867|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
92907868|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92907869|NCT05141006|Botulinum Toxins|botulinum toxins|mesh-list
92907870|NCT05141006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92907871|NCT05141006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92907872|NCT05141006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92907873|NCT05141006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92907874|NCT05141006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907875|NCT05141006|Cholinergic Agents|cholinergic agents|mesh-ancestor
92907876|NCT05141006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907877|NCT05141006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907878|NCT05141006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92907879|NCT05141006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907880|NCT05133531|Eculizumab|eculizumab|mesh-list
92907881|NCT05133531|Ravulizumab|ravulizumab|mesh-list
92907882|NCT05133531|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92907883|NCT05133531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92907884|NCT05133531|Immunologic Factors|immunologic factors|mesh-ancestor
92907885|NCT05133531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907886|NCT05124210|Sotrovimab|sotrovimab|mesh-list
92907887|NCT05124210|Antiviral Agents|antiviral agents|mesh-ancestor
92907888|NCT05124210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907889|NCT05124080|Deucravacitinib|deucravacitinib|mesh-list
92907890|NCT05124080|Dermatologic Agents|dermatologic agents|mesh-ancestor
92907891|NCT05124080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92907892|NCT05124080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92907893|NCT05124080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907894|NCT05118399|Bupivacaine|bupivacaine|mesh-list
92907895|NCT05118399|Anesthetics, Local|anesthetics, local|mesh-ancestor
92907896|NCT05118399|Anesthetics|anesthetics|mesh-ancestor
92907897|NCT05118399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907898|NCT05118399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907899|NCT05118399|Sensory System Agents|sensory system agents|mesh-ancestor
92907900|NCT05118399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907901|NCT05098938|Acyclovir|acyclovir|mesh-list
92907902|NCT05098938|Antiviral Agents|antiviral agents|mesh-ancestor
92907903|NCT05098938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907904|NCT05074433|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92907905|NCT05074433|Antiviral Agents|antiviral agents|mesh-ancestor
92907906|NCT05074433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92907907|NCT05064319|Gabapentin|gabapentin|mesh-list
92907908|NCT05064319|Analgesics|analgesics|mesh-ancestor
92907909|NCT05064319|Sensory System Agents|sensory system agents|mesh-ancestor
92907910|NCT05064319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907911|NCT05064319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907912|NCT05064319|Anticonvulsants|anticonvulsants|mesh-ancestor
92907913|NCT05064319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92907914|NCT05064319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92907915|NCT05064319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907916|NCT05064319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92907917|NCT05064319|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92907918|NCT05064319|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92907919|NCT05064319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907920|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907921|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
92907922|NCT05063994|Hydrocortisone|hydrocortisone|mesh-list
92907923|NCT05063994|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92907924|NCT05063994|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92907925|NCT05063994|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92907926|NCT05063994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907927|NCT05062044|Folic Acid|folic acid|mesh-list
92907928|NCT05062044|Hematinics|hematinics|mesh-ancestor
92907929|NCT05062044|Vitamin B Complex|vitamin b complex|mesh-ancestor
92907930|NCT05062044|Vitamins|vitamins|mesh-ancestor
92907931|NCT05062044|Micronutrients|micronutrients|mesh-ancestor
92907932|NCT05062044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907933|NCT04973605|Dexamethasone|dexamethasone|mesh-list
92907934|NCT04973605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907935|NCT04973605|Antiemetics|antiemetics|mesh-ancestor
92907936|NCT04973605|Autonomic Agents|autonomic agents|mesh-ancestor
92907937|NCT04973605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907938|NCT04973605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907939|NCT04973605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907940|NCT04973605|Glucocorticoids|glucocorticoids|mesh-ancestor
92907941|NCT04973605|Hormones|hormones|mesh-ancestor
92907942|NCT04973605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92907943|NCT04973605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92907944|NCT04973605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907945|NCT04973163|Midazolam|midazolam|mesh-list
92907946|NCT04973163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92907947|NCT04973163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92907948|NCT04973163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92907949|NCT04973163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907950|NCT04973163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92907951|NCT04973163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92907952|NCT04973163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92907953|NCT04973163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92907954|NCT04973163|Anesthetics, General|anesthetics, general|mesh-ancestor
92907955|NCT04973163|Anesthetics|anesthetics|mesh-ancestor
92907956|NCT04973163|GABA Modulators|gaba modulators|mesh-ancestor
92907957|NCT04973163|GABA Agents|gaba agents|mesh-ancestor
92907958|NCT04973163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907959|NCT04973163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907960|NCT04970355|Erenumab|erenumab|mesh-list
92907961|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92907962|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907963|NCT04970355|Analgesics|analgesics|mesh-ancestor
92907964|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
92907965|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907966|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907967|NCT04952571|Bevacizumab|bevacizumab|mesh-list
92907968|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907969|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907970|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92907971|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92907972|NCT04952571|Growth Substances|growth substances|mesh-ancestor
92907973|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907974|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
92907975|NCT04945733|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92907976|NCT04945733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92907977|NCT04945733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92907978|NCT04940390|Dihydroergotamine|dihydroergotamine|mesh-list
92907979|NCT04940390|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92907980|NCT04940390|Dopamine Agonists|dopamine agonists|mesh-ancestor
92907981|NCT04940390|Dopamine Agents|dopamine agents|mesh-ancestor
92907982|NCT04940390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92907983|NCT04940390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92907984|NCT04940390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907985|NCT04940390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92907986|NCT04940390|Analgesics|analgesics|mesh-ancestor
92907987|NCT04940390|Sensory System Agents|sensory system agents|mesh-ancestor
92907988|NCT04940390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907989|NCT04939142|Dexamethasone|dexamethasone|mesh-list
92907990|NCT04939142|Dexamethasone acetate|dexamethasone acetate|mesh-list
92907991|NCT04939142|Bortezomib|bortezomib|mesh-list
92907992|NCT04939142|BB 1101|bb 1101|mesh-list
92907993|NCT04939142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92907994|NCT04939142|Antiemetics|antiemetics|mesh-ancestor
92907995|NCT04939142|Autonomic Agents|autonomic agents|mesh-ancestor
92907996|NCT04939142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92907997|NCT04939142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92907998|NCT04939142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92907999|NCT04939142|Glucocorticoids|glucocorticoids|mesh-ancestor
92908000|NCT04939142|Hormones|hormones|mesh-ancestor
92908001|NCT04939142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908002|NCT04939142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908003|NCT04939142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908004|NCT04939142|Protease Inhibitors|protease inhibitors|mesh-ancestor
92908005|NCT04939142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908006|NCT04939142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553528|NCT00062556|Niacin|niacin|mesh-list
92908007|NCT04929041|Paclitaxel|paclitaxel|mesh-list
92908008|NCT04929041|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92908009|NCT04929041|Carboplatin|carboplatin|mesh-list
92908010|NCT04929041|Pembrolizumab|pembrolizumab|mesh-list
92908011|NCT04929041|Nivolumab|nivolumab|mesh-list
92908012|NCT04929041|Pemetrexed|pemetrexed|mesh-list
92908013|NCT04929041|Ipilimumab|ipilimumab|mesh-list
92908014|NCT04929041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908015|NCT04929041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908016|NCT04929041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908017|NCT04929041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908018|NCT04929041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92908019|NCT04929041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908020|NCT04929041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908021|NCT04929041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908022|NCT04929041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908023|NCT04929041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92908024|NCT04929041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908025|NCT04909450|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92908026|NCT04909450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92908027|NCT04905693|Treprostinil|treprostinil|mesh-list
92908028|NCT04905693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92908029|NCT04887935|Dapagliflozin|dapagliflozin|mesh-list
92908030|NCT04887935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92908031|NCT04887935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908032|NCT04887935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92908033|NCT04887935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908034|NCT04849416|Pirtobrutinib|pirtobrutinib|mesh-list
92908035|NCT04849416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908036|NCT04849416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908037|NCT04849416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908038|NCT04808843|Dienogest|dienogest|mesh-list
92908039|NCT04808843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92908040|NCT04808843|Contraceptive Agents|contraceptive agents|mesh-ancestor
92908041|NCT04808843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92908042|NCT04808843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908043|NCT04808843|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92908044|NCT04808843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92908045|NCT04808843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92908046|NCT04808843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92908047|NCT04808843|Hormone Antagonists|hormone antagonists|mesh-ancestor
92908048|NCT04808843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908049|NCT04808843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908050|NCT04808843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908052|NCT04776252|Antiviral Agents|antiviral agents|mesh-ancestor
92908053|NCT04776252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908054|NCT04776252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908055|NCT04776252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908056|NCT04776252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92908057|NCT04776252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908058|NCT04776252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92908059|NCT04768023|Vitamin D|vitamin d|mesh-list
92908060|NCT04768023|Vitamins|vitamins|mesh-ancestor
92908061|NCT04768023|Micronutrients|micronutrients|mesh-ancestor
92908062|NCT04768023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908063|NCT04768023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92908064|NCT04767984|Calcium, Dietary|calcium, dietary|mesh-list
92908065|NCT04767984|Atorvastatin|atorvastatin|mesh-list
92908066|NCT04767984|Calcium|calcium|mesh-list
92908067|NCT04767984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92908068|NCT04767984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908069|NCT04767984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92908070|NCT04767984|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92162160|NCT03262103|Poly I-C|poly i-c|mesh-list
92908071|NCT04767984|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92908072|NCT04767984|Antimetabolites|antimetabolites|mesh-ancestor
92908073|NCT04767984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908074|NCT04767984|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92908075|NCT04767984|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92908076|NCT04767984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908077|NCT04760288|Pralsetinib|pralsetinib|mesh-list
92908078|NCT04760288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553566|NCT00062595|Vitamin K 1|vitamin k 1|mesh-list
92908079|NCT04722354|Abscisic Acid|abscisic acid|mesh-list
92908080|NCT04722354|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92908081|NCT04722354|Growth Substances|growth substances|mesh-ancestor
92908082|NCT04722354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908083|NCT04721977|Capecitabine|capecitabine|mesh-list
92908084|NCT04721977|Trastuzumab|trastuzumab|mesh-list
92908086|NCT04721977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908087|NCT04721977|Antimetabolites|antimetabolites|mesh-ancestor
92908088|NCT04721977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908089|NCT04721977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908090|NCT04721977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908091|NCT04721977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908092|NCT04721977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908093|NCT04665570|Metformin|metformin|mesh-list
92908094|NCT04665570|Acarbose|acarbose|mesh-list
92908095|NCT04665570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92908096|NCT04665570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908097|NCT04665570|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92908098|NCT04665570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908099|NCT04665570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908100|NCT04657302|Obinutuzumab|obinutuzumab|mesh-list
92908101|NCT04657302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908102|NCT04657302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908103|NCT04628767|Cisplatin|cisplatin|mesh-list
92908104|NCT04628767|Gemcitabine|gemcitabine|mesh-list
92908105|NCT04628767|Doxorubicin|doxorubicin|mesh-list
92908106|NCT04628767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92908107|NCT04628767|Methotrexate|methotrexate|mesh-list
92908108|NCT04628767|Durvalumab|durvalumab|mesh-list
92908109|NCT04628767|Vinblastine|vinblastine|mesh-list
92908110|NCT04628767|Lenograstim|lenograstim|mesh-list
92908111|NCT04628767|Immunoglobulins|immunoglobulins|mesh-list
92908112|NCT04628767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908113|NCT04628767|Immunoglobulin G|immunoglobulin g|mesh-list
92908114|NCT04628767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908115|NCT04628767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908116|NCT04628767|Antimetabolites|antimetabolites|mesh-ancestor
92908117|NCT04628767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908118|NCT04628767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92908119|NCT04628767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92908120|NCT04628767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908121|NCT04628767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908122|NCT04628767|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92908123|NCT04628767|Abortifacient Agents|abortifacient agents|mesh-ancestor
92908124|NCT04628767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92908125|NCT04628767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908126|NCT04628767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92908127|NCT04628767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92908128|NCT04628767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908129|NCT04628767|Immunologic Factors|immunologic factors|mesh-ancestor
92908130|NCT04628767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92908131|NCT04628767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908132|NCT04628767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92908133|NCT04628767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908134|NCT04628767|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908135|NCT04628767|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908136|NCT04628767|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908137|NCT04628767|Mitosis Modulators|mitosis modulators|mesh-ancestor
92908138|NCT04624204|Pembrolizumab|pembrolizumab|mesh-list
92908139|NCT04624204|Etoposide|etoposide|mesh-list
92908140|NCT04624204|Olaparib|olaparib|mesh-list
92908141|NCT04624204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908142|NCT04624204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908143|NCT04624204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908144|NCT04624204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908145|NCT04624204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908146|NCT04624204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92908147|NCT04624204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908148|NCT04624204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908149|NCT04624204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92908150|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92908151|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908152|NCT04607954|Durvalumab|durvalumab|mesh-list
92908153|NCT04607954|Immunoglobulins|immunoglobulins|mesh-list
92908154|NCT04607954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908155|NCT04607954|Immunoglobulin G|immunoglobulin g|mesh-list
92908156|NCT04607954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908157|NCT04607954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908158|NCT04607954|Immunologic Factors|immunologic factors|mesh-ancestor
92908159|NCT04607954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908160|NCT04597125|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92908161|NCT04597125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908162|NCT04587427|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92908163|NCT04587427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908164|NCT04585841|Cannabidiol|cannabidiol|mesh-list
92908165|NCT04585841|Anticonvulsants|anticonvulsants|mesh-ancestor
92908166|NCT04583007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908167|NCT04583007|Immunologic Factors|immunologic factors|mesh-ancestor
92908168|NCT04583007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908169|NCT04576091|Pembrolizumab|pembrolizumab|mesh-list
92908170|NCT04576091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908171|NCT04576091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908172|NCT04576091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908173|NCT04576091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908174|NCT04565236|Factor VIII|factor viii|mesh-list
92908175|NCT04565236|Coagulants|coagulants|mesh-ancestor
92908176|NCT04557020|Gemcitabine|gemcitabine|mesh-list
92908177|NCT04557020|Antibodies|antibodies|mesh-list
92908178|NCT04557020|Immunologic Factors|immunologic factors|mesh-ancestor
92908179|NCT04557020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908180|NCT04557020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908181|NCT04557020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908182|NCT04557020|Antimetabolites|antimetabolites|mesh-ancestor
92908183|NCT04557020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908184|NCT04541017|Mogamulizumab|mogamulizumab|mesh-list
92908185|NCT04541017|Magrolimab|magrolimab|mesh-list
92908186|NCT04541017|Immunoglobulins|immunoglobulins|mesh-list
92908187|NCT04541017|Immunoglobulin G|immunoglobulin g|mesh-list
92908188|NCT04541017|Immunologic Factors|immunologic factors|mesh-ancestor
92908189|NCT04541017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908190|NCT04541017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908191|NCT04541017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908192|NCT04533750|Peposertib|peposertib|mesh-list
92908193|NCT04533750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908194|NCT04533750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908195|NCT04533750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908196|NCT04525014|Irinotecan|irinotecan|mesh-list
92908197|NCT04525014|Temozolomide|temozolomide|mesh-list
92908198|NCT04525014|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92908199|NCT04525014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908200|NCT04525014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908201|NCT04525014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908202|NCT04525014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908203|NCT04525014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92908205|NCT04521361|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92908206|NCT04521361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908207|NCT04521140|Dexamethasone|dexamethasone|mesh-list
92908208|NCT04521140|Prednisolone|prednisolone|mesh-list
92908209|NCT04521140|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92908210|NCT04521140|Methylprednisolone|methylprednisolone|mesh-list
92908211|NCT04521140|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92908212|NCT04521140|Prednisolone acetate|prednisolone acetate|mesh-list
92908213|NCT04521140|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92908214|NCT04521140|Prednisolone phosphate|prednisolone phosphate|mesh-list
92908215|NCT04521140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908216|NCT04521140|Antiemetics|antiemetics|mesh-ancestor
92908217|NCT04521140|Autonomic Agents|autonomic agents|mesh-ancestor
92908218|NCT04521140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908219|NCT04521140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908220|NCT04521140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92908221|NCT04521140|Glucocorticoids|glucocorticoids|mesh-ancestor
92908222|NCT04521140|Hormones|hormones|mesh-ancestor
92908223|NCT04521140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908224|NCT04521140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908225|NCT04521140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908226|NCT04521140|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92908227|NCT04521140|Protective Agents|protective agents|mesh-ancestor
92908228|NCT04512235|Dexamethasone|dexamethasone|mesh-list
92908229|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
92908230|NCT04512235|Bortezomib|bortezomib|mesh-list
92908231|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908232|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
92553709|NCT00036374|Infliximab|infliximab|mesh-list
92908233|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908234|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92908235|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92908236|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
92908237|NCT04512235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908238|NCT04512235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908239|NCT04512235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92908240|NCT04512235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908242|NCT04512235|Autonomic Agents|autonomic agents|mesh-ancestor
92908243|NCT04512235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908244|NCT04512235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92908245|NCT04512235|Glucocorticoids|glucocorticoids|mesh-ancestor
92908246|NCT04512235|Hormones|hormones|mesh-ancestor
92908247|NCT04512235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908248|NCT04512235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908249|NCT04507178|Nadroparin|nadroparin|mesh-list
92908250|NCT04507178|Anticoagulants|anticoagulants|mesh-ancestor
92908251|NCT04507178|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92908252|NCT04507178|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92908253|NCT04507178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908254|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
92908255|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908256|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92908257|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908258|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908259|NCT04493853|Hormone Antagonists|hormone antagonists|mesh-ancestor
92908260|NCT04493853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908261|NCT04493853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908262|NCT04493853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92908263|NCT04493060|Niraparib|niraparib|mesh-list
92908264|NCT04493060|Dostarlimab|dostarlimab|mesh-list
92908265|NCT04493060|Immunoglobulins|immunoglobulins|mesh-list
92908266|NCT04493060|Immunoglobulin G|immunoglobulin g|mesh-list
92908267|NCT04493060|Immunologic Factors|immunologic factors|mesh-ancestor
92908268|NCT04493060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908269|NCT04493060|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92908270|NCT04493060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908271|NCT04493060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908272|NCT04493060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908273|NCT04485949|Temozolomide|temozolomide|mesh-list
92908274|NCT04485949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92908275|NCT04485949|Alkylating Agents|alkylating agents|mesh-ancestor
92253118|NCT05946655|Ofloxacin|ofloxacin|mesh-list
92908276|NCT04485949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908277|NCT04485949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908278|NCT04483466|Methotrexate|methotrexate|mesh-list
92908279|NCT04483466|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92908280|NCT04483466|Abortifacient Agents|abortifacient agents|mesh-ancestor
92908281|NCT04483466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92908282|NCT04483466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908283|NCT04483466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908284|NCT04483466|Antimetabolites|antimetabolites|mesh-ancestor
92908285|NCT04483466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908286|NCT04483466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908287|NCT04483466|Dermatologic Agents|dermatologic agents|mesh-ancestor
92908288|NCT04483466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908289|NCT04483466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92908290|NCT04483466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908291|NCT04483466|Immunologic Factors|immunologic factors|mesh-ancestor
92908292|NCT04483466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92908293|NCT04483466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908294|NCT04458259|Axitinib|axitinib|mesh-list
92908295|NCT04458259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908296|NCT04458259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908297|NCT04458259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908298|NCT04458259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908299|NCT04457258|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92908300|NCT04457258|FAPI-46|fapi-46|mesh-list
92908301|NCT04457258|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92908302|NCT04457258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908303|NCT04449861|Durvalumab|durvalumab|mesh-list
92908304|NCT04449861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908305|NCT04449861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908306|NCT04428151|Paclitaxel|paclitaxel|mesh-list
92908307|NCT04428151|Docetaxel|docetaxel|mesh-list
92908308|NCT04428151|Pembrolizumab|pembrolizumab|mesh-list
92908309|NCT04428151|Capecitabine|capecitabine|mesh-list
92908310|NCT04428151|Cetuximab|cetuximab|mesh-list
92908311|NCT04428151|Lenvatinib|lenvatinib|mesh-list
92908312|NCT04428151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908313|NCT04428151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908314|NCT04428151|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908315|NCT04428151|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908316|NCT04428151|Mitosis Modulators|mitosis modulators|mesh-ancestor
92908317|NCT04428151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908318|NCT04428151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908319|NCT04428151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908320|NCT04428151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908321|NCT04428151|Antimetabolites|antimetabolites|mesh-ancestor
92908322|NCT04428151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908323|NCT04428151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908324|NCT04423211|Leuprolide|leuprolide|mesh-list
92908325|NCT04423211|Goserelin|goserelin|mesh-list
92908326|NCT04423211|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92908327|NCT04423211|Tryptophan|tryptophan|mesh-list
92908328|NCT04423211|Relugolix|relugolix|mesh-list
92908329|NCT04423211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908330|NCT04423211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908331|NCT04423211|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92908332|NCT04423211|Fertility Agents|fertility agents|mesh-ancestor
92908333|NCT04423211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92908334|NCT04423211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908335|NCT04423211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908336|NCT04423211|Luteolytic Agents|luteolytic agents|mesh-ancestor
92908337|NCT04423211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92908338|NCT04423211|Contraceptive Agents|contraceptive agents|mesh-ancestor
92908339|NCT04423211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92908340|NCT04423211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92908341|NCT04423211|Antidepressive Agents|antidepressive agents|mesh-ancestor
92908342|NCT04423211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92908343|NCT04423211|Androgen Antagonists|androgen antagonists|mesh-ancestor
92908344|NCT04423211|Hormone Antagonists|hormone antagonists|mesh-ancestor
92908345|NCT04392375|Nifedipine|nifedipine|mesh-list
92908346|NCT04392375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92908347|NCT04392375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92908348|NCT04392375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908349|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92908350|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908351|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
92908352|NCT04392375|Tocolytic Agents|tocolytic agents|mesh-ancestor
92908353|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92908354|NCT04380636|Paclitaxel|paclitaxel|mesh-list
92908355|NCT04380636|Etoposide|etoposide|mesh-list
92908356|NCT04380636|Carboplatin|carboplatin|mesh-list
92908357|NCT04380636|Pembrolizumab|pembrolizumab|mesh-list
92908358|NCT04380636|Pemetrexed|pemetrexed|mesh-list
92908359|NCT04380636|Durvalumab|durvalumab|mesh-list
92908360|NCT04380636|Olaparib|olaparib|mesh-list
92908361|NCT04380636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908362|NCT04380636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908363|NCT04380636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908364|NCT04380636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908365|NCT04380636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92908366|NCT04380636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908367|NCT04380636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908368|NCT04380636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908369|NCT04380636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92908370|NCT04380636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908371|NCT04380636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908372|NCT04380636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92908373|NCT04380636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908374|NCT04380636|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92908375|NCT04336982|Azacitidine|azacitidine|mesh-list
92908376|NCT04336982|Venetoclax|venetoclax|mesh-list
92908377|NCT04336982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908378|NCT04336982|Antimetabolites|antimetabolites|mesh-ancestor
92908379|NCT04336982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908380|NCT04336982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908381|NCT04336982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908382|NCT04314570|Ropivacaine|ropivacaine|mesh-list
92908383|NCT04314570|Anesthetics, Local|anesthetics, local|mesh-ancestor
92908384|NCT04314570|Anesthetics|anesthetics|mesh-ancestor
92908385|NCT04314570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92908386|NCT04314570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908387|NCT04314570|Sensory System Agents|sensory system agents|mesh-ancestor
92908388|NCT04314570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908389|NCT04310007|Paclitaxel|paclitaxel|mesh-list
92908390|NCT04310007|Docetaxel|docetaxel|mesh-list
92908391|NCT04310007|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92908392|NCT04310007|Gemcitabine|gemcitabine|mesh-list
92908393|NCT04310007|Nivolumab|nivolumab|mesh-list
92908394|NCT04310007|Ramucirumab|ramucirumab|mesh-list
92908395|NCT04310007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92908396|NCT04310007|Antibodies|antibodies|mesh-list
92908397|NCT04310007|Immunoglobulins|immunoglobulins|mesh-list
92908398|NCT04310007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908399|NCT04310007|Lexatumumab|lexatumumab|mesh-list
92908400|NCT04310007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908401|NCT04310007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908402|NCT04310007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908403|NCT04310007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908404|NCT04310007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92908405|NCT04310007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908406|NCT04310007|Immunologic Factors|immunologic factors|mesh-ancestor
92908407|NCT04310007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908408|NCT04310007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908409|NCT04310007|Antimetabolites|antimetabolites|mesh-ancestor
92908410|NCT04310007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908411|NCT04278573|Vitamin D|vitamin d|mesh-list
92908412|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
92908413|NCT04278573|Vitamins|vitamins|mesh-ancestor
92908414|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
92908415|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908416|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92908417|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92908418|NCT04252742|Erenumab|erenumab|mesh-list
92908419|NCT04252742|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92908420|NCT04252742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908421|NCT04252742|Analgesics|analgesics|mesh-ancestor
92908422|NCT04252742|Sensory System Agents|sensory system agents|mesh-ancestor
92908423|NCT04252742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908424|NCT04252742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908426|NCT04247542|Ibezapolstat|ibezapolstat|mesh-list
92908427|NCT04247542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92908428|NCT04247542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908429|NCT04247542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908430|NCT04247542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162176|NCT04775225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908431|NCT04247542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908432|NCT04234568|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92908433|NCT04234568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908434|NCT04234568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92908435|NCT04233580|Chlorhexidine|chlorhexidine|mesh-list
92908436|NCT04233580|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92908437|NCT04233580|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92908438|NCT04233580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908439|NCT04233580|Disinfectants|disinfectants|mesh-ancestor
92908440|NCT04233580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92908441|NCT04216290|Cisplatin|cisplatin|mesh-list
92908442|NCT04216290|Gemcitabine|gemcitabine|mesh-list
92908443|NCT04216290|Fluorouracil|fluorouracil|mesh-list
92908444|NCT04216290|Durvalumab|durvalumab|mesh-list
92908445|NCT04216290|Mitomycins|mitomycins|mesh-list
92908446|NCT04216290|Mitomycin|mitomycin|mesh-list
92908447|NCT04216290|Immunoglobulins|immunoglobulins|mesh-list
92908448|NCT04216290|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908449|NCT04216290|Immunoglobulin G|immunoglobulin g|mesh-list
92908450|NCT04216290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908451|NCT04216290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908452|NCT04216290|Antimetabolites|antimetabolites|mesh-ancestor
92908453|NCT04216290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908454|NCT04216290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908455|NCT04216290|Immunologic Factors|immunologic factors|mesh-ancestor
92908456|NCT04216290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908457|NCT04216290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908458|NCT04216290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92908459|NCT04216290|Alkylating Agents|alkylating agents|mesh-ancestor
92908460|NCT04216290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908461|NCT04216290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908462|NCT04201197|Dronabinol|dronabinol|mesh-list
92908463|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
92908464|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908465|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92908466|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92908467|NCT04201197|Analgesics|analgesics|mesh-ancestor
92908468|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
92908469|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908470|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92908471|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92908472|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908473|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908474|NCT04201197|Hormones|hormones|mesh-ancestor
92908475|NCT04201197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908476|NCT04181060|Bevacizumab|bevacizumab|mesh-list
92908477|NCT04181060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92908478|NCT04181060|Osimertinib|osimertinib|mesh-list
92908479|NCT04181060|Endothelial Growth Factors|endothelial growth factors|mesh-list
92908480|NCT04181060|Antibodies|antibodies|mesh-list
92908481|NCT04181060|Immunoglobulins|immunoglobulins|mesh-list
92908482|NCT04181060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908483|NCT04181060|Immunoglobulin G|immunoglobulin g|mesh-list
92908484|NCT04181060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908485|NCT04181060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92908486|NCT04181060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92908487|NCT04181060|Growth Substances|growth substances|mesh-ancestor
92908488|NCT04181060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908489|NCT04181060|Growth Inhibitors|growth inhibitors|mesh-ancestor
92908490|NCT04181060|Immunologic Factors|immunologic factors|mesh-ancestor
92908491|NCT04181060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908492|NCT04181060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908493|NCT04181060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908494|NCT04164082|Gemcitabine|gemcitabine|mesh-list
92908495|NCT04164082|Pembrolizumab|pembrolizumab|mesh-list
92908496|NCT04164082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908497|NCT04164082|Antimetabolites|antimetabolites|mesh-ancestor
92908498|NCT04164082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908500|NCT04164082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908501|NCT04164082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908502|NCT04107740|TA 0910|ta 0910|mesh-list
92908503|NCT04107740|Nootropic Agents|nootropic agents|mesh-ancestor
92908504|NCT04104139|Trifluridine|trifluridine|mesh-list
92908505|NCT04104139|Antimetabolites|antimetabolites|mesh-ancestor
92908506|NCT04104139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908507|NCT04104139|Antiviral Agents|antiviral agents|mesh-ancestor
92908508|NCT04104139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908509|NCT04092283|Paclitaxel|paclitaxel|mesh-list
92908510|NCT04092283|Etoposide|etoposide|mesh-list
92908511|NCT04092283|Podophyllotoxin|podophyllotoxin|mesh-list
92908512|NCT04092283|Cisplatin|cisplatin|mesh-list
92908513|NCT04092283|Carboplatin|carboplatin|mesh-list
92908514|NCT04092283|Pemetrexed|pemetrexed|mesh-list
92908515|NCT04092283|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92908516|NCT04092283|Etoposide phosphate|etoposide phosphate|mesh-list
92908517|NCT04092283|Durvalumab|durvalumab|mesh-list
92908518|NCT04092283|Immunoglobulins|immunoglobulins|mesh-list
92908519|NCT04092283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908520|NCT04092283|Immunoglobulin G|immunoglobulin g|mesh-list
92908521|NCT04092283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908522|NCT04092283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908523|NCT04092283|Tubulin Modulators|tubulin modulators|mesh-ancestor
92908524|NCT04092283|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908525|NCT04092283|Mitosis Modulators|mitosis modulators|mesh-ancestor
92908526|NCT04092283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908527|NCT04092283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92908528|NCT04092283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908529|NCT04092283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908530|NCT04092283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92908531|NCT04092283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908532|NCT04092283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554004|NCT00038012|Carboplatin|carboplatin|mesh-list
92908533|NCT04092283|Immunologic Factors|immunologic factors|mesh-ancestor
92908534|NCT04092283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908535|NCT04092283|Keratolytic Agents|keratolytic agents|mesh-ancestor
92908536|NCT04092283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92908537|NCT04085315|Osimertinib|osimertinib|mesh-list
92908538|NCT04085315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908539|NCT04085315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908540|NCT04085315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908541|NCT04085315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908542|NCT04082520|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92908543|NCT04082520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908544|NCT04082520|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92908545|NCT04071223|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92908546|NCT04071223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908547|NCT04064060|Luspatercept|luspatercept|mesh-list
92908548|NCT04064060|Hematinics|hematinics|mesh-ancestor
92908549|NCT04028050|Carboplatin|carboplatin|mesh-list
92908550|NCT04028050|Etoposide|etoposide|mesh-list
92908551|NCT04028050|Atezolizumab|atezolizumab|mesh-list
92908552|NCT04028050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908553|NCT04028050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92908554|NCT04028050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92908555|NCT04028050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908556|NCT04028050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908557|NCT04028050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908558|NCT04028050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908559|NCT04028050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908560|NCT04022005|Rituximab|rituximab|mesh-list
92908561|NCT04022005|Gemcitabine|gemcitabine|mesh-list
92908562|NCT04022005|Oxaliplatin|oxaliplatin|mesh-list
92908563|NCT04022005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908564|NCT04022005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908565|NCT04022005|Immunologic Factors|immunologic factors|mesh-ancestor
92908566|NCT04022005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908567|NCT04022005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92908568|NCT04022005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908569|NCT04022005|Antimetabolites|antimetabolites|mesh-ancestor
92908570|NCT04022005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908571|NCT04016805|Venetoclax|venetoclax|mesh-list
92908573|NCT04016805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908574|NCT03979885|Nicotine|nicotine|mesh-list
92908575|NCT03979885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92908576|NCT03979885|Autonomic Agents|autonomic agents|mesh-ancestor
92908577|NCT03979885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908578|NCT03979885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908579|NCT03979885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92908580|NCT03979885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92908581|NCT03979885|Cholinergic Agents|cholinergic agents|mesh-ancestor
92908582|NCT03979885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908583|NCT03979885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908584|NCT03972527|Analgesics|analgesics|mesh-list
92908585|NCT03972527|Sensory System Agents|sensory system agents|mesh-ancestor
92908586|NCT03972527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908587|NCT03972527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908588|NCT03969901|Relebactam|relebactam|mesh-list
92908589|NCT03969901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92908590|NCT03969901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908591|NCT03969901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908592|NCT03969901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92908593|NCT03969901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908594|NCT03968393|Rivaroxaban|rivaroxaban|mesh-list
92908595|NCT03968393|Apixaban|apixaban|mesh-list
92908596|NCT03968393|Edoxaban|edoxaban|mesh-list
92908597|NCT03968393|Dabigatran|dabigatran|mesh-list
92908598|NCT03968393|Anticoagulants|anticoagulants|mesh-list
92908599|NCT03968393|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92908600|NCT03968393|Antithrombins|antithrombins|mesh-ancestor
92908601|NCT03968393|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92908602|NCT03968393|Protease Inhibitors|protease inhibitors|mesh-ancestor
92908603|NCT03968393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908604|NCT03968393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908605|NCT03959358|Lenalidomide|lenalidomide|mesh-list
92908606|NCT03959358|Pomalidomide|pomalidomide|mesh-list
92908607|NCT03959358|Immunologic Factors|immunologic factors|mesh-ancestor
92908608|NCT03959358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554100|NCT00398814|Sorafenib|sorafenib|mesh-list
92908609|NCT03959358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92908610|NCT03959358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92908611|NCT03959358|Growth Substances|growth substances|mesh-ancestor
92908612|NCT03959358|Growth Inhibitors|growth inhibitors|mesh-ancestor
92908613|NCT03959358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908614|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92908615|NCT03941730|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92908616|NCT03941730|Estradiol|estradiol|mesh-list
92908617|NCT03941730|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92908618|NCT03941730|Estrogens|estrogens|mesh-ancestor
92908619|NCT03941730|Hormones|hormones|mesh-ancestor
92908620|NCT03941730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908621|NCT03941730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908622|NCT03941730|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92908623|NCT03941730|Contraceptive Agents|contraceptive agents|mesh-ancestor
92908624|NCT03941730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92908625|NCT03941730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92908626|NCT03939767|Aflibercept|aflibercept|mesh-list
92908627|NCT03939767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92908628|NCT03939767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92908629|NCT03939767|Growth Substances|growth substances|mesh-ancestor
92908630|NCT03939767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908631|NCT03939767|Growth Inhibitors|growth inhibitors|mesh-ancestor
92908632|NCT03939767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908633|NCT03866382|Nivolumab|nivolumab|mesh-list
92908634|NCT03866382|Ipilimumab|ipilimumab|mesh-list
92908635|NCT03866382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908636|NCT03866382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908637|NCT03866382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908638|NCT03866382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908639|NCT03866239|Atezolizumab|atezolizumab|mesh-list
92908640|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
92908641|NCT03866239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908642|NCT03866239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908643|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908644|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908645|NCT03842228|Durvalumab|durvalumab|mesh-list
92908646|NCT03842228|Olaparib|olaparib|mesh-list
92908647|NCT03842228|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92908648|NCT03842228|Immunoglobulins|immunoglobulins|mesh-list
92908649|NCT03842228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908650|NCT03842228|Immunoglobulin G|immunoglobulin g|mesh-list
92908651|NCT03842228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908652|NCT03842228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908653|NCT03842228|Immunologic Factors|immunologic factors|mesh-ancestor
92908654|NCT03842228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908655|NCT03842228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908656|NCT03842228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908657|NCT03811015|Cisplatin|cisplatin|mesh-list
92908658|NCT03811015|Nivolumab|nivolumab|mesh-list
92908659|NCT03811015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908660|NCT03811015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908661|NCT03811015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908662|NCT03811015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908663|NCT03775265|Cisplatin|cisplatin|mesh-list
92908664|NCT03775265|Gemcitabine|gemcitabine|mesh-list
92908665|NCT03775265|Fluorouracil|fluorouracil|mesh-list
92908666|NCT03775265|Atezolizumab|atezolizumab|mesh-list
92908667|NCT03775265|Mitomycins|mitomycins|mesh-list
92908668|NCT03775265|Mitomycin|mitomycin|mesh-list
92908669|NCT03775265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908670|NCT03775265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908671|NCT03775265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908672|NCT03775265|Antimetabolites|antimetabolites|mesh-ancestor
92908673|NCT03775265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908674|NCT03775265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908675|NCT03775265|Immunologic Factors|immunologic factors|mesh-ancestor
92908676|NCT03775265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908677|NCT03775265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908678|NCT03775265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908679|NCT03775265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92908680|NCT03775265|Alkylating Agents|alkylating agents|mesh-ancestor
92908681|NCT03775265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92908682|NCT03775265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908683|NCT03739814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92908684|NCT03739814|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92908685|NCT03739814|Blinatumomab|blinatumomab|mesh-list
92908686|NCT03739814|Antibodies|antibodies|mesh-list
92908687|NCT03739814|Immunoglobulins|immunoglobulins|mesh-list
92908688|NCT03739814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908689|NCT03739814|Muromonab-CD3|muromonab-cd3|mesh-list
92908690|NCT03739814|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92908691|NCT03739814|Immunologic Factors|immunologic factors|mesh-ancestor
92908692|NCT03739814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908693|NCT03739814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908694|NCT03739814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92908695|NCT03739814|Immunotoxins|immunotoxins|mesh-ancestor
92908696|NCT03739814|Immunoconjugates|immunoconjugates|mesh-ancestor
92908697|NCT03739814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908698|NCT03729349|Golimumab|golimumab|mesh-list
92908699|NCT03729349|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92908700|NCT03729349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908701|NCT03729349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908702|NCT03729349|Immunologic Factors|immunologic factors|mesh-ancestor
92908703|NCT03729349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908704|NCT03719768|Avelumab|avelumab|mesh-list
92908705|NCT03719768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908706|NCT03719768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908707|NCT03714308|Aflibercept|aflibercept|mesh-list
92908708|NCT03714308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92908709|NCT03714308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92908710|NCT03714308|Growth Substances|growth substances|mesh-ancestor
92908711|NCT03714308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908712|NCT03714308|Growth Inhibitors|growth inhibitors|mesh-ancestor
92908713|NCT03714308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908714|NCT03713593|Pembrolizumab|pembrolizumab|mesh-list
92908715|NCT03713593|Lenvatinib|lenvatinib|mesh-list
92908716|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908717|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908718|NCT03713593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908719|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908720|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908721|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908722|NCT03702270|Penicillins|penicillins|mesh-list
92908723|NCT03702270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92908724|NCT03702270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908725|NCT03701581|4-Aminopyridine|4-aminopyridine|mesh-list
92908726|NCT03701581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92908727|NCT03701581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92908728|NCT03701581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908729|NCT03687957|Temozolomide|temozolomide|mesh-list
92908730|NCT03687957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92908731|NCT03687957|Alkylating Agents|alkylating agents|mesh-ancestor
92908732|NCT03687957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908733|NCT03687957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908734|NCT03617679|Rucaparib|rucaparib|mesh-list
92908735|NCT03617679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92908736|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908737|NCT03617679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908738|NCT03617679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908739|NCT03598257|Olaparib|olaparib|mesh-list
92908740|NCT03598257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92908741|NCT03598257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908742|NCT03598257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908743|NCT03598257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908744|NCT03580369|Omalizumab|omalizumab|mesh-list
92908745|NCT03580369|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92908746|NCT03580369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92908747|NCT03580369|Respiratory System Agents|respiratory system agents|mesh-ancestor
92908748|NCT03568630|Chrysarobin|chrysarobin|mesh-list
92908749|NCT03568630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92908750|NCT03568630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92908751|NCT03568630|Analgesics|analgesics|mesh-ancestor
92908752|NCT03568630|Sensory System Agents|sensory system agents|mesh-ancestor
92908753|NCT03568630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908754|NCT03568630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908755|NCT03568630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908756|NCT03568630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92908757|NCT03554083|Atezolizumab|atezolizumab|mesh-list
92908758|NCT03554083|Vemurafenib|vemurafenib|mesh-list
92908759|NCT03554083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908760|NCT03554083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908761|NCT03554083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908762|NCT03554083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908763|NCT03554083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908764|NCT03554083|Immunologic Factors|immunologic factors|mesh-ancestor
92162225|NCT04399343|Dexmedetomidine|dexmedetomidine|mesh-list
92908765|NCT03554083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908766|NCT03554083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908767|NCT03554083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908768|NCT03539900|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
92908769|NCT03539900|Naltrexone|naltrexone|mesh-list
92908770|NCT03539900|Bupropion|bupropion|mesh-list
92908771|NCT03539900|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92908772|NCT03539900|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92908773|NCT03539900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908774|NCT03539900|Sensory System Agents|sensory system agents|mesh-ancestor
92908775|NCT03539900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908776|NCT03539900|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92908777|NCT03539900|Antidepressive Agents|antidepressive agents|mesh-ancestor
92908778|NCT03539900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92908779|NCT03539900|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92908780|NCT03539900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92908781|NCT03539900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92908782|NCT03539900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908783|NCT03539900|Dopamine Agents|dopamine agents|mesh-ancestor
92908784|NCT03539900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908785|NCT03539900|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92908786|NCT03539900|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92908787|NCT03539900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908788|NCT03539900|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92908789|NCT03539744|Dexamethasone|dexamethasone|mesh-list
92908790|NCT03539744|Venetoclax|venetoclax|mesh-list
92908791|NCT03539744|Pomalidomide|pomalidomide|mesh-list
92908792|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908793|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
92908794|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
92908795|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908796|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908797|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92908798|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
92908799|NCT03539744|Hormones|hormones|mesh-ancestor
92908800|NCT03539744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908801|NCT03539744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908802|NCT03539744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908803|NCT03539744|Immunologic Factors|immunologic factors|mesh-ancestor
92908804|NCT03539744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92908805|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92908806|NCT03539744|Growth Substances|growth substances|mesh-ancestor
92908807|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
92908808|NCT03526250|Palbociclib|palbociclib|mesh-list
92908809|NCT03526250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908810|NCT03526250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92908811|NCT03526250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908812|NCT03526250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908813|NCT03479476|Metformin|metformin|mesh-list
92908814|NCT03479476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92908815|NCT03479476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908816|NCT03440372|Ozanimod|ozanimod|mesh-list
92908817|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92908818|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908819|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908820|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
92908821|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908822|NCT03412565|Dexamethasone|dexamethasone|mesh-list
92908823|NCT03412565|Prednisone|prednisone|mesh-list
92908824|NCT03412565|Lenalidomide|lenalidomide|mesh-list
92908825|NCT03412565|Bortezomib|bortezomib|mesh-list
92908826|NCT03412565|Melphalan|melphalan|mesh-list
92908827|NCT03412565|Daratumumab|daratumumab|mesh-list
92908828|NCT03412565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908829|NCT03412565|Antiemetics|antiemetics|mesh-ancestor
92908830|NCT03412565|Autonomic Agents|autonomic agents|mesh-ancestor
92908831|NCT03412565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908832|NCT03412565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908833|NCT03412565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92908834|NCT03412565|Glucocorticoids|glucocorticoids|mesh-ancestor
92908835|NCT03412565|Hormones|hormones|mesh-ancestor
92908836|NCT03412565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149556|NCT03358875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92908837|NCT03412565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908838|NCT03412565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908839|NCT03412565|Immunologic Factors|immunologic factors|mesh-ancestor
92908840|NCT03412565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92908841|NCT03412565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92908842|NCT03412565|Growth Substances|growth substances|mesh-ancestor
92908843|NCT03412565|Growth Inhibitors|growth inhibitors|mesh-ancestor
92908844|NCT03412565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92908845|NCT03412565|Alkylating Agents|alkylating agents|mesh-ancestor
92908846|NCT03412565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908847|NCT03412565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92908848|NCT03412565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908849|NCT03399539|Dexamethasone|dexamethasone|mesh-list
92908850|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
92908852|NCT03399539|Ixazomib|ixazomib|mesh-list
92908853|NCT03399539|Ichthammol|ichthammol|mesh-list
92908854|NCT03399539|BB 1101|bb 1101|mesh-list
92908855|NCT03399539|Glycine|glycine|mesh-list
92908856|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92908857|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
92908858|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
92908859|NCT03399539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908860|NCT03399539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908861|NCT03399539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92908862|NCT03399539|Glucocorticoids|glucocorticoids|mesh-ancestor
92908863|NCT03399539|Hormones|hormones|mesh-ancestor
92908864|NCT03399539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908865|NCT03399539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92908866|NCT03399539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908867|NCT03399539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908868|NCT03399539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92908869|NCT03399539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908870|NCT03399539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92908871|NCT03399539|Glycine Agents|glycine agents|mesh-ancestor
92908872|NCT03399539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908873|NCT03374254|Leucovorin|leucovorin|mesh-list
92908874|NCT03374254|Pembrolizumab|pembrolizumab|mesh-list
92908875|NCT03374254|Fluorouracil|fluorouracil|mesh-list
92908876|NCT03374254|Oxaliplatin|oxaliplatin|mesh-list
92908877|NCT03374254|Irinotecan|irinotecan|mesh-list
92908878|NCT03374254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92908879|NCT03374254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908880|NCT03374254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908881|NCT03374254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908882|NCT03374254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908883|NCT03374254|Antimetabolites|antimetabolites|mesh-ancestor
92908884|NCT03374254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908885|NCT03374254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92908886|NCT03374254|Immunologic Factors|immunologic factors|mesh-ancestor
92908887|NCT03374254|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92908888|NCT03374254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92908889|NCT03374254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908890|NCT03374254|Antidotes|antidotes|mesh-ancestor
92908891|NCT03374254|Protective Agents|protective agents|mesh-ancestor
92908892|NCT03374254|Vitamin B Complex|vitamin b complex|mesh-ancestor
92908893|NCT03374254|Vitamins|vitamins|mesh-ancestor
92908894|NCT03374254|Micronutrients|micronutrients|mesh-ancestor
92908895|NCT03358706|Vitamin K|vitamin k|mesh-list
92908896|NCT03358706|Midazolam|midazolam|mesh-list
92908897|NCT03358706|Dextromethorphan|dextromethorphan|mesh-list
92908898|NCT03358706|Caffeine|caffeine|mesh-list
92908899|NCT03358706|Ustekinumab|ustekinumab|mesh-list
92908900|NCT03358706|Omeprazole|omeprazole|mesh-list
92908901|NCT03358706|Warfarin|warfarin|mesh-list
92908902|NCT03358706|Vitamins|vitamins|mesh-ancestor
92908903|NCT03358706|Micronutrients|micronutrients|mesh-ancestor
92908904|NCT03358706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908905|NCT03358706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92908906|NCT03358706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92908907|NCT03358706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92908908|NCT03358706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92908909|NCT03358706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92908910|NCT03358706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92908911|NCT03358706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92908912|NCT03358706|Anesthetics, General|anesthetics, general|mesh-ancestor
92554381|NCT00066417|Fludarabine|fludarabine|mesh-list
92908913|NCT03358706|Anesthetics|anesthetics|mesh-ancestor
92908914|NCT03358706|GABA Modulators|gaba modulators|mesh-ancestor
92908915|NCT03358706|GABA Agents|gaba agents|mesh-ancestor
92908916|NCT03358706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908917|NCT03358706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908918|NCT03358706|Anticoagulants|anticoagulants|mesh-ancestor
92908919|NCT03358706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92908920|NCT03358706|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92908921|NCT03358706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92908922|NCT03358706|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92908923|NCT03358706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92908924|NCT03358706|Purinergic Agents|purinergic agents|mesh-ancestor
92908925|NCT03358706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92908926|NCT03358706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92908927|NCT03358706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92908928|NCT03358706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92908929|NCT03358706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92908930|NCT03358706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92908931|NCT03358706|Hemostatics|hemostatics|mesh-ancestor
92908932|NCT03358706|Coagulants|coagulants|mesh-ancestor
92908933|NCT03358706|Antitussive Agents|antitussive agents|mesh-ancestor
92908934|NCT03358706|Respiratory System Agents|respiratory system agents|mesh-ancestor
92908935|NCT03358706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92908936|NCT03358706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92908937|NCT03338920|Sumatriptan|sumatriptan|mesh-list
92908938|NCT03338920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92908939|NCT03338920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92908940|NCT03338920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92908941|NCT03338920|Serotonin Agents|serotonin agents|mesh-ancestor
92908942|NCT03338920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908943|NCT03338920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908944|NCT03338920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908945|NCT03331289|Dapagliflozin|dapagliflozin|mesh-list
92908947|NCT03331289|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92908948|NCT03331289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908949|NCT03331289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92908950|NCT03331289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908951|NCT03331289|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92908952|NCT03331289|Incretins|incretins|mesh-ancestor
92908953|NCT03331289|Hormones|hormones|mesh-ancestor
92908954|NCT03331289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92908955|NCT03321643|Rituximab|rituximab|mesh-list
92908956|NCT03321643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92908957|NCT03321643|Atezolizumab|atezolizumab|mesh-list
92908958|NCT03321643|Gemcitabine|gemcitabine|mesh-list
92908959|NCT03321643|Oxaliplatin|oxaliplatin|mesh-list
92908960|NCT03321643|Antibodies|antibodies|mesh-list
92908961|NCT03321643|Immunoglobulins|immunoglobulins|mesh-list
92908962|NCT03321643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92908963|NCT03321643|Immunologic Factors|immunologic factors|mesh-ancestor
92908964|NCT03321643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908965|NCT03321643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92908966|NCT03321643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92908967|NCT03321643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92908968|NCT03321643|Antimetabolites|antimetabolites|mesh-ancestor
92908969|NCT03321643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908970|NCT03321643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92908971|NCT03220776|Acetylcysteine|acetylcysteine|mesh-list
92908972|NCT03220776|Gabapentin|gabapentin|mesh-list
92908973|NCT03220776|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92908974|NCT03220776|Analgesics|analgesics|mesh-ancestor
92908975|NCT03220776|Sensory System Agents|sensory system agents|mesh-ancestor
92908976|NCT03220776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92908977|NCT03220776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92908978|NCT03220776|Anticonvulsants|anticonvulsants|mesh-ancestor
92908979|NCT03220776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92908980|NCT03220776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92908981|NCT03220776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92908982|NCT03220776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92908983|NCT03220776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92908984|NCT03220776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92908985|NCT03220776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92908986|NCT03220776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92908987|NCT03220776|Antimanic Agents|antimanic agents|mesh-ancestor
92908988|NCT03220776|Antiviral Agents|antiviral agents|mesh-ancestor
92908989|NCT03220776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92908990|NCT03220776|Expectorants|expectorants|mesh-ancestor
92908991|NCT03220776|Respiratory System Agents|respiratory system agents|mesh-ancestor
92908992|NCT03220776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92908993|NCT03220776|Antioxidants|antioxidants|mesh-ancestor
92908994|NCT03220776|Protective Agents|protective agents|mesh-ancestor
92908995|NCT03220776|Antidotes|antidotes|mesh-ancestor
92908996|NCT03215810|Cyclophosphamide|cyclophosphamide|mesh-list
92908997|NCT03215810|Nivolumab|nivolumab|mesh-list
92908998|NCT03215810|Fludarabine|fludarabine|mesh-list
92908999|NCT03215810|Interleukin-2|interleukin-2|mesh-list
92909000|NCT03215810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909001|NCT03215810|Immunologic Factors|immunologic factors|mesh-ancestor
92909002|NCT03215810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909003|NCT03215810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909004|NCT03215810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909005|NCT03215810|Alkylating Agents|alkylating agents|mesh-ancestor
92909006|NCT03215810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909007|NCT03215810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909008|NCT03215810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92909009|NCT03215810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909010|NCT03215810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909011|NCT03215810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92909012|NCT03215810|Analgesics|analgesics|mesh-ancestor
92909013|NCT03215810|Sensory System Agents|sensory system agents|mesh-ancestor
92909014|NCT03215810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909015|NCT03215693|Ensartinib|ensartinib|mesh-list
92909016|NCT03215693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909017|NCT03215693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909018|NCT03215693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909019|NCT03215693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909020|NCT03126630|Pembrolizumab|pembrolizumab|mesh-list
92909021|NCT03126630|Maytansine|maytansine|mesh-list
92909022|NCT03126630|Anetumab ravtansine|anetumab ravtansine|mesh-list
92909023|NCT03126630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909024|NCT03126630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909025|NCT03126630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162268|NCT04348409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92909026|NCT03126630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909027|NCT03126630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909028|NCT03126630|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909029|NCT03126630|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909030|NCT03126630|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909031|NCT03126630|Immunoconjugates|immunoconjugates|mesh-ancestor
92909032|NCT03126630|Immunologic Factors|immunologic factors|mesh-ancestor
92909033|NCT03126630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909034|NCT03036930|Vaccines|vaccines|mesh-list
92909035|NCT03036930|Immunologic Factors|immunologic factors|mesh-ancestor
92909036|NCT03036930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909037|NCT03032406|Hydroxychloroquine|hydroxychloroquine|mesh-list
92909038|NCT03032406|Everolimus|everolimus|mesh-list
92909039|NCT03032406|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92909040|NCT03032406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909041|NCT03032406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909042|NCT03032406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909043|NCT03032406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909044|NCT03032406|Immunologic Factors|immunologic factors|mesh-ancestor
92909045|NCT03032406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909046|NCT03032406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909047|NCT03032406|Antimalarials|antimalarials|mesh-ancestor
92909048|NCT03032406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92909049|NCT03032406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92909050|NCT03032406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909051|NCT03032406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909052|NCT03008408|Everolimus|everolimus|mesh-list
92909053|NCT03008408|Letrozole|letrozole|mesh-list
92909054|NCT03008408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92909055|NCT03008408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909056|NCT03008408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909057|NCT03008408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909058|NCT03008408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909059|NCT03008408|Immunologic Factors|immunologic factors|mesh-ancestor
92909060|NCT03008408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909061|NCT03008408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909062|NCT03008408|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92909063|NCT03008408|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92909064|NCT03008408|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92909065|NCT03008408|Hormone Antagonists|hormone antagonists|mesh-ancestor
92909066|NCT03008408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909067|NCT02977468|Pembrolizumab|pembrolizumab|mesh-list
92909068|NCT02977468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909069|NCT02977468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909070|NCT02977468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909071|NCT02977468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909072|NCT02967692|Trametinib|trametinib|mesh-list
92909073|NCT02967692|Dabrafenib|dabrafenib|mesh-list
92909074|NCT02967692|Spartalizumab|spartalizumab|mesh-list
92909075|NCT02967692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909076|NCT02967692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909077|NCT02967692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909078|NCT02967692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909079|NCT02967692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909080|NCT02967692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909081|NCT02955355|Immunoglobulins|immunoglobulins|mesh-list
92909082|NCT02955355|Immunologic Factors|immunologic factors|mesh-ancestor
92909083|NCT02955355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909084|NCT02953457|Durvalumab|durvalumab|mesh-list
92909085|NCT02953457|Ipilimumab|ipilimumab|mesh-list
92909086|NCT02953457|Olaparib|olaparib|mesh-list
92909087|NCT02953457|Tremelimumab|tremelimumab|mesh-list
92909088|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92909089|NCT02953457|Immunoglobulins|immunoglobulins|mesh-list
92909090|NCT02953457|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92909091|NCT02953457|Immunoglobulin G|immunoglobulin g|mesh-list
92909092|NCT02953457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909093|NCT02953457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909094|NCT02953457|Immunologic Factors|immunologic factors|mesh-ancestor
92253906|NCT05103696|Propofol|propofol|mesh-list
92909095|NCT02953457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909096|NCT02953457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909097|NCT02953457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909098|NCT02953457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909100|NCT02893917|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92909101|NCT02893917|Cediranib|cediranib|mesh-list
92909102|NCT02893917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909103|NCT02893917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909104|NCT02893917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909105|NCT02893917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909106|NCT02891538|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92909107|NCT02891538|Antioxidants|antioxidants|mesh-ancestor
92909108|NCT02891538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909109|NCT02891538|Protective Agents|protective agents|mesh-ancestor
92909110|NCT02891538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909111|NCT02891538|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92909112|NCT02891538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92909113|NCT02891538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909114|NCT02891538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92909115|NCT02817659|Glucagon|glucagon|mesh-list
92909116|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909117|NCT02817659|Hormones|hormones|mesh-ancestor
92909118|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909119|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909120|NCT02677922|Azacitidine|azacitidine|mesh-list
92909121|NCT02677922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92909122|NCT02677922|Antimetabolites|antimetabolites|mesh-ancestor
92909123|NCT02677922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909124|NCT02677922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909125|NCT02677922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909126|NCT02593175|Paclitaxel|paclitaxel|mesh-list
92909127|NCT02593175|Carboplatin|carboplatin|mesh-list
92909128|NCT02593175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92909129|NCT02593175|Panitumumab|panitumumab|mesh-list
92909130|NCT02593175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92909131|NCT02593175|Antibodies|antibodies|mesh-list
92909132|NCT02593175|Immunoglobulins|immunoglobulins|mesh-list
92909133|NCT02593175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92909134|NCT02593175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909135|NCT02593175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909136|NCT02593175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909137|NCT02593175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909138|NCT02593175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909139|NCT02593175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909140|NCT02593175|Immunologic Factors|immunologic factors|mesh-ancestor
92554620|NCT00396929|Paclitaxel|paclitaxel|mesh-list
92909141|NCT02593175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909143|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
92909144|NCT02565628|Dopamine Agents|dopamine agents|mesh-ancestor
92909145|NCT02565628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909146|NCT02565628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909147|NCT02565628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909148|NCT02535533|Selenium|selenium|mesh-list
92909149|NCT02535533|Axitinib|axitinib|mesh-list
92909150|NCT02535533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909151|NCT02535533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909152|NCT02535533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909153|NCT02535533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909154|NCT02535533|Antioxidants|antioxidants|mesh-ancestor
92909155|NCT02535533|Protective Agents|protective agents|mesh-ancestor
92909156|NCT02535533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909157|NCT02535533|Trace Elements|trace elements|mesh-ancestor
92909158|NCT02535533|Micronutrients|micronutrients|mesh-ancestor
92909159|NCT02520362|Denosumab|denosumab|mesh-list
92909160|NCT02520362|Diphosphonates|diphosphonates|mesh-list
92909161|NCT02520362|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92909162|NCT02520362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909163|NCT02496663|Osimertinib|osimertinib|mesh-list
92909164|NCT02496663|Necitumumab|necitumumab|mesh-list
92909165|NCT02496663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92909166|NCT02496663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909167|NCT02496663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909168|NCT02496663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909169|NCT02496663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909170|NCT02496663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909171|NCT02496663|Immunologic Factors|immunologic factors|mesh-ancestor
92909172|NCT02496663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909173|NCT02496585|Prednisone|prednisone|mesh-list
92909174|NCT02496585|Nintedanib|nintedanib|mesh-list
92909175|NCT02496585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909176|NCT02496585|Glucocorticoids|glucocorticoids|mesh-ancestor
92909177|NCT02496585|Hormones|hormones|mesh-ancestor
92909178|NCT02496585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909179|NCT02496585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909180|NCT02496585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92909181|NCT02496585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909182|NCT02496585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909183|NCT02496585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909184|NCT02496585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909185|NCT02486640|Interferons|interferons|mesh-list
92909186|NCT02486640|Interferon-beta|interferon-beta|mesh-list
92909187|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
92909188|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909189|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
92909190|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909191|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
92909192|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909193|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92909194|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
92909195|NCT02344355|Temozolomide|temozolomide|mesh-list
92909196|NCT02344355|Vitamins|vitamins|mesh-ancestor
92909197|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
92909198|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909199|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909200|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
92909201|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909202|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909203|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
92909204|NCT02344355|Protective Agents|protective agents|mesh-ancestor
92909205|NCT02339571|Nivolumab|nivolumab|mesh-list
92909206|NCT02339571|Ipilimumab|ipilimumab|mesh-list
92909207|NCT02339571|Sargramostim|sargramostim|mesh-list
92909208|NCT02339571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909209|NCT02339571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909210|NCT02339571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909211|NCT02339571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909212|NCT02339571|Immunologic Factors|immunologic factors|mesh-ancestor
92909213|NCT02339571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909214|NCT02330991|Temozolomide|temozolomide|mesh-list
92909215|NCT02330991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909216|NCT02330991|Alkylating Agents|alkylating agents|mesh-ancestor
92554693|NCT00067431|Valproic Acid|valproic acid|mesh-list
92909217|NCT02330991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909218|NCT02330991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909220|NCT02307812|Ramucirumab|ramucirumab|mesh-list
92909221|NCT02307812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909222|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909223|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909224|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909225|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909226|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909227|NCT02117791|Riociguat|riociguat|mesh-list
92909228|NCT02117791|Enzyme Activators|enzyme activators|mesh-ancestor
92909229|NCT02117791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909230|NCT02105766|Sirolimus|sirolimus|mesh-list
92909231|NCT02105766|Cyclophosphamide|cyclophosphamide|mesh-list
92909232|NCT02105766|Alemtuzumab|alemtuzumab|mesh-list
92909233|NCT02105766|Pentostatin|pentostatin|mesh-list
92909234|NCT02105766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909235|NCT02105766|Immunologic Factors|immunologic factors|mesh-ancestor
92909236|NCT02105766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909237|NCT02105766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909238|NCT02105766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909239|NCT02105766|Alkylating Agents|alkylating agents|mesh-ancestor
92909240|NCT02105766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909241|NCT02105766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909242|NCT02105766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92909243|NCT02105766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909244|NCT02105766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909245|NCT02105766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92909246|NCT02105766|Antifungal Agents|antifungal agents|mesh-ancestor
92909247|NCT02105766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909248|NCT02105766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909249|NCT02105766|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92909250|NCT02085148|Irinotecan|irinotecan|mesh-list
92909251|NCT02085148|Vincristine|vincristine|mesh-list
92909252|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92909253|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909254|NCT02085148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909255|NCT02085148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909256|NCT02085148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909257|NCT02085148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909258|NCT02085148|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909259|NCT02085148|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909260|NCT02085148|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909261|NCT02065765|Ramucirumab|ramucirumab|mesh-list
92909262|NCT02065765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909263|NCT01585805|Cisplatin|cisplatin|mesh-list
92909264|NCT01585805|Gemcitabine|gemcitabine|mesh-list
92909265|NCT01585805|Veliparib|veliparib|mesh-list
92909266|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909267|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92909268|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
92909269|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909270|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92909271|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909272|NCT01582737|Rivaroxaban|rivaroxaban|mesh-list
92909273|NCT01582737|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92909274|NCT01582737|Antithrombins|antithrombins|mesh-ancestor
92909275|NCT01582737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92909276|NCT01582737|Protease Inhibitors|protease inhibitors|mesh-ancestor
92909277|NCT01582737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909278|NCT01582737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909279|NCT01582737|Anticoagulants|anticoagulants|mesh-ancestor
92909280|NCT01321567|Rabeprazole|rabeprazole|mesh-list
92909281|NCT01321567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92909282|NCT01321567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909283|NCT01321567|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92909284|NCT01321567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909285|NCT01321567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909286|NCT01290445|Varenicline|varenicline|mesh-list
92909287|NCT01290445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92909288|NCT01290445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92909289|NCT01290445|Cholinergic Agents|cholinergic agents|mesh-ancestor
92909290|NCT01290445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909291|NCT01290445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909292|NCT01290445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909294|NCT01251718|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92909295|NCT01251718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909296|NCT01251718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909297|NCT01251718|Cholinergic Agents|cholinergic agents|mesh-ancestor
92909298|NCT01251718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909299|NCT01251718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909300|NCT01251718|Nootropic Agents|nootropic agents|mesh-ancestor
92254127|NCT04468984|Navitoclax|navitoclax|mesh-list
92909301|NCT01211405|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92909302|NCT01211405|Hallucinogens|hallucinogens|mesh-ancestor
92909303|NCT01211405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909304|NCT01211405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92909305|NCT01211405|Serotonin Agents|serotonin agents|mesh-ancestor
92909306|NCT01211405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909307|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909308|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92909309|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92909310|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909311|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92909312|NCT01012817|Topotecan|topotecan|mesh-list
92909313|NCT01012817|Veliparib|veliparib|mesh-list
92909314|NCT01012817|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92909315|NCT01012817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909316|NCT01012817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909317|NCT01012817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909318|NCT01012817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909319|NCT01012817|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92909320|NCT00581828|Vitamin D|vitamin d|mesh-list
92909321|NCT00581828|Ergocalciferols|ergocalciferols|mesh-list
92909322|NCT00581828|Cholecalciferol|cholecalciferol|mesh-list
92909323|NCT00581828|Vitamins|vitamins|mesh-list
92909324|NCT00581828|Micronutrients|micronutrients|mesh-ancestor
92909325|NCT00581828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909326|NCT00581828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92909327|NCT00581828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92909328|NCT00220337|Lacosamide|lacosamide|mesh-list
92909329|NCT00220337|Anticonvulsants|anticonvulsants|mesh-ancestor
92909330|NCT00220337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92909331|NCT00220337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92909332|NCT00220337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909333|NCT00220337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909334|NCT00090064|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92909335|NCT00090064|Hallucinogens|hallucinogens|mesh-ancestor
92909336|NCT00090064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909337|NCT00090064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92909338|NCT00090064|Serotonin Agents|serotonin agents|mesh-ancestor
92909339|NCT00090064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909340|NCT00090064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909341|NCT00090064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92909342|NCT00090064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92909343|NCT00090064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909344|NCT00090064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92909345|NCT00071708|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92909346|NCT00071708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92909347|NCT00071708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92909348|NCT00071708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909349|NCT00071708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909350|NCT00071708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909351|NCT00071708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909352|NCT00071708|Analgesics|analgesics|mesh-ancestor
92909353|NCT00071708|Sensory System Agents|sensory system agents|mesh-ancestor
92909354|NCT00071708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909355|NCT00071708|Antidepressive Agents|antidepressive agents|mesh-ancestor
92909356|NCT00071708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92909357|NCT00071708|Dopamine Agents|dopamine agents|mesh-ancestor
92909358|NCT00576316|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92909359|NCT00576316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92909360|NCT00576316|Respiratory System Agents|respiratory system agents|mesh-ancestor
92909361|NCT00745810|Complement System Proteins|complement system proteins|mesh-list
92909362|NCT00745810|Immunologic Factors|immunologic factors|mesh-ancestor
92909363|NCT00745810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909364|NCT00755872|Risedronic Acid|risedronic acid|mesh-list
92909365|NCT00755872|Etidronic Acid|etidronic acid|mesh-list
92909366|NCT00755872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92909367|NCT00755872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909368|NCT00755872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909369|NCT00755872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92909370|NCT00755872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909371|NCT00755872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92909373|NCT00755950|Antioxidants|antioxidants|mesh-ancestor
92909374|NCT00755950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909375|NCT00755950|Protective Agents|protective agents|mesh-ancestor
92909376|NCT00755950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909377|NCT00705354|Bacitracin|bacitracin|mesh-list
92909378|NCT00705354|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92909379|NCT00705354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909380|NCT00705354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909381|NCT00575380|Azithromycin|azithromycin|mesh-list
92909382|NCT00575380|Moxifloxacin|moxifloxacin|mesh-list
92909383|NCT00575380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92909384|NCT00575380|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92909385|NCT00575380|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92909386|NCT00575380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909387|NCT00575380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909388|NCT00575380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92909389|NCT00575380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909390|NCT00575380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909391|NCT00575380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909392|NCT00575380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909393|NCT00575380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92909394|NCT00575380|Contraceptive Agents|contraceptive agents|mesh-ancestor
92909395|NCT00575380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92909396|NCT00575380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909397|NCT00575380|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92909398|NCT00575380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92909399|NCT00575380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92909400|NCT00840996|Lidocaine|lidocaine|mesh-list
92909401|NCT00840996|Anesthetics, Local|anesthetics, local|mesh-ancestor
92909402|NCT00840996|Anesthetics|anesthetics|mesh-ancestor
92909403|NCT00840996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909404|NCT00840996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909405|NCT00840996|Sensory System Agents|sensory system agents|mesh-ancestor
92909406|NCT00840996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909407|NCT00840996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92909408|NCT00840996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92909409|NCT00840996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92909410|NCT00840996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909411|NCT00840996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909412|NCT00756184|Travoprost|travoprost|mesh-list
92909413|NCT00756184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92909414|NCT00756340|Bevacizumab|bevacizumab|mesh-list
92909415|NCT00756340|Everolimus|everolimus|mesh-list
92909416|NCT00756340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909417|NCT00756340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909418|NCT00756340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92909419|NCT00756340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92909420|NCT00756340|Growth Substances|growth substances|mesh-ancestor
92909421|NCT00756340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909422|NCT00756340|Growth Inhibitors|growth inhibitors|mesh-ancestor
92909423|NCT00756340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92909424|NCT00756340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909425|NCT00756340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909426|NCT00756340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909427|NCT00756340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909428|NCT00756340|Immunologic Factors|immunologic factors|mesh-ancestor
92909429|NCT00705510|Cyclosporine|cyclosporine|mesh-list
92909430|NCT00705510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92909431|NCT00705510|Cyclosporins|cyclosporins|mesh-list
92909432|NCT00705510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909433|NCT00705510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909434|NCT00705510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909435|NCT00705510|Immunologic Factors|immunologic factors|mesh-ancestor
92909436|NCT00705510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909438|NCT00705510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909439|NCT00705510|Dermatologic Agents|dermatologic agents|mesh-ancestor
92909440|NCT00705510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526061|NCT00027703|Gemcitabine|gemcitabine|mesh-list
92909441|NCT00705510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92909442|NCT00705510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92909443|NCT00680914|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92909444|NCT00680914|Immunologic Factors|immunologic factors|mesh-ancestor
92909445|NCT00680914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909446|NCT00680836|Rifaximin|rifaximin|mesh-list
92909447|NCT00680836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909448|NCT00680836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909449|NCT00680836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909450|NCT05428306|Acetaminophen|acetaminophen|mesh-list
92909451|NCT05428306|Ibuprofen|ibuprofen|mesh-list
92909452|NCT05428306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92909453|NCT05428306|Analgesics|analgesics|mesh-ancestor
92909454|NCT05428306|Sensory System Agents|sensory system agents|mesh-ancestor
92909455|NCT05428306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909456|NCT05428306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909457|NCT05428306|Antipyretics|antipyretics|mesh-ancestor
92909458|NCT05428306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92909459|NCT05428306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909460|NCT05428306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909461|NCT05428306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92909462|NCT05428306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909463|NCT05428306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909464|NCT05424796|Hemostatics|hemostatics|mesh-list
92909465|NCT05424796|Coagulants|coagulants|mesh-ancestor
92909466|NCT00757198|Remifentanil|remifentanil|mesh-list
92909467|NCT00757198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92909468|NCT00757198|Narcotics|narcotics|mesh-ancestor
92909469|NCT00757198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909470|NCT00757198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909471|NCT00757198|Analgesics|analgesics|mesh-ancestor
92909472|NCT00757198|Sensory System Agents|sensory system agents|mesh-ancestor
92909473|NCT00757198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909474|NCT00679432|Budesonide|budesonide|mesh-list
92909475|NCT00679432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909476|NCT00679432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92909477|NCT00679432|Autonomic Agents|autonomic agents|mesh-ancestor
92909478|NCT00679432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909479|NCT00679432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909480|NCT00679432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92909481|NCT00679432|Respiratory System Agents|respiratory system agents|mesh-ancestor
92909482|NCT00679432|Glucocorticoids|glucocorticoids|mesh-ancestor
92909483|NCT00679432|Hormones|hormones|mesh-ancestor
92909484|NCT00679432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909485|NCT02560870|Chlorhexidine|chlorhexidine|mesh-list
92909486|NCT02560870|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92909487|NCT02560870|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92909488|NCT02560870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909489|NCT02560870|Disinfectants|disinfectants|mesh-ancestor
92909490|NCT02560870|Dermatologic Agents|dermatologic agents|mesh-ancestor
92909491|NCT04050826|Lidocaine|lidocaine|mesh-list
92909492|NCT04050826|Prilocaine|prilocaine|mesh-list
92909493|NCT04050826|Anesthetics, Local|anesthetics, local|mesh-ancestor
92909494|NCT04050826|Anesthetics|anesthetics|mesh-ancestor
92909495|NCT04050826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909496|NCT04050826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909497|NCT04050826|Sensory System Agents|sensory system agents|mesh-ancestor
92909498|NCT04050826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909499|NCT04050826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92909500|NCT04050826|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92909501|NCT04050826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92909502|NCT04050826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909503|NCT04050826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909504|NCT00757978|Memantine|memantine|mesh-list
92909505|NCT00757978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92909506|NCT00757978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92909507|NCT00757978|Dopamine Agents|dopamine agents|mesh-ancestor
92909508|NCT00757978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909509|NCT00757978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909510|NCT00757978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909511|NCT00757978|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92909513|NCT00754702|Vinorelbine|vinorelbine|mesh-list
92909514|NCT00754702|Lapatinib|lapatinib|mesh-list
92526068|NCT00027703|Growth Substances|growth substances|mesh-ancestor
92909515|NCT00754702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909516|NCT00754702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909517|NCT00754702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909518|NCT00754702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909519|NCT00754702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909520|NCT00754702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909521|NCT00754702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909522|NCT00754702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909523|NCT00754780|Pirfenidone|pirfenidone|mesh-list
92909524|NCT00754780|Analgesics|analgesics|mesh-ancestor
92909525|NCT00754780|Sensory System Agents|sensory system agents|mesh-ancestor
92909526|NCT00754780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909527|NCT00754780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909528|NCT00754780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92909529|NCT00754780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92909530|NCT00754780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909531|NCT00754780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909532|NCT00754780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909533|NCT00822900|Progesterone|progesterone|mesh-list
92909534|NCT00822900|Progestins|progestins|mesh-ancestor
92909535|NCT00822900|Hormones|hormones|mesh-ancestor
92909536|NCT00822900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909537|NCT00822900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909538|NCT00682786|Fluorouracil|fluorouracil|mesh-list
92909539|NCT00682786|Irinotecan|irinotecan|mesh-list
92909540|NCT00682786|Antimetabolites|antimetabolites|mesh-ancestor
92909541|NCT00682786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909542|NCT00682786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92909543|NCT00682786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909544|NCT00682786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909545|NCT00682786|Immunologic Factors|immunologic factors|mesh-ancestor
92909546|NCT00682786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909547|NCT00682786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92909548|NCT00682786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909549|NCT00682786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909550|NCT00840450|Paclitaxel|paclitaxel|mesh-list
92909551|NCT00840450|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92909552|NCT00840450|Imatinib Mesylate|imatinib mesylate|mesh-list
92909553|NCT00840450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909554|NCT00840450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909555|NCT00840450|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909556|NCT00840450|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909557|NCT00840450|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909558|NCT00840450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909559|NCT00840450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909560|NCT00840450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909561|NCT00754858|Belotecan|belotecan|mesh-list
92909562|NCT00754858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909563|NCT00754858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92909564|NCT00754858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909565|NCT00754858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909566|NCT00754858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909567|NCT00755014|Ethanol|ethanol|mesh-list
92909568|NCT00755014|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92909569|NCT00755014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909570|NCT00755014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909571|NCT00755014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909572|NCT00705588|Tadalafil|tadalafil|mesh-list
92909573|NCT00705588|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92909574|NCT00705588|Vasodilator Agents|vasodilator agents|mesh-ancestor
92909575|NCT00705588|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92909576|NCT00705588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92909577|NCT00705588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909578|NCT00705588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909579|NCT00705588|Urological Agents|urological agents|mesh-ancestor
92909580|NCT00755170|Bevacizumab|bevacizumab|mesh-list
92909581|NCT00755170|Vinorelbine|vinorelbine|mesh-list
92909582|NCT00755170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909583|NCT00755170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909584|NCT00755170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92909585|NCT00755170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92909586|NCT00755170|Growth Substances|growth substances|mesh-ancestor
92909587|NCT00755170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909588|NCT00755170|Growth Inhibitors|growth inhibitors|mesh-ancestor
92909589|NCT00755170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909590|NCT00755170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909591|NCT00755170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909592|NCT00755170|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909593|NCT00755170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909594|NCT00705822|Prednisone|prednisone|mesh-list
92909595|NCT00705822|Hydrocortisone|hydrocortisone|mesh-list
92909596|NCT00705822|Docetaxel|docetaxel|mesh-list
92909597|NCT00705822|Estramustine|estramustine|mesh-list
92909598|NCT00705822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909599|NCT00705822|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909600|NCT00705822|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909601|NCT00705822|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909602|NCT00705822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909603|NCT00705822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909604|NCT00705822|Glucocorticoids|glucocorticoids|mesh-ancestor
92909605|NCT00705822|Hormones|hormones|mesh-ancestor
92909606|NCT00705822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909607|NCT00705822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909608|NCT00705822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92909609|NCT00705822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909610|NCT00705822|Alkylating Agents|alkylating agents|mesh-ancestor
92909611|NCT00840294|Ciprofloxacin|ciprofloxacin|mesh-list
92909612|NCT00840294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909613|NCT00840294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909614|NCT00840294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92909615|NCT00840294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909616|NCT00840294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909617|NCT00840294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909618|NCT00840294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909619|NCT00840294|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92909620|NCT00840294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92909621|NCT00755404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92909622|NCT00703170|Sirolimus|sirolimus|mesh-list
92909623|NCT00703170|Doxorubicin|doxorubicin|mesh-list
92909624|NCT00703170|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92909625|NCT00703170|Temsirolimus|temsirolimus|mesh-list
92909626|NCT00703170|MTOR Inhibitors|mtor inhibitors|mesh-list
92909627|NCT00703170|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92909628|NCT00703170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909629|NCT00703170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92909630|NCT00703170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909631|NCT00703170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909632|NCT00703170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909633|NCT00703170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909634|NCT00703170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909635|NCT00703170|Immunologic Factors|immunologic factors|mesh-ancestor
92909636|NCT00703170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909637|NCT00703170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909638|NCT00703170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909639|NCT00703170|Antifungal Agents|antifungal agents|mesh-ancestor
92909640|NCT05370040|Vaccines|vaccines|mesh-list
92909641|NCT05370040|Immunologic Factors|immunologic factors|mesh-ancestor
92909642|NCT05370040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909643|NCT00758134|Trastuzumab|trastuzumab|mesh-list
92909644|NCT00758134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909645|NCT00758134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909646|NCT02560636|Pembrolizumab|pembrolizumab|mesh-list
92909647|NCT02560636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909648|NCT02560636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909649|NCT02560636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909650|NCT02560636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909651|NCT00758212|Vaccines|vaccines|mesh-list
92909652|NCT00758212|Immunologic Factors|immunologic factors|mesh-ancestor
92909653|NCT00758212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909654|NCT00679042|Exenatide|exenatide|mesh-list
92909655|NCT00679042|Sirolimus|sirolimus|mesh-list
92909656|NCT00679042|Etanercept|etanercept|mesh-list
92909657|NCT00679042|Tacrolimus|tacrolimus|mesh-list
92909658|NCT00679042|Basiliximab|basiliximab|mesh-list
92909659|NCT00679042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909660|NCT00679042|Immunologic Factors|immunologic factors|mesh-ancestor
92909661|NCT00679042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909662|NCT00679042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92909663|NCT00679042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909664|NCT00679042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909665|NCT00679042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909666|NCT00679042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909667|NCT00679042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92909668|NCT00679042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909669|NCT00679042|Antifungal Agents|antifungal agents|mesh-ancestor
92909670|NCT00679042|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92909671|NCT00679042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92909672|NCT00679042|Analgesics|analgesics|mesh-ancestor
92909673|NCT00679042|Sensory System Agents|sensory system agents|mesh-ancestor
92909674|NCT00679042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909675|NCT00679042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909676|NCT00679042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909677|NCT00679042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909678|NCT00679042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92909679|NCT00679042|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92909680|NCT00679042|Incretins|incretins|mesh-ancestor
92909681|NCT00679042|Hormones|hormones|mesh-ancestor
92909682|NCT00679042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909683|NCT00680056|Formoterol Fumarate|formoterol fumarate|mesh-list
92909684|NCT00680056|Tiotropium Bromide|tiotropium bromide|mesh-list
92909685|NCT00680056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92909686|NCT00680056|Autonomic Agents|autonomic agents|mesh-ancestor
92909687|NCT00680056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909688|NCT00680056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909689|NCT00680056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92909690|NCT00680056|Respiratory System Agents|respiratory system agents|mesh-ancestor
92909691|NCT00680056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92909692|NCT00680056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92909693|NCT00680056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92909694|NCT00680056|Adrenergic Agents|adrenergic agents|mesh-ancestor
92909695|NCT00680056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909696|NCT00680056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909697|NCT00680056|Parasympatholytics|parasympatholytics|mesh-ancestor
92909698|NCT00680056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92909699|NCT00680056|Cholinergic Agents|cholinergic agents|mesh-ancestor
92909700|NCT00758368|Apomorphine|apomorphine|mesh-list
92909701|NCT00758368|Emetics|emetics|mesh-ancestor
92909702|NCT00758368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909703|NCT00758368|Autonomic Agents|autonomic agents|mesh-ancestor
92909704|NCT00758368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909705|NCT00758368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909706|NCT00758368|Dopamine Agonists|dopamine agonists|mesh-ancestor
92909707|NCT00758368|Dopamine Agents|dopamine agents|mesh-ancestor
92909708|NCT00758368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909709|NCT00758368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909710|NCT05435560|Dexmedetomidine|dexmedetomidine|mesh-list
92909711|NCT05435560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92909712|NCT05435560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909713|NCT05435560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909714|NCT05435560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92909715|NCT05435560|Analgesics|analgesics|mesh-ancestor
92909716|NCT05435560|Sensory System Agents|sensory system agents|mesh-ancestor
92909717|NCT05435560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909718|NCT05435560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92909719|NCT05435560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92909720|NCT05435560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92909721|NCT05435560|Adrenergic Agents|adrenergic agents|mesh-ancestor
92909722|NCT05435560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909723|NCT05435560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909724|NCT00680992|Denosumab|denosumab|mesh-list
92909725|NCT00680992|Immunoglobulins|immunoglobulins|mesh-list
92909726|NCT00680992|Immunoglobulin G|immunoglobulin g|mesh-list
92909727|NCT00680992|Immunologic Factors|immunologic factors|mesh-ancestor
92909728|NCT00680992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909729|NCT00680992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92909730|NCT02559154|Thalidomide|thalidomide|mesh-list
92909731|NCT02559154|Dexamethasone|dexamethasone|mesh-list
92909732|NCT02559154|Cyclophosphamide|cyclophosphamide|mesh-list
92909733|NCT02559154|Doxorubicin|doxorubicin|mesh-list
92909734|NCT02559154|Bortezomib|bortezomib|mesh-list
92909735|NCT02559154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909736|NCT02559154|Immunologic Factors|immunologic factors|mesh-ancestor
92909737|NCT02559154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909738|NCT02559154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909739|NCT02559154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909740|NCT02559154|Alkylating Agents|alkylating agents|mesh-ancestor
92909741|NCT02559154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909742|NCT02559154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909743|NCT02559154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92909744|NCT02559154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909745|NCT02559154|Antiemetics|antiemetics|mesh-ancestor
92909746|NCT02559154|Autonomic Agents|autonomic agents|mesh-ancestor
92909747|NCT02559154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909748|NCT02559154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909749|NCT02559154|Glucocorticoids|glucocorticoids|mesh-ancestor
92909750|NCT02559154|Hormones|hormones|mesh-ancestor
92909751|NCT02559154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909752|NCT02559154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92909753|NCT02559154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92909754|NCT02559154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92909755|NCT02559154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909756|NCT02559154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909757|NCT02559154|Leprostatic Agents|leprostatic agents|mesh-ancestor
92909758|NCT02559154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909759|NCT02559154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909760|NCT02559154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92909761|NCT02559154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92909762|NCT02559154|Growth Substances|growth substances|mesh-ancestor
92909763|NCT02559154|Growth Inhibitors|growth inhibitors|mesh-ancestor
92909764|NCT00678886|Muromonab-CD3|muromonab-cd3|mesh-list
92909765|NCT00678886|Immunologic Factors|immunologic factors|mesh-ancestor
92909766|NCT00678886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909767|NCT00678886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909768|NCT05747469|Lidocaine|lidocaine|mesh-list
92909769|NCT05747469|Anesthetics, Local|anesthetics, local|mesh-list
92909770|NCT05747469|Anesthetics|anesthetics|mesh-list
92909771|NCT05747469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909772|NCT05747469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909773|NCT05747469|Sensory System Agents|sensory system agents|mesh-ancestor
92909774|NCT05747469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909775|NCT05747469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92909776|NCT05747469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92909777|NCT05747469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92909778|NCT05747469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92909779|NCT05747469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909781|NCT00804843|Atorvastatin|atorvastatin|mesh-list
92909782|NCT00804843|Simvastatin|simvastatin|mesh-list
92909783|NCT00804843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92909784|NCT00804843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92909785|NCT00804843|Antimetabolites|antimetabolites|mesh-ancestor
92909786|NCT00804843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909787|NCT00804843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92909788|NCT00804843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92909789|NCT00804843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909790|NCT00804843|Vasodilator Agents|vasodilator agents|mesh-ancestor
92909791|NCT00804843|Vitamin B Complex|vitamin b complex|mesh-ancestor
92909792|NCT00804843|Vitamins|vitamins|mesh-ancestor
92909793|NCT00804843|Micronutrients|micronutrients|mesh-ancestor
92909794|NCT00804843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909795|NCT00822120|Prednisone|prednisone|mesh-list
92909796|NCT00822120|Cyclophosphamide|cyclophosphamide|mesh-list
92909797|NCT00822120|Dacarbazine|dacarbazine|mesh-list
92909798|NCT00822120|Doxorubicin|doxorubicin|mesh-list
92909799|NCT00822120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92909800|NCT00822120|Etoposide|etoposide|mesh-list
92909801|NCT00822120|Vincristine|vincristine|mesh-list
92909802|NCT00822120|Bleomycin|bleomycin|mesh-list
92909803|NCT00822120|Vinblastine|vinblastine|mesh-list
92909804|NCT00822120|Procarbazine|procarbazine|mesh-list
92909805|NCT00822120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909806|NCT00822120|Immunologic Factors|immunologic factors|mesh-ancestor
92909807|NCT00822120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909808|NCT00822120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909809|NCT00822120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92909810|NCT00822120|Alkylating Agents|alkylating agents|mesh-ancestor
92909811|NCT00822120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909812|NCT00822120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909813|NCT00822120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92909814|NCT00822120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92909815|NCT00822120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92909816|NCT00822120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909817|NCT00822120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909818|NCT00822120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909819|NCT00822120|Glucocorticoids|glucocorticoids|mesh-ancestor
92909820|NCT00822120|Hormones|hormones|mesh-ancestor
92909821|NCT00822120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909822|NCT00822120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92909823|NCT00822120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92909824|NCT00822120|Tubulin Modulators|tubulin modulators|mesh-ancestor
92909825|NCT00822120|Antimitotic Agents|antimitotic agents|mesh-ancestor
92909826|NCT00822120|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909827|NCT00804687|Pseudoephedrine|pseudoephedrine|mesh-list
92909828|NCT00804687|Ephedrine|ephedrine|mesh-list
92909829|NCT00804687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92909830|NCT00804687|Autonomic Agents|autonomic agents|mesh-ancestor
92909831|NCT00804687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909832|NCT00804687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909833|NCT00804687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92909834|NCT00804687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92909835|NCT00804687|Nasal Decongestants|nasal decongestants|mesh-ancestor
92909836|NCT00804687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92909837|NCT00804687|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92909838|NCT00804687|Sympathomimetics|sympathomimetics|mesh-ancestor
92909839|NCT00804687|Adrenergic Agents|adrenergic agents|mesh-ancestor
92909840|NCT00804687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909841|NCT00804687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909842|NCT00678652|Vaccines|vaccines|mesh-list
92909843|NCT00678652|Immunologic Factors|immunologic factors|mesh-ancestor
92909844|NCT00678652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909845|NCT02607657|Eplerenone|eplerenone|mesh-list
92909846|NCT02607657|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92909847|NCT02607657|Hormone Antagonists|hormone antagonists|mesh-ancestor
92909848|NCT02607657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909849|NCT02607657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909850|NCT02607657|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92909851|NCT02607657|Diuretics|diuretics|mesh-ancestor
92909852|NCT02607657|Natriuretic Agents|natriuretic agents|mesh-ancestor
92909853|NCT02607657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92909854|NCT00574912|Insulin|insulin|mesh-list
92909855|NCT00574912|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92909856|NCT00574912|Insulin Glargine|insulin glargine|mesh-list
92909857|NCT00574912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92909858|NCT00574912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909859|NCT00922896|Gemcitabine|gemcitabine|mesh-list
92909860|NCT00922896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92909861|NCT00922896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909862|NCT00922896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92909863|NCT00922896|Antimetabolites|antimetabolites|mesh-ancestor
92909864|NCT00922896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909865|NCT00922896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909866|NCT00922896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909867|NCT00761020|Mefloquine|mefloquine|mesh-list
92909868|NCT00761020|Antimalarials|antimalarials|mesh-ancestor
92909869|NCT00761020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92909870|NCT00761020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92909871|NCT00761020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909872|NCT00804141|Bromides|bromides|mesh-list
92909873|NCT00804141|Methylnaltrexone|methylnaltrexone|mesh-list
92909874|NCT00804141|Anticonvulsants|anticonvulsants|mesh-ancestor
92909875|NCT00804141|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92909876|NCT00804141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909877|NCT00804141|Sensory System Agents|sensory system agents|mesh-ancestor
92909878|NCT00804141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909879|NCT00677092|Imatinib Mesylate|imatinib mesylate|mesh-list
92909880|NCT00677092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909881|NCT00677092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909882|NCT00677092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909883|NCT00677092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909884|NCT02607579|Ropivacaine|ropivacaine|mesh-list
92909885|NCT02607579|Anesthetics, Local|anesthetics, local|mesh-ancestor
92909886|NCT02607579|Anesthetics|anesthetics|mesh-ancestor
92909887|NCT02607579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92909888|NCT02607579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909889|NCT02607579|Sensory System Agents|sensory system agents|mesh-ancestor
92909890|NCT02607579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909891|NCT03539367|Acetazolamide|acetazolamide|mesh-list
92909892|NCT03539367|Anticonvulsants|anticonvulsants|mesh-ancestor
92909893|NCT03539367|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92909894|NCT03539367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162295|NCT01233921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92909895|NCT03539367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909896|NCT03539367|Diuretics|diuretics|mesh-ancestor
92909897|NCT03539367|Natriuretic Agents|natriuretic agents|mesh-ancestor
92909898|NCT03539367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909899|NCT03416361|Vitamin D|vitamin d|mesh-list
92909900|NCT03416361|Cholecalciferol|cholecalciferol|mesh-list
92909901|NCT03416361|Vitamins|vitamins|mesh-ancestor
92909902|NCT03416361|Micronutrients|micronutrients|mesh-ancestor
92909903|NCT03416361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909904|NCT03416361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92909905|NCT03416361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92909906|NCT00761254|Domperidone|domperidone|mesh-list
92909907|NCT00761254|Antiemetics|antiemetics|mesh-ancestor
92909908|NCT00761254|Autonomic Agents|autonomic agents|mesh-ancestor
92909909|NCT00761254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909910|NCT00761254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909911|NCT00761254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92909912|NCT00761254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92909913|NCT00761254|Dopamine Agents|dopamine agents|mesh-ancestor
92909914|NCT00761254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92909915|NCT00761254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909916|NCT00761332|Teriparatide|teriparatide|mesh-list
92909917|NCT00761332|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92909918|NCT00761332|Diphosphonates|diphosphonates|mesh-list
92909919|NCT00761332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92909920|NCT00761332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909921|NCT00761332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92909922|NCT00761332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92909923|NCT00761332|Hormone Antagonists|hormone antagonists|mesh-ancestor
92909924|NCT00761332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909925|NCT00761332|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92909926|NCT00761332|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92909927|NCT04741438|Nivolumab|nivolumab|mesh-list
92909928|NCT04741438|Ipilimumab|ipilimumab|mesh-list
92909929|NCT04741438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909930|NCT04741438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909931|NCT04741438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909932|NCT04741438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909933|NCT03321201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92909934|NCT03321201|Hemostatics|hemostatics|mesh-ancestor
92909935|NCT03321201|Coagulants|coagulants|mesh-ancestor
92909936|NCT02612220|Hemostatics|hemostatics|mesh-list
92909937|NCT02612220|Coagulants|coagulants|mesh-ancestor
92909938|NCT04627246|Vaccines|vaccines|mesh-list
92909939|NCT04627246|Immunologic Factors|immunologic factors|mesh-ancestor
92909940|NCT04627246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909941|NCT00761644|Sirolimus|sirolimus|mesh-list
92909942|NCT00761644|Bevacizumab|bevacizumab|mesh-list
92909943|NCT00761644|Doxorubicin|doxorubicin|mesh-list
92909944|NCT00761644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92909945|NCT00761644|Temsirolimus|temsirolimus|mesh-list
92909946|NCT00761644|MTOR Inhibitors|mtor inhibitors|mesh-list
92909947|NCT00761644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909948|NCT00761644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909949|NCT00761644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92909950|NCT00761644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92909951|NCT00761644|Growth Substances|growth substances|mesh-ancestor
92909952|NCT00761644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909953|NCT00761644|Growth Inhibitors|growth inhibitors|mesh-ancestor
92909954|NCT00761644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92909955|NCT00761644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92909956|NCT00761644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92909957|NCT00761644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909958|NCT00761644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909959|NCT00761644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92909960|NCT00761644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92909961|NCT00761644|Immunologic Factors|immunologic factors|mesh-ancestor
92909962|NCT00761644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92909963|NCT00761644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92909964|NCT00761644|Antifungal Agents|antifungal agents|mesh-ancestor
92909965|NCT02559388|Montelukast|montelukast|mesh-list
92909966|NCT02559388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92909967|NCT02559388|Respiratory System Agents|respiratory system agents|mesh-ancestor
92909968|NCT02559388|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92909969|NCT02559388|Hormone Antagonists|hormone antagonists|mesh-ancestor
92909970|NCT02559388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92909971|NCT02559388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909972|NCT02559388|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92909973|NCT02559388|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92909974|NCT02559388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909975|NCT03168256|Apremilast|apremilast|mesh-list
92909976|NCT03168256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92909977|NCT03168256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92909978|NCT03168256|Analgesics|analgesics|mesh-ancestor
92909979|NCT03168256|Sensory System Agents|sensory system agents|mesh-ancestor
92909980|NCT03168256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92909981|NCT03168256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92909982|NCT03168256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92909983|NCT03168256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92909984|NCT03168256|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92909985|NCT03168256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92909986|NCT03168256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909987|NCT03168256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909988|NCT00761722|Azacitidine|azacitidine|mesh-list
92909989|NCT00761722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92909990|NCT00761722|Antimetabolites|antimetabolites|mesh-ancestor
92909991|NCT00761722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909992|NCT00761722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909993|NCT00761722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92909994|NCT04507906|Nivolumab|nivolumab|mesh-list
92909995|NCT04507906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92909996|NCT04507906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92909997|NCT04507906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92909998|NCT04507906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92909999|NCT00762190|Insulin|insulin|mesh-list
92910000|NCT00762190|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92910001|NCT00762190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910002|NCT00762190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910003|NCT00762346|Zoledronic Acid|zoledronic acid|mesh-list
92910004|NCT00762346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92910005|NCT00762346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910006|NCT00762658|Betamethasone|betamethasone|mesh-list
92910007|NCT00762658|Tacrolimus|tacrolimus|mesh-list
92910008|NCT00762658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92910009|NCT00762658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910010|NCT00762658|Immunologic Factors|immunologic factors|mesh-ancestor
92910011|NCT00762658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910012|NCT00762658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92910013|NCT00762658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910014|NCT00762658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910015|NCT00762658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910016|NCT00762658|Glucocorticoids|glucocorticoids|mesh-ancestor
92910017|NCT00762658|Hormones|hormones|mesh-ancestor
92910018|NCT00762658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910019|NCT00762658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92910020|NCT00762658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92910021|NCT02558452|Tacrolimus|tacrolimus|mesh-list
92910022|NCT02558452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910023|NCT02558452|Immunologic Factors|immunologic factors|mesh-ancestor
92910024|NCT02558452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910025|NCT02558452|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92910026|NCT02558452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910027|NCT02558452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910028|NCT00762736|Pioglitazone|pioglitazone|mesh-list
92910029|NCT00762736|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92910030|NCT00762736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910031|NCT00762736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910032|NCT00762736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92910033|NCT00762736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92910034|NCT00762736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910035|NCT02915224|Obinutuzumab|obinutuzumab|mesh-list
92910037|NCT02915224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910038|NCT02915224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910039|NCT02915224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92910040|NCT02915224|Alkylating Agents|alkylating agents|mesh-ancestor
92910041|NCT02915224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910042|NCT02870920|Durvalumab|durvalumab|mesh-list
92910043|NCT02870920|Tremelimumab|tremelimumab|mesh-list
92910044|NCT02870920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910045|NCT02870920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910046|NCT02813824|Aspirin|aspirin|mesh-list
92910047|NCT02813824|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
92910048|NCT02813824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910049|NCT02813824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910050|NCT02813824|Analgesics|analgesics|mesh-ancestor
92910051|NCT02813824|Sensory System Agents|sensory system agents|mesh-ancestor
92910052|NCT02813824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910053|NCT02813824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910054|NCT02813824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910055|NCT02813824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910056|NCT02813824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92910057|NCT02813824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92910058|NCT02813824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910059|NCT02813824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92910060|NCT02813824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92910061|NCT02813824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910062|NCT02813824|Antipyretics|antipyretics|mesh-ancestor
92910063|NCT00673894|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92910064|NCT00673894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910065|NCT00673894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910066|NCT00673894|Incretins|incretins|mesh-ancestor
92910067|NCT00673894|Hormones|hormones|mesh-ancestor
92910068|NCT00673894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910069|NCT00673894|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92910070|NCT00673894|Protease Inhibitors|protease inhibitors|mesh-ancestor
92910071|NCT00673894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910072|NCT00673894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910073|NCT00763204|Betamethasone|betamethasone|mesh-list
92910074|NCT00763204|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92910075|NCT00763204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910076|NCT00763204|Glucocorticoids|glucocorticoids|mesh-ancestor
92910077|NCT00763204|Hormones|hormones|mesh-ancestor
92910078|NCT00763204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910079|NCT00763204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910080|NCT00763204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92910081|NCT00763204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92910082|NCT02558218|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92910083|NCT02558218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910084|NCT02558218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910085|NCT02558218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910086|NCT02558218|Glucocorticoids|glucocorticoids|mesh-ancestor
92910087|NCT02558218|Hormones|hormones|mesh-ancestor
92910088|NCT02558218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910089|NCT02558218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910090|NCT02558218|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92910091|NCT02558218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92910092|NCT00763438|Sertindole|sertindole|mesh-list
92910093|NCT00763438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92910094|NCT00763438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92910095|NCT00763438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910096|NCT00763438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910097|NCT00763438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910098|NCT02559232|Anticoagulants|anticoagulants|mesh-list
92910099|NCT00673816|Sunitinib|sunitinib|mesh-list
92910100|NCT00673816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526079|NCT00011934|Antiviral Agents|antiviral agents|mesh-ancestor
92910101|NCT00673816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92910102|NCT00673816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92910103|NCT00673816|Growth Substances|growth substances|mesh-ancestor
92910104|NCT00673816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910105|NCT00673816|Growth Inhibitors|growth inhibitors|mesh-ancestor
92910106|NCT00673816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92910107|NCT00673816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555588|NCT00411190|Antimetabolites|antimetabolites|mesh-ancestor
92910108|NCT00673816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910110|NCT00763906|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92910111|NCT00763906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92910112|NCT00763906|Adrenergic Agents|adrenergic agents|mesh-ancestor
92910113|NCT00763906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910114|NCT00763906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910115|NCT00763906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910116|NCT00763906|Sympathomimetics|sympathomimetics|mesh-ancestor
92910117|NCT00763906|Autonomic Agents|autonomic agents|mesh-ancestor
92910118|NCT00763906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910119|NCT00763906|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92910120|NCT00764062|Amoxicillin|amoxicillin|mesh-list
92910121|NCT00764062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910122|NCT00764062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910123|NCT00758914|Vitamin E|vitamin e|mesh-list
92910124|NCT00758914|Vitamins|vitamins|mesh-ancestor
92910125|NCT00758914|Micronutrients|micronutrients|mesh-ancestor
92910126|NCT00758914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910127|NCT00758914|Antioxidants|antioxidants|mesh-ancestor
92910128|NCT00758914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910129|NCT00758914|Protective Agents|protective agents|mesh-ancestor
92910130|NCT00759070|Ritonavir|ritonavir|mesh-list
92910131|NCT00759070|Lopinavir|lopinavir|mesh-list
92910132|NCT00759070|Tenofovir|tenofovir|mesh-list
92910133|NCT00759070|Emtricitabine|emtricitabine|mesh-list
92910134|NCT00759070|Efavirenz|efavirenz|mesh-list
92910135|NCT00759070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92910136|NCT00759070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92910137|NCT00759070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92910138|NCT00759070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910139|NCT00759070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910140|NCT00759070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92910141|NCT00759070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92910142|NCT00759070|Antiviral Agents|antiviral agents|mesh-ancestor
92910143|NCT00759070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910144|NCT00759070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92910145|NCT00759070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92910146|NCT00759070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92910147|NCT00759070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92910148|NCT00759070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92910149|NCT00759070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92910150|NCT00759070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92910151|NCT00759070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92910152|NCT00759070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92910153|NCT00764140|Mitogens|mitogens|mesh-list
92910154|NCT00764140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92910155|NCT00764140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910156|NCT00672958|Vortioxetine|vortioxetine|mesh-list
92910157|NCT00672958|Antidepressive Agents|antidepressive agents|mesh-ancestor
92910158|NCT00672958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910159|NCT00672958|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92910160|NCT00672958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92910161|NCT00672958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910162|NCT00672958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910163|NCT00672958|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92910164|NCT00672958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92910165|NCT00672958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92910166|NCT00672958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910167|NCT00672958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910168|NCT00672958|Serotonin Agents|serotonin agents|mesh-ancestor
92910169|NCT00672958|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92910170|NCT00672958|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92526080|NCT00011934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910171|NCT00672958|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92910173|NCT00764374|Z 338|z 338|mesh-list
92910174|NCT00764374|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92910175|NCT00764374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910176|NCT00764374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910177|NCT00764374|Cholinergic Agents|cholinergic agents|mesh-ancestor
92910178|NCT00764374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910179|NCT00764374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555664|NCT00040040|Bupropion|bupropion|mesh-list
92910180|NCT00764374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92910181|NCT00759226|Leucovorin|leucovorin|mesh-list
92910182|NCT00759226|Folic Acid|folic acid|mesh-list
92910183|NCT00759226|Cisplatin|cisplatin|mesh-list
92910184|NCT00759226|Gemcitabine|gemcitabine|mesh-list
92910185|NCT00759226|Levoleucovorin|levoleucovorin|mesh-list
92910186|NCT00759226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910187|NCT00759226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910188|NCT00759226|Antimetabolites|antimetabolites|mesh-ancestor
92910189|NCT00759226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910190|NCT00759226|Antidotes|antidotes|mesh-ancestor
92910191|NCT00759226|Protective Agents|protective agents|mesh-ancestor
92910192|NCT00759226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910193|NCT00759226|Vitamin B Complex|vitamin b complex|mesh-ancestor
92910194|NCT00759226|Vitamins|vitamins|mesh-ancestor
92910195|NCT00759226|Micronutrients|micronutrients|mesh-ancestor
92910196|NCT00759226|Hematinics|hematinics|mesh-ancestor
92910197|NCT00672646|Naproxen|naproxen|mesh-list
92910198|NCT00672646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910199|NCT00672646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910200|NCT00672646|Analgesics|analgesics|mesh-ancestor
92910201|NCT00672646|Sensory System Agents|sensory system agents|mesh-ancestor
92910202|NCT00672646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910203|NCT00672646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910204|NCT00672646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910205|NCT00672646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910206|NCT00672646|Gout Suppressants|gout suppressants|mesh-ancestor
92910207|NCT00672646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92910208|NCT00672646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910209|NCT00672646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910210|NCT00759460|Olanzapine|olanzapine|mesh-list
92910211|NCT00759460|Sertindole|sertindole|mesh-list
92910212|NCT00759460|Antiemetics|antiemetics|mesh-ancestor
92910213|NCT00759460|Autonomic Agents|autonomic agents|mesh-ancestor
92910214|NCT00759460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910215|NCT00759460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910216|NCT00759460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92910217|NCT00759460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92910218|NCT00759460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92910219|NCT00759460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910220|NCT00759460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910221|NCT00759460|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92910222|NCT00759460|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92910223|NCT00759460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92910224|NCT00759460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910225|NCT00759460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910226|NCT00759460|Serotonin Agents|serotonin agents|mesh-ancestor
92910227|NCT00765154|Ritonavir|ritonavir|mesh-list
92910228|NCT00765154|Darunavir|darunavir|mesh-list
92910229|NCT00765154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92910230|NCT00765154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92910231|NCT00765154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92910232|NCT00765154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910233|NCT00765154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910234|NCT00765154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92910235|NCT00765154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92910236|NCT00765154|Antiviral Agents|antiviral agents|mesh-ancestor
92910237|NCT00765154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910238|NCT00765154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92910239|NCT00765154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92910240|NCT00672490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92910241|NCT00672490|Antidepressive Agents|antidepressive agents|mesh-ancestor
92910242|NCT00672490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910243|NCT00672490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92910244|NCT00672490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92910245|NCT00672490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910246|NCT00672490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910248|NCT00770302|Incretins|incretins|mesh-ancestor
92910249|NCT00770302|Hormones|hormones|mesh-ancestor
92910250|NCT00770302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162313|NCT01160445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92910251|NCT00770302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910252|NCT00770302|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92910253|NCT00770302|Protease Inhibitors|protease inhibitors|mesh-ancestor
92910254|NCT00770302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910255|NCT00770302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910256|NCT00770302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910257|NCT02557984|Naltrexone|naltrexone|mesh-list
92910258|NCT02557984|Amisulpride|amisulpride|mesh-list
92910259|NCT02557984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92910260|NCT02557984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92910261|NCT02557984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910262|NCT02557984|Sensory System Agents|sensory system agents|mesh-ancestor
92910263|NCT02557984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910264|NCT02557984|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92910265|NCT02557984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92910266|NCT02557984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910267|NCT02557984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910268|NCT02557984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92910269|NCT02557984|Dopamine Agents|dopamine agents|mesh-ancestor
92910270|NCT02557984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910271|NCT02557984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910272|NCT02557984|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92910273|NCT02557984|Antidepressive Agents|antidepressive agents|mesh-ancestor
92910274|NCT00759928|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92910275|NCT00759928|Sorafenib|sorafenib|mesh-list
92910276|NCT00759928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910277|NCT00759928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92910278|NCT00759928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910279|NCT00759928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910280|NCT00670930|Omalizumab|omalizumab|mesh-list
92910281|NCT00670930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92910282|NCT00670930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92910283|NCT00670930|Respiratory System Agents|respiratory system agents|mesh-ancestor
92910284|NCT00770536|Doxorubicin|doxorubicin|mesh-list
92910285|NCT00770536|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92910286|NCT00770536|Topotecan|topotecan|mesh-list
92910287|NCT00770536|Trebananib|trebananib|mesh-list
92910288|NCT00770536|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92910289|NCT00770536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910290|NCT00770536|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92910291|NCT00770536|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92910292|NCT00770536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910293|NCT00770536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910294|NCT00770536|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92910295|NCT00770536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92910296|NCT00770536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92910297|NCT00770536|Growth Substances|growth substances|mesh-ancestor
92910298|NCT00770536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910299|NCT00770536|Growth Inhibitors|growth inhibitors|mesh-ancestor
92910300|NCT00771004|Pioglitazone|pioglitazone|mesh-list
92910301|NCT00771004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910302|NCT00771004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910303|NCT00674362|Certolizumab Pegol|certolizumab pegol|mesh-list
92910304|NCT00674362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92910305|NCT00674362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910306|NCT00674362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910307|NCT00674362|Immunologic Factors|immunologic factors|mesh-ancestor
92910308|NCT00674362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910309|NCT00674362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910310|NCT00820950|Betamethasone|betamethasone|mesh-list
92910311|NCT00820950|Betamethasone Valerate|betamethasone valerate|mesh-list
92910312|NCT00820950|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92910313|NCT00820950|Betamethasone benzoate|betamethasone benzoate|mesh-list
92910314|NCT00820950|Calcipotriene|calcipotriene|mesh-list
92910315|NCT00820950|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92910316|NCT00820950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910317|NCT00820950|Glucocorticoids|glucocorticoids|mesh-ancestor
92910318|NCT00820950|Hormones|hormones|mesh-ancestor
92910319|NCT00820950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910320|NCT00820950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910321|NCT00820950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92910322|NCT00820950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92910323|NCT00820950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92910324|NCT00765934|Lidocaine|lidocaine|mesh-list
92910325|NCT00765934|Tetracaine|tetracaine|mesh-list
92910326|NCT00765934|Anesthetics, Local|anesthetics, local|mesh-ancestor
92910327|NCT00765934|Anesthetics|anesthetics|mesh-ancestor
92910328|NCT00765934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910329|NCT00765934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910330|NCT00765934|Sensory System Agents|sensory system agents|mesh-ancestor
92910331|NCT00765934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910332|NCT00765934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92910333|NCT00765934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92910334|NCT00765934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92910335|NCT00765934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92910336|NCT00765934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910338|NCT04049344|Decitabine|decitabine|mesh-list
92910339|NCT04049344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910340|NCT04049344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910341|NCT04049344|Antimetabolites|antimetabolites|mesh-ancestor
92910342|NCT04049344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910343|NCT04049344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910344|NCT00670306|Cetrorelix|cetrorelix|mesh-list
92910345|NCT00670306|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92910346|NCT00670306|Fertility Agents|fertility agents|mesh-ancestor
92910347|NCT00670306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910348|NCT00670306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910349|NCT00670306|Hormone Antagonists|hormone antagonists|mesh-ancestor
92910350|NCT00670306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910351|NCT00709254|Fentanyl|fentanyl|mesh-list
92910352|NCT00709254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92910353|NCT00709254|Narcotics|narcotics|mesh-ancestor
92910354|NCT00709254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910355|NCT00709254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910356|NCT00709254|Analgesics|analgesics|mesh-ancestor
92910357|NCT00709254|Sensory System Agents|sensory system agents|mesh-ancestor
92910358|NCT00709254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910359|NCT00709254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92910360|NCT00709254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92910361|NCT00709254|Anesthetics, General|anesthetics, general|mesh-ancestor
92910362|NCT00709254|Anesthetics|anesthetics|mesh-ancestor
92910363|NCT00760318|Levetiracetam|levetiracetam|mesh-list
92910364|NCT00760318|Anticonvulsants|anticonvulsants|mesh-ancestor
92910365|NCT00760318|Nootropic Agents|nootropic agents|mesh-ancestor
92910366|NCT00591630|Cytarabine|cytarabine|mesh-list
92910367|NCT00591630|Rituximab|rituximab|mesh-list
92910368|NCT00591630|Etoposide|etoposide|mesh-list
92910369|NCT00591630|Melphalan|melphalan|mesh-list
92910370|NCT00591630|Carmustine|carmustine|mesh-list
92910371|NCT00591630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910372|NCT00591630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910373|NCT00591630|Immunologic Factors|immunologic factors|mesh-ancestor
92910374|NCT00591630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910375|NCT00591630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910376|NCT00591630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92910377|NCT00591630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92910378|NCT00591630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92910379|NCT00591630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910380|NCT00591630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910381|NCT00591630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910382|NCT00591630|Antimetabolites|antimetabolites|mesh-ancestor
92910383|NCT00591630|Antiviral Agents|antiviral agents|mesh-ancestor
92910384|NCT00591630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910385|NCT00591630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910386|NCT00591630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92910387|NCT00591630|Alkylating Agents|alkylating agents|mesh-ancestor
92910388|NCT00591630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92910389|NCT00771394|Tamsulosin|tamsulosin|mesh-list
92910390|NCT00771394|Solifenacin Succinate|solifenacin succinate|mesh-list
92910391|NCT00771394|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92910392|NCT00771394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92910393|NCT00771394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92910394|NCT00771394|Adrenergic Agents|adrenergic agents|mesh-ancestor
92910395|NCT00771394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910396|NCT00771394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910397|NCT00771394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910398|NCT00771394|Urological Agents|urological agents|mesh-ancestor
92910399|NCT00771394|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92910400|NCT00771394|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92910401|NCT00771394|Cholinergic Agents|cholinergic agents|mesh-ancestor
92910403|NCT00670228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92910404|NCT00670228|Insulin Glargine|insulin glargine|mesh-list
92555900|NCT00208039|Calfactant|calfactant|mesh-list
92910405|NCT00670228|Insulin glulisine|insulin glulisine|mesh-list
92910406|NCT00670228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910407|NCT00670228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910408|NCT00766246|Bevacizumab|bevacizumab|mesh-list
92910409|NCT00766246|Carboplatin|carboplatin|mesh-list
92910410|NCT00766246|Docetaxel|docetaxel|mesh-list
92910411|NCT00766246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910412|NCT00766246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910413|NCT00766246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92910414|NCT00766246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92910415|NCT00766246|Growth Substances|growth substances|mesh-ancestor
92910416|NCT00766246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910417|NCT00766246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92910418|NCT00766246|Tubulin Modulators|tubulin modulators|mesh-ancestor
92910419|NCT00766246|Antimitotic Agents|antimitotic agents|mesh-ancestor
92910420|NCT00766246|Mitosis Modulators|mitosis modulators|mesh-ancestor
92910421|NCT00766246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910422|NCT00766402|Acetaminophen|acetaminophen|mesh-list
92910423|NCT00766402|Diclofenac|diclofenac|mesh-list
92910424|NCT00766402|Tramadol|tramadol|mesh-list
92910425|NCT00766402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910426|NCT00766402|Analgesics|analgesics|mesh-ancestor
92910427|NCT00766402|Sensory System Agents|sensory system agents|mesh-ancestor
92910428|NCT00766402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910429|NCT00766402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910430|NCT00766402|Antipyretics|antipyretics|mesh-ancestor
92910431|NCT00766402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910432|NCT00766402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910433|NCT00766402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910434|NCT00766402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92910435|NCT00766402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910436|NCT00766402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910437|NCT00766402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92910438|NCT00766402|Narcotics|narcotics|mesh-ancestor
92910439|NCT00766402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910440|NCT00771706|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92910441|NCT00771706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910442|NCT00771706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910443|NCT00760864|Methotrexate|methotrexate|mesh-list
92910444|NCT00760864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92910445|NCT00760864|Abortifacient Agents|abortifacient agents|mesh-ancestor
92910446|NCT00760864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910447|NCT00760864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910448|NCT00760864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910449|NCT00760864|Antimetabolites|antimetabolites|mesh-ancestor
92910450|NCT00760864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910451|NCT00760864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910452|NCT00760864|Dermatologic Agents|dermatologic agents|mesh-ancestor
92910453|NCT00760864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910454|NCT00760864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92910455|NCT00760864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910456|NCT00760864|Immunologic Factors|immunologic factors|mesh-ancestor
92910457|NCT00760864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910458|NCT00760864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92910459|NCT00766480|Fluorouracil|fluorouracil|mesh-list
92910460|NCT00766480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910461|NCT00766480|Antimetabolites|antimetabolites|mesh-ancestor
92910462|NCT00766480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910463|NCT00766480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910464|NCT00766480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910465|NCT00766480|Immunologic Factors|immunologic factors|mesh-ancestor
92526087|NCT00027742|Antiviral Agents|antiviral agents|mesh-ancestor
92910466|NCT00766480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910468|NCT00772174|Pioglitazone|pioglitazone|mesh-list
92910469|NCT00772174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910470|NCT00772174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910471|NCT00772564|Atorvastatin|atorvastatin|mesh-list
92910472|NCT00772564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92910473|NCT00772564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92910474|NCT00772564|Antimetabolites|antimetabolites|mesh-ancestor
92910475|NCT00772564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910476|NCT00772564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92910477|NCT00772564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92910478|NCT00772564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910479|NCT00766870|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92910480|NCT00766870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92910481|NCT00766870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92910482|NCT00766870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92910483|NCT00766870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910484|NCT00766870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910485|NCT00766870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910486|NCT00766870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92910487|NCT00766870|Antidepressive Agents|antidepressive agents|mesh-ancestor
92910488|NCT00766870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910489|NCT00772720|Raltegravir Potassium|raltegravir potassium|mesh-list
92910490|NCT00772720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92910491|NCT00772720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92910492|NCT00772720|Antiviral Agents|antiviral agents|mesh-ancestor
92910493|NCT00772720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910494|NCT00772720|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92910495|NCT00772720|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92910496|NCT00772720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910497|NCT00772720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910498|NCT00775294|Maraviroc|maraviroc|mesh-list
92910499|NCT00775294|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92910500|NCT00775294|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92910501|NCT00775294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910502|NCT00775294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92910503|NCT00775294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92910504|NCT00775294|Antiviral Agents|antiviral agents|mesh-ancestor
92910505|NCT00775294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910506|NCT00775294|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92910507|NCT00772798|Paclitaxel|paclitaxel|mesh-list
92910508|NCT00772798|Carboplatin|carboplatin|mesh-list
92910509|NCT00772798|Vorinostat|vorinostat|mesh-list
92910510|NCT00772798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92910511|NCT00772798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910512|NCT00772798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92910513|NCT00772798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92910514|NCT00772798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92910515|NCT00772798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910516|NCT00772798|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92910517|NCT00772798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910518|NCT00570778|Glycopyrrolate|glycopyrrolate|mesh-list
92910519|NCT00570778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92910520|NCT00570778|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92910521|NCT00570778|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92910522|NCT00570778|Cholinergic Agents|cholinergic agents|mesh-ancestor
92910523|NCT00570778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910524|NCT00570778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910525|NCT00570778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910526|NCT00775372|Clarithromycin|clarithromycin|mesh-list
92910527|NCT00775372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910528|NCT00775372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162334|NCT01237197|Incretins|incretins|mesh-ancestor
92910529|NCT00775372|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92910530|NCT00775372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910531|NCT00775372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910532|NCT00775372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92910533|NCT00775372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92910534|NCT00668746|Minocycline|minocycline|mesh-list
92910535|NCT00668746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910536|NCT00668746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910538|NCT04047940|Valsartan|valsartan|mesh-list
92910539|NCT04047940|Atorvastatin|atorvastatin|mesh-list
92910540|NCT04047940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910541|NCT04047940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910542|NCT04047940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92910543|NCT04047940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92910544|NCT04047940|Antimetabolites|antimetabolites|mesh-ancestor
92910545|NCT04047940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910546|NCT04047940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92910547|NCT04047940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92910548|NCT04047940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910549|NCT04047940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92910550|NCT04047940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92910551|NCT04047940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92910552|NCT00773188|Bevacizumab|bevacizumab|mesh-list
92910553|NCT00773188|Vinorelbine|vinorelbine|mesh-list
92556040|NCT00040859|Antimetabolites|antimetabolites|mesh-ancestor
92910554|NCT00773188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910555|NCT00773188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910556|NCT00773188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92910557|NCT00773188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92910558|NCT00773188|Growth Substances|growth substances|mesh-ancestor
92910559|NCT00773188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910560|NCT00773188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92910561|NCT00773188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92910562|NCT00773188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92910563|NCT00773188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92910564|NCT00773188|Mitosis Modulators|mitosis modulators|mesh-ancestor
92910565|NCT00773188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910566|NCT00767260|Insulin|insulin|mesh-list
92910567|NCT00767260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910568|NCT00767260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910569|NCT00767494|Travoprost|travoprost|mesh-list
92910570|NCT00767494|Brinzolamide|brinzolamide|mesh-list
92910571|NCT00767494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92910572|NCT00767494|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92910573|NCT00767494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910574|NCT00767494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910575|NCT00773578|Nitric Oxide|nitric oxide|mesh-list
92910576|NCT00773578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92910577|NCT00773578|Autonomic Agents|autonomic agents|mesh-ancestor
92910578|NCT00773578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910579|NCT00773578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910580|NCT00773578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92910581|NCT00773578|Respiratory System Agents|respiratory system agents|mesh-ancestor
92910582|NCT00773578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92910583|NCT00773578|Antioxidants|antioxidants|mesh-ancestor
92910584|NCT00773578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910585|NCT00773578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910586|NCT00773578|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92910587|NCT00773578|Vasodilator Agents|vasodilator agents|mesh-ancestor
92910588|NCT00773578|Gasotransmitters|gasotransmitters|mesh-ancestor
92910589|NCT00773578|Protective Agents|protective agents|mesh-ancestor
92910590|NCT00775762|Aspirin|aspirin|mesh-list
92910591|NCT00775762|Clopidogrel|clopidogrel|mesh-list
92910592|NCT00775762|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910593|NCT00775762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910594|NCT00775762|Analgesics|analgesics|mesh-ancestor
92910595|NCT00775762|Sensory System Agents|sensory system agents|mesh-ancestor
92910596|NCT00775762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910597|NCT00775762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910598|NCT00775762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910599|NCT00775762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910600|NCT00775762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92910601|NCT00775762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92910602|NCT00775762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910603|NCT00775762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92910604|NCT00775762|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92910605|NCT00775762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910606|NCT00775762|Antipyretics|antipyretics|mesh-ancestor
92910607|NCT00775762|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92910608|NCT00775762|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92910609|NCT00775762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92910610|NCT00775762|Purinergic Agents|purinergic agents|mesh-ancestor
92910611|NCT00775762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910612|NCT00775840|Candesartan|candesartan|mesh-list
92910613|NCT00775840|Candesartan cilexetil|candesartan cilexetil|mesh-list
92910614|NCT00775840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92910615|NCT00775840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92910616|NCT00775840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92910617|NCT00775840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910618|NCT00775918|Doxycycline|doxycycline|mesh-list
92910619|NCT00775918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910620|NCT00775918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910621|NCT00775918|Antimalarials|antimalarials|mesh-ancestor
92910622|NCT00775918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92910623|NCT00775918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92910624|NCT00878189|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92910625|NCT00878189|Nirogacestat|nirogacestat|mesh-list
92910626|NCT00878189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556115|NCT00208897|Fluoxetine|fluoxetine|mesh-list
92910627|NCT00878189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910628|NCT00775996|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
92910629|NCT00775996|Anticonvulsants|anticonvulsants|mesh-ancestor
92910630|NCT00775996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92910631|NCT00775996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92910632|NCT00775996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910633|NCT00775996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910634|NCT00775996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910635|NCT00775996|GABA Modulators|gaba modulators|mesh-ancestor
92910636|NCT00775996|GABA Agents|gaba agents|mesh-ancestor
92910637|NCT00775996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910638|NCT00775996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910639|NCT00773812|Mecamylamine|mecamylamine|mesh-list
92910640|NCT00773812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92910641|NCT00773812|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92910642|NCT00773812|Autonomic Agents|autonomic agents|mesh-ancestor
92910643|NCT00773812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910644|NCT00773812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910645|NCT00773812|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92910646|NCT00773812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92910647|NCT00773812|Cholinergic Agents|cholinergic agents|mesh-ancestor
92910648|NCT00773812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910649|NCT00773812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910650|NCT00767728|Mesalamine|mesalamine|mesh-list
92910651|NCT00767728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910652|NCT00767728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910653|NCT00767728|Analgesics|analgesics|mesh-ancestor
92910654|NCT00767728|Sensory System Agents|sensory system agents|mesh-ancestor
92910655|NCT00767728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910656|NCT00767728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910657|NCT00767728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910658|NCT00767728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910659|NCT00776074|Leuprolide|leuprolide|mesh-list
92910660|NCT00776074|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92910661|NCT00776074|Fertility Agents|fertility agents|mesh-ancestor
92910662|NCT00776074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910663|NCT00776074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910664|NCT00776074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92910665|NCT00776074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910666|NCT02628587|Clopidogrel|clopidogrel|mesh-list
92910667|NCT02628587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92910668|NCT02628587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92910669|NCT02628587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92910670|NCT02628587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92910671|NCT02628587|Purinergic Agents|purinergic agents|mesh-ancestor
92910672|NCT02628587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910673|NCT02628587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910674|NCT02628587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910675|NCT02634437|Ulipristal acetate|ulipristal acetate|mesh-list
92910676|NCT02634437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92910677|NCT02634437|Contraceptive Agents|contraceptive agents|mesh-ancestor
92910678|NCT02634437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910679|NCT02634437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910680|NCT02634437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92910681|NCT00668200|Vitamin D|vitamin d|mesh-list
92910682|NCT00668200|Zoledronic Acid|zoledronic acid|mesh-list
92910683|NCT00668200|Calcium|calcium|mesh-list
92910684|NCT00668200|Vitamins|vitamins|mesh-ancestor
92910685|NCT00668200|Micronutrients|micronutrients|mesh-ancestor
92910686|NCT00668200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910687|NCT00668200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92910688|NCT00668200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92910689|NCT00679601|Tavaborole|tavaborole|mesh-list
92910690|NCT00679601|Antifungal Agents|antifungal agents|mesh-ancestor
92910691|NCT00679601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910692|NCT00675779|Atorvastatin|atorvastatin|mesh-list
92910693|NCT00675779|Contraceptive Agents|contraceptive agents|mesh-list
92910694|NCT00675779|Contraceptives, Oral|contraceptives, oral|mesh-list
92910695|NCT00675779|Dacuronium|dacuronium|mesh-list
92910696|NCT00675779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92910697|NCT00675779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92910698|NCT00675779|Antimetabolites|antimetabolites|mesh-ancestor
92910699|NCT00675779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910700|NCT00675779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93047008|NCT01051934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910701|NCT00675779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92910702|NCT00675779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910703|NCT00675779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910704|NCT00675779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910705|NCT00675779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92910706|NCT00675779|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92910707|NCT00675779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92910708|NCT00675779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92910709|NCT00675779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910710|NCT00774280|Cyclophosphamide|cyclophosphamide|mesh-list
92910711|NCT00774280|Busulfan|busulfan|mesh-list
92910712|NCT00774280|Fludarabine|fludarabine|mesh-list
92910713|NCT00774280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910714|NCT00774280|Immunologic Factors|immunologic factors|mesh-ancestor
92910715|NCT00774280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910716|NCT00774280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910717|NCT00774280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92910718|NCT00774280|Alkylating Agents|alkylating agents|mesh-ancestor
92910719|NCT00774280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910720|NCT00774280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910721|NCT00774280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92910722|NCT04151147|Mitogens|mitogens|mesh-list
92910723|NCT04151147|Mitosis Modulators|mitosis modulators|mesh-ancestor
92910724|NCT04151147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910725|NCT00774358|Aldesleukin|aldesleukin|mesh-list
92910726|NCT00774358|Interleukin-2|interleukin-2|mesh-list
92910727|NCT00774358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910728|NCT00774358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910729|NCT00774358|Analgesics|analgesics|mesh-ancestor
92910730|NCT00774358|Sensory System Agents|sensory system agents|mesh-ancestor
92910731|NCT00774358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910732|NCT00774358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910733|NCT00774358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92910734|NCT00774358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92910735|NCT00774358|Antiviral Agents|antiviral agents|mesh-ancestor
92910736|NCT00774358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910737|NCT02627417|Dapsone|dapsone|mesh-list
92910738|NCT02627417|Prednisone|prednisone|mesh-list
92910739|NCT02627417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910740|NCT02627417|Glucocorticoids|glucocorticoids|mesh-ancestor
92910741|NCT02627417|Hormones|hormones|mesh-ancestor
92910742|NCT02627417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92910743|NCT02627417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910744|NCT02627417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92910745|NCT02627417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910746|NCT02627417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910747|NCT02627417|Antimalarials|antimalarials|mesh-ancestor
92910748|NCT02627417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92910749|NCT02627417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92910750|NCT02627417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92910751|NCT02627417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910752|NCT02627417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910754|NCT02627417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910755|NCT00679679|Metformin|metformin|mesh-list
92910756|NCT00679679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910757|NCT00679679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910758|NCT00838578|Irinotecan|irinotecan|mesh-list
92910759|NCT00838578|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92910760|NCT00838578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92910761|NCT00838578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910762|NCT00838578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910763|NCT00838578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910764|NCT02634515|Insulin|insulin|mesh-list
92910765|NCT02634515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92910766|NCT02634515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910767|NCT02634515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910768|NCT00705900|Calcipotriene|calcipotriene|mesh-list
92910769|NCT00705900|Dermatologic Agents|dermatologic agents|mesh-ancestor
92910770|NCT00679835|Daptomycin|daptomycin|mesh-list
92910771|NCT00679835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910772|NCT00679835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910773|NCT00774904|Losartan|losartan|mesh-list
92910774|NCT00774904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92910775|NCT00774904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92556265|NCT00209716|Antimetabolites|antimetabolites|mesh-ancestor
92910776|NCT00774904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92910777|NCT00774904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92910778|NCT00774904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910780|NCT00829296|Nebivolol|nebivolol|mesh-list
92910781|NCT00829296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92910782|NCT00829296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92910783|NCT00829296|Sympatholytics|sympatholytics|mesh-ancestor
92910784|NCT00829296|Autonomic Agents|autonomic agents|mesh-ancestor
92910785|NCT00829296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910786|NCT00829296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910787|NCT00829296|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92910788|NCT00829296|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92910789|NCT00829296|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92910790|NCT00829296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92910791|NCT00829296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910792|NCT00829296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910793|NCT00829296|Vasodilator Agents|vasodilator agents|mesh-ancestor
92910794|NCT00829296|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92910795|NCT00829296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92910796|NCT00829296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92910797|NCT00774982|Mercaptopurine|mercaptopurine|mesh-list
92910798|NCT00774982|Antimetabolites|antimetabolites|mesh-ancestor
92910799|NCT00774982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910800|NCT00774982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910801|NCT00774982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910802|NCT00774982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910803|NCT00774982|Immunologic Factors|immunologic factors|mesh-ancestor
92910804|NCT00774982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910805|NCT00774982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92910806|NCT00774982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910807|NCT00881621|Capecitabine|capecitabine|mesh-list
92910808|NCT00881621|Lapatinib|lapatinib|mesh-list
92910809|NCT00881621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910810|NCT00881621|Antimetabolites|antimetabolites|mesh-ancestor
92910811|NCT00881621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910812|NCT00881621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910813|NCT00881621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92910814|NCT00881621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910815|NCT02634281|Varenicline|varenicline|mesh-list
92910816|NCT02634281|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92910817|NCT02634281|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92910818|NCT02634281|Cholinergic Agents|cholinergic agents|mesh-ancestor
92910819|NCT02634281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910820|NCT02634281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910821|NCT02634281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910822|NCT00818766|Vancomycin|vancomycin|mesh-list
92910823|NCT00818766|Cefazolin|cefazolin|mesh-list
92910824|NCT00818766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910825|NCT00818766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910826|NCT00779350|Sertraline|sertraline|mesh-list
92910827|NCT00779350|Antidepressive Agents|antidepressive agents|mesh-ancestor
92910828|NCT00779350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92910829|NCT00779350|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92910830|NCT00779350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92910831|NCT00779350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92910832|NCT00779350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910833|NCT00779350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910834|NCT00779350|Serotonin Agents|serotonin agents|mesh-ancestor
92910835|NCT00779350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910836|NCT00705978|Pancreatin|pancreatin|mesh-list
92910837|NCT00705978|Pancrelipase|pancrelipase|mesh-list
92910838|NCT00705978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92910839|NCT02556970|Acetaminophen|acetaminophen|mesh-list
92910840|NCT02556970|Diclofenac|diclofenac|mesh-list
92910841|NCT02556970|Levobupivacaine|levobupivacaine|mesh-list
92910842|NCT02556970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910843|NCT02556970|Analgesics|analgesics|mesh-ancestor
92910844|NCT02556970|Sensory System Agents|sensory system agents|mesh-ancestor
92910845|NCT02556970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910846|NCT02556970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910847|NCT02556970|Antipyretics|antipyretics|mesh-ancestor
92910848|NCT02556970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910849|NCT02556970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910850|NCT02556970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910851|NCT02556970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92910852|NCT02556970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910853|NCT02556970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910854|NCT02556970|Anesthetics, Local|anesthetics, local|mesh-ancestor
92910855|NCT02556970|Anesthetics|anesthetics|mesh-ancestor
92910856|NCT02556970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92910857|NCT00594815|Leucovorin|leucovorin|mesh-list
92910858|NCT00594815|Cytarabine|cytarabine|mesh-list
92910859|NCT00594815|Rituximab|rituximab|mesh-list
92910860|NCT00594815|Methotrexate|methotrexate|mesh-list
92910861|NCT00594815|Vincristine|vincristine|mesh-list
92910862|NCT00594815|Procarbazine|procarbazine|mesh-list
92910863|NCT00594815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910864|NCT00594815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910865|NCT00594815|Immunologic Factors|immunologic factors|mesh-ancestor
92910866|NCT00594815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910867|NCT00594815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910868|NCT00594815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92910869|NCT00594815|Abortifacient Agents|abortifacient agents|mesh-ancestor
92910870|NCT00594815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910871|NCT00594815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92910872|NCT00594815|Antimetabolites|antimetabolites|mesh-ancestor
92910873|NCT00594815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910874|NCT00594815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92910875|NCT00594815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910876|NCT00594815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92910877|NCT00594815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910878|NCT00594815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92910879|NCT00594815|Antiviral Agents|antiviral agents|mesh-ancestor
92910880|NCT00594815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910881|NCT00594815|Antidotes|antidotes|mesh-ancestor
92910882|NCT00594815|Protective Agents|protective agents|mesh-ancestor
92910883|NCT00594815|Vitamin B Complex|vitamin b complex|mesh-ancestor
92910884|NCT00594815|Vitamins|vitamins|mesh-ancestor
92910885|NCT00594815|Micronutrients|micronutrients|mesh-ancestor
92910886|NCT00594815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92910887|NCT00594815|Tubulin Modulators|tubulin modulators|mesh-ancestor
92910888|NCT00594815|Antimitotic Agents|antimitotic agents|mesh-ancestor
92910889|NCT00594815|Mitosis Modulators|mitosis modulators|mesh-ancestor
92910890|NCT00776542|Minocycline|minocycline|mesh-list
92910891|NCT00776542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910892|NCT00776542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910893|NCT00776620|Glimepiride|glimepiride|mesh-list
92910894|NCT00776620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92910895|NCT00776620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92910896|NCT00776620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910897|NCT00776620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92910898|NCT00776620|Immunologic Factors|immunologic factors|mesh-ancestor
92910899|NCT00776698|Bevacizumab|bevacizumab|mesh-list
92910900|NCT00776698|Etoposide|etoposide|mesh-list
92910901|NCT00776698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92526098|NCT00027820|Cyclosporins|cyclosporins|mesh-list
92910902|NCT00776698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910903|NCT00776698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92910904|NCT00776698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92910905|NCT00776698|Growth Substances|growth substances|mesh-ancestor
92910906|NCT00776698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910907|NCT00776698|Growth Inhibitors|growth inhibitors|mesh-ancestor
92910908|NCT00776698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92910909|NCT00776698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92910910|NCT00776698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92910911|NCT00776698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910912|NCT00776698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910913|NCT00820248|Panitumumab|panitumumab|mesh-list
92910914|NCT00820248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910915|NCT00820248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92910916|NCT04150757|Ketamine|ketamine|mesh-list
92910917|NCT04150757|Analgesics|analgesics|mesh-ancestor
92910918|NCT04150757|Sensory System Agents|sensory system agents|mesh-ancestor
92910919|NCT04150757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910920|NCT04150757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910921|NCT04150757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92910922|NCT04150757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92910923|NCT04150757|Anesthetics, General|anesthetics, general|mesh-ancestor
92910924|NCT04150757|Anesthetics|anesthetics|mesh-ancestor
92910925|NCT04150757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047009|NCT01051934|Tubulin Modulators|tubulin modulators|mesh-ancestor
92910926|NCT04150757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92910927|NCT04150757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92910928|NCT04150757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910929|NCT04150757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910930|NCT04150367|Rifampin|rifampin|mesh-list
92910931|NCT04150367|Isoniazid|isoniazid|mesh-list
92910932|NCT04150367|Ethambutol|ethambutol|mesh-list
92910933|NCT04150367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92910934|NCT04150367|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92910935|NCT04150367|Antitubercular Agents|antitubercular agents|mesh-ancestor
92910936|NCT04150367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92910937|NCT04150367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92910938|NCT04150367|Leprostatic Agents|leprostatic agents|mesh-ancestor
92910939|NCT04150367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92910940|NCT04150367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910941|NCT04150367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162364|NCT04410341|Protease Inhibitors|protease inhibitors|mesh-ancestor
92910942|NCT04150367|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92910943|NCT04150367|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92910944|NCT04150367|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92910945|NCT04150367|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92910946|NCT04150367|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92910947|NCT04150367|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92910948|NCT04150367|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92910949|NCT04150367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92910950|NCT04150367|Antimetabolites|antimetabolites|mesh-ancestor
92910951|NCT04150367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92910952|NCT02634203|Riociguat|riociguat|mesh-list
92910953|NCT02634203|Enzyme Activators|enzyme activators|mesh-ancestor
92910954|NCT02634203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910955|NCT00681005|Rabeprazole|rabeprazole|mesh-list
92910956|NCT00681005|Pantoprazole|pantoprazole|mesh-list
92910957|NCT00681005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92910958|NCT00681005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92910959|NCT00681005|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92910960|NCT00681005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910961|NCT00681005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910962|NCT02633969|Indomethacin|indomethacin|mesh-list
92910963|NCT02633969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92910964|NCT02633969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92910965|NCT02633969|Analgesics|analgesics|mesh-ancestor
92910966|NCT02633969|Sensory System Agents|sensory system agents|mesh-ancestor
92255800|NCT03217448|Warfarin|warfarin|mesh-list
92910967|NCT02633969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910968|NCT02633969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910969|NCT02633969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92910970|NCT02633969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92910971|NCT02633969|Gout Suppressants|gout suppressants|mesh-ancestor
92910972|NCT02633969|Tocolytic Agents|tocolytic agents|mesh-ancestor
92910973|NCT02633969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910974|NCT02633969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92910975|NCT02633969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92910976|NCT02633969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910977|NCT00684827|Albuterol|albuterol|mesh-list
92910978|NCT00684827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92910979|NCT00684827|Autonomic Agents|autonomic agents|mesh-ancestor
92910980|NCT00684827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92910981|NCT00684827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92910982|NCT00684827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92910983|NCT00684827|Respiratory System Agents|respiratory system agents|mesh-ancestor
92910984|NCT00684827|Tocolytic Agents|tocolytic agents|mesh-ancestor
92910985|NCT00684827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92910986|NCT00684827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92910987|NCT00684827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92910988|NCT00684827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92910989|NCT00684827|Adrenergic Agents|adrenergic agents|mesh-ancestor
92910990|NCT00684827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92910991|NCT00684827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92910992|NCT00820170|Paclitaxel|paclitaxel|mesh-list
92910993|NCT00820170|Dasatinib|dasatinib|mesh-list
92910994|NCT00820170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92910995|NCT00820170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92910996|NCT00820170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92910997|NCT00820170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92910998|NCT00820170|Mitosis Modulators|mitosis modulators|mesh-ancestor
93047010|NCT01051934|Antimitotic Agents|antimitotic agents|mesh-ancestor
92910999|NCT00820170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911000|NCT00820170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92911001|NCT00820170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911002|NCT02627027|Metformin|metformin|mesh-list
92911003|NCT02627027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911004|NCT02627027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911005|NCT00709332|Folic Acid|folic acid|mesh-list
92911006|NCT00709332|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92911007|NCT00709332|Norgestimate|norgestimate|mesh-list
92911008|NCT00709332|Estradiol|estradiol|mesh-list
92911009|NCT00709332|Estrogens|estrogens|mesh-ancestor
92911010|NCT00709332|Hormones|hormones|mesh-ancestor
92911011|NCT00709332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911012|NCT00709332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911013|NCT00709332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92911014|NCT00709332|Contraceptive Agents|contraceptive agents|mesh-ancestor
92911015|NCT00709332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92911016|NCT00709332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92911017|NCT00709332|Hematinics|hematinics|mesh-ancestor
92911018|NCT00709332|Vitamin B Complex|vitamin b complex|mesh-ancestor
92911019|NCT00709332|Vitamins|vitamins|mesh-ancestor
92911020|NCT00709332|Micronutrients|micronutrients|mesh-ancestor
92911021|NCT00709332|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92911022|NCT00709332|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92911023|NCT00709332|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92911024|NCT00684905|Leuprolide|leuprolide|mesh-list
92911025|NCT00684905|Bicalutamide|bicalutamide|mesh-list
92911026|NCT00684905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92911027|NCT00684905|Fertility Agents|fertility agents|mesh-ancestor
92911028|NCT00684905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92911029|NCT00684905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911030|NCT00684905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911031|NCT00684905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911032|NCT00684905|Androgen Antagonists|androgen antagonists|mesh-ancestor
92911033|NCT00684905|Hormone Antagonists|hormone antagonists|mesh-ancestor
92911034|NCT00684905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911035|NCT00685061|Alemtuzumab|alemtuzumab|mesh-list
92911036|NCT00685061|Thymoglobulin|thymoglobulin|mesh-list
92911037|NCT00685061|Daclizumab|daclizumab|mesh-list
92911038|NCT00685061|Immunologic Factors|immunologic factors|mesh-ancestor
92911039|NCT00685061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911040|NCT00685061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911041|NCT00685061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92911042|NCT00685061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911043|NCT02633813|Naftifine|naftifine|mesh-list
92911044|NCT02633813|Antifungal Agents|antifungal agents|mesh-ancestor
92911045|NCT02633813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911046|NCT00818454|Albuterol|albuterol|mesh-list
92911047|NCT00818454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92911048|NCT00818454|Autonomic Agents|autonomic agents|mesh-ancestor
92911049|NCT00818454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911050|NCT00818454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911051|NCT00818454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92911052|NCT00818454|Respiratory System Agents|respiratory system agents|mesh-ancestor
92911053|NCT00818454|Tocolytic Agents|tocolytic agents|mesh-ancestor
92911054|NCT00818454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92911055|NCT00818454|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92911056|NCT00818454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92911057|NCT00818454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92911058|NCT00818454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92911059|NCT00818454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911060|NCT00818454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911061|NCT02626247|Vitamin A|vitamin a|mesh-list
92911062|NCT02626247|Vitamins|vitamins|mesh-ancestor
92911063|NCT02626247|Micronutrients|micronutrients|mesh-ancestor
92911064|NCT02626247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911065|NCT05758818|Moxifloxacin|moxifloxacin|mesh-list
92911066|NCT05758818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911067|NCT05758818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911068|NCT05758818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92911069|NCT05758818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92911070|NCT05758818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911071|NCT05758818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911072|NCT05758818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911073|NCT00828984|Laxatives|laxatives|mesh-list
92911074|NCT00828984|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92911075|NCT00828984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911076|NCT00819390|Chloroquine|chloroquine|mesh-list
92911077|NCT00819390|Amebicides|amebicides|mesh-ancestor
92911078|NCT00819390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92911079|NCT00819390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92911080|NCT00819390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911081|NCT00819390|Antimalarials|antimalarials|mesh-ancestor
92911082|NCT00819390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911083|NCT00876395|Paclitaxel|paclitaxel|mesh-list
92911084|NCT00876395|Trastuzumab|trastuzumab|mesh-list
92911085|NCT00876395|Everolimus|everolimus|mesh-list
92911086|NCT00876395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92911087|NCT00876395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911088|NCT00876395|Tubulin Modulators|tubulin modulators|mesh-ancestor
92911089|NCT00876395|Antimitotic Agents|antimitotic agents|mesh-ancestor
92911090|NCT00876395|Mitosis Modulators|mitosis modulators|mesh-ancestor
92911091|NCT00876395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911092|NCT00876395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92911093|NCT00876395|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92911094|NCT00876395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92911095|NCT00876395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911096|NCT00876395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911097|NCT00876395|Immunologic Factors|immunologic factors|mesh-ancestor
92911098|NCT00876395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911099|NCT05758662|Listerine|listerine|mesh-list
92911100|NCT05758662|Fluorides|fluorides|mesh-list
92911101|NCT05758662|Sodium Fluoride|sodium fluoride|mesh-list
92911102|NCT05758662|Cariostatic Agents|cariostatic agents|mesh-ancestor
92911103|NCT05758662|Protective Agents|protective agents|mesh-ancestor
92911104|NCT05758662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911105|NCT05758662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92911106|NCT05758662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911107|NCT02633657|Gabapentin|gabapentin|mesh-list
92911108|NCT02633657|Analgesics|analgesics|mesh-ancestor
92911109|NCT02633657|Sensory System Agents|sensory system agents|mesh-ancestor
92911110|NCT02633657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911111|NCT02633657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911112|NCT02633657|Anticonvulsants|anticonvulsants|mesh-ancestor
92911113|NCT02633657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92911114|NCT02633657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92911115|NCT02633657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911116|NCT02633657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92911117|NCT02633657|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92911118|NCT02633657|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92911120|NCT02633657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911121|NCT02633657|Antimanic Agents|antimanic agents|mesh-ancestor
92911122|NCT02626169|Clopidogrel|clopidogrel|mesh-list
92911123|NCT02626169|Ticagrelor|ticagrelor|mesh-list
92911124|NCT02626169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92911125|NCT02626169|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92911126|NCT02626169|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92911127|NCT02626169|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92911128|NCT02626169|Purinergic Agents|purinergic agents|mesh-ancestor
92911129|NCT02626169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911130|NCT02626169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911131|NCT02626169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911132|NCT04139915|Dactolisib|dactolisib|mesh-list
92911133|NCT04139915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911134|NCT04148183|Metformin|metformin|mesh-list
92911135|NCT04148183|Rosiglitazone|rosiglitazone|mesh-list
92911136|NCT04148183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911137|NCT04148183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911138|NCT00681395|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92911139|NCT00681395|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92911140|NCT00681395|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92911141|NCT00681395|Antimetabolites|antimetabolites|mesh-ancestor
92911142|NCT00681395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911143|NCT00681395|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92911144|NCT00681395|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92911145|NCT00681395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911146|NCT02633579|Erythromycin|erythromycin|mesh-list
92911147|NCT02633579|Erythromycin Estolate|erythromycin estolate|mesh-list
92911148|NCT02633579|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92911149|NCT02633579|Erythromycin stearate|erythromycin stearate|mesh-list
92911150|NCT02633579|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
92911151|NCT02633579|Atropine|atropine|mesh-list
92911152|NCT02633579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92911153|NCT02633579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92911154|NCT02633579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92911155|NCT02633579|Autonomic Agents|autonomic agents|mesh-ancestor
92911156|NCT02633579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911157|NCT02633579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911158|NCT02633579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92911159|NCT02633579|Respiratory System Agents|respiratory system agents|mesh-ancestor
92911160|NCT02633579|Mydriatics|mydriatics|mesh-ancestor
92911161|NCT02633579|Parasympatholytics|parasympatholytics|mesh-ancestor
92911162|NCT02633579|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92911163|NCT02633579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92162373|NCT03010761|Serotonin Agents|serotonin agents|mesh-ancestor
92911164|NCT02633579|Cholinergic Agents|cholinergic agents|mesh-ancestor
92911165|NCT02633579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911166|NCT02633579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911167|NCT02633579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911168|NCT02633579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911169|NCT02633579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911170|NCT02633579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92911171|NCT02633579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911172|NCT00685529|Formoterol Fumarate|formoterol fumarate|mesh-list
92911173|NCT00685529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92911174|NCT00685529|Autonomic Agents|autonomic agents|mesh-ancestor
92911175|NCT00685529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911176|NCT00685529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911177|NCT00685529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92911178|NCT00685529|Respiratory System Agents|respiratory system agents|mesh-ancestor
92911179|NCT00685529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92911180|NCT00685529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92911181|NCT00685529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92911182|NCT00685529|Adrenergic Agents|adrenergic agents|mesh-ancestor
92911183|NCT00685529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911184|NCT00685529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911185|NCT00685607|Simethicone|simethicone|mesh-list
92911186|NCT00685607|Loperamide|loperamide|mesh-list
92911187|NCT00685607|Antidiarrheals|antidiarrheals|mesh-list
92911188|NCT00685607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911189|NCT00685607|Antifoaming Agents|antifoaming agents|mesh-ancestor
92526108|NCT00027820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911190|NCT00685607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911191|NCT00685607|Emollients|emollients|mesh-ancestor
92911192|NCT00685607|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911193|NCT00657059|Mycophenolic Acid|mycophenolic acid|mesh-list
92911195|NCT00657059|Methylprednisolone|methylprednisolone|mesh-list
92911196|NCT00657059|Irbesartan|irbesartan|mesh-list
92911197|NCT00657059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911198|NCT00657059|Glucocorticoids|glucocorticoids|mesh-ancestor
92911199|NCT00657059|Hormones|hormones|mesh-ancestor
92911200|NCT00657059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911201|NCT00657059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911202|NCT00657059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911203|NCT00657059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911204|NCT00657059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92911205|NCT00657059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92911206|NCT00657059|Antitubercular Agents|antitubercular agents|mesh-ancestor
92911207|NCT00657059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911208|NCT00657059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911209|NCT00657059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911210|NCT00657059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911211|NCT00657059|Antiemetics|antiemetics|mesh-ancestor
92911212|NCT00657059|Autonomic Agents|autonomic agents|mesh-ancestor
92911213|NCT00657059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911214|NCT00657059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911215|NCT00657059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92911216|NCT00657059|Protective Agents|protective agents|mesh-ancestor
92911217|NCT00657059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911218|NCT00657059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92911219|NCT00657059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92911220|NCT00667732|Exenatide|exenatide|mesh-list
92911221|NCT00667732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911222|NCT00667732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911223|NCT00667732|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92911224|NCT00667732|Incretins|incretins|mesh-ancestor
92911225|NCT00667732|Hormones|hormones|mesh-ancestor
92911226|NCT00667732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911227|NCT04161209|Citalopram|citalopram|mesh-list
92911228|NCT04161209|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92911229|NCT04161209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92911230|NCT04161209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911231|NCT04161209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911232|NCT04161209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911233|NCT04161209|Serotonin Agents|serotonin agents|mesh-ancestor
92911234|NCT04161209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911235|NCT04161209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92911236|NCT04161209|Antidepressive Agents|antidepressive agents|mesh-ancestor
92911237|NCT04161209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92911238|NCT04161053|Rifaximin|rifaximin|mesh-list
92911239|NCT04161053|Nitazoxanide|nitazoxanide|mesh-list
92911240|NCT04161053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911241|NCT04161053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911242|NCT04161053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911243|NCT04161053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92911244|NCT00685841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92911245|NCT00685841|Formoterol Fumarate|formoterol fumarate|mesh-list
92911246|NCT00685841|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92911247|NCT00685841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92911248|NCT00685841|Autonomic Agents|autonomic agents|mesh-ancestor
92911249|NCT00685841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911250|NCT00685841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911251|NCT00685841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92911252|NCT00685841|Respiratory System Agents|respiratory system agents|mesh-ancestor
92911253|NCT00685841|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92911254|NCT00685841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92911255|NCT00685841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92911256|NCT00685841|Adrenergic Agents|adrenergic agents|mesh-ancestor
92911257|NCT00685841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911258|NCT00685841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911259|NCT00681785|Dalteparin|dalteparin|mesh-list
92911260|NCT00681785|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92911261|NCT00681785|Anticoagulants|anticoagulants|mesh-ancestor
92911262|NCT00681785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92911263|NCT00681785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92911264|NCT00681785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911265|NCT00671788|Dasatinib|dasatinib|mesh-list
92911266|NCT00671788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911267|NCT00671788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92911268|NCT00671788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911269|NCT00671788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911270|NCT02626481|Dexamethasone|dexamethasone|mesh-list
92911271|NCT02626481|Daratumumab|daratumumab|mesh-list
92911272|NCT02626481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911273|NCT02626481|Antiemetics|antiemetics|mesh-ancestor
92911274|NCT02626481|Autonomic Agents|autonomic agents|mesh-ancestor
92911275|NCT02626481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911276|NCT02626481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911277|NCT02626481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911278|NCT02626481|Glucocorticoids|glucocorticoids|mesh-ancestor
92911279|NCT02626481|Hormones|hormones|mesh-ancestor
92911280|NCT02626481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911281|NCT02626481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911282|NCT02626481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911283|NCT00777166|Oxytocin|oxytocin|mesh-list
92911284|NCT00777166|Oxytocics|oxytocics|mesh-ancestor
92911285|NCT00777166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92911286|NCT00777166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911287|NCT00681941|Sevelamer|sevelamer|mesh-list
92911288|NCT00681941|Chelating Agents|chelating agents|mesh-ancestor
92911289|NCT00681941|Sequestering Agents|sequestering agents|mesh-ancestor
92911290|NCT00681941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911291|NCT00657137|Capecitabine|capecitabine|mesh-list
92911292|NCT00657137|Lapatinib|lapatinib|mesh-list
92911293|NCT00657137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92911294|NCT00657137|Antimetabolites|antimetabolites|mesh-ancestor
92911295|NCT00657137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911296|NCT00657137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911297|NCT00657137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92911298|NCT00657137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911299|NCT00777244|Mitotane|mitotane|mesh-list
92911300|NCT00777244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911301|NCT00777244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911302|NCT04160897|Tenofovir|tenofovir|mesh-list
92911303|NCT04160897|Entecavir|entecavir|mesh-list
92911304|NCT04160897|Antiviral Agents|antiviral agents|mesh-ancestor
92911305|NCT04160897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911306|NCT04160897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92911307|NCT04160897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92911308|NCT04160897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911309|NCT04160897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911310|NCT04160897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92911311|NCT04160897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92911312|NCT00777322|Riboflavin|riboflavin|mesh-list
92911313|NCT00777322|Dextrans|dextrans|mesh-list
92911314|NCT00777322|Vitamin B Complex|vitamin b complex|mesh-ancestor
92911315|NCT00777322|Vitamins|vitamins|mesh-ancestor
92911316|NCT00777322|Micronutrients|micronutrients|mesh-ancestor
92911317|NCT00777322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911318|NCT00777322|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92911319|NCT00777322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911320|NCT00777322|Anticoagulants|anticoagulants|mesh-ancestor
92911321|NCT00777322|Plasma Substitutes|plasma substitutes|mesh-ancestor
92911322|NCT00777322|Blood Substitutes|blood substitutes|mesh-ancestor
92911323|NCT00682019|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92911324|NCT00682019|Vasodilator Agents|vasodilator agents|mesh-ancestor
92911325|NCT00682019|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92911326|NCT00682019|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92911327|NCT00682019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911328|NCT00682019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911329|NCT00682019|Urological Agents|urological agents|mesh-ancestor
92911330|NCT00779896|Tazarotene|tazarotene|mesh-list
92911331|NCT00779896|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911332|NCT00779896|Keratolytic Agents|keratolytic agents|mesh-ancestor
92911333|NCT02556268|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92977266|NCT01070641|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92911334|NCT02556268|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92911335|NCT02556268|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92911336|NCT02556268|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
92911337|NCT02556268|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
92911338|NCT02556268|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92911339|NCT02556268|Riociguat|riociguat|mesh-list
92911340|NCT02556268|Protease Inhibitors|protease inhibitors|mesh-list
92911341|NCT02556268|Antiviral Agents|antiviral agents|mesh-ancestor
92911342|NCT02556268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911343|NCT02556268|Enzyme Activators|enzyme activators|mesh-ancestor
92911344|NCT02556268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911345|NCT02556268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92911346|NCT02556268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92911347|NCT02556268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911348|NCT02556268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92911349|NCT02556268|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92911350|NCT00875615|Carboplatin|carboplatin|mesh-list
92911351|NCT00875615|Sorafenib|sorafenib|mesh-list
92911352|NCT00875615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911353|NCT00875615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92911354|NCT00875615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911355|NCT00875615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911356|NCT02626559|Bupivacaine|bupivacaine|mesh-list
92911357|NCT02626559|Anesthetics, Local|anesthetics, local|mesh-ancestor
92911358|NCT02626559|Anesthetics|anesthetics|mesh-ancestor
92911359|NCT02626559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911360|NCT02626559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911361|NCT02626559|Sensory System Agents|sensory system agents|mesh-ancestor
92911362|NCT02626559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911363|NCT00768508|Naltrexone|naltrexone|mesh-list
92911364|NCT00768508|Ondansetron|ondansetron|mesh-list
92911365|NCT00768508|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92911366|NCT00768508|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92911367|NCT00768508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911368|NCT00768508|Sensory System Agents|sensory system agents|mesh-ancestor
92911369|NCT00768508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911370|NCT00768508|Antiemetics|antiemetics|mesh-ancestor
92911371|NCT00768508|Autonomic Agents|autonomic agents|mesh-ancestor
92911372|NCT00768508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911373|NCT00768508|Antipruritics|antipruritics|mesh-ancestor
92556866|NCT00214318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92911374|NCT00768508|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911375|NCT00768508|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92911376|NCT00768508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92911377|NCT00768508|Serotonin Agents|serotonin agents|mesh-ancestor
92911378|NCT00768508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911379|NCT00768508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911380|NCT00682487|Hydrocortisone|hydrocortisone|mesh-list
92911381|NCT00682487|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92911382|NCT00682487|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92911383|NCT00682487|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92911384|NCT00682487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911385|NCT00777478|Sunitinib|sunitinib|mesh-list
92911386|NCT00777478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911387|NCT00777478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92911388|NCT00777478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92911389|NCT00777478|Growth Substances|growth substances|mesh-ancestor
92911390|NCT00777478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911391|NCT00777478|Growth Inhibitors|growth inhibitors|mesh-ancestor
92911392|NCT00777478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92911393|NCT00777478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911394|NCT00777478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911395|NCT00780598|Tosedostat|tosedostat|mesh-list
92911396|NCT00780598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911397|NCT00780598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911398|NCT00780754|Dutasteride|dutasteride|mesh-list
92911399|NCT00780754|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92911400|NCT00780754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92911401|NCT00780754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911402|NCT00780754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911403|NCT00780754|Hormone Antagonists|hormone antagonists|mesh-ancestor
92911404|NCT00780754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911405|NCT00780754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911406|NCT00780832|Caffeine|caffeine|mesh-list
92911407|NCT00780832|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92911408|NCT00780832|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92911409|NCT00780832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911410|NCT00780832|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92911411|NCT00780832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911412|NCT00780832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911413|NCT00780832|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92911414|NCT00780832|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92911415|NCT00780832|Purinergic Agents|purinergic agents|mesh-ancestor
92911416|NCT00780832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911417|NCT00780832|Cholinergic Agents|cholinergic agents|mesh-ancestor
92911418|NCT00597701|Lorazepam|lorazepam|mesh-list
92911419|NCT00597701|Baclofen|baclofen|mesh-list
92911420|NCT00597701|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92911421|NCT00597701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911422|NCT00597701|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92911423|NCT00597701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911424|NCT00597701|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92911425|NCT00597701|GABA Agonists|gaba agonists|mesh-ancestor
92911426|NCT00597701|GABA Agents|gaba agents|mesh-ancestor
92911427|NCT00597701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911428|NCT00597701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911429|NCT00597701|Anticonvulsants|anticonvulsants|mesh-ancestor
92911430|NCT00597701|Antiemetics|antiemetics|mesh-ancestor
92911431|NCT00597701|Autonomic Agents|autonomic agents|mesh-ancestor
92911432|NCT00597701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92162398|NCT04354649|Hydroxychloroquine|hydroxychloroquine|mesh-list
92911433|NCT00597701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92911434|NCT00597701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911435|NCT00597701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92911436|NCT00597701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92911437|NCT00597701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92911438|NCT00597701|GABA Modulators|gaba modulators|mesh-ancestor
92911439|NCT02556658|Anesthetics|anesthetics|mesh-list
92911440|NCT02556658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911441|NCT02556658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911442|NCT00682721|Valacyclovir|valacyclovir|mesh-list
92911443|NCT00682721|Antiviral Agents|antiviral agents|mesh-ancestor
92911444|NCT00682721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911445|NCT02556814|Dexamethasone|dexamethasone|mesh-list
92911446|NCT02556814|Caffeic acid|caffeic acid|mesh-list
92911447|NCT02556814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911448|NCT02556814|Antiemetics|antiemetics|mesh-ancestor
92556940|NCT00214825|Hormone Antagonists|hormone antagonists|mesh-ancestor
92911449|NCT02556814|Autonomic Agents|autonomic agents|mesh-ancestor
92911450|NCT02556814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911451|NCT02556814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911452|NCT02556814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911453|NCT02556814|Glucocorticoids|glucocorticoids|mesh-ancestor
92911454|NCT02556814|Hormones|hormones|mesh-ancestor
92911455|NCT02556814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911456|NCT02556814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911457|NCT02556814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911458|NCT02556814|Antioxidants|antioxidants|mesh-ancestor
92911459|NCT02556814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911460|NCT02556814|Protective Agents|protective agents|mesh-ancestor
92911462|NCT00682955|Zinc Sulfate|zinc sulfate|mesh-list
92911463|NCT00682955|Trace Elements|trace elements|mesh-ancestor
92911464|NCT00682955|Micronutrients|micronutrients|mesh-ancestor
92911465|NCT00682955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911466|NCT00682955|Astringents|astringents|mesh-ancestor
92911467|NCT00682955|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911468|NCT00686621|Posaconazole|posaconazole|mesh-list
92911469|NCT00686621|Antifungal Agents|antifungal agents|mesh-ancestor
92911470|NCT00686621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911471|NCT00686621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92911472|NCT00686621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92911473|NCT00686621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92911474|NCT00686621|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92911475|NCT00686621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92911476|NCT00686621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526115|NCT00027820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911477|NCT00686621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911478|NCT00686621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92911479|NCT00686621|Hormone Antagonists|hormone antagonists|mesh-ancestor
92911480|NCT00686621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911481|NCT00686621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911482|NCT00683111|Esomeprazole|esomeprazole|mesh-list
92911484|NCT00683111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92911485|NCT00683111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911486|NCT00683111|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92911487|NCT00683111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911488|NCT00683111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911489|NCT00683111|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92911490|NCT00683111|Histamine Antagonists|histamine antagonists|mesh-ancestor
92911491|NCT00683111|Histamine Agents|histamine agents|mesh-ancestor
92911492|NCT00683111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911493|NCT00683111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911494|NCT04138901|Ropivacaine|ropivacaine|mesh-list
92911495|NCT04138901|Anesthetics, Local|anesthetics, local|mesh-ancestor
92911496|NCT04138901|Anesthetics|anesthetics|mesh-ancestor
92911497|NCT04138901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911498|NCT04138901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911499|NCT04138901|Sensory System Agents|sensory system agents|mesh-ancestor
92911500|NCT04138901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911501|NCT00922649|Insulin|insulin|mesh-list
92911502|NCT00922649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911503|NCT00922649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911504|NCT04142411|Insulin|insulin|mesh-list
92911505|NCT04142411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92911506|NCT04142411|Hyaluronic Acid|hyaluronic acid|mesh-list
92911507|NCT04142411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911508|NCT04142411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911509|NCT04142411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92911510|NCT04142411|Immunologic Factors|immunologic factors|mesh-ancestor
92911511|NCT04142411|Viscosupplements|viscosupplements|mesh-ancestor
92911512|NCT04142411|Protective Agents|protective agents|mesh-ancestor
92911513|NCT00683189|Warfarin|warfarin|mesh-list
92911514|NCT00683189|Anticoagulants|anticoagulants|mesh-ancestor
92911515|NCT00667576|Maxacalcitol|maxacalcitol|mesh-list
92911516|NCT00667576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911517|NCT00667576|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911518|NCT00667576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92911519|NCT00667576|Protective Agents|protective agents|mesh-ancestor
92911520|NCT00667576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911521|NCT04141787|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92911522|NCT04141787|Cefazolin|cefazolin|mesh-list
92911523|NCT04141787|Ceftriaxone|ceftriaxone|mesh-list
92911524|NCT04141787|Daptomycin|daptomycin|mesh-list
92911525|NCT04141787|Cloxacillin|cloxacillin|mesh-list
92911526|NCT04141787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911527|NCT02557594|Tenofovir|tenofovir|mesh-list
92911529|NCT02557594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911530|NCT02557594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92911531|NCT02557594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92911532|NCT02557594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911533|NCT02557594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911534|NCT02557594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92911535|NCT02557594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92911536|NCT00687011|Dexamethasone|dexamethasone|mesh-list
92911537|NCT00687011|Palonosetron|palonosetron|mesh-list
92911538|NCT00687011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911539|NCT00687011|Antiemetics|antiemetics|mesh-ancestor
92911540|NCT00687011|Autonomic Agents|autonomic agents|mesh-ancestor
92911541|NCT00687011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911542|NCT00687011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911543|NCT00687011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911544|NCT00687011|Glucocorticoids|glucocorticoids|mesh-ancestor
92911545|NCT00687011|Hormones|hormones|mesh-ancestor
92911546|NCT00687011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911547|NCT00687011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911548|NCT00687011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911549|NCT00687011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92911550|NCT00687011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92911551|NCT00687011|Serotonin Agents|serotonin agents|mesh-ancestor
92911552|NCT00687011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911553|NCT00687011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911555|NCT00683267|Antipruritics|antipruritics|mesh-ancestor
92911556|NCT00683267|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911557|NCT00683267|Sensory System Agents|sensory system agents|mesh-ancestor
92911558|NCT00683267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911559|NCT00683267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911560|NCT00683345|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92911561|NCT00683345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911562|NCT00687245|Esomeprazole|esomeprazole|mesh-list
92911563|NCT00687245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92911564|NCT00687245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911565|NCT00687245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92911566|NCT00687245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911567|NCT00687245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911568|NCT00690521|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92911569|NCT00690521|Metolazone|metolazone|mesh-list
92911570|NCT00690521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911571|NCT00690521|Diuretics|diuretics|mesh-ancestor
92911572|NCT00690521|Natriuretic Agents|natriuretic agents|mesh-ancestor
92911573|NCT00690521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911574|NCT00690521|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92911575|NCT00690521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911576|NCT00690521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911577|NCT00666718|Insulin|insulin|mesh-list
92911578|NCT00666718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92911579|NCT00666718|Insulin Glargine|insulin glargine|mesh-list
92911580|NCT00666718|Insulin Lispro|insulin lispro|mesh-list
92911581|NCT00666718|Protamines|protamines|mesh-list
92911582|NCT00666718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911583|NCT00666718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911584|NCT00666718|Heparin Antagonists|heparin antagonists|mesh-ancestor
92911585|NCT00666718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911586|NCT00666718|Coagulants|coagulants|mesh-ancestor
92911587|NCT00683735|Metformin|metformin|mesh-list
92911588|NCT00683735|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92911589|NCT00683735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911590|NCT00683735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911591|NCT00683735|Incretins|incretins|mesh-ancestor
92911592|NCT00683735|Hormones|hormones|mesh-ancestor
92911593|NCT00683735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911594|NCT00683735|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92911595|NCT00683735|Protease Inhibitors|protease inhibitors|mesh-ancestor
92911596|NCT00683735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911597|NCT00683735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911598|NCT04139681|Menthol|menthol|mesh-list
92911599|NCT04139681|Antipruritics|antipruritics|mesh-ancestor
92911600|NCT04139681|Dermatologic Agents|dermatologic agents|mesh-ancestor
92911601|NCT04047394|Rasburicase|rasburicase|mesh-list
92911602|NCT04047394|Gout Suppressants|gout suppressants|mesh-ancestor
92911603|NCT04047394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911604|NCT02625779|Valproic Acid|valproic acid|mesh-list
92911605|NCT02625779|Anticonvulsants|anticonvulsants|mesh-ancestor
92911606|NCT02625779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911607|NCT02625779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911608|NCT02625779|GABA Agents|gaba agents|mesh-ancestor
92911609|NCT02625779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911610|NCT02625779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911611|NCT02625779|Antimanic Agents|antimanic agents|mesh-ancestor
92911612|NCT02625779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92911613|NCT02625779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911614|NCT02625779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92911615|NCT00667420|Oxaliplatin|oxaliplatin|mesh-list
92911616|NCT00667420|Epirubicin|epirubicin|mesh-list
92911617|NCT00667420|Panitumumab|panitumumab|mesh-list
92911618|NCT00667420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911619|NCT00667420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911620|NCT00667420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92911621|NCT00667420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92911622|NCT00667420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92911623|NCT00667420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911624|NCT00667420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92911625|NCT04141319|Ketorolac|ketorolac|mesh-list
92911626|NCT04141319|Epinephrine|epinephrine|mesh-list
92911627|NCT04141319|Ropivacaine|ropivacaine|mesh-list
92911628|NCT04141319|Anesthetics, Local|anesthetics, local|mesh-ancestor
92911629|NCT04141319|Anesthetics|anesthetics|mesh-ancestor
92911630|NCT04141319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911631|NCT04141319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911632|NCT04141319|Sensory System Agents|sensory system agents|mesh-ancestor
92911633|NCT04141319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911634|NCT04141319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92911635|NCT04141319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92911636|NCT04141319|Adrenergic Agents|adrenergic agents|mesh-ancestor
92911637|NCT04141319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911638|NCT04141319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911639|NCT04141319|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92911640|NCT04141319|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92911641|NCT04141319|Autonomic Agents|autonomic agents|mesh-ancestor
92911642|NCT04141319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92911643|NCT04141319|Respiratory System Agents|respiratory system agents|mesh-ancestor
92911644|NCT04141319|Mydriatics|mydriatics|mesh-ancestor
92911645|NCT04141319|Sympathomimetics|sympathomimetics|mesh-ancestor
92911646|NCT04141319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92911647|NCT04141319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92911648|NCT04141319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92911649|NCT04141319|Analgesics|analgesics|mesh-ancestor
92911650|NCT04141319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911651|NCT04141319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911652|NCT04141319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92911653|NCT04141319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911654|NCT00683891|Clozapine|clozapine|mesh-list
92911655|NCT00683891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92911656|NCT00683891|Serotonin Agents|serotonin agents|mesh-ancestor
92911657|NCT00683891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911658|NCT00683891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911659|NCT00683891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911660|NCT00683891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92911661|NCT00683891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92911662|NCT00683891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911663|NCT00683891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92911664|NCT00683891|GABA Antagonists|gaba antagonists|mesh-ancestor
92911665|NCT00683891|GABA Agents|gaba agents|mesh-ancestor
92911666|NCT00683969|Mycophenolic Acid|mycophenolic acid|mesh-list
92911667|NCT00683969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92911668|NCT00683969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911669|NCT00683969|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92911670|NCT00683969|Antitubercular Agents|antitubercular agents|mesh-ancestor
92911671|NCT00683969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911672|NCT00683969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911673|NCT00683969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911674|NCT00683969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911675|NCT00778024|Fluoxetine|fluoxetine|mesh-list
92911676|NCT00778024|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92911677|NCT00778024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93047011|NCT01051934|Mitosis Modulators|mitosis modulators|mesh-ancestor
92911679|NCT00778024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911680|NCT00778024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911681|NCT00778024|Serotonin Agents|serotonin agents|mesh-ancestor
92911682|NCT00778024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911683|NCT00778024|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92911684|NCT00778024|Antidepressive Agents|antidepressive agents|mesh-ancestor
92911685|NCT00778024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92911686|NCT00778024|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92911687|NCT00778024|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92911688|NCT00778024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911689|NCT00853658|Enalapril|enalapril|mesh-list
92911690|NCT00853658|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92911691|NCT00853658|Protease Inhibitors|protease inhibitors|mesh-ancestor
92911692|NCT00853658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911693|NCT00853658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911694|NCT00853658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911695|NCT00690677|Panobinostat|panobinostat|mesh-list
92911696|NCT00690677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911697|NCT00690677|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92911698|NCT00690677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911699|NCT00690677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911700|NCT00781300|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92911701|NCT00781300|Dexamethasone|dexamethasone|mesh-list
92911702|NCT00781300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911704|NCT00781300|Autonomic Agents|autonomic agents|mesh-ancestor
92911705|NCT00781300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911706|NCT00781300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911707|NCT00781300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92911708|NCT00781300|Glucocorticoids|glucocorticoids|mesh-ancestor
92911709|NCT00781300|Hormones|hormones|mesh-ancestor
92911710|NCT00781300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911711|NCT00781300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92911712|NCT00781300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911713|NCT00781300|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92911714|NCT00781378|Plasminogen|plasminogen|mesh-list
92911715|NCT00781378|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92911716|NCT00781378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92911717|NCT00781378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92911718|NCT00781378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911719|NCT02625389|Ethiodized Oil|ethiodized oil|mesh-list
92911720|NCT02625389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911721|NCT00666562|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92911722|NCT00666562|Antioxidants|antioxidants|mesh-ancestor
92911723|NCT00666562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911724|NCT00666562|Protective Agents|protective agents|mesh-ancestor
92911725|NCT00666562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911726|NCT00666562|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92911727|NCT00666562|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92911728|NCT00666562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911729|NCT00666562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92911730|NCT00769054|Ropivacaine|ropivacaine|mesh-list
92911731|NCT00769054|Anesthetics, Local|anesthetics, local|mesh-ancestor
92911732|NCT00769054|Anesthetics|anesthetics|mesh-ancestor
92911733|NCT00769054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911734|NCT00769054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911735|NCT00769054|Sensory System Agents|sensory system agents|mesh-ancestor
92911736|NCT00769054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911737|NCT04138979|Cyclophosphamide|cyclophosphamide|mesh-list
92911738|NCT04138979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911739|NCT04138979|Immunologic Factors|immunologic factors|mesh-ancestor
92911740|NCT04138979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911741|NCT04138979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911742|NCT04138979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92911743|NCT04138979|Alkylating Agents|alkylating agents|mesh-ancestor
92911744|NCT04138979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911745|NCT04138979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911746|NCT04138979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92911747|NCT00666328|Clevidipine|clevidipine|mesh-list
92911748|NCT00666328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92911749|NCT00666328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911750|NCT00666328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911751|NCT00666328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92911752|NCT00666328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911753|NCT00694343|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92911754|NCT00778180|Furosemide|furosemide|mesh-list
92911755|NCT00778180|Diuretics|diuretics|mesh-ancestor
92911756|NCT00778180|Natriuretic Agents|natriuretic agents|mesh-ancestor
92911757|NCT00778180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911758|NCT00778180|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92911759|NCT00778180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911760|NCT00778180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911761|NCT00769210|Simvastatin|simvastatin|mesh-list
92911762|NCT00769210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92911763|NCT00769210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92911764|NCT00769210|Antimetabolites|antimetabolites|mesh-ancestor
92911765|NCT00769210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911766|NCT00769210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92911767|NCT00769210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92911768|NCT00769210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911769|NCT00690911|Adalimumab|adalimumab|mesh-list
92911770|NCT00690911|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92911771|NCT00690911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911772|NCT00690911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911774|NCT00781846|Bevacizumab|bevacizumab|mesh-list
92911775|NCT00781846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92911776|NCT00781846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911777|NCT00781846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92911778|NCT00781846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92911779|NCT00781846|Growth Substances|growth substances|mesh-ancestor
92911780|NCT00781846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911781|NCT00781846|Growth Inhibitors|growth inhibitors|mesh-ancestor
92911782|NCT00781846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911783|NCT00781846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911784|NCT00781846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92911785|NCT00781846|Antifungal Agents|antifungal agents|mesh-ancestor
92911786|NCT00781846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911787|NCT00781846|Immunologic Factors|immunologic factors|mesh-ancestor
92911788|NCT00853580|Lovastatin|lovastatin|mesh-list
92911789|NCT00853580|L 647318|l 647318|mesh-list
92911790|NCT00853580|Dihydromevinolin|dihydromevinolin|mesh-list
92911791|NCT00853580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92911792|NCT00853580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92911793|NCT00853580|Antimetabolites|antimetabolites|mesh-ancestor
92911794|NCT00853580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911795|NCT00853580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92911796|NCT00853580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92911797|NCT00853580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911798|NCT00688493|Dapagliflozin|dapagliflozin|mesh-list
92911799|NCT00688493|Moxifloxacin|moxifloxacin|mesh-list
92911800|NCT00688493|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92911801|NCT00688493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911802|NCT00688493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911803|NCT00688493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92911804|NCT00688493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92911805|NCT00688493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911806|NCT00688493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911807|NCT00688493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911808|NCT00688493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92911809|NCT00688493|Contraceptive Agents|contraceptive agents|mesh-ancestor
92911810|NCT00688493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92911811|NCT00688493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911812|NCT00688493|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92911813|NCT00688493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92911814|NCT00688493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92911815|NCT00688493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92911816|NCT00688493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92911817|NCT00778414|Amoxicillin|amoxicillin|mesh-list
92911818|NCT00778414|Clavulanic Acids|clavulanic acids|mesh-list
92911819|NCT00778414|Clavulanic Acid|clavulanic acid|mesh-list
92911820|NCT00778414|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92911821|NCT00778414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911822|NCT00778414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911823|NCT00778414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911824|NCT00778414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911825|NCT00778414|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92911826|NCT00769288|2'-fluoro-5-ethylarabinosyluracil|2'-fluoro-5-ethylarabinosyluracil|mesh-list
92911828|NCT00769288|Antimetabolites|antimetabolites|mesh-ancestor
92911829|NCT00769288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911830|NCT00769288|Antiviral Agents|antiviral agents|mesh-ancestor
92911831|NCT00769288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911832|NCT00769288|Growth Inhibitors|growth inhibitors|mesh-ancestor
92911833|NCT00769288|Growth Substances|growth substances|mesh-ancestor
92911834|NCT00769288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911835|NCT00912938|Zoledronic Acid|zoledronic acid|mesh-list
92911836|NCT00912938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92911837|NCT00912938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911838|NCT00688805|Propranolol|propranolol|mesh-list
92911839|NCT00688805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92911840|NCT00688805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92911841|NCT00688805|Adrenergic Agents|adrenergic agents|mesh-ancestor
92911842|NCT00688805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911843|NCT00688805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911844|NCT00688805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911845|NCT00688805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92911846|NCT00688805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911847|NCT00688805|Vasodilator Agents|vasodilator agents|mesh-ancestor
92911848|NCT04136639|Proanthocyanidin|proanthocyanidin|mesh-list
92911849|NCT04136639|Grape Seed Extract|grape seed extract|mesh-list
92911850|NCT04136639|Fluorides|fluorides|mesh-list
92911851|NCT04136639|Sodium Fluoride|sodium fluoride|mesh-list
92911852|NCT04136639|Cariostatic Agents|cariostatic agents|mesh-ancestor
92911853|NCT04136639|Protective Agents|protective agents|mesh-ancestor
92911854|NCT04136639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911855|NCT04136639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911856|NCT04136639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92911857|NCT04136639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911858|NCT04136639|Antioxidants|antioxidants|mesh-ancestor
92911859|NCT04136639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911860|NCT04136639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92911861|NCT04136639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92911862|NCT02613026|Cyclophosphamide|cyclophosphamide|mesh-list
92911863|NCT02613026|Docetaxel|docetaxel|mesh-list
92911864|NCT02613026|Pirarubicin|pirarubicin|mesh-list
92911865|NCT02613026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911866|NCT02613026|Immunologic Factors|immunologic factors|mesh-ancestor
92162416|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
92911867|NCT02613026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911868|NCT02613026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911869|NCT02613026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92911870|NCT02613026|Alkylating Agents|alkylating agents|mesh-ancestor
92911871|NCT02613026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911872|NCT02613026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911873|NCT02613026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92911874|NCT02613026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92911875|NCT02613026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92911876|NCT02613026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92911877|NCT00778726|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92911878|NCT00778726|Benazepril|benazepril|mesh-list
92911879|NCT00778726|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911880|NCT00778726|Diuretics|diuretics|mesh-ancestor
92911881|NCT00778726|Natriuretic Agents|natriuretic agents|mesh-ancestor
92911882|NCT00778726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911883|NCT00778726|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92911884|NCT00778726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911885|NCT00778726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911886|NCT00778726|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92911887|NCT00778726|Protease Inhibitors|protease inhibitors|mesh-ancestor
92911888|NCT00778726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911889|NCT00688883|Fludarabine|fludarabine|mesh-list
92911890|NCT00688883|Fludarabine phosphate|fludarabine phosphate|mesh-list
92911891|NCT00688883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911892|NCT00688883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92911893|NCT00688883|Antimetabolites|antimetabolites|mesh-ancestor
92911894|NCT00688883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911895|NCT00688883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911896|NCT00688883|Immunologic Factors|immunologic factors|mesh-ancestor
92911897|NCT00688883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911899|NCT00769522|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92911900|NCT00769522|Rituximab|rituximab|mesh-list
92911901|NCT00769522|Fludarabine|fludarabine|mesh-list
92911902|NCT00769522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911903|NCT00769522|Immunologic Factors|immunologic factors|mesh-ancestor
92911904|NCT00769522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911905|NCT00769522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911906|NCT00769522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92911907|NCT00769522|Alkylating Agents|alkylating agents|mesh-ancestor
92911908|NCT00769522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911909|NCT00769522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911910|NCT00769522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92911911|NCT00769522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92911912|NCT00688961|Aspirin|aspirin|mesh-list
92911913|NCT00688961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92911914|NCT00688961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92911915|NCT00688961|Analgesics|analgesics|mesh-ancestor
92911916|NCT00688961|Sensory System Agents|sensory system agents|mesh-ancestor
92911917|NCT00688961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911918|NCT00688961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911919|NCT00688961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911920|NCT00688961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911921|NCT00688961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92911922|NCT00688961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92911923|NCT00688961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911924|NCT00688961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92911925|NCT00688961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92911926|NCT00688961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911927|NCT00688961|Antipyretics|antipyretics|mesh-ancestor
92911928|NCT00782470|Factor VIII|factor viii|mesh-list
92911929|NCT00782470|Coagulants|coagulants|mesh-ancestor
92911930|NCT00865280|Moxifloxacin|moxifloxacin|mesh-list
92911931|NCT00865280|Linezolid|linezolid|mesh-list
92911932|NCT00865280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92911933|NCT00865280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92911934|NCT00865280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92911935|NCT00865280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92911936|NCT00865280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911937|NCT00865280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911938|NCT00865280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911939|NCT00865280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92911940|NCT04136327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92911941|NCT00782548|Morphine|morphine|mesh-list
92911942|NCT00782548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92911943|NCT00782548|Narcotics|narcotics|mesh-ancestor
92911944|NCT00782548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92911945|NCT00782548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911946|NCT00782548|Analgesics|analgesics|mesh-ancestor
92911947|NCT00782548|Sensory System Agents|sensory system agents|mesh-ancestor
92911948|NCT00782548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911949|NCT00689195|Curcumin|curcumin|mesh-list
92911950|NCT00689195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92911951|NCT00689195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92911952|NCT00689195|Analgesics|analgesics|mesh-ancestor
92911953|NCT00689195|Sensory System Agents|sensory system agents|mesh-ancestor
92911954|NCT00689195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92911955|NCT00689195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911956|NCT00689195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92911957|NCT00689195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92911958|NCT00689195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92911959|NCT00689195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911960|NCT00689195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911961|NCT00865124|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92911962|NCT00865124|Spironolactone|spironolactone|mesh-list
92911963|NCT00865124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92911964|NCT00865124|Diuretics|diuretics|mesh-ancestor
92911965|NCT00865124|Natriuretic Agents|natriuretic agents|mesh-ancestor
92911966|NCT00865124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911967|NCT00865124|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92911968|NCT00865124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92911969|NCT00865124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557465|NCT00218374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92911970|NCT00865124|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92911971|NCT00865124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92911972|NCT00865124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911973|NCT00865124|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92911974|NCT00691067|Mifepristone|mifepristone|mesh-list
92911975|NCT00691067|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92911976|NCT00691067|Abortifacient Agents|abortifacient agents|mesh-ancestor
92911977|NCT00691067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92911978|NCT00691067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911979|NCT00691067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92911980|NCT00691067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92911981|NCT00691067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92911982|NCT00691067|Contraceptive Agents|contraceptive agents|mesh-ancestor
92911983|NCT00691067|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92911984|NCT00691067|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92911985|NCT00691067|Hormone Antagonists|hormone antagonists|mesh-ancestor
92911986|NCT00691067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92911987|NCT00691067|Luteolytic Agents|luteolytic agents|mesh-ancestor
92911988|NCT00691067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92911989|NCT00691067|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92911990|NCT00691145|Tacrolimus|tacrolimus|mesh-list
92911991|NCT00691145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92911992|NCT00691145|Immunologic Factors|immunologic factors|mesh-ancestor
92911993|NCT00691145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92911994|NCT00691145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92911995|NCT00691145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92911996|NCT00691145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92911997|NCT00694967|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92911998|NCT00694967|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92911999|NCT00694967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92912000|NCT00694967|Hormone Antagonists|hormone antagonists|mesh-ancestor
92912001|NCT00694967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912002|NCT00694967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912003|NCT00694967|Progestins|progestins|mesh-ancestor
92912005|NCT00695045|Morphine|morphine|mesh-list
92912006|NCT00695045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92912007|NCT00695045|Narcotics|narcotics|mesh-ancestor
92912008|NCT00695045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912009|NCT00695045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912010|NCT00695045|Analgesics|analgesics|mesh-ancestor
92912011|NCT00695045|Sensory System Agents|sensory system agents|mesh-ancestor
92912012|NCT00695045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912013|NCT02624453|Fluconazole|fluconazole|mesh-list
92912014|NCT02624453|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92912015|NCT02624453|Antifungal Agents|antifungal agents|mesh-ancestor
92912016|NCT02624453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912017|NCT02624453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92912018|NCT02624453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92912019|NCT02624453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912020|NCT02624453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912021|NCT02624453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92912022|NCT02624453|Hormone Antagonists|hormone antagonists|mesh-ancestor
92912023|NCT02624453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912024|NCT02624453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912025|NCT02624453|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92912026|NCT02624453|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92912027|NCT02624453|Antiviral Agents|antiviral agents|mesh-ancestor
92912028|NCT00819234|Pramlintide|pramlintide|mesh-list
92912029|NCT00819234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92912030|NCT00819234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912031|NCT00695201|Oxaliplatin|oxaliplatin|mesh-list
92912032|NCT00695201|Irinotecan|irinotecan|mesh-list
92912033|NCT00695201|Floxuridine|floxuridine|mesh-list
92912034|NCT00695201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912035|NCT00695201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92912036|NCT00695201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92912037|NCT00695201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912038|NCT00695201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912039|NCT00695201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912040|NCT00695201|Antimetabolites|antimetabolites|mesh-ancestor
92557537|NCT00219388|Simendan|simendan|mesh-list
92912042|NCT00689585|Anticonvulsants|anticonvulsants|mesh-ancestor
92912043|NCT00667342|Bevacizumab|bevacizumab|mesh-list
92912044|NCT00667342|Doxorubicin|doxorubicin|mesh-list
92912045|NCT00667342|Methotrexate|methotrexate|mesh-list
92912046|NCT00667342|Etoposide|etoposide|mesh-list
92912047|NCT00667342|Ifosfamide|ifosfamide|mesh-list
92912048|NCT00667342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912049|NCT00667342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912050|NCT00667342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912051|NCT00667342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912052|NCT00667342|Growth Substances|growth substances|mesh-ancestor
92912053|NCT00667342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912054|NCT00667342|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912055|NCT00667342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92912056|NCT00667342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92912057|NCT00667342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92912058|NCT00667342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912059|NCT00667342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912060|NCT00667342|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92912061|NCT00667342|Abortifacient Agents|abortifacient agents|mesh-ancestor
92912062|NCT00667342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92912063|NCT00667342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912064|NCT00667342|Antimetabolites|antimetabolites|mesh-ancestor
92912065|NCT00667342|Dermatologic Agents|dermatologic agents|mesh-ancestor
92912066|NCT00667342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92912067|NCT00667342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92912068|NCT00667342|Immunologic Factors|immunologic factors|mesh-ancestor
92162435|NCT01281501|Antiemetics|antiemetics|mesh-ancestor
92912069|NCT00667342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912070|NCT00667342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92912071|NCT00667342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92912072|NCT00667342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92912073|NCT00667342|Alkylating Agents|alkylating agents|mesh-ancestor
92912074|NCT00783016|Morphine|morphine|mesh-list
92912075|NCT00783016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92912076|NCT00783016|Narcotics|narcotics|mesh-ancestor
92912077|NCT00783016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912078|NCT00783016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912079|NCT00783016|Analgesics|analgesics|mesh-ancestor
92912080|NCT00783016|Sensory System Agents|sensory system agents|mesh-ancestor
92912081|NCT00783016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912082|NCT00769990|Genistein|genistein|mesh-list
92912083|NCT00769990|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92912084|NCT00769990|Protective Agents|protective agents|mesh-ancestor
92912085|NCT00769990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912086|NCT00769990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912087|NCT00769990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912088|NCT00769990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912089|NCT00769990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912090|NCT00769990|Phytoestrogens|phytoestrogens|mesh-ancestor
92912091|NCT00769990|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92912092|NCT00769990|Estrogens|estrogens|mesh-ancestor
92912093|NCT00769990|Hormones|hormones|mesh-ancestor
92912094|NCT00769990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912095|NCT00784420|Raltegravir Potassium|raltegravir potassium|mesh-list
92912096|NCT00784420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92912097|NCT00784420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92912098|NCT00784420|Antiviral Agents|antiviral agents|mesh-ancestor
92912099|NCT00784420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912100|NCT00784420|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92912101|NCT00784420|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92912102|NCT00784420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912103|NCT00784420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912104|NCT02555800|Cidofovir|cidofovir|mesh-list
92912105|NCT02555800|Bevacizumab|bevacizumab|mesh-list
92912106|NCT02555800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912107|NCT02555800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912108|NCT02555800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912109|NCT02555800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912110|NCT02555800|Growth Substances|growth substances|mesh-ancestor
92912111|NCT02555800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912112|NCT02555800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912113|NCT02555800|Antiviral Agents|antiviral agents|mesh-ancestor
92912114|NCT02555800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912115|NCT02555800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912116|NCT02555800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912117|NCT00783172|Gemcitabine|gemcitabine|mesh-list
92912118|NCT00783172|Mitogens|mitogens|mesh-list
92912119|NCT00783172|Enkephalins|enkephalins|mesh-list
92912120|NCT00783172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912121|NCT00783172|Antimetabolites|antimetabolites|mesh-ancestor
92912122|NCT00783172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912123|NCT00783172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912124|NCT00783172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912125|NCT00783172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912126|NCT00783172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912127|NCT00783250|Albuterol|albuterol|mesh-list
92912128|NCT00783250|Tiotropium Bromide|tiotropium bromide|mesh-list
92912129|NCT00783250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92912130|NCT00783250|Autonomic Agents|autonomic agents|mesh-ancestor
92912131|NCT00783250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912132|NCT00783250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912133|NCT00783250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92912134|NCT00783250|Respiratory System Agents|respiratory system agents|mesh-ancestor
92912135|NCT00783250|Parasympatholytics|parasympatholytics|mesh-ancestor
92912136|NCT00783250|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92912137|NCT00783250|Cholinergic Agents|cholinergic agents|mesh-ancestor
92912138|NCT00783250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912139|NCT00783250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912140|NCT00783250|Tocolytic Agents|tocolytic agents|mesh-ancestor
92912141|NCT00783250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92912142|NCT00783250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92912143|NCT00783250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92912144|NCT00783250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92912145|NCT00783250|Adrenergic Agents|adrenergic agents|mesh-ancestor
92912146|NCT02555644|Cetuximab|cetuximab|mesh-list
92912147|NCT02555644|Prexasertib|prexasertib|mesh-list
92912148|NCT02555644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912149|NCT02555644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912150|NCT02555644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912151|NCT02555644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912152|NCT02555644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912153|NCT00871403|Pemetrexed|pemetrexed|mesh-list
92912154|NCT00871403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912155|NCT00871403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912156|NCT00871403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912157|NCT00871403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92912158|NCT00871403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92912159|NCT00691379|Paclitaxel|paclitaxel|mesh-list
92912160|NCT00691379|Bevacizumab|bevacizumab|mesh-list
92912161|NCT00691379|Carboplatin|carboplatin|mesh-list
92912162|NCT00691379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92912163|NCT00691379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912164|NCT00691379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912165|NCT00691379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912166|NCT00691379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912167|NCT00691379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912168|NCT00691379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912169|NCT00691379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912170|NCT00691379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912171|NCT00691379|Growth Substances|growth substances|mesh-ancestor
92912172|NCT00691379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912173|NCT00691379|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912174|NCT02624531|Cisplatin|cisplatin|mesh-list
92912175|NCT02624531|Taxane|taxane|mesh-list
92912176|NCT02624531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912177|NCT00691457|Contact Lens Solutions|contact lens solutions|mesh-list
92912178|NCT00691457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92912179|NCT00691457|Disinfectants|disinfectants|mesh-ancestor
92912180|NCT00691457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912181|NCT04136015|Dasatinib|dasatinib|mesh-list
92912182|NCT04136015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912183|NCT04136015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912184|NCT04136015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912185|NCT04136015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912186|NCT02624063|Sofosbuvir|sofosbuvir|mesh-list
92912187|NCT02624063|Simeprevir|simeprevir|mesh-list
92912188|NCT02624063|Antiviral Agents|antiviral agents|mesh-ancestor
92912189|NCT02624063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912190|NCT02624063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92912191|NCT02624063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912192|NCT02624063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912194|NCT05298683|Diphenhydramine|diphenhydramine|mesh-list
92912195|NCT05298683|Promethazine|promethazine|mesh-list
92912196|NCT05298683|Dexamethasone|dexamethasone|mesh-list
92912197|NCT05298683|Pomalidomide|pomalidomide|mesh-list
92912198|NCT05298683|Ranitidine|ranitidine|mesh-list
92912199|NCT05298683|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92912200|NCT05298683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912201|NCT05298683|Antiemetics|antiemetics|mesh-ancestor
92912202|NCT05298683|Autonomic Agents|autonomic agents|mesh-ancestor
92912203|NCT05298683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912204|NCT05298683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912205|NCT05298683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92912206|NCT05298683|Glucocorticoids|glucocorticoids|mesh-ancestor
92912207|NCT05298683|Hormones|hormones|mesh-ancestor
92912208|NCT05298683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912209|NCT05298683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92912210|NCT05298683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912211|NCT05298683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92912212|NCT05298683|Analgesics|analgesics|mesh-ancestor
92912213|NCT05298683|Sensory System Agents|sensory system agents|mesh-ancestor
92912214|NCT05298683|Antipyretics|antipyretics|mesh-ancestor
92912215|NCT05298683|Immunologic Factors|immunologic factors|mesh-ancestor
92912216|NCT05298683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912217|NCT05298683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912218|NCT05298683|Growth Substances|growth substances|mesh-ancestor
92912219|NCT05298683|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912220|NCT05298683|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92912221|NCT05298683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92912222|NCT05298683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912223|NCT05298683|Anesthetics, Local|anesthetics, local|mesh-ancestor
92912224|NCT05298683|Anesthetics|anesthetics|mesh-ancestor
92912225|NCT05298683|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92912226|NCT05298683|Histamine Antagonists|histamine antagonists|mesh-ancestor
92912227|NCT05298683|Histamine Agents|histamine agents|mesh-ancestor
92912228|NCT05298683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912229|NCT05298683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912230|NCT05298683|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92912231|NCT05298683|Antipruritics|antipruritics|mesh-ancestor
92912232|NCT05298683|Dermatologic Agents|dermatologic agents|mesh-ancestor
92912233|NCT05298683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92912234|NCT05298683|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92912235|NCT00853112|Sildenafil Citrate|sildenafil citrate|mesh-list
92912236|NCT00853112|Vasodilator Agents|vasodilator agents|mesh-ancestor
92912237|NCT00853112|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92912238|NCT00853112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92912239|NCT00853112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912240|NCT00853112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912241|NCT00853112|Urological Agents|urological agents|mesh-ancestor
92912242|NCT02624141|Epoetin Alfa|epoetin alfa|mesh-list
92912243|NCT02624141|Hematinics|hematinics|mesh-ancestor
92912244|NCT00691613|Epoetin Alfa|epoetin alfa|mesh-list
92912245|NCT00691613|Hematinics|hematinics|mesh-ancestor
92912246|NCT00460603|Bevacizumab|bevacizumab|mesh-list
92912247|NCT00460603|Axitinib|axitinib|mesh-list
92912248|NCT00460603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912249|NCT00460603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912250|NCT00460603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912251|NCT00460603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912252|NCT00460603|Growth Substances|growth substances|mesh-ancestor
92912253|NCT00460603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912254|NCT00460603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912255|NCT00460603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912256|NCT00460603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912257|NCT00460603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912258|NCT00696059|Adalimumab|adalimumab|mesh-list
92912259|NCT00696059|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92912260|NCT00696059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912261|NCT00696059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912262|NCT00700466|Metoprolol|metoprolol|mesh-list
92912263|NCT00700466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92912264|NCT00700466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92912265|NCT00700466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92912266|NCT00700466|Sympatholytics|sympatholytics|mesh-ancestor
92912267|NCT00700466|Autonomic Agents|autonomic agents|mesh-ancestor
92912268|NCT00700466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912269|NCT00700466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912270|NCT00700466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92912271|NCT00700466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92912273|NCT00700466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912274|NCT00700466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912275|NCT00700544|Norethandrolone|norethandrolone|mesh-list
92912276|NCT00700544|Anabolic Agents|anabolic agents|mesh-ancestor
92912277|NCT00700544|Hormones|hormones|mesh-ancestor
92912278|NCT00700544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912279|NCT00700544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912280|NCT02612792|Atorvastatin|atorvastatin|mesh-list
92912281|NCT02612792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92912282|NCT02612792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92912283|NCT02612792|Antimetabolites|antimetabolites|mesh-ancestor
92912284|NCT02612792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912285|NCT02612792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162451|NCT03353831|Growth Substances|growth substances|mesh-ancestor
92912286|NCT02612792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92912287|NCT02612792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912288|NCT00662038|Pirfenidone|pirfenidone|mesh-list
92912289|NCT00662038|Analgesics|analgesics|mesh-ancestor
92912290|NCT00662038|Sensory System Agents|sensory system agents|mesh-ancestor
92912291|NCT00662038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912292|NCT00662038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912293|NCT00662038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92912294|NCT00662038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92912295|NCT00662038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912296|NCT00662038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912297|NCT00662038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912298|NCT00701792|Liver Extracts|liver extracts|mesh-list
92912299|NCT00701792|Hematinics|hematinics|mesh-ancestor
92912300|NCT00784498|Midazolam|midazolam|mesh-list
92912301|NCT00784498|Ketamine|ketamine|mesh-list
92912302|NCT00784498|Propofol|propofol|mesh-list
92912303|NCT00784498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92912304|NCT00784498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912305|NCT00784498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912306|NCT00784498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92912307|NCT00784498|Anesthetics, General|anesthetics, general|mesh-ancestor
92912308|NCT00784498|Anesthetics|anesthetics|mesh-ancestor
92912309|NCT00784498|Analgesics|analgesics|mesh-ancestor
92912310|NCT00784498|Sensory System Agents|sensory system agents|mesh-ancestor
92912311|NCT00784498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912312|NCT00784498|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92912313|NCT00784498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92912314|NCT00784498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92912315|NCT00784498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912316|NCT00784498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912317|NCT00784498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92912318|NCT00784498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92912319|NCT00784498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92912320|NCT00784498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912321|NCT00784498|GABA Modulators|gaba modulators|mesh-ancestor
92912322|NCT00784498|GABA Agents|gaba agents|mesh-ancestor
92912323|NCT01022983|Simendan|simendan|mesh-list
92912324|NCT01022983|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92912325|NCT01022983|Vasodilator Agents|vasodilator agents|mesh-ancestor
92912326|NCT01022983|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92912327|NCT01022983|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92912328|NCT01022983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912329|NCT01022983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912330|NCT01022983|Protective Agents|protective agents|mesh-ancestor
92912331|NCT01022983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912332|NCT00912860|Interferons|interferons|mesh-list
92912333|NCT00912860|Interferon-beta|interferon-beta|mesh-list
92912334|NCT00912860|Interferon beta-1a|interferon beta-1a|mesh-list
92912335|NCT00912860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912336|NCT00912860|Antiviral Agents|antiviral agents|mesh-ancestor
92912337|NCT00912860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912338|NCT00912860|Immunologic Factors|immunologic factors|mesh-ancestor
92912339|NCT00912860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912340|NCT00912860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92912341|NCT02623673|Dexamethasone|dexamethasone|mesh-list
92912342|NCT02623673|Bevacizumab|bevacizumab|mesh-list
92912343|NCT02623673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912344|NCT02623673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912345|NCT02623673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912346|NCT02623673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912347|NCT02623673|Growth Substances|growth substances|mesh-ancestor
92912348|NCT02623673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912349|NCT02623673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912350|NCT02623673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912351|NCT02623673|Antiemetics|antiemetics|mesh-ancestor
92912352|NCT02623673|Autonomic Agents|autonomic agents|mesh-ancestor
92912353|NCT02623673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912354|NCT02623673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92912355|NCT02623673|Glucocorticoids|glucocorticoids|mesh-ancestor
92912356|NCT02623673|Hormones|hormones|mesh-ancestor
92912357|NCT02623673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912358|NCT02623673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92912359|NCT00784732|Mometasone Furoate|mometasone furoate|mesh-list
92912360|NCT00784732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912361|NCT00784732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92912362|NCT00784732|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92912363|NCT00459979|Sunitinib|sunitinib|mesh-list
92912365|NCT00459979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912366|NCT00459979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912367|NCT00459979|Growth Substances|growth substances|mesh-ancestor
92912368|NCT00459979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912369|NCT00459979|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912370|NCT00459979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912371|NCT00459979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912372|NCT00459979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912373|NCT00783484|Maraviroc|maraviroc|mesh-list
92912374|NCT00783484|Darunavir|darunavir|mesh-list
92912375|NCT00783484|Midazolam|midazolam|mesh-list
92912376|NCT00783484|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92912377|NCT00783484|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92912378|NCT00783484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912379|NCT00783484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912380|NCT00783484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92912381|NCT00783484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92912382|NCT00783484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912383|NCT00783484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92912384|NCT00783484|Anesthetics, General|anesthetics, general|mesh-ancestor
92912385|NCT00783484|Anesthetics|anesthetics|mesh-ancestor
92912386|NCT00783484|GABA Modulators|gaba modulators|mesh-ancestor
92912387|NCT00783484|GABA Agents|gaba agents|mesh-ancestor
92912388|NCT00783484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912389|NCT00783484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912390|NCT00783484|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92912391|NCT00783484|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92912392|NCT00783484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92912393|NCT00783484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92912394|NCT00783484|Antiviral Agents|antiviral agents|mesh-ancestor
92912395|NCT00783484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912396|NCT00783484|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92912397|NCT00783484|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92912398|NCT00783484|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92912399|NCT00783484|Protease Inhibitors|protease inhibitors|mesh-ancestor
92912400|NCT00783484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912401|NCT00828672|Bevacizumab|bevacizumab|mesh-list
92912402|NCT00828672|Capecitabine|capecitabine|mesh-list
92912403|NCT00828672|Oxaliplatin|oxaliplatin|mesh-list
92912404|NCT00828672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912405|NCT00828672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912406|NCT00828672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912407|NCT00828672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912408|NCT00828672|Growth Substances|growth substances|mesh-ancestor
92912409|NCT00828672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912410|NCT00828672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912411|NCT00828672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912412|NCT00828672|Antimetabolites|antimetabolites|mesh-ancestor
92912413|NCT00828672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557920|NCT00077532|Ipilimumab|ipilimumab|mesh-list
92912414|NCT00784888|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92912415|NCT00784888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92912416|NCT00784888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912417|NCT00784888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912418|NCT00784888|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92912419|NCT00784888|Hormone Antagonists|hormone antagonists|mesh-ancestor
92912420|NCT00784888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912421|NCT00784888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912423|NCT00873119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92912424|NCT00873119|Carboplatin|carboplatin|mesh-list
92912425|NCT00873119|Belinostat|belinostat|mesh-list
92912426|NCT00873119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92912427|NCT00873119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912428|NCT00873119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912429|NCT00873119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912430|NCT00873119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912431|NCT00873119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912432|NCT00873119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92912433|NCT00873119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912434|NCT00661726|Decitabine|decitabine|mesh-list
92912435|NCT00661726|Azacitidine|azacitidine|mesh-list
92912436|NCT00661726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912437|NCT00661726|Antimetabolites|antimetabolites|mesh-ancestor
92912438|NCT00661726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912439|NCT00661726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912441|NCT00706680|Cyclosporine|cyclosporine|mesh-list
92912442|NCT00706680|Mycophenolic Acid|mycophenolic acid|mesh-list
92912443|NCT00706680|Prednisone|prednisone|mesh-list
92912444|NCT00706680|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92912445|NCT00706680|Cyclosporins|cyclosporins|mesh-list
92912446|NCT00706680|Thymoglobulin|thymoglobulin|mesh-list
92912447|NCT00706680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912448|NCT00706680|Glucocorticoids|glucocorticoids|mesh-ancestor
92912449|NCT00706680|Hormones|hormones|mesh-ancestor
92912450|NCT00706680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912451|NCT00706680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912452|NCT00706680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92912453|NCT00706680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912454|NCT00706680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912455|NCT00706680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912456|NCT00706680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92912457|NCT00706680|Immunologic Factors|immunologic factors|mesh-ancestor
92912458|NCT00706680|Antifungal Agents|antifungal agents|mesh-ancestor
92912459|NCT00706680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912460|NCT00706680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92912461|NCT00706680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912462|NCT00706680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92912463|NCT00706680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92912464|NCT00706680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92912465|NCT00706680|Antitubercular Agents|antitubercular agents|mesh-ancestor
92912466|NCT00706680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92912467|NCT00706680|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92912468|NCT00706680|Protective Agents|protective agents|mesh-ancestor
92912469|NCT02624999|Cisplatin|cisplatin|mesh-list
92912470|NCT02624999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912471|NCT02612480|Aspirin|aspirin|mesh-list
92912472|NCT02612480|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
92912473|NCT02612480|Clopidogrel|clopidogrel|mesh-list
92912474|NCT02612480|Ticagrelor|ticagrelor|mesh-list
92912475|NCT02612480|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92912476|NCT02612480|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92912477|NCT02612480|Analgesics|analgesics|mesh-ancestor
92912478|NCT02612480|Sensory System Agents|sensory system agents|mesh-ancestor
92912479|NCT02612480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912480|NCT02612480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912481|NCT02612480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912482|NCT02612480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912483|NCT02612480|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92912484|NCT02612480|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92912485|NCT02612480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912486|NCT02612480|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92912487|NCT02612480|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92912488|NCT02612480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912489|NCT02612480|Antipyretics|antipyretics|mesh-ancestor
92912490|NCT02612480|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92912491|NCT02612480|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92912492|NCT02612480|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92912493|NCT02612480|Purinergic Agents|purinergic agents|mesh-ancestor
92912494|NCT02612480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912496|NCT00784966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92912497|NCT00784966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92912498|NCT00784966|Analgesics|analgesics|mesh-ancestor
92912499|NCT00784966|Sensory System Agents|sensory system agents|mesh-ancestor
92912500|NCT00784966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912501|NCT00784966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912502|NCT00784966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912503|NCT00784966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912504|NCT00784966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92912505|NCT00784966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92912506|NCT00784966|Immunologic Factors|immunologic factors|mesh-ancestor
92912507|NCT02623595|Molgramostim|molgramostim|mesh-list
92912508|NCT02623595|Sargramostim|sargramostim|mesh-list
92912509|NCT02623595|Immunologic Factors|immunologic factors|mesh-ancestor
92912510|NCT02623595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212841|NCT01832363|Xenon|xenon|mesh-list
92912511|NCT02623595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912512|NCT00665392|Docetaxel|docetaxel|mesh-list
92912513|NCT00665392|Fluorouracil|fluorouracil|mesh-list
92912514|NCT00665392|Cetuximab|cetuximab|mesh-list
92912515|NCT00665392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912516|NCT00665392|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912517|NCT00665392|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912518|NCT00665392|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912519|NCT00665392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912520|NCT00665392|Antimetabolites|antimetabolites|mesh-ancestor
92912521|NCT00665392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912522|NCT00665392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92912523|NCT00665392|Immunologic Factors|immunologic factors|mesh-ancestor
92912524|NCT00665392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912525|NCT00665392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912526|NCT00851630|Lamivudine|lamivudine|mesh-list
92912527|NCT00851630|Zidovudine|zidovudine|mesh-list
92912528|NCT00851630|Abacavir|abacavir|mesh-list
92912529|NCT00851630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92912530|NCT00851630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92912531|NCT00851630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912532|NCT00851630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912533|NCT00851630|Antiviral Agents|antiviral agents|mesh-ancestor
92912534|NCT00851630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912535|NCT00851630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92912536|NCT00851630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92912537|NCT00851630|Antimetabolites|antimetabolites|mesh-ancestor
92912538|NCT05298761|Lidocaine|lidocaine|mesh-list
92912539|NCT05298761|Nalbuphine|nalbuphine|mesh-list
92912540|NCT05298761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92912541|NCT05298761|Narcotics|narcotics|mesh-ancestor
92912542|NCT05298761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912543|NCT05298761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912544|NCT05298761|Analgesics|analgesics|mesh-ancestor
92912545|NCT05298761|Sensory System Agents|sensory system agents|mesh-ancestor
92912546|NCT05298761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912547|NCT05298761|Anesthetics, Local|anesthetics, local|mesh-ancestor
92912548|NCT05298761|Anesthetics|anesthetics|mesh-ancestor
92912549|NCT05298761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92912550|NCT05298761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92912551|NCT05298761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92912552|NCT05298761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92912553|NCT05298761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912554|NCT00459667|Interferons|interferons|mesh-list
92912555|NCT00459667|Interferon-beta|interferon-beta|mesh-list
92912556|NCT00459667|Interferon beta-1b|interferon beta-1b|mesh-list
92912557|NCT00459667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912558|NCT00459667|Antiviral Agents|antiviral agents|mesh-ancestor
92912559|NCT00459667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912560|NCT00459667|Immunologic Factors|immunologic factors|mesh-ancestor
92912561|NCT00459667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912562|NCT00459667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92912563|NCT02621255|Bupivacaine|bupivacaine|mesh-list
92912564|NCT02621255|Anesthetics|anesthetics|mesh-list
92912565|NCT02621255|Sevoflurane|sevoflurane|mesh-list
92912566|NCT02621255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92912567|NCT02621255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912568|NCT02621255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912569|NCT02621255|Sensory System Agents|sensory system agents|mesh-ancestor
92912570|NCT02621255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912571|NCT02621255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92912572|NCT02621255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92912573|NCT02621255|Anesthetics, General|anesthetics, general|mesh-ancestor
92912574|NCT00828204|Interferons|interferons|mesh-list
92912575|NCT00828204|Interferon-beta|interferon-beta|mesh-list
92912576|NCT00828204|Interferon beta-1a|interferon beta-1a|mesh-list
92912577|NCT00828204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912578|NCT00828204|Antiviral Agents|antiviral agents|mesh-ancestor
92912579|NCT00828204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912580|NCT00828204|Immunologic Factors|immunologic factors|mesh-ancestor
92912581|NCT00828204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912582|NCT00828204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92912584|NCT00696215|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92912585|NCT00696215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162456|NCT01246713|Acetaminophen|acetaminophen|mesh-list
92912586|NCT00696215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912587|NCT00696215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92912588|NCT00696215|Protective Agents|protective agents|mesh-ancestor
92912589|NCT00696215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912590|NCT00784186|Misoprostol|misoprostol|mesh-list
92912591|NCT00784186|Mifepristone|mifepristone|mesh-list
92912592|NCT00784186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92912593|NCT00784186|Abortifacient Agents|abortifacient agents|mesh-ancestor
92912594|NCT00784186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92912595|NCT00784186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912596|NCT00784186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92912597|NCT00784186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92912598|NCT00784186|Oxytocics|oxytocics|mesh-ancestor
92912599|NCT00784186|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92912600|NCT00784186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92912601|NCT00784186|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92912602|NCT00784186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92912603|NCT00784186|Contraceptive Agents|contraceptive agents|mesh-ancestor
92912604|NCT00784186|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92912605|NCT00784186|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92912606|NCT00784186|Hormone Antagonists|hormone antagonists|mesh-ancestor
92912607|NCT00784186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912608|NCT00784186|Luteolytic Agents|luteolytic agents|mesh-ancestor
92912609|NCT00784186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92912610|NCT00784186|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92912611|NCT00851552|Rituximab|rituximab|mesh-list
92912612|NCT00851552|Doxorubicin|doxorubicin|mesh-list
92912613|NCT00851552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92912614|NCT00851552|Bortezomib|bortezomib|mesh-list
92912615|NCT00851552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912616|NCT00851552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912617|NCT00851552|Immunologic Factors|immunologic factors|mesh-ancestor
92912618|NCT00851552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912619|NCT00851552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912620|NCT00851552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92912621|NCT00851552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92912622|NCT00851552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92912623|NCT00851552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912624|NCT00851552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912625|NCT00785122|Cyclophosphamide|cyclophosphamide|mesh-list
92912626|NCT00785122|Molgramostim|molgramostim|mesh-list
92912627|NCT00785122|Imiquimod|imiquimod|mesh-list
92912628|NCT00785122|Sargramostim|sargramostim|mesh-list
92912629|NCT00785122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92912630|NCT00785122|Immunologic Factors|immunologic factors|mesh-ancestor
92912631|NCT00785122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912632|NCT00785122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912633|NCT00785122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92912634|NCT00785122|Alkylating Agents|alkylating agents|mesh-ancestor
92912635|NCT00785122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912636|NCT00785122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912637|NCT00785122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92912638|NCT00785122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92912639|NCT00785122|Interferon Inducers|interferon inducers|mesh-ancestor
92912640|NCT04116554|Bupivacaine|bupivacaine|mesh-list
92912641|NCT04116554|Anesthetics, Local|anesthetics, local|mesh-ancestor
92912642|NCT04116554|Anesthetics|anesthetics|mesh-ancestor
92912643|NCT04116554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912644|NCT04116554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912645|NCT04116554|Sensory System Agents|sensory system agents|mesh-ancestor
92912646|NCT04116554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912647|NCT00700856|Pioglitazone|pioglitazone|mesh-list
92912648|NCT00700856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92912649|NCT00700856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912650|NCT00790114|Midazolam|midazolam|mesh-list
92912651|NCT00790114|Caffeine|caffeine|mesh-list
92912652|NCT00790114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92912653|NCT00790114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92912654|NCT00790114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912655|NCT00790114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912656|NCT00790114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92912657|NCT00790114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92912658|NCT00790114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912659|NCT00790114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92912660|NCT00790114|Anesthetics, General|anesthetics, general|mesh-ancestor
92912661|NCT00790114|Anesthetics|anesthetics|mesh-ancestor
92912662|NCT00790114|GABA Modulators|gaba modulators|mesh-ancestor
92912663|NCT00790114|GABA Agents|gaba agents|mesh-ancestor
92912664|NCT00790114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912665|NCT00790114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912666|NCT00790114|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92912667|NCT00790114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92912668|NCT00790114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912669|NCT00790114|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92912670|NCT00790114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92912671|NCT00790114|Purinergic Agents|purinergic agents|mesh-ancestor
92912672|NCT01023139|Sibutramine|sibutramine|mesh-list
92912673|NCT01023139|Antidepressive Agents|antidepressive agents|mesh-ancestor
92912674|NCT01023139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912675|NCT01023139|Appetite Depressants|appetite depressants|mesh-ancestor
92912676|NCT01023139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92912677|NCT00459043|Docetaxel|docetaxel|mesh-list
92912678|NCT00459043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912679|NCT00459043|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912680|NCT00459043|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912681|NCT00459043|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912682|NCT00459043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912683|NCT00795262|Thioctic Acid|thioctic acid|mesh-list
92912684|NCT00795262|Quinapril|quinapril|mesh-list
92912685|NCT00795262|Antioxidants|antioxidants|mesh-ancestor
92912686|NCT00795262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912687|NCT00795262|Protective Agents|protective agents|mesh-ancestor
92912688|NCT00795262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912689|NCT00795262|Vitamin B Complex|vitamin b complex|mesh-ancestor
92912690|NCT00795262|Vitamins|vitamins|mesh-ancestor
92912691|NCT00795262|Micronutrients|micronutrients|mesh-ancestor
92912692|NCT00795262|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92912693|NCT00795262|Protease Inhibitors|protease inhibitors|mesh-ancestor
92912694|NCT00795262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912695|NCT00795262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92912696|NCT00785200|Chlorhexidine|chlorhexidine|mesh-list
92912697|NCT00785200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92912698|NCT00785200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92912699|NCT00785200|Disinfectants|disinfectants|mesh-ancestor
92912700|NCT00817206|Tacrolimus|tacrolimus|mesh-list
92912701|NCT00817206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92912702|NCT00817206|Immunologic Factors|immunologic factors|mesh-ancestor
92912703|NCT00817206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912704|NCT00817206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92912705|NCT00817206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912706|NCT00817206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912707|NCT02611518|Metformin|metformin|mesh-list
92912708|NCT02611518|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92912709|NCT02611518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92912710|NCT02611518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912711|NCT02611518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92912712|NCT02611518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92912713|NCT02611518|Antimetabolites|antimetabolites|mesh-ancestor
92912714|NCT02611518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912715|NCT02611518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92912716|NCT02611518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92912717|NCT02611518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558209|NCT00043121|Vitamins|vitamins|mesh-ancestor
92912718|NCT01023607|Atorvastatin|atorvastatin|mesh-list
92912719|NCT01023607|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92912720|NCT01023607|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92912721|NCT01023607|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92912722|NCT01023607|Antimetabolites|antimetabolites|mesh-ancestor
92912723|NCT01023607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912724|NCT01023607|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92912725|NCT01023607|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92912726|NCT01023607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912727|NCT00665002|Sargramostim|sargramostim|mesh-list
92912728|NCT00665002|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92912729|NCT00665002|Immunologic Factors|immunologic factors|mesh-ancestor
92912730|NCT00665002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912731|NCT00665002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92912732|NCT00660010|Leuprolide|leuprolide|mesh-list
92912733|NCT00660010|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92912734|NCT00660010|Fertility Agents|fertility agents|mesh-ancestor
92912735|NCT00660010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92912736|NCT00660010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526131|NCT00027937|Aldesleukin|aldesleukin|mesh-list
92912737|NCT00660010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92912738|NCT00660010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912739|NCT04015908|Acetaminophen|acetaminophen|mesh-list
92912741|NCT04015908|Pregabalin|pregabalin|mesh-list
92912742|NCT04015908|Oxycodone|oxycodone|mesh-list
92912743|NCT04015908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92912744|NCT04015908|Analgesics|analgesics|mesh-ancestor
92912745|NCT04015908|Sensory System Agents|sensory system agents|mesh-ancestor
92912746|NCT04015908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912747|NCT04015908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912748|NCT04015908|Antipyretics|antipyretics|mesh-ancestor
92912749|NCT04015908|Anticonvulsants|anticonvulsants|mesh-ancestor
92912750|NCT04015908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92912751|NCT04015908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92912752|NCT04015908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912753|NCT04015908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92912754|NCT04015908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92912755|NCT04015908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92912756|NCT04015908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912757|NCT04015908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912758|NCT04015908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92912759|NCT04015908|Narcotics|narcotics|mesh-ancestor
92912760|NCT04015908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92912761|NCT04015908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912762|NCT04015908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912763|NCT04015908|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92912764|NCT04015908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92912765|NCT04015908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912766|NCT00790816|Lapatinib|lapatinib|mesh-list
92912767|NCT00790816|Antineoplastic Agents|antineoplastic agents|mesh-list
92912768|NCT00790816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912769|NCT00790816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912770|NCT00790816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912771|NCT00873041|Deferasirox|deferasirox|mesh-list
92912772|NCT00873041|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92912773|NCT00873041|Chelating Agents|chelating agents|mesh-ancestor
92912774|NCT00873041|Sequestering Agents|sequestering agents|mesh-ancestor
92912775|NCT00873041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912776|NCT00795496|Histamine|histamine|mesh-list
92912777|NCT00795496|Histamine Agonists|histamine agonists|mesh-ancestor
92912778|NCT00795496|Histamine Agents|histamine agents|mesh-ancestor
92912779|NCT00795496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912780|NCT00795496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912781|NCT00795496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912782|NCT00795574|Infliximab|infliximab|mesh-list
92912783|NCT00795574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92912784|NCT00795574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92912785|NCT00795574|Dermatologic Agents|dermatologic agents|mesh-ancestor
92912786|NCT00795574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92912787|NCT00795574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92912788|NCT00785434|Escitalopram|escitalopram|mesh-list
92912789|NCT00785434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92912790|NCT00785434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92912791|NCT00785434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92912792|NCT00785434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912793|NCT00785434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912794|NCT00785434|Serotonin Agents|serotonin agents|mesh-ancestor
92912795|NCT00785434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912796|NCT00790894|Epothilones|epothilones|mesh-list
92912797|NCT00790894|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912798|NCT00790894|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912799|NCT00790894|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912800|NCT00790894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912801|NCT00790894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912802|NCT02623127|Sunitinib|sunitinib|mesh-list
92912803|NCT02623127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912804|NCT02623127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92912805|NCT02623127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92912806|NCT02623127|Growth Substances|growth substances|mesh-ancestor
92912807|NCT02623127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912808|NCT02623127|Growth Inhibitors|growth inhibitors|mesh-ancestor
92912809|NCT02623127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912810|NCT02623127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912811|NCT02623127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912812|NCT05263492|Pembrolizumab|pembrolizumab|mesh-list
92912813|NCT05263492|Lenvatinib|lenvatinib|mesh-list
92912814|NCT05263492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912815|NCT05263492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912816|NCT05263492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92912817|NCT05263492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912818|NCT05263492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92912819|NCT05263492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912820|NCT04134611|Hyaluronic Acid|hyaluronic acid|mesh-list
92912821|NCT04134611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92912822|NCT04134611|Immunologic Factors|immunologic factors|mesh-ancestor
92912823|NCT04134611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912824|NCT04134611|Viscosupplements|viscosupplements|mesh-ancestor
92912825|NCT04134611|Protective Agents|protective agents|mesh-ancestor
92912826|NCT02620631|Morphine|morphine|mesh-list
92912827|NCT02620631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92912828|NCT02620631|Narcotics|narcotics|mesh-ancestor
92912829|NCT02620631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912830|NCT02620631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912831|NCT02620631|Analgesics|analgesics|mesh-ancestor
92912832|NCT02620631|Sensory System Agents|sensory system agents|mesh-ancestor
92912833|NCT02620631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912834|NCT04030572|Clonidine|clonidine|mesh-list
92912835|NCT04030572|Analgesics|analgesics|mesh-ancestor
92912836|NCT04030572|Sensory System Agents|sensory system agents|mesh-ancestor
92912837|NCT04030572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912838|NCT04030572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912839|NCT04030572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92912840|NCT04030572|Sympatholytics|sympatholytics|mesh-ancestor
92912841|NCT04030572|Autonomic Agents|autonomic agents|mesh-ancestor
92912842|NCT04030572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92912843|NCT04030572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92912844|NCT04030572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92912845|NCT04030572|Adrenergic Agents|adrenergic agents|mesh-ancestor
92912846|NCT04030572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912847|NCT04030572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912848|NCT00795808|Metformin|metformin|mesh-list
92912849|NCT00795808|Clomiphene|clomiphene|mesh-list
92912850|NCT00795808|Enclomiphene|enclomiphene|mesh-list
92912851|NCT00795808|Zuclomiphene|zuclomiphene|mesh-list
92912852|NCT00795808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92912853|NCT00795808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912854|NCT00795808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92912855|NCT00795808|Hormone Antagonists|hormone antagonists|mesh-ancestor
92912856|NCT00795808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92912857|NCT00795808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92912858|NCT00795808|Fertility Agents|fertility agents|mesh-ancestor
92912859|NCT00795808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92912860|NCT00795808|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92912861|NCT00795808|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92912862|NCT04135781|Paclitaxel|paclitaxel|mesh-list
92912863|NCT04135781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92912864|NCT04135781|Capecitabine|capecitabine|mesh-list
92912865|NCT04135781|Oxaliplatin|oxaliplatin|mesh-list
92912866|NCT04135781|Tegafur|tegafur|mesh-list
92912867|NCT04135781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92912868|NCT04135781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912869|NCT04135781|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912870|NCT04135781|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912871|NCT04135781|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912872|NCT04135781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912873|NCT04135781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912874|NCT04135781|Antimetabolites|antimetabolites|mesh-ancestor
92912875|NCT04135313|Capecitabine|capecitabine|mesh-list
92912876|NCT04135313|Oxaliplatin|oxaliplatin|mesh-list
92912877|NCT04135313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92912878|NCT04135313|Antimetabolites|antimetabolites|mesh-ancestor
92912879|NCT04135313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912880|NCT04135313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912881|NCT00692159|Pemetrexed|pemetrexed|mesh-list
92912882|NCT00692159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912883|NCT00692159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912884|NCT00692159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912885|NCT00692159|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92912886|NCT00692159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92912887|NCT00692315|Vitamin B 12|vitamin b 12|mesh-list
92912888|NCT00692315|Vitamins|vitamins|mesh-ancestor
92912889|NCT00692315|Micronutrients|micronutrients|mesh-ancestor
92912890|NCT00692315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912891|NCT00692315|Vitamin B Complex|vitamin b complex|mesh-ancestor
92912892|NCT02623049|Anticoagulants|anticoagulants|mesh-list
92912893|NCT02608944|Adenosine|adenosine|mesh-list
92912894|NCT02608944|Regadenoson|regadenoson|mesh-list
92912895|NCT02608944|Analgesics|analgesics|mesh-ancestor
92912896|NCT02608944|Sensory System Agents|sensory system agents|mesh-ancestor
92912897|NCT02608944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912898|NCT02608944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912899|NCT02608944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92912900|NCT02608944|Vasodilator Agents|vasodilator agents|mesh-ancestor
92912901|NCT02608944|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92912902|NCT02608944|Purinergic Agonists|purinergic agonists|mesh-ancestor
92912903|NCT02608944|Purinergic Agents|purinergic agents|mesh-ancestor
92912904|NCT02608944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912905|NCT02608944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912906|NCT02608944|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92912907|NCT00913614|SR 46349B|sr 46349b|mesh-list
92912908|NCT00913614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92912909|NCT00913614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92912910|NCT00913614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912911|NCT00913614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92912912|NCT00913614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92912913|NCT00913614|Serotonin Agents|serotonin agents|mesh-ancestor
92912914|NCT00913614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912915|NCT00913614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912916|NCT00664534|Insulin|insulin|mesh-list
92912917|NCT00664534|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92912918|NCT00664534|Insulin Glargine|insulin glargine|mesh-list
92912919|NCT00664534|Insulin Lispro|insulin lispro|mesh-list
92912920|NCT00664534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92912921|NCT00664534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912922|NCT00913848|Valproic Acid|valproic acid|mesh-list
92912923|NCT00913848|Anticonvulsants|anticonvulsants|mesh-ancestor
92912924|NCT00913848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92912925|NCT00913848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912926|NCT00913848|GABA Agents|gaba agents|mesh-ancestor
92912927|NCT00913848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92912928|NCT00913848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912929|NCT00913848|Antimanic Agents|antimanic agents|mesh-ancestor
92912930|NCT00913848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92912931|NCT00913848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912932|NCT00913848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912933|NCT02620163|Amlodipine|amlodipine|mesh-list
92912934|NCT02620163|Telmisartan|telmisartan|mesh-list
92912935|NCT02620163|Chlorthalidone|chlorthalidone|mesh-list
92912936|NCT02620163|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92912937|NCT02620163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92912938|NCT02620163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92912939|NCT02620163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92912940|NCT02620163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912941|NCT02620163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92912942|NCT02620163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912943|NCT02620163|Vasodilator Agents|vasodilator agents|mesh-ancestor
92912944|NCT02620163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92912945|NCT02620163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92558424|NCT00125905|Bupropion|bupropion|mesh-list
92912946|NCT02620163|Diuretics|diuretics|mesh-ancestor
92912947|NCT02620163|Natriuretic Agents|natriuretic agents|mesh-ancestor
92912948|NCT02620163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92912950|NCT05758116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912951|NCT05758116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912952|NCT00912821|Dialysis Solutions|dialysis solutions|mesh-list
92912953|NCT00912821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92912954|NCT00570310|Pregabalin|pregabalin|mesh-list
92912955|NCT00570310|Analgesics|analgesics|mesh-ancestor
92912956|NCT00570310|Sensory System Agents|sensory system agents|mesh-ancestor
92912957|NCT00570310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92912958|NCT00570310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912960|NCT00570310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92912961|NCT00570310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92912962|NCT00570310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912963|NCT00570310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92912964|NCT00570310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92912965|NCT00570310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92912966|NCT00570310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92912967|NCT00570310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92912968|NCT00696995|Insulin Aspart|insulin aspart|mesh-list
92912969|NCT00696995|Biphasic Insulins|biphasic insulins|mesh-list
92912970|NCT00696995|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92912971|NCT00696995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92912972|NCT00696995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912973|NCT00664066|Epoetin Alfa|epoetin alfa|mesh-list
92912974|NCT00664066|Hematinics|hematinics|mesh-ancestor
92912975|NCT04676958|Vitamin K|vitamin k|mesh-list
92912976|NCT04676958|Vitamin K 2|vitamin k 2|mesh-list
92912977|NCT04676958|Vitamins|vitamins|mesh-ancestor
92912978|NCT04676958|Micronutrients|micronutrients|mesh-ancestor
92912979|NCT04676958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92912980|NCT04676958|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92912981|NCT04676958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92912982|NCT04676958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912983|NCT04676958|Hemostatics|hemostatics|mesh-ancestor
92912984|NCT04676958|Coagulants|coagulants|mesh-ancestor
92912985|NCT02619929|Vinorelbine|vinorelbine|mesh-list
92912986|NCT02619929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92912987|NCT02619929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912988|NCT02619929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92912989|NCT02619929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92912990|NCT02619929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92912991|NCT02619929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92912992|NCT00796198|Latanoprost|latanoprost|mesh-list
92912993|NCT00796198|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92912994|NCT00796198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92912995|NCT02622503|Rituximab|rituximab|mesh-list
92912996|NCT02622503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92912997|NCT02622503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92912998|NCT02622503|Immunologic Factors|immunologic factors|mesh-ancestor
92912999|NCT02622503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913000|NCT02622503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913001|NCT00814710|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92913002|NCT00814710|Immunologic Factors|immunologic factors|mesh-ancestor
92913003|NCT00814710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913004|NCT00796276|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92913005|NCT00796276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92913006|NCT00796276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92913007|NCT00796276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162488|NCT05345639|Ropivacaine|ropivacaine|mesh-list
92913008|NCT00796276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913009|NCT00796276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913010|NCT00796276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92913011|NCT00796276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92913012|NCT00796276|Serotonin Agents|serotonin agents|mesh-ancestor
92913013|NCT00796276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913014|NCT00796276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913015|NCT00796276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92913016|NCT00796276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92913017|NCT00796276|Dopamine Agents|dopamine agents|mesh-ancestor
92913018|NCT00796432|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92913019|NCT00796432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92913020|NCT00796432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92913021|NCT00796432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913023|NCT00796432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913024|NCT00796432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92913025|NCT00796432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92913026|NCT00796432|Serotonin Agents|serotonin agents|mesh-ancestor
92913027|NCT00796432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913028|NCT00796432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913029|NCT00796432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92913030|NCT00796432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92913031|NCT00796432|Dopamine Agents|dopamine agents|mesh-ancestor
92913032|NCT00786058|Fluorouracil|fluorouracil|mesh-list
92913033|NCT00786058|Antimetabolites|antimetabolites|mesh-ancestor
92913034|NCT00786058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913035|NCT00786058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92913036|NCT00786058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913037|NCT00786058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913038|NCT00786058|Immunologic Factors|immunologic factors|mesh-ancestor
92913039|NCT00786058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913040|NCT00871169|Oxaliplatin|oxaliplatin|mesh-list
92913041|NCT00871169|Irinotecan|irinotecan|mesh-list
92913042|NCT00871169|Cetuximab|cetuximab|mesh-list
92913043|NCT00871169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913044|NCT00871169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92913045|NCT00871169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913046|NCT00871169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913047|NCT00871169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913048|NCT00871169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92913049|NCT00791284|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92913050|NCT00791284|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92913051|NCT00791284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92913052|NCT00791284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913053|NCT00791284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913054|NCT00791284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913055|NCT00791284|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92913056|NCT00791284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92913057|NCT00791284|Serotonin Agents|serotonin agents|mesh-ancestor
92913058|NCT00791284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913059|NCT00791284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913060|NCT00791284|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92913061|NCT00791284|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92913062|NCT00791284|Dopamine Agents|dopamine agents|mesh-ancestor
92913063|NCT00814632|Apremilast|apremilast|mesh-list
92913064|NCT00814632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913065|NCT00814632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913066|NCT00814632|Analgesics|analgesics|mesh-ancestor
92913067|NCT00814632|Sensory System Agents|sensory system agents|mesh-ancestor
92913068|NCT00814632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913069|NCT00814632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913070|NCT00814632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913071|NCT00814632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913072|NCT00814632|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92913073|NCT00814632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92913074|NCT00814632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913075|NCT00814632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913076|NCT00786136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92913077|NCT00786136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92913078|NCT00786136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92913079|NCT00786136|Antimetabolites|antimetabolites|mesh-ancestor
92913080|NCT00786136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913081|NCT00786136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92913082|NCT00786136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92913083|NCT00786136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913084|NCT02620007|Ciprofloxacin|ciprofloxacin|mesh-list
92913085|NCT02620007|Rifaximin|rifaximin|mesh-list
92913086|NCT02620007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913087|NCT02620007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913088|NCT02620007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92913089|NCT02620007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913090|NCT02620007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913091|NCT02620007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913092|NCT02620007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913093|NCT02620007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92913094|NCT02620007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92913095|NCT02620007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92913096|NCT02554942|Epoetin Alfa|epoetin alfa|mesh-list
92913097|NCT02554942|Hematinics|hematinics|mesh-ancestor
92913099|NCT02619773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913100|NCT02619773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913101|NCT02619773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92913102|NCT02619773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913103|NCT02619773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913104|NCT02555488|Methylene Blue|methylene blue|mesh-list
92913106|NCT02555488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913107|NCT02554864|Lidocaine|lidocaine|mesh-list
92913108|NCT02554864|Ropivacaine|ropivacaine|mesh-list
92913109|NCT02554864|Anesthetics, Local|anesthetics, local|mesh-ancestor
92913110|NCT02554864|Anesthetics|anesthetics|mesh-ancestor
92913111|NCT02554864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913112|NCT02554864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913113|NCT02554864|Sensory System Agents|sensory system agents|mesh-ancestor
92913114|NCT02554864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913115|NCT02554864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92913116|NCT02554864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92913117|NCT02554864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92913118|NCT02554864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913119|NCT02554864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913120|NCT00851318|Certolizumab Pegol|certolizumab pegol|mesh-list
92913121|NCT00851318|Methotrexate|methotrexate|mesh-list
92913122|NCT00851318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92913123|NCT00851318|Abortifacient Agents|abortifacient agents|mesh-ancestor
92913124|NCT00851318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92913125|NCT00851318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913126|NCT00851318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92913127|NCT00851318|Antimetabolites|antimetabolites|mesh-ancestor
92913128|NCT00851318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913129|NCT00851318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913130|NCT00851318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92913131|NCT00851318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913132|NCT00851318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92913133|NCT00851318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913134|NCT00851318|Immunologic Factors|immunologic factors|mesh-ancestor
92913135|NCT00851318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913136|NCT00851318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92913137|NCT00851318|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92913138|NCT00851318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913139|NCT00786370|Dexmedetomidine|dexmedetomidine|mesh-list
92913140|NCT00786370|Propofol|propofol|mesh-list
92913141|NCT00786370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92913142|NCT00786370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913143|NCT00786370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913144|NCT00786370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913145|NCT00786370|Analgesics|analgesics|mesh-ancestor
92913146|NCT00786370|Sensory System Agents|sensory system agents|mesh-ancestor
92913147|NCT00786370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913148|NCT00786370|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92913149|NCT00786370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92913150|NCT00786370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92913151|NCT00786370|Adrenergic Agents|adrenergic agents|mesh-ancestor
92913152|NCT00786370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913153|NCT00786370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913154|NCT00786370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92913155|NCT00786370|Anesthetics, General|anesthetics, general|mesh-ancestor
92913156|NCT00786370|Anesthetics|anesthetics|mesh-ancestor
92913157|NCT00796900|Dantrolene|dantrolene|mesh-list
92913158|NCT00796900|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92913159|NCT00796900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913160|NCT00796900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92913161|NCT00796900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913162|NCT00791830|Irbesartan|irbesartan|mesh-list
92913163|NCT00791830|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92913164|NCT00791830|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92913165|NCT00791830|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92913166|NCT00791830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913167|NCT00786448|Darifenacin|darifenacin|mesh-list
92913168|NCT00786448|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92913169|NCT00786448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92913170|NCT00786448|Cholinergic Agents|cholinergic agents|mesh-ancestor
92913171|NCT00786448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913172|NCT00786448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913173|NCT00786448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913174|NCT00786448|Urological Agents|urological agents|mesh-ancestor
92913175|NCT04137653|Paclitaxel|paclitaxel|mesh-list
92913176|NCT04137653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92913177|NCT04137653|Carboplatin|carboplatin|mesh-list
92913178|NCT04137653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92913179|NCT04137653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913180|NCT04137653|Tubulin Modulators|tubulin modulators|mesh-ancestor
92913181|NCT04137653|Antimitotic Agents|antimitotic agents|mesh-ancestor
92913182|NCT04137653|Mitosis Modulators|mitosis modulators|mesh-ancestor
92913183|NCT04137653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913184|NCT00797056|Aspirin|aspirin|mesh-list
92913185|NCT00797056|Clopidogrel|clopidogrel|mesh-list
92913186|NCT00797056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913187|NCT00797056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913188|NCT00797056|Analgesics|analgesics|mesh-ancestor
92913189|NCT00797056|Sensory System Agents|sensory system agents|mesh-ancestor
92913190|NCT00797056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913191|NCT00797056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913192|NCT00797056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913193|NCT00797056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913194|NCT00797056|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92913195|NCT00797056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913196|NCT00797056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913197|NCT00797056|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92913198|NCT00797056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92913199|NCT00797056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913200|NCT00797056|Antipyretics|antipyretics|mesh-ancestor
92913201|NCT00797056|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92913202|NCT00797056|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92913203|NCT00797056|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92913204|NCT00797056|Purinergic Agents|purinergic agents|mesh-ancestor
92913205|NCT00797056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913206|NCT00593957|Dextromethorphan|dextromethorphan|mesh-list
92913207|NCT00593957|Antitussive Agents|antitussive agents|mesh-ancestor
92913208|NCT00593957|Respiratory System Agents|respiratory system agents|mesh-ancestor
92913209|NCT00593957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92913210|NCT00593957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92913211|NCT00593957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913212|NCT00593957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913213|NCT00593957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913214|NCT00697151|Aspirin|aspirin|mesh-list
92913215|NCT00697151|Warfarin|warfarin|mesh-list
92913216|NCT00697151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913217|NCT00697151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913218|NCT00697151|Analgesics|analgesics|mesh-ancestor
92913219|NCT00697151|Sensory System Agents|sensory system agents|mesh-ancestor
92913220|NCT00697151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913221|NCT00697151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913222|NCT00697151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913223|NCT00697151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913224|NCT00697151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92913225|NCT00697151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913226|NCT00697151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913227|NCT00697151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92913228|NCT00697151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92913229|NCT00697151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913230|NCT00697151|Antipyretics|antipyretics|mesh-ancestor
92913231|NCT00697151|Anticoagulants|anticoagulants|mesh-ancestor
92913232|NCT02621957|Pravastatin|pravastatin|mesh-list
92913233|NCT02621957|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92913234|NCT02621957|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92913235|NCT02621957|Antimetabolites|antimetabolites|mesh-ancestor
92913236|NCT02621957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913237|NCT02621957|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92913238|NCT02621957|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92913239|NCT02621957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913240|NCT00851084|Leucovorin|leucovorin|mesh-list
92913241|NCT00851084|Folic Acid|folic acid|mesh-list
92913242|NCT00851084|Oxaliplatin|oxaliplatin|mesh-list
92913243|NCT00851084|Aflibercept|aflibercept|mesh-list
92913244|NCT00851084|Levoleucovorin|levoleucovorin|mesh-list
92913245|NCT00851084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913246|NCT00851084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92913247|NCT00851084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92913248|NCT00851084|Growth Substances|growth substances|mesh-ancestor
92913249|NCT00851084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913250|NCT00851084|Growth Inhibitors|growth inhibitors|mesh-ancestor
92913251|NCT00851084|Antidotes|antidotes|mesh-ancestor
92913252|NCT00851084|Protective Agents|protective agents|mesh-ancestor
92913253|NCT00851084|Vitamin B Complex|vitamin b complex|mesh-ancestor
92913255|NCT00851084|Micronutrients|micronutrients|mesh-ancestor
92913256|NCT00851084|Hematinics|hematinics|mesh-ancestor
92913257|NCT02617199|Fentanyl|fentanyl|mesh-list
92913258|NCT02617199|Analgesics|analgesics|mesh-list
92913259|NCT02617199|Ropivacaine|ropivacaine|mesh-list
92913260|NCT02617199|Anesthetics|anesthetics|mesh-ancestor
92913261|NCT02617199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913262|NCT02617199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913263|NCT02617199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92913264|NCT02617199|Sensory System Agents|sensory system agents|mesh-ancestor
92913265|NCT02617199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913266|NCT02617199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92913267|NCT02617199|Narcotics|narcotics|mesh-ancestor
92913268|NCT02617199|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92913269|NCT02617199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92913270|NCT02617199|Anesthetics, General|anesthetics, general|mesh-ancestor
92913271|NCT00845858|Metoclopramide|metoclopramide|mesh-list
92913272|NCT00845858|Antiemetics|antiemetics|mesh-ancestor
92913273|NCT00845858|Autonomic Agents|autonomic agents|mesh-ancestor
92913274|NCT00845858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913275|NCT00845858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913276|NCT00845858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92913277|NCT00845858|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92913278|NCT00845858|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92913279|NCT00845858|Dopamine Agents|dopamine agents|mesh-ancestor
92913280|NCT00845858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913281|NCT00845858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913282|NCT02619149|Tazobactam|tazobactam|mesh-list
92913283|NCT02619149|Piperacillin|piperacillin|mesh-list
92913284|NCT02619149|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92913285|NCT02619149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913286|NCT02619149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913287|NCT02619149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92913288|NCT02619149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913289|NCT02619149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913290|NCT04134065|Vitamin D|vitamin d|mesh-list
92913291|NCT04134065|Vitamins|vitamins|mesh-ancestor
92913292|NCT04134065|Micronutrients|micronutrients|mesh-ancestor
92913293|NCT04134065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913294|NCT04134065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92913295|NCT02616731|Tranexamic Acid|tranexamic acid|mesh-list
92913296|NCT02616731|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92913297|NCT02616731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913298|NCT02616731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913299|NCT02616731|Hemostatics|hemostatics|mesh-ancestor
92913300|NCT02616731|Coagulants|coagulants|mesh-ancestor
92913301|NCT00850460|Atorvastatin|atorvastatin|mesh-list
92913302|NCT00850460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92913303|NCT00850460|Simvastatin|simvastatin|mesh-list
92913304|NCT00850460|Pravastatin|pravastatin|mesh-list
92913305|NCT00850460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92913306|NCT00850460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92913307|NCT00850460|Antimetabolites|antimetabolites|mesh-ancestor
92913308|NCT00850460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913309|NCT00850460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92913310|NCT00850460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92913311|NCT00850460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913312|NCT00661492|Cetuximab|cetuximab|mesh-list
92913313|NCT00661492|Mitoxantrone|mitoxantrone|mesh-list
92913314|NCT00661492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558755|NCT00399477|Levodopa|levodopa|mesh-list
92913315|NCT00661492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913316|NCT00661492|Analgesics|analgesics|mesh-ancestor
92913317|NCT00661492|Sensory System Agents|sensory system agents|mesh-ancestor
92913318|NCT00661492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913319|NCT00661492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913320|NCT00661492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92913321|NCT00661492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913322|NCT00661492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913323|NCT00661492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913324|NCT00693251|Sirolimus|sirolimus|mesh-list
92913325|NCT00693251|Paclitaxel|paclitaxel|mesh-list
92913326|NCT00693251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92913327|NCT00693251|Everolimus|everolimus|mesh-list
92913328|NCT00693251|Temsirolimus|temsirolimus|mesh-list
92913329|NCT00693251|MTOR Inhibitors|mtor inhibitors|mesh-list
92913330|NCT00693251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92913331|NCT00693251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913332|NCT00693251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92913333|NCT00693251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92913334|NCT00693251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92913335|NCT00693251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913336|NCT00693251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913337|NCT00693251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913338|NCT00693251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913339|NCT00693251|Immunologic Factors|immunologic factors|mesh-ancestor
92913340|NCT00693251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913341|NCT00693251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913342|NCT00693251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913343|NCT00693251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92913344|NCT00693251|Antifungal Agents|antifungal agents|mesh-ancestor
92913345|NCT00792376|Diclofenac|diclofenac|mesh-list
92913346|NCT00792376|Etoricoxib|etoricoxib|mesh-list
92913347|NCT00792376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913348|NCT00792376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913349|NCT00792376|Analgesics|analgesics|mesh-ancestor
92913350|NCT00792376|Sensory System Agents|sensory system agents|mesh-ancestor
92913351|NCT00792376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913352|NCT00792376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913353|NCT00792376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913354|NCT00792376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913355|NCT00792376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92913356|NCT00792376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913357|NCT00792376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913358|NCT00792376|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92913359|NCT00592358|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92913360|NCT00592358|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92913361|NCT00592358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92913362|NCT00592358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913363|NCT00592358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913364|NCT00592358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913365|NCT00592358|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92913366|NCT00592358|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92913367|NCT00592358|Serotonin Agents|serotonin agents|mesh-ancestor
92913368|NCT00592358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913369|NCT00592358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913370|NCT00592358|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92913371|NCT00592358|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92913372|NCT00592358|Dopamine Agents|dopamine agents|mesh-ancestor
92913373|NCT00814320|Immunoglobulins|immunoglobulins|mesh-list
92913374|NCT00814320|Antibodies|antibodies|mesh-list
92913375|NCT00814320|gamma-Globulins|gamma-globulins|mesh-list
92913376|NCT00814320|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92913377|NCT00814320|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92913378|NCT00814320|Immunoglobulin G|immunoglobulin g|mesh-list
92913379|NCT00814320|Immunologic Factors|immunologic factors|mesh-ancestor
92913380|NCT00814320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913381|NCT00869999|Rituximab|rituximab|mesh-list
92913382|NCT00869999|Everolimus|everolimus|mesh-list
92913383|NCT00869999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92913384|NCT00869999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913385|NCT00869999|Immunologic Factors|immunologic factors|mesh-ancestor
92913386|NCT00869999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913387|NCT00869999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913388|NCT00869999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92913389|NCT00869999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913390|NCT00869999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913391|NCT00869999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913392|NCT00869999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913393|NCT04030988|Dexamethasone|dexamethasone|mesh-list
92913394|NCT04030988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913395|NCT04030988|Antiemetics|antiemetics|mesh-ancestor
92913396|NCT04030988|Autonomic Agents|autonomic agents|mesh-ancestor
92913397|NCT04030988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913398|NCT04030988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913399|NCT04030988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92913400|NCT04030988|Glucocorticoids|glucocorticoids|mesh-ancestor
92913401|NCT04030988|Hormones|hormones|mesh-ancestor
92913402|NCT04030988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913403|NCT04030988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92913404|NCT04030988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913405|NCT00703352|Eplerenone|eplerenone|mesh-list
92913406|NCT00703352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92913407|NCT00703352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92913408|NCT00703352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913409|NCT00703352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913410|NCT00703352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92913411|NCT00703352|Diuretics|diuretics|mesh-ancestor
92913412|NCT00703352|Natriuretic Agents|natriuretic agents|mesh-ancestor
92913413|NCT00703352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92913414|NCT00703430|Memantine|memantine|mesh-list
92913415|NCT00703430|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92913416|NCT00703430|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92913417|NCT00703430|Dopamine Agents|dopamine agents|mesh-ancestor
92913418|NCT00703430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913419|NCT00703430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913420|NCT00703430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913421|NCT00703430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92913422|NCT00703430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92913423|NCT00797836|Interferons|interferons|mesh-list
92913424|NCT00797836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913425|NCT00797836|Antiviral Agents|antiviral agents|mesh-ancestor
92913426|NCT00797836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913427|NCT00693407|Capsaicin|capsaicin|mesh-list
92913428|NCT00693407|Antipruritics|antipruritics|mesh-ancestor
92913429|NCT00693407|Dermatologic Agents|dermatologic agents|mesh-ancestor
92913430|NCT00693407|Sensory System Agents|sensory system agents|mesh-ancestor
92913431|NCT00693407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913432|NCT00693407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913433|NCT02618603|Triamcinolone|triamcinolone|mesh-list
92913434|NCT02618603|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92913435|NCT02618603|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92913436|NCT02618603|Botulinum Toxins|botulinum toxins|mesh-list
92913437|NCT02618603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92913438|NCT02618603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92913439|NCT02618603|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92913440|NCT02618603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92913441|NCT02618603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913442|NCT02618603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913443|NCT02618603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92913444|NCT02618603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913445|NCT02618603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913446|NCT02618603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913447|NCT02618603|Glucocorticoids|glucocorticoids|mesh-ancestor
92913448|NCT02618603|Hormones|hormones|mesh-ancestor
92913449|NCT02618603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913450|NCT02618603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913451|NCT02618603|Immunologic Factors|immunologic factors|mesh-ancestor
92913452|NCT02618603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913453|NCT02618603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92913454|NCT02618603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913455|NCT02616497|Aspirin|aspirin|mesh-list
92913456|NCT02616497|Triflusal|triflusal|mesh-list
92913457|NCT02616497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913458|NCT02616497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913459|NCT02616497|Analgesics|analgesics|mesh-ancestor
92913460|NCT02616497|Sensory System Agents|sensory system agents|mesh-ancestor
92913461|NCT02616497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913462|NCT02616497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913463|NCT02616497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913464|NCT02616497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913465|NCT02616497|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92913466|NCT02616497|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913467|NCT02616497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913468|NCT02616497|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92913469|NCT02616497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92913470|NCT02616497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913471|NCT02616497|Antipyretics|antipyretics|mesh-ancestor
92913472|NCT00570232|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92913473|NCT00570232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913474|NCT00570232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913475|NCT00570232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913476|NCT00570232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913477|NCT05755854|Cyclophosphamide|cyclophosphamide|mesh-list
92913478|NCT05755854|Fludarabine|fludarabine|mesh-list
92913479|NCT05755854|Fludarabine phosphate|fludarabine phosphate|mesh-list
92913480|NCT05755854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913481|NCT05755854|Immunologic Factors|immunologic factors|mesh-ancestor
92913482|NCT05755854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913483|NCT05755854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913484|NCT05755854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92913485|NCT05755854|Alkylating Agents|alkylating agents|mesh-ancestor
92913486|NCT05755854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913487|NCT05755854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913488|NCT05755854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92913489|NCT05755854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92913490|NCT05755854|Antimetabolites|antimetabolites|mesh-ancestor
92913491|NCT00787384|Imatinib Mesylate|imatinib mesylate|mesh-list
92913492|NCT00787384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913493|NCT00787384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913494|NCT00787384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913495|NCT00787384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913496|NCT04669002|Olaparib|olaparib|mesh-list
92913497|NCT04669002|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92913498|NCT04669002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913499|NCT04669002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913500|NCT04669002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913501|NCT02616419|Lidocaine|lidocaine|mesh-list
92913502|NCT02616419|Anesthetics, Local|anesthetics, local|mesh-ancestor
92913503|NCT02616419|Anesthetics|anesthetics|mesh-ancestor
92913504|NCT02616419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913505|NCT02616419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913506|NCT02616419|Sensory System Agents|sensory system agents|mesh-ancestor
92913507|NCT02616419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913508|NCT02616419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92913509|NCT02616419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92913510|NCT02616419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92913511|NCT02616419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913512|NCT02616419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913513|NCT00798070|Cyclophosphamide|cyclophosphamide|mesh-list
92913514|NCT00798070|Fluorouracil|fluorouracil|mesh-list
92913515|NCT00798070|Docetaxel|docetaxel|mesh-list
92913516|NCT00798070|Epirubicin|epirubicin|mesh-list
92913517|NCT00798070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913518|NCT00798070|Immunologic Factors|immunologic factors|mesh-ancestor
92913519|NCT00798070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913520|NCT00798070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913521|NCT00798070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92913522|NCT00798070|Alkylating Agents|alkylating agents|mesh-ancestor
92913523|NCT00798070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913524|NCT00798070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913525|NCT00798070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92913526|NCT00798070|Antimetabolites|antimetabolites|mesh-ancestor
92913527|NCT00798070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92913528|NCT00798070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92913529|NCT00798070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92913530|NCT00798070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92913531|NCT00798070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92913532|NCT00798070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92913533|NCT00798070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913534|NCT00798070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913535|NCT00809328|Azithromycin|azithromycin|mesh-list
92913536|NCT00809328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913537|NCT00809328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913538|NCT00798148|Carboplatin|carboplatin|mesh-list
92913539|NCT00798148|Etoposide|etoposide|mesh-list
92913540|NCT00798148|Melphalan|melphalan|mesh-list
92913541|NCT00798148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913542|NCT00798148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92558975|NCT00078195|Omalizumab|omalizumab|mesh-list
92913543|NCT00798148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92913544|NCT00798148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913545|NCT00798148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526144|NCT00027937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913546|NCT00798148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913547|NCT00798148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92913548|NCT00798148|Alkylating Agents|alkylating agents|mesh-ancestor
92913549|NCT00798148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92913550|NCT00798148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913551|NCT00798148|Immunologic Factors|immunologic factors|mesh-ancestor
92913552|NCT00798148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913553|NCT00787462|Pregabalin|pregabalin|mesh-list
92913554|NCT00787462|Analgesics|analgesics|mesh-ancestor
92913555|NCT00787462|Sensory System Agents|sensory system agents|mesh-ancestor
92913556|NCT00787462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913557|NCT00787462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913558|NCT00787462|Anticonvulsants|anticonvulsants|mesh-ancestor
92913559|NCT00787462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92913560|NCT00787462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913561|NCT00787462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913562|NCT00787462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92913563|NCT00787462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92913564|NCT00787462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92913565|NCT00787462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913566|NCT00787462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913567|NCT00792766|Everolimus|everolimus|mesh-list
92913568|NCT00792766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92913569|NCT00792766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913570|NCT00792766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913571|NCT00792766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913572|NCT00792766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92913573|NCT00792766|Immunologic Factors|immunologic factors|mesh-ancestor
92913574|NCT00792766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913575|NCT00792766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913576|NCT00798460|Lamivudine|lamivudine|mesh-list
92913577|NCT00798460|Adefovir|adefovir|mesh-list
92913578|NCT00798460|Clevudine|clevudine|mesh-list
92913579|NCT00798460|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92913580|NCT00798460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92162509|NCT04248335|Anesthetics|anesthetics|mesh-ancestor
92913581|NCT00798460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913582|NCT00798460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913583|NCT00798460|Antiviral Agents|antiviral agents|mesh-ancestor
92913584|NCT00798460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913585|NCT00798460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92913586|NCT00798460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92913587|NCT02615873|Levodopa|levodopa|mesh-list
92913588|NCT02615873|Carbidopa|carbidopa|mesh-list
92913589|NCT02615873|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92913590|NCT02615873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92913591|NCT02615873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92913592|NCT02615873|Dopamine Agents|dopamine agents|mesh-ancestor
92913593|NCT02615873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913594|NCT02615873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913595|NCT02615873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913596|NCT02615873|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92913597|NCT02615873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913598|NCT02615873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92913599|NCT02615873|Immunologic Factors|immunologic factors|mesh-ancestor
92913600|NCT02615873|Dopamine Agonists|dopamine agonists|mesh-ancestor
92913601|NCT00814164|Daunorubicin|daunorubicin|mesh-list
92913602|NCT00814164|Clofarabine|clofarabine|mesh-list
92913603|NCT00814164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92913604|NCT00814164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913605|NCT00814164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92913606|NCT00814164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913607|NCT00814164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913608|NCT00814164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913609|NCT00814164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92913610|NCT00814164|Antimetabolites|antimetabolites|mesh-ancestor
92913611|NCT02609334|Pemirolast|pemirolast|mesh-list
92913612|NCT02609334|Histamine Antagonists|histamine antagonists|mesh-ancestor
92913613|NCT02609334|Histamine Agents|histamine agents|mesh-ancestor
92913614|NCT02609334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913615|NCT02609334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913616|NCT02609334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913617|NCT00659230|Dopamine|dopamine|mesh-list
92258450|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
92913618|NCT00659230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92913619|NCT00659230|Sympathomimetics|sympathomimetics|mesh-ancestor
92913620|NCT00659230|Autonomic Agents|autonomic agents|mesh-ancestor
92913621|NCT00659230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913622|NCT00659230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913623|NCT00659230|Dopamine Agents|dopamine agents|mesh-ancestor
92913624|NCT00659230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913625|NCT00659230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913626|NCT00659230|Protective Agents|protective agents|mesh-ancestor
92913627|NCT00809094|Acetylcysteine|acetylcysteine|mesh-list
92913628|NCT00809094|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92913629|NCT00809094|Antiviral Agents|antiviral agents|mesh-ancestor
92913630|NCT00809094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913631|NCT00809094|Expectorants|expectorants|mesh-ancestor
92913632|NCT00809094|Respiratory System Agents|respiratory system agents|mesh-ancestor
92913633|NCT00809094|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92913634|NCT00809094|Antioxidants|antioxidants|mesh-ancestor
92913635|NCT00809094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913636|NCT00809094|Protective Agents|protective agents|mesh-ancestor
92913637|NCT00809094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913638|NCT00809094|Antidotes|antidotes|mesh-ancestor
92913639|NCT02615639|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92913640|NCT02615639|Interferon-alpha|interferon-alpha|mesh-list
92913641|NCT02615639|Entecavir|entecavir|mesh-list
92913642|NCT02615639|Telbivudine|telbivudine|mesh-list
92913643|NCT02615639|Interferon alpha-2|interferon alpha-2|mesh-list
92913644|NCT02615639|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92913645|NCT02615639|Vaccines|vaccines|mesh-list
92913646|NCT02615639|Immunologic Factors|immunologic factors|mesh-ancestor
92913647|NCT02615639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913648|NCT02615639|Antiviral Agents|antiviral agents|mesh-ancestor
92913649|NCT02615639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162512|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913650|NCT02615639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92913651|NCT02615639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913652|NCT02615639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913653|NCT02615639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913654|NCT00798616|Methylprednisolone|methylprednisolone|mesh-list
92913655|NCT00798616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92913656|NCT00798616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92913657|NCT00798616|Prednisolone|prednisolone|mesh-list
92913658|NCT00798616|Prednisolone acetate|prednisolone acetate|mesh-list
92913659|NCT00798616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92913660|NCT00798616|Prednisolone phosphate|prednisolone phosphate|mesh-list
92913661|NCT00798616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913662|NCT00798616|Antiemetics|antiemetics|mesh-ancestor
92913663|NCT00798616|Autonomic Agents|autonomic agents|mesh-ancestor
92913664|NCT00798616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913665|NCT00798616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913666|NCT00798616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92913667|NCT00798616|Glucocorticoids|glucocorticoids|mesh-ancestor
92913668|NCT00798616|Hormones|hormones|mesh-ancestor
92913669|NCT00798616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913670|NCT00798616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92913671|NCT00798616|Protective Agents|protective agents|mesh-ancestor
92913672|NCT00798616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92913673|NCT00798616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913674|NCT02618057|Levofloxacin|levofloxacin|mesh-list
92913675|NCT02618057|Prednisolone|prednisolone|mesh-list
92913676|NCT02618057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913677|NCT02618057|Glucocorticoids|glucocorticoids|mesh-ancestor
92913678|NCT02618057|Hormones|hormones|mesh-ancestor
92913679|NCT02618057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913680|NCT02618057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913681|NCT02618057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92913682|NCT02618057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913683|NCT02618057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92913684|NCT02618057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913685|NCT02618057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913686|NCT02618057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92913687|NCT02618057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92913688|NCT02618057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913689|NCT02618057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913690|NCT02618057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92913691|NCT02618057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92913692|NCT04137029|Bromides|bromides|mesh-list
92913694|NCT04137029|Tiotropium Bromide|tiotropium bromide|mesh-list
92913695|NCT04137029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92913696|NCT04137029|Autonomic Agents|autonomic agents|mesh-ancestor
92913697|NCT04137029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913698|NCT04137029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913699|NCT04137029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92913700|NCT04137029|Respiratory System Agents|respiratory system agents|mesh-ancestor
92913701|NCT04137029|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92913702|NCT04137029|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92913703|NCT04137029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92913704|NCT04137029|Adrenergic Agents|adrenergic agents|mesh-ancestor
92913705|NCT04137029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913706|NCT04137029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913707|NCT04137029|Parasympatholytics|parasympatholytics|mesh-ancestor
92913708|NCT04137029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92913709|NCT04137029|Cholinergic Agents|cholinergic agents|mesh-ancestor
92913710|NCT04137029|Anticonvulsants|anticonvulsants|mesh-ancestor
92913711|NCT00787774|Raltegravir Potassium|raltegravir potassium|mesh-list
92913712|NCT00787774|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92913713|NCT00787774|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92913714|NCT00787774|Antiviral Agents|antiviral agents|mesh-ancestor
92913715|NCT00787774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913716|NCT00787774|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92913717|NCT00787774|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92913718|NCT00787774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913719|NCT00787774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913720|NCT00452413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92913721|NCT00452413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913722|NCT00452413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913723|NCT00452413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913724|NCT00452413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913725|NCT00798772|Micronutrients|micronutrients|mesh-list
92913726|NCT00798772|Trace Elements|trace elements|mesh-list
92913727|NCT00798772|Antioxidants|antioxidants|mesh-list
92913728|NCT00798772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913729|NCT00798772|Protective Agents|protective agents|mesh-ancestor
92913730|NCT00798772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913731|NCT00867503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92913732|NCT00867503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92913733|NCT00867503|Alkylating Agents|alkylating agents|mesh-ancestor
92913734|NCT00867503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913735|NCT00867503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913736|NCT00788164|Imiquimod|imiquimod|mesh-list
92913737|NCT00788164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92913738|NCT00788164|Immunologic Factors|immunologic factors|mesh-ancestor
92913739|NCT00788164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913740|NCT00788164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913741|NCT00788164|Interferon Inducers|interferon inducers|mesh-ancestor
92913742|NCT02615561|Pantothenic Acid|pantothenic acid|mesh-list
92913743|NCT02615561|Vitamin B Complex|vitamin b complex|mesh-ancestor
92913744|NCT02615561|Vitamins|vitamins|mesh-ancestor
92913745|NCT02615561|Micronutrients|micronutrients|mesh-ancestor
92913746|NCT02615561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913747|NCT00793234|Enoxaparin|enoxaparin|mesh-list
92913748|NCT00793234|Anticoagulants|anticoagulants|mesh-ancestor
92913749|NCT00793234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92913750|NCT00793234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913751|NCT00793234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913752|NCT00697775|Vaccines|vaccines|mesh-list
92913753|NCT00697775|Immunologic Factors|immunologic factors|mesh-ancestor
92913754|NCT00697775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913755|NCT04133051|Bupivacaine|bupivacaine|mesh-list
92913756|NCT04133051|Anesthetics, Local|anesthetics, local|mesh-ancestor
92913757|NCT04133051|Anesthetics|anesthetics|mesh-ancestor
92913758|NCT04133051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913759|NCT04133051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913760|NCT04133051|Sensory System Agents|sensory system agents|mesh-ancestor
92913761|NCT04133051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913762|NCT00788242|Insulin|insulin|mesh-list
92913763|NCT00788242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92913764|NCT00788242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913765|NCT04031027|Apremilast|apremilast|mesh-list
92526147|NCT00027937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913766|NCT04031027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913767|NCT04031027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913768|NCT04031027|Analgesics|analgesics|mesh-ancestor
92913769|NCT04031027|Sensory System Agents|sensory system agents|mesh-ancestor
92913770|NCT04031027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913771|NCT04031027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913772|NCT04031027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913774|NCT04031027|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92913775|NCT04031027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92913776|NCT04031027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913777|NCT04031027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913778|NCT02609802|Sevoflurane|sevoflurane|mesh-list
92913779|NCT02609802|Desflurane|desflurane|mesh-list
92913780|NCT02609802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92913781|NCT02609802|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92913782|NCT02609802|Anesthetics, General|anesthetics, general|mesh-ancestor
92913783|NCT02609802|Anesthetics|anesthetics|mesh-ancestor
92913784|NCT02609802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913785|NCT02609802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913786|NCT02609646|Vancomycin|vancomycin|mesh-list
92913787|NCT02609646|Meropenem|meropenem|mesh-list
92913788|NCT02609646|Linezolid|linezolid|mesh-list
92913789|NCT02609646|Tazobactam|tazobactam|mesh-list
92913790|NCT02609646|Piperacillin|piperacillin|mesh-list
92913791|NCT02609646|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92913792|NCT02609646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92913793|NCT02609646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913794|NCT02609646|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92913795|NCT02609646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913796|NCT02609646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913797|NCT02609646|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92913798|NCT02610504|Hyaluronic Acid|hyaluronic acid|mesh-list
92913799|NCT02610504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92913800|NCT02610504|Immunologic Factors|immunologic factors|mesh-ancestor
92913801|NCT02610504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913802|NCT02610504|Viscosupplements|viscosupplements|mesh-ancestor
92913803|NCT02610504|Protective Agents|protective agents|mesh-ancestor
92913804|NCT04132583|Diclofenac|diclofenac|mesh-list
92913805|NCT04132583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913806|NCT04132583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913807|NCT04132583|Analgesics|analgesics|mesh-ancestor
92913808|NCT04132583|Sensory System Agents|sensory system agents|mesh-ancestor
92913809|NCT04132583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913810|NCT04132583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913811|NCT04132583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913812|NCT04132583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913813|NCT04132583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92913814|NCT04132583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913815|NCT04132583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913816|NCT05754762|Remifentanil|remifentanil|mesh-list
92913817|NCT05754762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92913818|NCT05754762|Narcotics|narcotics|mesh-ancestor
92913819|NCT05754762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913820|NCT05754762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913821|NCT05754762|Analgesics|analgesics|mesh-ancestor
92913822|NCT05754762|Sensory System Agents|sensory system agents|mesh-ancestor
92913823|NCT05754762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913824|NCT05326152|Immunomodulating Agents|immunomodulating agents|mesh-list
92913825|NCT05326152|Immunologic Factors|immunologic factors|mesh-ancestor
92913826|NCT05326152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913827|NCT05757648|Anesthetics|anesthetics|mesh-list
92913828|NCT05757648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913829|NCT05757648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913830|NCT00914004|Desipramine|desipramine|mesh-list
92913831|NCT00914004|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92913832|NCT00914004|Antidepressive Agents|antidepressive agents|mesh-ancestor
92913833|NCT00914004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913834|NCT00914004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913835|NCT00914004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913836|NCT00914004|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92913837|NCT00914004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92913838|NCT00914004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913839|NCT00914004|Adrenergic Agents|adrenergic agents|mesh-ancestor
92913840|NCT00914004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913841|NCT00914004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913842|NCT00867113|Imatinib Mesylate|imatinib mesylate|mesh-list
92913843|NCT00867113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913844|NCT00867113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92913845|NCT00867113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913846|NCT00867113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913847|NCT02608710|Verinurad|verinurad|mesh-list
92913848|NCT02608710|Gout Suppressants|gout suppressants|mesh-ancestor
92913849|NCT02608710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913850|NCT04030260|Antibodies|antibodies|mesh-list
92913851|NCT04030260|Immunoglobulins|immunoglobulins|mesh-list
92913852|NCT04030260|Immunologic Factors|immunologic factors|mesh-ancestor
92913853|NCT04030260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913854|NCT00697385|Tranexamic Acid|tranexamic acid|mesh-list
92913855|NCT00697385|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92913856|NCT00697385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92913857|NCT00697385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913858|NCT00697385|Hemostatics|hemostatics|mesh-ancestor
92913859|NCT00697385|Coagulants|coagulants|mesh-ancestor
92913860|NCT00451555|Fulvestrant|fulvestrant|mesh-list
92913861|NCT00451555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92913862|NCT00451555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913863|NCT00451555|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92913864|NCT00451555|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92214199|NCT00373126|Autonomic Agents|autonomic agents|mesh-ancestor
92913865|NCT00451555|Hormone Antagonists|hormone antagonists|mesh-ancestor
92913866|NCT00451555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913867|NCT00451555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913868|NCT00867035|Chlorhexidine|chlorhexidine|mesh-list
92913869|NCT00867035|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92913870|NCT00867035|Chlorine dioxide|chlorine dioxide|mesh-list
92913871|NCT00867035|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92913872|NCT00867035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913873|NCT00867035|Disinfectants|disinfectants|mesh-ancestor
92913874|NCT00867035|Dermatologic Agents|dermatologic agents|mesh-ancestor
92913875|NCT00867035|Dental Disinfectants|dental disinfectants|mesh-ancestor
92913876|NCT05754684|Aldesleukin|aldesleukin|mesh-list
92913877|NCT05754684|Interleukin-2|interleukin-2|mesh-list
92913878|NCT05754684|Molgramostim|molgramostim|mesh-list
92913879|NCT05754684|Dinutuximab|dinutuximab|mesh-list
92913880|NCT05754684|Spironolactone|spironolactone|mesh-list
92913881|NCT05754684|Sargramostim|sargramostim|mesh-list
92913882|NCT05754684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913883|NCT05754684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913884|NCT05754684|Analgesics|analgesics|mesh-ancestor
92913885|NCT05754684|Sensory System Agents|sensory system agents|mesh-ancestor
92913886|NCT05754684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913887|NCT05754684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913888|NCT05754684|Immunologic Factors|immunologic factors|mesh-ancestor
92913889|NCT05754684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92913890|NCT05754684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92913891|NCT05754684|Antiviral Agents|antiviral agents|mesh-ancestor
92913892|NCT05754684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92913893|NCT05754684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92913894|NCT05754684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92913895|NCT05754684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92913896|NCT05754684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92913897|NCT05754684|Diuretics|diuretics|mesh-ancestor
92913898|NCT05754684|Natriuretic Agents|natriuretic agents|mesh-ancestor
92913899|NCT00694187|Zaleplon|zaleplon|mesh-list
92913900|NCT00694187|Anticonvulsants|anticonvulsants|mesh-ancestor
92913901|NCT00694187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92913902|NCT00694187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913903|NCT00694187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913904|NCT00694187|GABA Modulators|gaba modulators|mesh-ancestor
92913905|NCT00694187|GABA Agents|gaba agents|mesh-ancestor
92913906|NCT00694187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913907|NCT00694187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913908|NCT02617121|Gabapentin|gabapentin|mesh-list
92913909|NCT02617121|Ramosetron|ramosetron|mesh-list
92913910|NCT02617121|Analgesics|analgesics|mesh-ancestor
92913911|NCT02617121|Sensory System Agents|sensory system agents|mesh-ancestor
92913912|NCT02617121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913913|NCT02617121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913914|NCT02617121|Anticonvulsants|anticonvulsants|mesh-ancestor
92913915|NCT02617121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92913916|NCT02617121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92913917|NCT02617121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92913918|NCT02617121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92913919|NCT02617121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92913920|NCT02617121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92913921|NCT02617121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92913922|NCT02617121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913923|NCT02617121|Antimanic Agents|antimanic agents|mesh-ancestor
92913924|NCT02617121|Antiemetics|antiemetics|mesh-ancestor
92913925|NCT02617121|Autonomic Agents|autonomic agents|mesh-ancestor
92913926|NCT02617121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92913927|NCT02617121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92913928|NCT02617121|Serotonin Agents|serotonin agents|mesh-ancestor
92913929|NCT02609490|Olmesartan|olmesartan|mesh-list
92913930|NCT02609490|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92913931|NCT02609490|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92913932|NCT02609490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92913933|NCT02609490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92913934|NCT02609490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92913935|NCT02609490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913936|NCT02610348|Vaccines|vaccines|mesh-list
92913937|NCT02610348|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92913938|NCT02610348|Immunologic Factors|immunologic factors|mesh-ancestor
92913939|NCT02610348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913940|NCT05757336|Paclitaxel|paclitaxel|mesh-list
92913941|NCT05757336|Bevacizumab|bevacizumab|mesh-list
92913942|NCT05757336|Gemcitabine|gemcitabine|mesh-list
92913943|NCT05757336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92913944|NCT05757336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92913945|NCT05757336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92913946|NCT05757336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92913947|NCT05757336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92913948|NCT05757336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913949|NCT05757336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92913950|NCT05757336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92913951|NCT05757336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92913952|NCT05757336|Growth Substances|growth substances|mesh-ancestor
92913953|NCT05757336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913954|NCT05757336|Growth Inhibitors|growth inhibitors|mesh-ancestor
92913955|NCT05757336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92913956|NCT05757336|Antimetabolites|antimetabolites|mesh-ancestor
92913957|NCT00871871|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92913958|NCT00871871|Isosorbide|isosorbide|mesh-list
92913959|NCT00871871|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92913960|NCT00871871|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92913961|NCT00871871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92913962|NCT00871871|Diuretics|diuretics|mesh-ancestor
92913963|NCT00871871|Natriuretic Agents|natriuretic agents|mesh-ancestor
92913964|NCT00871871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913965|NCT00871871|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92913966|NCT00871871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913967|NCT00871871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913968|NCT00871871|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92913969|NCT00871871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92913970|NCT00871871|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92913971|NCT02608788|Ketorolac|ketorolac|mesh-list
92913972|NCT02608788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92913973|NCT02608788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92913974|NCT02608788|Analgesics|analgesics|mesh-ancestor
92913975|NCT02608788|Sensory System Agents|sensory system agents|mesh-ancestor
92913976|NCT02608788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92913977|NCT02608788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913978|NCT02608788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92913979|NCT02608788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92913980|NCT02608788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92913981|NCT02608788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92913982|NCT02608788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913983|NCT04132349|Ulipristal acetate|ulipristal acetate|mesh-list
92913984|NCT04132349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92913985|NCT04132349|Contraceptive Agents|contraceptive agents|mesh-ancestor
92913986|NCT04132349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526151|NCT00027937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92913987|NCT04132349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913988|NCT04132349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92913989|NCT04961190|Paroxetine|paroxetine|mesh-list
92913990|NCT04961190|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92913991|NCT04961190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92913992|NCT04961190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92913993|NCT04961190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92913994|NCT04961190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92913996|NCT04961190|Serotonin Agents|serotonin agents|mesh-ancestor
92913997|NCT04961190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92913998|NCT04961190|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92913999|NCT04961190|Antidepressive Agents|antidepressive agents|mesh-ancestor
92914000|NCT04961190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914001|NCT04961190|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92914002|NCT04961190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92914003|NCT04961190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914004|NCT04961190|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92914005|NCT00849680|Vaccines|vaccines|mesh-list
92914006|NCT00849680|Immunologic Factors|immunologic factors|mesh-ancestor
92914007|NCT00849680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914008|NCT00866723|Bevacizumab|bevacizumab|mesh-list
92914009|NCT00866723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914010|NCT00866723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914011|NCT00866723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92914012|NCT00866723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92914013|NCT00866723|Growth Substances|growth substances|mesh-ancestor
92914014|NCT00866723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914015|NCT00866723|Growth Inhibitors|growth inhibitors|mesh-ancestor
92914016|NCT02613455|Triamcinolone|triamcinolone|mesh-list
92914017|NCT02613455|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92914018|NCT02613455|Lidocaine|lidocaine|mesh-list
92914019|NCT02613455|Anesthetics, Local|anesthetics, local|mesh-ancestor
92914020|NCT02613455|Anesthetics|anesthetics|mesh-ancestor
92914021|NCT02613455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914022|NCT02613455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914023|NCT02613455|Sensory System Agents|sensory system agents|mesh-ancestor
92914024|NCT02613455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914025|NCT02613455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92914026|NCT02613455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92914027|NCT02613455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92914028|NCT02613455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914029|NCT02613455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914030|NCT02613455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914031|NCT02613455|Glucocorticoids|glucocorticoids|mesh-ancestor
92914032|NCT02613455|Hormones|hormones|mesh-ancestor
92914033|NCT02613455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914034|NCT02613455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914035|NCT02613455|Immunologic Factors|immunologic factors|mesh-ancestor
92914036|NCT00703586|Maraviroc|maraviroc|mesh-list
92914037|NCT00703586|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92914038|NCT00703586|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92914039|NCT00703586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914040|NCT00703586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92914041|NCT00703586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92914042|NCT00703586|Antiviral Agents|antiviral agents|mesh-ancestor
92914043|NCT00703586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914044|NCT00703586|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92914045|NCT04130399|Folfirinox|folfirinox|mesh-list
92914046|NCT04130399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914047|NCT00849056|rGLP-1 protein|rglp-1 protein|mesh-list
92914048|NCT00849056|Incretins|incretins|mesh-ancestor
92914049|NCT00849056|Hormones|hormones|mesh-ancestor
92914050|NCT00849056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914051|NCT00849056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914052|NCT02612948|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92914053|NCT02612948|Antidepressive Agents|antidepressive agents|mesh-ancestor
92914054|NCT02612948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914055|NCT02612948|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92914056|NCT02612948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92914057|NCT02612948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914058|NCT02612948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914059|NCT00706862|Lactoferrin|lactoferrin|mesh-list
92914061|NCT00706862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914062|NCT00706862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914063|NCT02612714|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92914064|NCT02612714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92914065|NCT02612714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92914066|NCT02612714|Antimetabolites|antimetabolites|mesh-ancestor
92914067|NCT02612714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914068|NCT02612714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92914069|NCT02612714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92914070|NCT02612714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914072|NCT00837434|Etanercept|etanercept|mesh-list
92914073|NCT00837434|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92914074|NCT00837434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914075|NCT00837434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914076|NCT00837434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92914077|NCT00837434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92914078|NCT00837434|Analgesics|analgesics|mesh-ancestor
92914079|NCT00837434|Sensory System Agents|sensory system agents|mesh-ancestor
92914080|NCT00837434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914081|NCT00837434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914082|NCT00837434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914083|NCT00837434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914084|NCT00837434|Immunologic Factors|immunologic factors|mesh-ancestor
92914085|NCT00703742|Escitalopram|escitalopram|mesh-list
92914086|NCT00703742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92914087|NCT00703742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92914088|NCT00703742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914089|NCT00703742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914090|NCT00703742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914091|NCT00703742|Serotonin Agents|serotonin agents|mesh-ancestor
92914092|NCT00703742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914093|NCT00702182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92914094|NCT00702182|Vinorelbine|vinorelbine|mesh-list
92914095|NCT00702182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914096|NCT00702182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914097|NCT00702182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914098|NCT00702182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914099|NCT00702182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92914100|NCT00702182|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914101|NCT00702182|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914102|NCT00702182|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914103|NCT00702260|Ramipril|ramipril|mesh-list
92914104|NCT00702260|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92914105|NCT00702260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92914106|NCT00702260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914107|NCT00702260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914108|NCT00702260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92914109|NCT00702416|Acetaminophen|acetaminophen|mesh-list
92914110|NCT00702416|Fentanyl|fentanyl|mesh-list
92914111|NCT00702416|Morphine|morphine|mesh-list
92914112|NCT00702416|Analgesics, Opioid|analgesics, opioid|mesh-list
92914113|NCT00702416|Narcotics|narcotics|mesh-list
92914114|NCT00702416|Analgesics|analgesics|mesh-list
92914115|NCT00702416|Anesthetics|anesthetics|mesh-list
92914116|NCT00702416|Ropivacaine|ropivacaine|mesh-list
92914117|NCT00702416|Anesthetics, Local|anesthetics, local|mesh-list
92914118|NCT00702416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914119|NCT00702416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914120|NCT00702416|Sensory System Agents|sensory system agents|mesh-ancestor
92914121|NCT00702416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914122|NCT00702416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92914123|NCT00702416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92914124|NCT00702416|Anesthetics, General|anesthetics, general|mesh-ancestor
92914125|NCT00702416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92914126|NCT00702416|Antipyretics|antipyretics|mesh-ancestor
92914127|NCT00827918|Olanzapine|olanzapine|mesh-list
92914128|NCT00827918|Antiemetics|antiemetics|mesh-ancestor
92914129|NCT00827918|Autonomic Agents|autonomic agents|mesh-ancestor
92914130|NCT00827918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914131|NCT00827918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914132|NCT00827918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914133|NCT00827918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92914134|NCT00827918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92914135|NCT00827918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914136|NCT00827918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914137|NCT00827918|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92914138|NCT00827918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92914139|NCT00827918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914140|NCT00827918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914141|NCT00827918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914142|NCT00827918|Serotonin Agents|serotonin agents|mesh-ancestor
92914143|NCT00813150|Dexamethasone|dexamethasone|mesh-list
92914144|NCT00813150|Cyclophosphamide|cyclophosphamide|mesh-list
92914145|NCT00813150|Bortezomib|bortezomib|mesh-list
92914146|NCT00813150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914147|NCT00813150|Immunologic Factors|immunologic factors|mesh-ancestor
92914148|NCT00813150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914149|NCT00813150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914150|NCT00813150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92914151|NCT00813150|Alkylating Agents|alkylating agents|mesh-ancestor
92914152|NCT00813150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914153|NCT00813150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914154|NCT00813150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92914155|NCT00813150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914156|NCT00813150|Antiemetics|antiemetics|mesh-ancestor
92914157|NCT00813150|Autonomic Agents|autonomic agents|mesh-ancestor
92914158|NCT00813150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914159|NCT00813150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914160|NCT00813150|Glucocorticoids|glucocorticoids|mesh-ancestor
92914161|NCT00813150|Hormones|hormones|mesh-ancestor
92914162|NCT00813150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914163|NCT00813150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92914164|NCT00807846|Celecoxib|celecoxib|mesh-list
92914165|NCT00807846|Naproxen|naproxen|mesh-list
92914166|NCT00807846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92914167|NCT00807846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92914168|NCT00807846|Analgesics|analgesics|mesh-ancestor
92914169|NCT00807846|Sensory System Agents|sensory system agents|mesh-ancestor
92914170|NCT00807846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914171|NCT00807846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914172|NCT00807846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914173|NCT00807846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914174|NCT00807846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92914175|NCT00807846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92914176|NCT00807846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914177|NCT00807846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914178|NCT00807846|Gout Suppressants|gout suppressants|mesh-ancestor
92914179|NCT00810108|Ritonavir|ritonavir|mesh-list
92914180|NCT00810108|Lopinavir|lopinavir|mesh-list
92914181|NCT00810108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92914182|NCT00810108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92914183|NCT00810108|Protease Inhibitors|protease inhibitors|mesh-ancestor
92914184|NCT00810108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914185|NCT00810108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914186|NCT00810108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92914187|NCT00810108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92914188|NCT00810108|Antiviral Agents|antiviral agents|mesh-ancestor
92914189|NCT00810108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914190|NCT00810108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92914191|NCT00810108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92914192|NCT00827606|Atorvastatin|atorvastatin|mesh-list
92914193|NCT00827606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92914194|NCT00827606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92914195|NCT00827606|Antimetabolites|antimetabolites|mesh-ancestor
92914196|NCT00827606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914197|NCT00827606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92914198|NCT00827606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92914199|NCT00827606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914200|NCT04016220|Budesonide|budesonide|mesh-list
92914201|NCT04016220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914202|NCT04016220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92914203|NCT04016220|Autonomic Agents|autonomic agents|mesh-ancestor
92914204|NCT04016220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914205|NCT04016220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914206|NCT04016220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92914207|NCT04016220|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914208|NCT04016220|Glucocorticoids|glucocorticoids|mesh-ancestor
92914209|NCT04016220|Hormones|hormones|mesh-ancestor
92914210|NCT04016220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914211|NCT00663052|Etanercept|etanercept|mesh-list
92914212|NCT00663052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92914213|NCT00663052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92914214|NCT00663052|Analgesics|analgesics|mesh-ancestor
92914215|NCT00663052|Sensory System Agents|sensory system agents|mesh-ancestor
92914216|NCT00663052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914217|NCT00663052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914218|NCT00663052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914219|NCT00663052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914220|NCT00663052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914221|NCT00663052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914222|NCT00663052|Immunologic Factors|immunologic factors|mesh-ancestor
92914224|NCT05599880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914225|NCT00707252|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92914226|NCT00707252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914227|NCT00707252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914228|NCT00707252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914229|NCT00707252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914230|NCT00826748|Beclomethasone|beclomethasone|mesh-list
92914231|NCT00826748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914232|NCT00826748|Glucocorticoids|glucocorticoids|mesh-ancestor
92914233|NCT00826748|Hormones|hormones|mesh-ancestor
92914234|NCT00826748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914235|NCT00826748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914236|NCT00826748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92914237|NCT00826748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914238|NCT00922844|Sevoflurane|sevoflurane|mesh-list
92914239|NCT00922844|Isoflurane|isoflurane|mesh-list
92914240|NCT00922844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92914241|NCT00922844|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92914242|NCT00922844|Anesthetics, General|anesthetics, general|mesh-ancestor
92914243|NCT00922844|Anesthetics|anesthetics|mesh-ancestor
92914244|NCT00922844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914245|NCT00922844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914246|NCT00707330|Clarithromycin|clarithromycin|mesh-list
92914247|NCT00707330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914248|NCT00707330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914249|NCT00707330|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92914250|NCT00707330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914251|NCT00707330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914252|NCT00707330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92914253|NCT00707330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92914254|NCT00707408|Imatinib Mesylate|imatinib mesylate|mesh-list
92914255|NCT00707408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914256|NCT00707408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914257|NCT00707408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914258|NCT00707408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914259|NCT00788320|Vitamin D|vitamin d|mesh-list
92914260|NCT00788320|Cholecalciferol|cholecalciferol|mesh-list
92914261|NCT00788320|Vitamins|vitamins|mesh-ancestor
92914262|NCT00788320|Micronutrients|micronutrients|mesh-ancestor
92914263|NCT00788320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914264|NCT00788320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92914265|NCT00788320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92914266|NCT00807144|Tacrolimus|tacrolimus|mesh-list
92914267|NCT00807144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914268|NCT00807144|Immunologic Factors|immunologic factors|mesh-ancestor
92914269|NCT00807144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914270|NCT00807144|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92914271|NCT00807144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914272|NCT00807144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914273|NCT00799240|Cisplatin|cisplatin|mesh-list
92914274|NCT00799240|Pemetrexed|pemetrexed|mesh-list
92914275|NCT00799240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92914276|NCT00799240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914277|NCT00799240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914278|NCT00799240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914279|NCT00799240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92914280|NCT00799240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92914281|NCT00799240|Immunologic Factors|immunologic factors|mesh-ancestor
92914282|NCT00799240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914283|NCT00591006|Hydrocortisone|hydrocortisone|mesh-list
92914285|NCT00591006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914286|NCT00591006|Anticonvulsants|anticonvulsants|mesh-ancestor
92914287|NCT00591006|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92914288|NCT00591006|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92914289|NCT00591006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914290|NCT00591006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162550|NCT04176419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914291|NCT00591006|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92914292|NCT00591006|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92914293|NCT00788398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92914294|NCT00844844|Eculizumab|eculizumab|mesh-list
92914295|NCT00844844|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92914296|NCT00844844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914297|NCT00844844|Immunologic Factors|immunologic factors|mesh-ancestor
92914298|NCT00844844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914299|NCT05748054|Fluorides|fluorides|mesh-list
92914300|NCT05748054|Cariostatic Agents|cariostatic agents|mesh-ancestor
92914301|NCT05748054|Protective Agents|protective agents|mesh-ancestor
92914302|NCT05748054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914303|NCT00702572|Paclitaxel|paclitaxel|mesh-list
92914304|NCT00702572|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92914305|NCT00702572|Bevacizumab|bevacizumab|mesh-list
92914306|NCT00702572|Carboplatin|carboplatin|mesh-list
92914307|NCT00702572|Vorinostat|vorinostat|mesh-list
92914308|NCT00702572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92914309|NCT00702572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914310|NCT00702572|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914311|NCT00702572|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914312|NCT00702572|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914313|NCT00702572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914314|NCT00702572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914315|NCT00702572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92914316|NCT00702572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92914317|NCT00702572|Growth Substances|growth substances|mesh-ancestor
92914318|NCT00702572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914319|NCT00702572|Growth Inhibitors|growth inhibitors|mesh-ancestor
92914320|NCT00702572|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92914321|NCT00702572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914322|NCT00793468|Nicotine|nicotine|mesh-list
92914323|NCT00793468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92914324|NCT00793468|Autonomic Agents|autonomic agents|mesh-ancestor
92914325|NCT00793468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914326|NCT00793468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914327|NCT00793468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92914328|NCT00793468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92914329|NCT00793468|Cholinergic Agents|cholinergic agents|mesh-ancestor
92914330|NCT00793468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914331|NCT00793468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914332|NCT00836810|Prednisone|prednisone|mesh-list
92914333|NCT00836810|Prednisolone|prednisolone|mesh-list
92914334|NCT00836810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914335|NCT00836810|Glucocorticoids|glucocorticoids|mesh-ancestor
92914336|NCT00836810|Hormones|hormones|mesh-ancestor
92914337|NCT00836810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914338|NCT00836810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914339|NCT00836810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92914340|NCT00836810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914341|NCT00658684|Fesoterodine|fesoterodine|mesh-list
92914342|NCT00658684|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92914343|NCT00658684|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92914344|NCT00658684|Cholinergic Agents|cholinergic agents|mesh-ancestor
92914345|NCT00658684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914346|NCT00658684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914347|NCT00658684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914348|NCT00658684|Urological Agents|urological agents|mesh-ancestor
92914349|NCT00660400|Azacitidine|azacitidine|mesh-list
92914350|NCT00660400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92914351|NCT00660400|Antimetabolites|antimetabolites|mesh-ancestor
92914352|NCT00660400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914353|NCT00660400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914354|NCT00660400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914356|NCT00826514|Analgesics|analgesics|mesh-ancestor
92914357|NCT00826514|Sensory System Agents|sensory system agents|mesh-ancestor
92914358|NCT00826514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914359|NCT00826514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914360|NCT00800566|Clofarabine|clofarabine|mesh-list
92914361|NCT00800566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92914362|NCT00800566|Antimetabolites|antimetabolites|mesh-ancestor
92162551|NCT04176419|Anticonvulsants|anticonvulsants|mesh-ancestor
92914363|NCT00800566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914364|NCT00800566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914365|NCT00793858|Ciclesonide|ciclesonide|mesh-list
92914366|NCT00793858|Glucocorticoids|glucocorticoids|mesh-ancestor
92914367|NCT00793858|Hormones|hormones|mesh-ancestor
92914368|NCT00793858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914369|NCT00793858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914370|NCT00793858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92914371|NCT00800722|Sirolimus|sirolimus|mesh-list
92914372|NCT00800722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914373|NCT00800722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914374|NCT00800722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92914375|NCT00800722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914376|NCT00800722|Antifungal Agents|antifungal agents|mesh-ancestor
92914377|NCT00800722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914378|NCT00800722|Immunologic Factors|immunologic factors|mesh-ancestor
92914379|NCT00800722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914380|NCT00826280|Caffeine|caffeine|mesh-list
92914381|NCT00826280|Regadenoson|regadenoson|mesh-list
92914382|NCT00826280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92914383|NCT00826280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914384|NCT00826280|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92914385|NCT00826280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914386|NCT00826280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914387|NCT00826280|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92914388|NCT00826280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92914389|NCT00826280|Purinergic Agents|purinergic agents|mesh-ancestor
92914390|NCT00826280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914391|NCT00826280|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92914392|NCT00826280|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92914393|NCT00826280|Purinergic Agonists|purinergic agonists|mesh-ancestor
92914394|NCT00800800|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92914395|NCT00800800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92914396|NCT00800800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92914397|NCT00800800|Antimetabolites|antimetabolites|mesh-ancestor
92914398|NCT00800800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914399|NCT00800800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92914400|NCT00800800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92914401|NCT00800800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914402|NCT00703898|Nevirapine|nevirapine|mesh-list
92914403|NCT00703898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92914404|NCT00703898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92914405|NCT00703898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914406|NCT00703898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914407|NCT00703898|Antiviral Agents|antiviral agents|mesh-ancestor
92914408|NCT00703898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914409|NCT00703898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92914410|NCT00703898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92914411|NCT00703898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92914412|NCT00703898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92914413|NCT04030442|Morphine|morphine|mesh-list
92914414|NCT04030442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92914415|NCT04030442|Narcotics|narcotics|mesh-ancestor
92914416|NCT04030442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914417|NCT04030442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914418|NCT04030442|Analgesics|analgesics|mesh-ancestor
92914419|NCT04030442|Sensory System Agents|sensory system agents|mesh-ancestor
92914420|NCT04030442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914421|NCT00801034|Calcium|calcium|mesh-list
92914422|NCT00801034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92914423|NCT00801034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914424|NCT04130477|Nickel|nickel|mesh-list
92914425|NCT04130477|Trace Elements|trace elements|mesh-ancestor
92914426|NCT04130477|Micronutrients|micronutrients|mesh-ancestor
92914427|NCT04130477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914428|NCT00794326|Dialysis Solutions|dialysis solutions|mesh-list
92914429|NCT00794326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92914431|NCT00702728|Diuretics|diuretics|mesh-ancestor
92914432|NCT00702728|Natriuretic Agents|natriuretic agents|mesh-ancestor
92914433|NCT00702728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162555|NCT04176419|Antimanic Agents|antimanic agents|mesh-ancestor
92914434|NCT00702728|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92914435|NCT00702728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914436|NCT00702728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914437|NCT04132115|Vancomycin|vancomycin|mesh-list
92914438|NCT04132115|Gentamicins|gentamicins|mesh-list
92914439|NCT04132115|Meropenem|meropenem|mesh-list
92914440|NCT04132115|Linezolid|linezolid|mesh-list
92914441|NCT04132115|Tazobactam|tazobactam|mesh-list
92914442|NCT04132115|Piperacillin|piperacillin|mesh-list
92914443|NCT04132115|Daptomycin|daptomycin|mesh-list
92914444|NCT04132115|Amikacin|amikacin|mesh-list
92914445|NCT04132115|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92914446|NCT04132115|Ceftobiprole|ceftobiprole|mesh-list
92914447|NCT04132115|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92914448|NCT04132115|Acyclovir|acyclovir|mesh-list
92914449|NCT04132115|Ganciclovir|ganciclovir|mesh-list
92914450|NCT04132115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914451|NCT04132115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914452|NCT04132115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92914453|NCT04132115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914454|NCT04132115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914455|NCT04132115|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92914456|NCT04132115|Antiviral Agents|antiviral agents|mesh-ancestor
92914457|NCT00801268|Emodin|emodin|mesh-list
92914458|NCT00801268|Cathartics|cathartics|mesh-ancestor
92914459|NCT00801268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914460|NCT00801268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914461|NCT00801268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914462|NCT00801268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914463|NCT02614937|Squalamine|squalamine|mesh-list
92914464|NCT02614937|Ranibizumab|ranibizumab|mesh-list
92914465|NCT02614937|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92914466|NCT02614937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92914467|NCT02614937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92914468|NCT02614937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92914469|NCT02614937|Growth Substances|growth substances|mesh-ancestor
92914470|NCT02614937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914471|NCT02614937|Growth Inhibitors|growth inhibitors|mesh-ancestor
92914472|NCT02614937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914473|NCT02614937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914474|NCT02614937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914475|NCT02614937|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92914476|NCT02614937|Protective Agents|protective agents|mesh-ancestor
92914477|NCT00707642|Vaccines|vaccines|mesh-list
92914478|NCT00707642|Immunologic Factors|immunologic factors|mesh-ancestor
92914479|NCT00707642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914480|NCT00789568|Moxifloxacin|moxifloxacin|mesh-list
92914481|NCT00789568|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92914482|NCT00789568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914483|NCT00789568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914484|NCT00789568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92914485|NCT00789568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92914486|NCT00789568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914487|NCT00789568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914488|NCT00789568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914489|NCT00789568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92914490|NCT00789568|Contraceptive Agents|contraceptive agents|mesh-ancestor
92914491|NCT00789568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92914492|NCT00789568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914493|NCT00789568|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92914494|NCT00789568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92914495|NCT00789568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92914496|NCT00789646|Lidocaine|lidocaine|mesh-list
92914497|NCT00789646|Anesthetics, Local|anesthetics, local|mesh-ancestor
92914498|NCT00789646|Anesthetics|anesthetics|mesh-ancestor
92914499|NCT00789646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914500|NCT00789646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914501|NCT00789646|Sensory System Agents|sensory system agents|mesh-ancestor
92914502|NCT00789646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914503|NCT00789646|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92914504|NCT00789646|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92914506|NCT00789646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914507|NCT00789646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914508|NCT00856973|Eszopiclone|eszopiclone|mesh-list
92914509|NCT00856973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92914510|NCT00856973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914511|NCT00856973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914512|NCT00794638|Rituximab|rituximab|mesh-list
92914513|NCT00794638|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92914514|NCT00794638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914515|NCT00794638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914516|NCT00794638|Immunologic Factors|immunologic factors|mesh-ancestor
92914517|NCT00794638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914518|NCT00794638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914519|NCT00794638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92914520|NCT00794638|Alkylating Agents|alkylating agents|mesh-ancestor
92914521|NCT00794638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914522|NCT00801580|Doxorubicin|doxorubicin|mesh-list
92914523|NCT00801580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92914524|NCT00801580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92914525|NCT00801580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914526|NCT00801580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92914527|NCT00801580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92914528|NCT00801580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914529|NCT00801580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914530|NCT00805194|Docetaxel|docetaxel|mesh-list
92914531|NCT00805194|Nintedanib|nintedanib|mesh-list
92914532|NCT00805194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914533|NCT00805194|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914534|NCT00805194|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914535|NCT00805194|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914536|NCT00805194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914537|NCT00805194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914538|NCT00805194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914539|NCT00657046|Droxidopa|droxidopa|mesh-list
92914540|NCT00657046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92914541|NCT00657046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92914542|NCT00707798|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92914543|NCT00707798|Immunologic Factors|immunologic factors|mesh-ancestor
92914544|NCT00707798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914545|NCT00801736|Paclitaxel|paclitaxel|mesh-list
92914546|NCT00801736|Cisplatin|cisplatin|mesh-list
92914547|NCT00801736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92914548|NCT00801736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914549|NCT00801736|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914550|NCT00801736|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914551|NCT00801736|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914552|NCT00801736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914553|NCT00856661|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
92914554|NCT00856661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92914555|NCT00856661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92914556|NCT00856661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914557|NCT02606994|Diphenhydramine|diphenhydramine|mesh-list
92914558|NCT02606994|Lidocaine|lidocaine|mesh-list
92914559|NCT02606994|Anesthetics, Local|anesthetics, local|mesh-ancestor
92914560|NCT02606994|Anesthetics|anesthetics|mesh-ancestor
92914561|NCT02606994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914562|NCT02606994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914563|NCT02606994|Sensory System Agents|sensory system agents|mesh-ancestor
92914564|NCT02606994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914565|NCT02606994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92914566|NCT02606994|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92914567|NCT02606994|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92914568|NCT02606994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914569|NCT02606994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914570|NCT02606994|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92914571|NCT02606994|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92914572|NCT02606994|Antiemetics|antiemetics|mesh-ancestor
92914573|NCT02606994|Autonomic Agents|autonomic agents|mesh-ancestor
92914574|NCT02606994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914575|NCT02606994|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92914576|NCT02606994|Histamine Antagonists|histamine antagonists|mesh-ancestor
92914578|NCT02606994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914579|NCT02606994|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92914580|NCT00844376|Atorvastatin|atorvastatin|mesh-list
92914581|NCT00844376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92914582|NCT00844376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92914583|NCT00844376|Antimetabolites|antimetabolites|mesh-ancestor
92914584|NCT00844376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914585|NCT00844376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92914586|NCT00844376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92914587|NCT00844376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914588|NCT04046302|Dinoprostone|dinoprostone|mesh-list
92914589|NCT04046302|Oxytocics|oxytocics|mesh-ancestor
92914590|NCT04046302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92914591|NCT04046302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914592|NCT00914394|Phenylephrine|phenylephrine|mesh-list
92914593|NCT00914394|Oxymetazoline|oxymetazoline|mesh-list
92914594|NCT00914394|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92914595|NCT00914394|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92914596|NCT00914394|Mydriatics|mydriatics|mesh-ancestor
92914597|NCT00914394|Autonomic Agents|autonomic agents|mesh-ancestor
92914598|NCT00914394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914599|NCT00914394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914600|NCT00914394|Sympathomimetics|sympathomimetics|mesh-ancestor
92914601|NCT00914394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92914602|NCT00914394|Nasal Decongestants|nasal decongestants|mesh-ancestor
92914603|NCT00914394|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914604|NCT00914394|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92914605|NCT00914394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92914606|NCT00914394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92914607|NCT00914394|Adrenergic Agents|adrenergic agents|mesh-ancestor
92914608|NCT00914394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914609|NCT00914394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914610|NCT00914394|Protective Agents|protective agents|mesh-ancestor
92914611|NCT00914394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914612|NCT04045678|Rotigotine|rotigotine|mesh-list
92914613|NCT04045678|Dopamine Agonists|dopamine agonists|mesh-ancestor
92914614|NCT04045678|Dopamine Agents|dopamine agents|mesh-ancestor
92914615|NCT04045678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914616|NCT04045678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914617|NCT04045678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914618|NCT00658606|Alefacept|alefacept|mesh-list
92914619|NCT00658606|Dermatologic Agents|dermatologic agents|mesh-ancestor
92914620|NCT00658606|Immunologic Factors|immunologic factors|mesh-ancestor
92914621|NCT00658606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914622|NCT00795106|Capsaicin|capsaicin|mesh-list
92914623|NCT00795106|Antipruritics|antipruritics|mesh-ancestor
92914624|NCT00795106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92914625|NCT00795106|Sensory System Agents|sensory system agents|mesh-ancestor
92914626|NCT00795106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914627|NCT00795106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914628|NCT00589290|Belinostat|belinostat|mesh-list
92914629|NCT00589290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914630|NCT00589290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92914631|NCT00589290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914632|NCT00589290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914633|NCT00802048|Ropivacaine|ropivacaine|mesh-list
92914634|NCT00802048|Anesthetics, Local|anesthetics, local|mesh-list
92914635|NCT00802048|Anesthetics|anesthetics|mesh-list
92914636|NCT00802048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914637|NCT00802048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914638|NCT00802048|Sensory System Agents|sensory system agents|mesh-ancestor
92914639|NCT00802048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914640|NCT00809536|Metformin|metformin|mesh-list
92914641|NCT00809536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92914642|NCT00809536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914643|NCT00809692|Histamine|histamine|mesh-list
92914644|NCT00809692|Histamine phosphate|histamine phosphate|mesh-list
92914645|NCT00809692|Histamine Agonists|histamine agonists|mesh-ancestor
92914646|NCT00809692|Histamine Agents|histamine agents|mesh-ancestor
92914647|NCT00809692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914648|NCT00809692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914649|NCT00809692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914650|NCT00843284|Pregabalin|pregabalin|mesh-list
92914651|NCT00843284|Analgesics|analgesics|mesh-ancestor
92914652|NCT00843284|Sensory System Agents|sensory system agents|mesh-ancestor
92914653|NCT00843284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914654|NCT00843284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914655|NCT00843284|Anticonvulsants|anticonvulsants|mesh-ancestor
92914656|NCT00843284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92914657|NCT00843284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914658|NCT00843284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914659|NCT00843284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92914660|NCT00843284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92914661|NCT00843284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92914662|NCT00843284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914663|NCT00843284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914664|NCT00802282|Psilocybin|psilocybin|mesh-list
92914665|NCT00802282|Hallucinogens|hallucinogens|mesh-ancestor
92914666|NCT00802282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914667|NCT00802282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914668|NCT00652834|Mycophenolic Acid|mycophenolic acid|mesh-list
92914669|NCT00652834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92914670|NCT00652834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914671|NCT00652834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92914672|NCT00652834|Antitubercular Agents|antitubercular agents|mesh-ancestor
92914673|NCT00652834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914674|NCT00652834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914675|NCT00652834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914676|NCT00652834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914677|NCT00825812|Atropine|atropine|mesh-list
92914678|NCT00825812|Neostigmine|neostigmine|mesh-list
92914679|NCT00825812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92914680|NCT00825812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92914681|NCT00825812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92914682|NCT00825812|Autonomic Agents|autonomic agents|mesh-ancestor
92914683|NCT00825812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914684|NCT00825812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914685|NCT00825812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92914686|NCT00825812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914687|NCT00825812|Mydriatics|mydriatics|mesh-ancestor
92914688|NCT00825812|Parasympatholytics|parasympatholytics|mesh-ancestor
92914689|NCT00825812|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92914690|NCT00825812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92914691|NCT00825812|Cholinergic Agents|cholinergic agents|mesh-ancestor
92914692|NCT00825812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914693|NCT00825812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914694|NCT00825812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92914695|NCT00825812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914696|NCT00825812|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92914697|NCT00802594|Pafuramidine|pafuramidine|mesh-list
92914698|NCT00802594|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92914699|NCT00802594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92914700|NCT00802594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92914701|NCT00802594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914702|NCT00707876|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92914703|NCT00707876|Hematinics|hematinics|mesh-ancestor
92914704|NCT00707876|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92914705|NCT00707876|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92914706|NCT02606448|Bupivacaine|bupivacaine|mesh-list
92914707|NCT02606448|Anesthetics, Local|anesthetics, local|mesh-ancestor
92914708|NCT02606448|Anesthetics|anesthetics|mesh-ancestor
92914709|NCT02606448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914710|NCT02606448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914711|NCT02606448|Sensory System Agents|sensory system agents|mesh-ancestor
92914712|NCT02606448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914713|NCT00802828|Famotidine|famotidine|mesh-list
92914714|NCT00802828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92914715|NCT00802828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914716|NCT00802828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92914717|NCT00802828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92914718|NCT00802828|Histamine Agents|histamine agents|mesh-ancestor
92914719|NCT00802828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914720|NCT00802828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914721|NCT00802828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914722|NCT00802906|Bevacizumab|bevacizumab|mesh-list
92162569|NCT03211949|Sensory System Agents|sensory system agents|mesh-ancestor
92914723|NCT00802906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914724|NCT00802906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914725|NCT00802906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92914726|NCT00802906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92914727|NCT00802906|Growth Substances|growth substances|mesh-ancestor
92914728|NCT00802906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914729|NCT00802906|Growth Inhibitors|growth inhibitors|mesh-ancestor
92914731|NCT00803218|Xhance|xhance|mesh-list
92914732|NCT00803218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914733|NCT00803218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92914734|NCT00803218|Autonomic Agents|autonomic agents|mesh-ancestor
92914735|NCT00803218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914736|NCT00803218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914737|NCT00803218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92914738|NCT00803218|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914739|NCT00803218|Dermatologic Agents|dermatologic agents|mesh-ancestor
92914740|NCT00803218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92914741|NCT00824564|Tranexamic Acid|tranexamic acid|mesh-list
92914742|NCT00824564|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92914743|NCT00824564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92914744|NCT00824564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914745|NCT00824564|Hemostatics|hemostatics|mesh-ancestor
92914746|NCT00824564|Coagulants|coagulants|mesh-ancestor
92914747|NCT00803374|Ipilimumab|ipilimumab|mesh-list
92914748|NCT00803374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92914749|NCT00803374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914750|NCT00803374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914751|NCT00803374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92914752|NCT00803374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914753|NCT00803374|Immunologic Factors|immunologic factors|mesh-ancestor
92914754|NCT00803374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914755|NCT00803530|Ascorbic Acid|ascorbic acid|mesh-list
92914756|NCT00803530|Antioxidants|antioxidants|mesh-ancestor
92914757|NCT00803530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914758|NCT00803530|Protective Agents|protective agents|mesh-ancestor
92914759|NCT00803530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914760|NCT00803530|Vitamins|vitamins|mesh-ancestor
92914761|NCT00803530|Micronutrients|micronutrients|mesh-ancestor
92914762|NCT00803764|Naproxen|naproxen|mesh-list
92914763|NCT00803764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92914764|NCT00803764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92914765|NCT00803764|Analgesics|analgesics|mesh-ancestor
92914766|NCT00803764|Sensory System Agents|sensory system agents|mesh-ancestor
92914767|NCT00803764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914768|NCT00803764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914769|NCT00803764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914770|NCT00803764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914771|NCT00803764|Gout Suppressants|gout suppressants|mesh-ancestor
92914772|NCT00803764|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92914773|NCT00803764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914774|NCT00803764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914775|NCT00704366|Saracatinib|saracatinib|mesh-list
92914776|NCT00704366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914777|NCT00704366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914778|NCT00704366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914779|NCT00708266|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92914780|NCT00708266|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92914781|NCT00708266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92914782|NCT00708266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92914783|NCT00803842|Doxycycline|doxycycline|mesh-list
92914784|NCT00803842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914785|NCT00803842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914786|NCT00803842|Antimalarials|antimalarials|mesh-ancestor
92914787|NCT00803842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92914788|NCT00803842|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92914789|NCT00658528|Esomeprazole|esomeprazole|mesh-list
92914790|NCT00658528|Rabeprazole|rabeprazole|mesh-list
92914791|NCT00658528|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92914792|NCT00658528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914793|NCT00658528|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92914794|NCT00658528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914795|NCT00658528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914796|NCT02864394|Docetaxel|docetaxel|mesh-list
92914797|NCT02864394|Pembrolizumab|pembrolizumab|mesh-list
92914798|NCT02864394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914799|NCT02864394|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914800|NCT02864394|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914801|NCT02864394|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914802|NCT02864394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914803|NCT02864394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914804|NCT02864394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92914806|NCT00856583|Sertindole|sertindole|mesh-list
92914807|NCT00856583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92914808|NCT00856583|Serotonin Agents|serotonin agents|mesh-ancestor
92914809|NCT00856583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914810|NCT00856583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914811|NCT00856583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914812|NCT00856583|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92914813|NCT00856583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92914814|NCT00856583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914815|NCT00856583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914816|NCT00856583|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92914818|NCT00803244|Immunomodulating Agents|immunomodulating agents|mesh-list
92914819|NCT00803244|Immunologic Factors|immunologic factors|mesh-ancestor
92914820|NCT00803244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914821|NCT05753280|Vitamin D|vitamin d|mesh-list
92914822|NCT05753280|Vitamins|vitamins|mesh-ancestor
92914823|NCT05753280|Micronutrients|micronutrients|mesh-ancestor
92914824|NCT05753280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914825|NCT05753280|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92914826|NCT00824408|Pemetrexed|pemetrexed|mesh-list
92914827|NCT00824408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914828|NCT00824408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914829|NCT00824408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914830|NCT00824408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92914831|NCT00824408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92914832|NCT02611700|Paclitaxel|paclitaxel|mesh-list
92914833|NCT02611700|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92914834|NCT02611700|Cisplatin|cisplatin|mesh-list
92914835|NCT02611700|Nimotuzumab|nimotuzumab|mesh-list
92914836|NCT02611700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92914837|NCT02611700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914838|NCT02611700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914839|NCT02611700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914840|NCT02611700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914841|NCT02611700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914842|NCT02611700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914843|NCT00708344|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92914844|NCT00708344|Irbesartan|irbesartan|mesh-list
92914845|NCT00708344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92914846|NCT00708344|Diuretics|diuretics|mesh-ancestor
92914847|NCT00708344|Natriuretic Agents|natriuretic agents|mesh-ancestor
92914848|NCT00708344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914849|NCT00708344|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92914850|NCT00708344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914851|NCT00708344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914852|NCT00708344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92914853|NCT00708344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92914854|NCT00866333|Entinostat|entinostat|mesh-list
92914855|NCT00866333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914856|NCT00866333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92914857|NCT00866333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914858|NCT00866333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914859|NCT00834080|Naltrexone|naltrexone|mesh-list
92914860|NCT00834080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92914861|NCT00834080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92914862|NCT00834080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914863|NCT00834080|Sensory System Agents|sensory system agents|mesh-ancestor
92914864|NCT00834080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914865|NCT00823472|Ganirelix|ganirelix|mesh-list
92914866|NCT00823472|Hormone Antagonists|hormone antagonists|mesh-ancestor
92914867|NCT00823472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914868|NCT00823472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914869|NCT04118699|Rifaximin|rifaximin|mesh-list
92914870|NCT04118699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92914871|NCT04118699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914872|NCT04118699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92914873|NCT00856193|Glycopyrrolate|glycopyrrolate|mesh-list
92914874|NCT00856193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92259707|NCT02486406|Ritonavir|ritonavir|mesh-list
92914875|NCT00856193|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92914876|NCT00856193|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92914877|NCT00856193|Cholinergic Agents|cholinergic agents|mesh-ancestor
92914878|NCT00856193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92914879|NCT00856193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914880|NCT00856193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914881|NCT04130087|Selegiline|selegiline|mesh-list
92914882|NCT04130087|Antidepressive Agents|antidepressive agents|mesh-ancestor
92914883|NCT04130087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92914884|NCT04130087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92914885|NCT04130087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92914886|NCT04130087|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92914887|NCT04130087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914888|NCT04130087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914889|NCT04130087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92914890|NCT04130087|Protective Agents|protective agents|mesh-ancestor
92914891|NCT04130087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914893|NCT00652366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92914894|NCT00652366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92914895|NCT00652366|Antimetabolites|antimetabolites|mesh-ancestor
92914896|NCT00652366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914897|NCT00652366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914898|NCT00652366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914899|NCT00652366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914900|NCT00841568|Tolvaptan|tolvaptan|mesh-list
92914901|NCT00841568|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92914902|NCT00841568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914903|NCT00841568|Natriuretic Agents|natriuretic agents|mesh-ancestor
92914904|NCT00841568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914905|NCT00855959|Budesonide|budesonide|mesh-list
92914906|NCT00855959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914907|NCT00855959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92914908|NCT00855959|Autonomic Agents|autonomic agents|mesh-ancestor
92914909|NCT00855959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914910|NCT00855959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914911|NCT00855959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92914912|NCT00855959|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914913|NCT00855959|Glucocorticoids|glucocorticoids|mesh-ancestor
92914914|NCT00855959|Hormones|hormones|mesh-ancestor
92914915|NCT00855959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914916|NCT00704600|Nelfinavir|nelfinavir|mesh-list
92914917|NCT00704600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92914918|NCT00704600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92914919|NCT00704600|Protease Inhibitors|protease inhibitors|mesh-ancestor
92914920|NCT00704600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92914921|NCT00704600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914922|NCT00704600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92914923|NCT00704600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92914924|NCT00704600|Antiviral Agents|antiviral agents|mesh-ancestor
92914925|NCT00704600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92914926|NCT00699881|Cetuximab|cetuximab|mesh-list
92914927|NCT00699881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914928|NCT00699881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914929|NCT00708578|Metformin|metformin|mesh-list
92914930|NCT00708578|Insulin Glargine|insulin glargine|mesh-list
92914931|NCT00708578|Glimepiride|glimepiride|mesh-list
92914932|NCT00708578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92914933|NCT00708578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914934|NCT00708578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92914935|NCT00708578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92914936|NCT00708578|Immunologic Factors|immunologic factors|mesh-ancestor
92914937|NCT00704678|Sevelamer|sevelamer|mesh-list
92914938|NCT00704678|Chelating Agents|chelating agents|mesh-ancestor
92914939|NCT00704678|Sequestering Agents|sequestering agents|mesh-ancestor
92914940|NCT00704678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914941|NCT00708656|Mesalamine|mesalamine|mesh-list
92914942|NCT00708656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92914943|NCT00708656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92914944|NCT00708656|Analgesics|analgesics|mesh-ancestor
92914945|NCT00708656|Sensory System Agents|sensory system agents|mesh-ancestor
92914946|NCT00708656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914947|NCT00708656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914948|NCT00708656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92914949|NCT00708656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914950|NCT00913328|Montelukast|montelukast|mesh-list
92914951|NCT00913328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92914952|NCT00913328|Respiratory System Agents|respiratory system agents|mesh-ancestor
92914953|NCT00913328|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92914954|NCT00913328|Hormone Antagonists|hormone antagonists|mesh-ancestor
92914955|NCT00913328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92914956|NCT00913328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914957|NCT00913328|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92914958|NCT00913328|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92914959|NCT00913328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914960|NCT00804310|Lapatinib|lapatinib|mesh-list
92914961|NCT00804310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914962|NCT00804310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92914963|NCT00804310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560406|NCT00047099|Tamoxifen|tamoxifen|mesh-list
92914964|NCT00804310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914966|NCT04118777|Anesthetics, Local|anesthetics, local|mesh-ancestor
92914967|NCT04118777|Anesthetics|anesthetics|mesh-ancestor
92914968|NCT04118777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92914969|NCT04118777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914970|NCT04118777|Sensory System Agents|sensory system agents|mesh-ancestor
92914971|NCT04118777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92914972|NCT00708812|Paclitaxel|paclitaxel|mesh-list
92914973|NCT00708812|Carboplatin|carboplatin|mesh-list
92914974|NCT00708812|Endostar protein|endostar protein|mesh-list
92914975|NCT00708812|Endostatins|endostatins|mesh-list
92914976|NCT00708812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92914977|NCT00708812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914978|NCT00708812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92914979|NCT00708812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92914980|NCT00708812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92914981|NCT00708812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914982|NCT00708812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92914983|NCT00708812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92914984|NCT00708812|Growth Substances|growth substances|mesh-ancestor
92914985|NCT00708812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914986|NCT00708812|Growth Inhibitors|growth inhibitors|mesh-ancestor
92914987|NCT04127747|Rituximab|rituximab|mesh-list
92914988|NCT04127747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92914989|NCT04127747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92914990|NCT04127747|Immunologic Factors|immunologic factors|mesh-ancestor
92914991|NCT04127747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92914992|NCT04127747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92914993|NCT00822926|Botulinum Toxins|botulinum toxins|mesh-list
92914994|NCT00822926|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92914995|NCT00822926|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92914996|NCT00822926|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92914997|NCT00822926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92914998|NCT00822926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92914999|NCT00822926|Cholinergic Agents|cholinergic agents|mesh-ancestor
92915000|NCT00822926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915001|NCT00822926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915002|NCT00822926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92915003|NCT00822926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915004|NCT00822770|Plerixafor|plerixafor|mesh-list
92915005|NCT00822770|Fludarabine|fludarabine|mesh-list
92915006|NCT00822770|Fludarabine phosphate|fludarabine phosphate|mesh-list
92915007|NCT00822770|Busulfan|busulfan|mesh-list
92915008|NCT00822770|Thymoglobulin|thymoglobulin|mesh-list
92915009|NCT00822770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92915010|NCT00822770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915011|NCT00822770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92915012|NCT00822770|Antimetabolites|antimetabolites|mesh-ancestor
92915013|NCT00822770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915014|NCT00822770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915015|NCT00822770|Immunologic Factors|immunologic factors|mesh-ancestor
92915016|NCT00822770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915017|NCT00822770|Antiviral Agents|antiviral agents|mesh-ancestor
92915018|NCT00822770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915019|NCT00822770|Alkylating Agents|alkylating agents|mesh-ancestor
92915020|NCT00822770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92915021|NCT00822770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92915022|NCT00822770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92915023|NCT00822770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92915024|NCT02842086|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92915025|NCT02842086|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92915026|NCT02842086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92915027|NCT02842086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92915028|NCT02842086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915029|NCT02842086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915030|NCT02842086|Antiviral Agents|antiviral agents|mesh-ancestor
92915031|NCT02842086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915032|NCT02842086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92915033|NCT02842086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92915034|NCT00822692|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92915035|NCT00822692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92915036|NCT00822692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915037|NCT00822692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92915038|NCT00822692|Antimalarials|antimalarials|mesh-ancestor
92915039|NCT00822692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92915040|NCT00822692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92915041|NCT02607111|Dalteparin|dalteparin|mesh-list
92915042|NCT02607111|Tinzaparin|tinzaparin|mesh-list
92915043|NCT02607111|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92915044|NCT02607111|Anticoagulants|anticoagulants|mesh-ancestor
92915045|NCT02607111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92915046|NCT02607111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92915047|NCT02607111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915048|NCT00703196|Folic Acid|folic acid|mesh-list
92915049|NCT00703196|Hematinics|hematinics|mesh-ancestor
92915050|NCT00703196|Vitamin B Complex|vitamin b complex|mesh-ancestor
92915051|NCT00703196|Vitamins|vitamins|mesh-ancestor
92915052|NCT00703196|Micronutrients|micronutrients|mesh-ancestor
92915053|NCT00703196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915054|NCT00913250|Interferon beta-1a|interferon beta-1a|mesh-list
92915055|NCT00913250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92915056|NCT00913250|Immunologic Factors|immunologic factors|mesh-ancestor
92915057|NCT00913250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915058|NCT00913250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915059|NCT00913250|Antiviral Agents|antiviral agents|mesh-ancestor
92915060|NCT00913250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915061|NCT00914277|Sildenafil Citrate|sildenafil citrate|mesh-list
92915062|NCT00914277|Vasodilator Agents|vasodilator agents|mesh-ancestor
92915063|NCT00914277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92915064|NCT00914277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92915065|NCT00914277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915066|NCT00914277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915067|NCT00914277|Urological Agents|urological agents|mesh-ancestor
92915068|NCT00704756|Ribavirin|ribavirin|mesh-list
92915069|NCT00704756|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92915070|NCT00704756|Interferon-alpha|interferon-alpha|mesh-list
92915071|NCT00704756|Antimetabolites|antimetabolites|mesh-ancestor
92915072|NCT00704756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915073|NCT00704756|Antiviral Agents|antiviral agents|mesh-ancestor
92915074|NCT00704756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915075|NCT00704756|Immunologic Factors|immunologic factors|mesh-ancestor
92915076|NCT00704756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915077|NCT00806442|Borage oil|borage oil|mesh-list
92915078|NCT00806442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915079|NCT02608242|Amlodipine|amlodipine|mesh-list
92915080|NCT02608242|Telmisartan|telmisartan|mesh-list
92915081|NCT02608242|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92915082|NCT02608242|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92915083|NCT02608242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92915084|NCT02608242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92915085|NCT02608242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92915086|NCT02608242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915087|NCT02608242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92915088|NCT02608242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915089|NCT02608242|Vasodilator Agents|vasodilator agents|mesh-ancestor
92915090|NCT02608242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92915091|NCT02608242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92915092|NCT02608242|Antimetabolites|antimetabolites|mesh-ancestor
92915093|NCT02608242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92915094|NCT02608242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92915095|NCT02608242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915096|NCT02608242|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92915097|NCT02608242|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92915098|NCT02607696|Zolpidem|zolpidem|mesh-list
92915099|NCT02607696|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92915100|NCT02607696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92915101|NCT02607696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915102|NCT02607696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915103|NCT02607696|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92915104|NCT02607696|GABA Agonists|gaba agonists|mesh-ancestor
92915105|NCT02607696|GABA Agents|gaba agents|mesh-ancestor
92915106|NCT02607696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915107|NCT02607696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915108|NCT00839852|Cariprazine|cariprazine|mesh-list
92915109|NCT00839852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92915110|NCT00839852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915111|NCT00839852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915112|NCT00839852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915113|NCT00839852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915114|NCT02604849|Gentamicins|gentamicins|mesh-list
92915115|NCT02604849|Neomycin|neomycin|mesh-list
92915116|NCT02604849|Streptomycin|streptomycin|mesh-list
92915117|NCT02604849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92915118|NCT02604849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915119|NCT02604849|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92915120|NCT02604849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915121|NCT02604849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915122|NCT00709046|Pantoprazole|pantoprazole|mesh-list
92915123|NCT00709046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92915124|NCT00709046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915125|NCT00709046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92915126|NCT00709046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915127|NCT00709046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915128|NCT00820898|Gemcitabine|gemcitabine|mesh-list
92915129|NCT00820898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92915130|NCT00820898|Antimetabolites|antimetabolites|mesh-ancestor
92915131|NCT00820898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915132|NCT00820898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915133|NCT00865709|Leucovorin|leucovorin|mesh-list
92915134|NCT00865709|Oxaliplatin|oxaliplatin|mesh-list
92915135|NCT00865709|Fluorouracil|fluorouracil|mesh-list
92915136|NCT00865709|Sorafenib|sorafenib|mesh-list
92915137|NCT00865709|Levoleucovorin|levoleucovorin|mesh-list
92915138|NCT00865709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915139|NCT00865709|Antidotes|antidotes|mesh-ancestor
92915140|NCT00865709|Protective Agents|protective agents|mesh-ancestor
92915141|NCT00865709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915142|NCT00865709|Vitamin B Complex|vitamin b complex|mesh-ancestor
92915143|NCT00865709|Vitamins|vitamins|mesh-ancestor
92915144|NCT00865709|Micronutrients|micronutrients|mesh-ancestor
92915145|NCT00865709|Antimetabolites|antimetabolites|mesh-ancestor
92915146|NCT00865709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915147|NCT00865709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92915148|NCT00865709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915149|NCT00865709|Immunologic Factors|immunologic factors|mesh-ancestor
92915150|NCT00865709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92915151|NCT00865709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915152|NCT00839306|Rabeprazole|rabeprazole|mesh-list
92915153|NCT00839306|Ranitidine|ranitidine|mesh-list
92915154|NCT00839306|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92915155|NCT00839306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92915156|NCT00839306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915157|NCT00839306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92915158|NCT00839306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162582|NCT01286805|Bupivacaine|bupivacaine|mesh-list
92915159|NCT00839306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915160|NCT00839306|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92915161|NCT00839306|Histamine Antagonists|histamine antagonists|mesh-ancestor
92915162|NCT00839306|Histamine Agents|histamine agents|mesh-ancestor
92915163|NCT00839306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915164|NCT00839306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915165|NCT04131335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92915166|NCT04131335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92915167|NCT00839072|Trazodone|trazodone|mesh-list
92915168|NCT00839072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92915169|NCT00839072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915170|NCT00839072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915171|NCT00839072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915172|NCT00839072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915173|NCT00839072|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92915174|NCT00839072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92915175|NCT00839072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92915176|NCT00839072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915177|NCT00839072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915178|NCT00839072|Serotonin Agents|serotonin agents|mesh-ancestor
92915179|NCT00839072|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92915180|NCT00839072|Antidepressive Agents|antidepressive agents|mesh-ancestor
92915182|NCT00704990|Ascorbic Acid|ascorbic acid|mesh-list
92915183|NCT00704990|Vitamin B 6|vitamin b 6|mesh-list
92915184|NCT00704990|Pyridoxal|pyridoxal|mesh-list
92915185|NCT00704990|Pyridoxine|pyridoxine|mesh-list
92915186|NCT00704990|Zinc|zinc|mesh-list
92915187|NCT00704990|Vitamin B Complex|vitamin b complex|mesh-list
92915188|NCT00704990|Micronutrients|micronutrients|mesh-ancestor
92915189|NCT00704990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915190|NCT00704990|Trace Elements|trace elements|mesh-ancestor
92915191|NCT00704990|Antioxidants|antioxidants|mesh-ancestor
92915192|NCT00704990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915193|NCT00704990|Protective Agents|protective agents|mesh-ancestor
92915194|NCT03553836|Pembrolizumab|pembrolizumab|mesh-list
92915195|NCT03553836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915196|NCT03553836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915197|NCT03553836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92915198|NCT03553836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915199|NCT02607774|Midazolam|midazolam|mesh-list
92915200|NCT02607774|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92915201|NCT02607774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92915202|NCT02607774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915203|NCT02607774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915204|NCT02607774|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92915205|NCT02607774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915206|NCT02607774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915207|NCT02607774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92915208|NCT02607774|Anesthetics, General|anesthetics, general|mesh-ancestor
92915209|NCT02607774|Anesthetics|anesthetics|mesh-ancestor
92915210|NCT02607774|GABA Modulators|gaba modulators|mesh-ancestor
92915211|NCT02607774|GABA Agents|gaba agents|mesh-ancestor
92915212|NCT02607774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915213|NCT02607774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915214|NCT00838916|Insulin Glargine|insulin glargine|mesh-list
92915215|NCT00838916|rGLP-1 protein|rglp-1 protein|mesh-list
92915216|NCT00838916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92915217|NCT00838916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915218|NCT00838916|Incretins|incretins|mesh-ancestor
92915219|NCT00838916|Hormones|hormones|mesh-ancestor
92915220|NCT00838916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915221|NCT00838682|Omeprazole|omeprazole|mesh-list
92915222|NCT00838682|Rabeprazole|rabeprazole|mesh-list
92915223|NCT00838682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92915224|NCT00838682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915225|NCT00838682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92915226|NCT00838682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915227|NCT00838682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915228|NCT00913484|Disulfiram|disulfiram|mesh-list
92915229|NCT00913484|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92915230|NCT00913484|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92915231|NCT00913484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915232|NCT00913484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915233|NCT00803712|Vitamin D|vitamin d|mesh-list
92915234|NCT00803712|Ergocalciferols|ergocalciferols|mesh-list
92915235|NCT00803712|Cholecalciferol|cholecalciferol|mesh-list
92915236|NCT00803712|Vitamins|vitamins|mesh-list
92915237|NCT00803712|Cinacalcet|cinacalcet|mesh-list
92915238|NCT00803712|Micronutrients|micronutrients|mesh-ancestor
92915239|NCT00803712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915240|NCT00803712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92915241|NCT00803712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92915242|NCT00803712|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92915243|NCT00803712|Hormone Antagonists|hormone antagonists|mesh-ancestor
92915244|NCT00803712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915245|NCT00803634|Antihypertensive Agents|antihypertensive agents|mesh-list
92915247|NCT00803634|Nitroprusside|nitroprusside|mesh-list
92915248|NCT00803634|Nicardipine|nicardipine|mesh-list
92915249|NCT00803634|Clevidipine|clevidipine|mesh-list
92915250|NCT00803634|Isosorbide|isosorbide|mesh-list
92915251|NCT00803634|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92915252|NCT00803634|Nitroglycerin|nitroglycerin|mesh-list
92915253|NCT00803634|Vasodilator Agents|vasodilator agents|mesh-ancestor
92915254|NCT00803634|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92915255|NCT00803634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92915256|NCT00803634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915257|NCT00803634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92915258|NCT00803634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915259|NCT00803634|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92915260|NCT00803634|Diuretics|diuretics|mesh-ancestor
92915261|NCT00803634|Natriuretic Agents|natriuretic agents|mesh-ancestor
92915262|NCT00803634|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92915263|NCT00838526|Rabeprazole|rabeprazole|mesh-list
92915264|NCT00838526|Ranitidine|ranitidine|mesh-list
92915265|NCT00838526|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92915266|NCT00838526|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92915267|NCT00838526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915268|NCT00838526|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92915269|NCT00838526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915270|NCT00838526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915271|NCT00838526|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92915272|NCT00838526|Histamine Antagonists|histamine antagonists|mesh-ancestor
92915273|NCT00838526|Histamine Agents|histamine agents|mesh-ancestor
92915274|NCT00838526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915275|NCT00838526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915276|NCT00914472|Heparin|heparin|mesh-list
92915277|NCT00914472|Calcium heparin|calcium heparin|mesh-list
92915278|NCT00914472|Anticoagulants|anticoagulants|mesh-ancestor
92915279|NCT00914472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92915280|NCT00914472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92915281|NCT00914472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915282|NCT02611466|Naproxen|naproxen|mesh-list
92915283|NCT02611466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915284|NCT02611466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915285|NCT02611466|Analgesics|analgesics|mesh-ancestor
92915286|NCT02611466|Sensory System Agents|sensory system agents|mesh-ancestor
92915287|NCT02611466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915288|NCT02611466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915289|NCT02611466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915290|NCT02611466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915291|NCT02611466|Gout Suppressants|gout suppressants|mesh-ancestor
92915292|NCT02611466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92915293|NCT02611466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915294|NCT02611466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915295|NCT02688270|Nitroglycerin|nitroglycerin|mesh-list
92915296|NCT02688270|Vasodilator Agents|vasodilator agents|mesh-ancestor
92915297|NCT02610920|Iron|iron|mesh-list
92915298|NCT02610920|Trace Elements|trace elements|mesh-ancestor
92915299|NCT02610920|Micronutrients|micronutrients|mesh-ancestor
92915300|NCT02610920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915301|NCT00913562|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92915302|NCT00913562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92915303|NCT00913562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92915304|NCT00913562|Antimetabolites|antimetabolites|mesh-ancestor
92915305|NCT00913562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915306|NCT00913562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92915307|NCT00913562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92915308|NCT00913562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915309|NCT00818168|Infliximab|infliximab|mesh-list
92915310|NCT00818168|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92915311|NCT00818168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915312|NCT00818168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92915313|NCT00818168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915314|NCT00818168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915315|NCT02607540|Cisplatin|cisplatin|mesh-list
92915316|NCT02607540|Fluorouracil|fluorouracil|mesh-list
92915317|NCT02607540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915318|NCT02607540|Antimetabolites|antimetabolites|mesh-ancestor
92526174|NCT00012051|Hormones|hormones|mesh-ancestor
92915319|NCT02607540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915320|NCT02607540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92915321|NCT02607540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915322|NCT02607540|Immunologic Factors|immunologic factors|mesh-ancestor
92915323|NCT02607540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915324|NCT00705692|Levamisole|levamisole|mesh-list
92915325|NCT00705692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92915326|NCT00705692|Immunologic Factors|immunologic factors|mesh-ancestor
92915327|NCT00705692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915328|NCT00705692|Antinematodal Agents|antinematodal agents|mesh-ancestor
92915329|NCT00705692|Anthelmintics|anthelmintics|mesh-ancestor
92915330|NCT00705692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92915331|NCT00705692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915332|NCT00705692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915333|NCT00705770|Hydrocortisone|hydrocortisone|mesh-list
92915334|NCT00705770|Anecortave|anecortave|mesh-list
92915335|NCT00705770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92915336|NCT00705770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92915337|NCT00705770|Growth Substances|growth substances|mesh-ancestor
92915338|NCT00705770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915339|NCT00705770|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915340|NCT00705770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915341|NCT00705770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915342|NCT00796653|Formoterol Fumarate|formoterol fumarate|mesh-list
92560780|NCT00042861|Vitamin B Complex|vitamin b complex|mesh-ancestor
92915343|NCT00796653|Olodaterol|olodaterol|mesh-list
92915344|NCT00796653|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92915345|NCT00796653|Autonomic Agents|autonomic agents|mesh-ancestor
92915346|NCT00796653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915347|NCT00796653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915348|NCT00796653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92915349|NCT00796653|Respiratory System Agents|respiratory system agents|mesh-ancestor
92915350|NCT00796653|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92915351|NCT00796653|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92915352|NCT00796653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92915353|NCT00796653|Adrenergic Agents|adrenergic agents|mesh-ancestor
92915354|NCT00796653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915355|NCT00796653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915356|NCT00806286|Paclitaxel|paclitaxel|mesh-list
92915357|NCT00806286|Carboplatin|carboplatin|mesh-list
92915358|NCT00806286|Efatutazone|efatutazone|mesh-list
92915359|NCT00806286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92915360|NCT00806286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915361|NCT00806286|Tubulin Modulators|tubulin modulators|mesh-ancestor
92915362|NCT00806286|Antimitotic Agents|antimitotic agents|mesh-ancestor
92915363|NCT00806286|Mitosis Modulators|mitosis modulators|mesh-ancestor
92915364|NCT00806286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915365|NCT03537924|Acetazolamide|acetazolamide|mesh-list
92915366|NCT03537924|Anticonvulsants|anticonvulsants|mesh-ancestor
92915367|NCT03537924|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92915368|NCT03537924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915369|NCT03537924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915370|NCT03537924|Diuretics|diuretics|mesh-ancestor
92915371|NCT03537924|Natriuretic Agents|natriuretic agents|mesh-ancestor
92915372|NCT03537924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915373|NCT00590538|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92915374|NCT00590538|Genistein|genistein|mesh-list
92915375|NCT00590538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915376|NCT00590538|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92915377|NCT00590538|Protective Agents|protective agents|mesh-ancestor
92915378|NCT00590538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915379|NCT00590538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92915380|NCT00590538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915381|NCT00590538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915382|NCT00590538|Phytoestrogens|phytoestrogens|mesh-ancestor
92915383|NCT00590538|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92915384|NCT00590538|Estrogens|estrogens|mesh-ancestor
92915385|NCT00590538|Hormones|hormones|mesh-ancestor
92915386|NCT00590538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915387|NCT02608320|Fentanyl|fentanyl|mesh-list
92915388|NCT02608320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92915389|NCT02608320|Narcotics|narcotics|mesh-ancestor
92915390|NCT02608320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915391|NCT02608320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915392|NCT02608320|Analgesics|analgesics|mesh-ancestor
92915393|NCT02608320|Sensory System Agents|sensory system agents|mesh-ancestor
92915394|NCT02608320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915395|NCT02608320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92915396|NCT02608320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92915397|NCT02608320|Anesthetics, General|anesthetics, general|mesh-ancestor
92915398|NCT02608320|Anesthetics|anesthetics|mesh-ancestor
92915399|NCT01731444|Phenylephrine|phenylephrine|mesh-list
92915400|NCT01731444|Oxymetazoline|oxymetazoline|mesh-list
92915401|NCT01731444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92915402|NCT01731444|Mydriatics|mydriatics|mesh-ancestor
92915403|NCT01731444|Autonomic Agents|autonomic agents|mesh-ancestor
92915404|NCT01731444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915405|NCT01731444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915406|NCT01731444|Sympathomimetics|sympathomimetics|mesh-ancestor
92915407|NCT01731444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92915408|NCT01731444|Nasal Decongestants|nasal decongestants|mesh-ancestor
92915409|NCT01731444|Respiratory System Agents|respiratory system agents|mesh-ancestor
92915410|NCT01731444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92915411|NCT01731444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92915412|NCT01731444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92915413|NCT01731444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92915414|NCT01731444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915415|NCT01731444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915416|NCT01731444|Protective Agents|protective agents|mesh-ancestor
92915417|NCT05728788|Antineoplastic Agents|antineoplastic agents|mesh-list
92915418|NCT02608164|Vitamin D|vitamin d|mesh-list
92915419|NCT02608164|Cholecalciferol|cholecalciferol|mesh-list
92915420|NCT02608164|Vitamins|vitamins|mesh-ancestor
92915421|NCT02608164|Micronutrients|micronutrients|mesh-ancestor
92915422|NCT02608164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915423|NCT02608164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92915424|NCT02608164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92915425|NCT00796419|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92915426|NCT00796419|Plasma Substitutes|plasma substitutes|mesh-ancestor
92915427|NCT00796419|Blood Substitutes|blood substitutes|mesh-ancestor
92915428|NCT04110873|Ubiquinone|ubiquinone|mesh-list
92915429|NCT04110873|Micronutrients|micronutrients|mesh-ancestor
92915430|NCT04110873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915431|NCT02604615|Capecitabine|capecitabine|mesh-list
92915432|NCT02604615|Oxaliplatin|oxaliplatin|mesh-list
92915433|NCT02604615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92915434|NCT02604615|Antimetabolites|antimetabolites|mesh-ancestor
92915435|NCT02604615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915436|NCT02604615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915437|NCT00796107|Letrozole|letrozole|mesh-list
92915438|NCT00796107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915439|NCT00796107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92915440|NCT00796107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92915441|NCT00796107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915442|NCT00796107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915443|NCT00796107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92915444|NCT00796107|Hormone Antagonists|hormone antagonists|mesh-ancestor
92915445|NCT00796107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915446|NCT00796107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915447|NCT00805740|Caspofungin|caspofungin|mesh-list
92915448|NCT00805740|Anidulafungin|anidulafungin|mesh-list
92915449|NCT00805740|Antifungal Agents|antifungal agents|mesh-ancestor
92915450|NCT00805740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915451|NCT00805740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915452|NCT00805740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915453|NCT05613075|Hyaluronic Acid|hyaluronic acid|mesh-list
92915454|NCT05613075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92915455|NCT05613075|Immunologic Factors|immunologic factors|mesh-ancestor
92915456|NCT05613075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915457|NCT05613075|Viscosupplements|viscosupplements|mesh-ancestor
92915458|NCT05613075|Protective Agents|protective agents|mesh-ancestor
92915459|NCT01227876|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92915460|NCT01227876|Methylprednisolone|methylprednisolone|mesh-list
92915461|NCT01227876|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92915462|NCT01227876|Prednisolone|prednisolone|mesh-list
92915463|NCT01227876|Prednisolone acetate|prednisolone acetate|mesh-list
92915464|NCT01227876|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92915465|NCT01227876|Prednisolone phosphate|prednisolone phosphate|mesh-list
92915466|NCT01227876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915467|NCT01227876|Antiemetics|antiemetics|mesh-ancestor
92915468|NCT01227876|Autonomic Agents|autonomic agents|mesh-ancestor
92915469|NCT01227876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915470|NCT01227876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915471|NCT01227876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915472|NCT01227876|Glucocorticoids|glucocorticoids|mesh-ancestor
92915473|NCT01227876|Hormones|hormones|mesh-ancestor
92915474|NCT01227876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915475|NCT01227876|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92915476|NCT01227876|Protective Agents|protective agents|mesh-ancestor
92915477|NCT01227876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92915478|NCT01227876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915479|NCT00795639|Sitaxsentan|sitaxsentan|mesh-list
92915480|NCT00795639|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92915481|NCT00795639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915482|NCT05297292|Ranibizumab|ranibizumab|mesh-list
92915483|NCT05297292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92915484|NCT05297292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92915485|NCT05297292|Growth Substances|growth substances|mesh-ancestor
92915486|NCT05297292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915487|NCT05297292|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915488|NCT05297292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915489|NCT02604459|Fentanyl|fentanyl|mesh-list
92915490|NCT02604459|Anesthetics|anesthetics|mesh-list
92915491|NCT02604459|Propofol|propofol|mesh-list
92915492|NCT02604459|Sevoflurane|sevoflurane|mesh-list
92915493|NCT02604459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915494|NCT02604459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915495|NCT02604459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92915496|NCT02604459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92915497|NCT02604459|Anesthetics, General|anesthetics, general|mesh-ancestor
92915498|NCT02604459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92915499|NCT02604459|Narcotics|narcotics|mesh-ancestor
92915500|NCT02604459|Analgesics|analgesics|mesh-ancestor
92915501|NCT02604459|Sensory System Agents|sensory system agents|mesh-ancestor
92915502|NCT02604459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915503|NCT02604459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92915504|NCT02604459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92915505|NCT02604459|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92915506|NCT02604225|Methoxyflurane|methoxyflurane|mesh-list
92915507|NCT02604225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92915508|NCT02604225|Anesthetics, General|anesthetics, general|mesh-ancestor
92915509|NCT02604225|Anesthetics|anesthetics|mesh-ancestor
92915510|NCT02604225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915511|NCT02604225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915512|NCT02607072|Aspirin|aspirin|mesh-list
92915513|NCT02607072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915514|NCT02607072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915515|NCT02607072|Analgesics|analgesics|mesh-ancestor
92915516|NCT02607072|Sensory System Agents|sensory system agents|mesh-ancestor
92915517|NCT02607072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915518|NCT02607072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915519|NCT02607072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915520|NCT02607072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915521|NCT02607072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92915522|NCT02607072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92162598|NCT01288521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915523|NCT02607072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915524|NCT02607072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92915525|NCT02607072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92915526|NCT02607072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915527|NCT02607072|Antipyretics|antipyretics|mesh-ancestor
92915528|NCT04110093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92915529|NCT04110093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915530|NCT04110093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915531|NCT04110093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915532|NCT03161652|Ranibizumab|ranibizumab|mesh-list
92915533|NCT03161652|Dopamine|dopamine|mesh-list
92915534|NCT03161652|Sulpiride|sulpiride|mesh-list
92915535|NCT03161652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92915536|NCT03161652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92915537|NCT03161652|Growth Substances|growth substances|mesh-ancestor
92915538|NCT03161652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915539|NCT03161652|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915540|NCT03161652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915541|NCT03161652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92915542|NCT03161652|Sympathomimetics|sympathomimetics|mesh-ancestor
92915543|NCT03161652|Autonomic Agents|autonomic agents|mesh-ancestor
92915544|NCT03161652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915545|NCT03161652|Dopamine Agents|dopamine agents|mesh-ancestor
92915546|NCT03161652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915547|NCT03161652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915548|NCT03161652|Protective Agents|protective agents|mesh-ancestor
92915549|NCT03161652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92915550|NCT03161652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915551|NCT03161652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915552|NCT03161652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915553|NCT03161652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92915554|NCT03161652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92915555|NCT03161652|Antidepressive Agents|antidepressive agents|mesh-ancestor
92915556|NCT00588237|Paclitaxel|paclitaxel|mesh-list
92915557|NCT00588237|Bevacizumab|bevacizumab|mesh-list
92915558|NCT00588237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92915559|NCT00588237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915560|NCT00588237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92915561|NCT00588237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92915562|NCT00588237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92915563|NCT00588237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915564|NCT00588237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915565|NCT00588237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92915566|NCT00588237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92915567|NCT00588237|Growth Substances|growth substances|mesh-ancestor
92915568|NCT00588237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915569|NCT00588237|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915570|NCT02605746|Ceritinib|ceritinib|mesh-list
92915571|NCT02605746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915572|NCT02605746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92915573|NCT02605746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915574|NCT02605746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915575|NCT04109859|Methylene Blue|methylene blue|mesh-list
92915576|NCT04109859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915577|NCT04109859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915578|NCT00790023|Ciclesonide|ciclesonide|mesh-list
92915579|NCT00790023|Glucocorticoids|glucocorticoids|mesh-ancestor
92915581|NCT00790023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915582|NCT00790023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915583|NCT00790023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92915584|NCT00588822|Rituximab|rituximab|mesh-list
92915585|NCT00588822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915586|NCT00588822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915587|NCT00588822|Immunologic Factors|immunologic factors|mesh-ancestor
92915588|NCT00588822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915589|NCT00588822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915590|NCT05563467|Pembrolizumab|pembrolizumab|mesh-list
92915591|NCT05563467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915592|NCT05563467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162605|NCT00632749|Cytarabine|cytarabine|mesh-list
92915593|NCT05563467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92915594|NCT05563467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915595|NCT00589914|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92915596|NCT00589914|Risperidone|risperidone|mesh-list
92915597|NCT00589914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92915598|NCT00589914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915599|NCT00589914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915600|NCT00589914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915601|NCT00589914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915602|NCT00589914|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92915603|NCT00589914|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92915604|NCT00589914|Serotonin Agents|serotonin agents|mesh-ancestor
92915605|NCT00589914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915606|NCT00589914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915607|NCT00589914|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92915608|NCT00589914|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92915609|NCT00589914|Dopamine Agents|dopamine agents|mesh-ancestor
92915610|NCT00789555|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92915611|NCT00789555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915612|NCT00789555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915613|NCT00789555|Analgesics|analgesics|mesh-ancestor
92915614|NCT00789555|Sensory System Agents|sensory system agents|mesh-ancestor
92915615|NCT00789555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915616|NCT00789555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915617|NCT00789555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915618|NCT00789555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915619|NCT00789555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92915620|NCT00789555|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92915621|NCT00789555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92915622|NCT00789555|Histamine Antagonists|histamine antagonists|mesh-ancestor
92915623|NCT00789555|Histamine Agents|histamine agents|mesh-ancestor
92915624|NCT00789555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915625|NCT00789555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915626|NCT03770455|Avelumab|avelumab|mesh-list
92915627|NCT03770455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915628|NCT03770455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915629|NCT01026337|Sunitinib|sunitinib|mesh-list
92915630|NCT01026337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915631|NCT01026337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92915632|NCT01026337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92915633|NCT01026337|Growth Substances|growth substances|mesh-ancestor
92915634|NCT01026337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915635|NCT01026337|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915636|NCT01026337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92915637|NCT01026337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915638|NCT01026337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915639|NCT03746275|Aspirin|aspirin|mesh-list
92915640|NCT03746275|Rivaroxaban|rivaroxaban|mesh-list
92915641|NCT03746275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915642|NCT03746275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915643|NCT03746275|Analgesics|analgesics|mesh-ancestor
92915645|NCT03746275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915646|NCT03746275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915647|NCT03746275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915648|NCT03746275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915649|NCT03746275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92915650|NCT03746275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92915651|NCT03746275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915652|NCT03746275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92915653|NCT03746275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92915654|NCT03746275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915655|NCT03746275|Antipyretics|antipyretics|mesh-ancestor
92915656|NCT03746275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92915657|NCT03746275|Antithrombins|antithrombins|mesh-ancestor
92915658|NCT03746275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92915659|NCT03746275|Protease Inhibitors|protease inhibitors|mesh-ancestor
92915660|NCT03746275|Anticoagulants|anticoagulants|mesh-ancestor
92915661|NCT01026415|Rifampin|rifampin|mesh-list
92915662|NCT01026415|Ketoconazole|ketoconazole|mesh-list
92915663|NCT01026415|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92915664|NCT01026415|Midazolam|midazolam|mesh-list
92915665|NCT01026415|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92915666|NCT01026415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92915667|NCT01026415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92915668|NCT01026415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915669|NCT01026415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915670|NCT01026415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92915671|NCT01026415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915672|NCT01026415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915673|NCT01026415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92915674|NCT01026415|Anesthetics, General|anesthetics, general|mesh-ancestor
92915675|NCT01026415|Anesthetics|anesthetics|mesh-ancestor
92915676|NCT01026415|GABA Modulators|gaba modulators|mesh-ancestor
92915677|NCT01026415|GABA Agents|gaba agents|mesh-ancestor
92915678|NCT01026415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915679|NCT01026415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915680|NCT01026415|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92915681|NCT01026415|Antitubercular Agents|antitubercular agents|mesh-ancestor
92915682|NCT01026415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92915683|NCT01026415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915684|NCT01026415|Leprostatic Agents|leprostatic agents|mesh-ancestor
92915685|NCT01026415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92915686|NCT01026415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915687|NCT01026415|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92915688|NCT01026415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92915689|NCT01026415|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92915690|NCT01026415|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92915691|NCT01026415|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92915692|NCT01026415|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92915693|NCT01026415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915694|NCT01026415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915695|NCT01026415|Immunotoxins|immunotoxins|mesh-ancestor
92915696|NCT01026415|Immunoconjugates|immunoconjugates|mesh-ancestor
92915697|NCT01026415|Immunologic Factors|immunologic factors|mesh-ancestor
92915698|NCT01026415|Antifungal Agents|antifungal agents|mesh-ancestor
92915699|NCT01026415|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92915700|NCT01026415|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92915701|NCT01026415|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92915702|NCT01026415|Hormone Antagonists|hormone antagonists|mesh-ancestor
92915703|NCT01026415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915704|NCT01026415|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92915705|NCT01026727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92915706|NCT01026727|Antiviral Agents|antiviral agents|mesh-ancestor
92915707|NCT01026727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915708|NCT02604966|Artesunate|artesunate|mesh-list
92915709|NCT02604966|Antimalarials|antimalarials|mesh-ancestor
92915710|NCT02604966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92915711|NCT02604966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92915712|NCT02604966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915713|NCT02604966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915714|NCT02604966|Antiviral Agents|antiviral agents|mesh-ancestor
92915715|NCT02604966|Schistosomicides|schistosomicides|mesh-ancestor
92915716|NCT02604966|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92915717|NCT02604966|Anthelmintics|anthelmintics|mesh-ancestor
92915718|NCT00914160|Diclofenac|diclofenac|mesh-list
92915719|NCT00914160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915720|NCT00914160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915721|NCT00914160|Analgesics|analgesics|mesh-ancestor
92915722|NCT00914160|Sensory System Agents|sensory system agents|mesh-ancestor
92915723|NCT00914160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915724|NCT00914160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915725|NCT00914160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915726|NCT00914160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915727|NCT00914160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92915728|NCT00914160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915729|NCT00914160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915730|NCT00450619|Metronidazole|metronidazole|mesh-list
92915731|NCT00450619|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92915732|NCT00450619|Vaccines|vaccines|mesh-list
92915733|NCT00450619|Sargramostim|sargramostim|mesh-list
92915734|NCT00450619|Immunologic Factors|immunologic factors|mesh-ancestor
92915735|NCT00450619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915736|NCT00450619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915737|NCT00450619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92915738|NCT00450619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92915739|NCT00450619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92915740|NCT00450619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915741|NCT00450619|Analgesics|analgesics|mesh-ancestor
92915742|NCT00450619|Sensory System Agents|sensory system agents|mesh-ancestor
92915743|NCT00450619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915744|NCT00802074|Ritonavir|ritonavir|mesh-list
92915745|NCT00802074|Fosamprenavir|fosamprenavir|mesh-list
92915746|NCT00802074|Raltegravir Potassium|raltegravir potassium|mesh-list
92915747|NCT00802074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92915748|NCT00802074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92915749|NCT00802074|Protease Inhibitors|protease inhibitors|mesh-ancestor
92915750|NCT00802074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915751|NCT00802074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915752|NCT00802074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92915753|NCT00802074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92915754|NCT00802074|Antiviral Agents|antiviral agents|mesh-ancestor
92915755|NCT00802074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915756|NCT00802074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92915757|NCT00802074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92915758|NCT00802074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92915759|NCT00802074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92915760|NCT04112394|Anesthetics|anesthetics|mesh-list
92915761|NCT04112394|Anesthetics, Local|anesthetics, local|mesh-list
92915762|NCT04112394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915763|NCT04112394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915764|NCT04112394|Sensory System Agents|sensory system agents|mesh-ancestor
92915765|NCT04112394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915766|NCT00450385|Prednisone|prednisone|mesh-list
92915767|NCT00450385|Cyclophosphamide|cyclophosphamide|mesh-list
92915768|NCT00450385|Rituximab|rituximab|mesh-list
92915769|NCT00450385|Doxorubicin|doxorubicin|mesh-list
92915770|NCT00450385|Vincristine|vincristine|mesh-list
92915771|NCT00450385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915772|NCT00450385|Immunologic Factors|immunologic factors|mesh-ancestor
92915773|NCT00450385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915774|NCT00450385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915775|NCT00450385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92915776|NCT00450385|Alkylating Agents|alkylating agents|mesh-ancestor
92915777|NCT00450385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915778|NCT00450385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915779|NCT00450385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92915780|NCT00450385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92915781|NCT00450385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92915782|NCT00450385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92915783|NCT00450385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92915784|NCT00450385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915785|NCT00450385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915786|NCT00450385|Glucocorticoids|glucocorticoids|mesh-ancestor
92915787|NCT00450385|Hormones|hormones|mesh-ancestor
92915788|NCT00450385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915789|NCT00450385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92915790|NCT00450385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92915791|NCT00450385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92915792|NCT00450385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92915793|NCT00450385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561234|NCT00147355|Codeine|codeine|mesh-list
92915794|NCT00588354|Triamcinolone|triamcinolone|mesh-list
92915795|NCT00588354|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92915796|NCT00588354|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92915797|NCT00588354|Lidocaine|lidocaine|mesh-list
92915798|NCT00588354|Clonidine|clonidine|mesh-list
92915799|NCT00588354|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92915800|NCT00588354|Anesthetics, Local|anesthetics, local|mesh-ancestor
92915801|NCT00588354|Anesthetics|anesthetics|mesh-ancestor
92915802|NCT00588354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915803|NCT00588354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915804|NCT00588354|Sensory System Agents|sensory system agents|mesh-ancestor
92915805|NCT00588354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915806|NCT00588354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92915807|NCT00588354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92915808|NCT00588354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92915809|NCT00588354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92915810|NCT00588354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915811|NCT00588354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915812|NCT00588354|Glucocorticoids|glucocorticoids|mesh-ancestor
92915813|NCT00588354|Hormones|hormones|mesh-ancestor
92915814|NCT00588354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915815|NCT00588354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915816|NCT00588354|Immunologic Factors|immunologic factors|mesh-ancestor
92915817|NCT00588354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915818|NCT00588354|Analgesics|analgesics|mesh-ancestor
92915819|NCT00588354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92915820|NCT00588354|Sympatholytics|sympatholytics|mesh-ancestor
92915821|NCT00588354|Autonomic Agents|autonomic agents|mesh-ancestor
92915822|NCT00588354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92915823|NCT00588354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92915824|NCT00588354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92915825|NCT00588354|Adrenergic Agents|adrenergic agents|mesh-ancestor
92915826|NCT00588354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915827|NCT00449761|Panobinostat|panobinostat|mesh-list
92915828|NCT00449761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915829|NCT00449761|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92915830|NCT00449761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915831|NCT00449761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915832|NCT00800982|Etanercept|etanercept|mesh-list
92915833|NCT00800982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915834|NCT00800982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915835|NCT00800982|Analgesics|analgesics|mesh-ancestor
92915836|NCT00800982|Sensory System Agents|sensory system agents|mesh-ancestor
92915837|NCT00800982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915838|NCT00800982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915839|NCT00800982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915840|NCT00800982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915841|NCT00800982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915842|NCT00800982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915843|NCT00800982|Immunologic Factors|immunologic factors|mesh-ancestor
92915844|NCT01019395|Daptomycin|daptomycin|mesh-list
92915845|NCT01019395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92915846|NCT01019395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915847|NCT00830960|Clopidogrel|clopidogrel|mesh-list
92915848|NCT00830960|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92915849|NCT00830960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92915850|NCT00830960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92915851|NCT00830960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92915852|NCT00830960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92915853|NCT00830960|Purinergic Agents|purinergic agents|mesh-ancestor
92915854|NCT00830960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915855|NCT00830960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915856|NCT00830960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915857|NCT01026961|Acetaminophen|acetaminophen|mesh-list
92915858|NCT01026961|Dimethindene|dimethindene|mesh-list
92915859|NCT01026961|Phenylephrine|phenylephrine|mesh-list
92915860|NCT01026961|Oxymetazoline|oxymetazoline|mesh-list
92915861|NCT01026961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915862|NCT01026961|Analgesics|analgesics|mesh-ancestor
92915863|NCT01026961|Sensory System Agents|sensory system agents|mesh-ancestor
92915864|NCT01026961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915865|NCT01026961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915866|NCT01026961|Antipyretics|antipyretics|mesh-ancestor
92915867|NCT01026961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915868|NCT01026961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92915870|NCT01026961|Autonomic Agents|autonomic agents|mesh-ancestor
92915871|NCT01026961|Sympathomimetics|sympathomimetics|mesh-ancestor
92915872|NCT01026961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92915873|NCT01026961|Nasal Decongestants|nasal decongestants|mesh-ancestor
92915874|NCT01026961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92915875|NCT01026961|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92915876|NCT01026961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92915877|NCT01026961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92162615|NCT01289067|Satraplatin|satraplatin|mesh-list
92915878|NCT01026961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92915879|NCT01026961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915880|NCT01026961|Protective Agents|protective agents|mesh-ancestor
92915881|NCT01026961|Antipruritics|antipruritics|mesh-ancestor
92915882|NCT01026961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92915883|NCT01026961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92915884|NCT01026961|Histamine Antagonists|histamine antagonists|mesh-ancestor
92915885|NCT01026961|Histamine Agents|histamine agents|mesh-ancestor
92915886|NCT01026961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92915887|NCT01566253|Acetaminophen|acetaminophen|mesh-list
92915888|NCT01566253|Ketoprofen|ketoprofen|mesh-list
92915889|NCT01566253|Morphine|morphine|mesh-list
92915890|NCT01566253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92915891|NCT01566253|Narcotics|narcotics|mesh-ancestor
92915892|NCT01566253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915893|NCT01566253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915894|NCT01566253|Analgesics|analgesics|mesh-ancestor
92915895|NCT01566253|Sensory System Agents|sensory system agents|mesh-ancestor
92915896|NCT01566253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915897|NCT01566253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92915898|NCT01566253|Antipyretics|antipyretics|mesh-ancestor
92915899|NCT01566253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92915900|NCT01566253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915901|NCT01566253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915902|NCT01566253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92915903|NCT01566253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915904|NCT01566253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915905|NCT03849313|Adalimumab|adalimumab|mesh-list
92915906|NCT03849313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92915907|NCT03849313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915908|NCT03849313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92915909|NCT04111614|Tofacitinib|tofacitinib|mesh-list
92915910|NCT04111614|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92915911|NCT04111614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92915912|NCT04111614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915913|NCT04111614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915914|NCT01023919|Sirolimus|sirolimus|mesh-list
92915915|NCT01023919|Paclitaxel|paclitaxel|mesh-list
92915916|NCT01023919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92915917|NCT01023919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915918|NCT01023919|Tubulin Modulators|tubulin modulators|mesh-ancestor
92915919|NCT01023919|Antimitotic Agents|antimitotic agents|mesh-ancestor
92915920|NCT01023919|Mitosis Modulators|mitosis modulators|mesh-ancestor
92915921|NCT01023919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915922|NCT01023919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92915923|NCT01023919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915924|NCT01023919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92915925|NCT01023919|Antifungal Agents|antifungal agents|mesh-ancestor
92915926|NCT01023919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92915927|NCT01023919|Immunologic Factors|immunologic factors|mesh-ancestor
92915928|NCT01023919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915929|NCT04028622|Anesthetics|anesthetics|mesh-list
92915930|NCT04028622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915931|NCT04028622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915932|NCT00830804|Ritonavir|ritonavir|mesh-list
92915933|NCT00830804|Darunavir|darunavir|mesh-list
92915934|NCT00830804|Raltegravir Potassium|raltegravir potassium|mesh-list
92915935|NCT00830804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92915936|NCT00830804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92915937|NCT00830804|Protease Inhibitors|protease inhibitors|mesh-ancestor
92915938|NCT00830804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915939|NCT00830804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915940|NCT00830804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92915941|NCT00830804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92915942|NCT00830804|Antiviral Agents|antiviral agents|mesh-ancestor
92915943|NCT00830804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92915944|NCT00830804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92915945|NCT00830804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92915946|NCT00830804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92915947|NCT00830804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92915948|NCT00789477|Aflibercept|aflibercept|mesh-list
92915949|NCT00789477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92915950|NCT00789477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92915951|NCT00789477|Growth Substances|growth substances|mesh-ancestor
92915952|NCT00789477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915953|NCT00789477|Growth Inhibitors|growth inhibitors|mesh-ancestor
92915954|NCT00789477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915955|NCT01024075|Dexamethasone|dexamethasone|mesh-list
92915956|NCT01024075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92915957|NCT01024075|Antiemetics|antiemetics|mesh-ancestor
92915958|NCT01024075|Autonomic Agents|autonomic agents|mesh-ancestor
92915959|NCT01024075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92915960|NCT01024075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915961|NCT01024075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92915962|NCT01024075|Glucocorticoids|glucocorticoids|mesh-ancestor
92915963|NCT01024075|Hormones|hormones|mesh-ancestor
92915964|NCT01024075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92915965|NCT01024075|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92915966|NCT01024075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915967|NCT05756348|Protective Agents|protective agents|mesh-list
92915968|NCT05756348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915969|NCT00913874|Valproic Acid|valproic acid|mesh-list
92915970|NCT00913874|Anticonvulsants|anticonvulsants|mesh-ancestor
92915971|NCT00913874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915972|NCT00913874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915973|NCT00913874|GABA Agents|gaba agents|mesh-ancestor
92915974|NCT00913874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915975|NCT00913874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915976|NCT00913874|Antimanic Agents|antimanic agents|mesh-ancestor
92915977|NCT00913874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92915978|NCT00913874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92915979|NCT00913874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92915980|NCT00796614|Tamsulosin|tamsulosin|mesh-list
92915981|NCT00796614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92915982|NCT00796614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92915983|NCT00796614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92915984|NCT00796614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92915985|NCT00796614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92915986|NCT00796614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915987|NCT00796614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92915988|NCT00796614|Urological Agents|urological agents|mesh-ancestor
92915989|NCT02603445|Idelalisib|idelalisib|mesh-list
92915990|NCT02603445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92915991|NCT02603445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92915992|NCT02603445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92915993|NCT02603679|Tamoxifen|tamoxifen|mesh-list
92915994|NCT02603679|Paclitaxel|paclitaxel|mesh-list
92915995|NCT02603679|Letrozole|letrozole|mesh-list
92915996|NCT02603679|Palbociclib|palbociclib|mesh-list
92915997|NCT02603679|Anastrozole|anastrozole|mesh-list
92915998|NCT02603679|Exemestane|exemestane|mesh-list
92915999|NCT02603679|Goserelin|goserelin|mesh-list
92916000|NCT02603679|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92916001|NCT02603679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92916002|NCT02603679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916003|NCT02603679|Tubulin Modulators|tubulin modulators|mesh-ancestor
92916004|NCT02603679|Antimitotic Agents|antimitotic agents|mesh-ancestor
92916005|NCT02603679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92916006|NCT02603679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916007|NCT02603679|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92916008|NCT02603679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916009|NCT02603679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92916010|NCT02603679|Hormone Antagonists|hormone antagonists|mesh-ancestor
92916011|NCT02603679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916012|NCT02603679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916013|NCT02603679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92916014|NCT02603679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92916015|NCT02603679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92561463|NCT00148330|Triamcinolone|triamcinolone|mesh-list
92916016|NCT02603679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92916017|NCT02603679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92916018|NCT03995485|Sofosbuvir|sofosbuvir|mesh-list
92916019|NCT03995485|Antiviral Agents|antiviral agents|mesh-ancestor
92916020|NCT03995485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916021|NCT02605434|Levodopa|levodopa|mesh-list
92916022|NCT02605434|Carbidopa|carbidopa|mesh-list
92916023|NCT02605434|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92916024|NCT02605434|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92916025|NCT02605434|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92916026|NCT02605434|Dopamine Agents|dopamine agents|mesh-ancestor
92916027|NCT02605434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916028|NCT02605434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916029|NCT02605434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916030|NCT02605434|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92916031|NCT02605434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916032|NCT02605434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92916033|NCT02605434|Immunologic Factors|immunologic factors|mesh-ancestor
92916034|NCT02605434|Dopamine Agonists|dopamine agonists|mesh-ancestor
92916035|NCT00863681|Riociguat|riociguat|mesh-list
92916036|NCT00863681|Enzyme Activators|enzyme activators|mesh-ancestor
92916037|NCT00863681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916038|NCT05758298|Nicotine|nicotine|mesh-list
92916039|NCT05758298|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92916040|NCT05758298|Autonomic Agents|autonomic agents|mesh-ancestor
92916041|NCT05758298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916042|NCT05758298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916043|NCT05758298|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92916044|NCT05758298|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92916045|NCT05758298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92916046|NCT05758298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916047|NCT05758298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916048|NCT00789321|Amlodipine|amlodipine|mesh-list
92916049|NCT00789321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92916050|NCT00789321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92916051|NCT00789321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916052|NCT00789321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916053|NCT00789321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92916054|NCT00789321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916055|NCT00789321|Vasodilator Agents|vasodilator agents|mesh-ancestor
92916056|NCT00811928|Fluconazole|fluconazole|mesh-list
92916057|NCT00811928|Posaconazole|posaconazole|mesh-list
92916058|NCT00811928|Antifungal Agents|antifungal agents|mesh-ancestor
92916059|NCT00811928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916060|NCT00811928|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92916061|NCT00811928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92916062|NCT00811928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916063|NCT00811928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916064|NCT00811928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92916065|NCT00811928|Hormone Antagonists|hormone antagonists|mesh-ancestor
92916066|NCT00811928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916067|NCT00811928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916068|NCT00811928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92916069|NCT00811928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92916070|NCT00811928|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92916071|NCT00811928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92916072|NCT00811928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92916073|NCT00448669|Tenofovir|tenofovir|mesh-list
92916074|NCT00448669|Emtricitabine|emtricitabine|mesh-list
92916075|NCT00448669|Antiviral Agents|antiviral agents|mesh-ancestor
92916076|NCT00448669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916077|NCT00448669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92916078|NCT00448669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92916079|NCT00448669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916080|NCT00448669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916081|NCT00448669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92916082|NCT00448669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92916083|NCT00591734|Bevacizumab|bevacizumab|mesh-list
92916084|NCT00591734|Everolimus|everolimus|mesh-list
92916085|NCT00591734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916086|NCT00591734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916087|NCT00591734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92916088|NCT00591734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92916089|NCT00591734|Growth Substances|growth substances|mesh-ancestor
92916090|NCT00591734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916091|NCT00591734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92561534|NCT00148564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916092|NCT00591734|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92916093|NCT00591734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92916094|NCT00591734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916095|NCT00591734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916096|NCT00591734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916097|NCT00591734|Immunologic Factors|immunologic factors|mesh-ancestor
92916098|NCT00848549|Carbamazepine|carbamazepine|mesh-list
92916099|NCT00848549|Zonisamide|zonisamide|mesh-list
92916100|NCT00848549|Anticonvulsants|anticonvulsants|mesh-ancestor
92916101|NCT00848549|Antimanic Agents|antimanic agents|mesh-ancestor
92916102|NCT00848549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92916103|NCT00848549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916104|NCT00848549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916105|NCT00848549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92916106|NCT00848549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916107|NCT00848549|Analgesics|analgesics|mesh-ancestor
92916108|NCT00848549|Sensory System Agents|sensory system agents|mesh-ancestor
92916109|NCT00848549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916110|NCT00848549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92916111|NCT00848549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916112|NCT00848549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916113|NCT00848549|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92916114|NCT00848549|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92916115|NCT00848549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92916116|NCT00848549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92916117|NCT00788151|Vaccines|vaccines|mesh-list
92916118|NCT00788151|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92916119|NCT00788151|Immunologic Factors|immunologic factors|mesh-ancestor
92916120|NCT00788151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916121|NCT04116359|Cisplatin|cisplatin|mesh-list
92916122|NCT04116359|Etoposide|etoposide|mesh-list
92916123|NCT04116359|Etoposide phosphate|etoposide phosphate|mesh-list
92916124|NCT04116359|Podophyllotoxin|podophyllotoxin|mesh-list
92916125|NCT04116359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916126|NCT04116359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92916127|NCT04116359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92916128|NCT04116359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92916129|NCT04116359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916130|NCT04116359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916131|NCT04116359|Keratolytic Agents|keratolytic agents|mesh-ancestor
92916132|NCT04116359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916133|NCT04116359|Tubulin Modulators|tubulin modulators|mesh-ancestor
92916134|NCT04116359|Antimitotic Agents|antimitotic agents|mesh-ancestor
92916135|NCT04116359|Mitosis Modulators|mitosis modulators|mesh-ancestor
92916136|NCT04118153|Abatacept|abatacept|mesh-list
92916137|NCT04118153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92916138|NCT04118153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916139|NCT04118153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916140|NCT04118153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916141|NCT04118153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916142|NCT04118153|Immunologic Factors|immunologic factors|mesh-ancestor
92916143|NCT04118153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916144|NCT04118153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916145|NCT00848393|Fentanyl|fentanyl|mesh-list
92916146|NCT00848393|Dexmedetomidine|dexmedetomidine|mesh-list
92916147|NCT00848393|Citric Acid|citric acid|mesh-list
92916148|NCT00848393|Sodium Citrate|sodium citrate|mesh-list
92916149|NCT00848393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92916150|NCT00848393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916151|NCT00848393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916152|NCT00848393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916153|NCT00848393|Analgesics|analgesics|mesh-ancestor
92916154|NCT00848393|Sensory System Agents|sensory system agents|mesh-ancestor
92916155|NCT00848393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916156|NCT00848393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92916157|NCT00848393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92916158|NCT00848393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92916159|NCT00848393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92916160|NCT00848393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916161|NCT00848393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916162|NCT00848393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92916163|NCT00848393|Narcotics|narcotics|mesh-ancestor
92916164|NCT00848393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92916165|NCT00848393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92916166|NCT00848393|Anesthetics, General|anesthetics, general|mesh-ancestor
92916167|NCT00848393|Anesthetics|anesthetics|mesh-ancestor
92916168|NCT00848393|Anticoagulants|anticoagulants|mesh-ancestor
92916169|NCT00848393|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92916170|NCT00848393|Chelating Agents|chelating agents|mesh-ancestor
92916171|NCT00848393|Sequestering Agents|sequestering agents|mesh-ancestor
92916172|NCT00815516|Amphotericin B|amphotericin b|mesh-list
92916173|NCT00815516|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92916174|NCT00815516|Micafungin|micafungin|mesh-list
92916175|NCT00815516|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92916176|NCT00815516|Deoxycholic Acid|deoxycholic acid|mesh-list
92916177|NCT00815516|Amebicides|amebicides|mesh-ancestor
92916178|NCT00815516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92916179|NCT00815516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92916180|NCT00815516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916181|NCT00815516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92916182|NCT00815516|Antifungal Agents|antifungal agents|mesh-ancestor
92916183|NCT00815516|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92916184|NCT00815516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92916185|NCT00705926|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92916186|NCT00705926|Antiviral Agents|antiviral agents|mesh-ancestor
92916187|NCT00705926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916188|NCT00787917|Omalizumab|omalizumab|mesh-list
92916189|NCT00787917|Itraconazole|itraconazole|mesh-list
92916190|NCT00787917|Antifungal Agents|antifungal agents|mesh-ancestor
92916191|NCT00787917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916192|NCT00787917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92916193|NCT00787917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92916194|NCT00787917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916195|NCT00787917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916196|NCT00787917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92916197|NCT00787917|Hormone Antagonists|hormone antagonists|mesh-ancestor
92916198|NCT00787917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916199|NCT00787917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916200|NCT00787917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92916201|NCT00787917|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92916202|NCT00787917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92526185|NCT00012051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92916203|NCT00787917|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916204|NCT05758064|Dydrogesterone|dydrogesterone|mesh-list
92916205|NCT05758064|Progestins|progestins|mesh-ancestor
92916206|NCT05758064|Hormones|hormones|mesh-ancestor
92916207|NCT05758064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916208|NCT05758064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916209|NCT00829244|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92916210|NCT00829244|Hormones|hormones|mesh-ancestor
92916211|NCT00829244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916212|NCT00829244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916213|NCT00787605|Amlodipine|amlodipine|mesh-list
92916214|NCT00787605|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92916215|NCT00787605|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92916216|NCT00787605|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92916217|NCT00787605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916218|NCT00787605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916219|NCT00787605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92916220|NCT00787605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916221|NCT00787605|Vasodilator Agents|vasodilator agents|mesh-ancestor
92916222|NCT00787605|Diuretics|diuretics|mesh-ancestor
92916223|NCT00787605|Natriuretic Agents|natriuretic agents|mesh-ancestor
92916224|NCT00787605|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92916225|NCT00448591|Bevacizumab|bevacizumab|mesh-list
92916226|NCT00448591|Taxane|taxane|mesh-list
92916227|NCT00448591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916228|NCT00448591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916229|NCT00448591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92916230|NCT00448591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92916231|NCT00448591|Growth Substances|growth substances|mesh-ancestor
92916232|NCT00448591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916233|NCT00448591|Growth Inhibitors|growth inhibitors|mesh-ancestor
92916234|NCT00787527|Prednisone|prednisone|mesh-list
92916235|NCT00787527|Cyclophosphamide|cyclophosphamide|mesh-list
92916236|NCT00787527|Doxorubicin|doxorubicin|mesh-list
92916237|NCT00787527|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92916238|NCT00787527|Vincristine|vincristine|mesh-list
92916239|NCT00787527|Vorinostat|vorinostat|mesh-list
92916240|NCT00787527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916241|NCT00787527|Immunologic Factors|immunologic factors|mesh-ancestor
92916242|NCT00787527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916243|NCT00787527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916244|NCT00787527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92916245|NCT00787527|Alkylating Agents|alkylating agents|mesh-ancestor
92916246|NCT00787527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916247|NCT00787527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916248|NCT00787527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92916249|NCT00787527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92916250|NCT00787527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92916251|NCT00787527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92916252|NCT00787527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916253|NCT00787527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916254|NCT00787527|Glucocorticoids|glucocorticoids|mesh-ancestor
92916255|NCT00787527|Hormones|hormones|mesh-ancestor
92916256|NCT00787527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916257|NCT00787527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92916258|NCT00787527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92916259|NCT00787527|Tubulin Modulators|tubulin modulators|mesh-ancestor
92916260|NCT00787527|Antimitotic Agents|antimitotic agents|mesh-ancestor
92916261|NCT00787527|Mitosis Modulators|mitosis modulators|mesh-ancestor
92916262|NCT00787527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92916263|NCT00804388|Vitamin E|vitamin e|mesh-list
92916264|NCT00804388|Vitamins|vitamins|mesh-ancestor
92916265|NCT00804388|Micronutrients|micronutrients|mesh-ancestor
92916266|NCT00804388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916267|NCT00804388|Antioxidants|antioxidants|mesh-ancestor
92916268|NCT00804388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916269|NCT00804388|Protective Agents|protective agents|mesh-ancestor
92916270|NCT00806962|Vaccines|vaccines|mesh-list
92916271|NCT00806962|Immunologic Factors|immunologic factors|mesh-ancestor
92916272|NCT00806962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916273|NCT02553226|Oxytocin|oxytocin|mesh-list
92916274|NCT02553226|Oxytocics|oxytocics|mesh-ancestor
92916275|NCT02553226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92916276|NCT02553226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916277|NCT00810316|Clonazepam|clonazepam|mesh-list
92916278|NCT00810316|Alprazolam|alprazolam|mesh-list
92916279|NCT00810316|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92916280|NCT00810316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916281|NCT00810316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916282|NCT00810316|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92916283|NCT00810316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92916284|NCT00810316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92916285|NCT00810316|GABA Modulators|gaba modulators|mesh-ancestor
92916286|NCT00810316|GABA Agents|gaba agents|mesh-ancestor
92916287|NCT00810316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916288|NCT00810316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916289|NCT00810316|Anticonvulsants|anticonvulsants|mesh-ancestor
92916290|NCT00448435|Fluticasone|fluticasone|mesh-list
92916291|NCT00448435|Xhance|xhance|mesh-list
92916292|NCT00448435|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92916293|NCT00448435|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92916294|NCT00448435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916295|NCT00448435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92916296|NCT00448435|Autonomic Agents|autonomic agents|mesh-ancestor
92916297|NCT00448435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916298|NCT00448435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916299|NCT00448435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92916300|NCT00448435|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916301|NCT00448435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916302|NCT00448435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92916303|NCT00448435|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92916304|NCT00448435|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92162637|NCT03954899|Melatonin|melatonin|mesh-list
92916305|NCT00448435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92916306|NCT00448435|Adrenergic Agents|adrenergic agents|mesh-ancestor
92916307|NCT00448435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916308|NCT00448435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916309|NCT00448435|Glucocorticoids|glucocorticoids|mesh-ancestor
92916310|NCT00448435|Hormones|hormones|mesh-ancestor
92916311|NCT00448435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916312|NCT00448435|Sympathomimetics|sympathomimetics|mesh-ancestor
92916313|NCT00804622|Tenofovir|tenofovir|mesh-list
92916314|NCT00804622|Telbivudine|telbivudine|mesh-list
92916315|NCT00804622|Antiviral Agents|antiviral agents|mesh-ancestor
92916316|NCT00804622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916317|NCT00804622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92916318|NCT00804622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92916319|NCT00804622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916320|NCT00804622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916321|NCT00804622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92916322|NCT00804622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92916323|NCT02603055|Vaccines|vaccines|mesh-list
92916324|NCT02603055|Immunologic Factors|immunologic factors|mesh-ancestor
92916325|NCT02603055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916326|NCT02602743|Ketamine|ketamine|mesh-list
92916327|NCT02602743|Remifentanil|remifentanil|mesh-list
92916328|NCT02602743|Propofol|propofol|mesh-list
92916329|NCT02602743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92916330|NCT02602743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916331|NCT02602743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916332|NCT02602743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92916333|NCT02602743|Anesthetics, General|anesthetics, general|mesh-ancestor
92916334|NCT02602743|Anesthetics|anesthetics|mesh-ancestor
92916335|NCT02602743|Analgesics|analgesics|mesh-ancestor
92916336|NCT02602743|Sensory System Agents|sensory system agents|mesh-ancestor
92916337|NCT02602743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916338|NCT02602743|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92916339|NCT02602743|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92916340|NCT02602743|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92916341|NCT02602743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916342|NCT02602743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916343|NCT02602743|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92916344|NCT02602743|Narcotics|narcotics|mesh-ancestor
92916345|NCT00807118|Fesoterodine|fesoterodine|mesh-list
92916346|NCT00807118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92916347|NCT00807118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92916348|NCT00807118|Cholinergic Agents|cholinergic agents|mesh-ancestor
92916349|NCT00807118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916350|NCT00807118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916351|NCT00807118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916352|NCT00807118|Urological Agents|urological agents|mesh-ancestor
92916353|NCT00448279|Trastuzumab|trastuzumab|mesh-list
92916354|NCT00448279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916355|NCT00448279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916356|NCT00804856|Cytarabine|cytarabine|mesh-list
92916357|NCT00804856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92916358|NCT00804856|Antimetabolites|antimetabolites|mesh-ancestor
92916359|NCT00804856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916360|NCT00804856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916361|NCT00804856|Antiviral Agents|antiviral agents|mesh-ancestor
92916362|NCT00804856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916363|NCT00804856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916364|NCT00804856|Immunologic Factors|immunologic factors|mesh-ancestor
92916365|NCT00804856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916366|NCT00810706|Exemestane|exemestane|mesh-list
92916367|NCT00810706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916368|NCT00810706|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92916369|NCT00810706|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92916370|NCT00810706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916371|NCT00810706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916372|NCT00810706|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92916373|NCT00810706|Hormone Antagonists|hormone antagonists|mesh-ancestor
92916374|NCT00810706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916375|NCT00810706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916376|NCT00807196|Cyclophosphamide|cyclophosphamide|mesh-list
92916377|NCT00807196|Rituximab|rituximab|mesh-list
92916378|NCT00807196|Fludarabine|fludarabine|mesh-list
92916379|NCT00807196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916380|NCT00807196|Immunologic Factors|immunologic factors|mesh-ancestor
92916381|NCT00807196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916382|NCT00807196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916383|NCT00807196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92916384|NCT00807196|Alkylating Agents|alkylating agents|mesh-ancestor
92916385|NCT00807196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916386|NCT00807196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916387|NCT00807196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92916388|NCT00807196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916389|NCT00448123|Tamsulosin|tamsulosin|mesh-list
92916390|NCT00448123|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92916391|NCT00448123|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92916392|NCT00448123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92561831|NCT00082251|Niacin|niacin|mesh-list
92916393|NCT00448123|Adrenergic Agents|adrenergic agents|mesh-ancestor
92916394|NCT00448123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916395|NCT00448123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916396|NCT00448123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916397|NCT00448123|Urological Agents|urological agents|mesh-ancestor
92916398|NCT00804934|Ranibizumab|ranibizumab|mesh-list
92916399|NCT00804934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92916400|NCT00804934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92916401|NCT00804934|Growth Substances|growth substances|mesh-ancestor
92916402|NCT00804934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916403|NCT00804934|Growth Inhibitors|growth inhibitors|mesh-ancestor
92916404|NCT00804934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916405|NCT00805012|Docetaxel|docetaxel|mesh-list
92916406|NCT00805012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916407|NCT00805012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92916408|NCT00805012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92916409|NCT00805012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92916410|NCT00805012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916411|NCT00447499|Lanreotide|lanreotide|mesh-list
92916412|NCT00447499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916413|NCT00805090|Itraconazole|itraconazole|mesh-list
92916414|NCT00805090|Diclofenac|diclofenac|mesh-list
92916415|NCT00805090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92916416|NCT00805090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916417|NCT00805090|Analgesics|analgesics|mesh-ancestor
92916418|NCT00805090|Sensory System Agents|sensory system agents|mesh-ancestor
92916419|NCT00805090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916420|NCT00805090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916421|NCT00805090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916422|NCT00805090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916423|NCT00805090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92916424|NCT00805090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916425|NCT00805090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916426|NCT00805090|Antifungal Agents|antifungal agents|mesh-ancestor
92916427|NCT00805090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916428|NCT00805090|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92916429|NCT00805090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92916430|NCT00805090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92916431|NCT00805090|Hormone Antagonists|hormone antagonists|mesh-ancestor
92916432|NCT00805090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916433|NCT00805090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92916434|NCT00810862|Pimecrolimus|pimecrolimus|mesh-list
92916436|NCT00810862|Cathartics|cathartics|mesh-ancestor
92916437|NCT00810862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92916438|NCT00810862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92916439|NCT00810862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916440|NCT00810862|Analgesics|analgesics|mesh-ancestor
92916441|NCT00810862|Sensory System Agents|sensory system agents|mesh-ancestor
92916442|NCT00810862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916443|NCT00810862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916444|NCT00810862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916445|NCT00810862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916446|NCT00810862|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916447|NCT00810862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916448|NCT00810862|Immunologic Factors|immunologic factors|mesh-ancestor
92916449|NCT00810862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92916450|NCT00810862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916451|NCT00810862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916452|NCT00800436|Trastuzumab|trastuzumab|mesh-list
92916453|NCT00800436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916454|NCT00800436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916455|NCT00810940|Mannitol|mannitol|mesh-list
92916456|NCT00810940|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92916457|NCT00810940|Diuretics|diuretics|mesh-ancestor
92916458|NCT00810940|Natriuretic Agents|natriuretic agents|mesh-ancestor
92916459|NCT00810940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916460|NCT00655564|Alefacept|alefacept|mesh-list
92916461|NCT00655564|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916462|NCT00655564|Immunologic Factors|immunologic factors|mesh-ancestor
92916463|NCT00655564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916464|NCT00447421|Pemetrexed|pemetrexed|mesh-list
92916465|NCT00447421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916466|NCT00447421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916467|NCT00447421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916468|NCT00447421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92916469|NCT00447421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92916470|NCT00651118|Fluticasone|fluticasone|mesh-list
92916472|NCT00651118|Azelastine|azelastine|mesh-list
92916473|NCT00651118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916474|NCT00651118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92916475|NCT00651118|Autonomic Agents|autonomic agents|mesh-ancestor
92916476|NCT00651118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916477|NCT00651118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916478|NCT00651118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92916479|NCT00651118|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916480|NCT00651118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916481|NCT00651118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92916482|NCT00651118|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92916483|NCT00651118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916484|NCT00651118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916485|NCT00651118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92916486|NCT00651118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92916487|NCT00651118|Histamine Antagonists|histamine antagonists|mesh-ancestor
92916488|NCT00651118|Histamine Agents|histamine agents|mesh-ancestor
92916489|NCT00651118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916490|NCT00447265|Etanercept|etanercept|mesh-list
92916491|NCT00447265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92916492|NCT00447265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916493|NCT00447265|Analgesics|analgesics|mesh-ancestor
92916494|NCT00447265|Sensory System Agents|sensory system agents|mesh-ancestor
92916495|NCT00447265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916496|NCT00447265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916497|NCT00447265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916499|NCT00447265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92916500|NCT00447265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916501|NCT00447265|Immunologic Factors|immunologic factors|mesh-ancestor
92916502|NCT03641755|Olaparib|olaparib|mesh-list
92916503|NCT03641755|Sapacitabine|sapacitabine|mesh-list
92916504|NCT03641755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92916505|NCT03641755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916506|NCT03641755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916507|NCT03641755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916508|NCT00657358|Lidocaine|lidocaine|mesh-list
92916509|NCT00657358|Anesthetics, Local|anesthetics, local|mesh-ancestor
92916510|NCT00657358|Anesthetics|anesthetics|mesh-ancestor
92916511|NCT00657358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916512|NCT00657358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916513|NCT00657358|Sensory System Agents|sensory system agents|mesh-ancestor
92916514|NCT00657358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916515|NCT00657358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92916516|NCT00657358|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92916517|NCT00657358|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92916518|NCT00657358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916519|NCT00657358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916520|NCT00457639|Cholic Acids|cholic acids|mesh-list
92916521|NCT00457639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92916522|NCT00800202|Paclitaxel|paclitaxel|mesh-list
92916523|NCT00800202|Bevacizumab|bevacizumab|mesh-list
92916524|NCT00800202|Carboplatin|carboplatin|mesh-list
92916525|NCT00800202|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92916526|NCT00800202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92916527|NCT00800202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916528|NCT00800202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92916529|NCT00800202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92916530|NCT00800202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92916531|NCT00800202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916532|NCT00800202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916533|NCT00800202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92916534|NCT00800202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92916535|NCT00800202|Growth Substances|growth substances|mesh-ancestor
92916536|NCT00800202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916537|NCT00800202|Growth Inhibitors|growth inhibitors|mesh-ancestor
92916538|NCT00800202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92916539|NCT00800202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916540|NCT00811096|Chloroquine|chloroquine|mesh-list
92916541|NCT00811096|Tinidazole|tinidazole|mesh-list
92916542|NCT00811096|Amebicides|amebicides|mesh-ancestor
92916543|NCT00811096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92916544|NCT00811096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92916545|NCT00811096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916546|NCT00811096|Antimalarials|antimalarials|mesh-ancestor
92916547|NCT00811096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916548|NCT00811096|Alkylating Agents|alkylating agents|mesh-ancestor
92916549|NCT00811096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916550|NCT00811096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92916551|NCT00811096|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92916553|NCT05146804|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92916554|NCT05146804|Protective Agents|protective agents|mesh-ancestor
92916555|NCT05146804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916556|NCT05146804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916557|NCT00655486|Lacosamide|lacosamide|mesh-list
92916558|NCT00655486|Anticonvulsants|anticonvulsants|mesh-ancestor
92916559|NCT00655486|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92916560|NCT00655486|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92916561|NCT00655486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916562|NCT00655486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916563|NCT04111302|Dezocine|dezocine|mesh-list
92916564|NCT04111302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92916565|NCT04111302|Narcotics|narcotics|mesh-ancestor
92916566|NCT04111302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916567|NCT04111302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916568|NCT04111302|Analgesics|analgesics|mesh-ancestor
92916569|NCT04111302|Sensory System Agents|sensory system agents|mesh-ancestor
92916570|NCT04111302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916571|NCT04111848|Ketamine|ketamine|mesh-list
92916572|NCT04111848|Analgesics|analgesics|mesh-ancestor
92916573|NCT04111848|Sensory System Agents|sensory system agents|mesh-ancestor
92916574|NCT04111848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916575|NCT04111848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916576|NCT04111848|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92916577|NCT04111848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92916578|NCT04111848|Anesthetics, General|anesthetics, general|mesh-ancestor
92916579|NCT04111848|Anesthetics|anesthetics|mesh-ancestor
92916580|NCT04111848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916581|NCT04111848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92916582|NCT04111848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92916583|NCT04111848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916584|NCT04111848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916585|NCT00457015|Ecallantide|ecallantide|mesh-list
92916586|NCT00457015|Analgesics|analgesics|mesh-ancestor
92916587|NCT00457015|Sensory System Agents|sensory system agents|mesh-ancestor
92916588|NCT00457015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916589|NCT00457015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916590|NCT00457015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92916591|NCT00457015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916592|NCT00457015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916593|NCT00457015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916594|NCT00654940|Pregabalin|pregabalin|mesh-list
92916595|NCT00654940|Analgesics|analgesics|mesh-ancestor
92916596|NCT00654940|Sensory System Agents|sensory system agents|mesh-ancestor
92916597|NCT00654940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916598|NCT00654940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916599|NCT00654940|Anticonvulsants|anticonvulsants|mesh-ancestor
92916600|NCT00654940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92916601|NCT00654940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916602|NCT00654940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916603|NCT00654940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92916604|NCT00654940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92916605|NCT00654940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92916606|NCT00654940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916607|NCT00654940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92916608|NCT00588666|Bevacizumab|bevacizumab|mesh-list
92916609|NCT00588666|Carboplatin|carboplatin|mesh-list
92916610|NCT00588666|Gemcitabine|gemcitabine|mesh-list
92916611|NCT00588666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916612|NCT00588666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916613|NCT00588666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92916614|NCT00588666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92916615|NCT00588666|Growth Substances|growth substances|mesh-ancestor
92562053|NCT00151138|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92916616|NCT00588666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916617|NCT00588666|Growth Inhibitors|growth inhibitors|mesh-ancestor
92916618|NCT00588666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92916619|NCT00588666|Antimetabolites|antimetabolites|mesh-ancestor
92916620|NCT00588666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916621|NCT00805558|Moxifloxacin|moxifloxacin|mesh-list
92916622|NCT00805558|Metronidazole|metronidazole|mesh-list
92916623|NCT00805558|Ciprofloxacin|ciprofloxacin|mesh-list
92916624|NCT00805558|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92916625|NCT00805558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92916626|NCT00805558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916627|NCT00805558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92916628|NCT00805558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92916629|NCT00805558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916630|NCT00805558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916631|NCT00805558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916632|NCT00805558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92916633|NCT00805558|Contraceptive Agents|contraceptive agents|mesh-ancestor
92916634|NCT00805558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92916635|NCT00805558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916636|NCT00805558|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92916637|NCT00805558|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92916638|NCT00805558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92916639|NCT00805558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92916640|NCT00805558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92916641|NCT00805558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92916642|NCT00805558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92916643|NCT01019785|Ergocalciferols|ergocalciferols|mesh-list
92916644|NCT01019785|Vitamin D|vitamin d|mesh-list
92977267|NCT01070641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92916645|NCT01019785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92916646|NCT01019785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916647|NCT01019785|Vitamins|vitamins|mesh-ancestor
92916648|NCT01019785|Micronutrients|micronutrients|mesh-ancestor
92916649|NCT01019785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92916650|NCT02604186|Botulinum Toxins|botulinum toxins|mesh-list
92916651|NCT02604186|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92916652|NCT02604186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916653|NCT02604186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916654|NCT02604186|Cholinergic Agents|cholinergic agents|mesh-ancestor
92916655|NCT02604186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916656|NCT02604186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916657|NCT01024543|Phenylephrine|phenylephrine|mesh-list
92916658|NCT01024543|Oxymetazoline|oxymetazoline|mesh-list
92916659|NCT01024543|Angiotensin II|angiotensin ii|mesh-list
92916660|NCT01024543|Giapreza|giapreza|mesh-list
92916661|NCT01024543|Angiotensinogen|angiotensinogen|mesh-list
92916662|NCT01024543|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92916663|NCT01024543|Mydriatics|mydriatics|mesh-ancestor
92916664|NCT01024543|Autonomic Agents|autonomic agents|mesh-ancestor
92916665|NCT01024543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916666|NCT01024543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916667|NCT01024543|Sympathomimetics|sympathomimetics|mesh-ancestor
92916668|NCT01024543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92916669|NCT01024543|Nasal Decongestants|nasal decongestants|mesh-ancestor
92916670|NCT01024543|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916671|NCT01024543|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92916672|NCT01024543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92916673|NCT01024543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92916674|NCT01024543|Adrenergic Agents|adrenergic agents|mesh-ancestor
92916675|NCT01024543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916676|NCT01024543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916677|NCT01024543|Protective Agents|protective agents|mesh-ancestor
92916678|NCT01024543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92916679|NCT01024543|Protease Inhibitors|protease inhibitors|mesh-ancestor
92916680|NCT01024543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916681|NCT00811330|Atorvastatin|atorvastatin|mesh-list
92916682|NCT00811330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92916683|NCT00811330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92916684|NCT00811330|Antimetabolites|antimetabolites|mesh-ancestor
92916685|NCT00811330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916686|NCT00811330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92916687|NCT00811330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92916688|NCT00811330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916689|NCT00811408|Cidofovir|cidofovir|mesh-list
92916690|NCT00811408|Carboplatin|carboplatin|mesh-list
92916691|NCT00811408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916692|NCT00811408|Antiviral Agents|antiviral agents|mesh-ancestor
92916693|NCT00811408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916694|NCT00811408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916695|NCT00811408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916696|NCT00446797|Celecoxib|celecoxib|mesh-list
92916697|NCT00446797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92916698|NCT00446797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916699|NCT00446797|Analgesics|analgesics|mesh-ancestor
92916700|NCT00446797|Sensory System Agents|sensory system agents|mesh-ancestor
92916701|NCT00446797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916702|NCT00446797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916703|NCT00446797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916704|NCT00446797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916705|NCT00446797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92916706|NCT00446797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92916707|NCT00446797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916708|NCT00446797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916709|NCT00855335|Ritonavir|ritonavir|mesh-list
92916710|NCT00855335|Darunavir|darunavir|mesh-list
92916711|NCT00855335|Cobicistat|cobicistat|mesh-list
92916712|NCT00855335|Rilpivirine|rilpivirine|mesh-list
92916713|NCT00855335|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92916714|NCT00855335|Etravirine|etravirine|mesh-list
92916715|NCT00855335|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92916716|NCT00855335|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92916717|NCT00855335|Protease Inhibitors|protease inhibitors|mesh-ancestor
92916718|NCT00855335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916719|NCT00855335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916720|NCT00855335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92916721|NCT00855335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92916722|NCT00855335|Antiviral Agents|antiviral agents|mesh-ancestor
92916723|NCT00855335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916724|NCT00855335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92916725|NCT00855335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92916726|NCT00855335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92916727|NCT00855335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92916728|NCT00811486|Spironolactone|spironolactone|mesh-list
92916729|NCT00811486|Conivaptan|conivaptan|mesh-list
92916730|NCT00811486|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92916731|NCT00811486|Hormone Antagonists|hormone antagonists|mesh-ancestor
92916732|NCT00811486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916733|NCT00811486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916734|NCT00811486|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92916735|NCT00811486|Diuretics|diuretics|mesh-ancestor
92916736|NCT00811486|Natriuretic Agents|natriuretic agents|mesh-ancestor
92916737|NCT00811486|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92916738|NCT00811486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916739|NCT04114188|Prednisolone|prednisolone|mesh-list
92916740|NCT04114188|Infliximab|infliximab|mesh-list
92916741|NCT04114188|Tacrolimus|tacrolimus|mesh-list
92916742|NCT04114188|Thymoglobulin|thymoglobulin|mesh-list
92916743|NCT04114188|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92916744|NCT04114188|Immunoglobulins|immunoglobulins|mesh-list
92916745|NCT04114188|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92916746|NCT04114188|Antibodies|antibodies|mesh-list
92916747|NCT04114188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916748|NCT04114188|Immunologic Factors|immunologic factors|mesh-ancestor
92916749|NCT04114188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916750|NCT04114188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92916751|NCT04114188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916752|NCT04114188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916753|NCT04114188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916754|NCT04114188|Glucocorticoids|glucocorticoids|mesh-ancestor
92916755|NCT04114188|Hormones|hormones|mesh-ancestor
92916756|NCT04114188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916757|NCT04114188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92916758|NCT04114188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916759|NCT04114188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92916760|NCT04114188|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92916761|NCT04114188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916762|NCT04114188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916763|NCT00811876|Leuprolide|leuprolide|mesh-list
92916764|NCT00811876|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92916765|NCT00811876|Fertility Agents|fertility agents|mesh-ancestor
92916766|NCT00811876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92916767|NCT00811876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916768|NCT00811876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92916769|NCT00811876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916770|NCT00915252|Cytarabine|cytarabine|mesh-list
92916771|NCT00915252|Azacitidine|azacitidine|mesh-list
92916772|NCT00915252|Daunorubicin|daunorubicin|mesh-list
92916773|NCT00915252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92916774|NCT00915252|Antimetabolites|antimetabolites|mesh-ancestor
92916775|NCT00915252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916776|NCT00915252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916777|NCT00915252|Antiviral Agents|antiviral agents|mesh-ancestor
92916778|NCT00915252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916779|NCT00915252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916780|NCT00915252|Immunologic Factors|immunologic factors|mesh-ancestor
92916781|NCT00915252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916782|NCT00915252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916783|NCT00915252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92916784|NCT00915252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92916785|NCT00915252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92916786|NCT00593489|Insulin|insulin|mesh-list
92916787|NCT00593489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92916788|NCT00593489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916789|NCT00446641|Cilostazol|cilostazol|mesh-list
92916790|NCT00446641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92916791|NCT00446641|Autonomic Agents|autonomic agents|mesh-ancestor
92916792|NCT00446641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916793|NCT00446641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916794|NCT00446641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92916795|NCT00446641|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916797|NCT00446641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92916798|NCT00446641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916799|NCT00446641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92916800|NCT00446641|Vasodilator Agents|vasodilator agents|mesh-ancestor
92916801|NCT00446641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92916802|NCT00446641|Protective Agents|protective agents|mesh-ancestor
92916803|NCT00446641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92916804|NCT00446641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92916805|NCT00446641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916806|NCT00646282|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92916807|NCT00646282|Vitamins|vitamins|mesh-ancestor
92916808|NCT00646282|Micronutrients|micronutrients|mesh-ancestor
92916809|NCT00646282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916810|NCT00646282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92916811|NCT00792636|Naproxen|naproxen|mesh-list
92916812|NCT00792636|Sumatriptan|sumatriptan|mesh-list
92916813|NCT00792636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92916814|NCT00792636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92916815|NCT00792636|Analgesics|analgesics|mesh-ancestor
92916816|NCT00792636|Sensory System Agents|sensory system agents|mesh-ancestor
92916817|NCT00792636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916818|NCT00792636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916819|NCT00792636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916820|NCT00792636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916821|NCT00792636|Gout Suppressants|gout suppressants|mesh-ancestor
92916822|NCT00792636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92916823|NCT00792636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916824|NCT00792636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916825|NCT00792636|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92916826|NCT00792636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92916827|NCT00792636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92916828|NCT00792636|Serotonin Agents|serotonin agents|mesh-ancestor
92916829|NCT00792636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916830|NCT00446563|Losartan|losartan|mesh-list
92916831|NCT00446563|Amlodipine|amlodipine|mesh-list
92916832|NCT00446563|Valsartan|valsartan|mesh-list
92916833|NCT00446563|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92916834|NCT00446563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92916835|NCT00446563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92916836|NCT00446563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916837|NCT00446563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916838|NCT00446563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92916839|NCT00446563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916840|NCT00446563|Vasodilator Agents|vasodilator agents|mesh-ancestor
92916841|NCT00446563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92916842|NCT00446563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92916843|NCT00446563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92916844|NCT00446563|Diuretics|diuretics|mesh-ancestor
92916845|NCT00446563|Natriuretic Agents|natriuretic agents|mesh-ancestor
92916846|NCT00446563|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92916847|NCT00650806|Canagliflozin|canagliflozin|mesh-list
92916848|NCT00650806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92916849|NCT00650806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916850|NCT00650806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92916851|NCT00650806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916852|NCT00863057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92916853|NCT00863057|Methadone|methadone|mesh-list
92916854|NCT00863057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92916855|NCT00863057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92916856|NCT00863057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916857|NCT00863057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916858|NCT00863057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916859|NCT00863057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916860|NCT00863057|Analgesics|analgesics|mesh-ancestor
92916861|NCT00863057|Sensory System Agents|sensory system agents|mesh-ancestor
92916862|NCT00863057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916863|NCT00863057|Antidepressive Agents|antidepressive agents|mesh-ancestor
92916864|NCT00863057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92916865|NCT00863057|Dopamine Agents|dopamine agents|mesh-ancestor
92916866|NCT00863057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92916867|NCT00863057|Narcotics|narcotics|mesh-ancestor
92916868|NCT00863057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916869|NCT00863057|Antitussive Agents|antitussive agents|mesh-ancestor
92916870|NCT00863057|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916871|NCT00814216|Fluticasone|fluticasone|mesh-list
92916873|NCT00814216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916874|NCT00814216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92916875|NCT00814216|Autonomic Agents|autonomic agents|mesh-ancestor
92916876|NCT00814216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916877|NCT00814216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916878|NCT00814216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92916879|NCT00814216|Respiratory System Agents|respiratory system agents|mesh-ancestor
92916880|NCT00814216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916881|NCT00814216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92916882|NCT00829166|Capecitabine|capecitabine|mesh-list
92916883|NCT00829166|Trastuzumab|trastuzumab|mesh-list
92916884|NCT00829166|Lapatinib|lapatinib|mesh-list
92916885|NCT00829166|Maytansine|maytansine|mesh-list
92916886|NCT00829166|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92916887|NCT00829166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92916888|NCT00829166|Antimetabolites|antimetabolites|mesh-ancestor
92916889|NCT00829166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916890|NCT00829166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916891|NCT00829166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92916892|NCT00829166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92916893|NCT00829166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916894|NCT00829166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92916895|NCT00829166|Tubulin Modulators|tubulin modulators|mesh-ancestor
92916896|NCT00829166|Antimitotic Agents|antimitotic agents|mesh-ancestor
92916897|NCT00829166|Mitosis Modulators|mitosis modulators|mesh-ancestor
92916898|NCT00829166|Immunotoxins|immunotoxins|mesh-ancestor
92916899|NCT00829166|Immunoconjugates|immunoconjugates|mesh-ancestor
92916900|NCT00829166|Immunologic Factors|immunologic factors|mesh-ancestor
92916901|NCT00829166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916902|NCT00799266|Zoledronic Acid|zoledronic acid|mesh-list
92916903|NCT00799266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92916904|NCT00799266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916905|NCT00650104|Ropinirole|ropinirole|mesh-list
92916906|NCT00650104|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92916907|NCT00650104|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92916908|NCT00650104|Dopamine Agonists|dopamine agonists|mesh-ancestor
92916909|NCT00650104|Dopamine Agents|dopamine agents|mesh-ancestor
92916910|NCT00650104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92916911|NCT00650104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916912|NCT00650104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916913|NCT00808054|Lidocaine|lidocaine|mesh-list
92916914|NCT00808054|Prilocaine|prilocaine|mesh-list
92916915|NCT00808054|Anesthetics, Local|anesthetics, local|mesh-ancestor
92916916|NCT00808054|Anesthetics|anesthetics|mesh-ancestor
92916917|NCT00808054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92916918|NCT00808054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916919|NCT00808054|Sensory System Agents|sensory system agents|mesh-ancestor
92916920|NCT00808054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916921|NCT00808054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92916922|NCT00808054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92916923|NCT00808054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92916924|NCT00808054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92916925|NCT00808054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916926|NCT05102734|Nitroglycerin|nitroglycerin|mesh-list
92916927|NCT05102734|Vasodilator Agents|vasodilator agents|mesh-ancestor
92916928|NCT00814528|Imiquimod|imiquimod|mesh-list
92916929|NCT00814528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92916930|NCT00814528|Immunologic Factors|immunologic factors|mesh-ancestor
92916931|NCT00814528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916932|NCT00814528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916933|NCT00814528|Interferon Inducers|interferon inducers|mesh-ancestor
92916934|NCT00814606|Ribavirin|ribavirin|mesh-list
92916935|NCT00814606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92916936|NCT00814606|Antimetabolites|antimetabolites|mesh-ancestor
92916937|NCT00814606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916938|NCT00814606|Antiviral Agents|antiviral agents|mesh-ancestor
92916939|NCT00814606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916940|NCT00814762|Vaccines|vaccines|mesh-list
92916941|NCT00814762|Immunologic Factors|immunologic factors|mesh-ancestor
92916942|NCT00814762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916943|NCT00654238|Sorafenib|sorafenib|mesh-list
92916944|NCT00654238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916945|NCT00654238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92162670|NCT04398251|Febuxostat|febuxostat|mesh-list
92916946|NCT00654238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916947|NCT00654238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916948|NCT00862979|Cyclosporine|cyclosporine|mesh-list
92916949|NCT00862979|Mycophenolic Acid|mycophenolic acid|mesh-list
92916950|NCT00862979|Everolimus|everolimus|mesh-list
92916951|NCT00862979|Tacrolimus|tacrolimus|mesh-list
92916952|NCT00862979|Cyclosporins|cyclosporins|mesh-list
92916953|NCT00862979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92916954|NCT00862979|Immunologic Factors|immunologic factors|mesh-ancestor
92916955|NCT00862979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916956|NCT00862979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92916957|NCT00862979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916958|NCT00862979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916959|NCT00862979|Antifungal Agents|antifungal agents|mesh-ancestor
92916960|NCT00862979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92916961|NCT00862979|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916962|NCT00862979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92916963|NCT00862979|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92916964|NCT00862979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92916965|NCT00862979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916966|NCT00862979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92916967|NCT00862979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92916968|NCT00862979|Antitubercular Agents|antitubercular agents|mesh-ancestor
92916969|NCT00862979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92916970|NCT02605356|Dexamethasone|dexamethasone|mesh-list
92916971|NCT02605356|Bortezomib|bortezomib|mesh-list
92916972|NCT02605356|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92916973|NCT02605356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92916974|NCT02605356|Antiemetics|antiemetics|mesh-ancestor
92916975|NCT02605356|Autonomic Agents|autonomic agents|mesh-ancestor
92916976|NCT02605356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92916977|NCT02605356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92916978|NCT02605356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92916979|NCT02605356|Glucocorticoids|glucocorticoids|mesh-ancestor
92916980|NCT02605356|Hormones|hormones|mesh-ancestor
92916981|NCT02605356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92916982|NCT02605356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92916983|NCT02605356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916984|NCT00812266|Carboplatin|carboplatin|mesh-list
92916985|NCT00812266|Etoposide|etoposide|mesh-list
92916986|NCT00812266|Topotecan|topotecan|mesh-list
92916987|NCT00812266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92916988|NCT00812266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92916989|NCT00812266|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92916990|NCT00812266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92916991|NCT00812266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92916992|NCT00812266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92916993|NCT00812266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92916994|NCT00814918|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92916995|NCT00814918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92916996|NCT00814918|Dermatologic Agents|dermatologic agents|mesh-ancestor
92916997|NCT04113954|Prilocaine|prilocaine|mesh-list
92916998|NCT04113954|Mepivacaine|mepivacaine|mesh-list
92916999|NCT04113954|Anesthetics, Local|anesthetics, local|mesh-ancestor
92917000|NCT04113954|Anesthetics|anesthetics|mesh-ancestor
92917001|NCT04113954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917002|NCT04113954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917003|NCT04113954|Sensory System Agents|sensory system agents|mesh-ancestor
92917004|NCT04113954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917005|NCT00812344|Ketoconazole|ketoconazole|mesh-list
92917006|NCT00812344|Antifungal Agents|antifungal agents|mesh-ancestor
92917007|NCT00812344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917008|NCT00812344|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92917009|NCT00812344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92917010|NCT00812344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917011|NCT00812344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917012|NCT00812344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92526196|NCT00027976|Celecoxib|celecoxib|mesh-list
92917014|NCT00812344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917015|NCT00812344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917016|NCT00812344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92917017|NCT00446251|Mycophenolic Acid|mycophenolic acid|mesh-list
92917018|NCT00446251|Rituximab|rituximab|mesh-list
92917019|NCT00446251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92917020|NCT00446251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917021|NCT00446251|Immunologic Factors|immunologic factors|mesh-ancestor
92917022|NCT00446251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917023|NCT00446251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917024|NCT00446251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92917025|NCT00446251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92917026|NCT00446251|Antitubercular Agents|antitubercular agents|mesh-ancestor
92917027|NCT00446251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917028|NCT00446251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917029|NCT00446251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917030|NCT00446251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917031|NCT00812422|Ibuprofen|ibuprofen|mesh-list
92917032|NCT00812422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92917033|NCT00812422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917034|NCT00812422|Analgesics|analgesics|mesh-ancestor
92917035|NCT00812422|Sensory System Agents|sensory system agents|mesh-ancestor
92917036|NCT00812422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917037|NCT00812422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917038|NCT00812422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917039|NCT00812422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917040|NCT00812422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92917041|NCT00812422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917042|NCT00812422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917043|NCT04110834|Itraconazole|itraconazole|mesh-list
92917044|NCT04110834|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92917045|NCT04110834|Antifungal Agents|antifungal agents|mesh-ancestor
92917046|NCT04110834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917047|NCT04110834|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92917048|NCT04110834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92917049|NCT04110834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917050|NCT04110834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917051|NCT04110834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92917052|NCT04110834|Hormone Antagonists|hormone antagonists|mesh-ancestor
92917053|NCT04110834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917054|NCT04110834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917055|NCT04110834|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92917056|NCT00812578|Cholecalciferol|cholecalciferol|mesh-list
92917057|NCT00812578|Vitamin D|vitamin d|mesh-list
92917058|NCT00812578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92917059|NCT00812578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917060|NCT00812578|Vitamins|vitamins|mesh-ancestor
92917061|NCT00812578|Micronutrients|micronutrients|mesh-ancestor
92917062|NCT00812578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92562541|NCT00152893|Niacin|niacin|mesh-list
92917063|NCT00796224|Azithromycin|azithromycin|mesh-list
92917064|NCT00796224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917065|NCT00796224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917066|NCT00808366|Antifungal Agents|antifungal agents|mesh-list
92917067|NCT00808366|Clotrimazole|clotrimazole|mesh-list
92917068|NCT00808366|Miconazole|miconazole|mesh-list
92917069|NCT00808366|Keratolytic Agents|keratolytic agents|mesh-list
92917070|NCT00808366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917071|NCT00808366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92917072|NCT00808366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92917073|NCT00808366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92917074|NCT00808366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917075|NCT00808366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917076|NCT00808366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92917077|NCT00808366|Hormone Antagonists|hormone antagonists|mesh-ancestor
92917078|NCT00808366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917079|NCT00808366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917080|NCT00808366|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92917081|NCT00808366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92917082|NCT00808366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917084|NCT04045522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92917085|NCT04045522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917086|NCT02551276|Albuterol|albuterol|mesh-list
92917087|NCT02551276|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92917088|NCT02551276|Autonomic Agents|autonomic agents|mesh-ancestor
92917089|NCT02551276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917090|NCT02551276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917091|NCT02551276|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92917092|NCT02551276|Respiratory System Agents|respiratory system agents|mesh-ancestor
92917093|NCT02551276|Tocolytic Agents|tocolytic agents|mesh-ancestor
92917094|NCT02551276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92917095|NCT02551276|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92917096|NCT02551276|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92917097|NCT02551276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92917098|NCT02551276|Adrenergic Agents|adrenergic agents|mesh-ancestor
92917099|NCT02551276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917100|NCT02551276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917101|NCT00848081|Tadalafil|tadalafil|mesh-list
92917102|NCT00848081|Vasodilator Agents|vasodilator agents|mesh-ancestor
92917103|NCT00848081|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92917104|NCT00848081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92917105|NCT00848081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917106|NCT00848081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917107|NCT00848081|Urological Agents|urological agents|mesh-ancestor
92917108|NCT00815464|Antiviral Agents|antiviral agents|mesh-list
92917109|NCT00815464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917110|NCT04111380|Paclitaxel|paclitaxel|mesh-list
92917111|NCT04111380|Cisplatin|cisplatin|mesh-list
92917112|NCT04111380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92917113|NCT04111380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917114|NCT04111380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92917115|NCT04111380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92917116|NCT04111380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92917117|NCT04111380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917118|NCT04117919|Triamcinolone|triamcinolone|mesh-list
92917119|NCT04117919|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92917120|NCT04117919|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92917121|NCT04117919|Hydrocortisone|hydrocortisone|mesh-list
92917122|NCT04117919|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92917123|NCT04117919|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92917124|NCT04117919|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92917125|NCT04117919|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92917126|NCT04117919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917127|NCT04117919|Glucocorticoids|glucocorticoids|mesh-ancestor
92917128|NCT04117919|Hormones|hormones|mesh-ancestor
92917129|NCT04117919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917130|NCT04117919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917131|NCT04117919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917132|NCT04117919|Immunologic Factors|immunologic factors|mesh-ancestor
92917133|NCT04117919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917134|NCT04117919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562578|NCT00083031|Antimetabolites|antimetabolites|mesh-ancestor
92917135|NCT00701285|Pravastatin|pravastatin|mesh-list
92917137|NCT00701285|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92917138|NCT00701285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92917139|NCT00701285|Antimetabolites|antimetabolites|mesh-ancestor
92917140|NCT00701285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917141|NCT00701285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92917142|NCT00701285|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92917143|NCT00701285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917144|NCT02604498|Nemonoxacin|nemonoxacin|mesh-list
92917145|NCT02604498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917146|NCT02604498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917147|NCT00700037|Atorvastatin|atorvastatin|mesh-list
92917148|NCT00700037|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92917149|NCT00700037|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92917150|NCT00700037|Antimetabolites|antimetabolites|mesh-ancestor
92917151|NCT00700037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917152|NCT00700037|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92917153|NCT00700037|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92917154|NCT00700037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917155|NCT00815542|Dinoprostone|dinoprostone|mesh-list
92917156|NCT00815542|Oxytocics|oxytocics|mesh-ancestor
92917157|NCT00815542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92917158|NCT00815542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917160|NCT00791778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917161|NCT00791778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92917162|NCT00791778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917163|NCT00791778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917164|NCT02604576|Bromopride|bromopride|mesh-list
92917165|NCT02604576|Metoclopramide|metoclopramide|mesh-list
92917166|NCT02604576|Simethicone|simethicone|mesh-list
92917167|NCT02604576|Antifoaming Agents|antifoaming agents|mesh-ancestor
92917168|NCT02604576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917169|NCT02604576|Emollients|emollients|mesh-ancestor
92917170|NCT02604576|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917171|NCT02604576|Antiemetics|antiemetics|mesh-ancestor
92917172|NCT02604576|Autonomic Agents|autonomic agents|mesh-ancestor
92917173|NCT02604576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917174|NCT02604576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917175|NCT02604576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917176|NCT02604576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92917177|NCT02604576|Dopamine Agents|dopamine agents|mesh-ancestor
92917178|NCT02604576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917179|NCT02604576|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92917180|NCT04110132|Bupivacaine|bupivacaine|mesh-list
92917181|NCT04110132|Anesthetics, Local|anesthetics, local|mesh-ancestor
92917182|NCT04110132|Anesthetics|anesthetics|mesh-ancestor
92917183|NCT04110132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917184|NCT04110132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917185|NCT04110132|Sensory System Agents|sensory system agents|mesh-ancestor
92917186|NCT04110132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917187|NCT00795600|Insulin|insulin|mesh-list
92917188|NCT00795600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92917189|NCT00795600|Insulin Detemir|insulin detemir|mesh-list
92917190|NCT00795600|Isophane Insulin, Human|isophane insulin, human|mesh-list
92917191|NCT00795600|Insulin, Isophane|insulin, isophane|mesh-list
92917192|NCT00795600|Isophane insulin, beef|isophane insulin, beef|mesh-list
92917193|NCT00795600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92917194|NCT00795600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917195|NCT00795132|Cyclosporine|cyclosporine|mesh-list
92917196|NCT00795132|Mycophenolic Acid|mycophenolic acid|mesh-list
92917197|NCT00795132|Fludarabine|fludarabine|mesh-list
92917198|NCT00795132|Busulfan|busulfan|mesh-list
92917199|NCT00795132|Cyclosporins|cyclosporins|mesh-list
92917200|NCT00795132|Thymoglobulin|thymoglobulin|mesh-list
92917201|NCT00795132|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92917202|NCT00795132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917203|NCT00795132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917204|NCT00795132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917205|NCT00795132|Immunologic Factors|immunologic factors|mesh-ancestor
92917206|NCT00795132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917207|NCT00795132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917208|NCT00795132|Antifungal Agents|antifungal agents|mesh-ancestor
92917209|NCT00795132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917210|NCT00795132|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917211|NCT00795132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917212|NCT00795132|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92917213|NCT00795132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92917214|NCT00795132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92917215|NCT00795132|Antitubercular Agents|antitubercular agents|mesh-ancestor
92917216|NCT00795132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917217|NCT00795132|Alkylating Agents|alkylating agents|mesh-ancestor
92917218|NCT00795132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92917219|NCT00795132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92917220|NCT02604420|Eculizumab|eculizumab|mesh-list
92917221|NCT02604420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92917222|NCT02604420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917223|NCT02604420|Immunologic Factors|immunologic factors|mesh-ancestor
92917224|NCT02604420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917225|NCT04110210|Morphine|morphine|mesh-list
92917226|NCT04110210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92917227|NCT04110210|Narcotics|narcotics|mesh-ancestor
92917228|NCT04110210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917229|NCT04110210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917230|NCT04110210|Analgesics|analgesics|mesh-ancestor
92917231|NCT04110210|Sensory System Agents|sensory system agents|mesh-ancestor
92917232|NCT04110210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917233|NCT00647296|Pramipexole|pramipexole|mesh-list
92917234|NCT00647296|Antioxidants|antioxidants|mesh-ancestor
92917235|NCT00647296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917236|NCT00647296|Protective Agents|protective agents|mesh-ancestor
92917237|NCT00647296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917238|NCT00647296|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92917239|NCT00647296|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92917240|NCT00647296|Dopamine Agonists|dopamine agonists|mesh-ancestor
92917241|NCT00647296|Dopamine Agents|dopamine agents|mesh-ancestor
92917242|NCT00647296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917243|NCT00813202|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92917244|NCT00813202|Natriuretic Agents|natriuretic agents|mesh-ancestor
92917245|NCT00813202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917246|NCT00646906|Aspirin|aspirin|mesh-list
92917247|NCT00646906|Acetaminophen|acetaminophen|mesh-list
92917248|NCT00646906|Ibuprofen|ibuprofen|mesh-list
92917249|NCT00646906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92917250|NCT00646906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917251|NCT00646906|Analgesics|analgesics|mesh-ancestor
92917252|NCT00646906|Sensory System Agents|sensory system agents|mesh-ancestor
92917253|NCT00646906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917254|NCT00646906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917255|NCT00646906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917256|NCT00646906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917257|NCT00646906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92917258|NCT00646906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92917259|NCT00646906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917260|NCT00646906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92917261|NCT00646906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92917262|NCT00646906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917263|NCT00646906|Antipyretics|antipyretics|mesh-ancestor
92917264|NCT00813436|Oxytocin|oxytocin|mesh-list
92917265|NCT00813436|Oxytocics|oxytocics|mesh-ancestor
92917266|NCT00813436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92917267|NCT00813436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917268|NCT00808678|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92917269|NCT00808678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92917270|NCT00808678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92917271|NCT00808678|Antimetabolites|antimetabolites|mesh-ancestor
92917272|NCT00808678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917273|NCT00808678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92917274|NCT00808678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92917275|NCT00808678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917276|NCT00815854|Folic Acid|folic acid|mesh-list
92917277|NCT00815854|Hematinics|hematinics|mesh-ancestor
92917278|NCT00815854|Vitamin B Complex|vitamin b complex|mesh-ancestor
92917279|NCT00815854|Vitamins|vitamins|mesh-ancestor
92917280|NCT00815854|Micronutrients|micronutrients|mesh-ancestor
92917281|NCT00815854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917282|NCT00817648|Risperidone|risperidone|mesh-list
92917283|NCT00817648|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92917284|NCT00817648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92917285|NCT00817648|Serotonin Agents|serotonin agents|mesh-ancestor
92917286|NCT00817648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917287|NCT00817648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917288|NCT00817648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917289|NCT00817648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92917290|NCT00817648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92917291|NCT00817648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917292|NCT00817648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92917293|NCT00817648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92917294|NCT00817648|Dopamine Agents|dopamine agents|mesh-ancestor
92917295|NCT00817648|Antidepressive Agents|antidepressive agents|mesh-ancestor
92917296|NCT00829010|Vaccines|vaccines|mesh-list
92917297|NCT00829010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92917298|NCT00829010|Immunologic Factors|immunologic factors|mesh-ancestor
92917299|NCT00829010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917300|NCT00644332|Ranolazine|ranolazine|mesh-list
92917301|NCT00644332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92917302|NCT00644332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917303|NCT00644332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917304|NCT00808912|Sildenafil Citrate|sildenafil citrate|mesh-list
92917305|NCT00808912|Vasodilator Agents|vasodilator agents|mesh-ancestor
92917306|NCT00808912|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92917307|NCT00808912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92917308|NCT00808912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917309|NCT00808912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917310|NCT00808912|Urological Agents|urological agents|mesh-ancestor
92917312|NCT02551042|Coagulants|coagulants|mesh-ancestor
92917313|NCT00445939|Adalimumab|adalimumab|mesh-list
92917314|NCT00445939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92917315|NCT00445939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917316|NCT00445939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917317|NCT00816244|Atorvastatin|atorvastatin|mesh-list
92917318|NCT00816244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92917319|NCT00816244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92917320|NCT00816244|Antimetabolites|antimetabolites|mesh-ancestor
92917321|NCT00816244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917322|NCT00816244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92917323|NCT00816244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92917324|NCT00816244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917325|NCT00817960|Methylphenidate|methylphenidate|mesh-list
92917326|NCT00817960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92917327|NCT00817960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917328|NCT00817960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92917329|NCT00817960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917330|NCT00817960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917331|NCT00817960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917332|NCT00817960|Dopamine Agents|dopamine agents|mesh-ancestor
92917333|NCT00817960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917334|NCT00818038|Natalizumab|natalizumab|mesh-list
92917335|NCT00818038|Immunologic Factors|immunologic factors|mesh-ancestor
92917336|NCT00818038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917337|NCT00482053|Acetaminophen|acetaminophen|mesh-list
92917338|NCT00482053|Diphenhydramine|diphenhydramine|mesh-list
92917339|NCT00482053|Promethazine|promethazine|mesh-list
92917340|NCT00482053|Cyclosporine|cyclosporine|mesh-list
92917341|NCT00482053|Mycophenolic Acid|mycophenolic acid|mesh-list
92917342|NCT00482053|Methylprednisolone|methylprednisolone|mesh-list
92917343|NCT00482053|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92917344|NCT00482053|Hydrocortisone|hydrocortisone|mesh-list
92917345|NCT00482053|Cyclophosphamide|cyclophosphamide|mesh-list
92917346|NCT00482053|Carmustine|carmustine|mesh-list
92917347|NCT00482053|Rituximab|rituximab|mesh-list
92917348|NCT00482053|Etoposide|etoposide|mesh-list
92917349|NCT00482053|Cyclosporins|cyclosporins|mesh-list
92917350|NCT00482053|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92917351|NCT00482053|Lenograstim|lenograstim|mesh-list
92917352|NCT00482053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917353|NCT00482053|Immunologic Factors|immunologic factors|mesh-ancestor
92917354|NCT00482053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917355|NCT00482053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917356|NCT00482053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92917357|NCT00482053|Alkylating Agents|alkylating agents|mesh-ancestor
92917358|NCT00482053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917359|NCT00482053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917360|NCT00482053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92917361|NCT00482053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92917362|NCT00482053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92917363|NCT00482053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92917364|NCT00482053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92917365|NCT00482053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917366|NCT00482053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92917367|NCT00482053|Antifungal Agents|antifungal agents|mesh-ancestor
92917368|NCT00482053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917369|NCT00482053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917370|NCT00482053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92917371|NCT00482053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917372|NCT00482053|Analgesics|analgesics|mesh-ancestor
92917373|NCT00482053|Sensory System Agents|sensory system agents|mesh-ancestor
92917374|NCT00482053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917375|NCT00482053|Antipyretics|antipyretics|mesh-ancestor
92917376|NCT00482053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92917377|NCT00482053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92917378|NCT00482053|Antitubercular Agents|antitubercular agents|mesh-ancestor
92917379|NCT00482053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917380|NCT00482053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917381|NCT00482053|Antiemetics|antiemetics|mesh-ancestor
92917382|NCT00482053|Autonomic Agents|autonomic agents|mesh-ancestor
92162687|NCT01289457|Immunologic Factors|immunologic factors|mesh-ancestor
92917383|NCT00482053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917384|NCT00482053|Glucocorticoids|glucocorticoids|mesh-ancestor
92917385|NCT00482053|Hormones|hormones|mesh-ancestor
92917386|NCT00482053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917387|NCT00482053|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92917388|NCT00482053|Protective Agents|protective agents|mesh-ancestor
92917389|NCT00482053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92917390|NCT00482053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92917391|NCT00482053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92917392|NCT00482053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917393|NCT00482053|Anesthetics, Local|anesthetics, local|mesh-ancestor
92917394|NCT00482053|Anesthetics|anesthetics|mesh-ancestor
92917395|NCT00482053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92917396|NCT00482053|Histamine Antagonists|histamine antagonists|mesh-ancestor
92917397|NCT00482053|Histamine Agents|histamine agents|mesh-ancestor
92917398|NCT00482053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917399|NCT00482053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92917400|NCT00482053|Antipruritics|antipruritics|mesh-ancestor
92917401|NCT00455923|Fluticasone|fluticasone|mesh-list
92917402|NCT00455923|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92917403|NCT00455923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92917404|NCT00455923|Autonomic Agents|autonomic agents|mesh-ancestor
92917405|NCT00455923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917406|NCT00455923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917407|NCT00455923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92917408|NCT00455923|Respiratory System Agents|respiratory system agents|mesh-ancestor
92917409|NCT00455923|Glucocorticoids|glucocorticoids|mesh-ancestor
92917410|NCT00455923|Hormones|hormones|mesh-ancestor
92917411|NCT00455923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917412|NCT00455923|Sympathomimetics|sympathomimetics|mesh-ancestor
92917413|NCT00455923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917414|NCT00455923|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917415|NCT00455923|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92917416|NCT00642616|Insulin|insulin|mesh-list
92917417|NCT00642616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92917418|NCT00642616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917419|NCT00809068|Tibolone|tibolone|mesh-list
92917420|NCT00809068|Fenofibrate|fenofibrate|mesh-list
92917421|NCT00809068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92917422|NCT00809068|Antimetabolites|antimetabolites|mesh-ancestor
92917423|NCT00809068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917424|NCT00809068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92917425|NCT00809068|Androgen Antagonists|androgen antagonists|mesh-ancestor
92917426|NCT00809068|Hormone Antagonists|hormone antagonists|mesh-ancestor
92917427|NCT00809068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917428|NCT00809068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917429|NCT00809068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92917430|NCT00809068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92917431|NCT00809068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917432|NCT00809068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92917433|NCT00809068|Anabolic Agents|anabolic agents|mesh-ancestor
92917434|NCT00809068|Hormones|hormones|mesh-ancestor
92917435|NCT03844945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92917436|NCT03844945|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92917437|NCT01027117|Sildenafil Citrate|sildenafil citrate|mesh-list
92917438|NCT01027117|Vasodilator Agents|vasodilator agents|mesh-ancestor
92917439|NCT01027117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92917440|NCT01027117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92917442|NCT01027117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917443|NCT01027117|Urological Agents|urological agents|mesh-ancestor
92917444|NCT03995563|Dexamethasone|dexamethasone|mesh-list
92917445|NCT03995563|Ropivacaine|ropivacaine|mesh-list
92917446|NCT03995563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917447|NCT03995563|Antiemetics|antiemetics|mesh-ancestor
92917448|NCT03995563|Autonomic Agents|autonomic agents|mesh-ancestor
92917449|NCT03995563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917450|NCT03995563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917451|NCT03995563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917452|NCT03995563|Glucocorticoids|glucocorticoids|mesh-ancestor
92917453|NCT03995563|Hormones|hormones|mesh-ancestor
92917454|NCT03995563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917455|NCT03995563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92917456|NCT03995563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917458|NCT03995563|Anesthetics|anesthetics|mesh-ancestor
92917459|NCT03995563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917460|NCT03995563|Sensory System Agents|sensory system agents|mesh-ancestor
92917461|NCT00445003|Triamcinolone|triamcinolone|mesh-list
92917462|NCT00445003|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92917463|NCT00445003|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92917464|NCT00445003|Ranibizumab|ranibizumab|mesh-list
92917465|NCT00445003|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92917466|NCT00445003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92917467|NCT00445003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92917468|NCT00445003|Growth Substances|growth substances|mesh-ancestor
92917469|NCT00445003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917470|NCT00445003|Growth Inhibitors|growth inhibitors|mesh-ancestor
92917471|NCT00445003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917472|NCT00445003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917473|NCT00445003|Glucocorticoids|glucocorticoids|mesh-ancestor
92917474|NCT00445003|Hormones|hormones|mesh-ancestor
92917475|NCT00445003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917476|NCT00445003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917477|NCT00445003|Immunologic Factors|immunologic factors|mesh-ancestor
92917478|NCT00445003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917479|NCT00445003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917480|NCT00642460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92917481|NCT00642460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92917482|NCT00642460|Methotrexate|methotrexate|mesh-list
92917483|NCT00642460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92917484|NCT00642460|Abortifacient Agents|abortifacient agents|mesh-ancestor
92917485|NCT00642460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92917486|NCT00642460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917487|NCT00642460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92917488|NCT00642460|Antimetabolites|antimetabolites|mesh-ancestor
92917489|NCT00642460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917490|NCT00642460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917491|NCT00642460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917492|NCT00642460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917493|NCT00642460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92917494|NCT00642460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917495|NCT00642460|Immunologic Factors|immunologic factors|mesh-ancestor
92917496|NCT00642460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917497|NCT00642460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92917498|NCT00642460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917499|NCT00642460|Analgesics|analgesics|mesh-ancestor
92917500|NCT00642460|Sensory System Agents|sensory system agents|mesh-ancestor
92917501|NCT00642460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917502|NCT00814658|Nimodipine|nimodipine|mesh-list
92917503|NCT00814658|Galantamine|galantamine|mesh-list
92917504|NCT00814658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92917505|NCT00814658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917506|NCT00814658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917507|NCT00814658|Cholinergic Agents|cholinergic agents|mesh-ancestor
92917508|NCT00814658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917509|NCT00814658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917510|NCT00814658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92917511|NCT00814658|Autonomic Agents|autonomic agents|mesh-ancestor
92917512|NCT00814658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917513|NCT00814658|Nootropic Agents|nootropic agents|mesh-ancestor
92917514|NCT00814658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92917515|NCT00814658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92917516|NCT00814658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917517|NCT00814658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92917518|NCT00814658|Vasodilator Agents|vasodilator agents|mesh-ancestor
92917519|NCT00816634|Paclitaxel|paclitaxel|mesh-list
92917520|NCT00816634|Capecitabine|capecitabine|mesh-list
92917521|NCT00816634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92917522|NCT00816634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917523|NCT00816634|Tubulin Modulators|tubulin modulators|mesh-ancestor
92917524|NCT00816634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92917525|NCT00816634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92917526|NCT00816634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917527|NCT00816634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92917528|NCT00816634|Antimetabolites|antimetabolites|mesh-ancestor
92917529|NCT00642304|Epoetin Alfa|epoetin alfa|mesh-list
92917530|NCT00642304|Hematinics|hematinics|mesh-ancestor
92917531|NCT00814580|Oxycodone|oxycodone|mesh-list
92917532|NCT00814580|Tapentadol|tapentadol|mesh-list
92917533|NCT00814580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92917534|NCT00814580|Narcotics|narcotics|mesh-ancestor
92917535|NCT00814580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917536|NCT00814580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917537|NCT00814580|Analgesics|analgesics|mesh-ancestor
92917538|NCT00814580|Sensory System Agents|sensory system agents|mesh-ancestor
92917539|NCT00814580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917540|NCT00814580|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92917541|NCT00814580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917542|NCT00814580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917543|NCT00814580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917544|NCT00814580|Adrenergic Agents|adrenergic agents|mesh-ancestor
92917545|NCT00814580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917546|NCT00643162|Escitalopram|escitalopram|mesh-list
92917547|NCT00643162|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92917548|NCT00643162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917549|NCT00643162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917550|NCT00643162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917551|NCT00643162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917552|NCT00643162|Serotonin Agents|serotonin agents|mesh-ancestor
92917553|NCT00643162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917554|NCT00814502|Zolpidem|zolpidem|mesh-list
92917555|NCT00814502|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92917556|NCT00814502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92917557|NCT00814502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917558|NCT00814502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917559|NCT00814502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92917560|NCT00814502|GABA Agonists|gaba agonists|mesh-ancestor
92917561|NCT00814502|GABA Agents|gaba agents|mesh-ancestor
92917562|NCT00814502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917563|NCT00814502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917564|NCT00653224|Levocetirizine|levocetirizine|mesh-list
92917565|NCT00653224|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92917566|NCT00653224|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92917567|NCT00653224|Histamine Antagonists|histamine antagonists|mesh-ancestor
92917568|NCT00653224|Histamine Agents|histamine agents|mesh-ancestor
92917569|NCT00653224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917570|NCT00653224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917571|NCT00653224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917572|NCT00444925|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92917573|NCT00444925|Fesoterodine|fesoterodine|mesh-list
92917574|NCT00444925|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92917575|NCT00444925|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92917576|NCT00444925|Cholinergic Agents|cholinergic agents|mesh-ancestor
92917577|NCT00444925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917578|NCT00444925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917579|NCT00444925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917580|NCT00444925|Urological Agents|urological agents|mesh-ancestor
92917581|NCT00641056|Insulin Glargine|insulin glargine|mesh-list
92917582|NCT00641056|Exenatide|exenatide|mesh-list
92917583|NCT00641056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92917584|NCT00641056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917585|NCT00641056|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92917586|NCT00641056|Incretins|incretins|mesh-ancestor
92917587|NCT00641056|Hormones|hormones|mesh-ancestor
92917588|NCT00641056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917589|NCT00569374|Modafinil|modafinil|mesh-list
92917590|NCT00569374|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92917591|NCT00569374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917592|NCT00569374|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92917593|NCT00569374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92917594|NCT00569374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92917595|NCT00569374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917596|NCT00828464|Clobetasol|clobetasol|mesh-list
92917597|NCT00828464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917598|NCT00828464|Glucocorticoids|glucocorticoids|mesh-ancestor
92917599|NCT00828464|Hormones|hormones|mesh-ancestor
92917600|NCT00828464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917601|NCT00828464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917602|NCT00816712|Methyltestosterone|methyltestosterone|mesh-list
92917604|NCT00816712|Testosterone undecanoate|testosterone undecanoate|mesh-list
92917605|NCT00816712|Testosterone enanthate|testosterone enanthate|mesh-list
92917606|NCT00816712|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92917607|NCT00816712|Androgens|androgens|mesh-ancestor
92917608|NCT00816712|Hormones|hormones|mesh-ancestor
92917609|NCT00816712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92917610|NCT00816712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917611|NCT00816712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92917612|NCT00816712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917613|NCT00816712|Anabolic Agents|anabolic agents|mesh-ancestor
92917614|NCT00818194|Cyclosporine|cyclosporine|mesh-list
92917615|NCT00818194|Tacrolimus|tacrolimus|mesh-list
92917616|NCT00818194|Cyclosporins|cyclosporins|mesh-list
92917617|NCT00818194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917618|NCT00818194|Immunologic Factors|immunologic factors|mesh-ancestor
92917619|NCT00818194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917620|NCT00818194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92917621|NCT00818194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917622|NCT00818194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917623|NCT00818194|Antifungal Agents|antifungal agents|mesh-ancestor
92917624|NCT00818194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917625|NCT00818194|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917626|NCT00818194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917627|NCT02610686|Chloroquine|chloroquine|mesh-list
92917628|NCT02610686|Amebicides|amebicides|mesh-ancestor
92917629|NCT02610686|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92917630|NCT02610686|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92917631|NCT02610686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917632|NCT02610686|Antimalarials|antimalarials|mesh-ancestor
92917633|NCT02610686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917634|NCT00816790|Tazobactam|tazobactam|mesh-list
92917635|NCT00816790|Piperacillin|piperacillin|mesh-list
92917636|NCT00816790|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92917637|NCT00816790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917638|NCT00816790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917639|NCT00816790|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92917640|NCT00816790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917641|NCT00816790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917642|NCT00818350|Sunitinib|sunitinib|mesh-list
92917643|NCT00818350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917644|NCT00818350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92917645|NCT00818350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92917646|NCT00818350|Growth Substances|growth substances|mesh-ancestor
92917647|NCT00818350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917648|NCT00818350|Growth Inhibitors|growth inhibitors|mesh-ancestor
92917649|NCT00818350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92917650|NCT00818350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917651|NCT00818350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917652|NCT00810602|Vorinostat|vorinostat|mesh-list
92917653|NCT00810602|Tacrolimus|tacrolimus|mesh-list
92917654|NCT00810602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917655|NCT00810602|Immunologic Factors|immunologic factors|mesh-ancestor
92917656|NCT00810602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917657|NCT00810602|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92917658|NCT00810602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917659|NCT00810602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917660|NCT00810602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917661|NCT00810602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92917662|NCT00816868|Capecitabine|capecitabine|mesh-list
92917663|NCT00816868|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92563097|NCT00155350|Pioglitazone|pioglitazone|mesh-list
92917664|NCT00816868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92917665|NCT00816868|Antimetabolites|antimetabolites|mesh-ancestor
92917666|NCT00816868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917667|NCT00816868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917668|NCT00816868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92917669|NCT00816868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917671|NCT05500586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917672|NCT05500586|Hormones|hormones|mesh-ancestor
92917673|NCT05500586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162695|NCT03830333|Metronidazole|metronidazole|mesh-list
92917674|NCT05500586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917675|NCT00791700|Maraviroc|maraviroc|mesh-list
92917676|NCT00791700|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92917677|NCT00791700|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92917678|NCT00791700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917679|NCT00791700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92917680|NCT00791700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92917681|NCT00791700|Antiviral Agents|antiviral agents|mesh-ancestor
92917682|NCT00791700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917683|NCT00791700|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92917684|NCT00628108|Levocetirizine|levocetirizine|mesh-list
92917685|NCT00628108|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92917686|NCT00628108|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92917687|NCT00628108|Histamine Antagonists|histamine antagonists|mesh-ancestor
92917688|NCT00628108|Histamine Agents|histamine agents|mesh-ancestor
92917689|NCT00628108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917690|NCT00628108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917691|NCT00628108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917692|NCT00821392|Febuxostat|febuxostat|mesh-list
92917693|NCT00821392|Gout Suppressants|gout suppressants|mesh-ancestor
92917694|NCT00821392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917695|NCT00591578|Valsartan|valsartan|mesh-list
92917696|NCT00591578|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92917697|NCT00591578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92917698|NCT00591578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92917699|NCT00591578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92917700|NCT00591578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917701|NCT00797862|Amlodipine|amlodipine|mesh-list
92917702|NCT00797862|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92917703|NCT00797862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92917704|NCT00797862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92917705|NCT00797862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917706|NCT00797862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917707|NCT00797862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92917708|NCT00797862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917709|NCT00797862|Vasodilator Agents|vasodilator agents|mesh-ancestor
92917710|NCT00797862|Diuretics|diuretics|mesh-ancestor
92917711|NCT00797862|Natriuretic Agents|natriuretic agents|mesh-ancestor
92917712|NCT00797862|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92917713|NCT00817258|Cisplatin|cisplatin|mesh-list
92917714|NCT00817258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917715|NCT00794820|Cyclophosphamide|cyclophosphamide|mesh-list
92917716|NCT00794820|Rituximab|rituximab|mesh-list
92917717|NCT00794820|Fludarabine|fludarabine|mesh-list
92917718|NCT00794820|Fludarabine phosphate|fludarabine phosphate|mesh-list
92917719|NCT00794820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917720|NCT00794820|Immunologic Factors|immunologic factors|mesh-ancestor
92917721|NCT00794820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917722|NCT00794820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917723|NCT00794820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92917724|NCT00794820|Alkylating Agents|alkylating agents|mesh-ancestor
92917725|NCT00794820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917726|NCT00794820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917727|NCT00794820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92917728|NCT00794820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92917729|NCT00794820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92917730|NCT00794820|Antimetabolites|antimetabolites|mesh-ancestor
92917731|NCT00455533|Paclitaxel|paclitaxel|mesh-list
92917732|NCT00455533|Epothilones|epothilones|mesh-list
92917733|NCT00455533|Cyclophosphamide|cyclophosphamide|mesh-list
92917734|NCT00455533|Doxorubicin|doxorubicin|mesh-list
92917735|NCT00455533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92917736|NCT00455533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917737|NCT00455533|Tubulin Modulators|tubulin modulators|mesh-ancestor
92917738|NCT00455533|Antimitotic Agents|antimitotic agents|mesh-ancestor
92917739|NCT00455533|Mitosis Modulators|mitosis modulators|mesh-ancestor
92917740|NCT00455533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917741|NCT00455533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92917742|NCT00455533|Immunologic Factors|immunologic factors|mesh-ancestor
92917743|NCT00455533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917744|NCT00455533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917745|NCT00455533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92162698|NCT03830333|Ceftolozane|ceftolozane|mesh-list
92917746|NCT00455533|Alkylating Agents|alkylating agents|mesh-ancestor
92917747|NCT00455533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92917748|NCT00455533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92917749|NCT00455533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92917750|NCT00455533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92917751|NCT00455533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917752|NCT00818584|Micafungin|micafungin|mesh-list
92917753|NCT00818584|Antifungal Agents|antifungal agents|mesh-ancestor
92917754|NCT00818584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917755|NCT02610530|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92917756|NCT02610530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917757|NCT00923000|Morphine|morphine|mesh-list
92917758|NCT00923000|Nalbuphine|nalbuphine|mesh-list
92917759|NCT00923000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92917760|NCT00923000|Narcotics|narcotics|mesh-ancestor
92917761|NCT00923000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917762|NCT00923000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917763|NCT00923000|Analgesics|analgesics|mesh-ancestor
92917764|NCT00923000|Sensory System Agents|sensory system agents|mesh-ancestor
92917765|NCT00923000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917766|NCT01019863|Oxaliplatin|oxaliplatin|mesh-list
92917767|NCT01019863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917768|NCT00642850|Epoetin Alfa|epoetin alfa|mesh-list
92917769|NCT00642850|Hematinics|hematinics|mesh-ancestor
92917770|NCT00455455|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92917771|NCT00913952|Clomipramine|clomipramine|mesh-list
92917772|NCT00913952|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92917773|NCT00913952|Antidepressive Agents|antidepressive agents|mesh-ancestor
92917774|NCT00913952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92917775|NCT00913952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92917776|NCT00913952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917777|NCT00913952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917778|NCT00913952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917779|NCT00913952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917780|NCT00913952|Serotonin Agents|serotonin agents|mesh-ancestor
92917781|NCT00913952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917782|NCT04581382|Pembrolizumab|pembrolizumab|mesh-list
92917783|NCT04581382|Nivolumab|nivolumab|mesh-list
92917784|NCT04581382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92917785|NCT04581382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917786|NCT04581382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92917787|NCT04581382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917788|NCT00818818|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92917789|NCT00818818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92917790|NCT00818818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92917791|NCT00818818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917792|NCT03840811|Ciprofloxacin|ciprofloxacin|mesh-list
92917793|NCT03840811|Ceftriaxone|ceftriaxone|mesh-list
92917794|NCT03840811|Cefixime|cefixime|mesh-list
92917795|NCT03840811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917796|NCT03840811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917797|NCT03840811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92917798|NCT03840811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92917799|NCT03840811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917800|NCT03840811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917801|NCT03840811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917802|NCT03840811|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92917803|NCT03840811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92917804|NCT00640510|Olanzapine|olanzapine|mesh-list
92917805|NCT00640510|Antiemetics|antiemetics|mesh-ancestor
92917806|NCT00640510|Autonomic Agents|autonomic agents|mesh-ancestor
92917807|NCT00640510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917808|NCT00640510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917809|NCT00640510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917810|NCT00640510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92917811|NCT00640510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92917812|NCT00640510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563246|NCT00051389|Fosinopril|fosinopril|mesh-list
92917813|NCT00640510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92917814|NCT00640510|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92917815|NCT00640510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917816|NCT00640510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917817|NCT00640510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917818|NCT00640510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917819|NCT00640510|Serotonin Agents|serotonin agents|mesh-ancestor
92917820|NCT00913718|Fluoxetine|fluoxetine|mesh-list
92917821|NCT00913718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92917822|NCT00913718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917823|NCT00913718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917824|NCT00913718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917825|NCT00913718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917826|NCT00913718|Serotonin Agents|serotonin agents|mesh-ancestor
92917827|NCT00913718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917828|NCT00913718|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92917829|NCT00913718|Antidepressive Agents|antidepressive agents|mesh-ancestor
92917830|NCT00913718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92917831|NCT00913718|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92917832|NCT00913718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92917833|NCT00913718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917834|NCT00813800|Varenicline|varenicline|mesh-list
92917835|NCT00813800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92917836|NCT00813800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92917837|NCT00813800|Cholinergic Agents|cholinergic agents|mesh-ancestor
92917838|NCT00813800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917839|NCT00813800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917840|NCT00813800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917841|NCT00627016|Dexlansoprazole|dexlansoprazole|mesh-list
92917842|NCT00627016|Lansoprazole|lansoprazole|mesh-list
92917843|NCT00627016|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92917844|NCT00627016|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917845|NCT00627016|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92917846|NCT00627016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917847|NCT00627016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917848|NCT00794664|Mipomersen|mipomersen|mesh-list
92917849|NCT00794664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92917850|NCT00794664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92917851|NCT00794664|Antimetabolites|antimetabolites|mesh-ancestor
92917852|NCT00794664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917853|NCT00794664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92917854|NCT00444535|Bevacizumab|bevacizumab|mesh-list
92917855|NCT00444535|Lapatinib|lapatinib|mesh-list
92917856|NCT00444535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92917857|NCT00444535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917858|NCT00444535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92917859|NCT00444535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92917860|NCT00444535|Growth Substances|growth substances|mesh-ancestor
92917861|NCT00444535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917862|NCT00444535|Growth Inhibitors|growth inhibitors|mesh-ancestor
92917863|NCT00444535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92917864|NCT00444535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917865|NCT00444535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917866|NCT04110288|Paclitaxel|paclitaxel|mesh-list
92917867|NCT04110288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92917868|NCT04110288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917869|NCT04110288|Tubulin Modulators|tubulin modulators|mesh-ancestor
92917870|NCT04110288|Antimitotic Agents|antimitotic agents|mesh-ancestor
92917871|NCT04110288|Mitosis Modulators|mitosis modulators|mesh-ancestor
92917872|NCT04110288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917873|NCT00826306|Sunscreening Agents|sunscreening agents|mesh-list
92917874|NCT00826306|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92917875|NCT00826306|Protective Agents|protective agents|mesh-ancestor
92917876|NCT00826306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917877|NCT00826306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917878|NCT05753852|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92917879|NCT05753852|Antiviral Agents|antiviral agents|mesh-ancestor
92917880|NCT05753852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917881|NCT05753852|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92917882|NCT05753852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92917883|NCT00821782|Azithromycin|azithromycin|mesh-list
92917884|NCT00821782|Levofloxacin|levofloxacin|mesh-list
92917885|NCT00821782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92917886|NCT00821782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917887|NCT00821782|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92917888|NCT00821782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92917889|NCT00821782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92917890|NCT00821782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917891|NCT00821782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917892|NCT00821782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917893|NCT00821782|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92917894|NCT00821782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92917896|NCT00847613|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92917897|NCT00847613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92917898|NCT00847613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917899|NCT00847613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917900|NCT00794196|Antidepressive Agents|antidepressive agents|mesh-list
92917901|NCT00794196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92917902|NCT00807092|Insulin|insulin|mesh-list
92917903|NCT00807092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92917904|NCT00807092|Metformin|metformin|mesh-list
92917905|NCT00807092|Insulin Aspart|insulin aspart|mesh-list
92917906|NCT00807092|Biphasic Insulins|biphasic insulins|mesh-list
92917907|NCT00807092|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92917908|NCT00807092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92917909|NCT00807092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917910|NCT04112550|Acetaminophen|acetaminophen|mesh-list
92917911|NCT04112550|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92917912|NCT04112550|Oxycodone|oxycodone|mesh-list
92917913|NCT04112550|Methadone|methadone|mesh-list
92917914|NCT04112550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917915|NCT04112550|Analgesics|analgesics|mesh-ancestor
92917916|NCT04112550|Sensory System Agents|sensory system agents|mesh-ancestor
92917917|NCT04112550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917918|NCT04112550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917919|NCT04112550|Antipyretics|antipyretics|mesh-ancestor
92917920|NCT04112550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92917921|NCT04112550|Narcotics|narcotics|mesh-ancestor
92917922|NCT04112550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917923|NCT04112550|Antitussive Agents|antitussive agents|mesh-ancestor
92917924|NCT04112550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92917925|NCT04112550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92917926|NCT04112550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917927|NCT04112550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917928|NCT00640042|Morphine|morphine|mesh-list
92917929|NCT00640042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92917930|NCT00640042|Narcotics|narcotics|mesh-ancestor
92917931|NCT00640042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917932|NCT00640042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917933|NCT00640042|Analgesics|analgesics|mesh-ancestor
92917934|NCT00640042|Sensory System Agents|sensory system agents|mesh-ancestor
92917935|NCT00640042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917936|NCT00807014|Adapalene|adapalene|mesh-list
92917937|NCT00807014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92917938|NCT00807014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917939|NCT00807014|Analgesics|analgesics|mesh-ancestor
92917940|NCT00807014|Sensory System Agents|sensory system agents|mesh-ancestor
92917941|NCT00807014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917942|NCT00807014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917943|NCT00807014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917944|NCT00807014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917945|NCT00807014|Dermatologic Agents|dermatologic agents|mesh-ancestor
92917946|NCT00794040|Methylphenidate|methylphenidate|mesh-list
92917947|NCT00794040|Citalopram|citalopram|mesh-list
92917948|NCT00794040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92917949|NCT00794040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917950|NCT00794040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92917951|NCT00794040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92917952|NCT00794040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917953|NCT00794040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917954|NCT00794040|Dopamine Agents|dopamine agents|mesh-ancestor
92917955|NCT00794040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92917956|NCT00794040|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92917957|NCT00794040|Serotonin Agents|serotonin agents|mesh-ancestor
92917958|NCT00794040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92563402|NCT00051584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917959|NCT00794040|Antidepressive Agents|antidepressive agents|mesh-ancestor
92917960|NCT00794040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92917962|NCT04109742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92917963|NCT04109742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92917964|NCT04109742|Analgesics|analgesics|mesh-ancestor
92917965|NCT04109742|Sensory System Agents|sensory system agents|mesh-ancestor
92917966|NCT04109742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917967|NCT04109742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917968|NCT04109742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92917969|NCT04109742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92917970|NCT04109742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92917971|NCT04109742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92917972|NCT04109742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917973|NCT00813488|Fentanyl|fentanyl|mesh-list
92917974|NCT00813488|Oxycodone|oxycodone|mesh-list
92917975|NCT00813488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92917976|NCT00813488|Narcotics|narcotics|mesh-ancestor
92917977|NCT00813488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92917978|NCT00813488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917979|NCT00813488|Analgesics|analgesics|mesh-ancestor
92917980|NCT00813488|Sensory System Agents|sensory system agents|mesh-ancestor
92917981|NCT00813488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92917982|NCT00813488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92917983|NCT00813488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92917984|NCT00813488|Anesthetics, General|anesthetics, general|mesh-ancestor
92917985|NCT00813488|Anesthetics|anesthetics|mesh-ancestor
92917986|NCT00797316|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92917987|NCT00797316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92917988|NCT00797316|Diuretics|diuretics|mesh-ancestor
92917989|NCT00797316|Natriuretic Agents|natriuretic agents|mesh-ancestor
92917990|NCT00797316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92917991|NCT00797316|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92917992|NCT00797316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92917993|NCT00797316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92917994|NCT05640336|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92917995|NCT05640336|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92917996|NCT05640336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92917997|NCT05640336|Antitubercular Agents|antitubercular agents|mesh-ancestor
92917998|NCT05753696|Losartan|losartan|mesh-list
92917999|NCT05753696|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92918000|NCT05753696|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92918001|NCT05753696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92918002|NCT05753696|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92918003|NCT05753696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92918004|NCT05753696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918005|NCT04107480|Dopamine|dopamine|mesh-list
92918006|NCT04107480|Dopamine Agonists|dopamine agonists|mesh-list
92918007|NCT04107480|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92918008|NCT04107480|Sympathomimetics|sympathomimetics|mesh-ancestor
92918009|NCT04107480|Autonomic Agents|autonomic agents|mesh-ancestor
92918010|NCT04107480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918011|NCT04107480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918012|NCT04107480|Dopamine Agents|dopamine agents|mesh-ancestor
92918013|NCT04107480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918014|NCT04107480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918015|NCT04107480|Protective Agents|protective agents|mesh-ancestor
92918016|NCT00915408|Dexamethasone|dexamethasone|mesh-list
92918017|NCT00915408|Cyclophosphamide|cyclophosphamide|mesh-list
92918018|NCT00915408|Lenalidomide|lenalidomide|mesh-list
92918019|NCT00915408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918020|NCT00915408|Immunologic Factors|immunologic factors|mesh-ancestor
92918021|NCT00915408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918022|NCT00915408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918023|NCT00915408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92918024|NCT00915408|Alkylating Agents|alkylating agents|mesh-ancestor
92918025|NCT00915408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918026|NCT00915408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918027|NCT00915408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92918028|NCT00915408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918029|NCT00915408|Antiemetics|antiemetics|mesh-ancestor
92918030|NCT00915408|Autonomic Agents|autonomic agents|mesh-ancestor
92918031|NCT00915408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218392|NCT03296800|Vasodilator Agents|vasodilator agents|mesh-ancestor
92918032|NCT00915408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563482|NCT00158548|Amebicides|amebicides|mesh-ancestor
92918033|NCT00915408|Glucocorticoids|glucocorticoids|mesh-ancestor
92918034|NCT00915408|Hormones|hormones|mesh-ancestor
92918035|NCT00915408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918036|NCT00915408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92918037|NCT00915408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92918038|NCT00915408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92918039|NCT00915408|Growth Substances|growth substances|mesh-ancestor
92918040|NCT00915408|Growth Inhibitors|growth inhibitors|mesh-ancestor
92918042|NCT05573724|Antifungal Agents|antifungal agents|mesh-ancestor
92918043|NCT05573724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918044|NCT05573724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92918045|NCT05573724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92918046|NCT05573724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918047|NCT05573724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918048|NCT05573724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92918049|NCT05573724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92918050|NCT05573724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918051|NCT05573724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918052|NCT05573724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92918053|NCT00791076|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
92918054|NCT00791076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918055|NCT00791076|Hormones|hormones|mesh-ancestor
92918056|NCT00791076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918057|NCT00791076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918058|NCT02610062|AGS67E|ags67e|mesh-list
92918059|NCT02610062|Immunoconjugates|immunoconjugates|mesh-ancestor
92918060|NCT02610062|Immunologic Factors|immunologic factors|mesh-ancestor
92918061|NCT02610062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918062|NCT00625378|Sorafenib|sorafenib|mesh-list
92918063|NCT00625378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918064|NCT00625378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92918065|NCT00625378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918066|NCT00625378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918067|NCT00806624|Warfarin|warfarin|mesh-list
92918068|NCT00806624|Edoxaban|edoxaban|mesh-list
92918069|NCT00806624|Anticoagulants|anticoagulants|mesh-ancestor
92918070|NCT00806624|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92918071|NCT00806624|Antithrombins|antithrombins|mesh-ancestor
92918072|NCT00806624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92918073|NCT00806624|Protease Inhibitors|protease inhibitors|mesh-ancestor
92918074|NCT00806624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918075|NCT00806624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918076|NCT00624832|Omalizumab|omalizumab|mesh-list
92918077|NCT00624832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92918078|NCT00624832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92918079|NCT00624832|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918080|NCT05753150|Primaquine|primaquine|mesh-list
92918081|NCT05753150|Tafenoquine|tafenoquine|mesh-list
92918082|NCT05753150|Antimalarials|antimalarials|mesh-ancestor
92918083|NCT05753150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92918084|NCT05753150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92918085|NCT05753150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918086|NCT00826852|Carboplatin|carboplatin|mesh-list
92918087|NCT00826852|Docetaxel|docetaxel|mesh-list
92918088|NCT00826852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918089|NCT00826852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92918090|NCT00826852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92918091|NCT00826852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92918092|NCT00826852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918093|NCT00826930|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92918094|NCT00826930|Antioxidants|antioxidants|mesh-ancestor
92918095|NCT00826930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918096|NCT00826930|Protective Agents|protective agents|mesh-ancestor
92918097|NCT00826930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918098|NCT00826930|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92918099|NCT00826930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918100|NCT00913796|Potassium Citrate|potassium citrate|mesh-list
92918101|NCT00913796|Diuretics|diuretics|mesh-ancestor
92918102|NCT00913796|Natriuretic Agents|natriuretic agents|mesh-ancestor
92918103|NCT00913796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918104|NCT00913796|Expectorants|expectorants|mesh-ancestor
92918105|NCT00913796|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918106|NCT00633880|Droxidopa|droxidopa|mesh-list
92918107|NCT00633880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92563553|NCT00159094|Vinorelbine|vinorelbine|mesh-list
92918108|NCT00633880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92918109|NCT04029428|Octreotide|octreotide|mesh-list
92918110|NCT04029428|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92918111|NCT04029428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92918112|NCT04029428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918113|NCT04029428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918114|NCT04029428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92977268|NCT00982449|Fialuridine|fialuridine|mesh-list
92918115|NCT04029428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918116|NCT00819520|Ivermectin|ivermectin|mesh-list
92918117|NCT00819520|Malathion|malathion|mesh-list
92918118|NCT00819520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92918119|NCT00819520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918120|NCT00819520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92918121|NCT00819520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918122|NCT00819520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918123|NCT00819520|Cholinergic Agents|cholinergic agents|mesh-ancestor
92918124|NCT00819520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918125|NCT00819520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918126|NCT00631696|Pregabalin|pregabalin|mesh-list
92918127|NCT00631696|Analgesics|analgesics|mesh-ancestor
92918128|NCT00631696|Sensory System Agents|sensory system agents|mesh-ancestor
92918129|NCT00631696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918130|NCT00631696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918131|NCT00631696|Anticonvulsants|anticonvulsants|mesh-ancestor
92918132|NCT00631696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92918133|NCT00631696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918134|NCT00631696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918135|NCT00631696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92918136|NCT00631696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92918137|NCT00631696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918138|NCT00631696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918139|NCT00631696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918140|NCT02608112|Methotrexate|methotrexate|mesh-list
92918141|NCT02608112|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92918142|NCT02608112|Abortifacient Agents|abortifacient agents|mesh-ancestor
92918143|NCT02608112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92918144|NCT02608112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918145|NCT02608112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92918146|NCT02608112|Antimetabolites|antimetabolites|mesh-ancestor
92918147|NCT02608112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918148|NCT02608112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918149|NCT02608112|Dermatologic Agents|dermatologic agents|mesh-ancestor
92918150|NCT02608112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918151|NCT02608112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92918152|NCT02608112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918153|NCT02608112|Immunologic Factors|immunologic factors|mesh-ancestor
92918154|NCT02608112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918155|NCT02608112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92918156|NCT04375384|Cetuximab|cetuximab|mesh-list
92918157|NCT04375384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918158|NCT04375384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918159|NCT02549326|Vitamin D|vitamin d|mesh-list
92918160|NCT02549326|Cholecalciferol|cholecalciferol|mesh-list
92918161|NCT02549326|Vitamins|vitamins|mesh-ancestor
92918162|NCT02549326|Micronutrients|micronutrients|mesh-ancestor
92918163|NCT02549326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918164|NCT02549326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92918165|NCT02549326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92918166|NCT00819676|Nitric Oxide|nitric oxide|mesh-list
92918167|NCT00819676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92918168|NCT00819676|Autonomic Agents|autonomic agents|mesh-ancestor
92918169|NCT00819676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918170|NCT00819676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918171|NCT00819676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92918172|NCT00819676|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918173|NCT00819676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92918174|NCT00819676|Antioxidants|antioxidants|mesh-ancestor
92162710|NCT01251315|Antiviral Agents|antiviral agents|mesh-ancestor
92918175|NCT00819676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918176|NCT00819676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918177|NCT00819676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92918178|NCT00819676|Vasodilator Agents|vasodilator agents|mesh-ancestor
92918179|NCT00819676|Gasotransmitters|gasotransmitters|mesh-ancestor
92918180|NCT00819676|Protective Agents|protective agents|mesh-ancestor
92918181|NCT00827320|Levetiracetam|levetiracetam|mesh-list
92918182|NCT00827320|Anticonvulsants|anticonvulsants|mesh-ancestor
92918183|NCT00827320|Nootropic Agents|nootropic agents|mesh-ancestor
92918185|NCT00819754|Capecitabine|capecitabine|mesh-list
92918186|NCT00819754|Oxaliplatin|oxaliplatin|mesh-list
92918187|NCT00819754|Irinotecan|irinotecan|mesh-list
92918188|NCT00819754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918189|NCT00819754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918190|NCT00819754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92918191|NCT00819754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92918192|NCT00819754|Growth Substances|growth substances|mesh-ancestor
92918193|NCT00819754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918194|NCT00819754|Growth Inhibitors|growth inhibitors|mesh-ancestor
92918195|NCT00819754|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92918196|NCT00819754|Antimetabolites|antimetabolites|mesh-ancestor
92918197|NCT00819754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918198|NCT00819754|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92918199|NCT00819754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92918200|NCT00819754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918201|NCT00819988|Pregabalin|pregabalin|mesh-list
92918202|NCT00819988|Analgesics|analgesics|mesh-ancestor
92918203|NCT00819988|Sensory System Agents|sensory system agents|mesh-ancestor
92918204|NCT00819988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918205|NCT00819988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918206|NCT00819988|Anticonvulsants|anticonvulsants|mesh-ancestor
92918207|NCT00819988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92918208|NCT00819988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918209|NCT00819988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918210|NCT00819988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92918211|NCT00819988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92918212|NCT00819988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918213|NCT00819988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918214|NCT00819988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918215|NCT00827554|Nadroparin|nadroparin|mesh-list
92918216|NCT00827554|Anticoagulants|anticoagulants|mesh-ancestor
92918217|NCT00827554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92918218|NCT00827554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92918219|NCT00827554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918220|NCT00847145|Vaccines|vaccines|mesh-list
92918221|NCT00847145|Immunologic Factors|immunologic factors|mesh-ancestor
92918222|NCT00847145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918223|NCT00701597|Bosentan|bosentan|mesh-list
92918224|NCT00701597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92918225|NCT00701597|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92918226|NCT00701597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918227|NCT00700193|Vaccines|vaccines|mesh-list
92918228|NCT00700193|Immunologic Factors|immunologic factors|mesh-ancestor
92918229|NCT00700193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918230|NCT00846521|Acarbose|acarbose|mesh-list
92918231|NCT00846521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92918232|NCT00846521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918233|NCT00846521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918234|NCT00846521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918235|NCT00846521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918236|NCT00698945|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92918237|NCT00698945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92918238|NCT00698945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92918239|NCT00698945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92918240|NCT00698945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92918241|NCT00698945|Adrenergic Agents|adrenergic agents|mesh-ancestor
92918242|NCT00698945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918243|NCT00698945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918244|NCT00698945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918245|NCT00862823|Tenofovir|tenofovir|mesh-list
92918246|NCT00862823|Emtricitabine|emtricitabine|mesh-list
92918247|NCT00862823|Efavirenz|efavirenz|mesh-list
92918248|NCT00862823|Antiviral Agents|antiviral agents|mesh-ancestor
92918249|NCT00862823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918250|NCT00862823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92918251|NCT00862823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92918252|NCT00862823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918253|NCT00862823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918254|NCT00862823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92918255|NCT00862823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92918256|NCT00862823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92918257|NCT00862823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92918258|NCT00862823|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92918259|NCT00862823|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92918260|NCT00862823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92918261|NCT00862823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92918263|NCT00790842|Lenalidomide|lenalidomide|mesh-list
92918264|NCT00790842|Heparin|heparin|mesh-list
92918265|NCT00790842|Calcium heparin|calcium heparin|mesh-list
92918266|NCT00790842|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92918267|NCT00790842|Tinzaparin|tinzaparin|mesh-list
92918268|NCT00790842|Dalteparin|dalteparin|mesh-list
92918269|NCT00790842|Anticoagulants|anticoagulants|mesh-list
92918270|NCT00790842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918271|NCT00790842|Antiemetics|antiemetics|mesh-ancestor
92918272|NCT00790842|Autonomic Agents|autonomic agents|mesh-ancestor
92918273|NCT00790842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918274|NCT00790842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918275|NCT00790842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918276|NCT00790842|Glucocorticoids|glucocorticoids|mesh-ancestor
92918277|NCT00790842|Hormones|hormones|mesh-ancestor
92918278|NCT00790842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918279|NCT00790842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92918280|NCT00790842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918281|NCT00790842|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92918282|NCT00790842|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92918283|NCT00790842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918284|NCT00790842|Immunologic Factors|immunologic factors|mesh-ancestor
92918285|NCT00790842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92918286|NCT00790842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92918287|NCT00790842|Growth Substances|growth substances|mesh-ancestor
92918288|NCT00790842|Growth Inhibitors|growth inhibitors|mesh-ancestor
92918289|NCT04104204|Morphine|morphine|mesh-list
92918290|NCT04104204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92918291|NCT04104204|Narcotics|narcotics|mesh-ancestor
92918292|NCT04104204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918293|NCT04104204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918294|NCT04104204|Analgesics|analgesics|mesh-ancestor
92918295|NCT04104204|Sensory System Agents|sensory system agents|mesh-ancestor
92918296|NCT04104204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918297|NCT05572476|Carboplatin|carboplatin|mesh-list
92918298|NCT05572476|Etoposide|etoposide|mesh-list
92918299|NCT05572476|Durvalumab|durvalumab|mesh-list
92918300|NCT05572476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918301|NCT05572476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92918302|NCT05572476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92918303|NCT05572476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92918304|NCT05572476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918305|NCT05572476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918306|NCT05572476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918307|NCT00574288|Dexamethasone|dexamethasone|mesh-list
92918308|NCT00574288|Methylprednisolone|methylprednisolone|mesh-list
92918309|NCT00574288|Daratumumab|daratumumab|mesh-list
92918310|NCT00574288|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92918311|NCT00574288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918312|NCT00574288|Antiemetics|antiemetics|mesh-ancestor
92918313|NCT00574288|Autonomic Agents|autonomic agents|mesh-ancestor
92918314|NCT00574288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918315|NCT00574288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918316|NCT00574288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918317|NCT00574288|Glucocorticoids|glucocorticoids|mesh-ancestor
92918318|NCT00574288|Hormones|hormones|mesh-ancestor
92918319|NCT00574288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918320|NCT00574288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92918321|NCT00574288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918322|NCT00574288|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92918323|NCT00574288|Protective Agents|protective agents|mesh-ancestor
92918324|NCT00574288|Immunologic Factors|immunologic factors|mesh-ancestor
92918325|NCT00790452|Aspirin|aspirin|mesh-list
92918326|NCT00790452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92918327|NCT00790452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92918328|NCT00790452|Analgesics|analgesics|mesh-ancestor
92918329|NCT00790452|Sensory System Agents|sensory system agents|mesh-ancestor
92918330|NCT00790452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918331|NCT00790452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918332|NCT00790452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918333|NCT00790452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918334|NCT00790452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92918335|NCT00790452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92918336|NCT00790452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918337|NCT00790452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92918338|NCT00790452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92918339|NCT00790452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918340|NCT00790452|Antipyretics|antipyretics|mesh-ancestor
92918342|NCT00823030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92918343|NCT00823030|Anesthetics|anesthetics|mesh-ancestor
92918344|NCT00823030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918345|NCT00823030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918346|NCT00823030|Sensory System Agents|sensory system agents|mesh-ancestor
92918347|NCT00823030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918348|NCT00823030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92918349|NCT00823030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92918350|NCT00823030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92918351|NCT00823030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918352|NCT00823030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918353|NCT00823186|Paclitaxel|paclitaxel|mesh-list
92918354|NCT00823186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92918355|NCT00823186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918356|NCT00823186|Tubulin Modulators|tubulin modulators|mesh-ancestor
92918357|NCT00823186|Antimitotic Agents|antimitotic agents|mesh-ancestor
92918358|NCT00823186|Mitosis Modulators|mitosis modulators|mesh-ancestor
92918359|NCT00823186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918360|NCT00626392|Aspirin|aspirin|mesh-list
92918361|NCT00626392|Niacin|niacin|mesh-list
92918362|NCT00626392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92918363|NCT00626392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92918364|NCT00626392|Analgesics|analgesics|mesh-ancestor
92918365|NCT00626392|Sensory System Agents|sensory system agents|mesh-ancestor
92918366|NCT00626392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918367|NCT00626392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918368|NCT00626392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918369|NCT00626392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918370|NCT00626392|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92918371|NCT00626392|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92918372|NCT00626392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918373|NCT00626392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92918374|NCT00626392|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92918375|NCT00626392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918376|NCT00626392|Antipyretics|antipyretics|mesh-ancestor
92918377|NCT00626392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92918378|NCT00626392|Antimetabolites|antimetabolites|mesh-ancestor
92918379|NCT00626392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92918380|NCT00626392|Vasodilator Agents|vasodilator agents|mesh-ancestor
92918381|NCT00626392|Vitamin B Complex|vitamin b complex|mesh-ancestor
92918382|NCT00626392|Vitamins|vitamins|mesh-ancestor
92918383|NCT00626392|Micronutrients|micronutrients|mesh-ancestor
92918384|NCT00820690|Paclitaxel|paclitaxel|mesh-list
92918385|NCT00820690|Cyclophosphamide|cyclophosphamide|mesh-list
92918386|NCT00820690|Doxorubicin|doxorubicin|mesh-list
92918387|NCT00820690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92918388|NCT00820690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918389|NCT00820690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92918390|NCT00820690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92918391|NCT00820690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92918392|NCT00820690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918393|NCT00820690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918394|NCT00820690|Immunologic Factors|immunologic factors|mesh-ancestor
92918395|NCT00820690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918396|NCT00820690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918397|NCT00820690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92918398|NCT00820690|Alkylating Agents|alkylating agents|mesh-ancestor
92918399|NCT00820690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92918400|NCT00820690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92918401|NCT00820690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92918402|NCT00820690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92918403|NCT00820690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918404|NCT00820768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92918405|NCT00820768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918406|NCT00624052|Amlodipine|amlodipine|mesh-list
92563856|NCT00052559|Bevacizumab|bevacizumab|mesh-list
92918408|NCT00624052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92918409|NCT00624052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92918410|NCT00624052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918411|NCT00624052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977269|NCT00982449|Antiviral Agents|antiviral agents|mesh-ancestor
92918412|NCT00624052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92918413|NCT00624052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918414|NCT00624052|Vasodilator Agents|vasodilator agents|mesh-ancestor
92918415|NCT00624052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92918416|NCT00624052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92918418|NCT00821080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92918419|NCT00821080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918420|NCT00821080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92918421|NCT00821080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918422|NCT00821080|Antifungal Agents|antifungal agents|mesh-ancestor
92918423|NCT00821080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918424|NCT00821080|Immunologic Factors|immunologic factors|mesh-ancestor
92918425|NCT00821080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918426|NCT04044430|Nivolumab|nivolumab|mesh-list
92918427|NCT04044430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918428|NCT04044430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918429|NCT04044430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92918430|NCT04044430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918431|NCT00821158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92918432|NCT00821158|Antioxidants|antioxidants|mesh-list
92918433|NCT00821158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918434|NCT00821158|Protective Agents|protective agents|mesh-ancestor
92918435|NCT00821158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918436|NCT00828646|BMS 708163|bms 708163|mesh-list
92918437|NCT00828646|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92918438|NCT00828646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918439|NCT00828646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918440|NCT02548936|Simvastatin|simvastatin|mesh-list
92918441|NCT02548936|Ezetimibe|ezetimibe|mesh-list
92918442|NCT02548936|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92918443|NCT02548936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92918444|NCT02548936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92918445|NCT02548936|Antimetabolites|antimetabolites|mesh-ancestor
92918446|NCT02548936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918447|NCT02548936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92918448|NCT02548936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92918449|NCT02548936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918450|NCT00828802|Lenalidomide|lenalidomide|mesh-list
92918451|NCT00828802|Decitabine|decitabine|mesh-list
92918452|NCT00828802|Immunologic Factors|immunologic factors|mesh-ancestor
92918453|NCT00828802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918454|NCT00828802|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92918455|NCT00828802|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92918456|NCT00828802|Growth Substances|growth substances|mesh-ancestor
92918457|NCT00828802|Growth Inhibitors|growth inhibitors|mesh-ancestor
92918458|NCT00828802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918459|NCT00828802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92918460|NCT00828802|Antimetabolites|antimetabolites|mesh-ancestor
92162719|NCT01251315|Antidotes|antidotes|mesh-ancestor
92918461|NCT00828802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918462|NCT00828802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918463|NCT00785577|Pregabalin|pregabalin|mesh-list
92918464|NCT00785577|Analgesics|analgesics|mesh-ancestor
92918465|NCT00785577|Sensory System Agents|sensory system agents|mesh-ancestor
92918466|NCT00785577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918467|NCT00785577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918468|NCT00785577|Anticonvulsants|anticonvulsants|mesh-ancestor
92918469|NCT00785577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92918470|NCT00785577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918471|NCT00785577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918472|NCT00785577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92918473|NCT00785577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92918474|NCT00785577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918475|NCT00785577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918476|NCT00785577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918477|NCT00830830|Hyaluronic Acid|hyaluronic acid|mesh-list
92918478|NCT00830830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92918479|NCT00830830|Immunologic Factors|immunologic factors|mesh-ancestor
92918480|NCT00830830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918481|NCT00830830|Viscosupplements|viscosupplements|mesh-ancestor
92918482|NCT00830830|Protective Agents|protective agents|mesh-ancestor
92918483|NCT00828958|Risperidone|risperidone|mesh-list
92263326|NCT04158258|Pertuzumab|pertuzumab|mesh-list
92918485|NCT00828958|Serotonin Agents|serotonin agents|mesh-ancestor
92918486|NCT00828958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918487|NCT00828958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918488|NCT00828958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918489|NCT00828958|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92918490|NCT00828958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918491|NCT00828958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918492|NCT00828958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918493|NCT00828958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92918494|NCT00828958|Dopamine Agents|dopamine agents|mesh-ancestor
92918495|NCT02548780|Doxorubicin|doxorubicin|mesh-list
92918496|NCT02548780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92918497|NCT02548780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918498|NCT02548780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92918499|NCT02548780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92918500|NCT02548780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918501|NCT02548780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918502|NCT04105023|Genistein|genistein|mesh-list
92918503|NCT04105023|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92918504|NCT04105023|Protective Agents|protective agents|mesh-ancestor
92918505|NCT04105023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918506|NCT04105023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918507|NCT04105023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92918508|NCT04105023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918509|NCT04105023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918510|NCT04105023|Phytoestrogens|phytoestrogens|mesh-ancestor
92918511|NCT04105023|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92918512|NCT04105023|Estrogens|estrogens|mesh-ancestor
92918513|NCT04105023|Hormones|hormones|mesh-ancestor
92918514|NCT04105023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918515|NCT04104867|Domperidone|domperidone|mesh-list
92918516|NCT04104867|Antiemetics|antiemetics|mesh-ancestor
92918517|NCT04104867|Autonomic Agents|autonomic agents|mesh-ancestor
92918518|NCT04104867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918519|NCT04104867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918520|NCT04104867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918521|NCT04104867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92918522|NCT04104867|Dopamine Agents|dopamine agents|mesh-ancestor
92918523|NCT04104867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918524|NCT04104867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918525|NCT00789828|Everolimus|everolimus|mesh-list
92918526|NCT00789828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92918527|NCT00789828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92918528|NCT00789828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918529|NCT00789828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918530|NCT00789828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918531|NCT00789828|Immunologic Factors|immunologic factors|mesh-ancestor
92918532|NCT00789828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162726|NCT03810287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92918533|NCT00789828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918534|NCT02550262|Fentanyl|fentanyl|mesh-list
92918535|NCT02550262|Bupivacaine|bupivacaine|mesh-list
92918536|NCT02550262|Anesthetics, Local|anesthetics, local|mesh-ancestor
92918537|NCT02550262|Anesthetics|anesthetics|mesh-ancestor
92918538|NCT02550262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918539|NCT02550262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918540|NCT02550262|Sensory System Agents|sensory system agents|mesh-ancestor
92918541|NCT02550262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918542|NCT02550262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92918543|NCT02550262|Narcotics|narcotics|mesh-ancestor
92918544|NCT02550262|Analgesics|analgesics|mesh-ancestor
92918545|NCT02550262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92918546|NCT02550262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92918547|NCT02550262|Anesthetics, General|anesthetics, general|mesh-ancestor
92918548|NCT02550418|Budesonide|budesonide|mesh-list
92918549|NCT02550418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918550|NCT02550418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92918551|NCT02550418|Autonomic Agents|autonomic agents|mesh-ancestor
92918552|NCT02550418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918553|NCT02550418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918554|NCT02550418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92918555|NCT02550418|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918556|NCT02550418|Glucocorticoids|glucocorticoids|mesh-ancestor
92918557|NCT02550418|Hormones|hormones|mesh-ancestor
92977270|NCT00982449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918558|NCT02550418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918559|NCT00829114|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92918561|NCT00829114|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92918562|NCT00829114|Estradiol|estradiol|mesh-list
92918563|NCT00829114|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92918564|NCT00829114|Estrogens|estrogens|mesh-ancestor
92918565|NCT00829114|Hormones|hormones|mesh-ancestor
92918566|NCT00829114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918567|NCT00829114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918568|NCT00829114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92918569|NCT00829114|Contraceptive Agents|contraceptive agents|mesh-ancestor
92918570|NCT00829114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92918571|NCT00829114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92918572|NCT00829114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92918573|NCT00829114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92918574|NCT00790296|Hormones|hormones|mesh-list
92918575|NCT00790296|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
92918576|NCT00790296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918577|NCT00790296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918578|NCT00829192|Afamelanotide|afamelanotide|mesh-list
92918579|NCT00829192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92918580|NCT00623194|Insulin|insulin|mesh-list
92918581|NCT00623194|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92918582|NCT00623194|Insulin Aspart|insulin aspart|mesh-list
92918583|NCT00623194|Insulin Detemir|insulin detemir|mesh-list
92918584|NCT00623194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918585|NCT00623194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918586|NCT00784368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92918587|NCT02548468|Mycophenolic Acid|mycophenolic acid|mesh-list
92918588|NCT02548468|Cyclophosphamide|cyclophosphamide|mesh-list
92918589|NCT02548468|Fludarabine|fludarabine|mesh-list
92918590|NCT02548468|Fludarabine phosphate|fludarabine phosphate|mesh-list
92918591|NCT02548468|Tacrolimus|tacrolimus|mesh-list
92918592|NCT02548468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918593|NCT02548468|Immunologic Factors|immunologic factors|mesh-ancestor
92918594|NCT02548468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918595|NCT02548468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918596|NCT02548468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92918597|NCT02548468|Alkylating Agents|alkylating agents|mesh-ancestor
92918598|NCT02548468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918599|NCT02548468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918600|NCT02548468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92918601|NCT02548468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92918602|NCT02548468|Antimetabolites|antimetabolites|mesh-ancestor
92918603|NCT02548468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918604|NCT02548468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92918605|NCT02548468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918606|NCT02548468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92918607|NCT02548468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92918608|NCT02548468|Antitubercular Agents|antitubercular agents|mesh-ancestor
92918609|NCT02548468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92918610|NCT00829660|Acarbose|acarbose|mesh-list
92918611|NCT00829660|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92918612|NCT00829660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918613|NCT00829660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918614|NCT00829660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918615|NCT00829660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918616|NCT00915564|Simeprevir|simeprevir|mesh-list
92918617|NCT00915564|Methadone|methadone|mesh-list
92918618|NCT00915564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92918619|NCT00915564|Narcotics|narcotics|mesh-ancestor
92918620|NCT00915564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918621|NCT00915564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918622|NCT00915564|Analgesics|analgesics|mesh-ancestor
92918623|NCT00915564|Sensory System Agents|sensory system agents|mesh-ancestor
92918624|NCT00915564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918625|NCT00915564|Antitussive Agents|antitussive agents|mesh-ancestor
92918626|NCT00915564|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918627|NCT00915564|Antiviral Agents|antiviral agents|mesh-ancestor
92918628|NCT00915564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918629|NCT00915564|Protease Inhibitors|protease inhibitors|mesh-ancestor
92918630|NCT00915564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918631|NCT00915564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918632|NCT02603406|Epoetin Alfa|epoetin alfa|mesh-list
92918633|NCT02603406|Hematinics|hematinics|mesh-ancestor
92918634|NCT04106700|Apixaban|apixaban|mesh-list
92918635|NCT04106700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92918636|NCT04106700|Antithrombins|antithrombins|mesh-ancestor
92918637|NCT04106700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92918638|NCT04106700|Protease Inhibitors|protease inhibitors|mesh-ancestor
92918639|NCT04106700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918640|NCT04106700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918641|NCT04106700|Anticoagulants|anticoagulants|mesh-ancestor
92918642|NCT00831376|Albuterol|albuterol|mesh-list
92918643|NCT00831376|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92918644|NCT00831376|Autonomic Agents|autonomic agents|mesh-ancestor
92918645|NCT00831376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918646|NCT00831376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918647|NCT00831376|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92918648|NCT00831376|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918649|NCT00831376|Tocolytic Agents|tocolytic agents|mesh-ancestor
92918650|NCT00831376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92918651|NCT00831376|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92918652|NCT00831376|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92918653|NCT00831376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92918654|NCT00831376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92918655|NCT00831376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918656|NCT00831376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918657|NCT02602470|Metronidazole|metronidazole|mesh-list
92918658|NCT02602470|Azelaic acid|azelaic acid|mesh-list
92918659|NCT02602470|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92918660|NCT02602470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918661|NCT02602470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92918662|NCT02602470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92918663|NCT02602470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92918664|NCT02602470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92918665|NCT02602470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92918666|NCT02602470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92918667|NCT02602470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92918668|NCT02602470|Adrenergic Agents|adrenergic agents|mesh-ancestor
92918669|NCT02602470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918670|NCT02602470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918671|NCT02602470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918672|NCT02602470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918673|NCT02602470|Dermatologic Agents|dermatologic agents|mesh-ancestor
92918674|NCT00824200|Tamsulosin|tamsulosin|mesh-list
92918675|NCT00824200|Adrenergic Agents|adrenergic agents|mesh-list
92918676|NCT00824200|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92918677|NCT00824200|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92918678|NCT00824200|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92918679|NCT00824200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918680|NCT00824200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918681|NCT00824200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918682|NCT00824200|Urological Agents|urological agents|mesh-ancestor
92918683|NCT00829894|Risperidone|risperidone|mesh-list
92918684|NCT00829894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92918685|NCT00829894|Serotonin Agents|serotonin agents|mesh-ancestor
92918686|NCT00829894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918687|NCT00829894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918688|NCT00829894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918689|NCT00829894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92918690|NCT00829894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918691|NCT00829894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918692|NCT00829894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918693|NCT00829894|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92918694|NCT00829894|Dopamine Agents|dopamine agents|mesh-ancestor
92918695|NCT00622726|Bevacizumab|bevacizumab|mesh-list
92918696|NCT00622726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918697|NCT00622726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918698|NCT00622726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92918699|NCT00622726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92918700|NCT00622726|Growth Substances|growth substances|mesh-ancestor
92918701|NCT00622726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918702|NCT00622726|Growth Inhibitors|growth inhibitors|mesh-ancestor
92918703|NCT00830050|Naproxen|naproxen|mesh-list
92526216|NCT00000479|Analgesics|analgesics|mesh-ancestor
92918704|NCT00830050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92918705|NCT00830050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92918707|NCT00830050|Sensory System Agents|sensory system agents|mesh-ancestor
92918708|NCT00830050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918709|NCT00830050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918710|NCT00830050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918711|NCT00830050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918712|NCT00830050|Gout Suppressants|gout suppressants|mesh-ancestor
92918713|NCT00830050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92918714|NCT00830050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918715|NCT00830050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918716|NCT00623428|Ribavirin|ribavirin|mesh-list
92918717|NCT00623428|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92918718|NCT00623428|Antimetabolites|antimetabolites|mesh-ancestor
92918719|NCT00623428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918720|NCT00623428|Antiviral Agents|antiviral agents|mesh-ancestor
92918721|NCT00623428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918722|NCT00824668|Insulin|insulin|mesh-list
92918723|NCT00824668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92918724|NCT00824668|Insulin Glargine|insulin glargine|mesh-list
92918725|NCT00824668|Insulin Aspart|insulin aspart|mesh-list
92918726|NCT00824668|Biphasic Insulins|biphasic insulins|mesh-list
92918727|NCT00824668|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92918728|NCT00824668|Insulin glulisine|insulin glulisine|mesh-list
92918729|NCT00824668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918730|NCT00824668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918731|NCT00832234|Dexamethasone|dexamethasone|mesh-list
92918732|NCT00832234|Rituximab|rituximab|mesh-list
92918733|NCT00832234|Bortezomib|bortezomib|mesh-list
92918734|NCT00832234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918735|NCT00832234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918736|NCT00832234|Immunologic Factors|immunologic factors|mesh-ancestor
92918737|NCT00832234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918738|NCT00832234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918739|NCT00832234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918740|NCT00832234|Antiemetics|antiemetics|mesh-ancestor
92918741|NCT00832234|Autonomic Agents|autonomic agents|mesh-ancestor
92918742|NCT00832234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918743|NCT00832234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918744|NCT00832234|Glucocorticoids|glucocorticoids|mesh-ancestor
92918745|NCT00832234|Hormones|hormones|mesh-ancestor
92918746|NCT00832234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918747|NCT00832234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92918748|NCT05036980|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92918749|NCT05036980|Antioxidants|antioxidants|mesh-ancestor
92918750|NCT05036980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918751|NCT05036980|Protective Agents|protective agents|mesh-ancestor
92918752|NCT05036980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918753|NCT05036980|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92918754|NCT05036980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918755|NCT00837850|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92918756|NCT00837850|Vasodilator Agents|vasodilator agents|mesh-ancestor
92918757|NCT00837850|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92918758|NCT00837850|Protective Agents|protective agents|mesh-ancestor
92918759|NCT00837850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918760|NCT00784134|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92918761|NCT00784134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92918762|NCT00784134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92918763|NCT00784134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918764|NCT00837928|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92918765|NCT00837928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92918766|NCT00837928|Alkylating Agents|alkylating agents|mesh-ancestor
92918767|NCT00837928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918768|NCT00837928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918769|NCT04102566|Ibuprofen|ibuprofen|mesh-list
92918770|NCT04102566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92918771|NCT04102566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92918772|NCT04102566|Analgesics|analgesics|mesh-ancestor
92918773|NCT04102566|Sensory System Agents|sensory system agents|mesh-ancestor
92918774|NCT04102566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918775|NCT04102566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918776|NCT04102566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918777|NCT04102566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918778|NCT04102566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92918779|NCT04102566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918780|NCT04102566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918781|NCT04102176|Tin Fluorides|tin fluorides|mesh-list
92918782|NCT04102176|Cariostatic Agents|cariostatic agents|mesh-ancestor
92918783|NCT04102176|Protective Agents|protective agents|mesh-ancestor
92918784|NCT04102176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918785|NCT00783432|Azelastine|azelastine|mesh-list
92918786|NCT00783432|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92918787|NCT00783432|Autonomic Agents|autonomic agents|mesh-ancestor
92918788|NCT00783432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918789|NCT00783432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918790|NCT00783432|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92918791|NCT00783432|Respiratory System Agents|respiratory system agents|mesh-ancestor
92918792|NCT00783432|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92918793|NCT00783432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918794|NCT00783432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918795|NCT00783432|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92918796|NCT00783432|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92918797|NCT00783432|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92918798|NCT00783432|Histamine Antagonists|histamine antagonists|mesh-ancestor
92918799|NCT00783432|Histamine Agents|histamine agents|mesh-ancestor
92918800|NCT00783432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918801|NCT00789360|Loxapine|loxapine|mesh-list
92918802|NCT00789360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92918803|NCT00789360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918804|NCT00789360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918805|NCT00789360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918806|NCT00789360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918807|NCT00789360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92918808|NCT00789360|Dopamine Agents|dopamine agents|mesh-ancestor
92918809|NCT00789360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918810|NCT00789360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918811|NCT05526924|Fluorouracil|fluorouracil|mesh-list
92918812|NCT05526924|Tislelizumab|tislelizumab|mesh-list
92918813|NCT05526924|Hydroxyurea|hydroxyurea|mesh-list
92918814|NCT05526924|Pamiparib|pamiparib|mesh-list
92918815|NCT05526924|Antimetabolites|antimetabolites|mesh-ancestor
92918816|NCT05526924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918817|NCT05526924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92918818|NCT05526924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918819|NCT05526924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918820|NCT05526924|Immunologic Factors|immunologic factors|mesh-ancestor
92918821|NCT05526924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918822|NCT05526924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918823|NCT05526924|Antisickling Agents|antisickling agents|mesh-ancestor
92918824|NCT05526924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918825|NCT05526924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92918826|NCT05526924|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92918827|NCT00782418|Exenatide|exenatide|mesh-list
92918828|NCT00782418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918829|NCT00782418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918830|NCT00782418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92918831|NCT00782418|Incretins|incretins|mesh-ancestor
92918832|NCT00782418|Hormones|hormones|mesh-ancestor
92918833|NCT00782418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918834|NCT00782340|Droxidopa|droxidopa|mesh-list
92918835|NCT00782340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92918836|NCT00782340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92918837|NCT00774852|Prednisone|prednisone|mesh-list
92918838|NCT00774852|Cyclophosphamide|cyclophosphamide|mesh-list
92918839|NCT00774852|Abatacept|abatacept|mesh-list
92918840|NCT00774852|Azathioprine|azathioprine|mesh-list
92918841|NCT00774852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92918842|NCT00774852|Immunologic Factors|immunologic factors|mesh-ancestor
92918843|NCT00774852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918844|NCT00774852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918845|NCT00774852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92918846|NCT00774852|Alkylating Agents|alkylating agents|mesh-ancestor
92918847|NCT00774852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918848|NCT00774852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918849|NCT00774852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92918850|NCT00774852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918851|NCT00774852|Glucocorticoids|glucocorticoids|mesh-ancestor
92918852|NCT00774852|Hormones|hormones|mesh-ancestor
92918853|NCT00774852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918854|NCT00774852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92918855|NCT00774852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92918856|NCT00774852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92918857|NCT00774852|Antimetabolites|antimetabolites|mesh-ancestor
92918858|NCT00774852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92918859|NCT00774306|Phenytoin|phenytoin|mesh-list
92918860|NCT00774306|Levetiracetam|levetiracetam|mesh-list
92918861|NCT00774306|Valproic Acid|valproic acid|mesh-list
92918862|NCT00774306|Anticonvulsants|anticonvulsants|mesh-ancestor
92918863|NCT00774306|Nootropic Agents|nootropic agents|mesh-ancestor
92918864|NCT00774306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918865|NCT00774306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918866|NCT00774306|GABA Agents|gaba agents|mesh-ancestor
92918867|NCT00774306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918868|NCT00774306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918869|NCT00774306|Antimanic Agents|antimanic agents|mesh-ancestor
92918870|NCT00774306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92918871|NCT00774306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918872|NCT00774306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92918873|NCT00774306|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92918874|NCT00774306|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92918875|NCT00774306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918876|NCT00774306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92918877|NCT00774306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92918878|NCT04105920|Hyaluronic Acid|hyaluronic acid|mesh-list
92918879|NCT04105920|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92918880|NCT04105920|Immunologic Factors|immunologic factors|mesh-ancestor
92918881|NCT04105920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918882|NCT04105920|Viscosupplements|viscosupplements|mesh-ancestor
92918883|NCT04105920|Protective Agents|protective agents|mesh-ancestor
92918884|NCT04105764|Bromides|bromides|mesh-list
92918885|NCT04105764|Rocuronium|rocuronium|mesh-list
92918886|NCT04105764|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92918887|NCT04105764|Anticonvulsants|anticonvulsants|mesh-ancestor
92918888|NCT04105764|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92918889|NCT04105764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92918890|NCT04105764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918891|NCT04105764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918892|NCT00781326|Nimodipine|nimodipine|mesh-list
92918893|NCT00781326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92918894|NCT00781326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92918895|NCT00781326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92918896|NCT00781326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918897|NCT00781326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92918898|NCT00781326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918899|NCT00781326|Vasodilator Agents|vasodilator agents|mesh-ancestor
92918900|NCT00773838|Dexamethasone|dexamethasone|mesh-list
92918901|NCT00773838|Bortezomib|bortezomib|mesh-list
92918902|NCT00773838|Vorinostat|vorinostat|mesh-list
92918903|NCT00773838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918904|NCT00773838|Antiemetics|antiemetics|mesh-ancestor
92918905|NCT00773838|Autonomic Agents|autonomic agents|mesh-ancestor
92918906|NCT00773838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918907|NCT00773838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918908|NCT00773838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918909|NCT00773838|Glucocorticoids|glucocorticoids|mesh-ancestor
92918910|NCT00773838|Hormones|hormones|mesh-ancestor
92918911|NCT00773838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92918912|NCT00773838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92918913|NCT00773838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918914|NCT00773838|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92918915|NCT00773838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918916|NCT00773838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918917|NCT00787644|Pioglitazone|pioglitazone|mesh-list
92918918|NCT00787644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918919|NCT00787644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918920|NCT02602002|Remifentanil|remifentanil|mesh-list
92918921|NCT02602002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92918922|NCT02602002|Narcotics|narcotics|mesh-ancestor
92918923|NCT02602002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918924|NCT02602002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918925|NCT02602002|Analgesics|analgesics|mesh-ancestor
92918926|NCT02602002|Sensory System Agents|sensory system agents|mesh-ancestor
92918927|NCT02602002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918928|NCT00787566|Granisetron|granisetron|mesh-list
92918929|NCT00787566|Antiemetics|antiemetics|mesh-ancestor
92918930|NCT00787566|Autonomic Agents|autonomic agents|mesh-ancestor
92918931|NCT00787566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918932|NCT00787566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918933|NCT00787566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918934|NCT00787566|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92918935|NCT00787566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92918936|NCT00787566|Serotonin Agents|serotonin agents|mesh-ancestor
92918937|NCT00787566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918938|NCT00787566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918940|NCT02602938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92918941|NCT02602938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92918942|NCT02602938|Analgesics|analgesics|mesh-ancestor
92918943|NCT02602938|Sensory System Agents|sensory system agents|mesh-ancestor
92918944|NCT02602938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918945|NCT02602938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918946|NCT02602938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92918947|NCT02602938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92918948|NCT02602938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92918949|NCT02602938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92918950|NCT02602938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918951|NCT02602938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92918952|NCT02602938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92918953|NCT02602938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918954|NCT02602938|Antipyretics|antipyretics|mesh-ancestor
92918955|NCT00787254|Lansoprazole|lansoprazole|mesh-list
92918956|NCT00787254|Dexlansoprazole|dexlansoprazole|mesh-list
92918957|NCT00787254|Gefarnate|gefarnate|mesh-list
92918958|NCT00787254|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92918959|NCT00787254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92918960|NCT00787254|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92918961|NCT00787254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92918962|NCT00787254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918963|NCT00922402|Insulin|insulin|mesh-list
92918964|NCT00922402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92918965|NCT00922402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918966|NCT02550028|Levetiracetam|levetiracetam|mesh-list
92918967|NCT02550028|Phenobarbital|phenobarbital|mesh-list
92918968|NCT02550028|Anticonvulsants|anticonvulsants|mesh-ancestor
92918969|NCT02550028|Nootropic Agents|nootropic agents|mesh-ancestor
92918970|NCT02550028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92918971|NCT02550028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918972|NCT02550028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918973|NCT02550028|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92918974|NCT02550028|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92918975|NCT02550028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92918976|NCT02550028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918977|NCT02550028|GABA Modulators|gaba modulators|mesh-ancestor
92918978|NCT02550028|GABA Agents|gaba agents|mesh-ancestor
92918979|NCT02550028|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92918980|NCT02550028|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92918981|NCT02550028|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92918982|NCT04105374|Flucytosine|flucytosine|mesh-list
92918983|NCT04105374|Temozolomide|temozolomide|mesh-list
92918984|NCT04105374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92918985|NCT04105374|Alkylating Agents|alkylating agents|mesh-ancestor
92918986|NCT04105374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92918987|NCT04105374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92918988|NCT04105374|Antifungal Agents|antifungal agents|mesh-ancestor
92918989|NCT04105374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92918990|NCT04105374|Antimetabolites|antimetabolites|mesh-ancestor
92918991|NCT04102878|Anesthetics|anesthetics|mesh-list
92918992|NCT04102878|Anesthetics, Local|anesthetics, local|mesh-list
92918993|NCT04102878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92918994|NCT04102878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92918995|NCT04102878|Sensory System Agents|sensory system agents|mesh-ancestor
92918996|NCT04102878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92918997|NCT00838240|Cytarabine|cytarabine|mesh-list
92918998|NCT00838240|Clofarabine|clofarabine|mesh-list
92918999|NCT00838240|Idarubicin|idarubicin|mesh-list
92919000|NCT00838240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92919002|NCT00838240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919003|NCT00838240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919004|NCT00838240|Antiviral Agents|antiviral agents|mesh-ancestor
92919005|NCT00838240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919007|NCT00838240|Immunologic Factors|immunologic factors|mesh-ancestor
92919008|NCT00838240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919009|NCT00838240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92919010|NCT00838240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92919011|NCT00838240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92919012|NCT00838240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919013|NCT00773292|Cyclosporine|cyclosporine|mesh-list
92919014|NCT00773292|Cyclosporins|cyclosporins|mesh-list
92919015|NCT00773292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919016|NCT00773292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919017|NCT00773292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919018|NCT00773292|Immunologic Factors|immunologic factors|mesh-ancestor
92919019|NCT00773292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919020|NCT00773292|Antifungal Agents|antifungal agents|mesh-ancestor
92919021|NCT00773292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919022|NCT00773292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919023|NCT00773292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919024|NCT00773292|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92919025|NCT00838396|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
92919026|NCT00838396|Baclofen|baclofen|mesh-list
92919027|NCT00838396|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92919028|NCT00838396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919029|NCT00838396|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92919030|NCT00838396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919031|NCT00838396|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92919032|NCT00838396|GABA Agonists|gaba agonists|mesh-ancestor
92919033|NCT00838396|GABA Agents|gaba agents|mesh-ancestor
92919034|NCT00838396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919035|NCT00838396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919036|NCT00838864|Ceftriaxone|ceftriaxone|mesh-list
92919037|NCT00838864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919038|NCT00838864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919039|NCT00833326|Docetaxel|docetaxel|mesh-list
92919040|NCT00833326|Antimitotic Agents|antimitotic agents|mesh-list
92919041|NCT00833326|Mitogens|mitogens|mesh-list
92919042|NCT00833326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919043|NCT00833326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92919044|NCT00833326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92919045|NCT00833326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919046|NCT00833404|Nicotine|nicotine|mesh-list
92919047|NCT00833404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92919048|NCT00833404|Autonomic Agents|autonomic agents|mesh-ancestor
92919049|NCT00833404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919050|NCT00833404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919051|NCT00833404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92919052|NCT00833404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92919053|NCT00833404|Cholinergic Agents|cholinergic agents|mesh-ancestor
92919054|NCT00833404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919055|NCT00833404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919056|NCT00621322|Vaccines|vaccines|mesh-list
92919057|NCT00621322|Immunologic Factors|immunologic factors|mesh-ancestor
92919058|NCT00621322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919059|NCT00839488|Pantoprazole|pantoprazole|mesh-list
92919060|NCT00839488|Famotidine|famotidine|mesh-list
92919061|NCT00839488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92919062|NCT00839488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919063|NCT00839488|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92919064|NCT00839488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919065|NCT00839488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919066|NCT00839488|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92919067|NCT00839488|Histamine Antagonists|histamine antagonists|mesh-ancestor
92919068|NCT00839488|Histamine Agents|histamine agents|mesh-ancestor
92919069|NCT00839488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919070|NCT00839488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919071|NCT00834184|Nikkomycin|nikkomycin|mesh-list
92919072|NCT00834184|Antifungal Agents|antifungal agents|mesh-ancestor
92919073|NCT00834184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919074|NCT00834184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919075|NCT00834184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919076|NCT00834262|Insulin|insulin|mesh-list
92919077|NCT00834262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92919078|NCT00834262|Insulin Aspart|insulin aspart|mesh-list
92919079|NCT00834262|Insulin, Long-Acting|insulin, long-acting|mesh-list
92919080|NCT00834262|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92919081|NCT00834262|Biphasic Insulins|biphasic insulins|mesh-list
92919082|NCT00834262|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92919083|NCT00834262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92919084|NCT00834262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919086|NCT00853385|Tofacitinib|tofacitinib|mesh-list
92919087|NCT00853385|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92919088|NCT00853385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919089|NCT00853385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919090|NCT00853385|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92919091|NCT00853385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919092|NCT00853385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919093|NCT00853385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919094|NCT00622336|Lenalidomide|lenalidomide|mesh-list
92919095|NCT00622336|Immunologic Factors|immunologic factors|mesh-ancestor
92919096|NCT00622336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919097|NCT00622336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92919098|NCT00622336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92919099|NCT00622336|Growth Substances|growth substances|mesh-ancestor
92919100|NCT00622336|Growth Inhibitors|growth inhibitors|mesh-ancestor
92919101|NCT00622336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919102|NCT00846365|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92919103|NCT00846365|Olmesartan|olmesartan|mesh-list
92919104|NCT00846365|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92919105|NCT00846365|Chlorthalidone|chlorthalidone|mesh-list
92919106|NCT00846365|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92919107|NCT00846365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92919108|NCT00846365|Diuretics|diuretics|mesh-ancestor
92919109|NCT00846365|Natriuretic Agents|natriuretic agents|mesh-ancestor
92919110|NCT00846365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919111|NCT00846365|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92919112|NCT00846365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919113|NCT00846365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919114|NCT00846365|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92919115|NCT00846365|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92919116|NCT00834730|Ketamine|ketamine|mesh-list
92919117|NCT00834730|Analgesics|analgesics|mesh-ancestor
92919118|NCT00834730|Sensory System Agents|sensory system agents|mesh-ancestor
92919119|NCT00834730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919120|NCT00834730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919121|NCT00834730|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92919122|NCT00834730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92919123|NCT00834730|Anesthetics, General|anesthetics, general|mesh-ancestor
92919124|NCT00834730|Anesthetics|anesthetics|mesh-ancestor
92919125|NCT00834730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919126|NCT00834730|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92919127|NCT00834730|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92919128|NCT00834730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919129|NCT00834730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919130|NCT02601924|Anesthetics|anesthetics|mesh-list
92919131|NCT02601924|Anesthetics, Local|anesthetics, local|mesh-list
92919132|NCT02601924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919133|NCT02601924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919134|NCT02601924|Sensory System Agents|sensory system agents|mesh-ancestor
92919135|NCT02601924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919136|NCT00840112|Vitamin E|vitamin e|mesh-list
92919137|NCT00840112|Tocopherols|tocopherols|mesh-list
92919138|NCT00840112|alpha-Tocopherol|alpha-tocopherol|mesh-list
92919139|NCT00840112|Vitamins|vitamins|mesh-ancestor
92919140|NCT00840112|Micronutrients|micronutrients|mesh-ancestor
92919141|NCT00840112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919142|NCT00840112|Antioxidants|antioxidants|mesh-ancestor
92919143|NCT00840112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919144|NCT00840112|Protective Agents|protective agents|mesh-ancestor
92919145|NCT04101474|Ketamine|ketamine|mesh-list
92919146|NCT04101474|Analgesics|analgesics|mesh-ancestor
92919147|NCT04101474|Sensory System Agents|sensory system agents|mesh-ancestor
92919148|NCT04101474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919149|NCT04101474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919150|NCT04101474|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92919151|NCT04101474|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92919152|NCT04101474|Anesthetics, General|anesthetics, general|mesh-ancestor
92919153|NCT04101474|Anesthetics|anesthetics|mesh-ancestor
92919154|NCT04101474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919155|NCT04101474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92919156|NCT04101474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92919157|NCT04101474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919158|NCT04101474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919159|NCT04101708|Amoxicillin|amoxicillin|mesh-list
92919160|NCT04101708|Clarithromycin|clarithromycin|mesh-list
92919161|NCT04101708|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92919162|NCT04101708|Lansoprazole|lansoprazole|mesh-list
92919163|NCT04101708|Dexlansoprazole|dexlansoprazole|mesh-list
92919164|NCT04101708|Bismuth|bismuth|mesh-list
92919165|NCT04101708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919166|NCT04101708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919167|NCT04101708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92919168|NCT04101708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919169|NCT04101708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919170|NCT04101708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92919171|NCT04101708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92919172|NCT04101708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92919173|NCT04101708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919174|NCT04101708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92919175|NCT04101708|Antacids|antacids|mesh-ancestor
92919176|NCT00779142|Methotrexate|methotrexate|mesh-list
92919177|NCT00779142|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92919178|NCT00779142|Abortifacient Agents|abortifacient agents|mesh-ancestor
92919179|NCT00779142|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92919180|NCT00779142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919181|NCT00779142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92919182|NCT00779142|Antimetabolites|antimetabolites|mesh-ancestor
92919183|NCT00779142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919184|NCT00779142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919185|NCT00779142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919186|NCT00779142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919187|NCT00779142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92919188|NCT00779142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919189|NCT00779142|Immunologic Factors|immunologic factors|mesh-ancestor
92919190|NCT00779142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919191|NCT00779142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92919192|NCT00840346|Panobinostat|panobinostat|mesh-list
92919193|NCT00840346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919194|NCT00840346|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92919195|NCT00840346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919196|NCT00840346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919197|NCT04105140|Oxytocin|oxytocin|mesh-list
92919198|NCT04105140|Oxytocics|oxytocics|mesh-ancestor
92919199|NCT04105140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92919200|NCT04105140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919201|NCT00840580|Moxifloxacin|moxifloxacin|mesh-list
92919202|NCT00840580|Levofloxacin|levofloxacin|mesh-list
92919203|NCT00840580|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92919204|NCT00840580|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92919205|NCT00840580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92919206|NCT00840580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919207|NCT00840580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919208|NCT00840580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92919209|NCT00840580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92919210|NCT00840580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919211|NCT00840580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919212|NCT00840580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919213|NCT00840580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92919214|NCT00840580|Contraceptive Agents|contraceptive agents|mesh-ancestor
92919215|NCT00840580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92919216|NCT00840580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919217|NCT00840580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92919218|NCT00840580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92919219|NCT00840580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92919220|NCT00840580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92919221|NCT00840580|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92919222|NCT00840580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92919223|NCT00773136|Bimatoprost|bimatoprost|mesh-list
92919224|NCT00773136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92919225|NCT02602860|Levetiracetam|levetiracetam|mesh-list
92919226|NCT02602860|Brivaracetam|brivaracetam|mesh-list
92919227|NCT02602860|Anticonvulsants|anticonvulsants|mesh-ancestor
92919228|NCT02602860|Nootropic Agents|nootropic agents|mesh-ancestor
92919229|NCT00825058|Paroxetine|paroxetine|mesh-list
92564679|NCT00053885|Vatalanib|vatalanib|mesh-list
92919230|NCT00825058|Amibegron|amibegron|mesh-list
92919231|NCT00825058|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92919232|NCT00825058|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92919233|NCT00825058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92919234|NCT00825058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919235|NCT00825058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919236|NCT00825058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919237|NCT00825058|Serotonin Agents|serotonin agents|mesh-ancestor
92919238|NCT00825058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919239|NCT00825058|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92919240|NCT00825058|Antidepressive Agents|antidepressive agents|mesh-ancestor
92919241|NCT00825058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92919242|NCT00825058|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92919243|NCT00825058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92919244|NCT00825058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919245|NCT00825058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92919246|NCT00825058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92919247|NCT00825058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92919248|NCT00825058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92919249|NCT00701831|Insulin Glargine|insulin glargine|mesh-list
92919250|NCT00701831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92919251|NCT00701831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919252|NCT00835744|Clomiphene|clomiphene|mesh-list
92919253|NCT00835744|Enclomiphene|enclomiphene|mesh-list
92919254|NCT00835744|Zuclomiphene|zuclomiphene|mesh-list
92919255|NCT00835744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92919256|NCT00835744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92919257|NCT00835744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919258|NCT00835744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919259|NCT00835744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92919260|NCT00835744|Fertility Agents|fertility agents|mesh-ancestor
92919261|NCT00835744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92919262|NCT00835744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92919263|NCT00835744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92919264|NCT00778830|Cetuximab|cetuximab|mesh-list
92919265|NCT00778830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919266|NCT00778830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919267|NCT00772668|Prednisone|prednisone|mesh-list
92919268|NCT00772668|Cyclophosphamide|cyclophosphamide|mesh-list
92919269|NCT00772668|Rituximab|rituximab|mesh-list
92919270|NCT00772668|Bortezomib|bortezomib|mesh-list
92919271|NCT00772668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919272|NCT00772668|Immunologic Factors|immunologic factors|mesh-ancestor
92919273|NCT00772668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919274|NCT00772668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919275|NCT00772668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92919276|NCT00772668|Alkylating Agents|alkylating agents|mesh-ancestor
92919277|NCT00772668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919278|NCT00772668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919279|NCT00772668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92919280|NCT00772668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919281|NCT00772668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919282|NCT00772668|Glucocorticoids|glucocorticoids|mesh-ancestor
92919283|NCT00772668|Hormones|hormones|mesh-ancestor
92919284|NCT00772668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919285|NCT00772668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92919286|NCT00786474|Dalteparin|dalteparin|mesh-list
92919287|NCT00786474|Tinzaparin|tinzaparin|mesh-list
92919288|NCT00786474|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92919289|NCT00786474|Anticoagulants|anticoagulants|mesh-ancestor
92919290|NCT00786474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92919291|NCT00786474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92919292|NCT00786474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919293|NCT00784875|Zolpidem|zolpidem|mesh-list
92919294|NCT00784875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92919295|NCT00784875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92919296|NCT00784875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919297|NCT00784875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919298|NCT00784875|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92919299|NCT00784875|GABA Agonists|gaba agonists|mesh-ancestor
92919300|NCT00784875|GABA Agents|gaba agents|mesh-ancestor
92919301|NCT00784875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919302|NCT00784875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919303|NCT00701909|Ketamine|ketamine|mesh-list
92919304|NCT00701909|Morphine|morphine|mesh-list
92919305|NCT00701909|Analgesics|analgesics|mesh-ancestor
92919306|NCT00701909|Sensory System Agents|sensory system agents|mesh-ancestor
92919307|NCT00701909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919308|NCT00701909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919309|NCT00701909|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92919310|NCT00701909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92919311|NCT00701909|Anesthetics, General|anesthetics, general|mesh-ancestor
92919312|NCT00701909|Anesthetics|anesthetics|mesh-ancestor
92919313|NCT00701909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919314|NCT00701909|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92919315|NCT00701909|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92919316|NCT00701909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919317|NCT00701909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919318|NCT00701909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92919319|NCT00701909|Narcotics|narcotics|mesh-ancestor
92919320|NCT00699023|Simvastatin|simvastatin|mesh-list
92919321|NCT00699023|Ezetimibe|ezetimibe|mesh-list
92919322|NCT00699023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92919323|NCT00699023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92919324|NCT00699023|Antimetabolites|antimetabolites|mesh-ancestor
92919325|NCT00699023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919326|NCT00699023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92919327|NCT00699023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92919328|NCT00699023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919329|NCT00853229|Pregabalin|pregabalin|mesh-list
92919330|NCT00853229|Analgesics|analgesics|mesh-ancestor
92919331|NCT00853229|Sensory System Agents|sensory system agents|mesh-ancestor
92919332|NCT00853229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919333|NCT00853229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919334|NCT00853229|Anticonvulsants|anticonvulsants|mesh-ancestor
92919335|NCT00853229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92919336|NCT00853229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919337|NCT00853229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919338|NCT00853229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92919339|NCT00853229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92919340|NCT00853229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92919341|NCT00853229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919342|NCT00853229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92919343|NCT00853073|Bevacizumab|bevacizumab|mesh-list
92919344|NCT00853073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919345|NCT00853073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919346|NCT00853073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92919347|NCT00853073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92919348|NCT00853073|Growth Substances|growth substances|mesh-ancestor
92919349|NCT00853073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919350|NCT00853073|Growth Inhibitors|growth inhibitors|mesh-ancestor
92919351|NCT00845897|Botulinum Toxins|botulinum toxins|mesh-list
92919352|NCT00845897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92919353|NCT00845897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919354|NCT00845897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919355|NCT00845897|Cholinergic Agents|cholinergic agents|mesh-ancestor
92919356|NCT00845897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919357|NCT00845897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919358|NCT04120337|Lidocaine|lidocaine|mesh-list
92919359|NCT04120337|Anesthetics, Local|anesthetics, local|mesh-ancestor
92919361|NCT04120337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919362|NCT04120337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919363|NCT04120337|Sensory System Agents|sensory system agents|mesh-ancestor
92919364|NCT04120337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919365|NCT04120337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92919366|NCT04120337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92919367|NCT04120337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92919368|NCT04120337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919369|NCT04120337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919370|NCT00592319|Celecoxib|celecoxib|mesh-list
92919371|NCT00592319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92919372|NCT00592319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919373|NCT00592319|Analgesics|analgesics|mesh-ancestor
92919374|NCT00592319|Sensory System Agents|sensory system agents|mesh-ancestor
92919375|NCT00592319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919376|NCT00592319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919378|NCT00592319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919379|NCT00592319|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92919380|NCT00592319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92919381|NCT00592319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919382|NCT00592319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919383|NCT00862121|Mesalamine|mesalamine|mesh-list
92919384|NCT00862121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92919385|NCT00862121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919386|NCT00862121|Analgesics|analgesics|mesh-ancestor
92919387|NCT00862121|Sensory System Agents|sensory system agents|mesh-ancestor
92919388|NCT00862121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919389|NCT00862121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919390|NCT00862121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919391|NCT00862121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919392|NCT00784719|Cyclosporine|cyclosporine|mesh-list
92919393|NCT00784719|Cyclosporins|cyclosporins|mesh-list
92919394|NCT00784719|Tofacitinib|tofacitinib|mesh-list
92919395|NCT00784719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919396|NCT00784719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919397|NCT00784719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919398|NCT00784719|Immunologic Factors|immunologic factors|mesh-ancestor
92919399|NCT00784719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919400|NCT00784719|Antifungal Agents|antifungal agents|mesh-ancestor
92919401|NCT00784719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919402|NCT00784719|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919403|NCT00784719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919404|NCT00784719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92919405|NCT00784719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92919406|NCT00784719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919407|NCT00852917|Tramadol|tramadol|mesh-list
92919408|NCT00852917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92919409|NCT00852917|Narcotics|narcotics|mesh-ancestor
92919410|NCT00852917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919411|NCT00852917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919412|NCT00852917|Analgesics|analgesics|mesh-ancestor
92919413|NCT00852917|Sensory System Agents|sensory system agents|mesh-ancestor
92919414|NCT00852917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919415|NCT00700583|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92919416|NCT00700583|Terazosin|terazosin|mesh-list
92919417|NCT00700583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92919418|NCT00700583|Diuretics|diuretics|mesh-ancestor
92919419|NCT00700583|Natriuretic Agents|natriuretic agents|mesh-ancestor
92919420|NCT00700583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919421|NCT00700583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92919422|NCT00700583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919423|NCT00700583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919424|NCT00700583|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92919425|NCT00700583|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92919426|NCT00700583|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92919427|NCT00700583|Adrenergic Agents|adrenergic agents|mesh-ancestor
92919428|NCT00700583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919429|NCT00700583|Urological Agents|urological agents|mesh-ancestor
92919430|NCT00913055|Octreotide|octreotide|mesh-list
92919431|NCT00913055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919432|NCT00913055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92919433|NCT00913055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919434|NCT04117139|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92919435|NCT04117139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92919436|NCT04117139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919437|NCT00845429|Vaccines|vaccines|mesh-list
92919438|NCT00845429|Immunologic Factors|immunologic factors|mesh-ancestor
92919439|NCT00845429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919440|NCT00844883|Sorafenib|sorafenib|mesh-list
92919441|NCT00844883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919442|NCT00844883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919443|NCT00844883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919444|NCT00844883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919445|NCT00851903|Metformin|metformin|mesh-list
92919446|NCT00851903|Insulin Glargine|insulin glargine|mesh-list
92919447|NCT00851903|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92919448|NCT00851903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92919449|NCT00851903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919450|NCT00851903|Incretins|incretins|mesh-ancestor
92919451|NCT00851903|Hormones|hormones|mesh-ancestor
92919452|NCT00851903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919453|NCT00851903|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92919454|NCT00851903|Protease Inhibitors|protease inhibitors|mesh-ancestor
92919455|NCT00851903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919456|NCT00851903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919457|NCT00587457|Immunotoxin HA22|immunotoxin ha22|mesh-list
92919458|NCT00587457|Immunotoxins|immunotoxins|mesh-ancestor
92919459|NCT00587457|Immunoconjugates|immunoconjugates|mesh-ancestor
92919460|NCT00587457|Immunologic Factors|immunologic factors|mesh-ancestor
92919461|NCT00587457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919462|NCT00587457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919463|NCT00851747|Deoxycholic Acid|deoxycholic acid|mesh-list
92919464|NCT00851747|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92919465|NCT00851747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919466|NCT04099563|Abrocitinib|abrocitinib|mesh-list
92919467|NCT04099563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919468|NCT04099563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919469|NCT04099563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919470|NCT00767325|Methotrexate|methotrexate|mesh-list
92919471|NCT00767325|Abatacept|abatacept|mesh-list
92919472|NCT00767325|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92919473|NCT00767325|Abortifacient Agents|abortifacient agents|mesh-ancestor
92919474|NCT00767325|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92919475|NCT00767325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919476|NCT00767325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92919477|NCT00767325|Antimetabolites|antimetabolites|mesh-ancestor
92919478|NCT00767325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919479|NCT00767325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919480|NCT00767325|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919481|NCT00767325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919482|NCT00767325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92919483|NCT00767325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919484|NCT00767325|Immunologic Factors|immunologic factors|mesh-ancestor
92919485|NCT00767325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919486|NCT00767325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92919487|NCT00767325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92919488|NCT00767325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919489|NCT00851591|Psyllium|psyllium|mesh-list
92919490|NCT00851591|Cathartics|cathartics|mesh-ancestor
92919491|NCT00851591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919492|NCT02612363|Dexmedetomidine|dexmedetomidine|mesh-list
92919493|NCT02612363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92919494|NCT02612363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919495|NCT02612363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919496|NCT02612363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919497|NCT02612363|Analgesics|analgesics|mesh-ancestor
92919498|NCT02612363|Sensory System Agents|sensory system agents|mesh-ancestor
92919499|NCT02612363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919500|NCT02612363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92919501|NCT02612363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92919502|NCT02612363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92919503|NCT02612363|Adrenergic Agents|adrenergic agents|mesh-ancestor
92919504|NCT02612363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919505|NCT02612363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919506|NCT00702767|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92919507|NCT00702767|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92919508|NCT00702767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92919509|NCT00702767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92919510|NCT00912899|Noscapine|noscapine|mesh-list
92919511|NCT00912899|Antitussive Agents|antitussive agents|mesh-ancestor
92919512|NCT00912899|Respiratory System Agents|respiratory system agents|mesh-ancestor
92919513|NCT00700895|Warfarin|warfarin|mesh-list
92919514|NCT00700895|Anticoagulants|anticoagulants|mesh-ancestor
92919515|NCT00861341|Aspirin|aspirin|mesh-list
92919516|NCT00861341|Pioglitazone|pioglitazone|mesh-list
92919517|NCT00861341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92919518|NCT00861341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919519|NCT00861341|Analgesics|analgesics|mesh-ancestor
92162772|NCT01255449|Albuterol|albuterol|mesh-list
92919520|NCT00861341|Sensory System Agents|sensory system agents|mesh-ancestor
92919521|NCT00861341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919522|NCT00861341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919523|NCT00861341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919524|NCT00861341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919525|NCT00861341|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92564995|NCT00167518|Hormones|hormones|mesh-ancestor
92919527|NCT00861341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919528|NCT00861341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92919529|NCT00861341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92919530|NCT00861341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919531|NCT00861341|Antipyretics|antipyretics|mesh-ancestor
92919532|NCT00861341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92919533|NCT00766467|Modafinil|modafinil|mesh-list
92919534|NCT00766467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92919535|NCT00766467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919536|NCT00766467|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92919537|NCT00766467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92919538|NCT00766467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92919539|NCT00766467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919540|NCT00850499|Rituximab|rituximab|mesh-list
92919541|NCT00850499|Fludarabine|fludarabine|mesh-list
92919542|NCT00850499|Bortezomib|bortezomib|mesh-list
92919543|NCT00850499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919544|NCT00850499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919545|NCT00850499|Immunologic Factors|immunologic factors|mesh-ancestor
92919546|NCT00850499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919547|NCT00850499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919548|NCT00844805|Infliximab|infliximab|mesh-list
92919549|NCT00844805|Naproxen|naproxen|mesh-list
92919550|NCT00844805|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92919551|NCT00844805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919552|NCT00844805|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919553|NCT00844805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919554|NCT00844805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919555|NCT00844805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92919556|NCT00844805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919557|NCT00844805|Analgesics|analgesics|mesh-ancestor
92919558|NCT00844805|Sensory System Agents|sensory system agents|mesh-ancestor
92919559|NCT00844805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919560|NCT00844805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919561|NCT00844805|Gout Suppressants|gout suppressants|mesh-ancestor
92919562|NCT00844805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92919563|NCT00844805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919564|NCT00844805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919565|NCT00765999|Linaclotide|linaclotide|mesh-list
92919566|NCT00765999|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92919567|NCT00765999|Enzyme Activators|enzyme activators|mesh-ancestor
92919568|NCT00765999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919569|NCT00765999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919570|NCT04099407|Pirfenidone|pirfenidone|mesh-list
92919571|NCT04099407|Analgesics|analgesics|mesh-ancestor
92919572|NCT04099407|Sensory System Agents|sensory system agents|mesh-ancestor
92919573|NCT04099407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919574|NCT04099407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919575|NCT04099407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92919576|NCT04099407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919577|NCT04099407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919578|NCT04099407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919579|NCT04099407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919580|NCT00765063|Dalteparin|dalteparin|mesh-list
92919581|NCT00765063|Anticoagulants|anticoagulants|mesh-ancestor
92919582|NCT00765063|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92919583|NCT00765063|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92919584|NCT00765063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919585|NCT00764751|Calcipotriene|calcipotriene|mesh-list
92919586|NCT00764751|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919587|NCT00764517|Rituximab|rituximab|mesh-list
92919588|NCT00764517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92919589|NCT00764517|Vorinostat|vorinostat|mesh-list
92919590|NCT00764517|Cladribine|cladribine|mesh-list
92919591|NCT00764517|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92919592|NCT00764517|Antibodies|antibodies|mesh-list
92919593|NCT00764517|Immunoglobulins|immunoglobulins|mesh-list
92919594|NCT00764517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92919595|NCT00764517|Immunologic Factors|immunologic factors|mesh-ancestor
92919596|NCT00764517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919597|NCT00764517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919598|NCT00764517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919599|NCT00764517|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92919600|NCT00764517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919601|NCT00764517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919602|NCT00764517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919603|NCT00764517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92919605|NCT00764361|Doxycycline|doxycycline|mesh-list
92919606|NCT00764361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919607|NCT00764361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919608|NCT00764361|Antimalarials|antimalarials|mesh-ancestor
92919609|NCT00764361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92919610|NCT00764361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92919611|NCT00763971|Methylphenidate|methylphenidate|mesh-list
92919612|NCT00763971|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92919613|NCT00763971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92919614|NCT00763971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919615|NCT00763971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92919616|NCT00763971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92919617|NCT00763971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919618|NCT00763971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919619|NCT00763971|Dopamine Agents|dopamine agents|mesh-ancestor
92919620|NCT00763971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919621|NCT00763815|Metformin|metformin|mesh-list
92919622|NCT00763815|Pioglitazone|pioglitazone|mesh-list
92919623|NCT00763815|Lixisenatide|lixisenatide|mesh-list
92919624|NCT00763815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92919625|NCT00763815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919626|NCT00763269|Silicon|silicon|mesh-list
92919627|NCT00763269|Triclosan|triclosan|mesh-list
92919628|NCT00763269|Fluorides|fluorides|mesh-list
92919629|NCT00763269|Cariostatic Agents|cariostatic agents|mesh-ancestor
92919630|NCT00763269|Protective Agents|protective agents|mesh-ancestor
92919631|NCT00763269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919632|NCT00763269|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92919633|NCT00763269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919634|NCT00763269|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92919635|NCT00763269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92919636|NCT00763269|Antimetabolites|antimetabolites|mesh-ancestor
92919637|NCT00763269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919638|NCT00763269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92919639|NCT00763269|Trace Elements|trace elements|mesh-ancestor
92919640|NCT00763269|Micronutrients|micronutrients|mesh-ancestor
92919641|NCT00763035|Dobutamine|dobutamine|mesh-list
92919642|NCT00763035|Regadenoson|regadenoson|mesh-list
92919643|NCT00763035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92919644|NCT00763035|Sympathomimetics|sympathomimetics|mesh-ancestor
92919645|NCT00763035|Autonomic Agents|autonomic agents|mesh-ancestor
92919646|NCT00763035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919647|NCT00763035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919648|NCT00763035|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92919649|NCT00763035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92919650|NCT00763035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92919651|NCT00763035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92919652|NCT00763035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919653|NCT00763035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919654|NCT00763035|Protective Agents|protective agents|mesh-ancestor
92919655|NCT00763035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92919656|NCT00763035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92919657|NCT00763035|Purinergic Agonists|purinergic agonists|mesh-ancestor
92919658|NCT00763035|Purinergic Agents|purinergic agents|mesh-ancestor
92919660|NCT00844649|Gemcitabine|gemcitabine|mesh-list
92919661|NCT00844649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92919662|NCT00844649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92919663|NCT00844649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919664|NCT00844649|Tubulin Modulators|tubulin modulators|mesh-ancestor
92919665|NCT00844649|Antimitotic Agents|antimitotic agents|mesh-ancestor
92919666|NCT00844649|Mitosis Modulators|mitosis modulators|mesh-ancestor
92919667|NCT00844649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919668|NCT00844649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92919669|NCT00844649|Antimetabolites|antimetabolites|mesh-ancestor
92919670|NCT04098861|Timolol|timolol|mesh-list
92919671|NCT04098861|Latanoprost|latanoprost|mesh-list
92919672|NCT04098861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92919673|NCT04098861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92919674|NCT04098861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92919675|NCT04098861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565135|NCT00168493|Serotonin|serotonin|mesh-list
92919676|NCT04098861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919677|NCT04098861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919678|NCT04098861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92919679|NCT04098861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92919680|NCT04098861|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92919681|NCT04098861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92919682|NCT00850343|Certolizumab Pegol|certolizumab pegol|mesh-list
92919683|NCT00850343|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92919684|NCT00850343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919685|NCT00850343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919686|NCT00850343|Immunologic Factors|immunologic factors|mesh-ancestor
92919687|NCT00850343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919688|NCT00850343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919689|NCT00849875|Dacarbazine|dacarbazine|mesh-list
92919690|NCT00849875|Imidazole|imidazole|mesh-list
92919691|NCT00849875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92919692|NCT00849875|Alkylating Agents|alkylating agents|mesh-ancestor
92919693|NCT00849875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919694|NCT00849875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919695|NCT00849875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919696|NCT00844415|Dabigatran|dabigatran|mesh-list
92919697|NCT00844415|Antithrombins|antithrombins|mesh-ancestor
92919698|NCT00844415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92919699|NCT00844415|Protease Inhibitors|protease inhibitors|mesh-ancestor
92919700|NCT00844415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919701|NCT00844415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919702|NCT00844415|Anticoagulants|anticoagulants|mesh-ancestor
92919703|NCT00843635|Tadalafil|tadalafil|mesh-list
92919704|NCT00843635|Vasodilator Agents|vasodilator agents|mesh-ancestor
92919705|NCT00843635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92919706|NCT00843635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92919707|NCT00843635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919708|NCT00843635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919709|NCT00843635|Urological Agents|urological agents|mesh-ancestor
92919710|NCT00699179|Insulin Aspart|insulin aspart|mesh-list
92919711|NCT00699179|Biphasic Insulins|biphasic insulins|mesh-list
92919712|NCT00699179|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92919713|NCT00699179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92919714|NCT00699179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919715|NCT04116827|Tamoxifen|tamoxifen|mesh-list
92919716|NCT04116827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92919717|NCT04116827|Hormone Antagonists|hormone antagonists|mesh-ancestor
92919718|NCT04116827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919719|NCT04116827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919720|NCT04116827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92919721|NCT04116827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919722|NCT04116827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92919723|NCT04116827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92919724|NCT04116827|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92919725|NCT00849017|rGLP-1 protein|rglp-1 protein|mesh-list
92919726|NCT00849017|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92919727|NCT00849017|Incretins|incretins|mesh-ancestor
92919728|NCT00849017|Hormones|hormones|mesh-ancestor
92919729|NCT00849017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919730|NCT00849017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919731|NCT00842309|Cycloserine|cycloserine|mesh-list
92919732|NCT00842309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92919733|NCT00842309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919734|NCT00842309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92919735|NCT00842309|Antitubercular Agents|antitubercular agents|mesh-ancestor
92919736|NCT00842309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919737|NCT00842309|Antimetabolites|antimetabolites|mesh-ancestor
92919738|NCT00842309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919739|NCT00842153|Clobetasol|clobetasol|mesh-list
92919740|NCT00842153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919741|NCT00842153|Glucocorticoids|glucocorticoids|mesh-ancestor
92919742|NCT00842153|Hormones|hormones|mesh-ancestor
92919743|NCT00842153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919744|NCT00842153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919745|NCT00762411|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
92565208|NCT04731909|Cisplatin|cisplatin|mesh-list
92919746|NCT00762411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92919747|NCT00762411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919748|NCT00762411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919750|NCT00841763|Immunologic Factors|immunologic factors|mesh-ancestor
92919751|NCT00841763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919752|NCT05603429|Antioxidants|antioxidants|mesh-list
92919753|NCT05603429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919754|NCT05603429|Protective Agents|protective agents|mesh-ancestor
92919755|NCT05603429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919756|NCT00785538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92919757|NCT00785538|Immunologic Factors|immunologic factors|mesh-ancestor
92919758|NCT00785538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919759|NCT02602704|Bazedoxifene|bazedoxifene|mesh-list
92919760|NCT02602704|Calcium|calcium|mesh-list
92919761|NCT02602704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92919762|NCT02602704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919763|NCT02602704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92919764|NCT02602704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92919765|NCT02602704|Hormone Antagonists|hormone antagonists|mesh-ancestor
92919766|NCT02602704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919767|NCT02602704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92919768|NCT00860405|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92919769|NCT00860405|Plasma Substitutes|plasma substitutes|mesh-ancestor
92919770|NCT00860405|Blood Substitutes|blood substitutes|mesh-ancestor
92919771|NCT00703313|Moxifloxacin|moxifloxacin|mesh-list
92919772|NCT00703313|Levofloxacin|levofloxacin|mesh-list
92919773|NCT00703313|Gatifloxacin|gatifloxacin|mesh-list
92919774|NCT00703313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92919775|NCT00703313|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92919776|NCT00703313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92919777|NCT00703313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919778|NCT00703313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919779|NCT00703313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92919780|NCT00703313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92919781|NCT00703313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919782|NCT00703313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919783|NCT00703313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919784|NCT00703313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92919785|NCT00703313|Contraceptive Agents|contraceptive agents|mesh-ancestor
92919786|NCT00703313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92919787|NCT00703313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919788|NCT00703313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92919789|NCT00703313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92919790|NCT00703313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92919791|NCT00703313|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92919792|NCT00703313|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92919793|NCT00703313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92919794|NCT00703079|Octreotide|octreotide|mesh-list
92919795|NCT00703079|Lanreotide|lanreotide|mesh-list
92919796|NCT00703079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92526237|NCT00028132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92919797|NCT00703079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92919798|NCT00703079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919799|NCT00840827|Cyclosporine|cyclosporine|mesh-list
92919800|NCT00840827|Lenalidomide|lenalidomide|mesh-list
92919801|NCT00840827|Cyclosporins|cyclosporins|mesh-list
92919802|NCT00840827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919803|NCT00840827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162796|NCT00631657|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92919804|NCT00840827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919805|NCT00840827|Immunologic Factors|immunologic factors|mesh-ancestor
92919806|NCT00840827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919807|NCT00840827|Antifungal Agents|antifungal agents|mesh-ancestor
92919808|NCT00840827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919809|NCT00840827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919810|NCT00840827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919811|NCT00840827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92919812|NCT00840827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92919813|NCT00840827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92919814|NCT00840827|Growth Substances|growth substances|mesh-ancestor
92919815|NCT00840827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92919816|NCT00840827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919817|NCT00703469|Nivolumab|nivolumab|mesh-list
92565280|NCT00169039|Dopamine Agents|dopamine agents|mesh-ancestor
92919818|NCT00703469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919819|NCT00703469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919820|NCT00703469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92919821|NCT00703469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919823|NCT02612207|Antioxidants|antioxidants|mesh-ancestor
92919824|NCT02612207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919825|NCT02612207|Protective Agents|protective agents|mesh-ancestor
92919826|NCT02612207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919827|NCT00859937|Dasatinib|dasatinib|mesh-list
92919828|NCT00859937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919829|NCT00859937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919830|NCT00859937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919831|NCT00859937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919832|NCT04030715|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92919833|NCT04030715|Bismuth|bismuth|mesh-list
92919834|NCT04030715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919835|NCT04030715|Antacids|antacids|mesh-ancestor
92919836|NCT04030715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919837|NCT04030715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92919838|NCT00592007|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92919839|NCT00592007|Fulvestrant|fulvestrant|mesh-list
92919840|NCT00592007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919841|NCT00592007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919842|NCT00592007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919843|NCT00592007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919844|NCT00592007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92919845|NCT00592007|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92919846|NCT00592007|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92919847|NCT00592007|Hormone Antagonists|hormone antagonists|mesh-ancestor
92919848|NCT00592007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92919849|NCT00592007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919850|NCT00591851|Paclitaxel|paclitaxel|mesh-list
92919851|NCT00591851|Cyclophosphamide|cyclophosphamide|mesh-list
92919852|NCT00591851|Doxorubicin|doxorubicin|mesh-list
92919853|NCT00591851|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92919854|NCT00591851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92919855|NCT00591851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919856|NCT00591851|Tubulin Modulators|tubulin modulators|mesh-ancestor
92919857|NCT00591851|Antimitotic Agents|antimitotic agents|mesh-ancestor
92919858|NCT00591851|Mitosis Modulators|mitosis modulators|mesh-ancestor
92919859|NCT00591851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919860|NCT00591851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919861|NCT00591851|Immunologic Factors|immunologic factors|mesh-ancestor
92919862|NCT00591851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919863|NCT00591851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919864|NCT00591851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92919865|NCT00591851|Alkylating Agents|alkylating agents|mesh-ancestor
92919866|NCT00591851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92919867|NCT00591851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92919868|NCT00591851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92919869|NCT00591851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92919870|NCT00591851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919871|NCT00839423|Vortioxetine|vortioxetine|mesh-list
92919872|NCT00839423|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92919873|NCT00839423|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92919874|NCT00839423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92919875|NCT00839423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92919876|NCT00839423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919877|NCT00839423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919878|NCT00839423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919879|NCT00839423|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92919880|NCT00839423|Antidepressive Agents|antidepressive agents|mesh-ancestor
92919881|NCT00839423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92919882|NCT00839423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92919883|NCT00839423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92919884|NCT00839423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919885|NCT00839423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92919886|NCT00839423|Serotonin Agents|serotonin agents|mesh-ancestor
92919887|NCT00839423|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92565355|NCT00169546|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919888|NCT00839423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92919889|NCT00839423|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92919890|NCT00839423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92919891|NCT00859469|Gemcitabine|gemcitabine|mesh-list
92919892|NCT00859469|Oxaliplatin|oxaliplatin|mesh-list
92919893|NCT00859469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92919894|NCT00859469|Antimetabolites|antimetabolites|mesh-ancestor
92919895|NCT00859469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919896|NCT00859469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919897|NCT00703625|Sirolimus|sirolimus|mesh-list
92919898|NCT00703625|Docetaxel|docetaxel|mesh-list
92919899|NCT00703625|Temsirolimus|temsirolimus|mesh-list
92919900|NCT00703625|MTOR Inhibitors|mtor inhibitors|mesh-list
92919901|NCT00703625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919902|NCT00703625|Tubulin Modulators|tubulin modulators|mesh-ancestor
92919903|NCT00703625|Antimitotic Agents|antimitotic agents|mesh-ancestor
92919904|NCT00703625|Mitosis Modulators|mitosis modulators|mesh-ancestor
92919905|NCT00703625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919906|NCT00703625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919907|NCT00703625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919908|NCT00703625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919909|NCT00703625|Immunologic Factors|immunologic factors|mesh-ancestor
92919910|NCT00703625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919911|NCT00703625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919912|NCT00703625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919913|NCT00703625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92919914|NCT00703625|Antifungal Agents|antifungal agents|mesh-ancestor
92919915|NCT00703703|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92919916|NCT00703703|Darifenacin|darifenacin|mesh-list
92919917|NCT00703703|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92919918|NCT00703703|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92919919|NCT00703703|Cholinergic Agents|cholinergic agents|mesh-ancestor
92919920|NCT00703703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92919921|NCT00703703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919922|NCT00703703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919923|NCT00703703|Urological Agents|urological agents|mesh-ancestor
92919924|NCT00859313|Sufentanil|sufentanil|mesh-list
92919925|NCT00859313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92919926|NCT00859313|Narcotics|narcotics|mesh-ancestor
92919927|NCT00859313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92919928|NCT00859313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919929|NCT00859313|Analgesics|analgesics|mesh-ancestor
92919930|NCT00859313|Sensory System Agents|sensory system agents|mesh-ancestor
92919931|NCT00859313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919932|NCT00859313|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92919933|NCT00859313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92919934|NCT00859313|Anesthetics, General|anesthetics, general|mesh-ancestor
92919935|NCT00859313|Anesthetics|anesthetics|mesh-ancestor
92919936|NCT02611973|Aspirin|aspirin|mesh-list
92919937|NCT02611973|Hydroxyurea|hydroxyurea|mesh-list
92919938|NCT02611973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92919939|NCT02611973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92919940|NCT02611973|Analgesics|analgesics|mesh-ancestor
92919941|NCT02611973|Sensory System Agents|sensory system agents|mesh-ancestor
92919942|NCT02611973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92919943|NCT02611973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919944|NCT02611973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92919945|NCT02611973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92919946|NCT02611973|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92919947|NCT02611973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92919948|NCT02611973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919949|NCT02611973|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92919950|NCT02611973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92919951|NCT02611973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919952|NCT02611973|Antipyretics|antipyretics|mesh-ancestor
92919953|NCT02611973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919954|NCT02611973|Antisickling Agents|antisickling agents|mesh-ancestor
92919955|NCT02611973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92919956|NCT00771810|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92919957|NCT00771810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92919958|NCT00771810|Vasodilator Agents|vasodilator agents|mesh-ancestor
92919959|NCT00836927|Sirolimus|sirolimus|mesh-list
92919960|NCT00836927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92919961|NCT00836927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919962|NCT00836927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92565430|NCT00170209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919963|NCT00836927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919964|NCT00836927|Antifungal Agents|antifungal agents|mesh-ancestor
92919965|NCT00836927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92919966|NCT00836927|Immunologic Factors|immunologic factors|mesh-ancestor
92919967|NCT00836927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919968|NCT00703235|Bevacizumab|bevacizumab|mesh-list
92919969|NCT00703235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92919970|NCT00703235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919971|NCT00703235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92919972|NCT00703235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92919973|NCT00703235|Growth Substances|growth substances|mesh-ancestor
92919974|NCT00703235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919975|NCT00703235|Growth Inhibitors|growth inhibitors|mesh-ancestor
92919976|NCT02612051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92919977|NCT00771030|Brodalumab|brodalumab|mesh-list
92919978|NCT00771030|Dermatologic Agents|dermatologic agents|mesh-ancestor
92919979|NCT00768300|Ambrisentan|ambrisentan|mesh-list
92919980|NCT00768300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92919981|NCT00768222|Triclosan|triclosan|mesh-list
92919982|NCT00768222|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92919983|NCT00768222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92919984|NCT00768222|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92919985|NCT00768222|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92919986|NCT00768222|Antimetabolites|antimetabolites|mesh-ancestor
92919987|NCT00768222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919988|NCT00768222|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92919989|NCT00768144|Sunitinib|sunitinib|mesh-list
92919990|NCT00768144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92919991|NCT00768144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92919992|NCT00768144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92919993|NCT00768144|Growth Substances|growth substances|mesh-ancestor
92919994|NCT00768144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92919995|NCT00768144|Growth Inhibitors|growth inhibitors|mesh-ancestor
92919996|NCT00768144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92919997|NCT00768144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92919998|NCT00768144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92919999|NCT00784836|Interferons|interferons|mesh-list
92920000|NCT00784836|Interferon-beta|interferon-beta|mesh-list
92920001|NCT00784836|Interferon beta-1a|interferon beta-1a|mesh-list
92920002|NCT00784836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920003|NCT00784836|Antiviral Agents|antiviral agents|mesh-ancestor
92920004|NCT00784836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920005|NCT00784836|Immunologic Factors|immunologic factors|mesh-ancestor
92920006|NCT00784836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920007|NCT00784836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92920008|NCT04104984|Tocolytic Agents|tocolytic agents|mesh-list
92920009|NCT04104984|Progesterone|progesterone|mesh-list
92920010|NCT04104984|Progestins|progestins|mesh-ancestor
92920011|NCT04104984|Hormones|hormones|mesh-ancestor
92920012|NCT04104984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920013|NCT04104984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920014|NCT04104984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92920015|NCT00767520|Dasatinib|dasatinib|mesh-list
92920016|NCT00767520|Exemestane|exemestane|mesh-list
92920017|NCT00767520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920018|NCT00767520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920019|NCT00767520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920020|NCT00767520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920021|NCT00767520|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92920022|NCT00767520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92920023|NCT00767520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92920024|NCT00767520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920025|NCT00767520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920026|NCT00767520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920027|NCT00858845|Clonidine|clonidine|mesh-list
92920028|NCT00858845|Analgesics|analgesics|mesh-ancestor
92920029|NCT00858845|Sensory System Agents|sensory system agents|mesh-ancestor
92920030|NCT00858845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920031|NCT00858845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920032|NCT00858845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92920033|NCT00858845|Sympatholytics|sympatholytics|mesh-ancestor
92920034|NCT00858845|Autonomic Agents|autonomic agents|mesh-ancestor
92920035|NCT00858845|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92920036|NCT00858845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92920037|NCT00858845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92920038|NCT00858845|Adrenergic Agents|adrenergic agents|mesh-ancestor
92920039|NCT00858845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920040|NCT00858845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920041|NCT05591339|BCG Vaccine|bcg vaccine|mesh-list
92920042|NCT05591339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92920043|NCT05591339|Immunologic Factors|immunologic factors|mesh-ancestor
92920044|NCT05591339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920045|NCT00770562|Dexamethasone|dexamethasone|mesh-list
92920046|NCT00770562|Rituximab|rituximab|mesh-list
92920047|NCT00770562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920048|NCT00770562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920049|NCT00770562|Immunologic Factors|immunologic factors|mesh-ancestor
92920050|NCT00770562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920051|NCT00770562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920052|NCT00770562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920053|NCT00770562|Antiemetics|antiemetics|mesh-ancestor
92920054|NCT00770562|Autonomic Agents|autonomic agents|mesh-ancestor
92920055|NCT00770562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920056|NCT00770562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920057|NCT00770562|Glucocorticoids|glucocorticoids|mesh-ancestor
92920058|NCT00770562|Hormones|hormones|mesh-ancestor
92920059|NCT00770562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920060|NCT00770562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92920061|NCT00836693|Tadalafil|tadalafil|mesh-list
92920062|NCT00836693|Vasodilator Agents|vasodilator agents|mesh-ancestor
92920063|NCT00836693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92920064|NCT00836693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92920065|NCT00836693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920066|NCT00836693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920067|NCT00836693|Urological Agents|urological agents|mesh-ancestor
92920068|NCT00770484|Propranolol|propranolol|mesh-list
92920069|NCT00770484|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92920070|NCT00770484|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92920071|NCT00770484|Adrenergic Agents|adrenergic agents|mesh-ancestor
92920072|NCT00770484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920073|NCT00770484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920074|NCT00770484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920075|NCT00770484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92920076|NCT00770484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92920077|NCT00770484|Vasodilator Agents|vasodilator agents|mesh-ancestor
92920078|NCT00835679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92920079|NCT00835679|Cetuximab|cetuximab|mesh-list
92920080|NCT00835679|Dasatinib|dasatinib|mesh-list
92920081|NCT00835679|Antibodies|antibodies|mesh-list
92920082|NCT00835679|Immunoglobulins|immunoglobulins|mesh-list
92920083|NCT00835679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92920084|NCT00835679|Immunologic Factors|immunologic factors|mesh-ancestor
92920085|NCT00835679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920086|NCT00835679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920087|NCT00835679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920088|NCT00835679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920089|NCT00835679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920090|NCT00766506|Fentanyl|fentanyl|mesh-list
92920091|NCT00766506|Morphine|morphine|mesh-list
92920092|NCT00766506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920093|NCT00766506|Narcotics|narcotics|mesh-ancestor
92920094|NCT00766506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920095|NCT00766506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920096|NCT00766506|Analgesics|analgesics|mesh-ancestor
92920097|NCT00766506|Sensory System Agents|sensory system agents|mesh-ancestor
92920098|NCT00766506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920099|NCT00766506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92920100|NCT00766506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92920101|NCT00766506|Anesthetics, General|anesthetics, general|mesh-ancestor
92920102|NCT00766506|Anesthetics|anesthetics|mesh-ancestor
92920103|NCT00770328|Pentoxifylline|pentoxifylline|mesh-list
92920104|NCT00770328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92920105|NCT00770328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920106|NCT00770328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920107|NCT00770328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92920108|NCT00770328|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92920109|NCT00770328|Protective Agents|protective agents|mesh-ancestor
92920110|NCT00770328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920111|NCT00770328|Vasodilator Agents|vasodilator agents|mesh-ancestor
92920112|NCT00770328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92920113|NCT00770328|Antioxidants|antioxidants|mesh-ancestor
92920114|NCT05500092|Cisplatin|cisplatin|mesh-list
92920115|NCT05500092|Gemcitabine|gemcitabine|mesh-list
92920116|NCT05500092|Docetaxel|docetaxel|mesh-list
92920117|NCT05500092|Nivolumab|nivolumab|mesh-list
92920118|NCT05500092|Pemetrexed|pemetrexed|mesh-list
92920119|NCT05500092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920120|NCT05500092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92920121|NCT05500092|Antimetabolites|antimetabolites|mesh-ancestor
92920122|NCT05500092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920123|NCT05500092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92920124|NCT05500092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92920125|NCT05500092|Mitosis Modulators|mitosis modulators|mesh-ancestor
92920126|NCT05500092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920127|NCT05500092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92920128|NCT05500092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920129|NCT05500092|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92920130|NCT05500092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920131|NCT00916500|Cisplatin|cisplatin|mesh-list
92920132|NCT00916500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920133|NCT03110094|Adalimumab|adalimumab|mesh-list
92920134|NCT03110094|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92920135|NCT03110094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920136|NCT03110094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920137|NCT02600988|Vitamin D|vitamin d|mesh-list
92920138|NCT02600988|Ergocalciferols|ergocalciferols|mesh-list
92920139|NCT02600988|Cholecalciferol|cholecalciferol|mesh-list
92920140|NCT02600988|Vitamins|vitamins|mesh-list
92920141|NCT02600988|Micronutrients|micronutrients|mesh-ancestor
92920142|NCT02600988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920143|NCT02600988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92920144|NCT02600988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92920145|NCT04097574|Menthol|menthol|mesh-list
92920146|NCT04097574|Antipruritics|antipruritics|mesh-ancestor
92920147|NCT04097574|Dermatologic Agents|dermatologic agents|mesh-ancestor
92920148|NCT00766038|Hormones|hormones|mesh-list
92920149|NCT00766038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920150|NCT00766038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920151|NCT00765882|Linaclotide|linaclotide|mesh-list
92920152|NCT00765882|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92920153|NCT00765882|Enzyme Activators|enzyme activators|mesh-ancestor
92920154|NCT00765882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920155|NCT00765882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920156|NCT00913367|Insulin|insulin|mesh-list
92920157|NCT00913367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92920158|NCT00913367|Metformin|metformin|mesh-list
92920159|NCT00913367|Insulin Glargine|insulin glargine|mesh-list
92920160|NCT00913367|Glimepiride|glimepiride|mesh-list
92920161|NCT00913367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92920162|NCT00913367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920163|NCT00913367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92920164|NCT00913367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92920165|NCT00913367|Immunologic Factors|immunologic factors|mesh-ancestor
92920166|NCT00828113|Varenicline|varenicline|mesh-list
92920167|NCT00828113|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92920168|NCT00828113|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92920169|NCT00828113|Cholinergic Agents|cholinergic agents|mesh-ancestor
92920170|NCT00828113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920171|NCT00828113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920172|NCT00828113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920173|NCT00707135|Sirolimus|sirolimus|mesh-list
92920174|NCT00707135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920175|NCT00707135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920176|NCT00707135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92920177|NCT00707135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920178|NCT00707135|Antifungal Agents|antifungal agents|mesh-ancestor
92920179|NCT00707135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92920180|NCT00707135|Immunologic Factors|immunologic factors|mesh-ancestor
92920181|NCT00707135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920182|NCT00769704|Molgramostim|molgramostim|mesh-list
92920183|NCT00769704|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92920184|NCT00769704|Sargramostim|sargramostim|mesh-list
92920185|NCT00769704|Immunologic Factors|immunologic factors|mesh-ancestor
92920186|NCT00769704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920187|NCT00769704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920188|NCT00769704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920189|NCT00818753|Heparin|heparin|mesh-list
92920190|NCT00818753|Calcium heparin|calcium heparin|mesh-list
92920191|NCT00818753|Dabigatran|dabigatran|mesh-list
92920192|NCT00818753|Anticoagulants|anticoagulants|mesh-ancestor
92920193|NCT00818753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92920194|NCT00818753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92920195|NCT00818753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920197|NCT00818753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92920198|NCT00818753|Protease Inhibitors|protease inhibitors|mesh-ancestor
92920199|NCT00818753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920200|NCT00704249|Nevirapine|nevirapine|mesh-list
92920201|NCT00704249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92920202|NCT00704249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920203|NCT00704249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920204|NCT00704249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920205|NCT00704249|Antiviral Agents|antiviral agents|mesh-ancestor
92920206|NCT00704249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920207|NCT00704249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92920208|NCT00704249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92920209|NCT00704249|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92920210|NCT00704249|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92920211|NCT00765726|Factor VIII|factor viii|mesh-list
92920212|NCT00765726|Coagulants|coagulants|mesh-ancestor
92920213|NCT04100226|Vitamin D|vitamin d|mesh-list
92920214|NCT04100226|Cholecalciferol|cholecalciferol|mesh-list
92920215|NCT04100226|Calcium Carbonate|calcium carbonate|mesh-list
92920216|NCT04100226|Vitamins|vitamins|mesh-ancestor
92920217|NCT04100226|Micronutrients|micronutrients|mesh-ancestor
92920218|NCT04100226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920219|NCT04100226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92920220|NCT04100226|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92920221|NCT04100226|Antacids|antacids|mesh-ancestor
92920222|NCT04100226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920223|NCT04100226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920224|NCT00765336|Minocycline|minocycline|mesh-list
92920225|NCT00765336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920226|NCT00765336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920227|NCT00818519|Drospirenone|drospirenone|mesh-list
92920228|NCT00818519|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92920229|NCT00818519|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920230|NCT00818519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920231|NCT00818519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920232|NCT00818519|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92920233|NCT00818519|Diuretics|diuretics|mesh-ancestor
92920234|NCT00818519|Natriuretic Agents|natriuretic agents|mesh-ancestor
92920235|NCT00827567|Everolimus|everolimus|mesh-list
92920236|NCT00827567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92920237|NCT00827567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920238|NCT00827567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920239|NCT00827567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920240|NCT00827567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92920241|NCT00827567|Immunologic Factors|immunologic factors|mesh-ancestor
92920242|NCT00827567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920243|NCT00827567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920245|NCT00765102|Romidepsin|romidepsin|mesh-list
92920246|NCT00765102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920247|NCT00765102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92920248|NCT00765102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92920249|NCT00765102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920250|NCT00765102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920251|NCT00809354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92920252|NCT00809354|Tanezumab|tanezumab|mesh-list
92920253|NCT00809354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92920254|NCT00809354|Analgesics|analgesics|mesh-ancestor
92920255|NCT00809354|Sensory System Agents|sensory system agents|mesh-ancestor
92920256|NCT00809354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920257|NCT00809354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920258|NCT00809354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920259|NCT00809354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920260|NCT00834899|Eptifibatide|eptifibatide|mesh-list
92920261|NCT00834899|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92920262|NCT00764946|Raltegravir Potassium|raltegravir potassium|mesh-list
92920263|NCT00764946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92920264|NCT00764946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92920265|NCT00764946|Antiviral Agents|antiviral agents|mesh-ancestor
92920266|NCT00764946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920267|NCT00764946|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92920268|NCT00764946|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92920269|NCT00764946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920270|NCT00764946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920271|NCT00764868|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92920272|NCT00764868|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92920273|NCT00764868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920274|NCT00764868|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92920275|NCT00764868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920276|NCT00764868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92920277|NCT00764868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920278|NCT00764868|Dopamine Agents|dopamine agents|mesh-ancestor
92920279|NCT00764868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920280|NCT05752916|Clopidogrel|clopidogrel|mesh-list
92920281|NCT05752916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92920282|NCT05752916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920283|NCT05752916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920284|NCT05752916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92920285|NCT05752916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92920286|NCT05752916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92920287|NCT05752916|Purinergic Agents|purinergic agents|mesh-ancestor
92920288|NCT05752916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920289|NCT03990896|Talazoparib|talazoparib|mesh-list
92920290|NCT03990896|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92920291|NCT03990896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920292|NCT03990896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920293|NCT03990896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920294|NCT00756444|Panitumumab|panitumumab|mesh-list
92920295|NCT00756444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920296|NCT00756444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920297|NCT00753012|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92920298|NCT00753012|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92920299|NCT00753012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920300|NCT00753012|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92920301|NCT00753012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920302|NCT00753012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92920303|NCT00753012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920304|NCT00753012|Dopamine Agents|dopamine agents|mesh-ancestor
92920305|NCT00753012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920306|NCT00806156|Etirinotecan pegol|etirinotecan pegol|mesh-list
92920307|NCT00806156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920308|NCT00806156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92920309|NCT00806156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92920310|NCT00806156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920311|NCT00806156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920312|NCT00764478|Asenapine|asenapine|mesh-list
92920313|NCT00764478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92920314|NCT00764478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92920315|NCT00764478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920316|NCT00764478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920317|NCT00764478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92920318|NCT00805766|Infliximab|infliximab|mesh-list
92920319|NCT00805766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92920320|NCT00805766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920321|NCT00805766|Dermatologic Agents|dermatologic agents|mesh-ancestor
92920322|NCT00805766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920323|NCT00805766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920324|NCT00764322|Tamoxifen|tamoxifen|mesh-list
92920325|NCT00764322|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92920326|NCT00764322|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920327|NCT00764322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920328|NCT00764322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920329|NCT00764322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92920330|NCT00764322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920331|NCT00764322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92920332|NCT00764322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92920333|NCT00764322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92920334|NCT03908060|Morphine|morphine|mesh-list
92920335|NCT03908060|Methadone|methadone|mesh-list
92920336|NCT03908060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920337|NCT03908060|Narcotics|narcotics|mesh-ancestor
92920338|NCT03908060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92565804|NCT04732845|Cyclophosphamide|cyclophosphamide|mesh-list
92920339|NCT03908060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920341|NCT03908060|Sensory System Agents|sensory system agents|mesh-ancestor
92920342|NCT03908060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920343|NCT03908060|Antitussive Agents|antitussive agents|mesh-ancestor
92920344|NCT03908060|Respiratory System Agents|respiratory system agents|mesh-ancestor
92920345|NCT00752856|Ritonavir|ritonavir|mesh-list
92920346|NCT00752856|Lopinavir|lopinavir|mesh-list
92920347|NCT00752856|Tenofovir|tenofovir|mesh-list
92920348|NCT00752856|Emtricitabine|emtricitabine|mesh-list
92920349|NCT00752856|Raltegravir Potassium|raltegravir potassium|mesh-list
92920350|NCT00752856|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92920351|NCT00752856|Efavirenz|efavirenz|mesh-list
92920352|NCT00752856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92920353|NCT00752856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92920354|NCT00752856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92920355|NCT00752856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920356|NCT00752856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920357|NCT00752856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92920358|NCT00752856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92920359|NCT00752856|Antiviral Agents|antiviral agents|mesh-ancestor
92920360|NCT00752856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920361|NCT00752856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92920362|NCT00752856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92920363|NCT00752856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92920364|NCT00752856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920365|NCT00752856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92920366|NCT00752856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92920367|NCT00752856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92920368|NCT00752856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92920369|NCT00752856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92920370|NCT00752856|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92920371|NCT00752856|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92920372|NCT00805142|Tapentadol|tapentadol|mesh-list
92920373|NCT00805142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920374|NCT00805142|Narcotics|narcotics|mesh-ancestor
92920375|NCT00805142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920376|NCT00805142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920377|NCT00805142|Analgesics|analgesics|mesh-ancestor
92920378|NCT00805142|Sensory System Agents|sensory system agents|mesh-ancestor
92920379|NCT00805142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920380|NCT00805142|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92920381|NCT00805142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920382|NCT00805142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526246|NCT00012090|Goserelin|goserelin|mesh-list
92920383|NCT00805142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920384|NCT00805142|Adrenergic Agents|adrenergic agents|mesh-ancestor
92920385|NCT00805142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920386|NCT00761631|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92920387|NCT00761631|Immunologic Factors|immunologic factors|mesh-ancestor
92920388|NCT00761631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920389|NCT00761319|Travoprost|travoprost|mesh-list
92920390|NCT00761319|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92920391|NCT00761319|Latanoprost|latanoprost|mesh-list
92920392|NCT00761319|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92920393|NCT00761319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92920394|NCT00704639|Carboplatin|carboplatin|mesh-list
92920395|NCT00704639|Cetuximab|cetuximab|mesh-list
92920396|NCT00704639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920397|NCT00704639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920398|NCT00826943|Cetirizine|cetirizine|mesh-list
92920399|NCT00826943|Levocetirizine|levocetirizine|mesh-list
92920400|NCT00826943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92920401|NCT00826943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92920402|NCT00826943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92920403|NCT00826943|Histamine Antagonists|histamine antagonists|mesh-ancestor
92920404|NCT00826943|Histamine Agents|histamine agents|mesh-ancestor
92920405|NCT00826943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920406|NCT00826943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920407|NCT00826943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565878|NCT00056030|Antimetabolites|antimetabolites|mesh-ancestor
92920408|NCT00707369|Amoxicillin|amoxicillin|mesh-list
92920409|NCT00707369|Metronidazole|metronidazole|mesh-list
92920410|NCT00707369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920411|NCT00707369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920412|NCT00707369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92920413|NCT00707369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92920414|NCT00760929|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92920415|NCT00760929|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92920416|NCT00760929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920417|NCT00760929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920418|NCT00760929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920419|NCT00760929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920420|NCT00760929|Immunologic Factors|immunologic factors|mesh-ancestor
92920421|NCT00760929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920422|NCT00704951|Posaconazole|posaconazole|mesh-list
92920423|NCT00704951|Antifungal Agents|antifungal agents|mesh-ancestor
92920424|NCT00704951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920425|NCT00704951|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92920426|NCT00704951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92920427|NCT00704951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92920428|NCT00704951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92920429|NCT00704951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92920430|NCT00704951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920431|NCT00704951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920432|NCT00704951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92920433|NCT00704951|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920434|NCT00704951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920435|NCT00704951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920436|NCT00759915|Morphine|morphine|mesh-list
92920437|NCT00759915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920438|NCT00759915|Narcotics|narcotics|mesh-ancestor
92920439|NCT00759915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920440|NCT00759915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920441|NCT00759915|Analgesics|analgesics|mesh-ancestor
92920442|NCT00759915|Sensory System Agents|sensory system agents|mesh-ancestor
92920443|NCT00759915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920444|NCT00759759|Morphine|morphine|mesh-list
92920445|NCT00759759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920446|NCT00759759|Narcotics|narcotics|mesh-ancestor
92920447|NCT00759759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920448|NCT00759759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920449|NCT00759759|Analgesics|analgesics|mesh-ancestor
92920450|NCT00759759|Sensory System Agents|sensory system agents|mesh-ancestor
92920451|NCT00759759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920452|NCT00759681|Thrombin|thrombin|mesh-list
92920453|NCT00759681|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92920454|NCT00759681|Hemostatics|hemostatics|mesh-ancestor
92920455|NCT00759681|Coagulants|coagulants|mesh-ancestor
92920456|NCT00826241|Temozolomide|temozolomide|mesh-list
92920457|NCT00826241|Lapatinib|lapatinib|mesh-list
92920458|NCT00826241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92920459|NCT00826241|Alkylating Agents|alkylating agents|mesh-ancestor
92920460|NCT00826241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920461|NCT00826241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920462|NCT00826241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920463|NCT00826241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920464|NCT04097847|Clodronic Acid|clodronic acid|mesh-list
92920465|NCT04097847|Tocopherols|tocopherols|mesh-list
92920466|NCT04097847|Vitamin E|vitamin e|mesh-list
92920467|NCT04097847|Tocotrienols|tocotrienols|mesh-list
92920468|NCT04097847|alpha-Tocopherol|alpha-tocopherol|mesh-list
92920469|NCT04097847|Pentoxifylline|pentoxifylline|mesh-list
92920470|NCT04097847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92920471|NCT04097847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920472|NCT04097847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920473|NCT04097847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92920474|NCT04097847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92920475|NCT04097847|Protective Agents|protective agents|mesh-ancestor
92920476|NCT04097847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920477|NCT04097847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92920478|NCT04097847|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92920479|NCT04097847|Antioxidants|antioxidants|mesh-ancestor
92920480|NCT04097847|Vitamins|vitamins|mesh-ancestor
92920481|NCT04097847|Micronutrients|micronutrients|mesh-ancestor
92920482|NCT04097847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92920483|NCT00762372|Nitrous Oxide|nitrous oxide|mesh-list
92920484|NCT00762372|Sevoflurane|sevoflurane|mesh-list
92920485|NCT00762372|Desflurane|desflurane|mesh-list
92920486|NCT00762372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92920487|NCT00762372|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92920488|NCT00762372|Anesthetics, General|anesthetics, general|mesh-ancestor
92920489|NCT00762372|Anesthetics|anesthetics|mesh-ancestor
92920490|NCT00762372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920491|NCT00762372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920492|NCT00762372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92920493|NCT00762372|Analgesics|analgesics|mesh-ancestor
92920494|NCT00762372|Sensory System Agents|sensory system agents|mesh-ancestor
92920495|NCT00762372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920496|NCT00833261|Paclitaxel|paclitaxel|mesh-list
92920497|NCT00833261|Cetuximab|cetuximab|mesh-list
92920498|NCT00833261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92920499|NCT00833261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920500|NCT00833261|Tubulin Modulators|tubulin modulators|mesh-ancestor
92920501|NCT00833261|Antimitotic Agents|antimitotic agents|mesh-ancestor
92920502|NCT00833261|Mitosis Modulators|mitosis modulators|mesh-ancestor
92920503|NCT00833261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920504|NCT00833261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920505|NCT00833027|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92920506|NCT00833027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92920507|NCT00833027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920508|NCT00833027|Incretins|incretins|mesh-ancestor
92920509|NCT00833027|Hormones|hormones|mesh-ancestor
92920510|NCT00833027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920511|NCT00833027|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92920512|NCT00833027|Protease Inhibitors|protease inhibitors|mesh-ancestor
92920513|NCT00833027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920514|NCT00833027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920515|NCT00752622|Infliximab|infliximab|mesh-list
92920516|NCT00752622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92920517|NCT00752622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920518|NCT00752622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92920519|NCT00752622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920520|NCT00752622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920521|NCT00754650|Bevacizumab|bevacizumab|mesh-list
92920522|NCT00754650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92920523|NCT00754650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920524|NCT00754650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92920525|NCT00754650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92920526|NCT00754650|Growth Substances|growth substances|mesh-ancestor
92162817|NCT00631189|Atorvastatin|atorvastatin|mesh-list
92920527|NCT00754650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920528|NCT00754650|Growth Inhibitors|growth inhibitors|mesh-ancestor
92920529|NCT02611271|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92920530|NCT02611271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920531|NCT00825305|Vaccines|vaccines|mesh-list
92920532|NCT00825305|Immunologic Factors|immunologic factors|mesh-ancestor
92920533|NCT00825305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920534|NCT00754572|Methotrexate|methotrexate|mesh-list
92920535|NCT00754572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92920536|NCT00754572|Abortifacient Agents|abortifacient agents|mesh-ancestor
92920537|NCT00754572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92920538|NCT00754572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920539|NCT00754572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92920540|NCT00754572|Antimetabolites|antimetabolites|mesh-ancestor
92920541|NCT00754572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920542|NCT00754572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920543|NCT00754572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92920544|NCT00754572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920545|NCT00754572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92920546|NCT00754572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92920547|NCT00754572|Immunologic Factors|immunologic factors|mesh-ancestor
92920548|NCT00754572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920549|NCT00754572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920550|NCT00824993|Ibandronic Acid|ibandronic acid|mesh-list
92920551|NCT00824993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920552|NCT00824993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92920553|NCT04095312|Pancrelipase|pancrelipase|mesh-list
92920554|NCT04095312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920555|NCT04095390|Capecitabine|capecitabine|mesh-list
92920556|NCT04095390|Letrozole|letrozole|mesh-list
92920557|NCT04095390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92920558|NCT04095390|Antimetabolites|antimetabolites|mesh-ancestor
92920559|NCT04095390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920560|NCT04095390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920561|NCT04095390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92920562|NCT04095390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92920563|NCT04095390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920564|NCT04095390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92920565|NCT04095390|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920566|NCT04095390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920567|NCT04095390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920568|NCT00754338|Dipivefrin|dipivefrin|mesh-list
92920569|NCT00754338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92920570|NCT00754338|Adrenergic Agents|adrenergic agents|mesh-ancestor
92920571|NCT00754338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920572|NCT00754338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920573|NCT00754338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920574|NCT00708149|Lansoprazole|lansoprazole|mesh-list
92920575|NCT00708149|Dexlansoprazole|dexlansoprazole|mesh-list
92920576|NCT00708149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92920577|NCT00708149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920578|NCT00708149|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92920579|NCT00708149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920580|NCT00708149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920581|NCT04016051|Clarithromycin|clarithromycin|mesh-list
92920582|NCT04016051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920583|NCT04016051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920584|NCT04016051|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92920585|NCT04016051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920586|NCT04016051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162820|NCT00631189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92920587|NCT04016051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92920588|NCT04016051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92920589|NCT00761514|Adalimumab|adalimumab|mesh-list
92920590|NCT00761514|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92920591|NCT00761514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920592|NCT00761514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920593|NCT00831779|Dapagliflozin|dapagliflozin|mesh-list
92920594|NCT00831779|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92920595|NCT00831779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920596|NCT00831779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92920597|NCT00831779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920598|NCT00758043|Ribavirin|ribavirin|mesh-list
92920599|NCT00758043|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92920600|NCT00758043|Antimetabolites|antimetabolites|mesh-ancestor
92920601|NCT00758043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920602|NCT00758043|Antiviral Agents|antiviral agents|mesh-ancestor
92920603|NCT00758043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920604|NCT00831701|Tamsulosin|tamsulosin|mesh-list
92920605|NCT00831701|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92920606|NCT00831701|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92920607|NCT00831701|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92920608|NCT00831701|Adrenergic Agents|adrenergic agents|mesh-ancestor
92920609|NCT00831701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920610|NCT00831701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920611|NCT00831701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920612|NCT00831701|Urological Agents|urological agents|mesh-ancestor
92920613|NCT00705419|Tenofovir|tenofovir|mesh-list
92920614|NCT00705419|Emtricitabine|emtricitabine|mesh-list
92920615|NCT00705419|Maleic acid|maleic acid|mesh-list
92920616|NCT00705419|Antiviral Agents|antiviral agents|mesh-ancestor
92920617|NCT00705419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920618|NCT00705419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92920619|NCT00705419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920620|NCT00705419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920621|NCT00705419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920622|NCT00705419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92920623|NCT00705419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92920624|NCT05425355|Acetaminophen|acetaminophen|mesh-list
92920625|NCT05425355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92920626|NCT05425355|Analgesics|analgesics|mesh-ancestor
92920627|NCT05425355|Sensory System Agents|sensory system agents|mesh-ancestor
92920628|NCT05425355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920629|NCT05425355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920630|NCT05425355|Antipyretics|antipyretics|mesh-ancestor
92920631|NCT04093713|Nordefrin|nordefrin|mesh-list
92920632|NCT04093713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92920633|NCT00831311|Vaccines|vaccines|mesh-list
92920634|NCT00831311|Immunologic Factors|immunologic factors|mesh-ancestor
92920635|NCT00831311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920636|NCT00831233|Goserelin|goserelin|mesh-list
92920637|NCT00831233|Bicalutamide|bicalutamide|mesh-list
92566127|NCT00175357|Methadone|methadone|mesh-list
92920638|NCT00831233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92920639|NCT00831233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920640|NCT00831233|Androgen Antagonists|androgen antagonists|mesh-ancestor
92920641|NCT00831233|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920642|NCT00831233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920643|NCT00831233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920644|NCT05438277|Methylprednisolone|methylprednisolone|mesh-list
92920645|NCT05438277|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92920646|NCT05438277|Triamcinolone|triamcinolone|mesh-list
92920647|NCT05438277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92920648|NCT05438277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92920649|NCT05438277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92920650|NCT05438277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920651|NCT05438277|Antiemetics|antiemetics|mesh-ancestor
92920652|NCT05438277|Autonomic Agents|autonomic agents|mesh-ancestor
92920653|NCT05438277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920654|NCT05438277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920655|NCT05438277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92920656|NCT05438277|Glucocorticoids|glucocorticoids|mesh-ancestor
92920657|NCT05438277|Hormones|hormones|mesh-ancestor
92920658|NCT05438277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920659|NCT05438277|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92920660|NCT05438277|Protective Agents|protective agents|mesh-ancestor
92920661|NCT05438277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92920662|NCT05438277|Immunologic Factors|immunologic factors|mesh-ancestor
92920663|NCT05438277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920664|NCT05438277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920665|NCT00761280|Temozolomide|temozolomide|mesh-list
92920666|NCT00761280|Carmustine|carmustine|mesh-list
92920667|NCT00761280|Lomustine|lomustine|mesh-list
92920668|NCT00761280|Trabedersen|trabedersen|mesh-list
92920669|NCT00761280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92920670|NCT00761280|Alkylating Agents|alkylating agents|mesh-ancestor
92920671|NCT00761280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920672|NCT00761280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920673|NCT00916890|Fentanyl|fentanyl|mesh-list
92920674|NCT00916890|Morphine|morphine|mesh-list
92920675|NCT00916890|Oxycodone|oxycodone|mesh-list
92920676|NCT00916890|Buprenorphine|buprenorphine|mesh-list
92920677|NCT00916890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920678|NCT00916890|Narcotics|narcotics|mesh-ancestor
92920679|NCT00916890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920680|NCT00916890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920681|NCT00916890|Analgesics|analgesics|mesh-ancestor
92920682|NCT00916890|Sensory System Agents|sensory system agents|mesh-ancestor
92920683|NCT00916890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920684|NCT00916890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92920685|NCT00916890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92920686|NCT00916890|Anesthetics, General|anesthetics, general|mesh-ancestor
92920687|NCT00916890|Anesthetics|anesthetics|mesh-ancestor
92920688|NCT00916890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92920689|NCT02599701|Gabapentin|gabapentin|mesh-list
92920690|NCT02599701|Analgesics|analgesics|mesh-ancestor
92920691|NCT02599701|Sensory System Agents|sensory system agents|mesh-ancestor
92920692|NCT02599701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920693|NCT02599701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920694|NCT02599701|Anticonvulsants|anticonvulsants|mesh-ancestor
92920695|NCT02599701|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92920696|NCT02599701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92920697|NCT02599701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920698|NCT02599701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92920699|NCT02599701|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92920700|NCT02599701|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92920701|NCT02599701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920702|NCT02599701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920703|NCT02599701|Antimanic Agents|antimanic agents|mesh-ancestor
92920704|NCT00824291|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92920705|NCT00824291|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92920706|NCT00824291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920707|NCT00824291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92920708|NCT00824291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920709|NCT00824291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920710|NCT00824291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920711|NCT00824291|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566203|NCT00175747|Budesonide|budesonide|mesh-list
92920712|NCT00824291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92920713|NCT00752232|Saponin QA-21V1|saponin qa-21v1|mesh-list
92920714|NCT00752232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92920715|NCT00752232|Immunologic Factors|immunologic factors|mesh-ancestor
92920716|NCT00752232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920717|NCT00760266|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92920718|NCT00760266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92920719|NCT00760266|Diuretics|diuretics|mesh-ancestor
92920720|NCT00760266|Natriuretic Agents|natriuretic agents|mesh-ancestor
92920721|NCT00760266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920722|NCT00760266|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92920723|NCT00760266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92920724|NCT00760266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920725|NCT00753714|Gemcitabine|gemcitabine|mesh-list
92920726|NCT00753714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92920727|NCT00753714|Antimetabolites|antimetabolites|mesh-ancestor
92920728|NCT00753714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920729|NCT00753714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920730|NCT00759954|Morphine|morphine|mesh-list
92920731|NCT00759954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92920732|NCT00759954|Narcotics|narcotics|mesh-ancestor
92920733|NCT00759954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920734|NCT00759954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920735|NCT00759954|Analgesics|analgesics|mesh-ancestor
92920736|NCT00759954|Sensory System Agents|sensory system agents|mesh-ancestor
92920737|NCT00759954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920738|NCT00804908|Temozolomide|temozolomide|mesh-list
92920739|NCT00804908|Veliparib|veliparib|mesh-list
92920740|NCT00804908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92920741|NCT00804908|Alkylating Agents|alkylating agents|mesh-ancestor
92920742|NCT00804908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920743|NCT00804908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920744|NCT00804908|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92920745|NCT00804908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920746|NCT02608034|Itraconazole|itraconazole|mesh-list
92920747|NCT02608034|Rifampin|rifampin|mesh-list
92920748|NCT02608034|Vemurafenib|vemurafenib|mesh-list
92920749|NCT02608034|Antifungal Agents|antifungal agents|mesh-ancestor
92920750|NCT02608034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526251|NCT00012090|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920751|NCT02608034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92920752|NCT02608034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92920753|NCT02608034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920754|NCT02608034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920755|NCT02608034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92920756|NCT02608034|Hormone Antagonists|hormone antagonists|mesh-ancestor
92920757|NCT02608034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920758|NCT02608034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920759|NCT02608034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92920760|NCT02608034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92920761|NCT02608034|Antitubercular Agents|antitubercular agents|mesh-ancestor
92920762|NCT02608034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920763|NCT02608034|Leprostatic Agents|leprostatic agents|mesh-ancestor
92920764|NCT02608034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920765|NCT02608034|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92920766|NCT02608034|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92920767|NCT02608034|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92920768|NCT02608034|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92920769|NCT02608034|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92920770|NCT02608034|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92920771|NCT02608034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920772|NCT02608034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920773|NCT00589784|Sunitinib|sunitinib|mesh-list
92920774|NCT00589784|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-list
92920775|NCT00589784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920776|NCT00589784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92920777|NCT00589784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92920778|NCT00589784|Growth Substances|growth substances|mesh-ancestor
92920779|NCT00589784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920780|NCT00589784|Growth Inhibitors|growth inhibitors|mesh-ancestor
92920781|NCT00589784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920782|NCT00589784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920783|NCT00589784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920784|NCT00589784|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92920785|NCT05742854|Oxytocin|oxytocin|mesh-list
92920786|NCT05742854|Carbetocin|carbetocin|mesh-list
92920787|NCT05742854|Oxytocics|oxytocics|mesh-ancestor
92920788|NCT05742854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92920789|NCT05742854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920790|NCT00823979|Etravirine|etravirine|mesh-list
92920791|NCT00823979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92920792|NCT00823979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92920793|NCT00823979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920794|NCT00823979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920795|NCT00823979|Antiviral Agents|antiviral agents|mesh-ancestor
92920796|NCT00823979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920797|NCT04094766|Immunomodulating Agents|immunomodulating agents|mesh-list
92920798|NCT04094766|Immunologic Factors|immunologic factors|mesh-ancestor
92920799|NCT04094766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920800|NCT02606864|Nifurtimox|nifurtimox|mesh-list
92920801|NCT02606864|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92920802|NCT02606864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92920803|NCT02606864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92920804|NCT02606864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920805|NCT00823901|Clindamycin|clindamycin|mesh-list
92920806|NCT00823901|Clindamycin palmitate|clindamycin palmitate|mesh-list
92920807|NCT00823901|Clindamycin phosphate|clindamycin phosphate|mesh-list
92920808|NCT00823901|Tretinoin|tretinoin|mesh-list
92920809|NCT00823901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920810|NCT00823901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920811|NCT00823901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92920812|NCT00823901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920813|NCT00823901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920814|NCT00823901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920815|NCT00823901|Keratolytic Agents|keratolytic agents|mesh-ancestor
92920816|NCT00823901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92920817|NCT00823823|Calpastatin|calpastatin|mesh-list
92920818|NCT00823823|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92920819|NCT00823823|Protease Inhibitors|protease inhibitors|mesh-ancestor
92920820|NCT00823823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920821|NCT00823823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920822|NCT02926898|Fenfluramine|fenfluramine|mesh-list
92920823|NCT02926898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92920824|NCT02926898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920826|NCT02926898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920827|NCT02926898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920828|NCT02926898|Serotonin Agents|serotonin agents|mesh-ancestor
92920829|NCT02926898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920830|NCT00759564|Lactams|lactams|mesh-list
92920831|NCT00759564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92920832|NCT00759564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920833|NCT00816023|Ecallantide|ecallantide|mesh-list
92920834|NCT00816023|Analgesics|analgesics|mesh-ancestor
92920835|NCT00816023|Sensory System Agents|sensory system agents|mesh-ancestor
92920836|NCT00816023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920837|NCT00816023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920838|NCT00816023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92920839|NCT00816023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92920840|NCT00816023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920841|NCT00816023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920842|NCT00815633|Alefacept|alefacept|mesh-list
92920843|NCT00815633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92920844|NCT00815633|Immunologic Factors|immunologic factors|mesh-ancestor
92920845|NCT00815633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920846|NCT02610881|Iron|iron|mesh-list
92920847|NCT02610881|Trace Elements|trace elements|mesh-list
92920848|NCT02610881|Folic Acid|folic acid|mesh-list
92920849|NCT02610881|Micronutrients|micronutrients|mesh-list
92920850|NCT02610881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920851|NCT02610881|Hematinics|hematinics|mesh-ancestor
92920852|NCT02610881|Vitamin B Complex|vitamin b complex|mesh-ancestor
92920853|NCT02610881|Vitamins|vitamins|mesh-ancestor
92920854|NCT00830765|Progesterone|progesterone|mesh-list
92920855|NCT00830765|Progestins|progestins|mesh-ancestor
92920856|NCT00830765|Hormones|hormones|mesh-ancestor
92920857|NCT00830765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920858|NCT00830765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920859|NCT04093206|Vitamins|vitamins|mesh-list
92920860|NCT04093206|Ascorbic Acid|ascorbic acid|mesh-list
92920861|NCT04093206|Micronutrients|micronutrients|mesh-ancestor
92920862|NCT04093206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920863|NCT04093206|Antioxidants|antioxidants|mesh-ancestor
92920864|NCT04093206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920865|NCT04093206|Protective Agents|protective agents|mesh-ancestor
92920866|NCT00830375|Memantine|memantine|mesh-list
92920867|NCT00830375|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92920868|NCT00830375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92920869|NCT00830375|Dopamine Agents|dopamine agents|mesh-ancestor
92920870|NCT00830375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920871|NCT00830375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920872|NCT00830375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920873|NCT00830375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92920874|NCT00830375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92920875|NCT00708539|Progesterone|progesterone|mesh-list
92920876|NCT00708539|Progestins|progestins|mesh-ancestor
92920877|NCT00708539|Hormones|hormones|mesh-ancestor
92920878|NCT00708539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92920879|NCT00708539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920880|NCT00914420|Trapidil|trapidil|mesh-list
92920881|NCT00914420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92920882|NCT00914420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920883|NCT00914420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920884|NCT00914420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92920885|NCT00914420|Vasodilator Agents|vasodilator agents|mesh-ancestor
92920886|NCT04094532|Bupivacaine|bupivacaine|mesh-list
92920887|NCT04094532|Anesthetics, Local|anesthetics, local|mesh-ancestor
92920888|NCT04094532|Anesthetics|anesthetics|mesh-ancestor
92920889|NCT04094532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920890|NCT04094532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920891|NCT04094532|Sensory System Agents|sensory system agents|mesh-ancestor
92920892|NCT04094532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920893|NCT00708773|Irinotecan|irinotecan|mesh-list
92920894|NCT00708773|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92920895|NCT00708773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92920896|NCT00708773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920897|NCT00708773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920898|NCT00708773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920899|NCT05758259|Vitamin D|vitamin d|mesh-list
92920900|NCT05758259|Ergocalciferols|ergocalciferols|mesh-list
92920901|NCT05758259|Cholecalciferol|cholecalciferol|mesh-list
92920902|NCT05758259|Vitamins|vitamins|mesh-list
92920903|NCT05758259|Micronutrients|micronutrients|mesh-ancestor
92920904|NCT05758259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920905|NCT05758259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92920906|NCT05758259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92920907|NCT00803738|Terconazole|terconazole|mesh-list
92920908|NCT00803738|Antifungal Agents|antifungal agents|mesh-ancestor
92920909|NCT00803738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920910|NCT00591266|Amlodipine|amlodipine|mesh-list
92920911|NCT00591266|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92920912|NCT00591266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92920913|NCT00591266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92920914|NCT00591266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92920915|NCT00591266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920916|NCT00591266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92920917|NCT00591266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920918|NCT00591266|Vasodilator Agents|vasodilator agents|mesh-ancestor
92920919|NCT00591266|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92920920|NCT00591266|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92920921|NCT04093050|Vasopressins|vasopressins|mesh-list
92920922|NCT04093050|Hemostatics|hemostatics|mesh-ancestor
92920923|NCT04093050|Coagulants|coagulants|mesh-ancestor
92920924|NCT04093050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92920925|NCT04093050|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92920926|NCT04093050|Natriuretic Agents|natriuretic agents|mesh-ancestor
92920927|NCT04093050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920928|NCT00758394|Listerine|listerine|mesh-list
92920929|NCT00758394|Triclosan|triclosan|mesh-list
92920930|NCT00758394|Fluorides|fluorides|mesh-list
92920931|NCT00758394|Sodium Fluoride|sodium fluoride|mesh-list
92920932|NCT00758394|Fluorophosphate|fluorophosphate|mesh-list
92920933|NCT00758394|Cariostatic Agents|cariostatic agents|mesh-ancestor
92920934|NCT00758394|Protective Agents|protective agents|mesh-ancestor
92920935|NCT00758394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920936|NCT00758394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92920937|NCT00758394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92920938|NCT00758394|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92920939|NCT00758394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92920940|NCT00758394|Antimetabolites|antimetabolites|mesh-ancestor
92920941|NCT00758394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920942|NCT00758394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92920943|NCT04450394|Insulin|insulin|mesh-list
92920944|NCT04450394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92920945|NCT04450394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920946|NCT00758160|Methylphenidate|methylphenidate|mesh-list
92920947|NCT00758160|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92920948|NCT00758160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920949|NCT00758160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92920950|NCT00758160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92920951|NCT00758160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92920952|NCT00758160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920953|NCT00758160|Dopamine Agents|dopamine agents|mesh-ancestor
92920954|NCT00758160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920955|NCT02606552|Aspirin|aspirin|mesh-list
92920956|NCT02606552|Clopidogrel|clopidogrel|mesh-list
92920957|NCT02606552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92920958|NCT02606552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92920959|NCT02606552|Analgesics|analgesics|mesh-ancestor
92920960|NCT02606552|Sensory System Agents|sensory system agents|mesh-ancestor
92920961|NCT02606552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92920962|NCT02606552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920963|NCT02606552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92920964|NCT02606552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92920965|NCT02606552|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92920966|NCT02606552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92920967|NCT02606552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920968|NCT02606552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92920969|NCT02606552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92920970|NCT02606552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920971|NCT02606552|Antipyretics|antipyretics|mesh-ancestor
92920972|NCT02606552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92920973|NCT02606552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92920974|NCT02606552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92920975|NCT02606552|Purinergic Agents|purinergic agents|mesh-ancestor
92920976|NCT02606552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920978|NCT02852486|Imatinib Mesylate|imatinib mesylate|mesh-list
92920979|NCT02852486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92920980|NCT02852486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920981|NCT02852486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92920982|NCT02852486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92920983|NCT02852486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920984|NCT02852486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920985|NCT02608736|Valproic Acid|valproic acid|mesh-list
92920986|NCT02608736|Anticonvulsants|anticonvulsants|mesh-ancestor
92920987|NCT02608736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92920988|NCT02608736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92920989|NCT02608736|GABA Agents|gaba agents|mesh-ancestor
92920990|NCT02608736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92920991|NCT02608736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92920992|NCT02608736|Antimanic Agents|antimanic agents|mesh-ancestor
92920993|NCT02608736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92920994|NCT02608736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92920995|NCT02608736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92920996|NCT02607410|Insulin|insulin|mesh-list
92920997|NCT02607410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92920998|NCT02607410|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92920999|NCT02607410|Insulin, Isophane|insulin, isophane|mesh-list
92921000|NCT02607410|Isophane Insulin, Human|isophane insulin, human|mesh-list
92921001|NCT02607410|Isophane insulin, beef|isophane insulin, beef|mesh-list
92921002|NCT02607410|Insulin, Long-Acting|insulin, long-acting|mesh-list
92921003|NCT02607410|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92921004|NCT02607410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921005|NCT02607410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921006|NCT02607410|Incretins|incretins|mesh-ancestor
92921007|NCT02607410|Hormones|hormones|mesh-ancestor
92921008|NCT02607410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921009|NCT02607410|Protease Inhibitors|protease inhibitors|mesh-ancestor
92921010|NCT02607410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921011|NCT02607410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921012|NCT05693090|Osimertinib|osimertinib|mesh-list
92921013|NCT05693090|Tipifarnib|tipifarnib|mesh-list
92921014|NCT05693090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921015|NCT05693090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921016|NCT05693090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921017|NCT05693090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921018|NCT00751296|Lenalidomide|lenalidomide|mesh-list
92921019|NCT00751296|Immunologic Factors|immunologic factors|mesh-ancestor
92921020|NCT00751296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921021|NCT00751296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92921022|NCT00751296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92921023|NCT00751296|Growth Substances|growth substances|mesh-ancestor
92921024|NCT00751296|Growth Inhibitors|growth inhibitors|mesh-ancestor
92921025|NCT00751296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921026|NCT04093518|Estradiol|estradiol|mesh-list
92921027|NCT04093518|Estrogens|estrogens|mesh-ancestor
92921028|NCT04093518|Hormones|hormones|mesh-ancestor
92921029|NCT04093518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921030|NCT04093518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921031|NCT02606084|Esketamine|esketamine|mesh-list
92921032|NCT02606084|Antidepressive Agents|antidepressive agents|mesh-ancestor
92921033|NCT02606084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921034|NCT02607488|Lidocaine|lidocaine|mesh-list
92921035|NCT02607488|Anesthetics, Local|anesthetics, local|mesh-ancestor
92921036|NCT02607488|Anesthetics|anesthetics|mesh-ancestor
92921037|NCT02607488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921038|NCT02607488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921039|NCT02607488|Sensory System Agents|sensory system agents|mesh-ancestor
92921040|NCT02607488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921041|NCT02607488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92921042|NCT02607488|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92921043|NCT02607488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92921044|NCT02607488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921045|NCT02607488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921046|NCT00914498|Lidocaine|lidocaine|mesh-list
92921047|NCT00914498|Anesthetics, Local|anesthetics, local|mesh-ancestor
92921048|NCT00914498|Anesthetics|anesthetics|mesh-ancestor
92921049|NCT00914498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921050|NCT00914498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921051|NCT00914498|Sensory System Agents|sensory system agents|mesh-ancestor
92921052|NCT00914498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921053|NCT00914498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92921054|NCT00914498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92921055|NCT00914498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92921056|NCT00914498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921057|NCT00914498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921058|NCT00751881|Teriflunomide|teriflunomide|mesh-list
92921059|NCT00751881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921060|NCT00751881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921061|NCT00751881|Analgesics|analgesics|mesh-ancestor
92921062|NCT00751881|Sensory System Agents|sensory system agents|mesh-ancestor
92921063|NCT00751881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921064|NCT00751881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921065|NCT00751881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921066|NCT00751881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921067|NCT00751881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92921068|NCT00751881|Immunologic Factors|immunologic factors|mesh-ancestor
92921069|NCT02599779|Pembrolizumab|pembrolizumab|mesh-list
92921070|NCT02599779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92921071|NCT02599779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921072|NCT02599779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92921073|NCT02599779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921074|NCT02597556|Albendazole|albendazole|mesh-list
92921075|NCT02597556|Anthelmintics|anthelmintics|mesh-ancestor
92921076|NCT02597556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92921077|NCT02597556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921078|NCT02597556|Anticestodal Agents|anticestodal agents|mesh-ancestor
92921079|NCT02597556|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92921080|NCT02597556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92921081|NCT02597556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92921082|NCT02597556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92921083|NCT02597556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92921084|NCT02597556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921085|NCT02597556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921086|NCT02599857|Bisoprolol|bisoprolol|mesh-list
92921087|NCT02599857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921088|NCT02599857|Sympatholytics|sympatholytics|mesh-ancestor
92921089|NCT02599857|Autonomic Agents|autonomic agents|mesh-ancestor
92921090|NCT02599857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921091|NCT02599857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921092|NCT02599857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92921093|NCT02599857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92921094|NCT02599857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92921095|NCT02599857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92921096|NCT02599857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921097|NCT02599857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921098|NCT05406726|Palmidrol|palmidrol|mesh-list
92921099|NCT05406726|Analgesics|analgesics|mesh-ancestor
92921100|NCT05406726|Sensory System Agents|sensory system agents|mesh-ancestor
92921101|NCT05406726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921102|NCT05406726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921103|NCT05406726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921104|NCT05406726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921105|NCT05406726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921106|NCT05406726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921107|NCT05406726|Antiviral Agents|antiviral agents|mesh-ancestor
92921108|NCT05406726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921109|NCT05406726|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92921110|NCT05406726|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92921111|NCT05406726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921112|NCT05406726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921113|NCT05406726|Hormones|hormones|mesh-ancestor
92977271|NCT00982449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92921114|NCT05406726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921115|NCT02599623|Anesthetics|anesthetics|mesh-list
92921116|NCT02599623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921117|NCT02599623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921118|NCT02597400|Metformin|metformin|mesh-list
92921119|NCT02597400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921120|NCT02597400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921121|NCT00830063|Naproxen|naproxen|mesh-list
92921122|NCT00830063|Tanezumab|tanezumab|mesh-list
92921123|NCT00830063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921124|NCT00830063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921125|NCT00830063|Analgesics|analgesics|mesh-ancestor
92921126|NCT00830063|Sensory System Agents|sensory system agents|mesh-ancestor
92921127|NCT00830063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921128|NCT00830063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921129|NCT00830063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921130|NCT00830063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921131|NCT00830063|Gout Suppressants|gout suppressants|mesh-ancestor
92921132|NCT00830063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92921133|NCT00830063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921134|NCT00830063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921135|NCT04092621|Amiodarone|amiodarone|mesh-list
92921136|NCT04092621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92921137|NCT04092621|Vasodilator Agents|vasodilator agents|mesh-ancestor
92921138|NCT04092621|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92921139|NCT04092621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921140|NCT04092621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921141|NCT04092621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92921142|NCT04092621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92921143|NCT04092621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92921144|NCT04092621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921145|NCT04092621|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92921146|NCT04092621|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92921147|NCT04092621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92921148|NCT00751101|Nicotine|nicotine|mesh-list
92921149|NCT00751101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92921150|NCT00751101|Autonomic Agents|autonomic agents|mesh-ancestor
92921151|NCT00751101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921152|NCT00751101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921153|NCT00751101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92921154|NCT00751101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92921155|NCT00751101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92921156|NCT00751101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921157|NCT00751101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566632|NCT00179062|Olanzapine|olanzapine|mesh-list
92921158|NCT04092309|Valsartan|valsartan|mesh-list
92921159|NCT04092309|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92921160|NCT04092309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92921161|NCT04092309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921162|NCT04092309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92921163|NCT04092309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92921164|NCT04092309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921165|NCT04092309|Protease Inhibitors|protease inhibitors|mesh-ancestor
92921166|NCT04092309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921167|NCT02598414|Fluorophosphate|fluorophosphate|mesh-list
92921168|NCT02598414|Cariostatic Agents|cariostatic agents|mesh-ancestor
92921169|NCT02598414|Protective Agents|protective agents|mesh-ancestor
92921170|NCT02598414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921171|NCT04020003|Simendan|simendan|mesh-list
92921172|NCT04020003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92921173|NCT04020003|Vasodilator Agents|vasodilator agents|mesh-ancestor
92921174|NCT04020003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92921175|NCT04020003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92921176|NCT04020003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921177|NCT04020003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921178|NCT04020003|Protective Agents|protective agents|mesh-ancestor
92921179|NCT04020003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921180|NCT03977142|Chrysarobin|chrysarobin|mesh-list
92921181|NCT03977142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921182|NCT03977142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921183|NCT03977142|Analgesics|analgesics|mesh-ancestor
92921184|NCT03977142|Sensory System Agents|sensory system agents|mesh-ancestor
92921185|NCT03977142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921186|NCT03977142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921187|NCT03977142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921188|NCT03977142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921189|NCT00751023|Modafinil|modafinil|mesh-list
92921190|NCT00751023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92921191|NCT00751023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921192|NCT00751023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92921193|NCT00751023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92921194|NCT00751023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92921195|NCT00751023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921196|NCT00917592|Amoxicillin|amoxicillin|mesh-list
92921197|NCT00917592|Clavulanic Acids|clavulanic acids|mesh-list
92921198|NCT00917592|Clavulanic Acid|clavulanic acid|mesh-list
92921199|NCT00917592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92921200|NCT00917592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921201|NCT00917592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921202|NCT00917592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921203|NCT00917592|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92921204|NCT04091412|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92921205|NCT04091412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92921206|NCT04091412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92921207|NCT04091412|Protective Agents|protective agents|mesh-ancestor
92921208|NCT04091412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921209|NCT02599311|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92921210|NCT02599311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92921211|NCT02599311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92921212|NCT02599311|Cholinergic Agents|cholinergic agents|mesh-ancestor
92921213|NCT02599311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921214|NCT02599311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921215|NCT02599311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921216|NCT02599311|Urological Agents|urological agents|mesh-ancestor
92921217|NCT00591773|Chlorthalidone|chlorthalidone|mesh-list
92921218|NCT00591773|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92921219|NCT00591773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92921220|NCT00591773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92921221|NCT00591773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921222|NCT00591773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921223|NCT00591773|Diuretics|diuretics|mesh-ancestor
92921224|NCT00591773|Natriuretic Agents|natriuretic agents|mesh-ancestor
92921225|NCT00591773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921226|NCT00591773|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92921227|NCT00591773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921228|NCT00750867|Immunoglobulins|immunoglobulins|mesh-list
92921229|NCT00750867|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92921230|NCT00750867|Antibodies|antibodies|mesh-list
92921231|NCT00750867|gamma-Globulins|gamma-globulins|mesh-list
92921232|NCT00750867|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92921233|NCT00750867|Immunologic Factors|immunologic factors|mesh-ancestor
92921234|NCT00750867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921235|NCT00744042|Immunoglobulin G|immunoglobulin g|mesh-list
92921236|NCT00744042|Immunologic Factors|immunologic factors|mesh-ancestor
92921237|NCT00744042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921238|NCT04091763|Polidocanol|polidocanol|mesh-list
92921239|NCT04091763|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92921240|NCT04091763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92921241|NCT00829829|Rilonacept|rilonacept|mesh-list
92921242|NCT00829829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921243|NCT00829439|Levodopa|levodopa|mesh-list
92921244|NCT00829439|Carbidopa|carbidopa|mesh-list
92921245|NCT00829439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92921246|NCT00829439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92921247|NCT00829439|Dopamine Agents|dopamine agents|mesh-ancestor
92921248|NCT00829439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921249|NCT00829439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921250|NCT00829439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921251|NCT00829439|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92921252|NCT00829439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921253|NCT02599077|Dienogest|dienogest|mesh-list
92921254|NCT02599077|Levonorgestrel|levonorgestrel|mesh-list
92921255|NCT02599077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92921256|NCT02599077|Contraceptive Agents|contraceptive agents|mesh-ancestor
92921257|NCT02599077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92921259|NCT02599077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92921260|NCT02599077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92921261|NCT02599077|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92921262|NCT02599077|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92921263|NCT02599077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92921264|NCT02599077|Hormone Antagonists|hormone antagonists|mesh-ancestor
92921265|NCT02599077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921266|NCT02599077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92921267|NCT02599077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921268|NCT00829283|Orlistat|orlistat|mesh-list
92921269|NCT00829283|Sibutramine|sibutramine|mesh-list
92921270|NCT00829283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921271|NCT00829283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921272|NCT00829283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92921273|NCT00829283|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92921274|NCT00829283|Antidepressive Agents|antidepressive agents|mesh-ancestor
92921275|NCT00829283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921276|NCT00829283|Appetite Depressants|appetite depressants|mesh-ancestor
92921277|NCT05758025|Parathyroid Hormone|parathyroid hormone|mesh-list
92921278|NCT05758025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92921279|NCT05758025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921280|NCT00706277|Fentanyl|fentanyl|mesh-list
92921281|NCT00706277|Remifentanil|remifentanil|mesh-list
92921282|NCT00706277|Nitrous Oxide|nitrous oxide|mesh-list
92921283|NCT00706277|Propofol|propofol|mesh-list
92921284|NCT00706277|Sevoflurane|sevoflurane|mesh-list
92921285|NCT00706277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92921286|NCT00706277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921287|NCT00706277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921288|NCT00706277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92921289|NCT00706277|Anesthetics, General|anesthetics, general|mesh-ancestor
92921290|NCT00706277|Anesthetics|anesthetics|mesh-ancestor
92921291|NCT00706277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92921292|NCT00706277|Narcotics|narcotics|mesh-ancestor
92921293|NCT00706277|Analgesics|analgesics|mesh-ancestor
92921294|NCT00706277|Sensory System Agents|sensory system agents|mesh-ancestor
92921295|NCT00706277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921296|NCT00706277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92921297|NCT00706277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92921298|NCT00706277|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92921299|NCT00706277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921300|NCT00749463|Nicotine|nicotine|mesh-list
92921301|NCT00749463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92921302|NCT00749463|Autonomic Agents|autonomic agents|mesh-ancestor
92921303|NCT00749463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566767|NCT00180115|Antimetabolites|antimetabolites|mesh-ancestor
92921304|NCT00749463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921305|NCT00749463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92921306|NCT00749463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92921307|NCT00749463|Cholinergic Agents|cholinergic agents|mesh-ancestor
92921308|NCT00749463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921309|NCT00749463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921310|NCT00821327|Gemcitabine|gemcitabine|mesh-list
92921311|NCT00821327|Sunitinib|sunitinib|mesh-list
92921312|NCT00821327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921313|NCT00821327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92921314|NCT00821327|Antimetabolites|antimetabolites|mesh-ancestor
92921315|NCT00821327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921316|NCT00821327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92921317|NCT00821327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92921318|NCT00821327|Growth Substances|growth substances|mesh-ancestor
92921319|NCT00821327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921320|NCT00821327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92921321|NCT00821327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921322|NCT00821327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921323|NCT00709007|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92921324|NCT00709007|Antiviral Agents|antiviral agents|mesh-ancestor
92921325|NCT00709007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921326|NCT00821093|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92921327|NCT00821093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92921328|NCT00821093|Autonomic Agents|autonomic agents|mesh-ancestor
92921329|NCT00821093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921330|NCT00821093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921331|NCT00821093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92921332|NCT00821093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92921333|NCT00821093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92162894|NCT02134301|Oritavancin|oritavancin|mesh-list
92921334|NCT00821093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92921335|NCT00821093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92921336|NCT00821093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92921337|NCT00821093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921338|NCT00821093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921339|NCT00709163|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92921340|NCT00709163|Natriuretic Agents|natriuretic agents|mesh-ancestor
92921341|NCT00709163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921342|NCT02611505|Esketamine|esketamine|mesh-list
92921343|NCT02611505|Antidepressive Agents|antidepressive agents|mesh-ancestor
92921344|NCT02611505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921345|NCT00743652|Vaccines|vaccines|mesh-list
92921346|NCT00743652|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92921347|NCT00743652|Immunologic Factors|immunologic factors|mesh-ancestor
92921348|NCT00743652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921349|NCT00748215|Antidiarrheals|antidiarrheals|mesh-list
92921350|NCT00748215|Loperamide|loperamide|mesh-list
92921351|NCT00748215|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
92921352|NCT00748215|Calcium|calcium|mesh-list
92921353|NCT00748215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92921354|NCT00748215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921355|NCT00748215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921356|NCT00917163|Sirolimus|sirolimus|mesh-list
92921357|NCT00917163|Everolimus|everolimus|mesh-list
92921358|NCT00917163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92921359|NCT00917163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921360|NCT00917163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921361|NCT00917163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921362|NCT00917163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92921363|NCT00917163|Immunologic Factors|immunologic factors|mesh-ancestor
92921364|NCT00917163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921365|NCT00917163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921366|NCT00917163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92921367|NCT00917163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921368|NCT00917163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92921369|NCT00917163|Antifungal Agents|antifungal agents|mesh-ancestor
92921370|NCT00749892|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92921371|NCT00749892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921372|NCT00749892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921373|NCT00749892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921374|NCT00749892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921375|NCT00749580|Raltegravir Potassium|raltegravir potassium|mesh-list
92921376|NCT00749580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92921377|NCT00749580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92921378|NCT00749580|Antiviral Agents|antiviral agents|mesh-ancestor
92921379|NCT00749580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921380|NCT00749580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92921381|NCT00749580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92921382|NCT00749580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921383|NCT00749580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921384|NCT00747006|Insulin Lispro|insulin lispro|mesh-list
92921385|NCT00747006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921386|NCT00747006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921387|NCT04091178|Vitamin D|vitamin d|mesh-list
92921388|NCT04091178|Vitamins|vitamins|mesh-ancestor
92921389|NCT04091178|Micronutrients|micronutrients|mesh-ancestor
92921390|NCT04091178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921391|NCT04091178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92921392|NCT00917358|Interferons|interferons|mesh-list
92921393|NCT00917358|Interferon-alpha|interferon-alpha|mesh-list
92921394|NCT00917358|Interferon alpha-2|interferon alpha-2|mesh-list
92921395|NCT00917358|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92921396|NCT00917358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921397|NCT00917358|Antiviral Agents|antiviral agents|mesh-ancestor
92921398|NCT00917358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921399|NCT00917358|Immunologic Factors|immunologic factors|mesh-ancestor
92921400|NCT00917358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921401|NCT00743340|Emtricitabine|emtricitabine|mesh-list
92921402|NCT00743340|Antiviral Agents|antiviral agents|mesh-ancestor
92921403|NCT00743340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921404|NCT00743340|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92921405|NCT00743340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92921406|NCT00743340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921407|NCT00743340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921409|NCT00743340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92921410|NCT00749190|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92921411|NCT00749190|Empagliflozin|empagliflozin|mesh-list
92921412|NCT00749190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921413|NCT00749190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921414|NCT00749190|Incretins|incretins|mesh-ancestor
92921415|NCT00749190|Hormones|hormones|mesh-ancestor
92921416|NCT00749190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921417|NCT00749190|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92921418|NCT00749190|Protease Inhibitors|protease inhibitors|mesh-ancestor
92921419|NCT00749190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921420|NCT00749190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921421|NCT00749190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92921422|NCT00748566|Ziprasidone|ziprasidone|mesh-list
92921423|NCT00748566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92921424|NCT00748566|Serotonin Agents|serotonin agents|mesh-ancestor
92921425|NCT00748566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921426|NCT00748566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921427|NCT00748566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921428|NCT00748566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92921429|NCT00748566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92921430|NCT00748566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921431|NCT00748566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921432|NCT00748566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92921433|NCT00748566|Dopamine Agents|dopamine agents|mesh-ancestor
92921434|NCT02597166|Sofosbuvir|sofosbuvir|mesh-list
92921435|NCT02597166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92921436|NCT02597166|Ledipasvir|ledipasvir|mesh-list
92921437|NCT02597166|Antiviral Agents|antiviral agents|mesh-ancestor
92921438|NCT02597166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921439|NCT00743106|Fenoldopam|fenoldopam|mesh-list
92921440|NCT00743106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921441|NCT00743106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92921442|NCT00743106|Dopamine Agonists|dopamine agonists|mesh-ancestor
92921443|NCT00743106|Dopamine Agents|dopamine agents|mesh-ancestor
92921444|NCT00743106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921445|NCT00743106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921446|NCT00743106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921447|NCT02597322|Axitinib|axitinib|mesh-list
92921448|NCT02597322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921449|NCT02597322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921450|NCT02597322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921451|NCT02597322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921452|NCT00738699|Paclitaxel|paclitaxel|mesh-list
92921453|NCT00738699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92921454|NCT00738699|Farletuzumab|farletuzumab|mesh-list
92921455|NCT00738699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92566918|NCT00181870|Carbamazepine|carbamazepine|mesh-list
92921456|NCT00738699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921457|NCT00738699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92921458|NCT00738699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92921459|NCT00738699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92921460|NCT00738699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921461|NCT00814307|Tofacitinib|tofacitinib|mesh-list
92921462|NCT00814307|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92921463|NCT00814307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921464|NCT00814307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921465|NCT00814307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921466|NCT02596776|Deuterium Oxide|deuterium oxide|mesh-list
92921467|NCT02596776|Propranolol|propranolol|mesh-list
92921468|NCT02596776|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92921469|NCT02596776|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92921470|NCT02596776|Adrenergic Agents|adrenergic agents|mesh-ancestor
92921471|NCT02596776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921472|NCT02596776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921473|NCT02596776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921474|NCT02596776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92921475|NCT02596776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921476|NCT02596776|Vasodilator Agents|vasodilator agents|mesh-ancestor
92921477|NCT02596776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921478|NCT02596776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92921480|NCT00748098|Gabapentin|gabapentin|mesh-list
92921481|NCT00748098|Analgesics|analgesics|mesh-ancestor
92921482|NCT00748098|Sensory System Agents|sensory system agents|mesh-ancestor
92921483|NCT00748098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921484|NCT00748098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921485|NCT00748098|Anticonvulsants|anticonvulsants|mesh-ancestor
92921486|NCT00748098|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92921487|NCT00748098|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92921488|NCT00748098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921489|NCT00748098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921490|NCT00748098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92921491|NCT00748098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92921492|NCT00748098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921493|NCT00748098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921494|NCT00748098|Antimanic Agents|antimanic agents|mesh-ancestor
92921495|NCT00813995|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92921496|NCT00813995|Metformin|metformin|mesh-list
92921497|NCT00813995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921498|NCT00813995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921499|NCT00813995|Incretins|incretins|mesh-ancestor
92921500|NCT00813995|Hormones|hormones|mesh-ancestor
92921501|NCT00813995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921502|NCT00813995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92921503|NCT00813995|Protease Inhibitors|protease inhibitors|mesh-ancestor
92921504|NCT00813995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921505|NCT00813995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921506|NCT00737529|Lenalidomide|lenalidomide|mesh-list
92921507|NCT00737529|Immunologic Factors|immunologic factors|mesh-ancestor
92921508|NCT00737529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921509|NCT00737529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92921510|NCT00737529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92921511|NCT00737529|Growth Substances|growth substances|mesh-ancestor
92921512|NCT00737529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92921513|NCT00737529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921514|NCT00813917|Varenicline|varenicline|mesh-list
92921515|NCT00813917|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92921516|NCT00813917|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92921517|NCT00813917|Cholinergic Agents|cholinergic agents|mesh-ancestor
92921518|NCT00813917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921519|NCT00813917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921520|NCT00813917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921521|NCT02598102|Diclofenac|diclofenac|mesh-list
92921522|NCT02598102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921523|NCT02598102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921524|NCT02598102|Analgesics|analgesics|mesh-ancestor
92921525|NCT02598102|Sensory System Agents|sensory system agents|mesh-ancestor
92921526|NCT02598102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921527|NCT02598102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921528|NCT02598102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921529|NCT02598102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921530|NCT02598102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92921531|NCT02598102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921532|NCT02598102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921533|NCT02610647|Anesthetics|anesthetics|mesh-list
92921534|NCT02610647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921535|NCT02610647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921536|NCT02595918|Nivolumab|nivolumab|mesh-list
92921537|NCT02595918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92921538|NCT02595918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921539|NCT02595918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92921540|NCT02595918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921541|NCT02595840|Pemetrexed|pemetrexed|mesh-list
92921542|NCT02595840|Afatinib|afatinib|mesh-list
92921543|NCT02595840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921544|NCT02595840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921545|NCT02595840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921546|NCT02595840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92921547|NCT02595840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92921548|NCT02595840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921549|NCT02594241|Prednisolone|prednisolone|mesh-list
92921550|NCT02594241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92921551|NCT02594241|Methylprednisolone|methylprednisolone|mesh-list
92921552|NCT02594241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92921553|NCT02594241|Prednisolone acetate|prednisolone acetate|mesh-list
92921554|NCT02594241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92921555|NCT02594241|Prednisolone phosphate|prednisolone phosphate|mesh-list
92921556|NCT02594241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921557|NCT02594241|Glucocorticoids|glucocorticoids|mesh-ancestor
92921558|NCT02594241|Hormones|hormones|mesh-ancestor
92921559|NCT02594241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921560|NCT02594241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921561|NCT02594241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92921562|NCT02594241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921563|NCT02594241|Antiemetics|antiemetics|mesh-ancestor
92921564|NCT02594241|Autonomic Agents|autonomic agents|mesh-ancestor
92921565|NCT02594241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921566|NCT02594241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921567|NCT02594241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92921568|NCT02594241|Protective Agents|protective agents|mesh-ancestor
92921569|NCT00585975|Bromfenac|bromfenac|mesh-list
92921570|NCT00585975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92921571|NCT00585975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92921572|NCT00585975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921573|NCT00585975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921574|NCT00585975|Analgesics|analgesics|mesh-ancestor
92921575|NCT00585975|Sensory System Agents|sensory system agents|mesh-ancestor
92921576|NCT00585975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921577|NCT00585975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921578|NCT00585975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921579|NCT00585975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921580|NCT00918021|Olanzapine|olanzapine|mesh-list
92921581|NCT00918021|Antiemetics|antiemetics|mesh-ancestor
92921582|NCT00918021|Autonomic Agents|autonomic agents|mesh-ancestor
92921583|NCT00918021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921584|NCT00918021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921585|NCT00918021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921586|NCT00918021|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92921587|NCT00918021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92921588|NCT00918021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921589|NCT00918021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921590|NCT00918021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92921591|NCT00918021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92921592|NCT00918021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921593|NCT00918021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921594|NCT00918021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921595|NCT00918021|Serotonin Agents|serotonin agents|mesh-ancestor
92921596|NCT00585585|Betahistine|betahistine|mesh-list
92921597|NCT00585585|Vasodilator Agents|vasodilator agents|mesh-ancestor
92921598|NCT00585585|Histamine Agonists|histamine agonists|mesh-ancestor
92921599|NCT00585585|Histamine Agents|histamine agents|mesh-ancestor
92921600|NCT00585585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921601|NCT00585585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921602|NCT00585585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567065|NCT00182884|Donepezil|donepezil|mesh-list
92921603|NCT02593695|Fluoxetine|fluoxetine|mesh-list
92921604|NCT02593695|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92921605|NCT02593695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92921606|NCT02593695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921607|NCT02593695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921608|NCT02593695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921609|NCT02593695|Serotonin Agents|serotonin agents|mesh-ancestor
92921610|NCT02593695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222037|NCT00982280|Tapentadol|tapentadol|mesh-list
92921611|NCT02593695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92921612|NCT02593695|Antidepressive Agents|antidepressive agents|mesh-ancestor
92921613|NCT02593695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921614|NCT02593695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92921615|NCT02593695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92921616|NCT02593695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921617|NCT00734097|Esomeprazole|esomeprazole|mesh-list
92921618|NCT00734097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92921619|NCT00734097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921620|NCT00734097|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92921621|NCT00734097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921622|NCT00734097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921623|NCT00819767|Valsartan|valsartan|mesh-list
92921624|NCT00819767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921625|NCT00819767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92921626|NCT00819767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92921627|NCT00819767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921628|NCT04088175|Menthol|menthol|mesh-list
92921629|NCT04088175|Nicotine|nicotine|mesh-list
92921630|NCT04088175|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92921631|NCT04088175|Autonomic Agents|autonomic agents|mesh-ancestor
92921632|NCT04088175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921633|NCT04088175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921634|NCT04088175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92921635|NCT04088175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92921636|NCT04088175|Cholinergic Agents|cholinergic agents|mesh-ancestor
92921637|NCT04088175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921638|NCT04088175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921639|NCT04088175|Antipruritics|antipruritics|mesh-ancestor
92921640|NCT04088175|Dermatologic Agents|dermatologic agents|mesh-ancestor
92921641|NCT00733005|Mometasone Furoate|mometasone furoate|mesh-list
92921642|NCT00733005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921643|NCT00733005|Dermatologic Agents|dermatologic agents|mesh-ancestor
92921644|NCT00733005|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92921645|NCT05756621|Topiramate|topiramate|mesh-list
92921646|NCT05756621|Lacosamide|lacosamide|mesh-list
92921647|NCT05756621|Phenytoin|phenytoin|mesh-list
92921648|NCT05756621|Midazolam|midazolam|mesh-list
92921649|NCT05756621|Ketamine|ketamine|mesh-list
92921650|NCT05756621|Levetiracetam|levetiracetam|mesh-list
92921651|NCT05756621|Thiopental|thiopental|mesh-list
92921652|NCT05756621|Anticonvulsants|anticonvulsants|mesh-list
92921653|NCT05756621|Propofol|propofol|mesh-list
92921654|NCT05756621|Anesthetics|anesthetics|mesh-list
92921655|NCT05756621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92921656|NCT05756621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921657|NCT05756621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921658|NCT05756621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92921659|NCT05756621|Anesthetics, General|anesthetics, general|mesh-ancestor
92921660|NCT05756621|Analgesics|analgesics|mesh-ancestor
92921661|NCT05756621|Sensory System Agents|sensory system agents|mesh-ancestor
92921662|NCT05756621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921663|NCT05756621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92921664|NCT05756621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92921665|NCT05756621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92921666|NCT05756621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921667|NCT05756621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921668|NCT05756621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92921669|NCT05756621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92921670|NCT05756621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92921671|NCT05756621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921672|NCT05756621|GABA Modulators|gaba modulators|mesh-ancestor
92921673|NCT05756621|GABA Agents|gaba agents|mesh-ancestor
92921674|NCT05756621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921675|NCT05756621|Nootropic Agents|nootropic agents|mesh-ancestor
92921676|NCT05756621|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92921677|NCT05756621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92921678|NCT05756621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921679|NCT05756621|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92921680|NCT05756621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92921681|NCT00732381|Mometasone Furoate|mometasone furoate|mesh-list
92921682|NCT00732381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921683|NCT00732381|Dermatologic Agents|dermatologic agents|mesh-ancestor
92921684|NCT00732381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92921685|NCT00732303|Pemetrexed|pemetrexed|mesh-list
92921686|NCT00732303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921687|NCT00732303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921688|NCT00732303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921689|NCT00732303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92921690|NCT00732303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92921691|NCT00813761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92921692|NCT00732069|Valsartan|valsartan|mesh-list
92921693|NCT00732069|Ramipril|ramipril|mesh-list
92921694|NCT00732069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921695|NCT00732069|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92921696|NCT00732069|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92921697|NCT00732069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921698|NCT00732069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92921699|NCT00732069|Protease Inhibitors|protease inhibitors|mesh-ancestor
92921700|NCT00732069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921701|NCT02593383|Clindamycin|clindamycin|mesh-list
92921702|NCT02593383|Clindamycin palmitate|clindamycin palmitate|mesh-list
92921703|NCT02593383|Clindamycin phosphate|clindamycin phosphate|mesh-list
92921705|NCT02593383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92921706|NCT02593383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921707|NCT02593383|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92921708|NCT02593383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921709|NCT02593383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921710|NCT02593383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921711|NCT02593383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921712|NCT02593383|Analgesics|analgesics|mesh-ancestor
92921713|NCT02593383|Sensory System Agents|sensory system agents|mesh-ancestor
92921714|NCT02593383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921715|NCT02593383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921716|NCT02593383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921717|NCT02593383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921718|NCT02593383|Dermatologic Agents|dermatologic agents|mesh-ancestor
92921719|NCT00731679|Rifaximin|rifaximin|mesh-list
92921720|NCT00731679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92921721|NCT00731679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921722|NCT00731679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921723|NCT02609087|Propofol|propofol|mesh-list
92921724|NCT02609087|Sevoflurane|sevoflurane|mesh-list
92921725|NCT02609087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92921726|NCT02609087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921727|NCT02609087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921728|NCT02609087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92921729|NCT02609087|Anesthetics, General|anesthetics, general|mesh-ancestor
92921730|NCT02609087|Anesthetics|anesthetics|mesh-ancestor
92921731|NCT02609087|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92921732|NCT02609087|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92921733|NCT00731133|Disulfiram|disulfiram|mesh-list
92921734|NCT00731133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92921735|NCT00731133|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92921736|NCT00731133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921737|NCT00731133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921738|NCT00730275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92921739|NCT00730275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92921740|NCT00730275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921741|NCT00730275|Incretins|incretins|mesh-ancestor
92921742|NCT00730275|Hormones|hormones|mesh-ancestor
92921743|NCT00730275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921744|NCT00730275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92921745|NCT00730275|Protease Inhibitors|protease inhibitors|mesh-ancestor
92921746|NCT00730275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921747|NCT00730275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921748|NCT04793711|Decanoic acid|decanoic acid|mesh-list
92921749|NCT04793711|Antifungal Agents|antifungal agents|mesh-ancestor
92921750|NCT04793711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921751|NCT00729651|Cholecalciferol|cholecalciferol|mesh-list
92921752|NCT00729651|Vitamin D|vitamin d|mesh-list
92921753|NCT00729651|Alendronate|alendronate|mesh-list
92921755|NCT00729651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92921756|NCT00729651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921757|NCT00729651|Vitamins|vitamins|mesh-ancestor
92921758|NCT00729651|Micronutrients|micronutrients|mesh-ancestor
92162925|NCT00630331|Vaccines|vaccines|mesh-list
92921759|NCT00729651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92921760|NCT00729183|Calcium, Dietary|calcium, dietary|mesh-list
92921761|NCT00729183|Vitamin D|vitamin d|mesh-list
92921762|NCT00729183|Cholecalciferol|cholecalciferol|mesh-list
92921763|NCT00729183|Calcium Carbonate|calcium carbonate|mesh-list
92921764|NCT00729183|Calcium|calcium|mesh-list
92921765|NCT00729183|Vitamins|vitamins|mesh-ancestor
92921766|NCT00729183|Micronutrients|micronutrients|mesh-ancestor
92921767|NCT00729183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921768|NCT00729183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92977272|NCT00982449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921769|NCT00729183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92921770|NCT00729183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921771|NCT00729183|Antacids|antacids|mesh-ancestor
92921772|NCT00729183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921773|NCT00811733|Ofatumumab|ofatumumab|mesh-list
92921774|NCT00811733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921775|NCT00728949|Tamoxifen|tamoxifen|mesh-list
92921776|NCT00728949|Letrozole|letrozole|mesh-list
92921777|NCT00728949|Fulvestrant|fulvestrant|mesh-list
92921778|NCT00728949|Anastrozole|anastrozole|mesh-list
92921779|NCT00728949|Exemestane|exemestane|mesh-list
92921780|NCT00728949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92921781|NCT00728949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921782|NCT00728949|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92921783|NCT00728949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92921784|NCT00728949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921785|NCT00728949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921786|NCT00728949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92921787|NCT00728949|Hormone Antagonists|hormone antagonists|mesh-ancestor
92921788|NCT00728949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921789|NCT00728949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921790|NCT00728949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92921791|NCT00728949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92921792|NCT00728949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92921793|NCT00728949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92921794|NCT00728949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92921795|NCT00728949|Immunologic Factors|immunologic factors|mesh-ancestor
92921796|NCT00918177|Levodopa|levodopa|mesh-list
92921797|NCT00918177|Carbidopa|carbidopa|mesh-list
92921798|NCT00918177|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92921799|NCT00918177|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92921800|NCT00918177|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92921801|NCT00918177|Dopamine Agents|dopamine agents|mesh-ancestor
92921802|NCT00918177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921803|NCT00918177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921804|NCT00918177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921805|NCT00918177|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92921806|NCT00918177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921807|NCT00918177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92921808|NCT00918177|Immunologic Factors|immunologic factors|mesh-ancestor
92921809|NCT00918177|Dopamine Agonists|dopamine agonists|mesh-ancestor
92921810|NCT00728481|Budesonide|budesonide|mesh-list
92921811|NCT00728481|Esomeprazole|esomeprazole|mesh-list
92921812|NCT00728481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921813|NCT00728481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92921814|NCT00728481|Autonomic Agents|autonomic agents|mesh-ancestor
92921815|NCT00728481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921816|NCT00728481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921817|NCT00728481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92921818|NCT00728481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92921819|NCT00728481|Glucocorticoids|glucocorticoids|mesh-ancestor
92921820|NCT00728481|Hormones|hormones|mesh-ancestor
92921821|NCT00728481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921822|NCT00728481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92921823|NCT00728481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921824|NCT00728481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92921825|NCT00728481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921826|NCT00728481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921827|NCT02593227|Cyclophosphamide|cyclophosphamide|mesh-list
92921828|NCT02593227|Vaccines|vaccines|mesh-list
92921829|NCT02593227|Immunologic Factors|immunologic factors|mesh-ancestor
92921830|NCT02593227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921831|NCT02593227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92921832|NCT02593227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921833|NCT02593227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92921834|NCT02593227|Alkylating Agents|alkylating agents|mesh-ancestor
92921835|NCT02593227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921836|NCT02593227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921837|NCT02593227|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92921838|NCT04030481|Anesthetics|anesthetics|mesh-list
92921839|NCT04030481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921840|NCT04030481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921841|NCT02592915|Clonidine|clonidine|mesh-list
92921842|NCT02592915|Anesthetics|anesthetics|mesh-list
92921843|NCT02592915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921844|NCT02592915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921846|NCT02592915|Sensory System Agents|sensory system agents|mesh-ancestor
92921847|NCT02592915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921848|NCT02592915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92921849|NCT02592915|Sympatholytics|sympatholytics|mesh-ancestor
92921850|NCT02592915|Autonomic Agents|autonomic agents|mesh-ancestor
92921851|NCT02592915|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92921852|NCT02592915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92921853|NCT02592915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92921854|NCT02592915|Adrenergic Agents|adrenergic agents|mesh-ancestor
92921855|NCT02592915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921856|NCT02592915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921857|NCT00727311|Ribavirin|ribavirin|mesh-list
92921858|NCT00727311|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92921859|NCT00727311|Interferon-alpha|interferon-alpha|mesh-list
92921860|NCT00727311|Antimetabolites|antimetabolites|mesh-ancestor
92921861|NCT00727311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921862|NCT00727311|Antiviral Agents|antiviral agents|mesh-ancestor
92921863|NCT00727311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921864|NCT00727311|Immunologic Factors|immunologic factors|mesh-ancestor
92921865|NCT00727311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921866|NCT00726999|Morphine|morphine|mesh-list
92921867|NCT00726999|Gabapentin|gabapentin|mesh-list
92921868|NCT00726999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92921869|NCT00726999|Narcotics|narcotics|mesh-ancestor
92921870|NCT00726999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92921871|NCT00726999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921872|NCT00726999|Analgesics|analgesics|mesh-ancestor
92921873|NCT00726999|Sensory System Agents|sensory system agents|mesh-ancestor
92921874|NCT00726999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921875|NCT00726999|Anticonvulsants|anticonvulsants|mesh-ancestor
92921876|NCT00726999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92921877|NCT00726999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92921878|NCT00726999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921879|NCT00726999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92921880|NCT00726999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92921881|NCT00726999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921882|NCT00726999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921883|NCT00726999|Antimanic Agents|antimanic agents|mesh-ancestor
92921884|NCT00585351|Ranitidine|ranitidine|mesh-list
92921885|NCT00585351|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92921886|NCT00585351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92921887|NCT00585351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92921888|NCT00585351|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92921889|NCT00585351|Histamine Antagonists|histamine antagonists|mesh-ancestor
92921890|NCT00585351|Histamine Agents|histamine agents|mesh-ancestor
92921891|NCT00585351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921892|NCT00585351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921893|NCT00585351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921894|NCT00726609|Posaconazole|posaconazole|mesh-list
92921895|NCT00726609|Antifungal Agents|antifungal agents|mesh-ancestor
92921896|NCT00726609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92921897|NCT00726609|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92921898|NCT00726609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92921899|NCT00726609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92921900|NCT00726609|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92921901|NCT00726609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92921902|NCT00726609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921903|NCT00726609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921904|NCT00726609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92921905|NCT00726609|Hormone Antagonists|hormone antagonists|mesh-ancestor
92921906|NCT00726609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92921907|NCT00726609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921908|NCT00808028|Vaccines|vaccines|mesh-list
92921909|NCT00808028|Immunologic Factors|immunologic factors|mesh-ancestor
92921910|NCT00808028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921911|NCT03466346|Fluoxetine|fluoxetine|mesh-list
92921912|NCT03466346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92921913|NCT03466346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92921914|NCT03466346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266793|NCT02685267|Prednisone|prednisone|mesh-list
92921915|NCT03466346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921916|NCT03466346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921917|NCT03466346|Serotonin Agents|serotonin agents|mesh-ancestor
92921918|NCT03466346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921919|NCT03466346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92921920|NCT03466346|Antidepressive Agents|antidepressive agents|mesh-ancestor
92921921|NCT03466346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921922|NCT03466346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92921923|NCT03466346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92921924|NCT03466346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921925|NCT05754242|Ascorbic Acid|ascorbic acid|mesh-list
92921926|NCT05754242|Vitamins|vitamins|mesh-ancestor
92921927|NCT05754242|Micronutrients|micronutrients|mesh-ancestor
92921928|NCT05754242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921929|NCT05754242|Antioxidants|antioxidants|mesh-ancestor
92921930|NCT05754242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921931|NCT05754242|Protective Agents|protective agents|mesh-ancestor
92921932|NCT00809783|Tanezumab|tanezumab|mesh-list
92921933|NCT00809783|Analgesics|analgesics|mesh-ancestor
92921934|NCT00809783|Sensory System Agents|sensory system agents|mesh-ancestor
92921935|NCT00809783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921936|NCT00809783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921937|NCT05675462|Lenvatinib|lenvatinib|mesh-list
92921938|NCT05675462|Tislelizumab|tislelizumab|mesh-list
92921939|NCT05675462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921940|NCT05675462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92921941|NCT05675462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92921942|NCT05675462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921943|NCT05675462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92921944|NCT02608658|Immunoglobulins|immunoglobulins|mesh-list
92921945|NCT02608658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92921946|NCT02608658|Antibodies|antibodies|mesh-list
92921947|NCT02608658|Immunologic Factors|immunologic factors|mesh-ancestor
92921948|NCT02608658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921949|NCT00807248|Gaboxadol|gaboxadol|mesh-list
92921950|NCT00807248|Dexetimide|dexetimide|mesh-list
92921951|NCT00807248|Citalopram|citalopram|mesh-list
92921952|NCT00807248|Escitalopram|escitalopram|mesh-list
92921953|NCT00807248|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92921954|NCT00807248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92921955|NCT00807248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92921956|NCT00807248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921957|NCT00807248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92921958|NCT00807248|Serotonin Agents|serotonin agents|mesh-ancestor
92921959|NCT00807248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921960|NCT00807248|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92921961|NCT00807248|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92921962|NCT00807248|Parasympatholytics|parasympatholytics|mesh-ancestor
92921963|NCT00807248|Autonomic Agents|autonomic agents|mesh-ancestor
92921964|NCT00807248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921965|NCT00807248|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92921966|NCT00807248|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92921967|NCT00807248|Cholinergic Agents|cholinergic agents|mesh-ancestor
92921968|NCT00807248|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92921969|NCT00807248|Antidepressive Agents|antidepressive agents|mesh-ancestor
92921970|NCT00807248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92921971|NCT00807248|Analgesics|analgesics|mesh-ancestor
92921972|NCT00807248|Sensory System Agents|sensory system agents|mesh-ancestor
92921973|NCT00807248|Anticonvulsants|anticonvulsants|mesh-ancestor
92921974|NCT00807248|GABA Agonists|gaba agonists|mesh-ancestor
92921975|NCT00807248|GABA Agents|gaba agents|mesh-ancestor
92921976|NCT02607332|Paclitaxel|paclitaxel|mesh-list
92921977|NCT02607332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92921978|NCT02607332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92921979|NCT02607332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92921980|NCT02607332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92921981|NCT02607332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92921982|NCT02607332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921983|NCT03356756|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92921984|NCT03356756|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92921985|NCT03356756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92921986|NCT05297669|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
92921987|NCT05297669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92921988|NCT05297669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92921989|NCT05297669|Analgesics|analgesics|mesh-ancestor
92921990|NCT05297669|Sensory System Agents|sensory system agents|mesh-ancestor
92921991|NCT05297669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92921992|NCT05297669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92921993|NCT05297669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921994|NCT05297669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92921996|NCT00589628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92921997|NCT00589628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92921998|NCT00589628|Dermatologic Agents|dermatologic agents|mesh-ancestor
92921999|NCT00589628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922000|NCT00589628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922001|NCT05754983|Immunomodulating Agents|immunomodulating agents|mesh-list
92922002|NCT05754983|Immunologic Factors|immunologic factors|mesh-ancestor
92922003|NCT05754983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922004|NCT00914576|Vitamins|vitamins|mesh-list
92922005|NCT00914576|Micronutrients|micronutrients|mesh-ancestor
92922006|NCT00914576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922007|NCT00914654|Formoterol Fumarate|formoterol fumarate|mesh-list
92922008|NCT00914654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92922009|NCT00914654|Autonomic Agents|autonomic agents|mesh-ancestor
92922010|NCT00914654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922011|NCT00914654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922012|NCT00914654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92922013|NCT00914654|Respiratory System Agents|respiratory system agents|mesh-ancestor
92922014|NCT00914654|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92922015|NCT00914654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92922016|NCT00914654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92922017|NCT00914654|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922018|NCT00914654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922019|NCT00914654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922020|NCT02605772|Metformin|metformin|mesh-list
92922021|NCT02605772|Saxagliptin|saxagliptin|mesh-list
92922022|NCT02605772|Acarbose|acarbose|mesh-list
92922023|NCT02605772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92922024|NCT02605772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922025|NCT02605772|Incretins|incretins|mesh-ancestor
92922026|NCT02605772|Hormones|hormones|mesh-ancestor
92922027|NCT02605772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162957|NCT04559347|Bupivacaine|bupivacaine|mesh-list
92922028|NCT02605772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92922029|NCT02605772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92922030|NCT02605772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922031|NCT02605772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922032|NCT02605772|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92922033|NCT04115462|Morphine|morphine|mesh-list
92922034|NCT04115462|Histamine|histamine|mesh-list
92922035|NCT04115462|Histamine phosphate|histamine phosphate|mesh-list
92922036|NCT04115462|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92922037|NCT04115462|Narcotics|narcotics|mesh-ancestor
92922038|NCT04115462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922039|NCT04115462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922040|NCT04115462|Analgesics|analgesics|mesh-ancestor
92922041|NCT04115462|Sensory System Agents|sensory system agents|mesh-ancestor
92922042|NCT04115462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922043|NCT04115462|Histamine Agonists|histamine agonists|mesh-ancestor
92922044|NCT04115462|Histamine Agents|histamine agents|mesh-ancestor
92922045|NCT04115462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922046|NCT04115462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922047|NCT02605460|Plerixafor|plerixafor|mesh-list
92922048|NCT02605460|Cyclophosphamide|cyclophosphamide|mesh-list
92922049|NCT02605460|Busulfan|busulfan|mesh-list
92922050|NCT02605460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92922051|NCT02605460|Immunologic Factors|immunologic factors|mesh-ancestor
92922052|NCT02605460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922053|NCT02605460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922054|NCT02605460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92922055|NCT02605460|Alkylating Agents|alkylating agents|mesh-ancestor
92922056|NCT02605460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922057|NCT02605460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922058|NCT02605460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92922060|NCT02605460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92922061|NCT02605460|Antiviral Agents|antiviral agents|mesh-ancestor
92922062|NCT02605460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922063|NCT00797108|Amoxicillin|amoxicillin|mesh-list
92922064|NCT00797108|Ceftriaxone|ceftriaxone|mesh-list
92922065|NCT00797108|Clavulanic Acid|clavulanic acid|mesh-list
92266943|NCT01473368|Amoxicillin|amoxicillin|mesh-list
92922066|NCT00797108|Clavulanic Acids|clavulanic acids|mesh-list
92922067|NCT00797108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92922068|NCT00797108|Lactams|lactams|mesh-list
92922069|NCT00797108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92922070|NCT00797108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922071|NCT00797108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92922072|NCT00797108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922073|NCT00797108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922074|NCT00742560|Dexamethasone|dexamethasone|mesh-list
92922075|NCT00742560|Dexamethasone acetate|dexamethasone acetate|mesh-list
92922076|NCT00742560|Lenalidomide|lenalidomide|mesh-list
92922077|NCT00742560|Elotuzumab|elotuzumab|mesh-list
92922078|NCT00742560|BB 1101|bb 1101|mesh-list
92922079|NCT00742560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922080|NCT00742560|Antiemetics|antiemetics|mesh-ancestor
92922081|NCT00742560|Autonomic Agents|autonomic agents|mesh-ancestor
92922082|NCT00742560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922083|NCT00742560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922084|NCT00742560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922085|NCT00742560|Glucocorticoids|glucocorticoids|mesh-ancestor
92922086|NCT00742560|Hormones|hormones|mesh-ancestor
92922087|NCT00742560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922088|NCT00742560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92922089|NCT00742560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922090|NCT00742560|Protease Inhibitors|protease inhibitors|mesh-ancestor
92922091|NCT00742560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922092|NCT00742560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922093|NCT00742560|Immunologic Factors|immunologic factors|mesh-ancestor
92922094|NCT00742560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92922095|NCT00742560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92922096|NCT00742560|Growth Substances|growth substances|mesh-ancestor
92922097|NCT00742560|Growth Inhibitors|growth inhibitors|mesh-ancestor
92922098|NCT02604914|Levodopa|levodopa|mesh-list
92922099|NCT02604914|Carbidopa|carbidopa|mesh-list
92922100|NCT02604914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92922101|NCT02604914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92162958|NCT04559347|Ropivacaine|ropivacaine|mesh-list
92922102|NCT02604914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92922103|NCT02604914|Dopamine Agents|dopamine agents|mesh-ancestor
92922104|NCT02604914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922105|NCT02604914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922106|NCT02604914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922107|NCT02604914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92922108|NCT02604914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922109|NCT02604914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92922110|NCT02604914|Immunologic Factors|immunologic factors|mesh-ancestor
92922111|NCT02604914|Dopamine Agonists|dopamine agonists|mesh-ancestor
92922112|NCT00796718|Capecitabine|capecitabine|mesh-list
92922113|NCT00796718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92922114|NCT00796718|Antimetabolites|antimetabolites|mesh-ancestor
92922115|NCT00796718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922116|NCT00796718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922117|NCT00745368|Raltegravir Potassium|raltegravir potassium|mesh-list
92922118|NCT00745368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92922119|NCT00745368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92922120|NCT00745368|Antiviral Agents|antiviral agents|mesh-ancestor
92922121|NCT00745368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922122|NCT00745368|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92922123|NCT00745368|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92922124|NCT00745368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922125|NCT00745368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922126|NCT04025840|Dexamethasone|dexamethasone|mesh-list
92922127|NCT04025840|Glucocorticoids|glucocorticoids|mesh-list
92922128|NCT04025840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922129|NCT04025840|Antiemetics|antiemetics|mesh-ancestor
92922130|NCT04025840|Autonomic Agents|autonomic agents|mesh-ancestor
92922131|NCT04025840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922132|NCT04025840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922134|NCT04025840|Hormones|hormones|mesh-ancestor
92922135|NCT04025840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922136|NCT04025840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92922137|NCT04025840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922138|NCT00589472|Vorinostat|vorinostat|mesh-list
92922139|NCT00589472|Leuprolide|leuprolide|mesh-list
92922140|NCT00589472|Goserelin|goserelin|mesh-list
92922141|NCT00589472|Bicalutamide|bicalutamide|mesh-list
92922142|NCT00589472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922143|NCT00589472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92922144|NCT00589472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922145|NCT00589472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922146|NCT00589472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92922147|NCT00589472|Fertility Agents|fertility agents|mesh-ancestor
92922148|NCT00589472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92922149|NCT00589472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922150|NCT00589472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92922151|NCT00589472|Androgen Antagonists|androgen antagonists|mesh-ancestor
92922152|NCT00589472|Hormone Antagonists|hormone antagonists|mesh-ancestor
92922153|NCT00589472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922154|NCT02608931|Dronabinol|dronabinol|mesh-list
92922155|NCT02608931|Hallucinogens|hallucinogens|mesh-ancestor
92922156|NCT02608931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922157|NCT02608931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922158|NCT02608931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922159|NCT02608931|Analgesics|analgesics|mesh-ancestor
92922160|NCT02608931|Sensory System Agents|sensory system agents|mesh-ancestor
92922161|NCT02608931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922162|NCT02608931|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92922163|NCT02608931|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92922164|NCT02608931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922165|NCT02608931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922166|NCT02608931|Hormones|hormones|mesh-ancestor
92922167|NCT02608931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922168|NCT00744978|Varenicline|varenicline|mesh-list
92922169|NCT00744978|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92922170|NCT00744978|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92922171|NCT00744978|Cholinergic Agents|cholinergic agents|mesh-ancestor
92922172|NCT00744978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162961|NCT04559347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922173|NCT00744978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922174|NCT00744978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922175|NCT02595606|Hyaluronic Acid|hyaluronic acid|mesh-list
92922176|NCT02595606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92922177|NCT02595606|Immunologic Factors|immunologic factors|mesh-ancestor
92922178|NCT02595606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922179|NCT02595606|Viscosupplements|viscosupplements|mesh-ancestor
92922180|NCT02595606|Protective Agents|protective agents|mesh-ancestor
92922181|NCT02609945|Oxazolidinones|oxazolidinones|mesh-list
92922182|NCT02609945|Zolmitriptan|zolmitriptan|mesh-list
92922183|NCT02609945|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92922184|NCT02609945|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92922185|NCT02609945|Serotonin Agents|serotonin agents|mesh-ancestor
92922186|NCT02609945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922187|NCT02609945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922188|NCT02609945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922189|NCT02609945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922190|NCT02609945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92922191|NCT02609945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922192|NCT04570475|Vitamin D|vitamin d|mesh-list
92922193|NCT04570475|Vitamins|vitamins|mesh-ancestor
92922194|NCT04570475|Micronutrients|micronutrients|mesh-ancestor
92922195|NCT04570475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922196|NCT04570475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92922197|NCT02609165|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92922198|NCT02609165|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92922199|NCT00739596|Amlodipine|amlodipine|mesh-list
92922200|NCT00739596|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92922201|NCT00739596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92922202|NCT00739596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92922203|NCT00739596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92567673|NCT00187174|Everolimus|everolimus|mesh-list
92922204|NCT00739596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922205|NCT00739596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92922206|NCT00739596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922207|NCT00739596|Vasodilator Agents|vasodilator agents|mesh-ancestor
92922209|NCT00739596|Natriuretic Agents|natriuretic agents|mesh-ancestor
92922210|NCT00739596|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92922211|NCT00742326|Pioglitazone|pioglitazone|mesh-list
92922212|NCT00742326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92922213|NCT00742326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922214|NCT02597868|Capecitabine|capecitabine|mesh-list
92922215|NCT02597868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92922216|NCT02597868|Antimetabolites|antimetabolites|mesh-ancestor
92922217|NCT02597868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922218|NCT02597868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922219|NCT00811187|Lidocaine|lidocaine|mesh-list
92922220|NCT00811187|Anesthetics, Local|anesthetics, local|mesh-ancestor
92922221|NCT00811187|Anesthetics|anesthetics|mesh-ancestor
92922222|NCT00811187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922223|NCT00811187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922224|NCT00811187|Sensory System Agents|sensory system agents|mesh-ancestor
92922225|NCT00811187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922226|NCT00811187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92922227|NCT00811187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92922228|NCT00811187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92922229|NCT00811187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92922230|NCT00811187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922231|NCT00917748|Docetaxel|docetaxel|mesh-list
92922232|NCT00917748|Modafinil|modafinil|mesh-list
92922233|NCT00917748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922234|NCT00917748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92922235|NCT00917748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92922236|NCT00917748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92922237|NCT00917748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922238|NCT00917748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92922239|NCT00917748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922240|NCT00917748|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92922241|NCT00917748|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92922242|NCT00917748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92922243|NCT02595138|Zoledronic Acid|zoledronic acid|mesh-list
92922244|NCT02595138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92922245|NCT02595138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922246|NCT00591149|Docetaxel|docetaxel|mesh-list
92922247|NCT00591149|Oxaliplatin|oxaliplatin|mesh-list
92922248|NCT00591149|Cetuximab|cetuximab|mesh-list
92922249|NCT00591149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922250|NCT00591149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92922251|NCT00591149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92922252|NCT00591149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92922253|NCT00591149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922254|NCT00591149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92922255|NCT00735072|Maraviroc|maraviroc|mesh-list
92922256|NCT00735072|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92922257|NCT00735072|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92922258|NCT00735072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922259|NCT00735072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92922260|NCT00735072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92922261|NCT00735072|Antiviral Agents|antiviral agents|mesh-ancestor
92922262|NCT00735072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922263|NCT00735072|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92922264|NCT00793598|Brincidofovir|brincidofovir|mesh-list
92922265|NCT00793598|Antiviral Agents|antiviral agents|mesh-ancestor
92922266|NCT00793598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922267|NCT04115072|Praziquantel|praziquantel|mesh-list
92922268|NCT04115072|Anthelmintics|anthelmintics|mesh-ancestor
92922269|NCT04115072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92922270|NCT04115072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922271|NCT00796562|Cyclophosphamide|cyclophosphamide|mesh-list
92922272|NCT00796562|Busulfan|busulfan|mesh-list
92922273|NCT00796562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92922274|NCT00796562|Immunologic Factors|immunologic factors|mesh-ancestor
92922275|NCT00796562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922276|NCT00796562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922277|NCT00796562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92922279|NCT00796562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922280|NCT00796562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922281|NCT00796562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92922282|NCT00801632|Prednisone|prednisone|mesh-list
92922283|NCT00801632|Methylprednisolone|methylprednisolone|mesh-list
92922284|NCT00801632|Cyclophosphamide|cyclophosphamide|mesh-list
92922285|NCT00801632|Rituximab|rituximab|mesh-list
92922286|NCT00801632|Tacrolimus|tacrolimus|mesh-list
92922287|NCT00801632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92922288|NCT00801632|Immunologic Factors|immunologic factors|mesh-ancestor
92922289|NCT00801632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922290|NCT00801632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922291|NCT00801632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92922292|NCT00801632|Alkylating Agents|alkylating agents|mesh-ancestor
92922293|NCT00801632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922294|NCT00801632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922295|NCT00801632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92922296|NCT00801632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92922297|NCT00801632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922298|NCT00801632|Glucocorticoids|glucocorticoids|mesh-ancestor
92922299|NCT00801632|Hormones|hormones|mesh-ancestor
92922300|NCT00801632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922301|NCT00801632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92922302|NCT00801632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92922303|NCT00801632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922304|NCT00801632|Antiemetics|antiemetics|mesh-ancestor
92922305|NCT00801632|Autonomic Agents|autonomic agents|mesh-ancestor
92922306|NCT00801632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922307|NCT00801632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922308|NCT00801632|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92922309|NCT00801632|Protective Agents|protective agents|mesh-ancestor
92922310|NCT04111484|Adrenomedullin|adrenomedullin|mesh-list
92922311|NCT04111484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92922312|NCT04111484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92922313|NCT04111484|Autonomic Agents|autonomic agents|mesh-ancestor
92922314|NCT04111484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922315|NCT04111484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922316|NCT04111484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92922317|NCT04111484|Respiratory System Agents|respiratory system agents|mesh-ancestor
92922318|NCT04111484|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92922319|NCT04111484|Vasodilator Agents|vasodilator agents|mesh-ancestor
92922320|NCT04111484|Protective Agents|protective agents|mesh-ancestor
92922321|NCT04111328|Sufentanil|sufentanil|mesh-list
92922322|NCT04111328|Dexmedetomidine|dexmedetomidine|mesh-list
92922323|NCT04111328|Dsuvia|dsuvia|mesh-list
92922324|NCT04111328|Hydromorphone|hydromorphone|mesh-list
92922325|NCT04111328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92922326|NCT04111328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922327|NCT04111328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922328|NCT04111328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922329|NCT04111328|Analgesics|analgesics|mesh-ancestor
92922330|NCT04111328|Sensory System Agents|sensory system agents|mesh-ancestor
92922331|NCT04111328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922332|NCT04111328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92922333|NCT04111328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92922334|NCT04111328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92922335|NCT04111328|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922336|NCT04111328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922337|NCT04111328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922338|NCT04111328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92922339|NCT04111328|Narcotics|narcotics|mesh-ancestor
92922340|NCT04111328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92922341|NCT04111328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92922342|NCT04111328|Anesthetics, General|anesthetics, general|mesh-ancestor
92922343|NCT04111328|Anesthetics|anesthetics|mesh-ancestor
92922344|NCT00806819|Folic Acid|folic acid|mesh-list
92922345|NCT00806819|Vitamin B Complex|vitamin b complex|mesh-list
92922346|NCT00806819|Hydroxocobalamin|hydroxocobalamin|mesh-list
92922347|NCT00806819|Vitamin B 12|vitamin b 12|mesh-list
92922348|NCT00806819|Dexamethasone|dexamethasone|mesh-list
92922349|NCT00806819|Dexamethasone acetate|dexamethasone acetate|mesh-list
92922350|NCT00806819|Pemetrexed|pemetrexed|mesh-list
92922351|NCT00806819|Nintedanib|nintedanib|mesh-list
92922352|NCT00806819|BB 1101|bb 1101|mesh-list
92922353|NCT00806819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922354|NCT00806819|Antiemetics|antiemetics|mesh-ancestor
92922355|NCT00806819|Autonomic Agents|autonomic agents|mesh-ancestor
92922356|NCT00806819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922357|NCT00806819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922358|NCT00806819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922359|NCT00806819|Glucocorticoids|glucocorticoids|mesh-ancestor
92922360|NCT00806819|Hormones|hormones|mesh-ancestor
92922361|NCT00806819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922362|NCT00806819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92922363|NCT00806819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922364|NCT00806819|Protease Inhibitors|protease inhibitors|mesh-ancestor
92922365|NCT00806819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922366|NCT00806819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922367|NCT00806819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92922368|NCT00806819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92922369|NCT00806819|Hematinics|hematinics|mesh-ancestor
92922370|NCT00806819|Vitamins|vitamins|mesh-ancestor
92922371|NCT00806819|Micronutrients|micronutrients|mesh-ancestor
92922372|NCT00806819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92922373|NCT04109534|Methacholine Chloride|methacholine chloride|mesh-list
92922374|NCT04109534|Miotics|miotics|mesh-ancestor
92922375|NCT04109534|Autonomic Agents|autonomic agents|mesh-ancestor
92922376|NCT04109534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922377|NCT04109534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922378|NCT04109534|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92922379|NCT04109534|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92922380|NCT04109534|Respiratory System Agents|respiratory system agents|mesh-ancestor
92922381|NCT04109534|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92922382|NCT04109534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92922383|NCT04109534|Cholinergic Agents|cholinergic agents|mesh-ancestor
92922384|NCT04109534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922385|NCT04109534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922386|NCT05326139|Tranexamic Acid|tranexamic acid|mesh-list
92922387|NCT05326139|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92922388|NCT05326139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92922389|NCT05326139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922390|NCT05326139|Hemostatics|hemostatics|mesh-ancestor
92922391|NCT05326139|Coagulants|coagulants|mesh-ancestor
92922392|NCT02605694|Prednisone|prednisone|mesh-list
92922393|NCT02605694|Rituximab|rituximab|mesh-list
92922394|NCT02605694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92922395|NCT02605694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922396|NCT02605694|Immunologic Factors|immunologic factors|mesh-ancestor
92922397|NCT02605694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922398|NCT02605694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922399|NCT02605694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922400|NCT02605694|Glucocorticoids|glucocorticoids|mesh-ancestor
92922401|NCT02605694|Hormones|hormones|mesh-ancestor
92922402|NCT02605694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922403|NCT02605694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92922404|NCT02604134|Silver Nitrate|silver nitrate|mesh-list
92922405|NCT02604134|Fluorides|fluorides|mesh-list
92922406|NCT02604134|Fluorides, Topical|fluorides, topical|mesh-list
92922407|NCT02604134|Cariostatic Agents|cariostatic agents|mesh-ancestor
92922408|NCT02604134|Protective Agents|protective agents|mesh-ancestor
92922409|NCT02604134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922410|NCT02604134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92922411|NCT02604134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922412|NCT00800540|Timolol|timolol|mesh-list
92922413|NCT00800540|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92922414|NCT00800540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92922415|NCT00800540|Brinzolamide|brinzolamide|mesh-list
92922416|NCT00800540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92922417|NCT00800540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92922418|NCT00800540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92922419|NCT00800540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922420|NCT00800540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922421|NCT00800540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922422|NCT00800540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922423|NCT00800540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92922424|NCT00800540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92922425|NCT00800540|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92922426|NCT00800540|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92922427|NCT00800540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92922428|NCT00800540|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92922429|NCT00800540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922430|NCT00796328|Phenylephrine|phenylephrine|mesh-list
92922431|NCT00796328|Oxymetazoline|oxymetazoline|mesh-list
92922432|NCT00796328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92922433|NCT00796328|Mydriatics|mydriatics|mesh-ancestor
92922434|NCT00796328|Autonomic Agents|autonomic agents|mesh-ancestor
92922435|NCT00796328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922436|NCT00796328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922437|NCT00796328|Sympathomimetics|sympathomimetics|mesh-ancestor
92922438|NCT00796328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92922439|NCT00796328|Nasal Decongestants|nasal decongestants|mesh-ancestor
92922440|NCT00796328|Respiratory System Agents|respiratory system agents|mesh-ancestor
92922441|NCT00796328|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92922442|NCT00796328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92922443|NCT00796328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92922444|NCT00796328|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922445|NCT00796328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922446|NCT00796328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922447|NCT00796328|Protective Agents|protective agents|mesh-ancestor
92922448|NCT02605382|Chlorhexidine|chlorhexidine|mesh-list
92922449|NCT02605382|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92922450|NCT02605382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92922451|NCT02605382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922452|NCT02605382|Disinfectants|disinfectants|mesh-ancestor
92922453|NCT02605382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92922454|NCT04110860|Voriconazole|voriconazole|mesh-list
92922455|NCT04110860|Antifungal Agents|antifungal agents|mesh-ancestor
92922456|NCT04110860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922457|NCT04110860|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92922458|NCT04110860|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92922459|NCT04110860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922460|NCT04110860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922461|NCT04110860|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92922462|NCT04110860|Hormone Antagonists|hormone antagonists|mesh-ancestor
92922463|NCT04110860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922464|NCT04110860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922465|NCT04110860|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92922466|NCT02604836|Ibandronic Acid|ibandronic acid|mesh-list
92922467|NCT02604836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92922468|NCT02604836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922469|NCT04114526|Nicotine|nicotine|mesh-list
92922470|NCT04114526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92922471|NCT04114526|Autonomic Agents|autonomic agents|mesh-ancestor
92922472|NCT04114526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922473|NCT04114526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922474|NCT04114526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92922475|NCT04114526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92922476|NCT04114526|Cholinergic Agents|cholinergic agents|mesh-ancestor
92922477|NCT04114526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922478|NCT04114526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922479|NCT00915200|Acetylcysteine|acetylcysteine|mesh-list
92922480|NCT00915200|Silybin|silybin|mesh-list
92922481|NCT00915200|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92922482|NCT00915200|Antiviral Agents|antiviral agents|mesh-ancestor
92922483|NCT00915200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922484|NCT00915200|Expectorants|expectorants|mesh-ancestor
92922485|NCT00915200|Respiratory System Agents|respiratory system agents|mesh-ancestor
92922486|NCT00915200|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92922487|NCT00915200|Antioxidants|antioxidants|mesh-ancestor
92922488|NCT00915200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922489|NCT00915200|Protective Agents|protective agents|mesh-ancestor
92922490|NCT00915200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922491|NCT00915200|Antidotes|antidotes|mesh-ancestor
92922492|NCT00915200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92922493|NCT00915200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922494|NCT00588146|Interferons|interferons|mesh-list
92922495|NCT00588146|Interferon-alpha|interferon-alpha|mesh-list
92922496|NCT00588146|Interferon alpha-2|interferon alpha-2|mesh-list
92922497|NCT00588146|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92922498|NCT00588146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922499|NCT00588146|Antiviral Agents|antiviral agents|mesh-ancestor
92922500|NCT00588146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922501|NCT00588146|Immunologic Factors|immunologic factors|mesh-ancestor
92922502|NCT00588146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922503|NCT00444457|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92922504|NCT00444457|Immunologic Factors|immunologic factors|mesh-ancestor
92922505|NCT00444457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922506|NCT00799058|Dapivirine|dapivirine|mesh-list
92922507|NCT00799058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92922508|NCT00799058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92922509|NCT00799058|Antiviral Agents|antiviral agents|mesh-ancestor
92922510|NCT00799058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922511|NCT00725985|Cladribine|cladribine|mesh-list
92922512|NCT00725985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922513|NCT00725985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92922514|NCT00725985|Immunologic Factors|immunologic factors|mesh-ancestor
92922515|NCT00725985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922516|NCT00793910|Gabapentin|gabapentin|mesh-list
92922517|NCT00793910|Analgesics|analgesics|mesh-ancestor
92922518|NCT00793910|Sensory System Agents|sensory system agents|mesh-ancestor
92922519|NCT00793910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922520|NCT00793910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922521|NCT00793910|Anticonvulsants|anticonvulsants|mesh-ancestor
92922522|NCT00793910|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92922523|NCT00793910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92922524|NCT00793910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922525|NCT00793910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922526|NCT00793910|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92922527|NCT00793910|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92922528|NCT00793910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922529|NCT00793910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922530|NCT00793910|Antimanic Agents|antimanic agents|mesh-ancestor
92922531|NCT01019941|Docetaxel|docetaxel|mesh-list
92922532|NCT01019941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922533|NCT01019941|Tubulin Modulators|tubulin modulators|mesh-ancestor
92922534|NCT01019941|Antimitotic Agents|antimitotic agents|mesh-ancestor
92922535|NCT01019941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92922536|NCT01019941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922537|NCT04113668|Diflunisal|diflunisal|mesh-list
92922538|NCT04113668|Deucravacitinib|deucravacitinib|mesh-list
92922539|NCT04113668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92922540|NCT04113668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92922541|NCT04113668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922542|NCT04113668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922543|NCT04113668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92922544|NCT04113668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922545|NCT04113668|Analgesics|analgesics|mesh-ancestor
92922546|NCT04113668|Sensory System Agents|sensory system agents|mesh-ancestor
92922547|NCT04113668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922548|NCT04113668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922549|NCT04113668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922550|NCT04113668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922551|NCT04113668|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92922552|NCT00444145|Lansoprazole|lansoprazole|mesh-list
92922553|NCT00444145|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92922554|NCT00444145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922555|NCT00444145|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92922556|NCT00444145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922557|NCT00444145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922558|NCT04107896|Tamsulosin|tamsulosin|mesh-list
92922559|NCT04107896|Silodosin|silodosin|mesh-list
92922560|NCT04107896|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92922561|NCT04107896|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92922562|NCT04107896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92922563|NCT04107896|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922564|NCT04107896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922565|NCT04107896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922566|NCT04107896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922567|NCT04107896|Urological Agents|urological agents|mesh-ancestor
92922568|NCT01024777|Vitamin D|vitamin d|mesh-list
92922569|NCT01024777|Ergocalciferols|ergocalciferols|mesh-list
92922570|NCT01024777|Cholecalciferol|cholecalciferol|mesh-list
92922571|NCT01024777|Vitamins|vitamins|mesh-list
92922572|NCT01024777|Micronutrients|micronutrients|mesh-ancestor
92922573|NCT01024777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922574|NCT01024777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92922575|NCT01024777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92922576|NCT00789854|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92922577|NCT00789854|Lithium Carbonate|lithium carbonate|mesh-list
92922578|NCT00789854|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92922579|NCT00789854|Antidepressive Agents|antidepressive agents|mesh-ancestor
92922580|NCT00789854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922581|NCT00789854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92922582|NCT00789854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92922583|NCT00789854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922584|NCT00789854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922585|NCT00789854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922586|NCT00789854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922587|NCT00789854|Antimanic Agents|antimanic agents|mesh-ancestor
92526277|NCT00395551|Ranibizumab|ranibizumab|mesh-list
92922588|NCT00789854|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92922589|NCT00789854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92922590|NCT00789854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92922591|NCT00789854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922592|NCT00789854|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92922593|NCT00725205|Ribavirin|ribavirin|mesh-list
92922594|NCT00725205|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92922595|NCT00725205|Interferon-alpha|interferon-alpha|mesh-list
92922596|NCT00725205|Antimetabolites|antimetabolites|mesh-ancestor
92922597|NCT00725205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922598|NCT00725205|Antiviral Agents|antiviral agents|mesh-ancestor
92922599|NCT00725205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922600|NCT00725205|Immunologic Factors|immunologic factors|mesh-ancestor
92922601|NCT00725205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922602|NCT00443755|Metformin|metformin|mesh-list
92922603|NCT00443755|Pioglitazone|pioglitazone|mesh-list
92922604|NCT00443755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92922605|NCT00443755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922606|NCT00724971|Rituximab|rituximab|mesh-list
92922607|NCT00724971|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92922608|NCT00724971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92922609|NCT00724971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922610|NCT00724971|Immunologic Factors|immunologic factors|mesh-ancestor
92922611|NCT00724971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922612|NCT00724971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922613|NCT00724971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92922614|NCT00724971|Immunotoxins|immunotoxins|mesh-ancestor
92922615|NCT00724971|Immunoconjugates|immunoconjugates|mesh-ancestor
92922616|NCT00443599|Insulin|insulin|mesh-list
92922617|NCT00443599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92922618|NCT00443599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92922619|NCT00443599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922620|NCT04107428|Somatostatin|somatostatin|mesh-list
92922621|NCT04107428|Hormones|hormones|mesh-ancestor
92922622|NCT04107428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922623|NCT04107428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922624|NCT00455143|Dexmedetomidine|dexmedetomidine|mesh-list
92922625|NCT00455143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92922626|NCT00455143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922627|NCT00455143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922628|NCT00455143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922629|NCT00455143|Analgesics|analgesics|mesh-ancestor
92922630|NCT00455143|Sensory System Agents|sensory system agents|mesh-ancestor
92922631|NCT00455143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922632|NCT00455143|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92922633|NCT00455143|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92922634|NCT00455143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92922635|NCT00455143|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922636|NCT00455143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922637|NCT00455143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922638|NCT00724893|Interferons|interferons|mesh-list
92922639|NCT00724893|Ribavirin|ribavirin|mesh-list
92922640|NCT00724893|Interferon-alpha|interferon-alpha|mesh-list
92922641|NCT00724893|Interferon alpha-2|interferon alpha-2|mesh-list
92922642|NCT00724893|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92922643|NCT00724893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922644|NCT00724893|Antiviral Agents|antiviral agents|mesh-ancestor
92922645|NCT00724893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922646|NCT00724893|Antimetabolites|antimetabolites|mesh-ancestor
92922647|NCT00724893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922648|NCT00724893|Immunologic Factors|immunologic factors|mesh-ancestor
92922649|NCT00724893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922650|NCT00789698|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92922651|NCT00789698|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92922652|NCT00789698|Antidepressive Agents|antidepressive agents|mesh-ancestor
92922653|NCT00789698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922654|NCT00789698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92922655|NCT00789698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92568127|NCT00047229|Oblimersen|oblimersen|mesh-list
92922656|NCT00789698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922657|NCT00789698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922658|NCT00789698|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92922659|NCT00789698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92922662|NCT00789698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922663|NCT00789698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922664|NCT00789698|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92922665|NCT00789698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92922666|NCT00789698|Serotonin Agents|serotonin agents|mesh-ancestor
92922667|NCT00789698|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92922668|NCT00789698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92922669|NCT00789698|Dopamine Agents|dopamine agents|mesh-ancestor
92922670|NCT00724815|Sumatriptan|sumatriptan|mesh-list
92922671|NCT00724815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92922672|NCT00724815|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92922673|NCT00724815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92922674|NCT00724815|Serotonin Agents|serotonin agents|mesh-ancestor
92922675|NCT00724815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922676|NCT00724815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922677|NCT00724815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922678|NCT00798590|Glucagon|glucagon|mesh-list
92922679|NCT00798590|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92922680|NCT00798590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922681|NCT00798590|Hormones|hormones|mesh-ancestor
92922682|NCT00798590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922683|NCT00798590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922684|NCT00798590|Incretins|incretins|mesh-ancestor
92922685|NCT00481195|Modafinil|modafinil|mesh-list
92922686|NCT00481195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92922687|NCT00481195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922688|NCT00481195|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92922689|NCT00481195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92922690|NCT00481195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92922691|NCT00481195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922692|NCT03604549|Ethiodized Oil|ethiodized oil|mesh-list
92922693|NCT03604549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922694|NCT01027429|Amoxicillin|amoxicillin|mesh-list
92922695|NCT01027429|Gentamicins|gentamicins|mesh-list
92922696|NCT01027429|Penicillins|penicillins|mesh-list
92922697|NCT01027429|Penicillin G Procaine|penicillin g procaine|mesh-list
92922698|NCT01027429|Penicillin G|penicillin g|mesh-list
92922699|NCT01027429|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92922700|NCT01027429|Procaine|procaine|mesh-list
92922701|NCT01027429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92922702|NCT01027429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922703|NCT01027429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92922704|NCT01027429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922705|NCT01027429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922706|NCT01027429|Anesthetics, Local|anesthetics, local|mesh-ancestor
92922707|NCT01027429|Anesthetics|anesthetics|mesh-ancestor
92922708|NCT01027429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922709|NCT01027429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922710|NCT01027429|Sensory System Agents|sensory system agents|mesh-ancestor
92922711|NCT01027429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922712|NCT01020253|Alendronate|alendronate|mesh-list
92922713|NCT01020253|Alfacalcidol|alfacalcidol|mesh-list
92922714|NCT01020253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92922715|NCT01020253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92922716|NCT01020253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922717|NCT01020253|Vitamins|vitamins|mesh-ancestor
92922718|NCT01020253|Micronutrients|micronutrients|mesh-ancestor
92922719|NCT00454207|Sildenafil Citrate|sildenafil citrate|mesh-list
92922720|NCT00454207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922721|NCT00454207|Vasodilator Agents|vasodilator agents|mesh-ancestor
92922722|NCT00454207|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92922723|NCT00454207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92922724|NCT00454207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922725|NCT00454207|Urological Agents|urological agents|mesh-ancestor
92922726|NCT01020331|Memantine|memantine|mesh-list
92922727|NCT01020331|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92922728|NCT01020331|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92922729|NCT01020331|Dopamine Agents|dopamine agents|mesh-ancestor
92922730|NCT01020331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922731|NCT01020331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922733|NCT01020331|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92922734|NCT01020331|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92922735|NCT00738894|Dipyridamole|dipyridamole|mesh-list
92922736|NCT00738894|Clopidogrel|clopidogrel|mesh-list
92922737|NCT00738894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922738|NCT00738894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922739|NCT00738894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92922740|NCT00738894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922741|NCT00738894|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92922742|NCT00738894|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92922743|NCT00738894|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92922744|NCT00738894|Purinergic Agents|purinergic agents|mesh-ancestor
92922745|NCT00738894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922746|NCT00738894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92922747|NCT00738894|Vasodilator Agents|vasodilator agents|mesh-ancestor
92922748|NCT00734994|Mitomycins|mitomycins|mesh-list
92922749|NCT00734994|Mitomycin|mitomycin|mesh-list
92922750|NCT00734994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92922751|NCT00734994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922752|NCT00734994|Alkylating Agents|alkylating agents|mesh-ancestor
92223182|NCT03829592|Oxytocics|oxytocics|mesh-ancestor
92922753|NCT00734994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922754|NCT00734994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92922755|NCT00734994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922756|NCT02593734|Olanzapine|olanzapine|mesh-list
92922757|NCT02593734|Risperidone|risperidone|mesh-list
92922758|NCT02593734|Fluoxetine|fluoxetine|mesh-list
92922759|NCT02593734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92922760|NCT02593734|Serotonin Agents|serotonin agents|mesh-ancestor
92922761|NCT02593734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922762|NCT02593734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922763|NCT02593734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922764|NCT02593734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92922765|NCT02593734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92922766|NCT02593734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922767|NCT02593734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922768|NCT02593734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92922769|NCT02593734|Dopamine Agents|dopamine agents|mesh-ancestor
92922770|NCT02593734|Antiemetics|antiemetics|mesh-ancestor
92922771|NCT02593734|Autonomic Agents|autonomic agents|mesh-ancestor
92922772|NCT02593734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922773|NCT02593734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922774|NCT02593734|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92922775|NCT02593734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92922776|NCT02593734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92922777|NCT02593734|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92922778|NCT02593734|Antidepressive Agents|antidepressive agents|mesh-ancestor
92922779|NCT02593734|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92922780|NCT02593734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92922781|NCT02593734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922782|NCT00798434|Fesoterodine|fesoterodine|mesh-list
92922783|NCT00798434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92922784|NCT00798434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92922785|NCT00798434|Cholinergic Agents|cholinergic agents|mesh-ancestor
92922786|NCT00798434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922787|NCT00798434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922788|NCT00798434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922789|NCT00798434|Urological Agents|urological agents|mesh-ancestor
92922790|NCT04106804|Abatacept|abatacept|mesh-list
92922791|NCT04106804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92922792|NCT04106804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922793|NCT04106804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92922794|NCT04106804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922795|NCT04106804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92922796|NCT04106804|Immunologic Factors|immunologic factors|mesh-ancestor
92922797|NCT04106804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922798|NCT04106804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922799|NCT00791648|Atorvastatin|atorvastatin|mesh-list
92922800|NCT00791648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92922801|NCT00791648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92922802|NCT00791648|Antimetabolites|antimetabolites|mesh-ancestor
92922803|NCT00791648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922804|NCT00791648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92922805|NCT00791648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92922806|NCT00791648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922808|NCT05366595|Astringents|astringents|mesh-ancestor
92922809|NCT05366595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922810|NCT05366595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92922811|NCT04087239|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92922812|NCT04087239|Antiviral Agents|antiviral agents|mesh-ancestor
92922813|NCT04087239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922814|NCT04017338|Ezetimibe|ezetimibe|mesh-list
92922815|NCT04017338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92922816|NCT04017338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92922817|NCT04017338|Antimetabolites|antimetabolites|mesh-ancestor
92922818|NCT04017338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922819|NCT04017338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92922820|NCT04106726|Ivermectin|ivermectin|mesh-list
92922821|NCT04106726|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92922822|NCT04106726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922823|NCT03998774|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
92922824|NCT03998774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92922825|NCT03998774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922826|NCT03998774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922827|NCT03998774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922828|NCT00723957|Paclitaxel|paclitaxel|mesh-list
92922829|NCT00723957|Carboplatin|carboplatin|mesh-list
92922830|NCT00723957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92922831|NCT00723957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922832|NCT00723957|Tubulin Modulators|tubulin modulators|mesh-ancestor
92922833|NCT00723957|Antimitotic Agents|antimitotic agents|mesh-ancestor
92922834|NCT00723957|Mitosis Modulators|mitosis modulators|mesh-ancestor
92922835|NCT00723957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922836|NCT02603822|Indomethacin|indomethacin|mesh-list
92922837|NCT02603822|Mannitol|mannitol|mesh-list
92922838|NCT02603822|Lactulose|lactulose|mesh-list
92922839|NCT02603822|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92922840|NCT02603822|Diuretics|diuretics|mesh-ancestor
92922841|NCT02603822|Natriuretic Agents|natriuretic agents|mesh-ancestor
92922842|NCT02603822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922843|NCT02603822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92922844|NCT02603822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922845|NCT02603822|Analgesics|analgesics|mesh-ancestor
92922846|NCT02603822|Sensory System Agents|sensory system agents|mesh-ancestor
92922847|NCT02603822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922848|NCT02603822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922849|NCT02603822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922850|NCT02603822|Gout Suppressants|gout suppressants|mesh-ancestor
92922851|NCT02603822|Tocolytic Agents|tocolytic agents|mesh-ancestor
92922852|NCT02603822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92922853|NCT02603822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92922854|NCT02603822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922855|NCT02603822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922856|NCT02603822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92922857|NCT02592057|Sofosbuvir|sofosbuvir|mesh-list
92922858|NCT02592057|Antiviral Agents|antiviral agents|mesh-ancestor
92922859|NCT02592057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922860|NCT00723801|Losartan|losartan|mesh-list
92922861|NCT00723801|Atenolol|atenolol|mesh-list
92922862|NCT00723801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92922863|NCT00723801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92922864|NCT00723801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92922865|NCT00723801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92922866|NCT00723801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922867|NCT00723801|Sympatholytics|sympatholytics|mesh-ancestor
92922868|NCT00723801|Autonomic Agents|autonomic agents|mesh-ancestor
92922869|NCT00723801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922870|NCT00723801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922871|NCT00723801|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92922872|NCT00723801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92922873|NCT00723801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92922874|NCT00723801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922875|NCT00723801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922876|NCT00797966|Fluoxetine|fluoxetine|mesh-list
92922877|NCT00797966|Paroxetine|paroxetine|mesh-list
92922878|NCT00797966|Sertraline|sertraline|mesh-list
92922879|NCT00797966|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92922881|NCT00797966|Brexpiprazole|brexpiprazole|mesh-list
92922882|NCT00797966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92526282|NCT00395551|Growth Inhibitors|growth inhibitors|mesh-ancestor
92922883|NCT00797966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92922884|NCT00797966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92922885|NCT00797966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922886|NCT00797966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922888|NCT00797966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922889|NCT00797966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92922890|NCT00797966|Antidepressive Agents|antidepressive agents|mesh-ancestor
92922891|NCT00797966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92922892|NCT00797966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92922893|NCT00797966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92922894|NCT00797966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922895|NCT00797966|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92922896|NCT00797966|Dopamine Agonists|dopamine agonists|mesh-ancestor
92922897|NCT00797966|Dopamine Agents|dopamine agents|mesh-ancestor
92922898|NCT05361837|Dexmedetomidine|dexmedetomidine|mesh-list
92922899|NCT05361837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92922900|NCT05361837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92922901|NCT05361837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922902|NCT05361837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922903|NCT05361837|Analgesics|analgesics|mesh-ancestor
92922904|NCT05361837|Sensory System Agents|sensory system agents|mesh-ancestor
92922905|NCT05361837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922906|NCT05361837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92922907|NCT05361837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92922908|NCT05361837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92922909|NCT05361837|Adrenergic Agents|adrenergic agents|mesh-ancestor
92922910|NCT05361837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92922911|NCT05361837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922912|NCT00723255|Sirolimus|sirolimus|mesh-list
92922913|NCT00723255|Bevacizumab|bevacizumab|mesh-list
92922914|NCT00723255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92922915|NCT00723255|Temsirolimus|temsirolimus|mesh-list
92922916|NCT00723255|MTOR Inhibitors|mtor inhibitors|mesh-list
92922917|NCT00723255|Antibodies|antibodies|mesh-list
92922918|NCT00723255|Immunoglobulins|immunoglobulins|mesh-list
92922919|NCT00723255|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92922920|NCT00723255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922921|NCT00723255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92922922|NCT00723255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92922923|NCT00723255|Growth Substances|growth substances|mesh-ancestor
92922924|NCT00723255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922925|NCT00723255|Growth Inhibitors|growth inhibitors|mesh-ancestor
92922926|NCT00723255|Immunologic Factors|immunologic factors|mesh-ancestor
92922927|NCT00723255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92922928|NCT00723255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922929|NCT00723255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922930|NCT00723255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92922931|NCT00723255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92922932|NCT00723255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922933|NCT00723255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92922934|NCT00723255|Antifungal Agents|antifungal agents|mesh-ancestor
92922935|NCT00791258|Amlodipine|amlodipine|mesh-list
92922936|NCT00791258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92922937|NCT00791258|Olmesartan|olmesartan|mesh-list
92922938|NCT00791258|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92922939|NCT00791258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92922940|NCT00791258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92922941|NCT00791258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92922942|NCT00791258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922943|NCT00791258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92922944|NCT00791258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922945|NCT00791258|Vasodilator Agents|vasodilator agents|mesh-ancestor
92922946|NCT00791258|Diuretics|diuretics|mesh-ancestor
92922947|NCT00791258|Natriuretic Agents|natriuretic agents|mesh-ancestor
92922948|NCT00791258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92922949|NCT00791258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92922950|NCT00791258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92922951|NCT00808067|Dabigatran|dabigatran|mesh-list
92922952|NCT00808067|Antithrombins|antithrombins|mesh-ancestor
92922953|NCT00808067|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92922954|NCT00808067|Protease Inhibitors|protease inhibitors|mesh-ancestor
92922955|NCT00808067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922956|NCT00808067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922958|NCT00723021|Zileuton|zileuton|mesh-list
92922959|NCT00723021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92922960|NCT00723021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922961|NCT00723021|Analgesics|analgesics|mesh-ancestor
92922962|NCT00723021|Sensory System Agents|sensory system agents|mesh-ancestor
92922963|NCT00723021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922964|NCT00723021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922965|NCT00723021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922966|NCT00723021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922967|NCT00723021|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92922968|NCT00723021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922969|NCT00723021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922970|NCT00723021|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92922971|NCT00723021|Hormone Antagonists|hormone antagonists|mesh-ancestor
92922972|NCT00723021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92922973|NCT04087317|Acetaminophen|acetaminophen|mesh-list
92922974|NCT04087317|Ibuprofen|ibuprofen|mesh-list
92922975|NCT04087317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92922976|NCT04087317|Analgesics|analgesics|mesh-ancestor
92922977|NCT04087317|Sensory System Agents|sensory system agents|mesh-ancestor
92922978|NCT04087317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92922979|NCT04087317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92922980|NCT04087317|Antipyretics|antipyretics|mesh-ancestor
92922981|NCT04087317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92922982|NCT04087317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92922983|NCT04087317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92922984|NCT04087317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92922985|NCT04087317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92922986|NCT04087317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922987|NCT04309409|Nivolumab|nivolumab|mesh-list
92922988|NCT04309409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92922989|NCT04309409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92922990|NCT04309409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92922991|NCT04309409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922992|NCT04086537|Hepcidins|hepcidins|mesh-list
92922993|NCT04086537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92922994|NCT02608619|Choline|choline|mesh-list
92922995|NCT02608619|Lipotropic Agents|lipotropic agents|mesh-ancestor
92922996|NCT02608619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92922997|NCT02608619|Antimetabolites|antimetabolites|mesh-ancestor
92922998|NCT02608619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92922999|NCT02608619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92923000|NCT02608619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92923001|NCT02608619|Nootropic Agents|nootropic agents|mesh-ancestor
92923002|NCT02591667|Bevacizumab|bevacizumab|mesh-list
92923003|NCT02591667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92923004|NCT02591667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923005|NCT02591667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92923006|NCT02591667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92923007|NCT02591667|Growth Substances|growth substances|mesh-ancestor
92923008|NCT02591667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923009|NCT02591667|Growth Inhibitors|growth inhibitors|mesh-ancestor
92923010|NCT00807599|Dexamethasone|dexamethasone|mesh-list
92923011|NCT00807599|Dexamethasone acetate|dexamethasone acetate|mesh-list
92923012|NCT00807599|Lenalidomide|lenalidomide|mesh-list
92923013|NCT00807599|Melphalan|melphalan|mesh-list
92923014|NCT00807599|BB 1101|bb 1101|mesh-list
92923015|NCT00807599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92923016|NCT00807599|Antiemetics|antiemetics|mesh-ancestor
92923017|NCT00807599|Autonomic Agents|autonomic agents|mesh-ancestor
92923018|NCT00807599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923019|NCT00807599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923020|NCT00807599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92923021|NCT00807599|Glucocorticoids|glucocorticoids|mesh-ancestor
92923022|NCT00807599|Hormones|hormones|mesh-ancestor
92923023|NCT00807599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923024|NCT00807599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92923025|NCT00807599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923026|NCT00807599|Protease Inhibitors|protease inhibitors|mesh-ancestor
92923027|NCT00807599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923028|NCT00807599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923030|NCT00807599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92923031|NCT00807599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92923032|NCT00807599|Growth Substances|growth substances|mesh-ancestor
92923033|NCT00807599|Growth Inhibitors|growth inhibitors|mesh-ancestor
92923034|NCT00807599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92923035|NCT00807599|Alkylating Agents|alkylating agents|mesh-ancestor
92923036|NCT00807599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92923037|NCT00807599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92923038|NCT00788372|Fentanyl|fentanyl|mesh-list
92923039|NCT00788372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92923040|NCT00788372|Narcotics|narcotics|mesh-ancestor
92923041|NCT00788372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923042|NCT00788372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923043|NCT00788372|Analgesics|analgesics|mesh-ancestor
92923044|NCT00788372|Sensory System Agents|sensory system agents|mesh-ancestor
92923045|NCT00788372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923046|NCT00788372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92923047|NCT00788372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92923048|NCT00788372|Anesthetics, General|anesthetics, general|mesh-ancestor
92923049|NCT00788372|Anesthetics|anesthetics|mesh-ancestor
92923050|NCT00738582|Pemetrexed|pemetrexed|mesh-list
92923051|NCT00738582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923052|NCT00738582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923053|NCT00738582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923054|NCT00738582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92923055|NCT00738582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92923056|NCT05753657|Pioglitazone|pioglitazone|mesh-list
92923057|NCT05753657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92923058|NCT05753657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923059|NCT00720759|Cycloserine|cycloserine|mesh-list
92923060|NCT00720759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92923061|NCT00720759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923062|NCT00720759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92923063|NCT00720759|Antitubercular Agents|antitubercular agents|mesh-ancestor
92923064|NCT00720759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92923065|NCT00720759|Antimetabolites|antimetabolites|mesh-ancestor
92923066|NCT00720759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923067|NCT00918411|Ramosetron|ramosetron|mesh-list
92923068|NCT00918411|Antiemetics|antiemetics|mesh-ancestor
92923069|NCT00918411|Autonomic Agents|autonomic agents|mesh-ancestor
92923070|NCT00918411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923071|NCT00918411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923072|NCT00918411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92923073|NCT00918411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92923074|NCT00918411|Serotonin Agents|serotonin agents|mesh-ancestor
92923075|NCT00918411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923076|NCT00918411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923077|NCT00810407|Rifabutin|rifabutin|mesh-list
92923078|NCT00810407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92923079|NCT00810407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923080|NCT00810407|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92923081|NCT00810407|Antitubercular Agents|antitubercular agents|mesh-ancestor
92923082|NCT00720057|Naproxen|naproxen|mesh-list
92923083|NCT00720057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92923084|NCT00720057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923085|NCT00720057|Analgesics|analgesics|mesh-ancestor
92923086|NCT00720057|Sensory System Agents|sensory system agents|mesh-ancestor
92923087|NCT00720057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923088|NCT00720057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923089|NCT00720057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92923090|NCT00720057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92923091|NCT00720057|Gout Suppressants|gout suppressants|mesh-ancestor
92923092|NCT00720057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92923093|NCT00720057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923094|NCT00720057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923095|NCT00790868|Cycloserine|cycloserine|mesh-list
92923096|NCT00790868|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92923097|NCT00790868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923098|NCT00790868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92923099|NCT00790868|Antitubercular Agents|antitubercular agents|mesh-ancestor
92923100|NCT00790868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92923101|NCT00790868|Antimetabolites|antimetabolites|mesh-ancestor
92923102|NCT00790868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923104|NCT00719901|Obatoclax|obatoclax|mesh-list
92923105|NCT00719901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923106|NCT00719901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923107|NCT00719901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923108|NCT02603276|Red yeast rice|red yeast rice|mesh-list
92923109|NCT02603276|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92923110|NCT02603276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92923111|NCT02603276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92923112|NCT02603276|Antimetabolites|antimetabolites|mesh-ancestor
92923113|NCT02603276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923114|NCT02603276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163001|NCT01924273|Talaporfin|talaporfin|mesh-list
92923115|NCT02603276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92923116|NCT02591277|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92923117|NCT02591277|Antiviral Agents|antiviral agents|mesh-ancestor
92923118|NCT02591277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923119|NCT00807365|Hormones|hormones|mesh-list
92923120|NCT00807365|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92923121|NCT00807365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923122|NCT00807365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923123|NCT02609711|Candesartan|candesartan|mesh-list
92923124|NCT02609711|Candesartan cilexetil|candesartan cilexetil|mesh-list
92923125|NCT02609711|Atorvastatin|atorvastatin|mesh-list
92923126|NCT02609711|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92923127|NCT02609711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92923128|NCT02609711|Antimetabolites|antimetabolites|mesh-ancestor
92923129|NCT02609711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923130|NCT02609711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92923131|NCT02609711|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92923132|NCT02609711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923133|NCT02609711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92923134|NCT02609711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92923135|NCT02609711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92923136|NCT04016207|Guanfacine|guanfacine|mesh-list
92923137|NCT04016207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92923138|NCT04016207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92923139|NCT04016207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92923140|NCT04016207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923141|NCT04016207|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923142|NCT04016207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923143|NCT04016207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923144|NCT04016207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923145|NCT04030091|Insulin|insulin|mesh-list
92923146|NCT04030091|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92923147|NCT04030091|Insulin, Isophane|insulin, isophane|mesh-list
92923148|NCT04030091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92923149|NCT04030091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923150|NCT00734604|Sildenafil Citrate|sildenafil citrate|mesh-list
92923151|NCT00734604|Tadalafil|tadalafil|mesh-list
92923152|NCT00734604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923153|NCT00734604|Vasodilator Agents|vasodilator agents|mesh-ancestor
92923154|NCT00734604|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92923155|NCT00734604|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92923156|NCT00734604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923157|NCT00734604|Urological Agents|urological agents|mesh-ancestor
92923158|NCT00590681|Bevacizumab|bevacizumab|mesh-list
92923159|NCT00590681|Temozolomide|temozolomide|mesh-list
92923160|NCT00590681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92923161|NCT00590681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923162|NCT00590681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92923163|NCT00590681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92923164|NCT00590681|Growth Substances|growth substances|mesh-ancestor
92923165|NCT00590681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923166|NCT00590681|Growth Inhibitors|growth inhibitors|mesh-ancestor
92923167|NCT00590681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92923168|NCT00590681|Alkylating Agents|alkylating agents|mesh-ancestor
92923169|NCT00590681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923170|NCT00727272|Quinine|quinine|mesh-list
92923171|NCT00727272|Antimalarials|antimalarials|mesh-ancestor
92923172|NCT00727272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92923173|NCT00727272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92923174|NCT00727272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923176|NCT00727272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526287|NCT00028288|Daclizumab|daclizumab|mesh-list
92923177|NCT00727272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92923178|NCT00727272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923179|NCT00727272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923180|NCT00727272|Analgesics|analgesics|mesh-ancestor
92923181|NCT00727272|Sensory System Agents|sensory system agents|mesh-ancestor
92923182|NCT02609477|Phentermine|phentermine|mesh-list
92923183|NCT02609477|Istradefylline|istradefylline|mesh-list
92923184|NCT02609477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92923185|NCT02609477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923186|NCT02609477|Appetite Depressants|appetite depressants|mesh-ancestor
92923187|NCT02609477|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92923188|NCT02609477|Sympathomimetics|sympathomimetics|mesh-ancestor
92923189|NCT02609477|Autonomic Agents|autonomic agents|mesh-ancestor
92923190|NCT02609477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923191|NCT02609477|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923192|NCT02609477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923193|NCT02609477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923194|NCT02609477|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92923195|NCT02609477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92923196|NCT02609477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92923197|NCT02609477|Purinergic Agents|purinergic agents|mesh-ancestor
92923198|NCT02592720|Tenecteplase|tenecteplase|mesh-list
92923199|NCT02592720|Tirofiban|tirofiban|mesh-list
92923200|NCT02592720|Bivalirudin|bivalirudin|mesh-list
92923201|NCT02592720|Antithrombins|antithrombins|mesh-ancestor
92923202|NCT02592720|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92923203|NCT02592720|Protease Inhibitors|protease inhibitors|mesh-ancestor
92923204|NCT02592720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923205|NCT02592720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923206|NCT02592720|Anticoagulants|anticoagulants|mesh-ancestor
92923207|NCT02592720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92923208|NCT02592720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92923209|NCT02592720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92923210|NCT02608073|Capecitabine|capecitabine|mesh-list
92923211|NCT02608073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923212|NCT02608073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92923213|NCT02608073|Antimetabolites|antimetabolites|mesh-ancestor
92923214|NCT02608073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923215|NCT04041791|Amoxicillin|amoxicillin|mesh-list
92923216|NCT04041791|Gentamicins|gentamicins|mesh-list
92923217|NCT04041791|Ceftriaxone|ceftriaxone|mesh-list
92923218|NCT04041791|Clavulanic Acid|clavulanic acid|mesh-list
92923219|NCT04041791|Clavulanic Acids|clavulanic acids|mesh-list
92923220|NCT04041791|Penicillins|penicillins|mesh-list
92923221|NCT04041791|Ampicillin|ampicillin|mesh-list
92923222|NCT04041791|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92923223|NCT04041791|Penicillin G|penicillin g|mesh-list
92923224|NCT04041791|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92923225|NCT04041791|Penicillin G Procaine|penicillin g procaine|mesh-list
92923226|NCT04041791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92923227|NCT04041791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923228|NCT04041791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92923229|NCT04041791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923230|NCT04041791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923231|NCT04041791|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92923232|NCT02605226|Bicalutamide|bicalutamide|mesh-list
92923233|NCT02605226|Hormones|hormones|mesh-list
92923234|NCT02605226|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92923235|NCT02605226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923236|NCT02605226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923237|NCT02605226|Androgen Antagonists|androgen antagonists|mesh-ancestor
92923238|NCT02605226|Hormone Antagonists|hormone antagonists|mesh-ancestor
92923239|NCT02605226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923240|NCT05571878|Insulin Lispro|insulin lispro|mesh-list
92923241|NCT05571878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92923242|NCT05571878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923243|NCT04088448|Metformin|metformin|mesh-list
92923244|NCT04088448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92923245|NCT04088448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923246|NCT00806351|Caspofungin|caspofungin|mesh-list
92923247|NCT00806351|Anidulafungin|anidulafungin|mesh-list
92923248|NCT00806351|Antifungal Agents|antifungal agents|mesh-ancestor
92923249|NCT00806351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923250|NCT00806351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923251|NCT00806351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923252|NCT03995251|Testosterone|testosterone|mesh-list
92923253|NCT03995251|Androgens|androgens|mesh-ancestor
92923254|NCT03995251|Hormones|hormones|mesh-ancestor
92923255|NCT03995251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923256|NCT03995251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923257|NCT01031017|Progesterone|progesterone|mesh-list
92923258|NCT01031017|Progestins|progestins|mesh-ancestor
92923259|NCT01031017|Hormones|hormones|mesh-ancestor
92923260|NCT01031017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923261|NCT01031017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923262|NCT03742531|Oxytocin|oxytocin|mesh-list
92923263|NCT03742531|Oxytocics|oxytocics|mesh-ancestor
92923264|NCT03742531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92923265|NCT03742531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923266|NCT05738135|Aminophylline|aminophylline|mesh-list
92923267|NCT05738135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923268|NCT05738135|Autonomic Agents|autonomic agents|mesh-ancestor
92923269|NCT05738135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923270|NCT05738135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923271|NCT05738135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923272|NCT05738135|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923273|NCT05738135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92923274|NCT05738135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92923275|NCT05738135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923276|NCT05738135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923277|NCT05738135|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92923278|NCT05738135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92923279|NCT05738135|Purinergic Agents|purinergic agents|mesh-ancestor
92923280|NCT05738135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923281|NCT05738135|Protective Agents|protective agents|mesh-ancestor
92923282|NCT00733902|Tanezumab|tanezumab|mesh-list
92923283|NCT00733902|Analgesics|analgesics|mesh-ancestor
92923284|NCT00733902|Sensory System Agents|sensory system agents|mesh-ancestor
92923285|NCT00733902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923286|NCT00733902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923287|NCT05737355|Red yeast rice|red yeast rice|mesh-list
92923288|NCT05737355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92923289|NCT05737355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92923290|NCT05737355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92923291|NCT05737355|Antimetabolites|antimetabolites|mesh-ancestor
92923292|NCT05737355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923293|NCT05737355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923294|NCT05737355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92923295|NCT03540017|Cisplatin|cisplatin|mesh-list
92923296|NCT03540017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923297|NCT02606981|Vitamins|vitamins|mesh-list
92923298|NCT02606981|Ascorbic Acid|ascorbic acid|mesh-list
92923299|NCT02606981|Micronutrients|micronutrients|mesh-ancestor
92923300|NCT02606981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923301|NCT02606981|Antioxidants|antioxidants|mesh-ancestor
92923302|NCT02606981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923303|NCT02606981|Protective Agents|protective agents|mesh-ancestor
92923304|NCT00914888|Metronidazole|metronidazole|mesh-list
92923305|NCT00914888|Clarithromycin|clarithromycin|mesh-list
92923306|NCT00914888|Ceftriaxone|ceftriaxone|mesh-list
92923307|NCT00914888|Tigecycline|tigecycline|mesh-list
92923308|NCT00914888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923309|NCT00914888|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92923310|NCT00914888|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92923311|NCT00914888|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92923312|NCT00914888|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92923313|NCT00914888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923314|NCT00914888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923315|NCT00914888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92923316|NCT00914888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92923317|NCT02603198|Epinephrine|epinephrine|mesh-list
92923318|NCT02603198|Nordefrin|nordefrin|mesh-list
92923319|NCT02603198|Anesthetics|anesthetics|mesh-list
92923320|NCT02603198|Mepivacaine|mepivacaine|mesh-list
92923321|NCT02603198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923322|NCT02603198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923323|NCT02603198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92923324|NCT02603198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923325|NCT02603198|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923326|NCT02603198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923327|NCT02603198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923328|NCT02603198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92923329|NCT02603198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923330|NCT02603198|Autonomic Agents|autonomic agents|mesh-ancestor
92923331|NCT02603198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923332|NCT02603198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923333|NCT02603198|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923335|NCT02603198|Sympathomimetics|sympathomimetics|mesh-ancestor
92923336|NCT02603198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92923337|NCT02603198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92923338|NCT02603198|Sensory System Agents|sensory system agents|mesh-ancestor
92923339|NCT00719043|Vaccines|vaccines|mesh-list
92923340|NCT00719043|Immunologic Factors|immunologic factors|mesh-ancestor
92923341|NCT00719043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923342|NCT00786422|Rivaroxaban|rivaroxaban|mesh-list
92923343|NCT00786422|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92923344|NCT00786422|Antithrombins|antithrombins|mesh-ancestor
92923345|NCT00786422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92923346|NCT00786422|Protease Inhibitors|protease inhibitors|mesh-ancestor
92923347|NCT00786422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923348|NCT00786422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923349|NCT00786422|Anticoagulants|anticoagulants|mesh-ancestor
92923350|NCT00718887|Entecavir|entecavir|mesh-list
92923351|NCT00718887|Adefovir|adefovir|mesh-list
92923352|NCT00718887|Antiviral Agents|antiviral agents|mesh-ancestor
92923353|NCT00718887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923354|NCT00718887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92923355|NCT00718887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92923356|NCT00718887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923357|NCT00718887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923358|NCT00786188|Paroxetine|paroxetine|mesh-list
92923359|NCT00786188|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92923360|NCT00786188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92923361|NCT00786188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92923362|NCT00786188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923363|NCT00786188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923364|NCT00786188|Serotonin Agents|serotonin agents|mesh-ancestor
92923365|NCT00786188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923366|NCT00786188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92923367|NCT00786188|Antidepressive Agents|antidepressive agents|mesh-ancestor
92923368|NCT00786188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92923369|NCT00786188|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92923370|NCT00786188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92923371|NCT00786188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923372|NCT00733824|Plerixafor|plerixafor|mesh-list
92923373|NCT00733824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92923374|NCT00733824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92923375|NCT00733824|Antiviral Agents|antiviral agents|mesh-ancestor
92923376|NCT00733824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923377|NCT00718809|Saracatinib|saracatinib|mesh-list
92923378|NCT00718809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923379|NCT00718809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923380|NCT00718809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923381|NCT00585039|Albuterol|albuterol|mesh-list
92923382|NCT00585039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923383|NCT00585039|Autonomic Agents|autonomic agents|mesh-ancestor
92923384|NCT00585039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923385|NCT00585039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923386|NCT00585039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923387|NCT00585039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923388|NCT00585039|Tocolytic Agents|tocolytic agents|mesh-ancestor
92923389|NCT00585039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92923390|NCT00585039|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92923391|NCT00585039|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92923392|NCT00585039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923393|NCT00585039|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923394|NCT00585039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923395|NCT00585039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923396|NCT04085913|Lidocaine|lidocaine|mesh-list
92923397|NCT04085913|Epinephrine|epinephrine|mesh-list
92923398|NCT04085913|Racepinephrine|racepinephrine|mesh-list
92923400|NCT04085913|Epinephryl borate|epinephryl borate|mesh-list
92923401|NCT04085913|Anesthetics, Local|anesthetics, local|mesh-ancestor
92923402|NCT04085913|Anesthetics|anesthetics|mesh-ancestor
92923404|NCT04085913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923405|NCT04085913|Sensory System Agents|sensory system agents|mesh-ancestor
92163011|NCT00667121|Escitalopram|escitalopram|mesh-list
92923406|NCT04085913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923407|NCT04085913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92923408|NCT04085913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92923409|NCT04085913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92923410|NCT04085913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92923411|NCT04085913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923412|NCT04085913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92923413|NCT04085913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923414|NCT04085913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923415|NCT04085913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923416|NCT04085913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92923417|NCT04085913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923418|NCT04085913|Autonomic Agents|autonomic agents|mesh-ancestor
92923419|NCT04085913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923420|NCT04085913|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923421|NCT04085913|Mydriatics|mydriatics|mesh-ancestor
92923422|NCT04085913|Sympathomimetics|sympathomimetics|mesh-ancestor
92923423|NCT04085913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92923424|NCT00806195|Vaccines|vaccines|mesh-list
92923425|NCT00806195|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92923426|NCT00806195|Immunologic Factors|immunologic factors|mesh-ancestor
92923427|NCT00806195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923428|NCT03462329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92923429|NCT03462329|Doxycycline|doxycycline|mesh-list
92923430|NCT03462329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923431|NCT03462329|Antimalarials|antimalarials|mesh-ancestor
92923432|NCT03462329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92923433|NCT03462329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92923434|NCT05728151|Epinephrine|epinephrine|mesh-list
92923435|NCT05728151|Levobupivacaine|levobupivacaine|mesh-list
92923436|NCT05728151|Carticaine|carticaine|mesh-list
92923437|NCT05728151|Mepivacaine|mepivacaine|mesh-list
92923438|NCT05728151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92923439|NCT05728151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923440|NCT05728151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923441|NCT05728151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923442|NCT05728151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923443|NCT05728151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923444|NCT05728151|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92923445|NCT05728151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923446|NCT05728151|Autonomic Agents|autonomic agents|mesh-ancestor
92923447|NCT05728151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923448|NCT05728151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923449|NCT05728151|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923450|NCT05728151|Mydriatics|mydriatics|mesh-ancestor
92923451|NCT05728151|Sympathomimetics|sympathomimetics|mesh-ancestor
92923452|NCT05728151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92923453|NCT05728151|Anesthetics, Local|anesthetics, local|mesh-ancestor
92923454|NCT05728151|Anesthetics|anesthetics|mesh-ancestor
92923455|NCT05728151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923456|NCT05728151|Sensory System Agents|sensory system agents|mesh-ancestor
92923457|NCT00733746|Gemcitabine|gemcitabine|mesh-list
92923458|NCT00733746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92923459|NCT00733746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92923460|NCT00733746|Antimetabolites|antimetabolites|mesh-ancestor
92923461|NCT00733746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923462|NCT00733746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923463|NCT00733746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92923464|NCT00733746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923465|NCT03422705|Lisinopril|lisinopril|mesh-list
92923466|NCT03422705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92923467|NCT03422705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92923468|NCT03422705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923469|NCT03422705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923470|NCT03422705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92923471|NCT03422705|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92923472|NCT03422705|Protective Agents|protective agents|mesh-ancestor
92923473|NCT03422705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923474|NCT02607293|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92923475|NCT02607293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92923476|NCT02607293|Hormones|hormones|mesh-ancestor
92923477|NCT02607293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146609|NCT03482167|Vitamins|vitamins|mesh-ancestor
92923478|NCT02607293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923479|NCT02607371|Rivaroxaban|rivaroxaban|mesh-list
92923480|NCT02607371|Apixaban|apixaban|mesh-list
92923481|NCT02607371|Edoxaban|edoxaban|mesh-list
92923482|NCT02607371|Dabigatran|dabigatran|mesh-list
92923483|NCT02607371|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92923484|NCT02607371|Antithrombins|antithrombins|mesh-ancestor
92923485|NCT02607371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92923486|NCT02607371|Protease Inhibitors|protease inhibitors|mesh-ancestor
92923487|NCT02607371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923488|NCT02607371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923489|NCT02607371|Anticoagulants|anticoagulants|mesh-ancestor
92923490|NCT04085757|Dinoprostone|dinoprostone|mesh-list
92923491|NCT04085757|Oxytocics|oxytocics|mesh-ancestor
92923492|NCT04085757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92923493|NCT04085757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923494|NCT00727194|Eculizumab|eculizumab|mesh-list
92923495|NCT00727194|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92923496|NCT00727194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92923497|NCT00727194|Immunologic Factors|immunologic factors|mesh-ancestor
92923498|NCT00727194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923499|NCT00717093|Varenicline|varenicline|mesh-list
92923500|NCT00717093|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92923501|NCT00717093|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92923502|NCT00717093|Cholinergic Agents|cholinergic agents|mesh-ancestor
92923503|NCT00717093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923504|NCT00717093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923505|NCT00717093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923506|NCT00716859|Timolol|timolol|mesh-list
92923507|NCT00716859|Latanoprost|latanoprost|mesh-list
92923508|NCT00716859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92923509|NCT00716859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92923510|NCT00716859|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923511|NCT00716859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923512|NCT00716859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923513|NCT00716859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923514|NCT00716859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92923515|NCT00716859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92923516|NCT00716859|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92923517|NCT00716859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92923518|NCT00590135|Atorvastatin|atorvastatin|mesh-list
92923519|NCT00590135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92923520|NCT00590135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92923521|NCT00590135|Antimetabolites|antimetabolites|mesh-ancestor
92923522|NCT00590135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923523|NCT00590135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92923524|NCT00590135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92923525|NCT00590135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923526|NCT00589667|Gemcitabine|gemcitabine|mesh-list
92923527|NCT00589667|Pemetrexed|pemetrexed|mesh-list
92923528|NCT00589667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92923529|NCT00589667|Antimetabolites|antimetabolites|mesh-ancestor
92923530|NCT00589667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923531|NCT00589667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923532|NCT00589667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923533|NCT00589667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92923534|NCT00589667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92923535|NCT00737568|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92923536|NCT00737568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92923537|NCT00737568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92923538|NCT00737568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923539|NCT00737568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923540|NCT00737568|Antiviral Agents|antiviral agents|mesh-ancestor
92923541|NCT00737568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923542|NCT00737568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92923543|NCT00737568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92923544|NCT05752799|Analgesics, Opioid|analgesics, opioid|mesh-list
92923545|NCT05752799|Anesthetics|anesthetics|mesh-list
92923546|NCT05752799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923547|NCT05752799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923548|NCT05752799|Narcotics|narcotics|mesh-ancestor
92923549|NCT05752799|Analgesics|analgesics|mesh-ancestor
92923550|NCT05752799|Sensory System Agents|sensory system agents|mesh-ancestor
92569005|NCT00195754|Valproic Acid|valproic acid|mesh-list
92923551|NCT05752799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923552|NCT00737100|Bromides|bromides|mesh-list
92923553|NCT00737100|Tiotropium Bromide|tiotropium bromide|mesh-list
92923554|NCT00737100|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923555|NCT00737100|Autonomic Agents|autonomic agents|mesh-ancestor
92923556|NCT00737100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923557|NCT00737100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923558|NCT00737100|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923559|NCT00737100|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923560|NCT00737100|Parasympatholytics|parasympatholytics|mesh-ancestor
92923561|NCT00737100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92923562|NCT00737100|Cholinergic Agents|cholinergic agents|mesh-ancestor
92923563|NCT00737100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923564|NCT00737100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923565|NCT00737100|Anticonvulsants|anticonvulsants|mesh-ancestor
92923566|NCT00732498|Cytarabine|cytarabine|mesh-list
92923567|NCT00732498|Methylprednisolone|methylprednisolone|mesh-list
92923568|NCT00732498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92923569|NCT00732498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92923570|NCT00732498|Prednisolone|prednisolone|mesh-list
92923571|NCT00732498|Prednisolone acetate|prednisolone acetate|mesh-list
92923572|NCT00732498|Rituximab|rituximab|mesh-list
92923573|NCT00732498|Etoposide|etoposide|mesh-list
92923574|NCT00732498|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92923575|NCT00732498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92923576|NCT00732498|Prednisolone phosphate|prednisolone phosphate|mesh-list
92923577|NCT00732498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92923578|NCT00732498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923579|NCT00732498|Immunologic Factors|immunologic factors|mesh-ancestor
92923580|NCT00732498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923581|NCT00732498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92923582|NCT00732498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92923583|NCT00732498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92923584|NCT00732498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92923585|NCT00732498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923586|NCT00732498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923587|NCT00732498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92923588|NCT00732498|Antimetabolites|antimetabolites|mesh-ancestor
92923589|NCT00732498|Antiviral Agents|antiviral agents|mesh-ancestor
92923590|NCT00732498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923591|NCT00732498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92923592|NCT00732498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92923593|NCT00732498|Antiemetics|antiemetics|mesh-ancestor
92923594|NCT00732498|Autonomic Agents|autonomic agents|mesh-ancestor
92923595|NCT00732498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923596|NCT00732498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92923597|NCT00732498|Glucocorticoids|glucocorticoids|mesh-ancestor
92923598|NCT00732498|Hormones|hormones|mesh-ancestor
92923599|NCT00732498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923600|NCT00732498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92923601|NCT00732498|Protective Agents|protective agents|mesh-ancestor
92923602|NCT00732498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92923603|NCT00790400|Everolimus|everolimus|mesh-list
92923604|NCT00790400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92923605|NCT00790400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92923606|NCT00790400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923607|NCT00790400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923608|NCT00790400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92923609|NCT00790400|Immunologic Factors|immunologic factors|mesh-ancestor
92923610|NCT00790400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923611|NCT00790400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923612|NCT00915512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92923613|NCT00915512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92923614|NCT00915512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92923615|NCT00915512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923616|NCT00915512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923617|NCT00915512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163025|NCT00667121|Antimanic Agents|antimanic agents|mesh-ancestor
92923618|NCT00915512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92923619|NCT00915512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92923620|NCT00915512|Serotonin Agents|serotonin agents|mesh-ancestor
92923621|NCT00915512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923622|NCT00915512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923623|NCT00915512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92923624|NCT00915512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92923625|NCT00915512|Dopamine Agents|dopamine agents|mesh-ancestor
92923627|NCT02602652|Immunologic Factors|immunologic factors|mesh-ancestor
92923628|NCT02602652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923629|NCT02593500|Budesonide|budesonide|mesh-list
92923630|NCT02593500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92923631|NCT02593500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923632|NCT02593500|Autonomic Agents|autonomic agents|mesh-ancestor
92923633|NCT02593500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923634|NCT02593500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923635|NCT02593500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923636|NCT02593500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923637|NCT02593500|Glucocorticoids|glucocorticoids|mesh-ancestor
92923638|NCT02593500|Hormones|hormones|mesh-ancestor
92923639|NCT02593500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923640|NCT02594358|Caffeine|caffeine|mesh-list
92923641|NCT02594358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92923642|NCT02594358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923643|NCT02594358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92923644|NCT02594358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923645|NCT02594358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923646|NCT02594358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92923647|NCT02594358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92923648|NCT02594358|Purinergic Agents|purinergic agents|mesh-ancestor
92923649|NCT02594358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923650|NCT00785486|Quinine|quinine|mesh-list
92923651|NCT00785486|Midazolam|midazolam|mesh-list
92923652|NCT00785486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92923653|NCT00785486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92923654|NCT00785486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923655|NCT00785486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923656|NCT00785486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92923657|NCT00785486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92923658|NCT00785486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92923659|NCT00785486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92923660|NCT00785486|Anesthetics, General|anesthetics, general|mesh-ancestor
92923661|NCT00785486|Anesthetics|anesthetics|mesh-ancestor
92923662|NCT00785486|GABA Modulators|gaba modulators|mesh-ancestor
92923663|NCT00785486|GABA Agents|gaba agents|mesh-ancestor
92923664|NCT00785486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923665|NCT00785486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923666|NCT00785486|Antimalarials|antimalarials|mesh-ancestor
92923667|NCT00785486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92923668|NCT00785486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92923669|NCT00785486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923670|NCT00785486|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92923671|NCT00785486|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92923672|NCT00785486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923673|NCT00785486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923674|NCT00785486|Analgesics|analgesics|mesh-ancestor
92923675|NCT00785486|Sensory System Agents|sensory system agents|mesh-ancestor
92923676|NCT00917904|Dapivirine|dapivirine|mesh-list
92923677|NCT00917904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92923678|NCT00917904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92923679|NCT00917904|Antiviral Agents|antiviral agents|mesh-ancestor
92923680|NCT00917904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923681|NCT00589979|Lidocaine|lidocaine|mesh-list
92923682|NCT00589979|Anesthetics, Local|anesthetics, local|mesh-ancestor
92923683|NCT00589979|Anesthetics|anesthetics|mesh-ancestor
92923684|NCT00589979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923685|NCT00589979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923686|NCT00589979|Sensory System Agents|sensory system agents|mesh-ancestor
92923687|NCT00589979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923688|NCT00589979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92923689|NCT00589979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92923690|NCT00589979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92923691|NCT00589979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92923692|NCT00589979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923693|NCT02590653|Atorvastatin|atorvastatin|mesh-list
92923694|NCT02590653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92923695|NCT02590653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92923696|NCT02590653|Antimetabolites|antimetabolites|mesh-ancestor
92923697|NCT02590653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923698|NCT02590653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92923699|NCT02590653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92923700|NCT02590653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923702|NCT00915746|Antifungal Agents|antifungal agents|mesh-ancestor
92923703|NCT00915746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923704|NCT00915746|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92923705|NCT00915746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92923706|NCT00915746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923707|NCT00915746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923708|NCT00915746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92923709|NCT00915746|Hormone Antagonists|hormone antagonists|mesh-ancestor
92923710|NCT00915746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923711|NCT00915746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923712|NCT00915746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92923713|NCT00736944|Cisplatin|cisplatin|mesh-list
92923714|NCT00736944|Cetuximab|cetuximab|mesh-list
92923715|NCT00736944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92923716|NCT00736944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923717|NCT00736944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92923718|NCT02603510|Insulin Lispro|insulin lispro|mesh-list
92923719|NCT02603510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92923720|NCT02603510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923721|NCT04084977|Antibodies|antibodies|mesh-list
92923722|NCT04084977|Immunologic Factors|immunologic factors|mesh-ancestor
92923723|NCT04084977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923724|NCT04107194|Amoxicillin|amoxicillin|mesh-list
92923725|NCT04107194|Metronidazole|metronidazole|mesh-list
92923726|NCT04107194|Clarithromycin|clarithromycin|mesh-list
92923727|NCT04107194|Levofloxacin|levofloxacin|mesh-list
92923728|NCT04107194|Tetracycline|tetracycline|mesh-list
92923729|NCT04107194|Rifabutin|rifabutin|mesh-list
92923730|NCT04107194|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92923731|NCT04107194|Pantoprazole|pantoprazole|mesh-list
92923732|NCT04107194|Bismuth|bismuth|mesh-list
92923733|NCT04107194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92923734|NCT04107194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923735|NCT04107194|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92923736|NCT04107194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92923737|NCT04107194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92923738|NCT04107194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923739|NCT04107194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923740|NCT04107194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92923741|NCT04107194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92923742|NCT04107194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92923743|NCT04107194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92923744|NCT04107194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92923745|NCT04107194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923746|NCT04107194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92923747|NCT04107194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92923748|NCT04107194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92923749|NCT04107194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92923750|NCT04107194|Antacids|antacids|mesh-ancestor
92923751|NCT04107194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92923752|NCT04107194|Antitubercular Agents|antitubercular agents|mesh-ancestor
92923753|NCT02590263|Temozolomide|temozolomide|mesh-list
92923754|NCT02590263|ABT-414|abt-414|mesh-list
92923755|NCT02590263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92923756|NCT02590263|Alkylating Agents|alkylating agents|mesh-ancestor
92923757|NCT02590263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923758|NCT02590263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923759|NCT02590263|Immunoconjugates|immunoconjugates|mesh-ancestor
92923760|NCT02590263|Immunologic Factors|immunologic factors|mesh-ancestor
92923761|NCT02590263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923762|NCT00736476|Vaccines|vaccines|mesh-list
92923763|NCT00736476|Immunologic Factors|immunologic factors|mesh-ancestor
92923764|NCT00736476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923765|NCT02606357|Insulin Glargine|insulin glargine|mesh-list
92526301|NCT00000482|Antimetabolites|antimetabolites|mesh-ancestor
92923766|NCT02606357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92923767|NCT02606357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923768|NCT04019496|Calcitonin|calcitonin|mesh-list
92923769|NCT04019496|Salmon calcitonin|salmon calcitonin|mesh-list
92923770|NCT04019496|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92923771|NCT04019496|Antibodies|antibodies|mesh-list
92923772|NCT04019496|Katacalcin|katacalcin|mesh-list
92923773|NCT04019496|Immunologic Factors|immunologic factors|mesh-ancestor
92569233|NCT00048204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92923774|NCT04019496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923775|NCT04019496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92923776|NCT04019496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92923777|NCT04019496|Vasodilator Agents|vasodilator agents|mesh-ancestor
92923778|NCT05717153|Eflornithine|eflornithine|mesh-list
92923779|NCT05717153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923780|NCT05717153|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92923781|NCT05717153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92923782|NCT05717153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92923783|NCT05717153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923784|NCT05717153|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92923785|NCT05717153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923786|NCT05717153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923787|NCT00918489|Vorinostat|vorinostat|mesh-list
92923788|NCT00918489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923789|NCT00918489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92923790|NCT00918489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923791|NCT00918489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923792|NCT05690087|Lidocaine|lidocaine|mesh-list
92923793|NCT05690087|Anesthetics, Local|anesthetics, local|mesh-ancestor
92923794|NCT05690087|Anesthetics|anesthetics|mesh-ancestor
92923795|NCT05690087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923796|NCT05690087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923797|NCT05690087|Sensory System Agents|sensory system agents|mesh-ancestor
92923798|NCT05690087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923799|NCT05690087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92923800|NCT05690087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92923801|NCT05690087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92923802|NCT05690087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92923803|NCT05690087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923804|NCT02604992|Dronabinol|dronabinol|mesh-list
92923805|NCT02604992|Hallucinogens|hallucinogens|mesh-ancestor
92923806|NCT02604992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923807|NCT02604992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92923808|NCT02604992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923809|NCT02604992|Analgesics|analgesics|mesh-ancestor
92923810|NCT02604992|Sensory System Agents|sensory system agents|mesh-ancestor
92923811|NCT02604992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923812|NCT02604992|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92923813|NCT02604992|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92923814|NCT02604992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923815|NCT02604992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923816|NCT02604992|Hormones|hormones|mesh-ancestor
92923817|NCT02604992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923818|NCT03899597|Oxytocin|oxytocin|mesh-list
92923819|NCT03899597|Oxytocics|oxytocics|mesh-ancestor
92923820|NCT03899597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92923821|NCT03899597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923822|NCT00714285|Vaccines|vaccines|mesh-list
92923823|NCT00714285|Immunologic Factors|immunologic factors|mesh-ancestor
92923824|NCT00714285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923825|NCT02823665|Atropine|atropine|mesh-list
92923826|NCT02823665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92923827|NCT02823665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92923828|NCT02823665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923829|NCT02823665|Autonomic Agents|autonomic agents|mesh-ancestor
92923830|NCT02823665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923831|NCT02823665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923832|NCT02823665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923833|NCT02823665|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923834|NCT02823665|Mydriatics|mydriatics|mesh-ancestor
92923835|NCT02823665|Parasympatholytics|parasympatholytics|mesh-ancestor
92923836|NCT02823665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92923837|NCT02823665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92923838|NCT02823665|Cholinergic Agents|cholinergic agents|mesh-ancestor
92923839|NCT02823665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923840|NCT02823665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923841|NCT00776984|Tiotropium Bromide|tiotropium bromide|mesh-list
92923842|NCT00776984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923843|NCT00776984|Autonomic Agents|autonomic agents|mesh-ancestor
92923844|NCT00776984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923845|NCT00776984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923846|NCT00776984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923847|NCT00776984|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923848|NCT00776984|Parasympatholytics|parasympatholytics|mesh-ancestor
92923849|NCT00776984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92923850|NCT00776984|Cholinergic Agents|cholinergic agents|mesh-ancestor
92923851|NCT00776984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923852|NCT00776984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923853|NCT04015557|Acetaminophen|acetaminophen|mesh-list
92923854|NCT04015557|Acetylcysteine|acetylcysteine|mesh-list
92923855|NCT04015557|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92923856|NCT04015557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923857|NCT04015557|Analgesics|analgesics|mesh-ancestor
92923858|NCT04015557|Sensory System Agents|sensory system agents|mesh-ancestor
92923859|NCT04015557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923860|NCT04015557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923861|NCT04015557|Antipyretics|antipyretics|mesh-ancestor
92923862|NCT04015557|Antiviral Agents|antiviral agents|mesh-ancestor
92923863|NCT04015557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923864|NCT04015557|Expectorants|expectorants|mesh-ancestor
92923865|NCT04015557|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923866|NCT04015557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92923867|NCT04015557|Antioxidants|antioxidants|mesh-ancestor
92923868|NCT04015557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923869|NCT04015557|Protective Agents|protective agents|mesh-ancestor
92923870|NCT04015557|Antidotes|antidotes|mesh-ancestor
92923871|NCT00784784|Zanamivir|zanamivir|mesh-list
92923872|NCT00784784|Antiviral Agents|antiviral agents|mesh-ancestor
92923873|NCT00784784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923874|NCT00784784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923875|NCT00784784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923876|NCT00587288|Reslizumab|reslizumab|mesh-list
92923877|NCT00587288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923878|NCT00587288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923879|NCT00800735|Interferons|interferons|mesh-list
92923880|NCT00800735|Ribavirin|ribavirin|mesh-list
92923881|NCT00800735|Interferon-alpha|interferon-alpha|mesh-list
92923882|NCT00800735|Interferon alpha-2|interferon alpha-2|mesh-list
92923883|NCT00800735|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92923884|NCT00800735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923885|NCT00800735|Antiviral Agents|antiviral agents|mesh-ancestor
92923886|NCT00800735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92923887|NCT00800735|Antimetabolites|antimetabolites|mesh-ancestor
92923888|NCT00800735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923889|NCT00800735|Immunologic Factors|immunologic factors|mesh-ancestor
92923890|NCT00800735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923891|NCT05324163|Celecoxib|celecoxib|mesh-list
92923892|NCT05324163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92923893|NCT05324163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923894|NCT05324163|Analgesics|analgesics|mesh-ancestor
92923895|NCT05324163|Sensory System Agents|sensory system agents|mesh-ancestor
92923896|NCT05324163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923897|NCT05324163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923898|NCT05324163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92923899|NCT05324163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92923900|NCT05324163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92923901|NCT05324163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92923902|NCT05324163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923903|NCT05324163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923904|NCT00730158|Irinotecan|irinotecan|mesh-list
92923905|NCT00730158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92923906|NCT00730158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92923907|NCT00730158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92923908|NCT00730158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923909|NCT00730158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92923910|NCT04114643|Thrombin|thrombin|mesh-list
92923911|NCT04114643|Hemostatics|hemostatics|mesh-ancestor
92923912|NCT04114643|Coagulants|coagulants|mesh-ancestor
92923913|NCT02989662|Mifepristone|mifepristone|mesh-list
92923914|NCT02989662|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92923915|NCT02989662|Abortifacient Agents|abortifacient agents|mesh-ancestor
92923916|NCT02989662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92923917|NCT02989662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923918|NCT02989662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92923919|NCT02989662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92923920|NCT02989662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92923921|NCT02989662|Contraceptive Agents|contraceptive agents|mesh-ancestor
92923922|NCT02989662|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92923923|NCT02989662|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92923924|NCT02989662|Hormone Antagonists|hormone antagonists|mesh-ancestor
92923925|NCT02989662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92923926|NCT02989662|Luteolytic Agents|luteolytic agents|mesh-ancestor
92923927|NCT02989662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92923928|NCT02989662|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92923930|NCT00784550|Xhance|xhance|mesh-list
92923931|NCT00784550|Bromides|bromides|mesh-list
92923932|NCT00784550|Tiotropium Bromide|tiotropium bromide|mesh-list
92923933|NCT00784550|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92923934|NCT00784550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92923935|NCT00784550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92923936|NCT00784550|Autonomic Agents|autonomic agents|mesh-ancestor
92923937|NCT00784550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923938|NCT00784550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923939|NCT00784550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92923940|NCT00784550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92923941|NCT00784550|Dermatologic Agents|dermatologic agents|mesh-ancestor
92923942|NCT00784550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92923943|NCT00784550|Parasympatholytics|parasympatholytics|mesh-ancestor
92923944|NCT00784550|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92923945|NCT00784550|Cholinergic Agents|cholinergic agents|mesh-ancestor
92923946|NCT00784550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923947|NCT00784550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923948|NCT00784550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92923949|NCT00784550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92923950|NCT00784550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923951|NCT00784550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923952|NCT00784550|Anticonvulsants|anticonvulsants|mesh-ancestor
92923953|NCT00729690|Pregabalin|pregabalin|mesh-list
92923954|NCT00729690|Analgesics|analgesics|mesh-ancestor
92923955|NCT00729690|Sensory System Agents|sensory system agents|mesh-ancestor
92923956|NCT00729690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923957|NCT00729690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923958|NCT00729690|Anticonvulsants|anticonvulsants|mesh-ancestor
92923959|NCT00729690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92923960|NCT00729690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92923961|NCT00729690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923962|NCT00729690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92923963|NCT00729690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92923964|NCT00729690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92923965|NCT00729690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923966|NCT00729690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92923967|NCT04027829|Dexmedetomidine|dexmedetomidine|mesh-list
92923968|NCT04027829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92923969|NCT04027829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923970|NCT04027829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923971|NCT04027829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92923972|NCT04027829|Analgesics|analgesics|mesh-ancestor
92923973|NCT04027829|Sensory System Agents|sensory system agents|mesh-ancestor
92923974|NCT04027829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92923975|NCT04027829|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92923976|NCT04027829|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92923977|NCT04027829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92923978|NCT04027829|Adrenergic Agents|adrenergic agents|mesh-ancestor
92923979|NCT04027829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923980|NCT04027829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923981|NCT00784238|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92923982|NCT00784238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92923983|NCT00784238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92923984|NCT00784238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92923985|NCT00784238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92923986|NCT00784238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92923987|NCT00784238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92923988|NCT00784238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92923989|NCT00784238|Serotonin Agents|serotonin agents|mesh-ancestor
92923990|NCT00784238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92923991|NCT00784238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92923992|NCT00784238|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92923993|NCT00784238|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92923994|NCT00784238|Dopamine Agents|dopamine agents|mesh-ancestor
92923995|NCT00729612|Paclitaxel|paclitaxel|mesh-list
92923996|NCT00729612|Carboplatin|carboplatin|mesh-list
92923997|NCT00729612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92923998|NCT00729612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92923999|NCT00729612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924000|NCT00729612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92924001|NCT00729612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92924002|NCT00729612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92924003|NCT00729612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924005|NCT05684913|Coagulants|coagulants|mesh-ancestor
92924006|NCT00585546|Clenbuterol|clenbuterol|mesh-list
92924007|NCT00585546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92924008|NCT00585546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92924009|NCT00585546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92924010|NCT00585546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924011|NCT00585546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924012|NCT00585546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924013|NCT00585546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924014|NCT00585546|Autonomic Agents|autonomic agents|mesh-ancestor
92924015|NCT00585546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924016|NCT00585546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924017|NCT00585546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924018|NCT00585546|Sympathomimetics|sympathomimetics|mesh-ancestor
92924019|NCT00768248|Ropivacaine|ropivacaine|mesh-list
92924020|NCT00768248|Anesthetics, Local|anesthetics, local|mesh-ancestor
92924021|NCT00768248|Anesthetics|anesthetics|mesh-ancestor
92924022|NCT00768248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924023|NCT00768248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924024|NCT00768248|Sensory System Agents|sensory system agents|mesh-ancestor
92924025|NCT00768248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924026|NCT02589717|Atezolizumab|atezolizumab|mesh-list
92924027|NCT02589717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92924028|NCT02589717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924029|NCT02589717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924030|NCT02589717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924031|NCT02602028|Colchicine|colchicine|mesh-list
92924032|NCT02602028|Gout Suppressants|gout suppressants|mesh-ancestor
92924033|NCT02602028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92924034|NCT02602028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92924035|NCT02602028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92924036|NCT02602028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92924037|NCT02602028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924038|NCT02602028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924039|NCT04103684|Dexamethasone|dexamethasone|mesh-list
92924040|NCT04103684|Methylprednisolone|methylprednisolone|mesh-list
92924041|NCT04103684|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92924042|NCT04103684|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92924043|NCT04103684|Prednisolone|prednisolone|mesh-list
92924044|NCT04103684|Prednisolone acetate|prednisolone acetate|mesh-list
92924045|NCT04103684|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92924046|NCT04103684|Prednisolone phosphate|prednisolone phosphate|mesh-list
92924047|NCT04103684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924048|NCT04103684|Antiemetics|antiemetics|mesh-ancestor
92924049|NCT04103684|Autonomic Agents|autonomic agents|mesh-ancestor
92924050|NCT04103684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924051|NCT04103684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924052|NCT04103684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92924053|NCT04103684|Glucocorticoids|glucocorticoids|mesh-ancestor
92924054|NCT04103684|Hormones|hormones|mesh-ancestor
92924055|NCT04103684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924056|NCT04103684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92924057|NCT04103684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924058|NCT04103684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92268939|NCT03996057|Estrogens|estrogens|mesh-list
92924059|NCT04103684|Protective Agents|protective agents|mesh-ancestor
92924060|NCT00775268|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92924061|NCT00775268|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92924062|NCT00775268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924063|NCT00775190|Moxifloxacin|moxifloxacin|mesh-list
92924064|NCT00775190|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92924065|NCT00775190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92924066|NCT00775190|Contraceptive Agents|contraceptive agents|mesh-ancestor
92924067|NCT00775190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92924068|NCT00775190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924069|NCT00775190|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92924070|NCT00775190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92924071|NCT00775190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92924072|NCT00775190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92924073|NCT00775190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924074|NCT00775190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92924075|NCT00775190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92924077|NCT00775190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924078|NCT00775190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924079|NCT00479557|Saponin QA-21V1|saponin qa-21v1|mesh-list
92924080|NCT00479557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92924081|NCT00479557|Immunologic Factors|immunologic factors|mesh-ancestor
92924082|NCT00479557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924083|NCT00774800|Insulin|insulin|mesh-list
92924084|NCT00774800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92924085|NCT00774800|Insulin Lispro|insulin lispro|mesh-list
92924086|NCT00774800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92924087|NCT00774800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924088|NCT00439309|Thrombin|thrombin|mesh-list
92924089|NCT00439309|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92924090|NCT00439309|Hemostatics|hemostatics|mesh-ancestor
92924091|NCT00439309|Coagulants|coagulants|mesh-ancestor
92924092|NCT00479167|Bortezomib|bortezomib|mesh-list
92924093|NCT00479167|Tositumomab I-131|tositumomab i-131|mesh-list
92924094|NCT00479167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924095|NCT00725322|Botulinum Toxins|botulinum toxins|mesh-list
92924096|NCT00725322|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92924097|NCT00725322|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92924098|NCT00725322|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92924099|NCT00725322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924100|NCT00725322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924101|NCT00725322|Cholinergic Agents|cholinergic agents|mesh-ancestor
92924102|NCT00725322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924103|NCT00725322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924104|NCT00725322|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92924105|NCT00725322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924106|NCT00725010|Temozolomide|temozolomide|mesh-list
92924107|NCT00725010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92924108|NCT00725010|Alkylating Agents|alkylating agents|mesh-ancestor
92924109|NCT00725010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924110|NCT00725010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924111|NCT05216055|Dexamethasone|dexamethasone|mesh-list
92924112|NCT05216055|Dexamethasone acetate|dexamethasone acetate|mesh-list
92924113|NCT05216055|Dexmedetomidine|dexmedetomidine|mesh-list
92924114|NCT05216055|Bupivacaine|bupivacaine|mesh-list
92924115|NCT05216055|Ropivacaine|ropivacaine|mesh-list
92924116|NCT05216055|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92924117|NCT05216055|BB 1101|bb 1101|mesh-list
92924118|NCT05216055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924119|NCT05216055|Antiemetics|antiemetics|mesh-ancestor
92924120|NCT05216055|Autonomic Agents|autonomic agents|mesh-ancestor
92924121|NCT05216055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924122|NCT05216055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924123|NCT05216055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92924124|NCT05216055|Glucocorticoids|glucocorticoids|mesh-ancestor
92924125|NCT05216055|Hormones|hormones|mesh-ancestor
93026475|NCT00402051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924126|NCT05216055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924127|NCT05216055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92924128|NCT05216055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924129|NCT05216055|Anesthetics, Local|anesthetics, local|mesh-ancestor
92924130|NCT05216055|Anesthetics|anesthetics|mesh-ancestor
92924131|NCT05216055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924132|NCT05216055|Sensory System Agents|sensory system agents|mesh-ancestor
92924133|NCT05216055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92924134|NCT05216055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92924135|NCT05216055|Analgesics|analgesics|mesh-ancestor
92924136|NCT05216055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92924137|NCT05216055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92924138|NCT05216055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92924139|NCT05216055|Adrenergic Agents|adrenergic agents|mesh-ancestor
92924140|NCT05216055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924141|NCT05216055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924142|NCT05216055|Protease Inhibitors|protease inhibitors|mesh-ancestor
92924143|NCT05216055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924145|NCT00767000|Insulin Glargine|insulin glargine|mesh-list
92924146|NCT00767000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92924147|NCT00767000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924148|NCT05194449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92924149|NCT05194449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924150|NCT05194449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924152|NCT00724932|Bromides|bromides|mesh-list
92924153|NCT00724932|Rocuronium|rocuronium|mesh-list
92924154|NCT00724932|Neostigmine|neostigmine|mesh-list
92924155|NCT00724932|Anticonvulsants|anticonvulsants|mesh-ancestor
92924156|NCT00724932|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92924157|NCT00724932|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92924158|NCT00724932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92924159|NCT00724932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924160|NCT00724932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924161|NCT00724932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92924162|NCT00724932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92924163|NCT00724932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924164|NCT00724932|Autonomic Agents|autonomic agents|mesh-ancestor
92924165|NCT00724932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924166|NCT00724932|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924167|NCT00724932|Mydriatics|mydriatics|mesh-ancestor
92924168|NCT00724932|Parasympatholytics|parasympatholytics|mesh-ancestor
92924169|NCT00724932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92924170|NCT00724932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92924171|NCT00724932|Cholinergic Agents|cholinergic agents|mesh-ancestor
92924172|NCT00724932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924173|NCT00724932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924174|NCT00724932|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92924175|NCT00724932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924176|NCT00724932|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92924177|NCT00766532|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92924178|NCT00766532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92924179|NCT00766532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924180|NCT00766532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924181|NCT00766532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92924182|NCT00766532|Hormone Antagonists|hormone antagonists|mesh-ancestor
92924183|NCT00766532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924184|NCT00766532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924185|NCT04083807|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92924186|NCT04083807|Thrombin|thrombin|mesh-list
92924187|NCT04083807|Hemostatics|hemostatics|mesh-ancestor
92924188|NCT04083807|Coagulants|coagulants|mesh-ancestor
92924189|NCT05163483|Bevacizumab|bevacizumab|mesh-list
92924190|NCT05163483|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92924191|NCT05163483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924192|NCT05163483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924193|NCT05163483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92924194|NCT05163483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92924195|NCT05163483|Growth Substances|growth substances|mesh-ancestor
92924196|NCT05163483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924197|NCT05163483|Growth Inhibitors|growth inhibitors|mesh-ancestor
92924198|NCT05163483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924199|NCT00766142|Leucovorin|leucovorin|mesh-list
92924200|NCT00766142|Fluorouracil|fluorouracil|mesh-list
92924201|NCT00766142|Oxaliplatin|oxaliplatin|mesh-list
92924202|NCT00766142|Cetuximab|cetuximab|mesh-list
92924203|NCT00766142|Calcium|calcium|mesh-list
92924204|NCT00766142|Levoleucovorin|levoleucovorin|mesh-list
92924205|NCT00766142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92924206|NCT00766142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924207|NCT00766142|Antimetabolites|antimetabolites|mesh-ancestor
92924208|NCT00766142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924209|NCT00766142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92924210|NCT00766142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924211|NCT00766142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92924212|NCT00766142|Immunologic Factors|immunologic factors|mesh-ancestor
92924213|NCT00766142|Antidotes|antidotes|mesh-ancestor
92924214|NCT00766142|Protective Agents|protective agents|mesh-ancestor
92924215|NCT00766142|Vitamin B Complex|vitamin b complex|mesh-ancestor
92924216|NCT00766142|Vitamins|vitamins|mesh-ancestor
92924217|NCT00766142|Micronutrients|micronutrients|mesh-ancestor
92924218|NCT00766142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924219|NCT00916526|Mannitol|mannitol|mesh-list
92924220|NCT00916526|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92924221|NCT00916526|Diuretics|diuretics|mesh-ancestor
92924222|NCT00916526|Natriuretic Agents|natriuretic agents|mesh-ancestor
92924223|NCT00916526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924224|NCT00724854|Ribavirin|ribavirin|mesh-list
92924225|NCT00724854|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92924226|NCT00724854|Interferon-alpha|interferon-alpha|mesh-list
92924227|NCT00724854|Antimetabolites|antimetabolites|mesh-ancestor
92924228|NCT00724854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924229|NCT00724854|Antiviral Agents|antiviral agents|mesh-ancestor
92924230|NCT00724854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924231|NCT00724854|Immunologic Factors|immunologic factors|mesh-ancestor
92924232|NCT00724854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924233|NCT04083651|Bromides|bromides|mesh-list
92924234|NCT04083651|Methylnaltrexone|methylnaltrexone|mesh-list
92924235|NCT04083651|Anticonvulsants|anticonvulsants|mesh-ancestor
92924236|NCT04083651|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92924237|NCT04083651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924238|NCT04083651|Sensory System Agents|sensory system agents|mesh-ancestor
92924239|NCT04083651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924240|NCT00728988|Atorvastatin|atorvastatin|mesh-list
92924241|NCT00728988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92924242|NCT00728988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92924243|NCT00728988|Antimetabolites|antimetabolites|mesh-ancestor
92924244|NCT00728988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924245|NCT00728988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92924246|NCT00728988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92924247|NCT00728988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924248|NCT04087746|Ranibizumab|ranibizumab|mesh-list
92924249|NCT04087746|Aflibercept|aflibercept|mesh-list
92924250|NCT04087746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92924251|NCT04087746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92924252|NCT04087746|Growth Substances|growth substances|mesh-ancestor
92924253|NCT04087746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924254|NCT04087746|Growth Inhibitors|growth inhibitors|mesh-ancestor
92924255|NCT04087746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924256|NCT04083417|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92924257|NCT04083417|Penicillins|penicillins|mesh-list
92924258|NCT04083417|Penicillin V|penicillin v|mesh-list
92924259|NCT04083417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924260|NCT02588937|Entecavir|entecavir|mesh-list
92924261|NCT02588937|Antiviral Agents|antiviral agents|mesh-ancestor
92924262|NCT02588937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924263|NCT04083105|Midazolam|midazolam|mesh-list
92924264|NCT04083105|Nitrous Oxide|nitrous oxide|mesh-list
92924265|NCT04083105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92924266|NCT04083105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92924267|NCT04083105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924268|NCT04083105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924269|NCT04083105|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92924270|NCT04083105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92924271|NCT04083105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92924272|NCT04083105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92924273|NCT04083105|Anesthetics, General|anesthetics, general|mesh-ancestor
92924274|NCT04083105|Anesthetics|anesthetics|mesh-ancestor
92924275|NCT04083105|GABA Modulators|gaba modulators|mesh-ancestor
92924276|NCT04083105|GABA Agents|gaba agents|mesh-ancestor
92924277|NCT04083105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924278|NCT04083105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924279|NCT04083105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92924280|NCT04083105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92924281|NCT04083105|Analgesics|analgesics|mesh-ancestor
92924282|NCT04083105|Sensory System Agents|sensory system agents|mesh-ancestor
92924283|NCT04083105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924284|NCT00735696|Paclitaxel|paclitaxel|mesh-list
92924285|NCT00735696|Carboplatin|carboplatin|mesh-list
92924286|NCT00735696|Ramucirumab|ramucirumab|mesh-list
92924287|NCT00735696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92924288|NCT00735696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924289|NCT00735696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92924290|NCT00735696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92924291|NCT00735696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92924292|NCT00735696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924293|NCT02593968|Interferons|interferons|mesh-list
92924294|NCT02593968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924295|NCT02593968|Antiviral Agents|antiviral agents|mesh-ancestor
92924296|NCT02593968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924297|NCT02588547|Granisetron|granisetron|mesh-list
92924298|NCT02588547|Antiemetics|antiemetics|mesh-ancestor
92924299|NCT02588547|Autonomic Agents|autonomic agents|mesh-ancestor
92569752|NCT00410254|Anesthetics|anesthetics|mesh-ancestor
92924300|NCT02588547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924301|NCT02588547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924302|NCT02588547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92924303|NCT02588547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92924304|NCT02588547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92924305|NCT02588547|Serotonin Agents|serotonin agents|mesh-ancestor
92924306|NCT02588547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924307|NCT02588547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924308|NCT00478231|Maraviroc|maraviroc|mesh-list
92924309|NCT00478231|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92924310|NCT00478231|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92924311|NCT00478231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924312|NCT00478231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92924313|NCT00478231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92924314|NCT00478231|Antiviral Agents|antiviral agents|mesh-ancestor
92924315|NCT00478231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924316|NCT00478231|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92924317|NCT00474175|Benzocaine|benzocaine|mesh-list
92924318|NCT00474175|Anesthetics, Local|anesthetics, local|mesh-ancestor
92924319|NCT00474175|Anesthetics|anesthetics|mesh-ancestor
92924320|NCT00474175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924321|NCT00474175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924322|NCT00474175|Sensory System Agents|sensory system agents|mesh-ancestor
92924323|NCT00474175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924324|NCT03002389|Fluticasone|fluticasone|mesh-list
92924326|NCT03002389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924327|NCT03002389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924328|NCT03002389|Autonomic Agents|autonomic agents|mesh-ancestor
92924329|NCT03002389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924330|NCT03002389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924331|NCT03002389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924332|NCT03002389|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924333|NCT03002389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92924334|NCT03002389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92924335|NCT04082949|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92924336|NCT04082949|Hemostatics|hemostatics|mesh-ancestor
92924337|NCT04082949|Coagulants|coagulants|mesh-ancestor
92924338|NCT01020643|Propofol|propofol|mesh-list
92924339|NCT01020643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92924340|NCT01020643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924341|NCT01020643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924342|NCT01020643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92924343|NCT01020643|Anesthetics, General|anesthetics, general|mesh-ancestor
92924344|NCT01020643|Anesthetics|anesthetics|mesh-ancestor
92924345|NCT03537391|Fluorides|fluorides|mesh-list
92924346|NCT03537391|Cariostatic Agents|cariostatic agents|mesh-ancestor
92924347|NCT03537391|Protective Agents|protective agents|mesh-ancestor
92924348|NCT03537391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924349|NCT04082715|Celecoxib|celecoxib|mesh-list
92924350|NCT04082715|Levodopa|levodopa|mesh-list
92924351|NCT04082715|Carbidopa|carbidopa|mesh-list
92924352|NCT04082715|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92924353|NCT04082715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92924354|NCT04082715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92924355|NCT04082715|Analgesics|analgesics|mesh-ancestor
92924356|NCT04082715|Sensory System Agents|sensory system agents|mesh-ancestor
92924357|NCT04082715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924358|NCT04082715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924359|NCT04082715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924360|NCT04082715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92924361|NCT04082715|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92924362|NCT04082715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92924363|NCT04082715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924364|NCT04082715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924365|NCT04082715|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92924366|NCT04082715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92924367|NCT04082715|Dopamine Agents|dopamine agents|mesh-ancestor
92924368|NCT04082715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924369|NCT04082715|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92924370|NCT04082715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92924371|NCT04082715|Immunologic Factors|immunologic factors|mesh-ancestor
92924372|NCT04082715|Dopamine Agonists|dopamine agonists|mesh-ancestor
92924373|NCT00443209|Rizatriptan|rizatriptan|mesh-list
92924374|NCT00443209|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92924375|NCT00443209|Serotonin Agents|serotonin agents|mesh-ancestor
92924376|NCT00443209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924377|NCT00443209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924378|NCT00443209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924379|NCT02588235|Atorvastatin|atorvastatin|mesh-list
92924380|NCT02588235|Ezetimibe|ezetimibe|mesh-list
92924381|NCT02588235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92924382|NCT02588235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92924383|NCT02588235|Antimetabolites|antimetabolites|mesh-ancestor
92924384|NCT02588235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924385|NCT02588235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92924386|NCT02588235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92924387|NCT02588235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924388|NCT01020955|Mecasermin|mecasermin|mesh-list
92924389|NCT01020955|Growth Substances|growth substances|mesh-ancestor
92924390|NCT01020955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924391|NCT04082793|Diclofenac|diclofenac|mesh-list
92924392|NCT04082793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92924393|NCT04082793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92924394|NCT04082793|Analgesics|analgesics|mesh-ancestor
92924395|NCT04082793|Sensory System Agents|sensory system agents|mesh-ancestor
92924396|NCT04082793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924397|NCT04082793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924398|NCT04082793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924399|NCT04082793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92924400|NCT04082793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92924401|NCT04082793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924402|NCT04082793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924403|NCT00439231|Lenalidomide|lenalidomide|mesh-list
92924404|NCT00439231|Immunologic Factors|immunologic factors|mesh-ancestor
92924405|NCT00439231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924406|NCT00439231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92924407|NCT00439231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92924408|NCT00439231|Growth Substances|growth substances|mesh-ancestor
92924409|NCT00439231|Growth Inhibitors|growth inhibitors|mesh-ancestor
92924410|NCT00439231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924411|NCT00783692|Vedolizumab|vedolizumab|mesh-list
92924412|NCT00783692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92924413|NCT04992273|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92924414|NCT04992273|Antiviral Agents|antiviral agents|mesh-ancestor
92924415|NCT04992273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924416|NCT00783224|Fluticasone|fluticasone|mesh-list
92924417|NCT00783224|Mometasone Furoate|mometasone furoate|mesh-list
92924418|NCT00783224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924419|NCT00783224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924420|NCT00783224|Autonomic Agents|autonomic agents|mesh-ancestor
92924421|NCT00783224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924422|NCT00783224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924423|NCT00783224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924424|NCT00783224|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924425|NCT00783224|Dermatologic Agents|dermatologic agents|mesh-ancestor
92924426|NCT00783224|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92924427|NCT04102124|Fluzoparib|fluzoparib|mesh-list
92924428|NCT04102124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92924429|NCT04102124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924430|NCT04102124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924431|NCT04102124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924432|NCT04082559|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92924433|NCT04082559|Metronidazole|metronidazole|mesh-list
92924434|NCT04082559|Doxycycline|doxycycline|mesh-list
92924436|NCT04082559|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92924437|NCT04082559|Complement Factor H|complement factor h|mesh-list
92924438|NCT04082559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924439|NCT04082559|Antitubercular Agents|antitubercular agents|mesh-ancestor
92924440|NCT04082559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92924441|NCT04082559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92924442|NCT04082559|Antimalarials|antimalarials|mesh-ancestor
92924443|NCT04082559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92924444|NCT04082559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92924445|NCT04082559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924446|NCT04082559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924447|NCT04082559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924448|NCT04082559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92924449|NCT04082559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92924450|NCT04082559|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92924451|NCT04082559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92924452|NCT04082559|Immunologic Factors|immunologic factors|mesh-ancestor
92924453|NCT04082559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924455|NCT02587845|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92924456|NCT02587845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92924457|NCT02587845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924458|NCT02587845|Hemostatics|hemostatics|mesh-ancestor
92924459|NCT02587845|Coagulants|coagulants|mesh-ancestor
92924460|NCT00765674|Amlodipine|amlodipine|mesh-list
92924461|NCT00765674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92924462|NCT00765674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92924463|NCT00765674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92924464|NCT00765674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924465|NCT00765674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924466|NCT00765674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92924467|NCT00765674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924468|NCT00765674|Vasodilator Agents|vasodilator agents|mesh-ancestor
92924469|NCT00765674|Diuretics|diuretics|mesh-ancestor
92924470|NCT00765674|Natriuretic Agents|natriuretic agents|mesh-ancestor
92924471|NCT00765674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92924472|NCT00586898|Ketoconazole|ketoconazole|mesh-list
92924473|NCT00586898|Bicalutamide|bicalutamide|mesh-list
92924474|NCT00586898|Testosterone|testosterone|mesh-list
92924475|NCT00586898|Estrogens|estrogens|mesh-list
92924476|NCT00586898|Androgens|androgens|mesh-ancestor
92924477|NCT00586898|Hormones|hormones|mesh-ancestor
92924478|NCT00586898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924479|NCT00586898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924480|NCT00586898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924481|NCT00586898|Antifungal Agents|antifungal agents|mesh-ancestor
92924482|NCT00586898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924483|NCT00586898|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92924484|NCT00586898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92924485|NCT00586898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924486|NCT00586898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924487|NCT00586898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92924488|NCT00586898|Hormone Antagonists|hormone antagonists|mesh-ancestor
92924489|NCT00586898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92924490|NCT00586898|Androgen Antagonists|androgen antagonists|mesh-ancestor
92924491|NCT02587455|Pembrolizumab|pembrolizumab|mesh-list
92924492|NCT02587455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924493|NCT02587455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924494|NCT02587455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92924495|NCT02587455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924496|NCT04099238|Warfarin|warfarin|mesh-list
92924497|NCT04099238|Rivaroxaban|rivaroxaban|mesh-list
92924498|NCT04099238|Dabigatran|dabigatran|mesh-list
92924499|NCT04099238|Apixaban|apixaban|mesh-list
92924500|NCT04099238|Anticoagulants|anticoagulants|mesh-list
92924501|NCT04099238|Edoxaban|edoxaban|mesh-list
92924502|NCT04099238|Acenocoumarol|acenocoumarol|mesh-list
92924503|NCT04099238|Phenindione|phenindione|mesh-list
92924504|NCT04099238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92924505|NCT04099238|Antithrombins|antithrombins|mesh-ancestor
92924506|NCT04099238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92924507|NCT04099238|Protease Inhibitors|protease inhibitors|mesh-ancestor
92924508|NCT04099238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924509|NCT04099238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924510|NCT04932135|Hormones|hormones|mesh-list
92924511|NCT04932135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924512|NCT04932135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924514|NCT04101812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92924515|NCT04101812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92924516|NCT04101812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924517|NCT04101812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92924518|NCT04101812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92924519|NCT04101812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924520|NCT04101812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924521|NCT04923867|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92924522|NCT04923867|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92924523|NCT04923867|Estradiol|estradiol|mesh-list
92924524|NCT04923867|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92924525|NCT04923867|Estrogens|estrogens|mesh-ancestor
92924526|NCT04923867|Hormones|hormones|mesh-ancestor
92924527|NCT04923867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924528|NCT04923867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924529|NCT04923867|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92924530|NCT04923867|Contraceptive Agents|contraceptive agents|mesh-ancestor
92924531|NCT04923867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92924532|NCT04923867|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92924534|NCT02587533|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92924535|NCT02587533|Sympathomimetics|sympathomimetics|mesh-ancestor
92924536|NCT02587533|Autonomic Agents|autonomic agents|mesh-ancestor
92924537|NCT02587533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924538|NCT02587533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924539|NCT02587533|Dopamine Agents|dopamine agents|mesh-ancestor
92924540|NCT02587533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924541|NCT02587533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924542|NCT02587533|Protective Agents|protective agents|mesh-ancestor
92924543|NCT04847661|Mefloquine|mefloquine|mesh-list
92924544|NCT04847661|Antimalarials|antimalarials|mesh-ancestor
92924545|NCT04847661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92924546|NCT04847661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92924547|NCT04847661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924548|NCT00919815|Cyclosporine|cyclosporine|mesh-list
92924549|NCT00919815|Prednisolone|prednisolone|mesh-list
92924550|NCT00919815|Cyclosporins|cyclosporins|mesh-list
92924551|NCT00919815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924552|NCT00919815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924553|NCT00919815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92924554|NCT00919815|Immunologic Factors|immunologic factors|mesh-ancestor
92924555|NCT00919815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924556|NCT00919815|Antifungal Agents|antifungal agents|mesh-ancestor
92924557|NCT00919815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924558|NCT00919815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92924559|NCT00919815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92924560|NCT00919815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92924561|NCT00919815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924562|NCT00919815|Glucocorticoids|glucocorticoids|mesh-ancestor
92924563|NCT00919815|Hormones|hormones|mesh-ancestor
92924564|NCT00919815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924565|NCT00919815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92924566|NCT00919815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924567|NCT00796991|Paclitaxel|paclitaxel|mesh-list
92924568|NCT00796991|Carboplatin|carboplatin|mesh-list
92924569|NCT00796991|Ipilimumab|ipilimumab|mesh-list
92924570|NCT00796991|Dacarbazine|dacarbazine|mesh-list
92924571|NCT00796991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92924572|NCT00796991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924573|NCT00796991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92924574|NCT00796991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92924575|NCT00796991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92924576|NCT00796991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924577|NCT00796991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924578|NCT00796991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92924579|NCT00796991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92924580|NCT00796991|Alkylating Agents|alkylating agents|mesh-ancestor
92924581|NCT04112147|Ubiquinone|ubiquinone|mesh-list
92924582|NCT04112147|Micronutrients|micronutrients|mesh-ancestor
92924583|NCT04112147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924584|NCT00914771|Vaccines|vaccines|mesh-list
92924586|NCT00914771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924587|NCT02586987|Durvalumab|durvalumab|mesh-list
92924588|NCT02586987|Tremelimumab|tremelimumab|mesh-list
92924589|NCT02586987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924590|NCT02586987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924591|NCT02586753|Paclitaxel|paclitaxel|mesh-list
92924592|NCT02586753|Cisplatin|cisplatin|mesh-list
92924593|NCT02586753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92924594|NCT02586753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924595|NCT02586753|Tubulin Modulators|tubulin modulators|mesh-ancestor
92924596|NCT02586753|Antimitotic Agents|antimitotic agents|mesh-ancestor
92924597|NCT02586753|Mitosis Modulators|mitosis modulators|mesh-ancestor
92924598|NCT02586753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924599|NCT00799487|Methylphenidate|methylphenidate|mesh-list
92924600|NCT00799487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92924601|NCT00799487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924602|NCT00799487|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92924603|NCT00799487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92924604|NCT00799487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924605|NCT00799487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924606|NCT00799487|Dopamine Agents|dopamine agents|mesh-ancestor
92924607|NCT00799487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924608|NCT00799409|Methylphenidate|methylphenidate|mesh-list
92924609|NCT00799409|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92924610|NCT00799409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924611|NCT00799409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92924612|NCT00799409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92924613|NCT00799409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924614|NCT00799409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924615|NCT00799409|Dopamine Agents|dopamine agents|mesh-ancestor
92924616|NCT00799409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924617|NCT00782210|Olodaterol|olodaterol|mesh-list
92924618|NCT00782210|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924619|NCT00782210|Autonomic Agents|autonomic agents|mesh-ancestor
92924620|NCT00782210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924621|NCT00782210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924622|NCT00782210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924623|NCT00782210|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924624|NCT01558115|Denosumab|denosumab|mesh-list
92924625|NCT01558115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92924626|NCT01558115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924627|NCT02605265|Capecitabine|capecitabine|mesh-list
92924628|NCT02605265|Oxaliplatin|oxaliplatin|mesh-list
92924629|NCT02605265|Irinotecan|irinotecan|mesh-list
92924630|NCT02605265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92924631|NCT02605265|Antimetabolites|antimetabolites|mesh-ancestor
92924632|NCT02605265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924633|NCT02605265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924634|NCT02605265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92924635|NCT02605265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92924636|NCT02605265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924637|NCT04101500|Aminophylline|aminophylline|mesh-list
92924638|NCT04101500|Bromides|bromides|mesh-list
92924639|NCT04101500|Ipratropium|ipratropium|mesh-list
92924640|NCT04101500|Anticonvulsants|anticonvulsants|mesh-ancestor
92924641|NCT04101500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924642|NCT04101500|Autonomic Agents|autonomic agents|mesh-ancestor
92924643|NCT04101500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924644|NCT04101500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924645|NCT04101500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924646|NCT04101500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924647|NCT04101500|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92924648|NCT04101500|Cholinergic Agents|cholinergic agents|mesh-ancestor
92924649|NCT04101500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924650|NCT04101500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924651|NCT04101500|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92924652|NCT04101500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92924653|NCT04101500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924654|NCT04101500|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92924655|NCT04101500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92924656|NCT04101500|Purinergic Agents|purinergic agents|mesh-ancestor
92924657|NCT04101500|Protective Agents|protective agents|mesh-ancestor
92924658|NCT02586441|Bromides|bromides|mesh-list
92924659|NCT02586441|Propofol|propofol|mesh-list
92924660|NCT02586441|Rocuronium|rocuronium|mesh-list
92924661|NCT02586441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92924662|NCT02586441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924663|NCT02586441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924664|NCT02586441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92924665|NCT02586441|Anesthetics, General|anesthetics, general|mesh-ancestor
92924666|NCT02586441|Anesthetics|anesthetics|mesh-ancestor
92924667|NCT02586441|Anticonvulsants|anticonvulsants|mesh-ancestor
92924668|NCT02586441|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92924669|NCT02586441|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92924670|NCT02586441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92924671|NCT02586441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924672|NCT02586363|Entecavir|entecavir|mesh-list
92924673|NCT02586363|Antiviral Agents|antiviral agents|mesh-ancestor
92924674|NCT02586363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924675|NCT02586129|Metformin|metformin|mesh-list
92924676|NCT02586129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92924677|NCT02586129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92924678|NCT02586129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924679|NCT02586129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92924680|NCT02586129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92924681|NCT02586129|Antimetabolites|antimetabolites|mesh-ancestor
92924682|NCT02586129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924683|NCT02586129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92924684|NCT02586129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92924685|NCT02586129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924687|NCT04081077|Linezolid|linezolid|mesh-list
92924688|NCT04081077|Bedaquiline|bedaquiline|mesh-list
92924689|NCT04081077|Clofazimine|clofazimine|mesh-list
92924690|NCT04081077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92924691|NCT04081077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924692|NCT04081077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92924693|NCT04081077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92924694|NCT04081077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924695|NCT04081077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924696|NCT04081077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924697|NCT04081077|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92924698|NCT04081077|Antitubercular Agents|antitubercular agents|mesh-ancestor
92924699|NCT04081077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924700|NCT04081077|Leprostatic Agents|leprostatic agents|mesh-ancestor
92924701|NCT04669665|Ketamine|ketamine|mesh-list
92924702|NCT04669665|Analgesics|analgesics|mesh-ancestor
92924703|NCT04669665|Sensory System Agents|sensory system agents|mesh-ancestor
92924704|NCT04669665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924705|NCT04669665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924706|NCT04669665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92924707|NCT04669665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92924708|NCT04669665|Anesthetics, General|anesthetics, general|mesh-ancestor
92924709|NCT04669665|Anesthetics|anesthetics|mesh-ancestor
92924710|NCT04669665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924711|NCT04669665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92924712|NCT04669665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92924713|NCT04669665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924714|NCT04669665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924715|NCT02586051|Obinutuzumab|obinutuzumab|mesh-list
92924716|NCT02586051|Immunoglobulins|immunoglobulins|mesh-list
92924717|NCT02586051|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92924718|NCT02586051|Antibodies|antibodies|mesh-list
92924719|NCT02586051|gamma-Globulins|gamma-globulins|mesh-list
92924720|NCT02586051|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92924721|NCT02586051|Immunologic Factors|immunologic factors|mesh-ancestor
92924722|NCT02586051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924723|NCT02586051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92924724|NCT02586051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924725|NCT00763958|Buprenorphine|buprenorphine|mesh-list
92924726|NCT00763958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92924727|NCT00763958|Narcotics|narcotics|mesh-ancestor
92924728|NCT00763958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924729|NCT00763958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924730|NCT00763958|Analgesics|analgesics|mesh-ancestor
92924731|NCT00763958|Sensory System Agents|sensory system agents|mesh-ancestor
92924732|NCT00763958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924733|NCT00763958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92924734|NCT04101578|Cyclosporine|cyclosporine|mesh-list
92924735|NCT04101578|Mycophenolic Acid|mycophenolic acid|mesh-list
92924736|NCT04101578|Prednisone|prednisone|mesh-list
92924737|NCT04101578|Methylprednisolone|methylprednisolone|mesh-list
92924738|NCT04101578|Cyclophosphamide|cyclophosphamide|mesh-list
92924739|NCT04101578|Methotrexate|methotrexate|mesh-list
92924740|NCT04101578|Azathioprine|azathioprine|mesh-list
92924741|NCT04101578|Bromides|bromides|mesh-list
92924742|NCT04101578|Tacrolimus|tacrolimus|mesh-list
92924743|NCT04101578|Cyclosporins|cyclosporins|mesh-list
92924744|NCT04101578|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92924745|NCT04101578|Immunoglobulins|immunoglobulins|mesh-list
92924746|NCT04101578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92924747|NCT04101578|gamma-Globulins|gamma-globulins|mesh-list
92924748|NCT04101578|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92924749|NCT04101578|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92924750|NCT04101578|Immunologic Factors|immunologic factors|mesh-ancestor
92924751|NCT04101578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924752|NCT04101578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92924753|NCT04101578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92924754|NCT04101578|Alkylating Agents|alkylating agents|mesh-ancestor
92924755|NCT04101578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924756|NCT04101578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924757|NCT04101578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92924758|NCT04101578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92924759|NCT04101578|Glucocorticoids|glucocorticoids|mesh-ancestor
92924761|NCT04101578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924762|NCT04101578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92924763|NCT04101578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92924764|NCT04101578|Abortifacient Agents|abortifacient agents|mesh-ancestor
92924765|NCT04101578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92924766|NCT04101578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92924767|NCT04101578|Antimetabolites|antimetabolites|mesh-ancestor
92924768|NCT04101578|Dermatologic Agents|dermatologic agents|mesh-ancestor
92924769|NCT04101578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924770|NCT04101578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92924771|NCT04101578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92924772|NCT04101578|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92924773|NCT04101578|Antifungal Agents|antifungal agents|mesh-ancestor
92924774|NCT04101578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924775|NCT04101578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92924776|NCT04101578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92163074|NCT04346407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92924777|NCT04101578|Antitubercular Agents|antitubercular agents|mesh-ancestor
92924778|NCT04101578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92924779|NCT04101578|Antiemetics|antiemetics|mesh-ancestor
92924780|NCT04101578|Autonomic Agents|autonomic agents|mesh-ancestor
92924781|NCT04101578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924782|NCT04101578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92924783|NCT04101578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92924784|NCT04101578|Protective Agents|protective agents|mesh-ancestor
92924785|NCT04101578|Anticonvulsants|anticonvulsants|mesh-ancestor
92924786|NCT04101578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92924787|NCT04101578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92924788|NCT04101578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924789|NCT00763256|Triclosan|triclosan|mesh-list
92924790|NCT00763256|Fluorides|fluorides|mesh-list
92924791|NCT00763256|Cariostatic Agents|cariostatic agents|mesh-ancestor
92924792|NCT00763256|Protective Agents|protective agents|mesh-ancestor
92924793|NCT00763256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924794|NCT00763256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92924795|NCT00763256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924796|NCT00763256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92924797|NCT00763256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92924798|NCT00763256|Antimetabolites|antimetabolites|mesh-ancestor
92924799|NCT00763256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924800|NCT00763256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92924801|NCT02585973|Cisplatin|cisplatin|mesh-list
92924802|NCT02585973|Adavosertib|adavosertib|mesh-list
92924803|NCT02585973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924804|NCT02585973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924805|NCT02585973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924806|NCT00920283|Cobalt|cobalt|mesh-list
92924807|NCT00920283|Trace Elements|trace elements|mesh-ancestor
92924808|NCT00920283|Micronutrients|micronutrients|mesh-ancestor
92924809|NCT00920283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924810|NCT00583947|Albuterol|albuterol|mesh-list
92924811|NCT00583947|Formoterol Fumarate|formoterol fumarate|mesh-list
92924812|NCT00583947|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924813|NCT00583947|Autonomic Agents|autonomic agents|mesh-ancestor
92924814|NCT00583947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924815|NCT00583947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924816|NCT00583947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924817|NCT00583947|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924818|NCT00583947|Tocolytic Agents|tocolytic agents|mesh-ancestor
92924819|NCT00583947|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92924820|NCT00583947|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92924821|NCT00583947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92924822|NCT00583947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92924823|NCT00583947|Adrenergic Agents|adrenergic agents|mesh-ancestor
92924824|NCT00583947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924825|NCT00583947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924826|NCT00772928|Vaccines|vaccines|mesh-list
92924827|NCT00772928|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92924828|NCT00772928|Immunologic Factors|immunologic factors|mesh-ancestor
92924829|NCT00772928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924830|NCT00762164|Simvastatin|simvastatin|mesh-list
92924831|NCT00762164|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92924832|NCT00762164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92924833|NCT00762164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92924834|NCT00762164|Antimetabolites|antimetabolites|mesh-ancestor
92924835|NCT00762164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924836|NCT00762164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92924837|NCT00762164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92924838|NCT00762164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924839|NCT00761774|Brivaracetam|brivaracetam|mesh-list
92924840|NCT00761774|Anticonvulsants|anticonvulsants|mesh-ancestor
92924841|NCT04080375|Dinoprostone|dinoprostone|mesh-list
92924842|NCT04080375|Oxytocics|oxytocics|mesh-ancestor
92924843|NCT04080375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92924844|NCT04080375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924845|NCT00781274|Ribavirin|ribavirin|mesh-list
92924846|NCT00781274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92924847|NCT00781274|Antimetabolites|antimetabolites|mesh-ancestor
92924848|NCT00781274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924849|NCT00781274|Antiviral Agents|antiviral agents|mesh-ancestor
92924850|NCT00781274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924851|NCT05520177|Ranibizumab|ranibizumab|mesh-list
92924852|NCT05520177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92924853|NCT05520177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92924854|NCT05520177|Growth Substances|growth substances|mesh-ancestor
92924855|NCT05520177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924856|NCT05520177|Growth Inhibitors|growth inhibitors|mesh-ancestor
92924857|NCT05520177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924858|NCT00780416|Ribavirin|ribavirin|mesh-list
92924859|NCT00780416|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92924860|NCT00780416|Interferon-alpha|interferon-alpha|mesh-list
92924861|NCT00780416|Antimetabolites|antimetabolites|mesh-ancestor
92924862|NCT00780416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924863|NCT00780416|Antiviral Agents|antiviral agents|mesh-ancestor
92924864|NCT00780416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924865|NCT00780416|Immunologic Factors|immunologic factors|mesh-ancestor
92924866|NCT00780416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924867|NCT02584881|Analgesics, Opioid|analgesics, opioid|mesh-list
92924868|NCT02584881|Narcotics|narcotics|mesh-ancestor
92924869|NCT02584881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924870|NCT02584881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924871|NCT02584881|Analgesics|analgesics|mesh-ancestor
92924872|NCT02584881|Sensory System Agents|sensory system agents|mesh-ancestor
92924873|NCT02584881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924874|NCT00761462|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92924875|NCT00761462|Ciprofloxacin|ciprofloxacin|mesh-list
92924876|NCT00761462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924877|NCT00761462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92924878|NCT00761462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92924879|NCT00761462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92924880|NCT00761462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924881|NCT00761462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924882|NCT00761462|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92924883|NCT00761462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92924884|NCT00761306|Vortioxetine|vortioxetine|mesh-list
92924885|NCT00761306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92924886|NCT00761306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92924887|NCT00761306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92924888|NCT00761306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92924889|NCT00761306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924890|NCT00761306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924891|NCT00761306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92924892|NCT00761306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92924893|NCT00761306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924894|NCT00761306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924895|NCT00761306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924896|NCT00761306|Serotonin Agents|serotonin agents|mesh-ancestor
92924897|NCT00761306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92924898|NCT00761306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92924899|NCT00761306|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92924900|NCT00761306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92924901|NCT00772538|Tiotropium Bromide|tiotropium bromide|mesh-list
92924902|NCT00772538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92924903|NCT00772538|Autonomic Agents|autonomic agents|mesh-ancestor
92924904|NCT00772538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924905|NCT00772538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924906|NCT00772538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92924907|NCT00772538|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924908|NCT00772538|Parasympatholytics|parasympatholytics|mesh-ancestor
92924909|NCT00772538|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92924910|NCT00772538|Cholinergic Agents|cholinergic agents|mesh-ancestor
92924911|NCT00772538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92924912|NCT00772538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924913|NCT04079517|Tamoxifen|tamoxifen|mesh-list
92924914|NCT04079517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92924915|NCT04079517|Hormone Antagonists|hormone antagonists|mesh-ancestor
92924916|NCT04079517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92924917|NCT04079517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924918|NCT04079517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92924919|NCT04079517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924920|NCT04079517|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92924921|NCT04079517|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92924922|NCT04079517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92924923|NCT00761150|Acetaminophen|acetaminophen|mesh-list
92924924|NCT00761150|Hydrocodone|hydrocodone|mesh-list
92924925|NCT00761150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92924926|NCT00761150|Analgesics|analgesics|mesh-ancestor
92924927|NCT00761150|Sensory System Agents|sensory system agents|mesh-ancestor
92924928|NCT00761150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924929|NCT00761150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924930|NCT00761150|Antipyretics|antipyretics|mesh-ancestor
92924931|NCT00761150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92924932|NCT00761150|Narcotics|narcotics|mesh-ancestor
92924933|NCT00761150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924934|NCT00761150|Antitussive Agents|antitussive agents|mesh-ancestor
92924935|NCT00761150|Respiratory System Agents|respiratory system agents|mesh-ancestor
92924936|NCT00583557|Belimumab|belimumab|mesh-list
92924937|NCT00583557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92924938|NCT00583557|Immunologic Factors|immunologic factors|mesh-ancestor
92924939|NCT00583557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924940|NCT00586820|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92924941|NCT00586820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92924942|NCT00586820|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92924943|NCT00586820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924944|NCT00760838|Azithromycin|azithromycin|mesh-list
92924945|NCT00760838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92924946|NCT00760838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924947|NCT00586664|Bepotastine besilate|bepotastine besilate|mesh-list
92924948|NCT00586664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92924949|NCT00586664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92924950|NCT00586664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92924951|NCT02584335|Lidocaine|lidocaine|mesh-list
92924952|NCT02584335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92924953|NCT02584335|Anesthetics, Local|anesthetics, local|mesh-ancestor
92924954|NCT02584335|Anesthetics|anesthetics|mesh-ancestor
92924955|NCT02584335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924956|NCT02584335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924957|NCT02584335|Sensory System Agents|sensory system agents|mesh-ancestor
92924958|NCT02584335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924959|NCT02584335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92924960|NCT02584335|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92924961|NCT02584335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92924962|NCT02584335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924963|NCT02584335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924964|NCT00437281|Pregabalin|pregabalin|mesh-list
92924965|NCT00437281|Analgesics|analgesics|mesh-ancestor
92924966|NCT00437281|Sensory System Agents|sensory system agents|mesh-ancestor
92924967|NCT00437281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924968|NCT00437281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924969|NCT00437281|Anticonvulsants|anticonvulsants|mesh-ancestor
92924970|NCT00437281|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92924971|NCT00437281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92924972|NCT00437281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92924973|NCT00437281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92924974|NCT00437281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92924975|NCT00437281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92924976|NCT00437281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92924977|NCT00437281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570429|NCT00062036|Cyclophosphamide|cyclophosphamide|mesh-list
92924978|NCT04544007|Poly ICLC|poly iclc|mesh-list
92924979|NCT04544007|Interferon Inducers|interferon inducers|mesh-ancestor
92924980|NCT04544007|Immunologic Factors|immunologic factors|mesh-ancestor
92924981|NCT04544007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924982|NCT05468073|Aldesleukin|aldesleukin|mesh-list
92924983|NCT05468073|Interleukin-2|interleukin-2|mesh-list
92924984|NCT05468073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92924985|NCT05468073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92924986|NCT05468073|Analgesics|analgesics|mesh-ancestor
92924987|NCT05468073|Sensory System Agents|sensory system agents|mesh-ancestor
92924988|NCT05468073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92924989|NCT05468073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92924990|NCT05468073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92924991|NCT05468073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92924992|NCT05468073|Antiviral Agents|antiviral agents|mesh-ancestor
92924993|NCT05468073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92924994|NCT05674695|Omalizumab|omalizumab|mesh-list
92924995|NCT05674695|Cyclosporine|cyclosporine|mesh-list
92924996|NCT05674695|Methotrexate|methotrexate|mesh-list
92924997|NCT05674695|Upadacitinib|upadacitinib|mesh-list
92924998|NCT05674695|Cyclosporins|cyclosporins|mesh-list
92924999|NCT05674695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92925000|NCT05674695|Abortifacient Agents|abortifacient agents|mesh-ancestor
92925001|NCT05674695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925002|NCT05674695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925003|NCT05674695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92925004|NCT05674695|Antimetabolites|antimetabolites|mesh-ancestor
92925005|NCT05674695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925006|NCT05674695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925007|NCT05674695|Dermatologic Agents|dermatologic agents|mesh-ancestor
92925008|NCT05674695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925009|NCT05674695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92925010|NCT05674695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925011|NCT05674695|Immunologic Factors|immunologic factors|mesh-ancestor
92925012|NCT05674695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925013|NCT05674695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92925014|NCT05674695|Antifungal Agents|antifungal agents|mesh-ancestor
92925015|NCT05674695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925016|NCT05674695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92925017|NCT05674695|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92925018|NCT05674695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92925019|NCT05674695|Respiratory System Agents|respiratory system agents|mesh-ancestor
92925020|NCT05674695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92925021|NCT05674695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92925022|NCT02596269|Nefopam|nefopam|mesh-list
92925023|NCT02596269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925024|NCT02596269|Analgesics|analgesics|mesh-ancestor
92925025|NCT02596269|Sensory System Agents|sensory system agents|mesh-ancestor
92925026|NCT02596269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925027|NCT02596269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925028|NCT00741039|Vaccines|vaccines|mesh-list
92925029|NCT00741039|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92925030|NCT00741039|Immunologic Factors|immunologic factors|mesh-ancestor
92925031|NCT00741039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925032|NCT02583321|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92925033|NCT02583321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92925034|NCT02583321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925036|NCT04454229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925037|NCT04454229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925038|NCT04078659|Lidocaine|lidocaine|mesh-list
92925039|NCT04078659|Magnesium Sulfate|magnesium sulfate|mesh-list
92925040|NCT04078659|Fentanyl|fentanyl|mesh-list
92925041|NCT04078659|Propofol|propofol|mesh-list
92925042|NCT04078659|Atracurium|atracurium|mesh-list
92925043|NCT04078659|Anesthetics, Local|anesthetics, local|mesh-ancestor
92925044|NCT04078659|Anesthetics|anesthetics|mesh-ancestor
92925045|NCT04078659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925046|NCT04078659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925047|NCT04078659|Sensory System Agents|sensory system agents|mesh-ancestor
92925048|NCT04078659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925049|NCT04078659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92925050|NCT04078659|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92925051|NCT04078659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92925052|NCT04078659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925053|NCT04078659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925054|NCT04078659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92925055|NCT04078659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92925056|NCT04078659|Anesthetics, General|anesthetics, general|mesh-ancestor
92925057|NCT04078659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925058|NCT04078659|Narcotics|narcotics|mesh-ancestor
92925059|NCT04078659|Analgesics|analgesics|mesh-ancestor
92925060|NCT04078659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92925061|NCT04078659|Anticonvulsants|anticonvulsants|mesh-ancestor
92925062|NCT04078659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92925063|NCT04078659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92925064|NCT04078659|Tocolytic Agents|tocolytic agents|mesh-ancestor
92925065|NCT04078659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925066|NCT04078659|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92925067|NCT04078659|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92925068|NCT04078659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92925069|NCT04078659|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92925070|NCT04078659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92925071|NCT04078659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92925072|NCT04078659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925073|NCT02583243|Buprenorphine|buprenorphine|mesh-list
92925074|NCT02583243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925075|NCT02583243|Narcotics|narcotics|mesh-ancestor
92925076|NCT02583243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925077|NCT02583243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925078|NCT02583243|Analgesics|analgesics|mesh-ancestor
92925079|NCT02583243|Sensory System Agents|sensory system agents|mesh-ancestor
92925080|NCT02583243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925081|NCT02583243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92925082|NCT00798707|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92925083|NCT00798707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92925084|NCT00798707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92925085|NCT00798707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925086|NCT00798707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925087|NCT00798707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925088|NCT00798707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925089|NCT00798707|Antidepressive Agents|antidepressive agents|mesh-ancestor
92925090|NCT00798707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92925091|NCT00760214|Ramipril|ramipril|mesh-list
92925092|NCT00760214|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92925093|NCT00760214|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92925094|NCT00760214|Protease Inhibitors|protease inhibitors|mesh-ancestor
92925095|NCT00760214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925096|NCT00760214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925097|NCT00760214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92925098|NCT00760214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92925099|NCT00760214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92925100|NCT04078425|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92925101|NCT04078425|Hormone Antagonists|hormone antagonists|mesh-ancestor
92925102|NCT04078425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526318|NCT00028327|Antiviral Agents|antiviral agents|mesh-ancestor
92925103|NCT04078425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925104|NCT04078425|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92925106|NCT04078425|Natriuretic Agents|natriuretic agents|mesh-ancestor
92925107|NCT00638391|Anastrozole|anastrozole|mesh-list
92925108|NCT00638391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92925109|NCT00638391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925110|NCT00638391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92925111|NCT00638391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92925112|NCT00638391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925113|NCT00638391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925114|NCT00638391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92925115|NCT00638391|Hormone Antagonists|hormone antagonists|mesh-ancestor
92925116|NCT00638391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925117|NCT00638391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925118|NCT02583633|Nifedipine|nifedipine|mesh-list
92925119|NCT02583633|Nitroglycerin|nitroglycerin|mesh-list
92925120|NCT02583633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92925121|NCT02583633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925122|NCT02583633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925123|NCT02583633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92925124|NCT02583633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925125|NCT02583633|Vasodilator Agents|vasodilator agents|mesh-ancestor
92925126|NCT02583633|Tocolytic Agents|tocolytic agents|mesh-ancestor
92925127|NCT02583633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92570575|NCT00224809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925128|NCT04487067|Bevacizumab|bevacizumab|mesh-list
92925129|NCT04487067|Atezolizumab|atezolizumab|mesh-list
92925130|NCT04487067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92925131|NCT04487067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925132|NCT04487067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92925133|NCT04487067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92925134|NCT04487067|Growth Substances|growth substances|mesh-ancestor
92925135|NCT04487067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925136|NCT04487067|Growth Inhibitors|growth inhibitors|mesh-ancestor
92925137|NCT04487067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92925138|NCT04487067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925139|NCT02582307|Acetaminophen|acetaminophen|mesh-list
92925140|NCT02582307|Scopolamine|scopolamine|mesh-list
92925141|NCT02582307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92925142|NCT02582307|Analgesics|analgesics|mesh-list
92925143|NCT02582307|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92925144|NCT02582307|Sensory System Agents|sensory system agents|mesh-ancestor
92925145|NCT02582307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925146|NCT02582307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925147|NCT02582307|Antipyretics|antipyretics|mesh-ancestor
92925148|NCT02582307|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92925149|NCT02582307|Antiemetics|antiemetics|mesh-ancestor
92925150|NCT02582307|Autonomic Agents|autonomic agents|mesh-ancestor
92925151|NCT02582307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925152|NCT02582307|Mydriatics|mydriatics|mesh-ancestor
92925153|NCT02582307|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92925154|NCT02582307|Cholinergic Agents|cholinergic agents|mesh-ancestor
92925155|NCT02582307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925156|NCT02582307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925157|NCT02582307|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92925158|NCT02582307|Parasympatholytics|parasympatholytics|mesh-ancestor
92925159|NCT02689245|Tenofovir|tenofovir|mesh-list
92925160|NCT02689245|Antiviral Agents|antiviral agents|mesh-ancestor
92925161|NCT02689245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925162|NCT02689245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92925163|NCT02689245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92925164|NCT02689245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925165|NCT02689245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925166|NCT02689245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92925167|NCT02689245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92925168|NCT00802841|Imatinib Mesylate|imatinib mesylate|mesh-list
92925169|NCT00802841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925170|NCT00802841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92925171|NCT00802841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925172|NCT00802841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925173|NCT00772148|Tacrolimus|tacrolimus|mesh-list
92925175|NCT00772148|Immunologic Factors|immunologic factors|mesh-ancestor
92925176|NCT00772148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925177|NCT00772148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92925178|NCT00772148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925179|NCT00772148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925180|NCT02689089|Rifapentine|rifapentine|mesh-list
92925181|NCT02689089|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92925182|NCT02689089|Antitubercular Agents|antitubercular agents|mesh-ancestor
92925183|NCT02689089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925184|NCT02689089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925185|NCT02689089|Leprostatic Agents|leprostatic agents|mesh-ancestor
92925186|NCT00759902|Morphine|morphine|mesh-list
92925187|NCT00759902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925188|NCT00759902|Narcotics|narcotics|mesh-ancestor
92925189|NCT00759902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925190|NCT00759902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925191|NCT00759902|Analgesics|analgesics|mesh-ancestor
92925192|NCT00759902|Sensory System Agents|sensory system agents|mesh-ancestor
92925193|NCT00759902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925194|NCT04077957|Hydroxychloroquine|hydroxychloroquine|mesh-list
92925195|NCT04077957|Sulfasalazine|sulfasalazine|mesh-list
92925196|NCT04077957|Etanercept|etanercept|mesh-list
92925197|NCT04077957|Methotrexate|methotrexate|mesh-list
92925198|NCT04077957|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92925199|NCT04077957|Abortifacient Agents|abortifacient agents|mesh-ancestor
92925200|NCT04077957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925201|NCT04077957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925202|NCT04077957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92925203|NCT04077957|Antimetabolites|antimetabolites|mesh-ancestor
92925204|NCT04077957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925206|NCT04077957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92925207|NCT04077957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925208|NCT04077957|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92925209|NCT04077957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925210|NCT04077957|Immunologic Factors|immunologic factors|mesh-ancestor
92925211|NCT04077957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925212|NCT04077957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92925213|NCT04077957|Antimalarials|antimalarials|mesh-ancestor
92925214|NCT04077957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92925215|NCT04077957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92925216|NCT04077957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925217|NCT04077957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92925218|NCT04077957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925219|NCT04077957|Analgesics|analgesics|mesh-ancestor
92925220|NCT04077957|Sensory System Agents|sensory system agents|mesh-ancestor
92925221|NCT04077957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925222|NCT04077957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925223|NCT04077957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925224|NCT04102670|Hyaluronic Acid|hyaluronic acid|mesh-list
92925225|NCT04102670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925226|NCT04102670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92925227|NCT04102670|Immunologic Factors|immunologic factors|mesh-ancestor
92925228|NCT04102670|Viscosupplements|viscosupplements|mesh-ancestor
92925229|NCT04102670|Protective Agents|protective agents|mesh-ancestor
92925230|NCT04114097|Betamethasone|betamethasone|mesh-list
92925231|NCT04114097|Betamethasone Valerate|betamethasone valerate|mesh-list
92925232|NCT04114097|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92925233|NCT04114097|Betamethasone benzoate|betamethasone benzoate|mesh-list
92925234|NCT04114097|Tacrolimus|tacrolimus|mesh-list
92925235|NCT04114097|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92925236|NCT04114097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925237|NCT04114097|Immunologic Factors|immunologic factors|mesh-ancestor
92925238|NCT04114097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925239|NCT04114097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92925240|NCT04114097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925241|NCT04114097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925242|NCT04114097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925243|NCT04114097|Glucocorticoids|glucocorticoids|mesh-ancestor
92925244|NCT04114097|Hormones|hormones|mesh-ancestor
92925245|NCT04114097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925246|NCT04114097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92925247|NCT04114097|Respiratory System Agents|respiratory system agents|mesh-ancestor
92925248|NCT04323189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92925249|NCT04323189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92925250|NCT04323189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925251|NCT04323189|Incretins|incretins|mesh-ancestor
92925252|NCT04323189|Hormones|hormones|mesh-ancestor
92925253|NCT04323189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925254|NCT04323189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92925255|NCT04323189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92925256|NCT04323189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925257|NCT04323189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925258|NCT00772070|Vaccines|vaccines|mesh-list
92925259|NCT00772070|Immunologic Factors|immunologic factors|mesh-ancestor
92925260|NCT00772070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925261|NCT00796757|Interferons|interferons|mesh-list
92925262|NCT00796757|Interferon-alpha|interferon-alpha|mesh-list
92925263|NCT00796757|Interferon alpha-2|interferon alpha-2|mesh-list
92925264|NCT00796757|Bevacizumab|bevacizumab|mesh-list
92925265|NCT00796757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92925266|NCT00796757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925267|NCT00796757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92925268|NCT00796757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92925269|NCT00796757|Growth Substances|growth substances|mesh-ancestor
92925270|NCT00796757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925271|NCT00796757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92925272|NCT00796757|Antiviral Agents|antiviral agents|mesh-ancestor
92925273|NCT00796757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925274|NCT00796757|Immunologic Factors|immunologic factors|mesh-ancestor
92925275|NCT00759356|Morphine|morphine|mesh-list
92925276|NCT00759356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925277|NCT00759356|Narcotics|narcotics|mesh-ancestor
92925278|NCT00759356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925279|NCT00759356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925280|NCT00759356|Analgesics|analgesics|mesh-ancestor
92925281|NCT00759356|Sensory System Agents|sensory system agents|mesh-ancestor
92925282|NCT00759356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925284|NCT05637515|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92925285|NCT05637515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925286|NCT05637515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925287|NCT04113941|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92925288|NCT04113941|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92925289|NCT04113941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925290|NCT04113941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925291|NCT04113941|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92925292|NCT04113941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925293|NCT04113941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925294|NCT04113941|Cholinergic Agents|cholinergic agents|mesh-ancestor
92925295|NCT04113941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925296|NCT04102592|Permethrin|permethrin|mesh-list
92925297|NCT04102592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925298|NCT04102592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925299|NCT04113551|Guanfacine|guanfacine|mesh-list
92925300|NCT04113551|Methylphenidate|methylphenidate|mesh-list
92925301|NCT04113551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92925302|NCT04113551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92925303|NCT04113551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92925304|NCT04113551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925305|NCT04113551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925306|NCT04113551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92925307|NCT04113551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925308|NCT04113551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925309|NCT04113551|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92925310|NCT04113551|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92925311|NCT04113551|Dopamine Agents|dopamine agents|mesh-ancestor
92925312|NCT04113551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92925313|NCT04113551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92925314|NCT04113551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92925315|NCT04113551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92925316|NCT00798317|Plasminogen|plasminogen|mesh-list
92925317|NCT00798317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92925318|NCT00798317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925319|NCT00798317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925320|NCT00077285|Cyclophosphamide|cyclophosphamide|mesh-list
92925321|NCT00077285|Ifosfamide|ifosfamide|mesh-list
92925322|NCT00077285|Carboplatin|carboplatin|mesh-list
92925323|NCT00077285|Doxorubicin|doxorubicin|mesh-list
92925324|NCT00077285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92925325|NCT00077285|Irinotecan|irinotecan|mesh-list
92925326|NCT00077285|Etoposide|etoposide|mesh-list
92925327|NCT00077285|Vincristine|vincristine|mesh-list
92925328|NCT00077285|Dexrazoxane|dexrazoxane|mesh-list
92925329|NCT00077285|Razoxane|razoxane|mesh-list
92925330|NCT00077285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925331|NCT00077285|Immunologic Factors|immunologic factors|mesh-ancestor
92925332|NCT00077285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925333|NCT00077285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925334|NCT00077285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92925335|NCT00077285|Alkylating Agents|alkylating agents|mesh-ancestor
92925336|NCT00077285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925337|NCT00077285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925338|NCT00077285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92925339|NCT00077285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92925340|NCT00077285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92925341|NCT00077285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92925342|NCT00077285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925343|NCT00077285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92925344|NCT00077285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92925345|NCT00077285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92925346|NCT00077285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92925347|NCT00077285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92925348|NCT00077285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92925349|NCT00077285|Protective Agents|protective agents|mesh-ancestor
92925350|NCT00771914|Aspirin|aspirin|mesh-list
92925351|NCT00771914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92925352|NCT00771914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925353|NCT00771914|Analgesics|analgesics|mesh-ancestor
92925354|NCT00771914|Sensory System Agents|sensory system agents|mesh-ancestor
92925355|NCT00771914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925356|NCT00771914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925357|NCT00771914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925358|NCT00771914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925359|NCT00771914|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92925360|NCT00771914|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925361|NCT00771914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925362|NCT00771914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92925363|NCT00771914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92925364|NCT00771914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925365|NCT00771914|Antipyretics|antipyretics|mesh-ancestor
92925366|NCT04307511|Aspirin|aspirin|mesh-list
92925367|NCT04307511|Ticagrelor|ticagrelor|mesh-list
92925368|NCT04307511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92925369|NCT04307511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925370|NCT04307511|Analgesics|analgesics|mesh-ancestor
92925371|NCT04307511|Sensory System Agents|sensory system agents|mesh-ancestor
92925372|NCT04307511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925373|NCT04307511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925374|NCT04307511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925375|NCT04307511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925376|NCT04307511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92925377|NCT04307511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925378|NCT04307511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925379|NCT04307511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92925380|NCT04307511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92925381|NCT04307511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925382|NCT04307511|Antipyretics|antipyretics|mesh-ancestor
92925383|NCT04307511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92925384|NCT04307511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92925385|NCT04307511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92925386|NCT04307511|Purinergic Agents|purinergic agents|mesh-ancestor
92925387|NCT04307511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925388|NCT00779324|Amantadine|amantadine|mesh-list
92925389|NCT00779324|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92925390|NCT00779324|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92925391|NCT00779324|Antiviral Agents|antiviral agents|mesh-ancestor
92925392|NCT00779324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925393|NCT00779324|Dopamine Agents|dopamine agents|mesh-ancestor
92925394|NCT00779324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925395|NCT00779324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925396|NCT00779324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925397|NCT00779324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925398|NCT00779324|Analgesics|analgesics|mesh-ancestor
92925399|NCT00779324|Sensory System Agents|sensory system agents|mesh-ancestor
92925400|NCT00779324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925401|NCT00779246|Chlorhexidine|chlorhexidine|mesh-list
92925402|NCT00779246|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92925403|NCT00779246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92925404|NCT00779246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925405|NCT00779246|Disinfectants|disinfectants|mesh-ancestor
92925406|NCT00779246|Dermatologic Agents|dermatologic agents|mesh-ancestor
92925407|NCT02581761|Misoprostol|misoprostol|mesh-list
92925408|NCT02581761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92925409|NCT02581761|Abortifacient Agents|abortifacient agents|mesh-ancestor
92925410|NCT02581761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925411|NCT02581761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925412|NCT02581761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92925413|NCT02581761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925414|NCT02581761|Oxytocics|oxytocics|mesh-ancestor
92925415|NCT00771758|Oxycodone|oxycodone|mesh-list
92925416|NCT00771758|Tapentadol|tapentadol|mesh-list
92925417|NCT00771758|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925418|NCT00771758|Narcotics|narcotics|mesh-ancestor
92925419|NCT00771758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925420|NCT00771758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925421|NCT00771758|Analgesics|analgesics|mesh-ancestor
92925422|NCT00771758|Sensory System Agents|sensory system agents|mesh-ancestor
92925423|NCT00771758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925424|NCT00771758|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92925425|NCT00771758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92925426|NCT00771758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925427|NCT00771758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925428|NCT00771758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92925429|NCT00771758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925430|NCT02581371|Cerebrolysin|cerebrolysin|mesh-list
92925431|NCT02581371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92925432|NCT02581371|Protective Agents|protective agents|mesh-ancestor
92925433|NCT02581371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925434|NCT02581371|Nootropic Agents|nootropic agents|mesh-ancestor
92925435|NCT02688465|Apomorphine|apomorphine|mesh-list
92925436|NCT02688465|Emetics|emetics|mesh-ancestor
92925437|NCT02688465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925438|NCT02688465|Autonomic Agents|autonomic agents|mesh-ancestor
92925439|NCT02688465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925440|NCT02688465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925441|NCT02688465|Dopamine Agonists|dopamine agonists|mesh-ancestor
92925442|NCT02688465|Dopamine Agents|dopamine agents|mesh-ancestor
92925443|NCT02688465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925444|NCT02688465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925445|NCT00758498|Modafinil|modafinil|mesh-list
92925446|NCT00758498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92925447|NCT00758498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925448|NCT00758498|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92925449|NCT00758498|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92925450|NCT00758498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92925451|NCT00758498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925452|NCT00798161|Metformin|metformin|mesh-list
92925453|NCT00798161|Linagliptin|linagliptin|mesh-list
92925454|NCT00798161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92925455|NCT00798161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925456|NCT00798161|Incretins|incretins|mesh-ancestor
92925457|NCT00798161|Hormones|hormones|mesh-ancestor
92925458|NCT00798161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925459|NCT00798161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92925460|NCT00798161|Protease Inhibitors|protease inhibitors|mesh-ancestor
92925461|NCT00798161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925462|NCT00798161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925463|NCT02581683|Magnesium Sulfate|magnesium sulfate|mesh-list
92925464|NCT02581683|Ropivacaine|ropivacaine|mesh-list
92925465|NCT02581683|Anesthetics, Local|anesthetics, local|mesh-ancestor
92925466|NCT02581683|Anesthetics|anesthetics|mesh-ancestor
92925467|NCT02581683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925468|NCT02581683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925469|NCT02581683|Sensory System Agents|sensory system agents|mesh-ancestor
92925470|NCT02581683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925471|NCT02581683|Analgesics|analgesics|mesh-ancestor
92925472|NCT02581683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92925473|NCT02581683|Anticonvulsants|anticonvulsants|mesh-ancestor
92925474|NCT02581683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92925475|NCT02581683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925476|NCT02581683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925477|NCT02581683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92925478|NCT02581683|Tocolytic Agents|tocolytic agents|mesh-ancestor
92925479|NCT02581683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925480|NCT04170855|Furosemide|furosemide|mesh-list
92925481|NCT04170855|Diuretics|diuretics|mesh-ancestor
92925482|NCT04170855|Natriuretic Agents|natriuretic agents|mesh-ancestor
92925483|NCT04170855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925484|NCT04170855|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92925485|NCT04170855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925486|NCT04170855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925487|NCT04076709|Anesthetics|anesthetics|mesh-list
92925488|NCT04076709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925489|NCT04076709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925490|NCT00638781|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
92925491|NCT00638781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92925492|NCT00638781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925493|NCT00638781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925494|NCT04115423|Adalimumab|adalimumab|mesh-list
92925495|NCT04115423|Infliximab|infliximab|mesh-list
92925496|NCT04115423|Golimumab|golimumab|mesh-list
92925497|NCT04115423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92925498|NCT04115423|Etanercept|etanercept|mesh-list
92925499|NCT04115423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925500|NCT04115423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925501|NCT04115423|Dermatologic Agents|dermatologic agents|mesh-ancestor
92925502|NCT04115423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925503|NCT04115423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92925504|NCT04115423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925505|NCT04115423|Analgesics|analgesics|mesh-ancestor
92925506|NCT04115423|Sensory System Agents|sensory system agents|mesh-ancestor
92925507|NCT04115423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925508|NCT04115423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925509|NCT04115423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925510|NCT04115423|Immunologic Factors|immunologic factors|mesh-ancestor
92925511|NCT04113005|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92925512|NCT04113005|Hemostatics|hemostatics|mesh-ancestor
92925513|NCT04113005|Coagulants|coagulants|mesh-ancestor
92925514|NCT04113005|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92925515|NCT04113005|Natriuretic Agents|natriuretic agents|mesh-ancestor
92925516|NCT04113005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925517|NCT00588341|Temozolomide|temozolomide|mesh-list
92925518|NCT00588341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92925519|NCT00588341|Alkylating Agents|alkylating agents|mesh-ancestor
92925520|NCT00588341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925521|NCT00588341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925522|NCT00914693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92925523|NCT00914693|Gestodene|gestodene|mesh-list
92925524|NCT00914693|Femovan|femovan|mesh-list
92925525|NCT00914693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92925526|NCT00914693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92925527|NCT00914693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92925528|NCT00914693|Contraceptive Agents|contraceptive agents|mesh-ancestor
92925529|NCT00914693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925530|NCT00914693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925531|NCT00914693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92925532|NCT00914693|Estrogens|estrogens|mesh-ancestor
92925533|NCT00914693|Hormones|hormones|mesh-ancestor
92925534|NCT00914693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925535|NCT00914693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92925536|NCT00914693|Progestins|progestins|mesh-ancestor
92925537|NCT00914693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92925538|NCT00915083|Amrubicin|amrubicin|mesh-list
92925539|NCT00915083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925540|NCT00802529|Gentamicins|gentamicins|mesh-list
92925541|NCT00802529|Methylprednisolone|methylprednisolone|mesh-list
92925542|NCT00802529|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92925543|NCT00802529|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92925544|NCT00802529|Prednisolone|prednisolone|mesh-list
92925545|NCT00802529|Prednisolone acetate|prednisolone acetate|mesh-list
92925546|NCT00802529|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92925547|NCT00802529|Prednisolone phosphate|prednisolone phosphate|mesh-list
92925548|NCT00802529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925549|NCT00802529|Antiemetics|antiemetics|mesh-ancestor
92925550|NCT00802529|Autonomic Agents|autonomic agents|mesh-ancestor
92925551|NCT00802529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925552|NCT00802529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925553|NCT00802529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925554|NCT00802529|Glucocorticoids|glucocorticoids|mesh-ancestor
92925556|NCT00802529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925557|NCT00802529|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92925558|NCT00802529|Protective Agents|protective agents|mesh-ancestor
92925559|NCT00802529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92925560|NCT00802529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925561|NCT00802529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925562|NCT00802529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925563|NCT00802529|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92925564|NCT00802529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925565|NCT00802529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925566|NCT02605811|Temozolomide|temozolomide|mesh-list
92925567|NCT02605811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92925568|NCT02605811|Alkylating Agents|alkylating agents|mesh-ancestor
92925569|NCT02605811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925570|NCT02605811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925571|NCT00758264|Vaccines|vaccines|mesh-list
92925572|NCT00758264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92925573|NCT00758264|Immunologic Factors|immunologic factors|mesh-ancestor
92925574|NCT00758264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925575|NCT04027517|Darbepoetin alfa|darbepoetin alfa|mesh-list
92925576|NCT04027517|Hematinics|hematinics|mesh-ancestor
92925577|NCT00588731|Cannabidiol|cannabidiol|mesh-list
92925578|NCT00588731|Anticonvulsants|anticonvulsants|mesh-ancestor
92925579|NCT04111367|Sofosbuvir|sofosbuvir|mesh-list
92925580|NCT04111367|Antiviral Agents|antiviral agents|mesh-ancestor
92925581|NCT04111367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925582|NCT05629949|Docetaxel|docetaxel|mesh-list
92925583|NCT05629949|Trastuzumab|trastuzumab|mesh-list
92925584|NCT05629949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925585|NCT05629949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92925586|NCT05629949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92925587|NCT05629949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92925588|NCT05629949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925589|NCT05629949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92925590|NCT05628233|Azasetron|azasetron|mesh-list
92925591|NCT05628233|Antiemetics|antiemetics|mesh-ancestor
92925592|NCT05628233|Autonomic Agents|autonomic agents|mesh-ancestor
92925593|NCT05628233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925594|NCT05628233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925595|NCT05628233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925596|NCT05628233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92925597|NCT05628233|Serotonin Agents|serotonin agents|mesh-ancestor
92925598|NCT05628233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925599|NCT05628233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925600|NCT04109261|Palbociclib|palbociclib|mesh-list
92925601|NCT04109261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925602|NCT04109261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92925603|NCT04109261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925604|NCT04109261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925605|NCT04109339|Oxytocin|oxytocin|mesh-list
92925606|NCT04109339|Oxytocics|oxytocics|mesh-ancestor
92925607|NCT04109339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925608|NCT04109339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925609|NCT00757172|Docetaxel|docetaxel|mesh-list
92925610|NCT00757172|Panitumumab|panitumumab|mesh-list
92925611|NCT00757172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925612|NCT00757172|Tubulin Modulators|tubulin modulators|mesh-ancestor
92925613|NCT00757172|Antimitotic Agents|antimitotic agents|mesh-ancestor
92925614|NCT00757172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92925615|NCT00757172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925616|NCT00757172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92925617|NCT00797225|Leuprolide|leuprolide|mesh-list
92925618|NCT00797225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92925619|NCT00797225|Fertility Agents|fertility agents|mesh-ancestor
92925620|NCT00797225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925621|NCT00797225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925622|NCT00797225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92925623|NCT00797225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925625|NCT05277285|Antidotes|antidotes|mesh-ancestor
92925626|NCT05277285|Protective Agents|protective agents|mesh-ancestor
92925627|NCT05277285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925628|NCT05277285|Antioxidants|antioxidants|mesh-ancestor
92925629|NCT05277285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925630|NCT05277285|Antitubercular Agents|antitubercular agents|mesh-ancestor
92925631|NCT05277285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925632|NCT05277285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925633|NCT05277285|Chelating Agents|chelating agents|mesh-ancestor
92925634|NCT05277285|Sequestering Agents|sequestering agents|mesh-ancestor
92925635|NCT04110665|Acetaminophen|acetaminophen|mesh-list
92925636|NCT04110665|Morphine|morphine|mesh-list
92925637|NCT04110665|Oxycodone|oxycodone|mesh-list
92925638|NCT04110665|Tramadol|tramadol|mesh-list
92925639|NCT04110665|Nefopam|nefopam|mesh-list
92925640|NCT04110665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925641|NCT04110665|Narcotics|narcotics|mesh-ancestor
92925642|NCT04110665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925643|NCT04110665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925644|NCT04110665|Analgesics|analgesics|mesh-ancestor
92925645|NCT04110665|Sensory System Agents|sensory system agents|mesh-ancestor
92925646|NCT04110665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925647|NCT04110665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925648|NCT04110665|Antipyretics|antipyretics|mesh-ancestor
92925649|NCT04077333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92925650|NCT04077333|Respiratory System Agents|respiratory system agents|mesh-ancestor
92925651|NCT00638859|Telithromycin|telithromycin|mesh-list
92925652|NCT00638859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925653|NCT00638859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925654|NCT02537847|Ertapenem|ertapenem|mesh-list
92925655|NCT02537847|Fluoroquinolones|fluoroquinolones|mesh-list
92925656|NCT02537847|Sitafloxacin|sitafloxacin|mesh-list
92925657|NCT02537847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925658|NCT02537847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925659|NCT02537847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92925660|NCT02537847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925661|NCT02537847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925662|NCT02537847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92925663|NCT02537847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92925664|NCT02537847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925665|NCT04033029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92925666|NCT04033029|Tazobactam|tazobactam|mesh-list
92925667|NCT04033029|Piperacillin|piperacillin|mesh-list
92925668|NCT04033029|Daptomycin|daptomycin|mesh-list
92925669|NCT04033029|Ceftazidime|ceftazidime|mesh-list
92925670|NCT04033029|Cefepime|cefepime|mesh-list
92925671|NCT04033029|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92925672|NCT04033029|Ceftolozane|ceftolozane|mesh-list
92925673|NCT04033029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925674|NCT04033029|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92925675|NCT04033029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925676|NCT04033029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925677|NCT02687841|Pentoxifylline|pentoxifylline|mesh-list
92925678|NCT02687841|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92925679|NCT02687841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925680|NCT02687841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925681|NCT02687841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92925682|NCT02687841|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92925683|NCT02687841|Protective Agents|protective agents|mesh-ancestor
92925684|NCT02687841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925685|NCT02687841|Vasodilator Agents|vasodilator agents|mesh-ancestor
92925686|NCT02687841|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92925687|NCT02687841|Antioxidants|antioxidants|mesh-ancestor
92925688|NCT00778622|Metformin|metformin|mesh-list
92925689|NCT00778622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92925690|NCT00778622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925691|NCT00777920|Ambrisentan|ambrisentan|mesh-list
92925692|NCT00777920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92925693|NCT04236141|Rituximab|rituximab|mesh-list
92925694|NCT04236141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92925695|NCT04236141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92925696|NCT04236141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92270564|NCT02988089|Antacids|antacids|mesh-ancestor
92925697|NCT04236141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925698|NCT04236141|Immunologic Factors|immunologic factors|mesh-ancestor
92925699|NCT04236141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925700|NCT04236141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925701|NCT04236141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92925702|NCT04236141|Alkylating Agents|alkylating agents|mesh-ancestor
92925703|NCT04236141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925704|NCT04236141|Immunoconjugates|immunoconjugates|mesh-ancestor
92925706|NCT04097444|Bevacizumab|bevacizumab|mesh-list
92925707|NCT04097444|Fluorouracil|fluorouracil|mesh-list
92925708|NCT04097444|Capecitabine|capecitabine|mesh-list
92925709|NCT04097444|Oxaliplatin|oxaliplatin|mesh-list
92925710|NCT04097444|Irinotecan|irinotecan|mesh-list
92925711|NCT04097444|Calcium|calcium|mesh-list
92925712|NCT04097444|Levoleucovorin|levoleucovorin|mesh-list
92925713|NCT04097444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92925714|NCT04097444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925715|NCT04097444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92925716|NCT04097444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92925717|NCT04097444|Growth Substances|growth substances|mesh-ancestor
92163113|NCT01920919|Dexamethasone|dexamethasone|mesh-list
92925718|NCT04097444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925719|NCT04097444|Growth Inhibitors|growth inhibitors|mesh-ancestor
92925720|NCT04097444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92925721|NCT04097444|Antimetabolites|antimetabolites|mesh-ancestor
92925722|NCT04097444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925723|NCT04097444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92925724|NCT04097444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925725|NCT04097444|Immunologic Factors|immunologic factors|mesh-ancestor
92925726|NCT04097444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92925727|NCT04097444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92925728|NCT04097444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925729|NCT04097444|Antidotes|antidotes|mesh-ancestor
92925730|NCT04097444|Protective Agents|protective agents|mesh-ancestor
92925731|NCT04097444|Vitamin B Complex|vitamin b complex|mesh-ancestor
92571176|NCT00227812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92925732|NCT04097444|Vitamins|vitamins|mesh-ancestor
92925733|NCT04097444|Micronutrients|micronutrients|mesh-ancestor
92925735|NCT04097288|Citalopram|citalopram|mesh-list
92925736|NCT04097288|Reboxetine|reboxetine|mesh-list
92925737|NCT04097288|Escitalopram|escitalopram|mesh-list
92925738|NCT04097288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92925739|NCT04097288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92925740|NCT04097288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925741|NCT04097288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925742|NCT04097288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925743|NCT04097288|Serotonin Agents|serotonin agents|mesh-ancestor
92925744|NCT04097288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925745|NCT04097288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92925746|NCT04097288|Antidepressive Agents|antidepressive agents|mesh-ancestor
92925747|NCT04097288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92925748|NCT04097288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92925749|NCT04097288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92925750|NCT04097288|Parasympatholytics|parasympatholytics|mesh-ancestor
92925751|NCT04097288|Autonomic Agents|autonomic agents|mesh-ancestor
92925752|NCT04097288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925753|NCT04097288|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92925754|NCT04097288|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92925755|NCT04097288|Cholinergic Agents|cholinergic agents|mesh-ancestor
92925756|NCT04097288|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92925757|NCT04097288|Adrenergic Agents|adrenergic agents|mesh-ancestor
92925758|NCT04219449|Protein C|protein c|mesh-list
92925759|NCT04219449|Anticoagulants|anticoagulants|mesh-ancestor
92925760|NCT04219449|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92925761|NCT04219449|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925762|NCT04219449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925763|NCT04209855|Paclitaxel|paclitaxel|mesh-list
92925764|NCT04209855|Maytansine|maytansine|mesh-list
92925765|NCT04209855|Doxorubicin|doxorubicin|mesh-list
92925766|NCT04209855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92925767|NCT04209855|Topotecan|topotecan|mesh-list
92925768|NCT04209855|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92925769|NCT04209855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92925770|NCT04209855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925771|NCT04209855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92925772|NCT04209855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92925773|NCT04209855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92925774|NCT04209855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925775|NCT04209855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92925776|NCT04209855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92925777|NCT04209855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92925778|NCT04209855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925779|NCT04209855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92925780|NCT04209855|Immunoconjugates|immunoconjugates|mesh-ancestor
92925781|NCT04209855|Immunologic Factors|immunologic factors|mesh-ancestor
92925782|NCT04209855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925784|NCT00756938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92925785|NCT00756938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92925786|NCT00756938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92925787|NCT00756938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92163114|NCT01920919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925788|NCT00756938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925789|NCT04076865|Lidocaine|lidocaine|mesh-list
92925790|NCT04076865|Histamine|histamine|mesh-list
92925791|NCT04076865|Anesthetics, Local|anesthetics, local|mesh-ancestor
92925792|NCT04076865|Anesthetics|anesthetics|mesh-ancestor
92925793|NCT04076865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925794|NCT04076865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925795|NCT04076865|Sensory System Agents|sensory system agents|mesh-ancestor
92925796|NCT04076865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925797|NCT04076865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92925798|NCT04076865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92925799|NCT04076865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92925800|NCT04076865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92925801|NCT04076865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925802|NCT04076865|Histamine Agonists|histamine agonists|mesh-ancestor
92925803|NCT04076865|Histamine Agents|histamine agents|mesh-ancestor
92925804|NCT04076865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925805|NCT00770588|Gefitinib|gefitinib|mesh-list
92925806|NCT00770588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925807|NCT00770588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92925808|NCT00770588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925809|NCT00770588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925810|NCT02604719|Tranexamic Acid|tranexamic acid|mesh-list
92925811|NCT02604719|Ethamsylate|ethamsylate|mesh-list
92925812|NCT02604719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92925813|NCT02604719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92925814|NCT02604719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925815|NCT02604719|Hemostatics|hemostatics|mesh-ancestor
92925816|NCT02604719|Coagulants|coagulants|mesh-ancestor
92925817|NCT02604797|Flurbiprofen|flurbiprofen|mesh-list
92925818|NCT02604797|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92925819|NCT02604797|Sufentanil|sufentanil|mesh-list
92925820|NCT02604797|Dsuvia|dsuvia|mesh-list
92925821|NCT02604797|Nalbuphine|nalbuphine|mesh-list
92925822|NCT02604797|Ramosetron|ramosetron|mesh-list
92925823|NCT02604797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92925824|NCT02604797|Narcotics|narcotics|mesh-ancestor
92925825|NCT02604797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925826|NCT02604797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925827|NCT02604797|Analgesics|analgesics|mesh-ancestor
92925828|NCT02604797|Sensory System Agents|sensory system agents|mesh-ancestor
92925829|NCT02604797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92925830|NCT02604797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92925831|NCT02604797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92925832|NCT02604797|Anesthetics, General|anesthetics, general|mesh-ancestor
92925833|NCT02604797|Anesthetics|anesthetics|mesh-ancestor
92925834|NCT02604797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92925835|NCT02604797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92925836|NCT02604797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92925837|NCT02604797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925838|NCT02604797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92925839|NCT02604797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925840|NCT02604797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925841|NCT02604797|Antiemetics|antiemetics|mesh-ancestor
92925842|NCT02604797|Autonomic Agents|autonomic agents|mesh-ancestor
92925843|NCT02604797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925844|NCT02604797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92925845|NCT02604797|Serotonin Agents|serotonin agents|mesh-ancestor
92925846|NCT02604797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925847|NCT00777608|Donepezil|donepezil|mesh-list
92270710|NCT01596842|Vitamins|vitamins|mesh-ancestor
92925848|NCT00777608|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92925849|NCT00777608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925850|NCT00777608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925851|NCT00777608|Cholinergic Agents|cholinergic agents|mesh-ancestor
92925852|NCT00777608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925853|NCT00777608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925854|NCT00777608|Nootropic Agents|nootropic agents|mesh-ancestor
92925856|NCT00792935|Glimepiride|glimepiride|mesh-list
92925857|NCT00792935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92925858|NCT00792935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925859|NCT00792935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92925860|NCT00792935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925861|NCT00792935|Immunologic Factors|immunologic factors|mesh-ancestor
92925862|NCT03904563|Bevacizumab|bevacizumab|mesh-list
92925863|NCT03904563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92925864|NCT03904563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925865|NCT03904563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92925866|NCT03904563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92925867|NCT03904563|Growth Substances|growth substances|mesh-ancestor
92925868|NCT03904563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925869|NCT03904563|Growth Inhibitors|growth inhibitors|mesh-ancestor
92925870|NCT00770510|Zolpidem|zolpidem|mesh-list
92925871|NCT00770510|Eszopiclone|eszopiclone|mesh-list
92925872|NCT00770510|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92925873|NCT00770510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92925874|NCT00770510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925875|NCT00770510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925876|NCT00770510|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92925877|NCT00770510|GABA Agonists|gaba agonists|mesh-ancestor
92925878|NCT00770510|GABA Agents|gaba agents|mesh-ancestor
92925879|NCT00770510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925880|NCT00770510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925881|NCT04077255|Paclitaxel|paclitaxel|mesh-list
92925882|NCT04077255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92925883|NCT04077255|Antibodies|antibodies|mesh-list
92925884|NCT04077255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92571346|NCT00075543|Docetaxel|docetaxel|mesh-list
92925885|NCT04077255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925886|NCT04077255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92925887|NCT04077255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92925888|NCT04077255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92925889|NCT04077255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925890|NCT04077255|Immunologic Factors|immunologic factors|mesh-ancestor
92925891|NCT04077255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925892|NCT00770432|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92925893|NCT00770432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92925894|NCT00770432|Laxatives|laxatives|mesh-ancestor
92925895|NCT00770432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925896|NCT00792701|Gemcitabine|gemcitabine|mesh-list
92925897|NCT00792701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925898|NCT00792701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92925899|NCT00792701|Antimetabolites|antimetabolites|mesh-ancestor
92925900|NCT00792701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925901|NCT03772353|Letrozole|letrozole|mesh-list
92925902|NCT03772353|Fulvestrant|fulvestrant|mesh-list
92925903|NCT03772353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925904|NCT03772353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92925905|NCT03772353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92925906|NCT03772353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925907|NCT03772353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925908|NCT03772353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92925909|NCT03772353|Hormone Antagonists|hormone antagonists|mesh-ancestor
92925910|NCT03772353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925911|NCT03772353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925912|NCT03772353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92925913|NCT03772353|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92925914|NCT05559983|Aluminum phosphate|aluminum phosphate|mesh-list
92925915|NCT05559983|Vaccines|vaccines|mesh-list
92925916|NCT05559983|Immunologic Factors|immunologic factors|mesh-ancestor
92925917|NCT05559983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925918|NCT05559983|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92925919|NCT05559983|Antacids|antacids|mesh-ancestor
92925920|NCT05559983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270799|NCT01684397|Antibodies|antibodies|mesh-list
92925921|NCT05559983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92925922|NCT03765567|Vancomycin|vancomycin|mesh-list
92925923|NCT03765567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925924|NCT03765567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925925|NCT00777296|Amikacin|amikacin|mesh-list
92925926|NCT00777296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925927|NCT00777296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925928|NCT00756470|Paclitaxel|paclitaxel|mesh-list
92925929|NCT00756470|Cyclophosphamide|cyclophosphamide|mesh-list
92925930|NCT00756470|Fluorouracil|fluorouracil|mesh-list
92925931|NCT00756470|Epirubicin|epirubicin|mesh-list
92925932|NCT00756470|Lapatinib|lapatinib|mesh-list
92925933|NCT00756470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92925934|NCT00756470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925935|NCT00756470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92925936|NCT00756470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92925937|NCT00756470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92925938|NCT00756470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925939|NCT00756470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92925940|NCT00756470|Immunologic Factors|immunologic factors|mesh-ancestor
92925941|NCT00756470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925942|NCT00756470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92925943|NCT00756470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92925944|NCT00756470|Alkylating Agents|alkylating agents|mesh-ancestor
92925945|NCT00756470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92925946|NCT00756470|Antimetabolites|antimetabolites|mesh-ancestor
92925947|NCT00756470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92925948|NCT00756470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92925949|NCT00756470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92925950|NCT00756470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92925951|NCT00756470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925952|NCT00756470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92925953|NCT00756314|Contraceptive Agents|contraceptive agents|mesh-list
92925954|NCT00756314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92925955|NCT00756314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925956|NCT00727506|Afatinib|afatinib|mesh-list
92925957|NCT00727506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92925958|NCT00727506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92925959|NCT00727506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925960|NCT00727506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925961|NCT00789815|Midazolam|midazolam|mesh-list
92925962|NCT00789815|Propofol|propofol|mesh-list
92925963|NCT00789815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92925964|NCT00789815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92925965|NCT00789815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925966|NCT00789815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92925967|NCT00789815|Anesthetics, General|anesthetics, general|mesh-ancestor
92925968|NCT00789815|Anesthetics|anesthetics|mesh-ancestor
92925969|NCT00789815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92925970|NCT00789815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92925971|NCT00789815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92925972|NCT00789815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92925973|NCT00789815|GABA Modulators|gaba modulators|mesh-ancestor
92925974|NCT00789815|GABA Agents|gaba agents|mesh-ancestor
92925975|NCT00789815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92925976|NCT00789815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925977|NCT00721578|Voriconazole|voriconazole|mesh-list
92925978|NCT00721578|Antifungal Agents|antifungal agents|mesh-ancestor
92925979|NCT00721578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925980|NCT00721578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92925981|NCT00721578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92925982|NCT00721578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92925983|NCT00721578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925984|NCT00721578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92925985|NCT00721578|Hormone Antagonists|hormone antagonists|mesh-ancestor
92925986|NCT00721578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92925987|NCT00721578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92925988|NCT00721578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92925989|NCT00789737|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92925990|NCT00789737|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92925991|NCT00789737|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92925992|NCT00789737|Antimetabolites|antimetabolites|mesh-ancestor
92925993|NCT00789737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92925994|NCT00789737|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92925996|NCT04019574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92925997|NCT04019574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92925998|NCT04019574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92925999|NCT04019574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92926000|NCT04019574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926001|NCT04019574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926002|NCT04019574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926003|NCT00792467|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92926004|NCT00792467|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92926005|NCT00792467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926006|NCT00792467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926007|NCT00585468|Mycophenolic Acid|mycophenolic acid|mesh-list
92146610|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
92926008|NCT00585468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92926009|NCT00585468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926010|NCT00585468|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92926011|NCT00585468|Antitubercular Agents|antitubercular agents|mesh-ancestor
92926012|NCT00585468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926013|NCT00585468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926014|NCT00585468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926015|NCT00585468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926016|NCT05600387|Empagliflozin|empagliflozin|mesh-list
92926017|NCT05600387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92926018|NCT05600387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926019|NCT05600387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92926020|NCT05600387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926021|NCT00721110|Lidocaine|lidocaine|mesh-list
92926022|NCT00721110|Ketamine|ketamine|mesh-list
92926023|NCT00721110|Anesthetics, Local|anesthetics, local|mesh-ancestor
92926024|NCT00721110|Anesthetics|anesthetics|mesh-ancestor
92926025|NCT00721110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926026|NCT00721110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926027|NCT00721110|Sensory System Agents|sensory system agents|mesh-ancestor
92926028|NCT00721110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926029|NCT00721110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92926030|NCT00721110|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92926031|NCT00721110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92926032|NCT00721110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571484|NCT00229567|Lidocaine|lidocaine|mesh-list
92926033|NCT00721110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926034|NCT00721110|Analgesics|analgesics|mesh-ancestor
92926035|NCT00721110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92926036|NCT00721110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92926037|NCT00721110|Anesthetics, General|anesthetics, general|mesh-ancestor
92926038|NCT00721110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92926039|NCT00721110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92926040|NCT00721110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926041|NCT02592096|Carbamide Peroxide|carbamide peroxide|mesh-list
92926042|NCT02592096|Pazufloxacin|pazufloxacin|mesh-list
92926043|NCT02592096|Fluoroquinolones|fluoroquinolones|mesh-list
92926044|NCT02592096|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92926045|NCT02592096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926046|NCT02592096|Antitubercular Agents|antitubercular agents|mesh-ancestor
92926047|NCT02592096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926048|NCT02592096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92926049|NCT02592096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92926050|NCT02592096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926051|NCT02592096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926052|NCT02592096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926053|NCT02592096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92926054|NCT00791999|Certolizumab Pegol|certolizumab pegol|mesh-list
92926055|NCT00791999|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92926056|NCT00791999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926057|NCT00791999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926058|NCT00791999|Immunologic Factors|immunologic factors|mesh-ancestor
92926059|NCT00791999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926060|NCT00791999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926061|NCT04085484|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
92926062|NCT04085484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92926063|NCT04033263|Fluorides|fluorides|mesh-list
92926064|NCT04033263|Cariostatic Agents|cariostatic agents|mesh-ancestor
92926065|NCT04033263|Protective Agents|protective agents|mesh-ancestor
92270946|NCT03019887|Analgesics|analgesics|mesh-ancestor
92926066|NCT04033263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926067|NCT04075227|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92926068|NCT04075227|Dexamethasone|dexamethasone|mesh-list
92926069|NCT04075227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926070|NCT04075227|Antiemetics|antiemetics|mesh-ancestor
92926071|NCT04075227|Autonomic Agents|autonomic agents|mesh-ancestor
92926072|NCT04075227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926073|NCT04075227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926074|NCT04075227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926075|NCT04075227|Glucocorticoids|glucocorticoids|mesh-ancestor
92926076|NCT04075227|Hormones|hormones|mesh-ancestor
92926077|NCT04075227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163125|NCT01925911|Midazolam|midazolam|mesh-list
92926078|NCT04075227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92926079|NCT04075227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926080|NCT04075227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92926081|NCT00585078|Capecitabine|capecitabine|mesh-list
92926082|NCT00585078|Oxaliplatin|oxaliplatin|mesh-list
92926083|NCT00585078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926084|NCT00585078|Antimetabolites|antimetabolites|mesh-ancestor
92926085|NCT00585078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926086|NCT00585078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926087|NCT00720876|Rituximab|rituximab|mesh-list
92926088|NCT00720876|Vorinostat|vorinostat|mesh-list
92926089|NCT00720876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926090|NCT00720876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926091|NCT00720876|Immunologic Factors|immunologic factors|mesh-ancestor
92926092|NCT00720876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926093|NCT00720876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926094|NCT00720876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92926095|NCT00720876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926096|NCT00720876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926097|NCT00789581|Paclitaxel|paclitaxel|mesh-list
92926098|NCT00789581|Cyclophosphamide|cyclophosphamide|mesh-list
92926099|NCT00789581|Doxorubicin|doxorubicin|mesh-list
92926100|NCT00789581|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92926101|NCT00789581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92926102|NCT00789581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926103|NCT00789581|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926104|NCT00789581|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926105|NCT00789581|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926106|NCT00789581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926107|NCT00789581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926108|NCT00789581|Immunologic Factors|immunologic factors|mesh-ancestor
92926109|NCT00789581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926110|NCT00789581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926111|NCT00789581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92926112|NCT00789581|Alkylating Agents|alkylating agents|mesh-ancestor
92926113|NCT00789581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92926114|NCT00789581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92926115|NCT00789581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92926116|NCT00789581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92926117|NCT00789581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926119|NCT00717756|Immunologic Factors|immunologic factors|mesh-ancestor
92926120|NCT00717756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926121|NCT00717756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926122|NCT00717756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926123|NCT00717756|Growth Substances|growth substances|mesh-ancestor
92926124|NCT00717756|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926125|NCT00717756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926126|NCT04111289|Tirofiban|tirofiban|mesh-list
92926127|NCT04111289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92926128|NCT04111289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92926129|NCT04111289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926130|NCT04111289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92926131|NCT04108637|Penicillins|penicillins|mesh-list
92926132|NCT04108637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926133|NCT04108637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926134|NCT05674539|Vidarabine|vidarabine|mesh-list
92926135|NCT05674539|Fludarabine|fludarabine|mesh-list
92926136|NCT05674539|Fludarabine phosphate|fludarabine phosphate|mesh-list
92926137|NCT05674539|Melphalan|melphalan|mesh-list
92926138|NCT05674539|Busulfan|busulfan|mesh-list
92926139|NCT05674539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926140|NCT05674539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926141|NCT05674539|Antimetabolites|antimetabolites|mesh-ancestor
92926142|NCT05674539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926143|NCT05674539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926144|NCT05674539|Immunologic Factors|immunologic factors|mesh-ancestor
92926145|NCT05674539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926146|NCT05674539|Antiviral Agents|antiviral agents|mesh-ancestor
92926147|NCT05674539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926148|NCT05674539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92926149|NCT05674539|Alkylating Agents|alkylating agents|mesh-ancestor
92926150|NCT05674539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92926151|NCT00717522|Pomalidomide|pomalidomide|mesh-list
92926152|NCT00717522|Immunologic Factors|immunologic factors|mesh-ancestor
92926153|NCT00717522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926154|NCT00717522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926155|NCT00717522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926156|NCT00717522|Growth Substances|growth substances|mesh-ancestor
92926157|NCT00717522|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926158|NCT00717522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926159|NCT00791921|Certolizumab Pegol|certolizumab pegol|mesh-list
92926160|NCT00791921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92926161|NCT00791921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926162|NCT00791921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926163|NCT00791921|Immunologic Factors|immunologic factors|mesh-ancestor
92926164|NCT00791921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926165|NCT00791921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926166|NCT04106843|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92926167|NCT04106843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926168|NCT04106843|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92926169|NCT03475953|Avelumab|avelumab|mesh-list
92926170|NCT03475953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92926171|NCT03475953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926172|NCT03475953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926173|NCT03475953|Immunologic Factors|immunologic factors|mesh-ancestor
92926174|NCT03475953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926175|NCT00582933|Vidarabine|vidarabine|mesh-list
92926176|NCT00582933|Fludarabine|fludarabine|mesh-list
92926177|NCT00582933|Fludarabine phosphate|fludarabine phosphate|mesh-list
92926178|NCT00582933|Melphalan|melphalan|mesh-list
92926179|NCT00582933|Busulfan|busulfan|mesh-list
92926180|NCT00582933|Lenograstim|lenograstim|mesh-list
92926181|NCT00582933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571641|NCT00230503|Adefovir|adefovir|mesh-list
92926182|NCT00582933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926183|NCT00582933|Antimetabolites|antimetabolites|mesh-ancestor
92926184|NCT00582933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926185|NCT00582933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926186|NCT00582933|Immunologic Factors|immunologic factors|mesh-ancestor
92926187|NCT00582933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926188|NCT00582933|Antiviral Agents|antiviral agents|mesh-ancestor
92926189|NCT00582933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926190|NCT00582933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92926191|NCT00582933|Alkylating Agents|alkylating agents|mesh-ancestor
92926192|NCT00582933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92926193|NCT00582933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92926195|NCT00791765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92926196|NCT00791765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92926197|NCT00791765|Analgesics|analgesics|mesh-ancestor
92926198|NCT00791765|Sensory System Agents|sensory system agents|mesh-ancestor
92926199|NCT00791765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926200|NCT00791765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926201|NCT00791765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926202|NCT00791765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926203|NCT00791765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926204|NCT00791765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926205|NCT00791765|Immunologic Factors|immunologic factors|mesh-ancestor
92926206|NCT00789191|Metformin|metformin|mesh-list
92926207|NCT00789191|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92926208|NCT00789191|Insulin Detemir|insulin detemir|mesh-list
92926209|NCT00789191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92926210|NCT00789191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926211|NCT00789191|Incretins|incretins|mesh-ancestor
92926212|NCT00789191|Hormones|hormones|mesh-ancestor
92163144|NCT01921231|Bupivacaine|bupivacaine|mesh-list
92926213|NCT00789191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926214|NCT00789191|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92926215|NCT00789191|Protease Inhibitors|protease inhibitors|mesh-ancestor
92926216|NCT00789191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926217|NCT00789191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926218|NCT02603315|Mitogens|mitogens|mesh-list
92926219|NCT02603315|Endothelial Growth Factors|endothelial growth factors|mesh-list
92926220|NCT02603315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926221|NCT02603315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926222|NCT02603315|Growth Substances|growth substances|mesh-ancestor
92926223|NCT02603315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926224|NCT00789035|Metformin|metformin|mesh-list
92926225|NCT00789035|Empagliflozin|empagliflozin|mesh-list
92926226|NCT00789035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92926227|NCT00789035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926228|NCT00789035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92926229|NCT00789035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926230|NCT04108013|Paclitaxel|paclitaxel|mesh-list
92926231|NCT04108013|Carboplatin|carboplatin|mesh-list
92926232|NCT04108013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92926233|NCT04108013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926234|NCT04108013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926235|NCT04108013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926236|NCT04108013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926237|NCT04108013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926238|NCT04105985|Oxymetazoline|oxymetazoline|mesh-list
92926239|NCT04105985|Tetracaine|tetracaine|mesh-list
92926240|NCT04105985|Carticaine|carticaine|mesh-list
92926241|NCT04105985|Anesthetics, Local|anesthetics, local|mesh-ancestor
92926242|NCT04105985|Anesthetics|anesthetics|mesh-ancestor
92926243|NCT04105985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926244|NCT04105985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926245|NCT04105985|Sensory System Agents|sensory system agents|mesh-ancestor
92926246|NCT04105985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926247|NCT04105985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92926248|NCT04105985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92926249|NCT04105985|Adrenergic Agents|adrenergic agents|mesh-ancestor
92926250|NCT04105985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926251|NCT04105985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926252|NCT04105985|Sympathomimetics|sympathomimetics|mesh-ancestor
92926253|NCT04105985|Autonomic Agents|autonomic agents|mesh-ancestor
92926254|NCT04105985|Nasal Decongestants|nasal decongestants|mesh-ancestor
92926255|NCT04105985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92926256|NCT04105985|Respiratory System Agents|respiratory system agents|mesh-ancestor
92926257|NCT04074213|Clozapine|clozapine|mesh-list
92571698|NCT00075738|Irinotecan|irinotecan|mesh-list
92926258|NCT04074213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92926259|NCT04074213|Serotonin Agents|serotonin agents|mesh-ancestor
92926260|NCT04074213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926261|NCT04074213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926262|NCT04074213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926263|NCT04074213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92926264|NCT04074213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92926265|NCT04074213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926266|NCT04074213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92926267|NCT04074213|GABA Antagonists|gaba antagonists|mesh-ancestor
92926268|NCT04074213|GABA Agents|gaba agents|mesh-ancestor
92926269|NCT04110587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92926270|NCT04110587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92926271|NCT04110587|Analgesics|analgesics|mesh-list
92926272|NCT04110587|Hyaluronic Acid|hyaluronic acid|mesh-list
92926273|NCT04110587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926274|NCT04110587|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92926275|NCT04110587|Immunologic Factors|immunologic factors|mesh-ancestor
92926276|NCT04110587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926277|NCT04110587|Viscosupplements|viscosupplements|mesh-ancestor
92926278|NCT04110587|Protective Agents|protective agents|mesh-ancestor
92926279|NCT04110587|Sensory System Agents|sensory system agents|mesh-ancestor
92926280|NCT04110587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926281|NCT03534453|Olaparib|olaparib|mesh-list
92926282|NCT03534453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92926283|NCT03534453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926284|NCT03534453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926285|NCT03534453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926286|NCT04074915|Chlorhexidine|chlorhexidine|mesh-list
92926287|NCT04074915|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92926288|NCT04074915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926289|NCT04074915|Disinfectants|disinfectants|mesh-ancestor
92926290|NCT02579733|Azathioprine|azathioprine|mesh-list
92926291|NCT02579733|Antimetabolites|antimetabolites|mesh-ancestor
92926292|NCT02579733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926293|NCT02579733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926294|NCT02579733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926295|NCT02579733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926296|NCT02579733|Immunologic Factors|immunologic factors|mesh-ancestor
92926297|NCT02579733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926298|NCT02579733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926299|NCT03326193|Bevacizumab|bevacizumab|mesh-list
92926300|NCT03326193|Niraparib|niraparib|mesh-list
92926301|NCT03326193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926302|NCT03326193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926303|NCT03326193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926304|NCT03326193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926305|NCT03326193|Growth Substances|growth substances|mesh-ancestor
92926306|NCT03326193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926307|NCT03326193|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926308|NCT03326193|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92926309|NCT03326193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926310|NCT03326193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926311|NCT02517099|Azithromycin|azithromycin|mesh-list
92926312|NCT02517099|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92926313|NCT02517099|Beclomethasone|beclomethasone|mesh-list
92926314|NCT02517099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926315|NCT02517099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926316|NCT02517099|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92926317|NCT02517099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926318|NCT02517099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926319|NCT02517099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926320|NCT02517099|Glucocorticoids|glucocorticoids|mesh-ancestor
92926321|NCT02517099|Hormones|hormones|mesh-ancestor
92926322|NCT02517099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926323|NCT02517099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926324|NCT02517099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92926325|NCT02517099|Respiratory System Agents|respiratory system agents|mesh-ancestor
92926326|NCT02478099|Atezolizumab|atezolizumab|mesh-list
92926327|NCT02478099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92926328|NCT02478099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926329|NCT02478099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926330|NCT02478099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926331|NCT02473263|Ceftriaxone|ceftriaxone|mesh-list
92926332|NCT02473263|Tazobactam|tazobactam|mesh-list
92926333|NCT02473263|Piperacillin|piperacillin|mesh-list
92926334|NCT02473263|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92926335|NCT02473263|Hydrocortisone|hydrocortisone|mesh-list
92926336|NCT02473263|Norepinephrine|norepinephrine|mesh-list
92926337|NCT02473263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926338|NCT02473263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92926339|NCT02473263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92926340|NCT02473263|Adrenergic Agents|adrenergic agents|mesh-ancestor
92926341|NCT02473263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926342|NCT02473263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926343|NCT02473263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926344|NCT02473263|Sympathomimetics|sympathomimetics|mesh-ancestor
92926345|NCT02473263|Autonomic Agents|autonomic agents|mesh-ancestor
92926346|NCT02473263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926347|NCT02473263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92926348|NCT02473263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926349|NCT02473263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926350|NCT02473263|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92926351|NCT02473263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926352|NCT03249831|Mycophenolic Acid|mycophenolic acid|mesh-list
92926353|NCT03249831|Cyclophosphamide|cyclophosphamide|mesh-list
92926354|NCT03249831|Pentostatin|pentostatin|mesh-list
92926355|NCT03249831|Tacrolimus|tacrolimus|mesh-list
92926356|NCT03249831|Thymoglobulin|thymoglobulin|mesh-list
92926357|NCT03249831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92926358|NCT03249831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926359|NCT03249831|Immunologic Factors|immunologic factors|mesh-ancestor
92926360|NCT03249831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926361|NCT03249831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926362|NCT03249831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92926363|NCT03249831|Alkylating Agents|alkylating agents|mesh-ancestor
92926364|NCT03249831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926365|NCT03249831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926366|NCT03249831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92926367|NCT03249831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92926368|NCT03249831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926369|NCT03249831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92926370|NCT03249831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92926371|NCT03249831|Antitubercular Agents|antitubercular agents|mesh-ancestor
92926372|NCT03249831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926373|NCT03249831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926374|NCT03249831|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92926375|NCT03222609|Navitoclax|navitoclax|mesh-list
92926376|NCT03222609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926377|NCT00437203|Gemcitabine|gemcitabine|mesh-list
92926378|NCT00437203|PF 00477736|pf 00477736|mesh-list
92926379|NCT00437203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926380|NCT00437203|Antimetabolites|antimetabolites|mesh-ancestor
92926381|NCT00437203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926382|NCT00437203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926383|NCT00437203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92926384|NCT00437203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926385|NCT02419287|Crizotinib|crizotinib|mesh-list
92926386|NCT02419287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926387|NCT02419287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92926388|NCT02419287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926389|NCT02419287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926390|NCT00437125|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92926391|NCT00437125|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92926392|NCT00437125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92926393|NCT00437125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92926394|NCT00437125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926395|NCT00437125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926396|NCT00437125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926397|NCT00437125|Analgesics|analgesics|mesh-ancestor
92926398|NCT00437125|Sensory System Agents|sensory system agents|mesh-ancestor
92926399|NCT00437125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926400|NCT00437125|Antidepressive Agents|antidepressive agents|mesh-ancestor
92926401|NCT00437125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92926402|NCT00437125|Dopamine Agents|dopamine agents|mesh-ancestor
92926403|NCT01028287|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92926404|NCT01028287|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92926405|NCT01028287|beta-Endorphin|beta-endorphin|mesh-list
92571853|NCT00075933|Beta-lapachone|beta-lapachone|mesh-list
92926406|NCT01028287|Hormones|hormones|mesh-ancestor
92926407|NCT01028287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926408|NCT01028287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926409|NCT01028287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926410|NCT01028287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926411|NCT01028443|Cyclosporine|cyclosporine|mesh-list
92926412|NCT01028443|Antifungal Agents|antifungal agents|mesh-ancestor
92926413|NCT01028443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926414|NCT01028443|Dermatologic Agents|dermatologic agents|mesh-ancestor
92926415|NCT01028443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926416|NCT01028443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926417|NCT01028443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926418|NCT01028443|Immunologic Factors|immunologic factors|mesh-ancestor
92926419|NCT01028443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926420|NCT01028443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926421|NCT01028443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92926422|NCT03116997|Glycopyrrolate|glycopyrrolate|mesh-list
92926423|NCT03116997|Neostigmine|neostigmine|mesh-list
92926424|NCT03116997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92926425|NCT03116997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926426|NCT03116997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926427|NCT03116997|Cholinergic Agents|cholinergic agents|mesh-ancestor
92926428|NCT03116997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926429|NCT03116997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926430|NCT03116997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92926431|NCT03116997|Autonomic Agents|autonomic agents|mesh-ancestor
92926432|NCT03116997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926433|NCT03116997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92926434|NCT03116997|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92926435|NCT03116997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92926436|NCT02600780|Allopurinol|allopurinol|mesh-list
92926437|NCT02600780|Febuxostat|febuxostat|mesh-list
92926438|NCT02600780|Antimetabolites|antimetabolites|mesh-ancestor
92926439|NCT02600780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926440|NCT02600780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926441|NCT02600780|Gout Suppressants|gout suppressants|mesh-ancestor
92926442|NCT02600780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926443|NCT02600780|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92926444|NCT02600780|Antioxidants|antioxidants|mesh-ancestor
92926445|NCT02600780|Protective Agents|protective agents|mesh-ancestor
92926446|NCT02600780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926447|NCT00582309|Insulin|insulin|mesh-list
92926448|NCT00582309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92926449|NCT00582309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92926450|NCT00582309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926451|NCT00443053|PENTA|penta|mesh-list
92926452|NCT00443053|Fondaparinux|fondaparinux|mesh-list
92926453|NCT00443053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92926454|NCT00443053|Antithrombins|antithrombins|mesh-ancestor
92926455|NCT00443053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92926456|NCT00443053|Protease Inhibitors|protease inhibitors|mesh-ancestor
92926457|NCT00443053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926458|NCT00443053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926459|NCT00443053|Anticoagulants|anticoagulants|mesh-ancestor
92926460|NCT00443053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92926461|NCT00443053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92926462|NCT00720798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92926463|NCT00720798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92926464|NCT00720798|Antirheumatic Agents|antirheumatic agents|mesh-list
92926465|NCT00720798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92926466|NCT00720798|Analgesics|analgesics|mesh-ancestor
92926467|NCT00720798|Sensory System Agents|sensory system agents|mesh-ancestor
92926468|NCT00720798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926469|NCT00720798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926470|NCT01816971|Dexamethasone|dexamethasone|mesh-list
92926471|NCT01816971|Lenalidomide|lenalidomide|mesh-list
92926472|NCT01816971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926473|NCT01816971|Antiemetics|antiemetics|mesh-ancestor
92926474|NCT01816971|Autonomic Agents|autonomic agents|mesh-ancestor
92926475|NCT01816971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926476|NCT01816971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926477|NCT01816971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926478|NCT01816971|Glucocorticoids|glucocorticoids|mesh-ancestor
92926479|NCT01816971|Hormones|hormones|mesh-ancestor
92926480|NCT01816971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926481|NCT01816971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92926482|NCT01816971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926483|NCT01816971|Immunologic Factors|immunologic factors|mesh-ancestor
92926484|NCT01816971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926485|NCT01816971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926486|NCT01816971|Growth Substances|growth substances|mesh-ancestor
92926487|NCT01816971|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926488|NCT01021267|Saw palmetto extract|saw palmetto extract|mesh-list
92926489|NCT01021267|Urological Agents|urological agents|mesh-ancestor
92926490|NCT00717366|Epoetin Alfa|epoetin alfa|mesh-list
92926491|NCT00717366|Hematinics|hematinics|mesh-ancestor
92926492|NCT02939989|Ribavirin|ribavirin|mesh-list
92926493|NCT02939989|Sofosbuvir|sofosbuvir|mesh-list
92926494|NCT02939989|Antimetabolites|antimetabolites|mesh-ancestor
92926495|NCT02939989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926496|NCT02939989|Antiviral Agents|antiviral agents|mesh-ancestor
92926497|NCT02939989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926498|NCT04096742|Tretinoin|tretinoin|mesh-list
92926499|NCT04096742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926500|NCT04096742|Keratolytic Agents|keratolytic agents|mesh-ancestor
92926501|NCT04096742|Dermatologic Agents|dermatologic agents|mesh-ancestor
92926502|NCT04085640|Ropivacaine|ropivacaine|mesh-list
92926503|NCT04085640|Anesthetics, Local|anesthetics, local|mesh-ancestor
92926504|NCT04085640|Anesthetics|anesthetics|mesh-ancestor
92926505|NCT04085640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926506|NCT04085640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926507|NCT04085640|Sensory System Agents|sensory system agents|mesh-ancestor
92926508|NCT04085640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926509|NCT01031719|Vaccines|vaccines|mesh-list
92926510|NCT01031719|Immunologic Factors|immunologic factors|mesh-ancestor
92926511|NCT01031719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926512|NCT00723606|Haloperidol|haloperidol|mesh-list
92926513|NCT00723606|Haloperidol decanoate|haloperidol decanoate|mesh-list
92926514|NCT00723606|Ziprasidone|ziprasidone|mesh-list
92926515|NCT00723606|Antiemetics|antiemetics|mesh-ancestor
92926516|NCT00723606|Autonomic Agents|autonomic agents|mesh-ancestor
92926517|NCT00723606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926518|NCT00723606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926519|NCT00723606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926520|NCT00723606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92926521|NCT00723606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92926522|NCT00723606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926523|NCT00723606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92926524|NCT00723606|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92926525|NCT00723606|Dopamine Agents|dopamine agents|mesh-ancestor
92926526|NCT00723606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926527|NCT00723606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926528|NCT00723606|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92926529|NCT00723606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92926530|NCT00723606|Serotonin Agents|serotonin agents|mesh-ancestor
92926531|NCT01021501|Nifedipine|nifedipine|mesh-list
92926532|NCT01021501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92926533|NCT01021501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92926534|NCT01021501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926535|NCT01021501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92926536|NCT01021501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926537|NCT01021501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92926538|NCT01021501|Tocolytic Agents|tocolytic agents|mesh-ancestor
92926539|NCT01021501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92926540|NCT01021579|Metformin|metformin|mesh-list
92926541|NCT01021579|Simvastatin|simvastatin|mesh-list
92926542|NCT01021579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92926543|NCT01021579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926544|NCT01021579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92926545|NCT01021579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92926546|NCT01021579|Antimetabolites|antimetabolites|mesh-ancestor
92926547|NCT01021579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926548|NCT01021579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92926549|NCT01021579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92926550|NCT01021579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926551|NCT01031875|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92926552|NCT01031875|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92926553|NCT01031875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926554|NCT01021735|Adalimumab|adalimumab|mesh-list
92926555|NCT01021735|Etanercept|etanercept|mesh-list
92926556|NCT01021735|Rituximab|rituximab|mesh-list
92926557|NCT01021735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926558|NCT01021735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926559|NCT01021735|Immunologic Factors|immunologic factors|mesh-ancestor
92926560|NCT01021735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926561|NCT01021735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926562|NCT01021735|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92926563|NCT01021735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926564|NCT01021735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92926565|NCT01021735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92926566|NCT01021735|Analgesics|analgesics|mesh-ancestor
92926567|NCT01021735|Sensory System Agents|sensory system agents|mesh-ancestor
92926568|NCT01021735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926569|NCT01021735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926570|NCT01021735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926571|NCT00442351|Mometasone Furoate|mometasone furoate|mesh-list
92926572|NCT00442351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926573|NCT00442351|Dermatologic Agents|dermatologic agents|mesh-ancestor
92926574|NCT00442351|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92926575|NCT00436501|Docetaxel|docetaxel|mesh-list
92926576|NCT00436501|Aflibercept|aflibercept|mesh-list
92926577|NCT00436501|Endothelial Growth Factors|endothelial growth factors|mesh-list
92926578|NCT00436501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926579|NCT00436501|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926580|NCT00436501|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926581|NCT00436501|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926582|NCT00436501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926583|NCT00436501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926584|NCT00436501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926585|NCT00436501|Growth Substances|growth substances|mesh-ancestor
92926586|NCT00436501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926587|NCT00436501|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926588|NCT00755846|Alogliptin|alogliptin|mesh-list
92926589|NCT00755846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92926590|NCT00755846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926591|NCT00755846|Incretins|incretins|mesh-ancestor
92926592|NCT00755846|Hormones|hormones|mesh-ancestor
92926593|NCT00755846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926594|NCT00755846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92926595|NCT00755846|Protease Inhibitors|protease inhibitors|mesh-ancestor
92926596|NCT00755846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926597|NCT00755846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926598|NCT03850093|Bisoprolol|bisoprolol|mesh-list
92926599|NCT03850093|Gabapentin|gabapentin|mesh-list
92926600|NCT03850093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926601|NCT03850093|Analgesics|analgesics|mesh-ancestor
92926602|NCT03850093|Sensory System Agents|sensory system agents|mesh-ancestor
92926603|NCT03850093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926604|NCT03850093|Anticonvulsants|anticonvulsants|mesh-ancestor
92926605|NCT03850093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92926606|NCT03850093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92926607|NCT03850093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926608|NCT03850093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92926609|NCT03850093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92926610|NCT03850093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92926611|NCT03850093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926612|NCT03850093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926613|NCT03850093|Antimanic Agents|antimanic agents|mesh-ancestor
92926614|NCT03850093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92926615|NCT03850093|Sympatholytics|sympatholytics|mesh-ancestor
92926616|NCT03850093|Autonomic Agents|autonomic agents|mesh-ancestor
92926617|NCT03850093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92926618|NCT03850093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92926619|NCT03850093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92926620|NCT03850093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92926621|NCT00442117|Mometasone Furoate|mometasone furoate|mesh-list
92926622|NCT00442117|Budesonide|budesonide|mesh-list
92926623|NCT00442117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926624|NCT00442117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92926625|NCT00442117|Autonomic Agents|autonomic agents|mesh-ancestor
92926626|NCT00442117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926627|NCT00442117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926628|NCT00442117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92926629|NCT00442117|Respiratory System Agents|respiratory system agents|mesh-ancestor
92926630|NCT00442117|Glucocorticoids|glucocorticoids|mesh-ancestor
92926631|NCT00442117|Hormones|hormones|mesh-ancestor
92926632|NCT00442117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926633|NCT00442117|Dermatologic Agents|dermatologic agents|mesh-ancestor
92926634|NCT00442117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92926635|NCT00752726|Orlistat|orlistat|mesh-list
92926636|NCT00752726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926637|NCT00752726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926638|NCT00752726|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92926639|NCT00752726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92926640|NCT04072497|Vaccines|vaccines|mesh-list
92926641|NCT04072497|Immunologic Factors|immunologic factors|mesh-ancestor
92926642|NCT04072497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926643|NCT04072263|Interferons|interferons|mesh-list
92926644|NCT04072263|Interferon-alpha|interferon-alpha|mesh-list
92926645|NCT04072263|Interferon alpha-2|interferon alpha-2|mesh-list
92926646|NCT04072263|Paclitaxel|paclitaxel|mesh-list
92926647|NCT04072263|Carboplatin|carboplatin|mesh-list
92926648|NCT04072263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92926649|NCT04072263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926650|NCT04072263|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926651|NCT04072263|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926652|NCT04072263|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926653|NCT04072263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926654|NCT04072263|Antiviral Agents|antiviral agents|mesh-ancestor
92926655|NCT04072263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926656|NCT04072263|Immunologic Factors|immunologic factors|mesh-ancestor
92926657|NCT04072263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926658|NCT00441727|Esomeprazole|esomeprazole|mesh-list
92926659|NCT00441727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92926660|NCT00441727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926661|NCT00441727|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92926662|NCT00441727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926663|NCT00441727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926664|NCT00770120|Everolimus|everolimus|mesh-list
92926665|NCT00770120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92926666|NCT00770120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92926667|NCT00770120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926668|NCT00770120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926669|NCT00770120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926670|NCT00770120|Immunologic Factors|immunologic factors|mesh-ancestor
92926671|NCT00770120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926672|NCT00770120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926673|NCT03996655|Neostigmine|neostigmine|mesh-list
92163201|NCT02393183|Selenium|selenium|mesh-list
92926674|NCT03996655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92926675|NCT03996655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926676|NCT03996655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926677|NCT03996655|Cholinergic Agents|cholinergic agents|mesh-ancestor
92926678|NCT03996655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926679|NCT03996655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926680|NCT03996655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92926681|NCT03996655|Autonomic Agents|autonomic agents|mesh-ancestor
92926682|NCT03996655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926683|NCT01032109|Bevacizumab|bevacizumab|mesh-list
92926684|NCT01032109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926685|NCT01032109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926686|NCT01032109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926687|NCT01032109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926688|NCT01032109|Growth Substances|growth substances|mesh-ancestor
92926689|NCT01032109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926690|NCT01032109|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926692|NCT04100330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926693|NCT04100330|Antimetabolites|antimetabolites|mesh-ancestor
92926694|NCT04100330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926695|NCT04100330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926696|NCT04100330|Antiviral Agents|antiviral agents|mesh-ancestor
92926697|NCT04100330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926698|NCT04100330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926699|NCT04100330|Immunologic Factors|immunologic factors|mesh-ancestor
92926700|NCT04100330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926701|NCT00436345|Remifentanil|remifentanil|mesh-list
92926702|NCT00436345|Propofol|propofol|mesh-list
92926703|NCT00436345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92926704|NCT00436345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926705|NCT00436345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926706|NCT00436345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92926707|NCT00436345|Anesthetics, General|anesthetics, general|mesh-ancestor
92926708|NCT00436345|Anesthetics|anesthetics|mesh-ancestor
92926709|NCT00436345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92926710|NCT00436345|Narcotics|narcotics|mesh-ancestor
92926711|NCT00436345|Analgesics|analgesics|mesh-ancestor
92926712|NCT00436345|Sensory System Agents|sensory system agents|mesh-ancestor
92926713|NCT00436345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926714|NCT00916448|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92926715|NCT00916448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92926716|NCT00916448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92926717|NCT00916448|Protease Inhibitors|protease inhibitors|mesh-ancestor
92926718|NCT00916448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926719|NCT00916448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926720|NCT00916448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92926721|NCT00916448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92926722|NCT00916448|Antiviral Agents|antiviral agents|mesh-ancestor
92926723|NCT00916448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926724|NCT01032187|Amphotericin B|amphotericin b|mesh-list
92926725|NCT01032187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92926726|NCT01032187|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92926727|NCT01032187|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92926728|NCT01032187|Deoxycholic Acid|deoxycholic acid|mesh-list
92926729|NCT01032187|Amebicides|amebicides|mesh-ancestor
92926730|NCT01032187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92926731|NCT01032187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92926732|NCT01032187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926733|NCT01032187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92926734|NCT01032187|Antifungal Agents|antifungal agents|mesh-ancestor
92926735|NCT01032187|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92926736|NCT01032187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926737|NCT00769184|Clobetasol|clobetasol|mesh-list
92926738|NCT00769184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526335|NCT00028366|Tenofovir|tenofovir|mesh-list
92926739|NCT00769184|Glucocorticoids|glucocorticoids|mesh-ancestor
92926741|NCT00769184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926742|NCT00769184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926743|NCT00768560|Nifedipine|nifedipine|mesh-list
92926744|NCT00768560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92926745|NCT00768560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92926746|NCT00768560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926747|NCT00768560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92926748|NCT00768560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926749|NCT00768560|Vasodilator Agents|vasodilator agents|mesh-ancestor
92926750|NCT00768560|Tocolytic Agents|tocolytic agents|mesh-ancestor
92926751|NCT00768560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92926752|NCT00468559|Esomeprazole|esomeprazole|mesh-list
92926753|NCT00468559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92926754|NCT00468559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926755|NCT00468559|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92926756|NCT00468559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026476|NCT00402051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92926757|NCT00468559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926758|NCT00754442|Teriparatide|teriparatide|mesh-list
92926759|NCT00754442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92926760|NCT00754442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926761|NCT00754442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92926762|NCT00754052|Donepezil|donepezil|mesh-list
92926763|NCT00754052|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92926764|NCT00754052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926765|NCT00754052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926766|NCT00754052|Cholinergic Agents|cholinergic agents|mesh-ancestor
92926767|NCT00754052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926768|NCT00754052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926769|NCT00754052|Nootropic Agents|nootropic agents|mesh-ancestor
92926770|NCT04095182|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92926771|NCT04095182|Anticonvulsants|anticonvulsants|mesh-ancestor
92926772|NCT04095182|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92926773|NCT04095182|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92926774|NCT04095182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92926775|NCT04095182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926776|NCT05430152|Naltrexone|naltrexone|mesh-list
92926777|NCT05430152|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92926778|NCT05430152|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92926779|NCT05430152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926780|NCT05430152|Sensory System Agents|sensory system agents|mesh-ancestor
92926781|NCT05430152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926782|NCT02927067|Valganciclovir|valganciclovir|mesh-list
92926783|NCT02927067|Maribavir|maribavir|mesh-list
92926784|NCT02927067|Antiviral Agents|antiviral agents|mesh-ancestor
92926785|NCT02927067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926786|NCT02600468|Abatacept|abatacept|mesh-list
92926787|NCT02600468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92926788|NCT02600468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926789|NCT02600468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926790|NCT02600468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926791|NCT02600468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926792|NCT02600468|Immunologic Factors|immunologic factors|mesh-ancestor
92926793|NCT02600468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926794|NCT02600468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926795|NCT02598596|Azathioprine|azathioprine|mesh-list
92926796|NCT02598596|Antimetabolites|antimetabolites|mesh-ancestor
92926797|NCT02598596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926798|NCT02598596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926799|NCT02598596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926800|NCT02598596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92926801|NCT02598596|Immunologic Factors|immunologic factors|mesh-ancestor
92926802|NCT02598596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926803|NCT02598596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926804|NCT01771107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92926805|NCT01771107|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92926806|NCT01771107|Doxorubicin|doxorubicin|mesh-list
92926807|NCT01771107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92926808|NCT01771107|Dacarbazine|dacarbazine|mesh-list
92926809|NCT01771107|Vinblastine|vinblastine|mesh-list
92926810|NCT01771107|Antibodies|antibodies|mesh-list
92271684|NCT02219516|Verinurad|verinurad|mesh-list
92926811|NCT01771107|Immunoglobulins|immunoglobulins|mesh-list
92926812|NCT01771107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92926813|NCT01771107|Imidazole|imidazole|mesh-list
92926814|NCT01771107|Immunoconjugates|immunoconjugates|mesh-list
92926815|NCT01771107|Immunologic Factors|immunologic factors|mesh-ancestor
92926816|NCT01771107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926817|NCT01771107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926818|NCT01771107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92926819|NCT01771107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92926820|NCT01771107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92926821|NCT01771107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926822|NCT01771107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926823|NCT01771107|Immunotoxins|immunotoxins|mesh-ancestor
92926824|NCT01771107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92926825|NCT01771107|Alkylating Agents|alkylating agents|mesh-ancestor
92926826|NCT01771107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92926827|NCT01771107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926828|NCT01771107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926829|NCT01771107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926830|NCT00586508|Bevacizumab|bevacizumab|mesh-list
92926831|NCT00586508|Anticonvulsants|anticonvulsants|mesh-list
92926832|NCT00586508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926833|NCT00586508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926834|NCT00586508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92926835|NCT00586508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92926836|NCT00586508|Growth Substances|growth substances|mesh-ancestor
92926837|NCT00586508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926838|NCT00586508|Growth Inhibitors|growth inhibitors|mesh-ancestor
92926839|NCT00581919|Acetylcarnitine|acetylcarnitine|mesh-list
92926840|NCT00581919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926841|NCT00581919|Vitamin B Complex|vitamin b complex|mesh-ancestor
92926842|NCT00581919|Vitamins|vitamins|mesh-ancestor
92926843|NCT00581919|Micronutrients|micronutrients|mesh-ancestor
92926844|NCT00581919|Nootropic Agents|nootropic agents|mesh-ancestor
92926845|NCT00723528|Ustekinumab|ustekinumab|mesh-list
92926846|NCT00723528|Dermatologic Agents|dermatologic agents|mesh-ancestor
92926847|NCT02892123|Paclitaxel|paclitaxel|mesh-list
92926848|NCT02892123|Vinorelbine|vinorelbine|mesh-list
92926849|NCT02892123|Capecitabine|capecitabine|mesh-list
92926850|NCT02892123|Tucatinib|tucatinib|mesh-list
92926851|NCT02892123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92926852|NCT02892123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926853|NCT02892123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926854|NCT02892123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926855|NCT02892123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926856|NCT02892123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926857|NCT02892123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92926858|NCT02892123|Antimetabolites|antimetabolites|mesh-ancestor
92926859|NCT02892123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92926860|NCT02892123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926861|NCT00751790|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92926862|NCT00751790|Luteolytic Agents|luteolytic agents|mesh-ancestor
92926863|NCT00751790|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92926864|NCT00751790|Contraceptive Agents|contraceptive agents|mesh-ancestor
92163310|NCT03342911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926865|NCT00751790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92926866|NCT00751790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926867|NCT00751790|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92926868|NCT00751790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92926869|NCT00751790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926870|NCT04020536|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92926871|NCT04020536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926872|NCT00916760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92926873|NCT00916760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92926874|NCT00916760|Immunologic Factors|immunologic factors|mesh-ancestor
92926875|NCT00916760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926876|NCT00916760|Antacids|antacids|mesh-ancestor
92926877|NCT00916760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926878|NCT00916760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926879|NCT05442554|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92926880|NCT05442554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926881|NCT05442554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926882|NCT05442554|Immunotoxins|immunotoxins|mesh-ancestor
92926883|NCT05442554|Immunoconjugates|immunoconjugates|mesh-ancestor
92926884|NCT05442554|Immunologic Factors|immunologic factors|mesh-ancestor
92926885|NCT05442554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926886|NCT00723450|Lamotrigine|lamotrigine|mesh-list
92926888|NCT00723450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92926889|NCT00723450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92926890|NCT00723450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926891|NCT00723450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92926892|NCT00723450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926893|NCT00723450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92926894|NCT00723450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92926895|NCT00723450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92926896|NCT00723450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92926897|NCT00723450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92926898|NCT02599532|Apixaban|apixaban|mesh-list
92926899|NCT02599532|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92926900|NCT02599532|Antithrombins|antithrombins|mesh-ancestor
92926901|NCT02599532|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92926902|NCT02599532|Protease Inhibitors|protease inhibitors|mesh-ancestor
92926903|NCT02599532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926904|NCT02599532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926905|NCT02599532|Anticoagulants|anticoagulants|mesh-ancestor
92926906|NCT04085094|Pilocarpine|pilocarpine|mesh-list
92926907|NCT04085094|Miotics|miotics|mesh-ancestor
92926908|NCT04085094|Autonomic Agents|autonomic agents|mesh-ancestor
92926909|NCT04085094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926910|NCT04085094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926911|NCT04085094|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92926912|NCT04085094|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92926913|NCT04085094|Cholinergic Agents|cholinergic agents|mesh-ancestor
92926914|NCT04085094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926915|NCT04085094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926916|NCT00751400|Naproxen|naproxen|mesh-list
92926917|NCT00751400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92926918|NCT00751400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92926919|NCT00751400|Analgesics|analgesics|mesh-ancestor
92926920|NCT00751400|Sensory System Agents|sensory system agents|mesh-ancestor
92926921|NCT00751400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926922|NCT00751400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926923|NCT00751400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926924|NCT00751400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926925|NCT00751400|Gout Suppressants|gout suppressants|mesh-ancestor
92926926|NCT00751400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92163323|NCT00636155|Rituximab|rituximab|mesh-list
92926927|NCT00751400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926928|NCT00751400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926929|NCT05420948|Paclitaxel|paclitaxel|mesh-list
92926930|NCT05420948|Carboplatin|carboplatin|mesh-list
92926931|NCT05420948|Pembrolizumab|pembrolizumab|mesh-list
92926932|NCT05420948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92926933|NCT05420948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926934|NCT05420948|Tubulin Modulators|tubulin modulators|mesh-ancestor
92926935|NCT05420948|Antimitotic Agents|antimitotic agents|mesh-ancestor
92926936|NCT05420948|Mitosis Modulators|mitosis modulators|mesh-ancestor
92926937|NCT05420948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926938|NCT05420948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92926939|NCT05420948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92926940|NCT00585312|Celecoxib|celecoxib|mesh-list
92926941|NCT00585312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92926942|NCT00585312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92926943|NCT00585312|Analgesics|analgesics|mesh-ancestor
92926944|NCT00585312|Sensory System Agents|sensory system agents|mesh-ancestor
92926945|NCT00585312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926946|NCT00585312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926947|NCT00585312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926948|NCT00585312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92926949|NCT00585312|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92926950|NCT00585312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92926951|NCT00585312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926952|NCT00585312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926953|NCT00753506|Artemisinins|artemisinins|mesh-list
92926954|NCT00753506|Artemisinin|artemisinin|mesh-list
92926955|NCT00753506|Antimalarials|antimalarials|mesh-ancestor
92926956|NCT00753506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92926957|NCT00753506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92926958|NCT00753506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92926959|NCT00720096|Doxorubicin|doxorubicin|mesh-list
92926960|NCT00720096|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92926962|NCT00720096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92926963|NCT00720096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926964|NCT00720096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92926965|NCT00720096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92926966|NCT00720096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926967|NCT00720096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926968|NCT00720096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92926969|NCT04086108|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92926970|NCT04086108|GABA Agents|gaba agents|mesh-ancestor
92926971|NCT04086108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92926972|NCT04086108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926973|NCT04086108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926974|NCT02577783|Dexamethasone|dexamethasone|mesh-list
92926975|NCT02577783|Dexamethasone acetate|dexamethasone acetate|mesh-list
92926976|NCT02577783|Doxorubicin|doxorubicin|mesh-list
92926977|NCT02577783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92926978|NCT02577783|BB 1101|bb 1101|mesh-list
92926979|NCT02577783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92926980|NCT02577783|Antiemetics|antiemetics|mesh-ancestor
92926981|NCT02577783|Autonomic Agents|autonomic agents|mesh-ancestor
92926982|NCT02577783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92926983|NCT02577783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92926984|NCT02577783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92926985|NCT02577783|Glucocorticoids|glucocorticoids|mesh-ancestor
92926986|NCT02577783|Hormones|hormones|mesh-ancestor
92163336|NCT00634907|Anticoagulants|anticoagulants|mesh-ancestor
92926987|NCT02577783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92926988|NCT02577783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92926989|NCT02577783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926990|NCT02577783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92926991|NCT02577783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92926992|NCT02577783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92926993|NCT02577783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92926994|NCT02577783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92926995|NCT02577783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92926996|NCT00918450|Navitoclax|navitoclax|mesh-list
92926997|NCT00918450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92926998|NCT02591628|Chlorthalidone|chlorthalidone|mesh-list
92926999|NCT02591628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92927000|NCT02591628|Diuretics|diuretics|mesh-ancestor
92927001|NCT02591628|Natriuretic Agents|natriuretic agents|mesh-ancestor
92927002|NCT02591628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927003|NCT02591628|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92927004|NCT02591628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927005|NCT02591628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927006|NCT04090112|Lidocaine|lidocaine|mesh-list
92927007|NCT04090112|Anesthetics, Local|anesthetics, local|mesh-ancestor
92927008|NCT04090112|Anesthetics|anesthetics|mesh-ancestor
92927009|NCT04090112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927010|NCT04090112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927011|NCT04090112|Sensory System Agents|sensory system agents|mesh-ancestor
92927012|NCT04090112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927013|NCT04090112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92927014|NCT04090112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92927015|NCT04090112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92927016|NCT04090112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927017|NCT04090112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927018|NCT00747344|Ustekinumab|ustekinumab|mesh-list
92927019|NCT00747344|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927020|NCT00580983|Paclitaxel|paclitaxel|mesh-list
92927021|NCT00580983|Carboplatin|carboplatin|mesh-list
92927022|NCT00580983|Fluorouracil|fluorouracil|mesh-list
92927023|NCT00580983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927024|NCT00580983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927025|NCT00580983|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927026|NCT00580983|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927027|NCT00580983|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927028|NCT00580983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927029|NCT00580983|Antimetabolites|antimetabolites|mesh-ancestor
92927030|NCT00580983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927031|NCT00580983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927032|NCT00580983|Immunologic Factors|immunologic factors|mesh-ancestor
92927033|NCT00580983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927034|NCT02576223|Ropivacaine|ropivacaine|mesh-list
92927035|NCT02576223|Anesthetics, Local|anesthetics, local|mesh-ancestor
92927036|NCT02576223|Anesthetics|anesthetics|mesh-ancestor
92927037|NCT02576223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927038|NCT02576223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927039|NCT02576223|Sensory System Agents|sensory system agents|mesh-ancestor
92927040|NCT02576223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927041|NCT02309931|Antidiarrheals|antidiarrheals|mesh-list
92927042|NCT02309931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927043|NCT02577393|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92927044|NCT02577393|Antioxidants|antioxidants|mesh-ancestor
92927045|NCT02577393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927046|NCT02577393|Protective Agents|protective agents|mesh-ancestor
92927047|NCT02577393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927048|NCT02577393|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92927049|NCT02577393|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92927050|NCT02577393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927051|NCT02577393|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92927052|NCT00753896|Exenatide|exenatide|mesh-list
92927053|NCT00753896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92927054|NCT00753896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927055|NCT00753896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92927056|NCT00753896|Incretins|incretins|mesh-ancestor
92927057|NCT00753896|Hormones|hormones|mesh-ancestor
92927058|NCT00753896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927059|NCT02597114|Insulin|insulin|mesh-list
92927060|NCT02597114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92927061|NCT02597114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92927062|NCT02597114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927063|NCT00716976|Sodium thiosulfate|sodium thiosulfate|mesh-list
92927064|NCT00716976|Antidotes|antidotes|mesh-ancestor
92927065|NCT00716976|Protective Agents|protective agents|mesh-ancestor
92927066|NCT00716976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927067|NCT00716976|Antioxidants|antioxidants|mesh-ancestor
92927068|NCT00716976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927069|NCT00716976|Antitubercular Agents|antitubercular agents|mesh-ancestor
92927070|NCT00716976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92927071|NCT00716976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927072|NCT00716976|Chelating Agents|chelating agents|mesh-ancestor
92927073|NCT00716976|Sequestering Agents|sequestering agents|mesh-ancestor
92927074|NCT00743444|Lesogaberan|lesogaberan|mesh-list
92927075|NCT00743444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927076|NCT00743444|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92927077|NCT00743444|GABA Agonists|gaba agonists|mesh-ancestor
92927078|NCT00743444|GABA Agents|gaba agents|mesh-ancestor
92927079|NCT00743444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927080|NCT00743444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927081|NCT00743444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927082|NCT00743366|Riboflavin|riboflavin|mesh-list
92927083|NCT00743366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92927084|NCT00743366|Antidepressive Agents|antidepressive agents|mesh-ancestor
92927085|NCT00743366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92927086|NCT00743366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92927087|NCT00743366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92927088|NCT00743366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927089|NCT00743366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927090|NCT00743366|Vitamin B Complex|vitamin b complex|mesh-ancestor
92927091|NCT00743366|Vitamins|vitamins|mesh-ancestor
92927092|NCT00743366|Micronutrients|micronutrients|mesh-ancestor
92927093|NCT00743366|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92927094|NCT00743366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927095|NCT01760655|Mycophenolic Acid|mycophenolic acid|mesh-list
92927096|NCT01760655|Cyclophosphamide|cyclophosphamide|mesh-list
92927097|NCT01760655|Busulfan|busulfan|mesh-list
92927098|NCT01760655|Methyl Methanesulfonate|methyl methanesulfonate|mesh-list
92927099|NCT01760655|Fludarabine|fludarabine|mesh-list
92927100|NCT01760655|Fludarabine phosphate|fludarabine phosphate|mesh-list
92927101|NCT01760655|Tacrolimus|tacrolimus|mesh-list
92927102|NCT01760655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927103|NCT01760655|Immunologic Factors|immunologic factors|mesh-ancestor
92927104|NCT01760655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927105|NCT01760655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92927106|NCT01760655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92927107|NCT01760655|Alkylating Agents|alkylating agents|mesh-ancestor
92927108|NCT01760655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927109|NCT01760655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927110|NCT01760655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92927111|NCT01760655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927112|NCT01760655|Antimetabolites|antimetabolites|mesh-ancestor
92927113|NCT01760655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927114|NCT01760655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92927115|NCT01760655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927116|NCT01760655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92927117|NCT01760655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92927118|NCT01760655|Antitubercular Agents|antitubercular agents|mesh-ancestor
92927119|NCT01760655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92927120|NCT00743288|Melphalan|melphalan|mesh-list
92927121|NCT00743288|Panobinostat|panobinostat|mesh-list
92927122|NCT00743288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92927123|NCT00743288|Alkylating Agents|alkylating agents|mesh-ancestor
92927124|NCT00743288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927125|NCT00743288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927126|NCT00743288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92927127|NCT00743288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927128|NCT00743288|Immunologic Factors|immunologic factors|mesh-ancestor
92163358|NCT04127851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927129|NCT00743288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927130|NCT00743288|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92927131|NCT00743288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927132|NCT02579187|Anesthetics|anesthetics|mesh-list
92927133|NCT02579187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927134|NCT02579187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927135|NCT02598440|Alendronate|alendronate|mesh-list
92927136|NCT02598440|Ibandronic Acid|ibandronic acid|mesh-list
92927137|NCT02598440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92927138|NCT02598440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927139|NCT00750308|Ramipril|ramipril|mesh-list
92927140|NCT00750308|Tadalafil|tadalafil|mesh-list
92927141|NCT00750308|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927142|NCT00750308|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92927143|NCT00750308|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92927144|NCT00750308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927145|NCT00750308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927146|NCT00750308|Urological Agents|urological agents|mesh-ancestor
92927147|NCT00750308|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92927148|NCT00750308|Protease Inhibitors|protease inhibitors|mesh-ancestor
92927149|NCT00750308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92927150|NCT05392790|Calcium|calcium|mesh-list
92927151|NCT05392790|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92927152|NCT05392790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927153|NCT02597036|Zansecimab|zansecimab|mesh-list
92927154|NCT02597036|Paclitaxel|paclitaxel|mesh-list
92927155|NCT02597036|Ramucirumab|ramucirumab|mesh-list
92927156|NCT02597036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927157|NCT02597036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927158|NCT02597036|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927159|NCT02597036|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927160|NCT02597036|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927161|NCT02597036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927162|NCT02597036|Antiviral Agents|antiviral agents|mesh-ancestor
92572618|NCT00236392|Rabeprazole|rabeprazole|mesh-list
92927163|NCT02597036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927164|NCT04071639|Ubiquinone|ubiquinone|mesh-list
92927165|NCT04071639|Haloperidol|haloperidol|mesh-list
92927166|NCT04071639|Risperidone|risperidone|mesh-list
92927167|NCT04071639|Haloperidol decanoate|haloperidol decanoate|mesh-list
92927168|NCT04071639|Sertraline|sertraline|mesh-list
92927169|NCT04071639|Tetrabenazine|tetrabenazine|mesh-list
92927170|NCT04071639|Idebenone|idebenone|mesh-list
92927171|NCT04071639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92927172|NCT04071639|Serotonin Agents|serotonin agents|mesh-ancestor
92927173|NCT04071639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927174|NCT04071639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927175|NCT04071639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927176|NCT04071639|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92927177|NCT04071639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92927178|NCT04071639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927179|NCT04071639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92927180|NCT04071639|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92927181|NCT04071639|Dopamine Agents|dopamine agents|mesh-ancestor
92927182|NCT04071639|Antidepressive Agents|antidepressive agents|mesh-ancestor
92927183|NCT04071639|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92927184|NCT04071639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92927185|NCT04071639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927186|NCT04071639|Antiemetics|antiemetics|mesh-ancestor
92927187|NCT04071639|Autonomic Agents|autonomic agents|mesh-ancestor
92927188|NCT04071639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927189|NCT04071639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927190|NCT04071639|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92927191|NCT04071639|Antioxidants|antioxidants|mesh-ancestor
92927192|NCT04071639|Protective Agents|protective agents|mesh-ancestor
92927193|NCT04071639|Micronutrients|micronutrients|mesh-ancestor
92927194|NCT04071639|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92927195|NCT04071639|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927196|NCT04089176|Oxytocin|oxytocin|mesh-list
92927197|NCT04089176|Carbetocin|carbetocin|mesh-list
92927198|NCT04089176|Oxytocics|oxytocics|mesh-ancestor
92927199|NCT04089176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92927200|NCT04089176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927201|NCT02577159|Dapagliflozin|dapagliflozin|mesh-list
92927202|NCT02577159|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92927203|NCT02577159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927204|NCT02577159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92927205|NCT02577159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927206|NCT00749684|Interferons|interferons|mesh-list
92927207|NCT00749684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927208|NCT00749684|Antiviral Agents|antiviral agents|mesh-ancestor
92927209|NCT00749684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927210|NCT02575755|Azithromycin|azithromycin|mesh-list
92927211|NCT02575755|Pyrimethamine|pyrimethamine|mesh-list
92927212|NCT02575755|Piperaquine|piperaquine|mesh-list
92927213|NCT02575755|Sulfadoxine|sulfadoxine|mesh-list
92927214|NCT02575755|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92927215|NCT02575755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92927216|NCT02575755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927217|NCT02575755|Antimalarials|antimalarials|mesh-ancestor
92927218|NCT02575755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92927219|NCT02575755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92927220|NCT02575755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92927221|NCT02575755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927222|NCT02575755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927223|NCT02575755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92927224|NCT00746798|Vaccines|vaccines|mesh-list
92927225|NCT00746798|Immunologic Factors|immunologic factors|mesh-ancestor
92927226|NCT00746798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927227|NCT00716274|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92927228|NCT00716274|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92927229|NCT00716274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92927230|NCT00716274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927231|NCT00716274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927232|NCT00716274|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927233|NCT00716274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927234|NCT00716274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927235|NCT01298193|Phenothiazine|phenothiazine|mesh-list
92927236|NCT01298193|Droperidol|droperidol|mesh-list
92927237|NCT01298193|Haloperidol|haloperidol|mesh-list
92927238|NCT01298193|Aprepitant|aprepitant|mesh-list
92927239|NCT01298193|Metoclopramide|metoclopramide|mesh-list
92927240|NCT01298193|Domperidone|domperidone|mesh-list
92927242|NCT01298193|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-list
92927243|NCT01298193|Antiemetics|antiemetics|mesh-ancestor
92927244|NCT01298193|Autonomic Agents|autonomic agents|mesh-ancestor
92927245|NCT01298193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927246|NCT01298193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927247|NCT01298193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927248|NCT01298193|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92927249|NCT01298193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927250|NCT01298193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927251|NCT01298193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92927252|NCT01298193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92927253|NCT01298193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927254|NCT01298193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92927255|NCT01298193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92927256|NCT01298193|Dopamine Agents|dopamine agents|mesh-ancestor
92927257|NCT01298193|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92927258|NCT01298193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92927259|NCT01298193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92927260|NCT01298193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92927261|NCT01298193|Serotonin Agents|serotonin agents|mesh-ancestor
92927262|NCT01298193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92927263|NCT01298193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92927264|NCT01298193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927265|NCT02590536|Sildenafil Citrate|sildenafil citrate|mesh-list
92927266|NCT02590536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927267|NCT02590536|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927268|NCT02590536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92927269|NCT02590536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92927270|NCT02590536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927271|NCT02590536|Urological Agents|urological agents|mesh-ancestor
92927272|NCT00719862|Azelastine|azelastine|mesh-list
92927273|NCT00719862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92927274|NCT00719862|Autonomic Agents|autonomic agents|mesh-ancestor
92927275|NCT00719862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927276|NCT00719862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927277|NCT00719862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92927278|NCT00719862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92927279|NCT00719862|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92927280|NCT00719862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927281|NCT00719862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927282|NCT00719862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92927283|NCT00719862|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92927284|NCT00719862|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92927285|NCT00719862|Histamine Antagonists|histamine antagonists|mesh-ancestor
92927286|NCT00719862|Histamine Agents|histamine agents|mesh-ancestor
92927287|NCT00719862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927288|NCT02578953|Dutasteride|dutasteride|mesh-list
92927289|NCT02578953|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92927290|NCT02578953|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92927291|NCT02578953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927292|NCT02578953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927293|NCT02578953|Hormone Antagonists|hormone antagonists|mesh-ancestor
92927294|NCT02578953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927295|NCT02578953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927296|NCT02578719|Bupivacaine|bupivacaine|mesh-list
92927297|NCT02578719|Anesthetics, Local|anesthetics, local|mesh-ancestor
92927298|NCT02578719|Anesthetics|anesthetics|mesh-ancestor
92927299|NCT02578719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927300|NCT02578719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927301|NCT02578719|Sensory System Agents|sensory system agents|mesh-ancestor
92927302|NCT02578719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927303|NCT00742508|Carvedilol|carvedilol|mesh-list
92927304|NCT00742508|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92927305|NCT00742508|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92927306|NCT00742508|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927307|NCT00742508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927308|NCT00742508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927309|NCT00742508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927310|NCT00742508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92927311|NCT00742508|Antioxidants|antioxidants|mesh-ancestor
92927312|NCT00742508|Protective Agents|protective agents|mesh-ancestor
92927313|NCT00742508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92927314|NCT00742508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927315|NCT00742508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92927316|NCT00742508|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927317|NCT00742508|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92927318|NCT00742508|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92927319|NCT02590614|Vitamin D|vitamin d|mesh-list
92927320|NCT02590614|Vitamins|vitamins|mesh-ancestor
92927321|NCT02590614|Micronutrients|micronutrients|mesh-ancestor
92927322|NCT02590614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927323|NCT02590614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92927324|NCT02575443|Rocuronium|rocuronium|mesh-list
92927325|NCT02575443|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92927326|NCT02575443|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92927327|NCT02575443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92927328|NCT02575443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927329|NCT02575443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927330|NCT05382650|Immunoglobulins|immunoglobulins|mesh-list
92927331|NCT05382650|Antibodies|antibodies|mesh-list
92163376|NCT05602129|Heparin|heparin|mesh-list
92927332|NCT05382650|gamma-Globulins|gamma-globulins|mesh-list
92927333|NCT05382650|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92927334|NCT05382650|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92927335|NCT05382650|Immunologic Factors|immunologic factors|mesh-ancestor
92927336|NCT05382650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927338|NCT02596334|Abacavir|abacavir|mesh-list
92927339|NCT02596334|Dolutegravir|dolutegravir|mesh-list
92927340|NCT02596334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92927341|NCT02596334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92927342|NCT02596334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927343|NCT02596334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927344|NCT02596334|Antiviral Agents|antiviral agents|mesh-ancestor
92927345|NCT02596334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927346|NCT02596334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92927347|NCT02596334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92927348|NCT02596334|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92927349|NCT02596334|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92927350|NCT00719706|Acetylcarnitine|acetylcarnitine|mesh-list
92927351|NCT00719706|Vitamin B Complex|vitamin b complex|mesh-ancestor
92927352|NCT00719706|Vitamins|vitamins|mesh-ancestor
92927353|NCT00719706|Micronutrients|micronutrients|mesh-ancestor
92927354|NCT00719706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927355|NCT00719706|Nootropic Agents|nootropic agents|mesh-ancestor
92927356|NCT02575521|Dexmedetomidine|dexmedetomidine|mesh-list
92927357|NCT02575521|Propofol|propofol|mesh-list
92927358|NCT02575521|Sevoflurane|sevoflurane|mesh-list
92927359|NCT02575521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92927360|NCT02575521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927361|NCT02575521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927362|NCT02575521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92927363|NCT02575521|Analgesics|analgesics|mesh-ancestor
92927364|NCT02575521|Sensory System Agents|sensory system agents|mesh-ancestor
92927365|NCT02575521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927366|NCT02575521|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92927367|NCT02575521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92927368|NCT02575521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92927369|NCT02575521|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927370|NCT02575521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927371|NCT02575521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927372|NCT02575521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92927373|NCT02575521|Anesthetics, General|anesthetics, general|mesh-ancestor
92927374|NCT02575521|Anesthetics|anesthetics|mesh-ancestor
92927375|NCT02575521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92927376|NCT02575521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92927377|NCT02576457|BMS-936559|bms-936559|mesh-list
92927378|NCT02576457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927379|NCT02576457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927380|NCT05276102|Emollients|emollients|mesh-list
92927381|NCT05276102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927382|NCT02596100|Betrixaban|betrixaban|mesh-list
92927383|NCT02596100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92927384|NCT02596100|Antithrombins|antithrombins|mesh-ancestor
92927385|NCT02596100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92927386|NCT02596100|Protease Inhibitors|protease inhibitors|mesh-ancestor
92927387|NCT02596100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927388|NCT02596100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927389|NCT02596100|Anticoagulants|anticoagulants|mesh-ancestor
92927390|NCT01192971|Apatinib|apatinib|mesh-list
92927391|NCT01192971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927392|NCT01192971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92927393|NCT01192971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927394|NCT01192971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927395|NCT00719472|Antipyretics|antipyretics|mesh-list
92927396|NCT00719472|Prednisone|prednisone|mesh-list
92927397|NCT00719472|Cyclophosphamide|cyclophosphamide|mesh-list
92927398|NCT00719472|Rituximab|rituximab|mesh-list
92927399|NCT00719472|Doxorubicin|doxorubicin|mesh-list
92927400|NCT00719472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92927401|NCT00719472|Vincristine|vincristine|mesh-list
92927402|NCT00719472|Analgesics|analgesics|mesh-list
92927403|NCT00719472|Histamine Antagonists|histamine antagonists|mesh-list
92927404|NCT00719472|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92927405|NCT00719472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927406|NCT00719472|Immunologic Factors|immunologic factors|mesh-ancestor
92927407|NCT00719472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927408|NCT00719472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92927409|NCT00719472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92927410|NCT00719472|Alkylating Agents|alkylating agents|mesh-ancestor
92927411|NCT00719472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927412|NCT00719472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927413|NCT00719472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92927414|NCT00719472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927415|NCT00719472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92927416|NCT00719472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92927417|NCT00719472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92927418|NCT00719472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927419|NCT00719472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927420|NCT00719472|Glucocorticoids|glucocorticoids|mesh-ancestor
92927421|NCT00719472|Hormones|hormones|mesh-ancestor
92927422|NCT00719472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927423|NCT00719472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92927424|NCT00719472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927425|NCT00719472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927426|NCT00719472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927427|NCT00719472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927428|NCT00719472|Sensory System Agents|sensory system agents|mesh-ancestor
92927429|NCT00719472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927430|NCT00719472|Histamine Agents|histamine agents|mesh-ancestor
92927431|NCT00719472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927432|NCT00579501|Dexamethasone|dexamethasone|mesh-list
92927433|NCT00579501|Trabectedin|trabectedin|mesh-list
92927434|NCT00579501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927435|NCT00579501|Antiemetics|antiemetics|mesh-ancestor
92927436|NCT00579501|Autonomic Agents|autonomic agents|mesh-ancestor
92927437|NCT00579501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927438|NCT00579501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927439|NCT00579501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927440|NCT00579501|Glucocorticoids|glucocorticoids|mesh-ancestor
92927441|NCT00579501|Hormones|hormones|mesh-ancestor
92927442|NCT00579501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927443|NCT00579501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92927444|NCT00579501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927445|NCT00579501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92927446|NCT00579501|Alkylating Agents|alkylating agents|mesh-ancestor
92927447|NCT00579501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927448|NCT02598362|Ciprofloxacin|ciprofloxacin|mesh-list
92927449|NCT02598362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92927450|NCT02598362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927451|NCT02598362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92927452|NCT02598362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92927453|NCT02598362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927454|NCT02598362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927455|NCT02598362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927456|NCT02598362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92927457|NCT02598362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92927458|NCT02576301|Cytarabine|cytarabine|mesh-list
92927459|NCT02576301|Combretastatin|combretastatin|mesh-list
92927460|NCT02576301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927461|NCT02576301|Antimetabolites|antimetabolites|mesh-ancestor
92927462|NCT02576301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927463|NCT02576301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572917|NCT04709731|Ponatinib|ponatinib|mesh-list
92927464|NCT02576301|Antiviral Agents|antiviral agents|mesh-ancestor
92927465|NCT02576301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927466|NCT02576301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927467|NCT02576301|Immunologic Factors|immunologic factors|mesh-ancestor
92927468|NCT02576301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927469|NCT02576301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927470|NCT02576301|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927471|NCT02576301|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927472|NCT02576301|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927474|NCT04086186|Anesthetics, Local|anesthetics, local|mesh-ancestor
92927475|NCT04086186|Anesthetics|anesthetics|mesh-ancestor
92927476|NCT04086186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927477|NCT04086186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927478|NCT04086186|Sensory System Agents|sensory system agents|mesh-ancestor
92927479|NCT04086186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927480|NCT00741338|Cyclosporine|cyclosporine|mesh-list
92927481|NCT00741338|Azathioprine|azathioprine|mesh-list
92927482|NCT00741338|Cyclosporins|cyclosporins|mesh-list
92927483|NCT00741338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927484|NCT00741338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927486|NCT00741338|Immunologic Factors|immunologic factors|mesh-ancestor
92927487|NCT00741338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927488|NCT00741338|Antifungal Agents|antifungal agents|mesh-ancestor
92927489|NCT00741338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927490|NCT00741338|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927491|NCT00741338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92927492|NCT00741338|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92927493|NCT00741338|Antimetabolites|antimetabolites|mesh-ancestor
92927494|NCT00741338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927495|NCT00741338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927496|NCT02598830|Vitamin D|vitamin d|mesh-list
92927497|NCT02598830|Cholecalciferol|cholecalciferol|mesh-list
92927498|NCT02598830|Vitamins|vitamins|mesh-ancestor
92927499|NCT02598830|Micronutrients|micronutrients|mesh-ancestor
92927500|NCT02598830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927501|NCT02598830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92927502|NCT02598830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92927503|NCT02578251|Acetaminophen|acetaminophen|mesh-list
92927504|NCT02578251|Meperidine|meperidine|mesh-list
92927505|NCT02578251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92927506|NCT02578251|Analgesics|analgesics|mesh-ancestor
92927507|NCT02578251|Sensory System Agents|sensory system agents|mesh-ancestor
92927508|NCT02578251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927509|NCT02578251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927510|NCT02578251|Antipyretics|antipyretics|mesh-ancestor
92927511|NCT02578251|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92927512|NCT02578251|Narcotics|narcotics|mesh-ancestor
92927513|NCT02578251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927514|NCT02578251|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92927515|NCT05285358|Paclitaxel|paclitaxel|mesh-list
92927516|NCT05285358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92927517|NCT05285358|Cisplatin|cisplatin|mesh-list
92927518|NCT05285358|Gemcitabine|gemcitabine|mesh-list
92927519|NCT05285358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927520|NCT05285358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927521|NCT05285358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927522|NCT05285358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927523|NCT05285358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927524|NCT05285358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927525|NCT05285358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927526|NCT05285358|Antimetabolites|antimetabolites|mesh-ancestor
92927527|NCT00746330|Mometasone Furoate|mometasone furoate|mesh-list
92927528|NCT00746330|Formoterol Fumarate|formoterol fumarate|mesh-list
92927529|NCT00746330|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92927530|NCT00746330|Autonomic Agents|autonomic agents|mesh-ancestor
92927531|NCT00746330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927532|NCT00746330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927533|NCT00746330|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92927534|NCT00746330|Respiratory System Agents|respiratory system agents|mesh-ancestor
92927535|NCT00746330|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92927536|NCT00746330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92927537|NCT00746330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92927538|NCT00746330|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927539|NCT00746330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927540|NCT00746330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927541|NCT00746330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927542|NCT00746330|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927543|NCT00746330|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92927544|NCT02590224|Glycine|glycine|mesh-list
92927545|NCT02590224|Glycine Agents|glycine agents|mesh-ancestor
92927546|NCT02590224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927547|NCT02590224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927548|NCT02590224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927549|NCT00709449|Papaverine|papaverine|mesh-list
92927550|NCT00709449|Moxaverine|moxaverine|mesh-list
92927551|NCT00709449|Parasympatholytics|parasympatholytics|mesh-ancestor
92927552|NCT00709449|Autonomic Agents|autonomic agents|mesh-ancestor
92927553|NCT00709449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927554|NCT00709449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927555|NCT00709449|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92927556|NCT00709449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927557|NCT00709449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927558|NCT00709449|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927559|NCT00709449|Urological Agents|urological agents|mesh-ancestor
92927561|NCT00746252|Aripiprazole|aripiprazole|mesh-list
92927562|NCT00746252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92927563|NCT00746252|Serotonin Agents|serotonin agents|mesh-ancestor
92927564|NCT00746252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927565|NCT00746252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927566|NCT00746252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927567|NCT00746252|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92927568|NCT00746252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92927569|NCT00746252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927570|NCT00746252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92927571|NCT00746252|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92927572|NCT00746252|Dopamine Agents|dopamine agents|mesh-ancestor
92927573|NCT00746252|Antidepressive Agents|antidepressive agents|mesh-ancestor
92927574|NCT00746252|Dopamine Agonists|dopamine agonists|mesh-ancestor
92927575|NCT00746252|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92927576|NCT00746252|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92927577|NCT00746252|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92927578|NCT00746252|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92927579|NCT02574975|Budesonide|budesonide|mesh-list
92927580|NCT02574975|Adenosine|adenosine|mesh-list
92927581|NCT02574975|Formoterol Fumarate|formoterol fumarate|mesh-list
92927582|NCT02574975|Methacholine Chloride|methacholine chloride|mesh-list
92927583|NCT02574975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927584|NCT02574975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92927585|NCT02574975|Autonomic Agents|autonomic agents|mesh-ancestor
92927586|NCT02574975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927587|NCT02574975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927588|NCT02574975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92927589|NCT02574975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92927590|NCT02574975|Glucocorticoids|glucocorticoids|mesh-ancestor
92927591|NCT02574975|Hormones|hormones|mesh-ancestor
92927592|NCT02574975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927593|NCT02574975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92927594|NCT02574975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92927595|NCT02574975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92927596|NCT02574975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927597|NCT02574975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927598|NCT02574975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927599|NCT02574975|Analgesics|analgesics|mesh-ancestor
92163416|NCT04394377|Heparin|heparin|mesh-list
92927600|NCT02574975|Sensory System Agents|sensory system agents|mesh-ancestor
92927601|NCT02574975|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92927602|NCT02574975|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927603|NCT02574975|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92927604|NCT02574975|Purinergic Agonists|purinergic agonists|mesh-ancestor
92927605|NCT02574975|Purinergic Agents|purinergic agents|mesh-ancestor
92927606|NCT02574975|Miotics|miotics|mesh-ancestor
92927607|NCT02574975|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92927608|NCT02574975|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92927609|NCT02574975|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92927610|NCT02574975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92927611|NCT02574975|Cholinergic Agents|cholinergic agents|mesh-ancestor
92927612|NCT00718770|Bexarotene|bexarotene|mesh-list
92927613|NCT00718770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927614|NCT04084158|Paclitaxel|paclitaxel|mesh-list
92927615|NCT04084158|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92927616|NCT04084158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927618|NCT04084158|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927619|NCT04084158|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927620|NCT04084158|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927621|NCT04084158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927622|NCT00714519|Castor Oil|castor oil|mesh-list
92927623|NCT00714519|Cathartics|cathartics|mesh-ancestor
92927624|NCT00714519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927625|NCT00714948|Gemcitabine|gemcitabine|mesh-list
92927626|NCT00714948|Sorafenib|sorafenib|mesh-list
92927627|NCT00714948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927628|NCT00714948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927629|NCT00714948|Antimetabolites|antimetabolites|mesh-ancestor
92927630|NCT00714948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927631|NCT00714948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92927632|NCT00714948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927633|NCT00714714|Adapalene|adapalene|mesh-list
92927634|NCT00714714|Tretinoin|tretinoin|mesh-list
92927635|NCT00714714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92927636|NCT00714714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92927637|NCT00714714|Analgesics|analgesics|mesh-ancestor
92927638|NCT00714714|Sensory System Agents|sensory system agents|mesh-ancestor
92927639|NCT00714714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927640|NCT00714714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927641|NCT00714714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927642|NCT00714714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92927643|NCT00714714|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927644|NCT00714714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927645|NCT00714714|Keratolytic Agents|keratolytic agents|mesh-ancestor
92927646|NCT00441337|Nivolumab|nivolumab|mesh-list
92927647|NCT00441337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927648|NCT00441337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927649|NCT00441337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92927650|NCT00441337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927651|NCT00578877|Nonoxynol|nonoxynol|mesh-list
92927652|NCT00578877|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92927653|NCT00578877|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92927654|NCT00578877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927655|NCT00578877|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92927656|NCT00578877|Contraceptive Agents|contraceptive agents|mesh-ancestor
92927657|NCT00578877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92927658|NCT00578877|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92927659|NCT02573727|Terlipressin|terlipressin|mesh-list
92927660|NCT02573727|Epinephrine|epinephrine|mesh-list
92927661|NCT02573727|Racepinephrine|racepinephrine|mesh-list
92927662|NCT02573727|Norepinephrine|norepinephrine|mesh-list
92927663|NCT02573727|Epinephryl borate|epinephryl borate|mesh-list
92927664|NCT02573727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92927665|NCT02573727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92927666|NCT02573727|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927667|NCT02573727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927668|NCT02573727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927669|NCT02573727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927670|NCT02573727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92927671|NCT02573727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92927672|NCT02573727|Autonomic Agents|autonomic agents|mesh-ancestor
92927673|NCT02573727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927674|NCT02573727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92927675|NCT02573727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92927676|NCT02573727|Mydriatics|mydriatics|mesh-ancestor
92927677|NCT02573727|Sympathomimetics|sympathomimetics|mesh-ancestor
92927678|NCT02573727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92927679|NCT02573727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92927680|NCT00709683|Insulin Aspart|insulin aspart|mesh-list
92927681|NCT00709683|Biphasic Insulins|biphasic insulins|mesh-list
92927682|NCT00709683|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92927683|NCT00709683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92927684|NCT00709683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927685|NCT00918840|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92927686|NCT00918840|Antiviral Agents|antiviral agents|mesh-ancestor
92927687|NCT00918840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927688|NCT00918528|Mitomycins|mitomycins|mesh-list
92927689|NCT00918528|Mitomycin|mitomycin|mesh-list
92927690|NCT00918528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92927691|NCT00918528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927692|NCT00918528|Alkylating Agents|alkylating agents|mesh-ancestor
92927693|NCT00918528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927694|NCT00918528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92927695|NCT00918528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927696|NCT00468481|Drospirenone|drospirenone|mesh-list
92927697|NCT00468481|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92927698|NCT00468481|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92927699|NCT00468481|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92927700|NCT00468481|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92927701|NCT00468481|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92927702|NCT00468481|Contraceptive Agents|contraceptive agents|mesh-ancestor
92927703|NCT00468481|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92927704|NCT00468481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927705|NCT00468481|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92927706|NCT00468481|Estrogens|estrogens|mesh-ancestor
92927707|NCT00468481|Hormones|hormones|mesh-ancestor
92927708|NCT00468481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526344|NCT00028366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927709|NCT00468481|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92927710|NCT00468481|Hormone Antagonists|hormone antagonists|mesh-ancestor
92927711|NCT00468481|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92927712|NCT00468481|Diuretics|diuretics|mesh-ancestor
92927713|NCT00468481|Natriuretic Agents|natriuretic agents|mesh-ancestor
92927714|NCT02574819|Methylnaltrexone|methylnaltrexone|mesh-list
92927715|NCT02574819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92927716|NCT02574819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927717|NCT02574819|Sensory System Agents|sensory system agents|mesh-ancestor
92927718|NCT02574819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927719|NCT00709839|Hydrocortisone|hydrocortisone|mesh-list
92927720|NCT00709839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927722|NCT03949153|Ipilimumab|ipilimumab|mesh-list
92927723|NCT03949153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927724|NCT03949153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927725|NCT03949153|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92927726|NCT03949153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927727|NCT00709917|Repaglinide|repaglinide|mesh-list
92927728|NCT00709917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92927729|NCT00709917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927730|NCT02574741|Aripiprazole|aripiprazole|mesh-list
92927731|NCT02574741|Antidepressive Agents|antidepressive agents|mesh-ancestor
92927732|NCT02574741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92927733|NCT02574741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92927734|NCT02574741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92927735|NCT02574741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927736|NCT02574741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927737|NCT02574741|Dopamine Agonists|dopamine agonists|mesh-ancestor
92927738|NCT02574741|Dopamine Agents|dopamine agents|mesh-ancestor
92927739|NCT02574741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927740|NCT02574741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927741|NCT02574741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92927742|NCT02574741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92927743|NCT02574741|Serotonin Agents|serotonin agents|mesh-ancestor
92927744|NCT02574741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92927745|NCT02574741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92927746|NCT02574741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92927747|NCT02574741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92927748|NCT00468169|Cetuximab|cetuximab|mesh-list
92927749|NCT00468169|Hydroxyurea|hydroxyurea|mesh-list
92927750|NCT00468169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927751|NCT00468169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927752|NCT00468169|Antisickling Agents|antisickling agents|mesh-ancestor
92927753|NCT00468169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927754|NCT00468169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927755|NCT00468169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92927756|NCT05251974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92927757|NCT05251974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92927758|NCT05251974|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927759|NCT05251974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927760|NCT05251974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927761|NCT05251974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927762|NCT02589444|Vitamin D|vitamin d|mesh-list
92927763|NCT02589444|Cholecalciferol|cholecalciferol|mesh-list
92927764|NCT02589444|Vitamins|vitamins|mesh-ancestor
92927765|NCT02589444|Micronutrients|micronutrients|mesh-ancestor
92927766|NCT02589444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927767|NCT02589444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92927768|NCT02589444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92927769|NCT05325684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92927770|NCT05325684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927771|NCT05325684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927772|NCT05325684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927774|NCT00435487|Calcium heparin|calcium heparin|mesh-list
92927775|NCT00435487|Dalteparin|dalteparin|mesh-list
92927776|NCT00435487|Tinzaparin|tinzaparin|mesh-list
92927777|NCT00435487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92927778|NCT00435487|Anticoagulants|anticoagulants|mesh-ancestor
92927779|NCT00435487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92927780|NCT00435487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92927781|NCT00435487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927782|NCT02589678|Vaccines|vaccines|mesh-list
92927783|NCT02589678|Immunologic Factors|immunologic factors|mesh-ancestor
92927784|NCT02589678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927785|NCT05328258|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92927786|NCT05328258|Luteolytic Agents|luteolytic agents|mesh-ancestor
92927787|NCT05328258|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92927788|NCT05328258|Contraceptive Agents|contraceptive agents|mesh-ancestor
92927789|NCT05328258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92927790|NCT05328258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927791|NCT05328258|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92927792|NCT05328258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92927793|NCT05328258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927795|NCT02591004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92927796|NCT02591004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927797|NCT02591004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927798|NCT02591004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92927799|NCT02591004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927800|NCT02591004|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927801|NCT02591004|Tocolytic Agents|tocolytic agents|mesh-ancestor
92927802|NCT02591004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92927803|NCT05310786|Analgesics, Opioid|analgesics, opioid|mesh-list
92927804|NCT05310786|Narcotics|narcotics|mesh-ancestor
92927805|NCT05310786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927806|NCT05310786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927807|NCT05310786|Analgesics|analgesics|mesh-ancestor
92927808|NCT05310786|Sensory System Agents|sensory system agents|mesh-ancestor
92927809|NCT05310786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927810|NCT04085562|Amlodipine|amlodipine|mesh-list
92927811|NCT04085562|Bisoprolol|bisoprolol|mesh-list
92927812|NCT04085562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92927813|NCT04085562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92927814|NCT04085562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927815|NCT04085562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927816|NCT04085562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92927817|NCT04085562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927818|NCT04085562|Vasodilator Agents|vasodilator agents|mesh-ancestor
92927819|NCT04085562|Sympatholytics|sympatholytics|mesh-ancestor
92927820|NCT04085562|Autonomic Agents|autonomic agents|mesh-ancestor
92927821|NCT04085562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927822|NCT04085562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92927823|NCT04085562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92927824|NCT04085562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92927825|NCT04085562|Adrenergic Agents|adrenergic agents|mesh-ancestor
92927826|NCT04085562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927827|NCT05048238|Tofacitinib|tofacitinib|mesh-list
92927828|NCT05048238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92927829|NCT05048238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92927830|NCT05048238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927831|NCT05048238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927832|NCT05683626|Adalimumab|adalimumab|mesh-list
92927833|NCT05683626|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92927834|NCT05683626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927835|NCT05683626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92927836|NCT04082988|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92927837|NCT04082988|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92927838|NCT04082988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927839|NCT05168202|Azacitidine|azacitidine|mesh-list
92927840|NCT05168202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927841|NCT05168202|Antimetabolites|antimetabolites|mesh-ancestor
92927842|NCT05168202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927843|NCT05168202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927844|NCT05168202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927845|NCT02588196|Dexamethasone|dexamethasone|mesh-list
92927846|NCT02588196|Dexamethasone acetate|dexamethasone acetate|mesh-list
92927847|NCT02588196|BB 1101|bb 1101|mesh-list
92927848|NCT02588196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927849|NCT02588196|Antiemetics|antiemetics|mesh-ancestor
92927850|NCT02588196|Autonomic Agents|autonomic agents|mesh-ancestor
92927851|NCT02588196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927852|NCT02588196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927853|NCT02588196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927854|NCT02588196|Glucocorticoids|glucocorticoids|mesh-ancestor
92927855|NCT02588196|Hormones|hormones|mesh-ancestor
92927856|NCT02588196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927857|NCT02588196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92927858|NCT02588196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927859|NCT02588196|Protease Inhibitors|protease inhibitors|mesh-ancestor
92927860|NCT02588196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927861|NCT02588196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927862|NCT02588820|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92927863|NCT02588820|Antiviral Agents|antiviral agents|mesh-ancestor
92927864|NCT02588820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927865|NCT00579345|Vaccines|vaccines|mesh-list
92927866|NCT00579345|Immunologic Factors|immunologic factors|mesh-ancestor
92927867|NCT00579345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927868|NCT00715377|Benztropine|benztropine|mesh-list
92927869|NCT00715377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92927870|NCT00715377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92927871|NCT00715377|Parasympatholytics|parasympatholytics|mesh-ancestor
92927872|NCT00715377|Autonomic Agents|autonomic agents|mesh-ancestor
92927873|NCT00715377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927874|NCT00715377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927875|NCT00715377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92927876|NCT00715377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92927877|NCT00715377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92927878|NCT00715377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927879|NCT00715377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927880|NCT00715377|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92927881|NCT00715377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92927882|NCT00715377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92927883|NCT00715377|Dopamine Agents|dopamine agents|mesh-ancestor
92927884|NCT00715455|Heparin|heparin|mesh-list
92927885|NCT00715455|Calcium heparin|calcium heparin|mesh-list
92927886|NCT00715455|Anticoagulants|anticoagulants|mesh-ancestor
92927887|NCT00715455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92927888|NCT00715455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92927889|NCT00715455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927890|NCT02574663|Leucovorin|leucovorin|mesh-list
92927891|NCT02574663|Folic Acid|folic acid|mesh-list
92927892|NCT02574663|Paclitaxel|paclitaxel|mesh-list
92927893|NCT02574663|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92927894|NCT02574663|Bevacizumab|bevacizumab|mesh-list
92927895|NCT02574663|Gemcitabine|gemcitabine|mesh-list
92927896|NCT02574663|Fluorouracil|fluorouracil|mesh-list
92927897|NCT02574663|Oxaliplatin|oxaliplatin|mesh-list
92927898|NCT02574663|Levoleucovorin|levoleucovorin|mesh-list
92927899|NCT02574663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92927900|NCT02574663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927901|NCT02574663|Tubulin Modulators|tubulin modulators|mesh-ancestor
92927902|NCT02574663|Antimitotic Agents|antimitotic agents|mesh-ancestor
92927903|NCT02574663|Mitosis Modulators|mitosis modulators|mesh-ancestor
92927904|NCT02574663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927905|NCT02574663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92927906|NCT02574663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92927907|NCT02574663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92927908|NCT02574663|Growth Substances|growth substances|mesh-ancestor
92927909|NCT02574663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927910|NCT02574663|Growth Inhibitors|growth inhibitors|mesh-ancestor
92927911|NCT02574663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92927912|NCT02574663|Antimetabolites|antimetabolites|mesh-ancestor
92927913|NCT02574663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927914|NCT02574663|Immunologic Factors|immunologic factors|mesh-ancestor
92573364|NCT00239980|Dalteparin|dalteparin|mesh-list
92927915|NCT02574663|Antidotes|antidotes|mesh-ancestor
92927916|NCT02574663|Protective Agents|protective agents|mesh-ancestor
92927917|NCT02574663|Vitamin B Complex|vitamin b complex|mesh-ancestor
92927918|NCT02574663|Vitamins|vitamins|mesh-ancestor
92927919|NCT02574663|Micronutrients|micronutrients|mesh-ancestor
92927920|NCT02574663|Hematinics|hematinics|mesh-ancestor
92927921|NCT04069845|Doxorubicin|doxorubicin|mesh-list
92927922|NCT04069845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92927923|NCT04069845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92927924|NCT04069845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927925|NCT04069845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92927926|NCT04069845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92927927|NCT04069845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927928|NCT04069845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927929|NCT05158140|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92927930|NCT05158140|Immunologic Factors|immunologic factors|mesh-ancestor
92927931|NCT05158140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927932|NCT00715689|Hormones|hormones|mesh-list
92927933|NCT00715689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927934|NCT00715689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927935|NCT00919542|Cyclosporine|cyclosporine|mesh-list
92927936|NCT00919542|Prednisolone|prednisolone|mesh-list
92927937|NCT00919542|Cyclosporins|cyclosporins|mesh-list
92927938|NCT00919542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92927939|NCT00919542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927940|NCT00919542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92927941|NCT00919542|Immunologic Factors|immunologic factors|mesh-ancestor
92927942|NCT00919542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927943|NCT00919542|Antifungal Agents|antifungal agents|mesh-ancestor
92927944|NCT00919542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92927945|NCT00919542|Dermatologic Agents|dermatologic agents|mesh-ancestor
92927946|NCT00919542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92927947|NCT00919542|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92927948|NCT00919542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92927949|NCT00919542|Glucocorticoids|glucocorticoids|mesh-ancestor
92927950|NCT00919542|Hormones|hormones|mesh-ancestor
92927951|NCT00919542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92927952|NCT00919542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92927953|NCT00919542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92927954|NCT04240626|Acetaminophen|acetaminophen|mesh-list
92927955|NCT04240626|Scopolamine|scopolamine|mesh-list
92927956|NCT04240626|Oxycodone|oxycodone|mesh-list
92927957|NCT04240626|Gabapentin|gabapentin|mesh-list
92927958|NCT04240626|Hydromorphone|hydromorphone|mesh-list
92927959|NCT04240626|Hydrocodone|hydrocodone|mesh-list
92927960|NCT04240626|Bupivacaine|bupivacaine|mesh-list
92927961|NCT04240626|Cyclobenzaprine|cyclobenzaprine|mesh-list
92927962|NCT04240626|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92927963|NCT04240626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92927964|NCT04240626|Analgesics|analgesics|mesh-ancestor
92927965|NCT04240626|Sensory System Agents|sensory system agents|mesh-ancestor
92927966|NCT04240626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92927967|NCT04240626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92927968|NCT04240626|Antipyretics|antipyretics|mesh-ancestor
92927969|NCT04240626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92927970|NCT04240626|Narcotics|narcotics|mesh-ancestor
92927971|NCT04240626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92927972|NCT04240626|Anticonvulsants|anticonvulsants|mesh-ancestor
92927973|NCT04240626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92927974|NCT04240626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92927975|NCT04240626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92927976|NCT04240626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92927977|NCT04240626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92927978|NCT04240626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92927979|NCT04240626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92927980|NCT04240626|Antimanic Agents|antimanic agents|mesh-ancestor
92927981|NCT04240626|Anesthetics, Local|anesthetics, local|mesh-ancestor
92927982|NCT04240626|Anesthetics|anesthetics|mesh-ancestor
92927983|NCT04240626|Antiemetics|antiemetics|mesh-ancestor
92927984|NCT04240626|Autonomic Agents|autonomic agents|mesh-ancestor
92927985|NCT04240626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92927986|NCT04240626|Antitussive Agents|antitussive agents|mesh-ancestor
92927987|NCT04240626|Respiratory System Agents|respiratory system agents|mesh-ancestor
92927988|NCT04240626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92927989|NCT04240626|Mydriatics|mydriatics|mesh-ancestor
92927990|NCT04240626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92927991|NCT04240626|Cholinergic Agents|cholinergic agents|mesh-ancestor
92927992|NCT04240626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92927993|NCT04240626|Parasympatholytics|parasympatholytics|mesh-ancestor
92927994|NCT04240626|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92927995|NCT04240626|Antidepressive Agents|antidepressive agents|mesh-ancestor
92927996|NCT04240626|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92927997|NCT04240626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92927999|NCT00719121|R 115866|r 115866|mesh-list
92928000|NCT00719121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92928001|NCT00719121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92928002|NCT00719121|Analgesics|analgesics|mesh-ancestor
92928003|NCT00719121|Sensory System Agents|sensory system agents|mesh-ancestor
92928004|NCT00719121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928005|NCT00719121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928006|NCT00719121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928007|NCT00719121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928008|NCT00719121|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928009|NCT00719121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92928010|NCT00719121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928011|NCT00719121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928013|NCT00719199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928014|NCT00719199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928015|NCT02589288|Ropivacaine|ropivacaine|mesh-list
92928016|NCT02589288|Anesthetics, Local|anesthetics, local|mesh-ancestor
92928017|NCT02589288|Anesthetics|anesthetics|mesh-ancestor
92928018|NCT02589288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928019|NCT02589288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928020|NCT02589288|Sensory System Agents|sensory system agents|mesh-ancestor
92146842|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
92928021|NCT02589288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928022|NCT00716001|Acetylcysteine|acetylcysteine|mesh-list
92928023|NCT00716001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92928024|NCT00716001|Antiviral Agents|antiviral agents|mesh-ancestor
92928025|NCT00716001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928026|NCT00716001|Expectorants|expectorants|mesh-ancestor
92928027|NCT00716001|Respiratory System Agents|respiratory system agents|mesh-ancestor
92928028|NCT00716001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92928029|NCT00716001|Antioxidants|antioxidants|mesh-ancestor
92928030|NCT00716001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928031|NCT00716001|Protective Agents|protective agents|mesh-ancestor
92928032|NCT00716001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928033|NCT00716001|Antidotes|antidotes|mesh-ancestor
92928034|NCT05136846|Paclitaxel|paclitaxel|mesh-list
92928035|NCT05136846|Carboplatin|carboplatin|mesh-list
92928036|NCT05136846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92928037|NCT05136846|Durvalumab|durvalumab|mesh-list
92928038|NCT05136846|Papaverine|papaverine|mesh-list
92928039|NCT05136846|Immunoglobulins|immunoglobulins|mesh-list
92928040|NCT05136846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92928041|NCT05136846|Immunoglobulin G|immunoglobulin g|mesh-list
92928042|NCT05136846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92928043|NCT05136846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928044|NCT05136846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92928045|NCT05136846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92928046|NCT05136846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92928047|NCT05136846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928048|NCT05136846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928049|NCT05136846|Immunologic Factors|immunologic factors|mesh-ancestor
92928050|NCT05136846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928051|NCT05136846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92928052|NCT05136846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928053|NCT05136846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92928054|NCT05136846|Urological Agents|urological agents|mesh-ancestor
92928055|NCT00710229|Bevacizumab|bevacizumab|mesh-list
92928056|NCT00710229|Ranibizumab|ranibizumab|mesh-list
92928057|NCT00710229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928058|NCT00710229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928059|NCT00710229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92928060|NCT00710229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92928061|NCT00710229|Growth Substances|growth substances|mesh-ancestor
92928062|NCT00710229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928063|NCT00710229|Growth Inhibitors|growth inhibitors|mesh-ancestor
92928064|NCT00710619|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92928065|NCT00710619|Coagulants|coagulants|mesh-ancestor
92928066|NCT05192460|Vaccines|vaccines|mesh-list
92573503|NCT04720807|Letrozole|letrozole|mesh-list
92928067|NCT05192460|Immunologic Factors|immunologic factors|mesh-ancestor
92928068|NCT05192460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928069|NCT00719433|Armin|armin|mesh-list
92928070|NCT00719433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92928071|NCT00719433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928072|NCT00719433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928073|NCT00719433|Cholinergic Agents|cholinergic agents|mesh-ancestor
92928074|NCT00719433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928075|NCT00719433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928076|NCT04068519|Tislelizumab|tislelizumab|mesh-list
92928077|NCT04068519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928078|NCT04068519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928079|NCT04978272|Piperaquine|piperaquine|mesh-list
92928080|NCT04978272|Artenimol|artenimol|mesh-list
92928081|NCT04978272|Antimalarials|antimalarials|mesh-ancestor
92928082|NCT04978272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92928083|NCT04978272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92928084|NCT04978272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928085|NCT04973124|Dexmedetomidine|dexmedetomidine|mesh-list
92928086|NCT04973124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92928087|NCT04973124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928088|NCT04973124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928089|NCT04973124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92928090|NCT04973124|Analgesics|analgesics|mesh-ancestor
92928091|NCT04973124|Sensory System Agents|sensory system agents|mesh-ancestor
92928092|NCT04973124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928093|NCT04973124|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92928094|NCT04973124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92928095|NCT04973124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92928096|NCT04973124|Adrenergic Agents|adrenergic agents|mesh-ancestor
92928097|NCT04973124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928098|NCT04973124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928099|NCT04971720|Valsartan|valsartan|mesh-list
92928100|NCT04971720|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92928101|NCT04971720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92928102|NCT04971720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92928103|NCT04971720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92928104|NCT04971720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928105|NCT00711165|Mometasone Furoate|mometasone furoate|mesh-list
92928106|NCT00711165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928107|NCT00711165|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928108|NCT00711165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92928109|NCT00719745|Tacrolimus|tacrolimus|mesh-list
92928110|NCT00719745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928111|NCT00719745|Immunologic Factors|immunologic factors|mesh-ancestor
92928112|NCT00719745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928113|NCT00719745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92928114|NCT00719745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928115|NCT00719745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928116|NCT02587416|Atorvastatin|atorvastatin|mesh-list
92928117|NCT02587416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92928118|NCT02587416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92928119|NCT02587416|Antimetabolites|antimetabolites|mesh-ancestor
92928120|NCT02587416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928121|NCT02587416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92928122|NCT02587416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92928123|NCT02587416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928124|NCT00719823|Maraviroc|maraviroc|mesh-list
92928125|NCT00719823|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92928126|NCT00719823|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92928127|NCT00719823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928128|NCT00719823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92928129|NCT00719823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92928130|NCT00719823|Antiviral Agents|antiviral agents|mesh-ancestor
92928131|NCT00719823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928132|NCT00719823|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92928133|NCT00919776|Cyclosporine|cyclosporine|mesh-list
92928134|NCT00919776|Prednisolone|prednisolone|mesh-list
92928135|NCT00919776|Cyclosporins|cyclosporins|mesh-list
92928136|NCT00919776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928137|NCT00919776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928138|NCT00919776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928139|NCT00919776|Immunologic Factors|immunologic factors|mesh-ancestor
92928140|NCT00919776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928141|NCT00919776|Antifungal Agents|antifungal agents|mesh-ancestor
92928142|NCT00919776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928143|NCT00919776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928144|NCT00919776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928145|NCT00919776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92928146|NCT00919776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928147|NCT00919776|Glucocorticoids|glucocorticoids|mesh-ancestor
92928148|NCT00919776|Hormones|hormones|mesh-ancestor
92928149|NCT00919776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928150|NCT00919776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92928151|NCT00919776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928152|NCT00720135|Rituximab|rituximab|mesh-list
92928153|NCT00720135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92928154|NCT00720135|Interleukin-2|interleukin-2|mesh-list
92928155|NCT00720135|Antibodies|antibodies|mesh-list
92928157|NCT00720135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92928158|NCT00720135|Immunologic Factors|immunologic factors|mesh-ancestor
92928159|NCT00720135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928160|NCT00720135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928161|NCT00720135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928162|NCT00720135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92928163|NCT00720135|Analgesics|analgesics|mesh-ancestor
92928164|NCT00720135|Sensory System Agents|sensory system agents|mesh-ancestor
92928165|NCT00720135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928166|NCT02588118|Propofol|propofol|mesh-list
92928167|NCT02588118|Cisatracurium|cisatracurium|mesh-list
92928168|NCT02588118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92928169|NCT02588118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928170|NCT02588118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928171|NCT02588118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92928172|NCT02588118|Anesthetics, General|anesthetics, general|mesh-ancestor
92928173|NCT02588118|Anesthetics|anesthetics|mesh-ancestor
92928174|NCT02588118|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92928175|NCT02588118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92928176|NCT02588118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928177|NCT00716391|Cisplatin|cisplatin|mesh-list
92928178|NCT00716391|Cetuximab|cetuximab|mesh-list
92928179|NCT00716391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928180|NCT00716391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928181|NCT00716469|Talaporfin|talaporfin|mesh-list
92928182|NCT00716469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928183|NCT00716469|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92928184|NCT00716469|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928185|NCT04082598|Amoxicillin|amoxicillin|mesh-list
92928186|NCT04082598|Clavulanic Acid|clavulanic acid|mesh-list
92928187|NCT04082598|Clavulanic Acids|clavulanic acids|mesh-list
92928188|NCT04082598|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92928189|NCT04082598|Lactoferrin|lactoferrin|mesh-list
92928190|NCT04082598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928191|NCT04082598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928192|NCT04082598|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92928193|NCT04082598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928194|NCT04082598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928195|NCT03895203|Adalimumab|adalimumab|mesh-list
92928196|NCT03895203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92928197|NCT03895203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928198|NCT03895203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928199|NCT04958226|Midazolam|midazolam|mesh-list
92928200|NCT04958226|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92928201|NCT04958226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92928202|NCT04958226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928203|NCT04958226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928204|NCT04958226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92928205|NCT04958226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92928206|NCT04958226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92928207|NCT04958226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92928208|NCT04958226|Anesthetics, General|anesthetics, general|mesh-ancestor
92928209|NCT04958226|Anesthetics|anesthetics|mesh-ancestor
92928210|NCT04958226|GABA Modulators|gaba modulators|mesh-ancestor
92928211|NCT04958226|GABA Agents|gaba agents|mesh-ancestor
92928212|NCT04958226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928213|NCT04958226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928214|NCT00716547|Celecoxib|celecoxib|mesh-list
92928215|NCT00716547|Ketoprofen|ketoprofen|mesh-list
92163565|NCT04123249|Propofol|propofol|mesh-list
92928216|NCT00716547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92928217|NCT00716547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92928218|NCT00716547|Analgesics|analgesics|mesh-ancestor
92928219|NCT00716547|Sensory System Agents|sensory system agents|mesh-ancestor
92573694|NCT00066482|Mesna|mesna|mesh-list
92928220|NCT00716547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928221|NCT00716547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928222|NCT00716547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928223|NCT00716547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928224|NCT00716547|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92928225|NCT00716547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92928226|NCT00716547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928227|NCT00716547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928228|NCT02573025|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92928229|NCT02573025|Interferon-alpha|interferon-alpha|mesh-list
92928230|NCT02573025|Interferon alpha-2|interferon alpha-2|mesh-list
92928231|NCT02573025|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92928232|NCT02573025|Antiviral Agents|antiviral agents|mesh-ancestor
92928233|NCT02573025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928234|NCT02573025|Immunologic Factors|immunologic factors|mesh-ancestor
92928235|NCT02573025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928236|NCT02573025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928237|NCT00720291|Metronidazole|metronidazole|mesh-list
92928238|NCT00720291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928239|NCT00720291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928240|NCT00720291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92928241|NCT00720291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92928242|NCT00578643|Cyclosporine|cyclosporine|mesh-list
92928243|NCT00578643|Cyclophosphamide|cyclophosphamide|mesh-list
92928245|NCT00578643|Fludarabine|fludarabine|mesh-list
92928246|NCT00578643|Alemtuzumab|alemtuzumab|mesh-list
92928247|NCT00578643|Cyclosporins|cyclosporins|mesh-list
92928248|NCT00578643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928249|NCT00578643|Immunologic Factors|immunologic factors|mesh-ancestor
92928250|NCT00578643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928251|NCT00578643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928252|NCT00578643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92928253|NCT00578643|Alkylating Agents|alkylating agents|mesh-ancestor
92928254|NCT00578643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928255|NCT00578643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928256|NCT00578643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92928257|NCT00578643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928258|NCT00578643|Antifungal Agents|antifungal agents|mesh-ancestor
92928259|NCT00578643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928260|NCT00578643|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928261|NCT00578643|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92928262|NCT00578643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928263|NCT04082286|Antibodies|antibodies|mesh-list
92928264|NCT04082286|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92928265|NCT04082286|Immunologic Factors|immunologic factors|mesh-ancestor
92928266|NCT04082286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928267|NCT00720447|Cytarabine|cytarabine|mesh-list
92928268|NCT00720447|Etoposide|etoposide|mesh-list
92928269|NCT00720447|Melphalan|melphalan|mesh-list
92928270|NCT00720447|Alemtuzumab|alemtuzumab|mesh-list
92928271|NCT00720447|Carmustine|carmustine|mesh-list
92928272|NCT00720447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92928273|NCT00720447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928274|NCT00720447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92928275|NCT00720447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92928276|NCT00720447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928277|NCT00720447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928278|NCT00720447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928279|NCT00720447|Antimetabolites|antimetabolites|mesh-ancestor
92928280|NCT00720447|Antiviral Agents|antiviral agents|mesh-ancestor
92928281|NCT00720447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928282|NCT00720447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928283|NCT00720447|Immunologic Factors|immunologic factors|mesh-ancestor
92928284|NCT00720447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928285|NCT00720447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92928286|NCT00720447|Alkylating Agents|alkylating agents|mesh-ancestor
92928287|NCT00720447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92928288|NCT00720447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928289|NCT04828824|Moxifloxacin|moxifloxacin|mesh-list
92928290|NCT04828824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92928291|NCT04828824|Norgestimate|norgestimate|mesh-list
92928292|NCT04828824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92928293|NCT04828824|Estradiol|estradiol|mesh-list
92928294|NCT04828824|Estrogens|estrogens|mesh-ancestor
92928295|NCT04828824|Hormones|hormones|mesh-ancestor
92928296|NCT04828824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928297|NCT04828824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928298|NCT04828824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92928299|NCT04828824|Contraceptive Agents|contraceptive agents|mesh-ancestor
92928300|NCT04828824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92928301|NCT04828824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92928302|NCT04828824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92928303|NCT04828824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92928304|NCT04828824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92928305|NCT04828824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928306|NCT04828824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928307|NCT04828824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92928308|NCT04828824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92928309|NCT04828824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928310|NCT04828824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928311|NCT04828824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928312|NCT04828824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92928314|NCT00578565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928315|NCT00578565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928316|NCT00578565|Immunologic Factors|immunologic factors|mesh-ancestor
92928317|NCT00578565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928318|NCT00578565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928319|NCT02572089|Naloxone|naloxone|mesh-list
92928320|NCT02572089|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92928321|NCT02572089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928322|NCT02572089|Sensory System Agents|sensory system agents|mesh-ancestor
92928323|NCT02572089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928324|NCT02588742|Melatonin|melatonin|mesh-list
92928325|NCT02588742|Antioxidants|antioxidants|mesh-ancestor
92928326|NCT02588742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928327|NCT02588742|Protective Agents|protective agents|mesh-ancestor
92928328|NCT02588742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928329|NCT02588742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928330|NCT00720603|Plerixafor|plerixafor|mesh-list
92928331|NCT00720603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92928332|NCT00720603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92928333|NCT00720603|Antiviral Agents|antiviral agents|mesh-ancestor
92928334|NCT00720603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928335|NCT04936854|Sirolimus|sirolimus|mesh-list
92928336|NCT04936854|Methylprednisolone|methylprednisolone|mesh-list
92928337|NCT04936854|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92928338|NCT04936854|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92928339|NCT04936854|Prednisolone|prednisolone|mesh-list
92928340|NCT04936854|Prednisolone acetate|prednisolone acetate|mesh-list
92928341|NCT04936854|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92928342|NCT04936854|Prednisolone phosphate|prednisolone phosphate|mesh-list
92928343|NCT04936854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928344|NCT04936854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928345|NCT04936854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92928346|NCT04936854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928347|NCT04936854|Antifungal Agents|antifungal agents|mesh-ancestor
92928348|NCT04936854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928349|NCT04936854|Immunologic Factors|immunologic factors|mesh-ancestor
92928350|NCT04936854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928351|NCT04936854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928352|NCT04936854|Antiemetics|antiemetics|mesh-ancestor
92928353|NCT04936854|Autonomic Agents|autonomic agents|mesh-ancestor
92928354|NCT04936854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928355|NCT04936854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92928356|NCT04936854|Glucocorticoids|glucocorticoids|mesh-ancestor
92928357|NCT04936854|Hormones|hormones|mesh-ancestor
92928358|NCT04936854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928359|NCT04936854|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92928360|NCT04936854|Protective Agents|protective agents|mesh-ancestor
92928361|NCT04936854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92928362|NCT00711789|Angiotensin II|angiotensin ii|mesh-list
92928363|NCT00711789|Giapreza|giapreza|mesh-list
92928364|NCT00711789|Angiotensinogen|angiotensinogen|mesh-list
92928365|NCT00711789|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92928366|NCT00711789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92928367|NCT00711789|Protease Inhibitors|protease inhibitors|mesh-ancestor
92928368|NCT00711789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928369|NCT00711789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928370|NCT00741260|Capecitabine|capecitabine|mesh-list
92928371|NCT00741260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928372|NCT00741260|Antimetabolites|antimetabolites|mesh-ancestor
92573824|NCT00242437|Thrombin|thrombin|mesh-list
92928373|NCT00741260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928374|NCT00741260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928375|NCT02587260|Clopidogrel|clopidogrel|mesh-list
92928376|NCT02587260|Ticagrelor|ticagrelor|mesh-list
92928377|NCT02587260|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92928378|NCT02587260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92928379|NCT02587260|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92928380|NCT02587260|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92273253|NCT01651442|Zolpidem|zolpidem|mesh-list
92928382|NCT02587260|Purinergic Agents|purinergic agents|mesh-ancestor
92928383|NCT02587260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928384|NCT02587260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928385|NCT02587260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928386|NCT02596256|Docetaxel|docetaxel|mesh-list
92928387|NCT02596256|Apatinib|apatinib|mesh-list
92928388|NCT02596256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928389|NCT02596256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92928390|NCT02596256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92928391|NCT02596256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92928392|NCT02596256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928393|NCT02596256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92928394|NCT02596256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928395|NCT04089722|Deoxycholic Acid|deoxycholic acid|mesh-list
92928396|NCT04089722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92928397|NCT04089722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92928398|NCT00717561|Amoxicillin|amoxicillin|mesh-list
92928399|NCT00717561|Azithromycin|azithromycin|mesh-list
92928400|NCT00717561|Moxifloxacin|moxifloxacin|mesh-list
92928401|NCT00717561|Clarithromycin|clarithromycin|mesh-list
92928402|NCT00717561|Ceftriaxone|ceftriaxone|mesh-list
92928403|NCT00717561|Clavulanic Acid|clavulanic acid|mesh-list
92928404|NCT00717561|Clavulanic Acids|clavulanic acids|mesh-list
92928405|NCT00717561|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92928406|NCT00717561|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92928407|NCT00717561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928408|NCT00717561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928409|NCT00717561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92928410|NCT00717561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92928411|NCT00717561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928412|NCT00717561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928413|NCT00717561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928414|NCT00717561|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92928415|NCT00717561|Contraceptive Agents|contraceptive agents|mesh-ancestor
92928416|NCT00717561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92928417|NCT00717561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928418|NCT00717561|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92928419|NCT00717561|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92928420|NCT00717561|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92928421|NCT00717561|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92928422|NCT00717561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92928423|NCT00717561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92928424|NCT00717561|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92928425|NCT00720915|Anticoagulants|anticoagulants|mesh-list
92928426|NCT00720915|Fibrin fragment D|fibrin fragment d|mesh-list
92928427|NCT00720915|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92928428|NCT00720915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92928429|NCT00720915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928430|NCT00720915|Hemostatics|hemostatics|mesh-ancestor
92928431|NCT00720915|Coagulants|coagulants|mesh-ancestor
92928432|NCT00712101|Abciximab|abciximab|mesh-list
92928433|NCT00712101|Anticoagulants|anticoagulants|mesh-ancestor
92928434|NCT00712101|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92928435|NCT00712257|Heparin|heparin|mesh-list
92928436|NCT00712257|Anticoagulants|anticoagulants|mesh-ancestor
92928437|NCT00712257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92928438|NCT00712257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92928439|NCT00712257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928440|NCT00740792|Fluticasone|fluticasone|mesh-list
92928442|NCT00740792|Azelastine|azelastine|mesh-list
92928443|NCT00740792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928444|NCT00740792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92928445|NCT00740792|Autonomic Agents|autonomic agents|mesh-ancestor
92928446|NCT00740792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928447|NCT00740792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928448|NCT00740792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92928449|NCT00740792|Respiratory System Agents|respiratory system agents|mesh-ancestor
92928450|NCT00740792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928451|NCT00740792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92928452|NCT00740792|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92928453|NCT00740792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928454|NCT00740792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928455|NCT00740792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92928456|NCT00740792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92928457|NCT00740792|Histamine Antagonists|histamine antagonists|mesh-ancestor
92928458|NCT00740792|Histamine Agents|histamine agents|mesh-ancestor
92928459|NCT00740792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928460|NCT00721305|Lovastatin|lovastatin|mesh-list
92928461|NCT00721305|L 647318|l 647318|mesh-list
92928462|NCT00721305|Dihydromevinolin|dihydromevinolin|mesh-list
92928463|NCT00721305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92928464|NCT00721305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92928465|NCT00721305|Antimetabolites|antimetabolites|mesh-ancestor
92928466|NCT00721305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928467|NCT00721305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92928468|NCT00721305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92928469|NCT00721305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928470|NCT00717951|Capecitabine|capecitabine|mesh-list
92928471|NCT00717951|Docetaxel|docetaxel|mesh-list
92928472|NCT00717951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928473|NCT00717951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928474|NCT00717951|Antimetabolites|antimetabolites|mesh-ancestor
92928475|NCT00717951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928476|NCT00717951|Tubulin Modulators|tubulin modulators|mesh-ancestor
92928477|NCT00717951|Antimitotic Agents|antimitotic agents|mesh-ancestor
92928478|NCT00717951|Mitosis Modulators|mitosis modulators|mesh-ancestor
92928479|NCT02572947|Dolutegravir|dolutegravir|mesh-list
92928480|NCT02572947|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92928481|NCT02572947|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92928482|NCT02572947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928483|NCT02572947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928484|NCT02572947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92928485|NCT02572947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92928486|NCT02572947|Antiviral Agents|antiviral agents|mesh-ancestor
92928487|NCT02572947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928488|NCT00712491|Sirolimus|sirolimus|mesh-list
92928489|NCT00712491|Temsirolimus|temsirolimus|mesh-list
92928490|NCT00712491|MTOR Inhibitors|mtor inhibitors|mesh-list
92928491|NCT00712491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928492|NCT00712491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928493|NCT00712491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92928494|NCT00712491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928495|NCT00712491|Antifungal Agents|antifungal agents|mesh-ancestor
92928496|NCT00712491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928497|NCT00712491|Immunologic Factors|immunologic factors|mesh-ancestor
92928498|NCT00712491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928499|NCT00712491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92928500|NCT00712491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928501|NCT00712491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928502|NCT04083066|Cytarabine|cytarabine|mesh-list
92928503|NCT04083066|Dexamethasone|dexamethasone|mesh-list
92928504|NCT04083066|Rituximab|rituximab|mesh-list
92928505|NCT04083066|Methotrexate|methotrexate|mesh-list
92928506|NCT04083066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928507|NCT04083066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928508|NCT04083066|Immunologic Factors|immunologic factors|mesh-ancestor
92928509|NCT04083066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928510|NCT04083066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928511|NCT04083066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928512|NCT04083066|Antiemetics|antiemetics|mesh-ancestor
92928513|NCT04083066|Autonomic Agents|autonomic agents|mesh-ancestor
92928514|NCT04083066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928515|NCT04083066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92928516|NCT04083066|Glucocorticoids|glucocorticoids|mesh-ancestor
92928517|NCT04083066|Hormones|hormones|mesh-ancestor
92928518|NCT04083066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928519|NCT04083066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92928520|NCT04083066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92928521|NCT04083066|Abortifacient Agents|abortifacient agents|mesh-ancestor
92928522|NCT04083066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92928523|NCT04083066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928524|NCT04083066|Antimetabolites|antimetabolites|mesh-ancestor
92928525|NCT04083066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928526|NCT04083066|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928527|NCT04083066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928528|NCT04083066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92928529|NCT04083066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526355|NCT00012207|Cyclophosphamide|cyclophosphamide|mesh-list
92928530|NCT04083066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92928531|NCT04083066|Antiviral Agents|antiviral agents|mesh-ancestor
92928532|NCT04083066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928533|NCT05683782|Chitosan|chitosan|mesh-list
92928534|NCT05683782|Epoetin Alfa|epoetin alfa|mesh-list
92928535|NCT05683782|Hematinics|hematinics|mesh-ancestor
92928536|NCT05683782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92928537|NCT05683782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92928538|NCT05683782|Antimetabolites|antimetabolites|mesh-ancestor
92928539|NCT05683782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928540|NCT05683782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92928541|NCT05683782|Chelating Agents|chelating agents|mesh-ancestor
92928542|NCT05683782|Sequestering Agents|sequestering agents|mesh-ancestor
92928543|NCT05683782|Hemostatics|hemostatics|mesh-ancestor
92928544|NCT05683782|Coagulants|coagulants|mesh-ancestor
92928545|NCT00740714|Vitamins|vitamins|mesh-list
92928546|NCT00740714|Vitamin E|vitamin e|mesh-list
92928547|NCT00740714|Tocopherols|tocopherols|mesh-list
92928548|NCT00740714|Tocotrienols|tocotrienols|mesh-list
92928549|NCT00740714|alpha-Tocopherol|alpha-tocopherol|mesh-list
92928550|NCT00740714|Coenzyme Q10|coenzyme q10|mesh-list
92928551|NCT00740714|Ubiquinone|ubiquinone|mesh-list
92928552|NCT00740714|Micronutrients|micronutrients|mesh-ancestor
92928553|NCT00740714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928554|NCT00740714|Antioxidants|antioxidants|mesh-ancestor
92928555|NCT00740714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928556|NCT00740714|Protective Agents|protective agents|mesh-ancestor
92928557|NCT00721773|Valsartan|valsartan|mesh-list
92928558|NCT00721773|Benazepril|benazepril|mesh-list
92928559|NCT00721773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92928560|NCT00721773|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92928561|NCT00721773|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92928562|NCT00721773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928563|NCT00721773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92928564|NCT00721773|Protease Inhibitors|protease inhibitors|mesh-ancestor
92928565|NCT00721773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928566|NCT05676684|Dapagliflozin|dapagliflozin|mesh-list
92928567|NCT05676684|Spironolactone|spironolactone|mesh-list
92928568|NCT05676684|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92928569|NCT05676684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928570|NCT05676684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92928571|NCT05676684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928572|NCT05676684|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92928573|NCT05676684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92928574|NCT05676684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928575|NCT05676684|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92928576|NCT05676684|Diuretics|diuretics|mesh-ancestor
92928577|NCT05676684|Natriuretic Agents|natriuretic agents|mesh-ancestor
92928578|NCT04070469|Amoxicillin|amoxicillin|mesh-list
92928579|NCT04070469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928580|NCT04070469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928581|NCT00712647|Beta Carotene|beta carotene|mesh-list
92928582|NCT00712647|Vitamin A|vitamin a|mesh-list
92928583|NCT00712647|Carotenoids|carotenoids|mesh-list
92928584|NCT00712647|Antioxidants|antioxidants|mesh-ancestor
92928585|NCT00712647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928586|NCT00712647|Protective Agents|protective agents|mesh-ancestor
92928587|NCT00712647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928588|NCT00712647|Provitamins|provitamins|mesh-ancestor
92928589|NCT00712647|Vitamins|vitamins|mesh-ancestor
92928590|NCT00712647|Micronutrients|micronutrients|mesh-ancestor
92928591|NCT00788957|Panitumumab|panitumumab|mesh-list
92928592|NCT00788957|Rilotumumab|rilotumumab|mesh-list
92928593|NCT00788957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928594|NCT00788957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928595|NCT04067817|Phenylephrine|phenylephrine|mesh-list
92928596|NCT04067817|Oxymetazoline|oxymetazoline|mesh-list
92928597|NCT04067817|Norepinephrine|norepinephrine|mesh-list
92928598|NCT04067817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92928599|NCT04067817|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92928600|NCT04067817|Mydriatics|mydriatics|mesh-ancestor
92928601|NCT04067817|Autonomic Agents|autonomic agents|mesh-ancestor
92928602|NCT04067817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928603|NCT04067817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928604|NCT04067817|Sympathomimetics|sympathomimetics|mesh-ancestor
92928605|NCT04067817|Nasal Decongestants|nasal decongestants|mesh-ancestor
92928606|NCT04067817|Respiratory System Agents|respiratory system agents|mesh-ancestor
92928607|NCT04067817|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92928608|NCT04067817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92928609|NCT04067817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92928610|NCT04067817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92928611|NCT04067817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928612|NCT04067817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928613|NCT04067817|Protective Agents|protective agents|mesh-ancestor
92928614|NCT00740636|Temozolomide|temozolomide|mesh-list
92928615|NCT00740636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92928616|NCT00740636|Alkylating Agents|alkylating agents|mesh-ancestor
92928617|NCT00740636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928618|NCT00740636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928619|NCT02603159|Capecitabine|capecitabine|mesh-list
92928620|NCT02603159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928621|NCT02603159|Antimetabolites|antimetabolites|mesh-ancestor
92928622|NCT02603159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928623|NCT02603159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928624|NCT02595554|Paclitaxel|paclitaxel|mesh-list
92928625|NCT02595554|Cisplatin|cisplatin|mesh-list
92928626|NCT02595554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92928627|NCT02595554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928628|NCT02595554|Tubulin Modulators|tubulin modulators|mesh-ancestor
92928629|NCT02595554|Antimitotic Agents|antimitotic agents|mesh-ancestor
92928630|NCT02595554|Mitosis Modulators|mitosis modulators|mesh-ancestor
92928631|NCT02595554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928632|NCT04069065|Tacrolimus|tacrolimus|mesh-list
92928633|NCT04069065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928634|NCT04069065|Immunologic Factors|immunologic factors|mesh-ancestor
92928635|NCT04069065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928636|NCT04069065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92928637|NCT04069065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928638|NCT04069065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928639|NCT04070391|Vitamin B 6|vitamin b 6|mesh-list
92928640|NCT04070391|Pyridoxal|pyridoxal|mesh-list
92928641|NCT04070391|Pyridoxine|pyridoxine|mesh-list
92928642|NCT04070391|Vitamins|vitamins|mesh-ancestor
92928643|NCT04070391|Micronutrients|micronutrients|mesh-ancestor
92928644|NCT04070391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928645|NCT04070391|Vitamin B Complex|vitamin b complex|mesh-ancestor
92928646|NCT05615051|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92928647|NCT05615051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92928648|NCT05615051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928649|NCT00795509|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92928650|NCT00795509|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92928651|NCT00795509|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92928652|NCT00795509|Cholinergic Agents|cholinergic agents|mesh-ancestor
92928653|NCT00795509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928654|NCT00795509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928655|NCT00795509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928656|NCT00795509|Urological Agents|urological agents|mesh-ancestor
92928657|NCT02603003|Pemetrexed|pemetrexed|mesh-list
92928658|NCT02603003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928659|NCT02603003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928660|NCT02603003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928661|NCT02603003|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92928662|NCT02603003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92928663|NCT04106297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92928664|NCT02603081|Ebselen|ebselen|mesh-list
92928665|NCT02603081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92928666|NCT02603081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92928667|NCT02603081|Analgesics|analgesics|mesh-ancestor
92928668|NCT02603081|Sensory System Agents|sensory system agents|mesh-ancestor
92146843|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
92928669|NCT02603081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928670|NCT02603081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928671|NCT02603081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928672|NCT02603081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928673|NCT02603081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92928674|NCT02603081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92928675|NCT02603081|Antioxidants|antioxidants|mesh-ancestor
92928676|NCT02603081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928677|NCT02603081|Protective Agents|protective agents|mesh-ancestor
92928678|NCT02603081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92928679|NCT02603081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928680|NCT02603081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92928681|NCT00787787|Capecitabine|capecitabine|mesh-list
92928683|NCT00787787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928684|NCT00787787|Antimetabolites|antimetabolites|mesh-ancestor
92928685|NCT00787787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928686|NCT00787787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928687|NCT00787787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92928688|NCT00787787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92928689|NCT00787787|Growth Substances|growth substances|mesh-ancestor
92928690|NCT00787787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928691|NCT00787787|Growth Inhibitors|growth inhibitors|mesh-ancestor
92928692|NCT00787787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92928693|NCT00787787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928694|NCT00722475|Immunoglobulins|immunoglobulins|mesh-list
92928695|NCT00722475|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92928696|NCT00722475|Antibodies|antibodies|mesh-list
92928697|NCT00722475|gamma-Globulins|gamma-globulins|mesh-list
92928698|NCT00722475|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92928699|NCT00722475|Immunologic Factors|immunologic factors|mesh-ancestor
92928700|NCT00722475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928701|NCT05549297|Pembrolizumab|pembrolizumab|mesh-list
92928702|NCT05549297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92928703|NCT05549297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928704|NCT05549297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92928705|NCT05549297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928706|NCT00915239|Pantoprazole|pantoprazole|mesh-list
92928707|NCT00915239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92928708|NCT00915239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92928709|NCT00915239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92928710|NCT00915239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928711|NCT00915239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928712|NCT00722631|Pioglitazone|pioglitazone|mesh-list
92928713|NCT00722631|Glimepiride|glimepiride|mesh-list
92928714|NCT00722631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92928715|NCT00722631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928716|NCT00722631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92928717|NCT00722631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928718|NCT00722631|Immunologic Factors|immunologic factors|mesh-ancestor
92928719|NCT02604095|Melatonin|melatonin|mesh-list
92928720|NCT02604095|Antioxidants|antioxidants|mesh-ancestor
92928721|NCT02604095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928722|NCT02604095|Protective Agents|protective agents|mesh-ancestor
92928723|NCT02604095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928724|NCT02604095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928725|NCT02571543|Ibuprofen|ibuprofen|mesh-list
92928726|NCT02571543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92928727|NCT02571543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92928728|NCT02571543|Analgesics|analgesics|mesh-ancestor
92928729|NCT02571543|Sensory System Agents|sensory system agents|mesh-ancestor
92928730|NCT02571543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928731|NCT02571543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928732|NCT02571543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928733|NCT02571543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928734|NCT02571543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92928735|NCT02571543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928736|NCT02571543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928737|NCT04107779|Menthol|menthol|mesh-list
92928738|NCT04107779|Nicotine|nicotine|mesh-list
92928739|NCT04107779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92928740|NCT04107779|Autonomic Agents|autonomic agents|mesh-ancestor
92928741|NCT04107779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928742|NCT04107779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928743|NCT04107779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92928744|NCT04107779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92928745|NCT04107779|Cholinergic Agents|cholinergic agents|mesh-ancestor
92928746|NCT04107779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928747|NCT04107779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928748|NCT04107779|Antipruritics|antipruritics|mesh-ancestor
92928749|NCT04107779|Dermatologic Agents|dermatologic agents|mesh-ancestor
92928750|NCT04067505|Nadroparin|nadroparin|mesh-list
92928751|NCT04067505|Warfarin|warfarin|mesh-list
92928752|NCT04067505|Rivaroxaban|rivaroxaban|mesh-list
92928753|NCT04067505|Anticoagulants|anticoagulants|mesh-ancestor
92928754|NCT04067505|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92928755|NCT04067505|Antithrombins|antithrombins|mesh-ancestor
92928756|NCT04067505|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92928757|NCT04067505|Protease Inhibitors|protease inhibitors|mesh-ancestor
92928758|NCT04067505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928759|NCT04067505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928760|NCT04067505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92928761|NCT04067505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92928762|NCT00794963|Metformin|metformin|mesh-list
92928763|NCT00794963|Orlistat|orlistat|mesh-list
92928764|NCT00794963|Irbesartan|irbesartan|mesh-list
92928765|NCT00794963|Fenofibrate|fenofibrate|mesh-list
92928766|NCT00794963|Pravastatin|pravastatin|mesh-list
92928767|NCT00794963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92928768|NCT00794963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928769|NCT00794963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92928770|NCT00794963|Antimetabolites|antimetabolites|mesh-ancestor
92928771|NCT00794963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928772|NCT00794963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92928773|NCT00794963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92928774|NCT00794963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92928775|NCT00794963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928776|NCT00794963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92928777|NCT00794963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92928778|NCT00794963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92928779|NCT00794963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92928780|NCT00713271|AZD-3199|azd-3199|mesh-list
92928781|NCT00713271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92928782|NCT00713271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92928783|NCT00713271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92928784|NCT00713271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92928785|NCT00713271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928786|NCT00713271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928787|NCT00713271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928788|NCT05673135|Antihypertensive Agents|antihypertensive agents|mesh-list
92928789|NCT00722709|Ropivacaine|ropivacaine|mesh-list
92928790|NCT00722709|Anesthetics, Local|anesthetics, local|mesh-ancestor
92928791|NCT00722709|Anesthetics|anesthetics|mesh-ancestor
92928792|NCT00722709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928793|NCT00722709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928794|NCT00722709|Sensory System Agents|sensory system agents|mesh-ancestor
92928795|NCT00722709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928796|NCT04105205|Apramycin|apramycin|mesh-list
92163670|NCT03830827|Vortioxetine|vortioxetine|mesh-list
92928797|NCT04105205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928798|NCT04105205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928799|NCT00794573|Varenicline|varenicline|mesh-list
92928800|NCT00794573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92928801|NCT00794573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92928802|NCT00794573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92928803|NCT00794573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928804|NCT00794573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928805|NCT00794573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928806|NCT05061654|Tazobactam|tazobactam|mesh-list
92928807|NCT05061654|Ceftolozane|ceftolozane|mesh-list
92928808|NCT05061654|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92928809|NCT05061654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92928810|NCT05061654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928811|NCT05061654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92928812|NCT05061654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928813|NCT05061654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928814|NCT05061654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92928815|NCT04070079|Tenofovir|tenofovir|mesh-list
92928816|NCT04070079|Antiviral Agents|antiviral agents|mesh-ancestor
92928817|NCT04070079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928818|NCT04070079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92928819|NCT04070079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92928820|NCT04070079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928821|NCT04070079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928822|NCT04070079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92928823|NCT04070079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92928824|NCT00739934|Voriconazole|voriconazole|mesh-list
92928825|NCT00739934|Antifungal Agents|antifungal agents|mesh-ancestor
92574256|NCT00102843|Antimetabolites|antimetabolites|mesh-ancestor
92928826|NCT00739934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928827|NCT00739934|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92526360|NCT00012207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928828|NCT00739934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92928830|NCT00739934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928831|NCT00739934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92928832|NCT00739934|Hormone Antagonists|hormone antagonists|mesh-ancestor
92928833|NCT00739934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928834|NCT00739934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928835|NCT00739934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92928837|NCT00723411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92928838|NCT00723411|Immunologic Factors|immunologic factors|mesh-ancestor
92928839|NCT00723411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928840|NCT02586636|Metformin|metformin|mesh-list
92928841|NCT02586636|Omeprazole|omeprazole|mesh-list
92928842|NCT02586636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92928843|NCT02586636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928844|NCT02586636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92928845|NCT02586636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92928846|NCT02586636|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92928847|NCT02586636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928848|NCT02586636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928849|NCT00713739|Prazosin|prazosin|mesh-list
92928850|NCT00713739|Doxazosin|doxazosin|mesh-list
92928851|NCT00713739|Nifedipine|nifedipine|mesh-list
92928852|NCT00713739|Alfuzosin|alfuzosin|mesh-list
92928853|NCT00713739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92928854|NCT00713739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92928855|NCT00713739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928856|NCT00713739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92928857|NCT00713739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928858|NCT00713739|Vasodilator Agents|vasodilator agents|mesh-ancestor
92928859|NCT00713739|Tocolytic Agents|tocolytic agents|mesh-ancestor
92928860|NCT00713739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92928861|NCT00713739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92928862|NCT00713739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92928863|NCT00713739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92928864|NCT00713739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92928865|NCT00713739|Adrenergic Agents|adrenergic agents|mesh-ancestor
92928866|NCT00713739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928867|NCT00713739|Urological Agents|urological agents|mesh-ancestor
92928868|NCT02595476|Remifentanil|remifentanil|mesh-list
92928869|NCT02595476|Propofol|propofol|mesh-list
92928870|NCT02595476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92928871|NCT02595476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928872|NCT02595476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928873|NCT02595476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92928874|NCT02595476|Anesthetics, General|anesthetics, general|mesh-ancestor
92928875|NCT02595476|Anesthetics|anesthetics|mesh-ancestor
92928876|NCT02595476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92928877|NCT02595476|Narcotics|narcotics|mesh-ancestor
92928878|NCT02595476|Analgesics|analgesics|mesh-ancestor
92928879|NCT02595476|Sensory System Agents|sensory system agents|mesh-ancestor
92928880|NCT02595476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928881|NCT02586402|Epoetin Alfa|epoetin alfa|mesh-list
92928882|NCT02586402|Hematinics|hematinics|mesh-ancestor
92928883|NCT00734630|Losartan|losartan|mesh-list
92928884|NCT00734630|Lisinopril|lisinopril|mesh-list
92928885|NCT00734630|Nebivolol|nebivolol|mesh-list
92928886|NCT00734630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92928887|NCT00734630|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92928888|NCT00734630|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92928889|NCT00734630|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92928890|NCT00734630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928891|NCT00734630|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92928892|NCT00734630|Protease Inhibitors|protease inhibitors|mesh-ancestor
92928893|NCT00734630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928894|NCT00734630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92928895|NCT00734630|Protective Agents|protective agents|mesh-ancestor
92928896|NCT00734630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928897|NCT00734630|Vasodilator Agents|vasodilator agents|mesh-ancestor
92928898|NCT00734630|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92928899|NCT00734630|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92928900|NCT00734630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92574347|NCT00102882|Xhance|xhance|mesh-list
92928901|NCT00734630|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526362|NCT00012207|Alkylating Agents|alkylating agents|mesh-ancestor
92928902|NCT00734630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928903|NCT05636514|Decitabine|decitabine|mesh-list
92928904|NCT05636514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928905|NCT05636514|Antimetabolites|antimetabolites|mesh-ancestor
92928906|NCT05636514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928907|NCT05636514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928908|NCT05636514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928909|NCT02586246|Certolizumab Pegol|certolizumab pegol|mesh-list
92928910|NCT02586246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92928911|NCT02586246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92928912|NCT02586246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92928913|NCT02586246|Immunologic Factors|immunologic factors|mesh-ancestor
92928914|NCT02586246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928915|NCT02586246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92928916|NCT00920244|Atropine|atropine|mesh-list
92928917|NCT00920244|Amiodarone|amiodarone|mesh-list
92928918|NCT00920244|Epinephrine|epinephrine|mesh-list
92928919|NCT00920244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92928920|NCT00920244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92928921|NCT00920244|Adrenergic Agents|adrenergic agents|mesh-ancestor
92928922|NCT00920244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928923|NCT00920244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928924|NCT00920244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928925|NCT00920244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92928926|NCT00920244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92928927|NCT00920244|Autonomic Agents|autonomic agents|mesh-ancestor
92928928|NCT00920244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928929|NCT00920244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92928930|NCT00920244|Respiratory System Agents|respiratory system agents|mesh-ancestor
92928931|NCT00920244|Mydriatics|mydriatics|mesh-ancestor
92928932|NCT00920244|Sympathomimetics|sympathomimetics|mesh-ancestor
92928933|NCT00920244|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92928934|NCT00920244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92928935|NCT00920244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92928936|NCT00920244|Parasympatholytics|parasympatholytics|mesh-ancestor
92928937|NCT00920244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92928938|NCT00920244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92928939|NCT00920244|Cholinergic Agents|cholinergic agents|mesh-ancestor
92928940|NCT00920244|Vasodilator Agents|vasodilator agents|mesh-ancestor
92928941|NCT00920244|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92928942|NCT00920244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92928943|NCT00920244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92928944|NCT00920244|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92928945|NCT00920244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92928946|NCT00920244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928947|NCT00920244|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92928948|NCT00920244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92928949|NCT00920244|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92928950|NCT00578175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92928951|NCT00578175|Immunologic Factors|immunologic factors|mesh-ancestor
92928952|NCT00578175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928953|NCT00723879|Ribavirin|ribavirin|mesh-list
92928954|NCT00723879|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92928955|NCT00723879|Antimetabolites|antimetabolites|mesh-ancestor
92928956|NCT00723879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928957|NCT00723879|Antiviral Agents|antiviral agents|mesh-ancestor
92928958|NCT00723879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92928959|NCT03907605|Hormones|hormones|mesh-list
92928960|NCT03907605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92928961|NCT03907605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928963|NCT00435409|Sunitinib|sunitinib|mesh-list
92928964|NCT00435409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92928965|NCT00435409|Antimetabolites|antimetabolites|mesh-ancestor
92928966|NCT00435409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928967|NCT00435409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92928968|NCT00435409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92928969|NCT00435409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92928970|NCT00435409|Growth Substances|growth substances|mesh-ancestor
92928971|NCT00435409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928972|NCT00435409|Growth Inhibitors|growth inhibitors|mesh-ancestor
92928973|NCT00435409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92928974|NCT00435409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92928975|NCT00724035|Fentanyl|fentanyl|mesh-list
92928976|NCT00724035|Midazolam|midazolam|mesh-list
92928977|NCT00724035|Analgesics|analgesics|mesh-list
92928978|NCT00724035|Anesthetics|anesthetics|mesh-list
92928979|NCT00724035|Ropivacaine|ropivacaine|mesh-list
92928980|NCT00724035|Anesthetics, Local|anesthetics, local|mesh-list
92928981|NCT00724035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92928982|NCT00724035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92928983|NCT00724035|Sensory System Agents|sensory system agents|mesh-ancestor
92928984|NCT00724035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92928985|NCT00724035|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92928986|NCT00724035|Narcotics|narcotics|mesh-ancestor
92928987|NCT00724035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92928988|NCT00724035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92928989|NCT00724035|Anesthetics, General|anesthetics, general|mesh-ancestor
92928990|NCT00724035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92928991|NCT00724035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92928992|NCT00724035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92928993|NCT00724035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92928994|NCT00724035|GABA Modulators|gaba modulators|mesh-ancestor
92928995|NCT00724035|GABA Agents|gaba agents|mesh-ancestor
92928996|NCT00724035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92928997|NCT00724035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92928998|NCT04126824|Triamcinolone|triamcinolone|mesh-list
92928999|NCT04126824|Bupivacaine|bupivacaine|mesh-list
92929000|NCT04126824|Anesthetics, Local|anesthetics, local|mesh-ancestor
92929001|NCT04126824|Anesthetics|anesthetics|mesh-ancestor
92929002|NCT04126824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929003|NCT04126824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929004|NCT04126824|Sensory System Agents|sensory system agents|mesh-ancestor
92929005|NCT04126824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929006|NCT04126824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929007|NCT04126824|Glucocorticoids|glucocorticoids|mesh-ancestor
92929008|NCT04126824|Hormones|hormones|mesh-ancestor
92929009|NCT04126824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929010|NCT00724113|Lidocaine|lidocaine|mesh-list
92929011|NCT00724113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92929012|NCT00724113|Anesthetics|anesthetics|mesh-ancestor
92929013|NCT00724113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929014|NCT00724113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929015|NCT00724113|Sensory System Agents|sensory system agents|mesh-ancestor
92929016|NCT00724113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929017|NCT00724113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92929018|NCT00724113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92929019|NCT00724113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92929020|NCT00724113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929021|NCT00724113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929022|NCT04070001|Ibuprofen|ibuprofen|mesh-list
92929023|NCT04070001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92929024|NCT04070001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929025|NCT04070001|Analgesics|analgesics|mesh-ancestor
92929026|NCT04070001|Sensory System Agents|sensory system agents|mesh-ancestor
92929027|NCT04070001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929028|NCT04070001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929029|NCT04070001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929030|NCT04070001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929031|NCT04070001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526380|NCT00028483|Doxorubicin|doxorubicin|mesh-list
92929032|NCT04070001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929033|NCT04070001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929034|NCT00435019|Insulin|insulin|mesh-list
92929035|NCT00435019|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92929036|NCT00435019|Insulin Aspart|insulin aspart|mesh-list
92929037|NCT00435019|Insulin Detemir|insulin detemir|mesh-list
92929038|NCT00435019|Isophane Insulin, Human|isophane insulin, human|mesh-list
92929039|NCT00435019|Insulin, Isophane|insulin, isophane|mesh-list
92929040|NCT00435019|Isophane insulin, beef|isophane insulin, beef|mesh-list
92929041|NCT00435019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92929042|NCT00435019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929043|NCT00724581|Amiodarone|amiodarone|mesh-list
92929044|NCT00724581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92929045|NCT00724581|Vasodilator Agents|vasodilator agents|mesh-ancestor
92929046|NCT00724581|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92929047|NCT00724581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929048|NCT00724581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929049|NCT00724581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92929050|NCT00724581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92929051|NCT00724581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92929052|NCT00724581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929053|NCT00724581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92929054|NCT00724581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92929055|NCT00724581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92929057|NCT02570841|Antipruritics|antipruritics|mesh-ancestor
92929058|NCT02570841|Dermatologic Agents|dermatologic agents|mesh-ancestor
92929059|NCT02570841|Sensory System Agents|sensory system agents|mesh-ancestor
92929060|NCT02570841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929061|NCT02570841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929062|NCT00577863|Teriparatide|teriparatide|mesh-list
92929063|NCT00577863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92929064|NCT00577863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929065|NCT00577863|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92929066|NCT04956627|Itraconazole|itraconazole|mesh-list
92929067|NCT04956627|Phenytoin|phenytoin|mesh-list
92929068|NCT04956627|Gemfibrozil|gemfibrozil|mesh-list
92929069|NCT04956627|Antifungal Agents|antifungal agents|mesh-ancestor
92929070|NCT04956627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929071|NCT04956627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92929072|NCT04956627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92929073|NCT04956627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929074|NCT04956627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929075|NCT04956627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92929076|NCT04956627|Hormone Antagonists|hormone antagonists|mesh-ancestor
92929077|NCT04956627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929078|NCT04956627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929079|NCT04956627|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92929080|NCT04956627|Anticonvulsants|anticonvulsants|mesh-ancestor
92929081|NCT04956627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92929082|NCT04956627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92929083|NCT04956627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929084|NCT04956627|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92929085|NCT04956627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92929086|NCT04956627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92929087|NCT04956627|Antimetabolites|antimetabolites|mesh-ancestor
92929088|NCT04956627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92929089|NCT04956627|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92929090|NCT00920088|Ritonavir|ritonavir|mesh-list
92929091|NCT00920088|Lopinavir|lopinavir|mesh-list
92929092|NCT00920088|Darunavir|darunavir|mesh-list
92929093|NCT00920088|Flurbiprofen|flurbiprofen|mesh-list
92929094|NCT00920088|Midazolam|midazolam|mesh-list
92929095|NCT00920088|Dextromethorphan|dextromethorphan|mesh-list
92929096|NCT00920088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92929097|NCT00920088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92929098|NCT00920088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929099|NCT00920088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929100|NCT00920088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92929101|NCT00920088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92929102|NCT00920088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92929103|NCT00920088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92929104|NCT00920088|Anesthetics, General|anesthetics, general|mesh-ancestor
92929105|NCT00920088|Anesthetics|anesthetics|mesh-ancestor
92929106|NCT00920088|GABA Modulators|gaba modulators|mesh-ancestor
92929107|NCT00920088|GABA Agents|gaba agents|mesh-ancestor
92929108|NCT00920088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929109|NCT00920088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929110|NCT00920088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92929111|NCT00920088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92929112|NCT00920088|Protease Inhibitors|protease inhibitors|mesh-ancestor
92929113|NCT00920088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929114|NCT00920088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92929115|NCT00920088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92929116|NCT00920088|Antiviral Agents|antiviral agents|mesh-ancestor
92929117|NCT00920088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929118|NCT00920088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92929119|NCT00920088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92929120|NCT00920088|Antitussive Agents|antitussive agents|mesh-ancestor
92929121|NCT00920088|Respiratory System Agents|respiratory system agents|mesh-ancestor
92929122|NCT00920088|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92929123|NCT00920088|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92929124|NCT00920088|Analgesics|analgesics|mesh-ancestor
92929125|NCT00920088|Sensory System Agents|sensory system agents|mesh-ancestor
92929126|NCT00920088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929127|NCT00920088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92929128|NCT00920088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929129|NCT00920088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929130|NCT00920088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929131|NCT00920088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92929132|NCT04018833|Ranibizumab|ranibizumab|mesh-list
92929133|NCT04018833|Aflibercept|aflibercept|mesh-list
92929134|NCT04018833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92929135|NCT04018833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92929136|NCT04018833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92929137|NCT04018833|Growth Substances|growth substances|mesh-ancestor
92929138|NCT04018833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929139|NCT04018833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92929140|NCT04018833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929141|NCT04066803|Folic Acid|folic acid|mesh-list
92929142|NCT04066803|Hematinics|hematinics|mesh-ancestor
92929143|NCT04066803|Vitamin B Complex|vitamin b complex|mesh-ancestor
92929144|NCT04066803|Vitamins|vitamins|mesh-ancestor
92929145|NCT04066803|Micronutrients|micronutrients|mesh-ancestor
92929146|NCT04066803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929147|NCT04921371|Listerine|listerine|mesh-list
92929148|NCT04921371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92929149|NCT04921371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929150|NCT00725439|R 115866|r 115866|mesh-list
92929151|NCT00725439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92929152|NCT00725439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929153|NCT00725439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929154|NCT03205761|Olaparib|olaparib|mesh-list
92929155|NCT03205761|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92929156|NCT03205761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929157|NCT03205761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929158|NCT03205761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929159|NCT00725517|Icodextrin|icodextrin|mesh-list
92929160|NCT00725517|Dialysis Solutions|dialysis solutions|mesh-ancestor
92929161|NCT00725517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92929162|NCT04066881|Vaccines|vaccines|mesh-list
92929163|NCT04066881|Immunologic Factors|immunologic factors|mesh-ancestor
92929164|NCT04066881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929165|NCT04620291|UB-421|ub-421|mesh-list
92929166|NCT04620291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92929167|NCT04620291|Antiviral Agents|antiviral agents|mesh-ancestor
92929168|NCT04620291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929169|NCT04657068|Gemcitabine|gemcitabine|mesh-list
92929170|NCT04657068|Irinotecan|irinotecan|mesh-list
92929171|NCT04657068|Camptothecin|camptothecin|mesh-list
92929172|NCT04657068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92929173|NCT04657068|Antimetabolites|antimetabolites|mesh-ancestor
92929174|NCT04657068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929175|NCT04657068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929176|NCT04657068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92929177|NCT04657068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92929178|NCT04657068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929179|NCT04657068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92929180|NCT00794417|Pemetrexed|pemetrexed|mesh-list
92929181|NCT00794417|Aflibercept|aflibercept|mesh-list
92929182|NCT00794417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929183|NCT00794417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929184|NCT00794417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929185|NCT00794417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92929186|NCT00794417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92929187|NCT00794417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92929188|NCT00794417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92929189|NCT00794417|Growth Substances|growth substances|mesh-ancestor
92929190|NCT00794417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929191|NCT00794417|Growth Inhibitors|growth inhibitors|mesh-ancestor
92929192|NCT04483206|Melphalan|melphalan|mesh-list
92929193|NCT04483206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92929194|NCT04483206|Alkylating Agents|alkylating agents|mesh-ancestor
92929195|NCT04483206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929196|NCT04483206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929197|NCT04483206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92929198|NCT04483206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929199|NCT04483206|Immunologic Factors|immunologic factors|mesh-ancestor
92929200|NCT04483206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929201|NCT00725829|Simvastatin|simvastatin|mesh-list
92929202|NCT00725829|Ezetimibe|ezetimibe|mesh-list
92929203|NCT00725829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92929205|NCT00725829|Antimetabolites|antimetabolites|mesh-ancestor
92929206|NCT00725829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929207|NCT00725829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92929208|NCT00725829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92929209|NCT00725829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929210|NCT00794339|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92929211|NCT00794339|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92929212|NCT00794339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929213|NCT02583438|Saxagliptin|saxagliptin|mesh-list
92929214|NCT02583438|Incretins|incretins|mesh-ancestor
92929215|NCT02583438|Hormones|hormones|mesh-ancestor
92929216|NCT02583438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929217|NCT02583438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929218|NCT02583438|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92929219|NCT02583438|Protease Inhibitors|protease inhibitors|mesh-ancestor
92929220|NCT02583438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929221|NCT02583438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929222|NCT02583438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92929223|NCT02603861|Modafinil|modafinil|mesh-list
92929224|NCT02603861|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92929225|NCT02603861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146995|NCT03086239|Immunologic Factors|immunologic factors|mesh-ancestor
92929226|NCT02603861|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92929227|NCT02603861|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92929228|NCT02603861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92929229|NCT02603861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929230|NCT02569905|Flurbiprofen|flurbiprofen|mesh-list
92929231|NCT02569905|Parecoxib|parecoxib|mesh-list
92929232|NCT02569905|Analgesics|analgesics|mesh-ancestor
92929233|NCT02569905|Sensory System Agents|sensory system agents|mesh-ancestor
92929234|NCT02569905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929235|NCT02569905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929236|NCT02569905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92929237|NCT02569905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929238|NCT02569905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929239|NCT02569905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929240|NCT02569905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92929241|NCT02569905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929242|NCT02569905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929243|NCT02569905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92929244|NCT02603783|Capsaicin|capsaicin|mesh-list
92929245|NCT02603783|Antipruritics|antipruritics|mesh-ancestor
92929246|NCT02603783|Dermatologic Agents|dermatologic agents|mesh-ancestor
92929247|NCT02603783|Sensory System Agents|sensory system agents|mesh-ancestor
92929248|NCT02603783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929249|NCT02603783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929250|NCT04110275|Plasminogen|plasminogen|mesh-list
92929251|NCT04110275|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92929252|NCT04110275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92929253|NCT04110275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92929254|NCT04110275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929255|NCT04250883|Iodine|iodine|mesh-list
92929256|NCT04250883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92929257|NCT04250883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929258|NCT04250883|Trace Elements|trace elements|mesh-ancestor
92929259|NCT04250883|Micronutrients|micronutrients|mesh-ancestor
92929260|NCT04250883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929261|NCT04469634|Antibodies|antibodies|mesh-list
92929262|NCT04469634|Immunologic Factors|immunologic factors|mesh-ancestor
92929263|NCT04469634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929264|NCT04209543|Progesterone|progesterone|mesh-list
92929265|NCT04209543|Progestins|progestins|mesh-ancestor
92929266|NCT04209543|Hormones|hormones|mesh-ancestor
92929267|NCT04209543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929268|NCT04209543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929269|NCT04465500|Androgens|androgens|mesh-list
92929270|NCT04465500|Hormones|hormones|mesh-ancestor
92929271|NCT04465500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929272|NCT04465500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929273|NCT04080726|Esomeprazole|esomeprazole|mesh-list
92929274|NCT04080726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92929275|NCT04080726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929276|NCT04080726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92929277|NCT04080726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929278|NCT04080726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929279|NCT04639986|Gemcitabine|gemcitabine|mesh-list
92929280|NCT04639986|Capecitabine|capecitabine|mesh-list
92929281|NCT04639986|Vinorelbine|vinorelbine|mesh-list
92929282|NCT04639986|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92929283|NCT04639986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92929284|NCT04639986|Antimetabolites|antimetabolites|mesh-ancestor
92929285|NCT04639986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929286|NCT04639986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929287|NCT04639986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92929288|NCT04639986|Tubulin Modulators|tubulin modulators|mesh-ancestor
92929289|NCT04639986|Antimitotic Agents|antimitotic agents|mesh-ancestor
92929290|NCT04639986|Mitosis Modulators|mitosis modulators|mesh-ancestor
92929291|NCT04639986|Immunoconjugates|immunoconjugates|mesh-ancestor
92929292|NCT04639986|Immunologic Factors|immunologic factors|mesh-ancestor
92929293|NCT04639986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929294|NCT04126317|Aflibercept|aflibercept|mesh-list
92929295|NCT04126317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92929296|NCT04126317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92929297|NCT04126317|Growth Substances|growth substances|mesh-ancestor
92929298|NCT04126317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929299|NCT04126317|Growth Inhibitors|growth inhibitors|mesh-ancestor
92929300|NCT04126317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929301|NCT02583516|Vemurafenib|vemurafenib|mesh-list
92929302|NCT02583516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929303|NCT02583516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929304|NCT02583516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929305|NCT02583516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929306|NCT00790907|Heparin|heparin|mesh-list
92929307|NCT00790907|PENTA|penta|mesh-list
92929308|NCT00790907|Fondaparinux|fondaparinux|mesh-list
92929309|NCT00790907|Anticoagulants|anticoagulants|mesh-ancestor
92929310|NCT00790907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92929311|NCT00790907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92929312|NCT00790907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929313|NCT00790907|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92929314|NCT00790907|Antithrombins|antithrombins|mesh-ancestor
92929315|NCT00790907|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92929316|NCT00790907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92929317|NCT00790907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929318|NCT03109353|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92929319|NCT03109353|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92929320|NCT03109353|Dermatologic Agents|dermatologic agents|mesh-ancestor
92929321|NCT04066179|Prednisolone|prednisolone|mesh-list
92929322|NCT04066179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929323|NCT04066179|Glucocorticoids|glucocorticoids|mesh-ancestor
92929324|NCT04066179|Hormones|hormones|mesh-ancestor
92929325|NCT04066179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929326|NCT04066179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929327|NCT04066179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92929328|NCT04066179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929329|NCT04110119|Diclofenac|diclofenac|mesh-list
92929330|NCT04110119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92929331|NCT04110119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929332|NCT04110119|Analgesics|analgesics|mesh-ancestor
92929333|NCT04110119|Sensory System Agents|sensory system agents|mesh-ancestor
92929334|NCT04110119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929335|NCT04110119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929336|NCT04110119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929337|NCT04110119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929338|NCT04110119|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92929339|NCT04110119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929340|NCT04110119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929341|NCT00726687|Capecitabine|capecitabine|mesh-list
92929342|NCT00726687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92929343|NCT00726687|Antimetabolites|antimetabolites|mesh-ancestor
92929344|NCT00726687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929345|NCT00726687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929346|NCT00727077|Interferons|interferons|mesh-list
92929347|NCT00727077|Ribavirin|ribavirin|mesh-list
92929348|NCT00727077|Interferon-alpha|interferon-alpha|mesh-list
92574777|NCT00068315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929349|NCT00727077|Interferon alpha-2|interferon alpha-2|mesh-list
92929350|NCT00727077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929352|NCT00727077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929353|NCT00727077|Antimetabolites|antimetabolites|mesh-ancestor
92929354|NCT00727077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929355|NCT00727077|Immunologic Factors|immunologic factors|mesh-ancestor
92929356|NCT00727077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929357|NCT02585388|Letrozole|letrozole|mesh-list
92929358|NCT02585388|Vinorelbine|vinorelbine|mesh-list
92929359|NCT02585388|Anastrozole|anastrozole|mesh-list
92929360|NCT02585388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929361|NCT02585388|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92929362|NCT02585388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92929363|NCT02585388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929364|NCT02585388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929365|NCT02585388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92929366|NCT02585388|Hormone Antagonists|hormone antagonists|mesh-ancestor
92929367|NCT02585388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929368|NCT02585388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929369|NCT02585388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92929370|NCT02585388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92929371|NCT02585388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92929372|NCT02585388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92929373|NCT02585388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92929374|NCT04080336|Misoprostol|misoprostol|mesh-list
92929375|NCT04080336|Dinoprostone|dinoprostone|mesh-list
92929376|NCT04080336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92929377|NCT04080336|Abortifacient Agents|abortifacient agents|mesh-ancestor
92929378|NCT04080336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92929379|NCT04080336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929380|NCT04080336|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92929381|NCT04080336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929382|NCT04080336|Oxytocics|oxytocics|mesh-ancestor
92929383|NCT00793871|Sunitinib|sunitinib|mesh-list
92929384|NCT00793871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929385|NCT00793871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92929386|NCT00793871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92929387|NCT00793871|Growth Substances|growth substances|mesh-ancestor
92929388|NCT00793871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929389|NCT00793871|Growth Inhibitors|growth inhibitors|mesh-ancestor
92929390|NCT00793871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929391|NCT00793871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929392|NCT00793871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929393|NCT05466474|Tislelizumab|tislelizumab|mesh-list
92929394|NCT05466474|Dacarbazine|dacarbazine|mesh-list
92929395|NCT05466474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92929396|NCT05466474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929397|NCT05466474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92929398|NCT05466474|Alkylating Agents|alkylating agents|mesh-ancestor
92929399|NCT05466474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929400|NCT00727233|Sorafenib|sorafenib|mesh-list
92929401|NCT00727233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929402|NCT00727233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929403|NCT00727233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526384|NCT00028483|Antimitotic Agents|antimitotic agents|mesh-ancestor
92929404|NCT00727233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929405|NCT04105283|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
92929406|NCT04105283|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92929407|NCT04105283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929408|NCT04066257|Metronidazole|metronidazole|mesh-list
92929409|NCT04066257|Tetracycline|tetracycline|mesh-list
92929411|NCT04066257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929412|NCT04066257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92929413|NCT04066257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92929414|NCT04066257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92929415|NCT04066257|Antacids|antacids|mesh-ancestor
92929416|NCT04066257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929417|NCT04066257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929418|NCT04066257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92929419|NCT04066257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929420|NCT03655821|Pemetrexed|pemetrexed|mesh-list
92929421|NCT03655821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929422|NCT03655821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929423|NCT03655821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574853|NCT00250315|Dobutamine|dobutamine|mesh-list
92929424|NCT03655821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92929425|NCT03655821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92929426|NCT04524702|Hydroxychloroquine|hydroxychloroquine|mesh-list
92929427|NCT04524702|Paclitaxel|paclitaxel|mesh-list
92929428|NCT04524702|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92929429|NCT04524702|Gemcitabine|gemcitabine|mesh-list
92929430|NCT04524702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92929431|NCT04524702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929432|NCT04524702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92929433|NCT04524702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92929434|NCT04524702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92929435|NCT04524702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929436|NCT04524702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92929437|NCT04524702|Antimetabolites|antimetabolites|mesh-ancestor
92929438|NCT04524702|Antimalarials|antimalarials|mesh-ancestor
92929439|NCT04524702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92929440|NCT04524702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92929441|NCT04524702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929442|NCT04524702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929443|NCT04524702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929444|NCT00730197|Albuterol|albuterol|mesh-list
92929445|NCT00730197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92929446|NCT00730197|Autonomic Agents|autonomic agents|mesh-ancestor
92929447|NCT00730197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929448|NCT00730197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929449|NCT00730197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92929450|NCT00730197|Respiratory System Agents|respiratory system agents|mesh-ancestor
92929451|NCT00730197|Tocolytic Agents|tocolytic agents|mesh-ancestor
92929452|NCT00730197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92929453|NCT00730197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92929454|NCT00730197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92929455|NCT00730197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92929456|NCT00730197|Adrenergic Agents|adrenergic agents|mesh-ancestor
92929457|NCT00730197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929458|NCT00730197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929459|NCT00727545|Chelating Agents|chelating agents|mesh-list
92929460|NCT00727545|Sequestering Agents|sequestering agents|mesh-ancestor
92929461|NCT00727545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929462|NCT02582892|Vitamin D|vitamin d|mesh-list
92929463|NCT02582892|Vitamins|vitamins|mesh-ancestor
92929464|NCT02582892|Micronutrients|micronutrients|mesh-ancestor
92929465|NCT02582892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929466|NCT02582892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92929467|NCT00730509|Vitamin B 12|vitamin b 12|mesh-list
92929468|NCT00730509|Hydroxocobalamin|hydroxocobalamin|mesh-list
92929469|NCT00730509|Vitamins|vitamins|mesh-ancestor
92929470|NCT00730509|Micronutrients|micronutrients|mesh-ancestor
92929471|NCT00730509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929472|NCT00730509|Vitamin B Complex|vitamin b complex|mesh-ancestor
92929473|NCT00730509|Hematinics|hematinics|mesh-ancestor
92929474|NCT02582736|Methotrimeprazine|methotrimeprazine|mesh-list
92929475|NCT02582736|Haloperidol|haloperidol|mesh-list
92929476|NCT02582736|Pimozide|pimozide|mesh-list
92929477|NCT02582736|Olanzapine|olanzapine|mesh-list
92929478|NCT02582736|Chlorpromazine|chlorpromazine|mesh-list
92929479|NCT02582736|Trifluoperazine|trifluoperazine|mesh-list
92929480|NCT02582736|Risperidone|risperidone|mesh-list
92929481|NCT02582736|Aripiprazole|aripiprazole|mesh-list
92929482|NCT02582736|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92929483|NCT02582736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92929484|NCT02582736|Ziprasidone|ziprasidone|mesh-list
92929485|NCT02582736|Antipsychotic Agents|antipsychotic agents|mesh-list
92929486|NCT02582736|Clozapine|clozapine|mesh-list
92929487|NCT02582736|Loxapine|loxapine|mesh-list
92929488|NCT02582736|Perphenazine|perphenazine|mesh-list
92929489|NCT02582736|Fluphenazine|fluphenazine|mesh-list
92929490|NCT02582736|Flupenthixol|flupenthixol|mesh-list
92929491|NCT02582736|Thioridazine|thioridazine|mesh-list
92929492|NCT02582736|Clopenthixol|clopenthixol|mesh-list
92929493|NCT02582736|Chlorprothixene|chlorprothixene|mesh-list
92929494|NCT02582736|Fluspirilene|fluspirilene|mesh-list
92929495|NCT02582736|Thiothixene|thiothixene|mesh-list
92929496|NCT02582736|Mesoridazine|mesoridazine|mesh-list
92929497|NCT02582736|Chlormezanone|chlormezanone|mesh-list
92574925|NCT00103623|Abarelix|abarelix|mesh-list
92929498|NCT02582736|Tetrabenazine|tetrabenazine|mesh-list
92929499|NCT02582736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92929500|NCT02582736|Serotonin Agents|serotonin agents|mesh-ancestor
92929501|NCT02582736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929502|NCT02582736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929503|NCT02582736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929504|NCT02582736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92929505|NCT02582736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929506|NCT02582736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92929507|NCT02582736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92929508|NCT02582736|Dopamine Agents|dopamine agents|mesh-ancestor
92929509|NCT02582736|Antiemetics|antiemetics|mesh-ancestor
92929510|NCT02582736|Autonomic Agents|autonomic agents|mesh-ancestor
92929511|NCT02582736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929512|NCT02582736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929513|NCT02582736|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92929514|NCT02582736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92929515|NCT02582736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929516|NCT02582736|Antidepressive Agents|antidepressive agents|mesh-ancestor
92929517|NCT02582736|Dopamine Agonists|dopamine agonists|mesh-ancestor
92929518|NCT02582736|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92929519|NCT02582736|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92929520|NCT02582736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92929521|NCT02582736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92929522|NCT02582736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92929523|NCT02582736|GABA Antagonists|gaba antagonists|mesh-ancestor
92929524|NCT02582736|GABA Agents|gaba agents|mesh-ancestor
92929525|NCT02582736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92929526|NCT02582736|Adrenergic Agents|adrenergic agents|mesh-ancestor
92929527|NCT02582736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929528|NCT02582736|Analgesics|analgesics|mesh-ancestor
92929529|NCT02582736|Sensory System Agents|sensory system agents|mesh-ancestor
92929530|NCT02582736|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92929531|NCT02582736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92929532|NCT02582736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92929533|NCT04019652|Moxifloxacin|moxifloxacin|mesh-list
92929534|NCT04019652|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92929535|NCT04019652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92929536|NCT04019652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929537|NCT04019652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92929538|NCT04019652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92929539|NCT04019652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929540|NCT04019652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929541|NCT04019652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929542|NCT04019652|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92929543|NCT04019652|Contraceptive Agents|contraceptive agents|mesh-ancestor
92929544|NCT04019652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92929545|NCT04019652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929546|NCT04019652|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92929547|NCT04019652|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92929548|NCT04019652|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92929549|NCT00735345|Docetaxel|docetaxel|mesh-list
92929550|NCT00735345|Cetuximab|cetuximab|mesh-list
92929551|NCT00735345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929552|NCT00735345|Tubulin Modulators|tubulin modulators|mesh-ancestor
92929553|NCT00735345|Antimitotic Agents|antimitotic agents|mesh-ancestor
92274430|NCT04812626|Hormones|hormones|mesh-ancestor
92929554|NCT00735345|Mitosis Modulators|mitosis modulators|mesh-ancestor
92929555|NCT00735345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929556|NCT00735345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92929558|NCT00735501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92929559|NCT00735501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929560|NCT00727935|Lidocaine|lidocaine|mesh-list
92929561|NCT00727935|Ropivacaine|ropivacaine|mesh-list
92929562|NCT00727935|Anesthetics, Local|anesthetics, local|mesh-ancestor
92929563|NCT00727935|Anesthetics|anesthetics|mesh-ancestor
92929564|NCT00727935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929565|NCT00727935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929566|NCT00727935|Sensory System Agents|sensory system agents|mesh-ancestor
92929567|NCT00727935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929568|NCT00727935|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92929569|NCT00727935|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92929570|NCT00727935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92929571|NCT00727935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929572|NCT00727935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929573|NCT00728013|Atorvastatin|atorvastatin|mesh-list
92929574|NCT00728013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92929575|NCT00728013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92929576|NCT00728013|Antimetabolites|antimetabolites|mesh-ancestor
92929577|NCT00728013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575001|NCT00068744|Mitomycins|mitomycins|mesh-list
92929579|NCT00728013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92929580|NCT00728013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929581|NCT00577707|Pemetrexed|pemetrexed|mesh-list
92929582|NCT00577707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92929583|NCT00577707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929584|NCT00577707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929585|NCT00577707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929586|NCT00577707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92929587|NCT00577707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92929588|NCT00577707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929589|NCT00730821|Nintedanib|nintedanib|mesh-list
92929590|NCT00730821|Afatinib|afatinib|mesh-list
92929591|NCT00730821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929592|NCT00730821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929593|NCT00730821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929594|NCT00730821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929595|NCT00728559|Bupivacaine|bupivacaine|mesh-list
92929596|NCT00728559|Anesthetics, Local|anesthetics, local|mesh-ancestor
92929597|NCT00728559|Anesthetics|anesthetics|mesh-ancestor
92929598|NCT00728559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929599|NCT00728559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929600|NCT00728559|Sensory System Agents|sensory system agents|mesh-ancestor
92929601|NCT00728559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929602|NCT00735813|Heparin|heparin|mesh-list
92929603|NCT00735813|Anticoagulants|anticoagulants|mesh-ancestor
92929604|NCT00735813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92929605|NCT00735813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92929606|NCT00735813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929607|NCT04064619|Solifenacin Succinate|solifenacin succinate|mesh-list
92929608|NCT04064619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92929609|NCT04064619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92929610|NCT04064619|Cholinergic Agents|cholinergic agents|mesh-ancestor
92929611|NCT04064619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929612|NCT04064619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929613|NCT04064619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929614|NCT04064619|Urological Agents|urological agents|mesh-ancestor
92929615|NCT00730977|Mannitol|mannitol|mesh-list
92929616|NCT00730977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92929617|NCT00730977|Diuretics|diuretics|mesh-ancestor
92929618|NCT00730977|Natriuretic Agents|natriuretic agents|mesh-ancestor
92929619|NCT00730977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929620|NCT00728715|Budesonide|budesonide|mesh-list
92929621|NCT00728715|Formoterol Fumarate|formoterol fumarate|mesh-list
92929622|NCT00728715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929623|NCT00728715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92929624|NCT00728715|Autonomic Agents|autonomic agents|mesh-ancestor
92929625|NCT00728715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929626|NCT00728715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274490|NCT01968317|Metformin|metformin|mesh-list
92929627|NCT00728715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92929628|NCT00728715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92929629|NCT00728715|Glucocorticoids|glucocorticoids|mesh-ancestor
92929630|NCT00728715|Hormones|hormones|mesh-ancestor
92929631|NCT00728715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929632|NCT00728715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92929633|NCT00728715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92929634|NCT00728715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92929635|NCT00728715|Adrenergic Agents|adrenergic agents|mesh-ancestor
92929636|NCT00728715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929637|NCT00728715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929638|NCT00731289|Triamcinolone|triamcinolone|mesh-list
92929639|NCT00731289|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92929640|NCT00731289|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92929641|NCT00731289|Hyaluronic Acid|hyaluronic acid|mesh-list
92929642|NCT00731289|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92929643|NCT00731289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929644|NCT00731289|Glucocorticoids|glucocorticoids|mesh-ancestor
92929645|NCT00731289|Hormones|hormones|mesh-ancestor
92929646|NCT00731289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929647|NCT00731289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929648|NCT00731289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929649|NCT00731289|Immunologic Factors|immunologic factors|mesh-ancestor
92929650|NCT00731289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575081|NCT00068861|Metformin|metformin|mesh-list
92929651|NCT00731289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929653|NCT00731289|Viscosupplements|viscosupplements|mesh-ancestor
92929654|NCT00731289|Protective Agents|protective agents|mesh-ancestor
92929655|NCT00736515|Insulin|insulin|mesh-list
92929656|NCT00736515|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92929657|NCT00736515|Insulin Glargine|insulin glargine|mesh-list
92929658|NCT00736515|Gliclazide|gliclazide|mesh-list
92929659|NCT00736515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92929660|NCT00736515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929661|NCT00045201|Irinotecan|irinotecan|mesh-list
92929662|NCT00045201|Camptothecin|camptothecin|mesh-list
92929663|NCT00045201|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92929664|NCT00045201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92929665|NCT00045201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92929666|NCT00045201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929667|NCT00045201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929668|NCT00045201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929669|NCT00045201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929670|NCT00045201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92929671|NCT00731367|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92929672|NCT00731367|Laxatives|laxatives|mesh-ancestor
92929673|NCT00731367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929674|NCT00731523|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92929675|NCT00731523|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92929676|NCT00731523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929677|NCT00731523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929678|NCT00731523|Immunologic Factors|immunologic factors|mesh-ancestor
92929679|NCT00731523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929680|NCT05601531|Calcitriol|calcitriol|mesh-list
92929681|NCT05601531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92929682|NCT05601531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929683|NCT05601531|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92929684|NCT05601531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929685|NCT05601531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929686|NCT05601531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92929687|NCT05601531|Vitamins|vitamins|mesh-ancestor
92929688|NCT05601531|Micronutrients|micronutrients|mesh-ancestor
92929689|NCT05601531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92929690|NCT02569125|Everolimus|everolimus|mesh-list
92929691|NCT02569125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92929692|NCT02569125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92929693|NCT02569125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929694|NCT02569125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929695|NCT02569125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929696|NCT02569125|Immunologic Factors|immunologic factors|mesh-ancestor
92929697|NCT02569125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929698|NCT02569125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929699|NCT00731601|Pantoprazole|pantoprazole|mesh-list
92929700|NCT00731601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92929701|NCT00731601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929702|NCT00731601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92929703|NCT00731601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929704|NCT00731601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929705|NCT00736905|Rilpivirine|rilpivirine|mesh-list
92929706|NCT00736905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92929707|NCT00736905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92929708|NCT00736905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929709|NCT00736905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929710|NCT00736905|Antiviral Agents|antiviral agents|mesh-ancestor
92929711|NCT00736905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929712|NCT00736905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92929713|NCT00736905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92929714|NCT00736983|Ciprofloxacin|ciprofloxacin|mesh-list
92929715|NCT00736983|Adalimumab|adalimumab|mesh-list
92929716|NCT00736983|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92929717|NCT00736983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929718|NCT00736983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929719|NCT00736983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92929720|NCT00736983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929721|NCT00736983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92929722|NCT00736983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92929723|NCT00736983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575160|NCT00251914|Esomeprazole|esomeprazole|mesh-list
92929724|NCT00736983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929725|NCT00736983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929726|NCT00736983|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92147073|NCT05135286|Protective Agents|protective agents|mesh-ancestor
92929727|NCT00736983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92929729|NCT00729339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929730|NCT00729339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92929731|NCT00729339|Serotonin Agents|serotonin agents|mesh-ancestor
92929732|NCT00729339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929733|NCT00729339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929734|NCT00729339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929735|NCT00737139|Epinephrine|epinephrine|mesh-list
92929736|NCT00737139|Bupivacaine|bupivacaine|mesh-list
92929737|NCT00737139|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92929738|NCT00737139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92929739|NCT00737139|Adrenergic Agents|adrenergic agents|mesh-ancestor
92929740|NCT00737139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929741|NCT00737139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929742|NCT00737139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929743|NCT00737139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92929744|NCT00737139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92929745|NCT00737139|Autonomic Agents|autonomic agents|mesh-ancestor
92929746|NCT00737139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929747|NCT00737139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92929748|NCT00737139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92929749|NCT00737139|Mydriatics|mydriatics|mesh-ancestor
92929750|NCT00737139|Sympathomimetics|sympathomimetics|mesh-ancestor
92929751|NCT00737139|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92929752|NCT00737139|Anesthetics, Local|anesthetics, local|mesh-ancestor
92929753|NCT00737139|Anesthetics|anesthetics|mesh-ancestor
92929754|NCT00737139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929755|NCT00737139|Sensory System Agents|sensory system agents|mesh-ancestor
92929756|NCT00732147|Pramlintide|pramlintide|mesh-list
92929757|NCT00732147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92929758|NCT00732147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929759|NCT02569515|Epoetin Alfa|epoetin alfa|mesh-list
92929760|NCT02569515|Hematinics|hematinics|mesh-ancestor
92929761|NCT00737373|Leucovorin|leucovorin|mesh-list
92929762|NCT00737373|Folic Acid|folic acid|mesh-list
92929763|NCT00737373|Docetaxel|docetaxel|mesh-list
92929764|NCT00737373|Fluorouracil|fluorouracil|mesh-list
92929765|NCT00737373|Oxaliplatin|oxaliplatin|mesh-list
92929766|NCT00737373|Levoleucovorin|levoleucovorin|mesh-list
92929767|NCT00737373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929768|NCT00737373|Tubulin Modulators|tubulin modulators|mesh-ancestor
92929769|NCT00737373|Antimitotic Agents|antimitotic agents|mesh-ancestor
92929770|NCT00737373|Mitosis Modulators|mitosis modulators|mesh-ancestor
92929771|NCT00737373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929772|NCT00737373|Antimetabolites|antimetabolites|mesh-ancestor
92929773|NCT00737373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92929774|NCT00737373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929775|NCT00737373|Immunologic Factors|immunologic factors|mesh-ancestor
92929776|NCT00737373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929777|NCT00737373|Antidotes|antidotes|mesh-ancestor
92929778|NCT00737373|Protective Agents|protective agents|mesh-ancestor
92929779|NCT00737373|Vitamin B Complex|vitamin b complex|mesh-ancestor
92929780|NCT00737373|Vitamins|vitamins|mesh-ancestor
92929781|NCT00737373|Micronutrients|micronutrients|mesh-ancestor
92929782|NCT00737373|Hematinics|hematinics|mesh-ancestor
92929783|NCT00729495|Celecoxib|celecoxib|mesh-list
92929784|NCT00729495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92929785|NCT00729495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929786|NCT00729495|Analgesics|analgesics|mesh-ancestor
92929787|NCT00729495|Sensory System Agents|sensory system agents|mesh-ancestor
92929788|NCT00729495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929789|NCT00729495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929790|NCT00729495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929791|NCT00729495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929792|NCT00729495|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92929793|NCT00729495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92929794|NCT00729495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929795|NCT00729495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929796|NCT00737685|Cyclophosphamide|cyclophosphamide|mesh-list
92929797|NCT00737685|Fludarabine|fludarabine|mesh-list
92929798|NCT00737685|Thymoglobulin|thymoglobulin|mesh-list
92929799|NCT00737685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929800|NCT00737685|Immunologic Factors|immunologic factors|mesh-ancestor
92929801|NCT00737685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929802|NCT00737685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929803|NCT00737685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92929804|NCT00737685|Alkylating Agents|alkylating agents|mesh-ancestor
92929805|NCT00737685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929806|NCT00737685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929807|NCT00737685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92929808|NCT00732537|Nitric Oxide|nitric oxide|mesh-list
92929809|NCT00732537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92929810|NCT00732537|Autonomic Agents|autonomic agents|mesh-ancestor
92929811|NCT00732537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929812|NCT00732537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929813|NCT00732537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92929814|NCT00732537|Respiratory System Agents|respiratory system agents|mesh-ancestor
92929815|NCT00732537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92929816|NCT00732537|Antioxidants|antioxidants|mesh-ancestor
92929817|NCT00732537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929818|NCT00732537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929819|NCT00732537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92929820|NCT00732537|Vasodilator Agents|vasodilator agents|mesh-ancestor
92929821|NCT00732537|Gasotransmitters|gasotransmitters|mesh-ancestor
92929822|NCT00732537|Protective Agents|protective agents|mesh-ancestor
92929823|NCT00732693|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92929824|NCT00732693|Norethindrone|norethindrone|mesh-list
92929825|NCT00732693|Norethindrone Acetate|norethindrone acetate|mesh-list
92929826|NCT00732693|Estradiol|estradiol|mesh-list
92929827|NCT00732693|Progesterone|progesterone|mesh-list
92929828|NCT00732693|Estrogens|estrogens|mesh-ancestor
92929829|NCT00732693|Hormones|hormones|mesh-ancestor
92929830|NCT00732693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929831|NCT00732693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929832|NCT00732693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92929833|NCT00732693|Contraceptive Agents|contraceptive agents|mesh-ancestor
92929834|NCT00732693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92929835|NCT00732693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92929836|NCT00732693|Progestins|progestins|mesh-ancestor
92929837|NCT00732693|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92929838|NCT00732693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92929839|NCT00732693|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92929840|NCT00729963|Sibutramine|sibutramine|mesh-list
92929841|NCT00729963|Antidepressive Agents|antidepressive agents|mesh-ancestor
92929842|NCT00729963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92929843|NCT00729963|Appetite Depressants|appetite depressants|mesh-ancestor
92929844|NCT00729963|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92929845|NCT00737997|Morphine|morphine|mesh-list
92929846|NCT00737997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92929847|NCT00737997|Narcotics|narcotics|mesh-ancestor
92929848|NCT00737997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929849|NCT00737997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929850|NCT00737997|Analgesics|analgesics|mesh-ancestor
92929851|NCT00737997|Sensory System Agents|sensory system agents|mesh-ancestor
92929852|NCT00737997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929853|NCT00732927|Aspirin|aspirin|mesh-list
92929854|NCT00732927|Parnaparin|parnaparin|mesh-list
92929855|NCT00732927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92929856|NCT00732927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92929857|NCT00732927|Analgesics|analgesics|mesh-ancestor
92929858|NCT00732927|Sensory System Agents|sensory system agents|mesh-ancestor
92929859|NCT00732927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929860|NCT00732927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929861|NCT00732927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929862|NCT00732927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929863|NCT00732927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92929864|NCT00732927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92929865|NCT00732927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929866|NCT00732927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92929867|NCT00732927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92929868|NCT00732927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929869|NCT00732927|Antipyretics|antipyretics|mesh-ancestor
92929870|NCT00732927|Anticoagulants|anticoagulants|mesh-ancestor
92929871|NCT00733083|Dexamethasone|dexamethasone|mesh-list
92929872|NCT00733083|Morphine|morphine|mesh-list
92929873|NCT00733083|Oxycodone|oxycodone|mesh-list
92929874|NCT00733083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929875|NCT00733083|Antiemetics|antiemetics|mesh-ancestor
92929876|NCT00733083|Autonomic Agents|autonomic agents|mesh-ancestor
92230359|NCT05276219|Furosemide|furosemide|mesh-list
92929877|NCT00733083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929878|NCT00733083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929879|NCT00733083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929880|NCT00733083|Glucocorticoids|glucocorticoids|mesh-ancestor
92929881|NCT00733083|Hormones|hormones|mesh-ancestor
92929882|NCT00733083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929883|NCT00733083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92929884|NCT00733083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929885|NCT00733083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92929886|NCT00733083|Narcotics|narcotics|mesh-ancestor
92929887|NCT00733083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929888|NCT00733083|Analgesics|analgesics|mesh-ancestor
92929889|NCT00733083|Sensory System Agents|sensory system agents|mesh-ancestor
92929890|NCT00712335|Fluticasone|fluticasone|mesh-list
92929892|NCT00712335|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92929893|NCT00712335|Montelukast|montelukast|mesh-list
92929894|NCT00712335|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92929895|NCT00712335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929896|NCT00712335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92929897|NCT00712335|Autonomic Agents|autonomic agents|mesh-ancestor
92929898|NCT00712335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929899|NCT00712335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929900|NCT00712335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92929901|NCT00712335|Respiratory System Agents|respiratory system agents|mesh-ancestor
92929902|NCT00712335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92929903|NCT00712335|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92929904|NCT00712335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92929905|NCT00712335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92929906|NCT00712335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92929907|NCT00712335|Adrenergic Agents|adrenergic agents|mesh-ancestor
92929908|NCT00712335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929909|NCT00712335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929910|NCT00712335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92929911|NCT00712335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929912|NCT00712335|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92929913|NCT00712335|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92929914|NCT00738621|Dexamethasone|dexamethasone|mesh-list
92929915|NCT00738621|Dexamethasone acetate|dexamethasone acetate|mesh-list
92929916|NCT00738621|Ondansetron|ondansetron|mesh-list
92929917|NCT00738621|Aprepitant|aprepitant|mesh-list
92929918|NCT00738621|Fosaprepitant|fosaprepitant|mesh-list
92929919|NCT00738621|BB 1101|bb 1101|mesh-list
92929920|NCT00738621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92929921|NCT00738621|Antiemetics|antiemetics|mesh-ancestor
92929922|NCT00738621|Autonomic Agents|autonomic agents|mesh-ancestor
92526391|NCT00028483|Immunologic Factors|immunologic factors|mesh-ancestor
92929923|NCT00738621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92929924|NCT00738621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929925|NCT00738621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92929926|NCT00738621|Glucocorticoids|glucocorticoids|mesh-ancestor
92929927|NCT00738621|Hormones|hormones|mesh-ancestor
92929928|NCT00738621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92929929|NCT00738621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92929930|NCT00738621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929931|NCT00738621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92929932|NCT00738621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92929933|NCT00738621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929934|NCT00738621|Antipruritics|antipruritics|mesh-ancestor
92929935|NCT00738621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92929936|NCT00738621|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92929937|NCT00738621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92929938|NCT00738621|Serotonin Agents|serotonin agents|mesh-ancestor
92929939|NCT00738621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929940|NCT00738621|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92929941|NCT00733239|Cycloserine|cycloserine|mesh-list
92929942|NCT00733239|Verapamil|verapamil|mesh-list
92929943|NCT00733239|Diltiazem|diltiazem|mesh-list
92929944|NCT00733239|Isradipine|isradipine|mesh-list
92929945|NCT00733239|Nifedipine|nifedipine|mesh-list
92929946|NCT00733239|Gabapentin|gabapentin|mesh-list
92929947|NCT00733239|Naloxone|naloxone|mesh-list
92929948|NCT00733239|Analgesics|analgesics|mesh-ancestor
92929949|NCT00733239|Sensory System Agents|sensory system agents|mesh-ancestor
92929950|NCT00733239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575369|NCT00253474|Interferons|interferons|mesh-list
92929951|NCT00733239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929952|NCT00733239|Anticonvulsants|anticonvulsants|mesh-ancestor
92929953|NCT00733239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92929954|NCT00733239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92929955|NCT00733239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92929956|NCT00733239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92929957|NCT00733239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92929958|NCT00733239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92929959|NCT00733239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92929960|NCT00733239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929961|NCT00733239|Antimanic Agents|antimanic agents|mesh-ancestor
92929962|NCT00733239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92929963|NCT00733239|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92929964|NCT00733239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92929965|NCT00733239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92929966|NCT00733239|Vasodilator Agents|vasodilator agents|mesh-ancestor
92929967|NCT00733239|Tocolytic Agents|tocolytic agents|mesh-ancestor
92929968|NCT00733239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92929969|NCT00733239|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92929970|NCT00733239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92929971|NCT00733239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92929972|NCT00733239|Antitubercular Agents|antitubercular agents|mesh-ancestor
92929973|NCT00733239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92929974|NCT00733239|Antimetabolites|antimetabolites|mesh-ancestor
92929975|NCT00733239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92929976|NCT00733239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92929977|NCT00738153|Insulin Detemir|insulin detemir|mesh-list
92929978|NCT00738153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92929979|NCT00738153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929980|NCT04065165|Lanreotide|lanreotide|mesh-list
92929981|NCT04065165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929982|NCT00577629|Cytarabine|cytarabine|mesh-list
92929983|NCT00577629|Cyclophosphamide|cyclophosphamide|mesh-list
92929984|NCT00577629|Rituximab|rituximab|mesh-list
92929985|NCT00577629|Doxorubicin|doxorubicin|mesh-list
92929986|NCT00577629|Etoposide|etoposide|mesh-list
92929987|NCT00577629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92929988|NCT00577629|Immunologic Factors|immunologic factors|mesh-ancestor
92929989|NCT00577629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92929990|NCT00577629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92929991|NCT00577629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92929992|NCT00577629|Alkylating Agents|alkylating agents|mesh-ancestor
92929993|NCT00577629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92929994|NCT00577629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92929995|NCT00577629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92929996|NCT00577629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92929997|NCT00577629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92929998|NCT00577629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92929999|NCT00577629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92930000|NCT00577629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930001|NCT00577629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92930002|NCT00577629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930003|NCT00577629|Antimetabolites|antimetabolites|mesh-ancestor
92930004|NCT00577629|Antiviral Agents|antiviral agents|mesh-ancestor
92930005|NCT00577629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930007|NCT00733317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930008|NCT00733317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92930009|NCT00733317|Autonomic Agents|autonomic agents|mesh-ancestor
92930010|NCT00733317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930011|NCT00733317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930012|NCT00733317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92930013|NCT00733317|Respiratory System Agents|respiratory system agents|mesh-ancestor
92930014|NCT00733317|Glucocorticoids|glucocorticoids|mesh-ancestor
92930015|NCT00733317|Hormones|hormones|mesh-ancestor
92930016|NCT00733317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930017|NCT02568735|Etoricoxib|etoricoxib|mesh-list
92930018|NCT02568735|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92930019|NCT02568735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92930020|NCT02568735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930021|NCT02568735|Analgesics|analgesics|mesh-ancestor
92930022|NCT02568735|Sensory System Agents|sensory system agents|mesh-ancestor
92930023|NCT02568735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930024|NCT02568735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930025|NCT02568735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930026|NCT02568735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930027|NCT02568735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92930028|NCT02568735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92575449|NCT00254137|Capecitabine|capecitabine|mesh-list
92930029|NCT02568735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930030|NCT02568735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930031|NCT00733473|Budesonide|budesonide|mesh-list
92930032|NCT00733473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930033|NCT00733473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92930034|NCT00733473|Autonomic Agents|autonomic agents|mesh-ancestor
92930035|NCT00733473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930036|NCT00733473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930037|NCT00733473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92930038|NCT00733473|Respiratory System Agents|respiratory system agents|mesh-ancestor
92930039|NCT00733473|Glucocorticoids|glucocorticoids|mesh-ancestor
92930040|NCT00733473|Hormones|hormones|mesh-ancestor
92930041|NCT00733473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930042|NCT00710385|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92930043|NCT00710385|Buprenorphine|buprenorphine|mesh-list
92930044|NCT00710385|Heroin|heroin|mesh-list
92930045|NCT00710385|Naloxone|naloxone|mesh-list
92930046|NCT00710385|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92930047|NCT00710385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930048|NCT00710385|Sensory System Agents|sensory system agents|mesh-ancestor
92930049|NCT00710385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930050|NCT00710385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92930051|NCT00710385|Narcotics|narcotics|mesh-ancestor
92930052|NCT00710385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930053|NCT00710385|Analgesics|analgesics|mesh-ancestor
92930054|NCT04063527|Paclitaxel|paclitaxel|mesh-list
92930055|NCT04063527|Carboplatin|carboplatin|mesh-list
92930056|NCT04063527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92930057|NCT04063527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930058|NCT04063527|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930059|NCT04063527|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930060|NCT04063527|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930061|NCT04063527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930062|NCT00738777|Tamoxifen|tamoxifen|mesh-list
92930063|NCT00738777|Fulvestrant|fulvestrant|mesh-list
92930064|NCT00738777|Anastrozole|anastrozole|mesh-list
92930065|NCT00738777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92930066|NCT00738777|Hormone Antagonists|hormone antagonists|mesh-ancestor
92930067|NCT00738777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930068|NCT00738777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930069|NCT00738777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92930070|NCT00738777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930071|NCT00738777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92930072|NCT00738777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92930073|NCT00738777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92930074|NCT00738777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92930075|NCT00738777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92930076|NCT00738777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92930077|NCT00738777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930078|NCT00738777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930079|NCT00733785|Rosiglitazone|rosiglitazone|mesh-list
92930080|NCT00733785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92930081|NCT00733785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930082|NCT04063449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92930083|NCT04063449|Endostar protein|endostar protein|mesh-list
92930084|NCT04063449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930085|NCT04063449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930086|NCT04063449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930087|NCT04063449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92930088|NCT04063449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92930089|NCT04063449|Growth Substances|growth substances|mesh-ancestor
92930090|NCT04063449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930091|NCT04063449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92930092|NCT00700011|Clofarabine|clofarabine|mesh-list
92930093|NCT00700011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930094|NCT00700011|Antimetabolites|antimetabolites|mesh-ancestor
92930095|NCT00700011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930096|NCT00700011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930097|NCT05512767|Capecitabine|capecitabine|mesh-list
92930098|NCT05512767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930099|NCT05512767|Antimetabolites|antimetabolites|mesh-ancestor
92930100|NCT05512767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930101|NCT05512767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930102|NCT02567955|Vaccines|vaccines|mesh-list
92930103|NCT02567955|Immunologic Factors|immunologic factors|mesh-ancestor
92930104|NCT02567955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930105|NCT02568423|Mirikizumab|mirikizumab|mesh-list
92930106|NCT02568423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92930107|NCT02568423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930108|NCT02568423|Analgesics|analgesics|mesh-ancestor
92930109|NCT02568423|Sensory System Agents|sensory system agents|mesh-ancestor
92930110|NCT02568423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930111|NCT02568423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930112|NCT02568423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930113|NCT02568423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930114|NCT02568423|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92930115|NCT02568423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92930116|NCT00921063|Alprazolam|alprazolam|mesh-list
92930117|NCT00921063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92930118|NCT00921063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930119|NCT00921063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930120|NCT00921063|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92930121|NCT00921063|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92930122|NCT00921063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92930123|NCT00921063|GABA Modulators|gaba modulators|mesh-ancestor
92930124|NCT00921063|GABA Agents|gaba agents|mesh-ancestor
92930125|NCT00921063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930126|NCT00921063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930127|NCT00707031|Metformin|metformin|mesh-list
92930128|NCT00707031|Exenatide|exenatide|mesh-list
92930129|NCT00707031|Lixisenatide|lixisenatide|mesh-list
92930130|NCT00707031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92930131|NCT00707031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930132|NCT00707031|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92930133|NCT00707031|Incretins|incretins|mesh-ancestor
92930134|NCT00707031|Hormones|hormones|mesh-ancestor
92930135|NCT00707031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930136|NCT00711477|Naltrexone|naltrexone|mesh-list
92930137|NCT00711477|Bupropion|bupropion|mesh-list
92930138|NCT00711477|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92930139|NCT00711477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92930140|NCT00711477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930141|NCT00711477|Sensory System Agents|sensory system agents|mesh-ancestor
92930142|NCT00711477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930143|NCT00711477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92930144|NCT00711477|Antidepressive Agents|antidepressive agents|mesh-ancestor
92930145|NCT00711477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92930146|NCT00711477|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92930147|NCT00711477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92930148|NCT00711477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930149|NCT00711477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930150|NCT00711477|Dopamine Agents|dopamine agents|mesh-ancestor
92930151|NCT00711477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930152|NCT00711477|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92930153|NCT00711477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92930154|NCT00711477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930155|NCT00734474|Metformin|metformin|mesh-list
92930156|NCT00734474|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92930157|NCT00734474|Dulaglutide|dulaglutide|mesh-list
92930158|NCT00734474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92930159|NCT00734474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930160|NCT00734474|Incretins|incretins|mesh-ancestor
92930161|NCT00734474|Hormones|hormones|mesh-ancestor
92930162|NCT00734474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930163|NCT00734474|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92930164|NCT00734474|Protease Inhibitors|protease inhibitors|mesh-ancestor
92930165|NCT00734474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930166|NCT00734474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930167|NCT00583362|Belimumab|belimumab|mesh-list
92930168|NCT00583362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930169|NCT00583362|Immunologic Factors|immunologic factors|mesh-ancestor
92930170|NCT00583362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930171|NCT00577473|Mesalamine|mesalamine|mesh-list
92930172|NCT00577473|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92930173|NCT00577473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930174|NCT00577473|Analgesics|analgesics|mesh-ancestor
92930175|NCT00577473|Sensory System Agents|sensory system agents|mesh-ancestor
92930176|NCT00577473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930177|NCT00577473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930178|NCT00577473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930179|NCT00577473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930180|NCT00740103|Semapimod|semapimod|mesh-list
92930181|NCT00740103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92930182|NCT00740103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930183|NCT00740103|Analgesics|analgesics|mesh-ancestor
92930184|NCT00740103|Sensory System Agents|sensory system agents|mesh-ancestor
92930185|NCT00740103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930186|NCT00740103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930187|NCT00740103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930188|NCT00740103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930189|NCT00740103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930190|NCT00740103|Immunologic Factors|immunologic factors|mesh-ancestor
92930191|NCT02583828|Cyclophosphamide|cyclophosphamide|mesh-list
92930192|NCT02583828|Letrozole|letrozole|mesh-list
92930193|NCT02583828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930194|NCT02583828|Immunologic Factors|immunologic factors|mesh-ancestor
92930195|NCT02583828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930196|NCT02583828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930197|NCT02583828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92930198|NCT02583828|Alkylating Agents|alkylating agents|mesh-ancestor
92930199|NCT02583828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930200|NCT02583828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930201|NCT02583828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92930202|NCT02583828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92930203|NCT02583828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92930204|NCT02583828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930205|NCT02583828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92930206|NCT02583828|Hormone Antagonists|hormone antagonists|mesh-ancestor
92930207|NCT02583828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930208|NCT02568111|Interferons|interferons|mesh-list
92930209|NCT02568111|Interferon-beta|interferon-beta|mesh-list
92930210|NCT02568111|Interferon beta-1a|interferon beta-1a|mesh-list
92930211|NCT02568111|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92930212|NCT02568111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930213|NCT02568111|Antiviral Agents|antiviral agents|mesh-ancestor
92930214|NCT02568111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930215|NCT02568111|Immunologic Factors|immunologic factors|mesh-ancestor
92930216|NCT02568111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930217|NCT02568111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92930218|NCT02568111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92930219|NCT02568111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92930220|NCT02568111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92930221|NCT02568111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92930222|NCT02568111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930223|NCT02568111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930224|NCT02568111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92930225|NCT05711667|Acetic Acid|acetic acid|mesh-list
92930226|NCT05711667|Letermovir|letermovir|mesh-list
92930227|NCT05711667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92930228|NCT05711667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930229|NCT05711667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930230|NCT05711667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930231|NCT05711667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930232|NCT05711667|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92930233|NCT05711667|Antiviral Agents|antiviral agents|mesh-ancestor
92930234|NCT04384692|Mycophenolic Acid|mycophenolic acid|mesh-list
92182581|NCT01466348|Acetaminophen|acetaminophen|mesh-list
92930235|NCT04384692|Cyclophosphamide|cyclophosphamide|mesh-list
92930236|NCT04384692|Melphalan|melphalan|mesh-list
92930237|NCT04384692|Busulfan|busulfan|mesh-list
92930238|NCT04384692|Mechlorethamine|mechlorethamine|mesh-list
92930239|NCT04384692|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92930240|NCT04384692|Methotrexate|methotrexate|mesh-list
92930241|NCT04384692|Fludarabine|fludarabine|mesh-list
92930242|NCT04384692|Tacrolimus|tacrolimus|mesh-list
92930243|NCT04384692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930244|NCT04384692|Immunologic Factors|immunologic factors|mesh-ancestor
92930245|NCT04384692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930246|NCT04384692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930247|NCT04384692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92930248|NCT04384692|Alkylating Agents|alkylating agents|mesh-ancestor
92930249|NCT04384692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930250|NCT04384692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930251|NCT04384692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92930252|NCT04384692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92930253|NCT04384692|Abortifacient Agents|abortifacient agents|mesh-ancestor
92930254|NCT04384692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92930255|NCT04384692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930257|NCT04384692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92930258|NCT04384692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930259|NCT04384692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92930260|NCT04384692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92930261|NCT04384692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92930262|NCT04384692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92930263|NCT04384692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92930264|NCT04384692|Antitubercular Agents|antitubercular agents|mesh-ancestor
92930265|NCT04384692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92930266|NCT04384692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930267|NCT00785291|Paclitaxel|paclitaxel|mesh-list
92930268|NCT00785291|Epothilones|epothilones|mesh-list
92930269|NCT00785291|Epothilone B|epothilone b|mesh-list
92930270|NCT00785291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92930271|NCT00785291|Bevacizumab|bevacizumab|mesh-list
92930272|NCT00785291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92930273|NCT00785291|Endothelial Growth Factors|endothelial growth factors|mesh-list
92930274|NCT00785291|Antibodies|antibodies|mesh-list
92930275|NCT00785291|Immunoglobulins|immunoglobulins|mesh-list
92930276|NCT00785291|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92930277|NCT00785291|Immunoglobulin G|immunoglobulin g|mesh-list
92930278|NCT00785291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92930279|NCT00785291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930280|NCT00785291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930281|NCT00785291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930282|NCT00785291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930283|NCT00785291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930284|NCT00785291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92930285|NCT00785291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92930286|NCT00785291|Growth Substances|growth substances|mesh-ancestor
92930287|NCT00785291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930288|NCT00785291|Growth Inhibitors|growth inhibitors|mesh-ancestor
92930289|NCT00785291|Immunologic Factors|immunologic factors|mesh-ancestor
92930291|NCT00740259|Anticonvulsants|anticonvulsants|mesh-ancestor
92930292|NCT00740259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92930293|NCT00740259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930294|NCT00740259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930295|NCT00740259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92930296|NCT00740259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930297|NCT00740259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92930298|NCT00740259|Histamine Antagonists|histamine antagonists|mesh-ancestor
92930299|NCT00740259|Histamine Agents|histamine agents|mesh-ancestor
92930300|NCT00740259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930301|NCT00740259|Vasodilator Agents|vasodilator agents|mesh-ancestor
92930302|NCT04063839|Sofosbuvir|sofosbuvir|mesh-list
92930303|NCT04063839|Grazoprevir|grazoprevir|mesh-list
92930304|NCT04063839|Ledipasvir|ledipasvir|mesh-list
92930305|NCT04063839|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92930306|NCT04063839|Antiviral Agents|antiviral agents|mesh-ancestor
92930307|NCT04063839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930308|NCT00785213|Rosiglitazone|rosiglitazone|mesh-list
92930309|NCT00785213|Quinine|quinine|mesh-list
92930310|NCT00785213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92930311|NCT00785213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930312|NCT00785213|Antimalarials|antimalarials|mesh-ancestor
92930313|NCT00785213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92930314|NCT00785213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92930315|NCT00785213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930316|NCT00785213|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92930317|NCT00785213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92930318|NCT00785213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930319|NCT00785213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930320|NCT00785213|Analgesics|analgesics|mesh-ancestor
92930321|NCT00785213|Sensory System Agents|sensory system agents|mesh-ancestor
92930322|NCT02583594|Loratadine|loratadine|mesh-list
92930323|NCT02583594|Acyclovir|acyclovir|mesh-list
92930324|NCT02583594|Methylprednisolone|methylprednisolone|mesh-list
92930325|NCT02583594|Alemtuzumab|alemtuzumab|mesh-list
92930326|NCT02583594|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92930327|NCT02583594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92575754|NCT00415285|Docetaxel|docetaxel|mesh-list
92930328|NCT02583594|Antiemetics|antiemetics|mesh-ancestor
92930329|NCT02583594|Autonomic Agents|autonomic agents|mesh-ancestor
92930330|NCT02583594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930331|NCT02583594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930332|NCT02583594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92930333|NCT02583594|Glucocorticoids|glucocorticoids|mesh-ancestor
92930334|NCT02583594|Hormones|hormones|mesh-ancestor
92930335|NCT02583594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930336|NCT02583594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92930337|NCT02583594|Protective Agents|protective agents|mesh-ancestor
92930338|NCT02583594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930339|NCT02583594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930340|NCT02583594|Antiviral Agents|antiviral agents|mesh-ancestor
92930341|NCT02583594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930342|NCT02583594|Antipruritics|antipruritics|mesh-ancestor
92930343|NCT02583594|Dermatologic Agents|dermatologic agents|mesh-ancestor
92930344|NCT02583594|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92930345|NCT02583594|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92930346|NCT02583594|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92930347|NCT02583594|Histamine Antagonists|histamine antagonists|mesh-ancestor
92930348|NCT02583594|Histamine Agents|histamine agents|mesh-ancestor
92930349|NCT02583594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930350|NCT02583594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930351|NCT00740415|Dexamethasone|dexamethasone|mesh-list
92930352|NCT00740415|Rituximab|rituximab|mesh-list
92930353|NCT00740415|Bortezomib|bortezomib|mesh-list
92930354|NCT00740415|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92930355|NCT00740415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930356|NCT00740415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930357|NCT00740415|Immunologic Factors|immunologic factors|mesh-ancestor
92930358|NCT00740415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930359|NCT00740415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930360|NCT00740415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930361|NCT00740415|Antiemetics|antiemetics|mesh-ancestor
92930362|NCT00740415|Autonomic Agents|autonomic agents|mesh-ancestor
92930363|NCT00740415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930364|NCT00740415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92275227|NCT01748240|Azacitidine|azacitidine|mesh-list
92930365|NCT00740415|Glucocorticoids|glucocorticoids|mesh-ancestor
92930366|NCT00740415|Hormones|hormones|mesh-ancestor
92930367|NCT00740415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930368|NCT00740415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92930369|NCT00740415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92930370|NCT00740415|Alkylating Agents|alkylating agents|mesh-ancestor
92930371|NCT00740415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930372|NCT00734162|Tenofovir|tenofovir|mesh-list
92930373|NCT00734162|Antiviral Agents|antiviral agents|mesh-ancestor
92930374|NCT00734162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930375|NCT00734162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92930376|NCT00734162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92930377|NCT00734162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930378|NCT00734162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930379|NCT00734162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92930380|NCT00734162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92930381|NCT00740493|Warfarin|warfarin|mesh-list
92930382|NCT00740493|Anticoagulants|anticoagulants|mesh-ancestor
92930383|NCT00740571|Pregabalin|pregabalin|mesh-list
92930384|NCT00740571|Amitriptyline|amitriptyline|mesh-list
92930385|NCT00740571|Analgesics|analgesics|mesh-ancestor
92930386|NCT00740571|Sensory System Agents|sensory system agents|mesh-ancestor
92930387|NCT00740571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930388|NCT00740571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930389|NCT00740571|Anticonvulsants|anticonvulsants|mesh-ancestor
92930390|NCT00740571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92930391|NCT00740571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930392|NCT00740571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930393|NCT00740571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92930394|NCT00740571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92930395|NCT00740571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92930396|NCT00740571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930397|NCT00740571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92930398|NCT00740571|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92930399|NCT00740571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92930400|NCT00740571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930401|NCT00740571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92930402|NCT00740571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92930403|NCT00740571|Adrenergic Agents|adrenergic agents|mesh-ancestor
92930404|NCT00740571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930405|NCT00784979|Immunoglobulins|immunoglobulins|mesh-list
92930406|NCT00784979|Immunologic Factors|immunologic factors|mesh-ancestor
92930407|NCT00784979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930408|NCT02595242|Prednisone|prednisone|mesh-list
92930409|NCT02595242|Cyclophosphamide|cyclophosphamide|mesh-list
92930410|NCT02595242|Vincristine|vincristine|mesh-list
92930411|NCT02595242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930412|NCT02595242|Immunologic Factors|immunologic factors|mesh-ancestor
92930413|NCT02595242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930414|NCT02595242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930415|NCT02595242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92930416|NCT02595242|Alkylating Agents|alkylating agents|mesh-ancestor
92930417|NCT02595242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930418|NCT02595242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930419|NCT02595242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92930420|NCT02595242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92930421|NCT02595242|Glucocorticoids|glucocorticoids|mesh-ancestor
92930422|NCT02595242|Hormones|hormones|mesh-ancestor
92930423|NCT02595242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930424|NCT02595242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92930425|NCT02595242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92930426|NCT02595242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930427|NCT02595242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930428|NCT02595242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930429|NCT04487106|Azacitidine|azacitidine|mesh-list
92930430|NCT04487106|Venetoclax|venetoclax|mesh-list
92930431|NCT04487106|Trametinib|trametinib|mesh-list
92930432|NCT04487106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930433|NCT04487106|Antimetabolites|antimetabolites|mesh-ancestor
92930434|NCT04487106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930435|NCT04487106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930436|NCT04487106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930437|NCT04487106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92930438|NCT00740883|Warfarin|warfarin|mesh-list
92930439|NCT00740883|Anticoagulants|anticoagulants|mesh-ancestor
92930440|NCT02568033|Paclitaxel|paclitaxel|mesh-list
92930441|NCT02568033|Docetaxel|docetaxel|mesh-list
92930442|NCT02568033|Carboplatin|carboplatin|mesh-list
92930443|NCT02568033|Pemetrexed|pemetrexed|mesh-list
92930444|NCT02568033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92930445|NCT02568033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930446|NCT02568033|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930447|NCT02568033|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930448|NCT02568033|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930449|NCT02568033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930450|NCT02568033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930451|NCT02568033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92930452|NCT02568033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92930453|NCT00582972|Omeprazole|omeprazole|mesh-list
92930454|NCT00582972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92930455|NCT00582972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92930456|NCT00582972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92930457|NCT00582972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930458|NCT00582972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930459|NCT05224401|Amoxicillin|amoxicillin|mesh-list
92930460|NCT05224401|Ciprofloxacin|ciprofloxacin|mesh-list
92930461|NCT05224401|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92930462|NCT05224401|Clavulanic Acids|clavulanic acids|mesh-list
92930463|NCT05224401|Clavulanic Acid|clavulanic acid|mesh-list
92930464|NCT05224401|Ertapenem|ertapenem|mesh-list
92930465|NCT05224401|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
92930466|NCT05224401|Trimethoprim|trimethoprim|mesh-list
92930467|NCT05224401|Sulfamethoxazole|sulfamethoxazole|mesh-list
92930468|NCT05224401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92930469|NCT05224401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930470|NCT05224401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92930471|NCT05224401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92930472|NCT05224401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930473|NCT05224401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930474|NCT05224401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930475|NCT05224401|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92930476|NCT05224401|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92930477|NCT05224401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92930478|NCT05224401|Antimalarials|antimalarials|mesh-ancestor
92930479|NCT05224401|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92930480|NCT05224401|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92930481|NCT05224401|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92930483|NCT05224401|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92930484|NCT05224401|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92930485|NCT00918086|Vitamin D|vitamin d|mesh-list
92930486|NCT00918086|Vitamins|vitamins|mesh-ancestor
92930487|NCT00918086|Micronutrients|micronutrients|mesh-ancestor
92930488|NCT00918086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930489|NCT00918086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92930490|NCT02567487|Levobupivacaine|levobupivacaine|mesh-list
92930491|NCT02567487|Anesthetics, Local|anesthetics, local|mesh-ancestor
92930492|NCT02567487|Anesthetics|anesthetics|mesh-ancestor
92930493|NCT02567487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930494|NCT02567487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930495|NCT02567487|Sensory System Agents|sensory system agents|mesh-ancestor
92930496|NCT02567487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930497|NCT04317066|Pembrolizumab|pembrolizumab|mesh-list
92930498|NCT04317066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930499|NCT04317066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930500|NCT04317066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92930501|NCT04317066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930502|NCT04366908|Calcifediol|calcifediol|mesh-list
92930503|NCT04366908|Vitamins|vitamins|mesh-ancestor
92930504|NCT04366908|Micronutrients|micronutrients|mesh-ancestor
92930505|NCT04366908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930506|NCT04366908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92930507|NCT00711243|Docetaxel|docetaxel|mesh-list
92930508|NCT00711243|Fluorouracil|fluorouracil|mesh-list
92930509|NCT00711243|Oxaliplatin|oxaliplatin|mesh-list
92930510|NCT00711243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930511|NCT00711243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930512|NCT00711243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930513|NCT00711243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930514|NCT00711243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930515|NCT00711243|Antimetabolites|antimetabolites|mesh-ancestor
92930516|NCT00711243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930517|NCT00711243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930518|NCT00711243|Immunologic Factors|immunologic factors|mesh-ancestor
92930519|NCT00711243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930521|NCT04366518|Rivastigmine|rivastigmine|mesh-list
92930522|NCT04366518|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92930523|NCT04366518|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92930524|NCT04366518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930525|NCT04366518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930526|NCT04366518|Cholinergic Agents|cholinergic agents|mesh-ancestor
92930527|NCT04366518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930528|NCT04366518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231019|NCT01113476|Paclitaxel|paclitaxel|mesh-list
92930529|NCT04366518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92930530|NCT04366518|Protective Agents|protective agents|mesh-ancestor
92930531|NCT04366518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92930532|NCT04366518|Antiemetics|antiemetics|mesh-ancestor
92930533|NCT04366518|Autonomic Agents|autonomic agents|mesh-ancestor
92930534|NCT04366518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930535|NCT04366518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92930536|NCT04366518|Mydriatics|mydriatics|mesh-ancestor
92930537|NCT04366518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92930538|NCT04366518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92930539|NCT04366518|Parasympatholytics|parasympatholytics|mesh-ancestor
92930540|NCT00733226|Broncho-Vaxom|broncho-vaxom|mesh-list
92930541|NCT00733226|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92930542|NCT00733226|Immunologic Factors|immunologic factors|mesh-ancestor
92930543|NCT00733226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930544|NCT04076436|Fosfomycin|fosfomycin|mesh-list
92930545|NCT04076436|Lactams|lactams|mesh-list
92930546|NCT04076436|beta-Lactams|beta-lactams|mesh-list
92930547|NCT04076436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92930548|NCT04076436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930549|NCT05526417|Coal Tar|coal tar|mesh-list
92930550|NCT05526417|Keratolytic Agents|keratolytic agents|mesh-ancestor
92930551|NCT05526417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92930552|NCT04096170|Lidocaine|lidocaine|mesh-list
92930553|NCT04096170|Anesthetics, Local|anesthetics, local|mesh-ancestor
92930554|NCT04096170|Anesthetics|anesthetics|mesh-ancestor
92930555|NCT04096170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92575966|NCT00257257|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92930556|NCT04096170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930557|NCT04096170|Sensory System Agents|sensory system agents|mesh-ancestor
92930558|NCT04096170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930559|NCT04096170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92930560|NCT04096170|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92930561|NCT04096170|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92930562|NCT04096170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930563|NCT04096170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930564|NCT00741117|Bilirubin|bilirubin|mesh-list
92930565|NCT00741117|Antioxidants|antioxidants|mesh-ancestor
92930566|NCT00741117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930567|NCT00741117|Protective Agents|protective agents|mesh-ancestor
92930568|NCT00741117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930569|NCT00732992|Pemetrexed|pemetrexed|mesh-list
92930570|NCT00732992|Sunitinib|sunitinib|mesh-list
92930571|NCT00732992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930572|NCT00732992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930573|NCT00732992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930574|NCT00732992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92930575|NCT00732992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92930576|NCT00732992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92930577|NCT00732992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92930578|NCT00732992|Growth Substances|growth substances|mesh-ancestor
92930579|NCT00732992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930580|NCT00732992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92930581|NCT00732992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92930582|NCT00741195|Bevacizumab|bevacizumab|mesh-list
92930583|NCT00741195|Docetaxel|docetaxel|mesh-list
92930584|NCT00741195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930585|NCT00741195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526406|NCT00028600|Melphalan|melphalan|mesh-list
92930586|NCT00741195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92930587|NCT00741195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92930588|NCT00741195|Growth Substances|growth substances|mesh-ancestor
92930589|NCT00741195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930590|NCT00741195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92930591|NCT00741195|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930592|NCT00741195|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930593|NCT00741195|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930594|NCT00741195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930595|NCT05338632|Naloxone|naloxone|mesh-list
92930596|NCT05338632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92930597|NCT05338632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930598|NCT05338632|Sensory System Agents|sensory system agents|mesh-ancestor
92930599|NCT05338632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930600|NCT00732758|Vitamin D|vitamin d|mesh-list
92930601|NCT00732758|Cholecalciferol|cholecalciferol|mesh-list
92930602|NCT00732758|Vitamins|vitamins|mesh-ancestor
92930603|NCT00732758|Micronutrients|micronutrients|mesh-ancestor
92930604|NCT00732758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930605|NCT00732758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92930606|NCT00732758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92930607|NCT00741351|Fentanyl|fentanyl|mesh-list
92930608|NCT00741351|Remifentanil|remifentanil|mesh-list
92930609|NCT00741351|Propofol|propofol|mesh-list
92930610|NCT00741351|Sevoflurane|sevoflurane|mesh-list
92930611|NCT00741351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92930612|NCT00741351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930613|NCT00741351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930614|NCT00741351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92930615|NCT00741351|Anesthetics, General|anesthetics, general|mesh-ancestor
92930616|NCT00741351|Anesthetics|anesthetics|mesh-ancestor
92930617|NCT00741351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92930618|NCT00741351|Narcotics|narcotics|mesh-ancestor
92930619|NCT00741351|Analgesics|analgesics|mesh-ancestor
92930620|NCT00741351|Sensory System Agents|sensory system agents|mesh-ancestor
92930621|NCT00741351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930622|NCT00741351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92930623|NCT00741351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92930624|NCT00741351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92930625|NCT02582190|Colchicine|colchicine|mesh-list
92930626|NCT02582190|Gout Suppressants|gout suppressants|mesh-ancestor
92930627|NCT02582190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930628|NCT02582190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930629|NCT02582190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930630|NCT02582190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930631|NCT02582190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930632|NCT02582190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930633|NCT00699153|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92930634|NCT00699153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92930635|NCT04277442|Nivolumab|nivolumab|mesh-list
92930636|NCT04277442|Decitabine|decitabine|mesh-list
92930637|NCT04277442|Venetoclax|venetoclax|mesh-list
92930638|NCT04277442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930639|NCT04277442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930640|NCT04277442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92930641|NCT04277442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930642|NCT04277442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930643|NCT04277442|Antimetabolites|antimetabolites|mesh-ancestor
92930644|NCT04277442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930645|NCT05742243|Insulin|insulin|mesh-list
92930646|NCT05742243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92930647|NCT05742243|Abatacept|abatacept|mesh-list
92930648|NCT05742243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92930649|NCT05742243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930650|NCT05742243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92930651|NCT05742243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930652|NCT05742243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930653|NCT05742243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930654|NCT05742243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92930655|NCT05742243|Immunologic Factors|immunologic factors|mesh-ancestor
92930656|NCT05742243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930657|NCT04076748|Sufentanil|sufentanil|mesh-list
92930658|NCT04076748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92930659|NCT04076748|Narcotics|narcotics|mesh-ancestor
92930660|NCT04076748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930661|NCT04076748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930662|NCT04076748|Analgesics|analgesics|mesh-ancestor
92930663|NCT04076748|Sensory System Agents|sensory system agents|mesh-ancestor
92930664|NCT04076748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930665|NCT04076748|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92930666|NCT04076748|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92930667|NCT04076748|Anesthetics, General|anesthetics, general|mesh-ancestor
92930668|NCT04076748|Anesthetics|anesthetics|mesh-ancestor
92930669|NCT00711087|Botulinum Toxins|botulinum toxins|mesh-list
92930670|NCT00711087|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92930671|NCT00711087|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92930672|NCT00711087|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92930673|NCT00711087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930674|NCT00711087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930675|NCT00711087|Cholinergic Agents|cholinergic agents|mesh-ancestor
92930676|NCT00711087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930677|NCT00711087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930678|NCT00711087|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92930679|NCT00711087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930680|NCT04262466|Pembrolizumab|pembrolizumab|mesh-list
92930681|NCT04262466|Atezolizumab|atezolizumab|mesh-list
92930682|NCT04262466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930683|NCT04262466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930684|NCT04262466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92930685|NCT04262466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930686|NCT04255602|Ticagrelor|ticagrelor|mesh-list
92930687|NCT04255602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92930688|NCT04255602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92930689|NCT04255602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92930690|NCT04255602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92930691|NCT04255602|Purinergic Agents|purinergic agents|mesh-ancestor
92930692|NCT04255602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930693|NCT04255602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930694|NCT04255602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930695|NCT00738530|Interferons|interferons|mesh-list
92930696|NCT00738530|Interferon-alpha|interferon-alpha|mesh-list
92930697|NCT00738530|Interferon alpha-2|interferon alpha-2|mesh-list
92930698|NCT00738530|Bevacizumab|bevacizumab|mesh-list
92930699|NCT00738530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930700|NCT00738530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930701|NCT00738530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92930702|NCT00738530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92930703|NCT00738530|Growth Substances|growth substances|mesh-ancestor
92930704|NCT00738530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930705|NCT00738530|Growth Inhibitors|growth inhibitors|mesh-ancestor
92930706|NCT00738530|Antiviral Agents|antiviral agents|mesh-ancestor
92930707|NCT00738530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930708|NCT00738530|Immunologic Factors|immunologic factors|mesh-ancestor
92930709|NCT04077684|Interleukin-2|interleukin-2|mesh-list
92930710|NCT04077684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930711|NCT04077684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930712|NCT04077684|Analgesics|analgesics|mesh-ancestor
92930713|NCT04077684|Sensory System Agents|sensory system agents|mesh-ancestor
92930714|NCT04077684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930715|NCT04077684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930716|NCT00711009|Ritonavir|ritonavir|mesh-list
92930717|NCT00711009|Lopinavir|lopinavir|mesh-list
92930718|NCT00711009|Tenofovir|tenofovir|mesh-list
92930719|NCT00711009|Emtricitabine|emtricitabine|mesh-list
92930720|NCT00711009|Raltegravir Potassium|raltegravir potassium|mesh-list
92930721|NCT00711009|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92930722|NCT00711009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92930723|NCT00711009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92930724|NCT00711009|Protease Inhibitors|protease inhibitors|mesh-ancestor
92930725|NCT00711009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930726|NCT00711009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930727|NCT00711009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92930728|NCT00711009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92930729|NCT00711009|Antiviral Agents|antiviral agents|mesh-ancestor
92930730|NCT00711009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930731|NCT00711009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92930732|NCT00711009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92930733|NCT00711009|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92930734|NCT00711009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92930735|NCT00711009|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92930736|NCT00711009|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92930737|NCT02567799|Paclitaxel|paclitaxel|mesh-list
92930738|NCT02567799|Carboplatin|carboplatin|mesh-list
92930739|NCT02567799|Genistein|genistein|mesh-list
92930740|NCT02567799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92930741|NCT02567799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930742|NCT02567799|Tubulin Modulators|tubulin modulators|mesh-ancestor
92930743|NCT02567799|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930744|NCT02567799|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930745|NCT02567799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930746|NCT02567799|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92930747|NCT02567799|Protective Agents|protective agents|mesh-ancestor
92930748|NCT02567799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930749|NCT02567799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92930750|NCT02567799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930751|NCT02567799|Phytoestrogens|phytoestrogens|mesh-ancestor
92930752|NCT02567799|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92930753|NCT02567799|Estrogens|estrogens|mesh-ancestor
92930754|NCT02567799|Hormones|hormones|mesh-ancestor
92930755|NCT02567799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930756|NCT00921219|Ivermectin|ivermectin|mesh-list
92930757|NCT00921219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92930758|NCT00921219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930759|NCT02567331|Capecitabine|capecitabine|mesh-list
92930760|NCT02567331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930761|NCT02567331|Antimetabolites|antimetabolites|mesh-ancestor
92930762|NCT02567331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930763|NCT02567331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930764|NCT00577005|Levetiracetam|levetiracetam|mesh-list
92930765|NCT00577005|Anticonvulsants|anticonvulsants|mesh-ancestor
92930766|NCT00577005|Nootropic Agents|nootropic agents|mesh-ancestor
92930767|NCT02581566|Dexmedetomidine|dexmedetomidine|mesh-list
92930768|NCT02581566|Bupivacaine|bupivacaine|mesh-list
92930769|NCT02581566|Anesthetics, Local|anesthetics, local|mesh-ancestor
92930770|NCT02581566|Anesthetics|anesthetics|mesh-ancestor
92930771|NCT02581566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930772|NCT02581566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930773|NCT02581566|Sensory System Agents|sensory system agents|mesh-ancestor
92930774|NCT02581566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930775|NCT02581566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92930776|NCT02581566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930777|NCT02581566|Analgesics|analgesics|mesh-ancestor
92930778|NCT02581566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92930779|NCT02581566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92930780|NCT02581566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92930781|NCT02581566|Adrenergic Agents|adrenergic agents|mesh-ancestor
92930782|NCT02581566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930783|NCT02581566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930784|NCT04003506|Bupivacaine|bupivacaine|mesh-list
92930786|NCT04003506|Anesthetics|anesthetics|mesh-ancestor
92930787|NCT04003506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930788|NCT04003506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930789|NCT04003506|Sensory System Agents|sensory system agents|mesh-ancestor
92930790|NCT04003506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930791|NCT00698841|Cetuximab|cetuximab|mesh-list
92930792|NCT00698841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930793|NCT00698841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930794|NCT00577395|Risedronic Acid|risedronic acid|mesh-list
92930795|NCT00577395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92930796|NCT00577395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930797|NCT00577395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930798|NCT00577395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92930799|NCT00577395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930800|NCT00577395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92930801|NCT04062357|Lidocaine|lidocaine|mesh-list
92930802|NCT04062357|Anesthetics, Local|anesthetics, local|mesh-ancestor
92930804|NCT04062357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930805|NCT04062357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930806|NCT04062357|Sensory System Agents|sensory system agents|mesh-ancestor
92930807|NCT04062357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930808|NCT04062357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92930809|NCT04062357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92930810|NCT04062357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92930811|NCT04062357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930812|NCT04062357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930813|NCT05190120|Ropivacaine|ropivacaine|mesh-list
92930814|NCT05190120|Anesthetics, Local|anesthetics, local|mesh-ancestor
92930815|NCT05190120|Anesthetics|anesthetics|mesh-ancestor
92930816|NCT05190120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930817|NCT05190120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930818|NCT05190120|Sensory System Agents|sensory system agents|mesh-ancestor
92930819|NCT05190120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930820|NCT00738374|Rituximab|rituximab|mesh-list
92930821|NCT00738374|Chlorambucil|chlorambucil|mesh-list
92930822|NCT00738374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930823|NCT00738374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930824|NCT00738374|Immunologic Factors|immunologic factors|mesh-ancestor
92930825|NCT00738374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930826|NCT00738374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930827|NCT00738374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92930828|NCT00738374|Alkylating Agents|alkylating agents|mesh-ancestor
92930829|NCT00738374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930830|NCT02581176|Apixaban|apixaban|mesh-list
92930831|NCT02581176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92930832|NCT02581176|Antithrombins|antithrombins|mesh-ancestor
92930833|NCT02581176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92930834|NCT02581176|Protease Inhibitors|protease inhibitors|mesh-ancestor
92930835|NCT02581176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930836|NCT02581176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930837|NCT02581176|Anticoagulants|anticoagulants|mesh-ancestor
92930838|NCT00697593|Antibodies|antibodies|mesh-list
92930839|NCT00697593|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92930840|NCT00697593|Immunologic Factors|immunologic factors|mesh-ancestor
92930841|NCT00697593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930842|NCT04183452|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92930843|NCT04183452|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92930844|NCT04183452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92930845|NCT04183452|Hormone Antagonists|hormone antagonists|mesh-ancestor
92930846|NCT04183452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930847|NCT04183452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930848|NCT04183452|Progestins|progestins|mesh-ancestor
92930849|NCT04183452|Hormones|hormones|mesh-ancestor
92930850|NCT04075578|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92930851|NCT04075578|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92930852|NCT04075578|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92930853|NCT04075578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930854|NCT04075578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930855|NCT04075578|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92930856|NCT04075578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92930857|NCT04075578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930858|NCT04075578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92930859|NCT04075578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930860|NCT04445025|Leuprolide|leuprolide|mesh-list
92930861|NCT04445025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92930862|NCT04445025|Fertility Agents|fertility agents|mesh-ancestor
92930863|NCT04445025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92930864|NCT04445025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930865|NCT04445025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92930866|NCT04445025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930867|NCT02580474|Asunaprevir|asunaprevir|mesh-list
92930868|NCT02580474|Protease Inhibitors|protease inhibitors|mesh-ancestor
92930869|NCT02580474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930870|NCT02580474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930871|NCT04166604|Trifluridine|trifluridine|mesh-list
92930872|NCT04166604|Antimetabolites|antimetabolites|mesh-ancestor
92930873|NCT04166604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930874|NCT04166604|Antiviral Agents|antiviral agents|mesh-ancestor
92930875|NCT04166604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92930876|NCT00738062|Droxidopa|droxidopa|mesh-list
92930877|NCT00738062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92930878|NCT00738062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92930879|NCT04156074|Vitamin D|vitamin d|mesh-list
92930880|NCT04156074|Ergocalciferols|ergocalciferols|mesh-list
92930881|NCT04156074|Cholecalciferol|cholecalciferol|mesh-list
92930882|NCT04156074|Vitamins|vitamins|mesh-list
92930883|NCT04156074|Micronutrients|micronutrients|mesh-ancestor
92930884|NCT04156074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930885|NCT04156074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92930886|NCT04156074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92930887|NCT04062045|Ropivacaine|ropivacaine|mesh-list
92930888|NCT04062045|Anesthetics, Local|anesthetics, local|mesh-ancestor
92930889|NCT04062045|Anesthetics|anesthetics|mesh-ancestor
92930890|NCT04062045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163755|NCT03824665|Fentanyl|fentanyl|mesh-list
92930891|NCT04062045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930892|NCT04062045|Sensory System Agents|sensory system agents|mesh-ancestor
92930893|NCT04062045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930894|NCT03733314|Quetmolimab|quetmolimab|mesh-list
92930895|NCT03733314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92930896|NCT04064073|Metformin|metformin|mesh-list
92930897|NCT04064073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92930898|NCT04064073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930899|NCT04137354|Vitamins|vitamins|mesh-list
92930900|NCT04137354|Vitamin A|vitamin a|mesh-list
92930902|NCT04137354|Retinol palmitate|retinol palmitate|mesh-list
92930903|NCT04137354|Micronutrients|micronutrients|mesh-ancestor
92930904|NCT04137354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930905|NCT04137354|Trace Elements|trace elements|mesh-ancestor
92930906|NCT04137354|Antioxidants|antioxidants|mesh-ancestor
92930907|NCT04137354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930908|NCT04137354|Protective Agents|protective agents|mesh-ancestor
92930909|NCT04137354|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92930910|NCT04137354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930911|NCT04902729|Oxytocin|oxytocin|mesh-list
92930912|NCT04902729|Carbetocin|carbetocin|mesh-list
92930913|NCT04902729|Oxytocics|oxytocics|mesh-ancestor
92930914|NCT04902729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92930915|NCT04902729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930916|NCT03498378|Cetuximab|cetuximab|mesh-list
92930917|NCT03498378|Avelumab|avelumab|mesh-list
92930918|NCT03498378|Palbociclib|palbociclib|mesh-list
92930919|NCT03498378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930920|NCT03498378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930921|NCT03498378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92930922|NCT03498378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930923|NCT03498378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930924|NCT03493932|Nivolumab|nivolumab|mesh-list
92930925|NCT03493932|Relatlimab|relatlimab|mesh-list
92930926|NCT03493932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930927|NCT03493932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930928|NCT03493932|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92930929|NCT03493932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930930|NCT04211259|Loratadine|loratadine|mesh-list
92930931|NCT04211259|Antipruritics|antipruritics|mesh-ancestor
92930932|NCT04211259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92930933|NCT04211259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92930934|NCT04211259|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92930935|NCT04211259|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92930936|NCT04211259|Histamine Antagonists|histamine antagonists|mesh-ancestor
92930937|NCT04211259|Histamine Agents|histamine agents|mesh-ancestor
92930938|NCT04211259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92930939|NCT04211259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930940|NCT04211259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930941|NCT00698685|Alemtuzumab|alemtuzumab|mesh-list
92930942|NCT00698685|Pentostatin|pentostatin|mesh-list
92930943|NCT00698685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930944|NCT00698685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930945|NCT00698685|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92930946|NCT00698685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930947|NCT00698685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930948|NCT04972968|Glucocorticoids|glucocorticoids|mesh-list
92930949|NCT04972968|Hormones|hormones|mesh-ancestor
92526419|NCT00028600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92930950|NCT04972968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92930951|NCT04972968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930952|NCT00737438|Bevacizumab|bevacizumab|mesh-list
92930953|NCT00737438|Docetaxel|docetaxel|mesh-list
92930954|NCT00737438|Capecitabine|capecitabine|mesh-list
92930955|NCT00737438|Irinotecan|irinotecan|mesh-list
92930956|NCT00737438|Epirubicin|epirubicin|mesh-list
92930957|NCT00737438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92930958|NCT00737438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92930959|NCT00737438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92930960|NCT00737438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92930961|NCT00737438|Growth Substances|growth substances|mesh-ancestor
92930962|NCT00737438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930963|NCT00737438|Growth Inhibitors|growth inhibitors|mesh-ancestor
92930964|NCT00737438|Tubulin Modulators|tubulin modulators|mesh-ancestor
92163758|NCT03824665|Narcotics|narcotics|mesh-ancestor
92930965|NCT00737438|Antimitotic Agents|antimitotic agents|mesh-ancestor
92930966|NCT00737438|Mitosis Modulators|mitosis modulators|mesh-ancestor
92930967|NCT00737438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92930968|NCT00737438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92930969|NCT00737438|Antimetabolites|antimetabolites|mesh-ancestor
92930970|NCT00737438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92930971|NCT00737438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92930972|NCT00737438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92930973|NCT00737438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92930974|NCT00737438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92930975|NCT00737048|Acetaminophen|acetaminophen|mesh-list
92930976|NCT00737048|Tramadol|tramadol|mesh-list
92930977|NCT00737048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92930978|NCT00737048|Analgesics|analgesics|mesh-ancestor
92930979|NCT00737048|Sensory System Agents|sensory system agents|mesh-ancestor
92930980|NCT00737048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92930981|NCT00737048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930982|NCT00737048|Antipyretics|antipyretics|mesh-ancestor
92930983|NCT00737048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92930984|NCT00737048|Narcotics|narcotics|mesh-ancestor
92930985|NCT00737048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930986|NCT02593448|Anesthetics|anesthetics|mesh-list
92930987|NCT02593448|Propofol|propofol|mesh-list
92930988|NCT02593448|Sevoflurane|sevoflurane|mesh-list
92930989|NCT02593448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92930990|NCT02593448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92930991|NCT02593448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92930992|NCT02593448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92930993|NCT02593448|Anesthetics, General|anesthetics, general|mesh-ancestor
92930994|NCT02593448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92930995|NCT02593448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92930996|NCT02592746|Capecitabine|capecitabine|mesh-list
92930997|NCT02592746|Palbociclib|palbociclib|mesh-list
92930998|NCT02592746|Leuprolide|leuprolide|mesh-list
92930999|NCT02592746|Exemestane|exemestane|mesh-list
92931000|NCT02592746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92931001|NCT02592746|Antimetabolites|antimetabolites|mesh-ancestor
92931002|NCT02592746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931003|NCT02592746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931004|NCT02592746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931005|NCT02592746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931006|NCT02592746|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92931007|NCT02592746|Fertility Agents|fertility agents|mesh-ancestor
92931008|NCT02592746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92931009|NCT02592746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931010|NCT02592746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92931011|NCT02592746|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92931012|NCT02592746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92931013|NCT02592746|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92931014|NCT02592746|Hormone Antagonists|hormone antagonists|mesh-ancestor
92931015|NCT02592746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931016|NCT03365622|Acetaminophen|acetaminophen|mesh-list
92931017|NCT03365622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92931018|NCT03365622|Analgesics|analgesics|mesh-ancestor
92931019|NCT03365622|Sensory System Agents|sensory system agents|mesh-ancestor
92931020|NCT03365622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931021|NCT03365622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931022|NCT03365622|Antipyretics|antipyretics|mesh-ancestor
92931023|NCT00731120|Vortioxetine|vortioxetine|mesh-list
92931024|NCT00731120|Antidepressive Agents|antidepressive agents|mesh-ancestor
92931025|NCT00731120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92931026|NCT00731120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92931027|NCT00731120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92931028|NCT00731120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931029|NCT00731120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931030|NCT00731120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92931031|NCT00731120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92931032|NCT00731120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931033|NCT00731120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931034|NCT00731120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931035|NCT00731120|Serotonin Agents|serotonin agents|mesh-ancestor
92931036|NCT00731120|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92931037|NCT00731120|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92163760|NCT03824665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931038|NCT00731120|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92931039|NCT00731120|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92931040|NCT02580006|Epoetin Alfa|epoetin alfa|mesh-list
92931041|NCT02580006|Hematinics|hematinics|mesh-ancestor
92931042|NCT00731042|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92931043|NCT00731042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92931044|NCT00731042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931045|NCT00731042|Dermatologic Agents|dermatologic agents|mesh-ancestor
92931046|NCT02787642|Olaparib|olaparib|mesh-list
92931047|NCT02787642|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92931048|NCT02787642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931049|NCT02787642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931050|NCT02787642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931051|NCT04075188|Aflibercept|aflibercept|mesh-list
92931052|NCT04075188|Verteporfin|verteporfin|mesh-list
92931053|NCT04075188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931054|NCT04075188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92931055|NCT04075188|Growth Substances|growth substances|mesh-ancestor
92931056|NCT04075188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931057|NCT04075188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92931058|NCT04075188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931059|NCT04075188|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92931060|NCT04075188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92931061|NCT00726986|Etoposide|etoposide|mesh-list
92931062|NCT00726986|Sorafenib|sorafenib|mesh-list
92931063|NCT00726986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931064|NCT00726986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92931065|NCT00726986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92931066|NCT00726986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92931067|NCT00726986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931068|NCT00726986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931069|NCT00726986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931070|NCT00696657|Liraglutide|liraglutide|mesh-list
92931071|NCT00696657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92931072|NCT00696657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931073|NCT00696657|Incretins|incretins|mesh-ancestor
92931074|NCT00696657|Hormones|hormones|mesh-ancestor
92931075|NCT00696657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931076|NCT00726752|Axitinib|axitinib|mesh-list
92931077|NCT00726752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931078|NCT00726752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931079|NCT00726752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931080|NCT00726752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931081|NCT02594462|Contraceptive Agents|contraceptive agents|mesh-list
92931082|NCT02594462|Etonogestrel|etonogestrel|mesh-list
92931083|NCT02594462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92931084|NCT02594462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931085|NCT02594462|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92931086|NCT02594462|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92931087|NCT02664558|Ubenimex|ubenimex|mesh-list
92931088|NCT02664558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92931089|NCT02664558|Immunologic Factors|immunologic factors|mesh-ancestor
92931090|NCT02664558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931091|NCT02664558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931092|NCT02664558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931093|NCT02664558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92931094|NCT02664558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931095|NCT02664558|Protease Inhibitors|protease inhibitors|mesh-ancestor
92931096|NCT02664558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931097|NCT02664558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931098|NCT02664558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92931099|NCT02664558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92931100|NCT02664558|Antiviral Agents|antiviral agents|mesh-ancestor
92931101|NCT02566707|Lamivudine|lamivudine|mesh-list
92931102|NCT02566707|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92931103|NCT02566707|Dolutegravir|dolutegravir|mesh-list
92931104|NCT02566707|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92931105|NCT02566707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931106|NCT02566707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931107|NCT02566707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931108|NCT02566707|Antiviral Agents|antiviral agents|mesh-ancestor
92931109|NCT02566707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931110|NCT02566707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92931111|NCT02566707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92931112|NCT02566707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92931113|NCT02566707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92931114|NCT02566707|Protease Inhibitors|protease inhibitors|mesh-ancestor
92931115|NCT02566707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92931116|NCT02566707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92931117|NCT04063683|Paclitaxel|paclitaxel|mesh-list
92931118|NCT04063683|Cisplatin|cisplatin|mesh-list
92931119|NCT04063683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92931120|NCT04063683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931121|NCT04063683|Tubulin Modulators|tubulin modulators|mesh-ancestor
92931122|NCT04063683|Antimitotic Agents|antimitotic agents|mesh-ancestor
92931123|NCT04063683|Mitosis Modulators|mitosis modulators|mesh-ancestor
92931124|NCT04063683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931125|NCT00921531|Thalidomide|thalidomide|mesh-list
92931126|NCT00921531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92931127|NCT00921531|Immunologic Factors|immunologic factors|mesh-ancestor
92931128|NCT00921531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931129|NCT00921531|Leprostatic Agents|leprostatic agents|mesh-ancestor
92931130|NCT00921531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931131|NCT00921531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931132|NCT00921531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931133|NCT00921531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92931134|NCT00921531|Growth Substances|growth substances|mesh-ancestor
92931135|NCT00921531|Growth Inhibitors|growth inhibitors|mesh-ancestor
92931136|NCT00921531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931137|NCT00730028|Clindamycin|clindamycin|mesh-list
92931138|NCT00730028|Clindamycin palmitate|clindamycin palmitate|mesh-list
92931139|NCT00730028|Clindamycin phosphate|clindamycin phosphate|mesh-list
92931140|NCT00730028|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92931141|NCT00730028|Trimethoprim|trimethoprim|mesh-list
92931142|NCT00730028|Sulfamethoxazole|sulfamethoxazole|mesh-list
92931143|NCT00730028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931144|NCT00730028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931145|NCT00730028|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92931146|NCT00730028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931147|NCT00730028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931148|NCT00730028|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92931149|NCT00730028|Antimalarials|antimalarials|mesh-ancestor
92931150|NCT00730028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92931151|NCT00730028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92931152|NCT00730028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92931153|NCT00730028|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92931154|NCT00730028|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92931155|NCT00730028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92931156|NCT04088084|Palmidrol|palmidrol|mesh-list
92931157|NCT04088084|Analgesics|analgesics|mesh-ancestor
92931158|NCT04088084|Sensory System Agents|sensory system agents|mesh-ancestor
92931159|NCT04088084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931160|NCT04088084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931161|NCT04088084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92931162|NCT04088084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92931163|NCT04088084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931164|NCT04088084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92931165|NCT04088084|Antiviral Agents|antiviral agents|mesh-ancestor
92931166|NCT04088084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931167|NCT04088084|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92931168|NCT04088084|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92931169|NCT04088084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931170|NCT04088084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931171|NCT04088084|Hormones|hormones|mesh-ancestor
92526420|NCT00028600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92931172|NCT04088084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931174|NCT02593370|Epinephrine|epinephrine|mesh-list
92931175|NCT02593370|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92163768|NCT04120831|Abatacept|abatacept|mesh-list
92931176|NCT02593370|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931177|NCT02593370|Anesthetics|anesthetics|mesh-ancestor
92931178|NCT02593370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931179|NCT02593370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931180|NCT02593370|Sensory System Agents|sensory system agents|mesh-ancestor
92931181|NCT02593370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931182|NCT02593370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92931183|NCT02593370|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92931184|NCT02593370|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92931185|NCT02593370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931186|NCT02593370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931187|NCT02593370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92931188|NCT02593370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92931189|NCT02593370|Adrenergic Agents|adrenergic agents|mesh-ancestor
92931190|NCT02593370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931191|NCT02593370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92931192|NCT02593370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92931193|NCT02593370|Autonomic Agents|autonomic agents|mesh-ancestor
92931194|NCT02593370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92931195|NCT02593370|Respiratory System Agents|respiratory system agents|mesh-ancestor
92931196|NCT02593370|Mydriatics|mydriatics|mesh-ancestor
92931197|NCT02593370|Sympathomimetics|sympathomimetics|mesh-ancestor
92931198|NCT02593370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92931199|NCT02593370|Chelating Agents|chelating agents|mesh-ancestor
92931200|NCT02593370|Sequestering Agents|sequestering agents|mesh-ancestor
92931201|NCT00918320|Temozolomide|temozolomide|mesh-list
92931202|NCT00918320|Topotecan|topotecan|mesh-list
92931203|NCT00918320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92931204|NCT00918320|Alkylating Agents|alkylating agents|mesh-ancestor
92931205|NCT00918320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931206|NCT00918320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931207|NCT00918320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92931208|NCT00918320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92931209|NCT00918320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931210|NCT00729560|Flutamide|flutamide|mesh-list
92931211|NCT00729560|Androgen Antagonists|androgen antagonists|mesh-ancestor
92931212|NCT00729560|Hormone Antagonists|hormone antagonists|mesh-ancestor
92931213|NCT00729560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931214|NCT00729560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931215|NCT00729560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92931216|NCT00729560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931217|NCT00736190|Tenofovir|tenofovir|mesh-list
92931218|NCT00736190|Antiviral Agents|antiviral agents|mesh-ancestor
92931219|NCT00736190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931220|NCT00736190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92931221|NCT00736190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931222|NCT00736190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931223|NCT00736190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931224|NCT00736190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92931225|NCT00736190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92931226|NCT04686279|Tenofovir|tenofovir|mesh-list
92931227|NCT04686279|Antiviral Agents|antiviral agents|mesh-ancestor
92931228|NCT04686279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931229|NCT04686279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92931230|NCT04686279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931231|NCT04686279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931232|NCT04686279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931233|NCT04686279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92931234|NCT04686279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92931236|NCT00729326|Exenatide|exenatide|mesh-list
92931237|NCT00729326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92931238|NCT00729326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931239|NCT00729326|Incretins|incretins|mesh-ancestor
92931240|NCT00729326|Hormones|hormones|mesh-ancestor
92931241|NCT00729326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931242|NCT00729326|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92931243|NCT00729326|Protease Inhibitors|protease inhibitors|mesh-ancestor
92931244|NCT00729326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276110|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
92931245|NCT00729326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931247|NCT02565303|Ropivacaine|ropivacaine|mesh-list
92931248|NCT02565303|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931249|NCT02565303|Anesthetics|anesthetics|mesh-ancestor
92931250|NCT02565303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931251|NCT02565303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931252|NCT02565303|Sensory System Agents|sensory system agents|mesh-ancestor
92931253|NCT02565303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931254|NCT00698451|Bevacizumab|bevacizumab|mesh-list
92931255|NCT00698451|Carboplatin|carboplatin|mesh-list
92931256|NCT00698451|Doxorubicin|doxorubicin|mesh-list
92931257|NCT00698451|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92931258|NCT00698451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92931259|NCT00698451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931260|NCT00698451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931261|NCT00698451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92931262|NCT00698451|Growth Substances|growth substances|mesh-ancestor
92931263|NCT00698451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931264|NCT00698451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92931265|NCT00698451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92931266|NCT00698451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92931267|NCT00698451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92931268|NCT00698451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931269|NCT00698451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931270|NCT03980925|Carboplatin|carboplatin|mesh-list
92931271|NCT03980925|Nivolumab|nivolumab|mesh-list
92931272|NCT03980925|Etoposide|etoposide|mesh-list
92931273|NCT03980925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931274|NCT03980925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92931275|NCT03980925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92931276|NCT03980925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931277|NCT03980925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92931278|NCT03980925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92931279|NCT03980925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92931280|NCT03980925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931281|NCT00693693|Hydrocortisone|hydrocortisone|mesh-list
92931282|NCT00693693|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92931283|NCT00693693|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92931284|NCT00693693|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92931285|NCT00693693|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
92931286|NCT00693693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931287|NCT00693693|Dermatologic Agents|dermatologic agents|mesh-ancestor
92931288|NCT03966807|Nicotine|nicotine|mesh-list
92931289|NCT03966807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92931290|NCT03966807|Autonomic Agents|autonomic agents|mesh-ancestor
92931291|NCT03966807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931292|NCT03966807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931293|NCT03966807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92931294|NCT03966807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92931295|NCT03966807|Cholinergic Agents|cholinergic agents|mesh-ancestor
92931296|NCT03966807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931297|NCT03966807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931298|NCT02565693|Aspirin|aspirin|mesh-list
92931299|NCT02565693|Carbaspirin calcium|carbaspirin calcium|mesh-list
92931300|NCT02565693|Dipyridamole|dipyridamole|mesh-list
92931301|NCT02565693|Apixaban|apixaban|mesh-list
92931302|NCT02565693|Clopidogrel|clopidogrel|mesh-list
92931303|NCT02565693|Calcium|calcium|mesh-list
92931304|NCT02565693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92931305|NCT02565693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931306|NCT02565693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92931307|NCT02565693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92931308|NCT02565693|Analgesics|analgesics|mesh-ancestor
92931309|NCT02565693|Sensory System Agents|sensory system agents|mesh-ancestor
92931310|NCT02565693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931311|NCT02565693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931312|NCT02565693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92931313|NCT02565693|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92931314|NCT02565693|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92931315|NCT02565693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931316|NCT02565693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92931317|NCT02565693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92931318|NCT02565693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931319|NCT02565693|Antipyretics|antipyretics|mesh-ancestor
92931320|NCT02565693|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92931321|NCT02565693|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92931322|NCT02565693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92931323|NCT02565693|Purinergic Agents|purinergic agents|mesh-ancestor
92931324|NCT02565693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931325|NCT02565693|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92931326|NCT02565693|Antithrombins|antithrombins|mesh-ancestor
92931327|NCT02565693|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92931328|NCT02565693|Protease Inhibitors|protease inhibitors|mesh-ancestor
92931329|NCT02565693|Anticoagulants|anticoagulants|mesh-ancestor
92931330|NCT02565693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92931331|NCT02565693|Vasodilator Agents|vasodilator agents|mesh-ancestor
92931332|NCT04061655|Iron|iron|mesh-list
92931333|NCT04061655|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92931334|NCT04061655|Trace Elements|trace elements|mesh-ancestor
92931335|NCT04061655|Micronutrients|micronutrients|mesh-ancestor
92931336|NCT04061655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931337|NCT04061655|Hematinics|hematinics|mesh-ancestor
92931338|NCT04061265|Lidocaine|lidocaine|mesh-list
92931339|NCT04061265|Epinephrine|epinephrine|mesh-list
92931340|NCT04061265|Carticaine|carticaine|mesh-list
92931341|NCT04061265|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931342|NCT04061265|Anesthetics|anesthetics|mesh-ancestor
92931343|NCT04061265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931344|NCT04061265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931345|NCT04061265|Sensory System Agents|sensory system agents|mesh-ancestor
92931346|NCT04061265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931347|NCT04061265|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92931348|NCT04061265|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92931349|NCT04061265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92931350|NCT04061265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931351|NCT04061265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931352|NCT04061265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92931353|NCT04061265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92931354|NCT04061265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92931355|NCT04061265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931356|NCT04061265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92931357|NCT04061265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92931358|NCT04061265|Autonomic Agents|autonomic agents|mesh-ancestor
92931359|NCT04061265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92931360|NCT04061265|Respiratory System Agents|respiratory system agents|mesh-ancestor
92931361|NCT04061265|Mydriatics|mydriatics|mesh-ancestor
92931362|NCT04061265|Sympathomimetics|sympathomimetics|mesh-ancestor
92931363|NCT04061265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92931364|NCT02592980|Warfarin|warfarin|mesh-list
92931365|NCT02592980|Anticoagulants|anticoagulants|mesh-ancestor
92931366|NCT00727844|Linezolid|linezolid|mesh-list
92931367|NCT00727844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931368|NCT00727844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931369|NCT00727844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92931370|NCT00727844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931371|NCT00727844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931372|NCT00735878|Carboplatin|carboplatin|mesh-list
92931373|NCT00735878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931374|NCT00695955|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92931375|NCT00695955|Chlorthalidone|chlorthalidone|mesh-list
92931376|NCT00695955|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92931377|NCT00695955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92931378|NCT00695955|Diuretics|diuretics|mesh-ancestor
92931379|NCT00695955|Natriuretic Agents|natriuretic agents|mesh-ancestor
92931380|NCT00695955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931381|NCT00695955|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92931382|NCT00695955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931383|NCT00695955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931384|NCT00695955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92931385|NCT00695955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92931387|NCT00693225|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92931388|NCT00693225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92931389|NCT00693225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92931390|NCT00693225|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92931391|NCT00693225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931392|NCT00693225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931393|NCT00735644|Vaccines|vaccines|mesh-list
92931394|NCT00735644|Immunologic Factors|immunologic factors|mesh-ancestor
92931395|NCT00735644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931396|NCT02591888|Bupivacaine|bupivacaine|mesh-list
92931397|NCT02591888|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931398|NCT02591888|Anesthetics|anesthetics|mesh-ancestor
92931399|NCT02591888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931400|NCT02591888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931401|NCT02591888|Sensory System Agents|sensory system agents|mesh-ancestor
92931402|NCT02591888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931403|NCT00724958|Infliximab|infliximab|mesh-list
92931404|NCT00724958|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92931405|NCT00724958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931406|NCT00724958|Dermatologic Agents|dermatologic agents|mesh-ancestor
92931407|NCT00724958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92931408|NCT00724958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92931409|NCT04088006|Hyaluronic Acid|hyaluronic acid|mesh-list
92931410|NCT04088006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92931411|NCT04088006|Immunologic Factors|immunologic factors|mesh-ancestor
92931412|NCT04088006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931413|NCT04088006|Viscosupplements|viscosupplements|mesh-ancestor
92931414|NCT04088006|Protective Agents|protective agents|mesh-ancestor
92931415|NCT00695565|Clonidine|clonidine|mesh-list
92931416|NCT00695565|Analgesics|analgesics|mesh-ancestor
92931417|NCT00695565|Sensory System Agents|sensory system agents|mesh-ancestor
92931418|NCT00695565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931419|NCT00695565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931420|NCT00695565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92931421|NCT00695565|Sympatholytics|sympatholytics|mesh-ancestor
92931422|NCT00695565|Autonomic Agents|autonomic agents|mesh-ancestor
92931423|NCT00695565|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92931424|NCT00695565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92931425|NCT00695565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92931426|NCT00695565|Adrenergic Agents|adrenergic agents|mesh-ancestor
92931427|NCT00695565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931428|NCT00695565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931429|NCT00727532|Sorafenib|sorafenib|mesh-list
92931430|NCT00727532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931431|NCT00727532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931432|NCT00727532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931433|NCT00727532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931434|NCT00721214|Azacitidine|azacitidine|mesh-list
92931435|NCT00721214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92931436|NCT00721214|Antimetabolites|antimetabolites|mesh-ancestor
92931437|NCT00721214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931438|NCT00721214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931439|NCT00721214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931440|NCT03543813|CX-2029|cx-2029|mesh-list
92931441|NCT03543813|Immunoconjugates|immunoconjugates|mesh-ancestor
92931442|NCT03543813|Immunologic Factors|immunologic factors|mesh-ancestor
92931443|NCT03543813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931444|NCT00720902|Hormones|hormones|mesh-list
92931445|NCT00720902|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92931446|NCT00720902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931447|NCT00720902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931448|NCT02592278|Listerine|listerine|mesh-list
92931449|NCT02592278|Fluorides|fluorides|mesh-list
92931450|NCT02592278|Fluorides, Topical|fluorides, topical|mesh-list
92931451|NCT02592278|Sodium Fluoride|sodium fluoride|mesh-list
92931452|NCT02592278|Cariostatic Agents|cariostatic agents|mesh-ancestor
92931453|NCT02592278|Protective Agents|protective agents|mesh-ancestor
92931454|NCT02592278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931455|NCT02592278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92931456|NCT02592278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931457|NCT00695019|Interferons|interferons|mesh-list
92931458|NCT00695019|Interferon-alpha|interferon-alpha|mesh-list
92931459|NCT00695019|Interferon alpha-2|interferon alpha-2|mesh-list
92931460|NCT00695019|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92931462|NCT00695019|Antiviral Agents|antiviral agents|mesh-ancestor
92931463|NCT00695019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931464|NCT00695019|Immunologic Factors|immunologic factors|mesh-ancestor
92931465|NCT00695019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931466|NCT04019600|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92931467|NCT04019600|Natriuretic Agents|natriuretic agents|mesh-ancestor
92931468|NCT04019600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931469|NCT00742911|Copper|copper|mesh-list
92931470|NCT00742911|Disulfiram|disulfiram|mesh-list
92931471|NCT00742911|Trace Elements|trace elements|mesh-ancestor
92931472|NCT00742911|Micronutrients|micronutrients|mesh-ancestor
92931473|NCT00742911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931474|NCT00742911|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92931475|NCT00742911|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92931476|NCT00742911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931477|NCT00742911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931478|NCT00694707|Risperidone|risperidone|mesh-list
92931479|NCT00694707|Cariprazine|cariprazine|mesh-list
92931480|NCT00694707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92931481|NCT00694707|Serotonin Agents|serotonin agents|mesh-ancestor
92931482|NCT00694707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931483|NCT00694707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931484|NCT00694707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931485|NCT00694707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92931486|NCT00694707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92931487|NCT00694707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931488|NCT00694707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92931489|NCT00694707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92931490|NCT00694707|Dopamine Agents|dopamine agents|mesh-ancestor
92931491|NCT00692913|Cholecalciferol|cholecalciferol|mesh-list
92931492|NCT00692913|Vitamin D|vitamin d|mesh-list
92931493|NCT00692913|Alendronate|alendronate|mesh-list
92931494|NCT00692913|Calcium|calcium|mesh-list
92931495|NCT00692913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92931496|NCT00692913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931497|NCT00692913|Vitamins|vitamins|mesh-ancestor
92931498|NCT00692913|Micronutrients|micronutrients|mesh-ancestor
92931499|NCT00692913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92931500|NCT00694551|Poly I-C|poly i-c|mesh-list
92931501|NCT00694551|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92931502|NCT00694551|Vaccines|vaccines|mesh-list
92931503|NCT00694551|Poly ICLC|poly iclc|mesh-list
92931504|NCT00694551|Immunologic Factors|immunologic factors|mesh-ancestor
92931505|NCT00694551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931506|NCT00694551|Interferon Inducers|interferon inducers|mesh-ancestor
92931507|NCT00694551|Laxatives|laxatives|mesh-ancestor
92931508|NCT00694551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92931509|NCT00694551|Antiviral Agents|antiviral agents|mesh-ancestor
92931510|NCT00694551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931511|NCT02603705|Oxycodone|oxycodone|mesh-list
92931512|NCT02603705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92931513|NCT02603705|Narcotics|narcotics|mesh-ancestor
92931514|NCT02603705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931515|NCT02603705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931516|NCT02603705|Analgesics|analgesics|mesh-ancestor
92931517|NCT02603705|Sensory System Agents|sensory system agents|mesh-ancestor
92931518|NCT02603705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931519|NCT00776555|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92931520|NCT00776555|Dextroamphetamine|dextroamphetamine|mesh-list
92931521|NCT00776555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92931522|NCT00776555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931523|NCT00776555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92931524|NCT00776555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92931525|NCT00776555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931526|NCT00776555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931527|NCT00776555|Dopamine Agents|dopamine agents|mesh-ancestor
92931528|NCT00776555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931529|NCT00915785|Azacitidine|azacitidine|mesh-list
92931530|NCT00915785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92931531|NCT00915785|Antimetabolites|antimetabolites|mesh-ancestor
92931532|NCT00915785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931533|NCT00915785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931534|NCT00915785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931535|NCT00776009|Methylphenidate|methylphenidate|mesh-list
92931536|NCT00776009|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92931537|NCT00776009|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92931538|NCT00776009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931539|NCT00776009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92931540|NCT00776009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92931541|NCT00776009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931542|NCT00776009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931544|NCT00776009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931545|NCT00720356|Bevacizumab|bevacizumab|mesh-list
92931546|NCT00720356|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92931547|NCT00720356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92931548|NCT00720356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931549|NCT00720356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931550|NCT00720356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92931551|NCT00720356|Growth Substances|growth substances|mesh-ancestor
92931552|NCT00720356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931553|NCT00720356|Growth Inhibitors|growth inhibitors|mesh-ancestor
92931554|NCT00720356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931555|NCT00720356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931556|NCT00720356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931557|NCT00745953|Valsartan|valsartan|mesh-list
92931558|NCT00745953|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92931559|NCT00745953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92931560|NCT00745953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92931561|NCT00745953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92931562|NCT00745953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931563|NCT00745953|Diuretics|diuretics|mesh-ancestor
92931564|NCT00745953|Natriuretic Agents|natriuretic agents|mesh-ancestor
92931565|NCT00745953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931566|NCT00745953|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92931567|NCT00745953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931568|NCT00720278|Azelastine|azelastine|mesh-list
92931569|NCT00720278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92931570|NCT00720278|Autonomic Agents|autonomic agents|mesh-ancestor
92931571|NCT00720278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931572|NCT00720278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931573|NCT00720278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92931574|NCT00720278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92931575|NCT00720278|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92931576|NCT00720278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931577|NCT00720278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931578|NCT00720278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92931579|NCT00720278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92931580|NCT00720278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92931581|NCT00720278|Histamine Antagonists|histamine antagonists|mesh-ancestor
92931582|NCT00720278|Histamine Agents|histamine agents|mesh-ancestor
92931583|NCT00720278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931584|NCT00746031|Goserelin|goserelin|mesh-list
92931585|NCT00746031|Cetrorelix|cetrorelix|mesh-list
92931586|NCT00746031|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92931587|NCT00746031|Hormones|hormones|mesh-ancestor
92931588|NCT00746031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931589|NCT00746031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931590|NCT00746031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92931591|NCT00746031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931592|NCT00746031|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92931593|NCT00746031|Fertility Agents|fertility agents|mesh-ancestor
92931594|NCT00746031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92931595|NCT00746031|Hormone Antagonists|hormone antagonists|mesh-ancestor
92931596|NCT00720122|Insulin|insulin|mesh-list
92931597|NCT00720122|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92931598|NCT00720122|Mitogens|mitogens|mesh-list
92931599|NCT00720122|Mecasermin|mecasermin|mesh-list
92931600|NCT00720122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92931601|NCT00720122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931602|NCT00720122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92931603|NCT00720122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931604|NCT00720122|Growth Substances|growth substances|mesh-ancestor
92931605|NCT04085744|Mometasone Furoate|mometasone furoate|mesh-list
92931606|NCT04085744|Lidocaine|lidocaine|mesh-list
92931607|NCT04085744|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931608|NCT04085744|Anesthetics|anesthetics|mesh-ancestor
92931609|NCT04085744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931610|NCT04085744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931611|NCT04085744|Sensory System Agents|sensory system agents|mesh-ancestor
92931612|NCT04085744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931613|NCT04085744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92931614|NCT04085744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92931615|NCT04085744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92931616|NCT04085744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931617|NCT04085744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931618|NCT04085744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931619|NCT04085744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92931620|NCT04085744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92931621|NCT00743847|Varenicline|varenicline|mesh-list
92931622|NCT00743847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92931623|NCT00743847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92931624|NCT00743847|Cholinergic Agents|cholinergic agents|mesh-ancestor
92931625|NCT00743847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931626|NCT00743847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931627|NCT00743847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931628|NCT00717860|Caspofungin|caspofungin|mesh-list
92931629|NCT00717860|Micafungin|micafungin|mesh-list
92931630|NCT00717860|Antifungal Agents|antifungal agents|mesh-ancestor
92931631|NCT00717860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931632|NCT00717860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931633|NCT00717860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931634|NCT00746499|Raltegravir Potassium|raltegravir potassium|mesh-list
92931635|NCT00746499|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92931636|NCT00746499|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92931637|NCT00746499|Antiviral Agents|antiviral agents|mesh-ancestor
92931638|NCT00746499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931639|NCT00746499|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92931640|NCT00746499|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92931641|NCT00746499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163831|NCT00630539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92931642|NCT00746499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931643|NCT02592122|Bromides|bromides|mesh-list
92931644|NCT02592122|Albuterol|albuterol|mesh-list
92931645|NCT02592122|Anticonvulsants|anticonvulsants|mesh-ancestor
92931646|NCT02592122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92931647|NCT02592122|Autonomic Agents|autonomic agents|mesh-ancestor
92931648|NCT02592122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931649|NCT02592122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931650|NCT02592122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92931651|NCT02592122|Respiratory System Agents|respiratory system agents|mesh-ancestor
92931652|NCT02592122|Tocolytic Agents|tocolytic agents|mesh-ancestor
92931653|NCT02592122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92931654|NCT02592122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92931655|NCT02592122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92931656|NCT02592122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92931657|NCT02592122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92931658|NCT02592122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931659|NCT02592122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931660|NCT00923637|Oxaliplatin|oxaliplatin|mesh-list
92931661|NCT00923637|Pemetrexed|pemetrexed|mesh-list
92931662|NCT00923637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931663|NCT00923637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931664|NCT00923637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931665|NCT00923637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92931666|NCT00923637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931667|NCT00717314|Mycophenolic Acid|mycophenolic acid|mesh-list
92931668|NCT00717314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92931669|NCT00717314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931670|NCT00717314|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92931671|NCT00717314|Antitubercular Agents|antitubercular agents|mesh-ancestor
92931672|NCT00717314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931673|NCT00717314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931674|NCT00717314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931675|NCT00717314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931676|NCT01090089|Dexamethasone|dexamethasone|mesh-list
92931677|NCT01090089|Dexamethasone acetate|dexamethasone acetate|mesh-list
92931678|NCT01090089|Lenalidomide|lenalidomide|mesh-list
92931679|NCT01090089|BB 1101|bb 1101|mesh-list
92931680|NCT01090089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931681|NCT01090089|Antiemetics|antiemetics|mesh-ancestor
92931682|NCT01090089|Autonomic Agents|autonomic agents|mesh-ancestor
92931683|NCT01090089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931684|NCT01090089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931685|NCT01090089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92931686|NCT01090089|Glucocorticoids|glucocorticoids|mesh-ancestor
92931687|NCT01090089|Hormones|hormones|mesh-ancestor
92931688|NCT01090089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931689|NCT01090089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92931690|NCT01090089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931691|NCT01090089|Protease Inhibitors|protease inhibitors|mesh-ancestor
92931692|NCT01090089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931693|NCT01090089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931695|NCT01090089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931696|NCT01090089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92931697|NCT01090089|Growth Substances|growth substances|mesh-ancestor
92931698|NCT01090089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92931699|NCT00689793|Iron|iron|mesh-list
92931700|NCT00689793|Trace Elements|trace elements|mesh-ancestor
92931701|NCT00689793|Micronutrients|micronutrients|mesh-ancestor
92931702|NCT00689793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931703|NCT04086290|Androgens|androgens|mesh-list
92931704|NCT04086290|Hormones|hormones|mesh-ancestor
92931705|NCT04086290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931706|NCT04086290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931707|NCT00744393|Sodium Oxybate|sodium oxybate|mesh-list
92931708|NCT00744393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92931709|NCT00744393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92931710|NCT00744393|Anesthetics, General|anesthetics, general|mesh-ancestor
92931711|NCT00744393|Anesthetics|anesthetics|mesh-ancestor
92931712|NCT00744393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931713|NCT00744393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931714|NCT02563353|Teriparatide|teriparatide|mesh-list
92931715|NCT02563353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92931716|NCT02563353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931717|NCT02563353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92931718|NCT00688701|Lixisenatide|lixisenatide|mesh-list
92931719|NCT00688701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92931720|NCT00688701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931721|NCT00744549|Vitamin D|vitamin d|mesh-list
92931722|NCT00744549|Cholecalciferol|cholecalciferol|mesh-list
92931723|NCT00744549|Vitamins|vitamins|mesh-list
92931724|NCT00744549|Vitamin E|vitamin e|mesh-list
92931725|NCT00744549|Selenium|selenium|mesh-list
92931726|NCT00744549|Lycopene|lycopene|mesh-list
92931727|NCT00744549|Micronutrients|micronutrients|mesh-ancestor
92931728|NCT00744549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931729|NCT00744549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92931730|NCT00744549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92931731|NCT00744549|Antioxidants|antioxidants|mesh-ancestor
92931732|NCT00744549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931733|NCT00744549|Protective Agents|protective agents|mesh-ancestor
92931734|NCT00744549|Trace Elements|trace elements|mesh-ancestor
92931735|NCT00744549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931736|NCT00744549|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92931737|NCT00744549|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92931738|NCT00744549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931739|NCT00746655|Cisplatin|cisplatin|mesh-list
92931740|NCT00746655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931741|NCT04060719|Rifampin|rifampin|mesh-list
92931742|NCT04060719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92931743|NCT04060719|Antitubercular Agents|antitubercular agents|mesh-ancestor
92931744|NCT04060719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931745|NCT04060719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931746|NCT04060719|Leprostatic Agents|leprostatic agents|mesh-ancestor
92931747|NCT04060719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931748|NCT04060719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931749|NCT04060719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931750|NCT04060719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92931751|NCT04060719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92931752|NCT04060719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92931753|NCT04060719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92163840|NCT00634829|Albuterol|albuterol|mesh-list
92931754|NCT04060719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92931755|NCT04060719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92931756|NCT00741429|Insulin|insulin|mesh-list
92931757|NCT00741429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92931758|NCT00741429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931759|NCT00741507|Ethanol|ethanol|mesh-list
92931760|NCT00741507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92931761|NCT00741507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931762|NCT00741507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931763|NCT00741507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931765|NCT00688623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92931766|NCT00688623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931767|NCT00688623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526424|NCT00028600|Antimetabolites|antimetabolites|mesh-ancestor
92931768|NCT00688623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931769|NCT00688623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92931770|NCT00688623|Immunologic Factors|immunologic factors|mesh-ancestor
92931771|NCT00688623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931772|NCT00688623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931773|NCT02563821|Clonidine|clonidine|mesh-list
92931774|NCT02563821|Sufentanil|sufentanil|mesh-list
92931775|NCT02563821|Levobupivacaine|levobupivacaine|mesh-list
92931776|NCT02563821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92931777|NCT02563821|Narcotics|narcotics|mesh-ancestor
92931778|NCT02563821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931779|NCT02563821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931780|NCT02563821|Analgesics|analgesics|mesh-ancestor
92931781|NCT02563821|Sensory System Agents|sensory system agents|mesh-ancestor
92931782|NCT02563821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931783|NCT02563821|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92931784|NCT02563821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92931785|NCT02563821|Anesthetics, General|anesthetics, general|mesh-ancestor
92931786|NCT02563821|Anesthetics|anesthetics|mesh-ancestor
92931787|NCT02563821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92931788|NCT02563821|Sympatholytics|sympatholytics|mesh-ancestor
92931789|NCT02563821|Autonomic Agents|autonomic agents|mesh-ancestor
92931790|NCT02563821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92931791|NCT02563821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92931792|NCT02563821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92931793|NCT02563821|Adrenergic Agents|adrenergic agents|mesh-ancestor
92931794|NCT02563821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931795|NCT02563821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931796|NCT02563821|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931797|NCT00717236|Certolizumab Pegol|certolizumab pegol|mesh-list
92931798|NCT00717236|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92931799|NCT00717236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931800|NCT00717236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92931801|NCT00717236|Immunologic Factors|immunologic factors|mesh-ancestor
92931802|NCT00717236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931803|NCT00717236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92931804|NCT04085354|Vitamins|vitamins|mesh-list
92931805|NCT04085354|Folic Acid|folic acid|mesh-list
92931806|NCT04085354|Vitamin B 12|vitamin b 12|mesh-list
92931807|NCT04085354|Hydroxocobalamin|hydroxocobalamin|mesh-list
92931808|NCT04085354|Micronutrients|micronutrients|mesh-ancestor
92931809|NCT04085354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931810|NCT04085354|Hematinics|hematinics|mesh-ancestor
92931811|NCT04085354|Vitamin B Complex|vitamin b complex|mesh-ancestor
92931812|NCT00719810|Tigecycline|tigecycline|mesh-list
92931813|NCT00719810|Fluoroquinolones|fluoroquinolones|mesh-list
92931814|NCT00719810|Delafloxacin|delafloxacin|mesh-list
92931815|NCT00719810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92931816|NCT00719810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931817|NCT00719810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92931818|NCT00719810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931819|NCT00719810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931820|NCT00719810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931821|NCT00723710|Interferons|interferons|mesh-list
92931822|NCT00723710|Interferon-alpha|interferon-alpha|mesh-list
92931823|NCT00723710|Interferon alpha-2|interferon alpha-2|mesh-list
92931824|NCT00723710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931825|NCT00723710|Antiviral Agents|antiviral agents|mesh-ancestor
92931826|NCT00723710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931827|NCT00723710|Immunologic Factors|immunologic factors|mesh-ancestor
92931828|NCT00723710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931829|NCT00688545|Celecoxib|celecoxib|mesh-list
92931830|NCT00688545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92931831|NCT00688545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92931832|NCT00688545|Analgesics|analgesics|mesh-ancestor
92931833|NCT00688545|Sensory System Agents|sensory system agents|mesh-ancestor
92931834|NCT00688545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931835|NCT00688545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931836|NCT00688545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931837|NCT00688545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92931838|NCT00688545|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92931839|NCT00688545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92931840|NCT00688545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931841|NCT00688545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931842|NCT04060407|Nivolumab|nivolumab|mesh-list
92931843|NCT04060407|Ipilimumab|ipilimumab|mesh-list
92931844|NCT04060407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92931845|NCT04060407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931846|NCT04060407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92931847|NCT04060407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931848|NCT00741585|Atenolol|atenolol|mesh-list
92931849|NCT00741585|Amlodipine|amlodipine|mesh-list
92931850|NCT00741585|Valsartan|valsartan|mesh-list
92931851|NCT00741585|Telmisartan|telmisartan|mesh-list
92931852|NCT00741585|Carvedilol|carvedilol|mesh-list
92931853|NCT00741585|Candesartan|candesartan|mesh-list
92931854|NCT00741585|Candesartan cilexetil|candesartan cilexetil|mesh-list
92931855|NCT00741585|Ramipril|ramipril|mesh-list
92931856|NCT00741585|Olmesartan|olmesartan|mesh-list
92931857|NCT00741585|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92931858|NCT00741585|Enalapril|enalapril|mesh-list
92931859|NCT00741585|Enalaprilat|enalaprilat|mesh-list
92931860|NCT00741585|Lisinopril|lisinopril|mesh-list
92931861|NCT00741585|Irbesartan|irbesartan|mesh-list
92931862|NCT00741585|Antihypertensive Agents|antihypertensive agents|mesh-list
92931863|NCT00741585|Quinapril|quinapril|mesh-list
92931864|NCT00741585|Lercanidipine|lercanidipine|mesh-list
92931865|NCT00741585|Manidipine|manidipine|mesh-list
92931866|NCT00741585|Doxazosin|doxazosin|mesh-list
92931867|NCT00741585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92931868|NCT00741585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931869|NCT00741585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931870|NCT00741585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92931871|NCT00741585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931872|NCT00741585|Vasodilator Agents|vasodilator agents|mesh-ancestor
92931873|NCT00741585|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92931874|NCT00741585|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92931875|NCT00741585|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92931876|NCT00741585|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92931877|NCT00741585|Adrenergic Agents|adrenergic agents|mesh-ancestor
92931878|NCT00741585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931879|NCT00741585|Antioxidants|antioxidants|mesh-ancestor
92931880|NCT00741585|Protective Agents|protective agents|mesh-ancestor
92931881|NCT00741585|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92931882|NCT00741585|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92931883|NCT00741585|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92931884|NCT00741585|Protease Inhibitors|protease inhibitors|mesh-ancestor
92931885|NCT00741585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931886|NCT00741585|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92931887|NCT00741585|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92931888|NCT00741585|Sympatholytics|sympatholytics|mesh-ancestor
92931889|NCT00741585|Autonomic Agents|autonomic agents|mesh-ancestor
92931890|NCT00741585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931891|NCT00741585|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92931892|NCT00746967|Sildenafil Citrate|sildenafil citrate|mesh-list
92931893|NCT00746967|Vasodilator Agents|vasodilator agents|mesh-ancestor
92931894|NCT00746967|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92931895|NCT00746967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92931896|NCT00746967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931897|NCT00746967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931898|NCT00746967|Urological Agents|urological agents|mesh-ancestor
92931899|NCT02563041|Heparin|heparin|mesh-list
92931900|NCT02563041|Calcium heparin|calcium heparin|mesh-list
92931901|NCT02563041|Anticoagulants|anticoagulants|mesh-ancestor
92931902|NCT02563041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931903|NCT02563041|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92931904|NCT02563041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92931905|NCT00741663|Furosemide|furosemide|mesh-list
92931906|NCT00741663|Spironolactone|spironolactone|mesh-list
92931907|NCT00741663|Diuretics|diuretics|mesh-ancestor
92931908|NCT00741663|Natriuretic Agents|natriuretic agents|mesh-ancestor
92931909|NCT00741663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931910|NCT00741663|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92931911|NCT00741663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931912|NCT00741663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931913|NCT00741663|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92931914|NCT00741663|Hormone Antagonists|hormone antagonists|mesh-ancestor
92931915|NCT00741663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931916|NCT00741663|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92931917|NCT00745017|Antidepressive Agents|antidepressive agents|mesh-list
92931918|NCT00745017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92931920|NCT00741741|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92931921|NCT00741741|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92931922|NCT00741741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931923|NCT00741741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931924|NCT00741741|Antiviral Agents|antiviral agents|mesh-ancestor
92931925|NCT00741741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931926|NCT00741741|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92931927|NCT00741741|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92931928|NCT00745173|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92931929|NCT00745173|Estrogens|estrogens|mesh-ancestor
92931930|NCT00745173|Hormones|hormones|mesh-ancestor
92931931|NCT00745173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92931932|NCT00745173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931933|NCT04060095|Anesthetics|anesthetics|mesh-list
92931934|NCT04060095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931935|NCT04060095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931936|NCT00741897|Fexofenadine|fexofenadine|mesh-list
92931937|NCT00741897|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92931938|NCT00741897|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92931939|NCT00741897|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92931940|NCT00741897|Histamine Antagonists|histamine antagonists|mesh-ancestor
92931941|NCT00741897|Histamine Agents|histamine agents|mesh-ancestor
92931942|NCT00741897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92931943|NCT00741897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931944|NCT00741897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931945|NCT00745407|Fenofibrate|fenofibrate|mesh-list
92931946|NCT00745407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92931947|NCT00745407|Antimetabolites|antimetabolites|mesh-ancestor
92931948|NCT00745407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931949|NCT00745407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92931950|NCT00745485|Zoledronic Acid|zoledronic acid|mesh-list
92931951|NCT00745485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92931952|NCT00745485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931953|NCT00747279|Insulin|insulin|mesh-list
92931954|NCT00747279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92931955|NCT00747279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931956|NCT00742287|Proanthocyanidin|proanthocyanidin|mesh-list
92931957|NCT00742287|Procyanidin|procyanidin|mesh-list
92931958|NCT00742287|Antioxidants|antioxidants|mesh-ancestor
92931959|NCT00742287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931960|NCT00742287|Protective Agents|protective agents|mesh-ancestor
92931961|NCT00742287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931962|NCT00742287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92931963|NCT00742287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92931964|NCT00742287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931965|NCT00747669|Lidocaine|lidocaine|mesh-list
92931966|NCT00747669|Tetracaine|tetracaine|mesh-list
92931967|NCT00747669|Anesthetics, Local|anesthetics, local|mesh-ancestor
92931968|NCT00747669|Anesthetics|anesthetics|mesh-ancestor
92931969|NCT00747669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92931970|NCT00747669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931971|NCT00747669|Sensory System Agents|sensory system agents|mesh-ancestor
92931972|NCT00747669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92931973|NCT00747669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92931974|NCT00747669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92931975|NCT00747669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92931976|NCT00747669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92931977|NCT00747669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92931978|NCT00690573|Adalimumab|adalimumab|mesh-list
92931979|NCT00690573|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92931980|NCT00690573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92931981|NCT00690573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92931982|NCT00719264|Interferons|interferons|mesh-list
92931983|NCT00719264|Interferon-alpha|interferon-alpha|mesh-list
92931984|NCT00719264|Interferon alpha-2|interferon alpha-2|mesh-list
92931985|NCT00719264|Bevacizumab|bevacizumab|mesh-list
92931986|NCT00719264|Everolimus|everolimus|mesh-list
92931987|NCT00719264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92931988|NCT00719264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92931989|NCT00719264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92931990|NCT00719264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92931992|NCT00719264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92931993|NCT00719264|Growth Inhibitors|growth inhibitors|mesh-ancestor
92931994|NCT00719264|Antiviral Agents|antiviral agents|mesh-ancestor
92931995|NCT00719264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92931996|NCT00719264|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92931997|NCT00719264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92931998|NCT00719264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92931999|NCT00719264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932000|NCT00719264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932001|NCT00719264|Immunologic Factors|immunologic factors|mesh-ancestor
92932002|NCT00687609|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92932003|NCT00687609|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92932004|NCT00687609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932005|NCT00687609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932006|NCT00687609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932007|NCT00687609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92932008|NCT00687609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932009|NCT00687609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932011|NCT00751959|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92932012|NCT00751959|Respiratory System Agents|respiratory system agents|mesh-ancestor
92932013|NCT00723554|Iloprost|iloprost|mesh-list
92932014|NCT00723554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92932015|NCT00723554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92932016|NCT00687219|Ribavirin|ribavirin|mesh-list
92932017|NCT00687219|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92932018|NCT00687219|Antimetabolites|antimetabolites|mesh-ancestor
92932019|NCT00687219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932020|NCT00687219|Antiviral Agents|antiviral agents|mesh-ancestor
92932021|NCT00687219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932022|NCT04085120|Dexamethasone|dexamethasone|mesh-list
92932023|NCT04085120|Dexamethasone acetate|dexamethasone acetate|mesh-list
92932024|NCT04085120|Lidocaine|lidocaine|mesh-list
92932025|NCT04085120|Ropivacaine|ropivacaine|mesh-list
92932026|NCT04085120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932027|NCT04085120|Antiemetics|antiemetics|mesh-ancestor
92932028|NCT04085120|Autonomic Agents|autonomic agents|mesh-ancestor
92932029|NCT04085120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932030|NCT04085120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932031|NCT04085120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932032|NCT04085120|Glucocorticoids|glucocorticoids|mesh-ancestor
92932033|NCT04085120|Hormones|hormones|mesh-ancestor
92932034|NCT04085120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932035|NCT04085120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932036|NCT04085120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932037|NCT04085120|Anesthetics, Local|anesthetics, local|mesh-ancestor
92932038|NCT04085120|Anesthetics|anesthetics|mesh-ancestor
92932039|NCT04085120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92932040|NCT04085120|Sensory System Agents|sensory system agents|mesh-ancestor
92932041|NCT04085120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92932042|NCT04085120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92932043|NCT04085120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92932044|NCT04085120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932045|NCT04085120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932046|NCT00747903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92932047|NCT00747903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92932048|NCT00747903|Dermatologic Agents|dermatologic agents|mesh-ancestor
92932049|NCT02562183|Kallikreins|kallikreins|mesh-list
92932050|NCT02562183|Coagulants|coagulants|mesh-ancestor
92932051|NCT02562183|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92932052|NCT02562183|Fertility Agents|fertility agents|mesh-ancestor
92932053|NCT02562183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92932054|NCT02562183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932055|NCT00723398|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92932056|NCT00723398|Pitavastatin|pitavastatin|mesh-list
92932057|NCT00723398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92932058|NCT00723398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92932059|NCT00723398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92932060|NCT00723398|Antimetabolites|antimetabolites|mesh-ancestor
92932061|NCT00723398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932062|NCT00723398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932063|NCT00723398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92932064|NCT00723398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92932065|NCT00723398|Hormone Antagonists|hormone antagonists|mesh-ancestor
92932066|NCT00723398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932067|NCT00723398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932068|NCT00723398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92932069|NCT00723398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92932070|NCT00723398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92932071|NCT00716456|Cetuximab|cetuximab|mesh-list
92932072|NCT00716456|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92932073|NCT00716456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92932074|NCT00716456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932075|NCT00716456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92932076|NCT00716456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932077|NCT00716456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932078|NCT00684645|Sunitinib|sunitinib|mesh-list
92932079|NCT00684645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932080|NCT00684645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92932081|NCT00684645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92932082|NCT00684645|Growth Substances|growth substances|mesh-ancestor
92932083|NCT00684645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932084|NCT00684645|Growth Inhibitors|growth inhibitors|mesh-ancestor
92932085|NCT00684645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92932086|NCT00684645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932087|NCT00684645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932088|NCT00752037|Ritonavir|ritonavir|mesh-list
92932089|NCT00752037|Lopinavir|lopinavir|mesh-list
92932090|NCT00752037|Raltegravir Potassium|raltegravir potassium|mesh-list
92932091|NCT00752037|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92932092|NCT00752037|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92932093|NCT00752037|Protease Inhibitors|protease inhibitors|mesh-ancestor
92932094|NCT00752037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932095|NCT00752037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932096|NCT00752037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92932097|NCT00752037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92932098|NCT00752037|Antiviral Agents|antiviral agents|mesh-ancestor
92932099|NCT00752037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932100|NCT00752037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92932101|NCT00752037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92932102|NCT00752037|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92932103|NCT00752037|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92932104|NCT00716144|R 115866|r 115866|mesh-list
92932105|NCT00716144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92932106|NCT00716144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932107|NCT00716144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932108|NCT00752115|Paclitaxel|paclitaxel|mesh-list
92932109|NCT00752115|Carboplatin|carboplatin|mesh-list
92932110|NCT00752115|Sildenafil Citrate|sildenafil citrate|mesh-list
92932111|NCT00752115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92932112|NCT00752115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932113|NCT00752115|Tubulin Modulators|tubulin modulators|mesh-ancestor
92932114|NCT00752115|Antimitotic Agents|antimitotic agents|mesh-ancestor
92932115|NCT00752115|Mitosis Modulators|mitosis modulators|mesh-ancestor
92932116|NCT00752115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932117|NCT00752115|Vasodilator Agents|vasodilator agents|mesh-ancestor
92932118|NCT00752115|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92932119|NCT00752115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92932120|NCT00752115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932121|NCT00752115|Urological Agents|urological agents|mesh-ancestor
92932122|NCT00918476|Contraceptive Agents|contraceptive agents|mesh-list
92932123|NCT00918476|Contraceptives, Oral|contraceptives, oral|mesh-list
92932124|NCT00918476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92932125|NCT00918476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932126|NCT00918476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92932127|NCT00749385|Naproxen|naproxen|mesh-list
92932128|NCT00749385|Esomeprazole|esomeprazole|mesh-list
92932129|NCT00749385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92932130|NCT00749385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932131|NCT00749385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92932132|NCT00749385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932133|NCT00749385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932134|NCT00749385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932135|NCT00749385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932136|NCT00749385|Analgesics|analgesics|mesh-ancestor
92932137|NCT00749385|Sensory System Agents|sensory system agents|mesh-ancestor
92932138|NCT00749385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932139|NCT00749385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932140|NCT00749385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932141|NCT00749385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932142|NCT00749385|Gout Suppressants|gout suppressants|mesh-ancestor
92932143|NCT00749385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92932144|NCT00748059|Propranolol|propranolol|mesh-list
92932145|NCT00748059|Atropine|atropine|mesh-list
92932146|NCT00748059|Clonidine|clonidine|mesh-list
92932147|NCT00748059|Nitroprusside|nitroprusside|mesh-list
92932148|NCT00748059|Methyldopa|methyldopa|mesh-list
92932149|NCT00748059|Phenylephrine|phenylephrine|mesh-list
92932150|NCT00748059|Isoproterenol|isoproterenol|mesh-list
92932151|NCT00748059|Metoclopramide|metoclopramide|mesh-list
92932152|NCT00748059|Yohimbine|yohimbine|mesh-list
92932153|NCT00748059|Tyramine|tyramine|mesh-list
92932154|NCT00748059|Edrophonium|edrophonium|mesh-list
92932155|NCT00748059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92932156|NCT00748059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92932157|NCT00748059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92932158|NCT00748059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932159|NCT00748059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932160|NCT00748059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932161|NCT00748059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92932162|NCT00748059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92932163|NCT00748059|Vasodilator Agents|vasodilator agents|mesh-ancestor
92932164|NCT00748059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92932165|NCT00748059|Mydriatics|mydriatics|mesh-ancestor
92932166|NCT00748059|Autonomic Agents|autonomic agents|mesh-ancestor
92932167|NCT00748059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932168|NCT00748059|Sympathomimetics|sympathomimetics|mesh-ancestor
92932169|NCT00748059|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92932170|NCT00748059|Nasal Decongestants|nasal decongestants|mesh-ancestor
92932171|NCT00748059|Respiratory System Agents|respiratory system agents|mesh-ancestor
92932172|NCT00748059|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92932173|NCT00748059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92932174|NCT00748059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92932175|NCT00748059|Protective Agents|protective agents|mesh-ancestor
92932176|NCT00748059|Analgesics|analgesics|mesh-ancestor
92932177|NCT00748059|Sensory System Agents|sensory system agents|mesh-ancestor
92932178|NCT00748059|Sympatholytics|sympatholytics|mesh-ancestor
92932179|NCT00748059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92932180|NCT00748059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92932181|NCT00748059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92932182|NCT00748059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92932183|NCT00748059|Parasympatholytics|parasympatholytics|mesh-ancestor
92932184|NCT00748059|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92932185|NCT00748059|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92932186|NCT00748059|Cholinergic Agents|cholinergic agents|mesh-ancestor
92932187|NCT00748059|Antiemetics|antiemetics|mesh-ancestor
92932188|NCT00748059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932189|NCT00748059|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92932190|NCT00748059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92932191|NCT00748059|Dopamine Agents|dopamine agents|mesh-ancestor
92932192|NCT00748059|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92932193|NCT00748059|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92932194|NCT00748059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92932195|NCT00748059|Urological Agents|urological agents|mesh-ancestor
92932196|NCT00748059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92932197|NCT00748059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92932198|NCT00748059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932199|NCT00748059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932200|NCT00748059|Antidotes|antidotes|mesh-ancestor
92932201|NCT00748059|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92932202|NCT00748059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932204|NCT00576381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92932205|NCT00576381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92932206|NCT00576381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932207|NCT00576381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932208|NCT00576381|Analgesics|analgesics|mesh-ancestor
92932209|NCT00576381|Sensory System Agents|sensory system agents|mesh-ancestor
92932210|NCT00576381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577622|NCT00074204|Docetaxel|docetaxel|mesh-list
92932211|NCT00576381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92932212|NCT00576381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92932213|NCT00576381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92932214|NCT00576381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92932215|NCT00576381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932216|NCT00576381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932217|NCT02562417|Dexamethasone|dexamethasone|mesh-list
92932218|NCT02562417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932219|NCT02562417|Antiemetics|antiemetics|mesh-ancestor
92932220|NCT02562417|Autonomic Agents|autonomic agents|mesh-ancestor
92932221|NCT02562417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932222|NCT02562417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932223|NCT02562417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932224|NCT02562417|Glucocorticoids|glucocorticoids|mesh-ancestor
92932225|NCT02562417|Hormones|hormones|mesh-ancestor
92932226|NCT02562417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932227|NCT02562417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932228|NCT02562417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932229|NCT00749619|Taurolidine|taurolidine|mesh-list
92932230|NCT00749619|Heparin|heparin|mesh-list
92932231|NCT00749619|Calcium heparin|calcium heparin|mesh-list
92932232|NCT00749619|Citric Acid|citric acid|mesh-list
92932233|NCT00749619|Sodium Citrate|sodium citrate|mesh-list
92932234|NCT00749619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92932235|NCT00749619|Anticoagulants|anticoagulants|mesh-ancestor
92932236|NCT00749619|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92932237|NCT00749619|Chelating Agents|chelating agents|mesh-ancestor
92932238|NCT00749619|Sequestering Agents|sequestering agents|mesh-ancestor
92932239|NCT00749619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932240|NCT00749619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92932241|NCT00749619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92932242|NCT00749619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932243|NCT00749619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92932244|NCT00749619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932245|NCT00748371|Aspirin|aspirin|mesh-list
92932246|NCT00748371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932247|NCT00748371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932248|NCT00748371|Analgesics|analgesics|mesh-ancestor
92932249|NCT00748371|Sensory System Agents|sensory system agents|mesh-ancestor
92932250|NCT00748371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932251|NCT00748371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932252|NCT00748371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932253|NCT00748371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932254|NCT00748371|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92932255|NCT00748371|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92932256|NCT00748371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932257|NCT00748371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92932258|NCT00748371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92932259|NCT00748371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932260|NCT00748371|Antipyretics|antipyretics|mesh-ancestor
92932261|NCT00749853|Buserelin|buserelin|mesh-list
92932262|NCT00749853|Hormones|hormones|mesh-list
92932263|NCT00749853|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92932264|NCT00749853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932265|NCT00749853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932266|NCT00749853|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92932267|NCT00749853|Fertility Agents|fertility agents|mesh-ancestor
92932268|NCT00749853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92932269|NCT00684567|Temozolomide|temozolomide|mesh-list
92932270|NCT00684567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92932271|NCT00684567|Alkylating Agents|alkylating agents|mesh-ancestor
92932272|NCT00684567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932273|NCT00684567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932274|NCT00752427|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92932275|NCT00752427|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92932276|NCT00752427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92932277|NCT00752427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92932278|NCT00752427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932279|NCT00752427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92932280|NCT00752427|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92932281|NCT00752427|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92932282|NCT00752427|Serotonin Agents|serotonin agents|mesh-ancestor
92932283|NCT00752427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932284|NCT00752427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932285|NCT00752427|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92932286|NCT00752427|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92932287|NCT00752427|Dopamine Agents|dopamine agents|mesh-ancestor
92932288|NCT04053621|Thiamine|thiamine|mesh-list
92932289|NCT04053621|Thiamine Pyrophosphate|thiamine pyrophosphate|mesh-list
92932290|NCT04053621|Metformin|metformin|mesh-list
92932291|NCT04053621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92932292|NCT04053621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932293|NCT04053621|Vitamin B Complex|vitamin b complex|mesh-ancestor
92932294|NCT04053621|Vitamins|vitamins|mesh-ancestor
92932295|NCT04053621|Micronutrients|micronutrients|mesh-ancestor
92932296|NCT00684411|Imatinib Mesylate|imatinib mesylate|mesh-list
92932297|NCT00684411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932298|NCT00684411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92932299|NCT00684411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932300|NCT00684411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932301|NCT02562651|Doxycycline|doxycycline|mesh-list
92932302|NCT02562651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92932303|NCT02562651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932304|NCT02562651|Antimalarials|antimalarials|mesh-ancestor
92932305|NCT02562651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92932306|NCT02562651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92932307|NCT00748527|Carboplatin|carboplatin|mesh-list
92932308|NCT00748527|Decitabine|decitabine|mesh-list
92932309|NCT00748527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932310|NCT00748527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92932311|NCT00748527|Antimetabolites|antimetabolites|mesh-ancestor
92163918|NCT02921893|Hormones|hormones|mesh-ancestor
92932312|NCT00748527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932313|NCT00748527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932314|NCT00686829|Maleic acid|maleic acid|mesh-list
92932315|NCT00686829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932316|NCT00686829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932317|NCT00687297|Carboplatin|carboplatin|mesh-list
92932318|NCT00687297|Docetaxel|docetaxel|mesh-list
92932319|NCT00687297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932320|NCT00687297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92932321|NCT00687297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92932322|NCT00687297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92932323|NCT00687297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932324|NCT00684177|Retapamulin|retapamulin|mesh-list
92932325|NCT00684177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92932326|NCT00684177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932327|NCT00686595|Infliximab|infliximab|mesh-list
92932328|NCT00686595|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92932329|NCT00686595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932330|NCT00686595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92932331|NCT00686595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932332|NCT00686595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932333|NCT00752661|Tramadol|tramadol|mesh-list
92932334|NCT00752661|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92932335|NCT00752661|Narcotics|narcotics|mesh-ancestor
92932336|NCT00752661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92932337|NCT00752661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932338|NCT00752661|Analgesics|analgesics|mesh-ancestor
92932339|NCT00752661|Sensory System Agents|sensory system agents|mesh-ancestor
92932340|NCT00752661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932341|NCT00576303|Epoetin Alfa|epoetin alfa|mesh-list
92932342|NCT00576303|Hematinics|hematinics|mesh-ancestor
92932343|NCT00752739|Selenium|selenium|mesh-list
92932344|NCT00752739|Antioxidants|antioxidants|mesh-ancestor
92932345|NCT00752739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932346|NCT00752739|Protective Agents|protective agents|mesh-ancestor
92932347|NCT00752739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932348|NCT00752739|Trace Elements|trace elements|mesh-ancestor
92932349|NCT00752739|Micronutrients|micronutrients|mesh-ancestor
92932350|NCT00755781|Cyclosporine|cyclosporine|mesh-list
92932351|NCT00755781|Cyclosporins|cyclosporins|mesh-list
92932352|NCT00755781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932353|NCT00755781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932354|NCT00755781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932355|NCT00755781|Immunologic Factors|immunologic factors|mesh-ancestor
92932356|NCT00755781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932357|NCT00755781|Antifungal Agents|antifungal agents|mesh-ancestor
92932358|NCT00755781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932359|NCT00755781|Dermatologic Agents|dermatologic agents|mesh-ancestor
92932360|NCT00755781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932361|NCT00755781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92932362|NCT00755859|Prednisone|prednisone|mesh-list
92932363|NCT00755859|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92932364|NCT00755859|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92932365|NCT00755859|Methylprednisolone|methylprednisolone|mesh-list
92932366|NCT00755859|Prednisolone|prednisolone|mesh-list
92932367|NCT00755859|Prednisolone acetate|prednisolone acetate|mesh-list
92932368|NCT00755859|Azathioprine|azathioprine|mesh-list
92932369|NCT00755859|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92932370|NCT00755859|Prednisolone phosphate|prednisolone phosphate|mesh-list
92932371|NCT00755859|Antimetabolites|antimetabolites|mesh-ancestor
92932372|NCT00755859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932373|NCT00755859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92932374|NCT00755859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932375|NCT00755859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932376|NCT00755859|Immunologic Factors|immunologic factors|mesh-ancestor
92932377|NCT00755859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932378|NCT00755859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932379|NCT00755859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932380|NCT00755859|Glucocorticoids|glucocorticoids|mesh-ancestor
92932381|NCT00755859|Hormones|hormones|mesh-ancestor
92932382|NCT00755859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932383|NCT00755859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932384|NCT00755859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92932385|NCT00755859|Protective Agents|protective agents|mesh-ancestor
92932386|NCT00755859|Antiemetics|antiemetics|mesh-ancestor
92932387|NCT00755859|Autonomic Agents|autonomic agents|mesh-ancestor
92932388|NCT00755859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932389|NCT00755859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932390|NCT00686517|Interferons|interferons|mesh-list
92932391|NCT00686517|Ribavirin|ribavirin|mesh-list
92932392|NCT00686517|Interferon-alpha|interferon-alpha|mesh-list
92932393|NCT00686517|Interferon alpha-2|interferon alpha-2|mesh-list
92932394|NCT00686517|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92932395|NCT00686517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932396|NCT00686517|Antiviral Agents|antiviral agents|mesh-ancestor
92932397|NCT00686517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932398|NCT00686517|Antimetabolites|antimetabolites|mesh-ancestor
92932399|NCT00686517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932400|NCT00686517|Immunologic Factors|immunologic factors|mesh-ancestor
92932401|NCT00686517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932402|NCT00571701|Celecoxib|celecoxib|mesh-list
92932403|NCT00571701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932404|NCT00571701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932405|NCT00571701|Analgesics|analgesics|mesh-ancestor
92932406|NCT00571701|Sensory System Agents|sensory system agents|mesh-ancestor
92932407|NCT00571701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932408|NCT00571701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932409|NCT00571701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932410|NCT00571701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932411|NCT00571701|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92932412|NCT00571701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92932413|NCT00571701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932414|NCT00571701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932415|NCT00686127|Lidocaine|lidocaine|mesh-list
92932416|NCT00686127|Anesthetics, Local|anesthetics, local|mesh-ancestor
92932417|NCT00686127|Anesthetics|anesthetics|mesh-ancestor
92932418|NCT00686127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92932419|NCT00686127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277284|NCT03705273|BB 1101|bb 1101|mesh-list
92932420|NCT00686127|Sensory System Agents|sensory system agents|mesh-ancestor
92932421|NCT00686127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932422|NCT00686127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92932423|NCT00686127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92932424|NCT00686127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92932425|NCT00686127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932426|NCT00686127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932428|NCT00718718|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92932429|NCT00718718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92932430|NCT00718718|Abortifacient Agents|abortifacient agents|mesh-ancestor
92932431|NCT00718718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92932432|NCT00718718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932433|NCT00718718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92932434|NCT00718718|Antimetabolites|antimetabolites|mesh-ancestor
92932435|NCT00718718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932436|NCT00718718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932437|NCT00718718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92932438|NCT00718718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932439|NCT00718718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92932440|NCT00718718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932441|NCT00718718|Immunologic Factors|immunologic factors|mesh-ancestor
92932442|NCT00718718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932443|NCT00718718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92932444|NCT00683787|Docetaxel|docetaxel|mesh-list
92932445|NCT00683787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932446|NCT00683787|Tubulin Modulators|tubulin modulators|mesh-ancestor
92932447|NCT00683787|Antimitotic Agents|antimitotic agents|mesh-ancestor
92932448|NCT00683787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92932449|NCT00683787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932450|NCT02560935|Hydroxyurea|hydroxyurea|mesh-list
92932451|NCT02560935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932452|NCT02560935|Antisickling Agents|antisickling agents|mesh-ancestor
92932453|NCT02560935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932454|NCT02560935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932455|NCT02560935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92932456|NCT00750399|Ranibizumab|ranibizumab|mesh-list
92932457|NCT00750399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92932458|NCT00750399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92932459|NCT00750399|Growth Substances|growth substances|mesh-ancestor
92932460|NCT00750399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932461|NCT00750399|Growth Inhibitors|growth inhibitors|mesh-ancestor
92932462|NCT00750399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932463|NCT00756171|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92932464|NCT00756171|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92932465|NCT00756171|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92932466|NCT00756171|Antimetabolites|antimetabolites|mesh-ancestor
92932467|NCT00756171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932468|NCT00756171|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92932469|NCT00718640|Dexamethasone|dexamethasone|mesh-list
92932470|NCT00718640|Bortezomib|bortezomib|mesh-list
92932471|NCT00718640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932472|NCT00718640|Antiemetics|antiemetics|mesh-ancestor
92932473|NCT00718640|Autonomic Agents|autonomic agents|mesh-ancestor
92932474|NCT00718640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932475|NCT00718640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932476|NCT00718640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932477|NCT00718640|Glucocorticoids|glucocorticoids|mesh-ancestor
92932478|NCT00718640|Hormones|hormones|mesh-ancestor
92932479|NCT00718640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932480|NCT00718640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932481|NCT00718640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932482|NCT00753051|Haloperidol|haloperidol|mesh-list
92932483|NCT00753051|Haloperidol decanoate|haloperidol decanoate|mesh-list
92932484|NCT00753051|Clozapine|clozapine|mesh-list
92932485|NCT00753051|Antiemetics|antiemetics|mesh-ancestor
92932486|NCT00753051|Autonomic Agents|autonomic agents|mesh-ancestor
92932487|NCT00753051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932488|NCT00753051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932489|NCT00753051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932490|NCT00753051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92932491|NCT00753051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92932492|NCT00753051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277345|NCT03717051|Nicotine|nicotine|mesh-list
92932493|NCT00753051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92932494|NCT00753051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92932495|NCT00753051|Dopamine Agents|dopamine agents|mesh-ancestor
92932496|NCT00753051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932497|NCT00753051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932498|NCT00753051|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92932499|NCT00753051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92932500|NCT00753051|Serotonin Agents|serotonin agents|mesh-ancestor
92932501|NCT00753051|GABA Antagonists|gaba antagonists|mesh-ancestor
92932502|NCT00753051|GABA Agents|gaba agents|mesh-ancestor
92932503|NCT00753207|Epirubicin|epirubicin|mesh-list
92932504|NCT00753207|Lapatinib|lapatinib|mesh-list
92932505|NCT00753207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92932506|NCT00753207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932507|NCT00753207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92932508|NCT00753207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92932509|NCT00753207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932510|NCT00753207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932511|NCT00753207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92932512|NCT00715910|Vaccines|vaccines|mesh-list
92932513|NCT00715910|Immunologic Factors|immunologic factors|mesh-ancestor
92932514|NCT00715910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932515|NCT00715676|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92932516|NCT00715676|Vitamins|vitamins|mesh-ancestor
92932517|NCT00715676|Micronutrients|micronutrients|mesh-ancestor
92577929|NCT00271336|Pentoxifylline|pentoxifylline|mesh-list
92932518|NCT00715676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932519|NCT00715676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92932520|NCT00718328|Simvastatin|simvastatin|mesh-list
92932521|NCT00718328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92932522|NCT00718328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92932523|NCT00718328|Antimetabolites|antimetabolites|mesh-ancestor
92932524|NCT00718328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932525|NCT00718328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92932526|NCT00718328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92932527|NCT00718328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932528|NCT02590874|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92932529|NCT02590874|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92932530|NCT02590874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932531|NCT02590874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932532|NCT02590874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932533|NCT02590874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932534|NCT02590874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932535|NCT02590874|Analgesics|analgesics|mesh-ancestor
92932536|NCT02590874|Sensory System Agents|sensory system agents|mesh-ancestor
92932537|NCT02590874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932538|NCT02590874|Antidepressive Agents|antidepressive agents|mesh-ancestor
92932539|NCT02590874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92932540|NCT02590874|Dopamine Agents|dopamine agents|mesh-ancestor
92932542|NCT00715520|Carbidopa|carbidopa|mesh-list
92932543|NCT00715520|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92932544|NCT00715520|Methylphenidate|methylphenidate|mesh-list
92932545|NCT00715520|Amphetamine|amphetamine|mesh-list
92932546|NCT00715520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92932547|NCT00715520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932548|NCT00715520|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92932549|NCT00715520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932550|NCT00715520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932551|NCT00715520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932552|NCT00715520|Dopamine Agents|dopamine agents|mesh-ancestor
92932553|NCT00715520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932554|NCT00715520|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92932555|NCT00715520|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92932556|NCT00715520|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92932557|NCT00715520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932558|NCT00715520|Sympathomimetics|sympathomimetics|mesh-ancestor
92932559|NCT00715520|Autonomic Agents|autonomic agents|mesh-ancestor
92932560|NCT00715520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932561|NCT00715520|Adrenergic Agents|adrenergic agents|mesh-ancestor
92932562|NCT00715520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92932563|NCT00715520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92932564|NCT00715520|Immunologic Factors|immunologic factors|mesh-ancestor
92932565|NCT00715520|Dopamine Agonists|dopamine agonists|mesh-ancestor
92932566|NCT00756873|Etoricoxib|etoricoxib|mesh-list
92932567|NCT00756873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932568|NCT00756873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932569|NCT00756873|Analgesics|analgesics|mesh-ancestor
92932570|NCT00756873|Sensory System Agents|sensory system agents|mesh-ancestor
92932571|NCT00756873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932572|NCT00756873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932573|NCT00756873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932574|NCT00756873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932575|NCT00756873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92932576|NCT00756873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92932577|NCT00756873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932578|NCT00756873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932579|NCT00790205|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92932580|NCT00790205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92932581|NCT00790205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932582|NCT00790205|Incretins|incretins|mesh-ancestor
92932583|NCT00790205|Hormones|hormones|mesh-ancestor
92932584|NCT00790205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932585|NCT00790205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92932586|NCT00790205|Protease Inhibitors|protease inhibitors|mesh-ancestor
92932587|NCT00790205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932588|NCT00790205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932589|NCT04056039|Colchicine|colchicine|mesh-list
92932590|NCT04056039|Atorvastatin|atorvastatin|mesh-list
92932591|NCT04056039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92932592|NCT04056039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92932593|NCT04056039|Antimetabolites|antimetabolites|mesh-ancestor
92932594|NCT04056039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932595|NCT04056039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92932596|NCT04056039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92932597|NCT04056039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932598|NCT04056039|Gout Suppressants|gout suppressants|mesh-ancestor
92932599|NCT04056039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932600|NCT04056039|Tubulin Modulators|tubulin modulators|mesh-ancestor
92932601|NCT04056039|Antimitotic Agents|antimitotic agents|mesh-ancestor
92932602|NCT04056039|Mitosis Modulators|mitosis modulators|mesh-ancestor
92932603|NCT04056039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932604|NCT00715208|Prednisone|prednisone|mesh-list
92932605|NCT00715208|Cyclophosphamide|cyclophosphamide|mesh-list
92932606|NCT00715208|Rituximab|rituximab|mesh-list
92932607|NCT00715208|Doxorubicin|doxorubicin|mesh-list
92932608|NCT00715208|Bortezomib|bortezomib|mesh-list
92932609|NCT00715208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932610|NCT00715208|Immunologic Factors|immunologic factors|mesh-ancestor
92932611|NCT00715208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932612|NCT00715208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932613|NCT00715208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92932614|NCT00715208|Alkylating Agents|alkylating agents|mesh-ancestor
92932615|NCT00715208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932616|NCT00715208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932617|NCT00715208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92932618|NCT00715208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92932619|NCT00715208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92932620|NCT00715208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92932621|NCT00715208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92932622|NCT00715208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932623|NCT00715208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932624|NCT00715208|Glucocorticoids|glucocorticoids|mesh-ancestor
92932625|NCT00715208|Hormones|hormones|mesh-ancestor
92932626|NCT00715208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932627|NCT00715208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932628|NCT00919178|Vaccines|vaccines|mesh-list
92932629|NCT00919178|Immunologic Factors|immunologic factors|mesh-ancestor
92932630|NCT00919178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932631|NCT02590250|Botulinum Toxins|botulinum toxins|mesh-list
92932632|NCT02590250|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92932633|NCT02590250|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92932634|NCT02590250|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92932635|NCT02590250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932636|NCT02590250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932637|NCT02590250|Cholinergic Agents|cholinergic agents|mesh-ancestor
92932638|NCT02590250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932639|NCT02590250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932640|NCT02590250|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92163956|NCT03009513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932641|NCT02590250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932642|NCT00775463|Treprostinil|treprostinil|mesh-list
92932643|NCT00775463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92932644|NCT02589782|Moxifloxacin|moxifloxacin|mesh-list
92932645|NCT02589782|Linezolid|linezolid|mesh-list
92932646|NCT02589782|Bedaquiline|bedaquiline|mesh-list
92932647|NCT02589782|Clofazimine|clofazimine|mesh-list
92932648|NCT02589782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92932649|NCT02589782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932650|NCT02589782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92932651|NCT02589782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92932652|NCT02589782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932653|NCT02589782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932654|NCT02589782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932655|NCT02589782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92932656|NCT02589782|Antitubercular Agents|antitubercular agents|mesh-ancestor
92932657|NCT02589782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932658|NCT02589782|Leprostatic Agents|leprostatic agents|mesh-ancestor
92932659|NCT00918554|Methotrexate|methotrexate|mesh-list
92932660|NCT00918554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92932661|NCT00918554|Abortifacient Agents|abortifacient agents|mesh-ancestor
92932662|NCT00918554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92578076|NCT00272935|Hormones|hormones|mesh-ancestor
92932663|NCT00918554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932664|NCT00918554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92932665|NCT00918554|Antimetabolites|antimetabolites|mesh-ancestor
92932666|NCT00918554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932667|NCT00918554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932668|NCT00918554|Dermatologic Agents|dermatologic agents|mesh-ancestor
92932669|NCT00918554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932670|NCT00918554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92932671|NCT00918554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932672|NCT00918554|Immunologic Factors|immunologic factors|mesh-ancestor
92932673|NCT00918554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932674|NCT00918554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92932675|NCT02590016|Insulin|insulin|mesh-list
92932676|NCT02590016|Insulin Aspart|insulin aspart|mesh-list
92932677|NCT02590016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92932678|NCT02590016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932679|NCT00768053|Etanercept|etanercept|mesh-list
92932680|NCT00768053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932681|NCT00768053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932682|NCT00768053|Analgesics|analgesics|mesh-ancestor
92932683|NCT00768053|Sensory System Agents|sensory system agents|mesh-ancestor
92932684|NCT00768053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932685|NCT00768053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932686|NCT00768053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932687|NCT00768053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932688|NCT00768053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932689|NCT00768053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932690|NCT00768053|Immunologic Factors|immunologic factors|mesh-ancestor
92932691|NCT00683475|Prednisone|prednisone|mesh-list
92932692|NCT00683475|Mitoxantrone|mitoxantrone|mesh-list
92932693|NCT00683475|Ramucirumab|ramucirumab|mesh-list
92932694|NCT00683475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92932695|NCT00683475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932696|NCT00683475|Glucocorticoids|glucocorticoids|mesh-ancestor
92932697|NCT00683475|Hormones|hormones|mesh-ancestor
92932698|NCT00683475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932699|NCT00683475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932700|NCT00683475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932701|NCT00683475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932703|NCT00683475|Sensory System Agents|sensory system agents|mesh-ancestor
92932704|NCT00683475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932705|NCT00683475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92932706|NCT00683475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92932707|NCT00683475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932708|NCT00683475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932709|NCT00683475|Immunologic Factors|immunologic factors|mesh-ancestor
92932710|NCT02589158|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92932711|NCT02589158|Darunavir|darunavir|mesh-list
92932712|NCT02589158|Cobicistat|cobicistat|mesh-list
92932713|NCT02589158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92932714|NCT02589158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92932715|NCT02589158|Protease Inhibitors|protease inhibitors|mesh-ancestor
92932716|NCT02589158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932717|NCT02589158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932718|NCT02589158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92932719|NCT02589158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92932720|NCT02589158|Antiviral Agents|antiviral agents|mesh-ancestor
92932721|NCT02589158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932722|NCT02589158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92932723|NCT02589158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92932724|NCT00916253|Modafinil|modafinil|mesh-list
92932725|NCT00916253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92932726|NCT00916253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932727|NCT00916253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92932728|NCT00916253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92932729|NCT00916253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92932730|NCT00916253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932731|NCT00757029|Norepinephrine|norepinephrine|mesh-list
92932732|NCT00757029|Methylphenidate|methylphenidate|mesh-list
92932733|NCT00757029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92932734|NCT00757029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932735|NCT00757029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92932736|NCT00757029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932737|NCT00757029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932738|NCT00757029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932739|NCT00757029|Dopamine Agents|dopamine agents|mesh-ancestor
92932740|NCT00757029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932741|NCT00757029|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92932742|NCT00757029|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92932743|NCT00757029|Adrenergic Agents|adrenergic agents|mesh-ancestor
92932744|NCT00757029|Sympathomimetics|sympathomimetics|mesh-ancestor
92932745|NCT00757029|Autonomic Agents|autonomic agents|mesh-ancestor
92932746|NCT00757029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932747|NCT00757029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92932748|NCT04101929|Irinotecan|irinotecan|mesh-list
92932749|NCT04101929|Apatinib|apatinib|mesh-list
92932750|NCT04101929|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92932751|NCT04101929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92932752|NCT04101929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932753|NCT04101929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932754|NCT04101929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932755|NCT04101929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92932756|NCT00918632|Axitinib|axitinib|mesh-list
92932757|NCT00918632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932758|NCT00918632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92932759|NCT00918632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932760|NCT00918632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932761|NCT00751257|Acetylcysteine|acetylcysteine|mesh-list
92932762|NCT00751257|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92932763|NCT00751257|Antiviral Agents|antiviral agents|mesh-ancestor
92932764|NCT00751257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932765|NCT00751257|Expectorants|expectorants|mesh-ancestor
92932766|NCT00751257|Respiratory System Agents|respiratory system agents|mesh-ancestor
92932767|NCT00751257|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92932768|NCT00751257|Antioxidants|antioxidants|mesh-ancestor
92932769|NCT00751257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932770|NCT00751257|Protective Agents|protective agents|mesh-ancestor
92932771|NCT00751257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932772|NCT00751257|Antidotes|antidotes|mesh-ancestor
92932773|NCT00757185|Methyltestosterone|methyltestosterone|mesh-list
92932774|NCT00757185|Testosterone|testosterone|mesh-list
92932775|NCT00757185|Testosterone undecanoate|testosterone undecanoate|mesh-list
92932776|NCT00757185|Testosterone enanthate|testosterone enanthate|mesh-list
92932777|NCT00757185|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92932778|NCT00757185|Ganirelix|ganirelix|mesh-list
92932779|NCT00757185|Androgens|androgens|mesh-ancestor
92932780|NCT00757185|Hormones|hormones|mesh-ancestor
92932781|NCT00757185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932782|NCT00757185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932783|NCT00757185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932784|NCT00757185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932785|NCT00757185|Anabolic Agents|anabolic agents|mesh-ancestor
92932786|NCT00757185|Hormone Antagonists|hormone antagonists|mesh-ancestor
92932787|NCT00751491|Clopidogrel|clopidogrel|mesh-list
92932788|NCT00751491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92932789|NCT00751491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92932790|NCT00751491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92932791|NCT00751491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92932792|NCT00751491|Purinergic Agents|purinergic agents|mesh-ancestor
92932793|NCT00751491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932794|NCT00751491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932795|NCT00751491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932796|NCT02561169|Oseltamivir|oseltamivir|mesh-list
92932797|NCT02561169|Calcium Carbonate|calcium carbonate|mesh-list
92932798|NCT02561169|Antiviral Agents|antiviral agents|mesh-ancestor
92932799|NCT02561169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932800|NCT02561169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932801|NCT02561169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932802|NCT02561169|Antacids|antacids|mesh-ancestor
92932803|NCT02561169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932804|NCT00753597|Rituximab|rituximab|mesh-list
92932805|NCT00753597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92932806|NCT00753597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932807|NCT00753597|Immunologic Factors|immunologic factors|mesh-ancestor
92932808|NCT00753597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932809|NCT00753597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932810|NCT00757419|Lesogaberan|lesogaberan|mesh-list
92932811|NCT00757419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932812|NCT00757419|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92932813|NCT00757419|GABA Agonists|gaba agonists|mesh-ancestor
92932814|NCT00757419|GABA Agents|gaba agents|mesh-ancestor
92932815|NCT00757419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932816|NCT00757419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932817|NCT00757419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932818|NCT00757731|Milnacipran|milnacipran|mesh-list
92932819|NCT00757731|Levomilnacipran|levomilnacipran|mesh-list
92932820|NCT00757731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92932821|NCT00757731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932822|NCT00757731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932823|NCT00757731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932824|NCT00757731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932825|NCT00757731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932826|NCT00757731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932827|NCT00757731|Analgesics|analgesics|mesh-ancestor
92932828|NCT00757731|Sensory System Agents|sensory system agents|mesh-ancestor
92932829|NCT00757731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932830|NCT00757731|Antidepressive Agents|antidepressive agents|mesh-ancestor
92932831|NCT00757731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92932832|NCT00753909|Paclitaxel|paclitaxel|mesh-list
92932833|NCT00753909|Bevacizumab|bevacizumab|mesh-list
92932834|NCT00753909|Carboplatin|carboplatin|mesh-list
92932835|NCT00753909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92932836|NCT00753909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932837|NCT00753909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92932838|NCT00753909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92932839|NCT00753909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92932840|NCT00753909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932841|NCT00753909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92932842|NCT00753909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92932843|NCT00753909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92932844|NCT00753909|Growth Substances|growth substances|mesh-ancestor
92932845|NCT00753909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932846|NCT00753909|Growth Inhibitors|growth inhibitors|mesh-ancestor
92932847|NCT02560155|Chlorhexidine|chlorhexidine|mesh-list
92932848|NCT02560155|Mupirocin|mupirocin|mesh-list
92932849|NCT02560155|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92932850|NCT02560155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932851|NCT02560155|Disinfectants|disinfectants|mesh-ancestor
92932852|NCT02560155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92932853|NCT02560155|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92932854|NCT02560155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932855|NCT02560155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932856|NCT02559921|Vaccines|vaccines|mesh-list
92932857|NCT02559921|Immunologic Factors|immunologic factors|mesh-ancestor
92932858|NCT02559921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932859|NCT00754143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92932860|NCT00754143|Immunologic Factors|immunologic factors|mesh-ancestor
92932861|NCT00754143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932862|NCT05266040|Valacyclovir|valacyclovir|mesh-list
92932863|NCT05266040|Antiviral Agents|antiviral agents|mesh-ancestor
92932864|NCT05266040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932865|NCT00773747|Bortezomib|bortezomib|mesh-list
92932866|NCT00773747|Vorinostat|vorinostat|mesh-list
92932867|NCT00773747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932868|NCT00773747|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92932869|NCT00773747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932870|NCT00773747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932871|NCT00784277|Oxycodone|oxycodone|mesh-list
92932872|NCT00784277|Tapentadol|tapentadol|mesh-list
92932873|NCT00784277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92932874|NCT00784277|Narcotics|narcotics|mesh-ancestor
92932875|NCT00784277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92932876|NCT00784277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932877|NCT00784277|Analgesics|analgesics|mesh-ancestor
92932878|NCT00784277|Sensory System Agents|sensory system agents|mesh-ancestor
92932879|NCT00784277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932880|NCT00784277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92932881|NCT00784277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92932882|NCT00784277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92932883|NCT00784277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932884|NCT00784277|Adrenergic Agents|adrenergic agents|mesh-ancestor
92932885|NCT00784277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932886|NCT05113784|Meplazumab|meplazumab|mesh-list
92932887|NCT05113784|Antiviral Agents|antiviral agents|mesh-ancestor
92932888|NCT05113784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578296|NCT00274495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92932889|NCT02588534|Etanercept|etanercept|mesh-list
92932890|NCT02588534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932892|NCT02588534|Analgesics|analgesics|mesh-ancestor
92932893|NCT02588534|Sensory System Agents|sensory system agents|mesh-ancestor
92932894|NCT02588534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932895|NCT02588534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932896|NCT02588534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932897|NCT02588534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932898|NCT02588534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932899|NCT02588534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932900|NCT02588534|Immunologic Factors|immunologic factors|mesh-ancestor
92932901|NCT05099276|Tranexamic Acid|tranexamic acid|mesh-list
92932902|NCT05099276|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92932903|NCT05099276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92932904|NCT05099276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932905|NCT05099276|Hemostatics|hemostatics|mesh-ancestor
92932906|NCT05099276|Coagulants|coagulants|mesh-ancestor
92932907|NCT00682929|Dronabinol|dronabinol|mesh-list
92932908|NCT00682929|Hallucinogens|hallucinogens|mesh-ancestor
92932909|NCT00682929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932910|NCT00682929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92932911|NCT00682929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932912|NCT00682929|Analgesics|analgesics|mesh-ancestor
92932913|NCT00682929|Sensory System Agents|sensory system agents|mesh-ancestor
92932914|NCT00682929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932915|NCT00682929|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92932916|NCT00682929|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92932917|NCT00682929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92932918|NCT00682929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932919|NCT00682929|Hormones|hormones|mesh-ancestor
92932920|NCT00682929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932921|NCT00758199|Moxifloxacin|moxifloxacin|mesh-list
92932922|NCT00758199|Prednisolone|prednisolone|mesh-list
92932923|NCT00758199|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92932924|NCT00758199|Methylprednisolone|methylprednisolone|mesh-list
92932925|NCT00758199|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92932926|NCT00758199|Prednisolone acetate|prednisolone acetate|mesh-list
92932927|NCT00758199|Bromfenac|bromfenac|mesh-list
92932928|NCT00758199|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92932929|NCT00758199|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92932930|NCT00758199|Prednisolone phosphate|prednisolone phosphate|mesh-list
92932931|NCT00758199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932932|NCT00758199|Glucocorticoids|glucocorticoids|mesh-ancestor
92932933|NCT00758199|Hormones|hormones|mesh-ancestor
92932934|NCT00758199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92932935|NCT00758199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932936|NCT00758199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92932937|NCT00758199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92932938|NCT00758199|Antiemetics|antiemetics|mesh-ancestor
92932939|NCT00758199|Autonomic Agents|autonomic agents|mesh-ancestor
92932940|NCT00758199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932941|NCT00758199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92932942|NCT00758199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92932943|NCT00758199|Protective Agents|protective agents|mesh-ancestor
92932944|NCT00758199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92932945|NCT00758199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92932946|NCT00758199|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92932947|NCT00758199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92932948|NCT00758199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932949|NCT00758199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932950|NCT00758199|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92932951|NCT00758199|Contraceptive Agents|contraceptive agents|mesh-ancestor
92932952|NCT00758199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92932953|NCT00758199|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92932954|NCT00758199|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92932955|NCT00758199|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92932956|NCT00758199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932957|NCT00758199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932958|NCT00758199|Analgesics|analgesics|mesh-ancestor
92932959|NCT00758199|Sensory System Agents|sensory system agents|mesh-ancestor
92932960|NCT00758199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932961|NCT05683808|Apixaban|apixaban|mesh-list
92932962|NCT05683808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92932963|NCT05683808|Antithrombins|antithrombins|mesh-ancestor
92932964|NCT05683808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92932965|NCT05683808|Protease Inhibitors|protease inhibitors|mesh-ancestor
92932966|NCT05683808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92932967|NCT05683808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932968|NCT05683808|Anticoagulants|anticoagulants|mesh-ancestor
92932969|NCT00680745|Metformin|metformin|mesh-list
92932970|NCT00680745|Pioglitazone|pioglitazone|mesh-list
92932971|NCT00680745|Dapagliflozin|dapagliflozin|mesh-list
92932972|NCT00680745|Glimepiride|glimepiride|mesh-list
92932973|NCT00680745|Rosiglitazone|rosiglitazone|mesh-list
92932974|NCT00680745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92932975|NCT00680745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932976|NCT00680745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92932977|NCT00680745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92932978|NCT00680745|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92932979|NCT00680745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92932980|NCT00680745|Immunologic Factors|immunologic factors|mesh-ancestor
92932981|NCT05434377|Vitamin D|vitamin d|mesh-list
92932982|NCT05434377|Ergocalciferols|ergocalciferols|mesh-list
92932983|NCT05434377|Vitamins|vitamins|mesh-ancestor
92932984|NCT05434377|Micronutrients|micronutrients|mesh-ancestor
92932985|NCT05434377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932986|NCT05434377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92932987|NCT05434377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92932988|NCT05428293|Acetaminophen|acetaminophen|mesh-list
92932989|NCT05428293|Ibuprofen|ibuprofen|mesh-list
92932990|NCT05428293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92932991|NCT05428293|Analgesics|analgesics|mesh-ancestor
92932992|NCT05428293|Sensory System Agents|sensory system agents|mesh-ancestor
92932993|NCT05428293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92932994|NCT05428293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92932995|NCT05428293|Antipyretics|antipyretics|mesh-ancestor
92932996|NCT05428293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92932997|NCT05428293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92932998|NCT05428293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92932999|NCT05428293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92933000|NCT05428293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933001|NCT05428293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933002|NCT05427825|Anesthetics|anesthetics|mesh-list
92933003|NCT05427825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933004|NCT05427825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933005|NCT00680121|Benphothiamine|benphothiamine|mesh-list
92933006|NCT00680121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92933007|NCT00680121|Immunologic Factors|immunologic factors|mesh-ancestor
92933008|NCT00680121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933009|NCT00680121|Chelating Agents|chelating agents|mesh-ancestor
92933010|NCT00680121|Sequestering Agents|sequestering agents|mesh-ancestor
92933011|NCT00680121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933012|NCT00754689|Metformin|metformin|mesh-list
92933013|NCT00754689|Rimonabant|rimonabant|mesh-list
92933014|NCT00754689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92933015|NCT00754689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933016|NCT00754689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92933017|NCT00754689|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92933018|NCT00754689|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92933019|NCT00754689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933020|NCT00754689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933021|NCT00754689|Hormones|hormones|mesh-ancestor
92933022|NCT00754689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933023|NCT00767819|Everolimus|everolimus|mesh-list
92933024|NCT00767819|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92933025|NCT00767819|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92933026|NCT00767819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933027|NCT00767819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933028|NCT00767819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933029|NCT00767819|Immunologic Factors|immunologic factors|mesh-ancestor
92933030|NCT00767819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933031|NCT00767819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933032|NCT00758277|Levetiracetam|levetiracetam|mesh-list
92933033|NCT00758277|Anticonvulsants|anticonvulsants|mesh-ancestor
92933034|NCT00758277|Nootropic Agents|nootropic agents|mesh-ancestor
92933035|NCT00584870|Naproxen|naproxen|mesh-list
92933036|NCT00584870|Tanezumab|tanezumab|mesh-list
92933037|NCT00584870|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92933038|NCT00584870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92933039|NCT00584870|Analgesics|analgesics|mesh-ancestor
92933040|NCT00584870|Sensory System Agents|sensory system agents|mesh-ancestor
92933041|NCT00584870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933042|NCT00584870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933043|NCT00584870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933044|NCT00584870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933045|NCT00584870|Gout Suppressants|gout suppressants|mesh-ancestor
92933046|NCT00584870|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92933047|NCT00584870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933048|NCT00584870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933049|NCT00679341|Docetaxel|docetaxel|mesh-list
92933050|NCT00679341|Trastuzumab|trastuzumab|mesh-list
92933051|NCT00679341|Maytansine|maytansine|mesh-list
92933052|NCT00679341|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92933053|NCT00679341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933054|NCT00679341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933055|NCT00679341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933056|NCT00679341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933057|NCT00679341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933058|NCT00679341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933059|NCT00679341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92933060|NCT00679341|Immunotoxins|immunotoxins|mesh-ancestor
92933061|NCT00679341|Immunoconjugates|immunoconjugates|mesh-ancestor
92933062|NCT00679341|Immunologic Factors|immunologic factors|mesh-ancestor
92933063|NCT00679341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933064|NCT00680043|Epoetin Alfa|epoetin alfa|mesh-list
92933065|NCT00680043|Hematinics|hematinics|mesh-ancestor
92933066|NCT05436093|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92933067|NCT05436093|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92933068|NCT05436093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163984|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
92933069|NCT05058092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92933070|NCT00682539|Triamcinolone|triamcinolone|mesh-list
92933071|NCT00682539|Bevacizumab|bevacizumab|mesh-list
92933072|NCT00682539|Ranibizumab|ranibizumab|mesh-list
92933073|NCT00682539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933074|NCT00682539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933075|NCT00682539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933076|NCT00682539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933077|NCT00682539|Growth Substances|growth substances|mesh-ancestor
92933078|NCT00682539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933079|NCT00682539|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933080|NCT00682539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933081|NCT00682539|Glucocorticoids|glucocorticoids|mesh-ancestor
92933082|NCT00682539|Hormones|hormones|mesh-ancestor
92933083|NCT00682539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933084|NCT00682461|Nicotine|nicotine|mesh-list
92933085|NCT00682461|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92933086|NCT00682461|Autonomic Agents|autonomic agents|mesh-ancestor
92933087|NCT00682461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933088|NCT00682461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933089|NCT00682461|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92933090|NCT00682461|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92933091|NCT00682461|Cholinergic Agents|cholinergic agents|mesh-ancestor
92933092|NCT00682461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933093|NCT00682461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933094|NCT00921765|Ketamine|ketamine|mesh-list
92933095|NCT00921765|Naloxone|naloxone|mesh-list
92933096|NCT00921765|Analgesics|analgesics|mesh-ancestor
92933097|NCT00921765|Sensory System Agents|sensory system agents|mesh-ancestor
92933098|NCT00921765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933099|NCT00921765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933100|NCT00921765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92933101|NCT00921765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92933102|NCT00921765|Anesthetics, General|anesthetics, general|mesh-ancestor
92933103|NCT00921765|Anesthetics|anesthetics|mesh-ancestor
92933104|NCT00921765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933105|NCT00921765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92933106|NCT00921765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92933107|NCT00921765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933108|NCT00921765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933109|NCT00921765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92933110|NCT05435781|Hydrocortisone|hydrocortisone|mesh-list
92933111|NCT05435781|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92933112|NCT05435781|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92933113|NCT05435781|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92933114|NCT05435781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933115|NCT00755157|Bevacizumab|bevacizumab|mesh-list
92933116|NCT00755157|Docetaxel|docetaxel|mesh-list
92933117|NCT00755157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933118|NCT00755157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933119|NCT00755157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933120|NCT00755157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933121|NCT00755157|Growth Substances|growth substances|mesh-ancestor
92933122|NCT00755157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933123|NCT00755157|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933124|NCT00755157|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933125|NCT00755157|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933126|NCT00755157|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933127|NCT00755157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933128|NCT00919880|Paclitaxel|paclitaxel|mesh-list
92933129|NCT00919880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92933130|NCT00919880|Carboplatin|carboplatin|mesh-list
92933131|NCT00919880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92933132|NCT00919880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933133|NCT00919880|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933134|NCT00919880|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933135|NCT00919880|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933136|NCT00919880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933137|NCT00755313|Cyclophosphamide|cyclophosphamide|mesh-list
92933138|NCT00755313|Carboplatin|carboplatin|mesh-list
92933139|NCT00755313|Docetaxel|docetaxel|mesh-list
92933140|NCT00755313|Doxorubicin|doxorubicin|mesh-list
92933141|NCT00755313|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92933142|NCT00755313|Trastuzumab|trastuzumab|mesh-list
92933143|NCT00755313|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92933144|NCT00755313|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92933145|NCT00755313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933146|NCT00755313|Immunologic Factors|immunologic factors|mesh-ancestor
92526474|NCT00028756|Vinblastine|vinblastine|mesh-list
92933147|NCT00755313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933148|NCT00755313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933149|NCT00755313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92933150|NCT00755313|Alkylating Agents|alkylating agents|mesh-ancestor
92933151|NCT00755313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933152|NCT00755313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933153|NCT00755313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92933154|NCT00755313|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933155|NCT00755313|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933156|NCT00755313|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933157|NCT00755313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92933158|NCT00755313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92933159|NCT00755313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92933160|NCT00755313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933161|NCT00755313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933162|NCT00755313|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92933163|NCT00755313|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92933164|NCT00755313|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92933165|NCT00755313|Hormone Antagonists|hormone antagonists|mesh-ancestor
92933166|NCT00755313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933168|NCT04082858|Ketamine|ketamine|mesh-list
92933169|NCT04082858|Analgesics|analgesics|mesh-ancestor
92933170|NCT04082858|Sensory System Agents|sensory system agents|mesh-ancestor
92933171|NCT04082858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933172|NCT04082858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933173|NCT04082858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92933174|NCT04082858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92933175|NCT04082858|Anesthetics, General|anesthetics, general|mesh-ancestor
92933176|NCT04082858|Anesthetics|anesthetics|mesh-ancestor
92933177|NCT04082858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933178|NCT04082858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92933179|NCT04082858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92933180|NCT04082858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933181|NCT04082858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933182|NCT04082858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92933183|NCT04082858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92933184|NCT04082858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92933185|NCT04082858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92933186|NCT04082858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92933187|NCT04082858|GABA Modulators|gaba modulators|mesh-ancestor
92933188|NCT04082858|GABA Agents|gaba agents|mesh-ancestor
92578596|NCT00108771|Anesthetics, General|anesthetics, general|mesh-ancestor
92933189|NCT00679029|Cyclophosphamide|cyclophosphamide|mesh-list
92933191|NCT00679029|Gemcitabine|gemcitabine|mesh-list
92933192|NCT00679029|Doxorubicin|doxorubicin|mesh-list
92933193|NCT00679029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92933194|NCT00679029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92933195|NCT00679029|Antibodies|antibodies|mesh-list
92933196|NCT00679029|Immunoglobulins|immunoglobulins|mesh-list
92933197|NCT00679029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92933198|NCT00679029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933199|NCT00679029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933200|NCT00679029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933201|NCT00679029|Immunologic Factors|immunologic factors|mesh-ancestor
92933202|NCT00679029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933203|NCT00679029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933204|NCT00679029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92933205|NCT00679029|Alkylating Agents|alkylating agents|mesh-ancestor
92933206|NCT00679029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92933207|NCT00679029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933208|NCT00679029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933209|NCT00679029|Growth Substances|growth substances|mesh-ancestor
92933210|NCT00679029|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933211|NCT00679029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933212|NCT00679029|Antimetabolites|antimetabolites|mesh-ancestor
92933213|NCT00679029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92933214|NCT00679029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92933215|NCT00679029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92933216|NCT00679029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933217|NCT00919022|Cyproterone Acetate|cyproterone acetate|mesh-list
92933218|NCT00919022|Cyproterone|cyproterone|mesh-list
92933219|NCT00919022|Androgen Antagonists|androgen antagonists|mesh-ancestor
92933220|NCT00919022|Hormone Antagonists|hormone antagonists|mesh-ancestor
92278084|NCT02300610|Cisplatin|cisplatin|mesh-list
92933221|NCT00919022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933222|NCT00919022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933223|NCT00919022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933224|NCT00919022|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92933225|NCT00919022|Contraceptive Agents|contraceptive agents|mesh-ancestor
92933226|NCT00919022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92933228|NCT05004350|Irinotecan|irinotecan|mesh-list
92933229|NCT05004350|Cetuximab|cetuximab|mesh-list
92933230|NCT05004350|Antimetabolites|antimetabolites|mesh-ancestor
92933231|NCT05004350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933232|NCT05004350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933233|NCT05004350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933234|NCT05004350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933235|NCT05004350|Immunologic Factors|immunologic factors|mesh-ancestor
92933236|NCT05004350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933237|NCT05004350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92933238|NCT05004350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92933239|NCT05004350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933240|NCT05004350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933241|NCT05122221|Cyclophosphamide|cyclophosphamide|mesh-list
92933242|NCT05122221|Fludarabine|fludarabine|mesh-list
92933243|NCT05122221|Interleukin-2|interleukin-2|mesh-list
92933244|NCT05122221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933245|NCT05122221|Immunologic Factors|immunologic factors|mesh-ancestor
92933246|NCT05122221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933247|NCT05122221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933248|NCT05122221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92933249|NCT05122221|Alkylating Agents|alkylating agents|mesh-ancestor
92933250|NCT05122221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933251|NCT05122221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933252|NCT05122221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92933253|NCT05122221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92933254|NCT05122221|Analgesics|analgesics|mesh-ancestor
92933255|NCT05122221|Sensory System Agents|sensory system agents|mesh-ancestor
92933256|NCT05122221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933257|NCT03802305|Anesthetics|anesthetics|mesh-list
92933258|NCT03802305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933259|NCT03802305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933260|NCT02587052|Tacrolimus|tacrolimus|mesh-list
92933261|NCT02587052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933262|NCT02587052|Immunologic Factors|immunologic factors|mesh-ancestor
92933263|NCT02587052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933264|NCT02587052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92933265|NCT02587052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933266|NCT02587052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933267|NCT02587130|Ketamine|ketamine|mesh-list
92933268|NCT02587130|Analgesics|analgesics|mesh-ancestor
92933269|NCT02587130|Sensory System Agents|sensory system agents|mesh-ancestor
92933270|NCT02587130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933271|NCT02587130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933272|NCT02587130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92933273|NCT02587130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92933274|NCT02587130|Anesthetics, General|anesthetics, general|mesh-ancestor
92933275|NCT02587130|Anesthetics|anesthetics|mesh-ancestor
92933276|NCT02587130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933277|NCT02587130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92933278|NCT02587130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92933279|NCT02587130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933280|NCT02587130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933281|NCT02559141|Dobutamine|dobutamine|mesh-list
92933282|NCT02559141|Norepinephrine|norepinephrine|mesh-list
92933283|NCT02559141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92933284|NCT02559141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92933285|NCT02559141|Adrenergic Agents|adrenergic agents|mesh-ancestor
92933286|NCT02559141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933287|NCT02559141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933288|NCT02559141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933289|NCT02559141|Sympathomimetics|sympathomimetics|mesh-ancestor
92933290|NCT02559141|Autonomic Agents|autonomic agents|mesh-ancestor
92526477|NCT00028756|Antimetabolites|antimetabolites|mesh-ancestor
92933291|NCT02559141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933292|NCT02559141|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92933293|NCT02559141|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92933294|NCT02559141|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92933295|NCT02559141|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92933296|NCT02559141|Protective Agents|protective agents|mesh-ancestor
92933298|NCT02561013|Antifungal Agents|antifungal agents|mesh-ancestor
92933299|NCT02561013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933300|NCT02561013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92933301|NCT02561013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92933302|NCT02561013|Coccidiostats|coccidiostats|mesh-ancestor
92933303|NCT02561013|Proton Ionophores|proton ionophores|mesh-ancestor
92933304|NCT02561013|Uncoupling Agents|uncoupling agents|mesh-ancestor
92933305|NCT02561013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933306|NCT02561013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933307|NCT02561013|Ionophores|ionophores|mesh-ancestor
92933308|NCT02561013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933309|NCT02561013|Sodium Ionophores|sodium ionophores|mesh-ancestor
92933310|NCT00678795|Nabiximols|nabiximols|mesh-list
92933311|NCT00678795|Analgesics|analgesics|mesh-ancestor
92933312|NCT00678795|Sensory System Agents|sensory system agents|mesh-ancestor
92933313|NCT00678795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933314|NCT00678795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933316|NCT03417687|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92933317|NCT03417687|Anesthetics, General|anesthetics, general|mesh-ancestor
92933318|NCT03417687|Anesthetics|anesthetics|mesh-ancestor
92933319|NCT03417687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933320|NCT03417687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933321|NCT04767698|Belimumab|belimumab|mesh-list
92933322|NCT04767698|Ocrelizumab|ocrelizumab|mesh-list
92933323|NCT04767698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933324|NCT04767698|Immunologic Factors|immunologic factors|mesh-ancestor
92933325|NCT04767698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933326|NCT04049253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92933327|NCT03205137|Amlodipine|amlodipine|mesh-list
92933328|NCT03205137|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92933329|NCT03205137|Telmisartan|telmisartan|mesh-list
92933330|NCT03205137|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92933331|NCT03205137|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92933332|NCT03205137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92933333|NCT03205137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92933334|NCT03205137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933335|NCT03205137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933336|NCT03205137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92933337|NCT03205137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933338|NCT03205137|Vasodilator Agents|vasodilator agents|mesh-ancestor
92933339|NCT03205137|Diuretics|diuretics|mesh-ancestor
92933340|NCT03205137|Natriuretic Agents|natriuretic agents|mesh-ancestor
92933341|NCT03205137|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92933342|NCT03205137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92933343|NCT03205137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92933344|NCT00678561|Tofacitinib|tofacitinib|mesh-list
92933345|NCT00678561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92933346|NCT00678561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92933347|NCT00678561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933348|NCT00678561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933349|NCT04732286|Bevacizumab|bevacizumab|mesh-list
92933350|NCT04732286|Atezolizumab|atezolizumab|mesh-list
92933351|NCT04732286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933352|NCT04732286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933353|NCT04732286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933354|NCT04732286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933355|NCT04732286|Growth Substances|growth substances|mesh-ancestor
92933356|NCT04732286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933357|NCT04732286|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933358|NCT04732286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92933359|NCT04732286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933360|NCT05683340|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92933361|NCT05683340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92933362|NCT05683340|Antimetabolites|antimetabolites|mesh-ancestor
92933363|NCT05683340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933364|NCT05683340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92933365|NCT05683340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933366|NCT05683340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92933367|NCT05683340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933368|NCT04081376|Hydromorphone|hydromorphone|mesh-list
92933369|NCT04081376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92933370|NCT04081376|Narcotics|narcotics|mesh-ancestor
92933371|NCT04081376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933372|NCT04081376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933373|NCT04081376|Analgesics|analgesics|mesh-ancestor
92933374|NCT04081376|Sensory System Agents|sensory system agents|mesh-ancestor
92933375|NCT04081376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933377|NCT02584400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933378|NCT02584400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933379|NCT04585022|Cimetidine|cimetidine|mesh-list
92933380|NCT04585022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92933381|NCT04585022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92933382|NCT04585022|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92933383|NCT04585022|Histamine Antagonists|histamine antagonists|mesh-ancestor
92933384|NCT04585022|Histamine Agents|histamine agents|mesh-ancestor
92933385|NCT04585022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933386|NCT04585022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933387|NCT04585022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933388|NCT04585022|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92933389|NCT04585022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92933390|NCT04585022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933391|NCT02586194|Peficitinib|peficitinib|mesh-list
92933392|NCT02586194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933393|NCT02586194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933394|NCT02586194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933395|NCT02586194|Immunologic Factors|immunologic factors|mesh-ancestor
92933396|NCT02586194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933397|NCT00761241|Interferons|interferons|mesh-list
92933398|NCT00761241|Interferon-alpha|interferon-alpha|mesh-list
92933399|NCT00761241|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92933400|NCT00761241|Gemcitabine|gemcitabine|mesh-list
92933401|NCT00761241|Docetaxel|docetaxel|mesh-list
92933402|NCT00761241|Oxaliplatin|oxaliplatin|mesh-list
92933403|NCT00761241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933404|NCT00761241|Antimetabolites|antimetabolites|mesh-ancestor
92933405|NCT00761241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933406|NCT00761241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933407|NCT00761241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933408|NCT00761241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933409|NCT00761241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933410|NCT00761241|Antiviral Agents|antiviral agents|mesh-ancestor
92933411|NCT00761241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933412|NCT00761241|Immunologic Factors|immunologic factors|mesh-ancestor
92578824|NCT00109356|AQ4N|aq4n|mesh-list
92933413|NCT00761241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933414|NCT02981979|Prednisone|prednisone|mesh-list
92933415|NCT02981979|Leflunomide|leflunomide|mesh-list
92933416|NCT02981979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933417|NCT02981979|Glucocorticoids|glucocorticoids|mesh-ancestor
92933418|NCT02981979|Hormones|hormones|mesh-ancestor
92933419|NCT02981979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933420|NCT02981979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933421|NCT02981979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92933422|NCT02981979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933423|NCT02981979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933424|NCT02981979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933425|NCT02981979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933426|NCT02981979|Immunologic Factors|immunologic factors|mesh-ancestor
92933427|NCT04049409|Trastuzumab|trastuzumab|mesh-list
92933428|NCT04049409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933429|NCT04049409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933430|NCT00920660|Prednisolone|prednisolone|mesh-list
92933431|NCT00920660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933432|NCT00920660|Glucocorticoids|glucocorticoids|mesh-ancestor
92933433|NCT00920660|Hormones|hormones|mesh-ancestor
92933434|NCT00920660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933435|NCT00920660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933436|NCT00920660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92933437|NCT00920660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933438|NCT02583464|Tenofovir|tenofovir|mesh-list
92933439|NCT02583464|Emtricitabine|emtricitabine|mesh-list
92933440|NCT02583464|Antiviral Agents|antiviral agents|mesh-ancestor
92933441|NCT02583464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933442|NCT02583464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92933443|NCT02583464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92933444|NCT02583464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933445|NCT02583464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933446|NCT02583464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92933447|NCT02583464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92933448|NCT00675597|Bevacizumab|bevacizumab|mesh-list
92933449|NCT00675597|Docetaxel|docetaxel|mesh-list
92933450|NCT00675597|Vinorelbine|vinorelbine|mesh-list
92933451|NCT00675597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933452|NCT00675597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933453|NCT00675597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933454|NCT00675597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933455|NCT00675597|Growth Substances|growth substances|mesh-ancestor
92933456|NCT00675597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933457|NCT00675597|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933458|NCT00675597|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933459|NCT00675597|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933460|NCT00675597|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933461|NCT00675597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933462|NCT00675597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92933463|NCT02677545|Aspirin|aspirin|mesh-list
92933464|NCT02677545|Clopidogrel|clopidogrel|mesh-list
92933465|NCT02677545|Ticagrelor|ticagrelor|mesh-list
92933466|NCT02677545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92933467|NCT02677545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92933468|NCT02677545|Analgesics|analgesics|mesh-ancestor
92933469|NCT02677545|Sensory System Agents|sensory system agents|mesh-ancestor
92933470|NCT02677545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933471|NCT02677545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933472|NCT02677545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933473|NCT02677545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933474|NCT02677545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92933475|NCT02677545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92933476|NCT02677545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933477|NCT02677545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92933478|NCT02677545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92933479|NCT02677545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933480|NCT02677545|Antipyretics|antipyretics|mesh-ancestor
92933481|NCT02677545|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92933482|NCT02677545|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92933483|NCT02677545|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92933484|NCT02677545|Purinergic Agents|purinergic agents|mesh-ancestor
92933485|NCT02677545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933486|NCT04079426|Dimercaprol|dimercaprol|mesh-list
92933487|NCT04079426|Chelating Agents|chelating agents|mesh-ancestor
92933488|NCT04079426|Sequestering Agents|sequestering agents|mesh-ancestor
92933489|NCT04079426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933490|NCT00675441|Lenalidomide|lenalidomide|mesh-list
92933491|NCT00675441|Immunologic Factors|immunologic factors|mesh-ancestor
92933492|NCT00675441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933493|NCT00675441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933494|NCT00675441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933495|NCT00675441|Growth Substances|growth substances|mesh-ancestor
92933496|NCT00675441|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933497|NCT00675441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933498|NCT02559297|Sevoflurane|sevoflurane|mesh-list
92933499|NCT02559297|Desflurane|desflurane|mesh-list
92933500|NCT02559297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92933501|NCT02559297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92933502|NCT02559297|Anesthetics, General|anesthetics, general|mesh-ancestor
92933503|NCT02559297|Anesthetics|anesthetics|mesh-ancestor
92933504|NCT02559297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933505|NCT02559297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933506|NCT02558517|Prednisone|prednisone|mesh-list
92933507|NCT02558517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933508|NCT02558517|Glucocorticoids|glucocorticoids|mesh-ancestor
92933509|NCT02558517|Hormones|hormones|mesh-ancestor
92933510|NCT02558517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933511|NCT02558517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933512|NCT02558517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92933513|NCT02558517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933514|NCT00674973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92933515|NCT00674973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933516|NCT00674973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92933517|NCT00674973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933518|NCT00674973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933519|NCT00673179|Leucovorin|leucovorin|mesh-list
92933520|NCT00673179|Gemcitabine|gemcitabine|mesh-list
92933521|NCT00673179|Doxorubicin|doxorubicin|mesh-list
92933522|NCT00673179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92933523|NCT00673179|Methotrexate|methotrexate|mesh-list
92933524|NCT00673179|Ifosfamide|ifosfamide|mesh-list
92933525|NCT00673179|Dexrazoxane|dexrazoxane|mesh-list
92933526|NCT00673179|Razoxane|razoxane|mesh-list
92933527|NCT00673179|Sargramostim|sargramostim|mesh-list
92933528|NCT00673179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933529|NCT00673179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933530|NCT00673179|Antimetabolites|antimetabolites|mesh-ancestor
92933531|NCT00673179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933532|NCT00673179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92933533|NCT00673179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92933534|NCT00673179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92933535|NCT00673179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933536|NCT00673179|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92933537|NCT00673179|Abortifacient Agents|abortifacient agents|mesh-ancestor
92933538|NCT00673179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92933539|NCT00673179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933540|NCT00673179|Dermatologic Agents|dermatologic agents|mesh-ancestor
92933541|NCT00673179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92933542|NCT00673179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933543|NCT00673179|Immunologic Factors|immunologic factors|mesh-ancestor
92933544|NCT00673179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933545|NCT00673179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92933546|NCT00673179|Antidotes|antidotes|mesh-ancestor
92933547|NCT00673179|Protective Agents|protective agents|mesh-ancestor
92933548|NCT00673179|Vitamin B Complex|vitamin b complex|mesh-ancestor
92933549|NCT00673179|Vitamins|vitamins|mesh-ancestor
92933550|NCT00673179|Micronutrients|micronutrients|mesh-ancestor
92933551|NCT00673179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92933552|NCT00673179|Alkylating Agents|alkylating agents|mesh-ancestor
92933553|NCT00673179|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92933554|NCT00673179|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933555|NCT00673179|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933556|NCT00758433|Capsaicin|capsaicin|mesh-list
92933557|NCT00758433|Antipruritics|antipruritics|mesh-ancestor
92933558|NCT00758433|Dermatologic Agents|dermatologic agents|mesh-ancestor
92933559|NCT00758433|Sensory System Agents|sensory system agents|mesh-ancestor
92933560|NCT00758433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933561|NCT00758433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933562|NCT00584012|Docetaxel|docetaxel|mesh-list
92933563|NCT00584012|Lovastatin|lovastatin|mesh-list
92933564|NCT00584012|L 647318|l 647318|mesh-list
92933565|NCT00584012|Dihydromevinolin|dihydromevinolin|mesh-list
92933566|NCT00584012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933567|NCT00584012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933568|NCT00584012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933569|NCT00584012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933570|NCT00584012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933571|NCT00584012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92933572|NCT00584012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92933573|NCT00584012|Antimetabolites|antimetabolites|mesh-ancestor
92933574|NCT00584012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92933575|NCT00584012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92933576|NCT00584012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933577|NCT05435846|Trametinib|trametinib|mesh-list
92933578|NCT05435846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933579|NCT05435846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92933580|NCT05435846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933581|NCT05435846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933582|NCT00920270|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92933583|NCT00920270|Colistin|colistin|mesh-list
92933584|NCT00920270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933585|NCT04078724|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92933586|NCT04078724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92933587|NCT04078724|Antidepressive Agents|antidepressive agents|mesh-ancestor
92933588|NCT04078724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92933589|NCT02585882|Fluorides|fluorides|mesh-list
92933590|NCT02585882|Cariostatic Agents|cariostatic agents|mesh-ancestor
92278470|NCT00378027|PENTA|penta|mesh-list
92933591|NCT02585882|Protective Agents|protective agents|mesh-ancestor
92933592|NCT02585882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933593|NCT02585648|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92933594|NCT02585648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92933595|NCT02584010|Silicon|silicon|mesh-list
92933596|NCT02584010|Trace Elements|trace elements|mesh-ancestor
92933597|NCT02584010|Micronutrients|micronutrients|mesh-ancestor
92933598|NCT02584010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933599|NCT02585804|Dapagliflozin|dapagliflozin|mesh-list
92933600|NCT02585804|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92933601|NCT02585804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933602|NCT02585804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92933603|NCT02585804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933604|NCT02582996|Acetaminophen|acetaminophen|mesh-list
92933605|NCT02582996|Dihydroergotamine|dihydroergotamine|mesh-list
92933606|NCT02582996|Metoclopramide|metoclopramide|mesh-list
92933607|NCT02582996|Caffeine|caffeine|mesh-list
92933608|NCT02582996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92933609|NCT02582996|Analgesics|analgesics|mesh-ancestor
92933610|NCT02582996|Sensory System Agents|sensory system agents|mesh-ancestor
92933611|NCT02582996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933612|NCT02582996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933613|NCT02582996|Antipyretics|antipyretics|mesh-ancestor
92933614|NCT02582996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92933615|NCT02582996|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92933616|NCT02582996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933617|NCT02582996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933618|NCT02582996|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92933619|NCT02582996|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92933620|NCT02582996|Purinergic Agents|purinergic agents|mesh-ancestor
92933621|NCT02582996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933622|NCT02582996|Antiemetics|antiemetics|mesh-ancestor
92933623|NCT02582996|Autonomic Agents|autonomic agents|mesh-ancestor
92933624|NCT02582996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92933625|NCT02582996|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92933626|NCT02582996|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92933627|NCT02582996|Dopamine Agents|dopamine agents|mesh-ancestor
92933628|NCT02582996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92933629|NCT02582996|Dopamine Agonists|dopamine agonists|mesh-ancestor
92933630|NCT02585570|Phenylephrine|phenylephrine|mesh-list
92933631|NCT02585570|Oxymetazoline|oxymetazoline|mesh-list
92933632|NCT02585570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92933633|NCT02585570|Mydriatics|mydriatics|mesh-ancestor
92933634|NCT02585570|Autonomic Agents|autonomic agents|mesh-ancestor
92933635|NCT02585570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933636|NCT02585570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933637|NCT02585570|Sympathomimetics|sympathomimetics|mesh-ancestor
92933638|NCT02585570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92933639|NCT02585570|Nasal Decongestants|nasal decongestants|mesh-ancestor
92579046|NCT00109941|Analgesics|analgesics|mesh-ancestor
92933640|NCT02585570|Respiratory System Agents|respiratory system agents|mesh-ancestor
92933641|NCT02585570|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92933642|NCT02585570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92933643|NCT02585570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92933644|NCT02585570|Adrenergic Agents|adrenergic agents|mesh-ancestor
92933645|NCT02585570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933646|NCT02585570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933647|NCT02585570|Protective Agents|protective agents|mesh-ancestor
92933648|NCT02583854|Hemostatics|hemostatics|mesh-list
92933649|NCT02583854|Coagulants|coagulants|mesh-ancestor
92933650|NCT00764907|Leucovorin|leucovorin|mesh-list
92933651|NCT00764907|Cytarabine|cytarabine|mesh-list
92933652|NCT00764907|Dexamethasone|dexamethasone|mesh-list
92933653|NCT00764907|Prednisone|prednisone|mesh-list
92933654|NCT00764907|Cyclophosphamide|cyclophosphamide|mesh-list
92933655|NCT00764907|Ifosfamide|ifosfamide|mesh-list
92933656|NCT00764907|Doxorubicin|doxorubicin|mesh-list
92933657|NCT00764907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92933658|NCT00764907|Methotrexate|methotrexate|mesh-list
92933659|NCT00764907|Etoposide|etoposide|mesh-list
92933660|NCT00764907|Vincristine|vincristine|mesh-list
92933661|NCT00764907|Daunorubicin|daunorubicin|mesh-list
92933662|NCT00764907|Asparaginase|asparaginase|mesh-list
92933663|NCT00764907|Mercaptopurine|mercaptopurine|mesh-list
92933664|NCT00764907|Thioguanine|thioguanine|mesh-list
92933665|NCT00764907|Vindesine|vindesine|mesh-list
92933666|NCT00764907|Levoleucovorin|levoleucovorin|mesh-list
92933667|NCT00764907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933668|NCT00764907|Immunologic Factors|immunologic factors|mesh-ancestor
92933669|NCT00764907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933670|NCT00764907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92933671|NCT00764907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92933672|NCT00764907|Alkylating Agents|alkylating agents|mesh-ancestor
92933673|NCT00764907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933674|NCT00764907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933675|NCT00764907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92933676|NCT00764907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933678|NCT00764907|Autonomic Agents|autonomic agents|mesh-ancestor
92933679|NCT00764907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933680|NCT00764907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92933681|NCT00764907|Glucocorticoids|glucocorticoids|mesh-ancestor
92933682|NCT00764907|Hormones|hormones|mesh-ancestor
92933683|NCT00764907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933684|NCT00764907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92933685|NCT00764907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92933686|NCT00764907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92933687|NCT00764907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92933688|NCT00764907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933689|NCT00764907|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92933690|NCT00764907|Abortifacient Agents|abortifacient agents|mesh-ancestor
92933691|NCT00764907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92933692|NCT00764907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933693|NCT00764907|Antimetabolites|antimetabolites|mesh-ancestor
92933694|NCT00764907|Dermatologic Agents|dermatologic agents|mesh-ancestor
92933695|NCT00764907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92933696|NCT00764907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92933697|NCT00764907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92933698|NCT00764907|Antiviral Agents|antiviral agents|mesh-ancestor
92933699|NCT00764907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933700|NCT00764907|Antidotes|antidotes|mesh-ancestor
92933701|NCT00764907|Protective Agents|protective agents|mesh-ancestor
92933702|NCT00764907|Vitamin B Complex|vitamin b complex|mesh-ancestor
92933703|NCT00764907|Vitamins|vitamins|mesh-ancestor
92933704|NCT00764907|Micronutrients|micronutrients|mesh-ancestor
92933705|NCT00764907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933706|NCT00764907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933707|NCT00764907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933708|NCT02583698|Carvedilol|carvedilol|mesh-list
92933709|NCT02583698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92933710|NCT02583698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92933711|NCT02583698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92933712|NCT02583698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933713|NCT02583698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933714|NCT02583698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933715|NCT02583698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92933716|NCT02583698|Antioxidants|antioxidants|mesh-ancestor
92933717|NCT02583698|Protective Agents|protective agents|mesh-ancestor
92933718|NCT02583698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92933719|NCT02583698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92234226|NCT00003334|Paclitaxel|paclitaxel|mesh-list
92933720|NCT02583698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92933721|NCT02583698|Vasodilator Agents|vasodilator agents|mesh-ancestor
92933722|NCT02583698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92933723|NCT02583698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92933724|NCT00762099|Pregabalin|pregabalin|mesh-list
92933725|NCT00762099|Analgesics|analgesics|mesh-ancestor
92933726|NCT00762099|Sensory System Agents|sensory system agents|mesh-ancestor
92933727|NCT00762099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933728|NCT00762099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933729|NCT00762099|Anticonvulsants|anticonvulsants|mesh-ancestor
92933730|NCT00762099|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92933731|NCT00762099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933732|NCT00762099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933733|NCT00762099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92933734|NCT00762099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92933735|NCT00762099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92933736|NCT00762099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933737|NCT00762099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92933738|NCT00762255|Bevacizumab|bevacizumab|mesh-list
92933739|NCT00762255|Irinotecan|irinotecan|mesh-list
92933740|NCT00762255|Vorinostat|vorinostat|mesh-list
92933741|NCT00762255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933742|NCT00762255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933743|NCT00762255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933744|NCT00762255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933745|NCT00762255|Growth Substances|growth substances|mesh-ancestor
92933746|NCT00762255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933747|NCT00762255|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933748|NCT00762255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92933749|NCT00762255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92933750|NCT00762255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933751|NCT00762255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933752|NCT00762255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92933753|NCT02585180|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92933754|NCT02585180|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92933755|NCT02585180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933756|NCT02557971|Botulinum Toxins|botulinum toxins|mesh-list
92933757|NCT02557971|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92933758|NCT02557971|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92933759|NCT02557971|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92933760|NCT02557971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933761|NCT02557971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933762|NCT02557971|Cholinergic Agents|cholinergic agents|mesh-ancestor
92933763|NCT02557971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933764|NCT02557971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933765|NCT02557971|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92933766|NCT02557971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933767|NCT05332730|Golimumab|golimumab|mesh-list
92933768|NCT05332730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92933769|NCT05332730|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92933770|NCT05332730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92933771|NCT05332730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92933772|NCT05332730|Immunologic Factors|immunologic factors|mesh-ancestor
92933773|NCT05332730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933774|NCT02581826|Silodosin|silodosin|mesh-list
92933775|NCT02581826|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92933776|NCT02581826|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92933777|NCT02581826|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92933778|NCT02581826|Adrenergic Agents|adrenergic agents|mesh-ancestor
92933779|NCT02581826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933780|NCT02581826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933781|NCT02581826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933782|NCT02581826|Urological Agents|urological agents|mesh-ancestor
92933783|NCT04340882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92933784|NCT04340882|Pembrolizumab|pembrolizumab|mesh-list
92933785|NCT04340882|Docetaxel|docetaxel|mesh-list
92933786|NCT04340882|Ramucirumab|ramucirumab|mesh-list
92933787|NCT04340882|Antibodies|antibodies|mesh-list
92933788|NCT04340882|Immunoglobulins|immunoglobulins|mesh-list
92933789|NCT04340882|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92933790|NCT04340882|Lexatumumab|lexatumumab|mesh-list
92933791|NCT04340882|Immunologic Factors|immunologic factors|mesh-ancestor
92933792|NCT04340882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579217|NCT00282061|Melatonin|melatonin|mesh-list
92933793|NCT04340882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933794|NCT04340882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933795|NCT04340882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933796|NCT04340882|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933797|NCT04340882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933798|NCT04340882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92933799|NCT00765921|Ranibizumab|ranibizumab|mesh-list
92933800|NCT00765921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933801|NCT00765921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933802|NCT00765921|Growth Substances|growth substances|mesh-ancestor
92933803|NCT00765921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933804|NCT00765921|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933805|NCT00765921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933806|NCT02583308|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92933807|NCT02583308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92933808|NCT02583308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92933809|NCT00672477|Methylnaltrexone|methylnaltrexone|mesh-list
92933810|NCT00672477|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92933811|NCT00672477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933812|NCT00672477|Sensory System Agents|sensory system agents|mesh-ancestor
92933813|NCT00672477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933814|NCT00766155|Capecitabine|capecitabine|mesh-list
92933815|NCT00766155|Oxaliplatin|oxaliplatin|mesh-list
92933816|NCT00766155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933817|NCT00766155|Antimetabolites|antimetabolites|mesh-ancestor
92933818|NCT00766155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933819|NCT00766155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933820|NCT00762567|Phenylephrine|phenylephrine|mesh-list
92933821|NCT00762567|Oxymetazoline|oxymetazoline|mesh-list
92933822|NCT00762567|Nasal Decongestants|nasal decongestants|mesh-list
92933823|NCT00762567|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92933824|NCT00762567|Mydriatics|mydriatics|mesh-ancestor
92933825|NCT00762567|Autonomic Agents|autonomic agents|mesh-ancestor
92933826|NCT00762567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933827|NCT00762567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933828|NCT00762567|Sympathomimetics|sympathomimetics|mesh-ancestor
92933829|NCT00762567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92933830|NCT00762567|Respiratory System Agents|respiratory system agents|mesh-ancestor
92933831|NCT00762567|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92933832|NCT00762567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92933833|NCT00762567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92933834|NCT00762567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92933835|NCT00762567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933836|NCT00762567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933837|NCT00762567|Protective Agents|protective agents|mesh-ancestor
92933838|NCT04338620|Paclitaxel|paclitaxel|mesh-list
92933839|NCT04338620|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92933840|NCT04338620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92933841|NCT04338620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933842|NCT04338620|Tubulin Modulators|tubulin modulators|mesh-ancestor
92933843|NCT04338620|Antimitotic Agents|antimitotic agents|mesh-ancestor
92933844|NCT04338620|Mitosis Modulators|mitosis modulators|mesh-ancestor
92933845|NCT04338620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933846|NCT00923234|Lenalidomide|lenalidomide|mesh-list
92933847|NCT00923234|Azacitidine|azacitidine|mesh-list
92933848|NCT00923234|Immunologic Factors|immunologic factors|mesh-ancestor
92933849|NCT00923234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933850|NCT00923234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92933851|NCT00923234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92933852|NCT00923234|Growth Substances|growth substances|mesh-ancestor
92933853|NCT00923234|Growth Inhibitors|growth inhibitors|mesh-ancestor
92933854|NCT00923234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933855|NCT00923234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92933856|NCT00923234|Antimetabolites|antimetabolites|mesh-ancestor
92933857|NCT00923234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933858|NCT00923234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933859|NCT00674661|Riboflavin|riboflavin|mesh-list
92933860|NCT00674661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92933861|NCT00674661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92933862|NCT00674661|Vitamin B Complex|vitamin b complex|mesh-ancestor
92933863|NCT00674661|Vitamins|vitamins|mesh-ancestor
92933864|NCT00674661|Micronutrients|micronutrients|mesh-ancestor
92164018|NCT01921361|Anesthetics|anesthetics|mesh-ancestor
92933865|NCT00674661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933866|NCT00674661|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92933867|NCT00674661|Dermatologic Agents|dermatologic agents|mesh-ancestor
92933868|NCT00766545|Cilostazol|cilostazol|mesh-list
92933869|NCT00766545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92933870|NCT00766545|Autonomic Agents|autonomic agents|mesh-ancestor
92933871|NCT00766545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933872|NCT00766545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933873|NCT00766545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92933874|NCT00766545|Respiratory System Agents|respiratory system agents|mesh-ancestor
92933875|NCT00766545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92933876|NCT00766545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92933877|NCT00766545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933878|NCT00766545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92933879|NCT00766545|Vasodilator Agents|vasodilator agents|mesh-ancestor
92933880|NCT00766545|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92933881|NCT00766545|Protective Agents|protective agents|mesh-ancestor
92933882|NCT00766545|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92933883|NCT00766545|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92933884|NCT00766545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933885|NCT02558205|Liver Extracts|liver extracts|mesh-list
92933886|NCT02558205|Hematinics|hematinics|mesh-ancestor
92933887|NCT02557737|Botulinum Toxins|botulinum toxins|mesh-list
92933888|NCT02557737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92933889|NCT02557737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92933890|NCT02557737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92933891|NCT02557737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933892|NCT02557737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933893|NCT02557737|Cholinergic Agents|cholinergic agents|mesh-ancestor
92933894|NCT02557737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933895|NCT02557737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933896|NCT02557737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92933897|NCT02557737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933898|NCT00766857|Insulin|insulin|mesh-list
92933899|NCT00766857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92933900|NCT00766857|Insulin Glargine|insulin glargine|mesh-list
92933901|NCT00766857|Exenatide|exenatide|mesh-list
92933902|NCT00766857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92933903|NCT00766857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933904|NCT00766857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92933905|NCT00766857|Incretins|incretins|mesh-ancestor
92933906|NCT00766857|Hormones|hormones|mesh-ancestor
92933907|NCT00766857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92933908|NCT02558283|Lidocaine|lidocaine|mesh-list
92933909|NCT02558283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92933910|NCT02558283|Anesthetics|anesthetics|mesh-ancestor
92933911|NCT02558283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933912|NCT02558283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933913|NCT02558283|Sensory System Agents|sensory system agents|mesh-ancestor
92933914|NCT02558283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933915|NCT02558283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92933916|NCT02558283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92933917|NCT02558283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92933918|NCT02558283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933919|NCT02558283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933920|NCT00767091|Rivastigmine|rivastigmine|mesh-list
92933921|NCT00767091|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92933922|NCT00767091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933923|NCT00767091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933924|NCT00767091|Cholinergic Agents|cholinergic agents|mesh-ancestor
92933925|NCT00767091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933926|NCT00767091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933927|NCT00767091|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92933928|NCT00767091|Protective Agents|protective agents|mesh-ancestor
92933929|NCT00767169|Ibandronic Acid|ibandronic acid|mesh-list
92933930|NCT00767169|Pamidronate|pamidronate|mesh-list
92933931|NCT00767169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92933932|NCT00767169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933933|NCT05256381|Pembrolizumab|pembrolizumab|mesh-list
92933934|NCT05256381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92933935|NCT05256381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92933936|NCT05256381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92933937|NCT05256381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933938|NCT00767481|Travoprost|travoprost|mesh-list
92933939|NCT00767481|Brinzolamide|brinzolamide|mesh-list
92933940|NCT00767481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92933941|NCT00767481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92933942|NCT00767481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933943|NCT00767481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933944|NCT00671931|Dexmedetomidine|dexmedetomidine|mesh-list
92933945|NCT00671931|Propofol|propofol|mesh-list
92933946|NCT00671931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92933947|NCT00671931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933948|NCT00671931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933949|NCT00671931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92933950|NCT00671931|Analgesics|analgesics|mesh-ancestor
92933951|NCT00671931|Sensory System Agents|sensory system agents|mesh-ancestor
92933952|NCT00671931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933953|NCT00671931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92933954|NCT00671931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92933955|NCT00671931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92933956|NCT00671931|Adrenergic Agents|adrenergic agents|mesh-ancestor
92933957|NCT00671931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933958|NCT00671931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933959|NCT00671931|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92933960|NCT00671931|Anesthetics, General|anesthetics, general|mesh-ancestor
92933961|NCT00671931|Anesthetics|anesthetics|mesh-ancestor
92933962|NCT00767559|PENTA|penta|mesh-list
92933963|NCT00767559|Warfarin|warfarin|mesh-list
92933964|NCT00767559|Fondaparinux|fondaparinux|mesh-list
92933965|NCT00767559|Anticoagulants|anticoagulants|mesh-ancestor
92933966|NCT00767559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92933967|NCT00767559|Antithrombins|antithrombins|mesh-ancestor
92933968|NCT00767559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92933969|NCT00767559|Protease Inhibitors|protease inhibitors|mesh-ancestor
92933970|NCT00767559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92933971|NCT00767559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933972|NCT00767559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92933973|NCT00767559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92933974|NCT00767715|Haloperidol|haloperidol|mesh-list
92933975|NCT00767715|Olanzapine|olanzapine|mesh-list
92933976|NCT00767715|Haloperidol decanoate|haloperidol decanoate|mesh-list
92933977|NCT00767715|Antiemetics|antiemetics|mesh-ancestor
92933978|NCT00767715|Autonomic Agents|autonomic agents|mesh-ancestor
92933979|NCT00767715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92933980|NCT00767715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933981|NCT00767715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92933982|NCT00767715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92933983|NCT00767715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92933984|NCT00767715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92933985|NCT00767715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92933986|NCT00767715|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92933987|NCT00767715|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92933988|NCT00767715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92933989|NCT00767715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92933990|NCT00767715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92933991|NCT00767715|Serotonin Agents|serotonin agents|mesh-ancestor
92933992|NCT00767715|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92933993|NCT00767715|Dopamine Agents|dopamine agents|mesh-ancestor
92933994|NCT00767715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92933995|NCT00762957|Metformin|metformin|mesh-list
92933996|NCT00762957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92933997|NCT00762957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92933998|NCT00759993|Chromium|chromium|mesh-list
92933999|NCT00759993|Trace Elements|trace elements|mesh-ancestor
92934000|NCT00759993|Micronutrients|micronutrients|mesh-ancestor
92934001|NCT00759993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934002|NCT00673881|Choline|choline|mesh-list
92934003|NCT00673881|Fenofibrate|fenofibrate|mesh-list
92934004|NCT00673881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92934005|NCT00673881|Antimetabolites|antimetabolites|mesh-ancestor
92934006|NCT00673881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934007|NCT00673881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92934008|NCT00673881|Lipotropic Agents|lipotropic agents|mesh-ancestor
92934009|NCT00673881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934010|NCT00673881|Nootropic Agents|nootropic agents|mesh-ancestor
92934011|NCT00763347|Alogliptin|alogliptin|mesh-list
92934012|NCT00763347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934013|NCT00763347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934014|NCT00763347|Incretins|incretins|mesh-ancestor
92934015|NCT00763347|Hormones|hormones|mesh-ancestor
92934016|NCT00763347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934017|NCT00763347|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92934018|NCT00763347|Protease Inhibitors|protease inhibitors|mesh-ancestor
92934019|NCT00763347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934020|NCT00763347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934021|NCT00767871|Escitalopram|escitalopram|mesh-list
92934022|NCT00767871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92934023|NCT00767871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92934024|NCT00767871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92934025|NCT00767871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934026|NCT00767871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934028|NCT00767871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934029|NCT00760149|Rifampin|rifampin|mesh-list
92934030|NCT00760149|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92934031|NCT00760149|Antitubercular Agents|antitubercular agents|mesh-ancestor
92934032|NCT00760149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92934033|NCT00760149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934034|NCT00760149|Leprostatic Agents|leprostatic agents|mesh-ancestor
92934035|NCT00760149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92934036|NCT00760149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934037|NCT00760149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934038|NCT00760149|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92934039|NCT00760149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92934040|NCT00760149|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92934041|NCT00760149|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92934042|NCT00760149|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92934043|NCT00760149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92934044|NCT00671853|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92934045|NCT00671853|Antidepressive Agents|antidepressive agents|mesh-ancestor
92934046|NCT00671853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92934047|NCT00671853|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92934048|NCT00671853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92934049|NCT00671853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934050|NCT00671853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934051|NCT00768183|Ethanol|ethanol|mesh-list
92934052|NCT00768183|Morphine|morphine|mesh-list
92934053|NCT00768183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92934054|NCT00768183|Narcotics|narcotics|mesh-ancestor
92934055|NCT00768183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934056|NCT00768183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934057|NCT00768183|Analgesics|analgesics|mesh-ancestor
92934058|NCT00768183|Sensory System Agents|sensory system agents|mesh-ancestor
92934059|NCT00768183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934060|NCT00768183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92934061|NCT00768183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934062|NCT02557581|Terbutaline|terbutaline|mesh-list
92934063|NCT02557581|Clenbuterol|clenbuterol|mesh-list
92934064|NCT02557581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92934065|NCT02557581|Autonomic Agents|autonomic agents|mesh-ancestor
92934066|NCT02557581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934067|NCT02557581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934068|NCT02557581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92934069|NCT02557581|Respiratory System Agents|respiratory system agents|mesh-ancestor
92934070|NCT02557581|Sympathomimetics|sympathomimetics|mesh-ancestor
92934071|NCT02557581|Tocolytic Agents|tocolytic agents|mesh-ancestor
92934072|NCT02557581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92934073|NCT02557581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92934074|NCT02557581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92934075|NCT02557581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92934076|NCT02557581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92934077|NCT02557581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934078|NCT02557581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934079|NCT04077944|Trace Elements|trace elements|mesh-list
92934080|NCT04077944|Micronutrients|micronutrients|mesh-list
92934081|NCT04077944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934082|NCT02558751|Vaccines|vaccines|mesh-list
92934083|NCT02558751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92934084|NCT02558751|Immunologic Factors|immunologic factors|mesh-ancestor
92934085|NCT02558751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934086|NCT00768573|Sildenafil Citrate|sildenafil citrate|mesh-list
92934087|NCT00768573|Vasodilator Agents|vasodilator agents|mesh-ancestor
92934088|NCT00768573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92934089|NCT00768573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92934090|NCT00768573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934091|NCT00768573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934092|NCT00768573|Urological Agents|urological agents|mesh-ancestor
92934093|NCT02558361|Apremilast|apremilast|mesh-list
92526502|NCT00012324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92934094|NCT02558361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92934095|NCT02558361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934096|NCT02558361|Analgesics|analgesics|mesh-ancestor
92934097|NCT02558361|Sensory System Agents|sensory system agents|mesh-ancestor
92934098|NCT02558361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934099|NCT02558361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934100|NCT02558361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934101|NCT02558361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934102|NCT02558361|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92934103|NCT02558361|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92934104|NCT02558361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934105|NCT02558361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934106|NCT02558595|Niacinamide|niacinamide|mesh-list
92934108|NCT02558595|Nicotinic Acids|nicotinic acids|mesh-list
92934109|NCT02558595|Vitamins|vitamins|mesh-ancestor
92934110|NCT02558595|Micronutrients|micronutrients|mesh-ancestor
92934111|NCT02558595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934112|NCT02558595|Vitamin B Complex|vitamin b complex|mesh-ancestor
92934113|NCT02558595|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92934114|NCT02558595|Antimetabolites|antimetabolites|mesh-ancestor
92934115|NCT02558595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934116|NCT02558595|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92934117|NCT02558595|Vasodilator Agents|vasodilator agents|mesh-ancestor
92934118|NCT00760695|Dronabinol|dronabinol|mesh-list
92934119|NCT00760695|Hallucinogens|hallucinogens|mesh-ancestor
92934120|NCT00760695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934121|NCT00760695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92934122|NCT00760695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934123|NCT00760695|Analgesics|analgesics|mesh-ancestor
92934124|NCT00760695|Sensory System Agents|sensory system agents|mesh-ancestor
92934125|NCT00760695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934126|NCT00760695|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92934127|NCT00760695|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92934128|NCT00760695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934129|NCT00760695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934130|NCT00760695|Hormones|hormones|mesh-ancestor
92934131|NCT00760695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934132|NCT02582372|Fentanyl|fentanyl|mesh-list
92934133|NCT02582372|Dexmedetomidine|dexmedetomidine|mesh-list
92934134|NCT02582372|Bupivacaine|bupivacaine|mesh-list
92934135|NCT02582372|Anesthetics, Local|anesthetics, local|mesh-ancestor
92934136|NCT02582372|Anesthetics|anesthetics|mesh-ancestor
92934137|NCT02582372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934138|NCT02582372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934139|NCT02582372|Sensory System Agents|sensory system agents|mesh-ancestor
92934140|NCT02582372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934141|NCT02582372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92934142|NCT02582372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934143|NCT02582372|Analgesics|analgesics|mesh-ancestor
92934144|NCT02582372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92934145|NCT02582372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92934146|NCT02582372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92934147|NCT02582372|Adrenergic Agents|adrenergic agents|mesh-ancestor
92934148|NCT02582372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934149|NCT02582372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934150|NCT02582372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92934151|NCT02582372|Narcotics|narcotics|mesh-ancestor
92934152|NCT02582372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92934153|NCT02582372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92934154|NCT02582372|Anesthetics, General|anesthetics, general|mesh-ancestor
92934155|NCT00768729|Sirolimus|sirolimus|mesh-list
92934156|NCT00768729|Azathioprine|azathioprine|mesh-list
92934157|NCT00768729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92934158|NCT00768729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934159|NCT00768729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92934160|NCT00768729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934161|NCT00768729|Antifungal Agents|antifungal agents|mesh-ancestor
92934162|NCT00768729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934163|NCT00768729|Immunologic Factors|immunologic factors|mesh-ancestor
92934164|NCT00768729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934165|NCT00768729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934166|NCT00768729|Antimetabolites|antimetabolites|mesh-ancestor
92934167|NCT00768729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92934168|NCT00768729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934169|NCT00768963|Ranibizumab|ranibizumab|mesh-list
92934170|NCT00768963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92934171|NCT00768963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92934172|NCT00768963|Growth Substances|growth substances|mesh-ancestor
92934173|NCT00768963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934174|NCT00768963|Growth Inhibitors|growth inhibitors|mesh-ancestor
92934175|NCT00768963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934176|NCT00769041|Moxifloxacin|moxifloxacin|mesh-list
92934177|NCT00769041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92934178|NCT00769041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934179|NCT00769041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92934180|NCT00769041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92934181|NCT00769041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934182|NCT00769041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934183|NCT00769041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934184|NCT00770445|Insulin|insulin|mesh-list
92934185|NCT00770445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92934186|NCT00770445|Metformin|metformin|mesh-list
92934187|NCT00770445|Pioglitazone|pioglitazone|mesh-list
92934188|NCT00770445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934189|NCT00770445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934190|NCT04077398|Ropivacaine|ropivacaine|mesh-list
92934191|NCT04077398|Anesthetics, Local|anesthetics, local|mesh-ancestor
92934192|NCT04077398|Anesthetics|anesthetics|mesh-ancestor
92934193|NCT04077398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934194|NCT04077398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934195|NCT04077398|Sensory System Agents|sensory system agents|mesh-ancestor
92934196|NCT04077398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934197|NCT04239716|Anesthetics|anesthetics|mesh-list
92934198|NCT04239716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934199|NCT04239716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934200|NCT04048707|Octreotide|octreotide|mesh-list
92934201|NCT04048707|Midodrine|midodrine|mesh-list
92934202|NCT04048707|Angiotensin II|angiotensin ii|mesh-list
92934203|NCT04048707|Giapreza|giapreza|mesh-list
92934204|NCT04048707|Angiotensinogen|angiotensinogen|mesh-list
92934205|NCT04048707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934206|NCT04048707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92934207|NCT04048707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934208|NCT04048707|Sympathomimetics|sympathomimetics|mesh-ancestor
92934209|NCT04048707|Autonomic Agents|autonomic agents|mesh-ancestor
92934210|NCT04048707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934211|NCT04048707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934212|NCT04048707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92934213|NCT04048707|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92934214|NCT04048707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92934215|NCT04048707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92934216|NCT04048707|Adrenergic Agents|adrenergic agents|mesh-ancestor
92934217|NCT04048707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934218|NCT04048707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934219|NCT04048707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92934220|NCT04048707|Protease Inhibitors|protease inhibitors|mesh-ancestor
92934221|NCT04048707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934222|NCT00763893|Losartan|losartan|mesh-list
92934223|NCT00763893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92934224|NCT00763893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92934225|NCT00763893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92934226|NCT00763893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92934227|NCT00763893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934228|NCT00770835|Metformin|metformin|mesh-list
92934229|NCT00770835|Pioglitazone|pioglitazone|mesh-list
92934230|NCT00770835|Glyburide|glyburide|mesh-list
92934231|NCT00770835|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934232|NCT00770835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934233|NCT00769587|Thalidomide|thalidomide|mesh-list
92934234|NCT00769587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934235|NCT00769587|Immunologic Factors|immunologic factors|mesh-ancestor
92934236|NCT00769587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934237|NCT00769587|Leprostatic Agents|leprostatic agents|mesh-ancestor
92934238|NCT00769587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92934239|NCT00769587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934240|NCT00769587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92934241|NCT00769587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92934242|NCT00769587|Growth Substances|growth substances|mesh-ancestor
92934243|NCT00769587|Growth Inhibitors|growth inhibitors|mesh-ancestor
92934244|NCT00769587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934245|NCT00570921|Everolimus|everolimus|mesh-list
92934246|NCT00570921|Fulvestrant|fulvestrant|mesh-list
92934247|NCT00570921|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92934248|NCT00570921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92934249|NCT00570921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934250|NCT00570921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934251|NCT00570921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934252|NCT00570921|Immunologic Factors|immunologic factors|mesh-ancestor
92934253|NCT00570921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934254|NCT00570921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934255|NCT00570921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92934256|NCT00570921|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92934257|NCT00570921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92934258|NCT00570921|Hormone Antagonists|hormone antagonists|mesh-ancestor
92934259|NCT00570921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934260|NCT04076930|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92934261|NCT04076930|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92934262|NCT04076930|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92934263|NCT04076930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934264|NCT04076930|Protease Inhibitors|protease inhibitors|mesh-ancestor
92934265|NCT04048317|Doxorubicin|doxorubicin|mesh-list
92934266|NCT04048317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92934267|NCT04048317|Ethiodized Oil|ethiodized oil|mesh-list
92934268|NCT04048317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92934269|NCT04048317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934270|NCT04048317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92934271|NCT04048317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92934272|NCT04048317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934273|NCT04048317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934274|NCT04353986|Sofosbuvir|sofosbuvir|mesh-list
92934275|NCT04353986|Ledipasvir|ledipasvir|mesh-list
92934276|NCT04353986|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92934277|NCT04353986|Antiviral Agents|antiviral agents|mesh-ancestor
92934278|NCT04353986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934279|NCT00670449|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92934280|NCT00670449|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92934281|NCT00670449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934282|NCT00670449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934283|NCT00670449|Immunologic Factors|immunologic factors|mesh-ancestor
92934284|NCT00670449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934285|NCT00771147|Sorafenib|sorafenib|mesh-list
92934286|NCT00771147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934287|NCT00771147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92934288|NCT00771147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934289|NCT00771147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934290|NCT04155710|Interleukin-2|interleukin-2|mesh-list
92934291|NCT04155710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934292|NCT04155710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934293|NCT04155710|Analgesics|analgesics|mesh-ancestor
92934294|NCT04155710|Sensory System Agents|sensory system agents|mesh-ancestor
92934295|NCT04155710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934296|NCT04155710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934297|NCT00775047|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92934298|NCT00775047|Medroxyprogesterone|medroxyprogesterone|mesh-list
92934299|NCT00775047|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92934300|NCT00775047|Contraceptive Agents|contraceptive agents|mesh-ancestor
92934301|NCT00775047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92934302|NCT00775047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934303|NCT00775047|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92934304|NCT00775047|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92934305|NCT00775047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92934306|NCT00775047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934307|NCT00775047|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92934308|NCT00775047|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92934309|NCT00775047|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92934310|NCT00775125|Ritonavir|ritonavir|mesh-list
92934311|NCT00775125|Darunavir|darunavir|mesh-list
92934312|NCT00775125|Fosamprenavir|fosamprenavir|mesh-list
92934313|NCT00775125|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92934314|NCT00775125|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92934315|NCT00775125|Protease Inhibitors|protease inhibitors|mesh-ancestor
92934316|NCT00775125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934317|NCT00775125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934318|NCT00775125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92934319|NCT00775125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92934320|NCT00775125|Antiviral Agents|antiviral agents|mesh-ancestor
92934321|NCT00775125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934322|NCT00775125|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92934323|NCT00775125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92934325|NCT02557503|Oxaliplatin|oxaliplatin|mesh-list
92934326|NCT02557503|Antimetabolites|antimetabolites|mesh-ancestor
92934327|NCT02557503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934328|NCT02557503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92934329|NCT02557503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934330|NCT02557503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934331|NCT02557503|Immunologic Factors|immunologic factors|mesh-ancestor
92934332|NCT02557503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934333|NCT00764439|Nicotine|nicotine|mesh-list
92934334|NCT00764439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92934335|NCT00764439|Autonomic Agents|autonomic agents|mesh-ancestor
92934336|NCT00764439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934337|NCT00764439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934338|NCT00764439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92934339|NCT00764439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92934340|NCT00764439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92934341|NCT00764439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934342|NCT00764439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934343|NCT00771303|Fibrin fragment D|fibrin fragment d|mesh-list
92934344|NCT00771303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92934345|NCT00771303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92934346|NCT00771303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934347|NCT00771303|Hemostatics|hemostatics|mesh-ancestor
92934348|NCT00771303|Coagulants|coagulants|mesh-ancestor
92934349|NCT05674526|Cetuximab|cetuximab|mesh-list
92934350|NCT05674526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934351|NCT05674526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934352|NCT00771381|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92934353|NCT00771381|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92934354|NCT00771381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934355|NCT00771459|Ropivacaine|ropivacaine|mesh-list
92934356|NCT00771459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92934357|NCT00771459|Anesthetics|anesthetics|mesh-ancestor
92934358|NCT00771459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934359|NCT00771459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934360|NCT00771459|Sensory System Agents|sensory system agents|mesh-ancestor
92934361|NCT00771459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934362|NCT00775359|Fenofibrate|fenofibrate|mesh-list
92934363|NCT00775359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92934364|NCT00775359|Antimetabolites|antimetabolites|mesh-ancestor
92934365|NCT00775359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934366|NCT00775359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92934367|NCT05338502|Omeprazole|omeprazole|mesh-list
92934368|NCT05338502|Ranitidine|ranitidine|mesh-list
92934369|NCT05338502|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92934370|NCT05338502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92934371|NCT05338502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934372|NCT05338502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92934373|NCT05338502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934374|NCT05338502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934375|NCT05338502|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92934376|NCT05338502|Histamine Antagonists|histamine antagonists|mesh-ancestor
92934377|NCT05338502|Histamine Agents|histamine agents|mesh-ancestor
92934378|NCT05338502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934379|NCT05338502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934381|NCT02557269|Azelastine|azelastine|mesh-list
92934382|NCT02557269|Prednisolone|prednisolone|mesh-list
92934383|NCT02557269|Xylometazoline|xylometazoline|mesh-list
92934384|NCT02557269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934385|NCT02557269|Glucocorticoids|glucocorticoids|mesh-ancestor
92934386|NCT02557269|Hormones|hormones|mesh-ancestor
92934387|NCT02557269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934388|NCT02557269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934389|NCT02557269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92934390|NCT02557269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934391|NCT02557269|Autonomic Agents|autonomic agents|mesh-ancestor
92934392|NCT02557269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934393|NCT02557269|Dermatologic Agents|dermatologic agents|mesh-ancestor
92934394|NCT02557269|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92934395|NCT02557269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92934396|NCT02557269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92934397|NCT02557269|Respiratory System Agents|respiratory system agents|mesh-ancestor
92934398|NCT02557269|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92934399|NCT02557269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934400|NCT02557269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934401|NCT02557269|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92934402|NCT02557269|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92934403|NCT02557269|Histamine Antagonists|histamine antagonists|mesh-ancestor
92934404|NCT02557269|Histamine Agents|histamine agents|mesh-ancestor
92934405|NCT02557269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934406|NCT02557269|Nasal Decongestants|nasal decongestants|mesh-ancestor
92934407|NCT02557269|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92934408|NCT02556411|Levonorgestrel|levonorgestrel|mesh-list
92934409|NCT02556411|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92934410|NCT02556411|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92934411|NCT02556411|Contraceptive Agents|contraceptive agents|mesh-ancestor
92934412|NCT02556411|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92934413|NCT02556411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934414|NCT02556411|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92934415|NCT02556411|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92934416|NCT02556411|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92934417|NCT02556411|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92934418|NCT02556411|Estrogens|estrogens|mesh-ancestor
92934419|NCT02556411|Hormones|hormones|mesh-ancestor
92934420|NCT02556411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934421|NCT04085276|Paclitaxel|paclitaxel|mesh-list
92934422|NCT04085276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92934423|NCT04085276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92934424|NCT04085276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934425|NCT04085276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92934426|NCT04085276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92934427|NCT04085276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92934428|NCT04085276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934429|NCT00775827|Fenofibrate|fenofibrate|mesh-list
92934430|NCT00775827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92934431|NCT00775827|Antimetabolites|antimetabolites|mesh-ancestor
92934432|NCT00775827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934433|NCT00775827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92934434|NCT00775905|Amlodipine|amlodipine|mesh-list
92934435|NCT00775905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92934436|NCT00775905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92934437|NCT00775905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92934438|NCT00775905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934439|NCT00775905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92934440|NCT00775905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934441|NCT00775905|Vasodilator Agents|vasodilator agents|mesh-ancestor
92934442|NCT00772161|Methylphenidate|methylphenidate|mesh-list
92934443|NCT00772161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92934444|NCT00772161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934445|NCT00772161|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92934446|NCT00772161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92934447|NCT00772161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92934448|NCT00772161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934449|NCT00772161|Dopamine Agents|dopamine agents|mesh-ancestor
92934450|NCT00772161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934451|NCT00776139|Cetirizine|cetirizine|mesh-list
92934452|NCT00776139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92934453|NCT00776139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92934454|NCT00776139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92934455|NCT00776139|Histamine Antagonists|histamine antagonists|mesh-ancestor
92934456|NCT00776139|Histamine Agents|histamine agents|mesh-ancestor
92934457|NCT00776139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934458|NCT00776139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934459|NCT00776139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934460|NCT00779493|Curcumin|curcumin|mesh-list
92934461|NCT00779493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934462|NCT00779493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92934463|NCT00779493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934464|NCT00779493|Analgesics|analgesics|mesh-ancestor
92934465|NCT00779493|Sensory System Agents|sensory system agents|mesh-ancestor
92934466|NCT00779493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579866|NCT00111189|Dopamine Agents|dopamine agents|mesh-ancestor
92934467|NCT00779493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934468|NCT00779493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934469|NCT00779493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934470|NCT00779493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934471|NCT00779493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934472|NCT02580344|Ibuprofen|ibuprofen|mesh-list
92934473|NCT02580344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92934474|NCT02580344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934475|NCT02580344|Analgesics|analgesics|mesh-ancestor
92934476|NCT02580344|Sensory System Agents|sensory system agents|mesh-ancestor
92934477|NCT02580344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934478|NCT02580344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934479|NCT02580344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934480|NCT02580344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934481|NCT02580344|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92934482|NCT02580344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934483|NCT02580344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934484|NCT00779649|Bisacodyl|bisacodyl|mesh-list
92934485|NCT00779649|Cathartics|cathartics|mesh-ancestor
92934486|NCT00779649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934487|NCT00779649|Laxatives|laxatives|mesh-ancestor
92934488|NCT00776217|Loratadine|loratadine|mesh-list
92934489|NCT00776217|Antipruritics|antipruritics|mesh-ancestor
92934490|NCT00776217|Dermatologic Agents|dermatologic agents|mesh-ancestor
92934491|NCT00776217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92934492|NCT00776217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92934493|NCT00776217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92934494|NCT00776217|Histamine Antagonists|histamine antagonists|mesh-ancestor
92934495|NCT00776217|Histamine Agents|histamine agents|mesh-ancestor
92934496|NCT00776217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934497|NCT00776217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934498|NCT00776217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934499|NCT04990232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92934500|NCT04990232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934501|NCT00667875|Naltrexone|naltrexone|mesh-list
92934502|NCT00667875|Aripiprazole|aripiprazole|mesh-list
92934503|NCT00667875|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92934504|NCT00667875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92934505|NCT00667875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934506|NCT00667875|Sensory System Agents|sensory system agents|mesh-ancestor
92934507|NCT00667875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934508|NCT00667875|Antidepressive Agents|antidepressive agents|mesh-ancestor
92934509|NCT00667875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92934510|NCT00667875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92934511|NCT00667875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92934512|NCT00667875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934513|NCT00667875|Dopamine Agonists|dopamine agonists|mesh-ancestor
92934514|NCT00667875|Dopamine Agents|dopamine agents|mesh-ancestor
92934515|NCT00667875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934516|NCT00667875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934517|NCT00667875|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92934518|NCT00667875|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92934519|NCT00667875|Serotonin Agents|serotonin agents|mesh-ancestor
92934520|NCT00667875|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92934521|NCT00667875|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92934522|NCT00667875|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92934523|NCT00667875|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92934524|NCT02579642|Ketamine|ketamine|mesh-list
92934525|NCT02579642|Analgesics|analgesics|mesh-ancestor
92934526|NCT02579642|Sensory System Agents|sensory system agents|mesh-ancestor
92934527|NCT02579642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934528|NCT02579642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934529|NCT02579642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92934530|NCT02579642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92934531|NCT02579642|Anesthetics, General|anesthetics, general|mesh-ancestor
92934532|NCT02579642|Anesthetics|anesthetics|mesh-ancestor
92934533|NCT02579642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934534|NCT02579642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92934535|NCT02579642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92934536|NCT02579642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934537|NCT02579642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934538|NCT00779805|Pseudoephedrine|pseudoephedrine|mesh-list
92934539|NCT00779805|Ephedrine|ephedrine|mesh-list
92934540|NCT00779805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92934541|NCT00779805|Autonomic Agents|autonomic agents|mesh-ancestor
92934542|NCT00779805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934543|NCT00779805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934544|NCT00779805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92934545|NCT00779805|Respiratory System Agents|respiratory system agents|mesh-ancestor
92934546|NCT00779805|Nasal Decongestants|nasal decongestants|mesh-ancestor
92934547|NCT00779805|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92934548|NCT00779805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92934549|NCT00779805|Sympathomimetics|sympathomimetics|mesh-ancestor
92934550|NCT00779805|Adrenergic Agents|adrenergic agents|mesh-ancestor
92934551|NCT00779805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934552|NCT00779805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934553|NCT00772395|Risedronic Acid|risedronic acid|mesh-list
92934554|NCT00772395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92934555|NCT00772395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92934556|NCT00772395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934557|NCT00772395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92934558|NCT00772395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934559|NCT00772395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92934560|NCT00667251|Paclitaxel|paclitaxel|mesh-list
92934561|NCT00667251|Docetaxel|docetaxel|mesh-list
92934562|NCT00667251|Trastuzumab|trastuzumab|mesh-list
92934563|NCT00667251|Lapatinib|lapatinib|mesh-list
92934564|NCT00667251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92934565|NCT00667251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934566|NCT00667251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92934567|NCT00667251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92934568|NCT00667251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92934569|NCT00667251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934570|NCT00667251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934571|NCT00667251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92934572|NCT00667251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934573|NCT04063124|Dasatinib|dasatinib|mesh-list
92934574|NCT04063124|Quercetin|quercetin|mesh-list
92934575|NCT04063124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934576|NCT04063124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92934577|NCT04063124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934578|NCT04063124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934579|NCT04063124|Antioxidants|antioxidants|mesh-ancestor
92934580|NCT04063124|Protective Agents|protective agents|mesh-ancestor
92934581|NCT04063124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934582|NCT00772473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
92934583|NCT00772473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92934584|NCT00772473|Serotonin Agents|serotonin agents|mesh-ancestor
92934585|NCT00772473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934586|NCT00772473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934587|NCT00772473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934588|NCT00776607|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92934589|NCT00776607|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934590|NCT00776607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934591|NCT00780039|Carboplatin|carboplatin|mesh-list
92934592|NCT00780039|Doxorubicin|doxorubicin|mesh-list
92934593|NCT00780039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92934594|NCT00780039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934596|NCT00780039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92934597|NCT00780039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92934598|NCT00780039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934599|NCT00780039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934600|NCT00776763|Bevacizumab|bevacizumab|mesh-list
92934601|NCT00776763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934602|NCT00776763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934603|NCT00776763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92934604|NCT00776763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92934605|NCT00776763|Growth Substances|growth substances|mesh-ancestor
92934606|NCT00776763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934607|NCT00776763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92934608|NCT00772551|Raltegravir Potassium|raltegravir potassium|mesh-list
92934609|NCT00772551|Ezetimibe|ezetimibe|mesh-list
92934610|NCT00772551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92934611|NCT00772551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92934612|NCT00772551|Antimetabolites|antimetabolites|mesh-ancestor
92934613|NCT00772551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934614|NCT00772551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92934615|NCT00772551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92934616|NCT00772551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92934617|NCT00772551|Antiviral Agents|antiviral agents|mesh-ancestor
92934618|NCT00772551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934619|NCT00772551|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92934620|NCT00772551|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92934621|NCT00772551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934622|NCT00776841|Cholic Acids|cholic acids|mesh-list
92934623|NCT00776841|Bile Acids and Salts|bile acids and salts|mesh-list
92934624|NCT00776841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934625|NCT02556879|Liver Extracts|liver extracts|mesh-list
92934626|NCT02556879|Antibodies|antibodies|mesh-list
92934627|NCT02556879|Immunologic Factors|immunologic factors|mesh-ancestor
92934628|NCT02556879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934629|NCT02556879|Hematinics|hematinics|mesh-ancestor
92934630|NCT00772863|Docetaxel|docetaxel|mesh-list
92934631|NCT00772863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934632|NCT00772863|Tubulin Modulators|tubulin modulators|mesh-ancestor
92934633|NCT00772863|Antimitotic Agents|antimitotic agents|mesh-ancestor
92934634|NCT00772863|Mitosis Modulators|mitosis modulators|mesh-ancestor
92934635|NCT00772863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934636|NCT04075760|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92934637|NCT04075760|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92934638|NCT04075760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92934639|NCT04075760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934640|NCT04075760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934641|NCT04075760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934642|NCT00667719|Amlodipine|amlodipine|mesh-list
92934643|NCT00667719|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92934644|NCT00667719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92934645|NCT00667719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92934646|NCT00667719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164057|NCT03828019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92934647|NCT00667719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934648|NCT00667719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92934649|NCT00667719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934650|NCT00667719|Vasodilator Agents|vasodilator agents|mesh-ancestor
92934651|NCT00667719|Diuretics|diuretics|mesh-ancestor
92934652|NCT00667719|Natriuretic Agents|natriuretic agents|mesh-ancestor
92934653|NCT00667719|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92934654|NCT00669669|Plerixafor|plerixafor|mesh-list
92934655|NCT00669669|Temozolomide|temozolomide|mesh-list
92934656|NCT00669669|Carmustine|carmustine|mesh-list
92934657|NCT00669669|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92934658|NCT00669669|Lenograstim|lenograstim|mesh-list
92934659|NCT00669669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92934660|NCT00669669|Immunologic Factors|immunologic factors|mesh-ancestor
92934661|NCT00669669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934662|NCT00669669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92934663|NCT00669669|Alkylating Agents|alkylating agents|mesh-ancestor
92934664|NCT00669669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934665|NCT00669669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934666|NCT00669669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92934667|NCT00669669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92934668|NCT00669669|Antiviral Agents|antiviral agents|mesh-ancestor
92934669|NCT00669669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934671|NCT02579564|Paclitaxel|paclitaxel|mesh-list
92934672|NCT02579564|Vinorelbine|vinorelbine|mesh-list
92934673|NCT02579564|Gemcitabine|gemcitabine|mesh-list
92934674|NCT02579564|Pemetrexed|pemetrexed|mesh-list
92934675|NCT02579564|Endostar protein|endostar protein|mesh-list
92934676|NCT02579564|Endostatins|endostatins|mesh-list
92934677|NCT02579564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92934678|NCT02579564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934679|NCT02579564|Tubulin Modulators|tubulin modulators|mesh-ancestor
92934680|NCT02579564|Antimitotic Agents|antimitotic agents|mesh-ancestor
92934681|NCT02579564|Mitosis Modulators|mitosis modulators|mesh-ancestor
92934682|NCT02579564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934683|NCT02579564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92934684|NCT02579564|Antimetabolites|antimetabolites|mesh-ancestor
92934685|NCT02579564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934686|NCT02579564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92934687|NCT02579564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92934688|NCT02579564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92934689|NCT02579564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92934690|NCT02579564|Growth Substances|growth substances|mesh-ancestor
92934691|NCT02579564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934692|NCT02579564|Growth Inhibitors|growth inhibitors|mesh-ancestor
92934693|NCT00467779|Midazolam|midazolam|mesh-list
92934694|NCT00467779|Dextromethorphan|dextromethorphan|mesh-list
92934695|NCT00467779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92934696|NCT00467779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92934697|NCT00467779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92934698|NCT00467779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934699|NCT00467779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92934700|NCT00467779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92934701|NCT00467779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92934702|NCT00467779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92934703|NCT00467779|Anesthetics, General|anesthetics, general|mesh-ancestor
92934704|NCT00467779|Anesthetics|anesthetics|mesh-ancestor
92934705|NCT00467779|GABA Modulators|gaba modulators|mesh-ancestor
92934706|NCT00467779|GABA Agents|gaba agents|mesh-ancestor
92934707|NCT00467779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934708|NCT00467779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934709|NCT00467779|Antitussive Agents|antitussive agents|mesh-ancestor
92934710|NCT00467779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92934711|NCT00467779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92934712|NCT00467779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92934713|NCT03704480|Durvalumab|durvalumab|mesh-list
92934714|NCT03704480|Tremelimumab|tremelimumab|mesh-list
92934715|NCT03704480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934716|NCT03704480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934717|NCT03699254|Valganciclovir|valganciclovir|mesh-list
92934718|NCT03699254|Ganciclovir|ganciclovir|mesh-list
92934719|NCT03699254|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92934720|NCT03699254|Antiviral Agents|antiviral agents|mesh-ancestor
92934721|NCT03699254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934722|NCT03699254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92934723|NCT03699254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934724|NCT03699254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934725|NCT00570687|Insulin|insulin|mesh-list
92934726|NCT00570687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934727|NCT00570687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934728|NCT01021891|Insulin|insulin|mesh-list
92934729|NCT01021891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92934730|NCT01021891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934731|NCT01029223|Metoprolol|metoprolol|mesh-list
92934732|NCT01029223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92934733|NCT01029223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92934734|NCT01029223|Sympatholytics|sympatholytics|mesh-ancestor
92934735|NCT01029223|Autonomic Agents|autonomic agents|mesh-ancestor
92934736|NCT01029223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934737|NCT01029223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934738|NCT01029223|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92934739|NCT01029223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92934740|NCT01029223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92934741|NCT01029223|Adrenergic Agents|adrenergic agents|mesh-ancestor
92934742|NCT01029223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934743|NCT01029223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934744|NCT02556723|Aflibercept|aflibercept|mesh-list
92934745|NCT02556723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92934746|NCT02556723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92934747|NCT02556723|Growth Substances|growth substances|mesh-ancestor
92934748|NCT02556723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934749|NCT02556723|Growth Inhibitors|growth inhibitors|mesh-ancestor
92934750|NCT02556723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934751|NCT00777543|Ferulic acid|ferulic acid|mesh-list
92934752|NCT00777543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92934753|NCT00777543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92934754|NCT00777543|Analgesics|analgesics|mesh-ancestor
92934755|NCT00777543|Sensory System Agents|sensory system agents|mesh-ancestor
92934756|NCT00777543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934757|NCT00777543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934758|NCT00777543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934759|NCT00777543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934760|NCT00777543|Anticoagulants|anticoagulants|mesh-ancestor
92934761|NCT00777543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92934762|NCT00777543|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92934763|NCT00777543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934764|NCT00777543|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92934765|NCT00777543|Antioxidants|antioxidants|mesh-ancestor
92934766|NCT00777543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934767|NCT00777543|Protective Agents|protective agents|mesh-ancestor
92934768|NCT03410654|Tacrolimus|tacrolimus|mesh-list
92934769|NCT03410654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934770|NCT03410654|Immunologic Factors|immunologic factors|mesh-ancestor
92934771|NCT03410654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934772|NCT03410654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92934773|NCT03410654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934774|NCT03410654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934775|NCT04006262|Nivolumab|nivolumab|mesh-list
92934776|NCT04006262|Ipilimumab|ipilimumab|mesh-list
92934777|NCT04006262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934778|NCT04006262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934779|NCT04006262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92934780|NCT04006262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934781|NCT01032499|Oxytetracycline|oxytetracycline|mesh-list
92934782|NCT01032499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92934783|NCT01032499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934784|NCT01022047|Budesonide|budesonide|mesh-list
92934785|NCT01022047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934786|NCT01022047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92934787|NCT01022047|Autonomic Agents|autonomic agents|mesh-ancestor
92934788|NCT01022047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934789|NCT01022047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934790|NCT01022047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92934791|NCT01022047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92934792|NCT01022047|Glucocorticoids|glucocorticoids|mesh-ancestor
92934793|NCT01022047|Hormones|hormones|mesh-ancestor
92934794|NCT01022047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934795|NCT01022125|Simeprevir|simeprevir|mesh-list
92934796|NCT01022125|Antiviral Agents|antiviral agents|mesh-ancestor
92934797|NCT01022125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934798|NCT01022125|Protease Inhibitors|protease inhibitors|mesh-ancestor
92934799|NCT01022125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934800|NCT01022125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934801|NCT03385928|Tranexamic Acid|tranexamic acid|mesh-list
92934802|NCT03385928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92934803|NCT03385928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92934804|NCT03385928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934805|NCT03385928|Hemostatics|hemostatics|mesh-ancestor
92934806|NCT03385928|Coagulants|coagulants|mesh-ancestor
92934807|NCT05673980|Vitamin D|vitamin d|mesh-list
92934808|NCT05673980|Cholecalciferol|cholecalciferol|mesh-list
92934809|NCT05673980|Ergocalciferols|ergocalciferols|mesh-list
92934810|NCT05673980|Vitamins|vitamins|mesh-ancestor
92934811|NCT05673980|Micronutrients|micronutrients|mesh-ancestor
92934812|NCT05673980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934813|NCT05673980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92934814|NCT05673980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92934815|NCT02581124|Lapatinib|lapatinib|mesh-list
92934816|NCT02581124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934817|NCT02581124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92934818|NCT02581124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526520|NCT00012363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92934819|NCT02581124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934820|NCT02580968|Flunarizine|flunarizine|mesh-list
92934821|NCT02580968|Anticonvulsants|anticonvulsants|mesh-ancestor
92934822|NCT02580968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92934823|NCT02580968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92934824|NCT02580968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934825|NCT02580968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92934826|NCT02580968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934827|NCT02580968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92934828|NCT02580968|Histamine Antagonists|histamine antagonists|mesh-ancestor
92934829|NCT02580968|Histamine Agents|histamine agents|mesh-ancestor
92934830|NCT02580968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934831|NCT02580968|Vasodilator Agents|vasodilator agents|mesh-ancestor
92934832|NCT00441103|Interferon beta-1a|interferon beta-1a|mesh-list
92934833|NCT00441103|Interferon-beta|interferon-beta|mesh-list
92934834|NCT00441103|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92934835|NCT00441103|Immunologic Factors|immunologic factors|mesh-ancestor
92934836|NCT00441103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934837|NCT00441103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934838|NCT00441103|Antiviral Agents|antiviral agents|mesh-ancestor
92934839|NCT00441103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934840|NCT01029613|Adalimumab|adalimumab|mesh-list
92934841|NCT01029613|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92934842|NCT01029613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580246|NCT00112008|Hematinics|hematinics|mesh-ancestor
92934843|NCT01029613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934845|NCT03540212|Antiviral Agents|antiviral agents|mesh-ancestor
92934846|NCT03540212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934847|NCT03268057|Avelumab|avelumab|mesh-list
92934848|NCT03268057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934849|NCT03268057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934850|NCT01033903|Misoprostol|misoprostol|mesh-list
92934851|NCT01033903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92934852|NCT01033903|Abortifacient Agents|abortifacient agents|mesh-ancestor
92934853|NCT01033903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92934854|NCT01033903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934855|NCT01033903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92934856|NCT01033903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934857|NCT01033903|Oxytocics|oxytocics|mesh-ancestor
92934858|NCT03281954|Atezolizumab|atezolizumab|mesh-list
92934859|NCT03281954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92934860|NCT03281954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934861|NCT03281954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934862|NCT03281954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934863|NCT00433537|Dexamethasone|dexamethasone|mesh-list
92934864|NCT00433537|Cyclophosphamide|cyclophosphamide|mesh-list
92934865|NCT00433537|Rituximab|rituximab|mesh-list
92934866|NCT00433537|Doxorubicin|doxorubicin|mesh-list
92934867|NCT00433537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92934868|NCT00433537|Vincristine|vincristine|mesh-list
92934869|NCT00433537|Bortezomib|bortezomib|mesh-list
92934870|NCT00433537|Lenograstim|lenograstim|mesh-list
92934871|NCT00433537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934872|NCT00433537|Immunologic Factors|immunologic factors|mesh-ancestor
92934873|NCT00433537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934874|NCT00433537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934875|NCT00433537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92934876|NCT00433537|Alkylating Agents|alkylating agents|mesh-ancestor
92934877|NCT00433537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934878|NCT00433537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934879|NCT00433537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92934880|NCT00433537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92934881|NCT00433537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92934882|NCT00433537|Antiemetics|antiemetics|mesh-ancestor
92934883|NCT00433537|Autonomic Agents|autonomic agents|mesh-ancestor
92934884|NCT00433537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934885|NCT00433537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934886|NCT00433537|Glucocorticoids|glucocorticoids|mesh-ancestor
92934887|NCT00433537|Hormones|hormones|mesh-ancestor
92934888|NCT00433537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92934889|NCT00433537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92934890|NCT00433537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92934891|NCT00433537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92934892|NCT00433537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92934893|NCT00433537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934894|NCT00433537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92934895|NCT00433537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92934896|NCT00433537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92934897|NCT00433537|Antimitotic Agents|antimitotic agents|mesh-ancestor
92934898|NCT00433537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92934899|NCT00570765|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92934900|NCT00570765|Cathartics|cathartics|mesh-ancestor
92934901|NCT00570765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934902|NCT00777699|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92934903|NCT00777699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934904|NCT00777699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92934905|NCT00777699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934906|NCT00777699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934907|NCT05118477|Caffeine|caffeine|mesh-list
92934908|NCT05118477|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92934909|NCT05118477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934910|NCT05118477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92934911|NCT05118477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934912|NCT05118477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934913|NCT05118477|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92934914|NCT05118477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92934915|NCT05118477|Purinergic Agents|purinergic agents|mesh-ancestor
92934916|NCT05118477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934917|NCT00667095|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92934918|NCT00667095|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92934919|NCT00667095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92934920|NCT00667095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934921|NCT00667095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934922|NCT00667095|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92934923|NCT00667095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92934924|NCT00667095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934925|NCT00667095|Cholinergic Agents|cholinergic agents|mesh-ancestor
92934926|NCT00667095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934927|NCT00667095|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92934928|NCT00667095|Protective Agents|protective agents|mesh-ancestor
92934929|NCT00667095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92934930|NCT00667095|Antioxidants|antioxidants|mesh-ancestor
92934931|NCT00777933|Cyclosporine|cyclosporine|mesh-list
92934932|NCT00777933|Tacrolimus|tacrolimus|mesh-list
92934933|NCT00777933|Cyclosporins|cyclosporins|mesh-list
92934934|NCT00777933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92934935|NCT00777933|Immunologic Factors|immunologic factors|mesh-ancestor
92934936|NCT00777933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934937|NCT00777933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92934938|NCT00777933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934939|NCT00777933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934940|NCT00777933|Antifungal Agents|antifungal agents|mesh-ancestor
92934941|NCT00777933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92934942|NCT00777933|Dermatologic Agents|dermatologic agents|mesh-ancestor
92934943|NCT00777933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92934944|NCT00773331|Epoetin Alfa|epoetin alfa|mesh-list
92934945|NCT00773331|Hematinics|hematinics|mesh-ancestor
92934946|NCT00778011|Ondansetron|ondansetron|mesh-list
92934947|NCT00778011|Metoclopramide|metoclopramide|mesh-list
92934948|NCT00778011|Antiemetics|antiemetics|mesh-ancestor
92934949|NCT00778011|Autonomic Agents|autonomic agents|mesh-ancestor
92934950|NCT00778011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92934951|NCT00778011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934952|NCT00778011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92934953|NCT00778011|Antipruritics|antipruritics|mesh-ancestor
92934954|NCT00778011|Dermatologic Agents|dermatologic agents|mesh-ancestor
92934955|NCT00778011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92934956|NCT00778011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92934957|NCT00778011|Serotonin Agents|serotonin agents|mesh-ancestor
92934958|NCT00778011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92934959|NCT00778011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934960|NCT00778011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92934961|NCT00778011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92934962|NCT00778011|Dopamine Agents|dopamine agents|mesh-ancestor
92934963|NCT00778089|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92934964|NCT00778089|Vasodilator Agents|vasodilator agents|mesh-ancestor
92934965|NCT00778089|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92934966|NCT00778089|Protective Agents|protective agents|mesh-ancestor
92934967|NCT00778089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934968|NCT00433381|Bevacizumab|bevacizumab|mesh-list
92934969|NCT00433381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92934970|NCT00433381|Irinotecan|irinotecan|mesh-list
92934971|NCT00433381|Temozolomide|temozolomide|mesh-list
92934972|NCT00433381|Camptothecin|camptothecin|mesh-list
92934973|NCT00433381|Endothelial Growth Factors|endothelial growth factors|mesh-list
92934974|NCT00433381|Antibodies|antibodies|mesh-list
92934975|NCT00433381|Immunoglobulins|immunoglobulins|mesh-list
92934976|NCT00433381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92934977|NCT00433381|Immunoglobulin G|immunoglobulin g|mesh-list
92934978|NCT00433381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92934979|NCT00433381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92934980|NCT00433381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92934981|NCT00433381|Growth Substances|growth substances|mesh-ancestor
92934982|NCT00433381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934983|NCT00433381|Growth Inhibitors|growth inhibitors|mesh-ancestor
92934984|NCT00433381|Immunologic Factors|immunologic factors|mesh-ancestor
92934985|NCT00433381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92934986|NCT00433381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92934987|NCT00433381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92934988|NCT00433381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92934989|NCT00433381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92934990|NCT00433381|Alkylating Agents|alkylating agents|mesh-ancestor
92934991|NCT00433381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580395|NCT00291109|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92934992|NCT00667017|Immunotoxins|immunotoxins|mesh-list
92934993|NCT00667017|Immunoconjugates|immunoconjugates|mesh-ancestor
92934995|NCT00667017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92934996|NCT00781131|Pregabalin|pregabalin|mesh-list
92934997|NCT00781131|Analgesics|analgesics|mesh-ancestor
92934998|NCT00781131|Sensory System Agents|sensory system agents|mesh-ancestor
92934999|NCT00781131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935000|NCT00781131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935001|NCT00781131|Anticonvulsants|anticonvulsants|mesh-ancestor
92935002|NCT00781131|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92935003|NCT00781131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935004|NCT00781131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935005|NCT00781131|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92935006|NCT00781131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92935007|NCT00781131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935008|NCT00781131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935009|NCT00781131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935010|NCT00778245|Cefprozil|cefprozil|mesh-list
92935011|NCT00778245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935012|NCT00778245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935013|NCT00778401|Gabapentin|gabapentin|mesh-list
92935014|NCT00778401|Analgesics|analgesics|mesh-ancestor
92935015|NCT00778401|Sensory System Agents|sensory system agents|mesh-ancestor
92935016|NCT00778401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935017|NCT00778401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935018|NCT00778401|Anticonvulsants|anticonvulsants|mesh-ancestor
92935019|NCT00778401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92935020|NCT00778401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935021|NCT00778401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935022|NCT00778401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935023|NCT00778401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92935024|NCT00778401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92935025|NCT00778401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935026|NCT00778401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935027|NCT00778401|Antimanic Agents|antimanic agents|mesh-ancestor
92935028|NCT00666705|Raltegravir Potassium|raltegravir potassium|mesh-list
92935029|NCT00666705|Maraviroc|maraviroc|mesh-list
92935030|NCT00666705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935031|NCT00666705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935032|NCT00666705|Antiviral Agents|antiviral agents|mesh-ancestor
92935033|NCT00666705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935034|NCT00666705|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92935035|NCT00666705|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92935036|NCT00666705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935037|NCT00666705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935038|NCT00666705|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92935039|NCT00666705|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92935040|NCT00666705|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92935041|NCT04047849|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92935042|NCT04047849|Amoxicillin|amoxicillin|mesh-list
92935043|NCT04047849|Azithromycin|azithromycin|mesh-list
92935044|NCT04047849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935045|NCT00778557|Cefprozil|cefprozil|mesh-list
92935046|NCT00778557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935047|NCT00778557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935048|NCT00778713|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92935049|NCT00778713|Fosinopril|fosinopril|mesh-list
92935050|NCT00778713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92935051|NCT00778713|Diuretics|diuretics|mesh-ancestor
92935052|NCT00778713|Natriuretic Agents|natriuretic agents|mesh-ancestor
92935053|NCT00778713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935054|NCT00778713|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92935055|NCT00778713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935056|NCT00778713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935057|NCT00778713|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92935058|NCT00778713|Protease Inhibitors|protease inhibitors|mesh-ancestor
92935059|NCT00778713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935060|NCT00781287|Raltegravir Potassium|raltegravir potassium|mesh-list
92935061|NCT00781287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935062|NCT00781287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935063|NCT00781287|Antiviral Agents|antiviral agents|mesh-ancestor
92935064|NCT00781287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935065|NCT00781287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92935066|NCT00781287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92935067|NCT00781287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580469|NCT00291616|Antiviral Agents|antiviral agents|mesh-ancestor
92935068|NCT00781287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935069|NCT00774111|Dolutegravir|dolutegravir|mesh-list
92935070|NCT00774111|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92935071|NCT00774111|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92935072|NCT00774111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935073|NCT00774111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935074|NCT00774111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935075|NCT00774111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935076|NCT00774111|Antiviral Agents|antiviral agents|mesh-ancestor
92935077|NCT00774111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935078|NCT00778791|Metformin|metformin|mesh-list
92935079|NCT00778791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92935080|NCT00778791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935081|NCT00774189|Clarithromycin|clarithromycin|mesh-list
92935082|NCT00774189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935083|NCT00774189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935084|NCT00774189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92935085|NCT00774189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935086|NCT00774189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935087|NCT00774189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92935088|NCT00774189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935089|NCT00774423|Riluzole|riluzole|mesh-list
92935090|NCT00774423|Anticonvulsants|anticonvulsants|mesh-ancestor
92935091|NCT00774423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92935092|NCT00774423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92935093|NCT00774423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935094|NCT00774423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935095|NCT00774423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935096|NCT00774423|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92935097|NCT00774423|Protective Agents|protective agents|mesh-ancestor
92935098|NCT00781521|Ofloxacin|ofloxacin|mesh-list
92935099|NCT00781521|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92935100|NCT00781521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935101|NCT00781521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935102|NCT00781521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92935103|NCT00781521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935104|NCT00781521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935105|NCT00781521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935106|NCT00781521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935107|NCT00781521|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92935108|NCT00781521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935109|NCT00774501|Anesthetics|anesthetics|mesh-list
92935110|NCT00774501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935111|NCT00774501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935112|NCT00784485|Omalizumab|omalizumab|mesh-list
92935113|NCT00784485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92935114|NCT00784485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92935115|NCT00784485|Respiratory System Agents|respiratory system agents|mesh-ancestor
92935116|NCT00781755|Varenicline|varenicline|mesh-list
92935117|NCT00781755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92935118|NCT00781755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92935119|NCT00781755|Cholinergic Agents|cholinergic agents|mesh-ancestor
92935120|NCT00781755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935121|NCT00781755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935122|NCT00781755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935123|NCT00774735|Dolutegravir|dolutegravir|mesh-list
92935124|NCT00774735|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92935125|NCT00774735|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92935126|NCT00774735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935127|NCT00774735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935128|NCT00774735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935129|NCT00774735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935130|NCT00774735|Antiviral Agents|antiviral agents|mesh-ancestor
92935131|NCT00774735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935132|NCT00666237|Mitomycins|mitomycins|mesh-list
92935133|NCT00666237|Mitomycin|mitomycin|mesh-list
92935134|NCT00666237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92935135|NCT00666237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935136|NCT00666237|Alkylating Agents|alkylating agents|mesh-ancestor
92935137|NCT00666237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935138|NCT00666237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935139|NCT00666237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935140|NCT00774813|Citalopram|citalopram|mesh-list
92935141|NCT00774813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92935142|NCT00774813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92935143|NCT00774813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935144|NCT00774813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935145|NCT00774813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935147|NCT00774813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935148|NCT00774813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92935149|NCT00774813|Antidepressive Agents|antidepressive agents|mesh-ancestor
92935150|NCT00774813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935151|NCT00784797|Oxytocin|oxytocin|mesh-list
92935152|NCT00784797|Mifepristone|mifepristone|mesh-list
92935153|NCT00784797|Oxytocics|oxytocics|mesh-ancestor
92935154|NCT00784797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92935155|NCT00784797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935156|NCT00784797|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92935157|NCT00784797|Abortifacient Agents|abortifacient agents|mesh-ancestor
92935158|NCT00784797|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92935159|NCT00784797|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92935160|NCT00784797|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92935161|NCT00784797|Contraceptive Agents|contraceptive agents|mesh-ancestor
92935162|NCT00784797|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92935163|NCT00784797|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92935164|NCT00784797|Hormone Antagonists|hormone antagonists|mesh-ancestor
92935165|NCT00784797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935166|NCT00784797|Luteolytic Agents|luteolytic agents|mesh-ancestor
92935167|NCT00784797|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92935168|NCT00784797|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92935169|NCT00774969|Metronidazole|metronidazole|mesh-list
92935170|NCT00774969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935171|NCT00774969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935172|NCT00774969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92935173|NCT00774969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92935174|NCT00785109|Vitamin K|vitamin k|mesh-list
92935175|NCT00785109|Vitamins|vitamins|mesh-ancestor
92935176|NCT00785109|Micronutrients|micronutrients|mesh-ancestor
92935177|NCT00785109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935178|NCT00785109|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92935179|NCT00785109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92935180|NCT00785109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935181|NCT00785109|Hemostatics|hemostatics|mesh-ancestor
92935182|NCT00785109|Coagulants|coagulants|mesh-ancestor
92935183|NCT00662025|Capecitabine|capecitabine|mesh-list
92935184|NCT00662025|Sunitinib|sunitinib|mesh-list
92935185|NCT00662025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92935186|NCT00662025|Antimetabolites|antimetabolites|mesh-ancestor
92935187|NCT00662025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935188|NCT00662025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935189|NCT00662025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92935190|NCT00662025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92935191|NCT00662025|Growth Substances|growth substances|mesh-ancestor
92935192|NCT00662025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935193|NCT00662025|Growth Inhibitors|growth inhibitors|mesh-ancestor
92935194|NCT00662025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935195|NCT00662025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935196|NCT00789945|Insulin|insulin|mesh-list
92935197|NCT00789945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92935198|NCT00789945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92935199|NCT00789945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935200|NCT00790101|Risedronic Acid|risedronic acid|mesh-list
92935201|NCT00790101|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92935202|NCT00790101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92935203|NCT00790101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935204|NCT00790101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935205|NCT00790101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92935206|NCT00790101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935207|NCT00790101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92935208|NCT00790101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92935209|NCT00790101|Hormone Antagonists|hormone antagonists|mesh-ancestor
92935210|NCT00790101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935211|NCT00790101|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92935212|NCT00790101|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92935213|NCT00782301|Maraviroc|maraviroc|mesh-list
92935214|NCT00782301|Etravirine|etravirine|mesh-list
92935215|NCT00782301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92935216|NCT00782301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92935217|NCT00782301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935218|NCT00782301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935219|NCT00782301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935220|NCT00782301|Antiviral Agents|antiviral agents|mesh-ancestor
92935221|NCT00782301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935222|NCT00782301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92935223|NCT00782301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92935224|NCT00782301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935225|NCT00782301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935226|NCT00785421|Leucovorin|leucovorin|mesh-list
92935227|NCT00785421|Folic Acid|folic acid|mesh-list
92935228|NCT00785421|Cisplatin|cisplatin|mesh-list
92935229|NCT00785421|Gemcitabine|gemcitabine|mesh-list
92935230|NCT00785421|Enoxaparin|enoxaparin|mesh-list
92935231|NCT00785421|Enoxaparin sodium|enoxaparin sodium|mesh-list
92935232|NCT00785421|Levoleucovorin|levoleucovorin|mesh-list
92935233|NCT00785421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935234|NCT00785421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92935235|NCT00785421|Antimetabolites|antimetabolites|mesh-ancestor
92935236|NCT00785421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935237|NCT00785421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935238|NCT00785421|Antidotes|antidotes|mesh-ancestor
92935239|NCT00785421|Protective Agents|protective agents|mesh-ancestor
92935240|NCT00785421|Vitamin B Complex|vitamin b complex|mesh-ancestor
92935241|NCT00785421|Vitamins|vitamins|mesh-ancestor
92935242|NCT00785421|Micronutrients|micronutrients|mesh-ancestor
92935243|NCT00785421|Hematinics|hematinics|mesh-ancestor
92935244|NCT00785421|Anticoagulants|anticoagulants|mesh-ancestor
92935245|NCT00785421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92935246|NCT00785421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92935247|NCT00790179|Ropivacaine|ropivacaine|mesh-list
92935248|NCT00790179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92935249|NCT00790179|Anesthetics|anesthetics|mesh-ancestor
92935250|NCT00790179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935251|NCT00790179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935252|NCT00790179|Sensory System Agents|sensory system agents|mesh-ancestor
92935253|NCT00790179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935254|NCT00790413|Rituximab|rituximab|mesh-list
92935255|NCT00790413|Fludarabine|fludarabine|mesh-list
92935256|NCT00790413|Thiotepa|thiotepa|mesh-list
92935257|NCT00790413|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92935258|NCT00790413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935259|NCT00790413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935260|NCT00790413|Immunologic Factors|immunologic factors|mesh-ancestor
92935261|NCT00790413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935262|NCT00790413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92935263|NCT00790413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935264|NCT00790413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92935265|NCT00790413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92935266|NCT00790413|Alkylating Agents|alkylating agents|mesh-ancestor
92935267|NCT00790413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92935268|NCT00790413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935269|NCT00790413|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92935270|NCT00785811|N-Methylaspartate|n-methylaspartate|mesh-list
92935271|NCT00785811|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92935272|NCT00785811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92935273|NCT00785811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935274|NCT00785811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935275|NCT00785811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935276|NCT00440947|Ritonavir|ritonavir|mesh-list
92935277|NCT00440947|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92935278|NCT00440947|Lamivudine|lamivudine|mesh-list
92935279|NCT00440947|Abacavir|abacavir|mesh-list
92935280|NCT00440947|Dideoxynucleosides|dideoxynucleosides|mesh-list
92935281|NCT00440947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92935282|NCT00440947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92935283|NCT00440947|Protease Inhibitors|protease inhibitors|mesh-ancestor
92935284|NCT00440947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935285|NCT00440947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935286|NCT00440947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935287|NCT00440947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935288|NCT00440947|Antiviral Agents|antiviral agents|mesh-ancestor
92935289|NCT00440947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935290|NCT00440947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92935291|NCT00440947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935292|NCT00440947|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92935293|NCT00440947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935294|NCT00440947|Antimetabolites|antimetabolites|mesh-ancestor
92935295|NCT00790881|Lumefantrine|lumefantrine|mesh-list
92935296|NCT00790881|Artemether|artemether|mesh-list
92164084|NCT03111485|Immunologic Factors|immunologic factors|mesh-ancestor
92935297|NCT00790881|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92935298|NCT00790881|Antimalarials|antimalarials|mesh-ancestor
92935299|NCT00790881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92935300|NCT00790881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92935301|NCT00790881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935302|NCT01029769|Olanzapine|olanzapine|mesh-list
92935303|NCT01029769|Amisulpride|amisulpride|mesh-list
92935304|NCT01029769|Antiemetics|antiemetics|mesh-ancestor
92935305|NCT01029769|Autonomic Agents|autonomic agents|mesh-ancestor
92935306|NCT01029769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935307|NCT01029769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935308|NCT01029769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92935309|NCT01029769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92935310|NCT01029769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935311|NCT01029769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935312|NCT01029769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935313|NCT01029769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92935314|NCT01029769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92935315|NCT01029769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935316|NCT01029769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935317|NCT01029769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935318|NCT01029769|Serotonin Agents|serotonin agents|mesh-ancestor
92935319|NCT01029769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92935320|NCT01029769|Dopamine Agents|dopamine agents|mesh-ancestor
92935321|NCT01029769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92935322|NCT01029769|Antidepressive Agents|antidepressive agents|mesh-ancestor
92935323|NCT02557945|Gabapentin|gabapentin|mesh-list
92935324|NCT02557945|Analgesics|analgesics|mesh-ancestor
92935325|NCT02557945|Sensory System Agents|sensory system agents|mesh-ancestor
92935326|NCT02557945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935327|NCT02557945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935328|NCT02557945|Anticonvulsants|anticonvulsants|mesh-ancestor
92935329|NCT02557945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92935330|NCT02557945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935331|NCT02557945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935332|NCT02557945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935333|NCT02557945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92935334|NCT02557945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92935335|NCT02557945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935336|NCT02557945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935337|NCT02557945|Antimanic Agents|antimanic agents|mesh-ancestor
92935338|NCT03929666|Leucovorin|leucovorin|mesh-list
92935339|NCT03929666|Bevacizumab|bevacizumab|mesh-list
92935340|NCT03929666|Gemcitabine|gemcitabine|mesh-list
92935341|NCT03929666|Fluorouracil|fluorouracil|mesh-list
92935342|NCT03929666|Capecitabine|capecitabine|mesh-list
92935343|NCT03929666|Oxaliplatin|oxaliplatin|mesh-list
92935344|NCT03929666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935345|NCT03929666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935346|NCT03929666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92935347|NCT03929666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92935348|NCT03929666|Growth Substances|growth substances|mesh-ancestor
92935349|NCT03929666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935350|NCT03929666|Growth Inhibitors|growth inhibitors|mesh-ancestor
92935351|NCT03929666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92935352|NCT03929666|Antimetabolites|antimetabolites|mesh-ancestor
92935353|NCT03929666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935354|NCT03929666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92935355|NCT03929666|Immunologic Factors|immunologic factors|mesh-ancestor
92935356|NCT03929666|Antidotes|antidotes|mesh-ancestor
92935357|NCT03929666|Protective Agents|protective agents|mesh-ancestor
92935358|NCT03929666|Vitamin B Complex|vitamin b complex|mesh-ancestor
92935359|NCT03929666|Vitamins|vitamins|mesh-ancestor
92935360|NCT03929666|Micronutrients|micronutrients|mesh-ancestor
92935361|NCT00664521|Rituximab|rituximab|mesh-list
92935362|NCT00664521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935363|NCT00664521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935364|NCT00664521|Immunologic Factors|immunologic factors|mesh-ancestor
92935365|NCT00664521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935366|NCT00664521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92935367|NCT02581046|Dexamethasone|dexamethasone|mesh-list
92935368|NCT02581046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92935369|NCT02581046|Antiemetics|antiemetics|mesh-ancestor
92935370|NCT02581046|Autonomic Agents|autonomic agents|mesh-ancestor
92935371|NCT02581046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164087|NCT02856295|Anticoagulants|anticoagulants|mesh-ancestor
92935372|NCT02581046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935373|NCT02581046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92935374|NCT02581046|Glucocorticoids|glucocorticoids|mesh-ancestor
92935375|NCT02581046|Hormones|hormones|mesh-ancestor
92935376|NCT02581046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935377|NCT02581046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92935378|NCT02581046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935379|NCT00664209|Amoxicillin|amoxicillin|mesh-list
92935380|NCT00664209|Omeprazole|omeprazole|mesh-list
92935381|NCT00664209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935382|NCT00664209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935383|NCT00664209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92935384|NCT00664209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92935385|NCT00664209|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92935386|NCT00664209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935387|NCT00664209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935388|NCT03192332|Plasminogen|plasminogen|mesh-list
92935389|NCT03192332|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92935390|NCT03192332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92935391|NCT03192332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92935392|NCT03192332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935393|NCT02555943|Ritonavir|ritonavir|mesh-list
92935394|NCT02555943|Tenofovir|tenofovir|mesh-list
92935395|NCT02555943|Sofosbuvir|sofosbuvir|mesh-list
92935396|NCT02555943|Entecavir|entecavir|mesh-list
92935397|NCT02555943|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92935398|NCT02555943|Ledipasvir|ledipasvir|mesh-list
92935399|NCT02555943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92935400|NCT02555943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92935401|NCT02555943|Protease Inhibitors|protease inhibitors|mesh-ancestor
92935402|NCT02555943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935403|NCT02555943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935404|NCT02555943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935405|NCT02555943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935406|NCT02555943|Antiviral Agents|antiviral agents|mesh-ancestor
92935407|NCT02555943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935408|NCT02555943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92935409|NCT02555943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935410|NCT02555943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92935411|NCT02555943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935412|NCT00782847|Cyproterone Acetate|cyproterone acetate|mesh-list
92935413|NCT00782847|Cyproterone|cyproterone|mesh-list
92935414|NCT00782847|Androgen Antagonists|androgen antagonists|mesh-ancestor
92935415|NCT00782847|Hormone Antagonists|hormone antagonists|mesh-ancestor
92935416|NCT00782847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935417|NCT00782847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935418|NCT00782847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935419|NCT00782847|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92935420|NCT00782847|Contraceptive Agents|contraceptive agents|mesh-ancestor
92935421|NCT00782847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92935422|NCT00785967|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92935423|NCT00785967|Immunologic Factors|immunologic factors|mesh-ancestor
92935424|NCT00785967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935425|NCT00440557|Epoetin Alfa|epoetin alfa|mesh-list
92935426|NCT00440557|Hematinics|hematinics|mesh-ancestor
92935427|NCT05673590|Docetaxel|docetaxel|mesh-list
92935428|NCT05673590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935429|NCT05673590|Tubulin Modulators|tubulin modulators|mesh-ancestor
92935430|NCT05673590|Antimitotic Agents|antimitotic agents|mesh-ancestor
92935431|NCT05673590|Mitosis Modulators|mitosis modulators|mesh-ancestor
92935432|NCT05673590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935433|NCT01029847|Adalimumab|adalimumab|mesh-list
92935434|NCT01029847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92935435|NCT01029847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92935436|NCT01029847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92935437|NCT02452268|Spartalizumab|spartalizumab|mesh-list
92935438|NCT02452268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92935439|NCT02452268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935440|NCT02452268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935441|NCT02452268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935442|NCT02524249|Caffeine|caffeine|mesh-list
92935443|NCT02524249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92935444|NCT02524249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164088|NCT02856295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92935445|NCT02524249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92935446|NCT02524249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935447|NCT02524249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935448|NCT02524249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92935449|NCT02524249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92935450|NCT02524249|Purinergic Agents|purinergic agents|mesh-ancestor
92935451|NCT02524249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935452|NCT01033981|Sunitinib|sunitinib|mesh-list
92935453|NCT01033981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935454|NCT01033981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92935455|NCT01033981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92935456|NCT01033981|Growth Substances|growth substances|mesh-ancestor
92935457|NCT01033981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935458|NCT01033981|Growth Inhibitors|growth inhibitors|mesh-ancestor
92935459|NCT01033981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935460|NCT01033981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935461|NCT01033981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935462|NCT02430194|Interferons|interferons|mesh-list
92935463|NCT02430194|Ritonavir|ritonavir|mesh-list
92935464|NCT02430194|Interferon-alpha|interferon-alpha|mesh-list
92935465|NCT02430194|Interferon alpha-2|interferon alpha-2|mesh-list
92935466|NCT02430194|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92935467|NCT02430194|Lonafarnib|lonafarnib|mesh-list
92935468|NCT02430194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935469|NCT02430194|Antiviral Agents|antiviral agents|mesh-ancestor
92935470|NCT02430194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935471|NCT02430194|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92935472|NCT02430194|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92935473|NCT02430194|Protease Inhibitors|protease inhibitors|mesh-ancestor
92935474|NCT02430194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935475|NCT02430194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935476|NCT02430194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935477|NCT02430194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935478|NCT02430194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92935479|NCT02430194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935480|NCT02430194|Immunologic Factors|immunologic factors|mesh-ancestor
92935481|NCT02430194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935482|NCT00582608|N-(2-aminoethyl)-5-isoquinolinesulfonamide|n-(2-aminoethyl)-5-isoquinolinesulfonamide|mesh-list
92935483|NCT00582608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935484|NCT00582608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935485|NCT00582608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935486|NCT02400242|Dexamethasone|dexamethasone|mesh-list
92935487|NCT02400242|Pomalidomide|pomalidomide|mesh-list
92935488|NCT02400242|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92935489|NCT02400242|Immunomodulating Agents|immunomodulating agents|mesh-list
92935490|NCT02400242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92935491|NCT02400242|Antiemetics|antiemetics|mesh-ancestor
92935492|NCT02400242|Autonomic Agents|autonomic agents|mesh-ancestor
92935493|NCT02400242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935494|NCT02400242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935495|NCT02400242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92935496|NCT02400242|Glucocorticoids|glucocorticoids|mesh-ancestor
92935498|NCT02400242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935499|NCT02400242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92935500|NCT02400242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935501|NCT02400242|Immunologic Factors|immunologic factors|mesh-ancestor
92935502|NCT02400242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92935503|NCT02400242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92935504|NCT02400242|Growth Substances|growth substances|mesh-ancestor
92935505|NCT02400242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92935506|NCT02400242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935507|NCT02400242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935508|NCT03087656|Levofloxacin|levofloxacin|mesh-list
92935509|NCT03087656|Ceftriaxone|ceftriaxone|mesh-list
92935510|NCT03087656|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92935511|NCT03087656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935512|NCT03087656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935513|NCT03087656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92935514|NCT03087656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935515|NCT03087656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935516|NCT03087656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580922|NCT00298324|Antitubercular Agents|antitubercular agents|mesh-ancestor
92935517|NCT03087656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935518|NCT03087656|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92935519|NCT03087656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935520|NCT03068624|Aldesleukin|aldesleukin|mesh-list
92935521|NCT03068624|Cyclophosphamide|cyclophosphamide|mesh-list
92935522|NCT03068624|Ipilimumab|ipilimumab|mesh-list
92935523|NCT03068624|Interleukin-2|interleukin-2|mesh-list
92935524|NCT03068624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92935525|NCT03068624|Immunologic Factors|immunologic factors|mesh-ancestor
92935526|NCT03068624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935527|NCT03068624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92935528|NCT03068624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92935529|NCT03068624|Alkylating Agents|alkylating agents|mesh-ancestor
92935530|NCT03068624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935531|NCT03068624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935532|NCT03068624|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92935533|NCT03068624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935534|NCT03068624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92935535|NCT03068624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92935536|NCT03068624|Analgesics|analgesics|mesh-ancestor
92935537|NCT03068624|Sensory System Agents|sensory system agents|mesh-ancestor
92935538|NCT03068624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935539|NCT03068624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92935540|NCT03068624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92935541|NCT03068624|Antiviral Agents|antiviral agents|mesh-ancestor
92935542|NCT03068624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935543|NCT03005366|Flecainide|flecainide|mesh-list
92935544|NCT03005366|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92935545|NCT03005366|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92935546|NCT03005366|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92935547|NCT03005366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935548|NCT03005366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935549|NCT04076228|Pembrolizumab|pembrolizumab|mesh-list
92935550|NCT04076228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935551|NCT04076228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935552|NCT04076228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92935553|NCT04076228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935554|NCT02580734|Melatonin|melatonin|mesh-list
92935555|NCT02580734|Antioxidants|antioxidants|mesh-ancestor
92164093|NCT01266447|Lenograstim|lenograstim|mesh-list
92935556|NCT02580734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935557|NCT02580734|Protective Agents|protective agents|mesh-ancestor
92935558|NCT02580734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935559|NCT02580734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935560|NCT00427999|Pioglitazone|pioglitazone|mesh-list
92935561|NCT00427999|Dexamethasone|dexamethasone|mesh-list
92935562|NCT00427999|Dexamethasone acetate|dexamethasone acetate|mesh-list
92935564|NCT00427999|Imatinib Mesylate|imatinib mesylate|mesh-list
92935565|NCT00427999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92935566|NCT00427999|Antiemetics|antiemetics|mesh-ancestor
92935567|NCT00427999|Autonomic Agents|autonomic agents|mesh-ancestor
92935568|NCT00427999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935569|NCT00427999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935570|NCT00427999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92935571|NCT00427999|Glucocorticoids|glucocorticoids|mesh-ancestor
92935572|NCT00427999|Hormones|hormones|mesh-ancestor
92935573|NCT00427999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935574|NCT00427999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92935575|NCT00427999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935576|NCT00427999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92935577|NCT00427999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935578|NCT00427999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935579|NCT00427999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935580|NCT00427999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92935581|NCT00427999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92935582|NCT00427999|Analgesics|analgesics|mesh-ancestor
92935583|NCT00427999|Sensory System Agents|sensory system agents|mesh-ancestor
92935584|NCT00427999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92935585|NCT00427999|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92935586|NCT00427999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92935587|NCT04825652|177Lu-PSMA-617|177lu-psma-617|mesh-list
92935588|NCT04825652|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92935589|NCT04825652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935590|NCT00661713|Vaccines|vaccines|mesh-list
92935592|NCT00661713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935593|NCT02578472|Zolpidem|zolpidem|mesh-list
92935594|NCT02578472|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92935595|NCT02578472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92935596|NCT02578472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935597|NCT02578472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935598|NCT02578472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92935599|NCT02578472|GABA Agonists|gaba agonists|mesh-ancestor
92935600|NCT02578472|GABA Agents|gaba agents|mesh-ancestor
92935601|NCT02578472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935602|NCT02578472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935603|NCT03840902|Paclitaxel|paclitaxel|mesh-list
92935604|NCT03840902|Etoposide|etoposide|mesh-list
92935605|NCT03840902|Carboplatin|carboplatin|mesh-list
92935606|NCT03840902|Pemetrexed|pemetrexed|mesh-list
92935607|NCT03840902|Durvalumab|durvalumab|mesh-list
92935608|NCT03840902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92935609|NCT03840902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935610|NCT03840902|Tubulin Modulators|tubulin modulators|mesh-ancestor
92935611|NCT03840902|Antimitotic Agents|antimitotic agents|mesh-ancestor
92935612|NCT03840902|Mitosis Modulators|mitosis modulators|mesh-ancestor
92935613|NCT03840902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935614|NCT03840902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92935615|NCT03840902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935616|NCT03840902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935617|NCT03840902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92935618|NCT03840902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935619|NCT03840902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935620|NCT03835975|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92935621|NCT03835975|Immunologic Factors|immunologic factors|mesh-ancestor
92935622|NCT03835975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935623|NCT04038086|Insulin|insulin|mesh-list
92935624|NCT04038086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92935625|NCT04038086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935626|NCT04072640|Voriconazole|voriconazole|mesh-list
92935627|NCT04072640|Amphotericin B|amphotericin b|mesh-list
92935628|NCT04072640|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92935629|NCT04072640|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92935630|NCT04072640|Deoxycholic Acid|deoxycholic acid|mesh-list
92935631|NCT04072640|Antifungal Agents|antifungal agents|mesh-ancestor
92935632|NCT04072640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935633|NCT04072640|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92935634|NCT04072640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935635|NCT04072640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935636|NCT04072640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935637|NCT04072640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92935638|NCT04072640|Hormone Antagonists|hormone antagonists|mesh-ancestor
92935639|NCT04072640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935640|NCT04072640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935641|NCT04072640|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92935642|NCT04072640|Amebicides|amebicides|mesh-ancestor
92935643|NCT04072640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92935644|NCT04072640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92935645|NCT04072640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935646|NCT04072640|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92935647|NCT04072640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92935648|NCT01566487|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92935649|NCT01566487|Antidepressive Agents|antidepressive agents|mesh-ancestor
92935650|NCT01566487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935651|NCT01566487|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92935652|NCT01566487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935653|NCT01566487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935654|NCT01566487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935655|NCT02576288|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92935656|NCT02576288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92935657|NCT02576288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935658|NCT02576288|Incretins|incretins|mesh-ancestor
92935659|NCT02576288|Hormones|hormones|mesh-ancestor
92935660|NCT02576288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935661|NCT02576288|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92935662|NCT02576288|Protease Inhibitors|protease inhibitors|mesh-ancestor
92935663|NCT02576288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935664|NCT02576288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935666|NCT00427921|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92935667|NCT00427921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92935668|NCT00427921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92935669|NCT00432991|Ephedrine|ephedrine|mesh-list
92935670|NCT00432991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92935671|NCT00432991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935672|NCT00432991|Sympathomimetics|sympathomimetics|mesh-ancestor
92935673|NCT00432991|Autonomic Agents|autonomic agents|mesh-ancestor
92935674|NCT00432991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935675|NCT00432991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92935676|NCT00432991|Adrenergic Agents|adrenergic agents|mesh-ancestor
92935677|NCT00432991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935678|NCT00432991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935679|NCT00580970|Lovastatin|lovastatin|mesh-list
92935680|NCT00580970|L 647318|l 647318|mesh-list
92935681|NCT00580970|Dihydromevinolin|dihydromevinolin|mesh-list
92935682|NCT00580970|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92935683|NCT00580970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92935684|NCT00580970|Antimetabolites|antimetabolites|mesh-ancestor
92935685|NCT00580970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935686|NCT00580970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92935687|NCT00580970|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92935688|NCT00580970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935689|NCT01030081|Amlodipine|amlodipine|mesh-list
92935690|NCT01030081|Nifedipine|nifedipine|mesh-list
92935691|NCT01030081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92935692|NCT01030081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92935693|NCT01030081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935694|NCT01030081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935695|NCT01030081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92935696|NCT01030081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935697|NCT01030081|Vasodilator Agents|vasodilator agents|mesh-ancestor
92935698|NCT01030081|Tocolytic Agents|tocolytic agents|mesh-ancestor
92935699|NCT01030081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92935700|NCT00426751|Abciximab|abciximab|mesh-list
92935701|NCT00426751|Eptifibatide|eptifibatide|mesh-list
92935702|NCT00426751|Anticoagulants|anticoagulants|mesh-ancestor
92935703|NCT00426751|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92935704|NCT02576366|Rifampin|rifampin|mesh-list
92935705|NCT02576366|Voriconazole|voriconazole|mesh-list
92935706|NCT02576366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92935707|NCT02576366|Antitubercular Agents|antitubercular agents|mesh-ancestor
92935708|NCT02576366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935709|NCT02576366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935710|NCT02576366|Leprostatic Agents|leprostatic agents|mesh-ancestor
92935711|NCT02576366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935712|NCT02576366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935713|NCT02576366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935714|NCT02576366|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92935715|NCT02576366|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92935716|NCT02576366|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92935717|NCT02576366|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92935718|NCT02576366|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92935719|NCT02576366|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92935720|NCT02576366|Antifungal Agents|antifungal agents|mesh-ancestor
92935721|NCT02576366|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92935722|NCT02576366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935723|NCT02576366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92935724|NCT02576366|Hormone Antagonists|hormone antagonists|mesh-ancestor
92935725|NCT02576366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92935726|NCT02576366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935727|NCT02576366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92935728|NCT01030237|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92935729|NCT01030237|Lubricant Eye Drops|lubricant eye drops|mesh-list
92935730|NCT01030237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92935731|NCT04046679|Bleomycin|bleomycin|mesh-list
92935732|NCT04046679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92935733|NCT04046679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935734|NCT00786279|Ethanol|ethanol|mesh-list
92935735|NCT00786279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92935736|NCT00786279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935737|NCT00786279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935738|NCT00786279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935739|NCT00791193|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92935740|NCT00791193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92935741|NCT00791193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935742|NCT00791193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935743|NCT00791193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935744|NCT00791193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935745|NCT00791193|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92935746|NCT00791193|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92935747|NCT00791193|Serotonin Agents|serotonin agents|mesh-ancestor
92935748|NCT00791193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935749|NCT00791193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935750|NCT00791193|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92935751|NCT00791193|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92935752|NCT00791193|Dopamine Agents|dopamine agents|mesh-ancestor
92935753|NCT00791271|Interferons|interferons|mesh-list
92935754|NCT00791271|Interferon-alpha|interferon-alpha|mesh-list
92935755|NCT00791271|Interferon alpha-2|interferon alpha-2|mesh-list
92935756|NCT00791271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92935757|NCT00791271|Decitabine|decitabine|mesh-list
92935758|NCT00791271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935759|NCT00791271|Antiviral Agents|antiviral agents|mesh-ancestor
92935760|NCT00791271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935761|NCT00791271|Immunologic Factors|immunologic factors|mesh-ancestor
92935762|NCT00791271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935763|NCT00791271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92935764|NCT00791271|Antimetabolites|antimetabolites|mesh-ancestor
92935765|NCT00791271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935766|NCT00791271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935767|NCT00791349|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92935768|NCT00791349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92935769|NCT00791349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935770|NCT00791349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935771|NCT00791349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935772|NCT00791349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935773|NCT00791349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92935774|NCT00791349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92935775|NCT00791349|Serotonin Agents|serotonin agents|mesh-ancestor
92935776|NCT00791349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935777|NCT00791349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935778|NCT00791349|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92935779|NCT00791349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92935780|NCT00791349|Dopamine Agents|dopamine agents|mesh-ancestor
92935781|NCT00440401|Thrombin|thrombin|mesh-list
92935782|NCT00440401|Hemostatics|hemostatics|mesh-list
92935783|NCT00440401|Coagulants|coagulants|mesh-ancestor
92935784|NCT00791427|Ranibizumab|ranibizumab|mesh-list
92935785|NCT00791427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92935786|NCT00791427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92935787|NCT00791427|Growth Substances|growth substances|mesh-ancestor
92935788|NCT00791427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935789|NCT00791427|Growth Inhibitors|growth inhibitors|mesh-ancestor
92935790|NCT00791427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935791|NCT00786513|Anti-Infective Agents|anti-infective agents|mesh-list
92935792|NCT00786513|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92935793|NCT00791505|Ciprofloxacin|ciprofloxacin|mesh-list
92935794|NCT00791505|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92935795|NCT00791505|Fluoroquinolones|fluoroquinolones|mesh-list
92935796|NCT00791505|Trimethoprim|trimethoprim|mesh-list
92935797|NCT00791505|Sulfamethoxazole|sulfamethoxazole|mesh-list
92935798|NCT00791505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935799|NCT00791505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935800|NCT00791505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92935801|NCT00791505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935802|NCT00791505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935803|NCT00791505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935804|NCT00791505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935805|NCT00791505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92935806|NCT00791505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92935807|NCT00791505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92935808|NCT00791505|Antimalarials|antimalarials|mesh-ancestor
92935809|NCT00791505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92935810|NCT00791505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92935811|NCT00791505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92935812|NCT00791505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92935813|NCT00791505|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92935814|NCT00791505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935816|NCT02598960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935817|NCT02598960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935818|NCT02598960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92935819|NCT02598960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935820|NCT00426361|Vaccines|vaccines|mesh-list
92935821|NCT00426361|Immunologic Factors|immunologic factors|mesh-ancestor
92935822|NCT00426361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935823|NCT00665847|Etravirine|etravirine|mesh-list
92935824|NCT00665847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92935825|NCT00665847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935826|NCT00665847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935827|NCT00665847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935828|NCT00665847|Antiviral Agents|antiviral agents|mesh-ancestor
92935829|NCT00665847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935830|NCT01030393|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92935831|NCT01030393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92935832|NCT01030393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935833|NCT00783081|Cilostazol|cilostazol|mesh-list
92935834|NCT00783081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92935835|NCT00783081|Autonomic Agents|autonomic agents|mesh-ancestor
92935836|NCT00783081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935837|NCT00783081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935838|NCT00783081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92935839|NCT00783081|Respiratory System Agents|respiratory system agents|mesh-ancestor
92935840|NCT00783081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92935841|NCT00783081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93026477|NCT00402051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92935842|NCT00783081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935843|NCT00783081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92935844|NCT00783081|Vasodilator Agents|vasodilator agents|mesh-ancestor
92935845|NCT00783081|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92935846|NCT00783081|Protective Agents|protective agents|mesh-ancestor
92935847|NCT00783081|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92935848|NCT00783081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92935849|NCT00783081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935850|NCT00426127|Docetaxel|docetaxel|mesh-list
92935851|NCT00426127|Doxorubicin|doxorubicin|mesh-list
92935852|NCT00426127|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92935853|NCT00426127|Enoxaparin|enoxaparin|mesh-list
92935854|NCT00426127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935855|NCT00426127|Tubulin Modulators|tubulin modulators|mesh-ancestor
92935857|NCT00426127|Mitosis Modulators|mitosis modulators|mesh-ancestor
92935858|NCT00426127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935859|NCT00426127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92935860|NCT00426127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92935861|NCT00426127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935862|NCT00426127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935863|NCT00426127|Anticoagulants|anticoagulants|mesh-ancestor
92935864|NCT00426127|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92935865|NCT00426127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92935866|NCT02535078|Durvalumab|durvalumab|mesh-list
92935867|NCT02535078|Tremelimumab|tremelimumab|mesh-list
92935868|NCT02535078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935869|NCT02535078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935870|NCT00425503|Bortezomib|bortezomib|mesh-list
92935871|NCT00425503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935872|NCT00786669|Cefixime|cefixime|mesh-list
92935873|NCT00786669|Cefpodoxime|cefpodoxime|mesh-list
92935874|NCT00786669|Bevacizumab|bevacizumab|mesh-list
92935875|NCT00786669|Irinotecan|irinotecan|mesh-list
92935876|NCT00786669|Vincristine|vincristine|mesh-list
92935877|NCT00786669|Temozolomide|temozolomide|mesh-list
92935878|NCT00786669|Camptothecin|camptothecin|mesh-list
92935879|NCT00786669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935880|NCT00786669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935881|NCT00786669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92935882|NCT00786669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92935883|NCT00786669|Growth Substances|growth substances|mesh-ancestor
92935884|NCT00786669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581302|NCT00086268|Carboplatin|carboplatin|mesh-list
92935885|NCT00786669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92935886|NCT00786669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92935887|NCT00786669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935888|NCT00786669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935889|NCT00786669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935890|NCT00786669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92935891|NCT00786669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92935892|NCT00786669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92935893|NCT00786669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92935894|NCT00786669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92935895|NCT00786669|Alkylating Agents|alkylating agents|mesh-ancestor
92935896|NCT00786669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935897|NCT00786669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935898|NCT00791739|Pregabalin|pregabalin|mesh-list
92935899|NCT00791739|Trazodone|trazodone|mesh-list
92935900|NCT00791739|Analgesics|analgesics|mesh-ancestor
92935901|NCT00791739|Sensory System Agents|sensory system agents|mesh-ancestor
92935902|NCT00791739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935903|NCT00791739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935904|NCT00791739|Anticonvulsants|anticonvulsants|mesh-ancestor
92935905|NCT00791739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92935906|NCT00791739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92935907|NCT00791739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935908|NCT00791739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92935909|NCT00791739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92935910|NCT00791739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92935911|NCT00791739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935912|NCT00791739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92935913|NCT00791739|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92935914|NCT00791739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92935915|NCT00791739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935916|NCT00791739|Serotonin Agents|serotonin agents|mesh-ancestor
92935917|NCT00791739|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92935918|NCT00791739|Antidepressive Agents|antidepressive agents|mesh-ancestor
92935919|NCT00791895|Insulin Aspart|insulin aspart|mesh-list
92935920|NCT00791895|Biphasic Insulins|biphasic insulins|mesh-list
92935921|NCT00791895|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92935922|NCT00791895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92935923|NCT00791895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935924|NCT02503722|Osimertinib|osimertinib|mesh-list
92935925|NCT02503722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935926|NCT02503722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935927|NCT02503722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526532|NCT00028834|Immunoglobulins|immunoglobulins|mesh-list
92935928|NCT02503722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935930|NCT00430573|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92935931|NCT00430573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935932|NCT00430573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92935933|NCT00430573|Antitubercular Agents|antitubercular agents|mesh-ancestor
92935934|NCT00430573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935935|NCT00430573|Antimetabolites|antimetabolites|mesh-ancestor
92935936|NCT00430573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935937|NCT00783393|Temozolomide|temozolomide|mesh-list
92935938|NCT00783393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92935939|NCT00783393|Alkylating Agents|alkylating agents|mesh-ancestor
92935940|NCT00783393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935941|NCT00783393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935942|NCT00783471|Docetaxel|docetaxel|mesh-list
92935943|NCT00783471|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92935944|NCT00783471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935945|NCT00783471|Tubulin Modulators|tubulin modulators|mesh-ancestor
92935946|NCT00783471|Antimitotic Agents|antimitotic agents|mesh-ancestor
92935947|NCT00783471|Mitosis Modulators|mitosis modulators|mesh-ancestor
92935948|NCT00783471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935949|NCT00783471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935950|NCT00783471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935951|NCT02460900|Varenicline|varenicline|mesh-list
92935952|NCT02460900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92935953|NCT02460900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92935954|NCT02460900|Cholinergic Agents|cholinergic agents|mesh-ancestor
92935955|NCT02460900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92935956|NCT02460900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935957|NCT02460900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935958|NCT00787371|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92935959|NCT00787371|Interferon-alpha|interferon-alpha|mesh-list
92935960|NCT00787371|Antiviral Agents|antiviral agents|mesh-ancestor
92935961|NCT00787371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935962|NCT00787371|Immunologic Factors|immunologic factors|mesh-ancestor
92935963|NCT00787371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935964|NCT02075840|Crizotinib|crizotinib|mesh-list
92935965|NCT02075840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935966|NCT02075840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92935967|NCT02075840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935968|NCT02075840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935969|NCT02554695|Denosumab|denosumab|mesh-list
92935970|NCT02554695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92935971|NCT02554695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935972|NCT00792363|Irinotecan|irinotecan|mesh-list
92935973|NCT00792363|Panitumumab|panitumumab|mesh-list
92935974|NCT00792363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92935975|NCT00792363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92935976|NCT00792363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92935977|NCT00792363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92935978|NCT00792363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92935979|NCT00792363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92935980|NCT00425113|Metronidazole|metronidazole|mesh-list
92935981|NCT00425113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92935982|NCT00425113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92935983|NCT00425113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92935984|NCT00425113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92935985|NCT04895280|Triamcinolone|triamcinolone|mesh-list
92935986|NCT04895280|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92935987|NCT04895280|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92935988|NCT04895280|Ketorolac|ketorolac|mesh-list
92935989|NCT04895280|Bupivacaine|bupivacaine|mesh-list
92935990|NCT04895280|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92935991|NCT04895280|Anesthetics, Local|anesthetics, local|mesh-ancestor
92935992|NCT04895280|Anesthetics|anesthetics|mesh-ancestor
92935993|NCT04895280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92935994|NCT04895280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92935995|NCT04895280|Sensory System Agents|sensory system agents|mesh-ancestor
92935996|NCT04895280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92935997|NCT04895280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92935998|NCT04895280|Glucocorticoids|glucocorticoids|mesh-ancestor
92935999|NCT04895280|Hormones|hormones|mesh-ancestor
92936000|NCT04895280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936001|NCT04895280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936002|NCT04895280|Immunologic Factors|immunologic factors|mesh-ancestor
92936003|NCT04895280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936004|NCT04895280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936005|NCT04895280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92936006|NCT04895280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936007|NCT04895280|Analgesics|analgesics|mesh-ancestor
92936008|NCT04895280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936009|NCT04895280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92936010|NCT03994783|Methylprednisolone|methylprednisolone|mesh-list
92936011|NCT03994783|Rituximab|rituximab|mesh-list
92936012|NCT03994783|Immunoglobulins|immunoglobulins|mesh-list
92936013|NCT03994783|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92936014|NCT03994783|gamma-Globulins|gamma-globulins|mesh-list
92936015|NCT03994783|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92936016|NCT03994783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936017|NCT03994783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936018|NCT03994783|Immunologic Factors|immunologic factors|mesh-ancestor
92936019|NCT03994783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936020|NCT03994783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936021|NCT03994783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936022|NCT03994783|Antiemetics|antiemetics|mesh-ancestor
92936023|NCT03994783|Autonomic Agents|autonomic agents|mesh-ancestor
92936024|NCT03994783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936025|NCT03994783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936026|NCT03994783|Glucocorticoids|glucocorticoids|mesh-ancestor
92936027|NCT03994783|Hormones|hormones|mesh-ancestor
92936028|NCT03994783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936029|NCT03994783|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92936030|NCT03994783|Protective Agents|protective agents|mesh-ancestor
92936031|NCT00440011|Bimatoprost|bimatoprost|mesh-list
92936032|NCT00440011|Travoprost|travoprost|mesh-list
92936033|NCT00440011|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92936034|NCT00440011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92936035|NCT00440011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92936036|NCT03105102|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92936037|NCT03105102|Immunologic Factors|immunologic factors|mesh-ancestor
92936038|NCT03105102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936040|NCT01937468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936041|NCT01937468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936042|NCT01937468|Analgesics|analgesics|mesh-ancestor
92936043|NCT01937468|Sensory System Agents|sensory system agents|mesh-ancestor
92936044|NCT01937468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936045|NCT01937468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936046|NCT00663117|Naltrexone|naltrexone|mesh-list
92936047|NCT00663117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92936048|NCT00663117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92936049|NCT00663117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936050|NCT00663117|Sensory System Agents|sensory system agents|mesh-ancestor
92936051|NCT00663117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936052|NCT04072328|Midazolam|midazolam|mesh-list
92936053|NCT04072328|Propofol|propofol|mesh-list
92936054|NCT04072328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92936055|NCT04072328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936056|NCT04072328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936057|NCT04072328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92936058|NCT04072328|Anesthetics, General|anesthetics, general|mesh-ancestor
92936059|NCT04072328|Anesthetics|anesthetics|mesh-ancestor
92936060|NCT04072328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92936061|NCT04072328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92936062|NCT04072328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92936063|NCT04072328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92936064|NCT04072328|GABA Modulators|gaba modulators|mesh-ancestor
92936065|NCT04072328|GABA Agents|gaba agents|mesh-ancestor
92936066|NCT04072328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936067|NCT04072328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936068|NCT00495716|Acyclovir|acyclovir|mesh-list
92936069|NCT00495716|Antiviral Agents|antiviral agents|mesh-ancestor
92936070|NCT00495716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936071|NCT00784017|Asparaginase|asparaginase|mesh-list
92936072|NCT00784017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936073|NCT04074122|Adenosine|adenosine|mesh-list
92936074|NCT04074122|Isoproterenol|isoproterenol|mesh-list
92936075|NCT04074122|Epinephrine|epinephrine|mesh-list
92936076|NCT04074122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92936077|NCT04074122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92936078|NCT04074122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92936079|NCT04074122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936080|NCT04074122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936081|NCT04074122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936082|NCT04074122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92936083|NCT04074122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92936084|NCT04074122|Autonomic Agents|autonomic agents|mesh-ancestor
92936085|NCT04074122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936086|NCT04074122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92936087|NCT04074122|Respiratory System Agents|respiratory system agents|mesh-ancestor
92936088|NCT04074122|Mydriatics|mydriatics|mesh-ancestor
92936089|NCT04074122|Sympathomimetics|sympathomimetics|mesh-ancestor
92936090|NCT04074122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92936091|NCT04074122|Analgesics|analgesics|mesh-ancestor
92936092|NCT04074122|Sensory System Agents|sensory system agents|mesh-ancestor
92936093|NCT04074122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92936094|NCT04074122|Vasodilator Agents|vasodilator agents|mesh-ancestor
92936095|NCT04074122|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92936096|NCT04074122|Purinergic Agonists|purinergic agonists|mesh-ancestor
92936097|NCT04074122|Purinergic Agents|purinergic agents|mesh-ancestor
92936098|NCT04074122|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92936099|NCT04074122|Protective Agents|protective agents|mesh-ancestor
92936100|NCT02578550|Tenofovir|tenofovir|mesh-list
92936101|NCT02578550|Emtricitabine|emtricitabine|mesh-list
92936102|NCT02578550|Darunavir|darunavir|mesh-list
92936103|NCT02578550|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92936104|NCT02578550|Cobicistat|cobicistat|mesh-list
92936105|NCT02578550|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92936106|NCT02578550|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92936107|NCT02578550|Antiviral Agents|antiviral agents|mesh-ancestor
92936108|NCT02578550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936109|NCT02578550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92936110|NCT02578550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92936111|NCT02578550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936112|NCT02578550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936113|NCT02578550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92936114|NCT02578550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92936115|NCT02578550|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92936116|NCT02578550|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92936117|NCT02578550|Protease Inhibitors|protease inhibitors|mesh-ancestor
92936118|NCT02578550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92936119|NCT02578550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92936120|NCT00788463|Beclomethasone|beclomethasone|mesh-list
92936121|NCT00788463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936122|NCT00788463|Glucocorticoids|glucocorticoids|mesh-ancestor
92936123|NCT00788463|Hormones|hormones|mesh-ancestor
92936124|NCT00788463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936125|NCT00788463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936126|NCT00788463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92936127|NCT00788463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92936128|NCT00579254|Amlodipine|amlodipine|mesh-list
92936129|NCT00579254|Atorvastatin|atorvastatin|mesh-list
92936130|NCT00579254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92936131|NCT00579254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92936132|NCT00579254|Antimetabolites|antimetabolites|mesh-ancestor
92936133|NCT00579254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936134|NCT00579254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92936135|NCT00579254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92936136|NCT00579254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936137|NCT00579254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92936138|NCT00579254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92936139|NCT00579254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92936140|NCT00579254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92936141|NCT00579254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936142|NCT00579254|Vasodilator Agents|vasodilator agents|mesh-ancestor
92936143|NCT00793221|Sirolimus|sirolimus|mesh-list
92936144|NCT00793221|Everolimus|everolimus|mesh-list
92936145|NCT00793221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92936146|NCT00793221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936147|NCT00793221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936148|NCT00793221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936149|NCT00793221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936150|NCT00793221|Immunologic Factors|immunologic factors|mesh-ancestor
92936151|NCT00793221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936152|NCT00793221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936153|NCT00793221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92936154|NCT00793221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936155|NCT00793221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92936156|NCT00793221|Antifungal Agents|antifungal agents|mesh-ancestor
92936158|NCT00661089|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92936159|NCT00661089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92936160|NCT00661089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92936161|NCT00661089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92936162|NCT00661089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936163|NCT00661089|Cholinergic Agents|cholinergic agents|mesh-ancestor
92936164|NCT00661089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936165|NCT00661089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936166|NCT00661089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92936167|NCT00661089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936168|NCT01773278|Antioxidants|antioxidants|mesh-list
92936169|NCT01773278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936170|NCT01773278|Protective Agents|protective agents|mesh-ancestor
92936171|NCT01773278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936172|NCT00788931|Paclitaxel|paclitaxel|mesh-list
92936173|NCT00788931|Trastuzumab|trastuzumab|mesh-list
92936174|NCT00788931|Panobinostat|panobinostat|mesh-list
92936175|NCT00788931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92936176|NCT00788931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936177|NCT00788931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936178|NCT00788931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92936179|NCT00788931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936180|NCT00788931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936181|NCT00788931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936182|NCT00788931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92936183|NCT00788931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936184|NCT02577848|Liraglutide|liraglutide|mesh-list
92936185|NCT02577848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92936186|NCT02577848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936187|NCT02577848|Incretins|incretins|mesh-ancestor
92936188|NCT02577848|Hormones|hormones|mesh-ancestor
92936189|NCT02577848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936190|NCT00582426|Octreotide|octreotide|mesh-list
92936191|NCT00582426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936192|NCT00582426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92936193|NCT00582426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936194|NCT00709982|Folic Acid|folic acid|mesh-list
92936195|NCT00709982|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92936196|NCT00709982|Norgestimate|norgestimate|mesh-list
92936197|NCT00709982|Estradiol|estradiol|mesh-list
92936198|NCT00709982|Estrogens|estrogens|mesh-ancestor
92936199|NCT00709982|Hormones|hormones|mesh-ancestor
92936200|NCT00709982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936201|NCT00709982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936202|NCT00709982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92936203|NCT00709982|Contraceptive Agents|contraceptive agents|mesh-ancestor
92936204|NCT00709982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92936205|NCT00709982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92936206|NCT00709982|Hematinics|hematinics|mesh-ancestor
92936207|NCT00709982|Vitamin B Complex|vitamin b complex|mesh-ancestor
92936208|NCT00709982|Vitamins|vitamins|mesh-ancestor
92936209|NCT00709982|Micronutrients|micronutrients|mesh-ancestor
92936210|NCT00709982|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92936211|NCT00709982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92936212|NCT00709982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92936213|NCT04070690|Dialysis Solutions|dialysis solutions|mesh-list
92936214|NCT04070690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92936215|NCT00710138|Vitamins|vitamins|mesh-list
92936216|NCT00710138|Vitamin B 12|vitamin b 12|mesh-list
92936217|NCT00710138|Hydroxocobalamin|hydroxocobalamin|mesh-list
92936218|NCT00710138|Vitamin B Complex|vitamin b complex|mesh-list
92936219|NCT00710138|Micronutrients|micronutrients|mesh-ancestor
92936220|NCT00710138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936221|NCT00710138|Hematinics|hematinics|mesh-ancestor
92936222|NCT00580034|Alemtuzumab|alemtuzumab|mesh-list
92936223|NCT00580034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936224|NCT00580034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936225|NCT00710216|Lamivudine|lamivudine|mesh-list
92936226|NCT00710216|Telbivudine|telbivudine|mesh-list
92936227|NCT00710216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92936228|NCT00710216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92936229|NCT00710216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936230|NCT00710216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936231|NCT00710216|Antiviral Agents|antiviral agents|mesh-ancestor
92936232|NCT00710216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936233|NCT00710216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92936234|NCT00710216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92936235|NCT00773513|Epoetin Alfa|epoetin alfa|mesh-list
92936236|NCT00773513|Darbepoetin alfa|darbepoetin alfa|mesh-list
92936237|NCT00773513|Hematinics|hematinics|mesh-ancestor
92936238|NCT00710528|Idelalisib|idelalisib|mesh-list
92936239|NCT00710528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936240|NCT00710528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936241|NCT00710528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936242|NCT00711074|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92936243|NCT00711074|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92936244|NCT00711074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936245|NCT00711074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92936246|NCT00711074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92936247|NCT00711074|Antiviral Agents|antiviral agents|mesh-ancestor
92936248|NCT00711074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936249|NCT00711308|Vitamin K|vitamin k|mesh-list
92936250|NCT00711308|Tinzaparin|tinzaparin|mesh-list
92936251|NCT00711308|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92936252|NCT00711308|Dalteparin|dalteparin|mesh-list
92936253|NCT00711308|Acenocoumarol|acenocoumarol|mesh-list
92936254|NCT00711308|Vitamins|vitamins|mesh-ancestor
92936255|NCT00711308|Micronutrients|micronutrients|mesh-ancestor
92936256|NCT00711308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936257|NCT00711308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92936258|NCT00711308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92936259|NCT00711308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936260|NCT00711308|Hemostatics|hemostatics|mesh-ancestor
92936261|NCT00711308|Coagulants|coagulants|mesh-ancestor
92936262|NCT00711308|Anticoagulants|anticoagulants|mesh-ancestor
92936263|NCT00711308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92936264|NCT02601911|Acetaminophen|acetaminophen|mesh-list
92936265|NCT02601911|Ketorolac|ketorolac|mesh-list
92936266|NCT02601911|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92936267|NCT02601911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936268|NCT02601911|Analgesics|analgesics|mesh-ancestor
92936269|NCT02601911|Sensory System Agents|sensory system agents|mesh-ancestor
92936270|NCT02601911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936271|NCT02601911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936272|NCT02601911|Antipyretics|antipyretics|mesh-ancestor
92936273|NCT02601911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92936274|NCT02601911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936275|NCT02601911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936276|NCT02601911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92936277|NCT02601911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936278|NCT02601911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936279|NCT00711620|Thymalfasin|thymalfasin|mesh-list
92936280|NCT00711620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92936281|NCT00711620|Immunologic Factors|immunologic factors|mesh-ancestor
92936282|NCT00711620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936283|NCT02577614|Coagulants|coagulants|mesh-list
92936284|NCT02577614|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92936285|NCT02577458|Everolimus|everolimus|mesh-list
92936286|NCT02577458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92936287|NCT02577458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936288|NCT02577458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936289|NCT02577458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936290|NCT02577458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936291|NCT02577458|Immunologic Factors|immunologic factors|mesh-ancestor
92936292|NCT02577458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936293|NCT02577458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936294|NCT00767039|Poractant alfa|poractant alfa|mesh-list
92936295|NCT00767039|Beractant|beractant|mesh-list
92936296|NCT00767039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92936297|NCT00767039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92936298|NCT00662649|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92936299|NCT00662649|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92936300|NCT00662649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936301|NCT00662649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936302|NCT00662649|Immunologic Factors|immunologic factors|mesh-ancestor
92936303|NCT00662649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936304|NCT02577770|Caffeine|caffeine|mesh-list
92936305|NCT02577770|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92936306|NCT02577770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936307|NCT02577770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92936308|NCT02577770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936309|NCT02577770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936310|NCT02577770|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92936311|NCT02577770|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92936312|NCT02577770|Purinergic Agents|purinergic agents|mesh-ancestor
92936313|NCT02577770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936314|NCT00129896|Docetaxel|docetaxel|mesh-list
92936315|NCT00129896|Doxorubicin|doxorubicin|mesh-list
92936316|NCT00129896|Trastuzumab|trastuzumab|mesh-list
92936317|NCT00129896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936318|NCT00129896|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936319|NCT00129896|Antimitotic Agents|antimitotic agents|mesh-ancestor
92936320|NCT00129896|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936321|NCT00129896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936322|NCT00129896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92936323|NCT00129896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92936324|NCT00129896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936325|NCT00129896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936326|NCT00129896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936327|NCT02574338|Alprostadil|alprostadil|mesh-list
92936328|NCT02574338|Misoprostol|misoprostol|mesh-list
92936329|NCT02574338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92936330|NCT02574338|Abortifacient Agents|abortifacient agents|mesh-ancestor
92936331|NCT02574338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92936332|NCT02574338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936333|NCT02574338|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92936334|NCT02574338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936335|NCT02574338|Oxytocics|oxytocics|mesh-ancestor
92936336|NCT02574338|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92936337|NCT02574338|Vasodilator Agents|vasodilator agents|mesh-ancestor
92936338|NCT02574338|Urological Agents|urological agents|mesh-ancestor
92936339|NCT03070392|Pembrolizumab|pembrolizumab|mesh-list
92936340|NCT03070392|Ipilimumab|ipilimumab|mesh-list
92936342|NCT03070392|Imidazole|imidazole|mesh-list
92936343|NCT03070392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936344|NCT03070392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936345|NCT03070392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92936346|NCT03070392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936347|NCT03070392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92936348|NCT03070392|Alkylating Agents|alkylating agents|mesh-ancestor
92936349|NCT03070392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936350|NCT00711698|Analgesics, Opioid|analgesics, opioid|mesh-list
92936351|NCT00711698|Narcotics|narcotics|mesh-ancestor
92936352|NCT00711698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936353|NCT00711698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936354|NCT00711698|Analgesics|analgesics|mesh-ancestor
92936355|NCT00711698|Sensory System Agents|sensory system agents|mesh-ancestor
92936356|NCT00711698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936357|NCT00795171|Docetaxel|docetaxel|mesh-list
92936358|NCT00795171|Sunitinib|sunitinib|mesh-list
92936359|NCT00795171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936360|NCT00795171|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936361|NCT00795171|Antimitotic Agents|antimitotic agents|mesh-ancestor
92936362|NCT00795171|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936363|NCT00795171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936364|NCT00795171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92936365|NCT00795171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92936366|NCT00795171|Growth Substances|growth substances|mesh-ancestor
92936367|NCT00795171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936368|NCT00795171|Growth Inhibitors|growth inhibitors|mesh-ancestor
92936369|NCT00795171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936370|NCT00795171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936371|NCT00711854|Rifampin|rifampin|mesh-list
92936372|NCT00711854|Linezolid|linezolid|mesh-list
92936373|NCT00711854|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92936374|NCT00711854|Trimethoprim|trimethoprim|mesh-list
92936375|NCT00711854|Sulfamethoxazole|sulfamethoxazole|mesh-list
92936376|NCT00711854|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92936377|NCT00711854|Antitubercular Agents|antitubercular agents|mesh-ancestor
92936378|NCT00711854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92936379|NCT00711854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936380|NCT00711854|Leprostatic Agents|leprostatic agents|mesh-ancestor
92936381|NCT00711854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92936382|NCT00711854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936383|NCT00711854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936384|NCT00711854|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92936385|NCT00711854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92936386|NCT00711854|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92936387|NCT00711854|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92936388|NCT00711854|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92936389|NCT00711854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92936390|NCT00711854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92936391|NCT00711854|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92936393|NCT00711854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92936394|NCT00711854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92936395|NCT00711854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92936396|NCT00711854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92936397|NCT00711854|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92936398|NCT00711854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92936399|NCT00795483|Zoledronic Acid|zoledronic acid|mesh-list
92936400|NCT00795483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92164170|NCT01297335|Clonidine|clonidine|mesh-list
92936401|NCT00795483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936402|NCT00712400|Latanoprost|latanoprost|mesh-list
92936403|NCT00712400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92936404|NCT00712400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92936405|NCT00712478|Insulin|insulin|mesh-list
92936406|NCT00712478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92936407|NCT00712478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936408|NCT03015792|Dexamethasone|dexamethasone|mesh-list
92936409|NCT03015792|Dexamethasone acetate|dexamethasone acetate|mesh-list
92936410|NCT03015792|Lenalidomide|lenalidomide|mesh-list
92936411|NCT03015792|Ichthammol|ichthammol|mesh-list
92936412|NCT03015792|BB 1101|bb 1101|mesh-list
92936413|NCT03015792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936414|NCT03015792|Antiemetics|antiemetics|mesh-ancestor
92936415|NCT03015792|Autonomic Agents|autonomic agents|mesh-ancestor
92936416|NCT03015792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936417|NCT03015792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936418|NCT03015792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936419|NCT03015792|Glucocorticoids|glucocorticoids|mesh-ancestor
92936420|NCT03015792|Hormones|hormones|mesh-ancestor
92936421|NCT03015792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936422|NCT03015792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92936423|NCT03015792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936424|NCT03015792|Protease Inhibitors|protease inhibitors|mesh-ancestor
92936425|NCT03015792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936426|NCT03015792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936427|NCT03015792|Immunologic Factors|immunologic factors|mesh-ancestor
92936428|NCT03015792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92936429|NCT03015792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92936430|NCT03015792|Growth Substances|growth substances|mesh-ancestor
92936431|NCT03015792|Growth Inhibitors|growth inhibitors|mesh-ancestor
92936432|NCT03015792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92936433|NCT00789165|Quinidine|quinidine|mesh-list
92936434|NCT00789165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92936435|NCT00789165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92936436|NCT00789165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92936437|NCT00789165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936438|NCT00789165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936439|NCT00789165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936440|NCT00789165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92936441|NCT00789165|Antimalarials|antimalarials|mesh-ancestor
92936442|NCT00789165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92936443|NCT00789165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92936444|NCT00789165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936445|NCT00789165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936446|NCT00789165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92936447|NCT00789165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92936448|NCT00789165|Cholinergic Agents|cholinergic agents|mesh-ancestor
92936449|NCT00789165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92936450|NCT00789165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92936451|NCT00789165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92281337|NCT00002331|Ethambutol|ethambutol|mesh-list
92936452|NCT00789165|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92936453|NCT00789165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92936454|NCT00712556|Fluorides|fluorides|mesh-list
92936455|NCT00712556|Cariostatic Agents|cariostatic agents|mesh-ancestor
92936456|NCT00712556|Protective Agents|protective agents|mesh-ancestor
92936457|NCT00712556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936458|NCT00772967|Naproxen|naproxen|mesh-list
92936459|NCT00772967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92936460|NCT00772967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936461|NCT00772967|Analgesics|analgesics|mesh-ancestor
92936462|NCT00772967|Sensory System Agents|sensory system agents|mesh-ancestor
92936463|NCT00772967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936464|NCT00772967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936465|NCT00772967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936466|NCT00772967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936467|NCT00772967|Gout Suppressants|gout suppressants|mesh-ancestor
92936468|NCT00772967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92164184|NCT05498129|Micronutrients|micronutrients|mesh-list
92936469|NCT00772967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936470|NCT00772967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936471|NCT00793377|Tamoxifen|tamoxifen|mesh-list
92936472|NCT00793377|Cyclophosphamide|cyclophosphamide|mesh-list
92936473|NCT00793377|Docetaxel|docetaxel|mesh-list
92936474|NCT00793377|Doxorubicin|doxorubicin|mesh-list
92936475|NCT00793377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92936476|NCT00793377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936477|NCT00793377|Immunologic Factors|immunologic factors|mesh-ancestor
92936478|NCT00793377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936479|NCT00793377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936480|NCT00793377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92936481|NCT00793377|Alkylating Agents|alkylating agents|mesh-ancestor
92936482|NCT00793377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936483|NCT00793377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936484|NCT00793377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92936485|NCT00793377|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936486|NCT00793377|Antimitotic Agents|antimitotic agents|mesh-ancestor
92936487|NCT00793377|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936488|NCT00793377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92936489|NCT00793377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92936490|NCT00793377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936491|NCT00793377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936492|NCT00793377|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92936493|NCT00793377|Hormone Antagonists|hormone antagonists|mesh-ancestor
92936494|NCT00793377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936495|NCT00793377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92936496|NCT00793377|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92936497|NCT00793377|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92936498|NCT00793377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92936499|NCT00662259|Alprazolam|alprazolam|mesh-list
92936500|NCT00662259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92936501|NCT00662259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936502|NCT00662259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936503|NCT00662259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92936504|NCT00662259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92936505|NCT00662259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92936506|NCT00662259|GABA Modulators|gaba modulators|mesh-ancestor
92936507|NCT00662259|GABA Agents|gaba agents|mesh-ancestor
92936508|NCT00662259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936509|NCT00662259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936510|NCT00712790|Sorafenib|sorafenib|mesh-list
92936511|NCT00712790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936512|NCT00712790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936513|NCT00712790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936514|NCT00712790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936515|NCT00660699|Gemcitabine|gemcitabine|mesh-list
92936516|NCT00660699|Docetaxel|docetaxel|mesh-list
92936517|NCT00660699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92936518|NCT00660699|Antimetabolites|antimetabolites|mesh-ancestor
92936519|NCT00660699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936520|NCT00660699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936521|NCT00660699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936522|NCT00660699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92936523|NCT00660699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936524|NCT02577068|Propacetamol|propacetamol|mesh-list
92936525|NCT02577068|Nefopam|nefopam|mesh-list
92936526|NCT02577068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936527|NCT02577068|Analgesics|analgesics|mesh-ancestor
92936528|NCT02577068|Sensory System Agents|sensory system agents|mesh-ancestor
92936529|NCT02577068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936530|NCT02577068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936531|NCT02577068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92936532|NCT02577068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936533|NCT02577068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936534|NCT00582114|Atenolol|atenolol|mesh-list
92936535|NCT00582114|Lisinopril|lisinopril|mesh-list
92936536|NCT00582114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92936537|NCT00582114|Protease Inhibitors|protease inhibitors|mesh-ancestor
92936538|NCT00582114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936539|NCT00582114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936540|NCT00582114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92936541|NCT00582114|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92936542|NCT00582114|Protective Agents|protective agents|mesh-ancestor
92936543|NCT00582114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936544|NCT00582114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92936545|NCT00582114|Sympatholytics|sympatholytics|mesh-ancestor
92936546|NCT00582114|Autonomic Agents|autonomic agents|mesh-ancestor
92936547|NCT00582114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936548|NCT00582114|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92936549|NCT00582114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92936550|NCT00582114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92936551|NCT00582114|Adrenergic Agents|adrenergic agents|mesh-ancestor
92936552|NCT00582114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936553|NCT00582036|Insulin|insulin|mesh-list
92936554|NCT00582036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92936555|NCT00582036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92936556|NCT00582036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936557|NCT00581360|Doxorubicin|doxorubicin|mesh-list
92936558|NCT00581360|Bortezomib|bortezomib|mesh-list
92936559|NCT00581360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92936560|NCT00581360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936561|NCT00581360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92936562|NCT00581360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936563|NCT00581360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936564|NCT00581360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936565|NCT01650792|Aspirin|aspirin|mesh-list
92936566|NCT01650792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92936567|NCT01650792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936568|NCT01650792|Analgesics|analgesics|mesh-ancestor
92936569|NCT01650792|Sensory System Agents|sensory system agents|mesh-ancestor
92936570|NCT01650792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936571|NCT01650792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936572|NCT01650792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936573|NCT01650792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936574|NCT01650792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92936575|NCT01650792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92936576|NCT01650792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936577|NCT01650792|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92936578|NCT01650792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92936579|NCT01650792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936580|NCT01650792|Antipyretics|antipyretics|mesh-ancestor
92936581|NCT00660387|Levodopa|levodopa|mesh-list
92936582|NCT00660387|Carbidopa|carbidopa|mesh-list
92936583|NCT00660387|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92936584|NCT00660387|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92936585|NCT00660387|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92936586|NCT00660387|Dopamine Agents|dopamine agents|mesh-ancestor
92936587|NCT00660387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936588|NCT00660387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936589|NCT00660387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936590|NCT00660387|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92936591|NCT00660387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936592|NCT00660387|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92936593|NCT00660387|Immunologic Factors|immunologic factors|mesh-ancestor
92936594|NCT00660387|Dopamine Agonists|dopamine agonists|mesh-ancestor
92936595|NCT00582738|Everolimus|everolimus|mesh-list
92936596|NCT00582738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92936597|NCT00582738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936598|NCT00582738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936599|NCT00582738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936600|NCT00582738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936601|NCT00582738|Immunologic Factors|immunologic factors|mesh-ancestor
92936602|NCT00582738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936603|NCT00582738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936605|NCT00713336|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92936606|NCT00713336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92936607|NCT00713336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936608|NCT00713336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92936609|NCT00713336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936610|NCT00713336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936611|NCT00713336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936612|NCT00713336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936613|NCT00713336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92936614|NCT00713336|Contraceptive Agents|contraceptive agents|mesh-ancestor
92936615|NCT00713336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92936616|NCT00713336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936617|NCT00713336|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92936618|NCT00713336|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92936619|NCT00713336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92936620|NCT00789711|Insulin|insulin|mesh-list
92936621|NCT00789711|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92936622|NCT00789711|Insulin Aspart|insulin aspart|mesh-list
92936623|NCT00789711|Insulin Detemir|insulin detemir|mesh-list
92936624|NCT00789711|Biphasic Insulins|biphasic insulins|mesh-list
92936625|NCT00789711|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92936626|NCT00789711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92936627|NCT00789711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936628|NCT00713726|Fentanyl|fentanyl|mesh-list
92936629|NCT00713726|Tramadol|tramadol|mesh-list
92936630|NCT00713726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92936631|NCT00713726|Narcotics|narcotics|mesh-ancestor
92936632|NCT00713726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936633|NCT00713726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936634|NCT00713726|Analgesics|analgesics|mesh-ancestor
92936635|NCT00713726|Sensory System Agents|sensory system agents|mesh-ancestor
92936636|NCT00713726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936637|NCT00713726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92582049|NCT00302692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92936638|NCT00713726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92936639|NCT00713726|Anesthetics, General|anesthetics, general|mesh-ancestor
92936641|NCT00800553|Donepezil|donepezil|mesh-list
92936642|NCT00800553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92936643|NCT00800553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936644|NCT00800553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936645|NCT00800553|Cholinergic Agents|cholinergic agents|mesh-ancestor
92936646|NCT00800553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936647|NCT00800553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936648|NCT00800553|Nootropic Agents|nootropic agents|mesh-ancestor
92936649|NCT00793767|Epoetin Alfa|epoetin alfa|mesh-list
92936650|NCT00793767|Hematinics|hematinics|mesh-ancestor
92936651|NCT00796029|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92936652|NCT00796029|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92936653|NCT00796029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92936654|NCT00796029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936655|NCT00796029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936656|NCT00796029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92936657|NCT00796029|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92936658|NCT00796029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92936659|NCT00796029|Serotonin Agents|serotonin agents|mesh-ancestor
92936660|NCT00796029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936661|NCT00796029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936662|NCT00796029|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92936663|NCT00796029|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92936664|NCT00796029|Dopamine Agents|dopamine agents|mesh-ancestor
92936665|NCT00793845|Cyclophosphamide|cyclophosphamide|mesh-list
92936666|NCT00793845|Melphalan|melphalan|mesh-list
92936667|NCT00793845|Thiotepa|thiotepa|mesh-list
92936668|NCT00793845|Carboplatin|carboplatin|mesh-list
92936669|NCT00793845|Etoposide|etoposide|mesh-list
92936670|NCT00793845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936671|NCT00793845|Immunologic Factors|immunologic factors|mesh-ancestor
92936672|NCT00793845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936674|NCT00793845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92936675|NCT00793845|Alkylating Agents|alkylating agents|mesh-ancestor
92936676|NCT00793845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936677|NCT00793845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936678|NCT00793845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92936679|NCT00793845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92936680|NCT00793845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92936681|NCT00793845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936682|NCT00793845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936683|NCT00800709|Memantine|memantine|mesh-list
92936684|NCT00800709|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92936685|NCT00800709|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92936686|NCT00800709|Dopamine Agents|dopamine agents|mesh-ancestor
92936687|NCT00800709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936688|NCT00800709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936689|NCT00800709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936690|NCT00800709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92936691|NCT00800709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92936692|NCT00793923|Dexamethasone|dexamethasone|mesh-list
92936693|NCT00793923|Ranibizumab|ranibizumab|mesh-list
92936694|NCT00793923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936695|NCT00793923|Antiemetics|antiemetics|mesh-ancestor
92936696|NCT00793923|Autonomic Agents|autonomic agents|mesh-ancestor
92936697|NCT00793923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936698|NCT00793923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936699|NCT00793923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936700|NCT00793923|Glucocorticoids|glucocorticoids|mesh-ancestor
92936701|NCT00793923|Hormones|hormones|mesh-ancestor
92936702|NCT00793923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936703|NCT00793923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92936704|NCT00793923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936705|NCT00793923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92936706|NCT00793923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92936707|NCT00793923|Growth Substances|growth substances|mesh-ancestor
92936708|NCT00793923|Growth Inhibitors|growth inhibitors|mesh-ancestor
92936709|NCT01247324|Interferons|interferons|mesh-list
92936710|NCT01247324|Interferon-beta|interferon-beta|mesh-list
92936711|NCT01247324|Interferon beta-1a|interferon beta-1a|mesh-list
92936712|NCT01247324|Ocrelizumab|ocrelizumab|mesh-list
92936713|NCT01247324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936714|NCT01247324|Antiviral Agents|antiviral agents|mesh-ancestor
92936715|NCT01247324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936716|NCT01247324|Immunologic Factors|immunologic factors|mesh-ancestor
92936717|NCT01247324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936718|NCT01247324|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92936719|NCT00772577|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92936720|NCT00772577|Ramipril|ramipril|mesh-list
92936721|NCT00772577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92936722|NCT00772577|Diuretics|diuretics|mesh-ancestor
92936723|NCT00772577|Natriuretic Agents|natriuretic agents|mesh-ancestor
92936724|NCT00772577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936725|NCT00772577|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92936726|NCT00772577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92936727|NCT00772577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936728|NCT00772577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92936729|NCT00772577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92936730|NCT00772577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936731|NCT02345850|Cyclophosphamide|cyclophosphamide|mesh-list
92936732|NCT02345850|Methotrexate|methotrexate|mesh-list
92936733|NCT02345850|Tacrolimus|tacrolimus|mesh-list
92936734|NCT02345850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936735|NCT02345850|Immunologic Factors|immunologic factors|mesh-ancestor
92936736|NCT02345850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936737|NCT02345850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936738|NCT02345850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92936739|NCT02345850|Alkylating Agents|alkylating agents|mesh-ancestor
92936740|NCT02345850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936741|NCT02345850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936742|NCT02345850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92936743|NCT02345850|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92936744|NCT02345850|Abortifacient Agents|abortifacient agents|mesh-ancestor
92936745|NCT02345850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526542|NCT00028834|Antimetabolites|antimetabolites|mesh-ancestor
92936746|NCT02345850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92936747|NCT02345850|Antimetabolites|antimetabolites|mesh-ancestor
92936748|NCT02345850|Dermatologic Agents|dermatologic agents|mesh-ancestor
92936749|NCT02345850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936750|NCT02345850|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92936751|NCT02345850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92936752|NCT02345850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92936753|NCT00800787|Immunoglobulins|immunoglobulins|mesh-list
92936754|NCT00800787|Immunologic Factors|immunologic factors|mesh-ancestor
92936755|NCT00800787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936756|NCT04073550|Topotecan|topotecan|mesh-list
92936757|NCT04073550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92936758|NCT04073550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936759|NCT04073550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026478|NCT00401973|Metformin|metformin|mesh-list
92936760|NCT04073550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936761|NCT04073550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936762|NCT02576600|Remifentanil|remifentanil|mesh-list
92936763|NCT02576600|Propofol|propofol|mesh-list
92936764|NCT02576600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92936765|NCT02576600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936766|NCT02576600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936767|NCT02576600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92936768|NCT02576600|Anesthetics, General|anesthetics, general|mesh-ancestor
92936769|NCT02576600|Anesthetics|anesthetics|mesh-ancestor
92936770|NCT02576600|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92936771|NCT02576600|Narcotics|narcotics|mesh-ancestor
92936772|NCT02576600|Analgesics|analgesics|mesh-ancestor
92936773|NCT02576600|Sensory System Agents|sensory system agents|mesh-ancestor
92936774|NCT02576600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936775|NCT02863770|Pancrelipase|pancrelipase|mesh-list
92936776|NCT02863770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936777|NCT00796185|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92936778|NCT00796185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92936779|NCT00796185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92936780|NCT00796185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936781|NCT00796185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936782|NCT00796185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92936783|NCT00796185|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92936784|NCT00796185|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92936785|NCT00796185|Serotonin Agents|serotonin agents|mesh-ancestor
92936786|NCT00796185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936787|NCT00796185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582210|NCT00303745|Irinotecan|irinotecan|mesh-list
92936788|NCT00796185|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92936789|NCT00796185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92936790|NCT00796185|Dopamine Agents|dopamine agents|mesh-ancestor
92936791|NCT00660309|Irbesartan|irbesartan|mesh-list
92936792|NCT00660309|Captopril|captopril|mesh-list
92936793|NCT00660309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92936794|NCT00660309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92936795|NCT00660309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92936796|NCT00660309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936797|NCT00660309|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92936798|NCT00660309|Protease Inhibitors|protease inhibitors|mesh-ancestor
92936799|NCT00660309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936800|NCT04046133|Pembrolizumab|pembrolizumab|mesh-list
92936801|NCT04046133|Capecitabine|capecitabine|mesh-list
92936802|NCT04046133|Mitomycins|mitomycins|mesh-list
92936803|NCT04046133|Mitomycin|mitomycin|mesh-list
92936804|NCT04046133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936805|NCT04046133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936806|NCT04046133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92936807|NCT04046133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936808|NCT04046133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92936809|NCT04046133|Antimetabolites|antimetabolites|mesh-ancestor
92936810|NCT04046133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92936811|NCT04046133|Alkylating Agents|alkylating agents|mesh-ancestor
92936812|NCT04046133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92936813|NCT04046133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936814|NCT02573714|Ketamine|ketamine|mesh-list
92936815|NCT02573714|Analgesics|analgesics|mesh-ancestor
92936816|NCT02573714|Sensory System Agents|sensory system agents|mesh-ancestor
92936817|NCT02573714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936818|NCT02573714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281712|NCT00002451|Ritonavir|ritonavir|mesh-list
92936819|NCT02573714|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92936820|NCT02573714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92936822|NCT02573714|Anesthetics|anesthetics|mesh-ancestor
92936823|NCT02573714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936824|NCT02573714|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92936825|NCT02573714|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92936826|NCT02573714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936827|NCT02573714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936828|NCT00794235|Sorafenib|sorafenib|mesh-list
92936829|NCT00794235|Dacarbazine|dacarbazine|mesh-list
92936830|NCT00794235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164195|NCT01270659|Analgesics|analgesics|mesh-ancestor
92936831|NCT00794235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936832|NCT00794235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936833|NCT00794235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936834|NCT00794235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92936835|NCT00794235|Alkylating Agents|alkylating agents|mesh-ancestor
92936836|NCT00800943|Alemtuzumab|alemtuzumab|mesh-list
92936837|NCT00800943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936838|NCT00800943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936839|NCT02575664|Buprenorphine|buprenorphine|mesh-list
92936840|NCT02575664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92936841|NCT02575664|Narcotics|narcotics|mesh-ancestor
92936842|NCT02575664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936843|NCT02575664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936844|NCT02575664|Analgesics|analgesics|mesh-ancestor
92936845|NCT02575664|Sensory System Agents|sensory system agents|mesh-ancestor
92936846|NCT02575664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936847|NCT02575664|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92936848|NCT00796497|Ondansetron|ondansetron|mesh-list
92936849|NCT00796497|Antiemetics|antiemetics|mesh-ancestor
92936850|NCT00796497|Autonomic Agents|autonomic agents|mesh-ancestor
92936851|NCT00796497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936852|NCT00796497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936853|NCT00796497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936854|NCT00796497|Antipruritics|antipruritics|mesh-ancestor
92936855|NCT00796497|Dermatologic Agents|dermatologic agents|mesh-ancestor
92936856|NCT00796497|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92936857|NCT00796497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92936858|NCT00796497|Serotonin Agents|serotonin agents|mesh-ancestor
92936859|NCT00796497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936860|NCT00796497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936861|NCT04330820|Venetoclax|venetoclax|mesh-list
92936862|NCT04330820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936864|NCT00801177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92936865|NCT00801177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92936866|NCT00801177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936867|NCT00801177|Immunologic Factors|immunologic factors|mesh-ancestor
92936868|NCT00801177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936869|NCT00581100|Etanercept|etanercept|mesh-list
92936870|NCT00581100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92936871|NCT00581100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92936872|NCT00581100|Analgesics|analgesics|mesh-ancestor
92936873|NCT00581100|Sensory System Agents|sensory system agents|mesh-ancestor
92936874|NCT00581100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936875|NCT00581100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936876|NCT00581100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92936877|NCT00581100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936878|NCT00581100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936879|NCT00581100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936880|NCT00581100|Immunologic Factors|immunologic factors|mesh-ancestor
92936881|NCT00579098|Atorvastatin|atorvastatin|mesh-list
92936882|NCT00579098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92936883|NCT00579098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92936884|NCT00579098|Antimetabolites|antimetabolites|mesh-ancestor
92936885|NCT00579098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936886|NCT00579098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92936887|NCT00579098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92936888|NCT00579098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936889|NCT00772109|Vaccines|vaccines|mesh-list
92936890|NCT00772109|Immunologic Factors|immunologic factors|mesh-ancestor
92936891|NCT00772109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936892|NCT00801255|Lactams|lactams|mesh-list
92936894|NCT00801255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936895|NCT00794625|Valproic Acid|valproic acid|mesh-list
92936896|NCT00794625|Risperidone|risperidone|mesh-list
92936897|NCT00794625|Dextroamphetamine|dextroamphetamine|mesh-list
92936898|NCT00794625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92936899|NCT00794625|Serotonin Agents|serotonin agents|mesh-ancestor
92936900|NCT00794625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936901|NCT00794625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936902|NCT00794625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936903|NCT00794625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92936904|NCT00794625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92936905|NCT00794625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936906|NCT00794625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92936907|NCT00794625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92936908|NCT00794625|Dopamine Agents|dopamine agents|mesh-ancestor
92936909|NCT00794625|Anticonvulsants|anticonvulsants|mesh-ancestor
92936910|NCT00794625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936911|NCT00794625|GABA Agents|gaba agents|mesh-ancestor
92936912|NCT00794625|Antimanic Agents|antimanic agents|mesh-ancestor
92936913|NCT00794625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92936914|NCT00794625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92936915|NCT00794625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92936916|NCT00794625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92936917|NCT02577432|Fentanyl|fentanyl|mesh-list
92936918|NCT02577432|Bupivacaine|bupivacaine|mesh-list
92936919|NCT02577432|Anesthetics, Local|anesthetics, local|mesh-ancestor
92936920|NCT02577432|Anesthetics|anesthetics|mesh-ancestor
92936921|NCT02577432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92936922|NCT02577432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936923|NCT02577432|Sensory System Agents|sensory system agents|mesh-ancestor
92936924|NCT02577432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92936925|NCT02577432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92936926|NCT02577432|Narcotics|narcotics|mesh-ancestor
92936927|NCT02577432|Analgesics|analgesics|mesh-ancestor
92936928|NCT02577432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92936929|NCT02577432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92936930|NCT02577432|Anesthetics, General|anesthetics, general|mesh-ancestor
92936931|NCT00794703|Itraconazole|itraconazole|mesh-list
92936932|NCT00794703|Micafungin|micafungin|mesh-list
92936933|NCT00794703|Antifungal Agents|antifungal agents|mesh-ancestor
92936934|NCT00794703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92936935|NCT00794703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92936936|NCT00794703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92936937|NCT00794703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936938|NCT00794703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936939|NCT00794703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92936940|NCT00794703|Hormone Antagonists|hormone antagonists|mesh-ancestor
92936941|NCT00794703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92936942|NCT00794703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936943|NCT00794703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92936944|NCT00772031|Topiramate|topiramate|mesh-list
92936945|NCT00772031|Propranolol|propranolol|mesh-list
92936946|NCT00772031|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92936947|NCT00772031|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92936948|NCT00772031|Adrenergic Agents|adrenergic agents|mesh-ancestor
92936949|NCT00772031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92936950|NCT00772031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936951|NCT00772031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936952|NCT00772031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92936953|NCT00772031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92936954|NCT00772031|Vasodilator Agents|vasodilator agents|mesh-ancestor
92936955|NCT00772031|Anticonvulsants|anticonvulsants|mesh-ancestor
92936956|NCT00772031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92936957|NCT00801411|Cyclophosphamide|cyclophosphamide|mesh-list
92936958|NCT00801411|Docetaxel|docetaxel|mesh-list
92936959|NCT00801411|Doxorubicin|doxorubicin|mesh-list
92936960|NCT00801411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92936961|NCT00801411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92936962|NCT00801411|Immunologic Factors|immunologic factors|mesh-ancestor
92936963|NCT00801411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936964|NCT00801411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92936965|NCT00801411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92936966|NCT00801411|Alkylating Agents|alkylating agents|mesh-ancestor
92936967|NCT00801411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936968|NCT00801411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936969|NCT00801411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92936970|NCT00801411|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936971|NCT00801411|Antimitotic Agents|antimitotic agents|mesh-ancestor
92164203|NCT01270659|Antipyretics|antipyretics|mesh-ancestor
92936972|NCT00801411|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936973|NCT00801411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92936974|NCT00801411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92936975|NCT00801411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92936976|NCT00801411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936977|NCT00794859|Sorafenib|sorafenib|mesh-list
92936978|NCT00794859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936979|NCT00794859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92936980|NCT00794859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936981|NCT00794859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936982|NCT04940013|Misoprostol|misoprostol|mesh-list
92936983|NCT04940013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92936984|NCT04940013|Abortifacient Agents|abortifacient agents|mesh-ancestor
92936985|NCT04940013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92936986|NCT04940013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92936987|NCT04940013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92936988|NCT04940013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92936989|NCT04940013|Oxytocics|oxytocics|mesh-ancestor
92936990|NCT00771953|Docetaxel|docetaxel|mesh-list
92936991|NCT00771953|Pemetrexed|pemetrexed|mesh-list
92936992|NCT00771953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92936993|NCT00771953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92936994|NCT00771953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92936995|NCT00771953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92936996|NCT00771953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92936997|NCT00771953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92936998|NCT00771953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92936999|NCT00771953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92937000|NCT00714584|Naltrexone|naltrexone|mesh-list
92937001|NCT00714584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92937002|NCT00714584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92937003|NCT00714584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937004|NCT00714584|Sensory System Agents|sensory system agents|mesh-ancestor
92937005|NCT00714584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937006|NCT00621244|Panobinostat|panobinostat|mesh-list
92937007|NCT00621244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937008|NCT00621244|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92937009|NCT00621244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937010|NCT00621244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937011|NCT00916409|Temozolomide|temozolomide|mesh-list
92582421|NCT00082277|Anastrozole|anastrozole|mesh-list
92937012|NCT00916409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92937013|NCT00916409|Alkylating Agents|alkylating agents|mesh-ancestor
92937014|NCT00916409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937015|NCT00916409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937016|NCT00714740|Acetazolamide|acetazolamide|mesh-list
92937017|NCT00714740|Anticonvulsants|anticonvulsants|mesh-ancestor
92937018|NCT00714740|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92937019|NCT00714740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937020|NCT00714740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937021|NCT00714740|Diuretics|diuretics|mesh-ancestor
92937022|NCT00714740|Natriuretic Agents|natriuretic agents|mesh-ancestor
92937023|NCT00714740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937024|NCT00659529|Sildenafil Citrate|sildenafil citrate|mesh-list
92937025|NCT00659529|Vasodilator Agents|vasodilator agents|mesh-ancestor
92937026|NCT00659529|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92937027|NCT00659529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92937028|NCT00659529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937029|NCT00659529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937030|NCT00659529|Urological Agents|urological agents|mesh-ancestor
92937031|NCT02575508|Fluorouracil|fluorouracil|mesh-list
92937032|NCT02575508|Oxaliplatin|oxaliplatin|mesh-list
92937033|NCT02575508|Irinotecan|irinotecan|mesh-list
92937034|NCT02575508|Camptothecin|camptothecin|mesh-list
92937035|NCT02575508|Infigratinib|infigratinib|mesh-list
92937036|NCT02575508|Antimetabolites|antimetabolites|mesh-ancestor
92937037|NCT02575508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937038|NCT02575508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92937039|NCT02575508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937040|NCT02575508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937041|NCT02575508|Immunologic Factors|immunologic factors|mesh-ancestor
92937042|NCT02575508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937043|NCT02575508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92937045|NCT02575508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937046|NCT02575508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92937047|NCT00795015|Insulin|insulin|mesh-list
92937048|NCT00795015|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92937049|NCT00795015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937050|NCT00795015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937051|NCT00796887|Niacin|niacin|mesh-list
92937052|NCT00796887|Niacinamide|niacinamide|mesh-list
92937053|NCT00796887|Nicotinic Acids|nicotinic acids|mesh-list
92937054|NCT00796887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937055|NCT00796887|Antimetabolites|antimetabolites|mesh-ancestor
92937056|NCT00796887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937057|NCT00796887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937058|NCT00796887|Vasodilator Agents|vasodilator agents|mesh-ancestor
92937059|NCT00796887|Vitamin B Complex|vitamin b complex|mesh-ancestor
92937060|NCT00796887|Vitamins|vitamins|mesh-ancestor
92937061|NCT00796887|Micronutrients|micronutrients|mesh-ancestor
92937062|NCT00796887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937063|NCT00578942|Alemtuzumab|alemtuzumab|mesh-list
92937064|NCT00578942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937065|NCT00578942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937066|NCT00843934|Epirubicin|epirubicin|mesh-list
92937067|NCT00843934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937068|NCT00843934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92937069|NCT00843934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92937070|NCT00843934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92937071|NCT00843934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937072|NCT00843934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937073|NCT00805701|Dutasteride|dutasteride|mesh-list
92937074|NCT00805701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92937075|NCT00805701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92937076|NCT00805701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937077|NCT00805701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937078|NCT00805701|Hormone Antagonists|hormone antagonists|mesh-ancestor
92937079|NCT00805701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937080|NCT00805701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937081|NCT04042948|Acetaminophen|acetaminophen|mesh-list
92937082|NCT04042948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937083|NCT04042948|Analgesics|analgesics|mesh-ancestor
92937084|NCT04042948|Sensory System Agents|sensory system agents|mesh-ancestor
92937085|NCT04042948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937086|NCT04042948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937087|NCT04042948|Antipyretics|antipyretics|mesh-ancestor
92937088|NCT00765245|Rituximab|rituximab|mesh-list
92937089|NCT00765245|Lenalidomide|lenalidomide|mesh-list
92937090|NCT00765245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937091|NCT00765245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937092|NCT00765245|Immunologic Factors|immunologic factors|mesh-ancestor
92937093|NCT00765245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937094|NCT00765245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937095|NCT00765245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92937096|NCT00765245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92937097|NCT00765245|Growth Substances|growth substances|mesh-ancestor
92937098|NCT00765245|Growth Inhibitors|growth inhibitors|mesh-ancestor
92937099|NCT00801879|Mupirocin|mupirocin|mesh-list
92937100|NCT00801879|Calcium|calcium|mesh-list
92937101|NCT00801879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92937102|NCT00801879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937103|NCT00801879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92937104|NCT00801879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937105|NCT00801879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92937106|NCT00801879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937107|NCT00801879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937108|NCT00718484|Doxorubicin|doxorubicin|mesh-list
92937109|NCT00718484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92937110|NCT00718484|Isophosphamide mustard|isophosphamide mustard|mesh-list
92937111|NCT00718484|Ifosfamide|ifosfamide|mesh-list
92937112|NCT00718484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92937113|NCT00718484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937114|NCT00718484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92937115|NCT00718484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92937116|NCT00718484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937117|NCT00718484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026479|NCT00401973|Amantadine|amantadine|mesh-list
92937118|NCT00718484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92937119|NCT00718484|Alkylating Agents|alkylating agents|mesh-ancestor
92937121|NCT00841126|Trace Elements|trace elements|mesh-ancestor
92937122|NCT00841126|Micronutrients|micronutrients|mesh-ancestor
92937123|NCT00841126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937124|NCT00805857|Tipranavir|tipranavir|mesh-list
92937125|NCT00805857|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937126|NCT00805857|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937127|NCT00805857|Antiviral Agents|antiviral agents|mesh-ancestor
92937128|NCT00805857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937129|NCT00801957|Hydrocortisone|hydrocortisone|mesh-list
92937130|NCT00801957|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92937131|NCT00801957|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92937132|NCT00801957|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92937133|NCT00801957|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
92937134|NCT00801957|Tacrolimus|tacrolimus|mesh-list
92937135|NCT00801957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937136|NCT00801957|Immunologic Factors|immunologic factors|mesh-ancestor
92937137|NCT00801957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937138|NCT00801957|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92937139|NCT00801957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937140|NCT00801957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937141|NCT00801957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937142|NCT00801957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92937143|NCT00836134|Bupivacaine|bupivacaine|mesh-list
92937144|NCT00836134|Anesthetics, Local|anesthetics, local|mesh-list
92937145|NCT00836134|Anesthetics|anesthetics|mesh-list
92937146|NCT00836134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937147|NCT00836134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937148|NCT00836134|Sensory System Agents|sensory system agents|mesh-ancestor
92937149|NCT00836134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937150|NCT00782795|Pioglitazone|pioglitazone|mesh-list
92937151|NCT00782795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937152|NCT00782795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937153|NCT02573558|Dexmedetomidine|dexmedetomidine|mesh-list
92937154|NCT02573558|Propofol|propofol|mesh-list
92937155|NCT02573558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92937156|NCT02573558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937157|NCT02573558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937158|NCT02573558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937159|NCT02573558|Analgesics|analgesics|mesh-ancestor
92937160|NCT02573558|Sensory System Agents|sensory system agents|mesh-ancestor
92937161|NCT02573558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937162|NCT02573558|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92937163|NCT02573558|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92937164|NCT02573558|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92937165|NCT02573558|Adrenergic Agents|adrenergic agents|mesh-ancestor
92937166|NCT02573558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937167|NCT02573558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937168|NCT02573558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92937169|NCT02573558|Anesthetics, General|anesthetics, general|mesh-ancestor
92937170|NCT02573558|Anesthetics|anesthetics|mesh-ancestor
92937171|NCT00656799|Bromides|bromides|mesh-list
92937172|NCT00656799|Rocuronium|rocuronium|mesh-list
92937173|NCT00656799|Anticonvulsants|anticonvulsants|mesh-ancestor
92937174|NCT00656799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92937175|NCT00656799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92937176|NCT00656799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92937177|NCT00656799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937178|NCT00656799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937179|NCT00764699|Mecasermin|mecasermin|mesh-list
92937180|NCT00764699|Growth Substances|growth substances|mesh-ancestor
92937181|NCT00764699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937182|NCT00844012|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92937183|NCT00844012|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92937184|NCT00844012|Estradiol|estradiol|mesh-list
92937185|NCT00844012|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92937186|NCT00844012|Estrogens|estrogens|mesh-ancestor
92937187|NCT00844012|Hormones|hormones|mesh-ancestor
92937188|NCT00844012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937189|NCT00844012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937190|NCT00844012|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92937191|NCT00844012|Contraceptive Agents|contraceptive agents|mesh-ancestor
92937192|NCT00844012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92937193|NCT00844012|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92937194|NCT02574962|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92937195|NCT02574962|Hormones|hormones|mesh-ancestor
92937196|NCT02574962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937197|NCT02574962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937198|NCT00802035|Baclofen|baclofen|mesh-list
92937199|NCT00802035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92937200|NCT00802035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937201|NCT00802035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92937202|NCT00802035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937203|NCT00802035|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92937204|NCT00802035|GABA Agonists|gaba agonists|mesh-ancestor
92937205|NCT00802035|GABA Agents|gaba agents|mesh-ancestor
92937206|NCT00802035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937207|NCT00802035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937208|NCT00836212|Efavirenz|efavirenz|mesh-list
92937209|NCT00836212|Lopinavir|lopinavir|mesh-list
92937210|NCT00836212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92937211|NCT00836212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92937212|NCT00836212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937213|NCT00836212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937214|NCT00836212|Antiviral Agents|antiviral agents|mesh-ancestor
92937215|NCT00836212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937216|NCT00836212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92937217|NCT00836212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92937218|NCT00836212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92937219|NCT00836212|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92937220|NCT00836212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92937221|NCT00836212|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92937222|NCT00836212|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92937223|NCT00836212|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92937224|NCT00836212|Protease Inhibitors|protease inhibitors|mesh-ancestor
92937225|NCT00836212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937226|NCT00836212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937227|NCT00836212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92937228|NCT00782717|Prednisolone|prednisolone|mesh-list
92937229|NCT00782717|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92937230|NCT00782717|Methylprednisolone|methylprednisolone|mesh-list
92937231|NCT00782717|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92937232|NCT00782717|Prednisolone acetate|prednisolone acetate|mesh-list
92937233|NCT00782717|Nepafenac|nepafenac|mesh-list
92937234|NCT00782717|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92937235|NCT00782717|Prednisolone phosphate|prednisolone phosphate|mesh-list
92937236|NCT00782717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937237|NCT00782717|Glucocorticoids|glucocorticoids|mesh-ancestor
92937238|NCT00782717|Hormones|hormones|mesh-ancestor
92582645|NCT00082940|Denileukin diftitox|denileukin diftitox|mesh-list
92937239|NCT00782717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937240|NCT00782717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937241|NCT00782717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92937242|NCT00782717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937243|NCT00782717|Antiemetics|antiemetics|mesh-ancestor
92937244|NCT00782717|Autonomic Agents|autonomic agents|mesh-ancestor
92937245|NCT00782717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937246|NCT00782717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92937247|NCT00782717|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92937248|NCT00782717|Protective Agents|protective agents|mesh-ancestor
92937249|NCT00782717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92937250|NCT00782717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937251|NCT00782717|Analgesics|analgesics|mesh-ancestor
92937252|NCT00782717|Sensory System Agents|sensory system agents|mesh-ancestor
92937253|NCT00782717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937254|NCT00656175|Raltegravir Potassium|raltegravir potassium|mesh-list
92937255|NCT00656175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937256|NCT00656175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937257|NCT00656175|Antiviral Agents|antiviral agents|mesh-ancestor
92937258|NCT00656175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937259|NCT00656175|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92937260|NCT00656175|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92937261|NCT00656175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937262|NCT00656175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937263|NCT02601677|Fluoxetine|fluoxetine|mesh-list
92937264|NCT02601677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92937265|NCT02601677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92937266|NCT02601677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937267|NCT02601677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937268|NCT02601677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937269|NCT02601677|Serotonin Agents|serotonin agents|mesh-ancestor
92937270|NCT02601677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937271|NCT02601677|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92937272|NCT02601677|Antidepressive Agents|antidepressive agents|mesh-ancestor
92937273|NCT02601677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92937274|NCT02601677|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92937275|NCT02601677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92937276|NCT02601677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937277|NCT00620776|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92937278|NCT00620776|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92937279|NCT00620776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92937280|NCT00620776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937281|NCT00620776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937282|NCT00620776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937283|NCT00620776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937284|NCT00620776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92937285|NCT00620776|Antidepressive Agents|antidepressive agents|mesh-ancestor
92937286|NCT00620776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92937287|NCT05479097|Antihypertensive Agents|antihypertensive agents|mesh-list
92937288|NCT00656019|Vitamin D|vitamin d|mesh-list
92937289|NCT00656019|Calcipotriene|calcipotriene|mesh-list
92937290|NCT00656019|Vitamins|vitamins|mesh-ancestor
92937291|NCT00656019|Micronutrients|micronutrients|mesh-ancestor
92937292|NCT00656019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937293|NCT00656019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92937294|NCT00656019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92937295|NCT00841438|Abciximab|abciximab|mesh-list
92937296|NCT00841438|Anticoagulants|anticoagulants|mesh-ancestor
92937297|NCT00841438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92937298|NCT00841516|Immunomodulating Agents|immunomodulating agents|mesh-list
92937299|NCT00841516|Immunologic Factors|immunologic factors|mesh-ancestor
92937300|NCT00841516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937301|NCT00841594|Nitroglycerin|nitroglycerin|mesh-list
92937302|NCT00841594|Vasodilator Agents|vasodilator agents|mesh-ancestor
92937303|NCT04068974|Apatinib|apatinib|mesh-list
92937304|NCT04068974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937305|NCT04068974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92937306|NCT04068974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937307|NCT04068974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937308|NCT00836368|Vitamin E|vitamin e|mesh-list
92937309|NCT00836368|Tocopherols|tocopherols|mesh-list
92937310|NCT00836368|Tocotrienols|tocotrienols|mesh-list
92937311|NCT00836368|alpha-Tocopherol|alpha-tocopherol|mesh-list
92937312|NCT00836368|gamma-Tocopherol|gamma-tocopherol|mesh-list
92937313|NCT00836368|Vitamins|vitamins|mesh-ancestor
92937314|NCT00836368|Micronutrients|micronutrients|mesh-ancestor
92937315|NCT00836368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937316|NCT00836368|Antioxidants|antioxidants|mesh-ancestor
92937317|NCT00836368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937318|NCT00836368|Protective Agents|protective agents|mesh-ancestor
92937319|NCT00718796|Coenzyme Q10|coenzyme q10|mesh-list
92937320|NCT00718796|Ubiquinone|ubiquinone|mesh-list
92937321|NCT00718796|Atorvastatin|atorvastatin|mesh-list
92937322|NCT00718796|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92937323|NCT00718796|Simvastatin|simvastatin|mesh-list
92937324|NCT00718796|Pravastatin|pravastatin|mesh-list
92937325|NCT00718796|Lovastatin|lovastatin|mesh-list
92937326|NCT00718796|L 647318|l 647318|mesh-list
92937327|NCT00718796|Dihydromevinolin|dihydromevinolin|mesh-list
92937328|NCT00718796|Anticholesteremic Agents|anticholesteremic agents|mesh-list
92937329|NCT00718796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937330|NCT00718796|Antimetabolites|antimetabolites|mesh-ancestor
92937331|NCT00718796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937332|NCT00718796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937333|NCT00718796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92937334|NCT00718796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937335|NCT00718796|Vitamins|vitamins|mesh-ancestor
92937336|NCT00718796|Micronutrients|micronutrients|mesh-ancestor
92937337|NCT00718796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937338|NCT00844168|Sorafenib|sorafenib|mesh-list
92937339|NCT00844168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937340|NCT00844168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92937341|NCT00844168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937342|NCT00844168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937343|NCT02573168|Psychotropic Drugs|psychotropic drugs|mesh-list
92937344|NCT00764465|Ritonavir|ritonavir|mesh-list
92937345|NCT00764465|Fosamprenavir|fosamprenavir|mesh-list
92937346|NCT00764465|Maraviroc|maraviroc|mesh-list
92937347|NCT00764465|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92937348|NCT00764465|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92937349|NCT00764465|Protease Inhibitors|protease inhibitors|mesh-ancestor
92937350|NCT00764465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937351|NCT00764465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937352|NCT00764465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937353|NCT00764465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937354|NCT00764465|Antiviral Agents|antiviral agents|mesh-ancestor
92937355|NCT00764465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937356|NCT00764465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92937357|NCT00764465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92937358|NCT00764465|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92937359|NCT00764465|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92937360|NCT00764465|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92937361|NCT00655863|Pioglitazone|pioglitazone|mesh-list
92937362|NCT00655863|Alogliptin|alogliptin|mesh-list
92937363|NCT00655863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937364|NCT00655863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937365|NCT00655863|Incretins|incretins|mesh-ancestor
92937366|NCT00655863|Hormones|hormones|mesh-ancestor
92937367|NCT00655863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937368|NCT00655863|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92937369|NCT00655863|Protease Inhibitors|protease inhibitors|mesh-ancestor
92937370|NCT00655863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937371|NCT00655863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937372|NCT00718952|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92937373|NCT00718952|Vasodilator Agents|vasodilator agents|mesh-ancestor
92937374|NCT00718952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92937375|NCT00718952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92937376|NCT00718952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937377|NCT00718952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937378|NCT00718952|Urological Agents|urological agents|mesh-ancestor
92937379|NCT00781937|Liraglutide|liraglutide|mesh-list
92937380|NCT00781937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937381|NCT00781937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937382|NCT00781937|Incretins|incretins|mesh-ancestor
92937383|NCT00781937|Hormones|hormones|mesh-ancestor
92937384|NCT00781937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937385|NCT00802581|Anesthetics|anesthetics|mesh-list
92937386|NCT00802581|Anesthetics, Local|anesthetics, local|mesh-list
92937387|NCT00802581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937388|NCT00802581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582795|NCT00120822|Folic Acid|folic acid|mesh-list
92937390|NCT00802581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937391|NCT00719108|Insulin|insulin|mesh-list
92937392|NCT00719108|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92937393|NCT00719108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937394|NCT00719108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937395|NCT00842140|Metformin|metformin|mesh-list
92937396|NCT00842140|Spironolactone|spironolactone|mesh-list
92937397|NCT00842140|Contraceptive Agents|contraceptive agents|mesh-list
92937398|NCT00842140|Contraceptives, Oral|contraceptives, oral|mesh-list
92937399|NCT00842140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937400|NCT00842140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937401|NCT00842140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92937402|NCT00842140|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92937403|NCT00842140|Hormone Antagonists|hormone antagonists|mesh-ancestor
92937404|NCT00842140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937405|NCT00842140|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92937406|NCT00842140|Diuretics|diuretics|mesh-ancestor
92937407|NCT00842140|Natriuretic Agents|natriuretic agents|mesh-ancestor
92937408|NCT00842140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92937409|NCT00806169|Triamcinolone|triamcinolone|mesh-list
92937410|NCT00806169|Bevacizumab|bevacizumab|mesh-list
92937411|NCT00806169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937412|NCT00806169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937413|NCT00806169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92937414|NCT00806169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92937415|NCT00806169|Growth Substances|growth substances|mesh-ancestor
92937416|NCT00806169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937417|NCT00806169|Growth Inhibitors|growth inhibitors|mesh-ancestor
92937418|NCT00806169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937419|NCT00806169|Glucocorticoids|glucocorticoids|mesh-ancestor
92937420|NCT00806169|Hormones|hormones|mesh-ancestor
92937421|NCT00806169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937422|NCT00844324|Candesartan|candesartan|mesh-list
92937423|NCT00844324|Candesartan cilexetil|candesartan cilexetil|mesh-list
92937424|NCT00844324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92937425|NCT00844324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92937426|NCT00844324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92937427|NCT00844324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937428|NCT00802815|Etanercept|etanercept|mesh-list
92937429|NCT00802815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92937430|NCT00802815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937431|NCT00802815|Analgesics|analgesics|mesh-ancestor
92937432|NCT00802815|Sensory System Agents|sensory system agents|mesh-ancestor
92937433|NCT00802815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937434|NCT00802815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937435|NCT00802815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937436|NCT00802815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937437|NCT00802815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92937438|NCT00802815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937439|NCT00802815|Immunologic Factors|immunologic factors|mesh-ancestor
92937440|NCT04100759|Sildenafil Citrate|sildenafil citrate|mesh-list
92937441|NCT04100759|Vasodilator Agents|vasodilator agents|mesh-ancestor
92937442|NCT04100759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92937443|NCT04100759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92937444|NCT04100759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937445|NCT04100759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937446|NCT04100759|Urological Agents|urological agents|mesh-ancestor
92937447|NCT00836914|Idelalisib|idelalisib|mesh-list
92937448|NCT00836914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937449|NCT00836914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937450|NCT00836914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937451|NCT00844402|Atorvastatin|atorvastatin|mesh-list
92937452|NCT00844402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92937453|NCT00844402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937454|NCT00844402|Antimetabolites|antimetabolites|mesh-ancestor
92937455|NCT00844402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937456|NCT00844402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937457|NCT00844402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92937458|NCT00844402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937459|NCT00806247|Tapentadol|tapentadol|mesh-list
92937460|NCT00806247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92937461|NCT00806247|Narcotics|narcotics|mesh-ancestor
92582885|NCT00308503|SR 46349B|sr 46349b|mesh-list
92937462|NCT00806247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937463|NCT00806247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937464|NCT00806247|Analgesics|analgesics|mesh-ancestor
92937465|NCT00806247|Sensory System Agents|sensory system agents|mesh-ancestor
92937466|NCT00806247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937467|NCT00806247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92937468|NCT00806247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92937469|NCT00806247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937470|NCT00806247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937471|NCT00806247|Adrenergic Agents|adrenergic agents|mesh-ancestor
92937472|NCT00806247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937473|NCT00797745|Ritonavir|ritonavir|mesh-list
92937474|NCT00797745|Ribavirin|ribavirin|mesh-list
92937475|NCT00797745|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92937476|NCT00797745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92937477|NCT00797745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92937478|NCT00797745|Protease Inhibitors|protease inhibitors|mesh-ancestor
92937479|NCT00797745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937480|NCT00797745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937481|NCT00797745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937482|NCT00797745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937483|NCT00797745|Antiviral Agents|antiviral agents|mesh-ancestor
92937484|NCT00797745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937485|NCT00797745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92937486|NCT00797745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92937487|NCT00797745|Antimetabolites|antimetabolites|mesh-ancestor
92937488|NCT00659373|Tamoxifen|tamoxifen|mesh-list
92937489|NCT00659373|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92937490|NCT00659373|Exemestane|exemestane|mesh-list
92937491|NCT00659373|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92937492|NCT00659373|Hormone Antagonists|hormone antagonists|mesh-ancestor
92937493|NCT00659373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937494|NCT00659373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937495|NCT00659373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92937496|NCT00659373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937497|NCT00659373|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92937498|NCT00659373|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92937499|NCT00659373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92937500|NCT00659373|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92937501|NCT00659373|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92937502|NCT00659373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937503|NCT00659373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937504|NCT00659373|Luteolytic Agents|luteolytic agents|mesh-ancestor
92937505|NCT00659373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92937506|NCT00659373|Contraceptive Agents|contraceptive agents|mesh-ancestor
92937507|NCT00659373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92937508|NCT00659373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92937509|NCT00842452|Topotecan|topotecan|mesh-list
92937510|NCT00842452|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92937511|NCT00842452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92937512|NCT00842452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937513|NCT00842452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937514|NCT00842452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937515|NCT02552745|Parecoxib|parecoxib|mesh-list
92937516|NCT02552745|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92937517|NCT02552745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92937518|NCT02552745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937519|NCT02552745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937520|NCT02552745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92937521|NCT02552745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937522|NCT02552745|Analgesics|analgesics|mesh-ancestor
92937523|NCT02552745|Sensory System Agents|sensory system agents|mesh-ancestor
92937524|NCT02552745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937525|NCT02552745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937526|NCT02552745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937527|NCT02552745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937528|NCT02547844|Tenofovir|tenofovir|mesh-list
92937529|NCT02547844|Efavirenz|efavirenz|mesh-list
92937530|NCT02547844|Emtricitabine|emtricitabine|mesh-list
92937531|NCT02547844|Antiviral Agents|antiviral agents|mesh-ancestor
92937532|NCT02547844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937533|NCT02547844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92937534|NCT02547844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92937535|NCT02547844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937536|NCT02547844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937537|NCT02547844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937538|NCT02547844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937539|NCT02547844|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92937540|NCT02547844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92937541|NCT02547844|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92937542|NCT02547844|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92937543|NCT02547844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92937544|NCT02547844|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92937546|NCT00439777|Rivaroxaban|rivaroxaban|mesh-list
92937547|NCT00439777|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92937548|NCT00439777|Antithrombins|antithrombins|mesh-ancestor
92937549|NCT00439777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92937550|NCT00439777|Protease Inhibitors|protease inhibitors|mesh-ancestor
92937551|NCT00439777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937552|NCT00439777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937553|NCT00439777|Anticoagulants|anticoagulants|mesh-ancestor
92937554|NCT00439777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92937555|NCT00439777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92937556|NCT00842686|Bevacizumab|bevacizumab|mesh-list
92937557|NCT00842686|Capecitabine|capecitabine|mesh-list
92937558|NCT00842686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937559|NCT00842686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937560|NCT00842686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92937561|NCT00842686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92937562|NCT00842686|Growth Substances|growth substances|mesh-ancestor
92937563|NCT00842686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937564|NCT00842686|Growth Inhibitors|growth inhibitors|mesh-ancestor
92937565|NCT00842686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92937566|NCT00842686|Antimetabolites|antimetabolites|mesh-ancestor
92937567|NCT00842686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937569|NCT04045821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92937570|NCT04045821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92937571|NCT04045821|Antiviral Agents|antiviral agents|mesh-ancestor
92937572|NCT04045821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937573|NCT00803439|Clobetasol|clobetasol|mesh-list
92937574|NCT00803439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937575|NCT00803439|Glucocorticoids|glucocorticoids|mesh-ancestor
92937576|NCT00803439|Hormones|hormones|mesh-ancestor
92937577|NCT00803439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937578|NCT00803439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937579|NCT00806481|Sevelamer|sevelamer|mesh-list
92937580|NCT00806481|Chelating Agents|chelating agents|mesh-ancestor
92937581|NCT00806481|Sequestering Agents|sequestering agents|mesh-ancestor
92937582|NCT00806481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937583|NCT00709436|Ketamine|ketamine|mesh-list
92937584|NCT00709436|Analgesics|analgesics|mesh-ancestor
92937585|NCT00709436|Sensory System Agents|sensory system agents|mesh-ancestor
92937586|NCT00709436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937587|NCT00709436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937588|NCT00709436|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92937589|NCT00709436|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92937590|NCT00709436|Anesthetics, General|anesthetics, general|mesh-ancestor
92937591|NCT00709436|Anesthetics|anesthetics|mesh-ancestor
92937592|NCT00709436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937593|NCT00709436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92937594|NCT00709436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92937595|NCT00709436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026480|NCT00401973|Zonisamide|zonisamide|mesh-list
93026481|NCT00401973|Olanzapine|olanzapine|mesh-list
92937596|NCT00709436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937597|NCT00844792|Vitamin D|vitamin d|mesh-list
92937598|NCT00844792|Cholecalciferol|cholecalciferol|mesh-list
92937599|NCT00844792|Vitamins|vitamins|mesh-list
92937600|NCT00844792|Vitamin E|vitamin e|mesh-list
92937601|NCT00844792|Selenium|selenium|mesh-list
92937602|NCT00844792|Lycopene|lycopene|mesh-list
92937603|NCT00844792|Micronutrients|micronutrients|mesh-ancestor
92937604|NCT00844792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937605|NCT00844792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92937606|NCT00844792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92937607|NCT00844792|Antioxidants|antioxidants|mesh-ancestor
92937608|NCT00844792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583022|NCT00088491|Serotonin Agents|serotonin agents|mesh-ancestor
92937609|NCT00844792|Protective Agents|protective agents|mesh-ancestor
92937610|NCT00844792|Trace Elements|trace elements|mesh-ancestor
92937611|NCT00844792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937612|NCT00844792|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92937613|NCT00844792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92937614|NCT00844792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937615|NCT00719420|Amoxicillin|amoxicillin|mesh-list
92937616|NCT00719420|Metronidazole|metronidazole|mesh-list
92937617|NCT00719420|Clarithromycin|clarithromycin|mesh-list
92937618|NCT00719420|Omeprazole|omeprazole|mesh-list
92937619|NCT00719420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92937620|NCT00719420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937621|NCT00719420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92937622|NCT00719420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92937623|NCT00719420|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92937624|NCT00719420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92937625|NCT00719420|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92937626|NCT00719420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937627|NCT00719420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937628|NCT00719420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92937629|NCT00719420|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92937630|NCT00719420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92937631|NCT00803829|Sulfalene|sulfalene|mesh-list
92937632|NCT00803829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937634|NCT00803829|Antimalarials|antimalarials|mesh-ancestor
92937635|NCT00803829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92937636|NCT00803829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92937637|NCT00716612|Ubiquinone|ubiquinone|mesh-list
92937638|NCT00716612|Coenzyme Q10|coenzyme q10|mesh-list
92937639|NCT00716612|Micronutrients|micronutrients|mesh-ancestor
92937640|NCT00716612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937641|NCT00716612|Vitamins|vitamins|mesh-ancestor
92937642|NCT00842920|Simvastatin|simvastatin|mesh-list
92937643|NCT00842920|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92937644|NCT00842920|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937645|NCT00842920|Antimetabolites|antimetabolites|mesh-ancestor
92937646|NCT00842920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937647|NCT00842920|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937648|NCT00842920|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92937649|NCT00842920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937650|NCT00842998|Trastuzumab|trastuzumab|mesh-list
92937651|NCT00842998|Lapatinib|lapatinib|mesh-list
92937652|NCT00842998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937653|NCT00842998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937654|NCT00842998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92937655|NCT00842998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937656|NCT00842998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937657|NCT00716846|Atorvastatin|atorvastatin|mesh-list
92937658|NCT00716846|Simvastatin|simvastatin|mesh-list
92937659|NCT00716846|Pitavastatin|pitavastatin|mesh-list
92937660|NCT00716846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92937661|NCT00716846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937662|NCT00716846|Antimetabolites|antimetabolites|mesh-ancestor
92937663|NCT00716846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937664|NCT00716846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937665|NCT00716846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92937666|NCT00716846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937667|NCT00620854|Calcitonin|calcitonin|mesh-list
92937668|NCT00620854|Salmon calcitonin|salmon calcitonin|mesh-list
92937669|NCT00620854|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92937670|NCT00620854|Katacalcin|katacalcin|mesh-list
92937671|NCT00620854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92937672|NCT00620854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937673|NCT00620854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92937674|NCT00620854|Vasodilator Agents|vasodilator agents|mesh-ancestor
92937675|NCT00716924|Clopidogrel|clopidogrel|mesh-list
92937676|NCT00716924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92937677|NCT00716924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92937678|NCT00716924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92937679|NCT00716924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92937680|NCT00716924|Purinergic Agents|purinergic agents|mesh-ancestor
92937681|NCT00716924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937682|NCT00716924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937683|NCT00716924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937684|NCT00430027|Capecitabine|capecitabine|mesh-list
92937685|NCT00430027|Oxaliplatin|oxaliplatin|mesh-list
92937686|NCT00430027|Cetuximab|cetuximab|mesh-list
92937687|NCT00430027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92937688|NCT00430027|Antimetabolites|antimetabolites|mesh-ancestor
92937689|NCT00430027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937690|NCT00430027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937691|NCT00430027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937692|NCT04766229|Gabapentin|gabapentin|mesh-list
92937693|NCT04766229|Citalopram|citalopram|mesh-list
92937694|NCT04766229|Analgesics|analgesics|mesh-ancestor
92937695|NCT04766229|Sensory System Agents|sensory system agents|mesh-ancestor
92937696|NCT04766229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937697|NCT04766229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937698|NCT04766229|Anticonvulsants|anticonvulsants|mesh-ancestor
92937699|NCT04766229|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92937700|NCT04766229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92937701|NCT04766229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937702|NCT04766229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92937703|NCT04766229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92937704|NCT04766229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92937705|NCT04766229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937706|NCT04766229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937707|NCT04766229|Antimanic Agents|antimanic agents|mesh-ancestor
92937708|NCT04766229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92937709|NCT04766229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92937710|NCT04766229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937711|NCT04766229|Serotonin Agents|serotonin agents|mesh-ancestor
92937712|NCT04766229|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92937713|NCT04766229|Antidepressive Agents|antidepressive agents|mesh-ancestor
92937714|NCT04068506|Gabapentin|gabapentin|mesh-list
92937715|NCT04068506|Analgesics|analgesics|mesh-ancestor
92937716|NCT04068506|Sensory System Agents|sensory system agents|mesh-ancestor
92937717|NCT04068506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937718|NCT04068506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937719|NCT04068506|Anticonvulsants|anticonvulsants|mesh-ancestor
92937720|NCT04068506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92937721|NCT04068506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92937722|NCT04068506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937723|NCT04068506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92937724|NCT04068506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92937725|NCT04068506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92937726|NCT04068506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937727|NCT04068506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937728|NCT04068506|Antimanic Agents|antimanic agents|mesh-ancestor
92937729|NCT00803907|Imiquimod|imiquimod|mesh-list
92937730|NCT00803907|Immunologic Factors|immunologic factors|mesh-list
92937731|NCT00803907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92937732|NCT00803907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937733|NCT00803907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937734|NCT00803907|Interferon Inducers|interferon inducers|mesh-ancestor
92937735|NCT00843154|Candesartan|candesartan|mesh-list
92937736|NCT00843154|Candesartan cilexetil|candesartan cilexetil|mesh-list
92937737|NCT00843154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92937738|NCT00843154|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92937739|NCT00843154|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92937740|NCT00843154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937741|NCT00429793|Sirolimus|sirolimus|mesh-list
92937742|NCT00429793|Temsirolimus|temsirolimus|mesh-list
92937743|NCT00429793|MTOR Inhibitors|mtor inhibitors|mesh-list
92937744|NCT00429793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92937745|NCT00429793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937746|NCT00429793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937747|NCT00429793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937748|NCT00429793|Immunologic Factors|immunologic factors|mesh-ancestor
92937749|NCT00429793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937750|NCT00429793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937751|NCT00429793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92937752|NCT00429793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937753|NCT00429793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92937754|NCT00429793|Antifungal Agents|antifungal agents|mesh-ancestor
92937755|NCT00806871|Methylprednisolone|methylprednisolone|mesh-list
92937756|NCT00806871|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92937757|NCT00806871|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92937758|NCT00806871|Prednisolone|prednisolone|mesh-list
92937759|NCT00806871|Prednisolone acetate|prednisolone acetate|mesh-list
92937760|NCT00806871|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92937761|NCT00806871|Prednisolone phosphate|prednisolone phosphate|mesh-list
92937762|NCT00806871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937763|NCT00806871|Antiemetics|antiemetics|mesh-ancestor
92937764|NCT00806871|Autonomic Agents|autonomic agents|mesh-ancestor
92937765|NCT00806871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937766|NCT00806871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937767|NCT00806871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92937768|NCT00806871|Glucocorticoids|glucocorticoids|mesh-ancestor
92937770|NCT00806871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937771|NCT00806871|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92937772|NCT00806871|Protective Agents|protective agents|mesh-ancestor
92937773|NCT00806871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92937774|NCT00806871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937775|NCT00798213|Gemtuzumab|gemtuzumab|mesh-list
92937776|NCT00798213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92937777|NCT00798213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937778|NCT00798213|Immunotoxins|immunotoxins|mesh-ancestor
92526552|NCT00028912|Carboplatin|carboplatin|mesh-list
92937780|NCT00798213|Immunologic Factors|immunologic factors|mesh-ancestor
92937781|NCT00798213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937782|NCT04069208|Cytarabine|cytarabine|mesh-list
92937783|NCT04069208|Idarubicin|idarubicin|mesh-list
92937784|NCT04069208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92937785|NCT04069208|Antimetabolites|antimetabolites|mesh-ancestor
92937786|NCT04069208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937787|NCT04069208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937788|NCT04069208|Antiviral Agents|antiviral agents|mesh-ancestor
92937789|NCT04069208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937790|NCT04069208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937791|NCT04069208|Immunologic Factors|immunologic factors|mesh-ancestor
92937792|NCT04069208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937793|NCT04069208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92937794|NCT04069208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92937795|NCT04069208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92937796|NCT04069208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937797|NCT00845104|Bevacizumab|bevacizumab|mesh-list
92937798|NCT00845104|Rituximab|rituximab|mesh-list
92937799|NCT00845104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92937800|NCT00845104|Fludarabine|fludarabine|mesh-list
92937801|NCT00845104|Fludarabine phosphate|fludarabine phosphate|mesh-list
92937802|NCT00845104|Antibodies|antibodies|mesh-list
92937803|NCT00845104|Immunoglobulins|immunoglobulins|mesh-list
92937804|NCT00845104|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92937805|NCT00845104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937806|NCT00845104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92937807|NCT00845104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92937808|NCT00845104|Growth Substances|growth substances|mesh-ancestor
92937809|NCT00845104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937810|NCT00845104|Growth Inhibitors|growth inhibitors|mesh-ancestor
92937811|NCT00845104|Immunologic Factors|immunologic factors|mesh-ancestor
92937812|NCT00845104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937813|NCT00845104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92937814|NCT00845104|Antimetabolites|antimetabolites|mesh-ancestor
92937815|NCT00845104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937816|NCT00845104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937817|NCT00763451|Metformin|metformin|mesh-list
92937818|NCT00763451|Lixisenatide|lixisenatide|mesh-list
92937819|NCT00763451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937820|NCT00763451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937821|NCT00762762|Triclosan|triclosan|mesh-list
92937822|NCT00762762|Fluorides|fluorides|mesh-list
92937823|NCT00762762|Cariostatic Agents|cariostatic agents|mesh-ancestor
92937824|NCT00762762|Protective Agents|protective agents|mesh-ancestor
92937825|NCT00762762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937826|NCT00762762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92937827|NCT00762762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937828|NCT00762762|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92583246|NCT00309673|Anesthetics|anesthetics|mesh-ancestor
92937829|NCT00762762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937830|NCT00762762|Antimetabolites|antimetabolites|mesh-ancestor
92937831|NCT00762762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937832|NCT00762762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937833|NCT00424489|Methylprednisolone|methylprednisolone|mesh-list
92937834|NCT00424489|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92937835|NCT00424489|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92937836|NCT00424489|Prednisolone|prednisolone|mesh-list
92937837|NCT00424489|Prednisolone acetate|prednisolone acetate|mesh-list
92937838|NCT00424489|Cyclophosphamide|cyclophosphamide|mesh-list
92937839|NCT00424489|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92937840|NCT00424489|Prednisolone phosphate|prednisolone phosphate|mesh-list
92937841|NCT00424489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937842|NCT00424489|Immunologic Factors|immunologic factors|mesh-ancestor
92937843|NCT00424489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937844|NCT00424489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937845|NCT00424489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92937846|NCT00424489|Alkylating Agents|alkylating agents|mesh-ancestor
92937847|NCT00424489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937848|NCT00424489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937849|NCT00424489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92937850|NCT00424489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937851|NCT00424489|Antiemetics|antiemetics|mesh-ancestor
92526556|NCT00028951|Hemostatics|hemostatics|mesh-ancestor
92937853|NCT00424489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937854|NCT00424489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92937855|NCT00424489|Glucocorticoids|glucocorticoids|mesh-ancestor
92937856|NCT00424489|Hormones|hormones|mesh-ancestor
92937857|NCT00424489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937858|NCT00424489|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92937859|NCT00424489|Protective Agents|protective agents|mesh-ancestor
92937860|NCT00424489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92937861|NCT00578864|Cyclophosphamide|cyclophosphamide|mesh-list
92937862|NCT00578864|Doxorubicin|doxorubicin|mesh-list
92937863|NCT00578864|Etoposide|etoposide|mesh-list
92937864|NCT00578864|Etoposide phosphate|etoposide phosphate|mesh-list
92937865|NCT00578864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937866|NCT00578864|Immunologic Factors|immunologic factors|mesh-ancestor
92937867|NCT00578864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937868|NCT00578864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937869|NCT00578864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92937870|NCT00578864|Alkylating Agents|alkylating agents|mesh-ancestor
92937871|NCT00578864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937872|NCT00578864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937873|NCT00578864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92937874|NCT00578864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92937875|NCT00578864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92937876|NCT00578864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92937877|NCT00578864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937878|NCT00578864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92937879|NCT01034683|Leucovorin|leucovorin|mesh-list
92937880|NCT01034683|Antidotes|antidotes|mesh-ancestor
92937881|NCT01034683|Protective Agents|protective agents|mesh-ancestor
92937882|NCT01034683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937883|NCT01034683|Vitamin B Complex|vitamin b complex|mesh-ancestor
92937884|NCT01034683|Vitamins|vitamins|mesh-ancestor
92937885|NCT01034683|Micronutrients|micronutrients|mesh-ancestor
92937886|NCT00717470|Mycophenolic Acid|mycophenolic acid|mesh-list
92937887|NCT00717470|Prednisone|prednisone|mesh-list
92937888|NCT00717470|Methylprednisolone|methylprednisolone|mesh-list
92937889|NCT00717470|Tacrolimus|tacrolimus|mesh-list
92937890|NCT00717470|Basiliximab|basiliximab|mesh-list
92937891|NCT00717470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937892|NCT00717470|Glucocorticoids|glucocorticoids|mesh-ancestor
92937893|NCT00717470|Hormones|hormones|mesh-ancestor
92937894|NCT00717470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937895|NCT00717470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937896|NCT00717470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92937897|NCT00717470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937898|NCT00717470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92937899|NCT00717470|Immunologic Factors|immunologic factors|mesh-ancestor
92937900|NCT00717470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92937901|NCT00717470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937902|NCT00717470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937903|NCT00717470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92937904|NCT00717470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92937905|NCT00717470|Antitubercular Agents|antitubercular agents|mesh-ancestor
92937906|NCT00717470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92937907|NCT00717470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937908|NCT00717470|Antiemetics|antiemetics|mesh-ancestor
92937909|NCT00717470|Autonomic Agents|autonomic agents|mesh-ancestor
92937910|NCT00717470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937911|NCT00717470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92937912|NCT00717470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92937913|NCT00717470|Protective Agents|protective agents|mesh-ancestor
92937915|NCT00631566|Triclosan|triclosan|mesh-list
92937916|NCT00631566|Hexachlorophene|hexachlorophene|mesh-list
92937917|NCT00631566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92937918|NCT00631566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937919|NCT00631566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92937920|NCT00631566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937921|NCT00631566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526557|NCT00028951|Coagulants|coagulants|mesh-ancestor
92937922|NCT00631566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92937923|NCT00631566|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92937924|NCT00631566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92937925|NCT00631566|Antimetabolites|antimetabolites|mesh-ancestor
92937926|NCT00631566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92937927|NCT00722852|Ketoprofen|ketoprofen|mesh-list
92937928|NCT00722852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92937929|NCT00722852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937930|NCT00722852|Analgesics|analgesics|mesh-ancestor
92937931|NCT00722852|Sensory System Agents|sensory system agents|mesh-ancestor
92937932|NCT00722852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937933|NCT00722852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937934|NCT00722852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92937935|NCT00722852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92937936|NCT00722852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92937937|NCT00722852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92937938|NCT00722852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937939|NCT05657444|Tenecteplase|tenecteplase|mesh-list
92937940|NCT05657444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92937941|NCT05657444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92937942|NCT05657444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937943|NCT01410942|Methylphenidate|methylphenidate|mesh-list
92937944|NCT01410942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92937945|NCT01410942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937946|NCT01410942|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92937947|NCT01410942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92937948|NCT01410942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937949|NCT01410942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937950|NCT01410942|Dopamine Agents|dopamine agents|mesh-ancestor
92937951|NCT01410942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92937952|NCT04833426|Testosterone|testosterone|mesh-list
92937953|NCT04833426|Androgens|androgens|mesh-ancestor
92937954|NCT04833426|Hormones|hormones|mesh-ancestor
92937955|NCT04833426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92937956|NCT04833426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937957|NCT02576964|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92937958|NCT02576964|Capecitabine|capecitabine|mesh-list
92937959|NCT02576964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92937960|NCT02576964|Antimetabolites|antimetabolites|mesh-ancestor
92937961|NCT02576964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937962|NCT02576964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937963|NCT02576964|Antiviral Agents|antiviral agents|mesh-ancestor
92937964|NCT02576964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92937965|NCT00763139|Pioglitazone|pioglitazone|mesh-list
92937966|NCT00763139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937967|NCT00763139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937968|NCT01366092|Interleukin-2|interleukin-2|mesh-list
92937969|NCT01366092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92937970|NCT01366092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92937971|NCT01366092|Analgesics|analgesics|mesh-ancestor
92937972|NCT01366092|Sensory System Agents|sensory system agents|mesh-ancestor
92937973|NCT01366092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937974|NCT01366092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937975|NCT00781859|Plasminogen|plasminogen|mesh-list
92937976|NCT00781859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92937977|NCT00781859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92937978|NCT00781859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937979|NCT01344252|Lidocaine|lidocaine|mesh-list
92937980|NCT01344252|Anesthetics, Local|anesthetics, local|mesh-ancestor
92937981|NCT01344252|Anesthetics|anesthetics|mesh-ancestor
92937982|NCT01344252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92937983|NCT01344252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937984|NCT01344252|Sensory System Agents|sensory system agents|mesh-ancestor
92937985|NCT01344252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92937986|NCT01344252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92937987|NCT01344252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92937988|NCT01344252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92937989|NCT01344252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92937990|NCT01344252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92937991|NCT04101383|Insulin|insulin|mesh-list
92937992|NCT04101383|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92937993|NCT04101383|Insulin Glargine|insulin glargine|mesh-list
92937994|NCT04101383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92937995|NCT04101383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92937996|NCT02576808|Loratadine|loratadine|mesh-list
92937997|NCT02576808|Antipruritics|antipruritics|mesh-ancestor
92937998|NCT02576808|Dermatologic Agents|dermatologic agents|mesh-ancestor
92937999|NCT02576808|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92938000|NCT02576808|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92938001|NCT02576808|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92938002|NCT02576808|Histamine Antagonists|histamine antagonists|mesh-ancestor
92938003|NCT02576808|Histamine Agents|histamine agents|mesh-ancestor
92938004|NCT02576808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938005|NCT02576808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938006|NCT02576808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938007|NCT00580788|Parathyroid Hormone|parathyroid hormone|mesh-list
92938008|NCT00580788|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92938009|NCT00580788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938010|NCT00580788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92938011|NCT04073160|Durvalumab|durvalumab|mesh-list
92938012|NCT04073160|Tremelimumab|tremelimumab|mesh-list
92938013|NCT04073160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938014|NCT04073160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938015|NCT00417079|Prednisone|prednisone|mesh-list
92938016|NCT00417079|Mitoxantrone|mitoxantrone|mesh-list
92938017|NCT00417079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938018|NCT00417079|Glucocorticoids|glucocorticoids|mesh-ancestor
92938019|NCT00417079|Hormones|hormones|mesh-ancestor
92938020|NCT00417079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938021|NCT00417079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938022|NCT00417079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92938023|NCT00417079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938024|NCT00417079|Analgesics|analgesics|mesh-ancestor
92938025|NCT00417079|Sensory System Agents|sensory system agents|mesh-ancestor
92938026|NCT00417079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938027|NCT00417079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938028|NCT00417079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938029|NCT00417079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938030|NCT00417079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938031|NCT02578914|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92938032|NCT02578914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92938033|NCT00429169|Bupropion|bupropion|mesh-list
92938034|NCT00429169|Paroxetine|paroxetine|mesh-list
92938035|NCT00429169|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92938036|NCT00429169|Antidepressive Agents|antidepressive agents|mesh-ancestor
92938037|NCT00429169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92938038|NCT00429169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92938039|NCT00429169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92938040|NCT00429169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92938041|NCT00429169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938042|NCT00429169|Dopamine Agents|dopamine agents|mesh-ancestor
92938043|NCT00429169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938044|NCT00429169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938045|NCT00429169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92938046|NCT00429169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92938047|NCT00429169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938048|NCT00429169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92938049|NCT00429169|Serotonin Agents|serotonin agents|mesh-ancestor
92938050|NCT01037491|Aspirin|aspirin|mesh-list
92938051|NCT01037491|Rabeprazole|rabeprazole|mesh-list
92938052|NCT01037491|Clopidogrel|clopidogrel|mesh-list
92938053|NCT01037491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92938054|NCT01037491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92938055|NCT01037491|Analgesics|analgesics|mesh-ancestor
92938056|NCT01037491|Sensory System Agents|sensory system agents|mesh-ancestor
92938057|NCT01037491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583501|NCT00089115|Rituximab|rituximab|mesh-list
92938058|NCT01037491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938059|NCT01037491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938060|NCT01037491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92938061|NCT01037491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92938062|NCT01037491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92938063|NCT01037491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282988|NCT04696146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92938064|NCT01037491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92938065|NCT01037491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92938066|NCT01037491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938068|NCT01037491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92938069|NCT01037491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92938070|NCT01037491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92938071|NCT01037491|Purinergic Agents|purinergic agents|mesh-ancestor
92938072|NCT01037491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938073|NCT01037491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92938074|NCT01037491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938075|NCT01037491|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92938076|NCT01033279|Warfarin|warfarin|mesh-list
92938077|NCT01033279|Anticoagulants|anticoagulants|mesh-ancestor
92938078|NCT02576340|Octylonium|octylonium|mesh-list
92938079|NCT02576340|Bromides|bromides|mesh-list
92938080|NCT02576340|Anticonvulsants|anticonvulsants|mesh-ancestor
92938081|NCT02576340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92938082|NCT02576340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92938083|NCT02576340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938084|NCT02576340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92938085|NCT02576340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938086|NCT02576340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938087|NCT02576340|Parasympatholytics|parasympatholytics|mesh-ancestor
92938088|NCT02576340|Autonomic Agents|autonomic agents|mesh-ancestor
92938089|NCT02576340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938090|NCT02576340|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92938091|NCT02576340|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92938092|NCT02576340|Cholinergic Agents|cholinergic agents|mesh-ancestor
92938093|NCT02576340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938094|NCT02578602|Edetic Acid|edetic acid|mesh-list
92938095|NCT02578602|Pentetic Acid|pentetic acid|mesh-list
92938096|NCT02578602|Antidotes|antidotes|mesh-ancestor
92938097|NCT02578602|Protective Agents|protective agents|mesh-ancestor
92938098|NCT02578602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938099|NCT02578602|Chelating Agents|chelating agents|mesh-ancestor
92938100|NCT02578602|Sequestering Agents|sequestering agents|mesh-ancestor
92938101|NCT02578602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938102|NCT02578602|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92938103|NCT02578602|Anticoagulants|anticoagulants|mesh-ancestor
92938104|NCT02578602|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92938105|NCT00128856|Paclitaxel|paclitaxel|mesh-list
92938106|NCT00128856|Gemcitabine|gemcitabine|mesh-list
92938107|NCT00128856|Doxorubicin|doxorubicin|mesh-list
92938108|NCT00128856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92938109|NCT00128856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938110|NCT00128856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92938111|NCT00128856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92938112|NCT00128856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92938113|NCT00128856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938114|NCT00128856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92938115|NCT00128856|Antimetabolites|antimetabolites|mesh-ancestor
92938116|NCT00128856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92938117|NCT00128856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938118|NCT00128856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938119|NCT00128856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938120|NCT00128778|Doxorubicin|doxorubicin|mesh-list
92938121|NCT00128778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93026482|NCT00401973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92938122|NCT00128778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92938123|NCT00128778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938124|NCT00128778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938125|NCT00128778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938126|NCT00128778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938127|NCT00128778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938128|NCT00709488|Talaporfin|talaporfin|mesh-list
92938129|NCT00709488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938130|NCT00709488|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92938131|NCT00709488|Dermatologic Agents|dermatologic agents|mesh-ancestor
92938132|NCT00714246|Carboplatin|carboplatin|mesh-list
92938133|NCT00714246|Docetaxel|docetaxel|mesh-list
92938134|NCT00714246|Bortezomib|bortezomib|mesh-list
92938135|NCT00714246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938136|NCT00714246|Tubulin Modulators|tubulin modulators|mesh-ancestor
92938137|NCT00714246|Antimitotic Agents|antimitotic agents|mesh-ancestor
92938138|NCT00714246|Mitosis Modulators|mitosis modulators|mesh-ancestor
92938139|NCT00714246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938140|NCT00416455|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92938141|NCT00416455|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92938142|NCT00416455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938143|NCT00415909|Imatinib Mesylate|imatinib mesylate|mesh-list
92938144|NCT00415909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938145|NCT00415909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92938146|NCT00415909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938147|NCT00415909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938148|NCT00709644|Folic Acid|folic acid|mesh-list
92938149|NCT00709644|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92938150|NCT00709644|Norgestimate|norgestimate|mesh-list
92938151|NCT00709644|Estradiol|estradiol|mesh-list
92938152|NCT00709644|Estrogens|estrogens|mesh-ancestor
92938153|NCT00709644|Hormones|hormones|mesh-ancestor
92938154|NCT00709644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938155|NCT00709644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938156|NCT00709644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92938157|NCT00709644|Contraceptive Agents|contraceptive agents|mesh-ancestor
92938158|NCT00709644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938159|NCT00709644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92938160|NCT00709644|Hematinics|hematinics|mesh-ancestor
92938161|NCT00709644|Vitamin B Complex|vitamin b complex|mesh-ancestor
92938162|NCT00709644|Vitamins|vitamins|mesh-ancestor
92938163|NCT00709644|Micronutrients|micronutrients|mesh-ancestor
92938164|NCT00709644|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92938165|NCT00709644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92938166|NCT00709644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92938167|NCT00415597|Naltrexone|naltrexone|mesh-list
92938168|NCT00415597|Morphine|morphine|mesh-list
92938169|NCT00415597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92938170|NCT00415597|Narcotics|narcotics|mesh-ancestor
92938171|NCT00415597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938172|NCT00415597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938173|NCT00415597|Analgesics|analgesics|mesh-ancestor
92938174|NCT00415597|Sensory System Agents|sensory system agents|mesh-ancestor
92938175|NCT00415597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938176|NCT00415597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92938177|NCT00415597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92938178|NCT00714480|Thymoglobulin|thymoglobulin|mesh-list
92938179|NCT00714480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92938180|NCT00714480|Immunologic Factors|immunologic factors|mesh-ancestor
92938181|NCT00714480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938182|NCT00714480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92938183|NCT00714558|Fentanyl|fentanyl|mesh-list
92938184|NCT00714558|Naltrexone|naltrexone|mesh-list
92938185|NCT00714558|Naloxone|naloxone|mesh-list
92938186|NCT00714558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92938187|NCT00714558|Narcotics|narcotics|mesh-ancestor
92938188|NCT00714558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938189|NCT00714558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938190|NCT00714558|Analgesics|analgesics|mesh-ancestor
92938191|NCT00714558|Sensory System Agents|sensory system agents|mesh-ancestor
92938192|NCT00714558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938193|NCT00714558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92938194|NCT00714558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92938195|NCT00714558|Anesthetics, General|anesthetics, general|mesh-ancestor
92938196|NCT00714558|Anesthetics|anesthetics|mesh-ancestor
92938197|NCT00714558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92938198|NCT00714558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92938199|NCT02575638|Camptothecin|camptothecin|mesh-list
92938200|NCT02575638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92938201|NCT02575638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938202|NCT02575638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92938203|NCT02575638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938204|NCT02575638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938205|NCT02575638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938206|NCT02573610|Levofloxacin|levofloxacin|mesh-list
92938207|NCT02573610|Ofloxacin|ofloxacin|mesh-list
92938208|NCT02573610|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92938209|NCT02573610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583625|NCT00293332|Docetaxel|docetaxel|mesh-list
92938210|NCT02573610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92938211|NCT02573610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938212|NCT02573610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938213|NCT02573610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283133|NCT04186299|Carticaine|carticaine|mesh-list
92938214|NCT02573610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938215|NCT02573610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938216|NCT02573610|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92938217|NCT02573610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92938218|NCT02574468|Dexamethasone|dexamethasone|mesh-list
92938219|NCT02574468|Dexamethasone acetate|dexamethasone acetate|mesh-list
92938220|NCT02574468|BB 1101|bb 1101|mesh-list
92938221|NCT02574468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938222|NCT02574468|Antiemetics|antiemetics|mesh-ancestor
92938223|NCT02574468|Autonomic Agents|autonomic agents|mesh-ancestor
92938224|NCT02574468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938225|NCT02574468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938226|NCT02574468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938227|NCT02574468|Glucocorticoids|glucocorticoids|mesh-ancestor
92938228|NCT02574468|Hormones|hormones|mesh-ancestor
92938229|NCT02574468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938230|NCT02574468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92938231|NCT02574468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938232|NCT02574468|Protease Inhibitors|protease inhibitors|mesh-ancestor
92938233|NCT02574468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938234|NCT02574468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938235|NCT00710268|Bevacizumab|bevacizumab|mesh-list
92938236|NCT00710268|Olaparib|olaparib|mesh-list
92938237|NCT00710268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938238|NCT00710268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938239|NCT00710268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92938240|NCT00710268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92938241|NCT00710268|Growth Substances|growth substances|mesh-ancestor
92938242|NCT00710268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938243|NCT00710268|Growth Inhibitors|growth inhibitors|mesh-ancestor
92938244|NCT00710268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92938245|NCT00710268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938246|NCT00710268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938247|NCT02575248|Dienogest|dienogest|mesh-list
92938248|NCT02575248|Clomiphene|clomiphene|mesh-list
92938249|NCT02575248|Enclomiphene|enclomiphene|mesh-list
92938250|NCT02575248|Zuclomiphene|zuclomiphene|mesh-list
92938251|NCT02575248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92938252|NCT02575248|Hormone Antagonists|hormone antagonists|mesh-ancestor
92938253|NCT02575248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938254|NCT02575248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938255|NCT02575248|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92938256|NCT02575248|Fertility Agents|fertility agents|mesh-ancestor
92938257|NCT02575248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938258|NCT02575248|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92938259|NCT02575248|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92938260|NCT02575248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92938261|NCT02575248|Contraceptive Agents|contraceptive agents|mesh-ancestor
92938262|NCT02575248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92938263|NCT02575248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92938264|NCT02575248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92938265|NCT02575248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92938266|NCT02575248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92938267|NCT02575248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938268|NCT02575170|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92938269|NCT00710736|Fluorouracil|fluorouracil|mesh-list
92938270|NCT00710736|Capecitabine|capecitabine|mesh-list
92938271|NCT00710736|Antimetabolites|antimetabolites|mesh-ancestor
92938272|NCT00710736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938273|NCT00710736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92938274|NCT00710736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938275|NCT00710736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92938276|NCT00710736|Immunologic Factors|immunologic factors|mesh-ancestor
92938277|NCT00710736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938278|NCT00620542|Atorvastatin|atorvastatin|mesh-list
92938279|NCT00620542|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92938280|NCT00620542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92938281|NCT00620542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92938282|NCT00620542|Antimetabolites|antimetabolites|mesh-ancestor
92938283|NCT00620542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938284|NCT00620542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92938285|NCT00620542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92938287|NCT04070742|Minocycline|minocycline|mesh-list
92938288|NCT04070742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92938289|NCT04070742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938290|NCT00851344|Cetirizine|cetirizine|mesh-list
92938291|NCT00851344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92938292|NCT00851344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92938293|NCT00851344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92938294|NCT00851344|Histamine Antagonists|histamine antagonists|mesh-ancestor
92938295|NCT00851344|Histamine Agents|histamine agents|mesh-ancestor
92938296|NCT00851344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938297|NCT00851344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938298|NCT00851344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938299|NCT04523922|Oxytocin|oxytocin|mesh-list
92938300|NCT04523922|Oxytocics|oxytocics|mesh-ancestor
92938301|NCT04523922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938302|NCT04523922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938303|NCT00711204|Donepezil|donepezil|mesh-list
92938304|NCT00711204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92938305|NCT00711204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938306|NCT00711204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938307|NCT00711204|Cholinergic Agents|cholinergic agents|mesh-ancestor
92938308|NCT00711204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938309|NCT00711204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938310|NCT00711204|Nootropic Agents|nootropic agents|mesh-ancestor
92938311|NCT05810792|Interleukin-2|interleukin-2|mesh-list
92938312|NCT05810792|Histamine|histamine|mesh-list
92938313|NCT05810792|Histamine phosphate|histamine phosphate|mesh-list
92938314|NCT05810792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938315|NCT05810792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92938316|NCT05810792|Analgesics|analgesics|mesh-ancestor
92938317|NCT05810792|Sensory System Agents|sensory system agents|mesh-ancestor
92938318|NCT05810792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938319|NCT05810792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938320|NCT05810792|Histamine Agonists|histamine agonists|mesh-ancestor
92938321|NCT05810792|Histamine Agents|histamine agents|mesh-ancestor
92938322|NCT05810792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938323|NCT05810792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938324|NCT05810571|Morphine|morphine|mesh-list
92938325|NCT05810571|Remifentanil|remifentanil|mesh-list
92938326|NCT05810571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92938327|NCT05810571|Narcotics|narcotics|mesh-ancestor
92938328|NCT05810571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938329|NCT05810571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938330|NCT05810571|Analgesics|analgesics|mesh-ancestor
92938331|NCT05810571|Sensory System Agents|sensory system agents|mesh-ancestor
92938332|NCT05810571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938333|NCT05810558|Glycine|glycine|mesh-list
92938334|NCT05810558|Glycine Agents|glycine agents|mesh-ancestor
92938335|NCT05810558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938336|NCT05810558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938337|NCT05810558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938338|NCT05810389|Fluorides|fluorides|mesh-list
92938339|NCT05810389|Cariostatic Agents|cariostatic agents|mesh-ancestor
92938340|NCT05810389|Protective Agents|protective agents|mesh-ancestor
92938341|NCT05810389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938342|NCT05809986|Ofatumumab|ofatumumab|mesh-list
92938343|NCT05809986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938344|NCT05809869|Durvalumab|durvalumab|mesh-list
92938345|NCT05809869|Tremelimumab|tremelimumab|mesh-list
92938346|NCT05809869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938347|NCT05809869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938348|NCT05809843|Pancrelipase|pancrelipase|mesh-list
92938349|NCT05809843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938350|NCT05809804|Esketamine|esketamine|mesh-list
92938351|NCT05809804|Antidepressive Agents|antidepressive agents|mesh-ancestor
92938352|NCT05809804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92938353|NCT05809609|Ketamine|ketamine|mesh-list
92938354|NCT05809609|Analgesics|analgesics|mesh-ancestor
92938355|NCT05809609|Sensory System Agents|sensory system agents|mesh-ancestor
92938356|NCT05809609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938357|NCT05809609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938358|NCT05809609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92938359|NCT05809609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92938360|NCT05809609|Anesthetics, General|anesthetics, general|mesh-ancestor
92938361|NCT05809609|Anesthetics|anesthetics|mesh-ancestor
92938362|NCT05809609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938363|NCT05809609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92938364|NCT05809609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92938365|NCT05809609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938366|NCT05809609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938367|NCT05809518|Dexmedetomidine|dexmedetomidine|mesh-list
92938369|NCT05809518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92938370|NCT05809518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938371|NCT05809518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938372|NCT05809518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92938373|NCT05809518|Analgesics|analgesics|mesh-ancestor
92938374|NCT05809518|Sensory System Agents|sensory system agents|mesh-ancestor
92938375|NCT05809518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938376|NCT05809518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92938377|NCT05809518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92938378|NCT05809518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92938379|NCT05809518|Adrenergic Agents|adrenergic agents|mesh-ancestor
92938380|NCT05809518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938381|NCT05809518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938382|NCT05809518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92938383|NCT05809518|Anesthetics, General|anesthetics, general|mesh-ancestor
92938384|NCT05809518|Anesthetics|anesthetics|mesh-ancestor
92938385|NCT05809414|Amantadine|amantadine|mesh-list
92938386|NCT05809414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92938387|NCT05809414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92938388|NCT05809414|Antiviral Agents|antiviral agents|mesh-ancestor
92938389|NCT05809414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938390|NCT05809414|Dopamine Agents|dopamine agents|mesh-ancestor
92938391|NCT05809414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938392|NCT05809414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938393|NCT05809414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938394|NCT05809414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92938395|NCT05809414|Analgesics|analgesics|mesh-ancestor
92938396|NCT05809414|Sensory System Agents|sensory system agents|mesh-ancestor
92938397|NCT05809414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938398|NCT05809336|Pembrolizumab|pembrolizumab|mesh-list
92938399|NCT05809336|Atezolizumab|atezolizumab|mesh-list
92938400|NCT05809336|Tislelizumab|tislelizumab|mesh-list
92938401|NCT05809336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92938402|NCT05809336|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92938403|NCT05809336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938404|NCT05809336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938405|NCT05809336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938406|NCT05809336|Immunologic Factors|immunologic factors|mesh-ancestor
92938407|NCT05809336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938408|NCT05809271|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92938409|NCT05809271|Hallucinogens|hallucinogens|mesh-ancestor
92938410|NCT05809271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938411|NCT05809271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92938412|NCT05809271|Serotonin Agents|serotonin agents|mesh-ancestor
92938413|NCT05809271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938414|NCT05809271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938415|NCT05809271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92938416|NCT05809271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92938417|NCT05809271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92938418|NCT05809271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92938419|NCT05809024|Letrozole|letrozole|mesh-list
92938420|NCT05809024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938421|NCT05809024|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92938422|NCT05809024|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92938423|NCT05809024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938424|NCT05809024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938425|NCT05809024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92938426|NCT05809024|Hormone Antagonists|hormone antagonists|mesh-ancestor
92938427|NCT05809024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938428|NCT05809024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938429|NCT05808985|Butyric Acid|butyric acid|mesh-list
92938430|NCT05808985|Histamine Antagonists|histamine antagonists|mesh-ancestor
92938431|NCT05808985|Histamine Agents|histamine agents|mesh-ancestor
92938432|NCT05808985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938433|NCT05808985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938434|NCT05808985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938435|NCT05808972|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92938436|NCT05808946|Thioctic Acid|thioctic acid|mesh-list
92938437|NCT05808946|Antioxidants|antioxidants|mesh-ancestor
92938438|NCT05808946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938439|NCT05808946|Protective Agents|protective agents|mesh-ancestor
92938440|NCT05808946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938441|NCT05808946|Vitamin B Complex|vitamin b complex|mesh-ancestor
92938442|NCT05808946|Vitamins|vitamins|mesh-ancestor
92938443|NCT05808946|Micronutrients|micronutrients|mesh-ancestor
92938444|NCT05764876|Azithromycin|azithromycin|mesh-list
92938445|NCT05764876|Linezolid|linezolid|mesh-list
92938446|NCT05764876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92938447|NCT05764876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938448|NCT05764876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92938449|NCT05764876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938450|NCT05764876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938451|NCT05737576|Insulin Aspart|insulin aspart|mesh-list
92938452|NCT05737576|Insulin, Long-Acting|insulin, long-acting|mesh-list
92938453|NCT05737576|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92938454|NCT05737576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92938455|NCT05737576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938456|NCT05720988|Azacitidine|azacitidine|mesh-list
92938457|NCT05720988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92938458|NCT05720988|Antimetabolites|antimetabolites|mesh-ancestor
92938459|NCT05720988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164373|NCT01925027|Sirolimus|sirolimus|mesh-list
92938460|NCT05720988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938461|NCT05720988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938462|NCT05716763|Tramadol|tramadol|mesh-list
92938463|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92938464|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92938465|NCT05716763|Narcotics|narcotics|mesh-ancestor
92938466|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938467|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938468|NCT05716763|Analgesics|analgesics|mesh-ancestor
92938469|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
92938470|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938471|NCT05716503|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92938472|NCT05716503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938473|NCT05716009|Gemtuzumab|gemtuzumab|mesh-list
92938474|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938475|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938476|NCT05716009|Immunotoxins|immunotoxins|mesh-ancestor
92938477|NCT05716009|Immunoconjugates|immunoconjugates|mesh-ancestor
92938478|NCT05716009|Immunologic Factors|immunologic factors|mesh-ancestor
92938479|NCT05716009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938480|NCT05696938|Niacinamide|niacinamide|mesh-list
92938481|NCT05696938|Niacin|niacin|mesh-list
92938482|NCT05696938|Nicotinic Acids|nicotinic acids|mesh-list
92938483|NCT05696938|Vitamin B Complex|vitamin b complex|mesh-ancestor
92938484|NCT05696938|Vitamins|vitamins|mesh-ancestor
92938485|NCT05696938|Micronutrients|micronutrients|mesh-ancestor
92938486|NCT05696938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938487|NCT05696938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92938488|NCT05696938|Antimetabolites|antimetabolites|mesh-ancestor
92938489|NCT05696938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938490|NCT05696938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92938491|NCT05696938|Vasodilator Agents|vasodilator agents|mesh-ancestor
92938492|NCT05695508|Dexamethasone|dexamethasone|mesh-list
92938493|NCT05695508|Lenalidomide|lenalidomide|mesh-list
92938494|NCT05695508|Bortezomib|bortezomib|mesh-list
92938495|NCT05695508|Daratumumab|daratumumab|mesh-list
92938496|NCT05695508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938497|NCT05695508|Antiemetics|antiemetics|mesh-ancestor
92938498|NCT05695508|Autonomic Agents|autonomic agents|mesh-ancestor
92938499|NCT05695508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938500|NCT05695508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938501|NCT05695508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938502|NCT05695508|Glucocorticoids|glucocorticoids|mesh-ancestor
92938503|NCT05695508|Hormones|hormones|mesh-ancestor
92938504|NCT05695508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938505|NCT05695508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92938506|NCT05695508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583936|NCT00295165|Sargramostim|sargramostim|mesh-list
92938507|NCT05695508|Immunologic Factors|immunologic factors|mesh-ancestor
92938508|NCT05695508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283431|NCT02542657|Clarithromycin|clarithromycin|mesh-list
92938509|NCT05695508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92938510|NCT05695508|Growth Substances|growth substances|mesh-ancestor
92938511|NCT05695508|Growth Inhibitors|growth inhibitors|mesh-ancestor
92938513|NCT05679908|Oxytocics|oxytocics|mesh-ancestor
92938514|NCT05679908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938515|NCT05679908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938516|NCT05648435|Lithium Carbonate|lithium carbonate|mesh-list
92938517|NCT05648435|Antidepressive Agents|antidepressive agents|mesh-ancestor
92938518|NCT05648435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92938519|NCT05648435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938520|NCT05648435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938521|NCT05648435|Antimanic Agents|antimanic agents|mesh-ancestor
92938522|NCT05648435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92938523|NCT05648435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938524|NCT05648435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938525|NCT05642767|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92938526|NCT05642767|Cetrimonium|cetrimonium|mesh-list
92938527|NCT05642767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938528|NCT05642767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92938529|NCT05624138|Leucovorin|leucovorin|mesh-list
92938530|NCT05624138|Ketotifen|ketotifen|mesh-list
92938531|NCT05624138|Fluorouracil|fluorouracil|mesh-list
92938532|NCT05624138|Oxaliplatin|oxaliplatin|mesh-list
92938533|NCT05624138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938534|NCT05624138|Antimetabolites|antimetabolites|mesh-ancestor
92938535|NCT05624138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938536|NCT05624138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92938537|NCT05624138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938538|NCT05624138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92938539|NCT05624138|Immunologic Factors|immunologic factors|mesh-ancestor
92938540|NCT05624138|Antidotes|antidotes|mesh-ancestor
92938541|NCT05624138|Protective Agents|protective agents|mesh-ancestor
92938542|NCT05624138|Vitamin B Complex|vitamin b complex|mesh-ancestor
92938543|NCT05624138|Vitamins|vitamins|mesh-ancestor
92938544|NCT05624138|Micronutrients|micronutrients|mesh-ancestor
92938545|NCT05624138|Antipruritics|antipruritics|mesh-ancestor
92938546|NCT05624138|Dermatologic Agents|dermatologic agents|mesh-ancestor
92938547|NCT05624138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92938548|NCT05624138|Histamine Antagonists|histamine antagonists|mesh-ancestor
92938549|NCT05624138|Histamine Agents|histamine agents|mesh-ancestor
92938550|NCT05624138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938551|NCT05624138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92938552|NCT05610800|Exenatide|exenatide|mesh-list
92938553|NCT05610800|Nicotine|nicotine|mesh-list
92938554|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92938555|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
92938556|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938557|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938558|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92938559|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92938560|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
92938561|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938562|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938563|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92938564|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92938565|NCT05610800|Incretins|incretins|mesh-ancestor
92938566|NCT05610800|Hormones|hormones|mesh-ancestor
92938567|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938568|NCT05605080|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92938569|NCT05605080|Hemostatics|hemostatics|mesh-ancestor
92938570|NCT05605080|Coagulants|coagulants|mesh-ancestor
92938571|NCT05596383|Vitamin D|vitamin d|mesh-list
92938572|NCT05596383|Vitamins|vitamins|mesh-ancestor
92938573|NCT05596383|Micronutrients|micronutrients|mesh-ancestor
92938574|NCT05596383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938575|NCT05596383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92938576|NCT05594745|Lifitegrast|lifitegrast|mesh-list
92938577|NCT05594745|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92938578|NCT05594745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92938579|NCT05568953|Vaccines|vaccines|mesh-list
92938580|NCT05568953|Immunologic Factors|immunologic factors|mesh-ancestor
92938581|NCT05568953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938582|NCT05556200|Apatinib|apatinib|mesh-list
92938583|NCT05556200|Antibodies|antibodies|mesh-list
92938584|NCT05556200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92938585|NCT05556200|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92938586|NCT05556200|Immunologic Factors|immunologic factors|mesh-ancestor
92938587|NCT05556200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938589|NCT05556200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92938590|NCT05556200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938591|NCT05556200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938592|NCT05532215|Misoprostol|misoprostol|mesh-list
92938593|NCT05532215|Oxytocin|oxytocin|mesh-list
92938594|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
92938595|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938596|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938597|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92938598|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
92938599|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92938600|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938601|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92938602|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938603|NCT05505552|Vitamin K|vitamin k|mesh-list
92938604|NCT05505552|Vitamin K 1|vitamin k 1|mesh-list
92938605|NCT05505552|Vitamins|vitamins|mesh-ancestor
92938606|NCT05505552|Micronutrients|micronutrients|mesh-ancestor
92938607|NCT05505552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938608|NCT05505552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92938609|NCT05505552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92938610|NCT05505552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938611|NCT05505552|Hemostatics|hemostatics|mesh-ancestor
92938612|NCT05505552|Coagulants|coagulants|mesh-ancestor
92938613|NCT05471947|Glycolic acid|glycolic acid|mesh-list
92938614|NCT05471947|Keratolytic Agents|keratolytic agents|mesh-ancestor
92938615|NCT05471947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92938616|NCT05463601|Tamoxifen|tamoxifen|mesh-list
92938617|NCT05463601|Letrozole|letrozole|mesh-list
92938618|NCT05463601|Fulvestrant|fulvestrant|mesh-list
92938619|NCT05463601|Exemestane|exemestane|mesh-list
92938620|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938621|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92938622|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92938623|NCT05463601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938624|NCT05463601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938625|NCT05463601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92938626|NCT05463601|Hormone Antagonists|hormone antagonists|mesh-ancestor
92938627|NCT05463601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938628|NCT05463601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938629|NCT05463601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92938630|NCT05463601|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92938631|NCT05463601|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92938632|NCT05463601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92938633|NCT05463601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92938634|NCT05438082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92938635|NCT05438082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938636|NCT05427162|Epoprostenol|epoprostenol|mesh-list
92938637|NCT05427162|Tezosentan|tezosentan|mesh-list
92938638|NCT05427162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92938639|NCT05427162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92938640|NCT05427162|Vasodilator Agents|vasodilator agents|mesh-ancestor
92938641|NCT05408091|Antibodies|antibodies|mesh-list
92938642|NCT05408091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92938643|NCT05408091|Immunologic Factors|immunologic factors|mesh-ancestor
92938644|NCT05408091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938645|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
92938646|NCT05395195|Hematinics|hematinics|mesh-ancestor
92938647|NCT05391360|Entecavir|entecavir|mesh-list
92938648|NCT05391360|Antiviral Agents|antiviral agents|mesh-ancestor
92938649|NCT05391360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938650|NCT05372887|Cyclobenzaprine|cyclobenzaprine|mesh-list
92938651|NCT05372887|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92938652|NCT05372887|Antidepressive Agents|antidepressive agents|mesh-ancestor
92938653|NCT05372887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92938654|NCT05372887|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92938655|NCT05372887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938656|NCT05372887|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92938657|NCT05372887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938658|NCT05372887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92938659|NCT05372887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938660|NCT05366764|Albuterol|albuterol|mesh-list
92938661|NCT05366764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92938662|NCT05366764|Autonomic Agents|autonomic agents|mesh-ancestor
92938663|NCT05366764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584125|NCT00296530|Xhance|xhance|mesh-list
92938664|NCT05366764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938666|NCT05366764|Respiratory System Agents|respiratory system agents|mesh-ancestor
92938667|NCT05366764|Tocolytic Agents|tocolytic agents|mesh-ancestor
92938668|NCT05366764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938669|NCT05366764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92938670|NCT05366764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92938671|NCT05366764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92938672|NCT05366764|Adrenergic Agents|adrenergic agents|mesh-ancestor
92938673|NCT05366764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938674|NCT05366764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938675|NCT05366166|Cisplatin|cisplatin|mesh-list
92938676|NCT05366166|Pembrolizumab|pembrolizumab|mesh-list
92938677|NCT05366166|Olaparib|olaparib|mesh-list
92938678|NCT05366166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938679|NCT05366166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938680|NCT05366166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92938681|NCT05366166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938682|NCT05366166|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92938683|NCT05366166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938684|NCT05359835|Edetic Acid|edetic acid|mesh-list
92938685|NCT05359835|Calcium|calcium|mesh-list
92938686|NCT05359835|Pentetic Acid|pentetic acid|mesh-list
92938687|NCT05359835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92938688|NCT05359835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938689|NCT05359835|Antidotes|antidotes|mesh-ancestor
92938690|NCT05359835|Protective Agents|protective agents|mesh-ancestor
92938691|NCT05359835|Chelating Agents|chelating agents|mesh-ancestor
92938692|NCT05359835|Sequestering Agents|sequestering agents|mesh-ancestor
92938693|NCT05359835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938694|NCT05359835|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92938695|NCT05359835|Anticoagulants|anticoagulants|mesh-ancestor
92938696|NCT05359835|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92938697|NCT05355051|Pembrolizumab|pembrolizumab|mesh-list
92938698|NCT05355051|Azacitidine|azacitidine|mesh-list
92938699|NCT05355051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938700|NCT05355051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938701|NCT05355051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92938702|NCT05355051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938703|NCT05355051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92938704|NCT05355051|Antimetabolites|antimetabolites|mesh-ancestor
92938705|NCT05355051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938706|NCT05335148|Colchicine|colchicine|mesh-list
92938707|NCT05335148|Gout Suppressants|gout suppressants|mesh-ancestor
92938708|NCT05335148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92938709|NCT05335148|Tubulin Modulators|tubulin modulators|mesh-ancestor
92938710|NCT05335148|Antimitotic Agents|antimitotic agents|mesh-ancestor
92938711|NCT05335148|Mitosis Modulators|mitosis modulators|mesh-ancestor
92938712|NCT05335148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938713|NCT05335148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938714|NCT05314933|Deoxyglucose|deoxyglucose|mesh-list
92938715|NCT05314933|Antimetabolites|antimetabolites|mesh-ancestor
92938716|NCT05314933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938717|NCT05314933|Antiviral Agents|antiviral agents|mesh-ancestor
92938718|NCT05314933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938719|NCT05303844|Tislelizumab|tislelizumab|mesh-list
92938720|NCT05303844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938721|NCT05303844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938722|NCT05260606|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92938723|NCT05260606|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92938724|NCT05260606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938725|NCT05236946|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92938726|NCT05236946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92938727|NCT05236946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938728|NCT05236946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938729|NCT05222932|Avelumab|avelumab|mesh-list
92938730|NCT05222932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164417|NCT03101501|Mitomycins|mitomycins|mesh-list
92938731|NCT05222932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938732|NCT05216419|Cholecalciferol|cholecalciferol|mesh-list
92938733|NCT05216419|Vitamin D|vitamin d|mesh-list
92938734|NCT05216419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92938735|NCT05216419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938736|NCT05216419|Vitamins|vitamins|mesh-ancestor
92938737|NCT05216419|Micronutrients|micronutrients|mesh-ancestor
92938738|NCT05216419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92938739|NCT05117034|Morphine|morphine|mesh-list
92938740|NCT05117034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92584150|NCT00296530|Hormones|hormones|mesh-ancestor
92938741|NCT05117034|Narcotics|narcotics|mesh-ancestor
92938742|NCT05117034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938743|NCT05117034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938744|NCT05117034|Analgesics|analgesics|mesh-ancestor
92938745|NCT05117034|Sensory System Agents|sensory system agents|mesh-ancestor
92938746|NCT05117034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938747|NCT05115838|Islatravir|islatravir|mesh-list
92938748|NCT05115838|Antiviral Agents|antiviral agents|mesh-ancestor
92938749|NCT05115838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938750|NCT05115838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938751|NCT05115838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938752|NCT05115838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92938753|NCT05115838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92938754|NCT05115838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92938755|NCT05112939|Cabotegravir|cabotegravir|mesh-list
92938756|NCT05112939|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92938757|NCT05112939|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92938758|NCT05112939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938759|NCT05112939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938760|NCT05112939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92938761|NCT05112939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92938762|NCT05112939|Antiviral Agents|antiviral agents|mesh-ancestor
92938763|NCT05112939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938764|NCT05093920|Doxorubicin|doxorubicin|mesh-list
92938765|NCT05093920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92938766|NCT05093920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92938767|NCT05093920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938768|NCT05093920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938769|NCT05093920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938770|NCT05093920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938771|NCT05093920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938772|NCT05080946|Aspirin|aspirin|mesh-list
92938773|NCT05080946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92938774|NCT05080946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92938775|NCT05080946|Analgesics|analgesics|mesh-ancestor
92938776|NCT05080946|Sensory System Agents|sensory system agents|mesh-ancestor
92938777|NCT05080946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938778|NCT05080946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938779|NCT05080946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938780|NCT05080946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92938781|NCT05080946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92938782|NCT05080946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92938783|NCT05080946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938784|NCT05080946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92938785|NCT05080946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92938786|NCT05080946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938787|NCT05080946|Antipyretics|antipyretics|mesh-ancestor
92938788|NCT05068752|Sorafenib|sorafenib|mesh-list
92938789|NCT05068752|Vemurafenib|vemurafenib|mesh-list
92938790|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938791|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92938792|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938793|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938794|NCT05052879|Tadalafil|tadalafil|mesh-list
92938795|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
92938796|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92938797|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92938798|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938799|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938800|NCT05052879|Urological Agents|urological agents|mesh-ancestor
92938801|NCT05049707|Magnesium Sulfate|magnesium sulfate|mesh-list
92938802|NCT05049707|Analgesics|analgesics|mesh-ancestor
92938803|NCT05049707|Sensory System Agents|sensory system agents|mesh-ancestor
92938804|NCT05049707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938805|NCT05049707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938806|NCT05049707|Anesthetics|anesthetics|mesh-ancestor
92938807|NCT05049707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938808|NCT05049707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92938809|NCT05049707|Anticonvulsants|anticonvulsants|mesh-ancestor
92938810|NCT05049707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92938811|NCT05049707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92938812|NCT05049707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938813|NCT05049707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92584223|NCT00296959|Topiramate|topiramate|mesh-list
92938815|NCT05049707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92938817|NCT05043805|Antitussive Agents|antitussive agents|mesh-ancestor
92938818|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
92938819|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92938820|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92938821|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938822|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938823|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938824|NCT05042687|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92938825|NCT05042687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92938826|NCT05042687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938827|NCT05036109|Aspirin|aspirin|mesh-list
92938828|NCT05036109|Vitamin D|vitamin d|mesh-list
92938829|NCT05036109|Vitamins|vitamins|mesh-ancestor
92938830|NCT05036109|Micronutrients|micronutrients|mesh-ancestor
92938831|NCT05036109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938832|NCT05036109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92938833|NCT05036109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92938834|NCT05036109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92938835|NCT05036109|Analgesics|analgesics|mesh-ancestor
92938836|NCT05036109|Sensory System Agents|sensory system agents|mesh-ancestor
92938837|NCT05036109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92938838|NCT05036109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938839|NCT05036109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92938840|NCT05036109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92938841|NCT05036109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92938842|NCT05036109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938843|NCT05036109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92938844|NCT05036109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92938845|NCT05036109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938846|NCT05036109|Antipyretics|antipyretics|mesh-ancestor
92938847|NCT05033483|Ferrous fumarate|ferrous fumarate|mesh-list
92938848|NCT05033483|Trace Elements|trace elements|mesh-ancestor
92938849|NCT05033483|Micronutrients|micronutrients|mesh-ancestor
92938850|NCT05033483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938851|NCT04999969|Paclitaxel|paclitaxel|mesh-list
92938852|NCT04999969|Gemcitabine|gemcitabine|mesh-list
92938853|NCT04999969|Durvalumab|durvalumab|mesh-list
92938854|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92938855|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938856|NCT04999969|Tubulin Modulators|tubulin modulators|mesh-ancestor
92938857|NCT04999969|Antimitotic Agents|antimitotic agents|mesh-ancestor
92938858|NCT04999969|Mitosis Modulators|mitosis modulators|mesh-ancestor
92938859|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938860|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92938861|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
92938862|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938863|NCT04982913|Oseltamivir|oseltamivir|mesh-list
92938864|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
92938865|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938866|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938867|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938868|NCT04981899|Carboplatin|carboplatin|mesh-list
92938869|NCT04981899|Nivolumab|nivolumab|mesh-list
92938870|NCT04981899|Etoposide|etoposide|mesh-list
92938871|NCT04981899|Ifosfamide|ifosfamide|mesh-list
92938872|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938873|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938874|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92938875|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938876|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92938877|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938878|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938879|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938880|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92938881|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
92938882|NCT04977830|Xenon|xenon|mesh-list
92938883|NCT04977830|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92938884|NCT04977830|Anesthetics, General|anesthetics, general|mesh-ancestor
92938885|NCT04977830|Anesthetics|anesthetics|mesh-ancestor
92938886|NCT04977830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938887|NCT04977830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938888|NCT04929600|Amlodipine|amlodipine|mesh-list
92938889|NCT04929600|Valsartan|valsartan|mesh-list
92938890|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92938891|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92938892|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92938893|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92938894|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938895|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92938896|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938897|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
92938898|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92938899|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92938900|NCT04925648|Dasatinib|dasatinib|mesh-list
92938901|NCT04925648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938902|NCT04925648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92938903|NCT04925648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938904|NCT04925648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938905|NCT04904536|Atorvastatin|atorvastatin|mesh-list
92938906|NCT04904536|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92938907|NCT04904536|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92938908|NCT04904536|Antimetabolites|antimetabolites|mesh-ancestor
92938909|NCT04904536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938910|NCT04904536|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92938911|NCT04904536|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92938912|NCT04904536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938913|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92938914|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938915|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92938916|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938917|NCT04852367|Doxorubicin|doxorubicin|mesh-list
92938918|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92938919|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938920|NCT04852367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938921|NCT04852367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938922|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938923|NCT04852367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938924|NCT04848337|Pembrolizumab|pembrolizumab|mesh-list
92938925|NCT04848337|Lenvatinib|lenvatinib|mesh-list
92938926|NCT04848337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938927|NCT04848337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938928|NCT04848337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92938929|NCT04848337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938930|NCT04848337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92938931|NCT04848337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938932|NCT04824417|Itraconazole|itraconazole|mesh-list
92938933|NCT04824417|Voriconazole|voriconazole|mesh-list
92938934|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
92938935|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92938936|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92938937|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92938938|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938939|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938940|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92938941|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
92938942|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938943|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938944|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92938945|NCT04727996|Tislelizumab|tislelizumab|mesh-list
92938946|NCT04727996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92938947|NCT04727996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938948|NCT04720781|Esomeprazole|esomeprazole|mesh-list
92938949|NCT04720781|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92938950|NCT04720781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92938951|NCT04720781|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92938952|NCT04720781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938953|NCT04720781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938954|NCT04692623|Insulin|insulin|mesh-list
92938955|NCT04692623|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92938956|NCT04692623|Moxifloxacin|moxifloxacin|mesh-list
92938957|NCT04692623|Gemifloxacin|gemifloxacin|mesh-list
92938958|NCT04692623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92938959|NCT04692623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938960|NCT04692623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92938962|NCT04692623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92938963|NCT04692623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92938964|NCT04692623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938965|NCT04692623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938966|NCT04692623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92938967|NCT04690608|Triamcinolone|triamcinolone|mesh-list
92938968|NCT04690608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92938969|NCT04690608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92938970|NCT04690608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92938971|NCT04690608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92938972|NCT04690608|Glucocorticoids|glucocorticoids|mesh-ancestor
92938973|NCT04690608|Hormones|hormones|mesh-ancestor
92938974|NCT04690608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92938975|NCT04690608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938976|NCT04690608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92938977|NCT04690608|Immunologic Factors|immunologic factors|mesh-ancestor
92938978|NCT04690608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92938979|NCT04690608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938980|NCT04684238|Midazolam|midazolam|mesh-list
92938981|NCT04684238|Isoflurane|isoflurane|mesh-list
92938982|NCT04684238|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92938983|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92938984|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92938985|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92938986|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92938987|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92938988|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92938989|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92938990|NCT04684238|Anesthetics, General|anesthetics, general|mesh-ancestor
92938991|NCT04684238|Anesthetics|anesthetics|mesh-ancestor
92938992|NCT04684238|GABA Modulators|gaba modulators|mesh-ancestor
92938993|NCT04684238|GABA Agents|gaba agents|mesh-ancestor
92938994|NCT04684238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92938995|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92938996|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92938997|NCT04586348|Iodine|iodine|mesh-list
92938998|NCT04586348|Cadexomer iodine|cadexomer iodine|mesh-list
92938999|NCT04586348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92939000|NCT04586348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939001|NCT04586348|Trace Elements|trace elements|mesh-ancestor
92939002|NCT04586348|Micronutrients|micronutrients|mesh-ancestor
92939003|NCT04586348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939004|NCT04577001|Letrozole|letrozole|mesh-list
92939005|NCT04577001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939006|NCT04577001|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92939007|NCT04577001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92939008|NCT04577001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939009|NCT04577001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939010|NCT04577001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92939011|NCT04577001|Hormone Antagonists|hormone antagonists|mesh-ancestor
92939012|NCT04577001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939013|NCT04577001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939014|NCT04576078|Nefopam|nefopam|mesh-list
92939015|NCT04576078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92939016|NCT04576078|Analgesics|analgesics|mesh-ancestor
92939017|NCT04576078|Sensory System Agents|sensory system agents|mesh-ancestor
92147074|NCT03089671|Vitamins|vitamins|mesh-list
92939018|NCT04576078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939019|NCT04576078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939020|NCT04561557|Cyclophosphamide|cyclophosphamide|mesh-list
92939021|NCT04561557|Fludarabine|fludarabine|mesh-list
92939022|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939023|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
92939024|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939025|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92939026|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92939027|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
92939028|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939029|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939030|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92939031|NCT04561375|Fentanyl|fentanyl|mesh-list
92939032|NCT04561375|Sufentanil|sufentanil|mesh-list
92939033|NCT04561375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92939034|NCT04561375|Narcotics|narcotics|mesh-ancestor
92939035|NCT04561375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939036|NCT04561375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939037|NCT04561375|Analgesics|analgesics|mesh-ancestor
92939038|NCT04561375|Sensory System Agents|sensory system agents|mesh-ancestor
92939039|NCT04561375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939040|NCT04561375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92939041|NCT04561375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92939042|NCT04561375|Anesthetics, General|anesthetics, general|mesh-ancestor
92939043|NCT04561375|Anesthetics|anesthetics|mesh-ancestor
92939044|NCT04560127|Apatinib|apatinib|mesh-list
92939045|NCT04560127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939046|NCT04560127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92939047|NCT04560127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939048|NCT04560127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939049|NCT04553536|Sufentanil|sufentanil|mesh-list
92939050|NCT04553536|Remifentanil|remifentanil|mesh-list
92939051|NCT04553536|Dsuvia|dsuvia|mesh-list
92939052|NCT04553536|Bromides|bromides|mesh-list
92939053|NCT04553536|Propofol|propofol|mesh-list
92939054|NCT04553536|Esketamine|esketamine|mesh-list
92939055|NCT04553536|Rocuronium|rocuronium|mesh-list
92939056|NCT04553536|Cisatracurium|cisatracurium|mesh-list
92939057|NCT04553536|Atracurium|atracurium|mesh-list
92939058|NCT04553536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92939059|NCT04553536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939060|NCT04553536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939061|NCT04553536|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92939062|NCT04553536|Anesthetics, General|anesthetics, general|mesh-ancestor
92939063|NCT04553536|Anesthetics|anesthetics|mesh-ancestor
92939064|NCT04553536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92939065|NCT04553536|Narcotics|narcotics|mesh-ancestor
92939066|NCT04553536|Analgesics|analgesics|mesh-ancestor
92939067|NCT04553536|Sensory System Agents|sensory system agents|mesh-ancestor
92939068|NCT04553536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939069|NCT04553536|Anticonvulsants|anticonvulsants|mesh-ancestor
92939070|NCT04553536|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92939071|NCT04553536|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92939072|NCT04553536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92939073|NCT04553536|Antidepressive Agents|antidepressive agents|mesh-ancestor
92939074|NCT04553536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92939075|NCT04553536|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92939076|NCT04553536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92939077|NCT04553536|Cholinergic Agents|cholinergic agents|mesh-ancestor
92939078|NCT04553536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939079|NCT04553536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939080|NCT04553536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92939081|NCT04536532|Entecavir|entecavir|mesh-list
92939082|NCT04536532|Antiviral Agents|antiviral agents|mesh-ancestor
92939083|NCT04536532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939084|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
92939085|NCT04509115|Narcotics|narcotics|mesh-ancestor
92939086|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939087|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939088|NCT04509115|Analgesics|analgesics|mesh-ancestor
92939089|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
92939090|NCT04509115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939091|NCT04508634|Metformin|metformin|mesh-list
92939092|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92939093|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939094|NCT04489771|Belzutifan|belzutifan|mesh-list
92939095|NCT04489771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939096|NCT04480502|Ipilimumab|ipilimumab|mesh-list
92939097|NCT04480502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939098|NCT04480502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939099|NCT04480502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939100|NCT04480502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939101|NCT04447092|Leucovorin|leucovorin|mesh-list
92939102|NCT04447092|Paclitaxel|paclitaxel|mesh-list
92939103|NCT04447092|Gemcitabine|gemcitabine|mesh-list
92939104|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
92939105|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
92939106|NCT04447092|Irinotecan|irinotecan|mesh-list
92939107|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939108|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939109|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939110|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939111|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939112|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584521|NCT00323011|Vitamins|vitamins|mesh-ancestor
92939113|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939114|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
92939115|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939116|NCT04447092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939117|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92939118|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92939119|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939120|NCT04447092|Antidotes|antidotes|mesh-ancestor
92939121|NCT04447092|Protective Agents|protective agents|mesh-ancestor
92939122|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939123|NCT04447092|Vitamin B Complex|vitamin b complex|mesh-ancestor
92939124|NCT04447092|Vitamins|vitamins|mesh-ancestor
92939125|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
92939126|NCT04433780|Tenofovir|tenofovir|mesh-list
92939127|NCT04433780|Lamivudine|lamivudine|mesh-list
92939128|NCT04433780|Antiviral Agents|antiviral agents|mesh-ancestor
92939129|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939130|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92939131|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92939132|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939133|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939134|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92939135|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92939136|NCT04398524|Cemiplimab|cemiplimab|mesh-list
92939137|NCT04398524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939138|NCT04398524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939139|NCT04371224|Leucovorin|leucovorin|mesh-list
92939140|NCT04371224|Fluorouracil|fluorouracil|mesh-list
92939141|NCT04371224|Capecitabine|capecitabine|mesh-list
92939142|NCT04371224|Irinotecan|irinotecan|mesh-list
92939143|NCT04371224|Antimetabolites|antimetabolites|mesh-ancestor
92939144|NCT04371224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939145|NCT04371224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939146|NCT04371224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939147|NCT04371224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939148|NCT04371224|Immunologic Factors|immunologic factors|mesh-ancestor
92939149|NCT04371224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939150|NCT04371224|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92939151|NCT04371224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92939152|NCT04371224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939153|NCT04371224|Antidotes|antidotes|mesh-ancestor
92939154|NCT04371224|Protective Agents|protective agents|mesh-ancestor
92939155|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
92939156|NCT04371224|Vitamins|vitamins|mesh-ancestor
92939157|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
92939158|NCT04306900|Paclitaxel|paclitaxel|mesh-list
92939159|NCT04306900|Docetaxel|docetaxel|mesh-list
92939160|NCT04306900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92939161|NCT04306900|Gemcitabine|gemcitabine|mesh-list
92939162|NCT04306900|Pembrolizumab|pembrolizumab|mesh-list
92939163|NCT04306900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939164|NCT04306900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939165|NCT04306900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939166|NCT04306900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939167|NCT04306900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939168|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939169|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939170|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
92939171|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939172|NCT04306900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939173|NCT04288687|Niraparib|niraparib|mesh-list
92939174|NCT04288687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92939175|NCT04288687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939176|NCT04288687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939177|NCT04288687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939178|NCT04231708|Hydrocortisone|hydrocortisone|mesh-list
92939179|NCT04231708|Yohimbine|yohimbine|mesh-list
92939180|NCT04231708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92939181|NCT04231708|Mydriatics|mydriatics|mesh-ancestor
92939182|NCT04231708|Autonomic Agents|autonomic agents|mesh-ancestor
92939183|NCT04231708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939184|NCT04231708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939185|NCT04231708|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92939186|NCT04231708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92939187|NCT04231708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92939188|NCT04231708|Adrenergic Agents|adrenergic agents|mesh-ancestor
92584601|NCT00312598|Dopamine Agents|dopamine agents|mesh-ancestor
92939189|NCT04231708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939190|NCT04231708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939191|NCT04231708|Urological Agents|urological agents|mesh-ancestor
92939193|NCT04218786|Gout Suppressants|gout suppressants|mesh-ancestor
92939194|NCT04218786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92939195|NCT04218786|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939196|NCT04218786|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939197|NCT04218786|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939198|NCT04218786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939199|NCT04218786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939200|NCT04216524|Cytarabine|cytarabine|mesh-list
92939201|NCT04216524|Dexamethasone|dexamethasone|mesh-list
92939202|NCT04216524|Dexamethasone acetate|dexamethasone acetate|mesh-list
92939203|NCT04216524|Prednisone|prednisone|mesh-list
92939204|NCT04216524|Methylprednisolone|methylprednisolone|mesh-list
92939205|NCT04216524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92939206|NCT04216524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92939207|NCT04216524|Prednisolone|prednisolone|mesh-list
92939208|NCT04216524|Prednisolone acetate|prednisolone acetate|mesh-list
92939209|NCT04216524|Cortisone|cortisone|mesh-list
92939210|NCT04216524|Cyclophosphamide|cyclophosphamide|mesh-list
92939211|NCT04216524|Rituximab|rituximab|mesh-list
92939212|NCT04216524|Doxorubicin|doxorubicin|mesh-list
92939213|NCT04216524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92939214|NCT04216524|Methotrexate|methotrexate|mesh-list
92939215|NCT04216524|Vincristine|vincristine|mesh-list
92939216|NCT04216524|Daunorubicin|daunorubicin|mesh-list
92939217|NCT04216524|Venetoclax|venetoclax|mesh-list
92939218|NCT04216524|Mercaptopurine|mercaptopurine|mesh-list
92939219|NCT04216524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92939220|NCT04216524|Antibodies|antibodies|mesh-list
92939221|NCT04216524|Immunoglobulins|immunoglobulins|mesh-list
92939222|NCT04216524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92939223|NCT04216524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92939224|NCT04216524|Prednisolone phosphate|prednisolone phosphate|mesh-list
92939225|NCT04216524|BB 1101|bb 1101|mesh-list
92939226|NCT04216524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939227|NCT04216524|Immunologic Factors|immunologic factors|mesh-ancestor
92939228|NCT04216524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939229|NCT04216524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92939230|NCT04216524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92939231|NCT04216524|Alkylating Agents|alkylating agents|mesh-ancestor
92939232|NCT04216524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939233|NCT04216524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939234|NCT04216524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92939235|NCT04216524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92939236|NCT04216524|Antiemetics|antiemetics|mesh-ancestor
92939237|NCT04216524|Autonomic Agents|autonomic agents|mesh-ancestor
92939238|NCT04216524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939239|NCT04216524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939240|NCT04216524|Glucocorticoids|glucocorticoids|mesh-ancestor
92939241|NCT04216524|Hormones|hormones|mesh-ancestor
92939242|NCT04216524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939243|NCT04216524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92939244|NCT04216524|Protease Inhibitors|protease inhibitors|mesh-ancestor
92939245|NCT04216524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939246|NCT04216524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92939247|NCT04216524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92939248|NCT04216524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92939249|NCT04216524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92939250|NCT04216524|Abortifacient Agents|abortifacient agents|mesh-ancestor
92939251|NCT04216524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92939252|NCT04216524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939253|NCT04216524|Antimetabolites|antimetabolites|mesh-ancestor
92939254|NCT04216524|Dermatologic Agents|dermatologic agents|mesh-ancestor
92939255|NCT04216524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92939256|NCT04216524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92939258|NCT04216524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939259|NCT04216524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939260|NCT04216524|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939261|NCT04216524|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939262|NCT04216524|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939263|NCT04216524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92939264|NCT04216524|Protective Agents|protective agents|mesh-ancestor
92939265|NCT04202692|Magnesium trisilicate|magnesium trisilicate|mesh-list
92939266|NCT04202692|Hyaluronic Acid|hyaluronic acid|mesh-list
92939267|NCT04202692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92939268|NCT04202692|Immunologic Factors|immunologic factors|mesh-ancestor
92584669|NCT00122577|Ritonavir|ritonavir|mesh-list
92939269|NCT04202692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939271|NCT04202692|Protective Agents|protective agents|mesh-ancestor
92939272|NCT04202692|Antacids|antacids|mesh-ancestor
92939273|NCT04202692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939274|NCT04202692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939275|NCT04177758|Vitamin D|vitamin d|mesh-list
92939276|NCT04177758|Vitamins|vitamins|mesh-ancestor
92939277|NCT04177758|Micronutrients|micronutrients|mesh-ancestor
92939278|NCT04177758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939279|NCT04177758|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92939280|NCT04168112|Dexamethasone|dexamethasone|mesh-list
92939281|NCT04168112|Prednisolone|prednisolone|mesh-list
92939282|NCT04168112|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92939283|NCT04168112|Methylprednisolone|methylprednisolone|mesh-list
92939284|NCT04168112|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92939285|NCT04168112|Prednisolone acetate|prednisolone acetate|mesh-list
92939286|NCT04168112|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92939287|NCT04168112|Prednisolone phosphate|prednisolone phosphate|mesh-list
92939288|NCT04168112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92939289|NCT04168112|Antiemetics|antiemetics|mesh-ancestor
92939290|NCT04168112|Autonomic Agents|autonomic agents|mesh-ancestor
92939291|NCT04168112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939292|NCT04168112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939293|NCT04168112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939294|NCT04168112|Glucocorticoids|glucocorticoids|mesh-ancestor
92939295|NCT04168112|Hormones|hormones|mesh-ancestor
92939296|NCT04168112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939297|NCT04168112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92939298|NCT04168112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939299|NCT04168112|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92939300|NCT04168112|Protective Agents|protective agents|mesh-ancestor
92939301|NCT04150458|Choline|choline|mesh-list
92939302|NCT04150458|Lipotropic Agents|lipotropic agents|mesh-ancestor
92939303|NCT04150458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92939304|NCT04150458|Antimetabolites|antimetabolites|mesh-ancestor
92939305|NCT04150458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939306|NCT04150458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939307|NCT04150458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92939308|NCT04150458|Nootropic Agents|nootropic agents|mesh-ancestor
92939309|NCT04147208|Ritonavir|ritonavir|mesh-list
92939310|NCT04147208|Entecavir|entecavir|mesh-list
92939311|NCT04147208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92939312|NCT04147208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92939313|NCT04147208|Protease Inhibitors|protease inhibitors|mesh-ancestor
92939314|NCT04147208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939315|NCT04147208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939316|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92939317|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92939318|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
92939319|NCT04147208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939320|NCT04147208|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92939321|NCT04147208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92939322|NCT04140487|Azacitidine|azacitidine|mesh-list
92939323|NCT04140487|Venetoclax|venetoclax|mesh-list
92939324|NCT04140487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939325|NCT04140487|Antimetabolites|antimetabolites|mesh-ancestor
92939326|NCT04140487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939327|NCT04140487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939328|NCT04140487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939329|NCT04067726|Vitamin D|vitamin d|mesh-list
92939330|NCT04067726|Cholecalciferol|cholecalciferol|mesh-list
92939331|NCT04067726|Denosumab|denosumab|mesh-list
92939332|NCT04067726|Calcium|calcium|mesh-list
92939333|NCT04067726|Vitamins|vitamins|mesh-ancestor
92939334|NCT04067726|Micronutrients|micronutrients|mesh-ancestor
92939335|NCT04067726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939336|NCT04067726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92939337|NCT04067726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92939339|NCT04008706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939340|NCT04003103|Islatravir|islatravir|mesh-list
92939341|NCT04003103|Antiviral Agents|antiviral agents|mesh-ancestor
92939342|NCT04003103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939343|NCT04003103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939344|NCT04003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939345|NCT04003103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92939346|NCT04003103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92939347|NCT04003103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92939348|NCT03999216|Diuretics|diuretics|mesh-list
92939349|NCT03999216|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92939350|NCT03999216|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92939351|NCT03999216|Natriuretic Agents|natriuretic agents|mesh-ancestor
92939352|NCT03999216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939353|NCT03999216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92939354|NCT03999216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939355|NCT03978611|Ipilimumab|ipilimumab|mesh-list
92939356|NCT03978611|Relatlimab|relatlimab|mesh-list
92939357|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939358|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939359|NCT03978611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939360|NCT03978611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939361|NCT03945448|Fluconazole|fluconazole|mesh-list
92939362|NCT03945448|Amphotericin B|amphotericin b|mesh-list
92939363|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92939364|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
92939365|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939366|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92939367|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92939368|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939369|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939370|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92939371|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
92939372|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939373|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939374|NCT03945448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92939375|NCT03945448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92939376|NCT03945448|Amebicides|amebicides|mesh-ancestor
92939377|NCT03945448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92939378|NCT03945448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92939379|NCT03945448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92939380|NCT03941873|Tislelizumab|tislelizumab|mesh-list
92939381|NCT03941873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939382|NCT03941873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939383|NCT03941587|Aflibercept|aflibercept|mesh-list
92939384|NCT03941587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92939385|NCT03941587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92939386|NCT03941587|Growth Substances|growth substances|mesh-ancestor
92939387|NCT03941587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939388|NCT03941587|Growth Inhibitors|growth inhibitors|mesh-ancestor
92939389|NCT03941587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939390|NCT03917420|Tenofovir|tenofovir|mesh-list
92939391|NCT03917420|Emtricitabine|emtricitabine|mesh-list
92939392|NCT03917420|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92939393|NCT03917420|Antiviral Agents|antiviral agents|mesh-ancestor
92939394|NCT03917420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939395|NCT03917420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92939396|NCT03917420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92939397|NCT03917420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939398|NCT03917420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939399|NCT03917420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92939400|NCT03917420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92939401|NCT03913195|Ibalizumab|ibalizumab|mesh-list
92939402|NCT03913195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92939403|NCT03913195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92939404|NCT03913195|Antiviral Agents|antiviral agents|mesh-ancestor
92939405|NCT03913195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939406|NCT03913104|Mifepristone|mifepristone|mesh-list
92939407|NCT03913104|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92939408|NCT03913104|Abortifacient Agents|abortifacient agents|mesh-ancestor
92939409|NCT03913104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92939410|NCT03913104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939411|NCT03913104|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92939412|NCT03913104|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92939413|NCT03913104|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92939414|NCT03913104|Contraceptive Agents|contraceptive agents|mesh-ancestor
92939415|NCT03913104|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92939416|NCT03913104|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92939417|NCT03913104|Hormone Antagonists|hormone antagonists|mesh-ancestor
92584819|NCT00314704|Dopamine|dopamine|mesh-list
92939418|NCT03913104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939419|NCT03913104|Luteolytic Agents|luteolytic agents|mesh-ancestor
92939420|NCT03913104|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92939421|NCT03913104|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92939422|NCT03884556|Paclitaxel|paclitaxel|mesh-list
92939423|NCT03884556|Gemcitabine|gemcitabine|mesh-list
92939424|NCT03884556|Pembrolizumab|pembrolizumab|mesh-list
92939425|NCT03884556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939426|NCT03884556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939427|NCT03884556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939428|NCT03884556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939429|NCT03884556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939430|NCT03884556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939431|NCT03884556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939432|NCT03884556|Antimetabolites|antimetabolites|mesh-ancestor
92939433|NCT03884556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939434|NCT03884556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939435|NCT03720119|Lidocaine|lidocaine|mesh-list
92939436|NCT03720119|Anesthetics, Local|anesthetics, local|mesh-ancestor
92939437|NCT03720119|Anesthetics|anesthetics|mesh-ancestor
92939438|NCT03720119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939439|NCT03720119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939440|NCT03720119|Sensory System Agents|sensory system agents|mesh-ancestor
92939441|NCT03720119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939442|NCT03720119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92939443|NCT03720119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92939444|NCT03720119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92939445|NCT03720119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92939446|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939447|NCT03713528|Vancomycin|vancomycin|mesh-list
92939448|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92939449|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939450|NCT03705845|Tocotrienols|tocotrienols|mesh-list
92939451|NCT03705845|Vitamin E|vitamin e|mesh-list
92939452|NCT03705845|Tocopherols|tocopherols|mesh-list
92939453|NCT03705845|Antioxidants|antioxidants|mesh-ancestor
92939454|NCT03705845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939455|NCT03705845|Protective Agents|protective agents|mesh-ancestor
92939456|NCT03705845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939457|NCT03705845|Vitamins|vitamins|mesh-ancestor
92939458|NCT03705845|Micronutrients|micronutrients|mesh-ancestor
92939459|NCT03669718|Cemiplimab|cemiplimab|mesh-list
92939460|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939461|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939462|NCT03644966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92939463|NCT03644966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939464|NCT03642990|Niacinamide|niacinamide|mesh-list
92939465|NCT03642990|Niacin|niacin|mesh-list
92939466|NCT03642990|Nicotinic Acids|nicotinic acids|mesh-list
92939467|NCT03642990|Vitamin B Complex|vitamin b complex|mesh-ancestor
92939468|NCT03642990|Vitamins|vitamins|mesh-ancestor
92939469|NCT03642990|Micronutrients|micronutrients|mesh-ancestor
92939470|NCT03642990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939471|NCT03642990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92939472|NCT03642990|Antimetabolites|antimetabolites|mesh-ancestor
92939473|NCT03642990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939474|NCT03642990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92939475|NCT03642990|Vasodilator Agents|vasodilator agents|mesh-ancestor
92939476|NCT03582475|Cisplatin|cisplatin|mesh-list
92939477|NCT03582475|Carboplatin|carboplatin|mesh-list
92939478|NCT03582475|Docetaxel|docetaxel|mesh-list
92939479|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
92939480|NCT03582475|Etoposide|etoposide|mesh-list
92939481|NCT03582475|Etoposide phosphate|etoposide phosphate|mesh-list
92939482|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
92939483|NCT03582475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939484|NCT03582475|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939485|NCT03582475|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939486|NCT03582475|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939487|NCT03582475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939488|NCT03582475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939489|NCT03582475|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939490|NCT03582475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939491|NCT03582475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92939492|NCT03582475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92939493|NCT03582475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939494|NCT03582475|Keratolytic Agents|keratolytic agents|mesh-ancestor
92939495|NCT03582475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92939496|NCT03579784|Paclitaxel|paclitaxel|mesh-list
92939497|NCT03579784|Durvalumab|durvalumab|mesh-list
92939498|NCT03579784|Olaparib|olaparib|mesh-list
92939499|NCT03579784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939500|NCT03579784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939501|NCT03579784|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939502|NCT03579784|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939503|NCT03579784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939504|NCT03579784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939505|NCT03579784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939506|NCT03579784|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92939507|NCT03579784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939508|NCT03564678|Folic Acid|folic acid|mesh-list
92939509|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
92939510|NCT03564678|Vitamins|vitamins|mesh-ancestor
92939511|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
92939512|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939513|NCT03564678|Hematinics|hematinics|mesh-ancestor
92939514|NCT03553563|Esomeprazole|esomeprazole|mesh-list
92939515|NCT03553563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92939516|NCT03553563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939517|NCT03553563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92939518|NCT03553563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939519|NCT03553563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939520|NCT03542760|Methylene Blue|methylene blue|mesh-list
92939521|NCT03542760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939522|NCT03542760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939523|NCT03530397|Paclitaxel|paclitaxel|mesh-list
92939524|NCT03530397|Carboplatin|carboplatin|mesh-list
92939525|NCT03530397|Pembrolizumab|pembrolizumab|mesh-list
92939526|NCT03530397|Pemetrexed|pemetrexed|mesh-list
92939527|NCT03530397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939528|NCT03530397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939529|NCT03530397|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939530|NCT03530397|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939531|NCT03530397|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939532|NCT03530397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939533|NCT03530397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939534|NCT03530397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92939535|NCT03530397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939536|NCT03530397|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92939537|NCT03530397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92939538|NCT03515304|Evolocumab|evolocumab|mesh-list
92939539|NCT03515304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92939540|NCT03515304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92939541|NCT03515304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92939542|NCT03515304|Antimetabolites|antimetabolites|mesh-ancestor
92939543|NCT03515304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939544|NCT03515304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92939545|NCT03515304|Protease Inhibitors|protease inhibitors|mesh-ancestor
92939546|NCT03515304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939547|NCT03515304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92939548|NCT03479554|Antihypertensive Agents|antihypertensive agents|mesh-list
92939549|NCT03477292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92939550|NCT03477292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939551|NCT03465540|Dexamethasone|dexamethasone|mesh-list
92939552|NCT03465540|Azacitidine|azacitidine|mesh-list
92939553|NCT03465540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92939554|NCT03465540|Antiemetics|antiemetics|mesh-ancestor
92939555|NCT03465540|Autonomic Agents|autonomic agents|mesh-ancestor
92939556|NCT03465540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939557|NCT03465540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939559|NCT03465540|Glucocorticoids|glucocorticoids|mesh-ancestor
92939560|NCT03465540|Hormones|hormones|mesh-ancestor
92939561|NCT03465540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939562|NCT03465540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92939563|NCT03465540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939564|NCT03465540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939565|NCT03465540|Antimetabolites|antimetabolites|mesh-ancestor
92939566|NCT03465540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939567|NCT03465540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939568|NCT03368547|Edetic Acid|edetic acid|mesh-list
92939569|NCT03368547|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92939570|NCT03368547|Chelating Agents|chelating agents|mesh-ancestor
92939571|NCT03368547|Sequestering Agents|sequestering agents|mesh-ancestor
92939572|NCT03368547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939573|NCT03368547|Anticoagulants|anticoagulants|mesh-ancestor
92939574|NCT03368547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92939575|NCT03368547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92939576|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92939577|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939578|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939579|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939580|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92939581|NCT03152903|BCG Vaccine|bcg vaccine|mesh-list
92939582|NCT03152903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92939583|NCT03152903|Immunologic Factors|immunologic factors|mesh-ancestor
92939584|NCT03152903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939585|NCT03152890|Insulin|insulin|mesh-list
92939586|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92939587|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939588|NCT03125811|Ethanol|ethanol|mesh-list
92939589|NCT03125811|Ondansetron|ondansetron|mesh-list
92939590|NCT03125811|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92939591|NCT03125811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939592|NCT03125811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939593|NCT03125811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939594|NCT03125811|Antiemetics|antiemetics|mesh-ancestor
92939595|NCT03125811|Autonomic Agents|autonomic agents|mesh-ancestor
92939596|NCT03125811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939597|NCT03125811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939598|NCT03125811|Antipruritics|antipruritics|mesh-ancestor
92939599|NCT03125811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92939600|NCT03125811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92939601|NCT03125811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92939602|NCT03125811|Serotonin Agents|serotonin agents|mesh-ancestor
92939603|NCT03125811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939604|NCT03125811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939605|NCT03123029|Venetoclax|venetoclax|mesh-list
92939606|NCT03123029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939607|NCT03117933|Paclitaxel|paclitaxel|mesh-list
92939608|NCT03117933|Olaparib|olaparib|mesh-list
92939609|NCT03117933|Cediranib|cediranib|mesh-list
92939610|NCT03117933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939611|NCT03117933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939612|NCT03117933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939613|NCT03117933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939614|NCT03117933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939615|NCT03117933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939616|NCT03117933|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92939617|NCT03117933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939618|NCT03117933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92939619|NCT03077243|Cisplatin|cisplatin|mesh-list
92939620|NCT03077243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939621|NCT03048877|Apatinib|apatinib|mesh-list
92939622|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939623|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92939624|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939625|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939626|NCT02951351|Proxymetacaine|proxymetacaine|mesh-list
92939627|NCT02951351|Anesthetics, Local|anesthetics, local|mesh-ancestor
92939628|NCT02951351|Anesthetics|anesthetics|mesh-ancestor
92939629|NCT02951351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939630|NCT02951351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939631|NCT02951351|Sensory System Agents|sensory system agents|mesh-ancestor
92939633|NCT02940925|Cisplatin|cisplatin|mesh-list
92939634|NCT02940925|Fluorouracil|fluorouracil|mesh-list
92939635|NCT02940925|Capecitabine|capecitabine|mesh-list
92939636|NCT02940925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939637|NCT02940925|Antimetabolites|antimetabolites|mesh-ancestor
92939638|NCT02940925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939639|NCT02940925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939640|NCT02940925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939641|NCT02940925|Immunologic Factors|immunologic factors|mesh-ancestor
92939642|NCT02940925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939643|NCT02915705|Vitamin D|vitamin d|mesh-list
92939644|NCT02915705|Vitamins|vitamins|mesh-ancestor
92939645|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
92939646|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939647|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92939648|NCT02891278|Cytarabine|cytarabine|mesh-list
92939650|NCT02891278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939651|NCT02891278|Antimetabolites|antimetabolites|mesh-ancestor
92939652|NCT02891278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939653|NCT02891278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939654|NCT02891278|Antiviral Agents|antiviral agents|mesh-ancestor
92939655|NCT02891278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939656|NCT02891278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939657|NCT02891278|Immunologic Factors|immunologic factors|mesh-ancestor
92939658|NCT02891278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939659|NCT02891278|Antidepressive Agents|antidepressive agents|mesh-ancestor
92939660|NCT02891278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92939661|NCT02891278|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92939662|NCT02891278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92939663|NCT02891278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92939664|NCT02891278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939665|NCT02891278|Serotonin Agents|serotonin agents|mesh-ancestor
92939666|NCT02807181|Cisplatin|cisplatin|mesh-list
92939667|NCT02807181|Gemcitabine|gemcitabine|mesh-list
92939668|NCT02807181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939669|NCT02807181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939670|NCT02807181|Antimetabolites|antimetabolites|mesh-ancestor
92939671|NCT02807181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939672|NCT02454543|Androgens|androgens|mesh-list
92939673|NCT02454543|Hormones|hormones|mesh-ancestor
92939674|NCT02454543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939675|NCT02454543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939676|NCT02384512|Rasagiline|rasagiline|mesh-list
92939677|NCT02384512|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92939678|NCT02384512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939679|NCT02384512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939680|NCT02384512|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92939681|NCT02384512|Protective Agents|protective agents|mesh-ancestor
92939682|NCT02384512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939683|NCT02366494|Docetaxel|docetaxel|mesh-list
92939684|NCT02366494|Leuprolide|leuprolide|mesh-list
92939685|NCT02366494|Goserelin|goserelin|mesh-list
92939686|NCT02366494|Bicalutamide|bicalutamide|mesh-list
92939687|NCT02366494|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92939688|NCT02366494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939689|NCT02366494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939690|NCT02366494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939691|NCT02366494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939692|NCT02366494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939693|NCT02366494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92939694|NCT02366494|Fertility Agents|fertility agents|mesh-ancestor
92939695|NCT02366494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92939696|NCT02366494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939697|NCT02366494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92939698|NCT02366494|Androgen Antagonists|androgen antagonists|mesh-ancestor
92939699|NCT02366494|Hormone Antagonists|hormone antagonists|mesh-ancestor
92939700|NCT02366494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939701|NCT02366494|Luteolytic Agents|luteolytic agents|mesh-ancestor
92939702|NCT02366494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92939703|NCT02366494|Contraceptive Agents|contraceptive agents|mesh-ancestor
92526583|NCT00029224|Zoledronic Acid|zoledronic acid|mesh-list
92939704|NCT02366494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92939705|NCT02157610|Nicotine|nicotine|mesh-list
92939706|NCT02157610|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92939707|NCT02157610|Autonomic Agents|autonomic agents|mesh-ancestor
92939708|NCT02157610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939709|NCT02157610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939710|NCT02157610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92939711|NCT02157610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92939712|NCT02157610|Cholinergic Agents|cholinergic agents|mesh-ancestor
92939713|NCT02157610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164498|NCT01924481|Caffeine|caffeine|mesh-list
92939714|NCT02157610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939715|NCT02138617|Leucovorin|leucovorin|mesh-list
92939716|NCT02138617|Bevacizumab|bevacizumab|mesh-list
92939717|NCT02138617|Fluorouracil|fluorouracil|mesh-list
92939718|NCT02138617|Irinotecan|irinotecan|mesh-list
92939719|NCT02138617|Levoleucovorin|levoleucovorin|mesh-list
92939720|NCT02138617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939721|NCT02138617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585119|NCT03897868|Vasodilator Agents|vasodilator agents|mesh-ancestor
92939722|NCT02138617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92939723|NCT02138617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92939724|NCT02138617|Growth Substances|growth substances|mesh-ancestor
92939725|NCT02138617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939726|NCT02138617|Growth Inhibitors|growth inhibitors|mesh-ancestor
92939727|NCT02138617|Antimetabolites|antimetabolites|mesh-ancestor
92939728|NCT02138617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939729|NCT02138617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939730|NCT02138617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939731|NCT02138617|Immunologic Factors|immunologic factors|mesh-ancestor
92939732|NCT02138617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92939733|NCT02138617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92939734|NCT02138617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939735|NCT02138617|Antidotes|antidotes|mesh-ancestor
92939736|NCT02138617|Protective Agents|protective agents|mesh-ancestor
92939737|NCT02138617|Vitamin B Complex|vitamin b complex|mesh-ancestor
92939738|NCT02138617|Vitamins|vitamins|mesh-ancestor
92939739|NCT02138617|Micronutrients|micronutrients|mesh-ancestor
92939740|NCT02078869|Progesterone|progesterone|mesh-list
92939741|NCT02078869|Progestins|progestins|mesh-ancestor
92939742|NCT02078869|Hormones|hormones|mesh-ancestor
92939743|NCT02078869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939744|NCT02078869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939745|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92939746|NCT02070705|Hematinics|hematinics|mesh-ancestor
92939747|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92939748|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92939749|NCT01946815|Atorvastatin|atorvastatin|mesh-list
92939750|NCT01946815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92939751|NCT01946815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92939752|NCT01946815|Antimetabolites|antimetabolites|mesh-ancestor
92939753|NCT01946815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939754|NCT01946815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92939755|NCT01946815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92939756|NCT01946815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939757|NCT01937156|Granisetron|granisetron|mesh-list
92939758|NCT01937156|Antiemetics|antiemetics|mesh-ancestor
92939759|NCT01937156|Autonomic Agents|autonomic agents|mesh-ancestor
92939760|NCT01937156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939761|NCT01937156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939762|NCT01937156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939763|NCT01937156|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92939764|NCT01937156|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92939765|NCT01937156|Serotonin Agents|serotonin agents|mesh-ancestor
92939766|NCT01937156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939767|NCT01937156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939768|NCT01805804|Valsartan|valsartan|mesh-list
92939769|NCT01805804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92939770|NCT01805804|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92939771|NCT01805804|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92939772|NCT01805804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939773|NCT01718873|Leucovorin|leucovorin|mesh-list
92939774|NCT01718873|Folic Acid|folic acid|mesh-list
92939775|NCT01718873|Bevacizumab|bevacizumab|mesh-list
92939776|NCT01718873|Fluorouracil|fluorouracil|mesh-list
92939777|NCT01718873|Capecitabine|capecitabine|mesh-list
92939778|NCT01718873|Oxaliplatin|oxaliplatin|mesh-list
92939779|NCT01718873|Levoleucovorin|levoleucovorin|mesh-list
92939780|NCT01718873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92939781|NCT01718873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939782|NCT01718873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92939783|NCT01718873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92939784|NCT01718873|Growth Substances|growth substances|mesh-ancestor
92164502|NCT01924481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939785|NCT01718873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939786|NCT01718873|Growth Inhibitors|growth inhibitors|mesh-ancestor
92939787|NCT01718873|Antimetabolites|antimetabolites|mesh-ancestor
92939788|NCT01718873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939789|NCT01718873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939790|NCT01718873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939791|NCT01718873|Immunologic Factors|immunologic factors|mesh-ancestor
92939792|NCT01718873|Antidotes|antidotes|mesh-ancestor
92939793|NCT01718873|Protective Agents|protective agents|mesh-ancestor
92939794|NCT01718873|Vitamin B Complex|vitamin b complex|mesh-ancestor
92939795|NCT01718873|Vitamins|vitamins|mesh-ancestor
92939796|NCT01718873|Micronutrients|micronutrients|mesh-ancestor
92939797|NCT01718873|Hematinics|hematinics|mesh-ancestor
92939798|NCT01612351|Paclitaxel|paclitaxel|mesh-list
92939799|NCT01612351|Cisplatin|cisplatin|mesh-list
92939800|NCT01612351|Carboplatin|carboplatin|mesh-list
92939801|NCT01612351|Lapatinib|lapatinib|mesh-list
92939802|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92939803|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939804|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92939805|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92939806|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92939807|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939808|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92939809|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939810|NCT01424566|Nabiximols|nabiximols|mesh-list
92939811|NCT01424566|Analgesics|analgesics|mesh-ancestor
92939812|NCT01424566|Sensory System Agents|sensory system agents|mesh-ancestor
92939813|NCT01424566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939814|NCT01424566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939815|NCT01367561|Naloxone|naloxone|mesh-list
92939816|NCT01367561|Methylnaltrexone|methylnaltrexone|mesh-list
92939817|NCT01367561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92939818|NCT01367561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939819|NCT01367561|Sensory System Agents|sensory system agents|mesh-ancestor
92939820|NCT01367561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939821|NCT01361607|Nabiximols|nabiximols|mesh-list
92939822|NCT01361607|Analgesics|analgesics|mesh-ancestor
92939823|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
92939824|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939825|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939826|NCT01337089|Nabiximols|nabiximols|mesh-list
92939827|NCT01337089|Analgesics|analgesics|mesh-ancestor
92939828|NCT01337089|Sensory System Agents|sensory system agents|mesh-ancestor
92939829|NCT01337089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939830|NCT01337089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939831|NCT01297400|Sulfadiazine|sulfadiazine|mesh-list
92939832|NCT01297400|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92939833|NCT01297400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92939834|NCT01297400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939835|NCT01297400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92939836|NCT01297400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92939837|NCT01297400|Coccidiostats|coccidiostats|mesh-ancestor
92939838|NCT01297400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92939839|NCT01276587|Vitamin D|vitamin d|mesh-list
92939840|NCT01276587|Ergocalciferols|ergocalciferols|mesh-list
92939841|NCT01276587|Cholecalciferol|cholecalciferol|mesh-list
92939842|NCT01276587|Vitamins|vitamins|mesh-list
92939843|NCT01276587|Micronutrients|micronutrients|mesh-ancestor
92939844|NCT01276587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939845|NCT01276587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92939846|NCT01276587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92939847|NCT01217580|Ropivacaine|ropivacaine|mesh-list
92939848|NCT01217580|Anesthetics, Local|anesthetics, local|mesh-ancestor
92939849|NCT01217580|Anesthetics|anesthetics|mesh-ancestor
92939850|NCT01217580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939851|NCT01217580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939852|NCT01217580|Sensory System Agents|sensory system agents|mesh-ancestor
92939853|NCT01217580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939854|NCT00802646|Epinephrine|epinephrine|mesh-list
92939855|NCT00802646|Fentanyl|fentanyl|mesh-list
92939856|NCT00802646|Bupivacaine|bupivacaine|mesh-list
92939857|NCT00802646|Anesthetics, Local|anesthetics, local|mesh-ancestor
92939858|NCT00802646|Anesthetics|anesthetics|mesh-ancestor
92939859|NCT00802646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939860|NCT00802646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939861|NCT00802646|Sensory System Agents|sensory system agents|mesh-ancestor
92939862|NCT00802646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939863|NCT00802646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92939864|NCT00802646|Narcotics|narcotics|mesh-ancestor
92939865|NCT00802646|Analgesics|analgesics|mesh-ancestor
92939866|NCT00802646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92939867|NCT00802646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92939868|NCT00802646|Anesthetics, General|anesthetics, general|mesh-ancestor
92939869|NCT00802646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92939870|NCT00802646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92939871|NCT00802646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92939872|NCT00802646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939873|NCT00802646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939874|NCT00802646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92939875|NCT00802646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92939876|NCT00802646|Autonomic Agents|autonomic agents|mesh-ancestor
92939877|NCT00802646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92939878|NCT00802646|Respiratory System Agents|respiratory system agents|mesh-ancestor
92939879|NCT00802646|Mydriatics|mydriatics|mesh-ancestor
92939880|NCT00802646|Sympathomimetics|sympathomimetics|mesh-ancestor
92939881|NCT00802646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92939882|NCT00473707|Oxytocin|oxytocin|mesh-list
92939883|NCT00473707|Oxytocics|oxytocics|mesh-ancestor
92939884|NCT00473707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92939885|NCT00473707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939886|NCT00233675|Tiagabine|tiagabine|mesh-list
92939887|NCT00233675|Anticonvulsants|anticonvulsants|mesh-ancestor
92939888|NCT00233675|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92939889|NCT00233675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92939890|NCT00233675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92939891|NCT00233675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939892|NCT00233675|GABA Agents|gaba agents|mesh-ancestor
92939893|NCT00233675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939894|NCT00233675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939895|NCT00202774|Fluorouracil|fluorouracil|mesh-list
92939896|NCT00202774|Capecitabine|capecitabine|mesh-list
92939897|NCT00202774|Oxaliplatin|oxaliplatin|mesh-list
92939898|NCT00202774|Antimetabolites|antimetabolites|mesh-ancestor
92939899|NCT00202774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939900|NCT00202774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939901|NCT00202774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939902|NCT00202774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939903|NCT00202774|Immunologic Factors|immunologic factors|mesh-ancestor
92939904|NCT00202774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939905|NCT00114530|Cyclophosphamide|cyclophosphamide|mesh-list
92939906|NCT00114530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92939907|NCT00114530|Immunologic Factors|immunologic factors|mesh-ancestor
92939908|NCT00114530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939909|NCT00114530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92939910|NCT00114530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92939911|NCT00114530|Alkylating Agents|alkylating agents|mesh-ancestor
92939912|NCT00114530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939913|NCT00114530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939914|NCT00114530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92939915|NCT00107744|Caseins|caseins|mesh-list
92939916|NCT00107744|Chelating Agents|chelating agents|mesh-ancestor
92939917|NCT00107744|Sequestering Agents|sequestering agents|mesh-ancestor
92939918|NCT00107744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939919|NCT00845338|Darifenacin|darifenacin|mesh-list
92939920|NCT00845338|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92939921|NCT00845338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92939922|NCT00845338|Cholinergic Agents|cholinergic agents|mesh-ancestor
92939923|NCT00845338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939924|NCT00845338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939925|NCT00845338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939926|NCT00845338|Urological Agents|urological agents|mesh-ancestor
92939927|NCT00923962|Adenosine|adenosine|mesh-list
92939928|NCT00923962|Glucagon|glucagon|mesh-list
92939929|NCT00923962|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92939930|NCT00923962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92939931|NCT00923962|Hormones|hormones|mesh-ancestor
92939932|NCT00923962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92939933|NCT00923962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939934|NCT00923962|Incretins|incretins|mesh-ancestor
92939935|NCT00923962|Analgesics|analgesics|mesh-ancestor
92939936|NCT00923962|Sensory System Agents|sensory system agents|mesh-ancestor
92939937|NCT00923962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92939938|NCT00923962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92939939|NCT00923962|Vasodilator Agents|vasodilator agents|mesh-ancestor
92939940|NCT00923962|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92939941|NCT00923962|Purinergic Agonists|purinergic agonists|mesh-ancestor
92939942|NCT00923962|Purinergic Agents|purinergic agents|mesh-ancestor
92939943|NCT00923962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939944|NCT00923962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939945|NCT02575092|Folic Acid|folic acid|mesh-list
92939946|NCT02575092|Enalapril|enalapril|mesh-list
92939947|NCT02575092|Enalaprilat|enalaprilat|mesh-list
92939948|NCT02575092|Maleic acid|maleic acid|mesh-list
92939949|NCT02575092|Hematinics|hematinics|mesh-ancestor
92939950|NCT02575092|Vitamin B Complex|vitamin b complex|mesh-ancestor
92939951|NCT02575092|Vitamins|vitamins|mesh-ancestor
92585343|NCT00123318|Epirubicin|epirubicin|mesh-list
92939952|NCT02575092|Micronutrients|micronutrients|mesh-ancestor
92939953|NCT02575092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939954|NCT02575092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939955|NCT02575092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939956|NCT02575092|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92939957|NCT02575092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92939958|NCT02575092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92939960|NCT04097470|Midostaurin|midostaurin|mesh-list
92939961|NCT04097470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92939962|NCT04097470|Antimetabolites|antimetabolites|mesh-ancestor
92939963|NCT04097470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939964|NCT04097470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92939965|NCT04097470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939966|NCT04097470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92939967|NCT04041934|Tryptophan|tryptophan|mesh-list
92939968|NCT04041934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92939969|NCT04041934|Antidepressive Agents|antidepressive agents|mesh-ancestor
92939970|NCT04041934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92939971|NCT00851734|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92939972|NCT00851734|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92939973|NCT00845572|Risperidone|risperidone|mesh-list
92939974|NCT00845572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92939975|NCT00845572|Serotonin Agents|serotonin agents|mesh-ancestor
92939976|NCT00845572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92939977|NCT00845572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939978|NCT00845572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92939979|NCT00845572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92939980|NCT00845572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92939981|NCT00845572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92939982|NCT00845572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92939983|NCT00845572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92939984|NCT00845572|Dopamine Agents|dopamine agents|mesh-ancestor
92939985|NCT00711906|Pyrimethamine|pyrimethamine|mesh-list
92939986|NCT00711906|Sulfadoxine|sulfadoxine|mesh-list
92939987|NCT00711906|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92939988|NCT00711906|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92939989|NCT00711906|Antimalarials|antimalarials|mesh-ancestor
92939990|NCT00711906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92939991|NCT00711906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92939992|NCT00711906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92939993|NCT00711906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92939994|NCT00711906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92939995|NCT00711906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92939996|NCT00711906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92939997|NCT00711906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92939998|NCT04502550|Propofol|propofol|mesh-list
92939999|NCT04502550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92940000|NCT04502550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940001|NCT04502550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940002|NCT04502550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92940003|NCT04502550|Anesthetics, General|anesthetics, general|mesh-ancestor
92940004|NCT04502550|Anesthetics|anesthetics|mesh-ancestor
92940005|NCT04227184|Trospium chloride|trospium chloride|mesh-list
92940006|NCT04227184|Parasympatholytics|parasympatholytics|mesh-ancestor
92940007|NCT04227184|Autonomic Agents|autonomic agents|mesh-ancestor
92940008|NCT04227184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940009|NCT04227184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940010|NCT04227184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92940011|NCT04227184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92940012|NCT04227184|Cholinergic Agents|cholinergic agents|mesh-ancestor
92940013|NCT04227184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940014|NCT04227184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940015|NCT04227184|Urological Agents|urological agents|mesh-ancestor
92940016|NCT04018950|Durlobactam|durlobactam|mesh-list
92940017|NCT04018950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92940018|NCT04018950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940019|NCT04018950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940020|NCT04018950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940021|NCT04018950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940022|NCT02545972|Tacrolimus|tacrolimus|mesh-list
92940023|NCT02545972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940024|NCT02545972|Immunologic Factors|immunologic factors|mesh-ancestor
92940025|NCT02545972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940026|NCT02545972|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92940027|NCT02545972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940028|NCT02545972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940029|NCT00852046|Dexmedetomidine|dexmedetomidine|mesh-list
92940030|NCT00852046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92940031|NCT00852046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940032|NCT00852046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940033|NCT00852046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92940034|NCT00852046|Analgesics|analgesics|mesh-ancestor
92940035|NCT00852046|Sensory System Agents|sensory system agents|mesh-ancestor
92940036|NCT00852046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940037|NCT00852046|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92940038|NCT00852046|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92940039|NCT00852046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92940040|NCT00852046|Adrenergic Agents|adrenergic agents|mesh-ancestor
92940041|NCT00852046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940042|NCT00852046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940043|NCT02573064|Vancomycin|vancomycin|mesh-list
92940044|NCT02573064|Colistin|colistin|mesh-list
92940045|NCT02573064|Tigecycline|tigecycline|mesh-list
92940046|NCT02573064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940047|NCT02573064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940048|NCT02573064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92940049|NCT02573064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940050|NCT02573064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940051|NCT00845884|Bevacizumab|bevacizumab|mesh-list
92940052|NCT00845884|Cisplatin|cisplatin|mesh-list
92940053|NCT00845884|Docetaxel|docetaxel|mesh-list
92940054|NCT00845884|Capecitabine|capecitabine|mesh-list
92940055|NCT00845884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940056|NCT00845884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940057|NCT00845884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92940058|NCT00845884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92940059|NCT00845884|Growth Substances|growth substances|mesh-ancestor
92940060|NCT00845884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940061|NCT00845884|Growth Inhibitors|growth inhibitors|mesh-ancestor
92940062|NCT00845884|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940063|NCT00845884|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940064|NCT00845884|Mitosis Modulators|mitosis modulators|mesh-ancestor
92940065|NCT00845884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940066|NCT00845884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92940067|NCT00845884|Antimetabolites|antimetabolites|mesh-ancestor
92940068|NCT00923806|Aldesleukin|aldesleukin|mesh-list
92940069|NCT00923806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940070|NCT00923806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92940071|NCT00923806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92940072|NCT00923806|Antiviral Agents|antiviral agents|mesh-ancestor
92940073|NCT00923806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940074|NCT00848068|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92940075|NCT00848068|Lubricant Eye Drops|lubricant eye drops|mesh-list
92940076|NCT00848068|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92940077|NCT00718536|Raltegravir Potassium|raltegravir potassium|mesh-list
92940078|NCT00718536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92940079|NCT00718536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92940081|NCT00718536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940082|NCT00718536|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92940083|NCT00718536|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92940084|NCT00718536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940085|NCT00718536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940086|NCT00712062|Pemetrexed|pemetrexed|mesh-list
92940087|NCT00712062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940088|NCT00712062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940089|NCT00712062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940090|NCT00712062|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92940091|NCT00712062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92940092|NCT00712140|Trastuzumab|trastuzumab|mesh-list
92940093|NCT00712140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940094|NCT00712140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940095|NCT02545738|Liraglutide|liraglutide|mesh-list
92940096|NCT02545738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92940097|NCT02545738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940098|NCT02545738|Incretins|incretins|mesh-ancestor
92940099|NCT02545738|Hormones|hormones|mesh-ancestor
92940100|NCT02545738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92940101|NCT00848302|Nitric Oxide|nitric oxide|mesh-list
92940102|NCT00848302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92585504|NCT00092196|Aprepitant|aprepitant|mesh-list
92940103|NCT00848302|Autonomic Agents|autonomic agents|mesh-ancestor
92940104|NCT00848302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940105|NCT00848302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940106|NCT00848302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92940107|NCT00848302|Respiratory System Agents|respiratory system agents|mesh-ancestor
92940108|NCT00848302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92940109|NCT00848302|Antioxidants|antioxidants|mesh-ancestor
92940110|NCT00848302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940111|NCT00848302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940112|NCT00848302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92940113|NCT00848302|Vasodilator Agents|vasodilator agents|mesh-ancestor
92940114|NCT00848302|Gasotransmitters|gasotransmitters|mesh-ancestor
92940115|NCT00848302|Protective Agents|protective agents|mesh-ancestor
92940116|NCT02572596|Cyclophosphamide|cyclophosphamide|mesh-list
92940117|NCT02572596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940118|NCT02572596|Immunologic Factors|immunologic factors|mesh-ancestor
92940119|NCT02572596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940120|NCT02572596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940121|NCT02572596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92940122|NCT02572596|Alkylating Agents|alkylating agents|mesh-ancestor
92940123|NCT02572596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940124|NCT02572596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940125|NCT02572596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92940126|NCT00712374|Pyrimethamine|pyrimethamine|mesh-list
92940127|NCT00712374|Sulfadoxine|sulfadoxine|mesh-list
92940128|NCT00712374|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92940129|NCT00712374|Amodiaquine|amodiaquine|mesh-list
92940130|NCT00712374|Antimalarials|antimalarials|mesh-ancestor
92940131|NCT00712374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92940132|NCT00712374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92940133|NCT00712374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940134|NCT00712374|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92940135|NCT00712374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940136|NCT00712374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940137|NCT00712374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92940138|NCT02573220|Leucovorin|leucovorin|mesh-list
92940139|NCT02573220|Fluorouracil|fluorouracil|mesh-list
92940140|NCT02573220|Irinotecan|irinotecan|mesh-list
92940141|NCT02573220|Cetuximab|cetuximab|mesh-list
92940142|NCT02573220|Camptothecin|camptothecin|mesh-list
92940143|NCT02573220|Calcium|calcium|mesh-list
92940144|NCT02573220|Levoleucovorin|levoleucovorin|mesh-list
92940145|NCT02573220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92940146|NCT02573220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940147|NCT02573220|Antimetabolites|antimetabolites|mesh-ancestor
92940148|NCT02573220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940149|NCT02573220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92940150|NCT02573220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940151|NCT02573220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940152|NCT02573220|Immunologic Factors|immunologic factors|mesh-ancestor
92940153|NCT02573220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92940154|NCT02573220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92940155|NCT02573220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940156|NCT02573220|Antidotes|antidotes|mesh-ancestor
92940157|NCT02573220|Protective Agents|protective agents|mesh-ancestor
92940158|NCT02573220|Vitamin B Complex|vitamin b complex|mesh-ancestor
92940159|NCT02573220|Vitamins|vitamins|mesh-ancestor
92940160|NCT02573220|Micronutrients|micronutrients|mesh-ancestor
92940161|NCT02573220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940162|NCT02573220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92940163|NCT00712452|Cyclophosphamide|cyclophosphamide|mesh-list
92940164|NCT00712452|Vinblastine|vinblastine|mesh-list
92940165|NCT00712452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940166|NCT00712452|Immunologic Factors|immunologic factors|mesh-ancestor
92940167|NCT00712452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940168|NCT00712452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940169|NCT00712452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92940170|NCT00712452|Alkylating Agents|alkylating agents|mesh-ancestor
92940171|NCT00712452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940172|NCT00712452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940173|NCT00712452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92940174|NCT00712452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92940175|NCT00712452|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940176|NCT00712452|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940177|NCT00712452|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585584|NCT00316030|Bexarotene|bexarotene|mesh-list
92940178|NCT00618982|Sorafenib|sorafenib|mesh-list
92940179|NCT00618982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940180|NCT00618982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92940181|NCT00618982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940182|NCT00618982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940183|NCT02544880|Tadalafil|tadalafil|mesh-list
92940184|NCT02544880|Vaccines|vaccines|mesh-list
92940185|NCT02544880|Immunologic Factors|immunologic factors|mesh-ancestor
92940186|NCT02544880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940187|NCT02544880|Vasodilator Agents|vasodilator agents|mesh-ancestor
92940188|NCT02544880|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92940189|NCT02544880|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92940190|NCT02544880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940191|NCT02544880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940192|NCT02544880|Urological Agents|urological agents|mesh-ancestor
92940193|NCT00856570|Warfarin|warfarin|mesh-list
92940194|NCT00856570|Mirabegron|mirabegron|mesh-list
92940195|NCT00856570|Anticoagulants|anticoagulants|mesh-ancestor
92940196|NCT00856570|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92940197|NCT00856570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92940198|NCT00856570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92940199|NCT00856570|Adrenergic Agents|adrenergic agents|mesh-ancestor
92940200|NCT00856570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940201|NCT00856570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940202|NCT00856570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940203|NCT00856570|Urological Agents|urological agents|mesh-ancestor
92940204|NCT04068870|Contraceptive Agents|contraceptive agents|mesh-list
92940205|NCT04068870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92940206|NCT04068870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940207|NCT00856804|Ribavirin|ribavirin|mesh-list
92940208|NCT00856804|Thalidomide|thalidomide|mesh-list
92940209|NCT00856804|Antimetabolites|antimetabolites|mesh-ancestor
92940210|NCT00856804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940211|NCT00856804|Antiviral Agents|antiviral agents|mesh-ancestor
92940212|NCT00856804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940213|NCT00856804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940214|NCT00856804|Immunologic Factors|immunologic factors|mesh-ancestor
92940215|NCT00856804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940216|NCT00856804|Leprostatic Agents|leprostatic agents|mesh-ancestor
92940217|NCT00856804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940218|NCT00856804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92940219|NCT00856804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92940220|NCT00856804|Growth Substances|growth substances|mesh-ancestor
92940221|NCT00856804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92940222|NCT00856804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940223|NCT00856882|Caseins|caseins|mesh-list
92940224|NCT00856882|Chelating Agents|chelating agents|mesh-ancestor
92940225|NCT00856882|Sequestering Agents|sequestering agents|mesh-ancestor
92940226|NCT00856882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940227|NCT00712686|Olanzapine|olanzapine|mesh-list
92940228|NCT00712686|Aripiprazole|aripiprazole|mesh-list
92940229|NCT00712686|Antiemetics|antiemetics|mesh-ancestor
92940230|NCT00712686|Autonomic Agents|autonomic agents|mesh-ancestor
92940231|NCT00712686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940232|NCT00712686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940233|NCT00712686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92940234|NCT00712686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92940235|NCT00712686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92940236|NCT00712686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940237|NCT00712686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940238|NCT00712686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92940239|NCT00712686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92940240|NCT00712686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940241|NCT00712686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940242|NCT00712686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940243|NCT00712686|Serotonin Agents|serotonin agents|mesh-ancestor
92940244|NCT00712686|Antidepressive Agents|antidepressive agents|mesh-ancestor
92940245|NCT00712686|Dopamine Agonists|dopamine agonists|mesh-ancestor
92940246|NCT00712686|Dopamine Agents|dopamine agents|mesh-ancestor
92940247|NCT00712686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92940248|NCT00712686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92940249|NCT00712686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92940250|NCT00712686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92940251|NCT00712686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92940252|NCT00712686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92940254|NCT04041856|Povidone|povidone|mesh-list
92940255|NCT04041856|Plasma Substitutes|plasma substitutes|mesh-ancestor
92940256|NCT04041856|Blood Substitutes|blood substitutes|mesh-ancestor
92940257|NCT04041856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92940258|NCT04041856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940259|NCT00856960|Losartan|losartan|mesh-list
92940260|NCT00856960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92940261|NCT00856960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92940262|NCT00856960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92940263|NCT00856960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92940264|NCT00856960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940265|NCT00712764|Adenosine|adenosine|mesh-list
92940266|NCT00712764|Analgesics|analgesics|mesh-ancestor
92940267|NCT00712764|Sensory System Agents|sensory system agents|mesh-ancestor
92940268|NCT00712764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940269|NCT00712764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940270|NCT00712764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92940271|NCT00712764|Vasodilator Agents|vasodilator agents|mesh-ancestor
92940272|NCT00712764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92940273|NCT00712764|Purinergic Agonists|purinergic agonists|mesh-ancestor
92940274|NCT00712764|Purinergic Agents|purinergic agents|mesh-ancestor
92940275|NCT00712764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940276|NCT00712764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940277|NCT00848458|Azelaic acid|azelaic acid|mesh-list
92940278|NCT00848458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940279|NCT00848458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92940280|NCT00578786|Ambrisentan|ambrisentan|mesh-list
92940281|NCT00578786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92940282|NCT00424255|Lapatinib|lapatinib|mesh-list
92940283|NCT00424255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940284|NCT00424255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92940285|NCT00424255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940286|NCT00424255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940287|NCT02574156|Insulin|insulin|mesh-list
92940288|NCT02574156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92940289|NCT02574156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940290|NCT00848692|Rituximab|rituximab|mesh-list
92940291|NCT00848692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940292|NCT00848692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940293|NCT00848692|Immunologic Factors|immunologic factors|mesh-ancestor
92940294|NCT00848692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940295|NCT00848692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940296|NCT00848770|Norepinephrine|norepinephrine|mesh-list
92940297|NCT00848770|Esmolol|esmolol|mesh-list
92940298|NCT00848770|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92940299|NCT00848770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92940300|NCT00848770|Adrenergic Agents|adrenergic agents|mesh-ancestor
92940301|NCT00848770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940302|NCT00848770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940303|NCT00848770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940304|NCT00848770|Sympathomimetics|sympathomimetics|mesh-ancestor
92940305|NCT00848770|Autonomic Agents|autonomic agents|mesh-ancestor
92940306|NCT00848770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940307|NCT00848770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92940308|NCT00848770|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92940309|NCT00848770|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92940310|NCT00848770|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92940311|NCT00717704|Dasatinib|dasatinib|mesh-list
92940312|NCT00717704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940313|NCT00717704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92940314|NCT00717704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940315|NCT00717704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940316|NCT00620074|Voriconazole|voriconazole|mesh-list
92940317|NCT00620074|Anidulafungin|anidulafungin|mesh-list
92940318|NCT00620074|Antifungal Agents|antifungal agents|mesh-ancestor
92940319|NCT00620074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940320|NCT00620074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92940321|NCT00620074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92940322|NCT00620074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940323|NCT00620074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940324|NCT00620074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92940325|NCT00620074|Hormone Antagonists|hormone antagonists|mesh-ancestor
92940326|NCT00620074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92940327|NCT00620074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940328|NCT00620074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92940329|NCT02571296|Progesterone|progesterone|mesh-list
92940330|NCT02571296|Progestins|progestins|mesh-ancestor
92940331|NCT02571296|Hormones|hormones|mesh-ancestor
92940332|NCT02571296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92940333|NCT02571296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940334|NCT00857038|Doxycycline|doxycycline|mesh-list
92940335|NCT00857038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940336|NCT00857038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940337|NCT00857038|Antimalarials|antimalarials|mesh-ancestor
92940338|NCT00857038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92940339|NCT00857038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92940340|NCT00857116|Albendazole|albendazole|mesh-list
92940341|NCT00857116|Anthelmintics|anthelmintics|mesh-ancestor
92940342|NCT00857116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92940343|NCT00857116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940344|NCT00857116|Anticestodal Agents|anticestodal agents|mesh-ancestor
92940345|NCT00857116|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92940346|NCT00857116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92940347|NCT00857116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940348|NCT00857116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940349|NCT00857116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92940350|NCT00857116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940351|NCT00857116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940352|NCT00717782|Botulinum Toxins|botulinum toxins|mesh-list
92940353|NCT00717782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92940354|NCT00717782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940355|NCT00717782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940356|NCT00717782|Cholinergic Agents|cholinergic agents|mesh-ancestor
92940357|NCT00717782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940358|NCT00717782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940359|NCT00717938|Carboplatin|carboplatin|mesh-list
92940360|NCT00717938|Etoposide|etoposide|mesh-list
92940361|NCT00717938|Etoposide phosphate|etoposide phosphate|mesh-list
92940362|NCT00717938|Cisplatin|cisplatin|mesh-list
92940363|NCT00717938|Enoxaparin|enoxaparin|mesh-list
92940364|NCT00717938|Enoxaparin sodium|enoxaparin sodium|mesh-list
92940365|NCT00717938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940366|NCT00717938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92940367|NCT00717938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92940368|NCT00717938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92940369|NCT00717938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940370|NCT00717938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940371|NCT00717938|Anticoagulants|anticoagulants|mesh-ancestor
92940372|NCT00717938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92940373|NCT00717938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92940374|NCT00857428|Oxymorphone|oxymorphone|mesh-list
92940375|NCT00857428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940376|NCT00857428|Narcotics|narcotics|mesh-ancestor
92940377|NCT00857428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940378|NCT00857428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940379|NCT00857428|Analgesics|analgesics|mesh-ancestor
92940380|NCT00857428|Sensory System Agents|sensory system agents|mesh-ancestor
92940381|NCT00857428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940382|NCT00857428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92940383|NCT04018768|Acetaminophen|acetaminophen|mesh-list
92940384|NCT04018768|Ibuprofen|ibuprofen|mesh-list
92940385|NCT04018768|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92940386|NCT04018768|Oxycodone|oxycodone|mesh-list
92940387|NCT04018768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92940388|NCT04018768|Analgesics|analgesics|mesh-ancestor
92940389|NCT04018768|Sensory System Agents|sensory system agents|mesh-ancestor
92940390|NCT04018768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940391|NCT04018768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940392|NCT04018768|Antipyretics|antipyretics|mesh-ancestor
92940393|NCT04018768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92940394|NCT04018768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92940395|NCT04018768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940396|NCT04018768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92940397|NCT04018768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940398|NCT04018768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940399|NCT04018768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940400|NCT04018768|Narcotics|narcotics|mesh-ancestor
92940401|NCT04018768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940402|NCT03518060|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
92940403|NCT03518060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92940404|NCT03518060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92940405|NCT03518060|Antiviral Agents|antiviral agents|mesh-ancestor
92940406|NCT03518060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940407|NCT00848848|Vaccines|vaccines|mesh-list
92940408|NCT00848848|Immunologic Factors|immunologic factors|mesh-ancestor
92940409|NCT00848848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940410|NCT02573922|Oxycodone|oxycodone|mesh-list
92940411|NCT02573922|Naloxone|naloxone|mesh-list
92940412|NCT02573922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940413|NCT02573922|Narcotics|narcotics|mesh-ancestor
92940414|NCT02573922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940415|NCT02573922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940416|NCT02573922|Analgesics|analgesics|mesh-ancestor
92940417|NCT02573922|Sensory System Agents|sensory system agents|mesh-ancestor
92940418|NCT02573922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940419|NCT02573922|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92940420|NCT00852436|Pregabalin|pregabalin|mesh-list
92940421|NCT00852436|Analgesics|analgesics|mesh-ancestor
92940422|NCT00852436|Sensory System Agents|sensory system agents|mesh-ancestor
92940423|NCT00852436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940424|NCT00852436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940425|NCT00852436|Anticonvulsants|anticonvulsants|mesh-ancestor
92940426|NCT00852436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92940427|NCT00852436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940428|NCT00852436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940429|NCT00852436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92940430|NCT00852436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92940431|NCT00852436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92940432|NCT00852436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940433|NCT00852436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940434|NCT00720512|Leucovorin|leucovorin|mesh-list
92940435|NCT00720512|Bevacizumab|bevacizumab|mesh-list
92940436|NCT00720512|Fluorouracil|fluorouracil|mesh-list
92940437|NCT00720512|Oxaliplatin|oxaliplatin|mesh-list
92940438|NCT00720512|Irinotecan|irinotecan|mesh-list
92940439|NCT00720512|Calcium|calcium|mesh-list
92940440|NCT00720512|Levoleucovorin|levoleucovorin|mesh-list
92940441|NCT00720512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940442|NCT00720512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940443|NCT00720512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92940444|NCT00720512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92940445|NCT00720512|Growth Substances|growth substances|mesh-ancestor
92940446|NCT00720512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940447|NCT00720512|Growth Inhibitors|growth inhibitors|mesh-ancestor
92940448|NCT00720512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92940449|NCT00720512|Antimetabolites|antimetabolites|mesh-ancestor
92940450|NCT00720512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940451|NCT00720512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92940452|NCT00720512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940453|NCT00720512|Immunologic Factors|immunologic factors|mesh-ancestor
92940454|NCT00720512|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92940455|NCT00720512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92940456|NCT00720512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940457|NCT00720512|Antidotes|antidotes|mesh-ancestor
92940458|NCT00720512|Protective Agents|protective agents|mesh-ancestor
92940459|NCT00720512|Vitamin B Complex|vitamin b complex|mesh-ancestor
92940460|NCT00720512|Vitamins|vitamins|mesh-ancestor
92940461|NCT00720512|Micronutrients|micronutrients|mesh-ancestor
92940462|NCT04069286|Amoxicillin|amoxicillin|mesh-list
92940463|NCT04069286|Omeprazole|omeprazole|mesh-list
92940464|NCT04069286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940465|NCT04069286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940466|NCT04069286|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92940467|NCT04069286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92940468|NCT04069286|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92940469|NCT04069286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940470|NCT04069286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940471|NCT00713622|Zonisamide|zonisamide|mesh-list
92940472|NCT00713622|Valproic Acid|valproic acid|mesh-list
92940473|NCT00713622|Anticonvulsants|anticonvulsants|mesh-ancestor
92164573|NCT01926665|Antiemetics|antiemetics|mesh-ancestor
92940474|NCT00713622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940475|NCT00713622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940476|NCT00713622|GABA Agents|gaba agents|mesh-ancestor
92940477|NCT00713622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940478|NCT00713622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940479|NCT00713622|Antimanic Agents|antimanic agents|mesh-ancestor
92940480|NCT00713622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92940481|NCT00713622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940482|NCT00713622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940483|NCT00713622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92940484|NCT00713622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940485|NCT00713622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92940486|NCT00718172|Ribavirin|ribavirin|mesh-list
92940487|NCT00718172|Antimetabolites|antimetabolites|mesh-ancestor
92940488|NCT00718172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940489|NCT00718172|Antiviral Agents|antiviral agents|mesh-ancestor
92940490|NCT00718172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940491|NCT00720018|Sumatriptan|sumatriptan|mesh-list
92940492|NCT00720018|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92940493|NCT00720018|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92940494|NCT00720018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92940495|NCT00720018|Serotonin Agents|serotonin agents|mesh-ancestor
92940496|NCT00720018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940497|NCT00720018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940498|NCT00720018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940499|NCT03992456|Trifluridine|trifluridine|mesh-list
92940500|NCT03992456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92940501|NCT03992456|Panitumumab|panitumumab|mesh-list
92940502|NCT03992456|Antibodies|antibodies|mesh-list
92940503|NCT03992456|Immunoglobulins|immunoglobulins|mesh-list
92940504|NCT03992456|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92940505|NCT03992456|Immunologic Factors|immunologic factors|mesh-ancestor
92940506|NCT03992456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940507|NCT03992456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940508|NCT03992456|Antimetabolites|antimetabolites|mesh-ancestor
92940509|NCT03992456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940510|NCT03992456|Antiviral Agents|antiviral agents|mesh-ancestor
92940511|NCT03992456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940512|NCT00618826|Paclitaxel|paclitaxel|mesh-list
92940513|NCT00618826|Gemcitabine|gemcitabine|mesh-list
92940514|NCT00618826|Bevacizumab|bevacizumab|mesh-list
92940515|NCT00618826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92940516|NCT00618826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940517|NCT00618826|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940518|NCT00618826|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940519|NCT00618826|Mitosis Modulators|mitosis modulators|mesh-ancestor
92940520|NCT00618826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940521|NCT00618826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92940522|NCT00618826|Antimetabolites|antimetabolites|mesh-ancestor
92940523|NCT00618826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940524|NCT00618826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92940525|NCT00618826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92940526|NCT00618826|Growth Substances|growth substances|mesh-ancestor
92940527|NCT00618826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940528|NCT00618826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92940529|NCT00720174|Doxorubicin|doxorubicin|mesh-list
92940530|NCT00720174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92940531|NCT00720174|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92940532|NCT00720174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92940533|NCT00720174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940534|NCT00720174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92940535|NCT00720174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92940536|NCT00720174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940537|NCT00720174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940538|NCT00720174|Immunologic Factors|immunologic factors|mesh-ancestor
92940539|NCT00720174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940540|NCT00722930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92940541|NCT00722930|Immunologic Factors|immunologic factors|mesh-ancestor
92940542|NCT00722930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940543|NCT03834740|Everolimus|everolimus|mesh-list
92940544|NCT03834740|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92147075|NCT03089671|Riboflavin|riboflavin|mesh-list
92940545|NCT03834740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92940546|NCT03834740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940547|NCT03834740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940548|NCT03834740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940549|NCT03834740|Immunologic Factors|immunologic factors|mesh-ancestor
92940550|NCT03834740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940551|NCT03834740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940552|NCT00849082|Goserelin|goserelin|mesh-list
92940553|NCT00849082|Cyproterone Acetate|cyproterone acetate|mesh-list
92940554|NCT00849082|Cyproterone|cyproterone|mesh-list
92940555|NCT00849082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92940556|NCT00849082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940557|NCT00849082|Androgen Antagonists|androgen antagonists|mesh-ancestor
92940558|NCT00849082|Hormone Antagonists|hormone antagonists|mesh-ancestor
92940559|NCT00849082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92940560|NCT00849082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940561|NCT00849082|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92940562|NCT00849082|Contraceptive Agents|contraceptive agents|mesh-ancestor
92940563|NCT00849082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92940564|NCT00849160|Darunavir|darunavir|mesh-list
92940565|NCT00849160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92940566|NCT00849160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92940567|NCT00849160|Protease Inhibitors|protease inhibitors|mesh-ancestor
92940568|NCT00849160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940569|NCT00849160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940570|NCT00849160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92940571|NCT00849160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92940572|NCT00849160|Antiviral Agents|antiviral agents|mesh-ancestor
92940573|NCT00849160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940574|NCT00720590|Ritonavir|ritonavir|mesh-list
92940575|NCT00720590|Lopinavir|lopinavir|mesh-list
92940576|NCT00720590|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92940577|NCT00720590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92940578|NCT00720590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92940579|NCT00720590|Protease Inhibitors|protease inhibitors|mesh-ancestor
92940580|NCT00720590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940581|NCT00720590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940582|NCT00720590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92940583|NCT00720590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92940584|NCT00720590|Antiviral Agents|antiviral agents|mesh-ancestor
92940585|NCT00720590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940586|NCT00720590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92940587|NCT00720590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92940588|NCT00718406|Metoprolol|metoprolol|mesh-list
92940589|NCT00718406|Morphine|morphine|mesh-list
92940590|NCT00718406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940591|NCT00718406|Narcotics|narcotics|mesh-ancestor
92940592|NCT00718406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940593|NCT00718406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940594|NCT00718406|Analgesics|analgesics|mesh-ancestor
92940595|NCT00718406|Sensory System Agents|sensory system agents|mesh-ancestor
92940596|NCT00718406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940597|NCT00718406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92940598|NCT00718406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92940599|NCT00718406|Sympatholytics|sympatholytics|mesh-ancestor
92940600|NCT00718406|Autonomic Agents|autonomic agents|mesh-ancestor
92940601|NCT00718406|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92940602|NCT00718406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92940603|NCT00718406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92940604|NCT00718406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92940605|NCT00718406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940606|NCT00718406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940607|NCT00849238|Mycophenolic Acid|mycophenolic acid|mesh-list
92940608|NCT00849238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92940609|NCT00849238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940610|NCT00849238|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92940611|NCT00849238|Antitubercular Agents|antitubercular agents|mesh-ancestor
92940612|NCT00849238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940613|NCT00849238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940614|NCT00849238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940615|NCT00849238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940616|NCT00720408|Mycophenolic Acid|mycophenolic acid|mesh-list
92164578|NCT01926665|Glucocorticoids|glucocorticoids|mesh-ancestor
92940618|NCT00720408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940619|NCT00720408|Immunologic Factors|immunologic factors|mesh-ancestor
92940620|NCT00720408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940621|NCT00720408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92940622|NCT00720408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940623|NCT00720408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940624|NCT00720408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92940625|NCT00720408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940626|NCT00720408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92940627|NCT00720408|Antitubercular Agents|antitubercular agents|mesh-ancestor
92940628|NCT00720408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940629|NCT00720408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940630|NCT00849316|Insulin Aspart|insulin aspart|mesh-list
92940631|NCT00849316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92940632|NCT00849316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940634|NCT00852670|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92940635|NCT00852670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940636|NCT00852670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940637|NCT00852670|Immunologic Factors|immunologic factors|mesh-ancestor
92940638|NCT00852670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940639|NCT00717210|Temozolomide|temozolomide|mesh-list
92940640|NCT00717210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92940641|NCT00717210|Alkylating Agents|alkylating agents|mesh-ancestor
92940642|NCT00717210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940643|NCT00717210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940644|NCT00723086|Docetaxel|docetaxel|mesh-list
92940645|NCT00723086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940646|NCT00723086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940647|NCT00723086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940648|NCT00723086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92940649|NCT00723086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940650|NCT04018378|Varenicline|varenicline|mesh-list
92940651|NCT04018378|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92940652|NCT04018378|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92940653|NCT04018378|Cholinergic Agents|cholinergic agents|mesh-ancestor
92940654|NCT04018378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940655|NCT04018378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940656|NCT04018378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940657|NCT00849550|Bevacizumab|bevacizumab|mesh-list
92940658|NCT00849550|Capecitabine|capecitabine|mesh-list
92940659|NCT00849550|Oxaliplatin|oxaliplatin|mesh-list
92940660|NCT00849550|Everolimus|everolimus|mesh-list
92940661|NCT00849550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940662|NCT00849550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940663|NCT00849550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92940664|NCT00849550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92940665|NCT00849550|Growth Substances|growth substances|mesh-ancestor
92940666|NCT00849550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940667|NCT00849550|Growth Inhibitors|growth inhibitors|mesh-ancestor
92940668|NCT00849550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92940669|NCT00849550|Antimetabolites|antimetabolites|mesh-ancestor
92940670|NCT00849550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940671|NCT00849550|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92940672|NCT00849550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92940673|NCT00849550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940674|NCT00849550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940675|NCT00849550|Immunologic Factors|immunologic factors|mesh-ancestor
92940676|NCT03816488|Metformin|metformin|mesh-list
92940677|NCT03816488|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92940678|NCT03816488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92940679|NCT03816488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940680|NCT03816488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92940681|NCT03816488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92940682|NCT03816488|Analgesics|analgesics|mesh-ancestor
92940683|NCT03816488|Sensory System Agents|sensory system agents|mesh-ancestor
92940684|NCT03816488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940685|NCT03816488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92940686|NCT03816488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940687|NCT00858676|Acarbose|acarbose|mesh-list
92940688|NCT00858676|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92940689|NCT00858676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940690|NCT00858676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940691|NCT00858676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92940692|NCT00858676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940693|NCT00858754|Methylnaltrexone|methylnaltrexone|mesh-list
92940694|NCT00858754|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92940695|NCT00858754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940696|NCT00858754|Sensory System Agents|sensory system agents|mesh-ancestor
92940697|NCT00858754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940698|NCT00723164|Fentanyl|fentanyl|mesh-list
92940699|NCT00723164|Midazolam|midazolam|mesh-list
92940700|NCT00723164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940701|NCT00723164|Narcotics|narcotics|mesh-ancestor
92940702|NCT00723164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940703|NCT00723164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940704|NCT00723164|Analgesics|analgesics|mesh-ancestor
92586108|NCT00330577|Timolol|timolol|mesh-list
92940706|NCT00723164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940707|NCT00723164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92940708|NCT00723164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92940709|NCT00723164|Anesthetics, General|anesthetics, general|mesh-ancestor
92940710|NCT00723164|Anesthetics|anesthetics|mesh-ancestor
92940711|NCT00723164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92940712|NCT00723164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92940713|NCT00723164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92940714|NCT00723164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940715|NCT00723164|GABA Modulators|gaba modulators|mesh-ancestor
92940716|NCT00723164|GABA Agents|gaba agents|mesh-ancestor
92940717|NCT00723164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940718|NCT00723164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940719|NCT00723242|Ribavirin|ribavirin|mesh-list
92940720|NCT00723242|Antimetabolites|antimetabolites|mesh-ancestor
92940721|NCT00723242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940722|NCT00723242|Antiviral Agents|antiviral agents|mesh-ancestor
92940723|NCT00723242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940724|NCT02545426|Dialysis Solutions|dialysis solutions|mesh-list
92940725|NCT02545426|Calcium|calcium|mesh-list
92940726|NCT02545426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92940727|NCT02545426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940728|NCT02545426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92940729|NCT00720824|Anesthetics|anesthetics|mesh-list
92940730|NCT00720824|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92940731|NCT00720824|Anesthetics, Local|anesthetics, local|mesh-list
92940732|NCT00720824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940733|NCT00720824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940734|NCT00720824|Sensory System Agents|sensory system agents|mesh-ancestor
92940735|NCT00720824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940736|NCT05373134|Pentoxifylline|pentoxifylline|mesh-list
92940737|NCT05373134|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92940738|NCT05373134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940739|NCT05373134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940740|NCT05373134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92940741|NCT05373134|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92940742|NCT05373134|Protective Agents|protective agents|mesh-ancestor
92940743|NCT05373134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940744|NCT05373134|Vasodilator Agents|vasodilator agents|mesh-ancestor
92940745|NCT05373134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92940746|NCT05373134|Antioxidants|antioxidants|mesh-ancestor
92940747|NCT00723320|Atorvastatin|atorvastatin|mesh-list
92940748|NCT00723320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92940749|NCT00723320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92940750|NCT00723320|Antimetabolites|antimetabolites|mesh-ancestor
92940751|NCT00723320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940752|NCT00723320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92940753|NCT00723320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92940754|NCT00723320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940756|NCT00578448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92940757|NCT00578448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940758|NCT00578448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940759|NCT00578448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940760|NCT00578448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940761|NCT00578448|Immunologic Factors|immunologic factors|mesh-ancestor
92940762|NCT00578448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940763|NCT00578448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940764|NCT00720564|Temozolomide|temozolomide|mesh-list
92940765|NCT00720564|Arsenic Trioxide|arsenic trioxide|mesh-list
92940766|NCT00720564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92940767|NCT00720564|Alkylating Agents|alkylating agents|mesh-ancestor
92940768|NCT00720564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940769|NCT00720564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940770|NCT00714090|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92940771|NCT00714090|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92940772|NCT00714090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92940773|NCT00714090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940774|NCT00714090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940775|NCT00714090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940776|NCT00714090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940777|NCT00714090|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92940778|NCT00714090|Antidepressive Agents|antidepressive agents|mesh-ancestor
92940779|NCT00714090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940780|NCT04067024|Anesthetics|anesthetics|mesh-list
92940781|NCT04067024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940782|NCT04067024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940783|NCT00618748|Olanzapine|olanzapine|mesh-list
92940784|NCT00618748|Antiemetics|antiemetics|mesh-ancestor
92940785|NCT00618748|Autonomic Agents|autonomic agents|mesh-ancestor
92940786|NCT00618748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940787|NCT00618748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940788|NCT00618748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92940789|NCT00618748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92940790|NCT00618748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92940791|NCT00618748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940792|NCT00618748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940793|NCT00618748|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92940794|NCT00618748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92940795|NCT00618748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940796|NCT00618748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940797|NCT00618748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940798|NCT00618748|Serotonin Agents|serotonin agents|mesh-ancestor
92940799|NCT04067102|Paclitaxel|paclitaxel|mesh-list
92940800|NCT04067102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92940801|NCT04067102|Cyclophosphamide|cyclophosphamide|mesh-list
92940802|NCT04067102|Carboplatin|carboplatin|mesh-list
92940803|NCT04067102|Epirubicin|epirubicin|mesh-list
92940804|NCT04067102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92940805|NCT04067102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940806|NCT04067102|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940807|NCT04067102|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940808|NCT04067102|Mitosis Modulators|mitosis modulators|mesh-ancestor
92940809|NCT04067102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940810|NCT04067102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940811|NCT04067102|Immunologic Factors|immunologic factors|mesh-ancestor
92940812|NCT04067102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940813|NCT04067102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940814|NCT04067102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92940815|NCT04067102|Alkylating Agents|alkylating agents|mesh-ancestor
92940816|NCT04067102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526601|NCT00000491|Antipyretics|antipyretics|mesh-ancestor
92940817|NCT04067102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92940818|NCT04067102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92940819|NCT04067102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92940820|NCT04067102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940821|NCT05659290|Bevacizumab|bevacizumab|mesh-list
92940822|NCT05659290|Capecitabine|capecitabine|mesh-list
92940823|NCT05659290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940824|NCT05659290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940825|NCT05659290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92940826|NCT05659290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92940827|NCT05659290|Growth Substances|growth substances|mesh-ancestor
92940828|NCT05659290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940829|NCT05659290|Growth Inhibitors|growth inhibitors|mesh-ancestor
92940830|NCT05659290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92940831|NCT05659290|Antimetabolites|antimetabolites|mesh-ancestor
92940832|NCT05659290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940833|NCT00717678|Mycophenolic Acid|mycophenolic acid|mesh-list
92940834|NCT00717678|Tacrolimus|tacrolimus|mesh-list
92940835|NCT00717678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940836|NCT00717678|Immunologic Factors|immunologic factors|mesh-ancestor
92940837|NCT00717678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940838|NCT00717678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92940839|NCT00717678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940840|NCT00717678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940841|NCT00717678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92940842|NCT00717678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940843|NCT00717678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92940844|NCT00717678|Antitubercular Agents|antitubercular agents|mesh-ancestor
92940845|NCT00717678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92940846|NCT00717678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940847|NCT00859534|Afamelanotide|afamelanotide|mesh-list
92940848|NCT00859534|Dermatologic Agents|dermatologic agents|mesh-ancestor
92940849|NCT02571842|Prednisolone|prednisolone|mesh-list
92940850|NCT02571842|Rituximab|rituximab|mesh-list
92586249|NCT00084227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92940852|NCT02571842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940853|NCT02571842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940854|NCT02571842|Immunologic Factors|immunologic factors|mesh-ancestor
92940855|NCT02571842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940856|NCT02571842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940857|NCT02571842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92940858|NCT02571842|Glucocorticoids|glucocorticoids|mesh-ancestor
92940859|NCT02571842|Hormones|hormones|mesh-ancestor
92940860|NCT02571842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92940861|NCT02571842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92940862|NCT02571842|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92940863|NCT02571842|Protease Inhibitors|protease inhibitors|mesh-ancestor
92940864|NCT02571842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940865|NCT02571842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940866|NCT02571842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92940867|NCT02546284|Lenzilumab|lenzilumab|mesh-list
92940868|NCT02546284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92940869|NCT00721448|Ticagrelor|ticagrelor|mesh-list
92940870|NCT00721448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92940871|NCT00721448|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92940872|NCT00721448|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92940873|NCT00721448|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92940874|NCT00721448|Purinergic Agents|purinergic agents|mesh-ancestor
92940875|NCT00721448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940876|NCT00721448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940877|NCT00721448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940878|NCT00853216|Oxycodone|oxycodone|mesh-list
92940879|NCT00853216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940880|NCT00853216|Narcotics|narcotics|mesh-ancestor
92940881|NCT00853216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940882|NCT00853216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940883|NCT00853216|Analgesics|analgesics|mesh-ancestor
92940884|NCT00853216|Sensory System Agents|sensory system agents|mesh-ancestor
92940885|NCT00853216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940886|NCT04961528|Terlipressin|terlipressin|mesh-list
92940887|NCT04961528|Tranexamic Acid|tranexamic acid|mesh-list
92940888|NCT04961528|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92940889|NCT04961528|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92940890|NCT04961528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940892|NCT04961528|Coagulants|coagulants|mesh-ancestor
92940893|NCT04961528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92940894|NCT04961528|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92940895|NCT00721032|Amiodarone|amiodarone|mesh-list
92940896|NCT00721032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92940897|NCT00721032|Vasodilator Agents|vasodilator agents|mesh-ancestor
92940898|NCT00721032|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92940899|NCT00721032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940900|NCT00721032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940901|NCT00721032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92940902|NCT00721032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92940903|NCT00721032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92940904|NCT00721032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940905|NCT00721032|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92940906|NCT00721032|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92940907|NCT00721032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92940908|NCT00723866|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92940909|NCT00723866|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92940910|NCT00723866|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92940911|NCT00723866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940912|NCT00723866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940913|NCT00723866|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92940914|NCT00723866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92940915|NCT00723866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940916|NCT00723866|Cholinergic Agents|cholinergic agents|mesh-ancestor
92940917|NCT00723866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940918|NCT00853294|Chlorpheniramine|chlorpheniramine|mesh-list
92940919|NCT00853294|Hydrocodone|hydrocodone|mesh-list
92940920|NCT00853294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940921|NCT00853294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92940922|NCT00853294|Narcotics|narcotics|mesh-ancestor
92940923|NCT00853294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940924|NCT00853294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940925|NCT00853294|Analgesics|analgesics|mesh-ancestor
92940926|NCT00853294|Sensory System Agents|sensory system agents|mesh-ancestor
92940927|NCT00853294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940928|NCT00853294|Antitussive Agents|antitussive agents|mesh-ancestor
92940929|NCT00853294|Respiratory System Agents|respiratory system agents|mesh-ancestor
92940930|NCT00853294|Antipruritics|antipruritics|mesh-ancestor
92940931|NCT00853294|Dermatologic Agents|dermatologic agents|mesh-ancestor
92940932|NCT00853294|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92940933|NCT00853294|Histamine Antagonists|histamine antagonists|mesh-ancestor
92940934|NCT00853294|Histamine Agents|histamine agents|mesh-ancestor
92940935|NCT00853294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940936|NCT00853294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92940937|NCT03246230|BCG Vaccine|bcg vaccine|mesh-list
92940938|NCT03246230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92940939|NCT03246230|Immunologic Factors|immunologic factors|mesh-ancestor
92940940|NCT03246230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940941|NCT00717834|Formaldehyde|formaldehyde|mesh-list
92940942|NCT00717834|Disinfectants|disinfectants|mesh-ancestor
92940943|NCT00717834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940944|NCT00658359|Cyclosporine|cyclosporine|mesh-list
92940945|NCT00658359|Cyclosporins|cyclosporins|mesh-list
92940946|NCT00658359|Tofacitinib|tofacitinib|mesh-list
92940947|NCT00658359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940948|NCT00658359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940949|NCT00658359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92940950|NCT00658359|Immunologic Factors|immunologic factors|mesh-ancestor
92940951|NCT00658359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940952|NCT00658359|Antifungal Agents|antifungal agents|mesh-ancestor
92940953|NCT00658359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92940954|NCT00658359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92940955|NCT00658359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92940956|NCT00658359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92940957|NCT00658359|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92940958|NCT00658359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92940959|NCT00853450|Clopidogrel|clopidogrel|mesh-list
92940960|NCT00853450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92940961|NCT00853450|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92285875|NCT01690663|Hormones|hormones|mesh-ancestor
92940962|NCT00853450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92940963|NCT00853450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92940964|NCT00853450|Purinergic Agents|purinergic agents|mesh-ancestor
92940965|NCT00853450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940966|NCT00853450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940967|NCT00853450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940968|NCT04066790|Paclitaxel|paclitaxel|mesh-list
92940969|NCT04066790|Trastuzumab|trastuzumab|mesh-list
92940970|NCT04066790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92940971|NCT04066790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92940972|NCT04066790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92940973|NCT04066790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92940974|NCT04066790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92940975|NCT04066790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940976|NCT04066790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92940977|NCT00721526|Disulfiram|disulfiram|mesh-list
92940978|NCT00721526|Lorazepam|lorazepam|mesh-list
92940979|NCT00721526|Anticonvulsants|anticonvulsants|mesh-ancestor
92940980|NCT00721526|Antiemetics|antiemetics|mesh-ancestor
92940981|NCT00721526|Autonomic Agents|autonomic agents|mesh-ancestor
92940982|NCT00721526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92940983|NCT00721526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92940984|NCT00721526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92940985|NCT00721526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92940986|NCT00721526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92940987|NCT00721526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92940988|NCT00721526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92940989|NCT00721526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92940990|NCT00721526|GABA Modulators|gaba modulators|mesh-ancestor
92940991|NCT00721526|GABA Agents|gaba agents|mesh-ancestor
92940992|NCT00721526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92940993|NCT00721526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92940994|NCT00721526|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92940995|NCT00721526|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92940996|NCT00721526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92940997|NCT00721604|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92940998|NCT00721604|Plasma Substitutes|plasma substitutes|mesh-ancestor
92941000|NCT02571192|Volixibat|volixibat|mesh-list
92941001|NCT02571192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92941002|NCT00724022|Mycophenolic Acid|mycophenolic acid|mesh-list
92941003|NCT00724022|Prednisolone|prednisolone|mesh-list
92941004|NCT00724022|Tacrolimus|tacrolimus|mesh-list
92941005|NCT00724022|Thymoglobulin|thymoglobulin|mesh-list
92941006|NCT00724022|Basiliximab|basiliximab|mesh-list
92941007|NCT00724022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941008|NCT00724022|Immunologic Factors|immunologic factors|mesh-ancestor
92941009|NCT00724022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941010|NCT00724022|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92941011|NCT00724022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941012|NCT00724022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941013|NCT00724022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941014|NCT00724022|Glucocorticoids|glucocorticoids|mesh-ancestor
92941015|NCT00724022|Hormones|hormones|mesh-ancestor
92941016|NCT00724022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941017|NCT00724022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941018|NCT00724022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941019|NCT00724022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92941020|NCT00724022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92941021|NCT00724022|Antitubercular Agents|antitubercular agents|mesh-ancestor
92941022|NCT00724022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92941023|NCT00724022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941024|NCT00721344|Moxifloxacin|moxifloxacin|mesh-list
92941025|NCT00721344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92941026|NCT00721344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941027|NCT00721344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92941028|NCT00721344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92941029|NCT00721344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941030|NCT00721344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941031|NCT00721344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941032|NCT00717990|Bevacizumab|bevacizumab|mesh-list
92941033|NCT00717990|Capecitabine|capecitabine|mesh-list
92941034|NCT00717990|Irinotecan|irinotecan|mesh-list
92941035|NCT00717990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941036|NCT00717990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941037|NCT00717990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941038|NCT00717990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941039|NCT00717990|Growth Substances|growth substances|mesh-ancestor
92941040|NCT00717990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941041|NCT00717990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941042|NCT00717990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941043|NCT00717990|Antimetabolites|antimetabolites|mesh-ancestor
92941044|NCT00717990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941045|NCT00717990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92941046|NCT00717990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92941047|NCT00717990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941048|NCT02572986|Permethrin|permethrin|mesh-list
92941049|NCT02572986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941050|NCT02572986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941051|NCT00853684|Capecitabine|capecitabine|mesh-list
92941052|NCT00853684|Endostar protein|endostar protein|mesh-list
92941053|NCT00853684|Endostatins|endostatins|mesh-list
92941054|NCT00853684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941055|NCT00853684|Antimetabolites|antimetabolites|mesh-ancestor
92941056|NCT00853684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941057|NCT00853684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941058|NCT00853684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941059|NCT00853684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941060|NCT00853684|Growth Substances|growth substances|mesh-ancestor
92941061|NCT00853684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941062|NCT00853684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941063|NCT00723060|Escitalopram|escitalopram|mesh-list
92941064|NCT00723060|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92941065|NCT00723060|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92941066|NCT00723060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92941067|NCT00723060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941068|NCT00723060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941069|NCT00723060|Serotonin Agents|serotonin agents|mesh-ancestor
92941070|NCT00723060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941071|NCT02571140|Teriparatide|teriparatide|mesh-list
92941072|NCT02571140|Parathyroid Hormone|parathyroid hormone|mesh-list
92941073|NCT02571140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92941074|NCT02571140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941075|NCT02571140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92941076|NCT00723216|Enoxaparin|enoxaparin|mesh-list
92941077|NCT00723216|Anticoagulants|anticoagulants|mesh-ancestor
92941078|NCT00723216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92941079|NCT00723216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92941080|NCT00723216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941081|NCT00724178|Vitamin D|vitamin d|mesh-list
92941082|NCT00724178|Cholecalciferol|cholecalciferol|mesh-list
92941083|NCT00724178|Calcium Carbonate|calcium carbonate|mesh-list
92941084|NCT00724178|Calcium|calcium|mesh-list
92941085|NCT00724178|Vitamins|vitamins|mesh-ancestor
92941086|NCT00724178|Micronutrients|micronutrients|mesh-ancestor
92941087|NCT00724178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941088|NCT00724178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92941089|NCT00724178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92941090|NCT00724178|Antacids|antacids|mesh-ancestor
92941091|NCT00724178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941092|NCT00724178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941093|NCT02546050|Metformin|metformin|mesh-list
92941094|NCT02546050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92941095|NCT02546050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941096|NCT04800224|Propolis|propolis|mesh-list
92941097|NCT04800224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941098|NCT00718146|Vaccines|vaccines|mesh-list
92941099|NCT00718146|Immunologic Factors|immunologic factors|mesh-ancestor
92941100|NCT00718146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941101|NCT00860626|Interferons|interferons|mesh-list
92941102|NCT00860626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941103|NCT00860626|Antiviral Agents|antiviral agents|mesh-ancestor
92941104|NCT00860626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941105|NCT00724256|Ceftibuten|ceftibuten|mesh-list
92941106|NCT00724256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92941107|NCT00724256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941108|NCT04742660|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92941109|NCT04742660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941110|NCT01005914|Cytarabine|cytarabine|mesh-list
92941111|NCT01005914|Dexamethasone|dexamethasone|mesh-list
92941112|NCT01005914|Methylprednisolone|methylprednisolone|mesh-list
92526605|NCT00029380|Busulfan|busulfan|mesh-list
92941113|NCT01005914|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92941114|NCT01005914|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92941115|NCT01005914|Cyclophosphamide|cyclophosphamide|mesh-list
92941116|NCT01005914|Doxorubicin|doxorubicin|mesh-list
92941117|NCT01005914|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92941118|NCT01005914|Methotrexate|methotrexate|mesh-list
92941119|NCT01005914|Vincristine|vincristine|mesh-list
92941120|NCT01005914|Imatinib Mesylate|imatinib mesylate|mesh-list
92941121|NCT01005914|Asparaginase|asparaginase|mesh-list
92941122|NCT01005914|Pegaspargase|pegaspargase|mesh-list
92941123|NCT01005914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941124|NCT01005914|Immunologic Factors|immunologic factors|mesh-ancestor
92941125|NCT01005914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941126|NCT01005914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92941127|NCT01005914|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92941128|NCT01005914|Alkylating Agents|alkylating agents|mesh-ancestor
92941129|NCT01005914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941130|NCT01005914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941131|NCT01005914|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92941132|NCT01005914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941133|NCT01005914|Antiemetics|antiemetics|mesh-ancestor
92941134|NCT01005914|Autonomic Agents|autonomic agents|mesh-ancestor
92941135|NCT01005914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941136|NCT01005914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941137|NCT01005914|Glucocorticoids|glucocorticoids|mesh-ancestor
92941138|NCT01005914|Hormones|hormones|mesh-ancestor
92941139|NCT01005914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941140|NCT01005914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941141|NCT01005914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92941142|NCT01005914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92941143|NCT01005914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92941144|NCT01005914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941145|NCT01005914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92941146|NCT01005914|Abortifacient Agents|abortifacient agents|mesh-ancestor
92941147|NCT01005914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92941148|NCT01005914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941149|NCT01005914|Antimetabolites|antimetabolites|mesh-ancestor
92941150|NCT01005914|Dermatologic Agents|dermatologic agents|mesh-ancestor
92941151|NCT01005914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92941152|NCT01005914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92941153|NCT01005914|Antiviral Agents|antiviral agents|mesh-ancestor
92941154|NCT01005914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941155|NCT01005914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92941156|NCT01005914|Tubulin Modulators|tubulin modulators|mesh-ancestor
92941157|NCT01005914|Antimitotic Agents|antimitotic agents|mesh-ancestor
92941158|NCT01005914|Mitosis Modulators|mitosis modulators|mesh-ancestor
92941159|NCT01005914|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92941160|NCT01005914|Protective Agents|protective agents|mesh-ancestor
92941161|NCT01005914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92941162|NCT00854230|Naltrexone|naltrexone|mesh-list
92941163|NCT00854230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92941164|NCT00854230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92941165|NCT00854230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941166|NCT00854230|Sensory System Agents|sensory system agents|mesh-ancestor
92941167|NCT00854230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941168|NCT00861016|Metoprolol|metoprolol|mesh-list
92941169|NCT00861016|Felodipine|felodipine|mesh-list
92941170|NCT00861016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92941171|NCT00861016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92941172|NCT00861016|Sympatholytics|sympatholytics|mesh-ancestor
92941173|NCT00861016|Autonomic Agents|autonomic agents|mesh-ancestor
92941174|NCT00861016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941175|NCT00861016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941176|NCT00861016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92941177|NCT00861016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92941178|NCT00861016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92941179|NCT00861016|Adrenergic Agents|adrenergic agents|mesh-ancestor
92941180|NCT00861016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941181|NCT00861016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941182|NCT00861016|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92941183|NCT00861016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92941184|NCT00861016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92941185|NCT00861016|Vasodilator Agents|vasodilator agents|mesh-ancestor
92941186|NCT00721916|Leucovorin|leucovorin|mesh-list
92941187|NCT00721916|Oxaliplatin|oxaliplatin|mesh-list
92941188|NCT00721916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941189|NCT00721916|Antidotes|antidotes|mesh-ancestor
92941190|NCT00721916|Protective Agents|protective agents|mesh-ancestor
92941191|NCT00721916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941192|NCT00721916|Vitamin B Complex|vitamin b complex|mesh-ancestor
92941193|NCT00721916|Vitamins|vitamins|mesh-ancestor
92941194|NCT00721916|Micronutrients|micronutrients|mesh-ancestor
92941195|NCT00861250|Dexamethasone|dexamethasone|mesh-list
92941196|NCT00861250|Bortezomib|bortezomib|mesh-list
92941197|NCT00861250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941198|NCT00861250|Antiemetics|antiemetics|mesh-ancestor
92941199|NCT00861250|Autonomic Agents|autonomic agents|mesh-ancestor
92941200|NCT00861250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941201|NCT00861250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941202|NCT00861250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941203|NCT00861250|Glucocorticoids|glucocorticoids|mesh-ancestor
92941204|NCT00861250|Hormones|hormones|mesh-ancestor
92941205|NCT00861250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941206|NCT00861250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941207|NCT00861250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941208|NCT00722150|Artesunate|artesunate|mesh-list
92941209|NCT00722150|Antimalarials|antimalarials|mesh-ancestor
92941210|NCT00722150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92941211|NCT00722150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92941212|NCT00722150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941213|NCT00722150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941214|NCT00722150|Antiviral Agents|antiviral agents|mesh-ancestor
92941215|NCT00722150|Schistosomicides|schistosomicides|mesh-ancestor
92941216|NCT00722150|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92941217|NCT00722150|Anthelmintics|anthelmintics|mesh-ancestor
92941218|NCT00861094|Leucovorin|leucovorin|mesh-list
92941219|NCT00861094|Folic Acid|folic acid|mesh-list
92941220|NCT00861094|Fluorouracil|fluorouracil|mesh-list
92941221|NCT00861094|Oxaliplatin|oxaliplatin|mesh-list
92941222|NCT00861094|Levoleucovorin|levoleucovorin|mesh-list
92941223|NCT00861094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941224|NCT00861094|Antimetabolites|antimetabolites|mesh-ancestor
92941225|NCT00861094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941226|NCT00861094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941227|NCT00861094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941228|NCT00861094|Immunologic Factors|immunologic factors|mesh-ancestor
92941229|NCT00861094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941231|NCT00861094|Protective Agents|protective agents|mesh-ancestor
92941232|NCT00861094|Vitamin B Complex|vitamin b complex|mesh-ancestor
92941233|NCT00861094|Vitamins|vitamins|mesh-ancestor
92941234|NCT00861094|Micronutrients|micronutrients|mesh-ancestor
92941235|NCT00861094|Hematinics|hematinics|mesh-ancestor
92941236|NCT00807261|Gemcitabine|gemcitabine|mesh-list
92941237|NCT00807261|Docetaxel|docetaxel|mesh-list
92941238|NCT00807261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941239|NCT00807261|Antimetabolites|antimetabolites|mesh-ancestor
92941240|NCT00807261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941241|NCT00807261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941242|NCT00807261|Tubulin Modulators|tubulin modulators|mesh-ancestor
92941243|NCT00807261|Antimitotic Agents|antimitotic agents|mesh-ancestor
92941244|NCT00807261|Mitosis Modulators|mitosis modulators|mesh-ancestor
92941245|NCT04019106|Budesonide|budesonide|mesh-list
92941246|NCT04019106|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92941247|NCT04019106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941248|NCT04019106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92941249|NCT04019106|Autonomic Agents|autonomic agents|mesh-ancestor
92941250|NCT04019106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941251|NCT04019106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941252|NCT04019106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92941253|NCT04019106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92941254|NCT04019106|Glucocorticoids|glucocorticoids|mesh-ancestor
92941255|NCT04019106|Hormones|hormones|mesh-ancestor
92941256|NCT04019106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941257|NCT02571608|Metformin|metformin|mesh-list
92941258|NCT02571608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92941259|NCT02571608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941260|NCT00865072|Metformin|metformin|mesh-list
92941261|NCT00865072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92941262|NCT00865072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941263|NCT00804297|Octreotide|octreotide|mesh-list
92941264|NCT00804297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941265|NCT00804297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941266|NCT00804297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941267|NCT00861328|Oxaliplatin|oxaliplatin|mesh-list
92941268|NCT00861328|Irinotecan|irinotecan|mesh-list
92941269|NCT00861328|Camptothecin|camptothecin|mesh-list
92941270|NCT00861328|ON 01910|on 01910|mesh-list
92941271|NCT00861328|Glycine|glycine|mesh-list
92941272|NCT00861328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941273|NCT00861328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92941274|NCT00861328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92941275|NCT00861328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941276|NCT00861328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941277|NCT00861328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92941278|NCT00861328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92941279|NCT00861328|Glycine Agents|glycine agents|mesh-ancestor
92941280|NCT00861328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941281|NCT00861328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941282|NCT00861406|Interferons|interferons|mesh-list
92941283|NCT00861406|Interferon-alpha|interferon-alpha|mesh-list
92941284|NCT00861406|Interferon alpha-2|interferon alpha-2|mesh-list
92941285|NCT00861406|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92941286|NCT00861406|Vaccines|vaccines|mesh-list
92941287|NCT00861406|Immunologic Factors|immunologic factors|mesh-ancestor
92941288|NCT00861406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941289|NCT00861406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941290|NCT00861406|Antiviral Agents|antiviral agents|mesh-ancestor
92941291|NCT00861406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941292|NCT04261790|Ocrelizumab|ocrelizumab|mesh-list
92941293|NCT04261790|Immunologic Factors|immunologic factors|mesh-ancestor
92941294|NCT04261790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941295|NCT00865384|Mirtazapine|mirtazapine|mesh-list
92941296|NCT00865384|Antidepressive Agents|antidepressive agents|mesh-ancestor
92941297|NCT00865384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92941298|NCT00865384|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92941299|NCT00865384|Histamine Antagonists|histamine antagonists|mesh-ancestor
92941300|NCT00865384|Histamine Agents|histamine agents|mesh-ancestor
92941301|NCT00865384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941302|NCT00865384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941303|NCT00865384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941304|NCT00865384|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92941305|NCT00865384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92941306|NCT00865384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941307|NCT00865384|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92941308|NCT00865384|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92941309|NCT00865384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92941310|NCT00865384|Adrenergic Agents|adrenergic agents|mesh-ancestor
92941311|NCT00865384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92941312|NCT00865384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92941313|NCT00865384|Serotonin Agents|serotonin agents|mesh-ancestor
92941314|NCT00865384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92941315|NCT00724724|Aspirin|aspirin|mesh-list
92941316|NCT00724724|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92941317|NCT00724724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92941318|NCT00724724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92941319|NCT00724724|Analgesics|analgesics|mesh-ancestor
92941320|NCT00724724|Sensory System Agents|sensory system agents|mesh-ancestor
92941321|NCT00724724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941322|NCT00724724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941323|NCT00724724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941324|NCT00724724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92941325|NCT00724724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92941326|NCT00724724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92526607|NCT00029380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941327|NCT00724724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941328|NCT00724724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92941329|NCT00724724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92941330|NCT00724724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941331|NCT00724724|Antipyretics|antipyretics|mesh-ancestor
92941332|NCT00724724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92941333|NCT00724724|Protective Agents|protective agents|mesh-ancestor
92941334|NCT00865462|Bupropion|bupropion|mesh-list
92941335|NCT00865462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92941336|NCT00865462|Antidepressive Agents|antidepressive agents|mesh-ancestor
92941337|NCT00865462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92941338|NCT00865462|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92941339|NCT00865462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92241921|NCT04887857|Cc-486|cc-486|mesh-list
92941340|NCT00865462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92941341|NCT00865462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941342|NCT00865462|Dopamine Agents|dopamine agents|mesh-ancestor
92941343|NCT00865462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941344|NCT00865462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941345|NCT00865462|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92941346|NCT00865462|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92941347|NCT00865462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941348|NCT04042558|Bevacizumab|bevacizumab|mesh-list
92941349|NCT04042558|Atezolizumab|atezolizumab|mesh-list
92941350|NCT04042558|Carboplatin|carboplatin|mesh-list
92941351|NCT04042558|Pemetrexed|pemetrexed|mesh-list
92941352|NCT04042558|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92941353|NCT04042558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941354|NCT04042558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941355|NCT04042558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941356|NCT04042558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941357|NCT04042558|Growth Substances|growth substances|mesh-ancestor
92941358|NCT04042558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941359|NCT04042558|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941360|NCT04042558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941361|NCT04042558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941362|NCT04042558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92941363|NCT04042558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92941364|NCT04042558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92941365|NCT04042558|Immunologic Factors|immunologic factors|mesh-ancestor
92941366|NCT04130204|Colchicine|colchicine|mesh-list
92941367|NCT04130204|Gout Suppressants|gout suppressants|mesh-ancestor
92941368|NCT04130204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92941369|NCT04130204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92941370|NCT04130204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92941371|NCT04130204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92941372|NCT04130204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941373|NCT04130204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941374|NCT00723918|Methadone|methadone|mesh-list
92941375|NCT00723918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92941376|NCT00723918|Narcotics|narcotics|mesh-ancestor
92941377|NCT00723918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941378|NCT00723918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941379|NCT00723918|Analgesics|analgesics|mesh-ancestor
92941380|NCT00723918|Sensory System Agents|sensory system agents|mesh-ancestor
92941381|NCT00723918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941382|NCT00723918|Antitussive Agents|antitussive agents|mesh-ancestor
92941383|NCT00723918|Respiratory System Agents|respiratory system agents|mesh-ancestor
92941385|NCT00865540|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92941386|NCT00865540|Methylprednisolone|methylprednisolone|mesh-list
92941387|NCT00865540|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92941388|NCT00865540|Prednisolone acetate|prednisolone acetate|mesh-list
92941389|NCT00865540|Ketorolac|ketorolac|mesh-list
92941390|NCT00865540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92941391|NCT00865540|Nepafenac|nepafenac|mesh-list
92941392|NCT00865540|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92941393|NCT00865540|Prednisolone phosphate|prednisolone phosphate|mesh-list
92941394|NCT00865540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941395|NCT00865540|Glucocorticoids|glucocorticoids|mesh-ancestor
92941396|NCT00865540|Hormones|hormones|mesh-ancestor
92941397|NCT00865540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941398|NCT00865540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941399|NCT00865540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941400|NCT00865540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941401|NCT00865540|Antiemetics|antiemetics|mesh-ancestor
92941402|NCT00865540|Autonomic Agents|autonomic agents|mesh-ancestor
92941403|NCT00865540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941404|NCT00865540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941405|NCT00865540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92941406|NCT00865540|Protective Agents|protective agents|mesh-ancestor
92941407|NCT00865540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92941408|NCT00865540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92941409|NCT00865540|Analgesics|analgesics|mesh-ancestor
92941410|NCT00865540|Sensory System Agents|sensory system agents|mesh-ancestor
92941411|NCT00865540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92941412|NCT00865540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92941413|NCT00865540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941414|NCT00865540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941416|NCT00865618|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92941417|NCT00865618|Hormone Antagonists|hormone antagonists|mesh-ancestor
92941418|NCT00865618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941419|NCT00865618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941420|NCT00865618|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92941421|NCT00865618|Diuretics|diuretics|mesh-ancestor
92941422|NCT00865618|Natriuretic Agents|natriuretic agents|mesh-ancestor
92941423|NCT00865618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92941424|NCT00655629|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92941425|NCT00655629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92941426|NCT00655629|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92941427|NCT00655629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92941428|NCT00655629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941429|NCT00655629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941430|NCT00655629|Urological Agents|urological agents|mesh-ancestor
92941431|NCT00865696|Mirtazapine|mirtazapine|mesh-list
92941432|NCT00865696|Antidepressive Agents|antidepressive agents|mesh-ancestor
92941433|NCT00865696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92941434|NCT00865696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92941435|NCT00865696|Histamine Antagonists|histamine antagonists|mesh-ancestor
92941436|NCT00865696|Histamine Agents|histamine agents|mesh-ancestor
92941437|NCT00865696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941438|NCT00865696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941439|NCT00865696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941440|NCT00865696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92941441|NCT00865696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92941442|NCT00865696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941443|NCT00865696|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92941444|NCT00865696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92941445|NCT00865696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92941446|NCT00865696|Adrenergic Agents|adrenergic agents|mesh-ancestor
92941447|NCT00865696|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92941448|NCT00865696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92941449|NCT00865696|Serotonin Agents|serotonin agents|mesh-ancestor
92941450|NCT00865696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92941451|NCT00724802|Triacetin|triacetin|mesh-list
92941452|NCT00724802|Antifungal Agents|antifungal agents|mesh-ancestor
92941453|NCT00724802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941454|NCT02545114|Tolvaptan|tolvaptan|mesh-list
92941455|NCT02545114|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92941456|NCT02545114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941457|NCT02545114|Natriuretic Agents|natriuretic agents|mesh-ancestor
92941458|NCT02545114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941459|NCT00724880|Clopidogrel|clopidogrel|mesh-list
92941460|NCT00724880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92941461|NCT00724880|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92941462|NCT00724880|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92941463|NCT00724880|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92941464|NCT00724880|Purinergic Agents|purinergic agents|mesh-ancestor
92941465|NCT00724880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941466|NCT00724880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941467|NCT00724880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941468|NCT00724074|Bupivacaine|bupivacaine|mesh-list
92941469|NCT00724074|Anesthetics, Local|anesthetics, local|mesh-ancestor
92941470|NCT00724074|Anesthetics|anesthetics|mesh-ancestor
92941471|NCT00724074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941472|NCT00724074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286389|NCT00002901|Docetaxel|docetaxel|mesh-list
92941474|NCT00724074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941475|NCT00854776|Lansoprazole|lansoprazole|mesh-list
92941476|NCT00854776|Dexlansoprazole|dexlansoprazole|mesh-list
92941477|NCT00854776|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92941478|NCT00854776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92941479|NCT00854776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941480|NCT00854776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92941481|NCT00854776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941482|NCT00854776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941483|NCT00854776|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92941484|NCT00854776|Immunologic Factors|immunologic factors|mesh-ancestor
92941485|NCT00854776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941486|NCT00854776|Antacids|antacids|mesh-ancestor
92941487|NCT00798525|Lepirudin|lepirudin|mesh-list
92941488|NCT00798525|Argatroban|argatroban|mesh-list
92941489|NCT00798525|Antithrombins|antithrombins|mesh-ancestor
92941490|NCT00798525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92941491|NCT00798525|Protease Inhibitors|protease inhibitors|mesh-ancestor
92941492|NCT00798525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941493|NCT00798525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941494|NCT00798525|Anticoagulants|anticoagulants|mesh-ancestor
92941495|NCT00798525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92941496|NCT00798525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92941497|NCT00798525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92941498|NCT00861640|Omeprazole|omeprazole|mesh-list
92941499|NCT00861640|Rabeprazole|rabeprazole|mesh-list
92941500|NCT00861640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92941501|NCT00861640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941502|NCT00861640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92941503|NCT00861640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941504|NCT00861640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941505|NCT00724230|Ribavirin|ribavirin|mesh-list
92941506|NCT00724230|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92941507|NCT00724230|Interferon-alpha|interferon-alpha|mesh-list
92941508|NCT00724230|Antimetabolites|antimetabolites|mesh-ancestor
92941509|NCT00724230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941510|NCT00724230|Antiviral Agents|antiviral agents|mesh-ancestor
92941511|NCT00724230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941512|NCT00724230|Immunologic Factors|immunologic factors|mesh-ancestor
92941513|NCT00724230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941514|NCT00725036|Insulin|insulin|mesh-list
92941515|NCT00725036|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92941516|NCT00725036|Insulin Aspart|insulin aspart|mesh-list
92941517|NCT00725036|Isophane Insulin, Human|isophane insulin, human|mesh-list
92941518|NCT00725036|Insulin, Isophane|insulin, isophane|mesh-list
92941519|NCT00725036|Isophane insulin, beef|isophane insulin, beef|mesh-list
92941520|NCT00725036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92941521|NCT00725036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941522|NCT00724386|Paclitaxel|paclitaxel|mesh-list
92941523|NCT00724386|Vinorelbine|vinorelbine|mesh-list
92941524|NCT00724386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92941525|NCT00724386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941526|NCT00724386|Tubulin Modulators|tubulin modulators|mesh-ancestor
92941527|NCT00724386|Antimitotic Agents|antimitotic agents|mesh-ancestor
92941528|NCT00724386|Mitosis Modulators|mitosis modulators|mesh-ancestor
92941529|NCT00724386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941530|NCT00865852|Metformin|metformin|mesh-list
92941531|NCT00865852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92941532|NCT00865852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941533|NCT00725114|Tetrodotoxin|tetrodotoxin|mesh-list
92941534|NCT00725114|Anesthetics, Local|anesthetics, local|mesh-ancestor
92941535|NCT00725114|Anesthetics|anesthetics|mesh-ancestor
92941536|NCT00725114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941537|NCT00725114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941538|NCT00725114|Sensory System Agents|sensory system agents|mesh-ancestor
92941539|NCT00725114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941540|NCT00725114|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92941541|NCT00725114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92941542|NCT00725114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941543|NCT00724542|Voglibose|voglibose|mesh-list
92941544|NCT00724542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92941545|NCT00724542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941546|NCT00724542|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92941547|NCT00724542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941548|NCT00724542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941550|NCT00724620|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92941551|NCT00724620|Antimetabolites|antimetabolites|mesh-ancestor
92941552|NCT00724620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941553|NCT00724620|Antiviral Agents|antiviral agents|mesh-ancestor
92941554|NCT00724620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941555|NCT00866008|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92941556|NCT00866008|Ganirelix|ganirelix|mesh-list
92941557|NCT00866008|Luteolytic Agents|luteolytic agents|mesh-ancestor
92941558|NCT00866008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92941559|NCT00866008|Contraceptive Agents|contraceptive agents|mesh-ancestor
92941560|NCT00866008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92941561|NCT00866008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941562|NCT00866008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92941563|NCT00866008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941564|NCT00866008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941565|NCT00866008|Hormone Antagonists|hormone antagonists|mesh-ancestor
92941566|NCT00866008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941567|NCT02571426|Propofol|propofol|mesh-list
92941568|NCT02571426|Sevoflurane|sevoflurane|mesh-list
92941569|NCT02571426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92941570|NCT02571426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941571|NCT02571426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941572|NCT02571426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92941573|NCT02571426|Anesthetics, General|anesthetics, general|mesh-ancestor
92941574|NCT02571426|Anesthetics|anesthetics|mesh-ancestor
92941575|NCT02571426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92941576|NCT02571426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92941577|NCT03491540|Gentamicins|gentamicins|mesh-list
92941578|NCT03491540|Ornidazole|ornidazole|mesh-list
92941579|NCT03491540|Sennosides|sennosides|mesh-list
92941580|NCT03491540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92941581|NCT03491540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941582|NCT03491540|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92941583|NCT03491540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941584|NCT03491540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941585|NCT03491540|Laxatives|laxatives|mesh-ancestor
92941586|NCT03491540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941587|NCT03491540|Amebicides|amebicides|mesh-ancestor
92941588|NCT03491540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92941589|NCT03491540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92941590|NCT03491540|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92941591|NCT00854932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92941592|NCT00854932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941593|NCT00578292|Cyclophosphamide|cyclophosphamide|mesh-list
92941594|NCT00578292|Busulfan|busulfan|mesh-list
92941595|NCT00578292|Fludarabine|fludarabine|mesh-list
92941596|NCT00578292|Alemtuzumab|alemtuzumab|mesh-list
92941597|NCT00578292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941598|NCT00578292|Immunologic Factors|immunologic factors|mesh-ancestor
92941599|NCT00578292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941600|NCT00578292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92941601|NCT00578292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92941602|NCT00578292|Alkylating Agents|alkylating agents|mesh-ancestor
92941603|NCT00578292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941604|NCT00578292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586990|NCT00320359|Topotecan|topotecan|mesh-list
92941605|NCT00578292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92941606|NCT00578292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941608|NCT00861874|Decitabine|decitabine|mesh-list
92941609|NCT00861874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941610|NCT00861874|Antimetabolites|antimetabolites|mesh-ancestor
92941611|NCT00861874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941612|NCT00861874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941613|NCT00861874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941614|NCT00861874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92941615|NCT00861874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941616|NCT00861874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92941617|NCT00861874|Antifungal Agents|antifungal agents|mesh-ancestor
92941618|NCT00861874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941619|NCT00861874|Immunologic Factors|immunologic factors|mesh-ancestor
92941620|NCT00861874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941621|NCT05372874|Antiviral Agents|antiviral agents|mesh-list
92941622|NCT05372874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941623|NCT04067856|Dexamethasone|dexamethasone|mesh-list
92941625|NCT04067856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941626|NCT04067856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941627|NCT04067856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941628|NCT04067856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941629|NCT04067856|Growth Substances|growth substances|mesh-ancestor
92941630|NCT04067856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941631|NCT04067856|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941632|NCT04067856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941633|NCT04067856|Antiemetics|antiemetics|mesh-ancestor
92941634|NCT04067856|Autonomic Agents|autonomic agents|mesh-ancestor
92941635|NCT04067856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941636|NCT04067856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941637|NCT04067856|Glucocorticoids|glucocorticoids|mesh-ancestor
92941638|NCT04067856|Hormones|hormones|mesh-ancestor
92941639|NCT04067856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941640|NCT04067856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941641|NCT04042714|Trifluridine|trifluridine|mesh-list
92941642|NCT04042714|Antimetabolites|antimetabolites|mesh-ancestor
92941643|NCT04042714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941644|NCT04042714|Antiviral Agents|antiviral agents|mesh-ancestor
92941645|NCT04042714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941646|NCT03401918|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92941647|NCT03401918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941648|NCT00725348|R 115866|r 115866|mesh-list
92941649|NCT00725348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92941650|NCT00725348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941651|NCT00725348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941652|NCT00577772|Rifaximin|rifaximin|mesh-list
92941653|NCT00577772|Lactulose|lactulose|mesh-list
92941654|NCT00577772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92941655|NCT00577772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941656|NCT00577772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941657|NCT00578136|Bupivacaine|bupivacaine|mesh-list
92941658|NCT00578136|Anesthetics, Local|anesthetics, local|mesh-ancestor
92941659|NCT00578136|Anesthetics|anesthetics|mesh-ancestor
92941660|NCT00578136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941661|NCT00578136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941662|NCT00578136|Sensory System Agents|sensory system agents|mesh-ancestor
92941663|NCT00578136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941664|NCT00861952|Mineral Oil|mineral oil|mesh-list
92941665|NCT00861952|Emollients|emollients|mesh-ancestor
92941666|NCT00861952|Dermatologic Agents|dermatologic agents|mesh-ancestor
92941667|NCT00655551|Lacosamide|lacosamide|mesh-list
92941668|NCT00655551|Anticonvulsants|anticonvulsants|mesh-ancestor
92941669|NCT00655551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92941670|NCT00655551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92941671|NCT00655551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92941672|NCT00655551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941673|NCT00855088|Ritonavir|ritonavir|mesh-list
92941674|NCT00855088|Darunavir|darunavir|mesh-list
92941675|NCT00855088|Etravirine|etravirine|mesh-list
92941676|NCT00855088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92941677|NCT00855088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92941678|NCT00855088|Protease Inhibitors|protease inhibitors|mesh-ancestor
92941679|NCT00855088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941680|NCT00855088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941681|NCT00855088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92941682|NCT00855088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92941683|NCT00855088|Antiviral Agents|antiviral agents|mesh-ancestor
92941684|NCT00855088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941685|NCT00855088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92941686|NCT00855088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92941687|NCT00855088|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92941688|NCT00855088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92941689|NCT02553603|Hormones|hormones|mesh-list
92941690|NCT02553603|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92941691|NCT02553603|Tesamorelin|tesamorelin|mesh-list
92941692|NCT02553603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941693|NCT02553603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941694|NCT02553603|Growth Substances|growth substances|mesh-ancestor
92941695|NCT00804531|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92941696|NCT00804531|Methylprednisolone|methylprednisolone|mesh-list
92941697|NCT00804531|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92941698|NCT00804531|Prednisolone|prednisolone|mesh-list
92941699|NCT00804531|Prednisolone acetate|prednisolone acetate|mesh-list
92941700|NCT00804531|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92941701|NCT00804531|Prednisolone phosphate|prednisolone phosphate|mesh-list
92941702|NCT00804531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941704|NCT00804531|Autonomic Agents|autonomic agents|mesh-ancestor
92941705|NCT00804531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941706|NCT00804531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941707|NCT00804531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941708|NCT00804531|Glucocorticoids|glucocorticoids|mesh-ancestor
92941709|NCT00804531|Hormones|hormones|mesh-ancestor
92941710|NCT00804531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941711|NCT00804531|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92941712|NCT00804531|Protective Agents|protective agents|mesh-ancestor
92941713|NCT00804531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92941714|NCT00804531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941715|NCT00866866|Acetylcysteine|acetylcysteine|mesh-list
92941716|NCT00866866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92941717|NCT00866866|Antiviral Agents|antiviral agents|mesh-ancestor
92941718|NCT00866866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941719|NCT00866866|Expectorants|expectorants|mesh-ancestor
92941720|NCT00866866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92941721|NCT00866866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92941722|NCT00866866|Antioxidants|antioxidants|mesh-ancestor
92941723|NCT00866866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941724|NCT00866866|Protective Agents|protective agents|mesh-ancestor
92941725|NCT00866866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941726|NCT00866866|Antidotes|antidotes|mesh-ancestor
92941727|NCT00312728|Bevacizumab|bevacizumab|mesh-list
92941728|NCT00312728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941729|NCT00312728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941730|NCT00312728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941731|NCT00312728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941732|NCT00312728|Growth Substances|growth substances|mesh-ancestor
92941733|NCT00312728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941734|NCT00312728|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941735|NCT00804921|Bevacizumab|bevacizumab|mesh-list
92941736|NCT00804921|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92941737|NCT00804921|Acetazolamide|acetazolamide|mesh-list
92941738|NCT00804921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941739|NCT00804921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941740|NCT00804921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941741|NCT00804921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941742|NCT00804921|Growth Substances|growth substances|mesh-ancestor
92941743|NCT00804921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941744|NCT00804921|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941745|NCT00804921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92941746|NCT00804921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92941747|NCT00804921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92941748|NCT00804921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92941749|NCT00804921|Adrenergic Agents|adrenergic agents|mesh-ancestor
92941750|NCT00804921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941751|NCT00804921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941752|NCT00804921|Anticonvulsants|anticonvulsants|mesh-ancestor
92941753|NCT00804921|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92941754|NCT00804921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941755|NCT00804921|Diuretics|diuretics|mesh-ancestor
92587139|NCT00086255|Tiagabine|tiagabine|mesh-list
92941757|NCT00866944|Leucovorin|leucovorin|mesh-list
92941758|NCT00866944|Fluorouracil|fluorouracil|mesh-list
92941759|NCT00866944|Oxaliplatin|oxaliplatin|mesh-list
92941760|NCT00866944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92941761|NCT00866944|Antimetabolites|antimetabolites|mesh-ancestor
92941762|NCT00866944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941763|NCT00866944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941764|NCT00866944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941765|NCT00866944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941766|NCT00866944|Immunologic Factors|immunologic factors|mesh-ancestor
92941767|NCT00866944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941768|NCT00866944|Antidotes|antidotes|mesh-ancestor
92941769|NCT00866944|Protective Agents|protective agents|mesh-ancestor
92941770|NCT00866944|Vitamin B Complex|vitamin b complex|mesh-ancestor
92941771|NCT00866944|Vitamins|vitamins|mesh-ancestor
92941772|NCT00866944|Micronutrients|micronutrients|mesh-ancestor
92941773|NCT00577824|Exenatide|exenatide|mesh-list
92941774|NCT00577824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92286680|NCT02245087|Atorvastatin|atorvastatin|mesh-list
92941775|NCT00577824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941777|NCT00577824|Incretins|incretins|mesh-ancestor
92941778|NCT00577824|Hormones|hormones|mesh-ancestor
92941779|NCT00577824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941780|NCT02632448|Gemcitabine|gemcitabine|mesh-list
92941781|NCT02632448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92941782|NCT02632448|Antimetabolites|antimetabolites|mesh-ancestor
92941783|NCT02632448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941784|NCT02632448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941785|NCT04046289|Calcium, Dietary|calcium, dietary|mesh-list
92941786|NCT04046289|Calcium Carbonate|calcium carbonate|mesh-list
92941787|NCT04046289|Calcium|calcium|mesh-list
92941788|NCT04046289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92941789|NCT04046289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941790|NCT04046289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92941791|NCT04046289|Antacids|antacids|mesh-ancestor
92941792|NCT04046289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941793|NCT04046289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941794|NCT00807807|Folic Acid|folic acid|mesh-list
92941795|NCT00807807|Vitamin B Complex|vitamin b complex|mesh-list
92941796|NCT00807807|Hematinics|hematinics|mesh-ancestor
92941797|NCT00807807|Vitamins|vitamins|mesh-ancestor
92941798|NCT00807807|Micronutrients|micronutrients|mesh-ancestor
92941799|NCT00807807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941800|NCT03011814|Lenalidomide|lenalidomide|mesh-list
92941801|NCT03011814|Durvalumab|durvalumab|mesh-list
92941802|NCT03011814|Immunoglobulins|immunoglobulins|mesh-list
92941803|NCT03011814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92941804|NCT03011814|Immunoglobulin G|immunoglobulin g|mesh-list
92941805|NCT03011814|Immunologic Factors|immunologic factors|mesh-ancestor
92941806|NCT03011814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941807|NCT03011814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941808|NCT03011814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941809|NCT03011814|Growth Substances|growth substances|mesh-ancestor
92941810|NCT03011814|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941811|NCT03011814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941812|NCT03011814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941813|NCT00870298|Trimethoprim|trimethoprim|mesh-list
92941814|NCT00870298|Sulfamethoxazole|sulfamethoxazole|mesh-list
92941815|NCT00870298|Warfarin|warfarin|mesh-list
92941816|NCT00870298|Anticoagulants|anticoagulants|mesh-ancestor
92941817|NCT00870298|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92941818|NCT00870298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941819|NCT00870298|Antimalarials|antimalarials|mesh-ancestor
92941820|NCT00870298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92941821|NCT00870298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92941822|NCT00870298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92941823|NCT00870298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941824|NCT00870298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941825|NCT00870298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92941826|NCT00870298|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92941827|NCT00870298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92941828|NCT00805155|Mometasone Furoate|mometasone furoate|mesh-list
92587224|NCT00419653|Olanzapine|olanzapine|mesh-list
92941829|NCT00805155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941830|NCT00805155|Dermatologic Agents|dermatologic agents|mesh-ancestor
92941831|NCT00805155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92941832|NCT00807963|Zoledronic Acid|zoledronic acid|mesh-list
92941833|NCT00807963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92941834|NCT00807963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941835|NCT00730418|Doxazosin|doxazosin|mesh-list
92941836|NCT00730418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92941837|NCT00730418|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92941838|NCT00730418|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92941839|NCT00730418|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92941840|NCT00730418|Adrenergic Agents|adrenergic agents|mesh-ancestor
92941841|NCT00730418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941842|NCT00730418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941843|NCT00730418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941844|NCT00805233|Bromfenac|bromfenac|mesh-list
92941845|NCT00805233|Ranibizumab|ranibizumab|mesh-list
92941846|NCT00805233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941847|NCT00805233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941848|NCT00805233|Growth Substances|growth substances|mesh-ancestor
92526626|NCT00029458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92941849|NCT00805233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941851|NCT00805233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941852|NCT00805233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92941853|NCT00805233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92941854|NCT00805233|Analgesics|analgesics|mesh-ancestor
92941855|NCT00805233|Sensory System Agents|sensory system agents|mesh-ancestor
92941856|NCT00805233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941857|NCT00805233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941858|NCT00805233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92941859|NCT02569502|Enfuvirtide|enfuvirtide|mesh-list
92941860|NCT02569502|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92941861|NCT02569502|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92941862|NCT02569502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941863|NCT02569502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92941864|NCT02569502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92941865|NCT02569502|Antiviral Agents|antiviral agents|mesh-ancestor
92941866|NCT02569502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92941867|NCT00725400|Cetuximab|cetuximab|mesh-list
92941868|NCT00725400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941869|NCT00725400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941870|NCT00798915|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92941871|NCT00798915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92941872|NCT00798915|Incretins|incretins|mesh-ancestor
92941873|NCT00798915|Hormones|hormones|mesh-ancestor
92941874|NCT00798915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941875|NCT00798915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941876|NCT00798993|Cholecalciferol|cholecalciferol|mesh-list
92941877|NCT00798993|Vitamin D|vitamin d|mesh-list
92941878|NCT00798993|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92941879|NCT00798993|Calcifediol|calcifediol|mesh-list
92941880|NCT00798993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92941881|NCT00798993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941882|NCT00798993|Vitamins|vitamins|mesh-ancestor
92941883|NCT00798993|Micronutrients|micronutrients|mesh-ancestor
92941884|NCT00798993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92941885|NCT00862108|Methylphenidate|methylphenidate|mesh-list
92941886|NCT00862108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92941887|NCT00862108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941888|NCT00862108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92941889|NCT00862108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92941890|NCT00862108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92941891|NCT00862108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941892|NCT00862108|Dopamine Agents|dopamine agents|mesh-ancestor
92941893|NCT00862108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941894|NCT00862264|Beclomethasone|beclomethasone|mesh-list
92941895|NCT00862264|Norflurane|norflurane|mesh-list
92941896|NCT00862264|Formoterol Fumarate|formoterol fumarate|mesh-list
92941897|NCT00862264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92941898|NCT00862264|Autonomic Agents|autonomic agents|mesh-ancestor
92941899|NCT00862264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92941900|NCT00862264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941901|NCT00862264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92941902|NCT00862264|Respiratory System Agents|respiratory system agents|mesh-ancestor
92941903|NCT00862264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92941904|NCT00862264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92941905|NCT00862264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92941906|NCT00862264|Adrenergic Agents|adrenergic agents|mesh-ancestor
92941907|NCT00862264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941908|NCT00862264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941909|NCT00862264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92941910|NCT00862264|Glucocorticoids|glucocorticoids|mesh-ancestor
92941911|NCT00862264|Hormones|hormones|mesh-ancestor
92941912|NCT00862264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92941913|NCT00862264|Anesthetics|anesthetics|mesh-ancestor
92941914|NCT00862264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92941915|NCT00730574|Vitamins|vitamins|mesh-list
92941916|NCT00730574|Folic Acid|folic acid|mesh-list
92941917|NCT00730574|Vitamin B 12|vitamin b 12|mesh-list
92941918|NCT00730574|Hydroxocobalamin|hydroxocobalamin|mesh-list
92941919|NCT00730574|Vitamin B Complex|vitamin b complex|mesh-list
92941920|NCT00730574|Micronutrients|micronutrients|mesh-ancestor
92941921|NCT00730574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941922|NCT00730574|Hematinics|hematinics|mesh-ancestor
92941923|NCT00870532|Sorafenib|sorafenib|mesh-list
92941924|NCT00870532|Vinorelbine|vinorelbine|mesh-list
92941925|NCT00870532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941926|NCT00870532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92941927|NCT00870532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941928|NCT00870532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941929|NCT00870532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92941930|NCT00870532|Tubulin Modulators|tubulin modulators|mesh-ancestor
92941931|NCT00870532|Antimitotic Agents|antimitotic agents|mesh-ancestor
92941932|NCT00870532|Mitosis Modulators|mitosis modulators|mesh-ancestor
92941933|NCT00725478|Piribedil|piribedil|mesh-list
92941934|NCT00725478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92941935|NCT00725478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92941936|NCT00725478|Dopamine Agonists|dopamine agonists|mesh-ancestor
92941937|NCT00725478|Dopamine Agents|dopamine agents|mesh-ancestor
92941938|NCT00725478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941939|NCT00725478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941940|NCT00725478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941941|NCT01951274|Serlopitant|serlopitant|mesh-list
92941942|NCT01951274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92941943|NCT01951274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941944|NCT01951274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941945|NCT01951274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941946|NCT03355794|Everolimus|everolimus|mesh-list
92941947|NCT03355794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92941948|NCT03355794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92941949|NCT03355794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941950|NCT03355794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941951|NCT03355794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92941952|NCT03355794|Immunologic Factors|immunologic factors|mesh-ancestor
92941953|NCT03355794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941954|NCT03355794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941955|NCT01487174|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92941956|NCT01487174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941957|NCT01487174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92941958|NCT01487174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941959|NCT01487174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941960|NCT00725634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92941961|NCT00725634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92941962|NCT00725634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941963|NCT00725634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92941964|NCT00725634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92941965|NCT00725634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941966|NCT00725634|Immunologic Factors|immunologic factors|mesh-ancestor
92941967|NCT00725634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941968|NCT00617344|Vaccines|vaccines|mesh-list
92941969|NCT00617344|Immunologic Factors|immunologic factors|mesh-ancestor
92941970|NCT00617344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941971|NCT00862342|Bevacizumab|bevacizumab|mesh-list
92941972|NCT00862342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92941973|NCT00862342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941974|NCT00862342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941975|NCT00862342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941976|NCT00862342|Growth Substances|growth substances|mesh-ancestor
92941977|NCT00862342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941978|NCT00862342|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941979|NCT00732212|Hemostatics|hemostatics|mesh-list
92941980|NCT00732212|Coagulants|coagulants|mesh-ancestor
92941981|NCT02544724|Interleukin-12|interleukin-12|mesh-list
92941982|NCT02544724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92941983|NCT02544724|Immunologic Factors|immunologic factors|mesh-ancestor
92941984|NCT02544724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92941985|NCT02544724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92941986|NCT02544724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92941987|NCT02544724|Growth Substances|growth substances|mesh-ancestor
92941988|NCT02544724|Growth Inhibitors|growth inhibitors|mesh-ancestor
92941989|NCT02544724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92941991|NCT00862420|Clopidogrel|clopidogrel|mesh-list
92941992|NCT00862420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92941993|NCT00862420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92941994|NCT00862420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92941995|NCT00862420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92941996|NCT00862420|Purinergic Agents|purinergic agents|mesh-ancestor
92941997|NCT00862420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92941998|NCT00862420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92941999|NCT00862420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942001|NCT00862420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92942002|NCT00862420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92942003|NCT00862420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92942004|NCT00862420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942005|NCT00321698|Docetaxel|docetaxel|mesh-list
92942006|NCT00321698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942007|NCT00321698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92942008|NCT00321698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92942009|NCT00321698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92942010|NCT00321698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942011|NCT02569970|Fluoxetine|fluoxetine|mesh-list
92942012|NCT02569970|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92942013|NCT02569970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92942014|NCT02569970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942015|NCT02569970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942016|NCT02569970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942017|NCT02569970|Serotonin Agents|serotonin agents|mesh-ancestor
92942018|NCT02569970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942019|NCT02569970|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92942020|NCT02569970|Antidepressive Agents|antidepressive agents|mesh-ancestor
92942021|NCT02569970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92942022|NCT02569970|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92942023|NCT02569970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92942024|NCT02569970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942025|NCT00725790|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92942026|NCT00725790|Vasodilator Agents|vasodilator agents|mesh-ancestor
92942027|NCT00725790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92942028|NCT00725790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92942029|NCT00725790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942030|NCT00725790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942031|NCT00725790|Urological Agents|urological agents|mesh-ancestor
92942032|NCT00731276|Irinotecan|irinotecan|mesh-list
92942033|NCT00731276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92942034|NCT00731276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92942035|NCT00731276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942036|NCT00731276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942037|NCT00731276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942038|NCT00725946|Iodine|iodine|mesh-list
92942039|NCT00725946|Cadexomer iodine|cadexomer iodine|mesh-list
92942040|NCT00725946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92942041|NCT00725946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942042|NCT00725946|Trace Elements|trace elements|mesh-ancestor
92942043|NCT00725946|Micronutrients|micronutrients|mesh-ancestor
92942044|NCT00725946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942045|NCT02569346|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
92942046|NCT02569346|Lamivudine|lamivudine|mesh-list
92942047|NCT02569346|Abacavir|abacavir|mesh-list
92942048|NCT02569346|Dolutegravir|dolutegravir|mesh-list
92942049|NCT02569346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92942050|NCT02569346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92942051|NCT02569346|Antiviral Agents|antiviral agents|mesh-ancestor
92942052|NCT02569346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942053|NCT02569346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92587434|NCT00086840|Temsirolimus|temsirolimus|mesh-list
92942054|NCT02569346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92942055|NCT02569346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942056|NCT02569346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942057|NCT02569346|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92942058|NCT02569346|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92942059|NCT00726804|Adalimumab|adalimumab|mesh-list
92942060|NCT00726804|Etanercept|etanercept|mesh-list
92942061|NCT00726804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92942062|NCT00726804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942063|NCT00726804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942064|NCT00726804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942065|NCT00726804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942066|NCT00726804|Analgesics|analgesics|mesh-ancestor
92942067|NCT00726804|Sensory System Agents|sensory system agents|mesh-ancestor
92526627|NCT00029458|Serotonin Agents|serotonin agents|mesh-ancestor
92942068|NCT00726804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942069|NCT00726804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942070|NCT00726804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942071|NCT00726804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942072|NCT00726804|Immunologic Factors|immunologic factors|mesh-ancestor
92942073|NCT00726960|Buprenorphine|buprenorphine|mesh-list
92942074|NCT00726960|Aprepitant|aprepitant|mesh-list
92942075|NCT00726960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92942076|NCT00726960|Narcotics|narcotics|mesh-ancestor
92942077|NCT00726960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942078|NCT00726960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942079|NCT00726960|Analgesics|analgesics|mesh-ancestor
92942080|NCT00726960|Sensory System Agents|sensory system agents|mesh-ancestor
92942081|NCT00726960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942082|NCT00726960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92942083|NCT00726960|Antiemetics|antiemetics|mesh-ancestor
92942084|NCT00726960|Autonomic Agents|autonomic agents|mesh-ancestor
92942085|NCT00726960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942086|NCT00726960|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92942087|NCT00726960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942088|NCT00726960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942089|NCT00727038|Ranibizumab|ranibizumab|mesh-list
92942090|NCT00727038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92942091|NCT00727038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92942092|NCT00727038|Growth Substances|growth substances|mesh-ancestor
92942093|NCT00727038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942094|NCT00727038|Growth Inhibitors|growth inhibitors|mesh-ancestor
92942095|NCT00727038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942096|NCT00726258|Ketamine|ketamine|mesh-list
92942097|NCT00726258|Analgesics|analgesics|mesh-ancestor
92942098|NCT00726258|Sensory System Agents|sensory system agents|mesh-ancestor
92942099|NCT00726258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942100|NCT00726258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942101|NCT00726258|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92942102|NCT00726258|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92942103|NCT00726258|Anesthetics, General|anesthetics, general|mesh-ancestor
92942104|NCT00726258|Anesthetics|anesthetics|mesh-ancestor
92942105|NCT00726258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942106|NCT00726258|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92942107|NCT00726258|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92942108|NCT00726258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942109|NCT00726258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942110|NCT02950766|Ipilimumab|ipilimumab|mesh-list
92942111|NCT02950766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92942112|NCT02950766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942113|NCT02950766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92942114|NCT02950766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942115|NCT02569814|Amlodipine|amlodipine|mesh-list
92942116|NCT02569814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92942117|NCT02569814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92942118|NCT02569814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92942119|NCT02569814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942120|NCT02569814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942121|NCT02569814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92942122|NCT02569814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942123|NCT02569814|Vasodilator Agents|vasodilator agents|mesh-ancestor
92942124|NCT02569814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92942125|NCT02569814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92942126|NCT02569814|Antimetabolites|antimetabolites|mesh-ancestor
92942127|NCT02569814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92942128|NCT02569814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92942129|NCT02569814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942130|NCT00726570|Heparin|heparin|mesh-list
92942131|NCT00726570|Calcium heparin|calcium heparin|mesh-list
92942132|NCT00726570|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92942133|NCT00726570|Tinzaparin|tinzaparin|mesh-list
92942134|NCT00726570|Dalteparin|dalteparin|mesh-list
92942135|NCT00726570|Anticoagulants|anticoagulants|mesh-list
92942136|NCT00726570|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92942137|NCT00726570|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92942138|NCT00726570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942139|NCT00726726|Vitamin K|vitamin k|mesh-list
92942140|NCT00726726|Midazolam|midazolam|mesh-list
92942141|NCT00726726|Dextromethorphan|dextromethorphan|mesh-list
92942142|NCT00726726|Caffeine|caffeine|mesh-list
92942143|NCT00726726|Omeprazole|omeprazole|mesh-list
92942144|NCT00726726|Warfarin|warfarin|mesh-list
92942145|NCT00726726|BMS 708163|bms 708163|mesh-list
92942146|NCT00726726|Vitamins|vitamins|mesh-ancestor
92942147|NCT00726726|Micronutrients|micronutrients|mesh-ancestor
92942148|NCT00726726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942149|NCT00726726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92942150|NCT00726726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92942151|NCT00726726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942152|NCT00726726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92942153|NCT00726726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92942154|NCT00726726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92942155|NCT00726726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92942156|NCT00726726|Anesthetics, General|anesthetics, general|mesh-ancestor
92942157|NCT00726726|Anesthetics|anesthetics|mesh-ancestor
92942158|NCT00726726|GABA Modulators|gaba modulators|mesh-ancestor
92942159|NCT00726726|GABA Agents|gaba agents|mesh-ancestor
92942160|NCT00726726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942161|NCT00726726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942162|NCT00726726|Anticoagulants|anticoagulants|mesh-ancestor
92942163|NCT00726726|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92942164|NCT00726726|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92942165|NCT00726726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942166|NCT00726726|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92942167|NCT00726726|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92942168|NCT00726726|Purinergic Agents|purinergic agents|mesh-ancestor
92942169|NCT00726726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92942170|NCT00726726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942171|NCT00726726|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92942172|NCT00726726|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92942173|NCT00726726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92942174|NCT00726726|Hemostatics|hemostatics|mesh-ancestor
92942175|NCT00726726|Coagulants|coagulants|mesh-ancestor
92942176|NCT00726726|Antitussive Agents|antitussive agents|mesh-ancestor
92942177|NCT00726726|Respiratory System Agents|respiratory system agents|mesh-ancestor
92942178|NCT00726726|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92942179|NCT00726726|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92942180|NCT00726726|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92942181|NCT00654381|Inositol|inositol|mesh-list
92942182|NCT00654381|Linagliptin|linagliptin|mesh-list
92942183|NCT00654381|Voglibose|voglibose|mesh-list
92942184|NCT00654381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92942185|NCT00654381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942186|NCT00654381|Incretins|incretins|mesh-ancestor
92942187|NCT00654381|Hormones|hormones|mesh-ancestor
92942188|NCT00654381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942189|NCT00654381|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92942190|NCT00654381|Protease Inhibitors|protease inhibitors|mesh-ancestor
92942191|NCT00654381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942192|NCT00654381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942193|NCT00654381|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92942194|NCT00654381|Vitamin B Complex|vitamin b complex|mesh-ancestor
92942195|NCT00654381|Vitamins|vitamins|mesh-ancestor
92942196|NCT00654381|Micronutrients|micronutrients|mesh-ancestor
92942197|NCT04018482|Povidone-Iodine|povidone-iodine|mesh-list
92942198|NCT04018482|Povidone|povidone|mesh-list
92942199|NCT04018482|Plasma Substitutes|plasma substitutes|mesh-ancestor
92942200|NCT04018482|Blood Substitutes|blood substitutes|mesh-ancestor
92942201|NCT04018482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92942202|NCT04018482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942203|NCT00805311|Aspirin|aspirin|mesh-list
92942204|NCT00805311|Losartan|losartan|mesh-list
92942205|NCT00805311|Amlodipine|amlodipine|mesh-list
92942206|NCT00805311|Atorvastatin|atorvastatin|mesh-list
92942207|NCT00805311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942208|NCT00805311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942209|NCT00805311|Analgesics|analgesics|mesh-ancestor
92942210|NCT00805311|Sensory System Agents|sensory system agents|mesh-ancestor
92942211|NCT00805311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942212|NCT00805311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942213|NCT00805311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942214|NCT00805311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942215|NCT00805311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92942216|NCT00805311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92942217|NCT00805311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942218|NCT00805311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92942219|NCT00805311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92942221|NCT00805311|Antipyretics|antipyretics|mesh-ancestor
92942222|NCT00805311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92942223|NCT00805311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92942224|NCT00805311|Antimetabolites|antimetabolites|mesh-ancestor
92942225|NCT00805311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92942226|NCT00805311|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92942227|NCT00805311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92942228|NCT00805311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92942229|NCT00805311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942230|NCT00805311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92942231|NCT00805311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92942232|NCT00805311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92942233|NCT00805311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92942234|NCT00805311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92942236|NCT00732290|Clopidogrel|clopidogrel|mesh-list
92942237|NCT00732290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92942238|NCT00732290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92942239|NCT00732290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92942240|NCT00732290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92942241|NCT00732290|Purinergic Agents|purinergic agents|mesh-ancestor
92942242|NCT00732290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942243|NCT00732290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942244|NCT00732290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942245|NCT00732290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92942246|NCT00732290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92942247|NCT00732290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942248|NCT00732290|Serotonin Agents|serotonin agents|mesh-ancestor
92942249|NCT00732290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92942250|NCT00732290|Antidepressive Agents|antidepressive agents|mesh-ancestor
92942251|NCT00732290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92942252|NCT00732290|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92942253|NCT00732290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92942254|NCT00732290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942255|NCT02570334|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92942256|NCT02570334|Antiviral Agents|antiviral agents|mesh-ancestor
92942257|NCT02570334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942258|NCT00732446|Moxifloxacin|moxifloxacin|mesh-list
92942259|NCT00732446|Dexamethasone|dexamethasone|mesh-list
92942260|NCT00732446|Dexamethasone acetate|dexamethasone acetate|mesh-list
92942261|NCT00732446|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92942262|NCT00732446|BB 1101|bb 1101|mesh-list
92942263|NCT00732446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942264|NCT00732446|Antiemetics|antiemetics|mesh-ancestor
92942265|NCT00732446|Autonomic Agents|autonomic agents|mesh-ancestor
92942266|NCT00732446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942267|NCT00732446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942268|NCT00732446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942269|NCT00732446|Glucocorticoids|glucocorticoids|mesh-ancestor
92942270|NCT00732446|Hormones|hormones|mesh-ancestor
92942271|NCT00732446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942272|NCT00732446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92942273|NCT00732446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942274|NCT00732446|Protease Inhibitors|protease inhibitors|mesh-ancestor
92942275|NCT00732446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942276|NCT00732446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942277|NCT00732446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942278|NCT00732446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587665|NCT00419848|Azithromycin|azithromycin|mesh-list
92942279|NCT00732446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92942280|NCT00732446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92942281|NCT00732446|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92942283|NCT00732446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92942284|NCT00732446|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92942285|NCT00732446|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92942286|NCT00732446|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92942287|NCT00732524|Glipizide|glipizide|mesh-list
92942288|NCT00732524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92942289|NCT00732524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942290|NCT00657267|Temozolomide|temozolomide|mesh-list
92942291|NCT00657267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92942292|NCT00657267|Alkylating Agents|alkylating agents|mesh-ancestor
92942293|NCT00657267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942294|NCT00657267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942295|NCT00733850|Gemcitabine|gemcitabine|mesh-list
92942296|NCT00733850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942297|NCT00733850|Antimetabolites|antimetabolites|mesh-ancestor
92942298|NCT00733850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942299|NCT00733850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942300|NCT00727766|Clofarabine|clofarabine|mesh-list
92942301|NCT00727766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942302|NCT00727766|Antimetabolites|antimetabolites|mesh-ancestor
92942303|NCT00727766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942304|NCT00727766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942305|NCT00799071|Posaconazole|posaconazole|mesh-list
92942306|NCT00799071|Antifungal Agents|antifungal agents|mesh-ancestor
92942307|NCT00799071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942308|NCT00799071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92942309|NCT00799071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92942310|NCT00799071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92942311|NCT00799071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92942312|NCT00799071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92942313|NCT00799071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942314|NCT00799071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942315|NCT00799071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92942316|NCT00799071|Hormone Antagonists|hormone antagonists|mesh-ancestor
92942317|NCT00799071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942318|NCT00799071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942320|NCT00732836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92942321|NCT00732836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92942322|NCT00732836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942323|NCT00732836|Tubulin Modulators|tubulin modulators|mesh-ancestor
92942324|NCT00732836|Antimitotic Agents|antimitotic agents|mesh-ancestor
92942325|NCT00732836|Mitosis Modulators|mitosis modulators|mesh-ancestor
92942326|NCT00732836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942327|NCT00799149|Etoricoxib|etoricoxib|mesh-list
92942328|NCT00799149|Gabapentin|gabapentin|mesh-list
92942329|NCT00799149|Analgesics|analgesics|mesh-ancestor
92942330|NCT00799149|Sensory System Agents|sensory system agents|mesh-ancestor
92942331|NCT00799149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942332|NCT00799149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942333|NCT00799149|Anticonvulsants|anticonvulsants|mesh-ancestor
92942334|NCT00799149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92942335|NCT00799149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92942336|NCT00799149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942337|NCT00799149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92942338|NCT00799149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92942339|NCT00799149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92942340|NCT00799149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942341|NCT00799149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942342|NCT00799149|Antimanic Agents|antimanic agents|mesh-ancestor
92942343|NCT00799149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942344|NCT00799149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942345|NCT00799149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942346|NCT00799149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942347|NCT00799149|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92942348|NCT00799149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92942349|NCT00799149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942350|NCT00732914|Sorafenib|sorafenib|mesh-list
92942351|NCT00732914|Sunitinib|sunitinib|mesh-list
92942352|NCT00732914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942353|NCT00732914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92942354|NCT00732914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942355|NCT00732914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942356|NCT00732914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92942357|NCT00732914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92942358|NCT00732914|Growth Substances|growth substances|mesh-ancestor
92942359|NCT00732914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942360|NCT00732914|Growth Inhibitors|growth inhibitors|mesh-ancestor
92942361|NCT00808275|Calcium, Dietary|calcium, dietary|mesh-list
92942362|NCT00808275|Calcium|calcium|mesh-list
92942363|NCT00808275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92942364|NCT00808275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942365|NCT00808275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92942366|NCT00809289|Moxifloxacin|moxifloxacin|mesh-list
92942367|NCT00809289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942368|NCT00809289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942369|NCT00809289|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92942370|NCT00809289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92942371|NCT00809289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942372|NCT00809289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942373|NCT00809289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942374|NCT00728000|Gemcitabine|gemcitabine|mesh-list
92942375|NCT00728000|Oxaliplatin|oxaliplatin|mesh-list
92942376|NCT00728000|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92942377|NCT00728000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942378|NCT00728000|Antimetabolites|antimetabolites|mesh-ancestor
92942379|NCT00728000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942380|NCT00728000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942381|NCT00728000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92942382|NCT00728000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942383|NCT04065230|Tenofovir|tenofovir|mesh-list
92942384|NCT04065230|Antiviral Agents|antiviral agents|mesh-ancestor
92942385|NCT04065230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942386|NCT04065230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92942387|NCT04065230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92942388|NCT04065230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942389|NCT04065230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942390|NCT04065230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92942391|NCT04065230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92942392|NCT00728078|Thalidomide|thalidomide|mesh-list
92942393|NCT00728078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942394|NCT00728078|Immunologic Factors|immunologic factors|mesh-ancestor
92942395|NCT00728078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942396|NCT00728078|Leprostatic Agents|leprostatic agents|mesh-ancestor
92942397|NCT00728078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942398|NCT00728078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942399|NCT00728078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92942400|NCT00728078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92942401|NCT00728078|Growth Substances|growth substances|mesh-ancestor
92942402|NCT00728078|Growth Inhibitors|growth inhibitors|mesh-ancestor
92942403|NCT00728078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942404|NCT04066088|Guanfacine|guanfacine|mesh-list
92942405|NCT04066088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92942406|NCT04066088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92942407|NCT04066088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92942408|NCT04066088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92942409|NCT04066088|Adrenergic Agents|adrenergic agents|mesh-ancestor
92942410|NCT04066088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942411|NCT04066088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942412|NCT04066088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942413|NCT00733148|Insulin|insulin|mesh-list
92942414|NCT00733148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92942415|NCT00733148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942416|NCT00730392|Etanercept|etanercept|mesh-list
92942417|NCT00730392|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942418|NCT00730392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942419|NCT00730392|Analgesics|analgesics|mesh-ancestor
92942420|NCT00730392|Sensory System Agents|sensory system agents|mesh-ancestor
92942421|NCT00730392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942422|NCT00730392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942423|NCT00730392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942424|NCT00730392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942425|NCT00730392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942426|NCT00730392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942427|NCT00730392|Immunologic Factors|immunologic factors|mesh-ancestor
92942428|NCT01528046|Metformin|metformin|mesh-list
92942429|NCT01528046|Irinotecan|irinotecan|mesh-list
92942430|NCT01528046|Camptothecin|camptothecin|mesh-list
92942431|NCT01528046|Vincristine|vincristine|mesh-list
92942432|NCT01528046|Temozolomide|temozolomide|mesh-list
92942433|NCT01528046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92942434|NCT01528046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942435|NCT01528046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92942436|NCT01528046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92942437|NCT01528046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526632|NCT00029458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92942438|NCT01528046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942439|NCT01528046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942440|NCT01528046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92942441|NCT01528046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92942442|NCT01528046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92942443|NCT01528046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92942444|NCT01528046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92942445|NCT01528046|Alkylating Agents|alkylating agents|mesh-ancestor
92942446|NCT00652899|Aldesleukin|aldesleukin|mesh-list
92942447|NCT00652899|Cyclophosphamide|cyclophosphamide|mesh-list
92942448|NCT00652899|Fludarabine|fludarabine|mesh-list
92942449|NCT00652899|Fludarabine phosphate|fludarabine phosphate|mesh-list
92942450|NCT00652899|Interleukin-2|interleukin-2|mesh-list
92942451|NCT00652899|Allopurinol|allopurinol|mesh-list
92942452|NCT00652899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942453|NCT00652899|Immunologic Factors|immunologic factors|mesh-ancestor
92942454|NCT00652899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942455|NCT00652899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942456|NCT00652899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92942457|NCT00652899|Alkylating Agents|alkylating agents|mesh-ancestor
92942458|NCT00652899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942459|NCT00652899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942460|NCT00652899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92942461|NCT00652899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942462|NCT00652899|Antimetabolites|antimetabolites|mesh-ancestor
92942463|NCT00652899|Antiviral Agents|antiviral agents|mesh-ancestor
92942464|NCT00652899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942465|NCT00652899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942466|NCT00652899|Analgesics|analgesics|mesh-ancestor
92942467|NCT00652899|Sensory System Agents|sensory system agents|mesh-ancestor
92942468|NCT00652899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942469|NCT00652899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92942470|NCT00652899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92942471|NCT00652899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942472|NCT00652899|Gout Suppressants|gout suppressants|mesh-ancestor
92942473|NCT00652899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92942474|NCT00652899|Antioxidants|antioxidants|mesh-ancestor
92942475|NCT00652899|Protective Agents|protective agents|mesh-ancestor
92942476|NCT04066452|Immunoglobulins|immunoglobulins|mesh-list
92942477|NCT04066452|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92942478|NCT04066452|Antibodies|antibodies|mesh-list
92942479|NCT04066452|Immunologic Factors|immunologic factors|mesh-ancestor
92942480|NCT04066452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942481|NCT00728520|Azacitidine|azacitidine|mesh-list
92942482|NCT00728520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942483|NCT00728520|Antimetabolites|antimetabolites|mesh-ancestor
92942484|NCT00728520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942485|NCT00728520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942486|NCT00728520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942487|NCT04065308|Daratumumab|daratumumab|mesh-list
92942488|NCT04065308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942489|NCT00733538|Zoledronic Acid|zoledronic acid|mesh-list
92942490|NCT00733538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92942491|NCT00733538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942492|NCT00728156|Clopidogrel|clopidogrel|mesh-list
92942493|NCT00728156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92942494|NCT00728156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92942495|NCT00728156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92942496|NCT00728156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92942497|NCT00728156|Purinergic Agents|purinergic agents|mesh-ancestor
92942498|NCT00728156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942499|NCT00728156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942500|NCT00728156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942501|NCT02569554|Rabeprazole|rabeprazole|mesh-list
92942502|NCT02569554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92942503|NCT02569554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942504|NCT02569554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92942505|NCT02569554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942506|NCT02569554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942507|NCT00734318|Fluticasone|fluticasone|mesh-list
92942508|NCT00734318|Xhance|xhance|mesh-list
92942509|NCT00734318|Formoterol Fumarate|formoterol fumarate|mesh-list
92942510|NCT00734318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92942511|NCT00734318|Autonomic Agents|autonomic agents|mesh-ancestor
92942512|NCT00734318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942513|NCT00734318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942514|NCT00734318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92942515|NCT00734318|Respiratory System Agents|respiratory system agents|mesh-ancestor
92942516|NCT00734318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92942517|NCT00734318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92942518|NCT00734318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92942519|NCT00734318|Adrenergic Agents|adrenergic agents|mesh-ancestor
92942520|NCT00734318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942521|NCT00734318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942522|NCT00734318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942523|NCT00734318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92942524|NCT00734318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92942526|NCT00733616|Capecitabine|capecitabine|mesh-list
92942527|NCT00733616|Oxaliplatin|oxaliplatin|mesh-list
92942528|NCT00733616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942529|NCT00733616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92942530|NCT00733616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92942531|NCT00733616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92942532|NCT00733616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942533|NCT00733616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942534|NCT00733616|Antimetabolites|antimetabolites|mesh-ancestor
92942535|NCT00728832|Morphine|morphine|mesh-list
92942536|NCT00728832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92942537|NCT00728832|Narcotics|narcotics|mesh-ancestor
92942538|NCT00728832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942539|NCT00728832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942540|NCT00728832|Analgesics|analgesics|mesh-ancestor
92942541|NCT00728832|Sensory System Agents|sensory system agents|mesh-ancestor
92942542|NCT00728832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942543|NCT03924804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92942544|NCT00728312|Aripiprazole|aripiprazole|mesh-list
92942545|NCT00728312|Antidepressive Agents|antidepressive agents|mesh-ancestor
92942546|NCT00728312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92942547|NCT00728312|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92942548|NCT00728312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92942549|NCT00728312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942550|NCT00728312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942551|NCT00728312|Dopamine Agonists|dopamine agonists|mesh-ancestor
92942552|NCT00728312|Dopamine Agents|dopamine agents|mesh-ancestor
92942553|NCT00728312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942554|NCT00728312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942555|NCT00728312|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92942556|NCT00728312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92942557|NCT00728312|Serotonin Agents|serotonin agents|mesh-ancestor
92942558|NCT00728312|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92942559|NCT00728312|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92942560|NCT00728312|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92942561|NCT00728312|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92942562|NCT00728546|Isoniazid|isoniazid|mesh-list
92942563|NCT00728546|Antitubercular Agents|antitubercular agents|mesh-ancestor
92942564|NCT00728546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942565|NCT00728546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942566|NCT00728546|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92942567|NCT00728546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92942568|NCT00728546|Antimetabolites|antimetabolites|mesh-ancestor
92942569|NCT00728546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942570|NCT00728546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92942571|NCT00617890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92942572|NCT00617890|Immunologic Factors|immunologic factors|mesh-ancestor
92587958|NCT00420472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942573|NCT00617890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942574|NCT00728780|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92942575|NCT00728780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92942576|NCT00728780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92942577|NCT00728780|Antimetabolites|antimetabolites|mesh-ancestor
92942578|NCT00728780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942579|NCT00728780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92942580|NCT00728780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92942581|NCT00728780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942582|NCT04066296|Bupivacaine|bupivacaine|mesh-list
92942583|NCT04066296|Anesthetics, Local|anesthetics, local|mesh-list
92942584|NCT04066296|Anesthetics|anesthetics|mesh-list
92942585|NCT04066296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92942586|NCT04066296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942587|NCT04066296|Sensory System Agents|sensory system agents|mesh-ancestor
92942588|NCT04066296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942589|NCT02341014|Lenalidomide|lenalidomide|mesh-list
92942590|NCT02341014|Romidepsin|romidepsin|mesh-list
92942591|NCT02341014|Immunologic Factors|immunologic factors|mesh-ancestor
92942592|NCT02341014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942593|NCT02341014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92942594|NCT02341014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92942595|NCT02341014|Growth Substances|growth substances|mesh-ancestor
92942596|NCT02341014|Growth Inhibitors|growth inhibitors|mesh-ancestor
92942597|NCT02341014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942598|NCT02341014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92942599|NCT02341014|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92942600|NCT02341014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942601|NCT02341014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942602|NCT00868426|Budesonide|budesonide|mesh-list
92942603|NCT00868426|Formoterol Fumarate|formoterol fumarate|mesh-list
92942604|NCT00868426|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92942605|NCT00868426|Charcoal|charcoal|mesh-list
92942606|NCT00868426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942607|NCT00868426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92942608|NCT00868426|Autonomic Agents|autonomic agents|mesh-ancestor
92942609|NCT00868426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942610|NCT00868426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942611|NCT00868426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92942612|NCT00868426|Respiratory System Agents|respiratory system agents|mesh-ancestor
92942613|NCT00868426|Glucocorticoids|glucocorticoids|mesh-ancestor
92942614|NCT00868426|Hormones|hormones|mesh-ancestor
92942615|NCT00868426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942616|NCT00868426|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92942617|NCT00868426|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92942618|NCT00868426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92942619|NCT00868426|Adrenergic Agents|adrenergic agents|mesh-ancestor
92942620|NCT00868426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942621|NCT00868426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942622|NCT00868426|Antidotes|antidotes|mesh-ancestor
92942623|NCT00868426|Protective Agents|protective agents|mesh-ancestor
92942624|NCT03853746|Ocrelizumab|ocrelizumab|mesh-list
92942625|NCT03853746|Immunologic Factors|immunologic factors|mesh-ancestor
92942626|NCT03853746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942627|NCT00868738|Vitamin D|vitamin d|mesh-list
92942628|NCT00868738|Vitamins|vitamins|mesh-ancestor
92942629|NCT00868738|Micronutrients|micronutrients|mesh-ancestor
92942630|NCT00868738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942631|NCT00868738|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92942632|NCT00868816|Oxaliplatin|oxaliplatin|mesh-list
92942633|NCT00868816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942634|NCT02569866|Cephalexin|cephalexin|mesh-list
92942635|NCT02569866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942636|NCT02569866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942637|NCT00868894|Latanoprost|latanoprost|mesh-list
92942638|NCT00868894|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92942639|NCT00868894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92942640|NCT00730938|Cefuroxime|cefuroxime|mesh-list
92942641|NCT00730938|Cefuroxime axetil|cefuroxime axetil|mesh-list
92942642|NCT00730938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942643|NCT00730938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942644|NCT00712010|Caseins|caseins|mesh-list
92942645|NCT00712010|Chelating Agents|chelating agents|mesh-ancestor
92942646|NCT00712010|Sequestering Agents|sequestering agents|mesh-ancestor
92942647|NCT00712010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942648|NCT00731016|Zoledronic Acid|zoledronic acid|mesh-list
92942649|NCT00731016|Pravastatin|pravastatin|mesh-list
92942650|NCT00731016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92942651|NCT00731016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942652|NCT00731016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92942653|NCT00731016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92942654|NCT00731016|Antimetabolites|antimetabolites|mesh-ancestor
92942655|NCT00731016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942656|NCT00731016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92942657|NCT00731016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92942658|NCT00731016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942661|NCT00799539|Melphalan|melphalan|mesh-list
92942662|NCT00799539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942663|NCT00799539|Glucocorticoids|glucocorticoids|mesh-ancestor
92942664|NCT00799539|Hormones|hormones|mesh-ancestor
92942665|NCT00799539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942666|NCT00799539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942667|NCT00799539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92942668|NCT00799539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942669|NCT00799539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92942670|NCT00799539|Alkylating Agents|alkylating agents|mesh-ancestor
92942671|NCT00799539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942672|NCT00799539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92942673|NCT00799539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942674|NCT00799539|Immunologic Factors|immunologic factors|mesh-ancestor
92942675|NCT00731172|Glatiramer Acetate|glatiramer acetate|mesh-list
92942676|NCT00731172|(T,G)-A-L|(t,g)-a-l|mesh-list
92942677|NCT00731172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92942678|NCT00731172|Immunologic Factors|immunologic factors|mesh-ancestor
92942679|NCT00731172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942680|NCT00731172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942681|NCT00731172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942682|NCT00738842|Ticagrelor|ticagrelor|mesh-list
92942683|NCT00738842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92942684|NCT00738842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92942685|NCT00738842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92942686|NCT00738842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92942687|NCT00738842|Purinergic Agents|purinergic agents|mesh-ancestor
92942688|NCT00738842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942689|NCT00738842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942690|NCT00738842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942691|NCT00809913|Ciprofloxacin|ciprofloxacin|mesh-list
92942692|NCT00809913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942693|NCT00809913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942694|NCT00809913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92942695|NCT00809913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92942696|NCT00809913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942697|NCT00809913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942698|NCT00809913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942699|NCT00809913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92942700|NCT00809913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92942701|NCT00729222|Rolofylline|rolofylline|mesh-list
92942702|NCT00729222|Diuretics|diuretics|mesh-ancestor
92942703|NCT00729222|Natriuretic Agents|natriuretic agents|mesh-ancestor
92942704|NCT00729222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942705|NCT00808743|Celecoxib|celecoxib|mesh-list
92942706|NCT00808743|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92942707|NCT00808743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942708|NCT00808743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942709|NCT00808743|Analgesics|analgesics|mesh-ancestor
92942710|NCT00808743|Sensory System Agents|sensory system agents|mesh-ancestor
92942711|NCT00808743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942712|NCT00808743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942713|NCT00808743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942714|NCT00808743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942715|NCT00808743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92942716|NCT00808743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92942717|NCT00808743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942718|NCT00808743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942719|NCT00808743|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92942720|NCT00808743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942721|NCT00869596|Fluticasone|fluticasone|mesh-list
92942722|NCT00869596|Xhance|xhance|mesh-list
92942723|NCT00869596|Albuterol|albuterol|mesh-list
92942724|NCT00869596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942725|NCT00869596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92942726|NCT00869596|Autonomic Agents|autonomic agents|mesh-ancestor
92942727|NCT00869596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942728|NCT00869596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942729|NCT00869596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92942730|NCT00869596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92942731|NCT00869596|Dermatologic Agents|dermatologic agents|mesh-ancestor
92942732|NCT00869596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92942733|NCT00869596|Tocolytic Agents|tocolytic agents|mesh-ancestor
92942734|NCT00869596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92942735|NCT00869596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92942736|NCT00869596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92942737|NCT00869596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92942738|NCT00869596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92942739|NCT00869596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942740|NCT00869596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942741|NCT03743376|UB-421|ub-421|mesh-list
92942742|NCT03743376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92942743|NCT03743376|Antiviral Agents|antiviral agents|mesh-ancestor
92942744|NCT03743376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942745|NCT00734864|Anticonvulsants|anticonvulsants|mesh-list
92942746|NCT03728478|Etanercept|etanercept|mesh-list
92942747|NCT03728478|Methotrexate|methotrexate|mesh-list
92942748|NCT03728478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92942749|NCT03728478|Abortifacient Agents|abortifacient agents|mesh-ancestor
92942750|NCT03728478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92942751|NCT03728478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942752|NCT03728478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942753|NCT03728478|Antimetabolites|antimetabolites|mesh-ancestor
92942754|NCT03728478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942755|NCT03728478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942756|NCT03728478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92942757|NCT03728478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942758|NCT03728478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92942759|NCT03728478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942760|NCT03728478|Immunologic Factors|immunologic factors|mesh-ancestor
92942761|NCT03728478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942762|NCT03728478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92942763|NCT03728478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942764|NCT03728478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942765|NCT03728478|Analgesics|analgesics|mesh-ancestor
92942766|NCT03728478|Sensory System Agents|sensory system agents|mesh-ancestor
92942767|NCT03728478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942768|NCT03728478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942769|NCT03728478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942770|NCT00653523|Simvastatin|simvastatin|mesh-list
92942771|NCT00653523|Ezetimibe|ezetimibe|mesh-list
92942772|NCT00653523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92942773|NCT00653523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92942774|NCT00653523|Antimetabolites|antimetabolites|mesh-ancestor
92942775|NCT00653523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942776|NCT00653523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92942777|NCT00653523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92942778|NCT00653523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942779|NCT00869752|Etoposide|etoposide|mesh-list
92942780|NCT00869752|Antibodies|antibodies|mesh-list
92942781|NCT00869752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92942782|NCT00869752|Immunologic Factors|immunologic factors|mesh-ancestor
92942783|NCT00869752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942784|NCT00869752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942785|NCT00869752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92942786|NCT00869752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92942787|NCT00869752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92942788|NCT00869752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942789|NCT00869752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942790|NCT00808977|Mesalamine|mesalamine|mesh-list
92942791|NCT00808977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942792|NCT00808977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942793|NCT00808977|Analgesics|analgesics|mesh-ancestor
92942794|NCT00808977|Sensory System Agents|sensory system agents|mesh-ancestor
92942795|NCT00808977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942796|NCT00808977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942797|NCT00808977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942798|NCT00808977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942799|NCT00735020|Vaccines|vaccines|mesh-list
92942800|NCT00735020|Immunologic Factors|immunologic factors|mesh-ancestor
92942801|NCT00735020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942802|NCT04065906|Methylphenidate|methylphenidate|mesh-list
92942803|NCT04065906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92942804|NCT04065906|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92942805|NCT04065906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942806|NCT04065906|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92942807|NCT04065906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92942808|NCT04065906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942809|NCT04065906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942810|NCT04065906|Dopamine Agents|dopamine agents|mesh-ancestor
92942811|NCT04065906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942812|NCT04065906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92942813|NCT04065906|Adrenergic Agents|adrenergic agents|mesh-ancestor
92942815|NCT00739388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92942816|NCT00739388|Antimetabolites|antimetabolites|mesh-ancestor
92942817|NCT00739388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942818|NCT00739388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942819|NCT00739388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942820|NCT00862888|Sildenafil Citrate|sildenafil citrate|mesh-list
92942821|NCT00862888|Vasodilator Agents|vasodilator agents|mesh-ancestor
92942822|NCT00862888|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92942823|NCT00862888|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92942824|NCT00862888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942825|NCT00862888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942826|NCT00862888|Urological Agents|urological agents|mesh-ancestor
92942827|NCT00729170|Calcium|calcium|mesh-list
92942828|NCT00729170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92942829|NCT00729170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942830|NCT00862966|Heparin|heparin|mesh-list
92942831|NCT00862966|Anticoagulants|anticoagulants|mesh-ancestor
92942832|NCT00862966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942833|NCT00862966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92942834|NCT00862966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92942835|NCT02569320|Dexamethasone|dexamethasone|mesh-list
92942836|NCT02569320|Dexamethasone acetate|dexamethasone acetate|mesh-list
92942837|NCT02569320|Pomalidomide|pomalidomide|mesh-list
92942838|NCT02569320|Ichthammol|ichthammol|mesh-list
92942839|NCT02569320|BB 1101|bb 1101|mesh-list
92942840|NCT02569320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92942841|NCT02569320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942842|NCT02569320|Antiemetics|antiemetics|mesh-ancestor
92942843|NCT02569320|Autonomic Agents|autonomic agents|mesh-ancestor
92942844|NCT02569320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942845|NCT02569320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942846|NCT02569320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942847|NCT02569320|Glucocorticoids|glucocorticoids|mesh-ancestor
92942848|NCT02569320|Hormones|hormones|mesh-ancestor
92942849|NCT02569320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942850|NCT02569320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92942851|NCT02569320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942852|NCT02569320|Protease Inhibitors|protease inhibitors|mesh-ancestor
92942853|NCT02569320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942854|NCT02569320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942855|NCT02569320|Immunologic Factors|immunologic factors|mesh-ancestor
92942856|NCT02569320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92942857|NCT02569320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92942858|NCT02569320|Growth Substances|growth substances|mesh-ancestor
92942859|NCT02569320|Growth Inhibitors|growth inhibitors|mesh-ancestor
92942860|NCT02569320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92942861|NCT00739466|Alendronate|alendronate|mesh-list
92942862|NCT00739466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92942863|NCT00739466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942864|NCT00869908|Insulin|insulin|mesh-list
92942865|NCT00869908|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92942866|NCT00869908|Insulin Aspart|insulin aspart|mesh-list
92942867|NCT00869908|Insulin, Long-Acting|insulin, long-acting|mesh-list
92942868|NCT00869908|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92942869|NCT00869908|Insulin Detemir|insulin detemir|mesh-list
92942870|NCT00869908|Biphasic Insulins|biphasic insulins|mesh-list
92942871|NCT00869908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92942872|NCT00869908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942873|NCT00739622|Rilpivirine|rilpivirine|mesh-list
92942874|NCT00739622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92942875|NCT00739622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92942876|NCT00739622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942877|NCT00739622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942879|NCT00739622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942880|NCT00739622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92942881|NCT00739622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92942882|NCT00731562|Varenicline|varenicline|mesh-list
92942883|NCT00731562|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92942884|NCT00731562|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92942885|NCT00731562|Cholinergic Agents|cholinergic agents|mesh-ancestor
92942886|NCT00731562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92942887|NCT00731562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942888|NCT00731562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942889|NCT00870142|Amlodipine|amlodipine|mesh-list
92942890|NCT00870142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92942891|NCT00870142|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92942892|NCT00870142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942893|NCT00870142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942894|NCT00870142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92942895|NCT00870142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942896|NCT00870142|Vasodilator Agents|vasodilator agents|mesh-ancestor
92942897|NCT00870220|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92942898|NCT00870220|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92942899|NCT00870220|Estradiol|estradiol|mesh-list
92942900|NCT00870220|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92942901|NCT00870220|Estrogens|estrogens|mesh-ancestor
92942902|NCT00870220|Hormones|hormones|mesh-ancestor
92942903|NCT00870220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942904|NCT00870220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942905|NCT00870220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92942906|NCT00870220|Contraceptive Agents|contraceptive agents|mesh-ancestor
92942907|NCT00870220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92942908|NCT00870220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92942909|NCT00729768|Cyclosporine|cyclosporine|mesh-list
92942910|NCT00729768|Mycophenolic Acid|mycophenolic acid|mesh-list
92942911|NCT00729768|Cyclosporins|cyclosporins|mesh-list
92942912|NCT00729768|Basiliximab|basiliximab|mesh-list
92942913|NCT00729768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942914|NCT00729768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942915|NCT00729768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92942916|NCT00729768|Immunologic Factors|immunologic factors|mesh-ancestor
92942917|NCT00729768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942918|NCT00729768|Antifungal Agents|antifungal agents|mesh-ancestor
92942919|NCT00729768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942920|NCT00729768|Dermatologic Agents|dermatologic agents|mesh-ancestor
92942921|NCT00729768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942922|NCT00729768|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92942923|NCT00729768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92942924|NCT00729768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942925|NCT00729768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92942926|NCT00729768|Antitubercular Agents|antitubercular agents|mesh-ancestor
92942927|NCT00729768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92942928|NCT00871156|Chloroquine|chloroquine|mesh-list
92942929|NCT00871156|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92942930|NCT00871156|Tafenoquine|tafenoquine|mesh-list
92942931|NCT00871156|Amebicides|amebicides|mesh-ancestor
92942932|NCT00871156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92942933|NCT00871156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92942934|NCT00871156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92942935|NCT00871156|Antimalarials|antimalarials|mesh-ancestor
92942936|NCT00871156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92942937|NCT00871156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92942938|NCT00871156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92942939|NCT00871156|Analgesics|analgesics|mesh-ancestor
92942940|NCT00871156|Sensory System Agents|sensory system agents|mesh-ancestor
92942941|NCT00871156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92942942|NCT00871156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942943|NCT00871156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92942944|NCT00871156|Filaricides|filaricides|mesh-ancestor
92942945|NCT00871156|Antinematodal Agents|antinematodal agents|mesh-ancestor
92942946|NCT00871156|Anthelmintics|anthelmintics|mesh-ancestor
92942947|NCT00734448|Inositol|inositol|mesh-list
92942948|NCT00734448|Vitamin B Complex|vitamin b complex|mesh-ancestor
92942949|NCT00734448|Vitamins|vitamins|mesh-ancestor
92942950|NCT00734448|Micronutrients|micronutrients|mesh-ancestor
92942951|NCT00734448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942952|NCT00876226|Citalopram|citalopram|mesh-list
92942953|NCT00876226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92942954|NCT00876226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92942955|NCT00876226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92942956|NCT00876226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942958|NCT00876226|Serotonin Agents|serotonin agents|mesh-ancestor
92164723|NCT04161599|Picosulfate sodium|picosulfate sodium|mesh-list
92942959|NCT00876226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942960|NCT00876226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92942961|NCT00876226|Antidepressive Agents|antidepressive agents|mesh-ancestor
92942962|NCT00876226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92942963|NCT00734526|Temozolomide|temozolomide|mesh-list
92942964|NCT00734526|Sorafenib|sorafenib|mesh-list
92942965|NCT00734526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92942966|NCT00734526|Alkylating Agents|alkylating agents|mesh-ancestor
92942967|NCT00734526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942968|NCT00734526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942969|NCT00734526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92942970|NCT00734526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942971|NCT00729404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92942972|NCT00729404|Gestodene|gestodene|mesh-list
92942973|NCT00729404|Femovan|femovan|mesh-list
92942974|NCT00729404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92942975|NCT00729404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92942976|NCT00729404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92942977|NCT00729404|Contraceptive Agents|contraceptive agents|mesh-ancestor
92942978|NCT00729404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92942979|NCT00729404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92942980|NCT00729404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92942981|NCT00729404|Estrogens|estrogens|mesh-ancestor
92942982|NCT00729404|Hormones|hormones|mesh-ancestor
92942983|NCT00729404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92942984|NCT00729404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92942985|NCT00729404|Progestins|progestins|mesh-ancestor
92942986|NCT00729404|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92942987|NCT00731952|Bortezomib|bortezomib|mesh-list
92942988|NCT00731952|Vorinostat|vorinostat|mesh-list
92942989|NCT00731952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92942990|NCT00731952|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92942991|NCT00731952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92942992|NCT00731952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92942993|NCT04065932|Deucravacitinib|deucravacitinib|mesh-list
92942994|NCT04065932|Famotidine|famotidine|mesh-list
92942995|NCT04065932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92942996|NCT04065932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92942997|NCT04065932|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92942998|NCT04065932|Histamine Antagonists|histamine antagonists|mesh-ancestor
92942999|NCT04065932|Histamine Agents|histamine agents|mesh-ancestor
92943000|NCT04065932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943001|NCT04065932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943002|NCT04065932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943003|NCT04065932|Dermatologic Agents|dermatologic agents|mesh-ancestor
92943004|NCT04065932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943005|NCT04065932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943006|NCT00740090|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92943007|NCT00740090|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92943008|NCT00740090|Immunologic Factors|immunologic factors|mesh-ancestor
92943009|NCT00740090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943010|NCT00740090|Antacids|antacids|mesh-ancestor
92943011|NCT00740090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943012|NCT00740090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943013|NCT00738660|Telmisartan|telmisartan|mesh-list
92943014|NCT00738660|Ramipril|ramipril|mesh-list
92943015|NCT00738660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943016|NCT00738660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92943017|NCT00738660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92943018|NCT00738660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943019|NCT00738660|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92943020|NCT00738660|Protease Inhibitors|protease inhibitors|mesh-ancestor
92943021|NCT00738660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943022|NCT00740168|Bevacizumab|bevacizumab|mesh-list
92943023|NCT00740168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943024|NCT00740168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943025|NCT00740168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92943026|NCT00740168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92943027|NCT00740168|Growth Substances|growth substances|mesh-ancestor
92943028|NCT00740168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943029|NCT00740168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92943030|NCT05225974|Liraglutide|liraglutide|mesh-list
92943031|NCT05225974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92943032|NCT05225974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943033|NCT05225974|Incretins|incretins|mesh-ancestor
92943034|NCT05225974|Hormones|hormones|mesh-ancestor
92943035|NCT05225974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943036|NCT01139970|Temozolomide|temozolomide|mesh-list
92943037|NCT01139970|Veliparib|veliparib|mesh-list
92943038|NCT01139970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92943039|NCT01139970|Alkylating Agents|alkylating agents|mesh-ancestor
92943040|NCT01139970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943041|NCT01139970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943042|NCT01139970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92943043|NCT01139970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943044|NCT00729638|Lenalidomide|lenalidomide|mesh-list
92943045|NCT00729638|Everolimus|everolimus|mesh-list
92943046|NCT00729638|Immunologic Factors|immunologic factors|mesh-ancestor
92943047|NCT00729638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943048|NCT00729638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92943049|NCT00729638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92943050|NCT00729638|Growth Substances|growth substances|mesh-ancestor
92943051|NCT00729638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92943052|NCT00729638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943053|NCT00729638|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92943054|NCT00729638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943055|NCT00729638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943056|NCT00729638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943057|NCT00729638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943058|NCT00734682|Irinotecan|irinotecan|mesh-list
92943059|NCT00734682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92943060|NCT00734682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92943061|NCT00734682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943062|NCT00734682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943063|NCT00734682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943064|NCT00732108|Topiramate|topiramate|mesh-list
92943065|NCT00732108|Lactulose|lactulose|mesh-list
92943066|NCT00732108|Anticonvulsants|anticonvulsants|mesh-ancestor
92943067|NCT00732108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92943068|NCT00732108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943069|NCT00732108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943070|NCT00876616|Mycophenolic Acid|mycophenolic acid|mesh-list
92943071|NCT00876616|Cyclophosphamide|cyclophosphamide|mesh-list
92943072|NCT00876616|Tacrolimus|tacrolimus|mesh-list
92943073|NCT00876616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943074|NCT00876616|Immunologic Factors|immunologic factors|mesh-ancestor
92943075|NCT00876616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943076|NCT00876616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943077|NCT00876616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92943078|NCT00876616|Alkylating Agents|alkylating agents|mesh-ancestor
92943079|NCT00876616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943080|NCT00876616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943081|NCT00876616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92943082|NCT00876616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92943083|NCT00876616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943084|NCT00876616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92943085|NCT00876616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92943086|NCT00876616|Antitubercular Agents|antitubercular agents|mesh-ancestor
92943087|NCT00876616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943088|NCT00876616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943089|NCT05575440|Fluorides|fluorides|mesh-list
92943090|NCT05575440|Cariostatic Agents|cariostatic agents|mesh-ancestor
92943091|NCT05575440|Protective Agents|protective agents|mesh-ancestor
92943092|NCT05575440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943093|NCT00729794|Methylprednisolone|methylprednisolone|mesh-list
92943094|NCT00729794|Hydrocortisone|hydrocortisone|mesh-list
92943095|NCT00729794|Vasopressins|vasopressins|mesh-list
92943096|NCT00729794|Epinephrine|epinephrine|mesh-list
92943097|NCT00729794|Racepinephrine|racepinephrine|mesh-list
92943098|NCT00729794|Epinephryl borate|epinephryl borate|mesh-list
92943099|NCT00729794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92943100|NCT00729794|Antiemetics|antiemetics|mesh-ancestor
92943101|NCT00729794|Autonomic Agents|autonomic agents|mesh-ancestor
92943102|NCT00729794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943103|NCT00729794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943104|NCT00729794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943105|NCT00729794|Glucocorticoids|glucocorticoids|mesh-ancestor
92943106|NCT00729794|Hormones|hormones|mesh-ancestor
92943107|NCT00729794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943108|NCT00729794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92943109|NCT00729794|Protective Agents|protective agents|mesh-ancestor
92943110|NCT00729794|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92943111|NCT00729794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92943112|NCT00729794|Adrenergic Agents|adrenergic agents|mesh-ancestor
92943113|NCT00729794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943114|NCT00729794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943115|NCT00729794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92943116|NCT00729794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92943117|NCT00729794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92943118|NCT00729794|Respiratory System Agents|respiratory system agents|mesh-ancestor
92943119|NCT00729794|Mydriatics|mydriatics|mesh-ancestor
92943120|NCT00729794|Sympathomimetics|sympathomimetics|mesh-ancestor
92943121|NCT00729794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92943122|NCT00729794|Hemostatics|hemostatics|mesh-ancestor
92943123|NCT00729794|Coagulants|coagulants|mesh-ancestor
92943124|NCT00729794|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92943125|NCT00729794|Natriuretic Agents|natriuretic agents|mesh-ancestor
92943126|NCT00871546|Bortezomib|bortezomib|mesh-list
92943127|NCT00871546|Alemtuzumab|alemtuzumab|mesh-list
92943128|NCT00871546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943129|NCT00871546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943130|NCT03778294|Temozolomide|temozolomide|mesh-list
92943131|NCT03778294|Levodopa|levodopa|mesh-list
92943132|NCT03778294|Fluorides|fluorides|mesh-list
92943133|NCT03778294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92943134|NCT03778294|Alkylating Agents|alkylating agents|mesh-ancestor
92943135|NCT03778294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943136|NCT03778294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943137|NCT03778294|Cariostatic Agents|cariostatic agents|mesh-ancestor
92943138|NCT03778294|Protective Agents|protective agents|mesh-ancestor
92943139|NCT03778294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943140|NCT03778294|Dopamine Agents|dopamine agents|mesh-ancestor
92943141|NCT03778294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943142|NCT03778294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92943143|NCT03778294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92943144|NCT00732186|Ipilimumab|ipilimumab|mesh-list
92943145|NCT00732186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943146|NCT00732186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943147|NCT00732186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92943148|NCT00732186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943150|NCT04039828|Zinc Sulfate|zinc sulfate|mesh-list
92943151|NCT04039828|Trace Elements|trace elements|mesh-ancestor
92943152|NCT04039828|Micronutrients|micronutrients|mesh-ancestor
92943153|NCT04039828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943154|NCT04039828|Astringents|astringents|mesh-ancestor
92943155|NCT04039828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92943156|NCT00876772|Olanzapine|olanzapine|mesh-list
92943157|NCT00876772|Antiemetics|antiemetics|mesh-ancestor
92943158|NCT00876772|Autonomic Agents|autonomic agents|mesh-ancestor
92943159|NCT00876772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943160|NCT00876772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943161|NCT00876772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943162|NCT00876772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92943163|NCT00876772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943164|NCT00876772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943165|NCT00876772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943166|NCT00876772|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92943167|NCT00876772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92943168|NCT00876772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92943169|NCT00876772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943170|NCT00876772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943171|NCT00876772|Serotonin Agents|serotonin agents|mesh-ancestor
92943172|NCT00729950|Ipilimumab|ipilimumab|mesh-list
92943173|NCT00729950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943174|NCT00729950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943175|NCT00729950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92243699|NCT05287464|Avelumab|avelumab|mesh-list
92943176|NCT00729950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943177|NCT00616018|Acetaminophen|acetaminophen|mesh-list
92943178|NCT00616018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92943180|NCT00616018|Sensory System Agents|sensory system agents|mesh-ancestor
92943181|NCT00616018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943182|NCT00616018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943183|NCT00616018|Antipyretics|antipyretics|mesh-ancestor
92943184|NCT00740948|Rituximab|rituximab|mesh-list
92943185|NCT00740948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943186|NCT00740948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943187|NCT00740948|Immunologic Factors|immunologic factors|mesh-ancestor
92943188|NCT00740948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943189|NCT00740948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943190|NCT00876850|Linezolid|linezolid|mesh-list
92943191|NCT00876850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943192|NCT00876850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943193|NCT00876850|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92943194|NCT00876850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943195|NCT00876850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943196|NCT00734916|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92943197|NCT00734916|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92943198|NCT00734916|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92943199|NCT00734916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92943200|NCT05157412|Doxycycline|doxycycline|mesh-list
92943201|NCT05157412|Prednisolone|prednisolone|mesh-list
92943202|NCT05157412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92943203|NCT05157412|Methylprednisolone|methylprednisolone|mesh-list
92943204|NCT05157412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92943205|NCT05157412|Prednisolone acetate|prednisolone acetate|mesh-list
92943206|NCT05157412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92943207|NCT05157412|Prednisolone phosphate|prednisolone phosphate|mesh-list
92943208|NCT05157412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92943209|NCT05157412|Glucocorticoids|glucocorticoids|mesh-ancestor
92943210|NCT05157412|Hormones|hormones|mesh-ancestor
92943211|NCT05157412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943212|NCT05157412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943213|NCT05157412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92943214|NCT05157412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943215|NCT05157412|Antiemetics|antiemetics|mesh-ancestor
92943216|NCT05157412|Autonomic Agents|autonomic agents|mesh-ancestor
92943217|NCT05157412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943218|NCT05157412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943219|NCT05157412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92943220|NCT05157412|Protective Agents|protective agents|mesh-ancestor
92943221|NCT05157412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943222|NCT05157412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943223|NCT05157412|Antimalarials|antimalarials|mesh-ancestor
92943224|NCT05157412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92943225|NCT05157412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92943226|NCT00732420|Topotecan|topotecan|mesh-list
92943227|NCT00732420|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92943228|NCT00732420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92943229|NCT00732420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943230|NCT00732420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943231|NCT00732420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943232|NCT00735228|Pancrelipase|pancrelipase|mesh-list
92943233|NCT00735228|Pancreatin|pancreatin|mesh-list
92943234|NCT00735228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943235|NCT00739128|Vaccines|vaccines|mesh-list
92943236|NCT00739128|Immunologic Factors|immunologic factors|mesh-ancestor
92943237|NCT00739128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943238|NCT00863668|Tenofovir|tenofovir|mesh-list
92943239|NCT00863668|Emtricitabine|emtricitabine|mesh-list
92943240|NCT00863668|Efavirenz|efavirenz|mesh-list
92943241|NCT00863668|Raltegravir Potassium|raltegravir potassium|mesh-list
92943242|NCT00863668|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92943243|NCT00863668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92943244|NCT00863668|Integrase Inhibitors|integrase inhibitors|mesh-list
92943245|NCT00863668|Antiviral Agents|antiviral agents|mesh-ancestor
92943246|NCT00863668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943247|NCT00863668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92943248|NCT00863668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943249|NCT00863668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943250|NCT00863668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92943251|NCT00863668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92943252|NCT00863668|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92943253|NCT00863668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92943254|NCT00863668|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92943255|NCT00863668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92943256|NCT00863668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92943257|NCT00863668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92943258|NCT00863668|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92943259|NCT00872248|Anesthetics|anesthetics|mesh-list
92943260|NCT00872248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943261|NCT00872248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943262|NCT00732576|Vitamin K 2|vitamin k 2|mesh-list
92943263|NCT00732576|Vitamin K|vitamin k|mesh-list
92943264|NCT00732576|Menaquinone 7|menaquinone 7|mesh-list
92943265|NCT00732576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92943266|NCT00732576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92943267|NCT00732576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943268|NCT00732576|Hemostatics|hemostatics|mesh-ancestor
92943269|NCT00732576|Coagulants|coagulants|mesh-ancestor
92943270|NCT00732576|Vitamins|vitamins|mesh-ancestor
92943271|NCT00732576|Micronutrients|micronutrients|mesh-ancestor
92943272|NCT00732576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943273|NCT00863902|Cetirizine|cetirizine|mesh-list
92943274|NCT00863902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92943275|NCT00863902|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92943276|NCT00863902|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92943277|NCT00863902|Histamine Antagonists|histamine antagonists|mesh-ancestor
92943278|NCT00863902|Histamine Agents|histamine agents|mesh-ancestor
92943279|NCT00863902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943280|NCT00863902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943281|NCT00863902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943282|NCT00732810|Capecitabine|capecitabine|mesh-list
92943283|NCT00732810|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92943284|NCT00732810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92943285|NCT00732810|Antimetabolites|antimetabolites|mesh-ancestor
92943286|NCT00732810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943287|NCT00732810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943288|NCT00732810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943289|NCT00732810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943290|NCT00732888|Calcium Carbonate|calcium carbonate|mesh-list
92943291|NCT00732888|Calcium|calcium|mesh-list
92943292|NCT00732888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92943293|NCT00732888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943294|NCT00732888|Antacids|antacids|mesh-ancestor
92943295|NCT00732888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943296|NCT00732888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943297|NCT00732966|Losartan|losartan|mesh-list
92943298|NCT00732966|Valsartan|valsartan|mesh-list
92943299|NCT00732966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943300|NCT00732966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92943301|NCT00732966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92943302|NCT00732966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943303|NCT00732966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92943304|NCT02568618|Analgesics|analgesics|mesh-list
92943305|NCT02568618|Sensory System Agents|sensory system agents|mesh-ancestor
92943306|NCT02568618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943307|NCT02568618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943308|NCT00735852|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92943309|NCT00735852|Luteolytic Agents|luteolytic agents|mesh-ancestor
92943310|NCT00735852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92943311|NCT00735852|Contraceptive Agents|contraceptive agents|mesh-ancestor
92943312|NCT00735852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92943313|NCT00735852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943314|NCT00735852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92943315|NCT00735852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92943316|NCT00735852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943317|NCT00424021|Ambrisentan|ambrisentan|mesh-list
92943318|NCT00424021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943319|NCT00735930|Lenalidomide|lenalidomide|mesh-list
92943320|NCT00735930|Alvocidib|alvocidib|mesh-list
92943321|NCT00735930|Immunologic Factors|immunologic factors|mesh-ancestor
92943322|NCT00735930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943323|NCT00735930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92943324|NCT00735930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92943325|NCT00735930|Growth Substances|growth substances|mesh-ancestor
92943326|NCT00735930|Growth Inhibitors|growth inhibitors|mesh-ancestor
92943327|NCT00735930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943328|NCT00735930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943330|NCT00735930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943332|NCT00617734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92943333|NCT00617734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943334|NCT00617734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943335|NCT00617734|Immunologic Factors|immunologic factors|mesh-ancestor
92943336|NCT00617734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943337|NCT00577460|Pramipexole|pramipexole|mesh-list
92943338|NCT00577460|Antioxidants|antioxidants|mesh-ancestor
92943339|NCT00577460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943340|NCT00577460|Protective Agents|protective agents|mesh-ancestor
92943341|NCT00577460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943342|NCT00577460|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92943343|NCT00577460|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92943344|NCT00577460|Dopamine Agonists|dopamine agonists|mesh-ancestor
92943345|NCT00577460|Dopamine Agents|dopamine agents|mesh-ancestor
92943346|NCT00577460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943347|NCT00863980|Telmisartan|telmisartan|mesh-list
92943348|NCT00863980|Candesartan|candesartan|mesh-list
92943349|NCT00863980|Candesartan cilexetil|candesartan cilexetil|mesh-list
92943350|NCT00863980|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943351|NCT00863980|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92943352|NCT00863980|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92943353|NCT00863980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943354|NCT00415519|Edaravone|edaravone|mesh-list
92943355|NCT00415519|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92943356|NCT00415519|Antioxidants|antioxidants|mesh-ancestor
92943357|NCT00415519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943358|NCT00415519|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92943359|NCT00415519|Protective Agents|protective agents|mesh-ancestor
92943360|NCT00415519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943361|NCT05741294|Tirbanibulin|tirbanibulin|mesh-list
92943362|NCT05741294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943363|NCT05741294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943364|NCT02568176|Midazolam|midazolam|mesh-list
92943365|NCT02568176|Bupropion|bupropion|mesh-list
92943366|NCT02568176|Esketamine|esketamine|mesh-list
92943367|NCT02568176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92943368|NCT02568176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92943369|NCT02568176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943370|NCT02568176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943371|NCT02568176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92943372|NCT02568176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943373|NCT02568176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943374|NCT02568176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92943375|NCT02568176|Anesthetics, General|anesthetics, general|mesh-ancestor
92943376|NCT02568176|Anesthetics|anesthetics|mesh-ancestor
92943377|NCT02568176|GABA Modulators|gaba modulators|mesh-ancestor
92943378|NCT02568176|GABA Agents|gaba agents|mesh-ancestor
92943379|NCT02568176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943380|NCT02568176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943381|NCT02568176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92943382|NCT02568176|Antidepressive Agents|antidepressive agents|mesh-ancestor
92943383|NCT02568176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92943384|NCT02568176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92943385|NCT02568176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92943386|NCT02568176|Dopamine Agents|dopamine agents|mesh-ancestor
92943387|NCT02568176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92943388|NCT02568176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92943389|NCT02568176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943390|NCT00741182|Teriparatide|teriparatide|mesh-list
92943391|NCT00741182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92943392|NCT00741182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943393|NCT00741182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92943394|NCT00423943|Modafinil|modafinil|mesh-list
92943395|NCT00423943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92943396|NCT00423943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943397|NCT00423943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92943398|NCT00423943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92943399|NCT00423943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92943400|NCT00423943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943401|NCT00736346|Paroxetine|paroxetine|mesh-list
92943402|NCT00736346|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92943403|NCT00736346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92943404|NCT00736346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92943405|NCT00736346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943406|NCT00736346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943407|NCT00736346|Serotonin Agents|serotonin agents|mesh-ancestor
92943408|NCT00736346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943409|NCT00736346|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92943410|NCT00736346|Antidepressive Agents|antidepressive agents|mesh-ancestor
92943411|NCT00736346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943412|NCT00736346|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92943413|NCT00736346|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92943414|NCT00736346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943415|NCT00864058|Gabapentin|gabapentin|mesh-list
92943416|NCT00864058|Analgesics|analgesics|mesh-ancestor
92943417|NCT00864058|Sensory System Agents|sensory system agents|mesh-ancestor
92943418|NCT00864058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943419|NCT00864058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943420|NCT00864058|Anticonvulsants|anticonvulsants|mesh-ancestor
92943421|NCT00864058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92943422|NCT00864058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943423|NCT00864058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943424|NCT00864058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943425|NCT00864058|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92943426|NCT00864058|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92943427|NCT00864058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943428|NCT00864058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943429|NCT00864058|Antimanic Agents|antimanic agents|mesh-ancestor
92943430|NCT00864136|Levonorgestrel|levonorgestrel|mesh-list
92943431|NCT00864136|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92943432|NCT00864136|Contraceptive Agents|contraceptive agents|mesh-ancestor
92943433|NCT00864136|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92943434|NCT00864136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943435|NCT00864136|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92943436|NCT00864136|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92943437|NCT00864136|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92943438|NCT00864214|Hormones|hormones|mesh-list
92943439|NCT00864214|Estradiol|estradiol|mesh-list
92164768|NCT05605613|Antibodies|antibodies|mesh-list
92943440|NCT00864214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943441|NCT00864214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943442|NCT00864214|Estrogens|estrogens|mesh-ancestor
92943443|NCT00872482|Nimotuzumab|nimotuzumab|mesh-list
92943444|NCT00872482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943445|NCT00872482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943446|NCT00428389|Rivastigmine|rivastigmine|mesh-list
92943447|NCT00428389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92943448|NCT00428389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943449|NCT00428389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943450|NCT00428389|Cholinergic Agents|cholinergic agents|mesh-ancestor
92943451|NCT00428389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943452|NCT00428389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943453|NCT00428389|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92943454|NCT00428389|Protective Agents|protective agents|mesh-ancestor
92943455|NCT00616642|Rosiglitazone|rosiglitazone|mesh-list
92943456|NCT00616642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92943457|NCT00616642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943458|NCT02568488|Metformin|metformin|mesh-list
92943459|NCT02568488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92943460|NCT02568488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943461|NCT01324063|Cytarabine|cytarabine|mesh-list
92943462|NCT01324063|Daunorubicin|daunorubicin|mesh-list
92943463|NCT01324063|Amsacrine|amsacrine|mesh-list
92943464|NCT01324063|Sargramostim|sargramostim|mesh-list
92943465|NCT01324063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92943466|NCT01324063|Antimetabolites|antimetabolites|mesh-ancestor
92943467|NCT01324063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943468|NCT01324063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943469|NCT01324063|Antiviral Agents|antiviral agents|mesh-ancestor
92943470|NCT01324063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943471|NCT01324063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943472|NCT01324063|Immunologic Factors|immunologic factors|mesh-ancestor
92943473|NCT01324063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943474|NCT01324063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92943475|NCT01324063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92943476|NCT01324063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92943477|NCT01324063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943478|NCT00864448|Ramipril|ramipril|mesh-list
92943479|NCT00864448|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92943480|NCT00864448|Protease Inhibitors|protease inhibitors|mesh-ancestor
92943481|NCT00864448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943482|NCT00864448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943483|NCT00864448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943484|NCT00406315|Ziprasidone|ziprasidone|mesh-list
92943485|NCT00406315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92943486|NCT00406315|Serotonin Agents|serotonin agents|mesh-ancestor
92943487|NCT00406315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943488|NCT00406315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943489|NCT00406315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943490|NCT00406315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92943491|NCT00406315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943492|NCT00406315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943493|NCT00406315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943494|NCT00406315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92943495|NCT00406315|Dopamine Agents|dopamine agents|mesh-ancestor
92943496|NCT00872716|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92943497|NCT00872716|Antidepressive Agents|antidepressive agents|mesh-ancestor
92943498|NCT00872716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943499|NCT00872716|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92943500|NCT00872716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943501|NCT00872716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943502|NCT00872716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943503|NCT00864526|Ibuprofen|ibuprofen|mesh-list
92943504|NCT00864526|Oxycodone|oxycodone|mesh-list
92943505|NCT00864526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92943506|NCT00864526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92943507|NCT00864526|Analgesics|analgesics|mesh-ancestor
92943508|NCT00864526|Sensory System Agents|sensory system agents|mesh-ancestor
92943509|NCT00864526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943510|NCT00864526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943511|NCT00864526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92943512|NCT00864526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943513|NCT00864526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92943514|NCT00864526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943515|NCT00864526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943516|NCT00864526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92943517|NCT00864526|Narcotics|narcotics|mesh-ancestor
92943518|NCT00864526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943519|NCT00864604|Nabumetone|nabumetone|mesh-list
92943520|NCT00864604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92943521|NCT00864604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92943522|NCT00864604|Analgesics|analgesics|mesh-ancestor
92943523|NCT00864604|Sensory System Agents|sensory system agents|mesh-ancestor
92943524|NCT00864604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943525|NCT00864604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943526|NCT00864604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92943527|NCT00864604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943528|NCT00864604|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92943529|NCT00864604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92943530|NCT00864604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943531|NCT00864604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943532|NCT04064138|Anesthetics|anesthetics|mesh-list
92943533|NCT04064138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943534|NCT04064138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943535|NCT01323751|Ricolinostat|ricolinostat|mesh-list
92943536|NCT01323751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943537|NCT01323751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92943538|NCT01323751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943539|NCT01323751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943540|NCT00711594|Afatinib|afatinib|mesh-list
92943541|NCT00711594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943542|NCT00711594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943543|NCT00711594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943544|NCT00711594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943545|NCT00864760|Gabapentin|gabapentin|mesh-list
92943546|NCT00864760|Analgesics|analgesics|mesh-ancestor
92943547|NCT00864760|Sensory System Agents|sensory system agents|mesh-ancestor
92288467|NCT01823497|Morphine|morphine|mesh-list
92943548|NCT00864760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943549|NCT00864760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943551|NCT00864760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92943552|NCT00864760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943553|NCT00864760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943554|NCT00864760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943555|NCT00864760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92943556|NCT00864760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92943557|NCT00864760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943558|NCT00864760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943559|NCT00864760|Antimanic Agents|antimanic agents|mesh-ancestor
92943561|NCT00710762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943562|NCT00710762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943563|NCT00710762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943564|NCT00710762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943565|NCT05137912|Immunomodulating Agents|immunomodulating agents|mesh-list
92943566|NCT05137912|Immunologic Factors|immunologic factors|mesh-ancestor
92943567|NCT05137912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943568|NCT00736814|Carboplatin|carboplatin|mesh-list
92943569|NCT00736814|Gemcitabine|gemcitabine|mesh-list
92943570|NCT00736814|Docetaxel|docetaxel|mesh-list
92943571|NCT00736814|Vinorelbine|vinorelbine|mesh-list
92943572|NCT00736814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943573|NCT00736814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92943574|NCT00736814|Antimetabolites|antimetabolites|mesh-ancestor
92943575|NCT00736814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943576|NCT00736814|Tubulin Modulators|tubulin modulators|mesh-ancestor
92943577|NCT00736814|Antimitotic Agents|antimitotic agents|mesh-ancestor
92943578|NCT00736814|Mitosis Modulators|mitosis modulators|mesh-ancestor
92943579|NCT00736814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92943580|NCT04063904|Misoprostol|misoprostol|mesh-list
92943581|NCT04063904|Mifepristone|mifepristone|mesh-list
92943582|NCT04063904|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92943583|NCT04063904|Abortifacient Agents|abortifacient agents|mesh-ancestor
92943584|NCT04063904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92943585|NCT04063904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943586|NCT04063904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92943587|NCT04063904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943588|NCT04063904|Oxytocics|oxytocics|mesh-ancestor
92943589|NCT04063904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92943590|NCT04063904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92943591|NCT04063904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92943592|NCT04063904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92943593|NCT04063904|Contraceptive Agents|contraceptive agents|mesh-ancestor
92943594|NCT04063904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92943595|NCT04063904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92943596|NCT04063904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92943597|NCT04063904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943598|NCT04063904|Luteolytic Agents|luteolytic agents|mesh-ancestor
92943599|NCT04063904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92943600|NCT04063904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92943601|NCT00573430|Candesartan|candesartan|mesh-list
92943602|NCT00573430|Candesartan cilexetil|candesartan cilexetil|mesh-list
92943603|NCT00573430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943604|NCT00573430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92943605|NCT00573430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92943606|NCT00573430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943607|NCT00711516|Modafinil|modafinil|mesh-list
92943608|NCT00711516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92943609|NCT00711516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943610|NCT00711516|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92943611|NCT00711516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92943612|NCT00711516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92943613|NCT00711516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943614|NCT00864838|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92943615|NCT00864838|Acetazolamide|acetazolamide|mesh-list
92943616|NCT00864838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92943617|NCT00864838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92943618|NCT00864838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92943619|NCT00864838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92943620|NCT00864838|Adrenergic Agents|adrenergic agents|mesh-ancestor
92943621|NCT00864838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943622|NCT00864838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943623|NCT00864838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943624|NCT00864838|Anticonvulsants|anticonvulsants|mesh-ancestor
92943625|NCT00864838|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92943626|NCT00864838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943627|NCT00864838|Diuretics|diuretics|mesh-ancestor
92943628|NCT00864838|Natriuretic Agents|natriuretic agents|mesh-ancestor
92943629|NCT04039516|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92943630|NCT04039516|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92943631|NCT04039516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943632|NCT00615550|Progesterone|progesterone|mesh-list
92943633|NCT00615550|Progestins|progestins|mesh-ancestor
92943634|NCT00615550|Hormones|hormones|mesh-ancestor
92943635|NCT00615550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943636|NCT00615550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943637|NCT00186888|Cyclophosphamide|cyclophosphamide|mesh-list
92943638|NCT00186888|Carboplatin|carboplatin|mesh-list
92943639|NCT00186888|Doxorubicin|doxorubicin|mesh-list
92943640|NCT00186888|Etoposide|etoposide|mesh-list
92943641|NCT00186888|Etoposide phosphate|etoposide phosphate|mesh-list
92943642|NCT00186888|Vincristine|vincristine|mesh-list
92943643|NCT00186888|Topotecan|topotecan|mesh-list
92943644|NCT00186888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943645|NCT00186888|Immunologic Factors|immunologic factors|mesh-ancestor
92943646|NCT00186888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943647|NCT00186888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943648|NCT00186888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92943649|NCT00186888|Alkylating Agents|alkylating agents|mesh-ancestor
92943650|NCT00186888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943651|NCT00186888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943652|NCT00186888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92943653|NCT00186888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92164774|NCT05602259|Dimercaprol|dimercaprol|mesh-list
92943654|NCT00186888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92943655|NCT00186888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92943656|NCT00186888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943657|NCT00186888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92943658|NCT00186888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92943659|NCT00186888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92943660|NCT00186888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92943661|NCT00186888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92943662|NCT00736164|Selenium|selenium|mesh-list
92943663|NCT00736164|Antioxidants|antioxidants|mesh-ancestor
92943664|NCT00736164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943665|NCT00736164|Protective Agents|protective agents|mesh-ancestor
92943666|NCT00736164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943667|NCT00736164|Trace Elements|trace elements|mesh-ancestor
92943668|NCT00736164|Micronutrients|micronutrients|mesh-ancestor
92943669|NCT00739830|Sirolimus|sirolimus|mesh-list
92943670|NCT00739830|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92943671|NCT00739830|Megestrol|megestrol|mesh-list
92943672|NCT00739830|Megestrol Acetate|megestrol acetate|mesh-list
92943673|NCT00739830|Medroxyprogesterone|medroxyprogesterone|mesh-list
92943674|NCT00739830|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92943675|NCT00739830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92943676|NCT00739830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92943677|NCT00739830|Contraceptive Agents|contraceptive agents|mesh-ancestor
92943678|NCT00739830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92943679|NCT00739830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943680|NCT00739830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92943681|NCT00739830|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92943682|NCT00739830|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92943683|NCT00739830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92943684|NCT00739830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943685|NCT00739830|Appetite Stimulants|appetite stimulants|mesh-ancestor
92943686|NCT00739830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92943687|NCT00739830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943688|NCT00739830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943689|NCT00739830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92943690|NCT00739830|Antifungal Agents|antifungal agents|mesh-ancestor
92943691|NCT00739830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943692|NCT00739830|Immunologic Factors|immunologic factors|mesh-ancestor
92943693|NCT00577382|Sunitinib|sunitinib|mesh-list
92943694|NCT00577382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943695|NCT00577382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92589105|NCT03191864|Xhance|xhance|mesh-list
92943696|NCT00577382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92943697|NCT00577382|Growth Substances|growth substances|mesh-ancestor
92943698|NCT00577382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943699|NCT00577382|Growth Inhibitors|growth inhibitors|mesh-ancestor
92943700|NCT00577382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943701|NCT00577382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943702|NCT00577382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943703|NCT00733434|Alprostadil|alprostadil|mesh-list
92943704|NCT00733434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92943705|NCT00733434|Vasodilator Agents|vasodilator agents|mesh-ancestor
92943706|NCT00733434|Urological Agents|urological agents|mesh-ancestor
92943707|NCT00736320|Vincristine|vincristine|mesh-list
92943708|NCT00736320|Doxorubicin|doxorubicin|mesh-list
92943709|NCT00736320|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92943710|NCT00736320|Dacarbazine|dacarbazine|mesh-list
92943712|NCT00736320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92943713|NCT00736320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943714|NCT00736320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92943715|NCT00736320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92943716|NCT00736320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92943717|NCT00736320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943718|NCT00736320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92943719|NCT00736320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92943720|NCT00736320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92943721|NCT00736320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943722|NCT00736320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92943723|NCT00736320|Alkylating Agents|alkylating agents|mesh-ancestor
92943724|NCT04065282|Capecitabine|capecitabine|mesh-list
92943725|NCT04065282|Oxaliplatin|oxaliplatin|mesh-list
92943726|NCT04065282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92943727|NCT04065282|Antimetabolites|antimetabolites|mesh-ancestor
92943728|NCT04065282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943729|NCT04065282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943730|NCT00873262|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92943731|NCT00873262|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92943732|NCT00873262|Estropipate|estropipate|mesh-list
92943733|NCT00873262|Estradiol|estradiol|mesh-list
92943734|NCT00873262|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92943735|NCT00873262|Estrone|estrone|mesh-list
92943736|NCT00873262|Progesterone|progesterone|mesh-list
92943737|NCT00873262|Estrogens|estrogens|mesh-ancestor
92943738|NCT00873262|Hormones|hormones|mesh-ancestor
92943739|NCT00873262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943740|NCT00873262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943741|NCT00873262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92943742|NCT00873262|Contraceptive Agents|contraceptive agents|mesh-ancestor
92943743|NCT00873262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92943744|NCT00873262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92943745|NCT00873262|Progestins|progestins|mesh-ancestor
92943746|NCT00739986|Semapimod|semapimod|mesh-list
92943747|NCT00739986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92943748|NCT00739986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92943749|NCT00739986|Analgesics|analgesics|mesh-ancestor
92943750|NCT00739986|Sensory System Agents|sensory system agents|mesh-ancestor
92943751|NCT00739986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943752|NCT00739986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943753|NCT00739986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92943754|NCT00739986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943755|NCT00739986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943756|NCT00739986|Immunologic Factors|immunologic factors|mesh-ancestor
92943757|NCT00736970|Sirolimus|sirolimus|mesh-list
92943758|NCT00736970|Trastuzumab|trastuzumab|mesh-list
92943759|NCT00736970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943760|NCT00736970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943761|NCT00736970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943762|NCT00736970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943763|NCT00736970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92943764|NCT00736970|Antifungal Agents|antifungal agents|mesh-ancestor
92943765|NCT00736970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943766|NCT00736970|Immunologic Factors|immunologic factors|mesh-ancestor
92943767|NCT00736970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943768|NCT00873340|Interferons|interferons|mesh-list
92943769|NCT00873340|Interferon beta-1b|interferon beta-1b|mesh-list
92943770|NCT00873340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589164|NCT03002103|Paclitaxel|paclitaxel|mesh-list
92943771|NCT00873340|Antiviral Agents|antiviral agents|mesh-ancestor
92943772|NCT00873340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943773|NCT00873340|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92943774|NCT00873340|Immunologic Factors|immunologic factors|mesh-ancestor
92943775|NCT00873340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943776|NCT00740064|Lamivudine|lamivudine|mesh-list
92943777|NCT00740064|Abacavir|abacavir|mesh-list
92943778|NCT00740064|Raltegravir Potassium|raltegravir potassium|mesh-list
92943779|NCT00740064|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92943780|NCT00740064|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92943781|NCT00740064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943782|NCT00740064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943783|NCT00740064|Antiviral Agents|antiviral agents|mesh-ancestor
92943784|NCT00740064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943785|NCT00740064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92943786|NCT00740064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92943787|NCT00740064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92943788|NCT00740064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92943789|NCT00614926|Modafinil|modafinil|mesh-list
92943790|NCT00614926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92943791|NCT00614926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943792|NCT00614926|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92943793|NCT00614926|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92943794|NCT00614926|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92943795|NCT00614926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943796|NCT00873496|Hydroxychloroquine|hydroxychloroquine|mesh-list
92943797|NCT00873496|Antimalarials|antimalarials|mesh-ancestor
92943798|NCT00873496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92943799|NCT00873496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92943800|NCT00873496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943801|NCT00873496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943802|NCT00873496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943803|NCT00873496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943804|NCT00879892|Xenon|xenon|mesh-list
92943805|NCT00879892|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92943806|NCT00879892|Anesthetics, General|anesthetics, general|mesh-ancestor
92943807|NCT00879892|Anesthetics|anesthetics|mesh-ancestor
92943808|NCT00879892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943809|NCT00879892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943810|NCT00095784|Decitabine|decitabine|mesh-list
92943811|NCT00095784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92943812|NCT00095784|Antimetabolites|antimetabolites|mesh-ancestor
92526650|NCT00029497|Adrenergic Agents|adrenergic agents|mesh-ancestor
92943813|NCT00095784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943814|NCT00095784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943815|NCT00095784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943817|NCT00740142|N-Methylaspartate|n-methylaspartate|mesh-list
92943818|NCT00740142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943819|NCT00740142|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92943820|NCT00740142|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92943821|NCT00740142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943822|NCT00740142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943823|NCT00740142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943824|NCT00873652|Vaccines|vaccines|mesh-list
92943825|NCT00873652|Immunologic Factors|immunologic factors|mesh-ancestor
92943826|NCT00873652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943827|NCT00423319|Enoxaparin|enoxaparin|mesh-list
92943828|NCT00423319|Enoxaparin sodium|enoxaparin sodium|mesh-list
92943829|NCT00423319|Apixaban|apixaban|mesh-list
92943830|NCT00423319|Anticoagulants|anticoagulants|mesh-ancestor
92943831|NCT00423319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92943832|NCT00423319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92943833|NCT00423319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943834|NCT00423319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92943835|NCT00423319|Antithrombins|antithrombins|mesh-ancestor
92943836|NCT00423319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92943837|NCT00423319|Protease Inhibitors|protease inhibitors|mesh-ancestor
92943838|NCT00423319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943839|NCT05224492|Sulforaphane|sulforaphane|mesh-list
92943840|NCT05224492|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92943841|NCT05224492|Protective Agents|protective agents|mesh-ancestor
92943842|NCT05224492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943843|NCT05224492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943844|NCT00733668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92943845|NCT00733668|Antidepressive Agents|antidepressive agents|mesh-ancestor
92943846|NCT00733668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92943847|NCT00733668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92943848|NCT00733668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92943849|NCT00733668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943850|NCT00733668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943851|NCT04039126|Iodine|iodine|mesh-list
92943852|NCT04039126|Cadexomer iodine|cadexomer iodine|mesh-list
92943853|NCT04039126|Povidone-Iodine|povidone-iodine|mesh-list
92943854|NCT04039126|Tetracycline|tetracycline|mesh-list
92943855|NCT04039126|Povidone|povidone|mesh-list
92943856|NCT04039126|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92943857|NCT04039126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943858|NCT04039126|Trace Elements|trace elements|mesh-ancestor
92943859|NCT04039126|Micronutrients|micronutrients|mesh-ancestor
92943860|NCT04039126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943861|NCT04039126|Plasma Substitutes|plasma substitutes|mesh-ancestor
92943862|NCT04039126|Blood Substitutes|blood substitutes|mesh-ancestor
92943863|NCT04039126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943864|NCT04039126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92943865|NCT04039126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943866|NCT04039126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943867|NCT00873808|Zoledronic Acid|zoledronic acid|mesh-list
92943868|NCT00873808|Ibandronic Acid|ibandronic acid|mesh-list
92943869|NCT00873808|Clodronic Acid|clodronic acid|mesh-list
92943870|NCT00873808|Tetracycline|tetracycline|mesh-list
92943871|NCT00873808|Demeclocycline|demeclocycline|mesh-list
92943872|NCT00873808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92943873|NCT00873808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943874|NCT00873808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943875|NCT00873808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943876|NCT00873808|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92943877|NCT00873808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943878|NCT00873808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943879|NCT04064190|Durvalumab|durvalumab|mesh-list
92943880|NCT04064190|Vactosertib|vactosertib|mesh-list
92943881|NCT04064190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92943882|NCT04064190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943883|NCT04064190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943884|NCT04064190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943885|NCT04064190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943886|NCT00873886|Oseltamivir|oseltamivir|mesh-list
92943887|NCT00873886|Antiviral Agents|antiviral agents|mesh-ancestor
92943888|NCT00873886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943889|NCT00873886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943890|NCT00873886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943891|NCT00880282|Sirolimus|sirolimus|mesh-list
92943892|NCT00880282|Temsirolimus|temsirolimus|mesh-list
92943893|NCT00880282|MTOR Inhibitors|mtor inhibitors|mesh-list
92943894|NCT00880282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92943895|NCT00880282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92943896|NCT00880282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943897|NCT00880282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943898|NCT00880282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943899|NCT00880282|Immunologic Factors|immunologic factors|mesh-ancestor
92943900|NCT00880282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943901|NCT00880282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943902|NCT00880282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92943903|NCT00880282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943904|NCT00880282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92943905|NCT00880282|Antifungal Agents|antifungal agents|mesh-ancestor
92943906|NCT00879268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92943907|NCT00874042|Gemcitabine|gemcitabine|mesh-list
92943908|NCT00874042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92943909|NCT00874042|Antimetabolites|antimetabolites|mesh-ancestor
92943910|NCT00874042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943911|NCT00874042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92943912|NCT00736866|Acetylcysteine|acetylcysteine|mesh-list
92943913|NCT00736866|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92943914|NCT00736866|Antiviral Agents|antiviral agents|mesh-ancestor
92943915|NCT00736866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943916|NCT00736866|Expectorants|expectorants|mesh-ancestor
92943917|NCT00736866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92943918|NCT00736866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92943919|NCT00736866|Antioxidants|antioxidants|mesh-ancestor
92943920|NCT00736866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943921|NCT00736866|Protective Agents|protective agents|mesh-ancestor
92943922|NCT00736866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943923|NCT00736866|Antidotes|antidotes|mesh-ancestor
92943924|NCT00879424|Vitamin D|vitamin d|mesh-list
92589313|NCT02649790|Hormones|hormones|mesh-ancestor
92943925|NCT00879424|Cholecalciferol|cholecalciferol|mesh-list
92943927|NCT00879424|Micronutrients|micronutrients|mesh-ancestor
92943928|NCT00879424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943929|NCT00879424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92943930|NCT00879424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92943931|NCT00710684|Donepezil|donepezil|mesh-list
92943932|NCT00710684|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92943933|NCT00710684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92943934|NCT00710684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943935|NCT00710684|Cholinergic Agents|cholinergic agents|mesh-ancestor
92943936|NCT00710684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943937|NCT00710684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943938|NCT00710684|Nootropic Agents|nootropic agents|mesh-ancestor
92943939|NCT00710606|NuvaRing|nuvaring|mesh-list
92943940|NCT00710606|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92943941|NCT00710606|Desogestrel|desogestrel|mesh-list
92943942|NCT00710606|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92943943|NCT00710606|Contraceptive Agents|contraceptive agents|mesh-ancestor
92943944|NCT00710606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92943945|NCT00710606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943946|NCT00710606|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92943947|NCT00710606|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92943948|NCT00710606|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92943949|NCT00710606|Estrogens|estrogens|mesh-ancestor
92943950|NCT00710606|Hormones|hormones|mesh-ancestor
92943951|NCT00710606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92943952|NCT00710606|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92943953|NCT00710606|Progestins|progestins|mesh-ancestor
92943954|NCT00713544|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92943955|NCT00713544|Etanercept|etanercept|mesh-list
92943956|NCT00713544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92943957|NCT00713544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92943958|NCT00713544|Analgesics|analgesics|mesh-ancestor
92943959|NCT00713544|Sensory System Agents|sensory system agents|mesh-ancestor
92943960|NCT00713544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943961|NCT00713544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943962|NCT00713544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92943963|NCT00713544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92943964|NCT00713544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92943965|NCT00713544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92943966|NCT00713544|Immunologic Factors|immunologic factors|mesh-ancestor
92943967|NCT00713544|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92943968|NCT00713544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92943969|NCT00713544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92943970|NCT00713544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92943971|NCT00713544|Antiviral Agents|antiviral agents|mesh-ancestor
92943972|NCT00713544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92943973|NCT00737126|Folic Acid|folic acid|mesh-list
92943974|NCT00737126|Hematinics|hematinics|mesh-ancestor
92943975|NCT00737126|Vitamin B Complex|vitamin b complex|mesh-ancestor
92943976|NCT00737126|Vitamins|vitamins|mesh-ancestor
92943977|NCT00737126|Micronutrients|micronutrients|mesh-ancestor
92943978|NCT00737126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943979|NCT04063046|Anesthetics|anesthetics|mesh-list
92943980|NCT04063046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92943981|NCT04063046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943982|NCT05529056|Atropine|atropine|mesh-list
92943983|NCT05529056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92943984|NCT05529056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92943985|NCT05529056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92943986|NCT05529056|Autonomic Agents|autonomic agents|mesh-ancestor
92943987|NCT05529056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92943988|NCT05529056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92943989|NCT05529056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92943990|NCT05529056|Respiratory System Agents|respiratory system agents|mesh-ancestor
92943991|NCT05529056|Mydriatics|mydriatics|mesh-ancestor
92943992|NCT05529056|Parasympatholytics|parasympatholytics|mesh-ancestor
92943993|NCT05529056|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92943994|NCT05529056|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92943995|NCT05529056|Cholinergic Agents|cholinergic agents|mesh-ancestor
92943996|NCT05529056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92943997|NCT05529056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589391|NCT02496208|Nivolumab|nivolumab|mesh-list
92943998|NCT00740922|Becaplermin|becaplermin|mesh-list
92943999|NCT00740922|Anticoagulants|anticoagulants|mesh-ancestor
92944000|NCT00740922|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92944001|NCT00740922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944002|NCT00740922|Growth Substances|growth substances|mesh-ancestor
92944003|NCT00740922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944004|NCT05523440|Bevacizumab|bevacizumab|mesh-list
92944005|NCT05523440|Niraparib|niraparib|mesh-list
92944006|NCT05523440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944007|NCT05523440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944008|NCT05523440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944009|NCT05523440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944010|NCT05523440|Growth Substances|growth substances|mesh-ancestor
92944011|NCT05523440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944012|NCT05523440|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944013|NCT05523440|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92944014|NCT05523440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944015|NCT05523440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944016|NCT00741078|Amlodipine|amlodipine|mesh-list
92944017|NCT00741078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92944018|NCT00741078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92944019|NCT00741078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944020|NCT00741078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944021|NCT00741078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92944022|NCT00741078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944023|NCT00741078|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944024|NCT02568800|Cefepime|cefepime|mesh-list
92944025|NCT02568800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92944026|NCT02568800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944027|NCT00741234|Azacitidine|azacitidine|mesh-list
92944028|NCT00741234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944029|NCT00741234|Antimetabolites|antimetabolites|mesh-ancestor
92944030|NCT00741234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944031|NCT00741234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944032|NCT00741234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944033|NCT00713258|Alendronate|alendronate|mesh-list
92944034|NCT00713258|Hormones|hormones|mesh-list
92944035|NCT00713258|Parathyroid Hormone|parathyroid hormone|mesh-list
92944036|NCT00713258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944037|NCT00713258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944038|NCT00713258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92944039|NCT00713258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92944040|NCT00710034|Nicotine|nicotine|mesh-list
92944041|NCT00710034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92944042|NCT00710034|Autonomic Agents|autonomic agents|mesh-ancestor
92944043|NCT00710034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944044|NCT00710034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944045|NCT00710034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92944046|NCT00710034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92944047|NCT00710034|Cholinergic Agents|cholinergic agents|mesh-ancestor
92944048|NCT00710034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944049|NCT00710034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944050|NCT02567942|Propofol|propofol|mesh-list
92944051|NCT02567942|Sevoflurane|sevoflurane|mesh-list
92944052|NCT02567942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92944053|NCT02567942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944054|NCT02567942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944055|NCT02567942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92944056|NCT02567942|Anesthetics, General|anesthetics, general|mesh-ancestor
92944057|NCT02567942|Anesthetics|anesthetics|mesh-ancestor
92944058|NCT02567942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92944059|NCT02567942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92944060|NCT00414973|Teriparatide|teriparatide|mesh-list
92944061|NCT00414973|Calcitonin|calcitonin|mesh-list
92944062|NCT00414973|Salmon calcitonin|salmon calcitonin|mesh-list
92944063|NCT00414973|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92944064|NCT00414973|Katacalcin|katacalcin|mesh-list
92944065|NCT00414973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92944066|NCT00414973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944067|NCT00414973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92944068|NCT00414973|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944069|NCT00423085|Rivastigmine|rivastigmine|mesh-list
92944070|NCT00423085|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92589468|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
92944071|NCT00423085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944072|NCT00423085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944073|NCT00423085|Cholinergic Agents|cholinergic agents|mesh-ancestor
92944074|NCT00423085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944075|NCT00423085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944076|NCT00423085|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92944077|NCT00423085|Protective Agents|protective agents|mesh-ancestor
92944079|NCT00414661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92944080|NCT00414661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92944081|NCT00414661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944082|NCT00414661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944083|NCT01608451|Cholecalciferol|cholecalciferol|mesh-list
92944084|NCT01608451|Vitamin D|vitamin d|mesh-list
92944085|NCT01608451|Progesterone|progesterone|mesh-list
92164791|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92944086|NCT01608451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92944087|NCT01608451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944088|NCT01608451|Vitamins|vitamins|mesh-ancestor
92944089|NCT01608451|Micronutrients|micronutrients|mesh-ancestor
92944090|NCT01608451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92944091|NCT01608451|Progestins|progestins|mesh-ancestor
92944092|NCT01608451|Hormones|hormones|mesh-ancestor
92944093|NCT01608451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944094|NCT00405067|Ezetimibe|ezetimibe|mesh-list
92944095|NCT00405067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92944096|NCT00405067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92944097|NCT00405067|Antimetabolites|antimetabolites|mesh-ancestor
92944098|NCT00405067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944099|NCT00405067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92944100|NCT00708708|Etanercept|etanercept|mesh-list
92944101|NCT00708708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92944102|NCT00708708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92944103|NCT00708708|Analgesics|analgesics|mesh-ancestor
92944104|NCT00708708|Sensory System Agents|sensory system agents|mesh-ancestor
92944105|NCT00708708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944106|NCT00708708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944107|NCT00708708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944108|NCT00708708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92944109|NCT00708708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944110|NCT00708708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944111|NCT00708708|Immunologic Factors|immunologic factors|mesh-ancestor
92944112|NCT00404755|Bupropion|bupropion|mesh-list
92944113|NCT00404755|Imipramine|imipramine|mesh-list
92944114|NCT00404755|Escitalopram|escitalopram|mesh-list
92944115|NCT00404755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92944116|NCT00404755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92944117|NCT00404755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944118|NCT00404755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944119|NCT00404755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944120|NCT00404755|Serotonin Agents|serotonin agents|mesh-ancestor
92944121|NCT00404755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944122|NCT00404755|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92944123|NCT00404755|Antidepressive Agents|antidepressive agents|mesh-ancestor
92944124|NCT00404755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92944125|NCT00404755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92944126|NCT00404755|Dopamine Agents|dopamine agents|mesh-ancestor
92944127|NCT00404755|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92944128|NCT00404755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92944129|NCT00404755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944130|NCT00404755|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92944131|NCT00404755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92944132|NCT00404755|Adrenergic Agents|adrenergic agents|mesh-ancestor
92944133|NCT03904381|Fluorouracil|fluorouracil|mesh-list
92944134|NCT03904381|Antimetabolites|antimetabolites|mesh-ancestor
92944135|NCT03904381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944136|NCT03904381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944137|NCT03904381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944138|NCT03904381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944139|NCT03904381|Immunologic Factors|immunologic factors|mesh-ancestor
92944140|NCT03904381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944141|NCT00737256|Aripiprazole|aripiprazole|mesh-list
92944142|NCT00737256|Perphenazine|perphenazine|mesh-list
92944143|NCT00737256|Antidepressive Agents|antidepressive agents|mesh-ancestor
92944144|NCT00737256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92944145|NCT00737256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92944146|NCT00737256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92944147|NCT00737256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944148|NCT00737256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944149|NCT00737256|Dopamine Agonists|dopamine agonists|mesh-ancestor
92944150|NCT00737256|Dopamine Agents|dopamine agents|mesh-ancestor
92944151|NCT00737256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944152|NCT00737256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944153|NCT00737256|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92944154|NCT00737256|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92944155|NCT00737256|Serotonin Agents|serotonin agents|mesh-ancestor
92164794|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944156|NCT00737256|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92944157|NCT00737256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92944158|NCT00737256|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92944159|NCT00737256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92944160|NCT00614614|Vaccines|vaccines|mesh-list
92944161|NCT00614614|Immunologic Factors|immunologic factors|mesh-ancestor
92944162|NCT00614614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944163|NCT00713310|Mesalamine|mesalamine|mesh-list
92944164|NCT00713310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92944165|NCT00713310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92944166|NCT00713310|Analgesics|analgesics|mesh-ancestor
92944167|NCT00713310|Sensory System Agents|sensory system agents|mesh-ancestor
92944168|NCT00713310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944169|NCT00713310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944170|NCT00713310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944171|NCT00713310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92944172|NCT05740488|Hormones|hormones|mesh-list
92944173|NCT05740488|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92944174|NCT05740488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944175|NCT05740488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944176|NCT05742126|Heparin|heparin|mesh-list
92944177|NCT05742126|Calcium heparin|calcium heparin|mesh-list
92944178|NCT05742126|Anticoagulants|anticoagulants|mesh-ancestor
92944179|NCT05742126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92944180|NCT05742126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92944181|NCT05742126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944183|NCT00882856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92944184|NCT00882856|Sympatholytics|sympatholytics|mesh-ancestor
92944185|NCT00882856|Autonomic Agents|autonomic agents|mesh-ancestor
92944186|NCT00882856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944187|NCT00882856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944188|NCT00882856|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92944189|NCT00882856|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92944190|NCT00882856|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92944191|NCT00882856|Adrenergic Agents|adrenergic agents|mesh-ancestor
92944192|NCT00882856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944193|NCT00882856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944194|NCT00880672|Dutasteride|dutasteride|mesh-list
92944195|NCT00880672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92944196|NCT00880672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92944197|NCT00880672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944198|NCT00880672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944199|NCT00880672|Hormone Antagonists|hormone antagonists|mesh-ancestor
92944200|NCT00880672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944201|NCT00880672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944202|NCT00737724|Efavirenz|efavirenz|mesh-list
92944203|NCT00737724|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92944204|NCT00737724|Isoniazid|isoniazid|mesh-list
92944205|NCT00737724|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92944206|NCT00737724|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92944207|NCT00737724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944208|NCT00737724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944209|NCT00737724|Antiviral Agents|antiviral agents|mesh-ancestor
92944210|NCT00737724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944211|NCT00737724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92944212|NCT00737724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92944213|NCT00737724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92944214|NCT00737724|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92944215|NCT00737724|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92944216|NCT00737724|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92944217|NCT00737724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92944218|NCT00737724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92944219|NCT00737724|Antitubercular Agents|antitubercular agents|mesh-ancestor
92944220|NCT00737724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92944221|NCT00737724|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92944222|NCT00737724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92944223|NCT00737724|Antimetabolites|antimetabolites|mesh-ancestor
92944224|NCT00737724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92944225|NCT00880828|Acetaminophen|acetaminophen|mesh-list
92944226|NCT00880828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92944227|NCT00880828|Analgesics|analgesics|mesh-ancestor
92944228|NCT00880828|Sensory System Agents|sensory system agents|mesh-ancestor
92944229|NCT00880828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944230|NCT00880828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944231|NCT00880828|Antipyretics|antipyretics|mesh-ancestor
92944233|NCT00712920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92944234|NCT00712920|Autonomic Agents|autonomic agents|mesh-ancestor
92944235|NCT00712920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944236|NCT00712920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944237|NCT00712920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92944238|NCT00712920|Respiratory System Agents|respiratory system agents|mesh-ancestor
92944239|NCT00712920|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92944240|NCT00712920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944241|NCT00712920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944242|NCT00712920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92944243|NCT00712920|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92944244|NCT00712920|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92944245|NCT00712920|Histamine Antagonists|histamine antagonists|mesh-ancestor
92944246|NCT00712920|Histamine Agents|histamine agents|mesh-ancestor
92944247|NCT00712920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944248|NCT00874744|Triamcinolone|triamcinolone|mesh-list
92944249|NCT00874744|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92944250|NCT00874744|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92944251|NCT00874744|Bevacizumab|bevacizumab|mesh-list
92944252|NCT00874744|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92944253|NCT00874744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944254|NCT00874744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944255|NCT00874744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944256|NCT00874744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944257|NCT00874744|Growth Substances|growth substances|mesh-ancestor
92944258|NCT00874744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944259|NCT00874744|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944260|NCT00874744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944261|NCT00874744|Glucocorticoids|glucocorticoids|mesh-ancestor
92944262|NCT00874744|Hormones|hormones|mesh-ancestor
92944263|NCT00874744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944264|NCT00874744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944265|NCT00874744|Immunologic Factors|immunologic factors|mesh-ancestor
92944266|NCT00874744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944267|NCT00874744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944268|NCT05736744|Magnesium Sulfate|magnesium sulfate|mesh-list
92944269|NCT05736744|Bromides|bromides|mesh-list
92944270|NCT05736744|Rocuronium|rocuronium|mesh-list
92944271|NCT05736744|Atracurium|atracurium|mesh-list
92944272|NCT05736744|Cisatracurium|cisatracurium|mesh-list
92944273|NCT05736744|Anticonvulsants|anticonvulsants|mesh-ancestor
92944274|NCT05736744|Analgesics|analgesics|mesh-ancestor
92944275|NCT05736744|Sensory System Agents|sensory system agents|mesh-ancestor
92944276|NCT05736744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944277|NCT05736744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944278|NCT05736744|Anesthetics|anesthetics|mesh-ancestor
92944279|NCT05736744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944280|NCT05736744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92944281|NCT05736744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92944282|NCT05736744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944283|NCT05736744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944284|NCT05736744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92944285|NCT05736744|Tocolytic Agents|tocolytic agents|mesh-ancestor
92944286|NCT05736744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92944287|NCT05736744|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92944288|NCT05736744|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92944289|NCT05736744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92944290|NCT05736744|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92944291|NCT05736744|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92944292|NCT05736744|Cholinergic Agents|cholinergic agents|mesh-ancestor
92944293|NCT05736744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944295|NCT00920868|Capecitabine|capecitabine|mesh-list
92944296|NCT00920868|Oxaliplatin|oxaliplatin|mesh-list
92944297|NCT00920868|Dasatinib|dasatinib|mesh-list
92944298|NCT00920868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944299|NCT00920868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944300|NCT00920868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944301|NCT00920868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944302|NCT00920868|Growth Substances|growth substances|mesh-ancestor
92944303|NCT00920868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944304|NCT00920868|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944305|NCT00920868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944306|NCT00920868|Antimetabolites|antimetabolites|mesh-ancestor
92944307|NCT00920868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944308|NCT00920868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92944309|NCT00920868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944310|NCT05741814|Propofol|propofol|mesh-list
92944311|NCT05741814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92944312|NCT05741814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944313|NCT05741814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944314|NCT05741814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92944315|NCT05741814|Anesthetics, General|anesthetics, general|mesh-ancestor
92944316|NCT05741814|Anesthetics|anesthetics|mesh-ancestor
92944317|NCT04721626|Chlorhexidine|chlorhexidine|mesh-list
92944318|NCT04721626|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92944319|NCT04721626|Povidone-Iodine|povidone-iodine|mesh-list
92944320|NCT04721626|Tetracycline|tetracycline|mesh-list
92944321|NCT04721626|Doxycycline|doxycycline|mesh-list
92944322|NCT04721626|Povidone|povidone|mesh-list
92944323|NCT04721626|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92944324|NCT04721626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944325|NCT04721626|Disinfectants|disinfectants|mesh-ancestor
92944327|NCT04721626|Plasma Substitutes|plasma substitutes|mesh-ancestor
92944328|NCT04721626|Blood Substitutes|blood substitutes|mesh-ancestor
92944329|NCT04721626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92944330|NCT04721626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92944331|NCT04721626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944332|NCT04721626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944333|NCT04721626|Antimalarials|antimalarials|mesh-ancestor
92944334|NCT04721626|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92944335|NCT04721626|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92944336|NCT00881140|Mifepristone|mifepristone|mesh-list
92944337|NCT00881140|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92944338|NCT00881140|Abortifacient Agents|abortifacient agents|mesh-ancestor
92944339|NCT00881140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92944340|NCT00881140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944341|NCT00881140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92944342|NCT00881140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92944343|NCT00881140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92944344|NCT00881140|Contraceptive Agents|contraceptive agents|mesh-ancestor
92944345|NCT00881140|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92944346|NCT00881140|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92944347|NCT00881140|Hormone Antagonists|hormone antagonists|mesh-ancestor
92944348|NCT00881140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944349|NCT00881140|Luteolytic Agents|luteolytic agents|mesh-ancestor
92944350|NCT00881140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92944351|NCT00881140|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92944352|NCT05733078|Vitamins|vitamins|mesh-list
92944353|NCT05733078|Ascorbic Acid|ascorbic acid|mesh-list
92944354|NCT05733078|Micronutrients|micronutrients|mesh-ancestor
92944355|NCT05733078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944356|NCT05733078|Antioxidants|antioxidants|mesh-ancestor
92944357|NCT05733078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944358|NCT05733078|Protective Agents|protective agents|mesh-ancestor
92944359|NCT00874978|Lenalidomide|lenalidomide|mesh-list
92944360|NCT00874978|Immunologic Factors|immunologic factors|mesh-ancestor
92944361|NCT00874978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944362|NCT00874978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944363|NCT00874978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944364|NCT00874978|Growth Substances|growth substances|mesh-ancestor
92944365|NCT00874978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944366|NCT00874978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944367|NCT00737880|Pancrelipase|pancrelipase|mesh-list
92944368|NCT00737880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944369|NCT05728632|Nebivolol|nebivolol|mesh-list
92944370|NCT05728632|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92944371|NCT05728632|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944372|NCT05728632|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92944373|NCT05728632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92944374|NCT05728632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92944375|NCT05728632|Adrenergic Agents|adrenergic agents|mesh-ancestor
92944376|NCT05728632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944377|NCT05728632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944378|NCT05728632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944379|NCT05741502|Olanzapine|olanzapine|mesh-list
92944380|NCT05741502|Risperidone|risperidone|mesh-list
92944381|NCT05741502|Aripiprazole|aripiprazole|mesh-list
92944382|NCT05741502|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92944383|NCT05741502|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92944384|NCT05741502|Ziprasidone|ziprasidone|mesh-list
92944385|NCT05741502|Antipsychotic Agents|antipsychotic agents|mesh-list
92944386|NCT05741502|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92944387|NCT05741502|Clozapine|clozapine|mesh-list
92944388|NCT05741502|Cariprazine|cariprazine|mesh-list
92944389|NCT05741502|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92944390|NCT05741502|Serotonin Agents|serotonin agents|mesh-ancestor
92944391|NCT05741502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944392|NCT05741502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944393|NCT05741502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944394|NCT05741502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92944395|NCT05741502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944396|NCT05741502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92944397|NCT05741502|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92944398|NCT05741502|Dopamine Agents|dopamine agents|mesh-ancestor
92944399|NCT05741502|Antiemetics|antiemetics|mesh-ancestor
92944400|NCT05741502|Autonomic Agents|autonomic agents|mesh-ancestor
92944401|NCT05741502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944402|NCT05741502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944403|NCT05741502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92944404|NCT05741502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92944405|NCT05741502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944406|NCT05741502|Antidepressive Agents|antidepressive agents|mesh-ancestor
92944407|NCT05741502|Dopamine Agonists|dopamine agonists|mesh-ancestor
92944408|NCT05741502|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92944409|NCT05741502|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92944410|NCT05741502|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92944411|NCT05741502|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92944412|NCT05741502|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92944413|NCT05741502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92944414|NCT05741502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92944415|NCT05741502|Adrenergic Agents|adrenergic agents|mesh-ancestor
92944416|NCT05741502|GABA Antagonists|gaba antagonists|mesh-ancestor
92944417|NCT05741502|GABA Agents|gaba agents|mesh-ancestor
92944418|NCT00612586|Leucovorin|leucovorin|mesh-list
92944419|NCT00612586|Bevacizumab|bevacizumab|mesh-list
92944420|NCT00612586|Fluorouracil|fluorouracil|mesh-list
92944421|NCT00612586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944422|NCT00612586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944423|NCT00612586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944424|NCT00612586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944425|NCT00612586|Growth Substances|growth substances|mesh-ancestor
92944426|NCT00612586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944427|NCT00612586|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944428|NCT00612586|Antimetabolites|antimetabolites|mesh-ancestor
92944429|NCT00612586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944430|NCT00612586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944431|NCT00612586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944432|NCT00612586|Immunologic Factors|immunologic factors|mesh-ancestor
92944433|NCT00612586|Antidotes|antidotes|mesh-ancestor
92944434|NCT00612586|Protective Agents|protective agents|mesh-ancestor
92944435|NCT00612586|Vitamin B Complex|vitamin b complex|mesh-ancestor
92944436|NCT00612586|Vitamins|vitamins|mesh-ancestor
92944437|NCT00612586|Micronutrients|micronutrients|mesh-ancestor
92944438|NCT00883870|Plasma-lyte 148|plasma-lyte 148|mesh-list
92944439|NCT00883870|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92944440|NCT00883870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92944441|NCT00614380|Amlodipine|amlodipine|mesh-list
92944442|NCT00614380|Telmisartan|telmisartan|mesh-list
92589845|NCT05951361|Benzocaine|benzocaine|mesh-list
92944443|NCT00614380|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92944444|NCT00614380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92944445|NCT00614380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92944446|NCT00614380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944447|NCT00614380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944448|NCT00614380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92944449|NCT00614380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944450|NCT00614380|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944451|NCT00614380|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92944452|NCT00614380|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92944454|NCT00738192|Sufentanil|sufentanil|mesh-list
92944455|NCT00738192|Dsuvia|dsuvia|mesh-list
92944456|NCT00738192|Butorphanol|butorphanol|mesh-list
92944457|NCT00738192|Citric Acid|citric acid|mesh-list
92944458|NCT00738192|Sodium Citrate|sodium citrate|mesh-list
92944459|NCT00738192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92944460|NCT00738192|Narcotics|narcotics|mesh-ancestor
92944461|NCT00738192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944462|NCT00738192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944463|NCT00738192|Analgesics|analgesics|mesh-ancestor
92944464|NCT00738192|Sensory System Agents|sensory system agents|mesh-ancestor
92944465|NCT00738192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944466|NCT00738192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92944467|NCT00738192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92944468|NCT00738192|Anesthetics, General|anesthetics, general|mesh-ancestor
92944469|NCT00738192|Anesthetics|anesthetics|mesh-ancestor
92944470|NCT00738192|Anticoagulants|anticoagulants|mesh-ancestor
92944471|NCT00738192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92944472|NCT00738192|Chelating Agents|chelating agents|mesh-ancestor
92944473|NCT00738192|Sequestering Agents|sequestering agents|mesh-ancestor
92944474|NCT00738192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944475|NCT00738192|Antitussive Agents|antitussive agents|mesh-ancestor
92944476|NCT00738192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92944477|NCT00738192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92944478|NCT05500170|Niacinamide|niacinamide|mesh-list
92944480|NCT05500170|Nicotinic Acids|nicotinic acids|mesh-list
92944481|NCT05500170|Vitamins|vitamins|mesh-ancestor
92944482|NCT05500170|Micronutrients|micronutrients|mesh-ancestor
92944483|NCT05500170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944484|NCT05500170|Vitamin B Complex|vitamin b complex|mesh-ancestor
92944485|NCT05500170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92944486|NCT05500170|Antimetabolites|antimetabolites|mesh-ancestor
92944487|NCT05500170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944488|NCT05500170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92944489|NCT05500170|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944490|NCT00884104|Solifenacin Succinate|solifenacin succinate|mesh-list
92944491|NCT00884104|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92944492|NCT00884104|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92944493|NCT00884104|Cholinergic Agents|cholinergic agents|mesh-ancestor
92944494|NCT00884104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944495|NCT00884104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944496|NCT00884104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944497|NCT00884104|Urological Agents|urological agents|mesh-ancestor
92944498|NCT04140214|Carbocysteine|carbocysteine|mesh-list
92944499|NCT04140214|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92944500|NCT04140214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944501|NCT04140214|Expectorants|expectorants|mesh-ancestor
92944502|NCT04140214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92944503|NCT00612508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92944504|NCT00612508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92944505|NCT00612508|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92944506|NCT00612508|Etonogestrel|etonogestrel|mesh-list
92944507|NCT00612508|Desogestrel|desogestrel|mesh-list
92944508|NCT00612508|NuvaRing|nuvaring|mesh-list
92944509|NCT00612508|Estradiol|estradiol|mesh-list
92944510|NCT00612508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92944511|NCT00612508|Estrogens|estrogens|mesh-ancestor
92944512|NCT00612508|Hormones|hormones|mesh-ancestor
92944513|NCT00612508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944514|NCT00612508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944515|NCT00612508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92944516|NCT00612508|Contraceptive Agents|contraceptive agents|mesh-ancestor
92944517|NCT00612508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92944518|NCT00612508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92944519|NCT00612508|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92944520|NCT00612508|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92944521|NCT00612508|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92944523|NCT00881218|Regadenoson|regadenoson|mesh-list
92944524|NCT00881218|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92944525|NCT00881218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92944526|NCT00881218|Purinergic Agonists|purinergic agonists|mesh-ancestor
92944527|NCT00881218|Purinergic Agents|purinergic agents|mesh-ancestor
92944528|NCT00881218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944529|NCT00881218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944530|NCT00881218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944531|NCT00613834|Lidocaine|lidocaine|mesh-list
92944532|NCT00613834|Anesthetics, Local|anesthetics, local|mesh-ancestor
92944533|NCT00613834|Anesthetics|anesthetics|mesh-ancestor
92944534|NCT00613834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944535|NCT00613834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944536|NCT00613834|Sensory System Agents|sensory system agents|mesh-ancestor
92944537|NCT00613834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944538|NCT00613834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92944539|NCT00613834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92944540|NCT00613834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92944541|NCT00613834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944542|NCT00613834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944543|NCT00875368|Maraviroc|maraviroc|mesh-list
92944544|NCT00875368|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92944545|NCT00875368|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92944546|NCT00875368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944547|NCT00875368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92944548|NCT00875368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92944549|NCT00875368|Antiviral Agents|antiviral agents|mesh-ancestor
92944550|NCT00875368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944551|NCT00875368|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92944552|NCT03912298|Analgesics, Opioid|analgesics, opioid|mesh-list
92944553|NCT03912298|Narcotics|narcotics|mesh-ancestor
92944554|NCT03912298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944555|NCT03912298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944556|NCT03912298|Analgesics|analgesics|mesh-ancestor
92944557|NCT03912298|Sensory System Agents|sensory system agents|mesh-ancestor
92944558|NCT03912298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944560|NCT02543710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944561|NCT00884260|Levonorgestrel|levonorgestrel|mesh-list
92944562|NCT00884260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92944563|NCT00884260|Contraceptive Agents|contraceptive agents|mesh-ancestor
92944564|NCT00884260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92944565|NCT00884260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944566|NCT00884260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92944567|NCT00884260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92944568|NCT00884260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92944569|NCT00881296|Carboplatin|carboplatin|mesh-list
92944570|NCT00881296|Gemcitabine|gemcitabine|mesh-list
92944571|NCT00881296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944572|NCT00881296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944573|NCT00881296|Antimetabolites|antimetabolites|mesh-ancestor
92944574|NCT00881296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944575|NCT00613366|Misoprostol|misoprostol|mesh-list
92944576|NCT00613366|Magnesium Oxide|magnesium oxide|mesh-list
92944577|NCT00613366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92944578|NCT00613366|Abortifacient Agents|abortifacient agents|mesh-ancestor
92944579|NCT00613366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92944580|NCT00613366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944581|NCT00613366|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92944582|NCT00613366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944583|NCT00613366|Oxytocics|oxytocics|mesh-ancestor
92944584|NCT00613366|Antacids|antacids|mesh-ancestor
92944585|NCT00613366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944586|NCT00612352|Ethanol|ethanol|mesh-list
92944587|NCT00612352|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92944588|NCT00612352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944589|NCT00612352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944590|NCT00612352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944591|NCT00884416|Sorafenib|sorafenib|mesh-list
92164813|NCT04125745|CXA-10|cxa-10|mesh-list
92944592|NCT00884416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944593|NCT00884416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92944594|NCT00884416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944595|NCT00884416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944597|NCT00884494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92944598|NCT00884494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944599|NCT00881686|Adenosine|adenosine|mesh-list
92944600|NCT00881686|Analgesics|analgesics|mesh-ancestor
92944601|NCT00881686|Sensory System Agents|sensory system agents|mesh-ancestor
92944602|NCT00881686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944603|NCT00881686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944604|NCT00881686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92944605|NCT00881686|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944606|NCT00881686|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92944607|NCT00881686|Purinergic Agonists|purinergic agonists|mesh-ancestor
92944608|NCT00881686|Purinergic Agents|purinergic agents|mesh-ancestor
92944609|NCT00881686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944610|NCT00881686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944611|NCT00885508|Lenalidomide|lenalidomide|mesh-list
92944612|NCT00885508|Immunologic Factors|immunologic factors|mesh-ancestor
92944613|NCT00885508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944614|NCT00885508|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944615|NCT00885508|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944616|NCT00885508|Growth Substances|growth substances|mesh-ancestor
92944617|NCT00885508|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944618|NCT00885508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944619|NCT02543086|Piperaquine|piperaquine|mesh-list
92944620|NCT02543086|Antimalarials|antimalarials|mesh-ancestor
92944621|NCT02543086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92944622|NCT02543086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92944623|NCT02543086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944625|NCT00885586|Analgesics|analgesics|mesh-ancestor
92944626|NCT00885586|Sensory System Agents|sensory system agents|mesh-ancestor
92944627|NCT00885586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944628|NCT00885586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944629|NCT00885586|Anticonvulsants|anticonvulsants|mesh-ancestor
92944630|NCT00885586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92944631|NCT00885586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92944632|NCT00885586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944633|NCT00885586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92944634|NCT00885586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92944635|NCT00885586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92944636|NCT00885586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944637|NCT00885586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944638|NCT00885586|Antimanic Agents|antimanic agents|mesh-ancestor
92944639|NCT02542930|Thymalfasin|thymalfasin|mesh-list
92944640|NCT02542930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92944641|NCT02542930|Immunologic Factors|immunologic factors|mesh-ancestor
92944642|NCT02542930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944643|NCT00881764|Anesthetics|anesthetics|mesh-list
92944644|NCT00881764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944645|NCT00881764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944646|NCT04038034|Coenzyme Q10|coenzyme q10|mesh-list
92944647|NCT04038034|Vitamins|vitamins|mesh-ancestor
92944648|NCT04038034|Micronutrients|micronutrients|mesh-ancestor
92944649|NCT04038034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944650|NCT04037878|Tramadol|tramadol|mesh-list
92944651|NCT04037878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92944652|NCT04037878|Narcotics|narcotics|mesh-ancestor
92944653|NCT04037878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944654|NCT04037878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944655|NCT04037878|Analgesics|analgesics|mesh-ancestor
92944656|NCT04037878|Sensory System Agents|sensory system agents|mesh-ancestor
92944657|NCT04037878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944658|NCT02542852|Ritonavir|ritonavir|mesh-list
92944659|NCT02542852|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92944660|NCT02542852|Dolutegravir|dolutegravir|mesh-list
92944661|NCT02542852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92944662|NCT02542852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92944663|NCT02542852|Protease Inhibitors|protease inhibitors|mesh-ancestor
92944664|NCT02542852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164815|NCT04393805|Heparin|heparin|mesh-list
92944665|NCT02542852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944666|NCT02542852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92944667|NCT02542852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92944668|NCT02542852|Antiviral Agents|antiviral agents|mesh-ancestor
92944669|NCT02542852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944670|NCT02542852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92944671|NCT02542852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92944672|NCT02542852|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92944673|NCT02542852|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92944674|NCT00651261|Cytarabine|cytarabine|mesh-list
92944675|NCT00651261|Dexamethasone|dexamethasone|mesh-list
92944676|NCT00651261|Dexamethasone acetate|dexamethasone acetate|mesh-list
92944677|NCT00651261|Daunorubicin|daunorubicin|mesh-list
92944678|NCT00651261|Midostaurin|midostaurin|mesh-list
92944679|NCT00651261|BB 1101|bb 1101|mesh-list
92944680|NCT00651261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944681|NCT00651261|Antiemetics|antiemetics|mesh-ancestor
92944682|NCT00651261|Autonomic Agents|autonomic agents|mesh-ancestor
92944683|NCT00651261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944684|NCT00651261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944685|NCT00651261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944686|NCT00651261|Glucocorticoids|glucocorticoids|mesh-ancestor
92944687|NCT00651261|Hormones|hormones|mesh-ancestor
92944688|NCT00651261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944689|NCT00651261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92944690|NCT00651261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944691|NCT00651261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944692|NCT00651261|Antimetabolites|antimetabolites|mesh-ancestor
92944693|NCT00651261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944694|NCT00651261|Antiviral Agents|antiviral agents|mesh-ancestor
92944695|NCT00651261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944696|NCT00651261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944697|NCT00651261|Immunologic Factors|immunologic factors|mesh-ancestor
92944698|NCT00651261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92944699|NCT00651261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92944700|NCT00651261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92944701|NCT00651261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944702|NCT00651261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92944703|NCT00651261|Protease Inhibitors|protease inhibitors|mesh-ancestor
92944704|NCT00885820|Prednisone|prednisone|mesh-list
92944705|NCT00885820|Methylprednisolone|methylprednisolone|mesh-list
92944706|NCT00885820|Tacrolimus|tacrolimus|mesh-list
92944707|NCT00885820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944708|NCT00885820|Glucocorticoids|glucocorticoids|mesh-ancestor
92944709|NCT00885820|Hormones|hormones|mesh-ancestor
92944710|NCT00885820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944711|NCT00885820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944712|NCT00885820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92944713|NCT00885820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944714|NCT00885820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944715|NCT00885820|Immunologic Factors|immunologic factors|mesh-ancestor
92944716|NCT00885820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92944717|NCT00885820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944718|NCT00885820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944719|NCT00885820|Antiemetics|antiemetics|mesh-ancestor
92944720|NCT00885820|Autonomic Agents|autonomic agents|mesh-ancestor
92944721|NCT00885820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944722|NCT00885820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944723|NCT00885820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92944724|NCT00885820|Protective Agents|protective agents|mesh-ancestor
92944725|NCT02567838|Lidocaine|lidocaine|mesh-list
92944726|NCT02567838|Anesthetics, Local|anesthetics, local|mesh-ancestor
92944727|NCT02567838|Anesthetics|anesthetics|mesh-ancestor
92944728|NCT02567838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944729|NCT02567838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944730|NCT02567838|Sensory System Agents|sensory system agents|mesh-ancestor
92944731|NCT02567838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944732|NCT02567838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92944733|NCT02567838|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92944734|NCT02567838|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92944735|NCT02567838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92944736|NCT02567838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944737|NCT00651183|Pramipexole|pramipexole|mesh-list
92944738|NCT00651183|Antioxidants|antioxidants|mesh-ancestor
92944739|NCT00651183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944740|NCT00651183|Protective Agents|protective agents|mesh-ancestor
92944741|NCT00651183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944742|NCT00651183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92944743|NCT00651183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92944744|NCT00651183|Dopamine Agonists|dopamine agonists|mesh-ancestor
92944745|NCT00651183|Dopamine Agents|dopamine agents|mesh-ancestor
92944746|NCT00651183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944748|NCT00810381|Isosorbide|isosorbide|mesh-list
92944749|NCT00810381|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92944750|NCT00810381|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92944751|NCT00810381|Nitroglycerin|nitroglycerin|mesh-list
92944752|NCT00810381|Vasodilator Agents|vasodilator agents|mesh-ancestor
92944753|NCT00810381|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92944754|NCT00810381|Diuretics|diuretics|mesh-ancestor
92944755|NCT00810381|Natriuretic Agents|natriuretic agents|mesh-ancestor
92944756|NCT00810381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944757|NCT00810381|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92944758|NCT00810381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944759|NCT00810381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92944760|NCT00800319|ALKS-33|alks-33|mesh-list
92944761|NCT00800319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92944762|NCT00800319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944763|NCT00800319|Sensory System Agents|sensory system agents|mesh-ancestor
92944764|NCT00800319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944765|NCT00813501|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92944766|NCT00813501|Immunologic Factors|immunologic factors|mesh-ancestor
92944767|NCT00813501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944768|NCT00800475|Gemfibrozil|gemfibrozil|mesh-list
92944769|NCT00800475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92944770|NCT00800475|Antimetabolites|antimetabolites|mesh-ancestor
92944771|NCT00800475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944772|NCT00800475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92944773|NCT00800475|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92944774|NCT00800475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92944775|NCT00800475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944776|NCT00810849|Prednisolone|prednisolone|mesh-list
92944777|NCT00810849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944778|NCT00810849|Glucocorticoids|glucocorticoids|mesh-ancestor
92944779|NCT00810849|Hormones|hormones|mesh-ancestor
92944780|NCT00810849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944781|NCT00810849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944782|NCT00810849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92944783|NCT00810849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944784|NCT00811005|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
92944785|NCT00811005|Methoxsalen|methoxsalen|mesh-list
92944786|NCT00811005|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92944787|NCT00811005|Dermatologic Agents|dermatologic agents|mesh-ancestor
92944788|NCT00811005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944789|NCT00813735|Dexetimide|dexetimide|mesh-list
92944790|NCT00813735|Eszopiclone|eszopiclone|mesh-list
92944791|NCT00813735|Citalopram|citalopram|mesh-list
92944792|NCT00813735|Escitalopram|escitalopram|mesh-list
92944793|NCT00813735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92944794|NCT00813735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92944796|NCT00813735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944797|NCT00813735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944798|NCT00813735|Serotonin Agents|serotonin agents|mesh-ancestor
92944799|NCT00813735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944800|NCT00813735|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92944801|NCT00813735|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92944802|NCT00813735|Parasympatholytics|parasympatholytics|mesh-ancestor
92944803|NCT00813735|Autonomic Agents|autonomic agents|mesh-ancestor
92944804|NCT00813735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944805|NCT00813735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92944806|NCT00813735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92944807|NCT00813735|Cholinergic Agents|cholinergic agents|mesh-ancestor
92944808|NCT00813735|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92944809|NCT00813735|Antidepressive Agents|antidepressive agents|mesh-ancestor
92944810|NCT00813735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92944811|NCT00813735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92944812|NCT00813735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92944813|NCT00811083|Succimer|succimer|mesh-list
92944814|NCT00811083|Antidotes|antidotes|mesh-ancestor
92944815|NCT00811083|Protective Agents|protective agents|mesh-ancestor
92944816|NCT00811083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944817|NCT00811083|Chelating Agents|chelating agents|mesh-ancestor
92944818|NCT00811083|Sequestering Agents|sequestering agents|mesh-ancestor
92944819|NCT00811083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944820|NCT00642759|Paclitaxel|paclitaxel|mesh-list
92944821|NCT00642759|Bevacizumab|bevacizumab|mesh-list
92944822|NCT00642759|Carboplatin|carboplatin|mesh-list
92944823|NCT00642759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92944824|NCT00642759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944825|NCT00642759|Tubulin Modulators|tubulin modulators|mesh-ancestor
92944826|NCT00642759|Antimitotic Agents|antimitotic agents|mesh-ancestor
92944827|NCT00642759|Mitosis Modulators|mitosis modulators|mesh-ancestor
92944828|NCT00642759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944829|NCT00642759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944830|NCT00642759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944831|NCT00642759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944832|NCT00642759|Growth Substances|growth substances|mesh-ancestor
92944833|NCT00642759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944834|NCT00642759|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944835|NCT00813891|Ranibizumab|ranibizumab|mesh-list
92944836|NCT00813891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92944837|NCT00813891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92944838|NCT00813891|Growth Substances|growth substances|mesh-ancestor
92944839|NCT00813891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944840|NCT00813891|Growth Inhibitors|growth inhibitors|mesh-ancestor
92944841|NCT00813891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944842|NCT00817557|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92944843|NCT00817557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92944844|NCT00611026|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92944846|NCT00611026|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92944847|NCT00611026|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92944848|NCT00611026|Cholinergic Agents|cholinergic agents|mesh-ancestor
92944849|NCT00611026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944850|NCT00611026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944851|NCT00611026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944852|NCT00611026|Urological Agents|urological agents|mesh-ancestor
92944853|NCT02552589|Fluorides|fluorides|mesh-list
92944854|NCT02552589|Fluorophosphate|fluorophosphate|mesh-list
92944855|NCT02552589|Cariostatic Agents|cariostatic agents|mesh-ancestor
92944856|NCT02552589|Protective Agents|protective agents|mesh-ancestor
92944857|NCT02552589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944858|NCT00811239|Antivenins|antivenins|mesh-list
92944859|NCT00811239|Immunologic Factors|immunologic factors|mesh-ancestor
92944860|NCT00811239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944861|NCT00814047|Yohimbine|yohimbine|mesh-list
92944862|NCT00814047|Mydriatics|mydriatics|mesh-ancestor
92944863|NCT00814047|Autonomic Agents|autonomic agents|mesh-ancestor
92944864|NCT00814047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944865|NCT00814047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944866|NCT00814047|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92944867|NCT00814047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92944868|NCT00814047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92944869|NCT00814047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92944870|NCT00814047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92944871|NCT00814047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944872|NCT00814047|Urological Agents|urological agents|mesh-ancestor
92944873|NCT00814125|Tamoxifen|tamoxifen|mesh-list
92944874|NCT00814125|Anastrozole|anastrozole|mesh-list
92944875|NCT00814125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92944876|NCT00814125|Hormone Antagonists|hormone antagonists|mesh-ancestor
92944877|NCT00814125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944878|NCT00814125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944879|NCT00814125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92944880|NCT00814125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944881|NCT00814125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92944882|NCT00814125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92944883|NCT00814125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92944884|NCT00814125|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92944885|NCT00814125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92944886|NCT00814125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944887|NCT00814125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944888|NCT00817713|Ivermectin|ivermectin|mesh-list
92944889|NCT00817713|Albendazole|albendazole|mesh-list
92944890|NCT00817713|Praziquantel|praziquantel|mesh-list
92944891|NCT00817713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92944892|NCT00817713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944893|NCT00817713|Anthelmintics|anthelmintics|mesh-ancestor
92944894|NCT00817713|Anticestodal Agents|anticestodal agents|mesh-ancestor
92944895|NCT00817713|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92944896|NCT00817713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92944897|NCT00817713|Tubulin Modulators|tubulin modulators|mesh-ancestor
92944898|NCT00817713|Antimitotic Agents|antimitotic agents|mesh-ancestor
92944899|NCT00817713|Mitosis Modulators|mitosis modulators|mesh-ancestor
92944900|NCT00817713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944901|NCT00817713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944903|NCT00422383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92944904|NCT00422383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944905|NCT00422383|Immunologic Factors|immunologic factors|mesh-ancestor
92944906|NCT00422383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944907|NCT00422383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92944908|NCT00814281|Montelukast|montelukast|mesh-list
92944909|NCT00814281|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92944910|NCT00814281|Respiratory System Agents|respiratory system agents|mesh-ancestor
92944911|NCT00814281|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92944912|NCT00814281|Hormone Antagonists|hormone antagonists|mesh-ancestor
92944913|NCT00814281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92944914|NCT00814281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944915|NCT00814281|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92944916|NCT00814281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92944917|NCT00814281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944918|NCT00814359|Benzydamine|benzydamine|mesh-list
92944919|NCT00814359|Sucralfate|sucralfate|mesh-list
92944920|NCT00814359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944921|NCT00814359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92944922|NCT00814359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944923|NCT00612040|Insulin|insulin|mesh-list
92944924|NCT00612040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92944925|NCT00612040|Insulin Glargine|insulin glargine|mesh-list
92944926|NCT00612040|Insulin Aspart|insulin aspart|mesh-list
92944927|NCT00612040|Insulin, Long-Acting|insulin, long-acting|mesh-list
92944928|NCT00612040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92944929|NCT00612040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944930|NCT00422227|Hydroxychloroquine|hydroxychloroquine|mesh-list
92944931|NCT00422227|Sulfasalazine|sulfasalazine|mesh-list
92944932|NCT00422227|Etanercept|etanercept|mesh-list
92944933|NCT00422227|Methotrexate|methotrexate|mesh-list
92944934|NCT00422227|Leflunomide|leflunomide|mesh-list
92944935|NCT00422227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92944936|NCT00422227|Abortifacient Agents|abortifacient agents|mesh-ancestor
92944937|NCT00422227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92944938|NCT00422227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944939|NCT00422227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92944940|NCT00422227|Antimetabolites|antimetabolites|mesh-ancestor
92944941|NCT00422227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944942|NCT00422227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944943|NCT00422227|Dermatologic Agents|dermatologic agents|mesh-ancestor
92944944|NCT00422227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944945|NCT00422227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92944946|NCT00422227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944947|NCT00422227|Immunologic Factors|immunologic factors|mesh-ancestor
92944948|NCT00422227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92944949|NCT00422227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92944950|NCT00422227|Antimalarials|antimalarials|mesh-ancestor
92944951|NCT00422227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92944952|NCT00422227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92944953|NCT00422227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944954|NCT00422227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92944955|NCT00422227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92944956|NCT00422227|Analgesics|analgesics|mesh-ancestor
92944957|NCT00422227|Sensory System Agents|sensory system agents|mesh-ancestor
92164831|NCT04122755|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92944958|NCT00422227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944959|NCT00422227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944960|NCT00422227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92944961|NCT00811785|Copper|copper|mesh-list
92944962|NCT00811785|Trace Elements|trace elements|mesh-ancestor
92944963|NCT00811785|Micronutrients|micronutrients|mesh-ancestor
92944964|NCT00811785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944965|NCT00814515|Cyclosporine|cyclosporine|mesh-list
92944966|NCT00814515|Cyclosporins|cyclosporins|mesh-list
92944967|NCT00814515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92944968|NCT00814515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590369|NCT05543629|Nivolumab|nivolumab|mesh-list
92944969|NCT00814515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92944970|NCT00814515|Immunologic Factors|immunologic factors|mesh-ancestor
92944971|NCT00814515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944972|NCT00814515|Antifungal Agents|antifungal agents|mesh-ancestor
92944973|NCT00814515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92944974|NCT00814515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92944975|NCT00814515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92944976|NCT00814515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92944977|NCT00814593|Carmustine|carmustine|mesh-list
92944978|NCT00814593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92944979|NCT00814593|Alkylating Agents|alkylating agents|mesh-ancestor
92944980|NCT00814593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92944981|NCT00814593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92944982|NCT00421993|Adapalene|adapalene|mesh-list
92944983|NCT00421993|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92944984|NCT00421993|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92944985|NCT00421993|Dermatologic Agents|dermatologic agents|mesh-ancestor
92944986|NCT00421993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92944987|NCT00421993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92944988|NCT00421993|Analgesics|analgesics|mesh-ancestor
92944989|NCT00421993|Sensory System Agents|sensory system agents|mesh-ancestor
92944990|NCT00421993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92944991|NCT00421993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92944992|NCT00421993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92944993|NCT00421993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92944995|NCT00884884|Aripiprazole|aripiprazole|mesh-list
92944996|NCT00884884|Antidepressive Agents|antidepressive agents|mesh-ancestor
92944997|NCT00884884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92944998|NCT00884884|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92944999|NCT00884884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92945000|NCT00884884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945001|NCT00884884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945002|NCT00884884|Dopamine Agonists|dopamine agonists|mesh-ancestor
92945003|NCT00884884|Dopamine Agents|dopamine agents|mesh-ancestor
92945004|NCT00884884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945005|NCT00884884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945006|NCT00884884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92945007|NCT00884884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92945008|NCT00884884|Serotonin Agents|serotonin agents|mesh-ancestor
92945009|NCT00884884|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92945010|NCT00884884|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92945011|NCT00884884|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92945012|NCT00884884|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92945013|NCT00884884|Anticonvulsants|anticonvulsants|mesh-ancestor
92945014|NCT00884884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92945015|NCT01037725|Oxazolidinones|oxazolidinones|mesh-list
92945016|NCT01037725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945017|NCT01037725|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92945018|NCT01037725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945019|NCT01037725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945020|NCT02551029|Capsaicin|capsaicin|mesh-list
92945021|NCT02551029|Antipruritics|antipruritics|mesh-ancestor
92945022|NCT02551029|Dermatologic Agents|dermatologic agents|mesh-ancestor
92945023|NCT02551029|Sensory System Agents|sensory system agents|mesh-ancestor
92945024|NCT02551029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945025|NCT02551029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945026|NCT00812019|Vaccines|vaccines|mesh-list
92945027|NCT00812019|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92945028|NCT00812019|Immunologic Factors|immunologic factors|mesh-ancestor
92945029|NCT00812019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945030|NCT00812019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92945031|NCT00413959|Dexamethasone|dexamethasone|mesh-list
92945032|NCT00413959|Cyclophosphamide|cyclophosphamide|mesh-list
92945033|NCT00413959|Rituximab|rituximab|mesh-list
92945034|NCT00413959|Bortezomib|bortezomib|mesh-list
92945035|NCT00413959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945036|NCT00413959|Immunologic Factors|immunologic factors|mesh-ancestor
92945037|NCT00413959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945038|NCT00413959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945039|NCT00413959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92945040|NCT00413959|Alkylating Agents|alkylating agents|mesh-ancestor
92945041|NCT00413959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945042|NCT00413959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945043|NCT00413959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92945044|NCT00413959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945045|NCT00413959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92945046|NCT00413959|Antiemetics|antiemetics|mesh-ancestor
92945047|NCT00413959|Autonomic Agents|autonomic agents|mesh-ancestor
92590455|NCT05408429|Vaccines|vaccines|mesh-list
92945048|NCT00413959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945049|NCT00413959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945050|NCT00413959|Glucocorticoids|glucocorticoids|mesh-ancestor
92945051|NCT00413959|Hormones|hormones|mesh-ancestor
92945052|NCT00413959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945053|NCT00413959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92945054|NCT00814905|Clindamycin|clindamycin|mesh-list
92945055|NCT00814905|Clindamycin palmitate|clindamycin palmitate|mesh-list
92945056|NCT00814905|Clindamycin phosphate|clindamycin phosphate|mesh-list
92945057|NCT00814905|Gentamicins|gentamicins|mesh-list
92945058|NCT00814905|Ampicillin|ampicillin|mesh-list
92945059|NCT00814905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945060|NCT00814905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945061|NCT00814905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92945062|NCT00814905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945063|NCT00814905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945064|NCT00611884|Insulin|insulin|mesh-list
92945065|NCT00611884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92945066|NCT00611884|Metformin|metformin|mesh-list
92945067|NCT00611884|Insulin Glargine|insulin glargine|mesh-list
92945068|NCT00611884|Insulin, Long-Acting|insulin, long-acting|mesh-list
92945069|NCT00611884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92945070|NCT00611884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945071|NCT00611806|Folic Acid|folic acid|mesh-list
92945072|NCT00611806|Vitamin B 12|vitamin b 12|mesh-list
92945073|NCT00611806|Hematinics|hematinics|mesh-ancestor
92945074|NCT00611806|Vitamin B Complex|vitamin b complex|mesh-ancestor
92945075|NCT00611806|Vitamins|vitamins|mesh-ancestor
92945076|NCT00611806|Micronutrients|micronutrients|mesh-ancestor
92945077|NCT00611806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945078|NCT00413413|Amlodipine|amlodipine|mesh-list
92945079|NCT00413413|Valsartan|valsartan|mesh-list
92945080|NCT00413413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945081|NCT00413413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92945082|NCT00413413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945083|NCT00413413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945084|NCT00413413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92945085|NCT00413413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945086|NCT00413413|Vasodilator Agents|vasodilator agents|mesh-ancestor
92945087|NCT00413413|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92945088|NCT00413413|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92945089|NCT00886132|Sunitinib|sunitinib|mesh-list
92945090|NCT00886132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945091|NCT00886132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92945092|NCT00886132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945093|NCT00886132|Growth Substances|growth substances|mesh-ancestor
92945094|NCT00886132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945095|NCT00886132|Growth Inhibitors|growth inhibitors|mesh-ancestor
92945096|NCT00886132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92945097|NCT00886132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945098|NCT00886132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945099|NCT01040455|Lansoprazole|lansoprazole|mesh-list
92945100|NCT01040455|Dexlansoprazole|dexlansoprazole|mesh-list
92945101|NCT01040455|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92945102|NCT01040455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945103|NCT01040455|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92945104|NCT01040455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945105|NCT01040455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945106|NCT01041235|Docetaxel|docetaxel|mesh-list
92945107|NCT01041235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945108|NCT01041235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92945109|NCT01041235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92945110|NCT01041235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92945111|NCT01041235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945113|NCT01041313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92945114|NCT01041313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92945115|NCT01041313|Dopamine Agents|dopamine agents|mesh-ancestor
92945116|NCT01041313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945117|NCT01041313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945118|NCT01041313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945119|NCT01041313|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92945120|NCT01041313|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92945121|NCT00610714|Paclitaxel|paclitaxel|mesh-list
92945122|NCT00610714|Carboplatin|carboplatin|mesh-list
92590524|NCT05376111|Venetoclax|venetoclax|mesh-list
92945123|NCT00610714|Saracatinib|saracatinib|mesh-list
92945125|NCT00610714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945126|NCT00610714|Tubulin Modulators|tubulin modulators|mesh-ancestor
92945127|NCT00610714|Antimitotic Agents|antimitotic agents|mesh-ancestor
92945128|NCT00610714|Mitosis Modulators|mitosis modulators|mesh-ancestor
92945129|NCT00610714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945130|NCT00610714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945131|NCT00403585|Adefovir|adefovir|mesh-list
92945132|NCT00403585|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92945133|NCT00403585|Antiviral Agents|antiviral agents|mesh-ancestor
92945134|NCT00403585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945135|NCT00403585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92945136|NCT00403585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92945137|NCT00403585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945138|NCT00403585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945139|NCT00645411|Vaccines|vaccines|mesh-list
92945140|NCT00645411|Immunologic Factors|immunologic factors|mesh-ancestor
92945141|NCT00645411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945142|NCT00403273|Botulinum Toxins|botulinum toxins|mesh-list
92945143|NCT00403273|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92945144|NCT00403273|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92945145|NCT00403273|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92945146|NCT00403273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945147|NCT00403273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945148|NCT00403273|Cholinergic Agents|cholinergic agents|mesh-ancestor
92945149|NCT00403273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945150|NCT00403273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945151|NCT00403273|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92945152|NCT00403273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945153|NCT00885274|Magnesium Oxide|magnesium oxide|mesh-list
92945154|NCT00885274|Citric Acid|citric acid|mesh-list
92945155|NCT00885274|Antacids|antacids|mesh-ancestor
92945156|NCT00885274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945157|NCT00885274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945158|NCT00885274|Anticoagulants|anticoagulants|mesh-ancestor
92945159|NCT00885274|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92945160|NCT00885274|Chelating Agents|chelating agents|mesh-ancestor
92945161|NCT00885274|Sequestering Agents|sequestering agents|mesh-ancestor
92945162|NCT00402727|Amoxicillin|amoxicillin|mesh-list
92945163|NCT00402727|Moxifloxacin|moxifloxacin|mesh-list
92945164|NCT00402727|Tazobactam|tazobactam|mesh-list
92945165|NCT00402727|Piperacillin|piperacillin|mesh-list
92945166|NCT00402727|Clavulanic Acids|clavulanic acids|mesh-list
92945167|NCT00402727|Clavulanic Acid|clavulanic acid|mesh-list
92945168|NCT00402727|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92945169|NCT00402727|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92945170|NCT00402727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945171|NCT00402727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945172|NCT00402727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92945173|NCT00402727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92945174|NCT00402727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945175|NCT00402727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164841|NCT04129697|Antiemetics|antiemetics|mesh-ancestor
92945176|NCT00402727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945177|NCT00402727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92945178|NCT00402727|Contraceptive Agents|contraceptive agents|mesh-ancestor
92945179|NCT00402727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92945180|NCT00402727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945181|NCT00402727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92945182|NCT00402727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92945183|NCT00402727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92945184|NCT00402727|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92945185|NCT00923494|Ropivacaine|ropivacaine|mesh-list
92945186|NCT00923494|Anesthetics, Local|anesthetics, local|mesh-ancestor
92945187|NCT00923494|Anesthetics|anesthetics|mesh-ancestor
92945188|NCT00923494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945189|NCT00923494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945190|NCT00923494|Sensory System Agents|sensory system agents|mesh-ancestor
92945191|NCT00923494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945192|NCT00888784|Propranolol|propranolol|mesh-list
92945193|NCT00888784|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92945194|NCT00888784|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92945195|NCT00888784|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945196|NCT00888784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590622|NCT05222971|Durvalumab|durvalumab|mesh-list
92945197|NCT00888784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945198|NCT00888784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945199|NCT00888784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945200|NCT00888784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945201|NCT00888784|Vasodilator Agents|vasodilator agents|mesh-ancestor
92945202|NCT00886678|Carboplatin|carboplatin|mesh-list
92945203|NCT00886678|Pemetrexed|pemetrexed|mesh-list
92945204|NCT00886678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945205|NCT00886678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945206|NCT00886678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945207|NCT00886678|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92945208|NCT00886678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92945209|NCT00402337|Linaclotide|linaclotide|mesh-list
92945210|NCT00402337|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92945211|NCT00402337|Enzyme Activators|enzyme activators|mesh-ancestor
92945212|NCT00402337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945213|NCT00402337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945214|NCT00888862|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92945215|NCT00888862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92945216|NCT00888862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92945217|NCT00888862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945218|NCT00888862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945219|NCT00888862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945220|NCT00888862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945221|NCT00888862|Antidepressive Agents|antidepressive agents|mesh-ancestor
92945222|NCT00888862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92945223|NCT00886990|Ritonavir|ritonavir|mesh-list
92945224|NCT00886990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92945225|NCT00886990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92945226|NCT00886990|Protease Inhibitors|protease inhibitors|mesh-ancestor
92945227|NCT00886990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945228|NCT00886990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945229|NCT00886990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92945230|NCT00886990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92945231|NCT00886990|Antiviral Agents|antiviral agents|mesh-ancestor
92526905|NCT00030511|Fluorouracil|fluorouracil|mesh-list
92945232|NCT00886990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945233|NCT00886990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92945234|NCT00886990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92945235|NCT00650091|Acetylcysteine|acetylcysteine|mesh-list
92945236|NCT00650091|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92945237|NCT00650091|Antiviral Agents|antiviral agents|mesh-ancestor
92945238|NCT00650091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945239|NCT00650091|Expectorants|expectorants|mesh-ancestor
92945240|NCT00650091|Respiratory System Agents|respiratory system agents|mesh-ancestor
92945241|NCT00650091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92945242|NCT00650091|Antioxidants|antioxidants|mesh-ancestor
92945243|NCT00650091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945244|NCT00650091|Protective Agents|protective agents|mesh-ancestor
92945245|NCT00650091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945246|NCT00650091|Antidotes|antidotes|mesh-ancestor
92945247|NCT00889018|Carboplatin|carboplatin|mesh-list
92945248|NCT00889018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945249|NCT00889096|Propranolol|propranolol|mesh-list
92945250|NCT00889096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92945251|NCT00889096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92945252|NCT00889096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945253|NCT00889096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945254|NCT00889096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945255|NCT00889096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945256|NCT00889096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945257|NCT00889096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945258|NCT00889096|Vasodilator Agents|vasodilator agents|mesh-ancestor
92945259|NCT00818103|Interferons|interferons|mesh-list
92945260|NCT00818103|Atorvastatin|atorvastatin|mesh-list
92945261|NCT00818103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945262|NCT00818103|Antiviral Agents|antiviral agents|mesh-ancestor
92945263|NCT00818103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945264|NCT00818103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92945265|NCT00818103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92945266|NCT00818103|Antimetabolites|antimetabolites|mesh-ancestor
92945267|NCT00818103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945268|NCT00818103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92945269|NCT00818103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92945270|NCT00818103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945272|NCT00642369|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92945273|NCT00642369|Haloperidol decanoate|haloperidol decanoate|mesh-list
92945274|NCT00642369|Antidepressive Agents|antidepressive agents|mesh-ancestor
92945275|NCT00642369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92945276|NCT00642369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92945277|NCT00642369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92945278|NCT00642369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945279|NCT00642369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945280|NCT00642369|Antiemetics|antiemetics|mesh-ancestor
92945281|NCT00642369|Autonomic Agents|autonomic agents|mesh-ancestor
92945282|NCT00642369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945283|NCT00642369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945284|NCT00642369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92945285|NCT00642369|Dopamine Agents|dopamine agents|mesh-ancestor
92945286|NCT00642369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945287|NCT00642369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945288|NCT00642369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92945289|NCT01154335|Everolimus|everolimus|mesh-list
92945290|NCT01154335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92945291|NCT01154335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92945292|NCT01154335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945293|NCT01154335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945294|NCT01154335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945295|NCT01154335|Immunologic Factors|immunologic factors|mesh-ancestor
92945296|NCT01154335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945297|NCT01154335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945298|NCT00889642|Lidocaine|lidocaine|mesh-list
92945299|NCT00889642|Epinephrine|epinephrine|mesh-list
92945300|NCT00889642|Racepinephrine|racepinephrine|mesh-list
92945301|NCT00889642|Epinephryl borate|epinephryl borate|mesh-list
92945302|NCT00889642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92945303|NCT00889642|Anesthetics|anesthetics|mesh-ancestor
92945304|NCT00889642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945305|NCT00889642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945306|NCT00889642|Sensory System Agents|sensory system agents|mesh-ancestor
92945307|NCT00889642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945308|NCT00889642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945309|NCT00889642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92945310|NCT00889642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92945311|NCT00889642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945312|NCT00889642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945313|NCT00889642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92945314|NCT00889642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92945315|NCT00889642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945316|NCT00889642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945317|NCT00889642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92945318|NCT00889642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92945319|NCT00889642|Autonomic Agents|autonomic agents|mesh-ancestor
92945320|NCT00889642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92945321|NCT00889642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92945322|NCT00889642|Mydriatics|mydriatics|mesh-ancestor
92945323|NCT00889642|Sympathomimetics|sympathomimetics|mesh-ancestor
92945324|NCT00889642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92945325|NCT02541526|Mirtazapine|mirtazapine|mesh-list
92945326|NCT02541526|Antidepressive Agents|antidepressive agents|mesh-ancestor
92945327|NCT02541526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92945328|NCT02541526|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92945329|NCT02541526|Histamine Antagonists|histamine antagonists|mesh-ancestor
92945330|NCT02541526|Histamine Agents|histamine agents|mesh-ancestor
92945331|NCT02541526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945332|NCT02541526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945333|NCT02541526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945334|NCT02541526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92945335|NCT02541526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92945336|NCT02541526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945337|NCT02541526|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92945338|NCT02541526|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92945339|NCT02541526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92945340|NCT02541526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945341|NCT02541526|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92945342|NCT02541526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92945343|NCT02541526|Serotonin Agents|serotonin agents|mesh-ancestor
92590742|NCT05049902|Antacids|antacids|mesh-ancestor
92945344|NCT02541526|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92945345|NCT01037959|Norfloxacin|norfloxacin|mesh-list
92945346|NCT01037959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945347|NCT01037959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945348|NCT01037959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92945349|NCT01037959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92945350|NCT01037959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945351|NCT01037959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945352|NCT01037959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945353|NCT01037959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92945354|NCT01037959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92945355|NCT01038037|Carboplatin|carboplatin|mesh-list
92945356|NCT01038037|Vinorelbine|vinorelbine|mesh-list
92945357|NCT01038037|Panitumumab|panitumumab|mesh-list
92945358|NCT01038037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945359|NCT01038037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92945360|NCT01038037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92945361|NCT01038037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92945362|NCT01038037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92945363|NCT01038037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945364|NCT01038037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945365|NCT00645099|Olanzapine|olanzapine|mesh-list
92945366|NCT00645099|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92945367|NCT00645099|Antiemetics|antiemetics|mesh-ancestor
92945368|NCT00645099|Autonomic Agents|autonomic agents|mesh-ancestor
92945369|NCT00645099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945370|NCT00645099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945371|NCT00645099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945372|NCT00645099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92945373|NCT00645099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92945374|NCT00645099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945375|NCT00645099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92945376|NCT00645099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92945377|NCT00645099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92945378|NCT00645099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945379|NCT00645099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945380|NCT00645099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945381|NCT00645099|Serotonin Agents|serotonin agents|mesh-ancestor
92945382|NCT00645099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92945383|NCT00645099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92945384|NCT00645099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92945385|NCT00645099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92945386|NCT00645099|Dopamine Agents|dopamine agents|mesh-ancestor
92945387|NCT04401982|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92945388|NCT04401982|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92945389|NCT01038349|Methotrexate|methotrexate|mesh-list
92945390|NCT01038349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92945391|NCT01038349|Abortifacient Agents|abortifacient agents|mesh-ancestor
92945392|NCT01038349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526966|NCT00000539|Vitamins|vitamins|mesh-list
92945393|NCT01038349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945394|NCT01038349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92945395|NCT01038349|Antimetabolites|antimetabolites|mesh-ancestor
92945396|NCT01038349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945397|NCT01038349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945398|NCT01038349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92945399|NCT01038349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945400|NCT01038349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92945401|NCT01038349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945402|NCT01038349|Immunologic Factors|immunologic factors|mesh-ancestor
92945403|NCT01038349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945404|NCT01038349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92945405|NCT00887770|Moxifloxacin|moxifloxacin|mesh-list
92945406|NCT00887770|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92945407|NCT00887770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945408|NCT00887770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945409|NCT00887770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92945410|NCT00887770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92945411|NCT00887770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945412|NCT00887770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945413|NCT00887770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945414|NCT00887770|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92945415|NCT00887770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92945416|NCT00887770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92945417|NCT00887770|Antiviral Agents|antiviral agents|mesh-ancestor
92945418|NCT01038505|Sirolimus|sirolimus|mesh-list
92945419|NCT01038505|Mycophenolic Acid|mycophenolic acid|mesh-list
92945420|NCT01038505|Tacrolimus|tacrolimus|mesh-list
92945421|NCT01038505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945422|NCT01038505|Immunologic Factors|immunologic factors|mesh-ancestor
92945423|NCT01038505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945424|NCT01038505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92945425|NCT01038505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945426|NCT01038505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945427|NCT01038505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945428|NCT01038505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945429|NCT01038505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92945430|NCT01038505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945431|NCT01038505|Antifungal Agents|antifungal agents|mesh-ancestor
92945432|NCT01038505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92945433|NCT01038505|Antitubercular Agents|antitubercular agents|mesh-ancestor
92945434|NCT01038583|Aspirin|aspirin|mesh-list
92945435|NCT01038583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92945436|NCT01038583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92945437|NCT01038583|Analgesics|analgesics|mesh-ancestor
92945438|NCT01038583|Sensory System Agents|sensory system agents|mesh-ancestor
92945439|NCT01038583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945440|NCT01038583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945441|NCT01038583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92945442|NCT01038583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945443|NCT01038583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92945444|NCT01038583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92945445|NCT01038583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945446|NCT01038583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92945447|NCT01038583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92945448|NCT01038583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945449|NCT01038583|Antipyretics|antipyretics|mesh-ancestor
92945450|NCT02551107|Nitric Oxide|nitric oxide|mesh-list
92945451|NCT02551107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92945452|NCT02551107|Autonomic Agents|autonomic agents|mesh-ancestor
92945453|NCT02551107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945454|NCT02551107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945455|NCT02551107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92945456|NCT02551107|Respiratory System Agents|respiratory system agents|mesh-ancestor
92945457|NCT02551107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92945458|NCT02551107|Antioxidants|antioxidants|mesh-ancestor
92945459|NCT02551107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945460|NCT02551107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945461|NCT02551107|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92945462|NCT02551107|Vasodilator Agents|vasodilator agents|mesh-ancestor
92945463|NCT02551107|Gasotransmitters|gasotransmitters|mesh-ancestor
92945464|NCT02551107|Protective Agents|protective agents|mesh-ancestor
92945465|NCT01038661|Docetaxel|docetaxel|mesh-list
92945466|NCT01038661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945467|NCT01038661|Tubulin Modulators|tubulin modulators|mesh-ancestor
92945468|NCT01038661|Antimitotic Agents|antimitotic agents|mesh-ancestor
92945469|NCT01038661|Mitosis Modulators|mitosis modulators|mesh-ancestor
92945470|NCT01038661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945471|NCT01038817|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92945472|NCT01038817|Cariostatic Agents|cariostatic agents|mesh-ancestor
92945473|NCT01038817|Protective Agents|protective agents|mesh-ancestor
92945474|NCT01038817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945475|NCT00420511|Metformin|metformin|mesh-list
92945476|NCT00420511|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92945477|NCT00420511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92945478|NCT00420511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945479|NCT00420511|Incretins|incretins|mesh-ancestor
92945480|NCT00420511|Hormones|hormones|mesh-ancestor
92945481|NCT00420511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945482|NCT00420511|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92945483|NCT00420511|Protease Inhibitors|protease inhibitors|mesh-ancestor
92945484|NCT00420511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945485|NCT00420511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945486|NCT01038895|Ramipril|ramipril|mesh-list
92945487|NCT01038895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92945488|NCT01038895|Protease Inhibitors|protease inhibitors|mesh-ancestor
92945489|NCT01038895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945490|NCT01038895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945491|NCT01038895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945493|NCT00420199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92945494|NCT00420199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945495|NCT00420199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945496|NCT00420199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945497|NCT00420199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945498|NCT00420199|Immunologic Factors|immunologic factors|mesh-ancestor
92945499|NCT00420199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945500|NCT00420199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945501|NCT00649389|Amlodipine|amlodipine|mesh-list
92945502|NCT00649389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92945503|NCT00649389|Olmesartan|olmesartan|mesh-list
92945504|NCT00649389|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92945505|NCT00649389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945506|NCT00649389|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92945507|NCT00649389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945508|NCT00649389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945509|NCT00649389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92945510|NCT00649389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945511|NCT00649389|Vasodilator Agents|vasodilator agents|mesh-ancestor
92945512|NCT00649389|Diuretics|diuretics|mesh-ancestor
92945513|NCT00649389|Natriuretic Agents|natriuretic agents|mesh-ancestor
92945514|NCT00649389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92945515|NCT00649389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92945516|NCT00649389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92945517|NCT00402103|Amlodipine|amlodipine|mesh-list
92945518|NCT00402103|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92945519|NCT00402103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945520|NCT00402103|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92945521|NCT00402103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526985|NCT00030979|Donepezil|donepezil|mesh-list
92945522|NCT00402103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945523|NCT00402103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92945524|NCT00402103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945525|NCT00402103|Vasodilator Agents|vasodilator agents|mesh-ancestor
92945527|NCT00402103|Natriuretic Agents|natriuretic agents|mesh-ancestor
92945528|NCT00402103|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92945529|NCT00812175|Sorafenib|sorafenib|mesh-list
92945530|NCT00812175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945531|NCT00812175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92945532|NCT00812175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945533|NCT00812175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945534|NCT00815373|Timolol|timolol|mesh-list
92945535|NCT00815373|Dorzolamide|dorzolamide|mesh-list
92945536|NCT00815373|Latanoprost|latanoprost|mesh-list
92945537|NCT00815373|Maleic acid|maleic acid|mesh-list
92945538|NCT00815373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945539|NCT00815373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945540|NCT00815373|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92945541|NCT00815373|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92945542|NCT00815373|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945543|NCT00815373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945544|NCT00815373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945545|NCT00815373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945546|NCT00815373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945547|NCT00815373|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92945548|NCT00815373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92945549|NCT00815373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92945550|NCT00641667|Fentanyl|fentanyl|mesh-list
92945551|NCT00641667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92945552|NCT00641667|Narcotics|narcotics|mesh-ancestor
92945553|NCT00641667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945554|NCT00641667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945555|NCT00641667|Analgesics|analgesics|mesh-ancestor
92945556|NCT00641667|Sensory System Agents|sensory system agents|mesh-ancestor
92945557|NCT00641667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945558|NCT00641667|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92945560|NCT00641667|Anesthetics, General|anesthetics, general|mesh-ancestor
92945561|NCT00641667|Anesthetics|anesthetics|mesh-ancestor
92945562|NCT00704184|Interferons|interferons|mesh-list
92945563|NCT00704184|Ribavirin|ribavirin|mesh-list
92945565|NCT00704184|Antiviral Agents|antiviral agents|mesh-ancestor
92945566|NCT00704184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945567|NCT00704184|Antimetabolites|antimetabolites|mesh-ancestor
92945568|NCT00704184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945569|NCT00641043|Pioglitazone|pioglitazone|mesh-list
92945570|NCT00641043|Linagliptin|linagliptin|mesh-list
92945571|NCT00641043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92945572|NCT00641043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945573|NCT00641043|Incretins|incretins|mesh-ancestor
92945574|NCT00641043|Hormones|hormones|mesh-ancestor
92945575|NCT00641043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945576|NCT00641043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92945577|NCT00641043|Protease Inhibitors|protease inhibitors|mesh-ancestor
92945578|NCT00641043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945579|NCT00641043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945580|NCT02567916|Propofol|propofol|mesh-list
92945581|NCT02567916|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92945582|NCT02567916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945583|NCT02567916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945584|NCT02567916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92945585|NCT02567916|Anesthetics, General|anesthetics, general|mesh-ancestor
92945586|NCT02567916|Anesthetics|anesthetics|mesh-ancestor
92945587|NCT00402025|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92945588|NCT00402025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945589|NCT00402025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945590|NCT00609622|Bevacizumab|bevacizumab|mesh-list
92945591|NCT00609622|Sunitinib|sunitinib|mesh-list
92945592|NCT00609622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945593|NCT00609622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945594|NCT00609622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92945595|NCT00609622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945596|NCT00609622|Growth Substances|growth substances|mesh-ancestor
92945597|NCT00609622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945598|NCT00609622|Growth Inhibitors|growth inhibitors|mesh-ancestor
92945599|NCT00609622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92945600|NCT00609622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945601|NCT00609622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945602|NCT00818415|Naproxen|naproxen|mesh-list
92945603|NCT00818415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92945604|NCT00818415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92945605|NCT00818415|Analgesics|analgesics|mesh-ancestor
92945606|NCT00818415|Sensory System Agents|sensory system agents|mesh-ancestor
92945607|NCT00818415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945608|NCT00818415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945609|NCT00818415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92945610|NCT00818415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945611|NCT00818415|Gout Suppressants|gout suppressants|mesh-ancestor
92945612|NCT00818415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92945613|NCT00818415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945614|NCT00818415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945615|NCT00815841|Methylphenidate|methylphenidate|mesh-list
92945616|NCT00815841|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92945617|NCT00815841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945618|NCT00815841|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92945619|NCT00815841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92945620|NCT00815841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945621|NCT00815841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945623|NCT00815841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945624|NCT03897192|Bevacizumab|bevacizumab|mesh-list
92945625|NCT03897192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945626|NCT03897192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945627|NCT03897192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92945628|NCT03897192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945629|NCT03897192|Growth Substances|growth substances|mesh-ancestor
92945630|NCT03897192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945631|NCT03897192|Growth Inhibitors|growth inhibitors|mesh-ancestor
92945632|NCT02567214|Glycopyrrolate|glycopyrrolate|mesh-list
92945633|NCT02567214|Tiotropium Bromide|tiotropium bromide|mesh-list
92945634|NCT02567214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92945635|NCT02567214|Autonomic Agents|autonomic agents|mesh-ancestor
92591048|NCT04684212|Warfarin|warfarin|mesh-list
92945636|NCT02567214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945637|NCT02567214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945638|NCT02567214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92945639|NCT02567214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92945640|NCT02567214|Parasympatholytics|parasympatholytics|mesh-ancestor
92945641|NCT02567214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92945642|NCT02567214|Cholinergic Agents|cholinergic agents|mesh-ancestor
92945643|NCT02567214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945644|NCT02567214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945645|NCT02567214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92945646|NCT02567214|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92945647|NCT00890110|Sunitinib|sunitinib|mesh-list
92945648|NCT00890110|Vaccines|vaccines|mesh-list
92945649|NCT00890110|Immunologic Factors|immunologic factors|mesh-ancestor
92945650|NCT00890110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945651|NCT00890110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945652|NCT00890110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92945653|NCT00890110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945654|NCT00890110|Growth Substances|growth substances|mesh-ancestor
92945655|NCT00890110|Growth Inhibitors|growth inhibitors|mesh-ancestor
92945656|NCT00890110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92945657|NCT00890110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945658|NCT00890110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945659|NCT02566824|Methylphenidate|methylphenidate|mesh-list
92945660|NCT02566824|Amphetamine|amphetamine|mesh-list
92945661|NCT02566824|Adderall|adderall|mesh-list
92945662|NCT02566824|Dextroamphetamine|dextroamphetamine|mesh-list
92945663|NCT02566824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92945664|NCT02566824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945665|NCT02566824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92945666|NCT02566824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92945667|NCT02566824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945668|NCT02566824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945669|NCT02566824|Dopamine Agents|dopamine agents|mesh-ancestor
92945670|NCT02566824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945671|NCT02566824|Sympathomimetics|sympathomimetics|mesh-ancestor
92945672|NCT02566824|Autonomic Agents|autonomic agents|mesh-ancestor
92945673|NCT02566824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945674|NCT02566824|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945675|NCT02566824|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92945676|NCT00890188|Thalidomide|thalidomide|mesh-list
92945677|NCT00890188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945678|NCT00890188|Immunologic Factors|immunologic factors|mesh-ancestor
92945679|NCT00890188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945680|NCT00890188|Leprostatic Agents|leprostatic agents|mesh-ancestor
92945681|NCT00890188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945682|NCT00890188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945683|NCT00890188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92945684|NCT00890188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945685|NCT00890188|Growth Substances|growth substances|mesh-ancestor
92945686|NCT00890188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92945687|NCT00890188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945688|NCT05388942|Nitrous Oxide|nitrous oxide|mesh-list
92945689|NCT05388942|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92945690|NCT05388942|Anesthetics, General|anesthetics, general|mesh-ancestor
92945691|NCT05388942|Anesthetics|anesthetics|mesh-ancestor
92945692|NCT05388942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945693|NCT05388942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945694|NCT05388942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92945695|NCT05388942|Analgesics|analgesics|mesh-ancestor
92945696|NCT05388942|Sensory System Agents|sensory system agents|mesh-ancestor
92945697|NCT05388942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945698|NCT04037566|Cyclophosphamide|cyclophosphamide|mesh-list
92945699|NCT04037566|Fludarabine|fludarabine|mesh-list
92945700|NCT04037566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945701|NCT04037566|Immunologic Factors|immunologic factors|mesh-ancestor
92945702|NCT04037566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945703|NCT04037566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945704|NCT04037566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92945705|NCT04037566|Alkylating Agents|alkylating agents|mesh-ancestor
92945706|NCT04037566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945707|NCT04037566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945708|NCT04037566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92945709|NCT00888082|Goserelin|goserelin|mesh-list
92945711|NCT00888082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945712|NCT00627705|Acetylcysteine|acetylcysteine|mesh-list
92945713|NCT00627705|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92945714|NCT00627705|Antiviral Agents|antiviral agents|mesh-ancestor
92945715|NCT00627705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945716|NCT00627705|Expectorants|expectorants|mesh-ancestor
92945717|NCT00627705|Respiratory System Agents|respiratory system agents|mesh-ancestor
92945718|NCT00627705|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92945719|NCT00627705|Antioxidants|antioxidants|mesh-ancestor
92945720|NCT00627705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945721|NCT00627705|Protective Agents|protective agents|mesh-ancestor
92945722|NCT00627705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945723|NCT00627705|Antidotes|antidotes|mesh-ancestor
92945724|NCT00610168|Vaccines|vaccines|mesh-list
92945725|NCT00610168|Immunologic Factors|immunologic factors|mesh-ancestor
92945726|NCT00610168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945727|NCT00921102|Atropine|atropine|mesh-list
92945728|NCT00921102|Morphine|morphine|mesh-list
92945729|NCT00921102|Bupivacaine|bupivacaine|mesh-list
92945730|NCT00921102|Anesthetics, Local|anesthetics, local|mesh-list
92945731|NCT00921102|Anesthetics|anesthetics|mesh-list
92945732|NCT00921102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945733|NCT00921102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945734|NCT00921102|Sensory System Agents|sensory system agents|mesh-ancestor
92945735|NCT00921102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945736|NCT00921102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92945737|NCT00921102|Narcotics|narcotics|mesh-ancestor
92945738|NCT00921102|Analgesics|analgesics|mesh-ancestor
92945739|NCT00921102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92945740|NCT00921102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945741|NCT00921102|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92945742|NCT00921102|Autonomic Agents|autonomic agents|mesh-ancestor
92945743|NCT00921102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92945744|NCT00921102|Respiratory System Agents|respiratory system agents|mesh-ancestor
92945745|NCT00921102|Mydriatics|mydriatics|mesh-ancestor
92945746|NCT00921102|Parasympatholytics|parasympatholytics|mesh-ancestor
92945747|NCT00921102|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92945748|NCT00921102|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92945749|NCT00921102|Cholinergic Agents|cholinergic agents|mesh-ancestor
92945750|NCT00921102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945751|NCT00921102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945752|NCT00890500|Sirolimus|sirolimus|mesh-list
92945753|NCT00890500|Fludarabine|fludarabine|mesh-list
92945754|NCT00890500|Melphalan|melphalan|mesh-list
92945755|NCT00890500|Tacrolimus|tacrolimus|mesh-list
92945756|NCT00890500|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92945757|NCT00890500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945758|NCT00890500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945759|NCT00890500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945760|NCT00890500|Immunologic Factors|immunologic factors|mesh-ancestor
92945761|NCT00890500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945762|NCT00890500|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92945763|NCT00890500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945764|NCT00890500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92945765|NCT00890500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945766|NCT00890500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92945767|NCT00890500|Antifungal Agents|antifungal agents|mesh-ancestor
92945768|NCT00890500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92945769|NCT00890500|Alkylating Agents|alkylating agents|mesh-ancestor
92945770|NCT00890500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92945771|NCT04061772|Prednisone|prednisone|mesh-list
92945772|NCT04061772|Cyclophosphamide|cyclophosphamide|mesh-list
92945773|NCT04061772|Etoposide|etoposide|mesh-list
92945774|NCT04061772|Bortezomib|bortezomib|mesh-list
92945775|NCT04061772|Epirubicin|epirubicin|mesh-list
92945776|NCT04061772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945777|NCT04061772|Immunologic Factors|immunologic factors|mesh-ancestor
92945778|NCT04061772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945779|NCT04061772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945780|NCT04061772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92945781|NCT04061772|Alkylating Agents|alkylating agents|mesh-ancestor
92945782|NCT04061772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945783|NCT04061772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945784|NCT04061772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92945785|NCT04061772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92945786|NCT04061772|Glucocorticoids|glucocorticoids|mesh-ancestor
92945787|NCT04061772|Hormones|hormones|mesh-ancestor
92945788|NCT04061772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945789|NCT04061772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92945790|NCT04061772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92945791|NCT04061772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92945792|NCT04061772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92945793|NCT04061772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945794|NCT04061772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92945795|NCT00644787|Fentanyl|fentanyl|mesh-list
92945796|NCT00644787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92945797|NCT00644787|Narcotics|narcotics|mesh-ancestor
92945798|NCT00644787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945799|NCT00644787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945800|NCT00644787|Analgesics|analgesics|mesh-ancestor
92945801|NCT00644787|Sensory System Agents|sensory system agents|mesh-ancestor
92945802|NCT00644787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945803|NCT00644787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92945804|NCT00644787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92945805|NCT00644787|Anesthetics, General|anesthetics, general|mesh-ancestor
92945806|NCT00644787|Anesthetics|anesthetics|mesh-ancestor
92945807|NCT00821301|Fluphenazine|fluphenazine|mesh-list
92945808|NCT00821301|Fluphenazine depot|fluphenazine depot|mesh-list
92945809|NCT00821301|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92945810|NCT00821301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92945811|NCT00821301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92945812|NCT00821301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92945813|NCT00821301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945814|NCT00821301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92945815|NCT00821301|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92945816|NCT00821301|Dopamine Agents|dopamine agents|mesh-ancestor
92945817|NCT00821301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945818|NCT00821301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945819|NCT00699348|Epoetin Alfa|epoetin alfa|mesh-list
92945820|NCT00699348|Hematinics|hematinics|mesh-ancestor
92945821|NCT00643851|Metformin|metformin|mesh-list
92945822|NCT00643851|Dapagliflozin|dapagliflozin|mesh-list
92945823|NCT00643851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92945824|NCT00643851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945825|NCT00643851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92945826|NCT00643851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945827|NCT00821457|Mitogens|mitogens|mesh-list
92945828|NCT00821457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92945829|NCT00821457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945830|NCT03667690|Fluconazole|fluconazole|mesh-list
92945831|NCT03667690|Caspofungin|caspofungin|mesh-list
92945832|NCT03667690|Rezafungin|rezafungin|mesh-list
92945833|NCT03667690|Antifungal Agents|antifungal agents|mesh-ancestor
92945834|NCT03667690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945835|NCT03667690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92945836|NCT03667690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92945837|NCT03667690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945838|NCT03667690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945839|NCT03667690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92945840|NCT03667690|Hormone Antagonists|hormone antagonists|mesh-ancestor
92527055|NCT00396058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945841|NCT03667690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945842|NCT03667690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945843|NCT03667690|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92945844|NCT03667690|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92945846|NCT00821535|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92945847|NCT00821535|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92945848|NCT00821535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945849|NCT00821535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92945850|NCT00821535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92945851|NCT00821535|Antiviral Agents|antiviral agents|mesh-ancestor
92945852|NCT00821535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945853|NCT00821535|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92945854|NCT04062006|Aldesleukin|aldesleukin|mesh-list
92945855|NCT04062006|Interleukin-2|interleukin-2|mesh-list
92945856|NCT04062006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945857|NCT04062006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92945858|NCT04062006|Analgesics|analgesics|mesh-ancestor
92945859|NCT04062006|Sensory System Agents|sensory system agents|mesh-ancestor
92945860|NCT04062006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945861|NCT04062006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945862|NCT04062006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92945863|NCT04062006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92945864|NCT04062006|Antiviral Agents|antiviral agents|mesh-ancestor
92945865|NCT04062006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945866|NCT04872582|Bevacizumab|bevacizumab|mesh-list
92945867|NCT04872582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92945868|NCT04872582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92945869|NCT04872582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945870|NCT04872582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92945871|NCT04872582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92945872|NCT04872582|Growth Substances|growth substances|mesh-ancestor
92945873|NCT04872582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945874|NCT04872582|Growth Inhibitors|growth inhibitors|mesh-ancestor
92945875|NCT04872582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945876|NCT04061538|Zinc|zinc|mesh-list
92945877|NCT04061538|Zinc Sulfate|zinc sulfate|mesh-list
92945878|NCT04061538|Trace Elements|trace elements|mesh-ancestor
92945879|NCT04061538|Micronutrients|micronutrients|mesh-ancestor
92945880|NCT04061538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945881|NCT04061538|Astringents|astringents|mesh-ancestor
92945882|NCT04061538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92945883|NCT04351620|Hydroxychloroquine|hydroxychloroquine|mesh-list
92945884|NCT04351620|Antimalarials|antimalarials|mesh-ancestor
92945885|NCT04351620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92945886|NCT04351620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92945887|NCT04351620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92945888|NCT04351620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945889|NCT04351620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945890|NCT04351620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945891|NCT00888394|Imidacloprid|imidacloprid|mesh-list
92945892|NCT00888394|Cholinergic Agents|cholinergic agents|mesh-ancestor
92945893|NCT00888394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945894|NCT00888394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945895|NCT00888394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945896|NCT02541760|Mometasone Furoate|mometasone furoate|mesh-list
92945897|NCT02541760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92945898|NCT02541760|Dermatologic Agents|dermatologic agents|mesh-ancestor
92945899|NCT02541760|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92945900|NCT00627393|Anti-Infective Agents|anti-infective agents|mesh-list
92945901|NCT00627393|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92945902|NCT00627393|Dexamethasone|dexamethasone|mesh-list
92945903|NCT00627393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92945904|NCT00627393|Antiemetics|antiemetics|mesh-ancestor
92945905|NCT00627393|Autonomic Agents|autonomic agents|mesh-ancestor
92945906|NCT00627393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945907|NCT00627393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945908|NCT00627393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945909|NCT00627393|Glucocorticoids|glucocorticoids|mesh-ancestor
92945910|NCT00627393|Hormones|hormones|mesh-ancestor
92945911|NCT00627393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945912|NCT00627393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92945913|NCT00627393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945914|NCT00577122|Cyclophosphamide|cyclophosphamide|mesh-list
92945915|NCT00577122|Methotrexate|methotrexate|mesh-list
92945916|NCT00577122|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92945917|NCT00577122|Medroxyprogesterone|medroxyprogesterone|mesh-list
92945918|NCT00577122|Progesterone|progesterone|mesh-list
92945919|NCT00577122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92945920|NCT00577122|Immunologic Factors|immunologic factors|mesh-ancestor
92945921|NCT00577122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945922|NCT00577122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92945923|NCT00577122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92945924|NCT00577122|Alkylating Agents|alkylating agents|mesh-ancestor
92945925|NCT00577122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945926|NCT00577122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945927|NCT00577122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92945928|NCT00577122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92945929|NCT00577122|Abortifacient Agents|abortifacient agents|mesh-ancestor
92945930|NCT00577122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92945931|NCT00577122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92945932|NCT00577122|Antimetabolites|antimetabolites|mesh-ancestor
92945933|NCT00577122|Dermatologic Agents|dermatologic agents|mesh-ancestor
92945934|NCT00577122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945935|NCT00577122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92945936|NCT00577122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92945937|NCT00577122|Progestins|progestins|mesh-ancestor
92945939|NCT00577122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92945940|NCT00577122|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92945941|NCT00577122|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92945942|NCT00577122|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92945943|NCT00577122|Contraceptive Agents|contraceptive agents|mesh-ancestor
92945944|NCT00577122|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92945945|NCT00577122|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92945946|NCT00577122|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92945947|NCT00577122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92945948|NCT00822081|Timolol|timolol|mesh-list
92945949|NCT00822081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92945950|NCT00822081|Dorzolamide|dorzolamide|mesh-list
92945951|NCT00822081|Maleic acid|maleic acid|mesh-list
92945952|NCT00822081|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92945953|NCT00822081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92945954|NCT00822081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945955|NCT00822081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92945956|NCT00822081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92945957|NCT00822081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92945958|NCT00822081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945959|NCT00822081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945960|NCT00822081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92945961|NCT00822081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945962|NCT00822081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92945963|NCT00822081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92945964|NCT00822081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92945965|NCT00822081|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92945966|NCT00696774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92945967|NCT00696774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92945968|NCT00696774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92945969|NCT00696774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92945970|NCT00696774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945971|NCT00696774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92945972|NCT00696774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945973|NCT00696774|Analgesics|analgesics|mesh-ancestor
92945974|NCT00696774|Sensory System Agents|sensory system agents|mesh-ancestor
92945975|NCT00696774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92945976|NCT00696774|Antidepressive Agents|antidepressive agents|mesh-ancestor
92945977|NCT00696774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92945978|NCT00696774|Dopamine Agents|dopamine agents|mesh-ancestor
92945979|NCT00608842|Deoxycholic Acid|deoxycholic acid|mesh-list
92945980|NCT00608842|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92945981|NCT00608842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92945982|NCT00626925|Topiramate|topiramate|mesh-list
92945983|NCT00626925|Anticonvulsants|anticonvulsants|mesh-ancestor
92945984|NCT00626925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92945985|NCT00626925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92945986|NCT00816543|Docetaxel|docetaxel|mesh-list
92945987|NCT00816543|Oxaliplatin|oxaliplatin|mesh-list
92945988|NCT00816543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92945989|NCT00816543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92945990|NCT00816543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92945991|NCT00816543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92945992|NCT00816543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945993|NCT00698646|Valsartan|valsartan|mesh-list
92945994|NCT00698646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92945995|NCT00698646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92945996|NCT00698646|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92945997|NCT00698646|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92945998|NCT00698646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92945999|NCT00698646|Diuretics|diuretics|mesh-ancestor
92946000|NCT00698646|Natriuretic Agents|natriuretic agents|mesh-ancestor
92946001|NCT00698646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946002|NCT00698646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92946003|NCT00698646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946004|NCT02565888|Ritonavir|ritonavir|mesh-list
92946005|NCT02565888|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92946006|NCT02565888|Cobicistat|cobicistat|mesh-list
92946007|NCT02565888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92946008|NCT02565888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92946009|NCT02565888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92946010|NCT02565888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946011|NCT02565888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946012|NCT02565888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92946013|NCT02565888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92946014|NCT02565888|Antiviral Agents|antiviral agents|mesh-ancestor
92946015|NCT02565888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946016|NCT02565888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92946017|NCT02565888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92946018|NCT00609466|Morphine|morphine|mesh-list
92946019|NCT00609466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92946020|NCT00609466|Narcotics|narcotics|mesh-ancestor
92946021|NCT00609466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946022|NCT00609466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946023|NCT00609466|Analgesics|analgesics|mesh-ancestor
92946024|NCT00609466|Sensory System Agents|sensory system agents|mesh-ancestor
92946025|NCT00609466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946027|NCT00822315|Raltegravir Potassium|raltegravir potassium|mesh-list
92946028|NCT00822315|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92946029|NCT00822315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92946030|NCT00822315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946031|NCT00822315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946032|NCT00822315|Antiviral Agents|antiviral agents|mesh-ancestor
92946033|NCT00822315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946034|NCT00822315|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92946035|NCT00822315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92946036|NCT00822315|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92946037|NCT00822315|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92946038|NCT00822315|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92946039|NCT00822315|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92946040|NCT00822315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92946041|NCT00822315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92946042|NCT00822315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92946043|NCT00822315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92946044|NCT00696696|Gemcitabine|gemcitabine|mesh-list
92946045|NCT00696696|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92946046|NCT00696696|Sorafenib|sorafenib|mesh-list
92946047|NCT00696696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92946048|NCT00696696|Antimetabolites|antimetabolites|mesh-ancestor
92946049|NCT00696696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946050|NCT00696696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946051|NCT00696696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946052|NCT00696696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946053|NCT00822393|Busulfan|busulfan|mesh-list
92946054|NCT00822393|Treosulfan|treosulfan|mesh-list
92946055|NCT00822393|Alkylating Agents|alkylating agents|mesh-ancestor
92946056|NCT00822393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946057|NCT00822393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946058|NCT00822393|Immunologic Factors|immunologic factors|mesh-ancestor
92946059|NCT00822393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946060|NCT00822393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92946061|NCT00822393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946062|NCT00822393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92946063|NCT00819195|Glatiramer Acetate|glatiramer acetate|mesh-list
92946064|NCT00819195|(T,G)-A-L|(t,g)-a-l|mesh-list
92946065|NCT00819195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92946066|NCT00819195|Immunologic Factors|immunologic factors|mesh-ancestor
92946067|NCT00819195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946068|NCT00819195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946069|NCT00819195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946070|NCT00892918|Moxifloxacin|moxifloxacin|mesh-list
92946071|NCT00892918|Gatifloxacin|gatifloxacin|mesh-list
92946072|NCT00892918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92946073|NCT00892918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92946074|NCT00892918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946075|NCT00892918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946076|NCT00892918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92946077|NCT00892918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92946078|NCT00892918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946079|NCT00892918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946080|NCT00892918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946081|NCT02551185|Citarinostat|citarinostat|mesh-list
92946082|NCT02551185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92946083|NCT02551185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946084|NCT02551185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946085|NCT00892996|Dexamethasone|dexamethasone|mesh-list
92946086|NCT00892996|Dexamethasone acetate|dexamethasone acetate|mesh-list
92946087|NCT00892996|BB 1101|bb 1101|mesh-list
92946088|NCT00892996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946089|NCT00892996|Antiemetics|antiemetics|mesh-ancestor
92946090|NCT00892996|Autonomic Agents|autonomic agents|mesh-ancestor
92946091|NCT00892996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946092|NCT00892996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946093|NCT00892996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92946094|NCT00892996|Glucocorticoids|glucocorticoids|mesh-ancestor
92946095|NCT00892996|Hormones|hormones|mesh-ancestor
92946096|NCT00892996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92946097|NCT00892996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92946098|NCT00892996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946099|NCT00892996|Protease Inhibitors|protease inhibitors|mesh-ancestor
92946100|NCT00892996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946101|NCT00892996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946102|NCT00891670|Aspirin|aspirin|mesh-list
92946103|NCT00891670|Cilostazol|cilostazol|mesh-list
92946104|NCT00891670|Clopidogrel|clopidogrel|mesh-list
92946105|NCT00891670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946106|NCT00891670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946107|NCT00891670|Analgesics|analgesics|mesh-ancestor
92946108|NCT00891670|Sensory System Agents|sensory system agents|mesh-ancestor
92946109|NCT00891670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946110|NCT00891670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946111|NCT00891670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946112|NCT00891670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946113|NCT00891670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92946114|NCT00891670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92946115|NCT00891670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946116|NCT00891670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92946117|NCT00891670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92946118|NCT00891670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946119|NCT00891670|Antipyretics|antipyretics|mesh-ancestor
92946120|NCT00891670|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92946121|NCT00891670|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92946122|NCT00891670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92946123|NCT00891670|Purinergic Agents|purinergic agents|mesh-ancestor
92946124|NCT00891670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946125|NCT00891670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92946126|NCT00891670|Autonomic Agents|autonomic agents|mesh-ancestor
92946127|NCT00891670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92946128|NCT00891670|Respiratory System Agents|respiratory system agents|mesh-ancestor
92946129|NCT00891670|Vasodilator Agents|vasodilator agents|mesh-ancestor
92946130|NCT00891670|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92946131|NCT00891670|Protective Agents|protective agents|mesh-ancestor
92946132|NCT00891670|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92946133|NCT00891670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92946134|NCT00699192|Amlodipine|amlodipine|mesh-list
92946135|NCT00699192|Valsartan|valsartan|mesh-list
92946136|NCT00699192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92946137|NCT00699192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92946138|NCT00699192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946139|NCT00699192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946140|NCT00699192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92946141|NCT00699192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946142|NCT00699192|Vasodilator Agents|vasodilator agents|mesh-ancestor
92946143|NCT00699192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92946144|NCT00699192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92946145|NCT00921180|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92946146|NCT00921180|Interferon-alpha|interferon-alpha|mesh-list
92946148|NCT00921180|Antiviral Agents|antiviral agents|mesh-ancestor
92946149|NCT00921180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946150|NCT00921180|Immunologic Factors|immunologic factors|mesh-ancestor
92946151|NCT00921180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946152|NCT04671810|Eculizumab|eculizumab|mesh-list
92946153|NCT04671810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92946154|NCT04671810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946155|NCT04671810|Immunologic Factors|immunologic factors|mesh-ancestor
92946156|NCT04671810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946157|NCT00893542|Mycophenolic Acid|mycophenolic acid|mesh-list
92946158|NCT00893542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92946159|NCT00893542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946160|NCT00893542|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92946161|NCT00893542|Antitubercular Agents|antitubercular agents|mesh-ancestor
92946162|NCT00893542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946163|NCT00893542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946164|NCT00893542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946165|NCT00893542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946166|NCT00401245|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92946167|NCT00401245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92946168|NCT00401245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92946169|NCT00401245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946170|NCT00401245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946171|NCT00401245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946172|NCT00401245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946173|NCT00401245|Antidepressive Agents|antidepressive agents|mesh-ancestor
92946174|NCT00401245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946175|NCT04661280|Donepezil|donepezil|mesh-list
92946176|NCT04661280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92946177|NCT04661280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946178|NCT04661280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946179|NCT04661280|Cholinergic Agents|cholinergic agents|mesh-ancestor
92946180|NCT04661280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946181|NCT04661280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946182|NCT04661280|Nootropic Agents|nootropic agents|mesh-ancestor
92946183|NCT00696384|Antihypertensive Agents|antihypertensive agents|mesh-list
92946184|NCT00696384|Chlorthalidone|chlorthalidone|mesh-list
92946185|NCT00696384|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92946186|NCT00696384|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92946187|NCT00696384|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92946188|NCT00696384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946189|NCT00696384|Diuretics|diuretics|mesh-ancestor
92946190|NCT00696384|Natriuretic Agents|natriuretic agents|mesh-ancestor
92946191|NCT00696384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946192|NCT00696384|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92946193|NCT00696384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946194|NCT01041625|Apremilast|apremilast|mesh-list
92946195|NCT01041625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946196|NCT01041625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946197|NCT01041625|Analgesics|analgesics|mesh-ancestor
92946198|NCT01041625|Sensory System Agents|sensory system agents|mesh-ancestor
92946199|NCT01041625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946200|NCT01041625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946201|NCT01041625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946202|NCT01041625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946203|NCT01041625|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92946204|NCT01041625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92946205|NCT01041625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946206|NCT01041625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946207|NCT02566356|Oxytocin|oxytocin|mesh-list
92946208|NCT02566356|Oxytocics|oxytocics|mesh-ancestor
92946209|NCT02566356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92946210|NCT02566356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946211|NCT00892450|Oxybutynin|oxybutynin|mesh-list
92946212|NCT00892450|Darifenacin|darifenacin|mesh-list
92946213|NCT00892450|Parasympatholytics|parasympatholytics|mesh-ancestor
92946214|NCT00892450|Autonomic Agents|autonomic agents|mesh-ancestor
92946215|NCT00892450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946216|NCT00892450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946217|NCT00892450|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92946218|NCT00892450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92946219|NCT00892450|Cholinergic Agents|cholinergic agents|mesh-ancestor
92946220|NCT00892450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946221|NCT00892450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946222|NCT00892450|Urological Agents|urological agents|mesh-ancestor
92946223|NCT01566565|Theophylline|theophylline|mesh-list
92946224|NCT01566565|Bambuterol|bambuterol|mesh-list
92946225|NCT01566565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92946226|NCT01566565|Autonomic Agents|autonomic agents|mesh-ancestor
92946227|NCT01566565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946228|NCT01566565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946229|NCT01566565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92946230|NCT01566565|Respiratory System Agents|respiratory system agents|mesh-ancestor
92946231|NCT01566565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92946232|NCT01566565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946233|NCT01566565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946235|NCT01566565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92946236|NCT01566565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92946237|NCT01566565|Purinergic Agents|purinergic agents|mesh-ancestor
92946238|NCT01566565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946239|NCT01039363|Cytarabine|cytarabine|mesh-list
92946240|NCT01039363|Vorinostat|vorinostat|mesh-list
92946241|NCT01039363|Idarubicin|idarubicin|mesh-list
92946242|NCT01039363|Gemtuzumab|gemtuzumab|mesh-list
92946243|NCT01039363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92946244|NCT01039363|Antimetabolites|antimetabolites|mesh-ancestor
92946245|NCT01039363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946246|NCT01039363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946247|NCT01039363|Antiviral Agents|antiviral agents|mesh-ancestor
92946248|NCT01039363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946249|NCT01039363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946250|NCT01039363|Immunologic Factors|immunologic factors|mesh-ancestor
92946251|NCT01039363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946252|NCT01039363|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92946253|NCT01039363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946254|NCT01039363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92946255|NCT01039363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92946256|NCT01039363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92946257|NCT01039363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92946258|NCT01039363|Immunotoxins|immunotoxins|mesh-ancestor
92946259|NCT01039363|Immunoconjugates|immunoconjugates|mesh-ancestor
92946260|NCT01039441|Bupivacaine|bupivacaine|mesh-list
92946261|NCT01039441|Anesthetics, Local|anesthetics, local|mesh-ancestor
92946262|NCT01039441|Anesthetics|anesthetics|mesh-ancestor
92946263|NCT01039441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946264|NCT01039441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946265|NCT01039441|Sensory System Agents|sensory system agents|mesh-ancestor
92946266|NCT01039441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946267|NCT01034917|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92946269|NCT01034917|Antiviral Agents|antiviral agents|mesh-ancestor
92946270|NCT01034917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946271|NCT01034917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92946272|NCT01034917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92946273|NCT01034917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946274|NCT01034917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946275|NCT00816699|Anesthetics|anesthetics|mesh-list
92946276|NCT00816699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946277|NCT00816699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946278|NCT00822549|Morphine|morphine|mesh-list
92946279|NCT00822549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92946280|NCT00822549|Narcotics|narcotics|mesh-ancestor
92946281|NCT00822549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946282|NCT00822549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946283|NCT00822549|Analgesics|analgesics|mesh-ancestor
92946284|NCT00822549|Sensory System Agents|sensory system agents|mesh-ancestor
92946285|NCT00822549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946286|NCT00819351|Asparaginase|asparaginase|mesh-list
92946287|NCT00819351|Pegaspargase|pegaspargase|mesh-list
92946288|NCT00819351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946289|NCT00699998|Aspirin|aspirin|mesh-list
92946290|NCT00699998|Clopidogrel|clopidogrel|mesh-list
92946291|NCT00699998|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92946292|NCT00699998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946293|NCT00699998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946294|NCT00699998|Analgesics|analgesics|mesh-ancestor
92946295|NCT00699998|Sensory System Agents|sensory system agents|mesh-ancestor
92946296|NCT00699998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946297|NCT00699998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946298|NCT00699998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946299|NCT00699998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946300|NCT00699998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92946301|NCT00699998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92946302|NCT00699998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946303|NCT00699998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92946304|NCT00699998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92946305|NCT00699998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946306|NCT00699998|Antipyretics|antipyretics|mesh-ancestor
92946307|NCT00699998|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92946308|NCT00699998|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92946309|NCT00699998|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92946310|NCT00699998|Purinergic Agents|purinergic agents|mesh-ancestor
92946311|NCT00699998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946312|NCT00696072|Letrozole|letrozole|mesh-list
92946313|NCT00696072|Dasatinib|dasatinib|mesh-list
92946314|NCT00696072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946315|NCT00696072|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92946316|NCT00696072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92946317|NCT00696072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946318|NCT00696072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946319|NCT00696072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92946320|NCT00696072|Hormone Antagonists|hormone antagonists|mesh-ancestor
92946321|NCT00696072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92946322|NCT00696072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946323|NCT00696072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946324|NCT00816855|Docetaxel|docetaxel|mesh-list
92946325|NCT00816855|Fluorouracil|fluorouracil|mesh-list
92946326|NCT00816855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946327|NCT00816855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92946328|NCT00816855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92946329|NCT00816855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92946330|NCT00816855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946331|NCT00816855|Antimetabolites|antimetabolites|mesh-ancestor
92527159|NCT00031837|Dalteparin|dalteparin|mesh-list
92946332|NCT00816855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92946334|NCT00816855|Immunologic Factors|immunologic factors|mesh-ancestor
92946335|NCT00816855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946336|NCT00822783|Omalizumab|omalizumab|mesh-list
92946337|NCT00822783|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92946338|NCT00822783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92946339|NCT00822783|Respiratory System Agents|respiratory system agents|mesh-ancestor
92946340|NCT00634647|Prednisone|prednisone|mesh-list
92946341|NCT00634647|Satraplatin|satraplatin|mesh-list
92946342|NCT00634647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946343|NCT00634647|Glucocorticoids|glucocorticoids|mesh-ancestor
92946344|NCT00634647|Hormones|hormones|mesh-ancestor
92946345|NCT00634647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92946346|NCT00634647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946347|NCT00634647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92946348|NCT00634647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946349|NCT00576732|Risperidone|risperidone|mesh-list
92946350|NCT00576732|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92946351|NCT00576732|Serotonin Agents|serotonin agents|mesh-ancestor
92946352|NCT00576732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946353|NCT00576732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946354|NCT00576732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946355|NCT00576732|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92946356|NCT00576732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92946357|NCT00576732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946358|NCT00576732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946359|NCT00576732|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92946360|NCT00576732|Dopamine Agents|dopamine agents|mesh-ancestor
92946361|NCT00817011|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92946362|NCT00817011|Mirtazapine|mirtazapine|mesh-list
92946363|NCT00817011|Trazodone|trazodone|mesh-list
92946364|NCT00817011|Bupropion|bupropion|mesh-list
92946365|NCT00817011|Fluoxetine|fluoxetine|mesh-list
92946366|NCT00817011|Paroxetine|paroxetine|mesh-list
92946367|NCT00817011|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92946368|NCT00817011|Citalopram|citalopram|mesh-list
92946369|NCT00817011|Sertraline|sertraline|mesh-list
92946370|NCT00817011|Nortriptyline|nortriptyline|mesh-list
92946371|NCT00817011|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92946372|NCT00817011|Antidepressive Agents|antidepressive agents|mesh-ancestor
92946373|NCT00817011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946374|NCT00817011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92946375|NCT00817011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92946376|NCT00817011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946377|NCT00817011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946378|NCT00817011|Dopamine Agents|dopamine agents|mesh-ancestor
92946379|NCT00817011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946380|NCT00817011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946381|NCT00817011|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92946382|NCT00817011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92946383|NCT00817011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946384|NCT00817011|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92946385|NCT00817011|Analgesics|analgesics|mesh-ancestor
92946386|NCT00817011|Sensory System Agents|sensory system agents|mesh-ancestor
92946387|NCT00817011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164900|NCT05792995|Pembrolizumab|pembrolizumab|mesh-list
92946388|NCT00817011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92946389|NCT00817011|Serotonin Agents|serotonin agents|mesh-ancestor
92946390|NCT00817011|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92946391|NCT00817011|Histamine Antagonists|histamine antagonists|mesh-ancestor
92946392|NCT00817011|Histamine Agents|histamine agents|mesh-ancestor
92946393|NCT00817011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92946394|NCT00817011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92946395|NCT00817011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946396|NCT00817011|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92946397|NCT00817011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92946398|NCT00817011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92946399|NCT00817011|Adrenergic Agents|adrenergic agents|mesh-ancestor
92946400|NCT00817011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92946401|NCT00817011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92946402|NCT00817011|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92946403|NCT00817011|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92946404|NCT00817011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92946405|NCT00697788|Dexmedetomidine|dexmedetomidine|mesh-list
92946406|NCT00697788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92946407|NCT00697788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946408|NCT00697788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946409|NCT00697788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946410|NCT00697788|Analgesics|analgesics|mesh-ancestor
92946411|NCT00697788|Sensory System Agents|sensory system agents|mesh-ancestor
92946412|NCT00697788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946413|NCT00697788|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92946414|NCT00697788|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92946415|NCT00697788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92946416|NCT00697788|Adrenergic Agents|adrenergic agents|mesh-ancestor
92946417|NCT00697788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946418|NCT00697788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946419|NCT00400153|Ipratropium|ipratropium|mesh-list
92946420|NCT00400153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92946421|NCT00400153|Autonomic Agents|autonomic agents|mesh-ancestor
92946422|NCT00400153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946423|NCT00400153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946424|NCT00400153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92946425|NCT00400153|Respiratory System Agents|respiratory system agents|mesh-ancestor
92946426|NCT00400153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92946427|NCT00400153|Cholinergic Agents|cholinergic agents|mesh-ancestor
92946428|NCT00400153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946429|NCT00400153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946430|NCT04062890|Vigabatrin|vigabatrin|mesh-list
92946431|NCT04062890|Anticonvulsants|anticonvulsants|mesh-ancestor
92946432|NCT04062890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946433|NCT04062890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946434|NCT04062890|GABA Agents|gaba agents|mesh-ancestor
92946435|NCT04062890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946436|NCT04062890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946437|NCT00817245|Amoxicillin|amoxicillin|mesh-list
92946438|NCT00817245|Metronidazole|metronidazole|mesh-list
92946439|NCT00817245|Omeprazole|omeprazole|mesh-list
92946440|NCT00817245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946441|NCT00817245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946442|NCT00817245|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92946443|NCT00817245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92946444|NCT00817245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92946445|NCT00817245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92946446|NCT00817245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92946447|NCT00817245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946448|NCT00817245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946449|NCT02550483|Beta Carotene|beta carotene|mesh-list
92946450|NCT02550483|Lycopene|lycopene|mesh-list
92946451|NCT02550483|Carotenoids|carotenoids|mesh-list
92946452|NCT02550483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946453|NCT02550483|Antioxidants|antioxidants|mesh-ancestor
92946454|NCT02550483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946455|NCT02550483|Protective Agents|protective agents|mesh-ancestor
92946456|NCT02550483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946457|NCT02550483|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92946458|NCT02550483|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92946459|NCT02550483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946460|NCT02550483|Provitamins|provitamins|mesh-ancestor
92946462|NCT02550483|Micronutrients|micronutrients|mesh-ancestor
92946463|NCT04608318|Venetoclax|venetoclax|mesh-list
92946464|NCT04608318|Obinutuzumab|obinutuzumab|mesh-list
92946465|NCT04608318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946466|NCT04608318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92946467|NCT04063358|Ranibizumab|ranibizumab|mesh-list
92946468|NCT04063358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92527174|NCT00031876|Antimitotic Agents|antimitotic agents|mesh-ancestor
92946469|NCT04063358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92946470|NCT04063358|Growth Substances|growth substances|mesh-ancestor
92946471|NCT04063358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946472|NCT04063358|Growth Inhibitors|growth inhibitors|mesh-ancestor
92946473|NCT04063358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946475|NCT00631917|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92946476|NCT00631917|Protease Inhibitors|protease inhibitors|mesh-ancestor
92946477|NCT00631917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946478|NCT00631917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946479|NCT00631917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92946480|NCT00419341|Immunoglobulins|immunoglobulins|mesh-list
92946481|NCT00419341|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92946482|NCT00419341|Antibodies|antibodies|mesh-list
92946483|NCT00419341|Immunologic Factors|immunologic factors|mesh-ancestor
92946484|NCT00419341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946485|NCT00694122|Insulin Glargine|insulin glargine|mesh-list
92946486|NCT00694122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92946487|NCT00694122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946488|NCT03922620|Bupivacaine|bupivacaine|mesh-list
92946489|NCT03922620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92946490|NCT03922620|Anesthetics|anesthetics|mesh-ancestor
92946491|NCT03922620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946492|NCT03922620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946493|NCT03922620|Sensory System Agents|sensory system agents|mesh-ancestor
92946494|NCT03922620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946495|NCT00419263|Peramivir|peramivir|mesh-list
92946496|NCT00419263|Antiviral Agents|antiviral agents|mesh-ancestor
92946497|NCT00419263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946498|NCT00419263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946499|NCT00419263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946500|NCT01034995|Escitalopram|escitalopram|mesh-list
92946501|NCT01034995|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92946502|NCT01034995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92946503|NCT01034995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946504|NCT01034995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946505|NCT01034995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946506|NCT01034995|Serotonin Agents|serotonin agents|mesh-ancestor
92946507|NCT01034995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946508|NCT00921414|Rituximab|rituximab|mesh-list
92946509|NCT00921414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92946510|NCT00921414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946511|NCT00921414|Immunologic Factors|immunologic factors|mesh-ancestor
92946512|NCT00921414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946513|NCT00921414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946514|NCT04060914|Clopidogrel|clopidogrel|mesh-list
92946515|NCT04060914|Ticagrelor|ticagrelor|mesh-list
92946516|NCT04060914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92946517|NCT04060914|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92946518|NCT04060914|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92946519|NCT04060914|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92946520|NCT04060914|Purinergic Agents|purinergic agents|mesh-ancestor
92946521|NCT04060914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527177|NCT00031876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92946522|NCT04060914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946524|NCT03894696|Antiviral Agents|antiviral agents|mesh-list
92946525|NCT03894696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946526|NCT00399763|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92946527|NCT00399763|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92946528|NCT00399763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92946529|NCT00399763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946530|NCT00399763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946531|NCT00399763|Adrenergic Agents|adrenergic agents|mesh-ancestor
92946532|NCT00399763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946533|NCT00399763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946535|NCT05324904|Acyclovir|acyclovir|mesh-list
92946536|NCT05324904|Vitamins|vitamins|mesh-ancestor
92946537|NCT05324904|Micronutrients|micronutrients|mesh-ancestor
92946538|NCT05324904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946539|NCT05324904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92946540|NCT05324904|Antiviral Agents|antiviral agents|mesh-ancestor
92946541|NCT05324904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946542|NCT02085265|Telmisartan|telmisartan|mesh-list
92946543|NCT02085265|Perindopril|perindopril|mesh-list
92946544|NCT02085265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92946545|NCT02085265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92946546|NCT02085265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92946547|NCT02085265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946548|NCT02085265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92946549|NCT02085265|Protease Inhibitors|protease inhibitors|mesh-ancestor
92946550|NCT02085265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946551|NCT00699842|Lenalidomide|lenalidomide|mesh-list
92946552|NCT00699842|Immunologic Factors|immunologic factors|mesh-ancestor
92946553|NCT00699842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946554|NCT00699842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92946555|NCT00699842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92946556|NCT00699842|Growth Substances|growth substances|mesh-ancestor
92946557|NCT00699842|Growth Inhibitors|growth inhibitors|mesh-ancestor
92946558|NCT00699842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946559|NCT00399529|Cyclophosphamide|cyclophosphamide|mesh-list
92946560|NCT00399529|Trastuzumab|trastuzumab|mesh-list
92946561|NCT00399529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946562|NCT00399529|Immunologic Factors|immunologic factors|mesh-ancestor
92946563|NCT00399529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946564|NCT00399529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946565|NCT00399529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92946566|NCT00399529|Alkylating Agents|alkylating agents|mesh-ancestor
92946567|NCT00399529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946568|NCT00399529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946569|NCT00399529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92946570|NCT00399529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92946571|NCT00712712|Acetaminophen|acetaminophen|mesh-list
92946572|NCT00712712|Morphine|morphine|mesh-list
92946573|NCT00712712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92946574|NCT00712712|Narcotics|narcotics|mesh-ancestor
92527195|NCT00031993|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92946575|NCT00712712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946576|NCT00712712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946577|NCT00712712|Analgesics|analgesics|mesh-ancestor
92946578|NCT00712712|Sensory System Agents|sensory system agents|mesh-ancestor
92946579|NCT00712712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946580|NCT00712712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946581|NCT00712712|Antipyretics|antipyretics|mesh-ancestor
92946582|NCT00411151|Sunitinib|sunitinib|mesh-list
92946583|NCT00411151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946584|NCT00411151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92946585|NCT00411151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92946586|NCT00411151|Growth Substances|growth substances|mesh-ancestor
92946587|NCT00411151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946588|NCT00411151|Growth Inhibitors|growth inhibitors|mesh-ancestor
92946589|NCT00411151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946590|NCT00411151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946591|NCT00411151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946592|NCT00607048|Paclitaxel|paclitaxel|mesh-list
92946593|NCT00607048|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92946594|NCT00607048|Carboplatin|carboplatin|mesh-list
92946595|NCT00607048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92946596|NCT00607048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92946597|NCT00607048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247082|NCT01799798|Denosumab|denosumab|mesh-list
92946598|NCT00607048|Tubulin Modulators|tubulin modulators|mesh-ancestor
92946599|NCT00607048|Antimitotic Agents|antimitotic agents|mesh-ancestor
92946600|NCT00607048|Mitosis Modulators|mitosis modulators|mesh-ancestor
92946601|NCT00607048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946602|NCT00607048|Immunologic Factors|immunologic factors|mesh-ancestor
92946603|NCT00607048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946604|NCT03592576|Venetoclax|venetoclax|mesh-list
92946605|NCT03592576|Navitoclax|navitoclax|mesh-list
92946606|NCT03592576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946607|NCT04035850|Vortioxetine|vortioxetine|mesh-list
92946608|NCT04035850|Antidepressive Agents|antidepressive agents|mesh-ancestor
92946609|NCT04035850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946610|NCT04035850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92946611|NCT04035850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92946612|NCT04035850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946613|NCT04035850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946614|NCT04035850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92946615|NCT04035850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92946616|NCT04035850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946617|NCT04035850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946618|NCT04035850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946619|NCT04035850|Serotonin Agents|serotonin agents|mesh-ancestor
92946620|NCT04035850|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92946621|NCT04035850|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92946622|NCT04035850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92946623|NCT04035850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92946624|NCT00699608|Zopiclone|zopiclone|mesh-list
92946625|NCT00699608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92946626|NCT00699608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946627|NCT00699608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946628|NCT00895570|Modafinil|modafinil|mesh-list
92946629|NCT00895570|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92946630|NCT00895570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946631|NCT00895570|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92946632|NCT00895570|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92946633|NCT00895570|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92946634|NCT00895570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946635|NCT00895648|Pemetrexed|pemetrexed|mesh-list
92946636|NCT00895648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946637|NCT00895648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946638|NCT00895648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946639|NCT00895648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92946640|NCT00895648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92946641|NCT00893854|Triamcinolone|triamcinolone|mesh-list
92946642|NCT00893854|Diclofenac|diclofenac|mesh-list
92946643|NCT00893854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946644|NCT00893854|Glucocorticoids|glucocorticoids|mesh-ancestor
92946645|NCT00893854|Hormones|hormones|mesh-ancestor
92946646|NCT00893854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92946647|NCT00893854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946648|NCT00893854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946649|NCT00893854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946650|NCT00893854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946651|NCT00893854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946652|NCT00893854|Analgesics|analgesics|mesh-ancestor
92946653|NCT00893854|Sensory System Agents|sensory system agents|mesh-ancestor
92946654|NCT00893854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946655|NCT00893854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946656|NCT00893854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92946657|NCT00895804|Pindolol|pindolol|mesh-list
92946658|NCT00895804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92946659|NCT00895804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92946660|NCT00895804|Adrenergic Agents|adrenergic agents|mesh-ancestor
92946661|NCT00895804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946662|NCT00895804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946663|NCT00895804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946664|NCT00895804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92946665|NCT00895804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92946666|NCT00895804|Serotonin Agents|serotonin agents|mesh-ancestor
92946667|NCT00895804|Vasodilator Agents|vasodilator agents|mesh-ancestor
92946668|NCT00895882|Interferons|interferons|mesh-list
92946669|NCT00895882|Ribavirin|ribavirin|mesh-list
92946670|NCT00895882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946671|NCT00895882|Antiviral Agents|antiviral agents|mesh-ancestor
92946672|NCT00895882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946673|NCT00895882|Antimetabolites|antimetabolites|mesh-ancestor
92946674|NCT00895882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946675|NCT00706706|Sunitinib|sunitinib|mesh-list
92946676|NCT00706706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946677|NCT00706706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92946678|NCT00706706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92946679|NCT00706706|Growth Substances|growth substances|mesh-ancestor
92592108|NCT00125229|Mannitol|mannitol|mesh-list
92946680|NCT00706706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946681|NCT00706706|Growth Inhibitors|growth inhibitors|mesh-ancestor
92946682|NCT00706706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946683|NCT00706706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946684|NCT00706706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946685|NCT00894010|Carbamazepine|carbamazepine|mesh-list
92946686|NCT00894010|Levetiracetam|levetiracetam|mesh-list
92946687|NCT00894010|Anticonvulsants|anticonvulsants|mesh-ancestor
92946688|NCT00894010|Nootropic Agents|nootropic agents|mesh-ancestor
92946689|NCT00894010|Antimanic Agents|antimanic agents|mesh-ancestor
92946690|NCT00894010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92946691|NCT00894010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946692|NCT00894010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946693|NCT00894010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946694|NCT00894010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946695|NCT00894010|Analgesics|analgesics|mesh-ancestor
92946696|NCT00894010|Sensory System Agents|sensory system agents|mesh-ancestor
92946697|NCT00894010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946698|NCT00894010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92946699|NCT00894010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946700|NCT00894010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946701|NCT00894010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92946702|NCT00894010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92946703|NCT00895960|Temozolomide|temozolomide|mesh-list
92946704|NCT00895960|Dasatinib|dasatinib|mesh-list
92946705|NCT00895960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92946706|NCT00895960|Alkylating Agents|alkylating agents|mesh-ancestor
92946707|NCT00895960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946708|NCT00895960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946709|NCT00895960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946710|NCT00895960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946711|NCT00894088|Mycophenolic Acid|mycophenolic acid|mesh-list
92946712|NCT00894088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92946713|NCT00894088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946714|NCT00894088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92946715|NCT00894088|Antitubercular Agents|antitubercular agents|mesh-ancestor
92946716|NCT00894088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946717|NCT00894088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946718|NCT00894088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946719|NCT00894088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946720|NCT03818178|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92946721|NCT03818178|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92946722|NCT03818178|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92946723|NCT03818178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92946724|NCT00921128|Muscimol|muscimol|mesh-list
92946725|NCT00921128|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92946726|NCT00921128|GABA Agonists|gaba agonists|mesh-ancestor
92946727|NCT00921128|GABA Agents|gaba agents|mesh-ancestor
92946728|NCT00921128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946729|NCT00921128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946730|NCT00921128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946731|NCT05508776|Moxifloxacin|moxifloxacin|mesh-list
92946732|NCT05508776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946733|NCT05508776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946734|NCT05508776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92946735|NCT05508776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92946736|NCT05508776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946737|NCT05508776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946738|NCT05508776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946739|NCT00896428|Gallopamil|gallopamil|mesh-list
92946740|NCT00896428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92946741|NCT00896428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92946742|NCT00896428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946743|NCT00896428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92946744|NCT00896428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946745|NCT02962050|Capsaicin|capsaicin|mesh-list
92946746|NCT02962050|Antipruritics|antipruritics|mesh-ancestor
92946747|NCT02962050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92946748|NCT02962050|Sensory System Agents|sensory system agents|mesh-ancestor
92946749|NCT02962050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946750|NCT02962050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946751|NCT04486716|Ofatumumab|ofatumumab|mesh-list
92946752|NCT04486716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946753|NCT00410605|Dexamethasone|dexamethasone|mesh-list
92946754|NCT00410605|Bevacizumab|bevacizumab|mesh-list
92946755|NCT00410605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92946756|NCT00410605|Lenalidomide|lenalidomide|mesh-list
92946757|NCT00410605|Antibodies|antibodies|mesh-list
92946758|NCT00410605|Immunoglobulins|immunoglobulins|mesh-list
92946759|NCT00410605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92946760|NCT00410605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946761|NCT00410605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92946762|NCT00410605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92946763|NCT00410605|Growth Substances|growth substances|mesh-ancestor
92946764|NCT00410605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946765|NCT00410605|Growth Inhibitors|growth inhibitors|mesh-ancestor
92946766|NCT00410605|Immunologic Factors|immunologic factors|mesh-ancestor
92946767|NCT00410605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946768|NCT00410605|Antiemetics|antiemetics|mesh-ancestor
92946769|NCT00410605|Autonomic Agents|autonomic agents|mesh-ancestor
92946770|NCT00410605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946771|NCT00410605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92946772|NCT00410605|Glucocorticoids|glucocorticoids|mesh-ancestor
92946773|NCT00410605|Hormones|hormones|mesh-ancestor
92946774|NCT00410605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92946775|NCT00410605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92946776|NCT00742638|Valproic Acid|valproic acid|mesh-list
92946777|NCT00742638|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92946778|NCT00742638|Antidepressive Agents|antidepressive agents|mesh-ancestor
92946779|NCT00742638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946780|NCT00742638|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92946781|NCT00742638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92946782|NCT00742638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946783|NCT00742638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946784|NCT00742638|Anticonvulsants|anticonvulsants|mesh-ancestor
92946785|NCT00742638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946786|NCT00742638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946787|NCT00742638|GABA Agents|gaba agents|mesh-ancestor
92946788|NCT00742638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946789|NCT00742638|Antimanic Agents|antimanic agents|mesh-ancestor
92946790|NCT00418717|Etanercept|etanercept|mesh-list
92946791|NCT00418717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946792|NCT00418717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946793|NCT00418717|Analgesics|analgesics|mesh-ancestor
92946794|NCT00418717|Sensory System Agents|sensory system agents|mesh-ancestor
92946795|NCT00418717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946796|NCT00418717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946797|NCT00418717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946798|NCT00418717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946799|NCT00418717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92946800|NCT00418717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946801|NCT00418717|Immunologic Factors|immunologic factors|mesh-ancestor
92946802|NCT00572572|Aprepitant|aprepitant|mesh-list
92946803|NCT00572572|Antiemetics|antiemetics|mesh-ancestor
92946804|NCT00572572|Autonomic Agents|autonomic agents|mesh-ancestor
92946805|NCT00572572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946806|NCT00572572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946807|NCT00572572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92946808|NCT00572572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92946809|NCT00572572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946810|NCT00572572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946811|NCT00897130|Azacitidine|azacitidine|mesh-list
92946812|NCT00897130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92946813|NCT00897130|Antimetabolites|antimetabolites|mesh-ancestor
92946814|NCT00897130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946815|NCT00897130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946816|NCT00897130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946817|NCT00398047|Mitogens|mitogens|mesh-list
92946818|NCT00398047|Mitosis Modulators|mitosis modulators|mesh-ancestor
92946819|NCT00398047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946820|NCT00631371|Interferons|interferons|mesh-list
92946821|NCT00631371|Interferon-alpha|interferon-alpha|mesh-list
92946822|NCT00631371|Sirolimus|sirolimus|mesh-list
92946823|NCT00631371|Bevacizumab|bevacizumab|mesh-list
92946824|NCT00631371|Temsirolimus|temsirolimus|mesh-list
92946825|NCT00631371|MTOR Inhibitors|mtor inhibitors|mesh-list
92946826|NCT00631371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92946827|NCT00631371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946828|NCT00631371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92946829|NCT00631371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92946830|NCT00631371|Growth Substances|growth substances|mesh-ancestor
92946831|NCT00631371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946832|NCT00631371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92946833|NCT00631371|Antiviral Agents|antiviral agents|mesh-ancestor
92946834|NCT00631371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946835|NCT00631371|Immunologic Factors|immunologic factors|mesh-ancestor
92946836|NCT00631371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946837|NCT00631371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946838|NCT00631371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946839|NCT00631371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92946840|NCT00631371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946841|NCT00631371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92946842|NCT00631371|Antifungal Agents|antifungal agents|mesh-ancestor
92946844|NCT00409747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92946845|NCT00409747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946846|NCT04016740|Dexmedetomidine|dexmedetomidine|mesh-list
92946847|NCT04016740|Ketamine|ketamine|mesh-list
92946848|NCT04016740|Remifentanil|remifentanil|mesh-list
92946849|NCT04016740|Propofol|propofol|mesh-list
92946850|NCT04016740|Ropivacaine|ropivacaine|mesh-list
92946851|NCT04016740|Sevoflurane|sevoflurane|mesh-list
92946852|NCT04016740|Rocuronium|rocuronium|mesh-list
92946853|NCT04016740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92946854|NCT04016740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946855|NCT04016740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946856|NCT04016740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946857|NCT04016740|Analgesics|analgesics|mesh-ancestor
92946858|NCT04016740|Sensory System Agents|sensory system agents|mesh-ancestor
92946859|NCT04016740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946860|NCT04016740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92946861|NCT04016740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92946862|NCT04016740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92946863|NCT04016740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92946864|NCT04016740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946865|NCT04016740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946866|NCT04016740|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92946867|NCT04016740|Anesthetics, General|anesthetics, general|mesh-ancestor
92946868|NCT04016740|Anesthetics|anesthetics|mesh-ancestor
92946869|NCT04016740|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92946870|NCT04016740|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92946871|NCT04016740|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92946872|NCT04016740|Anesthetics, Local|anesthetics, local|mesh-ancestor
92946873|NCT04016740|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92946874|NCT04016740|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92946875|NCT04016740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92946876|NCT04016740|Narcotics|narcotics|mesh-ancestor
92946877|NCT04016740|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92946878|NCT04016740|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92946879|NCT04016740|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92946880|NCT02540512|Acetaminophen|acetaminophen|mesh-list
92946881|NCT02540512|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92946882|NCT02540512|Hydrocodone|hydrocodone|mesh-list
92946883|NCT02540512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946884|NCT02540512|Analgesics|analgesics|mesh-ancestor
92946885|NCT02540512|Sensory System Agents|sensory system agents|mesh-ancestor
92946886|NCT02540512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946887|NCT02540512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946888|NCT02540512|Antipyretics|antipyretics|mesh-ancestor
92946889|NCT02540512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92946890|NCT02540512|Narcotics|narcotics|mesh-ancestor
92946891|NCT02540512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946892|NCT02540512|Antitussive Agents|antitussive agents|mesh-ancestor
92946893|NCT02540512|Respiratory System Agents|respiratory system agents|mesh-ancestor
92946894|NCT02540512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946895|NCT02540512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946896|NCT02540512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946897|NCT00897520|Interferons|interferons|mesh-list
92946898|NCT00897520|Interferon-alpha|interferon-alpha|mesh-list
92946899|NCT00897520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946900|NCT00897520|Antiviral Agents|antiviral agents|mesh-ancestor
92946901|NCT00897520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946902|NCT00897520|Immunologic Factors|immunologic factors|mesh-ancestor
92946903|NCT00897520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946904|NCT00894634|Brompheniramine|brompheniramine|mesh-list
92946905|NCT00894634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946906|NCT00894634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92946908|NCT00894634|Histamine Agents|histamine agents|mesh-ancestor
92946909|NCT00894634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92946910|NCT00894634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946911|NCT00894634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92946912|NCT00894712|Sulforaphane|sulforaphane|mesh-list
92946913|NCT00894712|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92946914|NCT00894712|Protective Agents|protective agents|mesh-ancestor
92946915|NCT00894712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946916|NCT00894712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946917|NCT00823641|Infliximab|infliximab|mesh-list
92946918|NCT00823641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92946919|NCT00823641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946920|NCT00823641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92946921|NCT00823641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92946922|NCT00823641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946923|NCT00823875|Cilostazol|cilostazol|mesh-list
92946924|NCT00823875|Probucol|probucol|mesh-list
92946925|NCT00823875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92946926|NCT00823875|Autonomic Agents|autonomic agents|mesh-ancestor
92946927|NCT00823875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946928|NCT00823875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946929|NCT00823875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92946930|NCT00823875|Respiratory System Agents|respiratory system agents|mesh-ancestor
92946931|NCT00823875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92946932|NCT00823875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92946933|NCT00823875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946934|NCT00823875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92946935|NCT00823875|Vasodilator Agents|vasodilator agents|mesh-ancestor
92946936|NCT00823875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92946937|NCT00823875|Protective Agents|protective agents|mesh-ancestor
92946938|NCT00823875|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92946939|NCT00823875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92946940|NCT00823875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946941|NCT00823875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92946942|NCT00823875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92946943|NCT00823875|Antimetabolites|antimetabolites|mesh-ancestor
92946944|NCT00823875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92946945|NCT00823875|Antioxidants|antioxidants|mesh-ancestor
92946946|NCT00397189|Melatonin|melatonin|mesh-list
92946947|NCT00397189|Antioxidants|antioxidants|mesh-ancestor
92946948|NCT00397189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946949|NCT00397189|Protective Agents|protective agents|mesh-ancestor
92946950|NCT00397189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946951|NCT00397189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946952|NCT00824109|Anti-Infective Agents|anti-infective agents|mesh-list
92946953|NCT00824109|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92946954|NCT01035619|Moxidectin|moxidectin|mesh-list
92946955|NCT01035619|Anthelmintics|anthelmintics|mesh-ancestor
92946956|NCT01035619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92946957|NCT01035619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92946958|NCT01035619|Antinematodal Agents|antinematodal agents|mesh-ancestor
92946959|NCT04044651|Nivolumab|nivolumab|mesh-list
92946960|NCT04044651|Lenvatinib|lenvatinib|mesh-list
92946961|NCT04044651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92946962|NCT04044651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946963|NCT04044651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92946964|NCT04044651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946965|NCT04044651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92946966|NCT04044651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946967|NCT00606034|Insulin|insulin|mesh-list
92946968|NCT00606034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92946969|NCT00606034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946970|NCT00819975|Caseins|caseins|mesh-list
92946971|NCT00819975|Chelating Agents|chelating agents|mesh-ancestor
92946972|NCT00819975|Sequestering Agents|sequestering agents|mesh-ancestor
92946973|NCT00819975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946974|NCT04044417|Curcumin|curcumin|mesh-list
92946975|NCT04044417|Simvastatin|simvastatin|mesh-list
92946976|NCT04044417|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92946977|NCT04044417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92946978|NCT04044417|Antimetabolites|antimetabolites|mesh-ancestor
92946979|NCT04044417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92946980|NCT04044417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92946981|NCT04044417|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92946982|NCT04044417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92946983|NCT04044417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92946984|NCT04044417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92946985|NCT04044417|Analgesics|analgesics|mesh-ancestor
92946986|NCT04044417|Sensory System Agents|sensory system agents|mesh-ancestor
92946987|NCT04044417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92946988|NCT04044417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946989|NCT04044417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92946990|NCT04044417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92946991|NCT04044417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92946992|NCT00397033|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92946993|NCT00397033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92946994|NCT00397033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92946995|NCT00397033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92946996|NCT00397033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92946997|NCT00397033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92946998|NCT00397033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92946999|NCT00397033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92947000|NCT00397033|Serotonin Agents|serotonin agents|mesh-ancestor
92947001|NCT00397033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947002|NCT00397033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947003|NCT00397033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92947004|NCT00397033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92947005|NCT00397033|Dopamine Agents|dopamine agents|mesh-ancestor
92947006|NCT00820053|Epirubicin|epirubicin|mesh-list
92947007|NCT00820053|Ethiodized Oil|ethiodized oil|mesh-list
92947008|NCT00820053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92947009|NCT00820053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947010|NCT00820053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92947011|NCT00820053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92947012|NCT00820053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947013|NCT00820053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947014|NCT00572728|Alovudine|alovudine|mesh-list
92947015|NCT00572728|Dideoxynucleosides|dideoxynucleosides|mesh-list
92947016|NCT00572728|Antiviral Agents|antiviral agents|mesh-ancestor
92947017|NCT00572728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947018|NCT00572728|Antimetabolites|antimetabolites|mesh-ancestor
92947019|NCT00572728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947020|NCT00572728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92947021|NCT00572728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92947022|NCT00572728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947023|NCT00699374|Sorafenib|sorafenib|mesh-list
92947024|NCT00699374|Sunitinib|sunitinib|mesh-list
92947025|NCT00699374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947026|NCT00699374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947027|NCT00699374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947028|NCT00699374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947029|NCT00699374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947030|NCT00699374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947031|NCT00699374|Growth Substances|growth substances|mesh-ancestor
92947032|NCT00699374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947033|NCT00699374|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947034|NCT00898534|Chrysarobin|chrysarobin|mesh-list
92947035|NCT00898534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92947036|NCT00898534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947037|NCT00898534|Analgesics|analgesics|mesh-ancestor
92947038|NCT00898534|Sensory System Agents|sensory system agents|mesh-ancestor
92947039|NCT00898534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947040|NCT00898534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947041|NCT00898534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947042|NCT00898534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947043|NCT00606892|Nicotine|nicotine|mesh-list
92947044|NCT00606892|Varenicline|varenicline|mesh-list
92947045|NCT00606892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92947046|NCT00606892|Autonomic Agents|autonomic agents|mesh-ancestor
92947047|NCT00606892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947048|NCT00606892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947049|NCT00606892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92947050|NCT00606892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92947051|NCT00606892|Cholinergic Agents|cholinergic agents|mesh-ancestor
92947052|NCT00606892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947053|NCT00606892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947054|NCT00894946|Ethiodized Oil|ethiodized oil|mesh-list
92947055|NCT00894946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947056|NCT01042561|Vitamin D|vitamin d|mesh-list
92947057|NCT01042561|Ergocalciferols|ergocalciferols|mesh-list
92947058|NCT01042561|Cholecalciferol|cholecalciferol|mesh-list
92947059|NCT01042561|Vitamins|vitamins|mesh-list
92947060|NCT01042561|Micronutrients|micronutrients|mesh-ancestor
92947061|NCT01042561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947062|NCT01042561|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92947063|NCT01042561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92947065|NCT01035853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947066|NCT01035853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947067|NCT05268614|Cisplatin|cisplatin|mesh-list
92947068|NCT05268614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947069|NCT01042717|Plerixafor|plerixafor|mesh-list
92947070|NCT01042717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92947071|NCT01042717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92947072|NCT01042717|Antiviral Agents|antiviral agents|mesh-ancestor
92947073|NCT01042717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947074|NCT03648385|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92947075|NCT03648385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92947076|NCT03648385|Immunologic Factors|immunologic factors|mesh-ancestor
92947077|NCT03648385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947078|NCT00898846|Tegafur|tegafur|mesh-list
92947079|NCT00898846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92947080|NCT00898846|Antimetabolites|antimetabolites|mesh-ancestor
92947081|NCT00898846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947082|NCT00898846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947083|NCT00826371|Ranibizumab|ranibizumab|mesh-list
92947084|NCT00826371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947085|NCT00826371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947086|NCT00826371|Growth Substances|growth substances|mesh-ancestor
92947087|NCT00826371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947088|NCT00826371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947089|NCT00826371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947090|NCT02540824|Apatinib|apatinib|mesh-list
92947091|NCT02540824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947092|NCT02540824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947093|NCT02540824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947094|NCT02540824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947095|NCT00826527|Solifenacin Succinate|solifenacin succinate|mesh-list
92947096|NCT00826527|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92947097|NCT00826527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92947098|NCT00826527|Cholinergic Agents|cholinergic agents|mesh-ancestor
92947099|NCT00826527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947100|NCT00826527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947101|NCT00826527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947102|NCT00826527|Urological Agents|urological agents|mesh-ancestor
92947103|NCT02550717|Aspirin|aspirin|mesh-list
92947104|NCT02550717|Anticoagulants|anticoagulants|mesh-list
92947105|NCT02550717|Clopidogrel|clopidogrel|mesh-list
92947106|NCT02550717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92947107|NCT02550717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947108|NCT02550717|Analgesics|analgesics|mesh-ancestor
92947109|NCT02550717|Sensory System Agents|sensory system agents|mesh-ancestor
92947110|NCT02550717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947111|NCT02550717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947112|NCT02550717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947113|NCT02550717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947114|NCT02550717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92947115|NCT02550717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92947116|NCT02550717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947117|NCT02550717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92947118|NCT02550717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92947119|NCT02550717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947120|NCT02550717|Antipyretics|antipyretics|mesh-ancestor
92947121|NCT02550717|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92947122|NCT02550717|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92947123|NCT02550717|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92947124|NCT02550717|Purinergic Agents|purinergic agents|mesh-ancestor
92947125|NCT02550717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947126|NCT02550249|Nivolumab|nivolumab|mesh-list
92947127|NCT02550249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947128|NCT02550249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947129|NCT02550249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92947130|NCT02550249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947131|NCT00824811|Fluorometholone|fluorometholone|mesh-list
92947132|NCT00824811|Cyclosporine|cyclosporine|mesh-list
92947133|NCT00824811|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92947134|NCT00824811|Lubricant Eye Drops|lubricant eye drops|mesh-list
92947135|NCT00824811|Cyclosporins|cyclosporins|mesh-list
92947136|NCT00824811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947137|NCT00824811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947138|NCT00824811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92947139|NCT00824811|Immunologic Factors|immunologic factors|mesh-ancestor
92947140|NCT00824811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947141|NCT00824811|Antifungal Agents|antifungal agents|mesh-ancestor
92947142|NCT00824811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947143|NCT00824811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92947144|NCT00824811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947145|NCT00824811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92947146|NCT00824811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92947147|NCT00824811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947148|NCT00824811|Glucocorticoids|glucocorticoids|mesh-ancestor
92947149|NCT00824811|Hormones|hormones|mesh-ancestor
92947150|NCT00824811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947151|NCT00824811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92947152|NCT00606580|Paromomycin|paromomycin|mesh-list
92947153|NCT00606580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947154|NCT00606580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947155|NCT00606580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92947156|NCT00606580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92947157|NCT02550327|Paclitaxel|paclitaxel|mesh-list
92947158|NCT02550327|Gemcitabine|gemcitabine|mesh-list
92947159|NCT02550327|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92947160|NCT02550327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92947161|NCT02550327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947162|NCT02550327|Tubulin Modulators|tubulin modulators|mesh-ancestor
92947163|NCT02550327|Antimitotic Agents|antimitotic agents|mesh-ancestor
92947164|NCT02550327|Mitosis Modulators|mitosis modulators|mesh-ancestor
92947165|NCT02550327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947166|NCT02550327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92947167|NCT02550327|Antimetabolites|antimetabolites|mesh-ancestor
92947168|NCT02550327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947169|NCT00825045|Risperidone|risperidone|mesh-list
92947170|NCT00825045|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92947171|NCT00825045|Serotonin Agents|serotonin agents|mesh-ancestor
92947172|NCT00825045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947173|NCT00825045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947174|NCT00825045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947175|NCT00825045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92947176|NCT00825045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92947177|NCT00825045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947178|NCT00825045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92947179|NCT00825045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92947180|NCT00825045|Dopamine Agents|dopamine agents|mesh-ancestor
92947181|NCT00606502|Vitamins|vitamins|mesh-list
92947182|NCT00606502|Folic Acid|folic acid|mesh-list
92947183|NCT00606502|Vitamin B 12|vitamin b 12|mesh-list
92947184|NCT00606502|Vitamin B Complex|vitamin b complex|mesh-list
92947185|NCT00606502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92947186|NCT00606502|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92947187|NCT00606502|Micronutrients|micronutrients|mesh-ancestor
92947188|NCT00606502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947189|NCT00606502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947190|NCT00606502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947191|NCT00606502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947192|NCT00606502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947193|NCT00606502|Hematinics|hematinics|mesh-ancestor
92947194|NCT00606502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92947195|NCT00825123|Metoprolol|metoprolol|mesh-list
92947196|NCT00825123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92947197|NCT00825123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92947198|NCT00825123|Sympatholytics|sympatholytics|mesh-ancestor
92947199|NCT00825123|Autonomic Agents|autonomic agents|mesh-ancestor
92947200|NCT00825123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947201|NCT00825123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947202|NCT00825123|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92947203|NCT00825123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92947204|NCT00825123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92947205|NCT00825123|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947206|NCT00825123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947207|NCT00825123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947208|NCT00826839|Leuprolide|leuprolide|mesh-list
92947209|NCT00826839|Contraceptive Agents|contraceptive agents|mesh-list
92947210|NCT00826839|Contraceptives, Oral|contraceptives, oral|mesh-list
92947211|NCT00826839|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92947212|NCT00826839|Ganirelix|ganirelix|mesh-list
92947213|NCT00826839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92947214|NCT00826839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947215|NCT00826839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92947216|NCT00826839|Fertility Agents|fertility agents|mesh-ancestor
92947217|NCT00826839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92947218|NCT00826839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947219|NCT00826839|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92947220|NCT00826839|Hormone Antagonists|hormone antagonists|mesh-ancestor
92947221|NCT00826839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947222|NCT04017988|Ethanol|ethanol|mesh-list
92947223|NCT04017988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92947224|NCT04017988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947225|NCT04017988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947226|NCT04017988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947227|NCT00825201|Paclitaxel|paclitaxel|mesh-list
92947228|NCT00825201|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92947229|NCT00825201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92947230|NCT00825201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947231|NCT00825201|Tubulin Modulators|tubulin modulators|mesh-ancestor
92947232|NCT00825201|Antimitotic Agents|antimitotic agents|mesh-ancestor
92947233|NCT00825201|Mitosis Modulators|mitosis modulators|mesh-ancestor
92947234|NCT00825201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947235|NCT00820911|Cyclosporine|cyclosporine|mesh-list
92947236|NCT00820911|Everolimus|everolimus|mesh-list
92947237|NCT00820911|Cyclosporins|cyclosporins|mesh-list
92947238|NCT00820911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947239|NCT00820911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947240|NCT00820911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92947241|NCT00820911|Immunologic Factors|immunologic factors|mesh-ancestor
92947242|NCT00820911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947243|NCT00820911|Antifungal Agents|antifungal agents|mesh-ancestor
92947244|NCT00820911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947245|NCT00820911|Dermatologic Agents|dermatologic agents|mesh-ancestor
92947246|NCT00820911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947247|NCT00820911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92947248|NCT00820911|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92947249|NCT00820911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947250|NCT00820911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947251|NCT00605722|Bevacizumab|bevacizumab|mesh-list
92947252|NCT00605722|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92947253|NCT00605722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947254|NCT00605722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947255|NCT00605722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947256|NCT00605722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947257|NCT00605722|Growth Substances|growth substances|mesh-ancestor
92947258|NCT00605722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947259|NCT00605722|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947260|NCT00605722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947261|NCT00605722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947262|NCT00605722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947263|NCT00882076|Etoposide|etoposide|mesh-list
92947264|NCT00882076|Mitoxantrone|mitoxantrone|mesh-list
92947265|NCT00882076|Etoposide phosphate|etoposide phosphate|mesh-list
92947266|NCT00882076|Clofarabine|clofarabine|mesh-list
92947267|NCT00882076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92947268|NCT00882076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947269|NCT00882076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92947270|NCT00882076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92947271|NCT00882076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947272|NCT00882076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947273|NCT00882076|Analgesics|analgesics|mesh-ancestor
92947274|NCT00882076|Sensory System Agents|sensory system agents|mesh-ancestor
92947275|NCT00882076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947276|NCT00882076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947277|NCT00882076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92947278|NCT00882076|Antimetabolites|antimetabolites|mesh-ancestor
92947279|NCT00827151|Estrogens|estrogens|mesh-list
92947280|NCT00827151|Hormones|hormones|mesh-ancestor
92947281|NCT00827151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947282|NCT00827151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947283|NCT00882154|Cefdinir|cefdinir|mesh-list
92947284|NCT00882154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947285|NCT00882154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947286|NCT00825591|Melatonin|melatonin|mesh-list
92947287|NCT00825591|Antioxidants|antioxidants|mesh-ancestor
92947288|NCT00825591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947289|NCT00825591|Protective Agents|protective agents|mesh-ancestor
92947290|NCT00825591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947291|NCT00825591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947292|NCT00882232|Hyaluronic Acid|hyaluronic acid|mesh-list
92947293|NCT00882232|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92947294|NCT00882232|Immunologic Factors|immunologic factors|mesh-ancestor
92947295|NCT00882232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947296|NCT00882232|Viscosupplements|viscosupplements|mesh-ancestor
92947297|NCT00882232|Protective Agents|protective agents|mesh-ancestor
92947298|NCT00900172|Paclitaxel|paclitaxel|mesh-list
92947299|NCT00900172|Bevacizumab|bevacizumab|mesh-list
92947300|NCT00900172|Carboplatin|carboplatin|mesh-list
92947301|NCT00900172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92947302|NCT00900172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947303|NCT00900172|Tubulin Modulators|tubulin modulators|mesh-ancestor
92947304|NCT00900172|Antimitotic Agents|antimitotic agents|mesh-ancestor
92947305|NCT00900172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92947306|NCT00900172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947307|NCT00900172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947308|NCT00900172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947309|NCT00900172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947310|NCT00900172|Growth Substances|growth substances|mesh-ancestor
92947311|NCT00900172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947312|NCT00900172|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947313|NCT00605566|Cyclophosphamide|cyclophosphamide|mesh-list
92947314|NCT00605566|Sorafenib|sorafenib|mesh-list
92947315|NCT00605566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92947316|NCT00605566|Immunologic Factors|immunologic factors|mesh-ancestor
92947317|NCT00605566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947318|NCT00605566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947319|NCT00605566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92947320|NCT00605566|Alkylating Agents|alkylating agents|mesh-ancestor
92947321|NCT00605566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947322|NCT00605566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947323|NCT00605566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92947324|NCT00605566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947325|NCT00605566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947326|NCT00882388|Aspirin|aspirin|mesh-list
92947327|NCT00882388|Celecoxib|celecoxib|mesh-list
92947328|NCT00882388|Clopidogrel|clopidogrel|mesh-list
92947329|NCT00882388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92947330|NCT00882388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947331|NCT00882388|Analgesics|analgesics|mesh-ancestor
92947332|NCT00882388|Sensory System Agents|sensory system agents|mesh-ancestor
92947333|NCT00882388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947334|NCT00882388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947335|NCT00882388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947336|NCT00882388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947337|NCT00882388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92947338|NCT00882388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92947339|NCT00882388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947340|NCT00882388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92947341|NCT00882388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92947342|NCT00882388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947343|NCT00882388|Antipyretics|antipyretics|mesh-ancestor
92947344|NCT00882388|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92947345|NCT00882388|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92947346|NCT00882388|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92947347|NCT00882388|Purinergic Agents|purinergic agents|mesh-ancestor
92947348|NCT00882388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947349|NCT00882388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92947350|NCT00396877|Clopidogrel|clopidogrel|mesh-list
92947351|NCT00396877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92947352|NCT00396877|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92947353|NCT00396877|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92947354|NCT00396877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92947355|NCT00396877|Purinergic Agents|purinergic agents|mesh-ancestor
92947356|NCT00396877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947357|NCT00396877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947358|NCT00396877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947359|NCT00124891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92947360|NCT00882466|Epoetin Alfa|epoetin alfa|mesh-list
92947361|NCT00882466|Hematinics|hematinics|mesh-ancestor
92947362|NCT00901498|BMS 708163|bms 708163|mesh-list
92947363|NCT00901498|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92947364|NCT00901498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947365|NCT00901498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947366|NCT00628251|Doxorubicin|doxorubicin|mesh-list
92947367|NCT00628251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92947368|NCT00628251|Olaparib|olaparib|mesh-list
92947369|NCT00628251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92947370|NCT00628251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947371|NCT00628251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92947372|NCT00628251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92947373|NCT00628251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947374|NCT00628251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947375|NCT00628251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92947376|NCT01036399|Lenalidomide|lenalidomide|mesh-list
92947377|NCT01036399|Immunologic Factors|immunologic factors|mesh-ancestor
92947378|NCT01036399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947379|NCT01036399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947380|NCT01036399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947381|NCT01036399|Growth Substances|growth substances|mesh-ancestor
92947382|NCT01036399|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947383|NCT01036399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947384|NCT00901654|Vaccines|vaccines|mesh-list
92947385|NCT00901654|Immunologic Factors|immunologic factors|mesh-ancestor
92947386|NCT00901654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947387|NCT00625131|Bupropion|bupropion|mesh-list
92947388|NCT00625131|Nicotine|nicotine|mesh-list
92947389|NCT00625131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92947390|NCT00625131|Autonomic Agents|autonomic agents|mesh-ancestor
92947391|NCT00625131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947392|NCT00625131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947393|NCT00625131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92947394|NCT00625131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92947395|NCT00625131|Cholinergic Agents|cholinergic agents|mesh-ancestor
92947396|NCT00625131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947397|NCT00625131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947398|NCT00625131|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92947399|NCT00625131|Antidepressive Agents|antidepressive agents|mesh-ancestor
92947400|NCT00625131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92947401|NCT00625131|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92947402|NCT00625131|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92947403|NCT00625131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947404|NCT00625131|Dopamine Agents|dopamine agents|mesh-ancestor
92947405|NCT00625131|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92947406|NCT00625131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92947407|NCT00625131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947408|NCT00901732|Calcium|calcium|mesh-list
92947409|NCT00901732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92947410|NCT00901732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947411|NCT00882700|Cefdinir|cefdinir|mesh-list
92947412|NCT00882700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947413|NCT00882700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947414|NCT00408499|Cetuximab|cetuximab|mesh-list
92947415|NCT00408499|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92947416|NCT00408499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947417|NCT00408499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947418|NCT00408499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947419|NCT00408499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947420|NCT00408499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947421|NCT00837369|Regadenoson|regadenoson|mesh-list
92947422|NCT00837369|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92947423|NCT00837369|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92947424|NCT00837369|Purinergic Agonists|purinergic agonists|mesh-ancestor
92947425|NCT00837369|Purinergic Agents|purinergic agents|mesh-ancestor
92947426|NCT00837369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947427|NCT00837369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947428|NCT00837369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947429|NCT00900874|Albuterol|albuterol|mesh-list
92947430|NCT00900874|Formoterol Fumarate|formoterol fumarate|mesh-list
92947431|NCT00900874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92947432|NCT00900874|Autonomic Agents|autonomic agents|mesh-ancestor
92592868|NCT00343876|Antipyretics|antipyretics|mesh-ancestor
92947433|NCT00900874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947434|NCT00900874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947435|NCT00900874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92947436|NCT00900874|Respiratory System Agents|respiratory system agents|mesh-ancestor
92947437|NCT00900874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92947438|NCT00900874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92947439|NCT00900874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92947440|NCT00900874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947441|NCT00900874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947442|NCT00900874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947443|NCT00900874|Tocolytic Agents|tocolytic agents|mesh-ancestor
92947444|NCT00900874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92947445|NCT02539810|Antihypertensive Agents|antihypertensive agents|mesh-list
92947446|NCT00901888|Nitroprusside|nitroprusside|mesh-list
92947447|NCT00901888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92947448|NCT00901888|Vasodilator Agents|vasodilator agents|mesh-ancestor
92947449|NCT00901888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92947450|NCT00901888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947451|NCT00908362|Fluticasone|fluticasone|mesh-list
92947452|NCT00908362|Xhance|xhance|mesh-list
92947453|NCT00908362|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92947454|NCT00908362|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92947455|NCT00908362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947456|NCT00908362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92947457|NCT00908362|Autonomic Agents|autonomic agents|mesh-ancestor
92947458|NCT00908362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947459|NCT00908362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947460|NCT00908362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92947461|NCT00908362|Respiratory System Agents|respiratory system agents|mesh-ancestor
92947462|NCT00908362|Dermatologic Agents|dermatologic agents|mesh-ancestor
92947463|NCT00908362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92947464|NCT00908362|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92947465|NCT00908362|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92947466|NCT00908362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92947467|NCT00908362|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947468|NCT00908362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947469|NCT00908362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947470|NCT00908362|Glucocorticoids|glucocorticoids|mesh-ancestor
92947471|NCT00908362|Hormones|hormones|mesh-ancestor
92947472|NCT00908362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947473|NCT00908362|Sympathomimetics|sympathomimetics|mesh-ancestor
92947474|NCT02549469|Naproxen|naproxen|mesh-list
92947475|NCT02549469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92947476|NCT02549469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947477|NCT02549469|Analgesics|analgesics|mesh-ancestor
92947478|NCT02549469|Sensory System Agents|sensory system agents|mesh-ancestor
92947479|NCT02549469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947480|NCT02549469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947481|NCT02549469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947482|NCT02549469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947483|NCT02549469|Gout Suppressants|gout suppressants|mesh-ancestor
92947484|NCT02549469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92947485|NCT02549469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947486|NCT02549469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947487|NCT02548533|Lidocaine|lidocaine|mesh-list
92947488|NCT02548533|Epinephrine|epinephrine|mesh-list
92947489|NCT02548533|Prilocaine|prilocaine|mesh-list
92947490|NCT02548533|Carticaine|carticaine|mesh-list
92947491|NCT02548533|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92947492|NCT02548533|Anesthetics, Local|anesthetics, local|mesh-ancestor
92947493|NCT02548533|Anesthetics|anesthetics|mesh-ancestor
92947494|NCT02548533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947495|NCT02548533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947496|NCT02548533|Sensory System Agents|sensory system agents|mesh-ancestor
92947497|NCT02548533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947498|NCT02548533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92947499|NCT02548533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92947500|NCT02548533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92947501|NCT02548533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947502|NCT02548533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947503|NCT02548533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92947504|NCT02548533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92947505|NCT02548533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947506|NCT02548533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947507|NCT02548533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92947508|NCT02548533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92947509|NCT02548533|Autonomic Agents|autonomic agents|mesh-ancestor
92947510|NCT02548533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92947511|NCT02548533|Respiratory System Agents|respiratory system agents|mesh-ancestor
92947512|NCT02548533|Mydriatics|mydriatics|mesh-ancestor
92947513|NCT02548533|Sympathomimetics|sympathomimetics|mesh-ancestor
92947514|NCT02548533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92947515|NCT02548533|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92947516|NCT02549391|Cinacalcet|cinacalcet|mesh-list
92947517|NCT02549391|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92947518|NCT02549391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947519|NCT02549391|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92947520|NCT02549391|Hormone Antagonists|hormone antagonists|mesh-ancestor
92947521|NCT02549391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947522|NCT02538172|Valganciclovir|valganciclovir|mesh-list
92947523|NCT02538172|Antiviral Agents|antiviral agents|mesh-ancestor
92947524|NCT02538172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947525|NCT00837837|Chlorpheniramine|chlorpheniramine|mesh-list
92947526|NCT00837837|Antipruritics|antipruritics|mesh-ancestor
92947527|NCT00837837|Dermatologic Agents|dermatologic agents|mesh-ancestor
92947528|NCT00837837|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92947529|NCT00837837|Histamine Antagonists|histamine antagonists|mesh-ancestor
92947530|NCT00837837|Histamine Agents|histamine agents|mesh-ancestor
92947531|NCT00837837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947532|NCT00837837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947533|NCT00837837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947534|NCT00837837|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92947535|NCT00908674|Cyproterone Acetate|cyproterone acetate|mesh-list
92947536|NCT00908674|Cyproterone|cyproterone|mesh-list
92947537|NCT00908674|Androgen Antagonists|androgen antagonists|mesh-ancestor
92947538|NCT00908674|Hormone Antagonists|hormone antagonists|mesh-ancestor
92947539|NCT00908674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947540|NCT00908674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947541|NCT00908674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947542|NCT00908674|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92947543|NCT00908674|Contraceptive Agents|contraceptive agents|mesh-ancestor
92947544|NCT00908674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92947545|NCT00621777|Varenicline|varenicline|mesh-list
92947546|NCT00621777|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92947547|NCT00621777|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92947548|NCT00621777|Cholinergic Agents|cholinergic agents|mesh-ancestor
92947549|NCT00621777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947550|NCT00621777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947551|NCT00621777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947552|NCT02538718|Ritodrine|ritodrine|mesh-list
92947553|NCT02538718|Sympathomimetics|sympathomimetics|mesh-ancestor
92947554|NCT02538718|Autonomic Agents|autonomic agents|mesh-ancestor
92947555|NCT02538718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947556|NCT02538718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947557|NCT02538718|Tocolytic Agents|tocolytic agents|mesh-ancestor
92947558|NCT02538718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92947559|NCT02538718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92947560|NCT02538718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92947561|NCT02538718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92947562|NCT02538718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947563|NCT02538718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947564|NCT02538718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947565|NCT00902512|Sildenafil Citrate|sildenafil citrate|mesh-list
92947566|NCT00902512|Vasodilator Agents|vasodilator agents|mesh-ancestor
92947567|NCT00902512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92947568|NCT00902512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92947569|NCT00902512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947570|NCT00902512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947571|NCT00902512|Urological Agents|urological agents|mesh-ancestor
92947572|NCT00827307|Tamoxifen|tamoxifen|mesh-list
92947573|NCT00827307|Goserelin|goserelin|mesh-list
92947574|NCT00827307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92947575|NCT00827307|Hormone Antagonists|hormone antagonists|mesh-ancestor
92947576|NCT00827307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947577|NCT00827307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947578|NCT00827307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92947579|NCT00827307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947580|NCT00827307|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92947581|NCT00827307|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92947582|NCT00827307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92947583|NCT00837915|Loratadine|loratadine|mesh-list
92947584|NCT00837915|Pseudoephedrine|pseudoephedrine|mesh-list
92947585|NCT00837915|Ephedrine|ephedrine|mesh-list
92947586|NCT00837915|Antipruritics|antipruritics|mesh-ancestor
92947587|NCT00837915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92947588|NCT00837915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92947589|NCT00837915|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92947590|NCT00837915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92947591|NCT00837915|Histamine Antagonists|histamine antagonists|mesh-ancestor
92947592|NCT00837915|Histamine Agents|histamine agents|mesh-ancestor
92947593|NCT00837915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947594|NCT00837915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947595|NCT00837915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947596|NCT00837915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92947597|NCT00837915|Autonomic Agents|autonomic agents|mesh-ancestor
92947598|NCT00837915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947599|NCT00837915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92947600|NCT00837915|Respiratory System Agents|respiratory system agents|mesh-ancestor
92947601|NCT00837915|Nasal Decongestants|nasal decongestants|mesh-ancestor
92947602|NCT00837915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92947603|NCT00837915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92947604|NCT00837915|Sympathomimetics|sympathomimetics|mesh-ancestor
92947605|NCT00837915|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947606|NCT00908986|Rituximab|rituximab|mesh-list
92947607|NCT00908986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947608|NCT00908986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947609|NCT00908986|Immunologic Factors|immunologic factors|mesh-ancestor
92947610|NCT00908986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947611|NCT00908986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947612|NCT00909142|Clodronic Acid|clodronic acid|mesh-list
92947613|NCT00909142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92947614|NCT00909142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947615|NCT00838071|Immunoglobulins|immunoglobulins|mesh-list
92947616|NCT00838071|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92947617|NCT00838071|Antibodies|antibodies|mesh-list
92947618|NCT00838071|Immunologic Factors|immunologic factors|mesh-ancestor
92947619|NCT00838071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947620|NCT02547519|Insulin|insulin|mesh-list
92947621|NCT02547519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92947622|NCT02547519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947623|NCT00909454|Vitamin D|vitamin d|mesh-list
92947624|NCT00909454|Ergocalciferols|ergocalciferols|mesh-list
92947625|NCT00909454|Cholecalciferol|cholecalciferol|mesh-list
92947626|NCT00909454|Vitamins|vitamins|mesh-list
92947627|NCT00909454|Micronutrients|micronutrients|mesh-ancestor
92947628|NCT00909454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947629|NCT00909454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92947630|NCT00909454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92947631|NCT04035070|Clindamycin|clindamycin|mesh-list
92947632|NCT04035070|Clindamycin palmitate|clindamycin palmitate|mesh-list
92947633|NCT04035070|Clindamycin phosphate|clindamycin phosphate|mesh-list
92947634|NCT04035070|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92947635|NCT04035070|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92947637|NCT04035070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947638|NCT04035070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947639|NCT04035070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92947640|NCT04035070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947641|NCT04035070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947642|NCT04035070|Disinfectants|disinfectants|mesh-ancestor
92947643|NCT04035070|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92947644|NCT00408421|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92947645|NCT00408421|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92947646|NCT00408421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92947647|NCT00408421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947648|NCT00408421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947649|NCT00408421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947650|NCT00408421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947651|NCT00408421|Analgesics|analgesics|mesh-ancestor
92947652|NCT00408421|Sensory System Agents|sensory system agents|mesh-ancestor
92947653|NCT00408421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947654|NCT00408421|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593088|NCT00344851|Hormones|hormones|mesh-ancestor
92947655|NCT00408421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92947656|NCT00408421|Dopamine Agents|dopamine agents|mesh-ancestor
92947657|NCT00604786|Omalizumab|omalizumab|mesh-list
92947658|NCT00604786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92947659|NCT00604786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92947660|NCT00604786|Respiratory System Agents|respiratory system agents|mesh-ancestor
92947661|NCT01042873|Dobutamine|dobutamine|mesh-list
92947662|NCT01042873|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92947663|NCT01042873|Sympathomimetics|sympathomimetics|mesh-ancestor
92947664|NCT01042873|Autonomic Agents|autonomic agents|mesh-ancestor
92947665|NCT01042873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947666|NCT01042873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947667|NCT01042873|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92947668|NCT01042873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92947669|NCT01042873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92947670|NCT01042873|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947671|NCT01042873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947672|NCT01042873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947673|NCT01042873|Protective Agents|protective agents|mesh-ancestor
92947674|NCT01042951|Vaccines|vaccines|mesh-list
92947675|NCT01042951|Immunologic Factors|immunologic factors|mesh-ancestor
92947676|NCT01042951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947677|NCT01037023|Topotecan|topotecan|mesh-list
92947678|NCT01037023|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92947679|NCT01037023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92947680|NCT01037023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947681|NCT01037023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947682|NCT01037023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947683|NCT00604708|Vaccines|vaccines|mesh-list
92947684|NCT00604708|Immunologic Factors|immunologic factors|mesh-ancestor
92527302|NCT00000599|Niacin|niacin|mesh-list
92947685|NCT00604708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947686|NCT00909688|BLI-489|bli-489|mesh-list
92947687|NCT00909688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92947688|NCT00909688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947689|NCT00909688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947690|NCT00909688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947691|NCT00909688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947692|NCT00903214|Riluzole|riluzole|mesh-list
92947693|NCT00903214|Anticonvulsants|anticonvulsants|mesh-ancestor
92947694|NCT00903214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92947695|NCT00903214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92947696|NCT00903214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947697|NCT00903214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947698|NCT00903214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947699|NCT00903214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92947700|NCT00903214|Protective Agents|protective agents|mesh-ancestor
92947701|NCT04034836|Parecoxib|parecoxib|mesh-list
92947702|NCT04034836|Ropivacaine|ropivacaine|mesh-list
92947703|NCT04034836|Anesthetics, Local|anesthetics, local|mesh-ancestor
92947704|NCT04034836|Anesthetics|anesthetics|mesh-ancestor
92947705|NCT04034836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947706|NCT04034836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947707|NCT04034836|Sensory System Agents|sensory system agents|mesh-ancestor
92947708|NCT04034836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947709|NCT04034836|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92947710|NCT04034836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92947711|NCT04034836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947712|NCT04034836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947713|NCT04034836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92947714|NCT04034836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947715|NCT04034836|Analgesics|analgesics|mesh-ancestor
92947716|NCT04034836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947717|NCT04034836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947718|NCT00407797|Pregabalin|pregabalin|mesh-list
92947719|NCT00407797|Analgesics|analgesics|mesh-ancestor
92947720|NCT00407797|Sensory System Agents|sensory system agents|mesh-ancestor
92947721|NCT00407797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947722|NCT00407797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947723|NCT00407797|Anticonvulsants|anticonvulsants|mesh-ancestor
92947724|NCT00407797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92947725|NCT00407797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947726|NCT00407797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947727|NCT00407797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92947728|NCT00407797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92947729|NCT00407797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92947730|NCT00407797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947731|NCT00407797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92947732|NCT00903292|Pemetrexed|pemetrexed|mesh-list
92947733|NCT00903292|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92947734|NCT00903292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947735|NCT00903292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947736|NCT00903292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947737|NCT00903292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92947738|NCT00903292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92947739|NCT00903292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92947740|NCT00903838|Pramipexole|pramipexole|mesh-list
92947741|NCT00903838|Antioxidants|antioxidants|mesh-ancestor
92947742|NCT00903838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947743|NCT00903838|Protective Agents|protective agents|mesh-ancestor
92947744|NCT00903838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947745|NCT00903838|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92947746|NCT00903838|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92947747|NCT00903838|Dopamine Agonists|dopamine agonists|mesh-ancestor
92947748|NCT00903838|Dopamine Agents|dopamine agents|mesh-ancestor
92947749|NCT00903838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947750|NCT00924430|Simvastatin|simvastatin|mesh-list
92947751|NCT00924430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92947752|NCT00924430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92947753|NCT00924430|Antimetabolites|antimetabolites|mesh-ancestor
92947754|NCT00924430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947755|NCT00924430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92947756|NCT00924430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92947757|NCT00924430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947758|NCT00924586|Landiolol|landiolol|mesh-list
92947759|NCT00924586|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92947760|NCT00924586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92947761|NCT00924586|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947762|NCT00924586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947763|NCT00924586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947764|NCT00924586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947765|NCT00924586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92947766|NCT00903994|Ketoprofen|ketoprofen|mesh-list
92947767|NCT00903994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92947768|NCT00903994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947769|NCT00903994|Analgesics|analgesics|mesh-ancestor
92947770|NCT00903994|Sensory System Agents|sensory system agents|mesh-ancestor
92947771|NCT00903994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947772|NCT00903994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947773|NCT00903994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92947774|NCT00903994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92947775|NCT00903994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92947776|NCT00903994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947777|NCT00903994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947778|NCT00924742|Tazobactam|tazobactam|mesh-list
92947779|NCT00924742|Piperacillin|piperacillin|mesh-list
92947780|NCT00924742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947781|NCT00924742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947782|NCT00924742|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92947783|NCT00924742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947784|NCT00924742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947785|NCT00407563|Paclitaxel|paclitaxel|mesh-list
92947786|NCT00407563|Bevacizumab|bevacizumab|mesh-list
92947787|NCT00407563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92947788|NCT00407563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92947789|NCT00407563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947790|NCT00407563|Tubulin Modulators|tubulin modulators|mesh-ancestor
92947791|NCT00407563|Antimitotic Agents|antimitotic agents|mesh-ancestor
92947792|NCT00407563|Mitosis Modulators|mitosis modulators|mesh-ancestor
92947793|NCT00407563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947794|NCT00407563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947795|NCT00407563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947796|NCT00407563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947797|NCT00407563|Growth Substances|growth substances|mesh-ancestor
92947798|NCT00407563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947799|NCT00407563|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947800|NCT00906724|Insulin|insulin|mesh-list
92947801|NCT00906724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92947802|NCT00906724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593241|NCT00125736|Rabeprazole|rabeprazole|mesh-list
92947804|NCT01037101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92947805|NCT01037101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947806|NCT01037101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92947807|NCT01037101|Antitubercular Agents|antitubercular agents|mesh-ancestor
92947808|NCT01037101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92947809|NCT01037101|Antimetabolites|antimetabolites|mesh-ancestor
92947810|NCT01037101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947811|NCT00904306|Chromium|chromium|mesh-list
92947812|NCT00904306|Picolinic acid|picolinic acid|mesh-list
92947813|NCT00904306|Trace Elements|trace elements|mesh-ancestor
92947814|NCT00904306|Micronutrients|micronutrients|mesh-ancestor
92947815|NCT00904306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947816|NCT00904306|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92947817|NCT00904306|Chelating Agents|chelating agents|mesh-ancestor
92947818|NCT00904306|Sequestering Agents|sequestering agents|mesh-ancestor
92947819|NCT00904306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947820|NCT00623103|Rivastigmine|rivastigmine|mesh-list
92947821|NCT00623103|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92947822|NCT00623103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947823|NCT00623103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947824|NCT00623103|Cholinergic Agents|cholinergic agents|mesh-ancestor
92947825|NCT00623103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947826|NCT00623103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947827|NCT00623103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92947828|NCT00623103|Protective Agents|protective agents|mesh-ancestor
92947829|NCT01043341|Vaccines|vaccines|mesh-list
92947830|NCT01043341|Immunologic Factors|immunologic factors|mesh-ancestor
92947831|NCT01043341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947832|NCT01043419|Xenon|xenon|mesh-list
92947833|NCT01043419|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92947834|NCT01043419|Anesthetics, General|anesthetics, general|mesh-ancestor
92947835|NCT01043419|Anesthetics|anesthetics|mesh-ancestor
92947836|NCT01043419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947837|NCT01043419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947838|NCT01037335|Morphine|morphine|mesh-list
92947839|NCT01037335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92947840|NCT01037335|Narcotics|narcotics|mesh-ancestor
92947841|NCT01037335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947842|NCT01037335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947843|NCT01037335|Analgesics|analgesics|mesh-ancestor
92947844|NCT01037335|Sensory System Agents|sensory system agents|mesh-ancestor
92947845|NCT01037335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947846|NCT04015492|Factor VIII|factor viii|mesh-list
92947847|NCT04015492|BAX 855|bax 855|mesh-list
92947848|NCT04015492|Coagulants|coagulants|mesh-ancestor
92947849|NCT00904462|Lidocaine|lidocaine|mesh-list
92947850|NCT00904462|Anesthetics, Local|anesthetics, local|mesh-ancestor
92947851|NCT00904462|Anesthetics|anesthetics|mesh-ancestor
92947852|NCT00904462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947853|NCT00904462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947854|NCT00904462|Sensory System Agents|sensory system agents|mesh-ancestor
92947855|NCT00904462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947856|NCT00904462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92947857|NCT00904462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92947858|NCT00904462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92947859|NCT00904462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947860|NCT00904462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947861|NCT00396565|Olanzapine|olanzapine|mesh-list
92947862|NCT00396565|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92947863|NCT00396565|Antiemetics|antiemetics|mesh-ancestor
92947864|NCT00396565|Autonomic Agents|autonomic agents|mesh-ancestor
92947865|NCT00396565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947866|NCT00396565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947867|NCT00396565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92947868|NCT00396565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92947869|NCT00396565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92947870|NCT00396565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947871|NCT00396565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92947872|NCT00396565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92947873|NCT00396565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92947874|NCT00396565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947875|NCT00396565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947876|NCT00396565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947877|NCT00396565|Serotonin Agents|serotonin agents|mesh-ancestor
92947878|NCT00396565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92947879|NCT00396565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92947880|NCT00396565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92947881|NCT00396565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92947883|NCT00904540|Lidocaine|lidocaine|mesh-list
92947884|NCT00904540|Anesthetics, Local|anesthetics, local|mesh-ancestor
92947885|NCT00904540|Anesthetics|anesthetics|mesh-ancestor
92947886|NCT00904540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947887|NCT00904540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947888|NCT00904540|Sensory System Agents|sensory system agents|mesh-ancestor
92947889|NCT00904540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947890|NCT00904540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92947891|NCT00904540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92947892|NCT00904540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92947893|NCT00904540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947894|NCT00904540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947895|NCT00906880|Eflornithine|eflornithine|mesh-list
92947896|NCT00906880|Nifurtimox|nifurtimox|mesh-list
92947897|NCT00906880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947898|NCT00906880|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92947899|NCT00906880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92947900|NCT00906880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92947901|NCT00906880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92947902|NCT00906880|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92947903|NCT00906880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92947904|NCT00906880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947905|NCT00904852|Bevacizumab|bevacizumab|mesh-list
92947906|NCT00904852|Temozolomide|temozolomide|mesh-list
92947907|NCT00904852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92947908|NCT00904852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92947909|NCT00904852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92947910|NCT00904852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92947911|NCT00904852|Growth Substances|growth substances|mesh-ancestor
92947912|NCT00904852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947913|NCT00904852|Growth Inhibitors|growth inhibitors|mesh-ancestor
92947914|NCT00904852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92947915|NCT00904852|Alkylating Agents|alkylating agents|mesh-ancestor
92947916|NCT00904852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947917|NCT00394771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92947918|NCT00394771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92947919|NCT00394771|Levonorgestrel|levonorgestrel|mesh-list
92947920|NCT00394771|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92947921|NCT00394771|Estradiol|estradiol|mesh-list
92947922|NCT00394771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92947923|NCT00394771|Estrogens|estrogens|mesh-ancestor
92947924|NCT00394771|Hormones|hormones|mesh-ancestor
92947925|NCT00394771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92947926|NCT00394771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947927|NCT00394771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92947928|NCT00394771|Contraceptive Agents|contraceptive agents|mesh-ancestor
92947929|NCT00394771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92947930|NCT00394771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92947931|NCT00394771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92947932|NCT00394771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92947933|NCT00394771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92947934|NCT00396409|Omalizumab|omalizumab|mesh-list
92947935|NCT00396409|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92947936|NCT00396409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92947937|NCT00396409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92947938|NCT03653832|Clonidine|clonidine|mesh-list
92947939|NCT03653832|Dexmedetomidine|dexmedetomidine|mesh-list
92947940|NCT03653832|Propofol|propofol|mesh-list
92947941|NCT03653832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92947942|NCT03653832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947943|NCT03653832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947944|NCT03653832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92947945|NCT03653832|Analgesics|analgesics|mesh-ancestor
92947946|NCT03653832|Sensory System Agents|sensory system agents|mesh-ancestor
92947947|NCT03653832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947948|NCT03653832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92947949|NCT03653832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92947950|NCT03653832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92947951|NCT03653832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92947952|NCT03653832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947953|NCT03653832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947954|NCT03653832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92947955|NCT03653832|Anesthetics, General|anesthetics, general|mesh-ancestor
92947956|NCT03653832|Anesthetics|anesthetics|mesh-ancestor
92947957|NCT03653832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92947958|NCT03653832|Sympatholytics|sympatholytics|mesh-ancestor
92947959|NCT03653832|Autonomic Agents|autonomic agents|mesh-ancestor
92947960|NCT04060836|Factor VIII|factor viii|mesh-list
92947961|NCT04060836|Coagulants|coagulants|mesh-ancestor
92947962|NCT00693420|Bimatoprost|bimatoprost|mesh-list
92947963|NCT00693420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92947964|NCT00693420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92947965|NCT04034524|Insulin|insulin|mesh-list
92947966|NCT04034524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92947967|NCT04034524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92947968|NCT04034524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947969|NCT00925912|Bupivacaine|bupivacaine|mesh-list
92947970|NCT00925912|Anesthetics, Local|anesthetics, local|mesh-ancestor
92947971|NCT00925912|Anesthetics|anesthetics|mesh-ancestor
92947972|NCT00925912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92947973|NCT00925912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947974|NCT00925912|Sensory System Agents|sensory system agents|mesh-ancestor
92947975|NCT00925912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92947976|NCT00695136|Donepezil|donepezil|mesh-list
92947977|NCT00695136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92947978|NCT00695136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527307|NCT00000599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92947979|NCT00695136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947980|NCT00695136|Cholinergic Agents|cholinergic agents|mesh-ancestor
92947981|NCT00695136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92947982|NCT00695136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947983|NCT00695136|Nootropic Agents|nootropic agents|mesh-ancestor
92947984|NCT00921570|Amlodipine|amlodipine|mesh-list
92947985|NCT00921570|Valsartan|valsartan|mesh-list
92947986|NCT00921570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92947987|NCT00921570|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92947988|NCT00921570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92947989|NCT00921570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92947990|NCT00921570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92947991|NCT00921570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92947992|NCT00921570|Vasodilator Agents|vasodilator agents|mesh-ancestor
92947993|NCT00921570|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92947994|NCT00921570|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92947995|NCT02710890|Lacosamide|lacosamide|mesh-list
92947996|NCT02710890|Anticonvulsants|anticonvulsants|mesh-ancestor
92947997|NCT02710890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92947998|NCT02710890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92947999|NCT02710890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948000|NCT02710890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948001|NCT00605176|Imiquimod|imiquimod|mesh-list
92948002|NCT00605176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92948003|NCT00605176|Immunologic Factors|immunologic factors|mesh-ancestor
92948004|NCT00605176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948005|NCT00605176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948006|NCT00605176|Interferon Inducers|interferon inducers|mesh-ancestor
92948007|NCT00743028|Navitoclax|navitoclax|mesh-list
92948008|NCT00743028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948009|NCT00926302|Levetiracetam|levetiracetam|mesh-list
92948010|NCT00926302|Anticonvulsants|anticonvulsants|mesh-ancestor
92948011|NCT00926302|Nootropic Agents|nootropic agents|mesh-ancestor
92948012|NCT00907036|Cyclosporine|cyclosporine|mesh-list
92948013|NCT00907036|Fludarabine|fludarabine|mesh-list
92948014|NCT00907036|Fludarabine phosphate|fludarabine phosphate|mesh-list
92948015|NCT00907036|Melphalan|melphalan|mesh-list
92948016|NCT00907036|Alemtuzumab|alemtuzumab|mesh-list
92948017|NCT00907036|Cyclosporins|cyclosporins|mesh-list
92948018|NCT00907036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948019|NCT00907036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948020|NCT00907036|Antimetabolites|antimetabolites|mesh-ancestor
92948021|NCT00907036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948022|NCT00907036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948023|NCT00907036|Immunologic Factors|immunologic factors|mesh-ancestor
92948024|NCT00907036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948025|NCT00907036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948026|NCT00907036|Antifungal Agents|antifungal agents|mesh-ancestor
92593462|NCT00347152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948027|NCT00907036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948029|NCT00907036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948030|NCT00907036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92948031|NCT00907036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92948032|NCT00907036|Alkylating Agents|alkylating agents|mesh-ancestor
92948033|NCT00907036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92948034|NCT00907036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948035|NCT00926614|Pioglitazone|pioglitazone|mesh-list
92948036|NCT00926614|Atorvastatin|atorvastatin|mesh-list
92948037|NCT00926614|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92948038|NCT00926614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92948039|NCT00926614|Antimetabolites|antimetabolites|mesh-ancestor
92948040|NCT00926614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948041|NCT00926614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92948042|NCT00926614|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92948043|NCT00926614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948044|NCT00926614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948045|NCT00926614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948046|NCT00907114|Ketorolac|ketorolac|mesh-list
92948047|NCT00907114|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92948048|NCT00907114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92948049|NCT00907114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948050|NCT00907114|Analgesics|analgesics|mesh-ancestor
92948051|NCT00907114|Sensory System Agents|sensory system agents|mesh-ancestor
92948052|NCT00907114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948053|NCT00907114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948054|NCT00907114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948055|NCT00907114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948056|NCT00907114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92948057|NCT00907114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948058|NCT00907114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948059|NCT02564094|Epoetin Alfa|epoetin alfa|mesh-list
92948060|NCT02564094|Hematinics|hematinics|mesh-ancestor
92948061|NCT00745914|Pioglitazone|pioglitazone|mesh-list
92948062|NCT00745914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948063|NCT00745914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948064|NCT00746070|Spironolactone|spironolactone|mesh-list
92948065|NCT00746070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92948066|NCT00746070|Hormone Antagonists|hormone antagonists|mesh-ancestor
92948067|NCT00746070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948068|NCT00746070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948069|NCT00746070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92948070|NCT00746070|Diuretics|diuretics|mesh-ancestor
92948071|NCT00746070|Natriuretic Agents|natriuretic agents|mesh-ancestor
92948072|NCT00396331|Plerixafor|plerixafor|mesh-list
92948073|NCT00396331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92948074|NCT00396331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92948075|NCT00396331|Antiviral Agents|antiviral agents|mesh-ancestor
92948076|NCT00396331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948077|NCT00927550|Lithium Carbonate|lithium carbonate|mesh-list
92948078|NCT00927550|Antidepressive Agents|antidepressive agents|mesh-ancestor
92948079|NCT00927550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948080|NCT00927550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948081|NCT00927550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948082|NCT00927550|Antimanic Agents|antimanic agents|mesh-ancestor
92948083|NCT00927550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92948084|NCT00927550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948085|NCT00927550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948086|NCT00926926|Oxybutynin|oxybutynin|mesh-list
92948087|NCT00926926|Parasympatholytics|parasympatholytics|mesh-ancestor
92948088|NCT00926926|Autonomic Agents|autonomic agents|mesh-ancestor
92948089|NCT00926926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948090|NCT00926926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948091|NCT00926926|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92948092|NCT00926926|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92948093|NCT00926926|Cholinergic Agents|cholinergic agents|mesh-ancestor
92948094|NCT00926926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948095|NCT00926926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948096|NCT00926926|Urological Agents|urological agents|mesh-ancestor
92948097|NCT00396253|Tenecteplase|tenecteplase|mesh-list
92948098|NCT00396253|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92948099|NCT00396253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92948100|NCT00396253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948101|NCT00927004|Etoricoxib|etoricoxib|mesh-list
92948102|NCT00927004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92948103|NCT00927004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948105|NCT00927004|Sensory System Agents|sensory system agents|mesh-ancestor
92948106|NCT00927004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948107|NCT00927004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948108|NCT00927004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948109|NCT00927004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948110|NCT00927004|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92948111|NCT00927004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92948112|NCT00927004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948113|NCT00927004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948114|NCT00931450|Sunitinib|sunitinib|mesh-list
92948115|NCT00931450|Exemestane|exemestane|mesh-list
92948116|NCT00931450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948117|NCT00931450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948118|NCT00931450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948119|NCT00931450|Growth Substances|growth substances|mesh-ancestor
92948120|NCT00931450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948121|NCT00931450|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948122|NCT00931450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948123|NCT00931450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948124|NCT00931450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948125|NCT00931450|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92948126|NCT00931450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92948127|NCT00931450|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92948128|NCT00931450|Hormone Antagonists|hormone antagonists|mesh-ancestor
92948129|NCT00931450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948130|NCT00928330|Trastuzumab|trastuzumab|mesh-list
92948131|NCT00928330|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92948132|NCT00928330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948133|NCT00928330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948134|NCT00928330|Immunotoxins|immunotoxins|mesh-ancestor
92948135|NCT00928330|Immunoconjugates|immunoconjugates|mesh-ancestor
92948136|NCT00928330|Immunologic Factors|immunologic factors|mesh-ancestor
92948137|NCT00928330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948138|NCT00928330|Tubulin Modulators|tubulin modulators|mesh-ancestor
92948139|NCT00928330|Antimitotic Agents|antimitotic agents|mesh-ancestor
92948140|NCT00928330|Mitosis Modulators|mitosis modulators|mesh-ancestor
92948141|NCT00928330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948142|NCT00928798|Sirolimus|sirolimus|mesh-list
92948143|NCT00928798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92948144|NCT00928798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948145|NCT00928798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92948146|NCT00928798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948147|NCT00928798|Antifungal Agents|antifungal agents|mesh-ancestor
92948148|NCT00928798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948149|NCT00928798|Immunologic Factors|immunologic factors|mesh-ancestor
92948150|NCT00928798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948151|NCT00931840|Irinotecan|irinotecan|mesh-list
92948152|NCT00931840|Cetuximab|cetuximab|mesh-list
92948153|NCT00931840|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92948154|NCT00931840|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92948155|NCT00931840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948156|NCT00931840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948157|NCT00931840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948158|NCT00931840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948159|NCT04034368|Tenofovir|tenofovir|mesh-list
92948160|NCT04034368|Antiviral Agents|antiviral agents|mesh-ancestor
92948161|NCT04034368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948162|NCT04034368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92948163|NCT04034368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92948164|NCT04034368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948165|NCT04034368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948166|NCT04034368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92948167|NCT04034368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92948168|NCT00907270|Cholecalciferol|cholecalciferol|mesh-list
92948169|NCT00907270|Vitamin D|vitamin d|mesh-list
92948170|NCT00907270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92948171|NCT00907270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948172|NCT00907270|Vitamins|vitamins|mesh-ancestor
92948173|NCT00907270|Micronutrients|micronutrients|mesh-ancestor
92948174|NCT00907270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92948175|NCT00375505|Zoledronic Acid|zoledronic acid|mesh-list
92948176|NCT00375505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92948177|NCT00375505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948178|NCT00928876|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92948179|NCT00928876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948180|NCT00907504|Cisplatin|cisplatin|mesh-list
92948181|NCT00907504|Gemcitabine|gemcitabine|mesh-list
92948182|NCT00907504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948183|NCT00907504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948184|NCT00907504|Antimetabolites|antimetabolites|mesh-ancestor
92948185|NCT00907504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948186|NCT00932386|Dexmedetomidine|dexmedetomidine|mesh-list
92948187|NCT00932386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92948188|NCT00932386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948189|NCT00932386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948190|NCT00932386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948191|NCT00932386|Analgesics|analgesics|mesh-ancestor
92948192|NCT00932386|Sensory System Agents|sensory system agents|mesh-ancestor
92948193|NCT00932386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948194|NCT00932386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92948195|NCT00932386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92948196|NCT00932386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92948197|NCT00932386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92948198|NCT00932386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948199|NCT00932386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948201|NCT00932542|Prilocaine|prilocaine|mesh-list
92948202|NCT00932542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92948203|NCT00932542|Anesthetics|anesthetics|mesh-ancestor
92948204|NCT00932542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948205|NCT00932542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948206|NCT00932542|Sensory System Agents|sensory system agents|mesh-ancestor
92948207|NCT00932542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948208|NCT00932542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92948209|NCT00932542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92948210|NCT00932542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92948211|NCT00932542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948212|NCT00932542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948213|NCT00375427|Zoledronic Acid|zoledronic acid|mesh-list
92948214|NCT00375427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92948215|NCT00375427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948216|NCT04014634|Methylprednisolone|methylprednisolone|mesh-list
92948217|NCT04014634|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92948218|NCT04014634|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92948219|NCT04014634|Prednisolone|prednisolone|mesh-list
92948220|NCT04014634|Prednisolone acetate|prednisolone acetate|mesh-list
92948221|NCT04014634|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92948222|NCT04014634|Prednisolone phosphate|prednisolone phosphate|mesh-list
92948223|NCT04014634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948224|NCT04014634|Antiemetics|antiemetics|mesh-ancestor
92948225|NCT04014634|Autonomic Agents|autonomic agents|mesh-ancestor
92948226|NCT04014634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948227|NCT04014634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948228|NCT04014634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92948229|NCT04014634|Glucocorticoids|glucocorticoids|mesh-ancestor
92948230|NCT04014634|Hormones|hormones|mesh-ancestor
92948231|NCT04014634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948232|NCT04014634|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92948233|NCT04014634|Protective Agents|protective agents|mesh-ancestor
92948234|NCT04014634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92948235|NCT04014634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948236|NCT01043575|Rifampin|rifampin|mesh-list
92948237|NCT01043575|Rifapentine|rifapentine|mesh-list
92948238|NCT01043575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92948239|NCT01043575|Antitubercular Agents|antitubercular agents|mesh-ancestor
92948240|NCT01043575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92948241|NCT01043575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948242|NCT01043575|Leprostatic Agents|leprostatic agents|mesh-ancestor
92948243|NCT01043575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92948244|NCT01043575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948245|NCT01043575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948246|NCT01043575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92948247|NCT01043575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92948248|NCT01043575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92948249|NCT01043575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92948250|NCT01043575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92948251|NCT01043575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92948252|NCT01045837|Prednisolone|prednisolone|mesh-list
92948253|NCT01045837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948254|NCT01045837|Glucocorticoids|glucocorticoids|mesh-ancestor
92948255|NCT01045837|Hormones|hormones|mesh-ancestor
92948256|NCT01045837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948257|NCT01045837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948258|NCT01045837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92948259|NCT01045837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948260|NCT00567268|Gabapentin|gabapentin|mesh-list
92948261|NCT00567268|Analgesics|analgesics|mesh-ancestor
92948262|NCT00567268|Sensory System Agents|sensory system agents|mesh-ancestor
92948263|NCT00567268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948264|NCT00567268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948265|NCT00567268|Anticonvulsants|anticonvulsants|mesh-ancestor
92948266|NCT00567268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92948267|NCT00567268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92948268|NCT00567268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948269|NCT00567268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948270|NCT00567268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92527314|NCT00000602|Hydroxyurea|hydroxyurea|mesh-list
92948271|NCT00567268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92948272|NCT00567268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948273|NCT00567268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948274|NCT00567268|Antimanic Agents|antimanic agents|mesh-ancestor
92948275|NCT00907894|Telbivudine|telbivudine|mesh-list
92948276|NCT00907894|Antiviral Agents|antiviral agents|mesh-ancestor
92948277|NCT00907894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948278|NCT00907894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92948279|NCT00907894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948280|NCT00907894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948281|NCT04014556|Aflibercept|aflibercept|mesh-list
92948282|NCT04014556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948283|NCT04014556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948284|NCT04014556|Growth Substances|growth substances|mesh-ancestor
92948285|NCT04014556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948286|NCT04014556|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948287|NCT04014556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948288|NCT00929812|Glucagon|glucagon|mesh-list
92948289|NCT00929812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92948290|NCT00929812|Hormones|hormones|mesh-ancestor
92948291|NCT00929812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948292|NCT00929812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948293|NCT00907972|Vitamin D|vitamin d|mesh-list
92948294|NCT00907972|Ergocalciferols|ergocalciferols|mesh-list
92948295|NCT00907972|Cholecalciferol|cholecalciferol|mesh-list
92948296|NCT00907972|Vitamins|vitamins|mesh-list
92948297|NCT00907972|Micronutrients|micronutrients|mesh-ancestor
92948298|NCT00907972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948299|NCT00907972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92948300|NCT00907972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92948301|NCT03799744|Durvalumab|durvalumab|mesh-list
92948302|NCT03799744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948303|NCT03799744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948304|NCT00933634|Propafenone|propafenone|mesh-list
92948305|NCT00933634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92948306|NCT00933634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92948307|NCT00933634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92948308|NCT00933634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948309|NCT00933634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948310|NCT00933790|Rifampin|rifampin|mesh-list
92948311|NCT00933790|Pyrazinamide|pyrazinamide|mesh-list
92948312|NCT00933790|Ethambutol|ethambutol|mesh-list
92948313|NCT00933790|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92948314|NCT00933790|Antitubercular Agents|antitubercular agents|mesh-ancestor
92948315|NCT00933790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92948316|NCT00933790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948317|NCT00933790|Leprostatic Agents|leprostatic agents|mesh-ancestor
92948318|NCT00933790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92948319|NCT00933790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948320|NCT00933790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948321|NCT00933790|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92948322|NCT00933790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92948323|NCT00933790|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92948324|NCT00933790|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92948325|NCT00933790|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92948326|NCT00933790|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92948327|NCT00566254|Zonisamide|zonisamide|mesh-list
92948328|NCT00566254|Anticonvulsants|anticonvulsants|mesh-ancestor
92948329|NCT00566254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92948330|NCT00566254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948331|NCT00566254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948332|NCT00566254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92948333|NCT00566254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948334|NCT00930202|Conivaptan|conivaptan|mesh-list
92948335|NCT00930202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92948336|NCT00930202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948337|NCT00930202|Natriuretic Agents|natriuretic agents|mesh-ancestor
92948338|NCT00930202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948339|NCT00393367|Prednisone|prednisone|mesh-list
92948340|NCT00393367|Methylprednisolone|methylprednisolone|mesh-list
92948341|NCT00393367|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92948342|NCT00393367|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92948343|NCT00393367|Prednisolone|prednisolone|mesh-list
92948344|NCT00393367|Prednisolone acetate|prednisolone acetate|mesh-list
92948345|NCT00393367|Budesonide|budesonide|mesh-list
92948346|NCT00393367|Bromides|bromides|mesh-list
92948347|NCT00393367|Albuterol|albuterol|mesh-list
92948348|NCT00393367|Ipratropium|ipratropium|mesh-list
92948349|NCT00393367|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92948350|NCT00393367|Prednisolone phosphate|prednisolone phosphate|mesh-list
92948351|NCT00393367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948352|NCT00393367|Glucocorticoids|glucocorticoids|mesh-ancestor
92948353|NCT00393367|Hormones|hormones|mesh-ancestor
92948354|NCT00393367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948355|NCT00393367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948356|NCT00393367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92948357|NCT00393367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948358|NCT00393367|Antiemetics|antiemetics|mesh-ancestor
92948359|NCT00393367|Autonomic Agents|autonomic agents|mesh-ancestor
92948360|NCT00393367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948361|NCT00393367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92948362|NCT00393367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92248853|NCT03830684|Antioxidants|antioxidants|mesh-ancestor
92948363|NCT00393367|Protective Agents|protective agents|mesh-ancestor
92948364|NCT00393367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92948365|NCT00393367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92948366|NCT00393367|Respiratory System Agents|respiratory system agents|mesh-ancestor
92948367|NCT00393367|Anticonvulsants|anticonvulsants|mesh-ancestor
92948368|NCT00393367|Tocolytic Agents|tocolytic agents|mesh-ancestor
92948369|NCT00393367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92948370|NCT00393367|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92948371|NCT00393367|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92948372|NCT00393367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92948373|NCT00393367|Adrenergic Agents|adrenergic agents|mesh-ancestor
92948374|NCT00393367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948375|NCT00393367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948376|NCT00393367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92948377|NCT00393367|Cholinergic Agents|cholinergic agents|mesh-ancestor
92948378|NCT00395629|Deferasirox|deferasirox|mesh-list
92948379|NCT00395629|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92948380|NCT00395629|Chelating Agents|chelating agents|mesh-ancestor
92948381|NCT00395629|Sequestering Agents|sequestering agents|mesh-ancestor
92948382|NCT00395629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948383|NCT00392665|Sulindac|sulindac|mesh-list
92948384|NCT00392665|Bevacizumab|bevacizumab|mesh-list
92948385|NCT00392665|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92948386|NCT00392665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948387|NCT00392665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948388|NCT00392665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948389|NCT00392665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948390|NCT00392665|Growth Substances|growth substances|mesh-ancestor
92948391|NCT00392665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948392|NCT00392665|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948393|NCT00392665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948394|NCT00392665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948395|NCT00392665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948396|NCT00392665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92948397|NCT00392665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948398|NCT00392665|Analgesics|analgesics|mesh-ancestor
92948399|NCT00392665|Sensory System Agents|sensory system agents|mesh-ancestor
92948400|NCT00392665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948401|NCT00392665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948402|NCT00392665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948403|NCT00392665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92948404|NCT01043965|Metformin|metformin|mesh-list
92948405|NCT01043965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948406|NCT01043965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948407|NCT00622869|Everolimus|everolimus|mesh-list
92948408|NCT00622869|Tacrolimus|tacrolimus|mesh-list
92948409|NCT00622869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948410|NCT00622869|Immunologic Factors|immunologic factors|mesh-ancestor
92948411|NCT00622869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948412|NCT00622869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92948413|NCT00622869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948414|NCT00622869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948415|NCT00622869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92948416|NCT00622869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948417|NCT00622869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948418|NCT00366457|Bevacizumab|bevacizumab|mesh-list
92948419|NCT00366457|Gemcitabine|gemcitabine|mesh-list
92948420|NCT00366457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92948421|NCT00366457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948422|NCT00366457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948423|NCT00366457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948424|NCT00366457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948425|NCT00366457|Growth Substances|growth substances|mesh-ancestor
92948426|NCT00366457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948427|NCT00366457|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948428|NCT00366457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948429|NCT00366457|Antimetabolites|antimetabolites|mesh-ancestor
92948430|NCT00366457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948431|NCT00366457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948432|NCT00366457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948433|NCT00624819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92948434|NCT00624819|Immunologic Factors|immunologic factors|mesh-ancestor
92948435|NCT00624819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948436|NCT01049347|Amitriptyline|amitriptyline|mesh-list
92948437|NCT01049347|Paroxetine|paroxetine|mesh-list
92948438|NCT01049347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92948439|NCT01049347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92948440|NCT01049347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948441|NCT01049347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948442|NCT01049347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948443|NCT01049347|Serotonin Agents|serotonin agents|mesh-ancestor
92948444|NCT01049347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948445|NCT01049347|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92948446|NCT01049347|Antidepressive Agents|antidepressive agents|mesh-ancestor
92948447|NCT01049347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948448|NCT01049347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92948449|NCT01049347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92948450|NCT01049347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948451|NCT01049347|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92948452|NCT01049347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948453|NCT01049347|Analgesics|analgesics|mesh-ancestor
92948454|NCT01049347|Sensory System Agents|sensory system agents|mesh-ancestor
92948455|NCT01049347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948456|NCT01049347|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92948457|NCT01049347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92948458|NCT01049425|Cyclophosphamide|cyclophosphamide|mesh-list
92948459|NCT01049425|Docetaxel|docetaxel|mesh-list
92948460|NCT01049425|Epirubicin|epirubicin|mesh-list
92948461|NCT01049425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948462|NCT01049425|Immunologic Factors|immunologic factors|mesh-ancestor
92948463|NCT01049425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948464|NCT01049425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948465|NCT01049425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92948466|NCT01049425|Alkylating Agents|alkylating agents|mesh-ancestor
92948467|NCT01049425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948468|NCT01049425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948469|NCT01049425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92593912|NCT04704622|Anesthetics|anesthetics|mesh-ancestor
92948470|NCT01049425|Tubulin Modulators|tubulin modulators|mesh-ancestor
92948471|NCT01049425|Antimitotic Agents|antimitotic agents|mesh-ancestor
92948472|NCT01049425|Mitosis Modulators|mitosis modulators|mesh-ancestor
92948473|NCT01049425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92948474|NCT01049425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92948475|NCT01049425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92948476|NCT01049425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948478|NCT00838227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92948479|NCT00838227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948480|NCT00838227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92948481|NCT00838227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92948482|NCT00838227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92948483|NCT00838227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948484|NCT00366301|Metformin|metformin|mesh-list
92948485|NCT00366301|Insulin Glargine|insulin glargine|mesh-list
92948486|NCT00366301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948487|NCT00366301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948488|NCT00838305|Citalopram|citalopram|mesh-list
92948489|NCT00838305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92948490|NCT00838305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92948491|NCT00838305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948492|NCT00838305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948493|NCT00838305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948494|NCT00838305|Serotonin Agents|serotonin agents|mesh-ancestor
92948495|NCT00838305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948496|NCT00838305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92948497|NCT00838305|Antidepressive Agents|antidepressive agents|mesh-ancestor
92948498|NCT00838305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948499|NCT00622713|Rivastigmine|rivastigmine|mesh-list
92948500|NCT00622713|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92948501|NCT00622713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948502|NCT00622713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948503|NCT00622713|Cholinergic Agents|cholinergic agents|mesh-ancestor
92948504|NCT00622713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948505|NCT00622713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948506|NCT00622713|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92948507|NCT00622713|Protective Agents|protective agents|mesh-ancestor
92948508|NCT01046227|Vaccines|vaccines|mesh-list
92948509|NCT01046227|Immunologic Factors|immunologic factors|mesh-ancestor
92948510|NCT01046227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948511|NCT00392197|Aripiprazole|aripiprazole|mesh-list
92948512|NCT00392197|Antidepressive Agents|antidepressive agents|mesh-ancestor
92948513|NCT00392197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948514|NCT00392197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92948515|NCT00392197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92948516|NCT00392197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948517|NCT00392197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948518|NCT00392197|Dopamine Agonists|dopamine agonists|mesh-ancestor
92948519|NCT00392197|Dopamine Agents|dopamine agents|mesh-ancestor
92948520|NCT00392197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948521|NCT00392197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948522|NCT00392197|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92948523|NCT00392197|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92948524|NCT00392197|Serotonin Agents|serotonin agents|mesh-ancestor
92948525|NCT00392197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92948526|NCT00392197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92948527|NCT00392197|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92948528|NCT00392197|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92948529|NCT00391807|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92948530|NCT00391807|Norethindrone|norethindrone|mesh-list
92948531|NCT00391807|Norethindrone Acetate|norethindrone acetate|mesh-list
92948532|NCT00391807|Estradiol|estradiol|mesh-list
92948533|NCT00391807|Estrogens|estrogens|mesh-ancestor
92948534|NCT00391807|Hormones|hormones|mesh-ancestor
92948535|NCT00391807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948536|NCT00391807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948537|NCT00391807|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92948538|NCT00391807|Contraceptive Agents|contraceptive agents|mesh-ancestor
92948539|NCT00391807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92948540|NCT00391807|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92948541|NCT00391807|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92948542|NCT00391807|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92948543|NCT00391807|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92948545|NCT00624585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948546|NCT00624585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948547|NCT00624585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948548|NCT00624585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948549|NCT01046383|Caseins|caseins|mesh-list
92948550|NCT01046383|Chelating Agents|chelating agents|mesh-ancestor
92948551|NCT01046383|Sequestering Agents|sequestering agents|mesh-ancestor
92948552|NCT01046383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948553|NCT00831597|Rituximab|rituximab|mesh-list
92948554|NCT00831597|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92948555|NCT00831597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948556|NCT00831597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948557|NCT00831597|Immunologic Factors|immunologic factors|mesh-ancestor
92948558|NCT00831597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948559|NCT00831597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948560|NCT00831597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92948561|NCT00831597|Alkylating Agents|alkylating agents|mesh-ancestor
92948562|NCT00831597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948563|NCT00622635|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92948564|NCT00622635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92948565|NCT00622635|Autonomic Agents|autonomic agents|mesh-ancestor
92948566|NCT00622635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948567|NCT00622635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948568|NCT00622635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92948569|NCT00622635|Respiratory System Agents|respiratory system agents|mesh-ancestor
92948570|NCT00622635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92948571|NCT00622635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92948572|NCT00622635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92948573|NCT00622635|Adrenergic Agents|adrenergic agents|mesh-ancestor
92948574|NCT00622635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948575|NCT00622635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948576|NCT00391027|Insulin|insulin|mesh-list
92948577|NCT00391027|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92948578|NCT00391027|Insulin Glargine|insulin glargine|mesh-list
92948579|NCT00391027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948580|NCT00391027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948581|NCT00622401|Interleukin-12|interleukin-12|mesh-list
92948582|NCT00622401|Vaccines|vaccines|mesh-list
92948583|NCT00622401|Immunologic Factors|immunologic factors|mesh-ancestor
92948584|NCT00622401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948585|NCT00622401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92948586|NCT00622401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948587|NCT00622401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948588|NCT00622401|Growth Substances|growth substances|mesh-ancestor
92948589|NCT00622401|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948590|NCT00622401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948591|NCT04018365|Empagliflozin|empagliflozin|mesh-list
92948592|NCT04018365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92948593|NCT04018365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948594|NCT04018365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948595|NCT04018365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948596|NCT00828087|Cobalt|cobalt|mesh-list
92948597|NCT00828087|Chromium|chromium|mesh-list
92948598|NCT00828087|Everolimus|everolimus|mesh-list
92948599|NCT00828087|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92948600|NCT00828087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948601|NCT00828087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948602|NCT00828087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948603|NCT00828087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948604|NCT00828087|Immunologic Factors|immunologic factors|mesh-ancestor
92948605|NCT00828087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948606|NCT00828087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948607|NCT00828087|Trace Elements|trace elements|mesh-ancestor
92948608|NCT00828087|Micronutrients|micronutrients|mesh-ancestor
92948609|NCT00839085|Ascorbic Acid|ascorbic acid|mesh-list
92948610|NCT00839085|Grape Seed Extract|grape seed extract|mesh-list
92948611|NCT00839085|Antioxidants|antioxidants|mesh-ancestor
92948612|NCT00839085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948613|NCT00839085|Protective Agents|protective agents|mesh-ancestor
92948614|NCT00839085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948615|NCT00839085|Vitamins|vitamins|mesh-ancestor
92948616|NCT00839085|Micronutrients|micronutrients|mesh-ancestor
92594080|NCT03501498|Loperamide|loperamide|mesh-list
92948617|NCT00839085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92948618|NCT00839085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948620|NCT00839163|Enoxaparin|enoxaparin|mesh-list
92948621|NCT00839163|Rivaroxaban|rivaroxaban|mesh-list
92948622|NCT00839163|Vitamins|vitamins|mesh-ancestor
92948623|NCT00839163|Micronutrients|micronutrients|mesh-ancestor
92948624|NCT00839163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948625|NCT00839163|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92948626|NCT00839163|Antithrombins|antithrombins|mesh-ancestor
92948627|NCT00839163|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92948628|NCT00839163|Protease Inhibitors|protease inhibitors|mesh-ancestor
92948629|NCT00839163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948630|NCT00839163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948631|NCT00839163|Anticoagulants|anticoagulants|mesh-ancestor
92948632|NCT00839163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92948633|NCT00839163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92948634|NCT00839163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92948635|NCT00839163|Hemostatics|hemostatics|mesh-ancestor
92948636|NCT00839163|Coagulants|coagulants|mesh-ancestor
92948637|NCT02549001|Amorolfine|amorolfine|mesh-list
92948638|NCT02549001|Antifungal Agents|antifungal agents|mesh-ancestor
92948639|NCT02549001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948641|NCT00621543|Levonorgestrel|levonorgestrel|mesh-list
92948642|NCT00621543|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92948643|NCT00621543|Contraceptive Agents|contraceptive agents|mesh-ancestor
92948644|NCT00621543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92948645|NCT00621543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948646|NCT00621543|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92948647|NCT00621543|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92948648|NCT00621543|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92948649|NCT00621543|Trace Elements|trace elements|mesh-ancestor
92948650|NCT00621543|Micronutrients|micronutrients|mesh-ancestor
92948651|NCT00623805|Bevacizumab|bevacizumab|mesh-list
92948652|NCT00623805|Capecitabine|capecitabine|mesh-list
92948653|NCT00623805|Oxaliplatin|oxaliplatin|mesh-list
92948654|NCT00623805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948655|NCT00623805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948656|NCT00623805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948657|NCT00623805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948658|NCT00623805|Growth Substances|growth substances|mesh-ancestor
92948659|NCT00623805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948660|NCT00623805|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948661|NCT00623805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948662|NCT00623805|Antimetabolites|antimetabolites|mesh-ancestor
92948663|NCT00623805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948664|NCT02548923|Dexmedetomidine|dexmedetomidine|mesh-list
92948665|NCT02548923|Propofol|propofol|mesh-list
92948666|NCT02548923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92948667|NCT02548923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948668|NCT02548923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948669|NCT02548923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948670|NCT02548923|Analgesics|analgesics|mesh-ancestor
92948671|NCT02548923|Sensory System Agents|sensory system agents|mesh-ancestor
92948672|NCT02548923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948673|NCT02548923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92948674|NCT02548923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92948675|NCT02548923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92948676|NCT02548923|Adrenergic Agents|adrenergic agents|mesh-ancestor
92948677|NCT02548923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948678|NCT02548923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948679|NCT02548923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92948680|NCT02548923|Anesthetics, General|anesthetics, general|mesh-ancestor
92948681|NCT02548923|Anesthetics|anesthetics|mesh-ancestor
92948682|NCT00832221|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92948683|NCT00832221|Raclopride|raclopride|mesh-list
92948684|NCT00832221|Antidepressive Agents|antidepressive agents|mesh-ancestor
92948685|NCT00832221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948686|NCT00832221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92948687|NCT00832221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92948688|NCT00832221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948689|NCT00832221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948690|NCT00832221|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92948691|NCT00832221|Dopamine Agents|dopamine agents|mesh-ancestor
92948692|NCT00832221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594141|NCT00093509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948693|NCT00832221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948694|NCT00839397|Paroxetine|paroxetine|mesh-list
92948695|NCT00839397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92948696|NCT00839397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92948697|NCT00839397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92948698|NCT00839397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948699|NCT00839397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948700|NCT00839397|Serotonin Agents|serotonin agents|mesh-ancestor
92948701|NCT00839397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948702|NCT00839397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92948703|NCT00839397|Antidepressive Agents|antidepressive agents|mesh-ancestor
92948704|NCT00839397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92948705|NCT00839397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92948706|NCT00839397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92948707|NCT00839397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948708|NCT00828477|Nepafenac|nepafenac|mesh-list
92948709|NCT00828477|Bromfenac|bromfenac|mesh-list
92948710|NCT00828477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92948711|NCT00828477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948712|NCT00828477|Analgesics|analgesics|mesh-ancestor
92948713|NCT00828477|Sensory System Agents|sensory system agents|mesh-ancestor
92948714|NCT00828477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948715|NCT00828477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948716|NCT00828477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948717|NCT00828477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948718|NCT00621309|Rifampin|rifampin|mesh-list
92948719|NCT00621309|Rifamycins|rifamycins|mesh-list
92948720|NCT00621309|Sulforaphane|sulforaphane|mesh-list
92948721|NCT00621309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92948722|NCT00621309|Antitubercular Agents|antitubercular agents|mesh-ancestor
92948723|NCT00621309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92948724|NCT00621309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948725|NCT00621309|Leprostatic Agents|leprostatic agents|mesh-ancestor
92948726|NCT00621309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92948727|NCT00621309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948728|NCT00621309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948729|NCT00621309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92948730|NCT00621309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92948731|NCT00621309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92948732|NCT00621309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92948733|NCT00621309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92948734|NCT00621309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92948735|NCT00621309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92948736|NCT00621309|Protective Agents|protective agents|mesh-ancestor
92948737|NCT00621309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948738|NCT00621309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948739|NCT00839553|Minocycline|minocycline|mesh-list
92948740|NCT00839553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92948741|NCT00839553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948742|NCT00832689|Gemcitabine|gemcitabine|mesh-list
92948743|NCT00832689|Irinotecan|irinotecan|mesh-list
92948744|NCT00832689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948745|NCT00832689|Antimetabolites|antimetabolites|mesh-ancestor
92948746|NCT00832689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948747|NCT00832689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948748|NCT00832689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92948749|NCT00832689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92948750|NCT00832689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948751|NCT00567190|Docetaxel|docetaxel|mesh-list
92948752|NCT00567190|Trastuzumab|trastuzumab|mesh-list
92948753|NCT00567190|Pertuzumab|pertuzumab|mesh-list
92948754|NCT00567190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948755|NCT00567190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92948756|NCT00567190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92948757|NCT00567190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92948758|NCT00567190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948759|NCT00567190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948760|NCT00922389|Lenograstim|lenograstim|mesh-list
92948761|NCT00922389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92948762|NCT00922389|Immunologic Factors|immunologic factors|mesh-ancestor
92948763|NCT00922389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948764|NCT00691938|Decitabine|decitabine|mesh-list
92948765|NCT00691938|Panobinostat|panobinostat|mesh-list
92594220|NCT00093665|Fluorouracil|fluorouracil|mesh-list
92948766|NCT00691938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948767|NCT00691938|Antimetabolites|antimetabolites|mesh-ancestor
92948768|NCT00691938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948769|NCT00691938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948770|NCT00691938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948771|NCT00691938|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92948772|NCT00365365|Cyclophosphamide|cyclophosphamide|mesh-list
92948773|NCT00365365|Bevacizumab|bevacizumab|mesh-list
92948774|NCT00365365|Carboplatin|carboplatin|mesh-list
92948775|NCT00365365|Docetaxel|docetaxel|mesh-list
92948776|NCT00365365|Doxorubicin|doxorubicin|mesh-list
92948777|NCT00365365|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92948778|NCT00365365|Trastuzumab|trastuzumab|mesh-list
92948779|NCT00365365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948780|NCT00365365|Immunologic Factors|immunologic factors|mesh-ancestor
92948781|NCT00365365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948782|NCT00365365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948783|NCT00365365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92948784|NCT00365365|Alkylating Agents|alkylating agents|mesh-ancestor
92948785|NCT00365365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948786|NCT00365365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948787|NCT00365365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92948788|NCT00365365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948789|NCT00365365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948790|NCT00365365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948791|NCT00365365|Growth Substances|growth substances|mesh-ancestor
92948792|NCT00365365|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948793|NCT00365365|Tubulin Modulators|tubulin modulators|mesh-ancestor
92948794|NCT00365365|Antimitotic Agents|antimitotic agents|mesh-ancestor
92948795|NCT00365365|Mitosis Modulators|mitosis modulators|mesh-ancestor
92948796|NCT00365365|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92948797|NCT00365365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92948798|NCT00365365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92948799|NCT00365365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948800|NCT01046461|Dexamethasone|dexamethasone|mesh-list
92948801|NCT01046461|Aprepitant|aprepitant|mesh-list
92948802|NCT01046461|Ramosetron|ramosetron|mesh-list
92948803|NCT01046461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948804|NCT01046461|Antiemetics|antiemetics|mesh-ancestor
92948805|NCT01046461|Autonomic Agents|autonomic agents|mesh-ancestor
92948806|NCT01046461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948807|NCT01046461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948808|NCT01046461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92948809|NCT01046461|Glucocorticoids|glucocorticoids|mesh-ancestor
92948810|NCT01046461|Hormones|hormones|mesh-ancestor
92948811|NCT01046461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948812|NCT01046461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92948813|NCT01046461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948814|NCT01046461|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92948815|NCT01046461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948816|NCT01046461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948817|NCT01046461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92948818|NCT01046461|Serotonin Agents|serotonin agents|mesh-ancestor
92948819|NCT00623727|Factor VIII|factor viii|mesh-list
92948820|NCT00623727|Coagulants|coagulants|mesh-ancestor
92948821|NCT01046539|Buprenorphine|buprenorphine|mesh-list
92948822|NCT01046539|ALKS-33|alks-33|mesh-list
92948823|NCT01046539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92948824|NCT01046539|Narcotics|narcotics|mesh-ancestor
92948825|NCT01046539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948826|NCT01046539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948827|NCT01046539|Analgesics|analgesics|mesh-ancestor
92948828|NCT01046539|Sensory System Agents|sensory system agents|mesh-ancestor
92948829|NCT01046539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948830|NCT01046539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92948831|NCT01044199|Vaccines|vaccines|mesh-list
92948832|NCT01044199|Immunologic Factors|immunologic factors|mesh-ancestor
92948833|NCT01044199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948834|NCT00828789|Tenofovir|tenofovir|mesh-list
92948835|NCT00828789|Efavirenz|efavirenz|mesh-list
92948836|NCT00828789|Antiviral Agents|antiviral agents|mesh-ancestor
92948837|NCT00828789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948838|NCT00828789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92948839|NCT00828789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92948840|NCT00828789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948841|NCT00828789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948842|NCT00828789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92948843|NCT00828789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92948844|NCT00828789|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92948845|NCT00828789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92948846|NCT00828789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92948847|NCT00828789|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92948848|NCT00828789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92948849|NCT00828789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92948850|NCT00930358|Anesthetics|anesthetics|mesh-list
92948851|NCT00930358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948852|NCT00930358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948853|NCT00372775|Sunitinib|sunitinib|mesh-list
92948854|NCT00372775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948855|NCT00372775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92948856|NCT00372775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92948857|NCT00372775|Growth Substances|growth substances|mesh-ancestor
92948858|NCT00372775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948859|NCT00372775|Growth Inhibitors|growth inhibitors|mesh-ancestor
92948860|NCT00372775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92948861|NCT00372775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948862|NCT00372775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948863|NCT00936676|Rasagiline|rasagiline|mesh-list
92948864|NCT00936676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92948865|NCT00936676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948866|NCT00936676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948867|NCT00936676|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92948868|NCT00936676|Protective Agents|protective agents|mesh-ancestor
92948869|NCT00936676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948870|NCT00839787|Morphine|morphine|mesh-list
92948871|NCT00839787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92948872|NCT00839787|Narcotics|narcotics|mesh-ancestor
92948873|NCT00839787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92948874|NCT00839787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948875|NCT00839787|Analgesics|analgesics|mesh-ancestor
92948876|NCT00839787|Sensory System Agents|sensory system agents|mesh-ancestor
92948877|NCT00839787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948878|NCT00934258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92948879|NCT00934258|Fenofibrate|fenofibrate|mesh-list
92948880|NCT00934258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92948881|NCT00934258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92948882|NCT00934258|Antimetabolites|antimetabolites|mesh-ancestor
92948883|NCT00934258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948884|NCT00934258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92948885|NCT00934258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92948886|NCT00934258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948887|NCT00372697|Octreotide|octreotide|mesh-list
92948888|NCT00372697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92948889|NCT00372697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92948890|NCT00372697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948891|NCT00934414|Insulin|insulin|mesh-list
92948892|NCT00934414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948893|NCT00934414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948894|NCT00930514|Rituximab|rituximab|mesh-list
92948895|NCT00930514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948896|NCT00930514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948897|NCT00930514|Immunologic Factors|immunologic factors|mesh-ancestor
92948898|NCT00930514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948899|NCT00930514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948900|NCT00936988|Cinacalcet|cinacalcet|mesh-list
92948901|NCT00936988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92948902|NCT00936988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948903|NCT00936988|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92948904|NCT00936988|Hormone Antagonists|hormone antagonists|mesh-ancestor
92948905|NCT00936988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92948906|NCT00934492|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92948907|NCT00934492|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92948908|NCT00934492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92948909|NCT00934492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92948910|NCT00934492|Antimalarials|antimalarials|mesh-ancestor
92948911|NCT00934492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92948912|NCT00934492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92948913|NCT00934570|Metformin|metformin|mesh-list
92948914|NCT00934570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92948915|NCT00934570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948916|NCT00930670|Esomeprazole|esomeprazole|mesh-list
92948917|NCT00930670|Omeprazole|omeprazole|mesh-list
92948918|NCT00930670|Pantoprazole|pantoprazole|mesh-list
92948919|NCT00930670|Ranitidine|ranitidine|mesh-list
92948920|NCT00930670|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92948921|NCT00930670|Atorvastatin|atorvastatin|mesh-list
92948922|NCT00930670|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92948923|NCT00930670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92948924|NCT00930670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92948925|NCT00930670|Antimetabolites|antimetabolites|mesh-ancestor
92948926|NCT00930670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948927|NCT00930670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92948928|NCT00930670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92948929|NCT00930670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948930|NCT00930670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92948931|NCT00930670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92948932|NCT00930670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92948933|NCT00930670|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92948934|NCT00930670|Histamine Antagonists|histamine antagonists|mesh-ancestor
92948935|NCT00930670|Histamine Agents|histamine agents|mesh-ancestor
92948936|NCT00930670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92948937|NCT00930670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948938|NCT00937144|Sildenafil Citrate|sildenafil citrate|mesh-list
92948939|NCT00937144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92948940|NCT00937144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92948941|NCT00937144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92948942|NCT00937144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948943|NCT00937144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948944|NCT00937144|Urological Agents|urological agents|mesh-ancestor
92948945|NCT00937300|Cyclophosphamide|cyclophosphamide|mesh-list
92948946|NCT00937300|Fludarabine|fludarabine|mesh-list
92948947|NCT00937300|Fludarabine phosphate|fludarabine phosphate|mesh-list
92948948|NCT00937300|Interleukin-2|interleukin-2|mesh-list
92948949|NCT00937300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92948950|NCT00937300|Immunologic Factors|immunologic factors|mesh-ancestor
92948951|NCT00937300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948952|NCT00937300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948953|NCT00937300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92948954|NCT00937300|Alkylating Agents|alkylating agents|mesh-ancestor
92948955|NCT00937300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948956|NCT00937300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948957|NCT00937300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92948958|NCT00937300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92948959|NCT00937300|Antimetabolites|antimetabolites|mesh-ancestor
92948960|NCT00937300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948961|NCT00937300|Analgesics|analgesics|mesh-ancestor
92948962|NCT00937300|Sensory System Agents|sensory system agents|mesh-ancestor
92948963|NCT00937300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948964|NCT02226276|Copper|copper|mesh-list
92948965|NCT02226276|Trastuzumab|trastuzumab|mesh-list
92948966|NCT02226276|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92948967|NCT02226276|Maytansine|maytansine|mesh-list
92948968|NCT02226276|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92948969|NCT02226276|Immunoconjugates|immunoconjugates|mesh-list
92948970|NCT02226276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92948971|NCT02226276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92948972|NCT02226276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948973|NCT02226276|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92948974|NCT02226276|Trace Elements|trace elements|mesh-ancestor
92948975|NCT02226276|Micronutrients|micronutrients|mesh-ancestor
92948976|NCT02226276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948977|NCT02226276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92948978|NCT02226276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92948979|NCT02226276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92948980|NCT02226276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92948981|NCT02226276|Immunotoxins|immunotoxins|mesh-ancestor
92948982|NCT02226276|Immunologic Factors|immunologic factors|mesh-ancestor
92948983|NCT00935116|Etoricoxib|etoricoxib|mesh-list
92948984|NCT00935116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92948985|NCT00935116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92948986|NCT00935116|Analgesics|analgesics|mesh-ancestor
92948987|NCT00935116|Sensory System Agents|sensory system agents|mesh-ancestor
92948988|NCT00935116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92948989|NCT00935116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92948990|NCT00935116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92948991|NCT00935116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92948992|NCT00935116|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92948993|NCT00935116|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92948994|NCT00935116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92948995|NCT00935116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92948996|NCT00931138|Cytarabine|cytarabine|mesh-list
92948997|NCT00931138|Daunorubicin|daunorubicin|mesh-list
92948998|NCT00931138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92948999|NCT00931138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949000|NCT00931138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92949001|NCT00931138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949002|NCT00931138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949003|NCT00931138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949004|NCT00931138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92949005|NCT00931138|Antimetabolites|antimetabolites|mesh-ancestor
92949006|NCT00931138|Antiviral Agents|antiviral agents|mesh-ancestor
92949007|NCT00931138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949008|NCT00931138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949009|NCT00931138|Immunologic Factors|immunologic factors|mesh-ancestor
92949010|NCT00931138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949012|NCT00935194|Antiviral Agents|antiviral agents|mesh-ancestor
92949013|NCT00935194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949014|NCT00935194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949015|NCT00935194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949016|NCT00690378|Imipenem|imipenem|mesh-list
92949017|NCT00690378|Ceftazidime|ceftazidime|mesh-list
92949018|NCT00690378|Avibactam|avibactam|mesh-list
92949019|NCT00690378|Cilastatin|cilastatin|mesh-list
92949020|NCT00690378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92949021|NCT00690378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949022|NCT00690378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92949023|NCT00690378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949024|NCT00690378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949025|NCT00690378|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92949026|NCT00574275|Gemcitabine|gemcitabine|mesh-list
92949027|NCT00574275|Aflibercept|aflibercept|mesh-list
92949028|NCT00574275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92949029|NCT00574275|Antimetabolites|antimetabolites|mesh-ancestor
92949030|NCT00574275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949031|NCT00574275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949032|NCT00574275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92949033|NCT00574275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92949034|NCT00574275|Growth Substances|growth substances|mesh-ancestor
92949035|NCT00574275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949036|NCT00574275|Growth Inhibitors|growth inhibitors|mesh-ancestor
92949037|NCT01742832|Citalopram|citalopram|mesh-list
92949038|NCT01742832|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92949039|NCT01742832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92949040|NCT01742832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92949041|NCT01742832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949042|NCT01742832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949043|NCT01742832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949044|NCT01742832|Serotonin Agents|serotonin agents|mesh-ancestor
92949045|NCT01742832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949046|NCT01742832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92949047|NCT01742832|Antidepressive Agents|antidepressive agents|mesh-ancestor
92949048|NCT01742832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949049|NCT01742832|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92949050|NCT01742832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92949051|NCT00833079|Tacrolimus|tacrolimus|mesh-list
92949052|NCT00833079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949053|NCT00833079|Immunologic Factors|immunologic factors|mesh-ancestor
92949054|NCT00833079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949055|NCT00833079|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92949056|NCT00833079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949057|NCT00833079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949058|NCT00935506|Aspirin|aspirin|mesh-list
92949059|NCT00935506|Clopidogrel|clopidogrel|mesh-list
92949060|NCT00935506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92949061|NCT00935506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92949062|NCT00935506|Analgesics|analgesics|mesh-ancestor
92949063|NCT00935506|Sensory System Agents|sensory system agents|mesh-ancestor
92949064|NCT00935506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949065|NCT00935506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949066|NCT00935506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949067|NCT00935506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949068|NCT00935506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92949069|NCT00935506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92949070|NCT00935506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949071|NCT00935506|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92949072|NCT00935506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92949073|NCT00935506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949074|NCT00935506|Antipyretics|antipyretics|mesh-ancestor
92949075|NCT00935506|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92949076|NCT00935506|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92949077|NCT00935506|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92949078|NCT00935506|Purinergic Agents|purinergic agents|mesh-ancestor
92949079|NCT00935506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949081|NCT00833157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92949082|NCT00833157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92949083|NCT00833157|Analgesics|analgesics|mesh-ancestor
92949084|NCT00833157|Sensory System Agents|sensory system agents|mesh-ancestor
92949085|NCT00833157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949086|NCT00833157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949087|NCT00833157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949088|NCT00833157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949089|NCT00833157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92949090|NCT00833157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949091|NCT00833157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949092|NCT00833235|Lubricant Eye Drops|lubricant eye drops|mesh-list
92949093|NCT00833235|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92949094|NCT00833235|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92949095|NCT04285671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92949096|NCT04285671|Trastuzumab|trastuzumab|mesh-list
92949097|NCT04285671|Necitumumab|necitumumab|mesh-list
92949098|NCT04285671|Osimertinib|osimertinib|mesh-list
92949099|NCT04285671|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92949100|NCT04285671|Antibodies|antibodies|mesh-list
92949101|NCT04285671|Immunoglobulins|immunoglobulins|mesh-list
92949102|NCT04285671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92949103|NCT04285671|Immunologic Factors|immunologic factors|mesh-ancestor
92949104|NCT04285671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949105|NCT04285671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949106|NCT04285671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949107|NCT04285671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92949108|NCT04285671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949109|NCT00931372|Lixisenatide|lixisenatide|mesh-list
92949110|NCT00931372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92949111|NCT00931372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949112|NCT00829257|Fluticasone|fluticasone|mesh-list
92949113|NCT00829257|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92949114|NCT00829257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949115|NCT00829257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92949116|NCT00829257|Autonomic Agents|autonomic agents|mesh-ancestor
92949117|NCT00829257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949118|NCT00829257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949119|NCT00829257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92949120|NCT00829257|Respiratory System Agents|respiratory system agents|mesh-ancestor
92949121|NCT00829257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949122|NCT00829257|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92949123|NCT00829257|Glucocorticoids|glucocorticoids|mesh-ancestor
92949124|NCT00829257|Hormones|hormones|mesh-ancestor
92949125|NCT00829257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949126|NCT00829257|Sympathomimetics|sympathomimetics|mesh-ancestor
92949127|NCT03978832|Risperidone|risperidone|mesh-list
92949128|NCT03978832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92949129|NCT03978832|Serotonin Agents|serotonin agents|mesh-ancestor
92949130|NCT03978832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949131|NCT03978832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949132|NCT03978832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949133|NCT03978832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92949134|NCT03978832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92949135|NCT03978832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949136|NCT03978832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949137|NCT03978832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92949138|NCT03978832|Dopamine Agents|dopamine agents|mesh-ancestor
92949139|NCT00840333|Levofloxacin|levofloxacin|mesh-list
92949140|NCT00840333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92949141|NCT00840333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949142|NCT00840333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92949143|NCT00840333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92949144|NCT00840333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949145|NCT00840333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949146|NCT00840333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949147|NCT00840333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949148|NCT00840333|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92165035|NCT05617742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92949149|NCT00840333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92949150|NCT00840489|Ribavirin|ribavirin|mesh-list
92949151|NCT00840489|Colchicine|colchicine|mesh-list
92949152|NCT00840489|Antimetabolites|antimetabolites|mesh-ancestor
92527325|NCT00032773|Pentostatin|pentostatin|mesh-list
92949153|NCT00840489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949155|NCT00840489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949156|NCT00840489|Gout Suppressants|gout suppressants|mesh-ancestor
92949157|NCT00840489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949158|NCT00840489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92949159|NCT00840489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92949160|NCT00840489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92949161|NCT00840489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949162|NCT00743496|Antibodies|antibodies|mesh-list
92949163|NCT00743496|Immunologic Factors|immunologic factors|mesh-ancestor
92949164|NCT00743496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949165|NCT00829569|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92949166|NCT00829569|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92949167|NCT00829569|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92949168|NCT00829569|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92949169|NCT00840645|Mirabegron|mirabegron|mesh-list
92949170|NCT00840645|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92949171|NCT00840645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92949172|NCT00840645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92949173|NCT00840645|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949174|NCT00840645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949175|NCT00840645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949176|NCT00840645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949177|NCT00840645|Urological Agents|urological agents|mesh-ancestor
92949178|NCT00566722|Adalimumab|adalimumab|mesh-list
92949179|NCT00566722|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92949180|NCT00566722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949181|NCT00566722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949182|NCT00691704|Prednisone|prednisone|mesh-list
92949183|NCT00691704|Lenalidomide|lenalidomide|mesh-list
92949184|NCT00691704|Bortezomib|bortezomib|mesh-list
92949185|NCT00691704|Melphalan|melphalan|mesh-list
92949186|NCT00691704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949187|NCT00691704|Glucocorticoids|glucocorticoids|mesh-ancestor
92949188|NCT00691704|Hormones|hormones|mesh-ancestor
92949189|NCT00691704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949190|NCT00691704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949191|NCT00691704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949192|NCT00691704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949193|NCT00691704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949194|NCT00691704|Immunologic Factors|immunologic factors|mesh-ancestor
92949195|NCT00691704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92949196|NCT00691704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92949197|NCT00691704|Growth Substances|growth substances|mesh-ancestor
92949198|NCT00691704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92949199|NCT00691704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92949200|NCT00691704|Alkylating Agents|alkylating agents|mesh-ancestor
92949201|NCT00691704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92949202|NCT00691704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949203|NCT00829647|Lenalidomide|lenalidomide|mesh-list
92949204|NCT00829647|Dasatinib|dasatinib|mesh-list
92949205|NCT00829647|Immunologic Factors|immunologic factors|mesh-ancestor
92949206|NCT00829647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949207|NCT00829647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92949208|NCT00829647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92949209|NCT00829647|Growth Substances|growth substances|mesh-ancestor
92949210|NCT00829647|Growth Inhibitors|growth inhibitors|mesh-ancestor
92949211|NCT00829647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949212|NCT00829647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92949213|NCT00829647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949214|NCT00829647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949215|NCT00939328|Rituximab|rituximab|mesh-list
92949216|NCT00939328|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92594672|NCT01803594|Niacin|niacin|mesh-list
92949217|NCT00939328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92949218|NCT00939328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949219|NCT00939328|Immunologic Factors|immunologic factors|mesh-ancestor
92949220|NCT00939328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949221|NCT00939328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949222|NCT00939328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92949223|NCT00939328|Alkylating Agents|alkylating agents|mesh-ancestor
92949224|NCT00939328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949225|NCT00829881|Betahistine|betahistine|mesh-list
92949226|NCT00829881|Vasodilator Agents|vasodilator agents|mesh-ancestor
92949227|NCT00829881|Histamine Agonists|histamine agonists|mesh-ancestor
92949228|NCT00829881|Histamine Agents|histamine agents|mesh-ancestor
92949229|NCT00829881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949230|NCT00829881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949231|NCT00829881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949232|NCT04014244|Triamcinolone|triamcinolone|mesh-list
92949233|NCT04014244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92949234|NCT04014244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92949235|NCT04014244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92949236|NCT04014244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949237|NCT04014244|Glucocorticoids|glucocorticoids|mesh-ancestor
92949238|NCT04014244|Hormones|hormones|mesh-ancestor
92949239|NCT04014244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949240|NCT04014244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949241|NCT04014244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949242|NCT04014244|Immunologic Factors|immunologic factors|mesh-ancestor
92949243|NCT04014244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949244|NCT04014244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949245|NCT02548611|Clopidogrel|clopidogrel|mesh-list
92949246|NCT02548611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92949247|NCT02548611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92949248|NCT02548611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92949249|NCT02548611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92949250|NCT02548611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92949251|NCT02548611|Purinergic Agents|purinergic agents|mesh-ancestor
92949252|NCT02548611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949253|NCT02548611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949254|NCT02548611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949255|NCT00937924|Diphenhydramine|diphenhydramine|mesh-list
92949256|NCT00937924|Promethazine|promethazine|mesh-list
92949257|NCT00937924|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92949258|NCT00937924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92949259|NCT00937924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949260|NCT00937924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949261|NCT00937924|Anesthetics, Local|anesthetics, local|mesh-ancestor
92949262|NCT00937924|Anesthetics|anesthetics|mesh-ancestor
92949263|NCT00937924|Sensory System Agents|sensory system agents|mesh-ancestor
92949264|NCT00937924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949265|NCT00937924|Antiemetics|antiemetics|mesh-ancestor
92949266|NCT00937924|Autonomic Agents|autonomic agents|mesh-ancestor
92949267|NCT00937924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92949268|NCT00937924|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92949269|NCT00937924|Histamine Antagonists|histamine antagonists|mesh-ancestor
92949270|NCT00937924|Histamine Agents|histamine agents|mesh-ancestor
92949271|NCT00937924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949272|NCT00937924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949273|NCT00937924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92949274|NCT00937924|Antipruritics|antipruritics|mesh-ancestor
92949275|NCT00937924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949276|NCT00743886|Mitogens|mitogens|mesh-list
92949277|NCT00743886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92949278|NCT00743886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949279|NCT00830193|Acetylcysteine|acetylcysteine|mesh-list
92949280|NCT00830193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92949281|NCT00830193|Antiviral Agents|antiviral agents|mesh-ancestor
92949282|NCT00830193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949283|NCT00830193|Expectorants|expectorants|mesh-ancestor
92949284|NCT00830193|Respiratory System Agents|respiratory system agents|mesh-ancestor
92949285|NCT00830193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92949286|NCT00830193|Antioxidants|antioxidants|mesh-ancestor
92949287|NCT00830193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949288|NCT00830193|Protective Agents|protective agents|mesh-ancestor
92949289|NCT00830193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949290|NCT00830193|Antidotes|antidotes|mesh-ancestor
92949291|NCT00938158|rGLP-1 protein|rglp-1 protein|mesh-list
92949292|NCT00938158|Incretins|incretins|mesh-ancestor
92949293|NCT00938158|Hormones|hormones|mesh-ancestor
92949294|NCT00938158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949295|NCT00938158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949296|NCT00840957|Infliximab|infliximab|mesh-list
92949297|NCT00840957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92949298|NCT00840957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949299|NCT00840957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949300|NCT00840957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92949301|NCT00840957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949302|NCT00743964|Capecitabine|capecitabine|mesh-list
92949303|NCT00743964|Epirubicin|epirubicin|mesh-list
92949304|NCT00743964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949305|NCT00743964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92949306|NCT00743964|Antimetabolites|antimetabolites|mesh-ancestor
92949307|NCT00743964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949308|NCT00743964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92949309|NCT00743964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92949310|NCT00743964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949311|NCT00743964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949312|NCT00830349|Risperidone|risperidone|mesh-list
92949313|NCT00830349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92949314|NCT00830349|Serotonin Agents|serotonin agents|mesh-ancestor
92949315|NCT00830349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949316|NCT00830349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949317|NCT00830349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949318|NCT00830349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92949319|NCT00830349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92949320|NCT00830349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949321|NCT00830349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949322|NCT00830349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92949323|NCT00830349|Dopamine Agents|dopamine agents|mesh-ancestor
92949324|NCT00841113|Goserelin|goserelin|mesh-list
92949325|NCT00841113|Bicalutamide|bicalutamide|mesh-list
92949326|NCT00841113|Abarelix|abarelix|mesh-list
92949327|NCT00841113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949328|NCT00841113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949329|NCT00841113|Androgen Antagonists|androgen antagonists|mesh-ancestor
92949330|NCT00841113|Hormone Antagonists|hormone antagonists|mesh-ancestor
92949331|NCT00841113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949332|NCT00841113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949333|NCT00830505|Fluticasone|fluticasone|mesh-list
92949334|NCT00830505|Xhance|xhance|mesh-list
92949335|NCT00830505|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92949336|NCT00830505|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92949337|NCT00830505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949338|NCT00830505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92949339|NCT00830505|Autonomic Agents|autonomic agents|mesh-ancestor
92949340|NCT00830505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949341|NCT00830505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949342|NCT00830505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92949343|NCT00830505|Respiratory System Agents|respiratory system agents|mesh-ancestor
92949344|NCT00830505|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949345|NCT00830505|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92949346|NCT00830505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92949347|NCT00830505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92949348|NCT00830505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92949349|NCT00830505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949350|NCT00830505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949351|NCT00830505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949352|NCT00830505|Glucocorticoids|glucocorticoids|mesh-ancestor
92949353|NCT00830505|Hormones|hormones|mesh-ancestor
92949354|NCT00830505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949355|NCT00830505|Sympathomimetics|sympathomimetics|mesh-ancestor
92949356|NCT00566020|Lamotrigine|lamotrigine|mesh-list
92949357|NCT00566020|Anticonvulsants|anticonvulsants|mesh-ancestor
92949358|NCT00566020|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92949359|NCT00566020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949360|NCT00566020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949361|NCT00566020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92949362|NCT00566020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949363|NCT00566020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92949364|NCT00566020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92949365|NCT00566020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949366|NCT00566020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949367|NCT00566020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92527330|NCT00032812|Raclopride|raclopride|mesh-list
92949368|NCT02563782|Mycophenolic Acid|mycophenolic acid|mesh-list
92949369|NCT02563782|Tacrolimus|tacrolimus|mesh-list
92949370|NCT02563782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949371|NCT02563782|Immunologic Factors|immunologic factors|mesh-ancestor
92949372|NCT02563782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949373|NCT02563782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92949374|NCT02563782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949375|NCT02563782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949376|NCT02563782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92949377|NCT02563782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949378|NCT02563782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92949379|NCT02563782|Antitubercular Agents|antitubercular agents|mesh-ancestor
92949380|NCT02563782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92949381|NCT02563782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949382|NCT00841191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92949383|NCT00841191|Siltuximab|siltuximab|mesh-list
92949384|NCT00841191|Antibodies|antibodies|mesh-list
92949385|NCT00841191|Immunoglobulins|immunoglobulins|mesh-list
92949386|NCT00841191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92949387|NCT00841191|Immunologic Factors|immunologic factors|mesh-ancestor
92949388|NCT00841191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949389|NCT00841191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949390|NCT00843453|Vitamin B 12|vitamin b 12|mesh-list
92949391|NCT00843453|Hydroxocobalamin|hydroxocobalamin|mesh-list
92949392|NCT00843453|Vitamin B Complex|vitamin b complex|mesh-ancestor
92949393|NCT00843453|Vitamins|vitamins|mesh-ancestor
92949394|NCT00843453|Micronutrients|micronutrients|mesh-ancestor
92949395|NCT00843453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949396|NCT00843453|Hematinics|hematinics|mesh-ancestor
92949397|NCT00921726|Oseltamivir|oseltamivir|mesh-list
92949398|NCT00921726|Zanamivir|zanamivir|mesh-list
92949399|NCT00921726|Antiviral Agents|antiviral agents|mesh-ancestor
92949400|NCT00921726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949401|NCT00921726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949402|NCT00921726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949403|NCT00938236|Cyclosporine|cyclosporine|mesh-list
92949404|NCT00938236|Cyclosporins|cyclosporins|mesh-list
92949405|NCT00938236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949406|NCT00938236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949407|NCT00938236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949408|NCT00938236|Immunologic Factors|immunologic factors|mesh-ancestor
92949409|NCT00938236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949410|NCT00938236|Antifungal Agents|antifungal agents|mesh-ancestor
92949411|NCT00938236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949412|NCT00938236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949413|NCT00938236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949414|NCT00938236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92949415|NCT00741780|Plerixafor|plerixafor|mesh-list
92949416|NCT00741780|Lenograstim|lenograstim|mesh-list
92949417|NCT00741780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92949418|NCT00741780|Immunologic Factors|immunologic factors|mesh-ancestor
92949419|NCT00741780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949420|NCT00741780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92949421|NCT00741780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92949422|NCT00741780|Antiviral Agents|antiviral agents|mesh-ancestor
92949423|NCT00741780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949424|NCT00936442|Anastrozole|anastrozole|mesh-list
92949425|NCT00936442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949426|NCT00936442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949427|NCT00936442|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92949428|NCT00936442|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92949429|NCT00936442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949430|NCT00936442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949431|NCT00936442|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92949432|NCT00936442|Hormone Antagonists|hormone antagonists|mesh-ancestor
92949433|NCT00936442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949434|NCT00936442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949435|NCT00744354|Doxorubicin|doxorubicin|mesh-list
92949436|NCT00744354|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92949437|NCT00744354|Bortezomib|bortezomib|mesh-list
92949438|NCT00744354|Vorinostat|vorinostat|mesh-list
92949439|NCT00744354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92949440|NCT00744354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949441|NCT00744354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92949442|NCT00744354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949443|NCT00744354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527332|NCT00032812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92949444|NCT00744354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949445|NCT00744354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92949446|NCT04043325|Antibodies|antibodies|mesh-list
92949447|NCT04043325|Immunologic Factors|immunologic factors|mesh-ancestor
92949448|NCT04043325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949449|NCT00936520|Lifitegrast|lifitegrast|mesh-list
92949450|NCT00936520|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92949451|NCT00936520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92949452|NCT00835029|Clotrimazole|clotrimazole|mesh-list
92949453|NCT00835029|Miconazole|miconazole|mesh-list
92949454|NCT00835029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92949455|NCT00835029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949456|NCT00835029|Antifungal Agents|antifungal agents|mesh-ancestor
92949457|NCT00835029|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92949458|NCT00835029|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92949459|NCT00835029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949460|NCT00835029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949461|NCT00835029|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92949462|NCT00835029|Hormone Antagonists|hormone antagonists|mesh-ancestor
92949463|NCT00835029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949464|NCT00835029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949465|NCT00835029|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92949466|NCT00835029|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92949467|NCT00835107|Ziprasidone|ziprasidone|mesh-list
92949468|NCT00835107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92949469|NCT00835107|Serotonin Agents|serotonin agents|mesh-ancestor
92949470|NCT00835107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949471|NCT00835107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949472|NCT00835107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949473|NCT00835107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92949474|NCT00835107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92949475|NCT00835107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949476|NCT00835107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949477|NCT00835107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92949478|NCT00835107|Dopamine Agents|dopamine agents|mesh-ancestor
92949479|NCT00690612|Candesartan|candesartan|mesh-list
92949480|NCT00690612|Candesartan cilexetil|candesartan cilexetil|mesh-list
92949481|NCT00690612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92949482|NCT00690612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92949483|NCT00690612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92949484|NCT00690612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949485|NCT00742014|Sildenafil Citrate|sildenafil citrate|mesh-list
92949486|NCT00742014|Vasodilator Agents|vasodilator agents|mesh-ancestor
92949487|NCT00742014|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92949488|NCT00742014|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92949489|NCT00742014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949490|NCT00742014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949491|NCT00742014|Urological Agents|urological agents|mesh-ancestor
92949492|NCT00742092|Miglustat|miglustat|mesh-list
92949493|NCT00742092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949494|NCT00742092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949495|NCT00742092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92949496|NCT00742092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92949497|NCT00742092|Antiviral Agents|antiviral agents|mesh-ancestor
92949498|NCT00742092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949499|NCT00742092|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92949500|NCT00742092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92949501|NCT00742092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949502|NCT00841581|Ranibizumab|ranibizumab|mesh-list
92949503|NCT00841581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92949504|NCT00841581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92949505|NCT00841581|Growth Substances|growth substances|mesh-ancestor
92949506|NCT00841581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949507|NCT00841581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92949508|NCT00841581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949509|NCT00742248|Formoterol Fumarate|formoterol fumarate|mesh-list
92949510|NCT00742248|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92949511|NCT00742248|Autonomic Agents|autonomic agents|mesh-ancestor
92949512|NCT00742248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949513|NCT00742248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949514|NCT00742248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92949515|NCT00742248|Respiratory System Agents|respiratory system agents|mesh-ancestor
92594965|NCT00097019|Growth Inhibitors|growth inhibitors|mesh-ancestor
92949516|NCT00742248|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92949517|NCT00742248|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92949518|NCT00742248|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92949519|NCT00742248|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949520|NCT00742248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949521|NCT00742248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949522|NCT04249167|Paclitaxel|paclitaxel|mesh-list
92949523|NCT04249167|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92949524|NCT04249167|Atezolizumab|atezolizumab|mesh-list
92949525|NCT04249167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92949526|NCT04249167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92949527|NCT04249167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949528|NCT04249167|Tubulin Modulators|tubulin modulators|mesh-ancestor
92949529|NCT04249167|Antimitotic Agents|antimitotic agents|mesh-ancestor
92949530|NCT04249167|Mitosis Modulators|mitosis modulators|mesh-ancestor
92949531|NCT04249167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949532|NCT04249167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92949533|NCT04249167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92949534|NCT04249167|Immunologic Factors|immunologic factors|mesh-ancestor
92949535|NCT04249167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949536|NCT00621153|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92949537|NCT00621153|Candesartan|candesartan|mesh-list
92949538|NCT00621153|Candesartan cilexetil|candesartan cilexetil|mesh-list
92949539|NCT00621153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92949540|NCT00621153|Diuretics|diuretics|mesh-ancestor
92949541|NCT00621153|Natriuretic Agents|natriuretic agents|mesh-ancestor
92949542|NCT00621153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949543|NCT00621153|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92949544|NCT00621153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949545|NCT00621153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949546|NCT00621153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92949547|NCT00621153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92949548|NCT05447910|Letrozole|letrozole|mesh-list
92949549|NCT05447910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949550|NCT05447910|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92949551|NCT05447910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92949552|NCT05447910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949553|NCT05447910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949554|NCT05447910|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92949555|NCT05447910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92949556|NCT05447910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949557|NCT05447910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949558|NCT00574119|Spironolactone|spironolactone|mesh-list
92949559|NCT00574119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92949560|NCT00574119|Hormone Antagonists|hormone antagonists|mesh-ancestor
92949561|NCT00574119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949562|NCT00574119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949563|NCT00574119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92949564|NCT00574119|Diuretics|diuretics|mesh-ancestor
92949565|NCT00574119|Natriuretic Agents|natriuretic agents|mesh-ancestor
92949566|NCT00705614|Infliximab|infliximab|mesh-list
92949567|NCT00705614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92949568|NCT00705614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949569|NCT00705614|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949570|NCT00705614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92949571|NCT00705614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949572|NCT00844155|Oseltamivir|oseltamivir|mesh-list
92949573|NCT00844155|Antiviral Agents|antiviral agents|mesh-ancestor
92949574|NCT00844155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949575|NCT00844155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949576|NCT00844155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949577|NCT05669924|Methylphenidate|methylphenidate|mesh-list
92949578|NCT05669924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92949579|NCT05669924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949580|NCT05669924|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92949581|NCT05669924|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92949582|NCT05669924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949583|NCT05669924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949584|NCT05669924|Dopamine Agents|dopamine agents|mesh-ancestor
92949585|NCT05669924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595041|NCT00431392|Protective Agents|protective agents|mesh-ancestor
92949587|NCT00844233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92949588|NCT00844233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949589|NCT00844233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949590|NCT00844233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949591|NCT00844233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949592|NCT00841893|Mechlorethamine|mechlorethamine|mesh-list
92949593|NCT00841893|Alkylating Agents|alkylating agents|mesh-ancestor
92949594|NCT00841893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949595|NCT00841893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92949596|NCT00841893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949597|NCT00844311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92949598|NCT00844311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92949599|NCT00844311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949600|NCT00840801|Vaccines|vaccines|mesh-list
92949601|NCT00840801|Immunologic Factors|immunologic factors|mesh-ancestor
92949602|NCT00840801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949603|NCT02547597|Atenolol|atenolol|mesh-list
92949604|NCT02547597|Carvedilol|carvedilol|mesh-list
92949605|NCT02547597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92949606|NCT02547597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92949607|NCT02547597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949608|NCT02547597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949609|NCT02547597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949610|NCT02547597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165095|NCT05403502|Insulin|insulin|mesh-list
92949611|NCT02547597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92949612|NCT02547597|Antioxidants|antioxidants|mesh-ancestor
92949613|NCT02547597|Protective Agents|protective agents|mesh-ancestor
92949614|NCT02547597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92949615|NCT02547597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949616|NCT02547597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92949617|NCT02547597|Vasodilator Agents|vasodilator agents|mesh-ancestor
92949618|NCT02547597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92949619|NCT02547597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92949620|NCT02547597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92949621|NCT02547597|Sympatholytics|sympatholytics|mesh-ancestor
92949622|NCT02547597|Autonomic Agents|autonomic agents|mesh-ancestor
92949623|NCT02547597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949624|NCT02547597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92949625|NCT00842127|Methylphenidate|methylphenidate|mesh-list
92949626|NCT00842127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92949627|NCT00842127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949628|NCT00842127|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92949629|NCT00842127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92949630|NCT00842127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949631|NCT00842127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949632|NCT00842127|Dopamine Agents|dopamine agents|mesh-ancestor
92949633|NCT00842127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949634|NCT00835965|Dexamethasone|dexamethasone|mesh-list
92949635|NCT00835965|Dexamethasone acetate|dexamethasone acetate|mesh-list
92949636|NCT00835965|Aprepitant|aprepitant|mesh-list
92949637|NCT00835965|Fosaprepitant|fosaprepitant|mesh-list
92949638|NCT00835965|BB 1101|bb 1101|mesh-list
92949639|NCT00835965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949640|NCT00835965|Antiemetics|antiemetics|mesh-ancestor
92949641|NCT00835965|Autonomic Agents|autonomic agents|mesh-ancestor
92949642|NCT00835965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949643|NCT00835965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949644|NCT00835965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92949645|NCT00835965|Glucocorticoids|glucocorticoids|mesh-ancestor
92949646|NCT00835965|Hormones|hormones|mesh-ancestor
92949647|NCT00835965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949648|NCT00835965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949649|NCT00835965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949650|NCT00835965|Protease Inhibitors|protease inhibitors|mesh-ancestor
92949651|NCT00835965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949652|NCT00835965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949653|NCT00835965|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92949654|NCT00835965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949655|NCT02567786|Plasma-lyte 148|plasma-lyte 148|mesh-list
92949656|NCT02567786|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92949657|NCT02567786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92949658|NCT05667740|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92949659|NCT05667740|Immunologic Factors|immunologic factors|mesh-ancestor
92949660|NCT05667740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949661|NCT00842205|Interferons|interferons|mesh-list
92949662|NCT00842205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949663|NCT00842205|Antiviral Agents|antiviral agents|mesh-ancestor
92949664|NCT00842205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949665|NCT00738296|Simvastatin|simvastatin|mesh-list
92949666|NCT00738296|Ezetimibe|ezetimibe|mesh-list
92949667|NCT00738296|Pravastatin|pravastatin|mesh-list
92949668|NCT00738296|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92949669|NCT00738296|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92949670|NCT00738296|Antimetabolites|antimetabolites|mesh-ancestor
92949671|NCT00738296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949672|NCT00738296|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92949673|NCT00738296|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92949674|NCT00738296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949675|NCT00836043|Alemtuzumab|alemtuzumab|mesh-list
92949676|NCT00836043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92949677|NCT00836043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949678|NCT02567396|Talazoparib|talazoparib|mesh-list
92949679|NCT02567396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92949680|NCT02567396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949681|NCT02567396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949682|NCT02567396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949683|NCT00738452|Antibodies|antibodies|mesh-list
92949684|NCT00738452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92949685|NCT00738452|Immunologic Factors|immunologic factors|mesh-ancestor
92949686|NCT00738452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949687|NCT05667428|Leuprolide|leuprolide|mesh-list
92949688|NCT05667428|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92949689|NCT05667428|Fertility Agents|fertility agents|mesh-ancestor
92949690|NCT05667428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92949691|NCT05667428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949692|NCT05667428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949693|NCT05667428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949694|NCT05664542|Dexmedetomidine|dexmedetomidine|mesh-list
92949695|NCT05664542|Ropivacaine|ropivacaine|mesh-list
92949696|NCT05664542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92949697|NCT05664542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949698|NCT05664542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949699|NCT05664542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92949700|NCT05664542|Analgesics|analgesics|mesh-ancestor
92949701|NCT05664542|Sensory System Agents|sensory system agents|mesh-ancestor
92949702|NCT05664542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949703|NCT05664542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92949704|NCT05664542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92949705|NCT05664542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92949706|NCT05664542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949707|NCT05664542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949708|NCT05664542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949709|NCT05664542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92949710|NCT05664542|Anesthetics|anesthetics|mesh-ancestor
92949711|NCT00562978|Cyclophosphamide|cyclophosphamide|mesh-list
92949712|NCT00562978|Etoposide|etoposide|mesh-list
92949713|NCT00562978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949714|NCT00562978|Immunologic Factors|immunologic factors|mesh-ancestor
92949715|NCT00562978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949716|NCT00562978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949717|NCT00562978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92949718|NCT00562978|Alkylating Agents|alkylating agents|mesh-ancestor
92949719|NCT00562978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949720|NCT00562978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949721|NCT00562978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92949722|NCT00562978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92949723|NCT00562978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92949724|NCT00562978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949725|NCT00562978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949726|NCT00842595|Prednisone|prednisone|mesh-list
92949727|NCT00842595|Rituximab|rituximab|mesh-list
92949728|NCT00842595|Vinorelbine|vinorelbine|mesh-list
92949729|NCT00842595|Ifosfamide|ifosfamide|mesh-list
92949730|NCT00842595|Mitoxantrone|mitoxantrone|mesh-list
92949731|NCT00842595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92949732|NCT00842595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949733|NCT00842595|Immunologic Factors|immunologic factors|mesh-ancestor
92949734|NCT00842595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595193|NCT00097760|Natalizumab|natalizumab|mesh-list
92949735|NCT00842595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949736|NCT00842595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949737|NCT00842595|Glucocorticoids|glucocorticoids|mesh-ancestor
92949738|NCT00842595|Hormones|hormones|mesh-ancestor
92949739|NCT00842595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949740|NCT00842595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949741|NCT00842595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92949742|NCT00842595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92949743|NCT00842595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92949744|NCT00842595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92949745|NCT00842595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949746|NCT00842595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92949747|NCT00842595|Alkylating Agents|alkylating agents|mesh-ancestor
92949748|NCT00842595|Analgesics|analgesics|mesh-ancestor
92949749|NCT00842595|Sensory System Agents|sensory system agents|mesh-ancestor
92949750|NCT00842595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949751|NCT00842595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92949752|NCT00842595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92949753|NCT00842595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949754|NCT00938626|Antibodies|antibodies|mesh-list
92949755|NCT00938626|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92949756|NCT00938626|Immunologic Factors|immunologic factors|mesh-ancestor
92949757|NCT00938626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949758|NCT00836199|Vaccines|vaccines|mesh-list
92949759|NCT00836199|Immunologic Factors|immunologic factors|mesh-ancestor
92949760|NCT00836199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949761|NCT04013386|Dexamethasone|dexamethasone|mesh-list
92949762|NCT04013386|Dexamethasone acetate|dexamethasone acetate|mesh-list
92949763|NCT04013386|Aprepitant|aprepitant|mesh-list
92949764|NCT04013386|Mirtazapine|mirtazapine|mesh-list
92949765|NCT04013386|BB 1101|bb 1101|mesh-list
92949766|NCT04013386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949767|NCT04013386|Antiemetics|antiemetics|mesh-ancestor
92949768|NCT04013386|Autonomic Agents|autonomic agents|mesh-ancestor
92949769|NCT04013386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949770|NCT04013386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949771|NCT04013386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92949772|NCT04013386|Glucocorticoids|glucocorticoids|mesh-ancestor
92949773|NCT04013386|Hormones|hormones|mesh-ancestor
92949774|NCT04013386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949775|NCT04013386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92949776|NCT04013386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949777|NCT04013386|Protease Inhibitors|protease inhibitors|mesh-ancestor
92949778|NCT04013386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949779|NCT04013386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949780|NCT04013386|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92949781|NCT04013386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949782|NCT04013386|Antidepressive Agents|antidepressive agents|mesh-ancestor
92949783|NCT04013386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949784|NCT04013386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92949785|NCT04013386|Histamine Antagonists|histamine antagonists|mesh-ancestor
92949786|NCT04013386|Histamine Agents|histamine agents|mesh-ancestor
92949787|NCT04013386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92949788|NCT04013386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92949789|NCT04013386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949790|NCT04013386|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92949791|NCT04013386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92949792|NCT04013386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92949793|NCT04013386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949794|NCT04013386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92949795|NCT04013386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92949796|NCT04013386|Serotonin Agents|serotonin agents|mesh-ancestor
92949797|NCT04013386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92949798|NCT00940420|Ribavirin|ribavirin|mesh-list
92949799|NCT00940420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92949800|NCT00940420|Interferon-alpha|interferon-alpha|mesh-list
92949801|NCT00940420|Antimetabolites|antimetabolites|mesh-ancestor
92949802|NCT00940420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949803|NCT00940420|Antiviral Agents|antiviral agents|mesh-ancestor
92949804|NCT00940420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949805|NCT00940420|Immunologic Factors|immunologic factors|mesh-ancestor
92949806|NCT00940420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949807|NCT00842907|Tretinoin|tretinoin|mesh-list
92949808|NCT00842907|Isotretinoin|isotretinoin|mesh-list
92949809|NCT00842907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949810|NCT00842907|Keratolytic Agents|keratolytic agents|mesh-ancestor
92949811|NCT00842907|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949812|NCT00620373|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92949813|NCT00620373|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92949814|NCT00620373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949815|NCT00940654|Acetaminophen|acetaminophen|mesh-list
92949816|NCT00940654|Antipyretics|antipyretics|mesh-list
92949817|NCT00940654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92949818|NCT00940654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92949819|NCT00940654|Analgesics|analgesics|mesh-ancestor
92949820|NCT00940654|Sensory System Agents|sensory system agents|mesh-ancestor
92949821|NCT00940654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949822|NCT00940654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949823|NCT00843063|Pantoprazole|pantoprazole|mesh-list
92949824|NCT00843063|Famotidine|famotidine|mesh-list
92949825|NCT00843063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92949826|NCT00843063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92949827|NCT00843063|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92949828|NCT00843063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949829|NCT00843063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949830|NCT00843063|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92949831|NCT00843063|Histamine Antagonists|histamine antagonists|mesh-ancestor
92949832|NCT00843063|Histamine Agents|histamine agents|mesh-ancestor
92949833|NCT00843063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949834|NCT00843063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949835|NCT04013464|Escitalopram|escitalopram|mesh-list
92949836|NCT04013464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92949837|NCT04013464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92949838|NCT04013464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949839|NCT04013464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949840|NCT04013464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949841|NCT04013464|Serotonin Agents|serotonin agents|mesh-ancestor
92949842|NCT04013464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949843|NCT04012918|Capecitabine|capecitabine|mesh-list
92949844|NCT04012918|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92949845|NCT04012918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92949846|NCT04012918|Antimetabolites|antimetabolites|mesh-ancestor
92949847|NCT04012918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949848|NCT04012918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949849|NCT04012918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92949850|NCT04012918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949851|NCT04012918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92949852|NCT04012918|Hormone Antagonists|hormone antagonists|mesh-ancestor
92949853|NCT04012918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949854|NCT04012918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949855|NCT00939718|Vitamin B 12|vitamin b 12|mesh-list
92949856|NCT00939718|Hydroxocobalamin|hydroxocobalamin|mesh-list
92949857|NCT00939718|Vitamins|vitamins|mesh-ancestor
92949858|NCT00939718|Micronutrients|micronutrients|mesh-ancestor
92949859|NCT00939718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949860|NCT00939718|Vitamin B Complex|vitamin b complex|mesh-ancestor
92949861|NCT00939718|Hematinics|hematinics|mesh-ancestor
92949862|NCT00836667|Sertraline|sertraline|mesh-list
92949863|NCT00836667|Antidepressive Agents|antidepressive agents|mesh-ancestor
92949864|NCT00836667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92949865|NCT00836667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92949866|NCT00836667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92949867|NCT00836667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92949868|NCT00836667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949869|NCT00836667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949870|NCT00836667|Serotonin Agents|serotonin agents|mesh-ancestor
92949871|NCT00836667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949872|NCT00845559|Exenatide|exenatide|mesh-list
92949873|NCT00845559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92949874|NCT00845559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949875|NCT00845559|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92949876|NCT00845559|Incretins|incretins|mesh-ancestor
92949877|NCT00845559|Hormones|hormones|mesh-ancestor
92949878|NCT00845559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949879|NCT00836823|Alfuzosin|alfuzosin|mesh-list
92949880|NCT00836823|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92949881|NCT00836823|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92949882|NCT00836823|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92949883|NCT00836823|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949884|NCT00836823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949885|NCT00836823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949886|NCT00836823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949887|NCT00836823|Urological Agents|urological agents|mesh-ancestor
92949888|NCT02567240|Carbon Monoxide|carbon monoxide|mesh-list
92949889|NCT02567240|Antimetabolites|antimetabolites|mesh-ancestor
92949890|NCT02567240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949891|NCT02567240|Gasotransmitters|gasotransmitters|mesh-ancestor
92949892|NCT02567240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949893|NCT02567240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949895|NCT05107778|Antiviral Agents|antiviral agents|mesh-ancestor
92949896|NCT05107778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949897|NCT00372619|Cytarabine|cytarabine|mesh-list
92949898|NCT00372619|Methotrexate|methotrexate|mesh-list
92949899|NCT00372619|Clofarabine|clofarabine|mesh-list
92949900|NCT00372619|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92949901|NCT00372619|Abortifacient Agents|abortifacient agents|mesh-ancestor
92949902|NCT00372619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92949903|NCT00372619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949904|NCT00372619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92949905|NCT00372619|Antimetabolites|antimetabolites|mesh-ancestor
92949906|NCT00372619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949907|NCT00372619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949908|NCT00372619|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949909|NCT00372619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949910|NCT00372619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92949911|NCT00372619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92949912|NCT00372619|Immunologic Factors|immunologic factors|mesh-ancestor
92949913|NCT00372619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92949914|NCT00372619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92949915|NCT00372619|Antiviral Agents|antiviral agents|mesh-ancestor
92949916|NCT00372619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949917|NCT00851175|Caffeine|caffeine|mesh-list
92949918|NCT00851175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92949919|NCT00851175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92949920|NCT00851175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92949921|NCT00851175|Antimetabolites|antimetabolites|mesh-ancestor
92949922|NCT00851175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949923|NCT00851175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92949924|NCT00851175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92949925|NCT00851175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949926|NCT00851175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92949927|NCT00851175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949928|NCT00851175|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92949929|NCT00851175|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92949930|NCT00851175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92949931|NCT00851175|Purinergic Agents|purinergic agents|mesh-ancestor
92949932|NCT00851175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949933|NCT02566226|Morphine|morphine|mesh-list
92949934|NCT02566226|Bupivacaine|bupivacaine|mesh-list
92949935|NCT02566226|Anesthetics, Local|anesthetics, local|mesh-ancestor
92949936|NCT02566226|Anesthetics|anesthetics|mesh-ancestor
92949937|NCT02566226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92949938|NCT02566226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949939|NCT02566226|Sensory System Agents|sensory system agents|mesh-ancestor
92949940|NCT02566226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949941|NCT02566226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92949942|NCT02566226|Narcotics|narcotics|mesh-ancestor
92949943|NCT02566226|Analgesics|analgesics|mesh-ancestor
92949944|NCT00837135|Vaccines|vaccines|mesh-list
92949945|NCT00837135|Immunologic Factors|immunologic factors|mesh-ancestor
92949946|NCT00837135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949947|NCT00562588|Dipyridamole|dipyridamole|mesh-list
92949948|NCT00562588|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92949949|NCT00562588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92949950|NCT00562588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949951|NCT00562588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949952|NCT00562588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92949953|NCT00562588|Vasodilator Agents|vasodilator agents|mesh-ancestor
92949954|NCT04263038|Rivaroxaban|rivaroxaban|mesh-list
92949955|NCT04263038|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92949956|NCT04263038|Antithrombins|antithrombins|mesh-ancestor
92949957|NCT04263038|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92949958|NCT04263038|Protease Inhibitors|protease inhibitors|mesh-ancestor
92949959|NCT04263038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92949960|NCT04263038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949961|NCT04263038|Anticoagulants|anticoagulants|mesh-ancestor
92949962|NCT02546349|Fluticasone|fluticasone|mesh-list
92949963|NCT02546349|Tiotropium Bromide|tiotropium bromide|mesh-list
92949964|NCT02546349|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92949965|NCT02546349|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92949966|NCT02546349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92949967|NCT02546349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92949968|NCT02546349|Autonomic Agents|autonomic agents|mesh-ancestor
92949969|NCT02546349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92949970|NCT02546349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92949971|NCT02546349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92949972|NCT02546349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92949973|NCT02546349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92949974|NCT02546349|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92949975|NCT02546349|Parasympatholytics|parasympatholytics|mesh-ancestor
92949976|NCT02546349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92949977|NCT02546349|Cholinergic Agents|cholinergic agents|mesh-ancestor
92949978|NCT02546349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92949979|NCT02546349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92949980|NCT02546349|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92949981|NCT02546349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92949982|NCT02546349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92949983|NCT02546349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92949984|NCT02546349|Glucocorticoids|glucocorticoids|mesh-ancestor
92949985|NCT02546349|Hormones|hormones|mesh-ancestor
92949986|NCT02546349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92949987|NCT02546349|Sympathomimetics|sympathomimetics|mesh-ancestor
92949988|NCT00851487|Amoxicillin|amoxicillin|mesh-list
92949989|NCT00851487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92949990|NCT00851487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949991|NCT00372385|Interferons|interferons|mesh-list
92949992|NCT00372385|Ribavirin|ribavirin|mesh-list
92949993|NCT00372385|Interferon-alpha|interferon-alpha|mesh-list
92949994|NCT00372385|Interferon alpha-2|interferon alpha-2|mesh-list
92949995|NCT00372385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92949996|NCT00372385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92949997|NCT00372385|Antiviral Agents|antiviral agents|mesh-ancestor
92949998|NCT00372385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92949999|NCT00372385|Antimetabolites|antimetabolites|mesh-ancestor
92950000|NCT00372385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950001|NCT00372385|Immunologic Factors|immunologic factors|mesh-ancestor
92950002|NCT00372385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950003|NCT03830281|Insulin|insulin|mesh-list
92950004|NCT03830281|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92950005|NCT03830281|Insulin Lispro|insulin lispro|mesh-list
92950006|NCT03830281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92950007|NCT03830281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950008|NCT00563368|Topiramate|topiramate|mesh-list
92950009|NCT00563368|Phentermine|phentermine|mesh-list
92950010|NCT00563368|Anticonvulsants|anticonvulsants|mesh-ancestor
92950011|NCT00563368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92950012|NCT00563368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950013|NCT00563368|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92950014|NCT00563368|Appetite Depressants|appetite depressants|mesh-ancestor
92950015|NCT00563368|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92950016|NCT00563368|Sympathomimetics|sympathomimetics|mesh-ancestor
92950017|NCT00563368|Autonomic Agents|autonomic agents|mesh-ancestor
92950018|NCT00563368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950019|NCT00563368|Adrenergic Agents|adrenergic agents|mesh-ancestor
92950020|NCT00563368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950021|NCT00563368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950022|NCT00390013|Gabapentin|gabapentin|mesh-list
92950023|NCT00390013|Analgesics|analgesics|mesh-ancestor
92950024|NCT00390013|Sensory System Agents|sensory system agents|mesh-ancestor
92950025|NCT00390013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950026|NCT00390013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950027|NCT00390013|Anticonvulsants|anticonvulsants|mesh-ancestor
92950028|NCT00390013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92950029|NCT00390013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92950030|NCT00390013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950032|NCT00390013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92950033|NCT00390013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92950034|NCT00390013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950035|NCT00390013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950036|NCT00390013|Antimanic Agents|antimanic agents|mesh-ancestor
92950037|NCT00562120|Fexofenadine|fexofenadine|mesh-list
92950038|NCT00562120|Terfenadine|terfenadine|mesh-list
92950039|NCT00562120|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92950040|NCT00562120|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92950041|NCT00562120|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92950042|NCT00562120|Histamine Antagonists|histamine antagonists|mesh-ancestor
92950043|NCT00562120|Histamine Agents|histamine agents|mesh-ancestor
92950044|NCT00562120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950045|NCT00562120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950046|NCT00562120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950047|NCT00561730|Pantoprazole|pantoprazole|mesh-list
92950048|NCT00561730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92950049|NCT00561730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950050|NCT00561730|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92950051|NCT00561730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950052|NCT00561730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950053|NCT00697112|Sirolimus|sirolimus|mesh-list
92950054|NCT00697112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950055|NCT00697112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950056|NCT00697112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92950057|NCT00697112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950058|NCT00697112|Antifungal Agents|antifungal agents|mesh-ancestor
92950059|NCT00697112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950060|NCT00697112|Immunologic Factors|immunologic factors|mesh-ancestor
92950061|NCT00697112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950062|NCT00621855|Dabigatran|dabigatran|mesh-list
92950063|NCT00621855|Antithrombins|antithrombins|mesh-ancestor
92950064|NCT00621855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92950065|NCT00621855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92950066|NCT00621855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950067|NCT00621855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950068|NCT00621855|Anticoagulants|anticoagulants|mesh-ancestor
92950069|NCT00851565|Infliximab|infliximab|mesh-list
92950070|NCT00851565|Antibodies|antibodies|mesh-list
92950071|NCT00851565|Immunologic Factors|immunologic factors|mesh-ancestor
92950072|NCT00851565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950073|NCT00851565|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92950074|NCT00851565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950075|NCT00851565|Dermatologic Agents|dermatologic agents|mesh-ancestor
92950076|NCT00851565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950077|NCT00851565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950078|NCT00561574|Mirtazapine|mirtazapine|mesh-list
92950079|NCT00561574|Antidepressive Agents|antidepressive agents|mesh-ancestor
92950080|NCT00561574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92950081|NCT00561574|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92950082|NCT00561574|Histamine Antagonists|histamine antagonists|mesh-ancestor
92950083|NCT00561574|Histamine Agents|histamine agents|mesh-ancestor
92950084|NCT00561574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950085|NCT00561574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950086|NCT00561574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950087|NCT00561574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92950088|NCT00561574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92950089|NCT00561574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950090|NCT00561574|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92950091|NCT00561574|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92950092|NCT00561574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92950093|NCT00561574|Adrenergic Agents|adrenergic agents|mesh-ancestor
92950094|NCT00561574|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92950095|NCT00561574|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92950096|NCT00561574|Serotonin Agents|serotonin agents|mesh-ancestor
92950097|NCT00561574|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92950098|NCT00619827|Immunomodulating Agents|immunomodulating agents|mesh-list
92950099|NCT00619827|Immunologic Factors|immunologic factors|mesh-ancestor
92950100|NCT00619827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950101|NCT00687804|Ranibizumab|ranibizumab|mesh-list
92950102|NCT00687804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92950103|NCT00687804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92950104|NCT00687804|Growth Substances|growth substances|mesh-ancestor
92950105|NCT00687804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950106|NCT00687804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92950107|NCT00687804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950108|NCT02563704|Artesunate|artesunate|mesh-list
92950109|NCT02563704|Quinine|quinine|mesh-list
92950110|NCT02563704|Antimalarials|antimalarials|mesh-ancestor
92950111|NCT02563704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92950112|NCT02563704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92950113|NCT02563704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950114|NCT02563704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950115|NCT02563704|Antiviral Agents|antiviral agents|mesh-ancestor
92950116|NCT02563704|Schistosomicides|schistosomicides|mesh-ancestor
92950117|NCT02563704|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92950118|NCT02563704|Anthelmintics|anthelmintics|mesh-ancestor
92950119|NCT02563704|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92950120|NCT02563704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950121|NCT02563704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92950122|NCT02563704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950123|NCT02563704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950124|NCT02563704|Analgesics|analgesics|mesh-ancestor
92950125|NCT02563704|Sensory System Agents|sensory system agents|mesh-ancestor
92950126|NCT00848523|Panobinostat|panobinostat|mesh-list
92950127|NCT00848523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950128|NCT00848523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92950129|NCT00848523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950130|NCT00848523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950131|NCT05604170|Ganaxolone|ganaxolone|mesh-list
92950132|NCT05604170|Neurosteroids|neurosteroids|mesh-ancestor
92950133|NCT05604170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950134|NCT05604170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950135|NCT05604170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950136|NCT05604170|GABA Modulators|gaba modulators|mesh-ancestor
92950137|NCT05604170|GABA Agents|gaba agents|mesh-ancestor
92950138|NCT00742404|Dexamethasone|dexamethasone|mesh-list
92950139|NCT00742404|Doxorubicin|doxorubicin|mesh-list
92950140|NCT00742404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92950141|NCT00742404|Bortezomib|bortezomib|mesh-list
92950142|NCT00742404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950143|NCT00742404|Antiemetics|antiemetics|mesh-ancestor
92950144|NCT00742404|Autonomic Agents|autonomic agents|mesh-ancestor
92950145|NCT00742404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950146|NCT00742404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950147|NCT00742404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950148|NCT00742404|Glucocorticoids|glucocorticoids|mesh-ancestor
92950149|NCT00742404|Hormones|hormones|mesh-ancestor
92950150|NCT00742404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950151|NCT00742404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92950152|NCT00742404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950153|NCT00742404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92950154|NCT00742404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92950155|NCT00742404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92950156|NCT00742404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950157|NCT00742404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950158|NCT00744666|Prednisolone|prednisolone|mesh-list
92950159|NCT00744666|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92950160|NCT00744666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950161|NCT00744666|Glucocorticoids|glucocorticoids|mesh-ancestor
92950162|NCT00744666|Hormones|hormones|mesh-ancestor
92950163|NCT00744666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950164|NCT00744666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950165|NCT00744666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92950166|NCT00744666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950167|NCT00744666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92950168|NCT04013620|Abatacept|abatacept|mesh-list
92950169|NCT04013620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92950170|NCT04013620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950171|NCT04013620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950172|NCT04013620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950173|NCT04013620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950174|NCT04013620|Immunologic Factors|immunologic factors|mesh-ancestor
92950175|NCT04013620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950176|NCT04013620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950177|NCT00749112|Rituximab|rituximab|mesh-list
92950178|NCT00749112|Alemtuzumab|alemtuzumab|mesh-list
92950179|NCT00749112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950180|NCT00749112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950181|NCT00749112|Immunologic Factors|immunologic factors|mesh-ancestor
92950182|NCT00749112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950183|NCT00749112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950184|NCT00848679|Lidocaine|lidocaine|mesh-list
92950185|NCT00848679|Anesthetics, Local|anesthetics, local|mesh-ancestor
92950186|NCT00848679|Anesthetics|anesthetics|mesh-ancestor
92950187|NCT00848679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950188|NCT00848679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950189|NCT00848679|Sensory System Agents|sensory system agents|mesh-ancestor
92950190|NCT00848679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950191|NCT00848679|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92950192|NCT00848679|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92950193|NCT00848679|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92950194|NCT00848679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950195|NCT00848679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950196|NCT04012606|Carboplatin|carboplatin|mesh-list
92950197|NCT04012606|Etoposide|etoposide|mesh-list
92950198|NCT04012606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950199|NCT04012606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92950200|NCT04012606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92950201|NCT04012606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92950202|NCT04012606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950203|NCT04012606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950204|NCT02545959|Methylprednisolone|methylprednisolone|mesh-list
92950205|NCT02545959|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92950206|NCT02545959|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92950207|NCT02545959|Prednisolone|prednisolone|mesh-list
92950208|NCT02545959|Prednisolone acetate|prednisolone acetate|mesh-list
92950209|NCT02545959|Rituximab|rituximab|mesh-list
92950210|NCT02545959|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92950211|NCT02545959|Prednisolone phosphate|prednisolone phosphate|mesh-list
92950212|NCT02545959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950213|NCT02545959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950214|NCT02545959|Immunologic Factors|immunologic factors|mesh-ancestor
92950215|NCT02545959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950216|NCT02545959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950217|NCT02545959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950218|NCT02545959|Antiemetics|antiemetics|mesh-ancestor
92950219|NCT02545959|Autonomic Agents|autonomic agents|mesh-ancestor
92950220|NCT02545959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950221|NCT02545959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950222|NCT02545959|Glucocorticoids|glucocorticoids|mesh-ancestor
92950223|NCT02545959|Hormones|hormones|mesh-ancestor
92950224|NCT02545959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950225|NCT02545959|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92950226|NCT02545959|Protective Agents|protective agents|mesh-ancestor
92950227|NCT02545959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92950228|NCT00744900|Pemetrexed|pemetrexed|mesh-list
92950229|NCT00744900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950230|NCT00744900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950231|NCT00744900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950232|NCT00744900|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92950233|NCT00744900|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92950234|NCT00727090|Conivaptan|conivaptan|mesh-list
92950235|NCT00727090|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92950236|NCT00727090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950237|NCT00727090|Natriuretic Agents|natriuretic agents|mesh-ancestor
92950238|NCT00727090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950239|NCT00689052|Pramipexole|pramipexole|mesh-list
92950240|NCT00689052|Antioxidants|antioxidants|mesh-ancestor
92950241|NCT00689052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950242|NCT00689052|Protective Agents|protective agents|mesh-ancestor
92950243|NCT00689052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950244|NCT00689052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92950245|NCT00689052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92950246|NCT00689052|Dopamine Agonists|dopamine agonists|mesh-ancestor
92950247|NCT00689052|Dopamine Agents|dopamine agents|mesh-ancestor
92950248|NCT00689052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950249|NCT04012450|Anesthetics|anesthetics|mesh-list
92950250|NCT04012450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950251|NCT04012450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950252|NCT00945022|Anesthetics|anesthetics|mesh-list
92950253|NCT00945022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950254|NCT00945022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950255|NCT02565212|Montelukast|montelukast|mesh-list
92950256|NCT02565212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92950257|NCT02565212|Respiratory System Agents|respiratory system agents|mesh-ancestor
92950258|NCT02565212|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92950259|NCT02565212|Hormone Antagonists|hormone antagonists|mesh-ancestor
92950260|NCT02565212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950261|NCT02565212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950262|NCT02565212|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92950263|NCT02565212|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92950264|NCT02565212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950265|NCT00747708|Lenograstim|lenograstim|mesh-list
92950266|NCT00747708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92950267|NCT00747708|Immunologic Factors|immunologic factors|mesh-ancestor
92950268|NCT00747708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950269|NCT05602064|Acetaminophen|acetaminophen|mesh-list
92950270|NCT05602064|Ibuprofen|ibuprofen|mesh-list
92950271|NCT05602064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92950272|NCT05602064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950273|NCT05602064|Analgesics|analgesics|mesh-ancestor
92950274|NCT05602064|Sensory System Agents|sensory system agents|mesh-ancestor
92950275|NCT05602064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950276|NCT05602064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950277|NCT05602064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950278|NCT05602064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950279|NCT05602064|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92950280|NCT05602064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950281|NCT05602064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950282|NCT05602064|Antipyretics|antipyretics|mesh-ancestor
92950283|NCT00560950|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92950284|NCT00560950|Immunologic Factors|immunologic factors|mesh-ancestor
92950285|NCT00560950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950286|NCT02562144|Lidocaine|lidocaine|mesh-list
92950287|NCT02562144|Anesthetics, Local|anesthetics, local|mesh-ancestor
92950288|NCT02562144|Anesthetics|anesthetics|mesh-ancestor
92950289|NCT02562144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950290|NCT02562144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950291|NCT02562144|Sensory System Agents|sensory system agents|mesh-ancestor
92950292|NCT02562144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950293|NCT02562144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92950294|NCT02562144|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92950295|NCT02562144|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92950296|NCT02562144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950297|NCT02562144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950298|NCT02562300|Misoprostol|misoprostol|mesh-list
92950299|NCT02562300|Oxytocin|oxytocin|mesh-list
92950300|NCT02562300|Oxytocics|oxytocics|mesh-ancestor
92950301|NCT02562300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92950302|NCT02562300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950303|NCT02562300|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92950304|NCT02562300|Abortifacient Agents|abortifacient agents|mesh-ancestor
92950305|NCT02562300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92950306|NCT02562300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950307|NCT00945178|Naproxen|naproxen|mesh-list
92950308|NCT00945178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92950309|NCT00945178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950310|NCT00945178|Analgesics|analgesics|mesh-ancestor
92950311|NCT00945178|Sensory System Agents|sensory system agents|mesh-ancestor
92950312|NCT00945178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950313|NCT00945178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950314|NCT00945178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950315|NCT00945178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950316|NCT00945178|Gout Suppressants|gout suppressants|mesh-ancestor
92950317|NCT00945178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92950318|NCT00945178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950319|NCT00945178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950320|NCT00749346|Pemetrexed|pemetrexed|mesh-list
92950321|NCT00749346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950322|NCT00749346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295261|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950323|NCT00749346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950324|NCT00749346|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92950325|NCT00749346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92950327|NCT02562690|Hemostatics|hemostatics|mesh-ancestor
92950328|NCT02562690|Coagulants|coagulants|mesh-ancestor
92950329|NCT00576758|Rituximab|rituximab|mesh-list
92950330|NCT00576758|Obinutuzumab|obinutuzumab|mesh-list
92950331|NCT00576758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950332|NCT00576758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950333|NCT00576758|Immunologic Factors|immunologic factors|mesh-ancestor
92950334|NCT00576758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950335|NCT00576758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950336|NCT00923676|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92950337|NCT00923676|Fenofibrate|fenofibrate|mesh-list
92950338|NCT00923676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92950339|NCT00923676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92950340|NCT00923676|Antimetabolites|antimetabolites|mesh-ancestor
92950341|NCT00923676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950342|NCT00923676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92950343|NCT00923676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92950344|NCT00923676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950345|NCT00921284|Dexmedetomidine|dexmedetomidine|mesh-list
92950346|NCT00921284|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92950347|NCT00921284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950348|NCT00921284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950349|NCT00921284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950350|NCT00921284|Analgesics|analgesics|mesh-ancestor
92950351|NCT00921284|Sensory System Agents|sensory system agents|mesh-ancestor
92950352|NCT00921284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950353|NCT00921284|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92950354|NCT00921284|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92950355|NCT00921284|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92950356|NCT00921284|Adrenergic Agents|adrenergic agents|mesh-ancestor
92950357|NCT00921284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950358|NCT00921284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950359|NCT00749502|Niraparib|niraparib|mesh-list
92950360|NCT00749502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92950361|NCT00749502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950362|NCT00749502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950363|NCT00749502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950364|NCT00560794|Blinatumomab|blinatumomab|mesh-list
92950365|NCT00560794|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92950366|NCT00560794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950367|NCT00560794|Immunologic Factors|immunologic factors|mesh-ancestor
92950368|NCT00560794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950369|NCT00749736|Cholecalciferol|cholecalciferol|mesh-list
92950370|NCT00749736|Vitamin D|vitamin d|mesh-list
92950371|NCT00749736|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92950372|NCT00749736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92950373|NCT00749736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950374|NCT00749736|Vitamins|vitamins|mesh-ancestor
92950375|NCT00749736|Micronutrients|micronutrients|mesh-ancestor
92950376|NCT00749736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92950377|NCT00950404|Sildenafil Citrate|sildenafil citrate|mesh-list
92950378|NCT00950404|Vasodilator Agents|vasodilator agents|mesh-ancestor
92950379|NCT00950404|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92950380|NCT00950404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92950381|NCT00950404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950382|NCT00950404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165142|NCT05292664|Cortisone|cortisone|mesh-list
92950383|NCT00950404|Urological Agents|urological agents|mesh-ancestor
92950385|NCT00749814|Antioxidants|antioxidants|mesh-ancestor
92950386|NCT00749814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950387|NCT00749814|Protective Agents|protective agents|mesh-ancestor
92950388|NCT00749814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950389|NCT00749814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950390|NCT00748176|Anesthetics|anesthetics|mesh-list
92950391|NCT00748176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950392|NCT00748176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950393|NCT00619359|Dexamethasone|dexamethasone|mesh-list
92950394|NCT00619359|Dexamethasone acetate|dexamethasone acetate|mesh-list
92950395|NCT00619359|Ondansetron|ondansetron|mesh-list
92950396|NCT00619359|Aprepitant|aprepitant|mesh-list
92950397|NCT00619359|Fosaprepitant|fosaprepitant|mesh-list
92950398|NCT00619359|BB 1101|bb 1101|mesh-list
92950399|NCT00619359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950400|NCT00619359|Antiemetics|antiemetics|mesh-ancestor
92950401|NCT00619359|Autonomic Agents|autonomic agents|mesh-ancestor
92950402|NCT00619359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950403|NCT00619359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950404|NCT00619359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950405|NCT00619359|Glucocorticoids|glucocorticoids|mesh-ancestor
92950406|NCT00619359|Hormones|hormones|mesh-ancestor
92950407|NCT00619359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950408|NCT00619359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595859|NCT00099866|Metformin|metformin|mesh-list
92950409|NCT00619359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950410|NCT00619359|Protease Inhibitors|protease inhibitors|mesh-ancestor
92950411|NCT00619359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950412|NCT00619359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950413|NCT00619359|Antipruritics|antipruritics|mesh-ancestor
92950414|NCT00619359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92950415|NCT00619359|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92950416|NCT00619359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92950417|NCT00619359|Serotonin Agents|serotonin agents|mesh-ancestor
92950418|NCT00619359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950419|NCT00619359|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92950420|NCT00848991|Dexmedetomidine|dexmedetomidine|mesh-list
92950421|NCT00848991|Propofol|propofol|mesh-list
92950422|NCT00848991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92950423|NCT00848991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950424|NCT00848991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950425|NCT00848991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92950426|NCT00848991|Anesthetics, General|anesthetics, general|mesh-ancestor
92950427|NCT00848991|Anesthetics|anesthetics|mesh-ancestor
92950428|NCT00848991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950429|NCT00848991|Analgesics|analgesics|mesh-ancestor
92950430|NCT00848991|Sensory System Agents|sensory system agents|mesh-ancestor
92950431|NCT00848991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950432|NCT00848991|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92950433|NCT00848991|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92950434|NCT00848991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92950435|NCT00848991|Adrenergic Agents|adrenergic agents|mesh-ancestor
92950436|NCT00848991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950437|NCT00848991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950438|NCT00950794|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92950439|NCT00950794|Tulobuterol|tulobuterol|mesh-list
92950440|NCT00950794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92950441|NCT00950794|Autonomic Agents|autonomic agents|mesh-ancestor
92950442|NCT00950794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950443|NCT00950794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950444|NCT00950794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92950445|NCT00950794|Respiratory System Agents|respiratory system agents|mesh-ancestor
92950446|NCT00950794|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92950447|NCT00950794|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92950448|NCT00950794|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92950449|NCT00950794|Adrenergic Agents|adrenergic agents|mesh-ancestor
92950450|NCT00950794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950451|NCT00950794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950452|NCT00852189|Folic Acid|folic acid|mesh-list
92165148|NCT05292664|Dexrazoxane|dexrazoxane|mesh-list
92950453|NCT00852189|Vitamin B Complex|vitamin b complex|mesh-list
92950454|NCT00852189|Vinca Alkaloids|vinca alkaloids|mesh-list
92950455|NCT00852189|Hematinics|hematinics|mesh-ancestor
92950456|NCT00852189|Vitamins|vitamins|mesh-ancestor
92950457|NCT00852189|Micronutrients|micronutrients|mesh-ancestor
92950458|NCT00852189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950459|NCT00852189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950460|NCT00852189|Tubulin Modulators|tubulin modulators|mesh-ancestor
92950461|NCT00852189|Antimitotic Agents|antimitotic agents|mesh-ancestor
92950462|NCT00852189|Mitosis Modulators|mitosis modulators|mesh-ancestor
92950463|NCT00852189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950464|NCT00951106|Pyrimethamine|pyrimethamine|mesh-list
92950465|NCT00951106|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92950466|NCT00951106|Antimalarials|antimalarials|mesh-ancestor
92950467|NCT00951106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92950468|NCT00951106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92950469|NCT00951106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950470|NCT00951106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92950471|NCT00951106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950472|NCT00951106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950473|NCT00372229|Valganciclovir|valganciclovir|mesh-list
92950474|NCT00372229|Ganciclovir|ganciclovir|mesh-list
92950475|NCT00372229|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92950476|NCT00372229|Antiviral Agents|antiviral agents|mesh-ancestor
92950477|NCT00372229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950478|NCT00372229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92950479|NCT00372229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950480|NCT00372229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950481|NCT05301010|Docetaxel|docetaxel|mesh-list
92950482|NCT05301010|Trastuzumab|trastuzumab|mesh-list
92950483|NCT05301010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950484|NCT05301010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92950485|NCT05301010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92950486|NCT05301010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92950487|NCT05301010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950488|NCT05301010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950489|NCT00855699|Acamprosate|acamprosate|mesh-list
92950490|NCT00855699|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92950491|NCT00855777|Ibuprofen|ibuprofen|mesh-list
92950492|NCT00855777|Etoricoxib|etoricoxib|mesh-list
92950493|NCT00855777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92950494|NCT00855777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950495|NCT00855777|Analgesics|analgesics|mesh-ancestor
92950496|NCT00855777|Sensory System Agents|sensory system agents|mesh-ancestor
92950497|NCT00855777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950498|NCT00855777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950499|NCT00855777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950500|NCT00855777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950501|NCT00855777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92950502|NCT00855777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950503|NCT00855777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950504|NCT00855777|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92950505|NCT04012294|Allopurinol|allopurinol|mesh-list
92950506|NCT04012294|Antimetabolites|antimetabolites|mesh-ancestor
92950507|NCT04012294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950508|NCT04012294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950509|NCT04012294|Gout Suppressants|gout suppressants|mesh-ancestor
92950510|NCT04012294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950511|NCT04012294|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92950512|NCT04012294|Antioxidants|antioxidants|mesh-ancestor
92950513|NCT04012294|Protective Agents|protective agents|mesh-ancestor
92950514|NCT04012294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950515|NCT00849459|Interleukin-12|interleukin-12|mesh-list
92950516|NCT00849459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92950517|NCT00849459|Immunologic Factors|immunologic factors|mesh-ancestor
92950518|NCT00849459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950519|NCT00849459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92950520|NCT00849459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92950521|NCT00849459|Growth Substances|growth substances|mesh-ancestor
92950522|NCT00849459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92950523|NCT00849459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950524|NCT00852345|Clofazimine|clofazimine|mesh-list
92950525|NCT00852345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950526|NCT00852345|Leprostatic Agents|leprostatic agents|mesh-ancestor
92950527|NCT00852345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950528|NCT00852345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950529|NCT00852423|Artesunate|artesunate|mesh-list
92950530|NCT00852423|Lumefantrine|lumefantrine|mesh-list
92950531|NCT00852423|Artemether|artemether|mesh-list
92950532|NCT00852423|Piperaquine|piperaquine|mesh-list
92950533|NCT00852423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92950534|NCT00852423|Amodiaquine|amodiaquine|mesh-list
92950535|NCT00852423|Artenimol|artenimol|mesh-list
92950536|NCT00852423|Mefloquine|mefloquine|mesh-list
92950537|NCT00852423|Antimalarials|antimalarials|mesh-ancestor
92950538|NCT00852423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92950539|NCT00852423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92950540|NCT00852423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950541|NCT00852423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950542|NCT00852423|Antiviral Agents|antiviral agents|mesh-ancestor
92950543|NCT00852423|Schistosomicides|schistosomicides|mesh-ancestor
92950544|NCT00852423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92950545|NCT00852423|Anthelmintics|anthelmintics|mesh-ancestor
92950546|NCT00941824|Mycophenolic Acid|mycophenolic acid|mesh-list
92950547|NCT00941824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92950548|NCT00941824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950549|NCT00941824|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92950550|NCT00941824|Antitubercular Agents|antitubercular agents|mesh-ancestor
92950551|NCT00941824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950552|NCT00941824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950553|NCT00941824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950554|NCT00941824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950555|NCT00849537|Triamcinolone|triamcinolone|mesh-list
92950556|NCT00849537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950557|NCT00849537|Glucocorticoids|glucocorticoids|mesh-ancestor
92950558|NCT00849537|Hormones|hormones|mesh-ancestor
92950559|NCT00849537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950560|NCT00849537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596015|NCT04728386|Eusol|eusol|mesh-list
92950561|NCT01049815|Calcium Carbonate|calcium carbonate|mesh-list
92950563|NCT01049815|Sevelamer|sevelamer|mesh-list
92950564|NCT01049815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92950565|NCT01049815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950566|NCT01049815|Antacids|antacids|mesh-ancestor
92950567|NCT01049815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950568|NCT01049815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950569|NCT01049815|Chelating Agents|chelating agents|mesh-ancestor
92950570|NCT01049815|Sequestering Agents|sequestering agents|mesh-ancestor
92950571|NCT00849615|Leucovorin|leucovorin|mesh-list
92950572|NCT00849615|Folic Acid|folic acid|mesh-list
92950573|NCT00849615|Docetaxel|docetaxel|mesh-list
92950574|NCT00849615|Fluorouracil|fluorouracil|mesh-list
92950575|NCT00849615|Oxaliplatin|oxaliplatin|mesh-list
92950576|NCT00849615|Levoleucovorin|levoleucovorin|mesh-list
92950577|NCT00849615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950578|NCT00849615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92950579|NCT00849615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92950580|NCT00849615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92950581|NCT00849615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950582|NCT00849615|Antimetabolites|antimetabolites|mesh-ancestor
92950583|NCT00849615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92950584|NCT00849615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950585|NCT00849615|Immunologic Factors|immunologic factors|mesh-ancestor
92950586|NCT00849615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950587|NCT00849615|Antidotes|antidotes|mesh-ancestor
92950588|NCT00849615|Protective Agents|protective agents|mesh-ancestor
92950589|NCT00849615|Vitamin B Complex|vitamin b complex|mesh-ancestor
92950590|NCT00849615|Vitamins|vitamins|mesh-ancestor
92950591|NCT00849615|Micronutrients|micronutrients|mesh-ancestor
92950592|NCT00849615|Hematinics|hematinics|mesh-ancestor
92950593|NCT00946036|Sertraline|sertraline|mesh-list
92950594|NCT00946036|Antidepressive Agents|antidepressive agents|mesh-ancestor
92950595|NCT00946036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92950596|NCT00946036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92950597|NCT00946036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92950598|NCT00946036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950599|NCT00946036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950600|NCT00946036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950601|NCT00946036|Serotonin Agents|serotonin agents|mesh-ancestor
92165159|NCT05292664|Glucocorticoids|glucocorticoids|mesh-ancestor
92950602|NCT00946036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950603|NCT00688740|Cyclophosphamide|cyclophosphamide|mesh-list
92950604|NCT00688740|Docetaxel|docetaxel|mesh-list
92950605|NCT00688740|Doxorubicin|doxorubicin|mesh-list
92950606|NCT00688740|Fluorouracil|fluorouracil|mesh-list
92950607|NCT00688740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950608|NCT00688740|Immunologic Factors|immunologic factors|mesh-ancestor
92950609|NCT00688740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950610|NCT00688740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950611|NCT00688740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92950612|NCT00688740|Alkylating Agents|alkylating agents|mesh-ancestor
92950613|NCT00688740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950614|NCT00688740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950615|NCT00688740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92950616|NCT00688740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92950617|NCT00688740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92950618|NCT00688740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92950619|NCT00688740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92950620|NCT00688740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92950621|NCT00688740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92950622|NCT00688740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950623|NCT00688740|Antimetabolites|antimetabolites|mesh-ancestor
92950624|NCT00688740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92950625|NCT05323058|Benzydamine|benzydamine|mesh-list
92950626|NCT05323058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950627|NCT01046773|Cholecalciferol|cholecalciferol|mesh-list
92950628|NCT01046773|Vitamin D|vitamin d|mesh-list
92950629|NCT01046773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92950630|NCT01046773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950631|NCT01046773|Vitamins|vitamins|mesh-ancestor
92950632|NCT01046773|Micronutrients|micronutrients|mesh-ancestor
92950633|NCT01046773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92950634|NCT00850005|Immunoglobulins|immunoglobulins|mesh-list
92950635|NCT00850005|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92950636|NCT00850005|Antibodies|antibodies|mesh-list
92950637|NCT00850005|gamma-Globulins|gamma-globulins|mesh-list
92950638|NCT00850005|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92950639|NCT00850005|Immunologic Factors|immunologic factors|mesh-ancestor
92950640|NCT00850005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950641|NCT00852579|Azithromycin|azithromycin|mesh-list
92950642|NCT00852579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950643|NCT00852579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950644|NCT00942136|Dolutegravir|dolutegravir|mesh-list
92950645|NCT00942136|Omeprazole|omeprazole|mesh-list
92950646|NCT00942136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92950647|NCT00942136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950648|NCT00942136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92950649|NCT00942136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950650|NCT00942136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950651|NCT00942136|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92950652|NCT00942136|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92950653|NCT00942136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92950654|NCT00942136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92950655|NCT00942136|Antiviral Agents|antiviral agents|mesh-ancestor
92950656|NCT00942136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950657|NCT05300932|Cyclophosphamide|cyclophosphamide|mesh-list
92950658|NCT05300932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950659|NCT05300932|Immunologic Factors|immunologic factors|mesh-ancestor
92950660|NCT05300932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950661|NCT05300932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950662|NCT05300932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92950663|NCT05300932|Alkylating Agents|alkylating agents|mesh-ancestor
92950664|NCT05300932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950665|NCT05300932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950666|NCT05300932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92950667|NCT00942214|Natalizumab|natalizumab|mesh-list
92950668|NCT00942214|Immunologic Factors|immunologic factors|mesh-ancestor
92950669|NCT00942214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950670|NCT00850161|Insulin|insulin|mesh-list
92950671|NCT00850161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92950672|NCT00850161|Insulin Aspart|insulin aspart|mesh-list
92950673|NCT00850161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92950674|NCT00850161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950675|NCT00951574|Nadroparin|nadroparin|mesh-list
92950676|NCT00951574|Calcium|calcium|mesh-list
92950677|NCT00951574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92950678|NCT00951574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950679|NCT00951574|Anticoagulants|anticoagulants|mesh-ancestor
92950680|NCT00951574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92950681|NCT00951574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92950682|NCT00951574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950683|NCT00686790|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92950684|NCT00686790|Interferon-alpha|interferon-alpha|mesh-list
92950685|NCT00686790|Antiviral Agents|antiviral agents|mesh-ancestor
92950686|NCT00686790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950687|NCT00686790|Immunologic Factors|immunologic factors|mesh-ancestor
92950688|NCT00686790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950689|NCT00856089|Retapamulin|retapamulin|mesh-list
92950690|NCT00856089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950691|NCT00856089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950692|NCT00686712|Insulin|insulin|mesh-list
92950693|NCT00686712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92950694|NCT00686712|Insulin Glargine|insulin glargine|mesh-list
92950695|NCT00686712|Insulin, Isophane|insulin, isophane|mesh-list
92950696|NCT00686712|Isophane Insulin, Human|isophane insulin, human|mesh-list
92950697|NCT00686712|Isophane insulin, beef|isophane insulin, beef|mesh-list
92950698|NCT00686712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92950699|NCT00686712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950700|NCT00748644|Rituximab|rituximab|mesh-list
92950701|NCT00748644|Azathioprine|azathioprine|mesh-list
92950702|NCT00748644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950703|NCT00748644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950704|NCT00748644|Immunologic Factors|immunologic factors|mesh-ancestor
92950705|NCT00748644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950706|NCT00748644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950707|NCT00748644|Antimetabolites|antimetabolites|mesh-ancestor
92950708|NCT00748644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950709|NCT00748644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92950710|NCT00748644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950711|NCT00686634|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92950712|NCT00686634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92950713|NCT00686634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950714|NCT00686634|Incretins|incretins|mesh-ancestor
92950715|NCT00686634|Hormones|hormones|mesh-ancestor
92950716|NCT00686634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92950717|NCT00686634|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92950718|NCT00686634|Protease Inhibitors|protease inhibitors|mesh-ancestor
92950719|NCT00686634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950720|NCT00686634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950721|NCT00856401|Parathyroid Hormone|parathyroid hormone|mesh-list
92950722|NCT00856401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950723|NCT00856401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92950724|NCT00560404|Epoetin Alfa|epoetin alfa|mesh-list
92950725|NCT00560404|Hematinics|hematinics|mesh-ancestor
92950727|NCT00942526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950728|NCT00942526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950729|NCT00942526|Antifungal Agents|antifungal agents|mesh-ancestor
92950730|NCT00942526|Ionophores|ionophores|mesh-ancestor
92950731|NCT00942526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950732|NCT00942526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950733|NCT03967444|Hyaluronic Acid|hyaluronic acid|mesh-list
92950734|NCT03967444|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92950735|NCT03967444|Immunologic Factors|immunologic factors|mesh-ancestor
92950736|NCT03967444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950737|NCT03967444|Viscosupplements|viscosupplements|mesh-ancestor
92950738|NCT03967444|Protective Agents|protective agents|mesh-ancestor
92950739|NCT05300854|Anesthetics|anesthetics|mesh-list
92950740|NCT05300854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950741|NCT05300854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950742|NCT00946504|Glipizide|glipizide|mesh-list
92950743|NCT00946504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92950744|NCT00946504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950745|NCT00619983|Gabapentin|gabapentin|mesh-list
92950746|NCT00619983|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92950747|NCT00619983|Donepezil|donepezil|mesh-list
92950748|NCT00619983|Analgesics|analgesics|mesh-ancestor
92950749|NCT00619983|Sensory System Agents|sensory system agents|mesh-ancestor
92950750|NCT00619983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950751|NCT00619983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950752|NCT00619983|Anticonvulsants|anticonvulsants|mesh-ancestor
92950753|NCT00619983|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92950754|NCT00619983|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92950755|NCT00619983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92950756|NCT00619983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92950757|NCT00619983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92950758|NCT00619983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92950759|NCT00619983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950760|NCT00619983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950761|NCT00619983|Antimanic Agents|antimanic agents|mesh-ancestor
92950762|NCT00619983|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92950763|NCT00619983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92950764|NCT00619983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950766|NCT00619983|Dopamine Agents|dopamine agents|mesh-ancestor
92950767|NCT00619983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92950768|NCT00619983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950769|NCT00619983|Cholinergic Agents|cholinergic agents|mesh-ancestor
92950770|NCT00619983|Nootropic Agents|nootropic agents|mesh-ancestor
92950771|NCT00942682|Sorafenib|sorafenib|mesh-list
92950772|NCT00942682|Everolimus|everolimus|mesh-list
92950773|NCT00942682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950774|NCT00942682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92950775|NCT00942682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950776|NCT00942682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950777|NCT00942682|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92950778|NCT00942682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950779|NCT00942682|Immunologic Factors|immunologic factors|mesh-ancestor
92950780|NCT00942682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950781|NCT00853983|Saracatinib|saracatinib|mesh-list
92950782|NCT00853983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950783|NCT00853983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950784|NCT00853983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950785|NCT00750048|Acetaminophen|acetaminophen|mesh-list
92950786|NCT00750048|Naloxone|naloxone|mesh-list
92950787|NCT00750048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950788|NCT00750048|Analgesics|analgesics|mesh-ancestor
92950789|NCT00750048|Sensory System Agents|sensory system agents|mesh-ancestor
92950790|NCT00750048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950791|NCT00750048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950792|NCT00750048|Antipyretics|antipyretics|mesh-ancestor
92950793|NCT00750048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92950794|NCT00942838|Cisplatin|cisplatin|mesh-list
92950795|NCT00942838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950796|NCT04057014|Amoxicillin|amoxicillin|mesh-list
92950797|NCT04057014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950798|NCT04057014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950799|NCT00364351|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92950800|NCT00364351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950801|NCT00364351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92950802|NCT00364351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950803|NCT00364351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950804|NCT05279872|Zanubrutinib|zanubrutinib|mesh-list
92950805|NCT05279872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950806|NCT05279872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92950807|NCT05279872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950808|NCT05279872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950809|NCT00854139|Cyclosporine|cyclosporine|mesh-list
92950810|NCT00854139|Cyclophosphamide|cyclophosphamide|mesh-list
92950811|NCT00854139|Cyclosporins|cyclosporins|mesh-list
92950812|NCT00854139|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92950813|NCT00854139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950814|NCT00854139|Immunologic Factors|immunologic factors|mesh-ancestor
92950815|NCT00854139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950816|NCT00854139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950817|NCT00854139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92950818|NCT00854139|Alkylating Agents|alkylating agents|mesh-ancestor
92950819|NCT00854139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950820|NCT00854139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950821|NCT00854139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92950822|NCT00854139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950823|NCT00854139|Antifungal Agents|antifungal agents|mesh-ancestor
92950824|NCT00854139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950825|NCT00854139|Dermatologic Agents|dermatologic agents|mesh-ancestor
92950826|NCT00854139|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92950827|NCT00755820|Cycloserine|cycloserine|mesh-list
92950828|NCT00755820|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92950829|NCT00755820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950830|NCT00755820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92950831|NCT00755820|Antitubercular Agents|antitubercular agents|mesh-ancestor
92950832|NCT00755820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950833|NCT00755820|Antimetabolites|antimetabolites|mesh-ancestor
92950834|NCT00755820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950835|NCT00752154|Curcumin|curcumin|mesh-list
92527358|NCT00032929|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92950836|NCT00752154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92950837|NCT00752154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950838|NCT00752154|Analgesics|analgesics|mesh-ancestor
92950839|NCT00752154|Sensory System Agents|sensory system agents|mesh-ancestor
92950840|NCT00752154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950841|NCT00752154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950842|NCT00752154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950843|NCT00752154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950844|NCT00752154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950845|NCT00752154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950846|NCT00752154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950847|NCT00943228|Mycophenolic Acid|mycophenolic acid|mesh-list
92950848|NCT00943228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92950849|NCT00943228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950850|NCT00943228|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92950851|NCT00943228|Antitubercular Agents|antitubercular agents|mesh-ancestor
92950852|NCT00943228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950853|NCT00943228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950854|NCT00943228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950855|NCT00943228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950856|NCT00755898|Amantadine|amantadine|mesh-list
92950857|NCT00755898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92950858|NCT00755898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92950859|NCT00755898|Antiviral Agents|antiviral agents|mesh-ancestor
92950860|NCT00755898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950861|NCT00755898|Dopamine Agents|dopamine agents|mesh-ancestor
92950862|NCT00755898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950863|NCT00755898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950864|NCT00755898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950865|NCT00755898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92596312|NCT00135876|Dalteparin|dalteparin|mesh-list
92950867|NCT00755898|Sensory System Agents|sensory system agents|mesh-ancestor
92950868|NCT00755898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950869|NCT00750126|Fludarabine|fludarabine|mesh-list
92950870|NCT00750126|Busulfan|busulfan|mesh-list
92950871|NCT00750126|Thymoglobulin|thymoglobulin|mesh-list
92950872|NCT00750126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950873|NCT00750126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950874|NCT00750126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92950875|NCT00750126|Immunologic Factors|immunologic factors|mesh-ancestor
92950876|NCT00750126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950877|NCT00750126|Alkylating Agents|alkylating agents|mesh-ancestor
92950878|NCT00750126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92950879|NCT00750126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92950880|NCT00755976|Sulindac|sulindac|mesh-list
92950881|NCT00755976|Epirubicin|epirubicin|mesh-list
92950882|NCT00755976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92950883|NCT00755976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950884|NCT00755976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92950885|NCT00755976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92950886|NCT00755976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950887|NCT00755976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950888|NCT00755976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92950889|NCT00755976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950890|NCT00755976|Analgesics|analgesics|mesh-ancestor
92950891|NCT00755976|Sensory System Agents|sensory system agents|mesh-ancestor
92950892|NCT00755976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950893|NCT00755976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950894|NCT00755976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92950895|NCT00755976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92950896|NCT00755976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92950897|NCT00752310|Darunavir|darunavir|mesh-list
92950898|NCT00752310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92950899|NCT00752310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92950900|NCT00752310|Protease Inhibitors|protease inhibitors|mesh-ancestor
92950901|NCT00752310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950902|NCT00752310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950903|NCT00752310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92950904|NCT00752310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92950905|NCT00752310|Antiviral Agents|antiviral agents|mesh-ancestor
92950906|NCT00752310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950907|NCT00943462|Temozolomide|temozolomide|mesh-list
92950908|NCT00943462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92950910|NCT00943462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950911|NCT00943462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950912|NCT02560974|Capecitabine|capecitabine|mesh-list
92950913|NCT02560974|Oxaliplatin|oxaliplatin|mesh-list
92950914|NCT02560974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92950915|NCT02560974|Antimetabolites|antimetabolites|mesh-ancestor
92950916|NCT02560974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950917|NCT02560974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950918|NCT00854451|Amoxicillin|amoxicillin|mesh-list
92950919|NCT00854451|Omeprazole|omeprazole|mesh-list
92950920|NCT00854451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950921|NCT00854451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950922|NCT00854451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92950923|NCT00854451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92950924|NCT00854451|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92950925|NCT00854451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950926|NCT00854451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950927|NCT00854529|Bevacizumab|bevacizumab|mesh-list
92950928|NCT00854529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92950929|NCT00854529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950930|NCT00854529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92950931|NCT00854529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92950932|NCT00854529|Growth Substances|growth substances|mesh-ancestor
92950933|NCT00854529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950934|NCT00854529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92950935|NCT00952432|Carbamazepine|carbamazepine|mesh-list
92950936|NCT00952432|Anticonvulsants|anticonvulsants|mesh-ancestor
92950937|NCT00952432|Antimanic Agents|antimanic agents|mesh-ancestor
92950938|NCT00952432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92950939|NCT00952432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596420|NCT00135954|Hormones|hormones|mesh-ancestor
92950940|NCT00952432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950941|NCT00952432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92950942|NCT00952432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950944|NCT00952432|Sensory System Agents|sensory system agents|mesh-ancestor
92950945|NCT00952432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950946|NCT00952432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92950947|NCT00952432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950948|NCT00952432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950949|NCT00952432|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92950950|NCT00952432|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92950951|NCT00861315|Amikacin|amikacin|mesh-list
92950952|NCT00861315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92950953|NCT00861315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950954|NCT00943540|Lamivudine|lamivudine|mesh-list
92950955|NCT00943540|Emtricitabine|emtricitabine|mesh-list
92950956|NCT00943540|Raltegravir Potassium|raltegravir potassium|mesh-list
92950957|NCT00943540|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92950958|NCT00943540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92950959|NCT00943540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92950960|NCT00943540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92950961|NCT00943540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950962|NCT00943540|Antiviral Agents|antiviral agents|mesh-ancestor
92950963|NCT00943540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92950964|NCT00943540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92950965|NCT00943540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92950966|NCT00943540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92950967|NCT00943540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92950968|NCT00943540|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92950969|NCT00943540|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92950970|NCT00943540|Protease Inhibitors|protease inhibitors|mesh-ancestor
92950971|NCT00861627|Paclitaxel|paclitaxel|mesh-list
92950972|NCT00861627|Carboplatin|carboplatin|mesh-list
92950973|NCT00861627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92950974|NCT00861627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92950975|NCT00861627|Tubulin Modulators|tubulin modulators|mesh-ancestor
92950976|NCT00861627|Antimitotic Agents|antimitotic agents|mesh-ancestor
92950977|NCT00861627|Mitosis Modulators|mitosis modulators|mesh-ancestor
92950978|NCT00861627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950979|NCT00943930|Dronabinol|dronabinol|mesh-list
92950980|NCT00943930|Amphetamine|amphetamine|mesh-list
92950981|NCT00943930|Dextroamphetamine|dextroamphetamine|mesh-list
92950982|NCT00943930|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92950983|NCT00943930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92950984|NCT00943930|Sympathomimetics|sympathomimetics|mesh-ancestor
92950985|NCT00943930|Autonomic Agents|autonomic agents|mesh-ancestor
92950986|NCT00943930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92950987|NCT00943930|Dopamine Agents|dopamine agents|mesh-ancestor
92950988|NCT00943930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92950989|NCT00943930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92950990|NCT00943930|Adrenergic Agents|adrenergic agents|mesh-ancestor
92950991|NCT00943930|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92950992|NCT00943930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92950993|NCT00943930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92950994|NCT00943930|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92950995|NCT00943930|Hallucinogens|hallucinogens|mesh-ancestor
92950996|NCT00943930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92950997|NCT00943930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92950998|NCT00943930|Analgesics|analgesics|mesh-ancestor
92950999|NCT00943930|Sensory System Agents|sensory system agents|mesh-ancestor
92951000|NCT00943930|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92951001|NCT00943930|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92951002|NCT00943930|Hormones|hormones|mesh-ancestor
92951003|NCT00943930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951004|NCT00854763|Olmesartan|olmesartan|mesh-list
92951005|NCT00854763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951006|NCT00854763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92951007|NCT00854763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92951008|NCT00854763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951009|NCT00854841|Imatinib Mesylate|imatinib mesylate|mesh-list
92951010|NCT00854841|Dasatinib|dasatinib|mesh-list
92951011|NCT00854841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951012|NCT00854841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92951013|NCT00854841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951014|NCT00854841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951015|NCT00854919|Antipsychotic Agents|antipsychotic agents|mesh-list
92951016|NCT00854919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92951017|NCT00854919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951018|NCT00854919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951019|NCT00854919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951021|NCT00861783|Irinotecan|irinotecan|mesh-list
92951022|NCT00861783|Camptothecin|camptothecin|mesh-list
92951023|NCT00861783|ON 01910|on 01910|mesh-list
92951024|NCT00861783|Glycine|glycine|mesh-list
92951025|NCT00861783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951026|NCT00861783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92951027|NCT00861783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92951028|NCT00861783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951029|NCT00861783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951030|NCT00861783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92951031|NCT00861783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92951032|NCT00861783|Glycine Agents|glycine agents|mesh-ancestor
92951033|NCT00861783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951034|NCT00861783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951035|NCT00947128|Ondansetron|ondansetron|mesh-list
92951036|NCT00947128|Antiemetics|antiemetics|mesh-ancestor
92951037|NCT00947128|Autonomic Agents|autonomic agents|mesh-ancestor
92951038|NCT00947128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951039|NCT00947128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951040|NCT00947128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951041|NCT00947128|Antipruritics|antipruritics|mesh-ancestor
92951042|NCT00947128|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951043|NCT00947128|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92951044|NCT00947128|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92951045|NCT00947128|Serotonin Agents|serotonin agents|mesh-ancestor
92951046|NCT00947128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951047|NCT00947128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951048|NCT00861861|Atorvastatin|atorvastatin|mesh-list
92951049|NCT00861861|Pitavastatin|pitavastatin|mesh-list
92951050|NCT00861861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92951051|NCT00861861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92951052|NCT00861861|Antimetabolites|antimetabolites|mesh-ancestor
92951053|NCT00861861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951054|NCT00861861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92951055|NCT00861861|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92951056|NCT00861861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951057|NCT00686166|Capecitabine|capecitabine|mesh-list
92951058|NCT00686166|Oxaliplatin|oxaliplatin|mesh-list
92951059|NCT00686166|Cetuximab|cetuximab|mesh-list
92951060|NCT00686166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92951061|NCT00686166|Antimetabolites|antimetabolites|mesh-ancestor
92951062|NCT00686166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951063|NCT00686166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951064|NCT00686166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92951065|NCT04280536|Trifluridine|trifluridine|mesh-list
92951066|NCT04280536|Antimetabolites|antimetabolites|mesh-ancestor
92951067|NCT04280536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951068|NCT04280536|Antiviral Agents|antiviral agents|mesh-ancestor
92951069|NCT04280536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951070|NCT00944242|Sertraline|sertraline|mesh-list
92951071|NCT00944242|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951072|NCT00944242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951073|NCT00944242|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92951074|NCT00944242|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951075|NCT00944242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951076|NCT00944242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951077|NCT00944242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951078|NCT00944242|Serotonin Agents|serotonin agents|mesh-ancestor
92951079|NCT00944242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951080|NCT00363649|Interferons|interferons|mesh-list
92951081|NCT00363649|Interferon-alpha|interferon-alpha|mesh-list
92951082|NCT00363649|Sargramostim|sargramostim|mesh-list
92951083|NCT00363649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951084|NCT00363649|Antiviral Agents|antiviral agents|mesh-ancestor
92951085|NCT00363649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951086|NCT00363649|Immunologic Factors|immunologic factors|mesh-ancestor
92951087|NCT00363649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951088|NCT00855153|Cycloserine|cycloserine|mesh-list
92951089|NCT00855153|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92951090|NCT00855153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951091|NCT00855153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92951092|NCT00855153|Antitubercular Agents|antitubercular agents|mesh-ancestor
92951093|NCT00855153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951094|NCT00855153|Antimetabolites|antimetabolites|mesh-ancestor
92951095|NCT00855153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951096|NCT00952978|Omeprazole|omeprazole|mesh-list
92951097|NCT00952978|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92951098|NCT00952978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951099|NCT00952978|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92951100|NCT00952978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951101|NCT00952978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951102|NCT00861939|Bupropion|bupropion|mesh-list
92951103|NCT00861939|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92951104|NCT00861939|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951105|NCT00861939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951106|NCT00861939|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92951107|NCT00861939|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951108|NCT00861939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951109|NCT00861939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951110|NCT00861939|Dopamine Agents|dopamine agents|mesh-ancestor
92951111|NCT00861939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951112|NCT00861939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951113|NCT00861939|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92951114|NCT00861939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92951115|NCT00861939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951116|NCT00953134|Folic Acid|folic acid|mesh-list
92951117|NCT00953134|Micronutrients|micronutrients|mesh-list
92951118|NCT00953134|Ferrous fumarate|ferrous fumarate|mesh-list
92951119|NCT00953134|Trace Elements|trace elements|mesh-list
92951120|NCT00953134|Hematinics|hematinics|mesh-ancestor
92951121|NCT00953134|Vitamin B Complex|vitamin b complex|mesh-ancestor
92951122|NCT00953134|Vitamins|vitamins|mesh-ancestor
92951123|NCT00953134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951124|NCT00944398|Vitamins|vitamins|mesh-list
92951125|NCT00944398|Zinc|zinc|mesh-list
92951126|NCT00944398|Vitamin B Complex|vitamin b complex|mesh-list
92951127|NCT00944398|Zinc Sulfate|zinc sulfate|mesh-list
92951128|NCT00944398|Micronutrients|micronutrients|mesh-ancestor
92951129|NCT00944398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951130|NCT00944398|Trace Elements|trace elements|mesh-ancestor
92951131|NCT00944398|Astringents|astringents|mesh-ancestor
92951132|NCT00944398|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951133|NCT00855387|Pancrelipase|pancrelipase|mesh-list
92951134|NCT00855387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951135|NCT00947596|Atropine|atropine|mesh-list
92951136|NCT00947596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92951137|NCT00947596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951138|NCT00947596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92951139|NCT00947596|Autonomic Agents|autonomic agents|mesh-ancestor
92951140|NCT00947596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951141|NCT00947596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951142|NCT00947596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92951143|NCT00947596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92951144|NCT00947596|Mydriatics|mydriatics|mesh-ancestor
92951145|NCT00947596|Parasympatholytics|parasympatholytics|mesh-ancestor
92951146|NCT00947596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92951147|NCT00947596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92951148|NCT00947596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92951149|NCT00947596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951150|NCT00947596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951151|NCT00865059|Gabapentin|gabapentin|mesh-list
92951152|NCT00865059|Analgesics|analgesics|mesh-ancestor
92951153|NCT00865059|Sensory System Agents|sensory system agents|mesh-ancestor
92951154|NCT00865059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951155|NCT00865059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951156|NCT00865059|Anticonvulsants|anticonvulsants|mesh-ancestor
92951157|NCT00865059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92951158|NCT00865059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92951159|NCT00865059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951160|NCT00865059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951161|NCT00865059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92951162|NCT00865059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92951163|NCT00865059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951164|NCT00865059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951165|NCT00865059|Antimanic Agents|antimanic agents|mesh-ancestor
92951166|NCT00865137|Tacrolimus|tacrolimus|mesh-list
92951167|NCT00865137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951168|NCT00865137|Immunologic Factors|immunologic factors|mesh-ancestor
92951169|NCT00865137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951170|NCT00865137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92951171|NCT00865137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951172|NCT00865137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951173|NCT00862095|Topiramate|topiramate|mesh-list
92951174|NCT00862095|Propranolol|propranolol|mesh-list
92951175|NCT00862095|Amitriptyline|amitriptyline|mesh-list
92951176|NCT00862095|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92951177|NCT00862095|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92951178|NCT00862095|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951179|NCT00862095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951180|NCT00862095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951181|NCT00862095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951182|NCT00862095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951183|NCT00862095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951184|NCT00862095|Vasodilator Agents|vasodilator agents|mesh-ancestor
92951185|NCT00862095|Anticonvulsants|anticonvulsants|mesh-ancestor
92951186|NCT00862095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92951187|NCT00862095|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92951188|NCT00862095|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951189|NCT00862095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951190|NCT00862095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92951191|NCT00862095|Analgesics|analgesics|mesh-ancestor
92951192|NCT00862095|Sensory System Agents|sensory system agents|mesh-ancestor
92951193|NCT00862095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951194|NCT00862095|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92951195|NCT00862095|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951196|NCT00862095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951197|NCT04054128|Heparin|heparin|mesh-list
92951198|NCT04054128|Calcium heparin|calcium heparin|mesh-list
92951199|NCT04054128|Anticoagulants|anticoagulants|mesh-ancestor
92951200|NCT04054128|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92951201|NCT04054128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92951202|NCT04054128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951203|NCT00865215|Propranolol|propranolol|mesh-list
92951204|NCT00865215|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92951205|NCT00865215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92951206|NCT00865215|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951207|NCT00865215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951208|NCT00865215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951209|NCT00865215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951210|NCT00865215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951211|NCT00865215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951212|NCT00865215|Vasodilator Agents|vasodilator agents|mesh-ancestor
92951213|NCT00865371|Bupropion|bupropion|mesh-list
92951214|NCT00865371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92951215|NCT00865371|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951216|NCT00865371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951217|NCT00865371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92951218|NCT00865371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951219|NCT00865371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951220|NCT00865371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951221|NCT00865371|Dopamine Agents|dopamine agents|mesh-ancestor
92951222|NCT00865371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951223|NCT00865371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951224|NCT00865371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92951225|NCT00865371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92951226|NCT00865371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951227|NCT00865449|Spironolactone|spironolactone|mesh-list
92951228|NCT00865449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92951229|NCT00865449|Hormone Antagonists|hormone antagonists|mesh-ancestor
92951230|NCT00865449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951231|NCT00865449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951232|NCT00865449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92951233|NCT00865449|Diuretics|diuretics|mesh-ancestor
92951234|NCT00865449|Natriuretic Agents|natriuretic agents|mesh-ancestor
92951235|NCT00858195|Indomethacin|indomethacin|mesh-list
92951236|NCT00858195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92951237|NCT00858195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92951238|NCT00858195|Analgesics|analgesics|mesh-ancestor
92951239|NCT00858195|Sensory System Agents|sensory system agents|mesh-ancestor
92951240|NCT00858195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951241|NCT00858195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951242|NCT00858195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92951243|NCT00858195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92951244|NCT00858195|Gout Suppressants|gout suppressants|mesh-ancestor
92951245|NCT00858195|Tocolytic Agents|tocolytic agents|mesh-ancestor
92951246|NCT00858195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92951247|NCT00858195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92951248|NCT00858195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951249|NCT00858195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951250|NCT00618813|Cyclophosphamide|cyclophosphamide|mesh-list
92951251|NCT00618813|Ifosfamide|ifosfamide|mesh-list
92951252|NCT00618813|Doxorubicin|doxorubicin|mesh-list
92951253|NCT00618813|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92951254|NCT00618813|Etoposide|etoposide|mesh-list
92951255|NCT00618813|Vincristine|vincristine|mesh-list
92951256|NCT00618813|Etoposide phosphate|etoposide phosphate|mesh-list
92951257|NCT00618813|Topotecan|topotecan|mesh-list
92951258|NCT00618813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951259|NCT00618813|Immunologic Factors|immunologic factors|mesh-ancestor
92951260|NCT00618813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951261|NCT00618813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92951262|NCT00618813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92951263|NCT00618813|Alkylating Agents|alkylating agents|mesh-ancestor
92951264|NCT00618813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951265|NCT00618813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951266|NCT00618813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92951267|NCT00618813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92951268|NCT00618813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92951269|NCT00618813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92951270|NCT00618813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951271|NCT00618813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92951272|NCT00618813|Tubulin Modulators|tubulin modulators|mesh-ancestor
92951273|NCT00618813|Antimitotic Agents|antimitotic agents|mesh-ancestor
92951274|NCT00618813|Mitosis Modulators|mitosis modulators|mesh-ancestor
92951275|NCT00618813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92951276|NCT00554788|Cyclophosphamide|cyclophosphamide|mesh-list
92951277|NCT00554788|Thiotepa|thiotepa|mesh-list
92951278|NCT00554788|Cisplatin|cisplatin|mesh-list
92951279|NCT00554788|Carboplatin|carboplatin|mesh-list
92951280|NCT00554788|Etoposide|etoposide|mesh-list
92951281|NCT00554788|Vincristine|vincristine|mesh-list
92951282|NCT00554788|Etoposide phosphate|etoposide phosphate|mesh-list
92951283|NCT00554788|Podophyllotoxin|podophyllotoxin|mesh-list
92951284|NCT00554788|Lenograstim|lenograstim|mesh-list
92951285|NCT00554788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951286|NCT00554788|Immunologic Factors|immunologic factors|mesh-ancestor
92951287|NCT00554788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951288|NCT00554788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92951289|NCT00554788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92951290|NCT00554788|Alkylating Agents|alkylating agents|mesh-ancestor
92951291|NCT00554788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951292|NCT00554788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951293|NCT00554788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92951294|NCT00554788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92951295|NCT00554788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92951296|NCT00554788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92951297|NCT00554788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951298|NCT00554788|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92951299|NCT00554788|Tubulin Modulators|tubulin modulators|mesh-ancestor
92951300|NCT00554788|Antimitotic Agents|antimitotic agents|mesh-ancestor
92951301|NCT00554788|Mitosis Modulators|mitosis modulators|mesh-ancestor
92951302|NCT00554788|Keratolytic Agents|keratolytic agents|mesh-ancestor
92951303|NCT00554788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951304|NCT00685698|Nemonoxacin|nemonoxacin|mesh-list
92951305|NCT00685698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951306|NCT00685698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951307|NCT00858429|Capecitabine|capecitabine|mesh-list
92951308|NCT00858429|Doxifluridine|doxifluridine|mesh-list
92951309|NCT00858429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92951310|NCT00858429|Antimetabolites|antimetabolites|mesh-ancestor
92951311|NCT00858429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951312|NCT00858429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951313|NCT00858429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951314|NCT00858429|Immunologic Factors|immunologic factors|mesh-ancestor
92951315|NCT00858429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951316|NCT00858429|Appetite Stimulants|appetite stimulants|mesh-ancestor
92951317|NCT00858429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92951318|NCT02566928|Chlorhexidine|chlorhexidine|mesh-list
92951319|NCT02566928|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92951320|NCT02566928|Bacitracin|bacitracin|mesh-list
92951321|NCT02566928|Mupirocin|mupirocin|mesh-list
92951322|NCT02566928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92951323|NCT02566928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951324|NCT02566928|Disinfectants|disinfectants|mesh-ancestor
92951325|NCT02566928|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951326|NCT02566928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951327|NCT02566928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92951328|NCT02566928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951329|NCT02566928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951330|NCT00865605|Clobetasol|clobetasol|mesh-list
92951331|NCT00865605|Halobetasol|halobetasol|mesh-list
92951332|NCT00865605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92951333|NCT00865605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92951334|NCT00865605|Glucocorticoids|glucocorticoids|mesh-ancestor
92951335|NCT00865605|Hormones|hormones|mesh-ancestor
92951336|NCT00865605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951337|NCT00865605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951338|NCT00956644|Amlodipine|amlodipine|mesh-list
92951339|NCT00956644|Irbesartan|irbesartan|mesh-list
92951340|NCT00956644|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951341|NCT00956644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92951342|NCT00956644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951343|NCT00956644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951344|NCT00956644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92951345|NCT00956644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951346|NCT00956644|Vasodilator Agents|vasodilator agents|mesh-ancestor
92951347|NCT00956644|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92951348|NCT00956644|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92951349|NCT00858663|Everolimus|everolimus|mesh-list
92951350|NCT00858663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951351|NCT00858663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92527364|NCT00000611|Vitamin D|vitamin d|mesh-list
92951352|NCT00858663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92951353|NCT00858663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951354|NCT00858663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951355|NCT00858663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951356|NCT00858663|Immunologic Factors|immunologic factors|mesh-ancestor
92951357|NCT00858663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951358|NCT02544789|Clofarabine|clofarabine|mesh-list
92951359|NCT02544789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92951360|NCT02544789|Antimetabolites|antimetabolites|mesh-ancestor
92951361|NCT02544789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951362|NCT02544789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951363|NCT02565836|Thrombin|thrombin|mesh-list
92951364|NCT02565836|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92951365|NCT02565836|Hemostatics|hemostatics|mesh-ancestor
92951366|NCT02565836|Coagulants|coagulants|mesh-ancestor
92951367|NCT00865761|Alprazolam|alprazolam|mesh-list
92951368|NCT00865761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92951369|NCT00865761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951370|NCT00865761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951371|NCT00865761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92951372|NCT00865761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92951373|NCT00865761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951374|NCT00865761|GABA Modulators|gaba modulators|mesh-ancestor
92951375|NCT00865761|GABA Agents|gaba agents|mesh-ancestor
92951376|NCT00865761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951377|NCT00865761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951378|NCT00865839|Metformin|metformin|mesh-list
92951379|NCT00865839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92951380|NCT00865839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951381|NCT00865917|Metoprolol|metoprolol|mesh-list
92951382|NCT00865917|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92951383|NCT00865917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951384|NCT00865917|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951385|NCT00865917|Sympatholytics|sympatholytics|mesh-ancestor
92951386|NCT00865917|Autonomic Agents|autonomic agents|mesh-ancestor
92596838|NCT00136734|Dopamine Agents|dopamine agents|mesh-ancestor
92951387|NCT00865917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951388|NCT00865917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951389|NCT00865917|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92951390|NCT00865917|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92951391|NCT00865917|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951392|NCT00865917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951393|NCT00865917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951395|NCT00696410|Trace Elements|trace elements|mesh-ancestor
92951396|NCT00696410|Micronutrients|micronutrients|mesh-ancestor
92951397|NCT00696410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951398|NCT00683904|Carboplatin|carboplatin|mesh-list
92951399|NCT00683904|Epothilones|epothilones|mesh-list
92951400|NCT00683904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951401|NCT00683904|Tubulin Modulators|tubulin modulators|mesh-ancestor
92951402|NCT00683904|Antimitotic Agents|antimitotic agents|mesh-ancestor
92951403|NCT00683904|Mitosis Modulators|mitosis modulators|mesh-ancestor
92951404|NCT00683904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951405|NCT00862329|Caseins|caseins|mesh-list
92951406|NCT00862329|Chelating Agents|chelating agents|mesh-ancestor
92951407|NCT00862329|Sequestering Agents|sequestering agents|mesh-ancestor
92951408|NCT00862329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951409|NCT00866073|Decitabine|decitabine|mesh-list
92951410|NCT00866073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92951411|NCT00866073|Antimetabolites|antimetabolites|mesh-ancestor
92951412|NCT00866073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951413|NCT00866073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951414|NCT00866073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951415|NCT00752466|Topiramate|topiramate|mesh-list
92951416|NCT00752466|Flunarizine|flunarizine|mesh-list
92951417|NCT00752466|Anticonvulsants|anticonvulsants|mesh-ancestor
92951418|NCT00752466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92951419|NCT00752466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951420|NCT00752466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92951421|NCT00752466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951422|NCT00752466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951423|NCT00752466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92951424|NCT00752466|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92951425|NCT00752466|Histamine Antagonists|histamine antagonists|mesh-ancestor
92951426|NCT00752466|Histamine Agents|histamine agents|mesh-ancestor
92951427|NCT00752466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951428|NCT00752466|Vasodilator Agents|vasodilator agents|mesh-ancestor
92951430|NCT00957190|Dorzolamide|dorzolamide|mesh-list
92951431|NCT00957190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92951432|NCT00957190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92951433|NCT00957190|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951434|NCT00957190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951435|NCT00957190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951436|NCT00957190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951437|NCT00957190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951438|NCT00957190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951439|NCT00957190|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92951440|NCT00957190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951441|NCT00866229|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92951442|NCT00866229|Simvastatin|simvastatin|mesh-list
92951443|NCT00866229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92951444|NCT00866229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92951445|NCT00866229|Antimetabolites|antimetabolites|mesh-ancestor
92951446|NCT00866229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951447|NCT00866229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92951448|NCT00866229|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92951449|NCT00866229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951450|NCT00953914|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92951451|NCT00953914|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92951452|NCT00953914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951453|NCT00953914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951454|NCT00953914|Cholinergic Agents|cholinergic agents|mesh-ancestor
92951455|NCT00953914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951456|NCT00953914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951457|NCT00948220|Ribavirin|ribavirin|mesh-list
92951458|NCT00948220|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92951459|NCT00948220|Antimetabolites|antimetabolites|mesh-ancestor
92951460|NCT00948220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951461|NCT00948220|Antiviral Agents|antiviral agents|mesh-ancestor
92951462|NCT00948220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951463|NCT00756990|Naltrexone|naltrexone|mesh-list
92951464|NCT00756990|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92596909|NCT00137007|Ampicillin|ampicillin|mesh-list
92951465|NCT00756990|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92951466|NCT00756990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951467|NCT00756990|Sensory System Agents|sensory system agents|mesh-ancestor
92951468|NCT00756990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951469|NCT00957346|Misoprostol|misoprostol|mesh-list
92951470|NCT00957346|Mifepristone|mifepristone|mesh-list
92951471|NCT00957346|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92951472|NCT00957346|Abortifacient Agents|abortifacient agents|mesh-ancestor
92951473|NCT00957346|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92951474|NCT00957346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951475|NCT00957346|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92951476|NCT00957346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951477|NCT00957346|Oxytocics|oxytocics|mesh-ancestor
92951478|NCT00957346|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92951479|NCT00957346|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92951480|NCT00957346|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92951481|NCT00957346|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92951482|NCT00957346|Contraceptive Agents|contraceptive agents|mesh-ancestor
92951483|NCT00957346|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92951484|NCT00957346|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92951485|NCT00957346|Hormone Antagonists|hormone antagonists|mesh-ancestor
92951486|NCT00957346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951487|NCT00957346|Luteolytic Agents|luteolytic agents|mesh-ancestor
92951488|NCT00957346|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92951489|NCT00957346|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92951490|NCT00752544|Simeprevir|simeprevir|mesh-list
92951491|NCT00752544|Antiviral Agents|antiviral agents|mesh-ancestor
92951492|NCT00752544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951493|NCT00752544|Protease Inhibitors|protease inhibitors|mesh-ancestor
92951494|NCT00752544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951495|NCT00752544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951496|NCT00751062|Timolol|timolol|mesh-list
92951497|NCT00751062|Latanoprost|latanoprost|mesh-list
92527369|NCT00000611|Vitamins|vitamins|mesh-ancestor
92951498|NCT00751062|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92951499|NCT00751062|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92951500|NCT00751062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951501|NCT00751062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951502|NCT00751062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951503|NCT00751062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951504|NCT00751062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951505|NCT00751062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951506|NCT00751062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92951507|NCT00751062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92951509|NCT04030052|Coagulants|coagulants|mesh-ancestor
92951510|NCT00751374|Gentamicins|gentamicins|mesh-list
92951511|NCT00751374|Mupirocin|mupirocin|mesh-list
92951512|NCT00751374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951513|NCT00751374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951514|NCT00751374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92951515|NCT00751374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951516|NCT00751374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951517|NCT00954304|Loperamide|loperamide|mesh-list
92951518|NCT00954304|Antidiarrheals|antidiarrheals|mesh-list
92951519|NCT00954304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951520|NCT00363415|Carboplatin|carboplatin|mesh-list
92951521|NCT00363415|Etoposide|etoposide|mesh-list
92951522|NCT00363415|Pemetrexed|pemetrexed|mesh-list
92951523|NCT00363415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951524|NCT00363415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92951525|NCT00363415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92951526|NCT00363415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92951527|NCT00363415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951528|NCT00363415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951529|NCT00363415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92951530|NCT00363415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92951531|NCT00757380|Diminazene aceturate|diminazene aceturate|mesh-list
92951532|NCT00757380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92951533|NCT00757380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92951534|NCT00757380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951535|NCT00757380|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92951536|NCT00752934|Baclofen|baclofen|mesh-list
92951537|NCT00752934|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92951538|NCT00752934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951539|NCT00752934|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92596984|NCT00104741|Androgen Antagonists|androgen antagonists|mesh-ancestor
92951540|NCT00752934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951541|NCT00752934|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92951542|NCT00752934|GABA Agonists|gaba agonists|mesh-ancestor
92951543|NCT00752934|GABA Agents|gaba agents|mesh-ancestor
92951544|NCT00752934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951545|NCT00752934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951546|NCT00696020|Bromides|bromides|mesh-list
92951547|NCT00696020|Tiotropium Bromide|tiotropium bromide|mesh-list
92951548|NCT00696020|Olodaterol|olodaterol|mesh-list
92951549|NCT00696020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92951550|NCT00696020|Autonomic Agents|autonomic agents|mesh-ancestor
92951551|NCT00696020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951552|NCT00696020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951553|NCT00696020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92951554|NCT00696020|Respiratory System Agents|respiratory system agents|mesh-ancestor
92951555|NCT00696020|Parasympatholytics|parasympatholytics|mesh-ancestor
92951556|NCT00696020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92951557|NCT00696020|Cholinergic Agents|cholinergic agents|mesh-ancestor
92951558|NCT00696020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951559|NCT00696020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951560|NCT00696020|Anticonvulsants|anticonvulsants|mesh-ancestor
92951561|NCT00576576|Atorvastatin|atorvastatin|mesh-list
92951562|NCT00576576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92951563|NCT00576576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92951564|NCT00576576|Antimetabolites|antimetabolites|mesh-ancestor
92951565|NCT00576576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951566|NCT00576576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92951567|NCT00576576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92951568|NCT00576576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951569|NCT00751764|Moxidectin|moxidectin|mesh-list
92951570|NCT00751764|Anthelmintics|anthelmintics|mesh-ancestor
92951571|NCT00751764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92951572|NCT00751764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951573|NCT00751764|Antinematodal Agents|antinematodal agents|mesh-ancestor
92951574|NCT00757458|Propofol|propofol|mesh-list
92951575|NCT00757458|Edetic Acid|edetic acid|mesh-list
92951576|NCT00757458|Pentetic Acid|pentetic acid|mesh-list
92951577|NCT00757458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92951578|NCT00757458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951579|NCT00757458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951580|NCT00757458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92951581|NCT00757458|Anesthetics, General|anesthetics, general|mesh-ancestor
92951582|NCT00757458|Anesthetics|anesthetics|mesh-ancestor
92951583|NCT00757458|Anticoagulants|anticoagulants|mesh-ancestor
92951584|NCT00757458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92951585|NCT00757458|Chelating Agents|chelating agents|mesh-ancestor
92951586|NCT00757458|Sequestering Agents|sequestering agents|mesh-ancestor
92951587|NCT00757458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951588|NCT00757458|Antidotes|antidotes|mesh-ancestor
92951589|NCT00757458|Protective Agents|protective agents|mesh-ancestor
92951590|NCT00757458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92951591|NCT00923247|Bortezomib|bortezomib|mesh-list
92951592|NCT00923247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951593|NCT02866136|Carboplatin|carboplatin|mesh-list
92951594|NCT02866136|Etoposide|etoposide|mesh-list
92951595|NCT02866136|Etoposide phosphate|etoposide phosphate|mesh-list
92951596|NCT02866136|Melphalan|melphalan|mesh-list
92951597|NCT02866136|Vincristine|vincristine|mesh-list
92951598|NCT02866136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951599|NCT02866136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92951600|NCT02866136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92951601|NCT02866136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92951602|NCT02866136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951603|NCT02866136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951604|NCT02866136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92951605|NCT02866136|Alkylating Agents|alkylating agents|mesh-ancestor
92951606|NCT02866136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92951607|NCT02866136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951608|NCT02866136|Immunologic Factors|immunologic factors|mesh-ancestor
92951609|NCT02866136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951610|NCT02866136|Tubulin Modulators|tubulin modulators|mesh-ancestor
92951611|NCT02866136|Antimitotic Agents|antimitotic agents|mesh-ancestor
92951612|NCT02866136|Mitosis Modulators|mitosis modulators|mesh-ancestor
92951613|NCT00757692|Bicalutamide|bicalutamide|mesh-list
92951614|NCT00757692|Androgen Antagonists|androgen antagonists|mesh-ancestor
92951615|NCT00757692|Hormone Antagonists|hormone antagonists|mesh-ancestor
92951616|NCT00757692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951617|NCT00757692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951618|NCT00757692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951620|NCT00753168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92951621|NCT00753168|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92951622|NCT00753168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951623|NCT00753168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92951624|NCT00753168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92951625|NCT00753168|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951626|NCT00753168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951627|NCT00753168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951628|NCT00753168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92951629|NCT00753168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92951630|NCT02565602|Vitamin D|vitamin d|mesh-list
92951631|NCT02565602|Cholecalciferol|cholecalciferol|mesh-list
92951632|NCT02565602|Vitamins|vitamins|mesh-ancestor
92951633|NCT02565602|Micronutrients|micronutrients|mesh-ancestor
92951634|NCT02565602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951635|NCT02565602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92951636|NCT02565602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92951637|NCT00866463|Sildenafil Citrate|sildenafil citrate|mesh-list
92951638|NCT00866463|Vasodilator Agents|vasodilator agents|mesh-ancestor
92951639|NCT00866463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92951640|NCT00866463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92951641|NCT00866463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951642|NCT00866463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951643|NCT00866463|Urological Agents|urological agents|mesh-ancestor
92951644|NCT00695864|Ondansetron|ondansetron|mesh-list
92951645|NCT00695864|Antiemetics|antiemetics|mesh-ancestor
92951646|NCT00695864|Autonomic Agents|autonomic agents|mesh-ancestor
92951647|NCT00695864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951648|NCT00695864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951649|NCT00695864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951650|NCT00695864|Antipruritics|antipruritics|mesh-ancestor
92951651|NCT00695864|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951652|NCT00695864|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92951653|NCT00695864|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92951654|NCT00695864|Serotonin Agents|serotonin agents|mesh-ancestor
92951655|NCT00695864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951656|NCT00695864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951657|NCT00684996|Bevacizumab|bevacizumab|mesh-list
92951658|NCT00684996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92951659|NCT00684996|Antibodies|antibodies|mesh-list
92951660|NCT00684996|Immunoglobulins|immunoglobulins|mesh-list
92951661|NCT00684996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92951662|NCT00684996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951663|NCT00684996|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92951664|NCT00684996|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92951665|NCT00684996|Growth Substances|growth substances|mesh-ancestor
92951666|NCT00684996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951667|NCT00684996|Growth Inhibitors|growth inhibitors|mesh-ancestor
92951668|NCT00684996|Immunologic Factors|immunologic factors|mesh-ancestor
92951669|NCT05325008|Immunoglobulins|immunoglobulins|mesh-list
92951670|NCT05325008|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92951671|NCT05325008|Antibodies|antibodies|mesh-list
92951672|NCT05325008|gamma-Globulins|gamma-globulins|mesh-list
92951673|NCT05325008|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92951674|NCT05325008|Immunologic Factors|immunologic factors|mesh-ancestor
92951675|NCT05325008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951676|NCT00684762|Cilostazol|cilostazol|mesh-list
92951677|NCT00684762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92951678|NCT00684762|Autonomic Agents|autonomic agents|mesh-ancestor
92951679|NCT00684762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951680|NCT00684762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951681|NCT00684762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92951682|NCT00684762|Respiratory System Agents|respiratory system agents|mesh-ancestor
92951683|NCT00684762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92951684|NCT00684762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92951685|NCT00684762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951686|NCT00684762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92951687|NCT00684762|Vasodilator Agents|vasodilator agents|mesh-ancestor
92951688|NCT00684762|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92951689|NCT00684762|Protective Agents|protective agents|mesh-ancestor
92951690|NCT00684762|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92951691|NCT00684762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92951692|NCT00684762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951694|NCT00753246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92951695|NCT00753246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951697|NCT00695786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92951698|NCT00695786|Lenalidomide|lenalidomide|mesh-list
92951699|NCT00695786|Antibodies|antibodies|mesh-list
92951700|NCT00695786|Immunoglobulins|immunoglobulins|mesh-list
92951701|NCT00695786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92951702|NCT00695786|Immunologic Factors|immunologic factors|mesh-ancestor
92951703|NCT00695786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951704|NCT00695786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951705|NCT00695786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92951706|NCT00695786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92951707|NCT00695786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92951708|NCT00695786|Growth Substances|growth substances|mesh-ancestor
92951709|NCT00695786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92951710|NCT00753324|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92951711|NCT00753324|Antiviral Agents|antiviral agents|mesh-ancestor
92951712|NCT00753324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951713|NCT02561520|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92951714|NCT02561520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92951715|NCT00387127|Lapatinib|lapatinib|mesh-list
92951716|NCT00387127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951717|NCT00387127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92951718|NCT00387127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951719|NCT00387127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951720|NCT00683592|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92951721|NCT00683592|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951722|NCT00683592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951723|NCT00683592|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92951724|NCT00683592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951725|NCT00683592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951726|NCT00683592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951727|NCT00683592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951728|NCT00683592|Serotonin Agents|serotonin agents|mesh-ancestor
92951729|NCT00683592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951730|NCT00683592|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92951731|NCT00683592|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92951732|NCT00695396|Epoetin Alfa|epoetin alfa|mesh-list
92951733|NCT00695396|Hematinics|hematinics|mesh-ancestor
92951734|NCT00753402|Epinephrine|epinephrine|mesh-list
92951735|NCT00753402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92951736|NCT00753402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92951737|NCT00753402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92951738|NCT00753402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951739|NCT00753402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951740|NCT00753402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951741|NCT00753402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92951742|NCT00753402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92951743|NCT00753402|Autonomic Agents|autonomic agents|mesh-ancestor
92951744|NCT00753402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951745|NCT00753402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92951746|NCT00753402|Respiratory System Agents|respiratory system agents|mesh-ancestor
92951747|NCT00753402|Mydriatics|mydriatics|mesh-ancestor
92951748|NCT00753402|Sympathomimetics|sympathomimetics|mesh-ancestor
92951749|NCT00753402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92951750|NCT05434884|Salicylic Acid|salicylic acid|mesh-list
92951751|NCT05434884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951752|NCT05434884|Antifungal Agents|antifungal agents|mesh-ancestor
92951753|NCT05434884|Keratolytic Agents|keratolytic agents|mesh-ancestor
92951754|NCT05434884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951755|NCT00758004|Atorvastatin|atorvastatin|mesh-list
92951756|NCT00758004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92951757|NCT00758004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92951758|NCT00758004|Antimetabolites|antimetabolites|mesh-ancestor
92951759|NCT00758004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951760|NCT00758004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92951761|NCT00758004|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92951762|NCT00758004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951763|NCT02656706|Nivolumab|nivolumab|mesh-list
92951764|NCT02656706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92951765|NCT02656706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951766|NCT02656706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92951767|NCT02656706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951768|NCT04049916|Artesunate|artesunate|mesh-list
92951769|NCT04049916|Primaquine|primaquine|mesh-list
92951770|NCT04049916|Piperaquine|piperaquine|mesh-list
92951771|NCT04049916|Artenimol|artenimol|mesh-list
92951772|NCT04049916|Pyronaridine|pyronaridine|mesh-list
92951773|NCT04049916|Antimalarials|antimalarials|mesh-ancestor
92951774|NCT04049916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92951775|NCT04049916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92951776|NCT04049916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951777|NCT04049916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951778|NCT04049916|Antiviral Agents|antiviral agents|mesh-ancestor
92951779|NCT04049916|Schistosomicides|schistosomicides|mesh-ancestor
92951780|NCT04049916|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92951781|NCT04049916|Anthelmintics|anthelmintics|mesh-ancestor
92951782|NCT00753558|Gentamicins|gentamicins|mesh-list
92951783|NCT00753558|Polymyxins|polymyxins|mesh-list
92951784|NCT00753558|Colistin|colistin|mesh-list
92951785|NCT00753558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951786|NCT00753558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951787|NCT00753558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92951788|NCT00753558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951789|NCT00753558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951790|NCT00753792|Methylprednisolone|methylprednisolone|mesh-list
92951791|NCT00753792|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92951792|NCT00753792|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92951793|NCT00753792|Prednisolone|prednisolone|mesh-list
92951794|NCT00753792|Prednisolone acetate|prednisolone acetate|mesh-list
92951795|NCT00753792|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92951796|NCT00753792|Prednisolone phosphate|prednisolone phosphate|mesh-list
92951797|NCT00753792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92951798|NCT00753792|Antiemetics|antiemetics|mesh-ancestor
92951799|NCT00753792|Autonomic Agents|autonomic agents|mesh-ancestor
92951800|NCT00753792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951801|NCT00753792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951802|NCT00753792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951803|NCT00753792|Glucocorticoids|glucocorticoids|mesh-ancestor
92951804|NCT00753792|Hormones|hormones|mesh-ancestor
92951805|NCT00753792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951806|NCT00753792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92951807|NCT00753792|Protective Agents|protective agents|mesh-ancestor
92951808|NCT00753792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92951809|NCT00753792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951810|NCT00575094|Tigecycline|tigecycline|mesh-list
92951811|NCT00575094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951812|NCT00575094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951813|NCT00575094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92951814|NCT00575094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951815|NCT00575094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951816|NCT00553696|Sunitinib|sunitinib|mesh-list
92951817|NCT00553696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951818|NCT00553696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92951819|NCT00553696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92951820|NCT00553696|Growth Substances|growth substances|mesh-ancestor
92951821|NCT00553696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951822|NCT00553696|Growth Inhibitors|growth inhibitors|mesh-ancestor
92951823|NCT00553696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92951824|NCT00553696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165219|NCT05275907|Diuretics|diuretics|mesh-ancestor
92951825|NCT00553696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951826|NCT05430126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
92951827|NCT05430126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951828|NCT05430126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951829|NCT00958204|Fluoxetine|fluoxetine|mesh-list
92951830|NCT00958204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92951831|NCT00958204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951832|NCT00958204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951833|NCT00958204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951834|NCT00958204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951835|NCT00958204|Serotonin Agents|serotonin agents|mesh-ancestor
92951836|NCT00958204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951837|NCT00958204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92951838|NCT00958204|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951839|NCT00958204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951840|NCT00958204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92597283|NCT00137826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92951841|NCT00958204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92951842|NCT00958204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951844|NCT00617409|Tretinoin|tretinoin|mesh-list
92951845|NCT00617409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92951846|NCT00617409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951847|NCT00617409|Tubulin Modulators|tubulin modulators|mesh-ancestor
92951848|NCT00617409|Antimitotic Agents|antimitotic agents|mesh-ancestor
92951849|NCT00617409|Mitosis Modulators|mitosis modulators|mesh-ancestor
92951850|NCT00617409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951851|NCT00617409|Keratolytic Agents|keratolytic agents|mesh-ancestor
92951852|NCT00617409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951853|NCT00695318|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92951854|NCT00695318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92951855|NCT00695318|Glucocorticoids|glucocorticoids|mesh-ancestor
92951856|NCT00695318|Hormones|hormones|mesh-ancestor
92951857|NCT00695318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92951858|NCT00695318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951859|NCT00754104|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92951860|NCT00754104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951861|NCT00754104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92951862|NCT00754104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951863|NCT00754104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951864|NCT00386425|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92951865|NCT00386425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951866|NCT03529448|Temozolomide|temozolomide|mesh-list
92951867|NCT03529448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92951868|NCT03529448|Alkylating Agents|alkylating agents|mesh-ancestor
92951869|NCT03529448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951870|NCT03529448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951871|NCT05396898|Tacrolimus|tacrolimus|mesh-list
92951872|NCT05396898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92951873|NCT05396898|Immunologic Factors|immunologic factors|mesh-ancestor
92951874|NCT05396898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951875|NCT05396898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92951876|NCT05396898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951877|NCT05396898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951878|NCT00694304|Vortioxetine|vortioxetine|mesh-list
92951879|NCT00694304|Antidepressive Agents|antidepressive agents|mesh-ancestor
92951880|NCT00694304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951881|NCT00694304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92951882|NCT00694304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92951883|NCT00694304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951884|NCT00694304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951885|NCT00694304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92951886|NCT00694304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92951887|NCT00694304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92951888|NCT00694304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951889|NCT00694304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951890|NCT00694304|Serotonin Agents|serotonin agents|mesh-ancestor
92951891|NCT00694304|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92951892|NCT00694304|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92951893|NCT00694304|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92951894|NCT00694304|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92951895|NCT00866853|Simeprevir|simeprevir|mesh-list
92951896|NCT00866853|Antiviral Agents|antiviral agents|mesh-ancestor
92951897|NCT00866853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951898|NCT00866853|Protease Inhibitors|protease inhibitors|mesh-ancestor
92951899|NCT00866853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951900|NCT00866853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951901|NCT04685876|Bupivacaine|bupivacaine|mesh-list
92951902|NCT04685876|Anesthetics, Local|anesthetics, local|mesh-ancestor
92951903|NCT04685876|Anesthetics|anesthetics|mesh-ancestor
92951904|NCT04685876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951905|NCT04685876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951906|NCT04685876|Sensory System Agents|sensory system agents|mesh-ancestor
92951907|NCT04685876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92951908|NCT00682890|Metformin|metformin|mesh-list
92951909|NCT00682890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92951910|NCT00682890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951911|NCT02565368|Metformin|metformin|mesh-list
92951912|NCT02565368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92597363|NCT00135135|Alkylating Agents|alkylating agents|mesh-ancestor
92296872|NCT00358358|Hormones|hormones|mesh-ancestor
92951913|NCT02565368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951914|NCT03992365|Bisacodyl|bisacodyl|mesh-list
92951915|NCT03992365|Sodium sulfate|sodium sulfate|mesh-list
92951916|NCT03992365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92951917|NCT03992365|Cathartics|cathartics|mesh-ancestor
92951918|NCT03992365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92951919|NCT03992365|Laxatives|laxatives|mesh-ancestor
92951920|NCT00921804|Risperidone|risperidone|mesh-list
92951921|NCT00921804|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92951922|NCT00921804|Serotonin Agents|serotonin agents|mesh-ancestor
92951923|NCT00921804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92951924|NCT00921804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951925|NCT00921804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951926|NCT00921804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92951927|NCT00921804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92951928|NCT00921804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92951929|NCT00921804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92951930|NCT00921804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92951931|NCT00921804|Dopamine Agents|dopamine agents|mesh-ancestor
92951932|NCT00859911|Micronutrients|micronutrients|mesh-list
92951933|NCT00859911|Trace Elements|trace elements|mesh-list
92951934|NCT00859911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951935|NCT00698516|Bevacizumab|bevacizumab|mesh-list
92951936|NCT00698516|Topotecan|topotecan|mesh-list
92951937|NCT00698516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92951938|NCT00698516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951939|NCT00698516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92951940|NCT00698516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92951941|NCT00698516|Growth Substances|growth substances|mesh-ancestor
92951942|NCT00698516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951943|NCT00698516|Growth Inhibitors|growth inhibitors|mesh-ancestor
92951944|NCT00698516|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92951945|NCT00698516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92951946|NCT00698516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951947|NCT00698516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951948|NCT00679302|Trimethoprim|trimethoprim|mesh-list
92951949|NCT00679302|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92951950|NCT00679302|Sulfamethoxazole|sulfamethoxazole|mesh-list
92951951|NCT00679302|Simethicone|simethicone|mesh-list
92951952|NCT00679302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92951953|NCT00679302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951954|NCT00679302|Antimalarials|antimalarials|mesh-ancestor
92951955|NCT00679302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92951956|NCT00679302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92951957|NCT00679302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92951958|NCT00679302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951959|NCT00679302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951960|NCT00679302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92951961|NCT00679302|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92951962|NCT00679302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92951963|NCT00679302|Antifoaming Agents|antifoaming agents|mesh-ancestor
92951964|NCT00679302|Emollients|emollients|mesh-ancestor
92951965|NCT00679302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92951966|NCT00679302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951967|NCT04011124|Rifampin|rifampin|mesh-list
92951968|NCT04011124|Fluzoparib|fluzoparib|mesh-list
92951969|NCT04011124|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92951970|NCT04011124|Antitubercular Agents|antitubercular agents|mesh-ancestor
92951971|NCT04011124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92951972|NCT04011124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92951973|NCT04011124|Leprostatic Agents|leprostatic agents|mesh-ancestor
92951974|NCT04011124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92951975|NCT04011124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951976|NCT04011124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951977|NCT04011124|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92951978|NCT04011124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92951979|NCT04011124|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92951980|NCT04011124|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92951981|NCT04011124|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92951982|NCT04011124|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92951983|NCT04011124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92951984|NCT04011124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92951985|NCT00862875|Insulin|insulin|mesh-list
92951986|NCT00862875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92951988|NCT00862875|Insulin, Long-Acting|insulin, long-acting|mesh-list
92951989|NCT00862875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92951990|NCT00862875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951991|NCT02544165|Caffeine|caffeine|mesh-list
92951992|NCT02544165|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92951993|NCT02544165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92951994|NCT02544165|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92951995|NCT02544165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92951996|NCT02544165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92951997|NCT02544165|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92951998|NCT02544165|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92951999|NCT02544165|Purinergic Agents|purinergic agents|mesh-ancestor
92952000|NCT02544165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952001|NCT05343156|Dexamethasone|dexamethasone|mesh-list
92952002|NCT05343156|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92952003|NCT05343156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952004|NCT05343156|Antiemetics|antiemetics|mesh-ancestor
92952005|NCT05343156|Autonomic Agents|autonomic agents|mesh-ancestor
92952006|NCT05343156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952007|NCT05343156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952008|NCT05343156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952009|NCT05343156|Glucocorticoids|glucocorticoids|mesh-ancestor
92952010|NCT05343156|Hormones|hormones|mesh-ancestor
92952011|NCT05343156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92952012|NCT05343156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92952013|NCT05343156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952014|NCT05343156|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92952015|NCT00955162|Buprenorphine|buprenorphine|mesh-list
92952016|NCT00955162|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92952017|NCT00955162|Naloxone|naloxone|mesh-list
92952018|NCT00955162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92952019|NCT00955162|Narcotics|narcotics|mesh-ancestor
92952020|NCT00955162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952021|NCT00955162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952022|NCT00955162|Analgesics|analgesics|mesh-ancestor
92952023|NCT00955162|Sensory System Agents|sensory system agents|mesh-ancestor
92952024|NCT00955162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952025|NCT00955162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92952026|NCT00949546|Etanercept|etanercept|mesh-list
92952027|NCT00949546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92952028|NCT00949546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92952029|NCT00949546|Analgesics|analgesics|mesh-ancestor
92952030|NCT00949546|Sensory System Agents|sensory system agents|mesh-ancestor
92952031|NCT00949546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952032|NCT00949546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952033|NCT00949546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952034|NCT00949546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952035|NCT00949546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952036|NCT00949546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952037|NCT00949546|Immunologic Factors|immunologic factors|mesh-ancestor
92952038|NCT05291364|Ethanol|ethanol|mesh-list
92952039|NCT05291364|Dexmedetomidine|dexmedetomidine|mesh-list
92952040|NCT05291364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92952041|NCT05291364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952042|NCT05291364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952043|NCT05291364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92952044|NCT05291364|Analgesics|analgesics|mesh-ancestor
92952045|NCT05291364|Sensory System Agents|sensory system agents|mesh-ancestor
92952046|NCT05291364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952047|NCT05291364|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92952048|NCT05291364|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92952049|NCT05291364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92952050|NCT05291364|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952051|NCT05291364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952052|NCT05291364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952053|NCT05291364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92952054|NCT05291364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952055|NCT00949624|Docetaxel|docetaxel|mesh-list
92952056|NCT00949624|Axitinib|axitinib|mesh-list
92952057|NCT00949624|Crenolanib|crenolanib|mesh-list
92952058|NCT00949624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952059|NCT00949624|Tubulin Modulators|tubulin modulators|mesh-ancestor
92952060|NCT00949624|Antimitotic Agents|antimitotic agents|mesh-ancestor
92952061|NCT00949624|Mitosis Modulators|mitosis modulators|mesh-ancestor
92952062|NCT00949624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952063|NCT00949624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92952064|NCT00949624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952066|NCT04019379|Calcium|calcium|mesh-list
92952067|NCT04019379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92952068|NCT04019379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952069|NCT04019379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92952070|NCT05351788|Carboplatin|carboplatin|mesh-list
92952071|NCT05351788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952072|NCT04005339|Leucovorin|leucovorin|mesh-list
92952073|NCT04005339|Fluorouracil|fluorouracil|mesh-list
92952074|NCT04005339|Irinotecan|irinotecan|mesh-list
92952075|NCT04005339|Antimetabolites|antimetabolites|mesh-ancestor
92952076|NCT04005339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952077|NCT04005339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952078|NCT04005339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952079|NCT04005339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952080|NCT04005339|Immunologic Factors|immunologic factors|mesh-ancestor
92952081|NCT04005339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952082|NCT04005339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92952083|NCT04005339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92952084|NCT04005339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952085|NCT04005339|Antidotes|antidotes|mesh-ancestor
92952086|NCT04005339|Protective Agents|protective agents|mesh-ancestor
92952087|NCT04005339|Vitamin B Complex|vitamin b complex|mesh-ancestor
92952088|NCT04005339|Vitamins|vitamins|mesh-ancestor
92952089|NCT04005339|Micronutrients|micronutrients|mesh-ancestor
92952090|NCT00949780|Chloral Hydrate|chloral hydrate|mesh-list
92952091|NCT00949780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92952092|NCT00949780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952093|NCT00949780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952094|NCT02544243|Gemcitabine|gemcitabine|mesh-list
92952095|NCT02544243|Vinorelbine|vinorelbine|mesh-list
92952096|NCT02544243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952097|NCT02544243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952098|NCT02544243|Antimetabolites|antimetabolites|mesh-ancestor
92952099|NCT02544243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952100|NCT02544243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92952101|NCT02544243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92952102|NCT02544243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92952103|NCT02544243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92952104|NCT04011670|Caffeine|caffeine|mesh-list
92952105|NCT04011670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92952106|NCT04011670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952107|NCT04011670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92952108|NCT04011670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952109|NCT04011670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952110|NCT04011670|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92952111|NCT04011670|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92952112|NCT04011670|Purinergic Agents|purinergic agents|mesh-ancestor
92952113|NCT04011670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952114|NCT01581073|Darbepoetin alfa|darbepoetin alfa|mesh-list
92952115|NCT01581073|Hematinics|hematinics|mesh-ancestor
92952116|NCT00742820|Calcium, Dietary|calcium, dietary|mesh-list
92952117|NCT00742820|Calcium|calcium|mesh-list
92952118|NCT00742820|Calcium acetate|calcium acetate|mesh-list
92952119|NCT00742820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92952120|NCT00742820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952121|NCT00742820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92952122|NCT00742820|Chelating Agents|chelating agents|mesh-ancestor
92952123|NCT00742820|Sequestering Agents|sequestering agents|mesh-ancestor
92952124|NCT00742820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952125|NCT01324843|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92952126|NCT01324843|Anesthetics, Local|anesthetics, local|mesh-ancestor
92952127|NCT01324843|Anesthetics|anesthetics|mesh-ancestor
92952128|NCT01324843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952129|NCT01324843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952130|NCT01324843|Sensory System Agents|sensory system agents|mesh-ancestor
92952131|NCT01324843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952132|NCT01324843|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92952133|NCT00742976|Insulin|insulin|mesh-list
92952134|NCT00742976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92952135|NCT00742976|Insulin Detemir|insulin detemir|mesh-list
92297086|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
92952136|NCT00742976|Isophane Insulin, Human|isophane insulin, human|mesh-list
92952137|NCT00742976|Insulin, Isophane|insulin, isophane|mesh-list
92952138|NCT00742976|Isophane insulin, beef|isophane insulin, beef|mesh-list
92952140|NCT00742976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952141|NCT00571662|Cyclosporine|cyclosporine|mesh-list
92952142|NCT00571662|Mycophenolic Acid|mycophenolic acid|mesh-list
92952143|NCT00571662|Pentostatin|pentostatin|mesh-list
92952144|NCT00571662|Cyclosporins|cyclosporins|mesh-list
92952145|NCT00571662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952146|NCT00571662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952147|NCT00571662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952148|NCT00571662|Immunologic Factors|immunologic factors|mesh-ancestor
92952149|NCT00571662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952150|NCT00571662|Antifungal Agents|antifungal agents|mesh-ancestor
92952151|NCT00571662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952152|NCT00571662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92952153|NCT00571662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952154|NCT00571662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92952155|NCT00571662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92952156|NCT00571662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952157|NCT00571662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92952158|NCT00571662|Antitubercular Agents|antitubercular agents|mesh-ancestor
92952159|NCT00571662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92952160|NCT00571662|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92952161|NCT00955240|Fluorouracil|fluorouracil|mesh-list
92952162|NCT00955240|Cetuximab|cetuximab|mesh-list
92952163|NCT00955240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952164|NCT00955240|Antimetabolites|antimetabolites|mesh-ancestor
92952165|NCT00955240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952166|NCT00955240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952167|NCT00955240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952168|NCT00955240|Immunologic Factors|immunologic factors|mesh-ancestor
92952169|NCT00955240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952170|NCT00955240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952171|NCT03387085|Leucovorin|leucovorin|mesh-list
92952172|NCT03387085|Paclitaxel|paclitaxel|mesh-list
92952173|NCT03387085|Cyclophosphamide|cyclophosphamide|mesh-list
92952174|NCT03387085|Bevacizumab|bevacizumab|mesh-list
92952175|NCT03387085|Fluorouracil|fluorouracil|mesh-list
92952176|NCT03387085|Capecitabine|capecitabine|mesh-list
92952177|NCT03387085|Avelumab|avelumab|mesh-list
92952178|NCT03387085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92952179|NCT03387085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952180|NCT03387085|Tubulin Modulators|tubulin modulators|mesh-ancestor
92952181|NCT03387085|Antimitotic Agents|antimitotic agents|mesh-ancestor
92952182|NCT03387085|Mitosis Modulators|mitosis modulators|mesh-ancestor
92952183|NCT03387085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952184|NCT03387085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952185|NCT03387085|Immunologic Factors|immunologic factors|mesh-ancestor
92952186|NCT03387085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952187|NCT03387085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952188|NCT03387085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92952189|NCT03387085|Alkylating Agents|alkylating agents|mesh-ancestor
92952190|NCT03387085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92952191|NCT03387085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952192|NCT03387085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92952193|NCT03387085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92952194|NCT03387085|Growth Substances|growth substances|mesh-ancestor
92952195|NCT03387085|Growth Inhibitors|growth inhibitors|mesh-ancestor
92952196|NCT03387085|Antimetabolites|antimetabolites|mesh-ancestor
92952197|NCT03387085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952198|NCT03387085|Antidotes|antidotes|mesh-ancestor
92952199|NCT03387085|Protective Agents|protective agents|mesh-ancestor
92952200|NCT03387085|Vitamin B Complex|vitamin b complex|mesh-ancestor
92952201|NCT03387085|Vitamins|vitamins|mesh-ancestor
92952202|NCT03387085|Micronutrients|micronutrients|mesh-ancestor
92952203|NCT00867867|Ferrous fumarate|ferrous fumarate|mesh-list
92952204|NCT00867867|Trace Elements|trace elements|mesh-ancestor
92952205|NCT00867867|Micronutrients|micronutrients|mesh-ancestor
92952206|NCT00867867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952207|NCT00955318|Apomorphine|apomorphine|mesh-list
92952208|NCT00955318|Emetics|emetics|mesh-ancestor
92952209|NCT00955318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952210|NCT00955318|Autonomic Agents|autonomic agents|mesh-ancestor
92952211|NCT00955318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952212|NCT00955318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952213|NCT00955318|Dopamine Agonists|dopamine agonists|mesh-ancestor
92952214|NCT00955318|Dopamine Agents|dopamine agents|mesh-ancestor
92952215|NCT00955318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952216|NCT00955318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952217|NCT00860223|Digoxin|digoxin|mesh-list
92952218|NCT00860223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92952219|NCT00860223|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92952220|NCT00860223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952221|NCT00860223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952222|NCT00860223|Protective Agents|protective agents|mesh-ancestor
92952223|NCT00860223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952224|NCT00698204|Celecoxib|celecoxib|mesh-list
92952225|NCT00698204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92952226|NCT00698204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92952227|NCT00698204|Analgesics|analgesics|mesh-ancestor
92952228|NCT00698204|Sensory System Agents|sensory system agents|mesh-ancestor
92952229|NCT00698204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952230|NCT00698204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952231|NCT00698204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952232|NCT00698204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952233|NCT00698204|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92952234|NCT00698204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92952235|NCT00698204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952236|NCT00698204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952237|NCT00549718|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92952238|NCT00549718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92952239|NCT00549718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92952240|NCT00549718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952241|NCT00549718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952242|NCT00549718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952243|NCT00549718|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92952244|NCT00549718|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92952245|NCT00549718|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92952246|NCT00549718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952247|NCT00549718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952248|NCT00549718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952249|NCT00549718|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92952250|NCT00549718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92952251|NCT00549718|Serotonin Agents|serotonin agents|mesh-ancestor
92952252|NCT00549718|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92952253|NCT00549718|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92952254|NCT00549718|Dopamine Agents|dopamine agents|mesh-ancestor
92952255|NCT00863187|Rituximab|rituximab|mesh-list
92952256|NCT00863187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952257|NCT00863187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952258|NCT00863187|Immunologic Factors|immunologic factors|mesh-ancestor
92952259|NCT00863187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952260|NCT00863187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952261|NCT00754884|Calcitonin|calcitonin|mesh-list
92952262|NCT00754884|Salmon calcitonin|salmon calcitonin|mesh-list
92952263|NCT00754884|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92952264|NCT00754884|Glycerol|glycerol|mesh-list
92952265|NCT00754884|Katacalcin|katacalcin|mesh-list
92952266|NCT00754884|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92952267|NCT00754884|Protective Agents|protective agents|mesh-ancestor
92952268|NCT00754884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952269|NCT00754884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92952270|NCT00754884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92952271|NCT00754884|Vasodilator Agents|vasodilator agents|mesh-ancestor
92952272|NCT00371761|Interferons|interferons|mesh-list
92952273|NCT00371761|Interferon-alpha|interferon-alpha|mesh-list
92952274|NCT00371761|Interferon alpha-2|interferon alpha-2|mesh-list
92952275|NCT00371761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92952276|NCT00371761|Adefovir|adefovir|mesh-list
92952277|NCT00371761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92952278|NCT00371761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952279|NCT00371761|Antiviral Agents|antiviral agents|mesh-ancestor
92952280|NCT00371761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952281|NCT00371761|Immunologic Factors|immunologic factors|mesh-ancestor
92952282|NCT00371761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952283|NCT00371761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92952284|NCT00371761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92952285|NCT00371761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952286|NCT00371761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952287|NCT00754962|Protriptyline|protriptyline|mesh-list
92952288|NCT00754962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92952289|NCT00754962|Antidepressive Agents|antidepressive agents|mesh-ancestor
92952290|NCT00754962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952291|NCT00754962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92952292|NCT00754962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952293|NCT00754962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952294|NCT00754962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952295|NCT00754962|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952296|NCT00754962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952297|NCT00754962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952298|NCT00868023|Formoterol Fumarate|formoterol fumarate|mesh-list
92952299|NCT00868023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92952300|NCT00868023|Autonomic Agents|autonomic agents|mesh-ancestor
92952301|NCT00868023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952302|NCT00868023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952303|NCT00868023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92952304|NCT00868023|Respiratory System Agents|respiratory system agents|mesh-ancestor
92952305|NCT00868023|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92952306|NCT00868023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92952307|NCT00868023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92952308|NCT00868023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952309|NCT00868023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952310|NCT00868023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952311|NCT05300386|Escitalopram|escitalopram|mesh-list
92952312|NCT05300386|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92952313|NCT05300386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952314|NCT05300386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952315|NCT05300386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952316|NCT05300386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952317|NCT05300386|Serotonin Agents|serotonin agents|mesh-ancestor
92952318|NCT05300386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952319|NCT00863499|Methylphenidate|methylphenidate|mesh-list
92952320|NCT00863499|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92952321|NCT00863499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952322|NCT00863499|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92952323|NCT00863499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952324|NCT00863499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952325|NCT00863499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952326|NCT00863499|Dopamine Agents|dopamine agents|mesh-ancestor
92952327|NCT00863499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952328|NCT00755118|Leucovorin|leucovorin|mesh-list
92952329|NCT00755118|Bevacizumab|bevacizumab|mesh-list
92952330|NCT00755118|Cetuximab|cetuximab|mesh-list
92952331|NCT00755118|Fluorouracil|fluorouracil|mesh-list
92952332|NCT00755118|Oxaliplatin|oxaliplatin|mesh-list
92952333|NCT00755118|Irinotecan|irinotecan|mesh-list
92952334|NCT00755118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952335|NCT00755118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952336|NCT00755118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92952337|NCT00755118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92952338|NCT00755118|Growth Substances|growth substances|mesh-ancestor
92952339|NCT00755118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952340|NCT00755118|Growth Inhibitors|growth inhibitors|mesh-ancestor
92952341|NCT00755118|Antimetabolites|antimetabolites|mesh-ancestor
92952342|NCT00755118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952343|NCT00755118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952344|NCT00755118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952345|NCT00755118|Immunologic Factors|immunologic factors|mesh-ancestor
92952346|NCT00755118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92952347|NCT00755118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92952348|NCT00755118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952349|NCT00755118|Antidotes|antidotes|mesh-ancestor
92952350|NCT00755118|Protective Agents|protective agents|mesh-ancestor
92952351|NCT00755118|Vitamin B Complex|vitamin b complex|mesh-ancestor
92952352|NCT00755118|Vitamins|vitamins|mesh-ancestor
92952353|NCT00755118|Micronutrients|micronutrients|mesh-ancestor
92952354|NCT00755352|Pravastatin|pravastatin|mesh-list
92952355|NCT00755352|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92952356|NCT00755352|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92952357|NCT00755352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92952359|NCT00755352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952360|NCT00755352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92952361|NCT00755352|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92952362|NCT00755352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952363|NCT00549640|Methylphenidate|methylphenidate|mesh-list
92952364|NCT00549640|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92952365|NCT00549640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952366|NCT00549640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92952367|NCT00549640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952368|NCT00549640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952369|NCT00549640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952370|NCT00549640|Dopamine Agents|dopamine agents|mesh-ancestor
92952371|NCT00549640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952372|NCT04444804|Rivaroxaban|rivaroxaban|mesh-list
92952373|NCT04444804|Phenprocoumon|phenprocoumon|mesh-list
92952374|NCT04444804|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92952375|NCT04444804|Antithrombins|antithrombins|mesh-ancestor
92952376|NCT04444804|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92952377|NCT04444804|Protease Inhibitors|protease inhibitors|mesh-ancestor
92952378|NCT04444804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952379|NCT04444804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952380|NCT04444804|Anticoagulants|anticoagulants|mesh-ancestor
92952381|NCT00863577|Bemiparin|bemiparin|mesh-list
92952382|NCT00863577|Anticoagulants|anticoagulants|mesh-ancestor
92952383|NCT00868413|Cyclophosphamide|cyclophosphamide|mesh-list
92952384|NCT00868413|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92952385|NCT00868413|Rituximab|rituximab|mesh-list
92952386|NCT00868413|Fludarabine|fludarabine|mesh-list
92952387|NCT00868413|Navitoclax|navitoclax|mesh-list
92952388|NCT00868413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952389|NCT00868413|Immunologic Factors|immunologic factors|mesh-ancestor
92952390|NCT00868413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952391|NCT00868413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952392|NCT00868413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92952393|NCT00868413|Alkylating Agents|alkylating agents|mesh-ancestor
92952394|NCT00868413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952395|NCT00868413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952396|NCT00868413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92952397|NCT00868413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952398|NCT03897348|Lacosamide|lacosamide|mesh-list
92952399|NCT03897348|Anticonvulsants|anticonvulsants|mesh-ancestor
92952400|NCT03897348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92952401|NCT03897348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92952402|NCT03897348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952403|NCT03897348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952404|NCT04010578|Vitamin D|vitamin d|mesh-list
92952405|NCT04010578|Cholecalciferol|cholecalciferol|mesh-list
92952406|NCT04010578|Vitamins|vitamins|mesh-ancestor
92952407|NCT04010578|Micronutrients|micronutrients|mesh-ancestor
92952408|NCT04010578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952409|NCT04010578|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92952410|NCT04010578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92952411|NCT00868491|Cisplatin|cisplatin|mesh-list
92952412|NCT00868491|Docetaxel|docetaxel|mesh-list
92952413|NCT00868491|Fluorouracil|fluorouracil|mesh-list
92952414|NCT00868491|Cetuximab|cetuximab|mesh-list
92952415|NCT00868491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952416|NCT00868491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92952417|NCT00868491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92952418|NCT00868491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92952419|NCT00868491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952420|NCT00868491|Antimetabolites|antimetabolites|mesh-ancestor
92952421|NCT00868491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952422|NCT00868491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952423|NCT00868491|Immunologic Factors|immunologic factors|mesh-ancestor
92952424|NCT00868491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952425|NCT00868491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952426|NCT00955630|Ranibizumab|ranibizumab|mesh-list
92952427|NCT00955630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92952428|NCT00955630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92952429|NCT00955630|Growth Substances|growth substances|mesh-ancestor
92952430|NCT00955630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952431|NCT00955630|Growth Inhibitors|growth inhibitors|mesh-ancestor
92952432|NCT00955630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952434|NCT00868569|Fluorouracil|fluorouracil|mesh-list
92952435|NCT00868569|Oxaliplatin|oxaliplatin|mesh-list
92952436|NCT00868569|Antimetabolites|antimetabolites|mesh-ancestor
92952437|NCT00868569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952438|NCT00868569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952439|NCT00868569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952440|NCT00868569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952441|NCT00868569|Immunologic Factors|immunologic factors|mesh-ancestor
92952442|NCT00868569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952443|NCT00868569|Antidotes|antidotes|mesh-ancestor
92952444|NCT00868569|Protective Agents|protective agents|mesh-ancestor
92952445|NCT00868569|Vitamin B Complex|vitamin b complex|mesh-ancestor
92952446|NCT00868569|Vitamins|vitamins|mesh-ancestor
92952447|NCT00868569|Micronutrients|micronutrients|mesh-ancestor
92952448|NCT00863733|Acetic Acid|acetic acid|mesh-list
92952449|NCT00863733|Vadimezan|vadimezan|mesh-list
92952450|NCT00863733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92952451|NCT00863733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952452|NCT00863733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952453|NCT00549562|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92952454|NCT00549562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92952455|NCT00549562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92952456|NCT00549562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952457|NCT00549562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952458|NCT00549562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952459|NCT00549562|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92952460|NCT00549562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92952461|NCT00549562|Serotonin Agents|serotonin agents|mesh-ancestor
92952462|NCT00549562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952463|NCT00549562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952464|NCT00549562|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92952465|NCT00549562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92952466|NCT00549562|Dopamine Agents|dopamine agents|mesh-ancestor
92952467|NCT00860925|Clonidine|clonidine|mesh-list
92952468|NCT00860925|Analgesics|analgesics|mesh-ancestor
92952469|NCT00860925|Sensory System Agents|sensory system agents|mesh-ancestor
92952470|NCT00860925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952471|NCT00860925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952472|NCT00860925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92952473|NCT00860925|Sympatholytics|sympatholytics|mesh-ancestor
92952474|NCT00860925|Autonomic Agents|autonomic agents|mesh-ancestor
92952475|NCT00860925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92952476|NCT00860925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92952477|NCT00860925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92952478|NCT00860925|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952479|NCT00860925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952480|NCT00860925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952481|NCT04237012|Dexamethasone|dexamethasone|mesh-list
92952482|NCT04237012|Lubricant Eye Drops|lubricant eye drops|mesh-list
92952483|NCT04237012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952484|NCT04237012|Antiemetics|antiemetics|mesh-ancestor
92952485|NCT04237012|Autonomic Agents|autonomic agents|mesh-ancestor
92952486|NCT04237012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952487|NCT04237012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952488|NCT04237012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952489|NCT04237012|Glucocorticoids|glucocorticoids|mesh-ancestor
92952490|NCT04237012|Hormones|hormones|mesh-ancestor
92952491|NCT04237012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92952492|NCT04237012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92952493|NCT04237012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952494|NCT04237012|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92952495|NCT04237012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92952496|NCT00863889|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92165299|NCT04818632|Everolimus|everolimus|mesh-list
92952497|NCT00863889|Methylprednisolone|methylprednisolone|mesh-list
92952498|NCT00863889|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92952499|NCT00863889|Prednisolone|prednisolone|mesh-list
92952500|NCT00863889|Prednisolone acetate|prednisolone acetate|mesh-list
92952501|NCT00863889|Lidocaine|lidocaine|mesh-list
92952502|NCT00863889|Bupivacaine|bupivacaine|mesh-list
92952503|NCT00863889|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92952504|NCT00863889|Prednisolone phosphate|prednisolone phosphate|mesh-list
92952505|NCT00863889|Anesthetics, Local|anesthetics, local|mesh-ancestor
92952506|NCT00863889|Anesthetics|anesthetics|mesh-ancestor
92952507|NCT00863889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952508|NCT00863889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952509|NCT00863889|Sensory System Agents|sensory system agents|mesh-ancestor
92952510|NCT00863889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952511|NCT00863889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92952512|NCT00863889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92952513|NCT00863889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92952514|NCT00863889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952515|NCT00863889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952516|NCT00863889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952517|NCT00863889|Antiemetics|antiemetics|mesh-ancestor
92952518|NCT00863889|Autonomic Agents|autonomic agents|mesh-ancestor
92952519|NCT00863889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952520|NCT00863889|Glucocorticoids|glucocorticoids|mesh-ancestor
92952521|NCT00863889|Hormones|hormones|mesh-ancestor
92952522|NCT00863889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92952523|NCT00863889|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92952524|NCT00863889|Protective Agents|protective agents|mesh-ancestor
92952525|NCT00863889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92952526|NCT00863889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952527|NCT00677352|Sertraline|sertraline|mesh-list
92952528|NCT00677352|Paroxetine|paroxetine|mesh-list
92952529|NCT00677352|Antidepressive Agents|antidepressive agents|mesh-ancestor
92952530|NCT00677352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952531|NCT00677352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92952532|NCT00677352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952533|NCT00677352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952534|NCT00677352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952535|NCT00677352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952536|NCT00677352|Serotonin Agents|serotonin agents|mesh-ancestor
92952537|NCT00677352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952538|NCT00677352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92952539|NCT00677352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92952540|NCT00677352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92952541|NCT00677352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952542|NCT00864045|Olanzapine|olanzapine|mesh-list
92952543|NCT00864045|Sertindole|sertindole|mesh-list
92952544|NCT00864045|Antiemetics|antiemetics|mesh-ancestor
92952545|NCT00864045|Autonomic Agents|autonomic agents|mesh-ancestor
92952546|NCT00864045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952547|NCT00864045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952548|NCT00864045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952549|NCT00864045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92952550|NCT00864045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92952551|NCT00864045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952552|NCT00864045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952553|NCT00864045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92952554|NCT00864045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952555|NCT00864045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952556|NCT00864045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952557|NCT00864045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952558|NCT00864045|Serotonin Agents|serotonin agents|mesh-ancestor
92952559|NCT00755508|Gabapentin|gabapentin|mesh-list
92952560|NCT00755508|Analgesics|analgesics|mesh-ancestor
92952561|NCT00755508|Sensory System Agents|sensory system agents|mesh-ancestor
92952562|NCT00755508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952563|NCT00755508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952564|NCT00755508|Anticonvulsants|anticonvulsants|mesh-ancestor
92952565|NCT00755508|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92952566|NCT00755508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92165302|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92952567|NCT00755508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952568|NCT00755508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952569|NCT00755508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92952570|NCT00755508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92952571|NCT00755508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952572|NCT00755508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952573|NCT00755508|Antimanic Agents|antimanic agents|mesh-ancestor
92952574|NCT03680352|Cefepime|cefepime|mesh-list
92952575|NCT03680352|Enmetazobactam|enmetazobactam|mesh-list
92952576|NCT03680352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92952577|NCT03680352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952578|NCT03680352|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92952579|NCT03680352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952580|NCT03680352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952581|NCT00864201|Bosentan|bosentan|mesh-list
92952582|NCT00864201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92952583|NCT00864201|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92952584|NCT00864201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952585|NCT00864279|Cetirizine|cetirizine|mesh-list
92952586|NCT00864279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92952587|NCT00864279|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92952588|NCT00864279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92952589|NCT00864279|Histamine Antagonists|histamine antagonists|mesh-ancestor
92952590|NCT00864279|Histamine Agents|histamine agents|mesh-ancestor
92952591|NCT00864279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952592|NCT00864279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952593|NCT00864279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952595|NCT02559648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92952596|NCT02559648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952597|NCT00864357|Ibuprofen|ibuprofen|mesh-list
92952598|NCT00864357|Oxycodone|oxycodone|mesh-list
92952599|NCT00864357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92952600|NCT00864357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92952601|NCT00864357|Analgesics|analgesics|mesh-ancestor
92952602|NCT00864357|Sensory System Agents|sensory system agents|mesh-ancestor
92952603|NCT00864357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952604|NCT00864357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952605|NCT00864357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952606|NCT00864357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952607|NCT00864357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92952608|NCT00864357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952609|NCT00864357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952610|NCT00864357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92952611|NCT00864357|Narcotics|narcotics|mesh-ancestor
92952612|NCT00864357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952613|NCT00864435|Carvedilol|carvedilol|mesh-list
92952614|NCT00864435|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92952615|NCT00864435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92952616|NCT00864435|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952617|NCT00864435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952618|NCT00864435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952619|NCT00864435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952620|NCT00864435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92952621|NCT00864435|Antioxidants|antioxidants|mesh-ancestor
92952622|NCT00864435|Protective Agents|protective agents|mesh-ancestor
92952623|NCT00864435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92952624|NCT00864435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952625|NCT00864435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92952626|NCT00864435|Vasodilator Agents|vasodilator agents|mesh-ancestor
92952627|NCT00864435|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92952628|NCT00864435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92952629|NCT00755664|Vitamins|vitamins|mesh-list
92952630|NCT00755664|Vitamin B Complex|vitamin b complex|mesh-list
92952631|NCT00755664|Micronutrients|micronutrients|mesh-ancestor
92952632|NCT00755664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952633|NCT00956098|Oltipraz|oltipraz|mesh-list
92952634|NCT00956098|Antiviral Agents|antiviral agents|mesh-ancestor
92952635|NCT00956098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952636|NCT00956098|Schistosomicides|schistosomicides|mesh-ancestor
92952637|NCT00956098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92952638|NCT00956098|Anthelmintics|anthelmintics|mesh-ancestor
92952639|NCT00956098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92952640|NCT00956098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92952641|NCT00956098|Protective Agents|protective agents|mesh-ancestor
92952642|NCT00956098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952643|NCT00956098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952644|NCT00956098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92952645|NCT00956098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92952646|NCT00956098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952647|NCT00956098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952648|NCT00864591|Adenosine|adenosine|mesh-list
92952649|NCT00864591|Analgesics|analgesics|mesh-ancestor
92952650|NCT00864591|Sensory System Agents|sensory system agents|mesh-ancestor
92952651|NCT00864591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527410|NCT00033163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952652|NCT00864591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952653|NCT00864591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92952654|NCT00864591|Vasodilator Agents|vasodilator agents|mesh-ancestor
92952655|NCT00864591|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92952656|NCT00864591|Purinergic Agonists|purinergic agonists|mesh-ancestor
92952657|NCT00864591|Purinergic Agents|purinergic agents|mesh-ancestor
92952658|NCT00864591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952659|NCT00864591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952660|NCT05350384|Methylprednisolone|methylprednisolone|mesh-list
92952661|NCT05350384|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92952662|NCT05350384|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92952663|NCT05350384|Prednisolone|prednisolone|mesh-list
92952664|NCT05350384|Prednisolone acetate|prednisolone acetate|mesh-list
92952665|NCT05350384|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92952666|NCT05350384|Prednisolone phosphate|prednisolone phosphate|mesh-list
92952667|NCT05350384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952668|NCT05350384|Antiemetics|antiemetics|mesh-ancestor
92952669|NCT05350384|Autonomic Agents|autonomic agents|mesh-ancestor
92952670|NCT05350384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952671|NCT05350384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952672|NCT05350384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92952673|NCT05350384|Glucocorticoids|glucocorticoids|mesh-ancestor
92952674|NCT05350384|Hormones|hormones|mesh-ancestor
92952675|NCT05350384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92952676|NCT05350384|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92952677|NCT05350384|Protective Agents|protective agents|mesh-ancestor
92952678|NCT05350384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92952679|NCT05350384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952680|NCT00870441|Valacyclovir|valacyclovir|mesh-list
92952681|NCT00870441|Antiviral Agents|antiviral agents|mesh-ancestor
92952682|NCT00870441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952683|NCT04079452|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92952684|NCT04079452|Antiviral Agents|antiviral agents|mesh-ancestor
92952685|NCT04079452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952686|NCT04079452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92952687|NCT04079452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92952688|NCT04079452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952689|NCT04079452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952690|NCT04079452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92952691|NCT04079452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92952692|NCT00864669|Metformin|metformin|mesh-list
92952693|NCT00864669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92952694|NCT00864669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952695|NCT00864747|Propranolol|propranolol|mesh-list
92952696|NCT00864747|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92952697|NCT00864747|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92952698|NCT00864747|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952699|NCT00864747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952700|NCT00864747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952701|NCT00864747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952702|NCT00864747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92952703|NCT00864747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92952704|NCT00864747|Vasodilator Agents|vasodilator agents|mesh-ancestor
92952705|NCT05279716|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92952706|NCT05279716|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92952707|NCT02559102|Dexmedetomidine|dexmedetomidine|mesh-list
92952708|NCT02559102|Anesthetics|anesthetics|mesh-list
92952709|NCT02559102|Sevoflurane|sevoflurane|mesh-list
92952710|NCT02559102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92952711|NCT02559102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952712|NCT02559102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92952713|NCT02559102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92952714|NCT02559102|Analgesics|analgesics|mesh-ancestor
92952715|NCT02559102|Sensory System Agents|sensory system agents|mesh-ancestor
92952716|NCT02559102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952717|NCT02559102|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92952718|NCT02559102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92952719|NCT02559102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92952720|NCT02559102|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952721|NCT02559102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952722|NCT02559102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952723|NCT02559102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92952724|NCT02559102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92952725|NCT02559102|Anesthetics, General|anesthetics, general|mesh-ancestor
92952726|NCT05348668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92952727|NCT05348668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952728|NCT05348668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952729|NCT05348668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952730|NCT00864825|Allopurinol|allopurinol|mesh-list
92952731|NCT00864825|Antimetabolites|antimetabolites|mesh-ancestor
92952732|NCT00864825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952733|NCT00864825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952734|NCT00864825|Gout Suppressants|gout suppressants|mesh-ancestor
92952735|NCT00864825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952736|NCT00864825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92952737|NCT00864825|Antioxidants|antioxidants|mesh-ancestor
92952738|NCT00864825|Protective Agents|protective agents|mesh-ancestor
92952739|NCT00864825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952740|NCT00956176|Cidofovir|cidofovir|mesh-list
92952741|NCT00956176|Antiviral Agents|antiviral agents|mesh-ancestor
92952742|NCT00956176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952743|NCT00956176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952744|NCT00956176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952745|NCT00864981|Bupropion|bupropion|mesh-list
92952746|NCT00864981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92952747|NCT00864981|Antidepressive Agents|antidepressive agents|mesh-ancestor
92952748|NCT00864981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92952749|NCT00864981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92952750|NCT00864981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92952751|NCT00864981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952752|NCT00864981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952753|NCT00864981|Dopamine Agents|dopamine agents|mesh-ancestor
92952754|NCT00864981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952755|NCT00864981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952756|NCT00864981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92952757|NCT00864981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92952758|NCT00864981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952759|NCT00371683|Enoxaparin|enoxaparin|mesh-list
92952760|NCT00371683|Apixaban|apixaban|mesh-list
92952761|NCT00371683|Anticoagulants|anticoagulants|mesh-ancestor
92952762|NCT00371683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92952763|NCT00371683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92952764|NCT00371683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952765|NCT00371683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92952766|NCT00371683|Antithrombins|antithrombins|mesh-ancestor
92952767|NCT00371683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92952768|NCT00371683|Protease Inhibitors|protease inhibitors|mesh-ancestor
92952769|NCT00371683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952770|NCT00876135|Albuterol|albuterol|mesh-list
92952771|NCT00876135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92952772|NCT00876135|Autonomic Agents|autonomic agents|mesh-ancestor
92952773|NCT00876135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952774|NCT00876135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952775|NCT00876135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92952776|NCT00876135|Respiratory System Agents|respiratory system agents|mesh-ancestor
92952777|NCT00876135|Tocolytic Agents|tocolytic agents|mesh-ancestor
92952778|NCT00876135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92952779|NCT00876135|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92952780|NCT00876135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92952781|NCT00876135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92952782|NCT00876135|Adrenergic Agents|adrenergic agents|mesh-ancestor
92952783|NCT00876135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952784|NCT00876135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952785|NCT04039815|Ascorbic Acid|ascorbic acid|mesh-list
92952786|NCT04039815|Thiamine|thiamine|mesh-list
92952787|NCT04039815|Hydrocortisone|hydrocortisone|mesh-list
92952788|NCT04039815|Vitamins|vitamins|mesh-ancestor
92952789|NCT04039815|Micronutrients|micronutrients|mesh-ancestor
92952790|NCT04039815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952791|NCT04039815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952792|NCT04039815|Vitamin B Complex|vitamin b complex|mesh-ancestor
92952793|NCT04039815|Antioxidants|antioxidants|mesh-ancestor
92952794|NCT04039815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952795|NCT04039815|Protective Agents|protective agents|mesh-ancestor
92952796|NCT00870987|Vaccines|vaccines|mesh-list
92952797|NCT00870987|Immunologic Factors|immunologic factors|mesh-ancestor
92952798|NCT00870987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952800|NCT00871065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952801|NCT00871065|Vasodilator Agents|vasodilator agents|mesh-ancestor
92952802|NCT00871065|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92952803|NCT00871065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92952804|NCT00871065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952805|NCT00871065|Urological Agents|urological agents|mesh-ancestor
92952806|NCT00962026|Rilonacept|rilonacept|mesh-list
92952807|NCT00962026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952808|NCT00616239|Salicylic Acid|salicylic acid|mesh-list
92952809|NCT00616239|Salicylates|salicylates|mesh-list
92952810|NCT00616239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952811|NCT00616239|Antifungal Agents|antifungal agents|mesh-ancestor
92952812|NCT00616239|Keratolytic Agents|keratolytic agents|mesh-ancestor
92952813|NCT00616239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92952814|NCT00616239|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92952815|NCT00616239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92952816|NCT00616239|Analgesics|analgesics|mesh-ancestor
92952817|NCT00616239|Sensory System Agents|sensory system agents|mesh-ancestor
92952818|NCT00616239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952819|NCT00616239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952820|NCT00616239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952821|NCT00616239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952822|NCT00616239|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92952823|NCT00616239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952824|NCT00616239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952825|NCT00547534|Rituximab|rituximab|mesh-list
92952826|NCT00547534|Bortezomib|bortezomib|mesh-list
92952827|NCT00547534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92952828|NCT00547534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92952829|NCT00547534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952830|NCT00547534|Immunologic Factors|immunologic factors|mesh-ancestor
92952831|NCT00547534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952832|NCT00547534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952833|NCT00547534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92952834|NCT00547534|Alkylating Agents|alkylating agents|mesh-ancestor
92952835|NCT00547534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952836|NCT00871455|Baclofen|baclofen|mesh-list
92952837|NCT00871455|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92952838|NCT00871455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952839|NCT00871455|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92952840|NCT00871455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952841|NCT00871455|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92952842|NCT00871455|GABA Agonists|gaba agonists|mesh-ancestor
92952843|NCT00871455|GABA Agents|gaba agents|mesh-ancestor
92165324|NCT04707872|Antibodies|antibodies|mesh-list
92952844|NCT00871455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952845|NCT00871455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952846|NCT00871533|Interferon-alpha|interferon-alpha|mesh-list
92952847|NCT00871533|Interferon alpha-2|interferon alpha-2|mesh-list
92952848|NCT00871533|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92952849|NCT00871533|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92952850|NCT00871533|Antiviral Agents|antiviral agents|mesh-ancestor
92952851|NCT00871533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952852|NCT00871533|Immunologic Factors|immunologic factors|mesh-ancestor
92952853|NCT00871533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952854|NCT00871533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952855|NCT00877149|Telbivudine|telbivudine|mesh-list
92952856|NCT00877149|Antiviral Agents|antiviral agents|mesh-ancestor
92952857|NCT00877149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952858|NCT00877149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92952859|NCT00877149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952860|NCT00877149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952861|NCT00877227|Leucovorin|leucovorin|mesh-list
92952862|NCT00877227|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92952863|NCT00877227|Levoleucovorin|levoleucovorin|mesh-list
92952864|NCT00877227|Antidotes|antidotes|mesh-ancestor
92952865|NCT00877227|Protective Agents|protective agents|mesh-ancestor
92952866|NCT00877227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952867|NCT00877227|Vitamin B Complex|vitamin b complex|mesh-ancestor
92952868|NCT00877227|Vitamins|vitamins|mesh-ancestor
92952869|NCT00877227|Micronutrients|micronutrients|mesh-ancestor
92952870|NCT00871767|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92952871|NCT00871767|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92952872|NCT00871767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952873|NCT00871767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92952874|NCT00871767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92952875|NCT00871767|Antiviral Agents|antiviral agents|mesh-ancestor
92952876|NCT00871767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952877|NCT00384397|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92952878|NCT00384397|Immunologic Factors|immunologic factors|mesh-ancestor
92952879|NCT00384397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952880|NCT05119894|Brexpiprazole|brexpiprazole|mesh-list
92952881|NCT05119894|Serotonin Agents|serotonin agents|mesh-ancestor
92952882|NCT05119894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92952883|NCT05119894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952884|NCT05119894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952885|NCT05119894|Dopamine Agonists|dopamine agonists|mesh-ancestor
92952886|NCT05119894|Dopamine Agents|dopamine agents|mesh-ancestor
92952887|NCT00877539|Fluticasone|fluticasone|mesh-list
92952888|NCT00877539|Xhance|xhance|mesh-list
92952889|NCT00877539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952890|NCT00877539|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92952891|NCT00877539|Autonomic Agents|autonomic agents|mesh-ancestor
92952892|NCT00877539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952893|NCT00877539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952894|NCT00877539|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92952895|NCT00877539|Respiratory System Agents|respiratory system agents|mesh-ancestor
92952896|NCT00877539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92952897|NCT00877539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92952898|NCT00872235|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92952899|NCT00872235|Quinapril|quinapril|mesh-list
92952900|NCT00872235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92952901|NCT00872235|Diuretics|diuretics|mesh-ancestor
92952902|NCT00872235|Natriuretic Agents|natriuretic agents|mesh-ancestor
92952903|NCT00872235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952904|NCT00872235|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92952905|NCT00872235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952906|NCT00872235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952907|NCT00872235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92952908|NCT00872235|Protease Inhibitors|protease inhibitors|mesh-ancestor
92952909|NCT00872235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952910|NCT00872469|Tranexamic Acid|tranexamic acid|mesh-list
92952911|NCT00872469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92952912|NCT00872469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92952913|NCT00872469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952914|NCT00872469|Hemostatics|hemostatics|mesh-ancestor
92952915|NCT00872469|Coagulants|coagulants|mesh-ancestor
92952916|NCT00872625|Cyclophosphamide|cyclophosphamide|mesh-list
92952917|NCT00872625|Docetaxel|docetaxel|mesh-list
92952918|NCT00872625|Fluorouracil|fluorouracil|mesh-list
92952919|NCT00872625|Epirubicin|epirubicin|mesh-list
92952920|NCT00872625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92952921|NCT00872625|Immunologic Factors|immunologic factors|mesh-ancestor
92952922|NCT00872625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952923|NCT00872625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92952924|NCT00872625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92952925|NCT00872625|Alkylating Agents|alkylating agents|mesh-ancestor
92952926|NCT00872625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952927|NCT00872625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952928|NCT00872625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92952929|NCT00872625|Tubulin Modulators|tubulin modulators|mesh-ancestor
92952930|NCT00872625|Antimitotic Agents|antimitotic agents|mesh-ancestor
92952931|NCT00872625|Mitosis Modulators|mitosis modulators|mesh-ancestor
92952932|NCT00872625|Antimetabolites|antimetabolites|mesh-ancestor
92952933|NCT00872625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952934|NCT00872625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92952935|NCT00872625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92952936|NCT00872625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92952937|NCT00872625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952938|NCT00872781|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92952939|NCT00872781|Quinapril|quinapril|mesh-list
92952940|NCT00872781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92952941|NCT00872781|Diuretics|diuretics|mesh-ancestor
92952942|NCT00872781|Natriuretic Agents|natriuretic agents|mesh-ancestor
92952943|NCT00872781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952944|NCT00872781|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92952945|NCT00872781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92952946|NCT00872781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952947|NCT00872781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92952948|NCT00872781|Protease Inhibitors|protease inhibitors|mesh-ancestor
92952949|NCT00872781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952950|NCT00384085|Insulin|insulin|mesh-list
92952951|NCT00384085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92952952|NCT00384085|Insulin Glargine|insulin glargine|mesh-list
92952953|NCT00384085|Insulin glulisine|insulin glulisine|mesh-list
92952954|NCT00384085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92952955|NCT00384085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952956|NCT00361231|Bevacizumab|bevacizumab|mesh-list
92952957|NCT00361231|Gemcitabine|gemcitabine|mesh-list
92952958|NCT00361231|Oxaliplatin|oxaliplatin|mesh-list
92952959|NCT00361231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92598431|NCT00108368|Olanzapine|olanzapine|mesh-list
92952960|NCT00361231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952961|NCT00361231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92952962|NCT00361231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92952963|NCT00361231|Growth Substances|growth substances|mesh-ancestor
92952964|NCT00361231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952965|NCT00361231|Growth Inhibitors|growth inhibitors|mesh-ancestor
92952966|NCT00361231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92952967|NCT00361231|Antimetabolites|antimetabolites|mesh-ancestor
92952968|NCT00361231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952969|NCT00676650|Prednisone|prednisone|mesh-list
92952970|NCT00676650|Sunitinib|sunitinib|mesh-list
92952971|NCT00676650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92952972|NCT00676650|Glucocorticoids|glucocorticoids|mesh-ancestor
92952973|NCT00676650|Hormones|hormones|mesh-ancestor
92952974|NCT00676650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92952975|NCT00676650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952976|NCT00676650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92952977|NCT00676650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92952978|NCT00676650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92952979|NCT00676650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92952980|NCT00676650|Growth Substances|growth substances|mesh-ancestor
92952981|NCT00676650|Growth Inhibitors|growth inhibitors|mesh-ancestor
92952982|NCT00676650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92952983|NCT00676650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952984|NCT00676650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952985|NCT01045369|Etravirine|etravirine|mesh-list
92952986|NCT01045369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92952987|NCT01045369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92952988|NCT01045369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92952989|NCT01045369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92952990|NCT01045369|Antiviral Agents|antiviral agents|mesh-ancestor
92952991|NCT01045369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92952992|NCT00615459|Tiotropium Bromide|tiotropium bromide|mesh-list
92952993|NCT00615459|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92952994|NCT00615459|Autonomic Agents|autonomic agents|mesh-ancestor
92952995|NCT00615459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92952996|NCT00615459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92952997|NCT00615459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92952998|NCT00615459|Respiratory System Agents|respiratory system agents|mesh-ancestor
92952999|NCT00615459|Parasympatholytics|parasympatholytics|mesh-ancestor
92953000|NCT00615459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92953001|NCT00615459|Cholinergic Agents|cholinergic agents|mesh-ancestor
92953002|NCT00615459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953003|NCT00615459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953004|NCT03839511|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92953005|NCT03839511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953006|NCT00383149|Cetuximab|cetuximab|mesh-list
92953007|NCT00383149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92953008|NCT00383149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953009|NCT00878631|Dextrans|dextrans|mesh-list
92953010|NCT00878631|Anticoagulants|anticoagulants|mesh-ancestor
92953011|NCT00878631|Plasma Substitutes|plasma substitutes|mesh-ancestor
92953012|NCT00878631|Blood Substitutes|blood substitutes|mesh-ancestor
92953013|NCT00382993|Naproxen|naproxen|mesh-list
92953014|NCT00382993|Sumatriptan|sumatriptan|mesh-list
92953015|NCT00382993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92953016|NCT00382993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92953017|NCT00382993|Analgesics|analgesics|mesh-ancestor
92953018|NCT00382993|Sensory System Agents|sensory system agents|mesh-ancestor
92297971|NCT05921071|Coagulants|coagulants|mesh-ancestor
92953019|NCT00382993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953020|NCT00382993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953021|NCT00382993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92953022|NCT00382993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92953023|NCT00382993|Gout Suppressants|gout suppressants|mesh-ancestor
92953024|NCT00382993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92953025|NCT00382993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953026|NCT00382993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953027|NCT00382993|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92953028|NCT00382993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92953029|NCT00382993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92953030|NCT00382993|Serotonin Agents|serotonin agents|mesh-ancestor
92953031|NCT00382993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953032|NCT00760968|Methotrexate|methotrexate|mesh-list
92953033|NCT00760968|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92953034|NCT00760968|Abortifacient Agents|abortifacient agents|mesh-ancestor
92953035|NCT00760968|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92953036|NCT00760968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953037|NCT00760968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92953038|NCT00760968|Antimetabolites|antimetabolites|mesh-ancestor
92953039|NCT00760968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953040|NCT00760968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953041|NCT00760968|Dermatologic Agents|dermatologic agents|mesh-ancestor
92953042|NCT00760968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953043|NCT00760968|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92953044|NCT00760968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92953045|NCT00760968|Immunologic Factors|immunologic factors|mesh-ancestor
92953046|NCT00760968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92953047|NCT00760968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92953048|NCT00369967|Contraceptive Agents|contraceptive agents|mesh-list
92953049|NCT00369967|NuvaRing|nuvaring|mesh-list
92953050|NCT00369967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92953051|NCT00369967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953052|NCT00369967|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92953053|NCT00878865|Alprazolam|alprazolam|mesh-list
92953054|NCT00878865|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92953055|NCT00878865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953056|NCT00878865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953057|NCT00878865|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92953058|NCT00878865|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953059|NCT00878865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953060|NCT00878865|GABA Modulators|gaba modulators|mesh-ancestor
92953061|NCT00878865|GABA Agents|gaba agents|mesh-ancestor
92953062|NCT00878865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953063|NCT00878865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953064|NCT00873483|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92953065|NCT00873483|Gestodene|gestodene|mesh-list
92953066|NCT00873483|Femovan|femovan|mesh-list
92953067|NCT00873483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92953068|NCT00873483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92953069|NCT00873483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92953070|NCT00873483|Contraceptive Agents|contraceptive agents|mesh-ancestor
92953071|NCT00873483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92953072|NCT00873483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953073|NCT00873483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92953074|NCT00873483|Estrogens|estrogens|mesh-ancestor
92953075|NCT00873483|Hormones|hormones|mesh-ancestor
92953076|NCT00873483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953077|NCT00873483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92953078|NCT00873483|Progestins|progestins|mesh-ancestor
92953079|NCT00873483|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92953080|NCT01050517|Ivermectin|ivermectin|mesh-list
92953081|NCT01050517|Albendazole|albendazole|mesh-list
92953082|NCT01050517|Praziquantel|praziquantel|mesh-list
92953083|NCT01050517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92953084|NCT01050517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953085|NCT01050517|Anthelmintics|anthelmintics|mesh-ancestor
92953086|NCT01050517|Anticestodal Agents|anticestodal agents|mesh-ancestor
92953087|NCT01050517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92953088|NCT01050517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92953089|NCT01050517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92953090|NCT01050517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92953091|NCT01050517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92953092|NCT01050517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953093|NCT01050517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953094|NCT02534467|Montelukast|montelukast|mesh-list
92953095|NCT02534467|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92953096|NCT02534467|Respiratory System Agents|respiratory system agents|mesh-ancestor
92953097|NCT02534467|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92953098|NCT02534467|Hormone Antagonists|hormone antagonists|mesh-ancestor
92953099|NCT02534467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953100|NCT02534467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953101|NCT02534467|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92953102|NCT02534467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92953103|NCT02534467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953104|NCT01050595|Naltrexone|naltrexone|mesh-list
92953105|NCT01050595|Bromides|bromides|mesh-list
92953106|NCT01050595|Methylnaltrexone|methylnaltrexone|mesh-list
92953107|NCT01050595|Anticonvulsants|anticonvulsants|mesh-ancestor
92953108|NCT01050595|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92953109|NCT01050595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953110|NCT01050595|Sensory System Agents|sensory system agents|mesh-ancestor
92953111|NCT01050595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953112|NCT01050595|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92953113|NCT00878943|Sildenafil Citrate|sildenafil citrate|mesh-list
92953114|NCT00878943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953115|NCT00878943|Vasodilator Agents|vasodilator agents|mesh-ancestor
92953116|NCT00878943|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92953117|NCT00878943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92953118|NCT00878943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953119|NCT00878943|Urological Agents|urological agents|mesh-ancestor
92953120|NCT00873639|Insulin|insulin|mesh-list
92953121|NCT00873639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92953122|NCT00873639|Insulin Aspart|insulin aspart|mesh-list
92953123|NCT00873639|Insulin Detemir|insulin detemir|mesh-list
92953124|NCT00873639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92953125|NCT00873639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953126|NCT00879021|Pregabalin|pregabalin|mesh-list
92953127|NCT00879021|Analgesics|analgesics|mesh-ancestor
92953128|NCT00879021|Sensory System Agents|sensory system agents|mesh-ancestor
92953129|NCT00879021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953130|NCT00879021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165338|NCT04670081|Niacin|niacin|mesh-list
92953131|NCT00879021|Anticonvulsants|anticonvulsants|mesh-ancestor
92953132|NCT00879021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92953133|NCT00879021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953134|NCT00879021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953135|NCT00879021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92953136|NCT00879021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92953137|NCT00879021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953138|NCT00879021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953139|NCT00879021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953140|NCT00879099|Timolol|timolol|mesh-list
92953141|NCT00879099|Paroxetine|paroxetine|mesh-list
92953142|NCT00879099|Maleic acid|maleic acid|mesh-list
92953143|NCT00879099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953144|NCT00879099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953145|NCT00879099|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92953146|NCT00879099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92953147|NCT00879099|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953148|NCT00879099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953149|NCT00879099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953150|NCT00879099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92953151|NCT00879099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953152|NCT00879099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92953153|NCT00879099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92953154|NCT00879099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953155|NCT00879099|Serotonin Agents|serotonin agents|mesh-ancestor
92953156|NCT00879099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92953157|NCT00879099|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953158|NCT00879099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953159|NCT00879099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92953160|NCT00879099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92953161|NCT00369655|Aflibercept|aflibercept|mesh-list
92953162|NCT00369655|Endothelial Growth Factors|endothelial growth factors|mesh-list
92953163|NCT00369655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92527415|NCT00033163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92953164|NCT00369655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953165|NCT00369655|Growth Substances|growth substances|mesh-ancestor
92953166|NCT00369655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953167|NCT00369655|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953168|NCT00369655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953169|NCT00879177|Varenicline|varenicline|mesh-list
92953170|NCT00879177|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92953171|NCT00879177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92953172|NCT00879177|Cholinergic Agents|cholinergic agents|mesh-ancestor
92953173|NCT00879177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953174|NCT00879177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953175|NCT00879177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953176|NCT00676338|Metformin|metformin|mesh-list
92953177|NCT00676338|Pioglitazone|pioglitazone|mesh-list
92953178|NCT00676338|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92953179|NCT00676338|Exenatide|exenatide|mesh-list
92953180|NCT00676338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92953181|NCT00676338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953182|NCT00676338|Incretins|incretins|mesh-ancestor
92953183|NCT00676338|Hormones|hormones|mesh-ancestor
92953184|NCT00676338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953185|NCT00676338|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92953186|NCT00676338|Protease Inhibitors|protease inhibitors|mesh-ancestor
92953187|NCT00676338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953188|NCT00676338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953189|NCT00676338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92953191|NCT02534623|Bupivacaine|bupivacaine|mesh-list
92953192|NCT02534623|Anesthetics|anesthetics|mesh-list
92953193|NCT02534623|Propofol|propofol|mesh-list
92953194|NCT02534623|Sevoflurane|sevoflurane|mesh-list
92953195|NCT02534623|Anesthetics, Local|anesthetics, local|mesh-ancestor
92953196|NCT02534623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953197|NCT02534623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953198|NCT02534623|Sensory System Agents|sensory system agents|mesh-ancestor
92953199|NCT02534623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953200|NCT02534623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92953201|NCT02534623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92953202|NCT02534623|Anesthetics, General|anesthetics, general|mesh-ancestor
92953203|NCT02534623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92953204|NCT02534623|Narcotics|narcotics|mesh-ancestor
92953205|NCT02534623|Analgesics|analgesics|mesh-ancestor
92953206|NCT02534623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92953207|NCT02534623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92953208|NCT02534623|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92953209|NCT00873795|Aripiprazole|aripiprazole|mesh-list
92953210|NCT00873795|Sertraline|sertraline|mesh-list
92953211|NCT00873795|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953212|NCT00873795|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953213|NCT00873795|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92953214|NCT00873795|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953215|NCT00873795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953216|NCT00873795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953217|NCT00873795|Dopamine Agonists|dopamine agonists|mesh-ancestor
92953218|NCT00873795|Dopamine Agents|dopamine agents|mesh-ancestor
92953219|NCT00873795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953220|NCT00873795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953221|NCT00873795|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92953222|NCT00873795|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92953223|NCT00873795|Serotonin Agents|serotonin agents|mesh-ancestor
92953224|NCT00873795|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92953225|NCT00873795|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92953226|NCT00873795|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92953227|NCT00873795|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92953228|NCT00873795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92953229|NCT00873795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92953230|NCT00873795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953231|NCT00873951|Caseins|caseins|mesh-list
92953232|NCT00873951|Chelating Agents|chelating agents|mesh-ancestor
92953233|NCT00873951|Sequestering Agents|sequestering agents|mesh-ancestor
92953234|NCT00873951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953235|NCT00874107|Paclitaxel|paclitaxel|mesh-list
92953236|NCT00874107|Bevacizumab|bevacizumab|mesh-list
92953237|NCT00874107|Carboplatin|carboplatin|mesh-list
92953238|NCT00874107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92953239|NCT00874107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953240|NCT00874107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92953241|NCT00874107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92953242|NCT00874107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92953243|NCT00874107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953244|NCT00874107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92953245|NCT00874107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92953246|NCT00874107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953247|NCT00874107|Growth Substances|growth substances|mesh-ancestor
92953248|NCT00874107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953249|NCT00874107|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953250|NCT00761358|Z 338|z 338|mesh-list
92953251|NCT00761358|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92953252|NCT00761358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953253|NCT00761358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953254|NCT00761358|Cholinergic Agents|cholinergic agents|mesh-ancestor
92953255|NCT00761358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953256|NCT00761358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953257|NCT00761358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92953258|NCT00879723|Vitamins|vitamins|mesh-list
92953259|NCT00879723|Micronutrients|micronutrients|mesh-ancestor
92953261|NCT00874419|Carboplatin|carboplatin|mesh-list
92953262|NCT00874419|Gemcitabine|gemcitabine|mesh-list
92953263|NCT00874419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92953264|NCT00874419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953265|NCT00874419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92953266|NCT00874419|Antimetabolites|antimetabolites|mesh-ancestor
92953267|NCT00874419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953268|NCT00874419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953269|NCT00874419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953270|NCT00381043|Acamprosate|acamprosate|mesh-list
92953271|NCT00381043|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92953272|NCT01050985|Sirolimus|sirolimus|mesh-list
92953273|NCT01050985|Capecitabine|capecitabine|mesh-list
92953274|NCT01050985|Temsirolimus|temsirolimus|mesh-list
92953275|NCT01050985|MTOR Inhibitors|mtor inhibitors|mesh-list
92953276|NCT01050985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92953277|NCT01050985|Antimetabolites|antimetabolites|mesh-ancestor
92953278|NCT01050985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953279|NCT01050985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953280|NCT01050985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953281|NCT01050985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953282|NCT01050985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92953283|NCT01050985|Immunologic Factors|immunologic factors|mesh-ancestor
92953284|NCT01050985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953285|NCT01050985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92953286|NCT01050985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953287|NCT01050985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92953288|NCT01050985|Antifungal Agents|antifungal agents|mesh-ancestor
92953289|NCT00614991|Ritonavir|ritonavir|mesh-list
92953290|NCT00614991|Fosamprenavir|fosamprenavir|mesh-list
92953291|NCT00614991|Raltegravir Potassium|raltegravir potassium|mesh-list
92953292|NCT00614991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92953293|NCT00614991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92953294|NCT00614991|Protease Inhibitors|protease inhibitors|mesh-ancestor
92953295|NCT00614991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953296|NCT00614991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953297|NCT00614991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92953298|NCT00614991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92953299|NCT00614991|Antiviral Agents|antiviral agents|mesh-ancestor
92953300|NCT00614991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953301|NCT00614991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92953302|NCT00614991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92953303|NCT00614991|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92953304|NCT00614991|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92953305|NCT00874575|Vitamin D|vitamin d|mesh-list
92953306|NCT00874575|Ergocalciferols|ergocalciferols|mesh-list
92953307|NCT00874575|Cholecalciferol|cholecalciferol|mesh-list
92953308|NCT00874575|Vitamins|vitamins|mesh-list
92953309|NCT00874575|Micronutrients|micronutrients|mesh-ancestor
92953310|NCT00874575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953311|NCT00874575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92953312|NCT00874575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92953314|NCT03083808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92953315|NCT03083808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953316|NCT03083808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92953317|NCT03083808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953318|NCT00874653|Levonorgestrel|levonorgestrel|mesh-list
92953319|NCT00874653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92953320|NCT00874653|Contraceptive Agents|contraceptive agents|mesh-ancestor
92953321|NCT00874653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92953322|NCT00874653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953323|NCT00874653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92953324|NCT00874653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92953325|NCT00874653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92953326|NCT00369577|Loxapine|loxapine|mesh-list
92953327|NCT00369577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92953328|NCT00369577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953329|NCT00369577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953330|NCT00369577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953331|NCT00369577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953332|NCT00369577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92953333|NCT00369577|Dopamine Agents|dopamine agents|mesh-ancestor
92953334|NCT00369577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953335|NCT00369577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953336|NCT00879957|Heparin|heparin|mesh-list
92953337|NCT00879957|Calcium heparin|calcium heparin|mesh-list
92953338|NCT00879957|Anticoagulants|anticoagulants|mesh-ancestor
92953339|NCT00879957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92953340|NCT00879957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92953341|NCT00879957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953342|NCT00874809|Insulin|insulin|mesh-list
92165352|NCT04648280|Fostemsavir|fostemsavir|mesh-list
92953343|NCT00874809|Insulin, Short-Acting|insulin, short-acting|mesh-list
92953344|NCT00874809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92953345|NCT00874809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953346|NCT04376268|Chlorhexidine|chlorhexidine|mesh-list
92953347|NCT04376268|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92953348|NCT04376268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92953349|NCT04376268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953350|NCT04376268|Disinfectants|disinfectants|mesh-ancestor
92953351|NCT04376268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92953352|NCT00875355|Temozolomide|temozolomide|mesh-list
92953353|NCT00875355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92953354|NCT00875355|Alkylating Agents|alkylating agents|mesh-ancestor
92953355|NCT00875355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953356|NCT00875355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953357|NCT00678288|Interferons|interferons|mesh-list
92953358|NCT00678288|Sorafenib|sorafenib|mesh-list
92953359|NCT00678288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953360|NCT00678288|Antiviral Agents|antiviral agents|mesh-ancestor
92953361|NCT00678288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953362|NCT00678288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953363|NCT00678288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953364|NCT00678288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953365|NCT00880815|Rituximab|rituximab|mesh-list
92953366|NCT00880815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92953367|NCT00880815|Methotrexate|methotrexate|mesh-list
92953368|NCT00880815|Fludarabine|fludarabine|mesh-list
92953369|NCT00880815|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92953370|NCT00880815|Antibodies|antibodies|mesh-list
92953371|NCT00880815|Immunoglobulins|immunoglobulins|mesh-list
92953372|NCT00880815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92953373|NCT00880815|Lenograstim|lenograstim|mesh-list
92953374|NCT00880815|Tacrolimus|tacrolimus|mesh-list
92953375|NCT00880815|Thymoglobulin|thymoglobulin|mesh-list
92953376|NCT00880815|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92953377|NCT00880815|Immunologic Factors|immunologic factors|mesh-ancestor
92953378|NCT00880815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953379|NCT00880815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953380|NCT00880815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92953381|NCT00880815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92953382|NCT00880815|Abortifacient Agents|abortifacient agents|mesh-ancestor
92953383|NCT00880815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92953384|NCT00880815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92953385|NCT00880815|Antimetabolites|antimetabolites|mesh-ancestor
92953386|NCT00880815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953387|NCT00880815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92953388|NCT00880815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953389|NCT00880815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92953390|NCT00880815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92953391|NCT00880815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92953392|NCT00880815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92953393|NCT00880815|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92953394|NCT00880815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92953395|NCT00880815|Alkylating Agents|alkylating agents|mesh-ancestor
92953396|NCT00369343|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92953397|NCT00369343|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92953398|NCT00369343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92953399|NCT00369343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953400|NCT00369343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953401|NCT00369343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953402|NCT00369343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953403|NCT00369343|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953404|NCT00369343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953405|NCT00881049|Imatinib Mesylate|imatinib mesylate|mesh-list
92953406|NCT00881049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953407|NCT00881049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953408|NCT00881049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953409|NCT00881049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953411|NCT00881127|Pseudoephedrine|pseudoephedrine|mesh-list
92953412|NCT00881127|Ephedrine|ephedrine|mesh-list
92953413|NCT00881127|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92953414|NCT00881127|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92953415|NCT00881127|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92953416|NCT00881127|Histamine Antagonists|histamine antagonists|mesh-ancestor
92953417|NCT00881127|Histamine Agents|histamine agents|mesh-ancestor
92953418|NCT00881127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953419|NCT00881127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953420|NCT00881127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953421|NCT00881127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92953422|NCT00881127|Autonomic Agents|autonomic agents|mesh-ancestor
92953423|NCT00881127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953424|NCT00881127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92953425|NCT00881127|Respiratory System Agents|respiratory system agents|mesh-ancestor
92953426|NCT00881127|Nasal Decongestants|nasal decongestants|mesh-ancestor
92953427|NCT00881127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92953428|NCT00881127|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92953429|NCT00881127|Sympathomimetics|sympathomimetics|mesh-ancestor
92953430|NCT00881127|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953431|NCT00369265|Lansoprazole|lansoprazole|mesh-list
92953432|NCT00369265|Dexlansoprazole|dexlansoprazole|mesh-list
92953433|NCT00369265|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92953434|NCT00369265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92953435|NCT00369265|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92953436|NCT00369265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953437|NCT00369265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953438|NCT00875745|Sorafenib|sorafenib|mesh-list
92953439|NCT00875745|Vorinostat|vorinostat|mesh-list
92953440|NCT00875745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953441|NCT00875745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953442|NCT00875745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953443|NCT00875745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953444|NCT00875745|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92953445|NCT00368875|Paclitaxel|paclitaxel|mesh-list
92953446|NCT00368875|Bevacizumab|bevacizumab|mesh-list
92953447|NCT00368875|Vorinostat|vorinostat|mesh-list
92953448|NCT00368875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92953449|NCT00368875|Antibodies|antibodies|mesh-list
92953450|NCT00368875|Immunoglobulins|immunoglobulins|mesh-list
92953451|NCT00368875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92953452|NCT00368875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92953453|NCT00368875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953454|NCT00368875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92953455|NCT00368875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92953456|NCT00368875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92953457|NCT00368875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953458|NCT00368875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92953459|NCT00368875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953460|NCT00368875|Growth Substances|growth substances|mesh-ancestor
92953461|NCT00368875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953462|NCT00368875|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953463|NCT00368875|Immunologic Factors|immunologic factors|mesh-ancestor
92953464|NCT00368875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92953465|NCT00368875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953466|NCT00614055|Insulin|insulin|mesh-list
92953467|NCT00614055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92953468|NCT00614055|Metformin|metformin|mesh-list
92953469|NCT00614055|Insulin Glargine|insulin glargine|mesh-list
92953470|NCT00614055|Insulin Aspart|insulin aspart|mesh-list
92953471|NCT00614055|Insulin, Long-Acting|insulin, long-acting|mesh-list
92953472|NCT00614055|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92953473|NCT00614055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92953474|NCT00614055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953475|NCT00613821|Lidocaine|lidocaine|mesh-list
92953476|NCT00613821|Anesthetics, Local|anesthetics, local|mesh-ancestor
92953477|NCT00613821|Anesthetics|anesthetics|mesh-ancestor
92953478|NCT00613821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953479|NCT00613821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953480|NCT00613821|Sensory System Agents|sensory system agents|mesh-ancestor
92953481|NCT00613821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953482|NCT00613821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598917|NCT00452725|Hormones|hormones|mesh-list
92953483|NCT00613821|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92953484|NCT00613821|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92953485|NCT00613821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953486|NCT00613821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953487|NCT00882765|Genistein|genistein|mesh-list
92953488|NCT00882765|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92953489|NCT00882765|Protective Agents|protective agents|mesh-ancestor
92953490|NCT00882765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953491|NCT00882765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953492|NCT00882765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953493|NCT00882765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953494|NCT00882765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953495|NCT00882765|Phytoestrogens|phytoestrogens|mesh-ancestor
92953496|NCT00882765|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92953497|NCT00882765|Estrogens|estrogens|mesh-ancestor
92953498|NCT00882765|Hormones|hormones|mesh-ancestor
92953499|NCT00882765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953500|NCT00548548|Bevacizumab|bevacizumab|mesh-list
92953501|NCT00548548|Fluorouracil|fluorouracil|mesh-list
92953502|NCT00548548|Capecitabine|capecitabine|mesh-list
92953503|NCT00548548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92953504|NCT00548548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953505|NCT00548548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92953506|NCT00548548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953507|NCT00548548|Growth Substances|growth substances|mesh-ancestor
92953508|NCT00548548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953509|NCT00548548|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953510|NCT00548548|Antimetabolites|antimetabolites|mesh-ancestor
92953511|NCT00548548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953512|NCT00548548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92953513|NCT00548548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92953514|NCT00548548|Immunologic Factors|immunologic factors|mesh-ancestor
92953515|NCT00613509|Interferons|interferons|mesh-list
92953516|NCT00613509|Interferon-alpha|interferon-alpha|mesh-list
92953517|NCT00613509|Vaccines|vaccines|mesh-list
92953518|NCT00613509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953519|NCT00613509|Antiviral Agents|antiviral agents|mesh-ancestor
92953520|NCT00613509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953521|NCT00613509|Immunologic Factors|immunologic factors|mesh-ancestor
92527425|NCT00000620|Insulin|insulin|mesh-list
92953522|NCT00613509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953523|NCT00881517|Immunoglobulins|immunoglobulins|mesh-list
92953524|NCT00881517|Immunologic Factors|immunologic factors|mesh-ancestor
92953525|NCT00881517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953526|NCT00881595|Temozolomide|temozolomide|mesh-list
92953527|NCT00881595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92953528|NCT00881595|Alkylating Agents|alkylating agents|mesh-ancestor
92953529|NCT00881595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953530|NCT00881595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953531|NCT00883155|Bupropion|bupropion|mesh-list
92953532|NCT00883155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92953533|NCT00883155|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953534|NCT00883155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953535|NCT00883155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92953536|NCT00883155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92953537|NCT00883155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953538|NCT00883155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953539|NCT00883155|Dopamine Agents|dopamine agents|mesh-ancestor
92953540|NCT00883155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953541|NCT00883155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953542|NCT00883155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92953543|NCT00883155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92953544|NCT00883155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953545|NCT00881673|Dexamethasone|dexamethasone|mesh-list
92953546|NCT00881673|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92953547|NCT00881673|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92953548|NCT00881673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92953549|NCT00881673|Antiemetics|antiemetics|mesh-ancestor
92953550|NCT00881673|Autonomic Agents|autonomic agents|mesh-ancestor
92953551|NCT00881673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953552|NCT00881673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953553|NCT00881673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92953554|NCT00881673|Glucocorticoids|glucocorticoids|mesh-ancestor
92953555|NCT00881673|Hormones|hormones|mesh-ancestor
92953556|NCT00881673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953557|NCT00881673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92598989|NCT00453115|Gemcitabine|gemcitabine|mesh-list
92953558|NCT00881673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953560|NCT04638465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953561|NCT00881907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92953562|NCT00881907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92953563|NCT00881907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953564|NCT00881907|Antitubercular Agents|antitubercular agents|mesh-ancestor
92953565|NCT04487925|Hormones|hormones|mesh-list
92953566|NCT04487925|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92953567|NCT04487925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953568|NCT04487925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953569|NCT00547300|Metoprolol|metoprolol|mesh-list
92953570|NCT00547300|Nebivolol|nebivolol|mesh-list
92953571|NCT00547300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92953572|NCT00547300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953573|NCT00547300|Sympatholytics|sympatholytics|mesh-ancestor
92953574|NCT00547300|Autonomic Agents|autonomic agents|mesh-ancestor
92953575|NCT00547300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953576|NCT00547300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953577|NCT00547300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92953578|NCT00547300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92953579|NCT00547300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92953580|NCT00547300|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953581|NCT00547300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953582|NCT00547300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953583|NCT00547300|Vasodilator Agents|vasodilator agents|mesh-ancestor
92953584|NCT00547300|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92953585|NCT00547300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92953586|NCT00547300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92953587|NCT00612807|Tranylcypromine|tranylcypromine|mesh-list
92953588|NCT00612807|Bupropion|bupropion|mesh-list
92953589|NCT00612807|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92953590|NCT00612807|Sertraline|sertraline|mesh-list
92953591|NCT00612807|Nortriptyline|nortriptyline|mesh-list
92953592|NCT00612807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92953593|NCT00612807|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953594|NCT00612807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953595|NCT00612807|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92953596|NCT00612807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92953597|NCT00612807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953598|NCT00612807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953599|NCT00612807|Dopamine Agents|dopamine agents|mesh-ancestor
92953600|NCT00612807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953601|NCT00612807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953602|NCT00612807|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92953603|NCT00612807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92953604|NCT00612807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953605|NCT00612807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92953606|NCT00612807|Serotonin Agents|serotonin agents|mesh-ancestor
92953607|NCT00612807|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953608|NCT00612807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953609|NCT00612807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92953610|NCT00612807|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92953611|NCT00612807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92953612|NCT00612807|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953613|NCT00612807|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92953614|NCT00612807|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92953615|NCT00958750|Minoxidil|minoxidil|mesh-list
92953616|NCT00958750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953617|NCT00958750|Vasodilator Agents|vasodilator agents|mesh-ancestor
92953618|NCT00958906|Infliximab|infliximab|mesh-list
92953619|NCT00958906|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92953620|NCT00958906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92953621|NCT00958906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92953622|NCT00958906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92953623|NCT00958906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92953624|NCT00959062|Clonidine|clonidine|mesh-list
92953625|NCT00959062|Analgesics|analgesics|mesh-ancestor
92953626|NCT00959062|Sensory System Agents|sensory system agents|mesh-ancestor
92953627|NCT00959062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165365|NCT04601961|Propofol|propofol|mesh-list
92953628|NCT00959062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953629|NCT00959062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953630|NCT00959062|Sympatholytics|sympatholytics|mesh-ancestor
92953631|NCT00959062|Autonomic Agents|autonomic agents|mesh-ancestor
92953632|NCT00959062|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92953633|NCT00959062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92953634|NCT00959062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92953635|NCT00959062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953636|NCT00959062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953637|NCT00959062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953638|NCT04038411|Etoposide|etoposide|mesh-list
92953639|NCT04038411|Lenalidomide|lenalidomide|mesh-list
92953640|NCT04038411|Antibodies|antibodies|mesh-list
92953641|NCT04038411|Immunologic Factors|immunologic factors|mesh-ancestor
92953642|NCT04038411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953643|NCT04038411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92953644|NCT04038411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953645|NCT04038411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92953646|NCT04038411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92953647|NCT04038411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953648|NCT04038411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953649|NCT04038411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92953650|NCT04038411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953651|NCT04038411|Growth Substances|growth substances|mesh-ancestor
92953652|NCT04038411|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953653|NCT00882375|Nicotine|nicotine|mesh-list
92953654|NCT00882375|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92953655|NCT00882375|Autonomic Agents|autonomic agents|mesh-ancestor
92953656|NCT00882375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953657|NCT00882375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953658|NCT00882375|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92953659|NCT00882375|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92953660|NCT00882375|Cholinergic Agents|cholinergic agents|mesh-ancestor
92953661|NCT00882375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953662|NCT00882375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953663|NCT00882453|Interferons|interferons|mesh-list
92953664|NCT00882453|Interferon-beta|interferon-beta|mesh-list
92953665|NCT00882453|Interferon beta-1b|interferon beta-1b|mesh-list
92953666|NCT00882453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953667|NCT00882453|Antiviral Agents|antiviral agents|mesh-ancestor
92953668|NCT00882453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953669|NCT00882453|Immunologic Factors|immunologic factors|mesh-ancestor
92953670|NCT00882453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953671|NCT00882453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92953672|NCT00882531|Isotretinoin|isotretinoin|mesh-list
92953673|NCT00882531|Dermatologic Agents|dermatologic agents|mesh-ancestor
92953674|NCT00963274|Bortezomib|bortezomib|mesh-list
92953675|NCT00963274|Romidepsin|romidepsin|mesh-list
92953676|NCT00963274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953677|NCT00963274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92953678|NCT00963274|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92953679|NCT00963274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953680|NCT00963274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953681|NCT00882609|Fluorides|fluorides|mesh-list
92953682|NCT00882609|Cariostatic Agents|cariostatic agents|mesh-ancestor
92953683|NCT00882609|Protective Agents|protective agents|mesh-ancestor
92953684|NCT00882609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953685|NCT00883623|Lenalidomide|lenalidomide|mesh-list
92953686|NCT00883623|Immunologic Factors|immunologic factors|mesh-ancestor
92953687|NCT00883623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953688|NCT00883623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92953689|NCT00883623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953690|NCT00883623|Growth Substances|growth substances|mesh-ancestor
92953691|NCT00883623|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953692|NCT00883623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953693|NCT00959218|Dronabinol|dronabinol|mesh-list
92953694|NCT00959218|Hallucinogens|hallucinogens|mesh-ancestor
92953695|NCT00959218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953696|NCT00959218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953697|NCT00959218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92953698|NCT00959218|Analgesics|analgesics|mesh-ancestor
92953699|NCT00959218|Sensory System Agents|sensory system agents|mesh-ancestor
92953700|NCT00959218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953701|NCT00959218|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92953702|NCT00959218|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92953703|NCT00959218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953704|NCT00959218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953705|NCT00959218|Hormones|hormones|mesh-ancestor
92953706|NCT00959218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953707|NCT00678210|Tofacitinib|tofacitinib|mesh-list
92953708|NCT00678210|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92953709|NCT00678210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953710|NCT00678210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953711|NCT00678210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953712|NCT00611715|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92953713|NCT00611715|Letrozole|letrozole|mesh-list
92953714|NCT00611715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953715|NCT00611715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953716|NCT00611715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953717|NCT00611715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953718|NCT00611715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92953719|NCT00611715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92953720|NCT00611715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92953721|NCT00611715|Hormone Antagonists|hormone antagonists|mesh-ancestor
92953722|NCT00611715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953723|NCT00611715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953724|NCT04722718|Paclitaxel|paclitaxel|mesh-list
92953725|NCT04722718|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92953726|NCT04722718|Carboplatin|carboplatin|mesh-list
92953727|NCT04722718|Apatinib|apatinib|mesh-list
92953728|NCT04722718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92953729|NCT04722718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953730|NCT04722718|Tubulin Modulators|tubulin modulators|mesh-ancestor
92953731|NCT04722718|Antimitotic Agents|antimitotic agents|mesh-ancestor
92953732|NCT04722718|Mitosis Modulators|mitosis modulators|mesh-ancestor
92953733|NCT04722718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953734|NCT04722718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92953735|NCT04722718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953736|NCT00761670|Risperidone|risperidone|mesh-list
92953737|NCT00761670|Amisulpride|amisulpride|mesh-list
92953738|NCT00761670|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92953739|NCT00761670|Serotonin Agents|serotonin agents|mesh-ancestor
92953740|NCT00761670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527440|NCT00000620|Valsartan|valsartan|mesh-list
92953741|NCT00761670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953742|NCT00761670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953743|NCT00761670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92953744|NCT00761670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953745|NCT00761670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953746|NCT00761670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953747|NCT00761670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92953748|NCT00761670|Dopamine Agents|dopamine agents|mesh-ancestor
92953749|NCT00761670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92953750|NCT00761670|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953751|NCT00963664|Interferons|interferons|mesh-list
92953752|NCT00963664|Interferon-alpha|interferon-alpha|mesh-list
92953753|NCT00963664|Interferon alpha-2|interferon alpha-2|mesh-list
92953754|NCT00963664|Lovastatin|lovastatin|mesh-list
92953755|NCT00963664|L 647318|l 647318|mesh-list
92953756|NCT00963664|Dihydromevinolin|dihydromevinolin|mesh-list
92953757|NCT00963664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953758|NCT00963664|Antiviral Agents|antiviral agents|mesh-ancestor
92953759|NCT00963664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953760|NCT00963664|Immunologic Factors|immunologic factors|mesh-ancestor
92953761|NCT00963664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953762|NCT00963664|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92953763|NCT00963664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92953764|NCT00963664|Antimetabolites|antimetabolites|mesh-ancestor
92953765|NCT00963664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953766|NCT00963664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92953767|NCT00963664|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92953768|NCT00963664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953769|NCT00611559|PENTA|penta|mesh-list
92953770|NCT00611559|Anticoagulants|anticoagulants|mesh-ancestor
92953771|NCT00611559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92953772|NCT00611559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92953773|NCT00611559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953774|NCT00761904|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92953775|NCT00761904|Simvastatin|simvastatin|mesh-list
92953776|NCT00761904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92953777|NCT00761904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92953778|NCT00761904|Antimetabolites|antimetabolites|mesh-ancestor
92953779|NCT00761904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953780|NCT00761904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92953781|NCT00761904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92953782|NCT00761904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953783|NCT00761904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953784|NCT00761904|Diuretics|diuretics|mesh-ancestor
92953785|NCT00761904|Natriuretic Agents|natriuretic agents|mesh-ancestor
92953786|NCT00761904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953787|NCT00761904|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92953788|NCT00761904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92953789|NCT00963976|Enalapril|enalapril|mesh-list
92953790|NCT00963976|Labetalol|labetalol|mesh-list
92953791|NCT00963976|Hydralazine|hydralazine|mesh-list
92953792|NCT00963976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92953793|NCT00963976|Protease Inhibitors|protease inhibitors|mesh-ancestor
92953794|NCT00963976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953795|NCT00963976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953796|NCT00963976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953797|NCT00963976|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92953798|NCT00963976|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92953799|NCT00963976|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953800|NCT00963976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953801|NCT00963976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953802|NCT00963976|Sympathomimetics|sympathomimetics|mesh-ancestor
92953803|NCT00963976|Autonomic Agents|autonomic agents|mesh-ancestor
92953804|NCT00963976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953805|NCT00963976|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92953806|NCT00963976|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92953807|NCT00963976|Vasodilator Agents|vasodilator agents|mesh-ancestor
92953808|NCT02558868|Oxaliplatin|oxaliplatin|mesh-list
92953809|NCT02558868|Irinotecan|irinotecan|mesh-list
92953810|NCT02558868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953811|NCT02558868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92953812|NCT02558868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92953813|NCT02558868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953814|NCT02558868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953815|NCT00611247|Temozolomide|temozolomide|mesh-list
92953816|NCT00611247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92953818|NCT00611247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953819|NCT00611247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953820|NCT00883935|Ritonavir|ritonavir|mesh-list
92953821|NCT00883935|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92953822|NCT00883935|Dolutegravir|dolutegravir|mesh-list
92953823|NCT00883935|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92953824|NCT00883935|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92953825|NCT00883935|Protease Inhibitors|protease inhibitors|mesh-ancestor
92953826|NCT00883935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953827|NCT00883935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953828|NCT00883935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92953829|NCT00883935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92953830|NCT00883935|Antiviral Agents|antiviral agents|mesh-ancestor
92953831|NCT00883935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953832|NCT00883935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92953833|NCT00883935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92953834|NCT00883935|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92953835|NCT00883935|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92953836|NCT00675948|Nabiximols|nabiximols|mesh-list
92953837|NCT00675948|Analgesics|analgesics|mesh-ancestor
92953838|NCT00675948|Sensory System Agents|sensory system agents|mesh-ancestor
92953839|NCT00675948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953840|NCT00675948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953841|NCT00885885|Panitumumab|panitumumab|mesh-list
92953842|NCT00885885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92953843|NCT00885885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953844|NCT00610935|Peramivir|peramivir|mesh-list
92953845|NCT00610935|Antiviral Agents|antiviral agents|mesh-ancestor
92165372|NCT04601961|Anesthetics|anesthetics|mesh-ancestor
92953846|NCT00610935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953847|NCT00610935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953848|NCT00610935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953849|NCT02303028|Topotecan|topotecan|mesh-list
92953850|NCT02303028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92953851|NCT02303028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92953852|NCT02303028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953853|NCT02303028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953854|NCT02303028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953855|NCT02287818|Febuxostat|febuxostat|mesh-list
92953856|NCT02287818|Gout Suppressants|gout suppressants|mesh-ancestor
92953857|NCT02287818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92953858|NCT00762060|Anesthetics|anesthetics|mesh-list
92953860|NCT00762060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953861|NCT00762060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953862|NCT00762060|Sensory System Agents|sensory system agents|mesh-ancestor
92953863|NCT00762060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953864|NCT00610857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92953865|NCT00610857|Antibodies|antibodies|mesh-list
92953866|NCT00610857|Immunoglobulins|immunoglobulins|mesh-list
92953867|NCT00610857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92953868|NCT00610857|Immunologic Factors|immunologic factors|mesh-ancestor
92953869|NCT00610857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953870|NCT00610857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953871|NCT00672984|Moxifloxacin|moxifloxacin|mesh-list
92953872|NCT00672984|Guanfacine|guanfacine|mesh-list
92953873|NCT00672984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92953874|NCT00672984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953875|NCT00672984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92953876|NCT00672984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92953877|NCT00672984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92953878|NCT00672984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953879|NCT00672984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953880|NCT00672984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953881|NCT00672984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92953882|NCT00672984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92953883|NCT00672984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92953884|NCT00672984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92953885|NCT00672984|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953886|NCT00672984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953887|NCT02543697|Epinephrine|epinephrine|mesh-list
92953888|NCT02543697|Racepinephrine|racepinephrine|mesh-list
92953889|NCT02543697|Epinephryl borate|epinephryl borate|mesh-list
92953890|NCT02543697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92953891|NCT02543697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92953892|NCT02543697|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953893|NCT02543697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953894|NCT02543697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953895|NCT02543697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953896|NCT02543697|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92953897|NCT02543697|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92953898|NCT02543697|Autonomic Agents|autonomic agents|mesh-ancestor
92953899|NCT02543697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953900|NCT02543697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92953901|NCT02543697|Respiratory System Agents|respiratory system agents|mesh-ancestor
92953902|NCT02543697|Mydriatics|mydriatics|mesh-ancestor
92953903|NCT02543697|Sympathomimetics|sympathomimetics|mesh-ancestor
92953904|NCT02543697|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92953905|NCT00886275|Midazolam|midazolam|mesh-list
92953906|NCT00886275|Dexmedetomidine|dexmedetomidine|mesh-list
92953907|NCT00886275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92953908|NCT00886275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953909|NCT00886275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953910|NCT00886275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92953911|NCT00886275|Analgesics|analgesics|mesh-ancestor
92953912|NCT00886275|Sensory System Agents|sensory system agents|mesh-ancestor
92953913|NCT00886275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953914|NCT00886275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92953915|NCT00886275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92953916|NCT00886275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92953917|NCT00886275|Adrenergic Agents|adrenergic agents|mesh-ancestor
92953918|NCT00886275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165376|NCT04551430|Ipilimumab|ipilimumab|mesh-list
92953919|NCT00886275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953920|NCT00886275|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92953921|NCT00886275|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92953922|NCT00886275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92953923|NCT00886275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953924|NCT00886275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92953925|NCT00886275|Anesthetics, General|anesthetics, general|mesh-ancestor
92953926|NCT00886275|Anesthetics|anesthetics|mesh-ancestor
92953927|NCT00886275|GABA Modulators|gaba modulators|mesh-ancestor
92953928|NCT00886275|GABA Agents|gaba agents|mesh-ancestor
92953929|NCT04017897|Pembrolizumab|pembrolizumab|mesh-list
92953930|NCT04017897|Nivolumab|nivolumab|mesh-list
92953931|NCT04017897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92953932|NCT04017897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953933|NCT04017897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92953934|NCT04017897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953935|NCT02542137|Thymalfasin|thymalfasin|mesh-list
92953936|NCT02542137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92953937|NCT02542137|Immunologic Factors|immunologic factors|mesh-ancestor
92953938|NCT02542137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953939|NCT00886509|Lenograstim|lenograstim|mesh-list
92953940|NCT00886509|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92953941|NCT00886509|Immunologic Factors|immunologic factors|mesh-ancestor
92953942|NCT00886509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953943|NCT02543385|Ketamine|ketamine|mesh-list
92953944|NCT02543385|Esketamine|esketamine|mesh-list
92953945|NCT02543385|Analgesics|analgesics|mesh-ancestor
92953946|NCT02543385|Sensory System Agents|sensory system agents|mesh-ancestor
92953947|NCT02543385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92953948|NCT02543385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953949|NCT02543385|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92953950|NCT02543385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92953951|NCT02543385|Anesthetics, General|anesthetics, general|mesh-ancestor
92953952|NCT02543385|Anesthetics|anesthetics|mesh-ancestor
92953953|NCT02543385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953954|NCT02543385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92953955|NCT02543385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92953956|NCT02543385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92953957|NCT02543385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953958|NCT02543385|Antidepressive Agents|antidepressive agents|mesh-ancestor
92953959|NCT02543385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92953960|NCT00884481|Natalizumab|natalizumab|mesh-list
92953961|NCT00884481|Immunologic Factors|immunologic factors|mesh-ancestor
92953962|NCT00884481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953963|NCT02543229|Ranibizumab|ranibizumab|mesh-list
92953964|NCT02543229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92953965|NCT02543229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92953967|NCT02543229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953968|NCT02543229|Growth Inhibitors|growth inhibitors|mesh-ancestor
92953969|NCT02543229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953970|NCT02543073|Glucocorticoids|glucocorticoids|mesh-list
92953971|NCT02543073|Hormones|hormones|mesh-ancestor
92953972|NCT02543073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92953973|NCT02543073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953974|NCT00546364|Docetaxel|docetaxel|mesh-list
92953975|NCT00546364|Capecitabine|capecitabine|mesh-list
92953976|NCT00546364|Epothilones|epothilones|mesh-list
92953977|NCT00546364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953978|NCT00546364|Tubulin Modulators|tubulin modulators|mesh-ancestor
92953979|NCT00546364|Antimitotic Agents|antimitotic agents|mesh-ancestor
92953980|NCT00546364|Mitosis Modulators|mitosis modulators|mesh-ancestor
92953981|NCT00546364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92953982|NCT00546364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92953983|NCT00546364|Antimetabolites|antimetabolites|mesh-ancestor
92953984|NCT00887211|Sirolimus|sirolimus|mesh-list
92953985|NCT00887211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92953986|NCT00887211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953987|NCT00887211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92953988|NCT00887211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92953989|NCT00887211|Antifungal Agents|antifungal agents|mesh-ancestor
92953990|NCT00887211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92953991|NCT00887211|Immunologic Factors|immunologic factors|mesh-ancestor
92953992|NCT00887211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953993|NCT00887367|Ethanol|ethanol|mesh-list
92953994|NCT00887367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92953995|NCT00887367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92953996|NCT00887367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92953997|NCT00887367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92953998|NCT00964288|Lidocaine|lidocaine|mesh-list
92953999|NCT00964288|Anesthetics, Local|anesthetics, local|mesh-ancestor
92954000|NCT00964288|Anesthetics|anesthetics|mesh-ancestor
92954001|NCT00964288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954002|NCT00964288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954003|NCT00964288|Sensory System Agents|sensory system agents|mesh-ancestor
92954004|NCT00964288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954005|NCT00964288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92954006|NCT00964288|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92954007|NCT00964288|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92954008|NCT00964288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92954009|NCT00964288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954011|NCT05955040|Nifedipine|nifedipine|mesh-list
92954012|NCT05955040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92954013|NCT05955040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92954014|NCT05955040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954015|NCT05955040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92954016|NCT05955040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954017|NCT05955040|Vasodilator Agents|vasodilator agents|mesh-ancestor
92954018|NCT05955040|Tocolytic Agents|tocolytic agents|mesh-ancestor
92954019|NCT05955040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954020|NCT05955040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92954021|NCT05955040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92954022|NCT05955040|Adrenergic Agents|adrenergic agents|mesh-ancestor
92954023|NCT05955040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954024|NCT05955040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92954025|NCT05955040|Sympathomimetics|sympathomimetics|mesh-ancestor
92954026|NCT05955040|Autonomic Agents|autonomic agents|mesh-ancestor
92954027|NCT05955040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954028|NCT05955040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92954029|NCT05955040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92954030|NCT05955001|Tadalafil|tadalafil|mesh-list
92954031|NCT05955001|Vasodilator Agents|vasodilator agents|mesh-ancestor
92954032|NCT05955001|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92954033|NCT05955001|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92954034|NCT05955001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954035|NCT05955001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954036|NCT05955001|Urological Agents|urological agents|mesh-ancestor
92954037|NCT05954962|Progesterone|progesterone|mesh-list
92954038|NCT05954962|Ganirelix|ganirelix|mesh-list
92954039|NCT05954962|Progestins|progestins|mesh-ancestor
92954040|NCT05954962|Hormones|hormones|mesh-ancestor
92954041|NCT05954962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954042|NCT05954962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954043|NCT05954962|Hormone Antagonists|hormone antagonists|mesh-ancestor
92954044|NCT05954910|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92954045|NCT05954910|Immunoconjugates|immunoconjugates|mesh-ancestor
92954046|NCT05954910|Immunologic Factors|immunologic factors|mesh-ancestor
92954047|NCT05954910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954049|NCT05954897|Tislelizumab|tislelizumab|mesh-list
92954050|NCT05954897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954051|NCT05954897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954052|NCT05954897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954053|NCT05954897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954054|NCT05954897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954055|NCT05954871|Cetuximab|cetuximab|mesh-list
92954056|NCT05954871|Osimertinib|osimertinib|mesh-list
92954057|NCT05954871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954058|NCT05954871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954059|NCT05954871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954060|NCT05954871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954061|NCT05954871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954062|NCT05954806|Antivenins|antivenins|mesh-list
92954063|NCT05954806|Immunologic Factors|immunologic factors|mesh-ancestor
92954064|NCT05954806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954065|NCT05954624|Itraconazole|itraconazole|mesh-list
92954066|NCT05954624|Probenecid|probenecid|mesh-list
92954067|NCT05954624|Digoxin|digoxin|mesh-list
92954068|NCT05954624|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92954069|NCT05954624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92954070|NCT05954624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92954071|NCT05954624|Antimetabolites|antimetabolites|mesh-ancestor
92954072|NCT05954624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954073|NCT05954624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92954074|NCT05954624|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92954075|NCT05954624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954076|NCT05954624|Antifungal Agents|antifungal agents|mesh-ancestor
92954077|NCT05954624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954078|NCT05954624|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92954079|NCT05954624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92954080|NCT05954624|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92599512|NCT00457054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92954081|NCT05954624|Hormone Antagonists|hormone antagonists|mesh-ancestor
92954082|NCT05954624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954083|NCT05954624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954084|NCT05954624|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92954085|NCT05954624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92954086|NCT05954624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92954087|NCT05954624|Protective Agents|protective agents|mesh-ancestor
92954088|NCT05954624|Uricosuric Agents|uricosuric agents|mesh-ancestor
92954089|NCT05954624|Gout Suppressants|gout suppressants|mesh-ancestor
92954090|NCT05954624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954092|NCT05954143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954093|NCT05954143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954094|NCT05954078|Leucovorin|leucovorin|mesh-list
92954095|NCT05954078|Fluorouracil|fluorouracil|mesh-list
92954096|NCT05954078|Oxaliplatin|oxaliplatin|mesh-list
92954097|NCT05954078|Irinotecan|irinotecan|mesh-list
92954098|NCT05954078|Levoleucovorin|levoleucovorin|mesh-list
92954099|NCT05954078|Antimetabolites|antimetabolites|mesh-ancestor
92954100|NCT05954078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954101|NCT05954078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92954102|NCT05954078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954103|NCT05954078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954104|NCT05954078|Immunologic Factors|immunologic factors|mesh-ancestor
92954105|NCT05954078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954106|NCT05954078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92954107|NCT05954078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92954108|NCT05954078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954109|NCT05954078|Antidotes|antidotes|mesh-ancestor
92954110|NCT05954078|Protective Agents|protective agents|mesh-ancestor
92954111|NCT05954078|Vitamin B Complex|vitamin b complex|mesh-ancestor
92954112|NCT05954078|Vitamins|vitamins|mesh-ancestor
92954113|NCT05954078|Micronutrients|micronutrients|mesh-ancestor
92954114|NCT05953909|Paclitaxel|paclitaxel|mesh-list
92954115|NCT05953909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954116|NCT05953909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954117|NCT05953909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92954118|NCT05953909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954119|NCT05953909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954120|NCT05953909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954121|NCT05953896|Hyaluronic Acid|hyaluronic acid|mesh-list
92954122|NCT05953896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92954123|NCT05953896|Immunologic Factors|immunologic factors|mesh-ancestor
92954124|NCT05953896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954125|NCT05953896|Viscosupplements|viscosupplements|mesh-ancestor
92954126|NCT05953896|Protective Agents|protective agents|mesh-ancestor
92954127|NCT05953714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92954128|NCT05953714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954129|NCT05953675|Ethanol|ethanol|mesh-list
92954130|NCT05953675|Heparin|heparin|mesh-list
92954131|NCT05953675|Anticoagulants|anticoagulants|mesh-ancestor
92954132|NCT05953675|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92954133|NCT05953675|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92954134|NCT05953675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954135|NCT05953675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92954136|NCT05953675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954137|NCT05953675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954138|NCT05953675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954139|NCT05953610|Acetazolamide|acetazolamide|mesh-list
92954140|NCT05953610|Eszopiclone|eszopiclone|mesh-list
92954141|NCT05953610|Anticonvulsants|anticonvulsants|mesh-ancestor
92954142|NCT05953610|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92954143|NCT05953610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954144|NCT05953610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954145|NCT05953610|Diuretics|diuretics|mesh-ancestor
92954146|NCT05953610|Natriuretic Agents|natriuretic agents|mesh-ancestor
92954147|NCT05953610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954148|NCT05953610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92954149|NCT05953610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954150|NCT05953584|Hydroxyurea|hydroxyurea|mesh-list
92954151|NCT05953584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954152|NCT05953584|Antisickling Agents|antisickling agents|mesh-ancestor
92954153|NCT05953584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954154|NCT05953584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954155|NCT05953584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92954156|NCT05953428|Analgesics, Opioid|analgesics, opioid|mesh-list
92954157|NCT05953428|Anesthetics|anesthetics|mesh-list
92954158|NCT05953428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954159|NCT05953428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954160|NCT05953428|Narcotics|narcotics|mesh-ancestor
92954161|NCT05953428|Analgesics|analgesics|mesh-ancestor
92954162|NCT05953428|Sensory System Agents|sensory system agents|mesh-ancestor
92954163|NCT05953428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954164|NCT05953376|Calcium, Dietary|calcium, dietary|mesh-list
92954165|NCT05953376|Calcium|calcium|mesh-list
92954166|NCT05953376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92954167|NCT05953376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954168|NCT05953376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92954169|NCT05953350|Hydroxychloroquine|hydroxychloroquine|mesh-list
92954170|NCT05953350|Palbociclib|palbociclib|mesh-list
92954171|NCT05953350|Antimalarials|antimalarials|mesh-ancestor
92954172|NCT05953350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92954173|NCT05953350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92954174|NCT05953350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954175|NCT05953350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954176|NCT05953350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954177|NCT05953350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954178|NCT05953350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954179|NCT05953350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954180|NCT05950802|Cyclophosphamide|cyclophosphamide|mesh-list
92954181|NCT05950802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954182|NCT05950802|Immunologic Factors|immunologic factors|mesh-ancestor
92954183|NCT05950802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954184|NCT05950802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954185|NCT05950802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92954186|NCT05950802|Alkylating Agents|alkylating agents|mesh-ancestor
92954187|NCT05950802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954188|NCT05950802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954189|NCT05950802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92954190|NCT05946941|Deucravacitinib|deucravacitinib|mesh-list
92954191|NCT05946941|Dermatologic Agents|dermatologic agents|mesh-ancestor
92954192|NCT05946941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954193|NCT05946941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954194|NCT05946941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954195|NCT05938608|Primaquine|primaquine|mesh-list
92954196|NCT05938608|Antimalarials|antimalarials|mesh-ancestor
92954197|NCT05938608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92954198|NCT05938608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92954199|NCT05938608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954200|NCT05928312|Oxaliplatin|oxaliplatin|mesh-list
92954201|NCT05928312|Irinotecan|irinotecan|mesh-list
92954202|NCT05928312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954203|NCT05928312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92954204|NCT05928312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92954205|NCT05928312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954206|NCT05928312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954207|NCT05921760|Nivolumab|nivolumab|mesh-list
92954208|NCT05921760|Ipilimumab|ipilimumab|mesh-list
92954209|NCT05921760|Ivosidenib|ivosidenib|mesh-list
92954210|NCT05921760|Glycine|glycine|mesh-list
92954211|NCT05921760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954212|NCT05921760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954213|NCT05921760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954214|NCT05921760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954215|NCT05921760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954216|NCT05921760|Glycine Agents|glycine agents|mesh-ancestor
92954217|NCT05921760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954218|NCT05921760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954219|NCT05919147|Pioglitazone|pioglitazone|mesh-list
92954220|NCT05919147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92954221|NCT05919147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954222|NCT05919030|Paclitaxel|paclitaxel|mesh-list
92954223|NCT05919030|Tislelizumab|tislelizumab|mesh-list
92954224|NCT05919030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954225|NCT05919030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954226|NCT05919030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92954227|NCT05919030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954228|NCT05919030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954229|NCT05919030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954230|NCT05919030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954231|NCT05917509|Rilpivirine|rilpivirine|mesh-list
92954232|NCT05917509|Cabotegravir|cabotegravir|mesh-list
92954233|NCT05917509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92954234|NCT05917509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92954236|NCT05917509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954237|NCT05917509|Antiviral Agents|antiviral agents|mesh-ancestor
92954238|NCT05917509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954239|NCT05917509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92954240|NCT05917509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92954241|NCT05917509|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92954242|NCT05917509|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92954243|NCT05908786|Bevacizumab|bevacizumab|mesh-list
92954244|NCT05908786|Atezolizumab|atezolizumab|mesh-list
92954245|NCT05908786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954246|NCT05908786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954247|NCT05908786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92954248|NCT05908786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92954249|NCT05908786|Growth Substances|growth substances|mesh-ancestor
92954250|NCT05908786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954251|NCT05908786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92954252|NCT05908786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954253|NCT05908786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954254|NCT05908734|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92954255|NCT05908734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954256|NCT05908734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954257|NCT05895201|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92954258|NCT05895201|Cyclophosphamide|cyclophosphamide|mesh-list
92954259|NCT05895201|Bortezomib|bortezomib|mesh-list
92954260|NCT05895201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954261|NCT05895201|Immunologic Factors|immunologic factors|mesh-ancestor
92954262|NCT05895201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954263|NCT05895201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954264|NCT05895201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92954265|NCT05895201|Alkylating Agents|alkylating agents|mesh-ancestor
92954266|NCT05895201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954267|NCT05895201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954268|NCT05895201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92954269|NCT05895201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92954270|NCT05895201|Incretins|incretins|mesh-ancestor
92954271|NCT05895201|Hormones|hormones|mesh-ancestor
92954272|NCT05895201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954273|NCT05895201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92954274|NCT05895201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92954275|NCT05895201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954276|NCT05890027|Phenylephrine|phenylephrine|mesh-list
92954277|NCT05890027|Oxymetazoline|oxymetazoline|mesh-list
92954278|NCT05890027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92954279|NCT05890027|Mydriatics|mydriatics|mesh-ancestor
92954280|NCT05890027|Autonomic Agents|autonomic agents|mesh-ancestor
92954281|NCT05890027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954282|NCT05890027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954283|NCT05890027|Sympathomimetics|sympathomimetics|mesh-ancestor
92954284|NCT05890027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92954285|NCT05890027|Nasal Decongestants|nasal decongestants|mesh-ancestor
92954286|NCT05890027|Respiratory System Agents|respiratory system agents|mesh-ancestor
92954287|NCT05890027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92954288|NCT05890027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92954289|NCT05890027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92954290|NCT05890027|Adrenergic Agents|adrenergic agents|mesh-ancestor
92954291|NCT05890027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954292|NCT05890027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954293|NCT05890027|Protective Agents|protective agents|mesh-ancestor
92954294|NCT05884398|Androgens|androgens|mesh-list
92954295|NCT05884398|Hormones|hormones|mesh-ancestor
92954296|NCT05884398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954297|NCT05884398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954298|NCT05884242|Adalimumab|adalimumab|mesh-list
92954299|NCT05884242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92954300|NCT05884242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954301|NCT05884242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954302|NCT05870956|Nintedanib|nintedanib|mesh-list
92954303|NCT05870956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954304|NCT05870956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954305|NCT05870956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954306|NCT05870956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954307|NCT05866354|Tisotumab vedotin|tisotumab vedotin|mesh-list
92954308|NCT05866354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954309|NCT05866354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954310|NCT05864209|Bisphenol A|bisphenol a|mesh-list
92954311|NCT05864209|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92954312|NCT05864209|Estrogens|estrogens|mesh-ancestor
92954313|NCT05864209|Hormones|hormones|mesh-ancestor
92954314|NCT05864209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954315|NCT05864209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954316|NCT05864209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92954317|NCT05864209|Antioxidants|antioxidants|mesh-ancestor
92954318|NCT05864209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954319|NCT05864209|Protective Agents|protective agents|mesh-ancestor
92954320|NCT05861999|Risdiplam|risdiplam|mesh-list
92954321|NCT05861999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92954322|NCT05861999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954323|NCT05861999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954324|NCT05861986|Risdiplam|risdiplam|mesh-list
92954325|NCT05861986|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92954326|NCT05861986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954327|NCT05861986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954328|NCT05852769|Flurbiprofen|flurbiprofen|mesh-list
92954329|NCT05852769|Digoxin|digoxin|mesh-list
92954330|NCT05852769|Midazolam|midazolam|mesh-list
92954331|NCT05852769|Caffeine|caffeine|mesh-list
92954332|NCT05852769|Omeprazole|omeprazole|mesh-list
92954333|NCT05852769|Pravastatin|pravastatin|mesh-list
92954334|NCT05852769|Montelukast|montelukast|mesh-list
92954335|NCT05852769|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92299284|NCT04973254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954336|NCT05852769|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92954337|NCT05852769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954338|NCT05852769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954339|NCT05852769|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92954340|NCT05852769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92954341|NCT05852769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92954342|NCT05852769|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92954343|NCT05852769|Anesthetics, General|anesthetics, general|mesh-ancestor
92954344|NCT05852769|Anesthetics|anesthetics|mesh-ancestor
92954345|NCT05852769|GABA Modulators|gaba modulators|mesh-ancestor
92954346|NCT05852769|GABA Agents|gaba agents|mesh-ancestor
92954347|NCT05852769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954348|NCT05852769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954349|NCT05852769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92954350|NCT05852769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92954351|NCT05852769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165392|NCT04513314|GABA Agents|gaba agents|mesh-ancestor
92954352|NCT05852769|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92954353|NCT05852769|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92954354|NCT05852769|Purinergic Agents|purinergic agents|mesh-ancestor
92954355|NCT05852769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92954356|NCT05852769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92954357|NCT05852769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92954358|NCT05852769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92954359|NCT05852769|Respiratory System Agents|respiratory system agents|mesh-ancestor
92954360|NCT05852769|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92954361|NCT05852769|Hormone Antagonists|hormone antagonists|mesh-ancestor
92954362|NCT05852769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954363|NCT05852769|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92954364|NCT05852769|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92954365|NCT05852769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92954366|NCT05852769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92954367|NCT05852769|Protective Agents|protective agents|mesh-ancestor
92954368|NCT05852769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92954369|NCT05852769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92954370|NCT05852769|Antimetabolites|antimetabolites|mesh-ancestor
92954371|NCT05852769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92954372|NCT05852769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92954373|NCT05852769|Analgesics|analgesics|mesh-ancestor
92954374|NCT05852769|Sensory System Agents|sensory system agents|mesh-ancestor
92954375|NCT05852769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954376|NCT05852769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92954377|NCT05852769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92954378|NCT05852769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954379|NCT05852769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954380|NCT05852769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92954381|NCT05848765|Prednisone|prednisone|mesh-list
92954382|NCT05848765|Cyclophosphamide|cyclophosphamide|mesh-list
92954383|NCT05848765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92954384|NCT05848765|Rituximab|rituximab|mesh-list
92954385|NCT05848765|Doxorubicin|doxorubicin|mesh-list
92954386|NCT05848765|Vincristine|vincristine|mesh-list
92954387|NCT05848765|Lenalidomide|lenalidomide|mesh-list
92954388|NCT05848765|Obinutuzumab|obinutuzumab|mesh-list
92954389|NCT05848765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954390|NCT05848765|Immunologic Factors|immunologic factors|mesh-ancestor
92954391|NCT05848765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954392|NCT05848765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954393|NCT05848765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92954394|NCT05848765|Alkylating Agents|alkylating agents|mesh-ancestor
92954395|NCT05848765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954396|NCT05848765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954397|NCT05848765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92954398|NCT05848765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954399|NCT05848765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92954400|NCT05848765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92954401|NCT05848765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92954402|NCT05848765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954403|NCT05848765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954404|NCT05848765|Glucocorticoids|glucocorticoids|mesh-ancestor
92954405|NCT05848765|Hormones|hormones|mesh-ancestor
92954406|NCT05848765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954407|NCT05848765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954408|NCT05848765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954409|NCT05848765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92954410|NCT05848765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954411|NCT05848765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954412|NCT05848765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92954413|NCT05848765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92954414|NCT05848765|Growth Substances|growth substances|mesh-ancestor
92954415|NCT05848765|Growth Inhibitors|growth inhibitors|mesh-ancestor
92954416|NCT05847348|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92954417|NCT05847348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92954418|NCT05847348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954419|NCT05843383|Propofol|propofol|mesh-list
92954420|NCT05843383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92954421|NCT05843383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954422|NCT05843383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954423|NCT05843383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92954424|NCT05843383|Anesthetics, General|anesthetics, general|mesh-ancestor
92954425|NCT05843383|Anesthetics|anesthetics|mesh-ancestor
92954426|NCT05836753|Sarecycline|sarecycline|mesh-list
92954427|NCT05836753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92954428|NCT05836753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954429|NCT05836753|Dermatologic Agents|dermatologic agents|mesh-ancestor
92954430|NCT05827874|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92954431|NCT05827874|Immunologic Factors|immunologic factors|mesh-ancestor
92954432|NCT05827874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954433|NCT05827211|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92954434|NCT05827211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92954435|NCT05827211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954436|NCT05827211|Antitubercular Agents|antitubercular agents|mesh-ancestor
92954437|NCT05822063|Lidocaine|lidocaine|mesh-list
92954438|NCT05822063|Anesthetics, Local|anesthetics, local|mesh-ancestor
92954439|NCT05822063|Anesthetics|anesthetics|mesh-ancestor
92954440|NCT05822063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954441|NCT05822063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954442|NCT05822063|Sensory System Agents|sensory system agents|mesh-ancestor
92954443|NCT05822063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954444|NCT05822063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92954445|NCT05822063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92954446|NCT05822063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92954447|NCT05822063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92954448|NCT05822063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954449|NCT05820503|Anesthetics|anesthetics|mesh-list
92954450|NCT05820503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954451|NCT05820503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954452|NCT05817097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92954453|NCT05817097|Protease Inhibitors|protease inhibitors|mesh-ancestor
92954454|NCT05817097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954455|NCT05817097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954456|NCT05817097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92954457|NCT05817097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954458|NCT05814354|Paclitaxel|paclitaxel|mesh-list
92954459|NCT05814354|Gemcitabine|gemcitabine|mesh-list
92954460|NCT05814354|Capecitabine|capecitabine|mesh-list
92954461|NCT05814354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954462|NCT05814354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954463|NCT05814354|Tubulin Modulators|tubulin modulators|mesh-ancestor
92954464|NCT05814354|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954465|NCT05814354|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954466|NCT05814354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954467|NCT05814354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92954468|NCT05814354|Antimetabolites|antimetabolites|mesh-ancestor
92954469|NCT05811351|Prednisone|prednisone|mesh-list
92954470|NCT05811351|Triamcinolone|triamcinolone|mesh-list
92954471|NCT05811351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954472|NCT05811351|Glucocorticoids|glucocorticoids|mesh-ancestor
92954473|NCT05811351|Hormones|hormones|mesh-ancestor
92954474|NCT05811351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954475|NCT05811351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954476|NCT05811351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954477|NCT05811351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954478|NCT05795062|Warfarin|warfarin|mesh-list
92954479|NCT05795062|Apixaban|apixaban|mesh-list
92954480|NCT05795062|Anticoagulants|anticoagulants|mesh-ancestor
92527455|NCT00000620|Furosemide|furosemide|mesh-list
92954481|NCT05795062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92954482|NCT05795062|Antithrombins|antithrombins|mesh-ancestor
92954483|NCT05795062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92954484|NCT05795062|Protease Inhibitors|protease inhibitors|mesh-ancestor
92954485|NCT05795062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954486|NCT05795062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954487|NCT05794659|Paclitaxel|paclitaxel|mesh-list
92954488|NCT05794659|Carboplatin|carboplatin|mesh-list
92954489|NCT05794659|Molgramostim|molgramostim|mesh-list
92954490|NCT05794659|Sargramostim|sargramostim|mesh-list
92954491|NCT05794659|Immunologic Factors|immunologic factors|mesh-ancestor
92954492|NCT05794659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954493|NCT05794659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954494|NCT05794659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954495|NCT05794659|Tubulin Modulators|tubulin modulators|mesh-ancestor
92255028|NCT00837512|Insulin|insulin|mesh-list
92954496|NCT05794659|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954497|NCT05794659|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954498|NCT05794659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954499|NCT05791565|Norflurane|norflurane|mesh-list
92954500|NCT05791565|Albuterol|albuterol|mesh-list
92954501|NCT05791565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92954502|NCT05791565|Autonomic Agents|autonomic agents|mesh-ancestor
92954503|NCT05791565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954504|NCT05791565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954505|NCT05791565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92954506|NCT05791565|Respiratory System Agents|respiratory system agents|mesh-ancestor
92954507|NCT05791565|Tocolytic Agents|tocolytic agents|mesh-ancestor
92954508|NCT05791565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954509|NCT05791565|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92954510|NCT05791565|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92954511|NCT05791565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92954512|NCT05791565|Adrenergic Agents|adrenergic agents|mesh-ancestor
92954513|NCT05791565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954514|NCT05791565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954515|NCT05791565|Anesthetics|anesthetics|mesh-ancestor
92954516|NCT05791565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954517|NCT05776927|Fluticasone|fluticasone|mesh-list
92954519|NCT05776927|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92954520|NCT05776927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954521|NCT05776927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92954522|NCT05776927|Autonomic Agents|autonomic agents|mesh-ancestor
92954523|NCT05776927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954524|NCT05776927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954525|NCT05776927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92954526|NCT05776927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92954527|NCT05776927|Dermatologic Agents|dermatologic agents|mesh-ancestor
92954528|NCT05776927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92954529|NCT05776927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92954530|NCT05776927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92954531|NCT05776927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92954532|NCT05776927|Adrenergic Agents|adrenergic agents|mesh-ancestor
92599963|NCT00111410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954533|NCT05776927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954534|NCT05776927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954535|NCT05773066|Lidocaine|lidocaine|mesh-list
92954536|NCT05773066|Anesthetics, Local|anesthetics, local|mesh-ancestor
92954537|NCT05773066|Anesthetics|anesthetics|mesh-ancestor
92954538|NCT05773066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954539|NCT05773066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954540|NCT05773066|Sensory System Agents|sensory system agents|mesh-ancestor
92954541|NCT05773066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954542|NCT05773066|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92954543|NCT05773066|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92954544|NCT05773066|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92954545|NCT05773066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92954546|NCT05773066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954547|NCT05771584|Sargramostim|sargramostim|mesh-list
92954548|NCT05771584|Immunologic Factors|immunologic factors|mesh-ancestor
92954549|NCT05771584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954550|NCT05770531|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92954551|NCT05770531|Immunoconjugates|immunoconjugates|mesh-ancestor
92954552|NCT05770531|Immunologic Factors|immunologic factors|mesh-ancestor
92954553|NCT05770531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954555|NCT05761041|Fluorides|fluorides|mesh-list
92954556|NCT05761041|Sodium Fluoride|sodium fluoride|mesh-list
92954557|NCT05761041|Fluorides, Topical|fluorides, topical|mesh-list
92954558|NCT05761041|Cariostatic Agents|cariostatic agents|mesh-ancestor
92954559|NCT05761041|Protective Agents|protective agents|mesh-ancestor
92954560|NCT05761041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954561|NCT05761041|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92954562|NCT05761041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954563|NCT05757869|Apixaban|apixaban|mesh-list
92954564|NCT05757869|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92954565|NCT05757869|Antithrombins|antithrombins|mesh-ancestor
92954566|NCT05757869|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92954567|NCT05757869|Protease Inhibitors|protease inhibitors|mesh-ancestor
92954568|NCT05757869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954569|NCT05757869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954570|NCT05757869|Anticoagulants|anticoagulants|mesh-ancestor
92954571|NCT05753436|Curcumin|curcumin|mesh-list
92954572|NCT05753436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92954573|NCT05753436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92954574|NCT05753436|Analgesics|analgesics|mesh-ancestor
92954575|NCT05753436|Sensory System Agents|sensory system agents|mesh-ancestor
92954576|NCT05753436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954577|NCT05753436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954578|NCT05753436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954579|NCT05753436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954580|NCT05753436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954581|NCT05753436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954582|NCT05753436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954583|NCT05750966|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92954584|NCT05750966|Ciprofloxacin|ciprofloxacin|mesh-list
92954585|NCT05750966|Gentamicins|gentamicins|mesh-list
92954586|NCT05750966|Ceftriaxone|ceftriaxone|mesh-list
92954587|NCT05750966|Cefuroxime|cefuroxime|mesh-list
92954588|NCT05750966|Cefuroxime axetil|cefuroxime axetil|mesh-list
92954589|NCT05750966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92954590|NCT05750966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954591|NCT05750966|Antitubercular Agents|antitubercular agents|mesh-ancestor
92954592|NCT05750966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92954593|NCT05750966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92954594|NCT05750966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954595|NCT05750966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954596|NCT05750966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954597|NCT05750966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92954598|NCT05750966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92954599|NCT05750966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92954600|NCT05731492|Macitentan|macitentan|mesh-list
92954601|NCT05731492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92954602|NCT05731492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92954603|NCT05731492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954604|NCT05731492|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92954605|NCT05722015|Paclitaxel|paclitaxel|mesh-list
92954606|NCT05722015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92954607|NCT05722015|Carboplatin|carboplatin|mesh-list
92954608|NCT05722015|Pembrolizumab|pembrolizumab|mesh-list
92954610|NCT05722015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954611|NCT05722015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954612|NCT05722015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92954613|NCT05722015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954614|NCT05722015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954615|NCT05722015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954616|NCT05722015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954617|NCT05722015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954618|NCT05722015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954619|NCT05722015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92954620|NCT05722015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92954621|NCT05706753|Drospirenone|drospirenone|mesh-list
92954622|NCT05706753|Midazolam|midazolam|mesh-list
92954623|NCT05706753|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92954624|NCT05706753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92954625|NCT05706753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92954626|NCT05706753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954627|NCT05706753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954628|NCT05706753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92954630|NCT05706753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92954631|NCT05706753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92954632|NCT05706753|Anesthetics, General|anesthetics, general|mesh-ancestor
92954633|NCT05706753|Anesthetics|anesthetics|mesh-ancestor
92954634|NCT05706753|GABA Modulators|gaba modulators|mesh-ancestor
92954635|NCT05706753|GABA Agents|gaba agents|mesh-ancestor
92954636|NCT05706753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954637|NCT05706753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954638|NCT05706753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92954639|NCT05706753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92954640|NCT05706753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92954641|NCT05706753|Contraceptive Agents|contraceptive agents|mesh-ancestor
92954642|NCT05706753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954643|NCT05706753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92954644|NCT05706753|Estrogens|estrogens|mesh-ancestor
92954645|NCT05706753|Hormones|hormones|mesh-ancestor
92954646|NCT05706753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954647|NCT05706753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92954648|NCT05706753|Hormone Antagonists|hormone antagonists|mesh-ancestor
92954649|NCT05706753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92954650|NCT05706753|Diuretics|diuretics|mesh-ancestor
92954651|NCT05706753|Natriuretic Agents|natriuretic agents|mesh-ancestor
92954652|NCT05694013|Atezolizumab|atezolizumab|mesh-list
92954653|NCT05694013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954654|NCT05694013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954655|NCT05694013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954656|NCT05694013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954657|NCT05679921|Pembrolizumab|pembrolizumab|mesh-list
92954658|NCT05679921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954659|NCT05679921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954660|NCT05679921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954661|NCT05679921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954662|NCT05663866|Dexamethasone|dexamethasone|mesh-list
92954663|NCT05663866|Methotrexate|methotrexate|mesh-list
92954664|NCT05663866|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92954665|NCT05663866|Montelukast|montelukast|mesh-list
92954666|NCT05663866|Lazertinib|lazertinib|mesh-list
92954667|NCT05663866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954668|NCT05663866|Antiemetics|antiemetics|mesh-ancestor
92954669|NCT05663866|Autonomic Agents|autonomic agents|mesh-ancestor
92954670|NCT05663866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954671|NCT05663866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954672|NCT05663866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92954673|NCT05663866|Glucocorticoids|glucocorticoids|mesh-ancestor
92954674|NCT05663866|Hormones|hormones|mesh-ancestor
92954675|NCT05663866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954676|NCT05663866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954677|NCT05663866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954678|NCT05663866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92954679|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
92954680|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954681|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92954682|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
92954683|NCT05663866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954685|NCT05663866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954686|NCT05663866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92954687|NCT05663866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954688|NCT05663866|Immunologic Factors|immunologic factors|mesh-ancestor
92954689|NCT05663866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954690|NCT05663866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92954691|NCT05663866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92954692|NCT05663866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92954693|NCT05663866|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92954694|NCT05663866|Hormone Antagonists|hormone antagonists|mesh-ancestor
92954695|NCT05663866|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92954696|NCT05663866|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92954697|NCT05663866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954698|NCT05663866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954699|NCT05661578|Atezolizumab|atezolizumab|mesh-list
92954700|NCT05661578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954701|NCT05661578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299663|NCT04501367|Prednisone|prednisone|mesh-list
92954702|NCT05661578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954703|NCT05661578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954704|NCT05660746|Infliximab|infliximab|mesh-list
92954705|NCT05660746|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92954706|NCT05660746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954707|NCT05660746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92954708|NCT05660746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92954709|NCT05660746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954710|NCT05659537|Dulaglutide|dulaglutide|mesh-list
92954711|NCT05659537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92954712|NCT05659537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954713|NCT05658380|Atropine|atropine|mesh-list
92954714|NCT05658380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92954715|NCT05658380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92954716|NCT05658380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92954717|NCT05658380|Autonomic Agents|autonomic agents|mesh-ancestor
92954718|NCT05658380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954719|NCT05658380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954720|NCT05658380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92954721|NCT05658380|Respiratory System Agents|respiratory system agents|mesh-ancestor
92954722|NCT05658380|Mydriatics|mydriatics|mesh-ancestor
92954723|NCT05658380|Parasympatholytics|parasympatholytics|mesh-ancestor
92954724|NCT05658380|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92954725|NCT05658380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92954726|NCT05658380|Cholinergic Agents|cholinergic agents|mesh-ancestor
92954727|NCT05658380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954728|NCT05658380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954729|NCT05653427|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92954730|NCT05653427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954731|NCT05653427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954732|NCT05645692|Atezolizumab|atezolizumab|mesh-list
92954733|NCT05645692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954734|NCT05645692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954735|NCT05645692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954736|NCT05645692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954737|NCT05630755|Islatravir|islatravir|mesh-list
92954738|NCT05630755|Antiviral Agents|antiviral agents|mesh-ancestor
92954739|NCT05630755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954740|NCT05630755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954741|NCT05630755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954742|NCT05630755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92954743|NCT05630755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92954744|NCT05630755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92954745|NCT05625399|Nivolumab|nivolumab|mesh-list
92954746|NCT05625399|Relatlimab|relatlimab|mesh-list
92954747|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954748|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954749|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954750|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954751|NCT05610319|Faricimab|faricimab|mesh-list
92954752|NCT05610319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92954753|NCT05610319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92954754|NCT05610319|Growth Substances|growth substances|mesh-ancestor
92600192|NCT00350662|Siderophores|siderophores|mesh-ancestor
92954755|NCT05610319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954756|NCT05610319|Growth Inhibitors|growth inhibitors|mesh-ancestor
92954757|NCT05610319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954758|NCT05609968|Pembrolizumab|pembrolizumab|mesh-list
92954759|NCT05609968|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92954760|NCT05609968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954761|NCT05609968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954762|NCT05609968|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954763|NCT05609968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954764|NCT05609968|Immunoconjugates|immunoconjugates|mesh-ancestor
92954765|NCT05609968|Immunologic Factors|immunologic factors|mesh-ancestor
92954766|NCT05609968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954767|NCT05575063|Hyaluronic Acid|hyaluronic acid|mesh-list
92954768|NCT05575063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92954769|NCT05575063|Immunologic Factors|immunologic factors|mesh-ancestor
92954770|NCT05575063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954772|NCT05575063|Protective Agents|protective agents|mesh-ancestor
92954773|NCT05572515|Dexamethasone|dexamethasone|mesh-list
92954774|NCT05572515|Bortezomib|bortezomib|mesh-list
92954775|NCT05572515|Pomalidomide|pomalidomide|mesh-list
92954776|NCT05572515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954777|NCT05572515|Antiemetics|antiemetics|mesh-ancestor
92954778|NCT05572515|Autonomic Agents|autonomic agents|mesh-ancestor
92954779|NCT05572515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954780|NCT05572515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954781|NCT05572515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92954782|NCT05572515|Glucocorticoids|glucocorticoids|mesh-ancestor
92954783|NCT05572515|Hormones|hormones|mesh-ancestor
92954784|NCT05572515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954785|NCT05572515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954786|NCT05572515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954787|NCT05572515|Immunologic Factors|immunologic factors|mesh-ancestor
92954788|NCT05572515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92954789|NCT05572515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92954790|NCT05572515|Growth Substances|growth substances|mesh-ancestor
92954791|NCT05572515|Growth Inhibitors|growth inhibitors|mesh-ancestor
92954792|NCT05551104|Labetalol|labetalol|mesh-list
92954793|NCT05551104|Nifedipine|nifedipine|mesh-list
92954794|NCT05551104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92954795|NCT05551104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92954796|NCT05551104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954797|NCT05551104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92954798|NCT05551104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954799|NCT05551104|Vasodilator Agents|vasodilator agents|mesh-ancestor
92954800|NCT05551104|Tocolytic Agents|tocolytic agents|mesh-ancestor
92954801|NCT05551104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954802|NCT05551104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92954803|NCT05551104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92954804|NCT05551104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92954805|NCT05551104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92954806|NCT05551104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92954807|NCT05551104|Sympathomimetics|sympathomimetics|mesh-ancestor
92954808|NCT05551104|Autonomic Agents|autonomic agents|mesh-ancestor
92954809|NCT05551104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954810|NCT05551104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92954811|NCT05551104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92954812|NCT05550532|Aticaprant|aticaprant|mesh-list
92954813|NCT05550532|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92954814|NCT05550532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954815|NCT05550532|Sensory System Agents|sensory system agents|mesh-ancestor
92954816|NCT05550532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954817|NCT05539872|Insulin|insulin|mesh-list
92954818|NCT05539872|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92954819|NCT05539872|Insulin Aspart|insulin aspart|mesh-list
92954820|NCT05539872|Insulin, Long-Acting|insulin, long-acting|mesh-list
92954821|NCT05539872|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92954822|NCT05539872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92954823|NCT05539872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954824|NCT05528510|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92954825|NCT05528510|Immunologic Factors|immunologic factors|mesh-ancestor
92954826|NCT05528510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600278|NCT00351130|Amlodipine|amlodipine|mesh-list
92954827|NCT05527418|Dasatinib|dasatinib|mesh-list
92954828|NCT05527418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954829|NCT05527418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954830|NCT05527418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954831|NCT05527418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954832|NCT05521087|Cytarabine|cytarabine|mesh-list
92954833|NCT05521087|Dexamethasone|dexamethasone|mesh-list
92954834|NCT05521087|Fludarabine|fludarabine|mesh-list
92954835|NCT05521087|Vincristine|vincristine|mesh-list
92954836|NCT05521087|Pegaspargase|pegaspargase|mesh-list
92954837|NCT05521087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954838|NCT05521087|Antiemetics|antiemetics|mesh-ancestor
92954839|NCT05521087|Autonomic Agents|autonomic agents|mesh-ancestor
92954840|NCT05521087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954841|NCT05521087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954842|NCT05521087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92954843|NCT05521087|Glucocorticoids|glucocorticoids|mesh-ancestor
92954844|NCT05521087|Hormones|hormones|mesh-ancestor
92954845|NCT05521087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954846|NCT05521087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954847|NCT05521087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954848|NCT05521087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92954849|NCT05521087|Antimetabolites|antimetabolites|mesh-ancestor
92954850|NCT05521087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954851|NCT05521087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954852|NCT05521087|Immunologic Factors|immunologic factors|mesh-ancestor
92954853|NCT05521087|Antiviral Agents|antiviral agents|mesh-ancestor
92954854|NCT05521087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954855|NCT05521087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92954856|NCT05521087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92954857|NCT05521087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92954858|NCT05521087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92954859|NCT05518149|Aticaprant|aticaprant|mesh-list
92954860|NCT05518149|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92954861|NCT05518149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954862|NCT05518149|Sensory System Agents|sensory system agents|mesh-ancestor
92954863|NCT05518149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954864|NCT05512481|Temozolomide|temozolomide|mesh-list
92954865|NCT05512481|Apatinib|apatinib|mesh-list
92954866|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92954867|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
92954868|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954869|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954870|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954871|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954872|NCT05498428|Carboplatin|carboplatin|mesh-list
92954873|NCT05498428|Pemetrexed|pemetrexed|mesh-list
92954874|NCT05498428|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92954875|NCT05498428|Heparin|heparin|mesh-list
92954876|NCT05498428|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92954877|NCT05498428|Tinzaparin|tinzaparin|mesh-list
92954878|NCT05498428|Dalteparin|dalteparin|mesh-list
92954879|NCT05498428|Anticoagulants|anticoagulants|mesh-list
92954880|NCT05498428|Lazertinib|lazertinib|mesh-list
92954881|NCT05498428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954882|NCT05498428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954883|NCT05498428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954884|NCT05498428|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92954885|NCT05498428|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92954886|NCT05498428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92954887|NCT05498428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92954888|NCT05498428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92954889|NCT05498428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954890|NCT05494762|Tislelizumab|tislelizumab|mesh-list
92954891|NCT05494762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954892|NCT05494762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954893|NCT05493709|Leuprolide|leuprolide|mesh-list
92954894|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92954895|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
92954896|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954897|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954898|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954899|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954900|NCT05488314|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92954901|NCT05488314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954902|NCT05488314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954903|NCT05476926|Ranibizumab|ranibizumab|mesh-list
92954904|NCT05476926|Faricimab|faricimab|mesh-list
92954905|NCT05476926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92954906|NCT05476926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92954907|NCT05476926|Growth Substances|growth substances|mesh-ancestor
92954908|NCT05476926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954909|NCT05476926|Growth Inhibitors|growth inhibitors|mesh-ancestor
92954910|NCT05476926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954911|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92954912|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92954913|NCT05473273|Estradiol|estradiol|mesh-list
92954914|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92954915|NCT05473273|Progesterone|progesterone|mesh-list
92954916|NCT05473273|Estrogens|estrogens|mesh-ancestor
92954917|NCT05473273|Hormones|hormones|mesh-ancestor
92954918|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954919|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954920|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92954921|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
92954922|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92954923|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92954924|NCT05473273|Progestins|progestins|mesh-ancestor
92954925|NCT05464680|Dimercaprol|dimercaprol|mesh-list
92954926|NCT05464680|Chelating Agents|chelating agents|mesh-ancestor
92954927|NCT05464680|Sequestering Agents|sequestering agents|mesh-ancestor
92954928|NCT05464680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954929|NCT05455684|Aticaprant|aticaprant|mesh-list
92954930|NCT05455684|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92954931|NCT05455684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954932|NCT05455684|Sensory System Agents|sensory system agents|mesh-ancestor
92954933|NCT05455684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954934|NCT05455320|Dexamethasone|dexamethasone|mesh-list
92954935|NCT05455320|Daratumumab|daratumumab|mesh-list
92954936|NCT05455320|Pomalidomide|pomalidomide|mesh-list
92954937|NCT05455320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92954938|NCT05455320|Antiemetics|antiemetics|mesh-ancestor
92954939|NCT05455320|Autonomic Agents|autonomic agents|mesh-ancestor
92954940|NCT05455320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954941|NCT05455320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954942|NCT05455320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92954943|NCT05455320|Glucocorticoids|glucocorticoids|mesh-ancestor
92954944|NCT05455320|Hormones|hormones|mesh-ancestor
92954945|NCT05455320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92954946|NCT05455320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92954947|NCT05455320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954948|NCT05455320|Immunologic Factors|immunologic factors|mesh-ancestor
92954949|NCT05455320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92954950|NCT05455320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92954951|NCT05455320|Growth Substances|growth substances|mesh-ancestor
92954952|NCT05455320|Growth Inhibitors|growth inhibitors|mesh-ancestor
92954953|NCT05453903|Cytarabine|cytarabine|mesh-list
92954954|NCT05453903|Azacitidine|azacitidine|mesh-list
92954955|NCT05453903|Daunorubicin|daunorubicin|mesh-list
92954956|NCT05453903|Venetoclax|venetoclax|mesh-list
92954957|NCT05453903|Idarubicin|idarubicin|mesh-list
92954958|NCT05453903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92954959|NCT05453903|Antimetabolites|antimetabolites|mesh-ancestor
92954960|NCT05453903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954961|NCT05453903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954962|NCT05453903|Antiviral Agents|antiviral agents|mesh-ancestor
92954963|NCT05453903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92954964|NCT05453903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954965|NCT05453903|Immunologic Factors|immunologic factors|mesh-ancestor
92954966|NCT05453903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954967|NCT05453903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92954968|NCT05453903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92954969|NCT05453903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92954970|NCT05453903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92954971|NCT05451849|Cyclophosphamide|cyclophosphamide|mesh-list
92954972|NCT05451849|Fludarabine|fludarabine|mesh-list
92954973|NCT05451849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92954974|NCT05451849|Immunologic Factors|immunologic factors|mesh-ancestor
92954975|NCT05451849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954976|NCT05451849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92954977|NCT05451849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92954978|NCT05451849|Alkylating Agents|alkylating agents|mesh-ancestor
92954979|NCT05451849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954980|NCT05451849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954981|NCT05451849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92954982|NCT05444530|Ipilimumab|ipilimumab|mesh-list
92954983|NCT05444530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92954984|NCT05444530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92954985|NCT05444530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92954986|NCT05444530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92954988|NCT05421065|Psilocybin|psilocybin|mesh-list
92954989|NCT05421065|Analgesics|analgesics|mesh-ancestor
92954990|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
92954991|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92954992|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92954993|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92954994|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92954995|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
92954996|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
92954997|NCT05421065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92954998|NCT05421065|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92954999|NCT05421065|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92955000|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955001|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955002|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
92955003|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92955004|NCT05396833|Avelumab|avelumab|mesh-list
92955005|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955006|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955007|NCT05389813|Pregabalin|pregabalin|mesh-list
92955008|NCT05389813|Oxycodone|oxycodone|mesh-list
92955009|NCT05389813|Analgesics|analgesics|mesh-ancestor
92955010|NCT05389813|Sensory System Agents|sensory system agents|mesh-ancestor
92955011|NCT05389813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955012|NCT05389813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955013|NCT05389813|Anticonvulsants|anticonvulsants|mesh-ancestor
92955014|NCT05389813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92955015|NCT05389813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92955016|NCT05389813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955017|NCT05389813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92955018|NCT05389813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92955019|NCT05389813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92955020|NCT05389813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955021|NCT05389813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92955022|NCT05389813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92955023|NCT05389813|Narcotics|narcotics|mesh-ancestor
92955024|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92955025|NCT05388669|Lazertinib|lazertinib|mesh-list
92955026|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92955027|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955028|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955029|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955030|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955031|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955032|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
92955033|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955034|NCT05387811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92955035|NCT05387811|Diuretics|diuretics|mesh-list
92955036|NCT05387811|Natriuretic Agents|natriuretic agents|mesh-ancestor
92955037|NCT05387811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955038|NCT05379634|Glucocorticoids|glucocorticoids|mesh-list
92955039|NCT05379634|Hormones|hormones|mesh-ancestor
92955040|NCT05379634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955041|NCT05379634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955042|NCT05379595|Leucovorin|leucovorin|mesh-list
92955043|NCT05379595|Fluorouracil|fluorouracil|mesh-list
92955044|NCT05379595|Oxaliplatin|oxaliplatin|mesh-list
92955045|NCT05379595|Irinotecan|irinotecan|mesh-list
92955046|NCT05379595|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92955047|NCT05379595|Antimetabolites|antimetabolites|mesh-ancestor
92955048|NCT05379595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955049|NCT05379595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955050|NCT05379595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955051|NCT05379595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955052|NCT05379595|Immunologic Factors|immunologic factors|mesh-ancestor
92165448|NCT04265105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955053|NCT05379595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955054|NCT05379595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92955055|NCT05379595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92955056|NCT05379595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955057|NCT05379595|Antidotes|antidotes|mesh-ancestor
92955058|NCT05379595|Protective Agents|protective agents|mesh-ancestor
92955059|NCT05379595|Vitamin B Complex|vitamin b complex|mesh-ancestor
92955060|NCT05379595|Vitamins|vitamins|mesh-ancestor
92955061|NCT05379595|Micronutrients|micronutrients|mesh-ancestor
92955062|NCT05379595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955063|NCT05374512|Paclitaxel|paclitaxel|mesh-list
92955064|NCT05374512|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92955065|NCT05374512|Carboplatin|carboplatin|mesh-list
92955066|NCT05374512|Capecitabine|capecitabine|mesh-list
92955067|NCT05374512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92955068|NCT05374512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955069|NCT05374512|Tubulin Modulators|tubulin modulators|mesh-ancestor
92955070|NCT05374512|Antimitotic Agents|antimitotic agents|mesh-ancestor
92955071|NCT05374512|Mitosis Modulators|mitosis modulators|mesh-ancestor
92955072|NCT05374512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955073|NCT05374512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955074|NCT05374512|Antimetabolites|antimetabolites|mesh-ancestor
92955075|NCT05369832|Ozanimod|ozanimod|mesh-list
92955076|NCT05369832|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92955077|NCT05369832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955078|NCT05369832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955079|NCT05369832|Immunologic Factors|immunologic factors|mesh-ancestor
92955080|NCT05369832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955081|NCT05347485|Cyclophosphamide|cyclophosphamide|mesh-list
92955082|NCT05347485|Fludarabine|fludarabine|mesh-list
92955083|NCT05347485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955084|NCT05347485|Immunologic Factors|immunologic factors|mesh-ancestor
92955085|NCT05347485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955086|NCT05347485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92955087|NCT05347485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92955088|NCT05347485|Alkylating Agents|alkylating agents|mesh-ancestor
92955089|NCT05347485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955090|NCT05347485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955091|NCT05347485|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92955092|NCT05341167|Phenylephrine|phenylephrine|mesh-list
92955093|NCT05341167|Oxymetazoline|oxymetazoline|mesh-list
92955094|NCT05341167|Norepinephrine|norepinephrine|mesh-list
92955095|NCT05341167|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92955096|NCT05341167|Mydriatics|mydriatics|mesh-ancestor
92955097|NCT05341167|Autonomic Agents|autonomic agents|mesh-ancestor
92955098|NCT05341167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955099|NCT05341167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955100|NCT05341167|Sympathomimetics|sympathomimetics|mesh-ancestor
92955101|NCT05341167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92955102|NCT05341167|Nasal Decongestants|nasal decongestants|mesh-ancestor
92955103|NCT05341167|Respiratory System Agents|respiratory system agents|mesh-ancestor
92955104|NCT05341167|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92955105|NCT05341167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92955106|NCT05341167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92955107|NCT05341167|Adrenergic Agents|adrenergic agents|mesh-ancestor
92955108|NCT05341167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955109|NCT05341167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955110|NCT05341167|Protective Agents|protective agents|mesh-ancestor
92955111|NCT05338775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92955112|NCT05338775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955113|NCT05338775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955114|NCT05338775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955115|NCT05337137|Bevacizumab|bevacizumab|mesh-list
92955116|NCT05337137|Nivolumab|nivolumab|mesh-list
92955117|NCT05337137|Relatlimab|relatlimab|mesh-list
92955118|NCT05337137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255658|NCT01451411|Conivaptan|conivaptan|mesh-list
92955119|NCT05337137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955120|NCT05337137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92955121|NCT05337137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92955122|NCT05337137|Growth Substances|growth substances|mesh-ancestor
92955123|NCT05337137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955124|NCT05337137|Growth Inhibitors|growth inhibitors|mesh-ancestor
92955125|NCT05337137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955126|NCT05337137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955127|NCT05328297|JNJ-55308942|jnj-55308942|mesh-list
92955128|NCT05328297|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
92955129|NCT05328297|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92955130|NCT05328297|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92955131|NCT05328297|Purinergic Agents|purinergic agents|mesh-ancestor
92955132|NCT05328297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955133|NCT05328297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955135|NCT05312970|Polidocanol|polidocanol|mesh-list
92955136|NCT05312970|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92955137|NCT05312970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92955138|NCT05308979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92955139|NCT05308979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92955140|NCT05308979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92955141|NCT05308979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955142|NCT05308979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955143|NCT05308979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92955144|NCT05308979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92955145|NCT05308979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955146|NCT05308979|Cholinergic Agents|cholinergic agents|mesh-ancestor
92955147|NCT05308979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955148|NCT05301361|Methylphenidate|methylphenidate|mesh-list
92955149|NCT05301361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92955150|NCT05301361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955151|NCT05301361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92955152|NCT05301361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92955153|NCT05301361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92955154|NCT05301361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955155|NCT05301361|Dopamine Agents|dopamine agents|mesh-ancestor
92955156|NCT05301361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955157|NCT05293132|Coenzyme Q10|coenzyme q10|mesh-list
92955158|NCT05293132|Ubiquinone|ubiquinone|mesh-list
92955159|NCT05293132|Montelukast|montelukast|mesh-list
92955160|NCT05293132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92955161|NCT05293132|Respiratory System Agents|respiratory system agents|mesh-ancestor
92955162|NCT05293132|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92955163|NCT05293132|Hormone Antagonists|hormone antagonists|mesh-ancestor
92955164|NCT05293132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955165|NCT05293132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955166|NCT05293132|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92955167|NCT05293132|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92955168|NCT05293132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955169|NCT05293132|Vitamins|vitamins|mesh-ancestor
92955170|NCT05293132|Micronutrients|micronutrients|mesh-ancestor
92955171|NCT05288361|Acetylcholine|acetylcholine|mesh-list
92955172|NCT05288361|Vasodilator Agents|vasodilator agents|mesh-ancestor
92955173|NCT05288361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92955174|NCT05288361|Cholinergic Agents|cholinergic agents|mesh-ancestor
92955175|NCT05288361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955176|NCT05288361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955177|NCT05288361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955178|NCT05288283|Cannabidiol|cannabidiol|mesh-list
92955179|NCT05288283|Anticonvulsants|anticonvulsants|mesh-ancestor
92955180|NCT05281510|Vesatolimod|vesatolimod|mesh-list
92955181|NCT05281510|Antiviral Agents|antiviral agents|mesh-ancestor
92955182|NCT05281510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955183|NCT05275439|Azacitidine|azacitidine|mesh-list
92955184|NCT05275439|Venetoclax|venetoclax|mesh-list
92955185|NCT05275439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955186|NCT05275439|Antimetabolites|antimetabolites|mesh-ancestor
92955187|NCT05275439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955188|NCT05275439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955189|NCT05275439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955190|NCT05275023|Tenofovir|tenofovir|mesh-list
92955191|NCT05275023|Entecavir|entecavir|mesh-list
92955192|NCT05275023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92955193|NCT05275023|Antiviral Agents|antiviral agents|mesh-ancestor
92955194|NCT05275023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955195|NCT05275023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92955196|NCT05275023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955197|NCT05275023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955198|NCT05275023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955199|NCT05275023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92955200|NCT05275023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92955201|NCT05275023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955202|NCT05275023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955203|NCT05257590|Nivolumab|nivolumab|mesh-list
92955204|NCT05257590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955206|NCT05257590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955207|NCT05257590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955208|NCT05255601|Nivolumab|nivolumab|mesh-list
92955209|NCT05255601|Relatlimab|relatlimab|mesh-list
92955210|NCT05255601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955211|NCT05255601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955212|NCT05255601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955213|NCT05255601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955214|NCT05252533|Ustekinumab|ustekinumab|mesh-list
92955215|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955216|NCT05250973|Dexamethasone|dexamethasone|mesh-list
92955217|NCT05250973|Cyclophosphamide|cyclophosphamide|mesh-list
92955218|NCT05250973|Bortezomib|bortezomib|mesh-list
92955219|NCT05250973|Daratumumab|daratumumab|mesh-list
92955220|NCT05250973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955221|NCT05250973|Immunologic Factors|immunologic factors|mesh-ancestor
92955222|NCT05250973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955223|NCT05250973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92955224|NCT05250973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92955225|NCT05250973|Alkylating Agents|alkylating agents|mesh-ancestor
92955226|NCT05250973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955227|NCT05250973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955228|NCT05250973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92955229|NCT05250973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955230|NCT05250973|Antiemetics|antiemetics|mesh-ancestor
92955231|NCT05250973|Autonomic Agents|autonomic agents|mesh-ancestor
92955232|NCT05250973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955233|NCT05250973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92955234|NCT05250973|Glucocorticoids|glucocorticoids|mesh-ancestor
92955235|NCT05250973|Hormones|hormones|mesh-ancestor
92955236|NCT05250973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955237|NCT05250973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955238|NCT05242484|Golimumab|golimumab|mesh-list
92955239|NCT05242484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92955240|NCT05242484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955241|NCT05242484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955242|NCT05242484|Immunologic Factors|immunologic factors|mesh-ancestor
92955243|NCT05242484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955244|NCT05242471|Golimumab|golimumab|mesh-list
92955245|NCT05242471|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92955246|NCT05242471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955247|NCT05242471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955248|NCT05242471|Immunologic Factors|immunologic factors|mesh-ancestor
92955249|NCT05242471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955250|NCT05239169|Capecitabine|capecitabine|mesh-list
92955251|NCT05239169|Durvalumab|durvalumab|mesh-list
92955252|NCT05239169|Tremelimumab|tremelimumab|mesh-list
92955253|NCT05239169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955254|NCT05239169|Antimetabolites|antimetabolites|mesh-ancestor
92955255|NCT05239169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955256|NCT05239169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955257|NCT05239169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955258|NCT05232929|Risdiplam|risdiplam|mesh-list
92955259|NCT05232929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92955260|NCT05232929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955261|NCT05232929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955262|NCT05231980|Thioctic Acid|thioctic acid|mesh-list
92955263|NCT05231980|Pentoxifylline|pentoxifylline|mesh-list
92955264|NCT05231980|Clomiphene|clomiphene|mesh-list
92955265|NCT05231980|Enclomiphene|enclomiphene|mesh-list
92955266|NCT05231980|Zuclomiphene|zuclomiphene|mesh-list
92955267|NCT05231980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955268|NCT05231980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92955269|NCT05231980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955270|NCT05231980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92955271|NCT05231980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92955272|NCT05231980|Protective Agents|protective agents|mesh-ancestor
92955273|NCT05231980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955274|NCT05231980|Vasodilator Agents|vasodilator agents|mesh-ancestor
92955275|NCT05231980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92955276|NCT05231980|Antioxidants|antioxidants|mesh-ancestor
92955277|NCT05231980|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92955278|NCT05231980|Hormone Antagonists|hormone antagonists|mesh-ancestor
92955279|NCT05231980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955280|NCT05231980|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92955281|NCT05231980|Fertility Agents|fertility agents|mesh-ancestor
92600713|NCT00113048|Alemtuzumab|alemtuzumab|mesh-list
92955282|NCT05231980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92955283|NCT05231980|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92955284|NCT05231980|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92955285|NCT05231980|Vitamin B Complex|vitamin b complex|mesh-ancestor
92955286|NCT05231980|Vitamins|vitamins|mesh-ancestor
92955287|NCT05231980|Micronutrients|micronutrients|mesh-ancestor
92955288|NCT05215158|Dexmedetomidine|dexmedetomidine|mesh-list
92955289|NCT05215158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92955290|NCT05215158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955291|NCT05215158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955292|NCT05215158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92955293|NCT05215158|Analgesics|analgesics|mesh-ancestor
92955294|NCT05215158|Sensory System Agents|sensory system agents|mesh-ancestor
92955295|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955296|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92955297|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92955298|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92955299|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92955300|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955301|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955302|NCT05197049|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92955303|NCT05197049|Immunologic Factors|immunologic factors|mesh-ancestor
92955304|NCT05197049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955305|NCT05179876|Selexipag|selexipag|mesh-list
92955306|NCT05179876|Tadalafil|tadalafil|mesh-list
92955307|NCT05179876|Macitentan|macitentan|mesh-list
92955308|NCT05179876|Vasodilator Agents|vasodilator agents|mesh-ancestor
92955309|NCT05179876|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92955310|NCT05179876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92955311|NCT05179876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955312|NCT05179876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955313|NCT05179876|Urological Agents|urological agents|mesh-ancestor
92955314|NCT05179876|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92955315|NCT05179876|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92955316|NCT05179876|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92955317|NCT05179876|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92955318|NCT05173987|Paclitaxel|paclitaxel|mesh-list
92955319|NCT05173987|Docetaxel|docetaxel|mesh-list
92955320|NCT05173987|Carboplatin|carboplatin|mesh-list
92955321|NCT05173987|Pembrolizumab|pembrolizumab|mesh-list
92955322|NCT05173987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92955323|NCT05173987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955324|NCT05173987|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165473|NCT03943875|Vaccines|vaccines|mesh-list
92955325|NCT05173987|Antimitotic Agents|antimitotic agents|mesh-ancestor
92955326|NCT05173987|Mitosis Modulators|mitosis modulators|mesh-ancestor
92955327|NCT05173987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955328|NCT05173987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955329|NCT05173987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955330|NCT05171647|Rituximab|rituximab|mesh-list
92955331|NCT05171647|Gemcitabine|gemcitabine|mesh-list
92955332|NCT05171647|Oxaliplatin|oxaliplatin|mesh-list
92955333|NCT05171647|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92955334|NCT05171647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955335|NCT05171647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955336|NCT05171647|Immunologic Factors|immunologic factors|mesh-ancestor
92955337|NCT05171647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955338|NCT05171647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92955339|NCT05171647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955340|NCT05171647|Antimetabolites|antimetabolites|mesh-ancestor
92955341|NCT05171647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955342|NCT05171647|Immunoconjugates|immunoconjugates|mesh-ancestor
92955343|NCT05171062|Pembrolizumab|pembrolizumab|mesh-list
92955344|NCT05171062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955345|NCT05171062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955346|NCT05171062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955347|NCT05171062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955348|NCT05169554|Amoxicillin|amoxicillin|mesh-list
92955349|NCT05169554|Clarithromycin|clarithromycin|mesh-list
92955350|NCT05169554|Rifampin|rifampin|mesh-list
92955351|NCT05169554|Clavulanic Acid|clavulanic acid|mesh-list
92955352|NCT05169554|Clavulanic Acids|clavulanic acids|mesh-list
92527478|NCT00000620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955353|NCT05169554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92955354|NCT05169554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92955355|NCT05169554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955356|NCT05169554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92955357|NCT05169554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955358|NCT05169554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955359|NCT05169554|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92955360|NCT05169554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92955361|NCT05169554|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92955362|NCT05169554|Antitubercular Agents|antitubercular agents|mesh-ancestor
92955363|NCT05169554|Leprostatic Agents|leprostatic agents|mesh-ancestor
92955364|NCT05169554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955365|NCT05169554|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92955366|NCT05169554|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92955367|NCT05169554|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92955368|NCT05169554|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92955369|NCT05169554|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92955370|NCT05169554|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92955371|NCT05169554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92955372|NCT05167825|Macitentan|macitentan|mesh-list
92955373|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92955374|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92955375|NCT05167825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955376|NCT05167825|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92955377|NCT05151731|Ranibizumab|ranibizumab|mesh-list
92955378|NCT05151731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92955379|NCT05151731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92955380|NCT05151731|Growth Substances|growth substances|mesh-ancestor
92955381|NCT05151731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955382|NCT05151731|Growth Inhibitors|growth inhibitors|mesh-ancestor
92955383|NCT05151731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955384|NCT05148962|Vaccines|vaccines|mesh-list
92955385|NCT05148962|Immunologic Factors|immunologic factors|mesh-ancestor
92955386|NCT05148962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955387|NCT05140941|Sofosbuvir|sofosbuvir|mesh-list
92955388|NCT05140941|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92955389|NCT05140941|Velpatasvir|velpatasvir|mesh-list
92955390|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
92955391|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955392|NCT05123599|Tenofovir|tenofovir|mesh-list
92955393|NCT05123599|Antiviral Agents|antiviral agents|mesh-ancestor
92165481|NCT03908307|Dexamethasone|dexamethasone|mesh-list
92955394|NCT05123599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955395|NCT05123599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92955396|NCT05123599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955397|NCT05123599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955398|NCT05123599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955399|NCT05123599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92955400|NCT05123599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92955401|NCT05116202|Nivolumab|nivolumab|mesh-list
92955402|NCT05116202|Ipilimumab|ipilimumab|mesh-list
92955403|NCT05116202|Atezolizumab|atezolizumab|mesh-list
92955404|NCT05116202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955405|NCT05116202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955406|NCT05116202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955407|NCT05116202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955408|NCT05092269|Ustekinumab|ustekinumab|mesh-list
92955409|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955410|NCT05083182|Ustekinumab|ustekinumab|mesh-list
92955411|NCT05083182|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955412|NCT05083169|Dexamethasone|dexamethasone|mesh-list
92955413|NCT05083169|Bortezomib|bortezomib|mesh-list
92955414|NCT05083169|Daratumumab|daratumumab|mesh-list
92955415|NCT05083169|Pomalidomide|pomalidomide|mesh-list
92955416|NCT05083169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955417|NCT05083169|Antiemetics|antiemetics|mesh-ancestor
92955418|NCT05083169|Autonomic Agents|autonomic agents|mesh-ancestor
92955419|NCT05083169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955420|NCT05083169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955421|NCT05083169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92955422|NCT05083169|Glucocorticoids|glucocorticoids|mesh-ancestor
92955423|NCT05083169|Hormones|hormones|mesh-ancestor
92955424|NCT05083169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955425|NCT05083169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955426|NCT05083169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955427|NCT05083169|Immunologic Factors|immunologic factors|mesh-ancestor
92955428|NCT05083169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92955429|NCT05083169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92600854|NCT00115089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92955430|NCT05083169|Growth Substances|growth substances|mesh-ancestor
92955431|NCT05083169|Growth Inhibitors|growth inhibitors|mesh-ancestor
92955432|NCT05071664|Golimumab|golimumab|mesh-list
92955433|NCT05071664|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92955434|NCT05071664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955435|NCT05071664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955436|NCT05071664|Immunologic Factors|immunologic factors|mesh-ancestor
92955437|NCT05071664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955438|NCT05068440|Zanubrutinib|zanubrutinib|mesh-list
92955439|NCT05068440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955440|NCT05068440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955441|NCT05068440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955442|NCT05068440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955443|NCT05057494|Venetoclax|venetoclax|mesh-list
92955444|NCT05057494|Obinutuzumab|obinutuzumab|mesh-list
92955445|NCT05057494|Acalabrutinib|acalabrutinib|mesh-list
92955446|NCT05057494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955447|NCT05057494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955448|NCT05053334|Omalizumab|omalizumab|mesh-list
92955449|NCT05053334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92955450|NCT05053334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92955451|NCT05053334|Respiratory System Agents|respiratory system agents|mesh-ancestor
92955452|NCT05050305|Dexamethasone|dexamethasone|mesh-list
92955453|NCT05050305|Pomalidomide|pomalidomide|mesh-list
92955454|NCT05050305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955455|NCT05050305|Antiemetics|antiemetics|mesh-ancestor
92955456|NCT05050305|Autonomic Agents|autonomic agents|mesh-ancestor
92955457|NCT05050305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955458|NCT05050305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955459|NCT05050305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92955460|NCT05050305|Glucocorticoids|glucocorticoids|mesh-ancestor
92955461|NCT05050305|Hormones|hormones|mesh-ancestor
92955462|NCT05050305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955463|NCT05050305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955464|NCT05050305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955465|NCT05050305|Immunologic Factors|immunologic factors|mesh-ancestor
92955466|NCT05050305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92955467|NCT05050305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92955468|NCT05050305|Growth Substances|growth substances|mesh-ancestor
92955469|NCT05050305|Growth Inhibitors|growth inhibitors|mesh-ancestor
92955470|NCT05050097|Lenalidomide|lenalidomide|mesh-list
92955471|NCT05050097|Pomalidomide|pomalidomide|mesh-list
92955472|NCT05050097|Daratumumab|daratumumab|mesh-list
92955473|NCT05050097|Immunologic Factors|immunologic factors|mesh-ancestor
92955474|NCT05050097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955475|NCT05050097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92955476|NCT05050097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92955477|NCT05050097|Growth Substances|growth substances|mesh-ancestor
92955478|NCT05050097|Growth Inhibitors|growth inhibitors|mesh-ancestor
92955479|NCT05050097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955480|NCT05045612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92955481|NCT05045612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955482|NCT05044819|Cannabidiol|cannabidiol|mesh-list
92955483|NCT05044819|Anticonvulsants|anticonvulsants|mesh-ancestor
92955484|NCT05029921|Ustekinumab|ustekinumab|mesh-list
92955485|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955486|NCT05020327|Amoxicillin|amoxicillin|mesh-list
92955487|NCT05020327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92955488|NCT05020327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955489|NCT05016310|Vitamin D|vitamin d|mesh-list
92955490|NCT05016310|Ergocalciferols|ergocalciferols|mesh-list
92955491|NCT05016310|Cholecalciferol|cholecalciferol|mesh-list
92955492|NCT05016310|Vitamins|vitamins|mesh-list
92955493|NCT05016310|Micronutrients|micronutrients|mesh-ancestor
92955494|NCT05016310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955495|NCT05016310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92955496|NCT05016310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92955497|NCT05009979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92955498|NCT05009979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92955499|NCT05009979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955500|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
92955501|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92955502|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955503|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600930|NCT00444574|Dopamine Agents|dopamine agents|mesh-ancestor
92955504|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92955505|NCT04981951|Analgesics|analgesics|mesh-ancestor
92955506|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
92955507|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955508|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92955509|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92955510|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92955511|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
92955512|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955513|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955515|NCT04947527|Fluorides, Topical|fluorides, topical|mesh-list
92955516|NCT04947527|Cariostatic Agents|cariostatic agents|mesh-ancestor
92955517|NCT04947527|Protective Agents|protective agents|mesh-ancestor
92955518|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955519|NCT04940039|Risperidone|risperidone|mesh-list
92955520|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92955521|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92955522|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
92955523|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955524|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955525|NCT04940039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955526|NCT04940039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92955527|NCT04940039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92955528|NCT04940039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955529|NCT04940039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92955530|NCT04940039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92955531|NCT04940039|Dopamine Agents|dopamine agents|mesh-ancestor
92955532|NCT04940039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92955533|NCT04940039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92955534|NCT04939935|Metformin|metformin|mesh-list
92955535|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92955536|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955537|NCT04910815|Rifaximin|rifaximin|mesh-list
92955538|NCT04910815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92955539|NCT04910815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955540|NCT04910815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92955541|NCT04907214|Empagliflozin|empagliflozin|mesh-list
92955542|NCT04907214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92955543|NCT04907214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955544|NCT04907214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92955545|NCT04907214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955546|NCT04907032|Mirabegron|mirabegron|mesh-list
92955547|NCT04907032|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92955548|NCT04907032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92955549|NCT04907032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92955550|NCT04907032|Adrenergic Agents|adrenergic agents|mesh-ancestor
92955551|NCT04907032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955552|NCT04907032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955553|NCT04907032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955554|NCT04907032|Urological Agents|urological agents|mesh-ancestor
92955555|NCT04895358|Paclitaxel|paclitaxel|mesh-list
92955556|NCT04895358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92955557|NCT04895358|Doxorubicin|doxorubicin|mesh-list
92955558|NCT04895358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92955559|NCT04895358|Pembrolizumab|pembrolizumab|mesh-list
92955560|NCT04895358|Capecitabine|capecitabine|mesh-list
92955561|NCT04895358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92955562|NCT04895358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955563|NCT04895358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92955564|NCT04895358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92955565|NCT04895358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92955566|NCT04895358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955567|NCT04895358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92955568|NCT04895358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92955569|NCT04895358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92955570|NCT04895358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955571|NCT04895358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955572|NCT04895358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955573|NCT04895358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955575|NCT04891289|Dexamethasone|dexamethasone|mesh-list
92955576|NCT04891289|Gemcitabine|gemcitabine|mesh-list
92955577|NCT04891289|Oxaliplatin|oxaliplatin|mesh-list
92955578|NCT04891289|Floxuridine|floxuridine|mesh-list
92601015|NCT00113906|Melatonin|melatonin|mesh-list
92955579|NCT04891289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955580|NCT04891289|Antiemetics|antiemetics|mesh-ancestor
92955581|NCT04891289|Autonomic Agents|autonomic agents|mesh-ancestor
92955582|NCT04891289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955583|NCT04891289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955584|NCT04891289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92955585|NCT04891289|Glucocorticoids|glucocorticoids|mesh-ancestor
92955586|NCT04891289|Hormones|hormones|mesh-ancestor
92955587|NCT04891289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955588|NCT04891289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955589|NCT04891289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955590|NCT04891289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955591|NCT04891289|Antimetabolites|antimetabolites|mesh-ancestor
92955592|NCT04891289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955593|NCT04879368|Trifluridine|trifluridine|mesh-list
92955594|NCT04879368|Paclitaxel|paclitaxel|mesh-list
92955595|NCT04879368|Docetaxel|docetaxel|mesh-list
92955596|NCT04879368|Nivolumab|nivolumab|mesh-list
92955597|NCT04879368|Irinotecan|irinotecan|mesh-list
92955598|NCT04879368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92955599|NCT04879368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955600|NCT04879368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92955601|NCT04879368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92955602|NCT04879368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92955603|NCT04879368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955604|NCT04879368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955605|NCT04879368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955606|NCT04879368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92955607|NCT04879368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92955608|NCT04879368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955609|NCT04879368|Antimetabolites|antimetabolites|mesh-ancestor
92955610|NCT04879368|Antiviral Agents|antiviral agents|mesh-ancestor
92955611|NCT04879368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955612|NCT04877990|Deucravacitinib|deucravacitinib|mesh-list
92955613|NCT04877990|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955614|NCT04877990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955615|NCT04877990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955616|NCT04877990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955617|NCT04861051|Ketamine|ketamine|mesh-list
92955618|NCT04861051|Analgesics|analgesics|mesh-ancestor
92955619|NCT04861051|Sensory System Agents|sensory system agents|mesh-ancestor
92955620|NCT04861051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955621|NCT04861051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955622|NCT04861051|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92955623|NCT04861051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92955624|NCT04861051|Anesthetics, General|anesthetics, general|mesh-ancestor
92955625|NCT04861051|Anesthetics|anesthetics|mesh-ancestor
92955626|NCT04861051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955627|NCT04861051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92955628|NCT04861051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92955629|NCT04861051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955630|NCT04861051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955631|NCT04834375|Dexamethasone|dexamethasone|mesh-list
92955632|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
92955633|NCT04834375|BB 1101|bb 1101|mesh-list
92955634|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955635|NCT04834375|Antiemetics|antiemetics|mesh-ancestor
92955636|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
92955637|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955638|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955639|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92955640|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
92955641|NCT04834375|Hormones|hormones|mesh-ancestor
92955642|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955643|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955644|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955645|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
92955646|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955647|NCT04834375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955648|NCT04832854|Paclitaxel|paclitaxel|mesh-list
92955649|NCT04832854|Carboplatin|carboplatin|mesh-list
92955650|NCT04832854|Gemcitabine|gemcitabine|mesh-list
92955651|NCT04832854|Pemetrexed|pemetrexed|mesh-list
92955652|NCT04832854|Atezolizumab|atezolizumab|mesh-list
92955653|NCT04832854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92955654|NCT04832854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955655|NCT04832854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92955656|NCT04832854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601077|NCT00445900|Hormones|hormones|mesh-ancestor
92955657|NCT04832854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92955658|NCT04832854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955659|NCT04832854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955660|NCT04832854|Antimetabolites|antimetabolites|mesh-ancestor
92955661|NCT04832854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955662|NCT04832854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92955663|NCT04832854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955664|NCT04832854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955665|NCT04832854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955666|NCT04829318|Esketamine|esketamine|mesh-list
92955667|NCT04829318|Antidepressive Agents|antidepressive agents|mesh-ancestor
92955668|NCT04829318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92955669|NCT04802759|Trastuzumab|trastuzumab|mesh-list
92955670|NCT04802759|Atezolizumab|atezolizumab|mesh-list
92955671|NCT04802759|Pertuzumab|pertuzumab|mesh-list
92955672|NCT04802759|Everolimus|everolimus|mesh-list
92955673|NCT04802759|Palbociclib|palbociclib|mesh-list
92955674|NCT04802759|Ipatasertib|ipatasertib|mesh-list
92955675|NCT04802759|Inavolisib|inavolisib|mesh-list
92955676|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955677|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955678|NCT04802759|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92955679|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955680|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955681|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955682|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955683|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
92955684|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955685|NCT04802759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955686|NCT04802759|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92955687|NCT04788745|Trimetazidine|trimetazidine|mesh-list
92955688|NCT04788745|Vasodilator Agents|vasodilator agents|mesh-ancestor
92955689|NCT04768296|Topotecan|topotecan|mesh-list
92955690|NCT04768296|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92955691|NCT04768296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92955692|NCT04768296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955693|NCT04768296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955694|NCT04768296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955695|NCT04722146|Lenalidomide|lenalidomide|mesh-list
92955696|NCT04722146|Pomalidomide|pomalidomide|mesh-list
92955697|NCT04722146|Bortezomib|bortezomib|mesh-list
92955698|NCT04722146|Daratumumab|daratumumab|mesh-list
92955699|NCT04722146|Nirogacestat|nirogacestat|mesh-list
92955700|NCT04722146|Immunologic Factors|immunologic factors|mesh-ancestor
92955701|NCT04722146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955702|NCT04722146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92955703|NCT04722146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92955704|NCT04722146|Growth Substances|growth substances|mesh-ancestor
92955705|NCT04722146|Growth Inhibitors|growth inhibitors|mesh-ancestor
92955706|NCT04722146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955707|NCT04722146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92955708|NCT04722146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955709|NCT04722146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955710|NCT04712903|Carboplatin|carboplatin|mesh-list
92955711|NCT04712903|Etoposide|etoposide|mesh-list
92955712|NCT04712903|Durvalumab|durvalumab|mesh-list
92955713|NCT04712903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955714|NCT04712903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92955715|NCT04712903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92955716|NCT04712903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92955717|NCT04712903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955718|NCT04712903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955719|NCT04712903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955720|NCT04710927|Fluorides|fluorides|mesh-list
92955721|NCT04710927|Cariostatic Agents|cariostatic agents|mesh-ancestor
92955722|NCT04710927|Protective Agents|protective agents|mesh-ancestor
92955723|NCT04710927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955724|NCT04708470|Entinostat|entinostat|mesh-list
92955725|NCT04708470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955726|NCT04708470|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92955727|NCT04708470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955728|NCT04708470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955729|NCT04694976|Vitamin D|vitamin d|mesh-list
92955730|NCT04694976|Vitamins|vitamins|mesh-ancestor
92955731|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
92955732|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955733|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92955734|NCT04683627|Diclofenac|diclofenac|mesh-list
92955735|NCT04683627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92955736|NCT04683627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92955737|NCT04683627|Analgesics|analgesics|mesh-ancestor
92955738|NCT04683627|Sensory System Agents|sensory system agents|mesh-ancestor
92955739|NCT04683627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955740|NCT04683627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955741|NCT04683627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955742|NCT04683627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92955743|NCT04683627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92955744|NCT04683627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955745|NCT04683627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955746|NCT04683029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92955747|NCT04683029|Immunologic Factors|immunologic factors|mesh-ancestor
92955748|NCT04683029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955749|NCT04673357|Ustekinumab|ustekinumab|mesh-list
92955750|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955751|NCT04658862|Gemcitabine|gemcitabine|mesh-list
92955752|NCT04658862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955753|NCT04658862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955754|NCT04658862|Antimetabolites|antimetabolites|mesh-ancestor
92955755|NCT04658862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955756|NCT04657666|Nabiximols|nabiximols|mesh-list
92955757|NCT04657666|Analgesics|analgesics|mesh-ancestor
92955758|NCT04657666|Sensory System Agents|sensory system agents|mesh-ancestor
92955759|NCT04657666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955760|NCT04657666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955761|NCT04646967|Acetaminophen|acetaminophen|mesh-list
92955762|NCT04646967|Ibuprofen|ibuprofen|mesh-list
92955763|NCT04646967|Ketorolac|ketorolac|mesh-list
92955764|NCT04646967|Bupivacaine|bupivacaine|mesh-list
92955765|NCT04646967|Sevoflurane|sevoflurane|mesh-list
92955766|NCT04646967|Anesthetics, Local|anesthetics, local|mesh-ancestor
92955767|NCT04646967|Anesthetics|anesthetics|mesh-ancestor
92955768|NCT04646967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955769|NCT04646967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955770|NCT04646967|Sensory System Agents|sensory system agents|mesh-ancestor
92955771|NCT04646967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955772|NCT04646967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92955773|NCT04646967|Analgesics|analgesics|mesh-ancestor
92955774|NCT04646967|Antipyretics|antipyretics|mesh-ancestor
92955775|NCT04646967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92955776|NCT04646967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955777|NCT04646967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92955778|NCT04646967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92955779|NCT04646967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955780|NCT04646967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955781|NCT04646967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92955782|NCT04646967|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92955783|NCT04646967|Anesthetics, General|anesthetics, general|mesh-ancestor
92955784|NCT04640623|Gemcitabine|gemcitabine|mesh-list
92955785|NCT04640623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92955786|NCT04640623|Antimetabolites|antimetabolites|mesh-ancestor
92955787|NCT04640623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955788|NCT04640623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955789|NCT04630028|Ustekinumab|ustekinumab|mesh-list
92955790|NCT04630028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955791|NCT04619797|Carboplatin|carboplatin|mesh-list
92955792|NCT04619797|Pembrolizumab|pembrolizumab|mesh-list
92955793|NCT04619797|Pemetrexed|pemetrexed|mesh-list
92955794|NCT04619797|Atezolizumab|atezolizumab|mesh-list
92955795|NCT04619797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955796|NCT04619797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955797|NCT04619797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955798|NCT04619797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955799|NCT04619797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955800|NCT04619797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92955801|NCT04619797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955802|NCT04606381|Lazertinib|lazertinib|mesh-list
92955803|NCT04606381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955804|NCT04606381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955805|NCT04606381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955806|NCT04600336|Oxybutynin|oxybutynin|mesh-list
92955807|NCT04600336|Parasympatholytics|parasympatholytics|mesh-ancestor
92955808|NCT04600336|Autonomic Agents|autonomic agents|mesh-ancestor
92955809|NCT04600336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955810|NCT04600336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955811|NCT04600336|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92955812|NCT04600336|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92955813|NCT04600336|Cholinergic Agents|cholinergic agents|mesh-ancestor
92955814|NCT04600336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92955815|NCT04600336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955816|NCT04600336|Urological Agents|urological agents|mesh-ancestor
92955817|NCT04599855|Esketamine|esketamine|mesh-list
92955818|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
92955819|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92955820|NCT04586426|Daratumumab|daratumumab|mesh-list
92955821|NCT04586426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955822|NCT04585789|Tenofovir|tenofovir|mesh-list
92955823|NCT04585789|Entecavir|entecavir|mesh-list
92955824|NCT04585789|JNJ-56136379|jnj-56136379|mesh-list
92955825|NCT04585789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92955826|NCT04585789|Antiviral Agents|antiviral agents|mesh-ancestor
92955827|NCT04585789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955828|NCT04585789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92955829|NCT04585789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955830|NCT04585789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955831|NCT04585789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955832|NCT04585789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92955833|NCT04585789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92955834|NCT04577833|Prednisone|prednisone|mesh-list
92955835|NCT04577833|Abiraterone Acetate|abiraterone acetate|mesh-list
92955836|NCT04577833|Niraparib|niraparib|mesh-list
92955837|NCT04577833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955838|NCT04577833|Glucocorticoids|glucocorticoids|mesh-ancestor
92955839|NCT04577833|Hormones|hormones|mesh-ancestor
92955840|NCT04577833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955841|NCT04577833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955842|NCT04577833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955843|NCT04577833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955844|NCT04577833|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92955845|NCT04577833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955846|NCT04577833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955847|NCT04577833|Hormone Antagonists|hormone antagonists|mesh-ancestor
92955848|NCT04577833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92955849|NCT04577833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92955850|NCT04565990|Selexipag|selexipag|mesh-list
92955851|NCT04565990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92955852|NCT04563754|Proflavine|proflavine|mesh-list
92955853|NCT04563754|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92955854|NCT04563754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955855|NCT04551521|Trastuzumab|trastuzumab|mesh-list
92955856|NCT04551521|Atezolizumab|atezolizumab|mesh-list
92955857|NCT04551521|Pertuzumab|pertuzumab|mesh-list
92955858|NCT04551521|Vemurafenib|vemurafenib|mesh-list
92955859|NCT04551521|Ipatasertib|ipatasertib|mesh-list
92955860|NCT04551521|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92955861|NCT04551521|Inavolisib|inavolisib|mesh-list
92955862|NCT04551521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955863|NCT04551521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955864|NCT04551521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955865|NCT04551521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955866|NCT04551521|Immunologic Factors|immunologic factors|mesh-ancestor
92955867|NCT04551521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955868|NCT04551521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955869|NCT04551521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955870|NCT04551521|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92955871|NCT04543617|Atezolizumab|atezolizumab|mesh-list
92955872|NCT04543617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92955873|NCT04543617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92955874|NCT04543617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955875|NCT04543617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955876|NCT04543617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955877|NCT04543617|Immunologic Factors|immunologic factors|mesh-ancestor
92955878|NCT04543617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955879|NCT04539249|Magnesium Sulfate|magnesium sulfate|mesh-list
92955881|NCT04539249|Analgesics|analgesics|mesh-ancestor
92955882|NCT04539249|Sensory System Agents|sensory system agents|mesh-ancestor
92955883|NCT04539249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92955884|NCT04539249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601302|NCT00447577|Tobramycin|tobramycin|mesh-list
92955885|NCT04539249|Anesthetics|anesthetics|mesh-ancestor
92955886|NCT04539249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955887|NCT04539249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92955888|NCT04539249|Anticonvulsants|anticonvulsants|mesh-ancestor
92955889|NCT04539249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92955890|NCT04539249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92955891|NCT04539249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955892|NCT04539249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92955893|NCT04539249|Tocolytic Agents|tocolytic agents|mesh-ancestor
92955894|NCT04539249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92955895|NCT04539249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92955896|NCT04539249|Narcotics|narcotics|mesh-ancestor
92955897|NCT04539249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92955898|NCT04539249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92955899|NCT04538664|Carboplatin|carboplatin|mesh-list
92955900|NCT04538664|Pemetrexed|pemetrexed|mesh-list
92955901|NCT04538664|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92955902|NCT04538664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955903|NCT04538664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955904|NCT04538664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955905|NCT04538664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92955906|NCT04538664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955907|NCT04538664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955908|NCT04538378|Durvalumab|durvalumab|mesh-list
92955909|NCT04538378|Olaparib|olaparib|mesh-list
92955910|NCT04538378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955911|NCT04538378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955912|NCT04538378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92955913|NCT04538378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955914|NCT04538378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955915|NCT04535544|Tenofovir|tenofovir|mesh-list
92955916|NCT04535544|Entecavir|entecavir|mesh-list
92955917|NCT04535544|Antiviral Agents|antiviral agents|mesh-ancestor
92955918|NCT04535544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955919|NCT04535544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92955920|NCT04535544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955921|NCT04535544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955922|NCT04535544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955923|NCT04535544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92955924|NCT04535544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92955925|NCT04523493|Lenvatinib|lenvatinib|mesh-list
92955926|NCT04523493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955927|NCT04523493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955928|NCT04523493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955929|NCT04523493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955930|NCT04523207|Relugolix|relugolix|mesh-list
92955931|NCT04523207|Androgen Antagonists|androgen antagonists|mesh-ancestor
92955932|NCT04523207|Hormone Antagonists|hormone antagonists|mesh-ancestor
92955933|NCT04523207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955934|NCT04523207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955935|NCT04513912|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92955936|NCT04513912|Antidepressive Agents|antidepressive agents|mesh-ancestor
92955937|NCT04513912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92955938|NCT04513912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92955939|NCT04513912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92955940|NCT04513912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92955941|NCT04513912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955942|NCT04497844|Prednisone|prednisone|mesh-list
92955943|NCT04497844|Abiraterone Acetate|abiraterone acetate|mesh-list
92955944|NCT04497844|Niraparib|niraparib|mesh-list
92955945|NCT04497844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92955946|NCT04497844|Glucocorticoids|glucocorticoids|mesh-ancestor
92955947|NCT04497844|Hormones|hormones|mesh-ancestor
92955948|NCT04497844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92955949|NCT04497844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955950|NCT04497844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92955951|NCT04497844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955952|NCT04497844|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92955953|NCT04497844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955954|NCT04497844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955955|NCT04497844|Hormone Antagonists|hormone antagonists|mesh-ancestor
92955956|NCT04497844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92955957|NCT04497844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92955958|NCT04492891|Cyclosporine|cyclosporine|mesh-list
92955960|NCT04492891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955961|NCT04492891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955962|NCT04492891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92955963|NCT04492891|Immunologic Factors|immunologic factors|mesh-ancestor
92955964|NCT04492891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955965|NCT04492891|Antifungal Agents|antifungal agents|mesh-ancestor
92955966|NCT04492891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955967|NCT04492891|Dermatologic Agents|dermatologic agents|mesh-ancestor
92955968|NCT04492891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92955969|NCT04492891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92955970|NCT04487080|Osimertinib|osimertinib|mesh-list
92955971|NCT04487080|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92955972|NCT04487080|Lazertinib|lazertinib|mesh-list
92955973|NCT04487080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92955974|NCT04487080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92955975|NCT04487080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955976|NCT04487080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955977|NCT04487080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92955978|NCT04485104|Cannabidiol|cannabidiol|mesh-list
92955979|NCT04485104|Anticonvulsants|anticonvulsants|mesh-ancestor
92955980|NCT04449198|Resveratrol|resveratrol|mesh-list
92955981|NCT04449198|Antioxidants|antioxidants|mesh-ancestor
92955982|NCT04449198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955983|NCT04449198|Protective Agents|protective agents|mesh-ancestor
92955984|NCT04449198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92955985|NCT04449198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955986|NCT04449198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92955987|NCT04439539|Tenofovir|tenofovir|mesh-list
92955988|NCT04439539|JNJ-56136379|jnj-56136379|mesh-list
92955989|NCT04439539|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92955990|NCT04439539|Antiviral Agents|antiviral agents|mesh-ancestor
92955991|NCT04439539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92955992|NCT04439539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92955993|NCT04439539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92955994|NCT04439539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92955995|NCT04439539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92955996|NCT04439539|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92955997|NCT04439539|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92955998|NCT04372108|Ustekinumab|ustekinumab|mesh-list
92955999|NCT04372108|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956000|NCT04312659|Infliximab|infliximab|mesh-list
92956001|NCT04312659|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92956002|NCT04312659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956003|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956004|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956005|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956006|NCT04305327|Ustekinumab|ustekinumab|mesh-list
92956007|NCT04305327|Brodalumab|brodalumab|mesh-list
92956008|NCT04305327|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956009|NCT04303858|Atezolizumab|atezolizumab|mesh-list
92956010|NCT04303858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956011|NCT04303858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956012|NCT04303858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956013|NCT04303858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956014|NCT04302025|Atezolizumab|atezolizumab|mesh-list
92956015|NCT04302025|Vemurafenib|vemurafenib|mesh-list
92956016|NCT04302025|Pralsetinib|pralsetinib|mesh-list
92956017|NCT04302025|Entrectinib|entrectinib|mesh-list
92956018|NCT04302025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956019|NCT04302025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956020|NCT04302025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956021|NCT04302025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956022|NCT04302025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92956023|NCT04302025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956024|NCT04294810|Atezolizumab|atezolizumab|mesh-list
92956025|NCT04294810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956026|NCT04294810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956027|NCT04294810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956028|NCT04294810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956029|NCT04273945|Macitentan|macitentan|mesh-list
92956030|NCT04273945|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92956031|NCT04273945|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92956032|NCT04273945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601451|NCT00448942|Chlorhexidine|chlorhexidine|mesh-list
92956033|NCT04273945|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92956034|NCT04271475|Macitentan|macitentan|mesh-list
92956035|NCT04271475|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92956036|NCT04271475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92956037|NCT04271475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956038|NCT04271475|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92956039|NCT04271189|Metformin|metformin|mesh-list
92956040|NCT04271189|Pioglitazone|pioglitazone|mesh-list
92956041|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92956042|NCT04271189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92956043|NCT04271189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956044|NCT04271189|Incretins|incretins|mesh-ancestor
92956045|NCT04271189|Hormones|hormones|mesh-ancestor
92956046|NCT04271189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956047|NCT04271189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92956048|NCT04271189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92956049|NCT04271189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956050|NCT04271189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956051|NCT04221945|Cisplatin|cisplatin|mesh-list
92956052|NCT04221945|Pembrolizumab|pembrolizumab|mesh-list
92956053|NCT04221945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956054|NCT04221945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956055|NCT04221945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956056|NCT04221945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956057|NCT04199325|Uric Acid|uric acid|mesh-list
92956058|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
92956059|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956060|NCT04199325|Protective Agents|protective agents|mesh-ancestor
92956061|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956062|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92956063|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92956064|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956065|NCT04181827|Dexamethasone|dexamethasone|mesh-list
92956066|NCT04181827|Bortezomib|bortezomib|mesh-list
92956067|NCT04181827|Daratumumab|daratumumab|mesh-list
92956068|NCT04181827|Pomalidomide|pomalidomide|mesh-list
92956069|NCT04181827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956070|NCT04181827|Antiemetics|antiemetics|mesh-ancestor
92165542|NCT03331198|Venetoclax|venetoclax|mesh-list
92956071|NCT04181827|Autonomic Agents|autonomic agents|mesh-ancestor
92956072|NCT04181827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956073|NCT04181827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956074|NCT04181827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956075|NCT04181827|Glucocorticoids|glucocorticoids|mesh-ancestor
92956076|NCT04181827|Hormones|hormones|mesh-ancestor
92956077|NCT04181827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956078|NCT04181827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956079|NCT04181827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956080|NCT04181827|Immunologic Factors|immunologic factors|mesh-ancestor
92956081|NCT04181827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92956082|NCT04181827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92956083|NCT04181827|Growth Substances|growth substances|mesh-ancestor
92956084|NCT04181827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92956085|NCT04175600|Selexipag|selexipag|mesh-list
92956086|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92956087|NCT04166396|Resveratrol|resveratrol|mesh-list
92956088|NCT04166396|Antioxidants|antioxidants|mesh-ancestor
92956089|NCT04166396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956090|NCT04166396|Protective Agents|protective agents|mesh-ancestor
92956091|NCT04166396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956092|NCT04166396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956093|NCT04166396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92956095|NCT04160494|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
92956096|NCT04160494|Immunoconjugates|immunoconjugates|mesh-list
92956097|NCT04160494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956098|NCT04160494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956099|NCT04160494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956100|NCT04160494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956101|NCT04160494|Immunologic Factors|immunologic factors|mesh-ancestor
92956102|NCT04160494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956103|NCT04157725|Clomiphene|clomiphene|mesh-list
92956104|NCT04157725|Enclomiphene|enclomiphene|mesh-list
92956105|NCT04157725|Zuclomiphene|zuclomiphene|mesh-list
92956106|NCT04157725|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92601532|NCT00449410|Ezetimibe|ezetimibe|mesh-list
92956107|NCT04157725|Hormone Antagonists|hormone antagonists|mesh-ancestor
92956108|NCT04157725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956109|NCT04157725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956110|NCT04157725|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92956111|NCT04157725|Fertility Agents|fertility agents|mesh-ancestor
92956112|NCT04157725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92956113|NCT04157725|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92956114|NCT04157725|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92956115|NCT04145518|Naproxen|naproxen|mesh-list
92956116|NCT04145518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92956117|NCT04145518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92956118|NCT04145518|Analgesics|analgesics|mesh-ancestor
92956119|NCT04145518|Sensory System Agents|sensory system agents|mesh-ancestor
92956120|NCT04145518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956121|NCT04145518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956122|NCT04145518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956123|NCT04145518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956124|NCT04145518|Gout Suppressants|gout suppressants|mesh-ancestor
92956125|NCT04145518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92956126|NCT04145518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956127|NCT04145518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956128|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92956129|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92956130|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956131|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
92956132|NCT04133636|Dexamethasone|dexamethasone|mesh-list
92956133|NCT04133636|Lenalidomide|lenalidomide|mesh-list
92956134|NCT04133636|Bortezomib|bortezomib|mesh-list
92956135|NCT04133636|Daratumumab|daratumumab|mesh-list
92956136|NCT04133636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956137|NCT04133636|Antiemetics|antiemetics|mesh-ancestor
92956138|NCT04133636|Autonomic Agents|autonomic agents|mesh-ancestor
92956139|NCT04133636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956140|NCT04133636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956141|NCT04133636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956142|NCT04133636|Glucocorticoids|glucocorticoids|mesh-ancestor
92956143|NCT04133636|Hormones|hormones|mesh-ancestor
92956144|NCT04133636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956145|NCT04133636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956146|NCT04133636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956147|NCT04133636|Immunologic Factors|immunologic factors|mesh-ancestor
92956148|NCT04133636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92956149|NCT04133636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92956150|NCT04133636|Growth Substances|growth substances|mesh-ancestor
92956151|NCT04133636|Growth Inhibitors|growth inhibitors|mesh-ancestor
92956152|NCT04121260|Daratumumab|daratumumab|mesh-list
92956153|NCT04121260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956154|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92956155|NCT04113382|Laxatives|laxatives|mesh-ancestor
92956156|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956157|NCT04108208|Androgens|androgens|mesh-list
92956158|NCT04108208|Hormones|hormones|mesh-ancestor
92956159|NCT04108208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956160|NCT04108208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956161|NCT04108195|Daratumumab|daratumumab|mesh-list
92956162|NCT04108195|Pomalidomide|pomalidomide|mesh-list
92527488|NCT00000620|Antioxidants|antioxidants|mesh-ancestor
92956163|NCT04108195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956164|NCT04108195|Immunologic Factors|immunologic factors|mesh-ancestor
92956165|NCT04108195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956166|NCT04108195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92956167|NCT04108195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92956168|NCT04108195|Growth Substances|growth substances|mesh-ancestor
92956169|NCT04108195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92956170|NCT04101721|Aflibercept|aflibercept|mesh-list
92956171|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92956172|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92956173|NCT04101721|Growth Substances|growth substances|mesh-ancestor
92956174|NCT04101721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956175|NCT04101721|Growth Inhibitors|growth inhibitors|mesh-ancestor
92956176|NCT04101721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956177|NCT04100135|Clopidogrel|clopidogrel|mesh-list
92956178|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92956179|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92956180|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92956181|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92601605|NCT00449683|Urological Agents|urological agents|mesh-ancestor
92956182|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92956183|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
92956184|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92956185|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956186|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956188|NCT04083235|Paclitaxel|paclitaxel|mesh-list
92956189|NCT04083235|Gemcitabine|gemcitabine|mesh-list
92956190|NCT04083235|Fluorouracil|fluorouracil|mesh-list
92956191|NCT04083235|Oxaliplatin|oxaliplatin|mesh-list
92956192|NCT04083235|Irinotecan|irinotecan|mesh-list
92956193|NCT04083235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92956194|NCT04083235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956195|NCT04083235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956196|NCT04083235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956197|NCT04083235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956198|NCT04083235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956199|NCT04083235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956200|NCT04083235|Antimetabolites|antimetabolites|mesh-ancestor
92956201|NCT04083235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956202|NCT04083235|Immunologic Factors|immunologic factors|mesh-ancestor
92956203|NCT04083235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956204|NCT04083235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92956205|NCT04083235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92956206|NCT04083235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956207|NCT04083235|Antidotes|antidotes|mesh-ancestor
92956208|NCT04083235|Protective Agents|protective agents|mesh-ancestor
92956209|NCT04083235|Vitamin B Complex|vitamin b complex|mesh-ancestor
92956210|NCT04083235|Vitamins|vitamins|mesh-ancestor
92956211|NCT04083235|Micronutrients|micronutrients|mesh-ancestor
92956212|NCT04077723|Obinutuzumab|obinutuzumab|mesh-list
92956213|NCT04077723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956214|NCT04077723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956215|NCT04077463|Carboplatin|carboplatin|mesh-list
92956216|NCT04077463|Pemetrexed|pemetrexed|mesh-list
92956217|NCT04077463|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92956218|NCT04077463|Lazertinib|lazertinib|mesh-list
92956219|NCT04077463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956220|NCT04077463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956221|NCT04077463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956222|NCT04077463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92956223|NCT04077463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92956224|NCT04077463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92956225|NCT04077463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956226|NCT04055012|Metformin|metformin|mesh-list
92956227|NCT04055012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92956228|NCT04055012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956229|NCT04044690|Immunoglobulins|immunoglobulins|mesh-list
92956230|NCT04044690|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92956231|NCT04044690|Antibodies|antibodies|mesh-list
92956232|NCT04044690|Immunoglobulin G|immunoglobulin g|mesh-list
92956233|NCT04044690|Immunologic Factors|immunologic factors|mesh-ancestor
92956234|NCT04044690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956235|NCT04042831|Olaparib|olaparib|mesh-list
92956236|NCT04042831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92301197|NCT02101021|Paclitaxel|paclitaxel|mesh-list
92956237|NCT04042831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956238|NCT04042831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956239|NCT04042831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956240|NCT04034095|Prednisolone|prednisolone|mesh-list
92956241|NCT04034095|Docetaxel|docetaxel|mesh-list
92956242|NCT04034095|Bicalutamide|bicalutamide|mesh-list
92956243|NCT04034095|Androgens|androgens|mesh-list
92956244|NCT04034095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956245|NCT04034095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956246|NCT04034095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956247|NCT04034095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956248|NCT04034095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956249|NCT04034095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956250|NCT04034095|Glucocorticoids|glucocorticoids|mesh-ancestor
92956251|NCT04034095|Hormones|hormones|mesh-ancestor
92956252|NCT04034095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956253|NCT04034095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956254|NCT04034095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956255|NCT04034095|Androgen Antagonists|androgen antagonists|mesh-ancestor
92956256|NCT04034095|Hormone Antagonists|hormone antagonists|mesh-ancestor
92601679|NCT05536362|Sympatholytics|sympatholytics|mesh-ancestor
92956257|NCT04009668|Adalimumab|adalimumab|mesh-list
92956258|NCT04009668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92956259|NCT04009668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956260|NCT04009668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956261|NCT03968640|Coenzyme Q10|coenzyme q10|mesh-list
92956262|NCT03968640|Vitamins|vitamins|mesh-ancestor
92956263|NCT03968640|Micronutrients|micronutrients|mesh-ancestor
92956264|NCT03968640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956265|NCT03962647|Letrozole|letrozole|mesh-list
92956266|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956267|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92956268|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92956269|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956270|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956271|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92956272|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
92956273|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956274|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956275|NCT03948074|Dronabinol|dronabinol|mesh-list
92956276|NCT03948074|Cannabidiol|cannabidiol|mesh-list
92956277|NCT03948074|Anticonvulsants|anticonvulsants|mesh-ancestor
92956278|NCT03948074|Hallucinogens|hallucinogens|mesh-ancestor
92956279|NCT03948074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956280|NCT03948074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92956281|NCT03948074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92956282|NCT03948074|Analgesics|analgesics|mesh-ancestor
92956283|NCT03948074|Sensory System Agents|sensory system agents|mesh-ancestor
92956284|NCT03948074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956285|NCT03948074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92956286|NCT03948074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92956287|NCT03948074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92956288|NCT03948074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956289|NCT03948074|Hormones|hormones|mesh-ancestor
92956290|NCT03948074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956291|NCT03942328|Bevacizumab|bevacizumab|mesh-list
92956292|NCT03942328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92956293|NCT03942328|Atezolizumab|atezolizumab|mesh-list
92956294|NCT03942328|Vaccines|vaccines|mesh-list
92956295|NCT03942328|Antibodies|antibodies|mesh-list
92956296|NCT03942328|Immunoglobulins|immunoglobulins|mesh-list
92956297|NCT03942328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92956298|NCT03942328|Immunoglobulin G|immunoglobulin g|mesh-list
92956299|NCT03942328|Endothelial Growth Factors|endothelial growth factors|mesh-list
92956300|NCT03942328|Immunologic Factors|immunologic factors|mesh-ancestor
92956301|NCT03942328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956302|NCT03942328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956303|NCT03942328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92956304|NCT03942328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92956305|NCT03942328|Growth Substances|growth substances|mesh-ancestor
92956306|NCT03942328|Growth Inhibitors|growth inhibitors|mesh-ancestor
92956307|NCT03942328|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956308|NCT03942328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956309|NCT03939104|Artesunate|artesunate|mesh-list
92956310|NCT03939104|Lumefantrine|lumefantrine|mesh-list
92956312|NCT03939104|Piperaquine|piperaquine|mesh-list
92956313|NCT03939104|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92956314|NCT03939104|Amodiaquine|amodiaquine|mesh-list
92956315|NCT03939104|Mefloquine|mefloquine|mesh-list
92956316|NCT03939104|Antimalarials|antimalarials|mesh-ancestor
92956317|NCT03939104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92956318|NCT03939104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92956319|NCT03939104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956320|NCT03939104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956321|NCT03939104|Antiviral Agents|antiviral agents|mesh-ancestor
92956322|NCT03939104|Schistosomicides|schistosomicides|mesh-ancestor
92956323|NCT03939104|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92956324|NCT03939104|Anthelmintics|anthelmintics|mesh-ancestor
92956325|NCT03932318|Azacitidine|azacitidine|mesh-list
92956326|NCT03932318|Venetoclax|venetoclax|mesh-list
92956327|NCT03932318|Lintuzumab|lintuzumab|mesh-list
92956328|NCT03932318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956329|NCT03932318|Antimetabolites|antimetabolites|mesh-ancestor
92956330|NCT03932318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956331|NCT03932318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956332|NCT03932318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956333|NCT03932318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601763|NCT00458731|Cediranib|cediranib|mesh-list
92956334|NCT03924895|Pembrolizumab|pembrolizumab|mesh-list
92956335|NCT03924895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956337|NCT03924895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956338|NCT03924895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956339|NCT03923725|Artesunate|artesunate|mesh-list
92956340|NCT03923725|Lumefantrine|lumefantrine|mesh-list
92956341|NCT03923725|Artemether|artemether|mesh-list
92956342|NCT03923725|Piperaquine|piperaquine|mesh-list
92956343|NCT03923725|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92956344|NCT03923725|Amodiaquine|amodiaquine|mesh-list
92956345|NCT03923725|Mefloquine|mefloquine|mesh-list
92956346|NCT03923725|Antimalarials|antimalarials|mesh-ancestor
92956347|NCT03923725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92956348|NCT03923725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92956349|NCT03923725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956350|NCT03923725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956351|NCT03923725|Antiviral Agents|antiviral agents|mesh-ancestor
92956352|NCT03923725|Schistosomicides|schistosomicides|mesh-ancestor
92956353|NCT03923725|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92956354|NCT03923725|Anthelmintics|anthelmintics|mesh-ancestor
92956355|NCT03904693|Tadalafil|tadalafil|mesh-list
92956356|NCT03904693|Macitentan|macitentan|mesh-list
92956357|NCT03904693|Vasodilator Agents|vasodilator agents|mesh-ancestor
92956358|NCT03904693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92956359|NCT03904693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92956360|NCT03904693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956361|NCT03904693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956362|NCT03904693|Urological Agents|urological agents|mesh-ancestor
92956363|NCT03904693|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92956364|NCT03904693|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92956365|NCT03904693|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92956366|NCT03901963|Lenalidomide|lenalidomide|mesh-list
92956367|NCT03901963|Daratumumab|daratumumab|mesh-list
92956368|NCT03901963|Immunologic Factors|immunologic factors|mesh-ancestor
92956369|NCT03901963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956370|NCT03901963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92956371|NCT03901963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92956372|NCT03901963|Growth Substances|growth substances|mesh-ancestor
92956373|NCT03901963|Growth Inhibitors|growth inhibitors|mesh-ancestor
92956374|NCT03901963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956375|NCT03864926|Tacrolimus|tacrolimus|mesh-list
92956376|NCT03864926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956377|NCT03864926|Immunologic Factors|immunologic factors|mesh-ancestor
92956378|NCT03864926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956379|NCT03864926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92956380|NCT03864926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956381|NCT03864926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956382|NCT03836261|Venetoclax|venetoclax|mesh-list
92956383|NCT03836261|Obinutuzumab|obinutuzumab|mesh-list
92956384|NCT03836261|Acalabrutinib|acalabrutinib|mesh-list
92956385|NCT03836261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956386|NCT03836261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956387|NCT03809533|Sofosbuvir|sofosbuvir|mesh-list
92956388|NCT03809533|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92956390|NCT03809533|Antiviral Agents|antiviral agents|mesh-ancestor
92956391|NCT03809533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956392|NCT03767244|Androgens|androgens|mesh-list
92956393|NCT03767244|Hormones|hormones|mesh-ancestor
92956394|NCT03767244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956395|NCT03767244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956396|NCT03745326|Aldesleukin|aldesleukin|mesh-list
92956397|NCT03745326|Cyclophosphamide|cyclophosphamide|mesh-list
92956398|NCT03745326|Fludarabine|fludarabine|mesh-list
92956399|NCT03745326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956400|NCT03745326|Immunologic Factors|immunologic factors|mesh-ancestor
92956401|NCT03745326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956402|NCT03745326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956403|NCT03745326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956404|NCT03745326|Alkylating Agents|alkylating agents|mesh-ancestor
92956405|NCT03745326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956406|NCT03745326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956407|NCT03745326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92956408|NCT03745326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92165604|NCT02546440|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956409|NCT03745326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92956410|NCT03745326|Antiviral Agents|antiviral agents|mesh-ancestor
92956411|NCT03745326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956412|NCT03718234|Hydrocortisone|hydrocortisone|mesh-list
92956413|NCT03718234|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92956414|NCT03718234|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92956415|NCT03718234|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92956416|NCT03718234|Glucocorticoids|glucocorticoids|mesh-list
92956417|NCT03718234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956418|NCT03718234|Hormones|hormones|mesh-ancestor
92956419|NCT03718234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956420|NCT03718234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956421|NCT03654274|Norethindrone|norethindrone|mesh-list
92956422|NCT03654274|Norethindrone Acetate|norethindrone acetate|mesh-list
92956423|NCT03654274|Estradiol|estradiol|mesh-list
92956424|NCT03654274|Relugolix|relugolix|mesh-list
92956425|NCT03654274|Estrogens|estrogens|mesh-ancestor
92956426|NCT03654274|Hormones|hormones|mesh-ancestor
92956427|NCT03654274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956428|NCT03654274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956429|NCT03654274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92956430|NCT03654274|Contraceptive Agents|contraceptive agents|mesh-ancestor
92956431|NCT03654274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92956432|NCT03654274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92956433|NCT03654274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92956434|NCT03654274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92956435|NCT03654274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92956436|NCT03654274|Androgen Antagonists|androgen antagonists|mesh-ancestor
92956437|NCT03654274|Hormone Antagonists|hormone antagonists|mesh-ancestor
92956438|NCT03643107|Prednisolone|prednisolone|mesh-list
92956439|NCT03643107|Irofulven|irofulven|mesh-list
92956440|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956441|NCT03643107|Glucocorticoids|glucocorticoids|mesh-ancestor
92956442|NCT03643107|Hormones|hormones|mesh-ancestor
92956443|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956444|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956445|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956446|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956447|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956448|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
92956449|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956450|NCT03623243|Siponimod|siponimod|mesh-list
92956451|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92956452|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956453|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956454|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
92956455|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956456|NCT03619707|Progesterone|progesterone|mesh-list
92956457|NCT03619707|Progestins|progestins|mesh-ancestor
92956458|NCT03619707|Hormones|hormones|mesh-ancestor
92956459|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956460|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956461|NCT03597568|Resveratrol|resveratrol|mesh-list
92956463|NCT03597568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956464|NCT03597568|Protective Agents|protective agents|mesh-ancestor
92956465|NCT03597568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956466|NCT03597568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956467|NCT03597568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92956468|NCT03593408|Fentanyl|fentanyl|mesh-list
92956469|NCT03593408|Midazolam|midazolam|mesh-list
92956470|NCT03593408|Dexmedetomidine|dexmedetomidine|mesh-list
92956471|NCT03593408|Morphine|morphine|mesh-list
92956472|NCT03593408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92956473|NCT03593408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92956474|NCT03593408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956475|NCT03593408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92956476|NCT03593408|Analgesics|analgesics|mesh-ancestor
92956477|NCT03593408|Sensory System Agents|sensory system agents|mesh-ancestor
92956478|NCT03593408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165605|NCT02546440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956479|NCT03593408|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92956480|NCT03593408|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92956481|NCT03593408|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92956482|NCT03593408|Adrenergic Agents|adrenergic agents|mesh-ancestor
92956483|NCT03593408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92956484|NCT03593408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956485|NCT03593408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92601906|NCT00460369|Antiviral Agents|antiviral agents|mesh-ancestor
92956486|NCT03593408|Narcotics|narcotics|mesh-ancestor
92956487|NCT03593408|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92956488|NCT03593408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92956489|NCT03593408|Anesthetics, General|anesthetics, general|mesh-ancestor
92956490|NCT03593408|Anesthetics|anesthetics|mesh-ancestor
92956491|NCT03593408|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92956492|NCT03593408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92956493|NCT03593408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92956494|NCT03593408|GABA Modulators|gaba modulators|mesh-ancestor
92956495|NCT03593408|GABA Agents|gaba agents|mesh-ancestor
92956496|NCT03581240|Eflornithine|eflornithine|mesh-list
92956497|NCT03581240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956498|NCT03581240|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92956499|NCT03581240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92956500|NCT03581240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92956501|NCT03581240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956502|NCT03581240|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92956503|NCT03581240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956504|NCT03581240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956506|NCT03572582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956507|NCT03572582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956508|NCT03572582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956509|NCT03572582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956510|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92956511|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956512|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956513|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956514|NCT03466411|Ustekinumab|ustekinumab|mesh-list
92956515|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92956516|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956517|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
92956518|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956519|NCT03464097|Ozanimod|ozanimod|mesh-list
92956520|NCT03464097|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92956521|NCT03464097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956522|NCT03464097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956523|NCT03464097|Immunologic Factors|immunologic factors|mesh-ancestor
92956524|NCT03464097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956525|NCT03432871|Niacinamide|niacinamide|mesh-list
92956526|NCT03432871|Niacin|niacin|mesh-list
92956527|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
92956528|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
92956529|NCT03432871|Vitamins|vitamins|mesh-ancestor
92956530|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
92956531|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956532|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92956533|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
92956534|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956535|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92956536|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92956537|NCT03399318|Acetaminophen|acetaminophen|mesh-list
92956538|NCT03399318|Ibuprofen|ibuprofen|mesh-list
92956539|NCT03399318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92956540|NCT03399318|Analgesics|analgesics|mesh-ancestor
92956541|NCT03399318|Sensory System Agents|sensory system agents|mesh-ancestor
92956542|NCT03399318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956543|NCT03399318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956544|NCT03399318|Antipyretics|antipyretics|mesh-ancestor
92956545|NCT03399318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92956546|NCT03399318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956547|NCT03399318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956548|NCT03399318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92956549|NCT03399318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956550|NCT03399318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956551|NCT03390504|Docetaxel|docetaxel|mesh-list
92956552|NCT03390504|Pembrolizumab|pembrolizumab|mesh-list
92956553|NCT03390504|Mitogens|mitogens|mesh-list
92956554|NCT03390504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956555|NCT03390504|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956556|NCT03390504|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956557|NCT03390504|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956558|NCT03390504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956559|NCT03390504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956560|NCT03390504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956561|NCT03389139|Anesthetics|anesthetics|mesh-list
92956562|NCT03389139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92956563|NCT03389139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956564|NCT03382938|Dexmedetomidine|dexmedetomidine|mesh-list
92956565|NCT03382938|Ropivacaine|ropivacaine|mesh-list
92956566|NCT03382938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92956567|NCT03382938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92956568|NCT03382938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956569|NCT03382938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92956570|NCT03382938|Analgesics|analgesics|mesh-ancestor
92956571|NCT03382938|Sensory System Agents|sensory system agents|mesh-ancestor
92956572|NCT03382938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956573|NCT03382938|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92956574|NCT03382938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92956575|NCT03382938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92956576|NCT03382938|Adrenergic Agents|adrenergic agents|mesh-ancestor
92956577|NCT03382938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92956578|NCT03382938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956579|NCT03382938|Anesthetics, Local|anesthetics, local|mesh-ancestor
92956580|NCT03382938|Anesthetics|anesthetics|mesh-ancestor
92956581|NCT03380468|Pemetrexed|pemetrexed|mesh-list
92956582|NCT03380468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956583|NCT03380468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956584|NCT03380468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956585|NCT03380468|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92956586|NCT03380468|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92956587|NCT03371017|Carboplatin|carboplatin|mesh-list
92956588|NCT03371017|Gemcitabine|gemcitabine|mesh-list
92956589|NCT03371017|Capecitabine|capecitabine|mesh-list
92956590|NCT03371017|Atezolizumab|atezolizumab|mesh-list
92956591|NCT03371017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956592|NCT03371017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956593|NCT03371017|Antimetabolites|antimetabolites|mesh-ancestor
92956594|NCT03371017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956595|NCT03371017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956596|NCT03371017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956597|NCT03301220|Daratumumab|daratumumab|mesh-list
92956598|NCT03301220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165618|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92956599|NCT03279952|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92956600|NCT03279952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956601|NCT03258853|Pancrelipase|pancrelipase|mesh-list
92956602|NCT03258853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956603|NCT03246347|Docetaxel|docetaxel|mesh-list
92956604|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956605|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956606|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956607|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956608|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956609|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
92956610|NCT03236155|Narcotics|narcotics|mesh-ancestor
92956611|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92956612|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956613|NCT03236155|Analgesics|analgesics|mesh-ancestor
92956614|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
92956615|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956616|NCT03234972|Dexamethasone|dexamethasone|mesh-list
92956617|NCT03234972|Bortezomib|bortezomib|mesh-list
92956618|NCT03234972|Daratumumab|daratumumab|mesh-list
92956619|NCT03234972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956620|NCT03234972|Antiemetics|antiemetics|mesh-ancestor
92956621|NCT03234972|Autonomic Agents|autonomic agents|mesh-ancestor
92956622|NCT03234972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956623|NCT03234972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956624|NCT03234972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956625|NCT03234972|Glucocorticoids|glucocorticoids|mesh-ancestor
92956626|NCT03234972|Hormones|hormones|mesh-ancestor
92956627|NCT03234972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956628|NCT03234972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956629|NCT03234972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956630|NCT03233347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92956631|NCT03233347|Nivolumab|nivolumab|mesh-list
92956632|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92956633|NCT03233347|Doxorubicin|doxorubicin|mesh-list
92956634|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92956635|NCT03233347|Daunorubicin|daunorubicin|mesh-list
92956636|NCT03233347|Dacarbazine|dacarbazine|mesh-list
92602051|NCT04728308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956637|NCT03233347|Vinblastine|vinblastine|mesh-list
92956638|NCT03233347|Antibodies|antibodies|mesh-list
92956639|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
92956640|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92956641|NCT03233347|Imidazole|imidazole|mesh-list
92956642|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
92956643|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
92956644|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956645|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956646|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92956647|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92956648|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92956649|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956650|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956651|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956652|NCT03233347|Immunotoxins|immunotoxins|mesh-ancestor
92956653|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956654|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
92956655|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92956656|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956657|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956658|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956659|NCT03218488|Ustekinumab|ustekinumab|mesh-list
92956660|NCT03218488|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956661|NCT03217812|Prednisone|prednisone|mesh-list
92956662|NCT03217812|Bortezomib|bortezomib|mesh-list
92956663|NCT03217812|Melphalan|melphalan|mesh-list
92956664|NCT03217812|Daratumumab|daratumumab|mesh-list
92956665|NCT03217812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956666|NCT03217812|Glucocorticoids|glucocorticoids|mesh-ancestor
92956667|NCT03217812|Hormones|hormones|mesh-ancestor
92956668|NCT03217812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956669|NCT03217812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956670|NCT03217812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956671|NCT03217812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956672|NCT03217812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956673|NCT03217812|Alkylating Agents|alkylating agents|mesh-ancestor
92956674|NCT03217812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956675|NCT03217812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92956676|NCT03217812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956677|NCT03217812|Immunologic Factors|immunologic factors|mesh-ancestor
92956678|NCT03177122|Inositol|inositol|mesh-list
92956679|NCT03177122|Vitamin B Complex|vitamin b complex|mesh-ancestor
92956680|NCT03177122|Vitamins|vitamins|mesh-ancestor
92956681|NCT03177122|Micronutrients|micronutrients|mesh-ancestor
92956682|NCT03177122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956683|NCT03170518|Canagliflozin|canagliflozin|mesh-list
92527493|NCT00000620|Protease Inhibitors|protease inhibitors|mesh-ancestor
92956684|NCT03170518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92956685|NCT03170518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956686|NCT03170518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92956687|NCT03170518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956688|NCT03169166|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92956689|NCT03169166|Luteolytic Agents|luteolytic agents|mesh-ancestor
92956690|NCT03169166|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92956691|NCT03169166|Contraceptive Agents|contraceptive agents|mesh-ancestor
92956692|NCT03169166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92956693|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956694|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92956695|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956696|NCT03169166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956697|NCT03165994|Paclitaxel|paclitaxel|mesh-list
92956698|NCT03165994|Carboplatin|carboplatin|mesh-list
92956699|NCT03165994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92956700|NCT03165994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956701|NCT03165994|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956702|NCT03165994|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956703|NCT03165994|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956704|NCT03165994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956705|NCT03089606|Pembrolizumab|pembrolizumab|mesh-list
92956706|NCT03089606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956707|NCT03089606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956708|NCT03089606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956709|NCT03089606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956710|NCT03076554|Avelumab|avelumab|mesh-list
92956711|NCT03076554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956712|NCT03076554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956715|NCT03071406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956716|NCT03071406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956717|NCT03071406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956718|NCT03071406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956719|NCT03036098|Carboplatin|carboplatin|mesh-list
92956720|NCT03036098|Gemcitabine|gemcitabine|mesh-list
92956721|NCT03036098|Nivolumab|nivolumab|mesh-list
92956722|NCT03036098|Ipilimumab|ipilimumab|mesh-list
92956723|NCT03036098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956724|NCT03036098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956725|NCT03036098|Antimetabolites|antimetabolites|mesh-ancestor
92956726|NCT03036098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956727|NCT03036098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956728|NCT03036098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92956729|NCT03032172|Risdiplam|risdiplam|mesh-list
92956730|NCT03032172|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92956731|NCT03032172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956732|NCT03032172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956733|NCT03006848|Avelumab|avelumab|mesh-list
92956734|NCT03006848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956735|NCT03006848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956736|NCT02981069|Dapagliflozin|dapagliflozin|mesh-list
92956737|NCT02981069|Exenatide|exenatide|mesh-list
92956738|NCT02981069|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92956739|NCT02981069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956740|NCT02981069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92956741|NCT02981069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956742|NCT02981069|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92956743|NCT02981069|Incretins|incretins|mesh-ancestor
92956744|NCT02981069|Hormones|hormones|mesh-ancestor
92956745|NCT02981069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956746|NCT02980991|Pemetrexed|pemetrexed|mesh-list
92956747|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956748|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956749|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956750|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92956751|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92956752|NCT02942355|Palbociclib|palbociclib|mesh-list
92956753|NCT02942355|Anastrozole|anastrozole|mesh-list
92956754|NCT02942355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956755|NCT02942355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92956756|NCT02942355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956757|NCT02942355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956758|NCT02942355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956759|NCT02942355|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92956760|NCT02942355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92956761|NCT02942355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92956762|NCT02942355|Hormone Antagonists|hormone antagonists|mesh-ancestor
92956763|NCT02942355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956764|NCT02942355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956765|NCT02932410|Macitentan|macitentan|mesh-list
92956766|NCT02932410|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92956767|NCT02932410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92956768|NCT02932410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956769|NCT02932410|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92956770|NCT02923128|Sufentanil|sufentanil|mesh-list
92956771|NCT02923128|Dexmedetomidine|dexmedetomidine|mesh-list
92956772|NCT02923128|Dsuvia|dsuvia|mesh-list
92956773|NCT02923128|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92956774|NCT02923128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92956775|NCT02923128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956776|NCT02923128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92956777|NCT02923128|Analgesics|analgesics|mesh-ancestor
92956778|NCT02923128|Sensory System Agents|sensory system agents|mesh-ancestor
92956779|NCT02923128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956780|NCT02923128|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92956781|NCT02923128|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92956782|NCT02923128|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92956783|NCT02923128|Adrenergic Agents|adrenergic agents|mesh-ancestor
92956784|NCT02923128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602202|NCT00405015|Rosiglitazone|rosiglitazone|mesh-list
92956785|NCT02923128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956786|NCT02923128|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92956787|NCT02923128|Narcotics|narcotics|mesh-ancestor
92956788|NCT02923128|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92956789|NCT02923128|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92956790|NCT02923128|Anesthetics, General|anesthetics, general|mesh-ancestor
92956791|NCT02923128|Anesthetics|anesthetics|mesh-ancestor
92956792|NCT02839642|Rivastigmine|rivastigmine|mesh-list
92956793|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92956794|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956795|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956796|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
92956797|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92956798|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956799|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92956800|NCT02839642|Protective Agents|protective agents|mesh-ancestor
92956801|NCT02830724|Aldesleukin|aldesleukin|mesh-list
92956802|NCT02830724|Cyclophosphamide|cyclophosphamide|mesh-list
92956803|NCT02830724|Fludarabine|fludarabine|mesh-list
92956804|NCT02830724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956805|NCT02830724|Immunologic Factors|immunologic factors|mesh-ancestor
92956806|NCT02830724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956807|NCT02830724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956808|NCT02830724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956809|NCT02830724|Alkylating Agents|alkylating agents|mesh-ancestor
92956810|NCT02830724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956811|NCT02830724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956812|NCT02830724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92956813|NCT02830724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92956814|NCT02830724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92956815|NCT02830724|Antiviral Agents|antiviral agents|mesh-ancestor
92956816|NCT02830724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956817|NCT02828358|Calcium, Dietary|calcium, dietary|mesh-list
92956818|NCT02828358|Leucovorin|leucovorin|mesh-list
92956819|NCT02828358|Folic Acid|folic acid|mesh-list
92956820|NCT02828358|Cytarabine|cytarabine|mesh-list
92956821|NCT02828358|Dexamethasone|dexamethasone|mesh-list
92956822|NCT02828358|Dexamethasone acetate|dexamethasone acetate|mesh-list
92956823|NCT02828358|Prednisolone|prednisolone|mesh-list
92956824|NCT02828358|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92956825|NCT02828358|Methylprednisolone|methylprednisolone|mesh-list
92956826|NCT02828358|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92956827|NCT02828358|Prednisolone acetate|prednisolone acetate|mesh-list
92956828|NCT02828358|Hydrocortisone|hydrocortisone|mesh-list
92956829|NCT02828358|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92956830|NCT02828358|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92956831|NCT02828358|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92956832|NCT02828358|Cortisone|cortisone|mesh-list
92956834|NCT02828358|Methotrexate|methotrexate|mesh-list
92956835|NCT02828358|Vincristine|vincristine|mesh-list
92956836|NCT02828358|Azacitidine|azacitidine|mesh-list
92956837|NCT02828358|Daunorubicin|daunorubicin|mesh-list
92956838|NCT02828358|Asparaginase|asparaginase|mesh-list
92956839|NCT02828358|Mercaptopurine|mercaptopurine|mesh-list
92956840|NCT02828358|Pegaspargase|pegaspargase|mesh-list
92956841|NCT02828358|Thioguanine|thioguanine|mesh-list
92956842|NCT02828358|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92956843|NCT02828358|Prednisolone phosphate|prednisolone phosphate|mesh-list
92956844|NCT02828358|BB 1101|bb 1101|mesh-list
92956845|NCT02828358|Calcium|calcium|mesh-list
92956846|NCT02828358|2-Aminopurine|2-aminopurine|mesh-list
92956847|NCT02828358|Levoleucovorin|levoleucovorin|mesh-list
92956848|NCT02828358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956849|NCT02828358|Immunologic Factors|immunologic factors|mesh-ancestor
92956850|NCT02828358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956851|NCT02828358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92956852|NCT02828358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956853|NCT02828358|Alkylating Agents|alkylating agents|mesh-ancestor
92956854|NCT02828358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956855|NCT02828358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165663|NCT00251433|Docetaxel|docetaxel|mesh-list
92956856|NCT02828358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92956857|NCT02828358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92956858|NCT02828358|Antiemetics|antiemetics|mesh-ancestor
92956859|NCT02828358|Autonomic Agents|autonomic agents|mesh-ancestor
92956860|NCT02828358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92956861|NCT02828358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92956862|NCT02828358|Glucocorticoids|glucocorticoids|mesh-ancestor
92956863|NCT02828358|Hormones|hormones|mesh-ancestor
92956864|NCT02828358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956865|NCT02828358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92956866|NCT02828358|Protease Inhibitors|protease inhibitors|mesh-ancestor
92956867|NCT02828358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956868|NCT02828358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92956869|NCT02828358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92956870|NCT02828358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92956871|NCT02828358|Abortifacient Agents|abortifacient agents|mesh-ancestor
92956872|NCT02828358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92956873|NCT02828358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956874|NCT02828358|Antimetabolites|antimetabolites|mesh-ancestor
92956875|NCT02828358|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956876|NCT02828358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92956877|NCT02828358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92956878|NCT02828358|Antiviral Agents|antiviral agents|mesh-ancestor
92956879|NCT02828358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956880|NCT02828358|Antidotes|antidotes|mesh-ancestor
92956881|NCT02828358|Protective Agents|protective agents|mesh-ancestor
92956882|NCT02828358|Vitamin B Complex|vitamin b complex|mesh-ancestor
92956883|NCT02828358|Vitamins|vitamins|mesh-ancestor
92956884|NCT02828358|Micronutrients|micronutrients|mesh-ancestor
92956885|NCT02828358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92956886|NCT02828358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956887|NCT02828358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956888|NCT02828358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956889|NCT02828358|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92956890|NCT02828358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92956891|NCT02828358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92956892|NCT02828358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92956893|NCT02828358|Hematinics|hematinics|mesh-ancestor
92956894|NCT02810444|Immunoglobulins|immunoglobulins|mesh-list
92956895|NCT02810444|gamma-Globulins|gamma-globulins|mesh-list
92956896|NCT02810444|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92956897|NCT02810444|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92956898|NCT02810444|Immunologic Factors|immunologic factors|mesh-ancestor
92956899|NCT02810444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956900|NCT02797470|Cytarabine|cytarabine|mesh-list
92956901|NCT02797470|Etoposide|etoposide|mesh-list
92956902|NCT02797470|Podophyllotoxin|podophyllotoxin|mesh-list
92956903|NCT02797470|Etoposide phosphate|etoposide phosphate|mesh-list
92956904|NCT02797470|Melphalan|melphalan|mesh-list
92956905|NCT02797470|Mechlorethamine|mechlorethamine|mesh-list
92956906|NCT02797470|Carmustine|carmustine|mesh-list
92956907|NCT02797470|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92956908|NCT02797470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92956909|NCT02797470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956910|NCT02797470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92527496|NCT00000620|Urological Agents|urological agents|mesh-ancestor
92956911|NCT02797470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92956912|NCT02797470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956913|NCT02797470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956914|NCT02797470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956916|NCT02797470|Antiviral Agents|antiviral agents|mesh-ancestor
92956917|NCT02797470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956918|NCT02797470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257442|NCT03401606|Narcotics|narcotics|mesh-ancestor
92956919|NCT02797470|Immunologic Factors|immunologic factors|mesh-ancestor
92956920|NCT02797470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956921|NCT02797470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956922|NCT02797470|Alkylating Agents|alkylating agents|mesh-ancestor
92956923|NCT02797470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92956924|NCT02797470|Keratolytic Agents|keratolytic agents|mesh-ancestor
92956925|NCT02797470|Dermatologic Agents|dermatologic agents|mesh-ancestor
92956926|NCT02797470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92956927|NCT02797470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92956928|NCT02797470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92956929|NCT02769962|Olaparib|olaparib|mesh-list
92956930|NCT02769962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92956931|NCT02769962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956932|NCT02769962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956933|NCT02769962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956934|NCT02612311|Obinutuzumab|obinutuzumab|mesh-list
92956935|NCT02612311|Chlorambucil|chlorambucil|mesh-list
92956936|NCT02612311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956937|NCT02612311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956938|NCT02612311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92956939|NCT02612311|Alkylating Agents|alkylating agents|mesh-ancestor
92956940|NCT02612311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956941|NCT02609776|Carboplatin|carboplatin|mesh-list
92956942|NCT02609776|Pemetrexed|pemetrexed|mesh-list
92956943|NCT02609776|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92956944|NCT02609776|Lazertinib|lazertinib|mesh-list
92956945|NCT02609776|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92956946|NCT02609776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956947|NCT02609776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956948|NCT02609776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956949|NCT02609776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92956950|NCT02609776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92956951|NCT02609776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92956952|NCT02609776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956953|NCT02609776|Immunologic Factors|immunologic factors|mesh-ancestor
92956954|NCT02609776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956955|NCT02607319|Bemiparin|bemiparin|mesh-list
92956956|NCT02607319|Anticoagulants|anticoagulants|mesh-ancestor
92956957|NCT02581085|Tocotrienols|tocotrienols|mesh-list
92956958|NCT02581085|Vitamin E|vitamin e|mesh-list
92956959|NCT02581085|Tocopherols|tocopherols|mesh-list
92956960|NCT02581085|Antioxidants|antioxidants|mesh-ancestor
92956961|NCT02581085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956962|NCT02581085|Protective Agents|protective agents|mesh-ancestor
92956963|NCT02581085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956964|NCT02581085|Vitamins|vitamins|mesh-ancestor
92956965|NCT02581085|Micronutrients|micronutrients|mesh-ancestor
92956966|NCT02575963|Cytarabine|cytarabine|mesh-list
92956967|NCT02575963|Lintuzumab|lintuzumab|mesh-list
92956968|NCT02575963|Furosemide|furosemide|mesh-list
92956969|NCT02575963|Spironolactone|spironolactone|mesh-list
92956970|NCT02575963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92956971|NCT02575963|Antimetabolites|antimetabolites|mesh-ancestor
92956972|NCT02575963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956973|NCT02575963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956974|NCT02575963|Antiviral Agents|antiviral agents|mesh-ancestor
92956975|NCT02575963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92956976|NCT02575963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92956977|NCT02575963|Immunologic Factors|immunologic factors|mesh-ancestor
92956978|NCT02575963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92956979|NCT02575963|Diuretics|diuretics|mesh-ancestor
92956980|NCT02575963|Natriuretic Agents|natriuretic agents|mesh-ancestor
92956981|NCT02575963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92956982|NCT02575963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92956983|NCT02575963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92956984|NCT02575963|Hormone Antagonists|hormone antagonists|mesh-ancestor
92956985|NCT02575963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92956986|NCT02575963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92956987|NCT02575963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92956988|NCT02546661|Durvalumab|durvalumab|mesh-list
92956989|NCT02546661|Olaparib|olaparib|mesh-list
92956990|NCT02546661|Adavosertib|adavosertib|mesh-list
92956991|NCT02546661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165701|NCT02760667|Cisplatin|cisplatin|mesh-list
92956992|NCT02546661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92956993|NCT02546661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92956994|NCT02546661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92956995|NCT02546661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92956996|NCT02531516|Bicalutamide|bicalutamide|mesh-list
92956997|NCT02531516|Androgen Antagonists|androgen antagonists|mesh-ancestor
92956998|NCT02531516|Hormone Antagonists|hormone antagonists|mesh-ancestor
92956999|NCT02531516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957000|NCT02531516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957001|NCT02531516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957002|NCT02507284|SRX246|srx246|mesh-list
92957003|NCT02507284|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92957004|NCT02507284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957005|NCT02507284|Natriuretic Agents|natriuretic agents|mesh-ancestor
92957006|NCT02507284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957007|NCT02501096|Pembrolizumab|pembrolizumab|mesh-list
92957008|NCT02501096|Lenvatinib|lenvatinib|mesh-list
92957009|NCT02501096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92957010|NCT02501096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957011|NCT02501096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92957012|NCT02501096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957013|NCT02501096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92957014|NCT02501096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957015|NCT02494986|Rilpivirine|rilpivirine|mesh-list
92957016|NCT02494986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92957017|NCT02494986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92957018|NCT02494986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957019|NCT02494986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957020|NCT02494986|Antiviral Agents|antiviral agents|mesh-ancestor
92957021|NCT02494986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957022|NCT02494986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92957023|NCT02494986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92957024|NCT02432248|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92957025|NCT02432248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92957026|NCT02432248|Immunologic Factors|immunologic factors|mesh-ancestor
92957027|NCT02432248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957028|NCT02365597|Metformin|metformin|mesh-list
92957029|NCT02365597|Midazolam|midazolam|mesh-list
92957030|NCT02365597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92957031|NCT02365597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957032|NCT02365597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92957033|NCT02365597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92957034|NCT02365597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957035|NCT02365597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92957036|NCT02365597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92957037|NCT02365597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92957038|NCT02365597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92957039|NCT02365597|Anesthetics, General|anesthetics, general|mesh-ancestor
92957040|NCT02365597|Anesthetics|anesthetics|mesh-ancestor
92957041|NCT02365597|GABA Modulators|gaba modulators|mesh-ancestor
92957042|NCT02365597|GABA Agents|gaba agents|mesh-ancestor
92957043|NCT02365597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957044|NCT02365597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957045|NCT02364089|Epinephrine|epinephrine|mesh-list
92957046|NCT02364089|Racepinephrine|racepinephrine|mesh-list
92957047|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
92957048|NCT02364089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92957049|NCT02364089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92957050|NCT02364089|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957051|NCT02364089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957052|NCT02364089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957053|NCT02364089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957054|NCT02364089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92957055|NCT02364089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92957056|NCT02364089|Autonomic Agents|autonomic agents|mesh-ancestor
92957057|NCT02364089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957058|NCT02364089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92957059|NCT02364089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92957060|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
92957061|NCT02364089|Sympathomimetics|sympathomimetics|mesh-ancestor
92957062|NCT02364089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92957063|NCT02354014|Bedaquiline|bedaquiline|mesh-list
92957064|NCT02354014|Diarylquinolines|diarylquinolines|mesh-list
92957065|NCT02354014|Antitubercular Agents|antitubercular agents|mesh-ancestor
92957066|NCT02354014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92957067|NCT02354014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957068|NCT02316106|Daratumumab|daratumumab|mesh-list
92957069|NCT02316106|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92957070|NCT02316106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957071|NCT02316106|Immunologic Factors|immunologic factors|mesh-ancestor
92957072|NCT02316106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957073|NCT02193425|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92957074|NCT02193425|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92957075|NCT02193425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957076|NCT02123758|Prednisone|prednisone|mesh-list
92957077|NCT02123758|Abiraterone Acetate|abiraterone acetate|mesh-list
92957078|NCT02123758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957079|NCT02123758|Glucocorticoids|glucocorticoids|mesh-ancestor
92957080|NCT02123758|Hormones|hormones|mesh-ancestor
92957081|NCT02123758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957082|NCT02123758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957083|NCT02123758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957084|NCT02123758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957085|NCT02123758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92957086|NCT02123758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957087|NCT02123758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957088|NCT02123758|Hormone Antagonists|hormone antagonists|mesh-ancestor
92957089|NCT02123758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957090|NCT02122562|Ketamine|ketamine|mesh-list
92957091|NCT02122562|Analgesics|analgesics|mesh-ancestor
92957093|NCT02122562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957094|NCT02122562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957095|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92957096|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92957097|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
92957098|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
92957099|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957100|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92957101|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92957102|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957103|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957104|NCT02115724|Vitamins|vitamins|mesh-list
92957105|NCT02115724|Vitamin E|vitamin e|mesh-list
92957106|NCT02115724|Thioctic Acid|thioctic acid|mesh-list
92957107|NCT02115724|Nitroglycerin|nitroglycerin|mesh-list
92957108|NCT02115724|Antioxidants|antioxidants|mesh-list
92957109|NCT02115724|Micronutrients|micronutrients|mesh-ancestor
92957110|NCT02115724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957111|NCT02115724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957112|NCT02115724|Protective Agents|protective agents|mesh-ancestor
92957113|NCT02115724|Vitamin B Complex|vitamin b complex|mesh-ancestor
92957114|NCT02115724|Vasodilator Agents|vasodilator agents|mesh-ancestor
92957115|NCT02036372|Insulin|insulin|mesh-list
92957116|NCT02036372|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92957117|NCT02036372|Liraglutide|liraglutide|mesh-list
92957118|NCT02036372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92957119|NCT02036372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957120|NCT02036372|Incretins|incretins|mesh-ancestor
92957121|NCT02036372|Hormones|hormones|mesh-ancestor
92957122|NCT02036372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957123|NCT02016924|Cobicistat|cobicistat|mesh-list
92957124|NCT02016924|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92957125|NCT02016924|Emtricitabine|emtricitabine|mesh-list
92957126|NCT02016924|Tenofovir|tenofovir|mesh-list
92957127|NCT02016924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957128|NCT02016924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957129|NCT02016924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92957130|NCT02016924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92957131|NCT02016924|Antiviral Agents|antiviral agents|mesh-ancestor
92957132|NCT02016924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957133|NCT02016924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92957134|NCT02016924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957135|NCT02016924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92957136|NCT02016924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92957138|NCT01998971|Diphenhydramine|diphenhydramine|mesh-list
92957139|NCT01998971|Promethazine|promethazine|mesh-list
92957140|NCT01998971|Thalidomide|thalidomide|mesh-list
92957141|NCT01998971|Dexamethasone|dexamethasone|mesh-list
92957142|NCT01998971|Prednisone|prednisone|mesh-list
92957143|NCT01998971|Lenalidomide|lenalidomide|mesh-list
92957144|NCT01998971|Melphalan|melphalan|mesh-list
92957145|NCT01998971|Bortezomib|bortezomib|mesh-list
92957146|NCT01998971|Daratumumab|daratumumab|mesh-list
92957147|NCT01998971|Pomalidomide|pomalidomide|mesh-list
92957148|NCT01998971|Montelukast|montelukast|mesh-list
92957149|NCT01998971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957150|NCT01998971|Antiemetics|antiemetics|mesh-ancestor
92957151|NCT01998971|Autonomic Agents|autonomic agents|mesh-ancestor
92957152|NCT01998971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957153|NCT01998971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957154|NCT01998971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957155|NCT01998971|Glucocorticoids|glucocorticoids|mesh-ancestor
92957156|NCT01998971|Hormones|hormones|mesh-ancestor
92957157|NCT01998971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957158|NCT01998971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957159|NCT01998971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957160|NCT01998971|Immunologic Factors|immunologic factors|mesh-ancestor
92957161|NCT01998971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92957162|NCT01998971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92957163|NCT01998971|Growth Substances|growth substances|mesh-ancestor
92957164|NCT01998971|Growth Inhibitors|growth inhibitors|mesh-ancestor
92957165|NCT01998971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92957166|NCT01998971|Analgesics|analgesics|mesh-ancestor
92957167|NCT01998971|Sensory System Agents|sensory system agents|mesh-ancestor
92957168|NCT01998971|Antipyretics|antipyretics|mesh-ancestor
92602588|NCT00473980|Tocolytic Agents|tocolytic agents|mesh-ancestor
92957169|NCT01998971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92957170|NCT01998971|Alkylating Agents|alkylating agents|mesh-ancestor
92957171|NCT01998971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957172|NCT01998971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92957173|NCT01998971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957174|NCT01998971|Leprostatic Agents|leprostatic agents|mesh-ancestor
92957175|NCT01998971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92957176|NCT01998971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957177|NCT01998971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92957178|NCT01998971|Respiratory System Agents|respiratory system agents|mesh-ancestor
92957179|NCT01998971|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92957180|NCT01998971|Hormone Antagonists|hormone antagonists|mesh-ancestor
92957181|NCT01998971|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92957182|NCT01998971|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92957183|NCT01998971|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92957184|NCT01998971|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92957185|NCT01998971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165729|NCT02660905|Tenofovir|tenofovir|mesh-list
92957186|NCT01998971|Anesthetics, Local|anesthetics, local|mesh-ancestor
92957187|NCT01998971|Anesthetics|anesthetics|mesh-ancestor
92957188|NCT01998971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92957189|NCT01998971|Histamine Antagonists|histamine antagonists|mesh-ancestor
92957190|NCT01998971|Histamine Agents|histamine agents|mesh-ancestor
92957191|NCT01998971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957192|NCT01998971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92957193|NCT01998971|Antipruritics|antipruritics|mesh-ancestor
92957194|NCT01998971|Dermatologic Agents|dermatologic agents|mesh-ancestor
92957195|NCT01991977|Temozolomide|temozolomide|mesh-list
92957196|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92957197|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
92957198|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957199|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957200|NCT01932125|Bevacizumab|bevacizumab|mesh-list
92957201|NCT01932125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92957202|NCT01932125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957203|NCT01932125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92957204|NCT01932125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92957205|NCT01932125|Growth Substances|growth substances|mesh-ancestor
92957206|NCT01932125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957207|NCT01932125|Growth Inhibitors|growth inhibitors|mesh-ancestor
92957208|NCT01792687|Prednisone|prednisone|mesh-list
92957209|NCT01792687|Abiraterone Acetate|abiraterone acetate|mesh-list
92957210|NCT01792687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957211|NCT01792687|Glucocorticoids|glucocorticoids|mesh-ancestor
92957213|NCT01792687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957214|NCT01792687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957215|NCT01792687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957216|NCT01792687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957217|NCT01792687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92957218|NCT01792687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957219|NCT01792687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957220|NCT01792687|Hormone Antagonists|hormone antagonists|mesh-ancestor
92957221|NCT01792687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957222|NCT01633541|Carboplatin|carboplatin|mesh-list
92957223|NCT01633541|Docetaxel|docetaxel|mesh-list
92957224|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957225|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92957226|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92957227|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92957228|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957229|NCT01517100|Dronabinol|dronabinol|mesh-list
92957230|NCT01517100|Nabilone|nabilone|mesh-list
92957231|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
92957232|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
92957233|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957234|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957235|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957236|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92957237|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92957238|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957239|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92957240|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
92957241|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92957242|NCT01517100|Analgesics|analgesics|mesh-ancestor
92957243|NCT01517100|Sensory System Agents|sensory system agents|mesh-ancestor
92957244|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92957245|NCT01517100|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92957246|NCT01517100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957247|NCT01517100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957248|NCT01517100|Hormones|hormones|mesh-ancestor
92957249|NCT01517100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957250|NCT01399372|Cytarabine|cytarabine|mesh-list
92957251|NCT01399372|Rituximab|rituximab|mesh-list
92957252|NCT01399372|Methotrexate|methotrexate|mesh-list
92957253|NCT01399372|Vincristine|vincristine|mesh-list
92957254|NCT01399372|Procarbazine|procarbazine|mesh-list
92957255|NCT01399372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92957256|NCT01399372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957257|NCT01399372|Immunologic Factors|immunologic factors|mesh-ancestor
92957258|NCT01399372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957259|NCT01399372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957260|NCT01399372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92957261|NCT01399372|Abortifacient Agents|abortifacient agents|mesh-ancestor
92957262|NCT01399372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92957263|NCT01399372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957264|NCT01399372|Antimetabolites|antimetabolites|mesh-ancestor
92957265|NCT01399372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957266|NCT01399372|Dermatologic Agents|dermatologic agents|mesh-ancestor
92957267|NCT01399372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957268|NCT01399372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92957269|NCT01399372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957270|NCT01399372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92957271|NCT01399372|Antiviral Agents|antiviral agents|mesh-ancestor
92957272|NCT01399372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957273|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92957274|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92957275|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92957276|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92957277|NCT01319565|Aldesleukin|aldesleukin|mesh-list
92957278|NCT01319565|Cyclophosphamide|cyclophosphamide|mesh-list
92957279|NCT01319565|Fludarabine|fludarabine|mesh-list
92957280|NCT01319565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957281|NCT01319565|Immunologic Factors|immunologic factors|mesh-ancestor
92957282|NCT01319565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957283|NCT01319565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957284|NCT01319565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92957286|NCT01319565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957287|NCT01319565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957288|NCT01319565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92957289|NCT01319565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92957290|NCT01319565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92957291|NCT01319565|Antiviral Agents|antiviral agents|mesh-ancestor
92957292|NCT01319565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957293|NCT01267604|Inositol|inositol|mesh-list
92957294|NCT01267604|Melatonin|melatonin|mesh-list
92957295|NCT01267604|Antioxidants|antioxidants|mesh-ancestor
92957296|NCT01267604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957297|NCT01267604|Protective Agents|protective agents|mesh-ancestor
92957298|NCT01267604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957299|NCT01267604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957300|NCT01267604|Vitamin B Complex|vitamin b complex|mesh-ancestor
92957301|NCT01267604|Vitamins|vitamins|mesh-ancestor
92957302|NCT01267604|Micronutrients|micronutrients|mesh-ancestor
92957303|NCT01244399|Inositol|inositol|mesh-list
92957304|NCT01244399|Vitamin B Complex|vitamin b complex|mesh-ancestor
92957305|NCT01244399|Vitamins|vitamins|mesh-ancestor
92957306|NCT01244399|Micronutrients|micronutrients|mesh-ancestor
92957307|NCT01244399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957308|NCT01063517|Paclitaxel|paclitaxel|mesh-list
92957309|NCT01063517|Olaparib|olaparib|mesh-list
92957310|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92957311|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957312|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92957313|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92957314|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92957315|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957316|NCT01063517|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92957317|NCT01063517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957318|NCT00920621|Vitamin D|vitamin d|mesh-list
92957319|NCT00920621|Ergocalciferols|ergocalciferols|mesh-list
92957320|NCT00920621|Cholecalciferol|cholecalciferol|mesh-list
92957321|NCT00920621|Vitamins|vitamins|mesh-list
92957322|NCT00920621|Micronutrients|micronutrients|mesh-ancestor
92957323|NCT00920621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957324|NCT00920621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92957325|NCT00920621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92957326|NCT00887146|Vincristine|vincristine|mesh-list
92957327|NCT00887146|Temozolomide|temozolomide|mesh-list
92957328|NCT00887146|Procarbazine|procarbazine|mesh-list
92957329|NCT00887146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92957330|NCT00887146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957331|NCT00887146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92957332|NCT00887146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92957333|NCT00887146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92957334|NCT00887146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957335|NCT00887146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92957336|NCT00887146|Alkylating Agents|alkylating agents|mesh-ancestor
92957337|NCT00606346|Infliximab|infliximab|mesh-list
92957338|NCT00606346|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92957339|NCT00606346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957340|NCT00606346|Dermatologic Agents|dermatologic agents|mesh-ancestor
92957341|NCT00606346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957342|NCT00606346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957343|NCT00044304|Imatinib Mesylate|imatinib mesylate|mesh-list
92957344|NCT00044304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957345|NCT00044304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92957346|NCT00044304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957347|NCT00044304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957348|NCT00001247|Sirolimus|sirolimus|mesh-list
92957349|NCT00001247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92957350|NCT00001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957351|NCT00001247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92957352|NCT00001247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957353|NCT00001247|Antifungal Agents|antifungal agents|mesh-ancestor
92957354|NCT00001247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957355|NCT00001247|Immunologic Factors|immunologic factors|mesh-ancestor
92957356|NCT00001247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957357|NCT00964756|Ganciclovir|ganciclovir|mesh-list
92957358|NCT00964756|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92957359|NCT00964756|Antiviral Agents|antiviral agents|mesh-ancestor
92957360|NCT00964756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957361|NCT00964756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92957362|NCT00964756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957363|NCT00964756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957364|NCT00964834|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92957365|NCT00964834|Doxycycline|doxycycline|mesh-list
92957366|NCT00964834|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92957367|NCT00964834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957368|NCT00964834|Antitubercular Agents|antitubercular agents|mesh-ancestor
92957369|NCT00964834|Antimalarials|antimalarials|mesh-ancestor
92957370|NCT00964834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92957371|NCT00964834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92957372|NCT00612105|Ezogabine|ezogabine|mesh-list
92957373|NCT00612105|Anticonvulsants|anticonvulsants|mesh-ancestor
92957374|NCT00612105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957375|NCT00612105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957376|NCT04017741|Methylprednisolone|methylprednisolone|mesh-list
92957377|NCT04017741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92957378|NCT04017741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92957379|NCT04017741|Prednisolone|prednisolone|mesh-list
92957380|NCT04017741|Prednisolone acetate|prednisolone acetate|mesh-list
92957381|NCT04017741|Lidocaine|lidocaine|mesh-list
92957382|NCT04017741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92957383|NCT04017741|Prednisolone phosphate|prednisolone phosphate|mesh-list
92957384|NCT04017741|Anesthetics, Local|anesthetics, local|mesh-ancestor
92957385|NCT04017741|Anesthetics|anesthetics|mesh-ancestor
92957386|NCT04017741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957387|NCT04017741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957388|NCT04017741|Sensory System Agents|sensory system agents|mesh-ancestor
92957389|NCT04017741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957390|NCT04017741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92957391|NCT04017741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92957392|NCT04017741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92957393|NCT04017741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957394|NCT04017741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602806|NCT00475696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957395|NCT04017741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957396|NCT04017741|Antiemetics|antiemetics|mesh-ancestor
92957397|NCT04017741|Autonomic Agents|autonomic agents|mesh-ancestor
92957398|NCT04017741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957399|NCT04017741|Glucocorticoids|glucocorticoids|mesh-ancestor
92957401|NCT04017741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957402|NCT04017741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92957403|NCT04017741|Protective Agents|protective agents|mesh-ancestor
92957404|NCT04017741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957405|NCT04017741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957406|NCT00546052|Losartan|losartan|mesh-list
92957407|NCT00546052|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92957408|NCT00546052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92957409|NCT00546052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92957410|NCT00546052|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92957411|NCT00546052|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92957412|NCT00546052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957413|NCT00546052|Diuretics|diuretics|mesh-ancestor
92957414|NCT00546052|Natriuretic Agents|natriuretic agents|mesh-ancestor
92957415|NCT00546052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957416|NCT00546052|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92957417|NCT00546052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957418|NCT00887601|Donepezil|donepezil|mesh-list
92957419|NCT00887601|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92957420|NCT00887601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957421|NCT00887601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957422|NCT00887601|Cholinergic Agents|cholinergic agents|mesh-ancestor
92957423|NCT00887601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957424|NCT00887601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957425|NCT00887601|Nootropic Agents|nootropic agents|mesh-ancestor
92957426|NCT02542839|Botulinum Toxins|botulinum toxins|mesh-list
92957427|NCT02542839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92957428|NCT02542839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957429|NCT02542839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957430|NCT02542839|Cholinergic Agents|cholinergic agents|mesh-ancestor
92957431|NCT02542839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957432|NCT02542839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957433|NCT00887757|Gemcitabine|gemcitabine|mesh-list
92957434|NCT00887757|Navitoclax|navitoclax|mesh-list
92957435|NCT00887757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957436|NCT00887757|Antimetabolites|antimetabolites|mesh-ancestor
92957437|NCT00887757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957438|NCT00887757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957439|NCT00965224|Immunomodulating Agents|immunomodulating agents|mesh-list
92957440|NCT00965224|Immunologic Factors|immunologic factors|mesh-ancestor
92957441|NCT00965224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957442|NCT04392921|Amiodarone|amiodarone|mesh-list
92957443|NCT04392921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92957444|NCT04392921|Vasodilator Agents|vasodilator agents|mesh-ancestor
92957445|NCT04392921|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92957446|NCT04392921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957447|NCT04392921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957448|NCT04392921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92957449|NCT04392921|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92957450|NCT04392921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957451|NCT04392921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957452|NCT04392921|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92957453|NCT04392921|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92957454|NCT04392921|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92957455|NCT00673920|Methotrexate|methotrexate|mesh-list
92957456|NCT00673920|Ocrelizumab|ocrelizumab|mesh-list
92957457|NCT00673920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92957458|NCT00673920|Abortifacient Agents|abortifacient agents|mesh-ancestor
92957459|NCT00673920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92957460|NCT00673920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957461|NCT00673920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957462|NCT00673920|Antimetabolites|antimetabolites|mesh-ancestor
92957463|NCT00673920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957464|NCT00673920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957465|NCT00673920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92957466|NCT00673920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957467|NCT00673920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92957468|NCT00673920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957470|NCT00673920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957471|NCT00673920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92957472|NCT00959686|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92957473|NCT00959686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92957474|NCT00959686|Alkylating Agents|alkylating agents|mesh-ancestor
92957475|NCT00959686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957476|NCT00959686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957477|NCT00379795|Ranibizumab|ranibizumab|mesh-list
92957478|NCT00379795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92957479|NCT00379795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92957480|NCT00379795|Growth Substances|growth substances|mesh-ancestor
92957481|NCT00379795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957482|NCT00379795|Growth Inhibitors|growth inhibitors|mesh-ancestor
92957483|NCT00379795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957484|NCT04588948|Aflibercept|aflibercept|mesh-list
92957485|NCT04588948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92957486|NCT04588948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92957487|NCT04588948|Growth Substances|growth substances|mesh-ancestor
92957488|NCT04588948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957489|NCT04588948|Growth Inhibitors|growth inhibitors|mesh-ancestor
92957490|NCT04588948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957491|NCT00765024|Ivermectin|ivermectin|mesh-list
92957492|NCT00765024|Albendazole|albendazole|mesh-list
92957493|NCT00765024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92957494|NCT00765024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957495|NCT00765024|Anthelmintics|anthelmintics|mesh-ancestor
92957496|NCT00765024|Anticestodal Agents|anticestodal agents|mesh-ancestor
92957497|NCT00765024|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92957498|NCT00765024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92957499|NCT00765024|Tubulin Modulators|tubulin modulators|mesh-ancestor
92957500|NCT00765024|Antimitotic Agents|antimitotic agents|mesh-ancestor
92957501|NCT00765024|Mitosis Modulators|mitosis modulators|mesh-ancestor
92957502|NCT00765024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957503|NCT00765024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957504|NCT02557932|Bismuth|bismuth|mesh-list
92957505|NCT02557932|Antacids|antacids|mesh-ancestor
92957506|NCT02557932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957507|NCT02557932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957508|NCT00960232|Cholecalciferol|cholecalciferol|mesh-list
92957509|NCT00960232|Vitamin D|vitamin d|mesh-list
92957510|NCT00960232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92957511|NCT00960232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957512|NCT00960232|Vitamins|vitamins|mesh-ancestor
92957513|NCT00960232|Micronutrients|micronutrients|mesh-ancestor
92957514|NCT00960232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92957515|NCT04577014|Gemcitabine|gemcitabine|mesh-list
92957516|NCT04577014|Docetaxel|docetaxel|mesh-list
92957517|NCT04577014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957518|NCT04577014|Antimetabolites|antimetabolites|mesh-ancestor
92957519|NCT04577014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957520|NCT04577014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957521|NCT04577014|Tubulin Modulators|tubulin modulators|mesh-ancestor
92957522|NCT04577014|Antimitotic Agents|antimitotic agents|mesh-ancestor
92957523|NCT04577014|Mitosis Modulators|mitosis modulators|mesh-ancestor
92957524|NCT05282550|Trazodone|trazodone|mesh-list
92957525|NCT05282550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92957526|NCT05282550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92957527|NCT05282550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957528|NCT05282550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957529|NCT05282550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92957530|NCT05282550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92957531|NCT05282550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92957532|NCT05282550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957533|NCT05282550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957534|NCT05282550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957535|NCT05282550|Serotonin Agents|serotonin agents|mesh-ancestor
92957536|NCT05282550|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92957537|NCT05282550|Antidepressive Agents|antidepressive agents|mesh-ancestor
92957538|NCT00960310|Bicalutamide|bicalutamide|mesh-list
92957539|NCT00960310|Androgen Antagonists|androgen antagonists|mesh-ancestor
92957540|NCT00960310|Hormone Antagonists|hormone antagonists|mesh-ancestor
92602962|NCT02273947|BMS-955176|bms-955176|mesh-list
92165748|NCT03822715|Hormone Antagonists|hormone antagonists|mesh-ancestor
92957541|NCT00960310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957542|NCT00960310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957543|NCT00960310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957545|NCT00610155|Tramadol|tramadol|mesh-list
92957546|NCT00610155|Analgesics|analgesics|mesh-ancestor
92957547|NCT00610155|Sensory System Agents|sensory system agents|mesh-ancestor
92957548|NCT00610155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957549|NCT00610155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957550|NCT00610155|Anticonvulsants|anticonvulsants|mesh-ancestor
92957551|NCT00610155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92957552|NCT00610155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957553|NCT00610155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957554|NCT00610155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92957555|NCT00610155|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92957556|NCT00610155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92957557|NCT00610155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957558|NCT00610155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92957559|NCT00610155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92957560|NCT00610155|Narcotics|narcotics|mesh-ancestor
92957561|NCT00759018|Remestemcel-l|remestemcel-l|mesh-list
92957562|NCT00759018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957563|NCT00759018|Antiviral Agents|antiviral agents|mesh-ancestor
92957564|NCT00759018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957565|NCT00960544|Capecitabine|capecitabine|mesh-list
92957566|NCT00960544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957567|NCT00960544|Antimetabolites|antimetabolites|mesh-ancestor
92957568|NCT00960544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957569|NCT00960544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957570|NCT04488952|Anesthetics|anesthetics|mesh-list
92957571|NCT04488952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957572|NCT04488952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957573|NCT00888303|Dexamethasone|dexamethasone|mesh-list
92957574|NCT00888303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957575|NCT00888303|Antiemetics|antiemetics|mesh-ancestor
92957576|NCT00888303|Autonomic Agents|autonomic agents|mesh-ancestor
92957577|NCT00888303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957578|NCT00888303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957579|NCT00888303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957580|NCT00888303|Glucocorticoids|glucocorticoids|mesh-ancestor
92957581|NCT00888303|Hormones|hormones|mesh-ancestor
92957582|NCT00888303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957583|NCT00888303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957584|NCT00888303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957585|NCT00967642|Insulin|insulin|mesh-list
92957586|NCT00967642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92957587|NCT00967642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957588|NCT00674700|Immunomodulating Agents|immunomodulating agents|mesh-list
92957589|NCT00674700|Immunologic Factors|immunologic factors|mesh-list
92957590|NCT00674700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957591|NCT00762918|Vitamin D|vitamin d|mesh-list
92957592|NCT00762918|Cholecalciferol|cholecalciferol|mesh-list
92957593|NCT00762918|Vitamins|vitamins|mesh-ancestor
92957594|NCT00762918|Micronutrients|micronutrients|mesh-ancestor
92957595|NCT00762918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957596|NCT00762918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92957597|NCT00762918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92957598|NCT00546910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92957599|NCT00546910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92957600|NCT00546910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92957601|NCT00546910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957602|NCT00546910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957603|NCT00546910|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957604|NCT00546910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957605|NCT00546910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957606|NCT00759720|Glyburide|glyburide|mesh-list
92957607|NCT00759720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92957608|NCT00759720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957609|NCT00379639|Gemcitabine|gemcitabine|mesh-list
92957610|NCT00379639|Romidepsin|romidepsin|mesh-list
92957611|NCT00379639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957612|NCT00379639|Antimetabolites|antimetabolites|mesh-ancestor
92957613|NCT00379639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603039|NCT03277066|Diclofenac|diclofenac|mesh-list
92957614|NCT00379639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957615|NCT00379639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92957616|NCT00379639|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92957617|NCT00379639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957618|NCT00609765|Dexamethasone|dexamethasone|mesh-list
92957619|NCT00609765|Bevacizumab|bevacizumab|mesh-list
92957620|NCT00609765|Doxorubicin|doxorubicin|mesh-list
92957621|NCT00609765|Fluorouracil|fluorouracil|mesh-list
92957622|NCT00609765|Streptozocin|streptozocin|mesh-list
92957623|NCT00609765|Ondansetron|ondansetron|mesh-list
92957624|NCT00609765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92957625|NCT00609765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957626|NCT00609765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92957627|NCT00609765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92957628|NCT00609765|Growth Substances|growth substances|mesh-ancestor
92957629|NCT00609765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957630|NCT00609765|Growth Inhibitors|growth inhibitors|mesh-ancestor
92957631|NCT00609765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957632|NCT00609765|Antiemetics|antiemetics|mesh-ancestor
92957633|NCT00609765|Autonomic Agents|autonomic agents|mesh-ancestor
92957634|NCT00609765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957635|NCT00609765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957636|NCT00609765|Glucocorticoids|glucocorticoids|mesh-ancestor
92957637|NCT00609765|Hormones|hormones|mesh-ancestor
92957638|NCT00609765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957639|NCT00609765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957640|NCT00609765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92957641|NCT00609765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92957642|NCT00609765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92957643|NCT00609765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957644|NCT00609765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957645|NCT00609765|Antimetabolites|antimetabolites|mesh-ancestor
92957646|NCT00609765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92957647|NCT00609765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957648|NCT00609765|Immunologic Factors|immunologic factors|mesh-ancestor
92957649|NCT00609765|Antipruritics|antipruritics|mesh-ancestor
92957650|NCT00609765|Dermatologic Agents|dermatologic agents|mesh-ancestor
92957651|NCT00609765|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92957652|NCT00609765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92957653|NCT00609765|Serotonin Agents|serotonin agents|mesh-ancestor
92957655|NCT01051219|Losartan|losartan|mesh-list
92957656|NCT01051219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92957657|NCT01051219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92957658|NCT01051219|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92957659|NCT01051219|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92957660|NCT01051219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957661|NCT00961324|Insulin|insulin|mesh-list
92957662|NCT00961324|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92957663|NCT00961324|Insulin Glargine|insulin glargine|mesh-list
92957664|NCT00961324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92957665|NCT00961324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957666|NCT00766350|Amitriptyline|amitriptyline|mesh-list
92957667|NCT00766350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92957668|NCT00766350|Antidepressive Agents|antidepressive agents|mesh-ancestor
92957669|NCT00766350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92957670|NCT00766350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92957671|NCT00766350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92957672|NCT00766350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957673|NCT00766350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957674|NCT00766350|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92957675|NCT00766350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92957676|NCT00766350|Analgesics|analgesics|mesh-ancestor
92957677|NCT00766350|Sensory System Agents|sensory system agents|mesh-ancestor
92957678|NCT00766350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957679|NCT00766350|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92957680|NCT00766350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92957681|NCT00766350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92957682|NCT00766350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957683|NCT00766350|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957684|NCT00766350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957685|NCT00889161|Curcumin|curcumin|mesh-list
92957686|NCT00889161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92957687|NCT00889161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92957688|NCT00889161|Analgesics|analgesics|mesh-ancestor
92957689|NCT00889161|Sensory System Agents|sensory system agents|mesh-ancestor
92957690|NCT00889161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957691|NCT00889161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957692|NCT00889161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957693|NCT00889161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957694|NCT00889161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957695|NCT00889161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957696|NCT00889161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957697|NCT03992755|Treprostinil|treprostinil|mesh-list
92957698|NCT03992755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92957699|NCT01563328|Dolutegravir|dolutegravir|mesh-list
92957700|NCT01563328|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92957701|NCT01563328|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92957702|NCT01563328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957703|NCT01563328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957704|NCT01563328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92957705|NCT01563328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92957706|NCT01563328|Antiviral Agents|antiviral agents|mesh-ancestor
92957707|NCT01563328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957708|NCT00760032|Ciprofloxacin|ciprofloxacin|mesh-list
92957709|NCT00760032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92957710|NCT00760032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957711|NCT00760032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92957712|NCT00760032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92957713|NCT00760032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957714|NCT00760032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957715|NCT00760032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957716|NCT00760032|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92165793|NCT03825367|Antimetabolites|antimetabolites|mesh-ancestor
92957717|NCT00760032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957718|NCT00961480|Metformin|metformin|mesh-list
92957719|NCT00961480|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92957720|NCT00961480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92957721|NCT00961480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957722|NCT00961480|Incretins|incretins|mesh-ancestor
92957723|NCT00961480|Hormones|hormones|mesh-ancestor
92957724|NCT00961480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957725|NCT00961480|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92957726|NCT00961480|Protease Inhibitors|protease inhibitors|mesh-ancestor
92957727|NCT00961480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957728|NCT00961480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957729|NCT00766662|Pyrimethamine|pyrimethamine|mesh-list
92957730|NCT00766662|Sulfadoxine|sulfadoxine|mesh-list
92957731|NCT00766662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92957732|NCT00766662|Antimalarials|antimalarials|mesh-ancestor
92957733|NCT00766662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92957734|NCT00766662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92957735|NCT00766662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957736|NCT00766662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92957737|NCT00766662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957738|NCT00766662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957739|NCT00766662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92957740|NCT00965926|Mirabegron|mirabegron|mesh-list
92957741|NCT00965926|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92957742|NCT00965926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92957743|NCT00965926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92957744|NCT00965926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957745|NCT00965926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957746|NCT00965926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957747|NCT00965926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957748|NCT00965926|Urological Agents|urological agents|mesh-ancestor
92957749|NCT00966004|Mirabegron|mirabegron|mesh-list
92957750|NCT00966004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92957751|NCT00966004|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92957752|NCT00966004|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92957753|NCT00966004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92957754|NCT00966004|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957755|NCT00966004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957756|NCT00966004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957757|NCT00966004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957758|NCT00966004|Urological Agents|urological agents|mesh-ancestor
92957759|NCT00966004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92957760|NCT00966004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92957761|NCT00966004|Cholinergic Agents|cholinergic agents|mesh-ancestor
92603187|NCT00478114|Sorafenib|sorafenib|mesh-list
92957763|NCT00966082|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92957764|NCT00966082|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92957765|NCT00966082|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957766|NCT00966082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957767|NCT00966082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957768|NCT00966082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957769|NCT00966082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92957770|NCT00966082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92957771|NCT00966082|Vasodilator Agents|vasodilator agents|mesh-ancestor
92957772|NCT00889629|Vitamin D|vitamin d|mesh-list
92957773|NCT00889629|Cholecalciferol|cholecalciferol|mesh-list
92957774|NCT00889629|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92957775|NCT00889629|Ergocalciferols|ergocalciferols|mesh-list
92957776|NCT00889629|Vitamins|vitamins|mesh-ancestor
92957777|NCT00889629|Micronutrients|micronutrients|mesh-ancestor
92957778|NCT00889629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957779|NCT00889629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92957780|NCT00889629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92957781|NCT00966160|Ritonavir|ritonavir|mesh-list
92957782|NCT00966160|Lopinavir|lopinavir|mesh-list
92957783|NCT00966160|Lamivudine|lamivudine|mesh-list
92957784|NCT00966160|Zidovudine|zidovudine|mesh-list
92957785|NCT00966160|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92957786|NCT00966160|Efavirenz|efavirenz|mesh-list
92957787|NCT00966160|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92957788|NCT00966160|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92957789|NCT00966160|Protease Inhibitors|protease inhibitors|mesh-ancestor
92957790|NCT00966160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957791|NCT00966160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957792|NCT00966160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92957793|NCT00966160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92957794|NCT00966160|Antiviral Agents|antiviral agents|mesh-ancestor
92957795|NCT00966160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957796|NCT00966160|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92957797|NCT00966160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957798|NCT00966160|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92957799|NCT00966160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92957800|NCT00966160|Antimetabolites|antimetabolites|mesh-ancestor
92957801|NCT00966160|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92957802|NCT00966160|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92957803|NCT00966160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92957804|NCT00966160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92957805|NCT00966160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92957806|NCT00766818|Lopinavir|lopinavir|mesh-list
92957807|NCT00766818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92957808|NCT00766818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92957809|NCT00766818|Protease Inhibitors|protease inhibitors|mesh-ancestor
92957810|NCT00766818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957811|NCT00766818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957812|NCT00766818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92957813|NCT00766818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92957814|NCT00766818|Antiviral Agents|antiviral agents|mesh-ancestor
92957815|NCT00766818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957816|NCT00766818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92957817|NCT00766818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957818|NCT00966316|Aspirin|aspirin|mesh-list
92957819|NCT00966316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92957820|NCT00966316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92957821|NCT00966316|Analgesics|analgesics|mesh-ancestor
92957822|NCT00966316|Sensory System Agents|sensory system agents|mesh-ancestor
92957823|NCT00966316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957824|NCT00966316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957825|NCT00966316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957826|NCT00966316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957827|NCT00966316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92957828|NCT00966316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92957829|NCT00966316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957830|NCT00966316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92957831|NCT00966316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92957832|NCT00966316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957833|NCT00966316|Antipyretics|antipyretics|mesh-ancestor
92957834|NCT00892827|Rituximab|rituximab|mesh-list
92957835|NCT00892827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92957836|NCT00892827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957837|NCT00892827|Immunologic Factors|immunologic factors|mesh-ancestor
92957838|NCT00892827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957839|NCT00892827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957840|NCT00766896|Aspirin|aspirin|mesh-list
92957841|NCT00766896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92957842|NCT00766896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92957843|NCT00766896|Analgesics|analgesics|mesh-ancestor
92957844|NCT00766896|Sensory System Agents|sensory system agents|mesh-ancestor
92957845|NCT00766896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957846|NCT00766896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957847|NCT00766896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957848|NCT00766896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92957849|NCT00766896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92957850|NCT00766896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92957851|NCT00766896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957852|NCT00766896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92957853|NCT00766896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92957854|NCT00766896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957855|NCT00766896|Antipyretics|antipyretics|mesh-ancestor
92957856|NCT00763620|Dimercaprol|dimercaprol|mesh-list
92957857|NCT00763620|Chelating Agents|chelating agents|mesh-ancestor
92957858|NCT00763620|Sequestering Agents|sequestering agents|mesh-ancestor
92957859|NCT00763620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957860|NCT00973804|Sirolimus|sirolimus|mesh-list
92957861|NCT00973804|Tacrolimus|tacrolimus|mesh-list
92957862|NCT00973804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957863|NCT00973804|Immunologic Factors|immunologic factors|mesh-ancestor
92957864|NCT00973804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957865|NCT00973804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92957866|NCT00973804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957867|NCT00973804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957868|NCT00973804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92957869|NCT00973804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957870|NCT00973804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92957871|NCT00973804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957872|NCT00973804|Antifungal Agents|antifungal agents|mesh-ancestor
92957873|NCT04018131|Cimetidine|cimetidine|mesh-list
92957874|NCT04018131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92957875|NCT04018131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957876|NCT04018131|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92957877|NCT04018131|Histamine Antagonists|histamine antagonists|mesh-ancestor
92957878|NCT04018131|Histamine Agents|histamine agents|mesh-ancestor
92957879|NCT04018131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957880|NCT04018131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957881|NCT04018131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957882|NCT04018131|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92957883|NCT04018131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92957884|NCT04018131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957885|NCT00973882|Carboplatin|carboplatin|mesh-list
92957886|NCT00973882|Etoposide|etoposide|mesh-list
92957887|NCT00973882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957888|NCT00973882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92957889|NCT00973882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92957890|NCT00973882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92957891|NCT00973882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957892|NCT00973882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957893|NCT02558088|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92957894|NCT02558088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92957895|NCT02558088|Autonomic Agents|autonomic agents|mesh-ancestor
92957896|NCT02558088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957897|NCT02558088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957898|NCT02558088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92957899|NCT02558088|Respiratory System Agents|respiratory system agents|mesh-ancestor
92957900|NCT02558088|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92957901|NCT02558088|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92957902|NCT02558088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92957903|NCT02558088|Adrenergic Agents|adrenergic agents|mesh-ancestor
92957904|NCT02558088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957905|NCT02558088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957906|NCT05279482|Methylprednisolone|methylprednisolone|mesh-list
92957907|NCT05279482|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92957908|NCT05279482|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92957909|NCT05279482|Prednisolone|prednisolone|mesh-list
92957910|NCT05279482|Prednisolone acetate|prednisolone acetate|mesh-list
92957911|NCT05279482|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92957912|NCT05279482|Prednisolone phosphate|prednisolone phosphate|mesh-list
92957913|NCT05279482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957914|NCT05279482|Antiemetics|antiemetics|mesh-ancestor
92957915|NCT05279482|Autonomic Agents|autonomic agents|mesh-ancestor
92957916|NCT05279482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92957917|NCT05279482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957918|NCT05279482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92957919|NCT05279482|Glucocorticoids|glucocorticoids|mesh-ancestor
92957920|NCT05279482|Hormones|hormones|mesh-ancestor
92957921|NCT05279482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957922|NCT05279482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92957923|NCT05279482|Protective Agents|protective agents|mesh-ancestor
92957924|NCT05279482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957925|NCT05279482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957926|NCT00890175|Loxapine|loxapine|mesh-list
92957927|NCT00890175|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92957928|NCT00890175|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92957929|NCT00890175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92957930|NCT00890175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957931|NCT00890175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92957932|NCT00890175|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92957933|NCT00890175|Dopamine Agents|dopamine agents|mesh-ancestor
92957934|NCT00890175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92957935|NCT00890175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957936|NCT00966472|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92957937|NCT00966472|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92957938|NCT00966472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957939|NCT00966472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92957940|NCT00966472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957941|NCT00966472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957942|NCT00966472|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92957943|NCT00966472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92957944|NCT00966472|Antimetabolites|antimetabolites|mesh-ancestor
92957945|NCT00966472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92957946|NCT00966472|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92957947|NCT00890253|Mycophenolic Acid|mycophenolic acid|mesh-list
92957948|NCT00890253|Prednisone|prednisone|mesh-list
92957949|NCT00890253|Prednisolone|prednisolone|mesh-list
92957950|NCT00890253|Everolimus|everolimus|mesh-list
92957951|NCT00890253|Basiliximab|basiliximab|mesh-list
92957952|NCT00890253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92957953|NCT00890253|Glucocorticoids|glucocorticoids|mesh-ancestor
92957954|NCT00890253|Hormones|hormones|mesh-ancestor
92957955|NCT00890253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957956|NCT00890253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957957|NCT00890253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957958|NCT00890253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92957959|NCT00890253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92957960|NCT00890253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92957961|NCT00890253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92957962|NCT00890253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92957963|NCT00890253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92957964|NCT00890253|Immunologic Factors|immunologic factors|mesh-ancestor
92957965|NCT00890253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92957966|NCT00890253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92957967|NCT00890253|Antitubercular Agents|antitubercular agents|mesh-ancestor
92957968|NCT00890253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92957969|NCT00890253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92957970|NCT00674154|Vitamin D|vitamin d|mesh-list
92957971|NCT00674154|Cholecalciferol|cholecalciferol|mesh-list
92957972|NCT00674154|Vitamins|vitamins|mesh-ancestor
92957973|NCT00674154|Micronutrients|micronutrients|mesh-ancestor
92957974|NCT00674154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957975|NCT00674154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92957976|NCT00674154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92957977|NCT00967954|Hormones|hormones|mesh-list
92957978|NCT00967954|Androgen Antagonists|androgen antagonists|mesh-list
92957979|NCT00967954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957980|NCT00967954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957981|NCT00967954|Hormone Antagonists|hormone antagonists|mesh-ancestor
92957982|NCT00767286|Cobalt|cobalt|mesh-list
92957983|NCT00767286|Goserelin|goserelin|mesh-list
92957984|NCT00767286|Flutamide|flutamide|mesh-list
92957985|NCT00767286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92957987|NCT00767286|Trace Elements|trace elements|mesh-ancestor
92957988|NCT00767286|Micronutrients|micronutrients|mesh-ancestor
92957989|NCT00767286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92957990|NCT00767286|Androgen Antagonists|androgen antagonists|mesh-ancestor
92957991|NCT00767286|Hormone Antagonists|hormone antagonists|mesh-ancestor
92957992|NCT00767286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92957993|NCT00968110|Omalizumab|omalizumab|mesh-list
92957994|NCT00968110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92957995|NCT00968110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92957996|NCT00968110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92957997|NCT00608517|Methylprednisolone|methylprednisolone|mesh-list
92957998|NCT00608517|Cyclophosphamide|cyclophosphamide|mesh-list
92957999|NCT00608517|Fludarabine|fludarabine|mesh-list
92958000|NCT00608517|Fludarabine phosphate|fludarabine phosphate|mesh-list
92958001|NCT00608517|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92165815|NCT02654119|Paclitaxel|paclitaxel|mesh-list
92958002|NCT00608517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958003|NCT00608517|Immunologic Factors|immunologic factors|mesh-ancestor
92958004|NCT00608517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958005|NCT00608517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92958006|NCT00608517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92958007|NCT00608517|Alkylating Agents|alkylating agents|mesh-ancestor
92958008|NCT00608517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958009|NCT00608517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958010|NCT00608517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92958011|NCT00608517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958012|NCT00608517|Antimetabolites|antimetabolites|mesh-ancestor
92958013|NCT00608517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958014|NCT00608517|Antiemetics|antiemetics|mesh-ancestor
92958015|NCT00608517|Autonomic Agents|autonomic agents|mesh-ancestor
92958016|NCT00608517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958017|NCT00608517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958018|NCT00608517|Glucocorticoids|glucocorticoids|mesh-ancestor
92958019|NCT00608517|Hormones|hormones|mesh-ancestor
92958020|NCT00608517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527506|NCT00033280|Temozolomide|temozolomide|mesh-list
92958021|NCT00608517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92958022|NCT00608517|Protective Agents|protective agents|mesh-ancestor
92958024|NCT00966706|Docetaxel|docetaxel|mesh-list
92958025|NCT00966706|Capecitabine|capecitabine|mesh-list
92958026|NCT00966706|Epirubicin|epirubicin|mesh-list
92958027|NCT00966706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958028|NCT00966706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958029|NCT00966706|Antimetabolites|antimetabolites|mesh-ancestor
92958030|NCT00966706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958031|NCT00966706|Tubulin Modulators|tubulin modulators|mesh-ancestor
92958032|NCT00966706|Antimitotic Agents|antimitotic agents|mesh-ancestor
92958033|NCT00966706|Mitosis Modulators|mitosis modulators|mesh-ancestor
92958034|NCT00966706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92958035|NCT00966706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92958036|NCT00966706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92958037|NCT00966706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958038|NCT00893061|Tamoxifen|tamoxifen|mesh-list
92958039|NCT00893061|Letrozole|letrozole|mesh-list
92958040|NCT00893061|Anastrozole|anastrozole|mesh-list
92958041|NCT00893061|Exemestane|exemestane|mesh-list
92958042|NCT00893061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958043|NCT00893061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958044|NCT00893061|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92958045|NCT00893061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92958046|NCT00893061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958047|NCT00893061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92958048|NCT00893061|Hormone Antagonists|hormone antagonists|mesh-ancestor
92958049|NCT00893061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958050|NCT00893061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958051|NCT00893061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92958052|NCT00893061|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92958053|NCT00893061|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92958054|NCT00893061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92958055|NCT00974272|Exenatide|exenatide|mesh-list
92958056|NCT00974272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958057|NCT00974272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958058|NCT00974272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92958059|NCT00974272|Incretins|incretins|mesh-ancestor
92958060|NCT00974272|Hormones|hormones|mesh-ancestor
92603485|NCT00480571|Dopamine Agents|dopamine agents|mesh-ancestor
92958061|NCT00974272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958062|NCT00974428|Wobenzym|wobenzym|mesh-list
92958063|NCT00974428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92958064|NCT00974428|Immunologic Factors|immunologic factors|mesh-ancestor
92958065|NCT00974428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958066|NCT00974584|Paclitaxel|paclitaxel|mesh-list
92958067|NCT00974584|Bevacizumab|bevacizumab|mesh-list
92958068|NCT00974584|Carboplatin|carboplatin|mesh-list
92958069|NCT00974584|Pemetrexed|pemetrexed|mesh-list
92958070|NCT00974584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92958071|NCT00974584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958072|NCT00974584|Tubulin Modulators|tubulin modulators|mesh-ancestor
92958073|NCT00974584|Antimitotic Agents|antimitotic agents|mesh-ancestor
92958074|NCT00974584|Mitosis Modulators|mitosis modulators|mesh-ancestor
92958075|NCT00974584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958076|NCT00974584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92958077|NCT00974584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92958078|NCT00974584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92958079|NCT00974584|Growth Substances|growth substances|mesh-ancestor
92958080|NCT00974584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958081|NCT00974584|Growth Inhibitors|growth inhibitors|mesh-ancestor
92958082|NCT00974584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958083|NCT00974584|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92958084|NCT00974584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92958085|NCT00608205|Fluorouracil|fluorouracil|mesh-list
92958086|NCT00608205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958087|NCT00608205|Antimetabolites|antimetabolites|mesh-ancestor
92958088|NCT00608205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958089|NCT00608205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958090|NCT00608205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958091|NCT00608205|Immunologic Factors|immunologic factors|mesh-ancestor
92958092|NCT00608205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958093|NCT00974740|Atorvastatin|atorvastatin|mesh-list
92958094|NCT00974740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92303063|NCT00361244|Irinotecan|irinotecan|mesh-list
92958095|NCT00974740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92958096|NCT00974740|Antimetabolites|antimetabolites|mesh-ancestor
92958097|NCT00974740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958098|NCT00974740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92958099|NCT00974740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92958100|NCT00974740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958102|NCT00967096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92958103|NCT00967096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958104|NCT00967096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958105|NCT05227300|Lidocaine|lidocaine|mesh-list
92958106|NCT05227300|Epinephrine|epinephrine|mesh-list
92958107|NCT05227300|Anesthetics, Local|anesthetics, local|mesh-ancestor
92958108|NCT05227300|Anesthetics|anesthetics|mesh-ancestor
92958109|NCT05227300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958110|NCT05227300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958111|NCT05227300|Sensory System Agents|sensory system agents|mesh-ancestor
92958112|NCT05227300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958113|NCT05227300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92958114|NCT05227300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92958115|NCT05227300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92958116|NCT05227300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958117|NCT05227300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958118|NCT05227300|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92958119|NCT05227300|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92958120|NCT05227300|Adrenergic Agents|adrenergic agents|mesh-ancestor
92958121|NCT05227300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958122|NCT05227300|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92958123|NCT05227300|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92958124|NCT05227300|Autonomic Agents|autonomic agents|mesh-ancestor
92958125|NCT05227300|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92958126|NCT05227300|Respiratory System Agents|respiratory system agents|mesh-ancestor
92958127|NCT05227300|Mydriatics|mydriatics|mesh-ancestor
92958128|NCT05227300|Sympathomimetics|sympathomimetics|mesh-ancestor
92958129|NCT05227300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92958130|NCT00890487|Hyaluronic Acid|hyaluronic acid|mesh-list
92958131|NCT00890487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92958132|NCT00890487|Immunologic Factors|immunologic factors|mesh-ancestor
92958133|NCT00890487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958134|NCT00890487|Viscosupplements|viscosupplements|mesh-ancestor
92958135|NCT00890487|Protective Agents|protective agents|mesh-ancestor
92958136|NCT00890565|Granisetron|granisetron|mesh-list
92958137|NCT00890565|Antiemetics|antiemetics|mesh-ancestor
92958138|NCT00890565|Autonomic Agents|autonomic agents|mesh-ancestor
92958139|NCT00890565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958140|NCT00890565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958141|NCT00890565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958142|NCT00890565|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92958143|NCT00890565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92958144|NCT00890565|Serotonin Agents|serotonin agents|mesh-ancestor
92958145|NCT00890565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958146|NCT00890565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958147|NCT00890643|Prazosin|prazosin|mesh-list
92958148|NCT00890643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92958149|NCT00890643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92958150|NCT00890643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92958151|NCT00890643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92958152|NCT00890643|Adrenergic Agents|adrenergic agents|mesh-ancestor
92958153|NCT00890643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958154|NCT00890643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958155|NCT00890643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958156|NCT00893217|Interferons|interferons|mesh-list
92958157|NCT00893217|Interferon-beta|interferon-beta|mesh-list
92958158|NCT00893217|Interferon beta-1b|interferon beta-1b|mesh-list
92958159|NCT00893217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958160|NCT00893217|Antiviral Agents|antiviral agents|mesh-ancestor
92958161|NCT00893217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958162|NCT00893217|Immunologic Factors|immunologic factors|mesh-ancestor
92958163|NCT00893217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958164|NCT00893217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92958165|NCT00767598|Sildenafil Citrate|sildenafil citrate|mesh-list
92958166|NCT00767598|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92958167|NCT00767598|Udenafil|udenafil|mesh-list
92958168|NCT00767598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92303137|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
92958169|NCT00767598|Vasodilator Agents|vasodilator agents|mesh-ancestor
92958170|NCT00767598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92958171|NCT00767598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958172|NCT00767598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958173|NCT00767598|Urological Agents|urological agents|mesh-ancestor
92958174|NCT00670800|Metformin|metformin|mesh-list
92958175|NCT00670800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958176|NCT00670800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958177|NCT00764166|Docetaxel|docetaxel|mesh-list
92958178|NCT00764166|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92958179|NCT00764166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958180|NCT00764166|Tubulin Modulators|tubulin modulators|mesh-ancestor
92958181|NCT00764166|Antimitotic Agents|antimitotic agents|mesh-ancestor
92958182|NCT00764166|Mitosis Modulators|mitosis modulators|mesh-ancestor
92958183|NCT00764166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958184|NCT00764166|Hormones|hormones|mesh-ancestor
92958185|NCT00764166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958186|NCT00764166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958187|NCT00770406|Botulinum Toxins|botulinum toxins|mesh-list
92958188|NCT00770406|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92958189|NCT00770406|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92958190|NCT00770406|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92958191|NCT00770406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958192|NCT00770406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958193|NCT00770406|Cholinergic Agents|cholinergic agents|mesh-ancestor
92958194|NCT00770406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958195|NCT00770406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958196|NCT00770406|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92958197|NCT00770406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958198|NCT02557542|Polidocanol|polidocanol|mesh-list
92958199|NCT02557542|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
92958200|NCT02557542|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92958201|NCT02557542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92958202|NCT00767754|Paroxetine|paroxetine|mesh-list
92958203|NCT00767754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92958204|NCT00767754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92958205|NCT00767754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958206|NCT00767754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958207|NCT00767754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958208|NCT00767754|Serotonin Agents|serotonin agents|mesh-ancestor
92958209|NCT00767754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958210|NCT00767754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92958211|NCT00767754|Antidepressive Agents|antidepressive agents|mesh-ancestor
92958212|NCT00767754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92958213|NCT00767754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92958214|NCT00767754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92958215|NCT00767754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958216|NCT00764244|Triamcinolone|triamcinolone|mesh-list
92958217|NCT00764244|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92958218|NCT00764244|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92958219|NCT00764244|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92958220|NCT00764244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958221|NCT00764244|Glucocorticoids|glucocorticoids|mesh-ancestor
92958222|NCT00764244|Hormones|hormones|mesh-ancestor
92958223|NCT00764244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958224|NCT00764244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958225|NCT00764244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958226|NCT00764244|Immunologic Factors|immunologic factors|mesh-ancestor
92958227|NCT00764244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958228|NCT00764244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958229|NCT00770640|Insulin|insulin|mesh-list
92958230|NCT00770640|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92958231|NCT00770640|Pioglitazone|pioglitazone|mesh-list
92958232|NCT00770640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958233|NCT00770640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958234|NCT00770718|Thrombin|thrombin|mesh-list
92958235|NCT00770718|Hemostatics|hemostatics|mesh-ancestor
92958236|NCT00770718|Coagulants|coagulants|mesh-ancestor
92958237|NCT00770796|Atorvastatin|atorvastatin|mesh-list
92958238|NCT00770796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92958239|NCT00770796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92958240|NCT00770796|Antimetabolites|antimetabolites|mesh-ancestor
92527507|NCT00033280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92958241|NCT00770796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958242|NCT00770796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92958243|NCT00770796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92958244|NCT00770796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958245|NCT00545740|Mesalamine|mesalamine|mesh-list
92958246|NCT00545740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92958247|NCT00545740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92958248|NCT00545740|Analgesics|analgesics|mesh-ancestor
92958249|NCT00545740|Sensory System Agents|sensory system agents|mesh-ancestor
92958250|NCT00545740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958251|NCT00545740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958252|NCT00545740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958253|NCT00545740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92958254|NCT05208190|Clozapine|clozapine|mesh-list
92958255|NCT05208190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92958256|NCT05208190|Serotonin Agents|serotonin agents|mesh-ancestor
92958257|NCT05208190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958258|NCT05208190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958259|NCT05208190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958260|NCT05208190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92958261|NCT05208190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92958262|NCT05208190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958263|NCT05208190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92958264|NCT05208190|GABA Antagonists|gaba antagonists|mesh-ancestor
92958265|NCT05208190|GABA Agents|gaba agents|mesh-ancestor
92958266|NCT00609609|Methylprednisolone|methylprednisolone|mesh-list
92958267|NCT00609609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92958268|NCT00609609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92958269|NCT00609609|Prednisolone|prednisolone|mesh-list
92958270|NCT00609609|Prednisolone acetate|prednisolone acetate|mesh-list
92958271|NCT00609609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92958272|NCT00609609|Prednisolone phosphate|prednisolone phosphate|mesh-list
92958273|NCT00609609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958274|NCT00609609|Antiemetics|antiemetics|mesh-ancestor
92958275|NCT00609609|Autonomic Agents|autonomic agents|mesh-ancestor
92958276|NCT00609609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958277|NCT00609609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958278|NCT00609609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958279|NCT00609609|Glucocorticoids|glucocorticoids|mesh-ancestor
92958280|NCT00609609|Hormones|hormones|mesh-ancestor
92958281|NCT00609609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958282|NCT00609609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92958283|NCT00609609|Protective Agents|protective agents|mesh-ancestor
92958284|NCT00609609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92958285|NCT00609609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958286|NCT00673452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92958287|NCT00673452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92958288|NCT00673452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92958289|NCT00673452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958290|NCT00673452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958291|NCT00673452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958292|NCT00673452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958293|NCT00673452|Analgesics|analgesics|mesh-ancestor
92958294|NCT00673452|Sensory System Agents|sensory system agents|mesh-ancestor
92958295|NCT00673452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958296|NCT00673452|Antidepressive Agents|antidepressive agents|mesh-ancestor
92958297|NCT00673452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92958298|NCT00673452|Dopamine Agents|dopamine agents|mesh-ancestor
92958299|NCT00967174|Nicotine|nicotine|mesh-list
92958300|NCT00967174|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92958301|NCT00967174|Autonomic Agents|autonomic agents|mesh-ancestor
92958302|NCT00967174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958303|NCT00967174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958304|NCT00967174|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92958305|NCT00967174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92958306|NCT00967174|Cholinergic Agents|cholinergic agents|mesh-ancestor
92958307|NCT00967174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958308|NCT00967174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958309|NCT00967252|Atorvastatin|atorvastatin|mesh-list
92958310|NCT00967252|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92958311|NCT00967252|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92958312|NCT00967252|Antimetabolites|antimetabolites|mesh-ancestor
92958313|NCT00967252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958314|NCT00967252|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92958315|NCT00967252|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92958316|NCT00967252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958317|NCT00890955|Cyclophosphamide|cyclophosphamide|mesh-list
92958318|NCT00890955|Amrubicin|amrubicin|mesh-list
92958319|NCT00890955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958320|NCT00890955|Immunologic Factors|immunologic factors|mesh-ancestor
92958321|NCT00890955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958322|NCT00890955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92958323|NCT00890955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92958324|NCT00890955|Alkylating Agents|alkylating agents|mesh-ancestor
92958325|NCT00890955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958326|NCT00890955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958327|NCT00890955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92958328|NCT00975052|Metformin|metformin|mesh-list
92958329|NCT00975052|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92958330|NCT00975052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958331|NCT00975052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958332|NCT00975052|Incretins|incretins|mesh-ancestor
92958333|NCT00975052|Hormones|hormones|mesh-ancestor
92958334|NCT00975052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958335|NCT00975052|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92958336|NCT00975052|Protease Inhibitors|protease inhibitors|mesh-ancestor
92958337|NCT00975052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958338|NCT00975052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958339|NCT00891033|Bortezomib|bortezomib|mesh-list
92958340|NCT00891033|Panobinostat|panobinostat|mesh-list
92958341|NCT00891033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958342|NCT00891033|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92958343|NCT00891033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958344|NCT00891033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958345|NCT00770952|Pioglitazone|pioglitazone|mesh-list
92958346|NCT00770952|Glimepiride|glimepiride|mesh-list
92958347|NCT00770952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958348|NCT00770952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958349|NCT00770952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92958350|NCT00770952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958351|NCT00770952|Immunologic Factors|immunologic factors|mesh-ancestor
92958352|NCT00764556|Insulin|insulin|mesh-list
92958353|NCT00764556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958354|NCT00764556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958355|NCT00968578|Methylprednisolone|methylprednisolone|mesh-list
92958356|NCT00968578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92958357|NCT00968578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92958358|NCT00968578|Prednisolone|prednisolone|mesh-list
92958359|NCT00968578|Prednisolone acetate|prednisolone acetate|mesh-list
92958361|NCT00968578|Prednisolone phosphate|prednisolone phosphate|mesh-list
92958362|NCT00968578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958363|NCT00968578|Antiemetics|antiemetics|mesh-ancestor
92958364|NCT00968578|Autonomic Agents|autonomic agents|mesh-ancestor
92958365|NCT00968578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958366|NCT00968578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958367|NCT00968578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958368|NCT00968578|Glucocorticoids|glucocorticoids|mesh-ancestor
92958369|NCT00968578|Hormones|hormones|mesh-ancestor
92958370|NCT00968578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958371|NCT00968578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92958372|NCT00968578|Protective Agents|protective agents|mesh-ancestor
92958373|NCT00968578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92958374|NCT00968578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958375|NCT00893373|Sorafenib|sorafenib|mesh-list
92958376|NCT00893373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958377|NCT00893373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958378|NCT00893373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958379|NCT00893373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958380|NCT00891267|Amlodipine|amlodipine|mesh-list
92958381|NCT00891267|Olmesartan|olmesartan|mesh-list
92958382|NCT00891267|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92958383|NCT00891267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92958384|NCT00891267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92958385|NCT00891267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958386|NCT00891267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958387|NCT00891267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92527508|NCT00033280|Alkylating Agents|alkylating agents|mesh-ancestor
92958388|NCT00891267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958389|NCT00891267|Vasodilator Agents|vasodilator agents|mesh-ancestor
92958390|NCT00891267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92958391|NCT00891267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92958392|NCT00545584|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92958393|NCT00545584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958394|NCT00545584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958395|NCT00545584|Incretins|incretins|mesh-ancestor
92958396|NCT00545584|Hormones|hormones|mesh-ancestor
92958397|NCT00545584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958398|NCT00545584|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92958399|NCT00545584|Protease Inhibitors|protease inhibitors|mesh-ancestor
92958400|NCT00545584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958401|NCT00545584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958402|NCT00378703|Sirolimus|sirolimus|mesh-list
92958403|NCT00378703|Bevacizumab|bevacizumab|mesh-list
92958404|NCT00378703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92958405|NCT00378703|Sorafenib|sorafenib|mesh-list
92958406|NCT00378703|Temsirolimus|temsirolimus|mesh-list
92958407|NCT00378703|MTOR Inhibitors|mtor inhibitors|mesh-list
92958408|NCT00378703|Endothelial Growth Factors|endothelial growth factors|mesh-list
92958409|NCT00378703|Antibodies|antibodies|mesh-list
92958410|NCT00378703|Immunoglobulins|immunoglobulins|mesh-list
92958411|NCT00378703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92958412|NCT00378703|Immunoglobulin G|immunoglobulin g|mesh-list
92958413|NCT00378703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958414|NCT00378703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92958415|NCT00378703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92958416|NCT00378703|Growth Substances|growth substances|mesh-ancestor
92958417|NCT00378703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958418|NCT00378703|Growth Inhibitors|growth inhibitors|mesh-ancestor
92958419|NCT00378703|Immunologic Factors|immunologic factors|mesh-ancestor
92958420|NCT00378703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958421|NCT00378703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958422|NCT00378703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958423|NCT00378703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92958424|NCT00378703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958425|NCT00378703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92958426|NCT00378703|Antifungal Agents|antifungal agents|mesh-ancestor
92958427|NCT00378703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958428|NCT00893451|Vitamin D|vitamin d|mesh-list
92958429|NCT00893451|Cholecalciferol|cholecalciferol|mesh-list
92958430|NCT00893451|Vitamins|vitamins|mesh-ancestor
92958431|NCT00893451|Micronutrients|micronutrients|mesh-ancestor
92603867|NCT01241032|Udenafil|udenafil|mesh-list
92958432|NCT00893451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958433|NCT00893451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92958434|NCT00893451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92958435|NCT00967408|Escitalopram|escitalopram|mesh-list
92958436|NCT00967408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92958437|NCT00967408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92958438|NCT00967408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958439|NCT00967408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958440|NCT00967408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958441|NCT00967408|Serotonin Agents|serotonin agents|mesh-ancestor
92958442|NCT00967408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958443|NCT00891423|Meropenem|meropenem|mesh-list
92958444|NCT00891423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92958445|NCT00891423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958446|NCT04035382|Misoprostol|misoprostol|mesh-list
92958447|NCT04035382|Oxytocin|oxytocin|mesh-list
92958448|NCT04035382|Oxytocics|oxytocics|mesh-ancestor
92958449|NCT04035382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92958450|NCT04035382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958451|NCT04035382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92958452|NCT04035382|Abortifacient Agents|abortifacient agents|mesh-ancestor
92958453|NCT04035382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92958454|NCT04035382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958455|NCT02541045|Metadoxine|metadoxine|mesh-list
92958456|NCT02541045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92958457|NCT00891579|Pemetrexed|pemetrexed|mesh-list
92958458|NCT00891579|Gefitinib|gefitinib|mesh-list
92958459|NCT00891579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958460|NCT00891579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958461|NCT00891579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958462|NCT00891579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92958463|NCT00891579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92958464|NCT00891579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958465|NCT00968734|Cholecalciferol|cholecalciferol|mesh-list
92958466|NCT00968734|Vitamin D|vitamin d|mesh-list
92958467|NCT00968734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92958468|NCT00968734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958469|NCT00968734|Vitamins|vitamins|mesh-ancestor
92958470|NCT00968734|Micronutrients|micronutrients|mesh-ancestor
92958471|NCT00968734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92958472|NCT03620643|Fulvestrant|fulvestrant|mesh-list
92958473|NCT03620643|Crizotinib|crizotinib|mesh-list
92958474|NCT03620643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92958475|NCT03620643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958476|NCT03620643|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92958477|NCT03620643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92958478|NCT03620643|Hormone Antagonists|hormone antagonists|mesh-ancestor
92958479|NCT03620643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958480|NCT03620643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958481|NCT03620643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958482|NCT03620643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958483|NCT03620643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958484|NCT04008316|Colchicine|colchicine|mesh-list
92958485|NCT04008316|Gout Suppressants|gout suppressants|mesh-ancestor
92958486|NCT04008316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92958487|NCT04008316|Tubulin Modulators|tubulin modulators|mesh-ancestor
92958488|NCT04008316|Antimitotic Agents|antimitotic agents|mesh-ancestor
92958489|NCT04008316|Mitosis Modulators|mitosis modulators|mesh-ancestor
92958490|NCT04008316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958491|NCT04008316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958492|NCT00893607|Methoxamine|methoxamine|mesh-list
92958493|NCT00893607|Sympathomimetics|sympathomimetics|mesh-ancestor
92958494|NCT00893607|Autonomic Agents|autonomic agents|mesh-ancestor
92958495|NCT00893607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958496|NCT00893607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958497|NCT00893607|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92958498|NCT00893607|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92958499|NCT00893607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92958500|NCT00893607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92958501|NCT00893607|Adrenergic Agents|adrenergic agents|mesh-ancestor
92958502|NCT00893607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958503|NCT00893607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958504|NCT00969046|Epothilone B|epothilone b|mesh-list
92958505|NCT00969046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958506|NCT00969046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92958507|NCT00969046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92958508|NCT00969046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92958509|NCT00969046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958510|NCT05008354|Pyridoxine|pyridoxine|mesh-list
92958511|NCT05008354|Vitamin B Complex|vitamin b complex|mesh-ancestor
92958512|NCT05008354|Vitamins|vitamins|mesh-ancestor
92958513|NCT05008354|Micronutrients|micronutrients|mesh-ancestor
92958514|NCT05008354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958515|NCT00975754|Budesonide|budesonide|mesh-list
92958516|NCT00975754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958517|NCT00975754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92958518|NCT00975754|Autonomic Agents|autonomic agents|mesh-ancestor
92958519|NCT00975754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958520|NCT00975754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958521|NCT00975754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92958522|NCT00975754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92958523|NCT00975754|Glucocorticoids|glucocorticoids|mesh-ancestor
92958524|NCT00975754|Hormones|hormones|mesh-ancestor
92958525|NCT00975754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958526|NCT01045681|Dexamethasone|dexamethasone|mesh-list
92958527|NCT01045681|Dexamethasone acetate|dexamethasone acetate|mesh-list
92958528|NCT01045681|Bortezomib|bortezomib|mesh-list
92958529|NCT01045681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92958530|NCT01045681|BB 1101|bb 1101|mesh-list
92958531|NCT01045681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958532|NCT01045681|Antiemetics|antiemetics|mesh-ancestor
92958533|NCT01045681|Autonomic Agents|autonomic agents|mesh-ancestor
92958534|NCT01045681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958535|NCT01045681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958536|NCT01045681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958537|NCT01045681|Glucocorticoids|glucocorticoids|mesh-ancestor
92958538|NCT01045681|Hormones|hormones|mesh-ancestor
92958539|NCT01045681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958540|NCT01045681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92958541|NCT01045681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958542|NCT01045681|Protease Inhibitors|protease inhibitors|mesh-ancestor
92958543|NCT01045681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958544|NCT01045681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958545|NCT01045681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92958546|NCT01045681|Alkylating Agents|alkylating agents|mesh-ancestor
92958547|NCT00975910|Lidocaine|lidocaine|mesh-list
92958548|NCT00975910|Anesthetics, Local|anesthetics, local|mesh-ancestor
92958549|NCT00975910|Anesthetics|anesthetics|mesh-ancestor
92958550|NCT00975910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958551|NCT00975910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958552|NCT00975910|Sensory System Agents|sensory system agents|mesh-ancestor
92958553|NCT00975910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958554|NCT00975910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92958555|NCT00975910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92958556|NCT00975910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92958557|NCT00975910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958558|NCT00975910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958559|NCT03617913|Cisplatin|cisplatin|mesh-list
92958560|NCT03617913|Fluorouracil|fluorouracil|mesh-list
92958561|NCT03617913|Mitomycins|mitomycins|mesh-list
92958562|NCT03617913|Mitomycin|mitomycin|mesh-list
92958563|NCT03617913|Avelumab|avelumab|mesh-list
92958564|NCT03617913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92958565|NCT03617913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958566|NCT03617913|Antimetabolites|antimetabolites|mesh-ancestor
92958567|NCT03617913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958568|NCT03617913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958569|NCT03617913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958570|NCT03617913|Immunologic Factors|immunologic factors|mesh-ancestor
92958571|NCT03617913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958572|NCT03617913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92958573|NCT03617913|Alkylating Agents|alkylating agents|mesh-ancestor
92958574|NCT03617913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92958575|NCT03617913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958576|NCT03617913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92958577|NCT00975988|Lapatinib|lapatinib|mesh-list
92958578|NCT00975988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958579|NCT00975988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958580|NCT00975988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958581|NCT00975988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958582|NCT00976066|Naltrexone|naltrexone|mesh-list
92958583|NCT00976066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92958584|NCT00976066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92958585|NCT00976066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958586|NCT00976066|Sensory System Agents|sensory system agents|mesh-ancestor
92958587|NCT00976066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958588|NCT03557619|Venetoclax|venetoclax|mesh-list
92958589|NCT03557619|Levonorgestrel|levonorgestrel|mesh-list
92958590|NCT03557619|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92958591|NCT03557619|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92958592|NCT03557619|Estradiol|estradiol|mesh-list
92958593|NCT03557619|Estrogens|estrogens|mesh-ancestor
92958594|NCT03557619|Hormones|hormones|mesh-ancestor
92958595|NCT03557619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958596|NCT03557619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958597|NCT03557619|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92958598|NCT03557619|Contraceptive Agents|contraceptive agents|mesh-ancestor
92958599|NCT03557619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92958600|NCT03557619|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92958601|NCT03557619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958602|NCT03557619|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92958603|NCT03557619|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92958604|NCT03557619|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92958605|NCT03557619|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92958606|NCT00969592|Insulin|insulin|mesh-list
92958607|NCT00969592|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92958608|NCT00969592|Insulin Aspart|insulin aspart|mesh-list
92958609|NCT00969592|Insulin, Long-Acting|insulin, long-acting|mesh-list
92527511|NCT00033319|Aspirin|aspirin|mesh-list
92527512|NCT00033319|Folic Acid|folic acid|mesh-list
92958610|NCT00969592|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92958611|NCT00969592|Insulin glulisine|insulin glulisine|mesh-list
92958612|NCT00969592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958613|NCT00969592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958614|NCT00368641|Icodextrin|icodextrin|mesh-list
92958615|NCT00368641|Dialysis Solutions|dialysis solutions|mesh-ancestor
92958616|NCT00368641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92958617|NCT00976222|Ranibizumab|ranibizumab|mesh-list
92958618|NCT00976222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92958619|NCT00976222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92958620|NCT00976222|Growth Substances|growth substances|mesh-ancestor
92958621|NCT00976222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958622|NCT00976222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92958623|NCT00976222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958624|NCT00976300|Cyclosporine|cyclosporine|mesh-list
92958625|NCT00976300|Cyclophosphamide|cyclophosphamide|mesh-list
92958626|NCT00976300|Cyclosporins|cyclosporins|mesh-list
92958627|NCT00976300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958628|NCT00976300|Immunologic Factors|immunologic factors|mesh-ancestor
92958629|NCT00976300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958630|NCT00976300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92958631|NCT00976300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92958632|NCT00976300|Alkylating Agents|alkylating agents|mesh-ancestor
92958633|NCT00976300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958634|NCT00976300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958635|NCT00976300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92958636|NCT00976300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958637|NCT00976300|Antifungal Agents|antifungal agents|mesh-ancestor
92958638|NCT00976300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958639|NCT00976300|Dermatologic Agents|dermatologic agents|mesh-ancestor
92958640|NCT00976300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92958641|NCT00979966|Sirolimus|sirolimus|mesh-list
92958642|NCT00979966|Sunitinib|sunitinib|mesh-list
92958643|NCT00979966|Temsirolimus|temsirolimus|mesh-list
92958644|NCT00979966|MTOR Inhibitors|mtor inhibitors|mesh-list
92958645|NCT00979966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958646|NCT00979966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92958647|NCT00979966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92958648|NCT00979966|Growth Substances|growth substances|mesh-ancestor
92958649|NCT00979966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958650|NCT00979966|Growth Inhibitors|growth inhibitors|mesh-ancestor
92958651|NCT00979966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958652|NCT00979966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958653|NCT00979966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958654|NCT00979966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958655|NCT00979966|Immunologic Factors|immunologic factors|mesh-ancestor
92958656|NCT00979966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92958657|NCT00979966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958658|NCT00979966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92958659|NCT00979966|Antifungal Agents|antifungal agents|mesh-ancestor
92958660|NCT00969904|Acetylcysteine|acetylcysteine|mesh-list
92958661|NCT00969904|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92958662|NCT00969904|Antiviral Agents|antiviral agents|mesh-ancestor
92958663|NCT00969904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958664|NCT00969904|Expectorants|expectorants|mesh-ancestor
92958665|NCT00969904|Respiratory System Agents|respiratory system agents|mesh-ancestor
92958666|NCT00969904|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92958667|NCT00969904|Antioxidants|antioxidants|mesh-ancestor
92958668|NCT00969904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958669|NCT00969904|Protective Agents|protective agents|mesh-ancestor
92958670|NCT00969904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958671|NCT00969904|Antidotes|antidotes|mesh-ancestor
92958673|NCT00976690|Azathioprine|azathioprine|mesh-list
92958674|NCT00976690|Antimetabolites|antimetabolites|mesh-ancestor
92958675|NCT00976690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958676|NCT00976690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958677|NCT00976690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958678|NCT00976690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958679|NCT00976690|Immunologic Factors|immunologic factors|mesh-ancestor
92958680|NCT00976690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958681|NCT00976690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92958682|NCT00976690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92958683|NCT00976690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92958684|NCT00976690|Analgesics|analgesics|mesh-ancestor
92958685|NCT00976690|Sensory System Agents|sensory system agents|mesh-ancestor
92958686|NCT00976690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958687|NCT00976690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958688|NCT00976768|Fluorouracil|fluorouracil|mesh-list
92958689|NCT00976768|Oxaliplatin|oxaliplatin|mesh-list
92958690|NCT00976768|Antimetabolites|antimetabolites|mesh-ancestor
92958691|NCT00976768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958692|NCT00976768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958693|NCT00976768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958694|NCT00976768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958695|NCT00976768|Immunologic Factors|immunologic factors|mesh-ancestor
92958696|NCT00976768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958698|NCT00608985|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92958699|NCT00608985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92958700|NCT00608985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958701|NCT00608985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958702|NCT00608985|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92958703|NCT00608985|GABA Agonists|gaba agonists|mesh-ancestor
92958704|NCT00608985|GABA Agents|gaba agents|mesh-ancestor
92958705|NCT00608985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958706|NCT00608985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958707|NCT00969982|Misoprostol|misoprostol|mesh-list
92958708|NCT00969982|Mifepristone|mifepristone|mesh-list
92958709|NCT00969982|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92958710|NCT00969982|Abortifacient Agents|abortifacient agents|mesh-ancestor
92958711|NCT00969982|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92958712|NCT00969982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958713|NCT00969982|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92958714|NCT00969982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958715|NCT00969982|Oxytocics|oxytocics|mesh-ancestor
92958716|NCT00969982|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92958717|NCT00969982|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92958718|NCT00969982|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92958719|NCT00969982|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92958720|NCT00969982|Contraceptive Agents|contraceptive agents|mesh-ancestor
92958721|NCT00969982|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92958722|NCT00969982|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92958723|NCT00969982|Hormone Antagonists|hormone antagonists|mesh-ancestor
92958724|NCT00969982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958725|NCT00969982|Luteolytic Agents|luteolytic agents|mesh-ancestor
92958726|NCT00969982|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92958727|NCT00969982|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92958728|NCT00970138|Apatinib|apatinib|mesh-list
92958729|NCT00970138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958730|NCT00970138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92958731|NCT00970138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958732|NCT00970138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958733|NCT00892125|Carbamazepine|carbamazepine|mesh-list
92958734|NCT00892125|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92958735|NCT00892125|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92958736|NCT00892125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92958737|NCT00892125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958738|NCT00892125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958739|NCT00892125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92958740|NCT00892125|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92958741|NCT00892125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92958742|NCT00892125|Serotonin Agents|serotonin agents|mesh-ancestor
92958743|NCT00892125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958744|NCT00892125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958745|NCT00892125|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92958746|NCT00892125|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92958747|NCT00892125|Dopamine Agents|dopamine agents|mesh-ancestor
92958748|NCT00892125|Anticonvulsants|anticonvulsants|mesh-ancestor
92958749|NCT00892125|Antimanic Agents|antimanic agents|mesh-ancestor
92958750|NCT00892125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92958751|NCT00892125|Analgesics|analgesics|mesh-ancestor
92958752|NCT00892125|Sensory System Agents|sensory system agents|mesh-ancestor
92958753|NCT00892125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958754|NCT00892125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92958755|NCT00892125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92958756|NCT00892125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92958757|NCT00892125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92958758|NCT00980356|Vildagliptin|vildagliptin|mesh-list
92958759|NCT00980356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958760|NCT00980356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958761|NCT00980356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92958762|NCT00980356|Protease Inhibitors|protease inhibitors|mesh-ancestor
92958763|NCT00980356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958764|NCT00980356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958765|NCT00368251|Brivaracetam|brivaracetam|mesh-list
92958766|NCT00368251|Anticonvulsants|anticonvulsants|mesh-ancestor
92958767|NCT00893841|Pramipexole|pramipexole|mesh-list
92958768|NCT00893841|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92958769|NCT00893841|Antidepressive Agents|antidepressive agents|mesh-ancestor
92958770|NCT00893841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92958771|NCT00893841|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92958772|NCT00893841|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92958773|NCT00893841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958774|NCT00893841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958775|NCT00893841|Antioxidants|antioxidants|mesh-ancestor
92958776|NCT00893841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958777|NCT00893841|Protective Agents|protective agents|mesh-ancestor
92958778|NCT00893841|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92958779|NCT00893841|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92958780|NCT00893841|Dopamine Agonists|dopamine agonists|mesh-ancestor
92958781|NCT00893841|Dopamine Agents|dopamine agents|mesh-ancestor
92958782|NCT00893841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958783|NCT00378079|Methadone|methadone|mesh-list
92958784|NCT00378079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92958785|NCT00378079|Narcotics|narcotics|mesh-ancestor
92958786|NCT00378079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958787|NCT00378079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958788|NCT00378079|Analgesics|analgesics|mesh-ancestor
92958789|NCT00378079|Sensory System Agents|sensory system agents|mesh-ancestor
92958790|NCT00378079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958791|NCT00378079|Antitussive Agents|antitussive agents|mesh-ancestor
92958792|NCT00378079|Respiratory System Agents|respiratory system agents|mesh-ancestor
92958793|NCT00970450|Acetaminophen|acetaminophen|mesh-list
92958794|NCT00970450|Tropisetron|tropisetron|mesh-list
92958795|NCT00970450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92958796|NCT00970450|Analgesics|analgesics|mesh-ancestor
92958797|NCT00970450|Sensory System Agents|sensory system agents|mesh-ancestor
92958798|NCT00970450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958799|NCT00970450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958800|NCT00970450|Antipyretics|antipyretics|mesh-ancestor
92958801|NCT00970450|Antiemetics|antiemetics|mesh-ancestor
92958802|NCT00970450|Autonomic Agents|autonomic agents|mesh-ancestor
92958803|NCT00970450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958804|NCT00970450|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92958805|NCT00970450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92958806|NCT00970450|Serotonin Agents|serotonin agents|mesh-ancestor
92958807|NCT00970450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958808|NCT00970450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958809|NCT00970528|Acarbose|acarbose|mesh-list
92958810|NCT00970528|Voglibose|voglibose|mesh-list
92958811|NCT00970528|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92958812|NCT00970528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958813|NCT00970528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958814|NCT00970528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92958815|NCT00970528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958816|NCT00970762|Rocuronium|rocuronium|mesh-list
92958817|NCT00970762|Vecuronium Bromide|vecuronium bromide|mesh-list
92958818|NCT00970762|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92958819|NCT00970762|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92958820|NCT00970762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92958821|NCT00970762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958822|NCT00970762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958823|NCT00970762|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92958824|NCT00970762|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92958825|NCT00970762|Cholinergic Agents|cholinergic agents|mesh-ancestor
92958826|NCT00970762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958827|NCT00970762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958828|NCT00978172|Artesunate|artesunate|mesh-list
92958829|NCT00978172|Mefloquine|mefloquine|mesh-list
92958830|NCT00978172|Antimalarials|antimalarials|mesh-ancestor
92958831|NCT00978172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92958832|NCT00978172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92958833|NCT00978172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958834|NCT00978172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958835|NCT00978172|Antiviral Agents|antiviral agents|mesh-ancestor
92958836|NCT00978172|Schistosomicides|schistosomicides|mesh-ancestor
92958837|NCT00978172|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92958838|NCT00978172|Anthelmintics|anthelmintics|mesh-ancestor
92958839|NCT03923530|Eplerenone|eplerenone|mesh-list
92958840|NCT03923530|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92958841|NCT03923530|Hormone Antagonists|hormone antagonists|mesh-ancestor
92958842|NCT03923530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958843|NCT03923530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958844|NCT03923530|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92958845|NCT03923530|Diuretics|diuretics|mesh-ancestor
92958846|NCT03923530|Natriuretic Agents|natriuretic agents|mesh-ancestor
92958847|NCT03923530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92958848|NCT00608907|Rifampin|rifampin|mesh-list
92958849|NCT00608907|Dexamethasone|dexamethasone|mesh-list
92958850|NCT00608907|Dexamethasone acetate|dexamethasone acetate|mesh-list
92958851|NCT00608907|Bortezomib|bortezomib|mesh-list
92958852|NCT00608907|BB 1101|bb 1101|mesh-list
92958853|NCT00608907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92958854|NCT00608907|Antiemetics|antiemetics|mesh-ancestor
92958855|NCT00608907|Autonomic Agents|autonomic agents|mesh-ancestor
92958856|NCT00608907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958857|NCT00608907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958858|NCT00608907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92958859|NCT00608907|Glucocorticoids|glucocorticoids|mesh-ancestor
92958860|NCT00608907|Hormones|hormones|mesh-ancestor
92958861|NCT00608907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92958862|NCT00608907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92958863|NCT00608907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958864|NCT00608907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92958865|NCT00608907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958866|NCT00608907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958867|NCT00608907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92958868|NCT00608907|Antitubercular Agents|antitubercular agents|mesh-ancestor
92958869|NCT00608907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92958870|NCT00608907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958871|NCT00608907|Leprostatic Agents|leprostatic agents|mesh-ancestor
92958872|NCT00608907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92958873|NCT00608907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92958874|NCT00608907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92958875|NCT00608907|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92958876|NCT00608907|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92958877|NCT00608907|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92958878|NCT00608907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92958879|NCT00970996|Interferons|interferons|mesh-list
92958880|NCT00970996|Interferon-alpha|interferon-alpha|mesh-list
92958881|NCT00970996|Interferon alpha-2|interferon alpha-2|mesh-list
92958882|NCT00970996|Paclitaxel|paclitaxel|mesh-list
92958883|NCT00970996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92958884|NCT00970996|Cisplatin|cisplatin|mesh-list
92958885|NCT00970996|Temozolomide|temozolomide|mesh-list
92958886|NCT00970996|Interleukin-2|interleukin-2|mesh-list
92958887|NCT00970996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92958888|NCT00970996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958889|NCT00970996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92958890|NCT00970996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92958891|NCT00970996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92958892|NCT00970996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958893|NCT00970996|Antiviral Agents|antiviral agents|mesh-ancestor
92958894|NCT00970996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958895|NCT00970996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92958896|NCT00970996|Alkylating Agents|alkylating agents|mesh-ancestor
92958897|NCT00970996|Immunologic Factors|immunologic factors|mesh-ancestor
92958898|NCT00970996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958899|NCT00970996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92958901|NCT00970996|Sensory System Agents|sensory system agents|mesh-ancestor
92958902|NCT00970996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958903|NCT00869193|Grape Seed Extract|grape seed extract|mesh-list
92958904|NCT00869193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92958905|NCT00869193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958906|NCT00869193|Antioxidants|antioxidants|mesh-ancestor
92958907|NCT00869193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958908|NCT00869193|Protective Agents|protective agents|mesh-ancestor
92958909|NCT00869193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958910|NCT04009018|Anesthetics|anesthetics|mesh-list
92958911|NCT04009018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958912|NCT04009018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958913|NCT00869271|Leucovorin|leucovorin|mesh-list
92958914|NCT00869271|Fluorouracil|fluorouracil|mesh-list
92958915|NCT00869271|Oxaliplatin|oxaliplatin|mesh-list
92958916|NCT00869271|Antimetabolites|antimetabolites|mesh-ancestor
92958917|NCT00869271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958918|NCT00869271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92958919|NCT00869271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958920|NCT00869271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92958921|NCT00869271|Immunologic Factors|immunologic factors|mesh-ancestor
92958922|NCT00869271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958923|NCT00869271|Antidotes|antidotes|mesh-ancestor
92958924|NCT00869271|Protective Agents|protective agents|mesh-ancestor
92958925|NCT00869271|Vitamin B Complex|vitamin b complex|mesh-ancestor
92958926|NCT00869271|Vitamins|vitamins|mesh-ancestor
92958927|NCT00869271|Micronutrients|micronutrients|mesh-ancestor
92958929|NCT00971074|Viscosupplements|viscosupplements|mesh-ancestor
92958930|NCT00971074|Protective Agents|protective agents|mesh-ancestor
92958931|NCT00971074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958932|NCT00971152|Menotropins|menotropins|mesh-list
92958933|NCT00971152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92958934|NCT00971152|Fertility Agents|fertility agents|mesh-ancestor
92958935|NCT00971152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92958936|NCT00971152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958937|NCT00893919|Mycophenolic Acid|mycophenolic acid|mesh-list
92958938|NCT00893919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92958939|NCT00893919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958940|NCT00893919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92958941|NCT00893919|Antitubercular Agents|antitubercular agents|mesh-ancestor
92958942|NCT00893919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92958943|NCT00893919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958944|NCT00893919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958945|NCT00893919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958946|NCT00978328|Oxycodone|oxycodone|mesh-list
92958947|NCT00978328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92958948|NCT00978328|Narcotics|narcotics|mesh-ancestor
92958949|NCT00978328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958950|NCT00978328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958951|NCT00978328|Analgesics|analgesics|mesh-ancestor
92958952|NCT00978328|Sensory System Agents|sensory system agents|mesh-ancestor
92958953|NCT00978328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958954|NCT00892359|Anidulafungin|anidulafungin|mesh-list
92958955|NCT00892359|Antifungal Agents|antifungal agents|mesh-ancestor
92958956|NCT00892359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92958957|NCT01051531|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92958958|NCT01051531|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92958959|NCT01051531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92958960|NCT01051531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92958961|NCT01051531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604377|NCT00486694|Artesunate|artesunate|mesh-list
92958962|NCT01051531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92958963|NCT01051531|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92958964|NCT01051531|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92958965|NCT01051531|Serotonin Agents|serotonin agents|mesh-ancestor
92958966|NCT01051531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958967|NCT01051531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958968|NCT01051531|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92958969|NCT01051531|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92958970|NCT01051531|Dopamine Agents|dopamine agents|mesh-ancestor
92958971|NCT03992911|Carboplatin|carboplatin|mesh-list
92958972|NCT03992911|Etoposide|etoposide|mesh-list
92958973|NCT03992911|Etoposide phosphate|etoposide phosphate|mesh-list
92958974|NCT03992911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92958975|NCT03992911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92958976|NCT03992911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92958977|NCT03992911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92958978|NCT03992911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92958979|NCT03992911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958980|NCT00545272|Formoterol Fumarate|formoterol fumarate|mesh-list
92958981|NCT00545272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92958982|NCT00545272|Autonomic Agents|autonomic agents|mesh-ancestor
92958983|NCT00545272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92958984|NCT00545272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92958985|NCT00545272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92958986|NCT00545272|Respiratory System Agents|respiratory system agents|mesh-ancestor
92958987|NCT00545272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92958988|NCT00545272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92958989|NCT00545272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92958990|NCT00545272|Adrenergic Agents|adrenergic agents|mesh-ancestor
92958991|NCT00545272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92958992|NCT00545272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958993|NCT00377455|Bosentan|bosentan|mesh-list
92958994|NCT00377455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92958995|NCT00377455|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92958996|NCT00377455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92958997|NCT00895557|Varenicline|varenicline|mesh-list
92958998|NCT00895557|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92958999|NCT00895557|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92959000|NCT00895557|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959001|NCT00895557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959002|NCT00895557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959003|NCT00895557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959004|NCT00869973|Dexamethasone|dexamethasone|mesh-list
92959005|NCT00869973|Aprepitant|aprepitant|mesh-list
92959006|NCT00869973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959007|NCT00869973|Antiemetics|antiemetics|mesh-ancestor
92959008|NCT00869973|Autonomic Agents|autonomic agents|mesh-ancestor
92959009|NCT00869973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959010|NCT00869973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959011|NCT00869973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959012|NCT00869973|Glucocorticoids|glucocorticoids|mesh-ancestor
92959013|NCT00869973|Hormones|hormones|mesh-ancestor
92959014|NCT00869973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959015|NCT00869973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92959016|NCT00869973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959017|NCT00869973|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92959018|NCT00869973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959019|NCT00869973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959020|NCT04008784|Triamcinolone|triamcinolone|mesh-list
92959021|NCT04008784|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92959022|NCT04008784|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92959023|NCT04008784|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92959024|NCT04008784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959025|NCT04008784|Glucocorticoids|glucocorticoids|mesh-ancestor
92959026|NCT04008784|Hormones|hormones|mesh-ancestor
92959027|NCT04008784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959028|NCT04008784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959029|NCT04008784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92959030|NCT04008784|Immunologic Factors|immunologic factors|mesh-ancestor
92959031|NCT04008784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959032|NCT04008784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959033|NCT01051687|Botulinum Toxins|botulinum toxins|mesh-list
92959034|NCT01051687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92959035|NCT01051687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92959036|NCT01051687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92959037|NCT01051687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959038|NCT01051687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959039|NCT01051687|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959040|NCT01051687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959041|NCT01051687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959042|NCT01051687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92959043|NCT01051687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959044|NCT00978718|Selenium|selenium|mesh-list
92959045|NCT00978718|Antioxidants|antioxidants|mesh-ancestor
93026483|NCT00401973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959046|NCT00978718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959047|NCT00978718|Protective Agents|protective agents|mesh-ancestor
92959048|NCT00978718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959049|NCT00978718|Trace Elements|trace elements|mesh-ancestor
92959050|NCT00978718|Micronutrients|micronutrients|mesh-ancestor
92959051|NCT00895713|Immunoglobulins|immunoglobulins|mesh-list
92959052|NCT00895713|Antibodies|antibodies|mesh-list
92959053|NCT00895713|gamma-Globulins|gamma-globulins|mesh-list
92959054|NCT00895713|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92959055|NCT00895713|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92959056|NCT00895713|Immunologic Factors|immunologic factors|mesh-ancestor
92959057|NCT00895713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959058|NCT01051765|Irinotecan|irinotecan|mesh-list
92959059|NCT01051765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959060|NCT01051765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92959061|NCT01051765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92959062|NCT01051765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959063|NCT01051765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959064|NCT00978796|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92959065|NCT00978796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92959066|NCT00978796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959067|NCT00978796|Incretins|incretins|mesh-ancestor
92959068|NCT00978796|Hormones|hormones|mesh-ancestor
92959069|NCT00978796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959070|NCT00978796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92959071|NCT00978796|Protease Inhibitors|protease inhibitors|mesh-ancestor
92959072|NCT00978796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959073|NCT00978796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959074|NCT00894231|Levocetirizine|levocetirizine|mesh-list
92959075|NCT00894231|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92959076|NCT00894231|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92959077|NCT00894231|Histamine Antagonists|histamine antagonists|mesh-ancestor
92959078|NCT00894231|Histamine Agents|histamine agents|mesh-ancestor
92959079|NCT00894231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959080|NCT00894231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959081|NCT00894231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959082|NCT00377299|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92959083|NCT00377299|Nootropic Agents|nootropic agents|mesh-ancestor
92959084|NCT03472365|Capecitabine|capecitabine|mesh-list
92959085|NCT03472365|Oxaliplatin|oxaliplatin|mesh-list
92959086|NCT03472365|Apatinib|apatinib|mesh-list
92959087|NCT03472365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959088|NCT03472365|Antimetabolites|antimetabolites|mesh-ancestor
92959089|NCT03472365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959090|NCT03472365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959091|NCT03472365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92959092|NCT03472365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959093|NCT00894621|Norepinephrine|norepinephrine|mesh-list
92959094|NCT00894621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92959095|NCT00894621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92959096|NCT00894621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92959097|NCT00894621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959098|NCT00894621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959099|NCT00894621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959100|NCT00894621|Sympathomimetics|sympathomimetics|mesh-ancestor
92959101|NCT00894621|Autonomic Agents|autonomic agents|mesh-ancestor
92959102|NCT00894621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959103|NCT00894621|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92959104|NCT00376675|Methylphenidate|methylphenidate|mesh-list
92959105|NCT00376675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92959106|NCT00376675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959107|NCT00376675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92604525|NCT00488566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92959108|NCT00376675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92959109|NCT00376675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959110|NCT00376675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959111|NCT00376675|Dopamine Agents|dopamine agents|mesh-ancestor
92959112|NCT00376675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959113|NCT00979186|Hemostatics|hemostatics|mesh-list
92959114|NCT00979186|Coagulants|coagulants|mesh-ancestor
92959115|NCT05178628|Paclitaxel|paclitaxel|mesh-list
92959116|NCT05178628|Gemcitabine|gemcitabine|mesh-list
92959117|NCT05178628|Tinzaparin|tinzaparin|mesh-list
92959118|NCT05178628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92959119|NCT05178628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959120|NCT05178628|Tubulin Modulators|tubulin modulators|mesh-ancestor
92959121|NCT05178628|Antimitotic Agents|antimitotic agents|mesh-ancestor
92959122|NCT05178628|Mitosis Modulators|mitosis modulators|mesh-ancestor
92959123|NCT05178628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959124|NCT05178628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959125|NCT05178628|Antimetabolites|antimetabolites|mesh-ancestor
92959126|NCT05178628|Anticoagulants|anticoagulants|mesh-ancestor
92959127|NCT05178628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92959128|NCT05178628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92959129|NCT00896571|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92959130|NCT00896571|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92959131|NCT00896571|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92959132|NCT00896571|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92959133|NCT00896571|Contraceptive Agents|contraceptive agents|mesh-ancestor
92959134|NCT00896571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92959135|NCT00896571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959136|NCT00896571|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92959137|NCT00896571|Estrogens|estrogens|mesh-ancestor
92959138|NCT00896571|Hormones|hormones|mesh-ancestor
92959139|NCT00896571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959140|NCT00896727|Antibodies|antibodies|mesh-list
92959141|NCT00896727|Immunologic Factors|immunologic factors|mesh-ancestor
92959142|NCT00896727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959143|NCT00981838|Rituximab|rituximab|mesh-list
92959144|NCT00981838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92959145|NCT00981838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959146|NCT00981838|Immunologic Factors|immunologic factors|mesh-ancestor
92959147|NCT00981838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959148|NCT00981838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959149|NCT02533765|Olaparib|olaparib|mesh-list
92959150|NCT02533765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92959151|NCT02533765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959152|NCT02533765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959153|NCT02533765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959154|NCT04035993|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92959155|NCT04035993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959156|NCT00367237|Infliximab|infliximab|mesh-list
92959157|NCT00367237|Methotrexate|methotrexate|mesh-list
92959158|NCT00367237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92959159|NCT00367237|Abortifacient Agents|abortifacient agents|mesh-ancestor
92959160|NCT00367237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92959161|NCT00367237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959162|NCT00367237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959163|NCT00367237|Antimetabolites|antimetabolites|mesh-ancestor
92959164|NCT00367237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959165|NCT00367237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959166|NCT00367237|Dermatologic Agents|dermatologic agents|mesh-ancestor
92959167|NCT00367237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959168|NCT00367237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92959169|NCT00367237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92959170|NCT00367237|Immunologic Factors|immunologic factors|mesh-ancestor
92959171|NCT00367237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959172|NCT00367237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92959173|NCT00367237|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92959174|NCT00367237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959175|NCT00367237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959176|NCT00901407|Lamotrigine|lamotrigine|mesh-list
92959177|NCT00901407|Paroxetine|paroxetine|mesh-list
92959178|NCT00901407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92959179|NCT00901407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92959180|NCT00901407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959181|NCT00901407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959182|NCT00901407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959183|NCT00901407|Serotonin Agents|serotonin agents|mesh-ancestor
92959184|NCT00901407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165898|NCT04968132|Analgesics|analgesics|mesh-ancestor
92959185|NCT00901407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92959186|NCT00901407|Antidepressive Agents|antidepressive agents|mesh-ancestor
92959187|NCT00901407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92959188|NCT00901407|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92959189|NCT00901407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92959190|NCT00901407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959191|NCT00901407|Anticonvulsants|anticonvulsants|mesh-ancestor
92959192|NCT00901407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92959193|NCT00901407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92959194|NCT00901407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92959195|NCT00901407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92959196|NCT00901407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959197|NCT00901407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92959198|NCT00984724|Nicotine|nicotine|mesh-list
92959199|NCT00984724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92959200|NCT00984724|Autonomic Agents|autonomic agents|mesh-ancestor
92959201|NCT00984724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959202|NCT00984724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959203|NCT00984724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92959204|NCT00984724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92959205|NCT00984724|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959206|NCT00984724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959207|NCT00984724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959208|NCT00901719|Nitroprusside|nitroprusside|mesh-list
92959209|NCT00901719|Acetylcholine|acetylcholine|mesh-list
92959210|NCT00901719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92959211|NCT00901719|Vasodilator Agents|vasodilator agents|mesh-ancestor
92959212|NCT00901719|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92959213|NCT00901719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959214|NCT00901719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92959215|NCT00901719|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959216|NCT00901719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959217|NCT00901719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959218|NCT00972712|Bortezomib|bortezomib|mesh-list
92959219|NCT00972712|Tipifarnib|tipifarnib|mesh-list
92959220|NCT00972712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959221|NCT02539641|Hormones|hormones|mesh-list
92959222|NCT02539641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959223|NCT02539641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959224|NCT00544882|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92959225|NCT00544882|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92959226|NCT00544882|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92959227|NCT00544882|Desogestrel|desogestrel|mesh-list
92959228|NCT00544882|Oviol|oviol|mesh-list
92959229|NCT00544882|Estradiol|estradiol|mesh-list
92959230|NCT00544882|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92959231|NCT00544882|Estrogens|estrogens|mesh-ancestor
92959232|NCT00544882|Hormones|hormones|mesh-ancestor
92959233|NCT00544882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959234|NCT00544882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959235|NCT00544882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92959236|NCT00544882|Contraceptive Agents|contraceptive agents|mesh-ancestor
92959237|NCT00544882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92959238|NCT00544882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92959239|NCT00544882|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92959240|NCT00544882|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92959241|NCT00544882|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92959242|NCT00544882|Progestins|progestins|mesh-ancestor
92959243|NCT00544882|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92959244|NCT04035603|Cycloserine|cycloserine|mesh-list
92959245|NCT04035603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92959246|NCT04035603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959247|NCT04035603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92959248|NCT04035603|Antitubercular Agents|antitubercular agents|mesh-ancestor
92959249|NCT04035603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959250|NCT04035603|Antimetabolites|antimetabolites|mesh-ancestor
92959251|NCT04035603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959252|NCT00606801|Galantamine|galantamine|mesh-list
92959253|NCT00606801|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92959254|NCT00606801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959255|NCT00606801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604672|NCT01242631|Everolimus|everolimus|mesh-list
92959256|NCT00606801|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959257|NCT00606801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959258|NCT00606801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959259|NCT00606801|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92959260|NCT00606801|Autonomic Agents|autonomic agents|mesh-ancestor
92959261|NCT00606801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959262|NCT00606801|Nootropic Agents|nootropic agents|mesh-ancestor
92959263|NCT00972790|Bupivacaine|bupivacaine|mesh-list
92959264|NCT00972790|Anesthetics, Local|anesthetics, local|mesh-ancestor
92959265|NCT00972790|Anesthetics|anesthetics|mesh-ancestor
92959266|NCT00972790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959267|NCT00972790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959268|NCT00972790|Sensory System Agents|sensory system agents|mesh-ancestor
92959269|NCT00972790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959270|NCT00901875|Buprenorphine|buprenorphine|mesh-list
92959271|NCT00901875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92959273|NCT00901875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92959274|NCT00901875|Narcotics|narcotics|mesh-ancestor
92959275|NCT00901875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959276|NCT00901875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959277|NCT00901875|Analgesics|analgesics|mesh-ancestor
92959278|NCT00901875|Sensory System Agents|sensory system agents|mesh-ancestor
92959279|NCT00901875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959280|NCT00901875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92959281|NCT00972946|Dextrans|dextrans|mesh-list
92959282|NCT00972946|Anticoagulants|anticoagulants|mesh-ancestor
92959283|NCT00972946|Plasma Substitutes|plasma substitutes|mesh-ancestor
92959284|NCT00972946|Blood Substitutes|blood substitutes|mesh-ancestor
92959285|NCT00606177|Aripiprazole|aripiprazole|mesh-list
92959286|NCT00606177|Antidepressive Agents|antidepressive agents|mesh-ancestor
92959287|NCT00606177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92959288|NCT00606177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92959289|NCT00606177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92959290|NCT00606177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959291|NCT00606177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959292|NCT00606177|Dopamine Agonists|dopamine agonists|mesh-ancestor
92959293|NCT00606177|Dopamine Agents|dopamine agents|mesh-ancestor
92959294|NCT00606177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959295|NCT00606177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959296|NCT00606177|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92959297|NCT00606177|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92959298|NCT00606177|Serotonin Agents|serotonin agents|mesh-ancestor
92959299|NCT00606177|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92959300|NCT00606177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92959301|NCT00606177|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92959302|NCT00606177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92959303|NCT00985270|Rifampin|rifampin|mesh-list
92959304|NCT00985270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92959305|NCT00985270|Antitubercular Agents|antitubercular agents|mesh-ancestor
92959306|NCT00985270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959307|NCT00985270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959308|NCT00985270|Leprostatic Agents|leprostatic agents|mesh-ancestor
92959309|NCT00985270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92959310|NCT00985270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959311|NCT00985270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959312|NCT00985270|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92959313|NCT00985270|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92959314|NCT00985270|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92959315|NCT00985270|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92959316|NCT00985270|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92959317|NCT00985270|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92959318|NCT00359281|Niacin|niacin|mesh-list
92959319|NCT00359281|Dextromethorphan|dextromethorphan|mesh-list
92959320|NCT00359281|Atorvastatin|atorvastatin|mesh-list
92959321|NCT00359281|Simvastatin|simvastatin|mesh-list
92959322|NCT00359281|Ezetimibe|ezetimibe|mesh-list
92959323|NCT00359281|Fenofibrate|fenofibrate|mesh-list
92959324|NCT00359281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92959325|NCT00359281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92959326|NCT00359281|Antimetabolites|antimetabolites|mesh-ancestor
92959327|NCT00359281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959328|NCT00359281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92959329|NCT00359281|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92959330|NCT00359281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959331|NCT00359281|Vasodilator Agents|vasodilator agents|mesh-ancestor
92959332|NCT00359281|Vitamin B Complex|vitamin b complex|mesh-ancestor
92959334|NCT00359281|Micronutrients|micronutrients|mesh-ancestor
92959335|NCT00359281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959336|NCT00359281|Antitussive Agents|antitussive agents|mesh-ancestor
92959337|NCT00359281|Respiratory System Agents|respiratory system agents|mesh-ancestor
92959338|NCT00359281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92959339|NCT00359281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92959340|NCT00359281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959341|NCT00902031|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92959342|NCT00902031|Sennosides|sennosides|mesh-list
92959343|NCT00902031|Senna Extract|senna extract|mesh-list
92959344|NCT00902031|Antidiarrheals|antidiarrheals|mesh-ancestor
92959345|NCT00902031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959346|NCT00902031|Laxatives|laxatives|mesh-ancestor
92959347|NCT00902031|Cathartics|cathartics|mesh-ancestor
92959348|NCT00985348|Levetiracetam|levetiracetam|mesh-list
92959349|NCT00985348|Anticonvulsants|anticonvulsants|mesh-ancestor
92959350|NCT00985348|Nootropic Agents|nootropic agents|mesh-ancestor
92959351|NCT00973336|Vitamin D|vitamin d|mesh-list
92959352|NCT00973336|Calcium|calcium|mesh-list
92959353|NCT00973336|Vitamins|vitamins|mesh-ancestor
92959354|NCT00973336|Micronutrients|micronutrients|mesh-ancestor
92959355|NCT00973336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959356|NCT00973336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92959357|NCT00973336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92959358|NCT00902187|Fesoterodine|fesoterodine|mesh-list
92959359|NCT00902187|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92959360|NCT00902187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92959361|NCT00902187|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959362|NCT00902187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959363|NCT00902187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959364|NCT00902187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959365|NCT00902187|Urological Agents|urological agents|mesh-ancestor
92959366|NCT01052311|Niacin|niacin|mesh-list
92959367|NCT01052311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92959368|NCT01052311|Antimetabolites|antimetabolites|mesh-ancestor
92959369|NCT01052311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959370|NCT01052311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92959371|NCT01052311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92959372|NCT01052311|Vitamin B Complex|vitamin b complex|mesh-ancestor
92959373|NCT01052311|Vitamins|vitamins|mesh-ancestor
92959374|NCT01052311|Micronutrients|micronutrients|mesh-ancestor
92959375|NCT01052311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959376|NCT00988078|Metformin|metformin|mesh-list
92959377|NCT00988078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92959378|NCT00988078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959379|NCT00895089|Moxifloxacin|moxifloxacin|mesh-list
92959380|NCT00895089|Ceftriaxone|ceftriaxone|mesh-list
92959381|NCT00895089|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92959382|NCT00895089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959383|NCT00895089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959384|NCT00895089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92959385|NCT00895089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92959386|NCT00895089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959387|NCT00895089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959388|NCT00895089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959389|NCT00895089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92959390|NCT00895089|Contraceptive Agents|contraceptive agents|mesh-ancestor
92959391|NCT00895089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92959392|NCT00895089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959393|NCT00895089|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92959394|NCT00895089|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92959395|NCT00895089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92959396|NCT00982540|Caspofungin|caspofungin|mesh-list
92959397|NCT00982540|Antifungal Agents|antifungal agents|mesh-list
92959398|NCT00982540|Clotrimazole|clotrimazole|mesh-list
92959399|NCT00982540|Miconazole|miconazole|mesh-list
92959400|NCT00982540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959401|NCT00982540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959402|NCT00982540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959403|NCT00982540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92959404|NCT00982540|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93026484|NCT00401973|Antiemetics|antiemetics|mesh-ancestor
92959405|NCT00982540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92959406|NCT00982540|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92959407|NCT00982540|Hormone Antagonists|hormone antagonists|mesh-ancestor
92959408|NCT00982540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959409|NCT00982540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959410|NCT00982540|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92959411|NCT00982540|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92959412|NCT04674358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92959413|NCT04674358|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92959414|NCT00366535|Neurotropin|neurotropin|mesh-list
92959415|NCT00366535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92959416|NCT00366535|Immunologic Factors|immunologic factors|mesh-ancestor
92959417|NCT00366535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959418|NCT00366535|Analgesics|analgesics|mesh-ancestor
92959419|NCT00366535|Sensory System Agents|sensory system agents|mesh-ancestor
92959420|NCT00366535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959421|NCT00366535|Anticonvulsants|anticonvulsants|mesh-ancestor
92959422|NCT00982618|Lidocaine|lidocaine|mesh-list
92959423|NCT00982618|Morphine|morphine|mesh-list
92959424|NCT00982618|Anesthetics, Local|anesthetics, local|mesh-list
92959425|NCT00982618|Anesthetics|anesthetics|mesh-list
92959426|NCT00982618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959427|NCT00982618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959428|NCT00982618|Sensory System Agents|sensory system agents|mesh-ancestor
92959429|NCT00982618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959430|NCT00982618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92959431|NCT00982618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92959432|NCT00982618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92959433|NCT00982618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959434|NCT00982618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959435|NCT00982618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92959436|NCT00982618|Narcotics|narcotics|mesh-ancestor
92959437|NCT00982618|Analgesics|analgesics|mesh-ancestor
92959438|NCT00895167|Curcumin|curcumin|mesh-list
92959439|NCT00895167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92959440|NCT00895167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92959441|NCT00895167|Analgesics|analgesics|mesh-ancestor
92959442|NCT00895167|Sensory System Agents|sensory system agents|mesh-ancestor
92959443|NCT00895167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959444|NCT00895167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959445|NCT00895167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959446|NCT00895167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959447|NCT00895167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959448|NCT00895167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959449|NCT00895167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959450|NCT00902421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92959451|NCT00902421|Serotonin|serotonin|mesh-list
92959452|NCT00902421|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92959453|NCT00902421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92959454|NCT00902421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959455|NCT00902421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959456|NCT00902421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959457|NCT00902421|Serotonin Agents|serotonin agents|mesh-ancestor
92959458|NCT00902421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959459|NCT00902421|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92959460|NCT00902421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92959461|NCT00902421|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959462|NCT00985660|Nisoldipine|nisoldipine|mesh-list
92959463|NCT00985660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92959464|NCT00985660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92959465|NCT00985660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959466|NCT00985660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959467|NCT00985660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92959468|NCT00985660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959469|NCT00985660|Vasodilator Agents|vasodilator agents|mesh-ancestor
92959470|NCT00350545|Cyclosporine|cyclosporine|mesh-list
92959471|NCT00350545|Prednisone|prednisone|mesh-list
92959472|NCT00350545|Rituximab|rituximab|mesh-list
92959473|NCT00350545|Tacrolimus|tacrolimus|mesh-list
92959474|NCT00350545|Cyclosporins|cyclosporins|mesh-list
92959475|NCT00350545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92959476|NCT00350545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959477|NCT00350545|Immunologic Factors|immunologic factors|mesh-ancestor
92959478|NCT00350545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959479|NCT00350545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959480|NCT00350545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959481|NCT00350545|Glucocorticoids|glucocorticoids|mesh-ancestor
92959482|NCT00350545|Hormones|hormones|mesh-ancestor
92959483|NCT00350545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959484|NCT00350545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92959485|NCT00350545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92959486|NCT00350545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92959487|NCT00350545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959488|NCT00350545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959489|NCT00350545|Antifungal Agents|antifungal agents|mesh-ancestor
92959490|NCT00350545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959491|NCT00350545|Dermatologic Agents|dermatologic agents|mesh-ancestor
92959492|NCT04006054|Midazolam|midazolam|mesh-list
92959493|NCT04006054|Dexmedetomidine|dexmedetomidine|mesh-list
92959494|NCT04006054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92959495|NCT04006054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959496|NCT04006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959497|NCT04006054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92959498|NCT04006054|Analgesics|analgesics|mesh-ancestor
92959499|NCT04006054|Sensory System Agents|sensory system agents|mesh-ancestor
92959500|NCT04006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959501|NCT04006054|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92959502|NCT04006054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92959503|NCT04006054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92959504|NCT04006054|Adrenergic Agents|adrenergic agents|mesh-ancestor
92959505|NCT04006054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959506|NCT04006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959507|NCT04006054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92959508|NCT04006054|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92959509|NCT04006054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92959510|NCT04006054|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92959511|NCT04006054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92959512|NCT04006054|Anesthetics, General|anesthetics, general|mesh-ancestor
92959513|NCT04006054|Anesthetics|anesthetics|mesh-ancestor
92959514|NCT04006054|GABA Modulators|gaba modulators|mesh-ancestor
92959515|NCT04006054|GABA Agents|gaba agents|mesh-ancestor
92959516|NCT00897975|Red yeast rice|red yeast rice|mesh-list
92959517|NCT00897975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92959518|NCT00897975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92959519|NCT00897975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92959520|NCT00897975|Antimetabolites|antimetabolites|mesh-ancestor
92959521|NCT00897975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959522|NCT00897975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959523|NCT00897975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92959524|NCT01052389|Haloperidol|haloperidol|mesh-list
92959525|NCT01052389|Olanzapine|olanzapine|mesh-list
92959526|NCT01052389|Aripiprazole|aripiprazole|mesh-list
92959527|NCT01052389|Haloperidol decanoate|haloperidol decanoate|mesh-list
92959528|NCT01052389|Antiemetics|antiemetics|mesh-ancestor
92959529|NCT01052389|Autonomic Agents|autonomic agents|mesh-ancestor
92959530|NCT01052389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959531|NCT01052389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959532|NCT01052389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959533|NCT01052389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92959534|NCT01052389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92959535|NCT01052389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959536|NCT01052389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92959537|NCT01052389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92959538|NCT01052389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92959539|NCT01052389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959540|NCT01052389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959541|NCT01052389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959542|NCT01052389|Serotonin Agents|serotonin agents|mesh-ancestor
92959543|NCT01052389|Antidepressive Agents|antidepressive agents|mesh-ancestor
92959544|NCT01052389|Dopamine Agonists|dopamine agonists|mesh-ancestor
92959545|NCT01052389|Dopamine Agents|dopamine agents|mesh-ancestor
92959546|NCT01052389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92959547|NCT01052389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92959548|NCT01052389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92959549|NCT01052389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92959550|NCT01052389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92959551|NCT01052389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92959552|NCT01052389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92959553|NCT00895323|Antibodies|antibodies|mesh-list
92959554|NCT00895323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92959555|NCT00895323|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92959556|NCT00895323|Immunologic Factors|immunologic factors|mesh-ancestor
92959557|NCT00895323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959559|NCT00349921|Clonidine|clonidine|mesh-list
92959560|NCT00349921|Analgesics|analgesics|mesh-ancestor
92959561|NCT00349921|Sensory System Agents|sensory system agents|mesh-ancestor
92959562|NCT00349921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959563|NCT00349921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959564|NCT00349921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92959565|NCT00349921|Sympatholytics|sympatholytics|mesh-ancestor
92959566|NCT00349921|Autonomic Agents|autonomic agents|mesh-ancestor
92959567|NCT00349921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92959568|NCT00349921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92959569|NCT00349921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92959570|NCT00349921|Adrenergic Agents|adrenergic agents|mesh-ancestor
92959571|NCT00349921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959572|NCT00349921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959573|NCT00349921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92959574|NCT00349921|Vasodilator Agents|vasodilator agents|mesh-ancestor
92959575|NCT00349921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92959576|NCT00349921|Purinergic Agonists|purinergic agonists|mesh-ancestor
92959577|NCT00349921|Purinergic Agents|purinergic agents|mesh-ancestor
92959578|NCT00902655|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92959579|NCT00902655|Hemostatics|hemostatics|mesh-ancestor
92959580|NCT00902655|Coagulants|coagulants|mesh-ancestor
92959581|NCT00902655|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92959582|NCT00902655|Natriuretic Agents|natriuretic agents|mesh-ancestor
92959583|NCT00902655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959584|NCT01052623|Clonidine|clonidine|mesh-list
92959585|NCT01052623|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92959586|NCT01052623|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92959587|NCT01052623|Estradiol|estradiol|mesh-list
92959588|NCT01052623|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92959589|NCT01052623|Hormones|hormones|mesh-ancestor
92959590|NCT01052623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959591|NCT01052623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959592|NCT01052623|Estrogens|estrogens|mesh-ancestor
92959593|NCT01052623|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92959594|NCT01052623|Contraceptive Agents|contraceptive agents|mesh-ancestor
92959595|NCT01052623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92959596|NCT01052623|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92959597|NCT01052623|Analgesics|analgesics|mesh-ancestor
92959598|NCT01052623|Sensory System Agents|sensory system agents|mesh-ancestor
92959599|NCT01052623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959600|NCT01052623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92959601|NCT01052623|Sympatholytics|sympatholytics|mesh-ancestor
92959602|NCT01052623|Autonomic Agents|autonomic agents|mesh-ancestor
92959603|NCT01052623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92959604|NCT01052623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92959605|NCT01052623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92959606|NCT01052623|Adrenergic Agents|adrenergic agents|mesh-ancestor
92959607|NCT01052623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959608|NCT01052623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959609|NCT00902811|Artesunate|artesunate|mesh-list
92959610|NCT00902811|Amodiaquine|amodiaquine|mesh-list
92959611|NCT00902811|Antimalarials|antimalarials|mesh-ancestor
92959612|NCT00902811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92959613|NCT00902811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92959614|NCT00902811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959615|NCT00902811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959616|NCT00902811|Antiviral Agents|antiviral agents|mesh-ancestor
92959617|NCT00902811|Schistosomicides|schistosomicides|mesh-ancestor
92959618|NCT00902811|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92959619|NCT00902811|Anthelmintics|anthelmintics|mesh-ancestor
92959620|NCT00898287|Gemcitabine|gemcitabine|mesh-list
92959621|NCT00898287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959622|NCT00898287|Antimetabolites|antimetabolites|mesh-ancestor
92959623|NCT00898287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959624|NCT00898287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959625|NCT04034823|Docetaxel|docetaxel|mesh-list
92959626|NCT04034823|Trastuzumab|trastuzumab|mesh-list
92959627|NCT04034823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959628|NCT04034823|Tubulin Modulators|tubulin modulators|mesh-ancestor
92959629|NCT04034823|Antimitotic Agents|antimitotic agents|mesh-ancestor
92959630|NCT04034823|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605055|NCT02274454|Oxytocin|oxytocin|mesh-list
92959631|NCT04034823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959632|NCT04034823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92959634|NCT00606021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959635|NCT00606021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959636|NCT00606021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959637|NCT00606021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92959638|NCT00606021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92959639|NCT00337675|Montelukast|montelukast|mesh-list
92959640|NCT00337675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92959641|NCT00337675|Respiratory System Agents|respiratory system agents|mesh-ancestor
92959642|NCT00337675|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92959643|NCT00337675|Hormone Antagonists|hormone antagonists|mesh-ancestor
92959644|NCT00337675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959645|NCT00337675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959646|NCT00337675|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92959647|NCT00337675|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92959648|NCT00337675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959649|NCT00902967|Atorvastatin|atorvastatin|mesh-list
92959650|NCT00902967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92959651|NCT00902967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92959652|NCT00902967|Antimetabolites|antimetabolites|mesh-ancestor
92959653|NCT00902967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959654|NCT00902967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92959655|NCT00902967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92959656|NCT00902967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959657|NCT00903045|Propiverine|propiverine|mesh-list
92959658|NCT00903045|Parasympatholytics|parasympatholytics|mesh-ancestor
92959659|NCT00903045|Autonomic Agents|autonomic agents|mesh-ancestor
92959660|NCT00903045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959661|NCT00903045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959662|NCT00903045|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92959663|NCT00903045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92959664|NCT00903045|Cholinergic Agents|cholinergic agents|mesh-ancestor
92959665|NCT00903045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959666|NCT00903045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959667|NCT00903045|Urological Agents|urological agents|mesh-ancestor
92959668|NCT00337285|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92959669|NCT00337285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92959670|NCT00337285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959671|NCT00337285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92959672|NCT00337285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92959673|NCT00337285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959674|NCT00337285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959675|NCT00337285|Dopamine Agents|dopamine agents|mesh-ancestor
92959676|NCT00337285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959677|NCT04035525|Coenzyme Q10|coenzyme q10|mesh-list
92959678|NCT04035525|Ubiquinone|ubiquinone|mesh-list
92959679|NCT04035525|Vitamins|vitamins|mesh-ancestor
92959680|NCT04035525|Micronutrients|micronutrients|mesh-ancestor
92959681|NCT04035525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959682|NCT00905853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92959683|NCT00905853|Amiodarone|amiodarone|mesh-list
92959684|NCT00905853|Vasodilator Agents|vasodilator agents|mesh-ancestor
92959685|NCT00905853|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92959686|NCT00905853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959687|NCT00905853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959688|NCT00905853|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92959689|NCT00905853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92959690|NCT00905853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92959691|NCT00905853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959692|NCT00905853|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92959693|NCT00905853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92959694|NCT00905853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92959695|NCT00905931|Lycopene|lycopene|mesh-list
92959696|NCT00905931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959697|NCT00905931|Antioxidants|antioxidants|mesh-ancestor
92959698|NCT00905931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959699|NCT00905931|Protective Agents|protective agents|mesh-ancestor
92959700|NCT00905931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959701|NCT00905931|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92605122|NCT00126620|Sorafenib|sorafenib|mesh-list
92959702|NCT00905931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92959703|NCT00905931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959705|NCT04035135|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92959706|NCT04035135|Antibodies|antibodies|mesh-list
92959707|NCT04035135|gamma-Globulins|gamma-globulins|mesh-list
92959708|NCT04035135|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92959709|NCT04035135|Immunologic Factors|immunologic factors|mesh-ancestor
92959710|NCT04035135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959711|NCT00903279|Retapamulin|retapamulin|mesh-list
92959712|NCT00903279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959713|NCT00903279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959714|NCT02539017|Immunomodulating Agents|immunomodulating agents|mesh-list
92959715|NCT02539017|Immunologic Factors|immunologic factors|mesh-ancestor
92959716|NCT02539017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959717|NCT00605865|Sertraline|sertraline|mesh-list
92959718|NCT00605865|Antidepressive Agents|antidepressive agents|mesh-ancestor
92959719|NCT00605865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92959720|NCT00605865|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92959721|NCT00605865|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92959722|NCT00605865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959723|NCT00605865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959724|NCT00605865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959725|NCT00605865|Serotonin Agents|serotonin agents|mesh-ancestor
92959726|NCT00605865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959727|NCT00922467|Esmolol|esmolol|mesh-list
92959728|NCT00922467|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92959729|NCT00922467|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92959730|NCT00922467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92959731|NCT00922467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92959732|NCT00922467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959733|NCT00922467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959734|NCT00922467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959735|NCT00903747|Moxifloxacin|moxifloxacin|mesh-list
92959736|NCT00903747|Prucalopride|prucalopride|mesh-list
92959737|NCT00903747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959738|NCT00903747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959739|NCT00903747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92959740|NCT00903747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92959741|NCT00903747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959742|NCT00903747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959743|NCT00903747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959744|NCT00903747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959745|NCT00903747|Laxatives|laxatives|mesh-ancestor
92959746|NCT00903747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959747|NCT00903747|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92959748|NCT00903747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92959749|NCT00903747|Serotonin Agents|serotonin agents|mesh-ancestor
92959750|NCT00903747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92959751|NCT02538627|Trametinib|trametinib|mesh-list
92959752|NCT02538627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959753|NCT02538627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92959754|NCT02538627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959755|NCT02538627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959756|NCT00903825|Lidocaine|lidocaine|mesh-list
92959757|NCT00903825|Anesthetics, Local|anesthetics, local|mesh-list
92959758|NCT00903825|Anesthetics|anesthetics|mesh-list
92959759|NCT00903825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959760|NCT00903825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959761|NCT00903825|Sensory System Agents|sensory system agents|mesh-ancestor
92959762|NCT00903825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959763|NCT00903825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92959764|NCT00903825|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92959765|NCT00903825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92959766|NCT00903825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959767|NCT00903825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959768|NCT00904059|Asunaprevir|asunaprevir|mesh-list
92959769|NCT00904059|Protease Inhibitors|protease inhibitors|mesh-ancestor
92959770|NCT00904059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959771|NCT00904059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959772|NCT00337207|Bevacizumab|bevacizumab|mesh-list
92959773|NCT00337207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92959774|NCT00337207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959775|NCT00337207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92959776|NCT00337207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92959777|NCT00337207|Growth Substances|growth substances|mesh-ancestor
92959778|NCT00337207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959779|NCT00337207|Growth Inhibitors|growth inhibitors|mesh-ancestor
92959780|NCT01055743|Fluorouracil|fluorouracil|mesh-list
92959781|NCT01055743|Antimetabolites|antimetabolites|mesh-ancestor
92959782|NCT01055743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959783|NCT01055743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959784|NCT01055743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959785|NCT01055743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92959786|NCT01055743|Immunologic Factors|immunologic factors|mesh-ancestor
92959787|NCT01055743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959788|NCT00604695|Tenecteplase|tenecteplase|mesh-list
92959789|NCT00604695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92959790|NCT00604695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92959791|NCT00604695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959792|NCT01055821|Interferons|interferons|mesh-list
92959793|NCT01055821|Ribavirin|ribavirin|mesh-list
92959794|NCT01055821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959795|NCT01055821|Antiviral Agents|antiviral agents|mesh-ancestor
92959796|NCT01055821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959797|NCT01055821|Antimetabolites|antimetabolites|mesh-ancestor
92959798|NCT01055821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959799|NCT00904293|Warfarin|warfarin|mesh-list
92959800|NCT00904293|Anticoagulants|anticoagulants|mesh-ancestor
92959801|NCT00904449|Oxymorphone|oxymorphone|mesh-list
92959802|NCT00904449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92959803|NCT00904449|Narcotics|narcotics|mesh-ancestor
92959804|NCT00904449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959805|NCT00904449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959806|NCT00904449|Analgesics|analgesics|mesh-ancestor
92959807|NCT00904449|Sensory System Agents|sensory system agents|mesh-ancestor
92959808|NCT00904449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959809|NCT00904449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92959810|NCT00348595|Lenalidomide|lenalidomide|mesh-list
92959811|NCT00348595|Immunologic Factors|immunologic factors|mesh-ancestor
92959812|NCT00348595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959813|NCT00348595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92959814|NCT00348595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92959815|NCT00348595|Growth Substances|growth substances|mesh-ancestor
92959816|NCT00348595|Growth Inhibitors|growth inhibitors|mesh-ancestor
92959817|NCT00348595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959818|NCT02538939|Sodium thiosulfate|sodium thiosulfate|mesh-list
92959819|NCT02538939|Antidotes|antidotes|mesh-ancestor
92959820|NCT02538939|Protective Agents|protective agents|mesh-ancestor
92959821|NCT02538939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959822|NCT02538939|Antioxidants|antioxidants|mesh-ancestor
92959823|NCT02538939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959824|NCT02538939|Antitubercular Agents|antitubercular agents|mesh-ancestor
92959825|NCT02538939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959826|NCT02538939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959827|NCT02538939|Chelating Agents|chelating agents|mesh-ancestor
92959828|NCT02538939|Sequestering Agents|sequestering agents|mesh-ancestor
92959829|NCT00904605|Celecoxib|celecoxib|mesh-list
92959830|NCT00904605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92959831|NCT00904605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92959832|NCT00904605|Analgesics|analgesics|mesh-ancestor
92959833|NCT00904605|Sensory System Agents|sensory system agents|mesh-ancestor
92959834|NCT00904605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959835|NCT00904605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959836|NCT00904605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959837|NCT00904605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959838|NCT00904605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92959839|NCT00904605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92959840|NCT00904605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959841|NCT00904605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959842|NCT00905073|Cyclosporine|cyclosporine|mesh-list
92959843|NCT00905073|Methotrexate|methotrexate|mesh-list
92959844|NCT00905073|Cyclosporins|cyclosporins|mesh-list
92959845|NCT00905073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92959846|NCT00905073|Abortifacient Agents|abortifacient agents|mesh-ancestor
92959847|NCT00905073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92959848|NCT00905073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959849|NCT00905073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959850|NCT00905073|Antimetabolites|antimetabolites|mesh-ancestor
92959851|NCT00905073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959852|NCT00905073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959853|NCT00905073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92959854|NCT00905073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959855|NCT00905073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92959856|NCT00905073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92959857|NCT00905073|Immunologic Factors|immunologic factors|mesh-ancestor
92959858|NCT00905073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959859|NCT00905073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92959860|NCT00905073|Antifungal Agents|antifungal agents|mesh-ancestor
92959861|NCT00905073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959862|NCT00905073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92959864|NCT00905229|Vitamin K|vitamin k|mesh-list
92959865|NCT00905229|Vitamin K 1|vitamin k 1|mesh-list
92959866|NCT00905229|Micronutrients|micronutrients|mesh-ancestor
92959867|NCT00905229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959868|NCT00905229|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92959869|NCT00905229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92959870|NCT00905229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959871|NCT00905229|Hemostatics|hemostatics|mesh-ancestor
92959872|NCT00905229|Coagulants|coagulants|mesh-ancestor
92959873|NCT00905541|Simvastatin|simvastatin|mesh-list
92959874|NCT00905541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92959875|NCT00905541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92959876|NCT00905541|Antimetabolites|antimetabolites|mesh-ancestor
92959877|NCT00905541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959878|NCT00905541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92959879|NCT00905541|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92959880|NCT00905541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959881|NCT00348283|Adalimumab|adalimumab|mesh-list
92959882|NCT00348283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92959883|NCT00348283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959884|NCT00348283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92959885|NCT00336895|Mycophenolic Acid|mycophenolic acid|mesh-list
92959886|NCT00336895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92959887|NCT00336895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959888|NCT00336895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92959889|NCT00336895|Antitubercular Agents|antitubercular agents|mesh-ancestor
92959890|NCT00336895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959891|NCT00336895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959892|NCT00336895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959893|NCT00336895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959894|NCT00336583|Cytarabine|cytarabine|mesh-list
92959895|NCT00336583|Methylprednisolone|methylprednisolone|mesh-list
92959896|NCT00336583|Oxaliplatin|oxaliplatin|mesh-list
92959897|NCT00336583|Etoposide|etoposide|mesh-list
92959898|NCT00336583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959899|NCT00336583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92959900|NCT00336583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92959901|NCT00336583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92959902|NCT00336583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959903|NCT00336583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959904|NCT00336583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959905|NCT00336583|Antimetabolites|antimetabolites|mesh-ancestor
92959906|NCT00336583|Antiviral Agents|antiviral agents|mesh-ancestor
92165926|NCT03061734|Naltrexone|naltrexone|mesh-list
92959907|NCT00336583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959908|NCT00336583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92959909|NCT00336583|Immunologic Factors|immunologic factors|mesh-ancestor
92959910|NCT00336583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959911|NCT00336583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959913|NCT00336583|Autonomic Agents|autonomic agents|mesh-ancestor
92959914|NCT00336583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959915|NCT00336583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959916|NCT00336583|Glucocorticoids|glucocorticoids|mesh-ancestor
92959917|NCT00336583|Hormones|hormones|mesh-ancestor
92959918|NCT00336583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959919|NCT00336583|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92959920|NCT00336583|Protective Agents|protective agents|mesh-ancestor
92959921|NCT00336505|Clarithromycin|clarithromycin|mesh-list
92959922|NCT00336505|Cethromycin|cethromycin|mesh-list
92959923|NCT00336505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92959924|NCT00336505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959925|NCT00336505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92605341|NCT00127088|Docetaxel|docetaxel|mesh-list
92959926|NCT00336505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959927|NCT00336505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959928|NCT00336505|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92959929|NCT00336505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92959930|NCT00357877|Chlorhexidine|chlorhexidine|mesh-list
92959931|NCT00357877|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92959932|NCT00357877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92959933|NCT00357877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92959934|NCT00357877|Disinfectants|disinfectants|mesh-ancestor
92959935|NCT00357877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92959936|NCT03987529|Propofol|propofol|mesh-list
92959937|NCT03987529|Sevoflurane|sevoflurane|mesh-list
92959938|NCT03987529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92959939|NCT03987529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959940|NCT03987529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959941|NCT03987529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92959942|NCT03987529|Anesthetics, General|anesthetics, general|mesh-ancestor
92959943|NCT03987529|Anesthetics|anesthetics|mesh-ancestor
92959944|NCT03987529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92959945|NCT03987529|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92959946|NCT00335959|Capecitabine|capecitabine|mesh-list
92959947|NCT00335959|Oxaliplatin|oxaliplatin|mesh-list
92959948|NCT00335959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92959949|NCT00335959|Antimetabolites|antimetabolites|mesh-ancestor
92959950|NCT00335959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959951|NCT00335959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959952|NCT01053169|Thrombin|thrombin|mesh-list
92959953|NCT01053169|Hemostatics|hemostatics|mesh-ancestor
92959954|NCT01053169|Coagulants|coagulants|mesh-ancestor
92959955|NCT01059331|Pregabalin|pregabalin|mesh-list
92959956|NCT01059331|Analgesics|analgesics|mesh-ancestor
92959957|NCT01059331|Sensory System Agents|sensory system agents|mesh-ancestor
92959958|NCT01059331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959959|NCT01059331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959960|NCT01059331|Anticonvulsants|anticonvulsants|mesh-ancestor
92959961|NCT01059331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92959962|NCT01059331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92959963|NCT01059331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959964|NCT01059331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92959965|NCT01059331|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92959966|NCT01059331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92959967|NCT01059331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92959968|NCT01059331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92959969|NCT01059955|Dexamethasone|dexamethasone|mesh-list
92959970|NCT01059955|Dexamethasone acetate|dexamethasone acetate|mesh-list
92959971|NCT01059955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92959972|NCT01059955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92959973|NCT01059955|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92959974|NCT01059955|BB 1101|bb 1101|mesh-list
92959975|NCT01059955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92959976|NCT01059955|Antiemetics|antiemetics|mesh-ancestor
92959977|NCT01059955|Autonomic Agents|autonomic agents|mesh-ancestor
92959978|NCT01059955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92959979|NCT01059955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92959980|NCT01059955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92959981|NCT01059955|Glucocorticoids|glucocorticoids|mesh-ancestor
92959982|NCT01059955|Hormones|hormones|mesh-ancestor
92959983|NCT01059955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92959984|NCT01059955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92959985|NCT01059955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92959986|NCT01059955|Protease Inhibitors|protease inhibitors|mesh-ancestor
92959987|NCT01059955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92959988|NCT01059955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959989|NCT01060189|Tranexamic Acid|tranexamic acid|mesh-list
92959990|NCT01060189|Urinastatin|urinastatin|mesh-list
92959991|NCT01060189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92959992|NCT01060189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92959993|NCT01060189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92959994|NCT01060189|Hemostatics|hemostatics|mesh-ancestor
92959995|NCT01060189|Coagulants|coagulants|mesh-ancestor
92959996|NCT01060189|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92959997|NCT01060189|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92959998|NCT01060189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92959999|NCT01060189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960000|NCT01060267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92960001|NCT01060267|Erythromycin|erythromycin|mesh-list
92960002|NCT01060267|Erythromycin Estolate|erythromycin estolate|mesh-list
92960003|NCT01060267|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92960004|NCT01060267|Erythromycin stearate|erythromycin stearate|mesh-list
92960005|NCT01060267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960006|NCT01060267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960007|NCT01060267|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92960008|NCT01060267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960009|NCT01060267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960012|NCT01060423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92960013|NCT01060423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92960014|NCT01060423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960015|NCT01060423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960016|NCT01060423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960017|NCT01060423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960018|NCT01060501|Leucovorin|leucovorin|mesh-list
92960019|NCT01060501|Folic Acid|folic acid|mesh-list
92960020|NCT01060501|Interferons|interferons|mesh-list
92960021|NCT01060501|Interferon-alpha|interferon-alpha|mesh-list
92960022|NCT01060501|Levoleucovorin|levoleucovorin|mesh-list
92960023|NCT01060501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960024|NCT01060501|Antiviral Agents|antiviral agents|mesh-ancestor
92960025|NCT01060501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960026|NCT01060501|Immunologic Factors|immunologic factors|mesh-ancestor
92960027|NCT01060501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960028|NCT01060501|Antidotes|antidotes|mesh-ancestor
92960029|NCT01060501|Protective Agents|protective agents|mesh-ancestor
92960030|NCT01060501|Vitamin B Complex|vitamin b complex|mesh-ancestor
92960031|NCT01060501|Vitamins|vitamins|mesh-ancestor
92960032|NCT01060501|Micronutrients|micronutrients|mesh-ancestor
92960033|NCT01060501|Hematinics|hematinics|mesh-ancestor
92960034|NCT00671658|Cytarabine|cytarabine|mesh-list
92960035|NCT00671658|Dexamethasone|dexamethasone|mesh-list
92960036|NCT00671658|Methylprednisolone|methylprednisolone|mesh-list
92960037|NCT00671658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92960038|NCT00671658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92960039|NCT00671658|Prednisolone|prednisolone|mesh-list
92960040|NCT00671658|Prednisolone acetate|prednisolone acetate|mesh-list
92960041|NCT00671658|Cyclophosphamide|cyclophosphamide|mesh-list
92960042|NCT00671658|Rituximab|rituximab|mesh-list
92960043|NCT00671658|Doxorubicin|doxorubicin|mesh-list
92960044|NCT00671658|Methotrexate|methotrexate|mesh-list
92960045|NCT00671658|Vincristine|vincristine|mesh-list
92960046|NCT00671658|Asparaginase|asparaginase|mesh-list
92960047|NCT00671658|Pegaspargase|pegaspargase|mesh-list
92960048|NCT00671658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92960049|NCT00671658|Prednisolone phosphate|prednisolone phosphate|mesh-list
92960050|NCT00671658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960051|NCT00671658|Immunologic Factors|immunologic factors|mesh-ancestor
92960052|NCT00671658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960053|NCT00671658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960054|NCT00671658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92960055|NCT00671658|Alkylating Agents|alkylating agents|mesh-ancestor
93026485|NCT00401973|Autonomic Agents|autonomic agents|mesh-ancestor
92960056|NCT00671658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960057|NCT00671658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960058|NCT00671658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92960059|NCT00671658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960060|NCT00671658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960061|NCT00671658|Antiemetics|antiemetics|mesh-ancestor
92960062|NCT00671658|Autonomic Agents|autonomic agents|mesh-ancestor
92960063|NCT00671658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527556|NCT00033436|Niacinamide|niacinamide|mesh-list
92960064|NCT00671658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960065|NCT00671658|Glucocorticoids|glucocorticoids|mesh-ancestor
92960066|NCT00671658|Hormones|hormones|mesh-ancestor
92960067|NCT00671658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960068|NCT00671658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960069|NCT00671658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92960070|NCT00671658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92960071|NCT00671658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92960072|NCT00671658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960073|NCT00671658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92960074|NCT00671658|Abortifacient Agents|abortifacient agents|mesh-ancestor
92960075|NCT00671658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92960076|NCT00671658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92960077|NCT00671658|Antimetabolites|antimetabolites|mesh-ancestor
92960078|NCT00671658|Dermatologic Agents|dermatologic agents|mesh-ancestor
92960079|NCT00671658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92960080|NCT00671658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92960081|NCT00671658|Antiviral Agents|antiviral agents|mesh-ancestor
92960082|NCT00671658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960083|NCT00671658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92960084|NCT00671658|Tubulin Modulators|tubulin modulators|mesh-ancestor
92960085|NCT00671658|Antimitotic Agents|antimitotic agents|mesh-ancestor
92960086|NCT00671658|Mitosis Modulators|mitosis modulators|mesh-ancestor
92960087|NCT00671658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92960088|NCT00671658|Protective Agents|protective agents|mesh-ancestor
92960089|NCT00764712|Insulin|insulin|mesh-list
92960090|NCT00764712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960091|NCT00764712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960092|NCT00768456|Ropivacaine|ropivacaine|mesh-list
92960093|NCT00768456|Anesthetics, Local|anesthetics, local|mesh-ancestor
92960094|NCT00768456|Anesthetics|anesthetics|mesh-ancestor
92960095|NCT00768456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960096|NCT00768456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960097|NCT00768456|Sensory System Agents|sensory system agents|mesh-ancestor
92960098|NCT00768456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960099|NCT00768612|Risperidone|risperidone|mesh-list
92960100|NCT00768612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92960101|NCT00768612|Serotonin Agents|serotonin agents|mesh-ancestor
92960102|NCT00768612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960103|NCT00768612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960104|NCT00768612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960105|NCT00768612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92960106|NCT00768612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92960107|NCT00768612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960108|NCT00768612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92960109|NCT00768612|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92960110|NCT00768612|Dopamine Agents|dopamine agents|mesh-ancestor
92960111|NCT00604383|Ruboxistaurin|ruboxistaurin|mesh-list
92960112|NCT00604383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960113|NCT00604383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960114|NCT04048200|Fentanyl|fentanyl|mesh-list
92960115|NCT04048200|Dexmedetomidine|dexmedetomidine|mesh-list
92960116|NCT04048200|Ketamine|ketamine|mesh-list
92960117|NCT04048200|Analgesics, Opioid|analgesics, opioid|mesh-list
92960118|NCT04048200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92960119|NCT04048200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960120|NCT04048200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960121|NCT04048200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92960122|NCT04048200|Analgesics|analgesics|mesh-ancestor
92960123|NCT04048200|Sensory System Agents|sensory system agents|mesh-ancestor
92960124|NCT04048200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960125|NCT04048200|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92960126|NCT04048200|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92960127|NCT04048200|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92960128|NCT04048200|Adrenergic Agents|adrenergic agents|mesh-ancestor
92960129|NCT04048200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960130|NCT04048200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960131|NCT04048200|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92960132|NCT04048200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92960133|NCT04048200|Anesthetics, General|anesthetics, general|mesh-ancestor
92960134|NCT04048200|Anesthetics|anesthetics|mesh-ancestor
92960135|NCT04048200|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92960136|NCT04048200|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92960137|NCT04048200|Narcotics|narcotics|mesh-ancestor
92960138|NCT04048200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92960139|NCT04034589|Fulvestrant|fulvestrant|mesh-list
92960140|NCT04034589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960141|NCT04034589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960142|NCT04034589|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92960143|NCT04034589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92960144|NCT04034589|Hormone Antagonists|hormone antagonists|mesh-ancestor
92960145|NCT04034589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960146|NCT04034589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960147|NCT00988312|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92960148|NCT00988312|Immunologic Factors|immunologic factors|mesh-ancestor
92960149|NCT00988312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960150|NCT00906867|Methacholine Chloride|methacholine chloride|mesh-list
92960151|NCT00906867|Miotics|miotics|mesh-ancestor
92960152|NCT00906867|Autonomic Agents|autonomic agents|mesh-ancestor
92605567|NCT01244932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960153|NCT00906867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960154|NCT00906867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960156|NCT00906867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92960157|NCT00906867|Respiratory System Agents|respiratory system agents|mesh-ancestor
92960158|NCT00906867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92960159|NCT00906867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92960160|NCT00906867|Cholinergic Agents|cholinergic agents|mesh-ancestor
92960161|NCT00906867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960162|NCT00906867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960163|NCT00768690|Ketoconazole|ketoconazole|mesh-list
92960164|NCT00768690|Antifungal Agents|antifungal agents|mesh-ancestor
92960165|NCT00768690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960166|NCT00768690|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92960167|NCT00768690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92960168|NCT00768690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960169|NCT00768690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960170|NCT00768690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92960171|NCT00768690|Hormone Antagonists|hormone antagonists|mesh-ancestor
92960172|NCT00768690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960173|NCT00768690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960174|NCT00768690|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92960175|NCT00768768|Terbinafine|terbinafine|mesh-list
92960176|NCT00768768|Antifungal Agents|antifungal agents|mesh-ancestor
92960177|NCT00768768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960178|NCT00768768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960179|NCT00768768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960180|NCT00775086|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92960181|NCT00775086|Norelgestromin|norelgestromin|mesh-list
92960182|NCT00775086|Contraceptive Agents|contraceptive agents|mesh-list
92960183|NCT00775086|Estradiol|estradiol|mesh-list
92960184|NCT00775086|Estrogens|estrogens|mesh-ancestor
92960185|NCT00775086|Hormones|hormones|mesh-ancestor
92960186|NCT00775086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960187|NCT00775086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960188|NCT00775086|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92960189|NCT00775086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92960190|NCT00775086|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92960191|NCT00775086|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92960192|NCT00775086|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92960193|NCT02557854|Doxorubicin|doxorubicin|mesh-list
92960194|NCT02557854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92960195|NCT02557854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92960196|NCT02557854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960197|NCT02557854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92960198|NCT02557854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92960199|NCT02557854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960200|NCT02557854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960201|NCT02557386|Levobupivacaine|levobupivacaine|mesh-list
92960202|NCT02557386|Anesthetics, Local|anesthetics, local|mesh-ancestor
92960203|NCT02557386|Anesthetics|anesthetics|mesh-ancestor
92960204|NCT02557386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960205|NCT02557386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960206|NCT02557386|Sensory System Agents|sensory system agents|mesh-ancestor
92960207|NCT02557386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960208|NCT00986050|Sirolimus|sirolimus|mesh-list
92960209|NCT00986050|Abciximab|abciximab|mesh-list
92960211|NCT00986050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960212|NCT00986050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92960213|NCT00986050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960214|NCT00986050|Antifungal Agents|antifungal agents|mesh-ancestor
92960215|NCT00986050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960216|NCT00986050|Immunologic Factors|immunologic factors|mesh-ancestor
92960217|NCT00986050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960218|NCT00986050|Anticoagulants|anticoagulants|mesh-ancestor
92960219|NCT00986050|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92960220|NCT00986128|Topiramate|topiramate|mesh-list
92960221|NCT00986128|Anticonvulsants|anticonvulsants|mesh-ancestor
92960222|NCT00986128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960223|NCT00986128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960224|NCT00771342|Nitric Oxide|nitric oxide|mesh-list
92960225|NCT00771342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92960226|NCT00771342|Autonomic Agents|autonomic agents|mesh-ancestor
92605647|NCT00127868|Antioxidants|antioxidants|mesh-ancestor
92960227|NCT00771342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960228|NCT00771342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960229|NCT00771342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92960230|NCT00771342|Respiratory System Agents|respiratory system agents|mesh-ancestor
92960231|NCT00771342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92960232|NCT00771342|Antioxidants|antioxidants|mesh-ancestor
92960233|NCT00771342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960234|NCT00771342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960235|NCT00771342|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92960236|NCT00771342|Vasodilator Agents|vasodilator agents|mesh-ancestor
92960237|NCT00771342|Gasotransmitters|gasotransmitters|mesh-ancestor
92960238|NCT00771342|Protective Agents|protective agents|mesh-ancestor
92960239|NCT00775164|Metformin|metformin|mesh-list
92960240|NCT00775164|Pioglitazone|pioglitazone|mesh-list
92960241|NCT00775164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960242|NCT00775164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960243|NCT00771420|Mavrilimumab|mavrilimumab|mesh-list
92960244|NCT00771420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92960245|NCT00771420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960246|NCT00771420|Immunologic Factors|immunologic factors|mesh-ancestor
92960247|NCT00771420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960248|NCT04767256|Dexamethasone|dexamethasone|mesh-list
92960249|NCT04767256|Dexmedetomidine|dexmedetomidine|mesh-list
92960250|NCT04767256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960251|NCT04767256|Antiemetics|antiemetics|mesh-ancestor
92960252|NCT04767256|Autonomic Agents|autonomic agents|mesh-ancestor
92960253|NCT04767256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960254|NCT04767256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960255|NCT04767256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960256|NCT04767256|Glucocorticoids|glucocorticoids|mesh-ancestor
92960257|NCT04767256|Hormones|hormones|mesh-ancestor
92960258|NCT04767256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960259|NCT04767256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960260|NCT04767256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960261|NCT04767256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92960262|NCT04767256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960263|NCT04767256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92960264|NCT04767256|Analgesics|analgesics|mesh-ancestor
92960265|NCT04767256|Sensory System Agents|sensory system agents|mesh-ancestor
92960266|NCT04767256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92960267|NCT04767256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92960268|NCT04767256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92960269|NCT04767256|Adrenergic Agents|adrenergic agents|mesh-ancestor
92960270|NCT04767256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960271|NCT04767256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960272|NCT00771498|Lopinavir|lopinavir|mesh-list
92960273|NCT00771498|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92960274|NCT00771498|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92960275|NCT00771498|Protease Inhibitors|protease inhibitors|mesh-ancestor
92960276|NCT00771498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960277|NCT00771498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960278|NCT00771498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92960279|NCT00771498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92960280|NCT00771498|Antiviral Agents|antiviral agents|mesh-ancestor
92960281|NCT00771498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960282|NCT00771498|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92960283|NCT00771498|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92960284|NCT00986284|Gefitinib|gefitinib|mesh-list
92960285|NCT00986284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960286|NCT00986284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92960287|NCT00986284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960288|NCT00986284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960289|NCT00988780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92960290|NCT00988780|Efavirenz|efavirenz|mesh-list
92960291|NCT00988780|Maraviroc|maraviroc|mesh-list
92960292|NCT00988780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92960293|NCT00988780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92960294|NCT00988780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960295|NCT00988780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960296|NCT00988780|Antiviral Agents|antiviral agents|mesh-ancestor
92960297|NCT00988780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960298|NCT00988780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92960299|NCT00988780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92960300|NCT00988780|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92960301|NCT00988780|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92960302|NCT00988780|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92960303|NCT00988780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92960304|NCT00988780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92960305|NCT00988780|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92960306|NCT00988780|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92960307|NCT00988780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92960308|NCT00988780|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92960309|NCT00775242|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92960310|NCT00775242|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92960311|NCT00775242|Estradiol|estradiol|mesh-list
92960312|NCT00775242|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92960313|NCT00775242|Estrogens|estrogens|mesh-list
92960314|NCT00775242|Progesterone|progesterone|mesh-list
92960315|NCT00775242|Progestins|progestins|mesh-list
92960316|NCT00775242|Hormones|hormones|mesh-ancestor
92960317|NCT00775242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960318|NCT00775242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960319|NCT00775242|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92960320|NCT00775242|Contraceptive Agents|contraceptive agents|mesh-ancestor
92960321|NCT00775242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92960322|NCT00775242|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92960323|NCT00986518|Immunomodulating Agents|immunomodulating agents|mesh-list
92960324|NCT00986518|Immunologic Factors|immunologic factors|mesh-ancestor
92960325|NCT00986518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960326|NCT00769158|Topiramate|topiramate|mesh-list
92960327|NCT00769158|Naltrexone|naltrexone|mesh-list
92960328|NCT00769158|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92960329|NCT00769158|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92960330|NCT00769158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960331|NCT00769158|Sensory System Agents|sensory system agents|mesh-ancestor
92960332|NCT00769158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960333|NCT00769158|Anticonvulsants|anticonvulsants|mesh-ancestor
92960334|NCT00769158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960335|NCT00983164|Antioxidants|antioxidants|mesh-list
92165950|NCT03061656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92960336|NCT00983164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960337|NCT00983164|Protective Agents|protective agents|mesh-ancestor
92960338|NCT00983164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960339|NCT00333775|Bevacizumab|bevacizumab|mesh-list
92960340|NCT00333775|Docetaxel|docetaxel|mesh-list
92960341|NCT00333775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960342|NCT00333775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960343|NCT00333775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92960344|NCT00333775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92960345|NCT00333775|Growth Substances|growth substances|mesh-ancestor
92960346|NCT00333775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960347|NCT00333775|Growth Inhibitors|growth inhibitors|mesh-ancestor
92960348|NCT00333775|Tubulin Modulators|tubulin modulators|mesh-ancestor
92960349|NCT00333775|Antimitotic Agents|antimitotic agents|mesh-ancestor
92960350|NCT00333775|Mitosis Modulators|mitosis modulators|mesh-ancestor
92960351|NCT00333775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960352|NCT03860428|Acetaminophen|acetaminophen|mesh-list
92960353|NCT03860428|Ibuprofen|ibuprofen|mesh-list
92960354|NCT03860428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
92960355|NCT03860428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92960356|NCT03860428|Analgesics|analgesics|mesh-ancestor
92960357|NCT03860428|Sensory System Agents|sensory system agents|mesh-ancestor
92960358|NCT03860428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960359|NCT03860428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960360|NCT03860428|Antipyretics|antipyretics|mesh-ancestor
92960361|NCT03860428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92960362|NCT03860428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960363|NCT03860428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960364|NCT03860428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960365|NCT03860428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960366|NCT00771888|Lanreotide|lanreotide|mesh-list
92960367|NCT00771888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960368|NCT00605475|Metformin|metformin|mesh-list
92960369|NCT00605475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960370|NCT00605475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960371|NCT00986596|Vitamin D|vitamin d|mesh-list
92960372|NCT00986596|Cholecalciferol|cholecalciferol|mesh-list
92960373|NCT00986596|Vitamins|vitamins|mesh-ancestor
92960374|NCT00986596|Micronutrients|micronutrients|mesh-ancestor
92960375|NCT00986596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960376|NCT00986596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92960377|NCT00986596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92960378|NCT00769470|Carboplatin|carboplatin|mesh-list
92960379|NCT00769470|Docetaxel|docetaxel|mesh-list
92960380|NCT00769470|Trastuzumab|trastuzumab|mesh-list
92960381|NCT00769470|Lapatinib|lapatinib|mesh-list
92960382|NCT00769470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960383|NCT00769470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92960384|NCT00769470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92960385|NCT00769470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92960386|NCT00769470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960387|NCT00769470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960388|NCT00769470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92960389|NCT00769470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960390|NCT00605319|Fesoterodine|fesoterodine|mesh-list
92960391|NCT00605319|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92960392|NCT00605319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92960393|NCT00605319|Cholinergic Agents|cholinergic agents|mesh-ancestor
92960394|NCT00605319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960395|NCT00605319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960396|NCT00605319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960397|NCT00605319|Urological Agents|urological agents|mesh-ancestor
92960398|NCT00983320|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92960399|NCT00983320|Antidepressive Agents|antidepressive agents|mesh-ancestor
92960400|NCT00983320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92960401|NCT00983320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92960402|NCT00983320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92960403|NCT00983320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960404|NCT00983320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960405|NCT00908661|Cellulose, Oxidized|cellulose, oxidized|mesh-list
92960406|NCT00908661|Hemostatics|hemostatics|mesh-ancestor
92960407|NCT00908661|Coagulants|coagulants|mesh-ancestor
92165953|NCT02906761|Aspirin|aspirin|mesh-list
92960408|NCT00983398|Sodium thiosulfate|sodium thiosulfate|mesh-list
92960409|NCT00983398|Carboplatin|carboplatin|mesh-list
92960410|NCT00983398|Melphalan|melphalan|mesh-list
92960411|NCT00983398|Mechlorethamine|mechlorethamine|mesh-list
92960412|NCT00983398|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92960413|NCT00983398|Mannitol|mannitol|mesh-list
92960414|NCT00983398|Antidotes|antidotes|mesh-list
92960415|NCT00983398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960416|NCT00983398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92960417|NCT00983398|Alkylating Agents|alkylating agents|mesh-ancestor
92960418|NCT00983398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960419|NCT00983398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92960420|NCT00983398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960421|NCT00983398|Immunologic Factors|immunologic factors|mesh-ancestor
92960422|NCT00983398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960423|NCT00983398|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92960424|NCT00983398|Diuretics|diuretics|mesh-ancestor
92960425|NCT00983398|Natriuretic Agents|natriuretic agents|mesh-ancestor
92960426|NCT00983398|Protective Agents|protective agents|mesh-ancestor
92960427|NCT00983398|Antioxidants|antioxidants|mesh-ancestor
92960428|NCT00983398|Antitubercular Agents|antitubercular agents|mesh-ancestor
92960429|NCT00983398|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92960430|NCT00983398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960431|NCT00983398|Chelating Agents|chelating agents|mesh-ancestor
92960432|NCT00983398|Sequestering Agents|sequestering agents|mesh-ancestor
92960433|NCT00333229|Zoledronic Acid|zoledronic acid|mesh-list
92960434|NCT00333229|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92960435|NCT00333229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960436|NCT00769548|Goserelin|goserelin|mesh-list
92960437|NCT00769548|Flutamide|flutamide|mesh-list
92960438|NCT00769548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960439|NCT00769548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960440|NCT00769548|Androgen Antagonists|androgen antagonists|mesh-ancestor
92960441|NCT00769548|Hormone Antagonists|hormone antagonists|mesh-ancestor
92960442|NCT00769548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960443|NCT00769548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960444|NCT05277675|Bevacizumab|bevacizumab|mesh-list
92960445|NCT05277675|Tislelizumab|tislelizumab|mesh-list
92960446|NCT05277675|Lenvatinib|lenvatinib|mesh-list
92960447|NCT05277675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960448|NCT05277675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960449|NCT05277675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92960450|NCT05277675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92960451|NCT05277675|Growth Substances|growth substances|mesh-ancestor
92605873|NCT00499018|Cytarabine|cytarabine|mesh-list
92960452|NCT05277675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960453|NCT05277675|Growth Inhibitors|growth inhibitors|mesh-ancestor
92960454|NCT05277675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92960455|NCT05277675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960456|NCT05277675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960457|NCT03984409|Potassium Citrate|potassium citrate|mesh-list
92960458|NCT03984409|Diuretics|diuretics|mesh-ancestor
92960459|NCT03984409|Natriuretic Agents|natriuretic agents|mesh-ancestor
92960460|NCT03984409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960461|NCT03984409|Expectorants|expectorants|mesh-ancestor
92960462|NCT03984409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92960463|NCT00983554|Anastrozole|anastrozole|mesh-list
92960464|NCT00983554|Testosterone|testosterone|mesh-list
92960465|NCT00983554|Dutasteride|dutasteride|mesh-list
92960466|NCT00983554|Androgens|androgens|mesh-ancestor
92960467|NCT00983554|Hormones|hormones|mesh-ancestor
92960468|NCT00983554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960469|NCT00983554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960470|NCT00983554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960471|NCT00983554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960472|NCT00983554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92960473|NCT00983554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92960474|NCT00983554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960475|NCT00983554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960476|NCT00983554|Hormone Antagonists|hormone antagonists|mesh-ancestor
92960477|NCT00983554|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92960478|NCT00983554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92960479|NCT05004987|Dexetimide|dexetimide|mesh-list
92960480|NCT05004987|Citalopram|citalopram|mesh-list
92960481|NCT05004987|Escitalopram|escitalopram|mesh-list
92960482|NCT05004987|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92960483|NCT05004987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92960484|NCT05004987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92960485|NCT05004987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960486|NCT05004987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960487|NCT05004987|Serotonin Agents|serotonin agents|mesh-ancestor
92960488|NCT05004987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960489|NCT05004987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92960490|NCT05004987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92960491|NCT05004987|Parasympatholytics|parasympatholytics|mesh-ancestor
92960492|NCT05004987|Autonomic Agents|autonomic agents|mesh-ancestor
92960493|NCT05004987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960494|NCT05004987|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92960495|NCT05004987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92960496|NCT05004987|Cholinergic Agents|cholinergic agents|mesh-ancestor
92960497|NCT05004987|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92960498|NCT05004987|Antidepressive Agents|antidepressive agents|mesh-ancestor
92960499|NCT05004987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92960500|NCT00908817|Chlorhexidine|chlorhexidine|mesh-list
92960501|NCT00908817|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92960502|NCT00908817|Triamcinolone|triamcinolone|mesh-list
92960503|NCT00908817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92960504|NCT00908817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92960505|NCT00908817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92960506|NCT00908817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92960507|NCT00908817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960508|NCT00908817|Disinfectants|disinfectants|mesh-ancestor
92960509|NCT00908817|Dermatologic Agents|dermatologic agents|mesh-ancestor
92960510|NCT00908817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960511|NCT00908817|Glucocorticoids|glucocorticoids|mesh-ancestor
92960512|NCT00908817|Hormones|hormones|mesh-ancestor
92960513|NCT00908817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960514|NCT00908817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960515|NCT00908817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960516|NCT00908817|Immunologic Factors|immunologic factors|mesh-ancestor
92960517|NCT00908817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960518|NCT00908817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960519|NCT00332839|Cyclosporine|cyclosporine|mesh-list
92960520|NCT00332839|Mycophenolic Acid|mycophenolic acid|mesh-list
92960521|NCT00332839|Everolimus|everolimus|mesh-list
92960522|NCT00332839|Tacrolimus|tacrolimus|mesh-list
92960523|NCT00332839|Cyclosporins|cyclosporins|mesh-list
92960524|NCT00332839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960525|NCT00332839|Immunologic Factors|immunologic factors|mesh-ancestor
92960526|NCT00332839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960527|NCT00332839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92960528|NCT00332839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960529|NCT00332839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960530|NCT00332839|Antifungal Agents|antifungal agents|mesh-ancestor
92960531|NCT00332839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960532|NCT00332839|Dermatologic Agents|dermatologic agents|mesh-ancestor
92960533|NCT00332839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960534|NCT00332839|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92960535|NCT00332839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92960536|NCT00332839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960537|NCT00332839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92960538|NCT00332839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92960539|NCT00332839|Antitubercular Agents|antitubercular agents|mesh-ancestor
92960540|NCT00332839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92960541|NCT00927147|Cetuximab|cetuximab|mesh-list
92960542|NCT00927147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960543|NCT00927147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960544|NCT05712616|Strontium ranelate|strontium ranelate|mesh-list
92960545|NCT05712616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92960546|NCT05712616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960547|NCT00927225|Ropivacaine|ropivacaine|mesh-list
92960548|NCT00927225|Anesthetics, Local|anesthetics, local|mesh-ancestor
92960549|NCT00927225|Anesthetics|anesthetics|mesh-ancestor
92960550|NCT00927225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960551|NCT00927225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960552|NCT00927225|Sensory System Agents|sensory system agents|mesh-ancestor
92960553|NCT00927225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960554|NCT00357097|Ropinirole|ropinirole|mesh-list
92960555|NCT00357097|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92960556|NCT00357097|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92960557|NCT00357097|Dopamine Agonists|dopamine agonists|mesh-ancestor
92960558|NCT00357097|Dopamine Agents|dopamine agents|mesh-ancestor
92960559|NCT00357097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960560|NCT00357097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960561|NCT00357097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960562|NCT00983788|Bezafibrate|bezafibrate|mesh-list
92960563|NCT00983788|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92960564|NCT00983788|Antimetabolites|antimetabolites|mesh-ancestor
92960565|NCT00983788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960566|NCT00983788|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92960567|NCT00983944|Prednisone|prednisone|mesh-list
92960568|NCT00983944|Cyclophosphamide|cyclophosphamide|mesh-list
92960569|NCT00983944|Rituximab|rituximab|mesh-list
92960570|NCT00983944|Doxorubicin|doxorubicin|mesh-list
92960571|NCT00983944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92960572|NCT00983944|Etoposide|etoposide|mesh-list
92960573|NCT00983944|Vincristine|vincristine|mesh-list
92960574|NCT00983944|Bleomycin|bleomycin|mesh-list
92960575|NCT00983944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960576|NCT00983944|Immunologic Factors|immunologic factors|mesh-ancestor
92960577|NCT00983944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960578|NCT00983944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960579|NCT00983944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92960580|NCT00983944|Alkylating Agents|alkylating agents|mesh-ancestor
92960581|NCT00983944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960582|NCT00983944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960583|NCT00983944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92960584|NCT00983944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960585|NCT00983944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92960586|NCT00983944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92960588|NCT00983944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960589|NCT00983944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960590|NCT00983944|Glucocorticoids|glucocorticoids|mesh-ancestor
92960591|NCT00983944|Hormones|hormones|mesh-ancestor
92960592|NCT00983944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960593|NCT00983944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960594|NCT00983944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92960595|NCT00983944|Tubulin Modulators|tubulin modulators|mesh-ancestor
92960596|NCT00983944|Antimitotic Agents|antimitotic agents|mesh-ancestor
92960597|NCT00983944|Mitosis Modulators|mitosis modulators|mesh-ancestor
92960598|NCT00927537|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92960599|NCT00927537|Telmisartan|telmisartan|mesh-list
92960600|NCT00927537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92960601|NCT00927537|Diuretics|diuretics|mesh-ancestor
92960602|NCT00927537|Natriuretic Agents|natriuretic agents|mesh-ancestor
92960603|NCT00927537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960604|NCT00927537|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92606015|NCT00499837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92960605|NCT00927537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92960606|NCT00927537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960607|NCT00927537|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92960608|NCT00927537|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92960609|NCT02538003|Delpazolid|delpazolid|mesh-list
92960610|NCT02538003|Oxazolidinones|oxazolidinones|mesh-list
92960611|NCT02538003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92960612|NCT02538003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960613|NCT02538003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92960614|NCT02538003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960615|NCT02538003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960616|NCT00909129|Interferons|interferons|mesh-list
92960617|NCT00909129|Ribavirin|ribavirin|mesh-list
92960618|NCT00909129|Interferon-alpha|interferon-alpha|mesh-list
92960619|NCT00909129|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92960620|NCT00909129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960621|NCT00909129|Antiviral Agents|antiviral agents|mesh-ancestor
92960622|NCT00909129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960623|NCT00909129|Antimetabolites|antimetabolites|mesh-ancestor
92960624|NCT00909129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960625|NCT00909129|Immunologic Factors|immunologic factors|mesh-ancestor
92960626|NCT00909129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960627|NCT01053325|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92960628|NCT01053325|Antimalarials|antimalarials|mesh-ancestor
92960629|NCT01053325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92960630|NCT01053325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92960631|NCT01053325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960632|NCT01053325|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92960633|NCT01053325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92960634|NCT01053403|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92960635|NCT01053403|Hallucinogens|hallucinogens|mesh-ancestor
92960636|NCT01053403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960637|NCT01053403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92960638|NCT01053403|Serotonin Agents|serotonin agents|mesh-ancestor
92960639|NCT01053403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960640|NCT01053403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960641|NCT01053403|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92960642|NCT01053403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92960643|NCT01053403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92960644|NCT01053403|Adrenergic Agents|adrenergic agents|mesh-ancestor
92960645|NCT00927615|Abciximab|abciximab|mesh-list
92960646|NCT00927615|Anticoagulants|anticoagulants|mesh-ancestor
92960647|NCT00927615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92960648|NCT03990103|Paclitaxel|paclitaxel|mesh-list
92960649|NCT03990103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92960650|NCT03990103|Bevacizumab|bevacizumab|mesh-list
92960651|NCT03990103|Oxaliplatin|oxaliplatin|mesh-list
92960652|NCT03990103|Tegafur|tegafur|mesh-list
92960653|NCT03990103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92960654|NCT03990103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960655|NCT03990103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92960656|NCT03990103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92960657|NCT03990103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92960658|NCT03990103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960659|NCT03990103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960660|NCT03990103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92960661|NCT03990103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92960662|NCT03990103|Growth Substances|growth substances|mesh-ancestor
92960663|NCT03990103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960664|NCT03990103|Growth Inhibitors|growth inhibitors|mesh-ancestor
92960665|NCT03990103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92960666|NCT03990103|Antimetabolites|antimetabolites|mesh-ancestor
92960667|NCT00927693|Calcium|calcium|mesh-list
92960668|NCT00927693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92960669|NCT00927693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960670|NCT00987220|Donepezil|donepezil|mesh-list
92960671|NCT00987220|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92960672|NCT00987220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960673|NCT00987220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960674|NCT00987220|Cholinergic Agents|cholinergic agents|mesh-ancestor
92960675|NCT00987220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960676|NCT00987220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960677|NCT00987220|Nootropic Agents|nootropic agents|mesh-ancestor
92960678|NCT01581151|Dexamethasone|dexamethasone|mesh-list
92960680|NCT01581151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960681|NCT01581151|Antiemetics|antiemetics|mesh-ancestor
92960682|NCT01581151|Autonomic Agents|autonomic agents|mesh-ancestor
92960683|NCT01581151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960684|NCT01581151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960685|NCT01581151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960686|NCT01581151|Glucocorticoids|glucocorticoids|mesh-ancestor
92960687|NCT01581151|Hormones|hormones|mesh-ancestor
92960688|NCT01581151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960689|NCT01581151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960690|NCT01581151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960691|NCT01581151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92960692|NCT01581151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92960693|NCT01581151|Growth Substances|growth substances|mesh-ancestor
92960694|NCT01581151|Growth Inhibitors|growth inhibitors|mesh-ancestor
92960695|NCT01053481|Vitamin D|vitamin d|mesh-list
92960696|NCT01053481|Vitamins|vitamins|mesh-ancestor
92960697|NCT01053481|Micronutrients|micronutrients|mesh-ancestor
92960698|NCT01053481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960699|NCT01053481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92960700|NCT00927771|Azelaic acid|azelaic acid|mesh-list
92960701|NCT00927771|Hydroquinone|hydroquinone|mesh-list
92960702|NCT00927771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960703|NCT00927771|Dermatologic Agents|dermatologic agents|mesh-ancestor
92960704|NCT00927771|Antioxidants|antioxidants|mesh-ancestor
92960705|NCT00927771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960706|NCT00927771|Protective Agents|protective agents|mesh-ancestor
92960707|NCT00927771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960708|NCT00927771|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92960709|NCT01053559|Certolizumab Pegol|certolizumab pegol|mesh-list
92960710|NCT01053559|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92960711|NCT01053559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960712|NCT01053559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960713|NCT01053559|Immunologic Factors|immunologic factors|mesh-ancestor
92960714|NCT01053559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960715|NCT01053559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960716|NCT01053637|Acetaminophen|acetaminophen|mesh-list
92960717|NCT01053637|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92960718|NCT01053637|Hydrocodone|hydrocodone|mesh-list
92960719|NCT01053637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92960720|NCT01053637|Analgesics|analgesics|mesh-ancestor
92960721|NCT01053637|Sensory System Agents|sensory system agents|mesh-ancestor
92960722|NCT01053637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960723|NCT01053637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960724|NCT01053637|Antipyretics|antipyretics|mesh-ancestor
92960725|NCT01053637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92960726|NCT01053637|Narcotics|narcotics|mesh-ancestor
92960727|NCT01053637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960728|NCT01053637|Antitussive Agents|antitussive agents|mesh-ancestor
92960729|NCT01053637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92527564|NCT00033436|Antimetabolites|antimetabolites|mesh-ancestor
92960730|NCT01053637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92960731|NCT01053637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960732|NCT01053637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960733|NCT00928161|Dexlansoprazole|dexlansoprazole|mesh-list
92960734|NCT00928161|Lansoprazole|lansoprazole|mesh-list
92960735|NCT00928161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92960736|NCT00928161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960737|NCT00928161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92960738|NCT00928161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960739|NCT00928161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960740|NCT00909519|Naproxen|naproxen|mesh-list
92960741|NCT00909519|Furosemide|furosemide|mesh-list
92960742|NCT00909519|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92960743|NCT00909519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92960744|NCT00909519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92960745|NCT00909519|Analgesics|analgesics|mesh-ancestor
92960746|NCT00909519|Sensory System Agents|sensory system agents|mesh-ancestor
92960747|NCT00909519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960748|NCT00909519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960749|NCT00909519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960750|NCT00909519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92960751|NCT00909519|Gout Suppressants|gout suppressants|mesh-ancestor
92606178|NCT00147186|Hylan|hylan|mesh-list
92960752|NCT00909519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92960753|NCT00909519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960754|NCT00909519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960755|NCT00909519|Diuretics|diuretics|mesh-ancestor
92960756|NCT00909519|Natriuretic Agents|natriuretic agents|mesh-ancestor
92960757|NCT00909519|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92960758|NCT00909519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92960759|NCT00909519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92960760|NCT05014815|Tislelizumab|tislelizumab|mesh-list
92960761|NCT05014815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92960762|NCT05014815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960763|NCT00355615|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92960764|NCT00355615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92960765|NCT00355615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92960766|NCT00355615|Antimetabolites|antimetabolites|mesh-ancestor
92960767|NCT00355615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960768|NCT00355615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92960769|NCT00355615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92960770|NCT00355615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960771|NCT00907179|Pemetrexed|pemetrexed|mesh-list
92960772|NCT00907179|Panobinostat|panobinostat|mesh-list
92960773|NCT00907179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960774|NCT00907179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960775|NCT00907179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960776|NCT00907179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92960777|NCT00907179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92960778|NCT00907179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92960779|NCT00347269|Psychotropic Drugs|psychotropic drugs|mesh-list
92960780|NCT00544648|Paclitaxel|paclitaxel|mesh-list
92960781|NCT00544648|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92960782|NCT00544648|Carboplatin|carboplatin|mesh-list
92960783|NCT00544648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92960784|NCT00544648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960785|NCT00544648|Tubulin Modulators|tubulin modulators|mesh-ancestor
92960786|NCT00544648|Antimitotic Agents|antimitotic agents|mesh-ancestor
92960787|NCT00544648|Mitosis Modulators|mitosis modulators|mesh-ancestor
92960788|NCT00544648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960789|NCT01053871|Fentanyl|fentanyl|mesh-list
92960790|NCT01053871|Midazolam|midazolam|mesh-list
92960791|NCT01053871|Propofol|propofol|mesh-list
92960792|NCT01053871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92960793|NCT01053871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92960794|NCT01053871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960795|NCT01053871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92960796|NCT01053871|Anesthetics, General|anesthetics, general|mesh-ancestor
92960797|NCT01053871|Anesthetics|anesthetics|mesh-ancestor
92960798|NCT01053871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92960799|NCT01053871|Narcotics|narcotics|mesh-ancestor
92960800|NCT01053871|Analgesics|analgesics|mesh-ancestor
92960801|NCT01053871|Sensory System Agents|sensory system agents|mesh-ancestor
92960802|NCT01053871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960804|NCT01053871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92960805|NCT01053871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92960806|NCT01053871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92960807|NCT01053871|GABA Modulators|gaba modulators|mesh-ancestor
92960808|NCT01053871|GABA Agents|gaba agents|mesh-ancestor
92960809|NCT01053871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960810|NCT01053871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960811|NCT01053949|Thalidomide|thalidomide|mesh-list
92960812|NCT01053949|Pomalidomide|pomalidomide|mesh-list
92960813|NCT01053949|Immunologic Factors|immunologic factors|mesh-ancestor
92960814|NCT01053949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960815|NCT01053949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92960816|NCT01053949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92960817|NCT01053949|Growth Substances|growth substances|mesh-ancestor
92960818|NCT01053949|Growth Inhibitors|growth inhibitors|mesh-ancestor
92960819|NCT01053949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960820|NCT01053949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960821|NCT01053949|Leprostatic Agents|leprostatic agents|mesh-ancestor
92960822|NCT01053949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92960823|NCT01053949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960824|NCT00987376|Choline|choline|mesh-list
92960825|NCT00987376|Lipotropic Agents|lipotropic agents|mesh-ancestor
92960826|NCT00987376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92960827|NCT00987376|Antimetabolites|antimetabolites|mesh-ancestor
92960828|NCT00987376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960829|NCT00987376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960830|NCT00987376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92960831|NCT00987376|Nootropic Agents|nootropic agents|mesh-ancestor
92960832|NCT00987454|Epoetin Alfa|epoetin alfa|mesh-list
92960833|NCT00987454|Hematinics|hematinics|mesh-ancestor
92960834|NCT04005664|Phenylephrine|phenylephrine|mesh-list
92960835|NCT04005664|Oxymetazoline|oxymetazoline|mesh-list
92960836|NCT04005664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92960837|NCT04005664|Mydriatics|mydriatics|mesh-ancestor
92960838|NCT04005664|Autonomic Agents|autonomic agents|mesh-ancestor
92960839|NCT04005664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960840|NCT04005664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960841|NCT04005664|Sympathomimetics|sympathomimetics|mesh-ancestor
92960842|NCT04005664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92960843|NCT04005664|Nasal Decongestants|nasal decongestants|mesh-ancestor
92960844|NCT04005664|Respiratory System Agents|respiratory system agents|mesh-ancestor
92960845|NCT04005664|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92960846|NCT04005664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92960847|NCT04005664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92960848|NCT04005664|Adrenergic Agents|adrenergic agents|mesh-ancestor
92960849|NCT04005664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960850|NCT04005664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960851|NCT04005664|Protective Agents|protective agents|mesh-ancestor
92960852|NCT00330967|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92960853|NCT00330967|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92960854|NCT00330967|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92960855|NCT00330967|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92960856|NCT00924573|Metformin|metformin|mesh-list
92960857|NCT00924573|Glimepiride|glimepiride|mesh-list
92960858|NCT00924573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960859|NCT00924573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960860|NCT00924573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92960861|NCT00924573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92960862|NCT00924573|Immunologic Factors|immunologic factors|mesh-ancestor
92960863|NCT01054027|Phenylephrine|phenylephrine|mesh-list
92960864|NCT01054027|Oxymetazoline|oxymetazoline|mesh-list
92960865|NCT01054027|Cyclopentolate|cyclopentolate|mesh-list
92960866|NCT01054027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92960867|NCT01054027|Mydriatics|mydriatics|mesh-ancestor
92960868|NCT01054027|Autonomic Agents|autonomic agents|mesh-ancestor
92960869|NCT01054027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960870|NCT01054027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960871|NCT01054027|Sympathomimetics|sympathomimetics|mesh-ancestor
92960872|NCT01054027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92960873|NCT01054027|Nasal Decongestants|nasal decongestants|mesh-ancestor
92960874|NCT01054027|Respiratory System Agents|respiratory system agents|mesh-ancestor
92960875|NCT01054027|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92960876|NCT01054027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92960877|NCT01054027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92960878|NCT01054027|Adrenergic Agents|adrenergic agents|mesh-ancestor
92960879|NCT01054027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960880|NCT01054027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960881|NCT01054027|Protective Agents|protective agents|mesh-ancestor
92960882|NCT01054027|Parasympatholytics|parasympatholytics|mesh-ancestor
92960883|NCT01054027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92960884|NCT01054027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92960885|NCT01054027|Cholinergic Agents|cholinergic agents|mesh-ancestor
92960887|NCT01054105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92960888|NCT01054105|Vasodilator Agents|vasodilator agents|mesh-ancestor
92960889|NCT00330343|Naloxone|naloxone|mesh-list
92960890|NCT00330343|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92960891|NCT00330343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960892|NCT00330343|Sensory System Agents|sensory system agents|mesh-ancestor
92960893|NCT00330343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960894|NCT00987766|Gemcitabine|gemcitabine|mesh-list
92960895|NCT00987766|Oxaliplatin|oxaliplatin|mesh-list
92960896|NCT00987766|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92960897|NCT00987766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92960898|NCT00987766|Antimetabolites|antimetabolites|mesh-ancestor
92960899|NCT00987766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960900|NCT00987766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960901|NCT00987766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92960902|NCT00987766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960903|NCT04005430|Dexamethasone|dexamethasone|mesh-list
92606317|NCT00502762|Topotecan|topotecan|mesh-list
92960904|NCT04005430|Dexamethasone acetate|dexamethasone acetate|mesh-list
92960905|NCT04005430|BB 1101|bb 1101|mesh-list
92960906|NCT04005430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92960907|NCT04005430|Antiemetics|antiemetics|mesh-ancestor
92960908|NCT04005430|Autonomic Agents|autonomic agents|mesh-ancestor
92960909|NCT04005430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960910|NCT04005430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960911|NCT04005430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960912|NCT04005430|Glucocorticoids|glucocorticoids|mesh-ancestor
92960914|NCT04005430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960915|NCT04005430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92960916|NCT04005430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960917|NCT04005430|Protease Inhibitors|protease inhibitors|mesh-ancestor
92960918|NCT04005430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960919|NCT04005430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960920|NCT00330187|Bupropion|bupropion|mesh-list
92960921|NCT00330187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92960922|NCT00330187|Antidepressive Agents|antidepressive agents|mesh-ancestor
92960923|NCT00330187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92960924|NCT00330187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92960925|NCT00330187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92960926|NCT00330187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92960927|NCT00330187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960928|NCT00330187|Dopamine Agents|dopamine agents|mesh-ancestor
92960929|NCT00330187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960930|NCT00330187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960931|NCT00330187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92960932|NCT00330187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92960933|NCT00330187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960934|NCT00987844|Prucalopride|prucalopride|mesh-list
92960935|NCT00987844|Laxatives|laxatives|mesh-ancestor
92960936|NCT00987844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960937|NCT00987844|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92960938|NCT00987844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92960939|NCT00987844|Serotonin Agents|serotonin agents|mesh-ancestor
92960940|NCT00987844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960941|NCT00987844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960942|NCT00987844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960943|NCT03986905|Scopolamine|scopolamine|mesh-list
92960944|NCT03986905|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92960945|NCT03986905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92960946|NCT03986905|Antiemetics|antiemetics|mesh-ancestor
92960947|NCT03986905|Autonomic Agents|autonomic agents|mesh-ancestor
92960948|NCT03986905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92960949|NCT03986905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960950|NCT03986905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92960951|NCT03986905|Mydriatics|mydriatics|mesh-ancestor
92960952|NCT03986905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92960953|NCT03986905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92960954|NCT03986905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92960955|NCT03986905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960956|NCT03986905|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92960957|NCT03986905|Parasympatholytics|parasympatholytics|mesh-ancestor
92960958|NCT04864444|Primaquine|primaquine|mesh-list
92960959|NCT04864444|Piperaquine|piperaquine|mesh-list
92960960|NCT04864444|Artenimol|artenimol|mesh-list
92960961|NCT04864444|Antimalarials|antimalarials|mesh-ancestor
92960962|NCT04864444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92960963|NCT04864444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92960964|NCT04864444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92960965|NCT00329797|Vitamin D|vitamin d|mesh-list
92960966|NCT00329797|Zoledronic Acid|zoledronic acid|mesh-list
92960967|NCT00329797|Calcium|calcium|mesh-list
92960968|NCT00329797|Vitamins|vitamins|mesh-ancestor
92960969|NCT00329797|Micronutrients|micronutrients|mesh-ancestor
92960970|NCT00329797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960971|NCT00329797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92960972|NCT00329797|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92960973|NCT00541450|Metformin|metformin|mesh-list
92960974|NCT00541450|Pioglitazone|pioglitazone|mesh-list
92960975|NCT00541450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92960976|NCT00541450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92960977|NCT00541450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960978|NCT00541450|Incretins|incretins|mesh-ancestor
92960979|NCT00541450|Hormones|hormones|mesh-ancestor
92960980|NCT00541450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92960981|NCT00541450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92960982|NCT00541450|Protease Inhibitors|protease inhibitors|mesh-ancestor
92960983|NCT00541450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960984|NCT00541450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960985|NCT01056679|Doxorubicin|doxorubicin|mesh-list
92960986|NCT01056679|Lenalidomide|lenalidomide|mesh-list
92960987|NCT01056679|Vinblastine|vinblastine|mesh-list
92960988|NCT01056679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92960989|NCT01056679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92960990|NCT01056679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92960991|NCT01056679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92960992|NCT01056679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92960993|NCT01056679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92960994|NCT01056679|Immunologic Factors|immunologic factors|mesh-ancestor
92960995|NCT01056679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92960996|NCT01056679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92960997|NCT01056679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92960998|NCT01056679|Growth Substances|growth substances|mesh-ancestor
92960999|NCT01056679|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961000|NCT01056679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961001|NCT01056679|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961002|NCT01056679|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961003|NCT01056679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961004|NCT04769362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92961005|NCT04769362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92961006|NCT04769362|Adrenergic Agents|adrenergic agents|mesh-ancestor
92961007|NCT04769362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961008|NCT04769362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961009|NCT04769362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961010|NCT03983551|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92961011|NCT03983551|Protease Inhibitors|protease inhibitors|mesh-ancestor
92961012|NCT03983551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961013|NCT03983551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961014|NCT03983551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961015|NCT03983551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961016|NCT05709574|Tadalafil|tadalafil|mesh-list
92961017|NCT05709574|Vasodilator Agents|vasodilator agents|mesh-ancestor
92961018|NCT05709574|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92961019|NCT05709574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92961020|NCT05709574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961021|NCT05709574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961022|NCT05709574|Urological Agents|urological agents|mesh-ancestor
92961023|NCT05546242|Dolutegravir|dolutegravir|mesh-list
92961024|NCT05546242|Cabotegravir|cabotegravir|mesh-list
92961025|NCT05546242|Rilpivirine|rilpivirine|mesh-list
92961026|NCT05546242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92961027|NCT05546242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92961028|NCT05546242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92961029|NCT05546242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961030|NCT05546242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961031|NCT05546242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92961032|NCT05546242|Antiviral Agents|antiviral agents|mesh-ancestor
92961033|NCT05546242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961034|NCT05546242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92961035|NCT05546242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961036|NCT04690504|Melatonin|melatonin|mesh-list
92961037|NCT04690504|Antioxidants|antioxidants|mesh-ancestor
92961038|NCT04690504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961039|NCT04690504|Protective Agents|protective agents|mesh-ancestor
92961040|NCT04690504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961041|NCT04690504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961042|NCT00540124|Tadalafil|tadalafil|mesh-list
92961043|NCT00540124|Tamsulosin|tamsulosin|mesh-list
92961044|NCT00540124|Vasodilator Agents|vasodilator agents|mesh-ancestor
92961045|NCT00540124|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92961046|NCT00540124|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92961047|NCT00540124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165991|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
92961048|NCT00540124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961049|NCT00540124|Urological Agents|urological agents|mesh-ancestor
92961050|NCT00540124|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92961051|NCT00540124|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92961052|NCT00540124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92961053|NCT00540124|Adrenergic Agents|adrenergic agents|mesh-ancestor
92961054|NCT00540124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961055|NCT00540124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961057|NCT00540046|Trace Elements|trace elements|mesh-ancestor
92961058|NCT00540046|Micronutrients|micronutrients|mesh-ancestor
92961059|NCT00540046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961060|NCT05677126|Copper|copper|mesh-list
92961061|NCT05677126|Trace Elements|trace elements|mesh-list
92961062|NCT05677126|Selenious Acid|selenious acid|mesh-list
92961063|NCT05677126|Micronutrients|micronutrients|mesh-list
92961064|NCT05677126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961065|NCT04613830|Tramadol|tramadol|mesh-list
92961066|NCT04613830|Bupivacaine|bupivacaine|mesh-list
92961067|NCT04613830|Anesthetics, Local|anesthetics, local|mesh-ancestor
92961068|NCT04613830|Anesthetics|anesthetics|mesh-ancestor
92961069|NCT04613830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961070|NCT04613830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961071|NCT04613830|Sensory System Agents|sensory system agents|mesh-ancestor
92961072|NCT04613830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961073|NCT04613830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92961074|NCT04613830|Narcotics|narcotics|mesh-ancestor
92961075|NCT04613830|Analgesics|analgesics|mesh-ancestor
92961076|NCT00689936|Thalidomide|thalidomide|mesh-list
92961077|NCT00689936|Dexamethasone|dexamethasone|mesh-list
92961078|NCT00689936|Dexamethasone acetate|dexamethasone acetate|mesh-list
92961079|NCT00689936|Prednisone|prednisone|mesh-list
92961080|NCT00689936|Lenalidomide|lenalidomide|mesh-list
92961081|NCT00689936|Melphalan|melphalan|mesh-list
92961082|NCT00689936|BB 1101|bb 1101|mesh-list
92961083|NCT00689936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961084|NCT00689936|Antiemetics|antiemetics|mesh-ancestor
92961085|NCT00689936|Autonomic Agents|autonomic agents|mesh-ancestor
92961086|NCT00689936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961087|NCT00689936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961088|NCT00689936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961089|NCT00689936|Glucocorticoids|glucocorticoids|mesh-ancestor
92961090|NCT00689936|Hormones|hormones|mesh-ancestor
92961091|NCT00689936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961092|NCT00689936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92961093|NCT00689936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961094|NCT00689936|Protease Inhibitors|protease inhibitors|mesh-ancestor
92961095|NCT00689936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961096|NCT00689936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961097|NCT00689936|Immunologic Factors|immunologic factors|mesh-ancestor
92961098|NCT00689936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92961099|NCT00689936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92961100|NCT00689936|Growth Substances|growth substances|mesh-ancestor
92961101|NCT00689936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961102|NCT00689936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92961103|NCT00689936|Alkylating Agents|alkylating agents|mesh-ancestor
92961104|NCT00689936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92961105|NCT00689936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961106|NCT00689936|Leprostatic Agents|leprostatic agents|mesh-ancestor
92961107|NCT00689936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961108|NCT00689936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961109|NCT05661682|Zinc|zinc|mesh-list
92961110|NCT05661682|Copper|copper|mesh-list
92961111|NCT05661682|Manganese|manganese|mesh-list
92961112|NCT05661682|Trace Elements|trace elements|mesh-list
92961113|NCT05661682|Selenious Acid|selenious acid|mesh-list
92961114|NCT05661682|Micronutrients|micronutrients|mesh-list
92961115|NCT05661682|Copper Sulfate|copper sulfate|mesh-list
92961116|NCT05661682|Zinc Sulfate|zinc sulfate|mesh-list
92961117|NCT05661682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961118|NCT05661682|Astringents|astringents|mesh-ancestor
92961119|NCT05661682|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961120|NCT05661682|Antidotes|antidotes|mesh-ancestor
92961121|NCT05661682|Protective Agents|protective agents|mesh-ancestor
92961122|NCT05661682|Emetics|emetics|mesh-ancestor
92961123|NCT05661682|Autonomic Agents|autonomic agents|mesh-ancestor
92961124|NCT05661682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961125|NCT05661682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961126|NCT01563718|Naltrexone|naltrexone|mesh-list
92961127|NCT01563718|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92961128|NCT01563718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92961129|NCT01563718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961130|NCT01563718|Sensory System Agents|sensory system agents|mesh-ancestor
92961131|NCT01563718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961132|NCT05473234|Amoxicillin|amoxicillin|mesh-list
92961133|NCT05473234|Azithromycin|azithromycin|mesh-list
92961134|NCT05473234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961135|NCT05473234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961136|NCT04500418|Cenicriviroc|cenicriviroc|mesh-list
92961137|NCT04500418|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92961138|NCT04500418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961139|NCT04500418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92961140|NCT04500418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92961141|NCT04500418|Antiviral Agents|antiviral agents|mesh-ancestor
92961142|NCT04500418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961144|NCT00671034|Dexamethasone|dexamethasone|mesh-list
92961145|NCT00671034|Dexamethasone acetate|dexamethasone acetate|mesh-list
92961146|NCT00671034|Prednisone|prednisone|mesh-list
92961147|NCT00671034|Cortisone|cortisone|mesh-list
92961148|NCT00671034|Cyclophosphamide|cyclophosphamide|mesh-list
92961149|NCT00671034|Doxorubicin|doxorubicin|mesh-list
92961150|NCT00671034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92961151|NCT00671034|Methotrexate|methotrexate|mesh-list
92961152|NCT00671034|Vincristine|vincristine|mesh-list
92961153|NCT00671034|Daunorubicin|daunorubicin|mesh-list
92961154|NCT00671034|Asparaginase|asparaginase|mesh-list
92961155|NCT00671034|Mercaptopurine|mercaptopurine|mesh-list
92961156|NCT00671034|Pegaspargase|pegaspargase|mesh-list
92961157|NCT00671034|Thioguanine|thioguanine|mesh-list
92961158|NCT00671034|BB 1101|bb 1101|mesh-list
92961159|NCT00671034|2-Aminopurine|2-aminopurine|mesh-list
92961160|NCT00671034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961161|NCT00671034|Immunologic Factors|immunologic factors|mesh-ancestor
92961162|NCT00671034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961163|NCT00671034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961164|NCT00671034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92961165|NCT00671034|Alkylating Agents|alkylating agents|mesh-ancestor
92961166|NCT00671034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961167|NCT00671034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961168|NCT00671034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92961169|NCT00671034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961170|NCT00671034|Antiemetics|antiemetics|mesh-ancestor
92961171|NCT00671034|Autonomic Agents|autonomic agents|mesh-ancestor
92961172|NCT00671034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961173|NCT00671034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961174|NCT00671034|Glucocorticoids|glucocorticoids|mesh-ancestor
92961175|NCT00671034|Hormones|hormones|mesh-ancestor
92961176|NCT00671034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961177|NCT00671034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92961178|NCT00671034|Protease Inhibitors|protease inhibitors|mesh-ancestor
92961179|NCT00671034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961180|NCT00671034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92961181|NCT00671034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92961182|NCT00671034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92961183|NCT00671034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92961184|NCT00671034|Abortifacient Agents|abortifacient agents|mesh-ancestor
92961185|NCT00671034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961186|NCT00671034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961187|NCT00671034|Antimetabolites|antimetabolites|mesh-ancestor
92961188|NCT00671034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961189|NCT00671034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92961190|NCT00671034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961191|NCT00671034|Antiviral Agents|antiviral agents|mesh-ancestor
92961192|NCT00671034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961193|NCT00671034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961194|NCT00671034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961195|NCT00671034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961196|NCT00671034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961197|NCT04425070|Carboplatin|carboplatin|mesh-list
92961198|NCT04425070|Gemcitabine|gemcitabine|mesh-list
92961199|NCT04425070|Oxaliplatin|oxaliplatin|mesh-list
92961200|NCT04425070|Etoposide|etoposide|mesh-list
92961201|NCT04425070|Ifosfamide|ifosfamide|mesh-list
92961202|NCT04425070|Tislelizumab|tislelizumab|mesh-list
92961203|NCT04425070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961204|NCT04425070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961205|NCT04425070|Antimetabolites|antimetabolites|mesh-ancestor
92961206|NCT04425070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961207|NCT04425070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961208|NCT04425070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92961209|NCT04425070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92961210|NCT04425070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961211|NCT04425070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92961212|NCT04425070|Alkylating Agents|alkylating agents|mesh-ancestor
92961213|NCT04425070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961214|NCT00743678|Cetuximab|cetuximab|mesh-list
92961215|NCT00743678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961217|NCT02679508|Lansoprazole|lansoprazole|mesh-list
92961218|NCT02679508|Dexlansoprazole|dexlansoprazole|mesh-list
92961219|NCT02679508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92961220|NCT02679508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961221|NCT02679508|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92961222|NCT02679508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961223|NCT02679508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961224|NCT00775632|Cyclosporine|cyclosporine|mesh-list
92961225|NCT00775632|Methotrexate|methotrexate|mesh-list
92961226|NCT00775632|Alemtuzumab|alemtuzumab|mesh-list
92961227|NCT00775632|Cyclosporins|cyclosporins|mesh-list
92961228|NCT00775632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92961229|NCT00775632|Abortifacient Agents|abortifacient agents|mesh-ancestor
92961230|NCT00775632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961231|NCT00775632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961232|NCT00775632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961233|NCT00775632|Antimetabolites|antimetabolites|mesh-ancestor
92961234|NCT00775632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961235|NCT00775632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961236|NCT00775632|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961237|NCT00775632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961238|NCT00775632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92961239|NCT00775632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961240|NCT00775632|Immunologic Factors|immunologic factors|mesh-ancestor
92961241|NCT00775632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961242|NCT00775632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961243|NCT00775632|Antifungal Agents|antifungal agents|mesh-ancestor
92961244|NCT00775632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961245|NCT00775632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92961246|NCT00775632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961247|NCT04047654|Anticoagulants|anticoagulants|mesh-list
92961248|NCT00772356|Insulin|insulin|mesh-list
92961249|NCT00772356|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92961250|NCT00772356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961251|NCT00772356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961252|NCT04394182|Ritonavir|ritonavir|mesh-list
92961253|NCT04394182|Lopinavir|lopinavir|mesh-list
92961254|NCT04394182|Azithromycin|azithromycin|mesh-list
92961255|NCT04394182|Hydroxychloroquine|hydroxychloroquine|mesh-list
92961256|NCT04394182|Tazobactam|tazobactam|mesh-list
92961257|NCT04394182|Piperacillin|piperacillin|mesh-list
92961258|NCT04394182|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92961259|NCT04394182|Heparin|heparin|mesh-list
92961260|NCT04394182|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92961261|NCT04394182|Tinzaparin|tinzaparin|mesh-list
92961262|NCT04394182|Dalteparin|dalteparin|mesh-list
92961263|NCT04394182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92961264|NCT04394182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92961265|NCT04394182|Protease Inhibitors|protease inhibitors|mesh-ancestor
92961266|NCT04394182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961267|NCT04394182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961268|NCT04394182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92961269|NCT04394182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92961270|NCT04394182|Antiviral Agents|antiviral agents|mesh-ancestor
92961271|NCT04394182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961272|NCT04394182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92961273|NCT04394182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92961274|NCT04394182|Anticoagulants|anticoagulants|mesh-ancestor
92961275|NCT04394182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92961276|NCT04394182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92961277|NCT04394182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961278|NCT04394182|Antimalarials|antimalarials|mesh-ancestor
92961279|NCT04394182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92961280|NCT04394182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92961281|NCT04394182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961282|NCT04394182|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92961283|NCT05386576|Venetoclax|venetoclax|mesh-list
92961284|NCT05386576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961285|NCT04146922|Anti-Infective Agents|anti-infective agents|mesh-list
92961286|NCT04146922|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92961287|NCT05325580|Magnesium Sulfate|magnesium sulfate|mesh-list
92961288|NCT05325580|Analgesics|analgesics|mesh-ancestor
92961289|NCT05325580|Sensory System Agents|sensory system agents|mesh-ancestor
92606688|NCT01249846|Chlorhexidine|chlorhexidine|mesh-list
92961290|NCT05325580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961291|NCT05325580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961292|NCT05325580|Anesthetics|anesthetics|mesh-ancestor
92961293|NCT05325580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961294|NCT05325580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92961295|NCT05325580|Anticonvulsants|anticonvulsants|mesh-ancestor
92961296|NCT05325580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92961297|NCT05325580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961298|NCT05325580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961299|NCT05325580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92961300|NCT05325580|Tocolytic Agents|tocolytic agents|mesh-ancestor
92961301|NCT05325580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961302|NCT00539734|Ranibizumab|ranibizumab|mesh-list
92961303|NCT00539734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92961304|NCT00539734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92961305|NCT00539734|Growth Substances|growth substances|mesh-ancestor
92961306|NCT00539734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961307|NCT00539734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961308|NCT00539734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961309|NCT04004572|Pegaspargase|pegaspargase|mesh-list
92961310|NCT04004572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961311|NCT04050436|Cemiplimab|cemiplimab|mesh-list
92961312|NCT04050436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961313|NCT04050436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961314|NCT01093976|Dronabinol|dronabinol|mesh-list
92961315|NCT01093976|Hallucinogens|hallucinogens|mesh-ancestor
92961316|NCT01093976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961317|NCT01093976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92961318|NCT01093976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92961319|NCT01093976|Analgesics|analgesics|mesh-ancestor
92961320|NCT01093976|Sensory System Agents|sensory system agents|mesh-ancestor
92961321|NCT01093976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961322|NCT01093976|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92961323|NCT01093976|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92961324|NCT01093976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961325|NCT01093976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961326|NCT01093976|Hormones|hormones|mesh-ancestor
92961327|NCT01093976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961328|NCT00329719|Sirolimus|sirolimus|mesh-list
92961329|NCT00329719|Sorafenib|sorafenib|mesh-list
92961330|NCT00329719|Temsirolimus|temsirolimus|mesh-list
92961331|NCT00329719|MTOR Inhibitors|mtor inhibitors|mesh-list
92961332|NCT00329719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961333|NCT00329719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92961334|NCT00329719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961335|NCT00329719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961337|NCT00329719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961338|NCT00329719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92961339|NCT00329719|Antifungal Agents|antifungal agents|mesh-ancestor
92961340|NCT00329719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961341|NCT00329719|Immunologic Factors|immunologic factors|mesh-ancestor
92961342|NCT00329719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961343|NCT04008628|Nitrous Oxide|nitrous oxide|mesh-list
92961344|NCT04008628|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92961345|NCT04008628|Anesthetics, General|anesthetics, general|mesh-ancestor
92961346|NCT04008628|Anesthetics|anesthetics|mesh-ancestor
92961347|NCT04008628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961348|NCT04008628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961349|NCT04008628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92961350|NCT04008628|Analgesics|analgesics|mesh-ancestor
92961351|NCT04008628|Sensory System Agents|sensory system agents|mesh-ancestor
92961352|NCT04008628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961353|NCT00743834|Fluvoxamine|fluvoxamine|mesh-list
92961354|NCT00743834|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92961355|NCT00743834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92961356|NCT00743834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961357|NCT00743834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961358|NCT00743834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92961359|NCT00743834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92961360|NCT00743834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92961361|NCT00743834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961362|NCT00743834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961363|NCT00743834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961364|NCT00743834|Serotonin Agents|serotonin agents|mesh-ancestor
92961365|NCT00743834|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92961366|NCT00743834|Antidepressive Agents|antidepressive agents|mesh-ancestor
92961367|NCT00743834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92961368|NCT00743834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92961369|NCT00743834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961370|NCT00743834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92961371|NCT00743912|Rifaximin|rifaximin|mesh-list
92961372|NCT00743912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961373|NCT00743912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961374|NCT00743912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961375|NCT04060472|Paclitaxel|paclitaxel|mesh-list
92961376|NCT04060472|Oxaliplatin|oxaliplatin|mesh-list
92961377|NCT04060472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92961378|NCT04060472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961379|NCT04060472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961380|NCT04060472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961381|NCT04060472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961382|NCT04060472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961383|NCT04060472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961384|NCT00329641|Paclitaxel|paclitaxel|mesh-list
92961385|NCT00329641|Carboplatin|carboplatin|mesh-list
92961386|NCT00329641|Sorafenib|sorafenib|mesh-list
92961387|NCT00329641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961388|NCT00329641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961389|NCT00329641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961390|NCT00329641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961391|NCT00329641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961392|NCT00329641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961393|NCT00329641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92961394|NCT00329641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961395|NCT02533219|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92961396|NCT02533219|Dopamine Agents|dopamine agents|mesh-ancestor
92961397|NCT02533219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961398|NCT02533219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961399|NCT02533219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961400|NCT00743990|Camphor|camphor|mesh-list
92961401|NCT00743990|Menthol|menthol|mesh-list
92961402|NCT00743990|Petrolatum|petrolatum|mesh-list
92961403|NCT00743990|Antipruritics|antipruritics|mesh-ancestor
92961404|NCT00743990|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961405|NCT00743990|Emollients|emollients|mesh-ancestor
92961406|NCT00743990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92961407|NCT00743990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961408|NCT00329407|Topiramate|topiramate|mesh-list
92961409|NCT00329407|Anticonvulsants|anticonvulsants|mesh-ancestor
92961410|NCT00329407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961411|NCT00329407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961412|NCT01056757|Ribavirin|ribavirin|mesh-list
92961413|NCT01056757|Antimetabolites|antimetabolites|mesh-ancestor
92961414|NCT01056757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961415|NCT01056757|Antiviral Agents|antiviral agents|mesh-ancestor
92961416|NCT01056757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961417|NCT01056835|Epoprostenol|epoprostenol|mesh-list
92166019|NCT04963998|Copper|copper|mesh-list
92961418|NCT01056835|Tezosentan|tezosentan|mesh-list
92961419|NCT01056835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92961420|NCT01056835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92961421|NCT01056835|Vasodilator Agents|vasodilator agents|mesh-ancestor
92961422|NCT03986515|Apatinib|apatinib|mesh-list
92961423|NCT03986515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961424|NCT03986515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92961425|NCT03986515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961426|NCT03986515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961427|NCT00567489|Icodextrin|icodextrin|mesh-list
92961428|NCT00567489|Dialysis Solutions|dialysis solutions|mesh-ancestor
92961429|NCT00567489|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92961430|NCT02538393|Sorafenib|sorafenib|mesh-list
92961431|NCT02538393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961432|NCT02538393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92961433|NCT02538393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961434|NCT02538393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961435|NCT00924963|Lidocaine|lidocaine|mesh-list
92961436|NCT00924963|Anesthetics, Local|anesthetics, local|mesh-ancestor
92961437|NCT00924963|Anesthetics|anesthetics|mesh-ancestor
92961438|NCT00924963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961439|NCT00924963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961440|NCT00924963|Sensory System Agents|sensory system agents|mesh-ancestor
92961441|NCT00924963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961442|NCT00924963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92961443|NCT00924963|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92961444|NCT00924963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92961445|NCT00924963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961446|NCT00924963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961447|NCT00669864|Metformin|metformin|mesh-list
92961448|NCT00669864|Insulin Aspart|insulin aspart|mesh-list
92961449|NCT00669864|Biphasic Insulins|biphasic insulins|mesh-list
92961450|NCT00669864|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92961451|NCT00669864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961452|NCT00669864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961453|NCT00770172|Lenograstim|lenograstim|mesh-list
92961454|NCT00770172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92961455|NCT00770172|Immunologic Factors|immunologic factors|mesh-ancestor
92961456|NCT00770172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961457|NCT00776022|Cetirizine|cetirizine|mesh-list
92961458|NCT00776022|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92961459|NCT00776022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92961460|NCT00776022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92961461|NCT00776022|Histamine Antagonists|histamine antagonists|mesh-ancestor
92961462|NCT00776022|Histamine Agents|histamine agents|mesh-ancestor
92961463|NCT00776022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961464|NCT00776022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961465|NCT00776022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961466|NCT00772902|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92961467|NCT00772902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92961468|NCT00772902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961469|NCT00772902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961470|NCT00772902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961471|NCT00772902|Antiviral Agents|antiviral agents|mesh-ancestor
92961472|NCT00772902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961473|NCT00772902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92961474|NCT00772902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92961475|NCT00779220|Methotrexate|methotrexate|mesh-list
92961476|NCT00779220|Ocrelizumab|ocrelizumab|mesh-list
92306468|NCT00004233|Leucovorin|leucovorin|mesh-list
92961477|NCT00779220|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92961478|NCT00779220|Abortifacient Agents|abortifacient agents|mesh-ancestor
92961479|NCT00779220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961480|NCT00779220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961481|NCT00779220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961482|NCT00779220|Antimetabolites|antimetabolites|mesh-ancestor
92961483|NCT00779220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961484|NCT00779220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961485|NCT00779220|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961486|NCT00779220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961487|NCT00779220|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92961488|NCT00779220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961489|NCT00779220|Immunologic Factors|immunologic factors|mesh-ancestor
92961490|NCT00779220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961491|NCT00779220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961493|NCT00779376|Antimetabolites|antimetabolites|mesh-ancestor
92961494|NCT00779376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961495|NCT00779376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92961496|NCT00779376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961497|NCT00779376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961498|NCT00779376|Antiviral Agents|antiviral agents|mesh-ancestor
92961499|NCT00779376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961500|NCT00779376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92961501|NCT00779376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92961502|NCT00779454|Gemcitabine|gemcitabine|mesh-list
92961503|NCT00779454|Capecitabine|capecitabine|mesh-list
92961504|NCT00779454|Oxaliplatin|oxaliplatin|mesh-list
92961505|NCT00779454|Panitumumab|panitumumab|mesh-list
92961506|NCT00779454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961507|NCT00779454|Antimetabolites|antimetabolites|mesh-ancestor
92961508|NCT00779454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961509|NCT00779454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961510|NCT00779454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961511|NCT00773058|Hydrocortisone|hydrocortisone|mesh-list
92961512|NCT00773058|Glucocorticoids|glucocorticoids|mesh-list
92961513|NCT00773058|Hormones|hormones|mesh-ancestor
92961514|NCT00773058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961515|NCT00773058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961516|NCT00773058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961518|NCT00776334|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92961519|NCT00776334|Protease Inhibitors|protease inhibitors|mesh-ancestor
92961520|NCT00776334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961521|NCT00776334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961522|NCT00776334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92961523|NCT00668148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92961524|NCT00668148|Immunologic Factors|immunologic factors|mesh-ancestor
92961525|NCT00668148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961526|NCT00667992|Budesonide|budesonide|mesh-list
92961527|NCT00667992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961528|NCT00667992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92961529|NCT00667992|Autonomic Agents|autonomic agents|mesh-ancestor
92961530|NCT00667992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961531|NCT00667992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961532|NCT00667992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92961533|NCT00667992|Respiratory System Agents|respiratory system agents|mesh-ancestor
92961534|NCT00667992|Glucocorticoids|glucocorticoids|mesh-ancestor
92961535|NCT00667992|Hormones|hormones|mesh-ancestor
92961536|NCT00667992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961537|NCT00776490|Glimepiride|glimepiride|mesh-list
92961538|NCT00776490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92961539|NCT00776490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961540|NCT00776490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961541|NCT00776490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961542|NCT00776490|Immunologic Factors|immunologic factors|mesh-ancestor
92961543|NCT00776568|Antihypertensive Agents|antihypertensive agents|mesh-list
92961544|NCT00779922|Lenalidomide|lenalidomide|mesh-list
92961545|NCT00779922|Immunologic Factors|immunologic factors|mesh-ancestor
92961546|NCT00779922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961547|NCT00779922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92961548|NCT00779922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92961549|NCT00779922|Growth Substances|growth substances|mesh-ancestor
92961550|NCT00779922|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961551|NCT00779922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961552|NCT00776646|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92961553|NCT00776646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92961554|NCT00776646|Diuretics|diuretics|mesh-ancestor
92961555|NCT00776646|Natriuretic Agents|natriuretic agents|mesh-ancestor
92961556|NCT00776646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961557|NCT00776646|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92961558|NCT00776646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961559|NCT00776646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961560|NCT00776724|Docetaxel|docetaxel|mesh-list
92961561|NCT00776724|Epirubicin|epirubicin|mesh-list
92961562|NCT00776724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961563|NCT00776724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961564|NCT00776724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961565|NCT00776724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961566|NCT00776724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961567|NCT00776724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92961568|NCT00776724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92961569|NCT00776724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92961570|NCT00776724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961571|NCT00776802|Dexamethasone|dexamethasone|mesh-list
92961572|NCT00776802|Etoposide|etoposide|mesh-list
92961573|NCT00776802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961574|NCT00776802|Antiemetics|antiemetics|mesh-ancestor
92961575|NCT00776802|Autonomic Agents|autonomic agents|mesh-ancestor
92961576|NCT00776802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961577|NCT00776802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961578|NCT00776802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961579|NCT00776802|Glucocorticoids|glucocorticoids|mesh-ancestor
92961580|NCT00776802|Hormones|hormones|mesh-ancestor
92961581|NCT00776802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961582|NCT00776802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92961583|NCT00776802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961584|NCT00776802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961585|NCT00776802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92961586|NCT00776802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92961587|NCT00776802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961588|NCT00776802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961589|NCT00773916|Methylphenidate|methylphenidate|mesh-list
92606993|NCT00403442|Bevacizumab|bevacizumab|mesh-list
92961590|NCT00773916|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92961591|NCT00773916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961592|NCT00773916|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92961593|NCT00773916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92961594|NCT00773916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961595|NCT00773916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961596|NCT00773916|Dopamine Agents|dopamine agents|mesh-ancestor
92961597|NCT00773916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961598|NCT00774072|Tobramycin|tobramycin|mesh-list
92961599|NCT00774072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961600|NCT00774072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961601|NCT00780780|Triamcinolone|triamcinolone|mesh-list
92961602|NCT00780780|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92961603|NCT00780780|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92961604|NCT00780780|Nepafenac|nepafenac|mesh-list
92961605|NCT00780780|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92961606|NCT00780780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961607|NCT00780780|Glucocorticoids|glucocorticoids|mesh-ancestor
92961608|NCT00780780|Hormones|hormones|mesh-ancestor
92961609|NCT00780780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961610|NCT00780780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961611|NCT00780780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961612|NCT00780780|Immunologic Factors|immunologic factors|mesh-ancestor
92961613|NCT00780780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961614|NCT00780780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961615|NCT00780780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92961616|NCT00780780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92961617|NCT00780780|Analgesics|analgesics|mesh-ancestor
92961618|NCT00780780|Sensory System Agents|sensory system agents|mesh-ancestor
92961620|NCT00780780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961621|NCT00780858|Ganirelix|ganirelix|mesh-list
92961622|NCT00780858|Hormone Antagonists|hormone antagonists|mesh-ancestor
92961623|NCT00780858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961624|NCT00780858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961625|NCT00777114|Bortezomib|bortezomib|mesh-list
92961626|NCT00777114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961627|NCT00669396|Copper|copper|mesh-list
92961628|NCT00669396|Levonorgestrel|levonorgestrel|mesh-list
92961629|NCT00669396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92961630|NCT00669396|Contraceptive Agents|contraceptive agents|mesh-ancestor
92961631|NCT00669396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961632|NCT00669396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961633|NCT00669396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92961634|NCT00669396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92961635|NCT00669396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92961636|NCT00669396|Trace Elements|trace elements|mesh-ancestor
92961637|NCT00669396|Micronutrients|micronutrients|mesh-ancestor
92961638|NCT00774462|Rituximab|rituximab|mesh-list
92961639|NCT00774462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961640|NCT00774462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961641|NCT00774462|Immunologic Factors|immunologic factors|mesh-ancestor
92961642|NCT00774462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961643|NCT00774462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961644|NCT00669318|Rituximab|rituximab|mesh-list
92961645|NCT00669318|Alemtuzumab|alemtuzumab|mesh-list
92961646|NCT00669318|Pentostatin|pentostatin|mesh-list
92961647|NCT00669318|Sargramostim|sargramostim|mesh-list
92961648|NCT00669318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961649|NCT00669318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961650|NCT00669318|Immunologic Factors|immunologic factors|mesh-ancestor
92961651|NCT00669318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961652|NCT00669318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961653|NCT00669318|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92961654|NCT00669318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961655|NCT00669318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961656|NCT00774540|Ketorolac|ketorolac|mesh-list
92961657|NCT00774540|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92961658|NCT00774540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92961659|NCT00774540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92961660|NCT00774540|Analgesics|analgesics|mesh-ancestor
92961661|NCT00774540|Sensory System Agents|sensory system agents|mesh-ancestor
92607074|NCT03500913|Hormones|hormones|mesh-list
92961662|NCT00774540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961663|NCT00774540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961664|NCT00774540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961665|NCT00774540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961666|NCT00774540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92961667|NCT00774540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026486|NCT00401973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961668|NCT00774540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961669|NCT00669240|Varenicline|varenicline|mesh-list
92961670|NCT00669240|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92961671|NCT00669240|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92961672|NCT00669240|Cholinergic Agents|cholinergic agents|mesh-ancestor
92961673|NCT00669240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961674|NCT00669240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961675|NCT00669240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961676|NCT00669162|Docetaxel|docetaxel|mesh-list
92961677|NCT00669162|Leuprolide|leuprolide|mesh-list
92961678|NCT00669162|Goserelin|goserelin|mesh-list
92961679|NCT00669162|Bicalutamide|bicalutamide|mesh-list
92961680|NCT00669162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961681|NCT00669162|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961682|NCT00669162|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961683|NCT00669162|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961684|NCT00669162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961685|NCT00669162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92961686|NCT00669162|Fertility Agents|fertility agents|mesh-ancestor
92961687|NCT00669162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961688|NCT00669162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961689|NCT00669162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92961690|NCT00669162|Androgen Antagonists|androgen antagonists|mesh-ancestor
92961691|NCT00669162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92961692|NCT00669162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961693|NCT00774696|Clarithromycin|clarithromycin|mesh-list
92961694|NCT00774696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961695|NCT00774696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961696|NCT00774696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92961697|NCT00774696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961698|NCT00774696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961699|NCT00774696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92961700|NCT00774696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92961701|NCT02556060|Lamotrigine|lamotrigine|mesh-list
92961702|NCT02556060|Anticonvulsants|anticonvulsants|mesh-ancestor
92961703|NCT02556060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92961704|NCT02556060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961705|NCT02556060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961706|NCT02556060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92961707|NCT02556060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961708|NCT02556060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92961709|NCT02556060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92961710|NCT02556060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961711|NCT02556060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92961712|NCT02556060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92961714|NCT00400946|Cytarabine|cytarabine|mesh-list
92961715|NCT00400946|Dexamethasone|dexamethasone|mesh-list
92961716|NCT00400946|Methylprednisolone|methylprednisolone|mesh-list
92961717|NCT00400946|Prednisolone|prednisolone|mesh-list
92961718|NCT00400946|Hydrocortisone|hydrocortisone|mesh-list
92961719|NCT00400946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92961720|NCT00400946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92961721|NCT00400946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92961722|NCT00400946|Cyclophosphamide|cyclophosphamide|mesh-list
92961723|NCT00400946|Doxorubicin|doxorubicin|mesh-list
92961724|NCT00400946|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92961725|NCT00400946|Methotrexate|methotrexate|mesh-list
92961726|NCT00400946|Etoposide|etoposide|mesh-list
92961727|NCT00400946|Vincristine|vincristine|mesh-list
92961728|NCT00400946|Asparaginase|asparaginase|mesh-list
92961729|NCT00400946|Mercaptopurine|mercaptopurine|mesh-list
92961730|NCT00400946|Pegaspargase|pegaspargase|mesh-list
92961731|NCT00400946|Dexrazoxane|dexrazoxane|mesh-list
92961732|NCT00400946|Razoxane|razoxane|mesh-list
92961733|NCT00400946|Levoleucovorin|levoleucovorin|mesh-list
92961734|NCT00400946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961735|NCT00400946|Immunologic Factors|immunologic factors|mesh-ancestor
92961736|NCT00400946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961737|NCT00400946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961738|NCT00400946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92961739|NCT00400946|Alkylating Agents|alkylating agents|mesh-ancestor
92961740|NCT00400946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961741|NCT00400946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961742|NCT00400946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92961743|NCT00400946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961745|NCT00400946|Autonomic Agents|autonomic agents|mesh-ancestor
92961746|NCT00400946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961747|NCT00400946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961748|NCT00400946|Glucocorticoids|glucocorticoids|mesh-ancestor
92961749|NCT00400946|Hormones|hormones|mesh-ancestor
92961750|NCT00400946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961751|NCT00400946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92961752|NCT00400946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92961753|NCT00400946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92961754|NCT00400946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92961755|NCT00400946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961756|NCT00400946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92961757|NCT00400946|Abortifacient Agents|abortifacient agents|mesh-ancestor
92961758|NCT00400946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92961759|NCT00400946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961760|NCT00400946|Antimetabolites|antimetabolites|mesh-ancestor
92961761|NCT00400946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961762|NCT00400946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92961763|NCT00400946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92961764|NCT00400946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961765|NCT00400946|Antiviral Agents|antiviral agents|mesh-ancestor
92961766|NCT00400946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961767|NCT00400946|Antidotes|antidotes|mesh-ancestor
92961768|NCT00400946|Protective Agents|protective agents|mesh-ancestor
92961770|NCT00400946|Vitamins|vitamins|mesh-ancestor
92961771|NCT00400946|Micronutrients|micronutrients|mesh-ancestor
92961772|NCT00400946|Tubulin Modulators|tubulin modulators|mesh-ancestor
92961773|NCT00400946|Antimitotic Agents|antimitotic agents|mesh-ancestor
92961774|NCT00400946|Mitosis Modulators|mitosis modulators|mesh-ancestor
92961775|NCT00400946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92961776|NCT00400946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92961777|NCT00354770|Acetylcysteine|acetylcysteine|mesh-list
92961778|NCT00354770|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92961779|NCT00354770|Antiviral Agents|antiviral agents|mesh-ancestor
92961780|NCT00354770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961781|NCT00354770|Expectorants|expectorants|mesh-ancestor
92961782|NCT00354770|Respiratory System Agents|respiratory system agents|mesh-ancestor
92961783|NCT00354770|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92961784|NCT00354770|Antioxidants|antioxidants|mesh-ancestor
92961785|NCT00354770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961786|NCT00354770|Protective Agents|protective agents|mesh-ancestor
92961787|NCT00354770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961788|NCT00354770|Antidotes|antidotes|mesh-ancestor
92961789|NCT00744224|Exenatide|exenatide|mesh-list
92961790|NCT00744224|Prednisolone|prednisolone|mesh-list
92961791|NCT00744224|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92961792|NCT00744224|Methylprednisolone|methylprednisolone|mesh-list
92961793|NCT00744224|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92961794|NCT00744224|Prednisolone acetate|prednisolone acetate|mesh-list
92961795|NCT00744224|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92961796|NCT00744224|Prednisolone phosphate|prednisolone phosphate|mesh-list
92961797|NCT00744224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961798|NCT00744224|Glucocorticoids|glucocorticoids|mesh-ancestor
92961799|NCT00744224|Hormones|hormones|mesh-ancestor
92961800|NCT00744224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961801|NCT00744224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961802|NCT00744224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92961803|NCT00744224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961804|NCT00744224|Antiemetics|antiemetics|mesh-ancestor
92961805|NCT00744224|Autonomic Agents|autonomic agents|mesh-ancestor
92961806|NCT00744224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961807|NCT00744224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961808|NCT00744224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92961809|NCT00744224|Protective Agents|protective agents|mesh-ancestor
92961810|NCT00744224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961811|NCT00744224|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92961812|NCT00744224|Incretins|incretins|mesh-ancestor
92961813|NCT00744302|Dialysis Solutions|dialysis solutions|mesh-list
92961814|NCT00744302|Calcium|calcium|mesh-list
92607226|NCT00131144|Octreotide|octreotide|mesh-list
92961815|NCT00744302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92961816|NCT00744302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961817|NCT00744302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92961818|NCT00666588|Cytarabine|cytarabine|mesh-list
92961819|NCT00666588|Etoposide|etoposide|mesh-list
92961820|NCT00666588|Idarubicin|idarubicin|mesh-list
92961821|NCT00666588|Etoposide phosphate|etoposide phosphate|mesh-list
92961822|NCT00666588|Bortezomib|bortezomib|mesh-list
92961823|NCT00666588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92961824|NCT00666588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961825|NCT00666588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92961826|NCT00666588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92961827|NCT00666588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961828|NCT00666588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961829|NCT00666588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961830|NCT00666588|Antimetabolites|antimetabolites|mesh-ancestor
92961831|NCT00666588|Antiviral Agents|antiviral agents|mesh-ancestor
92961832|NCT00666588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961833|NCT00666588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961834|NCT00666588|Immunologic Factors|immunologic factors|mesh-ancestor
92961835|NCT00666588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961836|NCT00666588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92961837|NCT00689390|Ribavirin|ribavirin|mesh-list
92961838|NCT00689390|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92961839|NCT00689390|Antimetabolites|antimetabolites|mesh-ancestor
92961840|NCT00689390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961841|NCT00689390|Antiviral Agents|antiviral agents|mesh-ancestor
92961842|NCT00689390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961843|NCT00567879|Trastuzumab|trastuzumab|mesh-list
92961844|NCT00567879|Panobinostat|panobinostat|mesh-list
92961845|NCT00567879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961846|NCT00567879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961847|NCT00567879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92961848|NCT00567879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961849|NCT00567879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961850|NCT00781404|Adenosine|adenosine|mesh-list
92961851|NCT00781404|Analgesics|analgesics|mesh-ancestor
92961852|NCT00781404|Sensory System Agents|sensory system agents|mesh-ancestor
92961853|NCT00781404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961854|NCT00781404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961855|NCT00781404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92961856|NCT00781404|Vasodilator Agents|vasodilator agents|mesh-ancestor
92961857|NCT00781404|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92961858|NCT00781404|Purinergic Agonists|purinergic agonists|mesh-ancestor
92961859|NCT00781404|Purinergic Agents|purinergic agents|mesh-ancestor
92961860|NCT00781404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961861|NCT00781404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961862|NCT00777504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92961863|NCT00777504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92961864|NCT00777504|Growth Substances|growth substances|mesh-ancestor
92961865|NCT00777504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961866|NCT00777504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961867|NCT00777504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961868|NCT00781482|Zolpidem|zolpidem|mesh-list
92961869|NCT00781482|Eszopiclone|eszopiclone|mesh-list
92961870|NCT00781482|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92961871|NCT00781482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92961872|NCT00781482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92961873|NCT00781482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961874|NCT00781482|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92961875|NCT00781482|GABA Agonists|gaba agonists|mesh-ancestor
92961876|NCT00781482|GABA Agents|gaba agents|mesh-ancestor
92961877|NCT00781482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961878|NCT00781482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961879|NCT00603915|Carboplatin|carboplatin|mesh-list
92961880|NCT00603915|Gemcitabine|gemcitabine|mesh-list
92961881|NCT00603915|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92961882|NCT00603915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961883|NCT00603915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961884|NCT00603915|Antimetabolites|antimetabolites|mesh-ancestor
92961885|NCT00603915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961886|NCT00603915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92961887|NCT00603915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961888|NCT00929487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92961889|NCT00925977|Insulin|insulin|mesh-list
92961890|NCT00925977|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92961891|NCT00925977|Insulin Glargine|insulin glargine|mesh-list
92961892|NCT00925977|Insulin glulisine|insulin glulisine|mesh-list
92961893|NCT00925977|Isophane Insulin, Human|isophane insulin, human|mesh-list
92961894|NCT00925977|Insulin, Isophane|insulin, isophane|mesh-list
92961895|NCT00925977|Isophane insulin, beef|isophane insulin, beef|mesh-list
92961896|NCT00925977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961897|NCT00925977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961898|NCT00926055|Simvastatin|simvastatin|mesh-list
92961900|NCT00926055|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92961901|NCT00926055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92961902|NCT00926055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92961903|NCT00926055|Antimetabolites|antimetabolites|mesh-ancestor
92961904|NCT00926055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961905|NCT00926055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92961906|NCT00926055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92961907|NCT00926055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961908|NCT04034199|Zoledronic Acid|zoledronic acid|mesh-list
92961909|NCT04034199|Denosumab|denosumab|mesh-list
92961910|NCT04034199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92961911|NCT04034199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961912|NCT02538237|Ibuprofen|ibuprofen|mesh-list
92961913|NCT02538237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92961914|NCT02538237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92961915|NCT02538237|Analgesics|analgesics|mesh-ancestor
92961916|NCT02538237|Sensory System Agents|sensory system agents|mesh-ancestor
92961917|NCT02538237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961918|NCT02538237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961919|NCT02538237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961920|NCT02538237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961921|NCT02538237|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92961922|NCT02538237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961923|NCT02538237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961924|NCT00691028|Infliximab|infliximab|mesh-list
92961925|NCT00691028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92961926|NCT00691028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92961927|NCT00691028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92961928|NCT00691028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92961929|NCT00691028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92961930|NCT00690794|Travoprost|travoprost|mesh-list
92961931|NCT00690794|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92961932|NCT00690794|Latanoprost|latanoprost|mesh-list
92961933|NCT00690794|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92961934|NCT00690794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92961935|NCT00666276|Linezolid|linezolid|mesh-list
92961936|NCT00666276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92961937|NCT00666276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92961938|NCT00666276|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92961939|NCT00666276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961940|NCT00666276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961941|NCT00567255|Naltrexone|naltrexone|mesh-list
92961942|NCT00567255|Bupropion|bupropion|mesh-list
92961943|NCT00567255|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92961944|NCT00567255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92961945|NCT00567255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961946|NCT00567255|Sensory System Agents|sensory system agents|mesh-ancestor
92961947|NCT00567255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92961948|NCT00567255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92961949|NCT00567255|Antidepressive Agents|antidepressive agents|mesh-ancestor
92961950|NCT00567255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92961951|NCT00567255|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92961952|NCT00567255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92961953|NCT00567255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92961954|NCT00567255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961955|NCT00567255|Dopamine Agents|dopamine agents|mesh-ancestor
92961956|NCT00567255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92961957|NCT00567255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92961958|NCT00567255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92961959|NCT00567255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961960|NCT00746174|Rosiglitazone|rosiglitazone|mesh-list
92961961|NCT00746174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92961962|NCT00746174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961963|NCT00784446|Bevacizumab|bevacizumab|mesh-list
92961964|NCT00784446|Capecitabine|capecitabine|mesh-list
92961965|NCT00784446|Oxaliplatin|oxaliplatin|mesh-list
92961966|NCT00784446|Imatinib Mesylate|imatinib mesylate|mesh-list
92961967|NCT00784446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92961968|NCT00784446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961969|NCT00784446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92961970|NCT00784446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92961971|NCT00784446|Growth Substances|growth substances|mesh-ancestor
92961972|NCT00784446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961973|NCT00784446|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961974|NCT00784446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92961975|NCT00784446|Antimetabolites|antimetabolites|mesh-ancestor
92961976|NCT00784446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961977|NCT00784446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92961978|NCT00784446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92961979|NCT00744536|Lenalidomide|lenalidomide|mesh-list
92961980|NCT00744536|Melphalan|melphalan|mesh-list
92961981|NCT00744536|Immunologic Factors|immunologic factors|mesh-ancestor
92961982|NCT00744536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961983|NCT00744536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92961984|NCT00744536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92961985|NCT00744536|Growth Substances|growth substances|mesh-ancestor
92961986|NCT00744536|Growth Inhibitors|growth inhibitors|mesh-ancestor
92961987|NCT00744536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961988|NCT00744536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92961989|NCT00744536|Alkylating Agents|alkylating agents|mesh-ancestor
92961990|NCT00744536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92961991|NCT00744536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92961992|NCT00744536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92961994|NCT00929799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92961995|NCT00929799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92961996|NCT00777738|Bortezomib|bortezomib|mesh-list
92961997|NCT00777738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92961998|NCT00744770|Rilpivirine|rilpivirine|mesh-list
92961999|NCT00744770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92962000|NCT00744770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92962001|NCT00744770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962002|NCT00744770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962003|NCT00744770|Antiviral Agents|antiviral agents|mesh-ancestor
92962004|NCT00744770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962005|NCT00744770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92962006|NCT00744770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92962007|NCT00784680|Tamoxifen|tamoxifen|mesh-list
92962008|NCT00784680|Anastrozole|anastrozole|mesh-list
92962009|NCT00784680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92962010|NCT00784680|Hormone Antagonists|hormone antagonists|mesh-ancestor
92962011|NCT00784680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166097|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92962012|NCT00784680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962013|NCT00784680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962014|NCT00784680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962015|NCT00784680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92962016|NCT00784680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92962017|NCT00784680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92962018|NCT00784680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92962019|NCT00784680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92962020|NCT00784680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962021|NCT00784680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962022|NCT00908271|Dapagliflozin|dapagliflozin|mesh-list
92962023|NCT00908271|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92962024|NCT00908271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962025|NCT00908271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962026|NCT00908271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962027|NCT02556840|Insulin|insulin|mesh-list
92962028|NCT02556840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962029|NCT02556840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962030|NCT00929877|Ketoprofen|ketoprofen|mesh-list
92962031|NCT00929877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92962032|NCT00929877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962033|NCT00929877|Analgesics|analgesics|mesh-ancestor
92962034|NCT00929877|Sensory System Agents|sensory system agents|mesh-ancestor
92962035|NCT00929877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962036|NCT00929877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962037|NCT00929877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962038|NCT00929877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962039|NCT00929877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92607456|NCT00140517|Chloroquine|chloroquine|mesh-list
92962040|NCT00929877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962041|NCT00929877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962042|NCT00741884|Varenicline|varenicline|mesh-list
92962043|NCT00741884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92962044|NCT00741884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92962045|NCT00741884|Cholinergic Agents|cholinergic agents|mesh-ancestor
92962046|NCT00741884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962047|NCT00741884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962048|NCT00741884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962049|NCT00931437|Vitamin K|vitamin k|mesh-list
92962050|NCT00931437|Vitamins|vitamins|mesh-ancestor
92962051|NCT00931437|Micronutrients|micronutrients|mesh-ancestor
92962052|NCT00931437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962053|NCT00931437|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92962054|NCT00931437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92962055|NCT00931437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962056|NCT00931437|Hemostatics|hemostatics|mesh-ancestor
92962057|NCT00931437|Coagulants|coagulants|mesh-ancestor
92962058|NCT00742040|Captopril|captopril|mesh-list
92962059|NCT00742040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92962060|NCT00742040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962061|NCT00742040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962062|NCT00742040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962064|NCT00926757|Entecavir|entecavir|mesh-list
92962065|NCT00926757|Antiviral Agents|antiviral agents|mesh-ancestor
92962066|NCT00926757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962067|NCT00782106|Immunoglobulins|immunoglobulins|mesh-list
92962068|NCT00782106|Antibodies|antibodies|mesh-list
92962069|NCT00782106|gamma-Globulins|gamma-globulins|mesh-list
92962070|NCT00782106|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92962071|NCT00782106|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92962072|NCT00782106|Immunoglobulin G|immunoglobulin g|mesh-list
92962073|NCT00782106|Immunologic Factors|immunologic factors|mesh-ancestor
92962074|NCT00782106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962075|NCT00929955|Ondansetron|ondansetron|mesh-list
92962076|NCT00929955|Simvastatin|simvastatin|mesh-list
92962077|NCT00929955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92962078|NCT00929955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92962079|NCT00929955|Antimetabolites|antimetabolites|mesh-ancestor
92962080|NCT00929955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962081|NCT00929955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92962082|NCT00929955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92962083|NCT00929955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962084|NCT00929955|Antiemetics|antiemetics|mesh-ancestor
92962085|NCT00929955|Autonomic Agents|autonomic agents|mesh-ancestor
92962086|NCT00929955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962087|NCT00929955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962088|NCT00929955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962089|NCT00929955|Antipruritics|antipruritics|mesh-ancestor
92962090|NCT00929955|Dermatologic Agents|dermatologic agents|mesh-ancestor
92962091|NCT00929955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92962092|NCT00929955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92962093|NCT00929955|Serotonin Agents|serotonin agents|mesh-ancestor
92962094|NCT00929955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962095|NCT00784914|Sirolimus|sirolimus|mesh-list
92962096|NCT00784914|Temsirolimus|temsirolimus|mesh-list
92962097|NCT00784914|MTOR Inhibitors|mtor inhibitors|mesh-list
92962098|NCT00784914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962099|NCT00784914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962100|NCT00784914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962101|NCT00784914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92962102|NCT00784914|Immunologic Factors|immunologic factors|mesh-ancestor
92962103|NCT00784914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962104|NCT00784914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962105|NCT00784914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962106|NCT00784914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962107|NCT00784914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92962108|NCT00784914|Antifungal Agents|antifungal agents|mesh-ancestor
92962109|NCT00745004|Ondansetron|ondansetron|mesh-list
92962110|NCT00745004|Antiemetics|antiemetics|mesh-ancestor
92962111|NCT00745004|Autonomic Agents|autonomic agents|mesh-ancestor
92962112|NCT00745004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962113|NCT00745004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962114|NCT00745004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607520|NCT00140712|Ropinirole|ropinirole|mesh-list
92962115|NCT00745004|Antipruritics|antipruritics|mesh-ancestor
92962116|NCT00745004|Dermatologic Agents|dermatologic agents|mesh-ancestor
92962117|NCT00745004|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92962118|NCT00745004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92962120|NCT00745004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962121|NCT00745004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962122|NCT05450978|Lamotrigine|lamotrigine|mesh-list
92962123|NCT05450978|Levetiracetam|levetiracetam|mesh-list
92962124|NCT05450978|Anticonvulsants|anticonvulsants|mesh-list
92962125|NCT05450978|Nootropic Agents|nootropic agents|mesh-ancestor
92962126|NCT05450978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92962127|NCT05450978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962128|NCT05450978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962129|NCT05450978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92962130|NCT05450978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962131|NCT05450978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92962132|NCT05450978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92962133|NCT05450978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962134|NCT05450978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962135|NCT05450978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92962136|NCT04060550|Omalizumab|omalizumab|mesh-list
92962137|NCT04060550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92962138|NCT04060550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962139|NCT04060550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962140|NCT00921674|Ivermectin|ivermectin|mesh-list
92962141|NCT00921674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92962142|NCT00921674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962143|NCT00667446|Leuprolide|leuprolide|mesh-list
92962144|NCT00667446|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92962145|NCT00667446|Fertility Agents|fertility agents|mesh-ancestor
92962146|NCT00667446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92962147|NCT00667446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962148|NCT00667446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962149|NCT00667446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962150|NCT00777972|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92962151|NCT00777972|Fosinopril|fosinopril|mesh-list
92962152|NCT00777972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92962153|NCT00777972|Diuretics|diuretics|mesh-ancestor
92962154|NCT00777972|Natriuretic Agents|natriuretic agents|mesh-ancestor
92962155|NCT00777972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166108|NCT01456351|Immunologic Factors|immunologic factors|mesh-ancestor
92962156|NCT00777972|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92962157|NCT00777972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962158|NCT00777972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962159|NCT00777972|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92962160|NCT00777972|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962161|NCT00777972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962162|NCT00778050|Amoxicillin|amoxicillin|mesh-list
92962163|NCT00778050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962164|NCT00778050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962165|NCT00746486|Budesonide|budesonide|mesh-list
92962166|NCT00746486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962167|NCT00746486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92962168|NCT00746486|Autonomic Agents|autonomic agents|mesh-ancestor
92962169|NCT00746486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962170|NCT00746486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962171|NCT00746486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962172|NCT00746486|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962173|NCT00746486|Glucocorticoids|glucocorticoids|mesh-ancestor
92962174|NCT00746486|Hormones|hormones|mesh-ancestor
92962175|NCT00746486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962176|NCT00778128|Gemcitabine|gemcitabine|mesh-list
92962177|NCT00778128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92962178|NCT00778128|Antimetabolites|antimetabolites|mesh-ancestor
92962179|NCT00778128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962180|NCT00778128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962181|NCT00778284|Amoxicillin|amoxicillin|mesh-list
92962182|NCT00778284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962183|NCT00778284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962184|NCT00749138|Tamoxifen|tamoxifen|mesh-list
92962185|NCT00749138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92962186|NCT00749138|Hormone Antagonists|hormone antagonists|mesh-ancestor
92962187|NCT00749138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962188|NCT00749138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962189|NCT00749138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962190|NCT00749138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962191|NCT00749138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92962192|NCT00749138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92962193|NCT00749138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92962194|NCT02563340|Rituximab|rituximab|mesh-list
92962195|NCT02563340|Bortezomib|bortezomib|mesh-list
92962196|NCT02563340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92962197|NCT02563340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962198|NCT02563340|Immunologic Factors|immunologic factors|mesh-ancestor
92962199|NCT02563340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962200|NCT02563340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962201|NCT00782652|Nitric Oxide|nitric oxide|mesh-list
92962202|NCT00782652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92962203|NCT00782652|Autonomic Agents|autonomic agents|mesh-ancestor
92962204|NCT00782652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962205|NCT00782652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962206|NCT00782652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962207|NCT00782652|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962208|NCT00782652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92962209|NCT00782652|Antioxidants|antioxidants|mesh-ancestor
92962210|NCT00782652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962211|NCT00782652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962212|NCT00782652|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92962213|NCT00782652|Vasodilator Agents|vasodilator agents|mesh-ancestor
92962214|NCT00782652|Gasotransmitters|gasotransmitters|mesh-ancestor
92962215|NCT00782652|Protective Agents|protective agents|mesh-ancestor
92962216|NCT00785382|Pregabalin|pregabalin|mesh-list
92962217|NCT00785382|Analgesics|analgesics|mesh-ancestor
92962218|NCT00785382|Sensory System Agents|sensory system agents|mesh-ancestor
92962219|NCT00785382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962220|NCT00785382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962221|NCT00785382|Anticonvulsants|anticonvulsants|mesh-ancestor
92962222|NCT00785382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92962223|NCT00785382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962224|NCT00785382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962225|NCT00785382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92962226|NCT00785382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92962227|NCT00785382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92962228|NCT00785382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962229|NCT00785382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962230|NCT00667368|Metronidazole|metronidazole|mesh-list
92962231|NCT00667368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962232|NCT00667368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962233|NCT00667368|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92962234|NCT00667368|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92962235|NCT00785460|Benphothiamine|benphothiamine|mesh-list
92962236|NCT00785460|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92962237|NCT00785460|Immunologic Factors|immunologic factors|mesh-ancestor
92962238|NCT00785460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962239|NCT00785460|Chelating Agents|chelating agents|mesh-ancestor
92962240|NCT00785460|Sequestering Agents|sequestering agents|mesh-ancestor
92962241|NCT00785460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962242|NCT00567567|Vitamin A|vitamin a|mesh-list
92962243|NCT00567567|Cyclophosphamide|cyclophosphamide|mesh-list
92962244|NCT00567567|Melphalan|melphalan|mesh-list
92962245|NCT00567567|Mechlorethamine|mechlorethamine|mesh-list
92962246|NCT00567567|Thiotepa|thiotepa|mesh-list
92962247|NCT00567567|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92962248|NCT00567567|Cisplatin|cisplatin|mesh-list
92962249|NCT00567567|Carboplatin|carboplatin|mesh-list
92962250|NCT00567567|Doxorubicin|doxorubicin|mesh-list
92962251|NCT00567567|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92962252|NCT00567567|Etoposide|etoposide|mesh-list
92962253|NCT00567567|Vincristine|vincristine|mesh-list
92962254|NCT00567567|Etoposide phosphate|etoposide phosphate|mesh-list
92962255|NCT00567567|Topotecan|topotecan|mesh-list
92962256|NCT00567567|Tretinoin|tretinoin|mesh-list
92962257|NCT00567567|Podophyllotoxin|podophyllotoxin|mesh-list
92962258|NCT00567567|Isotretinoin|isotretinoin|mesh-list
92962259|NCT00567567|Lenograstim|lenograstim|mesh-list
92962260|NCT00567567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92962261|NCT00567567|Immunologic Factors|immunologic factors|mesh-ancestor
92962262|NCT00567567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962263|NCT00567567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962264|NCT00567567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92962265|NCT00567567|Alkylating Agents|alkylating agents|mesh-ancestor
92962266|NCT00567567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962267|NCT00567567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962268|NCT00567567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92962269|NCT00567567|Vitamins|vitamins|mesh-ancestor
92962270|NCT00567567|Micronutrients|micronutrients|mesh-ancestor
92962271|NCT00567567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92962272|NCT00567567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92962273|NCT00567567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92962274|NCT00567567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962275|NCT00567567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92962276|NCT00567567|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92962277|NCT00567567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92962278|NCT00567567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92962279|NCT00567567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92962280|NCT00567567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92962281|NCT00567567|Keratolytic Agents|keratolytic agents|mesh-ancestor
92962282|NCT00567567|Dermatologic Agents|dermatologic agents|mesh-ancestor
92962283|NCT00666198|Sildenafil Citrate|sildenafil citrate|mesh-list
92962284|NCT00666198|Vasodilator Agents|vasodilator agents|mesh-ancestor
92962285|NCT00666198|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92962286|NCT00666198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92962287|NCT00666198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962288|NCT00666198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962289|NCT00666198|Urological Agents|urological agents|mesh-ancestor
92962290|NCT00778596|Prednisolone|prednisolone|mesh-list
92962291|NCT00778596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962292|NCT00778596|Glucocorticoids|glucocorticoids|mesh-ancestor
92962293|NCT00778596|Hormones|hormones|mesh-ancestor
92962294|NCT00778596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962295|NCT00778596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962296|NCT00778596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962297|NCT00778596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962298|NCT00778674|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92962299|NCT00778674|Benazepril|benazepril|mesh-list
92962300|NCT00778674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92962301|NCT00778674|Diuretics|diuretics|mesh-ancestor
92962302|NCT00778674|Natriuretic Agents|natriuretic agents|mesh-ancestor
92962303|NCT00778674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962304|NCT00778674|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92962305|NCT00778674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962306|NCT00778674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962307|NCT00778674|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92962308|NCT00778674|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962309|NCT00778674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962310|NCT00778752|Lenalidomide|lenalidomide|mesh-list
92962311|NCT00778752|Immunologic Factors|immunologic factors|mesh-ancestor
92962312|NCT00778752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962313|NCT00778752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962314|NCT00778752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962315|NCT00778752|Growth Substances|growth substances|mesh-ancestor
92962316|NCT00778752|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962317|NCT00778752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962318|NCT00926835|Lamotrigine|lamotrigine|mesh-list
92962319|NCT00926835|Dexetimide|dexetimide|mesh-list
92962320|NCT00926835|Aripiprazole|aripiprazole|mesh-list
92962321|NCT00926835|Mirtazapine|mirtazapine|mesh-list
92962322|NCT00926835|Citalopram|citalopram|mesh-list
92962323|NCT00926835|Bupropion|bupropion|mesh-list
92962324|NCT00926835|Paroxetine|paroxetine|mesh-list
92962325|NCT00926835|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92962326|NCT00926835|Escitalopram|escitalopram|mesh-list
92962327|NCT00926835|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92962328|NCT00926835|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92962329|NCT00926835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962330|NCT00926835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962331|NCT00926835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962332|NCT00926835|Serotonin Agents|serotonin agents|mesh-ancestor
92962333|NCT00926835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962334|NCT00926835|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92962335|NCT00926835|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92962336|NCT00926835|Parasympatholytics|parasympatholytics|mesh-ancestor
92962337|NCT00926835|Autonomic Agents|autonomic agents|mesh-ancestor
92962338|NCT00926835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962339|NCT00926835|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92962340|NCT00926835|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92962341|NCT00926835|Cholinergic Agents|cholinergic agents|mesh-ancestor
92962342|NCT00926835|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92962343|NCT00926835|Antidepressive Agents|antidepressive agents|mesh-ancestor
92962344|NCT00926835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962345|NCT00926835|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92962347|NCT00926835|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92962348|NCT00926835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92962349|NCT00926835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962350|NCT00926835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92962351|NCT00926835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92962352|NCT00926835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962353|NCT00926835|Dopamine Agonists|dopamine agonists|mesh-ancestor
92962354|NCT00926835|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92962355|NCT00926835|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92962356|NCT00926835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92962357|NCT00926835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92962358|NCT00926835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92962359|NCT00926835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92962360|NCT00926835|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92962361|NCT00926835|Anticonvulsants|anticonvulsants|mesh-ancestor
92962362|NCT00926835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92962363|NCT00926835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92962364|NCT00926835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92962365|NCT00926835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92962366|NCT00926835|Histamine Antagonists|histamine antagonists|mesh-ancestor
92962367|NCT00926835|Histamine Agents|histamine agents|mesh-ancestor
92962368|NCT00926835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92962369|NCT00926835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92962370|NCT00926835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92962371|NCT00926835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92962372|NCT00926835|Adrenergic Agents|adrenergic agents|mesh-ancestor
92962373|NCT00926835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92962374|NCT00930033|Sunitinib|sunitinib|mesh-list
92962375|NCT00930033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962376|NCT00930033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962377|NCT00930033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962378|NCT00930033|Growth Substances|growth substances|mesh-ancestor
92962379|NCT00930033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962380|NCT00930033|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962381|NCT00930033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962382|NCT00930033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962383|NCT00930033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962384|NCT00664560|Celecoxib|celecoxib|mesh-list
92962385|NCT00664560|Antacids|antacids|mesh-list
92962386|NCT00664560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92962387|NCT00664560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962388|NCT00664560|Analgesics|analgesics|mesh-ancestor
92962389|NCT00664560|Sensory System Agents|sensory system agents|mesh-ancestor
92962390|NCT00664560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962391|NCT00664560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962392|NCT00664560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962393|NCT00664560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962394|NCT00664560|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92962395|NCT00664560|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92962396|NCT00664560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962397|NCT00664560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962398|NCT00664560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962399|NCT00783042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92962400|NCT00783042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92962401|NCT00783042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92962402|NCT00783042|Antimetabolites|antimetabolites|mesh-ancestor
92962403|NCT00783042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962404|NCT00783042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92962405|NCT00783042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92962406|NCT00783042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962407|NCT00688688|Mirabegron|mirabegron|mesh-list
92962408|NCT00688688|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92962409|NCT00688688|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92962410|NCT00688688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92962411|NCT00688688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92962412|NCT00688688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92962413|NCT00688688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962414|NCT00688688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607815|NCT00133406|Vitamins|vitamins|mesh-ancestor
92962415|NCT00688688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962416|NCT00688688|Urological Agents|urological agents|mesh-ancestor
92962417|NCT00688688|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92962418|NCT00688688|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92962419|NCT00688688|Cholinergic Agents|cholinergic agents|mesh-ancestor
92962421|NCT00930189|Ranibizumab|ranibizumab|mesh-list
92962422|NCT00930189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962423|NCT00930189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962424|NCT00930189|Growth Substances|growth substances|mesh-ancestor
92962425|NCT00930189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962426|NCT00930189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962427|NCT00930189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962428|NCT00930189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962429|NCT00930189|Glucocorticoids|glucocorticoids|mesh-ancestor
92962430|NCT00930189|Hormones|hormones|mesh-ancestor
92962431|NCT00930189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962432|NCT00936819|Plasma-lyte 148|plasma-lyte 148|mesh-list
92962433|NCT00936819|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92962434|NCT00936819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92962435|NCT00931827|Levonorgestrel|levonorgestrel|mesh-list
92962436|NCT00931827|Etonogestrel|etonogestrel|mesh-list
92962437|NCT00931827|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92962438|NCT00931827|Contraceptive Agents|contraceptive agents|mesh-ancestor
92962439|NCT00931827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92962440|NCT00931827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962441|NCT00931827|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92962442|NCT00931827|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92962443|NCT00931827|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92962444|NCT00778908|Cisplatin|cisplatin|mesh-list
92962445|NCT00778908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962446|NCT02561468|Nefopam|nefopam|mesh-list
92262989|NCT05478278|Psilocybin|psilocybin|mesh-list
92962447|NCT02561468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962448|NCT02561468|Analgesics|analgesics|mesh-ancestor
92962449|NCT02561468|Sensory System Agents|sensory system agents|mesh-ancestor
92962450|NCT02561468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962451|NCT02561468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962452|NCT02555748|Sunitinib|sunitinib|mesh-list
92962453|NCT02555748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962454|NCT02555748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962455|NCT02555748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962456|NCT02555748|Growth Substances|growth substances|mesh-ancestor
92962457|NCT02555748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962458|NCT02555748|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962459|NCT02555748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962460|NCT02555748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962461|NCT02555748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962462|NCT00930345|Sunitinib|sunitinib|mesh-list
92962463|NCT00930345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962464|NCT00930345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962465|NCT00930345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962466|NCT00930345|Growth Substances|growth substances|mesh-ancestor
92962467|NCT00930345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962468|NCT00930345|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962469|NCT00930345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962470|NCT00930345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962471|NCT00930345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962472|NCT02562326|Insulin Lispro|insulin lispro|mesh-list
92962473|NCT02562326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962474|NCT02562326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962475|NCT00746720|Etoricoxib|etoricoxib|mesh-list
92962476|NCT00746720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92962477|NCT00746720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962478|NCT00746720|Analgesics|analgesics|mesh-ancestor
92962479|NCT00746720|Sensory System Agents|sensory system agents|mesh-ancestor
92962480|NCT00746720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962481|NCT00746720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962482|NCT00746720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962483|NCT00746720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962484|NCT00746720|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92962485|NCT00746720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92962486|NCT00746720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962487|NCT00746720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962488|NCT00686972|Glucagon|glucagon|mesh-list
92962489|NCT00686972|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92962491|NCT00686972|Hormones|hormones|mesh-ancestor
92962492|NCT00686972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962493|NCT00686972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962494|NCT00686972|Incretins|incretins|mesh-ancestor
92962495|NCT00665652|Lenalidomide|lenalidomide|mesh-list
92962496|NCT00665652|Immunologic Factors|immunologic factors|mesh-ancestor
92962497|NCT00665652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962498|NCT00665652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962499|NCT00665652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962500|NCT00665652|Growth Substances|growth substances|mesh-ancestor
92962501|NCT00665652|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962502|NCT00665652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962503|NCT00752024|Hemostatics|hemostatics|mesh-list
92962504|NCT00752024|Coagulants|coagulants|mesh-ancestor
92962505|NCT00937677|Natalizumab|natalizumab|mesh-list
92962506|NCT00937677|Immunologic Factors|immunologic factors|mesh-ancestor
92962507|NCT00937677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962508|NCT00786240|Fesoterodine|fesoterodine|mesh-list
92962509|NCT00786240|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92962510|NCT00786240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92962511|NCT00786240|Cholinergic Agents|cholinergic agents|mesh-ancestor
92962512|NCT00786240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962513|NCT00786240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962514|NCT00786240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962515|NCT00786240|Urological Agents|urological agents|mesh-ancestor
92962516|NCT04498923|Dexamethasone|dexamethasone|mesh-list
92962517|NCT04498923|Epinephrine|epinephrine|mesh-list
92962518|NCT04498923|Bupivacaine|bupivacaine|mesh-list
92962519|NCT04498923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962520|NCT04498923|Antiemetics|antiemetics|mesh-ancestor
92962521|NCT04498923|Autonomic Agents|autonomic agents|mesh-ancestor
92962522|NCT04498923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962523|NCT04498923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962524|NCT04498923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962525|NCT04498923|Glucocorticoids|glucocorticoids|mesh-ancestor
92962526|NCT04498923|Hormones|hormones|mesh-ancestor
92962527|NCT04498923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962528|NCT04498923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962529|NCT04498923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962530|NCT04498923|Anesthetics, Local|anesthetics, local|mesh-ancestor
92962531|NCT04498923|Anesthetics|anesthetics|mesh-ancestor
92962532|NCT04498923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962533|NCT04498923|Sensory System Agents|sensory system agents|mesh-ancestor
92962534|NCT04498923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92962535|NCT04498923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92962536|NCT04498923|Adrenergic Agents|adrenergic agents|mesh-ancestor
92962537|NCT04498923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962538|NCT04498923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962539|NCT04498923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92962540|NCT04498923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92962541|NCT04498923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962542|NCT04498923|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962543|NCT04498923|Mydriatics|mydriatics|mesh-ancestor
92962544|NCT04498923|Sympathomimetics|sympathomimetics|mesh-ancestor
92962545|NCT04498923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92962546|NCT00779064|Rivaroxaban|rivaroxaban|mesh-list
92962547|NCT00779064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92962548|NCT00779064|Antithrombins|antithrombins|mesh-ancestor
92962549|NCT00779064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92962550|NCT00779064|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962551|NCT00779064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962552|NCT00779064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962553|NCT00779064|Anticoagulants|anticoagulants|mesh-ancestor
92962554|NCT04046874|Analgesics|analgesics|mesh-list
92962555|NCT04046874|Sensory System Agents|sensory system agents|mesh-ancestor
92962556|NCT04046874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962557|NCT04046874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962558|NCT00932217|Lenograstim|lenograstim|mesh-list
92962559|NCT00932217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92962560|NCT00932217|Immunologic Factors|immunologic factors|mesh-ancestor
92962561|NCT00932217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962562|NCT00786318|Ziprasidone|ziprasidone|mesh-list
92962563|NCT00786318|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92962564|NCT00786318|Serotonin Agents|serotonin agents|mesh-ancestor
92962565|NCT00786318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962566|NCT00786318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962567|NCT00786318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962568|NCT00786318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92962569|NCT00786318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92962570|NCT00786318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962571|NCT00786318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962572|NCT00786318|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92962573|NCT00786318|Dopamine Agents|dopamine agents|mesh-ancestor
92962574|NCT00566631|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92962575|NCT00566631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92962576|NCT00566631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92307563|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92962577|NCT00566631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962578|NCT00566631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962579|NCT00566631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962580|NCT00566631|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92962581|NCT00566631|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92962583|NCT00566631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962584|NCT00566631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962585|NCT00566631|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92962586|NCT00566631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92962587|NCT00566631|Dopamine Agents|dopamine agents|mesh-ancestor
92962588|NCT00937911|Darexaban|darexaban|mesh-list
92962589|NCT00937911|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92962590|NCT00937911|Antithrombins|antithrombins|mesh-ancestor
92962591|NCT00937911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92962592|NCT00937911|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962593|NCT00937911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962594|NCT00937911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962595|NCT00937911|Anticoagulants|anticoagulants|mesh-ancestor
92962596|NCT00930891|Bevacizumab|bevacizumab|mesh-list
92962597|NCT00930891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92962598|NCT00930891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962599|NCT00930891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962600|NCT00930891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962601|NCT00930891|Growth Substances|growth substances|mesh-ancestor
92962602|NCT00930891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962603|NCT00930891|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962604|NCT00938379|Insect Repellents|insect repellents|mesh-list
92962605|NCT00938379|Protective Agents|protective agents|mesh-ancestor
92962606|NCT00938379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962607|NCT00661830|Gemcitabine|gemcitabine|mesh-list
92962608|NCT00661830|Sorafenib|sorafenib|mesh-list
92962609|NCT00661830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92962610|NCT00661830|Antimetabolites|antimetabolites|mesh-ancestor
92962611|NCT00661830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962612|NCT00661830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962613|NCT00661830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962614|NCT00661830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962615|NCT00932529|Olanzapine|olanzapine|mesh-list
92962616|NCT00932529|Risperidone|risperidone|mesh-list
92962617|NCT00932529|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92962618|NCT00932529|Ziprasidone|ziprasidone|mesh-list
92962619|NCT00932529|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92962620|NCT00932529|Serotonin Agents|serotonin agents|mesh-ancestor
92962621|NCT00932529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962622|NCT00932529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962623|NCT00932529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962624|NCT00932529|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92962625|NCT00932529|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92962626|NCT00932529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962627|NCT00932529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962628|NCT00932529|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92962629|NCT00932529|Dopamine Agents|dopamine agents|mesh-ancestor
92962630|NCT00932529|Antiemetics|antiemetics|mesh-ancestor
92962631|NCT00932529|Autonomic Agents|autonomic agents|mesh-ancestor
92962632|NCT00932529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962633|NCT00932529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962634|NCT00932529|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92962635|NCT00932529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92962636|NCT00932529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962637|NCT00932529|Antidepressive Agents|antidepressive agents|mesh-ancestor
92962638|NCT00783744|Insulin|insulin|mesh-list
92962639|NCT00783744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92962640|NCT00783744|Metformin|metformin|mesh-list
92962641|NCT00783744|Insulin Glargine|insulin glargine|mesh-list
92962642|NCT00783744|Glimepiride|glimepiride|mesh-list
92962643|NCT00783744|Isophane Insulin, Human|isophane insulin, human|mesh-list
92962644|NCT00783744|Insulin, Isophane|insulin, isophane|mesh-list
92962645|NCT00783744|Isophane insulin, beef|isophane insulin, beef|mesh-list
92962646|NCT00783744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962647|NCT00783744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962648|NCT00783744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92527610|NCT00013689|Pyrimethamine|pyrimethamine|mesh-list
92962649|NCT00783744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92962650|NCT00783744|Immunologic Factors|immunologic factors|mesh-ancestor
92962651|NCT00932607|Immunomodulating Agents|immunomodulating agents|mesh-list
92962652|NCT00932607|Immunologic Factors|immunologic factors|mesh-ancestor
92962653|NCT00932607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962655|NCT00932685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92962656|NCT00932685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92962657|NCT00932685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962658|NCT00932685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962659|NCT00932685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92962660|NCT00932685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92962661|NCT00932685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92962662|NCT00932685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92962663|NCT00932685|Anesthetics, General|anesthetics, general|mesh-ancestor
92962664|NCT00932685|Anesthetics|anesthetics|mesh-ancestor
92962665|NCT00932685|GABA Modulators|gaba modulators|mesh-ancestor
92962666|NCT00932685|GABA Agents|gaba agents|mesh-ancestor
92962667|NCT00932685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962668|NCT00932685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962669|NCT00931125|Ranibizumab|ranibizumab|mesh-list
92962670|NCT00931125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962671|NCT00931125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962672|NCT00931125|Growth Substances|growth substances|mesh-ancestor
92962673|NCT00931125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962674|NCT00931125|Growth Inhibitors|growth inhibitors|mesh-ancestor
92962675|NCT00931125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962676|NCT00932763|Amlodipine|amlodipine|mesh-list
92962677|NCT00932763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92962678|NCT00932763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92962679|NCT00932763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92962680|NCT00932763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962681|NCT00932763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92962682|NCT00932763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962683|NCT00932763|Vasodilator Agents|vasodilator agents|mesh-ancestor
92962684|NCT00786396|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92962685|NCT00786396|Antiviral Agents|antiviral agents|mesh-ancestor
92962686|NCT00786396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962687|NCT00783900|Metoprolol|metoprolol|mesh-list
92962688|NCT00783900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92962689|NCT00783900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92962690|NCT00783900|Sympatholytics|sympatholytics|mesh-ancestor
92962691|NCT00783900|Autonomic Agents|autonomic agents|mesh-ancestor
92962692|NCT00783900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962693|NCT00783900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962694|NCT00783900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92962695|NCT00783900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92962696|NCT00783900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92962697|NCT00783900|Adrenergic Agents|adrenergic agents|mesh-ancestor
92962698|NCT00783900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962699|NCT00783900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962700|NCT00938613|Budesonide|budesonide|mesh-list
92962701|NCT00938613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962702|NCT00938613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92962703|NCT00938613|Autonomic Agents|autonomic agents|mesh-ancestor
92962704|NCT00938613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962705|NCT00938613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962706|NCT00938613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962707|NCT00938613|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962708|NCT00938613|Glucocorticoids|glucocorticoids|mesh-ancestor
92962709|NCT00938613|Hormones|hormones|mesh-ancestor
92962710|NCT00938613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962711|NCT00786552|Paclitaxel|paclitaxel|mesh-list
92962712|NCT00786552|Pemetrexed|pemetrexed|mesh-list
92962713|NCT00786552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92962714|NCT00786552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962715|NCT00786552|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608116|NCT00134693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962717|NCT00786552|Mitosis Modulators|mitosis modulators|mesh-ancestor
92962718|NCT00786552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962719|NCT00786552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962720|NCT00786552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92962721|NCT00786552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92962722|NCT04047186|Nivolumab|nivolumab|mesh-list
92527611|NCT00013689|Sulfadoxine|sulfadoxine|mesh-list
92962723|NCT04047186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92962724|NCT04047186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962725|NCT04047186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92962726|NCT04047186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962728|NCT00931203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92962729|NCT00931203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962730|NCT00931203|Analgesics|analgesics|mesh-ancestor
92962731|NCT00931203|Sensory System Agents|sensory system agents|mesh-ancestor
92962732|NCT00931203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962733|NCT00931203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962734|NCT00931203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962735|NCT00931203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962736|NCT00931203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92962737|NCT00931203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92962738|NCT00931203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962739|NCT00931203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962740|NCT00565773|Sirolimus|sirolimus|mesh-list
92962741|NCT00565773|Alemtuzumab|alemtuzumab|mesh-list
92962742|NCT00565773|Abatacept|abatacept|mesh-list
92962743|NCT00565773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962744|NCT00565773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962745|NCT00565773|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92962746|NCT00565773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962747|NCT00565773|Antifungal Agents|antifungal agents|mesh-ancestor
92962748|NCT00565773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92962749|NCT00565773|Immunologic Factors|immunologic factors|mesh-ancestor
92962750|NCT00565773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962751|NCT00565773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962752|NCT00565773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92962753|NCT00565773|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92962754|NCT00565773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962755|NCT00570492|Fluticasone|fluticasone|mesh-list
92962756|NCT00570492|Xhance|xhance|mesh-list
92962757|NCT00570492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962758|NCT00570492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92962759|NCT00570492|Autonomic Agents|autonomic agents|mesh-ancestor
92962760|NCT00570492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962761|NCT00570492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962762|NCT00570492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962763|NCT00570492|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962764|NCT00570492|Dermatologic Agents|dermatologic agents|mesh-ancestor
92962765|NCT00570492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92962766|NCT00931281|Ritonavir|ritonavir|mesh-list
92962767|NCT00931281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92962768|NCT00931281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92962769|NCT00931281|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962770|NCT00931281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962771|NCT00931281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962772|NCT00931281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92962773|NCT00931281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92962774|NCT00931281|Antiviral Agents|antiviral agents|mesh-ancestor
92962775|NCT00931281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962776|NCT00931281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92962777|NCT00931281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92962778|NCT04014855|Lactoferrin|lactoferrin|mesh-list
92962779|NCT04014855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962780|NCT00571922|Acamprosate|acamprosate|mesh-list
92962781|NCT00571922|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92962782|NCT00933231|Mycophenolic Acid|mycophenolic acid|mesh-list
92962783|NCT00933231|Prednisone|prednisone|mesh-list
92962784|NCT00933231|Methylprednisolone|methylprednisolone|mesh-list
92962785|NCT00933231|Ramipril|ramipril|mesh-list
92962786|NCT00933231|Irbesartan|irbesartan|mesh-list
92962787|NCT00933231|Tacrolimus|tacrolimus|mesh-list
92962788|NCT00933231|Basiliximab|basiliximab|mesh-list
92962789|NCT00933231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962790|NCT00933231|Glucocorticoids|glucocorticoids|mesh-ancestor
92962791|NCT00933231|Hormones|hormones|mesh-ancestor
92962792|NCT00933231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962793|NCT00933231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962794|NCT00933231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92962795|NCT00933231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962796|NCT00933231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92962798|NCT00933231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92962799|NCT00933231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962800|NCT00933231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962801|NCT00933231|Antiemetics|antiemetics|mesh-ancestor
92962802|NCT00933231|Autonomic Agents|autonomic agents|mesh-ancestor
92962803|NCT00933231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962804|NCT00933231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962805|NCT00933231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92962806|NCT00933231|Protective Agents|protective agents|mesh-ancestor
92962807|NCT00933231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92962808|NCT00933231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92962809|NCT00933231|Antitubercular Agents|antitubercular agents|mesh-ancestor
92962810|NCT00933231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962811|NCT00933231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962812|NCT00933231|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92962813|NCT00933231|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962814|NCT00933231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92962815|NCT00933231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92962816|NCT00933231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92962817|NCT03489525|Antibodies|antibodies|mesh-list
92962818|NCT03489525|Immunoglobulins|immunoglobulins|mesh-list
92962819|NCT03489525|Immunoconjugates|immunoconjugates|mesh-list
92962820|NCT03489525|Immunologic Factors|immunologic factors|mesh-ancestor
92962821|NCT03489525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962822|NCT00752180|Insulin|insulin|mesh-list
92962823|NCT00752180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92962824|NCT00752180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962825|NCT00752180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962826|NCT00784290|Orantinib|orantinib|mesh-list
92962827|NCT00784290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962828|NCT00784290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962829|NCT00784290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962830|NCT00752414|Levofloxacin|levofloxacin|mesh-list
92962831|NCT00752414|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92962832|NCT00752414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962833|NCT00752414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962834|NCT00752414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92962835|NCT00752414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92962836|NCT00752414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962837|NCT00752414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962838|NCT00752414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962839|NCT00752414|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92962840|NCT00752414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92962841|NCT04059224|Trametinib|trametinib|mesh-list
92962842|NCT04059224|Dabrafenib|dabrafenib|mesh-list
92962843|NCT04059224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962844|NCT04059224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962845|NCT04059224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962846|NCT04059224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962847|NCT00686894|Infliximab|infliximab|mesh-list
92962848|NCT00686894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92962849|NCT00686894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962850|NCT00686894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92962851|NCT00686894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962852|NCT00686894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962853|NCT00328627|Pioglitazone|pioglitazone|mesh-list
92962854|NCT00328627|Alogliptin|alogliptin|mesh-list
92962855|NCT00328627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962856|NCT00328627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962857|NCT00328627|Incretins|incretins|mesh-ancestor
92962858|NCT00328627|Hormones|hormones|mesh-ancestor
92962859|NCT00328627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962860|NCT00328627|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92962861|NCT00328627|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962862|NCT00328627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962863|NCT00328627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962864|NCT03977727|Insulin Aspart|insulin aspart|mesh-list
92962865|NCT03977727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92962866|NCT03977727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962868|NCT00663858|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92962869|NCT00663858|Fertility Agents|fertility agents|mesh-ancestor
92962870|NCT00663858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92962871|NCT00663858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962873|NCT00663858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92962874|NCT05223400|Clindamycin|clindamycin|mesh-list
92962875|NCT05223400|Clindamycin palmitate|clindamycin palmitate|mesh-list
92962876|NCT05223400|Clindamycin phosphate|clindamycin phosphate|mesh-list
92962877|NCT05223400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962878|NCT05223400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962879|NCT05223400|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92962880|NCT05223400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962881|NCT05223400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962882|NCT00790608|Nitric Oxide|nitric oxide|mesh-list
92962883|NCT00790608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92962884|NCT00790608|Autonomic Agents|autonomic agents|mesh-ancestor
92962885|NCT00790608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962886|NCT00790608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962887|NCT00790608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92962888|NCT00790608|Respiratory System Agents|respiratory system agents|mesh-ancestor
92962889|NCT00790608|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92962890|NCT00790608|Antioxidants|antioxidants|mesh-ancestor
92962891|NCT00790608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962892|NCT00790608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962893|NCT00790608|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92962894|NCT00790608|Vasodilator Agents|vasodilator agents|mesh-ancestor
92962895|NCT00790608|Gasotransmitters|gasotransmitters|mesh-ancestor
92962896|NCT00790608|Protective Agents|protective agents|mesh-ancestor
92962897|NCT00749450|Fluorouracil|fluorouracil|mesh-list
92962898|NCT00749450|Capecitabine|capecitabine|mesh-list
92962899|NCT00749450|Oxaliplatin|oxaliplatin|mesh-list
92962900|NCT00749450|Antimetabolites|antimetabolites|mesh-ancestor
92962901|NCT00749450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962902|NCT00749450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92962903|NCT00749450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962904|NCT00749450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92962905|NCT00749450|Immunologic Factors|immunologic factors|mesh-ancestor
92962906|NCT00749450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962907|NCT00795444|Maraviroc|maraviroc|mesh-list
92962908|NCT00795444|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92962909|NCT00795444|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92962910|NCT00795444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962911|NCT00795444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92962912|NCT00795444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92962913|NCT00795444|Antiviral Agents|antiviral agents|mesh-ancestor
92962914|NCT00795444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962915|NCT00795444|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92962916|NCT02561936|Rilpivirine|rilpivirine|mesh-list
92962917|NCT02561936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92962918|NCT02561936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92962919|NCT02561936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962920|NCT02561936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962921|NCT02561936|Antiviral Agents|antiviral agents|mesh-ancestor
92962922|NCT02561936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962923|NCT02561936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92962924|NCT02561936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92962925|NCT00752648|Simeprevir|simeprevir|mesh-list
92962926|NCT00752648|Antiviral Agents|antiviral agents|mesh-ancestor
92962927|NCT00752648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962928|NCT00752648|Protease Inhibitors|protease inhibitors|mesh-ancestor
92962929|NCT00752648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962930|NCT00752648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962931|NCT00790920|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
92962932|NCT00790920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92962933|NCT00790920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92962934|NCT00790920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962935|NCT00752882|Ceftazidime|ceftazidime|mesh-list
92962936|NCT00752882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92962937|NCT00752882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962938|NCT01060735|Vitamin D|vitamin d|mesh-list
92962939|NCT01060735|Vitamins|vitamins|mesh-ancestor
92962941|NCT01060735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962942|NCT01060735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92962943|NCT02555358|Docetaxel|docetaxel|mesh-list
92962944|NCT02555358|Capecitabine|capecitabine|mesh-list
92962945|NCT02555358|Oxaliplatin|oxaliplatin|mesh-list
92962946|NCT02555358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962947|NCT02555358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92962948|NCT02555358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92962949|NCT02555358|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026487|NCT00401973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92962950|NCT02555358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962951|NCT02555358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92962952|NCT02555358|Antimetabolites|antimetabolites|mesh-ancestor
92962953|NCT00683774|Diazoxide|diazoxide|mesh-list
92962954|NCT00683774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92962955|NCT00683774|Vasodilator Agents|vasodilator agents|mesh-ancestor
92962956|NCT00787410|Gefitinib|gefitinib|mesh-list
92962957|NCT00787410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962958|NCT00787410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92962959|NCT00787410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962960|NCT00787410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962961|NCT03989557|Aspirin|aspirin|mesh-list
92962962|NCT03989557|Clopidogrel|clopidogrel|mesh-list
92962963|NCT03989557|Ticagrelor|ticagrelor|mesh-list
92962964|NCT03989557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92962965|NCT03989557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92962966|NCT03989557|Analgesics|analgesics|mesh-ancestor
92962967|NCT03989557|Sensory System Agents|sensory system agents|mesh-ancestor
92962968|NCT03989557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92962969|NCT03989557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962970|NCT03989557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92962971|NCT03989557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92962972|NCT03989557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92962973|NCT03989557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92962974|NCT03989557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92962975|NCT03989557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92962976|NCT03989557|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92962977|NCT03989557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92962978|NCT03989557|Antipyretics|antipyretics|mesh-ancestor
92962979|NCT03989557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92962980|NCT03989557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92962981|NCT03989557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92962982|NCT03989557|Purinergic Agents|purinergic agents|mesh-ancestor
92962983|NCT03989557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92962984|NCT00790998|Ivermectin|ivermectin|mesh-list
92962985|NCT00790998|Moxidectin|moxidectin|mesh-list
92962986|NCT00790998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92962987|NCT00790998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92962988|NCT00790998|Anthelmintics|anthelmintics|mesh-ancestor
92962989|NCT00790998|Antinematodal Agents|antinematodal agents|mesh-ancestor
92962990|NCT02555046|Anesthetics|anesthetics|mesh-list
92962991|NCT02555046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92962992|NCT02555046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92962993|NCT00354679|Bevacizumab|bevacizumab|mesh-list
92962994|NCT00354679|Irinotecan|irinotecan|mesh-list
92962995|NCT00354679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92962996|NCT00354679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92962997|NCT00354679|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92962998|NCT00354679|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92962999|NCT00354679|Growth Substances|growth substances|mesh-ancestor
92963000|NCT00354679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963001|NCT00354679|Growth Inhibitors|growth inhibitors|mesh-ancestor
92963002|NCT00354679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92963003|NCT00354679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963004|NCT00354679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963005|NCT00354679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963006|NCT00540514|Paclitaxel|paclitaxel|mesh-list
92963007|NCT00540514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92963008|NCT00540514|Carboplatin|carboplatin|mesh-list
92963009|NCT00540514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963010|NCT00540514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963011|NCT00540514|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963012|NCT00540514|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963013|NCT00540514|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963014|NCT00540514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963015|NCT00663702|Abatacept|abatacept|mesh-list
92963016|NCT00663702|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92963017|NCT00663702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963018|NCT00663702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963019|NCT00663702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963020|NCT00663702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963021|NCT00663702|Immunologic Factors|immunologic factors|mesh-ancestor
92963022|NCT00663702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963023|NCT00663702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963024|NCT02022592|Midazolam|midazolam|mesh-list
92963025|NCT02022592|Lormetazepam|lormetazepam|mesh-list
92963026|NCT02022592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92963027|NCT02022592|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92963028|NCT02022592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963029|NCT02022592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963030|NCT02022592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92963031|NCT02022592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963032|NCT02022592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963033|NCT02022592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92963034|NCT02022592|Anesthetics, General|anesthetics, general|mesh-ancestor
92963035|NCT02022592|Anesthetics|anesthetics|mesh-ancestor
92963036|NCT02022592|GABA Modulators|gaba modulators|mesh-ancestor
92963037|NCT02022592|GABA Agents|gaba agents|mesh-ancestor
92963038|NCT02022592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963039|NCT02022592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963040|NCT00683618|Atorvastatin|atorvastatin|mesh-list
92963041|NCT00683618|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92963042|NCT00683618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92963043|NCT00683618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92963044|NCT00683618|Antimetabolites|antimetabolites|mesh-ancestor
92963045|NCT00683618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963046|NCT00683618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92963047|NCT00683618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92963048|NCT00683618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963049|NCT00795678|Paclitaxel|paclitaxel|mesh-list
92963050|NCT00795678|Vinorelbine|vinorelbine|mesh-list
92963051|NCT00795678|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92963052|NCT00795678|Cyclophosphamide|cyclophosphamide|mesh-list
92963053|NCT00795678|Gemcitabine|gemcitabine|mesh-list
92963054|NCT00795678|Doxorubicin|doxorubicin|mesh-list
92963055|NCT00795678|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92963056|NCT00795678|Capecitabine|capecitabine|mesh-list
92963057|NCT00795678|Trastuzumab|trastuzumab|mesh-list
92963058|NCT00795678|Lapatinib|lapatinib|mesh-list
92963059|NCT00795678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963060|NCT00795678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963061|NCT00795678|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963062|NCT00795678|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963063|NCT00795678|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963064|NCT00795678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963065|NCT00795678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963066|NCT00795678|Immunologic Factors|immunologic factors|mesh-ancestor
92963067|NCT00795678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963068|NCT00795678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963069|NCT00795678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92963070|NCT00795678|Alkylating Agents|alkylating agents|mesh-ancestor
92963071|NCT00795678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92963072|NCT00795678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963073|NCT00795678|Antimetabolites|antimetabolites|mesh-ancestor
92963074|NCT00795678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92963075|NCT00795678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92963076|NCT00795678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963077|NCT00795678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963078|NCT00795678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963079|NCT00795678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92963080|NCT00753038|Paclitaxel|paclitaxel|mesh-list
92963081|NCT00753038|Carboplatin|carboplatin|mesh-list
92963082|NCT00753038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963083|NCT00753038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963084|NCT00753038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963085|NCT00753038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963086|NCT00753038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963087|NCT00753038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963088|NCT00795756|Cytarabine|cytarabine|mesh-list
92963089|NCT00795756|Methotrexate|methotrexate|mesh-list
92963090|NCT00795756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92963091|NCT00795756|Abortifacient Agents|abortifacient agents|mesh-ancestor
92963092|NCT00795756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92963093|NCT00795756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963094|NCT00795756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963095|NCT00795756|Antimetabolites|antimetabolites|mesh-ancestor
93026488|NCT00401973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92963096|NCT00795756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963097|NCT00795756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963098|NCT00795756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92963099|NCT00795756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963100|NCT00795756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92963101|NCT00795756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963102|NCT00795756|Immunologic Factors|immunologic factors|mesh-ancestor
92963103|NCT00795756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963104|NCT00795756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92963105|NCT00795756|Antiviral Agents|antiviral agents|mesh-ancestor
92963106|NCT00795756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963107|NCT04058522|Triamcinolone|triamcinolone|mesh-list
92963108|NCT04058522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963109|NCT04058522|Glucocorticoids|glucocorticoids|mesh-ancestor
92963110|NCT04058522|Hormones|hormones|mesh-ancestor
92963111|NCT04058522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963112|NCT04058522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963113|NCT00791232|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92963114|NCT00791232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92963115|NCT00791232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963116|NCT00791232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963117|NCT00791232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963118|NCT00791232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963119|NCT00791232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92963120|NCT00791232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92963121|NCT00791232|Serotonin Agents|serotonin agents|mesh-ancestor
92963122|NCT00791232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963123|NCT00791232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963124|NCT00791232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92963125|NCT00791232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92963126|NCT00791232|Dopamine Agents|dopamine agents|mesh-ancestor
92963127|NCT01563952|Sirolimus|sirolimus|mesh-list
92963128|NCT01563952|Umirolimus|umirolimus|mesh-list
92963129|NCT01563952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92963130|NCT01563952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963131|NCT01563952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92963132|NCT01563952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963133|NCT01563952|Antifungal Agents|antifungal agents|mesh-ancestor
92963134|NCT01563952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963135|NCT01563952|Immunologic Factors|immunologic factors|mesh-ancestor
92963136|NCT01563952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963137|NCT01563952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963138|NCT00795912|Atorvastatin|atorvastatin|mesh-list
92963139|NCT00795912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92963140|NCT00795912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92963141|NCT00795912|Antimetabolites|antimetabolites|mesh-ancestor
92963142|NCT00795912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963143|NCT00795912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92963144|NCT00795912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92963145|NCT00795912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963146|NCT00788034|Vortioxetine|vortioxetine|mesh-list
92963147|NCT00788034|Antidepressive Agents|antidepressive agents|mesh-ancestor
92963148|NCT00788034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963149|NCT00788034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92963150|NCT00788034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963151|NCT00788034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963152|NCT00788034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963153|NCT00788034|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92963154|NCT00788034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92963155|NCT00788034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92963156|NCT00788034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963157|NCT00788034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963158|NCT00788034|Serotonin Agents|serotonin agents|mesh-ancestor
92963159|NCT00788034|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92963160|NCT00788034|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92963161|NCT00788034|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92963162|NCT00788034|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92963163|NCT04004884|Ulipristal acetate|ulipristal acetate|mesh-list
92963164|NCT04004884|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92963165|NCT04004884|Contraceptive Agents|contraceptive agents|mesh-ancestor
92963166|NCT04004884|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92963167|NCT04004884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963168|NCT04004884|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92963169|NCT00688064|Doxycycline|doxycycline|mesh-list
92963170|NCT00688064|Adapalene|adapalene|mesh-list
92963171|NCT00688064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92963172|NCT00688064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963173|NCT00688064|Antimalarials|antimalarials|mesh-ancestor
92963174|NCT00688064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92963175|NCT00688064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92963176|NCT00688064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963177|NCT00688064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963178|NCT00688064|Analgesics|analgesics|mesh-ancestor
92963179|NCT00688064|Sensory System Agents|sensory system agents|mesh-ancestor
92963180|NCT00688064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963181|NCT00688064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963182|NCT00688064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963183|NCT00688064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963184|NCT00688064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92963185|NCT00788112|Vorinostat|vorinostat|mesh-list
92963186|NCT00788112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963187|NCT00788112|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92963188|NCT00788112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963189|NCT00788112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963190|NCT03112174|Venetoclax|venetoclax|mesh-list
92963191|NCT03112174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963192|NCT00749918|Vitamin D|vitamin d|mesh-list
92963193|NCT00749918|Cholecalciferol|cholecalciferol|mesh-list
92963194|NCT00749918|Vitamins|vitamins|mesh-ancestor
92963195|NCT00749918|Micronutrients|micronutrients|mesh-ancestor
92963196|NCT00749918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963197|NCT00749918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92963198|NCT00749918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92963199|NCT04058132|Sildenafil Citrate|sildenafil citrate|mesh-list
92963200|NCT04058132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963201|NCT04058132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92963202|NCT04058132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92963203|NCT04058132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92963204|NCT04058132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963205|NCT04058132|Urological Agents|urological agents|mesh-ancestor
92963206|NCT00791544|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92963207|NCT00791544|Sorafenib|sorafenib|mesh-list
92963208|NCT00791544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963209|NCT00791544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92963210|NCT00791544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963211|NCT00791544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963212|NCT05171686|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92963213|NCT05171686|Chlorthalidone|chlorthalidone|mesh-list
92963214|NCT05171686|Torsemide|torsemide|mesh-list
92963215|NCT05171686|Furosemide|furosemide|mesh-list
92963216|NCT05171686|Bumetanide|bumetanide|mesh-list
92963217|NCT05171686|Diuretics|diuretics|mesh-list
92963218|NCT05171686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92963219|NCT05171686|Natriuretic Agents|natriuretic agents|mesh-ancestor
92963220|NCT05171686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963221|NCT05171686|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92963222|NCT05171686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92963223|NCT05171686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963224|NCT05171686|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92963225|NCT00990028|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92963226|NCT00990028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92963227|NCT00990028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92963228|NCT00990028|Antimetabolites|antimetabolites|mesh-ancestor
92963229|NCT00990028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963230|NCT00990028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92963231|NCT00990028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92963232|NCT00990028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963233|NCT00663234|Atorvastatin|atorvastatin|mesh-list
92963234|NCT00663234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92963235|NCT00663234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92963236|NCT00663234|Antimetabolites|antimetabolites|mesh-ancestor
92963237|NCT00663234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963238|NCT00663234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92963239|NCT00663234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92963240|NCT00663234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963242|NCT00683384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963243|NCT00683384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963244|NCT00683384|Analgesics|analgesics|mesh-ancestor
92963245|NCT00683384|Sensory System Agents|sensory system agents|mesh-ancestor
92963246|NCT00683384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963247|NCT00683384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963248|NCT00683384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963249|NCT00683384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963250|NCT00683384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92963251|NCT00683384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963252|NCT00683384|Immunologic Factors|immunologic factors|mesh-ancestor
92963253|NCT00753740|Camptothecin|camptothecin|mesh-list
92963254|NCT00753740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963255|NCT00753740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963256|NCT00753740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92963257|NCT00753740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963258|NCT00753740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963259|NCT00753740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963260|NCT00326911|Bevacizumab|bevacizumab|mesh-list
92963262|NCT00326911|Gemcitabine|gemcitabine|mesh-list
92963263|NCT00326911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963264|NCT00326911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963265|NCT00326911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92963266|NCT00326911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92963267|NCT00326911|Growth Substances|growth substances|mesh-ancestor
92963268|NCT00326911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963269|NCT00326911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92963270|NCT00326911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963271|NCT00326911|Antimetabolites|antimetabolites|mesh-ancestor
92963272|NCT00326911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963273|NCT00791622|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92963274|NCT00791622|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92963275|NCT00791622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963276|NCT00791622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963277|NCT00791622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963278|NCT00791622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963279|NCT00791622|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92963280|NCT00791622|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92963281|NCT00791622|Serotonin Agents|serotonin agents|mesh-ancestor
92963282|NCT00791622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963283|NCT00791622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963284|NCT00791622|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92963285|NCT00791622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92963286|NCT00791622|Dopamine Agents|dopamine agents|mesh-ancestor
92963287|NCT00747110|Budesonide|budesonide|mesh-list
92963288|NCT00747110|Mesalamine|mesalamine|mesh-list
92963289|NCT00747110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963290|NCT00747110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92963291|NCT00747110|Autonomic Agents|autonomic agents|mesh-ancestor
92963292|NCT00747110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963293|NCT00747110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963294|NCT00747110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92963295|NCT00747110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92963296|NCT00747110|Glucocorticoids|glucocorticoids|mesh-ancestor
92963297|NCT00747110|Hormones|hormones|mesh-ancestor
92963298|NCT00747110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963299|NCT00747110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963300|NCT00747110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963301|NCT00747110|Analgesics|analgesics|mesh-ancestor
92963302|NCT00747110|Sensory System Agents|sensory system agents|mesh-ancestor
92963303|NCT00747110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963304|NCT00796458|Docetaxel|docetaxel|mesh-list
92963305|NCT00796458|Hormones|hormones|mesh-list
92963306|NCT00796458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963307|NCT00796458|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963308|NCT00796458|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963309|NCT00796458|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963310|NCT00796458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963311|NCT00796458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963312|NCT00796458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963313|NCT04046016|Paclitaxel|paclitaxel|mesh-list
92963314|NCT04046016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963315|NCT04046016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963316|NCT04046016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963317|NCT04046016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963318|NCT04046016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963319|NCT04046016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963320|NCT01057615|Ascorbic Acid|ascorbic acid|mesh-list
92963321|NCT01057615|Vitamins|vitamins|mesh-ancestor
92963322|NCT01057615|Micronutrients|micronutrients|mesh-ancestor
92963323|NCT01057615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963324|NCT01057615|Antioxidants|antioxidants|mesh-ancestor
92963325|NCT01057615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963326|NCT01057615|Protective Agents|protective agents|mesh-ancestor
92963327|NCT00788424|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92963328|NCT00788424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92963329|NCT00788424|Immunologic Factors|immunologic factors|mesh-ancestor
92963330|NCT00788424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963331|NCT00788424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963332|NCT00788424|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92963333|NCT00788424|Protective Agents|protective agents|mesh-ancestor
92963334|NCT00788424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92963335|NCT00788424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92963336|NCT00788424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963337|NCT00788424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963338|NCT00788424|Antiviral Agents|antiviral agents|mesh-ancestor
92963339|NCT00788424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963340|NCT00791856|Methyltestosterone|methyltestosterone|mesh-list
92963341|NCT00791856|Testosterone|testosterone|mesh-list
92963342|NCT00791856|Testosterone undecanoate|testosterone undecanoate|mesh-list
92963343|NCT00791856|Testosterone enanthate|testosterone enanthate|mesh-list
92963344|NCT00791856|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92963345|NCT00791856|Androgens|androgens|mesh-ancestor
92963346|NCT00791856|Hormones|hormones|mesh-ancestor
92963347|NCT00791856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963348|NCT00791856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963349|NCT00791856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92963350|NCT00791856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963351|NCT00791856|Anabolic Agents|anabolic agents|mesh-ancestor
92963352|NCT00796692|Heparin|heparin|mesh-list
92963353|NCT00796692|Calcium heparin|calcium heparin|mesh-list
92963354|NCT00796692|Nadroparin|nadroparin|mesh-list
92963355|NCT00796692|Anticoagulants|anticoagulants|mesh-ancestor
92963356|NCT00796692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92963357|NCT00796692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92963358|NCT00796692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963359|NCT00540436|Ambrisentan|ambrisentan|mesh-list
92963360|NCT00540436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92963361|NCT00788580|Sirolimus|sirolimus|mesh-list
92963362|NCT00788580|Temsirolimus|temsirolimus|mesh-list
92963363|NCT00788580|MTOR Inhibitors|mtor inhibitors|mesh-list
92963364|NCT00788580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92963365|NCT00788580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963366|NCT00788580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963367|NCT00788580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963368|NCT00788580|Immunologic Factors|immunologic factors|mesh-ancestor
92963369|NCT00788580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963370|NCT00788580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963371|NCT00788580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92963372|NCT00788580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963373|NCT00788580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92963374|NCT00788580|Antifungal Agents|antifungal agents|mesh-ancestor
92963375|NCT00792012|Temozolomide|temozolomide|mesh-list
92963376|NCT00792012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92963377|NCT00792012|Alkylating Agents|alkylating agents|mesh-ancestor
92963378|NCT00792012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963379|NCT00792012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963380|NCT00990418|Fentanyl|fentanyl|mesh-list
92963381|NCT00990418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92963382|NCT00990418|Narcotics|narcotics|mesh-ancestor
92963383|NCT00990418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963384|NCT00990418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963385|NCT00990418|Analgesics|analgesics|mesh-ancestor
92963386|NCT00990418|Sensory System Agents|sensory system agents|mesh-ancestor
92963387|NCT00990418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963388|NCT00990418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92963389|NCT00990418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92963390|NCT00990418|Anesthetics, General|anesthetics, general|mesh-ancestor
92963392|NCT02562950|Midazolam|midazolam|mesh-list
92963393|NCT02562950|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92963394|NCT02562950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92963395|NCT02562950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963396|NCT02562950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963397|NCT02562950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92963398|NCT02562950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963399|NCT02562950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963400|NCT02562950|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92963401|NCT02562950|Anesthetics, General|anesthetics, general|mesh-ancestor
92963402|NCT02562950|Anesthetics|anesthetics|mesh-ancestor
92963403|NCT02562950|GABA Modulators|gaba modulators|mesh-ancestor
92963404|NCT02562950|GABA Agents|gaba agents|mesh-ancestor
92963405|NCT02562950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963406|NCT02562950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963407|NCT00792168|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92963408|NCT00792168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92963409|NCT00792168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92963410|NCT00792168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92963411|NCT00792168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963412|NCT00792168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963413|NCT00792168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963414|NCT00792168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92963415|NCT00792168|Antidepressive Agents|antidepressive agents|mesh-ancestor
92963416|NCT00792168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963417|NCT00687440|Docetaxel|docetaxel|mesh-list
92963418|NCT00687440|Doxorubicin|doxorubicin|mesh-list
92963419|NCT00687440|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92963420|NCT00687440|Trastuzumab|trastuzumab|mesh-list
92963421|NCT00687440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963422|NCT00687440|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963423|NCT00687440|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963424|NCT00687440|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963425|NCT00687440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963426|NCT00687440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92963427|NCT00687440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92963428|NCT00687440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963429|NCT00687440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166186|NCT04961970|Vitamins|vitamins|mesh-ancestor
92963430|NCT00687440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963431|NCT02554734|Levodopa|levodopa|mesh-list
92963432|NCT02554734|Carbidopa|carbidopa|mesh-list
92963433|NCT02554734|Entacapone|entacapone|mesh-list
92963434|NCT02554734|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92963435|NCT02554734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92963436|NCT02554734|Dopamine Agents|dopamine agents|mesh-ancestor
92963437|NCT02554734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963438|NCT02554734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963439|NCT02554734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963440|NCT02554734|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92963441|NCT02554734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963442|NCT02554734|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92963443|NCT00990496|Cyclophosphamide|cyclophosphamide|mesh-list
92963444|NCT00990496|Fludarabine|fludarabine|mesh-list
92963445|NCT00990496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963446|NCT00990496|Immunologic Factors|immunologic factors|mesh-ancestor
92963447|NCT00990496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963448|NCT00990496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963449|NCT00990496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92963450|NCT00990496|Alkylating Agents|alkylating agents|mesh-ancestor
92963451|NCT00990496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963452|NCT00990496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963453|NCT00990496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92963454|NCT00754910|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92963456|NCT00754910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963457|NCT00754910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92963458|NCT00754910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92963459|NCT00755066|Fluticasone|fluticasone|mesh-list
92963460|NCT00755066|Xhance|xhance|mesh-list
92963461|NCT00755066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963462|NCT00755066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92963463|NCT00755066|Autonomic Agents|autonomic agents|mesh-ancestor
92963464|NCT00755066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963465|NCT00755066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963466|NCT00755066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92963467|NCT00755066|Respiratory System Agents|respiratory system agents|mesh-ancestor
92963468|NCT00755066|Dermatologic Agents|dermatologic agents|mesh-ancestor
92963469|NCT00755066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92963471|NCT00990574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963472|NCT00990574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963473|NCT00659490|Naproxen|naproxen|mesh-list
92963474|NCT00659490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963475|NCT00659490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963476|NCT00659490|Analgesics|analgesics|mesh-ancestor
92963477|NCT00659490|Sensory System Agents|sensory system agents|mesh-ancestor
92963478|NCT00659490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963479|NCT00659490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963480|NCT00659490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963481|NCT00659490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963482|NCT00659490|Gout Suppressants|gout suppressants|mesh-ancestor
92963483|NCT00659490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92963484|NCT00659490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963485|NCT00659490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963486|NCT00792246|Voriconazole|voriconazole|mesh-list
92963487|NCT00792246|Antifungal Agents|antifungal agents|mesh-ancestor
92963488|NCT00792246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963489|NCT00792246|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92963490|NCT00792246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92963491|NCT00792246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963492|NCT00792246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963493|NCT00792246|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92963494|NCT00792246|Hormone Antagonists|hormone antagonists|mesh-ancestor
92963495|NCT00792246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963496|NCT00792246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963497|NCT00792246|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92963498|NCT00539500|Carboplatin|carboplatin|mesh-list
92963499|NCT00539500|Etoposide|etoposide|mesh-list
92963500|NCT00539500|Melphalan|melphalan|mesh-list
92166189|NCT01311687|Pomalidomide|pomalidomide|mesh-list
92963501|NCT00539500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963502|NCT00539500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963503|NCT00539500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92963504|NCT00539500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963505|NCT00539500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963506|NCT00539500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963507|NCT00539500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92963508|NCT00539500|Alkylating Agents|alkylating agents|mesh-ancestor
92963509|NCT00539500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92963510|NCT00539500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963511|NCT00539500|Immunologic Factors|immunologic factors|mesh-ancestor
92963512|NCT00539500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963513|NCT00662532|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92963514|NCT00662532|Minocycline|minocycline|mesh-list
92963515|NCT00662532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963516|NCT00792324|Efavirenz|efavirenz|mesh-list
92963517|NCT00792324|Etravirine|etravirine|mesh-list
92963518|NCT00792324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92963519|NCT00792324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92963520|NCT00792324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963521|NCT00792324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963522|NCT00792324|Antiviral Agents|antiviral agents|mesh-ancestor
92963523|NCT00792324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963524|NCT00792324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92963525|NCT00792324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92963526|NCT00792324|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92963527|NCT00792324|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92963528|NCT00792324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92963529|NCT00792324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92963530|NCT00990808|Atorvastatin|atorvastatin|mesh-list
92963531|NCT00990808|Anacetrapib|anacetrapib|mesh-list
92963532|NCT00990808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92963533|NCT00990808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92963534|NCT00990808|Antimetabolites|antimetabolites|mesh-ancestor
92963535|NCT00990808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963536|NCT00990808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92963537|NCT00990808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92963538|NCT00990808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963539|NCT00797160|Propofol|propofol|mesh-list
92963540|NCT00797160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92963541|NCT00797160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963542|NCT00797160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963543|NCT00797160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92963544|NCT00797160|Anesthetics, General|anesthetics, general|mesh-ancestor
92963545|NCT00797160|Anesthetics|anesthetics|mesh-ancestor
92963546|NCT00682448|Metformin|metformin|mesh-list
92963547|NCT00682448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92963548|NCT00682448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963549|NCT04003792|Bevacizumab|bevacizumab|mesh-list
92963550|NCT04003792|Oxaliplatin|oxaliplatin|mesh-list
92963551|NCT04003792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963552|NCT04003792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963553|NCT04003792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92963554|NCT04003792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92963555|NCT04003792|Growth Substances|growth substances|mesh-ancestor
92963556|NCT04003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963557|NCT04003792|Growth Inhibitors|growth inhibitors|mesh-ancestor
92963558|NCT00990886|Oxybutynin|oxybutynin|mesh-list
92963559|NCT00990886|Parasympatholytics|parasympatholytics|mesh-ancestor
92963560|NCT00990886|Autonomic Agents|autonomic agents|mesh-ancestor
92963561|NCT00990886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963562|NCT00990886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963563|NCT00990886|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92963564|NCT00990886|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92963565|NCT00990886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92963566|NCT00990886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026489|NCT00401973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963567|NCT00990886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963568|NCT00990886|Urological Agents|urological agents|mesh-ancestor
92963569|NCT00797394|Saw palmetto extract|saw palmetto extract|mesh-list
92963570|NCT00797394|Urological Agents|urological agents|mesh-ancestor
92963571|NCT00681824|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92963572|NCT00681824|Thrombin|thrombin|mesh-list
92963573|NCT00681824|Aprotinin|aprotinin|mesh-list
92963574|NCT00681824|Hemostatics|hemostatics|mesh-ancestor
92963575|NCT00681824|Coagulants|coagulants|mesh-ancestor
92963576|NCT00681824|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92963577|NCT00681824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92963578|NCT00681824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92963579|NCT00681824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963580|NCT00681824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963581|NCT00797472|Bleomycin|bleomycin|mesh-list
92963582|NCT00797472|Dacarbazine|dacarbazine|mesh-list
92963583|NCT00797472|Vinblastine|vinblastine|mesh-list
92963584|NCT00797472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92963585|NCT00797472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963586|NCT00797472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963587|NCT00797472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92963588|NCT00797472|Alkylating Agents|alkylating agents|mesh-ancestor
92963589|NCT00797472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963590|NCT00797472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963591|NCT00797472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963592|NCT00797472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963593|NCT00681668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92963594|NCT00681668|Antidepressive Agents|antidepressive agents|mesh-ancestor
92963595|NCT00681668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963596|NCT00681668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92963597|NCT00681668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963598|NCT00681668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963599|NCT00681668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963600|NCT00539188|Acetylcysteine|acetylcysteine|mesh-list
92963601|NCT00539188|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92963602|NCT00539188|Antiviral Agents|antiviral agents|mesh-ancestor
92963603|NCT00539188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963604|NCT00539188|Expectorants|expectorants|mesh-ancestor
92963605|NCT00539188|Respiratory System Agents|respiratory system agents|mesh-ancestor
92963606|NCT00539188|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92963607|NCT00539188|Antioxidants|antioxidants|mesh-ancestor
92963608|NCT00539188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963609|NCT00539188|Protective Agents|protective agents|mesh-ancestor
92963610|NCT00539188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963611|NCT00539188|Antidotes|antidotes|mesh-ancestor
92963613|NCT00681590|Ergocalciferols|ergocalciferols|mesh-list
92963614|NCT00681590|Cholecalciferol|cholecalciferol|mesh-list
92963615|NCT00681590|Vitamins|vitamins|mesh-list
92963616|NCT00681590|Micronutrients|micronutrients|mesh-ancestor
92963617|NCT00681590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963618|NCT00681590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92963619|NCT00681590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92963620|NCT05359432|Empagliflozin|empagliflozin|mesh-list
92963621|NCT05359432|Vildagliptin|vildagliptin|mesh-list
92963622|NCT05359432|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92963623|NCT05359432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963624|NCT05359432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92963625|NCT05359432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963626|NCT05359432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92963627|NCT05359432|Protease Inhibitors|protease inhibitors|mesh-ancestor
92963628|NCT05359432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963629|NCT00755456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92963630|NCT00755534|Capecitabine|capecitabine|mesh-list
92963631|NCT00755534|Oxaliplatin|oxaliplatin|mesh-list
92963632|NCT00755534|Irinotecan|irinotecan|mesh-list
92963633|NCT00755534|Cetuximab|cetuximab|mesh-list
92963634|NCT00755534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963635|NCT00755534|Antimetabolites|antimetabolites|mesh-ancestor
92963636|NCT00755534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963637|NCT00755534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963638|NCT00755534|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92963639|NCT00755534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963640|NCT00755534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963641|NCT00755534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963642|NCT00326599|Carboplatin|carboplatin|mesh-list
92963643|NCT00326599|Gemcitabine|gemcitabine|mesh-list
92963644|NCT00326599|Cediranib|cediranib|mesh-list
92963645|NCT00326599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963646|NCT00326599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963647|NCT00326599|Antimetabolites|antimetabolites|mesh-ancestor
92963648|NCT00326599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963649|NCT00326599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963650|NCT00326599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92963651|NCT05004688|BCG Vaccine|bcg vaccine|mesh-list
92963652|NCT05004688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92963653|NCT05004688|Immunologic Factors|immunologic factors|mesh-ancestor
92963654|NCT05004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963655|NCT00750386|Paclitaxel|paclitaxel|mesh-list
92963656|NCT00750386|Carboplatin|carboplatin|mesh-list
92963657|NCT00750386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963658|NCT00750386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963659|NCT00750386|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963660|NCT00750386|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963661|NCT00750386|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963662|NCT00750386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963663|NCT00539032|Vaccines|vaccines|mesh-list
92963664|NCT00539032|Immunologic Factors|immunologic factors|mesh-ancestor
92963665|NCT00539032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963666|NCT00685802|Cilostazol|cilostazol|mesh-list
92963667|NCT00685802|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92527644|NCT00000641|Azithromycin|azithromycin|mesh-list
92963668|NCT00685802|Autonomic Agents|autonomic agents|mesh-ancestor
92963669|NCT00685802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963670|NCT00685802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963671|NCT00685802|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92963672|NCT00685802|Respiratory System Agents|respiratory system agents|mesh-ancestor
92963673|NCT00685802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92963674|NCT00685802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92963675|NCT00685802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963676|NCT00685802|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92963677|NCT00685802|Vasodilator Agents|vasodilator agents|mesh-ancestor
92963678|NCT00685802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92963679|NCT00685802|Protective Agents|protective agents|mesh-ancestor
92963680|NCT00685802|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92963681|NCT00685802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92963682|NCT00685802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963683|NCT01054651|Artesunate|artesunate|mesh-list
92609088|NCT00154323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92963684|NCT01054651|Pyrimethamine|pyrimethamine|mesh-list
92963685|NCT01054651|Sulfalene|sulfalene|mesh-list
92963686|NCT01054651|Praziquantel|praziquantel|mesh-list
92963687|NCT01054651|Antimalarials|antimalarials|mesh-ancestor
92963688|NCT01054651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92963689|NCT01054651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92963690|NCT01054651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963691|NCT01054651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963692|NCT01054651|Antiviral Agents|antiviral agents|mesh-ancestor
92963693|NCT01054651|Schistosomicides|schistosomicides|mesh-ancestor
92963694|NCT01054651|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92963695|NCT01054651|Anthelmintics|anthelmintics|mesh-ancestor
92963696|NCT01054651|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92963697|NCT01054651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963698|NCT01054651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963699|NCT01054651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92963700|NCT00792714|Mannitol|mannitol|mesh-list
92963701|NCT00792714|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92963702|NCT00792714|Diuretics|diuretics|mesh-ancestor
92963703|NCT00792714|Natriuretic Agents|natriuretic agents|mesh-ancestor
92963704|NCT00792714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963705|NCT04961554|Anesthetics|anesthetics|mesh-list
92166205|NCT01311687|Growth Inhibitors|growth inhibitors|mesh-ancestor
92963706|NCT04961554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963707|NCT04961554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963708|NCT00354601|Docetaxel|docetaxel|mesh-list
92963709|NCT00354601|Capecitabine|capecitabine|mesh-list
92963710|NCT00354601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963711|NCT00354601|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963712|NCT00354601|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963713|NCT00354601|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963714|NCT00354601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963715|NCT00354601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963716|NCT00354601|Antimetabolites|antimetabolites|mesh-ancestor
92963717|NCT01563640|Permethrin|permethrin|mesh-list
92963718|NCT01563640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963719|NCT01563640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963720|NCT00750620|Mirabegron|mirabegron|mesh-list
92963721|NCT00750620|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92963722|NCT00750620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92963723|NCT00750620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92963724|NCT00750620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92963725|NCT00750620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963726|NCT00750620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963727|NCT00750620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963728|NCT00750620|Urological Agents|urological agents|mesh-ancestor
92963729|NCT03827473|Ascorbic Acid|ascorbic acid|mesh-list
92963730|NCT03827473|Prednisone|prednisone|mesh-list
92963731|NCT03827473|Cortisone|cortisone|mesh-list
92963732|NCT03827473|Docetaxel|docetaxel|mesh-list
92963733|NCT03827473|Abiraterone Acetate|abiraterone acetate|mesh-list
92963734|NCT03827473|Methyltestosterone|methyltestosterone|mesh-list
92963735|NCT03827473|Hormones|hormones|mesh-list
92963736|NCT03827473|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92963737|NCT03827473|Androgens|androgens|mesh-list
92963738|NCT03827473|Androgen Antagonists|androgen antagonists|mesh-list
92963739|NCT03827473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963740|NCT03827473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963741|NCT03827473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963742|NCT03827473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963743|NCT03827473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963744|NCT03827473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963745|NCT03827473|Glucocorticoids|glucocorticoids|mesh-ancestor
92963746|NCT03827473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963747|NCT03827473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963748|NCT03827473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92963749|NCT03827473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92963750|NCT03827473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963751|NCT03827473|Hormone Antagonists|hormone antagonists|mesh-ancestor
92963752|NCT03827473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92963754|NCT03827473|Protective Agents|protective agents|mesh-ancestor
92963755|NCT03827473|Vitamins|vitamins|mesh-ancestor
92963756|NCT03827473|Micronutrients|micronutrients|mesh-ancestor
92963757|NCT03827473|Estrogens|estrogens|mesh-ancestor
92963758|NCT03827473|Anabolic Agents|anabolic agents|mesh-ancestor
92963759|NCT00800592|Sildenafil Citrate|sildenafil citrate|mesh-list
92963760|NCT00800592|Vasodilator Agents|vasodilator agents|mesh-ancestor
92963761|NCT00800592|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92963762|NCT00800592|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92963763|NCT00800592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963764|NCT00800592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963765|NCT00800592|Urological Agents|urological agents|mesh-ancestor
92963767|NCT00797784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963768|NCT00797784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963769|NCT00797784|Analgesics|analgesics|mesh-ancestor
92963770|NCT00797784|Sensory System Agents|sensory system agents|mesh-ancestor
92963771|NCT00797784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963772|NCT00797784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963773|NCT00797784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963774|NCT00797784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963775|NCT00797784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92963776|NCT00797784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963777|NCT00797784|Immunologic Factors|immunologic factors|mesh-ancestor
92963778|NCT00747968|Exenatide|exenatide|mesh-list
92963779|NCT00747968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92963780|NCT00747968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963781|NCT00747968|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92963782|NCT00747968|Incretins|incretins|mesh-ancestor
92963783|NCT00747968|Hormones|hormones|mesh-ancestor
92963784|NCT00747968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963785|NCT00755924|Acetic Acid|acetic acid|mesh-list
92963786|NCT00755924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92963787|NCT00755924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963788|NCT00800748|Ribavirin|ribavirin|mesh-list
92963789|NCT00800748|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92963790|NCT00800748|Antimetabolites|antimetabolites|mesh-ancestor
92963791|NCT00800748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963792|NCT00800748|Antiviral Agents|antiviral agents|mesh-ancestor
92963793|NCT00800748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963794|NCT05426174|Vaccines|vaccines|mesh-list
92963795|NCT05426174|Immunologic Factors|immunologic factors|mesh-ancestor
92963796|NCT05426174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963797|NCT00798252|Paclitaxel|paclitaxel|mesh-list
92963798|NCT00798252|Docetaxel|docetaxel|mesh-list
92963799|NCT00798252|Doxorubicin|doxorubicin|mesh-list
92963800|NCT00798252|Capecitabine|capecitabine|mesh-list
92963801|NCT00798252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92963802|NCT00798252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963803|NCT00798252|Tubulin Modulators|tubulin modulators|mesh-ancestor
92963804|NCT00798252|Antimitotic Agents|antimitotic agents|mesh-ancestor
92963805|NCT00798252|Mitosis Modulators|mitosis modulators|mesh-ancestor
92963806|NCT00798252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963807|NCT00798252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92963808|NCT00798252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92963809|NCT00798252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92963810|NCT00798252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963811|NCT00798252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92963812|NCT00798252|Antimetabolites|antimetabolites|mesh-ancestor
92963813|NCT00748046|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92963814|NCT00748046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963815|NCT00326209|Mesalamine|mesalamine|mesh-list
92963816|NCT00326209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963817|NCT00326209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963818|NCT00326209|Analgesics|analgesics|mesh-ancestor
92963819|NCT00326209|Sensory System Agents|sensory system agents|mesh-ancestor
92963820|NCT00326209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963821|NCT00326209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963822|NCT00326209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963823|NCT00326209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963824|NCT00537940|Pregabalin|pregabalin|mesh-list
92963825|NCT00537940|Gabapentin|gabapentin|mesh-list
92963826|NCT00537940|Analgesics|analgesics|mesh-ancestor
92963827|NCT00537940|Sensory System Agents|sensory system agents|mesh-ancestor
92963828|NCT00537940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963829|NCT00537940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963830|NCT00537940|Anticonvulsants|anticonvulsants|mesh-ancestor
92963831|NCT00537940|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92963832|NCT00537940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92963833|NCT00537940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963834|NCT00537940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92963835|NCT00537940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92963836|NCT00537940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92963837|NCT00537940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963838|NCT00537940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92963839|NCT00537940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92963840|NCT00537940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92609239|NCT00139256|Betamethasone|betamethasone|mesh-list
92963841|NCT00537940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963842|NCT00537940|Antimanic Agents|antimanic agents|mesh-ancestor
92963844|NCT00661362|Saxagliptin|saxagliptin|mesh-list
92963845|NCT00661362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92963846|NCT00661362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963847|NCT00661362|Incretins|incretins|mesh-ancestor
92963848|NCT00661362|Hormones|hormones|mesh-ancestor
92166216|NCT04961268|Ibuprofen|ibuprofen|mesh-list
92963849|NCT00661362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963850|NCT00661362|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92963851|NCT00661362|Protease Inhibitors|protease inhibitors|mesh-ancestor
92963852|NCT00661362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963853|NCT00661362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963854|NCT00748202|Complement C1s|complement c1s|mesh-list
92963855|NCT00748202|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92963856|NCT00748202|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92963857|NCT00748202|Immunologic Factors|immunologic factors|mesh-ancestor
92963858|NCT00748202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963859|NCT00748202|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92963860|NCT00748202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963861|NCT00325897|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92963862|NCT00325897|Azithromycin|azithromycin|mesh-list
92963863|NCT00325897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92963864|NCT00800826|Dexmedetomidine|dexmedetomidine|mesh-list
92963865|NCT00800826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92963866|NCT00800826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963867|NCT00800826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963868|NCT00800826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963869|NCT00800826|Analgesics|analgesics|mesh-ancestor
92963870|NCT00800826|Sensory System Agents|sensory system agents|mesh-ancestor
92963871|NCT00800826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963872|NCT00800826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92963873|NCT00800826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92963874|NCT00800826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92963875|NCT00800826|Adrenergic Agents|adrenergic agents|mesh-ancestor
92963876|NCT00800826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963877|NCT00800826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963878|NCT03989089|Pembrolizumab|pembrolizumab|mesh-list
92963879|NCT03989089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92963880|NCT03989089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963881|NCT03989089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92963882|NCT03989089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963883|NCT00793338|Sildenafil Citrate|sildenafil citrate|mesh-list
92963884|NCT00793338|Vasodilator Agents|vasodilator agents|mesh-ancestor
92963885|NCT00793338|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92963886|NCT00793338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92963887|NCT00793338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963888|NCT00793338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963889|NCT00793338|Urological Agents|urological agents|mesh-ancestor
92963890|NCT05406856|Cisplatin|cisplatin|mesh-list
92527646|NCT00000641|Rifampin|rifampin|mesh-list
92963891|NCT05406856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963892|NCT00344773|Gefitinib|gefitinib|mesh-list
92963893|NCT00344773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963894|NCT00344773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92963895|NCT00344773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963896|NCT00344773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963897|NCT02554344|Curcumin|curcumin|mesh-list
92963898|NCT02554344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963899|NCT02554344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963900|NCT02554344|Analgesics|analgesics|mesh-ancestor
92963901|NCT02554344|Sensory System Agents|sensory system agents|mesh-ancestor
92963902|NCT02554344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963903|NCT02554344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963904|NCT02554344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963905|NCT02554344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92963906|NCT02554344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963907|NCT02554344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963908|NCT02554344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963909|NCT01055041|Budesonide|budesonide|mesh-list
92963910|NCT01055041|Doxofylline|doxofylline|mesh-list
92963911|NCT01055041|Montelukast|montelukast|mesh-list
92963912|NCT01055041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609329|NCT00406341|Difluprednate|difluprednate|mesh-list
92963913|NCT01055041|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92963914|NCT01055041|Autonomic Agents|autonomic agents|mesh-ancestor
92264458|NCT01232504|Molgramostim|molgramostim|mesh-list
92963915|NCT01055041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963916|NCT01055041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963917|NCT01055041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92963918|NCT01055041|Respiratory System Agents|respiratory system agents|mesh-ancestor
92963919|NCT01055041|Glucocorticoids|glucocorticoids|mesh-ancestor
92963920|NCT01055041|Hormones|hormones|mesh-ancestor
92963921|NCT01055041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963922|NCT01055041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92963923|NCT01055041|Hormone Antagonists|hormone antagonists|mesh-ancestor
92963924|NCT01055041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92963925|NCT01055041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92963926|NCT01055041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963927|NCT01055041|Antitussive Agents|antitussive agents|mesh-ancestor
92963928|NCT01055041|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92963929|NCT01055041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963930|NCT00325819|Acetaminophen|acetaminophen|mesh-list
92963931|NCT00325819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963932|NCT00325819|Analgesics|analgesics|mesh-ancestor
92963933|NCT00325819|Sensory System Agents|sensory system agents|mesh-ancestor
92963934|NCT00325819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963935|NCT00325819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963936|NCT00325819|Antipyretics|antipyretics|mesh-ancestor
92963937|NCT00748358|Sunitinib|sunitinib|mesh-list
92963938|NCT00748358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92963939|NCT00748358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92963940|NCT00748358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92963941|NCT00748358|Growth Substances|growth substances|mesh-ancestor
92963942|NCT00748358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963943|NCT00748358|Growth Inhibitors|growth inhibitors|mesh-ancestor
92963944|NCT00748358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92963945|NCT00748358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963946|NCT00748358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963947|NCT00748436|Betahistine|betahistine|mesh-list
92963948|NCT00748436|Vasodilator Agents|vasodilator agents|mesh-ancestor
92963949|NCT00748436|Histamine Agonists|histamine agonists|mesh-ancestor
92963950|NCT00748436|Histamine Agents|histamine agents|mesh-ancestor
92963951|NCT00748436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92963952|NCT00748436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963953|NCT00748436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963954|NCT00756860|Sevelamer|sevelamer|mesh-list
92963955|NCT00756860|Chelating Agents|chelating agents|mesh-ancestor
92963956|NCT00756860|Sequestering Agents|sequestering agents|mesh-ancestor
92963957|NCT00756860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963958|NCT00757016|Triamcinolone|triamcinolone|mesh-list
92963959|NCT00757016|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92963960|NCT00757016|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92963961|NCT00757016|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92963962|NCT00757016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963963|NCT00757016|Glucocorticoids|glucocorticoids|mesh-ancestor
92963965|NCT00757016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92963966|NCT00757016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963967|NCT00757016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92963968|NCT00757016|Immunologic Factors|immunologic factors|mesh-ancestor
92963969|NCT00757016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92963970|NCT00757016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92963971|NCT00687362|Infliximab|infliximab|mesh-list
92963972|NCT00687362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92963973|NCT00687362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963974|NCT00687362|Dermatologic Agents|dermatologic agents|mesh-ancestor
92963975|NCT00687362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92963976|NCT00687362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166231|NCT04961268|Narcotics|narcotics|mesh-ancestor
92963977|NCT00757250|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92963978|NCT00757250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92963979|NCT00757250|Vasodilator Agents|vasodilator agents|mesh-ancestor
92963980|NCT00751478|Naltrexone|naltrexone|mesh-list
92963981|NCT00751478|Morphine|morphine|mesh-list
92963982|NCT00751478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92963983|NCT00751478|Narcotics|narcotics|mesh-ancestor
92963984|NCT00751478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92963985|NCT00751478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963986|NCT00751478|Analgesics|analgesics|mesh-ancestor
92963987|NCT00751478|Sensory System Agents|sensory system agents|mesh-ancestor
92963988|NCT00751478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963989|NCT00751478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92963990|NCT00751478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92963991|NCT00751556|Naproxen|naproxen|mesh-list
92963992|NCT00751556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92963993|NCT00751556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92963994|NCT00751556|Analgesics|analgesics|mesh-ancestor
92963995|NCT00751556|Sensory System Agents|sensory system agents|mesh-ancestor
92963996|NCT00751556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92963997|NCT00751556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92963998|NCT00751556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92963999|NCT00751556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964000|NCT00751556|Gout Suppressants|gout suppressants|mesh-ancestor
92964001|NCT00751556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92964002|NCT00751556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964003|NCT00751556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964004|NCT00685334|Olanzapine|olanzapine|mesh-list
92964005|NCT00685334|Aripiprazole|aripiprazole|mesh-list
92964006|NCT00685334|Antiemetics|antiemetics|mesh-ancestor
92964007|NCT00685334|Autonomic Agents|autonomic agents|mesh-ancestor
92964008|NCT00685334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964009|NCT00685334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964010|NCT00685334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964011|NCT00685334|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92964012|NCT00685334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92964013|NCT00685334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964014|NCT00685334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92964015|NCT00685334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92964016|NCT00685334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92964017|NCT00685334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92964018|NCT00685334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964019|NCT00685334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964020|NCT00685334|Serotonin Agents|serotonin agents|mesh-ancestor
92964021|NCT00685334|Antidepressive Agents|antidepressive agents|mesh-ancestor
92964022|NCT00685334|Dopamine Agonists|dopamine agonists|mesh-ancestor
92964023|NCT00685334|Dopamine Agents|dopamine agents|mesh-ancestor
92964024|NCT00685334|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92964025|NCT00685334|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92964026|NCT00685334|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92964027|NCT00685334|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92964028|NCT00685334|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92964029|NCT00685334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92964030|NCT00801294|Nintedanib|nintedanib|mesh-list
92964031|NCT00801294|Afatinib|afatinib|mesh-list
92964032|NCT00801294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964033|NCT00801294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964034|NCT00801294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964035|NCT00801294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964036|NCT04013919|Insulin|insulin|mesh-list
92309041|NCT00300768|Ivermectin|ivermectin|mesh-list
92964037|NCT04013919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92964038|NCT04013919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964039|NCT04013919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964040|NCT00344461|Tenofovir|tenofovir|mesh-list
92964041|NCT00344461|Nevirapine|nevirapine|mesh-list
92964042|NCT00344461|Antiviral Agents|antiviral agents|mesh-ancestor
92964043|NCT00344461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964044|NCT00344461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92964045|NCT00344461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964046|NCT00344461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964047|NCT00344461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964048|NCT00344461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92964049|NCT00344461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92964050|NCT00344461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92964051|NCT00344461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92964052|NCT00685178|Topiramate|topiramate|mesh-list
92964053|NCT00685178|Anticonvulsants|anticonvulsants|mesh-ancestor
92964054|NCT00685178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964055|NCT00685178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964056|NCT00537394|Raltegravir Potassium|raltegravir potassium|mesh-list
92964057|NCT00537394|Maraviroc|maraviroc|mesh-list
92964058|NCT00537394|Darunavir|darunavir|mesh-list
92964059|NCT00537394|Tipranavir|tipranavir|mesh-list
92964060|NCT00537394|Enfuvirtide|enfuvirtide|mesh-list
92609456|NCT04724343|Menotropins|menotropins|mesh-list
92964061|NCT00537394|Etravirine|etravirine|mesh-list
92964062|NCT00537394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92964063|NCT00537394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92964064|NCT00537394|Antiviral Agents|antiviral agents|mesh-ancestor
92964065|NCT00537394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964066|NCT00537394|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92964067|NCT00537394|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92964068|NCT00537394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964069|NCT00537394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964070|NCT00537394|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92964071|NCT00537394|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92964072|NCT00537394|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92964073|NCT00537394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92964074|NCT00537394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92964075|NCT00537394|Protease Inhibitors|protease inhibitors|mesh-ancestor
92964076|NCT00537394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92964077|NCT00537394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964078|NCT00933309|Metformin|metformin|mesh-list
92964079|NCT00933309|Rosiglitazone|rosiglitazone|mesh-list
92964080|NCT00933309|Exemestane|exemestane|mesh-list
92964081|NCT00933309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964082|NCT00933309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964083|NCT00933309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964084|NCT00933309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92964085|NCT00933309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92964086|NCT00933309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964087|NCT00933309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964088|NCT00933309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92964089|NCT00933309|Hormone Antagonists|hormone antagonists|mesh-ancestor
92964090|NCT00933309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964091|NCT00352885|Escitalopram|escitalopram|mesh-list
92964092|NCT00352885|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92964093|NCT00352885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92964094|NCT00352885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92964095|NCT00352885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964096|NCT00352885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964097|NCT00352885|Serotonin Agents|serotonin agents|mesh-ancestor
92964098|NCT00352885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964099|NCT00933387|Paclitaxel|paclitaxel|mesh-list
92964100|NCT00933387|Cetuximab|cetuximab|mesh-list
92964101|NCT00933387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92964102|NCT00933387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964103|NCT00933387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964104|NCT00933387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964105|NCT00933387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964106|NCT00933387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964107|NCT00933387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92964108|NCT00660660|Esomeprazole|esomeprazole|mesh-list
92964109|NCT00660660|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92964110|NCT00660660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964111|NCT00660660|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92964112|NCT00660660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964113|NCT00660660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964114|NCT02560766|Gabapentin|gabapentin|mesh-list
92964115|NCT02560766|Analgesics|analgesics|mesh-ancestor
92964116|NCT02560766|Sensory System Agents|sensory system agents|mesh-ancestor
92964117|NCT02560766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964118|NCT02560766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964119|NCT02560766|Anticonvulsants|anticonvulsants|mesh-ancestor
92964120|NCT02560766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92964121|NCT02560766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92964122|NCT02560766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964123|NCT02560766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92964124|NCT02560766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92964125|NCT02560766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92964126|NCT02560766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964127|NCT02560766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964128|NCT02560766|Antimanic Agents|antimanic agents|mesh-ancestor
92964129|NCT00933465|Loperamide|loperamide|mesh-list
92964130|NCT00933465|Antidiarrheals|antidiarrheals|mesh-list
92964131|NCT00933465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964132|NCT00757874|Clobetasol|clobetasol|mesh-list
92964133|NCT00757874|Tacrolimus|tacrolimus|mesh-list
92964134|NCT00757874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964135|NCT00757874|Immunologic Factors|immunologic factors|mesh-ancestor
92964136|NCT00757874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964137|NCT00757874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92609530|NCT01240759|Metformin|metformin|mesh-list
92964139|NCT00757874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964140|NCT00757874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964141|NCT00757874|Glucocorticoids|glucocorticoids|mesh-ancestor
92964142|NCT00757874|Hormones|hormones|mesh-ancestor
92964143|NCT00757874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964144|NCT00344305|Vaccines|vaccines|mesh-list
92964145|NCT00344305|Immunologic Factors|immunologic factors|mesh-ancestor
92964146|NCT00344305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964147|NCT00933777|Everolimus|everolimus|mesh-list
92964148|NCT00933777|Sorafenib|sorafenib|mesh-list
92964149|NCT00933777|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92964150|NCT00933777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964151|NCT00933777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964152|NCT00933777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964153|NCT00933777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964154|NCT00933777|Immunologic Factors|immunologic factors|mesh-ancestor
92964155|NCT00933777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964156|NCT00933777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964157|NCT00801450|Triamcinolone|triamcinolone|mesh-list
92964158|NCT00801450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92964159|NCT00801450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92964160|NCT00801450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92964161|NCT00801450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964162|NCT00801450|Glucocorticoids|glucocorticoids|mesh-ancestor
92964163|NCT00801450|Hormones|hormones|mesh-ancestor
92964164|NCT00801450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964165|NCT00801450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964166|NCT00801450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964167|NCT00801450|Immunologic Factors|immunologic factors|mesh-ancestor
92964168|NCT00801450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964169|NCT00801450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964170|NCT00660816|Docetaxel|docetaxel|mesh-list
92964171|NCT00660816|Pemetrexed|pemetrexed|mesh-list
92964172|NCT00660816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92964173|NCT00660816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964174|NCT00660816|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964175|NCT00660816|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964176|NCT00660816|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964177|NCT00660816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964178|NCT00660816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964179|NCT00660816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92964180|NCT00660816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964181|NCT00660816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964182|NCT00801528|Diclofenac|diclofenac|mesh-list
92964183|NCT00801528|Ropivacaine|ropivacaine|mesh-list
92964184|NCT00801528|Anesthetics, Local|anesthetics, local|mesh-ancestor
92964185|NCT00801528|Anesthetics|anesthetics|mesh-ancestor
92964186|NCT00801528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964187|NCT00801528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964188|NCT00801528|Sensory System Agents|sensory system agents|mesh-ancestor
92964189|NCT00801528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964190|NCT00801528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92964191|NCT00801528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92964193|NCT00801528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964194|NCT00801528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964195|NCT00801528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92964196|NCT00801528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964197|NCT00801528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964198|NCT01060891|Colistin|colistin|mesh-list
92964199|NCT01060891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92964200|NCT01060891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964201|NCT04003402|Ethanol|ethanol|mesh-list
92964202|NCT04003402|ASP8062|asp8062|mesh-list
92964203|NCT04003402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92964204|NCT04003402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964205|NCT04003402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964206|NCT04003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964207|NCT04003402|Analgesics|analgesics|mesh-ancestor
92964208|NCT04003402|Sensory System Agents|sensory system agents|mesh-ancestor
92964209|NCT04003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964210|NCT04003402|GABA Modulators|gaba modulators|mesh-ancestor
92964211|NCT04003402|GABA Agents|gaba agents|mesh-ancestor
92964212|NCT04003402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964213|NCT04003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964215|NCT00576056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964216|NCT00576056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964217|NCT00576056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964218|NCT00576056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964219|NCT05360602|Thioctic Acid|thioctic acid|mesh-list
92964220|NCT05360602|Antioxidants|antioxidants|mesh-ancestor
92964221|NCT05360602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964222|NCT05360602|Protective Agents|protective agents|mesh-ancestor
92964223|NCT05360602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964224|NCT05360602|Vitamin B Complex|vitamin b complex|mesh-ancestor
92964225|NCT05360602|Vitamins|vitamins|mesh-ancestor
92964226|NCT05360602|Micronutrients|micronutrients|mesh-ancestor
92964227|NCT00991744|Cytarabine|cytarabine|mesh-list
92964228|NCT00991744|Cortisone|cortisone|mesh-list
92964229|NCT00991744|Prednisolone|prednisolone|mesh-list
92964230|NCT00991744|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92964231|NCT00991744|Methylprednisolone|methylprednisolone|mesh-list
92964232|NCT00991744|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92964233|NCT00991744|Prednisolone acetate|prednisolone acetate|mesh-list
92964234|NCT00991744|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92964235|NCT00991744|Prednisolone phosphate|prednisolone phosphate|mesh-list
92964236|NCT00991744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92964237|NCT00991744|Antimetabolites|antimetabolites|mesh-ancestor
92964238|NCT00991744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964239|NCT00991744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964240|NCT00991744|Antiviral Agents|antiviral agents|mesh-ancestor
92964241|NCT00991744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964242|NCT00991744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964243|NCT00991744|Immunologic Factors|immunologic factors|mesh-ancestor
92964244|NCT00991744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964245|NCT00991744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964246|NCT00991744|Glucocorticoids|glucocorticoids|mesh-ancestor
92964247|NCT00991744|Hormones|hormones|mesh-ancestor
92964248|NCT00991744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964249|NCT00991744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92964250|NCT00991744|Antiemetics|antiemetics|mesh-ancestor
92964251|NCT00991744|Autonomic Agents|autonomic agents|mesh-ancestor
92964252|NCT00991744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964253|NCT00991744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964254|NCT00991744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92964255|NCT00991744|Protective Agents|protective agents|mesh-ancestor
92964256|NCT00798876|Vitamin E|vitamin e|mesh-list
92964257|NCT00798876|Vitamins|vitamins|mesh-ancestor
92964258|NCT00798876|Micronutrients|micronutrients|mesh-ancestor
92964259|NCT00798876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964260|NCT00798876|Antioxidants|antioxidants|mesh-ancestor
92309256|NCT05026320|Diclofenac|diclofenac|mesh-list
92964261|NCT00798876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964262|NCT00798876|Protective Agents|protective agents|mesh-ancestor
92964263|NCT00989404|Zanamivir|zanamivir|mesh-list
92964264|NCT00989404|Antiviral Agents|antiviral agents|mesh-ancestor
92964265|NCT00989404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964266|NCT00989404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964267|NCT00989404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964268|NCT00758030|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92964269|NCT00758030|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92964270|NCT00758030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92964271|NCT00758030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964272|NCT00758030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964273|NCT00758030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92964274|NCT00758030|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92964275|NCT00758030|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92964276|NCT00758030|Serotonin Agents|serotonin agents|mesh-ancestor
92964277|NCT00758030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964278|NCT00758030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964279|NCT00758030|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92964280|NCT00758030|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92964281|NCT00758030|Dopamine Agents|dopamine agents|mesh-ancestor
92964282|NCT00991822|Timolol|timolol|mesh-list
92964283|NCT00991822|Dorzolamide|dorzolamide|mesh-list
92964284|NCT00991822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92609677|NCT00140933|Rofecoxib|rofecoxib|mesh-list
92964285|NCT00991822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92964286|NCT00991822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92964287|NCT00991822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964288|NCT00991822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964289|NCT00991822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964290|NCT00991822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92964291|NCT00991822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92964292|NCT00991822|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92964293|NCT00991822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964294|NCT00798954|Sirolimus|sirolimus|mesh-list
92964295|NCT00798954|Paclitaxel|paclitaxel|mesh-list
92964296|NCT00798954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92964297|NCT00798954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964298|NCT00798954|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964299|NCT00798954|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964300|NCT00798954|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964301|NCT00798954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964302|NCT00798954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92964303|NCT00798954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964304|NCT00798954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92964305|NCT00798954|Antifungal Agents|antifungal agents|mesh-ancestor
92964306|NCT00798954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964307|NCT00798954|Immunologic Factors|immunologic factors|mesh-ancestor
92964308|NCT00798954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964309|NCT00934011|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92964310|NCT00934011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92964311|NCT00934011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964312|NCT00934011|Antitubercular Agents|antitubercular agents|mesh-ancestor
92964313|NCT00934167|Heparin|heparin|mesh-list
92964314|NCT00934167|Calcium heparin|calcium heparin|mesh-list
92964315|NCT00934167|Anticoagulants|anticoagulants|mesh-ancestor
92964316|NCT00934167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92964317|NCT00934167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92964318|NCT00934167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964319|NCT00801606|Zinc|zinc|mesh-list
92964320|NCT00801606|Trace Elements|trace elements|mesh-list
92964321|NCT00801606|Micronutrients|micronutrients|mesh-list
92964322|NCT00801606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964323|NCT00934245|Vaccines|vaccines|mesh-list
92166270|NCT01457131|Fludarabine|fludarabine|mesh-list
92964324|NCT00934245|Immunologic Factors|immunologic factors|mesh-ancestor
92964325|NCT00934245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964326|NCT02560688|Clopidogrel|clopidogrel|mesh-list
92964327|NCT02560688|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92964328|NCT02560688|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92964329|NCT02560688|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92964330|NCT02560688|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92964331|NCT02560688|Purinergic Agents|purinergic agents|mesh-ancestor
92964332|NCT02560688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527654|NCT00000641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964333|NCT02560688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964334|NCT02560688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964335|NCT00939549|Cyclophosphamide|cyclophosphamide|mesh-list
92964336|NCT00939549|Glatiramer Acetate|glatiramer acetate|mesh-list
92964337|NCT00939549|(T,G)-A-L|(t,g)-a-l|mesh-list
92964338|NCT00939549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964339|NCT00939549|Immunologic Factors|immunologic factors|mesh-ancestor
92964340|NCT00939549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964341|NCT00939549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964342|NCT00939549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92964343|NCT00939549|Alkylating Agents|alkylating agents|mesh-ancestor
92964344|NCT00939549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964345|NCT00939549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964346|NCT00939549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92964347|NCT00939549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92964348|NCT00934323|Metformin|metformin|mesh-list
92964349|NCT00934323|Glimepiride|glimepiride|mesh-list
92964350|NCT00934323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964351|NCT00934323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964352|NCT00934323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92964353|NCT00934323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964354|NCT00934323|Immunologic Factors|immunologic factors|mesh-ancestor
92964355|NCT00575666|Insulin|insulin|mesh-list
92964356|NCT00575666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964357|NCT00575666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964358|NCT00934479|Lubiprostone|lubiprostone|mesh-list
92964359|NCT00934479|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92964360|NCT00934479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609751|NCT00141089|Tegaserod|tegaserod|mesh-list
92964361|NCT00934479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964362|NCT00658632|Esomeprazole|esomeprazole|mesh-list
92964364|NCT00658632|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92964365|NCT00658632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964366|NCT00658632|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92964367|NCT00658632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964368|NCT00658632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964369|NCT00677534|Vitamin D|vitamin d|mesh-list
92964370|NCT00677534|Cholecalciferol|cholecalciferol|mesh-list
92964371|NCT00677534|Ergocalciferols|ergocalciferols|mesh-list
92964372|NCT00677534|Vitamins|vitamins|mesh-ancestor
92964373|NCT00677534|Micronutrients|micronutrients|mesh-ancestor
92964374|NCT00677534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964375|NCT00677534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92964376|NCT00677534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92964377|NCT00989716|Antihypertensive Agents|antihypertensive agents|mesh-list
92964378|NCT00989716|Nitroglycerin|nitroglycerin|mesh-list
92964379|NCT00989716|Vasodilator Agents|vasodilator agents|mesh-ancestor
92964380|NCT00660348|Morphine|morphine|mesh-list
92964381|NCT00660348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92964382|NCT00660348|Narcotics|narcotics|mesh-ancestor
92964383|NCT00660348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964384|NCT00660348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964385|NCT00660348|Analgesics|analgesics|mesh-ancestor
92964386|NCT00660348|Sensory System Agents|sensory system agents|mesh-ancestor
92964387|NCT00660348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964388|NCT03734198|Daratumumab|daratumumab|mesh-list
92964389|NCT03734198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92964390|NCT03734198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964391|NCT03734198|Immunologic Factors|immunologic factors|mesh-ancestor
92166274|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964392|NCT03734198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964393|NCT01564108|Ranibizumab|ranibizumab|mesh-list
92964394|NCT01564108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92964395|NCT01564108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92964396|NCT01564108|Growth Substances|growth substances|mesh-ancestor
92964397|NCT01564108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964398|NCT01564108|Growth Inhibitors|growth inhibitors|mesh-ancestor
92964399|NCT01564108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964400|NCT00801918|Cyclophosphamide|cyclophosphamide|mesh-list
92964401|NCT00801918|Ifosfamide|ifosfamide|mesh-list
92964402|NCT00801918|Etoposide|etoposide|mesh-list
92964403|NCT00801918|Denileukin diftitox|denileukin diftitox|mesh-list
92964404|NCT00801918|Interleukin-2|interleukin-2|mesh-list
92964405|NCT00801918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964406|NCT00801918|Immunologic Factors|immunologic factors|mesh-ancestor
92309393|NCT02564029|Lorazepam|lorazepam|mesh-list
92964407|NCT00801918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964408|NCT00801918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964409|NCT00801918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92964410|NCT00801918|Alkylating Agents|alkylating agents|mesh-ancestor
92964411|NCT00801918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964412|NCT00801918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964413|NCT00801918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92964414|NCT00801918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92964415|NCT00801918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92964416|NCT00801918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92964417|NCT00801918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964418|NCT00801918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92964419|NCT00801918|Analgesics|analgesics|mesh-ancestor
92964420|NCT00801918|Sensory System Agents|sensory system agents|mesh-ancestor
92964421|NCT00801918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964422|NCT00799188|Everolimus|everolimus|mesh-list
92964423|NCT00799188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92964424|NCT00799188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964425|NCT00799188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964426|NCT00799188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964427|NCT00799188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964428|NCT00799188|Immunologic Factors|immunologic factors|mesh-ancestor
92964429|NCT00799188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964430|NCT00799188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964431|NCT00571688|Risperidone|risperidone|mesh-list
92964432|NCT00571688|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92964433|NCT00571688|Serotonin Agents|serotonin agents|mesh-ancestor
92964434|NCT00571688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964435|NCT00571688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964436|NCT00571688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964437|NCT00571688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92964438|NCT00571688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92964439|NCT00571688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964440|NCT00571688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92964441|NCT00571688|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92964443|NCT00799656|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
92964444|NCT00799656|Enzyme Activators|enzyme activators|mesh-ancestor
92964445|NCT00799656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964446|NCT05408104|Tolvaptan|tolvaptan|mesh-list
92964447|NCT05408104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92964448|NCT05408104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964449|NCT05408104|Natriuretic Agents|natriuretic agents|mesh-ancestor
92964450|NCT05408104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964451|NCT04837716|Bevacizumab|bevacizumab|mesh-list
92964452|NCT04837716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92964453|NCT04837716|Carboplatin|carboplatin|mesh-list
92964454|NCT04837716|Pemetrexed|pemetrexed|mesh-list
92964455|NCT04837716|Ensartinib|ensartinib|mesh-list
92964456|NCT04837716|Endothelial Growth Factors|endothelial growth factors|mesh-list
92964457|NCT04837716|Antibodies|antibodies|mesh-list
92964458|NCT04837716|Immunoglobulins|immunoglobulins|mesh-list
92964459|NCT04837716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92964460|NCT04837716|Immunoglobulin G|immunoglobulin g|mesh-list
92964461|NCT04837716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964462|NCT04837716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92964463|NCT04837716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92964464|NCT04837716|Growth Substances|growth substances|mesh-ancestor
92964465|NCT04837716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964466|NCT04837716|Growth Inhibitors|growth inhibitors|mesh-ancestor
92964467|NCT04837716|Immunologic Factors|immunologic factors|mesh-ancestor
92964468|NCT04837716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964469|NCT04837716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964470|NCT04837716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92964471|NCT04837716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964472|NCT04837716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964473|NCT00343291|Paclitaxel|paclitaxel|mesh-list
92964474|NCT00343291|Bevacizumab|bevacizumab|mesh-list
92964475|NCT00343291|Carboplatin|carboplatin|mesh-list
92964476|NCT00343291|Cetuximab|cetuximab|mesh-list
92964477|NCT00343291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92964478|NCT00343291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964479|NCT00343291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964480|NCT00343291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964481|NCT00343291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964482|NCT00343291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964483|NCT00343291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92964484|NCT00343291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92964485|NCT00343291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92964486|NCT00343291|Growth Substances|growth substances|mesh-ancestor
92964487|NCT00343291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964488|NCT00343291|Growth Inhibitors|growth inhibitors|mesh-ancestor
92964490|NCT05407870|Etomidate|etomidate|mesh-list
92964491|NCT05407870|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92964492|NCT05407870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964493|NCT05407870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964494|NCT05407870|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92964495|NCT05407870|Anesthetics, General|anesthetics, general|mesh-ancestor
92964496|NCT05407870|Anesthetics|anesthetics|mesh-ancestor
92964497|NCT03988231|Enoxaparin|enoxaparin|mesh-list
92964498|NCT03988231|Anticoagulants|anticoagulants|mesh-ancestor
92964499|NCT03988231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92964500|NCT03988231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92964501|NCT03988231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964502|NCT00658788|Calcitriol|calcitriol|mesh-list
92964503|NCT00658788|Clobetasol|clobetasol|mesh-list
92964504|NCT00658788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92964505|NCT00658788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964506|NCT00658788|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92964507|NCT00658788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92964508|NCT00658788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964509|NCT00658788|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92964510|NCT00658788|Vitamins|vitamins|mesh-ancestor
92964511|NCT00658788|Micronutrients|micronutrients|mesh-ancestor
92964512|NCT00658788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92964513|NCT00658788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964514|NCT00658788|Glucocorticoids|glucocorticoids|mesh-ancestor
92964515|NCT00658788|Hormones|hormones|mesh-ancestor
92964516|NCT00658788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964517|NCT01060969|Acetazolamide|acetazolamide|mesh-list
92964518|NCT01060969|Tadalafil|tadalafil|mesh-list
92964519|NCT01060969|Vasodilator Agents|vasodilator agents|mesh-ancestor
92964520|NCT01060969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92964521|NCT01060969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92964522|NCT01060969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964523|NCT01060969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964524|NCT01060969|Urological Agents|urological agents|mesh-ancestor
92964525|NCT01060969|Anticonvulsants|anticonvulsants|mesh-ancestor
92964526|NCT01060969|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92964527|NCT01060969|Diuretics|diuretics|mesh-ancestor
92964528|NCT01060969|Natriuretic Agents|natriuretic agents|mesh-ancestor
92964529|NCT01060969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964530|NCT05407246|Hemay005|hemay005|mesh-list
92964531|NCT05407246|Dermatologic Agents|dermatologic agents|mesh-ancestor
92964532|NCT05407246|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92964533|NCT05407246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92964534|NCT05407246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964535|NCT05407246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964536|NCT00799890|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92964537|NCT00799890|Antioxidants|antioxidants|mesh-ancestor
92964538|NCT00799890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964539|NCT00799890|Protective Agents|protective agents|mesh-ancestor
92964540|NCT00799890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964541|NCT00799890|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92964542|NCT00799890|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92964543|NCT00799890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964544|NCT00799890|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92964545|NCT00799968|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92964546|NCT00799968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92964547|NCT00799968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964548|NCT05590312|Anesthetics|anesthetics|mesh-list
92964549|NCT05590312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964550|NCT05590312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964551|NCT00802230|Terbutaline|terbutaline|mesh-list
92964552|NCT00802230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92964553|NCT00802230|Autonomic Agents|autonomic agents|mesh-ancestor
92964554|NCT00802230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964555|NCT00802230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964556|NCT00802230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92964557|NCT00802230|Respiratory System Agents|respiratory system agents|mesh-ancestor
92964558|NCT00802230|Sympathomimetics|sympathomimetics|mesh-ancestor
92964559|NCT00802230|Tocolytic Agents|tocolytic agents|mesh-ancestor
92964560|NCT00802230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92964561|NCT00802230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92964562|NCT00802230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92964563|NCT00802230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92964564|NCT00802230|Adrenergic Agents|adrenergic agents|mesh-ancestor
92964565|NCT00802230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964566|NCT00802230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964567|NCT00802308|Morphine|morphine|mesh-list
92964568|NCT00802308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92964569|NCT00802308|Narcotics|narcotics|mesh-ancestor
92964570|NCT00802308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964571|NCT00802308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964572|NCT00802308|Analgesics|analgesics|mesh-ancestor
92964573|NCT00802308|Sensory System Agents|sensory system agents|mesh-ancestor
92964574|NCT00802308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964575|NCT00562965|Dexamethasone|dexamethasone|mesh-list
92964576|NCT00562965|Prednisone|prednisone|mesh-list
92964577|NCT00562965|Prednisolone|prednisolone|mesh-list
92964578|NCT00562965|Cyclophosphamide|cyclophosphamide|mesh-list
92964579|NCT00562965|Rituximab|rituximab|mesh-list
92964580|NCT00562965|Fludarabine|fludarabine|mesh-list
92964581|NCT00562965|Vincristine|vincristine|mesh-list
92964582|NCT00562965|Mitoxantrone|mitoxantrone|mesh-list
92964583|NCT00562965|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92964584|NCT00562965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964585|NCT00562965|Immunologic Factors|immunologic factors|mesh-ancestor
92964586|NCT00562965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964587|NCT00562965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964588|NCT00562965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92964589|NCT00562965|Alkylating Agents|alkylating agents|mesh-ancestor
92964590|NCT00562965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964591|NCT00562965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964592|NCT00562965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92964593|NCT00562965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92964594|NCT00562965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964595|NCT00562965|Antiemetics|antiemetics|mesh-ancestor
92964596|NCT00562965|Autonomic Agents|autonomic agents|mesh-ancestor
92964597|NCT00562965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964598|NCT00562965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964599|NCT00562965|Glucocorticoids|glucocorticoids|mesh-ancestor
92964601|NCT00562965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964602|NCT00562965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92964603|NCT00562965|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92964604|NCT00562965|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964605|NCT00562965|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964606|NCT00562965|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964607|NCT00562965|Analgesics|analgesics|mesh-ancestor
92964608|NCT00562965|Sensory System Agents|sensory system agents|mesh-ancestor
92964609|NCT00562965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92964610|NCT00562965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92964611|NCT00562965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964612|NCT00562965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92964613|NCT00562965|Immunotoxins|immunotoxins|mesh-ancestor
92964614|NCT00562965|Immunoconjugates|immunoconjugates|mesh-ancestor
92964615|NCT05406934|Infliximab|infliximab|mesh-list
92964616|NCT05406934|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92964617|NCT05406934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964618|NCT05406934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92964619|NCT05406934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964620|NCT05406934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964621|NCT00794898|Infliximab|infliximab|mesh-list
92964622|NCT00794898|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92964623|NCT00794898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964624|NCT00794898|Dermatologic Agents|dermatologic agents|mesh-ancestor
92964625|NCT00794898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964626|NCT00794898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964627|NCT00800280|Cimetidine|cimetidine|mesh-list
92964628|NCT00800280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92964629|NCT00800280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964630|NCT00800280|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92964631|NCT00800280|Histamine Antagonists|histamine antagonists|mesh-ancestor
92964632|NCT00800280|Histamine Agents|histamine agents|mesh-ancestor
92964633|NCT00800280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964634|NCT00800280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964635|NCT00800280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964636|NCT00800280|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92964637|NCT00800280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92964638|NCT00800280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964639|NCT00800358|Calcitriol|calcitriol|mesh-list
92964640|NCT00800358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92964641|NCT00800358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964642|NCT00800358|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92964643|NCT00800358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92964644|NCT00800358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964645|NCT00800358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92964646|NCT00800358|Vitamins|vitamins|mesh-ancestor
92964647|NCT00800358|Micronutrients|micronutrients|mesh-ancestor
92964648|NCT00800358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92964649|NCT00934713|Montelukast|montelukast|mesh-list
92964650|NCT00934713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92964651|NCT00934713|Respiratory System Agents|respiratory system agents|mesh-ancestor
92964652|NCT00934713|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92964653|NCT00934713|Hormone Antagonists|hormone antagonists|mesh-ancestor
92964654|NCT00934713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964655|NCT00934713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964656|NCT00934713|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92964657|NCT00934713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92964658|NCT00934713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964659|NCT01057849|Olanzapine|olanzapine|mesh-list
92964660|NCT01057849|Risperidone|risperidone|mesh-list
92964661|NCT01057849|Aripiprazole|aripiprazole|mesh-list
92610043|NCT02275663|Antimetabolites|antimetabolites|mesh-ancestor
92964662|NCT01057849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92964663|NCT01057849|Serotonin Agents|serotonin agents|mesh-ancestor
92964664|NCT01057849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964665|NCT01057849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964666|NCT01057849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964667|NCT01057849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92964668|NCT01057849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92964669|NCT01057849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964670|NCT01057849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92964671|NCT01057849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92964672|NCT01057849|Dopamine Agents|dopamine agents|mesh-ancestor
92964673|NCT01057849|Antiemetics|antiemetics|mesh-ancestor
92964674|NCT01057849|Autonomic Agents|autonomic agents|mesh-ancestor
92964675|NCT01057849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964676|NCT01057849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964677|NCT01057849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92964678|NCT01057849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92964679|NCT01057849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92964680|NCT01057849|Antidepressive Agents|antidepressive agents|mesh-ancestor
92964681|NCT01057849|Dopamine Agonists|dopamine agonists|mesh-ancestor
92964682|NCT01057849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92964683|NCT01057849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92964684|NCT01057849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92964685|NCT01057849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92964686|NCT00794976|Dexamethasone|dexamethasone|mesh-list
92964687|NCT00794976|Dexamethasone acetate|dexamethasone acetate|mesh-list
92964689|NCT00794976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964690|NCT00794976|Antiemetics|antiemetics|mesh-ancestor
92964691|NCT00794976|Autonomic Agents|autonomic agents|mesh-ancestor
92964692|NCT00794976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964693|NCT00794976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964694|NCT00794976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964695|NCT00794976|Glucocorticoids|glucocorticoids|mesh-ancestor
92964696|NCT00794976|Hormones|hormones|mesh-ancestor
92964697|NCT00794976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964698|NCT00794976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92964699|NCT00794976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964700|NCT00794976|Protease Inhibitors|protease inhibitors|mesh-ancestor
92964701|NCT00794976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964702|NCT00794976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964703|NCT00939939|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92964704|NCT00939939|Glimepiride|glimepiride|mesh-list
92964705|NCT00939939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964706|NCT00939939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964707|NCT00939939|Incretins|incretins|mesh-ancestor
92964708|NCT00939939|Hormones|hormones|mesh-ancestor
92964709|NCT00939939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964710|NCT00939939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92964711|NCT00939939|Protease Inhibitors|protease inhibitors|mesh-ancestor
92964712|NCT00939939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964713|NCT00939939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964714|NCT00939939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92964715|NCT00939939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964716|NCT00939939|Immunologic Factors|immunologic factors|mesh-ancestor
92964717|NCT00537082|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92964718|NCT00537082|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92964719|NCT00537082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964720|NCT00537082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964721|NCT00537082|Immunologic Factors|immunologic factors|mesh-ancestor
92964722|NCT00537082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964723|NCT00805662|Oxytocin|oxytocin|mesh-list
92964724|NCT00805662|Oxytocics|oxytocics|mesh-ancestor
92964725|NCT00805662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92964726|NCT00805662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964727|NCT04978012|Fluzoparib|fluzoparib|mesh-list
92964728|NCT04978012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92964729|NCT04978012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964730|NCT04978012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964731|NCT04978012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964732|NCT00803166|Clobetasol|clobetasol|mesh-list
92964733|NCT00803166|Halobetasol|halobetasol|mesh-list
92964734|NCT00803166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92964735|NCT00803166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964736|NCT00803166|Glucocorticoids|glucocorticoids|mesh-ancestor
92964738|NCT00803166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964739|NCT00803166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964740|NCT00324961|Adefovir|adefovir|mesh-list
92964741|NCT00324961|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92964742|NCT00324961|Antiviral Agents|antiviral agents|mesh-ancestor
92964743|NCT00324961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964744|NCT00324961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92964745|NCT00324961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964746|NCT00324961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964747|NCT00324961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964748|NCT00935415|Montelukast|montelukast|mesh-list
92964749|NCT00935415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92964750|NCT00935415|Respiratory System Agents|respiratory system agents|mesh-ancestor
92964751|NCT00935415|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92964752|NCT00935415|Hormone Antagonists|hormone antagonists|mesh-ancestor
92964753|NCT00935415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964754|NCT00935415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964755|NCT00935415|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92964756|NCT00935415|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92964757|NCT00935415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964758|NCT00935571|Remifentanil|remifentanil|mesh-list
92964759|NCT00935571|Propofol|propofol|mesh-list
92964760|NCT00935571|Sevoflurane|sevoflurane|mesh-list
92964761|NCT00935571|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92964762|NCT00935571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964763|NCT00935571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964764|NCT00935571|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92964765|NCT00935571|Anesthetics, General|anesthetics, general|mesh-ancestor
92964766|NCT00935571|Anesthetics|anesthetics|mesh-ancestor
92964767|NCT00935571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92964768|NCT00935571|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92964769|NCT00935571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92964770|NCT00935571|Narcotics|narcotics|mesh-ancestor
92964771|NCT00935571|Analgesics|analgesics|mesh-ancestor
92964772|NCT00935571|Sensory System Agents|sensory system agents|mesh-ancestor
92964773|NCT00935571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964774|NCT00324649|Lamivudine|lamivudine|mesh-list
92964775|NCT00324649|Zidovudine|zidovudine|mesh-list
92964776|NCT00324649|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92964777|NCT00324649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92964778|NCT00324649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964779|NCT00324649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964780|NCT00324649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964781|NCT00324649|Antiviral Agents|antiviral agents|mesh-ancestor
92964782|NCT00324649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964783|NCT00324649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92964784|NCT00324649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92964785|NCT00324649|Antimetabolites|antimetabolites|mesh-ancestor
92964786|NCT03743259|Charcoal|charcoal|mesh-list
92964787|NCT03743259|Antidotes|antidotes|mesh-ancestor
92964788|NCT03743259|Protective Agents|protective agents|mesh-ancestor
92964789|NCT03743259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964790|NCT03983239|Efavirenz|efavirenz|mesh-list
92964791|NCT03983239|Rifampin|rifampin|mesh-list
92964792|NCT03983239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92964793|NCT03983239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964794|NCT03983239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964795|NCT03983239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964796|NCT03983239|Antiviral Agents|antiviral agents|mesh-ancestor
92964797|NCT03983239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964798|NCT03983239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92964799|NCT03983239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92964800|NCT03983239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92964801|NCT03983239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92964802|NCT03983239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92964803|NCT03983239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92964804|NCT03983239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92964805|NCT03983239|Antitubercular Agents|antitubercular agents|mesh-ancestor
92964806|NCT03983239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92964807|NCT03983239|Leprostatic Agents|leprostatic agents|mesh-ancestor
92964808|NCT03983239|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92964809|NCT03983239|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92964810|NCT03983239|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92964811|NCT00935805|Insulin|insulin|mesh-list
92964812|NCT00935805|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92964813|NCT00935805|Metformin|metformin|mesh-list
92964814|NCT00935805|Insulin, Isophane|insulin, isophane|mesh-list
92964815|NCT00935805|Isophane Insulin, Human|isophane insulin, human|mesh-list
92964816|NCT00935805|Isophane insulin, beef|isophane insulin, beef|mesh-list
92964817|NCT00935805|Glyburide|glyburide|mesh-list
92964818|NCT00935805|Propranolol|propranolol|mesh-list
92964819|NCT00935805|Amlodipine|amlodipine|mesh-list
92964820|NCT00935805|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92964821|NCT00935805|Captopril|captopril|mesh-list
92964822|NCT00935805|Diuretics|diuretics|mesh-list
92964823|NCT00935805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964824|NCT00935805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964825|NCT00935805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92964826|NCT00935805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92964827|NCT00935805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92964828|NCT00935805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964829|NCT00935805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92964830|NCT00935805|Vasodilator Agents|vasodilator agents|mesh-ancestor
92964831|NCT00935805|Natriuretic Agents|natriuretic agents|mesh-ancestor
92964832|NCT00935805|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92964833|NCT00935805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92964834|NCT00935805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92964835|NCT00935805|Adrenergic Agents|adrenergic agents|mesh-ancestor
92964836|NCT00935805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92964837|NCT00935805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92964838|NCT00935805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92964839|NCT00935805|Protease Inhibitors|protease inhibitors|mesh-ancestor
92964840|NCT00935805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964841|NCT00935961|Docetaxel|docetaxel|mesh-list
92964842|NCT00935961|Everolimus|everolimus|mesh-list
92964843|NCT00935961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964844|NCT00935961|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964845|NCT00935961|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964846|NCT00935961|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964847|NCT00935961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964848|NCT00935961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92964849|NCT00935961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92964850|NCT00935961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964851|NCT00935961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964852|NCT00935961|Immunologic Factors|immunologic factors|mesh-ancestor
92964853|NCT00935961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964854|NCT01055431|Iron|iron|mesh-list
92964855|NCT01055431|Trace Elements|trace elements|mesh-ancestor
92964856|NCT01055431|Micronutrients|micronutrients|mesh-ancestor
92964857|NCT01055431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964858|NCT00803556|Paclitaxel|paclitaxel|mesh-list
92964859|NCT00803556|Trastuzumab|trastuzumab|mesh-list
92964860|NCT00803556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92964861|NCT00803556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964862|NCT00803556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92964863|NCT00803556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92964864|NCT00803556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92964865|NCT00803556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964866|NCT00803556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92964867|NCT00936195|Ritonavir|ritonavir|mesh-list
92964868|NCT00936195|Lopinavir|lopinavir|mesh-list
92964869|NCT00936195|Tenofovir|tenofovir|mesh-list
92964870|NCT00936195|Lamivudine|lamivudine|mesh-list
92964871|NCT00936195|Emtricitabine|emtricitabine|mesh-list
92964872|NCT00936195|Zidovudine|zidovudine|mesh-list
92964873|NCT00936195|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92964874|NCT00936195|Efavirenz|efavirenz|mesh-list
92964875|NCT00936195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92964876|NCT00936195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92964877|NCT00936195|Protease Inhibitors|protease inhibitors|mesh-ancestor
92964878|NCT00936195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964879|NCT00936195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964880|NCT00936195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92964881|NCT00936195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92964882|NCT00936195|Antiviral Agents|antiviral agents|mesh-ancestor
92964883|NCT00936195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964884|NCT00936195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92964885|NCT00936195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92964887|NCT00936195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92964888|NCT00936195|Antimetabolites|antimetabolites|mesh-ancestor
92964889|NCT00936195|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92964890|NCT00936195|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92964891|NCT00936195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92964892|NCT00936195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92964893|NCT00936195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92964894|NCT00680186|Warfarin|warfarin|mesh-list
92964895|NCT00680186|Dabigatran|dabigatran|mesh-list
92964896|NCT00680186|Anticoagulants|anticoagulants|mesh-ancestor
92964897|NCT00680186|Antithrombins|antithrombins|mesh-ancestor
92964898|NCT00680186|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92964899|NCT00680186|Protease Inhibitors|protease inhibitors|mesh-ancestor
92964900|NCT00680186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964901|NCT00680186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964902|NCT00936429|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92964903|NCT00936429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92964904|NCT00936429|Immunologic Factors|immunologic factors|mesh-ancestor
92964905|NCT00936429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964906|NCT00936429|Antacids|antacids|mesh-ancestor
92964907|NCT00936429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964908|NCT00936429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92964909|NCT00656292|Simvastatin|simvastatin|mesh-list
92964910|NCT00656292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92964911|NCT00656292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92964912|NCT00656292|Antimetabolites|antimetabolites|mesh-ancestor
92964913|NCT00656292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964914|NCT00656292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92964915|NCT00656292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92964916|NCT00656292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964917|NCT00352417|Atreleuton|atreleuton|mesh-list
92964918|NCT00352417|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92964919|NCT00352417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964920|NCT00352417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964921|NCT00944541|Maraviroc|maraviroc|mesh-list
92964922|NCT00944541|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92964923|NCT00944541|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92964924|NCT00944541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964926|NCT00944541|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92964927|NCT00944541|Antiviral Agents|antiviral agents|mesh-ancestor
92964928|NCT00944541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92964929|NCT00944541|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92964930|NCT00944619|Insulin|insulin|mesh-list
92964931|NCT00944619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92964932|NCT00944619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964933|NCT00323869|Bevacizumab|bevacizumab|mesh-list
92964934|NCT00323869|Carboplatin|carboplatin|mesh-list
92964935|NCT00323869|Gemcitabine|gemcitabine|mesh-list
92964936|NCT00323869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92964937|NCT00323869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964938|NCT00323869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92964939|NCT00323869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92964940|NCT00323869|Growth Substances|growth substances|mesh-ancestor
92964941|NCT00323869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964942|NCT00323869|Growth Inhibitors|growth inhibitors|mesh-ancestor
92964943|NCT00323869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92964944|NCT00323869|Antimetabolites|antimetabolites|mesh-ancestor
92964945|NCT00323869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964946|NCT00323557|Molgramostim|molgramostim|mesh-list
92964947|NCT00323557|Sargramostim|sargramostim|mesh-list
92964948|NCT00323557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92964949|NCT00323557|Immunologic Factors|immunologic factors|mesh-ancestor
92964950|NCT00323557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964951|NCT00323557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964952|NCT00558363|Dutasteride|dutasteride|mesh-list
92964953|NCT00558363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92964954|NCT00558363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92964955|NCT00558363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964956|NCT00558363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964957|NCT00558363|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610348|NCT00142337|Antiviral Agents|antiviral agents|mesh-ancestor
92964958|NCT00558363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964959|NCT00558363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964961|NCT00323479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92964962|NCT00323479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964963|NCT00323479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92964964|NCT00323479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92964965|NCT00323479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964966|NCT00323479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964967|NCT00323479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92964968|NCT00323479|Hormone Antagonists|hormone antagonists|mesh-ancestor
92964969|NCT00323479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92964970|NCT00323479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964971|NCT00352105|Fluorouracil|fluorouracil|mesh-list
92964972|NCT00352105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92964973|NCT00352105|Antimetabolites|antimetabolites|mesh-ancestor
92964974|NCT00352105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964975|NCT00352105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92964976|NCT00352105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92964977|NCT00352105|Immunologic Factors|immunologic factors|mesh-ancestor
92964978|NCT00352105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964979|NCT03988075|Acetaminophen|acetaminophen|mesh-list
92964980|NCT03988075|Ibuprofen|ibuprofen|mesh-list
92964981|NCT03988075|Hydrocodone|hydrocodone|mesh-list
92964982|NCT03988075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92964983|NCT03988075|Analgesics|analgesics|mesh-ancestor
92964984|NCT03988075|Sensory System Agents|sensory system agents|mesh-ancestor
92964985|NCT03988075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92964986|NCT03988075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92964987|NCT03988075|Antipyretics|antipyretics|mesh-ancestor
92964988|NCT03988075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92964989|NCT03988075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92964990|NCT03988075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92964991|NCT03988075|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92964992|NCT03988075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92964993|NCT03988075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92964994|NCT03988075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92964995|NCT03988075|Narcotics|narcotics|mesh-ancestor
92964996|NCT03988075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92964997|NCT03988075|Antitussive Agents|antitussive agents|mesh-ancestor
92964998|NCT03988075|Respiratory System Agents|respiratory system agents|mesh-ancestor
92964999|NCT00944853|Zinc|zinc|mesh-list
92965000|NCT00944853|Trace Elements|trace elements|mesh-ancestor
92965001|NCT00944853|Micronutrients|micronutrients|mesh-ancestor
92965002|NCT00944853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965003|NCT03985891|Antibodies|antibodies|mesh-list
92965004|NCT03985891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92965005|NCT03985891|Immunologic Factors|immunologic factors|mesh-ancestor
92965006|NCT03985891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965007|NCT00350779|Metformin|metformin|mesh-list
92965008|NCT00350779|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92965009|NCT00350779|Rosiglitazone|rosiglitazone|mesh-list
92965010|NCT00350779|Glipizide|glipizide|mesh-list
92965011|NCT00350779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965012|NCT00350779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965013|NCT00350779|Incretins|incretins|mesh-ancestor
92965014|NCT00350779|Hormones|hormones|mesh-ancestor
92166327|NCT01312389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965015|NCT00350779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965016|NCT00350779|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92965017|NCT00350779|Protease Inhibitors|protease inhibitors|mesh-ancestor
92965018|NCT00350779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965019|NCT00350779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965020|NCT00656136|Afatinib|afatinib|mesh-list
92965021|NCT00656136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965022|NCT00656136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965023|NCT00656136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965024|NCT00656136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965025|NCT00676520|Everolimus|everolimus|mesh-list
92965026|NCT00676520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92965027|NCT00676520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965028|NCT00676520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965029|NCT00676520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965030|NCT00676520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965031|NCT00676520|Immunologic Factors|immunologic factors|mesh-ancestor
92965032|NCT00676520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965033|NCT00676520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965034|NCT02559908|Hyaluronic Acid|hyaluronic acid|mesh-list
92965035|NCT02559908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92965036|NCT02559908|Immunologic Factors|immunologic factors|mesh-ancestor
92965037|NCT02559908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965038|NCT02559908|Viscosupplements|viscosupplements|mesh-ancestor
92965039|NCT02559908|Protective Agents|protective agents|mesh-ancestor
92965040|NCT00322621|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92965041|NCT00322621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92965042|NCT00322621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92965043|NCT00322621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92965044|NCT00322621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965045|NCT00322621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965046|NCT00322621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965047|NCT00322621|Analgesics|analgesics|mesh-ancestor
92965048|NCT00322621|Sensory System Agents|sensory system agents|mesh-ancestor
92965049|NCT00322621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965050|NCT00322621|Antidepressive Agents|antidepressive agents|mesh-ancestor
92965051|NCT00322621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92965052|NCT00322621|Dopamine Agents|dopamine agents|mesh-ancestor
92965053|NCT02558972|Droxidopa|droxidopa|mesh-list
92965054|NCT02558972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92965055|NCT02558972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92965056|NCT00809718|Raltegravir Potassium|raltegravir potassium|mesh-list
92965057|NCT00809718|Rifapentine|rifapentine|mesh-list
92965058|NCT00809718|Rifampin|rifampin|mesh-list
92965059|NCT00809718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92965060|NCT00809718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92965061|NCT00809718|Antiviral Agents|antiviral agents|mesh-ancestor
92965062|NCT00809718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965063|NCT00809718|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92965064|NCT00809718|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92965065|NCT00809718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965066|NCT00809718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965067|NCT00809718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92965068|NCT00809718|Antitubercular Agents|antitubercular agents|mesh-ancestor
92965069|NCT00809718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92965070|NCT00809718|Leprostatic Agents|leprostatic agents|mesh-ancestor
92965071|NCT00809718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92965072|NCT00809718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92965073|NCT00809718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92965074|NCT00809718|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92965075|NCT00809718|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92965076|NCT00809718|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92965077|NCT00809718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92965079|NCT05427266|Anesthetics, Local|anesthetics, local|mesh-ancestor
92965080|NCT05427266|Anesthetics|anesthetics|mesh-ancestor
92965081|NCT05427266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965082|NCT05427266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965083|NCT05427266|Sensory System Agents|sensory system agents|mesh-ancestor
92965084|NCT05427266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965085|NCT00575042|Fenofibrate|fenofibrate|mesh-list
92965086|NCT00575042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92965087|NCT00575042|Antimetabolites|antimetabolites|mesh-ancestor
92965088|NCT00575042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965089|NCT00575042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92965090|NCT00656058|Montelukast|montelukast|mesh-list
92965091|NCT00656058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92965092|NCT00656058|Respiratory System Agents|respiratory system agents|mesh-ancestor
92965093|NCT00656058|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92965094|NCT00656058|Hormone Antagonists|hormone antagonists|mesh-ancestor
92965095|NCT00656058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965096|NCT00656058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965097|NCT00656058|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92965098|NCT00656058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92965099|NCT00656058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965100|NCT00537316|Infliximab|infliximab|mesh-list
92965101|NCT00537316|Azathioprine|azathioprine|mesh-list
92965102|NCT00537316|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92965103|NCT00537316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965104|NCT00537316|Dermatologic Agents|dermatologic agents|mesh-ancestor
92965105|NCT00537316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965106|NCT00537316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965107|NCT00537316|Antimetabolites|antimetabolites|mesh-ancestor
92965108|NCT00537316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965109|NCT00537316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92965110|NCT00537316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965111|NCT00537316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965112|NCT00537316|Immunologic Factors|immunologic factors|mesh-ancestor
92965113|NCT00537316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965114|NCT00803868|Varenicline|varenicline|mesh-list
92965115|NCT00803868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92965116|NCT00803868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92965117|NCT00803868|Cholinergic Agents|cholinergic agents|mesh-ancestor
92965118|NCT00803868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965119|NCT00803868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965120|NCT00803868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965121|NCT00655980|Folic Acid|folic acid|mesh-list
92965122|NCT00655980|Vitamin B 12|vitamin b 12|mesh-list
92965123|NCT00655980|Hydroxocobalamin|hydroxocobalamin|mesh-list
92965124|NCT00655980|Nitrous Oxide|nitrous oxide|mesh-list
92965125|NCT00655980|Vitamins|vitamins|mesh-ancestor
92965126|NCT00655980|Micronutrients|micronutrients|mesh-ancestor
92965127|NCT00655980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965128|NCT00655980|Hematinics|hematinics|mesh-ancestor
92965129|NCT00655980|Vitamin B Complex|vitamin b complex|mesh-ancestor
92965130|NCT00655980|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92965131|NCT00655980|Anesthetics, General|anesthetics, general|mesh-ancestor
92965132|NCT00655980|Anesthetics|anesthetics|mesh-ancestor
92965133|NCT00655980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965134|NCT00655980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92965135|NCT00655980|Analgesics|analgesics|mesh-ancestor
92965136|NCT00655980|Sensory System Agents|sensory system agents|mesh-ancestor
92965137|NCT00655980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965138|NCT01063621|Apomorphine|apomorphine|mesh-list
92965139|NCT01063621|Emetics|emetics|mesh-ancestor
92965140|NCT01063621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965141|NCT01063621|Autonomic Agents|autonomic agents|mesh-ancestor
92965142|NCT01063621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965143|NCT01063621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965144|NCT01063621|Dopamine Agonists|dopamine agonists|mesh-ancestor
92965145|NCT01063621|Dopamine Agents|dopamine agents|mesh-ancestor
92965146|NCT01063621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965147|NCT01063621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965149|NCT02533141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92965150|NCT02533141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92965151|NCT02533141|Antimetabolites|antimetabolites|mesh-ancestor
92965152|NCT02533141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965153|NCT02533141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92965154|NCT02533141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92965155|NCT02533141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965156|NCT00809796|Pentamidine|pentamidine|mesh-list
92965157|NCT00809796|Antifungal Agents|antifungal agents|mesh-ancestor
92965158|NCT00809796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965159|NCT00809796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92965160|NCT00809796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92965161|NCT00809796|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92965162|NCT05589454|Calcium, Dietary|calcium, dietary|mesh-list
92965163|NCT05589454|Atorvastatin|atorvastatin|mesh-list
92965164|NCT05589454|Calcium|calcium|mesh-list
92965165|NCT05589454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92965166|NCT05589454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965167|NCT05589454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92965168|NCT05589454|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92965169|NCT05589454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92965170|NCT05589454|Antimetabolites|antimetabolites|mesh-ancestor
92965171|NCT05589454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965172|NCT05589454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92965173|NCT05589454|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92965174|NCT05589454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965175|NCT00803946|Ibuprofen|ibuprofen|mesh-list
92965176|NCT00803946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92965177|NCT00803946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92965178|NCT00803946|Analgesics|analgesics|mesh-ancestor
92965179|NCT00803946|Sensory System Agents|sensory system agents|mesh-ancestor
92965180|NCT00803946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965181|NCT00803946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965182|NCT00803946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965183|NCT00803946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965184|NCT00803946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92965185|NCT00803946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965186|NCT00803946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965187|NCT00676130|Trimethoprim|trimethoprim|mesh-list
92965188|NCT00676130|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92965189|NCT00676130|Sulfamethoxazole|sulfamethoxazole|mesh-list
92965190|NCT00676130|Cephalexin|cephalexin|mesh-list
92965191|NCT00676130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92965192|NCT00676130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965193|NCT00676130|Antimalarials|antimalarials|mesh-ancestor
92965194|NCT00676130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92965195|NCT00676130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92965196|NCT00676130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92965197|NCT00676130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965198|NCT00676130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965199|NCT00676130|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92965200|NCT00676130|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92965201|NCT00676130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92965202|NCT00676130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92965203|NCT00809874|Caseins|caseins|mesh-list
92965204|NCT00809874|Chelating Agents|chelating agents|mesh-ancestor
92965205|NCT00809874|Sequestering Agents|sequestering agents|mesh-ancestor
92965206|NCT00809874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965207|NCT05436002|Hyaluronic Acid|hyaluronic acid|mesh-list
92965208|NCT05436002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92965209|NCT05436002|Immunologic Factors|immunologic factors|mesh-ancestor
92965210|NCT05436002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965211|NCT05436002|Viscosupplements|viscosupplements|mesh-ancestor
92965212|NCT05436002|Protective Agents|protective agents|mesh-ancestor
92965213|NCT02560376|Exenatide|exenatide|mesh-list
92965214|NCT02560376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965215|NCT02560376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965216|NCT02560376|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92965217|NCT02560376|Incretins|incretins|mesh-ancestor
92965218|NCT02560376|Hormones|hormones|mesh-ancestor
92965219|NCT02560376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965220|NCT00535288|Mirtazapine|mirtazapine|mesh-list
92965221|NCT00535288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965222|NCT00535288|Antidepressive Agents|antidepressive agents|mesh-ancestor
92965223|NCT00535288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92965224|NCT00535288|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92965225|NCT00535288|Histamine Antagonists|histamine antagonists|mesh-ancestor
92965226|NCT00535288|Histamine Agents|histamine agents|mesh-ancestor
92965227|NCT00535288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965228|NCT00535288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965229|NCT00535288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92965230|NCT00535288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92965231|NCT00535288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965232|NCT00535288|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92965233|NCT00535288|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92965234|NCT00535288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92965235|NCT00535288|Adrenergic Agents|adrenergic agents|mesh-ancestor
92965236|NCT00535288|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92965237|NCT00535288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92965238|NCT00535288|Serotonin Agents|serotonin agents|mesh-ancestor
92965239|NCT00535288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92965240|NCT00921830|Ibuprofen|ibuprofen|mesh-list
92965241|NCT00921830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92965242|NCT00921830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92965243|NCT00921830|Analgesics|analgesics|mesh-ancestor
92965244|NCT00921830|Sensory System Agents|sensory system agents|mesh-ancestor
92965245|NCT00921830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965246|NCT00921830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965247|NCT00921830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965248|NCT00921830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965249|NCT00921830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92965250|NCT00921830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965251|NCT00921830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965252|NCT02560220|Mitomycins|mitomycins|mesh-list
92965253|NCT02560220|Mitomycin|mitomycin|mesh-list
92965254|NCT02560220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92965255|NCT02560220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965256|NCT02560220|Alkylating Agents|alkylating agents|mesh-ancestor
92965257|NCT02560220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965258|NCT02560220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92965259|NCT02560220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965260|NCT05356078|Antidepressive Agents|antidepressive agents|mesh-list
92965261|NCT05356078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92965262|NCT04836832|Acalabrutinib|acalabrutinib|mesh-list
92965263|NCT04836832|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92965264|NCT04836832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965265|NCT04836832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965266|NCT04836832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965267|NCT04836832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965268|NCT05222438|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92965269|NCT05222438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92965270|NCT05222438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965271|NCT02783300|Pembrolizumab|pembrolizumab|mesh-list
92965272|NCT02783300|GSK-3326595|gsk-3326595|mesh-list
92965273|NCT02783300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92965274|NCT02783300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965275|NCT02783300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92965276|NCT02783300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965277|NCT02783300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965278|NCT00675506|Hormones|hormones|mesh-list
92965279|NCT00675506|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92965280|NCT00675506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965281|NCT00675506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965282|NCT05435378|Vitamins|vitamins|mesh-list
92965283|NCT05435378|Folic Acid|folic acid|mesh-list
92965284|NCT05435378|Niacinamide|niacinamide|mesh-list
92965285|NCT05435378|Vitamin B Complex|vitamin b complex|mesh-list
92965286|NCT05435378|Micronutrients|micronutrients|mesh-ancestor
92965287|NCT05435378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965288|NCT05435378|Hematinics|hematinics|mesh-ancestor
92965289|NCT05589220|Nicotine|nicotine|mesh-list
92965290|NCT05589220|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92965291|NCT05589220|Autonomic Agents|autonomic agents|mesh-ancestor
92965292|NCT05589220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965293|NCT05589220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965294|NCT05589220|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92965295|NCT05589220|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92965296|NCT05589220|Cholinergic Agents|cholinergic agents|mesh-ancestor
92965297|NCT05589220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965298|NCT05589220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965299|NCT03895840|Triamcinolone|triamcinolone|mesh-list
92965300|NCT03895840|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92965301|NCT03895840|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92965302|NCT03895840|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92965303|NCT03895840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965304|NCT03895840|Glucocorticoids|glucocorticoids|mesh-ancestor
92965305|NCT03895840|Hormones|hormones|mesh-ancestor
92965306|NCT03895840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965307|NCT03895840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965308|NCT03895840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965309|NCT03895840|Immunologic Factors|immunologic factors|mesh-ancestor
92965310|NCT03895840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965311|NCT03895840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965312|NCT00310375|Ezogabine|ezogabine|mesh-list
92965313|NCT00310375|Anticonvulsants|anticonvulsants|mesh-ancestor
92965314|NCT00310375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92965315|NCT00310375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965316|NCT00309907|Methylprednisolone|methylprednisolone|mesh-list
92965317|NCT00309907|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92965318|NCT00309907|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92965319|NCT00309907|Prednisolone|prednisolone|mesh-list
92965320|NCT00309907|Prednisolone acetate|prednisolone acetate|mesh-list
92965321|NCT00309907|Etanercept|etanercept|mesh-list
92965322|NCT00309907|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92965323|NCT00309907|Prednisolone phosphate|prednisolone phosphate|mesh-list
92965324|NCT00309907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965325|NCT00309907|Antiemetics|antiemetics|mesh-ancestor
92965326|NCT00309907|Autonomic Agents|autonomic agents|mesh-ancestor
92965327|NCT00309907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965328|NCT00309907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965329|NCT00309907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965331|NCT00309907|Hormones|hormones|mesh-ancestor
92965332|NCT00309907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965333|NCT00309907|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92965334|NCT00309907|Protective Agents|protective agents|mesh-ancestor
92965335|NCT00309907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92965336|NCT00309907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965337|NCT00309907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92965338|NCT00309907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92965339|NCT00309907|Analgesics|analgesics|mesh-ancestor
92965340|NCT00309907|Sensory System Agents|sensory system agents|mesh-ancestor
92965341|NCT00309907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965342|NCT00309907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965343|NCT00309907|Immunologic Factors|immunologic factors|mesh-ancestor
92965344|NCT00655824|Ofatumumab|ofatumumab|mesh-list
92965345|NCT00655824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965346|NCT03985969|Indomethacin|indomethacin|mesh-list
92965347|NCT03985969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92965348|NCT03985969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92965349|NCT03985969|Analgesics|analgesics|mesh-ancestor
92965350|NCT03985969|Sensory System Agents|sensory system agents|mesh-ancestor
92965351|NCT03985969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965352|NCT03985969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965353|NCT03985969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965354|NCT03985969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965355|NCT03985969|Gout Suppressants|gout suppressants|mesh-ancestor
92965356|NCT03985969|Tocolytic Agents|tocolytic agents|mesh-ancestor
92965357|NCT03985969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92965358|NCT03985969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92965359|NCT03985969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965360|NCT03985969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965361|NCT01061437|Lansoprazole|lansoprazole|mesh-list
92965362|NCT01061437|Dexlansoprazole|dexlansoprazole|mesh-list
92965363|NCT01061437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92965364|NCT01061437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965365|NCT01061437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92965366|NCT01061437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965367|NCT01061437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965368|NCT00575588|Metformin|metformin|mesh-list
92965369|NCT00575588|Saxagliptin|saxagliptin|mesh-list
92965370|NCT00575588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965371|NCT00575588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965372|NCT00575588|Incretins|incretins|mesh-ancestor
92965373|NCT00575588|Hormones|hormones|mesh-ancestor
92965374|NCT00575588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965375|NCT00575588|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92965376|NCT00575588|Protease Inhibitors|protease inhibitors|mesh-ancestor
92965377|NCT00575588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965378|NCT00575588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965379|NCT01058317|Propranolol|propranolol|mesh-list
92965380|NCT01058317|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92965381|NCT01058317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92965382|NCT01058317|Adrenergic Agents|adrenergic agents|mesh-ancestor
92965383|NCT01058317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965384|NCT01058317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965385|NCT01058317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965386|NCT01058317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92965387|NCT01058317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92965388|NCT01058317|Vasodilator Agents|vasodilator agents|mesh-ancestor
92965389|NCT00810030|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92965390|NCT00810030|Hematinics|hematinics|mesh-ancestor
92965391|NCT00675428|Natalizumab|natalizumab|mesh-list
92965392|NCT00675428|Immunologic Factors|immunologic factors|mesh-ancestor
92965393|NCT00675428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965394|NCT00760916|Treprostinil|treprostinil|mesh-list
92965395|NCT00760916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92965396|NCT00761228|Apomorphine|apomorphine|mesh-list
92965397|NCT00761228|Emetics|emetics|mesh-ancestor
92965398|NCT00761228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965399|NCT00761228|Autonomic Agents|autonomic agents|mesh-ancestor
92965400|NCT00761228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965401|NCT00761228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965402|NCT00761228|Dopamine Agonists|dopamine agonists|mesh-ancestor
92965403|NCT00761228|Dopamine Agents|dopamine agents|mesh-ancestor
92965404|NCT00761228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965405|NCT00761228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965406|NCT00758732|Carboplatin|carboplatin|mesh-list
92965407|NCT00758732|Docetaxel|docetaxel|mesh-list
92965408|NCT00758732|Doxorubicin|doxorubicin|mesh-list
92965409|NCT00758732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92965410|NCT00758732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965411|NCT00758732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92965412|NCT00758732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92965413|NCT00758732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92965414|NCT00758732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965415|NCT00758732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92965416|NCT00758732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92965417|NCT00758732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92965418|NCT00758732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965419|NCT02559674|Paclitaxel|paclitaxel|mesh-list
92965420|NCT02559674|Gemcitabine|gemcitabine|mesh-list
92965421|NCT02559674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92965422|NCT02559674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965423|NCT02559674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92965424|NCT02559674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92965425|NCT02559674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92965426|NCT02559674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965427|NCT02559674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92965428|NCT02559674|Antimetabolites|antimetabolites|mesh-ancestor
92965429|NCT00761540|Liraglutide|liraglutide|mesh-list
92965430|NCT00761540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965431|NCT00761540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965432|NCT00761540|Incretins|incretins|mesh-ancestor
92965433|NCT00761540|Hormones|hormones|mesh-ancestor
92965434|NCT00761540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965435|NCT00759122|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92965436|NCT00759122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92965437|NCT00759122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92965438|NCT00759122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92965439|NCT00759122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965440|NCT00759122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965441|NCT00759122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965442|NCT00759122|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92965443|NCT00759122|Antidepressive Agents|antidepressive agents|mesh-ancestor
92965444|NCT00759122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92965445|NCT00759200|Interferons|interferons|mesh-list
92965446|NCT00759200|Interferon-alpha|interferon-alpha|mesh-list
92965447|NCT00759200|Interferon alpha-2|interferon alpha-2|mesh-list
92965448|NCT00759200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965449|NCT00759200|Antiviral Agents|antiviral agents|mesh-ancestor
92965450|NCT00759200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965451|NCT00759200|Immunologic Factors|immunologic factors|mesh-ancestor
92965452|NCT00759200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965453|NCT02558816|Obinutuzumab|obinutuzumab|mesh-list
92965454|NCT02558816|Venetoclax|venetoclax|mesh-list
92965455|NCT02558816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92965456|NCT02558816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965457|NCT01299753|Propranolol|propranolol|mesh-list
92965458|NCT01299753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92965459|NCT01299753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92965460|NCT01299753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92965461|NCT01299753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965462|NCT01299753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965463|NCT01299753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965464|NCT01299753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92965465|NCT01299753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92965466|NCT01299753|Vasodilator Agents|vasodilator agents|mesh-ancestor
92965467|NCT02559440|Mometasone Furoate|mometasone furoate|mesh-list
92965468|NCT02559440|Phenylephrine|phenylephrine|mesh-list
92965469|NCT02559440|Oxymetazoline|oxymetazoline|mesh-list
92965470|NCT02559440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965471|NCT02559440|Dermatologic Agents|dermatologic agents|mesh-ancestor
92965472|NCT02559440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92965473|NCT02559440|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92965474|NCT02559440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92965475|NCT02559440|Adrenergic Agents|adrenergic agents|mesh-ancestor
92965476|NCT02559440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965477|NCT02559440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965478|NCT02559440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965479|NCT02559440|Sympathomimetics|sympathomimetics|mesh-ancestor
92965480|NCT02559440|Autonomic Agents|autonomic agents|mesh-ancestor
92965481|NCT02559440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965482|NCT02559440|Nasal Decongestants|nasal decongestants|mesh-ancestor
92965483|NCT02559440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92965484|NCT02559440|Respiratory System Agents|respiratory system agents|mesh-ancestor
92965485|NCT02559440|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92965486|NCT02559440|Mydriatics|mydriatics|mesh-ancestor
92965487|NCT02559440|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92965488|NCT02559440|Protective Agents|protective agents|mesh-ancestor
92965489|NCT00674570|Cycloserine|cycloserine|mesh-list
92965490|NCT00674570|Hydrocortisone|hydrocortisone|mesh-list
92965491|NCT00674570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965492|NCT00674570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92965493|NCT00674570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965494|NCT00674570|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92965495|NCT00674570|Antitubercular Agents|antitubercular agents|mesh-ancestor
92965496|NCT00674570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92965497|NCT00674570|Antimetabolites|antimetabolites|mesh-ancestor
92965498|NCT00674570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965499|NCT00940563|Imatinib Mesylate|imatinib mesylate|mesh-list
92965500|NCT00940563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965501|NCT00940563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965502|NCT00940563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166364|NCT01314417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965503|NCT00940563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965504|NCT00761852|Ruboxistaurin|ruboxistaurin|mesh-list
92965505|NCT00761852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965506|NCT00761852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965507|NCT00940719|Vitamin D|vitamin d|mesh-list
92965508|NCT00940719|Cholecalciferol|cholecalciferol|mesh-list
92965509|NCT00940719|Vitamins|vitamins|mesh-ancestor
92965510|NCT00940719|Micronutrients|micronutrients|mesh-ancestor
92965511|NCT00940719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965512|NCT00940719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92965513|NCT00940719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92965515|NCT00940953|Budesonide|budesonide|mesh-list
92965516|NCT00940953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965517|NCT00940953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92965518|NCT00940953|Autonomic Agents|autonomic agents|mesh-ancestor
92965519|NCT00940953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965520|NCT00940953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965521|NCT00940953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92965522|NCT00940953|Respiratory System Agents|respiratory system agents|mesh-ancestor
92965523|NCT00940953|Glucocorticoids|glucocorticoids|mesh-ancestor
92965524|NCT00940953|Hormones|hormones|mesh-ancestor
92965525|NCT00940953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965526|NCT00940953|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92965527|NCT00940953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965528|NCT00940953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965529|NCT00940953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92965530|NCT00940953|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92965531|NCT00940953|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92965532|NCT00940953|Histamine Antagonists|histamine antagonists|mesh-ancestor
92965533|NCT00940953|Histamine Agents|histamine agents|mesh-ancestor
92965534|NCT00940953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965535|NCT00759824|Cyclophosphamide|cyclophosphamide|mesh-list
92965536|NCT00759824|Doxorubicin|doxorubicin|mesh-list
92965537|NCT00759824|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92965538|NCT00759824|Vindesine|vindesine|mesh-list
92965539|NCT00759824|Valproic Acid|valproic acid|mesh-list
92965540|NCT00759824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965541|NCT00759824|Immunologic Factors|immunologic factors|mesh-ancestor
92965542|NCT00759824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965543|NCT00759824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965544|NCT00759824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92965545|NCT00759824|Alkylating Agents|alkylating agents|mesh-ancestor
92965546|NCT00759824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965547|NCT00759824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965548|NCT00759824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92965549|NCT00759824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92965550|NCT00759824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92965551|NCT00759824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92965552|NCT00759824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965553|NCT00759824|Anticonvulsants|anticonvulsants|mesh-ancestor
92965554|NCT00759824|GABA Agents|gaba agents|mesh-ancestor
92610946|NCT00506974|Sodium Oxybate|sodium oxybate|mesh-list
92965555|NCT00759824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965557|NCT00759824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92965558|NCT00759824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965559|NCT00759824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92965560|NCT00759824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92965561|NCT00759824|Tubulin Modulators|tubulin modulators|mesh-ancestor
92965562|NCT00759824|Antimitotic Agents|antimitotic agents|mesh-ancestor
92965563|NCT00759824|Mitosis Modulators|mitosis modulators|mesh-ancestor
92965564|NCT00561951|Fesoterodine|fesoterodine|mesh-list
92965565|NCT00561951|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92965566|NCT00561951|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92965567|NCT00561951|Cholinergic Agents|cholinergic agents|mesh-ancestor
92965568|NCT00561951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965569|NCT00561951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965570|NCT00561951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965571|NCT00561951|Urological Agents|urological agents|mesh-ancestor
92965572|NCT00762398|Chrysarobin|chrysarobin|mesh-list
92965573|NCT00762398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92965574|NCT00762398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92965575|NCT00762398|Analgesics|analgesics|mesh-ancestor
92965576|NCT00762398|Sensory System Agents|sensory system agents|mesh-ancestor
92965577|NCT00762398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965578|NCT00762398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965579|NCT00762398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965580|NCT00762398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965581|NCT04552886|Immunomodulating Agents|immunomodulating agents|mesh-list
92965582|NCT04552886|Immunologic Factors|immunologic factors|mesh-ancestor
92965583|NCT04552886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965584|NCT00762632|Everolimus|everolimus|mesh-list
92965585|NCT00762632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92965586|NCT00762632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965587|NCT00762632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965588|NCT00762632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965589|NCT00762632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965590|NCT00762632|Immunologic Factors|immunologic factors|mesh-ancestor
92965591|NCT00762632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965592|NCT00762632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965593|NCT00322387|Plerixafor|plerixafor|mesh-list
92965594|NCT00322387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92965595|NCT00322387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92965596|NCT00322387|Antiviral Agents|antiviral agents|mesh-ancestor
92965597|NCT00322387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965598|NCT00561015|Ribavirin|ribavirin|mesh-list
92965599|NCT00561015|Interferon alpha-2|interferon alpha-2|mesh-list
92965600|NCT00561015|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92965601|NCT00561015|Antimetabolites|antimetabolites|mesh-ancestor
92965602|NCT00561015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965603|NCT00561015|Antiviral Agents|antiviral agents|mesh-ancestor
92965604|NCT00561015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965605|NCT00561015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965606|NCT04012047|Cromakalim|cromakalim|mesh-list
92965607|NCT04012047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92965608|NCT04012047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92965609|NCT04012047|Autonomic Agents|autonomic agents|mesh-ancestor
92965610|NCT04012047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965611|NCT04012047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965612|NCT04012047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92965613|NCT04012047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92965614|NCT04012047|Parasympatholytics|parasympatholytics|mesh-ancestor
92965615|NCT04012047|Vasodilator Agents|vasodilator agents|mesh-ancestor
92965616|NCT00941265|Levodopa|levodopa|mesh-list
92965617|NCT00941265|Benserazide|benserazide|mesh-list
92965618|NCT00941265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92965619|NCT00941265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92965620|NCT00941265|Dopamine Agents|dopamine agents|mesh-ancestor
92965621|NCT00941265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965622|NCT00941265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965623|NCT00941265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965624|NCT00941265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965625|NCT00941343|Alfuzosin|alfuzosin|mesh-list
92965626|NCT00941343|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92965627|NCT00941343|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92965628|NCT00941343|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92965629|NCT00941343|Adrenergic Agents|adrenergic agents|mesh-ancestor
92611024|NCT00144482|Epoetin Alfa|epoetin alfa|mesh-list
92965630|NCT00941343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965631|NCT00941343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965632|NCT00941343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965633|NCT00941343|Urological Agents|urological agents|mesh-ancestor
92965634|NCT00561795|Paclitaxel|paclitaxel|mesh-list
92527678|NCT02971423|Imipenem|imipenem|mesh-list
92965635|NCT00561795|Carboplatin|carboplatin|mesh-list
92965636|NCT00561795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92965637|NCT00561795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965638|NCT00561795|Tubulin Modulators|tubulin modulators|mesh-ancestor
92965639|NCT00561795|Antimitotic Agents|antimitotic agents|mesh-ancestor
92965640|NCT00561795|Mitosis Modulators|mitosis modulators|mesh-ancestor
92166377|NCT02893423|Ropivacaine|ropivacaine|mesh-list
92965641|NCT00561795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965642|NCT00652626|Azacitidine|azacitidine|mesh-list
92965643|NCT00652626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92965644|NCT00652626|Antimetabolites|antimetabolites|mesh-ancestor
92965645|NCT00652626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965646|NCT00652626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965647|NCT00652626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965648|NCT00560703|Doxycycline|doxycycline|mesh-list
92965649|NCT00560703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92965650|NCT00560703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965651|NCT00560703|Antimalarials|antimalarials|mesh-ancestor
92965652|NCT00560703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92965653|NCT00560703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92965654|NCT00308737|Insulin|insulin|mesh-list
92965655|NCT00308737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965656|NCT00308737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965657|NCT04711902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92965658|NCT04711902|Immunologic Factors|immunologic factors|mesh-ancestor
92965659|NCT04711902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965660|NCT00941499|Leucovorin|leucovorin|mesh-list
92965661|NCT00941499|Bevacizumab|bevacizumab|mesh-list
92965662|NCT00941499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92965663|NCT00941499|Cetuximab|cetuximab|mesh-list
92965664|NCT00941499|Fluorouracil|fluorouracil|mesh-list
92965665|NCT00941499|Oxaliplatin|oxaliplatin|mesh-list
92965666|NCT00941499|Antibodies|antibodies|mesh-list
92965667|NCT00941499|Immunoglobulins|immunoglobulins|mesh-list
92965668|NCT00941499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92965669|NCT00941499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965670|NCT00941499|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92965671|NCT00941499|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92965672|NCT00941499|Growth Substances|growth substances|mesh-ancestor
92965673|NCT00941499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965674|NCT00941499|Growth Inhibitors|growth inhibitors|mesh-ancestor
92965675|NCT00941499|Immunologic Factors|immunologic factors|mesh-ancestor
92965676|NCT00941499|Antimetabolites|antimetabolites|mesh-ancestor
92965677|NCT00941499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965678|NCT00941499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92965679|NCT00941499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965680|NCT00941499|Antidotes|antidotes|mesh-ancestor
92965681|NCT00941499|Protective Agents|protective agents|mesh-ancestor
92965682|NCT00941499|Vitamin B Complex|vitamin b complex|mesh-ancestor
92965683|NCT00941499|Vitamins|vitamins|mesh-ancestor
92965684|NCT00941499|Micronutrients|micronutrients|mesh-ancestor
92965685|NCT04752384|Buprenorphine|buprenorphine|mesh-list
92965686|NCT04752384|Tramadol|tramadol|mesh-list
92965687|NCT04752384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92965688|NCT04752384|Narcotics|narcotics|mesh-ancestor
92965689|NCT04752384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965690|NCT04752384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965691|NCT04752384|Analgesics|analgesics|mesh-ancestor
92965692|NCT04752384|Sensory System Agents|sensory system agents|mesh-ancestor
92965693|NCT04752384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965694|NCT04752384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92965695|NCT04743804|Ravulizumab|ravulizumab|mesh-list
92965696|NCT04743804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92965697|NCT04743804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965698|NCT04743804|Immunologic Factors|immunologic factors|mesh-ancestor
92965699|NCT04743804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965700|NCT00945789|Nitric Oxide|nitric oxide|mesh-list
92965701|NCT00945789|Epoetin Alfa|epoetin alfa|mesh-list
92965702|NCT00945789|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92965703|NCT00945789|Autonomic Agents|autonomic agents|mesh-ancestor
92965704|NCT00945789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965705|NCT00945789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965706|NCT00945789|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92965707|NCT00945789|Respiratory System Agents|respiratory system agents|mesh-ancestor
92965708|NCT00945789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92965709|NCT00945789|Antioxidants|antioxidants|mesh-ancestor
92965710|NCT00945789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965711|NCT00945789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965712|NCT00945789|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92965713|NCT00945789|Vasodilator Agents|vasodilator agents|mesh-ancestor
92965714|NCT00945789|Gasotransmitters|gasotransmitters|mesh-ancestor
92965715|NCT00945789|Protective Agents|protective agents|mesh-ancestor
92965716|NCT00945789|Hematinics|hematinics|mesh-ancestor
92965717|NCT00941811|Imiquimod|imiquimod|mesh-list
92965718|NCT00941811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92965719|NCT00941811|Immunologic Factors|immunologic factors|mesh-ancestor
92965720|NCT00941811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965721|NCT00941811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965722|NCT00941811|Interferon Inducers|interferon inducers|mesh-ancestor
92965723|NCT02553018|Methotrexate|methotrexate|mesh-list
92965724|NCT02553018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92965725|NCT02553018|Abortifacient Agents|abortifacient agents|mesh-ancestor
92965726|NCT02553018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92965727|NCT02553018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965728|NCT02553018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92965729|NCT02553018|Antimetabolites|antimetabolites|mesh-ancestor
92965730|NCT02553018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965731|NCT02553018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965732|NCT02553018|Dermatologic Agents|dermatologic agents|mesh-ancestor
92965733|NCT02553018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965734|NCT02553018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92965735|NCT02553018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965736|NCT02553018|Immunologic Factors|immunologic factors|mesh-ancestor
92965737|NCT02553018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965738|NCT02553018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92965739|NCT00941967|Gemcitabine|gemcitabine|mesh-list
92965740|NCT00941967|Oxaliplatin|oxaliplatin|mesh-list
92965741|NCT00941967|Sorafenib|sorafenib|mesh-list
92965742|NCT00941967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92965743|NCT00941967|Antimetabolites|antimetabolites|mesh-ancestor
92965744|NCT00941967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965745|NCT00941967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965746|NCT00941967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965747|NCT00941967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965748|NCT00655746|Dasatinib|dasatinib|mesh-list
92965749|NCT00655746|Omeprazole|omeprazole|mesh-list
92965750|NCT00655746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92965751|NCT00655746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965752|NCT00655746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92965753|NCT00655746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965754|NCT00655746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965755|NCT00655746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965756|NCT00655746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965757|NCT00338455|Dobutamine|dobutamine|mesh-list
92965758|NCT00338455|Milrinone|milrinone|mesh-list
92965759|NCT00338455|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92965760|NCT00338455|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92965761|NCT00338455|Sympathomimetics|sympathomimetics|mesh-ancestor
92965762|NCT00338455|Autonomic Agents|autonomic agents|mesh-ancestor
92965763|NCT00338455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965764|NCT00338455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965765|NCT00338455|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92965766|NCT00338455|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92965767|NCT00338455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92965768|NCT00338455|Adrenergic Agents|adrenergic agents|mesh-ancestor
92965769|NCT00338455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965770|NCT00338455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965771|NCT00338455|Protective Agents|protective agents|mesh-ancestor
92965772|NCT00338455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92965773|NCT00338455|Vasodilator Agents|vasodilator agents|mesh-ancestor
92965774|NCT00338455|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92965775|NCT00338455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92965776|NCT00338455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965777|NCT00338455|Natriuretic Agents|natriuretic agents|mesh-ancestor
92965778|NCT00678392|Sorafenib|sorafenib|mesh-list
92965779|NCT00678392|Axitinib|axitinib|mesh-list
92965780|NCT00678392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965781|NCT00678392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965782|NCT00678392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965783|NCT00678392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965784|NCT00950391|Tacrolimus|tacrolimus|mesh-list
92965785|NCT00950391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965786|NCT00950391|Immunologic Factors|immunologic factors|mesh-ancestor
92965787|NCT00950391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965788|NCT00950391|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92965789|NCT00950391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166384|NCT05586919|Ethanol|ethanol|mesh-list
92965790|NCT00950391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965791|NCT00804336|Everolimus|everolimus|mesh-list
92965792|NCT00804336|Pasireotide|pasireotide|mesh-list
92965793|NCT00804336|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92965794|NCT00804336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965795|NCT00804336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965796|NCT00804336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965797|NCT00804336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965798|NCT00804336|Immunologic Factors|immunologic factors|mesh-ancestor
92965799|NCT00804336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965800|NCT00804336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965801|NCT00804336|Hormones|hormones|mesh-ancestor
92965802|NCT00804336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965803|NCT00942201|Dexamethasone|dexamethasone|mesh-list
92965804|NCT00942201|Dexamethasone acetate|dexamethasone acetate|mesh-list
92965805|NCT00942201|BB 1101|bb 1101|mesh-list
92965806|NCT00942201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965807|NCT00942201|Antiemetics|antiemetics|mesh-ancestor
92965808|NCT00942201|Autonomic Agents|autonomic agents|mesh-ancestor
92965809|NCT00942201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965810|NCT00942201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965811|NCT00942201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965812|NCT00942201|Glucocorticoids|glucocorticoids|mesh-ancestor
92965813|NCT00942201|Hormones|hormones|mesh-ancestor
92965814|NCT00942201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965815|NCT00942201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92965816|NCT00942201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965817|NCT00942201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92965818|NCT00942201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965819|NCT00942201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965820|NCT00942435|Darexaban|darexaban|mesh-list
92965821|NCT00942435|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92965822|NCT00942435|Antithrombins|antithrombins|mesh-ancestor
92965823|NCT00942435|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92965824|NCT00942435|Protease Inhibitors|protease inhibitors|mesh-ancestor
92965825|NCT00942435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965826|NCT00942435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965827|NCT00942435|Anticoagulants|anticoagulants|mesh-ancestor
92965828|NCT00946179|Vaccines|vaccines|mesh-list
92965829|NCT00946179|Immunologic Factors|immunologic factors|mesh-ancestor
92965830|NCT00946179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965831|NCT00950625|Lidocaine|lidocaine|mesh-list
92965832|NCT00950625|Anesthetics, Local|anesthetics, local|mesh-ancestor
92965833|NCT00950625|Anesthetics|anesthetics|mesh-ancestor
92965834|NCT00950625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92965835|NCT00950625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965836|NCT00950625|Sensory System Agents|sensory system agents|mesh-ancestor
92965837|NCT00950625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965838|NCT00950625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92965839|NCT00950625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92965840|NCT00950625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92965841|NCT00950625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92965842|NCT00950625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965843|NCT00942591|Interferons|interferons|mesh-list
92965844|NCT00942591|Interferon-beta|interferon-beta|mesh-list
92965845|NCT00942591|Atorvastatin|atorvastatin|mesh-list
92965846|NCT00942591|Interferon beta-1b|interferon beta-1b|mesh-list
92965847|NCT00942591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965848|NCT00942591|Antiviral Agents|antiviral agents|mesh-ancestor
92965849|NCT00942591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965850|NCT00942591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92965851|NCT00942591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92965852|NCT00942591|Antimetabolites|antimetabolites|mesh-ancestor
92965853|NCT00942591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965854|NCT00942591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92965855|NCT00942591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92965856|NCT00942591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965857|NCT00942591|Immunologic Factors|immunologic factors|mesh-ancestor
92965858|NCT00942591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266411|NCT01794455|Candesartan|candesartan|mesh-list
92965859|NCT00942591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92965861|NCT00946335|Veliparib|veliparib|mesh-list
92965862|NCT00946335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92965863|NCT00946335|Alkylating Agents|alkylating agents|mesh-ancestor
92965864|NCT00946335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965865|NCT00946335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965866|NCT00946335|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92965867|NCT00946335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965868|NCT00760370|Zoledronic Acid|zoledronic acid|mesh-list
92965869|NCT00760370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92965870|NCT00760370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965871|NCT00762944|Cimetidine|cimetidine|mesh-list
92965872|NCT00762944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92965873|NCT00762944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92965874|NCT00762944|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92965875|NCT00762944|Histamine Antagonists|histamine antagonists|mesh-ancestor
92965876|NCT00762944|Histamine Agents|histamine agents|mesh-ancestor
92965877|NCT00762944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965878|NCT00762944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965879|NCT00762944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965880|NCT00762944|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92965881|NCT00762944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92965882|NCT00762944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965883|NCT00760448|Insulin|insulin|mesh-list
92965884|NCT00760448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92965885|NCT00760448|Insulin Detemir|insulin detemir|mesh-list
92965886|NCT00760448|Isophane Insulin, Human|isophane insulin, human|mesh-list
92965887|NCT00760448|Insulin, Isophane|insulin, isophane|mesh-list
92965888|NCT00760448|Isophane insulin, beef|isophane insulin, beef|mesh-list
92965889|NCT00760448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965890|NCT00760448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965891|NCT00763178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92965892|NCT00763178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92965893|NCT00763178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92965894|NCT00763178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92965895|NCT00763178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965896|NCT00763178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965897|NCT00763178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965898|NCT00763178|Analgesics|analgesics|mesh-ancestor
92965899|NCT00763178|Sensory System Agents|sensory system agents|mesh-ancestor
92965900|NCT00763178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965901|NCT00763178|Antidepressive Agents|antidepressive agents|mesh-ancestor
92965902|NCT00763178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92965903|NCT00763178|Dopamine Agents|dopamine agents|mesh-ancestor
92965904|NCT04391348|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92965905|NCT04391348|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92965906|NCT04391348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965907|NCT00308581|Certolizumab Pegol|certolizumab pegol|mesh-list
92965908|NCT00308581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92965909|NCT00308581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92965910|NCT00308581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965911|NCT00308581|Immunologic Factors|immunologic factors|mesh-ancestor
92965912|NCT00308581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965913|NCT00308581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965914|NCT00678080|Metformin|metformin|mesh-list
92965915|NCT00678080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965916|NCT00678080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965917|NCT00658320|Cyclosporine|cyclosporine|mesh-list
92965918|NCT00658320|Mycophenolic Acid|mycophenolic acid|mesh-list
92965919|NCT00658320|Everolimus|everolimus|mesh-list
92965920|NCT00658320|Cyclosporins|cyclosporins|mesh-list
92965921|NCT00658320|Basiliximab|basiliximab|mesh-list
92965922|NCT00658320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965923|NCT00658320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965924|NCT00658320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92965925|NCT00658320|Immunologic Factors|immunologic factors|mesh-ancestor
92965926|NCT00658320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965927|NCT00658320|Antifungal Agents|antifungal agents|mesh-ancestor
92965928|NCT00658320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965929|NCT00658320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92965930|NCT00658320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92965931|NCT00658320|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92965932|NCT00658320|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92965933|NCT00658320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965935|NCT00658320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92965936|NCT00658320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92965937|NCT00658320|Antitubercular Agents|antitubercular agents|mesh-ancestor
92965938|NCT00658320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92965939|NCT02558270|Dapagliflozin|dapagliflozin|mesh-list
92965940|NCT02558270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92965941|NCT02558270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965942|NCT02558270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92965943|NCT02558270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965944|NCT00763568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92965945|NCT00763568|Nitazoxanide|nitazoxanide|mesh-list
92965946|NCT00763568|Antiviral Agents|antiviral agents|mesh-ancestor
92965947|NCT00763568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92965948|NCT00763568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92965949|NCT00806754|Ciclesonide|ciclesonide|mesh-list
92965950|NCT00806754|Azelastine|azelastine|mesh-list
92965951|NCT00806754|Glucocorticoids|glucocorticoids|mesh-ancestor
92965952|NCT00806754|Hormones|hormones|mesh-ancestor
92965953|NCT00806754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92965954|NCT00806754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965955|NCT00806754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92965956|NCT00806754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92965957|NCT00806754|Autonomic Agents|autonomic agents|mesh-ancestor
92965958|NCT00806754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92965959|NCT00806754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92965960|NCT00806754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92965961|NCT00806754|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92965962|NCT00806754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965963|NCT00806754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965964|NCT00806754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92965965|NCT00806754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92965966|NCT00806754|Histamine Antagonists|histamine antagonists|mesh-ancestor
92965967|NCT00806754|Histamine Agents|histamine agents|mesh-ancestor
92965968|NCT00806754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965969|NCT00764816|Caseins|caseins|mesh-list
92965970|NCT00764816|Chelating Agents|chelating agents|mesh-ancestor
92965971|NCT00764816|Sequestering Agents|sequestering agents|mesh-ancestor
92965972|NCT00764816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965973|NCT00322153|Memantine|memantine|mesh-list
92965974|NCT00322153|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92965975|NCT00322153|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92965976|NCT00322153|Dopamine Agents|dopamine agents|mesh-ancestor
92965977|NCT00322153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92965978|NCT00322153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965979|NCT00322153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965980|NCT00322153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92965981|NCT00322153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92965982|NCT00806910|Conivaptan|conivaptan|mesh-list
92965983|NCT00806910|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92965984|NCT00806910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965985|NCT00806910|Natriuretic Agents|natriuretic agents|mesh-ancestor
92965986|NCT00806910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92965987|NCT00807066|Gefitinib|gefitinib|mesh-list
92965988|NCT00807066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965989|NCT00807066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92965990|NCT00807066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965991|NCT00807066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965992|NCT00804960|Letrozole|letrozole|mesh-list
92965993|NCT00804960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92965994|NCT00804960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92965995|NCT00804960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92965996|NCT00804960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92965997|NCT00804960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92965998|NCT00804960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92965999|NCT00804960|Hormone Antagonists|hormone antagonists|mesh-ancestor
92966000|NCT00804960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527708|NCT00033982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966001|NCT00804960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966003|NCT00805116|Vitamins|vitamins|mesh-ancestor
92966004|NCT00805116|Micronutrients|micronutrients|mesh-ancestor
92966005|NCT00805116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966006|NCT03985735|Anesthetics|anesthetics|mesh-list
92966007|NCT03985735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966008|NCT03985735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966009|NCT00807222|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92966010|NCT00807222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92966011|NCT00807222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966012|NCT00807222|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92966013|NCT00807222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92966014|NCT00807222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966015|NCT00807222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966016|NCT00807222|Dopamine Agents|dopamine agents|mesh-ancestor
92966017|NCT00807222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966018|NCT00657618|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92966019|NCT00657618|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92966020|NCT00657618|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92966021|NCT00657618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966022|NCT00657618|Schistosomicides|schistosomicides|mesh-ancestor
92966023|NCT00657618|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92966024|NCT00657618|Anthelmintics|anthelmintics|mesh-ancestor
92966025|NCT00672620|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92966026|NCT00672620|Vortioxetine|vortioxetine|mesh-list
92966027|NCT00672620|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92966028|NCT00672620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92966029|NCT00672620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966030|NCT00672620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966031|NCT00672620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966032|NCT00672620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966033|NCT00672620|Analgesics|analgesics|mesh-ancestor
92966034|NCT00672620|Sensory System Agents|sensory system agents|mesh-ancestor
92966035|NCT00672620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966036|NCT00672620|Antidepressive Agents|antidepressive agents|mesh-ancestor
92966037|NCT00672620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966038|NCT00672620|Dopamine Agents|dopamine agents|mesh-ancestor
92966039|NCT00672620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92966040|NCT00672620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966041|NCT00672620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966042|NCT00672620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92966043|NCT00672620|Serotonin Agents|serotonin agents|mesh-ancestor
92966044|NCT00672620|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92966045|NCT00672620|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92966046|NCT00672620|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92966047|NCT00672620|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92966048|NCT00764972|Sorafenib|sorafenib|mesh-list
92966049|NCT00764972|Vinorelbine|vinorelbine|mesh-list
92966050|NCT00764972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966051|NCT00764972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966052|NCT00764972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966053|NCT00764972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966054|NCT00764972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92966055|NCT00764972|Tubulin Modulators|tubulin modulators|mesh-ancestor
92966056|NCT00764972|Antimitotic Agents|antimitotic agents|mesh-ancestor
92966057|NCT00764972|Mitosis Modulators|mitosis modulators|mesh-ancestor
92966058|NCT00673790|Losartan|losartan|mesh-list
92966059|NCT00673790|Lisinopril|lisinopril|mesh-list
92966060|NCT00673790|Nebivolol|nebivolol|mesh-list
92966061|NCT00673790|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92966062|NCT00673790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92966063|NCT00673790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92966064|NCT00673790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92966065|NCT00673790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966066|NCT00673790|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92966067|NCT00673790|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966068|NCT00673790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966069|NCT00673790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92966070|NCT00673790|Protective Agents|protective agents|mesh-ancestor
92966071|NCT00673790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966072|NCT00673790|Vasodilator Agents|vasodilator agents|mesh-ancestor
92266616|NCT01403246|Lenalidomide|lenalidomide|mesh-list
92966073|NCT00673790|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92966074|NCT00673790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92966075|NCT00673790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92966076|NCT00673790|Adrenergic Agents|adrenergic agents|mesh-ancestor
92966077|NCT00673790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966078|NCT00763646|Docetaxel|docetaxel|mesh-list
92611475|NCT00466609|Serotonin Agents|serotonin agents|mesh-ancestor
92966079|NCT00763646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966080|NCT00763646|Tubulin Modulators|tubulin modulators|mesh-ancestor
92966081|NCT00763646|Antimitotic Agents|antimitotic agents|mesh-ancestor
92966082|NCT00763646|Mitosis Modulators|mitosis modulators|mesh-ancestor
92966083|NCT00763646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966084|NCT00763880|Lidocaine|lidocaine|mesh-list
92966085|NCT00763880|Anesthetics, Local|anesthetics, local|mesh-ancestor
92966086|NCT00763880|Anesthetics|anesthetics|mesh-ancestor
92966087|NCT00763880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966088|NCT00763880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966089|NCT00763880|Sensory System Agents|sensory system agents|mesh-ancestor
92966090|NCT00763880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966091|NCT00763880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92966092|NCT00763880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92966093|NCT00763880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92966094|NCT00763880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966095|NCT00763880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966096|NCT00657150|Enoxaparin|enoxaparin|mesh-list
92966097|NCT00657150|Dabigatran|dabigatran|mesh-list
92966098|NCT00657150|Anticoagulants|anticoagulants|mesh-ancestor
92966099|NCT00657150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92966100|NCT00657150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92966101|NCT00657150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966102|NCT00657150|Antithrombins|antithrombins|mesh-ancestor
92966103|NCT00657150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92966104|NCT00657150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966105|NCT00657150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966106|NCT00770354|Letrozole|letrozole|mesh-list
92966107|NCT00770354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966108|NCT00770354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92966109|NCT00770354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92966110|NCT00770354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966111|NCT00770354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966112|NCT00770354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92966113|NCT00770354|Hormone Antagonists|hormone antagonists|mesh-ancestor
92966114|NCT00770354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966115|NCT00770354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966116|NCT00670748|Aldesleukin|aldesleukin|mesh-list
92966117|NCT00670748|Cyclophosphamide|cyclophosphamide|mesh-list
92966118|NCT00670748|Fludarabine|fludarabine|mesh-list
92966119|NCT00670748|Fludarabine phosphate|fludarabine phosphate|mesh-list
92966120|NCT00670748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966121|NCT00670748|Immunologic Factors|immunologic factors|mesh-ancestor
92966122|NCT00670748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966123|NCT00670748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92966124|NCT00670748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92966125|NCT00670748|Alkylating Agents|alkylating agents|mesh-ancestor
92966126|NCT00670748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966127|NCT00670748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966128|NCT00670748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92966129|NCT00670748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92966130|NCT00670748|Antimetabolites|antimetabolites|mesh-ancestor
92166398|NCT04951752|Ropivacaine|ropivacaine|mesh-list
92966131|NCT00670748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92966132|NCT00670748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92966133|NCT00670748|Antiviral Agents|antiviral agents|mesh-ancestor
92966134|NCT00670748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966135|NCT00646776|Ritonavir|ritonavir|mesh-list
92966136|NCT00646776|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92966137|NCT00646776|Rifabutin|rifabutin|mesh-list
92966138|NCT00646776|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92966139|NCT00646776|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92966140|NCT00646776|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966141|NCT00646776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966142|NCT00646776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966143|NCT00646776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92966144|NCT00646776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92966145|NCT00646776|Antiviral Agents|antiviral agents|mesh-ancestor
92966146|NCT00646776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966147|NCT00646776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92966148|NCT00646776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92966149|NCT00646776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966150|NCT00646776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92966151|NCT00646776|Antitubercular Agents|antitubercular agents|mesh-ancestor
92966152|NCT02558114|Ribavirin|ribavirin|mesh-list
92966153|NCT02558114|Antimetabolites|antimetabolites|mesh-ancestor
92966154|NCT02558114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966156|NCT02558114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966157|NCT00770666|Bupropion|bupropion|mesh-list
92966158|NCT00770666|Nicotine|nicotine|mesh-list
92966159|NCT00770666|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92966160|NCT00770666|Autonomic Agents|autonomic agents|mesh-ancestor
92966161|NCT00770666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966162|NCT00770666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966163|NCT00770666|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92966164|NCT00770666|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92966165|NCT00770666|Cholinergic Agents|cholinergic agents|mesh-ancestor
92966166|NCT00770666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966167|NCT00770666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966168|NCT00770666|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92966169|NCT00770666|Antidepressive Agents|antidepressive agents|mesh-ancestor
92966170|NCT00770666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966171|NCT00770666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92966172|NCT00770666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92966173|NCT00770666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966174|NCT00770666|Dopamine Agents|dopamine agents|mesh-ancestor
92966175|NCT00770666|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92966176|NCT00770666|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92966177|NCT00770666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966178|NCT00764036|Artesunate|artesunate|mesh-list
92966179|NCT00764036|Antimalarials|antimalarials|mesh-ancestor
92966180|NCT00764036|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92966181|NCT00764036|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92966182|NCT00764036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966183|NCT00764036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966184|NCT00764036|Antiviral Agents|antiviral agents|mesh-ancestor
92966185|NCT00764036|Schistosomicides|schistosomicides|mesh-ancestor
92966186|NCT00764036|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92966187|NCT00764036|Anthelmintics|anthelmintics|mesh-ancestor
92966188|NCT00764114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92966189|NCT00764114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966190|NCT00811200|Triamcinolone|triamcinolone|mesh-list
92966191|NCT00811200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92966192|NCT00811200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92966193|NCT00811200|Ranibizumab|ranibizumab|mesh-list
92966194|NCT00811200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92966195|NCT00811200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92966196|NCT00811200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92966197|NCT00811200|Growth Substances|growth substances|mesh-ancestor
92966198|NCT00811200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966199|NCT00811200|Growth Inhibitors|growth inhibitors|mesh-ancestor
92966200|NCT00811200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966201|NCT00811200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966202|NCT00811200|Glucocorticoids|glucocorticoids|mesh-ancestor
92966203|NCT00811200|Hormones|hormones|mesh-ancestor
92966204|NCT00811200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966205|NCT00811200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966206|NCT00811200|Immunologic Factors|immunologic factors|mesh-ancestor
92966207|NCT00811200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966208|NCT00811200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966209|NCT00811356|Rosiglitazone|rosiglitazone|mesh-list
92966210|NCT00811356|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92966211|NCT00811356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92966212|NCT00811356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92966213|NCT00811356|Antimetabolites|antimetabolites|mesh-ancestor
92966214|NCT00811356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966215|NCT00811356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92966216|NCT00811356|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92966217|NCT00811356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966218|NCT00811356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92966219|NCT00811356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966220|NCT00765986|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92966221|NCT00765986|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92966222|NCT00765986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92966223|NCT00765986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966224|NCT00766064|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92966225|NCT00766064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92966226|NCT00766064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966227|NCT00766064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966228|NCT00766064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966229|NCT00766064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966230|NCT00766064|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92966231|NCT00766064|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92966232|NCT00766064|Serotonin Agents|serotonin agents|mesh-ancestor
92966233|NCT00766064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966234|NCT00766064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966235|NCT00766064|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92966236|NCT00766064|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92966237|NCT00766064|Dopamine Agents|dopamine agents|mesh-ancestor
92966238|NCT00770744|Olanzapine|olanzapine|mesh-list
92966239|NCT00770744|Antiemetics|antiemetics|mesh-ancestor
92966240|NCT00770744|Autonomic Agents|autonomic agents|mesh-ancestor
92966241|NCT00770744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966242|NCT00770744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966243|NCT00770744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92966244|NCT00770744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92966245|NCT00770744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966246|NCT00770744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966247|NCT00770744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966248|NCT00770744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92966249|NCT00770744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92966250|NCT00770744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966251|NCT00770744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966252|NCT00770744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966253|NCT00770744|Serotonin Agents|serotonin agents|mesh-ancestor
92966254|NCT00655668|Lenalidomide|lenalidomide|mesh-list
92966255|NCT00655668|Immunologic Factors|immunologic factors|mesh-ancestor
92966256|NCT00655668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966257|NCT00655668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92966258|NCT00655668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92966259|NCT00655668|Growth Substances|growth substances|mesh-ancestor
92966260|NCT00655668|Growth Inhibitors|growth inhibitors|mesh-ancestor
92966261|NCT00655668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966262|NCT00770900|Montelukast|montelukast|mesh-list
92966263|NCT00770900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92966264|NCT00770900|Respiratory System Agents|respiratory system agents|mesh-ancestor
92966265|NCT00770900|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92966266|NCT00770900|Hormone Antagonists|hormone antagonists|mesh-ancestor
92966267|NCT00770900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966268|NCT00770900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966269|NCT00770900|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92966270|NCT00770900|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92966271|NCT00770900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966272|NCT00766220|Irinotecan|irinotecan|mesh-list
92966273|NCT00766220|Cetuximab|cetuximab|mesh-list
92966274|NCT00766220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92966275|NCT00766220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92966276|NCT00766220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966277|NCT00766220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966278|NCT00766220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966279|NCT00766220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92966280|NCT00770978|Ceftobiprole|ceftobiprole|mesh-list
92966281|NCT00770978|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92966282|NCT00770978|Cephalosporins|cephalosporins|mesh-list
92966283|NCT00770978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966284|NCT00770978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966285|NCT00764426|Ethanol|ethanol|mesh-list
92966286|NCT00764426|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92966287|NCT00764426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966288|NCT00764426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966289|NCT00764426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966290|NCT02558036|Pyrithione zinc|pyrithione zinc|mesh-list
92966291|NCT02558036|Keratolytic Agents|keratolytic agents|mesh-ancestor
92966292|NCT02558036|Dermatologic Agents|dermatologic agents|mesh-ancestor
92966293|NCT00764582|Moxifloxacin|moxifloxacin|mesh-list
92966294|NCT00764582|Levofloxacin|levofloxacin|mesh-list
92966295|NCT00764582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92966296|NCT00764582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92966297|NCT00764582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966298|NCT00764582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966299|NCT00764582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92966300|NCT00764582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92966301|NCT00764582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966302|NCT00764582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966303|NCT00764582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966304|NCT00764582|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92966305|NCT00764582|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92966306|NCT00764582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92966307|NCT04048226|Dexmedetomidine|dexmedetomidine|mesh-list
92966308|NCT04048226|Ketamine|ketamine|mesh-list
92966309|NCT04048226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92966310|NCT04048226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966311|NCT04048226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966312|NCT04048226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92966313|NCT04048226|Analgesics|analgesics|mesh-ancestor
92966314|NCT04048226|Sensory System Agents|sensory system agents|mesh-ancestor
92966315|NCT04048226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966316|NCT04048226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92966317|NCT04048226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92966318|NCT04048226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92966319|NCT04048226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92966320|NCT04048226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966321|NCT04048226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966322|NCT04048226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92966323|NCT04048226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92966324|NCT04048226|Anesthetics, General|anesthetics, general|mesh-ancestor
92966325|NCT04048226|Anesthetics|anesthetics|mesh-ancestor
92966326|NCT04048226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92966327|NCT04048226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92966328|NCT00811746|Eszopiclone|eszopiclone|mesh-list
92966329|NCT00811746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92966330|NCT00811746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966331|NCT00811746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966332|NCT04048070|Flurbiprofen|flurbiprofen|mesh-list
92966333|NCT04048070|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92966334|NCT04048070|Sufentanil|sufentanil|mesh-list
92966335|NCT04048070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92966336|NCT04048070|Narcotics|narcotics|mesh-ancestor
92966337|NCT04048070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966338|NCT04048070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966339|NCT04048070|Analgesics|analgesics|mesh-ancestor
92966340|NCT04048070|Sensory System Agents|sensory system agents|mesh-ancestor
92966341|NCT04048070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966342|NCT04048070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92966343|NCT04048070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92966344|NCT04048070|Anesthetics, General|anesthetics, general|mesh-ancestor
92966345|NCT04048070|Anesthetics|anesthetics|mesh-ancestor
92966346|NCT04048070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92966347|NCT04048070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92966348|NCT04048070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966349|NCT04048070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92966350|NCT04048070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92966351|NCT04048070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966352|NCT04048070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966353|NCT00571064|Donepezil|donepezil|mesh-list
92966354|NCT00571064|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92966355|NCT00571064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966356|NCT00571064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966357|NCT00571064|Cholinergic Agents|cholinergic agents|mesh-ancestor
92966358|NCT00571064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966359|NCT00571064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966360|NCT00571064|Nootropic Agents|nootropic agents|mesh-ancestor
92966361|NCT00811980|Vancomycin|vancomycin|mesh-list
92966362|NCT00811980|Linezolid|linezolid|mesh-list
92966363|NCT00811980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966364|NCT00811980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966365|NCT00811980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92966366|NCT00811980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966367|NCT00811980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966369|NCT00775034|Hemostatics|hemostatics|mesh-ancestor
92966370|NCT00775034|Coagulants|coagulants|mesh-ancestor
92966371|NCT00813696|Gemcitabine|gemcitabine|mesh-list
92966372|NCT00813696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966373|NCT00813696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92966374|NCT00813696|Antimetabolites|antimetabolites|mesh-ancestor
92966375|NCT00813696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966376|NCT00813774|Certolizumab Pegol|certolizumab pegol|mesh-list
92966377|NCT00813774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92966378|NCT00813774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966379|NCT00813774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966380|NCT00813774|Immunologic Factors|immunologic factors|mesh-ancestor
92966381|NCT00813774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966382|NCT00813774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92966383|NCT02557490|Oxaliplatin|oxaliplatin|mesh-list
92966384|NCT02557490|Raltitrexed|raltitrexed|mesh-list
92966385|NCT02557490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966386|NCT02557490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92966387|NCT02557490|Antimetabolites|antimetabolites|mesh-ancestor
92966388|NCT02557490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966389|NCT02557490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92966390|NCT02557490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966391|NCT02551848|Botulinum Toxins|botulinum toxins|mesh-list
92966392|NCT02551848|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92966393|NCT02551848|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92966394|NCT02551848|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92966395|NCT02551848|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92966396|NCT02551848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966397|NCT02551848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966398|NCT02551848|Cholinergic Agents|cholinergic agents|mesh-ancestor
92966399|NCT02551848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966400|NCT02551848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966401|NCT02551848|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92966402|NCT02551848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966404|NCT00807534|Ipratropium|ipratropium|mesh-list
92966405|NCT00807534|Anticonvulsants|anticonvulsants|mesh-ancestor
92966406|NCT00807534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92966407|NCT00807534|Autonomic Agents|autonomic agents|mesh-ancestor
92966408|NCT00807534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966409|NCT00807534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966410|NCT00807534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92966411|NCT00807534|Respiratory System Agents|respiratory system agents|mesh-ancestor
92966412|NCT00807534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92966413|NCT00807534|Cholinergic Agents|cholinergic agents|mesh-ancestor
92966414|NCT00807534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966415|NCT00807534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966416|NCT05589064|Vitamin D|vitamin d|mesh-list
92966417|NCT05589064|Cholecalciferol|cholecalciferol|mesh-list
92966418|NCT05589064|Vitamins|vitamins|mesh-ancestor
92966419|NCT05589064|Micronutrients|micronutrients|mesh-ancestor
92966420|NCT05589064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966421|NCT05589064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92966422|NCT05589064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92966423|NCT00807690|Tacrolimus|tacrolimus|mesh-list
92966424|NCT00807690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966425|NCT00807690|Immunologic Factors|immunologic factors|mesh-ancestor
92966426|NCT00807690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966427|NCT00807690|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92966428|NCT00807690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966429|NCT00807690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966430|NCT05355844|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92966431|NCT05355844|Dermatologic Agents|dermatologic agents|mesh-ancestor
92966432|NCT00814008|Insulin|insulin|mesh-list
92966433|NCT00814008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92966434|NCT00814008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966435|NCT00814086|Paclitaxel|paclitaxel|mesh-list
92966436|NCT00814086|Cisplatin|cisplatin|mesh-list
92966437|NCT00814086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92966438|NCT00814086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966439|NCT00814086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92966440|NCT00814086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92966441|NCT00814086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92966442|NCT00814086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966443|NCT00669110|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92966444|NCT00669110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92966445|NCT00669110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92966446|NCT00669110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966447|NCT00669110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966448|NCT00669110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611861|NCT05391893|Vasodilator Agents|vasodilator agents|mesh-ancestor
92966449|NCT00669110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966451|NCT00669110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966452|NCT00654732|Rituximab|rituximab|mesh-list
92166458|NCT01452451|Hormones|hormones|mesh-ancestor
92966453|NCT00654732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92966454|NCT00654732|Doxorubicin|doxorubicin|mesh-list
92966455|NCT00654732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92966456|NCT00654732|Dacarbazine|dacarbazine|mesh-list
92966457|NCT00654732|Bleomycin|bleomycin|mesh-list
92966458|NCT00654732|Vinblastine|vinblastine|mesh-list
92966459|NCT00654732|Antibodies|antibodies|mesh-list
92966460|NCT00654732|Immunoglobulins|immunoglobulins|mesh-list
92966461|NCT00654732|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92966462|NCT00654732|Imidazole|imidazole|mesh-list
92966463|NCT00654732|Immunologic Factors|immunologic factors|mesh-ancestor
92966464|NCT00654732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966465|NCT00654732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966466|NCT00654732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92966467|NCT00654732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92966468|NCT00654732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92966469|NCT00654732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92966470|NCT00654732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966471|NCT00654732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966472|NCT00654732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92966473|NCT00654732|Alkylating Agents|alkylating agents|mesh-ancestor
92966474|NCT00654732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92966475|NCT00654732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92966476|NCT00654732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92966477|NCT00654732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92966478|NCT00771368|Nitric Oxide|nitric oxide|mesh-list
92966479|NCT00771368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92966480|NCT00771368|Autonomic Agents|autonomic agents|mesh-ancestor
92966481|NCT00771368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966482|NCT00771368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966483|NCT00771368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92966484|NCT00771368|Respiratory System Agents|respiratory system agents|mesh-ancestor
92966485|NCT00771368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92966486|NCT00771368|Antioxidants|antioxidants|mesh-ancestor
92966487|NCT00771368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966488|NCT00771368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966489|NCT00771368|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92966490|NCT00771368|Vasodilator Agents|vasodilator agents|mesh-ancestor
92966491|NCT00771368|Gasotransmitters|gasotransmitters|mesh-ancestor
92966492|NCT00771368|Protective Agents|protective agents|mesh-ancestor
92966493|NCT00771524|Ceftobiprole|ceftobiprole|mesh-list
92966494|NCT00771524|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92966495|NCT00771524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966496|NCT00771524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966497|NCT00771680|Insulin|insulin|mesh-list
92966498|NCT00771680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92966499|NCT00771680|Insulin Aspart|insulin aspart|mesh-list
92966500|NCT00771680|Insulin, Long-Acting|insulin, long-acting|mesh-list
92966501|NCT00771680|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92966502|NCT00771680|Insulin Detemir|insulin detemir|mesh-list
92966503|NCT00771680|Biphasic Insulins|biphasic insulins|mesh-list
92966504|NCT00771680|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92966505|NCT00771680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92966506|NCT00771680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966507|NCT00767468|Sorafenib|sorafenib|mesh-list
92966508|NCT00767468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966509|NCT00767468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966510|NCT00767468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966511|NCT00767468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966512|NCT00669032|Hyaluronic Acid|hyaluronic acid|mesh-list
92966513|NCT00669032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92966514|NCT00669032|Immunologic Factors|immunologic factors|mesh-ancestor
92966515|NCT00669032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966516|NCT00669032|Viscosupplements|viscosupplements|mesh-ancestor
92966517|NCT00669032|Protective Agents|protective agents|mesh-ancestor
92966518|NCT00775580|Atenolol|atenolol|mesh-list
92966519|NCT00775580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92966520|NCT00775580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92966521|NCT00775580|Sympatholytics|sympatholytics|mesh-ancestor
92966522|NCT00775580|Autonomic Agents|autonomic agents|mesh-ancestor
92966523|NCT00775580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966524|NCT00775580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966525|NCT00775580|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92966526|NCT00775580|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92966527|NCT00775580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92966528|NCT00775580|Adrenergic Agents|adrenergic agents|mesh-ancestor
92966529|NCT00775580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966530|NCT00775580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966531|NCT00767546|Botulinum Toxins|botulinum toxins|mesh-list
92966532|NCT00767546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92966533|NCT00767546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966534|NCT00767546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966535|NCT00767546|Cholinergic Agents|cholinergic agents|mesh-ancestor
92966536|NCT00767546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966537|NCT00767546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966538|NCT00654498|Pramipexole|pramipexole|mesh-list
92966539|NCT00654498|Antioxidants|antioxidants|mesh-ancestor
92966540|NCT00654498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966541|NCT00654498|Protective Agents|protective agents|mesh-ancestor
92966542|NCT00654498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966543|NCT00654498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92966544|NCT00654498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92966545|NCT00654498|Dopamine Agonists|dopamine agonists|mesh-ancestor
92966546|NCT00654498|Dopamine Agents|dopamine agents|mesh-ancestor
92966547|NCT00654498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966548|NCT00670046|Valproic Acid|valproic acid|mesh-list
92966549|NCT00670046|Anticonvulsants|anticonvulsants|mesh-ancestor
92966550|NCT00670046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966551|NCT00670046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966552|NCT00670046|GABA Agents|gaba agents|mesh-ancestor
92966553|NCT00670046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966554|NCT00670046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966555|NCT00670046|Antimanic Agents|antimanic agents|mesh-ancestor
92966556|NCT00670046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966557|NCT00670046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966558|NCT00670046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966559|NCT00560391|Dexamethasone|dexamethasone|mesh-list
92966560|NCT00560391|Dexamethasone acetate|dexamethasone acetate|mesh-list
92966561|NCT00560391|Lenalidomide|lenalidomide|mesh-list
92966562|NCT00560391|Dasatinib|dasatinib|mesh-list
92966563|NCT00560391|BB 1101|bb 1101|mesh-list
92966564|NCT00560391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966565|NCT00560391|Antiemetics|antiemetics|mesh-ancestor
92966566|NCT00560391|Autonomic Agents|autonomic agents|mesh-ancestor
92966567|NCT00560391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966568|NCT00560391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966569|NCT00560391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92966570|NCT00560391|Glucocorticoids|glucocorticoids|mesh-ancestor
92966571|NCT00560391|Hormones|hormones|mesh-ancestor
92966572|NCT00560391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966573|NCT00560391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92966574|NCT00560391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966575|NCT00560391|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966576|NCT00560391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966577|NCT00560391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966578|NCT00560391|Immunologic Factors|immunologic factors|mesh-ancestor
92966579|NCT00560391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92966580|NCT00560391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92966581|NCT00560391|Growth Substances|growth substances|mesh-ancestor
92966582|NCT00560391|Growth Inhibitors|growth inhibitors|mesh-ancestor
92966583|NCT00560391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966584|NCT00775736|Insulin|insulin|mesh-list
92966585|NCT00775736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92966586|NCT00775736|Insulin Aspart|insulin aspart|mesh-list
92966587|NCT00775736|Insulin, Long-Acting|insulin, long-acting|mesh-list
92966588|NCT00775736|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92966590|NCT00775736|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92966591|NCT00775736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92966592|NCT00775736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966593|NCT00537238|Pregabalin|pregabalin|mesh-list
92966594|NCT00537238|Levetiracetam|levetiracetam|mesh-list
92966595|NCT00537238|Analgesics|analgesics|mesh-ancestor
92966596|NCT00537238|Sensory System Agents|sensory system agents|mesh-ancestor
92966597|NCT00537238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966598|NCT00537238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966599|NCT00537238|Anticonvulsants|anticonvulsants|mesh-ancestor
92966600|NCT00537238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92966601|NCT00537238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966602|NCT00537238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966603|NCT00537238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92966604|NCT00537238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92966605|NCT00537238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966606|NCT00537238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966607|NCT00537238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966608|NCT00537238|Nootropic Agents|nootropic agents|mesh-ancestor
92966609|NCT03982771|Cyclophosphamide|cyclophosphamide|mesh-list
92966610|NCT03982771|Bortezomib|bortezomib|mesh-list
92966611|NCT03982771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966612|NCT03982771|Immunologic Factors|immunologic factors|mesh-ancestor
92966613|NCT03982771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966614|NCT03982771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92966615|NCT03982771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92966616|NCT03982771|Alkylating Agents|alkylating agents|mesh-ancestor
92966617|NCT03982771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966618|NCT03982771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966619|NCT03982771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92966620|NCT00775814|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92966621|NCT00775814|Candesartan|candesartan|mesh-list
92966622|NCT00775814|Candesartan cilexetil|candesartan cilexetil|mesh-list
92966623|NCT00775814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92966624|NCT00775814|Diuretics|diuretics|mesh-ancestor
92966625|NCT00775814|Natriuretic Agents|natriuretic agents|mesh-ancestor
92966626|NCT00775814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966627|NCT00775814|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92966628|NCT00775814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92966629|NCT00775814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966630|NCT00775814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92966631|NCT00775814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92966632|NCT00942747|Sirolimus|sirolimus|mesh-list
92966633|NCT00942747|Temsirolimus|temsirolimus|mesh-list
92966634|NCT00942747|MTOR Inhibitors|mtor inhibitors|mesh-list
92966635|NCT00942747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966636|NCT00942747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966637|NCT00942747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966638|NCT00942747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966639|NCT00942747|Immunologic Factors|immunologic factors|mesh-ancestor
92966640|NCT00942747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966641|NCT00942747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966642|NCT00942747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966643|NCT00942747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966644|NCT00942747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92966645|NCT00942747|Antifungal Agents|antifungal agents|mesh-ancestor
92966646|NCT00946491|Haloperidol|haloperidol|mesh-list
92966647|NCT00946491|Haloperidol decanoate|haloperidol decanoate|mesh-list
92966648|NCT00946491|Antiemetics|antiemetics|mesh-ancestor
92966649|NCT00946491|Autonomic Agents|autonomic agents|mesh-ancestor
92966650|NCT00946491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966651|NCT00946491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966652|NCT00946491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92966653|NCT00946491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92966654|NCT00946491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966655|NCT00946491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966656|NCT00946491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966657|NCT00946491|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92966658|NCT00946491|Dopamine Agents|dopamine agents|mesh-ancestor
92966659|NCT00946491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966660|NCT00946491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966661|NCT00946491|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92966663|NCT05355610|Dexamethasone|dexamethasone|mesh-list
92966664|NCT05355610|Dexamethasone acetate|dexamethasone acetate|mesh-list
92966665|NCT05355610|BB 1101|bb 1101|mesh-list
92966666|NCT05355610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966667|NCT05355610|Antiemetics|antiemetics|mesh-ancestor
92966668|NCT05355610|Autonomic Agents|autonomic agents|mesh-ancestor
92966669|NCT05355610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966670|NCT05355610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966671|NCT05355610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92966672|NCT05355610|Glucocorticoids|glucocorticoids|mesh-ancestor
92966673|NCT05355610|Hormones|hormones|mesh-ancestor
92966674|NCT05355610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966675|NCT05355610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92966676|NCT05355610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966677|NCT05355610|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966678|NCT05355610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966679|NCT05355610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966680|NCT05355610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966681|NCT05355610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966682|NCT05355610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92966684|NCT00552669|Paclitaxel|paclitaxel|mesh-list
92966685|NCT00552669|Temsirolimus|temsirolimus|mesh-list
92966686|NCT00552669|MTOR Inhibitors|mtor inhibitors|mesh-list
92966687|NCT00552669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92966688|NCT00552669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966689|NCT00552669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92966690|NCT00552669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92966691|NCT00552669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92966692|NCT00552669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966693|NCT00552669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966694|NCT00552669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966695|NCT00552669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92966696|NCT00552669|Antifungal Agents|antifungal agents|mesh-ancestor
92966697|NCT00552669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966698|NCT00552669|Immunologic Factors|immunologic factors|mesh-ancestor
92966699|NCT00552669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966700|NCT00552669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966701|NCT00552669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966702|NCT00943059|Acipimox|acipimox|mesh-list
92966703|NCT00943059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92966704|NCT00943059|Antimetabolites|antimetabolites|mesh-ancestor
92966705|NCT00943059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966706|NCT00943059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92966707|NCT00943137|Fluorouracil|fluorouracil|mesh-list
92966708|NCT00943137|Antimetabolites|antimetabolites|mesh-ancestor
92966709|NCT00943137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966710|NCT00943137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92966711|NCT00943137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966712|NCT00943137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966713|NCT00943137|Immunologic Factors|immunologic factors|mesh-ancestor
92966714|NCT00943137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966715|NCT00772616|Sufentanil|sufentanil|mesh-list
92966716|NCT00772616|Remifentanil|remifentanil|mesh-list
92966717|NCT00772616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92966718|NCT00772616|Narcotics|narcotics|mesh-ancestor
92966719|NCT00772616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966720|NCT00772616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966721|NCT00772616|Analgesics|analgesics|mesh-ancestor
92966722|NCT00772616|Sensory System Agents|sensory system agents|mesh-ancestor
92966723|NCT00772616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966724|NCT00772616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92966725|NCT00772616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92966726|NCT00772616|Anesthetics, General|anesthetics, general|mesh-ancestor
92966727|NCT00772616|Anesthetics|anesthetics|mesh-ancestor
92966728|NCT05406700|Niraparib|niraparib|mesh-list
92966729|NCT05406700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92966730|NCT05406700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966731|NCT05406700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966732|NCT05406700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966733|NCT00768404|Phentermine|phentermine|mesh-list
92966734|NCT00768404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92966735|NCT00768404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966736|NCT00768404|Appetite Depressants|appetite depressants|mesh-ancestor
92966737|NCT00768404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92966738|NCT00768404|Sympathomimetics|sympathomimetics|mesh-ancestor
92966739|NCT00768404|Autonomic Agents|autonomic agents|mesh-ancestor
92966740|NCT00768404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966741|NCT00768404|Adrenergic Agents|adrenergic agents|mesh-ancestor
92966742|NCT00768404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966743|NCT00768404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966744|NCT05406622|Sirolimus|sirolimus|mesh-list
92966745|NCT05406622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966746|NCT05406622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966747|NCT05406622|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92966748|NCT05406622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966749|NCT05406622|Antifungal Agents|antifungal agents|mesh-ancestor
92966750|NCT05406622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966751|NCT05406622|Immunologic Factors|immunologic factors|mesh-ancestor
92966752|NCT05406622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966753|NCT00776282|Loratadine|loratadine|mesh-list
92966754|NCT00776282|Antipruritics|antipruritics|mesh-ancestor
92966755|NCT00776282|Dermatologic Agents|dermatologic agents|mesh-ancestor
92966756|NCT00776282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92966757|NCT00776282|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92966758|NCT00776282|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92966759|NCT00776282|Histamine Antagonists|histamine antagonists|mesh-ancestor
92966760|NCT00776282|Histamine Agents|histamine agents|mesh-ancestor
92966761|NCT00776282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966762|NCT00776282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966763|NCT00776282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966764|NCT00943293|Fludarabine|fludarabine|mesh-list
92966765|NCT00943293|Melphalan|melphalan|mesh-list
92966766|NCT00943293|Alemtuzumab|alemtuzumab|mesh-list
92966767|NCT00943293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966768|NCT00943293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966769|NCT00943293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966770|NCT00943293|Immunologic Factors|immunologic factors|mesh-ancestor
92966771|NCT00943293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966772|NCT00943293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92966773|NCT00943293|Alkylating Agents|alkylating agents|mesh-ancestor
92966774|NCT00943293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92966775|NCT00943293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92966776|NCT00776360|Oxytocin|oxytocin|mesh-list
92966777|NCT00776360|Oxytocics|oxytocics|mesh-ancestor
92966778|NCT00776360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92966779|NCT00776360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966780|NCT00946725|Atenolol|atenolol|mesh-list
92966781|NCT00946725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92966782|NCT00946725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92966783|NCT00946725|Sympatholytics|sympatholytics|mesh-ancestor
92966784|NCT00946725|Autonomic Agents|autonomic agents|mesh-ancestor
92966785|NCT00946725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966786|NCT00946725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966787|NCT00946725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92966788|NCT00946725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92966789|NCT00946725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92966790|NCT00946725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92966791|NCT00946725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966792|NCT00946725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966793|NCT03041740|Perflubron|perflubron|mesh-list
92966794|NCT03041740|Bromides|bromides|mesh-list
92966795|NCT03041740|Anticonvulsants|anticonvulsants|mesh-ancestor
92966796|NCT03041740|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92966797|NCT00772694|Sorafenib|sorafenib|mesh-list
92966798|NCT00772694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966799|NCT00772694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966800|NCT00772694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966801|NCT00772694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966802|NCT00776438|Vaccines|vaccines|mesh-list
92966803|NCT00776438|Immunologic Factors|immunologic factors|mesh-ancestor
92966804|NCT00776438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966805|NCT00943449|Sorafenib|sorafenib|mesh-list
92966806|NCT00943449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966807|NCT00943449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966808|NCT00943449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966809|NCT00943449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966810|NCT00952029|Leucovorin|leucovorin|mesh-list
92966811|NCT00952029|Bevacizumab|bevacizumab|mesh-list
92966812|NCT00952029|Fluorouracil|fluorouracil|mesh-list
92966814|NCT00952029|Calcium|calcium|mesh-list
92966815|NCT00952029|Levoleucovorin|levoleucovorin|mesh-list
92966816|NCT00952029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92966817|NCT00952029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966818|NCT00952029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92966819|NCT00952029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92966820|NCT00952029|Growth Substances|growth substances|mesh-ancestor
92966821|NCT00952029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966822|NCT00952029|Growth Inhibitors|growth inhibitors|mesh-ancestor
92966823|NCT00952029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92966824|NCT00952029|Antimetabolites|antimetabolites|mesh-ancestor
92966825|NCT00952029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966826|NCT00952029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92966827|NCT00952029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92966828|NCT00952029|Immunologic Factors|immunologic factors|mesh-ancestor
92966829|NCT00952029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92966830|NCT00952029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92966831|NCT00952029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966832|NCT00952029|Antidotes|antidotes|mesh-ancestor
92966833|NCT00952029|Protective Agents|protective agents|mesh-ancestor
92966834|NCT00952029|Vitamin B Complex|vitamin b complex|mesh-ancestor
92966835|NCT00952029|Vitamins|vitamins|mesh-ancestor
92966836|NCT00952029|Micronutrients|micronutrients|mesh-ancestor
92966837|NCT00667862|Panobinostat|panobinostat|mesh-list
92966838|NCT00667862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966839|NCT00667862|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92966840|NCT00667862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966841|NCT00667862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966842|NCT00952185|Antibodies|antibodies|mesh-list
92966843|NCT00952185|Immunologic Factors|immunologic factors|mesh-ancestor
92966844|NCT00952185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966845|NCT00776516|Rifampin|rifampin|mesh-list
92966846|NCT00776516|Mirabegron|mirabegron|mesh-list
92966847|NCT00776516|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92966848|NCT00776516|Antitubercular Agents|antitubercular agents|mesh-ancestor
92966849|NCT00776516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966850|NCT00776516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966851|NCT00776516|Leprostatic Agents|leprostatic agents|mesh-ancestor
92966852|NCT00776516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92966853|NCT00776516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966854|NCT00776516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966855|NCT00776516|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92966856|NCT00776516|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92966857|NCT00776516|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92966858|NCT00776516|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92966859|NCT00776516|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92966860|NCT00776516|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92966861|NCT00776516|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92966862|NCT00776516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92966863|NCT00776516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92966864|NCT00776516|Adrenergic Agents|adrenergic agents|mesh-ancestor
92966865|NCT00776516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966866|NCT00776516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966867|NCT00776516|Urological Agents|urological agents|mesh-ancestor
92966868|NCT00768638|Atorvastatin|atorvastatin|mesh-list
92966869|NCT00768638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92966870|NCT00768638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92966871|NCT00768638|Antimetabolites|antimetabolites|mesh-ancestor
92966872|NCT00768638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966873|NCT00768638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92966874|NCT00768638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92966875|NCT00768638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966876|NCT02557958|Azithromycin|azithromycin|mesh-list
92966877|NCT02557958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92966878|NCT02557958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966879|NCT00776672|Fosinopril|fosinopril|mesh-list
92966880|NCT00776672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92966881|NCT00776672|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966882|NCT00776672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966883|NCT00776672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966884|NCT00776672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92966885|NCT00535132|Risperidone|risperidone|mesh-list
92966886|NCT00535132|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92966887|NCT00535132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92966888|NCT00535132|Serotonin Agents|serotonin agents|mesh-ancestor
92966889|NCT00535132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92966890|NCT00535132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966891|NCT00535132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966892|NCT00535132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92966893|NCT00535132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966894|NCT00535132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966895|NCT00535132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966896|NCT00535132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92966897|NCT00535132|Dopamine Agents|dopamine agents|mesh-ancestor
92966898|NCT00535132|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92966899|NCT00535132|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92966900|NCT00570908|Capecitabine|capecitabine|mesh-list
92966901|NCT00570908|Sunitinib|sunitinib|mesh-list
92966902|NCT00570908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92966903|NCT00570908|Antimetabolites|antimetabolites|mesh-ancestor
92966904|NCT00570908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966905|NCT00570908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966906|NCT00570908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92966907|NCT00570908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92966908|NCT00570908|Growth Substances|growth substances|mesh-ancestor
92966909|NCT00570908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966910|NCT00570908|Growth Inhibitors|growth inhibitors|mesh-ancestor
92966911|NCT00570908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92966912|NCT00570908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966913|NCT00773084|Lisinopril|lisinopril|mesh-list
92966914|NCT00773084|Spironolactone|spironolactone|mesh-list
92966915|NCT00773084|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92966916|NCT00773084|Hormone Antagonists|hormone antagonists|mesh-ancestor
92966917|NCT00773084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966918|NCT00773084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966919|NCT00773084|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92966920|NCT00773084|Diuretics|diuretics|mesh-ancestor
92966921|NCT00773084|Natriuretic Agents|natriuretic agents|mesh-ancestor
92966922|NCT00773084|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92966923|NCT00773084|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966924|NCT00773084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966925|NCT00773084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966926|NCT00773084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92966927|NCT00773084|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92966928|NCT00773084|Protective Agents|protective agents|mesh-ancestor
92966929|NCT00321919|Epoetin Alfa|epoetin alfa|mesh-list
92966930|NCT00321919|Hematinics|hematinics|mesh-ancestor
92966931|NCT00781391|Warfarin|warfarin|mesh-list
92966932|NCT00781391|Edoxaban|edoxaban|mesh-list
92966933|NCT00781391|Anticoagulants|anticoagulants|mesh-ancestor
92966934|NCT00781391|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92966935|NCT00781391|Antithrombins|antithrombins|mesh-ancestor
92966936|NCT00781391|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92966937|NCT00781391|Protease Inhibitors|protease inhibitors|mesh-ancestor
92966938|NCT00781391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966939|NCT00781391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966940|NCT00534976|Montelukast|montelukast|mesh-list
92966941|NCT00534976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92966942|NCT00534976|Respiratory System Agents|respiratory system agents|mesh-ancestor
92966943|NCT00534976|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92966944|NCT00534976|Hormone Antagonists|hormone antagonists|mesh-ancestor
92966945|NCT00534976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966946|NCT00534976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966947|NCT00534976|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92966948|NCT00534976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92966949|NCT00534976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966950|NCT00773162|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92966951|NCT00773162|Antidepressive Agents|antidepressive agents|mesh-ancestor
92966952|NCT00773162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92966953|NCT00773162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92966954|NCT00773162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92966955|NCT00773162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92966956|NCT00773162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966957|NCT00776828|Cilostazol|cilostazol|mesh-list
92966958|NCT00776828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92966959|NCT00776828|Autonomic Agents|autonomic agents|mesh-ancestor
92966960|NCT00776828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92966961|NCT00776828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966962|NCT00776828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92966963|NCT00776828|Respiratory System Agents|respiratory system agents|mesh-ancestor
92966964|NCT00776828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92966965|NCT00776828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92966966|NCT00776828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966967|NCT00776828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92966968|NCT00776828|Vasodilator Agents|vasodilator agents|mesh-ancestor
92966969|NCT00776828|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92966970|NCT00776828|Protective Agents|protective agents|mesh-ancestor
92966971|NCT00776828|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92966972|NCT00776828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92612383|NCT00405119|Esomeprazole|esomeprazole|mesh-list
92966973|NCT00776828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966974|NCT01063933|Peramivir|peramivir|mesh-list
92966975|NCT01063933|Antiviral Agents|antiviral agents|mesh-ancestor
92966976|NCT01063933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92966977|NCT01063933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92966978|NCT01063933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92966979|NCT02556866|Prednisone|prednisone|mesh-list
92966980|NCT02556866|Rituximab|rituximab|mesh-list
92966981|NCT02556866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92966982|NCT02556866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92966983|NCT02556866|Immunologic Factors|immunologic factors|mesh-ancestor
92966984|NCT02556866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966985|NCT02556866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92966986|NCT02556866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966987|NCT02556866|Glucocorticoids|glucocorticoids|mesh-ancestor
92966988|NCT02556866|Hormones|hormones|mesh-ancestor
92966989|NCT02556866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966990|NCT02556866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92966991|NCT00308113|Ubiquinone|ubiquinone|mesh-list
92966992|NCT00308113|Coenzyme Q10|coenzyme q10|mesh-list
92966993|NCT00308113|Prednisone|prednisone|mesh-list
92966994|NCT00308113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92966995|NCT00308113|Glucocorticoids|glucocorticoids|mesh-ancestor
92966996|NCT00308113|Hormones|hormones|mesh-ancestor
92966997|NCT00308113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92966998|NCT00308113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92966999|NCT00308113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92967000|NCT00308113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967001|NCT00308113|Micronutrients|micronutrients|mesh-ancestor
92967002|NCT00308113|Vitamins|vitamins|mesh-ancestor
92967003|NCT03903640|Nivolumab|nivolumab|mesh-list
92967004|NCT03903640|Ipilimumab|ipilimumab|mesh-list
92967005|NCT03903640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92967006|NCT03903640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967007|NCT03903640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92967008|NCT03903640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967009|NCT03982849|Silymarin|silymarin|mesh-list
92967010|NCT03982849|Hydroquinone|hydroquinone|mesh-list
92967011|NCT03982849|Antioxidants|antioxidants|mesh-ancestor
92967012|NCT03982849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967013|NCT03982849|Protective Agents|protective agents|mesh-ancestor
92967014|NCT03982849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967015|NCT03982849|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92967016|NCT05357872|Anesthetics|anesthetics|mesh-list
92967017|NCT05357872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967018|NCT05357872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967019|NCT00777218|Topiramate|topiramate|mesh-list
92967020|NCT00777218|Propranolol|propranolol|mesh-list
92967021|NCT00777218|Zonisamide|zonisamide|mesh-list
92967022|NCT00777218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92967023|NCT00777218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92967024|NCT00777218|Adrenergic Agents|adrenergic agents|mesh-ancestor
92967025|NCT00777218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967026|NCT00777218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967027|NCT00777218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967028|NCT00777218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92967029|NCT00777218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92967030|NCT00777218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92967031|NCT00777218|Anticonvulsants|anticonvulsants|mesh-ancestor
92967032|NCT00777218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92967033|NCT00777218|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92967034|NCT00777218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92967035|NCT00777218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92967036|NCT04047758|Letrozole|letrozole|mesh-list
92967037|NCT04047758|Palbociclib|palbociclib|mesh-list
92967038|NCT04047758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967039|NCT04047758|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92967040|NCT04047758|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92967041|NCT04047758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967042|NCT04047758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967043|NCT04047758|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92967044|NCT04047758|Hormone Antagonists|hormone antagonists|mesh-ancestor
92967045|NCT04047758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967046|NCT04047758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967047|NCT04047758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967048|NCT00307801|Dienogest|dienogest|mesh-list
92967049|NCT00307801|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92967050|NCT00307801|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92967051|NCT00307801|Estradiol|estradiol|mesh-list
92967052|NCT00307801|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92967053|NCT00307801|Estrogens|estrogens|mesh-ancestor
92967054|NCT00307801|Hormones|hormones|mesh-ancestor
92967055|NCT00307801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967056|NCT00307801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967057|NCT00307801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92967058|NCT00307801|Contraceptive Agents|contraceptive agents|mesh-ancestor
92967059|NCT00307801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92967060|NCT00307801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92967061|NCT00307801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92967062|NCT00307801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92967063|NCT00307801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92967064|NCT00307801|Hormone Antagonists|hormone antagonists|mesh-ancestor
92967065|NCT00307801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92967066|NCT00307801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967067|NCT00671060|Misoprostol|misoprostol|mesh-list
92967068|NCT00671060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92967069|NCT00671060|Abortifacient Agents|abortifacient agents|mesh-ancestor
92967070|NCT00671060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92967071|NCT00671060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967072|NCT00671060|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92967073|NCT00671060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92967074|NCT00671060|Oxytocics|oxytocics|mesh-ancestor
92967075|NCT05354986|Povidone|povidone|mesh-list
92967076|NCT05354986|Plasma Substitutes|plasma substitutes|mesh-ancestor
92967077|NCT05354986|Blood Substitutes|blood substitutes|mesh-ancestor
92967078|NCT00773552|Solifenacin Succinate|solifenacin succinate|mesh-list
92967079|NCT00773552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92967080|NCT00773552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92967081|NCT00773552|Cholinergic Agents|cholinergic agents|mesh-ancestor
92967082|NCT00773552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967083|NCT00773552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967084|NCT00773552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967085|NCT00773552|Urological Agents|urological agents|mesh-ancestor
92967086|NCT04002700|Haloperidol|haloperidol|mesh-list
92967087|NCT04002700|Haloperidol decanoate|haloperidol decanoate|mesh-list
92967088|NCT04002700|Antipsychotic Agents|antipsychotic agents|mesh-list
92967089|NCT04002700|Antiemetics|antiemetics|mesh-ancestor
92967090|NCT04002700|Autonomic Agents|autonomic agents|mesh-ancestor
92967091|NCT04002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967092|NCT04002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967093|NCT04002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92967094|NCT04002700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92967095|NCT04002700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967096|NCT04002700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92967097|NCT04002700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92967098|NCT04002700|Dopamine Agents|dopamine agents|mesh-ancestor
92967099|NCT04002700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967100|NCT04002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967101|NCT04002700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92967102|NCT04098653|Cyclophosphamide|cyclophosphamide|mesh-list
92967103|NCT04098653|Busulfan|busulfan|mesh-list
92967104|NCT04098653|Decitabine|decitabine|mesh-list
92967105|NCT04098653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967106|NCT04098653|Immunologic Factors|immunologic factors|mesh-ancestor
92967107|NCT04098653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967108|NCT04098653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967109|NCT04098653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92967110|NCT04098653|Alkylating Agents|alkylating agents|mesh-ancestor
92967111|NCT04098653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967112|NCT04098653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967113|NCT04098653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92967114|NCT04098653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92967115|NCT04098653|Antimetabolites|antimetabolites|mesh-ancestor
92967116|NCT04098653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967118|NCT05297123|Arsenic Trioxide|arsenic trioxide|mesh-list
92967119|NCT05297123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967120|NCT05297123|Keratolytic Agents|keratolytic agents|mesh-ancestor
92967121|NCT05297123|Dermatologic Agents|dermatologic agents|mesh-ancestor
92967122|NCT00654420|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92967123|NCT00654420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967124|NCT00654420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967125|NCT00654420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967126|NCT00654420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967127|NCT00773630|Cilostazol|cilostazol|mesh-list
92967128|NCT00773630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92967129|NCT00773630|Autonomic Agents|autonomic agents|mesh-ancestor
92967130|NCT00773630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967131|NCT00773630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967132|NCT00773630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92967133|NCT00773630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92967134|NCT00773630|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92967135|NCT00773630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92967136|NCT00773630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967137|NCT00773630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92967138|NCT00773630|Vasodilator Agents|vasodilator agents|mesh-ancestor
92967139|NCT00773630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92967140|NCT00773630|Protective Agents|protective agents|mesh-ancestor
92967141|NCT00773630|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92967142|NCT00773630|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92967143|NCT00773630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967144|NCT04016922|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92967145|NCT04016922|Hematinics|hematinics|mesh-ancestor
92967146|NCT03646474|Tranexamic Acid|tranexamic acid|mesh-list
92967147|NCT03646474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92967148|NCT03646474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92967149|NCT03646474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967150|NCT03646474|Hemostatics|hemostatics|mesh-ancestor
92967151|NCT03646474|Coagulants|coagulants|mesh-ancestor
92967152|NCT00808002|Tenofovir|tenofovir|mesh-list
92967153|NCT00808002|Emtricitabine|emtricitabine|mesh-list
92967154|NCT00808002|Raltegravir Potassium|raltegravir potassium|mesh-list
92967155|NCT00808002|Maraviroc|maraviroc|mesh-list
92967156|NCT00808002|Antiviral Agents|antiviral agents|mesh-ancestor
92967157|NCT00808002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967158|NCT00808002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92967159|NCT00808002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967160|NCT00808002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967161|NCT00808002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967162|NCT00808002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967163|NCT00808002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967164|NCT00808002|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92967165|NCT00808002|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92967166|NCT00808002|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92967167|NCT00808002|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92967168|NCT00808002|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92967169|NCT00307489|Tenofovir|tenofovir|mesh-list
92967170|NCT00307489|Emtricitabine|emtricitabine|mesh-list
92967171|NCT00307489|Antiviral Agents|antiviral agents|mesh-ancestor
92967172|NCT00307489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967173|NCT00307489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92967174|NCT00307489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967175|NCT00307489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967176|NCT00307489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967177|NCT00307489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92312203|NCT05451056|Sotorasib|sotorasib|mesh-list
92967178|NCT00307489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967179|NCT00812292|Rilpivirine|rilpivirine|mesh-list
92967180|NCT00812292|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92967181|NCT00812292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967182|NCT00812292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967183|NCT00812292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967184|NCT00812292|Antiviral Agents|antiviral agents|mesh-ancestor
92967185|NCT00812292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967186|NCT00812292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967187|NCT00812292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967188|NCT00812370|Bivalirudin|bivalirudin|mesh-list
92967189|NCT00812370|Antithrombins|antithrombins|mesh-ancestor
92967190|NCT00812370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92967191|NCT00812370|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967192|NCT00812370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967193|NCT00812370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967194|NCT00812370|Anticoagulants|anticoagulants|mesh-ancestor
92967195|NCT00645840|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92967196|NCT00645840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967197|NCT00773708|Raltegravir Potassium|raltegravir potassium|mesh-list
92612615|NCT00510016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92967198|NCT00773708|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967199|NCT00773708|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967200|NCT00773708|Antiviral Agents|antiviral agents|mesh-ancestor
92967201|NCT00773708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967202|NCT00773708|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92967203|NCT00773708|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92967204|NCT00773708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967205|NCT00773708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967206|NCT00762359|Lansoprazole|lansoprazole|mesh-list
92967207|NCT00762359|Dexlansoprazole|dexlansoprazole|mesh-list
92967208|NCT00762359|Gefarnate|gefarnate|mesh-list
92967209|NCT00762359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92967210|NCT00762359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92967211|NCT00762359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92967212|NCT00762359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967213|NCT00762359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967214|NCT04003090|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92967215|NCT04003090|Nootropic Agents|nootropic agents|mesh-ancestor
92967216|NCT01061749|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92967217|NCT01061749|Immunologic Factors|immunologic factors|mesh-ancestor
92967218|NCT01061749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967219|NCT00770042|Ritonavir|ritonavir|mesh-list
92967220|NCT00770042|Ketoconazole|ketoconazole|mesh-list
92967221|NCT00770042|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92967222|NCT00770042|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92967223|NCT00770042|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967224|NCT00770042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166509|NCT04942002|Prednisolone acetate|prednisolone acetate|mesh-list
92967225|NCT00770042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967226|NCT00770042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967227|NCT00770042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967228|NCT00770042|Antiviral Agents|antiviral agents|mesh-ancestor
92967229|NCT00770042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967230|NCT00770042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92967231|NCT00770042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92967232|NCT00770042|Antifungal Agents|antifungal agents|mesh-ancestor
92967233|NCT00770042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92967234|NCT00770042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92967235|NCT00770042|Hormone Antagonists|hormone antagonists|mesh-ancestor
92967236|NCT00770042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967237|NCT00770042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967238|NCT00654186|Lenalidomide|lenalidomide|mesh-list
92967239|NCT00654186|Immunologic Factors|immunologic factors|mesh-ancestor
92967240|NCT00654186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967241|NCT00654186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967242|NCT00654186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967243|NCT00654186|Growth Substances|growth substances|mesh-ancestor
92967244|NCT00654186|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967245|NCT00654186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967246|NCT03275818|Paclitaxel|paclitaxel|mesh-list
92967247|NCT03275818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92967248|NCT03275818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967249|NCT03275818|Tubulin Modulators|tubulin modulators|mesh-ancestor
92967250|NCT03275818|Antimitotic Agents|antimitotic agents|mesh-ancestor
92967251|NCT03275818|Mitosis Modulators|mitosis modulators|mesh-ancestor
92967252|NCT03275818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967254|NCT03979105|Analgesics|analgesics|mesh-ancestor
92967255|NCT03979105|Sensory System Agents|sensory system agents|mesh-ancestor
92967256|NCT03979105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967257|NCT03979105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967258|NCT03979105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92967259|NCT03979105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92967260|NCT03979105|Anesthetics, General|anesthetics, general|mesh-ancestor
92967261|NCT03979105|Anesthetics|anesthetics|mesh-ancestor
92967262|NCT03979105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967263|NCT03979105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92967264|NCT03979105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92967265|NCT03979105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967266|NCT03979105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967267|NCT00774020|Zoledronic Acid|zoledronic acid|mesh-list
92967268|NCT00774020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92967269|NCT00774020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967270|NCT04100447|Tranexamic Acid|tranexamic acid|mesh-list
92967271|NCT04100447|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92967272|NCT04100447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92967273|NCT04100447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967274|NCT04100447|Hemostatics|hemostatics|mesh-ancestor
92967275|NCT04100447|Coagulants|coagulants|mesh-ancestor
92967276|NCT03274804|Maraviroc|maraviroc|mesh-list
92967277|NCT03274804|Pembrolizumab|pembrolizumab|mesh-list
92967278|NCT03274804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92967279|NCT03274804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967280|NCT03274804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92967281|NCT03274804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967282|NCT03274804|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92967283|NCT03274804|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92967284|NCT03274804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967285|NCT03274804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967286|NCT03274804|Antiviral Agents|antiviral agents|mesh-ancestor
92967287|NCT03274804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967288|NCT03274804|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92967289|NCT00761891|Aspirin|aspirin|mesh-list
92967290|NCT00761891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92967291|NCT00761891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92967292|NCT00761891|Analgesics|analgesics|mesh-ancestor
92967293|NCT00761891|Sensory System Agents|sensory system agents|mesh-ancestor
92967294|NCT00761891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967295|NCT00761891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967296|NCT00761891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967297|NCT00761891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967298|NCT00761891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92967299|NCT00761891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92967300|NCT00761891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967301|NCT00761891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92967302|NCT00761891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92967303|NCT00761891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967304|NCT00761891|Antipyretics|antipyretics|mesh-ancestor
92967305|NCT00321685|Calcium, Dietary|calcium, dietary|mesh-list
92967306|NCT00321685|Leucovorin|leucovorin|mesh-list
92967307|NCT00321685|Folic Acid|folic acid|mesh-list
92967308|NCT00321685|Bevacizumab|bevacizumab|mesh-list
92967309|NCT00321685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92967310|NCT00321685|Fluorouracil|fluorouracil|mesh-list
92967311|NCT00321685|Capecitabine|capecitabine|mesh-list
92967312|NCT00321685|Oxaliplatin|oxaliplatin|mesh-list
92967313|NCT00321685|Endothelial Growth Factors|endothelial growth factors|mesh-list
92967314|NCT00321685|Antibodies|antibodies|mesh-list
92967315|NCT00321685|Immunoglobulins|immunoglobulins|mesh-list
92967316|NCT00321685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92967317|NCT00321685|Immunoglobulin G|immunoglobulin g|mesh-list
92967318|NCT00321685|Calcium|calcium|mesh-list
92967319|NCT00321685|Levoleucovorin|levoleucovorin|mesh-list
92967320|NCT00321685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967321|NCT00321685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967322|NCT00321685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967323|NCT00321685|Growth Substances|growth substances|mesh-ancestor
92967324|NCT00321685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967325|NCT00321685|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967326|NCT00321685|Immunologic Factors|immunologic factors|mesh-ancestor
92967327|NCT00321685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92967328|NCT00321685|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92967329|NCT00321685|Antimetabolites|antimetabolites|mesh-ancestor
92967330|NCT00321685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967331|NCT00321685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92967332|NCT00321685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967333|NCT00321685|Antidotes|antidotes|mesh-ancestor
92967334|NCT00321685|Protective Agents|protective agents|mesh-ancestor
92967335|NCT00321685|Vitamin B Complex|vitamin b complex|mesh-ancestor
92967336|NCT00321685|Vitamins|vitamins|mesh-ancestor
92967337|NCT00321685|Micronutrients|micronutrients|mesh-ancestor
92967338|NCT00321685|Hematinics|hematinics|mesh-ancestor
92967339|NCT00777998|Ferrous fumarate|ferrous fumarate|mesh-list
92967340|NCT00777998|Thalidomide|thalidomide|mesh-list
92967341|NCT00777998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967342|NCT00777998|Immunologic Factors|immunologic factors|mesh-ancestor
92967343|NCT00777998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967344|NCT00777998|Leprostatic Agents|leprostatic agents|mesh-ancestor
92967345|NCT00777998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967346|NCT00777998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967347|NCT00777998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967348|NCT00777998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967349|NCT00777998|Growth Substances|growth substances|mesh-ancestor
92967350|NCT00777998|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967351|NCT00777998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967352|NCT00777998|Trace Elements|trace elements|mesh-ancestor
92967353|NCT00777998|Micronutrients|micronutrients|mesh-ancestor
92967354|NCT05348200|Clobetasol|clobetasol|mesh-list
92967355|NCT05348200|Lidocaine|lidocaine|mesh-list
92967356|NCT05348200|Halobetasol|halobetasol|mesh-list
92967357|NCT05348200|Anesthetics, Local|anesthetics, local|mesh-ancestor
92967358|NCT05348200|Anesthetics|anesthetics|mesh-ancestor
92967359|NCT05348200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967360|NCT05348200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967361|NCT05348200|Sensory System Agents|sensory system agents|mesh-ancestor
92967362|NCT05348200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967363|NCT05348200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92967364|NCT05348200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92967365|NCT05348200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92967366|NCT05348200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92967367|NCT05348200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967368|NCT05348200|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92967369|NCT05348200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967370|NCT05348200|Glucocorticoids|glucocorticoids|mesh-ancestor
92967371|NCT05348200|Hormones|hormones|mesh-ancestor
92967372|NCT05348200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967373|NCT00778076|Hyaluronic Acid|hyaluronic acid|mesh-list
92967374|NCT00778076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92967375|NCT00778076|Immunologic Factors|immunologic factors|mesh-ancestor
92967376|NCT00778076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967377|NCT00778076|Viscosupplements|viscosupplements|mesh-ancestor
92967378|NCT00778076|Protective Agents|protective agents|mesh-ancestor
92967379|NCT00306787|Valacyclovir|valacyclovir|mesh-list
92967380|NCT00306787|Famciclovir|famciclovir|mesh-list
92967381|NCT00306787|Antiviral Agents|antiviral agents|mesh-ancestor
92967382|NCT00306787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967383|NCT00306787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967384|NCT00306787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967385|NCT00306787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967386|NCT00778232|Gabapentin|gabapentin|mesh-list
92967387|NCT00778232|Analgesics|analgesics|mesh-ancestor
92967388|NCT00778232|Sensory System Agents|sensory system agents|mesh-ancestor
92967389|NCT00778232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967390|NCT00778232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967391|NCT00778232|Anticonvulsants|anticonvulsants|mesh-ancestor
92967392|NCT00778232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92967393|NCT00778232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92967394|NCT00778232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967395|NCT00778232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92967396|NCT00778232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92967397|NCT00778232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92967398|NCT00778232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967399|NCT00778232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967400|NCT00778232|Antimanic Agents|antimanic agents|mesh-ancestor
92967401|NCT00774488|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92967402|NCT00774488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92967403|NCT00774488|Incretins|incretins|mesh-ancestor
92967404|NCT00774488|Hormones|hormones|mesh-ancestor
92967405|NCT00774488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967406|NCT00774488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967407|NCT01066195|Pemetrexed|pemetrexed|mesh-list
92967408|NCT01066195|Gefitinib|gefitinib|mesh-list
92967409|NCT01066195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967410|NCT01066195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967411|NCT01066195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967412|NCT01066195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92967413|NCT01066195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967414|NCT01066195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967415|NCT00774644|Clarithromycin|clarithromycin|mesh-list
92967416|NCT00774644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967417|NCT00774644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967418|NCT00774644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92967419|NCT00774644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967420|NCT00774644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967421|NCT00774644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92967422|NCT00774644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92967423|NCT05123092|Morphine|morphine|mesh-list
92967424|NCT05123092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92967425|NCT05123092|Narcotics|narcotics|mesh-ancestor
92967426|NCT05123092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967427|NCT05123092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967429|NCT05123092|Sensory System Agents|sensory system agents|mesh-ancestor
92967430|NCT05123092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967431|NCT04001530|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92967432|NCT00769067|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92967433|NCT00769067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967434|NCT00769067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967435|NCT00769067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967436|NCT00769067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967437|NCT04001608|Sofosbuvir|sofosbuvir|mesh-list
92967438|NCT04001608|Antiviral Agents|antiviral agents|mesh-ancestor
92967439|NCT04001608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967440|NCT00667394|Bevacizumab|bevacizumab|mesh-list
92967441|NCT00667394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92967442|NCT00667394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967443|NCT00667394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967444|NCT00667394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967445|NCT00667394|Growth Substances|growth substances|mesh-ancestor
92967446|NCT00667394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967447|NCT00667394|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967448|NCT05357326|Atropine|atropine|mesh-list
92967449|NCT05357326|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92967450|NCT05357326|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92967451|NCT05357326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92967452|NCT05357326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92967453|NCT05357326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92967454|NCT05357326|Autonomic Agents|autonomic agents|mesh-ancestor
92967455|NCT05357326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967456|NCT05357326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967457|NCT05357326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92967458|NCT05357326|Respiratory System Agents|respiratory system agents|mesh-ancestor
92967459|NCT05357326|Mydriatics|mydriatics|mesh-ancestor
92967460|NCT05357326|Parasympatholytics|parasympatholytics|mesh-ancestor
92967461|NCT05357326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92967462|NCT05357326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92967463|NCT05357326|Cholinergic Agents|cholinergic agents|mesh-ancestor
92967464|NCT05357326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967465|NCT05357326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967466|NCT00778466|Metformin|metformin|mesh-list
92967467|NCT00778466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92967468|NCT00778466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967469|NCT00761735|Ribavirin|ribavirin|mesh-list
92967470|NCT00761735|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92967471|NCT00761735|Antimetabolites|antimetabolites|mesh-ancestor
92967472|NCT00761735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967473|NCT00761735|Antiviral Agents|antiviral agents|mesh-ancestor
92967474|NCT00761735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967475|NCT00569946|Axitinib|axitinib|mesh-list
92967476|NCT00569946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967477|NCT00569946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967478|NCT00569946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967479|NCT00569946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967481|NCT00778544|Clavulanic Acids|clavulanic acids|mesh-list
92967482|NCT00778544|Clavulanic Acid|clavulanic acid|mesh-list
92967483|NCT00778544|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92967484|NCT00778544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967485|NCT00778544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967486|NCT00778544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967487|NCT00778544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967488|NCT00778544|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92967489|NCT04001374|Ticagrelor|ticagrelor|mesh-list
92967490|NCT04001374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92967491|NCT04001374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92967492|NCT04001374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92967493|NCT04001374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92967494|NCT04001374|Purinergic Agents|purinergic agents|mesh-ancestor
92967495|NCT04001374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967496|NCT04001374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967497|NCT04001374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967498|NCT02556320|Anticonvulsants|anticonvulsants|mesh-list
92967499|NCT05265910|Loratadine|loratadine|mesh-list
92967500|NCT05265910|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92967501|NCT05265910|Dextrans|dextrans|mesh-list
92967502|NCT05265910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92967503|NCT05265910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92967504|NCT05265910|Antipruritics|antipruritics|mesh-ancestor
92967505|NCT05265910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92967506|NCT05265910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92967507|NCT05265910|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92967508|NCT05265910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92967509|NCT05265910|Histamine Antagonists|histamine antagonists|mesh-ancestor
92967510|NCT05265910|Histamine Agents|histamine agents|mesh-ancestor
92967511|NCT05265910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967512|NCT05265910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967513|NCT05265910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967514|NCT05265910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92967515|NCT05265910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92967516|NCT05265910|Analgesics|analgesics|mesh-ancestor
92967517|NCT05265910|Sensory System Agents|sensory system agents|mesh-ancestor
92967518|NCT05265910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967519|NCT05265910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967520|NCT05265910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967521|NCT05265910|Anticoagulants|anticoagulants|mesh-ancestor
92967522|NCT05265910|Plasma Substitutes|plasma substitutes|mesh-ancestor
92967523|NCT05265910|Blood Substitutes|blood substitutes|mesh-ancestor
92967524|NCT00814866|Adalimumab|adalimumab|mesh-list
92967525|NCT00814866|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92967526|NCT00814866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967527|NCT00814866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967528|NCT00991978|Bevacizumab|bevacizumab|mesh-list
92967529|NCT00991978|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
92967530|NCT00991978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92967531|NCT00991978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967532|NCT00991978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967533|NCT00991978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967534|NCT00991978|Growth Substances|growth substances|mesh-ancestor
92967535|NCT00991978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967536|NCT00991978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967537|NCT00991978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92967538|NCT00991978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967539|NCT00645528|Insulin|insulin|mesh-list
92967540|NCT00645528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92967541|NCT00645528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967542|NCT00812448|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92967543|NCT00812448|Antioxidants|antioxidants|mesh-ancestor
92967544|NCT00812448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967545|NCT00812448|Protective Agents|protective agents|mesh-ancestor
92967546|NCT00812448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967547|NCT00812448|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92967548|NCT00812448|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92527729|NCT00034177|Paclitaxel|paclitaxel|mesh-list
92967549|NCT00812448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967550|NCT00812448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92967551|NCT00295633|Metformin|metformin|mesh-list
92967552|NCT00295633|Pioglitazone|pioglitazone|mesh-list
92967553|NCT00295633|Rosiglitazone|rosiglitazone|mesh-list
92967554|NCT00295633|Saxagliptin|saxagliptin|mesh-list
92967555|NCT00295633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92967556|NCT00295633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967557|NCT00295633|Incretins|incretins|mesh-ancestor
92967558|NCT00295633|Hormones|hormones|mesh-ancestor
92967559|NCT00295633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967560|NCT00295633|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92967561|NCT00295633|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967562|NCT00295633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967563|NCT00295633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967564|NCT00570674|Paclitaxel|paclitaxel|mesh-list
92967565|NCT00570674|Carboplatin|carboplatin|mesh-list
92967566|NCT00570674|Cetuximab|cetuximab|mesh-list
92967567|NCT00570674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92967568|NCT00570674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92967569|NCT00570674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967570|NCT00570674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92967571|NCT00570674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92967572|NCT00570674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92967573|NCT00570674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967574|NCT00570674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612992|NCT00165633|Vitamins|vitamins|mesh-ancestor
92967575|NCT00808314|Dipyridamole|dipyridamole|mesh-list
92967576|NCT00808314|Regadenoson|regadenoson|mesh-list
92967577|NCT00808314|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92967578|NCT00808314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967579|NCT00808314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967580|NCT00808314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92967581|NCT00808314|Vasodilator Agents|vasodilator agents|mesh-ancestor
92967582|NCT00808314|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92967583|NCT00808314|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92967584|NCT00808314|Purinergic Agonists|purinergic agonists|mesh-ancestor
92967585|NCT00808314|Purinergic Agents|purinergic agents|mesh-ancestor
92967586|NCT00808314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967587|NCT00808314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967588|NCT04992052|Bone wax|bone wax|mesh-list
92967589|NCT04992052|Hemostatics|hemostatics|mesh-ancestor
92967590|NCT04992052|Coagulants|coagulants|mesh-ancestor
92967591|NCT00812682|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92967592|NCT00812682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92967593|NCT00812682|Respiratory System Agents|respiratory system agents|mesh-ancestor
92967594|NCT00768989|Ritonavir|ritonavir|mesh-list
92967595|NCT00768989|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92967596|NCT00768989|Tenofovir|tenofovir|mesh-list
92967597|NCT00768989|Emtricitabine|emtricitabine|mesh-list
92967598|NCT00768989|Raltegravir Potassium|raltegravir potassium|mesh-list
92967599|NCT00768989|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92967600|NCT00768989|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92967601|NCT00768989|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967602|NCT00768989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967603|NCT00768989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967604|NCT00768989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92967605|NCT00768989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967606|NCT00768989|Antiviral Agents|antiviral agents|mesh-ancestor
92967607|NCT00768989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967608|NCT00768989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92967609|NCT00768989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92967610|NCT00768989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92967611|NCT00768989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967612|NCT00768989|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92967613|NCT00768989|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92967614|NCT00779714|Cytarabine|cytarabine|mesh-list
92967615|NCT00779714|Paclitaxel|paclitaxel|mesh-list
92967616|NCT00779714|Cisplatin|cisplatin|mesh-list
92967617|NCT00779714|Dacarbazine|dacarbazine|mesh-list
92967618|NCT00779714|Treosulfan|treosulfan|mesh-list
92967619|NCT00779714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92967620|NCT00779714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967621|NCT00779714|Tubulin Modulators|tubulin modulators|mesh-ancestor
92967622|NCT00779714|Antimitotic Agents|antimitotic agents|mesh-ancestor
92967623|NCT00779714|Mitosis Modulators|mitosis modulators|mesh-ancestor
92967624|NCT00779714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967625|NCT00779714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92967626|NCT00779714|Antimetabolites|antimetabolites|mesh-ancestor
92967627|NCT00779714|Antiviral Agents|antiviral agents|mesh-ancestor
92967628|NCT00779714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967629|NCT00779714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967630|NCT00779714|Immunologic Factors|immunologic factors|mesh-ancestor
92967631|NCT00779714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967632|NCT00779714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92967633|NCT00779714|Alkylating Agents|alkylating agents|mesh-ancestor
92967635|NCT00812760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92967636|NCT00812760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92967637|NCT00812760|Dopamine Agents|dopamine agents|mesh-ancestor
92967638|NCT00812760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967639|NCT00812760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967640|NCT00812760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967641|NCT00814944|Sirolimus|sirolimus|mesh-list
92967642|NCT00814944|Temsirolimus|temsirolimus|mesh-list
92967643|NCT00814944|MTOR Inhibitors|mtor inhibitors|mesh-list
92967644|NCT00814944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967645|NCT00814944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967646|NCT00814944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92967647|NCT00814944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967648|NCT00814944|Antifungal Agents|antifungal agents|mesh-ancestor
92967649|NCT00814944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967650|NCT00814944|Immunologic Factors|immunologic factors|mesh-ancestor
92967651|NCT00814944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967652|NCT00814944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967653|NCT00814944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967654|NCT00814944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967655|NCT00779792|Triamcinolone|triamcinolone|mesh-list
92967656|NCT00779792|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92967657|NCT00779792|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92967658|NCT00779792|Clobetasol|clobetasol|mesh-list
92967659|NCT00779792|Mineral Oil|mineral oil|mesh-list
92967660|NCT00779792|Tacrolimus|tacrolimus|mesh-list
92967661|NCT00779792|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92967662|NCT00779792|Glycerol|glycerol|mesh-list
92967663|NCT00779792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967664|NCT00779792|Immunologic Factors|immunologic factors|mesh-ancestor
92967665|NCT00779792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967666|NCT00779792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92967667|NCT00779792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967668|NCT00779792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967669|NCT00779792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967670|NCT00779792|Glucocorticoids|glucocorticoids|mesh-ancestor
92967671|NCT00779792|Hormones|hormones|mesh-ancestor
92967672|NCT00779792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967673|NCT00779792|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92967674|NCT00779792|Protective Agents|protective agents|mesh-ancestor
92967675|NCT00779792|Emollients|emollients|mesh-ancestor
92967676|NCT00779792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92967677|NCT00992134|Cytarabine|cytarabine|mesh-list
92967678|NCT00992134|Rituximab|rituximab|mesh-list
92967679|NCT00992134|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92967680|NCT00992134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92967681|NCT00992134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967682|NCT00992134|Immunologic Factors|immunologic factors|mesh-ancestor
92967683|NCT00992134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967684|NCT00992134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967685|NCT00992134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92967686|NCT00992134|Antimetabolites|antimetabolites|mesh-ancestor
92967687|NCT00992134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967688|NCT00992134|Antiviral Agents|antiviral agents|mesh-ancestor
92967689|NCT00992134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967690|NCT00992134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967691|NCT00992134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92967692|NCT00992134|Alkylating Agents|alkylating agents|mesh-ancestor
92967693|NCT02551536|Fexofenadine|fexofenadine|mesh-list
92967694|NCT02551536|Montelukast|montelukast|mesh-list
92967695|NCT02551536|Levocetirizine|levocetirizine|mesh-list
92967696|NCT02551536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92967697|NCT02551536|Respiratory System Agents|respiratory system agents|mesh-ancestor
92967698|NCT02551536|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92967699|NCT02551536|Hormone Antagonists|hormone antagonists|mesh-ancestor
92967700|NCT02551536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967701|NCT02551536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967702|NCT02551536|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92967703|NCT02551536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92967704|NCT02551536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967705|NCT02551536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92967706|NCT02551536|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92967707|NCT02551536|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92967708|NCT02551536|Histamine Antagonists|histamine antagonists|mesh-ancestor
92967709|NCT02551536|Histamine Agents|histamine agents|mesh-ancestor
92967710|NCT02551536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967711|NCT00815022|Fentanyl|fentanyl|mesh-list
92967712|NCT00815022|Morphine|morphine|mesh-list
92967713|NCT00815022|Bupivacaine|bupivacaine|mesh-list
92967714|NCT00815022|Anesthetics, Local|anesthetics, local|mesh-ancestor
92967715|NCT00815022|Anesthetics|anesthetics|mesh-ancestor
92967716|NCT00815022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967717|NCT00815022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967718|NCT00815022|Sensory System Agents|sensory system agents|mesh-ancestor
92967719|NCT00815022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967720|NCT00815022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92967721|NCT00815022|Narcotics|narcotics|mesh-ancestor
92967722|NCT00815022|Analgesics|analgesics|mesh-ancestor
92967723|NCT00815022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92967724|NCT00815022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92613132|NCT00512980|Hormones|hormones|mesh-ancestor
92967725|NCT00815022|Anesthetics, General|anesthetics, general|mesh-ancestor
92967726|NCT00774722|Metronidazole|metronidazole|mesh-list
92967727|NCT00774722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166539|NCT01458769|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92967728|NCT00774722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967729|NCT00774722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92967730|NCT00774722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92967732|NCT00808392|Immunologic Factors|immunologic factors|mesh-ancestor
92967733|NCT00808392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967734|NCT04045548|Dinoprostone|dinoprostone|mesh-list
92967735|NCT04045548|Oxytocics|oxytocics|mesh-ancestor
92967736|NCT04045548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92967737|NCT04045548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967738|NCT00780104|Cytarabine|cytarabine|mesh-list
92967739|NCT00780104|Sirolimus|sirolimus|mesh-list
92967740|NCT00780104|Etoposide|etoposide|mesh-list
92967741|NCT00780104|Mitoxantrone|mitoxantrone|mesh-list
92967742|NCT00780104|Temsirolimus|temsirolimus|mesh-list
92967743|NCT00780104|MTOR Inhibitors|mtor inhibitors|mesh-list
92967744|NCT00780104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92967745|NCT00780104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967746|NCT00780104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92967747|NCT00780104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92967748|NCT00780104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967749|NCT00780104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967750|NCT00780104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92967751|NCT00780104|Antimetabolites|antimetabolites|mesh-ancestor
92967752|NCT00780104|Antiviral Agents|antiviral agents|mesh-ancestor
92967753|NCT00780104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967754|NCT00780104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967755|NCT00780104|Immunologic Factors|immunologic factors|mesh-ancestor
92967756|NCT00780104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967757|NCT00780104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967758|NCT00780104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92967759|NCT00780104|Antifungal Agents|antifungal agents|mesh-ancestor
92967760|NCT00780104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92967761|NCT00780104|Analgesics|analgesics|mesh-ancestor
92967762|NCT00780104|Sensory System Agents|sensory system agents|mesh-ancestor
92967763|NCT00780104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967764|NCT04047680|Ritonavir|ritonavir|mesh-list
92967765|NCT04047680|Sofosbuvir|sofosbuvir|mesh-list
92967766|NCT04047680|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92967767|NCT04047680|Grazoprevir|grazoprevir|mesh-list
92967768|NCT04047680|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92967769|NCT04047680|Ledipasvir|ledipasvir|mesh-list
92967770|NCT04047680|Velpatasvir|velpatasvir|mesh-list
92967771|NCT04047680|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92967772|NCT04047680|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92967773|NCT04047680|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92967774|NCT04047680|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967775|NCT04047680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967776|NCT04047680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967778|NCT04047680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92967779|NCT04047680|Antiviral Agents|antiviral agents|mesh-ancestor
92967780|NCT04047680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967781|NCT04047680|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92967782|NCT04047680|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92967783|NCT00774878|Fulvestrant|fulvestrant|mesh-list
92967784|NCT00774878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92967785|NCT00774878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967786|NCT00774878|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92967787|NCT00774878|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92967788|NCT00774878|Hormone Antagonists|hormone antagonists|mesh-ancestor
92967789|NCT00774878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967790|NCT00774878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967791|NCT00815256|Riboflavin|riboflavin|mesh-list
92967792|NCT00815256|Vitamin B Complex|vitamin b complex|mesh-ancestor
92967793|NCT00815256|Vitamins|vitamins|mesh-ancestor
92967794|NCT00815256|Micronutrients|micronutrients|mesh-ancestor
92967795|NCT00815256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967796|NCT00815256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92967797|NCT00815256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92967798|NCT00778778|Cefprozil|cefprozil|mesh-list
92967799|NCT00778778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92967800|NCT00778778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967801|NCT00305773|Vorinostat|vorinostat|mesh-list
92967802|NCT00305773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166542|NCT01458769|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967803|NCT00305773|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92967804|NCT00305773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967805|NCT00305773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967807|NCT00780182|Antiviral Agents|antiviral agents|mesh-ancestor
92967808|NCT00780182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967809|NCT00812994|Escitalopram|escitalopram|mesh-list
92967810|NCT00812994|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92967811|NCT00812994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92967812|NCT00812994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92967813|NCT00812994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967814|NCT00812994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967815|NCT00812994|Serotonin Agents|serotonin agents|mesh-ancestor
92967816|NCT00812994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967817|NCT00784394|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92967818|NCT00784394|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92967819|NCT00784394|Protective Agents|protective agents|mesh-ancestor
92967820|NCT00784394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967821|NCT00784394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967822|NCT00305695|Zoledronic Acid|zoledronic acid|mesh-list
92967823|NCT00305695|Imidazole|imidazole|mesh-list
92967824|NCT00305695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92967825|NCT00305695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967826|NCT00305695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967827|NCT00305695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967828|NCT00784472|Morphine|morphine|mesh-list
92967829|NCT00784472|Oxycodone|oxycodone|mesh-list
92967830|NCT00784472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92967831|NCT00784472|Narcotics|narcotics|mesh-ancestor
92967832|NCT00784472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92967833|NCT00784472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967834|NCT00784472|Analgesics|analgesics|mesh-ancestor
92967835|NCT00784472|Sensory System Agents|sensory system agents|mesh-ancestor
92967836|NCT00784472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967837|NCT00779012|Infliximab|infliximab|mesh-list
92967838|NCT00779012|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92967839|NCT00779012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967840|NCT00779012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92967841|NCT00779012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92967842|NCT00779012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92967843|NCT00647556|Adapalene|adapalene|mesh-list
92967844|NCT00647556|Tretinoin|tretinoin|mesh-list
92967845|NCT00647556|Emollients|emollients|mesh-list
92967846|NCT00647556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92967847|NCT00647556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92967848|NCT00647556|Analgesics|analgesics|mesh-ancestor
92967849|NCT00647556|Sensory System Agents|sensory system agents|mesh-ancestor
92967850|NCT00647556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967851|NCT00647556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967852|NCT00647556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967854|NCT00647556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92967855|NCT00647556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967856|NCT00647556|Keratolytic Agents|keratolytic agents|mesh-ancestor
92967857|NCT03978559|Trimethoprim|trimethoprim|mesh-list
92967858|NCT03978559|Caspofungin|caspofungin|mesh-list
92967859|NCT03978559|Sulfisoxazole|sulfisoxazole|mesh-list
92967860|NCT03978559|Methylprednisolone|methylprednisolone|mesh-list
92967861|NCT03978559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92967862|NCT03978559|Antiemetics|antiemetics|mesh-ancestor
92967863|NCT03978559|Autonomic Agents|autonomic agents|mesh-ancestor
92967864|NCT03978559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92967865|NCT03978559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967866|NCT03978559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92967867|NCT03978559|Glucocorticoids|glucocorticoids|mesh-ancestor
92967868|NCT03978559|Hormones|hormones|mesh-ancestor
92967869|NCT03978559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967870|NCT03978559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92967871|NCT03978559|Protective Agents|protective agents|mesh-ancestor
92967872|NCT03978559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92967873|NCT03978559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967874|NCT03978559|Antimalarials|antimalarials|mesh-ancestor
92967875|NCT03978559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92967876|NCT03978559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92967877|NCT03978559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92967878|NCT03978559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967879|NCT03978559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613288|NCT00513955|Hormones|hormones|mesh-ancestor
92967880|NCT03978559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92967881|NCT03978559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92967882|NCT03978559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92967883|NCT03978559|Antifungal Agents|antifungal agents|mesh-ancestor
92967884|NCT00813072|Docetaxel|docetaxel|mesh-list
92967885|NCT00813072|Irinotecan|irinotecan|mesh-list
92967886|NCT00813072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967887|NCT00813072|Tubulin Modulators|tubulin modulators|mesh-ancestor
92967888|NCT00813072|Antimitotic Agents|antimitotic agents|mesh-ancestor
92967889|NCT00813072|Mitosis Modulators|mitosis modulators|mesh-ancestor
92967890|NCT00813072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967891|NCT00813072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92967892|NCT00813072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92967893|NCT00813072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967894|NCT00813228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92967895|NCT00813228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92967896|NCT00813228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967897|NCT00813228|Incretins|incretins|mesh-ancestor
92967898|NCT00813228|Hormones|hormones|mesh-ancestor
92967899|NCT00813228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92967900|NCT00813228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92967901|NCT00813228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92967902|NCT00813228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967903|NCT00813228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967904|NCT00808704|Epoetin Alfa|epoetin alfa|mesh-list
92967905|NCT00808704|Hematinics|hematinics|mesh-ancestor
92967906|NCT00320515|Pemetrexed|pemetrexed|mesh-list
92967907|NCT00320515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967908|NCT00320515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967909|NCT00320515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967910|NCT00320515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92967911|NCT00320515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92967912|NCT00662012|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92967913|NCT00662012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92967914|NCT00662012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92967915|NCT00662012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92967916|NCT00662012|Schistosomicides|schistosomicides|mesh-ancestor
92967917|NCT00662012|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92967918|NCT00662012|Anthelmintics|anthelmintics|mesh-ancestor
92967919|NCT00815568|Fludarabine|fludarabine|mesh-list
92967920|NCT00815568|Fludarabine phosphate|fludarabine phosphate|mesh-list
92967921|NCT00815568|Busulfan|busulfan|mesh-list
92967922|NCT00815568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967923|NCT00815568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92967924|NCT00815568|Antimetabolites|antimetabolites|mesh-ancestor
92967925|NCT00815568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967926|NCT00815568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92967928|NCT00815568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967929|NCT00815568|Alkylating Agents|alkylating agents|mesh-ancestor
92967930|NCT00815568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92967931|NCT00815568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92967932|NCT00815646|Sildenafil Citrate|sildenafil citrate|mesh-list
92967933|NCT00815646|Vasodilator Agents|vasodilator agents|mesh-ancestor
92967934|NCT00815646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92967935|NCT00815646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92967936|NCT00815646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967937|NCT00815646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967938|NCT00815646|Urological Agents|urological agents|mesh-ancestor
92967939|NCT01066351|Epoetin Alfa|epoetin alfa|mesh-list
92967940|NCT01066351|Hematinics|hematinics|mesh-ancestor
92967941|NCT00809016|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92967942|NCT00809016|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92967943|NCT00809016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967944|NCT00661778|Bevacizumab|bevacizumab|mesh-list
92967945|NCT00661778|Docetaxel|docetaxel|mesh-list
92967946|NCT00661778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92967947|NCT00661778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967948|NCT00661778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92166550|NCT04941846|Nimodipine|nimodipine|mesh-list
92967949|NCT00661778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967950|NCT00661778|Growth Substances|growth substances|mesh-ancestor
92967951|NCT00661778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613358|NCT00514891|Micronutrients|micronutrients|mesh-ancestor
92967952|NCT00661778|Growth Inhibitors|growth inhibitors|mesh-ancestor
92967953|NCT00661778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92967954|NCT00661778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92967955|NCT00661778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92967956|NCT00661778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967957|NCT01062139|Cetirizine|cetirizine|mesh-list
92967958|NCT01062139|Levocetirizine|levocetirizine|mesh-list
92967959|NCT01062139|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92967960|NCT01062139|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92967961|NCT01062139|Histamine Antagonists|histamine antagonists|mesh-ancestor
92967962|NCT01062139|Histamine Agents|histamine agents|mesh-ancestor
92967963|NCT01062139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967964|NCT01062139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967965|NCT01062139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967966|NCT01062139|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92967967|NCT00780650|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92967968|NCT00780650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92967969|NCT00780650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92967970|NCT00780650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92967971|NCT00780650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967972|NCT00780650|Adrenergic Agents|adrenergic agents|mesh-ancestor
92967973|NCT00780650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92967974|NCT00780650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92967975|NCT00653328|Doxorubicin|doxorubicin|mesh-list
92967976|NCT00653328|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92967977|NCT00653328|Atrasentan|atrasentan|mesh-list
92967978|NCT00653328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92967979|NCT00653328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967980|NCT00653328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92967981|NCT00653328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92967982|NCT00653328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92967983|NCT00653328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92967984|NCT00653328|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92967985|NCT00653328|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92967986|NCT01664182|Bevacizumab|bevacizumab|mesh-list
92967987|NCT01664182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92967988|NCT01664182|Sunitinib|sunitinib|mesh-list
92967989|NCT01664182|Trebananib|trebananib|mesh-list
92967990|NCT01664182|Sorafenib|sorafenib|mesh-list
92967991|NCT01664182|Endothelial Growth Factors|endothelial growth factors|mesh-list
92967992|NCT01664182|Antibodies|antibodies|mesh-list
92967993|NCT01664182|Immunoglobulins|immunoglobulins|mesh-list
92967994|NCT01664182|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92967995|NCT01664182|Immunoglobulin G|immunoglobulin g|mesh-list
92967996|NCT01664182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92967997|NCT01664182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92967998|NCT01664182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92967999|NCT01664182|Growth Substances|growth substances|mesh-ancestor
92968000|NCT01664182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968001|NCT01664182|Growth Inhibitors|growth inhibitors|mesh-ancestor
92968002|NCT01664182|Immunologic Factors|immunologic factors|mesh-ancestor
92968003|NCT01664182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968004|NCT01664182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968005|NCT01664182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968006|NCT00780728|Sildenafil Citrate|sildenafil citrate|mesh-list
92968007|NCT00780728|Vasodilator Agents|vasodilator agents|mesh-ancestor
92968008|NCT00780728|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92968009|NCT00780728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92968010|NCT00780728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968011|NCT00780728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968012|NCT00780728|Urological Agents|urological agents|mesh-ancestor
92968013|NCT00809172|Cyclosporine|cyclosporine|mesh-list
92968014|NCT00809172|Methotrexate|methotrexate|mesh-list
92968015|NCT00809172|Cyclosporins|cyclosporins|mesh-list
92968016|NCT00809172|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92968017|NCT00809172|Abortifacient Agents|abortifacient agents|mesh-ancestor
92968018|NCT00809172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92968019|NCT00809172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968020|NCT00809172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92968021|NCT00809172|Antimetabolites|antimetabolites|mesh-ancestor
92968022|NCT00809172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968023|NCT00809172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968024|NCT00809172|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968025|NCT00809172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968026|NCT00809172|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92968027|NCT00809172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968028|NCT00809172|Immunologic Factors|immunologic factors|mesh-ancestor
92968029|NCT00809172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92968030|NCT00809172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92968031|NCT00809172|Antifungal Agents|antifungal agents|mesh-ancestor
92968032|NCT00809172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968033|NCT00809172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92968034|NCT00784862|Tamoxifen|tamoxifen|mesh-list
92968035|NCT00784862|Anastrozole|anastrozole|mesh-list
92968036|NCT00784862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92968037|NCT00784862|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968038|NCT00784862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968039|NCT00784862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968040|NCT00784862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968041|NCT00784862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968042|NCT00784862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92968043|NCT00784862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92968044|NCT00784862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92968045|NCT00784862|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92968046|NCT00784862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92968047|NCT00784862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968048|NCT00784862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968049|NCT00784940|Tamoxifen|tamoxifen|mesh-list
92968050|NCT00784940|Anastrozole|anastrozole|mesh-list
92968051|NCT00784940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92968052|NCT00784940|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968053|NCT00784940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968054|NCT00784940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968055|NCT00784940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968056|NCT00784940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968057|NCT00784940|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92968058|NCT00784940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92968059|NCT00784940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92968060|NCT00784940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92968061|NCT00784940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92968062|NCT00784940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968063|NCT00784940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968064|NCT00790244|Doxorubicin|doxorubicin|mesh-list
92968065|NCT00790244|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92968066|NCT00790244|Ifosfamide|ifosfamide|mesh-list
92968067|NCT00790244|Isophosphamide mustard|isophosphamide mustard|mesh-list
92166574|NCT04843423|Cariprazine|cariprazine|mesh-list
92968068|NCT00790244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92968069|NCT00790244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968070|NCT00790244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92968071|NCT00790244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92968072|NCT00790244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968073|NCT00790244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968074|NCT00790244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92968075|NCT00790244|Alkylating Agents|alkylating agents|mesh-ancestor
92968076|NCT00785018|Complement C1s|complement c1s|mesh-list
92968077|NCT00785018|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92968078|NCT00785018|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92968079|NCT00785018|Immunologic Factors|immunologic factors|mesh-ancestor
92968080|NCT00785018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968081|NCT00785018|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92968082|NCT00785018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968083|NCT00534352|Ritonavir|ritonavir|mesh-list
92968084|NCT00534352|Darunavir|darunavir|mesh-list
92968085|NCT00534352|Etravirine|etravirine|mesh-list
92968086|NCT00534352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92968087|NCT00534352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92968088|NCT00534352|Protease Inhibitors|protease inhibitors|mesh-ancestor
92968089|NCT00534352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968090|NCT00534352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968091|NCT00534352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92968092|NCT00534352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92968093|NCT00534352|Antiviral Agents|antiviral agents|mesh-ancestor
92968094|NCT00534352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968095|NCT00534352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92968096|NCT00534352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92968097|NCT00534352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92968098|NCT00534352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92968099|NCT00642174|Clopidogrel|clopidogrel|mesh-list
92968100|NCT00642174|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92968101|NCT00642174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92968102|NCT00642174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92968103|NCT00642174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92968104|NCT00642174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92968105|NCT00642174|Purinergic Agents|purinergic agents|mesh-ancestor
92968106|NCT00642174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968107|NCT00642174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968108|NCT00642174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968109|NCT02550444|Clonidine|clonidine|mesh-list
92968110|NCT02550444|Analgesics|analgesics|mesh-ancestor
92968111|NCT02550444|Sensory System Agents|sensory system agents|mesh-ancestor
92968112|NCT02550444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968113|NCT02550444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968114|NCT02550444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92968115|NCT02550444|Sympatholytics|sympatholytics|mesh-ancestor
92968116|NCT02550444|Autonomic Agents|autonomic agents|mesh-ancestor
92968117|NCT02550444|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92968118|NCT02550444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92968119|NCT02550444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92968120|NCT02550444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92968121|NCT02550444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968122|NCT02550444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968123|NCT00665366|Valproic Acid|valproic acid|mesh-list
92968124|NCT00665366|Aripiprazole|aripiprazole|mesh-list
92968125|NCT00665366|Antidepressive Agents|antidepressive agents|mesh-ancestor
92968126|NCT00665366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968127|NCT00665366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92968128|NCT00665366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92968129|NCT00665366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968130|NCT00665366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968131|NCT00665366|Dopamine Agonists|dopamine agonists|mesh-ancestor
92968132|NCT00665366|Dopamine Agents|dopamine agents|mesh-ancestor
92968133|NCT00665366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968134|NCT00665366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968135|NCT00665366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92968136|NCT00665366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92968137|NCT00665366|Serotonin Agents|serotonin agents|mesh-ancestor
92968138|NCT00665366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92968139|NCT00665366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92968140|NCT00665366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92968141|NCT00665366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92968142|NCT00665366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968143|NCT00665366|Antimanic Agents|antimanic agents|mesh-ancestor
92968144|NCT00665366|Anticonvulsants|anticonvulsants|mesh-ancestor
92968145|NCT00665366|GABA Agents|gaba agents|mesh-ancestor
92968146|NCT00775684|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92968147|NCT00775684|Exenatide|exenatide|mesh-list
92968148|NCT00775684|Glimepiride|glimepiride|mesh-list
92968149|NCT00775684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92968150|NCT00775684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968151|NCT00775684|Incretins|incretins|mesh-ancestor
92968152|NCT00775684|Hormones|hormones|mesh-ancestor
92968153|NCT00775684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968154|NCT00775684|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92968155|NCT00775684|Protease Inhibitors|protease inhibitors|mesh-ancestor
92968156|NCT00775684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968157|NCT00775684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968158|NCT00775684|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92968159|NCT00775684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92968160|NCT00775684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968161|NCT00775684|Immunologic Factors|immunologic factors|mesh-ancestor
92968162|NCT02556008|Cannabidiol|cannabidiol|mesh-list
92968163|NCT02556008|Anticonvulsants|anticonvulsants|mesh-ancestor
92968164|NCT00992524|Misoprostol|misoprostol|mesh-list
92968165|NCT00992524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92968166|NCT00992524|Abortifacient Agents|abortifacient agents|mesh-ancestor
92968167|NCT00992524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92968168|NCT00992524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968169|NCT00992524|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92968170|NCT00992524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968171|NCT00992524|Oxytocics|oxytocics|mesh-ancestor
92968172|NCT00642018|Prednisone|prednisone|mesh-list
92968173|NCT00642018|Docetaxel|docetaxel|mesh-list
92968174|NCT00642018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968175|NCT00642018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613583|NCT00516802|Olaparib|olaparib|mesh-list
92968176|NCT00642018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92968177|NCT00642018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92968178|NCT00642018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968179|NCT00642018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968180|NCT00642018|Glucocorticoids|glucocorticoids|mesh-ancestor
92968181|NCT00642018|Hormones|hormones|mesh-ancestor
92968182|NCT00642018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968183|NCT00642018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968184|NCT00642018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968185|NCT00532948|Capecitabine|capecitabine|mesh-list
92968186|NCT00532948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92968187|NCT00532948|Antimetabolites|antimetabolites|mesh-ancestor
92968188|NCT00532948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968189|NCT00532948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968190|NCT00998920|Equol|equol|mesh-list
92968191|NCT00998920|Phytoestrogens|phytoestrogens|mesh-ancestor
92968192|NCT00998920|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92968193|NCT00998920|Estrogens|estrogens|mesh-ancestor
92968194|NCT00998920|Hormones|hormones|mesh-ancestor
92968195|NCT00998920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968196|NCT00998920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968197|NCT00992758|Tositumomab I-131|tositumomab i-131|mesh-list
92968198|NCT00992758|Antibodies|antibodies|mesh-list
92968199|NCT00992758|Immunologic Factors|immunologic factors|mesh-ancestor
92968200|NCT00992758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968201|NCT00992758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968202|NCT00641706|Bortezomib|bortezomib|mesh-list
92968203|NCT00641706|Vorinostat|vorinostat|mesh-list
92968204|NCT00641706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968205|NCT00641706|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92968206|NCT00641706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968207|NCT00641706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968208|NCT00995332|Cytarabine|cytarabine|mesh-list
92968209|NCT00995332|Tretinoin|tretinoin|mesh-list
92968210|NCT00995332|Valproic Acid|valproic acid|mesh-list
92968211|NCT00995332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92968212|NCT00995332|Antimetabolites|antimetabolites|mesh-ancestor
92968213|NCT00995332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968214|NCT00995332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968215|NCT00995332|Antiviral Agents|antiviral agents|mesh-ancestor
92968216|NCT00995332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968217|NCT00995332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968218|NCT00995332|Immunologic Factors|immunologic factors|mesh-ancestor
92968219|NCT00995332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968220|NCT00995332|Keratolytic Agents|keratolytic agents|mesh-ancestor
92968221|NCT00995332|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968222|NCT00995332|Anticonvulsants|anticonvulsants|mesh-ancestor
92968223|NCT00995332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968225|NCT00995332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968226|NCT00995332|Antimanic Agents|antimanic agents|mesh-ancestor
92968227|NCT00995332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92968228|NCT00995332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968229|NCT00995332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968230|NCT00992914|Lidocaine|lidocaine|mesh-list
92968231|NCT00992914|Anesthetics, Local|anesthetics, local|mesh-ancestor
92968232|NCT00992914|Anesthetics|anesthetics|mesh-ancestor
92968233|NCT00992914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968234|NCT00992914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968235|NCT00992914|Sensory System Agents|sensory system agents|mesh-ancestor
92968236|NCT00992914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968237|NCT00992914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92968238|NCT00992914|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92968239|NCT00992914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92968240|NCT00992914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92968241|NCT00992914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968242|NCT00999232|Erythromycin|erythromycin|mesh-list
92968243|NCT00999232|Erythromycin Estolate|erythromycin estolate|mesh-list
92968244|NCT00999232|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92968245|NCT00999232|Erythromycin stearate|erythromycin stearate|mesh-list
92968246|NCT00999232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92968247|NCT00999232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968248|NCT00999232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968249|NCT00999232|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92968250|NCT00999232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613657|NCT05861063|Anesthetics, Local|anesthetics, local|mesh-ancestor
92968251|NCT00999232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968252|NCT00993070|Capsaicin|capsaicin|mesh-list
92968253|NCT00993070|Antipruritics|antipruritics|mesh-ancestor
92968254|NCT00993070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968255|NCT00993070|Sensory System Agents|sensory system agents|mesh-ancestor
92968256|NCT00993070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968257|NCT00993070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968258|NCT00993304|Liraglutide|liraglutide|mesh-list
92968259|NCT00993304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92968260|NCT00993304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968261|NCT00993304|Incretins|incretins|mesh-ancestor
92968262|NCT00993304|Hormones|hormones|mesh-ancestor
92968263|NCT00993304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968264|NCT05189002|Dalteparin|dalteparin|mesh-list
92968265|NCT05189002|Anticoagulants|anticoagulants|mesh-ancestor
92968266|NCT05189002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92968267|NCT05189002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92968268|NCT05189002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968269|NCT00644358|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92968270|NCT00644358|Antidepressive Agents|antidepressive agents|mesh-ancestor
92968271|NCT00644358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968272|NCT00644358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92968273|NCT00644358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92968274|NCT00644358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92968275|NCT00644358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968276|NCT00644358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968277|NCT00644358|Serotonin Agents|serotonin agents|mesh-ancestor
92968278|NCT00644358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968279|NCT00644358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92968280|NCT00644358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92968281|NCT00993694|Dapsone|dapsone|mesh-list
92166586|NCT04421196|Analgesics|analgesics|mesh-list
92968282|NCT00993694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968283|NCT00993694|Antimalarials|antimalarials|mesh-ancestor
92968284|NCT00993694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92968285|NCT00993694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92968286|NCT00993694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92968287|NCT00993694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968288|NCT00993694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968289|NCT00993694|Leprostatic Agents|leprostatic agents|mesh-ancestor
92313301|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
92968290|NCT00993694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92968291|NCT00640926|Radezolid|radezolid|mesh-list
92968292|NCT00640926|Oxazolidinones|oxazolidinones|mesh-list
92968293|NCT00640926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92968294|NCT00640926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968295|NCT00640926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92968296|NCT00640926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968297|NCT00640926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968298|NCT00821496|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92968299|NCT00821496|Norethindrone|norethindrone|mesh-list
92968300|NCT00821496|Norethindrone Acetate|norethindrone acetate|mesh-list
92968301|NCT00821496|Norinyl|norinyl|mesh-list
92968302|NCT00821496|Estradiol|estradiol|mesh-list
92968303|NCT00821496|Estrogens|estrogens|mesh-ancestor
92968304|NCT00821496|Hormones|hormones|mesh-ancestor
92968305|NCT00821496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968306|NCT00821496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968307|NCT00821496|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92968308|NCT00821496|Contraceptive Agents|contraceptive agents|mesh-ancestor
92968309|NCT00821496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92968310|NCT00821496|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92968311|NCT00821496|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92968312|NCT00821496|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92968313|NCT00821496|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92968314|NCT00821496|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92968315|NCT02550912|Vitamin D|vitamin d|mesh-list
92968316|NCT02550912|Ergocalciferols|ergocalciferols|mesh-list
92968317|NCT02550912|Cholecalciferol|cholecalciferol|mesh-list
92968318|NCT02550912|Vitamins|vitamins|mesh-list
92968319|NCT02550912|Micronutrients|micronutrients|mesh-ancestor
92968320|NCT02550912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968321|NCT02550912|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92968322|NCT02550912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92968323|NCT00999700|Cisplatin|cisplatin|mesh-list
92968324|NCT00999700|Docetaxel|docetaxel|mesh-list
92968325|NCT00999700|Fluorouracil|fluorouracil|mesh-list
92968326|NCT00999700|Cetuximab|cetuximab|mesh-list
92968327|NCT00999700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968328|NCT00999700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92968329|NCT00999700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92968330|NCT00999700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92968331|NCT00999700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968332|NCT00999700|Antimetabolites|antimetabolites|mesh-ancestor
92968333|NCT00999700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92968334|NCT00999700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968335|NCT00999700|Immunologic Factors|immunologic factors|mesh-ancestor
92968336|NCT00999700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968337|NCT00999700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92968338|NCT00818298|Ziprasidone|ziprasidone|mesh-list
92968339|NCT00818298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92968340|NCT00818298|Serotonin Agents|serotonin agents|mesh-ancestor
92968341|NCT00818298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968342|NCT00818298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968343|NCT00818298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968344|NCT00818298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92968345|NCT00818298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92968346|NCT00818298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968347|NCT00818298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968348|NCT00818298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92968349|NCT00818298|Dopamine Agents|dopamine agents|mesh-ancestor
92968350|NCT00821574|Valsartan|valsartan|mesh-list
92968351|NCT00821574|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92968352|NCT00821574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92968353|NCT00821574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92968354|NCT00821574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92968355|NCT00821574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968356|NCT00821574|Diuretics|diuretics|mesh-ancestor
92968357|NCT00821574|Natriuretic Agents|natriuretic agents|mesh-ancestor
92968358|NCT00821574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968359|NCT00821574|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92968360|NCT00821574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92968361|NCT00995800|Fluticasone|fluticasone|mesh-list
92313375|NCT02766673|Albuterol|albuterol|mesh-list
92968363|NCT00995800|Formoterol Fumarate|formoterol fumarate|mesh-list
92968364|NCT00995800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968365|NCT00995800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92968366|NCT00995800|Autonomic Agents|autonomic agents|mesh-ancestor
92968367|NCT00995800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968368|NCT00995800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968369|NCT00995800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92968370|NCT00995800|Respiratory System Agents|respiratory system agents|mesh-ancestor
92968371|NCT00995800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968372|NCT00995800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92968373|NCT00995800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92968374|NCT00995800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92968375|NCT00995800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92968376|NCT00995800|Adrenergic Agents|adrenergic agents|mesh-ancestor
92968377|NCT00995800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968378|NCT00995800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968379|NCT00821652|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92968380|NCT00821652|Freund's Adjuvant|freund's adjuvant|mesh-list
92968381|NCT00821652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92968382|NCT00821652|Immunologic Factors|immunologic factors|mesh-ancestor
92968383|NCT00821652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968384|NCT00319501|Diazepam|diazepam|mesh-list
92968385|NCT00319501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92968386|NCT00319501|Anticonvulsants|anticonvulsants|mesh-ancestor
92968387|NCT00319501|Antiemetics|antiemetics|mesh-ancestor
92968388|NCT00319501|Autonomic Agents|autonomic agents|mesh-ancestor
92968389|NCT00319501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968390|NCT00319501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968391|NCT00319501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968392|NCT00319501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92968393|NCT00319501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968394|NCT00319501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92968395|NCT00319501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92968396|NCT00319501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92968397|NCT00319501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92968398|NCT00319501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968399|NCT00319501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92968400|NCT00319501|Anesthetics, General|anesthetics, general|mesh-ancestor
92613818|NCT05859412|Hormones|hormones|mesh-ancestor
92968402|NCT00319501|GABA Modulators|gaba modulators|mesh-ancestor
92968403|NCT00319501|GABA Agents|gaba agents|mesh-ancestor
92968404|NCT00319501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968405|NCT00319501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968406|NCT00994006|Magnesium citrate|magnesium citrate|mesh-list
92968407|NCT00994006|Magnesium Oxide|magnesium oxide|mesh-list
92968408|NCT00994006|Levulinic acid|levulinic acid|mesh-list
92968409|NCT00994006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968410|NCT00994006|Cathartics|cathartics|mesh-ancestor
92968411|NCT00994006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968412|NCT00994006|Antacids|antacids|mesh-ancestor
92968413|NCT00994006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968414|NCT00818610|Amoxicillin|amoxicillin|mesh-list
92968415|NCT00818610|Clarithromycin|clarithromycin|mesh-list
92968416|NCT00818610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92968417|NCT00818610|Cefuroxime|cefuroxime|mesh-list
92968418|NCT00818610|Cefuroxime axetil|cefuroxime axetil|mesh-list
92968419|NCT00818610|Lactams|lactams|mesh-list
92968420|NCT00818610|beta-Lactams|beta-lactams|mesh-list
92968421|NCT00818610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92968422|NCT00818610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968423|NCT00818610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92968424|NCT00818610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968425|NCT00818610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968426|NCT00818610|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92968427|NCT00818610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92968428|NCT00818610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92968429|NCT00761579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92968430|NCT00761579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92968431|NCT00761579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92968432|NCT00761579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968433|NCT00761579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968434|NCT00761579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968435|NCT00761579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92968436|NCT00761579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92968437|NCT00761579|Serotonin Agents|serotonin agents|mesh-ancestor
92968438|NCT00761579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968439|NCT00761579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968440|NCT00761579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92968441|NCT00761579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92968442|NCT00761579|Dopamine Agents|dopamine agents|mesh-ancestor
92968443|NCT00627042|Ramucirumab|ramucirumab|mesh-list
92968444|NCT00627042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92968445|NCT00627042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968446|NCT00627042|Immunologic Factors|immunologic factors|mesh-ancestor
92968447|NCT00627042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968448|NCT00319111|Bosentan|bosentan|mesh-list
92968449|NCT00319111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92968450|NCT00319111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92968451|NCT00319111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968452|NCT00994396|Vitamin D|vitamin d|mesh-list
92968453|NCT00994396|Cholecalciferol|cholecalciferol|mesh-list
92968454|NCT00994396|Vitamins|vitamins|mesh-ancestor
92968455|NCT00994396|Micronutrients|micronutrients|mesh-ancestor
92968456|NCT00994396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968457|NCT00994396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92968458|NCT00994396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92968459|NCT00816426|Moxifloxacin|moxifloxacin|mesh-list
92968460|NCT00816426|Rifampin|rifampin|mesh-list
92968461|NCT00816426|Isoniazid|isoniazid|mesh-list
92968462|NCT00816426|Pyrazinamide|pyrazinamide|mesh-list
92968463|NCT00816426|Kanamycin|kanamycin|mesh-list
92968464|NCT00816426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92968465|NCT00816426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968466|NCT00816426|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92968467|NCT00816426|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92968468|NCT00816426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968469|NCT00816426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968470|NCT00816426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968471|NCT00816426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92968472|NCT00816426|Antitubercular Agents|antitubercular agents|mesh-ancestor
92968473|NCT00816426|Leprostatic Agents|leprostatic agents|mesh-ancestor
92968474|NCT00816426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92613885|NCT05779644|Incretins|incretins|mesh-ancestor
92968475|NCT00816426|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92968476|NCT00816426|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92968477|NCT00816426|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92968478|NCT00816426|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92968479|NCT00816426|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92968480|NCT00816426|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92968481|NCT00816426|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92968482|NCT00816426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92968483|NCT00816426|Antimetabolites|antimetabolites|mesh-ancestor
92968484|NCT00816426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92968485|NCT00816426|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92968486|NCT00996190|Phenylephrine|phenylephrine|mesh-list
92968487|NCT00996190|Oxymetazoline|oxymetazoline|mesh-list
92968488|NCT00996190|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92968489|NCT00996190|Mydriatics|mydriatics|mesh-ancestor
92968490|NCT00996190|Autonomic Agents|autonomic agents|mesh-ancestor
92968491|NCT00996190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968492|NCT00996190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968493|NCT00996190|Sympathomimetics|sympathomimetics|mesh-ancestor
92968494|NCT00996190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92968495|NCT00996190|Nasal Decongestants|nasal decongestants|mesh-ancestor
92968496|NCT00996190|Respiratory System Agents|respiratory system agents|mesh-ancestor
92968497|NCT00996190|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92968498|NCT00996190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92968499|NCT00996190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92968500|NCT00996190|Adrenergic Agents|adrenergic agents|mesh-ancestor
92968501|NCT00996190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968502|NCT00996190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968503|NCT00996190|Protective Agents|protective agents|mesh-ancestor
92968504|NCT00640224|Rosiglitazone|rosiglitazone|mesh-list
92968505|NCT00640224|Drospirenone|drospirenone|mesh-list
92968506|NCT00640224|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92968507|NCT00640224|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92968508|NCT00640224|Estradiol|estradiol|mesh-list
92968509|NCT00640224|Estrogens|estrogens|mesh-ancestor
92968510|NCT00640224|Hormones|hormones|mesh-ancestor
92968511|NCT00640224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968512|NCT00640224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968513|NCT00640224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92968514|NCT00640224|Contraceptive Agents|contraceptive agents|mesh-ancestor
92968515|NCT00640224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92968516|NCT00640224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92968517|NCT00640224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92968518|NCT00640224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92968519|NCT00640224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92968520|NCT00640224|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92968521|NCT00640224|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968522|NCT00640224|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92968523|NCT00640224|Diuretics|diuretics|mesh-ancestor
92968524|NCT00640224|Natriuretic Agents|natriuretic agents|mesh-ancestor
92968525|NCT01000792|Cetirizine|cetirizine|mesh-list
92968526|NCT01000792|Levocetirizine|levocetirizine|mesh-list
92968527|NCT01000792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92968528|NCT01000792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92968529|NCT01000792|Histamine Antagonists|histamine antagonists|mesh-ancestor
92968530|NCT01000792|Histamine Agents|histamine agents|mesh-ancestor
92968531|NCT01000792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968532|NCT01000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968533|NCT01000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968534|NCT01000792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92968535|NCT02550756|Capsaicin|capsaicin|mesh-list
92968536|NCT02550756|Antipruritics|antipruritics|mesh-ancestor
92968537|NCT02550756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968538|NCT02550756|Sensory System Agents|sensory system agents|mesh-ancestor
92968539|NCT02550756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968540|NCT02550756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968541|NCT01001260|Aspirin|aspirin|mesh-list
92968542|NCT01001260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92968543|NCT01001260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92968544|NCT01001260|Analgesics|analgesics|mesh-ancestor
92968545|NCT01001260|Sensory System Agents|sensory system agents|mesh-ancestor
92968546|NCT01001260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968547|NCT01001260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968548|NCT01001260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968549|NCT01001260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92968550|NCT01001260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92968551|NCT01001260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92968552|NCT01001260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968553|NCT01001260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92968554|NCT01001260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92968555|NCT01001260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968556|NCT01001260|Antipyretics|antipyretics|mesh-ancestor
92968557|NCT00996424|Acetylcysteine|acetylcysteine|mesh-list
92968558|NCT00996424|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92166609|NCT02865811|Pembrolizumab|pembrolizumab|mesh-list
92968559|NCT00996424|Antiviral Agents|antiviral agents|mesh-ancestor
92968560|NCT00996424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968561|NCT00996424|Expectorants|expectorants|mesh-ancestor
92968562|NCT00996424|Respiratory System Agents|respiratory system agents|mesh-ancestor
92968563|NCT00996424|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92968564|NCT00996424|Antioxidants|antioxidants|mesh-ancestor
92968565|NCT00996424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968566|NCT00996424|Protective Agents|protective agents|mesh-ancestor
92968567|NCT00996424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968568|NCT00996424|Antidotes|antidotes|mesh-ancestor
92968569|NCT05220280|Infliximab|infliximab|mesh-list
92968570|NCT05220280|Imatinib Mesylate|imatinib mesylate|mesh-list
92968571|NCT05220280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968572|NCT05220280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968573|NCT05220280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968574|NCT05220280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968575|NCT05220280|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92968576|NCT05220280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968577|NCT05220280|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968578|NCT05220280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968579|NCT05220280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92968580|NCT00318643|Mitomycins|mitomycins|mesh-list
92968581|NCT00318643|Mitomycin|mitomycin|mesh-list
92968582|NCT00318643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92313593|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
92968584|NCT00318643|Alkylating Agents|alkylating agents|mesh-ancestor
92968585|NCT00318643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968586|NCT00318643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92968587|NCT00318643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968588|NCT00994708|Esomeprazole|esomeprazole|mesh-list
92968589|NCT00994708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92968590|NCT00994708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968591|NCT00994708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92968592|NCT00994708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968593|NCT00994708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968594|NCT01064557|Tretinoin|tretinoin|mesh-list
92968595|NCT01064557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968596|NCT01064557|Keratolytic Agents|keratolytic agents|mesh-ancestor
92968597|NCT01064557|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968598|NCT01001962|Metformin|metformin|mesh-list
92968599|NCT01001962|Empagliflozin|empagliflozin|mesh-list
92968600|NCT01001962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92968601|NCT01001962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968602|NCT01001962|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92968603|NCT01001962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968604|NCT01066429|Dexamethasone|dexamethasone|mesh-list
92968605|NCT01066429|Dexamethasone acetate|dexamethasone acetate|mesh-list
92968606|NCT01066429|BB 1101|bb 1101|mesh-list
92968607|NCT01066429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968608|NCT01066429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968609|NCT01066429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968610|NCT01066429|Antiemetics|antiemetics|mesh-ancestor
92968611|NCT01066429|Autonomic Agents|autonomic agents|mesh-ancestor
92968612|NCT01066429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968613|NCT01066429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968614|NCT01066429|Glucocorticoids|glucocorticoids|mesh-ancestor
92968615|NCT01066429|Hormones|hormones|mesh-ancestor
92968616|NCT01066429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968617|NCT01066429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968618|NCT01066429|Protease Inhibitors|protease inhibitors|mesh-ancestor
92968619|NCT01066429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968620|NCT01066429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968621|NCT00994786|Pregabalin|pregabalin|mesh-list
92968622|NCT00994786|Analgesics|analgesics|mesh-ancestor
92968623|NCT00994786|Sensory System Agents|sensory system agents|mesh-ancestor
92968624|NCT00994786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968625|NCT00994786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968626|NCT00994786|Anticonvulsants|anticonvulsants|mesh-ancestor
92968628|NCT00994786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92968629|NCT00994786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968630|NCT00994786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92968631|NCT00994786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92968632|NCT00994786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92968633|NCT00994786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968634|NCT00994786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968635|NCT00994942|Morphine|morphine|mesh-list
92968636|NCT00994942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92968637|NCT00994942|Narcotics|narcotics|mesh-ancestor
92968638|NCT00994942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968639|NCT00994942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968640|NCT00994942|Analgesics|analgesics|mesh-ancestor
92968641|NCT00994942|Sensory System Agents|sensory system agents|mesh-ancestor
92968642|NCT00994942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968643|NCT01002898|Ritonavir|ritonavir|mesh-list
92968644|NCT01002898|Lopinavir|lopinavir|mesh-list
92968645|NCT01002898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92968646|NCT01002898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92968647|NCT01002898|Protease Inhibitors|protease inhibitors|mesh-ancestor
92968648|NCT01002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968649|NCT01002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968650|NCT01002898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92968651|NCT01002898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92968652|NCT01002898|Antiviral Agents|antiviral agents|mesh-ancestor
92968653|NCT01002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968654|NCT01002898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92968655|NCT01002898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92968657|NCT01003054|Busulfan|busulfan|mesh-list
92968658|NCT01003054|Imatinib Mesylate|imatinib mesylate|mesh-list
92968659|NCT01003054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968660|NCT01003054|Immunologic Factors|immunologic factors|mesh-ancestor
92968661|NCT01003054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968662|NCT01003054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92968663|NCT01003054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92968664|NCT01003054|Alkylating Agents|alkylating agents|mesh-ancestor
92968665|NCT01003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968666|NCT01003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968667|NCT01003054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92968668|NCT01003054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968669|NCT01003054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968670|NCT01004068|Clomiphene|clomiphene|mesh-list
92968671|NCT01004068|Enclomiphene|enclomiphene|mesh-list
92968672|NCT01004068|Zuclomiphene|zuclomiphene|mesh-list
92968673|NCT01004068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92968674|NCT01004068|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968675|NCT01004068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968676|NCT01004068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968677|NCT01004068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92968678|NCT01004068|Fertility Agents|fertility agents|mesh-ancestor
92968679|NCT01004068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92968680|NCT01004068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92968681|NCT01004068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92968682|NCT01004224|Infigratinib|infigratinib|mesh-list
92968683|NCT01004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968684|NCT00530920|Ritonavir|ritonavir|mesh-list
92968685|NCT00530920|Tipranavir|tipranavir|mesh-list
92968686|NCT00530920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92968687|NCT00530920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92968688|NCT00530920|Protease Inhibitors|protease inhibitors|mesh-ancestor
92968689|NCT00530920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968690|NCT00530920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968691|NCT00530920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92968692|NCT00530920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92968693|NCT00530920|Antiviral Agents|antiviral agents|mesh-ancestor
92968694|NCT00530920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968695|NCT00530920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92968696|NCT00530920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92968697|NCT01004380|Carboplatin|carboplatin|mesh-list
92968698|NCT01004380|Farletuzumab|farletuzumab|mesh-list
92968699|NCT01004380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968700|NCT01003522|Anesthetics|anesthetics|mesh-list
92968701|NCT01003522|Anesthetics, General|anesthetics, general|mesh-list
92968702|NCT01003522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968703|NCT01003522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968704|NCT01003678|Clofarabine|clofarabine|mesh-list
92968705|NCT01003678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92968706|NCT01003678|Antimetabolites|antimetabolites|mesh-ancestor
92968707|NCT01003678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968708|NCT01003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968709|NCT01004692|Salicylic Acid|salicylic acid|mesh-list
92968710|NCT01004692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968711|NCT01004692|Antifungal Agents|antifungal agents|mesh-ancestor
92968712|NCT01004692|Keratolytic Agents|keratolytic agents|mesh-ancestor
92968713|NCT01004692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968714|NCT04000126|Lidocaine|lidocaine|mesh-list
92968715|NCT04000126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92968716|NCT04000126|Anesthetics|anesthetics|mesh-ancestor
92968717|NCT04000126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968718|NCT04000126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968719|NCT04000126|Sensory System Agents|sensory system agents|mesh-ancestor
92968720|NCT04000126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968721|NCT04000126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92968722|NCT04000126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92968723|NCT04000126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92968724|NCT04000126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92968725|NCT04000126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968726|NCT01008982|Belimumab|belimumab|mesh-list
92968727|NCT01008982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968728|NCT01008982|Immunologic Factors|immunologic factors|mesh-ancestor
92968729|NCT01008982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968730|NCT01005160|Metformin|metformin|mesh-list
92968732|NCT01005160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968733|NCT05230810|Fulvestrant|fulvestrant|mesh-list
92968734|NCT05230810|Tucatinib|tucatinib|mesh-list
92968735|NCT05230810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968736|NCT05230810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968737|NCT05230810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92968738|NCT05230810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92968739|NCT05230810|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968740|NCT05230810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968741|NCT05230810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968742|NCT05230810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968743|NCT05230810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968744|NCT05230810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968745|NCT01005238|Lamivudine|lamivudine|mesh-list
92968746|NCT01005238|Telbivudine|telbivudine|mesh-list
92968747|NCT01005238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92968748|NCT01005238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92968749|NCT01005238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968750|NCT01005238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968751|NCT01005238|Antiviral Agents|antiviral agents|mesh-ancestor
92968752|NCT01005238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968753|NCT01005238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92968754|NCT01005238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92968755|NCT01005472|Temozolomide|temozolomide|mesh-list
92968756|NCT01005472|Sunitinib|sunitinib|mesh-list
92968757|NCT01005472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92968758|NCT01005472|Alkylating Agents|alkylating agents|mesh-ancestor
92968759|NCT01005472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968760|NCT01005472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968761|NCT01005472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92968762|NCT01005472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92968763|NCT01005472|Growth Substances|growth substances|mesh-ancestor
92968764|NCT01005472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968765|NCT01005472|Growth Inhibitors|growth inhibitors|mesh-ancestor
92968766|NCT01005472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968767|NCT01005472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968768|NCT01005550|Ropivacaine|ropivacaine|mesh-list
92968769|NCT01005550|Anesthetics, Local|anesthetics, local|mesh-ancestor
92968770|NCT01005550|Anesthetics|anesthetics|mesh-ancestor
92968771|NCT01005550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92968772|NCT01005550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968773|NCT01005550|Sensory System Agents|sensory system agents|mesh-ancestor
92968774|NCT01005550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968775|NCT03999580|Vitamin D|vitamin d|mesh-list
92968777|NCT03999580|Vitamins|vitamins|mesh-ancestor
92968778|NCT03999580|Micronutrients|micronutrients|mesh-ancestor
92968779|NCT03999580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968780|NCT03999580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92968781|NCT03999580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92968782|NCT00768755|Pemetrexed|pemetrexed|mesh-list
92968783|NCT00768755|Axitinib|axitinib|mesh-list
92968784|NCT00768755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968785|NCT00768755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968786|NCT00768755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968787|NCT00768755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92968788|NCT00768755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92968789|NCT00768755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968790|NCT01005628|Bortezomib|bortezomib|mesh-list
92968791|NCT01005628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968792|NCT00530842|Fluticasone|fluticasone|mesh-list
92968793|NCT00530842|Tiotropium Bromide|tiotropium bromide|mesh-list
92968794|NCT00530842|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92968795|NCT00530842|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92968796|NCT00530842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968797|NCT00530842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92968798|NCT00530842|Autonomic Agents|autonomic agents|mesh-ancestor
92968799|NCT00530842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968800|NCT00530842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968801|NCT00530842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92968802|NCT00530842|Respiratory System Agents|respiratory system agents|mesh-ancestor
92968803|NCT00530842|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968804|NCT00530842|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92968805|NCT00530842|Parasympatholytics|parasympatholytics|mesh-ancestor
92968806|NCT00530842|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92968807|NCT00530842|Cholinergic Agents|cholinergic agents|mesh-ancestor
92968808|NCT00530842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968809|NCT00530842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968810|NCT00530842|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92968811|NCT00530842|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92968812|NCT00530842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92968813|NCT00530842|Adrenergic Agents|adrenergic agents|mesh-ancestor
92968814|NCT00530842|Glucocorticoids|glucocorticoids|mesh-ancestor
92968815|NCT00530842|Hormones|hormones|mesh-ancestor
92968816|NCT00530842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968817|NCT00530842|Sympathomimetics|sympathomimetics|mesh-ancestor
92968818|NCT01005784|Cetrorelix|cetrorelix|mesh-list
92968819|NCT01005784|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92968820|NCT01005784|Fertility Agents|fertility agents|mesh-ancestor
92968821|NCT01005784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92968822|NCT01005784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968823|NCT01005784|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968824|NCT01005784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968825|NCT05154136|Itraconazole|itraconazole|mesh-list
92968826|NCT05154136|Antifungal Agents|antifungal agents|mesh-ancestor
92968827|NCT05154136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968828|NCT05154136|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92968829|NCT05154136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92968830|NCT05154136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968831|NCT05154136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968832|NCT05154136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92968833|NCT05154136|Hormone Antagonists|hormone antagonists|mesh-ancestor
92968834|NCT05154136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968835|NCT05154136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968836|NCT05154136|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92968837|NCT01006096|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92968838|NCT01006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968839|NCT01006096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92968840|NCT01006096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968841|NCT01006096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968842|NCT05733364|Vitamin B Complex|vitamin b complex|mesh-list
92968843|NCT05733364|Vitamins|vitamins|mesh-ancestor
92968844|NCT05733364|Micronutrients|micronutrients|mesh-ancestor
92968845|NCT05733364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968846|NCT01006720|Neostigmine|neostigmine|mesh-list
92968847|NCT01006720|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92968848|NCT01006720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968849|NCT01006720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968850|NCT01006720|Cholinergic Agents|cholinergic agents|mesh-ancestor
92968851|NCT01006720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968852|NCT01006720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968853|NCT01006720|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92968854|NCT01006720|Autonomic Agents|autonomic agents|mesh-ancestor
92968855|NCT01006720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968856|NCT01006798|Vaccines|vaccines|mesh-list
92968857|NCT01006798|Immunologic Factors|immunologic factors|mesh-ancestor
92968858|NCT01006798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968859|NCT01006876|Warfarin|warfarin|mesh-list
92968860|NCT01006876|Anticoagulants|anticoagulants|mesh-ancestor
92968861|NCT03882424|Bevacizumab|bevacizumab|mesh-list
92968862|NCT03882424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92968863|NCT03882424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968864|NCT03882424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92968865|NCT03882424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92968866|NCT03882424|Growth Substances|growth substances|mesh-ancestor
92968867|NCT03882424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968868|NCT03882424|Growth Inhibitors|growth inhibitors|mesh-ancestor
92968869|NCT03879772|Mometasone Furoate|mometasone furoate|mesh-list
92968870|NCT03879772|Chlorpheniramine|chlorpheniramine|mesh-list
92968871|NCT03879772|Beclomethasone|beclomethasone|mesh-list
92968872|NCT03879772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968873|NCT03879772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968874|NCT03879772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968875|NCT03879772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92968876|NCT03879772|Glucocorticoids|glucocorticoids|mesh-ancestor
92968877|NCT03879772|Hormones|hormones|mesh-ancestor
92313891|NCT04233229|Insulin|insulin|mesh-list
92968878|NCT03879772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968879|NCT03879772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968880|NCT03879772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92968881|NCT03879772|Respiratory System Agents|respiratory system agents|mesh-ancestor
92968882|NCT03879772|Antipruritics|antipruritics|mesh-ancestor
92968883|NCT03879772|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92968884|NCT03879772|Histamine Antagonists|histamine antagonists|mesh-ancestor
92968885|NCT03879772|Histamine Agents|histamine agents|mesh-ancestor
92968886|NCT03879772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968887|NCT01007500|Dexamethasone|dexamethasone|mesh-list
92968888|NCT01007500|Ondansetron|ondansetron|mesh-list
92968889|NCT01007500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968890|NCT01007500|Antiemetics|antiemetics|mesh-ancestor
92968891|NCT01007500|Autonomic Agents|autonomic agents|mesh-ancestor
92968892|NCT01007500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968893|NCT01007500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968894|NCT01007500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968895|NCT01007500|Glucocorticoids|glucocorticoids|mesh-ancestor
92968897|NCT01007500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968898|NCT01007500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968899|NCT01007500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968900|NCT01007500|Antipruritics|antipruritics|mesh-ancestor
92968901|NCT01007500|Dermatologic Agents|dermatologic agents|mesh-ancestor
92968902|NCT01007500|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92968903|NCT01007500|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92968904|NCT01007500|Serotonin Agents|serotonin agents|mesh-ancestor
92968905|NCT01007500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968906|NCT01007500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968907|NCT01007578|Paclitaxel|paclitaxel|mesh-list
92968908|NCT01007578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92968909|NCT01007578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968910|NCT01007578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92968911|NCT01007578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92968912|NCT01007578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92968913|NCT01007578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968914|NCT05130814|Hyaluronic Acid|hyaluronic acid|mesh-list
92968915|NCT05130814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92968916|NCT05130814|Immunologic Factors|immunologic factors|mesh-ancestor
92968917|NCT05130814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968918|NCT05130814|Viscosupplements|viscosupplements|mesh-ancestor
92968919|NCT05130814|Protective Agents|protective agents|mesh-ancestor
92968920|NCT00642954|Dexamethasone|dexamethasone|mesh-list
92968921|NCT00642954|Lenalidomide|lenalidomide|mesh-list
92968922|NCT00642954|Vorinostat|vorinostat|mesh-list
92968923|NCT00642954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92968924|NCT00642954|Antiemetics|antiemetics|mesh-ancestor
92968925|NCT00642954|Autonomic Agents|autonomic agents|mesh-ancestor
92968926|NCT00642954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968927|NCT00642954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968928|NCT00642954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92968929|NCT00642954|Glucocorticoids|glucocorticoids|mesh-ancestor
92968930|NCT00642954|Hormones|hormones|mesh-ancestor
92968931|NCT00642954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92968932|NCT00642954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92968933|NCT00642954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968934|NCT00642954|Immunologic Factors|immunologic factors|mesh-ancestor
92968935|NCT00642954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92968936|NCT00642954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92968937|NCT00642954|Growth Substances|growth substances|mesh-ancestor
92968938|NCT00642954|Growth Inhibitors|growth inhibitors|mesh-ancestor
92968939|NCT00642954|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92968940|NCT00642954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968941|NCT00642954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968942|NCT00816660|Factor VIII|factor viii|mesh-list
92968943|NCT00816660|Coagulants|coagulants|mesh-ancestor
92968944|NCT00819000|Interferon-beta|interferon-beta|mesh-list
92968945|NCT00819000|Glatiramer Acetate|glatiramer acetate|mesh-list
92968946|NCT00819000|Interferon beta-1b|interferon beta-1b|mesh-list
92968947|NCT00819000|(T,G)-A-L|(t,g)-a-l|mesh-list
92968948|NCT00819000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92968949|NCT00819000|Immunologic Factors|immunologic factors|mesh-ancestor
92968950|NCT00819000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968951|NCT00819000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92968952|NCT00819000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92968953|NCT00819000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92968954|NCT00819000|Antiviral Agents|antiviral agents|mesh-ancestor
92968955|NCT00819000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968956|NCT00640146|Bromides|bromides|mesh-list
92968957|NCT00640146|Methylnaltrexone|methylnaltrexone|mesh-list
92968958|NCT00640146|Anticonvulsants|anticonvulsants|mesh-ancestor
92968959|NCT00640146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92968960|NCT00640146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968961|NCT00640146|Sensory System Agents|sensory system agents|mesh-ancestor
92968962|NCT00640146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92968963|NCT00819078|Bupropion|bupropion|mesh-list
92968964|NCT00819078|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92968965|NCT00819078|Antidepressive Agents|antidepressive agents|mesh-ancestor
92968966|NCT00819078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92968967|NCT00819078|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92968968|NCT00819078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92968969|NCT00819078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92968970|NCT00819078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968971|NCT00819078|Dopamine Agents|dopamine agents|mesh-ancestor
92968972|NCT00819078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92968973|NCT00819078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968974|NCT00819078|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92968975|NCT00819078|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92968976|NCT00819078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92968977|NCT01008046|Metformin|metformin|mesh-list
92968978|NCT01008046|Acetylcysteine|acetylcysteine|mesh-list
92968979|NCT01008046|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92968980|NCT01008046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92968981|NCT01008046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968982|NCT01008046|Antiviral Agents|antiviral agents|mesh-ancestor
92968983|NCT01008046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968984|NCT01008046|Expectorants|expectorants|mesh-ancestor
92968985|NCT01008046|Respiratory System Agents|respiratory system agents|mesh-ancestor
92968986|NCT01008046|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92968987|NCT01008046|Antioxidants|antioxidants|mesh-ancestor
92968988|NCT01008046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92968989|NCT01008046|Protective Agents|protective agents|mesh-ancestor
92968990|NCT01008046|Antidotes|antidotes|mesh-ancestor
92968991|NCT00317473|Vaccines|vaccines|mesh-list
92968992|NCT00317473|Immunologic Factors|immunologic factors|mesh-ancestor
92968993|NCT00317473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92968994|NCT00530218|Ganciclovir|ganciclovir|mesh-list
92968995|NCT00530218|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92968996|NCT00530218|Antiviral Agents|antiviral agents|mesh-ancestor
92968997|NCT00530218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92968998|NCT00530218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92968999|NCT00530218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969000|NCT00530218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969001|NCT00761267|Fluconazole|fluconazole|mesh-list
92969002|NCT00761267|Anidulafungin|anidulafungin|mesh-list
92969003|NCT00761267|Antifungal Agents|antifungal agents|mesh-ancestor
92969004|NCT00761267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969005|NCT00761267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92969006|NCT00761267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92969007|NCT00761267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969008|NCT00761267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969009|NCT00761267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92969010|NCT00761267|Hormone Antagonists|hormone antagonists|mesh-ancestor
92969011|NCT00761267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969012|NCT00761267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969013|NCT00761267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92969014|NCT00761267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92969015|NCT00303667|Vidarabine|vidarabine|mesh-list
92969016|NCT00303667|Aldesleukin|aldesleukin|mesh-list
92969017|NCT00303667|Cyclosporine|cyclosporine|mesh-list
92969018|NCT00303667|Cyclophosphamide|cyclophosphamide|mesh-list
92969019|NCT00303667|Fludarabine|fludarabine|mesh-list
92969020|NCT00303667|Fludarabine phosphate|fludarabine phosphate|mesh-list
92969021|NCT00303667|Interleukin-2|interleukin-2|mesh-list
92969022|NCT00303667|Cyclosporins|cyclosporins|mesh-list
92969023|NCT00303667|Thymoglobulin|thymoglobulin|mesh-list
92969024|NCT00303667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969025|NCT00303667|Immunologic Factors|immunologic factors|mesh-ancestor
92969026|NCT00303667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969027|NCT00303667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969028|NCT00303667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92969029|NCT00303667|Alkylating Agents|alkylating agents|mesh-ancestor
92969030|NCT00303667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969031|NCT00303667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969032|NCT00303667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92969033|NCT00303667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92969034|NCT00303667|Antimetabolites|antimetabolites|mesh-ancestor
92969035|NCT00303667|Antiviral Agents|antiviral agents|mesh-ancestor
92969036|NCT00303667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969037|NCT00303667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969038|NCT00303667|Antifungal Agents|antifungal agents|mesh-ancestor
92969039|NCT00303667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92969040|NCT00303667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92969041|NCT00303667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92969042|NCT00303667|Analgesics|analgesics|mesh-ancestor
92969043|NCT00303667|Sensory System Agents|sensory system agents|mesh-ancestor
92969044|NCT00303667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969045|NCT00303667|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92969046|NCT00303667|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92969047|NCT00761189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92969048|NCT00761189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92969049|NCT00761189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92969050|NCT00761189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969051|NCT00761189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969052|NCT00761189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92969053|NCT00761189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92969054|NCT00761189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92969055|NCT00761189|Serotonin Agents|serotonin agents|mesh-ancestor
92166635|NCT02879617|Durvalumab|durvalumab|mesh-list
92969056|NCT00761189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969057|NCT00761189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969058|NCT00761189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92969059|NCT00761189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92969060|NCT00761189|Dopamine Agents|dopamine agents|mesh-ancestor
92969061|NCT01008358|Tremelimumab|tremelimumab|mesh-list
92969062|NCT01008358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969063|NCT01008592|Levocetirizine|levocetirizine|mesh-list
92969064|NCT01008592|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92969065|NCT01008592|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92969066|NCT01008592|Histamine Antagonists|histamine antagonists|mesh-ancestor
92969067|NCT01008592|Histamine Agents|histamine agents|mesh-ancestor
92969068|NCT01008592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969069|NCT01008592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969070|NCT01008592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969071|NCT01062529|Somatostatin|somatostatin|mesh-list
92969072|NCT01062529|Hormones|hormones|mesh-ancestor
92969073|NCT01062529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969074|NCT01062529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614484|NCT04552795|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92969075|NCT00760877|Imatinib Mesylate|imatinib mesylate|mesh-list
92969076|NCT00760877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969077|NCT00760877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969078|NCT00760877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969079|NCT00760877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969080|NCT00302731|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92969081|NCT00302731|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92969082|NCT00302731|Hormones|hormones|mesh-list
92969083|NCT00302731|Estradiol|estradiol|mesh-list
92969084|NCT00302731|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92969085|NCT00302731|Progesterone|progesterone|mesh-list
92969086|NCT00302731|Estrogens|estrogens|mesh-list
92969087|NCT00302731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969088|NCT00302731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969089|NCT00302731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92969090|NCT00302731|Contraceptive Agents|contraceptive agents|mesh-ancestor
92969091|NCT00302731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92969092|NCT00302731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92969093|NCT00302731|Progestins|progestins|mesh-ancestor
92969094|NCT00780143|Cytarabine|cytarabine|mesh-list
92969095|NCT00780143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92969096|NCT00780143|Antimetabolites|antimetabolites|mesh-ancestor
92969097|NCT00780143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969098|NCT00780143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969099|NCT00780143|Antiviral Agents|antiviral agents|mesh-ancestor
92969100|NCT00780143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969101|NCT00780143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969102|NCT00780143|Immunologic Factors|immunologic factors|mesh-ancestor
92969103|NCT00780143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969104|NCT01007968|Panobinostat|panobinostat|mesh-list
92969105|NCT01007968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969106|NCT01007968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92969107|NCT01007968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969108|NCT01007968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969109|NCT00779909|Vitamin D|vitamin d|mesh-list
92969110|NCT00779909|Cholecalciferol|cholecalciferol|mesh-list
92969111|NCT00779909|Vitamins|vitamins|mesh-ancestor
92969112|NCT00779909|Micronutrients|micronutrients|mesh-ancestor
92969113|NCT00779909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969114|NCT00779909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92969115|NCT00779909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92969116|NCT05559112|Vitamin D|vitamin d|mesh-list
92969117|NCT05559112|Vitamins|vitamins|mesh-ancestor
92969118|NCT05559112|Micronutrients|micronutrients|mesh-ancestor
92969119|NCT05559112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969120|NCT05559112|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92969121|NCT00302107|Mirtazapine|mirtazapine|mesh-list
92969122|NCT00302107|Antidepressive Agents|antidepressive agents|mesh-ancestor
92969123|NCT00302107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92969124|NCT00302107|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92969125|NCT00302107|Histamine Antagonists|histamine antagonists|mesh-ancestor
92969126|NCT00302107|Histamine Agents|histamine agents|mesh-ancestor
92969127|NCT00302107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969128|NCT00302107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969129|NCT00302107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969130|NCT00302107|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92969131|NCT00302107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92969132|NCT00302107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969133|NCT00302107|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92969134|NCT00302107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92969135|NCT00302107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92969136|NCT00302107|Adrenergic Agents|adrenergic agents|mesh-ancestor
92969137|NCT00302107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92969138|NCT00302107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92969139|NCT00302107|Serotonin Agents|serotonin agents|mesh-ancestor
92969140|NCT00302107|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92969141|NCT02602301|Oxytocin|oxytocin|mesh-list
92969142|NCT02602301|Oxytocics|oxytocics|mesh-ancestor
92969143|NCT02602301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92969144|NCT02602301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969145|NCT00316225|Pemetrexed|pemetrexed|mesh-list
92969146|NCT00316225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969147|NCT00316225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969148|NCT00316225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969149|NCT00316225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92614559|NCT04341311|Panobinostat|panobinostat|mesh-list
92969150|NCT00316225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92969151|NCT04988152|Sotrovimab|sotrovimab|mesh-list
92969152|NCT04988152|Antiviral Agents|antiviral agents|mesh-ancestor
92969153|NCT04988152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969154|NCT00586625|Bepotastine besilate|bepotastine besilate|mesh-list
92969155|NCT00586625|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92969156|NCT00636168|Ipilimumab|ipilimumab|mesh-list
92969157|NCT00636168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969158|NCT00636168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969159|NCT00636168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969160|NCT00636168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969161|NCT00759941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92969162|NCT00759941|Latanoprost|latanoprost|mesh-list
92969163|NCT00759941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92969164|NCT00759941|Brinzolamide|brinzolamide|mesh-list
92969165|NCT00759941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92969166|NCT00759941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969167|NCT00759941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969168|NCT00315445|Acetaminophen|acetaminophen|mesh-list
92969169|NCT00315445|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92969170|NCT00315445|Oxycodone|oxycodone|mesh-list
92969171|NCT00315445|Buprenorphine|buprenorphine|mesh-list
92969172|NCT00315445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92969174|NCT00315445|Sensory System Agents|sensory system agents|mesh-ancestor
92969175|NCT00315445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969176|NCT00315445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969177|NCT00315445|Antipyretics|antipyretics|mesh-ancestor
92969178|NCT00315445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92969179|NCT00315445|Narcotics|narcotics|mesh-ancestor
92969180|NCT00315445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969181|NCT00315445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92969182|NCT00315445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92969183|NCT00315445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969184|NCT00315445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969185|NCT03687736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92969186|NCT03687736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92969187|NCT03687736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92969188|NCT03687736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92969189|NCT03687736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969190|NCT03687736|Cholinergic Agents|cholinergic agents|mesh-ancestor
92969191|NCT03687736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969192|NCT03687736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969193|NCT03687736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92969194|NCT03687736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969195|NCT00779675|Infliximab|infliximab|mesh-list
92969196|NCT00779675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92969197|NCT00779675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969198|NCT00779675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92969199|NCT00779675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92969200|NCT00779675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969201|NCT04102943|Tacrolimus|tacrolimus|mesh-list
92969202|NCT04102943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969203|NCT04102943|Immunologic Factors|immunologic factors|mesh-ancestor
92969204|NCT04102943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969205|NCT04102943|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92969206|NCT04102943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969207|NCT04102943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969208|NCT00759785|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92969209|NCT00759785|Immunologic Factors|immunologic factors|mesh-ancestor
92969210|NCT00759785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969211|NCT00315055|Vaccines|vaccines|mesh-list
92969212|NCT00315055|Immunologic Factors|immunologic factors|mesh-ancestor
92969213|NCT00315055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969214|NCT00528970|Methylnaltrexone|methylnaltrexone|mesh-list
92969215|NCT00528970|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92969216|NCT00528970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969217|NCT00528970|Sensory System Agents|sensory system agents|mesh-ancestor
92969218|NCT00528970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969219|NCT00293293|Taxane|taxane|mesh-list
92969220|NCT00293293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969221|NCT05774626|Contraceptive Agents|contraceptive agents|mesh-list
92969222|NCT05774626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92614637|NCT04039607|Nivolumab|nivolumab|mesh-list
92969223|NCT05774626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969224|NCT05774574|Cannabidiol|cannabidiol|mesh-list
92969225|NCT05774574|Anticonvulsants|anticonvulsants|mesh-ancestor
92969226|NCT05774275|Doxorubicin|doxorubicin|mesh-list
92969227|NCT05774275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92969228|NCT05774275|Antibodies|antibodies|mesh-list
92969229|NCT05774275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92969230|NCT05774275|Immunologic Factors|immunologic factors|mesh-ancestor
92969231|NCT05774275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969232|NCT05774275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92969233|NCT05774275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969234|NCT05774275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92969235|NCT05774275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92969236|NCT05774275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969237|NCT05774275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969238|NCT05774028|Dexamethasone|dexamethasone|mesh-list
92969239|NCT05774028|Gemcitabine|gemcitabine|mesh-list
92969240|NCT05774028|Etoposide|etoposide|mesh-list
92969241|NCT05774028|Mitoxantrone|mitoxantrone|mesh-list
92969242|NCT05774028|Pegaspargase|pegaspargase|mesh-list
92969243|NCT05774028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969244|NCT05774028|Antiemetics|antiemetics|mesh-ancestor
92969245|NCT05774028|Autonomic Agents|autonomic agents|mesh-ancestor
92969246|NCT05774028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969247|NCT05774028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969248|NCT05774028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92969249|NCT05774028|Glucocorticoids|glucocorticoids|mesh-ancestor
92969250|NCT05774028|Hormones|hormones|mesh-ancestor
92969251|NCT05774028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969252|NCT05774028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92969253|NCT05774028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969254|NCT05774028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92969255|NCT05774028|Antimetabolites|antimetabolites|mesh-ancestor
92969256|NCT05774028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969257|NCT05774028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969258|NCT05774028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92969259|NCT05774028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92969260|NCT05774028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969261|NCT05774028|Analgesics|analgesics|mesh-ancestor
92969262|NCT05774028|Sensory System Agents|sensory system agents|mesh-ancestor
92969263|NCT05774015|Magnesium Oxide|magnesium oxide|mesh-list
92969264|NCT05774015|Antacids|antacids|mesh-ancestor
92969265|NCT05774015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969266|NCT05774015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92969267|NCT05773911|Chitosan|chitosan|mesh-list
92969268|NCT05773911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92969269|NCT05773911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92969270|NCT05773911|Antimetabolites|antimetabolites|mesh-ancestor
92969271|NCT05773911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969272|NCT05773911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92969273|NCT05773911|Chelating Agents|chelating agents|mesh-ancestor
92969274|NCT05773911|Sequestering Agents|sequestering agents|mesh-ancestor
92969275|NCT05773911|Hemostatics|hemostatics|mesh-ancestor
92969276|NCT05773911|Coagulants|coagulants|mesh-ancestor
92969277|NCT05773859|Vaccines|vaccines|mesh-list
92969278|NCT05773859|Immunologic Factors|immunologic factors|mesh-ancestor
92969279|NCT05773859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969280|NCT05773846|Ropivacaine|ropivacaine|mesh-list
92969281|NCT05773846|Anesthetics, Local|anesthetics, local|mesh-ancestor
92969282|NCT05773846|Anesthetics|anesthetics|mesh-ancestor
92969283|NCT05773846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969284|NCT05773846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969285|NCT05773846|Sensory System Agents|sensory system agents|mesh-ancestor
92969286|NCT05773846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969287|NCT05773807|Propofol|propofol|mesh-list
92969288|NCT05773807|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92969289|NCT05773807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969290|NCT05773807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969291|NCT05773807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92969292|NCT05773807|Anesthetics, General|anesthetics, general|mesh-ancestor
92969293|NCT05773807|Anesthetics|anesthetics|mesh-ancestor
92969294|NCT05773183|Testosterone|testosterone|mesh-list
92969295|NCT05773183|Androgens|androgens|mesh-ancestor
92969296|NCT05773183|Hormones|hormones|mesh-ancestor
92969297|NCT05773183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614706|NCT03854019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92969298|NCT05773183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969299|NCT05773092|Osimertinib|osimertinib|mesh-list
92969300|NCT05773092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969301|NCT05773092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969302|NCT05773092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969303|NCT05773092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969304|NCT05732051|Niacinamide|niacinamide|mesh-list
92969305|NCT05732051|Niacin|niacin|mesh-list
92969306|NCT05732051|Nicotinic Acids|nicotinic acids|mesh-list
92969307|NCT05732051|Vitamin B Complex|vitamin b complex|mesh-ancestor
92969308|NCT05732051|Vitamins|vitamins|mesh-ancestor
92969309|NCT05732051|Micronutrients|micronutrients|mesh-ancestor
92969310|NCT05732051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969311|NCT05732051|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92969312|NCT05732051|Antimetabolites|antimetabolites|mesh-ancestor
92969313|NCT05732051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969314|NCT05732051|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92969315|NCT05732051|Vasodilator Agents|vasodilator agents|mesh-ancestor
92969316|NCT05695027|Niacinamide|niacinamide|mesh-list
92969317|NCT05695027|Niacin|niacin|mesh-list
92969318|NCT05695027|Nicotinic Acids|nicotinic acids|mesh-list
92969319|NCT05695027|Vitamin B Complex|vitamin b complex|mesh-ancestor
92969320|NCT05695027|Vitamins|vitamins|mesh-ancestor
92969321|NCT05695027|Micronutrients|micronutrients|mesh-ancestor
92969322|NCT05695027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969323|NCT05695027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92969324|NCT05695027|Antimetabolites|antimetabolites|mesh-ancestor
92969325|NCT05695027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969326|NCT05695027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92969327|NCT05695027|Vasodilator Agents|vasodilator agents|mesh-ancestor
92969328|NCT05667922|Tacrolimus|tacrolimus|mesh-list
92969329|NCT05667922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969330|NCT05667922|Immunologic Factors|immunologic factors|mesh-ancestor
92969331|NCT05667922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969332|NCT05667922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92969333|NCT05667922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969334|NCT05667922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969335|NCT05667909|Rituximab|rituximab|mesh-list
92969336|NCT05667909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969337|NCT05667909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969338|NCT05667909|Immunologic Factors|immunologic factors|mesh-ancestor
92969339|NCT05667909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969340|NCT05667909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969341|NCT05667896|Tacrolimus|tacrolimus|mesh-list
92969342|NCT05667896|Glucocorticoids|glucocorticoids|mesh-list
92969343|NCT05667896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969344|NCT05667896|Immunologic Factors|immunologic factors|mesh-ancestor
92969345|NCT05667896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969346|NCT05667896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92969347|NCT05667896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969348|NCT05667896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969349|NCT05667896|Hormones|hormones|mesh-ancestor
92969350|NCT05667896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969351|NCT05667883|Cyclophosphamide|cyclophosphamide|mesh-list
92969352|NCT05667883|Glucocorticoids|glucocorticoids|mesh-list
92969353|NCT05667883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969354|NCT05667883|Immunologic Factors|immunologic factors|mesh-ancestor
92969355|NCT05667883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969356|NCT05667883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969357|NCT05667883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92969358|NCT05667883|Alkylating Agents|alkylating agents|mesh-ancestor
92969359|NCT05667883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969360|NCT05667883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969361|NCT05667883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92969362|NCT05667883|Hormones|hormones|mesh-ancestor
92969363|NCT05667883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969364|NCT05667805|Thrombin|thrombin|mesh-list
92969365|NCT05667805|Hemostatics|hemostatics|mesh-ancestor
92969366|NCT05667805|Coagulants|coagulants|mesh-ancestor
92969367|NCT05644496|Meloxicam|meloxicam|mesh-list
92969368|NCT05644496|Bupivacaine|bupivacaine|mesh-list
92969369|NCT05644496|Anesthetics, Local|anesthetics, local|mesh-ancestor
92969370|NCT05644496|Anesthetics|anesthetics|mesh-ancestor
92969371|NCT05644496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969372|NCT05644496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969373|NCT05644496|Sensory System Agents|sensory system agents|mesh-ancestor
92614781|NCT03405792|Pembrolizumab|pembrolizumab|mesh-list
92969374|NCT05644496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969375|NCT05644496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92969376|NCT05644496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92969377|NCT05644496|Analgesics|analgesics|mesh-ancestor
92969378|NCT05644496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969379|NCT05644496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969380|NCT05644496|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92969381|NCT05644496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92969382|NCT05644496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969383|NCT05644496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969384|NCT05613608|Cannabidiol|cannabidiol|mesh-list
92969385|NCT05613608|Anticonvulsants|anticonvulsants|mesh-ancestor
92969386|NCT05592613|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92969387|NCT05592613|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92969388|NCT05592613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92969389|NCT05592613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92969390|NCT05592613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969391|NCT05592613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969392|NCT05592613|Antiviral Agents|antiviral agents|mesh-ancestor
92969393|NCT05592613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969394|NCT05592613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92969395|NCT05567562|Clopidogrel|clopidogrel|mesh-list
92969396|NCT05567562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969397|NCT05567562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969398|NCT05567562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92969399|NCT05567562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92969400|NCT05567562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92969401|NCT05567562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92969402|NCT05567562|Purinergic Agents|purinergic agents|mesh-ancestor
92969403|NCT05567562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969404|NCT05554978|Landiolol|landiolol|mesh-list
92969405|NCT05554978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92969406|NCT05554978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92969407|NCT05554978|Adrenergic Agents|adrenergic agents|mesh-ancestor
92969408|NCT05554978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969409|NCT05554978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969410|NCT05554978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969411|NCT05554978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92969412|NCT05546866|Osimertinib|osimertinib|mesh-list
92969413|NCT05546866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969414|NCT05546866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969415|NCT05546866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969416|NCT05546866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969417|NCT05545969|Pembrolizumab|pembrolizumab|mesh-list
92969418|NCT05545969|Lenvatinib|lenvatinib|mesh-list
92969419|NCT05545969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969420|NCT05545969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969421|NCT05545969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969422|NCT05545969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969423|NCT05545969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969424|NCT05545969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969425|NCT05543642|Vaccines|vaccines|mesh-list
92969426|NCT05543642|Immunologic Factors|immunologic factors|mesh-ancestor
92969427|NCT05543642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969428|NCT05525247|Gemcitabine|gemcitabine|mesh-list
92969429|NCT05525247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92969430|NCT05525247|Antimetabolites|antimetabolites|mesh-ancestor
92969431|NCT05525247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969432|NCT05525247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969433|NCT05476770|Cytarabine|cytarabine|mesh-list
92969434|NCT05476770|Dexamethasone|dexamethasone|mesh-list
92969435|NCT05476770|Hydrocortisone|hydrocortisone|mesh-list
92969436|NCT05476770|Methotrexate|methotrexate|mesh-list
92969437|NCT05476770|Fludarabine|fludarabine|mesh-list
92969438|NCT05476770|Vincristine|vincristine|mesh-list
92969439|NCT05476770|Azacitidine|azacitidine|mesh-list
92969440|NCT05476770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969441|NCT05476770|Antiemetics|antiemetics|mesh-ancestor
92969442|NCT05476770|Autonomic Agents|autonomic agents|mesh-ancestor
92969443|NCT05476770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969444|NCT05476770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969445|NCT05476770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92969446|NCT05476770|Glucocorticoids|glucocorticoids|mesh-ancestor
92969447|NCT05476770|Hormones|hormones|mesh-ancestor
92969448|NCT05476770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969449|NCT05476770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92969450|NCT05476770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969451|NCT05476770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92969452|NCT05476770|Abortifacient Agents|abortifacient agents|mesh-ancestor
92969453|NCT05476770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92969454|NCT05476770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92969455|NCT05476770|Antimetabolites|antimetabolites|mesh-ancestor
92969456|NCT05476770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969457|NCT05476770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92969458|NCT05476770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969459|NCT05476770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92969460|NCT05476770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969461|NCT05476770|Immunologic Factors|immunologic factors|mesh-ancestor
92969462|NCT05476770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969463|NCT05476770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92969464|NCT05476770|Antiviral Agents|antiviral agents|mesh-ancestor
92969465|NCT05476770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969466|NCT05476770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969467|NCT05476770|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969468|NCT05476770|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969469|NCT05476770|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969470|NCT05475678|Carboplatin|carboplatin|mesh-list
92969471|NCT05475678|Docetaxel|docetaxel|mesh-list
92969472|NCT05475678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969473|NCT05475678|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969474|NCT05475678|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969475|NCT05475678|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969476|NCT05475678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969477|NCT05438888|Warfarin|warfarin|mesh-list
92969478|NCT05438888|Apixaban|apixaban|mesh-list
92969479|NCT05438888|Anticoagulants|anticoagulants|mesh-ancestor
92969480|NCT05438888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92969481|NCT05438888|Antithrombins|antithrombins|mesh-ancestor
92969482|NCT05438888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92969483|NCT05438888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92969484|NCT05438888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969485|NCT05438888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969486|NCT05430074|Calpastatin|calpastatin|mesh-list
92969487|NCT05430074|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92969488|NCT05430074|Protease Inhibitors|protease inhibitors|mesh-ancestor
92969489|NCT05430074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969490|NCT05430074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969491|NCT05418972|Nivolumab|nivolumab|mesh-list
92969492|NCT05418972|Relatlimab|relatlimab|mesh-list
92969493|NCT05418972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969494|NCT05418972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969495|NCT05418972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969496|NCT05418972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969497|NCT05414136|Trastuzumab|trastuzumab|mesh-list
92969498|NCT05414136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969499|NCT05414136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969500|NCT05351736|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92969501|NCT05351736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92969502|NCT05351736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92969503|NCT05351736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969504|NCT05351736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969505|NCT05351736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92969506|NCT05351736|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92969507|NCT05351736|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92969508|NCT05351736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92969509|NCT05351736|Adrenergic Agents|adrenergic agents|mesh-ancestor
92969510|NCT05351736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969511|NCT05351736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969512|NCT05351736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92969513|NCT05351736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92969514|NCT05351736|Serotonin Agents|serotonin agents|mesh-ancestor
92969515|NCT05351736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92969516|NCT05351736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92969517|NCT05351736|Dopamine Agents|dopamine agents|mesh-ancestor
92969518|NCT05335928|Abatacept|abatacept|mesh-list
92969519|NCT05335928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969520|NCT05335928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969521|NCT05335928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969522|NCT05335928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969523|NCT05335928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969524|NCT05335928|Immunologic Factors|immunologic factors|mesh-ancestor
92969525|NCT05335928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969526|NCT05335928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969527|NCT05319561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92969528|NCT05319561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969529|NCT05286957|Tislelizumab|tislelizumab|mesh-list
92969530|NCT05286957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969531|NCT05286957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969532|NCT05282108|Imatinib Mesylate|imatinib mesylate|mesh-list
92969533|NCT05282108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969534|NCT05282108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527758|NCT00000665|Ganciclovir|ganciclovir|mesh-list
92969535|NCT05282108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969536|NCT05282108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969537|NCT05255276|Itraconazole|itraconazole|mesh-list
92969538|NCT05255276|Rifampin|rifampin|mesh-list
92969539|NCT05255276|Antifungal Agents|antifungal agents|mesh-ancestor
92969540|NCT05255276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969541|NCT05255276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92969542|NCT05255276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92969543|NCT05255276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969544|NCT05255276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969545|NCT05255276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92969546|NCT05255276|Hormone Antagonists|hormone antagonists|mesh-ancestor
92969547|NCT05255276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969548|NCT05255276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969549|NCT05255276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92969550|NCT05255276|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92969551|NCT05255276|Antitubercular Agents|antitubercular agents|mesh-ancestor
92969552|NCT05255276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92969553|NCT05255276|Leprostatic Agents|leprostatic agents|mesh-ancestor
92969554|NCT05255276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92969555|NCT05255276|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92969556|NCT05255276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92969557|NCT05255276|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92969558|NCT05255276|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92969559|NCT05255276|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92969560|NCT05255276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92969561|NCT05243199|Valsartan|valsartan|mesh-list
92969562|NCT05243199|Irbesartan|irbesartan|mesh-list
92969563|NCT05243199|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92969564|NCT05243199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92969565|NCT05243199|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92969566|NCT05243199|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92969567|NCT05243199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969568|NCT05227716|Magnesium Sulfate|magnesium sulfate|mesh-list
92969569|NCT05227716|Analgesics|analgesics|mesh-ancestor
92969570|NCT05227716|Sensory System Agents|sensory system agents|mesh-ancestor
92969571|NCT05227716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969572|NCT05227716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969573|NCT05227716|Anesthetics|anesthetics|mesh-ancestor
92969574|NCT05227716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969575|NCT05227716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92969576|NCT05227716|Anticonvulsants|anticonvulsants|mesh-ancestor
92969577|NCT05227716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92969578|NCT05227716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92969579|NCT05227716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969580|NCT05227716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92969581|NCT05227716|Tocolytic Agents|tocolytic agents|mesh-ancestor
92969582|NCT05227716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92969583|NCT05201248|Prednisone|prednisone|mesh-list
92969584|NCT05201248|Cyclophosphamide|cyclophosphamide|mesh-list
92969585|NCT05201248|Rituximab|rituximab|mesh-list
92969586|NCT05201248|Doxorubicin|doxorubicin|mesh-list
92969587|NCT05201248|Vincristine|vincristine|mesh-list
92969588|NCT05201248|Lenalidomide|lenalidomide|mesh-list
92969589|NCT05201248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969590|NCT05201248|Immunologic Factors|immunologic factors|mesh-ancestor
92969591|NCT05201248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969592|NCT05201248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969593|NCT05201248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92969594|NCT05201248|Alkylating Agents|alkylating agents|mesh-ancestor
92969595|NCT05201248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615006|NCT02095184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969596|NCT05201248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969597|NCT05201248|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92969598|NCT05201248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969599|NCT05201248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92969600|NCT05201248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92969601|NCT05201248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92969602|NCT05201248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969603|NCT05201248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969604|NCT05201248|Glucocorticoids|glucocorticoids|mesh-ancestor
92969605|NCT05201248|Hormones|hormones|mesh-ancestor
92969606|NCT05201248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969607|NCT05201248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92969608|NCT05201248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969609|NCT05201248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969610|NCT05201248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969611|NCT05201248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969612|NCT05201248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92969613|NCT05201248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92969614|NCT05201248|Growth Substances|growth substances|mesh-ancestor
92969615|NCT05201248|Growth Inhibitors|growth inhibitors|mesh-ancestor
92969616|NCT05195996|Propranolol|propranolol|mesh-list
92969617|NCT05195996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92969618|NCT05195996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92969619|NCT05195996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92969620|NCT05195996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969621|NCT05195996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969622|NCT05195996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969623|NCT05195996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92969624|NCT05195996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92969625|NCT05195996|Vasodilator Agents|vasodilator agents|mesh-ancestor
92969626|NCT05113966|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92969627|NCT05113966|Immunoconjugates|immunoconjugates|mesh-ancestor
92969628|NCT05113966|Immunologic Factors|immunologic factors|mesh-ancestor
92969629|NCT05113966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969630|NCT05101564|Tamoxifen|tamoxifen|mesh-list
92969631|NCT05101564|Fulvestrant|fulvestrant|mesh-list
92969632|NCT05101564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92969633|NCT05101564|Hormone Antagonists|hormone antagonists|mesh-ancestor
92969634|NCT05101564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969635|NCT05101564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969636|NCT05101564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92969637|NCT05101564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969638|NCT05101564|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92969639|NCT05101564|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92969640|NCT05101564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92969641|NCT05101564|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92969642|NCT05073484|Antibodies|antibodies|mesh-list
92969643|NCT05073484|Immunoglobulins|immunoglobulins|mesh-list
92969644|NCT05073484|Immunologic Factors|immunologic factors|mesh-ancestor
92969645|NCT05073484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969646|NCT05071014|Pembrolizumab|pembrolizumab|mesh-list
92969647|NCT05071014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969648|NCT05071014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969649|NCT05071014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969650|NCT05071014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969651|NCT05025865|Hyaluronic Acid|hyaluronic acid|mesh-list
92969652|NCT05025865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92969653|NCT05025865|Immunologic Factors|immunologic factors|mesh-ancestor
92969654|NCT05025865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969655|NCT05025865|Viscosupplements|viscosupplements|mesh-ancestor
92969656|NCT05025865|Protective Agents|protective agents|mesh-ancestor
92969657|NCT05005741|Dulaglutide|dulaglutide|mesh-list
92969658|NCT05005741|Glucagon|glucagon|mesh-list
92969659|NCT05005741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92969660|NCT05005741|Incretins|incretins|mesh-ancestor
92969661|NCT05005741|Hormones|hormones|mesh-ancestor
92969662|NCT05005741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969663|NCT05005741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969664|NCT05005741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92969665|NCT05005741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92969666|NCT05002829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92969667|NCT05002829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92969668|NCT05002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615080|NCT02949583|Chlorhexidine|chlorhexidine|mesh-list
92969669|NCT05002829|Antitubercular Agents|antitubercular agents|mesh-ancestor
92969670|NCT04994990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92969671|NCT04994990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92969672|NCT04994990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92969673|NCT04994990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969674|NCT04994990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969675|NCT04994990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92969676|NCT04994990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92969677|NCT04994990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969678|NCT04994990|Cholinergic Agents|cholinergic agents|mesh-ancestor
92969679|NCT04994990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969680|NCT04974216|Rituximab|rituximab|mesh-list
92969681|NCT04974216|Lenalidomide|lenalidomide|mesh-list
92969682|NCT04974216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969683|NCT04974216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969684|NCT04974216|Immunologic Factors|immunologic factors|mesh-ancestor
92969685|NCT04974216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969686|NCT04974216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969687|NCT04974216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92969688|NCT04974216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92969689|NCT04974216|Growth Substances|growth substances|mesh-ancestor
92969690|NCT04974216|Growth Inhibitors|growth inhibitors|mesh-ancestor
92969691|NCT04972552|Ubiquinone|ubiquinone|mesh-list
92969692|NCT04972552|Coenzyme Q10|coenzyme q10|mesh-list
92969693|NCT04972552|Micronutrients|micronutrients|mesh-ancestor
92969694|NCT04972552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969695|NCT04972552|Vitamins|vitamins|mesh-ancestor
92969696|NCT04936685|Vaccines|vaccines|mesh-list
92969697|NCT04936685|Immunologic Factors|immunologic factors|mesh-ancestor
92969698|NCT04936685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969699|NCT04924699|Trastuzumab|trastuzumab|mesh-list
92969700|NCT04924699|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92969701|NCT04924699|Maytansine|maytansine|mesh-list
92969702|NCT04924699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969703|NCT04924699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969704|NCT04924699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969705|NCT04924699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969706|NCT04924699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969707|NCT04924699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969708|NCT04924699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969709|NCT04924699|Immunotoxins|immunotoxins|mesh-ancestor
92969710|NCT04924699|Immunoconjugates|immunoconjugates|mesh-ancestor
92969711|NCT04924699|Immunologic Factors|immunologic factors|mesh-ancestor
92969712|NCT04924699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969713|NCT04907539|Denosumab|denosumab|mesh-list
92969714|NCT04907539|Nivolumab|nivolumab|mesh-list
92969715|NCT04907539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969716|NCT04907539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969717|NCT04907539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969718|NCT04907539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969719|NCT04907539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92969720|NCT04907539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969721|NCT04877288|Cyclosporine|cyclosporine|mesh-list
92969722|NCT04877288|Mycophenolic Acid|mycophenolic acid|mesh-list
92969723|NCT04877288|Abatacept|abatacept|mesh-list
92969724|NCT04877288|Tacrolimus|tacrolimus|mesh-list
92969725|NCT04877288|Cyclosporins|cyclosporins|mesh-list
92969726|NCT04877288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969727|NCT04877288|Immunologic Factors|immunologic factors|mesh-ancestor
92969728|NCT04877288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969729|NCT04877288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92969730|NCT04877288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969731|NCT04877288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969732|NCT04877288|Antifungal Agents|antifungal agents|mesh-ancestor
92969733|NCT04877288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969734|NCT04877288|Dermatologic Agents|dermatologic agents|mesh-ancestor
92969735|NCT04877288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969736|NCT04877288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92969737|NCT04877288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969738|NCT04877288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92969739|NCT04877288|Antitubercular Agents|antitubercular agents|mesh-ancestor
92969740|NCT04877288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92969741|NCT04877288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969742|NCT04877288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969743|NCT04843566|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92969744|NCT04843566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969745|NCT04830397|Timolol|timolol|mesh-list
92969746|NCT04830397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969747|NCT04830397|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92969748|NCT04830397|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92969749|NCT04830397|Adrenergic Agents|adrenergic agents|mesh-ancestor
92969750|NCT04830397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969751|NCT04830397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969752|NCT04830397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92969753|NCT04830397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92969754|NCT04815876|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92969755|NCT04815876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969757|NCT04802590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969758|NCT04776993|Methimazole|methimazole|mesh-list
92969759|NCT04776993|Antithyroid Agents|antithyroid agents|mesh-ancestor
92969760|NCT04776993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92969761|NCT04776993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969762|NCT04776993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969763|NCT04671875|Antibodies|antibodies|mesh-list
92969764|NCT04671875|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92969765|NCT04671875|Immunologic Factors|immunologic factors|mesh-ancestor
92969766|NCT04671875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969767|NCT04664972|Cyclophosphamide|cyclophosphamide|mesh-list
92969768|NCT04664972|Docetaxel|docetaxel|mesh-list
92969769|NCT04664972|Doxorubicin|doxorubicin|mesh-list
92969770|NCT04664972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92969771|NCT04664972|Immunologic Factors|immunologic factors|mesh-ancestor
92969772|NCT04664972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969773|NCT04664972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969774|NCT04664972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92969775|NCT04664972|Alkylating Agents|alkylating agents|mesh-ancestor
92969776|NCT04664972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969777|NCT04664972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969778|NCT04664972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92969779|NCT04664972|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969780|NCT04664972|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969781|NCT04664972|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969782|NCT04664972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92969783|NCT04664972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92969784|NCT04664972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92969785|NCT04664972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969786|NCT04652076|Paclitaxel|paclitaxel|mesh-list
92969787|NCT04652076|Carboplatin|carboplatin|mesh-list
92969788|NCT04652076|Pembrolizumab|pembrolizumab|mesh-list
92969789|NCT04652076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969790|NCT04652076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969791|NCT04652076|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969792|NCT04652076|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969793|NCT04652076|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969794|NCT04652076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969795|NCT04652076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969796|NCT04652076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969797|NCT04632069|Acetylcysteine|acetylcysteine|mesh-list
92969798|NCT04632069|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92969799|NCT04632069|Antiviral Agents|antiviral agents|mesh-ancestor
92969800|NCT04632069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969801|NCT04632069|Expectorants|expectorants|mesh-ancestor
92969802|NCT04632069|Respiratory System Agents|respiratory system agents|mesh-ancestor
92969803|NCT04632069|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92969804|NCT04632069|Antioxidants|antioxidants|mesh-ancestor
92969805|NCT04632069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969806|NCT04632069|Protective Agents|protective agents|mesh-ancestor
92969807|NCT04632069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969808|NCT04632069|Antidotes|antidotes|mesh-ancestor
92969809|NCT04618913|Rivaroxaban|rivaroxaban|mesh-list
92969810|NCT04618913|Apixaban|apixaban|mesh-list
92969811|NCT04618913|Edoxaban|edoxaban|mesh-list
92969812|NCT04618913|Dabigatran|dabigatran|mesh-list
92969813|NCT04618913|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92969814|NCT04618913|Antithrombins|antithrombins|mesh-ancestor
92969815|NCT04618913|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92969816|NCT04618913|Protease Inhibitors|protease inhibitors|mesh-ancestor
92969817|NCT04618913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969818|NCT04618913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615232|NCT00518479|Diuretics|diuretics|mesh-ancestor
92969819|NCT04618913|Anticoagulants|anticoagulants|mesh-ancestor
92969820|NCT04547907|Paclitaxel|paclitaxel|mesh-list
92969821|NCT04547907|Docetaxel|docetaxel|mesh-list
92969822|NCT04547907|Carboplatin|carboplatin|mesh-list
92969823|NCT04547907|Trastuzumab|trastuzumab|mesh-list
92969824|NCT04547907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969825|NCT04547907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969826|NCT04547907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969827|NCT04547907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969828|NCT04547907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969829|NCT04547907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969830|NCT04547907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969831|NCT04545944|Midazolam|midazolam|mesh-list
92969832|NCT04545944|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92969833|NCT04545944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92969834|NCT04545944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969835|NCT04545944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969836|NCT04545944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92969837|NCT04545944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92969838|NCT04545944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147076|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
92969839|NCT04545944|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92969840|NCT04545944|Anesthetics, General|anesthetics, general|mesh-ancestor
92969841|NCT04545944|Anesthetics|anesthetics|mesh-ancestor
92969842|NCT04545944|GABA Modulators|gaba modulators|mesh-ancestor
92969843|NCT04545944|GABA Agents|gaba agents|mesh-ancestor
92969844|NCT04545944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969845|NCT04545944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969846|NCT04522804|Psilocybin|psilocybin|mesh-list
92969847|NCT04522804|Hallucinogens|hallucinogens|mesh-ancestor
92969848|NCT04522804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969849|NCT04522804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92969850|NCT04460937|Adavosertib|adavosertib|mesh-list
92969851|NCT04460937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969852|NCT04460937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969853|NCT04454203|Anesthetics|anesthetics|mesh-list
92969854|NCT04454203|Mepivacaine|mepivacaine|mesh-list
92969855|NCT04454203|Anesthetics, Local|anesthetics, local|mesh-list
92969856|NCT04454203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969857|NCT04454203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969858|NCT04454203|Sensory System Agents|sensory system agents|mesh-ancestor
92969859|NCT04454203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969860|NCT04393285|Letrozole|letrozole|mesh-list
92969861|NCT04393285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969862|NCT04393285|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92969863|NCT04393285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92969864|NCT04393285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969865|NCT04393285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969866|NCT04393285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92969867|NCT04393285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92969868|NCT04393285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969869|NCT04393285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969870|NCT04391283|Osimertinib|osimertinib|mesh-list
92969871|NCT04391283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969872|NCT04391283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969873|NCT04391283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969874|NCT04391283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969875|NCT04374799|Heparin|heparin|mesh-list
92969876|NCT04374799|Anticoagulants|anticoagulants|mesh-ancestor
92969877|NCT04374799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92969878|NCT04374799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92969879|NCT04374799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969880|NCT04367311|Docetaxel|docetaxel|mesh-list
92969881|NCT04367311|Pemetrexed|pemetrexed|mesh-list
92969882|NCT04367311|Atezolizumab|atezolizumab|mesh-list
92969883|NCT04367311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969884|NCT04367311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969885|NCT04367311|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969886|NCT04367311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969887|NCT04367311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969888|NCT04367311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969889|NCT04367311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92969890|NCT04367311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92969891|NCT04367311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969892|NCT04367311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969893|NCT04266275|Curcumin|curcumin|mesh-list
92969894|NCT04266275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92969895|NCT04266275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92969896|NCT04266275|Analgesics|analgesics|mesh-ancestor
92969897|NCT04266275|Sensory System Agents|sensory system agents|mesh-ancestor
92969898|NCT04266275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92969899|NCT04266275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969900|NCT04266275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92969901|NCT04266275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92969902|NCT04266275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969903|NCT04266275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969904|NCT04266275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969905|NCT04207086|Pembrolizumab|pembrolizumab|mesh-list
92969906|NCT04207086|Lenvatinib|lenvatinib|mesh-list
92969907|NCT04207086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969908|NCT04207086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969909|NCT04207086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92969910|NCT04207086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969911|NCT04207086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969912|NCT04207086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969913|NCT04194359|Bevacizumab|bevacizumab|mesh-list
92969914|NCT04194359|Capecitabine|capecitabine|mesh-list
92969915|NCT04194359|Oxaliplatin|oxaliplatin|mesh-list
92969916|NCT04194359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969917|NCT04194359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969918|NCT04194359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92969919|NCT04194359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92969920|NCT04194359|Growth Substances|growth substances|mesh-ancestor
92969921|NCT04194359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969922|NCT04194359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92969923|NCT04194359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92969924|NCT04194359|Antimetabolites|antimetabolites|mesh-ancestor
92969925|NCT04194359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969926|NCT04118010|Vitamin D|vitamin d|mesh-list
92969927|NCT04118010|Ergocalciferols|ergocalciferols|mesh-list
92969928|NCT04118010|Cholecalciferol|cholecalciferol|mesh-list
92969929|NCT04118010|Vitamins|vitamins|mesh-list
92969930|NCT04118010|Micronutrients|micronutrients|mesh-ancestor
92969931|NCT04118010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969932|NCT04118010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92969933|NCT04118010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92969934|NCT04113863|Anastrozole|anastrozole|mesh-list
92969935|NCT04113863|Tretinoin|tretinoin|mesh-list
92969936|NCT04113863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92969937|NCT04113863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969938|NCT04113863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92969939|NCT04113863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92969940|NCT04113863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969941|NCT04113863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969942|NCT04113863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92969943|NCT04113863|Hormone Antagonists|hormone antagonists|mesh-ancestor
92969944|NCT04113863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92969945|NCT04113863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969946|NCT04113863|Keratolytic Agents|keratolytic agents|mesh-ancestor
92969947|NCT04113863|Dermatologic Agents|dermatologic agents|mesh-ancestor
92969948|NCT04053491|Anesthetics|anesthetics|mesh-list
92969949|NCT04053491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92969950|NCT04053491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969951|NCT04041232|Glycerol|glycerol|mesh-list
92969952|NCT04041232|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92969953|NCT04041232|Protective Agents|protective agents|mesh-ancestor
92969954|NCT04041232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969955|NCT04030000|Paclitaxel|paclitaxel|mesh-list
92969956|NCT04030000|Carboplatin|carboplatin|mesh-list
92969957|NCT04030000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969958|NCT04030000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969959|NCT04030000|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969960|NCT04030000|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969961|NCT04030000|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969962|NCT04030000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969963|NCT04010539|Azithromycin|azithromycin|mesh-list
92969964|NCT04010539|Ceftriaxone|ceftriaxone|mesh-list
92969965|NCT04010539|Gepotidacin|gepotidacin|mesh-list
92969966|NCT04010539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92969967|NCT04010539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92969968|NCT04010539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92969969|NCT04010539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969970|NCT04010539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615377|NCT00519259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92969971|NCT04010539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969973|NCT03957590|Tislelizumab|tislelizumab|mesh-list
92969974|NCT03957590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92969975|NCT03957590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969976|NCT03957590|Tubulin Modulators|tubulin modulators|mesh-ancestor
92969977|NCT03957590|Antimitotic Agents|antimitotic agents|mesh-ancestor
92969978|NCT03957590|Mitosis Modulators|mitosis modulators|mesh-ancestor
92969979|NCT03957590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969980|NCT03957590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969981|NCT03944941|Cetuximab|cetuximab|mesh-list
92969982|NCT03944941|Avelumab|avelumab|mesh-list
92969983|NCT03944941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92969984|NCT03944941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969985|NCT03921866|Palbociclib|palbociclib|mesh-list
92969986|NCT03921866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92969987|NCT03921866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92969988|NCT03921866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92969989|NCT03921866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969990|NCT03919955|Oxybutynin|oxybutynin|mesh-list
92969991|NCT03919955|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92969992|NCT03919955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92969993|NCT03919955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92969994|NCT03919955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92969995|NCT03919955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92969996|NCT03919955|Adrenergic Agents|adrenergic agents|mesh-ancestor
92969997|NCT03919955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92969998|NCT03919955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92969999|NCT03919955|Parasympatholytics|parasympatholytics|mesh-ancestor
92970000|NCT03919955|Autonomic Agents|autonomic agents|mesh-ancestor
92970001|NCT03919955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970002|NCT03919955|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92970003|NCT03919955|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92970004|NCT03919955|Cholinergic Agents|cholinergic agents|mesh-ancestor
92970005|NCT03919955|Urological Agents|urological agents|mesh-ancestor
92970006|NCT03919799|Belumosudil|belumosudil|mesh-list
92970007|NCT03919799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92970008|NCT03919799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970009|NCT03919799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970010|NCT03760588|Valsartan|valsartan|mesh-list
92970011|NCT03760588|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92970012|NCT03760588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92970013|NCT03760588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92970014|NCT03760588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92970015|NCT03760588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970016|NCT03729778|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92970017|NCT03729778|Immunologic Factors|immunologic factors|mesh-ancestor
92970018|NCT03729778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970019|NCT03681561|Nivolumab|nivolumab|mesh-list
92970020|NCT03681561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970021|NCT03681561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970022|NCT03681561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970023|NCT03681561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970024|NCT03656081|Itraconazole|itraconazole|mesh-list
92970025|NCT03656081|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92970026|NCT03656081|Amphotericin B|amphotericin b|mesh-list
92970027|NCT03656081|Antifungal Agents|antifungal agents|mesh-ancestor
92970028|NCT03656081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970029|NCT03656081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92970030|NCT03656081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92970032|NCT03656081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970033|NCT03656081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92970034|NCT03656081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92970035|NCT03656081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970036|NCT03656081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970037|NCT03656081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92970038|NCT03656081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92970039|NCT03656081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92970040|NCT03656081|Amebicides|amebicides|mesh-ancestor
92970041|NCT03656081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92970042|NCT03649048|Cisplatin|cisplatin|mesh-list
92970043|NCT03649048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970044|NCT03642626|Vidarabine|vidarabine|mesh-list
92970045|NCT03642626|Cyclophosphamide|cyclophosphamide|mesh-list
92970046|NCT03642626|Fludarabine|fludarabine|mesh-list
92970047|NCT03642626|Fludarabine phosphate|fludarabine phosphate|mesh-list
92970048|NCT03642626|Tisagenlecleucel|tisagenlecleucel|mesh-list
92970049|NCT03642626|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92970050|NCT03642626|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92970051|NCT03642626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970052|NCT03642626|Immunologic Factors|immunologic factors|mesh-ancestor
92970053|NCT03642626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970054|NCT03642626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970055|NCT03642626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970056|NCT03642626|Alkylating Agents|alkylating agents|mesh-ancestor
92970057|NCT03642626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970058|NCT03642626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970059|NCT03642626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92970060|NCT03642626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970061|NCT03642626|Antimetabolites|antimetabolites|mesh-ancestor
92970062|NCT03642626|Antiviral Agents|antiviral agents|mesh-ancestor
92970063|NCT03642626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970064|NCT03642626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970065|NCT03621982|Pembrolizumab|pembrolizumab|mesh-list
92970066|NCT03621982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970067|NCT03621982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970068|NCT03621982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970069|NCT03621982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970070|NCT03609216|Gemcitabine|gemcitabine|mesh-list
92970071|NCT03609216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970072|NCT03609216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970073|NCT03609216|Antimetabolites|antimetabolites|mesh-ancestor
92970074|NCT03609216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970075|NCT03608163|Diazoxide|diazoxide|mesh-list
92970076|NCT03608163|Naloxone|naloxone|mesh-list
92970077|NCT03608163|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92970078|NCT03608163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970079|NCT03608163|Sensory System Agents|sensory system agents|mesh-ancestor
92970080|NCT03608163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970081|NCT03608163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92970082|NCT03608163|Vasodilator Agents|vasodilator agents|mesh-ancestor
92970083|NCT03604406|Vaccines|vaccines|mesh-list
92970084|NCT03604406|Immunologic Factors|immunologic factors|mesh-ancestor
92970085|NCT03604406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970086|NCT03599635|Bupivacaine|bupivacaine|mesh-list
92970087|NCT03599635|Anesthetics, Local|anesthetics, local|mesh-ancestor
92970088|NCT03599635|Anesthetics|anesthetics|mesh-ancestor
92970089|NCT03599635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970090|NCT03599635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970091|NCT03599635|Sensory System Agents|sensory system agents|mesh-ancestor
92970092|NCT03599635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970093|NCT03581292|Temozolomide|temozolomide|mesh-list
92970094|NCT03581292|Veliparib|veliparib|mesh-list
92970095|NCT03581292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970096|NCT03581292|Alkylating Agents|alkylating agents|mesh-ancestor
92970097|NCT03581292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970098|NCT03581292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970099|NCT03581292|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92970100|NCT03581292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970101|NCT03573700|Cyclophosphamide|cyclophosphamide|mesh-list
92970102|NCT03573700|Fludarabine|fludarabine|mesh-list
92970103|NCT03573700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970104|NCT03573700|Immunologic Factors|immunologic factors|mesh-ancestor
92970105|NCT03573700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970106|NCT03573700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970107|NCT03573700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970108|NCT03573700|Alkylating Agents|alkylating agents|mesh-ancestor
92970109|NCT03573700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970110|NCT03573700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970111|NCT03573700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92970112|NCT03573024|Azacitidine|azacitidine|mesh-list
92970113|NCT03573024|Venetoclax|venetoclax|mesh-list
92615526|NCT04694365|Fluzoparib|fluzoparib|mesh-list
92970114|NCT03573024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970115|NCT03573024|Antimetabolites|antimetabolites|mesh-ancestor
92970116|NCT03573024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970118|NCT03573024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970119|NCT03534947|Imiquimod|imiquimod|mesh-list
92970120|NCT03534947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92970121|NCT03534947|Immunologic Factors|immunologic factors|mesh-ancestor
92970122|NCT03534947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970123|NCT03534947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970124|NCT03534947|Interferon Inducers|interferon inducers|mesh-ancestor
92970125|NCT03530371|Dexmedetomidine|dexmedetomidine|mesh-list
92970126|NCT03530371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92970127|NCT03530371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970128|NCT03530371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970129|NCT03530371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92970130|NCT03530371|Analgesics|analgesics|mesh-ancestor
92970131|NCT03530371|Sensory System Agents|sensory system agents|mesh-ancestor
92970132|NCT03530371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970133|NCT03530371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92970134|NCT03530371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92970135|NCT03530371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92970136|NCT03530371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92970137|NCT03530371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970138|NCT03530371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970139|NCT03521830|Nivolumab|nivolumab|mesh-list
92970140|NCT03521830|Ipilimumab|ipilimumab|mesh-list
92970141|NCT03521830|Relatlimab|relatlimab|mesh-list
92970142|NCT03521830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970143|NCT03521830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970144|NCT03521830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970145|NCT03521830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970146|NCT03496610|Bupivacaine|bupivacaine|mesh-list
92970147|NCT03496610|Anesthetics, Local|anesthetics, local|mesh-ancestor
92970148|NCT03496610|Anesthetics|anesthetics|mesh-ancestor
92970149|NCT03496610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970150|NCT03496610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970151|NCT03496610|Sensory System Agents|sensory system agents|mesh-ancestor
92970152|NCT03496610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970153|NCT03449485|Chlorprothixene|chlorprothixene|mesh-list
92970154|NCT03449485|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92970155|NCT03449485|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92970156|NCT03449485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970157|NCT03449485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970158|NCT03449485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970159|NCT03449485|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92970160|NCT03449485|Dopamine Agents|dopamine agents|mesh-ancestor
92970161|NCT03449485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970162|NCT03449485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970163|NCT03448783|Apixaban|apixaban|mesh-list
92970164|NCT03448783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92970165|NCT03448783|Antithrombins|antithrombins|mesh-ancestor
92970166|NCT03448783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92970167|NCT03448783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92970168|NCT03448783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970169|NCT03448783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970170|NCT03448783|Anticoagulants|anticoagulants|mesh-ancestor
92970171|NCT03434730|Cyclosporine|cyclosporine|mesh-list
92970172|NCT03434730|Mycophenolic Acid|mycophenolic acid|mesh-list
92970173|NCT03434730|Lenograstim|lenograstim|mesh-list
92970174|NCT03434730|Cyclosporins|cyclosporins|mesh-list
92970175|NCT03434730|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92970177|NCT03434730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970178|NCT03434730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970179|NCT03434730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970180|NCT03434730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970181|NCT03434730|Antifungal Agents|antifungal agents|mesh-ancestor
92970182|NCT03434730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970183|NCT03434730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92970184|NCT03434730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970185|NCT03434730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92970186|NCT03434730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92970187|NCT03434730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970188|NCT03434730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92970189|NCT03434730|Antitubercular Agents|antitubercular agents|mesh-ancestor
92970190|NCT03434730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92970191|NCT03418649|Eplerenone|eplerenone|mesh-list
92970192|NCT03418649|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92970193|NCT03418649|Hormone Antagonists|hormone antagonists|mesh-ancestor
92970194|NCT03418649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970195|NCT03418649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970196|NCT03418649|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92970197|NCT03418649|Diuretics|diuretics|mesh-ancestor
92970198|NCT03418649|Natriuretic Agents|natriuretic agents|mesh-ancestor
92970199|NCT03418649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92970200|NCT03315832|Valsartan|valsartan|mesh-list
92970201|NCT03315832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92970202|NCT03315832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92970203|NCT03315832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92970204|NCT03315832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970205|NCT03260920|Oxytocin|oxytocin|mesh-list
92970206|NCT03260920|Oxytocics|oxytocics|mesh-ancestor
92970207|NCT03260920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970208|NCT03260920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970209|NCT03124355|Bromides|bromides|mesh-list
92970210|NCT03124355|Galantamine|galantamine|mesh-list
92970211|NCT03124355|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92970212|NCT03124355|Anticonvulsants|anticonvulsants|mesh-ancestor
92970213|NCT03124355|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92970214|NCT03124355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970215|NCT03124355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970216|NCT03124355|Cholinergic Agents|cholinergic agents|mesh-ancestor
92970217|NCT03124355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970218|NCT03124355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970219|NCT03124355|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92970220|NCT03124355|Autonomic Agents|autonomic agents|mesh-ancestor
92970221|NCT03124355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970222|NCT03124355|Nootropic Agents|nootropic agents|mesh-ancestor
92970223|NCT03122652|Teriflunomide|teriflunomide|mesh-list
92970224|NCT03122652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92970225|NCT03122652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92970226|NCT03122652|Analgesics|analgesics|mesh-ancestor
92970227|NCT03122652|Sensory System Agents|sensory system agents|mesh-ancestor
92970228|NCT03122652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970229|NCT03122652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970230|NCT03122652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970231|NCT03122652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970232|NCT03122652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970233|NCT03122652|Immunologic Factors|immunologic factors|mesh-ancestor
92970234|NCT03011268|Adalimumab|adalimumab|mesh-list
92970235|NCT03011268|Infliximab|infliximab|mesh-list
92970236|NCT03011268|Golimumab|golimumab|mesh-list
92970237|NCT03011268|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92970238|NCT03011268|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92970239|NCT03011268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970240|NCT03011268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970241|NCT03011268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92970242|NCT03011268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970243|NCT03011268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970244|NCT03011268|Immunologic Factors|immunologic factors|mesh-ancestor
92970245|NCT03011268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970246|NCT02944578|Curcumin|curcumin|mesh-list
92970247|NCT02944578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92970248|NCT02944578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92970249|NCT02944578|Analgesics|analgesics|mesh-ancestor
92970250|NCT02944578|Sensory System Agents|sensory system agents|mesh-ancestor
92970251|NCT02944578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970252|NCT02944578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970253|NCT02944578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970254|NCT02944578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970255|NCT02944578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970256|NCT02944578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970257|NCT02944578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970258|NCT02889523|Prednisolone|prednisolone|mesh-list
92970259|NCT02889523|Cyclophosphamide|cyclophosphamide|mesh-list
92970260|NCT02889523|Rituximab|rituximab|mesh-list
92970261|NCT02889523|Doxorubicin|doxorubicin|mesh-list
92970262|NCT02889523|Vincristine|vincristine|mesh-list
92970263|NCT02889523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970264|NCT02889523|Immunologic Factors|immunologic factors|mesh-ancestor
92970265|NCT02889523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970266|NCT02889523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970267|NCT02889523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970268|NCT02889523|Alkylating Agents|alkylating agents|mesh-ancestor
92970269|NCT02889523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970270|NCT02889523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970271|NCT02889523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92970272|NCT02889523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970273|NCT02889523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92970274|NCT02889523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92970275|NCT02889523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92970276|NCT02889523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970277|NCT02889523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92970278|NCT02889523|Tubulin Modulators|tubulin modulators|mesh-ancestor
92970279|NCT02889523|Antimitotic Agents|antimitotic agents|mesh-ancestor
92970280|NCT02889523|Mitosis Modulators|mitosis modulators|mesh-ancestor
92970281|NCT02889523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970282|NCT02889523|Glucocorticoids|glucocorticoids|mesh-ancestor
92970283|NCT02889523|Hormones|hormones|mesh-ancestor
92970284|NCT02889523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970285|NCT02889523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970286|NCT02771626|Nivolumab|nivolumab|mesh-list
92970287|NCT02771626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970288|NCT02771626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970289|NCT02771626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970290|NCT02771626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970291|NCT02616302|Dexlansoprazole|dexlansoprazole|mesh-list
92970292|NCT02616302|Lansoprazole|lansoprazole|mesh-list
92970293|NCT02616302|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92970294|NCT02616302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970295|NCT02616302|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92970296|NCT02616302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970297|NCT02616302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970298|NCT02469753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92970299|NCT02469753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92970300|NCT02469753|Analgesics|analgesics|mesh-ancestor
92970301|NCT02469753|Sensory System Agents|sensory system agents|mesh-ancestor
92970302|NCT02469753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970303|NCT02469753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970304|NCT02469753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970305|NCT02469753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970306|NCT02375204|Paclitaxel|paclitaxel|mesh-list
92970307|NCT02375204|Etoposide|etoposide|mesh-list
92970308|NCT02375204|Carboplatin|carboplatin|mesh-list
92970309|NCT02375204|Ifosfamide|ifosfamide|mesh-list
92970310|NCT02375204|Etoposide phosphate|etoposide phosphate|mesh-list
92970311|NCT02375204|Lenograstim|lenograstim|mesh-list
92970312|NCT02375204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92970313|NCT02375204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970314|NCT02375204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92970315|NCT02375204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92970316|NCT02375204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92970317|NCT02375204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970318|NCT02375204|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92970319|NCT02375204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92970320|NCT02375204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970321|NCT02375204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92970322|NCT02375204|Immunologic Factors|immunologic factors|mesh-ancestor
92970323|NCT02375204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970324|NCT02375204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970325|NCT02375204|Alkylating Agents|alkylating agents|mesh-ancestor
92970326|NCT02374242|Nivolumab|nivolumab|mesh-list
92970327|NCT02374242|Ipilimumab|ipilimumab|mesh-list
92970328|NCT02374242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970329|NCT02374242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970330|NCT02374242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970331|NCT02374242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970332|NCT02370329|Interferons|interferons|mesh-list
92970333|NCT02370329|Interferon-alpha|interferon-alpha|mesh-list
92970334|NCT02370329|Interferon alpha-2|interferon alpha-2|mesh-list
92970335|NCT02370329|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92970336|NCT02370329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92166701|NCT04937946|Analgesics|analgesics|mesh-ancestor
92970337|NCT02370329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970338|NCT02370329|Antiviral Agents|antiviral agents|mesh-ancestor
92970339|NCT02370329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970340|NCT02370329|Immunologic Factors|immunologic factors|mesh-ancestor
92970341|NCT02370329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970342|NCT02314988|Tranexamic Acid|tranexamic acid|mesh-list
92970343|NCT02314988|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92970344|NCT02314988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92970345|NCT02314988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970346|NCT02314988|Hemostatics|hemostatics|mesh-ancestor
92970347|NCT02314988|Coagulants|coagulants|mesh-ancestor
92970348|NCT02272790|Paclitaxel|paclitaxel|mesh-list
92970349|NCT02272790|Carboplatin|carboplatin|mesh-list
92970350|NCT02272790|Gemcitabine|gemcitabine|mesh-list
92970351|NCT02272790|Adavosertib|adavosertib|mesh-list
92970352|NCT02272790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92970353|NCT02272790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970354|NCT02272790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92970355|NCT02272790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92970356|NCT02272790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92970357|NCT02272790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970358|NCT02272790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970359|NCT02272790|Antimetabolites|antimetabolites|mesh-ancestor
92970360|NCT02272790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970361|NCT02113657|Ipilimumab|ipilimumab|mesh-list
92970362|NCT02113657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970363|NCT02113657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970364|NCT02113657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970365|NCT02113657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970366|NCT02035787|Metformin|metformin|mesh-list
92970367|NCT02035787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92970368|NCT02035787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970369|NCT02032953|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
92970370|NCT02032953|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92970371|NCT02032953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92970372|NCT01850355|Buspirone|buspirone|mesh-list
92970373|NCT01850355|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92970374|NCT01850355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92970375|NCT01850355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970376|NCT01850355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970377|NCT01850355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970378|NCT01850355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92970379|NCT01850355|Serotonin Agents|serotonin agents|mesh-ancestor
92970380|NCT01850355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970381|NCT01850355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970382|NCT01582776|Lenalidomide|lenalidomide|mesh-list
92970383|NCT01582776|Obinutuzumab|obinutuzumab|mesh-list
92970384|NCT01582776|Immunologic Factors|immunologic factors|mesh-ancestor
92970385|NCT01582776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970386|NCT01582776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92970387|NCT01582776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92970388|NCT01582776|Growth Substances|growth substances|mesh-ancestor
92970389|NCT01582776|Growth Inhibitors|growth inhibitors|mesh-ancestor
92970390|NCT01582776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970391|NCT01582776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970392|NCT01464164|Prednisone|prednisone|mesh-list
92970393|NCT01464164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970394|NCT01464164|Glucocorticoids|glucocorticoids|mesh-ancestor
92970395|NCT01464164|Hormones|hormones|mesh-ancestor
92970396|NCT01464164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970397|NCT01464164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970398|NCT01464164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970399|NCT01464164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970400|NCT01377389|Ipilimumab|ipilimumab|mesh-list
92970401|NCT01377389|Leuprolide|leuprolide|mesh-list
92970402|NCT01377389|Goserelin|goserelin|mesh-list
92970403|NCT01377389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970404|NCT01377389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970405|NCT01377389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970406|NCT01377389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970407|NCT01377389|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92970408|NCT01377389|Fertility Agents|fertility agents|mesh-ancestor
92970409|NCT01377389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970410|NCT01377389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970411|NCT01377389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970412|NCT01194271|Ipilimumab|ipilimumab|mesh-list
92970413|NCT01194271|Leuprolide|leuprolide|mesh-list
92970414|NCT01194271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970415|NCT01194271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970416|NCT01194271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92615822|NCT02948101|Immunologic Factors|immunologic factors|mesh-ancestor
92970417|NCT01194271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970418|NCT01194271|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92970419|NCT01194271|Fertility Agents|fertility agents|mesh-ancestor
92970420|NCT01194271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970421|NCT01194271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970422|NCT01194271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970423|NCT01119508|Temozolomide|temozolomide|mesh-list
92970424|NCT01119508|Ipilimumab|ipilimumab|mesh-list
92970425|NCT01119508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970426|NCT01119508|Alkylating Agents|alkylating agents|mesh-ancestor
92970427|NCT01119508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970428|NCT01119508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970429|NCT01119508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970430|NCT01119508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92970431|NCT00602459|Cyclophosphamide|cyclophosphamide|mesh-list
92970432|NCT00602459|Rituximab|rituximab|mesh-list
92970433|NCT00602459|Fludarabine|fludarabine|mesh-list
92970434|NCT00602459|Fludarabine phosphate|fludarabine phosphate|mesh-list
92970435|NCT00602459|Lenalidomide|lenalidomide|mesh-list
92970436|NCT00602459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92970437|NCT00602459|Antibodies|antibodies|mesh-list
92970438|NCT00602459|Immunoglobulins|immunoglobulins|mesh-list
92970439|NCT00602459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92970440|NCT00602459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970441|NCT00602459|Immunologic Factors|immunologic factors|mesh-ancestor
92970442|NCT00602459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970443|NCT00602459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970444|NCT00602459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970445|NCT00602459|Alkylating Agents|alkylating agents|mesh-ancestor
92970446|NCT00602459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970447|NCT00602459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970448|NCT00602459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92970449|NCT00602459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970450|NCT00602459|Antimetabolites|antimetabolites|mesh-ancestor
92970451|NCT00602459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92970452|NCT00602459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92970453|NCT00602459|Growth Substances|growth substances|mesh-ancestor
92970454|NCT00602459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92970455|NCT00199069|Cytarabine|cytarabine|mesh-list
92970456|NCT00199069|Dexamethasone|dexamethasone|mesh-list
92970457|NCT00199069|Prednisolone|prednisolone|mesh-list
92970458|NCT00199069|Cyclophosphamide|cyclophosphamide|mesh-list
92970459|NCT00199069|Ifosfamide|ifosfamide|mesh-list
92970460|NCT00199069|Methotrexate|methotrexate|mesh-list
92970461|NCT00199069|Vincristine|vincristine|mesh-list
92970462|NCT00199069|Doxorubicin|doxorubicin|mesh-list
92970463|NCT00199069|Daunorubicin|daunorubicin|mesh-list
92970464|NCT00199069|Asparaginase|asparaginase|mesh-list
92970465|NCT00199069|Mitoxantrone|mitoxantrone|mesh-list
92970466|NCT00199069|Mercaptopurine|mercaptopurine|mesh-list
92970467|NCT00199069|Thioguanine|thioguanine|mesh-list
92970468|NCT00199069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970469|NCT00199069|Immunologic Factors|immunologic factors|mesh-ancestor
92970470|NCT00199069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970471|NCT00199069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970472|NCT00199069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970473|NCT00199069|Alkylating Agents|alkylating agents|mesh-ancestor
92970474|NCT00199069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970475|NCT00199069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970476|NCT00199069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92970477|NCT00199069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970478|NCT00199069|Antiemetics|antiemetics|mesh-ancestor
92970479|NCT00199069|Autonomic Agents|autonomic agents|mesh-ancestor
92970480|NCT00199069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166708|NCT05160987|Midazolam|midazolam|mesh-list
92970481|NCT00199069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970482|NCT00199069|Glucocorticoids|glucocorticoids|mesh-ancestor
92970483|NCT00199069|Hormones|hormones|mesh-ancestor
92970484|NCT00199069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970485|NCT00199069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970486|NCT00199069|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92970487|NCT00199069|Abortifacient Agents|abortifacient agents|mesh-ancestor
92970488|NCT00199069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970489|NCT00199069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970490|NCT00199069|Antimetabolites|antimetabolites|mesh-ancestor
92970491|NCT00199069|Dermatologic Agents|dermatologic agents|mesh-ancestor
92970492|NCT00199069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970493|NCT00199069|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92970494|NCT00199069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92970495|NCT00199069|Antiviral Agents|antiviral agents|mesh-ancestor
92970496|NCT00199069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970497|NCT00199069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92970498|NCT00199069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92970499|NCT00199069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92970500|NCT00199069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92970501|NCT00199069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92970502|NCT00199069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92970503|NCT00199069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92970504|NCT00199069|Analgesics|analgesics|mesh-ancestor
92970505|NCT00199069|Sensory System Agents|sensory system agents|mesh-ancestor
92970506|NCT00199043|Allopurinol|allopurinol|mesh-list
92970507|NCT00199043|Rasburicase|rasburicase|mesh-list
92970508|NCT00199043|Antimetabolites|antimetabolites|mesh-ancestor
92970509|NCT00199043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970510|NCT00199043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970511|NCT00199043|Gout Suppressants|gout suppressants|mesh-ancestor
92970512|NCT00199043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970513|NCT00199043|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92970514|NCT00199043|Antioxidants|antioxidants|mesh-ancestor
92970515|NCT00199043|Protective Agents|protective agents|mesh-ancestor
92970516|NCT00199043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970517|NCT02601989|Tadalafil|tadalafil|mesh-list
92970518|NCT02601989|Vasodilator Agents|vasodilator agents|mesh-ancestor
92970519|NCT02601989|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92970520|NCT02601989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92970521|NCT02601989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970522|NCT02601989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970523|NCT02601989|Urological Agents|urological agents|mesh-ancestor
92970524|NCT01067053|Bevacizumab|bevacizumab|mesh-list
92970525|NCT01067053|Capecitabine|capecitabine|mesh-list
92970526|NCT01067053|Oxaliplatin|oxaliplatin|mesh-list
92970527|NCT01067053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970528|NCT01067053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970529|NCT01067053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92970530|NCT01067053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92970531|NCT01067053|Growth Substances|growth substances|mesh-ancestor
92970532|NCT01067053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970533|NCT01067053|Growth Inhibitors|growth inhibitors|mesh-ancestor
92970534|NCT01067053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970535|NCT01067053|Antimetabolites|antimetabolites|mesh-ancestor
92970536|NCT01067053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970537|NCT02601287|Botulinum Toxins|botulinum toxins|mesh-list
92970538|NCT02601287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92970539|NCT02601287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92970540|NCT02601287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92970541|NCT02601287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970542|NCT02601287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970543|NCT02601287|Cholinergic Agents|cholinergic agents|mesh-ancestor
92970544|NCT02601287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970545|NCT02601287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970546|NCT02601287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92970547|NCT02601287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970548|NCT01067365|Citric Acid|citric acid|mesh-list
92970549|NCT01067365|Sodium Citrate|sodium citrate|mesh-list
92970550|NCT01067365|Enclomiphene|enclomiphene|mesh-list
92970551|NCT01067365|Clomiphene|clomiphene|mesh-list
92970552|NCT01067365|Zuclomiphene|zuclomiphene|mesh-list
92970553|NCT01067365|Anticoagulants|anticoagulants|mesh-ancestor
92970554|NCT01067365|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92970555|NCT01067365|Chelating Agents|chelating agents|mesh-ancestor
92970556|NCT01067365|Sequestering Agents|sequestering agents|mesh-ancestor
92970557|NCT01067365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970558|NCT01067365|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92970559|NCT01067365|Hormone Antagonists|hormone antagonists|mesh-ancestor
92970560|NCT01067365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970561|NCT01067365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970562|NCT01067365|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92970563|NCT01067365|Fertility Agents|fertility agents|mesh-ancestor
92970564|NCT01067365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970565|NCT01067365|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92970566|NCT01067365|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92970567|NCT00568776|Inositol|inositol|mesh-list
92970568|NCT00568776|Vitamin B Complex|vitamin b complex|mesh-ancestor
92970569|NCT00568776|Vitamins|vitamins|mesh-ancestor
92970570|NCT00568776|Micronutrients|micronutrients|mesh-ancestor
92970571|NCT00568776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970572|NCT01067443|Amphotericin B|amphotericin b|mesh-list
92970573|NCT01067443|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92970574|NCT01067443|Miltefosine|miltefosine|mesh-list
92970575|NCT01067443|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92970576|NCT01067443|Amebicides|amebicides|mesh-ancestor
92970577|NCT01067443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92970578|NCT01067443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92970579|NCT01067443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970580|NCT01067443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92970581|NCT01067443|Antifungal Agents|antifungal agents|mesh-ancestor
92970582|NCT01067443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970583|NCT01067443|Schistosomicides|schistosomicides|mesh-ancestor
92970584|NCT01067443|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92970585|NCT01067443|Anthelmintics|anthelmintics|mesh-ancestor
92970586|NCT01065259|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92970587|NCT01065259|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92970588|NCT01065259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92970589|NCT01065259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970590|NCT01065259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970591|NCT01065259|Adrenergic Agents|adrenergic agents|mesh-ancestor
92970592|NCT01065259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970593|NCT01065259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970594|NCT00822666|Clopidogrel|clopidogrel|mesh-list
92970595|NCT00822666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92970596|NCT00822666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92970597|NCT00822666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92970598|NCT00822666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92970599|NCT00822666|Purinergic Agents|purinergic agents|mesh-ancestor
92970600|NCT00822666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970601|NCT00822666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970602|NCT00822666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970604|NCT00816816|Fluorouracil|fluorouracil|mesh-list
92970605|NCT00816816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970606|NCT00816816|Tubulin Modulators|tubulin modulators|mesh-ancestor
92970607|NCT00816816|Antimitotic Agents|antimitotic agents|mesh-ancestor
92970608|NCT00816816|Mitosis Modulators|mitosis modulators|mesh-ancestor
92970609|NCT00816816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970610|NCT00816816|Antimetabolites|antimetabolites|mesh-ancestor
92970611|NCT00816816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970612|NCT00816816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970613|NCT00816816|Immunologic Factors|immunologic factors|mesh-ancestor
92970614|NCT00816816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970615|NCT00816894|Olanzapine|olanzapine|mesh-list
92970616|NCT00816894|Antiemetics|antiemetics|mesh-ancestor
92970617|NCT00816894|Autonomic Agents|autonomic agents|mesh-ancestor
92970618|NCT00816894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970619|NCT00816894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970620|NCT00816894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970621|NCT00816894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92970622|NCT00816894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92970623|NCT00816894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970624|NCT00816894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970625|NCT00816894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92970626|NCT00816894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92970627|NCT00816894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970628|NCT00816894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970629|NCT00816894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970630|NCT00816894|Serotonin Agents|serotonin agents|mesh-ancestor
92970631|NCT00635154|Dexamethasone|dexamethasone|mesh-list
92970632|NCT00635154|Dexamethasone acetate|dexamethasone acetate|mesh-list
92970633|NCT00635154|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92970634|NCT00635154|BB 1101|bb 1101|mesh-list
92970635|NCT00635154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970636|NCT00635154|Antiemetics|antiemetics|mesh-ancestor
92970637|NCT00635154|Autonomic Agents|autonomic agents|mesh-ancestor
92970638|NCT00635154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970639|NCT00635154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970640|NCT00635154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970641|NCT00635154|Glucocorticoids|glucocorticoids|mesh-ancestor
92970642|NCT00635154|Hormones|hormones|mesh-ancestor
92970643|NCT00635154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970644|NCT00635154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970645|NCT00635154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970646|NCT00635154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970647|NCT00635154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92970648|NCT00635154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970649|NCT00635154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970651|NCT00822744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92970652|NCT00822744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92970653|NCT00822744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970654|NCT00822744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970655|NCT00822744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970656|NCT00822744|Serotonin Agents|serotonin agents|mesh-ancestor
92970657|NCT00822744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970658|NCT00819468|Teduglutide|teduglutide|mesh-list
92970659|NCT00819468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970660|NCT00819468|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92970661|NCT00819468|Protective Agents|protective agents|mesh-ancestor
92970662|NCT00819468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970663|NCT01067599|Nicotine|nicotine|mesh-list
92970664|NCT01067599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92970665|NCT01067599|Autonomic Agents|autonomic agents|mesh-ancestor
92970666|NCT01067599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970667|NCT01067599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970668|NCT01067599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92970669|NCT01067599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92970670|NCT01067599|Cholinergic Agents|cholinergic agents|mesh-ancestor
92970671|NCT01067599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970672|NCT01067599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970673|NCT00778817|Mitotane|mitotane|mesh-list
92970674|NCT00778817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970675|NCT00778817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970676|NCT00293059|Dienogest|dienogest|mesh-list
92970677|NCT00293059|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92970678|NCT00293059|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92970679|NCT00293059|Estradiol|estradiol|mesh-list
92970680|NCT00293059|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92970681|NCT00293059|Estrogens|estrogens|mesh-ancestor
92970682|NCT00293059|Hormones|hormones|mesh-ancestor
92970683|NCT00293059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970684|NCT00293059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970685|NCT00293059|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92970686|NCT00293059|Contraceptive Agents|contraceptive agents|mesh-ancestor
92970687|NCT00293059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970688|NCT00293059|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92970689|NCT00293059|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92970690|NCT00293059|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92970691|NCT00293059|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92970692|NCT00293059|Hormone Antagonists|hormone antagonists|mesh-ancestor
92970693|NCT00293059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92970694|NCT00293059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970695|NCT00756275|Nicotine|nicotine|mesh-list
92970696|NCT00756275|Varenicline|varenicline|mesh-list
92970697|NCT00756275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92970698|NCT00756275|Autonomic Agents|autonomic agents|mesh-ancestor
92970699|NCT00756275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970700|NCT00756275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970701|NCT00756275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92970702|NCT00756275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92970703|NCT00756275|Cholinergic Agents|cholinergic agents|mesh-ancestor
92970704|NCT00756275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970705|NCT00756275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970706|NCT04096547|Rivaroxaban|rivaroxaban|mesh-list
92970707|NCT04096547|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92970708|NCT04096547|Antithrombins|antithrombins|mesh-ancestor
92970709|NCT04096547|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92970710|NCT04096547|Protease Inhibitors|protease inhibitors|mesh-ancestor
92970711|NCT04096547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970712|NCT04096547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970713|NCT04096547|Anticoagulants|anticoagulants|mesh-ancestor
92970714|NCT00298831|Rocuronium|rocuronium|mesh-list
92970715|NCT00298831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92970716|NCT00298831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92970717|NCT00298831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92970718|NCT00298831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970719|NCT00298831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970720|NCT00758069|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92970721|NCT00758069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92970722|NCT00758069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970723|NCT00758069|Incretins|incretins|mesh-ancestor
92970724|NCT00758069|Hormones|hormones|mesh-ancestor
92970725|NCT00758069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970726|NCT00758069|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92970727|NCT00758069|Protease Inhibitors|protease inhibitors|mesh-ancestor
92970728|NCT00758069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970729|NCT00758069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970730|NCT01067677|Diphenhydramine|diphenhydramine|mesh-list
92970731|NCT01067677|Promethazine|promethazine|mesh-list
92970732|NCT01067677|Ondansetron|ondansetron|mesh-list
92970733|NCT01067677|Metoclopramide|metoclopramide|mesh-list
92970734|NCT01067677|Antiemetics|antiemetics|mesh-ancestor
92970735|NCT01067677|Autonomic Agents|autonomic agents|mesh-ancestor
92970736|NCT01067677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970737|NCT01067677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970738|NCT01067677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970739|NCT01067677|Antipruritics|antipruritics|mesh-ancestor
92970740|NCT01067677|Dermatologic Agents|dermatologic agents|mesh-ancestor
92970741|NCT01067677|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92970742|NCT01067677|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92970743|NCT01067677|Serotonin Agents|serotonin agents|mesh-ancestor
92970744|NCT01067677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970745|NCT01067677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970746|NCT01067677|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92970747|NCT01067677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92970748|NCT01067677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970749|NCT01067677|Anesthetics, Local|anesthetics, local|mesh-ancestor
92970750|NCT01067677|Anesthetics|anesthetics|mesh-ancestor
92970751|NCT01067677|Sensory System Agents|sensory system agents|mesh-ancestor
92970752|NCT01067677|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92970753|NCT01067677|Histamine Antagonists|histamine antagonists|mesh-ancestor
92970754|NCT01067677|Histamine Agents|histamine agents|mesh-ancestor
92970755|NCT01067677|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92970756|NCT01067677|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92970757|NCT01067677|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92970758|NCT01067677|Dopamine Agents|dopamine agents|mesh-ancestor
92970759|NCT03979651|Hydroxychloroquine|hydroxychloroquine|mesh-list
92970760|NCT03979651|Trametinib|trametinib|mesh-list
92970761|NCT03979651|Antimalarials|antimalarials|mesh-ancestor
92970762|NCT03979651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92970763|NCT03979651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92970764|NCT03979651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970765|NCT03979651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970766|NCT03979651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970767|NCT03979651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970768|NCT03979651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970769|NCT03979651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92970770|NCT02600741|Droperidol|droperidol|mesh-list
92970771|NCT02600741|Haloperidol|haloperidol|mesh-list
92970772|NCT02600741|Pimozide|pimozide|mesh-list
92970773|NCT02600741|Olanzapine|olanzapine|mesh-list
92970774|NCT02600741|Prochlorperazine|prochlorperazine|mesh-list
92970775|NCT02600741|Chlorpromazine|chlorpromazine|mesh-list
92970776|NCT02600741|Trifluoperazine|trifluoperazine|mesh-list
92970777|NCT02600741|Risperidone|risperidone|mesh-list
92970778|NCT02600741|Aripiprazole|aripiprazole|mesh-list
92970779|NCT02600741|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92970780|NCT02600741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92970781|NCT02600741|Ziprasidone|ziprasidone|mesh-list
92970782|NCT02600741|Clozapine|clozapine|mesh-list
92970783|NCT02600741|Asenapine|asenapine|mesh-list
92970784|NCT02600741|Loxapine|loxapine|mesh-list
92970785|NCT02600741|Iloperidone|iloperidone|mesh-list
92970786|NCT02600741|Perphenazine|perphenazine|mesh-list
92970787|NCT02600741|Fluphenazine|fluphenazine|mesh-list
92970788|NCT02600741|Fluphenazine depot|fluphenazine depot|mesh-list
92970789|NCT02600741|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92970790|NCT02600741|Thioridazine|thioridazine|mesh-list
92970791|NCT02600741|Thiothixene|thiothixene|mesh-list
92970792|NCT02600741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92970793|NCT02600741|Serotonin Agents|serotonin agents|mesh-ancestor
92970794|NCT02600741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970795|NCT02600741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970796|NCT02600741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970797|NCT02600741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92970798|NCT02600741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92970799|NCT02600741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970800|NCT02600741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970801|NCT02600741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92970802|NCT02600741|Dopamine Agents|dopamine agents|mesh-ancestor
92970803|NCT02600741|Antiemetics|antiemetics|mesh-ancestor
92970804|NCT02600741|Autonomic Agents|autonomic agents|mesh-ancestor
92970805|NCT02600741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970806|NCT02600741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970807|NCT02600741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92970808|NCT02600741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92970809|NCT02600741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970810|NCT02600741|Antidepressive Agents|antidepressive agents|mesh-ancestor
92970811|NCT02600741|Dopamine Agonists|dopamine agonists|mesh-ancestor
92970812|NCT02600741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92970813|NCT02600741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92970814|NCT02600741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92970815|NCT02600741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92970816|NCT02600741|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92970817|NCT02600741|GABA Antagonists|gaba antagonists|mesh-ancestor
92970818|NCT02600741|GABA Agents|gaba agents|mesh-ancestor
92970819|NCT02600741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92970820|NCT01065649|Nortriptyline|nortriptyline|mesh-list
92970821|NCT01065649|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92970822|NCT01065649|Antidepressive Agents|antidepressive agents|mesh-ancestor
92970823|NCT01065649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970824|NCT01065649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92970825|NCT01065649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92970826|NCT01065649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970827|NCT01065649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970828|NCT01065649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92970829|NCT01065649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970830|NCT01065649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970831|NCT01065727|Mitoxantrone|mitoxantrone|mesh-list
92970832|NCT01065727|Natalizumab|natalizumab|mesh-list
92970833|NCT01065727|Immunologic Factors|immunologic factors|mesh-list
92970834|NCT01065727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92970835|NCT01065727|Immunomodulating Agents|immunomodulating agents|mesh-list
92970836|NCT01065727|Analgesics|analgesics|mesh-ancestor
92970837|NCT01065727|Sensory System Agents|sensory system agents|mesh-ancestor
92970838|NCT01065727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970839|NCT01065727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527803|NCT00000671|Antimetabolites|antimetabolites|mesh-ancestor
92970840|NCT01065727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970841|NCT01065727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92970842|NCT01065727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92970843|NCT01065727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970844|NCT01065727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970845|NCT01065805|Alovudine|alovudine|mesh-list
92970846|NCT01065805|Antiviral Agents|antiviral agents|mesh-ancestor
92970847|NCT01065805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970848|NCT00311623|Sirolimus|sirolimus|mesh-list
92970849|NCT00311623|Temsirolimus|temsirolimus|mesh-list
92970850|NCT00311623|MTOR Inhibitors|mtor inhibitors|mesh-list
92970851|NCT00311623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92970852|NCT00311623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970853|NCT00311623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92970854|NCT00311623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970855|NCT00311623|Antifungal Agents|antifungal agents|mesh-ancestor
92970856|NCT00311623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970857|NCT00311623|Immunologic Factors|immunologic factors|mesh-ancestor
92970858|NCT00311623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970859|NCT00311623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92970860|NCT00311623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970861|NCT00311623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970862|NCT01067989|Zoledronic Acid|zoledronic acid|mesh-list
92970863|NCT01067989|Pamidronate|pamidronate|mesh-list
92970864|NCT01067989|Celecoxib|celecoxib|mesh-list
92970865|NCT01067989|Cyclophosphamide|cyclophosphamide|mesh-list
92970866|NCT01067989|Capecitabine|capecitabine|mesh-list
92970867|NCT01067989|Methotrexate|methotrexate|mesh-list
92970868|NCT01067989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92970869|NCT01067989|Immunologic Factors|immunologic factors|mesh-ancestor
92970870|NCT01067989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970871|NCT01067989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970872|NCT01067989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970873|NCT01067989|Alkylating Agents|alkylating agents|mesh-ancestor
92970874|NCT01067989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970875|NCT01067989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970876|NCT01067989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92970877|NCT01067989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92970878|NCT01067989|Antimetabolites|antimetabolites|mesh-ancestor
92970879|NCT01067989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92970880|NCT01067989|Abortifacient Agents|abortifacient agents|mesh-ancestor
92970881|NCT01067989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92970882|NCT01067989|Dermatologic Agents|dermatologic agents|mesh-ancestor
92970883|NCT01067989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970884|NCT01067989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92970885|NCT01067989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92970886|NCT01067989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92970887|NCT01067989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92970889|NCT01067989|Sensory System Agents|sensory system agents|mesh-ancestor
92970890|NCT01067989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970891|NCT01067989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92970892|NCT01067989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92970893|NCT01067989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92970894|NCT01067989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92970895|NCT00633594|Rituximab|rituximab|mesh-list
92970896|NCT00633594|Lenalidomide|lenalidomide|mesh-list
92970897|NCT00633594|Bortezomib|bortezomib|mesh-list
92970898|NCT00633594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970899|NCT00633594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970900|NCT00633594|Immunologic Factors|immunologic factors|mesh-ancestor
92970901|NCT00633594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970902|NCT00633594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92970903|NCT00633594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92970904|NCT00633594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92970905|NCT00633594|Growth Substances|growth substances|mesh-ancestor
92970906|NCT00633594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92970907|NCT04840888|Itraconazole|itraconazole|mesh-list
92970908|NCT04840888|Carbamazepine|carbamazepine|mesh-list
92970909|NCT04840888|Omeprazole|omeprazole|mesh-list
92970910|NCT04840888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92970911|NCT04840888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92970912|NCT04840888|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92970913|NCT04840888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970914|NCT04840888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970915|NCT04840888|Antifungal Agents|antifungal agents|mesh-ancestor
92970916|NCT04840888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970917|NCT04840888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92970918|NCT04840888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92970919|NCT04840888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92970920|NCT04840888|Hormone Antagonists|hormone antagonists|mesh-ancestor
92970921|NCT04840888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92970922|NCT04840888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970923|NCT04840888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92970924|NCT04840888|Anticonvulsants|anticonvulsants|mesh-ancestor
92970925|NCT04840888|Antimanic Agents|antimanic agents|mesh-ancestor
92970926|NCT04840888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92970927|NCT04840888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92970928|NCT04840888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970929|NCT04840888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92970930|NCT04840888|Analgesics|analgesics|mesh-ancestor
92970931|NCT04840888|Sensory System Agents|sensory system agents|mesh-ancestor
92970932|NCT04840888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970933|NCT04840888|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92970934|NCT04840888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970935|NCT04840888|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92970936|NCT04840888|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92970937|NCT00755807|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92970938|NCT00755807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92970939|NCT00755807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92970940|NCT00755807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92970941|NCT00755807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970942|NCT00755807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92970943|NCT00755807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970944|NCT00755807|Analgesics|analgesics|mesh-ancestor
92970945|NCT00755807|Sensory System Agents|sensory system agents|mesh-ancestor
92970946|NCT00755807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970947|NCT00755807|Antidepressive Agents|antidepressive agents|mesh-ancestor
92970948|NCT00755807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92970949|NCT00755807|Dopamine Agents|dopamine agents|mesh-ancestor
92970950|NCT05372224|Cholecalciferol|cholecalciferol|mesh-list
92970951|NCT05372224|Vitamin D|vitamin d|mesh-list
92970952|NCT05372224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92970953|NCT05372224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970954|NCT05372224|Vitamins|vitamins|mesh-ancestor
92970955|NCT05372224|Micronutrients|micronutrients|mesh-ancestor
92970956|NCT05372224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92970957|NCT00631410|Sunitinib|sunitinib|mesh-list
92970958|NCT00631410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970959|NCT00631410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92970960|NCT00631410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92970961|NCT00631410|Growth Substances|growth substances|mesh-ancestor
92970962|NCT00631410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970963|NCT00631410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92970964|NCT00631410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92970965|NCT00631410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970966|NCT00631410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970967|NCT05301712|Naloxone|naloxone|mesh-list
92970968|NCT05301712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92970969|NCT05301712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970970|NCT05301712|Sensory System Agents|sensory system agents|mesh-ancestor
92970971|NCT05301712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92970972|NCT00817284|Bevacizumab|bevacizumab|mesh-list
92970973|NCT00817284|Irinotecan|irinotecan|mesh-list
92970974|NCT00817284|Temozolomide|temozolomide|mesh-list
92970975|NCT00817284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92970976|NCT00817284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970977|NCT00817284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92970978|NCT00817284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92970979|NCT00817284|Growth Substances|growth substances|mesh-ancestor
92970980|NCT00817284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92970981|NCT00817284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92970982|NCT00817284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92970983|NCT00817284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92970984|NCT00817284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970985|NCT00817284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970986|NCT00817284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92970987|NCT00817284|Alkylating Agents|alkylating agents|mesh-ancestor
92970989|NCT04096157|Antifungal Agents|antifungal agents|mesh-ancestor
92970990|NCT04096157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92970991|NCT00823290|Sorafenib|sorafenib|mesh-list
92970992|NCT00823290|Panobinostat|panobinostat|mesh-list
92970993|NCT00823290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92970994|NCT00823290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92970995|NCT00823290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92970996|NCT00823290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92970997|NCT00823290|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92970998|NCT00755417|Gabapentin|gabapentin|mesh-list
92970999|NCT00755417|Analgesics|analgesics|mesh-ancestor
92971000|NCT00755417|Sensory System Agents|sensory system agents|mesh-ancestor
92971001|NCT00755417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971002|NCT00755417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971003|NCT00755417|Anticonvulsants|anticonvulsants|mesh-ancestor
92971004|NCT00755417|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92971005|NCT00755417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92971006|NCT00755417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971007|NCT00755417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971008|NCT00755417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92971009|NCT00755417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92971010|NCT00755417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971011|NCT00755417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971012|NCT00755417|Antimanic Agents|antimanic agents|mesh-ancestor
92971013|NCT00777803|Botulinum Toxins|botulinum toxins|mesh-list
92971014|NCT00777803|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92971015|NCT00777803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92971016|NCT00777803|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92971017|NCT00777803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92971018|NCT00777803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971019|NCT00777803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971020|NCT00777803|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971021|NCT00777803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971022|NCT00777803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971023|NCT00777803|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92971024|NCT00777803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971025|NCT00825864|Dexamethasone|dexamethasone|mesh-list
92971026|NCT00825864|Diclofenac|diclofenac|mesh-list
92971027|NCT00825864|Dexamethasone acetate|dexamethasone acetate|mesh-list
92971028|NCT00825864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92971029|NCT00825864|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92971030|NCT00825864|BB 1101|bb 1101|mesh-list
92971031|NCT00825864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971032|NCT00825864|Antiemetics|antiemetics|mesh-ancestor
92971033|NCT00825864|Autonomic Agents|autonomic agents|mesh-ancestor
92971034|NCT00825864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971035|NCT00825864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971036|NCT00825864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971037|NCT00825864|Glucocorticoids|glucocorticoids|mesh-ancestor
92971038|NCT00825864|Hormones|hormones|mesh-ancestor
92971039|NCT00825864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971040|NCT00825864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971041|NCT00825864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971042|NCT00825864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92971043|NCT00825864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92971044|NCT00825864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92971045|NCT00825864|Analgesics|analgesics|mesh-ancestor
92971046|NCT00825864|Sensory System Agents|sensory system agents|mesh-ancestor
92971047|NCT00825864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92971048|NCT00825864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92971049|NCT00825864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971050|NCT00825864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971051|NCT00825864|Protease Inhibitors|protease inhibitors|mesh-ancestor
92971052|NCT00825942|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92971053|NCT00825942|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92971054|NCT00527332|Fentanyl|fentanyl|mesh-list
92971055|NCT00527332|Morphine|morphine|mesh-list
92971056|NCT00527332|Bupivacaine|bupivacaine|mesh-list
92971057|NCT00527332|Propofol|propofol|mesh-list
92971058|NCT00527332|Anesthetics, Local|anesthetics, local|mesh-ancestor
92971059|NCT00527332|Anesthetics|anesthetics|mesh-ancestor
92971060|NCT00527332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971061|NCT00527332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971063|NCT00527332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971064|NCT00527332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92971065|NCT00527332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92971066|NCT00527332|Anesthetics, General|anesthetics, general|mesh-ancestor
92971067|NCT00527332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92971068|NCT00527332|Narcotics|narcotics|mesh-ancestor
92971069|NCT00527332|Analgesics|analgesics|mesh-ancestor
92971070|NCT00527332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92166723|NCT01892995|Ketamine|ketamine|mesh-list
92971071|NCT00820092|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92971072|NCT00820092|Hormones|hormones|mesh-ancestor
92971073|NCT00820092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971074|NCT00820092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971075|NCT00823602|Buserelin|buserelin|mesh-list
92971076|NCT00823602|Ganirelix|ganirelix|mesh-list
92971077|NCT00823602|Hormone Antagonists|hormone antagonists|mesh-ancestor
92971078|NCT00823602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971079|NCT00823602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971080|NCT00823602|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92971081|NCT00823602|Fertility Agents|fertility agents|mesh-ancestor
92971082|NCT00823602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92971083|NCT00820326|Dolasetron|dolasetron|mesh-list
92971084|NCT00820326|Antiemetics|antiemetics|mesh-ancestor
92971085|NCT00820326|Autonomic Agents|autonomic agents|mesh-ancestor
92971086|NCT00820326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971087|NCT00820326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971088|NCT00820326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971089|NCT00820326|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92971090|NCT00820326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92971091|NCT00820326|Serotonin Agents|serotonin agents|mesh-ancestor
92971092|NCT00820326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971093|NCT00820326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971094|NCT00916097|Docetaxel|docetaxel|mesh-list
92971095|NCT00916097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971096|NCT00916097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92971097|NCT00916097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92971098|NCT00916097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92971099|NCT00916097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971100|NCT00629772|Infliximab|infliximab|mesh-list
92971101|NCT00629772|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92971102|NCT00629772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971103|NCT00629772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92971104|NCT00629772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971105|NCT00629772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92971106|NCT00526630|Methylphenidate|methylphenidate|mesh-list
92971107|NCT00526630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92971108|NCT00526630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971109|NCT00526630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92971110|NCT00526630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92971111|NCT00526630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971112|NCT00526630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971113|NCT00526630|Dopamine Agents|dopamine agents|mesh-ancestor
92971114|NCT00526630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971115|NCT00755183|Methyltestosterone|methyltestosterone|mesh-list
92971116|NCT00755183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92971117|NCT00755183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92971118|NCT00755183|Testosterone|testosterone|mesh-list
92971119|NCT00755183|Testosterone undecanoate|testosterone undecanoate|mesh-list
92971120|NCT00755183|Testosterone enanthate|testosterone enanthate|mesh-list
92971121|NCT00755183|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92971122|NCT00755183|Androgens|androgens|mesh-ancestor
92971123|NCT00755183|Hormones|hormones|mesh-ancestor
92971124|NCT00755183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971125|NCT00755183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971126|NCT00755183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971127|NCT00755183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971128|NCT00755183|Anabolic Agents|anabolic agents|mesh-ancestor
92971129|NCT00826254|Vitamins|vitamins|mesh-list
92971130|NCT00826254|Vitamin K|vitamin k|mesh-list
92971131|NCT00826254|Micronutrients|micronutrients|mesh-ancestor
92971132|NCT00826254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971133|NCT00826254|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92971134|NCT00826254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92971135|NCT00826254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971136|NCT00826254|Hemostatics|hemostatics|mesh-ancestor
92971137|NCT00826254|Coagulants|coagulants|mesh-ancestor
92971138|NCT03875482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92971139|NCT03875482|Immunologic Factors|immunologic factors|mesh-ancestor
92971140|NCT03875482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971141|NCT00820404|BLI-489|bli-489|mesh-list
92971142|NCT00820404|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92971143|NCT00820404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971144|NCT00820404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971145|NCT00820404|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92971146|NCT00820404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971147|NCT00820482|Menotropins|menotropins|mesh-list
92971148|NCT00820482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92971149|NCT00820482|Fertility Agents|fertility agents|mesh-ancestor
92971150|NCT00820482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92971151|NCT00820482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971152|NCT00754793|Dexetimide|dexetimide|mesh-list
92971153|NCT00754793|Citalopram|citalopram|mesh-list
92971154|NCT00754793|Escitalopram|escitalopram|mesh-list
92971155|NCT00754793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92971156|NCT00754793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92971157|NCT00754793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971158|NCT00754793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971159|NCT00754793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971160|NCT00754793|Serotonin Agents|serotonin agents|mesh-ancestor
92971161|NCT00754793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971162|NCT00754793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92971163|NCT00754793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92971164|NCT00754793|Parasympatholytics|parasympatholytics|mesh-ancestor
92971165|NCT00754793|Autonomic Agents|autonomic agents|mesh-ancestor
92971166|NCT00754793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971167|NCT00754793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92971168|NCT00754793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92971169|NCT00754793|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971170|NCT00754793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92971171|NCT00754793|Antidepressive Agents|antidepressive agents|mesh-ancestor
92971172|NCT00754793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971173|NCT00826566|Caffeine|caffeine|mesh-list
92971174|NCT00826566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92971175|NCT00826566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971176|NCT00826566|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92971177|NCT00826566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971178|NCT00826566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971179|NCT00826566|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92971180|NCT00826566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92971181|NCT00826566|Purinergic Agents|purinergic agents|mesh-ancestor
92971182|NCT00826566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971183|NCT03999190|Raclopride|raclopride|mesh-list
92971184|NCT03999190|Dextroamphetamine|dextroamphetamine|mesh-list
92971185|NCT03999190|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92971186|NCT03999190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971187|NCT03999190|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92971188|NCT03999190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92971189|NCT03999190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971190|NCT03999190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971191|NCT03999190|Dopamine Agents|dopamine agents|mesh-ancestor
92971192|NCT03999190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971193|NCT03999190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92971194|NCT03999190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92971195|NCT03999190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971196|NCT03999190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971197|NCT03999190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92971198|NCT05244694|Insulin|insulin|mesh-list
92971199|NCT05244694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92971200|NCT05244694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971201|NCT00626028|Nitric Oxide|nitric oxide|mesh-list
92971202|NCT00626028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92971203|NCT00626028|Autonomic Agents|autonomic agents|mesh-ancestor
92971204|NCT00626028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971205|NCT00626028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971206|NCT00626028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92971207|NCT00626028|Respiratory System Agents|respiratory system agents|mesh-ancestor
92971208|NCT00626028|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92971210|NCT00626028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971211|NCT00626028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971212|NCT00626028|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92971213|NCT00626028|Vasodilator Agents|vasodilator agents|mesh-ancestor
92971214|NCT00626028|Gasotransmitters|gasotransmitters|mesh-ancestor
92971215|NCT00626028|Protective Agents|protective agents|mesh-ancestor
92971216|NCT00826644|Etoposide|etoposide|mesh-list
92971217|NCT00826644|Belotecan|belotecan|mesh-list
92971218|NCT00826644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971219|NCT00826644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92971220|NCT00826644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92971221|NCT00826644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92971222|NCT00826644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971223|NCT00826644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971224|NCT00826644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92971225|NCT00826722|Levetiracetam|levetiracetam|mesh-list
92971226|NCT00826722|Anticonvulsants|anticonvulsants|mesh-ancestor
92971227|NCT00826722|Nootropic Agents|nootropic agents|mesh-ancestor
92971228|NCT04922944|Vaccines|vaccines|mesh-list
92971229|NCT04922944|Immunologic Factors|immunologic factors|mesh-ancestor
92971230|NCT04922944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971231|NCT00820794|Lithium Carbonate|lithium carbonate|mesh-list
92971232|NCT00820794|Antidepressive Agents|antidepressive agents|mesh-ancestor
92971233|NCT00820794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971234|NCT00820794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971235|NCT00820794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971236|NCT00820794|Antimanic Agents|antimanic agents|mesh-ancestor
92971237|NCT00820794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92971238|NCT00820794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971239|NCT00820794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971240|NCT04044378|Ifosfamide|ifosfamide|mesh-list
92971241|NCT04044378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92971242|NCT04044378|Alkylating Agents|alkylating agents|mesh-ancestor
92971243|NCT04044378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971244|NCT04044378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971245|NCT00628758|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92971246|NCT00628758|Formoterol Fumarate|formoterol fumarate|mesh-list
92971247|NCT00628758|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92971248|NCT00628758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92971249|NCT00628758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92971250|NCT00628758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92971251|NCT00628758|Autonomic Agents|autonomic agents|mesh-ancestor
92971252|NCT00628758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971253|NCT00628758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971254|NCT00628758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92971255|NCT00628758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92971256|NCT00628758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92971257|NCT00628758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92971258|NCT00628758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971259|NCT00628758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971260|NCT00821028|Paclitaxel|paclitaxel|mesh-list
92971261|NCT00821028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92971262|NCT00821028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971263|NCT00821028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92971264|NCT00821028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92166750|NCT02181075|Liver Extracts|liver extracts|mesh-list
92971265|NCT00821028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92971266|NCT00821028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971267|NCT00826878|Tivozanib|tivozanib|mesh-list
92971268|NCT00826878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92971269|NCT00826878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971270|NCT00826878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971271|NCT00827034|Warfarin|warfarin|mesh-list
92971272|NCT00827034|Anticoagulants|anticoagulants|mesh-ancestor
92971273|NCT02600585|Vaccines|vaccines|mesh-list
92971274|NCT02600585|Immunologic Factors|immunologic factors|mesh-ancestor
92971275|NCT02600585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971276|NCT00525148|Afatinib|afatinib|mesh-list
92971277|NCT00525148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971278|NCT00525148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92971279|NCT00525148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971280|NCT00525148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971281|NCT00754325|Dasatinib|dasatinib|mesh-list
92971282|NCT00754325|Fulvestrant|fulvestrant|mesh-list
92971283|NCT00754325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971284|NCT00754325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92971285|NCT00754325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971286|NCT00754325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971287|NCT00754325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971288|NCT00754325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92971289|NCT00754325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92971290|NCT00754325|Hormone Antagonists|hormone antagonists|mesh-ancestor
92971291|NCT00754325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971292|NCT00754325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971293|NCT00524680|Cholecalciferol|cholecalciferol|mesh-list
92971294|NCT00524680|Vitamin D|vitamin d|mesh-list
92971295|NCT00524680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92971296|NCT00524680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971297|NCT00524680|Vitamins|vitamins|mesh-ancestor
92971298|NCT00524680|Micronutrients|micronutrients|mesh-ancestor
92971299|NCT00524680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92971300|NCT00298363|Tenofovir|tenofovir|mesh-list
92971301|NCT00298363|Emtricitabine|emtricitabine|mesh-list
92971302|NCT00298363|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92971303|NCT00298363|Entecavir|entecavir|mesh-list
92971304|NCT00298363|Antiviral Agents|antiviral agents|mesh-ancestor
92971305|NCT00298363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971306|NCT00298363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92971307|NCT00298363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92971308|NCT00298363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971309|NCT00298363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971310|NCT00298363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92971311|NCT00298363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92971312|NCT00821262|Propofol|propofol|mesh-list
92971313|NCT00821262|Sevoflurane|sevoflurane|mesh-list
92971314|NCT00821262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92971315|NCT00821262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971316|NCT00821262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971317|NCT00821262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92971318|NCT00821262|Anesthetics, General|anesthetics, general|mesh-ancestor
92971319|NCT00821262|Anesthetics|anesthetics|mesh-ancestor
92971320|NCT00821262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92971322|NCT00524368|Ritonavir|ritonavir|mesh-list
92971323|NCT00524368|Darunavir|darunavir|mesh-list
92971324|NCT00524368|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92971325|NCT00524368|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92971326|NCT00524368|Protease Inhibitors|protease inhibitors|mesh-ancestor
92971327|NCT00524368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971328|NCT00524368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971329|NCT00524368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92971330|NCT00524368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92971331|NCT00524368|Antiviral Agents|antiviral agents|mesh-ancestor
92971332|NCT00524368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971333|NCT00524368|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92971334|NCT00524368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92971335|NCT00777101|Capecitabine|capecitabine|mesh-list
92971336|NCT00777101|Lapatinib|lapatinib|mesh-list
92971337|NCT00777101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92971338|NCT00777101|Antimetabolites|antimetabolites|mesh-ancestor
92971339|NCT00777101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971340|NCT00777101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971341|NCT00777101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92971342|NCT00777101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971343|NCT00830856|Lamivudine|lamivudine|mesh-list
92971344|NCT00830856|Nevirapine|nevirapine|mesh-list
92971345|NCT00830856|Stavudine|stavudine|mesh-list
92971346|NCT00830856|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
92971347|NCT00830856|Fluconazole|fluconazole|mesh-list
92971348|NCT00830856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92971349|NCT00830856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92971350|NCT00830856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971351|NCT00830856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971352|NCT00830856|Antiviral Agents|antiviral agents|mesh-ancestor
92971353|NCT00830856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971354|NCT00830856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92971355|NCT00830856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92971357|NCT00830856|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92971358|NCT00830856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92971359|NCT00830856|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92971360|NCT00830856|Hormone Antagonists|hormone antagonists|mesh-ancestor
92971361|NCT00830856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971362|NCT00830856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971363|NCT00830856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92971364|NCT00830856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92971365|NCT00830856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92971366|NCT00830856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92971367|NCT00830856|Antimetabolites|antimetabolites|mesh-ancestor
92971368|NCT01068067|Tacrolimus|tacrolimus|mesh-list
92971369|NCT01068067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971370|NCT01068067|Immunologic Factors|immunologic factors|mesh-ancestor
92971371|NCT01068067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971372|NCT01068067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92971373|NCT01068067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971374|NCT01068067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971375|NCT00524134|Carvedilol|carvedilol|mesh-list
92971376|NCT00524134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92971377|NCT00524134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92971378|NCT00524134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92971379|NCT00524134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971380|NCT00524134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971381|NCT00524134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971382|NCT00524134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92971383|NCT00524134|Antioxidants|antioxidants|mesh-ancestor
92971384|NCT00524134|Protective Agents|protective agents|mesh-ancestor
92971385|NCT00524134|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92971386|NCT00524134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971387|NCT00524134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92971388|NCT00524134|Vasodilator Agents|vasodilator agents|mesh-ancestor
92971389|NCT00524134|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92971390|NCT00524134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92971391|NCT00777023|Gabapentin|gabapentin|mesh-list
92971392|NCT00777023|Analgesics|analgesics|mesh-ancestor
92971393|NCT00777023|Sensory System Agents|sensory system agents|mesh-ancestor
92971394|NCT00777023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971395|NCT00777023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971396|NCT00777023|Anticonvulsants|anticonvulsants|mesh-ancestor
92971397|NCT00777023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92971398|NCT00777023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92971399|NCT00777023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971400|NCT00777023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971401|NCT00777023|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92971402|NCT00777023|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92971403|NCT00777023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971404|NCT00777023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971405|NCT00777023|Antimanic Agents|antimanic agents|mesh-ancestor
92971406|NCT05062330|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92971407|NCT05062330|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92971408|NCT00297037|Pimecrolimus|pimecrolimus|mesh-list
92971409|NCT00297037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92971410|NCT00297037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92971411|NCT00297037|Analgesics|analgesics|mesh-ancestor
92971412|NCT00297037|Sensory System Agents|sensory system agents|mesh-ancestor
92971413|NCT00297037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971414|NCT00297037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971415|NCT00297037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971416|NCT00297037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92971417|NCT00297037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92971418|NCT00297037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971419|NCT00297037|Immunologic Factors|immunologic factors|mesh-ancestor
92971420|NCT00297037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92971421|NCT00297037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971422|NCT00297037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971424|NCT00292981|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92971425|NCT00292981|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92971426|NCT00292981|Immunologic Factors|immunologic factors|mesh-ancestor
92971427|NCT00292981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971428|NCT00292981|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92971429|NCT00292981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971430|NCT02598869|Triamcinolone|triamcinolone|mesh-list
92971431|NCT02598869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92971432|NCT02598869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92971433|NCT02598869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92971434|NCT02598869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971435|NCT02598869|Glucocorticoids|glucocorticoids|mesh-ancestor
92971436|NCT02598869|Hormones|hormones|mesh-ancestor
92971437|NCT02598869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971438|NCT02598869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971439|NCT02598869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971440|NCT02598869|Immunologic Factors|immunologic factors|mesh-ancestor
92971441|NCT02598869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971442|NCT02598869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971443|NCT04095455|Ketamine|ketamine|mesh-list
92971444|NCT04095455|Analgesics|analgesics|mesh-ancestor
92971445|NCT04095455|Sensory System Agents|sensory system agents|mesh-ancestor
92971446|NCT04095455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971447|NCT04095455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971448|NCT04095455|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92971449|NCT04095455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92971450|NCT04095455|Anesthetics, General|anesthetics, general|mesh-ancestor
92971451|NCT04095455|Anesthetics|anesthetics|mesh-ancestor
92971452|NCT04095455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971453|NCT04095455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92971454|NCT04095455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92971455|NCT04095455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971456|NCT04095455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971457|NCT04095299|Capecitabine|capecitabine|mesh-list
92971458|NCT04095299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92971459|NCT04095299|Antimetabolites|antimetabolites|mesh-ancestor
92971460|NCT04095299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971461|NCT04095299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971462|NCT00296725|Fluoxetine|fluoxetine|mesh-list
92971463|NCT00296725|Imipramine|imipramine|mesh-list
92971464|NCT00296725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92971465|NCT00296725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92616874|NCT00407862|Losartan|losartan|mesh-list
92971466|NCT00296725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971467|NCT00296725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971468|NCT00296725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971469|NCT00296725|Serotonin Agents|serotonin agents|mesh-ancestor
92971470|NCT00296725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971471|NCT00296725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92971472|NCT00296725|Antidepressive Agents|antidepressive agents|mesh-ancestor
92971473|NCT00296725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971474|NCT00296725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92971475|NCT00296725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92971476|NCT00296725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971477|NCT00296725|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92971478|NCT00296725|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92527815|NCT02971540|Ropivacaine|ropivacaine|mesh-list
92971479|NCT00296725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92971480|NCT00523978|Sotalol|sotalol|mesh-list
92971481|NCT00523978|Flecainide|flecainide|mesh-list
92971482|NCT00523978|Propafenone|propafenone|mesh-list
92971483|NCT00523978|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92971484|NCT00523978|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92971485|NCT00523978|Adrenergic Agents|adrenergic agents|mesh-ancestor
92971486|NCT00523978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971487|NCT00523978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971488|NCT00523978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971489|NCT00523978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92971490|NCT00523978|Sympatholytics|sympatholytics|mesh-ancestor
92971491|NCT00523978|Autonomic Agents|autonomic agents|mesh-ancestor
92971492|NCT00523978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971493|NCT00523978|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92971494|NCT00523978|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92971495|NCT00523978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971496|NCT00296647|Bupropion|bupropion|mesh-list
92971497|NCT00296647|Nicotine|nicotine|mesh-list
92971498|NCT00296647|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92971499|NCT00296647|Autonomic Agents|autonomic agents|mesh-ancestor
92971500|NCT00296647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971501|NCT00296647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971502|NCT00296647|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92971503|NCT00296647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92971504|NCT00296647|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971505|NCT00296647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971506|NCT00296647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971507|NCT00296647|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92971508|NCT00296647|Antidepressive Agents|antidepressive agents|mesh-ancestor
92971509|NCT00296647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971510|NCT00296647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92971511|NCT00296647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92971512|NCT00296647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971513|NCT00296647|Dopamine Agents|dopamine agents|mesh-ancestor
92971514|NCT00296647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92971515|NCT00296647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92971516|NCT00296647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971517|NCT00754013|Donepezil|donepezil|mesh-list
92971518|NCT00754013|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92971519|NCT00754013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971520|NCT00754013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971521|NCT00754013|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971522|NCT00754013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971523|NCT00754013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971524|NCT00754013|Nootropic Agents|nootropic agents|mesh-ancestor
92971525|NCT00523744|Amlodipine|amlodipine|mesh-list
92971526|NCT00523744|Valsartan|valsartan|mesh-list
92971527|NCT00523744|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92971528|NCT00523744|Olmesartan|olmesartan|mesh-list
92971529|NCT00523744|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92971530|NCT00523744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92971531|NCT00523744|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92971532|NCT00523744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971533|NCT00523744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971534|NCT00523744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92971535|NCT00523744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971536|NCT00523744|Vasodilator Agents|vasodilator agents|mesh-ancestor
92971537|NCT00523744|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92616946|NCT00144911|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92971538|NCT00523744|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92971539|NCT00523744|Diuretics|diuretics|mesh-ancestor
92971540|NCT00523744|Natriuretic Agents|natriuretic agents|mesh-ancestor
92971541|NCT00523744|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92971542|NCT03979625|Heparin|heparin|mesh-list
92971543|NCT03979625|Antibodies|antibodies|mesh-list
92971544|NCT03979625|Immunologic Factors|immunologic factors|mesh-ancestor
92971545|NCT03979625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971546|NCT03979625|Anticoagulants|anticoagulants|mesh-ancestor
92971547|NCT03979625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92971548|NCT03979625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92971549|NCT03979625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971550|NCT02548494|Insulin|insulin|mesh-list
92971551|NCT02548494|Insulin Glargine|insulin glargine|mesh-list
92971552|NCT02548494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92971553|NCT02548494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971554|NCT00752219|Metronidazole|metronidazole|mesh-list
92971555|NCT00752219|Meropenem|meropenem|mesh-list
92971556|NCT00752219|Ceftazidime|ceftazidime|mesh-list
92971557|NCT00752219|Avibactam|avibactam|mesh-list
92971558|NCT00752219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971559|NCT00752219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92971560|NCT00752219|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92971561|NCT00752219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92971562|NCT00752219|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92971563|NCT00752219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971564|NCT00752219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971565|NCT02598791|Glucagon|glucagon|mesh-list
92971566|NCT02598791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92971567|NCT02598791|Incretins|incretins|mesh-ancestor
92971568|NCT02598791|Hormones|hormones|mesh-ancestor
92971569|NCT02598791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971570|NCT02598791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971571|NCT02598791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971572|NCT00827346|Clopidogrel|clopidogrel|mesh-list
92971573|NCT00827346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92971574|NCT00827346|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92971575|NCT00827346|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92971576|NCT00827346|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92971577|NCT00827346|Purinergic Agents|purinergic agents|mesh-ancestor
92971578|NCT00827346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971579|NCT00827346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971580|NCT00827346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971581|NCT00997750|Lornoxicam|lornoxicam|mesh-list
92971582|NCT00997750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92971583|NCT00997750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92971584|NCT00997750|Analgesics|analgesics|mesh-ancestor
92971585|NCT00997750|Sensory System Agents|sensory system agents|mesh-ancestor
92971586|NCT00997750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971587|NCT00997750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971588|NCT00997750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971589|NCT00997750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92971590|NCT00622908|Besifloxacin|besifloxacin|mesh-list
92971591|NCT00622908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92971592|NCT00622908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971593|NCT00622908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92971594|NCT00622908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92971595|NCT00622908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971596|NCT00622908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971597|NCT00622908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971598|NCT00997828|Everolimus|everolimus|mesh-list
92971599|NCT00997828|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92971600|NCT00997828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92971601|NCT00997828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971602|NCT00997828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971603|NCT00997828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971604|NCT00997828|Immunologic Factors|immunologic factors|mesh-ancestor
92971605|NCT00997828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971606|NCT00997828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971607|NCT02598635|Cholecalciferol|cholecalciferol|mesh-list
92971608|NCT02598635|Vitamin D|vitamin d|mesh-list
92971609|NCT02598635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92971610|NCT02598635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971611|NCT02598635|Vitamins|vitamins|mesh-ancestor
92971612|NCT02598635|Micronutrients|micronutrients|mesh-ancestor
92971613|NCT02598635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92971614|NCT04093271|Diphenhydramine|diphenhydramine|mesh-list
92971615|NCT04093271|Promethazine|promethazine|mesh-list
92971616|NCT04093271|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92971617|NCT04093271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92166767|NCT01361217|Lovastatin|lovastatin|mesh-list
92971618|NCT04093271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971619|NCT04093271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971620|NCT04093271|Anesthetics, Local|anesthetics, local|mesh-ancestor
92971621|NCT04093271|Anesthetics|anesthetics|mesh-ancestor
92971622|NCT04093271|Sensory System Agents|sensory system agents|mesh-ancestor
92971623|NCT04093271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971624|NCT04093271|Antiemetics|antiemetics|mesh-ancestor
92971625|NCT04093271|Autonomic Agents|autonomic agents|mesh-ancestor
92971626|NCT04093271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971627|NCT04093271|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92971628|NCT04093271|Histamine Antagonists|histamine antagonists|mesh-ancestor
92971629|NCT04093271|Histamine Agents|histamine agents|mesh-ancestor
92971630|NCT04093271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971631|NCT04093271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971632|NCT04093271|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92971633|NCT04093271|Antipruritics|antipruritics|mesh-ancestor
92971634|NCT04093271|Dermatologic Agents|dermatologic agents|mesh-ancestor
92971635|NCT00827580|Eniluracil|eniluracil|mesh-list
92971636|NCT00827580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971637|NCT00827580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971638|NCT04094909|Paclitaxel|paclitaxel|mesh-list
92971639|NCT04094909|Cisplatin|cisplatin|mesh-list
92971640|NCT04094909|Carboplatin|carboplatin|mesh-list
92971641|NCT04094909|Pembrolizumab|pembrolizumab|mesh-list
92971642|NCT04094909|Pemetrexed|pemetrexed|mesh-list
92971643|NCT04094909|Endostatins|endostatins|mesh-list
92971644|NCT04094909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92971645|NCT04094909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971646|NCT04094909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92971647|NCT04094909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92971648|NCT04094909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92971649|NCT04094909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971650|NCT04094909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92971651|NCT04094909|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92971652|NCT04094909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971653|NCT04094909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92971654|NCT04094909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92971655|NCT04094909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92971656|NCT04094909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92971657|NCT04094909|Growth Substances|growth substances|mesh-ancestor
92971658|NCT04094909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971659|NCT04094909|Growth Inhibitors|growth inhibitors|mesh-ancestor
92971660|NCT02599571|Nicotine|nicotine|mesh-list
92971661|NCT02599571|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92971662|NCT02599571|Autonomic Agents|autonomic agents|mesh-ancestor
92971663|NCT02599571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971664|NCT02599571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971665|NCT02599571|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92971666|NCT02599571|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92971667|NCT02599571|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971668|NCT02599571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971669|NCT02599571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971670|NCT00296491|Fluticasone|fluticasone|mesh-list
92971671|NCT00296491|Xhance|xhance|mesh-list
92971672|NCT00296491|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92971673|NCT00296491|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92971674|NCT00296491|Montelukast|montelukast|mesh-list
92971675|NCT00296491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971676|NCT00296491|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92971677|NCT00296491|Autonomic Agents|autonomic agents|mesh-ancestor
92971678|NCT00296491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971679|NCT00296491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971680|NCT00296491|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92971681|NCT00296491|Respiratory System Agents|respiratory system agents|mesh-ancestor
92971682|NCT00296491|Dermatologic Agents|dermatologic agents|mesh-ancestor
92971683|NCT00296491|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92971684|NCT00296491|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92971685|NCT00296491|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92971686|NCT00296491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92971687|NCT00296491|Adrenergic Agents|adrenergic agents|mesh-ancestor
92971688|NCT00296491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971689|NCT00296491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971690|NCT00296491|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92971691|NCT00296491|Hormone Antagonists|hormone antagonists|mesh-ancestor
92527839|NCT00396487|Fluorouracil|fluorouracil|mesh-list
92971692|NCT00296491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971693|NCT00296491|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92971694|NCT00296491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92971695|NCT00296491|Glucocorticoids|glucocorticoids|mesh-ancestor
92971696|NCT00296491|Hormones|hormones|mesh-ancestor
92971697|NCT00296491|Sympathomimetics|sympathomimetics|mesh-ancestor
92971698|NCT00747617|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92971699|NCT00747617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92971700|NCT00747617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971701|NCT02599493|Rifampin|rifampin|mesh-list
92971702|NCT02599493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92971703|NCT02599493|Antitubercular Agents|antitubercular agents|mesh-ancestor
92971704|NCT02599493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92971705|NCT02599493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971706|NCT02599493|Leprostatic Agents|leprostatic agents|mesh-ancestor
92971707|NCT02599493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92971708|NCT02599493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971709|NCT02599493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971710|NCT02599493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92971711|NCT02599493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92971712|NCT02599493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92971713|NCT02599493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92971714|NCT02599493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92971715|NCT02599493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92971716|NCT04092725|Ibrexafungerp|ibrexafungerp|mesh-list
92971717|NCT04092725|Antifungal Agents|antifungal agents|mesh-ancestor
92971718|NCT04092725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971719|NCT00296335|Mitomycins|mitomycins|mesh-list
92971720|NCT00296335|Mitomycin|mitomycin|mesh-list
92971721|NCT00296335|Doxifluridine|doxifluridine|mesh-list
92971722|NCT00296335|Floxuridine|floxuridine|mesh-list
92971723|NCT00296335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971724|NCT00296335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92971725|NCT00296335|Alkylating Agents|alkylating agents|mesh-ancestor
92971726|NCT00296335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971727|NCT00296335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92971728|NCT00296335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971729|NCT00296335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92971730|NCT00296335|Antimetabolites|antimetabolites|mesh-ancestor
92971731|NCT00296335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971732|NCT00296335|Immunologic Factors|immunologic factors|mesh-ancestor
92971733|NCT00296335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971734|NCT00296335|Appetite Stimulants|appetite stimulants|mesh-ancestor
92971735|NCT00296335|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92971736|NCT04094597|Lactoferrin|lactoferrin|mesh-list
92971737|NCT04094597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971738|NCT01065961|Dexamethasone|dexamethasone|mesh-list
92971739|NCT01065961|Dexamethasone acetate|dexamethasone acetate|mesh-list
92971740|NCT01065961|BB 1101|bb 1101|mesh-list
92971741|NCT01065961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971742|NCT01065961|Antiemetics|antiemetics|mesh-ancestor
92971743|NCT01065961|Autonomic Agents|autonomic agents|mesh-ancestor
92971744|NCT01065961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971745|NCT01065961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971746|NCT01065961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971747|NCT01065961|Glucocorticoids|glucocorticoids|mesh-ancestor
92971748|NCT01065961|Hormones|hormones|mesh-ancestor
92971749|NCT01065961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971750|NCT01065961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971751|NCT01065961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971752|NCT01065961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92971753|NCT01065961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971754|NCT01065961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971755|NCT01068223|Cetirizine|cetirizine|mesh-list
92971756|NCT01068223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92971757|NCT01068223|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92971758|NCT01068223|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92971759|NCT01068223|Histamine Antagonists|histamine antagonists|mesh-ancestor
92971760|NCT01068223|Histamine Agents|histamine agents|mesh-ancestor
92971761|NCT01068223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971762|NCT01068223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971763|NCT01068223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971764|NCT04234360|Prednisone|prednisone|mesh-list
92971765|NCT04234360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971766|NCT04234360|Glucocorticoids|glucocorticoids|mesh-ancestor
92971768|NCT04234360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971769|NCT04234360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971770|NCT04234360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971771|NCT04234360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971772|NCT02600273|Nicotine|nicotine|mesh-list
92971773|NCT02600273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92971774|NCT02600273|Autonomic Agents|autonomic agents|mesh-ancestor
92971775|NCT02600273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971776|NCT02600273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971777|NCT02600273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92971778|NCT02600273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92971779|NCT02600273|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971780|NCT02600273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971781|NCT02600273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971782|NCT04187872|Pembrolizumab|pembrolizumab|mesh-list
92971783|NCT04187872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92971784|NCT04187872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971785|NCT04187872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92971786|NCT04187872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971787|NCT01068301|Plerixafor|plerixafor|mesh-list
92971788|NCT01068301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92971789|NCT01068301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92971790|NCT01068301|Antiviral Agents|antiviral agents|mesh-ancestor
92971791|NCT01068301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971792|NCT04999228|Infliximab|infliximab|mesh-list
92971793|NCT04999228|Mesalamine|mesalamine|mesh-list
92971794|NCT04999228|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92971795|NCT04999228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971796|NCT04999228|Dermatologic Agents|dermatologic agents|mesh-ancestor
92971797|NCT04999228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971798|NCT04999228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92971799|NCT04999228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92971800|NCT04999228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92971801|NCT04999228|Analgesics|analgesics|mesh-ancestor
92971802|NCT04999228|Sensory System Agents|sensory system agents|mesh-ancestor
92971803|NCT04999228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971804|NCT04999228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971805|NCT01564810|Cetuximab|cetuximab|mesh-list
92971806|NCT01564810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92971807|NCT01564810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971808|NCT04092101|Nicotine|nicotine|mesh-list
92971809|NCT04092101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92971810|NCT04092101|Autonomic Agents|autonomic agents|mesh-ancestor
92971811|NCT04092101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971812|NCT04092101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971813|NCT04092101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92971814|NCT04092101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92971815|NCT04092101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92971816|NCT04092101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971817|NCT04092101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971818|NCT04093895|Taurolidine|taurolidine|mesh-list
92971819|NCT04093895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971820|NCT04093895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92971821|NCT04093895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971822|NCT00624780|Pregabalin|pregabalin|mesh-list
92971823|NCT00624780|Lorazepam|lorazepam|mesh-list
92971824|NCT00624780|Analgesics|analgesics|mesh-ancestor
92971825|NCT00624780|Sensory System Agents|sensory system agents|mesh-ancestor
92971826|NCT00624780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971827|NCT00624780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971828|NCT00624780|Anticonvulsants|anticonvulsants|mesh-ancestor
92971829|NCT00624780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92971830|NCT00624780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971831|NCT00624780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971832|NCT00624780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92971833|NCT00624780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92971834|NCT00624780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92971835|NCT00624780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971836|NCT00624780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92971837|NCT00624780|Antiemetics|antiemetics|mesh-ancestor
92971838|NCT00624780|Autonomic Agents|autonomic agents|mesh-ancestor
92971839|NCT00624780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971840|NCT00624780|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92971841|NCT00624780|GABA Modulators|gaba modulators|mesh-ancestor
92971842|NCT00624780|GABA Agents|gaba agents|mesh-ancestor
92971843|NCT00624780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92971845|NCT02599337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971846|NCT02599337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92971847|NCT02599337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971848|NCT02599337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971849|NCT00831636|Cytarabine|cytarabine|mesh-list
92971850|NCT00831636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92971851|NCT00831636|Antimetabolites|antimetabolites|mesh-ancestor
92971852|NCT00831636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971853|NCT00831636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971854|NCT00831636|Antiviral Agents|antiviral agents|mesh-ancestor
92971855|NCT00831636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971856|NCT00831636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971857|NCT00831636|Immunologic Factors|immunologic factors|mesh-ancestor
92971858|NCT00831636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971859|NCT00750737|Amphotericin B|amphotericin b|mesh-list
92971860|NCT00750737|Posaconazole|posaconazole|mesh-list
92971861|NCT00750737|Amebicides|amebicides|mesh-ancestor
92971862|NCT00750737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92971863|NCT00750737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92971864|NCT00750737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971865|NCT00750737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92971866|NCT00750737|Antifungal Agents|antifungal agents|mesh-ancestor
92971867|NCT00750737|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92971868|NCT00750737|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92971869|NCT00750737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92971870|NCT00750737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971871|NCT00750737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971872|NCT00750737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92971873|NCT00750737|Hormone Antagonists|hormone antagonists|mesh-ancestor
92971874|NCT00750737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971875|NCT00750737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971876|NCT04093505|Gemtuzumab|gemtuzumab|mesh-list
92971877|NCT04093505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92971878|NCT04093505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971879|NCT04093505|Immunotoxins|immunotoxins|mesh-ancestor
92971880|NCT04093505|Immunoconjugates|immunoconjugates|mesh-ancestor
92971881|NCT04093505|Immunologic Factors|immunologic factors|mesh-ancestor
92971882|NCT04093505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971883|NCT00831714|Rivaroxaban|rivaroxaban|mesh-list
92971884|NCT00831714|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92971885|NCT00831714|Antithrombins|antithrombins|mesh-ancestor
92971886|NCT00831714|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92971887|NCT00831714|Protease Inhibitors|protease inhibitors|mesh-ancestor
92971888|NCT00831714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971889|NCT00831714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971890|NCT00831714|Anticoagulants|anticoagulants|mesh-ancestor
92971891|NCT02597699|Lidocaine|lidocaine|mesh-list
92971892|NCT02597699|Sufentanil|sufentanil|mesh-list
92971893|NCT02597699|Remifentanil|remifentanil|mesh-list
92971894|NCT02597699|Dsuvia|dsuvia|mesh-list
92971895|NCT02597699|Anesthetics, Local|anesthetics, local|mesh-ancestor
92971896|NCT02597699|Anesthetics|anesthetics|mesh-ancestor
92971897|NCT02597699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971898|NCT02597699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971899|NCT02597699|Sensory System Agents|sensory system agents|mesh-ancestor
92971900|NCT02597699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971901|NCT02597699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93026490|NCT00401973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92971902|NCT02597699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92971903|NCT02597699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92971904|NCT02597699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971905|NCT02597699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971906|NCT02597699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92971907|NCT02597699|Narcotics|narcotics|mesh-ancestor
92971908|NCT02597699|Analgesics|analgesics|mesh-ancestor
92971909|NCT02597699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92971910|NCT02597699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92971911|NCT02597699|Anesthetics, General|anesthetics, general|mesh-ancestor
92971912|NCT02574910|Abiraterone Acetate|abiraterone acetate|mesh-list
92971913|NCT02574910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617333|NCT00169065|GABA Agents|gaba agents|mesh-ancestor
92971914|NCT02574910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92971915|NCT02574910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971916|NCT02574910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971917|NCT02574910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92971918|NCT02574910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971919|NCT02574910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971920|NCT02574910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92971921|NCT00744653|Bleomycin|bleomycin|mesh-list
92971922|NCT00744653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92971923|NCT00744653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971924|NCT00998218|Ranolazine|ranolazine|mesh-list
92971925|NCT00998218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92971926|NCT00998218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971927|NCT00998218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971928|NCT00825396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92971929|NCT00825396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92971930|NCT00311311|Mycophenolic Acid|mycophenolic acid|mesh-list
92971931|NCT00311311|Sirolimus|sirolimus|mesh-list
92971932|NCT00311311|Prednisone|prednisone|mesh-list
92971933|NCT00311311|Tacrolimus|tacrolimus|mesh-list
92971934|NCT00311311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971935|NCT00311311|Glucocorticoids|glucocorticoids|mesh-ancestor
92971936|NCT00311311|Hormones|hormones|mesh-ancestor
92971937|NCT00311311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971938|NCT00311311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971939|NCT00311311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971940|NCT00311311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971941|NCT00311311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92971942|NCT00311311|Immunologic Factors|immunologic factors|mesh-ancestor
92971943|NCT00311311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92971944|NCT00311311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971945|NCT00311311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971946|NCT00311311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92971947|NCT00311311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92971948|NCT00311311|Antitubercular Agents|antitubercular agents|mesh-ancestor
92971949|NCT00311311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92971950|NCT00311311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92971951|NCT00311311|Antifungal Agents|antifungal agents|mesh-ancestor
92971952|NCT04089605|Dexamethasone|dexamethasone|mesh-list
92971953|NCT04089605|Dexamethasone acetate|dexamethasone acetate|mesh-list
92971954|NCT04089605|Ranibizumab|ranibizumab|mesh-list
92971955|NCT04089605|BB 1101|bb 1101|mesh-list
92971956|NCT04089605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92971957|NCT04089605|Antiemetics|antiemetics|mesh-ancestor
92971958|NCT04089605|Autonomic Agents|autonomic agents|mesh-ancestor
92971959|NCT04089605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92971960|NCT04089605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971961|NCT04089605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92971962|NCT04089605|Glucocorticoids|glucocorticoids|mesh-ancestor
92971963|NCT04089605|Hormones|hormones|mesh-ancestor
92971964|NCT04089605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92971965|NCT04089605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92971966|NCT04089605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971967|NCT04089605|Protease Inhibitors|protease inhibitors|mesh-ancestor
92971968|NCT04089605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92971969|NCT04089605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272567|NCT01951391|Triclocarban|triclocarban|mesh-list
92971970|NCT04089605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92971971|NCT04089605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92971972|NCT04089605|Growth Substances|growth substances|mesh-ancestor
92971973|NCT04089605|Growth Inhibitors|growth inhibitors|mesh-ancestor
92971974|NCT00521404|Gemcitabine|gemcitabine|mesh-list
92971975|NCT00521404|Antibodies|antibodies|mesh-list
92971976|NCT00521404|Immunologic Factors|immunologic factors|mesh-ancestor
92971977|NCT00521404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971978|NCT00521404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92971979|NCT00521404|Antimetabolites|antimetabolites|mesh-ancestor
92971980|NCT00521404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971981|NCT00521404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92971982|NCT00311155|Amlodipine|amlodipine|mesh-list
92971983|NCT00311155|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92971984|NCT00311155|Olmesartan|olmesartan|mesh-list
92971985|NCT00311155|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92971986|NCT00311155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92971987|NCT00311155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92971988|NCT00311155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92971989|NCT00311155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92971990|NCT00311155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92971991|NCT00311155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92971992|NCT00311155|Vasodilator Agents|vasodilator agents|mesh-ancestor
92971993|NCT00311155|Diuretics|diuretics|mesh-ancestor
92971994|NCT00311155|Natriuretic Agents|natriuretic agents|mesh-ancestor
92971995|NCT00311155|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92971996|NCT00311155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92971997|NCT00311155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92971998|NCT03981601|Lovastatin|lovastatin|mesh-list
92971999|NCT03981601|L 647318|l 647318|mesh-list
92972000|NCT03981601|Dihydromevinolin|dihydromevinolin|mesh-list
92972001|NCT03981601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92972002|NCT03981601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92972003|NCT03981601|Antimetabolites|antimetabolites|mesh-ancestor
92972004|NCT03981601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972005|NCT03981601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92972006|NCT03981601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92972007|NCT03981601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972008|NCT00274651|Belinostat|belinostat|mesh-list
92972009|NCT00274651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972010|NCT00274651|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92972011|NCT00274651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972012|NCT00274651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972013|NCT00274261|Nonoxynol|nonoxynol|mesh-list
92972014|NCT00274261|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92972015|NCT00274261|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92972016|NCT00274261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972017|NCT00274261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92972018|NCT00274261|Contraceptive Agents|contraceptive agents|mesh-ancestor
92972019|NCT00274261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92972020|NCT00274261|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92972021|NCT00827814|Dutasteride|dutasteride|mesh-list
92972022|NCT00827814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92972023|NCT00827814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92972024|NCT00827814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972025|NCT00827814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972026|NCT00827814|Hormone Antagonists|hormone antagonists|mesh-ancestor
92972027|NCT00827814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972028|NCT00827814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972029|NCT01068847|Cycloserine|cycloserine|mesh-list
92972030|NCT01068847|Verapamil|verapamil|mesh-list
92972031|NCT01068847|Nifedipine|nifedipine|mesh-list
92972032|NCT01068847|Tizanidine|tizanidine|mesh-list
92972033|NCT01068847|Naloxone|naloxone|mesh-list
92972034|NCT01068847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92972035|NCT01068847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972036|NCT01068847|Sensory System Agents|sensory system agents|mesh-ancestor
92972037|NCT01068847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972038|NCT01068847|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92972039|NCT01068847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972040|NCT01068847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972041|NCT01068847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92972042|NCT01068847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92972043|NCT01068847|Tocolytic Agents|tocolytic agents|mesh-ancestor
92972044|NCT01068847|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92972045|NCT01068847|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92972046|NCT01068847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972047|NCT01068847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92972048|NCT01068847|Antitubercular Agents|antitubercular agents|mesh-ancestor
92972049|NCT01068847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92972050|NCT01068847|Antimetabolites|antimetabolites|mesh-ancestor
92972051|NCT01068847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92972052|NCT01068847|Analgesics|analgesics|mesh-ancestor
92972053|NCT01068847|Anticonvulsants|anticonvulsants|mesh-ancestor
92972054|NCT01068847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92972055|NCT01068847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92972056|NCT01068847|Parasympatholytics|parasympatholytics|mesh-ancestor
92972057|NCT01068847|Autonomic Agents|autonomic agents|mesh-ancestor
92972058|NCT01068847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92972059|NCT01068847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92972060|NCT01068847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92972061|NCT01068847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92972062|NCT01068847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972063|NCT00827892|Pioglitazone|pioglitazone|mesh-list
92972064|NCT00827892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972065|NCT00827892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972066|NCT01070875|Heparin|heparin|mesh-list
92972067|NCT01070875|Calcium heparin|calcium heparin|mesh-list
92972068|NCT01070875|Anticoagulants|anticoagulants|mesh-ancestor
92972069|NCT01070875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92972070|NCT01070875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92972071|NCT01070875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972072|NCT04043676|Ponatinib|ponatinib|mesh-list
92972073|NCT04043676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972074|NCT04043676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972075|NCT04043676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972076|NCT04043676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972077|NCT01325935|Clopidogrel|clopidogrel|mesh-list
92972078|NCT01325935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92972079|NCT01325935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92972080|NCT01325935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92972081|NCT01325935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92972082|NCT01325935|Purinergic Agents|purinergic agents|mesh-ancestor
92972083|NCT01325935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972084|NCT01325935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972085|NCT01325935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972086|NCT02549742|Bleomycin|bleomycin|mesh-list
92972087|NCT02549742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92972088|NCT02549742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972089|NCT00521014|Cytarabine|cytarabine|mesh-list
92972090|NCT00521014|Rituximab|rituximab|mesh-list
92972091|NCT00521014|Etoposide|etoposide|mesh-list
92972092|NCT00521014|Melphalan|melphalan|mesh-list
92972093|NCT00521014|Carmustine|carmustine|mesh-list
92972094|NCT00521014|Sargramostim|sargramostim|mesh-list
92972095|NCT00521014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972096|NCT00521014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972097|NCT00521014|Immunologic Factors|immunologic factors|mesh-ancestor
92972098|NCT00521014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972099|NCT00521014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972100|NCT00521014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92972101|NCT00521014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92972102|NCT00521014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92972103|NCT00521014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972104|NCT00521014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972105|NCT00521014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972106|NCT00521014|Antimetabolites|antimetabolites|mesh-ancestor
92972107|NCT00521014|Antiviral Agents|antiviral agents|mesh-ancestor
92972108|NCT00521014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972109|NCT00521014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972110|NCT00521014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92972111|NCT00521014|Alkylating Agents|alkylating agents|mesh-ancestor
92972112|NCT00521014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92972113|NCT00825552|Risperidone|risperidone|mesh-list
92972114|NCT00825552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92972115|NCT00825552|Serotonin Agents|serotonin agents|mesh-ancestor
92972116|NCT00825552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972117|NCT00825552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972118|NCT00825552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972119|NCT00825552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92972120|NCT00825552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972121|NCT00825552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972122|NCT00825552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972123|NCT00825552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92972124|NCT00825552|Dopamine Agents|dopamine agents|mesh-ancestor
92972126|NCT00291577|Sunitinib|sunitinib|mesh-list
92972127|NCT00291577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972128|NCT00291577|Tubulin Modulators|tubulin modulators|mesh-ancestor
92972129|NCT00291577|Antimitotic Agents|antimitotic agents|mesh-ancestor
92972130|NCT00291577|Mitosis Modulators|mitosis modulators|mesh-ancestor
92972131|NCT00291577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972132|NCT00291577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92972133|NCT00291577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92972134|NCT00291577|Growth Substances|growth substances|mesh-ancestor
92972135|NCT00291577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972136|NCT00291577|Growth Inhibitors|growth inhibitors|mesh-ancestor
92972137|NCT00291577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972138|NCT00291577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972139|NCT00520936|Pemetrexed|pemetrexed|mesh-list
92972140|NCT00520936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972141|NCT00520936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972142|NCT00520936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972143|NCT00520936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92972144|NCT00520936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92972145|NCT02549430|Letrozole|letrozole|mesh-list
92972146|NCT02549430|Fulvestrant|fulvestrant|mesh-list
92972147|NCT02549430|Palbociclib|palbociclib|mesh-list
92972148|NCT02549430|Anastrozole|anastrozole|mesh-list
92972149|NCT02549430|Exemestane|exemestane|mesh-list
92972150|NCT02549430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972151|NCT02549430|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92972152|NCT02549430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92972153|NCT02549430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972154|NCT02549430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972155|NCT02549430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92972156|NCT02549430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92972157|NCT02549430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972158|NCT02549430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972159|NCT02549430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92972160|NCT02549430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92972161|NCT02549430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972162|NCT00943839|Sunitinib|sunitinib|mesh-list
92972163|NCT00943839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972164|NCT00943839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92972165|NCT00943839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92972166|NCT00943839|Growth Substances|growth substances|mesh-ancestor
92972167|NCT00943839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972168|NCT00943839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92972169|NCT00943839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972170|NCT00943839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972171|NCT00943839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972172|NCT00832182|Insulin|insulin|mesh-list
92972173|NCT00832182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92972174|NCT00832182|Insulin Aspart|insulin aspart|mesh-list
92972175|NCT00832182|Isophane Insulin, Human|isophane insulin, human|mesh-list
92972176|NCT00832182|Insulin, Isophane|insulin, isophane|mesh-list
92972177|NCT00832182|Isophane insulin, beef|isophane insulin, beef|mesh-list
92972178|NCT00832182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972179|NCT00832182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972180|NCT00952497|Capecitabine|capecitabine|mesh-list
92972181|NCT00952497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972182|NCT00952497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972183|NCT00952497|Antimetabolites|antimetabolites|mesh-ancestor
92972184|NCT00952497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972185|NCT00828282|Simvastatin|simvastatin|mesh-list
92972186|NCT00828282|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92972187|NCT00828282|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92972188|NCT00828282|Antimetabolites|antimetabolites|mesh-ancestor
92972189|NCT00828282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972190|NCT00828282|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92972191|NCT00828282|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92972192|NCT00828282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972193|NCT00952575|Immunoglobulins|immunoglobulins|mesh-list
92972194|NCT00952575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92972195|NCT00952575|Antibodies|antibodies|mesh-list
92972196|NCT00952575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92972197|NCT00952575|gamma-Globulins|gamma-globulins|mesh-list
92972198|NCT00952575|Immunologic Factors|immunologic factors|mesh-ancestor
92972199|NCT00952575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972200|NCT03865732|Pregnanolone|pregnanolone|mesh-list
92972201|NCT03865732|Ganaxolone|ganaxolone|mesh-list
92972202|NCT03865732|Neurosteroids|neurosteroids|mesh-ancestor
92972203|NCT03865732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972204|NCT03865732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972205|NCT03865732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972206|NCT03865732|GABA Modulators|gaba modulators|mesh-ancestor
92972207|NCT03865732|GABA Agents|gaba agents|mesh-ancestor
92972208|NCT03865732|Anesthetics|anesthetics|mesh-ancestor
92972209|NCT03865732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972210|NCT00944307|Raltegravir Potassium|raltegravir potassium|mesh-list
92972211|NCT00944307|Antacids|antacids|mesh-list
92972212|NCT00944307|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
92972213|NCT00944307|TEMPO|tempo|mesh-list
92972214|NCT00944307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92972215|NCT00944307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92972216|NCT00944307|Antiviral Agents|antiviral agents|mesh-ancestor
92972217|NCT00944307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972218|NCT00944307|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92972219|NCT00944307|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92972220|NCT00944307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972221|NCT00944307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972222|NCT00944307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972223|NCT00944307|Antioxidants|antioxidants|mesh-ancestor
92972224|NCT00944307|Protective Agents|protective agents|mesh-ancestor
92972225|NCT00944307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972226|NCT00944385|Urinastatin|urinastatin|mesh-list
92972227|NCT00944385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92972228|NCT00944385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92972229|NCT00944385|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972230|NCT00944385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972231|NCT00944385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972232|NCT00953355|Metformin|metformin|mesh-list
92972233|NCT00953355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972234|NCT00953355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972235|NCT00944463|Gemcitabine|gemcitabine|mesh-list
92972236|NCT00944463|Simvastatin|simvastatin|mesh-list
92972237|NCT00944463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972238|NCT00944463|Antimetabolites|antimetabolites|mesh-ancestor
92972239|NCT00944463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972240|NCT00944463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972241|NCT00944463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92972242|NCT00944463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92972243|NCT00944463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92972244|NCT00944463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92972245|NCT00944463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972246|NCT00956397|Rifaximin|rifaximin|mesh-list
92972247|NCT00956397|Lactulose|lactulose|mesh-list
92972248|NCT00956397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92972249|NCT00956397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972250|NCT00956397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972251|NCT05300373|Adenosine|adenosine|mesh-list
92972252|NCT05300373|Analgesics|analgesics|mesh-ancestor
92972253|NCT05300373|Sensory System Agents|sensory system agents|mesh-ancestor
92972254|NCT05300373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972255|NCT05300373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972256|NCT05300373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92972257|NCT05300373|Vasodilator Agents|vasodilator agents|mesh-ancestor
92972258|NCT05300373|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92972259|NCT05300373|Purinergic Agonists|purinergic agonists|mesh-ancestor
92972260|NCT05300373|Purinergic Agents|purinergic agents|mesh-ancestor
92972261|NCT05300373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972262|NCT05300373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972263|NCT00953589|Ribavirin|ribavirin|mesh-list
92972264|NCT00953589|Antimetabolites|antimetabolites|mesh-ancestor
92972265|NCT00953589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972266|NCT00953589|Antiviral Agents|antiviral agents|mesh-ancestor
92972267|NCT00953589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972268|NCT00947739|Camptothecin|camptothecin|mesh-list
92972269|NCT00947739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92972270|NCT00947739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972271|NCT00947739|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92972272|NCT00947739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92972273|NCT00947739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972274|NCT00947739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972275|NCT00956787|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
92972276|NCT00956787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92972277|NCT00956787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972278|NCT00947895|Methylprednisolone|methylprednisolone|mesh-list
92972279|NCT00947895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92972280|NCT00947895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92972281|NCT00947895|Prednisolone|prednisolone|mesh-list
92972282|NCT00947895|Prednisolone acetate|prednisolone acetate|mesh-list
92972283|NCT00947895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92972284|NCT00947895|Prednisolone phosphate|prednisolone phosphate|mesh-list
92972285|NCT00947895|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92972286|NCT00947895|Hormones|hormones|mesh-ancestor
92972287|NCT00947895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972288|NCT00947895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972289|NCT00947895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972290|NCT00947895|Antiemetics|antiemetics|mesh-ancestor
92617693|NCT02940379|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92972291|NCT00947895|Autonomic Agents|autonomic agents|mesh-ancestor
92972292|NCT00947895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972293|NCT00947895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972294|NCT00947895|Glucocorticoids|glucocorticoids|mesh-ancestor
92972295|NCT00947895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92972296|NCT00947895|Protective Agents|protective agents|mesh-ancestor
92972297|NCT00947895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92972298|NCT00947895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972299|NCT00623766|Dexamethasone|dexamethasone|mesh-list
92972300|NCT00623766|Prednisone|prednisone|mesh-list
92972301|NCT00623766|Methylprednisolone|methylprednisolone|mesh-list
92972302|NCT00623766|Prednisolone|prednisolone|mesh-list
92972303|NCT00623766|Triamcinolone|triamcinolone|mesh-list
92972304|NCT00623766|Hydrocortisone|hydrocortisone|mesh-list
92972305|NCT00623766|Betamethasone|betamethasone|mesh-list
92972306|NCT00623766|Fludrocortisone|fludrocortisone|mesh-list
92972307|NCT00623766|Ipilimumab|ipilimumab|mesh-list
92972308|NCT00623766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972309|NCT00623766|Antiemetics|antiemetics|mesh-ancestor
92972310|NCT00623766|Autonomic Agents|autonomic agents|mesh-ancestor
92972311|NCT00623766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972312|NCT00623766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972313|NCT00623766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972314|NCT00623766|Glucocorticoids|glucocorticoids|mesh-ancestor
92972315|NCT00623766|Hormones|hormones|mesh-ancestor
92972316|NCT00623766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972317|NCT00623766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92972318|NCT00623766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972319|NCT00623766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972320|NCT00623766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92972321|NCT00623766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972322|NCT00623766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92972323|NCT00623766|Protective Agents|protective agents|mesh-ancestor
92972324|NCT00623766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92972325|NCT00623766|Respiratory System Agents|respiratory system agents|mesh-ancestor
92972326|NCT00832494|Paclitaxel|paclitaxel|mesh-list
92972327|NCT00832494|Carboplatin|carboplatin|mesh-list
92972328|NCT00832494|Vadimezan|vadimezan|mesh-list
92972329|NCT00832494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92972330|NCT00832494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972331|NCT00832494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92972332|NCT00832494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92972333|NCT00832494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92972334|NCT00832494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972335|NCT00837564|Escitalopram|escitalopram|mesh-list
92972336|NCT00837564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92972337|NCT00837564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92972338|NCT00837564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972339|NCT00837564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972340|NCT00837564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972341|NCT00837564|Serotonin Agents|serotonin agents|mesh-ancestor
92972342|NCT00837564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972343|NCT00954135|Cyclophosphamide|cyclophosphamide|mesh-list
92972344|NCT00954135|Sorafenib|sorafenib|mesh-list
92972345|NCT00954135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972346|NCT00954135|Immunologic Factors|immunologic factors|mesh-ancestor
92972347|NCT00954135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972348|NCT00954135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972349|NCT00954135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92972350|NCT00954135|Alkylating Agents|alkylating agents|mesh-ancestor
92972351|NCT00954135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972352|NCT00954135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972353|NCT00954135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92972354|NCT00954135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972355|NCT00954135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972356|NCT00832806|Varenicline|varenicline|mesh-list
92972357|NCT00832806|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92972358|NCT00832806|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92972359|NCT00832806|Cholinergic Agents|cholinergic agents|mesh-ancestor
92972360|NCT00832806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972361|NCT00832806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972362|NCT00832806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972363|NCT00832884|Lacosamide|lacosamide|mesh-list
92972364|NCT00832884|Anticonvulsants|anticonvulsants|mesh-ancestor
92972365|NCT00832884|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92972366|NCT00832884|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92972367|NCT00832884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972368|NCT00832884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972369|NCT02549118|Tenoxicam|tenoxicam|mesh-list
92972370|NCT02549118|Meperidine|meperidine|mesh-list
92972371|NCT02549118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92972372|NCT02549118|Narcotics|narcotics|mesh-ancestor
92972373|NCT02549118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972374|NCT02549118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972375|NCT02549118|Analgesics|analgesics|mesh-ancestor
92972376|NCT02549118|Sensory System Agents|sensory system agents|mesh-ancestor
92972377|NCT02549118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972378|NCT02549118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92972379|NCT02549118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92972380|NCT02549118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92972381|NCT02549118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972382|NCT02549118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972383|NCT02549118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92972384|NCT02549118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972385|NCT02549118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972386|NCT00957177|Pregabalin|pregabalin|mesh-list
92972387|NCT00957177|Analgesics|analgesics|mesh-ancestor
92972388|NCT00957177|Sensory System Agents|sensory system agents|mesh-ancestor
92972389|NCT00957177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972390|NCT00957177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972391|NCT00957177|Anticonvulsants|anticonvulsants|mesh-ancestor
92972392|NCT00957177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92972393|NCT00957177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972394|NCT00957177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972395|NCT00957177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92972396|NCT00957177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92972397|NCT00957177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972398|NCT00957177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972399|NCT00957177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972400|NCT04337580|Omeprazole|omeprazole|mesh-list
92972401|NCT04337580|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92972402|NCT04337580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972403|NCT04337580|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92972404|NCT04337580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972405|NCT04337580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972406|NCT00828594|Sorafenib|sorafenib|mesh-list
92972407|NCT00828594|Everolimus|everolimus|mesh-list
92972408|NCT00828594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972409|NCT00828594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972410|NCT00828594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972411|NCT00828594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972412|NCT00828594|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92972413|NCT00828594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972414|NCT00828594|Immunologic Factors|immunologic factors|mesh-ancestor
92972415|NCT00828594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972416|NCT00550407|Lamotrigine|lamotrigine|mesh-list
92972417|NCT00550407|Anticonvulsants|anticonvulsants|mesh-ancestor
92972418|NCT00550407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92972419|NCT00550407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972420|NCT00550407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972421|NCT00550407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92972422|NCT00550407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972423|NCT00550407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92972424|NCT00550407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972425|NCT00550407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972426|NCT00550407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972427|NCT00550407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92972428|NCT00957411|Cetuximab|cetuximab|mesh-list
92972429|NCT00957411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972430|NCT00957411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972431|NCT00837954|Cellulose, Oxidized|cellulose, oxidized|mesh-list
92972432|NCT00837954|Hemostatics|hemostatics|mesh-ancestor
92972433|NCT00837954|Coagulants|coagulants|mesh-ancestor
92972434|NCT00954525|Gemcitabine|gemcitabine|mesh-list
92972435|NCT00954525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92972436|NCT00954525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972437|NCT00954525|Antimetabolites|antimetabolites|mesh-ancestor
92972438|NCT00954525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972439|NCT00954525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972440|NCT00954525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972441|NCT00954525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972442|NCT00838032|Haloperidol|haloperidol|mesh-list
92972443|NCT00838032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92972444|NCT00838032|Haloperidol decanoate|haloperidol decanoate|mesh-list
92972445|NCT00838032|Antidepressive Agents|antidepressive agents|mesh-ancestor
92972446|NCT00838032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972447|NCT00838032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92972448|NCT00838032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972449|NCT00838032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972450|NCT00838032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972451|NCT00838032|Antiemetics|antiemetics|mesh-ancestor
92972452|NCT00838032|Autonomic Agents|autonomic agents|mesh-ancestor
92972453|NCT00838032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972454|NCT00838032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972455|NCT00838032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92972456|NCT00838032|Dopamine Agents|dopamine agents|mesh-ancestor
92972457|NCT00838032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972458|NCT00838032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972459|NCT00838032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92972460|NCT00954603|Haloperidol|haloperidol|mesh-list
92972461|NCT00954603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92972462|NCT00954603|Haloperidol decanoate|haloperidol decanoate|mesh-list
92972463|NCT00954603|Antidepressive Agents|antidepressive agents|mesh-ancestor
92972464|NCT00954603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972465|NCT00954603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92972466|NCT00954603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972467|NCT00954603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972468|NCT00954603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972469|NCT00954603|Antiemetics|antiemetics|mesh-ancestor
92972470|NCT00954603|Autonomic Agents|autonomic agents|mesh-ancestor
92972471|NCT00954603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972472|NCT00954603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972473|NCT00954603|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92972474|NCT00954603|Dopamine Agents|dopamine agents|mesh-ancestor
92972475|NCT00954603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972476|NCT00954603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972477|NCT00954603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92972478|NCT00531934|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92972479|NCT00531934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972480|NCT00531934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972481|NCT00531934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972482|NCT00531934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972483|NCT02548806|Clonidine|clonidine|mesh-list
92972484|NCT02548806|Analgesics|analgesics|mesh-ancestor
92972485|NCT02548806|Sensory System Agents|sensory system agents|mesh-ancestor
92972486|NCT02548806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972487|NCT02548806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972488|NCT02548806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92972489|NCT02548806|Sympatholytics|sympatholytics|mesh-ancestor
92972490|NCT02548806|Autonomic Agents|autonomic agents|mesh-ancestor
92972491|NCT02548806|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92972492|NCT02548806|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92972493|NCT02548806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92972494|NCT02548806|Adrenergic Agents|adrenergic agents|mesh-ancestor
92972495|NCT02548806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972496|NCT02548806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972497|NCT00549939|Alfuzosin|alfuzosin|mesh-list
92972498|NCT00549939|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92972499|NCT00549939|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92972500|NCT00549939|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92972501|NCT00549939|Adrenergic Agents|adrenergic agents|mesh-ancestor
92972502|NCT00549939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972503|NCT00549939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972504|NCT00549939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972505|NCT00549939|Urological Agents|urological agents|mesh-ancestor
92972506|NCT00272779|Emtricitabine|emtricitabine|mesh-list
92972507|NCT00272779|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92972508|NCT00272779|Antiviral Agents|antiviral agents|mesh-ancestor
92972509|NCT00272779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972510|NCT00272779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92972511|NCT00272779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92972512|NCT00272779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972513|NCT00272779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972514|NCT00272779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92972515|NCT00272779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92972516|NCT00272779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92972517|NCT00272779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92972518|NCT00272779|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972519|NCT00957879|Calcitriol|calcitriol|mesh-list
92972520|NCT00957879|Ergocalciferols|ergocalciferols|mesh-list
92972521|NCT00957879|Vitamin D|vitamin d|mesh-list
92972522|NCT00957879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92972523|NCT00957879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972524|NCT00957879|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92972525|NCT00957879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972526|NCT00957879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972527|NCT00957879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92972528|NCT00957879|Vitamins|vitamins|mesh-ancestor
92972529|NCT00957879|Micronutrients|micronutrients|mesh-ancestor
92972530|NCT00957879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92972531|NCT00838266|Grape Seed Extract|grape seed extract|mesh-list
92972532|NCT00838266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92972533|NCT00838266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972534|NCT00838266|Antioxidants|antioxidants|mesh-ancestor
92972535|NCT00838266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972536|NCT00838266|Protective Agents|protective agents|mesh-ancestor
92972537|NCT00838266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972538|NCT04011033|Cyclophosphamide|cyclophosphamide|mesh-list
92972539|NCT04011033|Interleukin-2|interleukin-2|mesh-list
92972540|NCT04011033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972541|NCT04011033|Immunologic Factors|immunologic factors|mesh-ancestor
92972542|NCT04011033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972543|NCT04011033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972544|NCT04011033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92972545|NCT04011033|Alkylating Agents|alkylating agents|mesh-ancestor
92972546|NCT04011033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972547|NCT04011033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972548|NCT04011033|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92972549|NCT04011033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92972551|NCT04011033|Sensory System Agents|sensory system agents|mesh-ancestor
92972552|NCT04011033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972553|NCT00998608|Risperidone|risperidone|mesh-list
92972554|NCT00998608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92972555|NCT00998608|Serotonin Agents|serotonin agents|mesh-ancestor
92972556|NCT00998608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972557|NCT00998608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972558|NCT00998608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972559|NCT00998608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92972560|NCT00998608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972561|NCT00998608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972562|NCT00998608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972563|NCT00998608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92972564|NCT00998608|Dopamine Agents|dopamine agents|mesh-ancestor
92972565|NCT04011813|Antioxidants|antioxidants|mesh-list
92972566|NCT04011813|Hypotaurine|hypotaurine|mesh-list
92972567|NCT04011813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972568|NCT04011813|Protective Agents|protective agents|mesh-ancestor
92972569|NCT04011813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972570|NCT00998686|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92972571|NCT00998686|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972572|NCT00998686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972573|NCT00998686|Incretins|incretins|mesh-ancestor
92972574|NCT00998686|Hormones|hormones|mesh-ancestor
92972575|NCT00998686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972576|NCT00998686|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92972577|NCT00998686|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972578|NCT00998686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972579|NCT00998686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972580|NCT00958269|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92972581|NCT00958269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972582|NCT00958269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972583|NCT00958269|Incretins|incretins|mesh-ancestor
92972584|NCT00958269|Hormones|hormones|mesh-ancestor
92972585|NCT00958269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972586|NCT00958269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92972587|NCT00958269|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972588|NCT00958269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617988|NCT02938975|Permethrin|permethrin|mesh-list
92972589|NCT00958269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972591|NCT02547402|Simvastatin|simvastatin|mesh-list
92972592|NCT02547402|Ezetimibe|ezetimibe|mesh-list
92972593|NCT02547402|Pravastatin|pravastatin|mesh-list
92972594|NCT02547402|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92972595|NCT02547402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92972596|NCT02547402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92972597|NCT02547402|Antimetabolites|antimetabolites|mesh-ancestor
92972598|NCT02547402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972599|NCT02547402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92972600|NCT02547402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92972601|NCT02547402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972602|NCT02547402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972603|NCT01068925|Dolutegravir|dolutegravir|mesh-list
92972604|NCT01068925|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92972605|NCT01068925|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92972606|NCT01068925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972607|NCT01068925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972608|NCT01068925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92972609|NCT01068925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92972610|NCT01068925|Antiviral Agents|antiviral agents|mesh-ancestor
92972611|NCT01068925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972612|NCT00834600|Amlodipine|amlodipine|mesh-list
92972613|NCT00834600|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92972614|NCT00834600|Olmesartan|olmesartan|mesh-list
92972615|NCT00834600|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92972616|NCT00834600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92972617|NCT00834600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92972618|NCT00834600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92972619|NCT00834600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972620|NCT00834600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92972621|NCT00834600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972622|NCT00834600|Vasodilator Agents|vasodilator agents|mesh-ancestor
92972623|NCT00834600|Diuretics|diuretics|mesh-ancestor
92972624|NCT00834600|Natriuretic Agents|natriuretic agents|mesh-ancestor
92972625|NCT00834600|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92972626|NCT00834600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92972627|NCT00834600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92972628|NCT00958425|Hyaluronic Acid|hyaluronic acid|mesh-list
92972629|NCT00958425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92972630|NCT00958425|Immunologic Factors|immunologic factors|mesh-ancestor
92972631|NCT00958425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972632|NCT00958425|Viscosupplements|viscosupplements|mesh-ancestor
92972633|NCT00958425|Protective Agents|protective agents|mesh-ancestor
92972634|NCT02547480|Irinotecan|irinotecan|mesh-list
92972635|NCT02547480|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92972636|NCT02547480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92972637|NCT02547480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972638|NCT02547480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972639|NCT02547480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972640|NCT00838656|Paclitaxel|paclitaxel|mesh-list
92972641|NCT00838656|Carboplatin|carboplatin|mesh-list
92972642|NCT00838656|Gemcitabine|gemcitabine|mesh-list
92972643|NCT00838656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92972644|NCT00838656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972645|NCT00838656|Tubulin Modulators|tubulin modulators|mesh-ancestor
92972646|NCT00838656|Antimitotic Agents|antimitotic agents|mesh-ancestor
92972647|NCT00838656|Mitosis Modulators|mitosis modulators|mesh-ancestor
92972648|NCT00838656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972649|NCT00838656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972650|NCT00838656|Antimetabolites|antimetabolites|mesh-ancestor
92972651|NCT00829608|Vaccines|vaccines|mesh-list
92972652|NCT00829608|Immunologic Factors|immunologic factors|mesh-ancestor
92972653|NCT00829608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972654|NCT00553605|Ketoprofen|ketoprofen|mesh-list
92972655|NCT00553605|Parecoxib|parecoxib|mesh-list
92972656|NCT00553605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92972657|NCT00553605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92972658|NCT00553605|Analgesics|analgesics|mesh-ancestor
92972659|NCT00553605|Sensory System Agents|sensory system agents|mesh-ancestor
92972660|NCT00553605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972661|NCT00553605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972662|NCT00553605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972663|NCT00553605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972664|NCT00553605|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92972665|NCT00553605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972666|NCT00553605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972667|NCT00553605|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92972668|NCT00838968|Interferons|interferons|mesh-list
92972669|NCT00838968|Interferon-alpha|interferon-alpha|mesh-list
92972670|NCT00838968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972671|NCT00838968|Antiviral Agents|antiviral agents|mesh-ancestor
92972672|NCT00838968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972673|NCT00838968|Immunologic Factors|immunologic factors|mesh-ancestor
93026491|NCT00401973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972674|NCT00838968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972675|NCT04010955|Edoxaban|edoxaban|mesh-list
92972676|NCT04010955|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92972677|NCT04010955|Antithrombins|antithrombins|mesh-ancestor
92972678|NCT04010955|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92972679|NCT04010955|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972680|NCT04010955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972681|NCT04010955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972682|NCT04010955|Anticoagulants|anticoagulants|mesh-ancestor
92972683|NCT00948987|Aspirin|aspirin|mesh-list
92972684|NCT00948987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92972685|NCT00948987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92972686|NCT00948987|Analgesics|analgesics|mesh-ancestor
92972687|NCT00948987|Sensory System Agents|sensory system agents|mesh-ancestor
92972688|NCT00948987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972689|NCT00948987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972690|NCT00948987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972691|NCT00948987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972692|NCT00948987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92972693|NCT00948987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92972694|NCT00948987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972695|NCT00948987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92972696|NCT00948987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92972697|NCT00948987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972698|NCT00948987|Antipyretics|antipyretics|mesh-ancestor
92972699|NCT00744497|Prednisone|prednisone|mesh-list
92972700|NCT00744497|Docetaxel|docetaxel|mesh-list
92972701|NCT00744497|Dasatinib|dasatinib|mesh-list
92972702|NCT00744497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972703|NCT00744497|Tubulin Modulators|tubulin modulators|mesh-ancestor
92972704|NCT00744497|Antimitotic Agents|antimitotic agents|mesh-ancestor
92972705|NCT00744497|Mitosis Modulators|mitosis modulators|mesh-ancestor
92972706|NCT00744497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972707|NCT00744497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972708|NCT00744497|Glucocorticoids|glucocorticoids|mesh-ancestor
92972709|NCT00744497|Hormones|hormones|mesh-ancestor
92972710|NCT00744497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972711|NCT00744497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972712|NCT00744497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92972713|NCT00744497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972714|NCT00744497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972715|NCT00949065|Immunoglobulins|immunoglobulins|mesh-list
92972716|NCT00949065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92972717|NCT00949065|Antibodies|antibodies|mesh-list
92972718|NCT00949065|gamma-Globulins|gamma-globulins|mesh-list
92972719|NCT00949065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92972720|NCT00949065|Immunologic Factors|immunologic factors|mesh-ancestor
92972721|NCT00949065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972722|NCT00955149|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92972723|NCT00955149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972724|NCT00955149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972725|NCT00955149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972726|NCT00955149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972727|NCT05351385|Dimercaprol|dimercaprol|mesh-list
92972728|NCT05351385|Chelating Agents|chelating agents|mesh-ancestor
92972729|NCT05351385|Sequestering Agents|sequestering agents|mesh-ancestor
92972730|NCT05351385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972731|NCT00955227|Ezetimibe|ezetimibe|mesh-list
92972732|NCT00955227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92972733|NCT00955227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92972734|NCT00955227|Antimetabolites|antimetabolites|mesh-ancestor
92972735|NCT00955227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972736|NCT00955227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92972737|NCT00949299|Buprenorphine|buprenorphine|mesh-list
92972738|NCT00949299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92972739|NCT00949299|Narcotics|narcotics|mesh-ancestor
92972740|NCT00949299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972741|NCT00949299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972742|NCT00949299|Analgesics|analgesics|mesh-ancestor
92972743|NCT00949299|Sensory System Agents|sensory system agents|mesh-ancestor
92972744|NCT00949299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972745|NCT00949299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92972746|NCT00747149|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92972747|NCT00747149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92972748|NCT00747149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92972749|NCT00747149|Antimetabolites|antimetabolites|mesh-ancestor
92972750|NCT00747149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972751|NCT00747149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92972752|NCT00747149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92972753|NCT00747149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972754|NCT00271609|Bevacizumab|bevacizumab|mesh-list
92972755|NCT00271609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972756|NCT00271609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972757|NCT00271609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92972758|NCT00271609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92972759|NCT00271609|Growth Substances|growth substances|mesh-ancestor
92972760|NCT00271609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972761|NCT00271609|Growth Inhibitors|growth inhibitors|mesh-ancestor
92972762|NCT00548847|Interferons|interferons|mesh-list
92972763|NCT00548847|Interferon-alpha|interferon-alpha|mesh-list
92972764|NCT00548847|Interferon alpha-2|interferon alpha-2|mesh-list
92972765|NCT00548847|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92972766|NCT00548847|Molgramostim|molgramostim|mesh-list
92972767|NCT00548847|Sargramostim|sargramostim|mesh-list
92972768|NCT00548847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972769|NCT00548847|Antiviral Agents|antiviral agents|mesh-ancestor
92972770|NCT00548847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972771|NCT00548847|Immunologic Factors|immunologic factors|mesh-ancestor
92972772|NCT00548847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972774|NCT00949377|Methylnaltrexone|methylnaltrexone|mesh-list
92972775|NCT00949377|Anticonvulsants|anticonvulsants|mesh-ancestor
92972776|NCT00949377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92972777|NCT00949377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972778|NCT00949377|Sensory System Agents|sensory system agents|mesh-ancestor
92972779|NCT00949377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972780|NCT00290407|Rituximab|rituximab|mesh-list
92972781|NCT00290407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972782|NCT00290407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972783|NCT00290407|Immunologic Factors|immunologic factors|mesh-ancestor
92972784|NCT00290407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972785|NCT00290407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972786|NCT02597387|Mitoxantrone|mitoxantrone|mesh-list
92972787|NCT02597387|Analgesics|analgesics|mesh-ancestor
92972788|NCT02597387|Sensory System Agents|sensory system agents|mesh-ancestor
92972789|NCT02597387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972790|NCT02597387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972791|NCT02597387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972792|NCT02597387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92972793|NCT02597387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92972794|NCT02597387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972795|NCT02597387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972796|NCT01069081|Cisplatin|cisplatin|mesh-list
92972797|NCT01069081|Docetaxel|docetaxel|mesh-list
92972798|NCT01069081|Esomeprazole|esomeprazole|mesh-list
92972799|NCT01069081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972800|NCT01069081|Tubulin Modulators|tubulin modulators|mesh-ancestor
92972801|NCT01069081|Antimitotic Agents|antimitotic agents|mesh-ancestor
92972802|NCT01069081|Mitosis Modulators|mitosis modulators|mesh-ancestor
92972803|NCT01069081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972804|NCT01069081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92972805|NCT01069081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92972806|NCT01069081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92972807|NCT01069081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972808|NCT00949455|Lapatinib|lapatinib|mesh-list
92972809|NCT00949455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972810|NCT00949455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972811|NCT00949455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972812|NCT00949455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972813|NCT05296161|Ocrelizumab|ocrelizumab|mesh-list
92972814|NCT05296161|Immunologic Factors|immunologic factors|mesh-ancestor
92972815|NCT05296161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972816|NCT00955695|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92972818|NCT00955695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972819|NCT00955695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972820|NCT00955695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972821|NCT00955695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972822|NCT00955773|Everolimus|everolimus|mesh-list
92972823|NCT00955773|Trametinib|trametinib|mesh-list
92972824|NCT00955773|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92972825|NCT00955773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92972826|NCT00955773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972827|NCT00955773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972828|NCT00955773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972829|NCT00955773|Immunologic Factors|immunologic factors|mesh-ancestor
92972830|NCT00955773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972831|NCT00955773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972832|NCT00549549|Celecoxib|celecoxib|mesh-list
92972833|NCT00549549|Indomethacin|indomethacin|mesh-list
92972834|NCT00549549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92972835|NCT00549549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92972836|NCT00549549|Analgesics|analgesics|mesh-ancestor
92972837|NCT00549549|Sensory System Agents|sensory system agents|mesh-ancestor
92972838|NCT00549549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92972839|NCT00549549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972840|NCT00549549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92972841|NCT00549549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972842|NCT00549549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92972843|NCT00549549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92972844|NCT00549549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972845|NCT00549549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972846|NCT00549549|Gout Suppressants|gout suppressants|mesh-ancestor
92972847|NCT00549549|Tocolytic Agents|tocolytic agents|mesh-ancestor
92972848|NCT00549549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92972849|NCT00622284|Glimepiride|glimepiride|mesh-list
92972850|NCT00622284|Linagliptin|linagliptin|mesh-list
92972851|NCT00622284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92972852|NCT00622284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972853|NCT00622284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972854|NCT00622284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972855|NCT00622284|Immunologic Factors|immunologic factors|mesh-ancestor
92972856|NCT00622284|Incretins|incretins|mesh-ancestor
92972857|NCT00622284|Hormones|hormones|mesh-ancestor
92972858|NCT00622284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972859|NCT00622284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92972860|NCT00622284|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972861|NCT00622284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972862|NCT00622284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972863|NCT00269113|Rituximab|rituximab|mesh-list
92972864|NCT00269113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972865|NCT00269113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972866|NCT00269113|Immunologic Factors|immunologic factors|mesh-ancestor
92972867|NCT00269113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972868|NCT00269113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92972869|NCT01069159|Propranolol|propranolol|mesh-list
92972870|NCT01069159|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92972871|NCT01069159|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92972872|NCT01069159|Adrenergic Agents|adrenergic agents|mesh-ancestor
92972873|NCT01069159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972874|NCT01069159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972875|NCT01069159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972876|NCT01069159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92972877|NCT01069159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92972878|NCT01069159|Vasodilator Agents|vasodilator agents|mesh-ancestor
92972879|NCT03975205|Doxorubicin|doxorubicin|mesh-list
92972880|NCT03975205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92972881|NCT03975205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972882|NCT03975205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92972883|NCT03975205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92972884|NCT03975205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972885|NCT03975205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972886|NCT01325779|Heparin|heparin|mesh-list
92972887|NCT01325779|Enoxaparin|enoxaparin|mesh-list
92972888|NCT01325779|Anticoagulants|anticoagulants|mesh-ancestor
92972889|NCT01325779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92618288|NCT02930707|Tocolytic Agents|tocolytic agents|mesh-ancestor
92972890|NCT01325779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92972891|NCT01325779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972893|NCT05170659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972894|NCT05170659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972895|NCT05170659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92972896|NCT05170659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972897|NCT05352165|Pembrolizumab|pembrolizumab|mesh-list
92972898|NCT05352165|Fluorouracil|fluorouracil|mesh-list
92972899|NCT05352165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92972900|NCT05352165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92972901|NCT05352165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92972902|NCT05352165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972903|NCT05352165|Antimetabolites|antimetabolites|mesh-ancestor
92972904|NCT05352165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92972905|NCT05352165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972906|NCT05352165|Immunologic Factors|immunologic factors|mesh-ancestor
92972907|NCT05352165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972908|NCT00956163|Diphosphonates|diphosphonates|mesh-list
92972909|NCT00956163|Methylene diphosphonate|methylene diphosphonate|mesh-list
92972910|NCT00956163|Listerine|listerine|mesh-list
92972911|NCT00956163|Fluorides|fluorides|mesh-list
92972912|NCT00956163|Sodium Fluoride|sodium fluoride|mesh-list
92972913|NCT00956163|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92972914|NCT00956163|Cariostatic Agents|cariostatic agents|mesh-ancestor
92972915|NCT00956163|Protective Agents|protective agents|mesh-ancestor
92972916|NCT00956163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972917|NCT00956163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92972918|NCT00956163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972919|NCT00956163|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92972920|NCT00956163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972921|NCT00956163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92972923|NCT00956319|Zolpidem|zolpidem|mesh-list
92972924|NCT00956319|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92972925|NCT00956319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92972926|NCT00956319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972927|NCT00956319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972928|NCT00956319|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92972929|NCT00956319|GABA Agonists|gaba agonists|mesh-ancestor
92972930|NCT00956319|GABA Agents|gaba agents|mesh-ancestor
92972931|NCT00956319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92972932|NCT00956319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972933|NCT00956319|Anticonvulsants|anticonvulsants|mesh-ancestor
92972934|NCT00956319|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92972935|NCT00956319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92972936|NCT00956319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92972937|NCT00956319|GABA Modulators|gaba modulators|mesh-ancestor
92972938|NCT00835848|Exenatide|exenatide|mesh-list
92972939|NCT00835848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972940|NCT00835848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972941|NCT00835848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92972942|NCT00835848|Incretins|incretins|mesh-ancestor
92972943|NCT00835848|Hormones|hormones|mesh-ancestor
92972944|NCT00835848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972945|NCT00961857|Metformin|metformin|mesh-list
92972946|NCT00961857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92972947|NCT00961857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92972948|NCT00961857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972949|NCT00961857|Incretins|incretins|mesh-ancestor
92972950|NCT00961857|Hormones|hormones|mesh-ancestor
92972951|NCT00961857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972952|NCT00961857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92972953|NCT00961857|Protease Inhibitors|protease inhibitors|mesh-ancestor
92972954|NCT00961857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92972955|NCT00961857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972956|NCT02547792|Vaccines|vaccines|mesh-list
92972957|NCT02547792|Immunologic Factors|immunologic factors|mesh-ancestor
92972958|NCT02547792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972959|NCT00830466|Sirolimus|sirolimus|mesh-list
92972960|NCT00830466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92972961|NCT00830466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972962|NCT00830466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92972963|NCT00830466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618366|NCT00148382|Cetilistat|cetilistat|mesh-list
92972964|NCT00830466|Antifungal Agents|antifungal agents|mesh-ancestor
92972965|NCT00830466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92972966|NCT00830466|Immunologic Factors|immunologic factors|mesh-ancestor
92972967|NCT00830466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972968|NCT00843570|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92972969|NCT00843570|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92972970|NCT00843570|Nafarelin|nafarelin|mesh-list
92972971|NCT00843570|Estradiol|estradiol|mesh-list
92972972|NCT00843570|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92972973|NCT00843570|Progesterone|progesterone|mesh-list
92972974|NCT00843570|Estrogens|estrogens|mesh-ancestor
92972975|NCT00843570|Hormones|hormones|mesh-ancestor
92972976|NCT00843570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92972977|NCT00843570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972978|NCT00843570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92972979|NCT00843570|Contraceptive Agents|contraceptive agents|mesh-ancestor
92972980|NCT00843570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92972981|NCT00843570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92972982|NCT00843570|Progestins|progestins|mesh-ancestor
92972983|NCT00843570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92972984|NCT00843570|Fertility Agents|fertility agents|mesh-ancestor
92972985|NCT02547870|Rilpivirine|rilpivirine|mesh-list
92972986|NCT02547870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92972987|NCT02547870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92972988|NCT02547870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527894|NCT00034528|Glucocorticoids|glucocorticoids|mesh-ancestor
92972989|NCT02547870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92972990|NCT02547870|Antiviral Agents|antiviral agents|mesh-ancestor
92972991|NCT02547870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92972992|NCT02547870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92972993|NCT02547870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92972994|NCT00836316|Levobupivacaine|levobupivacaine|mesh-list
92972995|NCT00836316|Anesthetics, Local|anesthetics, local|mesh-ancestor
92972996|NCT00836316|Anesthetics|anesthetics|mesh-ancestor
92972997|NCT00836316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92972998|NCT00836316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92972999|NCT00836316|Sensory System Agents|sensory system agents|mesh-ancestor
92973000|NCT00836316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973001|NCT00621504|Clarithromycin|clarithromycin|mesh-list
92973002|NCT00621504|Ceftriaxone|ceftriaxone|mesh-list
92973003|NCT00621504|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92973004|NCT00621504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92973005|NCT00621504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973006|NCT00621504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92973007|NCT00621504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973008|NCT00621504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973009|NCT00621504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92973010|NCT00621504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92973011|NCT00548145|Ezetimibe|ezetimibe|mesh-list
92973012|NCT00548145|Pitavastatin|pitavastatin|mesh-list
92973013|NCT00548145|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92973014|NCT00548145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92973015|NCT00548145|Antimetabolites|antimetabolites|mesh-ancestor
92973016|NCT00548145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973017|NCT00548145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92973018|NCT00548145|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92973019|NCT00548145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973020|NCT00547911|Carbidopa|carbidopa|mesh-list
92973021|NCT00547911|Droxidopa|droxidopa|mesh-list
92973022|NCT00547911|Entacapone|entacapone|mesh-list
92973023|NCT00547911|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92973024|NCT00547911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92973025|NCT00547911|Dopamine Agents|dopamine agents|mesh-ancestor
92973026|NCT00547911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973027|NCT00547911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973028|NCT00547911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973029|NCT00547911|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92973030|NCT00547911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973031|NCT00547911|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92973032|NCT00839280|Pantothenic Acid|pantothenic acid|mesh-list
92973033|NCT00839280|Vitamin B Complex|vitamin b complex|mesh-ancestor
92973034|NCT00839280|Vitamins|vitamins|mesh-ancestor
92973035|NCT00839280|Micronutrients|micronutrients|mesh-ancestor
92973036|NCT00839280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973037|NCT00836628|Busulfan|busulfan|mesh-list
92973038|NCT00836628|Alkylating Agents|alkylating agents|mesh-ancestor
92618438|NCT00175812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92973039|NCT00836628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973040|NCT00836628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973041|NCT00836628|Immunologic Factors|immunologic factors|mesh-ancestor
92973042|NCT00836628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973043|NCT00836628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92973044|NCT00836628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973045|NCT00836628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92973047|NCT00962637|Sodium Citrate|sodium citrate|mesh-list
92973048|NCT00962637|Enclomiphene|enclomiphene|mesh-list
92973049|NCT00962637|Clomiphene|clomiphene|mesh-list
92973050|NCT00962637|Zuclomiphene|zuclomiphene|mesh-list
92973051|NCT00962637|Testosterone|testosterone|mesh-list
92973052|NCT00962637|Anticoagulants|anticoagulants|mesh-ancestor
92973053|NCT00962637|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92973054|NCT00962637|Chelating Agents|chelating agents|mesh-ancestor
92973055|NCT00962637|Sequestering Agents|sequestering agents|mesh-ancestor
92973056|NCT00962637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973057|NCT00962637|Androgens|androgens|mesh-ancestor
92973058|NCT00962637|Hormones|hormones|mesh-ancestor
92973059|NCT00962637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973060|NCT00962637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973061|NCT00962637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92973062|NCT00962637|Hormone Antagonists|hormone antagonists|mesh-ancestor
92973063|NCT00962637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92973064|NCT00962637|Fertility Agents|fertility agents|mesh-ancestor
92973065|NCT00962637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973066|NCT00962637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92973067|NCT00962637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92973069|NCT00839358|Sympathomimetics|sympathomimetics|mesh-ancestor
92973070|NCT00839358|Autonomic Agents|autonomic agents|mesh-ancestor
92973071|NCT00839358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973072|NCT00839358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973073|NCT00839358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92973074|NCT00839358|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92973075|NCT00839358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92973076|NCT00839358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92973077|NCT00839358|Adrenergic Agents|adrenergic agents|mesh-ancestor
92973078|NCT00839358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973079|NCT00839358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973080|NCT00962715|Interferons|interferons|mesh-list
92973081|NCT00962715|Interferon-alpha|interferon-alpha|mesh-list
92973082|NCT00962715|Interferon alpha-2|interferon alpha-2|mesh-list
92973083|NCT00962715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92973084|NCT00962715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973085|NCT00962715|Antiviral Agents|antiviral agents|mesh-ancestor
92973086|NCT00962715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973087|NCT00962715|Immunologic Factors|immunologic factors|mesh-ancestor
92973088|NCT00962715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973089|NCT00963027|Treprostinil|treprostinil|mesh-list
92973090|NCT00963027|Esomeprazole|esomeprazole|mesh-list
92973091|NCT00963027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92973092|NCT00963027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973093|NCT00963027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92973094|NCT00963027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973095|NCT00963027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973096|NCT00963027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92973097|NCT00837174|Bortezomib|bortezomib|mesh-list
92973098|NCT00837174|Vorinostat|vorinostat|mesh-list
92973099|NCT00837174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973100|NCT00837174|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92973101|NCT00837174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973102|NCT00837174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973103|NCT04042974|Dinoprostone|dinoprostone|mesh-list
92973104|NCT04042974|Oxytocics|oxytocics|mesh-ancestor
92973105|NCT04042974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973106|NCT04042974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973107|NCT00844350|Letrozole|letrozole|mesh-list
92973108|NCT00844350|Oxytocin|oxytocin|mesh-list
92973109|NCT00844350|Clomiphene|clomiphene|mesh-list
92973110|NCT00844350|Enclomiphene|enclomiphene|mesh-list
92973111|NCT00844350|Zuclomiphene|zuclomiphene|mesh-list
92973112|NCT00844350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166844|NCT04408560|Analgesics|analgesics|mesh-list
92973113|NCT00844350|Oxytocics|oxytocics|mesh-ancestor
92973114|NCT00844350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92618517|NCT00175929|Brivaracetam|brivaracetam|mesh-list
92973115|NCT00844350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973116|NCT00844350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973117|NCT00844350|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92973118|NCT00844350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92973119|NCT00844350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973120|NCT00844350|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92973121|NCT00844350|Hormone Antagonists|hormone antagonists|mesh-ancestor
92973122|NCT00844350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973123|NCT00844350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92973124|NCT00844350|Fertility Agents|fertility agents|mesh-ancestor
92973125|NCT00844350|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92973126|NCT00844350|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92973127|NCT00844506|Cyclophosphamide|cyclophosphamide|mesh-list
92973128|NCT00844506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973129|NCT00844506|Immunologic Factors|immunologic factors|mesh-ancestor
92973130|NCT00844506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973131|NCT00844506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973132|NCT00844506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92973133|NCT00844506|Alkylating Agents|alkylating agents|mesh-ancestor
92973134|NCT00844506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973135|NCT00844506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973136|NCT00844506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92973137|NCT00839826|Enoxaparin|enoxaparin|mesh-list
92973138|NCT00839826|Rivaroxaban|rivaroxaban|mesh-list
92973139|NCT00839826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92973141|NCT00839826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92973142|NCT00839826|Protease Inhibitors|protease inhibitors|mesh-ancestor
92973143|NCT00839826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973144|NCT00839826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973145|NCT00839826|Anticoagulants|anticoagulants|mesh-ancestor
92973146|NCT00839826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92973147|NCT00839826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92973148|NCT00844662|Sevelamer|sevelamer|mesh-list
92973149|NCT00844662|Chelating Agents|chelating agents|mesh-ancestor
92973150|NCT00844662|Sequestering Agents|sequestering agents|mesh-ancestor
92973151|NCT00844662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973152|NCT04678089|Bortezomib|bortezomib|mesh-list
92973153|NCT04678089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973154|NCT00963573|Loratadine|loratadine|mesh-list
92973155|NCT00963573|Betamethasone|betamethasone|mesh-list
92973156|NCT00963573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973157|NCT00963573|Glucocorticoids|glucocorticoids|mesh-ancestor
92973158|NCT00963573|Hormones|hormones|mesh-ancestor
92973159|NCT00963573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973160|NCT00963573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973161|NCT00963573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92973162|NCT00963573|Respiratory System Agents|respiratory system agents|mesh-ancestor
92973163|NCT00963573|Antipruritics|antipruritics|mesh-ancestor
92973164|NCT00963573|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973165|NCT00963573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92973166|NCT00963573|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92973167|NCT00963573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92973168|NCT00963573|Histamine Antagonists|histamine antagonists|mesh-ancestor
92973169|NCT00963573|Histamine Agents|histamine agents|mesh-ancestor
92973170|NCT00963573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973171|NCT00963573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973172|NCT05299593|Timolol|timolol|mesh-list
92973173|NCT05299593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92973174|NCT05299593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92973175|NCT05299593|Adrenergic Agents|adrenergic agents|mesh-ancestor
92973176|NCT05299593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973177|NCT05299593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973178|NCT05299593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973179|NCT05299593|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92973180|NCT05299593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92973181|NCT00844740|Cinacalcet|cinacalcet|mesh-list
92973182|NCT00844740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92166846|NCT04408560|Sensory System Agents|sensory system agents|mesh-ancestor
92973183|NCT00844740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973184|NCT00844740|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92973185|NCT00844740|Hormone Antagonists|hormone antagonists|mesh-ancestor
92973186|NCT00844740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973187|NCT00963729|Cyclophosphamide|cyclophosphamide|mesh-list
92973188|NCT00963729|Docetaxel|docetaxel|mesh-list
92618592|NCT02927353|Adalimumab|adalimumab|mesh-list
92973189|NCT00963729|Fluorouracil|fluorouracil|mesh-list
92973190|NCT00963729|Letrozole|letrozole|mesh-list
92973191|NCT00963729|Epirubicin|epirubicin|mesh-list
92973192|NCT00963729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973193|NCT00963729|Immunologic Factors|immunologic factors|mesh-ancestor
92973194|NCT00963729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973195|NCT00963729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973196|NCT00963729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92973197|NCT00963729|Alkylating Agents|alkylating agents|mesh-ancestor
92973198|NCT00963729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973199|NCT00963729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973200|NCT00963729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92973201|NCT00963729|Tubulin Modulators|tubulin modulators|mesh-ancestor
92973202|NCT00963729|Antimitotic Agents|antimitotic agents|mesh-ancestor
92973203|NCT00963729|Mitosis Modulators|mitosis modulators|mesh-ancestor
92973204|NCT00963729|Antimetabolites|antimetabolites|mesh-ancestor
92973205|NCT00963729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973206|NCT00963729|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92973207|NCT00963729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92973208|NCT00963729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973209|NCT00963729|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92973210|NCT00963729|Hormone Antagonists|hormone antagonists|mesh-ancestor
92973211|NCT00963729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973212|NCT00963729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92973213|NCT00963729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92973214|NCT00963729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973215|NCT00964041|Cycloserine|cycloserine|mesh-list
92973216|NCT00964041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92973217|NCT00964041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973218|NCT00964041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92973219|NCT00964041|Antitubercular Agents|antitubercular agents|mesh-ancestor
92973220|NCT00964041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92973221|NCT00964041|Antimetabolites|antimetabolites|mesh-ancestor
92973222|NCT00964041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973223|NCT04009317|Crizotinib|crizotinib|mesh-list
92973224|NCT04009317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973225|NCT04009317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92973226|NCT04009317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973227|NCT04009317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973228|NCT03641547|Capecitabine|capecitabine|mesh-list
92973229|NCT03641547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973230|NCT03641547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973231|NCT03641547|Antimetabolites|antimetabolites|mesh-ancestor
92973232|NCT03641547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973233|NCT00851370|Omalizumab|omalizumab|mesh-list
92973234|NCT00851370|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92973235|NCT00851370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92973236|NCT00851370|Respiratory System Agents|respiratory system agents|mesh-ancestor
92973237|NCT00967629|Calcium Carbonate|calcium carbonate|mesh-list
92973238|NCT00967629|Calcium|calcium|mesh-list
92973239|NCT00967629|Sevelamer|sevelamer|mesh-list
92973240|NCT00967629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92973241|NCT00967629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973242|NCT00967629|Antacids|antacids|mesh-ancestor
92973243|NCT00967629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973244|NCT00967629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973245|NCT00967629|Chelating Agents|chelating agents|mesh-ancestor
92973246|NCT00967629|Sequestering Agents|sequestering agents|mesh-ancestor
92973247|NCT00289783|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92973248|NCT00289783|Immunologic Factors|immunologic factors|mesh-ancestor
92973249|NCT00289783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973250|NCT00840606|Buspirone|buspirone|mesh-list
92973251|NCT00840606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92973252|NCT00840606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92973253|NCT00840606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973254|NCT00840606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973255|NCT00840606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92973256|NCT00840606|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92973257|NCT00840606|Serotonin Agents|serotonin agents|mesh-ancestor
92973258|NCT00840606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973259|NCT00840606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973260|NCT00840684|Cytarabine|cytarabine|mesh-list
92973261|NCT00840684|Melphalan|melphalan|mesh-list
92973262|NCT00840684|Busulfan|busulfan|mesh-list
92973263|NCT00840684|Daunorubicin|daunorubicin|mesh-list
92618666|NCT00149162|Aldesleukin|aldesleukin|mesh-list
92973264|NCT00840684|Mitoxantrone|mitoxantrone|mesh-list
92973265|NCT00840684|Amsacrine|amsacrine|mesh-list
92973266|NCT00840684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973267|NCT00840684|Antimetabolites|antimetabolites|mesh-ancestor
92973268|NCT00840684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973269|NCT00840684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973270|NCT00840684|Antiviral Agents|antiviral agents|mesh-ancestor
92973271|NCT00840684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973272|NCT00840684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973273|NCT00840684|Immunologic Factors|immunologic factors|mesh-ancestor
92973274|NCT00840684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973275|NCT00840684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92973276|NCT00840684|Alkylating Agents|alkylating agents|mesh-ancestor
92973277|NCT00840684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92973278|NCT00840684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92973279|NCT00840684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92973280|NCT00840684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973281|NCT00840684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973282|NCT00840684|Analgesics|analgesics|mesh-ancestor
92973283|NCT00840684|Sensory System Agents|sensory system agents|mesh-ancestor
92973284|NCT00840684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973286|NCT00574080|Thalidomide|thalidomide|mesh-list
92973287|NCT00574080|Dexamethasone|dexamethasone|mesh-list
92973288|NCT00574080|Dexamethasone acetate|dexamethasone acetate|mesh-list
92973289|NCT00574080|Cyclophosphamide|cyclophosphamide|mesh-list
92973290|NCT00574080|Melphalan|melphalan|mesh-list
92973291|NCT00574080|Carmustine|carmustine|mesh-list
92973292|NCT00574080|Cisplatin|cisplatin|mesh-list
92973293|NCT00574080|Etoposide|etoposide|mesh-list
92973294|NCT00574080|Etoposide phosphate|etoposide phosphate|mesh-list
92973295|NCT00574080|Doxorubicin|doxorubicin|mesh-list
92973296|NCT00574080|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92973297|NCT00574080|Bortezomib|bortezomib|mesh-list
92973298|NCT00574080|BB 1101|bb 1101|mesh-list
92973299|NCT00574080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973300|NCT00574080|Immunologic Factors|immunologic factors|mesh-ancestor
92973301|NCT00574080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973302|NCT00574080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973303|NCT00574080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92973304|NCT00574080|Alkylating Agents|alkylating agents|mesh-ancestor
92973305|NCT00574080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973306|NCT00574080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973307|NCT00574080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92973308|NCT00574080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973309|NCT00574080|Antiemetics|antiemetics|mesh-ancestor
92973310|NCT00574080|Autonomic Agents|autonomic agents|mesh-ancestor
92973311|NCT00574080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973312|NCT00574080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973313|NCT00574080|Glucocorticoids|glucocorticoids|mesh-ancestor
92973314|NCT00574080|Hormones|hormones|mesh-ancestor
92973315|NCT00574080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973316|NCT00574080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92973317|NCT00574080|Protease Inhibitors|protease inhibitors|mesh-ancestor
92973318|NCT00574080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973319|NCT00574080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92973320|NCT00574080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92973321|NCT00574080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973322|NCT00574080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973323|NCT00574080|Antimetabolites|antimetabolites|mesh-ancestor
92973324|NCT00574080|Antiviral Agents|antiviral agents|mesh-ancestor
92973325|NCT00574080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973326|NCT00574080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92973327|NCT00574080|Leprostatic Agents|leprostatic agents|mesh-ancestor
92973328|NCT00574080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92973329|NCT00574080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92973330|NCT00574080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92973331|NCT00574080|Growth Substances|growth substances|mesh-ancestor
92973332|NCT00574080|Growth Inhibitors|growth inhibitors|mesh-ancestor
92973333|NCT00845364|Perhexiline|perhexiline|mesh-list
92973334|NCT00845364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92973335|NCT00845364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92973336|NCT00845364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973337|NCT00845364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92973338|NCT00845364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973339|NCT00845364|Vasodilator Agents|vasodilator agents|mesh-ancestor
92973340|NCT00546351|Lacosamide|lacosamide|mesh-list
92973341|NCT00546351|Anticonvulsants|anticonvulsants|mesh-ancestor
92973342|NCT00546351|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92973343|NCT00546351|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92973344|NCT00546351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92973345|NCT00546351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973346|NCT00267865|Leucovorin|leucovorin|mesh-list
92973347|NCT00267865|Rituximab|rituximab|mesh-list
92973348|NCT00267865|Methotrexate|methotrexate|mesh-list
92973349|NCT00267865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973350|NCT00267865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973351|NCT00267865|Immunologic Factors|immunologic factors|mesh-ancestor
92973352|NCT00267865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973353|NCT00267865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973354|NCT00267865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92973355|NCT00267865|Abortifacient Agents|abortifacient agents|mesh-ancestor
92973356|NCT00267865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973357|NCT00267865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973358|NCT00267865|Antimetabolites|antimetabolites|mesh-ancestor
92973359|NCT00267865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973360|NCT00267865|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973361|NCT00267865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973362|NCT00267865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92973363|NCT00267865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973364|NCT00267865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973366|NCT00267865|Protective Agents|protective agents|mesh-ancestor
92973367|NCT00267865|Vitamin B Complex|vitamin b complex|mesh-ancestor
92973368|NCT00267865|Vitamins|vitamins|mesh-ancestor
92973369|NCT00267865|Micronutrients|micronutrients|mesh-ancestor
92973370|NCT00840918|Lidocaine|lidocaine|mesh-list
92973371|NCT00840918|Anesthetics, Local|anesthetics, local|mesh-ancestor
92973372|NCT00840918|Anesthetics|anesthetics|mesh-ancestor
92973373|NCT00840918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973374|NCT00840918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973375|NCT00840918|Sensory System Agents|sensory system agents|mesh-ancestor
92973376|NCT00840918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973377|NCT00840918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92973378|NCT00840918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92973379|NCT00840918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92973380|NCT00840918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92973381|NCT00840918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973382|NCT00546117|Lansoprazole|lansoprazole|mesh-list
92973383|NCT00546117|Dexlansoprazole|dexlansoprazole|mesh-list
92973384|NCT00546117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92973385|NCT00546117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973386|NCT00546117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92973387|NCT00546117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973388|NCT00546117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973389|NCT01582165|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92973390|NCT01582165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92973391|NCT01582165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92973392|NCT01582165|Antimetabolites|antimetabolites|mesh-ancestor
92973393|NCT01582165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973394|NCT01582165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92973395|NCT01582165|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92973396|NCT01582165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973397|NCT00841074|Chlorhexidine|chlorhexidine|mesh-list
92973398|NCT00841074|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92973399|NCT00841074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92973400|NCT00841074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973401|NCT00841074|Disinfectants|disinfectants|mesh-ancestor
92973402|NCT00841074|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973403|NCT00967707|Gabapentin|gabapentin|mesh-list
92973404|NCT00967707|Donepezil|donepezil|mesh-list
92973405|NCT00967707|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92973406|NCT00967707|Analgesics|analgesics|mesh-ancestor
92973407|NCT00967707|Sensory System Agents|sensory system agents|mesh-ancestor
92973408|NCT00967707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973409|NCT00967707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973410|NCT00967707|Anticonvulsants|anticonvulsants|mesh-ancestor
92973411|NCT00967707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92973412|NCT00967707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92973413|NCT00967707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973414|NCT00967707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92973415|NCT00967707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92973416|NCT00967707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92973417|NCT00967707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973418|NCT00967707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973419|NCT00967707|Antimanic Agents|antimanic agents|mesh-ancestor
92973420|NCT00967707|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92973421|NCT00967707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973422|NCT00967707|Cholinergic Agents|cholinergic agents|mesh-ancestor
92973423|NCT00967707|Nootropic Agents|nootropic agents|mesh-ancestor
92973424|NCT00967707|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92973425|NCT00967707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92973426|NCT00967707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92973427|NCT00967707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92973428|NCT00967707|Antidepressive Agents|antidepressive agents|mesh-ancestor
92973429|NCT00964275|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92973430|NCT00964275|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92973431|NCT00964275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973432|NCT00845598|Fluticasone|fluticasone|mesh-list
92973433|NCT00845598|Xhance|xhance|mesh-list
92973434|NCT00845598|Azelastine|azelastine|mesh-list
92973435|NCT00845598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973436|NCT00845598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92973437|NCT00845598|Autonomic Agents|autonomic agents|mesh-ancestor
92973438|NCT00845598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973439|NCT00845598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973440|NCT00845598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92973441|NCT00845598|Respiratory System Agents|respiratory system agents|mesh-ancestor
92973442|NCT00845598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973443|NCT00845598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92973444|NCT00845598|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92973445|NCT00845598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973446|NCT00845598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973447|NCT00845598|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92973448|NCT00845598|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92973449|NCT00845598|Histamine Antagonists|histamine antagonists|mesh-ancestor
92973450|NCT00845598|Histamine Agents|histamine agents|mesh-ancestor
92973451|NCT00845598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973452|NCT00251719|Lansoprazole|lansoprazole|mesh-list
92973453|NCT00251719|Dexlansoprazole|dexlansoprazole|mesh-list
92973454|NCT00251719|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92973455|NCT00251719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973456|NCT00251719|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92973457|NCT00251719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973458|NCT00251719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973459|NCT00845754|Ketorolac|ketorolac|mesh-list
92973460|NCT00845754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92973461|NCT00845754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92973462|NCT00845754|Analgesics|analgesics|mesh-ancestor
92973463|NCT00845754|Sensory System Agents|sensory system agents|mesh-ancestor
92973464|NCT00845754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973465|NCT00845754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973466|NCT00845754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973467|NCT00845754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973468|NCT00845754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92973469|NCT00845754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973470|NCT00845754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973471|NCT00964665|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92973472|NCT00964665|Interferon-alpha|interferon-alpha|mesh-list
92973473|NCT00964665|Antiviral Agents|antiviral agents|mesh-ancestor
92973474|NCT00964665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973475|NCT00964665|Immunologic Factors|immunologic factors|mesh-ancestor
92973476|NCT00964665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973477|NCT00841386|Riboflavin|riboflavin|mesh-list
92973478|NCT00841386|Flavin Mononucleotide|flavin mononucleotide|mesh-list
92973479|NCT00841386|Vitamin B Complex|vitamin b complex|mesh-ancestor
92973480|NCT00841386|Vitamins|vitamins|mesh-ancestor
92973481|NCT00841386|Micronutrients|micronutrients|mesh-ancestor
92973482|NCT00841386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973483|NCT00841386|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92973484|NCT00841386|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973485|NCT03952143|Insulin|insulin|mesh-list
92973486|NCT03952143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92973487|NCT03952143|Insulin Glargine|insulin glargine|mesh-list
92973488|NCT03952143|Insulin Lispro|insulin lispro|mesh-list
92973489|NCT03952143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973490|NCT03952143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973491|NCT00968331|Rituximab|rituximab|mesh-list
92973492|NCT00968331|Lenalidomide|lenalidomide|mesh-list
92973493|NCT00968331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973494|NCT00968331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973495|NCT00968331|Immunologic Factors|immunologic factors|mesh-ancestor
92973496|NCT00968331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973497|NCT00968331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973498|NCT00968331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92973499|NCT00968331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92973500|NCT00968331|Growth Substances|growth substances|mesh-ancestor
92973501|NCT00968331|Growth Inhibitors|growth inhibitors|mesh-ancestor
92973502|NCT00852228|Cetuximab|cetuximab|mesh-list
92973503|NCT00852228|Oxaliplatin|oxaliplatin|mesh-list
92973504|NCT00852228|Irinotecan|irinotecan|mesh-list
92973505|NCT00852228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973506|NCT00852228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973507|NCT00852228|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92973508|NCT00852228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973509|NCT00852228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973510|NCT00852228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973511|NCT00267007|Epoetin Alfa|epoetin alfa|mesh-list
92973512|NCT00267007|Hematinics|hematinics|mesh-ancestor
92973513|NCT00841854|Metronidazole|metronidazole|mesh-list
92973514|NCT00841854|Tetracycline|tetracycline|mesh-list
92973515|NCT00841854|Pantoprazole|pantoprazole|mesh-list
92973516|NCT00841854|Bismuth|bismuth|mesh-list
92973517|NCT00841854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973518|NCT00841854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92973519|NCT00841854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92973520|NCT00841854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92973521|NCT00841854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92973522|NCT00841854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973523|NCT00841854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92973524|NCT00841854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973525|NCT00841854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973526|NCT00841854|Antacids|antacids|mesh-ancestor
92973527|NCT00841854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92973528|NCT00848562|Nicorandil|nicorandil|mesh-list
92973529|NCT00848562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92973530|NCT00848562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92973531|NCT00848562|Vasodilator Agents|vasodilator agents|mesh-ancestor
92973532|NCT00848562|Vitamin B Complex|vitamin b complex|mesh-ancestor
92973533|NCT00848562|Vitamins|vitamins|mesh-ancestor
92973534|NCT00848562|Micronutrients|micronutrients|mesh-ancestor
92973535|NCT00848562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973536|NCT02879409|Insulin|insulin|mesh-list
92973537|NCT02879409|Metformin|metformin|mesh-list
92973538|NCT02879409|Pioglitazone|pioglitazone|mesh-list
92973539|NCT02879409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92973540|NCT02879409|Dapagliflozin|dapagliflozin|mesh-list
92973541|NCT02879409|Liraglutide|liraglutide|mesh-list
92973542|NCT02879409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92973543|NCT02879409|Gliclazide|gliclazide|mesh-list
92973544|NCT02879409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973545|NCT02879409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973546|NCT02879409|Incretins|incretins|mesh-ancestor
92973547|NCT02879409|Hormones|hormones|mesh-ancestor
92973548|NCT02879409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973549|NCT02879409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92973550|NCT02879409|Protease Inhibitors|protease inhibitors|mesh-ancestor
92973551|NCT02879409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973552|NCT02879409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973553|NCT02879409|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92973554|NCT02546154|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92973555|NCT02546154|Hematinics|hematinics|mesh-ancestor
92973556|NCT03943095|Fluorides|fluorides|mesh-list
92973557|NCT03943095|Tin Fluorides|tin fluorides|mesh-list
92973558|NCT03943095|Cariostatic Agents|cariostatic agents|mesh-ancestor
92973559|NCT03943095|Protective Agents|protective agents|mesh-ancestor
92973560|NCT03943095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973561|NCT00848640|Sorafenib|sorafenib|mesh-list
92973562|NCT00848640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973563|NCT00848640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92973564|NCT00848640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973565|NCT00848640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973566|NCT00968565|Citric Acid|citric acid|mesh-list
92973567|NCT00968565|Sodium Citrate|sodium citrate|mesh-list
92973568|NCT00968565|Anticoagulants|anticoagulants|mesh-ancestor
92618957|NCT05786339|Irbesartan|irbesartan|mesh-list
92973569|NCT00968565|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92973570|NCT00968565|Chelating Agents|chelating agents|mesh-ancestor
92973571|NCT00968565|Sequestering Agents|sequestering agents|mesh-ancestor
92973572|NCT00968565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973573|NCT00848796|Heparin|heparin|mesh-list
92973574|NCT00848796|Calcium heparin|calcium heparin|mesh-list
92973575|NCT00848796|Anticoagulants|anticoagulants|mesh-ancestor
92973576|NCT00848796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92973577|NCT00848796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92973578|NCT00848796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973579|NCT00965289|Rituximab|rituximab|mesh-list
92973580|NCT00965289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973581|NCT00965289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973582|NCT00965289|Immunologic Factors|immunologic factors|mesh-ancestor
92973583|NCT00965289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973584|NCT00965289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973585|NCT04042506|Nivolumab|nivolumab|mesh-list
92973586|NCT04042506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973587|NCT04042506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973588|NCT04042506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92973589|NCT04042506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973590|NCT00251641|Infliximab|infliximab|mesh-list
92973591|NCT00251641|Methotrexate|methotrexate|mesh-list
92973592|NCT00251641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92973593|NCT00251641|Abortifacient Agents|abortifacient agents|mesh-ancestor
92973594|NCT00251641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973595|NCT00251641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973596|NCT00251641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973597|NCT00251641|Antimetabolites|antimetabolites|mesh-ancestor
92973598|NCT00251641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973599|NCT00251641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973600|NCT00251641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973601|NCT00251641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973602|NCT00251641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92973603|NCT00251641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973604|NCT00251641|Immunologic Factors|immunologic factors|mesh-ancestor
92973605|NCT00251641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973606|NCT00251641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973607|NCT00251641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92973608|NCT00251641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973609|NCT00251641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973610|NCT00250705|Aripiprazole|aripiprazole|mesh-list
92973611|NCT00250705|Antidepressive Agents|antidepressive agents|mesh-ancestor
92973612|NCT00250705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92973613|NCT00250705|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92973614|NCT00250705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92973615|NCT00250705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973616|NCT00250705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973617|NCT00250705|Dopamine Agonists|dopamine agonists|mesh-ancestor
92973618|NCT00250705|Dopamine Agents|dopamine agents|mesh-ancestor
92973619|NCT00250705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973620|NCT00250705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973621|NCT00250705|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92973622|NCT00250705|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92973623|NCT00250705|Serotonin Agents|serotonin agents|mesh-ancestor
92973624|NCT00250705|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92973625|NCT00250705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92973626|NCT00250705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92973627|NCT00250705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92973628|NCT00849030|Tamoxifen|tamoxifen|mesh-list
92973629|NCT00849030|Anastrozole|anastrozole|mesh-list
92973630|NCT00849030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92973631|NCT00849030|Hormone Antagonists|hormone antagonists|mesh-ancestor
92973632|NCT00849030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973633|NCT00849030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973634|NCT00849030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92973635|NCT00849030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973636|NCT00849030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92973637|NCT00849030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92973638|NCT00849030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92973639|NCT00849030|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92973640|NCT00849030|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92973641|NCT00849030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973642|NCT00849030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973643|NCT00842400|Metformin|metformin|mesh-list
92973644|NCT00842400|Probenecid|probenecid|mesh-list
92973645|NCT00842400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973646|NCT00842400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973647|NCT00842400|Uricosuric Agents|uricosuric agents|mesh-ancestor
92973648|NCT00842400|Gout Suppressants|gout suppressants|mesh-ancestor
92973649|NCT00842400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973650|NCT00266695|Ruboxistaurin|ruboxistaurin|mesh-list
92973651|NCT00266695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973652|NCT00266695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973653|NCT00849264|Fluorouracil|fluorouracil|mesh-list
92973654|NCT00849264|Endostar protein|endostar protein|mesh-list
92973655|NCT00849264|Antimetabolites|antimetabolites|mesh-ancestor
92973656|NCT00849264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973657|NCT00849264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973658|NCT00849264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973659|NCT00849264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973660|NCT00849264|Immunologic Factors|immunologic factors|mesh-ancestor
92973661|NCT00849264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973662|NCT00849264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92973663|NCT00849264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92973664|NCT00849264|Growth Substances|growth substances|mesh-ancestor
92973665|NCT00849264|Growth Inhibitors|growth inhibitors|mesh-ancestor
92973666|NCT00849342|Insulin Detemir|insulin detemir|mesh-list
92973667|NCT00849342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973668|NCT00849342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973669|NCT00842556|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92973670|NCT00842556|Dapagliflozin|dapagliflozin|mesh-list
92973671|NCT00842556|Glimepiride|glimepiride|mesh-list
92973672|NCT00842556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973673|NCT00842556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973674|NCT00842556|Incretins|incretins|mesh-ancestor
92973675|NCT00842556|Hormones|hormones|mesh-ancestor
92973676|NCT00842556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973677|NCT00842556|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92973678|NCT00842556|Protease Inhibitors|protease inhibitors|mesh-ancestor
92973679|NCT00842556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973680|NCT00842556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973681|NCT00842556|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92973682|NCT00842556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92973683|NCT00842556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973684|NCT00842556|Immunologic Factors|immunologic factors|mesh-ancestor
92973685|NCT00849966|Celecoxib|celecoxib|mesh-list
92973686|NCT00849966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92973687|NCT00849966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92973688|NCT00849966|Analgesics|analgesics|mesh-ancestor
92973689|NCT00849966|Sensory System Agents|sensory system agents|mesh-ancestor
92973690|NCT00849966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973691|NCT00849966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973692|NCT00849966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973693|NCT00849966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973694|NCT00849966|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92973695|NCT00849966|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92973696|NCT00849966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973697|NCT00849966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973698|NCT00853008|Cytarabine|cytarabine|mesh-list
92973699|NCT00853008|Dexamethasone|dexamethasone|mesh-list
92973700|NCT00853008|Prednisone|prednisone|mesh-list
92973701|NCT00853008|Hydrocortisone|hydrocortisone|mesh-list
92973702|NCT00853008|Methotrexate|methotrexate|mesh-list
92973703|NCT00853008|Vincristine|vincristine|mesh-list
92973704|NCT00853008|Daunorubicin|daunorubicin|mesh-list
92973705|NCT00853008|Mitoxantrone|mitoxantrone|mesh-list
92973706|NCT00853008|Mercaptopurine|mercaptopurine|mesh-list
92973707|NCT00853008|Teniposide|teniposide|mesh-list
92973708|NCT00853008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973709|NCT00853008|Antiemetics|antiemetics|mesh-ancestor
92973710|NCT00853008|Autonomic Agents|autonomic agents|mesh-ancestor
92973711|NCT00853008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973712|NCT00853008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973713|NCT00853008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973714|NCT00853008|Glucocorticoids|glucocorticoids|mesh-ancestor
92973715|NCT00853008|Hormones|hormones|mesh-ancestor
92973716|NCT00853008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973717|NCT00853008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92973718|NCT00853008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619113|NCT05780437|Remdesivir|remdesivir|mesh-list
92973719|NCT00853008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92973720|NCT00853008|Abortifacient Agents|abortifacient agents|mesh-ancestor
92973721|NCT00853008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973722|NCT00853008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973723|NCT00853008|Antimetabolites|antimetabolites|mesh-ancestor
92973724|NCT00853008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973725|NCT00853008|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973726|NCT00853008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973727|NCT00853008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92973728|NCT00853008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973729|NCT00853008|Immunologic Factors|immunologic factors|mesh-ancestor
92973730|NCT00853008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973731|NCT00853008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973732|NCT00853008|Antiviral Agents|antiviral agents|mesh-ancestor
92973733|NCT00853008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973734|NCT00853008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92973735|NCT00853008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92973736|NCT00853008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92973737|NCT00853008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92973738|NCT00853008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92973739|NCT00853008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92973740|NCT00853008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973741|NCT00853008|Analgesics|analgesics|mesh-ancestor
92973742|NCT00853008|Sensory System Agents|sensory system agents|mesh-ancestor
92973743|NCT02545530|Clonidine|clonidine|mesh-list
92973744|NCT02545530|Analgesics|analgesics|mesh-ancestor
92973745|NCT02545530|Sensory System Agents|sensory system agents|mesh-ancestor
92973746|NCT02545530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973747|NCT02545530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973748|NCT02545530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92973749|NCT02545530|Sympatholytics|sympatholytics|mesh-ancestor
92973750|NCT02545530|Autonomic Agents|autonomic agents|mesh-ancestor
92973751|NCT02545530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92973752|NCT02545530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92973753|NCT02545530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92973754|NCT02545530|Adrenergic Agents|adrenergic agents|mesh-ancestor
92973755|NCT02545530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973756|NCT02545530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973757|NCT00853320|Oxycodone|oxycodone|mesh-list
92973758|NCT00853320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92973759|NCT00853320|Narcotics|narcotics|mesh-ancestor
92973760|NCT00853320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973761|NCT00853320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973762|NCT00853320|Analgesics|analgesics|mesh-ancestor
92973763|NCT00853320|Sensory System Agents|sensory system agents|mesh-ancestor
92973764|NCT00853320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973765|NCT00547521|Methotrexate|methotrexate|mesh-list
92973766|NCT00547521|Abatacept|abatacept|mesh-list
92973767|NCT00547521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92973768|NCT00547521|Abortifacient Agents|abortifacient agents|mesh-ancestor
92973769|NCT00547521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973770|NCT00547521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973771|NCT00547521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973772|NCT00547521|Antimetabolites|antimetabolites|mesh-ancestor
92973773|NCT00547521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973774|NCT00547521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973775|NCT00547521|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973776|NCT00547521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973777|NCT00547521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92973778|NCT00547521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973779|NCT00547521|Immunologic Factors|immunologic factors|mesh-ancestor
92973780|NCT00547521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973781|NCT00547521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973782|NCT00547521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92973783|NCT00547521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973784|NCT00850044|Ritonavir|ritonavir|mesh-list
92973785|NCT00850044|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92973786|NCT00850044|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92973787|NCT00850044|Protease Inhibitors|protease inhibitors|mesh-ancestor
92973788|NCT00850044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973789|NCT00850044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973790|NCT00850044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92973791|NCT00850044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92973792|NCT00850044|Antiviral Agents|antiviral agents|mesh-ancestor
92973793|NCT00850044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973794|NCT00850044|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92973795|NCT00850044|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92973796|NCT00266227|Rituximab|rituximab|mesh-list
92973797|NCT00266227|Methotrexate|methotrexate|mesh-list
92973798|NCT00266227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92973800|NCT00266227|Immunologic Factors|immunologic factors|mesh-ancestor
92973801|NCT00266227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973802|NCT00266227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973803|NCT00266227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92973804|NCT00266227|Abortifacient Agents|abortifacient agents|mesh-ancestor
92973805|NCT00266227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973806|NCT00266227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973807|NCT00266227|Antimetabolites|antimetabolites|mesh-ancestor
92973808|NCT00266227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973809|NCT00266227|Dermatologic Agents|dermatologic agents|mesh-ancestor
92973810|NCT00266227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973811|NCT00266227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92973812|NCT00266227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92973813|NCT00266227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973814|NCT04233216|Islatravir|islatravir|mesh-list
92973815|NCT04233216|Antiviral Agents|antiviral agents|mesh-ancestor
92973816|NCT04233216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973817|NCT04233216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973818|NCT04233216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973819|NCT04233216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92973820|NCT04233216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973821|NCT04233216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92973822|NCT00968877|Cholecalciferol|cholecalciferol|mesh-list
92973823|NCT00968877|Vitamin D|vitamin d|mesh-list
92973824|NCT00968877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92973825|NCT00968877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973826|NCT00968877|Vitamins|vitamins|mesh-ancestor
92973827|NCT00968877|Micronutrients|micronutrients|mesh-ancestor
92973828|NCT00968877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92973829|NCT00850122|Cefazolin|cefazolin|mesh-list
92973830|NCT00850122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92973831|NCT00850122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973832|NCT00968955|Ropivacaine|ropivacaine|mesh-list
92973833|NCT00968955|Anesthetics, Local|anesthetics, local|mesh-ancestor
92973834|NCT00968955|Anesthetics|anesthetics|mesh-ancestor
92973835|NCT00968955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973836|NCT00968955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973837|NCT00968955|Sensory System Agents|sensory system agents|mesh-ancestor
92973838|NCT00968955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973839|NCT00853554|Hydromorphone|hydromorphone|mesh-list
92973840|NCT00853554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92973841|NCT00853554|Narcotics|narcotics|mesh-ancestor
92973842|NCT00853554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973843|NCT00853554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973844|NCT00853554|Analgesics|analgesics|mesh-ancestor
92973845|NCT00853554|Sensory System Agents|sensory system agents|mesh-ancestor
92973846|NCT00853554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973847|NCT00969033|Irinotecan|irinotecan|mesh-list
92973848|NCT00969033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92973849|NCT00969033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973850|NCT00969033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973851|NCT00969033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973852|NCT00969033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973853|NCT00573768|Diclofenac|diclofenac|mesh-list
92973854|NCT00573768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92973855|NCT00573768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92973856|NCT00573768|Analgesics|analgesics|mesh-ancestor
92973857|NCT00573768|Sensory System Agents|sensory system agents|mesh-ancestor
92973858|NCT00573768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973859|NCT00573768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973860|NCT00573768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92973861|NCT00573768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92973862|NCT00573768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92973863|NCT00573768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973864|NCT00573768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973865|NCT00965913|Nicotine|nicotine|mesh-list
92973866|NCT00965913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92973867|NCT00965913|Autonomic Agents|autonomic agents|mesh-ancestor
92973868|NCT00965913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973869|NCT00965913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973870|NCT00965913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92973871|NCT00965913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92973872|NCT00965913|Cholinergic Agents|cholinergic agents|mesh-ancestor
92973873|NCT00965913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973874|NCT00965913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973875|NCT00853866|Reboxetine|reboxetine|mesh-list
92973876|NCT00853866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92973877|NCT00853866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92973878|NCT00853866|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92973879|NCT00853866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92973880|NCT00853866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92973881|NCT00853866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973882|NCT00853866|Adrenergic Agents|adrenergic agents|mesh-ancestor
92973883|NCT00853866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973884|NCT00853866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973885|NCT00855660|Riociguat|riociguat|mesh-list
92973886|NCT00855660|Enzyme Activators|enzyme activators|mesh-ancestor
92973887|NCT00855660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973888|NCT00965991|Metformin|metformin|mesh-list
92973889|NCT00965991|Glyburide|glyburide|mesh-list
92973890|NCT00965991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973891|NCT00965991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973892|NCT00853944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92973893|NCT00853944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92973894|NCT00853944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92973895|NCT00853944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973896|NCT00853944|Incretins|incretins|mesh-ancestor
92973897|NCT00853944|Hormones|hormones|mesh-ancestor
92973898|NCT00853944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973899|NCT00853944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92973900|NCT00853944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973901|NCT00853944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973902|NCT02545452|Anastrozole|anastrozole|mesh-list
92973903|NCT02545452|Levonorgestrel|levonorgestrel|mesh-list
92973904|NCT02545452|Nonoxynol|nonoxynol|mesh-list
92973905|NCT02545452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92973906|NCT02545452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973907|NCT02545452|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92973908|NCT02545452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92973909|NCT02545452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973910|NCT02545452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973911|NCT02545452|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92973912|NCT02545452|Hormone Antagonists|hormone antagonists|mesh-ancestor
92973913|NCT02545452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92973914|NCT02545452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973915|NCT02545452|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92973916|NCT02545452|Contraceptive Agents|contraceptive agents|mesh-ancestor
92973917|NCT02545452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92973918|NCT02545452|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92973919|NCT02545452|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92973920|NCT02545452|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92973921|NCT02545452|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92973922|NCT02545452|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92973923|NCT02545452|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92973924|NCT00547365|Immunoglobulins|immunoglobulins|mesh-list
92973925|NCT00547365|Antibodies|antibodies|mesh-list
92973926|NCT00547365|gamma-Globulins|gamma-globulins|mesh-list
92973927|NCT00547365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92973928|NCT00547365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92973929|NCT00547365|Immunologic Factors|immunologic factors|mesh-ancestor
92973930|NCT00547365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973931|NCT00854178|Anesthetics|anesthetics|mesh-list
92973932|NCT00854178|Isoflurane|isoflurane|mesh-list
92973933|NCT00854178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973934|NCT00854178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973935|NCT00854178|Anesthetics, General|anesthetics, general|mesh-ancestor
92973936|NCT00854178|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92973937|NCT00850668|Hypoxanthine arabinoside|hypoxanthine arabinoside|mesh-list
92973938|NCT00850668|Antiviral Agents|antiviral agents|mesh-ancestor
92973939|NCT00850668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973940|NCT00850746|Moxifloxacin|moxifloxacin|mesh-list
92973941|NCT00850746|Z 338|z 338|mesh-list
92973942|NCT00850746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92973943|NCT00850746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92973944|NCT00850746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92973945|NCT00850746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92973946|NCT00850746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973947|NCT00850746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973948|NCT00850746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973949|NCT00850746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973950|NCT00850746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92973951|NCT00850746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92973952|NCT00850746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973953|NCT00850746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92973954|NCT00969813|Tofacitinib|tofacitinib|mesh-list
92973955|NCT00969813|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92973956|NCT00969813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92973957|NCT00969813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973958|NCT00969813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973959|NCT00854256|Mitomycins|mitomycins|mesh-list
92973960|NCT00854256|Mitomycin|mitomycin|mesh-list
92973961|NCT00854256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92973962|NCT00854256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973963|NCT00854256|Alkylating Agents|alkylating agents|mesh-ancestor
92973964|NCT00854256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973965|NCT00854256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92973966|NCT00854256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973967|NCT00855972|Naltrexone|naltrexone|mesh-list
92973968|NCT00855972|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92973969|NCT00855972|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92973970|NCT00855972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973971|NCT00855972|Sensory System Agents|sensory system agents|mesh-ancestor
92973972|NCT00855972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973973|NCT02544906|Propofol|propofol|mesh-list
92973974|NCT02544906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92973975|NCT02544906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92973976|NCT02544906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973977|NCT02544906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92973978|NCT02544906|Anesthetics, General|anesthetics, general|mesh-ancestor
92973979|NCT02544906|Anesthetics|anesthetics|mesh-ancestor
92973980|NCT00861276|Nicotine|nicotine|mesh-list
92973981|NCT00861276|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92973982|NCT00861276|Autonomic Agents|autonomic agents|mesh-ancestor
92973983|NCT00861276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92973984|NCT00861276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92973985|NCT00861276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92973986|NCT00861276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92973987|NCT00861276|Cholinergic Agents|cholinergic agents|mesh-ancestor
92973988|NCT00861276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92973989|NCT00861276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973990|NCT02544828|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92973991|NCT02544828|Hematinics|hematinics|mesh-ancestor
92973992|NCT00861510|ON 01910|on 01910|mesh-list
92973993|NCT00861510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92973994|NCT00861510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92973995|NCT00861510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92973996|NCT00861510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92973997|NCT01095003|Capecitabine|capecitabine|mesh-list
92973998|NCT01095003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92973999|NCT01095003|Antimetabolites|antimetabolites|mesh-ancestor
92974000|NCT01095003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974001|NCT01095003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974002|NCT00854646|ON 01910|on 01910|mesh-list
92974003|NCT00854646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974004|NCT00854646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974005|NCT00854646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974006|NCT00854646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974007|NCT00856362|Moxidectin|moxidectin|mesh-list
92974008|NCT00856362|Midazolam|midazolam|mesh-list
92974009|NCT00856362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92974010|NCT00856362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92974011|NCT00856362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974012|NCT00856362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974013|NCT00856362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92974014|NCT00856362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92974015|NCT00856362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92974016|NCT00856362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92974017|NCT00856362|Anesthetics, General|anesthetics, general|mesh-ancestor
92974018|NCT00856362|Anesthetics|anesthetics|mesh-ancestor
92974019|NCT00856362|GABA Modulators|gaba modulators|mesh-ancestor
92974020|NCT00856362|GABA Agents|gaba agents|mesh-ancestor
92974021|NCT00856362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974022|NCT00856362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974023|NCT00856362|Anthelmintics|anthelmintics|mesh-ancestor
92974024|NCT00856362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92974025|NCT00856362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974026|NCT00856362|Antinematodal Agents|antinematodal agents|mesh-ancestor
92974028|NCT00854802|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92974029|NCT00854802|Cyclosporine|cyclosporine|mesh-list
92974030|NCT00854802|Antimetabolites|antimetabolites|mesh-ancestor
92974031|NCT00854802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974032|NCT00854802|Antiviral Agents|antiviral agents|mesh-ancestor
92974033|NCT00854802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974034|NCT00854802|Antifungal Agents|antifungal agents|mesh-ancestor
92974035|NCT00854802|Dermatologic Agents|dermatologic agents|mesh-ancestor
92974036|NCT00854802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974037|NCT00854802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974038|NCT00854802|Immunologic Factors|immunologic factors|mesh-ancestor
92974039|NCT00854802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974040|NCT00854802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974041|NCT00854802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92974042|NCT00958503|Thiamphenicol|thiamphenicol|mesh-list
92974043|NCT00958503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92974044|NCT00958503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974045|NCT04119024|Cyclophosphamide|cyclophosphamide|mesh-list
92974046|NCT04119024|Fludarabine|fludarabine|mesh-list
92974047|NCT04119024|Fludarabine phosphate|fludarabine phosphate|mesh-list
92974048|NCT04119024|Interleukin-2|interleukin-2|mesh-list
92974049|NCT04119024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974050|NCT04119024|Immunologic Factors|immunologic factors|mesh-ancestor
92974051|NCT04119024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974052|NCT04119024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974053|NCT04119024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92974054|NCT04119024|Alkylating Agents|alkylating agents|mesh-ancestor
92974055|NCT04119024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974056|NCT04119024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974057|NCT04119024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92974058|NCT04119024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92974059|NCT04119024|Antimetabolites|antimetabolites|mesh-ancestor
92974060|NCT04119024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974061|NCT04119024|Analgesics|analgesics|mesh-ancestor
92974062|NCT04119024|Sensory System Agents|sensory system agents|mesh-ancestor
92974063|NCT04119024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974064|NCT00966615|Dialysis Solutions|dialysis solutions|mesh-list
92974065|NCT00966615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92974066|NCT00966771|Copper|copper|mesh-list
92974067|NCT00966771|Levonorgestrel|levonorgestrel|mesh-list
92974068|NCT00966771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92974069|NCT00966771|Contraceptive Agents|contraceptive agents|mesh-ancestor
92974070|NCT00966771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92974071|NCT00966771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974072|NCT00966771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92974073|NCT00966771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92974074|NCT00966771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92974075|NCT00966771|Trace Elements|trace elements|mesh-ancestor
92974076|NCT00966771|Micronutrients|micronutrients|mesh-ancestor
92974077|NCT00856596|Sertaconazole|sertaconazole|mesh-list
92974078|NCT00856596|Antifungal Agents|antifungal agents|mesh-ancestor
92974079|NCT00856596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974080|NCT00855114|Everolimus|everolimus|mesh-list
92974081|NCT00855114|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92974082|NCT00855114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974083|NCT00855114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974084|NCT00855114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974085|NCT00855114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974086|NCT00855114|Immunologic Factors|immunologic factors|mesh-ancestor
92974087|NCT00855114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974088|NCT00855114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974089|NCT00855270|Hydrocortisone|hydrocortisone|mesh-list
92974090|NCT00855270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974091|NCT03937479|Tiotropium Bromide|tiotropium bromide|mesh-list
92974092|NCT03937479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92974093|NCT03937479|Autonomic Agents|autonomic agents|mesh-ancestor
92974094|NCT03937479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974095|NCT03937479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619491|NCT04748276|Sympathomimetics|sympathomimetics|mesh-ancestor
92974096|NCT03937479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92974097|NCT03937479|Respiratory System Agents|respiratory system agents|mesh-ancestor
92974098|NCT03937479|Parasympatholytics|parasympatholytics|mesh-ancestor
92974099|NCT03937479|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92974100|NCT03937479|Cholinergic Agents|cholinergic agents|mesh-ancestor
92974101|NCT03937479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974102|NCT03937479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974104|NCT00970905|Aprepitant|aprepitant|mesh-list
92974105|NCT00970905|Antiemetics|antiemetics|mesh-ancestor
92974106|NCT00970905|Autonomic Agents|autonomic agents|mesh-ancestor
92974107|NCT00970905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974108|NCT00970905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974109|NCT00970905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92974110|NCT00970905|Antipruritics|antipruritics|mesh-ancestor
92974111|NCT00970905|Dermatologic Agents|dermatologic agents|mesh-ancestor
92974112|NCT00970905|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92974113|NCT00970905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92974114|NCT00970905|Serotonin Agents|serotonin agents|mesh-ancestor
92974115|NCT00970905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974116|NCT00970905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974117|NCT00970905|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92974118|NCT00619476|Gabapentin|gabapentin|mesh-list
92974119|NCT00619476|Analgesics|analgesics|mesh-ancestor
92974120|NCT00619476|Sensory System Agents|sensory system agents|mesh-ancestor
92974121|NCT00619476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974122|NCT00619476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974123|NCT00619476|Anticonvulsants|anticonvulsants|mesh-ancestor
92974124|NCT00619476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92974125|NCT00619476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92974126|NCT00619476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974127|NCT00619476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92974128|NCT00619476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92974129|NCT00619476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92974130|NCT00619476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974131|NCT00619476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974132|NCT00619476|Antimanic Agents|antimanic agents|mesh-ancestor
92974133|NCT00973713|Everolimus|everolimus|mesh-list
92974134|NCT00973713|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92974135|NCT00973713|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974136|NCT00973713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974137|NCT00973713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974138|NCT00973713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974139|NCT00973713|Immunologic Factors|immunologic factors|mesh-ancestor
92974140|NCT00973713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974141|NCT00973713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974142|NCT00857142|Oxymorphone|oxymorphone|mesh-list
92974143|NCT00857142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92974144|NCT00857142|Narcotics|narcotics|mesh-ancestor
92974145|NCT00857142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974146|NCT00857142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974147|NCT00857142|Analgesics|analgesics|mesh-ancestor
92974148|NCT00857142|Sensory System Agents|sensory system agents|mesh-ancestor
92974149|NCT00857142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974150|NCT00857142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92974151|NCT00865176|Eplerenone|eplerenone|mesh-list
92974152|NCT00865176|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92974153|NCT00865176|Hormone Antagonists|hormone antagonists|mesh-ancestor
92974154|NCT00865176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974155|NCT00865176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974156|NCT00865176|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92974157|NCT00865176|Diuretics|diuretics|mesh-ancestor
92974158|NCT00865176|Natriuretic Agents|natriuretic agents|mesh-ancestor
92974159|NCT00865176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92974160|NCT00973869|Curcumin|curcumin|mesh-list
92974161|NCT00973869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92974162|NCT00973869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974163|NCT00973869|Analgesics|analgesics|mesh-ancestor
92974164|NCT00973869|Sensory System Agents|sensory system agents|mesh-ancestor
92974165|NCT00973869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974166|NCT00973869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974167|NCT00973869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974168|NCT00973869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974169|NCT00973869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974170|NCT00973869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974171|NCT00973869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974173|NCT00959439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92974174|NCT00959439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974175|NCT00959439|Analgesics|analgesics|mesh-ancestor
92974176|NCT00959439|Sensory System Agents|sensory system agents|mesh-ancestor
92974177|NCT00959439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974178|NCT00959439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974179|NCT00959439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974180|NCT00959439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974181|NCT00959439|Gout Suppressants|gout suppressants|mesh-ancestor
92974182|NCT00959439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92974183|NCT00959439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974184|NCT00959439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974185|NCT04041492|Vitamin D|vitamin d|mesh-list
92974186|NCT04041492|Cholecalciferol|cholecalciferol|mesh-list
92974187|NCT04041492|Vitamins|vitamins|mesh-ancestor
92974188|NCT04041492|Micronutrients|micronutrients|mesh-ancestor
92974189|NCT04041492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974190|NCT04041492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92974191|NCT04041492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92974192|NCT00857376|Thioctic Acid|thioctic acid|mesh-list
92974193|NCT00857376|Antioxidants|antioxidants|mesh-ancestor
92974194|NCT00857376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974195|NCT00857376|Protective Agents|protective agents|mesh-ancestor
92974196|NCT00857376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974197|NCT00857376|Vitamin B Complex|vitamin b complex|mesh-ancestor
92974198|NCT00857376|Vitamins|vitamins|mesh-ancestor
92974199|NCT00857376|Micronutrients|micronutrients|mesh-ancestor
92974200|NCT00618072|Metformin|metformin|mesh-list
92974201|NCT00618072|Rosiglitazone|rosiglitazone|mesh-list
92974202|NCT00618072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974203|NCT00618072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974204|NCT00959517|Artesunate|artesunate|mesh-list
92974205|NCT00959517|Chloroquine|chloroquine|mesh-list
92974206|NCT00959517|Pyrimethamine|pyrimethamine|mesh-list
92974207|NCT00959517|Primaquine|primaquine|mesh-list
92974208|NCT00959517|Sulfadoxine|sulfadoxine|mesh-list
92974209|NCT00959517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92974210|NCT00959517|Antimalarials|antimalarials|mesh-ancestor
92974211|NCT00959517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92974212|NCT00959517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92974213|NCT00959517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974214|NCT00959517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974215|NCT00959517|Antiviral Agents|antiviral agents|mesh-ancestor
92974216|NCT00959517|Schistosomicides|schistosomicides|mesh-ancestor
92974217|NCT00959517|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92974218|NCT00959517|Anthelmintics|anthelmintics|mesh-ancestor
92974219|NCT00959517|Amebicides|amebicides|mesh-ancestor
92974220|NCT00959517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974221|NCT00959517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92974222|NCT00959517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974223|NCT00959517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974224|NCT00959517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92974225|NCT00959595|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92974226|NCT00959595|Anesthetics, Local|anesthetics, local|mesh-ancestor
92974227|NCT00959595|Anesthetics|anesthetics|mesh-ancestor
92974228|NCT00959595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974229|NCT00959595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974230|NCT00959595|Sensory System Agents|sensory system agents|mesh-ancestor
92974231|NCT00959595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974232|NCT00959595|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92974233|NCT00865410|Bupropion|bupropion|mesh-list
92974234|NCT00865410|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92974235|NCT00865410|Antidepressive Agents|antidepressive agents|mesh-ancestor
92974236|NCT00865410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92974237|NCT00865410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92974238|NCT00865410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92974239|NCT00865410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974240|NCT00865410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974241|NCT00865410|Dopamine Agents|dopamine agents|mesh-ancestor
92974242|NCT00865410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974243|NCT00865410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974244|NCT00865410|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92619636|NCT04310176|Antimetabolites|antimetabolites|mesh-ancestor
92974245|NCT00865410|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92974246|NCT00865410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974247|NCT00974181|Paclitaxel|paclitaxel|mesh-list
92974248|NCT00974181|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92974249|NCT00974181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974250|NCT00974181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974251|NCT00974181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92974252|NCT00974181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92974253|NCT00974181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92974254|NCT00974181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974255|NCT00971607|Sevoflurane|sevoflurane|mesh-list
92974256|NCT00971607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92974257|NCT00971607|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92974258|NCT00971607|Anesthetics, General|anesthetics, general|mesh-ancestor
92974259|NCT00971607|Anesthetics|anesthetics|mesh-ancestor
92974260|NCT00971607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974261|NCT00971607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974262|NCT00971685|Dexamethasone|dexamethasone|mesh-list
92974263|NCT00971685|Lenalidomide|lenalidomide|mesh-list
92974264|NCT00971685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974265|NCT00971685|Antiemetics|antiemetics|mesh-ancestor
92974266|NCT00971685|Autonomic Agents|autonomic agents|mesh-ancestor
92974267|NCT00971685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974268|NCT00971685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974269|NCT00971685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92974270|NCT00971685|Glucocorticoids|glucocorticoids|mesh-ancestor
92974271|NCT00971685|Hormones|hormones|mesh-ancestor
92974272|NCT00971685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974273|NCT00971685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92974274|NCT00971685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974275|NCT00971685|Immunologic Factors|immunologic factors|mesh-ancestor
92974276|NCT00971685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92974277|NCT00971685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92974278|NCT00971685|Growth Substances|growth substances|mesh-ancestor
92974279|NCT00971685|Growth Inhibitors|growth inhibitors|mesh-ancestor
92974280|NCT03861052|Dulaglutide|dulaglutide|mesh-list
92974281|NCT03861052|Tirzepatide|tirzepatide|mesh-list
92974282|NCT03861052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974283|NCT03861052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974284|NCT03861052|Incretins|incretins|mesh-ancestor
92974285|NCT03861052|Hormones|hormones|mesh-ancestor
92974286|NCT03861052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974287|NCT00971763|Prednisolone|prednisolone|mesh-list
92974288|NCT00971763|Cyclophosphamide|cyclophosphamide|mesh-list
92974289|NCT00971763|Rituximab|rituximab|mesh-list
92974290|NCT00971763|Gemcitabine|gemcitabine|mesh-list
92974291|NCT00971763|Vincristine|vincristine|mesh-list
92974292|NCT00971763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974293|NCT00971763|Immunologic Factors|immunologic factors|mesh-ancestor
92974294|NCT00971763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974295|NCT00971763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974296|NCT00971763|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92974297|NCT00971763|Alkylating Agents|alkylating agents|mesh-ancestor
92974298|NCT00971763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974299|NCT00971763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974300|NCT00971763|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92974301|NCT00971763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92974302|NCT00971763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92974303|NCT00971763|Antimetabolites|antimetabolites|mesh-ancestor
92974304|NCT00971763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974305|NCT00971763|Tubulin Modulators|tubulin modulators|mesh-ancestor
92974306|NCT00971763|Antimitotic Agents|antimitotic agents|mesh-ancestor
92974307|NCT00971763|Mitosis Modulators|mitosis modulators|mesh-ancestor
92974308|NCT00971763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974309|NCT00971763|Glucocorticoids|glucocorticoids|mesh-ancestor
92974310|NCT00971763|Hormones|hormones|mesh-ancestor
92974311|NCT00971763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974312|NCT00971763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92974313|NCT00781196|Folic Acid|folic acid|mesh-list
92974314|NCT00781196|Hematinics|hematinics|mesh-ancestor
92974315|NCT00781196|Vitamin B Complex|vitamin b complex|mesh-ancestor
92974316|NCT00781196|Vitamins|vitamins|mesh-ancestor
92974317|NCT00781196|Micronutrients|micronutrients|mesh-ancestor
92974318|NCT00781196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974319|NCT00865644|Imiquimod|imiquimod|mesh-list
92974320|NCT00865644|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92974321|NCT00865644|Immunologic Factors|immunologic factors|mesh-ancestor
92974322|NCT00865644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974323|NCT00865644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974324|NCT00865644|Interferon Inducers|interferon inducers|mesh-ancestor
92974325|NCT00785330|Rituximab|rituximab|mesh-list
92974326|NCT00785330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92974327|NCT00785330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974328|NCT00785330|Immunologic Factors|immunologic factors|mesh-ancestor
92974329|NCT00785330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974330|NCT00785330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974331|NCT02555150|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92974332|NCT02555150|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92974333|NCT02555150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974334|NCT02555150|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92974335|NCT02555150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92974336|NCT02555150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974337|NCT02555150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974338|NCT02555150|Dopamine Agents|dopamine agents|mesh-ancestor
92974339|NCT02555150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974340|NCT05279469|Fibrin fragment D|fibrin fragment d|mesh-list
92974341|NCT05279469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92974342|NCT05279469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92974343|NCT05279469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974344|NCT05279469|Hemostatics|hemostatics|mesh-ancestor
92974345|NCT05279469|Coagulants|coagulants|mesh-ancestor
92974346|NCT00790946|Valsartan|valsartan|mesh-list
92974347|NCT00790946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92974348|NCT00790946|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92974349|NCT00790946|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92974350|NCT00790946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974351|NCT05179239|Paclitaxel|paclitaxel|mesh-list
92974352|NCT05179239|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92974353|NCT05179239|Cisplatin|cisplatin|mesh-list
92974354|NCT05179239|Carboplatin|carboplatin|mesh-list
92974355|NCT05179239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974356|NCT05179239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974357|NCT05179239|Tubulin Modulators|tubulin modulators|mesh-ancestor
92974358|NCT05179239|Antimitotic Agents|antimitotic agents|mesh-ancestor
92974359|NCT05179239|Mitosis Modulators|mitosis modulators|mesh-ancestor
92974360|NCT05179239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974361|NCT00972075|Melatonin|melatonin|mesh-list
92974362|NCT00972075|Antioxidants|antioxidants|mesh-ancestor
92974363|NCT00972075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974364|NCT00972075|Protective Agents|protective agents|mesh-ancestor
92974365|NCT00972075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974366|NCT00972075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974367|NCT00974805|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92974368|NCT00974805|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92974369|NCT00974805|Autonomic Agents|autonomic agents|mesh-ancestor
92974370|NCT00974805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974371|NCT00974805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974372|NCT00974805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92974373|NCT00974805|Respiratory System Agents|respiratory system agents|mesh-ancestor
92974374|NCT00974805|Glucocorticoids|glucocorticoids|mesh-ancestor
92974375|NCT00974805|Hormones|hormones|mesh-ancestor
92974376|NCT00974805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974377|NCT00974805|Sympathomimetics|sympathomimetics|mesh-ancestor
92974378|NCT00781352|Nitrous Oxide|nitrous oxide|mesh-list
92974379|NCT00781352|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92974380|NCT00781352|Anesthetics, General|anesthetics, general|mesh-ancestor
92974381|NCT00781352|Anesthetics|anesthetics|mesh-ancestor
92974382|NCT00781352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974383|NCT00781352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974384|NCT00781352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974385|NCT00781352|Analgesics|analgesics|mesh-ancestor
92974386|NCT00781352|Sensory System Agents|sensory system agents|mesh-ancestor
92974387|NCT00781352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974388|NCT00791024|Lidocaine|lidocaine|mesh-list
92974389|NCT00791024|Anesthetics, Local|anesthetics, local|mesh-ancestor
92974390|NCT00791024|Anesthetics|anesthetics|mesh-ancestor
92974391|NCT00791024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974392|NCT00791024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974393|NCT00791024|Sensory System Agents|sensory system agents|mesh-ancestor
92619797|NCT03460379|Citalopram|citalopram|mesh-list
92974394|NCT00791024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974396|NCT00791024|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92974397|NCT00791024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92974398|NCT00791024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974399|NCT00791024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974400|NCT03897244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92974401|NCT03897244|Amoxicillin|amoxicillin|mesh-list
92974402|NCT03897244|Metronidazole|metronidazole|mesh-list
92974403|NCT03897244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92974404|NCT03897244|Rabeprazole|rabeprazole|mesh-list
92974405|NCT03897244|Bismuth|bismuth|mesh-list
92974406|NCT03897244|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92974407|NCT03897244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974408|NCT03897244|Antitubercular Agents|antitubercular agents|mesh-ancestor
92974409|NCT03897244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92974410|NCT03897244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92974411|NCT03897244|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92974412|NCT03897244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92974413|NCT03897244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974414|NCT03897244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974415|NCT03897244|Antacids|antacids|mesh-ancestor
92974416|NCT00666536|Amlodipine|amlodipine|mesh-list
92974417|NCT00666536|Valsartan|valsartan|mesh-list
92974418|NCT00666536|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92974419|NCT00666536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92974420|NCT00666536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92974421|NCT00666536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974422|NCT00666536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974423|NCT00666536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92974424|NCT00666536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974425|NCT00666536|Vasodilator Agents|vasodilator agents|mesh-ancestor
92974426|NCT00666536|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92974427|NCT00666536|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92974428|NCT00519532|Rotigotine|rotigotine|mesh-list
92974429|NCT00519532|Dopamine Agonists|dopamine agonists|mesh-ancestor
92974430|NCT00519532|Dopamine Agents|dopamine agents|mesh-ancestor
92974431|NCT00519532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974432|NCT00519532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974433|NCT00519532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974434|NCT00666458|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92974435|NCT00666458|Saxagliptin|saxagliptin|mesh-list
92974436|NCT00666458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974437|NCT00666458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974438|NCT00666458|Incretins|incretins|mesh-ancestor
92974439|NCT00666458|Hormones|hormones|mesh-ancestor
92974440|NCT00666458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974441|NCT00666458|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92974442|NCT00666458|Protease Inhibitors|protease inhibitors|mesh-ancestor
92974443|NCT00666458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974444|NCT00666458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974445|NCT00974961|Bupivacaine|bupivacaine|mesh-list
92974446|NCT00974961|Levobupivacaine|levobupivacaine|mesh-list
92974447|NCT00974961|Anesthetics, Local|anesthetics, local|mesh-ancestor
92974448|NCT00974961|Anesthetics|anesthetics|mesh-ancestor
92974449|NCT00974961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974450|NCT00974961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974451|NCT00974961|Sensory System Agents|sensory system agents|mesh-ancestor
92974452|NCT00974961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974453|NCT00511108|Pioglitazone|pioglitazone|mesh-list
92974454|NCT00511108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92974455|NCT00511108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974456|NCT00511108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974457|NCT00511108|Incretins|incretins|mesh-ancestor
92974458|NCT00511108|Hormones|hormones|mesh-ancestor
92974459|NCT00511108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974460|NCT00511108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92974461|NCT00511108|Protease Inhibitors|protease inhibitors|mesh-ancestor
92974462|NCT00511108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974463|NCT00511108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974464|NCT00781586|Caffeine|caffeine|mesh-list
92166919|NCT04935450|Dimercaprol|dimercaprol|mesh-list
92974465|NCT00781586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974466|NCT00781586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92974467|NCT00781586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92974468|NCT00781586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974469|NCT00781586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974470|NCT00781586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92974471|NCT00781586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92974472|NCT00781586|Purinergic Agents|purinergic agents|mesh-ancestor
92974473|NCT00781586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974474|NCT00510952|Insulin|insulin|mesh-list
92974475|NCT00510952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92974476|NCT00510952|Insulin Glargine|insulin glargine|mesh-list
92974477|NCT00510952|Insulin Lispro|insulin lispro|mesh-list
92974478|NCT00510952|Protamines|protamines|mesh-list
92974479|NCT00510952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974480|NCT00510952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974481|NCT00510952|Heparin Antagonists|heparin antagonists|mesh-ancestor
92974482|NCT00510952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974483|NCT00510952|Coagulants|coagulants|mesh-ancestor
92974484|NCT00617604|Mycophenolic Acid|mycophenolic acid|mesh-list
92974485|NCT00617604|Alefacept|alefacept|mesh-list
92974486|NCT00617604|Tacrolimus|tacrolimus|mesh-list
92974487|NCT00617604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974488|NCT00617604|Immunologic Factors|immunologic factors|mesh-ancestor
92974489|NCT00617604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974490|NCT00617604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92974491|NCT00617604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974492|NCT00617604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974493|NCT00617604|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92974494|NCT00617604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974495|NCT00617604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92974496|NCT00617604|Antitubercular Agents|antitubercular agents|mesh-ancestor
92974497|NCT00617604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92974498|NCT00617604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974499|NCT00617604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92974500|NCT01012570|Adalimumab|adalimumab|mesh-list
92974501|NCT01012570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92974502|NCT01012570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974503|NCT01012570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974504|NCT00865878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92974505|NCT00865878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92974506|NCT00865878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92974507|NCT00661622|Molgramostim|molgramostim|mesh-list
92974508|NCT00661622|Sargramostim|sargramostim|mesh-list
92974509|NCT00661622|Immunologic Factors|immunologic factors|mesh-ancestor
92974510|NCT00661622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974511|NCT00661622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974512|NCT00781820|Bifonazole|bifonazole|mesh-list
92974513|NCT00781820|Antifungal Agents|antifungal agents|mesh-ancestor
92974514|NCT00781820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974515|NCT00786110|Paclitaxel|paclitaxel|mesh-list
92974516|NCT00786110|Sorafenib|sorafenib|mesh-list
92974517|NCT00786110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974518|NCT00786110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974519|NCT00786110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92974520|NCT00786110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92974521|NCT00786110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92974522|NCT00786110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974523|NCT00786110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974524|NCT00786110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974525|NCT00791804|Fentanyl|fentanyl|mesh-list
92974526|NCT00791804|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92974527|NCT00791804|Narcotics|narcotics|mesh-ancestor
92974528|NCT00791804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974529|NCT00791804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974530|NCT00791804|Analgesics|analgesics|mesh-ancestor
92974531|NCT00791804|Sensory System Agents|sensory system agents|mesh-ancestor
92974532|NCT00791804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974533|NCT00791804|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92974534|NCT00791804|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92974535|NCT00791804|Anesthetics, General|anesthetics, general|mesh-ancestor
92974536|NCT00791804|Anesthetics|anesthetics|mesh-ancestor
92974537|NCT00791960|Dimenhydrinate|dimenhydrinate|mesh-list
92974538|NCT00791960|Antiemetics|antiemetics|mesh-ancestor
92974539|NCT00791960|Autonomic Agents|autonomic agents|mesh-ancestor
92974540|NCT00791960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974541|NCT00791960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974542|NCT00791960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92619935|NCT02726581|Dexamethasone|dexamethasone|mesh-list
92974543|NCT00791960|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92974544|NCT00791960|Histamine Antagonists|histamine antagonists|mesh-ancestor
92974545|NCT00791960|Histamine Agents|histamine agents|mesh-ancestor
92974546|NCT00791960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974547|NCT00791960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974549|NCT00792350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974550|NCT00792350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974551|NCT00792350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974552|NCT00792350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974553|NCT00792584|Efavirenz|efavirenz|mesh-list
92974554|NCT00792584|Etravirine|etravirine|mesh-list
92974555|NCT00792584|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92974556|NCT00792584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92974557|NCT00792584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974558|NCT00792584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974559|NCT00792584|Antiviral Agents|antiviral agents|mesh-ancestor
92974560|NCT00792584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974561|NCT00792584|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92974562|NCT00792584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92974563|NCT00792584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92974564|NCT00792584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92974565|NCT00792584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92974566|NCT00792584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92974567|NCT00792662|Methylphenidate|methylphenidate|mesh-list
92974568|NCT00792662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92974569|NCT00792662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974570|NCT00792662|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92974571|NCT00792662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92974572|NCT00792662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974573|NCT00792662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974574|NCT00792662|Dopamine Agents|dopamine agents|mesh-ancestor
92974575|NCT00792662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974576|NCT02556086|Sofosbuvir|sofosbuvir|mesh-list
92974577|NCT02556086|Antiviral Agents|antiviral agents|mesh-ancestor
92974578|NCT02556086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974579|NCT04093752|Insulin Glargine|insulin glargine|mesh-list
92974580|NCT04093752|Tirzepatide|tirzepatide|mesh-list
92974581|NCT04093752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974582|NCT04093752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974583|NCT04093752|Incretins|incretins|mesh-ancestor
92974584|NCT04093752|Hormones|hormones|mesh-ancestor
92974585|NCT04093752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974586|NCT02544282|Acetaminophen|acetaminophen|mesh-list
92974587|NCT02544282|Sufentanil|sufentanil|mesh-list
92974588|NCT02544282|Tramadol|tramadol|mesh-list
92974589|NCT02544282|Pirinitramide|pirinitramide|mesh-list
92974590|NCT02544282|Propofol|propofol|mesh-list
92974591|NCT02544282|Sevoflurane|sevoflurane|mesh-list
92974592|NCT02544282|Levobupivacaine|levobupivacaine|mesh-list
92974593|NCT02544282|Atracurium|atracurium|mesh-list
92974594|NCT02544282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92974595|NCT02544282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974596|NCT02544282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974597|NCT02544282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92974598|NCT02544282|Anesthetics, General|anesthetics, general|mesh-ancestor
92974599|NCT02544282|Anesthetics|anesthetics|mesh-ancestor
92974600|NCT02544282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974601|NCT02544282|Analgesics|analgesics|mesh-ancestor
92974602|NCT02544282|Sensory System Agents|sensory system agents|mesh-ancestor
92974603|NCT02544282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974604|NCT02544282|Antipyretics|antipyretics|mesh-ancestor
92974605|NCT02544282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92974606|NCT02544282|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92974607|NCT02544282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92974608|NCT02544282|Narcotics|narcotics|mesh-ancestor
92974609|NCT02544282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92974610|NCT02544282|Anesthetics, Local|anesthetics, local|mesh-ancestor
92166926|NCT02181231|Narcotics|narcotics|mesh-ancestor
92974611|NCT02544282|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92974612|NCT02544282|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92974613|NCT02544282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92974614|NCT02544282|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92974615|NCT02544282|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92974616|NCT02544282|Cholinergic Agents|cholinergic agents|mesh-ancestor
92974617|NCT02544282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974618|NCT02544282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974619|NCT04041648|Treprostinil|treprostinil|mesh-list
92620013|NCT01964989|Vaccines|vaccines|mesh-list
92974620|NCT04041648|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92974621|NCT04041648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92974622|NCT00666224|Glatiramer Acetate|glatiramer acetate|mesh-list
92974623|NCT00666224|(T,G)-A-L|(t,g)-a-l|mesh-list
92974624|NCT00666224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92974625|NCT00666224|Immunologic Factors|immunologic factors|mesh-ancestor
92974626|NCT00666224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974627|NCT00666224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974628|NCT00666224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974629|NCT00663962|Pregabalin|pregabalin|mesh-list
92974630|NCT00663962|Analgesics|analgesics|mesh-ancestor
92974631|NCT00663962|Sensory System Agents|sensory system agents|mesh-ancestor
92974632|NCT00663962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974633|NCT00663962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974634|NCT00663962|Anticonvulsants|anticonvulsants|mesh-ancestor
92974635|NCT00663962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92974636|NCT00663962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974637|NCT00663962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974638|NCT00663962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92974639|NCT00663962|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92974640|NCT00663962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92974641|NCT00663962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974642|NCT00663962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92974643|NCT00858624|Ketamine|ketamine|mesh-list
92974644|NCT00858624|Analgesics|analgesics|mesh-ancestor
92974645|NCT00858624|Sensory System Agents|sensory system agents|mesh-ancestor
92974646|NCT00858624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974647|NCT00858624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974648|NCT00858624|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92974649|NCT00858624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92974650|NCT00858624|Anesthetics, General|anesthetics, general|mesh-ancestor
92974651|NCT00858624|Anesthetics|anesthetics|mesh-ancestor
92974652|NCT00858624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974653|NCT00858624|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92974654|NCT00858624|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92974655|NCT00858624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974656|NCT00858624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974657|NCT00960453|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92974658|NCT00960453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974659|NCT00960453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974660|NCT00960453|Incretins|incretins|mesh-ancestor
92974661|NCT00960453|Hormones|hormones|mesh-ancestor
92974662|NCT00960453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974663|NCT00960453|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92974664|NCT00960453|Protease Inhibitors|protease inhibitors|mesh-ancestor
92974665|NCT00960453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974666|NCT00960453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974667|NCT00265759|Letrozole|letrozole|mesh-list
92974668|NCT00265759|Anastrozole|anastrozole|mesh-list
92974669|NCT00265759|Exemestane|exemestane|mesh-list
92974670|NCT00265759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974671|NCT00265759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92974672|NCT00265759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92974673|NCT00265759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974674|NCT00265759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974675|NCT00265759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92974676|NCT00265759|Hormone Antagonists|hormone antagonists|mesh-ancestor
92974677|NCT00265759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974678|NCT00265759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974679|NCT00265759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92974680|NCT00972387|Prednisone|prednisone|mesh-list
92974681|NCT00972387|Prednisolone|prednisolone|mesh-list
92974682|NCT00972387|Cyclophosphamide|cyclophosphamide|mesh-list
92974683|NCT00972387|Doxorubicin|doxorubicin|mesh-list
92974684|NCT00972387|Vincristine|vincristine|mesh-list
92974685|NCT00972387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974686|NCT00972387|Immunologic Factors|immunologic factors|mesh-ancestor
92974687|NCT00972387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974688|NCT00972387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974689|NCT00972387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92974690|NCT00972387|Alkylating Agents|alkylating agents|mesh-ancestor
92974691|NCT00972387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974692|NCT00972387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974693|NCT00972387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92974694|NCT00972387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92974695|NCT00972387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92974696|NCT00972387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92974697|NCT00972387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974698|NCT00972387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974699|NCT00972387|Glucocorticoids|glucocorticoids|mesh-ancestor
92974700|NCT00972387|Hormones|hormones|mesh-ancestor
92974701|NCT00972387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974702|NCT00972387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92974703|NCT00972387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974704|NCT00972387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92974705|NCT00972387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92974706|NCT00972387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92974707|NCT00744263|Vaccines|vaccines|mesh-list
92974708|NCT00744263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92974709|NCT00744263|Immunologic Factors|immunologic factors|mesh-ancestor
92974710|NCT00744263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974711|NCT00783068|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
92974712|NCT00783068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92974713|NCT00783068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92974714|NCT00783068|Cholinergic Agents|cholinergic agents|mesh-ancestor
92974715|NCT00783068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974716|NCT00783068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974717|NCT00783068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974718|NCT00866736|Dasatinib|dasatinib|mesh-list
92974719|NCT00866736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974720|NCT00866736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974721|NCT00866736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974722|NCT00866736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974723|NCT00792818|Ibuprofen|ibuprofen|mesh-list
92974724|NCT00792818|Curcumin|curcumin|mesh-list
92974725|NCT00792818|Turmeric extract|turmeric extract|mesh-list
92974726|NCT00792818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92974727|NCT00792818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974728|NCT00792818|Analgesics|analgesics|mesh-ancestor
92974729|NCT00792818|Sensory System Agents|sensory system agents|mesh-ancestor
92974730|NCT00792818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974731|NCT00792818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974732|NCT00792818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974733|NCT00792818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974734|NCT00792818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92974735|NCT00792818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974736|NCT00792818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974737|NCT00792818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974738|NCT00792818|Antioxidants|antioxidants|mesh-ancestor
92974739|NCT00792818|Protective Agents|protective agents|mesh-ancestor
92974740|NCT00972465|Nimotuzumab|nimotuzumab|mesh-list
92974741|NCT00972465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92974742|NCT00972465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974743|NCT00975351|Tetrahydrofolates|tetrahydrofolates|mesh-list
92974744|NCT00975351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974745|NCT00975351|Vitamin B Complex|vitamin b complex|mesh-ancestor
92974746|NCT00975351|Vitamins|vitamins|mesh-ancestor
92974747|NCT00975351|Micronutrients|micronutrients|mesh-ancestor
92974748|NCT01071187|Varenicline|varenicline|mesh-list
92974749|NCT01071187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92974750|NCT01071187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92974751|NCT01071187|Cholinergic Agents|cholinergic agents|mesh-ancestor
92974752|NCT01071187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166929|NCT02181231|Analgesics|analgesics|mesh-ancestor
92974753|NCT01071187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974754|NCT01071187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974755|NCT00618774|Amlodipine|amlodipine|mesh-list
92974756|NCT00618774|Telmisartan|telmisartan|mesh-list
92974757|NCT00618774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92974758|NCT00618774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92974759|NCT00618774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92974760|NCT00618774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974761|NCT00618774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92974762|NCT00618774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974763|NCT00618774|Vasodilator Agents|vasodilator agents|mesh-ancestor
92974764|NCT00618774|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92974765|NCT00618774|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92974766|NCT00917345|Captopril|captopril|mesh-list
92974767|NCT00917345|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92974769|NCT00917345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974770|NCT00917345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974771|NCT00917345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92974772|NCT00793052|Dexamethasone|dexamethasone|mesh-list
92974773|NCT00793052|Etoricoxib|etoricoxib|mesh-list
92974774|NCT00793052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974775|NCT00793052|Antiemetics|antiemetics|mesh-ancestor
92974776|NCT00793052|Autonomic Agents|autonomic agents|mesh-ancestor
92974777|NCT00793052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974778|NCT00793052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974779|NCT00793052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92974780|NCT00793052|Glucocorticoids|glucocorticoids|mesh-ancestor
92974781|NCT00793052|Hormones|hormones|mesh-ancestor
92974782|NCT00793052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974783|NCT00793052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92974784|NCT00793052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974785|NCT00793052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92974786|NCT00793052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92974787|NCT00793052|Analgesics|analgesics|mesh-ancestor
92974788|NCT00793052|Sensory System Agents|sensory system agents|mesh-ancestor
92974789|NCT00793052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974790|NCT00793052|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92974791|NCT00793052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92974792|NCT00793052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974793|NCT00793052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974794|NCT02555852|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92974795|NCT02555852|Esomeprazole|esomeprazole|mesh-list
92974796|NCT02555852|Omeprazole|omeprazole|mesh-list
92974797|NCT02555852|Rabeprazole|rabeprazole|mesh-list
92974798|NCT02555852|Pantoprazole|pantoprazole|mesh-list
92974799|NCT02555852|Lansoprazole|lansoprazole|mesh-list
92974800|NCT02555852|Famotidine|famotidine|mesh-list
92974801|NCT02555852|Ranitidine|ranitidine|mesh-list
92974802|NCT02555852|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92974803|NCT02555852|Cimetidine|cimetidine|mesh-list
92974804|NCT02555852|Nizatidine|nizatidine|mesh-list
92974805|NCT02555852|Lafutidine|lafutidine|mesh-list
92974806|NCT02555852|Roxatidine acetate|roxatidine acetate|mesh-list
92974807|NCT02555852|Bismuth|bismuth|mesh-list
92974808|NCT02555852|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92974809|NCT02555852|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
92974810|NCT02555852|Histamine|histamine|mesh-list
92974811|NCT02555852|Histamine phosphate|histamine phosphate|mesh-list
92974812|NCT02555852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974813|NCT02555852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92974814|NCT02555852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92974815|NCT02555852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974816|NCT02555852|Antacids|antacids|mesh-ancestor
92974817|NCT02555852|Histamine Antagonists|histamine antagonists|mesh-ancestor
92974818|NCT02555852|Histamine Agents|histamine agents|mesh-ancestor
92974819|NCT02555852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974820|NCT02555852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974821|NCT02555852|Histamine Agonists|histamine agonists|mesh-ancestor
92974822|NCT02555852|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92974823|NCT02555852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92974824|NCT02555852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974825|NCT04091009|Buprenorphine|buprenorphine|mesh-list
92974826|NCT04091009|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92974827|NCT04091009|Naloxone|naloxone|mesh-list
92974828|NCT04091009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92974829|NCT04091009|Narcotics|narcotics|mesh-ancestor
92974830|NCT04091009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974831|NCT04091009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974832|NCT04091009|Analgesics|analgesics|mesh-ancestor
92974833|NCT04091009|Sensory System Agents|sensory system agents|mesh-ancestor
92974834|NCT04091009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974835|NCT04091009|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92974836|NCT02597231|Melatonin|melatonin|mesh-list
92974837|NCT02597231|Antioxidants|antioxidants|mesh-ancestor
92974838|NCT02597231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974839|NCT02597231|Protective Agents|protective agents|mesh-ancestor
92974840|NCT02597231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974841|NCT02597231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92974842|NCT00545571|Epoetin Alfa|epoetin alfa|mesh-list
92974843|NCT00545571|Hematinics|hematinics|mesh-ancestor
92974844|NCT00783380|Vaccines|vaccines|mesh-list
92974845|NCT00783380|Immunologic Factors|immunologic factors|mesh-ancestor
92974846|NCT00783380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974847|NCT04008225|Dimercaprol|dimercaprol|mesh-list
92974848|NCT04008225|Chelating Agents|chelating agents|mesh-ancestor
92974849|NCT04008225|Sequestering Agents|sequestering agents|mesh-ancestor
92974850|NCT04008225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974851|NCT00748709|Afatinib|afatinib|mesh-list
92974852|NCT00748709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974853|NCT00748709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92974854|NCT00748709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974855|NCT00748709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974856|NCT02597309|Canagliflozin|canagliflozin|mesh-list
92974857|NCT02597309|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92974858|NCT02597309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974859|NCT02597309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974860|NCT02597309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974861|NCT00863148|Busulfan|busulfan|mesh-list
92974862|NCT00863148|Clofarabine|clofarabine|mesh-list
92974863|NCT00863148|Alkylating Agents|alkylating agents|mesh-ancestor
92974864|NCT00863148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974865|NCT00863148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974866|NCT00863148|Immunologic Factors|immunologic factors|mesh-ancestor
92974867|NCT00863148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974868|NCT00863148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92974869|NCT00863148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974870|NCT00863148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92974871|NCT00863148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92974872|NCT00863148|Antimetabolites|antimetabolites|mesh-ancestor
92974873|NCT00786734|Pitavastatin|pitavastatin|mesh-list
92974874|NCT00786734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92974875|NCT00786734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92974876|NCT00786734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92974877|NCT00786734|Antimetabolites|antimetabolites|mesh-ancestor
92974878|NCT00786734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974879|NCT00786734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974880|NCT00786734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92974881|NCT00263887|Protease Inhibitors|protease inhibitors|mesh-list
92974882|NCT00263887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92974883|NCT00263887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974884|NCT00263887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974885|NCT00263887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92974886|NCT00263887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92974887|NCT00867126|Pioglitazone|pioglitazone|mesh-list
92974888|NCT00867126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92974889|NCT00867126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974890|NCT00748553|Paclitaxel|paclitaxel|mesh-list
92974891|NCT00748553|Azacitidine|azacitidine|mesh-list
92974892|NCT00748553|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92974893|NCT00748553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974894|NCT00748553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974895|NCT00748553|Tubulin Modulators|tubulin modulators|mesh-ancestor
92974896|NCT00748553|Antimitotic Agents|antimitotic agents|mesh-ancestor
92974897|NCT00748553|Mitosis Modulators|mitosis modulators|mesh-ancestor
92974898|NCT00748553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974899|NCT00748553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92974900|NCT00748553|Antimetabolites|antimetabolites|mesh-ancestor
92974901|NCT00748553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974902|NCT00661388|Epoetin Alfa|epoetin alfa|mesh-list
92974903|NCT00661388|Hematinics|hematinics|mesh-ancestor
92974904|NCT00972855|Bicalutamide|bicalutamide|mesh-list
92974905|NCT00972855|Androgen Antagonists|androgen antagonists|mesh-ancestor
92974906|NCT00972855|Hormone Antagonists|hormone antagonists|mesh-ancestor
92974907|NCT00972855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974908|NCT00972855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974909|NCT00972855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974910|NCT00972933|Ipilimumab|ipilimumab|mesh-list
92974911|NCT00972933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92974912|NCT00972933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527925|NCT00034645|Antifungal Agents|antifungal agents|mesh-ancestor
92974913|NCT00972933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92974914|NCT00972933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974915|NCT00263575|Fentanyl|fentanyl|mesh-list
92974916|NCT00263575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92974917|NCT00263575|Narcotics|narcotics|mesh-ancestor
92974918|NCT00263575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620323|NCT02913430|Tamoxifen|tamoxifen|mesh-list
92974919|NCT00263575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974921|NCT00263575|Sensory System Agents|sensory system agents|mesh-ancestor
92974922|NCT00263575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92974923|NCT00263575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92974924|NCT00263575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92974925|NCT00263575|Anesthetics, General|anesthetics, general|mesh-ancestor
92974926|NCT00263575|Anesthetics|anesthetics|mesh-ancestor
92974927|NCT00975663|Tacrolimus|tacrolimus|mesh-list
92974928|NCT00975663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974929|NCT00975663|Immunologic Factors|immunologic factors|mesh-ancestor
92974930|NCT00975663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974931|NCT00975663|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92974932|NCT00975663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974933|NCT00975663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974934|NCT00570128|Donepezil|donepezil|mesh-list
92974935|NCT00570128|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92974936|NCT00570128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974937|NCT00570128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974938|NCT00570128|Cholinergic Agents|cholinergic agents|mesh-ancestor
92974939|NCT00570128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92974940|NCT00570128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974941|NCT00570128|Nootropic Agents|nootropic agents|mesh-ancestor
92974942|NCT00960921|Iron|iron|mesh-list
92974943|NCT00960921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92974944|NCT00960921|Trace Elements|trace elements|mesh-ancestor
92974945|NCT00960921|Micronutrients|micronutrients|mesh-ancestor
92974946|NCT00960921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974947|NCT00960921|Hematinics|hematinics|mesh-ancestor
92974948|NCT00863460|Cytarabine|cytarabine|mesh-list
92974949|NCT00863460|Prednisone|prednisone|mesh-list
92974950|NCT00863460|Cyclophosphamide|cyclophosphamide|mesh-list
92974951|NCT00863460|Busulfan|busulfan|mesh-list
92974952|NCT00863460|Thiotepa|thiotepa|mesh-list
92974953|NCT00863460|Carmustine|carmustine|mesh-list
92974954|NCT00863460|Methotrexate|methotrexate|mesh-list
92974955|NCT00863460|Etoposide|etoposide|mesh-list
92974956|NCT00863460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974957|NCT00863460|Immunologic Factors|immunologic factors|mesh-ancestor
92974958|NCT00863460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974959|NCT00863460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92974960|NCT00863460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92974961|NCT00863460|Alkylating Agents|alkylating agents|mesh-ancestor
92974962|NCT00863460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974963|NCT00863460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974964|NCT00863460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92974965|NCT00863460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92974966|NCT00863460|Glucocorticoids|glucocorticoids|mesh-ancestor
92974967|NCT00863460|Hormones|hormones|mesh-ancestor
92974968|NCT00863460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92974969|NCT00863460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92974970|NCT00863460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92974971|NCT00863460|Abortifacient Agents|abortifacient agents|mesh-ancestor
92974972|NCT00863460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92974973|NCT00863460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92974974|NCT00863460|Antimetabolites|antimetabolites|mesh-ancestor
92974975|NCT00863460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92974976|NCT00863460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92974977|NCT00863460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92974978|NCT00863460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92974979|NCT00863460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92974980|NCT00863460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92974981|NCT00863460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92974982|NCT00863460|Antiviral Agents|antiviral agents|mesh-ancestor
92974983|NCT00863460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974984|NCT00262951|Interferons|interferons|mesh-list
92974985|NCT00262951|Interferon-alpha|interferon-alpha|mesh-list
92974986|NCT00262951|Interferon alpha-2|interferon alpha-2|mesh-list
92974987|NCT00262951|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92974988|NCT00262951|Cisplatin|cisplatin|mesh-list
92974989|NCT00262951|Fluorouracil|fluorouracil|mesh-list
92974990|NCT00262951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92974991|NCT00262951|Antimetabolites|antimetabolites|mesh-ancestor
92974992|NCT00262951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92974993|NCT00262951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92974994|NCT00262951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92974995|NCT00262951|Immunologic Factors|immunologic factors|mesh-ancestor
92974996|NCT00262951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92974997|NCT00262951|Antiviral Agents|antiviral agents|mesh-ancestor
92974998|NCT00262951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92974999|NCT02597153|Mitoxantrone|mitoxantrone|mesh-list
92975000|NCT02597153|Analgesics|analgesics|mesh-ancestor
92975001|NCT02597153|Sensory System Agents|sensory system agents|mesh-ancestor
92975002|NCT02597153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975003|NCT02597153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975004|NCT02597153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975005|NCT02597153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92975006|NCT02597153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975007|NCT02597153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975008|NCT02597153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975009|NCT00975741|Mometasone Furoate|mometasone furoate|mesh-list
92975010|NCT00975741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92975011|NCT00975741|Dermatologic Agents|dermatologic agents|mesh-ancestor
92975012|NCT00975741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92975013|NCT00262873|Bortezomib|bortezomib|mesh-list
92975014|NCT00262873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975015|NCT00975819|Sirolimus|sirolimus|mesh-list
92975016|NCT00975819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92975017|NCT00975819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975018|NCT00975819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92975019|NCT00975819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975020|NCT00975819|Antifungal Agents|antifungal agents|mesh-ancestor
92975021|NCT00975819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975022|NCT00975819|Immunologic Factors|immunologic factors|mesh-ancestor
92975023|NCT00975819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047012|NCT01051934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047013|NCT01051934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93047014|NCT01051934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93047015|NCT01051934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93047016|NCT01051934|Growth Substances|growth substances|mesh-ancestor
93047017|NCT01051934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047018|NCT01051934|Growth Inhibitors|growth inhibitors|mesh-ancestor
93047019|NCT01325168|Oxytocin|oxytocin|mesh-list
93047020|NCT01325168|Oxytocics|oxytocics|mesh-ancestor
93047021|NCT01325168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93047022|NCT01325168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047023|NCT00316914|Magnesium Sulfate|magnesium sulfate|mesh-list
93047024|NCT00316914|Calcium|calcium|mesh-list
93047025|NCT00316914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93047026|NCT00316914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047027|NCT00316914|Analgesics|analgesics|mesh-ancestor
93047028|NCT00316914|Sensory System Agents|sensory system agents|mesh-ancestor
93047029|NCT00316914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047030|NCT00316914|Anesthetics|anesthetics|mesh-ancestor
93047031|NCT00316914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047032|NCT00316914|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93047033|NCT00316914|Anticonvulsants|anticonvulsants|mesh-ancestor
93047034|NCT00316914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93047035|NCT00316914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047036|NCT00316914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047037|NCT00316914|Tocolytic Agents|tocolytic agents|mesh-ancestor
93047038|NCT00316914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93047039|NCT00316602|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93047040|NCT00316602|Antiviral Agents|antiviral agents|mesh-ancestor
93047041|NCT00316602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047042|NCT00335972|Dexmedetomidine|dexmedetomidine|mesh-list
93047043|NCT00335972|Remifentanil|remifentanil|mesh-list
93047044|NCT00335972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93047045|NCT00335972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047046|NCT00335972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047047|NCT00335972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047048|NCT00335972|Analgesics|analgesics|mesh-ancestor
93047049|NCT00335972|Sensory System Agents|sensory system agents|mesh-ancestor
93047050|NCT00335972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047051|NCT00335972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93047052|NCT00335972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93047053|NCT00335972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93047054|NCT00335972|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047055|NCT00335972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047056|NCT00335972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047057|NCT00335972|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92975025|NCT00859872|Risperidone|risperidone|mesh-list
92975026|NCT00859872|Haloperidol decanoate|haloperidol decanoate|mesh-list
92975027|NCT00859872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92975028|NCT00859872|Serotonin Agents|serotonin agents|mesh-ancestor
92975029|NCT00859872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975030|NCT00859872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975031|NCT00859872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975032|NCT00859872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92975033|NCT00859872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92975034|NCT00859872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975035|NCT00859872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92975036|NCT00859872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92975037|NCT00859872|Dopamine Agents|dopamine agents|mesh-ancestor
92975038|NCT00859872|Antiemetics|antiemetics|mesh-ancestor
92975039|NCT00859872|Autonomic Agents|autonomic agents|mesh-ancestor
92975040|NCT00859872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975041|NCT00859872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975042|NCT00859872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92975043|NCT02555696|Paclitaxel|paclitaxel|mesh-list
92975044|NCT02555696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92975045|NCT02555696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975046|NCT02555696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92975047|NCT02555696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92975048|NCT02555696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92975049|NCT02555696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975050|NCT00961077|Oxaliplatin|oxaliplatin|mesh-list
92975051|NCT00961077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975052|NCT05147493|Dexamethasone|dexamethasone|mesh-list
92975053|NCT05147493|Cyclophosphamide|cyclophosphamide|mesh-list
92975054|NCT05147493|Lenalidomide|lenalidomide|mesh-list
92975055|NCT05147493|Bortezomib|bortezomib|mesh-list
92975056|NCT05147493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975057|NCT05147493|Immunologic Factors|immunologic factors|mesh-ancestor
92975058|NCT05147493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975059|NCT05147493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975060|NCT05147493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92975061|NCT05147493|Alkylating Agents|alkylating agents|mesh-ancestor
92975062|NCT05147493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975063|NCT05147493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975064|NCT05147493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92975065|NCT05147493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92975066|NCT05147493|Antiemetics|antiemetics|mesh-ancestor
92975067|NCT05147493|Autonomic Agents|autonomic agents|mesh-ancestor
92975068|NCT05147493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975069|NCT05147493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975070|NCT05147493|Glucocorticoids|glucocorticoids|mesh-ancestor
92975071|NCT05147493|Hormones|hormones|mesh-ancestor
92975072|NCT05147493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975073|NCT05147493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92975074|NCT05147493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975075|NCT05147493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975076|NCT05147493|Growth Substances|growth substances|mesh-ancestor
92975077|NCT05147493|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975078|NCT00573534|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92975079|NCT00573534|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92975080|NCT00573534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975081|NCT00573534|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92975082|NCT00573534|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92975083|NCT00573534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92975084|NCT00573534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975085|NCT00573534|Dopamine Agents|dopamine agents|mesh-ancestor
92975086|NCT00573534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975087|NCT03974425|Aflibercept|aflibercept|mesh-list
92975088|NCT03974425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975089|NCT03974425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975090|NCT03974425|Growth Substances|growth substances|mesh-ancestor
92975091|NCT03974425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975092|NCT03974425|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975093|NCT03974425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975094|NCT00975897|Leucovorin|leucovorin|mesh-list
92975095|NCT00975897|Bevacizumab|bevacizumab|mesh-list
92620541|NCT00150605|Carbamazepine|carbamazepine|mesh-list
92975096|NCT00975897|Cetuximab|cetuximab|mesh-list
92975097|NCT00975897|Fluorouracil|fluorouracil|mesh-list
92975098|NCT00975897|Oxaliplatin|oxaliplatin|mesh-list
92975099|NCT00975897|Irinotecan|irinotecan|mesh-list
92975100|NCT00975897|Calcium|calcium|mesh-list
92975101|NCT00975897|Levoleucovorin|levoleucovorin|mesh-list
92975102|NCT00975897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975103|NCT00975897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975104|NCT00975897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975105|NCT00975897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975106|NCT00975897|Growth Substances|growth substances|mesh-ancestor
92975107|NCT00975897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975108|NCT00975897|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975109|NCT00975897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92975110|NCT00975897|Antimetabolites|antimetabolites|mesh-ancestor
92975111|NCT00975897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975112|NCT00975897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975113|NCT00975897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975114|NCT00975897|Immunologic Factors|immunologic factors|mesh-ancestor
92975115|NCT00975897|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92975116|NCT00975897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975117|NCT00975897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975118|NCT00975897|Antidotes|antidotes|mesh-ancestor
92975119|NCT00975897|Protective Agents|protective agents|mesh-ancestor
92975120|NCT00975897|Vitamin B Complex|vitamin b complex|mesh-ancestor
92975121|NCT00975897|Vitamins|vitamins|mesh-ancestor
92975122|NCT00975897|Micronutrients|micronutrients|mesh-ancestor
92975123|NCT00867672|Decitabine|decitabine|mesh-list
92975124|NCT00867672|Tretinoin|tretinoin|mesh-list
92975125|NCT00867672|Valproic Acid|valproic acid|mesh-list
92975126|NCT00867672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975127|NCT00867672|Antimetabolites|antimetabolites|mesh-ancestor
92975128|NCT00867672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975129|NCT00867672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975130|NCT00867672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975131|NCT00867672|Keratolytic Agents|keratolytic agents|mesh-ancestor
92975132|NCT00867672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92975133|NCT00867672|Anticonvulsants|anticonvulsants|mesh-ancestor
92975134|NCT00867672|GABA Agents|gaba agents|mesh-ancestor
92975135|NCT00867672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975136|NCT00867672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975137|NCT00867672|Antimanic Agents|antimanic agents|mesh-ancestor
92975138|NCT00867672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92975139|NCT00867672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975140|NCT00867672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92975141|NCT00783926|Hemagglutinins|hemagglutinins|mesh-list
92975142|NCT00783926|Vaccines|vaccines|mesh-list
92975143|NCT00783926|Immunologic Factors|immunologic factors|mesh-ancestor
92975144|NCT00783926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975145|NCT00783926|Agglutinins|agglutinins|mesh-ancestor
92975146|NCT00783926|Coagulants|coagulants|mesh-ancestor
92975147|NCT01071499|Morphine|morphine|mesh-list
92975148|NCT01071499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92975149|NCT01071499|Narcotics|narcotics|mesh-ancestor
92975150|NCT01071499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975151|NCT01071499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975152|NCT01071499|Analgesics|analgesics|mesh-ancestor
92975153|NCT01071499|Sensory System Agents|sensory system agents|mesh-ancestor
92975154|NCT01071499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975155|NCT00961155|Formoterol Fumarate|formoterol fumarate|mesh-list
92975156|NCT00961155|Montelukast|montelukast|mesh-list
92975157|NCT00961155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92975158|NCT00961155|Autonomic Agents|autonomic agents|mesh-ancestor
92975159|NCT00961155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975160|NCT00961155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975161|NCT00961155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92975162|NCT00961155|Respiratory System Agents|respiratory system agents|mesh-ancestor
92975163|NCT00961155|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92975164|NCT00961155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92975165|NCT00961155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92975166|NCT00961155|Adrenergic Agents|adrenergic agents|mesh-ancestor
92975167|NCT00961155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975168|NCT00961155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975169|NCT00961155|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92975170|NCT00961155|Hormone Antagonists|hormone antagonists|mesh-ancestor
92975171|NCT00961155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975172|NCT00961155|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92975173|NCT00961155|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92975174|NCT00260533|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92975175|NCT00260533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92975176|NCT00260533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92975177|NCT00260533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92975178|NCT00260533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975179|NCT00260533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92975180|NCT00260533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975181|NCT00260533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975183|NCT00973245|Rivaroxaban|rivaroxaban|mesh-list
92975184|NCT00973245|Anticoagulants|anticoagulants|mesh-ancestor
92975185|NCT00973245|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92975186|NCT00973245|Antithrombins|antithrombins|mesh-ancestor
92975187|NCT00973245|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92975188|NCT00973245|Protease Inhibitors|protease inhibitors|mesh-ancestor
92975189|NCT00973245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975190|NCT00973245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975191|NCT00793754|Aspirin|aspirin|mesh-list
92975192|NCT00793754|Atorvastatin|atorvastatin|mesh-list
92975193|NCT00793754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92975194|NCT00793754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92975195|NCT00793754|Analgesics|analgesics|mesh-ancestor
92975196|NCT00793754|Sensory System Agents|sensory system agents|mesh-ancestor
92975197|NCT00793754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975198|NCT00793754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975199|NCT00793754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92975200|NCT00793754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975201|NCT00793754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92975202|NCT00793754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92975203|NCT00793754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975204|NCT00793754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92975205|NCT00793754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92975206|NCT00793754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975207|NCT00793754|Antipyretics|antipyretics|mesh-ancestor
92975208|NCT00793754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92975209|NCT00793754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92975210|NCT00793754|Antimetabolites|antimetabolites|mesh-ancestor
92975211|NCT00793754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92975212|NCT00793754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92975213|NCT02596763|Baclofen|baclofen|mesh-list
92975214|NCT02596763|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92975215|NCT02596763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975216|NCT02596763|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92975217|NCT02596763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975218|NCT02596763|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92975219|NCT02596763|GABA Agonists|gaba agonists|mesh-ancestor
92975220|NCT02596763|GABA Agents|gaba agents|mesh-ancestor
92975221|NCT02596763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975222|NCT02596763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975223|NCT00973323|Warfarin|warfarin|mesh-list
92975224|NCT00973323|Rivaroxaban|rivaroxaban|mesh-list
92975225|NCT00973323|Anticoagulants|anticoagulants|mesh-ancestor
92975226|NCT00973323|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92975227|NCT00973323|Antithrombins|antithrombins|mesh-ancestor
92975228|NCT00973323|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92975229|NCT00973323|Protease Inhibitors|protease inhibitors|mesh-ancestor
92975230|NCT00973323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975231|NCT00973323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975232|NCT00793988|Anesthetics|anesthetics|mesh-list
92975233|NCT00793988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975234|NCT00793988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975235|NCT00973401|Insulin|insulin|mesh-list
92975236|NCT00973401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92975237|NCT00973401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975238|NCT04040322|Iloprost|iloprost|mesh-list
92975239|NCT04040322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92975240|NCT04040322|Vasodilator Agents|vasodilator agents|mesh-ancestor
92975242|NCT00787436|Timolol|timolol|mesh-list
92975243|NCT00787436|Propranolol|propranolol|mesh-list
92975244|NCT00787436|Nadolol|nadolol|mesh-list
92975245|NCT00787436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975246|NCT00787436|Immunologic Factors|immunologic factors|mesh-ancestor
92975247|NCT00787436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975248|NCT00787436|Leprostatic Agents|leprostatic agents|mesh-ancestor
92975249|NCT00787436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92975250|NCT00787436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975251|NCT00787436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975252|NCT00787436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975253|NCT00787436|Growth Substances|growth substances|mesh-ancestor
92975254|NCT00787436|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975255|NCT00787436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975256|NCT00787436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92975257|NCT00787436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92975258|NCT00787436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92975259|NCT00787436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975260|NCT00787436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975261|NCT00787436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92975262|NCT00787436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92975263|NCT00787436|Vasodilator Agents|vasodilator agents|mesh-ancestor
92975264|NCT00787436|Sympatholytics|sympatholytics|mesh-ancestor
92975265|NCT00787436|Autonomic Agents|autonomic agents|mesh-ancestor
92975266|NCT00787436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975268|NCT03945981|Dolutegravir|dolutegravir|mesh-list
92975269|NCT03945981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92975270|NCT03945981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92975271|NCT03945981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975272|NCT03945981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975273|NCT03945981|Antiviral Agents|antiviral agents|mesh-ancestor
92975274|NCT03945981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975275|NCT03945981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92975276|NCT03945981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92975277|NCT03945981|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92975278|NCT03945981|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92975279|NCT00784082|Hydroxyurea|hydroxyurea|mesh-list
92975280|NCT00784082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975281|NCT00784082|Antisickling Agents|antisickling agents|mesh-ancestor
92975282|NCT00784082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166951|NCT01321437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975283|NCT00784082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975284|NCT00784082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92975285|NCT00979563|Irinotecan|irinotecan|mesh-list
92975286|NCT00979563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92975287|NCT00979563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975288|NCT00979563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975289|NCT00979563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975290|NCT00979563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975291|NCT00745901|Drospirenone|drospirenone|mesh-list
92975292|NCT00745901|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92975293|NCT00745901|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92975294|NCT00745901|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92975295|NCT00745901|Norgestimate|norgestimate|mesh-list
92975296|NCT00745901|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92975297|NCT00745901|Estradiol|estradiol|mesh-list
92975298|NCT00745901|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92975299|NCT00745901|Estrogens|estrogens|mesh-ancestor
92975300|NCT00745901|Hormones|hormones|mesh-ancestor
92975301|NCT00745901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975302|NCT00745901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975303|NCT00745901|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92975304|NCT00745901|Contraceptive Agents|contraceptive agents|mesh-ancestor
92975305|NCT00745901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92975306|NCT00745901|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92975307|NCT00745901|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92975308|NCT00745901|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92975309|NCT00745901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92975310|NCT00745901|Hormone Antagonists|hormone antagonists|mesh-ancestor
92975311|NCT00745901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92975312|NCT00745901|Diuretics|diuretics|mesh-ancestor
92975313|NCT00745901|Natriuretic Agents|natriuretic agents|mesh-ancestor
92975314|NCT00745901|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92975315|NCT00863850|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92975316|NCT00863850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92975317|NCT00863850|Alkylating Agents|alkylating agents|mesh-ancestor
92975318|NCT00863850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975319|NCT00863850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975320|NCT00860340|Spironolactone|spironolactone|mesh-list
92975321|NCT00860340|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92975322|NCT00860340|Hormone Antagonists|hormone antagonists|mesh-ancestor
92975323|NCT00860340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620752|NCT00151073|Alkylating Agents|alkylating agents|mesh-ancestor
92975324|NCT00860340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975325|NCT00860340|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92975326|NCT00860340|Diuretics|diuretics|mesh-ancestor
92975327|NCT00860340|Natriuretic Agents|natriuretic agents|mesh-ancestor
92975329|NCT00784316|Amiodarone|amiodarone|mesh-list
92975330|NCT00784316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92975331|NCT00784316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92975332|NCT00784316|Sympatholytics|sympatholytics|mesh-ancestor
92975333|NCT00784316|Autonomic Agents|autonomic agents|mesh-ancestor
92975334|NCT00784316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975335|NCT00784316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975336|NCT00784316|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92975337|NCT00784316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92975338|NCT00784316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92975339|NCT00784316|Adrenergic Agents|adrenergic agents|mesh-ancestor
92975340|NCT00784316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975341|NCT00784316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975342|NCT00784316|Vasodilator Agents|vasodilator agents|mesh-ancestor
92975343|NCT00784316|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92975344|NCT00784316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92975345|NCT00784316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92975346|NCT00784316|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92166965|NCT02664181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92975347|NCT00784316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92975348|NCT00784316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975349|NCT00784316|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92975350|NCT00784316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92975351|NCT00784316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92975352|NCT00286429|Insulin|insulin|mesh-list
92975353|NCT00286429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92975354|NCT00286429|Alogliptin|alogliptin|mesh-list
92975355|NCT00286429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92975356|NCT00286429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975357|NCT00286429|Incretins|incretins|mesh-ancestor
92975358|NCT00286429|Hormones|hormones|mesh-ancestor
92975359|NCT00286429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975360|NCT00286429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92975361|NCT00286429|Protease Inhibitors|protease inhibitors|mesh-ancestor
92975362|NCT00286429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975363|NCT00286429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975364|NCT00665444|Aripiprazole|aripiprazole|mesh-list
92975365|NCT00665444|Antidepressive Agents|antidepressive agents|mesh-ancestor
92975366|NCT00665444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92975367|NCT00665444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92975368|NCT00665444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92975369|NCT00665444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975370|NCT00665444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975371|NCT00665444|Dopamine Agonists|dopamine agonists|mesh-ancestor
92975372|NCT00665444|Dopamine Agents|dopamine agents|mesh-ancestor
92975373|NCT00665444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975374|NCT00665444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975375|NCT00665444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92975376|NCT00665444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92975377|NCT00665444|Serotonin Agents|serotonin agents|mesh-ancestor
92975378|NCT00665444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92975379|NCT00665444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92975380|NCT00665444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92975381|NCT00665444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92975382|NCT00864006|Valproic Acid|valproic acid|mesh-list
92975383|NCT00864006|Anticonvulsants|anticonvulsants|mesh-ancestor
92975384|NCT00864006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975385|NCT00864006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975386|NCT00864006|GABA Agents|gaba agents|mesh-ancestor
92975387|NCT00864006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975388|NCT00864006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975389|NCT00864006|Antimanic Agents|antimanic agents|mesh-ancestor
92975390|NCT00864006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92975391|NCT00864006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975392|NCT00864006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92975393|NCT00860496|Cyclosporine|cyclosporine|mesh-list
92975394|NCT00860496|Tacrolimus|tacrolimus|mesh-list
92975395|NCT00860496|Cyclosporins|cyclosporins|mesh-list
92975396|NCT00860496|Tofacitinib|tofacitinib|mesh-list
92975397|NCT00860496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620829|NCT05466604|Hormones|hormones|mesh-ancestor
92975398|NCT00860496|Immunologic Factors|immunologic factors|mesh-ancestor
92975399|NCT00860496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975400|NCT00860496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92975401|NCT00860496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975402|NCT00860496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975403|NCT00860496|Antifungal Agents|antifungal agents|mesh-ancestor
92975404|NCT00860496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975405|NCT00860496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92975406|NCT00860496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975407|NCT00860496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92975408|NCT00860496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92975409|NCT00864162|Ramipril|ramipril|mesh-list
92975410|NCT00864162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92975411|NCT00864162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92975412|NCT00864162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975413|NCT00864162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975414|NCT00864162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92975415|NCT00787826|Vaccines|vaccines|mesh-list
92166974|NCT04407390|Vitamins|vitamins|mesh-ancestor
92975416|NCT00787826|Immunologic Factors|immunologic factors|mesh-ancestor
92975417|NCT00787826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975418|NCT00795314|Fentanyl|fentanyl|mesh-list
92975419|NCT00795314|Butorphanol|butorphanol|mesh-list
92975420|NCT00795314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92975421|NCT00795314|Narcotics|narcotics|mesh-ancestor
92975422|NCT00795314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975423|NCT00795314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975424|NCT00795314|Analgesics|analgesics|mesh-ancestor
92975425|NCT00795314|Sensory System Agents|sensory system agents|mesh-ancestor
92975426|NCT00795314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975427|NCT00795314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92975428|NCT00795314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92975429|NCT00795314|Anesthetics, General|anesthetics, general|mesh-ancestor
92975430|NCT00795314|Anesthetics|anesthetics|mesh-ancestor
92975431|NCT00795314|Antitussive Agents|antitussive agents|mesh-ancestor
92975432|NCT00795314|Respiratory System Agents|respiratory system agents|mesh-ancestor
92975433|NCT00795314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92975434|NCT03926169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92975435|NCT03926169|Immunologic Factors|immunologic factors|mesh-ancestor
92975436|NCT03926169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975437|NCT00864240|Clobetasol|clobetasol|mesh-list
92975438|NCT00864240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92975439|NCT00864240|Glucocorticoids|glucocorticoids|mesh-ancestor
92975440|NCT00864240|Hormones|hormones|mesh-ancestor
92975441|NCT00864240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975442|NCT00864240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975443|NCT00979641|Docetaxel|docetaxel|mesh-list
92975444|NCT00979641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975445|NCT00979641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92975446|NCT00979641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92975447|NCT00979641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92975448|NCT00979641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975449|NCT00864318|Paclitaxel|paclitaxel|mesh-list
92975450|NCT00864318|Etoposide|etoposide|mesh-list
92975451|NCT00864318|Ifosfamide|ifosfamide|mesh-list
92975452|NCT00864318|Carboplatin|carboplatin|mesh-list
92975453|NCT00864318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92975454|NCT00864318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975455|NCT00864318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92975456|NCT00864318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92975457|NCT00864318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92975458|NCT00864318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975459|NCT00864318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92975460|NCT00864318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975461|NCT00864318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975462|NCT00864318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92975463|NCT00864318|Alkylating Agents|alkylating agents|mesh-ancestor
92975465|NCT00788060|Sunitinib|sunitinib|mesh-list
92975466|NCT00788060|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92975467|NCT00788060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92975468|NCT00788060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975469|NCT00788060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975470|NCT00788060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620901|NCT00151463|Vasodilator Agents|vasodilator agents|mesh-ancestor
92975471|NCT00788060|Immunologic Factors|immunologic factors|mesh-ancestor
92975472|NCT00788060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975473|NCT00788060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975474|NCT00788060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975475|NCT00788060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975476|NCT00788060|Growth Substances|growth substances|mesh-ancestor
92975477|NCT00788060|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975478|NCT00788138|Vitamin D|vitamin d|mesh-list
92975479|NCT00788138|Cholecalciferol|cholecalciferol|mesh-list
92975480|NCT00788138|Vitamins|vitamins|mesh-ancestor
92975481|NCT00788138|Micronutrients|micronutrients|mesh-ancestor
92975482|NCT00788138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975483|NCT00788138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92975484|NCT00788138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92975485|NCT00864396|Lansoprazole|lansoprazole|mesh-list
92975486|NCT00864396|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92975487|NCT00864396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975488|NCT00864396|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92975489|NCT00864396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975490|NCT00864396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975491|NCT00745823|Raltegravir Potassium|raltegravir potassium|mesh-list
92975492|NCT00745823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92975493|NCT00745823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92975494|NCT00745823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92975495|NCT00745823|Antiviral Agents|antiviral agents|mesh-ancestor
92975496|NCT00745823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975497|NCT00745823|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92975498|NCT00745823|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92975499|NCT00745823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975500|NCT00745823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975501|NCT00745823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92975502|NCT00745823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92975503|NCT00961467|Thalidomide|thalidomide|mesh-list
92975504|NCT00961467|Prednisone|prednisone|mesh-list
92975505|NCT00961467|Melphalan|melphalan|mesh-list
92975506|NCT00961467|Lenalidomide|lenalidomide|mesh-list
92975507|NCT00961467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92975508|NCT00961467|Glucocorticoids|glucocorticoids|mesh-ancestor
92975509|NCT00961467|Hormones|hormones|mesh-ancestor
92975510|NCT00961467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975511|NCT00961467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975512|NCT00961467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92975513|NCT00961467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975514|NCT00961467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92975515|NCT00961467|Alkylating Agents|alkylating agents|mesh-ancestor
92975516|NCT00961467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975517|NCT00961467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92975518|NCT00961467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975519|NCT00961467|Immunologic Factors|immunologic factors|mesh-ancestor
92975520|NCT00961467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975521|NCT00961467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975522|NCT00961467|Growth Substances|growth substances|mesh-ancestor
92975523|NCT00961467|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975524|NCT00961467|Leprostatic Agents|leprostatic agents|mesh-ancestor
92975525|NCT00961467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92975526|NCT00961467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975527|NCT00980031|Eplerenone|eplerenone|mesh-list
92975528|NCT00980031|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92975529|NCT00980031|Hormone Antagonists|hormone antagonists|mesh-ancestor
92975530|NCT00980031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975531|NCT00980031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975532|NCT00980031|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92975533|NCT00980031|Diuretics|diuretics|mesh-ancestor
92975534|NCT00980031|Natriuretic Agents|natriuretic agents|mesh-ancestor
92975535|NCT00980031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92975536|NCT00663260|Dapagliflozin|dapagliflozin|mesh-list
92975537|NCT00663260|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92975538|NCT00663260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975539|NCT00663260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92975540|NCT00663260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975541|NCT00980109|Oseltamivir|oseltamivir|mesh-list
92975542|NCT00980109|Zanamivir|zanamivir|mesh-list
92975543|NCT00980109|Antiviral Agents|antiviral agents|mesh-ancestor
92975544|NCT00980109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975545|NCT00980109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975546|NCT00980109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975547|NCT04988841|Nivolumab|nivolumab|mesh-list
92975548|NCT04988841|Ipilimumab|ipilimumab|mesh-list
92975549|NCT04988841|Laxatives|laxatives|mesh-list
92975550|NCT04988841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92975551|NCT04988841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975552|NCT04988841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975553|NCT04988841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92975554|NCT04988841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975555|NCT04988841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975556|NCT00980187|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92975557|NCT00980187|Indapamide|indapamide|mesh-list
92975558|NCT00980187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92975559|NCT00980187|Diuretics|diuretics|mesh-ancestor
92975560|NCT00980187|Natriuretic Agents|natriuretic agents|mesh-ancestor
92975561|NCT00980187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975562|NCT00980187|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92975563|NCT00980187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92975564|NCT00980187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975565|NCT00795470|Anti-Infective Agents|anti-infective agents|mesh-list
92975566|NCT00795470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92975567|NCT00284089|Ranibizumab|ranibizumab|mesh-list
92975568|NCT00284089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975569|NCT00284089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975570|NCT00284089|Growth Substances|growth substances|mesh-ancestor
92975571|NCT00284089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975572|NCT00284089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975573|NCT00284089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975574|NCT00984633|Bromides|bromides|mesh-list
92975575|NCT00984633|Propofol|propofol|mesh-list
92975576|NCT00984633|Sevoflurane|sevoflurane|mesh-list
92975577|NCT00984633|Rocuronium|rocuronium|mesh-list
92975578|NCT00984633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92975579|NCT00984633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975580|NCT00984633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975581|NCT00984633|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92975582|NCT00984633|Anesthetics, General|anesthetics, general|mesh-ancestor
92975583|NCT00984633|Anesthetics|anesthetics|mesh-ancestor
92975584|NCT00984633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92975585|NCT00984633|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92975586|NCT00984633|Anticonvulsants|anticonvulsants|mesh-ancestor
92975587|NCT00984633|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92975588|NCT00984633|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92975589|NCT00984633|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92975590|NCT00984633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975591|NCT00659984|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92975592|NCT00659984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975593|NCT00659984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975594|NCT00659984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975595|NCT00659984|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92975596|NCT00976755|Everolimus|everolimus|mesh-list
92975597|NCT00976755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92975598|NCT00976755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92975599|NCT00976755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975600|NCT00976755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975601|NCT00976755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975602|NCT00976755|Immunologic Factors|immunologic factors|mesh-ancestor
92975603|NCT00976755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975604|NCT00976755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975605|NCT00864474|Maraviroc|maraviroc|mesh-list
92975606|NCT00864474|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92975607|NCT00864474|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92975608|NCT00864474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975609|NCT00864474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92975610|NCT00864474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92975611|NCT00864474|Antiviral Agents|antiviral agents|mesh-ancestor
92975612|NCT00864474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975613|NCT00864474|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92975615|NCT00283387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975616|NCT00283387|Lipotropic Agents|lipotropic agents|mesh-ancestor
92975617|NCT00283387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92975618|NCT00283387|Antimetabolites|antimetabolites|mesh-ancestor
92975619|NCT00283387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975620|NCT00283387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92975621|NCT00788294|Tanezumab|tanezumab|mesh-list
92975622|NCT00788294|Analgesics|analgesics|mesh-ancestor
92975623|NCT00788294|Sensory System Agents|sensory system agents|mesh-ancestor
92975624|NCT00788294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975625|NCT00788294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975626|NCT00795548|Azacitidine|azacitidine|mesh-list
92975627|NCT00795548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975628|NCT00795548|Antimetabolites|antimetabolites|mesh-ancestor
92975629|NCT00795548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166988|NCT02181387|Antipyretics|antipyretics|mesh-ancestor
92975630|NCT00795548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975631|NCT00795548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975632|NCT00282919|Azithromycin|azithromycin|mesh-list
92975633|NCT00282919|Chloroquine|chloroquine|mesh-list
92975634|NCT00282919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92975635|NCT00282919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975636|NCT00282919|Amebicides|amebicides|mesh-ancestor
92975637|NCT00282919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92975638|NCT00282919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92975639|NCT00282919|Antimalarials|antimalarials|mesh-ancestor
92975640|NCT00282919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975641|NCT00984789|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92975642|NCT00984789|Gestodene|gestodene|mesh-list
92975643|NCT00984789|Norelgestromin|norelgestromin|mesh-list
92975644|NCT00984789|Femovan|femovan|mesh-list
92975645|NCT00984789|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92975646|NCT00984789|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92975647|NCT00984789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92975648|NCT00984789|Contraceptive Agents|contraceptive agents|mesh-ancestor
92975649|NCT00984789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92975650|NCT00984789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975651|NCT00984789|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92975652|NCT00984789|Estrogens|estrogens|mesh-ancestor
92975653|NCT00984789|Hormones|hormones|mesh-ancestor
92975654|NCT00984789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975655|NCT00984789|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92975656|NCT00984789|Progestins|progestins|mesh-ancestor
92975657|NCT00984789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92975658|NCT00864552|Factor VIII|factor viii|mesh-list
92975659|NCT00864552|Coagulants|coagulants|mesh-ancestor
92975660|NCT04046822|Liraglutide|liraglutide|mesh-list
92975661|NCT04046822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92975662|NCT04046822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975663|NCT04046822|Incretins|incretins|mesh-ancestor
92975664|NCT04046822|Hormones|hormones|mesh-ancestor
92975665|NCT04046822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975666|NCT04007835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92975667|NCT04007835|Gefitinib|gefitinib|mesh-list
92975668|NCT04007835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975669|NCT04007835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92975670|NCT04007835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975671|NCT04007835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975672|NCT00800930|Butyric Acid|butyric acid|mesh-list
92975673|NCT00800930|Histamine Antagonists|histamine antagonists|mesh-ancestor
92975674|NCT00800930|Histamine Agents|histamine agents|mesh-ancestor
92975675|NCT00800930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975676|NCT00800930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975677|NCT00800930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975678|NCT00868062|Polygeline|polygeline|mesh-list
92975679|NCT00868062|Plasma Substitutes|plasma substitutes|mesh-ancestor
92975680|NCT00868062|Blood Substitutes|blood substitutes|mesh-ancestor
92975681|NCT00742859|Warfarin|warfarin|mesh-list
92975682|NCT00742859|Acenocoumarol|acenocoumarol|mesh-list
92975683|NCT00742859|Betrixaban|betrixaban|mesh-list
92975684|NCT00742859|Anticoagulants|anticoagulants|mesh-ancestor
92975685|NCT00742859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92975686|NCT00742859|Antithrombins|antithrombins|mesh-ancestor
92975687|NCT00742859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92975688|NCT00742859|Protease Inhibitors|protease inhibitors|mesh-ancestor
92975689|NCT00742859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975690|NCT00742859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975691|NCT00742781|Vitamin D|vitamin d|mesh-list
92975692|NCT00742781|Cholecalciferol|cholecalciferol|mesh-list
92975693|NCT00742781|Vitamins|vitamins|mesh-ancestor
92975694|NCT00742781|Micronutrients|micronutrients|mesh-ancestor
92975695|NCT00742781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975696|NCT00742781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92621122|NCT00164736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92975697|NCT00742781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92975698|NCT00280735|Carboplatin|carboplatin|mesh-list
92975699|NCT00280735|Docetaxel|docetaxel|mesh-list
92975700|NCT00280735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975701|NCT00280735|Tubulin Modulators|tubulin modulators|mesh-ancestor
92975702|NCT00280735|Antimitotic Agents|antimitotic agents|mesh-ancestor
92975703|NCT00280735|Mitosis Modulators|mitosis modulators|mesh-ancestor
92975704|NCT00280735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975705|NCT03975283|Bupivacaine|bupivacaine|mesh-list
92975706|NCT03975283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92975707|NCT03975283|Anesthetics|anesthetics|mesh-ancestor
92975708|NCT03975283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975709|NCT03975283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975710|NCT03975283|Sensory System Agents|sensory system agents|mesh-ancestor
92975711|NCT03975283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975712|NCT01070407|Cloricromen|cloricromen|mesh-list
92975713|NCT01070407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92975714|NCT00801086|Ethanol|ethanol|mesh-list
92975715|NCT00801086|Tempol|tempol|mesh-list
92975716|NCT00801086|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92975717|NCT00801086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975718|NCT00801086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975719|NCT00801086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975720|NCT00801086|Antioxidants|antioxidants|mesh-ancestor
92975721|NCT00801086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975722|NCT00801086|Protective Agents|protective agents|mesh-ancestor
92975723|NCT00801086|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92975724|NCT00801086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975725|NCT00801086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92975726|NCT00801086|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92975727|NCT00788606|Bevacizumab|bevacizumab|mesh-list
92975728|NCT00788606|Rituximab|rituximab|mesh-list
92975729|NCT00788606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975730|NCT00788606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975731|NCT00788606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975732|NCT00788606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975733|NCT00788606|Growth Substances|growth substances|mesh-ancestor
92975734|NCT00788606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975735|NCT00788606|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975736|NCT00788606|Immunologic Factors|immunologic factors|mesh-ancestor
92975737|NCT00788606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975738|NCT00795938|Sildenafil Citrate|sildenafil citrate|mesh-list
92975739|NCT00795938|Vasodilator Agents|vasodilator agents|mesh-ancestor
92975740|NCT00795938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92975741|NCT00795938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92975742|NCT00795938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975743|NCT00795938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975744|NCT00795938|Urological Agents|urological agents|mesh-ancestor
92975745|NCT00260065|Decitabine|decitabine|mesh-list
92975746|NCT00260065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975747|NCT00260065|Antimetabolites|antimetabolites|mesh-ancestor
92975748|NCT00260065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975749|NCT00260065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975750|NCT00260065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975751|NCT01071655|Fluorouracil|fluorouracil|mesh-list
92975752|NCT01071655|Antimetabolites|antimetabolites|mesh-ancestor
92975753|NCT01071655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975754|NCT01071655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975755|NCT01071655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975756|NCT01071655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975757|NCT01071655|Immunologic Factors|immunologic factors|mesh-ancestor
92975758|NCT01071655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975759|NCT02531581|Furosemide|furosemide|mesh-list
92975760|NCT02531581|Diuretics|diuretics|mesh-list
92975761|NCT02531581|Natriuretic Agents|natriuretic agents|mesh-ancestor
92975762|NCT02531581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975763|NCT02531581|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92975764|NCT02531581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92975765|NCT02531581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975766|NCT04046510|Oxytocin|oxytocin|mesh-list
92975767|NCT04046510|Oxytocics|oxytocics|mesh-ancestor
92975768|NCT04046510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92975769|NCT04046510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975770|NCT00506350|Vaccines|vaccines|mesh-list
92975771|NCT00506350|Immunologic Factors|immunologic factors|mesh-ancestor
92975772|NCT00506350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166997|NCT04921878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975773|NCT00788840|Isophane Insulin, Human|isophane insulin, human|mesh-list
92621194|NCT05060068|Anesthetics, General|anesthetics, general|mesh-ancestor
92975774|NCT00788840|Insulin, Isophane|insulin, isophane|mesh-list
92975775|NCT00788840|Isophane insulin, beef|isophane insulin, beef|mesh-list
92975776|NCT00788840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92975777|NCT00788840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975778|NCT00742625|Cytarabine|cytarabine|mesh-list
92975779|NCT00742625|Bortezomib|bortezomib|mesh-list
92975780|NCT00742625|Daunorubicin|daunorubicin|mesh-list
92975781|NCT00742625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975782|NCT00742625|Antimetabolites|antimetabolites|mesh-ancestor
92975783|NCT00742625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975784|NCT00742625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975785|NCT00742625|Antiviral Agents|antiviral agents|mesh-ancestor
92975786|NCT00742625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975787|NCT00742625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975788|NCT00742625|Immunologic Factors|immunologic factors|mesh-ancestor
92975789|NCT00742625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975790|NCT00742625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92975791|NCT00742625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92975792|NCT00742625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975793|NCT00742625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975794|NCT00801788|Oxycodone|oxycodone|mesh-list
92975795|NCT00801788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92975796|NCT00801788|Narcotics|narcotics|mesh-ancestor
92975797|NCT00801788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975798|NCT00801788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975799|NCT00801788|Analgesics|analgesics|mesh-ancestor
92975800|NCT00801788|Sensory System Agents|sensory system agents|mesh-ancestor
92975801|NCT00801788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975802|NCT01070485|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92975803|NCT01070485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975804|NCT00618618|Deoxycholic Acid|deoxycholic acid|mesh-list
92975805|NCT00618618|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92975806|NCT00618618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975807|NCT00796250|Prednisolone|prednisolone|mesh-list
92975808|NCT00796250|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92975809|NCT00796250|Methylprednisolone|methylprednisolone|mesh-list
92975810|NCT00796250|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92975811|NCT00796250|Prednisolone acetate|prednisolone acetate|mesh-list
92975812|NCT00796250|Infliximab|infliximab|mesh-list
92975813|NCT00796250|Azathioprine|azathioprine|mesh-list
92975814|NCT00796250|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92975815|NCT00796250|Prednisolone phosphate|prednisolone phosphate|mesh-list
92975816|NCT00796250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92975817|NCT00796250|Glucocorticoids|glucocorticoids|mesh-ancestor
92975818|NCT00796250|Hormones|hormones|mesh-ancestor
92975819|NCT00796250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975820|NCT00796250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975821|NCT00796250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92975822|NCT00796250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975823|NCT00796250|Antiemetics|antiemetics|mesh-ancestor
92975824|NCT00796250|Autonomic Agents|autonomic agents|mesh-ancestor
92975825|NCT00796250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975826|NCT00796250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975827|NCT00796250|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92975828|NCT00796250|Protective Agents|protective agents|mesh-ancestor
92975829|NCT00796250|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92975830|NCT00796250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92975831|NCT00796250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975832|NCT00796250|Antimetabolites|antimetabolites|mesh-ancestor
92975833|NCT00796250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975834|NCT00796250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92975835|NCT00796250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975836|NCT00796250|Immunologic Factors|immunologic factors|mesh-ancestor
92975837|NCT00788918|Interferons|interferons|mesh-list
92975838|NCT00788918|Ribavirin|ribavirin|mesh-list
92975839|NCT00788918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975840|NCT00788918|Antiviral Agents|antiviral agents|mesh-ancestor
92975841|NCT00788918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975842|NCT00788918|Antimetabolites|antimetabolites|mesh-ancestor
92975843|NCT00788918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975844|NCT02596373|Mitoxantrone|mitoxantrone|mesh-list
92975845|NCT02596373|Analgesics|analgesics|mesh-ancestor
92166999|NCT04351347|Ivermectin|ivermectin|mesh-list
92975846|NCT02596373|Sensory System Agents|sensory system agents|mesh-ancestor
92975847|NCT02596373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975848|NCT02596373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975849|NCT02596373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975850|NCT02596373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92975851|NCT02596373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975852|NCT02596373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975853|NCT02596373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975855|NCT00801866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975856|NCT00801866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975857|NCT00801866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975858|NCT00801866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975859|NCT00801866|Growth Substances|growth substances|mesh-ancestor
92975860|NCT00801866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975861|NCT00801866|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975862|NCT03973879|Atezolizumab|atezolizumab|mesh-list
92975863|NCT03973879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92975864|NCT03973879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975865|NCT03973879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975866|NCT03973879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975867|NCT00860964|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92975868|NCT00860964|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92975869|NCT00860964|Estradiol|estradiol|mesh-list
92975870|NCT00860964|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92975871|NCT00860964|Estrogens|estrogens|mesh-ancestor
92975872|NCT00860964|Hormones|hormones|mesh-ancestor
92975873|NCT00860964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975874|NCT00860964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975875|NCT00860964|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92975876|NCT00860964|Contraceptive Agents|contraceptive agents|mesh-ancestor
92975877|NCT00860964|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92975878|NCT00860964|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92975879|NCT00861042|Lacosamide|lacosamide|mesh-list
92975880|NCT00861042|Anticonvulsants|anticonvulsants|mesh-ancestor
92975881|NCT00861042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92975882|NCT00861042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92975883|NCT00861042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92975884|NCT00861042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975886|NCT04088903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975887|NCT00861120|Doxorubicin|doxorubicin|mesh-list
92975888|NCT00861120|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92975889|NCT00861120|Panitumumab|panitumumab|mesh-list
92975890|NCT00861120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92975891|NCT00861120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975892|NCT00861120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92975893|NCT00861120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92975894|NCT00861120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975895|NCT00861120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975896|NCT00861120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975897|NCT00740051|Glimepiride|glimepiride|mesh-list
92975898|NCT00740051|Linagliptin|linagliptin|mesh-list
92975899|NCT00740051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92975900|NCT00740051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92975901|NCT00740051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975902|NCT00740051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92975903|NCT00740051|Immunologic Factors|immunologic factors|mesh-ancestor
92975904|NCT00740051|Incretins|incretins|mesh-ancestor
92975905|NCT00740051|Hormones|hormones|mesh-ancestor
92975906|NCT00740051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975907|NCT00740051|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92975908|NCT00740051|Protease Inhibitors|protease inhibitors|mesh-ancestor
92975909|NCT00740051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975910|NCT00740051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975911|NCT00864864|Sunitinib|sunitinib|mesh-list
92975912|NCT00864864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975913|NCT00864864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975914|NCT00864864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92167002|NCT04932564|Leflunomide|leflunomide|mesh-list
92975915|NCT00864864|Growth Substances|growth substances|mesh-ancestor
92975916|NCT00864864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975917|NCT00864864|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975918|NCT00864864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92975919|NCT00864864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92975920|NCT00864864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975921|NCT00868764|Granisetron|granisetron|mesh-list
92975922|NCT00868764|Antiemetics|antiemetics|mesh-ancestor
92975923|NCT00868764|Autonomic Agents|autonomic agents|mesh-ancestor
92975924|NCT00868764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975925|NCT00868764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975926|NCT00868764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92975927|NCT00868764|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92975928|NCT00868764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92975930|NCT00868764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975931|NCT00868764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975932|NCT00518986|Modafinil|modafinil|mesh-list
92975933|NCT00518986|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92975934|NCT00518986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975935|NCT00518986|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92975936|NCT00518986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92975937|NCT00518986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92975938|NCT00518986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975939|NCT00864942|Lenalidomide|lenalidomide|mesh-list
92975940|NCT00864942|Rituximab|rituximab|mesh-list
92975941|NCT00864942|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92975942|NCT00864942|Immunologic Factors|immunologic factors|mesh-ancestor
92975943|NCT00864942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975944|NCT00864942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92975945|NCT00864942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92975946|NCT00864942|Growth Substances|growth substances|mesh-ancestor
92975947|NCT00864942|Growth Inhibitors|growth inhibitors|mesh-ancestor
92975948|NCT00864942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92975949|NCT00864942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92975950|NCT00864942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92975951|NCT00864942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92975952|NCT00864942|Alkylating Agents|alkylating agents|mesh-ancestor
92975953|NCT00864942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975954|NCT00870402|Spironolactone|spironolactone|mesh-list
92975955|NCT00870402|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92975956|NCT00870402|Hormone Antagonists|hormone antagonists|mesh-ancestor
92975957|NCT00870402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92975958|NCT00870402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975959|NCT00870402|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92975960|NCT00870402|Diuretics|diuretics|mesh-ancestor
92975961|NCT00870402|Natriuretic Agents|natriuretic agents|mesh-ancestor
92975962|NCT00742235|Vitamin D|vitamin d|mesh-list
92975963|NCT00742235|Ergocalciferols|ergocalciferols|mesh-list
92975964|NCT00742235|Vitamins|vitamins|mesh-ancestor
92975965|NCT00742235|Micronutrients|micronutrients|mesh-ancestor
92975966|NCT00742235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975967|NCT00742235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92975968|NCT00742235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92975969|NCT00742079|Cycloserine|cycloserine|mesh-list
92975970|NCT00742079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92975971|NCT00742079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92975972|NCT00742079|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92975973|NCT00742079|Antitubercular Agents|antitubercular agents|mesh-ancestor
92975974|NCT00742079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92975975|NCT00742079|Antimetabolites|antimetabolites|mesh-ancestor
92975976|NCT00742079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92975977|NCT04730362|Propofol|propofol|mesh-list
92975978|NCT04730362|Sevoflurane|sevoflurane|mesh-list
92975979|NCT04730362|Anesthetics|anesthetics|mesh-ancestor
92975980|NCT04730362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92975981|NCT04730362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975982|NCT04730362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92975983|NCT04730362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92975984|NCT04730362|Anesthetics, General|anesthetics, general|mesh-ancestor
92975985|NCT04730362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92975986|NCT04730362|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92975987|NCT00662792|Tiotropium Bromide|tiotropium bromide|mesh-list
92975988|NCT00662792|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92975989|NCT00662792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92975990|NCT00662792|Autonomic Agents|autonomic agents|mesh-ancestor
92975991|NCT00662792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92975992|NCT00662792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92975993|NCT00662792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92975994|NCT00662792|Respiratory System Agents|respiratory system agents|mesh-ancestor
92975995|NCT00662792|Parasympatholytics|parasympatholytics|mesh-ancestor
92975996|NCT00662792|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92975997|NCT00662792|Cholinergic Agents|cholinergic agents|mesh-ancestor
92975998|NCT00662792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92975999|NCT00662792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976000|NCT00662792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92976001|NCT00662792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92976002|NCT00662792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92976003|NCT00662792|Adrenergic Agents|adrenergic agents|mesh-ancestor
92976004|NCT00870480|Finasteride|finasteride|mesh-list
92976005|NCT00870480|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92976006|NCT00870480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92976007|NCT00870480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976008|NCT00870480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976009|NCT00870480|Hormone Antagonists|hormone antagonists|mesh-ancestor
92976010|NCT00870480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976011|NCT00870480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976012|NCT00870480|Urological Agents|urological agents|mesh-ancestor
92976013|NCT00870558|Ethiodized Oil|ethiodized oil|mesh-list
92976014|NCT00870558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976015|NCT01565278|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92976016|NCT01565278|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92976017|NCT01565278|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92976018|NCT01565278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92976019|NCT00616902|Ergocalciferols|ergocalciferols|mesh-list
92976020|NCT00616902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92976021|NCT00616902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976022|NCT00616902|Vitamins|vitamins|mesh-ancestor
92976023|NCT00616902|Micronutrients|micronutrients|mesh-ancestor
92976024|NCT00616902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92976025|NCT00801944|Solifenacin Succinate|solifenacin succinate|mesh-list
92976026|NCT00801944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92976027|NCT00801944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92976028|NCT00801944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92976029|NCT00801944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976030|NCT00801944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976031|NCT00801944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976032|NCT00801944|Urological Agents|urological agents|mesh-ancestor
92976033|NCT00870636|Bevacizumab|bevacizumab|mesh-list
92976034|NCT00870636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92976035|NCT00870636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976036|NCT00870636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92976037|NCT00870636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92976038|NCT00870636|Growth Substances|growth substances|mesh-ancestor
92976039|NCT00870636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976040|NCT00870636|Growth Inhibitors|growth inhibitors|mesh-ancestor
92976041|NCT00741611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92976042|NCT00870714|Ketoconazole|ketoconazole|mesh-list
92976043|NCT00870714|Docetaxel|docetaxel|mesh-list
92976044|NCT00870714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976045|NCT00870714|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976046|NCT00870714|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976047|NCT00870714|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167017|NCT02655601|Temozolomide|temozolomide|mesh-list
92976048|NCT00870714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976049|NCT00870714|Antifungal Agents|antifungal agents|mesh-ancestor
92976050|NCT00870714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976051|NCT00870714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92976052|NCT00870714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92976053|NCT00870714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976054|NCT00870714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92976055|NCT00870714|Hormone Antagonists|hormone antagonists|mesh-ancestor
92976056|NCT00870714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976057|NCT00870714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976058|NCT00870714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92976059|NCT02596217|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92976060|NCT02596217|Immunologic Factors|immunologic factors|mesh-ancestor
92976061|NCT02596217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976062|NCT00876330|Antihypertensive Agents|antihypertensive agents|mesh-list
92976063|NCT02598011|Flucytosine|flucytosine|mesh-list
92976064|NCT02598011|Antifungal Agents|antifungal agents|mesh-ancestor
92976065|NCT02598011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976066|NCT02598011|Antimetabolites|antimetabolites|mesh-ancestor
92976067|NCT02598011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976068|NCT00869310|Dexamethasone|dexamethasone|mesh-list
92976069|NCT00869310|Dexamethasone acetate|dexamethasone acetate|mesh-list
92976070|NCT00869310|Aprepitant|aprepitant|mesh-list
92976071|NCT00869310|Metoclopramide|metoclopramide|mesh-list
92976072|NCT00869310|BB 1101|bb 1101|mesh-list
92976073|NCT00869310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976074|NCT00869310|Antiemetics|antiemetics|mesh-ancestor
92976075|NCT00869310|Autonomic Agents|autonomic agents|mesh-ancestor
92976076|NCT00869310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976077|NCT00869310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976078|NCT00869310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976079|NCT00869310|Glucocorticoids|glucocorticoids|mesh-ancestor
92976080|NCT00869310|Hormones|hormones|mesh-ancestor
92976081|NCT00869310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976082|NCT00869310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92976083|NCT00869310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976084|NCT00869310|Protease Inhibitors|protease inhibitors|mesh-ancestor
92976085|NCT00869310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976086|NCT00869310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976087|NCT00869310|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92976088|NCT00869310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976089|NCT00869310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92976090|NCT00869310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92976091|NCT00869310|Dopamine Agents|dopamine agents|mesh-ancestor
92976092|NCT00662558|Celecoxib|celecoxib|mesh-list
92976093|NCT00662558|Tramadol|tramadol|mesh-list
92976094|NCT00662558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92976095|NCT00662558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92976096|NCT00662558|Analgesics|analgesics|mesh-ancestor
92976097|NCT00662558|Sensory System Agents|sensory system agents|mesh-ancestor
92976098|NCT00662558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976099|NCT00662558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976100|NCT00662558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976101|NCT00662558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527956|NCT00000686|Antiviral Agents|antiviral agents|mesh-ancestor
92976102|NCT00662558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92976103|NCT00662558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92976104|NCT00662558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976105|NCT00662558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976106|NCT00662558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92976107|NCT00662558|Narcotics|narcotics|mesh-ancestor
92976108|NCT00662558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976109|NCT00869700|Lumefantrine|lumefantrine|mesh-list
92976110|NCT00869700|Artemether|artemether|mesh-list
92976111|NCT00869700|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92976112|NCT00869700|Antimalarials|antimalarials|mesh-ancestor
92976113|NCT00869700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92976114|NCT00869700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92976115|NCT00869700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976116|NCT00869856|Epoetin Alfa|epoetin alfa|mesh-list
92976117|NCT00869856|Hematinics|hematinics|mesh-ancestor
92976118|NCT00876486|genexol-PM|genexol-pm|mesh-list
92976119|NCT00876486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976120|NCT00876486|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976121|NCT00876486|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976122|NCT00876486|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976123|NCT00876486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976124|NCT00802334|Ritonavir|ritonavir|mesh-list
92976125|NCT00802334|Lopinavir|lopinavir|mesh-list
92976126|NCT00802334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92976127|NCT00802334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92976128|NCT00802334|Protease Inhibitors|protease inhibitors|mesh-ancestor
92976129|NCT00802334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976130|NCT00802334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976131|NCT00802334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92976132|NCT00802334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92976133|NCT00802334|Antiviral Agents|antiviral agents|mesh-ancestor
92976134|NCT00802334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976135|NCT00802334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92976136|NCT00802334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92976137|NCT00796640|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92976138|NCT00796640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92976139|NCT00796640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92976140|NCT00796640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976141|NCT00796640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976142|NCT00796640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92976143|NCT00796640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92976144|NCT00796640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92976145|NCT00796640|Serotonin Agents|serotonin agents|mesh-ancestor
92976146|NCT00796640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621562|NCT00152867|Antiemetics|antiemetics|mesh-ancestor
92976147|NCT00796640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976148|NCT00796640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92976149|NCT00796640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92976150|NCT00796640|Dopamine Agents|dopamine agents|mesh-ancestor
92976151|NCT00796796|Sirolimus|sirolimus|mesh-list
92976152|NCT00796796|Temsirolimus|temsirolimus|mesh-list
92976153|NCT00796796|MTOR Inhibitors|mtor inhibitors|mesh-list
92976154|NCT00796796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976155|NCT00796796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976156|NCT00796796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976157|NCT00796796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976158|NCT00796796|Immunologic Factors|immunologic factors|mesh-ancestor
92976159|NCT00796796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976160|NCT00796796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976161|NCT00796796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92976162|NCT00796796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976163|NCT00796796|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92976164|NCT00796796|Antifungal Agents|antifungal agents|mesh-ancestor
92976165|NCT03794076|Cromolyn Sodium|cromolyn sodium|mesh-list
92976166|NCT03794076|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92976167|NCT03794076|Immunologic Factors|immunologic factors|mesh-ancestor
92976168|NCT03794076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976169|NCT03794076|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92976170|NCT03794076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976171|NCT03794076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92976172|NCT03794076|Respiratory System Agents|respiratory system agents|mesh-ancestor
92976173|NCT00739973|Amlodipine|amlodipine|mesh-list
92527958|NCT00000686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92976174|NCT00739973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92976175|NCT00739973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92976176|NCT00739973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92976177|NCT00739973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976178|NCT00739973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92976179|NCT00739973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976180|NCT00739973|Vasodilator Agents|vasodilator agents|mesh-ancestor
92976181|NCT00802568|Fludarabine|fludarabine|mesh-list
92976182|NCT00802568|Fludarabine phosphate|fludarabine phosphate|mesh-list
92976184|NCT00802568|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92976185|NCT00802568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976186|NCT00802568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92976187|NCT00802568|Antimetabolites|antimetabolites|mesh-ancestor
92976188|NCT00802568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167022|NCT02655601|Trace Elements|trace elements|mesh-ancestor
92976189|NCT00802568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976190|NCT00802568|Immunologic Factors|immunologic factors|mesh-ancestor
92976191|NCT00802568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976192|NCT00802568|Alkylating Agents|alkylating agents|mesh-ancestor
92976193|NCT00802568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976194|NCT00802568|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976195|NCT00802802|Efavirenz|efavirenz|mesh-list
92976196|NCT00802802|Rifampin|rifampin|mesh-list
92976197|NCT00802802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92976198|NCT00802802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92976199|NCT00802802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976200|NCT00802802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976201|NCT00802802|Antiviral Agents|antiviral agents|mesh-ancestor
92976202|NCT00802802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976203|NCT00802802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92976204|NCT00802802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92976205|NCT00802802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92976206|NCT00802802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92976207|NCT00802802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92976208|NCT00802802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92976209|NCT00802802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92976210|NCT00802802|Antitubercular Agents|antitubercular agents|mesh-ancestor
92976211|NCT00802802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92976212|NCT00802802|Leprostatic Agents|leprostatic agents|mesh-ancestor
92976213|NCT00802802|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92976214|NCT00802802|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92976215|NCT00802802|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92976216|NCT00802958|Clobetasol|clobetasol|mesh-list
92976217|NCT00802958|Halobetasol|halobetasol|mesh-list
92976218|NCT00802958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92621637|NCT00152945|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92976219|NCT00802958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976220|NCT00802958|Glucocorticoids|glucocorticoids|mesh-ancestor
92976221|NCT00802958|Hormones|hormones|mesh-ancestor
92976222|NCT00802958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976223|NCT00802958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976224|NCT01565512|Bupivacaine|bupivacaine|mesh-list
92976225|NCT01565512|Anesthetics, Local|anesthetics, local|mesh-ancestor
92976226|NCT01565512|Anesthetics|anesthetics|mesh-ancestor
92976227|NCT01565512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976228|NCT01565512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976229|NCT01565512|Sensory System Agents|sensory system agents|mesh-ancestor
92976230|NCT01565512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976231|NCT04895930|Aflutinib|aflutinib|mesh-list
92976232|NCT04895930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976233|NCT04895930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976234|NCT04895930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976235|NCT00615030|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92976236|NCT00615030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92976237|NCT00615030|Autonomic Agents|autonomic agents|mesh-ancestor
92976238|NCT00615030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976239|NCT00615030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976240|NCT00615030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92976241|NCT00615030|Respiratory System Agents|respiratory system agents|mesh-ancestor
92976242|NCT00615030|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92976243|NCT00615030|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92976244|NCT00615030|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92976245|NCT00615030|Adrenergic Agents|adrenergic agents|mesh-ancestor
92976246|NCT00615030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976247|NCT00615030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976249|NCT00789308|Sirolimus|sirolimus|mesh-list
92976250|NCT00789308|Mycophenolic Acid|mycophenolic acid|mesh-list
92976251|NCT00789308|Etanercept|etanercept|mesh-list
92976252|NCT00789308|Heparin|heparin|mesh-list
92976253|NCT00789308|Dextrans|dextrans|mesh-list
92976254|NCT00789308|Tacrolimus|tacrolimus|mesh-list
92976255|NCT00789308|Cyclosporins|cyclosporins|mesh-list
92976256|NCT00789308|Thymoglobulin|thymoglobulin|mesh-list
92976257|NCT00789308|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92976258|NCT00789308|Basiliximab|basiliximab|mesh-list
92976259|NCT00789308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976260|NCT00789308|Immunologic Factors|immunologic factors|mesh-ancestor
92976261|NCT00789308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976262|NCT00789308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92976263|NCT00789308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976264|NCT00789308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976265|NCT00789308|Antifungal Agents|antifungal agents|mesh-ancestor
92976266|NCT00789308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976267|NCT00789308|Dermatologic Agents|dermatologic agents|mesh-ancestor
92976268|NCT00789308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976269|NCT00789308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92976270|NCT00789308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976271|NCT00789308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92976272|NCT00789308|Antitubercular Agents|antitubercular agents|mesh-ancestor
92976273|NCT00789308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92976274|NCT00789308|Anticoagulants|anticoagulants|mesh-ancestor
92976275|NCT00789308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92976276|NCT00789308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92976277|NCT00789308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92976278|NCT00789308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92976279|NCT00789308|Analgesics|analgesics|mesh-ancestor
92976280|NCT00789308|Sensory System Agents|sensory system agents|mesh-ancestor
92976281|NCT00789308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976282|NCT00789308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976283|NCT00789308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976284|NCT00789308|Plasma Substitutes|plasma substitutes|mesh-ancestor
92976285|NCT00789308|Blood Substitutes|blood substitutes|mesh-ancestor
92976286|NCT00518284|Paclitaxel|paclitaxel|mesh-list
92976287|NCT00518284|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92976288|NCT00518284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92976289|NCT00518284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976290|NCT00518284|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976291|NCT00518284|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976292|NCT00518284|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976293|NCT00518284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976294|NCT02595359|Moxifloxacin|moxifloxacin|mesh-list
93047058|NCT00335972|Narcotics|narcotics|mesh-ancestor
92976295|NCT02595359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92976296|NCT02595359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976297|NCT02595359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92976298|NCT02595359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92976299|NCT02595359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976300|NCT02595359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976301|NCT02595359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976303|NCT00871104|Imipenem|imipenem|mesh-list
92976304|NCT00871104|Fosfomycin|fosfomycin|mesh-list
92976305|NCT00871104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92976306|NCT00871104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976307|NCT00614874|Rosiglitazone|rosiglitazone|mesh-list
92976308|NCT00614874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92976309|NCT00614874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976310|NCT00727415|Cyclophosphamide|cyclophosphamide|mesh-list
92976311|NCT00727415|Fludarabine|fludarabine|mesh-list
92976312|NCT00727415|Fludarabine phosphate|fludarabine phosphate|mesh-list
92976313|NCT00727415|Lenalidomide|lenalidomide|mesh-list
92976314|NCT00727415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976315|NCT00727415|Immunologic Factors|immunologic factors|mesh-ancestor
92976316|NCT00727415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976317|NCT00727415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976318|NCT00727415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976319|NCT00727415|Alkylating Agents|alkylating agents|mesh-ancestor
92527963|NCT00034801|Autonomic Agents|autonomic agents|mesh-ancestor
92976320|NCT00727415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976321|NCT00727415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976322|NCT00727415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976323|NCT00727415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92976324|NCT00727415|Antimetabolites|antimetabolites|mesh-ancestor
92976325|NCT00727415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92976326|NCT00727415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92976327|NCT00727415|Growth Substances|growth substances|mesh-ancestor
92976328|NCT00727415|Growth Inhibitors|growth inhibitors|mesh-ancestor
92976329|NCT00803192|Famotidine|famotidine|mesh-list
92976330|NCT00803192|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92976331|NCT00803192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976332|NCT00803192|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92976333|NCT00803192|Histamine Antagonists|histamine antagonists|mesh-ancestor
92976334|NCT00803192|Histamine Agents|histamine agents|mesh-ancestor
92976335|NCT00803192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976336|NCT00803192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976337|NCT00803192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976338|NCT00544557|Etanercept|etanercept|mesh-list
92976339|NCT00544557|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92976340|NCT00544557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92976341|NCT00544557|Analgesics|analgesics|mesh-ancestor
92976342|NCT00544557|Sensory System Agents|sensory system agents|mesh-ancestor
92976343|NCT00544557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976344|NCT00544557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976345|NCT00544557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976346|NCT00544557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976347|NCT00544557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976348|NCT00544557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976349|NCT00544557|Immunologic Factors|immunologic factors|mesh-ancestor
92976350|NCT00877110|Cyclophosphamide|cyclophosphamide|mesh-list
92976351|NCT00877110|Vincristine|vincristine|mesh-list
92976352|NCT00877110|Topotecan|topotecan|mesh-list
92976353|NCT00877110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976354|NCT00877110|Immunologic Factors|immunologic factors|mesh-ancestor
92976355|NCT00877110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976356|NCT00877110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976357|NCT00877110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976358|NCT00877110|Alkylating Agents|alkylating agents|mesh-ancestor
92976359|NCT00877110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976360|NCT00877110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976361|NCT00877110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976362|NCT00877110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92976363|NCT00877110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976364|NCT00877110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976365|NCT00877110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976366|NCT00877110|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92976367|NCT00877110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92976368|NCT00877110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976369|NCT00727259|Ribavirin|ribavirin|mesh-list
92976370|NCT00727259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92976371|NCT00727259|Antimetabolites|antimetabolites|mesh-ancestor
92976372|NCT00727259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976373|NCT00727259|Antiviral Agents|antiviral agents|mesh-ancestor
92976374|NCT00727259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976375|NCT00789386|Midazolam|midazolam|mesh-list
92976376|NCT00789386|Remifentanil|remifentanil|mesh-list
92976377|NCT00789386|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92976378|NCT00789386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92976379|NCT00789386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976380|NCT00789386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976381|NCT00789386|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92976382|NCT00789386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92976383|NCT00789386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92976384|NCT00789386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92976385|NCT00789386|Anesthetics, General|anesthetics, general|mesh-ancestor
92976386|NCT00789386|Anesthetics|anesthetics|mesh-ancestor
92976387|NCT00789386|GABA Modulators|gaba modulators|mesh-ancestor
92976388|NCT00789386|GABA Agents|gaba agents|mesh-ancestor
92976389|NCT00789386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976390|NCT00789386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976391|NCT00789386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92976392|NCT00789386|Narcotics|narcotics|mesh-ancestor
92976393|NCT00789386|Analgesics|analgesics|mesh-ancestor
92976394|NCT00789386|Sensory System Agents|sensory system agents|mesh-ancestor
92976395|NCT00789386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976396|NCT00789464|Trimethoprim|trimethoprim|mesh-list
92976397|NCT00789464|Sulfamethoxazole|sulfamethoxazole|mesh-list
92976398|NCT00789464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92976399|NCT00789464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976400|NCT00789464|Antimalarials|antimalarials|mesh-ancestor
92976401|NCT00789464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92976402|NCT00789464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92976403|NCT00789464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92976404|NCT00789464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976405|NCT00789464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976406|NCT00789464|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92976407|NCT00789464|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92976408|NCT00789464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92976409|NCT00797030|Cyclosporine|cyclosporine|mesh-list
92976410|NCT00797030|Cyclosporins|cyclosporins|mesh-list
92976411|NCT00797030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976412|NCT00797030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976413|NCT00797030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976414|NCT00797030|Immunologic Factors|immunologic factors|mesh-ancestor
92976415|NCT00797030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976416|NCT00797030|Antifungal Agents|antifungal agents|mesh-ancestor
92976417|NCT00797030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976418|NCT00797030|Dermatologic Agents|dermatologic agents|mesh-ancestor
92976419|NCT00797030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976420|NCT00797030|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92976421|NCT00977145|Interferon-gamma|interferon-gamma|mesh-list
92976422|NCT00977145|Antiviral Agents|antiviral agents|mesh-ancestor
92976423|NCT00977145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976424|NCT00918047|Oxcarbazepine|oxcarbazepine|mesh-list
92976425|NCT00918047|Anticonvulsants|anticonvulsants|mesh-ancestor
92976426|NCT00918047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92976427|NCT00918047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92976428|NCT00918047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92976429|NCT00918047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976430|NCT00918047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92976431|NCT00918047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92976432|NCT00877266|Mepivacaine|mepivacaine|mesh-list
92976433|NCT00877266|Anesthetics, Local|anesthetics, local|mesh-ancestor
92976434|NCT00877266|Anesthetics|anesthetics|mesh-ancestor
92976435|NCT00877266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976436|NCT00877266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976437|NCT00877266|Sensory System Agents|sensory system agents|mesh-ancestor
92976438|NCT00877266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976439|NCT02553824|Topiramate|topiramate|mesh-list
92976440|NCT02553824|Phentermine|phentermine|mesh-list
92976441|NCT02553824|Anticonvulsants|anticonvulsants|mesh-ancestor
92976442|NCT02553824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92976443|NCT02553824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976444|NCT02553824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92621878|NCT00153491|Artemether|artemether|mesh-list
92976445|NCT02553824|Appetite Depressants|appetite depressants|mesh-ancestor
92976446|NCT02553824|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92976447|NCT02553824|Sympathomimetics|sympathomimetics|mesh-ancestor
92976448|NCT02553824|Autonomic Agents|autonomic agents|mesh-ancestor
92976449|NCT02553824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976450|NCT02553824|Adrenergic Agents|adrenergic agents|mesh-ancestor
92976451|NCT02553824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976452|NCT02553824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976453|NCT04039854|Propofol|propofol|mesh-list
92976454|NCT04039854|Sevoflurane|sevoflurane|mesh-list
92976455|NCT04039854|Desflurane|desflurane|mesh-list
92976456|NCT04039854|Isoflurane|isoflurane|mesh-list
92976457|NCT04039854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92976458|NCT04039854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976459|NCT04039854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976460|NCT04039854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92976461|NCT04039854|Anesthetics, General|anesthetics, general|mesh-ancestor
92976462|NCT04039854|Anesthetics|anesthetics|mesh-ancestor
92976463|NCT04039854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92976464|NCT04039854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92976465|NCT04045730|Paclitaxel|paclitaxel|mesh-list
92976466|NCT04045730|Gemcitabine|gemcitabine|mesh-list
92976467|NCT04045730|Pembrolizumab|pembrolizumab|mesh-list
92976468|NCT04045730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92976469|NCT04045730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976470|NCT04045730|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976471|NCT04045730|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976472|NCT04045730|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976473|NCT04045730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976474|NCT04045730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92976475|NCT04045730|Antimetabolites|antimetabolites|mesh-ancestor
92976476|NCT04045730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92976477|NCT04045730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92976478|NCT00977223|Aprepitant|aprepitant|mesh-list
92976479|NCT00977223|Fosaprepitant|fosaprepitant|mesh-list
92976480|NCT00977223|Antiemetics|antiemetics|mesh-ancestor
92976481|NCT00977223|Autonomic Agents|autonomic agents|mesh-ancestor
92976482|NCT00977223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976483|NCT00977223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976484|NCT00977223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976485|NCT00977223|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92976486|NCT00977223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976487|NCT00977223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976488|NCT00977301|Ritonavir|ritonavir|mesh-list
92976489|NCT00977301|Fosamprenavir|fosamprenavir|mesh-list
92976490|NCT00977301|Olanzapine|olanzapine|mesh-list
92976491|NCT00977301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92976492|NCT00977301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92976493|NCT00977301|Protease Inhibitors|protease inhibitors|mesh-ancestor
92976494|NCT00977301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976495|NCT00977301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976496|NCT00977301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92976497|NCT00977301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92976498|NCT00977301|Antiviral Agents|antiviral agents|mesh-ancestor
92976499|NCT00977301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976500|NCT00977301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92976501|NCT00977301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92976502|NCT00977301|Antiemetics|antiemetics|mesh-ancestor
92976503|NCT00977301|Autonomic Agents|autonomic agents|mesh-ancestor
92976504|NCT00977301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976505|NCT00977301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976506|NCT00977301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976507|NCT00977301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92976508|NCT00977301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92976509|NCT00977301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976510|NCT00977301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92976511|NCT00977301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92976512|NCT00977301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92976513|NCT00977301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92976514|NCT00977301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976515|NCT00977301|Serotonin Agents|serotonin agents|mesh-ancestor
92976516|NCT00735371|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92976517|NCT00735371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92976518|NCT00735371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976519|NCT00735371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93047059|NCT03983460|Betamethasone|betamethasone|mesh-list
92347149|NCT01762800|Xhance|xhance|mesh-list
92976520|NCT00735371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92976521|NCT00735371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92976522|NCT00735371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976523|NCT00735371|Dopamine Agents|dopamine agents|mesh-ancestor
92976524|NCT00735371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976525|NCT00518206|Cyclophosphamide|cyclophosphamide|mesh-list
92976526|NCT00518206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976527|NCT00518206|Immunologic Factors|immunologic factors|mesh-ancestor
92976528|NCT00518206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976529|NCT00518206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976530|NCT00518206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976531|NCT00518206|Alkylating Agents|alkylating agents|mesh-ancestor
92976532|NCT00518206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976533|NCT00518206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976534|NCT00518206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976535|NCT00984945|Vaccines|vaccines|mesh-list
92976536|NCT00984945|Immunologic Factors|immunologic factors|mesh-ancestor
92976537|NCT00984945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976538|NCT00879918|Nicotine|nicotine|mesh-list
92976539|NCT00879918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92976540|NCT00879918|Autonomic Agents|autonomic agents|mesh-ancestor
92976541|NCT00879918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976542|NCT00879918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976543|NCT00879918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92976544|NCT00879918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92976545|NCT00879918|Cholinergic Agents|cholinergic agents|mesh-ancestor
92976546|NCT00879918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976547|NCT00879918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976548|NCT01565590|Dexmedetomidine|dexmedetomidine|mesh-list
92976549|NCT01565590|Propofol|propofol|mesh-list
92976550|NCT01565590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92976551|NCT01565590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976552|NCT01565590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976553|NCT01565590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92976554|NCT01565590|Analgesics|analgesics|mesh-ancestor
92976555|NCT01565590|Sensory System Agents|sensory system agents|mesh-ancestor
92976556|NCT01565590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976557|NCT01565590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92976558|NCT01565590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92976559|NCT01565590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92976560|NCT01565590|Adrenergic Agents|adrenergic agents|mesh-ancestor
92976561|NCT01565590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976562|NCT01565590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976563|NCT01565590|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92976564|NCT01565590|Anesthetics, General|anesthetics, general|mesh-ancestor
92976565|NCT01565590|Anesthetics|anesthetics|mesh-ancestor
92976566|NCT00877422|Vitamin D|vitamin d|mesh-list
92976567|NCT00877422|Cholecalciferol|cholecalciferol|mesh-list
92976568|NCT00877422|Vitamins|vitamins|mesh-ancestor
92976569|NCT00877422|Micronutrients|micronutrients|mesh-ancestor
92976570|NCT00877422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976571|NCT00877422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92976572|NCT00877422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92976573|NCT04039698|Sofosbuvir|sofosbuvir|mesh-list
92976574|NCT04039698|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92976575|NCT04039698|Velpatasvir|velpatasvir|mesh-list
92976576|NCT04039698|Antiviral Agents|antiviral agents|mesh-ancestor
92976577|NCT04039698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976578|NCT04006821|Apatinib|apatinib|mesh-list
92976579|NCT04006821|Antibodies|antibodies|mesh-list
92976580|NCT04006821|Immunologic Factors|immunologic factors|mesh-ancestor
92976581|NCT04006821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976582|NCT04006821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976583|NCT04006821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976584|NCT04006821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976585|NCT04006821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976586|NCT00803816|Everolimus|everolimus|mesh-list
92976587|NCT00803816|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92976588|NCT00803816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976589|NCT00803816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976590|NCT00803816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976591|NCT00803816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976592|NCT00803816|Immunologic Factors|immunologic factors|mesh-ancestor
92976593|NCT00803816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976594|NCT00803816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976595|NCT00797264|Ketamine|ketamine|mesh-list
92976596|NCT00797264|Morphine|morphine|mesh-list
92976597|NCT00797264|Analgesics|analgesics|mesh-ancestor
92976598|NCT00797264|Sensory System Agents|sensory system agents|mesh-ancestor
92976599|NCT00797264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976600|NCT00797264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976601|NCT00797264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92976602|NCT00797264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92976603|NCT00797264|Anesthetics, General|anesthetics, general|mesh-ancestor
92976604|NCT00797264|Anesthetics|anesthetics|mesh-ancestor
92976605|NCT00797264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976606|NCT00797264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92976607|NCT00797264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92976608|NCT00797264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976609|NCT00797264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976610|NCT00797264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92976611|NCT00797264|Narcotics|narcotics|mesh-ancestor
92976612|NCT00981201|Celecoxib|celecoxib|mesh-list
92976613|NCT00981201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92976614|NCT00981201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92976615|NCT00981201|Analgesics|analgesics|mesh-ancestor
92976616|NCT00981201|Sensory System Agents|sensory system agents|mesh-ancestor
92976617|NCT00981201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976618|NCT00981201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976619|NCT00981201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976620|NCT00981201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976621|NCT00981201|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92976622|NCT00981201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92976623|NCT00981201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976624|NCT00981201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976625|NCT05279391|Dexamethasone|dexamethasone|mesh-list
92976626|NCT05279391|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92976627|NCT05279391|Heparin|heparin|mesh-list
92976628|NCT05279391|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92976629|NCT05279391|Tinzaparin|tinzaparin|mesh-list
92976630|NCT05279391|Dalteparin|dalteparin|mesh-list
92976631|NCT05279391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976632|NCT05279391|Antiemetics|antiemetics|mesh-ancestor
92976633|NCT05279391|Autonomic Agents|autonomic agents|mesh-ancestor
92976634|NCT05279391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976635|NCT05279391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976636|NCT05279391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976637|NCT05279391|Glucocorticoids|glucocorticoids|mesh-ancestor
92976638|NCT05279391|Hormones|hormones|mesh-ancestor
92976639|NCT05279391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976640|NCT05279391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92976641|NCT05279391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976642|NCT05279391|Anticoagulants|anticoagulants|mesh-ancestor
92976643|NCT05279391|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92976644|NCT05279391|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92976645|NCT05279391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976646|NCT05279391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976647|NCT02595203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92976648|NCT00789620|Lidocaine|lidocaine|mesh-list
92976649|NCT00789620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92976650|NCT00789620|Anesthetics|anesthetics|mesh-ancestor
92976651|NCT00789620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976652|NCT00789620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976653|NCT00789620|Sensory System Agents|sensory system agents|mesh-ancestor
92976654|NCT00789620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976655|NCT00789620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92976656|NCT00789620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92976657|NCT00789620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92976658|NCT00789620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92976659|NCT00789620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976660|NCT03970265|Meropenem|meropenem|mesh-list
92976661|NCT03970265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92976662|NCT03970265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976663|NCT00877656|Zanolimumab|zanolimumab|mesh-list
92976664|NCT00877656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92976665|NCT00877656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976666|NCT00803894|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92976667|NCT00803894|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92976668|NCT00803894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976669|NCT00803894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976670|NCT05371925|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92976671|NCT05371925|Anticoagulants|anticoagulants|mesh-ancestor
92976672|NCT05371925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92976673|NCT05371925|Antimetabolites|antimetabolites|mesh-ancestor
92976674|NCT05371925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976675|NCT05371925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92976676|NCT05371925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92976677|NCT05371925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92976678|NCT05371925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92976679|NCT05371925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976680|NCT00797420|Fluconazole|fluconazole|mesh-list
92976681|NCT00797420|Antifungal Agents|antifungal agents|mesh-ancestor
92976682|NCT00797420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976683|NCT00797420|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92976684|NCT00797420|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92976686|NCT00797420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976687|NCT00797420|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92976688|NCT00797420|Hormone Antagonists|hormone antagonists|mesh-ancestor
92976689|NCT00797420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976690|NCT00797420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976691|NCT00797420|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92976692|NCT00797420|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92976693|NCT00981513|Vaccines|vaccines|mesh-list
92976694|NCT00981513|Immunologic Factors|immunologic factors|mesh-ancestor
92976695|NCT00981513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976696|NCT00872274|Sumatriptan|sumatriptan|mesh-list
92976697|NCT00872274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92976698|NCT00872274|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92976699|NCT00872274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92976700|NCT00872274|Serotonin Agents|serotonin agents|mesh-ancestor
92976701|NCT00872274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976702|NCT00872274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976703|NCT00872274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976704|NCT00872586|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92976705|NCT00872586|Olmesartan|olmesartan|mesh-list
92976706|NCT00872586|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92976707|NCT00872586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92976708|NCT00872586|Diuretics|diuretics|mesh-ancestor
92976709|NCT00872586|Natriuretic Agents|natriuretic agents|mesh-ancestor
92976710|NCT00872586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976711|NCT00872586|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92976712|NCT00872586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92976713|NCT00872586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976714|NCT00872586|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92976715|NCT00872586|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92976716|NCT00726557|Interferons|interferons|mesh-list
92976717|NCT00726557|Ribavirin|ribavirin|mesh-list
92976718|NCT00726557|Interferon-alpha|interferon-alpha|mesh-list
92976719|NCT00726557|Interferon alpha-2|interferon alpha-2|mesh-list
92976720|NCT00726557|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92976721|NCT00726557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976722|NCT00726557|Antiviral Agents|antiviral agents|mesh-ancestor
92976723|NCT00726557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976724|NCT00726557|Antimetabolites|antimetabolites|mesh-ancestor
92976725|NCT00726557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976726|NCT00726557|Immunologic Factors|immunologic factors|mesh-ancestor
92976727|NCT00726557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976728|NCT00803972|Insulin|insulin|mesh-list
92976729|NCT00803972|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92976730|NCT00803972|Insulin Lispro|insulin lispro|mesh-list
92976731|NCT00803972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92976732|NCT00803972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976733|NCT00880386|Losartan|losartan|mesh-list
92976734|NCT00880386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92976735|NCT00880386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92976736|NCT00880386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92976737|NCT00880386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92976738|NCT00880386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976739|NCT00978081|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92976740|NCT00978081|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92976741|NCT00978081|Dermatologic Agents|dermatologic agents|mesh-ancestor
92976742|NCT00804050|Vitamins|vitamins|mesh-list
92976743|NCT00804050|Micronutrients|micronutrients|mesh-ancestor
92976744|NCT00804050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976745|NCT00877734|Baclofen|baclofen|mesh-list
92976746|NCT00877734|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92976747|NCT00877734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976748|NCT00877734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92976749|NCT00877734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976750|NCT00877734|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92976751|NCT00877734|GABA Agonists|gaba agonists|mesh-ancestor
92976752|NCT00877734|GABA Agents|gaba agents|mesh-ancestor
92976753|NCT00877734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976754|NCT00877734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976755|NCT00981591|Iloprost|iloprost|mesh-list
92321862|NCT00000320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92976756|NCT00981591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92976757|NCT00981591|Vasodilator Agents|vasodilator agents|mesh-ancestor
92976758|NCT00978159|Esomeprazole|esomeprazole|mesh-list
92976759|NCT00978159|Famotidine|famotidine|mesh-list
92976760|NCT00978159|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92976761|NCT00978159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976762|NCT00978159|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92976763|NCT00978159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976764|NCT00978159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976765|NCT00978159|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92976766|NCT00978159|Histamine Antagonists|histamine antagonists|mesh-ancestor
92976767|NCT00978159|Histamine Agents|histamine agents|mesh-ancestor
92976768|NCT00978159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976769|NCT00978159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976770|NCT00804206|Bevacizumab|bevacizumab|mesh-list
92976771|NCT00804206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92976772|NCT00804206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976773|NCT00804206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92976774|NCT00804206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92976775|NCT00804206|Growth Substances|growth substances|mesh-ancestor
92976776|NCT00804206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976777|NCT00804206|Growth Inhibitors|growth inhibitors|mesh-ancestor
92976778|NCT00877812|Glycine|glycine|mesh-list
92976779|NCT00877812|Glycine Agents|glycine agents|mesh-ancestor
92976780|NCT00877812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976781|NCT00877812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976782|NCT00877812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976783|NCT00981903|Tinzaparin|tinzaparin|mesh-list
92976784|NCT00981903|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92976785|NCT00981903|Dalteparin|dalteparin|mesh-list
92976786|NCT00981903|Anticoagulants|anticoagulants|mesh-ancestor
92976787|NCT00981903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92976788|NCT00981903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92976789|NCT00981903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976790|NCT00738881|Pemetrexed|pemetrexed|mesh-list
92976791|NCT00738881|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92976792|NCT00738881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976793|NCT00738881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976794|NCT00738881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976795|NCT00738881|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92976796|NCT00738881|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92976797|NCT00738881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976798|NCT00657020|Nicotine|nicotine|mesh-list
92976799|NCT00657020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92976800|NCT00657020|Autonomic Agents|autonomic agents|mesh-ancestor
92976801|NCT00657020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976802|NCT00657020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976803|NCT00657020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92976804|NCT00657020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92976805|NCT00657020|Cholinergic Agents|cholinergic agents|mesh-ancestor
92976806|NCT00657020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976807|NCT00657020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976808|NCT03921723|Dolutegravir|dolutegravir|mesh-list
92976809|NCT03921723|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92976810|NCT03921723|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92976811|NCT03921723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976812|NCT03921723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976813|NCT03921723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92976814|NCT03921723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92976815|NCT03921723|Antiviral Agents|antiviral agents|mesh-ancestor
92976816|NCT03921723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976818|NCT00872664|Antioxidants|antioxidants|mesh-ancestor
92976819|NCT00872664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976820|NCT00872664|Protective Agents|protective agents|mesh-ancestor
92976821|NCT00872664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976822|NCT05056155|Lubricant Eye Drops|lubricant eye drops|mesh-list
92976823|NCT05056155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92976824|NCT05056155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92976825|NCT00878124|Ubiquinone|ubiquinone|mesh-list
92976826|NCT00878124|Coenzyme Q10|coenzyme q10|mesh-list
92976827|NCT00878124|Micronutrients|micronutrients|mesh-ancestor
92976828|NCT00878124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976829|NCT00878124|Vitamins|vitamins|mesh-ancestor
92976831|NCT00978315|Vitamin D|vitamin d|mesh-list
92976832|NCT00978315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92976833|NCT00978315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976834|NCT00978315|Vitamins|vitamins|mesh-ancestor
92976835|NCT00978315|Micronutrients|micronutrients|mesh-ancestor
92976836|NCT00978315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92976837|NCT00978393|Liraglutide|liraglutide|mesh-list
92976838|NCT00978393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92976839|NCT00978393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976840|NCT00978393|Incretins|incretins|mesh-ancestor
92976841|NCT00978393|Hormones|hormones|mesh-ancestor
92976842|NCT00978393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976843|NCT04740996|Pembrolizumab|pembrolizumab|mesh-list
92976844|NCT04740996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92976845|NCT04740996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976846|NCT04740996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92976847|NCT04740996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976848|NCT00872976|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92976849|NCT00872976|Dasatinib|dasatinib|mesh-list
92976850|NCT00872976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976851|NCT00872976|Alkylating Agents|alkylating agents|mesh-ancestor
92976852|NCT00872976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976853|NCT00872976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976854|NCT00872976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976855|NCT00872976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976856|NCT00544167|Paclitaxel|paclitaxel|mesh-list
92976857|NCT00544167|Cyclophosphamide|cyclophosphamide|mesh-list
92976858|NCT00544167|Doxorubicin|doxorubicin|mesh-list
92976859|NCT00544167|Sorafenib|sorafenib|mesh-list
92976860|NCT00544167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92976861|NCT00544167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976862|NCT00544167|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976863|NCT00544167|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976864|NCT00544167|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976865|NCT00544167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976866|NCT00544167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976867|NCT00544167|Immunologic Factors|immunologic factors|mesh-ancestor
92976868|NCT00544167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976869|NCT00544167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976870|NCT00544167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976871|NCT00544167|Alkylating Agents|alkylating agents|mesh-ancestor
92976872|NCT00544167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976873|NCT00544167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92976874|NCT00544167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92976875|NCT00544167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92976876|NCT00544167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976877|NCT00544167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976878|NCT00659438|Bicalutamide|bicalutamide|mesh-list
92976879|NCT00659438|Androgen Antagonists|androgen antagonists|mesh-ancestor
92976880|NCT00659438|Hormone Antagonists|hormone antagonists|mesh-ancestor
92976881|NCT00659438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976882|NCT00659438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976883|NCT00659438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976884|NCT05225844|Apatinib|apatinib|mesh-list
92976885|NCT05225844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976886|NCT05225844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976887|NCT05225844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976888|NCT05225844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976889|NCT00878514|Alprazolam|alprazolam|mesh-list
92976890|NCT00878514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92976891|NCT00878514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976892|NCT00878514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976893|NCT00878514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92976894|NCT00878514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92976895|NCT00878514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92976896|NCT00878514|GABA Modulators|gaba modulators|mesh-ancestor
92976897|NCT00878514|GABA Agents|gaba agents|mesh-ancestor
92976898|NCT00878514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277587|NCT04041219|Tacrolimus|tacrolimus|mesh-list
92976899|NCT00878514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976900|NCT00804440|Ibuprofen|ibuprofen|mesh-list
92976901|NCT00804440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92976902|NCT00804440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92976903|NCT00804440|Analgesics|analgesics|mesh-ancestor
92976904|NCT00804440|Sensory System Agents|sensory system agents|mesh-ancestor
92976905|NCT00804440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976906|NCT00804440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976907|NCT00804440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976908|NCT00804440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976909|NCT00804440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92976910|NCT00804440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976911|NCT00804440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976912|NCT00880854|Tremelimumab|tremelimumab|mesh-list
92976913|NCT00880854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976914|NCT00543855|Donepezil|donepezil|mesh-list
92976915|NCT00543855|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92976916|NCT00543855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976917|NCT00543855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976918|NCT00543855|Cholinergic Agents|cholinergic agents|mesh-ancestor
92976919|NCT00543855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92976920|NCT00543855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976921|NCT00543855|Nootropic Agents|nootropic agents|mesh-ancestor
92976922|NCT00797810|Cytarabine|cytarabine|mesh-list
92976923|NCT00797810|Dexamethasone|dexamethasone|mesh-list
92976924|NCT00797810|Prednisone|prednisone|mesh-list
92976925|NCT00797810|Cyclophosphamide|cyclophosphamide|mesh-list
92976926|NCT00797810|Ifosfamide|ifosfamide|mesh-list
92976927|NCT00797810|Rituximab|rituximab|mesh-list
92976928|NCT00797810|Vincristine|vincristine|mesh-list
92976929|NCT00797810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976930|NCT00797810|Immunologic Factors|immunologic factors|mesh-ancestor
92976931|NCT00797810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976932|NCT00797810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92976933|NCT00797810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976934|NCT00797810|Alkylating Agents|alkylating agents|mesh-ancestor
92976935|NCT00797810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976936|NCT00797810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976937|NCT00797810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976938|NCT00797810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92976939|NCT00797810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92976940|NCT00797810|Antiemetics|antiemetics|mesh-ancestor
92976941|NCT00797810|Autonomic Agents|autonomic agents|mesh-ancestor
92976942|NCT00797810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976943|NCT00797810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92976944|NCT00797810|Glucocorticoids|glucocorticoids|mesh-ancestor
92976945|NCT00797810|Hormones|hormones|mesh-ancestor
92976946|NCT00797810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92976947|NCT00797810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92976948|NCT00797810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92976949|NCT00797810|Antimetabolites|antimetabolites|mesh-ancestor
92976950|NCT00797810|Antiviral Agents|antiviral agents|mesh-ancestor
92976951|NCT00797810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92976952|NCT00797810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92976953|NCT00797810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976954|NCT00797810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976955|NCT00797810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976956|NCT00873210|Sunitinib|sunitinib|mesh-list
92976957|NCT00873210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976958|NCT00873210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92976959|NCT00873210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92976960|NCT00873210|Growth Substances|growth substances|mesh-ancestor
92976961|NCT00873210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976962|NCT00873210|Growth Inhibitors|growth inhibitors|mesh-ancestor
92976963|NCT00873210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92976964|NCT00873210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976965|NCT00873210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976966|NCT00978471|Thiotepa|thiotepa|mesh-list
92622384|NCT02920567|Octreotide|octreotide|mesh-list
92976967|NCT00978471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92976968|NCT00978471|Alkylating Agents|alkylating agents|mesh-ancestor
92976969|NCT00978471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976970|NCT00978471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976971|NCT00978471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92976972|NCT00978471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92976973|NCT00978471|Immunologic Factors|immunologic factors|mesh-ancestor
92976974|NCT00978471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976975|NCT00804674|Bupivacaine|bupivacaine|mesh-list
92976976|NCT00804674|Anesthetics, Local|anesthetics, local|mesh-ancestor
92976977|NCT00804674|Anesthetics|anesthetics|mesh-ancestor
92976978|NCT00804674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92976979|NCT00804674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92976980|NCT00804674|Sensory System Agents|sensory system agents|mesh-ancestor
92976981|NCT00804674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92976983|NCT00881088|Nadroparin|nadroparin|mesh-list
92976984|NCT00881088|Fondaparinux|fondaparinux|mesh-list
92976985|NCT00881088|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92976986|NCT00881088|Antithrombins|antithrombins|mesh-ancestor
92976987|NCT00881088|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92976988|NCT00881088|Protease Inhibitors|protease inhibitors|mesh-ancestor
92976989|NCT00881088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92976990|NCT00881088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92976991|NCT00881088|Anticoagulants|anticoagulants|mesh-ancestor
92976992|NCT00881088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92976993|NCT00881088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92976994|NCT00978549|Docetaxel|docetaxel|mesh-list
92976995|NCT00978549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92976996|NCT00978549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92976997|NCT00978549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92976998|NCT00978549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92976999|NCT00978549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977000|NCT00656084|Rituximab|rituximab|mesh-list
92977001|NCT00656084|Gemcitabine|gemcitabine|mesh-list
92977002|NCT00656084|Mitoxantrone|mitoxantrone|mesh-list
92977003|NCT00656084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977004|NCT00656084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977005|NCT00656084|Immunologic Factors|immunologic factors|mesh-ancestor
92977006|NCT00656084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977007|NCT00656084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977008|NCT00656084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92977009|NCT00656084|Antimetabolites|antimetabolites|mesh-ancestor
92977010|NCT00656084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977011|NCT00656084|Analgesics|analgesics|mesh-ancestor
92977012|NCT00656084|Sensory System Agents|sensory system agents|mesh-ancestor
92977013|NCT00656084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977014|NCT00656084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92977015|NCT00656084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92977016|NCT00656084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977017|NCT00881166|Paclitaxel|paclitaxel|mesh-list
92977018|NCT00881166|Etoposide|etoposide|mesh-list
92977019|NCT00881166|Docetaxel|docetaxel|mesh-list
92977020|NCT00881166|Carboplatin|carboplatin|mesh-list
92977021|NCT00881166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92977022|NCT00881166|Topotecan|topotecan|mesh-list
92977023|NCT00881166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92977024|NCT00881166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977025|NCT00881166|Tubulin Modulators|tubulin modulators|mesh-ancestor
92977026|NCT00881166|Antimitotic Agents|antimitotic agents|mesh-ancestor
92977027|NCT00881166|Mitosis Modulators|mitosis modulators|mesh-ancestor
92977028|NCT00881166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977029|NCT00881166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92977030|NCT00881166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92977031|NCT00881166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977032|NCT00881166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92977033|NCT00881166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92977034|NCT00804752|Vitamin D|vitamin d|mesh-list
92977035|NCT00804752|Ergocalciferols|ergocalciferols|mesh-list
92977036|NCT00804752|Cholecalciferol|cholecalciferol|mesh-list
92977037|NCT00804752|Vitamins|vitamins|mesh-list
92977038|NCT00804752|Micronutrients|micronutrients|mesh-ancestor
92977039|NCT00804752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977040|NCT00804752|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92977041|NCT00804752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92977042|NCT05225766|Bupivacaine|bupivacaine|mesh-list
92977043|NCT05225766|Anesthetics, Local|anesthetics, local|mesh-ancestor
92977044|NCT05225766|Anesthetics|anesthetics|mesh-ancestor
92977045|NCT05225766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977046|NCT05225766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977047|NCT05225766|Sensory System Agents|sensory system agents|mesh-ancestor
92977048|NCT05225766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977049|NCT00804830|Bevacizumab|bevacizumab|mesh-list
92977050|NCT00804830|Doxorubicin|doxorubicin|mesh-list
92977051|NCT00804830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977052|NCT00804830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977053|NCT00804830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92977054|NCT00804830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92977055|NCT00804830|Growth Substances|growth substances|mesh-ancestor
92977056|NCT00804830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977057|NCT00804830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92977058|NCT00804830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92977059|NCT00804830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92977060|NCT00804830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92977061|NCT00804830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977062|NCT00804830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977063|NCT00982215|Acetaminophen|acetaminophen|mesh-list
92977064|NCT00982215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977065|NCT00982215|Analgesics|analgesics|mesh-ancestor
92977066|NCT00982215|Sensory System Agents|sensory system agents|mesh-ancestor
92977067|NCT00982215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977068|NCT00982215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977069|NCT00982215|Antipyretics|antipyretics|mesh-ancestor
92977070|NCT00613938|Oxycodone|oxycodone|mesh-list
92977071|NCT00613938|Tapentadol|tapentadol|mesh-list
92977072|NCT00613938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92977073|NCT00613938|Narcotics|narcotics|mesh-ancestor
92977074|NCT00613938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977075|NCT00613938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977076|NCT00613938|Analgesics|analgesics|mesh-ancestor
92977077|NCT00613938|Sensory System Agents|sensory system agents|mesh-ancestor
92977078|NCT00613938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977079|NCT00613938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92977080|NCT00613938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92977081|NCT00613938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977082|NCT00613938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977083|NCT00613938|Adrenergic Agents|adrenergic agents|mesh-ancestor
92977084|NCT00613938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977085|NCT00978861|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92977086|NCT00978861|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92977087|NCT00978861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977088|NCT00805064|Triamcinolone|triamcinolone|mesh-list
92977089|NCT00805064|Bevacizumab|bevacizumab|mesh-list
92977090|NCT00805064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977091|NCT00805064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977092|NCT00805064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92977093|NCT00805064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92977094|NCT00805064|Growth Substances|growth substances|mesh-ancestor
92977095|NCT00805064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977096|NCT00805064|Growth Inhibitors|growth inhibitors|mesh-ancestor
92977097|NCT00805064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977098|NCT00805064|Glucocorticoids|glucocorticoids|mesh-ancestor
92977099|NCT00805064|Hormones|hormones|mesh-ancestor
92977100|NCT00805064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977101|NCT00655928|Acetylcysteine|acetylcysteine|mesh-list
92977102|NCT00655928|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92977103|NCT00655928|Antiviral Agents|antiviral agents|mesh-ancestor
92977104|NCT00655928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977105|NCT00655928|Expectorants|expectorants|mesh-ancestor
92977106|NCT00655928|Respiratory System Agents|respiratory system agents|mesh-ancestor
92977107|NCT00655928|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92977108|NCT00655928|Antioxidants|antioxidants|mesh-ancestor
92977109|NCT00655928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977110|NCT00655928|Protective Agents|protective agents|mesh-ancestor
92977111|NCT00655928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977112|NCT00655928|Antidotes|antidotes|mesh-ancestor
92977113|NCT00873756|Bevacizumab|bevacizumab|mesh-list
92977114|NCT00873756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977115|NCT00873756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167071|NCT02849899|Vildagliptin|vildagliptin|mesh-list
92977116|NCT00873756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92977117|NCT00873756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92977118|NCT00873756|Growth Substances|growth substances|mesh-ancestor
92977119|NCT00873756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977120|NCT00873756|Growth Inhibitors|growth inhibitors|mesh-ancestor
92977121|NCT00873834|Fluoxetine|fluoxetine|mesh-list
92977122|NCT00873834|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92977123|NCT00873834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92977124|NCT00873834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977125|NCT00873834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977273|NCT00982449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977274|NCT02593721|Ibuprofen|ibuprofen|mesh-list
92977275|NCT02593721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92977276|NCT02593721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977277|NCT02593721|Analgesics|analgesics|mesh-ancestor
92977278|NCT02593721|Sensory System Agents|sensory system agents|mesh-ancestor
92977279|NCT02593721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977280|NCT02593721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977281|NCT02593721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977282|NCT02593721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977283|NCT02593721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92977284|NCT02593721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977285|NCT02593721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977286|NCT00985647|Lamivudine|lamivudine|mesh-list
92977287|NCT00985647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92977288|NCT00985647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92977289|NCT00985647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977290|NCT00985647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977291|NCT00985647|Antiviral Agents|antiviral agents|mesh-ancestor
92977292|NCT00985647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977293|NCT00985647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977294|NCT00985647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92977295|NCT00806468|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92977296|NCT00806468|Hemostatics|hemostatics|mesh-ancestor
92977297|NCT00806468|Coagulants|coagulants|mesh-ancestor
92977298|NCT00806468|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92977299|NCT00806468|Natriuretic Agents|natriuretic agents|mesh-ancestor
92977300|NCT00806468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977301|NCT00982527|Fenoldopam|fenoldopam|mesh-list
92977302|NCT00982527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92977303|NCT00982527|Vasodilator Agents|vasodilator agents|mesh-ancestor
92977304|NCT00982527|Dopamine Agonists|dopamine agonists|mesh-ancestor
92977305|NCT00982527|Dopamine Agents|dopamine agents|mesh-ancestor
92977306|NCT00982527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977307|NCT00982527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977308|NCT00982527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977309|NCT00798980|Levonorgestrel|levonorgestrel|mesh-list
92977310|NCT00798980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92977311|NCT00798980|Contraceptive Agents|contraceptive agents|mesh-ancestor
92977312|NCT00798980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92977313|NCT00798980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977314|NCT00798980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92977315|NCT00798980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92977316|NCT00798980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92977317|NCT00725621|Infliximab|infliximab|mesh-list
92977318|NCT00725621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92977319|NCT00725621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977320|NCT00725621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977321|NCT00725621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977322|NCT00725621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977323|NCT00613626|Etoposide|etoposide|mesh-list
92977324|NCT00613626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977325|NCT00613626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92977326|NCT00613626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92977327|NCT00613626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92977328|NCT00613626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977329|NCT00613626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977330|NCT00725543|Infliximab|infliximab|mesh-list
92977331|NCT00725543|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92977332|NCT00725543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977333|NCT00725543|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977334|NCT00725543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977335|NCT00725543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977336|NCT00239005|Mycophenolic Acid|mycophenolic acid|mesh-list
92977337|NCT00239005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92977338|NCT00239005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977339|NCT00239005|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92977340|NCT00239005|Antitubercular Agents|antitubercular agents|mesh-ancestor
92977341|NCT00239005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977342|NCT00239005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977343|NCT00239005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977344|NCT00239005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977345|NCT00616434|Interferons|interferons|mesh-list
92977346|NCT00616434|Interferon-beta|interferon-beta|mesh-list
92977347|NCT00616434|Interferon beta-1a|interferon beta-1a|mesh-list
92977348|NCT00616434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977349|NCT00616434|Antiviral Agents|antiviral agents|mesh-ancestor
92977350|NCT00616434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977351|NCT00616434|Immunologic Factors|immunologic factors|mesh-ancestor
92977352|NCT00616434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977353|NCT00616434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92977354|NCT00652340|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92977355|NCT00652340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977356|NCT00652340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92977357|NCT00652340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977358|NCT00652340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977359|NCT00257725|Methylphenidate|methylphenidate|mesh-list
92977360|NCT00257725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92977361|NCT00257725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977362|NCT00257725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92977363|NCT00257725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92977364|NCT00257725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977365|NCT00257725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977366|NCT00257725|Dopamine Agents|dopamine agents|mesh-ancestor
92977367|NCT00257725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977368|NCT00544869|Tolvaptan|tolvaptan|mesh-list
92977369|NCT00544869|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92977370|NCT00544869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977371|NCT00544869|Natriuretic Agents|natriuretic agents|mesh-ancestor
92977372|NCT00544869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977373|NCT02593643|Midazolam|midazolam|mesh-list
92977374|NCT02593643|Ketamine|ketamine|mesh-list
92977375|NCT02593643|Analgesics|analgesics|mesh-ancestor
92977376|NCT02593643|Sensory System Agents|sensory system agents|mesh-ancestor
92977377|NCT02593643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977378|NCT02593643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977379|NCT02593643|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92977380|NCT02593643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92977381|NCT02593643|Anesthetics, General|anesthetics, general|mesh-ancestor
92977382|NCT02593643|Anesthetics|anesthetics|mesh-ancestor
92977383|NCT02593643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977384|NCT02593643|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92977385|NCT02593643|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92977386|NCT02593643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977387|NCT02593643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977388|NCT02593643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92977389|NCT02593643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92977390|NCT02593643|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92977391|NCT02593643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92977392|NCT02593643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977393|NCT02593643|GABA Modulators|gaba modulators|mesh-ancestor
92977394|NCT02593643|GABA Agents|gaba agents|mesh-ancestor
92977395|NCT00881556|Fludarabine|fludarabine|mesh-list
92977396|NCT00881556|Busulfan|busulfan|mesh-list
92977397|NCT00881556|Alemtuzumab|alemtuzumab|mesh-list
92977398|NCT00881556|Lorazepam|lorazepam|mesh-list
92977399|NCT00881556|Tacrolimus|tacrolimus|mesh-list
92977400|NCT00881556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977401|NCT00881556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977402|NCT00881556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92977403|NCT00881556|Immunologic Factors|immunologic factors|mesh-ancestor
92977404|NCT00881556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977405|NCT00881556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92977406|NCT00881556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977407|NCT00881556|Alkylating Agents|alkylating agents|mesh-ancestor
92977408|NCT00881556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92977409|NCT00881556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92977410|NCT00881556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977411|NCT00881556|Anticonvulsants|anticonvulsants|mesh-ancestor
92977412|NCT00881556|Antiemetics|antiemetics|mesh-ancestor
92977413|NCT00881556|Autonomic Agents|autonomic agents|mesh-ancestor
92977414|NCT00881556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977415|NCT00881556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977416|NCT00881556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93047060|NCT03983460|Betamethasone Valerate|betamethasone valerate|mesh-list
92977417|NCT00881556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977418|NCT00881556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92977419|NCT00881556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92977420|NCT00881556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977421|NCT00881556|GABA Modulators|gaba modulators|mesh-ancestor
92977422|NCT00881556|GABA Agents|gaba agents|mesh-ancestor
92977423|NCT00881556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977424|NCT00881634|Cetirizine|cetirizine|mesh-list
92977425|NCT00881634|Pseudoephedrine|pseudoephedrine|mesh-list
92977426|NCT00881634|Ephedrine|ephedrine|mesh-list
92977427|NCT00881634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92977428|NCT00881634|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92977429|NCT00881634|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92977430|NCT00881634|Histamine Antagonists|histamine antagonists|mesh-ancestor
92977431|NCT00881634|Histamine Agents|histamine agents|mesh-ancestor
92977432|NCT00881634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977433|NCT00881634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977434|NCT00881634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977435|NCT00881634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92977436|NCT00881634|Autonomic Agents|autonomic agents|mesh-ancestor
92977437|NCT00881634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977438|NCT00881634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92977439|NCT00881634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92977440|NCT00881634|Nasal Decongestants|nasal decongestants|mesh-ancestor
92977441|NCT00881634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92977442|NCT00881634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92977443|NCT00881634|Sympathomimetics|sympathomimetics|mesh-ancestor
92977444|NCT00881634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92977445|NCT00878670|Evening primrose oil|evening primrose oil|mesh-list
92977446|NCT00878670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92977447|NCT00878670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977448|NCT00878670|Analgesics|analgesics|mesh-ancestor
92977449|NCT00878670|Sensory System Agents|sensory system agents|mesh-ancestor
92977450|NCT00878670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977451|NCT00878670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977452|NCT00878670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977453|NCT00878670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977454|NCT00878670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92977455|NCT00878670|Antimetabolites|antimetabolites|mesh-ancestor
92977456|NCT00878670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977457|NCT00878670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92977458|NCT00878670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977459|NCT00878748|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92977460|NCT00878748|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92977461|NCT00878748|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92977462|NCT00878748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977463|NCT00878748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977464|NCT00878748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977465|NCT00878748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977466|NCT00878748|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92977467|NCT00878748|Antidepressive Agents|antidepressive agents|mesh-ancestor
92977468|NCT00878748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977469|NCT00652028|Fentanyl|fentanyl|mesh-list
92977470|NCT00652028|Midazolam|midazolam|mesh-list
92977471|NCT00652028|Dexmedetomidine|dexmedetomidine|mesh-list
92977472|NCT00652028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92977473|NCT00652028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977474|NCT00652028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977475|NCT00652028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977476|NCT00652028|Analgesics|analgesics|mesh-ancestor
92977477|NCT00652028|Sensory System Agents|sensory system agents|mesh-ancestor
92977478|NCT00652028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977479|NCT00652028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92977480|NCT00652028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92977481|NCT00652028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92977482|NCT00652028|Adrenergic Agents|adrenergic agents|mesh-ancestor
92977483|NCT00652028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977484|NCT00652028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977485|NCT00652028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92977486|NCT00652028|Narcotics|narcotics|mesh-ancestor
92977487|NCT00652028|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92977488|NCT00652028|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92977489|NCT00652028|Anesthetics, General|anesthetics, general|mesh-ancestor
92622912|NCT00181974|Coagulants|coagulants|mesh-ancestor
92977490|NCT00652028|Anesthetics|anesthetics|mesh-ancestor
92977491|NCT00652028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92977492|NCT00652028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92977493|NCT00652028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977494|NCT00652028|GABA Modulators|gaba modulators|mesh-ancestor
92977495|NCT00652028|GABA Agents|gaba agents|mesh-ancestor
92977496|NCT00799136|Prednisone|prednisone|mesh-list
92977497|NCT00799136|Vincristine|vincristine|mesh-list
92977498|NCT00799136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977499|NCT00799136|Glucocorticoids|glucocorticoids|mesh-ancestor
92977500|NCT00799136|Hormones|hormones|mesh-ancestor
92977501|NCT00799136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977502|NCT00799136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977503|NCT00799136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92977504|NCT00799136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977505|NCT00799136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92977506|NCT00799136|Tubulin Modulators|tubulin modulators|mesh-ancestor
92977507|NCT00799136|Antimitotic Agents|antimitotic agents|mesh-ancestor
92977508|NCT00799136|Mitosis Modulators|mitosis modulators|mesh-ancestor
92977509|NCT00799136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977510|NCT02592395|Folfirinox|folfirinox|mesh-list
92977511|NCT02592395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977512|NCT00799214|Metronidazole|metronidazole|mesh-list
92977513|NCT00799214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977514|NCT00799214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977515|NCT00799214|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92977516|NCT00799214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92977517|NCT00733421|Etoricoxib|etoricoxib|mesh-list
92977518|NCT00733421|Tramadol|tramadol|mesh-list
92977519|NCT00733421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92977520|NCT00733421|Narcotics|narcotics|mesh-ancestor
92977521|NCT00733421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977522|NCT00733421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977523|NCT00733421|Analgesics|analgesics|mesh-ancestor
92977524|NCT00733421|Sensory System Agents|sensory system agents|mesh-ancestor
92977525|NCT00733421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977526|NCT00733421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92977527|NCT00733421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977528|NCT00733421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977529|NCT00733421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977530|NCT00733421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92977531|NCT00733421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92977532|NCT00733421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977533|NCT00733421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977534|NCT00613080|Leucovorin|leucovorin|mesh-list
92977535|NCT00613080|Fluorouracil|fluorouracil|mesh-list
92977536|NCT00613080|Capecitabine|capecitabine|mesh-list
92977537|NCT00613080|Oxaliplatin|oxaliplatin|mesh-list
92977538|NCT00613080|Antimetabolites|antimetabolites|mesh-ancestor
92977539|NCT00613080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977540|NCT00613080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92977541|NCT00613080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977542|NCT00613080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92977543|NCT00613080|Immunologic Factors|immunologic factors|mesh-ancestor
92977544|NCT00613080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977545|NCT00613080|Antidotes|antidotes|mesh-ancestor
92977546|NCT00613080|Protective Agents|protective agents|mesh-ancestor
92977547|NCT00613080|Vitamin B Complex|vitamin b complex|mesh-ancestor
92977548|NCT00613080|Vitamins|vitamins|mesh-ancestor
92977549|NCT00613080|Micronutrients|micronutrients|mesh-ancestor
92977550|NCT00917891|Dapivirine|dapivirine|mesh-list
92977551|NCT00917891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977552|NCT00917891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92977553|NCT00917891|Antiviral Agents|antiviral agents|mesh-ancestor
92977554|NCT00917891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977555|NCT00732875|Infliximab|infliximab|mesh-list
92977556|NCT00732875|Methotrexate|methotrexate|mesh-list
92977557|NCT00732875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92977558|NCT00732875|Abortifacient Agents|abortifacient agents|mesh-ancestor
92977559|NCT00732875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92977560|NCT00732875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977561|NCT00732875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92977562|NCT00732875|Antimetabolites|antimetabolites|mesh-ancestor
92977563|NCT00732875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977564|NCT00732875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977565|NCT00732875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977566|NCT00732875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977567|NCT00732875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92977568|NCT00732875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92977569|NCT00732875|Immunologic Factors|immunologic factors|mesh-ancestor
92977570|NCT00732875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977571|NCT00732875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92977572|NCT00732875|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92977573|NCT00732875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977574|NCT00732875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977576|NCT00881790|Fluorides, Topical|fluorides, topical|mesh-list
92977577|NCT00881790|Cariostatic Agents|cariostatic agents|mesh-ancestor
92977578|NCT00881790|Protective Agents|protective agents|mesh-ancestor
92977579|NCT00881790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977580|NCT00810446|Rifabutin|rifabutin|mesh-list
92977581|NCT00810446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977582|NCT00810446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977583|NCT00810446|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92977584|NCT00810446|Antitubercular Agents|antitubercular agents|mesh-ancestor
92977585|NCT00810524|Lamivudine|lamivudine|mesh-list
92977586|NCT00810524|Adefovir|adefovir|mesh-list
92977587|NCT00810524|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92977588|NCT00810524|Telbivudine|telbivudine|mesh-list
92977589|NCT00810524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92977590|NCT00810524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92977591|NCT00810524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977592|NCT00810524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977593|NCT00810524|Antiviral Agents|antiviral agents|mesh-ancestor
92977594|NCT00810524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977595|NCT00810524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977596|NCT00810524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92977597|NCT00810680|Valproic Acid|valproic acid|mesh-list
92977598|NCT00810680|Anticonvulsants|anticonvulsants|mesh-ancestor
92977599|NCT00810680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977600|NCT00810680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977601|NCT00810680|GABA Agents|gaba agents|mesh-ancestor
92977602|NCT00810680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977603|NCT00810680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977604|NCT00810680|Antimanic Agents|antimanic agents|mesh-ancestor
92977605|NCT00810680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92977606|NCT00810680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977607|NCT00810680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977608|NCT00799448|Insulin|insulin|mesh-list
92977609|NCT00799448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92977610|NCT00799448|Repaglinide|repaglinide|mesh-list
92977611|NCT00799448|Isophane Insulin, Human|isophane insulin, human|mesh-list
92977612|NCT00799448|Insulin, Isophane|insulin, isophane|mesh-list
92977613|NCT00799448|Isophane insulin, beef|isophane insulin, beef|mesh-list
92977614|NCT00799448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92977615|NCT00799448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977616|NCT00806936|Insulin|insulin|mesh-list
92977617|NCT00806936|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92977618|NCT00806936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92977619|NCT00806936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977620|NCT00799682|Travoprost|travoprost|mesh-list
92977621|NCT00799682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92977622|NCT00799682|Latanoprost|latanoprost|mesh-list
92977623|NCT00799682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92977624|NCT00799682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92977625|NCT03829020|Metformin|metformin|mesh-list
92977626|NCT03829020|Nelfinavir|nelfinavir|mesh-list
92977627|NCT03829020|Bortezomib|bortezomib|mesh-list
92977628|NCT03829020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92977629|NCT03829020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977630|NCT03829020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977631|NCT03829020|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92977632|NCT03829020|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92977633|NCT03829020|Protease Inhibitors|protease inhibitors|mesh-ancestor
92977634|NCT03829020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977635|NCT03829020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977636|NCT03829020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977637|NCT03829020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92977638|NCT03829020|Antiviral Agents|antiviral agents|mesh-ancestor
92977639|NCT03829020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977640|NCT00810836|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92977641|NCT00810836|Dermatologic Agents|dermatologic agents|mesh-ancestor
92623064|NCT00536068|Naproxen|naproxen|mesh-list
92977642|NCT00810836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92977643|NCT00810836|Immunologic Factors|immunologic factors|mesh-ancestor
92977644|NCT00810836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977645|NCT00874926|Factor VIII|factor viii|mesh-list
92977647|NCT00810914|Bupivacaine|bupivacaine|mesh-list
92977648|NCT00810914|Anesthetics, Local|anesthetics, local|mesh-ancestor
92977649|NCT00810914|Anesthetics|anesthetics|mesh-ancestor
92977650|NCT00810914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977651|NCT00810914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977652|NCT00810914|Sensory System Agents|sensory system agents|mesh-ancestor
92977653|NCT00810914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977654|NCT00878904|Epirubicin|epirubicin|mesh-list
92977655|NCT00878904|Panobinostat|panobinostat|mesh-list
92977656|NCT00878904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92977657|NCT00878904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977658|NCT00878904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92977659|NCT00878904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92977660|NCT00878904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977661|NCT00878904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977662|NCT00878904|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92977663|NCT00737711|Epoetin Alfa|epoetin alfa|mesh-list
92977664|NCT00737711|Hematinics|hematinics|mesh-ancestor
92977665|NCT00807326|Simethicone|simethicone|mesh-list
92977666|NCT00807326|Loperamide|loperamide|mesh-list
92977667|NCT00807326|Antidiarrheals|antidiarrheals|mesh-list
92977668|NCT00807326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977669|NCT00807326|Antifoaming Agents|antifoaming agents|mesh-ancestor
92977670|NCT00807326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977671|NCT00807326|Emollients|emollients|mesh-ancestor
92977672|NCT00807326|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977673|NCT00875082|Montelukast|montelukast|mesh-list
92977674|NCT00875082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92977675|NCT00875082|Respiratory System Agents|respiratory system agents|mesh-ancestor
92977676|NCT00875082|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92977677|NCT00875082|Hormone Antagonists|hormone antagonists|mesh-ancestor
92977678|NCT00875082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977679|NCT00875082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977680|NCT00875082|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92977681|NCT00875082|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92977682|NCT00875082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977683|NCT02552342|Methylprednisolone|methylprednisolone|mesh-list
92977684|NCT02552342|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92977685|NCT02552342|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92977686|NCT02552342|Prednisolone|prednisolone|mesh-list
92977687|NCT02552342|Prednisolone acetate|prednisolone acetate|mesh-list
92977688|NCT02552342|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92977689|NCT02552342|Prednisolone phosphate|prednisolone phosphate|mesh-list
92977690|NCT02552342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977691|NCT02552342|Antiemetics|antiemetics|mesh-ancestor
92977692|NCT02552342|Autonomic Agents|autonomic agents|mesh-ancestor
92977693|NCT02552342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977694|NCT02552342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977695|NCT02552342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92977696|NCT02552342|Glucocorticoids|glucocorticoids|mesh-ancestor
92977697|NCT02552342|Hormones|hormones|mesh-ancestor
92977698|NCT02552342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977699|NCT02552342|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92977700|NCT02552342|Protective Agents|protective agents|mesh-ancestor
92977701|NCT02552342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92977702|NCT02552342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977703|NCT00811226|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92977704|NCT00811226|Olmesartan|olmesartan|mesh-list
92977705|NCT00811226|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92977706|NCT00811226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92977707|NCT00811226|Diuretics|diuretics|mesh-ancestor
92977708|NCT00811226|Natriuretic Agents|natriuretic agents|mesh-ancestor
92977709|NCT00811226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977710|NCT00811226|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92977711|NCT00811226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977712|NCT00811226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977713|NCT00811226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92977714|NCT00811226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92977715|NCT00238303|Vorinostat|vorinostat|mesh-list
92977716|NCT00238303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977717|NCT00238303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92977718|NCT00238303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977719|NCT00238303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977720|NCT00811460|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92977721|NCT00811460|Incretins|incretins|mesh-ancestor
92977722|NCT00811460|Hormones|hormones|mesh-ancestor
92977723|NCT00811460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977724|NCT00811460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977725|NCT00875238|Doxorubicin|doxorubicin|mesh-list
92977726|NCT00875238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92977727|NCT00875238|Trastuzumab|trastuzumab|mesh-list
92977728|NCT00875238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92977729|NCT00875238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977730|NCT00875238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92977731|NCT00875238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92977732|NCT00875238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977733|NCT00875238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977734|NCT00875238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977735|NCT00732251|Allopurinol|allopurinol|mesh-list
92977736|NCT00732251|Antimetabolites|antimetabolites|mesh-ancestor
92977737|NCT00732251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977738|NCT00732251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977739|NCT00732251|Gout Suppressants|gout suppressants|mesh-ancestor
92977740|NCT00732251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977741|NCT00732251|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92977742|NCT00732251|Antioxidants|antioxidants|mesh-ancestor
92977743|NCT00732251|Protective Agents|protective agents|mesh-ancestor
92977744|NCT00732251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977745|NCT00882024|Tranilast|tranilast|mesh-list
92977746|NCT00882024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92977747|NCT00882024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977748|NCT00882024|Analgesics|analgesics|mesh-ancestor
92977749|NCT00882024|Sensory System Agents|sensory system agents|mesh-ancestor
92977750|NCT00882024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977751|NCT00882024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977752|NCT00882024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977753|NCT00882024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977754|NCT00882024|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92977755|NCT00882024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92977756|NCT00882024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977757|NCT00882024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92977758|NCT00882024|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92977759|NCT00882024|Histamine Antagonists|histamine antagonists|mesh-ancestor
92977760|NCT00882024|Histamine Agents|histamine agents|mesh-ancestor
92977761|NCT00882024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977762|NCT00882024|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92977763|NCT00882024|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92977764|NCT00799760|Oseltamivir|oseltamivir|mesh-list
92977765|NCT00799760|Zanamivir|zanamivir|mesh-list
92977766|NCT00799760|Antiviral Agents|antiviral agents|mesh-ancestor
92977767|NCT00799760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977768|NCT00799760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167091|NCT01369875|Aldesleukin|aldesleukin|mesh-list
92977769|NCT00799760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977770|NCT00799838|Amoxicillin|amoxicillin|mesh-list
92977771|NCT00799838|Ketoprofen|ketoprofen|mesh-list
92977772|NCT00799838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977773|NCT00799838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977774|NCT00799838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92977775|NCT00799838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92977776|NCT00799838|Analgesics|analgesics|mesh-ancestor
92977777|NCT00799838|Sensory System Agents|sensory system agents|mesh-ancestor
92977778|NCT00799838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977779|NCT00799838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977780|NCT00799838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92977781|NCT00799838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92977782|NCT00799838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92977783|NCT00799838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977784|NCT00799838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977785|NCT00737477|Epoetin Alfa|epoetin alfa|mesh-list
92977786|NCT00737477|Hematinics|hematinics|mesh-ancestor
92977787|NCT00800150|Fludarabine|fludarabine|mesh-list
92977788|NCT00800150|Fludarabine phosphate|fludarabine phosphate|mesh-list
92977789|NCT00800150|Melphalan|melphalan|mesh-list
92977790|NCT00800150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977791|NCT00800150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92977792|NCT00800150|Antimetabolites|antimetabolites|mesh-ancestor
92977793|NCT00800150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977794|NCT00800150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92977795|NCT00800150|Immunologic Factors|immunologic factors|mesh-ancestor
92977796|NCT00800150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977797|NCT00800150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92977798|NCT00800150|Alkylating Agents|alkylating agents|mesh-ancestor
92977799|NCT00800150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92977800|NCT00800306|Simendan|simendan|mesh-list
92977801|NCT00800306|Dobutamine|dobutamine|mesh-list
92977802|NCT00800306|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92977803|NCT00800306|Vasodilator Agents|vasodilator agents|mesh-ancestor
92977804|NCT00800306|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92977805|NCT00800306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92977806|NCT00800306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977807|NCT00800306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977808|NCT00800306|Protective Agents|protective agents|mesh-ancestor
92977809|NCT00800306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977810|NCT00800306|Sympathomimetics|sympathomimetics|mesh-ancestor
92977811|NCT00800306|Autonomic Agents|autonomic agents|mesh-ancestor
92977812|NCT00800306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977813|NCT00800306|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92977814|NCT00800306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92977815|NCT00800306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92977816|NCT00800306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92977817|NCT00800306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977818|NCT01581775|Valproic Acid|valproic acid|mesh-list
92977819|NCT01581775|Anticonvulsants|anticonvulsants|mesh-ancestor
92977820|NCT01581775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977821|NCT01581775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977822|NCT01581775|GABA Agents|gaba agents|mesh-ancestor
92977823|NCT01581775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977824|NCT01581775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977825|NCT01581775|Antimanic Agents|antimanic agents|mesh-ancestor
92977826|NCT01581775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92977827|NCT01581775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977828|NCT01581775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977829|NCT04039152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92977830|NCT04039152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977831|NCT01072747|Heparin|heparin|mesh-list
92977832|NCT01072747|Calcium heparin|calcium heparin|mesh-list
92977833|NCT01072747|Anticoagulants|anticoagulants|mesh-ancestor
92977834|NCT01072747|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92977835|NCT01072747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92977836|NCT01072747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977837|NCT00879372|Tianeptine|tianeptine|mesh-list
92977838|NCT00879372|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92977839|NCT00879372|Antidepressive Agents|antidepressive agents|mesh-ancestor
92977840|NCT00879372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977841|NCT00731783|Chlorhexidine|chlorhexidine|mesh-list
92977842|NCT00731783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92977843|NCT00731783|Mupirocin|mupirocin|mesh-list
92977844|NCT00731783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92977845|NCT00731783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977846|NCT00731783|Disinfectants|disinfectants|mesh-ancestor
92977847|NCT00731783|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977848|NCT00731783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977849|NCT00731783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92977850|NCT00731783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977851|NCT00731783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977852|NCT03691350|Nicotine|nicotine|mesh-list
92977853|NCT03691350|Dimercaprol|dimercaprol|mesh-list
92977854|NCT03691350|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92977855|NCT03691350|Autonomic Agents|autonomic agents|mesh-ancestor
92977856|NCT03691350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977857|NCT03691350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977858|NCT03691350|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92977859|NCT03691350|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92977860|NCT03691350|Cholinergic Agents|cholinergic agents|mesh-ancestor
92977861|NCT03691350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977862|NCT03691350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977863|NCT03691350|Chelating Agents|chelating agents|mesh-ancestor
92977864|NCT03691350|Sequestering Agents|sequestering agents|mesh-ancestor
92977866|NCT02592083|Goserelin|goserelin|mesh-list
92977867|NCT02592083|Palbociclib|palbociclib|mesh-list
92977868|NCT02592083|Exemestane|exemestane|mesh-list
92977869|NCT02592083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92623289|NCT00536770|Calcitriol|calcitriol|mesh-list
92977870|NCT02592083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92977871|NCT02592083|Hormone Antagonists|hormone antagonists|mesh-ancestor
92977872|NCT02592083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92977873|NCT02592083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977874|NCT02592083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92977875|NCT02592083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977876|NCT02592083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92977877|NCT02592083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92977878|NCT02592083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92977879|NCT02592083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92977880|NCT02592083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977881|NCT02592083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977882|NCT02592083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92977883|NCT04589676|Naloxone|naloxone|mesh-list
92977884|NCT04589676|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92977885|NCT04589676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977886|NCT04589676|Sensory System Agents|sensory system agents|mesh-ancestor
92977887|NCT04589676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977888|NCT00724451|Ribavirin|ribavirin|mesh-list
92977889|NCT00724451|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92977890|NCT00724451|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92977891|NCT00724451|Antimetabolites|antimetabolites|mesh-ancestor
92977892|NCT00724451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977893|NCT00724451|Antiviral Agents|antiviral agents|mesh-ancestor
92977894|NCT00724451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977895|NCT00724373|Ribavirin|ribavirin|mesh-list
92977896|NCT00724373|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92977897|NCT00724373|Antimetabolites|antimetabolites|mesh-ancestor
92977898|NCT00724373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977899|NCT00724373|Antiviral Agents|antiviral agents|mesh-ancestor
92977900|NCT00724373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977901|NCT02594579|Vitamin D|vitamin d|mesh-list
92977902|NCT02594579|Cholecalciferol|cholecalciferol|mesh-list
92977903|NCT02594579|Vitamins|vitamins|mesh-ancestor
92977904|NCT02594579|Micronutrients|micronutrients|mesh-ancestor
92977905|NCT02594579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977906|NCT02594579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92977907|NCT02594579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92977908|NCT02593409|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92977909|NCT02593409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92977910|NCT02593409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92977911|NCT02593409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977912|NCT02593409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977913|NCT02593409|Antiviral Agents|antiviral agents|mesh-ancestor
92977914|NCT02593409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977915|NCT02593409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977916|NCT02593409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92977917|NCT00724061|Interferons|interferons|mesh-list
92977918|NCT00724061|Interferon-alpha|interferon-alpha|mesh-list
92977919|NCT00724061|Interferon alpha-2|interferon alpha-2|mesh-list
92977920|NCT00724061|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92977921|NCT00724061|Furocoumarins|furocoumarins|mesh-list
92977922|NCT00724061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977923|NCT00724061|Antiviral Agents|antiviral agents|mesh-ancestor
92977924|NCT00724061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977925|NCT00724061|Immunologic Factors|immunologic factors|mesh-ancestor
92977926|NCT00724061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977927|NCT00724061|Dermatologic Agents|dermatologic agents|mesh-ancestor
92977928|NCT00724061|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92977929|NCT02594423|Bevacizumab|bevacizumab|mesh-list
92977930|NCT02594423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92977931|NCT02594423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92977932|NCT02594423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92977933|NCT02594423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92977934|NCT02594423|Growth Substances|growth substances|mesh-ancestor
92977935|NCT02594423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977936|NCT02594423|Growth Inhibitors|growth inhibitors|mesh-ancestor
92977937|NCT00882414|Ferric Compounds|ferric compounds|mesh-list
92977938|NCT00882414|Hematinics|hematinics|mesh-ancestor
92977939|NCT02593487|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92977940|NCT02593487|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92977941|NCT02593487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92977942|NCT02593487|Antimetabolites|antimetabolites|mesh-ancestor
92977943|NCT02593487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977944|NCT02593487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92977945|NCT02593487|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92977946|NCT02593487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92977947|NCT00875784|Sumatriptan|sumatriptan|mesh-list
92977948|NCT00875784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92977949|NCT00875784|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92977950|NCT00875784|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92977951|NCT00875784|Serotonin Agents|serotonin agents|mesh-ancestor
92977952|NCT00875784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977953|NCT00875784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977954|NCT00875784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977955|NCT00731549|Aripiprazole|aripiprazole|mesh-list
92977956|NCT00731549|Antidepressive Agents|antidepressive agents|mesh-ancestor
92977957|NCT00731549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92977958|NCT00731549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92977959|NCT00731549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92977960|NCT00731549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977961|NCT00731549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977962|NCT00731549|Dopamine Agonists|dopamine agonists|mesh-ancestor
92977963|NCT00731549|Dopamine Agents|dopamine agents|mesh-ancestor
92977964|NCT00731549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92977965|NCT00731549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92977966|NCT00731549|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92977967|NCT00731549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92977968|NCT00731549|Serotonin Agents|serotonin agents|mesh-ancestor
92977969|NCT00731549|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92977970|NCT00731549|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92977971|NCT00731549|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92977972|NCT00731549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92977974|NCT00882570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92977975|NCT00882570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92977976|NCT00882882|Metformin|metformin|mesh-list
92977977|NCT00882882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92977978|NCT00882882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977979|NCT00882960|Fentanyl|fentanyl|mesh-list
92977980|NCT00882960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92977981|NCT00882960|Narcotics|narcotics|mesh-ancestor
92977982|NCT00882960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977983|NCT00882960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977984|NCT00882960|Analgesics|analgesics|mesh-ancestor
92167103|NCT01369875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92977985|NCT00882960|Sensory System Agents|sensory system agents|mesh-ancestor
92977986|NCT00882960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977987|NCT00882960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92977988|NCT00882960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92977989|NCT00882960|Anesthetics, General|anesthetics, general|mesh-ancestor
92977990|NCT00882960|Anesthetics|anesthetics|mesh-ancestor
92977991|NCT00883194|Ropivacaine|ropivacaine|mesh-list
92977992|NCT00883194|Anesthetics, Local|anesthetics, local|mesh-ancestor
92977993|NCT00883194|Anesthetics|anesthetics|mesh-ancestor
92977994|NCT00883194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92977995|NCT00883194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92977996|NCT00883194|Sensory System Agents|sensory system agents|mesh-ancestor
92977997|NCT00883194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92977998|NCT00888732|Insulin|insulin|mesh-list
92977999|NCT00888732|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92978000|NCT00888732|Insulin Aspart|insulin aspart|mesh-list
92978001|NCT00888732|Insulin, Long-Acting|insulin, long-acting|mesh-list
92978002|NCT00888732|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92978003|NCT00888732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92978004|NCT00888732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978005|NCT00730925|Paclitaxel|paclitaxel|mesh-list
92978006|NCT00730925|Afatinib|afatinib|mesh-list
92978007|NCT00730925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92978008|NCT00730925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978009|NCT00730925|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978010|NCT00730925|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978011|NCT00730925|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978012|NCT00730925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978013|NCT00730925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92978014|NCT00730925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978015|NCT00236899|Paclitaxel|paclitaxel|mesh-list
92978016|NCT00236899|Docetaxel|docetaxel|mesh-list
92978017|NCT00236899|Gemcitabine|gemcitabine|mesh-list
92978018|NCT00236899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92978019|NCT00236899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978020|NCT00236899|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978021|NCT00236899|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978022|NCT00236899|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978023|NCT00236899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978024|NCT00236899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92978025|NCT00236899|Antimetabolites|antimetabolites|mesh-ancestor
92978027|NCT00611130|Anticonvulsants|anticonvulsants|mesh-ancestor
92978028|NCT00611130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978029|NCT00611130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978030|NCT00611130|GABA Agents|gaba agents|mesh-ancestor
92978031|NCT00611130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978032|NCT00611130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978033|NCT00885690|Olanzapine|olanzapine|mesh-list
92978034|NCT00885690|Sertindole|sertindole|mesh-list
92978035|NCT00885690|Antiemetics|antiemetics|mesh-ancestor
92978036|NCT00885690|Autonomic Agents|autonomic agents|mesh-ancestor
92978037|NCT00885690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978038|NCT00885690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978039|NCT00885690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978040|NCT00885690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92978041|NCT00885690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92978042|NCT00885690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978043|NCT00885690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978044|NCT00885690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92978045|NCT00885690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92978046|NCT00885690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92978047|NCT00885690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978048|NCT00885690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978049|NCT00885690|Serotonin Agents|serotonin agents|mesh-ancestor
92978050|NCT00888810|Topotecan|topotecan|mesh-list
92978051|NCT00888810|Lapatinib|lapatinib|mesh-list
92978052|NCT00888810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92978053|NCT00888810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92978054|NCT00888810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978055|NCT00888810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978056|NCT00888810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978057|NCT00888810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92978058|NCT00256243|Paclitaxel|paclitaxel|mesh-list
92978059|NCT00256243|Cyclophosphamide|cyclophosphamide|mesh-list
92978060|NCT00256243|Carboplatin|carboplatin|mesh-list
92978061|NCT00256243|Doxorubicin|doxorubicin|mesh-list
92978062|NCT00256243|Trastuzumab|trastuzumab|mesh-list
92978063|NCT00256243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92978064|NCT00256243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978065|NCT00256243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978066|NCT00256243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978067|NCT00256243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978068|NCT00256243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978069|NCT00256243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92978070|NCT00256243|Immunologic Factors|immunologic factors|mesh-ancestor
92978071|NCT00256243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978072|NCT00256243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978073|NCT00256243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92978074|NCT00256243|Alkylating Agents|alkylating agents|mesh-ancestor
92978075|NCT00256243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92978076|NCT00256243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92978077|NCT00256243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92978078|NCT00256243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92978079|NCT00256243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978080|NCT00256243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92978082|NCT00236197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92978083|NCT00236197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978084|NCT00236197|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92978085|NCT00236197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978086|NCT00236197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978087|NCT02541708|Folic Acid|folic acid|mesh-list
92978088|NCT02541708|Hematinics|hematinics|mesh-ancestor
92978089|NCT02541708|Vitamin B Complex|vitamin b complex|mesh-ancestor
92978090|NCT02541708|Vitamins|vitamins|mesh-ancestor
92978091|NCT02541708|Micronutrients|micronutrients|mesh-ancestor
92978092|NCT02541708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978093|NCT03973567|Norepinephrine|norepinephrine|mesh-list
92978094|NCT03973567|Antidepressive Agents|antidepressive agents|mesh-list
92978095|NCT03973567|Serotonin|serotonin|mesh-list
92623524|NCT00534586|Narcotics|narcotics|mesh-ancestor
92978096|NCT03973567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92978097|NCT03973567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978098|NCT03973567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92978099|NCT03973567|Serotonin Agents|serotonin agents|mesh-ancestor
92978100|NCT03973567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978101|NCT03973567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978102|NCT03973567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978103|NCT03973567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92978104|NCT03973567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92978105|NCT03973567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92978106|NCT03973567|Sympathomimetics|sympathomimetics|mesh-ancestor
92978107|NCT03973567|Autonomic Agents|autonomic agents|mesh-ancestor
92978108|NCT03973567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978109|NCT03973567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92978110|NCT03973567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92978111|NCT03973567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92978112|NCT00885924|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92978113|NCT00885924|Hemostatics|hemostatics|mesh-ancestor
92978114|NCT00885924|Coagulants|coagulants|mesh-ancestor
92978115|NCT00885924|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92978116|NCT00885924|Natriuretic Agents|natriuretic agents|mesh-ancestor
92978117|NCT00885924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978118|NCT01071889|Flumazenil|flumazenil|mesh-list
92978119|NCT01071889|Antidotes|antidotes|mesh-ancestor
92978120|NCT01071889|Protective Agents|protective agents|mesh-ancestor
92978121|NCT01071889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978122|NCT01071889|GABA Modulators|gaba modulators|mesh-ancestor
92978123|NCT01071889|GABA Agents|gaba agents|mesh-ancestor
92978124|NCT01071889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978125|NCT01071889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978126|NCT03973411|Ondansetron|ondansetron|mesh-list
92978127|NCT03973411|Antiemetics|antiemetics|mesh-ancestor
92978128|NCT03973411|Autonomic Agents|autonomic agents|mesh-ancestor
92978129|NCT03973411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167108|NCT02620189|Certolizumab Pegol|certolizumab pegol|mesh-list
92978130|NCT03973411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978131|NCT03973411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978132|NCT03973411|Antipruritics|antipruritics|mesh-ancestor
92978133|NCT03973411|Dermatologic Agents|dermatologic agents|mesh-ancestor
92978134|NCT03973411|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92978135|NCT03973411|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92978136|NCT03973411|Serotonin Agents|serotonin agents|mesh-ancestor
92978137|NCT03973411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978138|NCT03973411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978139|NCT00883506|Lisinopril|lisinopril|mesh-list
92978140|NCT00883506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92978141|NCT00883506|Protease Inhibitors|protease inhibitors|mesh-ancestor
92978142|NCT00883506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978143|NCT00883506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978144|NCT00883506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92978145|NCT00883506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92978146|NCT00883506|Protective Agents|protective agents|mesh-ancestor
92978147|NCT00883506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978148|NCT00278395|Vorinostat|vorinostat|mesh-list
92978149|NCT00278395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978150|NCT00278395|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92978151|NCT00278395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978152|NCT00278395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978153|NCT00889044|Clopidogrel|clopidogrel|mesh-list
92323403|NCT03342157|Sennosides|sennosides|mesh-list
92978154|NCT00889044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92978155|NCT00889044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92978156|NCT00889044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92978157|NCT00889044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92978158|NCT00889044|Purinergic Agents|purinergic agents|mesh-ancestor
92978159|NCT00889044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978160|NCT00889044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978161|NCT00889044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978162|NCT00886002|Fentanyl|fentanyl|mesh-list
92978163|NCT00886002|Buprenorphine|buprenorphine|mesh-list
92978164|NCT00886002|Naloxone|naloxone|mesh-list
92978165|NCT00886002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92978166|NCT00886002|Narcotics|narcotics|mesh-ancestor
92978167|NCT00886002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978168|NCT00886002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978169|NCT00886002|Analgesics|analgesics|mesh-ancestor
92978170|NCT00886002|Sensory System Agents|sensory system agents|mesh-ancestor
92978171|NCT00886002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978172|NCT00886002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92978173|NCT00886002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978174|NCT00886002|Anesthetics, General|anesthetics, general|mesh-ancestor
92978175|NCT00886002|Anesthetics|anesthetics|mesh-ancestor
92978176|NCT00886002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92978177|NCT00883662|Levonorgestrel|levonorgestrel|mesh-list
92978178|NCT00883662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92978179|NCT00883662|Contraceptive Agents|contraceptive agents|mesh-ancestor
92978180|NCT00883662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92978181|NCT00883662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978182|NCT00883662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92978183|NCT00883662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92978184|NCT00883662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92978185|NCT00883818|Azithromycin|azithromycin|mesh-list
92978186|NCT00883818|Doxycycline|doxycycline|mesh-list
92978187|NCT00883818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978188|NCT00883818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978189|NCT00883818|Antimalarials|antimalarials|mesh-ancestor
92978190|NCT00883818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92978191|NCT00883818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92978192|NCT00889356|Clindamycin|clindamycin|mesh-list
92978193|NCT00889356|Clindamycin palmitate|clindamycin palmitate|mesh-list
92978194|NCT00889356|Clindamycin phosphate|clindamycin phosphate|mesh-list
92978195|NCT00889356|Amphotericin B|amphotericin b|mesh-list
92978196|NCT00889356|Tetracycline|tetracycline|mesh-list
92978197|NCT00889356|Ketoconazole|ketoconazole|mesh-list
92978198|NCT00889356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92978199|NCT00889356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978200|NCT00889356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978201|NCT00889356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92978202|NCT00889356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978203|NCT00889356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978204|NCT00889356|Antifungal Agents|antifungal agents|mesh-ancestor
92978205|NCT00889356|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92978206|NCT00889356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92978207|NCT00889356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92978208|NCT00889356|Hormone Antagonists|hormone antagonists|mesh-ancestor
92978209|NCT00889356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92978210|NCT00889356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978211|NCT00889356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92978212|NCT00889356|Amebicides|amebicides|mesh-ancestor
92978213|NCT00889356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92978214|NCT00889356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92978215|NCT00889434|Tocotrienols|tocotrienols|mesh-list
92978216|NCT00889434|Vitamin E|vitamin e|mesh-list
92978217|NCT00889434|Tocopherols|tocopherols|mesh-list
92978218|NCT00889434|Antioxidants|antioxidants|mesh-ancestor
92978219|NCT00889434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978220|NCT00889434|Protective Agents|protective agents|mesh-ancestor
92978221|NCT00889434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978222|NCT00889434|Vitamins|vitamins|mesh-ancestor
92978223|NCT00889434|Micronutrients|micronutrients|mesh-ancestor
92978224|NCT00612534|Sufentanil|sufentanil|mesh-list
92978225|NCT00612534|Dsuvia|dsuvia|mesh-list
92978226|NCT00612534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92978227|NCT00612534|Narcotics|narcotics|mesh-ancestor
92978228|NCT00612534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978229|NCT00612534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978230|NCT00612534|Analgesics|analgesics|mesh-ancestor
92978231|NCT00612534|Sensory System Agents|sensory system agents|mesh-ancestor
92978232|NCT00612534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978233|NCT00612534|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92978234|NCT00612534|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978235|NCT00612534|Anesthetics, General|anesthetics, general|mesh-ancestor
92978236|NCT00612534|Anesthetics|anesthetics|mesh-ancestor
92978237|NCT02542254|Albuterol|albuterol|mesh-list
92978238|NCT02542254|Ipratropium|ipratropium|mesh-list
92978239|NCT02542254|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92978240|NCT02542254|Autonomic Agents|autonomic agents|mesh-ancestor
92978241|NCT02542254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978242|NCT02542254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978243|NCT02542254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92978244|NCT02542254|Respiratory System Agents|respiratory system agents|mesh-ancestor
92978245|NCT02542254|Tocolytic Agents|tocolytic agents|mesh-ancestor
92978246|NCT02542254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92978247|NCT02542254|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92978248|NCT02542254|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92978249|NCT02542254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92978250|NCT02542254|Adrenergic Agents|adrenergic agents|mesh-ancestor
92978251|NCT02542254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978252|NCT02542254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978253|NCT02542254|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92978254|NCT02542254|Cholinergic Agents|cholinergic agents|mesh-ancestor
92978255|NCT00889590|Zoledronic Acid|zoledronic acid|mesh-list
92978256|NCT00889590|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92978257|NCT00889590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978258|NCT00736853|Acetaminophen|acetaminophen|mesh-list
92978259|NCT00736853|Tramadol|tramadol|mesh-list
92978260|NCT00736853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92978261|NCT00736853|Analgesics|analgesics|mesh-ancestor
92978262|NCT00736853|Sensory System Agents|sensory system agents|mesh-ancestor
92978263|NCT00736853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978264|NCT00736853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978265|NCT00736853|Antipyretics|antipyretics|mesh-ancestor
92978266|NCT00736853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92978267|NCT00736853|Narcotics|narcotics|mesh-ancestor
92978268|NCT00736853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978269|NCT04037514|Acetaminophen|acetaminophen|mesh-list
92978270|NCT04037514|Ibuprofen|ibuprofen|mesh-list
92978271|NCT04037514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92978272|NCT04037514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92978273|NCT04037514|Analgesics|analgesics|mesh-ancestor
92978274|NCT04037514|Sensory System Agents|sensory system agents|mesh-ancestor
92978275|NCT04037514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978276|NCT04037514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978277|NCT04037514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978278|NCT04037514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978279|NCT04037514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92978280|NCT04037514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978281|NCT04037514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978282|NCT04037514|Antipyretics|antipyretics|mesh-ancestor
92978283|NCT00730847|Vaccines|vaccines|mesh-list
92978284|NCT00730847|Immunologic Factors|immunologic factors|mesh-ancestor
92978285|NCT00730847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978286|NCT04034004|Naloxone|naloxone|mesh-list
92978287|NCT04034004|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92978288|NCT04034004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978289|NCT04034004|Sensory System Agents|sensory system agents|mesh-ancestor
92978290|NCT04034004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978291|NCT00573066|Dexmedetomidine|dexmedetomidine|mesh-list
92978292|NCT00573066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92978293|NCT00573066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978294|NCT00573066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978295|NCT00573066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92978296|NCT00573066|Analgesics|analgesics|mesh-ancestor
92978297|NCT00573066|Sensory System Agents|sensory system agents|mesh-ancestor
92978298|NCT00573066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978299|NCT00573066|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92978300|NCT00573066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92978301|NCT00573066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92978302|NCT00573066|Adrenergic Agents|adrenergic agents|mesh-ancestor
92978303|NCT00573066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978304|NCT00573066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978306|NCT02541552|Anesthetics, Local|anesthetics, local|mesh-ancestor
92978307|NCT02541552|Anesthetics|anesthetics|mesh-ancestor
92978308|NCT02541552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978309|NCT02541552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978310|NCT02541552|Sensory System Agents|sensory system agents|mesh-ancestor
92978311|NCT02541552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978312|NCT00886314|Midazolam|midazolam|mesh-list
92978313|NCT00886314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92978314|NCT00886314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92978315|NCT00886314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978316|NCT00886314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978317|NCT00886314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92978318|NCT00886314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92978319|NCT00886314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978320|NCT00886314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978321|NCT00886314|Anesthetics, General|anesthetics, general|mesh-ancestor
92978322|NCT00886314|Anesthetics|anesthetics|mesh-ancestor
92978323|NCT00886314|GABA Modulators|gaba modulators|mesh-ancestor
92978324|NCT00886314|GABA Agents|gaba agents|mesh-ancestor
92978325|NCT00886314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978326|NCT00886314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978327|NCT00890214|Epoprostenol|epoprostenol|mesh-list
92978328|NCT00890214|Heparin|heparin|mesh-list
92978329|NCT00890214|Calcium heparin|calcium heparin|mesh-list
92978330|NCT00890214|Tezosentan|tezosentan|mesh-list
92978331|NCT00890214|Anticoagulants|anticoagulants|mesh-ancestor
92978332|NCT00890214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92978333|NCT00890214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92978334|NCT00890214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978335|NCT00890214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92978336|NCT00890214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92978337|NCT00890214|Vasodilator Agents|vasodilator agents|mesh-ancestor
92978338|NCT00730691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92978339|NCT00730691|Vortioxetine|vortioxetine|mesh-list
92978340|NCT00730691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92978341|NCT00730691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92978342|NCT00730691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92978343|NCT00730691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978344|NCT00730691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978345|NCT00730691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978346|NCT00730691|Analgesics|analgesics|mesh-ancestor
92978347|NCT00730691|Sensory System Agents|sensory system agents|mesh-ancestor
92978348|NCT00730691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978349|NCT00730691|Antidepressive Agents|antidepressive agents|mesh-ancestor
92978350|NCT00730691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978351|NCT00730691|Dopamine Agents|dopamine agents|mesh-ancestor
92978352|NCT00730691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92978353|NCT00730691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92978354|NCT00730691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978355|NCT00730691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92978356|NCT00730691|Serotonin Agents|serotonin agents|mesh-ancestor
92978357|NCT00730691|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92978358|NCT00730691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92978359|NCT00730691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92978360|NCT00730691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92978361|NCT00886860|Misoprostol|misoprostol|mesh-list
92978362|NCT00886860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92978363|NCT00886860|Abortifacient Agents|abortifacient agents|mesh-ancestor
92978364|NCT00886860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92978365|NCT00886860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978366|NCT00886860|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92978367|NCT00886860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978368|NCT00886860|Oxytocics|oxytocics|mesh-ancestor
92978369|NCT00884442|Nifedipine|nifedipine|mesh-list
92978370|NCT00884442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92978371|NCT00884442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92978372|NCT00884442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978373|NCT00884442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92978374|NCT00884442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978375|NCT00884442|Vasodilator Agents|vasodilator agents|mesh-ancestor
92978376|NCT00884442|Tocolytic Agents|tocolytic agents|mesh-ancestor
92978377|NCT00884442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92978378|NCT02543034|Petrolatum|petrolatum|mesh-list
92978379|NCT02543034|Emollients|emollients|mesh-ancestor
92978380|NCT02543034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92978381|NCT00278161|Cyclophosphamide|cyclophosphamide|mesh-list
92978383|NCT00278161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92978384|NCT00278161|Immunologic Factors|immunologic factors|mesh-ancestor
92978385|NCT00278161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978386|NCT00278161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978387|NCT00278161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92978388|NCT00278161|Alkylating Agents|alkylating agents|mesh-ancestor
92978389|NCT00278161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978390|NCT00278161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978391|NCT00278161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92978392|NCT00278161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92978393|NCT02541396|Ketamine|ketamine|mesh-list
92978394|NCT02541396|Oxycodone|oxycodone|mesh-list
92978395|NCT02541396|Analgesics|analgesics|mesh-ancestor
92978396|NCT02541396|Sensory System Agents|sensory system agents|mesh-ancestor
92978397|NCT02541396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978398|NCT02541396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623831|NCT00190008|Piracetam|piracetam|mesh-list
92978399|NCT02541396|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92978400|NCT02541396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978401|NCT02541396|Anesthetics, General|anesthetics, general|mesh-ancestor
92978402|NCT02541396|Anesthetics|anesthetics|mesh-ancestor
92978403|NCT02541396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978404|NCT02541396|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92978405|NCT02541396|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92978406|NCT02541396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978407|NCT02541396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978408|NCT02541396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92978409|NCT02541396|Narcotics|narcotics|mesh-ancestor
92978410|NCT00890604|Acetaminophen|acetaminophen|mesh-list
92978411|NCT00890604|Ibuprofen|ibuprofen|mesh-list
92978412|NCT00890604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92978413|NCT00890604|Analgesics|analgesics|mesh-ancestor
92978414|NCT00890604|Sensory System Agents|sensory system agents|mesh-ancestor
92978415|NCT00890604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978416|NCT00890604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978417|NCT00890604|Antipyretics|antipyretics|mesh-ancestor
92978418|NCT00890604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92978419|NCT00890604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978420|NCT00890604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978421|NCT00890604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92978422|NCT00890604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978423|NCT00890604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978424|NCT00255151|Dexlansoprazole|dexlansoprazole|mesh-list
92978425|NCT00255151|Lansoprazole|lansoprazole|mesh-list
92978426|NCT00255151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92978427|NCT00255151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978428|NCT00255151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92978429|NCT00255151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978430|NCT00255151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978431|NCT03973957|Fentanyl|fentanyl|mesh-list
92978432|NCT03973957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92978433|NCT03973957|Narcotics|narcotics|mesh-ancestor
92978434|NCT03973957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978435|NCT03973957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978436|NCT03973957|Analgesics|analgesics|mesh-ancestor
92978437|NCT03973957|Sensory System Agents|sensory system agents|mesh-ancestor
92978438|NCT03973957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978439|NCT03973957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92978440|NCT03973957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978441|NCT03973957|Anesthetics, General|anesthetics, general|mesh-ancestor
92978442|NCT03973957|Anesthetics|anesthetics|mesh-ancestor
92978443|NCT00658658|Panitumumab|panitumumab|mesh-list
92978444|NCT00658658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92978445|NCT00658658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978446|NCT00723203|Panobinostat|panobinostat|mesh-list
92978447|NCT00723203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978448|NCT00723203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92978449|NCT00723203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978450|NCT00723203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528044|NCT00034879|Gefitinib|gefitinib|mesh-list
92978452|NCT00891072|Paclitaxel|paclitaxel|mesh-list
92978453|NCT00891072|Gossypol acetic acid|gossypol acetic acid|mesh-list
92978454|NCT00891072|Carboplatin|carboplatin|mesh-list
92978455|NCT00891072|Retinol acetate|retinol acetate|mesh-list
92978456|NCT00891072|Gossypol|gossypol|mesh-list
92978457|NCT00891072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92978458|NCT00891072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978459|NCT00891072|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978460|NCT00891072|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978461|NCT00891072|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978462|NCT00891072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978463|NCT00891072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978464|NCT00891072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978465|NCT00891072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92978466|NCT00891072|Immunologic Factors|immunologic factors|mesh-ancestor
92978467|NCT00891072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978468|NCT00891072|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92978469|NCT00891072|Protective Agents|protective agents|mesh-ancestor
92978470|NCT00891072|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92978471|NCT00891072|Contraceptive Agents|contraceptive agents|mesh-ancestor
92978472|NCT00891072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92623904|NCT05169229|Vancomycin|vancomycin|mesh-list
92978473|NCT00891072|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92978474|NCT00891072|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92978475|NCT00891072|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92978476|NCT02591927|Insulin|insulin|mesh-list
92978477|NCT02591927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92978478|NCT02591927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978479|NCT00891150|Oxytocin|oxytocin|mesh-list
92978480|NCT00891150|Oxytocics|oxytocics|mesh-ancestor
92978481|NCT00891150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92978482|NCT00891150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978483|NCT00800462|Bromides|bromides|mesh-list
92978484|NCT00800462|Oxybutynin|oxybutynin|mesh-list
92978485|NCT00800462|Darifenacin|darifenacin|mesh-list
92978486|NCT00800462|Anticonvulsants|anticonvulsants|mesh-ancestor
92978487|NCT00800462|Parasympatholytics|parasympatholytics|mesh-ancestor
92978488|NCT00800462|Autonomic Agents|autonomic agents|mesh-ancestor
92978489|NCT00800462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978490|NCT00800462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978491|NCT00800462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92978492|NCT00800462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92978493|NCT00800462|Cholinergic Agents|cholinergic agents|mesh-ancestor
92978494|NCT00800462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978495|NCT00800462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978496|NCT00800462|Urological Agents|urological agents|mesh-ancestor
92978497|NCT00233389|Rebamipide|rebamipide|mesh-list
92978498|NCT00233389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92978499|NCT00233389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978500|NCT00233389|Antioxidants|antioxidants|mesh-ancestor
92978501|NCT00233389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978502|NCT00233389|Protective Agents|protective agents|mesh-ancestor
92978503|NCT00233389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978504|NCT00233389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978505|NCT00891306|Cyclosporine|cyclosporine|mesh-list
92978506|NCT00891306|Mycophenolic Acid|mycophenolic acid|mesh-list
92978507|NCT00891306|Methylprednisolone|methylprednisolone|mesh-list
92978508|NCT00891306|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92978509|NCT00891306|Cyclosporins|cyclosporins|mesh-list
92978510|NCT00891306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978511|NCT00891306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978512|NCT00891306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92978513|NCT00891306|Immunologic Factors|immunologic factors|mesh-ancestor
92978514|NCT00891306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978515|NCT00891306|Antifungal Agents|antifungal agents|mesh-ancestor
92978516|NCT00891306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978517|NCT00891306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92978518|NCT00891306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978519|NCT00891306|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92978520|NCT00891306|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92978521|NCT00891306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978522|NCT00891306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92978523|NCT00891306|Antitubercular Agents|antitubercular agents|mesh-ancestor
92978524|NCT00891306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978525|NCT00891306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978526|NCT00891306|Antiemetics|antiemetics|mesh-ancestor
92978527|NCT00891306|Autonomic Agents|autonomic agents|mesh-ancestor
92978528|NCT00891306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978529|NCT00891306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978530|NCT00891306|Glucocorticoids|glucocorticoids|mesh-ancestor
92978531|NCT00891306|Hormones|hormones|mesh-ancestor
92978532|NCT00891306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92978533|NCT00891306|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92978534|NCT00891306|Protective Agents|protective agents|mesh-ancestor
92978535|NCT00891306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92978536|NCT00807872|Antibodies|antibodies|mesh-list
92978537|NCT00807872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92978538|NCT00807872|Immunologic Factors|immunologic factors|mesh-ancestor
92978539|NCT00807872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978540|NCT00813722|Losartan|losartan|mesh-list
92978541|NCT00813722|Atenolol|atenolol|mesh-list
92978542|NCT00813722|Amlodipine|amlodipine|mesh-list
92978543|NCT00813722|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92978544|NCT00813722|Calcium|calcium|mesh-list
92978545|NCT00813722|Diuretics|diuretics|mesh-list
92978546|NCT00813722|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92978547|NCT00813722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92978548|NCT00813722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978549|NCT00813722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92978550|NCT00813722|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92978551|NCT00813722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92978552|NCT00813722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978553|NCT00813722|Vasodilator Agents|vasodilator agents|mesh-ancestor
92978554|NCT00813722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92978555|NCT00813722|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92978556|NCT00813722|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92978557|NCT00813722|Natriuretic Agents|natriuretic agents|mesh-ancestor
92978558|NCT00813722|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92978559|NCT00813722|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92978560|NCT00813722|Adrenergic Agents|adrenergic agents|mesh-ancestor
92978561|NCT00813722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978562|NCT00813722|Sympatholytics|sympatholytics|mesh-ancestor
92978563|NCT00813722|Autonomic Agents|autonomic agents|mesh-ancestor
92978564|NCT00813722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978565|NCT00813722|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92978566|NCT00812318|Cabotegravir|cabotegravir|mesh-list
92978567|NCT00812318|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92978568|NCT00812318|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92978569|NCT00812318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978570|NCT00812318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978571|NCT00812318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92978572|NCT00812318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92978573|NCT00812318|Antiviral Agents|antiviral agents|mesh-ancestor
92978574|NCT00812318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978575|NCT00812396|Methyltestosterone|methyltestosterone|mesh-list
92978576|NCT00812396|Testosterone|testosterone|mesh-list
92978577|NCT00812396|Testosterone undecanoate|testosterone undecanoate|mesh-list
92978578|NCT00812396|Testosterone enanthate|testosterone enanthate|mesh-list
92978579|NCT00812396|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92978580|NCT00812396|Androgens|androgens|mesh-ancestor
92978581|NCT00812396|Hormones|hormones|mesh-ancestor
92978582|NCT00812396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92978583|NCT00812396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978584|NCT00812396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92978585|NCT00812396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978586|NCT00812396|Anabolic Agents|anabolic agents|mesh-ancestor
92978587|NCT00807950|Simvastatin|simvastatin|mesh-list
92978588|NCT00807950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92978589|NCT00807950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92978590|NCT00807950|Antimetabolites|antimetabolites|mesh-ancestor
92978591|NCT00807950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978592|NCT00807950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92978593|NCT00807950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92978594|NCT00807950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978595|NCT00649220|Memantine|memantine|mesh-list
92978596|NCT00649220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92978597|NCT00649220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92978598|NCT00649220|Dopamine Agents|dopamine agents|mesh-ancestor
92978599|NCT00649220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978600|NCT00649220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978601|NCT00649220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978602|NCT00649220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92978603|NCT00649220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92978604|NCT00654368|Etanercept|etanercept|mesh-list
92978605|NCT00654368|Methotrexate|methotrexate|mesh-list
92978606|NCT00654368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92978607|NCT00654368|Abortifacient Agents|abortifacient agents|mesh-ancestor
92978608|NCT00654368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92978609|NCT00654368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978610|NCT00654368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92978611|NCT00654368|Antimetabolites|antimetabolites|mesh-ancestor
92978612|NCT00654368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978613|NCT00654368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978614|NCT00654368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92978615|NCT00654368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978616|NCT00654368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92978617|NCT00654368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92978618|NCT00654368|Immunologic Factors|immunologic factors|mesh-ancestor
92978619|NCT00654368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978620|NCT00654368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92978621|NCT00654368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92978622|NCT00654368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92978623|NCT00654368|Analgesics|analgesics|mesh-ancestor
92978624|NCT00654368|Sensory System Agents|sensory system agents|mesh-ancestor
92624047|NCT00158873|Analgesics|analgesics|mesh-ancestor
92978625|NCT00654368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978626|NCT00654368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978627|NCT00654368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978628|NCT00812864|Capecitabine|capecitabine|mesh-list
92978629|NCT00812864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92978630|NCT00812864|Antimetabolites|antimetabolites|mesh-ancestor
92978631|NCT00812864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978632|NCT00812864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978633|NCT00808184|Raltegravir Potassium|raltegravir potassium|mesh-list
92978634|NCT00808184|Midazolam|midazolam|mesh-list
92978635|NCT00808184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92978636|NCT00808184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92978637|NCT00808184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978638|NCT00808184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978639|NCT00808184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92978640|NCT00808184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92978641|NCT00808184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978642|NCT00808184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978643|NCT00808184|Anesthetics, General|anesthetics, general|mesh-ancestor
92978644|NCT00808184|Anesthetics|anesthetics|mesh-ancestor
92978645|NCT00808184|GABA Modulators|gaba modulators|mesh-ancestor
92978646|NCT00808184|GABA Agents|gaba agents|mesh-ancestor
92978647|NCT00808184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978648|NCT00808184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978649|NCT00808184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92978650|NCT00808184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92978651|NCT00808184|Antiviral Agents|antiviral agents|mesh-ancestor
92978652|NCT00808184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978653|NCT00808184|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92978654|NCT00808184|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92978655|NCT00808184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978656|NCT00647426|Carboplatin|carboplatin|mesh-list
92978657|NCT00647426|Docetaxel|docetaxel|mesh-list
92978658|NCT00647426|Sorafenib|sorafenib|mesh-list
92978659|NCT00647426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978660|NCT00647426|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978661|NCT00647426|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978662|NCT00647426|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978663|NCT00647426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978664|NCT00647426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92978665|NCT00647426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978666|NCT00647348|Simvastatin|simvastatin|mesh-list
92978667|NCT00647348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92978668|NCT00647348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92978669|NCT00647348|Antimetabolites|antimetabolites|mesh-ancestor
92978670|NCT00647348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978671|NCT00647348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92978672|NCT00647348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92978673|NCT00647348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978675|NCT00647270|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92978676|NCT00647270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978677|NCT00647270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978678|NCT00645944|Eszopiclone|eszopiclone|mesh-list
92978679|NCT00645944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92978680|NCT00645944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978681|NCT00645944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978682|NCT00813332|Docetaxel|docetaxel|mesh-list
92978683|NCT00813332|Endostar protein|endostar protein|mesh-list
92978684|NCT00813332|Endostatins|endostatins|mesh-list
92978685|NCT00813332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978686|NCT00813332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978687|NCT00813332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978688|NCT00813332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978689|NCT00813332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978690|NCT00813332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92978691|NCT00813332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92978692|NCT00813332|Growth Substances|growth substances|mesh-ancestor
92978693|NCT00813332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978694|NCT00813332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92978695|NCT04708496|Efavirenz|efavirenz|mesh-list
92978696|NCT04708496|Lumefantrine|lumefantrine|mesh-list
92978697|NCT04708496|Dolutegravir|dolutegravir|mesh-list
92978698|NCT04708496|Artemether|artemether|mesh-list
92624126|NCT00183612|Olanzapine|olanzapine|mesh-list
92978699|NCT04708496|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92978700|NCT04708496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92978701|NCT04708496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92978702|NCT04708496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978703|NCT04708496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978704|NCT04708496|Antiviral Agents|antiviral agents|mesh-ancestor
92978705|NCT04708496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978706|NCT04708496|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92978707|NCT04708496|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92978708|NCT04708496|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92978709|NCT04708496|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92978710|NCT04708496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92978711|NCT04708496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92978712|NCT04708496|Antimalarials|antimalarials|mesh-ancestor
92978713|NCT04708496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92978714|NCT04708496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92978715|NCT04708496|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92978716|NCT04708496|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92978717|NCT04708496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92978718|NCT04708496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92978719|NCT00646958|Linezolid|linezolid|mesh-list
92978720|NCT00646958|Radezolid|radezolid|mesh-list
92978721|NCT00646958|Oxazolidinones|oxazolidinones|mesh-list
92978722|NCT00646958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978723|NCT00646958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978724|NCT00646958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92978725|NCT00646958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978726|NCT00646958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978727|NCT00813410|Insulin|insulin|mesh-list
92978728|NCT00813410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92978729|NCT00813410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978730|NCT00642746|Leucovorin|leucovorin|mesh-list
92978731|NCT00642746|Fluorouracil|fluorouracil|mesh-list
92978732|NCT00642746|Oxaliplatin|oxaliplatin|mesh-list
92978733|NCT00642746|Irinotecan|irinotecan|mesh-list
92978734|NCT00642746|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92978735|NCT00642746|Antimetabolites|antimetabolites|mesh-ancestor
92978736|NCT00642746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978737|NCT00642746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92978738|NCT00642746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978739|NCT00642746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92978740|NCT00642746|Immunologic Factors|immunologic factors|mesh-ancestor
92978741|NCT00642746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978742|NCT00642746|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92978743|NCT00642746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92978744|NCT00642746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978745|NCT00642746|Antidotes|antidotes|mesh-ancestor
92978746|NCT00642746|Protective Agents|protective agents|mesh-ancestor
92978747|NCT00642746|Vitamin B Complex|vitamin b complex|mesh-ancestor
92978748|NCT00642746|Vitamins|vitamins|mesh-ancestor
92978749|NCT00642746|Micronutrients|micronutrients|mesh-ancestor
92978750|NCT00642746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92978751|NCT00814268|Aspirin|aspirin|mesh-list
92978752|NCT00814268|Clopidogrel|clopidogrel|mesh-list
92978753|NCT00814268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92978754|NCT00814268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92978755|NCT00814268|Analgesics|analgesics|mesh-ancestor
92978756|NCT00814268|Sensory System Agents|sensory system agents|mesh-ancestor
92978757|NCT00814268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978758|NCT00814268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978759|NCT00814268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978760|NCT00814268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978761|NCT00814268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92978762|NCT00814268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92978763|NCT00814268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978764|NCT00814268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92978765|NCT00814268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92978766|NCT00814268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978767|NCT00814268|Antipyretics|antipyretics|mesh-ancestor
92978768|NCT00814268|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92978769|NCT00814268|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92978770|NCT00814268|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92978771|NCT00814268|Purinergic Agents|purinergic agents|mesh-ancestor
92978772|NCT00814268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978773|NCT00817622|Vitamin E|vitamin e|mesh-list
92978774|NCT00817622|Vitamins|vitamins|mesh-ancestor
92978775|NCT00817622|Micronutrients|micronutrients|mesh-ancestor
92978776|NCT00817622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978777|NCT00817622|Antioxidants|antioxidants|mesh-ancestor
92978778|NCT00817622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978779|NCT00817622|Protective Agents|protective agents|mesh-ancestor
92978780|NCT00808418|Docetaxel|docetaxel|mesh-list
92978781|NCT00808418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978782|NCT00808418|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978783|NCT00808418|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978784|NCT00808418|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978785|NCT00808418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978786|NCT00642668|Epoetin Alfa|epoetin alfa|mesh-list
92978787|NCT00642668|Hematinics|hematinics|mesh-ancestor
92978788|NCT00817934|Bisacodyl|bisacodyl|mesh-list
92978789|NCT00817934|Cathartics|cathartics|mesh-ancestor
92978790|NCT00817934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978791|NCT00817934|Laxatives|laxatives|mesh-ancestor
92978792|NCT00729833|Sunitinib|sunitinib|mesh-list
92978793|NCT00729833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978794|NCT00729833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92978795|NCT00729833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92978796|NCT00729833|Growth Substances|growth substances|mesh-ancestor
92978797|NCT00729833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978798|NCT00729833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92978799|NCT00729833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92978800|NCT00729833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978801|NCT00729833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978802|NCT00645788|Ciprofloxacin|ciprofloxacin|mesh-list
92978803|NCT00645788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978804|NCT00645788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978805|NCT00645788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92978806|NCT00645788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92978807|NCT00645788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978808|NCT00645788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978809|NCT00645788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978810|NCT00645788|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92978811|NCT00645788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92978812|NCT00814736|Sildenafil Citrate|sildenafil citrate|mesh-list
92978813|NCT00814736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92978814|NCT00814736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92978815|NCT00814736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92978816|NCT00814736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978817|NCT00814736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978818|NCT00814736|Urological Agents|urological agents|mesh-ancestor
92978819|NCT00818090|Paclitaxel|paclitaxel|mesh-list
92978820|NCT00818090|Cisplatin|cisplatin|mesh-list
92978821|NCT00818090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92978822|NCT00818090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978823|NCT00818090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978824|NCT00818090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978826|NCT00818090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978827|NCT00642356|Levodopa|levodopa|mesh-list
92978828|NCT00642356|Carbidopa|carbidopa|mesh-list
92978829|NCT00642356|Entacapone|entacapone|mesh-list
92978830|NCT00642356|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92978831|NCT00642356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92978832|NCT00642356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92978833|NCT00642356|Dopamine Agents|dopamine agents|mesh-ancestor
92978834|NCT00642356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978835|NCT00642356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978836|NCT00642356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978837|NCT00642356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92978838|NCT00642356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978839|NCT00642356|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92978840|NCT00642356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92978841|NCT00642356|Immunologic Factors|immunologic factors|mesh-ancestor
92978842|NCT00642356|Dopamine Agonists|dopamine agonists|mesh-ancestor
92978843|NCT00642278|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92978844|NCT00642278|Canagliflozin|canagliflozin|mesh-list
92978845|NCT00642278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92978846|NCT00642278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978847|NCT00642278|Incretins|incretins|mesh-ancestor
92978848|NCT00642278|Hormones|hormones|mesh-ancestor
92978849|NCT00642278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92978850|NCT00642278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92624274|NCT00540202|Lumefantrine|lumefantrine|mesh-list
92978851|NCT00642278|Protease Inhibitors|protease inhibitors|mesh-ancestor
92978852|NCT00642278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978853|NCT00642278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978854|NCT00642278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92978855|NCT00812786|Cyclosporine|cyclosporine|mesh-list
92978856|NCT00812786|Mycophenolic Acid|mycophenolic acid|mesh-list
92978857|NCT00812786|Everolimus|everolimus|mesh-list
92978858|NCT00812786|Tacrolimus|tacrolimus|mesh-list
92978859|NCT00812786|Cyclosporins|cyclosporins|mesh-list
92978860|NCT00812786|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92978861|NCT00812786|Immunologic Factors|immunologic factors|mesh-ancestor
92978862|NCT00812786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978863|NCT00812786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92978864|NCT00812786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978865|NCT00812786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978866|NCT00812786|Antifungal Agents|antifungal agents|mesh-ancestor
92978867|NCT00812786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978868|NCT00812786|Dermatologic Agents|dermatologic agents|mesh-ancestor
92978869|NCT00812786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92978870|NCT00812786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92978871|NCT00812786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92978872|NCT00812786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978873|NCT00812786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92978874|NCT00812786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92978875|NCT00812786|Antitubercular Agents|antitubercular agents|mesh-ancestor
92978876|NCT00812786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978877|NCT00815048|Atropine|atropine|mesh-list
92978878|NCT00815048|Fentanyl|fentanyl|mesh-list
92978879|NCT00815048|Remifentanil|remifentanil|mesh-list
92978880|NCT00815048|Succinylcholine|succinylcholine|mesh-list
92978881|NCT00815048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92978882|NCT00815048|Narcotics|narcotics|mesh-ancestor
92978883|NCT00815048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978884|NCT00815048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978885|NCT00815048|Analgesics|analgesics|mesh-ancestor
92978886|NCT00815048|Sensory System Agents|sensory system agents|mesh-ancestor
92978887|NCT00815048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978888|NCT00815048|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92978889|NCT00815048|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92978890|NCT00815048|Anesthetics, General|anesthetics, general|mesh-ancestor
92978891|NCT00815048|Anesthetics|anesthetics|mesh-ancestor
92978892|NCT00815048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92978893|NCT00815048|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92978894|NCT00815048|Autonomic Agents|autonomic agents|mesh-ancestor
92978895|NCT00815048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92978896|NCT00815048|Respiratory System Agents|respiratory system agents|mesh-ancestor
92978897|NCT00815048|Mydriatics|mydriatics|mesh-ancestor
92978898|NCT00815048|Parasympatholytics|parasympatholytics|mesh-ancestor
92978899|NCT00815048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92978900|NCT00815048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92978901|NCT00815048|Cholinergic Agents|cholinergic agents|mesh-ancestor
92978902|NCT00815048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978903|NCT00815048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978904|NCT00815048|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92978905|NCT00815048|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92978906|NCT00815048|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92978907|NCT02551796|Levofloxacin|levofloxacin|mesh-list
92978908|NCT02551796|Ofloxacin|ofloxacin|mesh-list
92978909|NCT02551796|Tobramycin|tobramycin|mesh-list
92978910|NCT02551796|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92978911|NCT02551796|Dexamethasone|dexamethasone|mesh-list
92978912|NCT02551796|Dexamethasone acetate|dexamethasone acetate|mesh-list
92978913|NCT02551796|BB 1101|bb 1101|mesh-list
92978914|NCT02551796|Hyaluronic Acid|hyaluronic acid|mesh-list
92978915|NCT02551796|Dipivefrin|dipivefrin|mesh-list
92978916|NCT02551796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978917|NCT02551796|Antiemetics|antiemetics|mesh-ancestor
92978918|NCT02551796|Autonomic Agents|autonomic agents|mesh-ancestor
92978919|NCT02551796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978920|NCT02551796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978921|NCT02551796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978922|NCT02551796|Glucocorticoids|glucocorticoids|mesh-ancestor
92978923|NCT02551796|Hormones|hormones|mesh-ancestor
92978924|NCT02551796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92978925|NCT02551796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92978926|NCT02551796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978927|NCT02551796|Protease Inhibitors|protease inhibitors|mesh-ancestor
92978928|NCT02551796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92978929|NCT02551796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978930|NCT02551796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92978931|NCT02551796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92978932|NCT02551796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92978933|NCT02551796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92978934|NCT02551796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92978935|NCT02551796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92978936|NCT02551796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92978937|NCT02551796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92978938|NCT02551796|Immunologic Factors|immunologic factors|mesh-ancestor
92978939|NCT02551796|Viscosupplements|viscosupplements|mesh-ancestor
92978940|NCT02551796|Protective Agents|protective agents|mesh-ancestor
92978941|NCT02551796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92978942|NCT02551796|Adrenergic Agents|adrenergic agents|mesh-ancestor
92978943|NCT02551796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978944|NCT02551796|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92978945|NCT02551796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92978946|NCT00723125|Paclitaxel|paclitaxel|mesh-list
92978947|NCT00723125|Bevacizumab|bevacizumab|mesh-list
92978948|NCT00723125|Carboplatin|carboplatin|mesh-list
92978949|NCT00723125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92978950|NCT00723125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92978951|NCT00723125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978952|NCT00723125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92978953|NCT00723125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92978954|NCT00723125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92978955|NCT00723125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978956|NCT00723125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92978957|NCT00723125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92978958|NCT00723125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92978959|NCT00723125|Growth Substances|growth substances|mesh-ancestor
92978960|NCT00723125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978961|NCT00723125|Growth Inhibitors|growth inhibitors|mesh-ancestor
92978962|NCT00640562|Risperidone|risperidone|mesh-list
92978963|NCT00640562|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92978964|NCT00640562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92978965|NCT00640562|Serotonin Agents|serotonin agents|mesh-ancestor
92978966|NCT00640562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978967|NCT00640562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978968|NCT00640562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978969|NCT00640562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92978970|NCT00640562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92978971|NCT00640562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978972|NCT00640562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978973|NCT00640562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92978974|NCT00640562|Dopamine Agents|dopamine agents|mesh-ancestor
92978975|NCT00640562|Antidepressive Agents|antidepressive agents|mesh-ancestor
92978977|NCT00815204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92978978|NCT00815204|Antiemetics|antiemetics|mesh-ancestor
92978979|NCT00815204|Autonomic Agents|autonomic agents|mesh-ancestor
92978980|NCT00815204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92978981|NCT00815204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978982|NCT00815204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92978983|NCT00815204|Glucocorticoids|glucocorticoids|mesh-ancestor
92978984|NCT00815204|Hormones|hormones|mesh-ancestor
92978985|NCT00815204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92978986|NCT00815204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92978987|NCT00815204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92978988|NCT00721955|Loxapine|loxapine|mesh-list
92978989|NCT00721955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92978990|NCT00721955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92978991|NCT00721955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92978992|NCT00721955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92978993|NCT00721955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92978994|NCT00721955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92978995|NCT00721955|Dopamine Agents|dopamine agents|mesh-ancestor
92978996|NCT00721955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92978997|NCT00721955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92978998|NCT00585689|Carboplatin|carboplatin|mesh-list
92978999|NCT00585689|Gemcitabine|gemcitabine|mesh-list
92979000|NCT00585689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92979001|NCT00585689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624423|NCT00541021|Antimetabolites|antimetabolites|mesh-ancestor
92979002|NCT00585689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92979003|NCT00585689|Antimetabolites|antimetabolites|mesh-ancestor
92979004|NCT00585689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979005|NCT00815282|Vaccines|vaccines|mesh-list
92979006|NCT00815282|Immunologic Factors|immunologic factors|mesh-ancestor
92979007|NCT00815282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979008|NCT02593019|Adavosertib|adavosertib|mesh-list
92979009|NCT02593019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979010|NCT02593019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979011|NCT00729365|Ramipril|ramipril|mesh-list
92979012|NCT00729365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92979013|NCT00729365|Protease Inhibitors|protease inhibitors|mesh-ancestor
92979014|NCT00729365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979015|NCT00729365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979016|NCT00729365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979017|NCT00818870|Omeprazole|omeprazole|mesh-list
92979018|NCT00818870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92979019|NCT00818870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979020|NCT00818870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92979021|NCT00818870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979022|NCT00818870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979023|NCT00254293|Abatacept|abatacept|mesh-list
92979024|NCT00254293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92979025|NCT00254293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92979026|NCT00254293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979027|NCT00254293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92979028|NCT00254293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979029|NCT00254293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92979030|NCT00254293|Immunologic Factors|immunologic factors|mesh-ancestor
92979031|NCT00254293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979032|NCT00254293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92979033|NCT00736385|Metformin|metformin|mesh-list
92979034|NCT00736385|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92979035|NCT00736385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979036|NCT00585221|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92979037|NCT00585221|Imatinib Mesylate|imatinib mesylate|mesh-list
92979038|NCT00585221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979039|NCT00585221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979040|NCT00585221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979041|NCT00585221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979042|NCT00585221|Antiviral Agents|antiviral agents|mesh-ancestor
92979043|NCT00585221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979044|NCT02594033|Insulin Aspart|insulin aspart|mesh-list
92979045|NCT02594033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92528049|NCT00000707|Pentamidine|pentamidine|mesh-list
92979046|NCT02594033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979047|NCT00253747|Methylphenidate|methylphenidate|mesh-list
92979048|NCT00253747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92979049|NCT00253747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979050|NCT00253747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92979051|NCT00253747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92979052|NCT00253747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92979053|NCT00253747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979054|NCT00253747|Dopamine Agents|dopamine agents|mesh-ancestor
92979055|NCT00253747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979056|NCT00252733|Candesartan|candesartan|mesh-list
92979057|NCT00252733|Candesartan cilexetil|candesartan cilexetil|mesh-list
92979058|NCT00252733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979059|NCT00252733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92979060|NCT00252733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92979061|NCT00252733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979062|NCT03974035|Ropivacaine|ropivacaine|mesh-list
92979063|NCT03974035|Anesthetics, Local|anesthetics, local|mesh-ancestor
92979064|NCT03974035|Anesthetics|anesthetics|mesh-ancestor
92979065|NCT03974035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979066|NCT03974035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979067|NCT03974035|Sensory System Agents|sensory system agents|mesh-ancestor
92979068|NCT03974035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979069|NCT00275821|Ranibizumab|ranibizumab|mesh-list
92979070|NCT00275821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979071|NCT00275821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979072|NCT00275821|Growth Substances|growth substances|mesh-ancestor
92979073|NCT00275821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979074|NCT00275821|Growth Inhibitors|growth inhibitors|mesh-ancestor
92624498|NCT00541411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979075|NCT00275821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979076|NCT00275509|Mycophenolic Acid|mycophenolic acid|mesh-list
92979077|NCT00275509|Dexamethasone|dexamethasone|mesh-list
92979078|NCT00275509|Prednisone|prednisone|mesh-list
92979079|NCT00275509|Tacrolimus|tacrolimus|mesh-list
92979080|NCT00275509|Thymoglobulin|thymoglobulin|mesh-list
92979081|NCT00275509|Daclizumab|daclizumab|mesh-list
92979082|NCT00275509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92979083|NCT00275509|Antiemetics|antiemetics|mesh-ancestor
92979084|NCT00275509|Autonomic Agents|autonomic agents|mesh-ancestor
92979085|NCT00275509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979086|NCT00275509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979087|NCT00275509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979088|NCT00275509|Glucocorticoids|glucocorticoids|mesh-ancestor
92979089|NCT00275509|Hormones|hormones|mesh-ancestor
92979090|NCT00275509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979091|NCT00275509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92979092|NCT00275509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979093|NCT00275509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92979094|NCT00275509|Immunologic Factors|immunologic factors|mesh-ancestor
92979095|NCT00275509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92979096|NCT00275509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979097|NCT00275509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979098|NCT00275509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92979099|NCT00275509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92979100|NCT00275509|Antitubercular Agents|antitubercular agents|mesh-ancestor
92979101|NCT00275509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979102|NCT00275509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979103|NCT01072045|Prednisone|prednisone|mesh-list
92979104|NCT01072045|Propranolol|propranolol|mesh-list
92979105|NCT01072045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92979106|NCT01072045|Glucocorticoids|glucocorticoids|mesh-ancestor
92979107|NCT01072045|Hormones|hormones|mesh-ancestor
92979108|NCT01072045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979109|NCT01072045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979110|NCT01072045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92979111|NCT01072045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979112|NCT01072045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92979113|NCT01072045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92979114|NCT01072045|Adrenergic Agents|adrenergic agents|mesh-ancestor
92979115|NCT01072045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979116|NCT01072045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979117|NCT01072045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92979118|NCT01072045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979119|NCT01072045|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979120|NCT01073059|Ertapenem|ertapenem|mesh-list
92979121|NCT01073059|Valproic Acid|valproic acid|mesh-list
92979122|NCT01073059|Anticonvulsants|anticonvulsants|mesh-ancestor
92979123|NCT01073059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979124|NCT01073059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979125|NCT01073059|GABA Agents|gaba agents|mesh-ancestor
92979126|NCT01073059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979127|NCT01073059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979128|NCT01073059|Antimanic Agents|antimanic agents|mesh-ancestor
92979129|NCT01073059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92979130|NCT01073059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979131|NCT01073059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92979132|NCT01073059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979133|NCT01073059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979134|NCT00252577|Lithium Carbonate|lithium carbonate|mesh-list
92979135|NCT00252577|Antidepressive Agents|antidepressive agents|mesh-ancestor
92979136|NCT00252577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92979137|NCT00252577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979138|NCT00252577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979139|NCT00252577|Antimanic Agents|antimanic agents|mesh-ancestor
92979140|NCT00252577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92979141|NCT00252577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979142|NCT00252577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979143|NCT00252499|Rosiglitazone|rosiglitazone|mesh-list
92979144|NCT00252499|Fenofibrate|fenofibrate|mesh-list
92979145|NCT00252499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92979146|NCT00252499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979147|NCT00252499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92979148|NCT00252499|Antimetabolites|antimetabolites|mesh-ancestor
92979149|NCT00252499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979150|NCT00252499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92979151|NCT00252187|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92979152|NCT00252187|Natriuretic Agents|natriuretic agents|mesh-ancestor
92979153|NCT00252187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979154|NCT00163657|Cyclosporine|cyclosporine|mesh-list
92979155|NCT00163657|Mycophenolic Acid|mycophenolic acid|mesh-list
92979156|NCT00163657|Tacrolimus|tacrolimus|mesh-list
92979157|NCT00163657|Cyclosporins|cyclosporins|mesh-list
92979158|NCT00163657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92979159|NCT00163657|Immunologic Factors|immunologic factors|mesh-ancestor
92979160|NCT00163657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979161|NCT00163657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92979162|NCT00163657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979163|NCT00163657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979164|NCT00163657|Antifungal Agents|antifungal agents|mesh-ancestor
92979165|NCT00163657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979166|NCT00163657|Dermatologic Agents|dermatologic agents|mesh-ancestor
92979167|NCT00163657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92979168|NCT00163657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92979169|NCT00163657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979170|NCT00163657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92979171|NCT00163657|Antitubercular Agents|antitubercular agents|mesh-ancestor
92979172|NCT00163657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979173|NCT01073683|Docetaxel|docetaxel|mesh-list
92979174|NCT01073683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979175|NCT01073683|Tubulin Modulators|tubulin modulators|mesh-ancestor
92979176|NCT01073683|Antimitotic Agents|antimitotic agents|mesh-ancestor
92979177|NCT01073683|Mitosis Modulators|mitosis modulators|mesh-ancestor
92979178|NCT01073683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979179|NCT00609492|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92979180|NCT00609492|Immunologic Factors|immunologic factors|mesh-ancestor
92979181|NCT00609492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979182|NCT00230971|Metronidazole|metronidazole|mesh-list
92979183|NCT00230971|Ceftriaxone|ceftriaxone|mesh-list
92979184|NCT00230971|Tigecycline|tigecycline|mesh-list
92979185|NCT00230971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979186|NCT00230971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979187|NCT00230971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92979188|NCT00230971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92979189|NCT00230971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92979190|NCT00230971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979191|NCT00230971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979192|NCT00211081|Spironolactone|spironolactone|mesh-list
92979193|NCT00211081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92979194|NCT00211081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92979195|NCT00211081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979196|NCT00211081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979197|NCT00211081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92979198|NCT00211081|Diuretics|diuretics|mesh-ancestor
92167171|NCT01375491|Doxycycline|doxycycline|mesh-list
92979199|NCT00211081|Natriuretic Agents|natriuretic agents|mesh-ancestor
92979200|NCT00884676|Sunitinib|sunitinib|mesh-list
92979201|NCT00884676|Epothilone B|epothilone b|mesh-list
92979202|NCT00884676|Epothilones|epothilones|mesh-list
92979203|NCT00884676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979204|NCT00884676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979205|NCT00884676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979206|NCT00884676|Growth Substances|growth substances|mesh-ancestor
92979207|NCT00884676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979208|NCT00884676|Growth Inhibitors|growth inhibitors|mesh-ancestor
92979209|NCT00884676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979210|NCT00884676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979211|NCT00884676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979212|NCT00884676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92979213|NCT00884676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92979214|NCT00884676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92979215|NCT00891384|Lenalidomide|lenalidomide|mesh-list
92979216|NCT00891384|Immunologic Factors|immunologic factors|mesh-ancestor
92979217|NCT00891384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979218|NCT00891384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979219|NCT00891384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979220|NCT00891384|Growth Substances|growth substances|mesh-ancestor
92979221|NCT00891384|Growth Inhibitors|growth inhibitors|mesh-ancestor
92979222|NCT00891384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979223|NCT00887328|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92979224|NCT00887328|Plasminogen|plasminogen|mesh-list
92979225|NCT00887328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92979226|NCT00887328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92979227|NCT00887328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979228|NCT00609336|Gemcitabine|gemcitabine|mesh-list
92979229|NCT00609336|Capecitabine|capecitabine|mesh-list
92979230|NCT00609336|Docetaxel|docetaxel|mesh-list
92979231|NCT00609336|Oxaliplatin|oxaliplatin|mesh-list
92979232|NCT00609336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92979233|NCT00609336|Antimetabolites|antimetabolites|mesh-ancestor
92979234|NCT00609336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979235|NCT00609336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979236|NCT00609336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92979237|NCT00609336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92979238|NCT00609336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92979239|NCT00612066|Rosiglitazone|rosiglitazone|mesh-list
92979240|NCT00612066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92979241|NCT00612066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979242|NCT02541084|Aflibercept|aflibercept|mesh-list
92979243|NCT02541084|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979244|NCT02541084|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979245|NCT02541084|Growth Substances|growth substances|mesh-ancestor
92979246|NCT02541084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979247|NCT02541084|Growth Inhibitors|growth inhibitors|mesh-ancestor
92979248|NCT02541084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979249|NCT04397406|Fentanyl|fentanyl|mesh-list
92979250|NCT04397406|Dexmedetomidine|dexmedetomidine|mesh-list
92979251|NCT04397406|Levobupivacaine|levobupivacaine|mesh-list
92979252|NCT04397406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92979253|NCT04397406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979254|NCT04397406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979255|NCT04397406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92979256|NCT04397406|Analgesics|analgesics|mesh-ancestor
92979257|NCT04397406|Sensory System Agents|sensory system agents|mesh-ancestor
92979258|NCT04397406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979259|NCT04397406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92979260|NCT04397406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92979261|NCT04397406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92979262|NCT04397406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92979263|NCT04397406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979264|NCT04397406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979265|NCT04397406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92979267|NCT04397406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92979268|NCT04397406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92979269|NCT04397406|Anesthetics, General|anesthetics, general|mesh-ancestor
92979270|NCT04397406|Anesthetics|anesthetics|mesh-ancestor
92979271|NCT04397406|Anesthetics, Local|anesthetics, local|mesh-ancestor
92979272|NCT00891540|Ropivacaine|ropivacaine|mesh-list
92979273|NCT00891540|Anesthetics, Local|anesthetics, local|mesh-ancestor
92979274|NCT00891540|Anesthetics|anesthetics|mesh-ancestor
92979275|NCT00891540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979276|NCT00891540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979277|NCT00891540|Sensory System Agents|sensory system agents|mesh-ancestor
92979278|NCT00891540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979279|NCT00573144|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92979280|NCT00573144|Natriuretic Agents|natriuretic agents|mesh-ancestor
92979281|NCT00573144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979282|NCT00891696|Sirolimus|sirolimus|mesh-list
92979283|NCT00891696|Nitroprusside|nitroprusside|mesh-list
92979284|NCT00891696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979285|NCT00891696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979286|NCT00891696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92979287|NCT00891696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979288|NCT00891696|Antifungal Agents|antifungal agents|mesh-ancestor
92979289|NCT00891696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92979290|NCT00891696|Immunologic Factors|immunologic factors|mesh-ancestor
92979291|NCT00891696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979292|NCT00891696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979293|NCT00891696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979294|NCT00891696|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979295|NCT00891696|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92979296|NCT00640328|Ofatumumab|ofatumumab|mesh-list
92979297|NCT00640328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92979298|NCT00640328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979299|NCT00640328|Immunologic Factors|immunologic factors|mesh-ancestor
92624744|NCT00543049|Sunitinib|sunitinib|mesh-list
92979300|NCT00640328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979301|NCT04036890|Minocycline|minocycline|mesh-list
92979302|NCT04036890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979303|NCT04036890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979305|NCT00162097|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92979306|NCT00162097|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92979307|NCT00162097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92979308|NCT00162097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979309|NCT00162097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979310|NCT00162097|Antiviral Agents|antiviral agents|mesh-ancestor
92979311|NCT00162097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979312|NCT00162097|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92979313|NCT00162097|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92979314|NCT00162097|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92979315|NCT00162097|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92979316|NCT00162097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92979317|NCT00162097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92979318|NCT02550782|Dexmedetomidine|dexmedetomidine|mesh-list
92979319|NCT02550782|Bupivacaine|bupivacaine|mesh-list
92979320|NCT02550782|Anesthetics, Local|anesthetics, local|mesh-ancestor
92979321|NCT02550782|Anesthetics|anesthetics|mesh-ancestor
92979322|NCT02550782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979323|NCT02550782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979324|NCT02550782|Sensory System Agents|sensory system agents|mesh-ancestor
92979325|NCT02550782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979326|NCT02550782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92979327|NCT02550782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92979328|NCT02550782|Analgesics|analgesics|mesh-ancestor
92979329|NCT02550782|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92979330|NCT02550782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92979331|NCT02550782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92979332|NCT02550782|Adrenergic Agents|adrenergic agents|mesh-ancestor
92979333|NCT02550782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979334|NCT02550782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979335|NCT05278728|Irinotecan|irinotecan|mesh-list
92979336|NCT05278728|Nimotuzumab|nimotuzumab|mesh-list
92979337|NCT05278728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92979338|NCT05278728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92979339|NCT05278728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324602|NCT00002768|Busulfan|busulfan|mesh-list
92979340|NCT05278728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979341|NCT05278728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979342|NCT05278728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92979343|NCT01073761|Ritonavir|ritonavir|mesh-list
92979344|NCT01073761|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92979345|NCT01073761|Darunavir|darunavir|mesh-list
92979346|NCT01073761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92979347|NCT01073761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92979348|NCT01073761|Protease Inhibitors|protease inhibitors|mesh-ancestor
92979349|NCT01073761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979350|NCT01073761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979351|NCT01073761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92979352|NCT01073761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92979353|NCT01073761|Antiviral Agents|antiviral agents|mesh-ancestor
92979354|NCT01073761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979355|NCT01073761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92979356|NCT01073761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92979357|NCT00819104|Metoprolol|metoprolol|mesh-list
92979358|NCT00819104|Amlodipine|amlodipine|mesh-list
92979359|NCT00819104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979360|NCT00819104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92979361|NCT00819104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92979362|NCT00819104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979363|NCT00819104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92979364|NCT00819104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979365|NCT00819104|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979366|NCT00819104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92979367|NCT00819104|Sympatholytics|sympatholytics|mesh-ancestor
92979368|NCT00819104|Autonomic Agents|autonomic agents|mesh-ancestor
92979369|NCT00819104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979370|NCT00819104|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92979371|NCT00819104|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92979372|NCT00819104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92979373|NCT00819104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92979374|NCT00819104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979375|NCT02542098|Hydrocodone|hydrocodone|mesh-list
92979376|NCT02542098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92979377|NCT02542098|Narcotics|narcotics|mesh-ancestor
92979378|NCT02542098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979379|NCT02542098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979380|NCT02542098|Analgesics|analgesics|mesh-ancestor
92979381|NCT02542098|Sensory System Agents|sensory system agents|mesh-ancestor
92979382|NCT02542098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979383|NCT02542098|Antitussive Agents|antitussive agents|mesh-ancestor
92979384|NCT02542098|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979385|NCT00640016|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92979386|NCT00640016|Immunologic Factors|immunologic factors|mesh-ancestor
92979387|NCT00640016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979388|NCT00892242|Zoledronic Acid|zoledronic acid|mesh-list
92979389|NCT00892242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92979390|NCT00892242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979391|NCT00885066|Gemcitabine|gemcitabine|mesh-list
92979392|NCT00885066|Capecitabine|capecitabine|mesh-list
92979393|NCT00885066|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92979394|NCT00885066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92979395|NCT00885066|Antimetabolites|antimetabolites|mesh-ancestor
92979396|NCT00885066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979397|NCT00885066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979398|NCT00885066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979399|NCT00885066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979400|NCT00888108|Docetaxel|docetaxel|mesh-list
92979401|NCT00888108|Navitoclax|navitoclax|mesh-list
92979402|NCT00888108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979403|NCT00888108|Tubulin Modulators|tubulin modulators|mesh-ancestor
92979404|NCT00888108|Antimitotic Agents|antimitotic agents|mesh-ancestor
92979405|NCT00888108|Mitosis Modulators|mitosis modulators|mesh-ancestor
92979406|NCT00888108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979407|NCT00885300|Cloxacillin|cloxacillin|mesh-list
92979408|NCT00885300|Heparin|heparin|mesh-list
92979409|NCT00885300|Anticoagulants|anticoagulants|mesh-ancestor
92979410|NCT00885300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92979411|NCT00885300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92979412|NCT00885300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979413|NCT00885300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979414|NCT00885300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979415|NCT00888186|Levodopa|levodopa|mesh-list
92979416|NCT00888186|Carbidopa|carbidopa|mesh-list
92979417|NCT00888186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92979418|NCT00888186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92979419|NCT00888186|Dopamine Agents|dopamine agents|mesh-ancestor
92979420|NCT00888186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979421|NCT00888186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979422|NCT00888186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979423|NCT00888186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92979424|NCT00888186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979425|NCT00892320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92979426|NCT00892320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92979427|NCT00892320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92979428|NCT00892320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979429|NCT00892320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979430|NCT00892320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92979431|NCT00892320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92979432|NCT00892320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92979433|NCT00892320|Serotonin Agents|serotonin agents|mesh-ancestor
92979434|NCT00892320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979435|NCT00892320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979436|NCT00892320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92979437|NCT00892320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92979438|NCT00892320|Dopamine Agents|dopamine agents|mesh-ancestor
92979439|NCT00892398|Ranibizumab|ranibizumab|mesh-list
92979440|NCT00892398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979441|NCT00892398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979442|NCT00892398|Growth Substances|growth substances|mesh-ancestor
92979443|NCT00892398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979444|NCT00892398|Growth Inhibitors|growth inhibitors|mesh-ancestor
92979445|NCT00892398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979446|NCT00892476|Calcium, Dietary|calcium, dietary|mesh-list
92979447|NCT00892476|Calcium|calcium|mesh-list
92979448|NCT00892476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92979449|NCT00892476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979450|NCT00892476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92979451|NCT02541786|Rabeprazole|rabeprazole|mesh-list
92979452|NCT02541786|Dexlansoprazole|dexlansoprazole|mesh-list
92979453|NCT02541786|Lansoprazole|lansoprazole|mesh-list
92979454|NCT02541786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92979455|NCT02541786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979456|NCT02541786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92979457|NCT02541786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979458|NCT02541786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979459|NCT00888342|Ethanol|ethanol|mesh-list
92979460|NCT00888342|Zopiclone|zopiclone|mesh-list
92979461|NCT00888342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92979462|NCT00888342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979463|NCT00888342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979464|NCT00888342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979465|NCT00888342|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92979466|NCT00608868|Gefitinib|gefitinib|mesh-list
92979467|NCT00608868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979468|NCT00608868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979469|NCT00608868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979470|NCT00608868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979471|NCT00900978|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92979472|NCT00900978|Immunologic Factors|immunologic factors|mesh-ancestor
92979473|NCT00900978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979474|NCT04036500|Estradiol|estradiol|mesh-list
92979475|NCT04036500|Estrogens|estrogens|mesh-ancestor
92979476|NCT04036500|Hormones|hormones|mesh-ancestor
92979477|NCT04036500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979478|NCT04036500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979479|NCT00895674|Sorafenib|sorafenib|mesh-list
92979480|NCT00895674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979481|NCT00895674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979482|NCT00895674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979483|NCT00895674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979484|NCT04035330|Etidronic Acid|etidronic acid|mesh-list
92979485|NCT04035330|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92979487|NCT04035330|Disinfectants|disinfectants|mesh-ancestor
92979488|NCT04035330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979489|NCT04035330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92979490|NCT04035330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979491|NCT04035096|Ascorbic Acid|ascorbic acid|mesh-list
92979492|NCT04035096|Antioxidants|antioxidants|mesh-ancestor
92979493|NCT04035096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979494|NCT04035096|Protective Agents|protective agents|mesh-ancestor
92979495|NCT04035096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979496|NCT04035096|Vitamins|vitamins|mesh-ancestor
92979497|NCT04035096|Micronutrients|micronutrients|mesh-ancestor
92979498|NCT00608322|Nitric Oxide|nitric oxide|mesh-list
92979499|NCT00608322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92979500|NCT00608322|Autonomic Agents|autonomic agents|mesh-ancestor
92979501|NCT00608322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979502|NCT00608322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979503|NCT00608322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92979504|NCT00608322|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979505|NCT00608322|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92979506|NCT00608322|Antioxidants|antioxidants|mesh-ancestor
92979507|NCT00608322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979508|NCT00608322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979509|NCT00608322|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92979510|NCT00608322|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979511|NCT00608322|Gasotransmitters|gasotransmitters|mesh-ancestor
92979512|NCT00608322|Protective Agents|protective agents|mesh-ancestor
92979513|NCT00608244|Tacrolimus|tacrolimus|mesh-list
92979514|NCT00608244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92979515|NCT00608244|Immunologic Factors|immunologic factors|mesh-ancestor
92979516|NCT00608244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979517|NCT00608244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92979518|NCT00608244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979519|NCT00608244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979520|NCT00893100|Diltiazem|diltiazem|mesh-list
92979521|NCT00893100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979522|NCT00893100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92624947|NCT00190866|Analgesics|analgesics|mesh-ancestor
92979523|NCT00893100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92979524|NCT00893100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047061|NCT03983460|Clobetasol|clobetasol|mesh-list
92979525|NCT00893100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92979526|NCT00893100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979527|NCT00893100|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979528|NCT00896376|Trastuzumab|trastuzumab|mesh-list
92979529|NCT00896376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92979530|NCT00896376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979531|NCT00901290|Contraceptive Agents|contraceptive agents|mesh-list
92979532|NCT00901290|Contraceptives, Oral|contraceptives, oral|mesh-list
92979533|NCT00901290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92979534|NCT00901290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979535|NCT00901290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92979536|NCT00893256|Risperidone|risperidone|mesh-list
92979537|NCT00893256|Citalopram|citalopram|mesh-list
92979538|NCT00893256|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92979539|NCT00893256|Serotonin Agents|serotonin agents|mesh-ancestor
92979540|NCT00893256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979541|NCT00893256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979542|NCT00893256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979543|NCT00893256|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92979544|NCT00893256|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92979545|NCT00893256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979546|NCT00893256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92979547|NCT00893256|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92979548|NCT00893256|Dopamine Agents|dopamine agents|mesh-ancestor
92979549|NCT00893256|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92979550|NCT00893256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92979551|NCT00893256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92979552|NCT00893256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92979553|NCT00893256|Antidepressive Agents|antidepressive agents|mesh-ancestor
92979554|NCT00901368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92979555|NCT00901368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92979556|NCT00901368|Autonomic Agents|autonomic agents|mesh-ancestor
92979557|NCT00901368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979558|NCT00901368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979559|NCT00901368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92979560|NCT00901368|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979561|NCT00901368|Glucocorticoids|glucocorticoids|mesh-ancestor
92979562|NCT00901368|Hormones|hormones|mesh-ancestor
92979563|NCT00901368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979564|NCT00901368|Sympathomimetics|sympathomimetics|mesh-ancestor
92979565|NCT00901524|Interferons|interferons|mesh-list
92979566|NCT00901524|Ribavirin|ribavirin|mesh-list
92979567|NCT00901524|Interferon-alpha|interferon-alpha|mesh-list
92979568|NCT00901524|Interferon alpha-2|interferon alpha-2|mesh-list
92979569|NCT00901524|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92979570|NCT00901524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979571|NCT00901524|Antiviral Agents|antiviral agents|mesh-ancestor
92979572|NCT00901524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979573|NCT00901524|Antimetabolites|antimetabolites|mesh-ancestor
92979574|NCT00901524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979575|NCT00901524|Immunologic Factors|immunologic factors|mesh-ancestor
92979576|NCT00901524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979577|NCT00893412|Tramadol|tramadol|mesh-list
92979578|NCT00893412|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92979579|NCT00893412|Narcotics|narcotics|mesh-ancestor
92979580|NCT00893412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979581|NCT00893412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979582|NCT00893412|Analgesics|analgesics|mesh-ancestor
92979583|NCT00893412|Sensory System Agents|sensory system agents|mesh-ancestor
92979584|NCT00893412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979585|NCT00893490|Mitomycins|mitomycins|mesh-list
92979586|NCT00893490|Mitomycin|mitomycin|mesh-list
92979587|NCT00893490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92979588|NCT00893490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979589|NCT00893490|Alkylating Agents|alkylating agents|mesh-ancestor
92979590|NCT00893490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979591|NCT00893490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92979592|NCT00893490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979593|NCT00901758|Nitroglycerin|nitroglycerin|mesh-list
92979594|NCT00901758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979595|NCT00638690|Prednisone|prednisone|mesh-list
92979596|NCT00638690|Prednisolone|prednisolone|mesh-list
92979597|NCT00638690|Abiraterone Acetate|abiraterone acetate|mesh-list
92979598|NCT00638690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92979599|NCT00638690|Glucocorticoids|glucocorticoids|mesh-ancestor
92979600|NCT00638690|Hormones|hormones|mesh-ancestor
92979601|NCT00638690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979602|NCT00638690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979603|NCT00638690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92979604|NCT00638690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979605|NCT00638690|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92979606|NCT00638690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979607|NCT00638690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979608|NCT00638690|Hormone Antagonists|hormone antagonists|mesh-ancestor
92979609|NCT00638690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92979610|NCT02540928|N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|n-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9h-purin-6-amine|mesh-list
92979611|NCT02540928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979612|NCT02540928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979613|NCT00893724|Tocopherols|tocopherols|mesh-list
92979615|NCT00893724|Tocotrienols|tocotrienols|mesh-list
92979616|NCT00893724|alpha-Tocopherol|alpha-tocopherol|mesh-list
92979617|NCT00893724|Coenzyme Q10|coenzyme q10|mesh-list
92979618|NCT00893724|Niacinamide|niacinamide|mesh-list
92979619|NCT00893724|Niacin|niacin|mesh-list
92979620|NCT00893724|Nicotinic Acids|nicotinic acids|mesh-list
92979621|NCT00893724|Ubiquinone|ubiquinone|mesh-list
92979622|NCT00893724|Minocycline|minocycline|mesh-list
92979623|NCT00893724|Acetylcysteine|acetylcysteine|mesh-list
92979624|NCT00893724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92979625|NCT00893724|Vitamins|vitamins|mesh-ancestor
92979626|NCT00893724|Micronutrients|micronutrients|mesh-ancestor
92979627|NCT00893724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979628|NCT00893724|Antioxidants|antioxidants|mesh-ancestor
92979629|NCT00893724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979630|NCT00893724|Protective Agents|protective agents|mesh-ancestor
92979631|NCT00893724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979632|NCT00893724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979633|NCT00893724|Antiviral Agents|antiviral agents|mesh-ancestor
92979634|NCT00893724|Expectorants|expectorants|mesh-ancestor
92979635|NCT00893724|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979636|NCT00893724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92979637|NCT00893724|Antidotes|antidotes|mesh-ancestor
92979638|NCT00893724|Vitamin B Complex|vitamin b complex|mesh-ancestor
92979639|NCT00893724|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92979640|NCT00893724|Antimetabolites|antimetabolites|mesh-ancestor
92979641|NCT00893724|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92979642|NCT00893724|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979643|NCT00893880|Nitric Oxide|nitric oxide|mesh-list
92979644|NCT00893880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92979645|NCT00893880|Autonomic Agents|autonomic agents|mesh-ancestor
92979646|NCT00893880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979647|NCT00893880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979648|NCT00893880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92979649|NCT00893880|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979650|NCT00893880|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92979651|NCT00893880|Antioxidants|antioxidants|mesh-ancestor
92979652|NCT00893880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979653|NCT00893880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979654|NCT00893880|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92979655|NCT00893880|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979656|NCT00893880|Gasotransmitters|gasotransmitters|mesh-ancestor
92979657|NCT00893880|Protective Agents|protective agents|mesh-ancestor
92979658|NCT00815594|Bevacizumab|bevacizumab|mesh-list
92979659|NCT00815594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92979660|NCT00815594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979661|NCT00815594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979662|NCT00815594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979663|NCT00815594|Growth Substances|growth substances|mesh-ancestor
92979664|NCT00815594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979665|NCT00815594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92979666|NCT00897312|Interferons|interferons|mesh-list
92979667|NCT00897312|Ribavirin|ribavirin|mesh-list
92979668|NCT00897312|Interferon-alpha|interferon-alpha|mesh-list
92979669|NCT00897312|Infliximab|infliximab|mesh-list
92979670|NCT00897312|Tremelimumab|tremelimumab|mesh-list
92979671|NCT00897312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979672|NCT00897312|Antiviral Agents|antiviral agents|mesh-ancestor
92979673|NCT00897312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979674|NCT00897312|Antimetabolites|antimetabolites|mesh-ancestor
92625096|NCT00160394|Adapalene|adapalene|mesh-list
92979675|NCT00897312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979676|NCT00897312|Immunologic Factors|immunologic factors|mesh-ancestor
92979677|NCT00897312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979678|NCT00897312|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92979679|NCT00897312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92979680|NCT00897312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92979681|NCT00897312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979682|NCT00897312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92979683|NCT02540460|Delpazolid|delpazolid|mesh-list
92979684|NCT02540460|Oxazolidinones|oxazolidinones|mesh-list
92979685|NCT02540460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979686|NCT02540460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979687|NCT02540460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92979688|NCT02540460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979689|NCT02540460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979690|NCT00543387|Docetaxel|docetaxel|mesh-list
92979691|NCT00543387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979692|NCT00543387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92979693|NCT00543387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92979694|NCT00543387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92979695|NCT00543387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979696|NCT03455556|Atezolizumab|atezolizumab|mesh-list
92979697|NCT03455556|Maytansine|maytansine|mesh-list
92979698|NCT03455556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92979699|NCT03455556|Anetumab ravtansine|anetumab ravtansine|mesh-list
92979700|NCT03455556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92979701|NCT03455556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979702|NCT03455556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92979703|NCT03455556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979704|NCT03455556|Immunologic Factors|immunologic factors|mesh-ancestor
92979705|NCT03455556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979706|NCT03455556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92979707|NCT03455556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92979708|NCT03455556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92979709|NCT03455556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92979710|NCT03455556|Immunoconjugates|immunoconjugates|mesh-ancestor
92979712|NCT04017624|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92979713|NCT04017624|Autonomic Agents|autonomic agents|mesh-ancestor
92979714|NCT04017624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979715|NCT04017624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979716|NCT04017624|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92979717|NCT04017624|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92979718|NCT04017624|Cholinergic Agents|cholinergic agents|mesh-ancestor
92979719|NCT04017624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979720|NCT04017624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979721|NCT00809042|Hydroxyurea|hydroxyurea|mesh-list
92979722|NCT00809042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979723|NCT00809042|Antisickling Agents|antisickling agents|mesh-ancestor
92979724|NCT00809042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979725|NCT00809042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979726|NCT00809042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92979727|NCT00986037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92979728|NCT00986037|Immunologic Factors|immunologic factors|mesh-ancestor
92979729|NCT00986037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979730|NCT00983151|Tramadol|tramadol|mesh-list
92979731|NCT00983151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92979732|NCT00983151|Narcotics|narcotics|mesh-ancestor
92979733|NCT00983151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979734|NCT00983151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979735|NCT00983151|Analgesics|analgesics|mesh-ancestor
92979736|NCT00983151|Sensory System Agents|sensory system agents|mesh-ancestor
92979737|NCT00983151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979738|NCT00635570|Moxifloxacin|moxifloxacin|mesh-list
92979739|NCT00635570|NuvaRing|nuvaring|mesh-list
92979740|NCT00635570|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92979741|NCT00635570|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92979742|NCT00635570|Contraceptive Agents|contraceptive agents|mesh-ancestor
92979743|NCT00635570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92979744|NCT00635570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979745|NCT00635570|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92979746|NCT00635570|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92979747|NCT00635570|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92979748|NCT00635570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979749|NCT00635570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979750|NCT00635570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92979751|NCT00635570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92979752|NCT00635570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979753|NCT00635570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979754|NCT00635570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979755|NCT00893958|Mycophenolic Acid|mycophenolic acid|mesh-list
92979756|NCT00893958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92979757|NCT00893958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979758|NCT00893958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92979759|NCT00893958|Antitubercular Agents|antitubercular agents|mesh-ancestor
92979760|NCT00893958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92979761|NCT00893958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979762|NCT00893958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979763|NCT00893958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979764|NCT00986115|Memantine|memantine|mesh-list
92979765|NCT00986115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92979766|NCT00986115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92979767|NCT00986115|Dopamine Agents|dopamine agents|mesh-ancestor
92979768|NCT00986115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979769|NCT00986115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979770|NCT00986115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979771|NCT00986115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92979772|NCT00986115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92979773|NCT04035876|Apatinib|apatinib|mesh-list
92167197|NCT04238637|Durvalumab|durvalumab|mesh-list
92979774|NCT04035876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979775|NCT04035876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979776|NCT04035876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979777|NCT04035876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979778|NCT00902070|Rocuronium|rocuronium|mesh-list
92979779|NCT00902070|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92979780|NCT00902070|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92979781|NCT00902070|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92979782|NCT00902070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979783|NCT00902070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979784|NCT00635492|Insulin|insulin|mesh-list
92979785|NCT00635492|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92979786|NCT00635492|Exenatide|exenatide|mesh-list
92979787|NCT00635492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92979788|NCT00635492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979789|NCT00635492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92979790|NCT00635492|Incretins|incretins|mesh-ancestor
92979791|NCT00635492|Hormones|hormones|mesh-ancestor
92979792|NCT00635492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979793|NCT00543309|Milrinone|milrinone|mesh-list
92979794|NCT00543309|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92979795|NCT00543309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92979796|NCT00543309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92979797|NCT00543309|Vasodilator Agents|vasodilator agents|mesh-ancestor
92979798|NCT00543309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92979799|NCT00543309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92979800|NCT00543309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979801|NCT00543309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979802|NCT00543309|Protective Agents|protective agents|mesh-ancestor
92979803|NCT00543309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979804|NCT00543309|Natriuretic Agents|natriuretic agents|mesh-ancestor
92979805|NCT00569582|Mifepristone|mifepristone|mesh-list
92979806|NCT00569582|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92979807|NCT00569582|Abortifacient Agents|abortifacient agents|mesh-ancestor
92979808|NCT00569582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92979809|NCT00569582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979810|NCT00569582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92979811|NCT00569582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92979812|NCT00569582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92979813|NCT00569582|Contraceptive Agents|contraceptive agents|mesh-ancestor
92979814|NCT00569582|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92979815|NCT00569582|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92979816|NCT00569582|Hormone Antagonists|hormone antagonists|mesh-ancestor
92979817|NCT00569582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979818|NCT00569582|Luteolytic Agents|luteolytic agents|mesh-ancestor
92979819|NCT00569582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92979820|NCT00569582|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92979821|NCT00988845|Indole-3-carbinol|indole-3-carbinol|mesh-list
92979822|NCT00988845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92979823|NCT00988845|Protective Agents|protective agents|mesh-ancestor
92979824|NCT00988845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979825|NCT00988845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979826|NCT00983697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92979827|NCT00983697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92979828|NCT00983697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979829|NCT00902460|Midazolam|midazolam|mesh-list
92979830|NCT00902460|Tofacitinib|tofacitinib|mesh-list
92979831|NCT00902460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92979832|NCT00902460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92979833|NCT00902460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979834|NCT00902460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979835|NCT00902460|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92979836|NCT00902460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92979837|NCT00902460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92979838|NCT00902460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92979839|NCT00902460|Anesthetics, General|anesthetics, general|mesh-ancestor
92979840|NCT00902460|Anesthetics|anesthetics|mesh-ancestor
92167201|NCT02588443|Paclitaxel|paclitaxel|mesh-list
92979841|NCT00902460|GABA Modulators|gaba modulators|mesh-ancestor
92979842|NCT00902460|GABA Agents|gaba agents|mesh-ancestor
92979843|NCT00902460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979844|NCT00902460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979845|NCT00902460|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92979846|NCT00902460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979847|NCT00902460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979848|NCT00989079|Ertugliflozin|ertugliflozin|mesh-list
92979849|NCT00989079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92979850|NCT00989079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979852|NCT00989079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979853|NCT00809198|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92979854|NCT00809198|Hyaluronic Acid|hyaluronic acid|mesh-list
92979855|NCT00809198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92979856|NCT00809198|Immunologic Factors|immunologic factors|mesh-ancestor
92979857|NCT00809198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979858|NCT00809198|Viscosupplements|viscosupplements|mesh-ancestor
92979859|NCT00809198|Protective Agents|protective agents|mesh-ancestor
92979860|NCT00809198|Laxatives|laxatives|mesh-ancestor
92979861|NCT00809198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979862|NCT00986505|Lidocaine|lidocaine|mesh-list
92979863|NCT00986505|Anesthetics, Local|anesthetics, local|mesh-ancestor
92979864|NCT00986505|Anesthetics|anesthetics|mesh-ancestor
92979865|NCT00986505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979866|NCT00986505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979867|NCT00986505|Sensory System Agents|sensory system agents|mesh-ancestor
92979868|NCT00986505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979869|NCT00986505|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92979870|NCT00986505|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92979871|NCT00986505|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92979872|NCT00986505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92979873|NCT00986505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979874|NCT03667443|Inositol|inositol|mesh-list
92979875|NCT03667443|Vitamin B Complex|vitamin b complex|mesh-ancestor
92979876|NCT03667443|Vitamins|vitamins|mesh-ancestor
92979877|NCT03667443|Micronutrients|micronutrients|mesh-ancestor
92979878|NCT03667443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979879|NCT00902772|Lorazepam|lorazepam|mesh-list
92979880|NCT00902772|Anticonvulsants|anticonvulsants|mesh-ancestor
92979881|NCT00902772|Antiemetics|antiemetics|mesh-ancestor
92979882|NCT00902772|Autonomic Agents|autonomic agents|mesh-ancestor
92979883|NCT00902772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979884|NCT00902772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979885|NCT00902772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979886|NCT00902772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92979887|NCT00902772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92979888|NCT00902772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92979889|NCT00902772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92979890|NCT00902772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92979891|NCT00902772|GABA Modulators|gaba modulators|mesh-ancestor
92979892|NCT00902772|GABA Agents|gaba agents|mesh-ancestor
92979893|NCT00902772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979894|NCT00902772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979895|NCT00894660|Amodiaquine|amodiaquine|mesh-list
92979896|NCT00894660|Antimalarials|antimalarials|mesh-ancestor
92979897|NCT00894660|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92979898|NCT00894660|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92979899|NCT00894660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979900|NCT00721409|Letrozole|letrozole|mesh-list
92979901|NCT00721409|Palbociclib|palbociclib|mesh-list
92979902|NCT00721409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979903|NCT00721409|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92979904|NCT00721409|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92979905|NCT00721409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979906|NCT00721409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979907|NCT00721409|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92979908|NCT00721409|Hormone Antagonists|hormone antagonists|mesh-ancestor
92979909|NCT00721409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979910|NCT00721409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979911|NCT00721409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979912|NCT00542997|Immunoglobulins|immunoglobulins|mesh-list
92979913|NCT00542997|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92979914|NCT00542997|Antibodies|antibodies|mesh-list
92979915|NCT00542997|Immunologic Factors|immunologic factors|mesh-ancestor
92979916|NCT00542997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979917|NCT00903084|Tenofovir|tenofovir|mesh-list
92979918|NCT00903084|Antiviral Agents|antiviral agents|mesh-ancestor
92979919|NCT00903084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979920|NCT00903084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92979921|NCT00903084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92979922|NCT00903084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979923|NCT00903084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979924|NCT00903084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92979925|NCT00903084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92979926|NCT02541006|Tiotropium Bromide|tiotropium bromide|mesh-list
92979927|NCT02541006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92979928|NCT02541006|Autonomic Agents|autonomic agents|mesh-ancestor
92979929|NCT02541006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979930|NCT02541006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979931|NCT02541006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92979932|NCT02541006|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979933|NCT02541006|Parasympatholytics|parasympatholytics|mesh-ancestor
92979934|NCT02541006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92979935|NCT02541006|Cholinergic Agents|cholinergic agents|mesh-ancestor
92979936|NCT02541006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979937|NCT02541006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979938|NCT02591771|Epinephrine|epinephrine|mesh-list
92979939|NCT02591771|Racepinephrine|racepinephrine|mesh-list
92979940|NCT02591771|Epinephryl borate|epinephryl borate|mesh-list
92979941|NCT02591771|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92979942|NCT02591771|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92979943|NCT02591771|Adrenergic Agents|adrenergic agents|mesh-ancestor
92979944|NCT02591771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92979945|NCT02591771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979946|NCT02591771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979947|NCT02591771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92979948|NCT02591771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92979949|NCT02591771|Autonomic Agents|autonomic agents|mesh-ancestor
92979950|NCT02591771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979951|NCT02591771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92979952|NCT02591771|Respiratory System Agents|respiratory system agents|mesh-ancestor
92979953|NCT02591771|Mydriatics|mydriatics|mesh-ancestor
92979954|NCT02591771|Sympathomimetics|sympathomimetics|mesh-ancestor
92979955|NCT02591771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92979956|NCT00986817|Terlipressin|terlipressin|mesh-list
92979957|NCT00986817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92979958|NCT00986817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92979959|NCT00572832|Vaccines|vaccines|mesh-list
92979960|NCT00572832|Immunologic Factors|immunologic factors|mesh-ancestor
92979961|NCT00572832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979962|NCT02591849|Glucagon|glucagon|mesh-list
92979963|NCT02591849|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92979964|NCT02591849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92979965|NCT02591849|Hormones|hormones|mesh-ancestor
92979966|NCT02591849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92979967|NCT02591849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979968|NCT02591849|Incretins|incretins|mesh-ancestor
92979969|NCT00898794|Bevacizumab|bevacizumab|mesh-list
92979970|NCT00898794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92979971|NCT00898794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92979972|NCT00898794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92979973|NCT00898794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92979974|NCT00898794|Growth Substances|growth substances|mesh-ancestor
92979975|NCT00898794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979976|NCT00898794|Growth Inhibitors|growth inhibitors|mesh-ancestor
92979978|NCT04086719|Deucravacitinib|deucravacitinib|mesh-list
92979979|NCT04086719|Antimalarials|antimalarials|mesh-ancestor
92979980|NCT04086719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92979981|NCT04086719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92979982|NCT04086719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92979983|NCT04086719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92979984|NCT04086719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92979985|NCT04086719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92979986|NCT04086719|Dermatologic Agents|dermatologic agents|mesh-ancestor
92979987|NCT04086719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92979988|NCT00898950|Aspirin|aspirin|mesh-list
92979989|NCT00898950|Salicylic Acid|salicylic acid|mesh-list
92979990|NCT00898950|Salicylates|salicylates|mesh-list
92979991|NCT00898950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92979992|NCT00898950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92979993|NCT00898950|Analgesics|analgesics|mesh-ancestor
92979994|NCT00898950|Sensory System Agents|sensory system agents|mesh-ancestor
92979995|NCT00898950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92979996|NCT00898950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92979997|NCT00898950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92979998|NCT00898950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92979999|NCT00898950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92980000|NCT00898950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92980001|NCT00898950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980002|NCT00898950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92980003|NCT00898950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92980004|NCT00898950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980005|NCT00898950|Antipyretics|antipyretics|mesh-ancestor
92980006|NCT00898950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980007|NCT00898950|Antifungal Agents|antifungal agents|mesh-ancestor
92980008|NCT00898950|Keratolytic Agents|keratolytic agents|mesh-ancestor
92980009|NCT00898950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92980010|NCT03622515|Anesthetics|anesthetics|mesh-list
92980011|NCT03622515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980012|NCT03622515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980013|NCT05279235|Favipiravir|favipiravir|mesh-list
92980014|NCT05279235|Antiviral Agents|antiviral agents|mesh-ancestor
92980015|NCT05279235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980016|NCT00229723|Gefitinib|gefitinib|mesh-list
92980017|NCT00229723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980018|NCT00229723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980019|NCT00229723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980020|NCT00229723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980021|NCT04035798|Memantine|memantine|mesh-list
92980022|NCT04035798|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92980023|NCT04035798|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92980024|NCT04035798|Dopamine Agents|dopamine agents|mesh-ancestor
92980025|NCT04035798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980026|NCT04035798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980027|NCT04035798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980028|NCT04035798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92980029|NCT04035798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92980030|NCT01075477|Rituximab|rituximab|mesh-list
92980031|NCT01075477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980032|NCT01075477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980033|NCT01075477|Immunologic Factors|immunologic factors|mesh-ancestor
92980034|NCT01075477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980035|NCT01075477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980036|NCT01075555|Sorafenib|sorafenib|mesh-list
92980037|NCT01075555|Pravastatin|pravastatin|mesh-list
92980038|NCT01075555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980039|NCT01075555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980040|NCT01075555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980041|NCT01075555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980042|NCT01075555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92980043|NCT01075555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92980044|NCT01075555|Antimetabolites|antimetabolites|mesh-ancestor
92980045|NCT01075555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92980046|NCT01075555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92980047|NCT00627926|Interferons|interferons|mesh-list
92980048|NCT00627926|Ribavirin|ribavirin|mesh-list
92980049|NCT00627926|Interferon-alpha|interferon-alpha|mesh-list
92980050|NCT00627926|Interferon alpha-2|interferon alpha-2|mesh-list
92980051|NCT00627926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92980052|NCT00627926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980053|NCT00627926|Antiviral Agents|antiviral agents|mesh-ancestor
92980054|NCT00627926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980055|NCT00627926|Antimetabolites|antimetabolites|mesh-ancestor
92980056|NCT00627926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980057|NCT00627926|Immunologic Factors|immunologic factors|mesh-ancestor
92980058|NCT00627926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980059|NCT00228553|Modafinil|modafinil|mesh-list
92980060|NCT00228553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92980061|NCT00228553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980062|NCT00228553|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92980063|NCT00228553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92980064|NCT00228553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92980065|NCT00228553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980066|NCT00922506|Doxazosin|doxazosin|mesh-list
92980067|NCT00922506|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92980068|NCT00922506|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92980069|NCT00922506|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92980070|NCT00922506|Cholinergic Agents|cholinergic agents|mesh-ancestor
92980071|NCT00922506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980072|NCT00922506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980073|NCT00922506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980074|NCT00922506|Urological Agents|urological agents|mesh-ancestor
92980075|NCT00922506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92980076|NCT00922506|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92980077|NCT00922506|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92980078|NCT00922506|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92980079|NCT00922506|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980080|NCT00816140|Clarithromycin|clarithromycin|mesh-list
92980081|NCT00816140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92980082|NCT00816140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980083|NCT00816140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92980084|NCT00816140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980085|NCT00816140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980086|NCT00816140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92980087|NCT00816140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92980088|NCT00895128|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92980089|NCT00895128|Dasatinib|dasatinib|mesh-list
92980090|NCT00895128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980091|NCT00895128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980092|NCT00895128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980093|NCT00895128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980094|NCT00903942|Paclitaxel|paclitaxel|mesh-list
92980095|NCT00903942|Carboplatin|carboplatin|mesh-list
92980096|NCT00903942|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92980097|NCT00903942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92980098|NCT00903942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980099|NCT00903942|Tubulin Modulators|tubulin modulators|mesh-ancestor
92980100|NCT00903942|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980101|NCT00903942|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980102|NCT00903942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980103|NCT00904020|Lidocaine|lidocaine|mesh-list
92980104|NCT00904020|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980105|NCT00904020|Anesthetics|anesthetics|mesh-ancestor
92980106|NCT00904020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980107|NCT00904020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980108|NCT00904020|Sensory System Agents|sensory system agents|mesh-ancestor
92980109|NCT00904020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980110|NCT00904020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92980111|NCT00904020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92980112|NCT00904020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92980113|NCT00904020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92980114|NCT00904020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980115|NCT00895362|Cetuximab|cetuximab|mesh-list
92980116|NCT00895362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92980117|NCT00895362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980118|NCT00895362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980119|NCT00895362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980120|NCT00895362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980121|NCT00895362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980122|NCT00904098|Frovatriptan|frovatriptan|mesh-list
92980123|NCT00904098|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92980124|NCT00904098|Serotonin Agents|serotonin agents|mesh-ancestor
92980125|NCT00904098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980126|NCT00904098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980127|NCT00904098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980128|NCT00904176|Dapagliflozin|dapagliflozin|mesh-list
92980130|NCT00904176|Warfarin|warfarin|mesh-list
92980131|NCT00904176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92980132|NCT00904176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980133|NCT00904176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92980134|NCT00904176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980135|NCT00904176|Anticoagulants|anticoagulants|mesh-ancestor
92980136|NCT00904176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92980137|NCT00904176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92980138|NCT00904176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980139|NCT00904176|Protective Agents|protective agents|mesh-ancestor
92980140|NCT02540070|Ketorolac|ketorolac|mesh-list
92980141|NCT02540070|Epinephrine|epinephrine|mesh-list
92980142|NCT02540070|Dexmedetomidine|dexmedetomidine|mesh-list
92980143|NCT02540070|Morphine|morphine|mesh-list
92980144|NCT02540070|Ropivacaine|ropivacaine|mesh-list
92980145|NCT02540070|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92980146|NCT02540070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980147|NCT02540070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980148|NCT02540070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92980149|NCT02540070|Analgesics|analgesics|mesh-ancestor
92980150|NCT02540070|Sensory System Agents|sensory system agents|mesh-ancestor
92980151|NCT02540070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980152|NCT02540070|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92980153|NCT02540070|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92980154|NCT02540070|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92980155|NCT02540070|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980156|NCT02540070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980157|NCT02540070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980158|NCT02540070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92980159|NCT02540070|Narcotics|narcotics|mesh-ancestor
92980160|NCT02540070|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980161|NCT02540070|Anesthetics|anesthetics|mesh-ancestor
92980162|NCT02540070|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92980163|NCT02540070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92980164|NCT02540070|Autonomic Agents|autonomic agents|mesh-ancestor
92980165|NCT02540070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92980166|NCT02540070|Respiratory System Agents|respiratory system agents|mesh-ancestor
92980167|NCT02540070|Mydriatics|mydriatics|mesh-ancestor
92980168|NCT02540070|Sympathomimetics|sympathomimetics|mesh-ancestor
92980169|NCT02540070|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92980170|NCT02540070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92980171|NCT02540070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980172|NCT02540070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980173|NCT02540070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92980174|NCT02540070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980175|NCT00905814|Axitinib|axitinib|mesh-list
92980176|NCT00905814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980177|NCT00905814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980178|NCT00905814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980179|NCT00905814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980180|NCT00900510|Trimethoprim|trimethoprim|mesh-list
92980181|NCT00900510|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92980182|NCT00900510|Sulfamethoxazole|sulfamethoxazole|mesh-list
92980183|NCT00900510|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92980184|NCT00900510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980185|NCT00900510|Antimalarials|antimalarials|mesh-ancestor
92980186|NCT00900510|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92980187|NCT00900510|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92980188|NCT00900510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92980189|NCT00900510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980190|NCT00900510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980191|NCT00900510|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92980192|NCT00900510|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92980193|NCT00900510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92980194|NCT00900510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92980195|NCT00160693|Certolizumab Pegol|certolizumab pegol|mesh-list
92980196|NCT00160693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92980197|NCT00160693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980198|NCT00160693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980199|NCT00160693|Immunologic Factors|immunologic factors|mesh-ancestor
92980200|NCT00160693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980201|NCT00160693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980202|NCT00906048|Levofloxacin|levofloxacin|mesh-list
92980203|NCT00906048|Rifampin|rifampin|mesh-list
92980204|NCT00906048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92980205|NCT00906048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980206|NCT00906048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92980207|NCT00906048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92980208|NCT00906048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92980209|NCT00906048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980210|NCT00906048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980211|NCT00906048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980212|NCT00906048|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92980213|NCT00906048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92980214|NCT00906048|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92980215|NCT00906048|Antitubercular Agents|antitubercular agents|mesh-ancestor
92980216|NCT00906048|Leprostatic Agents|leprostatic agents|mesh-ancestor
92980217|NCT00906048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92980218|NCT00906048|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92980219|NCT00906048|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92980220|NCT00906048|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92980221|NCT00906048|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92980222|NCT00906048|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92980223|NCT00906048|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92980225|NCT00906126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92980226|NCT00906126|Abortifacient Agents|abortifacient agents|mesh-ancestor
92980227|NCT00906126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92980228|NCT00906126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980229|NCT00906126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92980230|NCT00906126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92980231|NCT00906126|Oxytocics|oxytocics|mesh-ancestor
92980232|NCT00900744|Tamoxifen|tamoxifen|mesh-list
92980233|NCT00900744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92980234|NCT00900744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92980235|NCT00900744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92980236|NCT00900744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980237|NCT00900744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92980238|NCT00900744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980239|NCT00900744|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92980240|NCT00900744|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92980241|NCT00900744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92980242|NCT00643760|Pregabalin|pregabalin|mesh-list
92980243|NCT00643760|Gabapentin|gabapentin|mesh-list
92980244|NCT00643760|Analgesics|analgesics|mesh-ancestor
92980245|NCT00643760|Sensory System Agents|sensory system agents|mesh-ancestor
92980246|NCT00643760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980247|NCT00643760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980248|NCT00643760|Anticonvulsants|anticonvulsants|mesh-ancestor
92980249|NCT00643760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92980250|NCT00643760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92980251|NCT00643760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980252|NCT00643760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92980253|NCT00643760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92980254|NCT00643760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92167237|NCT00227253|Hormones|hormones|mesh-list
92980255|NCT00643760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980256|NCT00643760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92980257|NCT00643760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92980258|NCT00643760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92980259|NCT00643760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980260|NCT00643760|Antimanic Agents|antimanic agents|mesh-ancestor
92980261|NCT00904644|Raltegravir Potassium|raltegravir potassium|mesh-list
92980262|NCT00904644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92980263|NCT00904644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92980264|NCT00904644|Antiviral Agents|antiviral agents|mesh-ancestor
92980265|NCT00904644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980266|NCT00904644|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92980267|NCT00904644|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92980268|NCT00904644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980269|NCT00904644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980270|NCT00906360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92980271|NCT00906360|Cetuximab|cetuximab|mesh-list
92980272|NCT00906360|Sunitinib|sunitinib|mesh-list
92980274|NCT00906360|Immunoglobulins|immunoglobulins|mesh-list
92980275|NCT00906360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92980276|NCT00906360|Immunologic Factors|immunologic factors|mesh-ancestor
92980277|NCT00906360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980278|NCT00906360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980279|NCT00906360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92980280|NCT00906360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92980281|NCT00906360|Growth Substances|growth substances|mesh-ancestor
92980282|NCT00906360|Growth Inhibitors|growth inhibitors|mesh-ancestor
92980283|NCT00906360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980284|NCT00906360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980285|NCT00906360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980286|NCT00643604|Treprostinil|treprostinil|mesh-list
92980287|NCT00643604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92980288|NCT00603798|Imiquimod|imiquimod|mesh-list
92980289|NCT00603798|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92980290|NCT00603798|Immunologic Factors|immunologic factors|mesh-ancestor
92980291|NCT00603798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980292|NCT00603798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980293|NCT00603798|Interferon Inducers|interferon inducers|mesh-ancestor
92980294|NCT00819572|Antibodies|antibodies|mesh-list
92980295|NCT00819572|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
92980296|NCT00819572|Immunologic Factors|immunologic factors|mesh-ancestor
92980297|NCT00819572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980298|NCT00630812|Mannitol|mannitol|mesh-list
92980299|NCT00630812|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92980300|NCT00630812|Diuretics|diuretics|mesh-ancestor
92980301|NCT00630812|Natriuretic Agents|natriuretic agents|mesh-ancestor
92980302|NCT00630812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980303|NCT00906516|Bevacizumab|bevacizumab|mesh-list
92980304|NCT00906516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980305|NCT00906516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980306|NCT00906516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92980307|NCT00906516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92980308|NCT00906516|Growth Substances|growth substances|mesh-ancestor
92980309|NCT00906516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980310|NCT00906516|Growth Inhibitors|growth inhibitors|mesh-ancestor
92980311|NCT00629798|Fludarabine|fludarabine|mesh-list
92980312|NCT00629798|Melphalan|melphalan|mesh-list
92980313|NCT00629798|Busulfan|busulfan|mesh-list
92980314|NCT00629798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92980315|NCT00629798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980316|NCT00629798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980317|NCT00629798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980318|NCT00629798|Immunologic Factors|immunologic factors|mesh-ancestor
92980319|NCT00629798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980320|NCT00629798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92980321|NCT00629798|Alkylating Agents|alkylating agents|mesh-ancestor
92980322|NCT00629798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92980323|NCT00160615|Levetiracetam|levetiracetam|mesh-list
92980324|NCT00160615|Anticonvulsants|anticonvulsants|mesh-ancestor
92980325|NCT00160615|Nootropic Agents|nootropic agents|mesh-ancestor
92980326|NCT00906594|Latanoprost|latanoprost|mesh-list
92980327|NCT00906594|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92980328|NCT00906594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92980329|NCT03970759|Fluorides|fluorides|mesh-list
92980330|NCT03970759|Tin Fluorides|tin fluorides|mesh-list
92980331|NCT03970759|Cariostatic Agents|cariostatic agents|mesh-ancestor
92980332|NCT03970759|Protective Agents|protective agents|mesh-ancestor
92980333|NCT03970759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980334|NCT00905190|Ondansetron|ondansetron|mesh-list
92980335|NCT00905190|Antiemetics|antiemetics|mesh-ancestor
92980336|NCT00905190|Autonomic Agents|autonomic agents|mesh-ancestor
92980337|NCT00905190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980338|NCT00905190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980339|NCT00905190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92980340|NCT00905190|Antipruritics|antipruritics|mesh-ancestor
92980341|NCT00905190|Dermatologic Agents|dermatologic agents|mesh-ancestor
92980342|NCT00905190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92980343|NCT00905190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92980344|NCT00905190|Serotonin Agents|serotonin agents|mesh-ancestor
92980345|NCT00905190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980346|NCT00905190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980347|NCT00905502|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92625766|NCT00161681|Levonorgestrel|levonorgestrel|mesh-list
92980348|NCT00604500|Mometasone Furoate|mometasone furoate|mesh-list
92980349|NCT00604500|Formoterol Fumarate|formoterol fumarate|mesh-list
92980350|NCT00604500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92980351|NCT00604500|Autonomic Agents|autonomic agents|mesh-ancestor
92980352|NCT00604500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980353|NCT00604500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980354|NCT00604500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92980355|NCT00604500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92980356|NCT00604500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92980357|NCT00604500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92980358|NCT00604500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92980359|NCT00604500|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980360|NCT00604500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980361|NCT00604500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980362|NCT00604500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980363|NCT00604500|Dermatologic Agents|dermatologic agents|mesh-ancestor
92980364|NCT00604500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92980365|NCT00627458|Vaccines|vaccines|mesh-list
92980366|NCT00627458|Immunologic Factors|immunologic factors|mesh-ancestor
92980367|NCT00627458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980368|NCT00909168|Gemtuzumab|gemtuzumab|mesh-list
92980369|NCT00909168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980370|NCT00909168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980371|NCT00909168|Immunotoxins|immunotoxins|mesh-ancestor
92980372|NCT00909168|Immunoconjugates|immunoconjugates|mesh-ancestor
92980373|NCT00909168|Immunologic Factors|immunologic factors|mesh-ancestor
92980374|NCT00909168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980375|NCT00816218|Pioglitazone|pioglitazone|mesh-list
92980376|NCT00816218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92980377|NCT00816218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980378|NCT00819728|Docetaxel|docetaxel|mesh-list
92980379|NCT00819728|Irinotecan|irinotecan|mesh-list
92980380|NCT00819728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980381|NCT00819728|Tubulin Modulators|tubulin modulators|mesh-ancestor
92980382|NCT00819728|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980383|NCT00819728|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980384|NCT00819728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980385|NCT00819728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92980386|NCT00819728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92980387|NCT00819728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980388|NCT00906828|Levodopa|levodopa|mesh-list
92980389|NCT00906828|Carbidopa|carbidopa|mesh-list
92980390|NCT00906828|Entacapone|entacapone|mesh-list
92980391|NCT00906828|Tolcapone|tolcapone|mesh-list
92980392|NCT00906828|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92980393|NCT00906828|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92980394|NCT00906828|Dopamine Agents|dopamine agents|mesh-ancestor
92980395|NCT00906828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980396|NCT00906828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980397|NCT00906828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980398|NCT00906828|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92980399|NCT00906828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980400|NCT00906828|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92980401|NCT00819806|Cyclophosphamide|cyclophosphamide|mesh-list
92980402|NCT00819806|Vaccines|vaccines|mesh-list
92980403|NCT00819806|Immunologic Factors|immunologic factors|mesh-ancestor
92167243|NCT02730715|Thymoglobulin|thymoglobulin|mesh-list
92980404|NCT00819806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980405|NCT00819806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980406|NCT00819806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980407|NCT00819806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92980408|NCT00819806|Alkylating Agents|alkylating agents|mesh-ancestor
92980409|NCT00819806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980410|NCT00819806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980411|NCT00819806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92980412|NCT00909402|Capecitabine|capecitabine|mesh-list
92980413|NCT00909402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980414|NCT00909402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92980415|NCT00909402|Antimetabolites|antimetabolites|mesh-ancestor
92980416|NCT00909402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980417|NCT02537964|Chlorhexidine|chlorhexidine|mesh-list
92980418|NCT02537964|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92980419|NCT02537964|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92980420|NCT02537964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980421|NCT02537964|Disinfectants|disinfectants|mesh-ancestor
92625838|NCT00185133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92980422|NCT02537964|Dermatologic Agents|dermatologic agents|mesh-ancestor
92980423|NCT00821444|Ziprasidone|ziprasidone|mesh-list
92980424|NCT00821444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92980425|NCT00821444|Serotonin Agents|serotonin agents|mesh-ancestor
92980426|NCT00821444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980427|NCT00821444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980428|NCT00821444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980429|NCT00821444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92980430|NCT00821444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92980431|NCT00821444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980432|NCT00821444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92980433|NCT00821444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92980434|NCT00821444|Dopamine Agents|dopamine agents|mesh-ancestor
92980435|NCT00909558|Immunomodulating Agents|immunomodulating agents|mesh-list
92980436|NCT00909558|Immunologic Factors|immunologic factors|mesh-ancestor
92980437|NCT00909558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980438|NCT00819962|Bupivacaine|bupivacaine|mesh-list
92980439|NCT00819962|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980440|NCT00819962|Anesthetics|anesthetics|mesh-ancestor
92980441|NCT00819962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980442|NCT00819962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980443|NCT00819962|Sensory System Agents|sensory system agents|mesh-ancestor
92980444|NCT00819962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980445|NCT00820118|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92980446|NCT00820118|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92980447|NCT00820118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92980448|NCT00820118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92980449|NCT00820118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980450|NCT00820118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980451|NCT00820118|Antiviral Agents|antiviral agents|mesh-ancestor
92980452|NCT00820118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980453|NCT00820118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92980454|NCT00820118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92980455|NCT00820118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92980456|NCT00820118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92980457|NCT00820118|Protease Inhibitors|protease inhibitors|mesh-ancestor
92980458|NCT00927498|Cytarabine|cytarabine|mesh-list
92980459|NCT00927498|Daunorubicin|daunorubicin|mesh-list
92980460|NCT00927498|Gemtuzumab|gemtuzumab|mesh-list
92980461|NCT00927498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92980462|NCT00927498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980463|NCT00927498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92980464|NCT00927498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92980465|NCT00927498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980466|NCT00927498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980467|NCT00927498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980468|NCT00927498|Immunotoxins|immunotoxins|mesh-ancestor
92980469|NCT00927498|Immunoconjugates|immunoconjugates|mesh-ancestor
92980470|NCT00927498|Immunologic Factors|immunologic factors|mesh-ancestor
92980471|NCT00927498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980472|NCT00927498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92980473|NCT00927498|Antimetabolites|antimetabolites|mesh-ancestor
92980474|NCT00927498|Antiviral Agents|antiviral agents|mesh-ancestor
92980475|NCT00927498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980476|NCT00927498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980477|NCT00159913|Sildenafil Citrate|sildenafil citrate|mesh-list
92980478|NCT00159913|Citric Acid|citric acid|mesh-list
92980479|NCT00159913|Sodium Citrate|sodium citrate|mesh-list
92980480|NCT00159913|Anticoagulants|anticoagulants|mesh-ancestor
92980481|NCT00159913|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92980482|NCT00159913|Chelating Agents|chelating agents|mesh-ancestor
92980483|NCT00159913|Sequestering Agents|sequestering agents|mesh-ancestor
92980484|NCT00159913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980485|NCT00159913|Vasodilator Agents|vasodilator agents|mesh-ancestor
92980486|NCT00159913|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92980487|NCT00159913|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92980488|NCT00159913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980489|NCT00159913|Urological Agents|urological agents|mesh-ancestor
92980490|NCT05498259|Rituximab|rituximab|mesh-list
92980491|NCT05498259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980492|NCT05498259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980493|NCT05498259|Immunologic Factors|immunologic factors|mesh-ancestor
92980494|NCT05498259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980495|NCT05498259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980496|NCT00821600|Risperidone|risperidone|mesh-list
92980497|NCT00821600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92980498|NCT00821600|Serotonin Agents|serotonin agents|mesh-ancestor
92625915|NCT00551317|Darapladib|darapladib|mesh-list
92980499|NCT00821600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980500|NCT00821600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980501|NCT00821600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980502|NCT00821600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92980503|NCT00821600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92980504|NCT00821600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980505|NCT00821600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92980506|NCT00821600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92980508|NCT00987207|Cyclosporine|cyclosporine|mesh-list
92980509|NCT00987207|Cyclosporins|cyclosporins|mesh-list
92980510|NCT00987207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980511|NCT00987207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980512|NCT00987207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980513|NCT00987207|Immunologic Factors|immunologic factors|mesh-ancestor
92980514|NCT00987207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980515|NCT00987207|Antifungal Agents|antifungal agents|mesh-ancestor
92980516|NCT00987207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980517|NCT00987207|Dermatologic Agents|dermatologic agents|mesh-ancestor
92980518|NCT00987207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980519|NCT00987207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92980520|NCT00604188|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92980521|NCT00604188|Buprenorphine|buprenorphine|mesh-list
92980522|NCT00604188|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92980523|NCT00604188|Narcotics|narcotics|mesh-ancestor
92980524|NCT00604188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980525|NCT00604188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980526|NCT00604188|Analgesics|analgesics|mesh-ancestor
92980527|NCT00604188|Sensory System Agents|sensory system agents|mesh-ancestor
92980528|NCT00604188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980529|NCT00604188|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92980530|NCT00820352|Bosentan|bosentan|mesh-list
92980531|NCT00820352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92980532|NCT00820352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92980533|NCT00820352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980534|NCT00927654|Iloprost|iloprost|mesh-list
92980535|NCT00927654|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92980536|NCT00927654|Vasodilator Agents|vasodilator agents|mesh-ancestor
92980537|NCT00927732|Quinidine|quinidine|mesh-list
92980538|NCT00927732|Hydroquinidine|hydroquinidine|mesh-list
92980539|NCT00927732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92980540|NCT00927732|Parasympatholytics|parasympatholytics|mesh-ancestor
92980541|NCT00927732|Autonomic Agents|autonomic agents|mesh-ancestor
92980542|NCT00927732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980543|NCT00927732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980544|NCT00927732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92980545|NCT00927732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92980546|NCT00927732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980547|NCT00927732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980548|NCT00927732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980549|NCT00927732|Antimalarials|antimalarials|mesh-ancestor
92980550|NCT00927732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92980551|NCT00927732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92980552|NCT00927732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980553|NCT00927732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980554|NCT00927732|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92980555|NCT00927732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92980556|NCT00927732|Cholinergic Agents|cholinergic agents|mesh-ancestor
92980557|NCT00927732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92980558|NCT00927732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92980559|NCT00927732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92980560|NCT00927732|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92980561|NCT00927732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92980562|NCT00227539|Pemetrexed|pemetrexed|mesh-list
92980563|NCT00227539|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92980564|NCT00227539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980565|NCT00227539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980566|NCT00227539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980567|NCT00227539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92980568|NCT00227539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92980569|NCT00227539|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92980570|NCT02936622|Paclitaxel|paclitaxel|mesh-list
92980571|NCT02936622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92980572|NCT02936622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92980573|NCT02936622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980575|NCT02936622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980576|NCT02936622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980577|NCT02936622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980578|NCT00927966|Everolimus|everolimus|mesh-list
92980579|NCT00927966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92980580|NCT00927966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980581|NCT00927966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980582|NCT00927966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980583|NCT00927966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980584|NCT00927966|Immunologic Factors|immunologic factors|mesh-ancestor
92980585|NCT00927966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980586|NCT00927966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980587|NCT00227305|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92980588|NCT00227305|Antidepressive Agents|antidepressive agents|mesh-ancestor
92980589|NCT00227305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92980590|NCT00227305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92980591|NCT00227305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92980592|NCT00227305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980593|NCT00227305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980594|NCT00720941|Sunitinib|sunitinib|mesh-list
92980595|NCT00720941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980596|NCT00720941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92980597|NCT00720941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92980598|NCT00720941|Growth Substances|growth substances|mesh-ancestor
92980599|NCT00720941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980600|NCT00720941|Growth Inhibitors|growth inhibitors|mesh-ancestor
92980601|NCT00720941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980602|NCT00720941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980603|NCT00720941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980604|NCT00924222|Propofol|propofol|mesh-list
92980605|NCT00924222|Sevoflurane|sevoflurane|mesh-list
92980606|NCT00924222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92980607|NCT00924222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980608|NCT00924222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980609|NCT00924222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92980610|NCT00924222|Anesthetics, General|anesthetics, general|mesh-ancestor
92980611|NCT00924222|Anesthetics|anesthetics|mesh-ancestor
92980612|NCT00924222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92980613|NCT00924222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92980614|NCT01075711|Prednisone|prednisone|mesh-list
92980615|NCT01075711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980616|NCT01075711|Glucocorticoids|glucocorticoids|mesh-ancestor
92980617|NCT01075711|Hormones|hormones|mesh-ancestor
92980618|NCT01075711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92980619|NCT01075711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980620|NCT01075711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92980621|NCT01075711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980622|NCT01073371|Prilocaine|prilocaine|mesh-list
92980623|NCT01073371|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980624|NCT01073371|Anesthetics|anesthetics|mesh-ancestor
92980625|NCT01073371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980626|NCT01073371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980627|NCT01073371|Sensory System Agents|sensory system agents|mesh-ancestor
92980628|NCT01073371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980629|NCT03970213|Tranexamic Acid|tranexamic acid|mesh-list
92980630|NCT03970213|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92980631|NCT03970213|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92980632|NCT03970213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980633|NCT03970213|Hemostatics|hemostatics|mesh-ancestor
92980634|NCT03970213|Coagulants|coagulants|mesh-ancestor
92980635|NCT00821834|Ticlopidine|ticlopidine|mesh-list
92980636|NCT00821834|Clopidogrel|clopidogrel|mesh-list
92980637|NCT00821834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92980638|NCT00821834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92980639|NCT00821834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92980640|NCT00821834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92980641|NCT00821834|Purinergic Agents|purinergic agents|mesh-ancestor
92980642|NCT00821834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980643|NCT00821834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980644|NCT00821834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626059|NCT00162227|Efavirenz|efavirenz|mesh-list
92980645|NCT00821834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92980646|NCT00821834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92980647|NCT00821834|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92980648|NCT00821834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92980649|NCT00821834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980651|NCT04005417|Tin Fluorides|tin fluorides|mesh-list
92980652|NCT04005417|Cariostatic Agents|cariostatic agents|mesh-ancestor
92980653|NCT04005417|Protective Agents|protective agents|mesh-ancestor
92980654|NCT04005417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980655|NCT01073839|Gemcitabine|gemcitabine|mesh-list
92980656|NCT01073839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980657|NCT01073839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92980658|NCT01073839|Antimetabolites|antimetabolites|mesh-ancestor
92980659|NCT01073839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980660|NCT00585533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92980661|NCT00585533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980662|NCT00585533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980663|NCT00585533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980664|NCT00585533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980665|NCT00628862|Formoterol Fumarate|formoterol fumarate|mesh-list
92980666|NCT00628862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92980667|NCT00628862|Autonomic Agents|autonomic agents|mesh-ancestor
92980668|NCT00628862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980669|NCT00628862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980670|NCT00628862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92980671|NCT00628862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92980672|NCT00628862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92980673|NCT00628862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92980674|NCT00628862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92980675|NCT00628862|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980676|NCT00628862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980677|NCT00628862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980678|NCT05420727|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92980679|NCT05420727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92980680|NCT05420727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980681|NCT00987441|Sufentanil|sufentanil|mesh-list
92980682|NCT00987441|Dsuvia|dsuvia|mesh-list
92980683|NCT00987441|Ropivacaine|ropivacaine|mesh-list
92980684|NCT00987441|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980685|NCT00987441|Anesthetics|anesthetics|mesh-ancestor
92980686|NCT00987441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980687|NCT00987441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980688|NCT00987441|Sensory System Agents|sensory system agents|mesh-ancestor
92980689|NCT00987441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980690|NCT00987441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92980691|NCT00987441|Narcotics|narcotics|mesh-ancestor
92980692|NCT00987441|Analgesics|analgesics|mesh-ancestor
92980693|NCT00987441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92980694|NCT00987441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92980695|NCT00987441|Anesthetics, General|anesthetics, general|mesh-ancestor
92980696|NCT00584987|Fluticasone|fluticasone|mesh-list
92980697|NCT00584987|Xhance|xhance|mesh-list
92980698|NCT00584987|Phenylephrine|phenylephrine|mesh-list
92980699|NCT00584987|Oxymetazoline|oxymetazoline|mesh-list
92980700|NCT00584987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980701|NCT00584987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92980702|NCT00584987|Autonomic Agents|autonomic agents|mesh-ancestor
92980703|NCT00584987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980704|NCT00584987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980705|NCT00584987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92980706|NCT00584987|Respiratory System Agents|respiratory system agents|mesh-ancestor
92980707|NCT00584987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92980708|NCT00584987|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92980709|NCT00584987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92980710|NCT00584987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92980711|NCT00584987|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980712|NCT00584987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980713|NCT00584987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980714|NCT00584987|Sympathomimetics|sympathomimetics|mesh-ancestor
92980715|NCT00584987|Nasal Decongestants|nasal decongestants|mesh-ancestor
92980716|NCT00584987|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92980717|NCT00584987|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92980718|NCT00584987|Mydriatics|mydriatics|mesh-ancestor
92980719|NCT00584987|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92626133|NCT00162383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980720|NCT00584987|Protective Agents|protective agents|mesh-ancestor
92980721|NCT00727961|Doxorubicin|doxorubicin|mesh-list
92980722|NCT00727961|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92980723|NCT00727961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92980724|NCT00727961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980725|NCT00727961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92980726|NCT00727961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92980727|NCT00727961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980728|NCT00727961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980729|NCT00568958|Naltrexone|naltrexone|mesh-list
92980730|NCT00568958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92980731|NCT00568958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92980732|NCT00568958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980733|NCT00568958|Sensory System Agents|sensory system agents|mesh-ancestor
92980734|NCT00568958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980735|NCT00821912|Docetaxel|docetaxel|mesh-list
92980736|NCT00821912|Capecitabine|capecitabine|mesh-list
92980737|NCT00821912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980738|NCT00821912|Tubulin Modulators|tubulin modulators|mesh-ancestor
92980739|NCT00821912|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980740|NCT00821912|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980741|NCT00821912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980742|NCT00821912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92980743|NCT00821912|Antimetabolites|antimetabolites|mesh-ancestor
92980744|NCT00727649|Loperamide|loperamide|mesh-list
92980745|NCT00727649|Antidiarrheals|antidiarrheals|mesh-list
92980746|NCT00727649|Psyllium|psyllium|mesh-list
92980747|NCT00727649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92980748|NCT00727649|Cathartics|cathartics|mesh-ancestor
92980749|NCT04006041|Paclitaxel|paclitaxel|mesh-list
92980750|NCT04006041|Cisplatin|cisplatin|mesh-list
92980751|NCT04006041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92980752|NCT04006041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980753|NCT04006041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92980754|NCT04006041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980755|NCT04006041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980756|NCT04006041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980757|NCT00225277|Pioglitazone|pioglitazone|mesh-list
92980758|NCT00225277|Glimepiride|glimepiride|mesh-list
92980759|NCT00225277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92980760|NCT00225277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980761|NCT00225277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92980762|NCT00225277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980763|NCT00225277|Immunologic Factors|immunologic factors|mesh-ancestor
92980764|NCT00821054|Lapatinib|lapatinib|mesh-list
92980765|NCT00821054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980766|NCT00821054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980767|NCT00821054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980768|NCT00821054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980769|NCT00567996|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92980770|NCT00567996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92980771|NCT00567996|Autonomic Agents|autonomic agents|mesh-ancestor
92980772|NCT00567996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980773|NCT00567996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980774|NCT00567996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92980775|NCT00567996|Respiratory System Agents|respiratory system agents|mesh-ancestor
92980776|NCT00567996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92980777|NCT00567996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92980778|NCT00567996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92980779|NCT00567996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980780|NCT00567996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980781|NCT00567996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980782|NCT04388319|Zonisamide|zonisamide|mesh-list
92980783|NCT04388319|Bupropion|bupropion|mesh-list
92980784|NCT04388319|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92980785|NCT04388319|Antidepressive Agents|antidepressive agents|mesh-ancestor
92980786|NCT04388319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92980787|NCT04388319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92980788|NCT04388319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92980789|NCT04388319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92980790|NCT04388319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980791|NCT04388319|Dopamine Agents|dopamine agents|mesh-ancestor
92980792|NCT04388319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980793|NCT04388319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980794|NCT04388319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92980795|NCT04388319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92980796|NCT04388319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980797|NCT04388319|Anticonvulsants|anticonvulsants|mesh-ancestor
92980798|NCT04388319|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92980799|NCT04388319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92980801|NCT04085627|Valsartan|valsartan|mesh-list
92980802|NCT04085627|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92980803|NCT04085627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92980804|NCT04085627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92980805|NCT04085627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92980806|NCT04085627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980807|NCT04085627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92980808|NCT04085627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980809|NCT04085627|Vasodilator Agents|vasodilator agents|mesh-ancestor
92980810|NCT04085627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92980811|NCT04085627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92980812|NCT04085393|Granisetron|granisetron|mesh-list
92980813|NCT04085393|Antiemetics|antiemetics|mesh-ancestor
92980814|NCT04085393|Autonomic Agents|autonomic agents|mesh-ancestor
92980815|NCT04085393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980816|NCT04085393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980817|NCT04085393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92980818|NCT04085393|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92980819|NCT04085393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92980820|NCT04085393|Serotonin Agents|serotonin agents|mesh-ancestor
92980821|NCT04085393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980822|NCT04085393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980823|NCT00717275|Temozolomide|temozolomide|mesh-list
92980824|NCT00717275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92980825|NCT00717275|Alkylating Agents|alkylating agents|mesh-ancestor
92980826|NCT00717275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980827|NCT00717275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980828|NCT04006353|Rifampin|rifampin|mesh-list
92980829|NCT04006353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92980830|NCT04006353|Antitubercular Agents|antitubercular agents|mesh-ancestor
92980831|NCT04006353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92980832|NCT04006353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980833|NCT04006353|Leprostatic Agents|leprostatic agents|mesh-ancestor
92980834|NCT04006353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92980835|NCT04006353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980836|NCT04006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980837|NCT04006353|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92980838|NCT04006353|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92980839|NCT04006353|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92980840|NCT04006353|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92980841|NCT04006353|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92980842|NCT04006353|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92980843|NCT01075789|Lidocaine|lidocaine|mesh-list
92980844|NCT01075789|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980845|NCT01075789|Anesthetics|anesthetics|mesh-ancestor
92980846|NCT01075789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980847|NCT01075789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980848|NCT01075789|Sensory System Agents|sensory system agents|mesh-ancestor
92980849|NCT01075789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980850|NCT01075789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92980851|NCT01075789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92980852|NCT01075789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92980853|NCT01075789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92980854|NCT01075789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980855|NCT00826046|Remestemcel-l|remestemcel-l|mesh-list
92980856|NCT00826046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980857|NCT00826046|Antiviral Agents|antiviral agents|mesh-ancestor
92980858|NCT00826046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980859|NCT00584909|Paclitaxel|paclitaxel|mesh-list
92980860|NCT00584909|Carboplatin|carboplatin|mesh-list
92980861|NCT00584909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92980862|NCT00584909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980863|NCT00584909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92980864|NCT00584909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980865|NCT00584909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980866|NCT00584909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980867|NCT03947099|Ketamine|ketamine|mesh-list
92980868|NCT03947099|Analgesics|analgesics|mesh-ancestor
92980869|NCT03947099|Sensory System Agents|sensory system agents|mesh-ancestor
92980870|NCT03947099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980871|NCT03947099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980872|NCT03947099|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92980873|NCT03947099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92980874|NCT03947099|Anesthetics, General|anesthetics, general|mesh-ancestor
92980875|NCT03947099|Anesthetics|anesthetics|mesh-ancestor
92980876|NCT03947099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980877|NCT03947099|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92980878|NCT03947099|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92980879|NCT03947099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980880|NCT03947099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980881|NCT05361915|Abivertinib|abivertinib|mesh-list
92980882|NCT05361915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92980883|NCT05361915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92980884|NCT05361915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980885|NCT00929058|Bevacizumab|bevacizumab|mesh-list
92980886|NCT00929058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92980887|NCT00929058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980888|NCT00929058|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92980889|NCT00929058|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92980890|NCT00929058|Growth Substances|growth substances|mesh-ancestor
92980891|NCT00929058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980892|NCT00929058|Growth Inhibitors|growth inhibitors|mesh-ancestor
92980893|NCT00907452|Thalidomide|thalidomide|mesh-list
92980894|NCT00907452|Dexamethasone|dexamethasone|mesh-list
92980895|NCT00907452|Prednisone|prednisone|mesh-list
92980896|NCT00907452|Lenalidomide|lenalidomide|mesh-list
92980897|NCT00907452|Melphalan|melphalan|mesh-list
92980898|NCT00907452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92980899|NCT00907452|Antiemetics|antiemetics|mesh-ancestor
92980900|NCT00907452|Autonomic Agents|autonomic agents|mesh-ancestor
92980901|NCT00907452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980902|NCT00907452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980903|NCT00907452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92980904|NCT00907452|Glucocorticoids|glucocorticoids|mesh-ancestor
92980905|NCT00907452|Hormones|hormones|mesh-ancestor
92980906|NCT00907452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92980907|NCT00907452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92980908|NCT00907452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980909|NCT00907452|Immunologic Factors|immunologic factors|mesh-ancestor
92980910|NCT00907452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92980911|NCT00907452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92980912|NCT00907452|Growth Substances|growth substances|mesh-ancestor
92980913|NCT00907452|Growth Inhibitors|growth inhibitors|mesh-ancestor
92980914|NCT00907452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92980915|NCT00907452|Alkylating Agents|alkylating agents|mesh-ancestor
92980916|NCT00907452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980917|NCT00907452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92980918|NCT00907452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980919|NCT00907452|Leprostatic Agents|leprostatic agents|mesh-ancestor
92980920|NCT00907452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92980921|NCT00907452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980922|NCT00717197|Capecitabine|capecitabine|mesh-list
92980923|NCT00717197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92980924|NCT00717197|Antimetabolites|antimetabolites|mesh-ancestor
92980925|NCT00717197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980926|NCT00717197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980927|NCT00925392|Doripenem|doripenem|mesh-list
92980928|NCT00925392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92980929|NCT00925392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92980930|NCT05315271|Ketamine|ketamine|mesh-list
92980931|NCT05315271|Bupivacaine|bupivacaine|mesh-list
92980932|NCT05315271|Anesthetics, Local|anesthetics, local|mesh-ancestor
92980933|NCT05315271|Anesthetics|anesthetics|mesh-ancestor
92980934|NCT05315271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92980935|NCT05315271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980936|NCT05315271|Sensory System Agents|sensory system agents|mesh-ancestor
92980937|NCT05315271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92980938|NCT05315271|Analgesics|analgesics|mesh-ancestor
92980939|NCT05315271|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92980940|NCT05315271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92980941|NCT05315271|Anesthetics, General|anesthetics, general|mesh-ancestor
92980942|NCT05315271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92980943|NCT05315271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92980944|NCT05315271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980945|NCT05315271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980946|NCT00147745|Insulin Glargine|insulin glargine|mesh-list
92980947|NCT00147745|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92980948|NCT00147745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92980949|NCT00147745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980950|NCT00147745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92980951|NCT00147745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92980952|NCT00147745|Antimetabolites|antimetabolites|mesh-ancestor
92980953|NCT00147745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980954|NCT00147745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92980955|NCT05313477|Ergocalciferols|ergocalciferols|mesh-list
92980956|NCT05313477|Vitamin D|vitamin d|mesh-list
92980957|NCT05313477|Calcium Carbonate|calcium carbonate|mesh-list
92980958|NCT05313477|Calcium|calcium|mesh-list
92980959|NCT05313477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92980960|NCT05313477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980961|NCT05313477|Antacids|antacids|mesh-ancestor
92980962|NCT05313477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980963|NCT05313477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92980964|NCT05313477|Vitamins|vitamins|mesh-ancestor
92980965|NCT05313477|Micronutrients|micronutrients|mesh-ancestor
92980966|NCT05313477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92980967|NCT00224107|Silodosin|silodosin|mesh-list
92980968|NCT00224107|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92980969|NCT00224107|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92980970|NCT00224107|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92980971|NCT00224107|Adrenergic Agents|adrenergic agents|mesh-ancestor
92980972|NCT00224107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92980973|NCT00224107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980974|NCT00224107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980975|NCT00224107|Urological Agents|urological agents|mesh-ancestor
92980976|NCT04696731|Cyclophosphamide|cyclophosphamide|mesh-list
92980977|NCT04696731|Fludarabine|fludarabine|mesh-list
92980978|NCT04696731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980979|NCT04696731|Immunologic Factors|immunologic factors|mesh-ancestor
92980980|NCT04696731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92980981|NCT04696731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92980982|NCT04696731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92980983|NCT04696731|Alkylating Agents|alkylating agents|mesh-ancestor
92980984|NCT04696731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980985|NCT04696731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980986|NCT04696731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92980987|NCT04004871|Paclitaxel|paclitaxel|mesh-list
92980988|NCT04004871|Cisplatin|cisplatin|mesh-list
92980989|NCT04004871|Fluorouracil|fluorouracil|mesh-list
92980990|NCT04004871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92980991|NCT04004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92980992|NCT04004871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92980993|NCT04004871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92980994|NCT04004871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92980995|NCT04004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92980996|NCT04004871|Antimetabolites|antimetabolites|mesh-ancestor
92980997|NCT04004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92980998|NCT04004871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92980999|NCT04004871|Immunologic Factors|immunologic factors|mesh-ancestor
92981000|NCT04004871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981001|NCT00826358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92981002|NCT00826358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92981003|NCT00826358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92981004|NCT00826358|Antimetabolites|antimetabolites|mesh-ancestor
92981005|NCT00826358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981006|NCT00826358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92981007|NCT00826358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92981009|NCT00987909|Immunomodulating Agents|immunomodulating agents|mesh-list
92981010|NCT00987909|Immunologic Factors|immunologic factors|mesh-list
92981011|NCT00987909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981012|NCT00822380|Iron|iron|mesh-list
92981013|NCT00822380|Trace Elements|trace elements|mesh-list
92981014|NCT00822380|Folic Acid|folic acid|mesh-list
92981015|NCT00822380|Ascorbic Acid|ascorbic acid|mesh-list
92981016|NCT00822380|Micronutrients|micronutrients|mesh-list
92981017|NCT00822380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981018|NCT00822380|Hematinics|hematinics|mesh-ancestor
92981019|NCT00822380|Vitamin B Complex|vitamin b complex|mesh-ancestor
92981021|NCT00822380|Antioxidants|antioxidants|mesh-ancestor
92981022|NCT00822380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981023|NCT00822380|Protective Agents|protective agents|mesh-ancestor
92981024|NCT00720083|Cisplatin|cisplatin|mesh-list
92981025|NCT00720083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981026|NCT05621811|ATI 7505|ati 7505|mesh-list
92981027|NCT05621811|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92981028|NCT05621811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92981029|NCT05621811|Serotonin Agents|serotonin agents|mesh-ancestor
92981030|NCT05621811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981031|NCT05621811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981032|NCT05621811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981033|NCT00209131|Tamsulosin|tamsulosin|mesh-list
92981034|NCT00209131|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92981035|NCT00209131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92981036|NCT00209131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92981037|NCT00209131|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981038|NCT00209131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981039|NCT00209131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981040|NCT00209131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981041|NCT00209131|Urological Agents|urological agents|mesh-ancestor
92981042|NCT00907608|Darbepoetin alfa|darbepoetin alfa|mesh-list
92981043|NCT00907608|Hematinics|hematinics|mesh-ancestor
92981044|NCT00224029|Oxybutynin|oxybutynin|mesh-list
92981045|NCT00224029|Parasympatholytics|parasympatholytics|mesh-ancestor
92981046|NCT00224029|Autonomic Agents|autonomic agents|mesh-ancestor
92981047|NCT00224029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981048|NCT00224029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981049|NCT00224029|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92981050|NCT00224029|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92981051|NCT00224029|Cholinergic Agents|cholinergic agents|mesh-ancestor
92167270|NCT04037241|Vitamins|vitamins|mesh-ancestor
92981052|NCT00224029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981053|NCT00224029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981054|NCT00224029|Urological Agents|urological agents|mesh-ancestor
92981055|NCT00929370|Glycine|glycine|mesh-list
92981056|NCT00929370|Glycine Agents|glycine agents|mesh-ancestor
92981057|NCT00929370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981058|NCT00929370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981059|NCT00929370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981060|NCT00907764|Regadenoson|regadenoson|mesh-list
92981061|NCT00907764|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92981062|NCT00907764|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92981063|NCT00907764|Purinergic Agonists|purinergic agonists|mesh-ancestor
92981064|NCT00907764|Purinergic Agents|purinergic agents|mesh-ancestor
92981065|NCT00907764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981066|NCT00907764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981067|NCT00907764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981068|NCT02550314|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92981069|NCT02550314|Hemostatics|hemostatics|mesh-ancestor
92981070|NCT02550314|Coagulants|coagulants|mesh-ancestor
92981071|NCT01073527|Adenosine|adenosine|mesh-list
92981072|NCT01073527|Albuterol|albuterol|mesh-list
92981073|NCT01073527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92981074|NCT01073527|Autonomic Agents|autonomic agents|mesh-ancestor
92981075|NCT01073527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981076|NCT01073527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981077|NCT01073527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92981078|NCT01073527|Respiratory System Agents|respiratory system agents|mesh-ancestor
92981079|NCT01073527|Tocolytic Agents|tocolytic agents|mesh-ancestor
92981080|NCT01073527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981081|NCT01073527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92981082|NCT01073527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92981083|NCT01073527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981084|NCT01073527|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981085|NCT01073527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981086|NCT01073527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981087|NCT01073527|Analgesics|analgesics|mesh-ancestor
92981088|NCT01073527|Sensory System Agents|sensory system agents|mesh-ancestor
92981089|NCT01073527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92981090|NCT01073527|Vasodilator Agents|vasodilator agents|mesh-ancestor
92981091|NCT01073527|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92981092|NCT01073527|Purinergic Agonists|purinergic agonists|mesh-ancestor
92981093|NCT01073527|Purinergic Agents|purinergic agents|mesh-ancestor
92981094|NCT02538432|Gemcitabine|gemcitabine|mesh-list
92981095|NCT02538432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92981096|NCT02538432|Antimetabolites|antimetabolites|mesh-ancestor
92981097|NCT02538432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981098|NCT02538432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981099|NCT00719849|Cyclosporine|cyclosporine|mesh-list
92981100|NCT00719849|Mycophenolic Acid|mycophenolic acid|mesh-list
92981101|NCT00719849|Cyclophosphamide|cyclophosphamide|mesh-list
92981102|NCT00719849|Fludarabine|fludarabine|mesh-list
92981103|NCT00719849|Fludarabine phosphate|fludarabine phosphate|mesh-list
92981104|NCT00719849|Cyclosporins|cyclosporins|mesh-list
92981105|NCT00719849|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92981106|NCT00719849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981107|NCT00719849|Immunologic Factors|immunologic factors|mesh-ancestor
92981108|NCT00719849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981109|NCT00719849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981110|NCT00719849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92981111|NCT00719849|Alkylating Agents|alkylating agents|mesh-ancestor
92981112|NCT00719849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981113|NCT00719849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981114|NCT00719849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92981115|NCT00719849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92981116|NCT00719849|Antimetabolites|antimetabolites|mesh-ancestor
92981117|NCT00719849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981118|NCT00719849|Antifungal Agents|antifungal agents|mesh-ancestor
92981119|NCT00719849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981120|NCT00719849|Dermatologic Agents|dermatologic agents|mesh-ancestor
92981121|NCT00719849|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92981122|NCT00719849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92981123|NCT00719849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92981124|NCT00719849|Antitubercular Agents|antitubercular agents|mesh-ancestor
92981125|NCT00719849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981126|NCT00822536|Aspirin|aspirin|mesh-list
92981127|NCT00822536|Clopidogrel|clopidogrel|mesh-list
92981128|NCT00822536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92981129|NCT00822536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92981130|NCT00822536|Analgesics|analgesics|mesh-ancestor
92981131|NCT00822536|Sensory System Agents|sensory system agents|mesh-ancestor
92981132|NCT00822536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981133|NCT00822536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981134|NCT00822536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981135|NCT00822536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981136|NCT00822536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92981137|NCT00822536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92981138|NCT00822536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981139|NCT00822536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92981140|NCT00822536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92981141|NCT00822536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981142|NCT00822536|Antipyretics|antipyretics|mesh-ancestor
92981143|NCT00822536|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92981144|NCT00822536|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92981145|NCT00822536|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92981146|NCT00822536|Purinergic Agents|purinergic agents|mesh-ancestor
92981147|NCT00822536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981149|NCT00826826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92981150|NCT00826826|Vasodilator Agents|vasodilator agents|mesh-ancestor
92981151|NCT00826826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92981152|NCT00826826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981153|NCT00826826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981154|NCT00826826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92981155|NCT00826826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92981156|NCT00826826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92981157|NCT00826826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981158|NCT00826826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92981159|NCT00826826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92981160|NCT00826826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92981161|NCT02592941|Deflazacort|deflazacort|mesh-list
92981162|NCT02592941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981163|NCT02592941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981164|NCT02592941|Immunologic Factors|immunologic factors|mesh-ancestor
92981165|NCT02592941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981166|NCT00822614|Fentanyl|fentanyl|mesh-list
92981167|NCT00822614|Morphine|morphine|mesh-list
92981168|NCT00822614|Oxycodone|oxycodone|mesh-list
92981169|NCT00822614|Hydromorphone|hydromorphone|mesh-list
92981170|NCT00822614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92981171|NCT00822614|Narcotics|narcotics|mesh-ancestor
92981172|NCT00822614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981173|NCT00822614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981174|NCT00822614|Analgesics|analgesics|mesh-ancestor
92981175|NCT00822614|Sensory System Agents|sensory system agents|mesh-ancestor
92981176|NCT00822614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981177|NCT00822614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92981178|NCT00822614|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92981179|NCT00822614|Anesthetics, General|anesthetics, general|mesh-ancestor
92981180|NCT00822614|Anesthetics|anesthetics|mesh-ancestor
92981181|NCT04087967|Cytarabine|cytarabine|mesh-list
92981182|NCT04087967|Decitabine|decitabine|mesh-list
92981183|NCT04087967|Idarubicin|idarubicin|mesh-list
92981184|NCT04087967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92981185|NCT04087967|Antimetabolites|antimetabolites|mesh-ancestor
92981186|NCT04087967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981187|NCT04087967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981188|NCT04087967|Antiviral Agents|antiviral agents|mesh-ancestor
92981189|NCT04087967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981190|NCT04087967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981191|NCT04087967|Immunologic Factors|immunologic factors|mesh-ancestor
92981192|NCT04087967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981193|NCT04087967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981194|NCT04087967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92167278|NCT01327677|Fentanyl|fentanyl|mesh-list
92981195|NCT04087967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92981196|NCT04087967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981197|NCT00926016|Pioglitazone|pioglitazone|mesh-list
92981198|NCT00926016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92981199|NCT00926016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981200|NCT04017104|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92981201|NCT04017104|Edotreotide|edotreotide|mesh-list
92981202|NCT04017104|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92981203|NCT04017104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981204|NCT00827138|Rebastinib|rebastinib|mesh-list
92981205|NCT00827138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981206|NCT00827138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981207|NCT00827138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981208|NCT00827138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981209|NCT00817466|Epinephrine|epinephrine|mesh-list
92981210|NCT00817466|Racepinephrine|racepinephrine|mesh-list
92981211|NCT00817466|Epinephryl borate|epinephryl borate|mesh-list
92981212|NCT00817466|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92981213|NCT00817466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981214|NCT00817466|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981215|NCT00817466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981216|NCT00817466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981217|NCT00817466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981218|NCT00817466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92981219|NCT00817466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92981220|NCT00817466|Autonomic Agents|autonomic agents|mesh-ancestor
92981221|NCT00817466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981222|NCT00817466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92981223|NCT00817466|Respiratory System Agents|respiratory system agents|mesh-ancestor
92981224|NCT00817466|Mydriatics|mydriatics|mesh-ancestor
92981225|NCT00817466|Sympathomimetics|sympathomimetics|mesh-ancestor
92981226|NCT00817466|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92981227|NCT00930072|Clonidine|clonidine|mesh-list
92981228|NCT00930072|Bupivacaine|bupivacaine|mesh-list
92981229|NCT00930072|Anesthetics, Local|anesthetics, local|mesh-ancestor
92981230|NCT00930072|Anesthetics|anesthetics|mesh-ancestor
92981231|NCT00930072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981232|NCT00930072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981233|NCT00930072|Sensory System Agents|sensory system agents|mesh-ancestor
92981234|NCT00930072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981235|NCT00930072|Analgesics|analgesics|mesh-ancestor
92981236|NCT00930072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92981237|NCT00930072|Sympatholytics|sympatholytics|mesh-ancestor
92981238|NCT00930072|Autonomic Agents|autonomic agents|mesh-ancestor
92981239|NCT00930072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92981240|NCT00930072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92981241|NCT00930072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981242|NCT00930072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981243|NCT00930072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981244|NCT00930072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981245|NCT00626522|Bromides|bromides|mesh-list
92981246|NCT00626522|Formoterol Fumarate|formoterol fumarate|mesh-list
92981248|NCT00626522|Autonomic Agents|autonomic agents|mesh-ancestor
92981249|NCT00626522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981250|NCT00626522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981251|NCT00626522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92981252|NCT00626522|Respiratory System Agents|respiratory system agents|mesh-ancestor
92981253|NCT00626522|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92981254|NCT00626522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92981255|NCT00626522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981256|NCT00626522|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981257|NCT00626522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981258|NCT00626522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981259|NCT00626522|Anticonvulsants|anticonvulsants|mesh-ancestor
92981260|NCT00926640|Etoposide|etoposide|mesh-list
92981261|NCT00926640|Belinostat|belinostat|mesh-list
92981262|NCT00926640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981263|NCT00926640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92981264|NCT00926640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92981265|NCT00926640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981266|NCT00926640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981267|NCT00926640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167280|NCT01327677|Narcotics|narcotics|mesh-ancestor
92981268|NCT00926640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92981269|NCT00931398|Methylphenidate|methylphenidate|mesh-list
92981270|NCT00931398|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92981271|NCT00931398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981272|NCT00931398|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92981273|NCT00931398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92981274|NCT00931398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981275|NCT00931398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981276|NCT00931398|Dopamine Agents|dopamine agents|mesh-ancestor
92981277|NCT00931398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981278|NCT00827216|Erythromycin|erythromycin|mesh-list
92981279|NCT00827216|Erythromycin Estolate|erythromycin estolate|mesh-list
92981280|NCT00827216|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92981281|NCT00827216|Erythromycin stearate|erythromycin stearate|mesh-list
92981282|NCT00827216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981283|NCT00827216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981284|NCT00827216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92981285|NCT00827216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92981286|NCT00827216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981287|NCT00827216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981288|NCT00822848|Sorafenib|sorafenib|mesh-list
92981289|NCT00822848|Epirubicin|epirubicin|mesh-list
92981290|NCT00822848|Ifosfamide|ifosfamide|mesh-list
92981291|NCT00822848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981292|NCT00822848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981293|NCT00822848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981294|NCT00822848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981295|NCT00822848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92981296|NCT00822848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92981297|NCT00822848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981298|NCT00822848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92981299|NCT00822848|Alkylating Agents|alkylating agents|mesh-ancestor
92981300|NCT00926718|Remifentanil|remifentanil|mesh-list
92981301|NCT00926718|Rocuronium|rocuronium|mesh-list
92981302|NCT00926718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92981303|NCT00926718|Narcotics|narcotics|mesh-ancestor
92981304|NCT00926718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981305|NCT00926718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981306|NCT00926718|Analgesics|analgesics|mesh-ancestor
92981307|NCT00926718|Sensory System Agents|sensory system agents|mesh-ancestor
92981308|NCT00926718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981309|NCT00926718|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92981310|NCT00926718|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92981311|NCT00926718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92981312|NCT00823004|Letrozole|letrozole|mesh-list
92981313|NCT00823004|Contraceptive Agents|contraceptive agents|mesh-list
92981314|NCT00823004|Contraceptives, Oral|contraceptives, oral|mesh-list
92981315|NCT00823004|Buserelin|buserelin|mesh-list
92981316|NCT00823004|Ganirelix|ganirelix|mesh-list
92981317|NCT00823004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981318|NCT00823004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92981319|NCT00823004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92981320|NCT00823004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981321|NCT00823004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981323|NCT00823004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92981324|NCT00823004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92981325|NCT00823004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981326|NCT00823004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981327|NCT00823004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92981328|NCT00823004|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92981329|NCT00823004|Fertility Agents|fertility agents|mesh-ancestor
92981330|NCT00827450|Caffeine|caffeine|mesh-list
92981331|NCT00827450|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92981332|NCT00827450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981333|NCT00827450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92981334|NCT00827450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981335|NCT00827450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981336|NCT00827450|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92981337|NCT00827450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92981338|NCT00827450|Purinergic Agents|purinergic agents|mesh-ancestor
92981339|NCT00827450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981340|NCT00930306|Tolbutamide|tolbutamide|mesh-list
92981341|NCT00930306|Midazolam|midazolam|mesh-list
92981342|NCT00930306|Caffeine|caffeine|mesh-list
92981343|NCT00930306|Omeprazole|omeprazole|mesh-list
92981344|NCT00930306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92981345|NCT00930306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92981346|NCT00930306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981347|NCT00930306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981348|NCT00930306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92981349|NCT00930306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92981350|NCT00930306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92981351|NCT00930306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92981352|NCT00930306|Anesthetics, General|anesthetics, general|mesh-ancestor
92981353|NCT00930306|Anesthetics|anesthetics|mesh-ancestor
92981354|NCT00930306|GABA Modulators|gaba modulators|mesh-ancestor
92981355|NCT00930306|GABA Agents|gaba agents|mesh-ancestor
92981356|NCT00930306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981357|NCT00930306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981358|NCT00930306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92981359|NCT00930306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92981360|NCT00930306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981361|NCT00930306|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92981362|NCT00930306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92981363|NCT00930306|Purinergic Agents|purinergic agents|mesh-ancestor
92981364|NCT00930306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92981365|NCT00930306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92981366|NCT00930306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92981367|NCT00930306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92981368|NCT00830882|Albuterol|albuterol|mesh-list
92981369|NCT00830882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92981370|NCT00830882|Autonomic Agents|autonomic agents|mesh-ancestor
92981371|NCT00830882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981372|NCT00830882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981373|NCT00830882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92981374|NCT00830882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92981375|NCT00830882|Tocolytic Agents|tocolytic agents|mesh-ancestor
92981376|NCT00830882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981377|NCT00830882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92981378|NCT00830882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92981379|NCT00830882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981380|NCT00830882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981381|NCT00830882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981382|NCT00830882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981383|NCT00823238|Tobramycin|tobramycin|mesh-list
92981384|NCT00823238|Ceftazidime|ceftazidime|mesh-list
92981385|NCT00823238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981386|NCT00823238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981387|NCT00931788|Antihypertensive Agents|antihypertensive agents|mesh-list
92981388|NCT00827684|Sirolimus|sirolimus|mesh-list
92981389|NCT00827684|Irinotecan|irinotecan|mesh-list
92981390|NCT00827684|Temsirolimus|temsirolimus|mesh-list
92981391|NCT00827684|MTOR Inhibitors|mtor inhibitors|mesh-list
92981392|NCT00827684|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92981393|NCT00827684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981394|NCT00827684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626806|NCT05690698|Haloperidol|haloperidol|mesh-list
92981395|NCT00827684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981396|NCT00827684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981397|NCT00827684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981398|NCT00827684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981399|NCT00827684|Immunologic Factors|immunologic factors|mesh-ancestor
92981400|NCT00827684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981401|NCT00827684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981402|NCT00827684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981403|NCT00827684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92981404|NCT00827684|Antifungal Agents|antifungal agents|mesh-ancestor
92981405|NCT00927030|Melatonin|melatonin|mesh-list
92981406|NCT00927030|Antioxidants|antioxidants|mesh-ancestor
92981407|NCT00927030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981408|NCT00927030|Protective Agents|protective agents|mesh-ancestor
92981409|NCT00927030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981410|NCT00927030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981411|NCT00931866|Diclofenac|diclofenac|mesh-list
92981412|NCT00931866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92981413|NCT00931866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92981414|NCT00931866|Analgesics|analgesics|mesh-ancestor
92981415|NCT00931866|Sensory System Agents|sensory system agents|mesh-ancestor
92981416|NCT00931866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981417|NCT00931866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981418|NCT00931866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981419|NCT00931866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981420|NCT00931866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92981421|NCT00931866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981422|NCT00931866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981423|NCT00827840|Risperidone|risperidone|mesh-list
92981424|NCT00827840|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92981425|NCT00827840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92981426|NCT00827840|Serotonin Agents|serotonin agents|mesh-ancestor
92981427|NCT00827840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981428|NCT00827840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981429|NCT00827840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981430|NCT00827840|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92981431|NCT00827840|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92981432|NCT00827840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981433|NCT00827840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92981434|NCT00827840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92981435|NCT00827840|Dopamine Agents|dopamine agents|mesh-ancestor
92981436|NCT00827840|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92981437|NCT00827840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92981438|NCT00827996|Adalimumab|adalimumab|mesh-list
92981439|NCT00827996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92981440|NCT00827996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981441|NCT00827996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981442|NCT00936780|Paclitaxel|paclitaxel|mesh-list
92981443|NCT00936780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92981444|NCT00936780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981445|NCT00936780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92981446|NCT00936780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92981447|NCT00936780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92981448|NCT00936780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981449|NCT00823550|Lamivudine|lamivudine|mesh-list
92981450|NCT00823550|Entecavir|entecavir|mesh-list
92981451|NCT00823550|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92981452|NCT00823550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92981453|NCT00823550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981454|NCT00823550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981455|NCT00823550|Antiviral Agents|antiviral agents|mesh-ancestor
92981456|NCT00823550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981457|NCT00823550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92981458|NCT00823550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92981459|NCT00932100|Heparin|heparin|mesh-list
92981460|NCT00932100|Calcium heparin|calcium heparin|mesh-list
92981461|NCT00932100|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92981462|NCT00932100|Tinzaparin|tinzaparin|mesh-list
92981463|NCT00932100|Dalteparin|dalteparin|mesh-list
92981464|NCT00932100|Anticoagulants|anticoagulants|mesh-ancestor
92981465|NCT00932100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92981466|NCT00932100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92981467|NCT00932100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981468|NCT00828230|Budesonide|budesonide|mesh-list
92626879|NCT05617118|Cholinergic Agents|cholinergic agents|mesh-ancestor
92981469|NCT00828230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981470|NCT00828230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92981471|NCT00828230|Autonomic Agents|autonomic agents|mesh-ancestor
92981472|NCT00828230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981473|NCT00828230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981474|NCT00828230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92981475|NCT00828230|Respiratory System Agents|respiratory system agents|mesh-ancestor
92981476|NCT00828230|Glucocorticoids|glucocorticoids|mesh-ancestor
92981477|NCT00828230|Hormones|hormones|mesh-ancestor
92981478|NCT00828230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92981479|NCT04469556|Leucovorin|leucovorin|mesh-list
92981480|NCT04469556|Paclitaxel|paclitaxel|mesh-list
92981481|NCT04469556|Gemcitabine|gemcitabine|mesh-list
92981482|NCT04469556|Oxaliplatin|oxaliplatin|mesh-list
92981483|NCT04469556|Irinotecan|irinotecan|mesh-list
92981484|NCT04469556|Folfirinox|folfirinox|mesh-list
92981485|NCT04469556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92981486|NCT04469556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981487|NCT04469556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92981488|NCT04469556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92981489|NCT04469556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92981490|NCT04469556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981491|NCT04469556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92981492|NCT04469556|Antimetabolites|antimetabolites|mesh-ancestor
92981493|NCT04469556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92981494|NCT04469556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981495|NCT04469556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981496|NCT04469556|Antidotes|antidotes|mesh-ancestor
92981497|NCT04469556|Protective Agents|protective agents|mesh-ancestor
92981498|NCT04469556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981499|NCT04469556|Vitamin B Complex|vitamin b complex|mesh-ancestor
92981500|NCT04469556|Vitamins|vitamins|mesh-ancestor
92981501|NCT04469556|Micronutrients|micronutrients|mesh-ancestor
92981502|NCT00937092|Dopamine|dopamine|mesh-list
92981503|NCT00937092|Furosemide|furosemide|mesh-list
92981504|NCT00937092|Diuretics|diuretics|mesh-ancestor
92981505|NCT00937092|Natriuretic Agents|natriuretic agents|mesh-ancestor
92981506|NCT00937092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981507|NCT00937092|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92981508|NCT00937092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981509|NCT00937092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981510|NCT00937092|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92981511|NCT00937092|Sympathomimetics|sympathomimetics|mesh-ancestor
92981512|NCT00937092|Autonomic Agents|autonomic agents|mesh-ancestor
92981513|NCT00937092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981514|NCT00937092|Dopamine Agents|dopamine agents|mesh-ancestor
92981515|NCT00937092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981516|NCT00937092|Protective Agents|protective agents|mesh-ancestor
92981517|NCT04124601|Nivolumab|nivolumab|mesh-list
92981518|NCT04124601|Ipilimumab|ipilimumab|mesh-list
92981519|NCT04124601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92981520|NCT04124601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981521|NCT04124601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92981522|NCT04124601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981523|NCT05046639|Lidocaine|lidocaine|mesh-list
92981524|NCT05046639|Anesthetics, Local|anesthetics, local|mesh-ancestor
92981525|NCT05046639|Anesthetics|anesthetics|mesh-ancestor
92981526|NCT05046639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981527|NCT05046639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981528|NCT05046639|Sensory System Agents|sensory system agents|mesh-ancestor
92981529|NCT05046639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981530|NCT05046639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92981531|NCT05046639|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92981532|NCT05046639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92981533|NCT05046639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981534|NCT05046639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981535|NCT04521621|Pembrolizumab|pembrolizumab|mesh-list
92981536|NCT04521621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92981537|NCT04521621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981538|NCT04521621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92981539|NCT04521621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981540|NCT00931008|Docetaxel|docetaxel|mesh-list
92981541|NCT00931008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981542|NCT00931008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92981543|NCT00931008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92981544|NCT00931008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92981545|NCT00931008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981546|NCT00932802|Moxifloxacin|moxifloxacin|mesh-list
92981547|NCT00932802|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92981548|NCT00932802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981549|NCT00932802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981550|NCT00932802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92981551|NCT00932802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981552|NCT00932802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981553|NCT00932802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981554|NCT00932802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981555|NCT00932802|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92981556|NCT00932802|Contraceptive Agents|contraceptive agents|mesh-ancestor
92981557|NCT00932802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981558|NCT00932802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981559|NCT00932802|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92981560|NCT00932802|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92981561|NCT00932802|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92981562|NCT00932880|Amlodipine|amlodipine|mesh-list
92981563|NCT00932880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92981564|NCT00932880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92981565|NCT00932880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981566|NCT00932880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981567|NCT00932880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92981568|NCT00932880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981569|NCT00932880|Vasodilator Agents|vasodilator agents|mesh-ancestor
92981570|NCT00937482|Cediranib|cediranib|mesh-list
92981571|NCT00937482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981572|NCT00937482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981573|NCT00937482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981574|NCT00937482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981575|NCT00931086|Belimumab|belimumab|mesh-list
92981576|NCT00931086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981577|NCT00931086|Immunologic Factors|immunologic factors|mesh-ancestor
92981578|NCT00931086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981579|NCT04453839|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92981580|NCT04453839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92981581|NCT04453839|Vasodilator Agents|vasodilator agents|mesh-ancestor
92981582|NCT04453839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92981583|NCT04453839|Protective Agents|protective agents|mesh-ancestor
92981584|NCT04453839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981585|NCT03977454|Ropivacaine|ropivacaine|mesh-list
92981586|NCT03977454|Anesthetics, Local|anesthetics, local|mesh-ancestor
92981587|NCT03977454|Anesthetics|anesthetics|mesh-ancestor
92981588|NCT03977454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981589|NCT03977454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981591|NCT03977454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981592|NCT02549066|Milrinone|milrinone|mesh-list
92981593|NCT02549066|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92981594|NCT02549066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92981595|NCT02549066|Vasodilator Agents|vasodilator agents|mesh-ancestor
92981596|NCT02549066|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92981597|NCT02549066|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92981598|NCT02549066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981599|NCT02549066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981600|NCT02549066|Protective Agents|protective agents|mesh-ancestor
92981601|NCT02549066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981602|NCT00831350|Ranibizumab|ranibizumab|mesh-list
92981603|NCT00831350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92981604|NCT00831350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92981605|NCT00831350|Growth Substances|growth substances|mesh-ancestor
92981606|NCT00831350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981607|NCT00831350|Growth Inhibitors|growth inhibitors|mesh-ancestor
92981608|NCT00831350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981609|NCT00938184|Paroxetine|paroxetine|mesh-list
92981610|NCT00938184|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92981611|NCT00938184|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92981612|NCT00938184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981613|NCT00938184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981614|NCT00938184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981615|NCT00938184|Serotonin Agents|serotonin agents|mesh-ancestor
92981616|NCT00938184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981617|NCT00938184|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92981618|NCT00938184|Antidepressive Agents|antidepressive agents|mesh-ancestor
92981619|NCT00938184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92981620|NCT00938184|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92981621|NCT00938184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92981622|NCT00938184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981623|NCT00938262|Rifampin|rifampin|mesh-list
92981624|NCT00938262|Ketoconazole|ketoconazole|mesh-list
92981625|NCT00938262|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92981626|NCT00938262|Antitubercular Agents|antitubercular agents|mesh-ancestor
92981627|NCT00938262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981628|NCT00938262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981629|NCT00938262|Leprostatic Agents|leprostatic agents|mesh-ancestor
92981630|NCT00938262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92981631|NCT00938262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981632|NCT00938262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981633|NCT00938262|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92981634|NCT00938262|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92981635|NCT00938262|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92981636|NCT00938262|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92981637|NCT00938262|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92981638|NCT00938262|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92981639|NCT00938262|Antifungal Agents|antifungal agents|mesh-ancestor
92981640|NCT00938262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92981641|NCT00938262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92981642|NCT00938262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92981643|NCT00938262|Hormone Antagonists|hormone antagonists|mesh-ancestor
92981644|NCT00938262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92981645|NCT00938262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981646|NCT00938262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92981647|NCT00933426|Paclitaxel|paclitaxel|mesh-list
92981648|NCT00933426|Lenalidomide|lenalidomide|mesh-list
92981649|NCT00933426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92981650|NCT00933426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981651|NCT00933426|Tubulin Modulators|tubulin modulators|mesh-ancestor
92981652|NCT00933426|Antimitotic Agents|antimitotic agents|mesh-ancestor
92981653|NCT00933426|Mitosis Modulators|mitosis modulators|mesh-ancestor
92981654|NCT00933426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981655|NCT00933426|Immunologic Factors|immunologic factors|mesh-ancestor
92981656|NCT00933426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981657|NCT00933426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92981658|NCT00933426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92981659|NCT00933426|Growth Substances|growth substances|mesh-ancestor
92981660|NCT00933426|Growth Inhibitors|growth inhibitors|mesh-ancestor
92981661|NCT04013958|Ketamine|ketamine|mesh-list
92981662|NCT04013958|Analgesics|analgesics|mesh-ancestor
92981663|NCT04013958|Sensory System Agents|sensory system agents|mesh-ancestor
92981664|NCT04013958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981665|NCT04013958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981666|NCT04013958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92981667|NCT04013958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92981668|NCT04013958|Anesthetics, General|anesthetics, general|mesh-ancestor
92981669|NCT04013958|Anesthetics|anesthetics|mesh-ancestor
92981670|NCT04013958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981671|NCT04013958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92981672|NCT04013958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92981673|NCT04013958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981674|NCT04013958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981675|NCT00933582|Naproxen|naproxen|mesh-list
92981676|NCT00933582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92981677|NCT00933582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92981678|NCT00933582|Analgesics|analgesics|mesh-ancestor
92981679|NCT00933582|Sensory System Agents|sensory system agents|mesh-ancestor
92981680|NCT00933582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981681|NCT00933582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981682|NCT00933582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981683|NCT00933582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981684|NCT00933582|Gout Suppressants|gout suppressants|mesh-ancestor
92981685|NCT00933582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92981686|NCT00933582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981687|NCT00933582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981688|NCT00938730|Warfarin|warfarin|mesh-list
92981689|NCT00938730|Anticoagulants|anticoagulants|mesh-ancestor
92981690|NCT00933816|Fluorouracil|fluorouracil|mesh-list
92981691|NCT00933816|Sorafenib|sorafenib|mesh-list
92981692|NCT00933816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981693|NCT00933816|Antimetabolites|antimetabolites|mesh-ancestor
92981694|NCT00933816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981695|NCT00933816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92981696|NCT00933816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981697|NCT00933816|Immunologic Factors|immunologic factors|mesh-ancestor
92981698|NCT00933816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981699|NCT00933816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981700|NCT00933816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981701|NCT00538785|Palivizumab|palivizumab|mesh-list
92981702|NCT00538785|Antiviral Agents|antiviral agents|mesh-ancestor
92981703|NCT00538785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981704|NCT01563939|Remifentanil|remifentanil|mesh-list
92981705|NCT01563939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92981706|NCT01563939|Narcotics|narcotics|mesh-ancestor
92981707|NCT01563939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92981708|NCT01563939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981709|NCT01563939|Analgesics|analgesics|mesh-ancestor
92981710|NCT01563939|Sensory System Agents|sensory system agents|mesh-ancestor
92981711|NCT01563939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981712|NCT03287271|Paclitaxel|paclitaxel|mesh-list
92981713|NCT03287271|Carboplatin|carboplatin|mesh-list
92981714|NCT03287271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92981715|NCT03287271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981716|NCT03287271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92981717|NCT03287271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92981718|NCT03287271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92981719|NCT03287271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981720|NCT00990405|Amoxicillin|amoxicillin|mesh-list
92981721|NCT00990405|Clarithromycin|clarithromycin|mesh-list
92981722|NCT00990405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981723|NCT00990405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981724|NCT00990405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92981725|NCT00990405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981726|NCT00990405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981727|NCT00990405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92981728|NCT00990405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92981729|NCT00990639|Candesartan|candesartan|mesh-list
92981730|NCT00990639|Candesartan cilexetil|candesartan cilexetil|mesh-list
92981731|NCT00990639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92981732|NCT00990639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92981733|NCT00990639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92981734|NCT00990639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981735|NCT03742947|Hemostatics|hemostatics|mesh-list
92981736|NCT03742947|Coagulants|coagulants|mesh-ancestor
92981737|NCT05359497|Liver Extracts|liver extracts|mesh-list
92981738|NCT05359497|Hematinics|hematinics|mesh-ancestor
92981739|NCT00990795|Cyclosporine|cyclosporine|mesh-list
92981740|NCT00990795|Cyclosporins|cyclosporins|mesh-list
92981741|NCT00990795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981742|NCT00990795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981743|NCT00990795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981744|NCT00990795|Immunologic Factors|immunologic factors|mesh-ancestor
92981745|NCT00990795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981746|NCT00990795|Antifungal Agents|antifungal agents|mesh-ancestor
92981747|NCT00990795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981748|NCT00990795|Dermatologic Agents|dermatologic agents|mesh-ancestor
92981749|NCT00990795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981750|NCT00990795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92981751|NCT00622700|Teriflunomide|teriflunomide|mesh-list
92981752|NCT00622700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92981753|NCT00622700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92981754|NCT00622700|Analgesics|analgesics|mesh-ancestor
92981755|NCT00622700|Sensory System Agents|sensory system agents|mesh-ancestor
92981756|NCT00622700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981757|NCT00622700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981758|NCT00622700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981759|NCT00622700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981760|NCT00622700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981761|NCT00622700|Immunologic Factors|immunologic factors|mesh-ancestor
92981762|NCT00831506|Digoxin|digoxin|mesh-list
92627187|NCT04472767|Nivolumab|nivolumab|mesh-list
92981763|NCT00831506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92981764|NCT00831506|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92981765|NCT00831506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981766|NCT00831506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981767|NCT00831506|Protective Agents|protective agents|mesh-ancestor
92981768|NCT00831506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981769|NCT02842359|Irbesartan|irbesartan|mesh-list
92981770|NCT02842359|Atorvastatin|atorvastatin|mesh-list
92981771|NCT02842359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92981772|NCT02842359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92981773|NCT02842359|Antimetabolites|antimetabolites|mesh-ancestor
92981774|NCT02842359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981775|NCT02842359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92981776|NCT02842359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92981777|NCT02842359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981778|NCT02842359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92981779|NCT02842359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92981780|NCT02842359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92981781|NCT00828776|Heparin|heparin|mesh-list
92981782|NCT00828776|Calcium heparin|calcium heparin|mesh-list
92981783|NCT00828776|Anticoagulants|anticoagulants|mesh-ancestor
92981784|NCT00828776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92981785|NCT00828776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92981786|NCT00828776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981787|NCT00622466|Paclitaxel|paclitaxel|mesh-list
92981788|NCT00622466|Sorafenib|sorafenib|mesh-list
92981789|NCT00622466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92981790|NCT00622466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981791|NCT00622466|Tubulin Modulators|tubulin modulators|mesh-ancestor
92981792|NCT00622466|Antimitotic Agents|antimitotic agents|mesh-ancestor
92981793|NCT00622466|Mitosis Modulators|mitosis modulators|mesh-ancestor
92981794|NCT00622466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981795|NCT00622466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981796|NCT00622466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981797|NCT04043858|Midodrine|midodrine|mesh-list
92981798|NCT04043858|Sympathomimetics|sympathomimetics|mesh-ancestor
92981799|NCT04043858|Autonomic Agents|autonomic agents|mesh-ancestor
92981800|NCT04043858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981801|NCT04043858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981802|NCT04043858|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92981803|NCT04043858|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92981805|NCT04043858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981806|NCT04043858|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981807|NCT04043858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981808|NCT04043858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981809|NCT05359419|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92981810|NCT05359419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92981811|NCT05359419|Dermatologic Agents|dermatologic agents|mesh-ancestor
92981812|NCT00823862|Ribavirin|ribavirin|mesh-list
92981813|NCT00823862|Antimetabolites|antimetabolites|mesh-ancestor
92981814|NCT00823862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981815|NCT00823862|Antiviral Agents|antiviral agents|mesh-ancestor
92981816|NCT00823862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981817|NCT00537771|Tamoxifen|tamoxifen|mesh-list
92981818|NCT00537771|Anastrozole|anastrozole|mesh-list
92981819|NCT00537771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92981820|NCT00537771|Hormone Antagonists|hormone antagonists|mesh-ancestor
92981821|NCT00537771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92981822|NCT00537771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981823|NCT00537771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92981824|NCT00537771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981825|NCT00537771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92981826|NCT00537771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92981827|NCT00537771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92981828|NCT00537771|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92981829|NCT00537771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92981830|NCT00537771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981831|NCT00537771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981832|NCT00823940|Glucagon|glucagon|mesh-list
92981833|NCT00823940|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92981834|NCT00823940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92981835|NCT00823940|Hormones|hormones|mesh-ancestor
92981836|NCT00823940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92981837|NCT00823940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981838|NCT00823940|Incretins|incretins|mesh-ancestor
92981839|NCT00829322|Modafinil|modafinil|mesh-list
92981840|NCT00829322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92981841|NCT00829322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981842|NCT00829322|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92981843|NCT00829322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92981844|NCT00829322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92981845|NCT00829322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981846|NCT00623480|Factor VIII|factor viii|mesh-list
92981847|NCT00623480|Coagulants|coagulants|mesh-ancestor
92981848|NCT02513667|Ceritinib|ceritinib|mesh-list
92981849|NCT02513667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981850|NCT02513667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92981851|NCT02513667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981852|NCT02513667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981853|NCT03823911|Sofosbuvir|sofosbuvir|mesh-list
92981854|NCT03823911|Grazoprevir|grazoprevir|mesh-list
92981855|NCT03823911|Ledipasvir|ledipasvir|mesh-list
92981856|NCT03823911|Velpatasvir|velpatasvir|mesh-list
92981857|NCT03823911|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92981858|NCT03823911|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92981859|NCT03823911|Antiviral Agents|antiviral agents|mesh-ancestor
92981860|NCT03823911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981861|NCT00829634|Methamphetamine|methamphetamine|mesh-list
92981862|NCT00829634|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92981863|NCT00829634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981864|NCT00829634|Sympathomimetics|sympathomimetics|mesh-ancestor
92981865|NCT00829634|Autonomic Agents|autonomic agents|mesh-ancestor
92981866|NCT00829634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981867|NCT00829634|Dopamine Agents|dopamine agents|mesh-ancestor
92981868|NCT00829634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981869|NCT00829634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981870|NCT00829634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981871|NCT00829634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92981872|NCT00829634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92981873|NCT00829634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981874|NCT00829634|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92981875|NCT04003467|Teriparatide|teriparatide|mesh-list
92981876|NCT04003467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92981877|NCT04003467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981878|NCT04003467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92981879|NCT00832208|Amphotericin B|amphotericin b|mesh-list
92981880|NCT00832208|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92981881|NCT00832208|Amebicides|amebicides|mesh-ancestor
92981882|NCT00832208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92981883|NCT00832208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92981884|NCT00832208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981885|NCT00832208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981886|NCT00832208|Antifungal Agents|antifungal agents|mesh-ancestor
92981887|NCT05361057|Cytarabine|cytarabine|mesh-list
92981888|NCT05361057|Azacitidine|azacitidine|mesh-list
92981889|NCT05361057|Daunorubicin|daunorubicin|mesh-list
92981890|NCT05361057|Venetoclax|venetoclax|mesh-list
92981891|NCT05361057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92981892|NCT05361057|Antimetabolites|antimetabolites|mesh-ancestor
92981893|NCT05361057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981894|NCT05361057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981895|NCT05361057|Antiviral Agents|antiviral agents|mesh-ancestor
92981896|NCT05361057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981897|NCT05361057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981898|NCT05361057|Immunologic Factors|immunologic factors|mesh-ancestor
92981899|NCT05361057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981900|NCT05361057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981901|NCT05361057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92981902|NCT05361057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92981903|NCT05361057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981904|NCT00832286|Ciprofloxacin|ciprofloxacin|mesh-list
92981905|NCT00832286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92981906|NCT00832286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981907|NCT00832286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92981908|NCT00832286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92981909|NCT00832286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92981910|NCT00832286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981911|NCT00832286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981912|NCT00832286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92981913|NCT00832286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92981914|NCT00832364|Etanercept|etanercept|mesh-list
92981915|NCT00832364|Acitretin|acitretin|mesh-list
92981916|NCT00832364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92981917|NCT00832364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92981918|NCT00832364|Analgesics|analgesics|mesh-ancestor
92981919|NCT00832364|Sensory System Agents|sensory system agents|mesh-ancestor
92981920|NCT00832364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981921|NCT00832364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981922|NCT00832364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981923|NCT00832364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92981924|NCT00832364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92981925|NCT00832364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92981926|NCT00832364|Immunologic Factors|immunologic factors|mesh-ancestor
92981927|NCT00832364|Keratolytic Agents|keratolytic agents|mesh-ancestor
92981928|NCT00832364|Dermatologic Agents|dermatologic agents|mesh-ancestor
92981929|NCT00832442|Metoprolol|metoprolol|mesh-list
92981930|NCT00832442|Carvedilol|carvedilol|mesh-list
92981931|NCT00832442|Nebivolol|nebivolol|mesh-list
92981932|NCT00832442|Bisoprolol|bisoprolol|mesh-list
92981933|NCT00832442|Bucindolol|bucindolol|mesh-list
92981934|NCT00832442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92981935|NCT00832442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92981936|NCT00832442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92981937|NCT00832442|Sympatholytics|sympatholytics|mesh-ancestor
92981938|NCT00832442|Autonomic Agents|autonomic agents|mesh-ancestor
92981939|NCT00832442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92981940|NCT00832442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981941|NCT00832442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92981942|NCT00832442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92981943|NCT00832442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92981944|NCT00832442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92981945|NCT00832442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981946|NCT00832442|Antioxidants|antioxidants|mesh-ancestor
92981947|NCT00832442|Protective Agents|protective agents|mesh-ancestor
92981948|NCT00832442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92981949|NCT00832442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92981950|NCT00832442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92981951|NCT00832442|Vasodilator Agents|vasodilator agents|mesh-ancestor
92981952|NCT00832442|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92981953|NCT00832442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92981954|NCT00832442|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92981955|NCT00832442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92981956|NCT00832442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92981957|NCT00832442|Sympathomimetics|sympathomimetics|mesh-ancestor
92981958|NCT00830414|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92981959|NCT00830414|Medroxyprogesterone|medroxyprogesterone|mesh-list
92981960|NCT00830414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92981961|NCT00830414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92981962|NCT00830414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92981963|NCT00830414|Contraceptive Agents|contraceptive agents|mesh-ancestor
92981964|NCT00830414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981965|NCT00830414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981966|NCT00830414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92981967|NCT00830414|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92981968|NCT00830414|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92981969|NCT00830414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92981970|NCT00830414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92981971|NCT00830492|Clomiphene|clomiphene|mesh-list
92981972|NCT00830492|Enclomiphene|enclomiphene|mesh-list
92981973|NCT00830492|Zuclomiphene|zuclomiphene|mesh-list
92981974|NCT00830492|Buserelin|buserelin|mesh-list
92981975|NCT00830492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92981976|NCT00830492|Hormone Antagonists|hormone antagonists|mesh-ancestor
92981977|NCT00830492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92981978|NCT00830492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981979|NCT00830492|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92981980|NCT00830492|Fertility Agents|fertility agents|mesh-ancestor
92981981|NCT00830492|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92981982|NCT00830492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92981983|NCT00830492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92981984|NCT00830570|Warfarin|warfarin|mesh-list
92981985|NCT00830570|Anticoagulants|anticoagulants|mesh-ancestor
92981986|NCT00837746|Risedronic Acid|risedronic acid|mesh-list
92981987|NCT00837746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92981988|NCT00837746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047062|NCT03983460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92981989|NCT00837746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92981990|NCT00837746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92981991|NCT00837746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981992|NCT00837746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92981993|NCT04043702|Topiramate|topiramate|mesh-list
92981994|NCT04043702|Anticonvulsants|anticonvulsants|mesh-ancestor
92981995|NCT04043702|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92981996|NCT04043702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92981997|NCT02550080|Dapsone|dapsone|mesh-list
92981998|NCT02550080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92981999|NCT02550080|Antimalarials|antimalarials|mesh-ancestor
92982000|NCT02550080|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92982001|NCT02550080|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92982002|NCT02550080|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92982003|NCT02550080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982004|NCT02550080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982005|NCT02550080|Leprostatic Agents|leprostatic agents|mesh-ancestor
92982006|NCT02550080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92982007|NCT02547350|Pirarubicin|pirarubicin|mesh-list
92982008|NCT02547350|Epirubicin|epirubicin|mesh-list
92982009|NCT02547350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982010|NCT02547350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92982011|NCT02547350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92982012|NCT02547350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92982013|NCT02547350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982014|NCT02547350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982015|NCT00838214|Prednisone|prednisone|mesh-list
92982016|NCT00838214|Budesonide|budesonide|mesh-list
92982017|NCT00838214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982018|NCT00838214|Glucocorticoids|glucocorticoids|mesh-ancestor
92982019|NCT00838214|Hormones|hormones|mesh-ancestor
92982020|NCT00838214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982021|NCT00838214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528129|NCT00000719|Zidovudine|zidovudine|mesh-list
92982022|NCT00838214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92982023|NCT00838214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982024|NCT00838214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92982025|NCT00838214|Autonomic Agents|autonomic agents|mesh-ancestor
92982026|NCT00838214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982027|NCT00838214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92982028|NCT00838214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92982029|NCT00621764|Vaccines|vaccines|mesh-list
92982030|NCT00621764|Immunologic Factors|immunologic factors|mesh-ancestor
92982031|NCT00621764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982032|NCT00838370|Fluorouracil|fluorouracil|mesh-list
92982033|NCT00838370|Capecitabine|capecitabine|mesh-list
92982034|NCT00838370|Antimetabolites|antimetabolites|mesh-ancestor
92982035|NCT00838370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982036|NCT00838370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92982037|NCT00838370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982038|NCT00838370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982039|NCT00838370|Immunologic Factors|immunologic factors|mesh-ancestor
92982040|NCT00838370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982041|NCT00537381|Prednisone|prednisone|mesh-list
92982042|NCT00537381|Docetaxel|docetaxel|mesh-list
92982043|NCT00537381|Intetumumab|intetumumab|mesh-list
92982044|NCT00537381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982045|NCT00537381|Tubulin Modulators|tubulin modulators|mesh-ancestor
92982046|NCT00537381|Antimitotic Agents|antimitotic agents|mesh-ancestor
92982047|NCT00537381|Mitosis Modulators|mitosis modulators|mesh-ancestor
92982048|NCT00537381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982049|NCT00537381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982050|NCT00537381|Glucocorticoids|glucocorticoids|mesh-ancestor
92982051|NCT00537381|Hormones|hormones|mesh-ancestor
92982052|NCT00537381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982053|NCT00537381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982054|NCT00537381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92982055|NCT00537381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982056|NCT00833300|Haloperidol|haloperidol|mesh-list
92982057|NCT00833300|Olanzapine|olanzapine|mesh-list
92982058|NCT00833300|Haloperidol decanoate|haloperidol decanoate|mesh-list
92982059|NCT00833300|Antiemetics|antiemetics|mesh-ancestor
92982060|NCT00833300|Autonomic Agents|autonomic agents|mesh-ancestor
92982061|NCT00833300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982062|NCT00833300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982063|NCT00833300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982064|NCT00833300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92982065|NCT00833300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92982066|NCT00833300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982067|NCT00833300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92982068|NCT00833300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92982069|NCT00833300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92982070|NCT00833300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982071|NCT00833300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982072|NCT00833300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982073|NCT00833300|Serotonin Agents|serotonin agents|mesh-ancestor
92982074|NCT00833300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92982075|NCT00833300|Dopamine Agents|dopamine agents|mesh-ancestor
92982076|NCT00833300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92982077|NCT00833378|Ritonavir|ritonavir|mesh-list
92982078|NCT00833378|Lopinavir|lopinavir|mesh-list
92982079|NCT00833378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92982080|NCT00833378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92982081|NCT00833378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982082|NCT00833378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982083|NCT00833378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982084|NCT00833378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92982085|NCT00833378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92982086|NCT00833378|Antiviral Agents|antiviral agents|mesh-ancestor
92982087|NCT00833378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982088|NCT00833378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92982089|NCT00833378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92982090|NCT05359341|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92982091|NCT05359341|Empagliflozin|empagliflozin|mesh-list
92982092|NCT05359341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92982093|NCT05359341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92982094|NCT05359341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92528130|NCT00000719|Zalcitabine|zalcitabine|mesh-list
92982095|NCT05359341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982096|NCT05359341|Incretins|incretins|mesh-ancestor
92982097|NCT05359341|Hormones|hormones|mesh-ancestor
92982098|NCT05359341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982099|NCT05359341|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982100|NCT05359341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982101|NCT05359341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982102|NCT05398731|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92982103|NCT05398731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92982104|NCT05398731|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982105|NCT05398731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982106|NCT05398731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982107|NCT05398731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982108|NCT00838760|Darunavir|darunavir|mesh-list
92982109|NCT00838760|TMC-310911|tmc-310911|mesh-list
92982110|NCT00838760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92982111|NCT00838760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92982112|NCT00838760|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982113|NCT00838760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982114|NCT00838760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982115|NCT00838760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92982116|NCT00838760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92982117|NCT00838760|Antiviral Agents|antiviral agents|mesh-ancestor
92982118|NCT00838760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982119|NCT03791398|Nivolumab|nivolumab|mesh-list
92982120|NCT03791398|TIC10 compound|tic10 compound|mesh-list
92982121|NCT03791398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982122|NCT03791398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982123|NCT03791398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92982124|NCT03791398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982125|NCT00838838|Methyltestosterone|methyltestosterone|mesh-list
92982126|NCT00838838|Testosterone|testosterone|mesh-list
92982127|NCT00838838|Testosterone undecanoate|testosterone undecanoate|mesh-list
92982128|NCT00838838|Testosterone enanthate|testosterone enanthate|mesh-list
92982129|NCT00838838|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92982130|NCT00838838|Androgens|androgens|mesh-ancestor
92982131|NCT00838838|Hormones|hormones|mesh-ancestor
92982132|NCT00838838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982133|NCT00838838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982134|NCT00838838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92982135|NCT00838838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982136|NCT00838838|Anabolic Agents|anabolic agents|mesh-ancestor
92982137|NCT05360979|Endostatins|endostatins|mesh-list
92982138|NCT05360979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982139|NCT05360979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92982140|NCT05360979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92982141|NCT05360979|Growth Substances|growth substances|mesh-ancestor
92982142|NCT05360979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982143|NCT05360979|Growth Inhibitors|growth inhibitors|mesh-ancestor
92982145|NCT00833534|Lenalidomide|lenalidomide|mesh-list
92982146|NCT00833534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982147|NCT00833534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982148|NCT00833534|Immunologic Factors|immunologic factors|mesh-ancestor
92982149|NCT00833534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982150|NCT00833534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982151|NCT00833534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92982152|NCT00833534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92982153|NCT00833534|Growth Substances|growth substances|mesh-ancestor
92982154|NCT00833534|Growth Inhibitors|growth inhibitors|mesh-ancestor
92982155|NCT05591001|Ketamine|ketamine|mesh-list
92982156|NCT05591001|Propofol|propofol|mesh-list
92982157|NCT05591001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92982158|NCT05591001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982159|NCT05591001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982160|NCT05591001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92982161|NCT05591001|Anesthetics, General|anesthetics, general|mesh-ancestor
92982162|NCT05591001|Anesthetics|anesthetics|mesh-ancestor
92982163|NCT05591001|Analgesics|analgesics|mesh-ancestor
92982164|NCT05591001|Sensory System Agents|sensory system agents|mesh-ancestor
92982165|NCT05591001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982166|NCT05591001|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92982167|NCT05591001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92982168|NCT05591001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92982169|NCT05591001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982170|NCT05591001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982171|NCT00517192|Ritonavir|ritonavir|mesh-list
92982172|NCT00517192|Darunavir|darunavir|mesh-list
92982173|NCT00517192|Tipranavir|tipranavir|mesh-list
92982174|NCT00517192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92982175|NCT00517192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92982176|NCT00517192|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982177|NCT00517192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982178|NCT00517192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982179|NCT00517192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92982180|NCT00517192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92982181|NCT00517192|Antiviral Agents|antiviral agents|mesh-ancestor
92982182|NCT00517192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982183|NCT00517192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92982184|NCT00517192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92982185|NCT00145327|Zoledronic Acid|zoledronic acid|mesh-list
92982186|NCT00145327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92982187|NCT00145327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982188|NCT00833768|Sevelamer|sevelamer|mesh-list
92982189|NCT00833768|Chelating Agents|chelating agents|mesh-ancestor
92982190|NCT00833768|Sequestering Agents|sequestering agents|mesh-ancestor
92982191|NCT00833768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982192|NCT00510484|Pancrelipase|pancrelipase|mesh-list
92982193|NCT00510484|Pancreatin|pancreatin|mesh-list
92982194|NCT00510484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982195|NCT00839228|Perhexiline|perhexiline|mesh-list
92982196|NCT00839228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92982197|NCT00839228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982198|NCT00839228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982199|NCT00839228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92982200|NCT00839228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982201|NCT00839228|Vasodilator Agents|vasodilator agents|mesh-ancestor
92982202|NCT05408481|Hydrocortisone|hydrocortisone|mesh-list
92982203|NCT05408481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982204|NCT00839462|Pantothenic Acid|pantothenic acid|mesh-list
92982205|NCT00839462|Vitamin B Complex|vitamin b complex|mesh-ancestor
92982206|NCT00839462|Vitamins|vitamins|mesh-ancestor
92982207|NCT00839462|Micronutrients|micronutrients|mesh-ancestor
92982208|NCT00839462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982209|NCT05590221|Cyclophosphamide|cyclophosphamide|mesh-list
92982210|NCT05590221|Fludarabine|fludarabine|mesh-list
92982211|NCT05590221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982212|NCT05590221|Immunologic Factors|immunologic factors|mesh-ancestor
92982213|NCT05590221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982214|NCT05590221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982215|NCT05590221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92982216|NCT05590221|Alkylating Agents|alkylating agents|mesh-ancestor
92982217|NCT05590221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982218|NCT05590221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982219|NCT05590221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92982220|NCT05590143|Dapagliflozin|dapagliflozin|mesh-list
92982221|NCT05590143|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92982222|NCT05590143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982223|NCT05590143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982224|NCT05590143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982226|NCT00622388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982227|NCT01156389|Ritonavir|ritonavir|mesh-list
92982228|NCT01156389|Artesunate|artesunate|mesh-list
92982229|NCT01156389|Pyronaridine|pyronaridine|mesh-list
92982230|NCT01156389|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92982231|NCT01156389|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92982232|NCT01156389|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92982233|NCT01156389|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982234|NCT01156389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982235|NCT01156389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982236|NCT01156389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92982237|NCT01156389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92982238|NCT01156389|Antiviral Agents|antiviral agents|mesh-ancestor
92982239|NCT01156389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982240|NCT01156389|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92982241|NCT01156389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92982242|NCT01156389|Antimalarials|antimalarials|mesh-ancestor
92982244|NCT01156389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92982245|NCT01156389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982246|NCT01156389|Schistosomicides|schistosomicides|mesh-ancestor
92982247|NCT01156389|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92982248|NCT01156389|Anthelmintics|anthelmintics|mesh-ancestor
92982249|NCT04043624|Lidocaine|lidocaine|mesh-list
92982250|NCT04043624|Anesthetics, Local|anesthetics, local|mesh-ancestor
92982251|NCT04043624|Anesthetics|anesthetics|mesh-ancestor
92982252|NCT04043624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982253|NCT04043624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982254|NCT04043624|Sensory System Agents|sensory system agents|mesh-ancestor
92982255|NCT04043624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982256|NCT04043624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92982257|NCT04043624|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92982258|NCT04043624|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92982259|NCT04043624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982260|NCT04043624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982261|NCT01105767|Chlorhexidine|chlorhexidine|mesh-list
92982262|NCT01105767|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92982263|NCT01105767|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92982264|NCT01105767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982265|NCT01105767|Disinfectants|disinfectants|mesh-ancestor
92982266|NCT01105767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92982267|NCT00625742|Ibuprofen|ibuprofen|mesh-list
92982268|NCT00625742|Atenolol|atenolol|mesh-list
92982269|NCT00625742|Melatonin|melatonin|mesh-list
92982270|NCT00625742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92982271|NCT00625742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92982272|NCT00625742|Analgesics|analgesics|mesh-ancestor
92982273|NCT00625742|Sensory System Agents|sensory system agents|mesh-ancestor
92982274|NCT00625742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982275|NCT00625742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982276|NCT00625742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982277|NCT00625742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982278|NCT00625742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92982279|NCT00625742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982280|NCT00625742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982281|NCT00625742|Antioxidants|antioxidants|mesh-ancestor
92982282|NCT00625742|Protective Agents|protective agents|mesh-ancestor
92982283|NCT00625742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982284|NCT00625742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92982285|NCT00625742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982286|NCT00625742|Sympatholytics|sympatholytics|mesh-ancestor
92982287|NCT00625742|Autonomic Agents|autonomic agents|mesh-ancestor
92982288|NCT00625742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92982289|NCT00625742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92982290|NCT00625742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92982291|NCT00625742|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982292|NCT00625742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982293|NCT05589441|Insulin|insulin|mesh-list
92982294|NCT05589441|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92982295|NCT05589441|Albuterol|albuterol|mesh-list
92982296|NCT05589441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982297|NCT05589441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982298|NCT05589441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92982299|NCT05589441|Autonomic Agents|autonomic agents|mesh-ancestor
92982300|NCT05589441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982301|NCT05589441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92982302|NCT05589441|Respiratory System Agents|respiratory system agents|mesh-ancestor
92982303|NCT05589441|Tocolytic Agents|tocolytic agents|mesh-ancestor
92982304|NCT05589441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92982305|NCT05589441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92982306|NCT05589441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92982307|NCT05589441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92982308|NCT05589441|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982309|NCT05589441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982310|NCT05589441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982311|NCT00825188|Amlodipine|amlodipine|mesh-list
92982312|NCT00825188|Eplerenone|eplerenone|mesh-list
92982313|NCT00825188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982314|NCT00825188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92982315|NCT00825188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982316|NCT00825188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982317|NCT00825188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92982318|NCT00825188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982319|NCT00825188|Vasodilator Agents|vasodilator agents|mesh-ancestor
92982320|NCT00825188|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92982321|NCT00825188|Hormone Antagonists|hormone antagonists|mesh-ancestor
92982322|NCT00825188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982323|NCT00825188|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92982324|NCT00825188|Diuretics|diuretics|mesh-ancestor
92982325|NCT00825188|Natriuretic Agents|natriuretic agents|mesh-ancestor
92982326|NCT00834470|Atropine|atropine|mesh-list
92982327|NCT00834470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92982328|NCT00834470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92982329|NCT00834470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92982330|NCT00834470|Autonomic Agents|autonomic agents|mesh-ancestor
92982331|NCT00834470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982332|NCT00834470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982333|NCT00834470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92982334|NCT00834470|Respiratory System Agents|respiratory system agents|mesh-ancestor
92982335|NCT00834470|Mydriatics|mydriatics|mesh-ancestor
92982336|NCT00834470|Parasympatholytics|parasympatholytics|mesh-ancestor
92982337|NCT00834470|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92982338|NCT00834470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92982339|NCT00834470|Cholinergic Agents|cholinergic agents|mesh-ancestor
92982340|NCT00834470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982341|NCT00834470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982342|NCT03997864|Prazosin|prazosin|mesh-list
92982343|NCT03997864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982344|NCT03997864|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92982345|NCT03997864|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92982346|NCT03997864|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92982347|NCT03997864|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982348|NCT03997864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982349|NCT03997864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982350|NCT03997864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982351|NCT05407467|Curcumin|curcumin|mesh-list
92982352|NCT05407467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92982353|NCT05407467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92982354|NCT05407467|Analgesics|analgesics|mesh-ancestor
92982355|NCT05407467|Sensory System Agents|sensory system agents|mesh-ancestor
92982356|NCT05407467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982357|NCT05407467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982358|NCT05407467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982359|NCT05407467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982360|NCT05407467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982361|NCT05407467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047063|NCT03983460|Glucocorticoids|glucocorticoids|mesh-ancestor
92982362|NCT05407467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982363|NCT01010152|Codeine|codeine|mesh-list
92982364|NCT01010152|Analgesics|analgesics|mesh-ancestor
92982365|NCT01010152|Sensory System Agents|sensory system agents|mesh-ancestor
92982366|NCT01010152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982367|NCT01010152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982368|NCT01010152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92982369|NCT01010152|Narcotics|narcotics|mesh-ancestor
92982370|NCT01010152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982371|NCT01010152|Antitussive Agents|antitussive agents|mesh-ancestor
92982372|NCT01010152|Respiratory System Agents|respiratory system agents|mesh-ancestor
92982373|NCT05407233|Insulin|insulin|mesh-list
92982374|NCT05407233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92982375|NCT05407233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982376|NCT05407233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982377|NCT02549846|Atorvastatin|atorvastatin|mesh-list
92982378|NCT02549846|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92982379|NCT02549846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92982380|NCT02549846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92982381|NCT02549846|Antimetabolites|antimetabolites|mesh-ancestor
92982382|NCT02549846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982383|NCT02549846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92982384|NCT02549846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92982385|NCT02549846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982386|NCT05407155|Paclitaxel|paclitaxel|mesh-list
92982387|NCT05407155|Bevacizumab|bevacizumab|mesh-list
92982388|NCT05407155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327693|NCT00002215|Nelfinavir|nelfinavir|mesh-list
92982390|NCT05407155|Tubulin Modulators|tubulin modulators|mesh-ancestor
92982391|NCT05407155|Antimitotic Agents|antimitotic agents|mesh-ancestor
92982392|NCT05407155|Mitosis Modulators|mitosis modulators|mesh-ancestor
92982393|NCT05407155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982394|NCT05407155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982395|NCT05407155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92982396|NCT05407155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92982397|NCT05407155|Growth Substances|growth substances|mesh-ancestor
92982398|NCT05407155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982399|NCT05407155|Growth Inhibitors|growth inhibitors|mesh-ancestor
92982400|NCT00840242|Nicotine|nicotine|mesh-list
92982401|NCT00840242|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92982402|NCT00840242|Autonomic Agents|autonomic agents|mesh-ancestor
92982403|NCT00840242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982404|NCT00840242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982405|NCT00840242|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92982406|NCT00840242|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92982407|NCT00840242|Cholinergic Agents|cholinergic agents|mesh-ancestor
92982408|NCT00840242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982409|NCT00840242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982410|NCT00840398|Buspirone|buspirone|mesh-list
92982411|NCT00840398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92982412|NCT00840398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92982413|NCT00840398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982414|NCT00840398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982415|NCT00840398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92982416|NCT00840398|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92982417|NCT00840398|Serotonin Agents|serotonin agents|mesh-ancestor
92982418|NCT00840398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982419|NCT00840398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982420|NCT00537303|Insulin|insulin|mesh-list
92982421|NCT00537303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92982422|NCT00537303|Insulin Aspart|insulin aspart|mesh-list
92982423|NCT00537303|Insulin, Long-Acting|insulin, long-acting|mesh-list
92982424|NCT00537303|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92982425|NCT00537303|Insulin Detemir|insulin detemir|mesh-list
92982426|NCT00537303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982427|NCT00537303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982428|NCT02548286|Amlodipine|amlodipine|mesh-list
92982429|NCT02548286|Candesartan|candesartan|mesh-list
92982430|NCT02548286|Candesartan cilexetil|candesartan cilexetil|mesh-list
92982431|NCT02548286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982432|NCT02548286|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92982433|NCT02548286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982434|NCT02548286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982435|NCT02548286|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92627855|NCT00193089|Docetaxel|docetaxel|mesh-list
92982436|NCT02548286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982437|NCT02548286|Vasodilator Agents|vasodilator agents|mesh-ancestor
92982438|NCT02548286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92982439|NCT02548286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92982440|NCT05360433|Oxycodone|oxycodone|mesh-list
92982441|NCT05360433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92982442|NCT05360433|Narcotics|narcotics|mesh-ancestor
92982443|NCT05360433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982444|NCT05360433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982445|NCT05360433|Analgesics|analgesics|mesh-ancestor
92982446|NCT05360433|Sensory System Agents|sensory system agents|mesh-ancestor
92982447|NCT05360433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982448|NCT00834860|Ribavirin|ribavirin|mesh-list
92982449|NCT00834860|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92982450|NCT00834860|Antimetabolites|antimetabolites|mesh-ancestor
92982451|NCT00834860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982452|NCT00834860|Antiviral Agents|antiviral agents|mesh-ancestor
92982453|NCT00834860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982454|NCT04696575|Lamivudine|lamivudine|mesh-list
92982455|NCT04696575|Carboplatin|carboplatin|mesh-list
92982456|NCT04696575|Etoposide|etoposide|mesh-list
92982457|NCT04696575|Etoposide phosphate|etoposide phosphate|mesh-list
92982458|NCT04696575|Atezolizumab|atezolizumab|mesh-list
92982459|NCT04696575|Podophyllotoxin|podophyllotoxin|mesh-list
92982460|NCT04696575|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92982461|NCT04696575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982462|NCT04696575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92982463|NCT04696575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92982464|NCT04696575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92982465|NCT04696575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982466|NCT04696575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982467|NCT04696575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92982468|NCT04696575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982469|NCT04696575|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92982470|NCT04696575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92982471|NCT04696575|Antiviral Agents|antiviral agents|mesh-ancestor
92982472|NCT04696575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982473|NCT04696575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92982474|NCT04696575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92982475|NCT04696575|Immunologic Factors|immunologic factors|mesh-ancestor
92982476|NCT04696575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982477|NCT04696575|Keratolytic Agents|keratolytic agents|mesh-ancestor
92982478|NCT04696575|Dermatologic Agents|dermatologic agents|mesh-ancestor
92982479|NCT04696575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92982480|NCT04696575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92982481|NCT04696575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92982482|NCT00825422|Ropivacaine|ropivacaine|mesh-list
92982483|NCT00825422|Anesthetics, Local|anesthetics, local|mesh-ancestor
92982484|NCT00825422|Anesthetics|anesthetics|mesh-ancestor
92982485|NCT00825422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982486|NCT00825422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982487|NCT00825422|Sensory System Agents|sensory system agents|mesh-ancestor
92982488|NCT00825422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982489|NCT00505414|Morphine|morphine|mesh-list
92982490|NCT00505414|Tapentadol|tapentadol|mesh-list
92982491|NCT00505414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92982492|NCT00505414|Narcotics|narcotics|mesh-ancestor
92982493|NCT00505414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982494|NCT00505414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982495|NCT00505414|Analgesics|analgesics|mesh-ancestor
92982496|NCT00505414|Sensory System Agents|sensory system agents|mesh-ancestor
92982497|NCT00505414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982498|NCT00505414|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92982499|NCT00505414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92982500|NCT00505414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982501|NCT00505414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982502|NCT00505414|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982503|NCT00505414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982504|NCT02549924|Resveratrol|resveratrol|mesh-list
92982505|NCT02549924|Antioxidants|antioxidants|mesh-ancestor
92982506|NCT02549924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982507|NCT02549924|Protective Agents|protective agents|mesh-ancestor
92982508|NCT02549924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982509|NCT02549924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982510|NCT02549924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92627932|NCT00193323|Gemcitabine|gemcitabine|mesh-list
92982511|NCT01813227|Dexamethasone|dexamethasone|mesh-list
92982512|NCT01813227|Rituximab|rituximab|mesh-list
92982513|NCT01813227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982514|NCT01813227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982515|NCT01813227|Immunologic Factors|immunologic factors|mesh-ancestor
92982516|NCT01813227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982517|NCT01813227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982518|NCT01813227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982519|NCT01813227|Antiemetics|antiemetics|mesh-ancestor
92982520|NCT01813227|Autonomic Agents|autonomic agents|mesh-ancestor
92982521|NCT01813227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982522|NCT01813227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982523|NCT01813227|Glucocorticoids|glucocorticoids|mesh-ancestor
92982524|NCT01813227|Hormones|hormones|mesh-ancestor
92982525|NCT01813227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982526|NCT01813227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92982527|NCT01012882|Immunomodulating Agents|immunomodulating agents|mesh-list
92982528|NCT01012882|Immunologic Factors|immunologic factors|mesh-list
92982529|NCT01012882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982530|NCT00989469|Irinotecan|irinotecan|mesh-list
92982531|NCT00989469|Sorafenib|sorafenib|mesh-list
92982532|NCT00989469|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92982533|NCT00989469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92982534|NCT00989469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982535|NCT00989469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982536|NCT00989469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982537|NCT00989469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92982539|NCT01010308|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92982540|NCT01010308|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92982541|NCT01010308|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982542|NCT01010308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982543|NCT01010308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982544|NCT01010308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982545|NCT01010308|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92982546|NCT01010308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982547|NCT01010308|Sympatholytics|sympatholytics|mesh-ancestor
92982548|NCT01010308|Autonomic Agents|autonomic agents|mesh-ancestor
92982549|NCT01010308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982550|NCT02548052|Betamethasone|betamethasone|mesh-list
92982551|NCT02548052|Betamethasone Valerate|betamethasone valerate|mesh-list
92982552|NCT02548052|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92982553|NCT02548052|Betamethasone benzoate|betamethasone benzoate|mesh-list
92982554|NCT02548052|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92982555|NCT02548052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982556|NCT02548052|Glucocorticoids|glucocorticoids|mesh-ancestor
92982557|NCT02548052|Hormones|hormones|mesh-ancestor
92982558|NCT02548052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982559|NCT02548052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982560|NCT02548052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92982561|NCT02548052|Respiratory System Agents|respiratory system agents|mesh-ancestor
92982562|NCT04590417|Cyproterone Acetate|cyproterone acetate|mesh-list
92982563|NCT04590417|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92982564|NCT04590417|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92982565|NCT04590417|Estradiol|estradiol|mesh-list
92982566|NCT04590417|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92982567|NCT04590417|Cyproterone|cyproterone|mesh-list
92982568|NCT04590417|Estrogens|estrogens|mesh-ancestor
92982569|NCT04590417|Hormones|hormones|mesh-ancestor
92982570|NCT04590417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982571|NCT04590417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982572|NCT04590417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92982573|NCT04590417|Contraceptive Agents|contraceptive agents|mesh-ancestor
92982574|NCT04590417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92982575|NCT04590417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92982576|NCT04590417|Androgen Antagonists|androgen antagonists|mesh-ancestor
92982577|NCT04590417|Hormone Antagonists|hormone antagonists|mesh-ancestor
92982578|NCT04590417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982579|NCT04590417|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92982580|NCT00825656|Capsaicin|capsaicin|mesh-list
92982581|NCT00825656|Antipruritics|antipruritics|mesh-ancestor
92982582|NCT00825656|Dermatologic Agents|dermatologic agents|mesh-ancestor
92982583|NCT00825656|Sensory System Agents|sensory system agents|mesh-ancestor
92982584|NCT00825656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628006|NCT00164216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93047064|NCT03983460|Hormones|hormones|mesh-ancestor
92982585|NCT00825656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982586|NCT00989625|Naproxen|naproxen|mesh-list
92982587|NCT00989625|Sumatriptan|sumatriptan|mesh-list
92982588|NCT00989625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92982589|NCT00989625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92982590|NCT00989625|Analgesics|analgesics|mesh-ancestor
92982591|NCT00989625|Sensory System Agents|sensory system agents|mesh-ancestor
92982592|NCT00989625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982593|NCT00989625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982594|NCT00989625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982595|NCT00989625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982596|NCT00989625|Gout Suppressants|gout suppressants|mesh-ancestor
92982597|NCT00989625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92982598|NCT00989625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982599|NCT00989625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982600|NCT00989625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92982601|NCT00989625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92982602|NCT00989625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92982603|NCT00989625|Serotonin Agents|serotonin agents|mesh-ancestor
92982604|NCT00989625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982605|NCT00841256|Glycerol|glycerol|mesh-list
92982606|NCT00841256|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92982607|NCT00841256|Protective Agents|protective agents|mesh-ancestor
92982608|NCT00841256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982610|NCT00989703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92982611|NCT00989703|Abortifacient Agents|abortifacient agents|mesh-ancestor
92982612|NCT00989703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92982613|NCT00989703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982614|NCT00989703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92982615|NCT00989703|Antimetabolites|antimetabolites|mesh-ancestor
92167349|NCT05586763|Diphenhydramine|diphenhydramine|mesh-list
92982616|NCT00989703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982617|NCT00989703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982618|NCT00989703|Dermatologic Agents|dermatologic agents|mesh-ancestor
92982619|NCT00989703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982620|NCT00989703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92982621|NCT00989703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982622|NCT00989703|Immunologic Factors|immunologic factors|mesh-ancestor
92982623|NCT00989703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982624|NCT00989703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92982625|NCT01012960|Methylnaltrexone|methylnaltrexone|mesh-list
92982626|NCT01012960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92982627|NCT01012960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982628|NCT01012960|Sensory System Agents|sensory system agents|mesh-ancestor
92982629|NCT01012960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982630|NCT00625586|Gemcitabine|gemcitabine|mesh-list
92982631|NCT00625586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92982632|NCT00625586|Antimetabolites|antimetabolites|mesh-ancestor
92982633|NCT00625586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982634|NCT00625586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982635|NCT02547116|Rifampin|rifampin|mesh-list
92982636|NCT02547116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92982637|NCT02547116|Antitubercular Agents|antitubercular agents|mesh-ancestor
92982638|NCT02547116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92982639|NCT02547116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982640|NCT02547116|Leprostatic Agents|leprostatic agents|mesh-ancestor
92982641|NCT02547116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92982642|NCT02547116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982643|NCT02547116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982644|NCT02547116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92982645|NCT02547116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92982646|NCT02547116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92982647|NCT02547116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92982648|NCT02547116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92982649|NCT02547116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92982650|NCT02549690|Testosterone|testosterone|mesh-list
92982651|NCT02549690|Androgens|androgens|mesh-ancestor
92982652|NCT02549690|Hormones|hormones|mesh-ancestor
92982653|NCT02549690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982654|NCT02549690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982655|NCT02549768|Dexmedetomidine|dexmedetomidine|mesh-list
92982656|NCT02549768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92982657|NCT02549768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982658|NCT02549768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982659|NCT02549768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92982660|NCT02549768|Analgesics|analgesics|mesh-ancestor
92982661|NCT02549768|Sensory System Agents|sensory system agents|mesh-ancestor
92982662|NCT02549768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982663|NCT02549768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92982664|NCT02549768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92982665|NCT02549768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92982666|NCT02549768|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982667|NCT02549768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982668|NCT02549768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982669|NCT00841724|Fludarabine|fludarabine|mesh-list
92982670|NCT00841724|Busulfan|busulfan|mesh-list
92982671|NCT00841724|Thymoglobulin|thymoglobulin|mesh-list
92982672|NCT00841724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982673|NCT00841724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982674|NCT00841724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982675|NCT00841724|Immunologic Factors|immunologic factors|mesh-ancestor
92982676|NCT00841724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982677|NCT00841724|Alkylating Agents|alkylating agents|mesh-ancestor
92982678|NCT00841724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92982679|NCT00841724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92982680|NCT00843362|Dinoprostone|dinoprostone|mesh-list
92982681|NCT00843362|Oxytocics|oxytocics|mesh-ancestor
92982682|NCT00843362|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92982683|NCT00843362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982684|NCT00841802|Prednisone|prednisone|mesh-list
92982685|NCT00841802|Glucocorticoids|glucocorticoids|mesh-list
92982686|NCT00841802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982687|NCT00841802|Hormones|hormones|mesh-ancestor
92982688|NCT00841802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982689|NCT00841802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982690|NCT00841802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92982691|NCT00841802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982692|NCT00621140|Linagliptin|linagliptin|mesh-list
92982693|NCT00621140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982694|NCT00621140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982695|NCT00621140|Incretins|incretins|mesh-ancestor
92982696|NCT00621140|Hormones|hormones|mesh-ancestor
92982697|NCT00621140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982698|NCT00621140|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92982699|NCT00621140|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982700|NCT00621140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982701|NCT00621140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982702|NCT00207727|Ustekinumab|ustekinumab|mesh-list
92982703|NCT00207727|Dermatologic Agents|dermatologic agents|mesh-ancestor
92982704|NCT00841880|Felodipine|felodipine|mesh-list
92982705|NCT00841880|Ramipril|ramipril|mesh-list
92982706|NCT00841880|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92982707|NCT00841880|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982708|NCT00841880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982709|NCT00841880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982710|NCT00841880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982711|NCT00841880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92982712|NCT00841880|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92982713|NCT00841880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982714|NCT00841880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92982715|NCT00841880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982716|NCT00841880|Vasodilator Agents|vasodilator agents|mesh-ancestor
92982717|NCT00843440|Bevacizumab|bevacizumab|mesh-list
92982718|NCT00843440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982719|NCT00843440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982720|NCT00843440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92982721|NCT00843440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92982722|NCT00843440|Growth Substances|growth substances|mesh-ancestor
92982723|NCT00843440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982724|NCT00843440|Growth Inhibitors|growth inhibitors|mesh-ancestor
92982725|NCT00504556|Warfarin|warfarin|mesh-list
92982726|NCT00504556|Edoxaban|edoxaban|mesh-list
92982727|NCT00504556|Anticoagulants|anticoagulants|mesh-ancestor
92982728|NCT00504556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92982729|NCT00504556|Antithrombins|antithrombins|mesh-ancestor
92982730|NCT00504556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92982731|NCT00504556|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982732|NCT00504556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982733|NCT00504556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982734|NCT00206323|Topiramate|topiramate|mesh-list
92982735|NCT00206323|Anticonvulsants|anticonvulsants|mesh-ancestor
92982736|NCT00206323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982737|NCT00206323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982738|NCT02546804|Chlorhexidine|chlorhexidine|mesh-list
92982739|NCT02546804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92982740|NCT02546804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982741|NCT02546804|Disinfectants|disinfectants|mesh-ancestor
92982742|NCT00842114|Interferons|interferons|mesh-list
92982743|NCT00842114|Prednisone|prednisone|mesh-list
92982744|NCT00842114|Cyclophosphamide|cyclophosphamide|mesh-list
92982745|NCT00842114|Vincristine|vincristine|mesh-list
92982746|NCT00842114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982747|NCT00842114|Immunologic Factors|immunologic factors|mesh-ancestor
92982748|NCT00842114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982749|NCT00842114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982750|NCT00842114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92982751|NCT00842114|Alkylating Agents|alkylating agents|mesh-ancestor
92982752|NCT00842114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982753|NCT00842114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982754|NCT00842114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92982755|NCT00842114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982756|NCT00842114|Glucocorticoids|glucocorticoids|mesh-ancestor
92982757|NCT00842114|Hormones|hormones|mesh-ancestor
92167355|NCT05586763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982758|NCT00842114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982759|NCT00842114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92982760|NCT00842114|Antiviral Agents|antiviral agents|mesh-ancestor
92982761|NCT00842114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982762|NCT00842114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92982763|NCT00842114|Tubulin Modulators|tubulin modulators|mesh-ancestor
92982764|NCT00842114|Antimitotic Agents|antimitotic agents|mesh-ancestor
92982765|NCT00842114|Mitosis Modulators|mitosis modulators|mesh-ancestor
92982766|NCT00842192|Insulin Detemir|insulin detemir|mesh-list
92982767|NCT00842192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982768|NCT00842192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982769|NCT00536991|Calcitriol|calcitriol|mesh-list
92982770|NCT00536991|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92982771|NCT00536991|Ketoconazole|ketoconazole|mesh-list
92982772|NCT00536991|Hydrocortisone|hydrocortisone|mesh-list
92982773|NCT00536991|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92982774|NCT00536991|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92982775|NCT00536991|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92982776|NCT00536991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982777|NCT00536991|Antifungal Agents|antifungal agents|mesh-ancestor
92982778|NCT00536991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982779|NCT00536991|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92982780|NCT00536991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92982781|NCT00536991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982782|NCT00536991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982783|NCT00536991|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92982784|NCT00536991|Hormone Antagonists|hormone antagonists|mesh-ancestor
92982785|NCT00536991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982786|NCT00536991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982787|NCT00536991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92982788|NCT00536991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92982789|NCT00536991|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92982790|NCT00536991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92982791|NCT00536991|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92982792|NCT00536991|Vitamins|vitamins|mesh-ancestor
92982793|NCT00536991|Micronutrients|micronutrients|mesh-ancestor
92982794|NCT00536991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92982795|NCT03902613|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92982796|NCT03902613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92982797|NCT03902613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92982798|NCT03902613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982799|NCT03902613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982800|NCT03902613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92982801|NCT03902613|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92982802|NCT03902613|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92982803|NCT03902613|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92982804|NCT03902613|Adrenergic Agents|adrenergic agents|mesh-ancestor
92982805|NCT03902613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628237|NCT00165035|Paclitaxel|paclitaxel|mesh-list
92982806|NCT03902613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982807|NCT03902613|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92982808|NCT03902613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92982809|NCT03902613|Serotonin Agents|serotonin agents|mesh-ancestor
92982810|NCT03902613|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92982811|NCT03902613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92982812|NCT03902613|Dopamine Agents|dopamine agents|mesh-ancestor
92982813|NCT00504166|Alendronate|alendronate|mesh-list
92982814|NCT00504166|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92982815|NCT00504166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982816|NCT02546648|Tranexamic Acid|tranexamic acid|mesh-list
92982817|NCT02546648|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92982818|NCT02546648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92982819|NCT02546648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92982820|NCT02546648|Antimetabolites|antimetabolites|mesh-ancestor
92982821|NCT02546648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982822|NCT02546648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92982823|NCT02546648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92982824|NCT02546648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982825|NCT02546648|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92982826|NCT02546648|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92982827|NCT02546648|Hemostatics|hemostatics|mesh-ancestor
92982828|NCT02546648|Coagulants|coagulants|mesh-ancestor
92982829|NCT00842504|Micafungin|micafungin|mesh-list
92982830|NCT00842504|Antifungal Agents|antifungal agents|mesh-ancestor
92982831|NCT00842504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982832|NCT00842582|Azacitidine|azacitidine|mesh-list
92982833|NCT00842582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92982834|NCT00842582|Antimetabolites|antimetabolites|mesh-ancestor
92982835|NCT00842582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982836|NCT00842582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982837|NCT00842582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982838|NCT00843908|Imidacloprid|imidacloprid|mesh-list
92982839|NCT00843908|Cholinergic Agents|cholinergic agents|mesh-ancestor
92982840|NCT00843908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982841|NCT00843908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982842|NCT00843908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982843|NCT00842660|Gemcitabine|gemcitabine|mesh-list
92982844|NCT00842660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92982845|NCT00842660|Antimetabolites|antimetabolites|mesh-ancestor
92982846|NCT00842660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982847|NCT00842660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982848|NCT00509236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92982849|NCT00509236|Glipizide|glipizide|mesh-list
92982850|NCT00509236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982851|NCT00509236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982852|NCT00509236|Incretins|incretins|mesh-ancestor
92982853|NCT00509236|Hormones|hormones|mesh-ancestor
92982854|NCT00509236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982855|NCT00509236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92982856|NCT00509236|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982857|NCT00509236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982858|NCT00509236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982859|NCT00842894|Insulin|insulin|mesh-list
92982860|NCT00842894|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92982861|NCT00842894|Insulin Aspart|insulin aspart|mesh-list
92982862|NCT00842894|Insulin Detemir|insulin detemir|mesh-list
92982863|NCT00842894|Biphasic Insulins|biphasic insulins|mesh-list
92982864|NCT00842894|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92982865|NCT00842894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92982866|NCT00842894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982867|NCT00508924|Heparin|heparin|mesh-list
92982868|NCT00508924|Argatroban|argatroban|mesh-list
92982869|NCT00508924|Anticoagulants|anticoagulants|mesh-ancestor
92982870|NCT00508924|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92982871|NCT00508924|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92982872|NCT00508924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982873|NCT00508924|Antithrombins|antithrombins|mesh-ancestor
92982874|NCT00508924|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92982875|NCT00508924|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982876|NCT00508924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982877|NCT00508924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92982878|NCT00836576|Benazepril|benazepril|mesh-list
92982879|NCT00836576|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92628320|NCT00165308|Tamoxifen|tamoxifen|mesh-list
92982880|NCT00836576|Protease Inhibitors|protease inhibitors|mesh-ancestor
92982881|NCT00836576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982882|NCT00836576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982883|NCT00836576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92982885|NCT00836654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982886|NCT00844064|Trabedersen|trabedersen|mesh-list
92982887|NCT00844064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982888|NCT04688788|Fexofenadine|fexofenadine|mesh-list
92982889|NCT04688788|Methylprednisolone|methylprednisolone|mesh-list
92982890|NCT04688788|Rituximab|rituximab|mesh-list
92982891|NCT04688788|Ocrelizumab|ocrelizumab|mesh-list
92982892|NCT04688788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982893|NCT04688788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982894|NCT04688788|Immunologic Factors|immunologic factors|mesh-ancestor
92982895|NCT04688788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982896|NCT04688788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982897|NCT04688788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982898|NCT04688788|Antiemetics|antiemetics|mesh-ancestor
92982899|NCT04688788|Autonomic Agents|autonomic agents|mesh-ancestor
92982900|NCT04688788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982901|NCT04688788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982903|NCT04688788|Hormones|hormones|mesh-ancestor
92982904|NCT04688788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92982905|NCT04688788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92982906|NCT04688788|Protective Agents|protective agents|mesh-ancestor
92982907|NCT04688788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92982908|NCT04688788|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92982909|NCT04688788|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92982910|NCT04688788|Histamine Antagonists|histamine antagonists|mesh-ancestor
92982911|NCT04688788|Histamine Agents|histamine agents|mesh-ancestor
92982912|NCT04688788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92982913|NCT04688788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982914|NCT05221593|Lithium Carbonate|lithium carbonate|mesh-list
92982915|NCT05221593|Antidepressive Agents|antidepressive agents|mesh-ancestor
92982916|NCT05221593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92982917|NCT05221593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982918|NCT05221593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982919|NCT05221593|Antimanic Agents|antimanic agents|mesh-ancestor
92982920|NCT05221593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92982921|NCT05221593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92982922|NCT05221593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982923|NCT00844142|Sulfasalazine|sulfasalazine|mesh-list
92982924|NCT00844142|Etanercept|etanercept|mesh-list
92982925|NCT00844142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92982926|NCT00844142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92982927|NCT00844142|Analgesics|analgesics|mesh-ancestor
92982928|NCT00844142|Sensory System Agents|sensory system agents|mesh-ancestor
92982929|NCT00844142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982930|NCT00844142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982931|NCT00844142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982932|NCT00844142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982933|NCT00844142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982934|NCT00844142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982935|NCT00844142|Immunologic Factors|immunologic factors|mesh-ancestor
92982936|NCT00844142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982937|NCT00837044|Naproxen|naproxen|mesh-list
92982938|NCT00837044|Sumatriptan|sumatriptan|mesh-list
92982939|NCT00837044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92982940|NCT00837044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92982941|NCT00837044|Analgesics|analgesics|mesh-ancestor
92982942|NCT00837044|Sensory System Agents|sensory system agents|mesh-ancestor
92982943|NCT00837044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92982944|NCT00837044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982945|NCT00837044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92982946|NCT00837044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982947|NCT00837044|Gout Suppressants|gout suppressants|mesh-ancestor
92982948|NCT00837044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92982949|NCT00837044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982950|NCT00837044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982951|NCT00837044|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92982952|NCT00837044|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92982953|NCT00837044|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92982954|NCT00837044|Serotonin Agents|serotonin agents|mesh-ancestor
92982956|NCT01013272|Lamivudine|lamivudine|mesh-list
92982957|NCT01013272|Entecavir|entecavir|mesh-list
92982958|NCT01013272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92982959|NCT01013272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92982960|NCT01013272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982961|NCT01013272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982962|NCT01013272|Antiviral Agents|antiviral agents|mesh-ancestor
92982963|NCT01013272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982964|NCT01013272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92982965|NCT01013272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92982966|NCT04232085|Mycophenolic Acid|mycophenolic acid|mesh-list
92982967|NCT04232085|Cyclophosphamide|cyclophosphamide|mesh-list
92982968|NCT04232085|Melphalan|melphalan|mesh-list
92982969|NCT04232085|Fludarabine|fludarabine|mesh-list
92982970|NCT04232085|Alemtuzumab|alemtuzumab|mesh-list
92982971|NCT04232085|Tacrolimus|tacrolimus|mesh-list
92982972|NCT04232085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92982973|NCT04232085|Immunologic Factors|immunologic factors|mesh-ancestor
92982974|NCT04232085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92982975|NCT04232085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92982976|NCT04232085|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92982977|NCT04232085|Alkylating Agents|alkylating agents|mesh-ancestor
92982978|NCT04232085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92982979|NCT04232085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92982980|NCT04232085|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92982981|NCT04232085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92982982|NCT04232085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92982983|NCT04232085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92982984|NCT04232085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92982985|NCT04232085|Antitubercular Agents|antitubercular agents|mesh-ancestor
92982986|NCT04232085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92982987|NCT04232085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982988|NCT04232085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92982989|NCT02546024|Antidepressive Agents|antidepressive agents|mesh-list
92982990|NCT02546024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92982991|NCT01010698|Acyclovir|acyclovir|mesh-list
92982992|NCT01010698|Cimetidine|cimetidine|mesh-list
92982993|NCT01010698|Antiviral Agents|antiviral agents|mesh-ancestor
92982994|NCT01010698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92982995|NCT01010698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92982996|NCT01010698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92982997|NCT01010698|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92982998|NCT01010698|Histamine Antagonists|histamine antagonists|mesh-ancestor
92982999|NCT01010698|Histamine Agents|histamine agents|mesh-ancestor
92983000|NCT01010698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983001|NCT01010698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983002|NCT01010698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983003|NCT01010698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92983004|NCT01010698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92983005|NCT01010698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983006|NCT03541486|Gemcitabine|gemcitabine|mesh-list
92983007|NCT03541486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983008|NCT03541486|Antimetabolites|antimetabolites|mesh-ancestor
92983009|NCT03541486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983010|NCT03541486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983011|NCT00620750|Naltrexone|naltrexone|mesh-list
92983012|NCT00620750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92983013|NCT00620750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92983014|NCT00620750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983015|NCT00620750|Sensory System Agents|sensory system agents|mesh-ancestor
92983016|NCT00620750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983017|NCT02547896|Diclofenac|diclofenac|mesh-list
92983018|NCT02547896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92983019|NCT02547896|Codeine|codeine|mesh-list
92983020|NCT02547896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92983021|NCT02547896|Analgesics|analgesics|mesh-ancestor
92983022|NCT02547896|Sensory System Agents|sensory system agents|mesh-ancestor
92983023|NCT02547896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983024|NCT02547896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983025|NCT02547896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983026|NCT02547896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628454|NCT00165815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983027|NCT02547896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92983028|NCT02547896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983029|NCT02547896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983030|NCT02547896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92983031|NCT02547896|Narcotics|narcotics|mesh-ancestor
92983032|NCT02547896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983033|NCT02547896|Antitussive Agents|antitussive agents|mesh-ancestor
92983034|NCT02547896|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983035|NCT01564251|Gemcitabine|gemcitabine|mesh-list
92983036|NCT01564251|GDC-0575|gdc-0575|mesh-list
92983037|NCT01564251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983038|NCT01564251|Antimetabolites|antimetabolites|mesh-ancestor
92983039|NCT01564251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983040|NCT01564251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983041|NCT01564251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983042|NCT01564251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983043|NCT00508144|Pemetrexed|pemetrexed|mesh-list
92983044|NCT00508144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983045|NCT00508144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983046|NCT00508144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983047|NCT00508144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92983048|NCT00508144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92983049|NCT00844454|Ethanol|ethanol|mesh-list
92983050|NCT00844454|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92983051|NCT00844454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983052|NCT00844454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983053|NCT00844454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983054|NCT02545712|Ethanol|ethanol|mesh-list
92983055|NCT02545712|Benzyl Alcohol|benzyl alcohol|mesh-list
92983056|NCT02545712|Sorbitol|sorbitol|mesh-list
92983057|NCT02545712|Glycerol|glycerol|mesh-list
92983058|NCT02545712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92983059|NCT02545712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983060|NCT02545712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983061|NCT02545712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983062|NCT02545712|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92983063|NCT02545712|Protective Agents|protective agents|mesh-ancestor
92983064|NCT02545712|Cathartics|cathartics|mesh-ancestor
92983065|NCT02545712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92983066|NCT02545712|Anesthetics, Local|anesthetics, local|mesh-ancestor
92983067|NCT02545712|Anesthetics|anesthetics|mesh-ancestor
92983068|NCT02545712|Sensory System Agents|sensory system agents|mesh-ancestor
92983069|NCT02545712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983070|NCT01011010|Doxorubicin|doxorubicin|mesh-list
92983071|NCT01011010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92983072|NCT01011010|Mitomycins|mitomycins|mesh-list
92983073|NCT01011010|Mitomycin|mitomycin|mesh-list
92983074|NCT01011010|Sorafenib|sorafenib|mesh-list
92983075|NCT01011010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92983076|NCT01011010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983077|NCT01011010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92983078|NCT01011010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92983079|NCT01011010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983080|NCT01011010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983081|NCT01011010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983082|NCT01011010|Alkylating Agents|alkylating agents|mesh-ancestor
92983083|NCT01011010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92983084|NCT00851708|Acetylcysteine|acetylcysteine|mesh-list
92983085|NCT00851708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92983086|NCT00851708|Antiviral Agents|antiviral agents|mesh-ancestor
92983087|NCT00851708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983088|NCT00851708|Expectorants|expectorants|mesh-ancestor
92983089|NCT00851708|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983090|NCT00851708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92983091|NCT00851708|Antioxidants|antioxidants|mesh-ancestor
92983092|NCT00851708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983093|NCT00851708|Protective Agents|protective agents|mesh-ancestor
92983094|NCT00851708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983095|NCT00851708|Antidotes|antidotes|mesh-ancestor
92983096|NCT01011166|Ribavirin|ribavirin|mesh-list
92983097|NCT01011166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92983098|NCT01011166|Antimetabolites|antimetabolites|mesh-ancestor
92983099|NCT01011166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983100|NCT01011166|Antiviral Agents|antiviral agents|mesh-ancestor
92983101|NCT01011166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983102|NCT00621842|Lamotrigine|lamotrigine|mesh-list
92983103|NCT00621842|Anticonvulsants|anticonvulsants|mesh-list
92983104|NCT00621842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92983105|NCT00621842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983106|NCT00621842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983107|NCT00621842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92983108|NCT00621842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983109|NCT00621842|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92983110|NCT00621842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92983111|NCT00621842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983112|NCT00621842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92983113|NCT00621842|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92983114|NCT04849455|Morphine|morphine|mesh-list
92983115|NCT04849455|Ropivacaine|ropivacaine|mesh-list
92983116|NCT04849455|Anesthetics, Local|anesthetics, local|mesh-list
92983117|NCT04849455|Anesthetics|anesthetics|mesh-list
92983118|NCT04849455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92983119|NCT04849455|Narcotics|narcotics|mesh-ancestor
92983120|NCT04849455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983121|NCT04849455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983122|NCT04849455|Analgesics|analgesics|mesh-ancestor
92983123|NCT04849455|Sensory System Agents|sensory system agents|mesh-ancestor
92983124|NCT04849455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983125|NCT02545010|Paclitaxel|paclitaxel|mesh-list
92983126|NCT02545010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92983127|NCT02545010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983128|NCT02545010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92983129|NCT02545010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92983130|NCT02545010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92983131|NCT02545010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983132|NCT01013506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92983133|NCT01013506|Letrozole|letrozole|mesh-list
92983134|NCT01013506|Goserelin|goserelin|mesh-list
92983135|NCT01013506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983136|NCT01013506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983137|NCT01013506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983138|NCT01013506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983139|NCT01013506|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92983140|NCT01013506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92983141|NCT01013506|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92983142|NCT01013506|Hormone Antagonists|hormone antagonists|mesh-ancestor
92983143|NCT01013506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983144|NCT01013506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983145|NCT01013506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92983146|NCT00844688|Gemcitabine|gemcitabine|mesh-list
92983147|NCT00844688|Sorafenib|sorafenib|mesh-list
92983148|NCT00844688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983149|NCT00844688|Antimetabolites|antimetabolites|mesh-ancestor
92983150|NCT00844688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983151|NCT00844688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983152|NCT00844688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983153|NCT00844688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983154|NCT04541680|Nintedanib|nintedanib|mesh-list
92983155|NCT04541680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983156|NCT04541680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983157|NCT04541680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983158|NCT04541680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983159|NCT00855530|Amibegron|amibegron|mesh-list
92983160|NCT00855530|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92983161|NCT00855530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92983162|NCT00855530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92983163|NCT00855530|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983164|NCT00855530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983165|NCT00855530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983166|NCT00855530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983167|NCT00855530|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92983168|NCT00855608|Adalimumab|adalimumab|mesh-list
92983169|NCT00855608|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92983170|NCT00855608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983171|NCT00855608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983172|NCT00851864|Tinzaparin|tinzaparin|mesh-list
92983173|NCT00851864|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92983174|NCT00851864|Dalteparin|dalteparin|mesh-list
92983175|NCT00851864|Anticoagulants|anticoagulants|mesh-ancestor
92983176|NCT00851864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92983177|NCT00851864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92983178|NCT00851864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983179|NCT00851942|Cosyntropin|cosyntropin|mesh-list
92983180|NCT00851942|Hormones|hormones|mesh-ancestor
92983181|NCT00851942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983182|NCT00851942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983183|NCT00503776|Amifostine|amifostine|mesh-list
92983184|NCT00503776|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92983185|NCT00503776|Protective Agents|protective agents|mesh-ancestor
92983186|NCT00503776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983187|NCT02545634|Sulfalene|sulfalene|mesh-list
92983188|NCT02545634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983189|NCT02545634|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92983190|NCT02545634|Antimalarials|antimalarials|mesh-ancestor
92983191|NCT02545634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92983192|NCT02545634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92983193|NCT05260671|Cetuximab|cetuximab|mesh-list
92983194|NCT05260671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92983195|NCT05260671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983196|NCT00855686|Memantine|memantine|mesh-list
92983197|NCT00855686|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92983198|NCT00855686|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92983199|NCT00855686|Dopamine Agents|dopamine agents|mesh-ancestor
92983200|NCT00855686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983201|NCT00855686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983202|NCT00855686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983203|NCT00855686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92983204|NCT00855686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92983205|NCT00619112|Temozolomide|temozolomide|mesh-list
92983206|NCT00619112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92983207|NCT00619112|Alkylating Agents|alkylating agents|mesh-ancestor
92983208|NCT00619112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983209|NCT00619112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983210|NCT00845156|Thioctic Acid|thioctic acid|mesh-list
92983211|NCT00845156|Antioxidants|antioxidants|mesh-ancestor
92983212|NCT00845156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983213|NCT00845156|Protective Agents|protective agents|mesh-ancestor
92983214|NCT00845156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983215|NCT00845156|Vitamin B Complex|vitamin b complex|mesh-ancestor
92983216|NCT00845156|Vitamins|vitamins|mesh-ancestor
92983217|NCT00845156|Micronutrients|micronutrients|mesh-ancestor
92983218|NCT00852332|Curcumin|curcumin|mesh-list
92983219|NCT00852332|Docetaxel|docetaxel|mesh-list
92983220|NCT00852332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983221|NCT00852332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92983222|NCT00852332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92983223|NCT00852332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92983224|NCT00852332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983225|NCT00852332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92983226|NCT00852332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92983227|NCT00852332|Analgesics|analgesics|mesh-ancestor
92983228|NCT00852332|Sensory System Agents|sensory system agents|mesh-ancestor
92983229|NCT00852332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983230|NCT00852332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983231|NCT00852332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983232|NCT00852332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983233|NCT00852332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983234|NCT00852410|Lidocaine|lidocaine|mesh-list
92983235|NCT00852410|Epinephrine|epinephrine|mesh-list
92983236|NCT00852410|Racepinephrine|racepinephrine|mesh-list
92983237|NCT00852410|Epinephryl borate|epinephryl borate|mesh-list
92983238|NCT00852410|Anesthetics, Local|anesthetics, local|mesh-ancestor
92983239|NCT00852410|Anesthetics|anesthetics|mesh-ancestor
92983240|NCT00852410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983241|NCT00852410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983242|NCT00852410|Sensory System Agents|sensory system agents|mesh-ancestor
92983243|NCT00852410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983244|NCT00852410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92983245|NCT00852410|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92983246|NCT00852410|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92983247|NCT00852410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983248|NCT00852410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983249|NCT00852410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92983250|NCT00852410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92983251|NCT00852410|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983252|NCT00852410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983253|NCT00852410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92983254|NCT00852410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92628682|NCT00166556|Tacrolimus|tacrolimus|mesh-list
92983255|NCT00852410|Autonomic Agents|autonomic agents|mesh-ancestor
92983256|NCT00852410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92983257|NCT00852410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983258|NCT00852410|Mydriatics|mydriatics|mesh-ancestor
92983259|NCT00852410|Sympathomimetics|sympathomimetics|mesh-ancestor
92983260|NCT00852410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92983261|NCT00992121|Bevacizumab|bevacizumab|mesh-list
92983262|NCT00992121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92983263|NCT00992121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983264|NCT00992121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92983265|NCT00992121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92983266|NCT00992121|Growth Substances|growth substances|mesh-ancestor
92983267|NCT00992121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983268|NCT00992121|Growth Inhibitors|growth inhibitors|mesh-ancestor
92983269|NCT04420299|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92983270|NCT04420299|Bemiparin|bemiparin|mesh-list
92983271|NCT04420299|Anticoagulants|anticoagulants|mesh-ancestor
92983272|NCT04420299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92983273|NCT04420299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92983274|NCT04420299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983276|NCT00992199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983277|NCT00992199|Antimetabolites|antimetabolites|mesh-ancestor
92983278|NCT00992199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983279|NCT00992199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983280|NCT00992199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983281|NCT00992199|Immunologic Factors|immunologic factors|mesh-ancestor
92983282|NCT00992199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983283|NCT00856310|Fasinumab|fasinumab|mesh-list
92983284|NCT00856310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92983285|NCT00856310|Analgesics|analgesics|mesh-ancestor
92983286|NCT00856310|Sensory System Agents|sensory system agents|mesh-ancestor
92983287|NCT00856310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983288|NCT00856310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983289|NCT02773485|Cisplatin|cisplatin|mesh-list
92983290|NCT02773485|Gemcitabine|gemcitabine|mesh-list
92983291|NCT02773485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983292|NCT02773485|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983293|NCT02773485|Antimetabolites|antimetabolites|mesh-ancestor
92983294|NCT02773485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983295|NCT04042220|Glucocorticoids|glucocorticoids|mesh-list
92983296|NCT04042220|Hormones|hormones|mesh-ancestor
92983297|NCT04042220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983298|NCT04042220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983299|NCT00992355|Tobramycin|tobramycin|mesh-list
92983300|NCT00992355|Dexamethasone|dexamethasone|mesh-list
92983301|NCT00992355|Dexamethasone acetate|dexamethasone acetate|mesh-list
92983302|NCT00992355|Ketorolac|ketorolac|mesh-list
92983303|NCT00992355|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92983304|NCT00992355|BB 1101|bb 1101|mesh-list
92983305|NCT00992355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983306|NCT00992355|Antiemetics|antiemetics|mesh-ancestor
92983307|NCT00992355|Autonomic Agents|autonomic agents|mesh-ancestor
92983308|NCT00992355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983309|NCT00992355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983310|NCT00992355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92983311|NCT00992355|Glucocorticoids|glucocorticoids|mesh-ancestor
92983312|NCT00992355|Hormones|hormones|mesh-ancestor
92983313|NCT00992355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983314|NCT00992355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92983315|NCT00992355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983316|NCT00992355|Protease Inhibitors|protease inhibitors|mesh-ancestor
92983317|NCT00992355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983318|NCT00992355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983319|NCT00992355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92983320|NCT00992355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92983321|NCT00992355|Analgesics|analgesics|mesh-ancestor
92983322|NCT00992355|Sensory System Agents|sensory system agents|mesh-ancestor
92983323|NCT00992355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983324|NCT00992355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92983325|NCT00992355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92983326|NCT00992355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983327|NCT00852566|Imatinib Mesylate|imatinib mesylate|mesh-list
92983328|NCT00852566|Dasatinib|dasatinib|mesh-list
92983329|NCT00852566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983330|NCT00852566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983332|NCT00852566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983333|NCT00856622|Timolol|timolol|mesh-list
92983334|NCT00856622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92983335|NCT00856622|Latanoprost|latanoprost|mesh-list
92983336|NCT00856622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92983337|NCT00856622|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92983338|NCT00856622|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92983339|NCT00856622|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983340|NCT00856622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983341|NCT00856622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983342|NCT00856622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983343|NCT00856622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92983344|NCT00856622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92983345|NCT00856700|Incretins|incretins|mesh-list
92983346|NCT00856700|Hormones|hormones|mesh-ancestor
92983347|NCT00856700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983348|NCT00856700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983350|NCT00618956|Levomilnacipran|levomilnacipran|mesh-list
92983351|NCT00618956|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92983352|NCT00618956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92983353|NCT00618956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983354|NCT00618956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983355|NCT00618956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983356|NCT00618956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983357|NCT00618956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92983358|NCT00618956|Analgesics|analgesics|mesh-ancestor
92983359|NCT00618956|Sensory System Agents|sensory system agents|mesh-ancestor
92983360|NCT00618956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983361|NCT00618956|Antidepressive Agents|antidepressive agents|mesh-ancestor
92983362|NCT00618956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92983363|NCT00852800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92983364|NCT00845546|Loratadine|loratadine|mesh-list
92983365|NCT00845546|Pseudoephedrine|pseudoephedrine|mesh-list
92983366|NCT00845546|Ephedrine|ephedrine|mesh-list
92983367|NCT00845546|Antipruritics|antipruritics|mesh-ancestor
92983368|NCT00845546|Dermatologic Agents|dermatologic agents|mesh-ancestor
92983369|NCT00845546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92983370|NCT00845546|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92983371|NCT00845546|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92983372|NCT00845546|Histamine Antagonists|histamine antagonists|mesh-ancestor
92983373|NCT00845546|Histamine Agents|histamine agents|mesh-ancestor
92983374|NCT00845546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983375|NCT00845546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983376|NCT00845546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983377|NCT00845546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92983378|NCT00845546|Autonomic Agents|autonomic agents|mesh-ancestor
92983379|NCT00845546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983380|NCT00845546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92983381|NCT00845546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983382|NCT00845546|Nasal Decongestants|nasal decongestants|mesh-ancestor
92983383|NCT00845546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92983384|NCT00845546|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92983385|NCT00845546|Sympathomimetics|sympathomimetics|mesh-ancestor
92983386|NCT00845546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983387|NCT00852956|Betahistine|betahistine|mesh-list
92983388|NCT00852956|Vasodilator Agents|vasodilator agents|mesh-ancestor
92983389|NCT00852956|Histamine Agonists|histamine agonists|mesh-ancestor
92983390|NCT00852956|Histamine Agents|histamine agents|mesh-ancestor
92983391|NCT00852956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983392|NCT00852956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983393|NCT00852956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983394|NCT00716417|Afatinib|afatinib|mesh-list
92983395|NCT00716417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983396|NCT00716417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983397|NCT00716417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983398|NCT00716417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983399|NCT02592863|Pentoxifylline|pentoxifylline|mesh-list
92983400|NCT02592863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92983401|NCT02592863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983402|NCT02592863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983403|NCT02592863|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92983404|NCT02592863|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92983405|NCT02592863|Protective Agents|protective agents|mesh-ancestor
92983406|NCT02592863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983407|NCT02592863|Vasodilator Agents|vasodilator agents|mesh-ancestor
92983408|NCT02592863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92983409|NCT02592863|Antioxidants|antioxidants|mesh-ancestor
92983410|NCT00719537|Aspirin|aspirin|mesh-list
92983411|NCT00719537|Progesterone|progesterone|mesh-list
92983412|NCT00719537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92983413|NCT00719537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92983414|NCT00719537|Analgesics|analgesics|mesh-ancestor
92983415|NCT00719537|Sensory System Agents|sensory system agents|mesh-ancestor
92983416|NCT00719537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983417|NCT00719537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983418|NCT00719537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983419|NCT00719537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983420|NCT00719537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92983421|NCT00719537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92983422|NCT00719537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983423|NCT00719537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92983424|NCT00719537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92983425|NCT00719537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983426|NCT00719537|Antipyretics|antipyretics|mesh-ancestor
92983427|NCT00719537|Progestins|progestins|mesh-ancestor
92983428|NCT00719537|Hormones|hormones|mesh-ancestor
92983429|NCT00719537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983430|NCT00853190|Chlorpheniramine|chlorpheniramine|mesh-list
92983431|NCT00853190|Hydrocodone|hydrocodone|mesh-list
92983432|NCT00853190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983433|NCT00853190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92983434|NCT00853190|Narcotics|narcotics|mesh-ancestor
92983435|NCT00853190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983436|NCT00853190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983437|NCT00853190|Analgesics|analgesics|mesh-ancestor
92983438|NCT00853190|Sensory System Agents|sensory system agents|mesh-ancestor
92983439|NCT00853190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983440|NCT00853190|Antitussive Agents|antitussive agents|mesh-ancestor
92983441|NCT00853190|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983442|NCT00853190|Antipruritics|antipruritics|mesh-ancestor
92983443|NCT00853190|Dermatologic Agents|dermatologic agents|mesh-ancestor
92983444|NCT00853190|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92983445|NCT00853190|Histamine Antagonists|histamine antagonists|mesh-ancestor
92983446|NCT00853190|Histamine Agents|histamine agents|mesh-ancestor
92983447|NCT00853190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983448|NCT00853190|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92983449|NCT02591225|Phenprocoumon|phenprocoumon|mesh-list
92983450|NCT02591225|Anticoagulants|anticoagulants|mesh-ancestor
92983451|NCT00573794|Adalimumab|adalimumab|mesh-list
92983452|NCT00573794|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92983453|NCT00573794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983454|NCT00573794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983455|NCT00715793|Temozolomide|temozolomide|mesh-list
92983456|NCT00715793|Decitabine|decitabine|mesh-list
92983457|NCT00715793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92983458|NCT00715793|Alkylating Agents|alkylating agents|mesh-ancestor
92983459|NCT00715793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983460|NCT00715793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983461|NCT00715793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983462|NCT00715793|Antimetabolites|antimetabolites|mesh-ancestor
92983463|NCT00715793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983464|NCT00924014|Furosemide|furosemide|mesh-list
92983465|NCT00924014|Conivaptan|conivaptan|mesh-list
92983466|NCT00924014|Diuretics|diuretics|mesh-ancestor
92983467|NCT00924014|Natriuretic Agents|natriuretic agents|mesh-ancestor
92983468|NCT00924014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983469|NCT00924014|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92983470|NCT00924014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983471|NCT00924014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983472|NCT00924014|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92983473|NCT00853268|Oxycodone|oxycodone|mesh-list
92983474|NCT00853268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92983475|NCT00853268|Narcotics|narcotics|mesh-ancestor
92983476|NCT00853268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983477|NCT00853268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983478|NCT00853268|Analgesics|analgesics|mesh-ancestor
92628900|NCT00177567|Histamine Agents|histamine agents|mesh-ancestor
92983479|NCT00853268|Sensory System Agents|sensory system agents|mesh-ancestor
92983480|NCT00853268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983481|NCT00845780|Amiodarone|amiodarone|mesh-list
92983482|NCT00845780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92983483|NCT00845780|Vasodilator Agents|vasodilator agents|mesh-ancestor
92983484|NCT00845780|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92983485|NCT00845780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983486|NCT00845780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983487|NCT00845780|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92983488|NCT00845780|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92983489|NCT00845780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92983490|NCT00845780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983491|NCT00845780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92983492|NCT00845780|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92983493|NCT00845780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92983494|NCT00853502|Methyltestosterone|methyltestosterone|mesh-list
92983496|NCT00853502|Testosterone undecanoate|testosterone undecanoate|mesh-list
92983497|NCT00853502|Testosterone enanthate|testosterone enanthate|mesh-list
92983498|NCT00853502|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92983499|NCT00853502|Androgens|androgens|mesh-ancestor
92983500|NCT00853502|Hormones|hormones|mesh-ancestor
92983501|NCT00853502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983502|NCT00853502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983503|NCT00853502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92983504|NCT00853502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983505|NCT00853502|Anabolic Agents|anabolic agents|mesh-ancestor
92983506|NCT00853736|Oxycodone|oxycodone|mesh-list
92983507|NCT00853736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92983508|NCT00853736|Narcotics|narcotics|mesh-ancestor
92983509|NCT00853736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983510|NCT00853736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983511|NCT00853736|Analgesics|analgesics|mesh-ancestor
92983512|NCT00853736|Sensory System Agents|sensory system agents|mesh-ancestor
92983513|NCT00853736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983514|NCT00857168|Testosterone|testosterone|mesh-list
92983515|NCT00857168|Androgens|androgens|mesh-ancestor
92983516|NCT00857168|Hormones|hormones|mesh-ancestor
92983517|NCT00857168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983518|NCT00857168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983519|NCT00857324|Vorinostat|vorinostat|mesh-list
92983520|NCT00857324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983521|NCT00857324|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92983522|NCT00857324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983523|NCT00857324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983524|NCT00853892|Oxycodone|oxycodone|mesh-list
92983525|NCT00853892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92983526|NCT00853892|Narcotics|narcotics|mesh-ancestor
92983527|NCT00853892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983528|NCT00853892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983529|NCT00853892|Analgesics|analgesics|mesh-ancestor
92983530|NCT00853892|Sensory System Agents|sensory system agents|mesh-ancestor
92983531|NCT00853892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983532|NCT00857558|Saxagliptin|saxagliptin|mesh-list
92983533|NCT00857558|Incretins|incretins|mesh-ancestor
92983534|NCT00857558|Hormones|hormones|mesh-ancestor
92983535|NCT00857558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983536|NCT00857558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983537|NCT00857558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92983538|NCT00857558|Protease Inhibitors|protease inhibitors|mesh-ancestor
92983539|NCT00857558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983540|NCT00857558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983541|NCT00857558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92983542|NCT00718523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92983543|NCT00718523|Immunologic Factors|immunologic factors|mesh-ancestor
92983544|NCT00718523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983545|NCT00715559|Cysteamine|cysteamine|mesh-list
92983546|NCT00715559|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92983547|NCT00715559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983548|NCT05289869|Oxytocin|oxytocin|mesh-list
92983549|NCT05289869|Oxytocics|oxytocics|mesh-ancestor
92983550|NCT05289869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92983551|NCT05289869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983552|NCT00620282|Liraglutide|liraglutide|mesh-list
92983554|NCT00620282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92983555|NCT00620282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983556|NCT00620282|Incretins|incretins|mesh-ancestor
92983557|NCT00620282|Hormones|hormones|mesh-ancestor
92983558|NCT00620282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983559|NCT00620282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92983560|NCT00620282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983561|NCT00620282|Immunologic Factors|immunologic factors|mesh-ancestor
92983562|NCT05684861|Isotretinoin|isotretinoin|mesh-list
92983563|NCT05684861|Dermatologic Agents|dermatologic agents|mesh-ancestor
92983564|NCT04042688|Tranexamic Acid|tranexamic acid|mesh-list
92983565|NCT04042688|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92983566|NCT04042688|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92983567|NCT04042688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983569|NCT04042688|Coagulants|coagulants|mesh-ancestor
92983570|NCT02590133|Fluorouracil|fluorouracil|mesh-list
92983571|NCT02590133|Endostar protein|endostar protein|mesh-list
92983572|NCT02590133|Endostatins|endostatins|mesh-list
92983573|NCT02590133|Nedaplatin|nedaplatin|mesh-list
92983574|NCT02590133|Antimetabolites|antimetabolites|mesh-ancestor
92983575|NCT02590133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983576|NCT02590133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983577|NCT02590133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983578|NCT02590133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983579|NCT02590133|Immunologic Factors|immunologic factors|mesh-ancestor
92983580|NCT02590133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983581|NCT02590133|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92983582|NCT02590133|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92983583|NCT02590133|Growth Substances|growth substances|mesh-ancestor
92983584|NCT02590133|Growth Inhibitors|growth inhibitors|mesh-ancestor
92983585|NCT00854204|Darunavir|darunavir|mesh-list
92983586|NCT00854204|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92983587|NCT00854204|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92983588|NCT00854204|Protease Inhibitors|protease inhibitors|mesh-ancestor
92983589|NCT00854204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983590|NCT00854204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983591|NCT00854204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92983592|NCT00854204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92983593|NCT00854204|Antiviral Agents|antiviral agents|mesh-ancestor
92983594|NCT00854204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983595|NCT00857870|Metformin|metformin|mesh-list
92983596|NCT00857870|Insulin Glargine|insulin glargine|mesh-list
92983597|NCT00857870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92983598|NCT00857870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983599|NCT00848432|Risperidone|risperidone|mesh-list
92983600|NCT00848432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92983601|NCT00848432|Serotonin Agents|serotonin agents|mesh-ancestor
92983602|NCT00848432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983603|NCT00848432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983604|NCT00848432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983605|NCT00848432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92983606|NCT00848432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92983607|NCT00848432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983608|NCT00848432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92983609|NCT00848432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92983610|NCT00848432|Dopamine Agents|dopamine agents|mesh-ancestor
92983611|NCT00854750|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92983612|NCT00854750|Hormones|hormones|mesh-ancestor
92983613|NCT00854750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983614|NCT00854750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983615|NCT00858182|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92983616|NCT02545244|Chlorhexidine|chlorhexidine|mesh-list
92983617|NCT02545244|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92983618|NCT02545244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983619|NCT02545244|Disinfectants|disinfectants|mesh-ancestor
92983620|NCT00858338|Floxuridine|floxuridine|mesh-list
92983621|NCT00858338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983622|NCT00858338|Antimetabolites|antimetabolites|mesh-ancestor
92983623|NCT00858338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983624|NCT00858338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983625|NCT00515086|Everolimus|everolimus|mesh-list
92983626|NCT00515086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92983627|NCT00515086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983628|NCT00515086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983629|NCT00515086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983630|NCT00515086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983631|NCT00515086|Immunologic Factors|immunologic factors|mesh-ancestor
92983632|NCT00515086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983633|NCT00515086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983634|NCT00858806|Imatinib Mesylate|imatinib mesylate|mesh-list
92983635|NCT00858806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983636|NCT00858806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983637|NCT00858806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983638|NCT00858806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983639|NCT01011478|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92983640|NCT01011478|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92983641|NCT01011478|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92983642|NCT01011478|Antimetabolites|antimetabolites|mesh-ancestor
92983643|NCT01011478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983644|NCT01011478|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92983645|NCT01011478|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92983646|NCT01011478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983647|NCT00849368|Azathioprine|azathioprine|mesh-list
92983648|NCT00849368|Allopurinol|allopurinol|mesh-list
92983649|NCT00849368|Antimetabolites|antimetabolites|mesh-ancestor
92983650|NCT00849368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983651|NCT00849368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983652|NCT00849368|Gout Suppressants|gout suppressants|mesh-ancestor
92983653|NCT00849368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983654|NCT00849368|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92983655|NCT00849368|Antioxidants|antioxidants|mesh-ancestor
92983656|NCT00849368|Protective Agents|protective agents|mesh-ancestor
92983657|NCT00849368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983658|NCT00849368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983659|NCT00849368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983660|NCT00849368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983661|NCT00849368|Immunologic Factors|immunologic factors|mesh-ancestor
92983662|NCT02544932|Warfarin|warfarin|mesh-list
92983663|NCT02544932|Dabigatran|dabigatran|mesh-list
92983664|NCT02544932|Anticoagulants|anticoagulants|mesh-ancestor
92983665|NCT02544932|Antithrombins|antithrombins|mesh-ancestor
92983666|NCT02544932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92983667|NCT02544932|Protease Inhibitors|protease inhibitors|mesh-ancestor
92983668|NCT02544932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983669|NCT02544932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983670|NCT02544854|Propofol|propofol|mesh-list
92983671|NCT02544854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92983672|NCT02544854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983673|NCT02544854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983674|NCT02544854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92983675|NCT02544854|Anesthetics, General|anesthetics, general|mesh-ancestor
92983676|NCT02544854|Anesthetics|anesthetics|mesh-ancestor
92983677|NCT00861536|Thymoglobulin|thymoglobulin|mesh-list
92983678|NCT00861536|Immunologic Factors|immunologic factors|mesh-ancestor
92983679|NCT00861536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983680|NCT00861536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983681|NCT02544776|Amlodipine|amlodipine|mesh-list
92983682|NCT02544776|Clomiphene|clomiphene|mesh-list
92983683|NCT02544776|Enclomiphene|enclomiphene|mesh-list
92983684|NCT02544776|Zuclomiphene|zuclomiphene|mesh-list
92983685|NCT02544776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983686|NCT02544776|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92983687|NCT02544776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92983688|NCT02544776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983689|NCT02544776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92983690|NCT02544776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983691|NCT02544776|Vasodilator Agents|vasodilator agents|mesh-ancestor
92983692|NCT02544776|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92983693|NCT02544776|Hormone Antagonists|hormone antagonists|mesh-ancestor
92983694|NCT02544776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983695|NCT02544776|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92983696|NCT02544776|Fertility Agents|fertility agents|mesh-ancestor
92983697|NCT02544776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92983698|NCT02544776|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92983699|NCT02544776|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92983700|NCT00859118|Axitinib|axitinib|mesh-list
92983701|NCT00859118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983702|NCT00859118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983703|NCT00859118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983704|NCT00859118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983705|NCT00849602|Chloroquine|chloroquine|mesh-list
92983706|NCT00849602|Amebicides|amebicides|mesh-ancestor
92983707|NCT00849602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92983708|NCT00849602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92983709|NCT00849602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983710|NCT00849602|Antimalarials|antimalarials|mesh-ancestor
92983711|NCT00849602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983712|NCT00859274|Budesonide|budesonide|mesh-list
92983713|NCT00859274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983714|NCT00859274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92983715|NCT00859274|Autonomic Agents|autonomic agents|mesh-ancestor
92983716|NCT00859274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983717|NCT00859274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983718|NCT00859274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92983719|NCT00859274|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983720|NCT00859274|Glucocorticoids|glucocorticoids|mesh-ancestor
92983721|NCT00859274|Hormones|hormones|mesh-ancestor
92983722|NCT00859274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983723|NCT00859352|Midazolam|midazolam|mesh-list
92983724|NCT00859352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92983725|NCT00859352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92983726|NCT00859352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983727|NCT00859352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983728|NCT00859352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92983729|NCT00859352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92983730|NCT00859352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92983731|NCT00859352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92983732|NCT00859352|Anesthetics, General|anesthetics, general|mesh-ancestor
92983733|NCT00859352|Anesthetics|anesthetics|mesh-ancestor
92983734|NCT00859352|GABA Modulators|gaba modulators|mesh-ancestor
92983735|NCT00859352|GABA Agents|gaba agents|mesh-ancestor
92983736|NCT00859352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983737|NCT00859352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983738|NCT00861926|Beclomethasone|beclomethasone|mesh-list
92983739|NCT00861926|Albuterol|albuterol|mesh-list
92983740|NCT00861926|Formoterol Fumarate|formoterol fumarate|mesh-list
92983741|NCT00861926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92983742|NCT00861926|Autonomic Agents|autonomic agents|mesh-ancestor
92983743|NCT00861926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983744|NCT00861926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983745|NCT00861926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92983746|NCT00861926|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983747|NCT00861926|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92983748|NCT00861926|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92983749|NCT00861926|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92983750|NCT00861926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983751|NCT00861926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983752|NCT00861926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983753|NCT00861926|Tocolytic Agents|tocolytic agents|mesh-ancestor
92983754|NCT00861926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92983755|NCT00861926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983756|NCT00861926|Glucocorticoids|glucocorticoids|mesh-ancestor
92983757|NCT00861926|Hormones|hormones|mesh-ancestor
92983758|NCT00861926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983759|NCT00849992|Imiquimod|imiquimod|mesh-list
92983760|NCT00849992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92983761|NCT00849992|Immunologic Factors|immunologic factors|mesh-ancestor
92983762|NCT00849992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983763|NCT00849992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983764|NCT00849992|Interferon Inducers|interferon inducers|mesh-ancestor
92983765|NCT00618722|Deoxycholic Acid|deoxycholic acid|mesh-list
92983766|NCT00618722|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92983767|NCT00618722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92983768|NCT02544698|Vaccines|vaccines|mesh-list
92983769|NCT02544698|Immunologic Factors|immunologic factors|mesh-ancestor
92983770|NCT02544698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983771|NCT00862394|Formoterol Fumarate|formoterol fumarate|mesh-list
92983772|NCT00862394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92983773|NCT00862394|Autonomic Agents|autonomic agents|mesh-ancestor
92983774|NCT00862394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983775|NCT00862394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983776|NCT00862394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92983777|NCT00862394|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983778|NCT00862394|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92983779|NCT00862394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92983780|NCT00862394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92983781|NCT00862394|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983782|NCT00862394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983783|NCT00862394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983785|NCT00862472|Cloprostenol|cloprostenol|mesh-list
92983786|NCT00862472|Luteolytic Agents|luteolytic agents|mesh-ancestor
92983787|NCT00862472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92983788|NCT00862472|Contraceptive Agents|contraceptive agents|mesh-ancestor
92983789|NCT00862472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92983790|NCT00862472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983791|NCT00862472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92983792|NCT00862472|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92983793|NCT00862472|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92983794|NCT00862472|Adrenergic Agents|adrenergic agents|mesh-ancestor
92983795|NCT00862472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983796|NCT00862472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983797|NCT00862472|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92983798|NCT00862472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92983799|NCT00850304|Arsenic Trioxide|arsenic trioxide|mesh-list
92983800|NCT00850304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983801|NCT00850382|Cytarabine|cytarabine|mesh-list
92983802|NCT00850382|Daunorubicin|daunorubicin|mesh-list
92983803|NCT00850382|Dasatinib|dasatinib|mesh-list
92983804|NCT00850382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983805|NCT00850382|Antimetabolites|antimetabolites|mesh-ancestor
92983806|NCT00850382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983807|NCT00850382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983808|NCT00850382|Antiviral Agents|antiviral agents|mesh-ancestor
92983809|NCT00850382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983810|NCT00850382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983811|NCT00850382|Immunologic Factors|immunologic factors|mesh-ancestor
92983812|NCT00850382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983813|NCT00850382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92983814|NCT00850382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92983815|NCT00850382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92983816|NCT00850382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983817|NCT00850382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983818|NCT00860366|Uric Acid|uric acid|mesh-list
92983819|NCT00860366|Antioxidants|antioxidants|mesh-ancestor
92983820|NCT00860366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983821|NCT00860366|Protective Agents|protective agents|mesh-ancestor
92983822|NCT00860366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983823|NCT00862628|Rebamipide|rebamipide|mesh-list
92983824|NCT00862628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92983825|NCT00862628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92983826|NCT00862628|Antioxidants|antioxidants|mesh-ancestor
92983827|NCT00862628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983828|NCT00862628|Protective Agents|protective agents|mesh-ancestor
92983829|NCT00862628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983830|NCT00862628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983831|NCT00507442|Dexamethasone|dexamethasone|mesh-list
92983832|NCT00507442|Cyclophosphamide|cyclophosphamide|mesh-list
92983833|NCT00507442|Lenalidomide|lenalidomide|mesh-list
92983834|NCT00507442|Bortezomib|bortezomib|mesh-list
92983835|NCT00507442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983836|NCT00507442|Immunologic Factors|immunologic factors|mesh-ancestor
92983837|NCT00507442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983838|NCT00507442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983839|NCT00507442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92983840|NCT00507442|Alkylating Agents|alkylating agents|mesh-ancestor
92983841|NCT00507442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983842|NCT00507442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983843|NCT00507442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92983844|NCT00507442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983845|NCT00507442|Antiemetics|antiemetics|mesh-ancestor
92983846|NCT00507442|Autonomic Agents|autonomic agents|mesh-ancestor
92983847|NCT00507442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983848|NCT00507442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92983849|NCT00507442|Glucocorticoids|glucocorticoids|mesh-ancestor
92983850|NCT00507442|Hormones|hormones|mesh-ancestor
92983851|NCT00507442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983852|NCT00507442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92983853|NCT00507442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92983854|NCT00507442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92983855|NCT00507442|Growth Substances|growth substances|mesh-ancestor
92983856|NCT00507442|Growth Inhibitors|growth inhibitors|mesh-ancestor
92983857|NCT00862706|Telbivudine|telbivudine|mesh-list
92983858|NCT00862706|Antiviral Agents|antiviral agents|mesh-ancestor
92983859|NCT00862706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329191|NCT00003284|Paclitaxel|paclitaxel|mesh-list
92983860|NCT00862706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92983861|NCT00862706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983862|NCT00862706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983863|NCT04041362|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92983864|NCT04041362|UB-421|ub-421|mesh-list
92983865|NCT04041362|Antiviral Agents|antiviral agents|mesh-ancestor
92983866|NCT04041362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983867|NCT00850850|Physostigmine|physostigmine|mesh-list
92983868|NCT00850850|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92983869|NCT00850850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983870|NCT00850850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983871|NCT00850850|Cholinergic Agents|cholinergic agents|mesh-ancestor
92983872|NCT00850850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983873|NCT00850850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983874|NCT00850850|Miotics|miotics|mesh-ancestor
92983875|NCT00850850|Autonomic Agents|autonomic agents|mesh-ancestor
92983876|NCT00850850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983877|NCT00619892|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92983878|NCT00619892|Antidepressive Agents|antidepressive agents|mesh-ancestor
92983879|NCT00619892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92983880|NCT00619892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92983881|NCT00619892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92983882|NCT00619892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92983883|NCT00619892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983884|NCT00863096|Vaccines|vaccines|mesh-list
92983885|NCT00863096|Immunologic Factors|immunologic factors|mesh-ancestor
92983886|NCT00863096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983887|NCT00870272|Misoprostol|misoprostol|mesh-list
92983888|NCT00870272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92983889|NCT00870272|Abortifacient Agents|abortifacient agents|mesh-ancestor
92983890|NCT00870272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92983891|NCT00870272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983892|NCT00870272|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92983893|NCT00870272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92983894|NCT00870272|Oxytocics|oxytocics|mesh-ancestor
92983895|NCT00863252|Mycophenolic Acid|mycophenolic acid|mesh-list
92983896|NCT00863252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92983897|NCT00863252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983898|NCT00863252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92983899|NCT00863252|Antitubercular Agents|antitubercular agents|mesh-ancestor
92983900|NCT00863252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92983901|NCT00863252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983902|NCT00863252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983903|NCT00863252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983904|NCT00502996|Rituximab|rituximab|mesh-list
92983905|NCT00502996|Methotrexate|methotrexate|mesh-list
92983906|NCT00502996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92983907|NCT00502996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983908|NCT00502996|Immunologic Factors|immunologic factors|mesh-ancestor
92983909|NCT00502996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983910|NCT00502996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92983911|NCT00502996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92983912|NCT00502996|Abortifacient Agents|abortifacient agents|mesh-ancestor
92983913|NCT00502996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92983914|NCT00502996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92983915|NCT00502996|Antimetabolites|antimetabolites|mesh-ancestor
92983916|NCT00502996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983917|NCT00502996|Dermatologic Agents|dermatologic agents|mesh-ancestor
92983918|NCT00502996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983919|NCT00502996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92983920|NCT00502996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92983921|NCT00502996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92983922|NCT00865436|Metformin|metformin|mesh-list
92983923|NCT00865436|Glyburide|glyburide|mesh-list
92983924|NCT00865436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92983925|NCT00865436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983926|NCT00715403|Nintedanib|nintedanib|mesh-list
92983927|NCT00715403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92983928|NCT00715403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92983929|NCT00715403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92983930|NCT00715403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983931|NCT01013584|Cholecalciferol|cholecalciferol|mesh-list
92983932|NCT01013584|Vitamin D|vitamin d|mesh-list
92983933|NCT01013584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92983934|NCT01013584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983935|NCT01013584|Vitamins|vitamins|mesh-ancestor
92983936|NCT01013584|Micronutrients|micronutrients|mesh-ancestor
92983937|NCT01013584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92983938|NCT00864110|Deoxyglucose|deoxyglucose|mesh-list
92983939|NCT00864110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92983940|NCT00864110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92983941|NCT00864110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983942|NCT00864110|Antimetabolites|antimetabolites|mesh-ancestor
92983943|NCT00864110|Antiviral Agents|antiviral agents|mesh-ancestor
92983944|NCT00864110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983945|NCT00864188|Beta Carotene|beta carotene|mesh-list
92983946|NCT00864188|Carotenoids|carotenoids|mesh-list
92983947|NCT00864188|Antioxidants|antioxidants|mesh-ancestor
92983948|NCT00864188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983949|NCT00864188|Protective Agents|protective agents|mesh-ancestor
92983950|NCT00864188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983951|NCT00864188|Provitamins|provitamins|mesh-ancestor
92983952|NCT00864188|Vitamins|vitamins|mesh-ancestor
92983953|NCT00864188|Micronutrients|micronutrients|mesh-ancestor
92983954|NCT00865670|Azithromycin|azithromycin|mesh-list
92983955|NCT00865670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92983956|NCT00865670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92983957|NCT00864344|Sertraline|sertraline|mesh-list
92983958|NCT00864344|Antidepressive Agents|antidepressive agents|mesh-ancestor
92983959|NCT00864344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92983960|NCT00864344|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92983961|NCT00864344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92983962|NCT00864344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92983963|NCT00864344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983964|NCT00864344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983965|NCT00864344|Serotonin Agents|serotonin agents|mesh-ancestor
92983966|NCT00864344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983967|NCT00864500|Clobetasol|clobetasol|mesh-list
92983968|NCT00864500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983969|NCT00864500|Glucocorticoids|glucocorticoids|mesh-ancestor
92983970|NCT00864500|Hormones|hormones|mesh-ancestor
92983971|NCT00864500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92983972|NCT00864500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983973|NCT00864734|Metformin|metformin|mesh-list
92983974|NCT00864734|Glyburide|glyburide|mesh-list
92983975|NCT00864734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92983976|NCT00864734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983977|NCT00864812|Fluticasone|fluticasone|mesh-list
92983979|NCT00864812|Tiotropium Bromide|tiotropium bromide|mesh-list
92983980|NCT00864812|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92983981|NCT00864812|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92983982|NCT00864812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92983983|NCT00864812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92983984|NCT00864812|Autonomic Agents|autonomic agents|mesh-ancestor
92983985|NCT00864812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92983986|NCT00864812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92983987|NCT00864812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92983988|NCT00864812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92983989|NCT00864812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92983990|NCT00864812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92983991|NCT00864812|Parasympatholytics|parasympatholytics|mesh-ancestor
92983992|NCT00864812|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92983993|NCT00864812|Cholinergic Agents|cholinergic agents|mesh-ancestor
92983994|NCT00864812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92983995|NCT00864812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92983996|NCT00864812|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92983997|NCT00864812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92983998|NCT00864812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92983999|NCT00864812|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984000|NCT00864812|Glucocorticoids|glucocorticoids|mesh-ancestor
92984001|NCT00864812|Hormones|hormones|mesh-ancestor
92984002|NCT00864812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629424|NCT00168467|Ramipril|ramipril|mesh-list
92984003|NCT00864812|Sympathomimetics|sympathomimetics|mesh-ancestor
92984004|NCT02590055|Gemcitabine|gemcitabine|mesh-list
92984005|NCT02590055|Docetaxel|docetaxel|mesh-list
92984006|NCT02590055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984007|NCT02590055|Antimetabolites|antimetabolites|mesh-ancestor
92984008|NCT02590055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984009|NCT02590055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984010|NCT02590055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92984011|NCT02590055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92984012|NCT02590055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92984014|NCT00864890|Citalopram|citalopram|mesh-list
92984015|NCT00864890|Escitalopram|escitalopram|mesh-list
92984016|NCT00864890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92984017|NCT00864890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92984018|NCT00864890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984019|NCT00864890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984020|NCT00864890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984021|NCT00864890|Serotonin Agents|serotonin agents|mesh-ancestor
92984022|NCT00864890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984023|NCT00864890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92984024|NCT00864890|Antidepressive Agents|antidepressive agents|mesh-ancestor
92984025|NCT00864890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92984026|NCT00864890|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92984027|NCT00864890|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92984028|NCT00864890|Parasympatholytics|parasympatholytics|mesh-ancestor
92984029|NCT00864890|Autonomic Agents|autonomic agents|mesh-ancestor
92984030|NCT00864890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984031|NCT00864890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92984032|NCT00864890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92984033|NCT00864890|Cholinergic Agents|cholinergic agents|mesh-ancestor
92984034|NCT00919295|Mirtazapine|mirtazapine|mesh-list
92984035|NCT00919295|Antidepressive Agents|antidepressive agents|mesh-ancestor
92984036|NCT00919295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92984037|NCT00919295|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92984038|NCT00919295|Histamine Antagonists|histamine antagonists|mesh-ancestor
92984039|NCT00919295|Histamine Agents|histamine agents|mesh-ancestor
92984040|NCT00919295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984041|NCT00919295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984042|NCT00919295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984043|NCT00919295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92984044|NCT00919295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92984045|NCT00919295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984046|NCT00919295|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92984047|NCT00919295|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92984048|NCT00919295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92984049|NCT00919295|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984050|NCT00919295|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92984051|NCT00919295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92984052|NCT00919295|Serotonin Agents|serotonin agents|mesh-ancestor
92984053|NCT00919295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92984054|NCT00865748|Metformin|metformin|mesh-list
92984055|NCT00865748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92984056|NCT00865748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984057|NCT00865982|Docetaxel|docetaxel|mesh-list
92984058|NCT00865982|Capecitabine|capecitabine|mesh-list
92984059|NCT00865982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984060|NCT00865982|Tubulin Modulators|tubulin modulators|mesh-ancestor
92984061|NCT00865982|Antimitotic Agents|antimitotic agents|mesh-ancestor
92984062|NCT00865982|Mitosis Modulators|mitosis modulators|mesh-ancestor
92984063|NCT00865982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984064|NCT00865982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984065|NCT00865982|Antimetabolites|antimetabolites|mesh-ancestor
92984066|NCT00866060|Memantine|memantine|mesh-list
92984067|NCT00866060|Donepezil|donepezil|mesh-list
92984068|NCT00866060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92984069|NCT00866060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984070|NCT00866060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984071|NCT00866060|Cholinergic Agents|cholinergic agents|mesh-ancestor
92984072|NCT00866060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984073|NCT00866060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984074|NCT00866060|Nootropic Agents|nootropic agents|mesh-ancestor
92984075|NCT00866060|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92984076|NCT00866060|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92984077|NCT00866060|Dopamine Agents|dopamine agents|mesh-ancestor
92984078|NCT00866060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92984079|NCT00866060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92984080|NCT00871052|Vitamin D|vitamin d|mesh-list
92984082|NCT00871052|Vitamins|vitamins|mesh-ancestor
92984083|NCT00871052|Micronutrients|micronutrients|mesh-ancestor
92984084|NCT00871052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984085|NCT00871052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92984086|NCT00871052|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984087|NCT00502840|Rituximab|rituximab|mesh-list
92984088|NCT00502840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92984089|NCT00502840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984090|NCT00502840|Immunologic Factors|immunologic factors|mesh-ancestor
92984091|NCT00502840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984092|NCT00502840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984093|NCT00514540|Carboplatin|carboplatin|mesh-list
92984094|NCT00514540|Docetaxel|docetaxel|mesh-list
92984095|NCT00514540|Etoposide|etoposide|mesh-list
92984096|NCT00514540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984097|NCT00514540|Tubulin Modulators|tubulin modulators|mesh-ancestor
92984098|NCT00514540|Antimitotic Agents|antimitotic agents|mesh-ancestor
92984099|NCT00514540|Mitosis Modulators|mitosis modulators|mesh-ancestor
92984100|NCT00514540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984101|NCT00514540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92984102|NCT00514540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92984103|NCT00514540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92984104|NCT00514540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984105|NCT00506662|Insulin|insulin|mesh-list
92984106|NCT00506662|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92984107|NCT00506662|Insulin Detemir|insulin detemir|mesh-list
92984108|NCT00506662|Isophane Insulin, Human|isophane insulin, human|mesh-list
92984109|NCT00506662|Insulin, Isophane|insulin, isophane|mesh-list
92984110|NCT00506662|Isophane insulin, beef|isophane insulin, beef|mesh-list
92984111|NCT00506662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92984112|NCT00506662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984113|NCT03121534|Dexamethasone|dexamethasone|mesh-list
92984114|NCT03121534|Nivolumab|nivolumab|mesh-list
92984115|NCT03121534|Blinatumomab|blinatumomab|mesh-list
92984116|NCT03121534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984117|NCT03121534|Antiemetics|antiemetics|mesh-ancestor
92984118|NCT03121534|Autonomic Agents|autonomic agents|mesh-ancestor
92984119|NCT03121534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984120|NCT03121534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984121|NCT03121534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92984122|NCT03121534|Glucocorticoids|glucocorticoids|mesh-ancestor
92984123|NCT03121534|Hormones|hormones|mesh-ancestor
92984124|NCT03121534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984125|NCT03121534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92984126|NCT03121534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984127|NCT03121534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92984128|NCT03121534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92984129|NCT03121534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984130|NCT01012102|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92984131|NCT01012102|Freund's Adjuvant|freund's adjuvant|mesh-list
92984132|NCT01012102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92984133|NCT01012102|Immunologic Factors|immunologic factors|mesh-ancestor
92984134|NCT01012102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984135|NCT04615624|Furosemide|furosemide|mesh-list
92984136|NCT04615624|Diuretics|diuretics|mesh-ancestor
92984137|NCT04615624|Natriuretic Agents|natriuretic agents|mesh-ancestor
92984138|NCT04615624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984139|NCT04615624|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92984140|NCT04615624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984141|NCT04615624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984142|NCT00713609|Clindamycin|clindamycin|mesh-list
92984143|NCT00713609|Clindamycin palmitate|clindamycin palmitate|mesh-list
92984144|NCT00713609|Clindamycin phosphate|clindamycin phosphate|mesh-list
92984145|NCT00713609|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92984146|NCT00713609|Tazarotene|tazarotene|mesh-list
92984147|NCT00713609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984148|NCT00713609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984149|NCT00713609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92984150|NCT00713609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984151|NCT00713609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984152|NCT00713609|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984153|NCT00713609|Keratolytic Agents|keratolytic agents|mesh-ancestor
92984154|NCT00513682|Pancrelipase|pancrelipase|mesh-list
92984155|NCT00513682|Pancreatin|pancreatin|mesh-list
92629588|NCT02901145|Nivolumab|nivolumab|mesh-list
92984157|NCT00493012|Vitamin D|vitamin d|mesh-list
92984158|NCT00493012|Vitamins|vitamins|mesh-ancestor
92984159|NCT00493012|Micronutrients|micronutrients|mesh-ancestor
92984160|NCT00493012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984161|NCT00493012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92984163|NCT00918593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984164|NCT00918593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984165|NCT04083833|Tetrodotoxin|tetrodotoxin|mesh-list
92984166|NCT04083833|Anesthetics, Local|anesthetics, local|mesh-ancestor
92984167|NCT04083833|Anesthetics|anesthetics|mesh-ancestor
92984168|NCT04083833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984169|NCT04083833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984170|NCT04083833|Sensory System Agents|sensory system agents|mesh-ancestor
92984171|NCT04083833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984172|NCT04083833|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92984173|NCT04083833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984174|NCT04083833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984175|NCT05684705|Rifabutin|rifabutin|mesh-list
92984176|NCT05684705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984177|NCT05684705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984178|NCT05684705|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92984179|NCT05684705|Antitubercular Agents|antitubercular agents|mesh-ancestor
92984180|NCT05238233|Proxymetacaine|proxymetacaine|mesh-list
92984181|NCT05238233|Pilocarpine|pilocarpine|mesh-list
92984182|NCT05238233|Tropicamide|tropicamide|mesh-list
92984183|NCT05238233|Miotics|miotics|mesh-ancestor
92984184|NCT05238233|Autonomic Agents|autonomic agents|mesh-ancestor
92984185|NCT05238233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984186|NCT05238233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984187|NCT05238233|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92984188|NCT05238233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92984189|NCT05238233|Cholinergic Agents|cholinergic agents|mesh-ancestor
92984190|NCT05238233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984191|NCT05238233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984192|NCT05238233|Mydriatics|mydriatics|mesh-ancestor
92984193|NCT05238233|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92984194|NCT05238233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92984195|NCT05238233|Anesthetics, Local|anesthetics, local|mesh-ancestor
92984196|NCT05238233|Anesthetics|anesthetics|mesh-ancestor
92984197|NCT05238233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984198|NCT05238233|Sensory System Agents|sensory system agents|mesh-ancestor
92984199|NCT00617708|Gemcitabine|gemcitabine|mesh-list
92984200|NCT00617708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92984201|NCT00617708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92984202|NCT00617708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984203|NCT00617708|Antimetabolites|antimetabolites|mesh-ancestor
92984204|NCT00617708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984205|NCT00617708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984206|NCT00617708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92984207|NCT00617708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984208|NCT00617708|Immunologic Factors|immunologic factors|mesh-ancestor
92167412|NCT04929522|Anesthetics|anesthetics|mesh-list
92984209|NCT00617708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984210|NCT04083209|Analgesics, Opioid|analgesics, opioid|mesh-list
92984211|NCT04083209|Narcotics|narcotics|mesh-ancestor
92984212|NCT04083209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984213|NCT04083209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984214|NCT04083209|Analgesics|analgesics|mesh-ancestor
92984215|NCT04083209|Sensory System Agents|sensory system agents|mesh-ancestor
92984216|NCT04083209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984217|NCT00864968|Nabumetone|nabumetone|mesh-list
92984218|NCT00864968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92984219|NCT00864968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92984220|NCT00864968|Analgesics|analgesics|mesh-ancestor
92984221|NCT00864968|Sensory System Agents|sensory system agents|mesh-ancestor
92984222|NCT00864968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984223|NCT00864968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984224|NCT00864968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984225|NCT00864968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984226|NCT00864968|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92984227|NCT00864968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92984228|NCT00864968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984229|NCT00864968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984230|NCT00876044|Aflibercept|aflibercept|mesh-list
92984231|NCT00876044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92984232|NCT00876044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92984233|NCT00876044|Growth Substances|growth substances|mesh-ancestor
92984234|NCT00876044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984235|NCT00876044|Growth Inhibitors|growth inhibitors|mesh-ancestor
92984236|NCT00876044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984237|NCT00866216|Azithromycin|azithromycin|mesh-list
92984238|NCT00866216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984239|NCT00866216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984240|NCT00871208|Retapamulin|retapamulin|mesh-list
92984241|NCT00871208|Hydrocortisone|hydrocortisone|mesh-list
92984242|NCT00871208|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92984243|NCT00871208|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92984244|NCT00871208|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92984245|NCT00871208|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
92984246|NCT00871208|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984247|NCT00871208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984248|NCT00871208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984249|NCT00871208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984250|NCT00871364|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92984251|NCT00871364|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92984252|NCT00871364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92984253|NCT00871364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984254|NCT00871364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984255|NCT00871364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984256|NCT00871364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984257|NCT00871364|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92984258|NCT00871364|Antidepressive Agents|antidepressive agents|mesh-ancestor
92984259|NCT00871364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92984260|NCT00866450|Calcium, Dietary|calcium, dietary|mesh-list
92984261|NCT00866450|Calcium|calcium|mesh-list
92984262|NCT00866450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92984263|NCT00866450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984264|NCT00866450|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92984265|NCT03894969|Vaccines|vaccines|mesh-list
92984266|NCT03894969|Immunologic Factors|immunologic factors|mesh-ancestor
92984267|NCT03894969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984268|NCT00876434|Sirolimus|sirolimus|mesh-list
92984269|NCT00876434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984270|NCT00876434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984271|NCT00876434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984272|NCT00876434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984273|NCT00876434|Antifungal Agents|antifungal agents|mesh-ancestor
92984274|NCT00876434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984275|NCT00876434|Immunologic Factors|immunologic factors|mesh-ancestor
92984276|NCT00876434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984277|NCT00871442|Fentanyl|fentanyl|mesh-list
92984278|NCT00871442|Bupivacaine|bupivacaine|mesh-list
92984279|NCT00871442|Anesthetics|anesthetics|mesh-list
92984280|NCT00871442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92984281|NCT00871442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984282|NCT00871442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984283|NCT00871442|Sensory System Agents|sensory system agents|mesh-ancestor
92984284|NCT00871442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984285|NCT00871442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92984286|NCT00871442|Narcotics|narcotics|mesh-ancestor
92984287|NCT00871442|Analgesics|analgesics|mesh-ancestor
92984288|NCT00871442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92984289|NCT00871442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92984290|NCT00871442|Anesthetics, General|anesthetics, general|mesh-ancestor
92984291|NCT05355597|Clonidine|clonidine|mesh-list
92984292|NCT05355597|Epinephrine|epinephrine|mesh-list
92984293|NCT05355597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92984294|NCT05355597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92984295|NCT05355597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984296|NCT05355597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984297|NCT05355597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984298|NCT05355597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984299|NCT05355597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92984300|NCT05355597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92984301|NCT05355597|Autonomic Agents|autonomic agents|mesh-ancestor
92984302|NCT05355597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984303|NCT05355597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92984304|NCT05355597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92984305|NCT05355597|Mydriatics|mydriatics|mesh-ancestor
92984306|NCT05355597|Sympathomimetics|sympathomimetics|mesh-ancestor
92984307|NCT05355597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92984308|NCT05355597|Analgesics|analgesics|mesh-ancestor
92984309|NCT05355597|Sensory System Agents|sensory system agents|mesh-ancestor
92984310|NCT05355597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92984311|NCT05355597|Sympatholytics|sympatholytics|mesh-ancestor
92984312|NCT05355597|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92984313|NCT00866528|Paclitaxel|paclitaxel|mesh-list
92984314|NCT00866528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92984315|NCT00866528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984316|NCT00866528|Tubulin Modulators|tubulin modulators|mesh-ancestor
92984317|NCT00866528|Antimitotic Agents|antimitotic agents|mesh-ancestor
92984318|NCT00866528|Mitosis Modulators|mitosis modulators|mesh-ancestor
92984319|NCT00866528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984320|NCT00871598|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92984321|NCT00871598|Immunologic Factors|immunologic factors|mesh-ancestor
92984322|NCT00871598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984323|NCT00992667|Acetovanillone|acetovanillone|mesh-list
92984324|NCT00992667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92984325|NCT00992667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92984326|NCT00992667|Analgesics|analgesics|mesh-ancestor
92984327|NCT00992667|Sensory System Agents|sensory system agents|mesh-ancestor
92984328|NCT00992667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984329|NCT00992667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984330|NCT00992667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984331|NCT00992667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984332|NCT00992667|Antioxidants|antioxidants|mesh-ancestor
92984333|NCT00992667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984334|NCT00992667|Protective Agents|protective agents|mesh-ancestor
92984335|NCT00992667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984336|NCT05171972|Ofatumumab|ofatumumab|mesh-list
92984337|NCT05171972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984338|NCT00992823|Iron|iron|mesh-list
92984339|NCT00992823|Trace Elements|trace elements|mesh-ancestor
92984340|NCT00992823|Micronutrients|micronutrients|mesh-ancestor
92984341|NCT00992823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984342|NCT03894813|Metronidazole|metronidazole|mesh-list
92984343|NCT03894813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984344|NCT03894813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984345|NCT03894813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92984346|NCT03894813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92984347|NCT00615992|Tiotropium Bromide|tiotropium bromide|mesh-list
92984348|NCT00615992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92984349|NCT00615992|Autonomic Agents|autonomic agents|mesh-ancestor
92984350|NCT00615992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984351|NCT00615992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984352|NCT00615992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92984353|NCT00615992|Respiratory System Agents|respiratory system agents|mesh-ancestor
92984354|NCT00615992|Parasympatholytics|parasympatholytics|mesh-ancestor
92984355|NCT00615992|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92984356|NCT00615992|Cholinergic Agents|cholinergic agents|mesh-ancestor
92984357|NCT00615992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984358|NCT00615992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984359|NCT00876824|Amphotericin B|amphotericin b|mesh-list
92984360|NCT00876824|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92984361|NCT00876824|Amebicides|amebicides|mesh-ancestor
92984362|NCT00876824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92984363|NCT00876824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92984364|NCT00876824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984365|NCT00876824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984366|NCT00876824|Antifungal Agents|antifungal agents|mesh-ancestor
92984367|NCT00866684|Cyclosporine|cyclosporine|mesh-list
92984368|NCT00866684|Sirolimus|sirolimus|mesh-list
92984369|NCT00866684|Azathioprine|azathioprine|mesh-list
92984370|NCT00866684|Tacrolimus|tacrolimus|mesh-list
92984371|NCT00866684|Cyclosporins|cyclosporins|mesh-list
92984372|NCT00866684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984373|NCT00866684|Immunologic Factors|immunologic factors|mesh-ancestor
92984374|NCT00866684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984375|NCT00866684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92984376|NCT00866684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984377|NCT00866684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984378|NCT00866684|Antifungal Agents|antifungal agents|mesh-ancestor
92984379|NCT00866684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984380|NCT00866684|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984381|NCT00866684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984382|NCT00866684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984383|NCT00866684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984384|NCT00866684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984385|NCT00866684|Antimetabolites|antimetabolites|mesh-ancestor
92984386|NCT00866684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984387|NCT00993057|Insulin|insulin|mesh-list
92984388|NCT00993057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92984389|NCT00993057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984390|NCT00866762|Vorinostat|vorinostat|mesh-list
92984391|NCT00866762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92984392|NCT00866762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984393|NCT00866762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984394|NCT00866762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984395|NCT00876902|polysaccharide-K|polysaccharide-k|mesh-list
92984396|NCT00876902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92984397|NCT00876902|Immunologic Factors|immunologic factors|mesh-ancestor
92984398|NCT00876902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984399|NCT00876902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984400|NCT00876902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984401|NCT00876902|Antiviral Agents|antiviral agents|mesh-ancestor
92984402|NCT00876902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984403|NCT00876902|Interferon Inducers|interferon inducers|mesh-ancestor
92984404|NCT00876902|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92984405|NCT00876902|Protective Agents|protective agents|mesh-ancestor
92984406|NCT00993135|Methotrexate|methotrexate|mesh-list
92984407|NCT00993135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92984408|NCT00993135|Abortifacient Agents|abortifacient agents|mesh-ancestor
92984409|NCT00993135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92984410|NCT00993135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984411|NCT00993135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984412|NCT00993135|Antimetabolites|antimetabolites|mesh-ancestor
92984413|NCT00993135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984414|NCT00993135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984415|NCT00993135|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984416|NCT00993135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984417|NCT00993135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92984418|NCT00993135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984419|NCT00993135|Immunologic Factors|immunologic factors|mesh-ancestor
92984420|NCT00993135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984421|NCT00993135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92984422|NCT00866996|Methylphenidate|methylphenidate|mesh-list
92984423|NCT00866996|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92984424|NCT00866996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92167425|NCT02542969|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92984425|NCT00866996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984426|NCT00866996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92984427|NCT00866996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92984428|NCT00866996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984429|NCT00866996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984430|NCT00866996|Dopamine Agents|dopamine agents|mesh-ancestor
92984431|NCT00866996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984432|NCT00866996|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92984433|NCT00866996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984434|NCT00871910|Dexamethasone|dexamethasone|mesh-list
92984435|NCT00871910|Ondansetron|ondansetron|mesh-list
92984436|NCT00871910|Aprepitant|aprepitant|mesh-list
92984437|NCT00871910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984438|NCT00871910|Antiemetics|antiemetics|mesh-ancestor
92984439|NCT00871910|Autonomic Agents|autonomic agents|mesh-ancestor
92984440|NCT00871910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984441|NCT00871910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984442|NCT00871910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92984443|NCT00871910|Glucocorticoids|glucocorticoids|mesh-ancestor
92984444|NCT00871910|Hormones|hormones|mesh-ancestor
92984445|NCT00871910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984446|NCT00871910|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92984447|NCT00871910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984448|NCT00871910|Antipruritics|antipruritics|mesh-ancestor
92984449|NCT00871910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984450|NCT00871910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92984451|NCT00871910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92984452|NCT00871910|Serotonin Agents|serotonin agents|mesh-ancestor
92984453|NCT00871910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984454|NCT00871910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984455|NCT00871910|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92984456|NCT05355441|Analgesics|analgesics|mesh-list
92984457|NCT05355441|Sensory System Agents|sensory system agents|mesh-ancestor
92984458|NCT05355441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984459|NCT05355441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984460|NCT01564329|Endostar protein|endostar protein|mesh-list
92984461|NCT01564329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92984462|NCT01564329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92984464|NCT01564329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984465|NCT01564329|Growth Inhibitors|growth inhibitors|mesh-ancestor
92984466|NCT01564329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984467|NCT05213481|Tepotinib|tepotinib|mesh-list
92984468|NCT05213481|Carbamazepine|carbamazepine|mesh-list
92984469|NCT05213481|Anticonvulsants|anticonvulsants|mesh-ancestor
92984470|NCT05213481|Antimanic Agents|antimanic agents|mesh-ancestor
92984471|NCT05213481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92984472|NCT05213481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984473|NCT05213481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984474|NCT05213481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92984475|NCT05213481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92984476|NCT05213481|Analgesics|analgesics|mesh-ancestor
92984477|NCT05213481|Sensory System Agents|sensory system agents|mesh-ancestor
92984478|NCT05213481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984479|NCT05213481|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92984480|NCT05213481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984481|NCT05213481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984482|NCT05213481|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92984483|NCT05213481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92984484|NCT05213481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984485|NCT00993525|Ranibizumab|ranibizumab|mesh-list
92984486|NCT00993525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92984487|NCT00993525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92984488|NCT00993525|Growth Substances|growth substances|mesh-ancestor
92984489|NCT00993525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984490|NCT00993525|Growth Inhibitors|growth inhibitors|mesh-ancestor
92984491|NCT00993525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984492|NCT00993681|Vaccines|vaccines|mesh-list
92984493|NCT00993681|Immunologic Factors|immunologic factors|mesh-ancestor
92984494|NCT00993681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984495|NCT03892707|Folic Acid|folic acid|mesh-list
92984496|NCT03892707|Vitamin B Complex|vitamin b complex|mesh-list
92984497|NCT03892707|Celecoxib|celecoxib|mesh-list
92984498|NCT03892707|Etoricoxib|etoricoxib|mesh-list
92984499|NCT03892707|Meloxicam|meloxicam|mesh-list
92984500|NCT03892707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92984501|NCT03892707|Nimesulide|nimesulide|mesh-list
92984502|NCT03892707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92984503|NCT03892707|Benphothiamine|benphothiamine|mesh-list
92984504|NCT03892707|Vitamins|vitamins|mesh-ancestor
92984505|NCT03892707|Micronutrients|micronutrients|mesh-ancestor
92984506|NCT03892707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984507|NCT03892707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92984508|NCT03892707|Analgesics|analgesics|mesh-ancestor
92984509|NCT03892707|Sensory System Agents|sensory system agents|mesh-ancestor
92984510|NCT03892707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984511|NCT03892707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984512|NCT03892707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92984513|NCT03892707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92984514|NCT03892707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984515|NCT03892707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984516|NCT03892707|Hematinics|hematinics|mesh-ancestor
92984517|NCT03892707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92984518|NCT03892707|Immunologic Factors|immunologic factors|mesh-ancestor
92984519|NCT03892707|Chelating Agents|chelating agents|mesh-ancestor
92984520|NCT03892707|Sequestering Agents|sequestering agents|mesh-ancestor
92984521|NCT00513604|Aldesleukin|aldesleukin|mesh-list
92984522|NCT00513604|Cyclophosphamide|cyclophosphamide|mesh-list
92984523|NCT00513604|Fludarabine|fludarabine|mesh-list
92984524|NCT00513604|Fludarabine phosphate|fludarabine phosphate|mesh-list
92984525|NCT00513604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984526|NCT00513604|Immunologic Factors|immunologic factors|mesh-ancestor
92984527|NCT00513604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984528|NCT00513604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984529|NCT00513604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92984530|NCT00513604|Alkylating Agents|alkylating agents|mesh-ancestor
92984531|NCT00513604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984532|NCT00513604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984533|NCT00513604|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92984534|NCT00513604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984535|NCT00513604|Antimetabolites|antimetabolites|mesh-ancestor
92984536|NCT00513604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92984537|NCT00513604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92984538|NCT00513604|Antiviral Agents|antiviral agents|mesh-ancestor
92984539|NCT00513604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984540|NCT00872144|Nabiximols|nabiximols|mesh-list
92984541|NCT00872144|Analgesics|analgesics|mesh-ancestor
92984542|NCT00872144|Sensory System Agents|sensory system agents|mesh-ancestor
92984543|NCT00872144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984544|NCT00872144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984545|NCT00867152|Ritonavir|ritonavir|mesh-list
92984546|NCT00867152|Lopinavir|lopinavir|mesh-list
92984547|NCT00867152|Darunavir|darunavir|mesh-list
92984548|NCT00867152|Dolutegravir|dolutegravir|mesh-list
92984549|NCT00867152|Etravirine|etravirine|mesh-list
92984550|NCT00867152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92984551|NCT00867152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92984552|NCT00867152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92984553|NCT00867152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984554|NCT00867152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984555|NCT00867152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92984556|NCT00867152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92984557|NCT00867152|Antiviral Agents|antiviral agents|mesh-ancestor
92984558|NCT00867152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984559|NCT00867152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92984560|NCT00867152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92984561|NCT00867152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92984562|NCT00867152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92984563|NCT00867152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92984564|NCT00867152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92984565|NCT04039958|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92984566|NCT04039958|Antiviral Agents|antiviral agents|mesh-ancestor
92984567|NCT04039958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984568|NCT00872378|Exenatide|exenatide|mesh-list
92984569|NCT00872378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92984570|NCT00872378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984571|NCT00872378|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92984572|NCT00872378|Incretins|incretins|mesh-ancestor
92984573|NCT00872378|Hormones|hormones|mesh-ancestor
92984574|NCT00872378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984575|NCT00994071|Temozolomide|temozolomide|mesh-list
92984576|NCT00994071|Veliparib|veliparib|mesh-list
92984577|NCT00994071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92984578|NCT00994071|Alkylating Agents|alkylating agents|mesh-ancestor
92984579|NCT00994071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984580|NCT00994071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984581|NCT00994071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92984582|NCT00994071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984583|NCT00994149|Diazoxide|diazoxide|mesh-list
92984584|NCT00994149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92984585|NCT00994149|Vasodilator Agents|vasodilator agents|mesh-ancestor
92984586|NCT00573248|Nicotine|nicotine|mesh-list
92984587|NCT00573248|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92984588|NCT00573248|Autonomic Agents|autonomic agents|mesh-ancestor
92984589|NCT00573248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984590|NCT00573248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984591|NCT00573248|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92984592|NCT00573248|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92984593|NCT00573248|Cholinergic Agents|cholinergic agents|mesh-ancestor
92984594|NCT00573248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984595|NCT00573248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984596|NCT04039880|Olorofim|olorofim|mesh-list
92984597|NCT04039880|Antifungal Agents|antifungal agents|mesh-ancestor
92984598|NCT04039880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984599|NCT00994305|Acetylcysteine|acetylcysteine|mesh-list
92984600|NCT00994305|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92984601|NCT00994305|Antiviral Agents|antiviral agents|mesh-ancestor
92984602|NCT00994305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984603|NCT00994305|Expectorants|expectorants|mesh-ancestor
92984604|NCT00994305|Respiratory System Agents|respiratory system agents|mesh-ancestor
92984605|NCT00994305|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92984606|NCT00994305|Antioxidants|antioxidants|mesh-ancestor
92984607|NCT00994305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984609|NCT00994305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984610|NCT00994305|Antidotes|antidotes|mesh-ancestor
92984611|NCT00877760|Interferons|interferons|mesh-list
92984612|NCT00877760|Entecavir|entecavir|mesh-list
92984613|NCT00877760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984614|NCT00877760|Antiviral Agents|antiviral agents|mesh-ancestor
92984615|NCT00877760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984616|NCT04083911|Cytarabine|cytarabine|mesh-list
92984617|NCT04083911|Decitabine|decitabine|mesh-list
92984618|NCT04083911|Homoharringtonine|homoharringtonine|mesh-list
92984619|NCT04083911|Aclarubicin|aclarubicin|mesh-list
92984620|NCT04083911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984621|NCT04083911|Antimetabolites|antimetabolites|mesh-ancestor
92984622|NCT04083911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984623|NCT04083911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984624|NCT04083911|Antiviral Agents|antiviral agents|mesh-ancestor
92984625|NCT04083911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984626|NCT04083911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984627|NCT04083911|Immunologic Factors|immunologic factors|mesh-ancestor
92984628|NCT04083911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984629|NCT04083911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984630|NCT04083911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92984631|NCT04083911|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92984632|NCT04083911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984633|NCT04083911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92984634|NCT04083911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92984635|NCT00995241|Raltegravir Potassium|raltegravir potassium|mesh-list
92984636|NCT00995241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92984637|NCT00995241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92984638|NCT00995241|Antiviral Agents|antiviral agents|mesh-ancestor
92984639|NCT00995241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984640|NCT00995241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92984641|NCT00995241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92984642|NCT00995241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984643|NCT00995241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984644|NCT00994383|Morphine|morphine|mesh-list
92984645|NCT00994383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92984646|NCT00994383|Narcotics|narcotics|mesh-ancestor
92984647|NCT00994383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984648|NCT00994383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984649|NCT00994383|Analgesics|analgesics|mesh-ancestor
92984650|NCT00994383|Sensory System Agents|sensory system agents|mesh-ancestor
92984651|NCT00994383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984652|NCT02588417|Dexamethasone|dexamethasone|mesh-list
92984653|NCT02588417|Levobupivacaine|levobupivacaine|mesh-list
92984654|NCT02588417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984655|NCT02588417|Antiemetics|antiemetics|mesh-ancestor
92984656|NCT02588417|Autonomic Agents|autonomic agents|mesh-ancestor
92984657|NCT02588417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984658|NCT02588417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984659|NCT02588417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92984660|NCT02588417|Glucocorticoids|glucocorticoids|mesh-ancestor
92984661|NCT02588417|Hormones|hormones|mesh-ancestor
92984662|NCT02588417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984663|NCT02588417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92984664|NCT02588417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984665|NCT02588417|Anesthetics, Local|anesthetics, local|mesh-ancestor
92984666|NCT02588417|Anesthetics|anesthetics|mesh-ancestor
92984667|NCT02588417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984668|NCT02588417|Sensory System Agents|sensory system agents|mesh-ancestor
92984669|NCT00532935|Metformin|metformin|mesh-list
92984670|NCT00532935|Pioglitazone|pioglitazone|mesh-list
92984671|NCT00532935|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92984672|NCT00532935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92984673|NCT00532935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984674|NCT00532935|Incretins|incretins|mesh-ancestor
92984675|NCT00532935|Hormones|hormones|mesh-ancestor
92984676|NCT00532935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984677|NCT00532935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92984678|NCT00532935|Protease Inhibitors|protease inhibitors|mesh-ancestor
92984679|NCT00532935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984680|NCT00532935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984681|NCT00994539|Morphine|morphine|mesh-list
92984682|NCT00994539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92984683|NCT00994539|Narcotics|narcotics|mesh-ancestor
92528163|NCT00035113|Epothilones|epothilones|mesh-list
92984684|NCT00994539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984685|NCT00994539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984687|NCT00994539|Sensory System Agents|sensory system agents|mesh-ancestor
92984688|NCT00994539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984689|NCT00878306|Ritonavir|ritonavir|mesh-list
92984690|NCT00878306|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92984691|NCT00878306|Efavirenz|efavirenz|mesh-list
92984692|NCT00878306|Disulfiram|disulfiram|mesh-list
92984693|NCT00878306|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92984694|NCT00878306|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92984695|NCT00878306|Protease Inhibitors|protease inhibitors|mesh-ancestor
92984696|NCT00878306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984697|NCT00878306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984698|NCT00878306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92984699|NCT00878306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92984700|NCT00878306|Antiviral Agents|antiviral agents|mesh-ancestor
92984701|NCT00878306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984702|NCT00878306|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92984703|NCT00878306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92984704|NCT00878306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92984705|NCT00878306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92984706|NCT00878306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92984707|NCT00878306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92984708|NCT00878306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92984709|NCT00878306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92984710|NCT00878306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92984711|NCT00878306|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92984712|NCT00878306|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92984713|NCT00994617|Losartan|losartan|mesh-list
92984714|NCT00994617|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92984715|NCT00994617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92984716|NCT00994617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92167440|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92984717|NCT00994617|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92984718|NCT00994617|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92984719|NCT00994617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984720|NCT00994617|Diuretics|diuretics|mesh-ancestor
92984721|NCT00994617|Natriuretic Agents|natriuretic agents|mesh-ancestor
92984722|NCT00994617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984723|NCT00994617|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92984724|NCT00994617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984725|NCT00995397|Chlorpheniramine|chlorpheniramine|mesh-list
92984726|NCT00995397|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92984727|NCT00995397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92984728|NCT00995397|Histamine Antagonists|histamine antagonists|mesh-ancestor
92984729|NCT00995397|Histamine Agents|histamine agents|mesh-ancestor
92984730|NCT00995397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984731|NCT00995397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984732|NCT00995397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984733|NCT00995397|Antipruritics|antipruritics|mesh-ancestor
92984734|NCT00995397|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984735|NCT00995397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92984736|NCT00919451|Cyclosporine|cyclosporine|mesh-list
92984737|NCT00919451|Cyclosporins|cyclosporins|mesh-list
92984738|NCT00919451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984739|NCT00919451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984740|NCT00919451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984741|NCT00919451|Immunologic Factors|immunologic factors|mesh-ancestor
92984742|NCT00919451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984743|NCT00919451|Antifungal Agents|antifungal agents|mesh-ancestor
92984744|NCT00919451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984745|NCT00919451|Dermatologic Agents|dermatologic agents|mesh-ancestor
92984746|NCT00919451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984747|NCT00919451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92984748|NCT03016312|Atezolizumab|atezolizumab|mesh-list
92984749|NCT03016312|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92984750|NCT03016312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984751|NCT03016312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92984752|NCT03016312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984753|NCT05059223|Reboxetine|reboxetine|mesh-list
92984754|NCT05059223|Antidepressive Agents|antidepressive agents|mesh-ancestor
92984755|NCT05059223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92528164|NCT00035113|Epothilone B|epothilone b|mesh-list
92984757|NCT05059223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92984758|NCT05059223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984759|NCT05059223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984760|NCT05059223|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984761|NCT05059223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984762|NCT05059223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984763|NCT00919607|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92984764|NCT00919607|Antidepressive Agents|antidepressive agents|mesh-ancestor
92984765|NCT00919607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92984766|NCT00919607|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92984767|NCT00919607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92984768|NCT00919607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984769|NCT00919607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984770|NCT01014052|Retinol acetate|retinol acetate|mesh-list
92984771|NCT01014052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92984772|NCT01014052|Immunologic Factors|immunologic factors|mesh-ancestor
92984773|NCT01014052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984774|NCT01014052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92984775|NCT01014052|Protective Agents|protective agents|mesh-ancestor
92984776|NCT01014052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984777|NCT00512902|Imatinib Mesylate|imatinib mesylate|mesh-list
92984778|NCT00512902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984779|NCT00512902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92984780|NCT00512902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984781|NCT00512902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984782|NCT01014364|Hydrocortisone|hydrocortisone|mesh-list
92984783|NCT01014364|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92984784|NCT01014364|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92984785|NCT01014364|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92984786|NCT01014364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92984787|NCT01015300|Bevacizumab|bevacizumab|mesh-list
92984788|NCT01015300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92984789|NCT01015300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984790|NCT01015300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92984791|NCT01015300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92984792|NCT01015300|Growth Substances|growth substances|mesh-ancestor
92984793|NCT01015300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984794|NCT01015300|Growth Inhibitors|growth inhibitors|mesh-ancestor
92984795|NCT01015456|Mycophenolic Acid|mycophenolic acid|mesh-list
92984796|NCT01015456|Cyclophosphamide|cyclophosphamide|mesh-list
92984797|NCT01015456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984798|NCT01015456|Immunologic Factors|immunologic factors|mesh-ancestor
92984799|NCT01015456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984800|NCT01015456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92984801|NCT01015456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92984802|NCT01015456|Alkylating Agents|alkylating agents|mesh-ancestor
92984803|NCT01015456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984804|NCT01015456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984805|NCT01015456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92984806|NCT01015456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984807|NCT01015456|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92984808|NCT01015456|Antitubercular Agents|antitubercular agents|mesh-ancestor
92984809|NCT01015456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92984810|NCT01015456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984811|NCT01015456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984812|NCT02589041|Ropivacaine|ropivacaine|mesh-list
92984813|NCT02589041|Anesthetics, Local|anesthetics, local|mesh-ancestor
92984814|NCT02589041|Anesthetics|anesthetics|mesh-ancestor
92984815|NCT02589041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984816|NCT02589041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984817|NCT02589041|Sensory System Agents|sensory system agents|mesh-ancestor
92984818|NCT02589041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984819|NCT00492232|Zolpidem|zolpidem|mesh-list
92984820|NCT00492232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92984821|NCT00492232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92984822|NCT00492232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984823|NCT00492232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984824|NCT00492232|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92984825|NCT00492232|GABA Agonists|gaba agonists|mesh-ancestor
92984826|NCT00492232|GABA Agents|gaba agents|mesh-ancestor
92984827|NCT00492232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528165|NCT00035113|Tubulin Modulators|tubulin modulators|mesh-ancestor
92984828|NCT00492232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984829|NCT02587871|Cytarabine|cytarabine|mesh-list
92984830|NCT02587871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92984831|NCT02587871|Antimetabolites|antimetabolites|mesh-ancestor
92984832|NCT02587871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984833|NCT02587871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984834|NCT02587871|Antiviral Agents|antiviral agents|mesh-ancestor
92984835|NCT02587871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984836|NCT02587871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92984837|NCT02587871|Immunologic Factors|immunologic factors|mesh-ancestor
92630239|NCT02885272|Antiviral Agents|antiviral agents|mesh-ancestor
92984838|NCT02587871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984839|NCT00919919|Progesterone|progesterone|mesh-list
92984840|NCT00919919|Progestins|progestins|mesh-ancestor
92984841|NCT00919919|Hormones|hormones|mesh-ancestor
92984842|NCT00919919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984843|NCT00919919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984844|NCT00491764|Posaconazole|posaconazole|mesh-list
92984845|NCT00491764|Terbinafine|terbinafine|mesh-list
92984846|NCT00491764|Antifungal Agents|antifungal agents|mesh-ancestor
92984847|NCT00491764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984848|NCT00491764|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92984849|NCT00491764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92984850|NCT00491764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92984851|NCT00491764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92984852|NCT00491764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92984853|NCT00491764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984854|NCT00491764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984855|NCT00491764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92984856|NCT00491764|Hormone Antagonists|hormone antagonists|mesh-ancestor
92984857|NCT00491764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984858|NCT00491764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984859|NCT02586311|Amlodipine|amlodipine|mesh-list
92984860|NCT02586311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92984861|NCT02586311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92984862|NCT02586311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984863|NCT02586311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984864|NCT02586311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92984865|NCT02586311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984866|NCT02586311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92984867|NCT05557721|Lidocaine|lidocaine|mesh-list
92984868|NCT05557721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92984869|NCT05557721|Anesthetics|anesthetics|mesh-ancestor
92984870|NCT05557721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984871|NCT05557721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984872|NCT05557721|Sensory System Agents|sensory system agents|mesh-ancestor
92984873|NCT05557721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984874|NCT05557721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92984875|NCT05557721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92984876|NCT05557721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92984877|NCT05557721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92984878|NCT05557721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984879|NCT00615836|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92984880|NCT00615836|Hemostatics|hemostatics|mesh-ancestor
92984881|NCT00615836|Coagulants|coagulants|mesh-ancestor
92984882|NCT00615836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92984883|NCT00615836|Natriuretic Agents|natriuretic agents|mesh-ancestor
92984884|NCT00615836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984885|NCT05139212|Dexmedetomidine|dexmedetomidine|mesh-list
92984886|NCT05139212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92984887|NCT05139212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984888|NCT05139212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984889|NCT05139212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92984890|NCT05139212|Analgesics|analgesics|mesh-ancestor
92984891|NCT05139212|Sensory System Agents|sensory system agents|mesh-ancestor
92984892|NCT05139212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92984893|NCT05139212|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92984894|NCT05139212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92984895|NCT05139212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92984896|NCT05139212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984897|NCT05139212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984898|NCT05139212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984899|NCT00872924|Sumatriptan|sumatriptan|mesh-list
92984900|NCT00872924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92984901|NCT00872924|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92984902|NCT00872924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92984903|NCT00872924|Serotonin Agents|serotonin agents|mesh-ancestor
92984904|NCT00872924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984905|NCT00872924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984906|NCT00872924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984907|NCT00878540|Mirtazapine|mirtazapine|mesh-list
92984908|NCT00878540|Antidepressive Agents|antidepressive agents|mesh-ancestor
92984909|NCT00878540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92984910|NCT00878540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92630313|NCT02607748|Listerine|listerine|mesh-list
92984911|NCT00878540|Histamine Antagonists|histamine antagonists|mesh-ancestor
92984912|NCT00878540|Histamine Agents|histamine agents|mesh-ancestor
92984913|NCT00878540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92984914|NCT00878540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984915|NCT00878540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984916|NCT00878540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92984917|NCT00878540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92984918|NCT00878540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92984919|NCT00878540|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92984920|NCT00878540|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92984921|NCT00878540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92984922|NCT00878540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92984923|NCT00878540|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92984924|NCT00878540|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92984925|NCT00878540|Serotonin Agents|serotonin agents|mesh-ancestor
92984926|NCT00878540|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92984927|NCT04018274|Levonorgestrel|levonorgestrel|mesh-list
92984928|NCT04018274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92984929|NCT04018274|Contraceptive Agents|contraceptive agents|mesh-list
92984930|NCT04018274|Contraceptives, Oral|contraceptives, oral|mesh-list
92984931|NCT04018274|Estradiol|estradiol|mesh-list
92984932|NCT04018274|Estrogens|estrogens|mesh-ancestor
92984933|NCT04018274|Hormones|hormones|mesh-ancestor
92984934|NCT04018274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92984935|NCT04018274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984936|NCT04018274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92984937|NCT04018274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92984938|NCT04018274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92984939|NCT04018274|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92984940|NCT04018274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92984941|NCT00873002|Sorafenib|sorafenib|mesh-list
92984942|NCT00873002|Panobinostat|panobinostat|mesh-list
92984943|NCT00873002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984944|NCT00873002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92984945|NCT00873002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984946|NCT00873002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984947|NCT00873002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92984948|NCT00491530|Calcium, Dietary|calcium, dietary|mesh-list
92984949|NCT00491530|Atorvastatin|atorvastatin|mesh-list
92984950|NCT00491530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92984951|NCT00491530|Simvastatin|simvastatin|mesh-list
92984952|NCT00491530|Fenofibric acid|fenofibric acid|mesh-list
92984953|NCT00491530|Calcium|calcium|mesh-list
92984954|NCT00491530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92984955|NCT00491530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984956|NCT00491530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92984957|NCT00491530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92984958|NCT00491530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92984959|NCT00491530|Antimetabolites|antimetabolites|mesh-ancestor
92984960|NCT00491530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984961|NCT00491530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92984962|NCT00491530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92984963|NCT00491530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984964|NCT00617240|Metformin|metformin|mesh-list
92984965|NCT00617240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92984966|NCT00617240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984967|NCT00615290|Tipranavir|tipranavir|mesh-list
92984968|NCT00615290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92984969|NCT00615290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92984971|NCT00615290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984972|NCT02587169|Doxorubicin|doxorubicin|mesh-list
92984973|NCT02587169|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92984974|NCT02587169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92984975|NCT02587169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984976|NCT02587169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92984977|NCT02587169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92984978|NCT02587169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984979|NCT02587169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92984980|NCT00873236|Interferons|interferons|mesh-list
92984981|NCT00873236|Interferon-alpha|interferon-alpha|mesh-list
92984982|NCT00873236|Interferon alpha-2|interferon alpha-2|mesh-list
92984983|NCT00873236|Bevacizumab|bevacizumab|mesh-list
92984984|NCT00873236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92984985|NCT00873236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92984986|NCT00873236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92984987|NCT00873236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92984988|NCT00873236|Growth Substances|growth substances|mesh-ancestor
92984989|NCT00873236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92984990|NCT00873236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92984991|NCT00873236|Antiviral Agents|antiviral agents|mesh-ancestor
92984992|NCT00873236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92984993|NCT00873236|Immunologic Factors|immunologic factors|mesh-ancestor
92984994|NCT00868010|Donepezil|donepezil|mesh-list
92984995|NCT00868010|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92984996|NCT00868010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92984997|NCT00868010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167452|NCT02518945|Dapagliflozin|dapagliflozin|mesh-list
92984998|NCT00868010|Cholinergic Agents|cholinergic agents|mesh-ancestor
92984999|NCT00868010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985000|NCT00868010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985001|NCT00868010|Nootropic Agents|nootropic agents|mesh-ancestor
92985002|NCT05683301|Amlodipine|amlodipine|mesh-list
92985003|NCT05683301|Perindopril|perindopril|mesh-list
92985004|NCT05683301|Indapamide|indapamide|mesh-list
92985005|NCT05683301|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
92985006|NCT05683301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92985007|NCT05683301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92985008|NCT05683301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985009|NCT05683301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985010|NCT05683301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92985011|NCT05683301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985012|NCT05683301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92985013|NCT05683301|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92985014|NCT05683301|Protease Inhibitors|protease inhibitors|mesh-ancestor
92985015|NCT05683301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985016|NCT05683301|Diuretics|diuretics|mesh-ancestor
92985017|NCT05683301|Natriuretic Agents|natriuretic agents|mesh-ancestor
92985018|NCT05683301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92985019|NCT04770623|Docetaxel|docetaxel|mesh-list
92985020|NCT04770623|Irinotecan|irinotecan|mesh-list
92985021|NCT04770623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985022|NCT04770623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985023|NCT04770623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985024|NCT04770623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985025|NCT04770623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985026|NCT04770623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92985027|NCT04770623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92985028|NCT04770623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985029|NCT05653661|Paclitaxel|paclitaxel|mesh-list
92985030|NCT05653661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92985031|NCT05653661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92985032|NCT05653661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985033|NCT05653661|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985034|NCT05653661|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985035|NCT05653661|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985036|NCT05653661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985037|NCT00873392|Nicotine|nicotine|mesh-list
92985038|NCT00873392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92985039|NCT00873392|Autonomic Agents|autonomic agents|mesh-ancestor
92985040|NCT00873392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985041|NCT00873392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985042|NCT00873392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92985043|NCT00873392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92985044|NCT00873392|Cholinergic Agents|cholinergic agents|mesh-ancestor
92985045|NCT00873392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985046|NCT00873392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985047|NCT00879008|Moxifloxacin|moxifloxacin|mesh-list
92985048|NCT00879008|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92985049|NCT00879008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985050|NCT00879008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985051|NCT00879008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92985052|NCT00879008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92985053|NCT00879008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985054|NCT00879008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985055|NCT00879008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985056|NCT00879008|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92985057|NCT00879008|Contraceptive Agents|contraceptive agents|mesh-ancestor
92985058|NCT00879008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985059|NCT00879008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985060|NCT00879008|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92985061|NCT00879008|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92985062|NCT00879008|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92985063|NCT04658147|Nivolumab|nivolumab|mesh-list
92985064|NCT04658147|Relatlimab|relatlimab|mesh-list
92985065|NCT04658147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985066|NCT04658147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167458|NCT02518945|Incretins|incretins|mesh-ancestor
92985067|NCT04658147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92985068|NCT04658147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985069|NCT00879164|Bupivacaine|bupivacaine|mesh-list
92985070|NCT00879164|Anesthetics, Local|anesthetics, local|mesh-ancestor
92985071|NCT00879164|Anesthetics|anesthetics|mesh-ancestor
92985072|NCT00879164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985073|NCT00879164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985074|NCT00879164|Sensory System Agents|sensory system agents|mesh-ancestor
92985075|NCT00879164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985076|NCT04731155|Alirocumab|alirocumab|mesh-list
92985077|NCT04731155|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92985078|NCT04731155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92985079|NCT04731155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92985080|NCT04731155|Antimetabolites|antimetabolites|mesh-ancestor
92985081|NCT04731155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985082|NCT04731155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92985083|NCT04731155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92985084|NCT04731155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985085|NCT04731155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92985086|NCT04729049|Morphine|morphine|mesh-list
92985087|NCT04729049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92985088|NCT04729049|Narcotics|narcotics|mesh-ancestor
92985089|NCT04729049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985090|NCT04729049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985091|NCT04729049|Analgesics|analgesics|mesh-ancestor
92985092|NCT04729049|Sensory System Agents|sensory system agents|mesh-ancestor
92985093|NCT04729049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985094|NCT02585765|Pioglitazone|pioglitazone|mesh-list
92985095|NCT02585765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92985096|NCT02585765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985097|NCT04634669|Dextromethorphan|dextromethorphan|mesh-list
92985098|NCT04634669|Bupropion|bupropion|mesh-list
92985099|NCT04634669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92985100|NCT04634669|Antidepressive Agents|antidepressive agents|mesh-ancestor
92985101|NCT04634669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92985102|NCT04634669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92985103|NCT04634669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92985104|NCT04634669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985105|NCT04634669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985106|NCT04634669|Dopamine Agents|dopamine agents|mesh-ancestor
92985107|NCT04634669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985108|NCT04634669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985109|NCT04634669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92985110|NCT04634669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92985111|NCT04634669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985112|NCT04634669|Antitussive Agents|antitussive agents|mesh-ancestor
92985113|NCT04634669|Respiratory System Agents|respiratory system agents|mesh-ancestor
92985114|NCT04634669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92985115|NCT04634669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92985116|NCT04575311|Quemliclustat|quemliclustat|mesh-list
92985117|NCT04575311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92985118|NCT04575311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985119|NCT04575311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985120|NCT04575311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985122|NCT02585531|Epinephrine|epinephrine|mesh-list
92985123|NCT02585531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985124|NCT02585531|Antiemetics|antiemetics|mesh-ancestor
92985125|NCT02585531|Autonomic Agents|autonomic agents|mesh-ancestor
92985126|NCT02585531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985127|NCT02585531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985128|NCT02585531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985129|NCT02585531|Glucocorticoids|glucocorticoids|mesh-ancestor
92985130|NCT02585531|Hormones|hormones|mesh-ancestor
92985131|NCT02585531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985132|NCT02585531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92985133|NCT02585531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985134|NCT02585531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92985135|NCT02585531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92985136|NCT02585531|Adrenergic Agents|adrenergic agents|mesh-ancestor
92985137|NCT02585531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985138|NCT02585531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985139|NCT02585531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92985140|NCT02585531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92985141|NCT02585531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92985142|NCT02585531|Respiratory System Agents|respiratory system agents|mesh-ancestor
92985143|NCT02585531|Mydriatics|mydriatics|mesh-ancestor
92985144|NCT02585531|Sympathomimetics|sympathomimetics|mesh-ancestor
92985145|NCT02585531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92985146|NCT00920153|Cytarabine|cytarabine|mesh-list
92985147|NCT00920153|Dexamethasone|dexamethasone|mesh-list
92985148|NCT00920153|Methylprednisolone|methylprednisolone|mesh-list
92985149|NCT00920153|Gemcitabine|gemcitabine|mesh-list
92985150|NCT00920153|Doxorubicin|doxorubicin|mesh-list
92985151|NCT00920153|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92985152|NCT00920153|Etoposide|etoposide|mesh-list
92985153|NCT00920153|Vincristine|vincristine|mesh-list
92985154|NCT00920153|Melphalan|melphalan|mesh-list
92985155|NCT00920153|Vinorelbine|vinorelbine|mesh-list
92985156|NCT00920153|Ifosfamide|ifosfamide|mesh-list
92985157|NCT00920153|Dacarbazine|dacarbazine|mesh-list
92985158|NCT00920153|Carmustine|carmustine|mesh-list
92985159|NCT00920153|Bleomycin|bleomycin|mesh-list
92985160|NCT00920153|Vindesine|vindesine|mesh-list
92985161|NCT00920153|Mitoguazone|mitoguazone|mesh-list
92985162|NCT00920153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985163|NCT00920153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985164|NCT00920153|Antiemetics|antiemetics|mesh-ancestor
92985165|NCT00920153|Autonomic Agents|autonomic agents|mesh-ancestor
92985166|NCT00920153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985167|NCT00920153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985168|NCT00920153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985169|NCT00920153|Glucocorticoids|glucocorticoids|mesh-ancestor
92985170|NCT00920153|Hormones|hormones|mesh-ancestor
92985171|NCT00920153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985172|NCT00920153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92985173|NCT00920153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92985174|NCT00920153|Antimetabolites|antimetabolites|mesh-ancestor
92985175|NCT00920153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985176|NCT00920153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92985177|NCT00920153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92985178|NCT00920153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92985179|NCT00920153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985180|NCT00920153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92985181|NCT00920153|Antiviral Agents|antiviral agents|mesh-ancestor
92985182|NCT00920153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985183|NCT00920153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92985184|NCT00920153|Immunologic Factors|immunologic factors|mesh-ancestor
92985185|NCT00920153|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985186|NCT00920153|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985187|NCT00920153|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985188|NCT00920153|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92985189|NCT00920153|Protective Agents|protective agents|mesh-ancestor
92985190|NCT00920153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92985191|NCT00920153|Alkylating Agents|alkylating agents|mesh-ancestor
92985192|NCT00920153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92985193|NCT04080713|Budesonide|budesonide|mesh-list
92985194|NCT04080713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985195|NCT04080713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92985197|NCT04080713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985198|NCT04080713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985199|NCT04080713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92985200|NCT04080713|Respiratory System Agents|respiratory system agents|mesh-ancestor
92985201|NCT04080713|Glucocorticoids|glucocorticoids|mesh-ancestor
92985202|NCT04080713|Hormones|hormones|mesh-ancestor
92985203|NCT04080713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985204|NCT04081805|Estradiol|estradiol|mesh-list
92985205|NCT04081805|Estrogens|estrogens|mesh-ancestor
92985206|NCT04081805|Hormones|hormones|mesh-ancestor
92985207|NCT04081805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985208|NCT04081805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630613|NCT00171782|Valsartan|valsartan|mesh-list
92985209|NCT05519189|Ropivacaine|ropivacaine|mesh-list
92985210|NCT05519189|Anesthetics, Local|anesthetics, local|mesh-ancestor
92985211|NCT05519189|Anesthetics|anesthetics|mesh-ancestor
92985212|NCT05519189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985213|NCT05519189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985214|NCT05519189|Sensory System Agents|sensory system agents|mesh-ancestor
92985215|NCT05519189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985217|NCT04080323|Oxytocics|oxytocics|mesh-ancestor
92985218|NCT04080323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985219|NCT04080323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985220|NCT03930017|Vaccines|vaccines|mesh-list
92985221|NCT03930017|Immunologic Factors|immunologic factors|mesh-ancestor
92985222|NCT03930017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985223|NCT00533949|Paclitaxel|paclitaxel|mesh-list
92985224|NCT00533949|Carboplatin|carboplatin|mesh-list
92985225|NCT00533949|Cetuximab|cetuximab|mesh-list
92985226|NCT00533949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92985227|NCT00533949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985228|NCT00533949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985229|NCT00533949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985230|NCT00533949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985231|NCT00533949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985232|NCT00533949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985233|NCT00485134|Vaccines|vaccines|mesh-list
92985234|NCT00485134|Immunologic Factors|immunologic factors|mesh-ancestor
92985235|NCT00485134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985236|NCT02585141|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92985237|NCT02585141|Clindamycin|clindamycin|mesh-list
92985238|NCT02585141|Clindamycin palmitate|clindamycin palmitate|mesh-list
92985239|NCT02585141|Clindamycin phosphate|clindamycin phosphate|mesh-list
92985240|NCT02585141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985241|NCT02585141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92985242|NCT02585141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985243|NCT02585141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985244|NCT04079231|Aflibercept|aflibercept|mesh-list
92985245|NCT04079231|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92985246|NCT04079231|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92985247|NCT04079231|Growth Substances|growth substances|mesh-ancestor
92985248|NCT04079231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985249|NCT04079231|Growth Inhibitors|growth inhibitors|mesh-ancestor
92985250|NCT04079231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985251|NCT00994695|Vaccines|vaccines|mesh-list
92985252|NCT00994695|Immunologic Factors|immunologic factors|mesh-ancestor
92985253|NCT00994695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985254|NCT04521803|Rifampin|rifampin|mesh-list
92985255|NCT04521803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92985256|NCT04521803|Antitubercular Agents|antitubercular agents|mesh-ancestor
92985257|NCT04521803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985258|NCT04521803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985259|NCT04521803|Leprostatic Agents|leprostatic agents|mesh-ancestor
92985260|NCT04521803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92985261|NCT04521803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985262|NCT04521803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985263|NCT04521803|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92985264|NCT04521803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92985265|NCT04521803|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92985266|NCT04521803|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92985267|NCT04521803|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92985268|NCT04521803|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92985269|NCT00920465|Misoprostol|misoprostol|mesh-list
92985270|NCT00920465|Mifepristone|mifepristone|mesh-list
92985271|NCT00920465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92985272|NCT00920465|Abortifacient Agents|abortifacient agents|mesh-ancestor
92985273|NCT00920465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985274|NCT00920465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985275|NCT00920465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92985276|NCT00920465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985277|NCT00920465|Oxytocics|oxytocics|mesh-ancestor
92985278|NCT00920465|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92985279|NCT00920465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92985280|NCT00920465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92985281|NCT00920465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92985282|NCT00920465|Contraceptive Agents|contraceptive agents|mesh-ancestor
92985283|NCT00920465|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92985284|NCT00920465|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92985285|NCT00920465|Hormone Antagonists|hormone antagonists|mesh-ancestor
92985286|NCT00920465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985287|NCT00920465|Luteolytic Agents|luteolytic agents|mesh-ancestor
92985288|NCT00920465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92985289|NCT00920465|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92985291|NCT03890367|Immunologic Factors|immunologic factors|mesh-ancestor
92985292|NCT03890367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985294|NCT00994773|Entecavir|entecavir|mesh-list
92985295|NCT00994773|Simvastatin|simvastatin|mesh-list
92985296|NCT00994773|Antiviral Agents|antiviral agents|mesh-ancestor
92985297|NCT00994773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985298|NCT00994773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92985299|NCT00994773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92985300|NCT00994773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985301|NCT00994773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985302|NCT00994773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92985303|NCT00994773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92985304|NCT00994773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92985305|NCT00994773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92985306|NCT00994773|Antimetabolites|antimetabolites|mesh-ancestor
92985307|NCT00994773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92985308|NCT00994773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92985309|NCT02583191|Rivaroxaban|rivaroxaban|mesh-list
92985310|NCT02583191|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92985311|NCT02583191|Antithrombins|antithrombins|mesh-ancestor
92985312|NCT02583191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92985313|NCT02583191|Protease Inhibitors|protease inhibitors|mesh-ancestor
92985314|NCT02583191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985315|NCT02583191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985316|NCT02583191|Anticoagulants|anticoagulants|mesh-ancestor
92985317|NCT03084237|Docetaxel|docetaxel|mesh-list
92985318|NCT03084237|Trastuzumab|trastuzumab|mesh-list
92985319|NCT03084237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985320|NCT03084237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985321|NCT03084237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985322|NCT03084237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985323|NCT03084237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985324|NCT03084237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985325|NCT00996021|Moxifloxacin|moxifloxacin|mesh-list
92985326|NCT00996021|Dolutegravir|dolutegravir|mesh-list
92985327|NCT00996021|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92985328|NCT00996021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985329|NCT00996021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985330|NCT00996021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92985331|NCT00996021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92985332|NCT00996021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985333|NCT00996021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985334|NCT00996021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985335|NCT00996021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92985336|NCT00996021|Contraceptive Agents|contraceptive agents|mesh-ancestor
92985337|NCT00996021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985338|NCT00996021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985339|NCT00996021|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92985341|NCT00996021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92985342|NCT00996021|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92985343|NCT00996021|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92985344|NCT00996021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92985345|NCT00996021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92985346|NCT00996021|Antiviral Agents|antiviral agents|mesh-ancestor
92985347|NCT00996099|Insulin|insulin|mesh-list
92985348|NCT00996099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92985349|NCT00996099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92985350|NCT00996099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985351|NCT04515329|Cyclosporine|cyclosporine|mesh-list
92985352|NCT04515329|Lubricant Eye Drops|lubricant eye drops|mesh-list
92985353|NCT04515329|Cyclosporins|cyclosporins|mesh-list
92985354|NCT04515329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985355|NCT04515329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985356|NCT04515329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92985357|NCT04515329|Immunologic Factors|immunologic factors|mesh-ancestor
92985358|NCT04515329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630764|NCT00180024|Irbesartan|irbesartan|mesh-list
92985359|NCT04515329|Antifungal Agents|antifungal agents|mesh-ancestor
92985360|NCT04515329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985361|NCT04515329|Dermatologic Agents|dermatologic agents|mesh-ancestor
92985362|NCT04515329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92985363|NCT04515329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92985364|NCT04515329|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92985365|NCT04515329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92985366|NCT02584751|Nitric Oxide|nitric oxide|mesh-list
92985367|NCT02584751|Omeprazole|omeprazole|mesh-list
92985368|NCT02584751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92985369|NCT02584751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985370|NCT02584751|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92985371|NCT02584751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985372|NCT02584751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985373|NCT02584751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92985374|NCT02584751|Autonomic Agents|autonomic agents|mesh-ancestor
92985375|NCT02584751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985376|NCT02584751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985377|NCT02584751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92985378|NCT02584751|Respiratory System Agents|respiratory system agents|mesh-ancestor
92985379|NCT02584751|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92985380|NCT02584751|Antioxidants|antioxidants|mesh-ancestor
92985381|NCT02584751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985382|NCT02584751|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92985383|NCT02584751|Vasodilator Agents|vasodilator agents|mesh-ancestor
92985384|NCT02584751|Gasotransmitters|gasotransmitters|mesh-ancestor
92985385|NCT02584751|Protective Agents|protective agents|mesh-ancestor
92985386|NCT00999219|Zolpidem|zolpidem|mesh-list
92985387|NCT00999219|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92985388|NCT00999219|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92985389|NCT00999219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985390|NCT00999219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985391|NCT00999219|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92985392|NCT00999219|GABA Agonists|gaba agonists|mesh-ancestor
92985393|NCT00999219|GABA Agents|gaba agents|mesh-ancestor
92985394|NCT00999219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985395|NCT00999219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985396|NCT00996177|Fentanyl|fentanyl|mesh-list
92985397|NCT00996177|Morphine|morphine|mesh-list
92985398|NCT00996177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92985399|NCT00996177|Narcotics|narcotics|mesh-ancestor
92985400|NCT00996177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985401|NCT00996177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985402|NCT00996177|Analgesics|analgesics|mesh-ancestor
92985403|NCT00996177|Sensory System Agents|sensory system agents|mesh-ancestor
92985404|NCT00996177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985405|NCT00996177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92985406|NCT00996177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92985407|NCT00996177|Anesthetics, General|anesthetics, general|mesh-ancestor
92985408|NCT00996177|Anesthetics|anesthetics|mesh-ancestor
92985409|NCT04079933|Nicotine|nicotine|mesh-list
92985410|NCT04079933|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92985411|NCT04079933|Autonomic Agents|autonomic agents|mesh-ancestor
92985412|NCT04079933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985413|NCT04079933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985414|NCT04079933|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92985415|NCT04079933|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92985416|NCT04079933|Cholinergic Agents|cholinergic agents|mesh-ancestor
92985417|NCT04079933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985418|NCT04079933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985419|NCT00999297|Capsaicin|capsaicin|mesh-list
92985420|NCT00999297|Antipruritics|antipruritics|mesh-ancestor
92167472|NCT04757779|Docetaxel|docetaxel|mesh-list
92985421|NCT00999297|Dermatologic Agents|dermatologic agents|mesh-ancestor
92985422|NCT00999297|Sensory System Agents|sensory system agents|mesh-ancestor
92985423|NCT00999297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985424|NCT00999297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985425|NCT00583115|Imatinib Mesylate|imatinib mesylate|mesh-list
92985426|NCT00583115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985427|NCT00583115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92985428|NCT00583115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985429|NCT00583115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985430|NCT05371223|Gemcitabine|gemcitabine|mesh-list
92985431|NCT05371223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92985432|NCT05371223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92985433|NCT05371223|Antimetabolites|antimetabolites|mesh-ancestor
92985434|NCT05371223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985435|NCT05371223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985436|NCT00532779|Naltrexone|naltrexone|mesh-list
92985437|NCT00532779|Bupropion|bupropion|mesh-list
92985438|NCT00532779|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92985439|NCT00532779|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92985440|NCT00532779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985441|NCT00532779|Sensory System Agents|sensory system agents|mesh-ancestor
92985442|NCT00532779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985443|NCT00532779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92985444|NCT00532779|Antidepressive Agents|antidepressive agents|mesh-ancestor
92985445|NCT00532779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92985446|NCT00532779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92985447|NCT00532779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92985448|NCT00532779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985449|NCT00532779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985450|NCT00532779|Dopamine Agents|dopamine agents|mesh-ancestor
92985451|NCT00532779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985452|NCT00532779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92985453|NCT00532779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92985454|NCT00532779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985455|NCT00500266|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92985456|NCT00500266|Immunologic Factors|immunologic factors|mesh-ancestor
92985457|NCT00500266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985458|NCT00996411|Salvinorin A|salvinorin a|mesh-list
92985459|NCT00996411|Hallucinogens|hallucinogens|mesh-ancestor
92985460|NCT00996411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985461|NCT00996411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92985462|NCT00996567|Cetuximab|cetuximab|mesh-list
92985463|NCT00996567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985464|NCT00996567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985465|NCT04120805|Hemostatics|hemostatics|mesh-list
92985466|NCT04120805|Coagulants|coagulants|mesh-ancestor
92985467|NCT02852655|Pembrolizumab|pembrolizumab|mesh-list
92985468|NCT02852655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985469|NCT02852655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985470|NCT02852655|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92985471|NCT02852655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985472|NCT00500110|Docetaxel|docetaxel|mesh-list
92985473|NCT00500110|Imatinib Mesylate|imatinib mesylate|mesh-list
92985474|NCT00500110|Leuprolide|leuprolide|mesh-list
92985475|NCT00500110|Goserelin|goserelin|mesh-list
92985476|NCT00500110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985477|NCT00500110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985478|NCT00500110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985479|NCT00500110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985480|NCT00500110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985481|NCT00500110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92985482|NCT00500110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985483|NCT00500110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92985484|NCT00500110|Fertility Agents|fertility agents|mesh-ancestor
92985485|NCT00500110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985486|NCT00500110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985487|NCT00500110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92985488|NCT04358237|Pembrolizumab|pembrolizumab|mesh-list
92985489|NCT04358237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985490|NCT04358237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985491|NCT04358237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92985492|NCT04358237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985493|NCT05304533|Itraconazole|itraconazole|mesh-list
92985494|NCT05304533|Verapamil|verapamil|mesh-list
92985495|NCT05304533|Antifungal Agents|antifungal agents|mesh-ancestor
92985496|NCT05304533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985497|NCT05304533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92985498|NCT05304533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92985499|NCT05304533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985500|NCT05304533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985501|NCT05304533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92985502|NCT05304533|Hormone Antagonists|hormone antagonists|mesh-ancestor
92985503|NCT05304533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985504|NCT05304533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985505|NCT05304533|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92985506|NCT05304533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92985507|NCT05304533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92985508|NCT05304533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985509|NCT05304533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92985510|NCT05304533|Vasodilator Agents|vasodilator agents|mesh-ancestor
92985512|NCT00534495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985513|NCT04077827|Propofol|propofol|mesh-list
92985514|NCT04077827|Desflurane|desflurane|mesh-list
92985515|NCT04077827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92985516|NCT04077827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985517|NCT04077827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985518|NCT04077827|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92985519|NCT04077827|Anesthetics, General|anesthetics, general|mesh-ancestor
92985520|NCT04077827|Anesthetics|anesthetics|mesh-ancestor
92985521|NCT04077827|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92985522|NCT00996723|Dasatinib|dasatinib|mesh-list
92985523|NCT00996723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985524|NCT00996723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92985525|NCT00996723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985526|NCT00996723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985527|NCT05332587|Rituximab|rituximab|mesh-list
92985528|NCT05332587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985529|NCT05332587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985530|NCT05332587|Immunologic Factors|immunologic factors|mesh-ancestor
92985531|NCT05332587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985532|NCT05332587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92985533|NCT00996879|Midazolam|midazolam|mesh-list
92985534|NCT00996879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92985535|NCT00996879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92985536|NCT00996879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985537|NCT00996879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985538|NCT00996879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92985539|NCT00996879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92985540|NCT00996879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92985541|NCT00996879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92985542|NCT00996879|Anesthetics, General|anesthetics, general|mesh-ancestor
92985543|NCT00996879|Anesthetics|anesthetics|mesh-ancestor
92985544|NCT00996879|GABA Modulators|gaba modulators|mesh-ancestor
92985545|NCT00996879|GABA Agents|gaba agents|mesh-ancestor
92985546|NCT00996879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985547|NCT00996879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985548|NCT02582177|Ketoconazole|ketoconazole|mesh-list
92985549|NCT02582177|Clotrimazole|clotrimazole|mesh-list
92985550|NCT02582177|Miconazole|miconazole|mesh-list
92985551|NCT02582177|Dexamethasone|dexamethasone|mesh-list
92985552|NCT02582177|Dexamethasone acetate|dexamethasone acetate|mesh-list
92985553|NCT02582177|Betamethasone|betamethasone|mesh-list
92985554|NCT02582177|Betamethasone Valerate|betamethasone valerate|mesh-list
92167493|NCT02389309|Cyclophosphamide|cyclophosphamide|mesh-list
92985555|NCT02582177|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92985556|NCT02582177|Betamethasone benzoate|betamethasone benzoate|mesh-list
92985557|NCT02582177|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92985558|NCT02582177|BB 1101|bb 1101|mesh-list
92985559|NCT02582177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985560|NCT02582177|Antiemetics|antiemetics|mesh-ancestor
92985561|NCT02582177|Autonomic Agents|autonomic agents|mesh-ancestor
92985562|NCT02582177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985563|NCT02582177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985564|NCT02582177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985565|NCT02582177|Glucocorticoids|glucocorticoids|mesh-ancestor
92985566|NCT02582177|Hormones|hormones|mesh-ancestor
92985567|NCT02582177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985568|NCT02582177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92985569|NCT02582177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985570|NCT02582177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92985571|NCT02582177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985572|NCT02582177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985573|NCT02582177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92985574|NCT02582177|Respiratory System Agents|respiratory system agents|mesh-ancestor
92985575|NCT02582177|Antifungal Agents|antifungal agents|mesh-ancestor
92985576|NCT02582177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985577|NCT02582177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92985578|NCT02582177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92985579|NCT02582177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92985580|NCT02582177|Hormone Antagonists|hormone antagonists|mesh-ancestor
92985581|NCT02582177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92985582|NCT02582177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92985583|NCT02582177|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92985584|NCT02626715|Vidarabine|vidarabine|mesh-list
92985585|NCT02626715|Fludarabine phosphate|fludarabine phosphate|mesh-list
92985586|NCT02626715|Fludarabine|fludarabine|mesh-list
92985587|NCT02626715|Alemtuzumab|alemtuzumab|mesh-list
92985588|NCT02626715|Thiotepa|thiotepa|mesh-list
92985589|NCT02626715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92985590|NCT02626715|Antimetabolites|antimetabolites|mesh-ancestor
92985591|NCT02626715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985592|NCT02626715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985593|NCT02626715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92985594|NCT02626715|Immunologic Factors|immunologic factors|mesh-ancestor
92985595|NCT02626715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985596|NCT02626715|Antiviral Agents|antiviral agents|mesh-ancestor
92985597|NCT02626715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985598|NCT02626715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985599|NCT02626715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92985600|NCT02626715|Alkylating Agents|alkylating agents|mesh-ancestor
92985601|NCT02626715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92985602|NCT05325177|Ibuprofen|ibuprofen|mesh-list
92985603|NCT05325177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92985604|NCT05325177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92985605|NCT05325177|Analgesics|analgesics|mesh-ancestor
92985606|NCT05325177|Sensory System Agents|sensory system agents|mesh-ancestor
92985607|NCT05325177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985608|NCT05325177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985609|NCT05325177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985610|NCT05325177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92985611|NCT05325177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92985612|NCT05325177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985613|NCT05325177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985614|NCT04099667|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92985615|NCT04099667|Botulinum Toxins|botulinum toxins|mesh-list
92985616|NCT04099667|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92985617|NCT04099667|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92985618|NCT04099667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92985619|NCT04099667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985620|NCT04099667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985621|NCT04099667|Cholinergic Agents|cholinergic agents|mesh-ancestor
92985622|NCT04099667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985623|NCT04099667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985624|NCT04099667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92985625|NCT04099667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985626|NCT04099667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92985627|NCT00997191|Triamcinolone|triamcinolone|mesh-list
92985628|NCT00997191|Bevacizumab|bevacizumab|mesh-list
92985629|NCT00997191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985630|NCT00997191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985631|NCT00997191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92985632|NCT00997191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92985633|NCT00997191|Growth Substances|growth substances|mesh-ancestor
92985634|NCT00997191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985635|NCT00997191|Growth Inhibitors|growth inhibitors|mesh-ancestor
92985636|NCT00997191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985637|NCT00997191|Glucocorticoids|glucocorticoids|mesh-ancestor
92985638|NCT00997191|Hormones|hormones|mesh-ancestor
92985639|NCT00997191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985640|NCT00997269|Ubiquinone|ubiquinone|mesh-list
92985641|NCT00997269|Coenzyme Q10|coenzyme q10|mesh-list
92985642|NCT00997269|Micronutrients|micronutrients|mesh-ancestor
92985643|NCT00997269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985644|NCT00997269|Vitamins|vitamins|mesh-ancestor
92985645|NCT02582099|Gentamicins|gentamicins|mesh-list
92985646|NCT02582099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985647|NCT02582099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985648|NCT02582099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92985649|NCT02582099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985650|NCT02582099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985651|NCT00997347|Misoprostol|misoprostol|mesh-list
92985652|NCT00997347|Mifepristone|mifepristone|mesh-list
92985653|NCT00997347|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92985654|NCT00997347|Abortifacient Agents|abortifacient agents|mesh-ancestor
92985655|NCT00997347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985656|NCT00997347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985657|NCT00997347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92985658|NCT00997347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985659|NCT00997347|Oxytocics|oxytocics|mesh-ancestor
92985660|NCT00997347|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92985661|NCT00997347|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92985662|NCT00997347|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92985663|NCT00997347|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92985664|NCT00997347|Contraceptive Agents|contraceptive agents|mesh-ancestor
92985665|NCT00997347|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92985666|NCT00997347|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92985667|NCT00997347|Hormone Antagonists|hormone antagonists|mesh-ancestor
92985668|NCT00997347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985669|NCT00997347|Luteolytic Agents|luteolytic agents|mesh-ancestor
92985670|NCT00997347|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92985671|NCT00997347|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92985672|NCT00997581|Apremilast|apremilast|mesh-list
92985673|NCT00997581|Indomethacin|indomethacin|mesh-list
92985674|NCT00997581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92985675|NCT00997581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92985676|NCT00997581|Analgesics|analgesics|mesh-ancestor
92985677|NCT00997581|Sensory System Agents|sensory system agents|mesh-ancestor
92985678|NCT00997581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985679|NCT00997581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985680|NCT00997581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985681|NCT00997581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92985682|NCT00997581|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92985683|NCT00997581|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92985684|NCT00997581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985685|NCT00997581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985686|NCT00997581|Gout Suppressants|gout suppressants|mesh-ancestor
92985687|NCT00997581|Tocolytic Agents|tocolytic agents|mesh-ancestor
92985688|NCT00997581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92985689|NCT00997581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92985690|NCT02044497|Oxycodone|oxycodone|mesh-list
92985691|NCT02044497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92985692|NCT02044497|Narcotics|narcotics|mesh-ancestor
92985693|NCT02044497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985694|NCT02044497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985695|NCT02044497|Analgesics|analgesics|mesh-ancestor
92985696|NCT02044497|Sensory System Agents|sensory system agents|mesh-ancestor
92985697|NCT02044497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985698|NCT05183139|Dexamethasone|dexamethasone|mesh-list
92985699|NCT05183139|Lenalidomide|lenalidomide|mesh-list
92985700|NCT05183139|Pomalidomide|pomalidomide|mesh-list
92985701|NCT05183139|Ixazomib|ixazomib|mesh-list
92985702|NCT05183139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985703|NCT05183139|Antiemetics|antiemetics|mesh-ancestor
92985704|NCT05183139|Autonomic Agents|autonomic agents|mesh-ancestor
92985705|NCT05183139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985706|NCT05183139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985707|NCT05183139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985708|NCT05183139|Glucocorticoids|glucocorticoids|mesh-ancestor
92985709|NCT05183139|Hormones|hormones|mesh-ancestor
92985710|NCT05183139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985711|NCT05183139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92985712|NCT05183139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985713|NCT05183139|Immunologic Factors|immunologic factors|mesh-ancestor
92985714|NCT05183139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92985715|NCT05183139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92985716|NCT05183139|Growth Substances|growth substances|mesh-ancestor
92985717|NCT05183139|Growth Inhibitors|growth inhibitors|mesh-ancestor
92985718|NCT05183139|Protease Inhibitors|protease inhibitors|mesh-ancestor
92985719|NCT05183139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985720|NCT05183139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985721|NCT00999843|Sorafenib|sorafenib|mesh-list
92985722|NCT00999843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985723|NCT00999843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92985724|NCT00999843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985725|NCT00999843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985726|NCT00997659|Chromium|chromium|mesh-list
92985727|NCT00997659|Picolinic acid|picolinic acid|mesh-list
92985728|NCT00997659|Trace Elements|trace elements|mesh-ancestor
92985729|NCT00997659|Micronutrients|micronutrients|mesh-ancestor
92985730|NCT00997659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985731|NCT00997659|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92985732|NCT00997659|Chelating Agents|chelating agents|mesh-ancestor
92985733|NCT00997659|Sequestering Agents|sequestering agents|mesh-ancestor
92985734|NCT00997659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985735|NCT03827213|Bupivacaine|bupivacaine|mesh-list
92985736|NCT03827213|Anesthetics, Local|anesthetics, local|mesh-ancestor
92985737|NCT03827213|Anesthetics|anesthetics|mesh-ancestor
92985738|NCT03827213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985739|NCT03827213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985740|NCT03827213|Sensory System Agents|sensory system agents|mesh-ancestor
92985741|NCT03827213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985742|NCT00997815|Botulinum Toxins|botulinum toxins|mesh-list
92985743|NCT00997815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92985744|NCT00997815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92985745|NCT00997815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92985746|NCT00997815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985747|NCT00997815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985748|NCT00997815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92985749|NCT00997815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985750|NCT00997815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985751|NCT00997815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92985752|NCT00997815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985753|NCT04077983|Paclitaxel|paclitaxel|mesh-list
92985754|NCT04077983|Gemcitabine|gemcitabine|mesh-list
92985755|NCT04077983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92985756|NCT04077983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985757|NCT04077983|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985758|NCT04077983|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985759|NCT04077983|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985760|NCT04077983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985761|NCT04077983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92985762|NCT04077983|Antimetabolites|antimetabolites|mesh-ancestor
92985763|NCT03822845|Edetic Acid|edetic acid|mesh-list
92985764|NCT03822845|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92985765|NCT03822845|Chelating Agents|chelating agents|mesh-ancestor
92167512|NCT02489695|Axitinib|axitinib|mesh-list
92985766|NCT03822845|Sequestering Agents|sequestering agents|mesh-ancestor
92985767|NCT03822845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985768|NCT03822845|Anticoagulants|anticoagulants|mesh-ancestor
92985769|NCT03822845|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92985770|NCT03822845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92985771|NCT01000233|Inositol|inositol|mesh-list
92985772|NCT01000233|Vitamin B Complex|vitamin b complex|mesh-ancestor
92985773|NCT01000233|Vitamins|vitamins|mesh-ancestor
92985774|NCT01000233|Micronutrients|micronutrients|mesh-ancestor
92985775|NCT01000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985776|NCT04075955|Olanzapine|olanzapine|mesh-list
92985777|NCT04075955|Aprepitant|aprepitant|mesh-list
92985778|NCT04075955|Antiemetics|antiemetics|mesh-ancestor
92985779|NCT04075955|Autonomic Agents|autonomic agents|mesh-ancestor
92985780|NCT04075955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985781|NCT04075955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985782|NCT04075955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985783|NCT04075955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92985784|NCT04075955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92985785|NCT04075955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985786|NCT04075955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92985787|NCT04075955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92985788|NCT04075955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92985789|NCT04075955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985790|NCT04075955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985791|NCT04075955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985793|NCT04075955|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92985794|NCT00484198|Pioglitazone|pioglitazone|mesh-list
92985795|NCT00484198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92985796|NCT00484198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985797|NCT04077905|Methylprednisolone|methylprednisolone|mesh-list
92985798|NCT04077905|Doxorubicin|doxorubicin|mesh-list
92985799|NCT04077905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92985800|NCT04077905|Etoposide|etoposide|mesh-list
92985801|NCT04077905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92985802|NCT04077905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985803|NCT04077905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92985804|NCT04077905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92985805|NCT04077905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985806|NCT04077905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985807|NCT04077905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92985808|NCT04077905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985809|NCT04077905|Antiemetics|antiemetics|mesh-ancestor
92985810|NCT04077905|Autonomic Agents|autonomic agents|mesh-ancestor
92985811|NCT04077905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985812|NCT04077905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985813|NCT04077905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985815|NCT04077905|Hormones|hormones|mesh-ancestor
92985816|NCT04077905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985817|NCT04077905|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92985818|NCT04077905|Protective Agents|protective agents|mesh-ancestor
92985819|NCT04282187|Azacitidine|azacitidine|mesh-list
92985820|NCT04282187|Decitabine|decitabine|mesh-list
92985821|NCT04282187|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92985822|NCT04282187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92985823|NCT04282187|Antimetabolites|antimetabolites|mesh-ancestor
92985824|NCT04282187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985825|NCT04282187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985826|NCT04282187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985827|NCT04282187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92985828|NCT04471246|Cephalexin|cephalexin|mesh-list
92985829|NCT04471246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985830|NCT04471246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985831|NCT04276259|Naltrexone|naltrexone|mesh-list
92985832|NCT04276259|Buprenorphine|buprenorphine|mesh-list
92985833|NCT04276259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92985834|NCT04276259|Narcotics|narcotics|mesh-ancestor
92985835|NCT04276259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985836|NCT04276259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985837|NCT04276259|Analgesics|analgesics|mesh-ancestor
92985838|NCT04276259|Sensory System Agents|sensory system agents|mesh-ancestor
92985839|NCT04276259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985840|NCT04276259|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92985841|NCT04276259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92985842|NCT00499486|Sirolimus|sirolimus|mesh-list
92985843|NCT00499486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985844|NCT00499486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985845|NCT00499486|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92985846|NCT00499486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985847|NCT00499486|Antifungal Agents|antifungal agents|mesh-ancestor
92985848|NCT00499486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92985849|NCT00499486|Immunologic Factors|immunologic factors|mesh-ancestor
92985850|NCT00499486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985851|NCT01019278|Cisplatin|cisplatin|mesh-list
92985852|NCT01019278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985853|NCT01014520|Gabapentin|gabapentin|mesh-list
92985854|NCT01014520|Amitriptyline|amitriptyline|mesh-list
92985855|NCT01014520|Analgesics|analgesics|mesh-ancestor
92985856|NCT01014520|Sensory System Agents|sensory system agents|mesh-ancestor
92985857|NCT01014520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985858|NCT01014520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985859|NCT01014520|Anticonvulsants|anticonvulsants|mesh-ancestor
92985860|NCT01014520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92985861|NCT01014520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92985862|NCT01014520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985863|NCT01014520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92985864|NCT01014520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92985865|NCT01014520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92985866|NCT01014520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92985867|NCT01014520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985868|NCT01014520|Antimanic Agents|antimanic agents|mesh-ancestor
92985869|NCT01014520|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92985870|NCT01014520|Antidepressive Agents|antidepressive agents|mesh-ancestor
92985871|NCT01014520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92985872|NCT01014520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92985873|NCT01014520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92985874|NCT01014520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985875|NCT01014520|Adrenergic Agents|adrenergic agents|mesh-ancestor
92985876|NCT01016002|Temoporfin|temoporfin|mesh-list
92985877|NCT01016002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985878|NCT01016002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92985879|NCT01016002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92985880|NCT01019434|Sirolimus|sirolimus|mesh-list
92985881|NCT01019434|Temozolomide|temozolomide|mesh-list
92985882|NCT01019434|Temsirolimus|temsirolimus|mesh-list
92985883|NCT01019434|MTOR Inhibitors|mtor inhibitors|mesh-list
92985884|NCT01019434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92985885|NCT01019434|Alkylating Agents|alkylating agents|mesh-ancestor
92985886|NCT01019434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985887|NCT01019434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985888|NCT01019434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92985889|NCT01019434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92985890|NCT01019434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92985891|NCT01019434|Immunologic Factors|immunologic factors|mesh-ancestor
92985892|NCT01019434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985893|NCT01019434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92985894|NCT01019434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92985895|NCT01019434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92985896|NCT01019434|Antifungal Agents|antifungal agents|mesh-ancestor
92985897|NCT01016158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92985898|NCT01016158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92985899|NCT00499252|Paclitaxel|paclitaxel|mesh-list
92985900|NCT00499252|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92985901|NCT00499252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92985902|NCT00499252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985903|NCT00499252|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985904|NCT00499252|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985905|NCT00499252|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985906|NCT00499252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985907|NCT01019590|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92985908|NCT01019590|Olmesartan|olmesartan|mesh-list
92985909|NCT01019590|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92985910|NCT01019590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92985911|NCT01019590|Diuretics|diuretics|mesh-ancestor
92985912|NCT01019590|Natriuretic Agents|natriuretic agents|mesh-ancestor
92985913|NCT01019590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985914|NCT01019590|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92985915|NCT01019590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985916|NCT01019590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985917|NCT01019590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92985918|NCT01019590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92985919|NCT03775421|Macitentan|macitentan|mesh-list
92985920|NCT03775421|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92985921|NCT03775421|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92985922|NCT03775421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985923|NCT03775421|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92985924|NCT00532155|Dexamethasone|dexamethasone|mesh-list
92985925|NCT00532155|Docetaxel|docetaxel|mesh-list
92985926|NCT00532155|Aflibercept|aflibercept|mesh-list
92985927|NCT00532155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985928|NCT00532155|Antiemetics|antiemetics|mesh-ancestor
92985929|NCT00532155|Autonomic Agents|autonomic agents|mesh-ancestor
92985930|NCT00532155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92985931|NCT00532155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985932|NCT00532155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92985933|NCT00532155|Glucocorticoids|glucocorticoids|mesh-ancestor
92985934|NCT00532155|Hormones|hormones|mesh-ancestor
92985935|NCT00532155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985936|NCT00532155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92985937|NCT00532155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985938|NCT00532155|Tubulin Modulators|tubulin modulators|mesh-ancestor
92985939|NCT00532155|Antimitotic Agents|antimitotic agents|mesh-ancestor
92985940|NCT00532155|Mitosis Modulators|mitosis modulators|mesh-ancestor
92985941|NCT00532155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985942|NCT00532155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92985943|NCT00532155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92985944|NCT00532155|Growth Substances|growth substances|mesh-ancestor
92985945|NCT00532155|Growth Inhibitors|growth inhibitors|mesh-ancestor
92985946|NCT01019668|Verteporfin|verteporfin|mesh-list
92985947|NCT01019668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92985948|NCT01019668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92985949|NCT01019746|Propofol|propofol|mesh-list
92985950|NCT01019746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92985951|NCT01019746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92985952|NCT01019746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985953|NCT01019746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92985954|NCT01019746|Anesthetics, General|anesthetics, general|mesh-ancestor
92985955|NCT01019746|Anesthetics|anesthetics|mesh-ancestor
92985956|NCT00205777|Bazedoxifene|bazedoxifene|mesh-list
92985957|NCT00205777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92985958|NCT00205777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92985959|NCT00205777|Hormone Antagonists|hormone antagonists|mesh-ancestor
92985960|NCT00205777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92985961|NCT00205777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985962|NCT00205777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92985963|NCT03762395|CXA-10|cxa-10|mesh-list
92985964|NCT03762395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92985965|NCT01004055|Anti-Infective Agents|anti-infective agents|mesh-list
92985966|NCT01004055|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92985967|NCT00483652|4-Aminopyridine|4-aminopyridine|mesh-list
92985968|NCT00483652|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92985969|NCT00483652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92985970|NCT00483652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985971|NCT00998283|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92985972|NCT00998283|Immunologic Factors|immunologic factors|mesh-ancestor
92985973|NCT00998283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985974|NCT01014832|Insulin|insulin|mesh-list
92985975|NCT01014832|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92985976|NCT01014832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92985977|NCT01014832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985978|NCT03996473|Pembrolizumab|pembrolizumab|mesh-list
92985979|NCT03996473|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92985980|NCT03996473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92985981|NCT03996473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92985982|NCT03996473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92985983|NCT03996473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985984|NCT01000545|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92985985|NCT01000545|Anticoagulants|anticoagulants|mesh-ancestor
92985986|NCT01000545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92985987|NCT01000545|Antimetabolites|antimetabolites|mesh-ancestor
92985988|NCT01000545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92985989|NCT01000545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92985990|NCT01000545|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92985991|NCT01000545|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92985992|NCT01000545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92985993|NCT01000545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985994|NCT03992729|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92985995|NCT03992729|Immunologic Factors|immunologic factors|mesh-ancestor
92985996|NCT03992729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92985997|NCT00483574|Vaccines|vaccines|mesh-list
92985998|NCT00483574|Immunologic Factors|immunologic factors|mesh-ancestor
92985999|NCT00483574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986000|NCT01000623|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92986001|NCT01000623|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92986002|NCT01000623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92986003|NCT01000623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92986004|NCT01000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986005|NCT01000623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986006|NCT01000623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986007|NCT01000623|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92986008|NCT01000623|Antidepressive Agents|antidepressive agents|mesh-ancestor
92986009|NCT01000623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92986010|NCT00998439|Paclitaxel|paclitaxel|mesh-list
92986011|NCT00998439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986012|NCT00998439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986013|NCT00998439|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986014|NCT00998439|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986015|NCT00998439|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986016|NCT00998439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986017|NCT03996772|Rivaroxaban|rivaroxaban|mesh-list
92986018|NCT03996772|Apixaban|apixaban|mesh-list
92986019|NCT03996772|Edoxaban|edoxaban|mesh-list
92986020|NCT03996772|Dabigatran|dabigatran|mesh-list
92986021|NCT03996772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92986022|NCT03996772|Antithrombins|antithrombins|mesh-ancestor
92986023|NCT03996772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92986024|NCT03996772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986025|NCT03996772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986026|NCT03996772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986027|NCT03996772|Anticoagulants|anticoagulants|mesh-ancestor
92986028|NCT01000779|Propranolol|propranolol|mesh-list
92986029|NCT01000779|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92986030|NCT01000779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92986031|NCT01000779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92986032|NCT01000779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986033|NCT01000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631435|NCT00555100|Glucocorticoids|glucocorticoids|mesh-ancestor
92986034|NCT01000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986035|NCT01000779|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92986036|NCT01000779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986037|NCT01000779|Vasodilator Agents|vasodilator agents|mesh-ancestor
92986038|NCT01000857|Paroxetine|paroxetine|mesh-list
92986039|NCT01000857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92986040|NCT01000857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92986041|NCT01000857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92986042|NCT01000857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986043|NCT01000857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986044|NCT01000857|Serotonin Agents|serotonin agents|mesh-ancestor
92986045|NCT01000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986046|NCT01000857|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92986047|NCT01000857|Antidepressive Agents|antidepressive agents|mesh-ancestor
92986048|NCT01000857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92986049|NCT01000857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92986050|NCT01000857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92986051|NCT01000857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986052|NCT01004445|Amikacin|amikacin|mesh-list
92986053|NCT01004445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986054|NCT01004445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986055|NCT02580695|Hyaluronic Acid|hyaluronic acid|mesh-list
92986056|NCT02580695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92986057|NCT02580695|Immunologic Factors|immunologic factors|mesh-ancestor
92986058|NCT02580695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986059|NCT02580695|Viscosupplements|viscosupplements|mesh-ancestor
92986060|NCT02580695|Protective Agents|protective agents|mesh-ancestor
92986061|NCT02581553|Allopurinol|allopurinol|mesh-list
92986062|NCT02581553|Lesinurad|lesinurad|mesh-list
92986063|NCT02581553|Antimetabolites|antimetabolites|mesh-ancestor
92986064|NCT02581553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986065|NCT02581553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986066|NCT02581553|Gout Suppressants|gout suppressants|mesh-ancestor
92986067|NCT02581553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986068|NCT02581553|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92986069|NCT02581553|Antioxidants|antioxidants|mesh-ancestor
92986070|NCT02581553|Protective Agents|protective agents|mesh-ancestor
92986071|NCT02581553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986072|NCT02581553|Uricosuric Agents|uricosuric agents|mesh-ancestor
92986073|NCT03666065|Insulin|insulin|mesh-list
92986074|NCT03666065|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92986075|NCT03666065|Insulin Aspart|insulin aspart|mesh-list
92986076|NCT03666065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92986077|NCT03666065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986078|NCT03944915|Paclitaxel|paclitaxel|mesh-list
92986079|NCT03944915|Carboplatin|carboplatin|mesh-list
92986080|NCT03944915|Fluorouracil|fluorouracil|mesh-list
92986081|NCT03944915|Nivolumab|nivolumab|mesh-list
92986082|NCT03944915|Hydroxyurea|hydroxyurea|mesh-list
92986083|NCT03944915|Lenograstim|lenograstim|mesh-list
92986084|NCT03944915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986085|NCT03944915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986086|NCT03944915|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986087|NCT03944915|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986088|NCT03944915|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986089|NCT03944915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986090|NCT03944915|Antimetabolites|antimetabolites|mesh-ancestor
92986091|NCT03944915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986092|NCT03944915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986093|NCT03944915|Immunologic Factors|immunologic factors|mesh-ancestor
92986094|NCT03944915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986095|NCT03944915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986096|NCT03944915|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92986097|NCT03944915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92986098|NCT03944915|Antisickling Agents|antisickling agents|mesh-ancestor
92986099|NCT03944915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986100|NCT03944915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986101|NCT00482170|Etanercept|etanercept|mesh-list
92986102|NCT00482170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92986103|NCT00482170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986104|NCT00482170|Analgesics|analgesics|mesh-ancestor
92986105|NCT00482170|Sensory System Agents|sensory system agents|mesh-ancestor
92986106|NCT00482170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986107|NCT00482170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986108|NCT00482170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986109|NCT00482170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986110|NCT00482170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986111|NCT00482170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986112|NCT00482170|Immunologic Factors|immunologic factors|mesh-ancestor
92986113|NCT05228249|Cytarabine|cytarabine|mesh-list
92986114|NCT05228249|Etoposide|etoposide|mesh-list
92986115|NCT05228249|Podophyllotoxin|podophyllotoxin|mesh-list
92986116|NCT05228249|Etoposide phosphate|etoposide phosphate|mesh-list
92986117|NCT05228249|Melphalan|melphalan|mesh-list
92986118|NCT05228249|Mechlorethamine|mechlorethamine|mesh-list
92986119|NCT05228249|Carmustine|carmustine|mesh-list
92986120|NCT05228249|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92986121|NCT05228249|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92986122|NCT05228249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986123|NCT05228249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986124|NCT05228249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92986125|NCT05228249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986126|NCT05228249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986127|NCT05228249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986128|NCT05228249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986129|NCT05228249|Antimetabolites|antimetabolites|mesh-ancestor
92986130|NCT05228249|Antiviral Agents|antiviral agents|mesh-ancestor
92986131|NCT05228249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986132|NCT05228249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986133|NCT05228249|Immunologic Factors|immunologic factors|mesh-ancestor
92986134|NCT05228249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986135|NCT05228249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92986136|NCT05228249|Alkylating Agents|alkylating agents|mesh-ancestor
92986137|NCT05228249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92986138|NCT05228249|Keratolytic Agents|keratolytic agents|mesh-ancestor
92986139|NCT05228249|Dermatologic Agents|dermatologic agents|mesh-ancestor
92986140|NCT05228249|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986141|NCT05228249|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986142|NCT05228249|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986143|NCT05228249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986144|NCT02580227|Tranexamic Acid|tranexamic acid|mesh-list
92986145|NCT02580227|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92986146|NCT02580227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92986147|NCT02580227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986148|NCT02580227|Hemostatics|hemostatics|mesh-ancestor
92986149|NCT02580227|Coagulants|coagulants|mesh-ancestor
92986150|NCT04218695|Ceftriaxone|ceftriaxone|mesh-list
92986151|NCT04218695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986152|NCT04218695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986153|NCT01001013|Pioglitazone|pioglitazone|mesh-list
92986154|NCT01001013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92986155|NCT01001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986156|NCT01004601|Docetaxel|docetaxel|mesh-list
92986157|NCT01004601|Pemetrexed|pemetrexed|mesh-list
92986158|NCT01004601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986159|NCT01004601|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986160|NCT01004601|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986161|NCT01004601|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986162|NCT01004601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986163|NCT01004601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986164|NCT01004601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92986165|NCT01004601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986166|NCT01001247|Rilpivirine|rilpivirine|mesh-list
92986167|NCT01001247|Omeprazole|omeprazole|mesh-list
92986168|NCT01001247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92986169|NCT01001247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986170|NCT01001247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92986171|NCT01001247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986172|NCT01001247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986173|NCT01001247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92986174|NCT01001247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986175|NCT01001247|Antiviral Agents|antiviral agents|mesh-ancestor
92986176|NCT01001247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986177|NCT01001247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92986178|NCT01001247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92986179|NCT04205357|Sulfasalazine|sulfasalazine|mesh-list
92986180|NCT04205357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986181|NCT04205357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92986182|NCT04205357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986183|NCT04205357|Analgesics|analgesics|mesh-ancestor
92986184|NCT04205357|Sensory System Agents|sensory system agents|mesh-ancestor
92986185|NCT04205357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986186|NCT04205357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986187|NCT04205357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986188|NCT04205357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986189|NCT04205357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986191|NCT02580773|Anticoagulants|anticoagulants|mesh-ancestor
92986192|NCT02580773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92986193|NCT02580773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92986194|NCT02580773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986195|NCT01008813|Vaccines|vaccines|mesh-list
92986196|NCT01008813|Immunologic Factors|immunologic factors|mesh-ancestor
92986197|NCT01008813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986198|NCT01001637|Curcumin|curcumin|mesh-list
92986199|NCT01001637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92986200|NCT01001637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986201|NCT01001637|Analgesics|analgesics|mesh-ancestor
92986202|NCT01001637|Sensory System Agents|sensory system agents|mesh-ancestor
92986203|NCT01001637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986204|NCT01001637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986205|NCT01001637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986206|NCT01001637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986207|NCT01001637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986208|NCT01001637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986209|NCT01001637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986210|NCT01005147|Tranexamic Acid|tranexamic acid|mesh-list
92986211|NCT01005147|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92986212|NCT01005147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92986213|NCT01005147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986214|NCT01005147|Hemostatics|hemostatics|mesh-ancestor
92986215|NCT01005147|Coagulants|coagulants|mesh-ancestor
92986216|NCT03603899|Xenon|xenon|mesh-list
92986217|NCT03603899|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92986218|NCT03603899|Anesthetics, General|anesthetics, general|mesh-ancestor
92986219|NCT03603899|Anesthetics|anesthetics|mesh-ancestor
92986220|NCT03603899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92986221|NCT03603899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986222|NCT01001871|Vitamins|vitamins|mesh-list
92986223|NCT01001871|Micronutrients|micronutrients|mesh-ancestor
92986224|NCT01001871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986225|NCT01005303|Vitamin D|vitamin d|mesh-list
92986226|NCT01005303|Cholecalciferol|cholecalciferol|mesh-list
92986227|NCT01005303|Vitamins|vitamins|mesh-ancestor
92986229|NCT01005303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986230|NCT01005303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92986231|NCT01005303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92986232|NCT01005381|Calcium, Dietary|calcium, dietary|mesh-list
92986233|NCT01005381|Vitamin D|vitamin d|mesh-list
92986234|NCT01005381|Calcium Carbonate|calcium carbonate|mesh-list
92986235|NCT01005381|Calcium|calcium|mesh-list
92986236|NCT01005381|Vitamins|vitamins|mesh-ancestor
92986237|NCT01005381|Micronutrients|micronutrients|mesh-ancestor
92986238|NCT01005381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986239|NCT01005381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92986240|NCT01005381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92986241|NCT01005381|Antacids|antacids|mesh-ancestor
92986242|NCT01005381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986243|NCT01005381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986244|NCT01002183|Fosmidomycin|fosmidomycin|mesh-list
92986245|NCT01002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986246|NCT01002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986247|NCT05154279|Terlipressin|terlipressin|mesh-list
92986248|NCT05154279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986249|NCT05154279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92986250|NCT01005537|Aldesleukin|aldesleukin|mesh-list
92986251|NCT01005537|Cyclophosphamide|cyclophosphamide|mesh-list
92986252|NCT01005537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986253|NCT01005537|Immunologic Factors|immunologic factors|mesh-ancestor
92986254|NCT01005537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986255|NCT01005537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167552|NCT02384083|Growth Substances|growth substances|mesh-ancestor
92986256|NCT01005537|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92986257|NCT01005537|Alkylating Agents|alkylating agents|mesh-ancestor
92986258|NCT01005537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986259|NCT01005537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986260|NCT01005537|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92986261|NCT01005537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92986262|NCT01005537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92986263|NCT01005537|Antiviral Agents|antiviral agents|mesh-ancestor
92986264|NCT01005537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986265|NCT01005927|Calcium|calcium|mesh-list
92986266|NCT01005927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92986267|NCT01005927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986268|NCT03742713|Docetaxel|docetaxel|mesh-list
92986269|NCT03742713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986270|NCT03742713|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986271|NCT03742713|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986272|NCT03742713|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986273|NCT03742713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986274|NCT01002729|Oseltamivir|oseltamivir|mesh-list
92986275|NCT01002729|Antiviral Agents|antiviral agents|mesh-ancestor
92986276|NCT01002729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986277|NCT01002729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986278|NCT01002729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986279|NCT01002807|Metformin|metformin|mesh-list
92986280|NCT01002807|Dapagliflozin|dapagliflozin|mesh-list
92986281|NCT01002807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92986282|NCT01002807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986283|NCT01002807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92986284|NCT01002807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986285|NCT05733117|Vitamin D|vitamin d|mesh-list
92986286|NCT05733117|Vitamins|vitamins|mesh-ancestor
92986287|NCT05733117|Micronutrients|micronutrients|mesh-ancestor
92986288|NCT05733117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986289|NCT05733117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92986290|NCT01006395|Zoledronic Acid|zoledronic acid|mesh-list
92986291|NCT01006395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92986292|NCT01006395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986293|NCT00615056|Leucovorin|leucovorin|mesh-list
92986294|NCT00615056|Bevacizumab|bevacizumab|mesh-list
92986295|NCT00615056|Fluorouracil|fluorouracil|mesh-list
92986296|NCT00615056|Oxaliplatin|oxaliplatin|mesh-list
92986297|NCT00615056|Irinotecan|irinotecan|mesh-list
92986298|NCT00615056|Axitinib|axitinib|mesh-list
92986299|NCT00615056|Levoleucovorin|levoleucovorin|mesh-list
92986300|NCT00615056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986301|NCT00615056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986302|NCT00615056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92986303|NCT00615056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92986304|NCT00615056|Growth Substances|growth substances|mesh-ancestor
92986305|NCT00615056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986306|NCT00615056|Growth Inhibitors|growth inhibitors|mesh-ancestor
92986307|NCT00615056|Antimetabolites|antimetabolites|mesh-ancestor
92986308|NCT00615056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986309|NCT00615056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986310|NCT00615056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986311|NCT00615056|Immunologic Factors|immunologic factors|mesh-ancestor
92986312|NCT00615056|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92986313|NCT00615056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986314|NCT00615056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986315|NCT00615056|Antidotes|antidotes|mesh-ancestor
92986316|NCT00615056|Protective Agents|protective agents|mesh-ancestor
92986317|NCT00615056|Vitamin B Complex|vitamin b complex|mesh-ancestor
92986318|NCT00615056|Vitamins|vitamins|mesh-ancestor
92986319|NCT00615056|Micronutrients|micronutrients|mesh-ancestor
92986320|NCT00615056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92986321|NCT01006551|Ziprasidone|ziprasidone|mesh-list
92986322|NCT01006551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92986323|NCT01006551|Serotonin Agents|serotonin agents|mesh-ancestor
92986324|NCT01006551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986325|NCT01006551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986326|NCT01006551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986327|NCT01006551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92986328|NCT01006551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92986329|NCT01006551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92986330|NCT01006551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92986331|NCT01006551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92986332|NCT01006551|Dopamine Agents|dopamine agents|mesh-ancestor
92986333|NCT05732727|Antihypertensive Agents|antihypertensive agents|mesh-list
92986334|NCT00873626|Ciprofloxacin|ciprofloxacin|mesh-list
92986335|NCT00873626|Levofloxacin|levofloxacin|mesh-list
92986336|NCT00873626|Ofloxacin|ofloxacin|mesh-list
92986337|NCT00873626|Fluoroquinolones|fluoroquinolones|mesh-list
92986338|NCT00873626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631733|NCT00203814|Artesunate|artesunate|mesh-list
92986339|NCT00873626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986340|NCT00873626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92986341|NCT00873626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986342|NCT00873626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986343|NCT00873626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986344|NCT00873626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986345|NCT00873626|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92986346|NCT00873626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92986347|NCT00873626|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92986348|NCT00873626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986349|NCT00879242|Deferasirox|deferasirox|mesh-list
92986350|NCT00879242|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92986351|NCT00879242|Chelating Agents|chelating agents|mesh-ancestor
92986352|NCT00879242|Sequestering Agents|sequestering agents|mesh-ancestor
92986353|NCT00879242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986354|NCT05732493|Capecitabine|capecitabine|mesh-list
92986355|NCT05732493|Oxaliplatin|oxaliplatin|mesh-list
92986356|NCT05732493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986357|NCT05732493|Antimetabolites|antimetabolites|mesh-ancestor
92986358|NCT05732493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986359|NCT05732493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986360|NCT00868634|Bevacizumab|bevacizumab|mesh-list
92986361|NCT00868634|Capecitabine|capecitabine|mesh-list
92986362|NCT00868634|Vinorelbine|vinorelbine|mesh-list
92986363|NCT00868634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986364|NCT00868634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986365|NCT00868634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92986366|NCT00868634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92986367|NCT00868634|Growth Substances|growth substances|mesh-ancestor
92986368|NCT00868634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986369|NCT00868634|Growth Inhibitors|growth inhibitors|mesh-ancestor
92986370|NCT00868634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986371|NCT00868634|Antimetabolites|antimetabolites|mesh-ancestor
92986372|NCT00868634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986373|NCT00868634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986374|NCT00868634|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986375|NCT00868634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986376|NCT00868634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986377|NCT05232357|Sodium thiosulfate|sodium thiosulfate|mesh-list
92986378|NCT05232357|Methylene Blue|methylene blue|mesh-list
92986379|NCT05232357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986380|NCT05232357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986381|NCT05232357|Antidotes|antidotes|mesh-ancestor
92986382|NCT05232357|Protective Agents|protective agents|mesh-ancestor
92986383|NCT05232357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986384|NCT05232357|Antioxidants|antioxidants|mesh-ancestor
92986385|NCT05232357|Antitubercular Agents|antitubercular agents|mesh-ancestor
92986386|NCT05232357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986387|NCT05232357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986388|NCT05232357|Chelating Agents|chelating agents|mesh-ancestor
92986389|NCT05232357|Sequestering Agents|sequestering agents|mesh-ancestor
92986390|NCT00879476|Ramipril|ramipril|mesh-list
92986391|NCT00879476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92986392|NCT00879476|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986393|NCT00879476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986394|NCT00879476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986395|NCT00879476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986396|NCT00868946|Ribavirin|ribavirin|mesh-list
92986397|NCT00868946|Antimetabolites|antimetabolites|mesh-ancestor
92986398|NCT00868946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986399|NCT00868946|Antiviral Agents|antiviral agents|mesh-ancestor
92986400|NCT00868946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986401|NCT00482014|Carboplatin|carboplatin|mesh-list
92986402|NCT00482014|Pemetrexed|pemetrexed|mesh-list
92986403|NCT00482014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986404|NCT00482014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986405|NCT00482014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986406|NCT00482014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92986407|NCT00482014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986408|NCT00879788|Ramipril|ramipril|mesh-list
92986409|NCT00879788|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92986410|NCT00879788|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986411|NCT00879788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986412|NCT00879788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986413|NCT00879788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92631810|NCT00199017|Antiviral Agents|antiviral agents|mesh-ancestor
92986414|NCT03595553|Vancomycin|vancomycin|mesh-list
92986415|NCT03595553|Ridinilazole|ridinilazole|mesh-list
92986416|NCT03595553|Benzimidazole|benzimidazole|mesh-list
92986417|NCT03595553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986418|NCT03595553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986419|NCT03595553|Anthelmintics|anthelmintics|mesh-ancestor
92986420|NCT03595553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92986421|NCT00874172|Analgesics|analgesics|mesh-list
92986422|NCT00874172|Sensory System Agents|sensory system agents|mesh-ancestor
92986423|NCT00874172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986424|NCT00874172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986425|NCT00614822|Bevacizumab|bevacizumab|mesh-list
92986426|NCT00614822|Carboplatin|carboplatin|mesh-list
92986427|NCT00614822|Pemetrexed|pemetrexed|mesh-list
92986428|NCT00614822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986429|NCT00614822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986430|NCT00614822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92986431|NCT00614822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92986432|NCT00614822|Growth Substances|growth substances|mesh-ancestor
92986433|NCT00614822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986434|NCT00614822|Growth Inhibitors|growth inhibitors|mesh-ancestor
92986435|NCT00614822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986436|NCT00614822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986437|NCT00614822|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92986438|NCT00614822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986439|NCT04861298|Quercetin|quercetin|mesh-list
92986440|NCT04861298|Antioxidants|antioxidants|mesh-ancestor
92986441|NCT04861298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986442|NCT04861298|Protective Agents|protective agents|mesh-ancestor
92986443|NCT04861298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986444|NCT03582917|Alfacalcidol|alfacalcidol|mesh-list
92986445|NCT03582917|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92986446|NCT03582917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92986447|NCT03582917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986448|NCT03582917|Vitamins|vitamins|mesh-ancestor
92986449|NCT03582917|Micronutrients|micronutrients|mesh-ancestor
92986451|NCT05226728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986452|NCT05226728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986453|NCT05226728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92986454|NCT05226728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986455|NCT00869180|Diclofenac|diclofenac|mesh-list
92986456|NCT00869180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92986457|NCT00869180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986458|NCT00869180|Analgesics|analgesics|mesh-ancestor
92986459|NCT00869180|Sensory System Agents|sensory system agents|mesh-ancestor
92986460|NCT00869180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986461|NCT00869180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986462|NCT00869180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986463|NCT00869180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986464|NCT00869180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92986465|NCT00869180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986466|NCT00869180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986467|NCT00874328|Irinotecan|irinotecan|mesh-list
92986468|NCT00874328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986469|NCT00874328|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92986470|NCT00874328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986471|NCT00874328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986472|NCT00874328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986473|NCT00874406|Leucovorin|leucovorin|mesh-list
92986474|NCT00874406|Fluorouracil|fluorouracil|mesh-list
92986475|NCT00874406|Oxaliplatin|oxaliplatin|mesh-list
92986476|NCT00874406|Antimetabolites|antimetabolites|mesh-ancestor
92986477|NCT00874406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986478|NCT00874406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986479|NCT00874406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986480|NCT00874406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986481|NCT00874406|Immunologic Factors|immunologic factors|mesh-ancestor
92986482|NCT00874406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986483|NCT00874406|Antidotes|antidotes|mesh-ancestor
92986484|NCT00874406|Protective Agents|protective agents|mesh-ancestor
92986485|NCT00874406|Vitamin B Complex|vitamin b complex|mesh-ancestor
92986486|NCT00874406|Vitamins|vitamins|mesh-ancestor
92986487|NCT00874406|Micronutrients|micronutrients|mesh-ancestor
92986488|NCT04840628|Respiratory System Agents|respiratory system agents|mesh-list
92986489|NCT00880178|Niacin|niacin|mesh-list
92986490|NCT00880178|Niacinamide|niacinamide|mesh-list
92986491|NCT00880178|Nicotinic Acids|nicotinic acids|mesh-list
92986492|NCT00880178|Simvastatin|simvastatin|mesh-list
92986493|NCT00880178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92986494|NCT00880178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92986495|NCT00880178|Antimetabolites|antimetabolites|mesh-ancestor
92986496|NCT00880178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986497|NCT00880178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92986498|NCT00880178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92986499|NCT00880178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986500|NCT00880178|Vasodilator Agents|vasodilator agents|mesh-ancestor
92986501|NCT00880178|Vitamin B Complex|vitamin b complex|mesh-ancestor
92986502|NCT00880178|Vitamins|vitamins|mesh-ancestor
92986503|NCT00880178|Micronutrients|micronutrients|mesh-ancestor
92986504|NCT00880178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986505|NCT04077125|Rifaximin|rifaximin|mesh-list
92986506|NCT04077125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986507|NCT04077125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986508|NCT04077125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986509|NCT04194203|Paclitaxel|paclitaxel|mesh-list
92986510|NCT04194203|Bevacizumab|bevacizumab|mesh-list
92986511|NCT04194203|Carboplatin|carboplatin|mesh-list
92986512|NCT04194203|Pemetrexed|pemetrexed|mesh-list
92986513|NCT04194203|Atezolizumab|atezolizumab|mesh-list
92986514|NCT04194203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986515|NCT04194203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986516|NCT04194203|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986517|NCT04194203|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986518|NCT04194203|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986519|NCT04194203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986520|NCT04194203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986521|NCT04194203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92986522|NCT04194203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92986523|NCT04194203|Growth Substances|growth substances|mesh-ancestor
92986524|NCT04194203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986525|NCT04194203|Growth Inhibitors|growth inhibitors|mesh-ancestor
92986526|NCT04194203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986527|NCT04194203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92986528|NCT04194203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92986529|NCT04194203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92986530|NCT05172401|Triamcinolone|triamcinolone|mesh-list
92986531|NCT05172401|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92986532|NCT05172401|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92986533|NCT05172401|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92986534|NCT05172401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986535|NCT05172401|Glucocorticoids|glucocorticoids|mesh-ancestor
92986536|NCT05172401|Hormones|hormones|mesh-ancestor
92986537|NCT05172401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92986538|NCT05172401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986539|NCT05172401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986540|NCT05172401|Immunologic Factors|immunologic factors|mesh-ancestor
92287142|NCT00003063|Calcium|calcium|mesh-list
92986541|NCT05172401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986542|NCT05172401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986543|NCT00143455|Cisplatin|cisplatin|mesh-list
92986544|NCT00143455|Irinotecan|irinotecan|mesh-list
92986545|NCT00143455|Etoposide|etoposide|mesh-list
92986546|NCT00143455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986547|NCT00143455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92986548|NCT00143455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986549|NCT00143455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986550|NCT00143455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986551|NCT00143455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986552|NCT00143455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92986553|NCT01006863|Phenylephrine|phenylephrine|mesh-list
92986554|NCT01006863|Oxymetazoline|oxymetazoline|mesh-list
92986555|NCT01006863|Ephedrine|ephedrine|mesh-list
92986556|NCT01006863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92986557|NCT01006863|Mydriatics|mydriatics|mesh-ancestor
92986558|NCT01006863|Autonomic Agents|autonomic agents|mesh-ancestor
92986559|NCT01006863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986560|NCT01006863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986561|NCT01006863|Sympathomimetics|sympathomimetics|mesh-ancestor
92986562|NCT01006863|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92986563|NCT01006863|Nasal Decongestants|nasal decongestants|mesh-ancestor
92986564|NCT01006863|Respiratory System Agents|respiratory system agents|mesh-ancestor
92986565|NCT01006863|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92986566|NCT01006863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92632009|NCT00373711|Iodine|iodine|mesh-list
92986568|NCT01006863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92986569|NCT01006863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986570|NCT01006863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986571|NCT01006863|Protective Agents|protective agents|mesh-ancestor
92986572|NCT01006863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92986573|NCT03535727|Paclitaxel|paclitaxel|mesh-list
92986574|NCT03535727|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92986575|NCT03535727|Cisplatin|cisplatin|mesh-list
92986576|NCT03535727|Gemcitabine|gemcitabine|mesh-list
92986577|NCT03535727|Capecitabine|capecitabine|mesh-list
92986578|NCT03535727|Irinotecan|irinotecan|mesh-list
92986579|NCT03535727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986580|NCT03535727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986581|NCT03535727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986582|NCT03535727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986583|NCT03535727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986584|NCT03535727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986585|NCT03535727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986586|NCT03535727|Antimetabolites|antimetabolites|mesh-ancestor
92986587|NCT03535727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92986588|NCT03535727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986589|NCT03535727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986590|NCT03529955|Apremilast|apremilast|mesh-list
92986591|NCT03529955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92986592|NCT03529955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986593|NCT03529955|Analgesics|analgesics|mesh-ancestor
92986594|NCT03529955|Sensory System Agents|sensory system agents|mesh-ancestor
92986595|NCT03529955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986596|NCT03529955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986597|NCT03529955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986598|NCT03529955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528192|NCT00014352|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986599|NCT03529955|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92986600|NCT03529955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92986601|NCT03529955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986602|NCT03529955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986604|NCT00142909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986605|NCT00142909|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92986606|NCT00142909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986607|NCT00142909|Sensory System Agents|sensory system agents|mesh-ancestor
92986608|NCT00142909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986609|NCT00142909|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92986610|NCT00142909|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92986611|NCT00142909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92986612|NCT00142909|Adrenergic Agents|adrenergic agents|mesh-ancestor
92986613|NCT00142909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986614|NCT00142909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986615|NCT01007019|Esomeprazole|esomeprazole|mesh-list
92986616|NCT01007019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92986617|NCT01007019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986618|NCT01007019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92986619|NCT01007019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986620|NCT01007019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986621|NCT05633979|Trastuzumab|trastuzumab|mesh-list
92986622|NCT05633979|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92986623|NCT05633979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986624|NCT05633979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986625|NCT05633979|Immunoconjugates|immunoconjugates|mesh-ancestor
92986626|NCT05633979|Immunologic Factors|immunologic factors|mesh-ancestor
92986627|NCT05633979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986628|NCT03508739|Valsartan|valsartan|mesh-list
92986629|NCT03508739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92986630|NCT03508739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986631|NCT03508739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92986632|NCT03508739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92986633|NCT03508739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986634|NCT00205699|Olanzapine|olanzapine|mesh-list
92986635|NCT00205699|Risperidone|risperidone|mesh-list
92986636|NCT00205699|Aripiprazole|aripiprazole|mesh-list
92986637|NCT00205699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92986638|NCT00205699|Serotonin Agents|serotonin agents|mesh-ancestor
92986639|NCT00205699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632078|NCT00555607|Hormones|hormones|mesh-ancestor
92986640|NCT00205699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986641|NCT00205699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986642|NCT00205699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92986643|NCT00205699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92986644|NCT00205699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92986645|NCT00205699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92986646|NCT00205699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92986647|NCT00205699|Dopamine Agents|dopamine agents|mesh-ancestor
92986648|NCT00205699|Antiemetics|antiemetics|mesh-ancestor
92986649|NCT00205699|Autonomic Agents|autonomic agents|mesh-ancestor
92986650|NCT00205699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986651|NCT00205699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92986652|NCT00205699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92986653|NCT00205699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92986654|NCT00205699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92986655|NCT00205699|Antidepressive Agents|antidepressive agents|mesh-ancestor
92986656|NCT00205699|Dopamine Agonists|dopamine agonists|mesh-ancestor
92986657|NCT00205699|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92986658|NCT00205699|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92986659|NCT00205699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92986660|NCT00205699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92986661|NCT03503513|Gentamicins|gentamicins|mesh-list
92986662|NCT03503513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986663|NCT03503513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986664|NCT03503513|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92986665|NCT03503513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986666|NCT03503513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986667|NCT03498521|Bevacizumab|bevacizumab|mesh-list
92986668|NCT03498521|Carboplatin|carboplatin|mesh-list
92986670|NCT03498521|Trastuzumab|trastuzumab|mesh-list
92986671|NCT03498521|Atezolizumab|atezolizumab|mesh-list
92986672|NCT03498521|Olaparib|olaparib|mesh-list
92986673|NCT03498521|Pertuzumab|pertuzumab|mesh-list
92986674|NCT03498521|Vemurafenib|vemurafenib|mesh-list
92986675|NCT03498521|Ipatasertib|ipatasertib|mesh-list
92986676|NCT03498521|Ivosidenib|ivosidenib|mesh-list
92986677|NCT03498521|Entrectinib|entrectinib|mesh-list
92986678|NCT03498521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986679|NCT03498521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986680|NCT03498521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986681|NCT03498521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92986682|NCT03498521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92986683|NCT03498521|Growth Substances|growth substances|mesh-ancestor
92167579|NCT02461537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986684|NCT03498521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986685|NCT03498521|Growth Inhibitors|growth inhibitors|mesh-ancestor
92986686|NCT03498521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986687|NCT03498521|Antimetabolites|antimetabolites|mesh-ancestor
92986688|NCT03498521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92986689|NCT03498521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986690|NCT03498521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92986691|NCT03498521|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92986692|NCT02580149|Clopidogrel|clopidogrel|mesh-list
92986693|NCT02580149|Ticagrelor|ticagrelor|mesh-list
92986694|NCT02580149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92986695|NCT02580149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92986696|NCT02580149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92986697|NCT02580149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92986698|NCT02580149|Purinergic Agents|purinergic agents|mesh-ancestor
92986699|NCT02580149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986700|NCT02580149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986701|NCT02580149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986702|NCT04996017|Atezolizumab|atezolizumab|mesh-list
92986703|NCT04996017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92986704|NCT04996017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986705|NCT04996017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986706|NCT04996017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986707|NCT04994223|Rivaroxaban|rivaroxaban|mesh-list
92986708|NCT04994223|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92986709|NCT04994223|Antithrombins|antithrombins|mesh-ancestor
92986710|NCT04994223|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92986711|NCT04994223|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986712|NCT04994223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986713|NCT04994223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986714|NCT04994223|Anticoagulants|anticoagulants|mesh-ancestor
92986715|NCT01007565|Anesthetics|anesthetics|mesh-list
92986716|NCT01007565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92986717|NCT01007565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986718|NCT05229003|Irinotecan|irinotecan|mesh-list
92986719|NCT05229003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92986720|NCT05229003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986721|NCT05229003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986722|NCT05229003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986723|NCT05229003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986724|NCT01016626|Mycophenolic Acid|mycophenolic acid|mesh-list
92986725|NCT01016626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92986726|NCT01016626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986727|NCT01016626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92986728|NCT01016626|Antitubercular Agents|antitubercular agents|mesh-ancestor
92986729|NCT01016626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986730|NCT01016626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986731|NCT01016626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986732|NCT01016626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986733|NCT02798471|Heparin|heparin|mesh-list
92986734|NCT02798471|Enoxaparin|enoxaparin|mesh-list
92986735|NCT02798471|Warfarin|warfarin|mesh-list
92986736|NCT02798471|Edoxaban|edoxaban|mesh-list
92986737|NCT02798471|Fondaparinux|fondaparinux|mesh-list
92986738|NCT02798471|Anticoagulants|anticoagulants|mesh-ancestor
92986739|NCT02798471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92986740|NCT02798471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92986741|NCT02798471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986742|NCT02798471|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92986743|NCT02798471|Antithrombins|antithrombins|mesh-ancestor
92332129|NCT00002953|Paclitaxel|paclitaxel|mesh-list
92986744|NCT02798471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92986745|NCT02798471|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986746|NCT02798471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986747|NCT03443765|Vitamin D|vitamin d|mesh-list
92986748|NCT03443765|Immunoglobulins|immunoglobulins|mesh-list
92986749|NCT03443765|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92986750|NCT03443765|Antibodies|antibodies|mesh-list
92986751|NCT03443765|Vitamins|vitamins|mesh-ancestor
92986752|NCT03443765|Micronutrients|micronutrients|mesh-ancestor
92986753|NCT03443765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986754|NCT03443765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92986755|NCT03443765|Immunologic Factors|immunologic factors|mesh-ancestor
92986756|NCT03441893|Nitazoxanide|nitazoxanide|mesh-list
92986757|NCT03441893|Mesalamine|mesalamine|mesh-list
92986758|NCT03441893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92986759|NCT03441893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986760|NCT03441893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92986761|NCT03441893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986762|NCT03441893|Analgesics|analgesics|mesh-ancestor
92986763|NCT03441893|Sensory System Agents|sensory system agents|mesh-ancestor
92986764|NCT03441893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986765|NCT03441893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986766|NCT03441893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986767|NCT03441893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986768|NCT03440177|Ramipril|ramipril|mesh-list
92986769|NCT03440177|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92986770|NCT03440177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986771|NCT03440177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986772|NCT03440177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986773|NCT03440177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986774|NCT00489736|Amiodarone|amiodarone|mesh-list
92986775|NCT00489736|Dronedarone|dronedarone|mesh-list
92986776|NCT00489736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92986777|NCT00489736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92986778|NCT00489736|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92986779|NCT00489736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92986780|NCT00489736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986781|NCT00489736|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92986782|NCT00489736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92986783|NCT00489736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92986784|NCT00489736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986785|NCT00489736|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92986786|NCT00489736|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92986787|NCT00489736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92986788|NCT00617084|Everolimus|everolimus|mesh-list
92632184|NCT04306393|Vasodilator Agents|vasodilator agents|mesh-ancestor
92986789|NCT00617084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92986790|NCT00617084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92986791|NCT00617084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986792|NCT00617084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986793|NCT00617084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986794|NCT00617084|Immunologic Factors|immunologic factors|mesh-ancestor
92986795|NCT00617084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986796|NCT00617084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986797|NCT02758847|Paclitaxel|paclitaxel|mesh-list
92986798|NCT02758847|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92986799|NCT02758847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986800|NCT02758847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986801|NCT02758847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986802|NCT02758847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986803|NCT02758847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986804|NCT02758847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986805|NCT01016860|Irinotecan|irinotecan|mesh-list
92986806|NCT01016860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92986807|NCT01016860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986808|NCT01016860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986809|NCT01016860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986810|NCT01016860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986811|NCT00874484|Enoxaparin|enoxaparin|mesh-list
92986812|NCT00874484|Anticoagulants|anticoagulants|mesh-ancestor
92986813|NCT00874484|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92986814|NCT00874484|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92986815|NCT00874484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986816|NCT00869492|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92986817|NCT00869492|Dermatologic Agents|dermatologic agents|mesh-ancestor
92986818|NCT00489424|Acetaminophen|acetaminophen|mesh-list
92986819|NCT00489424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986820|NCT00489424|Analgesics|analgesics|mesh-ancestor
92986821|NCT00489424|Sensory System Agents|sensory system agents|mesh-ancestor
92986822|NCT00489424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986823|NCT00489424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986824|NCT00489424|Antipyretics|antipyretics|mesh-ancestor
92986825|NCT00869570|Capecitabine|capecitabine|mesh-list
92986826|NCT00869570|Sorafenib|sorafenib|mesh-list
92986827|NCT00869570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986828|NCT00869570|Antimetabolites|antimetabolites|mesh-ancestor
92986829|NCT00869570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986830|NCT00869570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986831|NCT00869570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92986832|NCT00869570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986833|NCT05127304|Bromides|bromides|mesh-list
92986834|NCT05127304|Tiotropium Bromide|tiotropium bromide|mesh-list
92986835|NCT05127304|Olodaterol|olodaterol|mesh-list
92986836|NCT05127304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92986837|NCT05127304|Autonomic Agents|autonomic agents|mesh-ancestor
92986838|NCT05127304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986839|NCT05127304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986840|NCT05127304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92986841|NCT05127304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92986842|NCT05127304|Parasympatholytics|parasympatholytics|mesh-ancestor
92986843|NCT05127304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92986844|NCT05127304|Cholinergic Agents|cholinergic agents|mesh-ancestor
92986845|NCT05127304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986846|NCT05127304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986847|NCT05127304|Anticonvulsants|anticonvulsants|mesh-ancestor
92986848|NCT00880412|Etazolate|etazolate|mesh-list
92986849|NCT00880412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92986850|NCT00880412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986851|NCT00880412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986852|NCT00880412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92986853|NCT00880412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92986854|NCT00880412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92986855|NCT00880412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986856|NCT00880412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92986857|NCT01020136|Axitinib|axitinib|mesh-list
92986858|NCT01020136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986859|NCT01020136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92986860|NCT01020136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986861|NCT01020136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986862|NCT03412643|Paclitaxel|paclitaxel|mesh-list
92986863|NCT03412643|Cyclophosphamide|cyclophosphamide|mesh-list
92986864|NCT03412643|Doxorubicin|doxorubicin|mesh-list
92986866|NCT03412643|Pertuzumab|pertuzumab|mesh-list
92986867|NCT03412643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986868|NCT03412643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986869|NCT03412643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986870|NCT03412643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986871|NCT03412643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986872|NCT03412643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986873|NCT03412643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92986874|NCT03412643|Immunologic Factors|immunologic factors|mesh-ancestor
92986875|NCT03412643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986876|NCT03412643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986877|NCT03412643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92986878|NCT03412643|Alkylating Agents|alkylating agents|mesh-ancestor
92986879|NCT03412643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92986880|NCT03412643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92986881|NCT03412643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92986882|NCT03412643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92986883|NCT03412643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986884|NCT03412643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986885|NCT01017094|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92986886|NCT01017094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92986887|NCT01017094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986888|NCT01020214|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92986889|NCT01020214|Olmesartan|olmesartan|mesh-list
92986890|NCT01020214|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92986891|NCT01020214|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92986892|NCT01020214|Diuretics|diuretics|mesh-ancestor
92986893|NCT01020214|Natriuretic Agents|natriuretic agents|mesh-ancestor
92986894|NCT01020214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986895|NCT01020214|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92986896|NCT01020214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92986897|NCT01020214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986898|NCT01020214|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92986899|NCT01020214|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92986900|NCT03970824|Adalimumab|adalimumab|mesh-list
92986901|NCT03970824|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92986902|NCT03970824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92986903|NCT03970824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92986904|NCT00933894|Escitalopram|escitalopram|mesh-list
92986905|NCT00933894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92986906|NCT00933894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92986907|NCT00933894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92986908|NCT00933894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986909|NCT00933894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92986910|NCT00933894|Serotonin Agents|serotonin agents|mesh-ancestor
92986911|NCT00933894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986912|NCT00564486|Acetaminophen|acetaminophen|mesh-list
92986913|NCT00564486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92986914|NCT00564486|Analgesics|analgesics|mesh-ancestor
92986915|NCT00564486|Sensory System Agents|sensory system agents|mesh-ancestor
92986916|NCT00564486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92986917|NCT00564486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986918|NCT00564486|Antipyretics|antipyretics|mesh-ancestor
92986919|NCT00481078|Paclitaxel|paclitaxel|mesh-list
92986920|NCT00481078|Carboplatin|carboplatin|mesh-list
92986921|NCT00481078|Vorinostat|vorinostat|mesh-list
92986922|NCT00481078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986923|NCT00481078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986924|NCT00481078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986925|NCT00481078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986926|NCT00481078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986927|NCT00481078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986928|NCT00481078|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92986929|NCT00481078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986930|NCT00480532|Doxycycline|doxycycline|mesh-list
92986931|NCT00480532|Levonorgestrel|levonorgestrel|mesh-list
92986932|NCT00480532|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92986933|NCT00480532|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92986934|NCT00480532|Estradiol|estradiol|mesh-list
92986935|NCT00480532|Estrogens|estrogens|mesh-ancestor
92986936|NCT00480532|Hormones|hormones|mesh-ancestor
92986937|NCT00480532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92986938|NCT00480532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986939|NCT00480532|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92986940|NCT00480532|Contraceptive Agents|contraceptive agents|mesh-ancestor
92986941|NCT00480532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92986942|NCT00480532|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92986943|NCT00480532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92986944|NCT00480532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986945|NCT00480532|Antimalarials|antimalarials|mesh-ancestor
92986946|NCT00480532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92986947|NCT00480532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92986948|NCT00480532|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92986949|NCT00480532|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92986950|NCT00480532|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92986951|NCT00480532|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92986952|NCT04013880|Decitabine|decitabine|mesh-list
92986953|NCT04013880|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92986954|NCT04013880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986955|NCT04013880|Antimetabolites|antimetabolites|mesh-ancestor
92986956|NCT04013880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986957|NCT04013880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986958|NCT04013880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986959|NCT00934518|Cetuximab|cetuximab|mesh-list
92986960|NCT00934518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986961|NCT00934518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986962|NCT00496366|Capecitabine|capecitabine|mesh-list
92986963|NCT00496366|Lapatinib|lapatinib|mesh-list
92986964|NCT00496366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92986965|NCT00496366|Antimetabolites|antimetabolites|mesh-ancestor
92986966|NCT00496366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986967|NCT00496366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986968|NCT00496366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92986969|NCT00496366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986970|NCT00934752|Paclitaxel|paclitaxel|mesh-list
92986971|NCT00934752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92986972|NCT00934752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986973|NCT00934752|Tubulin Modulators|tubulin modulators|mesh-ancestor
92986974|NCT00934752|Antimitotic Agents|antimitotic agents|mesh-ancestor
92986975|NCT00934752|Mitosis Modulators|mitosis modulators|mesh-ancestor
92986976|NCT00934752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986977|NCT01020292|Nelfinavir|nelfinavir|mesh-list
92986978|NCT01020292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92986979|NCT01020292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92986980|NCT01020292|Protease Inhibitors|protease inhibitors|mesh-ancestor
92986981|NCT01020292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92986982|NCT01020292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986983|NCT01020292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92986984|NCT01020292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92986985|NCT01020292|Antiviral Agents|antiviral agents|mesh-ancestor
92986986|NCT01020292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986987|NCT00934830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92986988|NCT00934830|Amoxicillin|amoxicillin|mesh-list
92986989|NCT00934830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92986990|NCT02575404|Pembrolizumab|pembrolizumab|mesh-list
92986991|NCT02575404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92986992|NCT02575404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92986993|NCT02575404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92986994|NCT02575404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92986995|NCT00564018|Insulin Detemir|insulin detemir|mesh-list
92986996|NCT00564018|Protamines|protamines|mesh-list
92986997|NCT00564018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92986998|NCT00564018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92986999|NCT00564018|Heparin Antagonists|heparin antagonists|mesh-ancestor
92987000|NCT00564018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987001|NCT00564018|Coagulants|coagulants|mesh-ancestor
92987002|NCT00935298|Tacrolimus|tacrolimus|mesh-list
92987003|NCT00935298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987004|NCT00935298|Immunologic Factors|immunologic factors|mesh-ancestor
92987005|NCT00935298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987006|NCT00935298|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92987007|NCT00935298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987008|NCT00935298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987009|NCT04014192|Dapagliflozin|dapagliflozin|mesh-list
92987010|NCT04014192|Empagliflozin|empagliflozin|mesh-list
92987011|NCT04014192|Canagliflozin|canagliflozin|mesh-list
92632420|NCT03252808|Paclitaxel|paclitaxel|mesh-list
92987012|NCT04014192|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92987013|NCT04014192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987014|NCT04014192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92987015|NCT04014192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987016|NCT00935610|Caseins|caseins|mesh-list
92987017|NCT00935610|Chelating Agents|chelating agents|mesh-ancestor
92987018|NCT00935610|Sequestering Agents|sequestering agents|mesh-ancestor
92987019|NCT00935610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987020|NCT04013646|Epoetin Alfa|epoetin alfa|mesh-list
92987021|NCT04013646|Hematinics|hematinics|mesh-ancestor
92987022|NCT04074473|Propranolol|propranolol|mesh-list
92987023|NCT04074473|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92987024|NCT04074473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92987025|NCT04074473|Adrenergic Agents|adrenergic agents|mesh-ancestor
92987026|NCT04074473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987027|NCT04074473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987028|NCT04074473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987029|NCT04074473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92987030|NCT04074473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92987031|NCT04074473|Vasodilator Agents|vasodilator agents|mesh-ancestor
92987032|NCT03093480|Factor VIII|factor viii|mesh-list
92987033|NCT03093480|Coagulants|coagulants|mesh-ancestor
92987034|NCT02578511|Ixazomib|ixazomib|mesh-list
92987035|NCT02578511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987036|NCT02578511|Protease Inhibitors|protease inhibitors|mesh-ancestor
92987037|NCT02578511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987038|NCT02578511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987039|NCT00563784|Paclitaxel|paclitaxel|mesh-list
92987040|NCT00563784|Carboplatin|carboplatin|mesh-list
92987041|NCT00563784|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92987042|NCT00563784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92987043|NCT00563784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987044|NCT00563784|Tubulin Modulators|tubulin modulators|mesh-ancestor
92987045|NCT00563784|Antimitotic Agents|antimitotic agents|mesh-ancestor
92987046|NCT00563784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92987047|NCT00563784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987048|NCT00563784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92987049|NCT00563784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987050|NCT00203047|Prednisone|prednisone|mesh-list
92987051|NCT00203047|Glatiramer Acetate|glatiramer acetate|mesh-list
92987052|NCT00203047|(T,G)-A-L|(t,g)-a-l|mesh-list
92987053|NCT00203047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987054|NCT00203047|Glucocorticoids|glucocorticoids|mesh-ancestor
92987055|NCT00203047|Hormones|hormones|mesh-ancestor
92987056|NCT00203047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987057|NCT00203047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987058|NCT00203047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92987059|NCT00203047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987060|NCT00203047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92987061|NCT00203047|Immunologic Factors|immunologic factors|mesh-ancestor
92987062|NCT00203047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987063|NCT00203047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987064|NCT00870038|Paclitaxel|paclitaxel|mesh-list
92987065|NCT00870038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92987066|NCT00870038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987067|NCT00870038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92987068|NCT00870038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92987069|NCT00870038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92987070|NCT00870038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987071|NCT04074551|Losartan|losartan|mesh-list
92987072|NCT04074551|Amlodipine|amlodipine|mesh-list
92987073|NCT04074551|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92987074|NCT04074551|Ezetimibe|ezetimibe|mesh-list
92987075|NCT04074551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92987076|NCT04074551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92987077|NCT04074551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92987078|NCT04074551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987079|NCT04074551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92987080|NCT04074551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987081|NCT04074551|Vasodilator Agents|vasodilator agents|mesh-ancestor
92987082|NCT04074551|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92987083|NCT04074551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92987084|NCT04074551|Antimetabolites|antimetabolites|mesh-ancestor
92987085|NCT04074551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92987086|NCT04074551|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92987087|NCT04074551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987088|NCT04074551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92987089|NCT04074551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92987090|NCT04074551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92987091|NCT02608385|Pembrolizumab|pembrolizumab|mesh-list
92987092|NCT02608385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987093|NCT02608385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987094|NCT02608385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92987095|NCT02608385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987096|NCT00142519|Morphine|morphine|mesh-list
92987097|NCT00142519|Methadone|methadone|mesh-list
92987098|NCT00142519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92987099|NCT00142519|Narcotics|narcotics|mesh-ancestor
92987100|NCT00142519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987101|NCT00142519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987102|NCT00142519|Analgesics|analgesics|mesh-ancestor
92987103|NCT00142519|Sensory System Agents|sensory system agents|mesh-ancestor
92987104|NCT00142519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987105|NCT00142519|Antitussive Agents|antitussive agents|mesh-ancestor
92167605|NCT02460445|Estrogens|estrogens|mesh-ancestor
92987106|NCT00142519|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987107|NCT03713294|Dexamethasone|dexamethasone|mesh-list
92987108|NCT03713294|Dexamethasone acetate|dexamethasone acetate|mesh-list
92987109|NCT03713294|Pomalidomide|pomalidomide|mesh-list
92987110|NCT03713294|Elotuzumab|elotuzumab|mesh-list
92987111|NCT03713294|Ichthammol|ichthammol|mesh-list
92987112|NCT03713294|BB 1101|bb 1101|mesh-list
92987113|NCT03713294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987115|NCT03713294|Autonomic Agents|autonomic agents|mesh-ancestor
92987116|NCT03713294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987117|NCT03713294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987118|NCT03713294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987119|NCT03713294|Glucocorticoids|glucocorticoids|mesh-ancestor
92987120|NCT03713294|Hormones|hormones|mesh-ancestor
92987121|NCT03713294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987122|NCT03713294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92987123|NCT03713294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987124|NCT03713294|Protease Inhibitors|protease inhibitors|mesh-ancestor
92987125|NCT03713294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987126|NCT03713294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987127|NCT03713294|Immunologic Factors|immunologic factors|mesh-ancestor
92987128|NCT03713294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987129|NCT03713294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987130|NCT03713294|Growth Substances|growth substances|mesh-ancestor
92987131|NCT03713294|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987132|NCT03713294|Dermatologic Agents|dermatologic agents|mesh-ancestor
92987133|NCT00141817|Pantoprazole|pantoprazole|mesh-list
92987134|NCT00141817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92987135|NCT00141817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987136|NCT00141817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92987137|NCT00141817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987138|NCT00141817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987139|NCT03967171|Oxytocin|oxytocin|mesh-list
92987140|NCT03967171|Oxytocics|oxytocics|mesh-ancestor
92987141|NCT03967171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92987142|NCT03967171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987143|NCT03967327|Morphine|morphine|mesh-list
92987144|NCT03967327|Buprenorphine|buprenorphine|mesh-list
92987145|NCT03967327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92987146|NCT03967327|Narcotics|narcotics|mesh-ancestor
92987147|NCT03967327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987148|NCT03967327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987149|NCT03967327|Analgesics|analgesics|mesh-ancestor
92987150|NCT03967327|Sensory System Agents|sensory system agents|mesh-ancestor
92987151|NCT03967327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987152|NCT03967327|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92987153|NCT01075945|Lumefantrine|lumefantrine|mesh-list
92987154|NCT01075945|Artemether|artemether|mesh-list
92987155|NCT01075945|Piperaquine|piperaquine|mesh-list
92987156|NCT01075945|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92987157|NCT01075945|Artenimol|artenimol|mesh-list
92987158|NCT01075945|Antimalarials|antimalarials|mesh-ancestor
92987159|NCT01075945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92987160|NCT01075945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92987161|NCT01075945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987162|NCT00874562|Sirolimus|sirolimus|mesh-list
92987163|NCT00874562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987164|NCT00874562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987165|NCT00874562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92632564|NCT02572141|Leucovorin|leucovorin|mesh-list
92987166|NCT00874562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987167|NCT00874562|Antifungal Agents|antifungal agents|mesh-ancestor
92987168|NCT00874562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987169|NCT00874562|Immunologic Factors|immunologic factors|mesh-ancestor
92987170|NCT00874562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987171|NCT00201643|Dexamethasone|dexamethasone|mesh-list
92987172|NCT00201643|Betamethasone|betamethasone|mesh-list
92987173|NCT00201643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987174|NCT00201643|Antiemetics|antiemetics|mesh-ancestor
92987175|NCT00201643|Autonomic Agents|autonomic agents|mesh-ancestor
92987176|NCT00201643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987177|NCT00201643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987178|NCT00201643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987179|NCT00201643|Glucocorticoids|glucocorticoids|mesh-ancestor
92987181|NCT00201643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987182|NCT00201643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92987183|NCT00201643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987184|NCT00201643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92987185|NCT00201643|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987186|NCT03798314|Nivolumab|nivolumab|mesh-list
92987187|NCT03798314|Pomalidomide|pomalidomide|mesh-list
92987188|NCT03798314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987189|NCT03798314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332596|NCT00003541|Prednisone|prednisone|mesh-list
92987191|NCT03798314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987192|NCT03798314|Immunologic Factors|immunologic factors|mesh-ancestor
92987193|NCT03798314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987194|NCT03798314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987195|NCT03798314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987196|NCT03798314|Growth Substances|growth substances|mesh-ancestor
92987197|NCT03798314|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987198|NCT01077427|Gemcitabine|gemcitabine|mesh-list
92987199|NCT01077427|Capecitabine|capecitabine|mesh-list
92987200|NCT01077427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987201|NCT01077427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92987202|NCT01077427|Antimetabolites|antimetabolites|mesh-ancestor
92987203|NCT01077427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987204|NCT00883064|Lisinopril|lisinopril|mesh-list
92987205|NCT00883064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92987206|NCT00883064|Protease Inhibitors|protease inhibitors|mesh-ancestor
92987207|NCT00883064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987208|NCT00883064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987209|NCT00883064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92987210|NCT00883064|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92987211|NCT00883064|Protective Agents|protective agents|mesh-ancestor
92987212|NCT00883064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987213|NCT01077505|Contraceptive Agents|contraceptive agents|mesh-list
92987214|NCT01077505|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92987215|NCT01077505|Contraceptives, Oral|contraceptives, oral|mesh-list
92987216|NCT01077505|rGLP-1 protein|rglp-1 protein|mesh-list
92987217|NCT01077505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92987218|NCT01077505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987219|NCT01077505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92987220|NCT01077505|Incretins|incretins|mesh-ancestor
92987221|NCT01077505|Hormones|hormones|mesh-ancestor
92987222|NCT01077505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987223|NCT01077505|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92987224|NCT01077505|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92987225|NCT01077505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92987226|NCT01077505|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92987227|NCT01077505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92987228|NCT01073995|Triamcinolone|triamcinolone|mesh-list
92987229|NCT01073995|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92987230|NCT01073995|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92987231|NCT01073995|Bupivacaine|bupivacaine|mesh-list
92987232|NCT01073995|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92987233|NCT01073995|Anesthetics, Local|anesthetics, local|mesh-ancestor
92987234|NCT01073995|Anesthetics|anesthetics|mesh-ancestor
92987235|NCT01073995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987236|NCT01073995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987237|NCT01073995|Sensory System Agents|sensory system agents|mesh-ancestor
92987238|NCT01073995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987239|NCT01073995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987240|NCT01073995|Glucocorticoids|glucocorticoids|mesh-ancestor
92987241|NCT01073995|Hormones|hormones|mesh-ancestor
92987242|NCT01073995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987243|NCT01073995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987244|NCT01073995|Immunologic Factors|immunologic factors|mesh-ancestor
92987245|NCT01073995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987246|NCT01073995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987247|NCT01074073|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92987248|NCT01074073|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92987249|NCT01074073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92987250|NCT01074073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987251|NCT01074073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987252|NCT01074073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92987253|NCT01074073|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92987254|NCT01074073|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92987255|NCT01074073|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92987256|NCT01074073|Adrenergic Agents|adrenergic agents|mesh-ancestor
92987257|NCT01074073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987258|NCT01074073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332655|NCT00383539|Vaccines|vaccines|mesh-list
92987259|NCT01074073|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92987260|NCT01074073|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92987261|NCT01074073|Serotonin Agents|serotonin agents|mesh-ancestor
92987262|NCT01074073|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92987263|NCT01074073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92987264|NCT01074073|Dopamine Agents|dopamine agents|mesh-ancestor
92987265|NCT00874874|Sorafenib|sorafenib|mesh-list
92987266|NCT00874874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987267|NCT00874874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92987268|NCT00874874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987269|NCT00874874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987270|NCT04489628|Vitamin D|vitamin d|mesh-list
92987271|NCT04489628|Cholecalciferol|cholecalciferol|mesh-list
92987272|NCT04489628|Vitamins|vitamins|mesh-ancestor
92987273|NCT04489628|Micronutrients|micronutrients|mesh-ancestor
92987274|NCT04489628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987275|NCT04489628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92987276|NCT04489628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92987277|NCT00130039|Cilostazol|cilostazol|mesh-list
92987278|NCT00130039|Clopidogrel|clopidogrel|mesh-list
92987279|NCT00130039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92987280|NCT00130039|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92987281|NCT00130039|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92987282|NCT00130039|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92987283|NCT00130039|Purinergic Agents|purinergic agents|mesh-ancestor
92987284|NCT00130039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987285|NCT00130039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987286|NCT00130039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987287|NCT00130039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92987288|NCT00130039|Autonomic Agents|autonomic agents|mesh-ancestor
92987289|NCT00130039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987290|NCT00130039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92987291|NCT00130039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987292|NCT00130039|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92987293|NCT00130039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92987294|NCT00130039|Vasodilator Agents|vasodilator agents|mesh-ancestor
92987295|NCT00130039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92987296|NCT00130039|Protective Agents|protective agents|mesh-ancestor
92987297|NCT00130039|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92987298|NCT00130039|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92987299|NCT00130039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987300|NCT00875030|Artesunate|artesunate|mesh-list
92987301|NCT00875030|Antimalarials|antimalarials|mesh-ancestor
92987302|NCT00875030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92987303|NCT00875030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92987304|NCT00875030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987305|NCT00875030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987306|NCT00875030|Antiviral Agents|antiviral agents|mesh-ancestor
92987307|NCT00875030|Schistosomicides|schistosomicides|mesh-ancestor
92987308|NCT00875030|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92987309|NCT00875030|Anthelmintics|anthelmintics|mesh-ancestor
92987310|NCT00883298|Bevacizumab|bevacizumab|mesh-list
92987311|NCT00883298|Temozolomide|temozolomide|mesh-list
92987312|NCT00883298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987313|NCT00883298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987314|NCT00883298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987315|NCT00883298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987316|NCT00883298|Growth Substances|growth substances|mesh-ancestor
92987317|NCT00883298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987318|NCT00883298|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987319|NCT00883298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92987320|NCT00883298|Alkylating Agents|alkylating agents|mesh-ancestor
92987321|NCT00883298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987323|NCT00881114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987324|NCT00881114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987325|NCT00475852|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92987326|NCT00475852|Natriuretic Agents|natriuretic agents|mesh-ancestor
92987327|NCT00475852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987328|NCT00141271|Ziprasidone|ziprasidone|mesh-list
92987329|NCT00141271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92987330|NCT00141271|Serotonin Agents|serotonin agents|mesh-ancestor
92987331|NCT00141271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987332|NCT00141271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987333|NCT00141271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987334|NCT00141271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92987335|NCT00141271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92987336|NCT00141271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987337|NCT00141271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92987338|NCT00141271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92987339|NCT00141271|Dopamine Agents|dopamine agents|mesh-ancestor
92987340|NCT01017640|Mitomycins|mitomycins|mesh-list
92987341|NCT01017640|Mitomycin|mitomycin|mesh-list
92987342|NCT01017640|Veliparib|veliparib|mesh-list
92987343|NCT01017640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92987344|NCT01017640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987345|NCT01017640|Alkylating Agents|alkylating agents|mesh-ancestor
92987346|NCT01017640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987347|NCT01017640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92987348|NCT01017640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987349|NCT01017640|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92987350|NCT00614120|Metformin|metformin|mesh-list
92987351|NCT00614120|Liraglutide|liraglutide|mesh-list
92987352|NCT00614120|Glimepiride|glimepiride|mesh-list
92987353|NCT00614120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92987354|NCT00614120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987355|NCT00614120|Incretins|incretins|mesh-ancestor
92987356|NCT00614120|Hormones|hormones|mesh-ancestor
92987357|NCT00614120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987358|NCT00614120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92987359|NCT00614120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987360|NCT00614120|Immunologic Factors|immunologic factors|mesh-ancestor
92987361|NCT00496054|Vaccines|vaccines|mesh-list
92987362|NCT00496054|Immunologic Factors|immunologic factors|mesh-ancestor
92987363|NCT00496054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987364|NCT00495820|Methylphenidate|methylphenidate|mesh-list
92987365|NCT00495820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92987366|NCT00495820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987367|NCT00495820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92987368|NCT00495820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92987369|NCT00495820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92987370|NCT00495820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987371|NCT00495820|Dopamine Agents|dopamine agents|mesh-ancestor
92987372|NCT00495820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987373|NCT04387240|Artesunate|artesunate|mesh-list
92987374|NCT04387240|Artemisinins|artemisinins|mesh-list
92987375|NCT04387240|Artemisinin|artemisinin|mesh-list
92987376|NCT04387240|Antimalarials|antimalarials|mesh-ancestor
92987377|NCT04387240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92987378|NCT04387240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92987379|NCT04387240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987380|NCT04387240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987381|NCT04387240|Antiviral Agents|antiviral agents|mesh-ancestor
92987382|NCT04387240|Schistosomicides|schistosomicides|mesh-ancestor
92987383|NCT04387240|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92987384|NCT04387240|Anthelmintics|anthelmintics|mesh-ancestor
92987385|NCT00495586|Amoxicillin|amoxicillin|mesh-list
92987386|NCT00495586|Clavulanic Acids|clavulanic acids|mesh-list
92987387|NCT00495586|Clavulanic Acid|clavulanic acid|mesh-list
92987388|NCT00495586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987389|NCT00495586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987390|NCT00495586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987391|NCT00495586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987392|NCT00495586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92987393|NCT00613730|Gemcitabine|gemcitabine|mesh-list
92987394|NCT00613730|Panitumumab|panitumumab|mesh-list
92987395|NCT00613730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92987396|NCT00613730|Antimetabolites|antimetabolites|mesh-ancestor
92288015|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
92987397|NCT00613730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987398|NCT00613730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987399|NCT00613730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987400|NCT00613574|Bromides|bromides|mesh-list
92987401|NCT00613574|Tiotropium Bromide|tiotropium bromide|mesh-list
92987402|NCT00613574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92987403|NCT00613574|Autonomic Agents|autonomic agents|mesh-ancestor
92987404|NCT00613574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987405|NCT00613574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987406|NCT00613574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92332796|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
92987407|NCT00613574|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987409|NCT00613574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92987410|NCT00613574|Cholinergic Agents|cholinergic agents|mesh-ancestor
92987411|NCT00613574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987412|NCT00613574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987413|NCT00613574|Anticonvulsants|anticonvulsants|mesh-ancestor
92987414|NCT00881426|Cefprozil|cefprozil|mesh-list
92987415|NCT00881426|Cephalosporins|cephalosporins|mesh-list
92987416|NCT00881426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987417|NCT00881426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987418|NCT00883532|Budesonide|budesonide|mesh-list
92987419|NCT00883532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92987420|NCT00883532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987421|NCT00883532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92987422|NCT00883532|Autonomic Agents|autonomic agents|mesh-ancestor
92987423|NCT00883532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987424|NCT00883532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987425|NCT00883532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92987426|NCT00883532|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987427|NCT00883532|Glucocorticoids|glucocorticoids|mesh-ancestor
92987428|NCT00883532|Hormones|hormones|mesh-ancestor
92987429|NCT00883532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987430|NCT00881582|Interferons|interferons|mesh-list
92987431|NCT00881582|Interferon-alpha|interferon-alpha|mesh-list
92987432|NCT00881582|Interferon alpha-2|interferon alpha-2|mesh-list
92987433|NCT00881582|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92987434|NCT00881582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987435|NCT00881582|Antiviral Agents|antiviral agents|mesh-ancestor
92987436|NCT00881582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987437|NCT00881582|Immunologic Factors|immunologic factors|mesh-ancestor
92987438|NCT00881582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987439|NCT00881738|Clarithromycin|clarithromycin|mesh-list
92987440|NCT00881738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987441|NCT00881738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987442|NCT00881738|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92987443|NCT00881738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987444|NCT00881738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987445|NCT00881738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92987446|NCT00881738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92987447|NCT00613106|Ibuprofen|ibuprofen|mesh-list
92987448|NCT00613106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92987449|NCT00613106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92987450|NCT00613106|Analgesics|analgesics|mesh-ancestor
92987451|NCT00613106|Sensory System Agents|sensory system agents|mesh-ancestor
92987452|NCT00613106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987453|NCT00613106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987454|NCT00613106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987455|NCT00613106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987456|NCT00613106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92987457|NCT00613106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987458|NCT00613106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987459|NCT00881816|Paclitaxel|paclitaxel|mesh-list
92987460|NCT00881816|Capecitabine|capecitabine|mesh-list
92987461|NCT00881816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92987462|NCT00881816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987463|NCT00881816|Tubulin Modulators|tubulin modulators|mesh-ancestor
92632863|NCT00177086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92987464|NCT00881816|Antimitotic Agents|antimitotic agents|mesh-ancestor
92987465|NCT00881816|Mitosis Modulators|mitosis modulators|mesh-ancestor
92987466|NCT00881816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987467|NCT00881816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92987468|NCT00881816|Antimetabolites|antimetabolites|mesh-ancestor
92987469|NCT03712904|Aflibercept|aflibercept|mesh-list
92987470|NCT03712904|Endothelial Growth Factors|endothelial growth factors|mesh-list
92987471|NCT03712904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987472|NCT03712904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987473|NCT03712904|Growth Substances|growth substances|mesh-ancestor
92987474|NCT03712904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987475|NCT03712904|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987476|NCT03712904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987477|NCT00875966|Azithromycin|azithromycin|mesh-list
92987478|NCT00875966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987479|NCT00875966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987480|NCT00141037|Mycophenolic Acid|mycophenolic acid|mesh-list
92987481|NCT00141037|Trimethoprim|trimethoprim|mesh-list
92987482|NCT00141037|Sulfamethoxazole|sulfamethoxazole|mesh-list
92987483|NCT00141037|Valganciclovir|valganciclovir|mesh-list
92987484|NCT00141037|Ganciclovir|ganciclovir|mesh-list
92987485|NCT00141037|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92987488|NCT00141037|Daclizumab|daclizumab|mesh-list
92987489|NCT00141037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987490|NCT00141037|Glucocorticoids|glucocorticoids|mesh-ancestor
92987491|NCT00141037|Hormones|hormones|mesh-ancestor
92987492|NCT00141037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987493|NCT00141037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987494|NCT00141037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92987495|NCT00141037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987496|NCT00141037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987497|NCT00141037|Immunologic Factors|immunologic factors|mesh-ancestor
92987498|NCT00141037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92987499|NCT00141037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987500|NCT00141037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987501|NCT00141037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92987502|NCT00141037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92987503|NCT00141037|Antitubercular Agents|antitubercular agents|mesh-ancestor
92987504|NCT00141037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987505|NCT00141037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987506|NCT00141037|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92987507|NCT00141037|Antimalarials|antimalarials|mesh-ancestor
92987508|NCT00141037|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92987509|NCT00141037|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92987510|NCT00141037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92987511|NCT00141037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92987512|NCT00141037|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92987513|NCT00141037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92987514|NCT00141037|Antiviral Agents|antiviral agents|mesh-ancestor
92987515|NCT00141037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92987516|NCT01582555|Acetylcysteine|acetylcysteine|mesh-list
92987517|NCT01582555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92987518|NCT01582555|Antidotes|antidotes|mesh-ancestor
92987519|NCT01582555|Protective Agents|protective agents|mesh-ancestor
92987520|NCT01582555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987521|NCT01582555|Antioxidants|antioxidants|mesh-ancestor
92987522|NCT01582555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987523|NCT01582555|Antiviral Agents|antiviral agents|mesh-ancestor
92987524|NCT01582555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987525|NCT01582555|Expectorants|expectorants|mesh-ancestor
92987526|NCT01582555|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987527|NCT01582555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92987528|NCT00923390|Aldesleukin|aldesleukin|mesh-list
92987529|NCT00923390|Cyclophosphamide|cyclophosphamide|mesh-list
92987530|NCT00923390|Fludarabine|fludarabine|mesh-list
92987531|NCT00923390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987532|NCT00923390|Immunologic Factors|immunologic factors|mesh-ancestor
92987533|NCT00923390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987534|NCT00923390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987535|NCT00923390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92987536|NCT00923390|Alkylating Agents|alkylating agents|mesh-ancestor
92987537|NCT00923390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987538|NCT00923390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987539|NCT00923390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92987541|NCT00923390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92987542|NCT00923390|Antiviral Agents|antiviral agents|mesh-ancestor
92987543|NCT00923390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987544|NCT00885794|Ranibizumab|ranibizumab|mesh-list
92987545|NCT00885794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987546|NCT00885794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987547|NCT00885794|Growth Substances|growth substances|mesh-ancestor
92987548|NCT00885794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987549|NCT00885794|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987550|NCT00885794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987551|NCT00888602|Psyllium|psyllium|mesh-list
92987552|NCT00888602|Calcium polycarbophil|calcium polycarbophil|mesh-list
92987553|NCT00888602|Cathartics|cathartics|mesh-ancestor
92987554|NCT00888602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987555|NCT00888602|Antidiarrheals|antidiarrheals|mesh-ancestor
92987556|NCT00885872|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92332942|NCT00002881|Leuprolide|leuprolide|mesh-list
92987557|NCT00885872|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92987558|NCT00885872|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92987559|NCT00885872|Antimetabolites|antimetabolites|mesh-ancestor
92987560|NCT00885872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987561|NCT00885872|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92987562|NCT00885872|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92987563|NCT00885872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987564|NCT00888758|Sirolimus|sirolimus|mesh-list
92987565|NCT00888758|Umirolimus|umirolimus|mesh-list
92987566|NCT00888758|Everolimus|everolimus|mesh-list
92987567|NCT00888758|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92987568|NCT00888758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92987569|NCT00888758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987570|NCT00888758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987571|NCT00888758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987572|NCT00888758|Immunologic Factors|immunologic factors|mesh-ancestor
92987573|NCT00888758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987574|NCT00888758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987575|NCT00888758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987576|NCT00888758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987577|NCT00888758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987578|NCT00888758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92987579|NCT00888758|Antifungal Agents|antifungal agents|mesh-ancestor
92987580|NCT00888836|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92987581|NCT00888836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987582|NCT04038320|Sofosbuvir|sofosbuvir|mesh-list
92987583|NCT04038320|Ledipasvir|ledipasvir|mesh-list
92987584|NCT04038320|Antiviral Agents|antiviral agents|mesh-ancestor
92987585|NCT04038320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987586|NCT00563706|Risperidone|risperidone|mesh-list
92987587|NCT00563706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92987588|NCT00563706|Serotonin Agents|serotonin agents|mesh-ancestor
92987589|NCT00563706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987590|NCT00563706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987591|NCT00563706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987592|NCT00563706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92987593|NCT00563706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92987594|NCT00563706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987595|NCT00563706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92987596|NCT00563706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92987597|NCT00563706|Dopamine Agents|dopamine agents|mesh-ancestor
92987598|NCT02543606|Esomeprazole|esomeprazole|mesh-list
92987599|NCT02543606|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92987600|NCT02543606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987601|NCT02543606|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92987602|NCT02543606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987603|NCT02543606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987604|NCT00939588|Valsartan|valsartan|mesh-list
92987605|NCT00939588|Telmisartan|telmisartan|mesh-list
92987606|NCT00939588|Ramipril|ramipril|mesh-list
92987607|NCT00939588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92987608|NCT00939588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92987609|NCT00939588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92987610|NCT00939588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633015|NCT00200499|Nebivolol|nebivolol|mesh-list
92987611|NCT00939588|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92987612|NCT00939588|Protease Inhibitors|protease inhibitors|mesh-ancestor
92987613|NCT00939588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987614|NCT00889148|Gabapentin|gabapentin|mesh-list
92987615|NCT00889148|Analgesics|analgesics|mesh-ancestor
92987616|NCT00889148|Sensory System Agents|sensory system agents|mesh-ancestor
92167621|NCT02455687|Glucocorticoids|glucocorticoids|mesh-ancestor
92987617|NCT00889148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987618|NCT00889148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987619|NCT00889148|Anticonvulsants|anticonvulsants|mesh-ancestor
92987620|NCT00889148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92987621|NCT00889148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92987622|NCT00889148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987623|NCT00889148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92987624|NCT00889148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92987625|NCT00889148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92987626|NCT00889148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987627|NCT00889148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987628|NCT00889148|Antimanic Agents|antimanic agents|mesh-ancestor
92987629|NCT00936156|Carboplatin|carboplatin|mesh-list
92987630|NCT00936156|Etoposide|etoposide|mesh-list
92987632|NCT00936156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987633|NCT00936156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92987634|NCT00936156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92987635|NCT00936156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92987636|NCT00936156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987637|NCT00936156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987638|NCT00936156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92987639|NCT00936156|Alkylating Agents|alkylating agents|mesh-ancestor
92987640|NCT00936156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92987641|NCT00936156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987642|NCT00936156|Immunologic Factors|immunologic factors|mesh-ancestor
92987643|NCT00936156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987644|NCT00129961|Cyclosporine|cyclosporine|mesh-list
92987645|NCT00129961|Sirolimus|sirolimus|mesh-list
92987646|NCT00129961|Tacrolimus|tacrolimus|mesh-list
92987647|NCT00129961|Cyclosporins|cyclosporins|mesh-list
92987648|NCT00129961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92987649|NCT00129961|Immunologic Factors|immunologic factors|mesh-ancestor
92987650|NCT00129961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987651|NCT00129961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92987652|NCT00129961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987653|NCT00129961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987654|NCT00129961|Antifungal Agents|antifungal agents|mesh-ancestor
92987655|NCT00129961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987656|NCT00129961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92987657|NCT00129961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987658|NCT00129961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987659|NCT00129961|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92987660|NCT00129961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987661|NCT00528567|Bevacizumab|bevacizumab|mesh-list
92987662|NCT00528567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987663|NCT00528567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987664|NCT00528567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987665|NCT00528567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987666|NCT00528567|Growth Substances|growth substances|mesh-ancestor
92987667|NCT00528567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987668|NCT00528567|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987669|NCT00936234|Vildagliptin|vildagliptin|mesh-list
92987670|NCT00936234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92987671|NCT00936234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987672|NCT00936234|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92987673|NCT00936234|Protease Inhibitors|protease inhibitors|mesh-ancestor
92987674|NCT00936234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987675|NCT00936234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987676|NCT00886028|Doxorubicin|doxorubicin|mesh-list
92987677|NCT00886028|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92987678|NCT00886028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987679|NCT00886028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92987680|NCT00886028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92987681|NCT00886028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92987682|NCT00886028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987683|NCT00886028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987684|NCT00936546|Rituximab|rituximab|mesh-list
92987685|NCT00936546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987686|NCT00936546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987687|NCT00936546|Immunologic Factors|immunologic factors|mesh-ancestor
92987688|NCT00936546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987689|NCT00936546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987690|NCT00936624|Montelukast|montelukast|mesh-list
92987691|NCT00936624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92987692|NCT00936624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987693|NCT00936624|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92987694|NCT00936624|Hormone Antagonists|hormone antagonists|mesh-ancestor
92987695|NCT00936624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987696|NCT00936624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987697|NCT00936624|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92987698|NCT00936624|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92987699|NCT00936624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987700|NCT00138151|Interferons|interferons|mesh-list
92987701|NCT00138151|Interferon-alpha|interferon-alpha|mesh-list
92987702|NCT00138151|Interferon alpha-2|interferon alpha-2|mesh-list
92987703|NCT00138151|Paclitaxel|paclitaxel|mesh-list
92987704|NCT00138151|Isotretinoin|isotretinoin|mesh-list
92987705|NCT00138151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92987706|NCT00138151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987707|NCT00138151|Tubulin Modulators|tubulin modulators|mesh-ancestor
92987708|NCT00138151|Antimitotic Agents|antimitotic agents|mesh-ancestor
92987709|NCT00138151|Mitosis Modulators|mitosis modulators|mesh-ancestor
92987710|NCT00138151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987711|NCT00138151|Antiviral Agents|antiviral agents|mesh-ancestor
92987712|NCT00138151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987713|NCT00138151|Immunologic Factors|immunologic factors|mesh-ancestor
92987714|NCT00138151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987715|NCT00138151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92987716|NCT02543060|Fluorides|fluorides|mesh-list
92987717|NCT02543060|Tin Fluorides|tin fluorides|mesh-list
92987718|NCT02543060|Cariostatic Agents|cariostatic agents|mesh-ancestor
92987719|NCT02543060|Protective Agents|protective agents|mesh-ancestor
92987720|NCT02543060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987721|NCT00889616|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92987722|NCT00889616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92987723|NCT00889616|Immunologic Factors|immunologic factors|mesh-ancestor
92987724|NCT00889616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987725|NCT00889616|Antacids|antacids|mesh-ancestor
92987726|NCT00889616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987727|NCT00889616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987728|NCT02581631|Nivolumab|nivolumab|mesh-list
92987729|NCT02581631|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92987730|NCT02581631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987731|NCT02581631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987732|NCT02581631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92987733|NCT02581631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987734|NCT02581631|Immunotoxins|immunotoxins|mesh-ancestor
92987735|NCT02581631|Immunoconjugates|immunoconjugates|mesh-ancestor
92987736|NCT02581631|Immunologic Factors|immunologic factors|mesh-ancestor
92987737|NCT02581631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987738|NCT00884546|Dexamethasone|dexamethasone|mesh-list
92987739|NCT00884546|Lenalidomide|lenalidomide|mesh-list
92987740|NCT00884546|Bortezomib|bortezomib|mesh-list
92987741|NCT00884546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987742|NCT00884546|Antiemetics|antiemetics|mesh-ancestor
92987743|NCT00884546|Autonomic Agents|autonomic agents|mesh-ancestor
92987744|NCT00884546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987745|NCT00884546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987746|NCT00884546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987747|NCT00884546|Glucocorticoids|glucocorticoids|mesh-ancestor
92987748|NCT00884546|Hormones|hormones|mesh-ancestor
92987749|NCT00884546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987750|NCT00884546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92987751|NCT00884546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987752|NCT00884546|Immunologic Factors|immunologic factors|mesh-ancestor
92987753|NCT00884546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987754|NCT00884546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987755|NCT00884546|Growth Substances|growth substances|mesh-ancestor
92987756|NCT00884546|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987757|NCT00886106|Midazolam|midazolam|mesh-list
92987758|NCT00886106|Remifentanil|remifentanil|mesh-list
92987759|NCT00886106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92987760|NCT00886106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92987761|NCT00886106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987762|NCT00886106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987763|NCT00886106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92987764|NCT00886106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92987765|NCT00886106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92987766|NCT00886106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92987767|NCT00886106|Anesthetics, General|anesthetics, general|mesh-ancestor
92987768|NCT00886106|Anesthetics|anesthetics|mesh-ancestor
92987769|NCT00886106|GABA Modulators|gaba modulators|mesh-ancestor
92987770|NCT00886106|GABA Agents|gaba agents|mesh-ancestor
92987771|NCT00886106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987772|NCT00886106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987773|NCT00886106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92987774|NCT00886106|Narcotics|narcotics|mesh-ancestor
92987775|NCT00886106|Analgesics|analgesics|mesh-ancestor
92987776|NCT00886106|Sensory System Agents|sensory system agents|mesh-ancestor
92987777|NCT00886106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987778|NCT00889694|Sulfasalazine|sulfasalazine|mesh-list
92987779|NCT00889694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987780|NCT00889694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92987781|NCT00889694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92987782|NCT00889694|Analgesics|analgesics|mesh-ancestor
92987783|NCT00889694|Sensory System Agents|sensory system agents|mesh-ancestor
92987784|NCT00889694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987785|NCT00889694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987786|NCT00889694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987787|NCT00889694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987788|NCT00889694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987789|NCT00529035|Interleukin-2|interleukin-2|mesh-list
92987790|NCT00529035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987791|NCT00529035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92987792|NCT00529035|Analgesics|analgesics|mesh-ancestor
92987793|NCT00529035|Sensory System Agents|sensory system agents|mesh-ancestor
92987794|NCT00529035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987795|NCT00529035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987796|NCT04421664|Hydroxychloroquine|hydroxychloroquine|mesh-list
92987797|NCT04421664|Antimalarials|antimalarials|mesh-ancestor
92987798|NCT04421664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92987799|NCT04421664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92987800|NCT04421664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987801|NCT04421664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987802|NCT04421664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987803|NCT04421664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987804|NCT02578043|Clindamycin|clindamycin|mesh-list
92987805|NCT02578043|Clindamycin palmitate|clindamycin palmitate|mesh-list
92987806|NCT02578043|Clindamycin phosphate|clindamycin phosphate|mesh-list
92987807|NCT02578043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92987808|NCT02578043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987809|NCT02578043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987810|NCT02578043|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92987811|NCT02578043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987812|NCT02578043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987813|NCT02578043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92987814|NCT00889850|Esomeprazole|esomeprazole|mesh-list
92987815|NCT00889850|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92987816|NCT00889850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987817|NCT00889850|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92987818|NCT00889850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987819|NCT00889850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987821|NCT04074317|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92987822|NCT04074317|Pramlintide|pramlintide|mesh-list
92987823|NCT04074317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92987824|NCT04074317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987825|NCT00941148|Insulin|insulin|mesh-list
92987826|NCT00941148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92987827|NCT00941148|Metformin|metformin|mesh-list
92987828|NCT00941148|Insulin Detemir|insulin detemir|mesh-list
92987829|NCT00941148|Insulin, Isophane|insulin, isophane|mesh-list
92987830|NCT00941148|Isophane Insulin, Human|isophane insulin, human|mesh-list
92987831|NCT00941148|Isophane insulin, beef|isophane insulin, beef|mesh-list
92987832|NCT00941148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92987833|NCT00941148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987834|NCT02541500|Minocycline|minocycline|mesh-list
92987835|NCT02541500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92987836|NCT02541500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987837|NCT04073849|Epoetin Alfa|epoetin alfa|mesh-list
92987838|NCT04073849|Hematinics|hematinics|mesh-ancestor
92987839|NCT03263429|Irinotecan|irinotecan|mesh-list
92987840|NCT03263429|Panitumumab|panitumumab|mesh-list
92987841|NCT03263429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92987842|NCT03263429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92987843|NCT03263429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987844|NCT03263429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987845|NCT03263429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987846|NCT03263429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987848|NCT00609674|Xhance|xhance|mesh-list
92987849|NCT00609674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987850|NCT00609674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92987851|NCT00609674|Autonomic Agents|autonomic agents|mesh-ancestor
92987852|NCT00609674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987853|NCT00609674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987854|NCT00609674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92987855|NCT00609674|Respiratory System Agents|respiratory system agents|mesh-ancestor
92987856|NCT00609674|Dermatologic Agents|dermatologic agents|mesh-ancestor
92987857|NCT00609674|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92987858|NCT00941382|Metformin|metformin|mesh-list
92987859|NCT00941382|Sibutramine|sibutramine|mesh-list
92987860|NCT00941382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92987861|NCT00941382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987862|NCT00941382|Antidepressive Agents|antidepressive agents|mesh-ancestor
92987863|NCT00941382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92987864|NCT00941382|Appetite Depressants|appetite depressants|mesh-ancestor
92987865|NCT00941382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92987867|NCT03253679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987868|NCT03253679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987869|NCT00137839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92987870|NCT00137839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987871|NCT00137839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92987872|NCT00137839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987873|NCT00137839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987874|NCT00941460|Temozolomide|temozolomide|mesh-list
92987875|NCT00941460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92987876|NCT00941460|Alkylating Agents|alkylating agents|mesh-ancestor
92987877|NCT00941460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987878|NCT00941460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987879|NCT00890318|Ketoconazole|ketoconazole|mesh-list
92987880|NCT00890318|Antifungal Agents|antifungal agents|mesh-ancestor
92987881|NCT00890318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987882|NCT00890318|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92987883|NCT00890318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92987884|NCT00890318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987885|NCT00890318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987886|NCT00890318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92987887|NCT00890318|Hormone Antagonists|hormone antagonists|mesh-ancestor
92987888|NCT00890318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987889|NCT00890318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987890|NCT00890318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92987891|NCT00563316|Irinotecan|irinotecan|mesh-list
92987892|NCT00563316|Panitumumab|panitumumab|mesh-list
92987893|NCT00563316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92987894|NCT00563316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92987895|NCT00563316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987896|NCT00563316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987897|NCT00563316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987898|NCT00563316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987899|NCT04037774|Dexmedetomidine|dexmedetomidine|mesh-list
92987900|NCT04037774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92987901|NCT04037774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92987902|NCT04037774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987903|NCT04037774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92987904|NCT04037774|Analgesics|analgesics|mesh-ancestor
92987905|NCT04037774|Sensory System Agents|sensory system agents|mesh-ancestor
92987906|NCT04037774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987907|NCT04037774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92987908|NCT04037774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92987909|NCT04037774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92987910|NCT04037774|Adrenergic Agents|adrenergic agents|mesh-ancestor
92987911|NCT04037774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987912|NCT04037774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987913|NCT02542748|Norepinephrine|norepinephrine|mesh-list
92987914|NCT02542748|Ephedrine|ephedrine|mesh-list
92987915|NCT02542748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92987916|NCT02542748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92987917|NCT02542748|Adrenergic Agents|adrenergic agents|mesh-ancestor
92987918|NCT02542748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92987919|NCT02542748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987920|NCT02542748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987921|NCT02542748|Sympathomimetics|sympathomimetics|mesh-ancestor
92987922|NCT02542748|Autonomic Agents|autonomic agents|mesh-ancestor
92987923|NCT02542748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987924|NCT02542748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92987925|NCT02542748|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92987926|NCT00941616|Factor VIII|factor viii|mesh-list
92987927|NCT00941616|Coagulants|coagulants|mesh-ancestor
92987928|NCT02542592|Methylprednisolone|methylprednisolone|mesh-list
92987929|NCT02542592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92987930|NCT02542592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92987931|NCT02542592|Prednisolone|prednisolone|mesh-list
92987932|NCT02542592|Prednisolone acetate|prednisolone acetate|mesh-list
92987933|NCT02542592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92987934|NCT02542592|Prednisolone phosphate|prednisolone phosphate|mesh-list
92987935|NCT02542592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92987936|NCT02542592|Antiemetics|antiemetics|mesh-ancestor
92987937|NCT02542592|Autonomic Agents|autonomic agents|mesh-ancestor
92987938|NCT02542592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92987939|NCT02542592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987940|NCT02542592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92987941|NCT02542592|Glucocorticoids|glucocorticoids|mesh-ancestor
92987942|NCT02542592|Hormones|hormones|mesh-ancestor
92987943|NCT02542592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987944|NCT02542592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92987945|NCT02542592|Protective Agents|protective agents|mesh-ancestor
92987946|NCT02542592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92987947|NCT02542592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987948|NCT03178487|Upadacitinib|upadacitinib|mesh-list
92987949|NCT03178487|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92987950|NCT03178487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92987951|NCT03178487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987952|NCT03178487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987953|NCT03178487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92987954|NCT04430036|Cisplatin|cisplatin|mesh-list
92987955|NCT04430036|Gemcitabine|gemcitabine|mesh-list
92987956|NCT04430036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987957|NCT04430036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92987958|NCT04430036|Antimetabolites|antimetabolites|mesh-ancestor
92987959|NCT04430036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987960|NCT00528957|Tenofovir|tenofovir|mesh-list
92987961|NCT00528957|Zidovudine|zidovudine|mesh-list
92987962|NCT00528957|Stavudine|stavudine|mesh-list
92987963|NCT00528957|Antiviral Agents|antiviral agents|mesh-ancestor
92987964|NCT00528957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987965|NCT00528957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92987966|NCT00528957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92987967|NCT00528957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987968|NCT00528957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987969|NCT00528957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92987970|NCT00528957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92987971|NCT00528957|Antimetabolites|antimetabolites|mesh-ancestor
92987972|NCT00890630|Oxytocin|oxytocin|mesh-list
92987973|NCT00890630|Oxytocics|oxytocics|mesh-ancestor
92987974|NCT00890630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92987975|NCT00890630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987976|NCT00890708|Voriconazole|voriconazole|mesh-list
92987977|NCT00890708|Antifungal Agents|antifungal agents|mesh-ancestor
92987978|NCT00890708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92987979|NCT00890708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92987980|NCT00890708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92987981|NCT00890708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92987982|NCT00890708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92987983|NCT00890708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92987984|NCT00890708|Hormone Antagonists|hormone antagonists|mesh-ancestor
92987985|NCT00890708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92987986|NCT00890708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987987|NCT00890708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92987988|NCT00890786|Bevacizumab|bevacizumab|mesh-list
92987989|NCT00890786|Irinotecan|irinotecan|mesh-list
92987990|NCT00890786|Temozolomide|temozolomide|mesh-list
92987991|NCT00890786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92987992|NCT00890786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92987993|NCT00890786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92987994|NCT00890786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92987995|NCT00890786|Growth Substances|growth substances|mesh-ancestor
92987996|NCT00890786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92987997|NCT00890786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92987998|NCT00890786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92987999|NCT00890786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92988000|NCT00890786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988001|NCT00890786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988002|NCT00890786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988003|NCT00890786|Alkylating Agents|alkylating agents|mesh-ancestor
92988004|NCT00560508|Pramipexole|pramipexole|mesh-list
92988005|NCT00560508|Antioxidants|antioxidants|mesh-ancestor
92988006|NCT00560508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988007|NCT00560508|Protective Agents|protective agents|mesh-ancestor
92988008|NCT00560508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988009|NCT00560508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92988010|NCT00560508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92988011|NCT00560508|Dopamine Agonists|dopamine agonists|mesh-ancestor
92988012|NCT00560508|Dopamine Agents|dopamine agents|mesh-ancestor
92988013|NCT00560508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988014|NCT00890942|Naloxone|naloxone|mesh-list
92988015|NCT00890942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92988016|NCT00890942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988017|NCT00890942|Sensory System Agents|sensory system agents|mesh-ancestor
92988018|NCT00890942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988019|NCT00942006|Doxycycline|doxycycline|mesh-list
92988020|NCT00942006|Ceftriaxone|ceftriaxone|mesh-list
92988021|NCT00942006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92988022|NCT00942006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988023|NCT00942006|Antimalarials|antimalarials|mesh-ancestor
92988024|NCT00942006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92988025|NCT00942006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92988026|NCT02542124|Interleukin-12|interleukin-12|mesh-list
92988027|NCT02542124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92988028|NCT02542124|Immunologic Factors|immunologic factors|mesh-ancestor
92988029|NCT02542124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988030|NCT02542124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92988031|NCT02542124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92988032|NCT02542124|Growth Substances|growth substances|mesh-ancestor
92988033|NCT02542124|Growth Inhibitors|growth inhibitors|mesh-ancestor
92988034|NCT02542124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988035|NCT00942318|Insulin|insulin|mesh-list
92988036|NCT00942318|Metformin|metformin|mesh-list
92988037|NCT00942318|Insulin Aspart|insulin aspart|mesh-list
92988038|NCT00942318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92988039|NCT00942318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988040|NCT04819269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92988041|NCT04819269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92988042|NCT05280054|Probenecid|probenecid|mesh-list
92988043|NCT05280054|Uricosuric Agents|uricosuric agents|mesh-ancestor
92988044|NCT05280054|Gout Suppressants|gout suppressants|mesh-ancestor
92988045|NCT05280054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988046|NCT03999099|Suvorexant|suvorexant|mesh-list
92988047|NCT03999099|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92988048|NCT03999099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92988049|NCT03999099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988050|NCT03999099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988051|NCT03999099|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92988052|NCT03999099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988053|NCT03999099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988054|NCT01007799|Vitamin D|vitamin d|mesh-list
92988055|NCT01007799|Ergocalciferols|ergocalciferols|mesh-list
92988056|NCT01007799|Cholecalciferol|cholecalciferol|mesh-list
92988057|NCT01007799|Vitamins|vitamins|mesh-list
92988058|NCT01007799|Micronutrients|micronutrients|mesh-ancestor
92988059|NCT01007799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988060|NCT01007799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92988061|NCT01007799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92988062|NCT00609518|Folic Acid|folic acid|mesh-list
92988063|NCT00609518|Vitamin B 12|vitamin b 12|mesh-list
92633455|NCT04637152|Valsartan|valsartan|mesh-list
92988064|NCT00609518|Vitamin B Complex|vitamin b complex|mesh-list
92988065|NCT00609518|Dexamethasone|dexamethasone|mesh-list
92988066|NCT00609518|Dexamethasone acetate|dexamethasone acetate|mesh-list
92988067|NCT00609518|Pemetrexed|pemetrexed|mesh-list
92988068|NCT00609518|BB 1101|bb 1101|mesh-list
92988069|NCT00609518|Vitamins|vitamins|mesh-ancestor
92988070|NCT00609518|Micronutrients|micronutrients|mesh-ancestor
92988071|NCT00609518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988072|NCT00609518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988073|NCT00609518|Antiemetics|antiemetics|mesh-ancestor
92988074|NCT00609518|Autonomic Agents|autonomic agents|mesh-ancestor
92988075|NCT00609518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988076|NCT00609518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92988077|NCT00609518|Glucocorticoids|glucocorticoids|mesh-ancestor
92988078|NCT00609518|Hormones|hormones|mesh-ancestor
92988079|NCT00609518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988080|NCT00609518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988081|NCT00609518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988082|NCT00609518|Protease Inhibitors|protease inhibitors|mesh-ancestor
92988083|NCT00609518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988084|NCT00609518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988085|NCT00609518|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92988086|NCT00609518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92988087|NCT00609518|Hematinics|hematinics|mesh-ancestor
92988088|NCT01008111|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92988089|NCT01008111|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92988090|NCT01008111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988091|NCT00886496|Lectins|lectins|mesh-list
92988092|NCT00886496|Agglutinins|agglutinins|mesh-ancestor
92988093|NCT00886496|Immunologic Factors|immunologic factors|mesh-ancestor
92988094|NCT00886496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988095|NCT00886496|Coagulants|coagulants|mesh-ancestor
92988096|NCT00884858|Maraviroc|maraviroc|mesh-list
92988097|NCT00884858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92988098|NCT00884858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92988099|NCT00884858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988100|NCT00884858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92988101|NCT00884858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92988102|NCT00884858|Antiviral Agents|antiviral agents|mesh-ancestor
92988103|NCT00884858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988104|NCT00884858|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92988105|NCT00891332|Leucovorin|leucovorin|mesh-list
92988106|NCT00891332|Antidotes|antidotes|mesh-ancestor
92988107|NCT00891332|Protective Agents|protective agents|mesh-ancestor
92988108|NCT00891332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988109|NCT00891332|Vitamin B Complex|vitamin b complex|mesh-ancestor
92988110|NCT00891332|Vitamins|vitamins|mesh-ancestor
92988111|NCT00891332|Micronutrients|micronutrients|mesh-ancestor
92988112|NCT00609362|Rosiglitazone|rosiglitazone|mesh-list
92988113|NCT00609362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92988114|NCT00609362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988115|NCT04038008|Fluconazole|fluconazole|mesh-list
92988116|NCT04038008|Antifungal Agents|antifungal agents|mesh-ancestor
92988117|NCT04038008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988118|NCT04038008|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92988119|NCT04038008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92988120|NCT04038008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167649|NCT02358967|Protective Agents|protective agents|mesh-ancestor
92988121|NCT04038008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988122|NCT04038008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92988123|NCT04038008|Hormone Antagonists|hormone antagonists|mesh-ancestor
92988124|NCT04038008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988125|NCT04038008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988126|NCT04038008|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92988127|NCT04038008|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92988128|NCT00886574|Aspirin|aspirin|mesh-list
92988129|NCT00886574|Cilostazol|cilostazol|mesh-list
92988130|NCT00886574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92988131|NCT00886574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988132|NCT00886574|Analgesics|analgesics|mesh-ancestor
92988133|NCT00886574|Sensory System Agents|sensory system agents|mesh-ancestor
92988134|NCT00886574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988135|NCT00886574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988136|NCT00886574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988137|NCT00886574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988138|NCT00886574|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92988139|NCT00886574|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92988140|NCT00886574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988141|NCT00886574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92988142|NCT00886574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92988143|NCT00886574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988144|NCT00886574|Antipyretics|antipyretics|mesh-ancestor
92633536|NCT00179114|GABA Agents|gaba agents|mesh-ancestor
92988146|NCT00886574|Autonomic Agents|autonomic agents|mesh-ancestor
92988147|NCT00886574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92988148|NCT00886574|Respiratory System Agents|respiratory system agents|mesh-ancestor
92988149|NCT00886574|Vasodilator Agents|vasodilator agents|mesh-ancestor
92988150|NCT00886574|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92988151|NCT00886574|Protective Agents|protective agents|mesh-ancestor
92988152|NCT00886574|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92988153|NCT00886574|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92988154|NCT00611858|Fluorouracil|fluorouracil|mesh-list
92988155|NCT00611858|Cetuximab|cetuximab|mesh-list
92988156|NCT00611858|Antimetabolites|antimetabolites|mesh-ancestor
92988157|NCT00611858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988158|NCT00611858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92988159|NCT00611858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988160|NCT00611858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988161|NCT00611858|Immunologic Factors|immunologic factors|mesh-ancestor
92988162|NCT00611858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988163|NCT00611858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92988164|NCT00137449|Sunitinib|sunitinib|mesh-list
92988165|NCT00137449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988166|NCT00137449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92988167|NCT00137449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92988168|NCT00137449|Growth Substances|growth substances|mesh-ancestor
92988169|NCT00137449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988170|NCT00137449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92988171|NCT00137449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988172|NCT00137449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988173|NCT00137449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988174|NCT00886886|Reboxetine|reboxetine|mesh-list
92988175|NCT00886886|Antidepressive Agents|antidepressive agents|mesh-ancestor
92988176|NCT00886886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92988177|NCT00886886|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92988178|NCT00886886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92988179|NCT00886886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92988180|NCT00886886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988181|NCT00886886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92988182|NCT00886886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988183|NCT00886886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988184|NCT00887042|Fludarabine|fludarabine|mesh-list
92988185|NCT00887042|Busulfan|busulfan|mesh-list
92988186|NCT00887042|Thymoglobulin|thymoglobulin|mesh-list
92988187|NCT00887042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988188|NCT00887042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988189|NCT00887042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988190|NCT00887042|Immunologic Factors|immunologic factors|mesh-ancestor
92988191|NCT00887042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988192|NCT00887042|Alkylating Agents|alkylating agents|mesh-ancestor
92988193|NCT00887042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988194|NCT00887042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92988195|NCT00892112|Plasma Substitutes|plasma substitutes|mesh-list
92988196|NCT00892112|Immunoglobulins|immunoglobulins|mesh-list
92988197|NCT00892112|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92988198|NCT00892112|Antibodies|antibodies|mesh-list
92988199|NCT00892112|gamma-Globulins|gamma-globulins|mesh-list
92988200|NCT00892112|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92988201|NCT00892112|Immunologic Factors|immunologic factors|mesh-ancestor
92988202|NCT00892112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988203|NCT00892112|Blood Substitutes|blood substitutes|mesh-ancestor
92988204|NCT00887120|Ritonavir|ritonavir|mesh-list
92988205|NCT00887120|Lopinavir|lopinavir|mesh-list
92988206|NCT00887120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92988207|NCT00887120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92988208|NCT00887120|Protease Inhibitors|protease inhibitors|mesh-ancestor
92988209|NCT00887120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988210|NCT00887120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988211|NCT00887120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92988212|NCT00887120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92988213|NCT00887120|Antiviral Agents|antiviral agents|mesh-ancestor
92988214|NCT00887120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988215|NCT00887120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92988216|NCT00887120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92988217|NCT00892190|Dasatinib|dasatinib|mesh-list
92988218|NCT00892190|Tretinoin|tretinoin|mesh-list
92988219|NCT00892190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988220|NCT00892190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988221|NCT00892190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988222|NCT00892190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988223|NCT00892190|Keratolytic Agents|keratolytic agents|mesh-ancestor
92988224|NCT00892190|Dermatologic Agents|dermatologic agents|mesh-ancestor
92988225|NCT00887276|Amoxicillin|amoxicillin|mesh-list
92988226|NCT00887276|Moxifloxacin|moxifloxacin|mesh-list
92988227|NCT00887276|Ampicillin|ampicillin|mesh-list
92988229|NCT00887276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988230|NCT00887276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92988231|NCT00887276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92988232|NCT00887276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988233|NCT00887276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988234|NCT00887276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988235|NCT00528879|Metformin|metformin|mesh-list
92988236|NCT00528879|Dapagliflozin|dapagliflozin|mesh-list
92988237|NCT00528879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92988238|NCT00528879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988239|NCT00528879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92988240|NCT00528879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988241|NCT00608894|Prednisone|prednisone|mesh-list
92988242|NCT00608894|Azathioprine|azathioprine|mesh-list
92988243|NCT00608894|Tacrolimus|tacrolimus|mesh-list
92988244|NCT00608894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988245|NCT00608894|Glucocorticoids|glucocorticoids|mesh-ancestor
92988246|NCT00608894|Hormones|hormones|mesh-ancestor
92988247|NCT00608894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988248|NCT00608894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988249|NCT00608894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988250|NCT00608894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988251|NCT00608894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988252|NCT00608894|Immunologic Factors|immunologic factors|mesh-ancestor
92988253|NCT00608894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92988254|NCT00608894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988255|NCT00608894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988256|NCT00608894|Antimetabolites|antimetabolites|mesh-ancestor
92988257|NCT00608894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92988258|NCT00608894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988259|NCT00892346|Thalidomide|thalidomide|mesh-list
92988260|NCT00892346|Melphalan|melphalan|mesh-list
92988261|NCT00892346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988262|NCT00892346|Alkylating Agents|alkylating agents|mesh-ancestor
92167657|NCT05586061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988263|NCT00892346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988264|NCT00892346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988265|NCT00892346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92988266|NCT00892346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988267|NCT00892346|Immunologic Factors|immunologic factors|mesh-ancestor
92988268|NCT00892346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988269|NCT00892346|Leprostatic Agents|leprostatic agents|mesh-ancestor
92988270|NCT00892346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92988271|NCT00892346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988272|NCT00892346|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92988273|NCT00892346|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92988274|NCT00892346|Growth Substances|growth substances|mesh-ancestor
92988275|NCT00892346|Growth Inhibitors|growth inhibitors|mesh-ancestor
92988276|NCT00892424|Sorafenib|sorafenib|mesh-list
92988277|NCT00892424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988278|NCT00892424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988279|NCT00892424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988280|NCT00892424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988281|NCT02541032|Minocycline|minocycline|mesh-list
92988282|NCT02541032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92988283|NCT02541032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988284|NCT00892502|Bismuth|bismuth|mesh-list
92988285|NCT00892502|Antacids|antacids|mesh-ancestor
92988286|NCT00892502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988287|NCT00892502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92988288|NCT00885404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92988289|NCT00885404|Plasma-lyte 148|plasma-lyte 148|mesh-list
92988290|NCT00885404|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92988291|NCT00191113|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92988292|NCT00191113|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92988293|NCT00191113|Medroxyprogesterone|medroxyprogesterone|mesh-list
92633677|NCT00179231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988294|NCT00191113|Estradiol|estradiol|mesh-list
92988296|NCT00191113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988297|NCT00191113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988298|NCT00191113|Estrogens|estrogens|mesh-ancestor
92988299|NCT00191113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92988300|NCT00191113|Contraceptive Agents|contraceptive agents|mesh-ancestor
92988301|NCT00191113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92988302|NCT00191113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92988303|NCT00191113|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92988304|NCT00191113|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92988305|NCT00191113|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92988306|NCT00191113|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92988307|NCT00191113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988308|NCT00191113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988309|NCT03965052|Travoprost|travoprost|mesh-list
92988310|NCT03965052|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92988311|NCT03965052|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92988312|NCT03965052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92988313|NCT00892658|Sorafenib|sorafenib|mesh-list
92988314|NCT00892658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988315|NCT00892658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988316|NCT00892658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988317|NCT00892658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988318|NCT00892736|Veliparib|veliparib|mesh-list
92988319|NCT00892736|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92988320|NCT00892736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988321|NCT00892736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988322|NCT00892736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988323|NCT03966235|Melatonin|melatonin|mesh-list
92988324|NCT03966235|Antioxidants|antioxidants|mesh-ancestor
92988325|NCT03966235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988326|NCT03966235|Protective Agents|protective agents|mesh-ancestor
92988327|NCT03966235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988328|NCT03966235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988329|NCT01077661|Nebivolol|nebivolol|mesh-list
92988330|NCT01077661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92988331|NCT01077661|Vasodilator Agents|vasodilator agents|mesh-ancestor
92988332|NCT01077661|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92988333|NCT01077661|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92988334|NCT01077661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92988335|NCT01077661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92988336|NCT01077661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988337|NCT01077661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988338|NCT01077661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988339|NCT00606320|Aripiprazole|aripiprazole|mesh-list
92988340|NCT00606320|Antidepressive Agents|antidepressive agents|mesh-ancestor
92988341|NCT00606320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92988342|NCT00606320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92988343|NCT00606320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92988344|NCT00606320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988345|NCT00606320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988346|NCT00606320|Dopamine Agonists|dopamine agonists|mesh-ancestor
92988347|NCT00606320|Dopamine Agents|dopamine agents|mesh-ancestor
92988348|NCT00606320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988349|NCT00606320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988350|NCT00606320|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92988351|NCT00606320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92988352|NCT00606320|Serotonin Agents|serotonin agents|mesh-ancestor
92988353|NCT00606320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92988354|NCT00606320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92988355|NCT00606320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92988356|NCT00606320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92988357|NCT03966079|Plasminogen|plasminogen|mesh-list
92988358|NCT03966079|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92988359|NCT03966079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92988360|NCT03966079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92988361|NCT03966079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988362|NCT02540486|Insulin Glargine|insulin glargine|mesh-list
92988363|NCT02540486|Insulin, Long-Acting|insulin, long-acting|mesh-list
92988364|NCT02540486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92988365|NCT02540486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988366|NCT03966859|Atorvastatin|atorvastatin|mesh-list
92633756|NCT04723238|Analgesics|analgesics|mesh-ancestor
92988367|NCT03966859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92988368|NCT03966859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92988369|NCT03966859|Antimetabolites|antimetabolites|mesh-ancestor
92988370|NCT03966859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988371|NCT03966859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92988372|NCT03966859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92988373|NCT03966859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988374|NCT00528411|Aspirin|aspirin|mesh-list
92988375|NCT00528411|Clopidogrel|clopidogrel|mesh-list
92988376|NCT00528411|Ticagrelor|ticagrelor|mesh-list
92988377|NCT00528411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92988378|NCT00528411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988379|NCT00528411|Analgesics|analgesics|mesh-ancestor
92988380|NCT00528411|Sensory System Agents|sensory system agents|mesh-ancestor
92988381|NCT00528411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988382|NCT00528411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988383|NCT00528411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988384|NCT00528411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988385|NCT00528411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92988386|NCT00528411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92988387|NCT00528411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988388|NCT00528411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92988389|NCT00528411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92988390|NCT00528411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988391|NCT00528411|Antipyretics|antipyretics|mesh-ancestor
92988392|NCT00528411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92988393|NCT00528411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92988394|NCT00528411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92988395|NCT00528411|Purinergic Agents|purinergic agents|mesh-ancestor
92988396|NCT00528411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988397|NCT00895544|Vaccines|vaccines|mesh-list
92988398|NCT00895544|Immunologic Factors|immunologic factors|mesh-ancestor
92988399|NCT00895544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988400|NCT00895778|Rocuronium|rocuronium|mesh-list
92988401|NCT00895778|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92988402|NCT00895778|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92988403|NCT00895778|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92988404|NCT00895778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988405|NCT00895778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988406|NCT00187135|Fentanyl|fentanyl|mesh-list
92988407|NCT00187135|Propofol|propofol|mesh-list
92988408|NCT00187135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92988409|NCT00187135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988410|NCT00187135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988411|NCT00187135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92988412|NCT00187135|Anesthetics, General|anesthetics, general|mesh-ancestor
92988413|NCT00187135|Anesthetics|anesthetics|mesh-ancestor
92988414|NCT00187135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92988415|NCT00187135|Narcotics|narcotics|mesh-ancestor
92988416|NCT00187135|Analgesics|analgesics|mesh-ancestor
92988417|NCT00187135|Sensory System Agents|sensory system agents|mesh-ancestor
92988418|NCT00187135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988419|NCT00187135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92988420|NCT00896402|Iodine|iodine|mesh-list
92988421|NCT00896402|Chlorhexidine|chlorhexidine|mesh-list
92988422|NCT00896402|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92988423|NCT00896402|Povidone-Iodine|povidone-iodine|mesh-list
92988424|NCT00896402|Povidone|povidone|mesh-list
92988425|NCT00896402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92988426|NCT00896402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988427|NCT00896402|Disinfectants|disinfectants|mesh-ancestor
92988428|NCT00896402|Dermatologic Agents|dermatologic agents|mesh-ancestor
92988429|NCT00896402|Trace Elements|trace elements|mesh-ancestor
92988430|NCT00896402|Micronutrients|micronutrients|mesh-ancestor
92988431|NCT00896402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988432|NCT00896402|Plasma Substitutes|plasma substitutes|mesh-ancestor
92988433|NCT00896402|Blood Substitutes|blood substitutes|mesh-ancestor
92988434|NCT00560352|Dexamethasone|dexamethasone|mesh-list
92988435|NCT00560352|Bortezomib|bortezomib|mesh-list
92988436|NCT00560352|Dasatinib|dasatinib|mesh-list
92988437|NCT00560352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988438|NCT00560352|Antiemetics|antiemetics|mesh-ancestor
92988439|NCT00560352|Autonomic Agents|autonomic agents|mesh-ancestor
92988440|NCT00560352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988441|NCT00560352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988442|NCT00560352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92988443|NCT00560352|Glucocorticoids|glucocorticoids|mesh-ancestor
92988444|NCT00560352|Hormones|hormones|mesh-ancestor
92988445|NCT00560352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988446|NCT00560352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988447|NCT00560352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988448|NCT00560352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92333857|NCT04329403|Adapalene|adapalene|mesh-list
92988449|NCT00560352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988450|NCT00560352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988452|NCT00892892|Rilmenidine|rilmenidine|mesh-list
92988453|NCT00892892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92988454|NCT00892892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92988455|NCT00892892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92988456|NCT00892892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988457|NCT00892892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92988458|NCT00892892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988459|NCT00892892|Vasodilator Agents|vasodilator agents|mesh-ancestor
92988460|NCT00892892|Sympatholytics|sympatholytics|mesh-ancestor
92988461|NCT00892892|Autonomic Agents|autonomic agents|mesh-ancestor
92988462|NCT00892892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988463|NCT00892892|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92988464|NCT00892892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92988465|NCT00892892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92988466|NCT00892892|Adrenergic Agents|adrenergic agents|mesh-ancestor
92988467|NCT00892892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988468|NCT00944814|Zinc|zinc|mesh-list
92988469|NCT00944814|Trace Elements|trace elements|mesh-ancestor
92988470|NCT00944814|Micronutrients|micronutrients|mesh-ancestor
92988471|NCT00944814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988472|NCT00527787|Naproxen|naproxen|mesh-list
92988473|NCT00527787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92988474|NCT00527787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988475|NCT00527787|Analgesics|analgesics|mesh-ancestor
92988476|NCT00527787|Sensory System Agents|sensory system agents|mesh-ancestor
92988477|NCT00527787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988478|NCT00527787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988479|NCT00527787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988480|NCT00527787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988481|NCT00527787|Gout Suppressants|gout suppressants|mesh-ancestor
92988482|NCT00527787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92988483|NCT00527787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988484|NCT00527787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988485|NCT00893048|Prednisone|prednisone|mesh-list
92988486|NCT00893048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988487|NCT00893048|Glucocorticoids|glucocorticoids|mesh-ancestor
92988488|NCT00893048|Hormones|hormones|mesh-ancestor
92988489|NCT00893048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988490|NCT00893048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988491|NCT00893048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988492|NCT00893048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988493|NCT00942864|Ranibizumab|ranibizumab|mesh-list
92988494|NCT00942864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92988495|NCT00942864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92988496|NCT00942864|Growth Substances|growth substances|mesh-ancestor
92988497|NCT00942864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988498|NCT00942864|Growth Inhibitors|growth inhibitors|mesh-ancestor
92988499|NCT00942864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988500|NCT04036448|Lenalidomide|lenalidomide|mesh-list
92988501|NCT04036448|Immunologic Factors|immunologic factors|mesh-ancestor
92988502|NCT04036448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988503|NCT04036448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92988504|NCT04036448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92988505|NCT04036448|Growth Substances|growth substances|mesh-ancestor
92988506|NCT04036448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92988507|NCT04036448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988508|NCT00896558|Midazolam|midazolam|mesh-list
92988509|NCT00896558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92988510|NCT00896558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92988511|NCT00896558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988512|NCT00896558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988513|NCT00896558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92988514|NCT00896558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92988515|NCT00896558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92988516|NCT00896558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92988517|NCT00896558|Anesthetics, General|anesthetics, general|mesh-ancestor
92988518|NCT00896558|Anesthetics|anesthetics|mesh-ancestor
92988519|NCT00896558|GABA Modulators|gaba modulators|mesh-ancestor
92988520|NCT00896558|GABA Agents|gaba agents|mesh-ancestor
92988521|NCT00896558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528212|NCT00035191|Galantamine|galantamine|mesh-list
92988522|NCT00896558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988523|NCT00943176|Modafinil|modafinil|mesh-list
92988524|NCT00943176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92988525|NCT00943176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988526|NCT00943176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92988527|NCT00943176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92988528|NCT00943176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92988529|NCT00943176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988530|NCT00129259|Iron|iron|mesh-list
92988531|NCT00129259|Trace Elements|trace elements|mesh-ancestor
92988532|NCT00129259|Micronutrients|micronutrients|mesh-ancestor
92988533|NCT00129259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988534|NCT00896714|Anesthetics|anesthetics|mesh-list
92988535|NCT00896714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988536|NCT00896714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988537|NCT00940524|Cytarabine|cytarabine|mesh-list
92988538|NCT00940524|Cyclophosphamide|cyclophosphamide|mesh-list
92988539|NCT00940524|Methotrexate|methotrexate|mesh-list
92988540|NCT00940524|Etoposide|etoposide|mesh-list
92988541|NCT00940524|Asparaginase|asparaginase|mesh-list
92988542|NCT00940524|Dasatinib|dasatinib|mesh-list
92988543|NCT00940524|Mitoxantrone|mitoxantrone|mesh-list
92988544|NCT00940524|Pegaspargase|pegaspargase|mesh-list
92988545|NCT00940524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988546|NCT00940524|Immunologic Factors|immunologic factors|mesh-ancestor
92988547|NCT00940524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988548|NCT00940524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988549|NCT00940524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988550|NCT00940524|Alkylating Agents|alkylating agents|mesh-ancestor
92988551|NCT00940524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988552|NCT00940524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988553|NCT00940524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92988554|NCT00940524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92988555|NCT00940524|Abortifacient Agents|abortifacient agents|mesh-ancestor
92988556|NCT00940524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92988557|NCT00940524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92988558|NCT00940524|Antimetabolites|antimetabolites|mesh-ancestor
92988559|NCT00940524|Dermatologic Agents|dermatologic agents|mesh-ancestor
92988560|NCT00940524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988561|NCT00940524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92988562|NCT00940524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92988563|NCT00940524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92988564|NCT00940524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92988565|NCT00940524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92988566|NCT00940524|Antiviral Agents|antiviral agents|mesh-ancestor
92988567|NCT00940524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988568|NCT00940524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988569|NCT00940524|Analgesics|analgesics|mesh-ancestor
92988570|NCT00940524|Sensory System Agents|sensory system agents|mesh-ancestor
92988571|NCT00940524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988572|NCT00186901|Vitamin D|vitamin d|mesh-list
92988573|NCT00186901|Calcium Carbonate|calcium carbonate|mesh-list
92988574|NCT00186901|Calcium|calcium|mesh-list
92988575|NCT00186901|Vitamins|vitamins|mesh-ancestor
92988576|NCT00186901|Micronutrients|micronutrients|mesh-ancestor
92988577|NCT00186901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988578|NCT00186901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92988579|NCT00186901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92988580|NCT00186901|Antacids|antacids|mesh-ancestor
92988581|NCT00186901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988582|NCT00186901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92988583|NCT00943410|Trastuzumab|trastuzumab|mesh-list
92988584|NCT00943410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92988585|NCT00943410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988586|NCT00896948|Antibodies|antibodies|mesh-list
92988587|NCT00896948|Immunologic Factors|immunologic factors|mesh-ancestor
92988588|NCT00896948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988589|NCT00186121|Anastrozole|anastrozole|mesh-list
92988590|NCT00186121|Goserelin|goserelin|mesh-list
92988591|NCT00186121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988592|NCT00186121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988593|NCT00186121|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92988594|NCT00186121|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92988595|NCT00186121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988596|NCT00186121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988597|NCT00186121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92988598|NCT00186121|Hormone Antagonists|hormone antagonists|mesh-ancestor
92988599|NCT00186121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988600|NCT00186121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988602|NCT00897026|Cyclophosphamide|cyclophosphamide|mesh-list
92988603|NCT00897026|Doxorubicin|doxorubicin|mesh-list
92988604|NCT00897026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92988605|NCT00897026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92988606|NCT00897026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988607|NCT00897026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92988608|NCT00897026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92988609|NCT00897026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92988610|NCT00897026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988611|NCT00897026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988612|NCT00897026|Immunologic Factors|immunologic factors|mesh-ancestor
92988613|NCT00897026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988614|NCT00897026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988615|NCT00897026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988616|NCT00897026|Alkylating Agents|alkylating agents|mesh-ancestor
92988617|NCT00897026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92988618|NCT00897026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92988619|NCT00897026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92988620|NCT00897026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92988621|NCT00897026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988622|NCT00186043|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92988623|NCT00186043|Antidepressive Agents|antidepressive agents|mesh-ancestor
92988624|NCT00186043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92988625|NCT00186043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92988626|NCT00186043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92988627|NCT00186043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988628|NCT00186043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988629|NCT01076491|Mannitol|mannitol|mesh-list
92988630|NCT01076491|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92988631|NCT01076491|Diuretics|diuretics|mesh-ancestor
92988632|NCT01076491|Natriuretic Agents|natriuretic agents|mesh-ancestor
92988633|NCT01076491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988634|NCT00127933|Capecitabine|capecitabine|mesh-list
92988635|NCT00127933|Docetaxel|docetaxel|mesh-list
92988636|NCT00127933|Trastuzumab|trastuzumab|mesh-list
92988637|NCT00127933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92988638|NCT00127933|Antimetabolites|antimetabolites|mesh-ancestor
92988639|NCT00127933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988640|NCT00127933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988641|NCT00127933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92988642|NCT00127933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92988643|NCT00127933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92988644|NCT00127933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92988645|NCT03875313|Talazoparib|talazoparib|mesh-list
92988646|NCT03875313|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92988647|NCT03875313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988648|NCT03875313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988649|NCT03875313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988650|NCT01008345|Ezetimibe|ezetimibe|mesh-list
92988651|NCT01008345|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92988652|NCT01008345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92988653|NCT01008345|Antimetabolites|antimetabolites|mesh-ancestor
92988654|NCT01008345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988655|NCT01008345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92988656|NCT05239533|Nivolumab|nivolumab|mesh-list
92988657|NCT05239533|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92988658|NCT05239533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92988659|NCT05239533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988660|NCT05239533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92988661|NCT05239533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988662|NCT05239533|Immunologic Factors|immunologic factors|mesh-ancestor
92988663|NCT05239533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988664|NCT04828083|Lidocaine|lidocaine|mesh-list
92988665|NCT04828083|Anesthetics, Local|anesthetics, local|mesh-ancestor
92988666|NCT04828083|Anesthetics|anesthetics|mesh-ancestor
92988667|NCT04828083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988668|NCT04828083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988669|NCT04828083|Sensory System Agents|sensory system agents|mesh-ancestor
92988670|NCT04828083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988671|NCT04828083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92988672|NCT04828083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92988673|NCT04828083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92988674|NCT04828083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92988675|NCT04828083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988677|NCT05225961|Tirofiban|tirofiban|mesh-list
92988678|NCT05225961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92988679|NCT05225961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988680|NCT05225961|Analgesics|analgesics|mesh-ancestor
92988681|NCT05225961|Sensory System Agents|sensory system agents|mesh-ancestor
92988682|NCT05225961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988683|NCT05225961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988684|NCT05225961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988685|NCT05225961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988686|NCT05225961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92988687|NCT05225961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92988688|NCT05225961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988689|NCT05225961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92988690|NCT05225961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92988691|NCT05225961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988692|NCT05225961|Antipyretics|antipyretics|mesh-ancestor
92988693|NCT00556998|Voriconazole|voriconazole|mesh-list
92988694|NCT00556998|Antifungal Agents|antifungal agents|mesh-ancestor
92988695|NCT00556998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988696|NCT00556998|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92988697|NCT00556998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92988698|NCT00556998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988699|NCT00556998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988700|NCT00556998|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92988701|NCT00556998|Hormone Antagonists|hormone antagonists|mesh-ancestor
92988702|NCT00556998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988703|NCT00556998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988704|NCT00556998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92988705|NCT00945360|Letrozole|letrozole|mesh-list
92988706|NCT00945360|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92988707|NCT00945360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988708|NCT00945360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92988709|NCT00945360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988710|NCT00945360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988711|NCT00945360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92988712|NCT00945360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92988713|NCT00945360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988714|NCT00945360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988715|NCT00943566|Sufentanil|sufentanil|mesh-list
92988716|NCT00943566|Morphine|morphine|mesh-list
92988717|NCT00943566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92988718|NCT00943566|Narcotics|narcotics|mesh-ancestor
92988719|NCT00943566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988720|NCT00943566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988721|NCT00943566|Analgesics|analgesics|mesh-ancestor
92988722|NCT00943566|Sensory System Agents|sensory system agents|mesh-ancestor
92988723|NCT00943566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988724|NCT00943566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92988725|NCT00943566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92988726|NCT00943566|Anesthetics, General|anesthetics, general|mesh-ancestor
92988727|NCT00943566|Anesthetics|anesthetics|mesh-ancestor
92988728|NCT00940680|Losartan|losartan|mesh-list
92988729|NCT00940680|Amlodipine|amlodipine|mesh-list
92988730|NCT00940680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92988731|NCT00940680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92988732|NCT00940680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92988733|NCT00940680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988734|NCT00940680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92988735|NCT00940680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988736|NCT00940680|Vasodilator Agents|vasodilator agents|mesh-ancestor
92988737|NCT00940680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92988738|NCT00940680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92988739|NCT00940680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92988740|NCT00945438|Vaccines|vaccines|mesh-list
92988742|NCT00945438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988743|NCT00527397|Insulin|insulin|mesh-list
92988744|NCT00527397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92988745|NCT00527397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988746|NCT00943956|Everolimus|everolimus|mesh-list
92988747|NCT00943956|Leuprolide|leuprolide|mesh-list
92988748|NCT00943956|Bicalutamide|bicalutamide|mesh-list
92988749|NCT00943956|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92988750|NCT00943956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988751|NCT00943956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988752|NCT00943956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988753|NCT00943956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988754|NCT00943956|Immunologic Factors|immunologic factors|mesh-ancestor
92988755|NCT00943956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988756|NCT00943956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988757|NCT00943956|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92988758|NCT00943956|Fertility Agents|fertility agents|mesh-ancestor
92988759|NCT00943956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92988760|NCT00943956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988761|NCT00943956|Androgen Antagonists|androgen antagonists|mesh-ancestor
92988762|NCT00943956|Hormone Antagonists|hormone antagonists|mesh-ancestor
92988763|NCT00943956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988764|NCT00944346|Metformin|metformin|mesh-list
92988765|NCT00944346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92988766|NCT00944346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988767|NCT04115319|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92988768|NCT04115319|Antidepressive Agents|antidepressive agents|mesh-ancestor
92988769|NCT04115319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92988770|NCT04115319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92988771|NCT04115319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92988772|NCT04115319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988773|NCT04115319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988774|NCT00134719|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92988775|NCT00134719|Immunologic Factors|immunologic factors|mesh-ancestor
92988776|NCT00134719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988777|NCT00940836|Acetaminophen|acetaminophen|mesh-list
92988778|NCT00940836|Chlorpheniramine|chlorpheniramine|mesh-list
92988779|NCT00940836|Phenylephrine|phenylephrine|mesh-list
92988780|NCT00940836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988781|NCT00940836|Analgesics|analgesics|mesh-ancestor
92988782|NCT00940836|Sensory System Agents|sensory system agents|mesh-ancestor
92988783|NCT00940836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988784|NCT00940836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988785|NCT00940836|Antipyretics|antipyretics|mesh-ancestor
92988786|NCT00940836|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92988787|NCT00940836|Mydriatics|mydriatics|mesh-ancestor
92988788|NCT00940836|Autonomic Agents|autonomic agents|mesh-ancestor
92988789|NCT00940836|Sympathomimetics|sympathomimetics|mesh-ancestor
92988790|NCT00940836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92988791|NCT00940836|Nasal Decongestants|nasal decongestants|mesh-ancestor
92988792|NCT00940836|Respiratory System Agents|respiratory system agents|mesh-ancestor
92988793|NCT00940836|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92988794|NCT00940836|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92988795|NCT00940836|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92988796|NCT00940836|Adrenergic Agents|adrenergic agents|mesh-ancestor
92988797|NCT00940836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988798|NCT00940836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988799|NCT00940836|Protective Agents|protective agents|mesh-ancestor
92988800|NCT00940836|Antipruritics|antipruritics|mesh-ancestor
92988801|NCT00940836|Dermatologic Agents|dermatologic agents|mesh-ancestor
92988802|NCT00940836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92988803|NCT00940836|Histamine Antagonists|histamine antagonists|mesh-ancestor
92988804|NCT00940836|Histamine Agents|histamine agents|mesh-ancestor
92988805|NCT00940836|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92988806|NCT00940914|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|2beta-carbomethoxy-3beta-(4-iodophenyl)tropane|mesh-list
92988807|NCT00940914|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92988808|NCT00940914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988809|NCT00944424|Vitamin D|vitamin d|mesh-list
92988810|NCT00944424|Ergocalciferols|ergocalciferols|mesh-list
92988811|NCT00944424|Cholecalciferol|cholecalciferol|mesh-list
92988812|NCT00944424|Vitamins|vitamins|mesh-list
92988813|NCT00944424|Docetaxel|docetaxel|mesh-list
92988814|NCT00944424|Micronutrients|micronutrients|mesh-ancestor
92988815|NCT00944424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634232|NCT00577837|Etidronic Acid|etidronic acid|mesh-list
92988816|NCT00944424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988817|NCT00944424|Tubulin Modulators|tubulin modulators|mesh-ancestor
92988818|NCT00944424|Antimitotic Agents|antimitotic agents|mesh-ancestor
92988819|NCT00944424|Mitosis Modulators|mitosis modulators|mesh-ancestor
92988820|NCT00944424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988821|NCT00944424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92988822|NCT00944424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92988823|NCT00944502|Dexamethasone|dexamethasone|mesh-list
92988824|NCT00944502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988825|NCT00944502|Antiemetics|antiemetics|mesh-ancestor
92988826|NCT00944502|Autonomic Agents|autonomic agents|mesh-ancestor
92988827|NCT00944502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988828|NCT00944502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988829|NCT00944502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92988830|NCT00944502|Glucocorticoids|glucocorticoids|mesh-ancestor
92988832|NCT00944502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988833|NCT00944502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988834|NCT00944502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988835|NCT00949962|Leuprolide|leuprolide|mesh-list
92988836|NCT00949962|Androgen Antagonists|androgen antagonists|mesh-list
92988837|NCT00949962|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92988838|NCT00949962|Fertility Agents|fertility agents|mesh-ancestor
92988839|NCT00949962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92167682|NCT02827201|Gemcitabine|gemcitabine|mesh-list
92988840|NCT00949962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988841|NCT00949962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988842|NCT00949962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988843|NCT00949962|Hormone Antagonists|hormone antagonists|mesh-ancestor
92988844|NCT00949962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988845|NCT00946374|Cyclosporine|cyclosporine|mesh-list
92988846|NCT00946374|Doxorubicin|doxorubicin|mesh-list
92988847|NCT00946374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92988848|NCT00946374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988849|NCT00946374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92988850|NCT00946374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92988851|NCT00946374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988852|NCT00946374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988853|NCT00946374|Immunologic Factors|immunologic factors|mesh-ancestor
92988854|NCT00946374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988855|NCT00946374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988856|NCT00946374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988857|NCT00946374|Antifungal Agents|antifungal agents|mesh-ancestor
92988858|NCT00946374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988859|NCT00946374|Dermatologic Agents|dermatologic agents|mesh-ancestor
92988860|NCT00946374|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92988861|NCT00950196|Amantadine|amantadine|mesh-list
92988862|NCT00950196|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92988863|NCT00950196|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92988864|NCT00950196|Antiviral Agents|antiviral agents|mesh-ancestor
92988865|NCT00950196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92988866|NCT00950196|Dopamine Agents|dopamine agents|mesh-ancestor
92988867|NCT00950196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988868|NCT00950196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988869|NCT00950196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988870|NCT00950196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988871|NCT00950196|Analgesics|analgesics|mesh-ancestor
92988872|NCT00950196|Sensory System Agents|sensory system agents|mesh-ancestor
92988873|NCT00950196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988874|NCT01565109|Docetaxel|docetaxel|mesh-list
92988875|NCT01565109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988876|NCT01565109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92988877|NCT01565109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92988878|NCT01565109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92988879|NCT01565109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988880|NCT00525915|Fluorouracil|fluorouracil|mesh-list
92988881|NCT00525915|Oxaliplatin|oxaliplatin|mesh-list
92988882|NCT00525915|Antimetabolites|antimetabolites|mesh-ancestor
92988883|NCT00525915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988884|NCT00525915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92988885|NCT00525915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988886|NCT00525915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988887|NCT00525915|Immunologic Factors|immunologic factors|mesh-ancestor
92988888|NCT00525915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988889|NCT00521001|Everolimus|everolimus|mesh-list
92988890|NCT00521001|Temozolomide|temozolomide|mesh-list
92988891|NCT00521001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92988892|NCT00521001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92988893|NCT00521001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988894|NCT00521001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988895|NCT00521001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988896|NCT00521001|Immunologic Factors|immunologic factors|mesh-ancestor
92988897|NCT00521001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988898|NCT00521001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988899|NCT00521001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988900|NCT00521001|Alkylating Agents|alkylating agents|mesh-ancestor
92988901|NCT00134563|Teriflunomide|teriflunomide|mesh-list
92988902|NCT00134563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92988903|NCT00134563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988904|NCT00134563|Analgesics|analgesics|mesh-ancestor
92988905|NCT00134563|Sensory System Agents|sensory system agents|mesh-ancestor
92988906|NCT00134563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988907|NCT00134563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988908|NCT00134563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988909|NCT00134563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988910|NCT00134563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988911|NCT00134563|Immunologic Factors|immunologic factors|mesh-ancestor
92988912|NCT03966547|Anesthetics|anesthetics|mesh-list
92988913|NCT03966547|Anesthetics, Local|anesthetics, local|mesh-list
92988914|NCT03966547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988915|NCT03966547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988916|NCT03966547|Sensory System Agents|sensory system agents|mesh-ancestor
92988917|NCT03966547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988918|NCT01326325|Ketamine|ketamine|mesh-list
92988919|NCT01326325|Analgesics|analgesics|mesh-ancestor
92988920|NCT01326325|Sensory System Agents|sensory system agents|mesh-ancestor
92988921|NCT01326325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988922|NCT01326325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988923|NCT01326325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92988924|NCT01326325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92988925|NCT01326325|Anesthetics, General|anesthetics, general|mesh-ancestor
92988926|NCT01326325|Anesthetics|anesthetics|mesh-ancestor
92988927|NCT01326325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92988928|NCT01326325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92988929|NCT01326325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92988930|NCT01326325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92988931|NCT01326325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988932|NCT01326403|Tranexamic Acid|tranexamic acid|mesh-list
92988933|NCT01326403|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92988934|NCT01326403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92988935|NCT01326403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988936|NCT01326403|Hemostatics|hemostatics|mesh-ancestor
92988937|NCT01326403|Coagulants|coagulants|mesh-ancestor
92988938|NCT00520845|Celecoxib|celecoxib|mesh-list
92988939|NCT00520845|Docetaxel|docetaxel|mesh-list
92988940|NCT00520845|Pemetrexed|pemetrexed|mesh-list
92988941|NCT00520845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988942|NCT00520845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92988943|NCT00520845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92988944|NCT00520845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92988945|NCT00520845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988946|NCT00520845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988947|NCT00520845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92988948|NCT00520845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92988949|NCT00520845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92988950|NCT00520845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92988951|NCT00520845|Analgesics|analgesics|mesh-ancestor
92988952|NCT00520845|Sensory System Agents|sensory system agents|mesh-ancestor
92988953|NCT00520845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988954|NCT00520845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988955|NCT00520845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988956|NCT00520845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92988957|NCT00520845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92988958|NCT00520845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92988959|NCT00185731|Atorvastatin|atorvastatin|mesh-list
92988960|NCT00185731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92988961|NCT00185731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92988962|NCT00185731|Antimetabolites|antimetabolites|mesh-ancestor
92988963|NCT00185731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988964|NCT00185731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92988965|NCT00185731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92988966|NCT00185731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988968|NCT00582491|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92988969|NCT00582491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988970|NCT00582491|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92988971|NCT00582491|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92988972|NCT00582491|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92988973|NCT00582491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988974|NCT00520767|Dexamethasone|dexamethasone|mesh-list
92988975|NCT00520767|Dexamethasone acetate|dexamethasone acetate|mesh-list
92988976|NCT00520767|Bortezomib|bortezomib|mesh-list
92988977|NCT00520767|Melphalan|melphalan|mesh-list
92988978|NCT00520767|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92988979|NCT00520767|BB 1101|bb 1101|mesh-list
92988980|NCT00520767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92988981|NCT00520767|Antiemetics|antiemetics|mesh-ancestor
92988982|NCT00520767|Autonomic Agents|autonomic agents|mesh-ancestor
92988983|NCT00520767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92988984|NCT00520767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92988985|NCT00520767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92988986|NCT00520767|Glucocorticoids|glucocorticoids|mesh-ancestor
92988987|NCT00520767|Hormones|hormones|mesh-ancestor
92988988|NCT00520767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92988989|NCT00520767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92988990|NCT00520767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92988991|NCT00520767|Protease Inhibitors|protease inhibitors|mesh-ancestor
92988992|NCT00520767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92988993|NCT00520767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92988994|NCT00520767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92988995|NCT00520767|Alkylating Agents|alkylating agents|mesh-ancestor
92988996|NCT00520767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92988997|NCT00520767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92988998|NCT00520767|Immunologic Factors|immunologic factors|mesh-ancestor
92988999|NCT03873987|Oritavancin|oritavancin|mesh-list
92989000|NCT03873987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92989001|NCT03873987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989002|NCT02579681|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92989003|NCT02579681|Dermatologic Agents|dermatologic agents|mesh-ancestor
92989004|NCT02579681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989005|NCT02579681|Immunologic Factors|immunologic factors|mesh-ancestor
92989006|NCT02579681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989007|NCT00528645|Saracatinib|saracatinib|mesh-list
92989008|NCT00528645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989009|NCT00528645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989010|NCT00528645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989011|NCT01017796|Ascorbic Acid|ascorbic acid|mesh-list
92989012|NCT01017796|Acetylcysteine|acetylcysteine|mesh-list
92989013|NCT01017796|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92989014|NCT01017796|Antiviral Agents|antiviral agents|mesh-ancestor
92989015|NCT01017796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989016|NCT01017796|Expectorants|expectorants|mesh-ancestor
92989017|NCT01017796|Respiratory System Agents|respiratory system agents|mesh-ancestor
92989018|NCT01017796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92989019|NCT01017796|Antioxidants|antioxidants|mesh-ancestor
92989020|NCT01017796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989021|NCT01017796|Protective Agents|protective agents|mesh-ancestor
92989022|NCT01017796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989023|NCT01017796|Antidotes|antidotes|mesh-ancestor
92989024|NCT01017796|Vitamins|vitamins|mesh-ancestor
92989025|NCT01017796|Micronutrients|micronutrients|mesh-ancestor
92989026|NCT01783535|Cyclophosphamide|cyclophosphamide|mesh-list
92989027|NCT01783535|Carboplatin|carboplatin|mesh-list
92989028|NCT01783535|Doxorubicin|doxorubicin|mesh-list
92989029|NCT01783535|Etoposide|etoposide|mesh-list
92989030|NCT01783535|Vincristine|vincristine|mesh-list
92989031|NCT01783535|Topotecan|topotecan|mesh-list
92989032|NCT01783535|Lenograstim|lenograstim|mesh-list
92989033|NCT01783535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989034|NCT01783535|Immunologic Factors|immunologic factors|mesh-ancestor
92989035|NCT01783535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989036|NCT01783535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989037|NCT01783535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92989038|NCT01783535|Alkylating Agents|alkylating agents|mesh-ancestor
92989039|NCT01783535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989040|NCT01783535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989041|NCT01783535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92989042|NCT01783535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92989043|NCT01783535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92989044|NCT01783535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92989045|NCT01783535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989046|NCT01783535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92989047|NCT01783535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92989048|NCT01783535|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989049|NCT01783535|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989050|NCT01783535|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989051|NCT01783535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92989054|NCT04073537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92989055|NCT04073537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989056|NCT04073537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989057|NCT04073537|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989058|NCT04073537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167690|NCT02827201|Antimetabolites|antimetabolites|mesh-ancestor
92989059|NCT04073537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989060|NCT01020994|Octenidine|octenidine|mesh-list
92989061|NCT01020994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989062|NCT01020994|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92989063|NCT00494026|Carboplatin|carboplatin|mesh-list
92989064|NCT00494026|Pemetrexed|pemetrexed|mesh-list
92989065|NCT00494026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989066|NCT00494026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989067|NCT00494026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989068|NCT00494026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92989069|NCT00494026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92989070|NCT00524589|Calcitriol|calcitriol|mesh-list
92989071|NCT00524589|Dexamethasone|dexamethasone|mesh-list
92989072|NCT00524589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989073|NCT00524589|Antiemetics|antiemetics|mesh-ancestor
92989074|NCT00524589|Autonomic Agents|autonomic agents|mesh-ancestor
92989075|NCT00524589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989076|NCT00524589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989077|NCT00524589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989078|NCT00524589|Glucocorticoids|glucocorticoids|mesh-ancestor
92989079|NCT00524589|Hormones|hormones|mesh-ancestor
92989080|NCT00524589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989081|NCT00524589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989082|NCT00524589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989083|NCT00524589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92989084|NCT00524589|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92989085|NCT00524589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989086|NCT00524589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989087|NCT00524589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92989088|NCT00524589|Vitamins|vitamins|mesh-ancestor
92989089|NCT00524589|Micronutrients|micronutrients|mesh-ancestor
92989090|NCT00524589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92989091|NCT01015066|Naltrexone|naltrexone|mesh-list
92989092|NCT01015066|Buprenorphine|buprenorphine|mesh-list
92989093|NCT01015066|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92989094|NCT01015066|Naloxone|naloxone|mesh-list
92989095|NCT01015066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92989096|NCT01015066|Narcotics|narcotics|mesh-ancestor
92989097|NCT01015066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989098|NCT01015066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989099|NCT01015066|Analgesics|analgesics|mesh-ancestor
92989100|NCT01015066|Sensory System Agents|sensory system agents|mesh-ancestor
92989101|NCT01015066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989102|NCT01015066|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92989103|NCT01015066|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92989104|NCT00472030|Omalizumab|omalizumab|mesh-list
92989105|NCT00472030|Prednisone|prednisone|mesh-list
92989106|NCT00472030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989107|NCT00472030|Glucocorticoids|glucocorticoids|mesh-ancestor
92989108|NCT00472030|Hormones|hormones|mesh-ancestor
92989109|NCT00472030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989110|NCT00472030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989111|NCT00472030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989112|NCT00472030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989113|NCT00472030|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92989114|NCT00472030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92989115|NCT00472030|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634508|NCT04576975|Ketamine|ketamine|mesh-list
92989117|NCT00127855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92989118|NCT00127855|Immunologic Factors|immunologic factors|mesh-ancestor
92989119|NCT00127855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989121|NCT00493636|Capecitabine|capecitabine|mesh-list
92989122|NCT00493636|Sorafenib|sorafenib|mesh-list
92989123|NCT00493636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989124|NCT00493636|Antimetabolites|antimetabolites|mesh-ancestor
92989125|NCT00493636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989126|NCT00493636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989127|NCT00493636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989128|NCT00493636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989129|NCT00524121|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92989130|NCT00524121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167691|NCT02346253|Leuprolide|leuprolide|mesh-list
92989131|NCT00524121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989132|NCT00524121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989133|NCT00524121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989134|NCT01018342|Nitrofurantoin|nitrofurantoin|mesh-list
92989135|NCT01018342|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92989136|NCT01018342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989137|NCT01018342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92989138|NCT03965767|Tranexamic Acid|tranexamic acid|mesh-list
92989139|NCT03965767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92989140|NCT03965767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92989141|NCT03965767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989142|NCT03965767|Hemostatics|hemostatics|mesh-ancestor
92989143|NCT03965767|Coagulants|coagulants|mesh-ancestor
92989144|NCT00133705|Mifepristone|mifepristone|mesh-list
92989145|NCT00133705|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92989146|NCT00133705|Abortifacient Agents|abortifacient agents|mesh-ancestor
92989147|NCT00133705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92989148|NCT00133705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989149|NCT00133705|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92989150|NCT00133705|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92989151|NCT00133705|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92989152|NCT00133705|Contraceptive Agents|contraceptive agents|mesh-ancestor
92989153|NCT00133705|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92989154|NCT00133705|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92989155|NCT00133705|Hormone Antagonists|hormone antagonists|mesh-ancestor
92989156|NCT00133705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989157|NCT00133705|Luteolytic Agents|luteolytic agents|mesh-ancestor
92989158|NCT00133705|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92989159|NCT00133705|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92989160|NCT00132769|MK 0873|mk 0873|mesh-list
92989161|NCT00132769|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92989162|NCT00132769|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92989163|NCT00132769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989164|NCT00132769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989165|NCT02478255|Xenon|xenon|mesh-list
92989166|NCT02478255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92989167|NCT02478255|Anesthetics, General|anesthetics, general|mesh-ancestor
92989168|NCT02478255|Anesthetics|anesthetics|mesh-ancestor
92989169|NCT02478255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989170|NCT02478255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989171|NCT00132691|Cyclosporine|cyclosporine|mesh-list
92989172|NCT00132691|Mycophenolic Acid|mycophenolic acid|mesh-list
92989173|NCT00132691|Infliximab|infliximab|mesh-list
92989174|NCT00132691|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92989175|NCT00132691|Cyclophosphamide|cyclophosphamide|mesh-list
92989176|NCT00132691|Chlorambucil|chlorambucil|mesh-list
92989177|NCT00132691|Methotrexate|methotrexate|mesh-list
92989178|NCT00132691|Azathioprine|azathioprine|mesh-list
92989179|NCT00132691|Tacrolimus|tacrolimus|mesh-list
92989180|NCT00132691|Cyclosporins|cyclosporins|mesh-list
92989181|NCT00132691|Daclizumab|daclizumab|mesh-list
92989182|NCT00132691|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92989183|NCT00132691|Alkylating Agents|alkylating agents|mesh-list
92989184|NCT00132691|Immunologic Factors|immunologic factors|mesh-ancestor
92989185|NCT00132691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989186|NCT00132691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989187|NCT00132691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92989188|NCT00132691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989189|NCT00132691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989190|NCT00132691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92989191|NCT00132691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92989192|NCT00132691|Abortifacient Agents|abortifacient agents|mesh-ancestor
92989193|NCT00132691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92989194|NCT00132691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989195|NCT00132691|Antimetabolites|antimetabolites|mesh-ancestor
92989196|NCT00132691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92989197|NCT00132691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989198|NCT00132691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92989199|NCT00132691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92989200|NCT00132691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92989201|NCT00132691|Antifungal Agents|antifungal agents|mesh-ancestor
92989202|NCT00132691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989203|NCT00132691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92989204|NCT00132691|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92989205|NCT00132691|Antitubercular Agents|antitubercular agents|mesh-ancestor
92989206|NCT00132691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92989207|NCT00132691|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92989208|NCT00132691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989209|NCT00132691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989210|NCT00132691|Glucocorticoids|glucocorticoids|mesh-ancestor
92989212|NCT00132691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989213|NCT02390427|Paclitaxel|paclitaxel|mesh-list
92989214|NCT02390427|Maytansine|maytansine|mesh-list
92989215|NCT02390427|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92989216|NCT02390427|Trastuzumab|trastuzumab|mesh-list
92989217|NCT02390427|Pertuzumab|pertuzumab|mesh-list
92989218|NCT02390427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92989219|NCT02390427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989220|NCT02390427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989221|NCT02390427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989222|NCT02390427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989223|NCT02390427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989224|NCT02390427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92989225|NCT02390427|Immunotoxins|immunotoxins|mesh-ancestor
92989226|NCT02390427|Immunoconjugates|immunoconjugates|mesh-ancestor
92989227|NCT02390427|Immunologic Factors|immunologic factors|mesh-ancestor
92989228|NCT02390427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989229|NCT00125359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92989230|NCT00125359|Bexarotene|bexarotene|mesh-list
92989231|NCT00125359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989232|NCT00125359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989233|NCT00125359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989234|NCT00125359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989235|NCT00524043|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92989236|NCT00524043|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92989237|NCT00524043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92989238|NCT00524043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989239|NCT00524043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989240|NCT00524043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92989241|NCT00524043|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92989242|NCT00524043|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92989243|NCT00524043|Serotonin Agents|serotonin agents|mesh-ancestor
92989244|NCT00524043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989245|NCT00524043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989246|NCT00524043|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92989247|NCT00524043|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92989248|NCT00524043|Dopamine Agents|dopamine agents|mesh-ancestor
92989249|NCT01076803|Lanreotide|lanreotide|mesh-list
92989250|NCT01076803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989251|NCT00523419|Pemetrexed|pemetrexed|mesh-list
92989252|NCT00523419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989253|NCT00523419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989254|NCT00523419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989255|NCT00523419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92989256|NCT00523419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92989257|NCT03868059|Methyltestosterone|methyltestosterone|mesh-list
92528223|NCT00035230|Topiramate|topiramate|mesh-list
92989259|NCT03868059|Testosterone|testosterone|mesh-list
92989260|NCT03868059|Testosterone undecanoate|testosterone undecanoate|mesh-list
92989261|NCT03868059|Testosterone enanthate|testosterone enanthate|mesh-list
92989262|NCT03868059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989263|NCT03868059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989264|NCT03868059|Anabolic Agents|anabolic agents|mesh-ancestor
92989265|NCT03868059|Hormones|hormones|mesh-ancestor
92989266|NCT03868059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989267|NCT03868059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989268|NCT03868059|Androgens|androgens|mesh-ancestor
92989269|NCT04028115|Ixazomib|ixazomib|mesh-list
92989270|NCT04028115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989271|NCT04028115|Protease Inhibitors|protease inhibitors|mesh-ancestor
92989272|NCT04028115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989273|NCT04028115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989274|NCT03865407|Allopurinol|allopurinol|mesh-list
92989275|NCT03865407|Antimetabolites|antimetabolites|mesh-ancestor
92989276|NCT03865407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989277|NCT03865407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989278|NCT03865407|Gout Suppressants|gout suppressants|mesh-ancestor
92989279|NCT03865407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989280|NCT03865407|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92989281|NCT03865407|Antioxidants|antioxidants|mesh-ancestor
92989282|NCT03865407|Protective Agents|protective agents|mesh-ancestor
92989283|NCT03865407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989284|NCT00487942|Modafinil|modafinil|mesh-list
92989285|NCT00487942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92989286|NCT00487942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989287|NCT00487942|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92989288|NCT00487942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92989289|NCT00487942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92989290|NCT00487942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989291|NCT00132301|Prednisone|prednisone|mesh-list
92989292|NCT00132301|Docetaxel|docetaxel|mesh-list
92989293|NCT00132301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989294|NCT00132301|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989295|NCT00132301|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989296|NCT00132301|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989297|NCT00132301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989298|NCT00132301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989299|NCT00132301|Glucocorticoids|glucocorticoids|mesh-ancestor
92989300|NCT00132301|Hormones|hormones|mesh-ancestor
92989301|NCT00132301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989302|NCT00132301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989303|NCT00132301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989304|NCT00519831|Cetuximab|cetuximab|mesh-list
92989305|NCT00519831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92989306|NCT00519831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989307|NCT04303845|Erenumab|erenumab|mesh-list
92989308|NCT04303845|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92989309|NCT04303845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989310|NCT04303845|Analgesics|analgesics|mesh-ancestor
92989311|NCT04303845|Sensory System Agents|sensory system agents|mesh-ancestor
92989312|NCT04303845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989313|NCT04303845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989314|NCT04187703|Azacitidine|azacitidine|mesh-list
92989315|NCT04187703|Decitabine|decitabine|mesh-list
92989316|NCT04187703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989317|NCT04187703|Antimetabolites|antimetabolites|mesh-ancestor
92989318|NCT04187703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989319|NCT04187703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989320|NCT04187703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989321|NCT00131911|Sorafenib|sorafenib|mesh-list
92989322|NCT00131911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989323|NCT00131911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989324|NCT00131911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989325|NCT00131911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989326|NCT00184093|Gemcitabine|gemcitabine|mesh-list
92989327|NCT00184093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989328|NCT00184093|Antimetabolites|antimetabolites|mesh-ancestor
92989329|NCT00184093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989331|NCT01074619|Memantine|memantine|mesh-list
92989332|NCT01074619|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92989333|NCT01074619|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92989334|NCT01074619|Dopamine Agents|dopamine agents|mesh-ancestor
92989335|NCT01074619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989336|NCT01074619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989337|NCT01074619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989338|NCT01074619|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92989339|NCT01074619|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92989340|NCT00183625|Olanzapine|olanzapine|mesh-list
92634728|NCT00584155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92989341|NCT00183625|Risperidone|risperidone|mesh-list
92989342|NCT00183625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92989343|NCT00183625|Serotonin Agents|serotonin agents|mesh-ancestor
92989344|NCT00183625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989345|NCT00183625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989346|NCT00183625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989347|NCT00183625|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92989348|NCT00183625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92989349|NCT00183625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989350|NCT00183625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92989351|NCT00183625|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92989352|NCT00183625|Dopamine Agents|dopamine agents|mesh-ancestor
92989353|NCT00183625|Antiemetics|antiemetics|mesh-ancestor
92989354|NCT00183625|Autonomic Agents|autonomic agents|mesh-ancestor
92989355|NCT00183625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989356|NCT00183625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989357|NCT00183625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92989358|NCT00183625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92989359|NCT00183625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989360|NCT00511875|Doxycycline|doxycycline|mesh-list
92989361|NCT00511875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92989362|NCT00511875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989363|NCT00511875|Antimalarials|antimalarials|mesh-ancestor
92989364|NCT00511875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92989365|NCT00511875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92989366|NCT02576327|Dexamethasone|dexamethasone|mesh-list
92989367|NCT02576327|Dexamethasone acetate|dexamethasone acetate|mesh-list
92989368|NCT02576327|Aprepitant|aprepitant|mesh-list
92989369|NCT02576327|Tropisetron|tropisetron|mesh-list
92989370|NCT02576327|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92989371|NCT02576327|BB 1101|bb 1101|mesh-list
92989372|NCT02576327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989373|NCT02576327|Antiemetics|antiemetics|mesh-ancestor
92989374|NCT02576327|Autonomic Agents|autonomic agents|mesh-ancestor
92989375|NCT02576327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989376|NCT02576327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989377|NCT02576327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989378|NCT02576327|Glucocorticoids|glucocorticoids|mesh-ancestor
92989379|NCT02576327|Hormones|hormones|mesh-ancestor
92989380|NCT02576327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989381|NCT02576327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989382|NCT02576327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989383|NCT02576327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92989384|NCT02576327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989385|NCT02576327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989386|NCT02576327|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92989388|NCT02576327|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92989389|NCT02576327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92989390|NCT02576327|Serotonin Agents|serotonin agents|mesh-ancestor
92989391|NCT00183391|Methylphenidate|methylphenidate|mesh-list
92989392|NCT00183391|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92989393|NCT00183391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92989394|NCT00183391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989395|NCT00183391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92989396|NCT00183391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92989397|NCT00183391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989398|NCT00183391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989399|NCT00183391|Dopamine Agents|dopamine agents|mesh-ancestor
92989400|NCT00183391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989401|NCT00183391|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92989402|NCT00183391|Adrenergic Agents|adrenergic agents|mesh-ancestor
92989403|NCT00493246|Acetaminophen|acetaminophen|mesh-list
92989404|NCT00493246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989405|NCT00493246|Analgesics|analgesics|mesh-ancestor
92989406|NCT00493246|Sensory System Agents|sensory system agents|mesh-ancestor
92989407|NCT00493246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989408|NCT00493246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989409|NCT00493246|Antipyretics|antipyretics|mesh-ancestor
92989410|NCT01021150|Cisplatin|cisplatin|mesh-list
92989411|NCT01021150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989412|NCT03997006|Atropine|atropine|mesh-list
92989413|NCT03997006|Aminophylline|aminophylline|mesh-list
92989414|NCT03997006|Neostigmine|neostigmine|mesh-list
92989415|NCT03997006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92634813|NCT00584779|Gabapentin|gabapentin|mesh-list
92989416|NCT03997006|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92989417|NCT03997006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92989418|NCT03997006|Autonomic Agents|autonomic agents|mesh-ancestor
92989419|NCT03997006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989420|NCT03997006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989421|NCT03997006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92989422|NCT03997006|Respiratory System Agents|respiratory system agents|mesh-ancestor
92989423|NCT03997006|Mydriatics|mydriatics|mesh-ancestor
92989424|NCT03997006|Parasympatholytics|parasympatholytics|mesh-ancestor
92989425|NCT03997006|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92989426|NCT03997006|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92989427|NCT03997006|Cholinergic Agents|cholinergic agents|mesh-ancestor
92989428|NCT03997006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989429|NCT03997006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989430|NCT03997006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92989431|NCT03997006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989432|NCT03997006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92989433|NCT03997006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92989434|NCT03997006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92989435|NCT03997006|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92989436|NCT03997006|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92989437|NCT03997006|Purinergic Agents|purinergic agents|mesh-ancestor
92989438|NCT03997006|Protective Agents|protective agents|mesh-ancestor
92989439|NCT02281955|Cisplatin|cisplatin|mesh-list
92989440|NCT02281955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989441|NCT02272049|Xenon|xenon|mesh-list
92989442|NCT02272049|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92989443|NCT02272049|Anesthetics, General|anesthetics, general|mesh-ancestor
92989444|NCT02272049|Anesthetics|anesthetics|mesh-ancestor
92989445|NCT02272049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989446|NCT02272049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989447|NCT03996538|Metformin|metformin|mesh-list
92989448|NCT03996538|Vaccines|vaccines|mesh-list
92989449|NCT03996538|Immunologic Factors|immunologic factors|mesh-ancestor
92989450|NCT03996538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989451|NCT03996538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92989452|NCT02576015|Lidocaine|lidocaine|mesh-list
92989453|NCT02576015|Ropivacaine|ropivacaine|mesh-list
92989454|NCT02576015|Anesthetics, Local|anesthetics, local|mesh-ancestor
92989455|NCT02576015|Anesthetics|anesthetics|mesh-ancestor
92989456|NCT02576015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989457|NCT02576015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989458|NCT02576015|Sensory System Agents|sensory system agents|mesh-ancestor
92989459|NCT02576015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989460|NCT02576015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92989461|NCT02576015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92989463|NCT02576015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989464|NCT02576015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989465|NCT02577965|Everolimus|everolimus|mesh-list
92989466|NCT02577965|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92989467|NCT02577965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989468|NCT02577965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989469|NCT02577965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989470|NCT02577965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989471|NCT02577965|Immunologic Factors|immunologic factors|mesh-ancestor
92989472|NCT02577965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989473|NCT02577965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989474|NCT00182689|Sorafenib|sorafenib|mesh-list
92989475|NCT00182689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989476|NCT00182689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989477|NCT00182689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989478|NCT00182689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989479|NCT02578121|Dexamethasone|dexamethasone|mesh-list
92989480|NCT02578121|Pomalidomide|pomalidomide|mesh-list
92989481|NCT02578121|Ixazomib|ixazomib|mesh-list
92989482|NCT02578121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989483|NCT02578121|Antiemetics|antiemetics|mesh-ancestor
92989484|NCT02578121|Autonomic Agents|autonomic agents|mesh-ancestor
92989485|NCT02578121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989486|NCT02578121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989487|NCT02578121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989488|NCT02578121|Glucocorticoids|glucocorticoids|mesh-ancestor
92989489|NCT02578121|Hormones|hormones|mesh-ancestor
92989490|NCT02578121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989491|NCT02578121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989492|NCT02578121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989493|NCT02578121|Immunologic Factors|immunologic factors|mesh-ancestor
92989494|NCT02578121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92989495|NCT02578121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92989496|NCT02578121|Growth Substances|growth substances|mesh-ancestor
92989497|NCT02578121|Growth Inhibitors|growth inhibitors|mesh-ancestor
92989498|NCT02578121|Protease Inhibitors|protease inhibitors|mesh-ancestor
92989499|NCT02578121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989500|NCT02578121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989501|NCT00487240|Insulin|insulin|mesh-list
92989502|NCT00487240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92989503|NCT00487240|Insulin Lispro|insulin lispro|mesh-list
92989504|NCT00487240|Insulin Detemir|insulin detemir|mesh-list
92989505|NCT00487240|Protamines|protamines|mesh-list
92989506|NCT00487240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92989507|NCT00487240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989508|NCT00487240|Heparin Antagonists|heparin antagonists|mesh-ancestor
92989509|NCT00487240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989510|NCT00487240|Coagulants|coagulants|mesh-ancestor
92989511|NCT02577809|Indomethacin|indomethacin|mesh-list
92989512|NCT02577809|Fentanyl|fentanyl|mesh-list
92989513|NCT02577809|Morphine|morphine|mesh-list
92989514|NCT02577809|Bupivacaine|bupivacaine|mesh-list
92989515|NCT02577809|Anesthetics, Local|anesthetics, local|mesh-ancestor
92989516|NCT02577809|Anesthetics|anesthetics|mesh-ancestor
92989517|NCT02577809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989518|NCT02577809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989519|NCT02577809|Sensory System Agents|sensory system agents|mesh-ancestor
92989520|NCT02577809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989521|NCT02577809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92989522|NCT02577809|Narcotics|narcotics|mesh-ancestor
92989523|NCT02577809|Analgesics|analgesics|mesh-ancestor
92989524|NCT02577809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92989525|NCT02577809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92989526|NCT02577809|Anesthetics, General|anesthetics, general|mesh-ancestor
92989527|NCT02577809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92989528|NCT02577809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989529|NCT02577809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989530|NCT02577809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989531|NCT02577809|Gout Suppressants|gout suppressants|mesh-ancestor
92989532|NCT02577809|Tocolytic Agents|tocolytic agents|mesh-ancestor
92989533|NCT02577809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92989534|NCT02577809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92989535|NCT02577809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989536|NCT02577809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989537|NCT02224391|Nicotine|nicotine|mesh-list
92989538|NCT02224391|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92989539|NCT02224391|Autonomic Agents|autonomic agents|mesh-ancestor
92989540|NCT02224391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989541|NCT02224391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989542|NCT02224391|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92989543|NCT02224391|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92989544|NCT02224391|Cholinergic Agents|cholinergic agents|mesh-ancestor
92989545|NCT02224391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989546|NCT02224391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989548|NCT00487162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92989549|NCT00487162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989550|NCT03871959|Pembrolizumab|pembrolizumab|mesh-list
92989551|NCT03871959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92989552|NCT03871959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989553|NCT03871959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92989554|NCT03871959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989555|NCT00487084|Lidocaine|lidocaine|mesh-list
92989556|NCT00487084|Morphine|morphine|mesh-list
92989557|NCT00487084|Anesthetics, Local|anesthetics, local|mesh-ancestor
92989558|NCT00487084|Anesthetics|anesthetics|mesh-ancestor
92989559|NCT00487084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989560|NCT00487084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989561|NCT00487084|Sensory System Agents|sensory system agents|mesh-ancestor
92989562|NCT00487084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989563|NCT00487084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92989564|NCT00487084|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92989565|NCT00487084|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92989566|NCT00487084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989567|NCT00487084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989568|NCT00487084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92989569|NCT00487084|Narcotics|narcotics|mesh-ancestor
92989570|NCT00487084|Analgesics|analgesics|mesh-ancestor
92989571|NCT00466726|Sargramostim|sargramostim|mesh-list
92989572|NCT00466726|Immunologic Factors|immunologic factors|mesh-ancestor
92989573|NCT00466726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989574|NCT01721291|Albuterol|albuterol|mesh-list
92989575|NCT01721291|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92989576|NCT01721291|Autonomic Agents|autonomic agents|mesh-ancestor
92989577|NCT01721291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989578|NCT01721291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989579|NCT01721291|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92989580|NCT01721291|Respiratory System Agents|respiratory system agents|mesh-ancestor
92989581|NCT01721291|Tocolytic Agents|tocolytic agents|mesh-ancestor
92989582|NCT01721291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92989583|NCT01721291|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92989584|NCT01721291|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92989585|NCT01721291|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92989586|NCT01721291|Adrenergic Agents|adrenergic agents|mesh-ancestor
92989587|NCT01721291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989588|NCT01721291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989589|NCT01021540|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92989590|NCT01021540|Hormones|hormones|mesh-ancestor
92989591|NCT01021540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167762|NCT03056118|Aspirin|aspirin|mesh-list
92989592|NCT01021540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989593|NCT04840511|Lidocaine|lidocaine|mesh-list
92989594|NCT04840511|Anesthetics, Local|anesthetics, local|mesh-ancestor
92989595|NCT04840511|Anesthetics|anesthetics|mesh-ancestor
92989596|NCT04840511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989597|NCT04840511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989598|NCT04840511|Sensory System Agents|sensory system agents|mesh-ancestor
92989599|NCT04840511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989600|NCT04840511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92989601|NCT04840511|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92989602|NCT04840511|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92989603|NCT04840511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989604|NCT04840511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989605|NCT02199665|Dexamethasone|dexamethasone|mesh-list
92989606|NCT02199665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989607|NCT02199665|Antiemetics|antiemetics|mesh-ancestor
92989608|NCT02199665|Autonomic Agents|autonomic agents|mesh-ancestor
92528247|NCT00035347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92989609|NCT02199665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989610|NCT02199665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989611|NCT02199665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989612|NCT02199665|Glucocorticoids|glucocorticoids|mesh-ancestor
92989613|NCT02199665|Hormones|hormones|mesh-ancestor
92989614|NCT02199665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989615|NCT02199665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989616|NCT02199665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989617|NCT01021696|Acetaminophen|acetaminophen|mesh-list
92989618|NCT01021696|Pregabalin|pregabalin|mesh-list
92989619|NCT01021696|Morphine|morphine|mesh-list
92989620|NCT01021696|Buprenorphine|buprenorphine|mesh-list
92989621|NCT01021696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92989622|NCT01021696|Narcotics|narcotics|mesh-ancestor
92989623|NCT01021696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989624|NCT01021696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989625|NCT01021696|Analgesics|analgesics|mesh-ancestor
92989626|NCT01021696|Sensory System Agents|sensory system agents|mesh-ancestor
92989627|NCT01021696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989628|NCT01021696|Anticonvulsants|anticonvulsants|mesh-ancestor
92989629|NCT01021696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92989630|NCT01021696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989631|NCT01021696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989632|NCT01021696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92989633|NCT01021696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92989634|NCT01021696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92989635|NCT01021696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92989636|NCT01021696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989637|NCT01021696|Antipyretics|antipyretics|mesh-ancestor
92989638|NCT01021696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92989639|NCT02577575|Oxytocin|oxytocin|mesh-list
92989640|NCT02577575|Oxytocics|oxytocics|mesh-ancestor
92989641|NCT02577575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92989642|NCT02577575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989643|NCT00485758|Niacin|niacin|mesh-list
92989644|NCT00485758|Niacinamide|niacinamide|mesh-list
92989645|NCT00485758|Nicotinic Acids|nicotinic acids|mesh-list
92989646|NCT00485758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92989647|NCT00485758|Antimetabolites|antimetabolites|mesh-ancestor
92989648|NCT00485758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989649|NCT00485758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92989650|NCT00485758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92989651|NCT00485758|Vitamin B Complex|vitamin b complex|mesh-ancestor
92989652|NCT00485758|Vitamins|vitamins|mesh-ancestor
92989653|NCT00485758|Micronutrients|micronutrients|mesh-ancestor
92989654|NCT00485758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989655|NCT02577341|Docetaxel|docetaxel|mesh-list
92989656|NCT02577341|Nimotuzumab|nimotuzumab|mesh-list
92989657|NCT02577341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989658|NCT02577341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989659|NCT02577341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989660|NCT02577341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989661|NCT02577341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989662|NCT02577341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92989663|NCT02577497|Fluticasone|fluticasone|mesh-list
92989664|NCT02577497|Beclomethasone|beclomethasone|mesh-list
92989665|NCT02577497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989666|NCT02577497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92989667|NCT02577497|Autonomic Agents|autonomic agents|mesh-ancestor
92989668|NCT02577497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989669|NCT02577497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989670|NCT02577497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92989671|NCT02577497|Respiratory System Agents|respiratory system agents|mesh-ancestor
92989672|NCT02577497|Dermatologic Agents|dermatologic agents|mesh-ancestor
92989673|NCT02577497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92989674|NCT02577497|Glucocorticoids|glucocorticoids|mesh-ancestor
92989675|NCT02577497|Hormones|hormones|mesh-ancestor
92989676|NCT02577497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989677|NCT02575859|Cisplatin|cisplatin|mesh-list
92989678|NCT02575859|Mitomycins|mitomycins|mesh-list
92989679|NCT02575859|Mitomycin|mitomycin|mesh-list
92989680|NCT02575859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989681|NCT02575859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92989682|NCT02575859|Alkylating Agents|alkylating agents|mesh-ancestor
92989683|NCT02575859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989684|NCT02575859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92989685|NCT02575859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989686|NCT03850444|Paclitaxel|paclitaxel|mesh-list
92989687|NCT03850444|Carboplatin|carboplatin|mesh-list
92989688|NCT03850444|Pembrolizumab|pembrolizumab|mesh-list
92989689|NCT03850444|Pemetrexed|pemetrexed|mesh-list
92989690|NCT03850444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92989691|NCT03850444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989692|NCT03850444|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989693|NCT03850444|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989694|NCT03850444|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989695|NCT03850444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989696|NCT03850444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92989697|NCT03850444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92989698|NCT03850444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989699|NCT03850444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92989700|NCT03850444|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92989701|NCT00469456|Memantine|memantine|mesh-list
92989702|NCT00469456|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92989703|NCT00469456|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92989704|NCT00469456|Dopamine Agents|dopamine agents|mesh-ancestor
92989705|NCT00469456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989706|NCT00469456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989707|NCT00469456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989708|NCT00469456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92989709|NCT00469456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92989710|NCT00581555|Etanercept|etanercept|mesh-list
92989711|NCT00581555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92989712|NCT00581555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989713|NCT00581555|Analgesics|analgesics|mesh-ancestor
92989714|NCT00581555|Sensory System Agents|sensory system agents|mesh-ancestor
92989715|NCT00581555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989716|NCT00581555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989717|NCT00581555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989718|NCT00581555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989719|NCT00581555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989720|NCT00581555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989721|NCT00581555|Immunologic Factors|immunologic factors|mesh-ancestor
92989722|NCT00469144|Fludarabine|fludarabine|mesh-list
92989723|NCT00469144|Busulfan|busulfan|mesh-list
92989724|NCT00469144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989725|NCT00469144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989726|NCT00469144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989727|NCT00469144|Immunologic Factors|immunologic factors|mesh-ancestor
92989728|NCT00469144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989729|NCT00469144|Alkylating Agents|alkylating agents|mesh-ancestor
92989730|NCT00469144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92989731|NCT00469144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92989732|NCT03987022|Acetaminophen|acetaminophen|mesh-list
92989733|NCT03987022|Ketorolac|ketorolac|mesh-list
92989734|NCT03987022|Oxycodone|oxycodone|mesh-list
92989735|NCT03987022|Hydromorphone|hydromorphone|mesh-list
92989736|NCT03987022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92989737|NCT03987022|Narcotics|narcotics|mesh-ancestor
92989738|NCT03987022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989739|NCT03987022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989740|NCT03987022|Analgesics|analgesics|mesh-ancestor
92989741|NCT03987022|Sensory System Agents|sensory system agents|mesh-ancestor
92989742|NCT03987022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989743|NCT03987022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92989744|NCT03987022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989745|NCT03987022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989746|NCT03987022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989747|NCT03987022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92989748|NCT03987022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989749|NCT03987022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989750|NCT03987022|Antipyretics|antipyretics|mesh-ancestor
92989751|NCT01025128|Vitamin D|vitamin d|mesh-list
92989752|NCT01025128|Vitamins|vitamins|mesh-ancestor
92989753|NCT01025128|Micronutrients|micronutrients|mesh-ancestor
92989754|NCT01025128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989755|NCT01025128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92989756|NCT00468910|Aspirin|aspirin|mesh-list
92989757|NCT00468910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92989758|NCT00468910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989759|NCT00468910|Analgesics|analgesics|mesh-ancestor
92989760|NCT00468910|Sensory System Agents|sensory system agents|mesh-ancestor
92989761|NCT00468910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989762|NCT00468910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989763|NCT00468910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989764|NCT00468910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989765|NCT00468910|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92989766|NCT00468910|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92989767|NCT00468910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989768|NCT00468910|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92989769|NCT00468910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92989770|NCT00468910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989771|NCT00468910|Antipyretics|antipyretics|mesh-ancestor
92989772|NCT01412333|Interferons|interferons|mesh-list
92989773|NCT01412333|Interferon-beta|interferon-beta|mesh-list
92989774|NCT01412333|Interferon beta-1a|interferon beta-1a|mesh-list
92989775|NCT01412333|Ocrelizumab|ocrelizumab|mesh-list
92989776|NCT01412333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989777|NCT01412333|Antiviral Agents|antiviral agents|mesh-ancestor
92989778|NCT01412333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989779|NCT01412333|Immunologic Factors|immunologic factors|mesh-ancestor
92989780|NCT01412333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989781|NCT01412333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92989782|NCT02577185|Botulinum Toxins|botulinum toxins|mesh-list
92989783|NCT02577185|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92989784|NCT02577185|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92989785|NCT02577185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92989786|NCT02577185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92989787|NCT02577185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989788|NCT02577185|Cholinergic Agents|cholinergic agents|mesh-ancestor
92989789|NCT02577185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989790|NCT02577185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989791|NCT02577185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92989792|NCT02577185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989793|NCT00519285|Prednisone|prednisone|mesh-list
92989794|NCT00519285|Prednisolone|prednisolone|mesh-list
92989795|NCT00519285|Docetaxel|docetaxel|mesh-list
92989796|NCT00519285|Aflibercept|aflibercept|mesh-list
92989797|NCT00519285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989798|NCT00519285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989799|NCT00519285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989800|NCT00519285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989801|NCT00519285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989802|NCT00519285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989803|NCT00519285|Glucocorticoids|glucocorticoids|mesh-ancestor
92989804|NCT00519285|Hormones|hormones|mesh-ancestor
92167770|NCT03056118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989805|NCT00519285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989806|NCT00519285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989807|NCT00519285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989808|NCT00519285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92989809|NCT00519285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92989810|NCT00519285|Growth Substances|growth substances|mesh-ancestor
92989811|NCT00519285|Growth Inhibitors|growth inhibitors|mesh-ancestor
92989812|NCT00464620|Dasatinib|dasatinib|mesh-list
92989813|NCT00464620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989814|NCT00464620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989815|NCT00464620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989816|NCT00464620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989817|NCT05212857|Leuprolide|leuprolide|mesh-list
92989818|NCT05212857|Goserelin|goserelin|mesh-list
92989819|NCT05212857|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92989820|NCT05212857|Abiraterone Acetate|abiraterone acetate|mesh-list
92989821|NCT05212857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92989822|NCT05212857|Fertility Agents|fertility agents|mesh-ancestor
92989823|NCT05212857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92989824|NCT05212857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989825|NCT05212857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989826|NCT05212857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989827|NCT05212857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92989828|NCT05212857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989829|NCT05212857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989830|NCT05212857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92989831|NCT05212857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989832|NCT05212857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92989833|NCT05212857|Luteolytic Agents|luteolytic agents|mesh-ancestor
92989834|NCT05212857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92989835|NCT05212857|Contraceptive Agents|contraceptive agents|mesh-ancestor
92989836|NCT05212857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92989837|NCT02099123|Atorvastatin|atorvastatin|mesh-list
92989838|NCT02099123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92989839|NCT02099123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92989840|NCT02099123|Antimetabolites|antimetabolites|mesh-ancestor
92989841|NCT02099123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989842|NCT02099123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92989843|NCT02099123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92989844|NCT02099123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989845|NCT00464542|Metronidazole|metronidazole|mesh-list
92989846|NCT00464542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989847|NCT00464542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92989848|NCT00464542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92989849|NCT00464542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92989850|NCT02578823|Antipyretics|antipyretics|mesh-list
92989851|NCT02578823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989852|NCT01969643|Trastuzumab|trastuzumab|mesh-list
92989853|NCT01969643|SGN-LIV1A|sgn-liv1a|mesh-list
92989854|NCT01969643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92989855|NCT01969643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989856|NCT01969643|Immunoconjugates|immunoconjugates|mesh-ancestor
92989857|NCT01969643|Immunologic Factors|immunologic factors|mesh-ancestor
92989858|NCT01969643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989859|NCT00464308|Esomeprazole|esomeprazole|mesh-list
92989860|NCT00464308|Rabeprazole|rabeprazole|mesh-list
92989861|NCT00464308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92989862|NCT00464308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989863|NCT00464308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92989864|NCT00464308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989865|NCT00464308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989866|NCT00463840|Fluorouracil|fluorouracil|mesh-list
92989867|NCT00463840|Oxaliplatin|oxaliplatin|mesh-list
92989868|NCT00463840|Antimetabolites|antimetabolites|mesh-ancestor
92989869|NCT00463840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989870|NCT00463840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989871|NCT00463840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989872|NCT00463840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989874|NCT00463840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989875|NCT00129389|Paclitaxel|paclitaxel|mesh-list
92989876|NCT00129389|Cyclophosphamide|cyclophosphamide|mesh-list
92989877|NCT00129389|Doxorubicin|doxorubicin|mesh-list
92989878|NCT00129389|Fluorouracil|fluorouracil|mesh-list
92989879|NCT00129389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92989880|NCT00129389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989881|NCT00129389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92989882|NCT00129389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92989883|NCT00129389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92989884|NCT00129389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989885|NCT00129389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989886|NCT00129389|Immunologic Factors|immunologic factors|mesh-ancestor
92989887|NCT00129389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989888|NCT00129389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92989889|NCT00129389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92989890|NCT00129389|Alkylating Agents|alkylating agents|mesh-ancestor
92989891|NCT00129389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92989892|NCT00129389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92989893|NCT00129389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92989894|NCT00129389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92989895|NCT00129389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989896|NCT00129389|Antimetabolites|antimetabolites|mesh-ancestor
92989897|NCT00129389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989898|NCT00468052|Fentanyl|fentanyl|mesh-list
92989899|NCT00468052|Dexmedetomidine|dexmedetomidine|mesh-list
92989900|NCT00468052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92989901|NCT00468052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92989902|NCT00468052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989903|NCT00468052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92989904|NCT00468052|Analgesics|analgesics|mesh-ancestor
92528253|NCT00014430|Trastuzumab|trastuzumab|mesh-list
92989905|NCT00468052|Sensory System Agents|sensory system agents|mesh-ancestor
92989906|NCT00468052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989907|NCT00468052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92989908|NCT00468052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92989909|NCT00468052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92989910|NCT00468052|Adrenergic Agents|adrenergic agents|mesh-ancestor
92989911|NCT00468052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989912|NCT00468052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989913|NCT00468052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92989914|NCT00468052|Narcotics|narcotics|mesh-ancestor
92989915|NCT00468052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92989916|NCT00468052|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92989917|NCT00468052|Anesthetics, General|anesthetics, general|mesh-ancestor
92989918|NCT00468052|Anesthetics|anesthetics|mesh-ancestor
92989919|NCT00453310|Sunitinib|sunitinib|mesh-list
92989920|NCT00453310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989921|NCT00453310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92989922|NCT00453310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92989923|NCT00453310|Growth Substances|growth substances|mesh-ancestor
92989924|NCT00453310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989925|NCT00453310|Growth Inhibitors|growth inhibitors|mesh-ancestor
92989926|NCT00453310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989927|NCT00453310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989928|NCT00453310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989929|NCT00128843|Anastrozole|anastrozole|mesh-list
92989930|NCT00128843|Exemestane|exemestane|mesh-list
92989931|NCT00128843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989932|NCT00128843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989933|NCT00128843|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92989934|NCT00128843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92989935|NCT00128843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989936|NCT00128843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989937|NCT00128843|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92989938|NCT00128843|Hormone Antagonists|hormone antagonists|mesh-ancestor
92989939|NCT00128843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989940|NCT00128843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989941|NCT04073927|Butyric Acid|butyric acid|mesh-list
92989942|NCT04073927|Histamine Antagonists|histamine antagonists|mesh-ancestor
92989943|NCT04073927|Histamine Agents|histamine agents|mesh-ancestor
92989944|NCT04073927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92989945|NCT04073927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989946|NCT04073927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989947|NCT00124657|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92989948|NCT00124657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989949|NCT00124657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989950|NCT00124657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989951|NCT00124657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989952|NCT02578277|BMS-955176|bms-955176|mesh-list
92989953|NCT02578277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92989954|NCT02578277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92989955|NCT02578277|Antiviral Agents|antiviral agents|mesh-ancestor
92989956|NCT02578277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989957|NCT00555906|Dexamethasone|dexamethasone|mesh-list
92989958|NCT00555906|Bortezomib|bortezomib|mesh-list
92989959|NCT00555906|Palbociclib|palbociclib|mesh-list
92989960|NCT00555906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92989961|NCT00555906|Antiemetics|antiemetics|mesh-ancestor
92989962|NCT00555906|Autonomic Agents|autonomic agents|mesh-ancestor
92989963|NCT00555906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92989964|NCT00555906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989965|NCT00555906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92989966|NCT00555906|Glucocorticoids|glucocorticoids|mesh-ancestor
92989967|NCT00555906|Hormones|hormones|mesh-ancestor
92989968|NCT00555906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92989969|NCT00555906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92989970|NCT00555906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989971|NCT00555906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989972|NCT00555906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989973|NCT00555906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989974|NCT04071353|Interferons|interferons|mesh-list
92989975|NCT04071353|Ribavirin|ribavirin|mesh-list
92989976|NCT04071353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989977|NCT04071353|Antiviral Agents|antiviral agents|mesh-ancestor
92989978|NCT04071353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92989979|NCT04071353|Antimetabolites|antimetabolites|mesh-ancestor
92989980|NCT04071353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989982|NCT00709475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92989983|NCT00709475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989984|NCT00555672|Fluorouracil|fluorouracil|mesh-list
92989985|NCT00555672|Sunitinib|sunitinib|mesh-list
92989986|NCT00555672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92989987|NCT00555672|Antimetabolites|antimetabolites|mesh-ancestor
92989988|NCT00555672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92989989|NCT00555672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92989990|NCT00555672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92989991|NCT00555672|Immunologic Factors|immunologic factors|mesh-ancestor
92989992|NCT00555672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92989993|NCT00555672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92989994|NCT00555672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92989995|NCT00555672|Growth Substances|growth substances|mesh-ancestor
92989996|NCT00555672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92989997|NCT00555672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92989998|NCT00555672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92989999|NCT02575547|Docetaxel|docetaxel|mesh-list
92990000|NCT02575547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990001|NCT02575547|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990002|NCT02575547|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990003|NCT02575547|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990004|NCT02575547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990005|NCT01037387|Bronchodilator Agents|bronchodilator agents|mesh-list
92990006|NCT01037387|Autonomic Agents|autonomic agents|mesh-ancestor
92990007|NCT01037387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990008|NCT01037387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990009|NCT01037387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92990010|NCT01037387|Respiratory System Agents|respiratory system agents|mesh-ancestor
92990011|NCT02574533|Pembrolizumab|pembrolizumab|mesh-list
92167793|NCT00987467|Cyclosporine|cyclosporine|mesh-list
92990012|NCT02574533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92990013|NCT02574533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92990014|NCT02574533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990015|NCT02574533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990016|NCT04652375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92990017|NCT00709553|Midazolam|midazolam|mesh-list
92990018|NCT00709553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92990019|NCT00709553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92990020|NCT00709553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92990021|NCT00709553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990022|NCT00709553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92990023|NCT00709553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92990024|NCT00709553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92990025|NCT00709553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92990026|NCT00709553|Anesthetics, General|anesthetics, general|mesh-ancestor
92990027|NCT00709553|Anesthetics|anesthetics|mesh-ancestor
92990028|NCT00709553|GABA Modulators|gaba modulators|mesh-ancestor
92990029|NCT00709553|GABA Agents|gaba agents|mesh-ancestor
92990030|NCT00709553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990031|NCT00709553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990032|NCT03958656|Cyclophosphamide|cyclophosphamide|mesh-list
92990033|NCT03958656|Fludarabine|fludarabine|mesh-list
92990034|NCT03958656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990035|NCT03958656|Immunologic Factors|immunologic factors|mesh-ancestor
92990036|NCT03958656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990037|NCT03958656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92990038|NCT03958656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92990039|NCT03958656|Alkylating Agents|alkylating agents|mesh-ancestor
92990040|NCT03958656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990041|NCT03958656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990042|NCT03958656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92990043|NCT00561912|Interferons|interferons|mesh-list
92990044|NCT00561912|Interferon-alpha|interferon-alpha|mesh-list
92990045|NCT00561912|Interferon alpha-2|interferon alpha-2|mesh-list
92990046|NCT00561912|Decitabine|decitabine|mesh-list
92990047|NCT00561912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990048|NCT00561912|Antiviral Agents|antiviral agents|mesh-ancestor
92990049|NCT00561912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990050|NCT00561912|Immunologic Factors|immunologic factors|mesh-ancestor
92990051|NCT00561912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990052|NCT00561912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990053|NCT00561912|Antimetabolites|antimetabolites|mesh-ancestor
92990054|NCT00561912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990055|NCT00561912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990056|NCT00561678|Dexmedetomidine|dexmedetomidine|mesh-list
92990057|NCT00561678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92990058|NCT00561678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92990059|NCT00561678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990060|NCT00561678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92990061|NCT00561678|Analgesics|analgesics|mesh-ancestor
92990062|NCT00561678|Sensory System Agents|sensory system agents|mesh-ancestor
92990063|NCT00561678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990064|NCT00561678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92990065|NCT00561678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92990066|NCT00561678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92990067|NCT00561678|Adrenergic Agents|adrenergic agents|mesh-ancestor
92990068|NCT00561678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990069|NCT00561678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990070|NCT00946608|Loratadine|loratadine|mesh-list
92990071|NCT00946608|Antipruritics|antipruritics|mesh-ancestor
92990072|NCT00946608|Dermatologic Agents|dermatologic agents|mesh-ancestor
92990073|NCT00946608|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92990074|NCT00946608|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92990075|NCT00946608|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92990076|NCT00946608|Histamine Antagonists|histamine antagonists|mesh-ancestor
92990077|NCT00946608|Histamine Agents|histamine agents|mesh-ancestor
92990078|NCT00946608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990079|NCT00946608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990080|NCT00946608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990081|NCT00463684|Vaccines|vaccines|mesh-list
92990082|NCT00463684|Immunologic Factors|immunologic factors|mesh-ancestor
92990083|NCT00463684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990084|NCT00463606|Calcium, Dietary|calcium, dietary|mesh-list
92990085|NCT00463606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92990086|NCT00463606|Fenofibric acid|fenofibric acid|mesh-list
92990087|NCT00463606|Calcium|calcium|mesh-list
92990088|NCT00463606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92990089|NCT00463606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990090|NCT00463606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92990091|NCT00463606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92990092|NCT00463606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92990093|NCT00463606|Antimetabolites|antimetabolites|mesh-ancestor
92990094|NCT00463606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990095|NCT00463606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92990096|NCT00463606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92990097|NCT00463606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990099|NCT03961308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92990100|NCT00956436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92990101|NCT00956436|Sorafenib|sorafenib|mesh-list
92990102|NCT00956436|Liver Extracts|liver extracts|mesh-list
92990103|NCT00956436|Antibodies|antibodies|mesh-list
92990104|NCT00956436|Immunoglobulins|immunoglobulins|mesh-list
92990105|NCT00956436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92990106|NCT00956436|Immunologic Factors|immunologic factors|mesh-ancestor
92990107|NCT00956436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990108|NCT00956436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990109|NCT00956436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990110|NCT00956436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990111|NCT00956436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990112|NCT00956436|Hematinics|hematinics|mesh-ancestor
92990113|NCT00950586|Dextromethorphan|dextromethorphan|mesh-list
92990114|NCT00950586|Antitussive Agents|antitussive agents|mesh-ancestor
92990115|NCT00950586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92990116|NCT00950586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92990117|NCT00950586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92990118|NCT00950586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990119|NCT00950586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990120|NCT00950586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990121|NCT00467896|Iloprost|iloprost|mesh-list
92990122|NCT00467896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92990123|NCT00467896|Vasodilator Agents|vasodilator agents|mesh-ancestor
92990124|NCT00946686|Leflunomide|leflunomide|mesh-list
92990125|NCT00946686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990126|NCT00946686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990127|NCT00946686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990129|NCT00946686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990130|NCT02531737|Docetaxel|docetaxel|mesh-list
92990131|NCT02531737|Nintedanib|nintedanib|mesh-list
92990132|NCT02531737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990133|NCT02531737|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990134|NCT02531737|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990135|NCT02531737|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990136|NCT02531737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990137|NCT02531737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990138|NCT02531737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990139|NCT01326559|Docetaxel|docetaxel|mesh-list
92990140|NCT01326559|Cetuximab|cetuximab|mesh-list
92990141|NCT01326559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990142|NCT01326559|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990143|NCT01326559|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990144|NCT01326559|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990145|NCT01326559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990146|NCT01326559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92990147|NCT04069949|Sorafenib|sorafenib|mesh-list
92990148|NCT04069949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990149|NCT04069949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990150|NCT04069949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990151|NCT04069949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990152|NCT02575235|Cetylpyridinium|cetylpyridinium|mesh-list
92990153|NCT02575235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92990154|NCT02575235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990155|NCT00467740|Olodaterol|olodaterol|mesh-list
92990156|NCT00467740|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92990157|NCT00467740|Autonomic Agents|autonomic agents|mesh-ancestor
92990158|NCT00467740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990159|NCT00467740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990160|NCT00467740|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92990161|NCT00467740|Respiratory System Agents|respiratory system agents|mesh-ancestor
92990162|NCT00710099|Sildenafil Citrate|sildenafil citrate|mesh-list
92990163|NCT00710099|Vasodilator Agents|vasodilator agents|mesh-ancestor
92990164|NCT00710099|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92990165|NCT00710099|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92990166|NCT00710099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990167|NCT00710099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635558|NCT00183404|Serotonin Agents|serotonin agents|mesh-ancestor
92990168|NCT00710099|Urological Agents|urological agents|mesh-ancestor
92990169|NCT03944044|Acetaminophen|acetaminophen|mesh-list
92990170|NCT03944044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92990171|NCT03944044|Analgesics|analgesics|mesh-ancestor
92990172|NCT03944044|Sensory System Agents|sensory system agents|mesh-ancestor
92990173|NCT03944044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990174|NCT03944044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990175|NCT03944044|Antipyretics|antipyretics|mesh-ancestor
92990177|NCT00714623|Temsirolimus|temsirolimus|mesh-list
92990178|NCT00714623|MTOR Inhibitors|mtor inhibitors|mesh-list
92990179|NCT00714623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92990180|NCT00714623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990181|NCT00714623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92990182|NCT00714623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990183|NCT00714623|Antifungal Agents|antifungal agents|mesh-ancestor
92990184|NCT00714623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990185|NCT00714623|Immunologic Factors|immunologic factors|mesh-ancestor
92990186|NCT00714623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990187|NCT00714623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990188|NCT00714623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990189|NCT00714623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990190|NCT01022476|Raltegravir Potassium|raltegravir potassium|mesh-list
92990191|NCT01022476|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92990192|NCT01022476|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92990193|NCT01022476|Antiviral Agents|antiviral agents|mesh-ancestor
92990194|NCT01022476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990195|NCT01022476|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92990196|NCT01022476|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92990197|NCT01022476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990198|NCT01022476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990199|NCT02575001|Hydrocortisone|hydrocortisone|mesh-list
92990200|NCT02575001|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92990201|NCT02575001|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92990202|NCT02575001|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92990203|NCT02575001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990204|NCT01021930|Sirolimus|sirolimus|mesh-list
92990205|NCT01021930|Paclitaxel|paclitaxel|mesh-list
92990206|NCT01021930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92990207|NCT01021930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990208|NCT01021930|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990209|NCT01021930|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990210|NCT01021930|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990211|NCT01021930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990212|NCT01021930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92990213|NCT01021930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990214|NCT01021930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92990215|NCT01021930|Antifungal Agents|antifungal agents|mesh-ancestor
92990216|NCT01021930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990217|NCT01021930|Immunologic Factors|immunologic factors|mesh-ancestor
92990218|NCT01021930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990219|NCT00946764|Imipramine|imipramine|mesh-list
92990220|NCT00946764|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92990221|NCT00946764|Antidepressive Agents|antidepressive agents|mesh-ancestor
92990222|NCT00946764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92990223|NCT00946764|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92990224|NCT00946764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92990225|NCT00946764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990226|NCT00946764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990227|NCT00946764|Adrenergic Agents|adrenergic agents|mesh-ancestor
92990228|NCT00946764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990229|NCT00946764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990230|NCT00950820|Capecitabine|capecitabine|mesh-list
92990231|NCT00950820|Oxaliplatin|oxaliplatin|mesh-list
92990232|NCT00950820|Panitumumab|panitumumab|mesh-list
92990233|NCT00950820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990234|NCT00950820|Antimetabolites|antimetabolites|mesh-ancestor
92990235|NCT00950820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990236|NCT00950820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990237|NCT00950820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92990238|NCT00950898|Caffeine|caffeine|mesh-list
92990239|NCT00950898|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92990240|NCT00950898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990241|NCT00950898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92990242|NCT00950898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990243|NCT00950898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990244|NCT00950898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92990245|NCT00950898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92990246|NCT00950898|Purinergic Agents|purinergic agents|mesh-ancestor
92990247|NCT00950898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990248|NCT00168805|Enoxaparin|enoxaparin|mesh-list
92990249|NCT00168805|Dabigatran|dabigatran|mesh-list
92990250|NCT00168805|Anticoagulants|anticoagulants|mesh-ancestor
92990251|NCT00168805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92990252|NCT00168805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92990253|NCT00168805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990254|NCT00168805|Antithrombins|antithrombins|mesh-ancestor
92990255|NCT00168805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92990256|NCT00168805|Protease Inhibitors|protease inhibitors|mesh-ancestor
92990257|NCT00168805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990258|NCT00467584|Aspirin|aspirin|mesh-list
92990259|NCT00467584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92990260|NCT00467584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92990261|NCT00467584|Analgesics|analgesics|mesh-ancestor
92990262|NCT00467584|Sensory System Agents|sensory system agents|mesh-ancestor
92990263|NCT00467584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990264|NCT00467584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990265|NCT00467584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990266|NCT00467584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92990267|NCT00467584|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92990268|NCT00467584|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92990269|NCT00467584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990270|NCT00467584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92990271|NCT00467584|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92990272|NCT00467584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990273|NCT00467584|Antipyretics|antipyretics|mesh-ancestor
92990274|NCT02574611|Glycopyrrolate|glycopyrrolate|mesh-list
92990275|NCT02574611|Neostigmine|neostigmine|mesh-list
92990276|NCT02574611|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92990277|NCT02574611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990278|NCT02574611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990279|NCT02574611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92990280|NCT02574611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990281|NCT02574611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990282|NCT02574611|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92990283|NCT02574611|Autonomic Agents|autonomic agents|mesh-ancestor
92990284|NCT02574611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990285|NCT02574611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92990286|NCT02574611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92990287|NCT02574611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92990288|NCT00714779|Fluoxetine|fluoxetine|mesh-list
92990289|NCT00714779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92990290|NCT00714779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92990291|NCT00714779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990292|NCT00714779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990293|NCT00714779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990294|NCT00714779|Serotonin Agents|serotonin agents|mesh-ancestor
92990295|NCT00714779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990296|NCT00714779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92990297|NCT00714779|Antidepressive Agents|antidepressive agents|mesh-ancestor
92990298|NCT00714779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92990299|NCT00714779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92990300|NCT00714779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92990301|NCT00714779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990302|NCT00168103|Complement C1s|complement c1s|mesh-list
92990303|NCT00168103|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92990304|NCT00168103|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92990305|NCT00168103|Immunologic Factors|immunologic factors|mesh-ancestor
92990306|NCT00168103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990307|NCT00168103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92990308|NCT00168103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990309|NCT00463060|Sunitinib|sunitinib|mesh-list
92990310|NCT00463060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990311|NCT00463060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92990312|NCT00463060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92990313|NCT00463060|Growth Substances|growth substances|mesh-ancestor
92990314|NCT00463060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990315|NCT00463060|Growth Inhibitors|growth inhibitors|mesh-ancestor
92990316|NCT00463060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990317|NCT00463060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990318|NCT00463060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990320|NCT03964753|Cisplatin|cisplatin|mesh-list
92990321|NCT03964753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92990322|NCT03964753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990323|NCT03964753|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990324|NCT03964753|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990325|NCT03964753|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990326|NCT03964753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990327|NCT00956748|Acetylcysteine|acetylcysteine|mesh-list
92990328|NCT00956748|Ciprofloxacin|ciprofloxacin|mesh-list
92990329|NCT00956748|Dexamethasone|dexamethasone|mesh-list
92990330|NCT00956748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990331|NCT00956748|Antiemetics|antiemetics|mesh-ancestor
92990332|NCT00956748|Autonomic Agents|autonomic agents|mesh-ancestor
92990333|NCT00956748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990334|NCT00956748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990335|NCT00956748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92990336|NCT00956748|Glucocorticoids|glucocorticoids|mesh-ancestor
92990337|NCT00956748|Hormones|hormones|mesh-ancestor
92990338|NCT00956748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990339|NCT00956748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92990340|NCT00956748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990341|NCT00956748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990342|NCT00956748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990343|NCT00956748|Antiviral Agents|antiviral agents|mesh-ancestor
92990344|NCT00956748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990345|NCT00956748|Expectorants|expectorants|mesh-ancestor
92990346|NCT00956748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92990347|NCT00956748|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92990348|NCT00956748|Antioxidants|antioxidants|mesh-ancestor
92990349|NCT00956748|Protective Agents|protective agents|mesh-ancestor
92990350|NCT00956748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92990351|NCT00956748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92990352|NCT00956748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92990353|NCT00956748|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92990354|NCT00956748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92990355|NCT01079923|Vitamin D|vitamin d|mesh-list
92990356|NCT01079923|Ergocalciferols|ergocalciferols|mesh-list
92990357|NCT01079923|Cholecalciferol|cholecalciferol|mesh-list
92990358|NCT01079923|Vitamins|vitamins|mesh-list
92990359|NCT01079923|Micronutrients|micronutrients|mesh-ancestor
92990360|NCT01079923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990361|NCT01079923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92990362|NCT01079923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92990363|NCT00947076|Fluoxetine|fluoxetine|mesh-list
92990364|NCT00947076|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92990365|NCT00947076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92990366|NCT00947076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990367|NCT00947076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990368|NCT00947076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990369|NCT00947076|Serotonin Agents|serotonin agents|mesh-ancestor
92990370|NCT00947076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990371|NCT00947076|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92990372|NCT00947076|Antidepressive Agents|antidepressive agents|mesh-ancestor
92990373|NCT00947076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92990374|NCT00947076|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92990375|NCT00947076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92990376|NCT00947076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990377|NCT00462982|Sunitinib|sunitinib|mesh-list
92990378|NCT00462982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990379|NCT00462982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92990380|NCT00462982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92990381|NCT00462982|Growth Substances|growth substances|mesh-ancestor
92990382|NCT00462982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990383|NCT00462982|Growth Inhibitors|growth inhibitors|mesh-ancestor
92990384|NCT00462982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990385|NCT00462982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990386|NCT00462982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990387|NCT02573597|Sufentanil|sufentanil|mesh-list
92990388|NCT02573597|Bupivacaine|bupivacaine|mesh-list
92990389|NCT02573597|Anesthetics, Local|anesthetics, local|mesh-ancestor
92990390|NCT02573597|Anesthetics|anesthetics|mesh-ancestor
92990391|NCT02573597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92990392|NCT02573597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990393|NCT02573597|Sensory System Agents|sensory system agents|mesh-ancestor
92990394|NCT02573597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990395|NCT02573597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92990397|NCT02573597|Analgesics|analgesics|mesh-ancestor
92990398|NCT02573597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92990399|NCT02573597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92990400|NCT02573597|Anesthetics, General|anesthetics, general|mesh-ancestor
92990401|NCT05300958|Deferoxamine|deferoxamine|mesh-list
92990402|NCT05300958|Siderophores|siderophores|mesh-ancestor
92990403|NCT05300958|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92990404|NCT05300958|Chelating Agents|chelating agents|mesh-ancestor
92990405|NCT05300958|Sequestering Agents|sequestering agents|mesh-ancestor
92990406|NCT05300958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990407|NCT04070729|Hyaluronic Acid|hyaluronic acid|mesh-list
92990408|NCT04070729|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92990409|NCT04070729|Immunologic Factors|immunologic factors|mesh-ancestor
92990410|NCT04070729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990411|NCT04070729|Viscosupplements|viscosupplements|mesh-ancestor
92990412|NCT04070729|Protective Agents|protective agents|mesh-ancestor
92990413|NCT00467272|Daptomycin|daptomycin|mesh-list
92990414|NCT00467272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92990415|NCT00467272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990416|NCT00956982|Interferons|interferons|mesh-list
92990417|NCT00956982|Ribavirin|ribavirin|mesh-list
92990418|NCT00956982|Interferon-alpha|interferon-alpha|mesh-list
92167823|NCT05874180|Metformin|metformin|mesh-list
92990419|NCT00956982|Interferon alpha-2|interferon alpha-2|mesh-list
92990420|NCT00956982|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92990421|NCT00956982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990422|NCT00956982|Antiviral Agents|antiviral agents|mesh-ancestor
92990423|NCT00956982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990424|NCT00956982|Antimetabolites|antimetabolites|mesh-ancestor
92990425|NCT00956982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990426|NCT00956982|Immunologic Factors|immunologic factors|mesh-ancestor
92990427|NCT00956982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990428|NCT00714857|Dexmedetomidine|dexmedetomidine|mesh-list
92990429|NCT00714857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92990430|NCT00714857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92990431|NCT00714857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990432|NCT00714857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92990433|NCT00714857|Analgesics|analgesics|mesh-ancestor
92990434|NCT00714857|Sensory System Agents|sensory system agents|mesh-ancestor
92990435|NCT00714857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990436|NCT00714857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92990437|NCT00714857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92990438|NCT00714857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92990439|NCT00714857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92990440|NCT00714857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990441|NCT00714857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990442|NCT00957060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92990443|NCT00957060|Glimepiride|glimepiride|mesh-list
92990444|NCT00957060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990445|NCT00957060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990446|NCT00957060|Incretins|incretins|mesh-ancestor
92990447|NCT00957060|Hormones|hormones|mesh-ancestor
92990448|NCT00957060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990449|NCT00957060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92990450|NCT00957060|Protease Inhibitors|protease inhibitors|mesh-ancestor
92990451|NCT00957060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990452|NCT00957060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990453|NCT00957060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92990454|NCT00957060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990455|NCT00957060|Immunologic Factors|immunologic factors|mesh-ancestor
92990456|NCT02573519|Acetylcholine|acetylcholine|mesh-list
92990457|NCT02573519|Donepezil|donepezil|mesh-list
92990458|NCT02573519|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92990459|NCT02573519|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92990460|NCT02573519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990461|NCT02573519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990462|NCT02573519|Cholinergic Agents|cholinergic agents|mesh-ancestor
92990463|NCT02573519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990464|NCT02573519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990465|NCT02573519|Nootropic Agents|nootropic agents|mesh-ancestor
92990466|NCT02573519|Vasodilator Agents|vasodilator agents|mesh-ancestor
92635846|NCT00210561|Antipyretics|antipyretics|mesh-ancestor
92990467|NCT02573519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92990468|NCT02572583|Oseltamivir|oseltamivir|mesh-list
92990469|NCT02572583|Antiviral Agents|antiviral agents|mesh-ancestor
92990470|NCT02572583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990471|NCT02572583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990472|NCT02572583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990473|NCT00951444|Carboplatin|carboplatin|mesh-list
92990474|NCT00951444|Gemcitabine|gemcitabine|mesh-list
92990475|NCT00951444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990476|NCT00951444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990477|NCT00951444|Antimetabolites|antimetabolites|mesh-ancestor
92990478|NCT00951444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990479|NCT00462826|Aflibercept|aflibercept|mesh-list
92990480|NCT00462826|Endothelial Growth Factors|endothelial growth factors|mesh-list
92990481|NCT00462826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92990482|NCT00462826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92990483|NCT00462826|Growth Substances|growth substances|mesh-ancestor
92990484|NCT00462826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990485|NCT00462826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92990486|NCT00462826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990487|NCT00718601|Imetelstat|imetelstat|mesh-list
92990488|NCT00718601|Motesanib diphosphate|motesanib diphosphate|mesh-list
92990489|NCT00718601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990490|NCT00718601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990491|NCT00718601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990492|NCT00947388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92990493|NCT00947388|Alemtuzumab|alemtuzumab|mesh-list
92990494|NCT00947388|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92990495|NCT00947388|Antibodies|antibodies|mesh-list
92990496|NCT00947388|Immunoglobulins|immunoglobulins|mesh-list
92990497|NCT00947388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92990498|NCT00947388|Immunologic Factors|immunologic factors|mesh-ancestor
92990499|NCT00947388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990500|NCT00947388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990501|NCT00947388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92990502|NCT00947388|Alkylating Agents|alkylating agents|mesh-ancestor
92990503|NCT00947388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990504|NCT00951600|Oxcarbazepine|oxcarbazepine|mesh-list
92990505|NCT00951600|Anticonvulsants|anticonvulsants|mesh-ancestor
92990506|NCT00951600|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92990507|NCT00951600|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92990508|NCT00951600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990509|NCT00951600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990510|NCT00951600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92990511|NCT00951600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92990512|NCT03910985|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
92990513|NCT03910985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92990514|NCT03910985|Autonomic Agents|autonomic agents|mesh-ancestor
92990515|NCT03910985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990516|NCT03910985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990517|NCT03910985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92990518|NCT03910985|Respiratory System Agents|respiratory system agents|mesh-ancestor
92990519|NCT00957216|Ubiquinone|ubiquinone|mesh-list
92990520|NCT00957216|Coenzyme Q10|coenzyme q10|mesh-list
92990521|NCT00957216|Micronutrients|micronutrients|mesh-ancestor
92990522|NCT00957216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990523|NCT00957216|Vitamins|vitamins|mesh-ancestor
92990524|NCT00718757|Dexamethasone|dexamethasone|mesh-list
92990525|NCT00718757|Irinotecan|irinotecan|mesh-list
92990526|NCT00718757|Vincristine|vincristine|mesh-list
92990527|NCT00718757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990528|NCT00718757|Antiemetics|antiemetics|mesh-ancestor
92990529|NCT00718757|Autonomic Agents|autonomic agents|mesh-ancestor
92990530|NCT00718757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990531|NCT00718757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990532|NCT00718757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92990533|NCT00718757|Glucocorticoids|glucocorticoids|mesh-ancestor
92990534|NCT00718757|Hormones|hormones|mesh-ancestor
92990535|NCT00718757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990536|NCT00718757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92990537|NCT00718757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990538|NCT00718757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92990539|NCT00718757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92990540|NCT00718757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635930|NCT00184496|Methadone|methadone|mesh-list
92990541|NCT00718757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990542|NCT00718757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92990543|NCT00718757|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990544|NCT00718757|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990545|NCT00718757|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990547|NCT00947466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92990548|NCT00947466|Narcotics|narcotics|mesh-ancestor
92990549|NCT00947466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92990550|NCT00947466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990551|NCT00947466|Analgesics|analgesics|mesh-ancestor
92990552|NCT00947466|Sensory System Agents|sensory system agents|mesh-ancestor
92990553|NCT00947466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990554|NCT00947466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92990555|NCT00951834|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92990556|NCT00951834|Antioxidants|antioxidants|mesh-ancestor
92990557|NCT00951834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990558|NCT00951834|Protective Agents|protective agents|mesh-ancestor
92990559|NCT00951834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990560|NCT00951834|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92990561|NCT00951834|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92990562|NCT00951834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990563|NCT00951834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92990564|NCT00715013|Epothilone B|epothilone b|mesh-list
92990565|NCT00715013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990566|NCT00715013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990567|NCT00715013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990568|NCT00715013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990569|NCT00715013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990570|NCT00715091|Diclofenac|diclofenac|mesh-list
92990571|NCT00715091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92990572|NCT00715091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92990574|NCT00715091|Sensory System Agents|sensory system agents|mesh-ancestor
92990575|NCT00715091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990576|NCT00715091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990577|NCT00715091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990578|NCT00715091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92990579|NCT00715091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92990580|NCT00715091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990581|NCT00715091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990582|NCT00718913|Docetaxel|docetaxel|mesh-list
92990583|NCT00718913|Capecitabine|capecitabine|mesh-list
92990584|NCT00718913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990585|NCT00718913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92990586|NCT00718913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92990587|NCT00718913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92990588|NCT00718913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990589|NCT00718913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990590|NCT00718913|Antimetabolites|antimetabolites|mesh-ancestor
92990591|NCT04011930|Vitamin D|vitamin d|mesh-list
92990592|NCT04011930|Cholecalciferol|cholecalciferol|mesh-list
92990593|NCT04011930|Calcitriol|calcitriol|mesh-list
92990594|NCT04011930|Vitamins|vitamins|mesh-ancestor
92990595|NCT04011930|Micronutrients|micronutrients|mesh-ancestor
92990596|NCT04011930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990597|NCT04011930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92990598|NCT04011930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92990599|NCT04011930|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92990600|NCT04011930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990601|NCT04011930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990602|NCT04011930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92990603|NCT00551616|Levonorgestrel|levonorgestrel|mesh-list
92990604|NCT00551616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92990605|NCT00551616|Contraceptive Agents|contraceptive agents|mesh-ancestor
92990606|NCT00551616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92990607|NCT00551616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990608|NCT00551616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92990609|NCT00551616|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92990610|NCT00551616|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92990611|NCT02574221|Fluorides|fluorides|mesh-list
92990612|NCT02574221|Tin Fluorides|tin fluorides|mesh-list
92990613|NCT02574221|Cariostatic Agents|cariostatic agents|mesh-ancestor
92636011|NCT00184847|Analgesics|analgesics|mesh-ancestor
92990614|NCT02574221|Protective Agents|protective agents|mesh-ancestor
92990615|NCT02574221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990616|NCT00452530|Enoxaparin|enoxaparin|mesh-list
92990617|NCT00452530|Enoxaparin sodium|enoxaparin sodium|mesh-list
92990618|NCT00452530|Apixaban|apixaban|mesh-list
92990619|NCT00452530|Anticoagulants|anticoagulants|mesh-ancestor
92990620|NCT00452530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92990621|NCT00452530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92990622|NCT00452530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990623|NCT00452530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92990624|NCT00452530|Antithrombins|antithrombins|mesh-ancestor
92990625|NCT00452530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92990626|NCT00452530|Protease Inhibitors|protease inhibitors|mesh-ancestor
92990627|NCT00452530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990628|NCT00549198|Tenofovir|tenofovir|mesh-list
92990629|NCT00549198|Lamivudine|lamivudine|mesh-list
92990630|NCT00549198|Emtricitabine|emtricitabine|mesh-list
92990631|NCT00549198|Efavirenz|efavirenz|mesh-list
92990632|NCT00549198|Abacavir|abacavir|mesh-list
92990633|NCT00549198|Antiviral Agents|antiviral agents|mesh-ancestor
92990634|NCT00549198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990635|NCT00549198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92990636|NCT00549198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92990637|NCT00549198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990638|NCT00549198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990639|NCT00549198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92990640|NCT00549198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92990641|NCT00549198|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92990642|NCT00549198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92990643|NCT00549198|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92990644|NCT00549198|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92336066|NCT02058108|Telbivudine|telbivudine|mesh-list
92990645|NCT00549198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92990646|NCT00549198|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92990648|NCT00506415|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92990649|NCT00506415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990650|NCT00506415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990651|NCT00506415|Cholinergic Agents|cholinergic agents|mesh-ancestor
92990652|NCT00506415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990653|NCT00506415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990654|NCT00506415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92990655|NCT00506415|Protective Agents|protective agents|mesh-ancestor
92990656|NCT04036526|Vaccines|vaccines|mesh-list
92990657|NCT04036526|Immunologic Factors|immunologic factors|mesh-ancestor
92990658|NCT04036526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990659|NCT00452452|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92990660|NCT00452452|Immunologic Factors|immunologic factors|mesh-ancestor
92990661|NCT00452452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990662|NCT01009437|Ritonavir|ritonavir|mesh-list
92990663|NCT01009437|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92990664|NCT01009437|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92990665|NCT01009437|Protease Inhibitors|protease inhibitors|mesh-ancestor
92990666|NCT01009437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990667|NCT01009437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990668|NCT01009437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92990669|NCT01009437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92990670|NCT01009437|Antiviral Agents|antiviral agents|mesh-ancestor
92990671|NCT01009437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990672|NCT01009437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92990673|NCT01009437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92990674|NCT00719381|Pioglitazone|pioglitazone|mesh-list
92990675|NCT00719381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990676|NCT00719381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990677|NCT00510783|Phenytoin|phenytoin|mesh-list
92990678|NCT00510783|Fosphenytoin|fosphenytoin|mesh-list
92990679|NCT00510783|Levetiracetam|levetiracetam|mesh-list
92990680|NCT00510783|Anticonvulsants|anticonvulsants|mesh-ancestor
92990681|NCT00510783|Nootropic Agents|nootropic agents|mesh-ancestor
92990682|NCT00510783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92990683|NCT00510783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92990684|NCT00510783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990685|NCT00510783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990686|NCT00510783|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92990687|NCT00510783|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92990688|NCT00952302|Iron|iron|mesh-list
92636077|NCT00218049|Dopamine Agents|dopamine agents|mesh-ancestor
92990689|NCT00952302|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92990690|NCT00952302|Trace Elements|trace elements|mesh-ancestor
92990691|NCT00952302|Micronutrients|micronutrients|mesh-ancestor
92990692|NCT00952302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990693|NCT00952302|Hematinics|hematinics|mesh-ancestor
92990694|NCT00518973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92990695|NCT00518973|Antidepressive Agents|antidepressive agents|mesh-ancestor
92990696|NCT00518973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92990697|NCT00518973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92990698|NCT00518973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92990699|NCT00518973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167852|NCT05874141|Hormones|hormones|mesh-list
92990700|NCT00518973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990701|NCT05300334|Adenosine|adenosine|mesh-list
92990702|NCT05300334|Analgesics|analgesics|mesh-ancestor
92990703|NCT05300334|Sensory System Agents|sensory system agents|mesh-ancestor
92990704|NCT05300334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990705|NCT05300334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990706|NCT05300334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92990707|NCT05300334|Vasodilator Agents|vasodilator agents|mesh-ancestor
92990708|NCT05300334|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92990709|NCT05300334|Purinergic Agonists|purinergic agonists|mesh-ancestor
92990710|NCT05300334|Purinergic Agents|purinergic agents|mesh-ancestor
92990711|NCT05300334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990712|NCT05300334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990713|NCT00897884|Metformin|metformin|mesh-list
92990714|NCT00897884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990715|NCT00897884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528262|NCT00035425|Vancomycin|vancomycin|mesh-list
92990717|NCT01022164|Hemostatics|hemostatics|mesh-ancestor
92990718|NCT01022164|Coagulants|coagulants|mesh-ancestor
92990719|NCT01012479|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92990720|NCT01012479|Candesartan|candesartan|mesh-list
92990721|NCT01012479|Candesartan cilexetil|candesartan cilexetil|mesh-list
92990722|NCT01012479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92990723|NCT01012479|Diuretics|diuretics|mesh-ancestor
92990724|NCT01012479|Natriuretic Agents|natriuretic agents|mesh-ancestor
92990725|NCT01012479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990726|NCT01012479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92990727|NCT01012479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990728|NCT01012479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990729|NCT01012479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92990730|NCT01012479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92990731|NCT02541734|Exenatide|exenatide|mesh-list
92990732|NCT02541734|Polygeline|polygeline|mesh-list
92990733|NCT02541734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990734|NCT02541734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990735|NCT02541734|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92990736|NCT02541734|Incretins|incretins|mesh-ancestor
92990737|NCT02541734|Hormones|hormones|mesh-ancestor
92990738|NCT02541734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990739|NCT02541734|Plasma Substitutes|plasma substitutes|mesh-ancestor
92990740|NCT02541734|Blood Substitutes|blood substitutes|mesh-ancestor
92990741|NCT00462670|Tolvaptan|tolvaptan|mesh-list
92990742|NCT00462670|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92990743|NCT00462670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990744|NCT00462670|Natriuretic Agents|natriuretic agents|mesh-ancestor
92990745|NCT00462670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990746|NCT01009593|Sorafenib|sorafenib|mesh-list
92990747|NCT01009593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990748|NCT01009593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92990749|NCT01009593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990750|NCT01009593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990751|NCT00719459|Iron|iron|mesh-list
92990752|NCT00719459|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92990753|NCT00719459|Trace Elements|trace elements|mesh-ancestor
92990754|NCT00719459|Micronutrients|micronutrients|mesh-ancestor
92990755|NCT00719459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990756|NCT00719459|Hematinics|hematinics|mesh-ancestor
92990757|NCT00711503|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92990758|NCT00711503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92990759|NCT00948168|Exenatide|exenatide|mesh-list
92990760|NCT00948168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990761|NCT00948168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990762|NCT00948168|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92990763|NCT00948168|Incretins|incretins|mesh-ancestor
92990764|NCT00948168|Hormones|hormones|mesh-ancestor
92990765|NCT00948168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990767|NCT00958386|Panitumumab|panitumumab|mesh-list
92990768|NCT00958386|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92990769|NCT00958386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92990770|NCT00958386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990771|NCT00958386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990772|NCT00958386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167855|NCT05873972|Cetuximab|cetuximab|mesh-list
92990773|NCT00958386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92990774|NCT00719693|Calcium, Dietary|calcium, dietary|mesh-list
92990775|NCT00719693|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92990776|NCT00719693|Fenofibric acid|fenofibric acid|mesh-list
92990777|NCT00719693|Fenofibrate|fenofibrate|mesh-list
92990778|NCT00719693|Calcium|calcium|mesh-list
92990779|NCT00719693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92990780|NCT00719693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990781|NCT00719693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92990782|NCT00719693|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92990783|NCT00719693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92990784|NCT00719693|Antimetabolites|antimetabolites|mesh-ancestor
92990785|NCT00719693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990786|NCT00719693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92990787|NCT00719693|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92990788|NCT00719693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990789|NCT00948402|Metformin|metformin|mesh-list
92990790|NCT00948402|Biguanides|biguanides|mesh-list
92990791|NCT00948402|Contraceptive Agents|contraceptive agents|mesh-list
92990792|NCT00948402|Contraceptives, Oral|contraceptives, oral|mesh-list
92990793|NCT00948402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990794|NCT00948402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990795|NCT00948402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92990796|NCT00948402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92990797|NCT05352126|Disinfectants|disinfectants|mesh-list
92990798|NCT05352126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990799|NCT00948480|Sargramostim|sargramostim|mesh-list
92990800|NCT00948480|Immunologic Factors|immunologic factors|mesh-ancestor
92990801|NCT00948480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990802|NCT03753555|Calcium, Dietary|calcium, dietary|mesh-list
92990803|NCT03753555|Atorvastatin|atorvastatin|mesh-list
92990804|NCT03753555|Probucol|probucol|mesh-list
92990805|NCT03753555|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92990806|NCT03753555|Calcium|calcium|mesh-list
92990807|NCT03753555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92990808|NCT03753555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990809|NCT03753555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92990810|NCT03753555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92990811|NCT03753555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92990812|NCT03753555|Antimetabolites|antimetabolites|mesh-ancestor
92990813|NCT03753555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990814|NCT03753555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92990815|NCT03753555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92990816|NCT03753555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990817|NCT03753555|Antioxidants|antioxidants|mesh-ancestor
92990818|NCT03753555|Protective Agents|protective agents|mesh-ancestor
92990819|NCT03753555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92990820|NCT03753555|Protease Inhibitors|protease inhibitors|mesh-ancestor
92990821|NCT00606086|Interferons|interferons|mesh-list
92990822|NCT00606086|Ribavirin|ribavirin|mesh-list
92990823|NCT00606086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92990824|NCT00606086|Interferon-alpha|interferon-alpha|mesh-list
92990825|NCT00606086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990826|NCT00606086|Antiviral Agents|antiviral agents|mesh-ancestor
92990827|NCT00606086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990828|NCT00606086|Antimetabolites|antimetabolites|mesh-ancestor
92990829|NCT00606086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990830|NCT00606086|Immunologic Factors|immunologic factors|mesh-ancestor
92990831|NCT00606086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990832|NCT02573363|Cytarabine|cytarabine|mesh-list
92990833|NCT02573363|Mitoxantrone|mitoxantrone|mesh-list
92990834|NCT02573363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990835|NCT02573363|Antimetabolites|antimetabolites|mesh-ancestor
92990836|NCT02573363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990837|NCT02573363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990838|NCT02573363|Antiviral Agents|antiviral agents|mesh-ancestor
92990839|NCT02573363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990840|NCT02573363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990841|NCT02573363|Immunologic Factors|immunologic factors|mesh-ancestor
92990842|NCT02573363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990843|NCT02573363|Analgesics|analgesics|mesh-ancestor
92990844|NCT02573363|Sensory System Agents|sensory system agents|mesh-ancestor
92990845|NCT02573363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990846|NCT02573363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92990847|NCT02573363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92990848|NCT02573363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990849|NCT00715637|Cytarabine|cytarabine|mesh-list
92990850|NCT00715637|Amonafide|amonafide|mesh-list
92990851|NCT00715637|Daunorubicin|daunorubicin|mesh-list
92990852|NCT00715637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990853|NCT00715637|Antimetabolites|antimetabolites|mesh-ancestor
92990854|NCT00715637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990855|NCT00715637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990856|NCT00715637|Antiviral Agents|antiviral agents|mesh-ancestor
92990857|NCT00715637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990858|NCT00715637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990859|NCT00715637|Immunologic Factors|immunologic factors|mesh-ancestor
92990860|NCT00715637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990861|NCT00715637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92990862|NCT00715637|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92990863|NCT00715637|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92990864|NCT00715637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990865|NCT05300490|Prednisolone|prednisolone|mesh-list
92990866|NCT05300490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990867|NCT05300490|Glucocorticoids|glucocorticoids|mesh-ancestor
92990868|NCT05300490|Hormones|hormones|mesh-ancestor
92990869|NCT05300490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990870|NCT05300490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990871|NCT05300490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92990872|NCT05300490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990873|NCT00893594|Naproxen|naproxen|mesh-list
92990874|NCT00893594|Sumatriptan|sumatriptan|mesh-list
92990875|NCT00893594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92990876|NCT00893594|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92990877|NCT00893594|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92990878|NCT00893594|Serotonin Agents|serotonin agents|mesh-ancestor
92990879|NCT00893594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990880|NCT00893594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990881|NCT00893594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990882|NCT00893594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92990883|NCT00893594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92990884|NCT00893594|Analgesics|analgesics|mesh-ancestor
92990885|NCT00893594|Sensory System Agents|sensory system agents|mesh-ancestor
92990886|NCT00893594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990887|NCT00893594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990888|NCT00893594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92990889|NCT00893594|Gout Suppressants|gout suppressants|mesh-ancestor
92990890|NCT00893594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92990891|NCT00893594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990892|NCT00715715|Prednisone|prednisone|mesh-list
92990893|NCT00715715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92990894|NCT00715715|Glucocorticoids|glucocorticoids|mesh-ancestor
92990895|NCT00715715|Hormones|hormones|mesh-ancestor
92990896|NCT00715715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92990897|NCT00715715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990898|NCT00715715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92990899|NCT00715715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990900|NCT00953394|Octreotide|octreotide|mesh-list
92990901|NCT00953394|Fluorouracil|fluorouracil|mesh-list
92990902|NCT00953394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92990903|NCT00953394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92990904|NCT00953394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990905|NCT00953394|Antimetabolites|antimetabolites|mesh-ancestor
92990906|NCT00953394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990907|NCT00953394|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92990908|NCT00953394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92990909|NCT00953394|Immunologic Factors|immunologic factors|mesh-ancestor
92990910|NCT00953394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990911|NCT00720161|Metformin|metformin|mesh-list
92990912|NCT00720161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990913|NCT00720161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990914|NCT00898508|Antibodies|antibodies|mesh-list
92990915|NCT00898508|Immunologic Factors|immunologic factors|mesh-ancestor
92990916|NCT00898508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990917|NCT00609986|Insulin|insulin|mesh-list
92990918|NCT00609986|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92990919|NCT00609986|Insulin Glargine|insulin glargine|mesh-list
92990920|NCT00609986|Insulin, Isophane|insulin, isophane|mesh-list
92990921|NCT00609986|Isophane Insulin, Human|isophane insulin, human|mesh-list
92990922|NCT00609986|Isophane insulin, beef|isophane insulin, beef|mesh-list
92990923|NCT00609986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92990924|NCT00609986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990925|NCT00715871|Nicotine|nicotine|mesh-list
92990926|NCT00715871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92990927|NCT00715871|Autonomic Agents|autonomic agents|mesh-ancestor
92990928|NCT00715871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990929|NCT00715871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990930|NCT00715871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92990931|NCT00715871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92990932|NCT00715871|Cholinergic Agents|cholinergic agents|mesh-ancestor
92990933|NCT00715871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92990934|NCT00715871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990935|NCT00712049|Nicotinic Acids|nicotinic acids|mesh-list
92990936|NCT00712049|Niacin|niacin|mesh-list
92990937|NCT00712049|Niacinamide|niacinamide|mesh-list
92990938|NCT00712049|Simvastatin|simvastatin|mesh-list
92990939|NCT00712049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92990940|NCT00712049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92990941|NCT00712049|Antimetabolites|antimetabolites|mesh-ancestor
92990942|NCT00712049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990943|NCT00712049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92990944|NCT00712049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92990945|NCT00712049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990946|NCT00712049|Vitamin B Complex|vitamin b complex|mesh-ancestor
92990947|NCT00712049|Vitamins|vitamins|mesh-ancestor
92990948|NCT00712049|Micronutrients|micronutrients|mesh-ancestor
92990949|NCT00712049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990950|NCT00712049|Vasodilator Agents|vasodilator agents|mesh-ancestor
92990951|NCT00712205|Calcitriol|calcitriol|mesh-list
92990952|NCT00712205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92990953|NCT00712205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990954|NCT00712205|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92990955|NCT00712205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92990956|NCT00712205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990957|NCT00712205|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92990958|NCT00712205|Vitamins|vitamins|mesh-ancestor
92990959|NCT00712205|Micronutrients|micronutrients|mesh-ancestor
92990960|NCT00712205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92990961|NCT00451906|Bevacizumab|bevacizumab|mesh-list
92990962|NCT00451906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92990963|NCT00451906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92990964|NCT00451906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92990965|NCT00451906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92990966|NCT00451906|Growth Substances|growth substances|mesh-ancestor
92990967|NCT00451906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990968|NCT00451906|Growth Inhibitors|growth inhibitors|mesh-ancestor
92990969|NCT04070495|Clarithromycin|clarithromycin|mesh-list
92990970|NCT04070495|Rifampin|rifampin|mesh-list
92990971|NCT04070495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92990972|NCT04070495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92990973|NCT04070495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92990974|NCT04070495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92990975|NCT04070495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92990976|NCT04070495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92990977|NCT04070495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92990978|NCT04070495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92990979|NCT04070495|Antitubercular Agents|antitubercular agents|mesh-ancestor
92990980|NCT04070495|Leprostatic Agents|leprostatic agents|mesh-ancestor
92990981|NCT04070495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92990982|NCT04070495|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92990983|NCT04070495|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92990984|NCT04070495|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92990985|NCT04070495|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92990986|NCT04070495|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92990987|NCT04070495|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92990988|NCT00712439|Gabapentin|gabapentin|mesh-list
92990989|NCT00712439|Analgesics|analgesics|mesh-ancestor
92990990|NCT00712439|Sensory System Agents|sensory system agents|mesh-ancestor
92990991|NCT00712439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92990992|NCT00712439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92990993|NCT00712439|Anticonvulsants|anticonvulsants|mesh-ancestor
92990994|NCT00712439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92990995|NCT00712439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92990996|NCT00712439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92990997|NCT00712439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92990998|NCT00712439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92990999|NCT00712439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92991000|NCT00712439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991001|NCT00712439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991002|NCT00712439|Antimanic Agents|antimanic agents|mesh-ancestor
92991003|NCT00716183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92991004|NCT00716183|Amoxicillin|amoxicillin|mesh-list
92991005|NCT00716183|Clavulanic Acids|clavulanic acids|mesh-list
92991006|NCT00716183|Clavulanic Acid|clavulanic acid|mesh-list
92991007|NCT00716183|Lactams|lactams|mesh-list
92991008|NCT00716183|beta-Lactams|beta-lactams|mesh-list
92991009|NCT00716183|Cloxacillin|cloxacillin|mesh-list
92991010|NCT00716183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991011|NCT00716183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991012|NCT00716183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991013|NCT00716183|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92991014|NCT00712517|Propofol|propofol|mesh-list
92991015|NCT00712517|Sevoflurane|sevoflurane|mesh-list
92991016|NCT00712517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92991017|NCT00712517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991018|NCT00712517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991019|NCT00712517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92991020|NCT00712517|Anesthetics, General|anesthetics, general|mesh-ancestor
92991021|NCT00712517|Anesthetics|anesthetics|mesh-ancestor
92991022|NCT00712517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92991023|NCT00712517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92991024|NCT00712595|Mifepristone|mifepristone|mesh-list
92991025|NCT00712595|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92991026|NCT00712595|Abortifacient Agents|abortifacient agents|mesh-ancestor
92991027|NCT00712595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92991028|NCT00712595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991029|NCT00712595|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92991030|NCT00712595|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92991031|NCT00712595|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92991032|NCT00712595|Contraceptive Agents|contraceptive agents|mesh-ancestor
92991033|NCT00712595|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92991034|NCT00712595|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92991035|NCT00712595|Hormone Antagonists|hormone antagonists|mesh-ancestor
92991036|NCT00712595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991037|NCT00712595|Luteolytic Agents|luteolytic agents|mesh-ancestor
92991038|NCT00712595|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92991039|NCT00712595|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92991040|NCT00115765|Bevacizumab|bevacizumab|mesh-list
92991041|NCT00115765|Panitumumab|panitumumab|mesh-list
92991042|NCT00115765|Oxaliplatin|oxaliplatin|mesh-list
92991043|NCT00115765|Irinotecan|irinotecan|mesh-list
92167885|NCT05873712|Fludarabine|fludarabine|mesh-list
92991044|NCT00115765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92991045|NCT00115765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991046|NCT00115765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92991047|NCT00115765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92991048|NCT00115765|Growth Substances|growth substances|mesh-ancestor
92991049|NCT00115765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991050|NCT00115765|Growth Inhibitors|growth inhibitors|mesh-ancestor
92991051|NCT00115765|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92991052|NCT00115765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92991053|NCT00115765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991054|NCT00115765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991055|NCT00606008|Sunitinib|sunitinib|mesh-list
92991056|NCT00606008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991057|NCT00606008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92991058|NCT00606008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92991059|NCT00606008|Growth Substances|growth substances|mesh-ancestor
92991060|NCT00606008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991061|NCT00606008|Growth Inhibitors|growth inhibitors|mesh-ancestor
92991062|NCT00606008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991063|NCT00606008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991064|NCT00606008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991065|NCT00461812|Mometasone Furoate|mometasone furoate|mesh-list
92991066|NCT00461812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991067|NCT00461812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991068|NCT00461812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92991069|NCT00721331|Mometasone Furoate|mometasone furoate|mesh-list
92991070|NCT00721331|Loratadine|loratadine|mesh-list
92991071|NCT00721331|Nortriptyline|nortriptyline|mesh-list
92991072|NCT00721331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991073|NCT00721331|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991074|NCT00721331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92991075|NCT00721331|Antipruritics|antipruritics|mesh-ancestor
92991076|NCT00721331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92991077|NCT00721331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92991078|NCT00721331|Histamine Antagonists|histamine antagonists|mesh-ancestor
92991079|NCT00721331|Histamine Agents|histamine agents|mesh-ancestor
92991080|NCT00721331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991081|NCT00721331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991082|NCT00721331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991083|NCT00721331|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92991084|NCT00721331|Antidepressive Agents|antidepressive agents|mesh-ancestor
92991085|NCT00721331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92991086|NCT00721331|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92991087|NCT00721331|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92991088|NCT00721331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92991090|NCT00123955|Spironolactone|spironolactone|mesh-list
92991091|NCT00123955|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92991092|NCT00123955|Hormone Antagonists|hormone antagonists|mesh-ancestor
92991093|NCT00123955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991094|NCT00123955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991095|NCT00123955|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92991096|NCT00123955|Diuretics|diuretics|mesh-ancestor
92991097|NCT00123955|Natriuretic Agents|natriuretic agents|mesh-ancestor
92991098|NCT01027546|Tranexamic Acid|tranexamic acid|mesh-list
92991099|NCT01027546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92991100|NCT01027546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92991101|NCT01027546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991102|NCT01027546|Hemostatics|hemostatics|mesh-ancestor
92991103|NCT01027546|Coagulants|coagulants|mesh-ancestor
92991104|NCT00115063|Orlistat|orlistat|mesh-list
92991105|NCT00115063|Sibutramine|sibutramine|mesh-list
92991106|NCT00115063|Diethylpropion|diethylpropion|mesh-list
92991107|NCT00115063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991108|NCT00115063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991109|NCT00115063|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92991110|NCT00115063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92991111|NCT00115063|Antidepressive Agents|antidepressive agents|mesh-ancestor
92991112|NCT00115063|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92991113|NCT00115063|Appetite Depressants|appetite depressants|mesh-ancestor
92991114|NCT01026064|Azithromycin|azithromycin|mesh-list
92991115|NCT01026064|Cantharidin|cantharidin|mesh-list
92991116|NCT01026064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92991117|NCT01026064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991118|NCT01026064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991119|NCT01026064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991120|NCT02571959|Amoxicillin|amoxicillin|mesh-list
92991121|NCT02571959|Clavulanic Acids|clavulanic acids|mesh-list
92991122|NCT02571959|Clavulanic Acid|clavulanic acid|mesh-list
92991123|NCT02571959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92991124|NCT02571959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991125|NCT02571959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991126|NCT02571959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991127|NCT02571959|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92991128|NCT00461500|Fluticasone|fluticasone|mesh-list
92991129|NCT00461500|Xhance|xhance|mesh-list
92991130|NCT00461500|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92991131|NCT00461500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991132|NCT00461500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92991133|NCT00461500|Autonomic Agents|autonomic agents|mesh-ancestor
92991134|NCT00461500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991135|NCT00461500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991136|NCT00461500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92991137|NCT00461500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92991138|NCT00461500|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991139|NCT00461500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92991140|NCT00461500|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92991141|NCT00461500|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92991142|NCT00461500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92991144|NCT00461500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991145|NCT00461500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991146|NCT00893906|Vaccines|vaccines|mesh-list
92991147|NCT00893906|Immunologic Factors|immunologic factors|mesh-ancestor
92991148|NCT00893906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991149|NCT00721487|Fluconazole|fluconazole|mesh-list
92991150|NCT00721487|Antifungal Agents|antifungal agents|mesh-ancestor
92991151|NCT00721487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991152|NCT00721487|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92991153|NCT00721487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92991154|NCT00721487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991155|NCT00721487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991156|NCT00721487|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92991157|NCT00721487|Hormone Antagonists|hormone antagonists|mesh-ancestor
92991158|NCT00721487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991159|NCT00721487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336584|NCT01945866|Hormones|hormones|mesh-ancestor
92991160|NCT00721487|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92991161|NCT00721487|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92991162|NCT00167245|Topiramate|topiramate|mesh-list
92991163|NCT00167245|Anticonvulsants|anticonvulsants|mesh-ancestor
92991164|NCT00167245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92991165|NCT00167245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991166|NCT00894062|Everolimus|everolimus|mesh-list
92991167|NCT00894062|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92991168|NCT00894062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991169|NCT00894062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991170|NCT00894062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991171|NCT00894062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991172|NCT00894062|Immunologic Factors|immunologic factors|mesh-ancestor
92991173|NCT00894062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991174|NCT00894062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991175|NCT00443560|Fentanyl|fentanyl|mesh-list
92991176|NCT00443560|Bupivacaine|bupivacaine|mesh-list
92991177|NCT00443560|Anesthetics, Local|anesthetics, local|mesh-ancestor
92991178|NCT00443560|Anesthetics|anesthetics|mesh-ancestor
92991179|NCT00443560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991180|NCT00443560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991181|NCT00443560|Sensory System Agents|sensory system agents|mesh-ancestor
92991182|NCT00443560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991183|NCT00443560|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92991184|NCT00443560|Narcotics|narcotics|mesh-ancestor
92991185|NCT00443560|Analgesics|analgesics|mesh-ancestor
92991186|NCT00443560|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92991187|NCT00443560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92991188|NCT00443560|Anesthetics, General|anesthetics, general|mesh-ancestor
92991189|NCT01022632|Curcumin|curcumin|mesh-list
92991190|NCT01022632|Fluoxetine|fluoxetine|mesh-list
92167888|NCT05873712|Immunologic Factors|immunologic factors|mesh-ancestor
92991191|NCT01022632|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92991192|NCT01022632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92991193|NCT01022632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92991194|NCT01022632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991195|NCT01022632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991196|NCT01022632|Serotonin Agents|serotonin agents|mesh-ancestor
92991197|NCT01022632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991198|NCT01022632|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92991199|NCT01022632|Antidepressive Agents|antidepressive agents|mesh-ancestor
92991200|NCT01022632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92991201|NCT01022632|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92991202|NCT01022632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92991203|NCT01022632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991204|NCT01022632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92991205|NCT01022632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92991206|NCT01022632|Analgesics|analgesics|mesh-ancestor
92991207|NCT01022632|Sensory System Agents|sensory system agents|mesh-ancestor
92991208|NCT01022632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991209|NCT01022632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991210|NCT01022632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991211|NCT01022632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991212|NCT01026376|Decitabine|decitabine|mesh-list
92991213|NCT01026376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92991214|NCT01026376|Antimetabolites|antimetabolites|mesh-ancestor
92636605|NCT02963051|Copper|copper|mesh-list
92991215|NCT01026376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991216|NCT01026376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991217|NCT01026376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991218|NCT00716573|Everolimus|everolimus|mesh-list
92991219|NCT00716573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92991220|NCT00716573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991221|NCT00716573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991222|NCT00716573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991223|NCT00716573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991224|NCT00716573|Immunologic Factors|immunologic factors|mesh-ancestor
92991225|NCT00716573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991226|NCT00716573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991227|NCT02539706|Rocuronium|rocuronium|mesh-list
92991228|NCT02539706|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92991229|NCT02539706|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92991230|NCT02539706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92991231|NCT02539706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991232|NCT02539706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991233|NCT00451204|Glatiramer Acetate|glatiramer acetate|mesh-list
92991234|NCT00451204|Estrogens|estrogens|mesh-list
92991235|NCT00451204|(T,G)-A-L|(t,g)-a-l|mesh-list
92991236|NCT00451204|Hormones|hormones|mesh-ancestor
92991237|NCT00451204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991238|NCT00451204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991239|NCT00451204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92991240|NCT00451204|Immunologic Factors|immunologic factors|mesh-ancestor
92991241|NCT00451204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991242|NCT00451204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991243|NCT00721877|Resveratrol|resveratrol|mesh-list
92991244|NCT00721877|Antioxidants|antioxidants|mesh-ancestor
92991245|NCT00721877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991246|NCT00721877|Protective Agents|protective agents|mesh-ancestor
92991247|NCT00721877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991248|NCT00721877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991249|NCT00721877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92991250|NCT03537586|Adenosine|adenosine|mesh-list
92991251|NCT03537586|Heparin|heparin|mesh-list
92991252|NCT03537586|Bivalirudin|bivalirudin|mesh-list
92991253|NCT03537586|Anticoagulants|anticoagulants|mesh-ancestor
92991254|NCT03537586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92991255|NCT03537586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92991256|NCT03537586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991257|NCT03537586|Analgesics|analgesics|mesh-ancestor
92991258|NCT03537586|Sensory System Agents|sensory system agents|mesh-ancestor
92991259|NCT03537586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991260|NCT03537586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991261|NCT03537586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92991262|NCT03537586|Vasodilator Agents|vasodilator agents|mesh-ancestor
92991263|NCT03537586|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92991264|NCT03537586|Purinergic Agonists|purinergic agonists|mesh-ancestor
92991265|NCT03537586|Purinergic Agents|purinergic agents|mesh-ancestor
92991266|NCT03537586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991267|NCT03537586|Antithrombins|antithrombins|mesh-ancestor
92991268|NCT03537586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92991269|NCT03537586|Protease Inhibitors|protease inhibitors|mesh-ancestor
92991270|NCT03537586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991271|NCT00722033|Indomethacin|indomethacin|mesh-list
92991272|NCT00722033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92991273|NCT00722033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92991274|NCT00722033|Analgesics|analgesics|mesh-ancestor
92991275|NCT00722033|Sensory System Agents|sensory system agents|mesh-ancestor
92991276|NCT00722033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991277|NCT00722033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991278|NCT00722033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991279|NCT00722033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991280|NCT00722033|Gout Suppressants|gout suppressants|mesh-ancestor
92991281|NCT00722033|Tocolytic Agents|tocolytic agents|mesh-ancestor
92991282|NCT00722033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92991283|NCT00722033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92991284|NCT00722033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991285|NCT00722033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991286|NCT00894374|Artesunate|artesunate|mesh-list
92991287|NCT00894374|Antimalarials|antimalarials|mesh-ancestor
92991288|NCT00894374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92991289|NCT00894374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92991290|NCT00894374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991291|NCT00894374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991292|NCT00894374|Antiviral Agents|antiviral agents|mesh-ancestor
92991293|NCT00894374|Schistosomicides|schistosomicides|mesh-ancestor
92991294|NCT00894374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92991295|NCT00894374|Anthelmintics|anthelmintics|mesh-ancestor
92991297|NCT04920149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92991298|NCT04920149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92991299|NCT04920149|Analgesics|analgesics|mesh-ancestor
92991300|NCT04920149|Sensory System Agents|sensory system agents|mesh-ancestor
92991301|NCT04920149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991302|NCT04920149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991303|NCT04920149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991304|NCT04920149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991305|NCT01026610|Entecavir|entecavir|mesh-list
92991306|NCT01026610|Antiviral Agents|antiviral agents|mesh-ancestor
92991307|NCT01026610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991308|NCT00901550|Infliximab|infliximab|mesh-list
92991309|NCT00901550|Methotrexate|methotrexate|mesh-list
92991310|NCT00901550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92991311|NCT00901550|Abortifacient Agents|abortifacient agents|mesh-ancestor
92991312|NCT00901550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92991313|NCT00901550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991314|NCT00901550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92991315|NCT00901550|Antimetabolites|antimetabolites|mesh-ancestor
92991316|NCT00901550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991317|NCT00901550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991318|NCT00901550|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991319|NCT00901550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991320|NCT00901550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92991321|NCT00901550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991322|NCT00901550|Immunologic Factors|immunologic factors|mesh-ancestor
92991323|NCT00901550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991324|NCT00901550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92991325|NCT00901550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92991326|NCT00901550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991327|NCT00901550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991328|NCT02573051|Isosorbide|isosorbide|mesh-list
92991329|NCT02573051|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92991330|NCT02573051|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92991331|NCT02573051|Misoprostol|misoprostol|mesh-list
92991332|NCT02573051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92991333|NCT02573051|Abortifacient Agents|abortifacient agents|mesh-ancestor
92991334|NCT02573051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92991335|NCT02573051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991336|NCT02573051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92991337|NCT02573051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991338|NCT02573051|Oxytocics|oxytocics|mesh-ancestor
92991339|NCT02573051|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92991340|NCT02573051|Diuretics|diuretics|mesh-ancestor
92991341|NCT02573051|Natriuretic Agents|natriuretic agents|mesh-ancestor
92991342|NCT02573051|Vasodilator Agents|vasodilator agents|mesh-ancestor
92991343|NCT02573051|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92991344|NCT02573051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991345|NCT02539940|Paclitaxel|paclitaxel|mesh-list
92991346|NCT02539940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92991347|NCT02539940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991348|NCT02539940|Tubulin Modulators|tubulin modulators|mesh-ancestor
92991349|NCT02539940|Antimitotic Agents|antimitotic agents|mesh-ancestor
92991350|NCT02539940|Mitosis Modulators|mitosis modulators|mesh-ancestor
92991351|NCT02539940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991352|NCT01028092|Cyclosporine|cyclosporine|mesh-list
92991353|NCT01028092|Everolimus|everolimus|mesh-list
92991354|NCT01028092|Interleukin-2|interleukin-2|mesh-list
92991355|NCT01028092|Cyclosporins|cyclosporins|mesh-list
92991356|NCT01028092|Thymoglobulin|thymoglobulin|mesh-list
92991357|NCT01028092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991358|NCT01028092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991359|NCT01028092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991360|NCT01028092|Immunologic Factors|immunologic factors|mesh-ancestor
92991361|NCT01028092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991362|NCT01028092|Antifungal Agents|antifungal agents|mesh-ancestor
92991363|NCT01028092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991364|NCT01028092|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991365|NCT01028092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991366|NCT01028092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92636764|NCT00189371|Paclitaxel|paclitaxel|mesh-list
92991367|NCT01028092|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92991368|NCT01028092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991369|NCT01028092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991370|NCT01028092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92991371|NCT01028092|Analgesics|analgesics|mesh-ancestor
92991372|NCT01028092|Sensory System Agents|sensory system agents|mesh-ancestor
92991373|NCT01028092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991374|NCT00605306|Mometasone Furoate|mometasone furoate|mesh-list
92991375|NCT00605306|Maleic acid|maleic acid|mesh-list
92991376|NCT00605306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991377|NCT00605306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991378|NCT00605306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991379|NCT00605306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991380|NCT00605306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92991382|NCT00905918|Vitamins|vitamins|mesh-ancestor
92991383|NCT00905918|Micronutrients|micronutrients|mesh-ancestor
92991384|NCT00905918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991385|NCT00905918|Antioxidants|antioxidants|mesh-ancestor
92991386|NCT00905918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991387|NCT00905918|Protective Agents|protective agents|mesh-ancestor
92991388|NCT00894608|Letrozole|letrozole|mesh-list
92991389|NCT00894608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991390|NCT00894608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92991391|NCT00894608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92991392|NCT00894608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991393|NCT00894608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991394|NCT00894608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92991395|NCT00894608|Hormone Antagonists|hormone antagonists|mesh-ancestor
92991396|NCT00894608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991397|NCT00894608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991398|NCT00901784|Topiramate|topiramate|mesh-list
92991399|NCT00901784|Anticonvulsants|anticonvulsants|mesh-ancestor
92991400|NCT00901784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92991401|NCT00901784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991402|NCT00905996|Propranolol|propranolol|mesh-list
92991403|NCT00905996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92991404|NCT00905996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92991405|NCT00905996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92991406|NCT00905996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991407|NCT00905996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991408|NCT00905996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991409|NCT00905996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92991410|NCT00905996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92991411|NCT00905996|Vasodilator Agents|vasodilator agents|mesh-ancestor
92991412|NCT02539628|Ropivacaine|ropivacaine|mesh-list
92991413|NCT02539628|Anesthetics, Local|anesthetics, local|mesh-ancestor
92991414|NCT02539628|Anesthetics|anesthetics|mesh-ancestor
92991415|NCT02539628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991416|NCT02539628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991417|NCT02539628|Sensory System Agents|sensory system agents|mesh-ancestor
92991418|NCT02539628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991419|NCT02573987|Lidocaine|lidocaine|mesh-list
92991420|NCT02573987|Nitrous Oxide|nitrous oxide|mesh-list
92991421|NCT02573987|Anesthetics, Local|anesthetics, local|mesh-ancestor
92991422|NCT02573987|Anesthetics|anesthetics|mesh-ancestor
92991423|NCT02573987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991424|NCT02573987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991425|NCT02573987|Sensory System Agents|sensory system agents|mesh-ancestor
92991426|NCT02573987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991427|NCT02573987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92991428|NCT02573987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92991429|NCT02573987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92991430|NCT02573987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92991431|NCT02573987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991432|NCT02573987|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92991433|NCT02573987|Anesthetics, General|anesthetics, general|mesh-ancestor
92991434|NCT02573987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92991435|NCT02573987|Analgesics|analgesics|mesh-ancestor
92991436|NCT00906386|Varenicline|varenicline|mesh-list
92991437|NCT00906386|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92991438|NCT00906386|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92991439|NCT00906386|Cholinergic Agents|cholinergic agents|mesh-ancestor
92991440|NCT00906386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991441|NCT00906386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991442|NCT00906386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991444|NCT00722579|Chromium|chromium|mesh-list
92991445|NCT00722579|Trace Elements|trace elements|mesh-ancestor
92991446|NCT00722579|Micronutrients|micronutrients|mesh-ancestor
92991447|NCT00722579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991448|NCT00713687|Gemcitabine|gemcitabine|mesh-list
92991449|NCT00713687|Oxaliplatin|oxaliplatin|mesh-list
92991450|NCT00713687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92991451|NCT00713687|Antimetabolites|antimetabolites|mesh-ancestor
92991452|NCT00713687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991453|NCT00713687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991454|NCT02540876|Ilorasertib|ilorasertib|mesh-list
92991455|NCT02540876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528275|NCT00000752|Guaifenesin|guaifenesin|mesh-list
92991456|NCT02540876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991457|NCT02540876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991458|NCT02540876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991460|NCT00894920|Vitamin B Complex|vitamin b complex|mesh-ancestor
92991461|NCT00894920|Vitamins|vitamins|mesh-ancestor
92991462|NCT00894920|Micronutrients|micronutrients|mesh-ancestor
92991463|NCT00894920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991464|NCT00722735|Ciprofloxacin|ciprofloxacin|mesh-list
92991465|NCT00722735|Finafloxacin|finafloxacin|mesh-list
92991466|NCT00722735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92991467|NCT00722735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991468|NCT00722735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92991469|NCT00722735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92991470|NCT00722735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991471|NCT00722735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991472|NCT00722735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991473|NCT00722735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92991474|NCT00722735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92991475|NCT00722735|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92991476|NCT04067531|Clindamycin|clindamycin|mesh-list
92991477|NCT04067531|Clindamycin palmitate|clindamycin palmitate|mesh-list
92991478|NCT04067531|Clindamycin phosphate|clindamycin phosphate|mesh-list
92991479|NCT04067531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92991480|NCT04067531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991481|NCT04067531|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92991482|NCT04067531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991483|NCT04067531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991484|NCT00713765|Donepezil|donepezil|mesh-list
92991485|NCT00713765|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92991486|NCT00713765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991487|NCT00713765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991488|NCT00713765|Cholinergic Agents|cholinergic agents|mesh-ancestor
92991489|NCT00713765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991490|NCT00713765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991491|NCT00713765|Nootropic Agents|nootropic agents|mesh-ancestor
92991492|NCT00717587|Sunitinib|sunitinib|mesh-list
92991493|NCT00717587|Motexafin gadolinium|motexafin gadolinium|mesh-list
92991494|NCT00717587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991495|NCT00717587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92991496|NCT00717587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92991497|NCT00717587|Growth Substances|growth substances|mesh-ancestor
92991498|NCT00717587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991499|NCT00717587|Growth Inhibitors|growth inhibitors|mesh-ancestor
92991500|NCT00717587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991501|NCT00717587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991502|NCT00717587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991503|NCT00717587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92991504|NCT00717587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991505|NCT00894998|Heparin|heparin|mesh-list
92991506|NCT00894998|Calcium heparin|calcium heparin|mesh-list
92991507|NCT00894998|Anticoagulants|anticoagulants|mesh-ancestor
92991508|NCT00894998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92991509|NCT00894998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92991510|NCT00894998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991511|NCT00713921|Fesoterodine|fesoterodine|mesh-list
92991512|NCT00713921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92991513|NCT00713921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92991514|NCT00713921|Cholinergic Agents|cholinergic agents|mesh-ancestor
92991515|NCT00713921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991516|NCT00713921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991517|NCT00713921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991518|NCT00713921|Urological Agents|urological agents|mesh-ancestor
92991519|NCT00713999|Praziquantel|praziquantel|mesh-list
92991520|NCT00713999|Anthelmintics|anthelmintics|mesh-ancestor
92991521|NCT00713999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92991522|NCT00713999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991523|NCT04072601|Atorvastatin|atorvastatin|mesh-list
92991524|NCT04072601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92991525|NCT04072601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92991526|NCT04072601|Antimetabolites|antimetabolites|mesh-ancestor
92991527|NCT04072601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991528|NCT04072601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92991529|NCT04072601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92991530|NCT04072601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991532|NCT00717821|Darbepoetin alfa|darbepoetin alfa|mesh-list
92991533|NCT00717821|Hematinics|hematinics|mesh-ancestor
92991534|NCT03476369|Fentanyl|fentanyl|mesh-list
92991535|NCT03476369|Ticagrelor|ticagrelor|mesh-list
92991536|NCT03476369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92991537|NCT03476369|Narcotics|narcotics|mesh-ancestor
92991538|NCT03476369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991539|NCT03476369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991540|NCT03476369|Analgesics|analgesics|mesh-ancestor
92991541|NCT03476369|Sensory System Agents|sensory system agents|mesh-ancestor
92991542|NCT03476369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991543|NCT03476369|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92991544|NCT03476369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92991545|NCT03476369|Anesthetics, General|anesthetics, general|mesh-ancestor
92991546|NCT03476369|Anesthetics|anesthetics|mesh-ancestor
92991547|NCT03476369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92991548|NCT03476369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92991549|NCT03476369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92991550|NCT03476369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92991551|NCT03476369|Purinergic Agents|purinergic agents|mesh-ancestor
92991552|NCT03476369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991553|NCT03476369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991554|NCT00722969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92991555|NCT00722969|Sorafenib|sorafenib|mesh-list
92991556|NCT00722969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167902|NCT05873673|Vitamins|vitamins|mesh-ancestor
92991557|NCT00722969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991558|NCT00722969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991559|NCT00722969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991560|NCT04069325|Febuxostat|febuxostat|mesh-list
92991561|NCT04069325|Gout Suppressants|gout suppressants|mesh-ancestor
92991562|NCT04069325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991563|NCT00723047|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92991564|NCT00723047|Hemostatics|hemostatics|mesh-ancestor
92991565|NCT00723047|Coagulants|coagulants|mesh-ancestor
92991566|NCT00450814|Cyclophosphamide|cyclophosphamide|mesh-list
92991567|NCT00450814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991568|NCT00450814|Immunologic Factors|immunologic factors|mesh-ancestor
92991569|NCT00450814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991570|NCT00450814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991571|NCT00450814|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92991572|NCT00450814|Alkylating Agents|alkylating agents|mesh-ancestor
92991573|NCT00450814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991574|NCT00450814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991575|NCT00450814|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92991576|NCT02571491|Ketamine|ketamine|mesh-list
92991577|NCT02571491|Morphine|morphine|mesh-list
92991578|NCT02571491|Remifentanil|remifentanil|mesh-list
92991579|NCT02571491|Analgesics|analgesics|mesh-ancestor
92991580|NCT02571491|Sensory System Agents|sensory system agents|mesh-ancestor
92991581|NCT02571491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991582|NCT02571491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991583|NCT02571491|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92991584|NCT02571491|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92991585|NCT02571491|Anesthetics, General|anesthetics, general|mesh-ancestor
92991586|NCT02571491|Anesthetics|anesthetics|mesh-ancestor
92991587|NCT02571491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991588|NCT02571491|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92991589|NCT02571491|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92991590|NCT02571491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991591|NCT02571491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991592|NCT02571491|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92991593|NCT02571491|Narcotics|narcotics|mesh-ancestor
92991594|NCT00723437|Acitretin|acitretin|mesh-list
92991595|NCT00723437|Keratolytic Agents|keratolytic agents|mesh-ancestor
92991596|NCT00723437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991597|NCT00723515|Listerine|listerine|mesh-list
92991598|NCT00723515|Calcium|calcium|mesh-list
92991599|NCT00723515|Fluorides|fluorides|mesh-list
92991600|NCT00723515|Sodium Fluoride|sodium fluoride|mesh-list
92991601|NCT00723515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92991602|NCT00723515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991603|NCT00723515|Cariostatic Agents|cariostatic agents|mesh-ancestor
92337021|NCT01930188|Hormones|hormones|mesh-ancestor
92991604|NCT00723515|Protective Agents|protective agents|mesh-ancestor
92991605|NCT00723515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92991606|NCT00723515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991607|NCT01028170|Furosemide|furosemide|mesh-list
92991608|NCT01028170|Diuretics|diuretics|mesh-ancestor
92991609|NCT01028170|Natriuretic Agents|natriuretic agents|mesh-ancestor
92991610|NCT01028170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991611|NCT01028170|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92991612|NCT01028170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92991613|NCT01028170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991614|NCT00518115|Exenatide|exenatide|mesh-list
92991615|NCT00518115|rGLP-1 protein|rglp-1 protein|mesh-list
92991616|NCT00518115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92991617|NCT00518115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991618|NCT00518115|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92991619|NCT00518115|Incretins|incretins|mesh-ancestor
92991620|NCT00518115|Hormones|hormones|mesh-ancestor
92991621|NCT00518115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991622|NCT00723983|Sumatriptan|sumatriptan|mesh-list
92991623|NCT00723983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92991624|NCT00723983|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92991625|NCT00723983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92991626|NCT00723983|Serotonin Agents|serotonin agents|mesh-ancestor
92167904|NCT05873465|Midazolam|midazolam|mesh-list
92991627|NCT00723983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991628|NCT00723983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991629|NCT00723983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991630|NCT00450658|Ibuprofen|ibuprofen|mesh-list
92991631|NCT00450658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92991632|NCT00450658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92991633|NCT00450658|Analgesics|analgesics|mesh-ancestor
92991634|NCT00450658|Sensory System Agents|sensory system agents|mesh-ancestor
92991635|NCT00450658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991636|NCT00450658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991637|NCT00450658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991638|NCT00450658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991639|NCT00450658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92991640|NCT00450658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991641|NCT00450658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991642|NCT02572505|Tenofovir|tenofovir|mesh-list
92991643|NCT02572505|Emtricitabine|emtricitabine|mesh-list
92991644|NCT02572505|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92991645|NCT02572505|Antiviral Agents|antiviral agents|mesh-ancestor
92991646|NCT02572505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991647|NCT02572505|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92991648|NCT02572505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92991649|NCT02572505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991650|NCT02572505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991651|NCT02572505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92991652|NCT02572505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92991653|NCT00517881|Epoetin Alfa|epoetin alfa|mesh-list
92991654|NCT00517881|Hematinics|hematinics|mesh-ancestor
92991655|NCT01010139|Codeine|codeine|mesh-list
92991656|NCT01010139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92991657|NCT01010139|Narcotics|narcotics|mesh-ancestor
92991658|NCT01010139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991659|NCT01010139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991660|NCT01010139|Analgesics|analgesics|mesh-ancestor
92991661|NCT01010139|Sensory System Agents|sensory system agents|mesh-ancestor
92991662|NCT01010139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991663|NCT01010139|Antitussive Agents|antitussive agents|mesh-ancestor
92991664|NCT01010139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92991665|NCT00724295|Ribavirin|ribavirin|mesh-list
92991666|NCT00724295|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92991667|NCT00724295|Antimetabolites|antimetabolites|mesh-ancestor
92991668|NCT00724295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991669|NCT00724295|Antiviral Agents|antiviral agents|mesh-ancestor
92991670|NCT00724295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991671|NCT00718289|Dialysis Solutions|dialysis solutions|mesh-list
92991672|NCT00718289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92991673|NCT00517413|Epoetin Alfa|epoetin alfa|mesh-list
92991674|NCT00517413|Hematinics|hematinics|mesh-ancestor
92991676|NCT00724529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92991677|NCT00724529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528279|NCT00000752|Hormones|hormones|mesh-ancestor
92991678|NCT00724529|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991679|NCT00724529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991680|NCT00724529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991682|NCT01012869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92991683|NCT01012869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991684|NCT01012869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991685|NCT01012869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991686|NCT01012869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991687|NCT01012869|Immunologic Factors|immunologic factors|mesh-ancestor
92991688|NCT01012869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991689|NCT01012869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991690|NCT01010295|Doxycycline|doxycycline|mesh-list
92991691|NCT01010295|Tetracycline|tetracycline|mesh-list
92991692|NCT01010295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92991693|NCT01010295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991694|NCT01010295|Antimalarials|antimalarials|mesh-ancestor
92991695|NCT01010295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92991696|NCT01010295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92991697|NCT01010295|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92991698|NCT01010295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991699|NCT01010295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991700|NCT01010373|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92991701|NCT01010373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92991702|NCT01010373|Immunologic Factors|immunologic factors|mesh-ancestor
92991703|NCT01010373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991704|NCT01010373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991705|NCT01010373|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92991706|NCT01010373|Protective Agents|protective agents|mesh-ancestor
92991707|NCT01010373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92991708|NCT01010373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92991709|NCT01010373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991710|NCT01010373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991711|NCT01010373|Antiviral Agents|antiviral agents|mesh-ancestor
92991712|NCT01010373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991713|NCT01010451|Anti-Infective Agents|anti-infective agents|mesh-list
92991714|NCT01010451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92991715|NCT01010451|Calcium|calcium|mesh-list
92991716|NCT01010451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92991717|NCT01010451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991718|NCT02570789|Sunitinib|sunitinib|mesh-list
92991719|NCT02570789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991720|NCT02570789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92991721|NCT02570789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92991722|NCT02570789|Growth Substances|growth substances|mesh-ancestor
92991723|NCT02570789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991724|NCT02570789|Growth Inhibitors|growth inhibitors|mesh-ancestor
92991725|NCT02570789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991726|NCT02570789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991727|NCT02570789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991728|NCT00604214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92991729|NCT00604214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991730|NCT00450580|Ritonavir|ritonavir|mesh-list
92991731|NCT00450580|Fosamprenavir|fosamprenavir|mesh-list
92991732|NCT00450580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92991733|NCT00450580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92991734|NCT00450580|Protease Inhibitors|protease inhibitors|mesh-ancestor
92991735|NCT00450580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991736|NCT00450580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991737|NCT00450580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92991738|NCT00450580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92991739|NCT00450580|Antiviral Agents|antiviral agents|mesh-ancestor
92991740|NCT00450580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991741|NCT00450580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92991742|NCT00450580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92991743|NCT00724685|Ropivacaine|ropivacaine|mesh-list
92991744|NCT00724685|Anesthetics, Local|anesthetics, local|mesh-ancestor
92991745|NCT00724685|Anesthetics|anesthetics|mesh-ancestor
92991746|NCT00724685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991747|NCT00724685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991748|NCT00724685|Sensory System Agents|sensory system agents|mesh-ancestor
92991749|NCT00724685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991750|NCT00123487|Dasatinib|dasatinib|mesh-list
92991751|NCT00123487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991752|NCT00123487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991753|NCT00123487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991754|NCT00123487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991756|NCT00509925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92991757|NCT00509925|Insulin Aspart|insulin aspart|mesh-list
92991758|NCT00509925|Insulin Detemir|insulin detemir|mesh-list
92991759|NCT00509925|Isophane Insulin, Human|isophane insulin, human|mesh-list
92991760|NCT00509925|Insulin, Isophane|insulin, isophane|mesh-list
92991761|NCT00509925|Isophane insulin, beef|isophane insulin, beef|mesh-list
92991762|NCT00509925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92991763|NCT00509925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991764|NCT05277974|Dexamethasone|dexamethasone|mesh-list
92991765|NCT05277974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991766|NCT05277974|Antiemetics|antiemetics|mesh-ancestor
92991767|NCT05277974|Autonomic Agents|autonomic agents|mesh-ancestor
92991768|NCT05277974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991769|NCT05277974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991770|NCT05277974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991771|NCT05277974|Glucocorticoids|glucocorticoids|mesh-ancestor
92991772|NCT05277974|Hormones|hormones|mesh-ancestor
92991773|NCT05277974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991774|NCT05277974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92991775|NCT05277974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991776|NCT00504777|Rituximab|rituximab|mesh-list
92991777|NCT00504777|Methotrexate|methotrexate|mesh-list
92991778|NCT00504777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92991779|NCT00504777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991780|NCT00504777|Immunologic Factors|immunologic factors|mesh-ancestor
92991781|NCT00504777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991782|NCT00504777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92991783|NCT00504777|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92991784|NCT00504777|Abortifacient Agents|abortifacient agents|mesh-ancestor
92991785|NCT00504777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92991786|NCT00504777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92991787|NCT00504777|Antimetabolites|antimetabolites|mesh-ancestor
92991788|NCT00504777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991789|NCT00504777|Dermatologic Agents|dermatologic agents|mesh-ancestor
92991790|NCT00504777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991791|NCT00504777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92991792|NCT00504777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991793|NCT00504777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92991794|NCT03968263|Hydrocodone|hydrocodone|mesh-list
92991795|NCT03968263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92991796|NCT03968263|Narcotics|narcotics|mesh-ancestor
92991797|NCT03968263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991798|NCT03968263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991799|NCT03968263|Analgesics|analgesics|mesh-ancestor
92991800|NCT03968263|Sensory System Agents|sensory system agents|mesh-ancestor
92991801|NCT03968263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991802|NCT03968263|Antitussive Agents|antitussive agents|mesh-ancestor
92991803|NCT03968263|Respiratory System Agents|respiratory system agents|mesh-ancestor
92991804|NCT00895076|Dexamethasone|dexamethasone|mesh-list
92991805|NCT00895076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991806|NCT00895076|Antiemetics|antiemetics|mesh-ancestor
92991807|NCT00895076|Autonomic Agents|autonomic agents|mesh-ancestor
92991808|NCT00895076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991809|NCT00895076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991810|NCT00895076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991811|NCT00895076|Glucocorticoids|glucocorticoids|mesh-ancestor
92991812|NCT00895076|Hormones|hormones|mesh-ancestor
92991813|NCT00895076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991814|NCT00895076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92991815|NCT00895076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991816|NCT01078519|Anesthetics|anesthetics|mesh-list
92637189|NCT00190814|Dopamine Agents|dopamine agents|mesh-ancestor
92991817|NCT01078519|Anesthetics, Local|anesthetics, local|mesh-list
92991818|NCT01078519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92991819|NCT01078519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991820|NCT01078519|Sensory System Agents|sensory system agents|mesh-ancestor
92991821|NCT01078519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991822|NCT02539316|SMOFlipid|smoflipid|mesh-list
92991823|NCT02539316|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92991824|NCT02539316|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92991825|NCT02539316|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92991826|NCT03968185|Analgesics|analgesics|mesh-list
92991827|NCT03968185|Sensory System Agents|sensory system agents|mesh-ancestor
92991828|NCT03968185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991829|NCT03968185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991830|NCT00509769|Trastuzumab|trastuzumab|mesh-list
92991831|NCT00509769|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92991832|NCT00509769|Maytansine|maytansine|mesh-list
92991833|NCT00509769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92991834|NCT00509769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991835|NCT00509769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92991836|NCT00509769|Tubulin Modulators|tubulin modulators|mesh-ancestor
92991837|NCT00509769|Antimitotic Agents|antimitotic agents|mesh-ancestor
92991838|NCT00509769|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167918|NCT05873465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92991839|NCT00509769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991840|NCT00509769|Immunotoxins|immunotoxins|mesh-ancestor
92991841|NCT00509769|Immunoconjugates|immunoconjugates|mesh-ancestor
92991842|NCT00509769|Immunologic Factors|immunologic factors|mesh-ancestor
92991843|NCT00509769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991844|NCT05206877|Insulin|insulin|mesh-list
92991845|NCT05206877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92991846|NCT05206877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92991847|NCT05206877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991848|NCT02977715|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92991849|NCT02977715|Antiviral Agents|antiviral agents|mesh-ancestor
92991850|NCT02977715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991851|NCT01074697|Dexamethasone|dexamethasone|mesh-list
92991852|NCT01074697|Palonosetron|palonosetron|mesh-list
92991853|NCT01074697|Fosaprepitant|fosaprepitant|mesh-list
92991854|NCT01074697|Aprepitant|aprepitant|mesh-list
92991855|NCT01074697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991856|NCT01074697|Antiemetics|antiemetics|mesh-ancestor
92991857|NCT01074697|Autonomic Agents|autonomic agents|mesh-ancestor
92991858|NCT01074697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991859|NCT01074697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991860|NCT01074697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991861|NCT01074697|Glucocorticoids|glucocorticoids|mesh-ancestor
92991862|NCT01074697|Hormones|hormones|mesh-ancestor
92991863|NCT01074697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991864|NCT01074697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92991865|NCT01074697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991866|NCT01074697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991867|NCT01074697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92991868|NCT01074697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92991869|NCT01074697|Serotonin Agents|serotonin agents|mesh-ancestor
92991870|NCT01074697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991871|NCT01074697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92991872|NCT05124275|Pilocarpine|pilocarpine|mesh-list
92991873|NCT05124275|Miotics|miotics|mesh-ancestor
92991874|NCT05124275|Autonomic Agents|autonomic agents|mesh-ancestor
92991875|NCT05124275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991876|NCT05124275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991877|NCT05124275|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92991878|NCT05124275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92991879|NCT05124275|Cholinergic Agents|cholinergic agents|mesh-ancestor
92991880|NCT05124275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991881|NCT05124275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991882|NCT01080079|Terbinafine|terbinafine|mesh-list
92991883|NCT01080079|Antifungal Agents|antifungal agents|mesh-ancestor
92991884|NCT01080079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991885|NCT01080079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991886|NCT01080079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991887|NCT00725231|Alemtuzumab|alemtuzumab|mesh-list
92991888|NCT00725231|Doxorubicin|doxorubicin|mesh-list
92991889|NCT00725231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92637263|NCT00190970|Ruboxistaurin|ruboxistaurin|mesh-list
92991890|NCT00725231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92991891|NCT00725231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991892|NCT00725231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92991893|NCT00725231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92991894|NCT00725231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528281|NCT00000752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991896|NCT00725231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991897|NCT00114127|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92991898|NCT00114127|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92991899|NCT00114127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92991900|NCT00114127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92991901|NCT00114127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991902|NCT00114127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991903|NCT00114127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991904|NCT00114127|Analgesics|analgesics|mesh-ancestor
92991905|NCT00114127|Sensory System Agents|sensory system agents|mesh-ancestor
92991906|NCT00114127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991907|NCT00114127|Antidepressive Agents|antidepressive agents|mesh-ancestor
92991908|NCT00114127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92991909|NCT00114127|Dopamine Agents|dopamine agents|mesh-ancestor
92991910|NCT00902954|Letrozole|letrozole|mesh-list
92991911|NCT00902954|Anastrozole|anastrozole|mesh-list
92991912|NCT00902954|Exemestane|exemestane|mesh-list
92991913|NCT00902954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991914|NCT00902954|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92991915|NCT00902954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92991916|NCT00902954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991917|NCT00902954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991918|NCT00902954|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92991919|NCT00902954|Hormone Antagonists|hormone antagonists|mesh-ancestor
92991920|NCT00902954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991921|NCT00902954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991922|NCT00902954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92991923|NCT02540720|Dexamethasone|dexamethasone|mesh-list
92991924|NCT02540720|gamma-Globulins|gamma-globulins|mesh-list
92991925|NCT02540720|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92991926|NCT02540720|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92991927|NCT02540720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92991928|NCT02540720|Antiemetics|antiemetics|mesh-ancestor
92991929|NCT02540720|Autonomic Agents|autonomic agents|mesh-ancestor
92991930|NCT02540720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92991931|NCT02540720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991932|NCT02540720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991933|NCT02540720|Glucocorticoids|glucocorticoids|mesh-ancestor
92991934|NCT02540720|Hormones|hormones|mesh-ancestor
92991935|NCT02540720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92991936|NCT02540720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92991937|NCT02540720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991938|NCT02540720|Immunologic Factors|immunologic factors|mesh-ancestor
92991939|NCT02540642|Vitamin B 12|vitamin b 12|mesh-list
92991940|NCT02540642|Vitamins|vitamins|mesh-ancestor
92991941|NCT02540642|Micronutrients|micronutrients|mesh-ancestor
92991942|NCT02540642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991943|NCT02540642|Vitamin B Complex|vitamin b complex|mesh-ancestor
92991944|NCT00122317|Eculizumab|eculizumab|mesh-list
92991945|NCT00122317|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92991946|NCT00122317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92991947|NCT00122317|Immunologic Factors|immunologic factors|mesh-ancestor
92991948|NCT00122317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991949|NCT00908336|Docetaxel|docetaxel|mesh-list
92991950|NCT00908336|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92991951|NCT00908336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991952|NCT00908336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92991953|NCT00908336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92991954|NCT00908336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92991955|NCT00908336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991956|NCT00908336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991957|NCT00908336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991958|NCT00908414|TMC-310911|tmc-310911|mesh-list
92991959|NCT00908414|Protease Inhibitors|protease inhibitors|mesh-ancestor
92991960|NCT00908414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991961|NCT00908414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991962|NCT01074853|Propranolol|propranolol|mesh-list
92991963|NCT01074853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92991964|NCT01074853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92991965|NCT01074853|Adrenergic Agents|adrenergic agents|mesh-ancestor
92991966|NCT01074853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92991967|NCT01074853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991968|NCT01074853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991969|NCT01074853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92991970|NCT01074853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92991971|NCT01074853|Vasodilator Agents|vasodilator agents|mesh-ancestor
92991972|NCT00725777|Lumefantrine|lumefantrine|mesh-list
92991973|NCT00725777|Artemether|artemether|mesh-list
92991974|NCT00725777|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92991975|NCT00725777|Antimalarials|antimalarials|mesh-ancestor
92991976|NCT00725777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92991977|NCT00725777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92991978|NCT00725777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92991979|NCT00165841|Rabeprazole|rabeprazole|mesh-list
92991980|NCT00165841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92991981|NCT00165841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92991982|NCT00165841|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92991983|NCT00165841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991984|NCT00165841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991985|NCT00907166|Gemcitabine|gemcitabine|mesh-list
92991986|NCT00907166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92991987|NCT00907166|Antimetabolites|antimetabolites|mesh-ancestor
92991988|NCT00907166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92991989|NCT00907166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991990|NCT00460798|Sunitinib|sunitinib|mesh-list
92991991|NCT00460798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92991992|NCT00460798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92991993|NCT00460798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92991994|NCT00460798|Growth Substances|growth substances|mesh-ancestor
92991995|NCT00460798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92991996|NCT00460798|Growth Inhibitors|growth inhibitors|mesh-ancestor
92991997|NCT00460798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92991998|NCT00460798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92991999|NCT00460798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992000|NCT03513406|Glycopyrrolate|glycopyrrolate|mesh-list
92992001|NCT03513406|Neostigmine|neostigmine|mesh-list
92992002|NCT03513406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92992003|NCT03513406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992004|NCT03513406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992005|NCT03513406|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992006|NCT03513406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992007|NCT03513406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992008|NCT03513406|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92992009|NCT03513406|Autonomic Agents|autonomic agents|mesh-ancestor
92992010|NCT03513406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992011|NCT03513406|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92992012|NCT03513406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92992013|NCT03513406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92992014|NCT00726869|Elotuzumab|elotuzumab|mesh-list
92992015|NCT00726869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992016|NCT01028248|Ranibizumab|ranibizumab|mesh-list
92992017|NCT01028248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92992018|NCT01028248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92992019|NCT01028248|Growth Substances|growth substances|mesh-ancestor
92992020|NCT01028248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992021|NCT01028248|Growth Inhibitors|growth inhibitors|mesh-ancestor
92992022|NCT01028248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992023|NCT00726011|Tetrodotoxin|tetrodotoxin|mesh-list
92992024|NCT00726011|Anesthetics, Local|anesthetics, local|mesh-ancestor
92992025|NCT00726011|Anesthetics|anesthetics|mesh-ancestor
92992026|NCT00726011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992027|NCT00726011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992028|NCT00726011|Sensory System Agents|sensory system agents|mesh-ancestor
92992029|NCT00726011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992030|NCT00726011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92992031|NCT00726011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992032|NCT00726011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992033|NCT00603980|Alprazolam|alprazolam|mesh-list
92992034|NCT00603980|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92992035|NCT00603980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992036|NCT00603980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992037|NCT00603980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92992038|NCT00603980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92992039|NCT00603980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992040|NCT00603980|GABA Modulators|gaba modulators|mesh-ancestor
92992042|NCT00603980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992043|NCT00603980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992045|NCT01028404|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92992046|NCT01028404|Insulin Aspart|insulin aspart|mesh-list
92992047|NCT01028404|Insulin, Long-Acting|insulin, long-acting|mesh-list
92992048|NCT01028404|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92992049|NCT01028404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92992050|NCT01028404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992051|NCT00727103|Varenicline|varenicline|mesh-list
92992052|NCT00727103|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92992053|NCT00727103|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92992054|NCT00727103|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992055|NCT00727103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992056|NCT00727103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992057|NCT00727103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992058|NCT01028482|Sertraline|sertraline|mesh-list
92992059|NCT01028482|Antidepressive Agents|antidepressive agents|mesh-ancestor
92992060|NCT01028482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992061|NCT01028482|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92992062|NCT01028482|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92992063|NCT01028482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992064|NCT01028482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992065|NCT01028482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992066|NCT01028482|Serotonin Agents|serotonin agents|mesh-ancestor
92992067|NCT01028482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992068|NCT00903188|Cyclosporine|cyclosporine|mesh-list
92992069|NCT00903188|Mycophenolic Acid|mycophenolic acid|mesh-list
92992070|NCT00903188|Methylprednisolone|methylprednisolone|mesh-list
92992071|NCT00903188|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92992072|NCT00903188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92992073|NCT00903188|Prednisolone|prednisolone|mesh-list
92992074|NCT00903188|Prednisolone acetate|prednisolone acetate|mesh-list
92992075|NCT00903188|Everolimus|everolimus|mesh-list
92992076|NCT00903188|Cyclosporins|cyclosporins|mesh-list
92992077|NCT00903188|Basiliximab|basiliximab|mesh-list
92992078|NCT00903188|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92992079|NCT00903188|Prednisolone phosphate|prednisolone phosphate|mesh-list
92992080|NCT00903188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992081|NCT00903188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992082|NCT00903188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992083|NCT00903188|Immunologic Factors|immunologic factors|mesh-ancestor
92992084|NCT00903188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992085|NCT00903188|Antifungal Agents|antifungal agents|mesh-ancestor
92992086|NCT00903188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992087|NCT00903188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92992088|NCT00903188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992089|NCT00903188|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92992090|NCT00903188|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92992091|NCT00903188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992092|NCT00903188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992093|NCT00903188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992094|NCT00903188|Antiemetics|antiemetics|mesh-ancestor
92992095|NCT00903188|Autonomic Agents|autonomic agents|mesh-ancestor
92992096|NCT00903188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992097|NCT00903188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92992098|NCT00903188|Glucocorticoids|glucocorticoids|mesh-ancestor
92992099|NCT00903188|Hormones|hormones|mesh-ancestor
92992100|NCT00903188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92992101|NCT00903188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92992102|NCT00903188|Protective Agents|protective agents|mesh-ancestor
92992103|NCT00903188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92992104|NCT00903188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92992105|NCT00903188|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92992106|NCT00903188|Antitubercular Agents|antitubercular agents|mesh-ancestor
92992107|NCT00903188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92992108|NCT00908726|Propofol|propofol|mesh-list
92992109|NCT00908726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92992110|NCT00908726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992111|NCT00908726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992112|NCT00908726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92992113|NCT00908726|Anesthetics, General|anesthetics, general|mesh-ancestor
92637478|NCT00191555|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92992114|NCT00908726|Anesthetics|anesthetics|mesh-ancestor
92992115|NCT02948309|Viscum album peptide|viscum album peptide|mesh-list
92992116|NCT02948309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992117|NCT02948309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92992118|NCT02948309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92992119|NCT02948309|Antiviral Agents|antiviral agents|mesh-ancestor
92992120|NCT02948309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992121|NCT00449956|Timolol|timolol|mesh-list
92992122|NCT00449956|Dorzolamide|dorzolamide|mesh-list
92992123|NCT00449956|Maleic acid|maleic acid|mesh-list
92992124|NCT00449956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992125|NCT00449956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992126|NCT00449956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92992127|NCT00449956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92992128|NCT00449956|Adrenergic Agents|adrenergic agents|mesh-ancestor
92992129|NCT00449956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992130|NCT00449956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992131|NCT00449956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92992132|NCT00449956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92992133|NCT00449956|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92992134|NCT00907400|Naproxen|naproxen|mesh-list
92992135|NCT00907400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92992136|NCT00907400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992137|NCT00907400|Analgesics|analgesics|mesh-ancestor
92992138|NCT00907400|Sensory System Agents|sensory system agents|mesh-ancestor
92992139|NCT00907400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992140|NCT00907400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992141|NCT00907400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992142|NCT00907400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992143|NCT00907400|Gout Suppressants|gout suppressants|mesh-ancestor
92992144|NCT00907400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92992145|NCT00907400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992146|NCT00907400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992147|NCT00727493|Alendronate|alendronate|mesh-list
92992148|NCT00727493|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92992149|NCT00727493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992150|NCT00727727|Piribedil|piribedil|mesh-list
92992151|NCT00727727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92992152|NCT00727727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92992153|NCT00727727|Dopamine Agonists|dopamine agonists|mesh-ancestor
92992154|NCT00727727|Dopamine Agents|dopamine agents|mesh-ancestor
92992155|NCT00727727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992156|NCT00727727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992157|NCT00727727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992158|NCT00903656|Lapatinib|lapatinib|mesh-list
92992159|NCT00903656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992160|NCT00903656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992161|NCT00903656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992162|NCT00903656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992163|NCT00730067|Sildenafil Citrate|sildenafil citrate|mesh-list
92992164|NCT00730067|Vasodilator Agents|vasodilator agents|mesh-ancestor
92992165|NCT00730067|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92992166|NCT00730067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92992167|NCT00730067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992168|NCT00730067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992169|NCT00730067|Urological Agents|urological agents|mesh-ancestor
92992170|NCT02538224|Doxycycline|doxycycline|mesh-list
92992171|NCT02538224|Ketoprofen|ketoprofen|mesh-list
92992172|NCT02538224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92992173|NCT02538224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992174|NCT02538224|Antimalarials|antimalarials|mesh-ancestor
92992175|NCT02538224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92992176|NCT02538224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92992177|NCT02538224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92992178|NCT02538224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992179|NCT02538224|Analgesics|analgesics|mesh-ancestor
92992180|NCT02538224|Sensory System Agents|sensory system agents|mesh-ancestor
92992181|NCT02538224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992182|NCT02538224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992183|NCT02538224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992184|NCT02538224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992185|NCT02538224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92992186|NCT02538224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992187|NCT02538224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992188|NCT02538302|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92992190|NCT02538302|Parasympatholytics|parasympatholytics|mesh-ancestor
92992192|NCT02538302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992193|NCT02538302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992194|NCT02538302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92992195|NCT02538302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92992196|NCT02538302|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992197|NCT02538302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992198|NCT02538302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992199|NCT02538302|Urological Agents|urological agents|mesh-ancestor
92992200|NCT02538302|Hemostatics|hemostatics|mesh-ancestor
92992201|NCT02538302|Coagulants|coagulants|mesh-ancestor
92992202|NCT02538302|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92992203|NCT02538302|Natriuretic Agents|natriuretic agents|mesh-ancestor
92992204|NCT00903734|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92992205|NCT00903734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992206|NCT00903734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992207|NCT00903734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992208|NCT00903734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992209|NCT00509067|Olanzapine|olanzapine|mesh-list
92992210|NCT00509067|Risperidone|risperidone|mesh-list
92992211|NCT00509067|Aripiprazole|aripiprazole|mesh-list
92992212|NCT00509067|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92992213|NCT00509067|Ziprasidone|ziprasidone|mesh-list
92992214|NCT00509067|Choline|choline|mesh-list
92992215|NCT00509067|Galantamine|galantamine|mesh-list
92992216|NCT00509067|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92992217|NCT00509067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92992218|NCT00509067|Serotonin Agents|serotonin agents|mesh-ancestor
92992219|NCT00509067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992220|NCT00509067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992221|NCT00509067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992222|NCT00509067|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92992223|NCT00509067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92992224|NCT00509067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992225|NCT00509067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992226|NCT00509067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92992227|NCT00509067|Dopamine Agents|dopamine agents|mesh-ancestor
92992228|NCT00509067|Antiemetics|antiemetics|mesh-ancestor
92992229|NCT00509067|Autonomic Agents|autonomic agents|mesh-ancestor
92992230|NCT00509067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992231|NCT00509067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92992232|NCT00509067|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92992233|NCT00509067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92992234|NCT00509067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992235|NCT00509067|Antidepressive Agents|antidepressive agents|mesh-ancestor
92992236|NCT00509067|Dopamine Agonists|dopamine agonists|mesh-ancestor
92992237|NCT00509067|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92992238|NCT00509067|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92992239|NCT00509067|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92992240|NCT00509067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92992241|NCT00509067|Lipotropic Agents|lipotropic agents|mesh-ancestor
92992242|NCT00509067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92992243|NCT00509067|Antimetabolites|antimetabolites|mesh-ancestor
92992244|NCT00509067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92992245|NCT00509067|Nootropic Agents|nootropic agents|mesh-ancestor
92992246|NCT00509067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92992247|NCT00509067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992248|NCT00509067|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992249|NCT00509067|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92992250|NCT02538146|Acetylcarnitine|acetylcarnitine|mesh-list
92992251|NCT02538146|Vitamin B Complex|vitamin b complex|mesh-ancestor
92992252|NCT02538146|Vitamins|vitamins|mesh-ancestor
92992253|NCT02538146|Micronutrients|micronutrients|mesh-ancestor
92992254|NCT02538146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992255|NCT02538146|Nootropic Agents|nootropic agents|mesh-ancestor
92992256|NCT00908024|Cetuximab|cetuximab|mesh-list
92992257|NCT00908024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92992258|NCT00908024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992259|NCT00730223|Efavirenz|efavirenz|mesh-list
92992260|NCT00730223|Nevirapine|nevirapine|mesh-list
92992261|NCT00730223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92992262|NCT00730223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92992263|NCT00730223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992264|NCT00730223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992265|NCT00730223|Antiviral Agents|antiviral agents|mesh-ancestor
92992266|NCT00730223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992267|NCT00730223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92992268|NCT00730223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92992269|NCT00730223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92992270|NCT00730223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92992271|NCT00730223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92992272|NCT00730223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92992273|NCT00730223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92992274|NCT00730223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92992275|NCT00908180|Cytarabine|cytarabine|mesh-list
92992276|NCT00908180|Cyclosporine|cyclosporine|mesh-list
92992277|NCT00908180|Etoposide|etoposide|mesh-list
92992278|NCT00908180|Melphalan|melphalan|mesh-list
92992279|NCT00908180|Alemtuzumab|alemtuzumab|mesh-list
92992280|NCT00908180|Carmustine|carmustine|mesh-list
92992281|NCT00908180|Cyclosporins|cyclosporins|mesh-list
92992282|NCT00908180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92992283|NCT00908180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992284|NCT00908180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92992285|NCT00908180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92992286|NCT00908180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992287|NCT00908180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992288|NCT00908180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92992289|NCT00908180|Antimetabolites|antimetabolites|mesh-ancestor
92992290|NCT00908180|Antiviral Agents|antiviral agents|mesh-ancestor
92992291|NCT00908180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992292|NCT00908180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992293|NCT00908180|Immunologic Factors|immunologic factors|mesh-ancestor
92992294|NCT00908180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992295|NCT00908180|Antifungal Agents|antifungal agents|mesh-ancestor
92992296|NCT00908180|Dermatologic Agents|dermatologic agents|mesh-ancestor
92992297|NCT00908180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992298|NCT00908180|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92992299|NCT00908180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92992300|NCT00908180|Alkylating Agents|alkylating agents|mesh-ancestor
92992301|NCT00908180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92992302|NCT00908180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92992303|NCT04480463|Aflibercept|aflibercept|mesh-list
92992304|NCT04480463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92992305|NCT04480463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92992306|NCT04480463|Growth Substances|growth substances|mesh-ancestor
92992307|NCT04480463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992308|NCT04480463|Growth Inhibitors|growth inhibitors|mesh-ancestor
92992309|NCT04480463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992310|NCT00909506|Metformin|metformin|mesh-list
92992311|NCT00909506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92992312|NCT00909506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992313|NCT03997539|Vinorelbine|vinorelbine|mesh-list
92992314|NCT03997539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92992315|NCT03997539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992316|NCT03997539|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992317|NCT03997539|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992318|NCT03997539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992319|NCT03997539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992320|NCT02570243|Heparin|heparin|mesh-list
92992321|NCT02570243|Calcium heparin|calcium heparin|mesh-list
92992322|NCT02570243|Anticoagulants|anticoagulants|mesh-ancestor
92992323|NCT02570243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92992324|NCT02570243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92992325|NCT02570243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992326|NCT00927212|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92992327|NCT00927212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92992328|NCT00927212|Immunologic Factors|immunologic factors|mesh-ancestor
92992329|NCT00927212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992330|NCT00927212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992331|NCT00927212|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92992332|NCT00927212|Protective Agents|protective agents|mesh-ancestor
92992333|NCT00927212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528290|NCT00000752|Sympathomimetics|sympathomimetics|mesh-ancestor
92992334|NCT00927212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92992335|NCT00927212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992336|NCT00927212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992337|NCT00927212|Antiviral Agents|antiviral agents|mesh-ancestor
92992338|NCT00927212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992339|NCT00927290|Pioglitazone|pioglitazone|mesh-list
92992340|NCT00927290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92637701|NCT00475033|Vaccines|vaccines|mesh-list
92992341|NCT00927290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992343|NCT00728195|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
92992344|NCT00728195|Antiemetics|antiemetics|mesh-ancestor
92992345|NCT00728195|Autonomic Agents|autonomic agents|mesh-ancestor
92992346|NCT00728195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992347|NCT00728195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992348|NCT00728195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92992349|NCT00728195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92992350|NCT00728195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92992351|NCT00728195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992352|NCT00728195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992353|NCT00728195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92992354|NCT00728195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92992355|NCT00728195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992356|NCT00728195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992357|NCT00728195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992358|NCT00728195|Serotonin Agents|serotonin agents|mesh-ancestor
92992359|NCT00728195|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92992360|NCT00728195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92992361|NCT00728195|Dopamine Agents|dopamine agents|mesh-ancestor
92992362|NCT00927524|Insulin|insulin|mesh-list
92992363|NCT00927524|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92992364|NCT00927524|Insulin glulisine|insulin glulisine|mesh-list
92992365|NCT00927524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92992366|NCT00927524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992367|NCT00728273|Micronutrients|micronutrients|mesh-list
92992368|NCT00728273|Trace Elements|trace elements|mesh-list
92992369|NCT00728273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992370|NCT00927602|PENTA|penta|mesh-list
92992371|NCT00927602|Fondaparinux|fondaparinux|mesh-list
92992372|NCT00927602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92992373|NCT00927602|Antithrombins|antithrombins|mesh-ancestor
92992374|NCT00927602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92992375|NCT00927602|Protease Inhibitors|protease inhibitors|mesh-ancestor
92992376|NCT00927602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992377|NCT00927602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992378|NCT00927602|Anticoagulants|anticoagulants|mesh-ancestor
92992379|NCT00927602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92992380|NCT00927602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92992381|NCT04286867|Ethanol|ethanol|mesh-list
92992382|NCT04286867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92992383|NCT04286867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992384|NCT04286867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992385|NCT04286867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992386|NCT00730535|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92992387|NCT00730535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92992388|NCT00730535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92992389|NCT00730535|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992390|NCT00730535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992391|NCT00730535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992392|NCT00730535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992393|NCT00730535|Urological Agents|urological agents|mesh-ancestor
92992394|NCT00904202|Lidocaine|lidocaine|mesh-list
92992395|NCT00904202|Gabapentin|gabapentin|mesh-list
92992396|NCT00904202|Anesthetics, Local|anesthetics, local|mesh-ancestor
92992397|NCT00904202|Anesthetics|anesthetics|mesh-ancestor
92992398|NCT00904202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992399|NCT00904202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992400|NCT00904202|Sensory System Agents|sensory system agents|mesh-ancestor
92992401|NCT00904202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992402|NCT00904202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92992403|NCT00904202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92992404|NCT00904202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92992405|NCT00904202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992406|NCT00904202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992407|NCT00904202|Analgesics|analgesics|mesh-ancestor
92992408|NCT00904202|Anticonvulsants|anticonvulsants|mesh-ancestor
92992409|NCT00904202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92992410|NCT00904202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92992411|NCT00904202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992412|NCT00904202|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92992413|NCT00904202|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92637780|NCT00221871|Ketamine|ketamine|mesh-list
92992414|NCT00904202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992415|NCT00904202|Antimanic Agents|antimanic agents|mesh-ancestor
92992416|NCT00927836|Lenograstim|lenograstim|mesh-list
92992417|NCT00927836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92992418|NCT00927836|Immunologic Factors|immunologic factors|mesh-ancestor
92992419|NCT00927836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992420|NCT00904280|Oxymorphone|oxymorphone|mesh-list
92992421|NCT00904280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92992422|NCT00904280|Narcotics|narcotics|mesh-ancestor
92992423|NCT00904280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992424|NCT00904280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992425|NCT00904280|Analgesics|analgesics|mesh-ancestor
92992426|NCT00904280|Sensory System Agents|sensory system agents|mesh-ancestor
92992427|NCT00904280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992428|NCT00904280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92992429|NCT00928148|Amphetamine|amphetamine|mesh-list
92992430|NCT00928148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92992431|NCT00928148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992432|NCT00928148|Sympathomimetics|sympathomimetics|mesh-ancestor
92992433|NCT00928148|Autonomic Agents|autonomic agents|mesh-ancestor
92992434|NCT00928148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992435|NCT00928148|Dopamine Agents|dopamine agents|mesh-ancestor
92992436|NCT00928148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992437|NCT00928148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992438|NCT00928148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92992439|NCT00928148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92992440|NCT00928148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92992441|NCT00928148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992442|NCT00928148|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92992443|NCT02430077|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92992444|NCT02430077|Cathartics|cathartics|mesh-ancestor
92992445|NCT02430077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92992446|NCT00904436|Ipratropium|ipratropium|mesh-list
92992447|NCT00904436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92992448|NCT00904436|Autonomic Agents|autonomic agents|mesh-ancestor
92992449|NCT00904436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992450|NCT00904436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992451|NCT00904436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92992452|NCT00904436|Respiratory System Agents|respiratory system agents|mesh-ancestor
92992453|NCT00904436|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92992454|NCT00904436|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992455|NCT00904436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992456|NCT00904436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992457|NCT00728585|Mitogens|mitogens|mesh-list
92992458|NCT00728585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992459|NCT00728585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992460|NCT00730769|Valganciclovir|valganciclovir|mesh-list
92992461|NCT00730769|Ganciclovir|ganciclovir|mesh-list
92992462|NCT00730769|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92992463|NCT00730769|Antiviral Agents|antiviral agents|mesh-ancestor
92992464|NCT00730769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992465|NCT00730769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92992466|NCT00730769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992467|NCT00730769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992468|NCT00728663|Docetaxel|docetaxel|mesh-list
92992469|NCT00728663|Cetuximab|cetuximab|mesh-list
92992470|NCT00728663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992471|NCT00728663|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992472|NCT00728663|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992473|NCT00728663|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992474|NCT00728663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992475|NCT00728663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92992476|NCT00731003|Tryptophan|tryptophan|mesh-list
92992477|NCT00731003|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92992478|NCT00731003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92992479|NCT00731003|Antidepressive Agents|antidepressive agents|mesh-ancestor
92992481|NCT00729131|Etanercept|etanercept|mesh-list
92992482|NCT00729131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92992483|NCT00729131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992484|NCT00729131|Analgesics|analgesics|mesh-ancestor
92992485|NCT00729131|Sensory System Agents|sensory system agents|mesh-ancestor
92992486|NCT00729131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992487|NCT00729131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637850|NCT00215163|Serotonin Agents|serotonin agents|mesh-ancestor
92992488|NCT00729131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992489|NCT00729131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992490|NCT00729131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92992491|NCT00729131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992492|NCT00729131|Immunologic Factors|immunologic factors|mesh-ancestor
92992493|NCT00729287|Selenium|selenium|mesh-list
92992494|NCT00729287|Antioxidants|antioxidants|mesh-ancestor
92992495|NCT00729287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992496|NCT00729287|Protective Agents|protective agents|mesh-ancestor
92992497|NCT00729287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992498|NCT00729287|Trace Elements|trace elements|mesh-ancestor
92992499|NCT00729287|Micronutrients|micronutrients|mesh-ancestor
92992500|NCT00731393|Vaccines|vaccines|mesh-list
92992501|NCT00731393|Immunologic Factors|immunologic factors|mesh-ancestor
92992502|NCT00731393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992503|NCT04390217|Tranexamic Acid|tranexamic acid|mesh-list
92992504|NCT04390217|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92992505|NCT04390217|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92992506|NCT04390217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992507|NCT04390217|Hemostatics|hemostatics|mesh-ancestor
92992508|NCT04390217|Coagulants|coagulants|mesh-ancestor
92992509|NCT02569463|Aldesleukin|aldesleukin|mesh-list
92992510|NCT02569463|Interleukin-2|interleukin-2|mesh-list
92992511|NCT02569463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992512|NCT02569463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992513|NCT02569463|Analgesics|analgesics|mesh-ancestor
92992514|NCT02569463|Sensory System Agents|sensory system agents|mesh-ancestor
92992515|NCT02569463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992516|NCT02569463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992517|NCT02569463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92992518|NCT02569463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92992519|NCT02569463|Antiviral Agents|antiviral agents|mesh-ancestor
92992520|NCT02569463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992521|NCT00731627|Simvastatin|simvastatin|mesh-list
92992522|NCT00731627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92992523|NCT00731627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92992524|NCT00731627|Antimetabolites|antimetabolites|mesh-ancestor
92992525|NCT00731627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992526|NCT00731627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92992527|NCT00731627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92992528|NCT00731627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992529|NCT00568178|Losartan|losartan|mesh-list
92992530|NCT00568178|Amlodipine|amlodipine|mesh-list
92992531|NCT00568178|Enalapril|enalapril|mesh-list
92992532|NCT00568178|Enalaprilat|enalaprilat|mesh-list
92992533|NCT00568178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92992534|NCT00568178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92992535|NCT00568178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992536|NCT00568178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992537|NCT00568178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92992538|NCT00568178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992539|NCT00568178|Vasodilator Agents|vasodilator agents|mesh-ancestor
92992540|NCT00568178|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92992541|NCT00568178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92992542|NCT00568178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92992543|NCT00568178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992544|NCT00568178|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92992545|NCT00568178|Protease Inhibitors|protease inhibitors|mesh-ancestor
92992546|NCT00577889|Gemcitabine|gemcitabine|mesh-list
92992547|NCT00577889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92992548|NCT00577889|Antimetabolites|antimetabolites|mesh-ancestor
92992549|NCT00577889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992550|NCT00577889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992551|NCT00729599|Cetylpyridinium|cetylpyridinium|mesh-list
92992552|NCT00729599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92992553|NCT00729599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992554|NCT02538926|Prednisone|prednisone|mesh-list
92992555|NCT02538926|Cortisone|cortisone|mesh-list
92992556|NCT02538926|Cyclophosphamide|cyclophosphamide|mesh-list
92992557|NCT02538926|Rituximab|rituximab|mesh-list
92992558|NCT02538926|Doxorubicin|doxorubicin|mesh-list
92992559|NCT02538926|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92992560|NCT02538926|Etoposide|etoposide|mesh-list
92992561|NCT02538926|Vincristine|vincristine|mesh-list
92992562|NCT02538926|Etoposide phosphate|etoposide phosphate|mesh-list
92992563|NCT02538926|Imatinib Mesylate|imatinib mesylate|mesh-list
92992564|NCT02538926|Asparaginase|asparaginase|mesh-list
92992565|NCT02538926|Podophyllotoxin|podophyllotoxin|mesh-list
92992566|NCT02538926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92992567|NCT02538926|Antibodies|antibodies|mesh-list
92992568|NCT02538926|Immunoglobulins|immunoglobulins|mesh-list
92992569|NCT02538926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92992570|NCT02538926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992571|NCT02538926|Immunologic Factors|immunologic factors|mesh-ancestor
92992572|NCT02538926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992573|NCT02538926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992574|NCT02538926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92992575|NCT02538926|Alkylating Agents|alkylating agents|mesh-ancestor
92992576|NCT02538926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992577|NCT02538926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992578|NCT02538926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92992579|NCT02538926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92992580|NCT02538926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92992581|NCT02538926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92992582|NCT02538926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992583|NCT02538926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992584|NCT02538926|Glucocorticoids|glucocorticoids|mesh-ancestor
92992585|NCT02538926|Hormones|hormones|mesh-ancestor
92992586|NCT02538926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92992587|NCT02538926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92992588|NCT02538926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92992589|NCT02538926|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992590|NCT02538926|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992591|NCT02538926|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992592|NCT02538926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992593|NCT02538926|Keratolytic Agents|keratolytic agents|mesh-ancestor
92992594|NCT02538926|Dermatologic Agents|dermatologic agents|mesh-ancestor
92992595|NCT00904904|Ketorolac|ketorolac|mesh-list
92992596|NCT00904904|Indomethacin|indomethacin|mesh-list
92992597|NCT00904904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92992598|NCT00904904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92992599|NCT00904904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92992600|NCT00904904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992601|NCT00904904|Analgesics|analgesics|mesh-ancestor
92992602|NCT00904904|Sensory System Agents|sensory system agents|mesh-ancestor
92992603|NCT00904904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992604|NCT00904904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992605|NCT00904904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992606|NCT00904904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992607|NCT00904904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92992608|NCT00904904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992609|NCT00904904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992610|NCT00904904|Gout Suppressants|gout suppressants|mesh-ancestor
92992611|NCT00904904|Tocolytic Agents|tocolytic agents|mesh-ancestor
92992612|NCT00904904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92992613|NCT00731861|Paclitaxel|paclitaxel|mesh-list
92992614|NCT00731861|Vatalanib|vatalanib|mesh-list
92992615|NCT00731861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92992616|NCT00731861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992617|NCT00731861|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992618|NCT00731861|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992619|NCT00731861|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992620|NCT00731861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992621|NCT00731861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992622|NCT00731861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992623|NCT00567476|Omalizumab|omalizumab|mesh-list
92992624|NCT00567476|Terbutaline|terbutaline|mesh-list
92992625|NCT00567476|Adrenergic Agents|adrenergic agents|mesh-list
92992626|NCT00567476|Adrenergic Agonists|adrenergic agonists|mesh-list
92992627|NCT00567476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92992628|NCT00567476|Autonomic Agents|autonomic agents|mesh-ancestor
92992629|NCT00567476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992630|NCT00567476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992631|NCT00567476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92992632|NCT00567476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92992633|NCT00567476|Tocolytic Agents|tocolytic agents|mesh-ancestor
92992634|NCT00567476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92992635|NCT00567476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92992636|NCT00567476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92992637|NCT00567476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992638|NCT00567476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637995|NCT00215592|Zonisamide|zonisamide|mesh-list
92992639|NCT00567476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92992640|NCT00567476|Sympathomimetics|sympathomimetics|mesh-ancestor
92992641|NCT00729911|Amiodarone|amiodarone|mesh-list
92992642|NCT00729911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92992643|NCT00729911|Vasodilator Agents|vasodilator agents|mesh-ancestor
92992644|NCT00729911|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92992645|NCT00729911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992646|NCT00729911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992647|NCT00729911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92992648|NCT00729911|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92992649|NCT00729911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92992650|NCT00729911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992651|NCT00729911|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92992652|NCT00729911|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92992653|NCT00729911|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92992654|NCT04018703|Midazolam|midazolam|mesh-list
92992655|NCT04018703|Dexmedetomidine|dexmedetomidine|mesh-list
92992656|NCT04018703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92992657|NCT04018703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92992658|NCT04018703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992659|NCT04018703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992660|NCT04018703|Analgesics|analgesics|mesh-ancestor
92992661|NCT04018703|Sensory System Agents|sensory system agents|mesh-ancestor
92992662|NCT04018703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992663|NCT04018703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92992664|NCT04018703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92992665|NCT04018703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92992666|NCT04018703|Adrenergic Agents|adrenergic agents|mesh-ancestor
92992667|NCT04018703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992668|NCT04018703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992669|NCT04018703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92992670|NCT04018703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92992671|NCT04018703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92992672|NCT04018703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992673|NCT04018703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92992674|NCT04018703|Anesthetics, General|anesthetics, general|mesh-ancestor
92992675|NCT04018703|Anesthetics|anesthetics|mesh-ancestor
92992676|NCT04018703|GABA Modulators|gaba modulators|mesh-ancestor
92992677|NCT04018703|GABA Agents|gaba agents|mesh-ancestor
92992678|NCT04629872|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92992679|NCT04629872|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92992680|NCT04629872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992681|NCT04629872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992682|NCT04629872|Immunologic Factors|immunologic factors|mesh-ancestor
92992683|NCT04629872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992684|NCT04065581|Metformin|metformin|mesh-list
92992685|NCT04065581|Acarbose|acarbose|mesh-list
92992686|NCT04065581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92992687|NCT04065581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992688|NCT04065581|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92992689|NCT04065581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992690|NCT04065581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992691|NCT00733889|Docetaxel|docetaxel|mesh-list
92992692|NCT00733889|Fluorouracil|fluorouracil|mesh-list
92992693|NCT00733889|Cetuximab|cetuximab|mesh-list
92992694|NCT00733889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992695|NCT00733889|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992696|NCT00733889|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992697|NCT00733889|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992698|NCT00733889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992699|NCT00733889|Antimetabolites|antimetabolites|mesh-ancestor
92992700|NCT00733889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92992701|NCT00733889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992702|NCT00733889|Immunologic Factors|immunologic factors|mesh-ancestor
92992703|NCT00733889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992704|NCT00733889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92992705|NCT00733967|Varenicline|varenicline|mesh-list
92992706|NCT00733967|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92992707|NCT00733967|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92992708|NCT00733967|Cholinergic Agents|cholinergic agents|mesh-ancestor
92992709|NCT00733967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992710|NCT00733967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992711|NCT00733967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992712|NCT04650243|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92638066|NCT00192842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992713|NCT04650243|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92992714|NCT04650243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92992716|NCT00738569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92992717|NCT00738569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92992718|NCT00738569|Antiviral Agents|antiviral agents|mesh-ancestor
92992719|NCT00738569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992720|NCT00738569|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92992721|NCT00738569|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92992722|NCT00738569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992723|NCT00738569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992724|NCT04644627|Gentamicins|gentamicins|mesh-list
92992725|NCT04644627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92992726|NCT04644627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992727|NCT04644627|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92992728|NCT04644627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992729|NCT04644627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992730|NCT00732407|Losartan|losartan|mesh-list
92992731|NCT00732407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92992732|NCT00732407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92992733|NCT00732407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92992734|NCT00732407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92992735|NCT00732407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992736|NCT00507819|Sildenafil Citrate|sildenafil citrate|mesh-list
92992737|NCT00507819|Vasodilator Agents|vasodilator agents|mesh-ancestor
92992738|NCT00507819|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92992739|NCT00507819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92992740|NCT00507819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992741|NCT00507819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992742|NCT00507819|Urological Agents|urological agents|mesh-ancestor
92992743|NCT02569307|Minocycline|minocycline|mesh-list
92992744|NCT02569307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92992745|NCT02569307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992746|NCT01013103|Atorvastatin|atorvastatin|mesh-list
92992747|NCT01013103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92992748|NCT01013103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92992749|NCT01013103|Antimetabolites|antimetabolites|mesh-ancestor
92992750|NCT01013103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992751|NCT01013103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92992752|NCT01013103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92992753|NCT01013103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992754|NCT00732485|Fenofibrate|fenofibrate|mesh-list
92992755|NCT00732485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92992756|NCT00732485|Antimetabolites|antimetabolites|mesh-ancestor
92992757|NCT00732485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992758|NCT00732485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92992759|NCT02569073|Dronabinol|dronabinol|mesh-list
92992760|NCT02569073|Hallucinogens|hallucinogens|mesh-ancestor
92992761|NCT02569073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992762|NCT02569073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92992763|NCT02569073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992764|NCT02569073|Analgesics|analgesics|mesh-ancestor
92992765|NCT02569073|Sensory System Agents|sensory system agents|mesh-ancestor
92992766|NCT02569073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992767|NCT02569073|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92992768|NCT02569073|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92992769|NCT02569073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992770|NCT02569073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992771|NCT02569073|Hormones|hormones|mesh-ancestor
92992772|NCT02569073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92992773|NCT00732563|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92992774|NCT00732563|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92992775|NCT00732563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992776|NCT00734123|Aspirin|aspirin|mesh-list
92992777|NCT00734123|Rimonabant|rimonabant|mesh-list
92992778|NCT00734123|Enalapril|enalapril|mesh-list
92992779|NCT00734123|Clopidogrel|clopidogrel|mesh-list
92992780|NCT00734123|Atorvastatin|atorvastatin|mesh-list
92992781|NCT00734123|Simvastatin|simvastatin|mesh-list
92992782|NCT00734123|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92992783|NCT00734123|Diuretics|diuretics|mesh-list
92992784|NCT00734123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92992785|NCT00734123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92992786|NCT00734123|Analgesics|analgesics|mesh-ancestor
92992787|NCT00734123|Sensory System Agents|sensory system agents|mesh-ancestor
92992788|NCT00734123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992789|NCT00734123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992790|NCT00734123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92992791|NCT00734123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92992792|NCT00734123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92992793|NCT00734123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92992794|NCT00734123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992795|NCT00734123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92992796|NCT00734123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92992797|NCT00734123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992798|NCT00734123|Antipyretics|antipyretics|mesh-ancestor
92992799|NCT00734123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92992800|NCT00734123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92992801|NCT00734123|Antimetabolites|antimetabolites|mesh-ancestor
92992802|NCT00734123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92992803|NCT00734123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92992804|NCT00734123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92992805|NCT00734123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92992806|NCT00734123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92992807|NCT00734123|Purinergic Agents|purinergic agents|mesh-ancestor
92992808|NCT00734123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992809|NCT00734123|Protease Inhibitors|protease inhibitors|mesh-ancestor
92992810|NCT00734123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92992811|NCT00734123|Natriuretic Agents|natriuretic agents|mesh-ancestor
92992812|NCT00734123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92992813|NCT00734123|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92992814|NCT00734123|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92992815|NCT00734123|Hormones|hormones|mesh-ancestor
92992816|NCT00734123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92992817|NCT00734279|Leuprolide|leuprolide|mesh-list
92992818|NCT00734279|Ganirelix|ganirelix|mesh-list
92992819|NCT00734279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92992820|NCT00734279|Fertility Agents|fertility agents|mesh-ancestor
92992821|NCT00734279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92992822|NCT00734279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992823|NCT00734279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92992824|NCT00734279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992825|NCT00734279|Hormone Antagonists|hormone antagonists|mesh-ancestor
92992826|NCT00734279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92992827|NCT00442936|Oxazolidinones|oxazolidinones|mesh-list
92992828|NCT00442936|Zolmitriptan|zolmitriptan|mesh-list
92992829|NCT00442936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92992830|NCT00442936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92992831|NCT00442936|Serotonin Agents|serotonin agents|mesh-ancestor
92992832|NCT00442936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992833|NCT00442936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992834|NCT00442936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992835|NCT00442936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992836|NCT00442936|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92992837|NCT00442936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992838|NCT03410043|Osimertinib|osimertinib|mesh-list
92992839|NCT03410043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992840|NCT03410043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992841|NCT03410043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992842|NCT03410043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992843|NCT00732953|Paclitaxel|paclitaxel|mesh-list
92992844|NCT00732953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92992845|NCT00732953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992846|NCT00732953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992847|NCT00732953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992848|NCT00732953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992849|NCT00732953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992850|NCT00577655|Albuterol|albuterol|mesh-list
92992851|NCT00577655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92992852|NCT00577655|Autonomic Agents|autonomic agents|mesh-ancestor
92992853|NCT00577655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92992854|NCT00577655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992855|NCT00577655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92992856|NCT00577655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92992857|NCT00577655|Tocolytic Agents|tocolytic agents|mesh-ancestor
92992858|NCT00577655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92638223|NCT00193349|Irinotecan|irinotecan|mesh-list
92992859|NCT00577655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92992860|NCT00577655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92992861|NCT00577655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92992862|NCT00577655|Adrenergic Agents|adrenergic agents|mesh-ancestor
92992863|NCT00577655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992864|NCT00577655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992865|NCT00733031|Gemcitabine|gemcitabine|mesh-list
92992866|NCT00733031|Pemetrexed|pemetrexed|mesh-list
92992867|NCT00733031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92992868|NCT00733031|Antimetabolites|antimetabolites|mesh-ancestor
92992869|NCT00733031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992870|NCT00733031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992871|NCT00733031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992872|NCT00733031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92992873|NCT00733031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92992874|NCT01327781|Tamoxifen|tamoxifen|mesh-list
92992875|NCT01327781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92992876|NCT01327781|Hormone Antagonists|hormone antagonists|mesh-ancestor
92992877|NCT01327781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92992878|NCT01327781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992879|NCT01327781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92992880|NCT01327781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992881|NCT01327781|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92992882|NCT01327781|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92992883|NCT01327781|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92992884|NCT00734669|Glyburide|glyburide|mesh-list
92992885|NCT00734669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92992886|NCT00734669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992887|NCT00113269|Mycophenolic Acid|mycophenolic acid|mesh-list
92992888|NCT00113269|Alemtuzumab|alemtuzumab|mesh-list
92992889|NCT00113269|Tacrolimus|tacrolimus|mesh-list
92992890|NCT00113269|Thymoglobulin|thymoglobulin|mesh-list
92992891|NCT00113269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92992892|NCT00113269|Basiliximab|basiliximab|mesh-list
92992893|NCT00113269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92992894|NCT00113269|Immunologic Factors|immunologic factors|mesh-ancestor
92992895|NCT00113269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992896|NCT00113269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92992897|NCT00113269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992898|NCT00113269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992899|NCT00113269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92992900|NCT00113269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992901|NCT00113269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92992902|NCT00113269|Antitubercular Agents|antitubercular agents|mesh-ancestor
92992903|NCT00113269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92992904|NCT00113269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992905|NCT00113269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92992906|NCT04065269|Olaparib|olaparib|mesh-list
92992907|NCT04065269|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92992908|NCT04065269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992909|NCT04065269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992910|NCT04065269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992911|NCT00515619|Lacosamide|lacosamide|mesh-list
92992912|NCT00515619|Anticonvulsants|anticonvulsants|mesh-ancestor
92992913|NCT00515619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92992914|NCT00515619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92992915|NCT00515619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92528301|NCT00035464|Azimilide|azimilide|mesh-list
92992916|NCT00515619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992917|NCT01815359|Leucovorin|leucovorin|mesh-list
92992918|NCT01815359|Mitomycins|mitomycins|mesh-list
92992919|NCT01815359|Mitomycin|mitomycin|mesh-list
92992920|NCT01815359|Antidotes|antidotes|mesh-ancestor
92992921|NCT01815359|Protective Agents|protective agents|mesh-ancestor
92992922|NCT01815359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992923|NCT01815359|Vitamin B Complex|vitamin b complex|mesh-ancestor
92992924|NCT01815359|Vitamins|vitamins|mesh-ancestor
92992925|NCT01815359|Micronutrients|micronutrients|mesh-ancestor
92992926|NCT01815359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92992927|NCT01815359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992928|NCT01815359|Alkylating Agents|alkylating agents|mesh-ancestor
92992929|NCT01815359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992930|NCT01815359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92992931|NCT01815359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992932|NCT00449644|Bedaquiline|bedaquiline|mesh-list
92992933|NCT00449644|Antitubercular Agents|antitubercular agents|mesh-ancestor
92992934|NCT00449644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92992935|NCT00449644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992936|NCT00733265|Ticagrelor|ticagrelor|mesh-list
92992937|NCT00733265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92992938|NCT00733265|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92992939|NCT00733265|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92992940|NCT00733265|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92992941|NCT00733265|Purinergic Agents|purinergic agents|mesh-ancestor
92992942|NCT00733265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92992943|NCT00733265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992944|NCT00733265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992945|NCT00112489|Paclitaxel|paclitaxel|mesh-list
92992946|NCT00112489|Carboplatin|carboplatin|mesh-list
92992947|NCT00112489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92992948|NCT00112489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992949|NCT00112489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92992950|NCT00112489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92992951|NCT00112489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92992952|NCT00112489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992953|NCT01023100|Tofacitinib|tofacitinib|mesh-list
92992954|NCT01023100|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92992955|NCT01023100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92992956|NCT01023100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992957|NCT01023100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992958|NCT00515463|Denosumab|denosumab|mesh-list
92992959|NCT00515463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92992960|NCT00515463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92992961|NCT01082731|Artesunate|artesunate|mesh-list
92992962|NCT01082731|Lumefantrine|lumefantrine|mesh-list
92992963|NCT01082731|Artemether|artemether|mesh-list
92992964|NCT01082731|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92992965|NCT01082731|Mefloquine|mefloquine|mesh-list
92992966|NCT01082731|Antimalarials|antimalarials|mesh-ancestor
92992967|NCT01082731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92992968|NCT01082731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92992969|NCT01082731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92992970|NCT01082731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92992971|NCT01082731|Antiviral Agents|antiviral agents|mesh-ancestor
92992972|NCT01082731|Schistosomicides|schistosomicides|mesh-ancestor
92992973|NCT01082731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92992974|NCT01082731|Anthelmintics|anthelmintics|mesh-ancestor
92992975|NCT00739193|Amiodarone|amiodarone|mesh-list
92992976|NCT00739193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92992977|NCT00739193|Vasodilator Agents|vasodilator agents|mesh-ancestor
92992978|NCT00739193|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92992979|NCT00739193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92992980|NCT00739193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992981|NCT00739193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92992982|NCT00739193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92992983|NCT00739193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92992984|NCT00739193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92992985|NCT00739193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92992986|NCT00739193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92992987|NCT00739193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92992988|NCT01011543|Dimercaprol|dimercaprol|mesh-list
92992989|NCT01011543|Chelating Agents|chelating agents|mesh-ancestor
92992990|NCT01011543|Sequestering Agents|sequestering agents|mesh-ancestor
92992991|NCT01011543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992993|NCT00733811|Deferoxamine|deferoxamine|mesh-list
92992994|NCT00733811|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92992995|NCT00733811|Chelating Agents|chelating agents|mesh-ancestor
92992996|NCT00733811|Sequestering Agents|sequestering agents|mesh-ancestor
92992997|NCT00733811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92992998|NCT00733811|Siderophores|siderophores|mesh-ancestor
92992999|NCT00739505|Immunoglobulin G|immunoglobulin g|mesh-list
92993000|NCT00739505|Immunologic Factors|immunologic factors|mesh-ancestor
92993001|NCT00739505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993002|NCT00507507|Tenofovir|tenofovir|mesh-list
92993003|NCT00507507|Antiviral Agents|antiviral agents|mesh-ancestor
92993004|NCT00507507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993005|NCT00507507|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92993006|NCT00507507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92993007|NCT00507507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993008|NCT00507507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993009|NCT00507507|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92993010|NCT00507507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92993012|NCT00459706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993013|NCT00459706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993014|NCT00459706|Analgesics|analgesics|mesh-ancestor
92993015|NCT00459706|Sensory System Agents|sensory system agents|mesh-ancestor
92993016|NCT00459706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993017|NCT00459706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993018|NCT00459706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993019|NCT00459706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993020|NCT00459706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993021|NCT00459706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993022|NCT00459706|Immunologic Factors|immunologic factors|mesh-ancestor
92993023|NCT00735527|Lorazepam|lorazepam|mesh-list
92993024|NCT00735527|Anticonvulsants|anticonvulsants|mesh-ancestor
92993025|NCT00735527|Antiemetics|antiemetics|mesh-ancestor
92993026|NCT00735527|Autonomic Agents|autonomic agents|mesh-ancestor
92993027|NCT00735527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993028|NCT00735527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993029|NCT00735527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993030|NCT00735527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92993031|NCT00735527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993032|NCT00735527|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92993033|NCT00735527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92993034|NCT00735527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993035|NCT00735527|GABA Modulators|gaba modulators|mesh-ancestor
92993036|NCT00735527|GABA Agents|gaba agents|mesh-ancestor
92993037|NCT00735527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993038|NCT00735527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993039|NCT00735761|Acyclovir|acyclovir|mesh-list
92993040|NCT00735761|Hydrocortisone|hydrocortisone|mesh-list
92993041|NCT00735761|Antiviral Agents|antiviral agents|mesh-ancestor
92993042|NCT00735761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993043|NCT00735761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993044|NCT00740285|Lidocaine|lidocaine|mesh-list
92993045|NCT00740285|Anesthetics, Local|anesthetics, local|mesh-ancestor
92993046|NCT00740285|Anesthetics|anesthetics|mesh-ancestor
92993047|NCT00740285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993048|NCT00740285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993049|NCT00740285|Sensory System Agents|sensory system agents|mesh-ancestor
92993050|NCT00740285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993051|NCT00740285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92993052|NCT00740285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92993053|NCT00740285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92993054|NCT00740285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92993055|NCT00740285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993056|NCT00507429|Paclitaxel|paclitaxel|mesh-list
92993057|NCT00507429|Fosbretabulin|fosbretabulin|mesh-list
92993058|NCT00507429|Combretastatin|combretastatin|mesh-list
92993059|NCT00507429|Carboplatin|carboplatin|mesh-list
92993060|NCT00507429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993061|NCT00507429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993062|NCT00507429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993063|NCT00507429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993064|NCT00507429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620218|NCT00150020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993065|NCT00507429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993066|NCT01011621|Prednisolone|prednisolone|mesh-list
92993067|NCT01011621|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92993068|NCT01011621|Methylprednisolone|methylprednisolone|mesh-list
92993069|NCT01011621|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92993070|NCT01011621|Prednisolone acetate|prednisolone acetate|mesh-list
92993071|NCT01011621|Betamethasone|betamethasone|mesh-list
92993072|NCT01011621|Betamethasone Valerate|betamethasone valerate|mesh-list
92993073|NCT01011621|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92993074|NCT01011621|Betamethasone benzoate|betamethasone benzoate|mesh-list
92993075|NCT01011621|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92993076|NCT01011621|Prednisolone phosphate|prednisolone phosphate|mesh-list
92993077|NCT01011621|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92993078|NCT01011621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993079|NCT01011621|Glucocorticoids|glucocorticoids|mesh-ancestor
92993080|NCT01011621|Hormones|hormones|mesh-ancestor
92993081|NCT01011621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993082|NCT01011621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993083|NCT01011621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92993084|NCT01011621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993085|NCT01011621|Antiemetics|antiemetics|mesh-ancestor
92993086|NCT01011621|Autonomic Agents|autonomic agents|mesh-ancestor
92993087|NCT01011621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993088|NCT01011621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993089|NCT01011621|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92993090|NCT01011621|Protective Agents|protective agents|mesh-ancestor
92993091|NCT01011621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92993092|NCT01011621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92993093|NCT00449176|Oxycodone|oxycodone|mesh-list
92993094|NCT00449176|Tapentadol|tapentadol|mesh-list
92993095|NCT00449176|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92993096|NCT00449176|Narcotics|narcotics|mesh-ancestor
92993097|NCT00449176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993098|NCT00449176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993099|NCT00449176|Analgesics|analgesics|mesh-ancestor
92993100|NCT00449176|Sensory System Agents|sensory system agents|mesh-ancestor
92993101|NCT00449176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993102|NCT00449176|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92993103|NCT00449176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92993104|NCT00449176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92993105|NCT00449176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993106|NCT00449176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92993107|NCT00449176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993108|NCT00515073|Diphenhydramine|diphenhydramine|mesh-list
92993109|NCT00515073|Promethazine|promethazine|mesh-list
92993110|NCT00515073|Dexamethasone|dexamethasone|mesh-list
92993111|NCT00515073|Paclitaxel|paclitaxel|mesh-list
92993112|NCT00515073|Cimetidine|cimetidine|mesh-list
92993113|NCT00515073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993114|NCT00515073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993115|NCT00515073|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993116|NCT00515073|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993117|NCT00515073|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993118|NCT00515073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993119|NCT00515073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993120|NCT00515073|Antiemetics|antiemetics|mesh-ancestor
92993121|NCT00515073|Autonomic Agents|autonomic agents|mesh-ancestor
92993122|NCT00515073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993123|NCT00515073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993124|NCT00515073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993125|NCT00515073|Glucocorticoids|glucocorticoids|mesh-ancestor
92993126|NCT00515073|Hormones|hormones|mesh-ancestor
92993127|NCT00515073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993128|NCT00515073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92993129|NCT00515073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92993130|NCT00515073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92993131|NCT00515073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993132|NCT00515073|Anesthetics, Local|anesthetics, local|mesh-ancestor
92993133|NCT00515073|Anesthetics|anesthetics|mesh-ancestor
92993134|NCT00515073|Sensory System Agents|sensory system agents|mesh-ancestor
92993135|NCT00515073|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92993136|NCT00515073|Histamine Antagonists|histamine antagonists|mesh-ancestor
92993138|NCT00515073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993139|NCT00515073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92993140|NCT00515073|Antipruritics|antipruritics|mesh-ancestor
92993141|NCT00515073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92993142|NCT00515073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92993143|NCT00515073|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92993144|NCT00515073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92993145|NCT00515073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92993146|NCT00515073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993147|NCT00710021|Vitamin D|vitamin d|mesh-list
92993148|NCT00710021|Ergocalciferols|ergocalciferols|mesh-list
92993149|NCT00710021|Cholecalciferol|cholecalciferol|mesh-list
92993150|NCT00710021|Vitamins|vitamins|mesh-list
92993151|NCT00710021|Micronutrients|micronutrients|mesh-ancestor
92993152|NCT00710021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993153|NCT00710021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993154|NCT00710021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993155|NCT00504153|Dasatinib|dasatinib|mesh-list
92993156|NCT00504153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993157|NCT00504153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993158|NCT00504153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993159|NCT00504153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993160|NCT00740363|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92993161|NCT00740363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92993162|NCT00740363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993163|NCT00740363|Incretins|incretins|mesh-ancestor
92993164|NCT00740363|Hormones|hormones|mesh-ancestor
92993165|NCT00740363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993166|NCT00740363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92993167|NCT00740363|Protease Inhibitors|protease inhibitors|mesh-ancestor
92993168|NCT00740363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993169|NCT00740363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993170|NCT04065035|Sunscreening Agents|sunscreening agents|mesh-list
92993171|NCT04065035|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92993172|NCT04065035|Protective Agents|protective agents|mesh-ancestor
92993173|NCT04065035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993174|NCT04065035|Dermatologic Agents|dermatologic agents|mesh-ancestor
92993175|NCT00442702|Darbepoetin alfa|darbepoetin alfa|mesh-list
92993176|NCT00442702|Hematinics|hematinics|mesh-ancestor
92993177|NCT00740519|Insulin Detemir|insulin detemir|mesh-list
92993178|NCT00740519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92993179|NCT00740519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993180|NCT00514917|Docetaxel|docetaxel|mesh-list
92993181|NCT00514917|Leuprolide|leuprolide|mesh-list
92993182|NCT00514917|Bicalutamide|bicalutamide|mesh-list
92993183|NCT00514917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993184|NCT00514917|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993185|NCT00514917|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993186|NCT00514917|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993187|NCT00514917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993188|NCT00514917|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92993189|NCT00514917|Fertility Agents|fertility agents|mesh-ancestor
92993190|NCT00514917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92993191|NCT00514917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993192|NCT00514917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92993193|NCT00514917|Androgen Antagonists|androgen antagonists|mesh-ancestor
92993194|NCT00514917|Hormone Antagonists|hormone antagonists|mesh-ancestor
92993195|NCT00514917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993196|NCT01011699|Niacinamide|niacinamide|mesh-list
92993197|NCT01011699|Niacin|niacin|mesh-list
92993198|NCT01011699|Nicotinic Acids|nicotinic acids|mesh-list
92993199|NCT01011699|Sevelamer|sevelamer|mesh-list
92993200|NCT01011699|Cinacalcet|cinacalcet|mesh-list
92993201|NCT01011699|Vitamin B Complex|vitamin b complex|mesh-ancestor
92993202|NCT01011699|Vitamins|vitamins|mesh-ancestor
92993203|NCT01011699|Micronutrients|micronutrients|mesh-ancestor
92993204|NCT01011699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993205|NCT01011699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92993206|NCT01011699|Antimetabolites|antimetabolites|mesh-ancestor
92993207|NCT01011699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993208|NCT01011699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92993209|NCT01011699|Vasodilator Agents|vasodilator agents|mesh-ancestor
92993210|NCT01011699|Chelating Agents|chelating agents|mesh-ancestor
92993211|NCT01011699|Sequestering Agents|sequestering agents|mesh-ancestor
92528309|NCT00014469|Melphalan|melphalan|mesh-list
92993212|NCT01011699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993213|NCT01011699|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92993214|NCT01011699|Hormone Antagonists|hormone antagonists|mesh-ancestor
92993215|NCT01011699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993216|NCT00504075|Immunoglobulins|immunoglobulins|mesh-list
92993217|NCT00504075|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92993219|NCT00504075|gamma-Globulins|gamma-globulins|mesh-list
92993220|NCT00504075|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92993221|NCT00504075|Immunologic Factors|immunologic factors|mesh-ancestor
92993222|NCT00504075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993223|NCT00503997|Oxaliplatin|oxaliplatin|mesh-list
92993224|NCT00503997|Pemetrexed|pemetrexed|mesh-list
92993225|NCT00503997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993226|NCT00503997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993227|NCT00503997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993228|NCT00503997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92993229|NCT00503997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92993230|NCT00741143|Fe(III)-EDTA|fe(iii)-edta|mesh-list
92993231|NCT00741143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92993232|NCT00741143|Chelating Agents|chelating agents|mesh-ancestor
92993233|NCT00741143|Sequestering Agents|sequestering agents|mesh-ancestor
92993234|NCT00741143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993235|NCT00736463|Atorvastatin|atorvastatin|mesh-list
92993236|NCT00736463|Simvastatin|simvastatin|mesh-list
92993237|NCT00736463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92993238|NCT00736463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92993239|NCT00736463|Antimetabolites|antimetabolites|mesh-ancestor
92993240|NCT00736463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993241|NCT00736463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92993242|NCT00736463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92993243|NCT00736463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993244|NCT00736541|Acetylcysteine|acetylcysteine|mesh-list
92993245|NCT00736541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92993246|NCT00736541|Cystatins|cystatins|mesh-list
92993247|NCT00736541|Antiviral Agents|antiviral agents|mesh-ancestor
92993248|NCT00736541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993249|NCT00736541|Expectorants|expectorants|mesh-ancestor
92993250|NCT00736541|Respiratory System Agents|respiratory system agents|mesh-ancestor
92993251|NCT00736541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92993252|NCT00736541|Antioxidants|antioxidants|mesh-ancestor
92993253|NCT00736541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993254|NCT00736541|Protective Agents|protective agents|mesh-ancestor
92993255|NCT00736541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993256|NCT00736541|Antidotes|antidotes|mesh-ancestor
92993257|NCT00736541|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92993258|NCT00736541|Protease Inhibitors|protease inhibitors|mesh-ancestor
92993259|NCT00736541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993260|NCT00096265|Temozolomide|temozolomide|mesh-list
92993261|NCT00096265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92993262|NCT00096265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92993263|NCT00096265|Alkylating Agents|alkylating agents|mesh-ancestor
92993264|NCT00096265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993265|NCT00096265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993266|NCT00096265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993267|NCT00096265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993268|NCT01082809|Sunitinib|sunitinib|mesh-list
92993269|NCT01082809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993270|NCT01082809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92993271|NCT01082809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92993272|NCT01082809|Growth Substances|growth substances|mesh-ancestor
92993273|NCT01082809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993274|NCT01082809|Growth Inhibitors|growth inhibitors|mesh-ancestor
92993275|NCT01082809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993276|NCT01082809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993277|NCT01082809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993278|NCT01080469|Tacrolimus|tacrolimus|mesh-list
92993279|NCT01080469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993280|NCT01080469|Immunologic Factors|immunologic factors|mesh-ancestor
92993281|NCT01080469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993282|NCT01080469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92993283|NCT01080469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993284|NCT01080469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993286|NCT01079065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92993287|NCT01079065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993288|NCT01079065|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92993289|NCT01079065|Histamine Antagonists|histamine antagonists|mesh-ancestor
92993290|NCT01079065|Histamine Agents|histamine agents|mesh-ancestor
92993291|NCT01079065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993292|NCT01079065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993293|NCT01079065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993294|NCT00711191|Antibodies|antibodies|mesh-list
92993295|NCT00711191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92993296|NCT00711191|Immunologic Factors|immunologic factors|mesh-ancestor
92993297|NCT00711191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993298|NCT00741221|Bevacizumab|bevacizumab|mesh-list
92993299|NCT00741221|Pemetrexed|pemetrexed|mesh-list
92993300|NCT00741221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993301|NCT00741221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993302|NCT00741221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92993303|NCT00741221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92993304|NCT00741221|Growth Substances|growth substances|mesh-ancestor
92993305|NCT00741221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993306|NCT00741221|Growth Inhibitors|growth inhibitors|mesh-ancestor
92993307|NCT00741221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993308|NCT00741221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993309|NCT00741221|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92993310|NCT00741221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92993311|NCT00736619|Paclitaxel|paclitaxel|mesh-list
92993312|NCT00736619|Cetuximab|cetuximab|mesh-list
92993313|NCT00736619|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92993314|NCT00736619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993315|NCT00736619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993316|NCT00736619|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993317|NCT00736619|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993318|NCT00736619|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993319|NCT00736619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993320|NCT00736619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993321|NCT00741377|Zoledronic Acid|zoledronic acid|mesh-list
92993322|NCT00741377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993323|NCT00741377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993324|NCT05742269|Atezolizumab|atezolizumab|mesh-list
92993325|NCT05742269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92993326|NCT05742269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993327|NCT05742269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993328|NCT05742269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993329|NCT00448864|Ecallantide|ecallantide|mesh-list
92993330|NCT00448864|Analgesics|analgesics|mesh-ancestor
92993331|NCT00448864|Sensory System Agents|sensory system agents|mesh-ancestor
92993332|NCT00448864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993333|NCT00448864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993334|NCT00448864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993335|NCT00448864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993336|NCT00448864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993337|NCT00448864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993338|NCT00567398|Icodextrin|icodextrin|mesh-list
92993339|NCT00567398|Dialysis Solutions|dialysis solutions|mesh-ancestor
92993340|NCT00567398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92993341|NCT00448708|Paclitaxel|paclitaxel|mesh-list
92993342|NCT00448708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92993343|NCT00448708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993344|NCT00448708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993345|NCT00448708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993346|NCT00448708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993347|NCT00448708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993348|NCT00448708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993349|NCT00925028|Warfarin|warfarin|mesh-list
92993350|NCT00925028|Anticoagulants|anticoagulants|mesh-ancestor
92993351|NCT00905216|Heparin|heparin|mesh-list
92993352|NCT00905216|Calcium heparin|calcium heparin|mesh-list
92993353|NCT00905216|Anticoagulants|anticoagulants|mesh-ancestor
92993354|NCT00905216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92993355|NCT00905216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92993356|NCT00905216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993357|NCT00929630|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92993358|NCT00929630|Hemostatics|hemostatics|mesh-ancestor
92993359|NCT00929630|Coagulants|coagulants|mesh-ancestor
92993361|NCT00925106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993362|NCT00925106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993363|NCT00925106|Analgesics|analgesics|mesh-ancestor
92993364|NCT00925106|Sensory System Agents|sensory system agents|mesh-ancestor
92993365|NCT00925106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993366|NCT00925106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993367|NCT00925106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993368|NCT00925106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993369|NCT00925106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92993370|NCT00925106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92993371|NCT00925106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993372|NCT00925106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993373|NCT00905528|Telmisartan|telmisartan|mesh-list
92993374|NCT00905528|Ramipril|ramipril|mesh-list
92993375|NCT00905528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92993376|NCT00905528|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92993377|NCT00905528|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92993378|NCT00905528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993379|NCT00905528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92993380|NCT00905528|Protease Inhibitors|protease inhibitors|mesh-ancestor
92993381|NCT00905528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993382|NCT00736697|Moxidectin|moxidectin|mesh-list
92993383|NCT00736697|Anthelmintics|anthelmintics|mesh-ancestor
92993384|NCT00736697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92993385|NCT00736697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993386|NCT00736697|Antinematodal Agents|antinematodal agents|mesh-ancestor
92993387|NCT02568995|Ketorolac|ketorolac|mesh-list
92993388|NCT02568995|Epinephrine|epinephrine|mesh-list
92993389|NCT02568995|Racepinephrine|racepinephrine|mesh-list
92993390|NCT02568995|Ropivacaine|ropivacaine|mesh-list
92993391|NCT02568995|Epinephryl borate|epinephryl borate|mesh-list
92993392|NCT02568995|Anesthetics, Local|anesthetics, local|mesh-ancestor
92993393|NCT02568995|Anesthetics|anesthetics|mesh-ancestor
92993394|NCT02568995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993395|NCT02568995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993396|NCT02568995|Sensory System Agents|sensory system agents|mesh-ancestor
92993397|NCT02568995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993398|NCT02568995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993399|NCT02568995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993400|NCT02568995|Analgesics|analgesics|mesh-ancestor
92993401|NCT02568995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993402|NCT02568995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993403|NCT02568995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92993404|NCT02568995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993405|NCT02568995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993406|NCT02568995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92993407|NCT02568995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92993408|NCT02568995|Adrenergic Agents|adrenergic agents|mesh-ancestor
92993409|NCT02568995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993410|NCT02568995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92993411|NCT02568995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92993412|NCT02568995|Autonomic Agents|autonomic agents|mesh-ancestor
92993413|NCT02568995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92993414|NCT02568995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92993415|NCT02568995|Mydriatics|mydriatics|mesh-ancestor
92993416|NCT02568995|Sympathomimetics|sympathomimetics|mesh-ancestor
92993417|NCT02568995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92993418|NCT00930020|Minocycline|minocycline|mesh-list
92993419|NCT00930020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993420|NCT00930020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993421|NCT00930098|Clofarabine|clofarabine|mesh-list
92993422|NCT00930098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92993423|NCT00930098|Antimetabolites|antimetabolites|mesh-ancestor
92993424|NCT00930098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993425|NCT00930098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993426|NCT00905684|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92993427|NCT00905684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92993428|NCT00905684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993429|NCT00905762|Moxifloxacin|moxifloxacin|mesh-list
92993430|NCT00905762|Gatifloxacin|gatifloxacin|mesh-list
92993431|NCT00905762|Besifloxacin|besifloxacin|mesh-list
92993432|NCT00905762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993434|NCT00905762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92993435|NCT00905762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92993436|NCT00905762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993437|NCT00905762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993438|NCT00905762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993439|NCT00905762|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92993440|NCT00905762|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92993441|NCT00930332|Methadone|methadone|mesh-list
92993442|NCT00930332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92993443|NCT00930332|Narcotics|narcotics|mesh-ancestor
92993444|NCT00930332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993445|NCT00930332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993446|NCT00930332|Analgesics|analgesics|mesh-ancestor
92993447|NCT00930332|Sensory System Agents|sensory system agents|mesh-ancestor
92993448|NCT00930332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993449|NCT00930332|Antitussive Agents|antitussive agents|mesh-ancestor
92993450|NCT00930332|Respiratory System Agents|respiratory system agents|mesh-ancestor
92993451|NCT02568839|Docetaxel|docetaxel|mesh-list
92993452|NCT02568839|Trastuzumab|trastuzumab|mesh-list
92993453|NCT02568839|Pertuzumab|pertuzumab|mesh-list
92993454|NCT02568839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993455|NCT02568839|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993456|NCT02568839|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993457|NCT02568839|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993458|NCT02568839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993459|NCT02568839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993460|NCT00930488|Moxifloxacin|moxifloxacin|mesh-list
92993461|NCT00930488|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92993462|NCT00930488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993463|NCT00930488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993464|NCT00930488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92993465|NCT00930488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92993466|NCT00930488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993467|NCT00930488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993468|NCT00930488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993469|NCT00930488|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92993470|NCT00930488|Contraceptive Agents|contraceptive agents|mesh-ancestor
92993471|NCT00930488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92993472|NCT00930488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993473|NCT00930488|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92993474|NCT00930488|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92993475|NCT00930488|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92993477|NCT00736931|Lorazepam|lorazepam|mesh-list
92993478|NCT00736931|Brivaracetam|brivaracetam|mesh-list
92993479|NCT00736931|Anticonvulsants|anticonvulsants|mesh-ancestor
92993480|NCT00736931|Nootropic Agents|nootropic agents|mesh-ancestor
92993481|NCT00736931|Antiemetics|antiemetics|mesh-ancestor
92993482|NCT00736931|Autonomic Agents|autonomic agents|mesh-ancestor
92993483|NCT00736931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993484|NCT00736931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993485|NCT00736931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993486|NCT00736931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92993487|NCT00736931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993488|NCT00736931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92993489|NCT00736931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92993490|NCT00736931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993491|NCT00736931|GABA Modulators|gaba modulators|mesh-ancestor
92993492|NCT00736931|GABA Agents|gaba agents|mesh-ancestor
92993493|NCT00736931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993494|NCT00736931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993495|NCT00567164|Drospirenone|drospirenone|mesh-list
92993496|NCT00567164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92993497|NCT00567164|Hormone Antagonists|hormone antagonists|mesh-ancestor
92993498|NCT00567164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993499|NCT00567164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993500|NCT00567164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92993501|NCT00567164|Diuretics|diuretics|mesh-ancestor
92993502|NCT00567164|Natriuretic Agents|natriuretic agents|mesh-ancestor
92993503|NCT00920933|Prednisolone|prednisolone|mesh-list
92993504|NCT00920933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993505|NCT00920933|Glucocorticoids|glucocorticoids|mesh-ancestor
92993506|NCT00920933|Hormones|hormones|mesh-ancestor
92168056|NCT05870319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92993507|NCT00920933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993509|NCT00920933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92993510|NCT00920933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993511|NCT00930566|Methoxsalen|methoxsalen|mesh-list
92993512|NCT00930566|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92993513|NCT00930566|Dermatologic Agents|dermatologic agents|mesh-ancestor
92993514|NCT00925730|Pimecrolimus|pimecrolimus|mesh-list
92993515|NCT00925730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993516|NCT00925730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993517|NCT00925730|Analgesics|analgesics|mesh-ancestor
92993518|NCT00925730|Sensory System Agents|sensory system agents|mesh-ancestor
92993519|NCT00925730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993520|NCT00925730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993521|NCT00925730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993522|NCT00925730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993523|NCT00925730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92993524|NCT00925730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993525|NCT00925730|Immunologic Factors|immunologic factors|mesh-ancestor
92993526|NCT00925730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92993527|NCT00925730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993528|NCT00925730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993529|NCT00713219|Docetaxel|docetaxel|mesh-list
92993530|NCT00713219|Cetuximab|cetuximab|mesh-list
92993531|NCT00713219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993532|NCT00713219|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993533|NCT00713219|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993534|NCT00713219|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993535|NCT00713219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993536|NCT00713219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993537|NCT00931580|Vitamin D|vitamin d|mesh-list
92638893|NCT00224445|Ritonavir|ritonavir|mesh-list
92993539|NCT00931580|Vitamins|vitamins|mesh-ancestor
92993540|NCT00931580|Micronutrients|micronutrients|mesh-ancestor
92993541|NCT00931580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993542|NCT00931580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993543|NCT00931580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993544|NCT05661461|Sirolimus|sirolimus|mesh-list
92993545|NCT05661461|Temsirolimus|temsirolimus|mesh-list
92993546|NCT05661461|MTOR Inhibitors|mtor inhibitors|mesh-list
92993547|NCT05661461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993548|NCT05661461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993549|NCT05661461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92993550|NCT05661461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993551|NCT05661461|Antifungal Agents|antifungal agents|mesh-ancestor
92993552|NCT05661461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993553|NCT05661461|Immunologic Factors|immunologic factors|mesh-ancestor
92993554|NCT05661461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993555|NCT05661461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993556|NCT05661461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993557|NCT05661461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993558|NCT00931736|Rifampin|rifampin|mesh-list
92993559|NCT00931736|Isoniazid|isoniazid|mesh-list
92993560|NCT00931736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92993561|NCT00931736|Antitubercular Agents|antitubercular agents|mesh-ancestor
92993562|NCT00931736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993563|NCT00931736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993564|NCT00931736|Leprostatic Agents|leprostatic agents|mesh-ancestor
92993565|NCT00931736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92993566|NCT00931736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993567|NCT00931736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993568|NCT00931736|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92993569|NCT00931736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92993570|NCT00931736|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92993571|NCT00931736|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92993572|NCT00931736|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92993573|NCT00931736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92993574|NCT00931736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92993575|NCT00931736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92993576|NCT00931736|Antimetabolites|antimetabolites|mesh-ancestor
92993577|NCT00931736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92993578|NCT02567981|Vitamin A|vitamin a|mesh-list
92993579|NCT02567981|Micronutrients|micronutrients|mesh-list
92993580|NCT02567981|Trace Elements|trace elements|mesh-list
92993581|NCT02567981|Vitamins|vitamins|mesh-ancestor
92993582|NCT02567981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993583|NCT00737555|Tosedostat|tosedostat|mesh-list
92993584|NCT00737555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993585|NCT00737555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993586|NCT00932048|Atorvastatin|atorvastatin|mesh-list
92993587|NCT00932048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92993588|NCT00932048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92993589|NCT00932048|Antimetabolites|antimetabolites|mesh-ancestor
92993590|NCT00932048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993591|NCT00932048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92993592|NCT00932048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92993593|NCT00932048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993594|NCT04015778|Paclitaxel|paclitaxel|mesh-list
92993595|NCT04015778|Carboplatin|carboplatin|mesh-list
92993596|NCT04015778|Nivolumab|nivolumab|mesh-list
92993597|NCT04015778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993598|NCT04015778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993599|NCT04015778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993600|NCT04015778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993601|NCT04015778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993602|NCT04015778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993603|NCT04015778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993604|NCT04015778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92993605|NCT00926354|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92993606|NCT00926354|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92993607|NCT00926354|Immunologic Factors|immunologic factors|mesh-ancestor
92993608|NCT00926354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993609|NCT00926354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993610|NCT00926354|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92993611|NCT00926354|Protective Agents|protective agents|mesh-ancestor
92993612|NCT00926354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92993613|NCT00926354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92993614|NCT00926354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993615|NCT00926354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993616|NCT00926354|Antiviral Agents|antiviral agents|mesh-ancestor
92993617|NCT00926354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993618|NCT00712985|Zoledronic Acid|zoledronic acid|mesh-list
92993619|NCT00712985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993620|NCT00712985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993621|NCT00737789|Mesalamine|mesalamine|mesh-list
92993622|NCT00737789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993623|NCT00737789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993624|NCT00737789|Analgesics|analgesics|mesh-ancestor
92993625|NCT00737789|Sensory System Agents|sensory system agents|mesh-ancestor
92993626|NCT00737789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993627|NCT00737789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993628|NCT00737789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993629|NCT00737789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993630|NCT00700115|Ritonavir|ritonavir|mesh-list
92993631|NCT00700115|Lopinavir|lopinavir|mesh-list
92993632|NCT00700115|Raltegravir Potassium|raltegravir potassium|mesh-list
92993633|NCT00700115|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92993634|NCT00700115|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92993635|NCT00700115|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92993636|NCT00700115|Protease Inhibitors|protease inhibitors|mesh-ancestor
92993637|NCT00700115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993638|NCT00700115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993639|NCT00700115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92993640|NCT00700115|Antiviral Agents|antiviral agents|mesh-ancestor
92993641|NCT00700115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993642|NCT00700115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92993643|NCT00700115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92993644|NCT00700115|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92993645|NCT00700115|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92993646|NCT05556473|Tryptophan|tryptophan|mesh-list
92993647|NCT05556473|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92993648|NCT05556473|Antidepressive Agents|antidepressive agents|mesh-ancestor
92993649|NCT05556473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993650|NCT00566852|Memantine|memantine|mesh-list
92993651|NCT00566852|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92993652|NCT00566852|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92993653|NCT00566852|Dopamine Agents|dopamine agents|mesh-ancestor
92993654|NCT00566852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993655|NCT00566852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993656|NCT00566852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993657|NCT00566852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92993658|NCT00566852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92993659|NCT00936650|Cinacalcet|cinacalcet|mesh-list
92993660|NCT00936650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993661|NCT00936650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993662|NCT00936650|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92993663|NCT00936650|Hormone Antagonists|hormone antagonists|mesh-ancestor
92993664|NCT00936650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92993665|NCT00442546|Pregabalin|pregabalin|mesh-list
92993666|NCT00442546|Analgesics|analgesics|mesh-ancestor
92993667|NCT00442546|Sensory System Agents|sensory system agents|mesh-ancestor
92993668|NCT00442546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993669|NCT00442546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993670|NCT00442546|Anticonvulsants|anticonvulsants|mesh-ancestor
92993671|NCT00442546|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92993672|NCT00442546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92993673|NCT00442546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993674|NCT00442546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993675|NCT00442546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92993676|NCT00442546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92993677|NCT00442546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993678|NCT00442546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993679|NCT00936962|Vaccines|vaccines|mesh-list
92993680|NCT00936962|Immunologic Factors|immunologic factors|mesh-ancestor
92993681|NCT00936962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993682|NCT00514683|Nintedanib|nintedanib|mesh-list
92993683|NCT00514683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993684|NCT00514683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993685|NCT00514683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993686|NCT00514683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993688|NCT00566696|Cyclophosphamide|cyclophosphamide|mesh-list
92993689|NCT00566696|Melphalan|melphalan|mesh-list
92993690|NCT00566696|Mechlorethamine|mechlorethamine|mesh-list
92993691|NCT00566696|Thiotepa|thiotepa|mesh-list
92993692|NCT00566696|Rituximab|rituximab|mesh-list
92993693|NCT00566696|Fludarabine|fludarabine|mesh-list
92993694|NCT00566696|Alemtuzumab|alemtuzumab|mesh-list
92993695|NCT00566696|Thymoglobulin|thymoglobulin|mesh-list
92993696|NCT00566696|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92993697|NCT00566696|Muromonab-CD3|muromonab-cd3|mesh-list
92993698|NCT00566696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993699|NCT00566696|Immunologic Factors|immunologic factors|mesh-ancestor
92993700|NCT00566696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993701|NCT00566696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993702|NCT00566696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92993703|NCT00566696|Alkylating Agents|alkylating agents|mesh-ancestor
92993704|NCT00566696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993705|NCT00566696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993706|NCT00566696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92993707|NCT00566696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993708|NCT00566696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92993709|NCT00566696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92993710|NCT00566696|Antitubercular Agents|antitubercular agents|mesh-ancestor
92993711|NCT00566696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993712|NCT00566696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993713|NCT00566696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993714|NCT00926666|Levobupivacaine|levobupivacaine|mesh-list
92993715|NCT00926666|Anesthetics, Local|anesthetics, local|mesh-ancestor
92993716|NCT00926666|Anesthetics|anesthetics|mesh-ancestor
92993717|NCT00926666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993718|NCT00926666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993719|NCT00926666|Sensory System Agents|sensory system agents|mesh-ancestor
92993720|NCT00926666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993721|NCT00926900|Cycloserine|cycloserine|mesh-list
92993722|NCT00926900|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92993723|NCT00926900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993724|NCT00926900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92993725|NCT00926900|Antitubercular Agents|antitubercular agents|mesh-ancestor
92993726|NCT00926900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92993728|NCT00926900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993729|NCT00503841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92993730|NCT00503841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993731|NCT00503841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993732|NCT00503841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993733|NCT00503841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993734|NCT00937508|Varenicline|varenicline|mesh-list
92993735|NCT00937508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92993736|NCT00937508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92993737|NCT00937508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92993738|NCT00937508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993739|NCT00937508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993740|NCT00937508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993741|NCT00937664|Gemcitabine|gemcitabine|mesh-list
92993742|NCT00937664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92993743|NCT00937664|Antimetabolites|antimetabolites|mesh-ancestor
92993744|NCT00937664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993745|NCT00937664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993746|NCT00937820|Darexaban|darexaban|mesh-list
92993747|NCT00937820|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92993748|NCT00937820|Antithrombins|antithrombins|mesh-ancestor
92993749|NCT00937820|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92993750|NCT00937820|Protease Inhibitors|protease inhibitors|mesh-ancestor
92993751|NCT00937820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993752|NCT00937820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993753|NCT00937820|Anticoagulants|anticoagulants|mesh-ancestor
92993754|NCT00506883|Colchicine|colchicine|mesh-list
92993755|NCT00506883|Gout Suppressants|gout suppressants|mesh-ancestor
92993756|NCT00506883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993757|NCT00506883|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993758|NCT00506883|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993759|NCT00506883|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993760|NCT00506883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993761|NCT00506883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993762|NCT01028638|Bevacizumab|bevacizumab|mesh-list
92993763|NCT01028638|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
92993764|NCT01028638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993765|NCT01028638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993766|NCT01028638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92993767|NCT01028638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92993768|NCT01028638|Growth Substances|growth substances|mesh-ancestor
92993769|NCT01028638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993770|NCT01028638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92993771|NCT01028638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92993772|NCT01028638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993773|NCT00938132|Warfarin|warfarin|mesh-list
92993774|NCT00938132|Anticoagulants|anticoagulants|mesh-ancestor
92993775|NCT01023334|Lidocaine|lidocaine|mesh-list
92993776|NCT01023334|Anesthetics|anesthetics|mesh-list
92993777|NCT01023334|Anesthetics, Local|anesthetics, local|mesh-ancestor
92993778|NCT01023334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993779|NCT01023334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993780|NCT01023334|Sensory System Agents|sensory system agents|mesh-ancestor
92993781|NCT01023334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993782|NCT01023334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92993783|NCT01023334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92993784|NCT01023334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92993785|NCT01023334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92993786|NCT01023334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993787|NCT00938522|Cilostazol|cilostazol|mesh-list
92993788|NCT00938522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92993789|NCT00938522|Autonomic Agents|autonomic agents|mesh-ancestor
92993790|NCT00938522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993791|NCT00938522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993792|NCT00938522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92993793|NCT00938522|Respiratory System Agents|respiratory system agents|mesh-ancestor
92993794|NCT00938522|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92993795|NCT00938522|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92993796|NCT00938522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993797|NCT00938522|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92993798|NCT00938522|Vasodilator Agents|vasodilator agents|mesh-ancestor
92993799|NCT00938522|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92993801|NCT00938522|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92993802|NCT00938522|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92993803|NCT00938522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993804|NCT00938600|Vitamin D|vitamin d|mesh-list
92993805|NCT00938600|Ergocalciferols|ergocalciferols|mesh-list
92993806|NCT00938600|Cholecalciferol|cholecalciferol|mesh-list
92993807|NCT00938600|Vitamins|vitamins|mesh-list
92993808|NCT00938600|Micronutrients|micronutrients|mesh-ancestor
92993809|NCT00938600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993810|NCT00938600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993811|NCT00938600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993812|NCT00503685|Cetuximab|cetuximab|mesh-list
92993813|NCT00503685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993814|NCT00503685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993815|NCT00712673|Metformin|metformin|mesh-list
92993816|NCT00712673|Lixisenatide|lixisenatide|mesh-list
92993817|NCT00712673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92993818|NCT00712673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993819|NCT01562990|Rituximab|rituximab|mesh-list
92993820|NCT01562990|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92993821|NCT01562990|Gemcitabine|gemcitabine|mesh-list
92993822|NCT01562990|Oxaliplatin|oxaliplatin|mesh-list
92993823|NCT01562990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993824|NCT01562990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993825|NCT01562990|Immunologic Factors|immunologic factors|mesh-ancestor
92993826|NCT01562990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993827|NCT01562990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993828|NCT01562990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92993829|NCT01562990|Antimetabolites|antimetabolites|mesh-ancestor
92993830|NCT01562990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993831|NCT01562990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92993832|NCT01562990|Immunotoxins|immunotoxins|mesh-ancestor
92993833|NCT01562990|Immunoconjugates|immunoconjugates|mesh-ancestor
92993834|NCT00737867|Carboplatin|carboplatin|mesh-list
92993835|NCT00737867|Gemcitabine|gemcitabine|mesh-list
92993836|NCT00737867|Vinorelbine|vinorelbine|mesh-list
92993837|NCT00737867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993838|NCT00737867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92993839|NCT00737867|Antimetabolites|antimetabolites|mesh-ancestor
92993840|NCT00737867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993841|NCT00737867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993842|NCT00737867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993843|NCT00737867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993844|NCT00737867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993845|NCT03976466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92993846|NCT03976466|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92993847|NCT03976466|Calcium|calcium|mesh-list
92993848|NCT03976466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92993849|NCT03976466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993850|NCT03976466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92993851|NCT03976466|Antitubercular Agents|antitubercular agents|mesh-ancestor
92993852|NCT02536755|Eliglustat|eliglustat|mesh-list
92993853|NCT02536755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993854|NCT02536755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993855|NCT02567279|Denosumab|denosumab|mesh-list
92993856|NCT02567279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92993857|NCT02567279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993858|NCT00933374|Paclitaxel|paclitaxel|mesh-list
92993859|NCT00933374|Everolimus|everolimus|mesh-list
92993860|NCT00933374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92993861|NCT00933374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993862|NCT00933374|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993863|NCT00933374|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993864|NCT00933374|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993865|NCT00933374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993866|NCT00933374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92993867|NCT00933374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993868|NCT00933374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993869|NCT00933374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993870|NCT00933374|Immunologic Factors|immunologic factors|mesh-ancestor
92993871|NCT00933374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993872|NCT03303105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92993873|NCT03303105|Immunologic Factors|immunologic factors|mesh-ancestor
92168067|NCT05868889|Alkylating Agents|alkylating agents|mesh-ancestor
92993874|NCT03303105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993875|NCT00933452|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92993876|NCT00933452|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92993877|NCT00933452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92993878|NCT00933452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92993879|NCT00933452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993880|NCT00933452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993881|NCT00933452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993882|NCT00933452|Analgesics|analgesics|mesh-ancestor
92993883|NCT00933452|Sensory System Agents|sensory system agents|mesh-ancestor
92993884|NCT00933452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993885|NCT00933452|Antidepressive Agents|antidepressive agents|mesh-ancestor
92993886|NCT00933452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993887|NCT00933452|Dopamine Agents|dopamine agents|mesh-ancestor
92993888|NCT00447694|Deferasirox|deferasirox|mesh-list
92993889|NCT00447694|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92993890|NCT00447694|Chelating Agents|chelating agents|mesh-ancestor
92993891|NCT00447694|Sequestering Agents|sequestering agents|mesh-ancestor
92993892|NCT00447694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993893|NCT00564278|Antidepressive Agents|antidepressive agents|mesh-list
92993894|NCT00564278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993895|NCT00447382|Insulin|insulin|mesh-list
92993896|NCT00447382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92993897|NCT00447382|Insulin Aspart|insulin aspart|mesh-list
92993898|NCT00447382|Insulin Detemir|insulin detemir|mesh-list
92993899|NCT00447382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92993900|NCT00447382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993901|NCT00938990|Midazolam|midazolam|mesh-list
92993902|NCT00938990|Etomidate|etomidate|mesh-list
92993903|NCT00938990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92993904|NCT00938990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92993905|NCT00938990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993906|NCT00938990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993907|NCT00938990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92993908|NCT00938990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92993909|NCT00938990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993910|NCT00938990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92993911|NCT00938990|Anesthetics, General|anesthetics, general|mesh-ancestor
92993912|NCT00938990|Anesthetics|anesthetics|mesh-ancestor
92993913|NCT00938990|GABA Modulators|gaba modulators|mesh-ancestor
92993914|NCT00938990|GABA Agents|gaba agents|mesh-ancestor
92993915|NCT00938990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993916|NCT00938990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993917|NCT00933998|Vitamin B 12|vitamin b 12|mesh-list
92993918|NCT00933998|Pyridoxal|pyridoxal|mesh-list
92993919|NCT00933998|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
92993920|NCT00933998|Vitamin B Complex|vitamin b complex|mesh-ancestor
92993921|NCT00933998|Vitamins|vitamins|mesh-ancestor
92993922|NCT00933998|Micronutrients|micronutrients|mesh-ancestor
92993923|NCT00933998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993924|NCT00447226|Lapatinib|lapatinib|mesh-list
92993925|NCT00447226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993926|NCT00447226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993927|NCT00447226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993928|NCT00447226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993929|NCT03360916|Atorvastatin|atorvastatin|mesh-list
92993930|NCT03360916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92993931|NCT03360916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92993932|NCT03360916|Antimetabolites|antimetabolites|mesh-ancestor
92993933|NCT03360916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993934|NCT03360916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92993935|NCT03360916|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92993936|NCT03360916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993937|NCT00446992|Olanzapine|olanzapine|mesh-list
92993938|NCT00446992|Antiemetics|antiemetics|mesh-ancestor
92993939|NCT00446992|Autonomic Agents|autonomic agents|mesh-ancestor
92993940|NCT00446992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993941|NCT00446992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993942|NCT00446992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993943|NCT00446992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92993944|NCT00446992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92993945|NCT00446992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92993946|NCT00446992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92993947|NCT00446992|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92993948|NCT00446992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92993949|NCT00446992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92993950|NCT00446992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993951|NCT00446992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92993952|NCT00446992|Serotonin Agents|serotonin agents|mesh-ancestor
92993953|NCT00503139|Etanercept|etanercept|mesh-list
92993954|NCT00503139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92993955|NCT00503139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92993956|NCT00503139|Analgesics|analgesics|mesh-ancestor
92993957|NCT00503139|Sensory System Agents|sensory system agents|mesh-ancestor
92993958|NCT00503139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92993959|NCT00503139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993960|NCT00503139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92993961|NCT00503139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92993962|NCT00503139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92993963|NCT00503139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993964|NCT00503139|Immunologic Factors|immunologic factors|mesh-ancestor
92993965|NCT00577031|Bevacizumab|bevacizumab|mesh-list
92993966|NCT00577031|Oxaliplatin|oxaliplatin|mesh-list
92993967|NCT00577031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92993968|NCT00577031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993969|NCT00577031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92993970|NCT00577031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92993971|NCT00577031|Growth Substances|growth substances|mesh-ancestor
92993972|NCT00577031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993973|NCT00577031|Growth Inhibitors|growth inhibitors|mesh-ancestor
92993974|NCT00565448|Docetaxel|docetaxel|mesh-list
92993975|NCT00565448|Fluorouracil|fluorouracil|mesh-list
92993976|NCT00565448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993977|NCT00565448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92993978|NCT00565448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92993979|NCT00565448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92993980|NCT00565448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993981|NCT00565448|Antimetabolites|antimetabolites|mesh-ancestor
92993982|NCT00565448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92993983|NCT00565448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92993984|NCT00565448|Immunologic Factors|immunologic factors|mesh-ancestor
92993985|NCT00565448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92993986|NCT01012011|Sorafenib|sorafenib|mesh-list
92639346|NCT00195728|Antitussive Agents|antitussive agents|mesh-ancestor
92993987|NCT01012011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993988|NCT01012011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993989|NCT01012011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993990|NCT01012011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993991|NCT00934076|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92993992|NCT00934076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92993993|NCT00934076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92993994|NCT00934076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92993995|NCT00934076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92993997|NCT00934154|Prednisolone|prednisolone|mesh-list
92993998|NCT00934154|Melphalan|melphalan|mesh-list
92993999|NCT00934154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994000|NCT00934154|Alkylating Agents|alkylating agents|mesh-ancestor
92994001|NCT00934154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994002|NCT00934154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994003|NCT00934154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92994004|NCT00934154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994005|NCT00934154|Immunologic Factors|immunologic factors|mesh-ancestor
92994006|NCT00934154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994007|NCT00934154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994008|NCT00934154|Glucocorticoids|glucocorticoids|mesh-ancestor
92994009|NCT00934154|Hormones|hormones|mesh-ancestor
92994010|NCT00934154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994011|NCT00934154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92994012|NCT00934154|Leprostatic Agents|leprostatic agents|mesh-ancestor
92994013|NCT00934154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92994014|NCT00934154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994015|NCT00934154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92994016|NCT00934154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92994017|NCT00934154|Growth Substances|growth substances|mesh-ancestor
92994018|NCT00934154|Growth Inhibitors|growth inhibitors|mesh-ancestor
92994019|NCT00446446|Panitumumab|panitumumab|mesh-list
92994020|NCT00446446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92994021|NCT00446446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994022|NCT05078255|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92994023|NCT05078255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994024|NCT05078255|Incretins|incretins|mesh-ancestor
92994025|NCT05078255|Hormones|hormones|mesh-ancestor
92994026|NCT05078255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994027|NCT05078255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994028|NCT00939458|Lamotrigine|lamotrigine|mesh-list
92994029|NCT00939458|Anticonvulsants|anticonvulsants|mesh-ancestor
92994030|NCT00939458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92994031|NCT00939458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994032|NCT00939458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994033|NCT00939458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92994034|NCT00939458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994035|NCT00939458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92994036|NCT00939458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92994037|NCT00939458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994038|NCT00939458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994039|NCT00939458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92994040|NCT02566967|Tofacitinib|tofacitinib|mesh-list
92994041|NCT02566967|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92994042|NCT02566967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994043|NCT02566967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994044|NCT02566967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994045|NCT00939068|Telbivudine|telbivudine|mesh-list
92994046|NCT00939068|Antiviral Agents|antiviral agents|mesh-ancestor
92994047|NCT00939068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994048|NCT00939068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92994049|NCT00939068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994050|NCT00939068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994051|NCT00934232|Busulfan|busulfan|mesh-list
92994052|NCT00934232|Alkylating Agents|alkylating agents|mesh-ancestor
92994053|NCT00934232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994054|NCT00934232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994055|NCT00934232|Immunologic Factors|immunologic factors|mesh-ancestor
92994056|NCT00934232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994057|NCT00934232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994058|NCT00934232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994059|NCT00934232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92994061|NCT01013571|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92994062|NCT01013571|Insulin Glargine|insulin glargine|mesh-list
92994063|NCT01013571|Insulin glulisine|insulin glulisine|mesh-list
92994064|NCT01013571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92994065|NCT01013571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994066|NCT00514449|Valacyclovir|valacyclovir|mesh-list
92994067|NCT00514449|Antiviral Agents|antiviral agents|mesh-ancestor
92994068|NCT00514449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994069|NCT00492921|Cyclophosphamide|cyclophosphamide|mesh-list
92994070|NCT00492921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994071|NCT00492921|Immunologic Factors|immunologic factors|mesh-ancestor
92994072|NCT00492921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994073|NCT00492921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994074|NCT00492921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994075|NCT00492921|Alkylating Agents|alkylating agents|mesh-ancestor
92994076|NCT00492921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994077|NCT00492921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994078|NCT00492921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92994079|NCT00738257|Pamidronate|pamidronate|mesh-list
92994080|NCT00738257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92994081|NCT00738257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994082|NCT00738335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92994083|NCT00738335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994084|NCT00738335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994085|NCT00738335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994086|NCT00738335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994087|NCT00502671|Capecitabine|capecitabine|mesh-list
92994088|NCT00502671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994089|NCT00502671|Antimetabolites|antimetabolites|mesh-ancestor
92994090|NCT00502671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994091|NCT00502671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994092|NCT00738413|Deferasirox|deferasirox|mesh-list
92994093|NCT00738413|Deferoxamine|deferoxamine|mesh-list
92994094|NCT00738413|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92994095|NCT00738413|Chelating Agents|chelating agents|mesh-ancestor
92994096|NCT00738413|Sequestering Agents|sequestering agents|mesh-ancestor
92994097|NCT00738413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994098|NCT00738413|Siderophores|siderophores|mesh-ancestor
92994099|NCT00697463|Teriparatide|teriparatide|mesh-list
92994100|NCT00697463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92994101|NCT00697463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994102|NCT00697463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92994103|NCT04409795|Metformin|metformin|mesh-list
92994104|NCT04409795|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92994105|NCT04409795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92994106|NCT04409795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994107|NCT04409795|Incretins|incretins|mesh-ancestor
92994108|NCT04409795|Hormones|hormones|mesh-ancestor
92994109|NCT04409795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994110|NCT04409795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92994111|NCT04409795|Protease Inhibitors|protease inhibitors|mesh-ancestor
92994112|NCT04409795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994113|NCT04409795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994114|NCT00492531|Sildenafil Citrate|sildenafil citrate|mesh-list
92994115|NCT00492531|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92994116|NCT00492531|Vasodilator Agents|vasodilator agents|mesh-ancestor
92994117|NCT00492531|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92994118|NCT00492531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994119|NCT00492531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994120|NCT00492531|Urological Agents|urological agents|mesh-ancestor
92994121|NCT01015209|Acetylcysteine|acetylcysteine|mesh-list
92994122|NCT01015209|Chitosan|chitosan|mesh-list
92994123|NCT01015209|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92994124|NCT01015209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92994125|NCT01015209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92994126|NCT01015209|Antiviral Agents|antiviral agents|mesh-ancestor
92994127|NCT01015209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994128|NCT01015209|Expectorants|expectorants|mesh-ancestor
92994129|NCT01015209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92994130|NCT01015209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92994131|NCT01015209|Antioxidants|antioxidants|mesh-ancestor
92994132|NCT01015209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994133|NCT01015209|Protective Agents|protective agents|mesh-ancestor
92994134|NCT01015209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994135|NCT01015209|Antidotes|antidotes|mesh-ancestor
92994136|NCT01015209|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92994137|NCT01015209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92994138|NCT01015209|Antimetabolites|antimetabolites|mesh-ancestor
92994139|NCT01015209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92994140|NCT01015209|Chelating Agents|chelating agents|mesh-ancestor
92994141|NCT01015209|Sequestering Agents|sequestering agents|mesh-ancestor
92994142|NCT01015209|Hemostatics|hemostatics|mesh-ancestor
92994143|NCT01015209|Coagulants|coagulants|mesh-ancestor
92994144|NCT04948463|Vancomycin|vancomycin|mesh-list
92994145|NCT04948463|Ciprofloxacin|ciprofloxacin|mesh-list
92994146|NCT04948463|Tazobactam|tazobactam|mesh-list
92994147|NCT04948463|Piperacillin|piperacillin|mesh-list
92994148|NCT04948463|Amikacin|amikacin|mesh-list
92994149|NCT04948463|Ceftazidime|ceftazidime|mesh-list
92994150|NCT04948463|Cefepime|cefepime|mesh-list
92994151|NCT04948463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92994152|NCT04948463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994153|NCT04948463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92994154|NCT04948463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92994155|NCT04948463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994156|NCT04948463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994157|NCT04948463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994158|NCT04948463|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92994159|NCT04948463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92994160|NCT04948463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92994161|NCT01080547|Capecitabine|capecitabine|mesh-list
92994162|NCT01080547|Oxaliplatin|oxaliplatin|mesh-list
92994163|NCT01080547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994164|NCT01080547|Antimetabolites|antimetabolites|mesh-ancestor
92994165|NCT01080547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994166|NCT01080547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994167|NCT04930991|Omeprazole|omeprazole|mesh-list
92994168|NCT04930991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92994169|NCT04930991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994170|NCT04930991|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92994171|NCT04930991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994172|NCT04930991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994173|NCT00111241|Letrozole|letrozole|mesh-list
92994174|NCT00111241|Anastrozole|anastrozole|mesh-list
92994175|NCT00111241|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92994176|NCT00111241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994177|NCT00111241|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92994178|NCT00111241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994179|NCT00111241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994180|NCT00111241|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92994181|NCT00111241|Hormone Antagonists|hormone antagonists|mesh-ancestor
92994182|NCT00111241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994183|NCT00111241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994184|NCT00111241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92994185|NCT00492297|Sorafenib|sorafenib|mesh-list
92994186|NCT00492297|Dacarbazine|dacarbazine|mesh-list
92994187|NCT00492297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994188|NCT00492297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994189|NCT00492297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994190|NCT00492297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994191|NCT00492297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994192|NCT00492297|Alkylating Agents|alkylating agents|mesh-ancestor
92994193|NCT00446134|Ribavirin|ribavirin|mesh-list
92994194|NCT00446134|Taribavirin|taribavirin|mesh-list
92994195|NCT00446134|Antimetabolites|antimetabolites|mesh-ancestor
92994196|NCT00446134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994197|NCT00446134|Antiviral Agents|antiviral agents|mesh-ancestor
92994198|NCT00446134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994199|NCT00934466|Dextromethorphan|dextromethorphan|mesh-list
92994200|NCT00934466|Antitussive Agents|antitussive agents|mesh-ancestor
92994201|NCT00934466|Respiratory System Agents|respiratory system agents|mesh-ancestor
92994202|NCT00934466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92994203|NCT00934466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92994204|NCT00934466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994205|NCT00934466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994206|NCT00934466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994207|NCT00921245|Darifenacin|darifenacin|mesh-list
92994208|NCT00921245|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92994209|NCT00921245|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92994210|NCT00921245|Cholinergic Agents|cholinergic agents|mesh-ancestor
92994211|NCT00921245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994212|NCT00921245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994213|NCT00921245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994214|NCT00921245|Urological Agents|urological agents|mesh-ancestor
92994215|NCT00940238|Dexetimide|dexetimide|mesh-list
92994216|NCT00940238|Citalopram|citalopram|mesh-list
92994217|NCT00940238|Escitalopram|escitalopram|mesh-list
92994218|NCT00940238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92994219|NCT00940238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92994220|NCT00940238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994221|NCT00940238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994222|NCT00940238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994223|NCT00940238|Serotonin Agents|serotonin agents|mesh-ancestor
92994224|NCT00940238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994225|NCT00940238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92994226|NCT00940238|Antidepressive Agents|antidepressive agents|mesh-ancestor
92994227|NCT00940238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994228|NCT00940238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92994229|NCT00940238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92994230|NCT00940238|Parasympatholytics|parasympatholytics|mesh-ancestor
92994231|NCT00940238|Autonomic Agents|autonomic agents|mesh-ancestor
92994232|NCT00940238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994233|NCT00940238|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92994234|NCT00940238|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92994235|NCT00940238|Cholinergic Agents|cholinergic agents|mesh-ancestor
92994236|NCT04013438|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92994237|NCT04013438|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92994238|NCT04013438|Saw palmetto extract|saw palmetto extract|mesh-list
92994239|NCT04013438|Estradiol|estradiol|mesh-list
92994240|NCT04013438|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92994241|NCT04013438|Estrogens|estrogens|mesh-ancestor
92994243|NCT04013438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994244|NCT04013438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994245|NCT04013438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92994246|NCT04013438|Contraceptive Agents|contraceptive agents|mesh-ancestor
92994247|NCT04013438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92994248|NCT04013438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92994249|NCT04013438|Urological Agents|urological agents|mesh-ancestor
92994250|NCT02565719|Interferons|interferons|mesh-list
92994251|NCT02565719|Tenofovir|tenofovir|mesh-list
92994252|NCT02565719|Interferon-alpha|interferon-alpha|mesh-list
92994253|NCT02565719|Interferon alpha-2|interferon alpha-2|mesh-list
92994254|NCT02565719|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92994255|NCT02565719|REP 2139|rep 2139|mesh-list
92994256|NCT02565719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994257|NCT02565719|Antiviral Agents|antiviral agents|mesh-ancestor
92994258|NCT02565719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994259|NCT02565719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92994260|NCT02565719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92994261|NCT02565719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994262|NCT02565719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994263|NCT02565719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92994264|NCT02565719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92994265|NCT02565719|Immunologic Factors|immunologic factors|mesh-ancestor
92994266|NCT02565719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994267|NCT00111007|Paclitaxel|paclitaxel|mesh-list
92994268|NCT00111007|Carboplatin|carboplatin|mesh-list
92994269|NCT00111007|Sorafenib|sorafenib|mesh-list
92994270|NCT00111007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92994271|NCT00111007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994272|NCT00111007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92994273|NCT00111007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92994274|NCT00111007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92994275|NCT00111007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994276|NCT00111007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994277|NCT00111007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994278|NCT00699335|Fentanyl|fentanyl|mesh-list
92994279|NCT00699335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92994280|NCT00699335|Narcotics|narcotics|mesh-ancestor
92994281|NCT00699335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994282|NCT00699335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994283|NCT00699335|Analgesics|analgesics|mesh-ancestor
92994284|NCT00699335|Sensory System Agents|sensory system agents|mesh-ancestor
92639646|NCT00196469|Heparin|heparin|mesh-list
92994285|NCT00699335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994286|NCT00699335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92994287|NCT00699335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92994289|NCT00699335|Anesthetics|anesthetics|mesh-ancestor
92994290|NCT00939614|Lamotrigine|lamotrigine|mesh-list
92994291|NCT00939614|Anticonvulsants|anticonvulsants|mesh-ancestor
92994292|NCT00939614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92994293|NCT00939614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92168102|NCT05797467|Cetuximab|cetuximab|mesh-list
92994294|NCT00939614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994295|NCT00939614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92994296|NCT00939614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994297|NCT00939614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92994298|NCT00939614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92994299|NCT00939614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994300|NCT00939614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994301|NCT00939614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92994302|NCT03962881|Vaccines|vaccines|mesh-list
92994303|NCT03962881|Immunologic Factors|immunologic factors|mesh-ancestor
92994304|NCT03962881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994305|NCT00935246|Dexetimide|dexetimide|mesh-list
92994306|NCT00935246|Citalopram|citalopram|mesh-list
92994307|NCT00935246|Escitalopram|escitalopram|mesh-list
92994308|NCT00935246|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92994309|NCT00935246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92994310|NCT00935246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994311|NCT00935246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994312|NCT00935246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994313|NCT00935246|Serotonin Agents|serotonin agents|mesh-ancestor
92994314|NCT00935246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994315|NCT00935246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92994316|NCT00935246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92994317|NCT00935246|Parasympatholytics|parasympatholytics|mesh-ancestor
92994318|NCT00935246|Autonomic Agents|autonomic agents|mesh-ancestor
92994319|NCT00935246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994320|NCT00935246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92994321|NCT00935246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92994322|NCT00935246|Cholinergic Agents|cholinergic agents|mesh-ancestor
92994323|NCT00935246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92994324|NCT00935246|Antidepressive Agents|antidepressive agents|mesh-ancestor
92994325|NCT00935246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994326|NCT00935480|Raltegravir Potassium|raltegravir potassium|mesh-list
92994327|NCT00935480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92994328|NCT00935480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92994329|NCT00935480|Antiviral Agents|antiviral agents|mesh-ancestor
92994330|NCT00935480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994331|NCT00935480|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92994332|NCT00935480|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92994333|NCT00935480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994334|NCT00935480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994335|NCT00939848|Cisplatin|cisplatin|mesh-list
92994336|NCT00939848|Gemcitabine|gemcitabine|mesh-list
92994337|NCT00939848|Cediranib|cediranib|mesh-list
92994338|NCT00939848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994339|NCT00939848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994340|NCT00939848|Antimetabolites|antimetabolites|mesh-ancestor
92994341|NCT00939848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994342|NCT00939848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994343|NCT00939848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994344|NCT04013048|Fluzoparib|fluzoparib|mesh-list
92994345|NCT04013048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92994346|NCT04013048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994347|NCT04013048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994348|NCT04013048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994349|NCT00935558|Interleukin-2|interleukin-2|mesh-list
92994350|NCT00935558|Exemestane|exemestane|mesh-list
92994351|NCT00935558|Anastrozole|anastrozole|mesh-list
92994352|NCT00935558|Letrozole|letrozole|mesh-list
92994353|NCT00935558|Lactitol|lactitol|mesh-list
92994354|NCT00935558|Vaccines|vaccines|mesh-list
92994355|NCT00935558|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92994356|NCT00935558|Immunologic Factors|immunologic factors|mesh-ancestor
92994357|NCT00935558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994358|NCT00935558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994359|NCT00935558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92994360|NCT00935558|Analgesics|analgesics|mesh-ancestor
92994361|NCT00935558|Sensory System Agents|sensory system agents|mesh-ancestor
92994362|NCT00935558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994363|NCT00935558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92994364|NCT00935558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994365|NCT00935558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994366|NCT00935558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92994367|NCT00935558|Hormone Antagonists|hormone antagonists|mesh-ancestor
92994368|NCT00935558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994369|NCT00935558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92994370|NCT00935558|Cathartics|cathartics|mesh-ancestor
92994371|NCT00935558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994373|NCT05280236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92994374|NCT05280236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994375|NCT05280236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994376|NCT05280236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92994377|NCT05280236|Anesthetics, General|anesthetics, general|mesh-ancestor
92994378|NCT05280236|Anesthetics|anesthetics|mesh-ancestor
92994379|NCT00940472|Metformin|metformin|mesh-list
92994380|NCT00940472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92994381|NCT00940472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994382|NCT00939926|Risperidone|risperidone|mesh-list
92994383|NCT00939926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92994384|NCT00939926|Serotonin Agents|serotonin agents|mesh-ancestor
92994385|NCT00939926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994386|NCT00939926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994387|NCT00939926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994388|NCT00939926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92994389|NCT00939926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92994390|NCT00939926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994391|NCT00939926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994392|NCT00939926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92994393|NCT00939926|Dopamine Agents|dopamine agents|mesh-ancestor
92994395|NCT00940550|Zolpidem|zolpidem|mesh-list
92994396|NCT00940550|Temazepam|temazepam|mesh-list
92994397|NCT00940550|Antioxidants|antioxidants|mesh-ancestor
92994398|NCT00940550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994399|NCT00940550|Protective Agents|protective agents|mesh-ancestor
92994400|NCT00940550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994401|NCT00940550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994402|NCT00940550|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92994403|NCT00940550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92994404|NCT00940550|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92994405|NCT00940550|GABA Agonists|gaba agonists|mesh-ancestor
92994406|NCT00940550|GABA Agents|gaba agents|mesh-ancestor
92994407|NCT00940550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994408|NCT00940550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92994409|NCT00940550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92994410|NCT00940550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994411|NCT00940550|GABA Modulators|gaba modulators|mesh-ancestor
92994412|NCT00940628|Orlistat|orlistat|mesh-list
92994413|NCT00940628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994414|NCT00940628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994415|NCT00940628|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92994416|NCT00940628|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92994417|NCT00936182|Fluconazole|fluconazole|mesh-list
92994418|NCT00936182|Antifungal Agents|antifungal agents|mesh-ancestor
92994419|NCT00936182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994420|NCT00936182|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92994421|NCT00936182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92994422|NCT00936182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994423|NCT00936182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994424|NCT00936182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92994425|NCT00936182|Hormone Antagonists|hormone antagonists|mesh-ancestor
92994426|NCT00936182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994427|NCT00936182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994428|NCT00936182|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92994429|NCT00936182|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92994430|NCT00936260|Alendronate|alendronate|mesh-list
92994431|NCT00936260|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92994432|NCT00936260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994433|NCT00445978|Verapamil|verapamil|mesh-list
92994434|NCT00445978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92994435|NCT00445978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92994436|NCT00445978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994437|NCT00445978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168105|NCT05797467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92994438|NCT00445978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92994439|NCT00445978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994440|NCT00445978|Vasodilator Agents|vasodilator agents|mesh-ancestor
92994442|NCT02566733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92994443|NCT02566733|Narcotics|narcotics|mesh-ancestor
92994444|NCT02566733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994445|NCT02566733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994446|NCT02566733|Analgesics|analgesics|mesh-ancestor
92994447|NCT02566733|Sensory System Agents|sensory system agents|mesh-ancestor
92994448|NCT02566733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994449|NCT01028950|Darexaban|darexaban|mesh-list
92994450|NCT01028950|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92994451|NCT01028950|Antithrombins|antithrombins|mesh-ancestor
92994452|NCT01028950|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92994453|NCT01028950|Protease Inhibitors|protease inhibitors|mesh-ancestor
92994454|NCT01028950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994455|NCT01028950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994456|NCT01028950|Anticoagulants|anticoagulants|mesh-ancestor
92994457|NCT00940784|Aspirin|aspirin|mesh-list
92994458|NCT00940784|Clopidogrel|clopidogrel|mesh-list
92994459|NCT00940784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92994460|NCT00940784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92994461|NCT00940784|Analgesics|analgesics|mesh-ancestor
92994462|NCT00940784|Sensory System Agents|sensory system agents|mesh-ancestor
92994463|NCT00940784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994464|NCT00940784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994465|NCT00940784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994466|NCT00940784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994467|NCT00940784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92994468|NCT00940784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92994469|NCT00940784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994470|NCT00940784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92994471|NCT00940784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92994472|NCT00940784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994473|NCT00940784|Antipyretics|antipyretics|mesh-ancestor
92994474|NCT00940784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92994475|NCT00940784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92994476|NCT00940784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92994477|NCT00940784|Purinergic Agents|purinergic agents|mesh-ancestor
92994478|NCT00940784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994479|NCT01023490|Vitamin D|vitamin d|mesh-list
92994480|NCT01023490|Vitamins|vitamins|mesh-ancestor
92994481|NCT01023490|Micronutrients|micronutrients|mesh-ancestor
92994482|NCT01023490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994483|NCT01023490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92994484|NCT00698009|Cyclophosphamide|cyclophosphamide|mesh-list
92994485|NCT00698009|Fludarabine|fludarabine|mesh-list
92994486|NCT00698009|Fludarabine phosphate|fludarabine phosphate|mesh-list
92994487|NCT00698009|Interleukin-2|interleukin-2|mesh-list
92994488|NCT00698009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994489|NCT00698009|Immunologic Factors|immunologic factors|mesh-ancestor
92994490|NCT00698009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994491|NCT00698009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994492|NCT00698009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994493|NCT00698009|Alkylating Agents|alkylating agents|mesh-ancestor
92994494|NCT00698009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994495|NCT00698009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994496|NCT00698009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92994497|NCT00698009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994498|NCT00698009|Antimetabolites|antimetabolites|mesh-ancestor
92994499|NCT00698009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92994500|NCT00698009|Analgesics|analgesics|mesh-ancestor
92994501|NCT00698009|Sensory System Agents|sensory system agents|mesh-ancestor
92994502|NCT00698009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994503|NCT04648631|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92994504|NCT04648631|Respiratory System Agents|respiratory system agents|mesh-ancestor
92994505|NCT00944606|Vitamin D|vitamin d|mesh-list
92994506|NCT00944606|Vitamins|vitamins|mesh-ancestor
92994507|NCT00944606|Micronutrients|micronutrients|mesh-ancestor
92994508|NCT00944606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994509|NCT00944606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92994510|NCT05257655|Analgesics, Opioid|analgesics, opioid|mesh-list
92994511|NCT05257655|Narcotics|narcotics|mesh-ancestor
92994512|NCT05257655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994513|NCT05257655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994514|NCT05257655|Analgesics|analgesics|mesh-ancestor
92994515|NCT05257655|Sensory System Agents|sensory system agents|mesh-ancestor
92994516|NCT05257655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994517|NCT00944684|Ribavirin|ribavirin|mesh-list
92994518|NCT00944684|Antimetabolites|antimetabolites|mesh-ancestor
92994519|NCT00944684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994520|NCT00944684|Antiviral Agents|antiviral agents|mesh-ancestor
92994521|NCT00944684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994522|NCT04061057|Lidocaine|lidocaine|mesh-list
92994523|NCT04061057|Anesthetics, Local|anesthetics, local|mesh-ancestor
92994524|NCT04061057|Anesthetics|anesthetics|mesh-ancestor
92994525|NCT04061057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994526|NCT04061057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994527|NCT04061057|Sensory System Agents|sensory system agents|mesh-ancestor
92994528|NCT04061057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994529|NCT04061057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92994530|NCT04061057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92994531|NCT04061057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92994532|NCT04061057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994533|NCT04061057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994534|NCT00921167|Bevacizumab|bevacizumab|mesh-list
92994535|NCT00921167|Irinotecan|irinotecan|mesh-list
92994536|NCT00921167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92994537|NCT00921167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994538|NCT00921167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92994539|NCT00921167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92994540|NCT00921167|Growth Substances|growth substances|mesh-ancestor
92994541|NCT00921167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994542|NCT00921167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92994543|NCT00921167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92994544|NCT00921167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92994545|NCT00921167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994546|NCT00921167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994548|NCT04061447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92994549|NCT04061447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994550|NCT04061447|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92994551|NCT04061447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994552|NCT04061447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994553|NCT04061447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92994554|NCT04061447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92994555|NCT03968978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92994556|NCT03968978|Immunologic Factors|immunologic factors|mesh-ancestor
92994557|NCT03968978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994558|NCT05472779|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92994559|NCT05472779|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92994560|NCT05472779|Estradiol|estradiol|mesh-list
92994561|NCT05472779|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92994562|NCT05472779|Estrogens|estrogens|mesh-ancestor
92994563|NCT05472779|Hormones|hormones|mesh-ancestor
92994564|NCT05472779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994565|NCT05472779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994566|NCT05472779|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92994567|NCT05472779|Contraceptive Agents|contraceptive agents|mesh-ancestor
92994568|NCT05472779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92994569|NCT05472779|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92994570|NCT02565953|Paclitaxel|paclitaxel|mesh-list
92994571|NCT02565953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92994572|NCT02565953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994573|NCT02565953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92994574|NCT02565953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92994575|NCT02565953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92994576|NCT02565953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994577|NCT00562718|Capecitabine|capecitabine|mesh-list
92994578|NCT00562718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994579|NCT00562718|Antimetabolites|antimetabolites|mesh-ancestor
92994580|NCT00562718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994581|NCT00562718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639944|NCT00203372|Cyclophosphamide|cyclophosphamide|mesh-list
92994582|NCT05222165|Infigratinib|infigratinib|mesh-list
92994583|NCT05222165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994584|NCT04555811|Rituximab|rituximab|mesh-list
92994585|NCT04555811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92994586|NCT04555811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994587|NCT04555811|Immunologic Factors|immunologic factors|mesh-ancestor
92994588|NCT04555811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994589|NCT04555811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994590|NCT00697619|Zoledronic Acid|zoledronic acid|mesh-list
92994591|NCT00697619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92994592|NCT00697619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994593|NCT02566187|Atorvastatin|atorvastatin|mesh-list
92994594|NCT02566187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92994595|NCT02566187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92994596|NCT02566187|Antimetabolites|antimetabolites|mesh-ancestor
92994597|NCT02566187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994598|NCT02566187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92994599|NCT02566187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92994600|NCT02566187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994601|NCT05324891|Fentanyl|fentanyl|mesh-list
92994602|NCT05324891|Dexmedetomidine|dexmedetomidine|mesh-list
92994603|NCT05324891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92994604|NCT05324891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994605|NCT05324891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994606|NCT05324891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92994607|NCT05324891|Analgesics|analgesics|mesh-ancestor
92994608|NCT05324891|Sensory System Agents|sensory system agents|mesh-ancestor
92994609|NCT05324891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994610|NCT05324891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92994611|NCT05324891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92994612|NCT05324891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92994613|NCT05324891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92994614|NCT05324891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994615|NCT05324891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994616|NCT05324891|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92994617|NCT05324891|Narcotics|narcotics|mesh-ancestor
92994618|NCT05324891|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92994619|NCT05324891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92994620|NCT05324891|Anesthetics, General|anesthetics, general|mesh-ancestor
92994621|NCT05324891|Anesthetics|anesthetics|mesh-ancestor
92994622|NCT05451329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92994623|NCT05451329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92994624|NCT00445432|Adalimumab|adalimumab|mesh-list
92994625|NCT00445432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92994626|NCT00445432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994627|NCT00445432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994628|NCT03370133|Ustekinumab|ustekinumab|mesh-list
92994629|NCT03370133|Dermatologic Agents|dermatologic agents|mesh-ancestor
92994630|NCT00696137|Fentanyl|fentanyl|mesh-list
92994631|NCT00696137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92994632|NCT00696137|Narcotics|narcotics|mesh-ancestor
92994633|NCT00696137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994634|NCT00696137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994635|NCT00696137|Analgesics|analgesics|mesh-ancestor
92994636|NCT00696137|Sensory System Agents|sensory system agents|mesh-ancestor
92994637|NCT00696137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994638|NCT00696137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92994639|NCT00696137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92994640|NCT00696137|Anesthetics, General|anesthetics, general|mesh-ancestor
92994641|NCT00696137|Anesthetics|anesthetics|mesh-ancestor
92994642|NCT02565641|Gemcitabine|gemcitabine|mesh-list
92994643|NCT02565641|Capecitabine|capecitabine|mesh-list
92994644|NCT02565641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994645|NCT02565641|Antimetabolites|antimetabolites|mesh-ancestor
92994646|NCT02565641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994647|NCT02565641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994648|NCT04036721|Prednisone|prednisone|mesh-list
92994649|NCT04036721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994650|NCT04036721|Glucocorticoids|glucocorticoids|mesh-ancestor
92994651|NCT04036721|Hormones|hormones|mesh-ancestor
92994652|NCT04036721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994653|NCT04036721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994654|NCT04036721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92994655|NCT04036721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994656|NCT00441142|Temozolomide|temozolomide|mesh-list
92994657|NCT00441142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994658|NCT00441142|Alkylating Agents|alkylating agents|mesh-ancestor
92994659|NCT00441142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994660|NCT00441142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994661|NCT03848416|Ixekizumab|ixekizumab|mesh-list
92994662|NCT03848416|Dermatologic Agents|dermatologic agents|mesh-ancestor
92994663|NCT01029418|Sorafenib|sorafenib|mesh-list
92994664|NCT01029418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994665|NCT01029418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994666|NCT01029418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994667|NCT01029418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994668|NCT04060979|Nitric Oxide|nitric oxide|mesh-list
92994669|NCT04060979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92994670|NCT04060979|Autonomic Agents|autonomic agents|mesh-ancestor
92994671|NCT04060979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994672|NCT04060979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994673|NCT04060979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92994674|NCT04060979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92994675|NCT04060979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92994676|NCT04060979|Antioxidants|antioxidants|mesh-ancestor
92994677|NCT04060979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994678|NCT04060979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994679|NCT04060979|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92994680|NCT04060979|Vasodilator Agents|vasodilator agents|mesh-ancestor
92994682|NCT04060979|Protective Agents|protective agents|mesh-ancestor
92994683|NCT00458302|Darunavir|darunavir|mesh-list
92994684|NCT00458302|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92994685|NCT00458302|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92994686|NCT00458302|Protease Inhibitors|protease inhibitors|mesh-ancestor
92994687|NCT00458302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994688|NCT00458302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994689|NCT00458302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92994690|NCT00458302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92994691|NCT00458302|Antiviral Agents|antiviral agents|mesh-ancestor
92994692|NCT00458302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994693|NCT00444106|Artesunate|artesunate|mesh-list
92994694|NCT00444106|Lumefantrine|lumefantrine|mesh-list
92994695|NCT00444106|Artemether|artemether|mesh-list
92994696|NCT00444106|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92994697|NCT00444106|Mefloquine|mefloquine|mesh-list
92994698|NCT00444106|Atovaquone|atovaquone|mesh-list
92994699|NCT00444106|Proguanil|proguanil|mesh-list
92994700|NCT00444106|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92994701|NCT00444106|Antimalarials|antimalarials|mesh-ancestor
92994702|NCT00444106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92994703|NCT00444106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92994704|NCT00444106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994705|NCT00444106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994706|NCT00444106|Antiviral Agents|antiviral agents|mesh-ancestor
92994707|NCT00444106|Schistosomicides|schistosomicides|mesh-ancestor
92994708|NCT00444106|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92994709|NCT00444106|Anthelmintics|anthelmintics|mesh-ancestor
92994710|NCT00444106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994711|NCT00444106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994712|NCT00444106|Antimetabolites|antimetabolites|mesh-ancestor
92994713|NCT00561470|Leucovorin|leucovorin|mesh-list
92994714|NCT00561470|Fluorouracil|fluorouracil|mesh-list
92994715|NCT00561470|Irinotecan|irinotecan|mesh-list
92994716|NCT00561470|Aflibercept|aflibercept|mesh-list
92994717|NCT00561470|Levoleucovorin|levoleucovorin|mesh-list
92994718|NCT00561470|Antimetabolites|antimetabolites|mesh-ancestor
92994719|NCT00561470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994720|NCT00561470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92994721|NCT00561470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994722|NCT00561470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994723|NCT00561470|Immunologic Factors|immunologic factors|mesh-ancestor
92994724|NCT00561470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994725|NCT00561470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92994726|NCT00561470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92994727|NCT00561470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994728|NCT00561470|Antidotes|antidotes|mesh-ancestor
92994729|NCT00561470|Protective Agents|protective agents|mesh-ancestor
92994730|NCT00561470|Vitamin B Complex|vitamin b complex|mesh-ancestor
92994731|NCT00561470|Vitamins|vitamins|mesh-ancestor
92994732|NCT00561470|Micronutrients|micronutrients|mesh-ancestor
92994733|NCT00561470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92994734|NCT00561470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92994735|NCT00561470|Growth Substances|growth substances|mesh-ancestor
92994736|NCT00561470|Growth Inhibitors|growth inhibitors|mesh-ancestor
92994737|NCT00443872|Selegiline|selegiline|mesh-list
92994738|NCT00443872|Antidepressive Agents|antidepressive agents|mesh-ancestor
92994739|NCT00443872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994740|NCT00443872|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92994741|NCT00443872|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92994742|NCT00443872|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92994743|NCT00443872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994744|NCT00443872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994745|NCT00443872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92994746|NCT00443872|Protective Agents|protective agents|mesh-ancestor
92994747|NCT00443872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994748|NCT01323244|Simeprevir|simeprevir|mesh-list
92994749|NCT01323244|Antiviral Agents|antiviral agents|mesh-ancestor
92994750|NCT01323244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994751|NCT01323244|Protease Inhibitors|protease inhibitors|mesh-ancestor
92994752|NCT01323244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994753|NCT01323244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994754|NCT03034642|Dimercaprol|dimercaprol|mesh-list
92994756|NCT03034642|Sequestering Agents|sequestering agents|mesh-ancestor
92994757|NCT03034642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994758|NCT03840226|Magnesium Oxide|magnesium oxide|mesh-list
92994759|NCT03840226|Antacids|antacids|mesh-ancestor
92994760|NCT03840226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994761|NCT03840226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994762|NCT03962738|Lasmiditan|lasmiditan|mesh-list
92994763|NCT03962738|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92994764|NCT03962738|Serotonin Agents|serotonin agents|mesh-ancestor
92994765|NCT03962738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994766|NCT03962738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994767|NCT03962738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994768|NCT00561392|Rivastigmine|rivastigmine|mesh-list
92994769|NCT00561392|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92994770|NCT00561392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994771|NCT00561392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994772|NCT00561392|Cholinergic Agents|cholinergic agents|mesh-ancestor
92994773|NCT00561392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994774|NCT00561392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994775|NCT00561392|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92994776|NCT00561392|Protective Agents|protective agents|mesh-ancestor
92994777|NCT00694109|Mipomersen|mipomersen|mesh-list
92994778|NCT00694109|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92994779|NCT00694109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92994780|NCT00694109|Antimetabolites|antimetabolites|mesh-ancestor
92994781|NCT00694109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994782|NCT00694109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92994783|NCT03070301|Everolimus|everolimus|mesh-list
92994784|NCT03070301|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92994785|NCT03070301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994786|NCT03070301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994787|NCT03070301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994788|NCT03070301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994789|NCT03070301|Immunologic Factors|immunologic factors|mesh-ancestor
92994790|NCT03070301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994791|NCT03070301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994792|NCT00940862|Adalimumab|adalimumab|mesh-list
92994793|NCT00940862|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92994794|NCT00940862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994795|NCT00940862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994796|NCT03068741|Ceftriaxone|ceftriaxone|mesh-list
92994797|NCT03068741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92994798|NCT03068741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994799|NCT00561080|Vaccines|vaccines|mesh-list
92994800|NCT00561080|Immunologic Factors|immunologic factors|mesh-ancestor
92994801|NCT00561080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994802|NCT01307306|Metformin|metformin|mesh-list
92994803|NCT01307306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92994804|NCT01307306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994805|NCT00941096|Timolol|timolol|mesh-list
92994806|NCT00941096|Bimatoprost|bimatoprost|mesh-list
92994807|NCT00941096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92994808|NCT00941096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92994809|NCT00941096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92994810|NCT00941096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994811|NCT00941096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994812|NCT00941096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994813|NCT00941096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92994814|NCT00941096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92994815|NCT04012424|Curcumin|curcumin|mesh-list
92994816|NCT04012424|Analgesics|analgesics|mesh-list
92994817|NCT04012424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92994818|NCT04012424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92994819|NCT04012424|Sensory System Agents|sensory system agents|mesh-ancestor
92994820|NCT04012424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994821|NCT04012424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994822|NCT04012424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994823|NCT04012424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994824|NCT04012424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994825|NCT04012424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994826|NCT04012424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994827|NCT00562094|Pantoprazole|pantoprazole|mesh-list
92994829|NCT00562094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994830|NCT00562094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92994831|NCT00562094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994832|NCT00562094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994833|NCT03817853|Prednisone|prednisone|mesh-list
92994834|NCT03817853|Methylprednisolone|methylprednisolone|mesh-list
92994835|NCT03817853|Prednisolone|prednisolone|mesh-list
92994836|NCT03817853|Cyclophosphamide|cyclophosphamide|mesh-list
92994837|NCT03817853|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92994838|NCT03817853|Doxorubicin|doxorubicin|mesh-list
92994839|NCT03817853|Vincristine|vincristine|mesh-list
92994840|NCT03817853|Obinutuzumab|obinutuzumab|mesh-list
92994841|NCT03817853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92994842|NCT03817853|Immunologic Factors|immunologic factors|mesh-ancestor
92994843|NCT03817853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994844|NCT03817853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994845|NCT03817853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92994846|NCT03817853|Alkylating Agents|alkylating agents|mesh-ancestor
92994847|NCT03817853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994848|NCT03817853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994849|NCT03817853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92994850|NCT03817853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92994851|NCT03817853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92994852|NCT03817853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92994853|NCT03817853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994854|NCT03817853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994855|NCT03817853|Glucocorticoids|glucocorticoids|mesh-ancestor
92994856|NCT03817853|Hormones|hormones|mesh-ancestor
92994857|NCT03817853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994858|NCT03817853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92994859|NCT03817853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92994860|NCT03817853|Tubulin Modulators|tubulin modulators|mesh-ancestor
92994861|NCT03817853|Antimitotic Agents|antimitotic agents|mesh-ancestor
92994862|NCT03817853|Mitosis Modulators|mitosis modulators|mesh-ancestor
92994863|NCT03817853|Antiemetics|antiemetics|mesh-ancestor
92994864|NCT03817853|Autonomic Agents|autonomic agents|mesh-ancestor
92994865|NCT03817853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994866|NCT03817853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994867|NCT03817853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92994868|NCT03817853|Protective Agents|protective agents|mesh-ancestor
92994869|NCT03817853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92994870|NCT00944840|Amodiaquine|amodiaquine|mesh-list
92994871|NCT00944840|Antimalarials|antimalarials|mesh-ancestor
92994872|NCT00944840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92994873|NCT00944840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92994874|NCT00944840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92994875|NCT00439270|Docetaxel|docetaxel|mesh-list
92994876|NCT00439270|Dasatinib|dasatinib|mesh-list
92994877|NCT00439270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994878|NCT00439270|Tubulin Modulators|tubulin modulators|mesh-ancestor
92994879|NCT00439270|Antimitotic Agents|antimitotic agents|mesh-ancestor
92994880|NCT00439270|Mitosis Modulators|mitosis modulators|mesh-ancestor
92994881|NCT00439270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994882|NCT00439270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92994883|NCT00439270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994884|NCT00944918|Fulvestrant|fulvestrant|mesh-list
92994885|NCT00944918|Anastrozole|anastrozole|mesh-list
92640240|NCT00204074|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92994886|NCT00944918|Exemestane|exemestane|mesh-list
92994887|NCT00944918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92994888|NCT00944918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994889|NCT00944918|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92994890|NCT00944918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92994891|NCT00944918|Hormone Antagonists|hormone antagonists|mesh-ancestor
92994892|NCT00944918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92994893|NCT00944918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994894|NCT00944918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92994895|NCT00944918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92994896|NCT00944918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994897|NCT00944918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994898|NCT04012268|Aspirin|aspirin|mesh-list
92994899|NCT04012268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92994900|NCT04012268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92994901|NCT04012268|Analgesics|analgesics|mesh-ancestor
92994902|NCT04012268|Sensory System Agents|sensory system agents|mesh-ancestor
92994903|NCT04012268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994904|NCT04012268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994905|NCT04012268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92994906|NCT04012268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92994907|NCT04012268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92994908|NCT04012268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92994909|NCT04012268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994910|NCT04012268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92994911|NCT04012268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92994912|NCT04012268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994913|NCT04012268|Antipyretics|antipyretics|mesh-ancestor
92994914|NCT03995134|Remifentanil|remifentanil|mesh-list
92994915|NCT03995134|Propofol|propofol|mesh-list
92994916|NCT03995134|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92994917|NCT03995134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994918|NCT03995134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994919|NCT03995134|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92994920|NCT03995134|Anesthetics, General|anesthetics, general|mesh-ancestor
92994921|NCT03995134|Anesthetics|anesthetics|mesh-ancestor
92994922|NCT03995134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92994923|NCT03995134|Narcotics|narcotics|mesh-ancestor
92994924|NCT03995134|Analgesics|analgesics|mesh-ancestor
92994925|NCT03995134|Sensory System Agents|sensory system agents|mesh-ancestor
92994926|NCT03995134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994927|NCT00553280|Pregabalin|pregabalin|mesh-list
92994928|NCT00553280|Analgesics|analgesics|mesh-ancestor
92994929|NCT00553280|Sensory System Agents|sensory system agents|mesh-ancestor
92994930|NCT00553280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92994931|NCT00553280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994932|NCT00553280|Anticonvulsants|anticonvulsants|mesh-ancestor
92994933|NCT00553280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92994934|NCT00553280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994935|NCT00553280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994936|NCT00553280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92994937|NCT00553280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92994938|NCT00553280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92994939|NCT00553280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994940|NCT00553280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994941|NCT01024192|Zolpidem|zolpidem|mesh-list
92994942|NCT01024192|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92994943|NCT01024192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92994944|NCT01024192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92994945|NCT01024192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994946|NCT01024192|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92994947|NCT01024192|GABA Agonists|gaba agonists|mesh-ancestor
92994948|NCT01024192|GABA Agents|gaba agents|mesh-ancestor
92994949|NCT01024192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994950|NCT01024192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994951|NCT01024270|Misoprostol|misoprostol|mesh-list
92994952|NCT01024270|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92994953|NCT01024270|Abortifacient Agents|abortifacient agents|mesh-ancestor
92994954|NCT01024270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92994955|NCT01024270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994956|NCT01024270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92994957|NCT01024270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92994958|NCT01024270|Oxytocics|oxytocics|mesh-ancestor
92994959|NCT00944996|Citalopram|citalopram|mesh-list
92994960|NCT00944996|Fluoxetine|fluoxetine|mesh-list
92994961|NCT00944996|Paroxetine|paroxetine|mesh-list
92994962|NCT00944996|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92994963|NCT00944996|Sertraline|sertraline|mesh-list
92994964|NCT00944996|Clomipramine|clomipramine|mesh-list
92994965|NCT00944996|Escitalopram|escitalopram|mesh-list
92994966|NCT00944996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92994967|NCT00944996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92994968|NCT00944996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994969|NCT00944996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994970|NCT00944996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92994971|NCT00944996|Serotonin Agents|serotonin agents|mesh-ancestor
92994972|NCT00944996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994973|NCT00944996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92994974|NCT00944996|Antidepressive Agents|antidepressive agents|mesh-ancestor
92994975|NCT00944996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92994976|NCT00944996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92994977|NCT00944996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92994978|NCT00944996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92994979|NCT00944996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92994980|NCT00944996|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92994981|NCT00950066|Amlodipine|amlodipine|mesh-list
92994982|NCT00950066|Irbesartan|irbesartan|mesh-list
92994983|NCT00950066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92994984|NCT00950066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92994985|NCT00950066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92994986|NCT00950066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92994987|NCT00950066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92994988|NCT00950066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92994989|NCT00950066|Vasodilator Agents|vasodilator agents|mesh-ancestor
92994990|NCT00950066|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92994991|NCT00950066|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92994992|NCT01031212|Acetic Acid|acetic acid|mesh-list
92994993|NCT01031212|Paclitaxel|paclitaxel|mesh-list
92994994|NCT01031212|Carboplatin|carboplatin|mesh-list
92994995|NCT01031212|Cetuximab|cetuximab|mesh-list
92994996|NCT01031212|Vadimezan|vadimezan|mesh-list
92994997|NCT01031212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92994998|NCT01031212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92994999|NCT01031212|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995000|NCT01031212|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995001|NCT01031212|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995002|NCT01031212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995003|NCT01031212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995004|NCT01031212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92995005|NCT01031212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995006|NCT01024348|Acetaminophen|acetaminophen|mesh-list
92995007|NCT01024348|Tramadol|tramadol|mesh-list
92995008|NCT01024348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92995009|NCT01024348|Analgesics|analgesics|mesh-ancestor
92995010|NCT01024348|Sensory System Agents|sensory system agents|mesh-ancestor
92995011|NCT01024348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995012|NCT01024348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995013|NCT01024348|Antipyretics|antipyretics|mesh-ancestor
92995014|NCT01024348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92995015|NCT01024348|Narcotics|narcotics|mesh-ancestor
92995016|NCT01024348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995017|NCT03994744|Metformin|metformin|mesh-list
92995018|NCT03994744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92995019|NCT03994744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92995020|NCT03994744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995021|NCT03994744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995022|NCT03994744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995023|NCT03994744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995024|NCT00950222|Imipenem|imipenem|mesh-list
92995025|NCT00950222|Amikacin|amikacin|mesh-list
92995026|NCT00950222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92995027|NCT00950222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995028|NCT05301530|Docetaxel|docetaxel|mesh-list
92995029|NCT05301530|Trastuzumab|trastuzumab|mesh-list
92995030|NCT05301530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995031|NCT05301530|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995032|NCT05301530|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995033|NCT05301530|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995034|NCT05301530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995035|NCT05301530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995036|NCT00941174|Leucovorin|leucovorin|mesh-list
92640407|NCT00227682|Hormones|hormones|mesh-ancestor
92995037|NCT00941174|Calcium|calcium|mesh-list
92995038|NCT00941174|Levoleucovorin|levoleucovorin|mesh-list
92995039|NCT00941174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92995040|NCT00941174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995041|NCT00941174|Antidotes|antidotes|mesh-ancestor
92995042|NCT00941174|Protective Agents|protective agents|mesh-ancestor
92995043|NCT00941174|Vitamin B Complex|vitamin b complex|mesh-ancestor
92995044|NCT00941174|Vitamins|vitamins|mesh-ancestor
92995045|NCT00941174|Micronutrients|micronutrients|mesh-ancestor
92995046|NCT00440518|Lacosamide|lacosamide|mesh-list
92995047|NCT00440518|Anticonvulsants|anticonvulsants|mesh-ancestor
92995048|NCT00440518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92995049|NCT00440518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92620219|NCT00150020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995050|NCT00440518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92995051|NCT00440518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995052|NCT00950534|Insulin Glargine|insulin glargine|mesh-list
92995053|NCT00950534|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92995054|NCT00950534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995055|NCT00941252|Imiquimod|imiquimod|mesh-list
92995056|NCT00941252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92995057|NCT00941252|Immunologic Factors|immunologic factors|mesh-ancestor
92995058|NCT00941252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995059|NCT00941252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995060|NCT00941252|Interferon Inducers|interferon inducers|mesh-ancestor
92995061|NCT01031368|Cytarabine|cytarabine|mesh-list
92995062|NCT01031368|Clofarabine|clofarabine|mesh-list
92995063|NCT01031368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995064|NCT01031368|Antimetabolites|antimetabolites|mesh-ancestor
92995065|NCT01031368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995066|NCT01031368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995067|NCT01031368|Antiviral Agents|antiviral agents|mesh-ancestor
92995068|NCT01031368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995069|NCT01031368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995070|NCT01031368|Immunologic Factors|immunologic factors|mesh-ancestor
92995071|NCT01031368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995072|NCT00945308|Eptifibatide|eptifibatide|mesh-list
92995073|NCT00945308|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92995074|NCT03172936|Spartalizumab|spartalizumab|mesh-list
92995075|NCT03172936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92995076|NCT03172936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995077|NCT03172936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995078|NCT03172936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995079|NCT01030042|Leucovorin|leucovorin|mesh-list
92995080|NCT01030042|Oxaliplatin|oxaliplatin|mesh-list
92995081|NCT01030042|Irinotecan|irinotecan|mesh-list
92995082|NCT01030042|Cetuximab|cetuximab|mesh-list
92995083|NCT01030042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995084|NCT01030042|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92995085|NCT01030042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92995086|NCT01030042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995087|NCT01030042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995088|NCT01030042|Antidotes|antidotes|mesh-ancestor
92995089|NCT01030042|Protective Agents|protective agents|mesh-ancestor
92995090|NCT01030042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995091|NCT01030042|Vitamin B Complex|vitamin b complex|mesh-ancestor
92995092|NCT01030042|Vitamins|vitamins|mesh-ancestor
92995093|NCT01030042|Micronutrients|micronutrients|mesh-ancestor
92995094|NCT01030042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995095|NCT01024504|Bevacizumab|bevacizumab|mesh-list
92995096|NCT01024504|Capecitabine|capecitabine|mesh-list
92995097|NCT01024504|Oxaliplatin|oxaliplatin|mesh-list
92995098|NCT01024504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995099|NCT01024504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995100|NCT01024504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92995101|NCT01024504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92995102|NCT01024504|Growth Substances|growth substances|mesh-ancestor
92995103|NCT01024504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995104|NCT01024504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92995105|NCT01024504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995106|NCT01024504|Antimetabolites|antimetabolites|mesh-ancestor
92995107|NCT01024504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995108|NCT01030120|Etanercept|etanercept|mesh-list
92995109|NCT01030120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92995110|NCT01030120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92995111|NCT01030120|Analgesics|analgesics|mesh-ancestor
92995112|NCT01030120|Sensory System Agents|sensory system agents|mesh-ancestor
92995113|NCT01030120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995114|NCT01030120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995115|NCT01030120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995116|NCT01030120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995117|NCT01030120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92995118|NCT01030120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995119|NCT01030120|Immunologic Factors|immunologic factors|mesh-ancestor
92995121|NCT00951236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995122|NCT00945542|Hemostatics|hemostatics|mesh-list
92995123|NCT00945542|Coagulants|coagulants|mesh-ancestor
92995124|NCT00438256|Capecitabine|capecitabine|mesh-list
92995125|NCT00438256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995126|NCT00438256|Antimetabolites|antimetabolites|mesh-ancestor
92995127|NCT00438256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995128|NCT00438256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995129|NCT01031524|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92995130|NCT01031524|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92995131|NCT01031524|Immunologic Factors|immunologic factors|mesh-ancestor
92995132|NCT01031524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995133|NCT00945620|Ropivacaine|ropivacaine|mesh-list
92995134|NCT00945620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92995135|NCT00945620|Anesthetics|anesthetics|mesh-ancestor
92995136|NCT00945620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995137|NCT00945620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995138|NCT00945620|Sensory System Agents|sensory system agents|mesh-ancestor
92995139|NCT00945620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995140|NCT01565746|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92995141|NCT01565746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995142|NCT01030510|Rocuronium|rocuronium|mesh-list
92995143|NCT01030510|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92995144|NCT01030510|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92995145|NCT01030510|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92995146|NCT01030510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995147|NCT01030510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995148|NCT04813822|Miconazole|miconazole|mesh-list
92995149|NCT04813822|Clotrimazole|clotrimazole|mesh-list
92995150|NCT04813822|Bromides|bromides|mesh-list
92995151|NCT04813822|Anticonvulsants|anticonvulsants|mesh-ancestor
92995152|NCT04813822|Antifungal Agents|antifungal agents|mesh-ancestor
92995153|NCT04813822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995154|NCT04813822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92995155|NCT04813822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92995156|NCT04813822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995157|NCT04813822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995158|NCT04813822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92995159|NCT04813822|Hormone Antagonists|hormone antagonists|mesh-ancestor
92995160|NCT04813822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995161|NCT04813822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995162|NCT04813822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92995163|NCT04813822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92995164|NCT04813822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92995165|NCT02917564|Triamcinolone|triamcinolone|mesh-list
92995166|NCT02917564|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92995167|NCT02917564|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92995168|NCT02917564|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92995169|NCT02917564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995170|NCT02917564|Glucocorticoids|glucocorticoids|mesh-ancestor
92995171|NCT02917564|Hormones|hormones|mesh-ancestor
92995172|NCT02917564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995173|NCT02917564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995174|NCT02917564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995175|NCT02917564|Immunologic Factors|immunologic factors|mesh-ancestor
92995176|NCT02917564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995177|NCT02917564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995178|NCT00952016|Methotrexate|methotrexate|mesh-list
92995179|NCT00952016|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92995180|NCT00952016|Abortifacient Agents|abortifacient agents|mesh-ancestor
92995181|NCT00952016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92995182|NCT00952016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995183|NCT00952016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995184|NCT00952016|Antimetabolites|antimetabolites|mesh-ancestor
92995185|NCT00952016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640541|NCT00228033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92995186|NCT00952016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995187|NCT00952016|Dermatologic Agents|dermatologic agents|mesh-ancestor
92995188|NCT00952016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995189|NCT00952016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92995190|NCT00952016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995191|NCT00952016|Immunologic Factors|immunologic factors|mesh-ancestor
92995192|NCT00952016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995193|NCT00952016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995194|NCT00952094|Cinacalcet|cinacalcet|mesh-list
92995195|NCT00952094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92995196|NCT00952094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995197|NCT00952094|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92995198|NCT00952094|Hormone Antagonists|hormone antagonists|mesh-ancestor
92995199|NCT00952094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995201|NCT00942344|Amlodipine|amlodipine|mesh-list
92995202|NCT00942344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92995203|NCT00942344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92995204|NCT00942344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92995205|NCT00942344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995206|NCT00942344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92995207|NCT00942344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995208|NCT00942344|Vasodilator Agents|vasodilator agents|mesh-ancestor
92995209|NCT00942344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92995210|NCT00942344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92995211|NCT00942344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92995212|NCT00946166|Simvastatin|simvastatin|mesh-list
92995213|NCT00946166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92995214|NCT00946166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92995215|NCT00946166|Antimetabolites|antimetabolites|mesh-ancestor
92995216|NCT00946166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995217|NCT00946166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92995218|NCT00946166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92995219|NCT00946166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995220|NCT00952562|Cholecalciferol|cholecalciferol|mesh-list
92995221|NCT00952562|Vitamin D|vitamin d|mesh-list
92995222|NCT00952562|Vitamins|vitamins|mesh-ancestor
92995223|NCT00952562|Micronutrients|micronutrients|mesh-ancestor
92995224|NCT00952562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995225|NCT00952562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92995226|NCT00952562|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92995227|NCT00952640|Vitamin A|vitamin a|mesh-list
92995228|NCT00952640|Vitamins|vitamins|mesh-ancestor
92995229|NCT00952640|Micronutrients|micronutrients|mesh-ancestor
92995230|NCT00952640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995231|NCT00952796|Moxifloxacin|moxifloxacin|mesh-list
92995232|NCT00952796|Ampicillin|ampicillin|mesh-list
92995233|NCT00952796|Sulbactam|sulbactam|mesh-list
92995234|NCT00952796|Sultamicillin|sultamicillin|mesh-list
92995235|NCT00952796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92995236|NCT00952796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995237|NCT00952796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92995238|NCT00952796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92995239|NCT00952796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995240|NCT00952796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995241|NCT00952796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995242|NCT00952796|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92995243|NCT00952952|Mesalamine|mesalamine|mesh-list
92995244|NCT00952952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92995245|NCT00952952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92995246|NCT00952952|Analgesics|analgesics|mesh-ancestor
92995247|NCT00952952|Sensory System Agents|sensory system agents|mesh-ancestor
92995248|NCT00952952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995249|NCT00952952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995250|NCT00952952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995251|NCT00952952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995252|NCT00953108|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92995253|NCT00953108|Escitalopram|escitalopram|mesh-list
92995254|NCT00953108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92995255|NCT00953108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92995256|NCT00953108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92995257|NCT00953108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995258|NCT00953108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995259|NCT00953108|Serotonin Agents|serotonin agents|mesh-ancestor
92995260|NCT00953108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995261|NCT00953108|Antidepressive Agents|antidepressive agents|mesh-ancestor
92995262|NCT00953108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92995263|NCT00953108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92995264|NCT00953108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92995265|NCT00953108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995266|NCT00953498|Pioglitazone|pioglitazone|mesh-list
92995267|NCT00953498|Rosiglitazone|rosiglitazone|mesh-list
92995268|NCT00953498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92995269|NCT00953498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995270|NCT00943358|Vaccines|vaccines|mesh-list
92995271|NCT00943358|Immunologic Factors|immunologic factors|mesh-ancestor
92995272|NCT00943358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995273|NCT00120289|Niacin|niacin|mesh-list
92995274|NCT00120289|Simvastatin|simvastatin|mesh-list
92995275|NCT00120289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92995276|NCT00120289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92995277|NCT00120289|Antimetabolites|antimetabolites|mesh-ancestor
92995278|NCT00120289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995279|NCT00120289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92995280|NCT00120289|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92995281|NCT00120289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995282|NCT00120289|Vasodilator Agents|vasodilator agents|mesh-ancestor
92995283|NCT00120289|Vitamin B Complex|vitamin b complex|mesh-ancestor
92995284|NCT00120289|Vitamins|vitamins|mesh-ancestor
92995285|NCT00120289|Micronutrients|micronutrients|mesh-ancestor
92995286|NCT00120289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995287|NCT00946556|Valacyclovir|valacyclovir|mesh-list
92995288|NCT00946556|Antiviral Agents|antiviral agents|mesh-ancestor
92995289|NCT00946556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995290|NCT00943748|Deferiprone|deferiprone|mesh-list
92995291|NCT00943748|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92995292|NCT00943748|Chelating Agents|chelating agents|mesh-ancestor
92995293|NCT00943748|Sequestering Agents|sequestering agents|mesh-ancestor
92995294|NCT00943748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995295|NCT00946790|Hydroxychloroquine|hydroxychloroquine|mesh-list
92995296|NCT00946790|Antimalarials|antimalarials|mesh-ancestor
92995297|NCT00946790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92995298|NCT00946790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92995299|NCT00946790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995300|NCT00946790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995301|NCT00946790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995302|NCT00946790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995303|NCT00954200|Ibuprofen|ibuprofen|mesh-list
92995304|NCT00954200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92995305|NCT00954200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92995306|NCT00954200|Analgesics|analgesics|mesh-ancestor
92995307|NCT00954200|Sensory System Agents|sensory system agents|mesh-ancestor
92995308|NCT00954200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995309|NCT00954200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995310|NCT00954200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995311|NCT00954200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995312|NCT00954200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92995313|NCT00954200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995314|NCT00954200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995315|NCT00954278|Sorafenib|sorafenib|mesh-list
92995316|NCT00954278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995317|NCT00954278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995318|NCT00954278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995319|NCT00954278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995320|NCT00550446|Adalimumab|adalimumab|mesh-list
92995321|NCT00550446|Tofacitinib|tofacitinib|mesh-list
92995322|NCT00550446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92995323|NCT00550446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995324|NCT00550446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995325|NCT00550446|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92995326|NCT00550446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995327|NCT00550446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995328|NCT00550446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995329|NCT00953472|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92995330|NCT00953472|Natriuretic Agents|natriuretic agents|mesh-ancestor
92995331|NCT00953472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995332|NCT00953550|Rocuronium|rocuronium|mesh-list
92995333|NCT00953550|Succinylcholine|succinylcholine|mesh-list
92995334|NCT00953550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92995335|NCT00953550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92995336|NCT00953550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92995337|NCT00953550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995338|NCT00953550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995339|NCT00953550|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92995340|NCT00953628|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92995341|NCT00953628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92995342|NCT00953628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995344|NCT00949026|Temsirolimus|temsirolimus|mesh-list
92995345|NCT00949026|MTOR Inhibitors|mtor inhibitors|mesh-list
92995346|NCT00949026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995347|NCT00949026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995348|NCT00949026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995349|NCT00949026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995350|NCT00949026|Immunologic Factors|immunologic factors|mesh-ancestor
92995351|NCT00949026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995352|NCT00949026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995353|NCT00949026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92995354|NCT00949026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995355|NCT00949026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92995356|NCT00949026|Antifungal Agents|antifungal agents|mesh-ancestor
92995357|NCT00436618|Everolimus|everolimus|mesh-list
92995358|NCT00436618|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92995359|NCT00436618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995360|NCT00436618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995361|NCT00436618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995362|NCT00436618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995363|NCT00436618|Immunologic Factors|immunologic factors|mesh-ancestor
92995364|NCT00436618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995365|NCT00436618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995366|NCT01024660|Donepezil|donepezil|mesh-list
92995367|NCT01024660|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92995368|NCT01024660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995369|NCT01024660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995370|NCT01024660|Cholinergic Agents|cholinergic agents|mesh-ancestor
92995371|NCT01024660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995372|NCT01024660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995373|NCT01024660|Nootropic Agents|nootropic agents|mesh-ancestor
92995374|NCT01751126|Cyclosporine|cyclosporine|mesh-list
92995375|NCT01751126|Cyclosporins|cyclosporins|mesh-list
92995376|NCT01751126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995377|NCT01751126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995378|NCT01751126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995379|NCT01751126|Immunologic Factors|immunologic factors|mesh-ancestor
92995380|NCT01751126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995381|NCT01751126|Antifungal Agents|antifungal agents|mesh-ancestor
92995382|NCT01751126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995383|NCT01751126|Dermatologic Agents|dermatologic agents|mesh-ancestor
92995384|NCT01751126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995385|NCT01751126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92995386|NCT00943982|Interferons|interferons|mesh-list
92995387|NCT00943982|Interferon-gamma|interferon-gamma|mesh-list
92995388|NCT00943982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995389|NCT00943982|Antiviral Agents|antiviral agents|mesh-ancestor
92995390|NCT00943982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995391|NCT00548808|Insulin|insulin|mesh-list
92995392|NCT00548808|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92995393|NCT00548808|Insulin Glargine|insulin glargine|mesh-list
92995394|NCT00548808|Insulin Lispro|insulin lispro|mesh-list
92995395|NCT00548808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92995396|NCT00548808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995397|NCT04011878|Mitomycins|mitomycins|mesh-list
92995398|NCT04011878|Mitomycin|mitomycin|mesh-list
92995399|NCT04011878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92995400|NCT04011878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995401|NCT04011878|Alkylating Agents|alkylating agents|mesh-ancestor
92995402|NCT04011878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995403|NCT04011878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995404|NCT04011878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995405|NCT00954096|Nicotine|nicotine|mesh-list
92995406|NCT00954096|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92995407|NCT00954096|Autonomic Agents|autonomic agents|mesh-ancestor
92995408|NCT00954096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995409|NCT00954096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995410|NCT00954096|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92640767|NCT00199004|Cyclophosphamide|cyclophosphamide|mesh-list
92995411|NCT00954096|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92995412|NCT00954096|Cholinergic Agents|cholinergic agents|mesh-ancestor
92995413|NCT00954096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995414|NCT00954096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995415|NCT00954252|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
92995416|NCT00954252|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92995417|NCT00954252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995418|NCT00954252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995419|NCT00110617|Deferasirox|deferasirox|mesh-list
92995420|NCT00110617|Deferoxamine|deferoxamine|mesh-list
92995421|NCT00110617|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92995422|NCT00110617|Chelating Agents|chelating agents|mesh-ancestor
92995423|NCT00110617|Sequestering Agents|sequestering agents|mesh-ancestor
92995424|NCT00110617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995425|NCT00110617|Siderophores|siderophores|mesh-ancestor
92995427|NCT00949494|Hyaluronic Acid|hyaluronic acid|mesh-list
92995428|NCT00949494|Viscosupplements|viscosupplements|mesh-ancestor
92995429|NCT00949494|Protective Agents|protective agents|mesh-ancestor
92995430|NCT00949494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995431|NCT00949494|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92995432|NCT00949494|Immunologic Factors|immunologic factors|mesh-ancestor
92995433|NCT00954486|Epoetin Alfa|epoetin alfa|mesh-list
92995434|NCT00954486|Hematinics|hematinics|mesh-ancestor
92995435|NCT00550238|Pimavanserin|pimavanserin|mesh-list
92995436|NCT00550238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92995437|NCT00550238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92995438|NCT00550238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92995439|NCT00550238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92995440|NCT00550238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995441|NCT00550238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995442|NCT00550238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92995443|NCT00550238|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92995444|NCT00550238|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92995445|NCT00550238|Serotonin Agents|serotonin agents|mesh-ancestor
92995446|NCT00550238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995447|NCT00550238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995448|NCT02903680|Dexamethasone|dexamethasone|mesh-list
92995449|NCT02903680|Dexamethasone acetate|dexamethasone acetate|mesh-list
92995450|NCT02903680|BB 1101|bb 1101|mesh-list
92995451|NCT02903680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995452|NCT02903680|Antiemetics|antiemetics|mesh-ancestor
92995453|NCT02903680|Autonomic Agents|autonomic agents|mesh-ancestor
92995454|NCT02903680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995455|NCT02903680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995456|NCT02903680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92995457|NCT02903680|Glucocorticoids|glucocorticoids|mesh-ancestor
92995458|NCT02903680|Hormones|hormones|mesh-ancestor
92995459|NCT02903680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995460|NCT02903680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92995461|NCT02903680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995462|NCT02903680|Protease Inhibitors|protease inhibitors|mesh-ancestor
92995463|NCT02903680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995464|NCT02903680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995465|NCT00946946|Mesalamine|mesalamine|mesh-list
92995466|NCT00946946|Azathioprine|azathioprine|mesh-list
92995467|NCT00946946|Antimetabolites|antimetabolites|mesh-ancestor
92995468|NCT00946946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995469|NCT00946946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995470|NCT00946946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995471|NCT00946946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995472|NCT00946946|Immunologic Factors|immunologic factors|mesh-ancestor
92995473|NCT00946946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995474|NCT00946946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995475|NCT00946946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92995476|NCT00946946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92995477|NCT00946946|Analgesics|analgesics|mesh-ancestor
92995478|NCT00946946|Sensory System Agents|sensory system agents|mesh-ancestor
92995479|NCT00946946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995480|NCT00946946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995481|NCT00947024|Glipizide|glipizide|mesh-list
92995482|NCT00947024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92995483|NCT00947024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995484|NCT00949572|Vaccines|vaccines|mesh-list
92995485|NCT00949572|Aluminum sulfate|aluminum sulfate|mesh-list
92995486|NCT00949572|Immunologic Factors|immunologic factors|mesh-ancestor
92995487|NCT00949572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995488|NCT00949572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92995489|NCT01031992|Tranexamic Acid|tranexamic acid|mesh-list
92995490|NCT01031992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92995491|NCT01031992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92995492|NCT01031992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995494|NCT01031992|Coagulants|coagulants|mesh-ancestor
92995495|NCT00954564|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92995496|NCT00954564|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92995497|NCT00954564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995498|NCT00954564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995499|NCT00954564|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92995500|NCT00954564|Hormone Antagonists|hormone antagonists|mesh-ancestor
92995501|NCT00954564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995502|NCT00954564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995503|NCT00949728|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92995504|NCT00949728|Hemostatics|hemostatics|mesh-ancestor
92995505|NCT00949728|Coagulants|coagulants|mesh-ancestor
92995506|NCT00954902|Antioxidants|antioxidants|mesh-list
92995507|NCT00954902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995508|NCT00954902|Protective Agents|protective agents|mesh-ancestor
92995509|NCT00954902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995510|NCT01034020|Nicotine|nicotine|mesh-list
92995511|NCT01034020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92995512|NCT01034020|Autonomic Agents|autonomic agents|mesh-ancestor
92995513|NCT01034020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995514|NCT01034020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995515|NCT01034020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92995516|NCT01034020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92995517|NCT01034020|Cholinergic Agents|cholinergic agents|mesh-ancestor
92995518|NCT01034020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995519|NCT01034020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995520|NCT01032148|Panobinostat|panobinostat|mesh-list
92995521|NCT01032148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995522|NCT01032148|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92995523|NCT01032148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995524|NCT01032148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995525|NCT01032304|Erdosteine|erdosteine|mesh-list
92995526|NCT01032304|Expectorants|expectorants|mesh-ancestor
92995527|NCT01032304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92995528|NCT00954642|Paclitaxel|paclitaxel|mesh-list
92995529|NCT00954642|Bevacizumab|bevacizumab|mesh-list
92995530|NCT00954642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92995531|NCT00954642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995532|NCT00954642|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995533|NCT00954642|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995534|NCT00954642|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995535|NCT00954642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995536|NCT00954642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995537|NCT00954642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92995538|NCT00954642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92995539|NCT00954642|Growth Substances|growth substances|mesh-ancestor
92995540|NCT00954642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995541|NCT00954642|Growth Inhibitors|growth inhibitors|mesh-ancestor
92995542|NCT00954798|Vaccines|vaccines|mesh-list
92995543|NCT00954798|Immunologic Factors|immunologic factors|mesh-ancestor
92995544|NCT00954798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995545|NCT00110305|Efavirenz|efavirenz|mesh-list
92995546|NCT00110305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92995547|NCT00110305|Rilpivirine|rilpivirine|mesh-list
92995548|NCT00110305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995549|NCT00110305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995550|NCT00110305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995551|NCT00110305|Antiviral Agents|antiviral agents|mesh-ancestor
92995552|NCT00110305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995553|NCT00110305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92995554|NCT00110305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92995555|NCT00110305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92995556|NCT00110305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92995557|NCT00110305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92995558|NCT00110305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92995559|NCT00110305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92995560|NCT00110305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92995562|NCT00560066|Immunologic Factors|immunologic factors|mesh-ancestor
92995563|NCT00560066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995564|NCT00549900|Vaccines|vaccines|mesh-list
92995565|NCT00549900|Immunologic Factors|immunologic factors|mesh-ancestor
92341024|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
92995566|NCT00549900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995567|NCT00435994|Epinephrine|epinephrine|mesh-list
92995568|NCT00435994|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92995569|NCT00435994|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92995570|NCT00435994|Adrenergic Agents|adrenergic agents|mesh-ancestor
92995571|NCT00435994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995572|NCT00435994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995573|NCT00435994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995574|NCT00435994|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92995575|NCT00435994|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92995576|NCT00435994|Autonomic Agents|autonomic agents|mesh-ancestor
92995577|NCT00435994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995578|NCT00435994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92995579|NCT00435994|Respiratory System Agents|respiratory system agents|mesh-ancestor
92995580|NCT00435994|Mydriatics|mydriatics|mesh-ancestor
92995581|NCT00435994|Sympathomimetics|sympathomimetics|mesh-ancestor
92995582|NCT00435994|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92995583|NCT01563120|Metformin|metformin|mesh-list
92995584|NCT01563120|Glyburide|glyburide|mesh-list
92995585|NCT01563120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92995586|NCT01563120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995587|NCT00435370|Tropisetron|tropisetron|mesh-list
92995588|NCT00435370|Risperidone|risperidone|mesh-list
92995589|NCT00435370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92995590|NCT00435370|Serotonin Agents|serotonin agents|mesh-ancestor
92995591|NCT00435370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995592|NCT00435370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995593|NCT00435370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995594|NCT00435370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92995595|NCT00435370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92995596|NCT00435370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995597|NCT00435370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92995598|NCT00435370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92995599|NCT00435370|Dopamine Agents|dopamine agents|mesh-ancestor
92995600|NCT00435370|Antiemetics|antiemetics|mesh-ancestor
92995601|NCT00435370|Autonomic Agents|autonomic agents|mesh-ancestor
92995602|NCT00435370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995603|NCT00435370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92995604|NCT00435370|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92995605|NCT00096031|Cetuximab|cetuximab|mesh-list
92995606|NCT00096031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995607|NCT00096031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995608|NCT00118417|Clonazepam|clonazepam|mesh-list
92995609|NCT00118417|Sertraline|sertraline|mesh-list
92995610|NCT00118417|Antidepressive Agents|antidepressive agents|mesh-ancestor
92995611|NCT00118417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92995612|NCT00118417|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92995613|NCT00118417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92995614|NCT00118417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92995615|NCT00118417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995616|NCT00118417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995617|NCT00118417|Serotonin Agents|serotonin agents|mesh-ancestor
92995618|NCT00118417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995619|NCT00118417|Anticonvulsants|anticonvulsants|mesh-ancestor
92995620|NCT00118417|GABA Modulators|gaba modulators|mesh-ancestor
92995621|NCT00118417|GABA Agents|gaba agents|mesh-ancestor
92995622|NCT04293744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92995623|NCT01079455|Corticosterone|corticosterone|mesh-list
92995624|NCT01079455|Bupivacaine|bupivacaine|mesh-list
92995625|NCT01079455|Hyaluronic Acid|hyaluronic acid|mesh-list
92995626|NCT01079455|Anesthetics, Local|anesthetics, local|mesh-ancestor
92995627|NCT01079455|Anesthetics|anesthetics|mesh-ancestor
92995628|NCT01079455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995629|NCT01079455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995630|NCT01079455|Sensory System Agents|sensory system agents|mesh-ancestor
92995631|NCT01079455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995632|NCT01079455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92995633|NCT01079455|Immunologic Factors|immunologic factors|mesh-ancestor
92995634|NCT01079455|Viscosupplements|viscosupplements|mesh-ancestor
92995635|NCT01079455|Protective Agents|protective agents|mesh-ancestor
92995636|NCT01079455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995638|NCT00549848|Dexamethasone|dexamethasone|mesh-list
92995639|NCT00549848|Dexamethasone acetate|dexamethasone acetate|mesh-list
92995640|NCT00549848|Prednisone|prednisone|mesh-list
92995641|NCT00549848|Prednisolone|prednisolone|mesh-list
92995642|NCT00549848|Cyclophosphamide|cyclophosphamide|mesh-list
92995644|NCT00549848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92995645|NCT00549848|Methotrexate|methotrexate|mesh-list
92995646|NCT00549848|Etoposide|etoposide|mesh-list
92995647|NCT00549848|Etoposide phosphate|etoposide phosphate|mesh-list
92995648|NCT00549848|Vincristine|vincristine|mesh-list
92995649|NCT00549848|Daunorubicin|daunorubicin|mesh-list
92995650|NCT00549848|Asparaginase|asparaginase|mesh-list
92995651|NCT00549848|Dasatinib|dasatinib|mesh-list
92995652|NCT00549848|Mercaptopurine|mercaptopurine|mesh-list
92995653|NCT00549848|Clofarabine|clofarabine|mesh-list
92995654|NCT00549848|Pegaspargase|pegaspargase|mesh-list
92995655|NCT00549848|Thioguanine|thioguanine|mesh-list
92995656|NCT00549848|BB 1101|bb 1101|mesh-list
92995657|NCT00549848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995658|NCT00549848|Immunologic Factors|immunologic factors|mesh-ancestor
92995659|NCT00549848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995660|NCT00549848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995661|NCT00549848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92995662|NCT00549848|Alkylating Agents|alkylating agents|mesh-ancestor
92995663|NCT00549848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995664|NCT00549848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995665|NCT00549848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92995666|NCT00549848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995667|NCT00549848|Antiemetics|antiemetics|mesh-ancestor
92995668|NCT00549848|Autonomic Agents|autonomic agents|mesh-ancestor
92995669|NCT00549848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995670|NCT00549848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92995671|NCT00549848|Glucocorticoids|glucocorticoids|mesh-ancestor
92995672|NCT00549848|Hormones|hormones|mesh-ancestor
92995673|NCT00549848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168159|NCT05733741|Hyaluronic Acid|hyaluronic acid|mesh-list
92995674|NCT00549848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92995675|NCT00549848|Protease Inhibitors|protease inhibitors|mesh-ancestor
92995676|NCT00549848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995677|NCT00549848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92995678|NCT00549848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92995679|NCT00549848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92995680|NCT00549848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92995681|NCT00549848|Abortifacient Agents|abortifacient agents|mesh-ancestor
92995682|NCT00549848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92995683|NCT00549848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995684|NCT00549848|Antimetabolites|antimetabolites|mesh-ancestor
92995685|NCT00549848|Dermatologic Agents|dermatologic agents|mesh-ancestor
92995686|NCT00549848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92995687|NCT00549848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995688|NCT00549848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92995689|NCT00549848|Antiviral Agents|antiviral agents|mesh-ancestor
92995690|NCT00549848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995691|NCT00549848|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995692|NCT00549848|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995693|NCT00549848|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995694|NCT00549848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995695|NCT01083589|Docetaxel|docetaxel|mesh-list
92995696|NCT01083589|Imatinib Mesylate|imatinib mesylate|mesh-list
92995697|NCT01083589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995698|NCT01083589|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995699|NCT01083589|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995700|NCT01083589|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995701|NCT01083589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995702|NCT01083589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995703|NCT01083589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995704|NCT00949182|Doxorubicin|doxorubicin|mesh-list
92995705|NCT00949182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92995706|NCT00949182|Mitomycins|mitomycins|mesh-list
92995707|NCT00949182|Mitomycin|mitomycin|mesh-list
92995708|NCT00949182|Sorafenib|sorafenib|mesh-list
92995709|NCT00949182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92995710|NCT00949182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995711|NCT00949182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92995712|NCT00949182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92995713|NCT00949182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995714|NCT00949182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995715|NCT00949182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995716|NCT00949182|Alkylating Agents|alkylating agents|mesh-ancestor
92995717|NCT00949182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995718|NCT00549770|Valsartan|valsartan|mesh-list
92995719|NCT00549770|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92995720|NCT00549770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92995721|NCT00549770|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92995722|NCT00549770|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92995723|NCT00549770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995724|NCT00548184|Trastuzumab|trastuzumab|mesh-list
92995725|NCT00548184|Lapatinib|lapatinib|mesh-list
92995726|NCT00548184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995727|NCT00548184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995728|NCT00548184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92995729|NCT00548184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995730|NCT00548184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995731|NCT00454636|Cisplatin|cisplatin|mesh-list
92995732|NCT00454636|Docetaxel|docetaxel|mesh-list
92995733|NCT00454636|Capecitabine|capecitabine|mesh-list
92995734|NCT00454636|Oxaliplatin|oxaliplatin|mesh-list
92995735|NCT00454636|Epirubicin|epirubicin|mesh-list
92995736|NCT00454636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995737|NCT00454636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995738|NCT00454636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995739|NCT00454636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995740|NCT00454636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995741|NCT00454636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995742|NCT00454636|Antimetabolites|antimetabolites|mesh-ancestor
92995743|NCT00454636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92995744|NCT00454636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92995745|NCT00454636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92995746|NCT00454636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995747|NCT00427960|Atorvastatin|atorvastatin|mesh-list
92995748|NCT00427960|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92995749|NCT00427960|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92995750|NCT00427960|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92995751|NCT00427960|Antimetabolites|antimetabolites|mesh-ancestor
92995752|NCT00427960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995753|NCT00427960|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92995754|NCT00427960|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92995755|NCT00427960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995756|NCT04768686|Pembrolizumab|pembrolizumab|mesh-list
92995757|NCT04768686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995758|NCT04768686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995759|NCT04768686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92995760|NCT04768686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995761|NCT00955890|Dexrazoxane|dexrazoxane|mesh-list
92995762|NCT00955890|Razoxane|razoxane|mesh-list
92995763|NCT00955890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995764|NCT00955890|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92995765|NCT00955890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92995766|NCT00955890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92995767|NCT00955890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995768|NCT00955890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995769|NCT00955890|Protective Agents|protective agents|mesh-ancestor
92995770|NCT00955890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995771|NCT00955890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995772|NCT00955890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995773|NCT00956046|Vaccines|vaccines|mesh-list
92995774|NCT00956046|Immunologic Factors|immunologic factors|mesh-ancestor
92995775|NCT00956046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995776|NCT00454246|Epoetin Alfa|epoetin alfa|mesh-list
92995777|NCT00454246|Darbepoetin alfa|darbepoetin alfa|mesh-list
92995778|NCT00454246|Hematinics|hematinics|mesh-ancestor
92995779|NCT00434590|Mycophenolic Acid|mycophenolic acid|mesh-list
92995780|NCT00434590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92995781|NCT00434590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995782|NCT00434590|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92995783|NCT00434590|Antitubercular Agents|antitubercular agents|mesh-ancestor
92995784|NCT00434590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92995785|NCT00434590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995786|NCT00434590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995787|NCT00434590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995788|NCT00956202|Vaccines|vaccines|mesh-list
92641147|NCT00229593|ST 1435|st 1435|mesh-list
92995790|NCT00956202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995791|NCT00695903|Vancomycin|vancomycin|mesh-list
92995792|NCT00695903|Daptomycin|daptomycin|mesh-list
92995793|NCT00695903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92995794|NCT00695903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995795|NCT02759861|Sofosbuvir|sofosbuvir|mesh-list
92995796|NCT02759861|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92995797|NCT02759861|Ledipasvir|ledipasvir|mesh-list
92995798|NCT02759861|Antiviral Agents|antiviral agents|mesh-ancestor
92995799|NCT02759861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995800|NCT00548262|Voriconazole|voriconazole|mesh-list
92995801|NCT00548262|Anidulafungin|anidulafungin|mesh-list
92995802|NCT00548262|Antifungal Agents|antifungal agents|mesh-ancestor
92995803|NCT00548262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995804|NCT00548262|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92995805|NCT00548262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92995806|NCT00548262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995807|NCT00548262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995808|NCT00548262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92995809|NCT00548262|Hormone Antagonists|hormone antagonists|mesh-ancestor
92995810|NCT00548262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995811|NCT00548262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995812|NCT00548262|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92995813|NCT02565173|Timolol|timolol|mesh-list
92995814|NCT02565173|Adenosine|adenosine|mesh-list
92995815|NCT02565173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92995816|NCT02565173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92995817|NCT02565173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92995818|NCT02565173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995819|NCT02565173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995820|NCT02565173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995821|NCT02565173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92995822|NCT02565173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92995823|NCT02565173|Analgesics|analgesics|mesh-ancestor
92995824|NCT02565173|Sensory System Agents|sensory system agents|mesh-ancestor
92995825|NCT02565173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995826|NCT02565173|Vasodilator Agents|vasodilator agents|mesh-ancestor
92995827|NCT02565173|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92995828|NCT02565173|Purinergic Agonists|purinergic agonists|mesh-ancestor
92995829|NCT02565173|Purinergic Agents|purinergic agents|mesh-ancestor
92995830|NCT02730923|Anastrozole|anastrozole|mesh-list
92995831|NCT02730923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92995832|NCT02730923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995833|NCT02730923|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92995834|NCT02730923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92995835|NCT02730923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995836|NCT02730923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995837|NCT02730923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92995838|NCT02730923|Hormone Antagonists|hormone antagonists|mesh-ancestor
92995839|NCT02730923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995840|NCT02730923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995841|NCT04619082|Tenofovir|tenofovir|mesh-list
92995842|NCT04619082|Antiviral Agents|antiviral agents|mesh-ancestor
92995843|NCT04619082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995844|NCT04619082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92995845|NCT04619082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995846|NCT04619082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995847|NCT04619082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995848|NCT04619082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92995849|NCT04619082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92995850|NCT03717623|Posaconazole|posaconazole|mesh-list
92995851|NCT03717623|Antifungal Agents|antifungal agents|mesh-ancestor
92995852|NCT03717623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92995853|NCT03717623|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92995854|NCT03717623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92995855|NCT03717623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92995856|NCT03717623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92995857|NCT03717623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92995858|NCT03717623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995859|NCT03717623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995860|NCT03717623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92995861|NCT03717623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92995862|NCT03717623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995863|NCT03717623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995864|NCT00095173|Abatacept|abatacept|mesh-list
92995865|NCT00095173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341325|NCT00383045|Naltrexone|naltrexone|mesh-list
92995866|NCT00095173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995867|NCT00095173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995868|NCT00095173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995869|NCT00095173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995871|NCT00095173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995872|NCT00095173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995873|NCT03704753|Ropivacaine|ropivacaine|mesh-list
92995874|NCT03704753|Anesthetics, Local|anesthetics, local|mesh-ancestor
92995875|NCT03704753|Anesthetics|anesthetics|mesh-ancestor
92995876|NCT03704753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995877|NCT03704753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995878|NCT03704753|Sensory System Agents|sensory system agents|mesh-ancestor
92995879|NCT03704753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995880|NCT00690443|Atorvastatin|atorvastatin|mesh-list
92995881|NCT00690443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92995882|NCT00690443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92995883|NCT00690443|Antimetabolites|antimetabolites|mesh-ancestor
92995884|NCT00690443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995885|NCT00690443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92995886|NCT00690443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92995887|NCT00690443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995888|NCT03954834|Tirzepatide|tirzepatide|mesh-list
92995889|NCT03954834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92995890|NCT03954834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995891|NCT03954834|Incretins|incretins|mesh-ancestor
92995892|NCT03954834|Hormones|hormones|mesh-ancestor
92995893|NCT03954834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92995894|NCT00693017|Zonisamide|zonisamide|mesh-list
92995895|NCT00693017|Anticonvulsants|anticonvulsants|mesh-ancestor
92995896|NCT00693017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92995897|NCT00693017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92995898|NCT00693017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995899|NCT00693017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92995900|NCT00693017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995901|NCT05299554|Hydrocortisone|hydrocortisone|mesh-list
92995902|NCT05299554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92995903|NCT00692237|Sildenafil Citrate|sildenafil citrate|mesh-list
92995904|NCT00692237|Vasodilator Agents|vasodilator agents|mesh-ancestor
92995905|NCT00692237|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92995906|NCT00692237|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92995907|NCT00692237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995908|NCT00692237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995909|NCT00692237|Urological Agents|urological agents|mesh-ancestor
92995910|NCT00110149|Rituximab|rituximab|mesh-list
92995911|NCT00110149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92995912|NCT00110149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995913|NCT00110149|Immunologic Factors|immunologic factors|mesh-ancestor
92995914|NCT00110149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995915|NCT00110149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995916|NCT01084057|Vorinostat|vorinostat|mesh-list
92995917|NCT01084057|Epothilone B|epothilone b|mesh-list
92995918|NCT01084057|Epothilones|epothilones|mesh-list
92995919|NCT01084057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995920|NCT01084057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92995921|NCT01084057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995922|NCT01084057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995923|NCT01084057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92995924|NCT01084057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92995925|NCT01084057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92995926|NCT03954444|Phenylephrine|phenylephrine|mesh-list
92995927|NCT03954444|Oxymetazoline|oxymetazoline|mesh-list
92995928|NCT03954444|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92995929|NCT03954444|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92995930|NCT03954444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92995931|NCT03954444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995932|NCT03954444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995933|NCT03954444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641303|NCT00206765|Risperidone|risperidone|mesh-list
92995934|NCT03954444|Sympathomimetics|sympathomimetics|mesh-ancestor
92995935|NCT03954444|Autonomic Agents|autonomic agents|mesh-ancestor
92995936|NCT03954444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995937|NCT03954444|Nasal Decongestants|nasal decongestants|mesh-ancestor
92528354|NCT00000758|Immunologic Factors|immunologic factors|mesh-ancestor
92995939|NCT03954444|Respiratory System Agents|respiratory system agents|mesh-ancestor
92995940|NCT03954444|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92995941|NCT03954444|Mydriatics|mydriatics|mesh-ancestor
92995942|NCT03954444|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92995943|NCT03954444|Protective Agents|protective agents|mesh-ancestor
92995944|NCT03953820|Diazepam|diazepam|mesh-list
92995945|NCT03953820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92995946|NCT03953820|Anticonvulsants|anticonvulsants|mesh-ancestor
92995947|NCT03953820|Antiemetics|antiemetics|mesh-ancestor
92995948|NCT03953820|Autonomic Agents|autonomic agents|mesh-ancestor
92995949|NCT03953820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92995950|NCT03953820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995951|NCT03953820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92995952|NCT03953820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92995953|NCT03953820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995954|NCT03953820|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92995955|NCT03953820|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92995956|NCT03953820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92995957|NCT03953820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92995958|NCT03953820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92995959|NCT03953820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92995960|NCT03953820|Anesthetics, General|anesthetics, general|mesh-ancestor
92995961|NCT03953820|Anesthetics|anesthetics|mesh-ancestor
92995962|NCT03953820|GABA Modulators|gaba modulators|mesh-ancestor
92995963|NCT03953820|GABA Agents|gaba agents|mesh-ancestor
92995964|NCT03953820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995965|NCT03953820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995966|NCT02611037|Gemcitabine|gemcitabine|mesh-list
92995967|NCT02611037|Methotrexate|methotrexate|mesh-list
92995968|NCT02611037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92995969|NCT02611037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92995970|NCT02611037|Antimetabolites|antimetabolites|mesh-ancestor
92995971|NCT02611037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995972|NCT02611037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92995973|NCT02611037|Abortifacient Agents|abortifacient agents|mesh-ancestor
92995974|NCT02611037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92995975|NCT02611037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995976|NCT02611037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92995977|NCT02611037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92995978|NCT02611037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92995979|NCT02611037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92995980|NCT02611037|Immunologic Factors|immunologic factors|mesh-ancestor
92995981|NCT02611037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92995982|NCT02611037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92995983|NCT03678636|Anti-Infective Agents|anti-infective agents|mesh-list
92995984|NCT03678636|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92995985|NCT04492956|Ecopipam|ecopipam|mesh-list
92995986|NCT04492956|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92995987|NCT04492956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92995988|NCT04492956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92995989|NCT04492956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92995990|NCT04492956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92995991|NCT04492956|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92995992|NCT04492956|Dopamine Agents|dopamine agents|mesh-ancestor
92995993|NCT04492956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92995994|NCT04492956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92995995|NCT01084213|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92995996|NCT01084213|Antimalarials|antimalarials|mesh-ancestor
92995997|NCT01084213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92995998|NCT01084213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92995999|NCT01084213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996000|NCT00742937|Vitamin A|vitamin a|mesh-list
92996001|NCT00742937|Vitamins|vitamins|mesh-ancestor
92996002|NCT00742937|Micronutrients|micronutrients|mesh-ancestor
92996003|NCT00742937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996004|NCT00692003|Zonisamide|zonisamide|mesh-list
92996005|NCT00692003|Anticonvulsants|anticonvulsants|mesh-ancestor
92996006|NCT00692003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92996007|NCT00692003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996008|NCT00692003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996009|NCT00692003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92996010|NCT00692003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996011|NCT02564315|Nicotine|nicotine|mesh-list
92996012|NCT02564315|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92996013|NCT02564315|Autonomic Agents|autonomic agents|mesh-ancestor
92996014|NCT02564315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996015|NCT02564315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996016|NCT02564315|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92996017|NCT02564315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92996018|NCT02564315|Cholinergic Agents|cholinergic agents|mesh-ancestor
92996019|NCT02564315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996020|NCT02564315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996021|NCT02564237|Vaccines|vaccines|mesh-list
92996022|NCT02564237|Immunologic Factors|immunologic factors|mesh-ancestor
92996023|NCT02564237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996024|NCT00427648|Lidocaine|lidocaine|mesh-list
92996025|NCT00427648|Anesthetics, Local|anesthetics, local|mesh-ancestor
92996026|NCT00427648|Anesthetics|anesthetics|mesh-ancestor
92996027|NCT00427648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996028|NCT00427648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996029|NCT00427648|Sensory System Agents|sensory system agents|mesh-ancestor
92996030|NCT00427648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996031|NCT00427648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92996032|NCT00427648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92996033|NCT00427648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92996034|NCT00427648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996035|NCT00427648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996036|NCT02153177|Acetaminophen|acetaminophen|mesh-list
92996037|NCT02153177|Ibuprofen|ibuprofen|mesh-list
92996038|NCT02153177|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92996039|NCT02153177|Hydrocodone|hydrocodone|mesh-list
92996040|NCT02153177|Oxycodone|oxycodone|mesh-list
92996041|NCT02153177|Omeprazole|omeprazole|mesh-list
92996042|NCT02153177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92996043|NCT02153177|Analgesics|analgesics|mesh-ancestor
92996044|NCT02153177|Sensory System Agents|sensory system agents|mesh-ancestor
92996045|NCT02153177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996046|NCT02153177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996047|NCT02153177|Antipyretics|antipyretics|mesh-ancestor
92996048|NCT02153177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92996049|NCT02153177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92996050|NCT02153177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996051|NCT02153177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92996052|NCT02153177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996053|NCT02153177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996054|NCT02153177|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92996055|NCT02153177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92996056|NCT02153177|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92996057|NCT02153177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92996058|NCT02153177|Narcotics|narcotics|mesh-ancestor
92996059|NCT02153177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996060|NCT02153177|Antitussive Agents|antitussive agents|mesh-ancestor
92996061|NCT02153177|Respiratory System Agents|respiratory system agents|mesh-ancestor
92996062|NCT00743327|Pioglitazone|pioglitazone|mesh-list
92996063|NCT00743327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92996064|NCT00743327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996065|NCT02564861|DS-1971a|ds-1971a|mesh-list
92996066|NCT02564861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92996067|NCT02564861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92996068|NCT02564861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996069|NCT02564861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996070|NCT00416884|Fludarabine|fludarabine|mesh-list
92996071|NCT00416884|Alemtuzumab|alemtuzumab|mesh-list
92996072|NCT00416884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996073|NCT00416884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996074|NCT03507257|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92996075|NCT03507257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92996076|NCT03507257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996077|NCT00555620|Capecitabine|capecitabine|mesh-list
92996078|NCT00555620|Oxaliplatin|oxaliplatin|mesh-list
92996079|NCT00555620|Sunitinib|sunitinib|mesh-list
92996080|NCT00555620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996081|NCT00555620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92996082|NCT00555620|Antimetabolites|antimetabolites|mesh-ancestor
92996083|NCT00555620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996085|NCT00555620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92996086|NCT00555620|Growth Substances|growth substances|mesh-ancestor
92996087|NCT00555620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996088|NCT00555620|Growth Inhibitors|growth inhibitors|mesh-ancestor
92996089|NCT00555620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996090|NCT00555620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996091|NCT00433966|Paclitaxel|paclitaxel|mesh-list
92996092|NCT00433966|Heparin|heparin|mesh-list
92996093|NCT00433966|Calcium heparin|calcium heparin|mesh-list
92996094|NCT00433966|Bivalirudin|bivalirudin|mesh-list
92996095|NCT00433966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996096|NCT00433966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996097|NCT00433966|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996098|NCT00433966|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996099|NCT00433966|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996100|NCT00433966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996101|NCT00433966|Anticoagulants|anticoagulants|mesh-ancestor
92996102|NCT00433966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92996103|NCT00433966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92996104|NCT00433966|Antithrombins|antithrombins|mesh-ancestor
92996105|NCT00433966|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92996106|NCT00433966|Protease Inhibitors|protease inhibitors|mesh-ancestor
92996107|NCT00433966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996108|NCT03463265|Sirolimus|sirolimus|mesh-list
92996109|NCT03463265|Bevacizumab|bevacizumab|mesh-list
92996110|NCT03463265|Temozolomide|temozolomide|mesh-list
92996111|NCT03463265|Temsirolimus|temsirolimus|mesh-list
92996112|NCT03463265|Lomustine|lomustine|mesh-list
92996113|NCT03463265|MTOR Inhibitors|mtor inhibitors|mesh-list
92996114|NCT03463265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996115|NCT03463265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996116|NCT03463265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92996117|NCT03463265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92996118|NCT03463265|Growth Substances|growth substances|mesh-ancestor
92996119|NCT03463265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996120|NCT03463265|Growth Inhibitors|growth inhibitors|mesh-ancestor
92996121|NCT03463265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92996122|NCT03463265|Alkylating Agents|alkylating agents|mesh-ancestor
92996123|NCT03463265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996124|NCT03463265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996125|NCT03463265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996126|NCT03463265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92996127|NCT03463265|Antifungal Agents|antifungal agents|mesh-ancestor
92996128|NCT03463265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996129|NCT03463265|Immunologic Factors|immunologic factors|mesh-ancestor
92996130|NCT03463265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996131|NCT03463265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996132|NCT00947336|Norfloxacin|norfloxacin|mesh-list
92996133|NCT00947336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996134|NCT00947336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996135|NCT00947336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92996136|NCT00947336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92996137|NCT00947336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996138|NCT00947336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996139|NCT00947336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996140|NCT00947336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92996141|NCT00947336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92996142|NCT00955214|Paclitaxel|paclitaxel|mesh-list
92996143|NCT00955214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996144|NCT00955214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996145|NCT00955214|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996146|NCT00955214|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996147|NCT00955214|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996148|NCT00955214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996149|NCT00956462|Dexamethasone|dexamethasone|mesh-list
92996150|NCT00956462|Ketorolac|ketorolac|mesh-list
92996151|NCT00956462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92996152|NCT00956462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92996153|NCT00956462|Antiemetics|antiemetics|mesh-ancestor
92996154|NCT00956462|Autonomic Agents|autonomic agents|mesh-ancestor
92996155|NCT00956462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996156|NCT00956462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996158|NCT00956462|Glucocorticoids|glucocorticoids|mesh-ancestor
92996159|NCT00956462|Hormones|hormones|mesh-ancestor
92996160|NCT00956462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92996161|NCT00956462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92996162|NCT00956462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996163|NCT00956462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92996164|NCT00956462|Analgesics|analgesics|mesh-ancestor
92996165|NCT00956462|Sensory System Agents|sensory system agents|mesh-ancestor
92996166|NCT00956462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996167|NCT00956462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92996168|NCT00956462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996169|NCT00956462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996170|NCT05300360|Adenosine|adenosine|mesh-list
92996171|NCT05300360|Analgesics|analgesics|mesh-ancestor
92996172|NCT05300360|Sensory System Agents|sensory system agents|mesh-ancestor
92996173|NCT05300360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996174|NCT05300360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996175|NCT05300360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92996176|NCT05300360|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996177|NCT05300360|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92996178|NCT05300360|Purinergic Agonists|purinergic agonists|mesh-ancestor
92996179|NCT05300360|Purinergic Agents|purinergic agents|mesh-ancestor
92996180|NCT05300360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996181|NCT05300360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996182|NCT00956696|Topiramate|topiramate|mesh-list
92996183|NCT00956696|Anticonvulsants|anticonvulsants|mesh-ancestor
92996184|NCT00956696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92996185|NCT00956696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996186|NCT03952650|Chloroquine|chloroquine|mesh-list
92996187|NCT03952650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92996188|NCT03952650|Pyrimethamine|pyrimethamine|mesh-list
92996189|NCT03952650|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92996190|NCT03952650|Ibuprofen|ibuprofen|mesh-list
92996191|NCT03952650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92996192|NCT03952650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92996193|NCT03952650|Analgesics|analgesics|mesh-ancestor
92996194|NCT03952650|Sensory System Agents|sensory system agents|mesh-ancestor
92996195|NCT03952650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996196|NCT03952650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996197|NCT03952650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92996198|NCT03952650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996199|NCT03952650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92996200|NCT03952650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996201|NCT03952650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996202|NCT03952650|Amebicides|amebicides|mesh-ancestor
92996203|NCT03952650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92996204|NCT03952650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92996205|NCT03952650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996206|NCT03952650|Antimalarials|antimalarials|mesh-ancestor
92996207|NCT03952650|Filaricides|filaricides|mesh-ancestor
92996208|NCT03952650|Antinematodal Agents|antinematodal agents|mesh-ancestor
92996209|NCT03952650|Anthelmintics|anthelmintics|mesh-ancestor
92996210|NCT03952650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92996211|NCT00955526|Istradefylline|istradefylline|mesh-list
92996212|NCT00955526|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92996213|NCT00955526|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92996214|NCT00955526|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92996215|NCT00955526|Purinergic Agents|purinergic agents|mesh-ancestor
92996216|NCT00955526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996217|NCT00955526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996218|NCT00955526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996219|NCT00955604|Rasagiline|rasagiline|mesh-list
92996220|NCT00955604|Antidepressive Agents|antidepressive agents|mesh-list
92996221|NCT00955604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92996222|NCT00955604|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92996223|NCT00955604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996224|NCT00955604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996225|NCT00955604|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92996226|NCT00955604|Protective Agents|protective agents|mesh-ancestor
92996227|NCT00955604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996228|NCT03623646|Immunomodulating Agents|immunomodulating agents|mesh-list
92996229|NCT03623646|Immunologic Factors|immunologic factors|mesh-ancestor
92996230|NCT03623646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996231|NCT00962286|Furosemide|furosemide|mesh-list
92996232|NCT00962286|Diuretics|diuretics|mesh-ancestor
92996233|NCT00962286|Natriuretic Agents|natriuretic agents|mesh-ancestor
92996234|NCT00962286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996235|NCT00962286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92996236|NCT00962286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996237|NCT00962286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996238|NCT00691301|Pemetrexed|pemetrexed|mesh-list
92147077|NCT03089671|Micronutrients|micronutrients|mesh-ancestor
92996239|NCT00691301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996240|NCT00691301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996241|NCT00691301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996242|NCT00691301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92996243|NCT00691301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92996244|NCT05277480|Apatinib|apatinib|mesh-list
92996245|NCT05277480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996246|NCT05277480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996247|NCT05277480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996248|NCT05277480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996249|NCT00956072|Imatinib Mesylate|imatinib mesylate|mesh-list
92996250|NCT00956072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996251|NCT00956072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996252|NCT00956072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996253|NCT00956072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996254|NCT02564003|Oxycodone|oxycodone|mesh-list
92996255|NCT02564003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92996256|NCT02564003|Narcotics|narcotics|mesh-ancestor
92996257|NCT02564003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996258|NCT02564003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996259|NCT02564003|Analgesics|analgesics|mesh-ancestor
92996260|NCT02564003|Sensory System Agents|sensory system agents|mesh-ancestor
92996261|NCT02564003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996262|NCT00956150|Rifaximin|rifaximin|mesh-list
92996263|NCT00956150|Lactulose|lactulose|mesh-list
92996264|NCT00956150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996265|NCT00956150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996266|NCT00956150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92996267|NCT00923663|Lenalidomide|lenalidomide|mesh-list
92996268|NCT00923663|Immunologic Factors|immunologic factors|mesh-ancestor
92996269|NCT00923663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996270|NCT00923663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92996271|NCT00923663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92996272|NCT00923663|Growth Substances|growth substances|mesh-ancestor
92996273|NCT00923663|Growth Inhibitors|growth inhibitors|mesh-ancestor
92996274|NCT00923663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996275|NCT03284502|Cetuximab|cetuximab|mesh-list
92996276|NCT03284502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996277|NCT03284502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996278|NCT00743873|Mitogens|mitogens|mesh-list
92996279|NCT00743873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996280|NCT00743873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996281|NCT04011098|Fentanyl|fentanyl|mesh-list
92996282|NCT04011098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92996283|NCT04011098|Narcotics|narcotics|mesh-ancestor
92996284|NCT04011098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996285|NCT04011098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996286|NCT04011098|Analgesics|analgesics|mesh-ancestor
92996287|NCT04011098|Sensory System Agents|sensory system agents|mesh-ancestor
92996288|NCT04011098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996289|NCT04011098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92996290|NCT04011098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92996291|NCT04011098|Anesthetics, General|anesthetics, general|mesh-ancestor
92996292|NCT04011098|Anesthetics|anesthetics|mesh-ancestor
92996293|NCT00927563|Tolcapone|tolcapone|mesh-list
92996294|NCT00927563|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92996295|NCT00927563|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92996296|NCT00927563|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92996297|NCT00927563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996298|NCT00927563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996299|NCT00956306|Udenafil|udenafil|mesh-list
92996300|NCT00956306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92996301|NCT00956306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92996302|NCT00956306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996303|NCT00956306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996304|NCT00775229|Naltrexone|naltrexone|mesh-list
92996305|NCT00775229|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92996306|NCT00775229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92996307|NCT00775229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996308|NCT00775229|Sensory System Agents|sensory system agents|mesh-ancestor
92168199|NCT05686993|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996309|NCT00775229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996310|NCT00962442|Acetylcysteine|acetylcysteine|mesh-list
92996311|NCT00962442|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92996312|NCT00962442|Antiviral Agents|antiviral agents|mesh-ancestor
92996313|NCT00962442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996314|NCT00962442|Expectorants|expectorants|mesh-ancestor
92996315|NCT00962442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92996316|NCT00962442|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92996317|NCT00962442|Antioxidants|antioxidants|mesh-ancestor
92996318|NCT00962442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996319|NCT00962442|Protective Agents|protective agents|mesh-ancestor
92996320|NCT00962442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996321|NCT00962442|Antidotes|antidotes|mesh-ancestor
92996322|NCT00957320|Sirolimus|sirolimus|mesh-list
92996323|NCT00957320|Asparaginase|asparaginase|mesh-list
92996324|NCT00957320|Pegaspargase|pegaspargase|mesh-list
92996325|NCT00957320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996326|NCT00957320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996327|NCT00957320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92996328|NCT00957320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996329|NCT00957320|Antifungal Agents|antifungal agents|mesh-ancestor
92996330|NCT00957320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996331|NCT00957320|Immunologic Factors|immunologic factors|mesh-ancestor
92996332|NCT00957320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996334|NCT00653159|Levonorgestrel|levonorgestrel|mesh-list
92996335|NCT00653159|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92996336|NCT00653159|Contraceptive Agents|contraceptive agents|mesh-ancestor
92996337|NCT00653159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92996338|NCT00653159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996339|NCT00653159|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92996340|NCT00653159|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92996341|NCT00653159|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92996342|NCT00653159|Trace Elements|trace elements|mesh-ancestor
92996343|NCT00653159|Micronutrients|micronutrients|mesh-ancestor
92996344|NCT03047070|Lidocaine|lidocaine|mesh-list
92996345|NCT03047070|Anesthetics, Local|anesthetics, local|mesh-ancestor
92996346|NCT03047070|Anesthetics|anesthetics|mesh-ancestor
92996347|NCT03047070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996348|NCT03047070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996349|NCT03047070|Sensory System Agents|sensory system agents|mesh-ancestor
92996350|NCT03047070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996351|NCT03047070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92996352|NCT03047070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92996353|NCT03047070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92996354|NCT03047070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996355|NCT03047070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996356|NCT00948272|Vaccines|vaccines|mesh-list
92996357|NCT00948272|Immunologic Factors|immunologic factors|mesh-ancestor
92996358|NCT00948272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996359|NCT00957554|Amlodipine|amlodipine|mesh-list
92996360|NCT00957554|Irbesartan|irbesartan|mesh-list
92996361|NCT00957554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92996362|NCT00957554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92996363|NCT00957554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996364|NCT00957554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996365|NCT00957554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92996366|NCT00957554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996367|NCT00957554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996368|NCT00957554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92996369|NCT00957554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92996370|NCT03024684|Atorvastatin|atorvastatin|mesh-list
92996371|NCT03024684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92996372|NCT03024684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92996373|NCT03024684|Antimetabolites|antimetabolites|mesh-ancestor
92996374|NCT03024684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996375|NCT03024684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92996376|NCT03024684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92996377|NCT03024684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996378|NCT00744107|Cobalt|cobalt|mesh-list
92996379|NCT00744107|Trace Elements|trace elements|mesh-ancestor
92996380|NCT00744107|Micronutrients|micronutrients|mesh-ancestor
92996381|NCT00744107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996382|NCT00117637|Interferons|interferons|mesh-list
92996383|NCT00117637|Sorafenib|sorafenib|mesh-list
92996384|NCT00117637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996385|NCT00117637|Antiviral Agents|antiviral agents|mesh-ancestor
92641730|NCT00208520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92996386|NCT00117637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996387|NCT00117637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996388|NCT00117637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996389|NCT00117637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996390|NCT00744185|Propranolol|propranolol|mesh-list
92996391|NCT00744185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92996392|NCT00744185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92996393|NCT00744185|Adrenergic Agents|adrenergic agents|mesh-ancestor
92996394|NCT00744185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996395|NCT00744185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996396|NCT00744185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996397|NCT00744185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92996398|NCT00744185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92996399|NCT00744185|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996400|NCT02897778|Entinostat|entinostat|mesh-list
92996401|NCT02897778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996402|NCT02897778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92996403|NCT02897778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996404|NCT02897778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996405|NCT01084291|Vaccines|vaccines|mesh-list
92996406|NCT01084291|Immunologic Factors|immunologic factors|mesh-ancestor
92996407|NCT01084291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996408|NCT00741767|Fluticasone|fluticasone|mesh-list
92996409|NCT00741767|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92996410|NCT00741767|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92996411|NCT00741767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92996412|NCT00741767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92996413|NCT00741767|Autonomic Agents|autonomic agents|mesh-ancestor
92996414|NCT00741767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996415|NCT00741767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996416|NCT00741767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92996417|NCT00741767|Respiratory System Agents|respiratory system agents|mesh-ancestor
92996418|NCT00741767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92996419|NCT00741767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92996420|NCT00741767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92996421|NCT00741767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92996422|NCT00741767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92996423|NCT00741767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92996424|NCT00741767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996425|NCT00741767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996426|NCT00741767|Glucocorticoids|glucocorticoids|mesh-ancestor
92996427|NCT00741767|Hormones|hormones|mesh-ancestor
92996428|NCT00741767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92996429|NCT00741767|Sympathomimetics|sympathomimetics|mesh-ancestor
92996430|NCT00741845|Metronidazole|metronidazole|mesh-list
92996431|NCT00741845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996432|NCT00741845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996433|NCT00741845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92996434|NCT00741845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92996435|NCT00746447|Mesalamine|mesalamine|mesh-list
92996436|NCT00746447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92996437|NCT00746447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92996438|NCT00746447|Analgesics|analgesics|mesh-ancestor
92996439|NCT00746447|Sensory System Agents|sensory system agents|mesh-ancestor
92996440|NCT00746447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996441|NCT00746447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996442|NCT00746447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92996443|NCT00746447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996444|NCT00744419|Pantoprazole|pantoprazole|mesh-list
92996445|NCT00744419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92996446|NCT00744419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92996447|NCT00744419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92996448|NCT00744419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996449|NCT00744419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996451|NCT00742157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92996452|NCT00742157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996453|NCT00549302|Tadalafil|tadalafil|mesh-list
92996454|NCT00549302|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996455|NCT00549302|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92996456|NCT00549302|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92996457|NCT00549302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996458|NCT00549302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996459|NCT00549302|Urological Agents|urological agents|mesh-ancestor
92996460|NCT04277858|Cisplatin|cisplatin|mesh-list
92996461|NCT04277858|Docetaxel|docetaxel|mesh-list
92996462|NCT04277858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996463|NCT04277858|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996464|NCT04277858|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996465|NCT04277858|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996466|NCT04277858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996468|NCT00957866|Ribavirin|ribavirin|mesh-list
92996469|NCT00957866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996470|NCT00957866|Antiviral Agents|antiviral agents|mesh-ancestor
92996471|NCT00957866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996472|NCT00957866|Antimetabolites|antimetabolites|mesh-ancestor
92996473|NCT00957866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996474|NCT00958022|Carboplatin|carboplatin|mesh-list
92996475|NCT00958022|Etoposide|etoposide|mesh-list
92996476|NCT00958022|Etoposide phosphate|etoposide phosphate|mesh-list
92996477|NCT00958022|Panobinostat|panobinostat|mesh-list
92996478|NCT00958022|Podophyllotoxin|podophyllotoxin|mesh-list
92996479|NCT00958022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996480|NCT00958022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996481|NCT00958022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92996482|NCT00958022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92996483|NCT00958022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996484|NCT00958022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996485|NCT00958022|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92996486|NCT00958022|Keratolytic Agents|keratolytic agents|mesh-ancestor
92996487|NCT00958022|Dermatologic Agents|dermatologic agents|mesh-ancestor
92996488|NCT00958022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996489|NCT00958022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996490|NCT00958022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996491|NCT00958100|Tenofovir|tenofovir|mesh-list
92996492|NCT00958100|Lamivudine|lamivudine|mesh-list
92996493|NCT00958100|Emtricitabine|emtricitabine|mesh-list
92996494|NCT00958100|Raltegravir Potassium|raltegravir potassium|mesh-list
92996495|NCT00958100|Abacavir|abacavir|mesh-list
92996496|NCT00958100|Dideoxynucleosides|dideoxynucleosides|mesh-list
92996497|NCT00958100|Antiviral Agents|antiviral agents|mesh-ancestor
92996498|NCT00958100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996499|NCT00958100|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92996500|NCT00958100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92996501|NCT00958100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996502|NCT00958100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996503|NCT00958100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92996504|NCT00958100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92996505|NCT00958100|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92996506|NCT00958100|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92996507|NCT00958100|Antimetabolites|antimetabolites|mesh-ancestor
92996508|NCT00948584|Insulin|insulin|mesh-list
92996509|NCT00948584|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92996510|NCT00948584|Insulin Glargine|insulin glargine|mesh-list
92996511|NCT00948584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92996512|NCT00948584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996513|NCT00948662|Ketoconazole|ketoconazole|mesh-list
92996514|NCT00948662|Antifungal Agents|antifungal agents|mesh-ancestor
92996515|NCT00948662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996516|NCT00948662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92996517|NCT00948662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92996518|NCT00948662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996519|NCT00948662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996520|NCT00948662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92996521|NCT00948662|Hormone Antagonists|hormone antagonists|mesh-ancestor
92996522|NCT00948662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92996523|NCT00948662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996524|NCT00948662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92996526|NCT00948740|Ergocalciferols|ergocalciferols|mesh-list
92996527|NCT00948740|Vitamins|vitamins|mesh-ancestor
92996528|NCT00948740|Micronutrients|micronutrients|mesh-ancestor
92996529|NCT00948740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996530|NCT00948740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92996531|NCT00948740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92996532|NCT00108433|Vancomycin|vancomycin|mesh-list
92996533|NCT00108433|Cefazolin|cefazolin|mesh-list
92996534|NCT00108433|Linezolid|linezolid|mesh-list
92641887|NCT00209222|Antiemetics|antiemetics|mesh-ancestor
92996535|NCT00108433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996536|NCT00108433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996537|NCT00108433|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92996538|NCT00108433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996539|NCT00108433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996540|NCT01084369|Methyltestosterone|methyltestosterone|mesh-list
92996541|NCT01084369|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92996542|NCT01084369|Testosterone|testosterone|mesh-list
92996543|NCT01084369|Testosterone undecanoate|testosterone undecanoate|mesh-list
92996544|NCT01084369|Testosterone enanthate|testosterone enanthate|mesh-list
92996545|NCT01084369|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92996546|NCT01084369|Androgens|androgens|mesh-ancestor
92996547|NCT01084369|Hormones|hormones|mesh-ancestor
92996548|NCT01084369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92996549|NCT01084369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996550|NCT01084369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92996551|NCT01084369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996552|NCT01084369|Anabolic Agents|anabolic agents|mesh-ancestor
92996553|NCT01084369|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996554|NCT01084369|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92996555|NCT01084369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92996556|NCT01084369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996557|NCT01084369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996558|NCT01084369|Urological Agents|urological agents|mesh-ancestor
92996559|NCT00949130|Linezolid|linezolid|mesh-list
92996560|NCT00949130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996561|NCT00949130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996562|NCT00949130|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92996563|NCT00949130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996564|NCT00949130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996565|NCT02815592|Carboplatin|carboplatin|mesh-list
92996566|NCT02815592|Etoposide|etoposide|mesh-list
92996567|NCT02815592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996568|NCT02815592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996569|NCT02815592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92996570|NCT02815592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92996571|NCT02815592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996572|NCT02815592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996573|NCT04010318|Anesthetics|anesthetics|mesh-list
92996574|NCT04010318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996575|NCT04010318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996576|NCT00108355|Octreotide|octreotide|mesh-list
92996577|NCT00108355|Midodrine|midodrine|mesh-list
92996578|NCT00108355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92996579|NCT00108355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92996580|NCT00108355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996581|NCT00108355|Sympathomimetics|sympathomimetics|mesh-ancestor
92996582|NCT00108355|Autonomic Agents|autonomic agents|mesh-ancestor
92996583|NCT00108355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996584|NCT00108355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996585|NCT00108355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92996586|NCT00108355|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92996587|NCT00108355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92996588|NCT00108355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92996589|NCT00108355|Adrenergic Agents|adrenergic agents|mesh-ancestor
92996590|NCT00108355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996591|NCT00108355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996592|NCT00963222|Vitamin A|vitamin a|mesh-list
92996593|NCT00963222|Vitamins|vitamins|mesh-ancestor
92996594|NCT00963222|Micronutrients|micronutrients|mesh-ancestor
92996595|NCT00963222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996596|NCT02703584|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92996597|NCT02703584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92996598|NCT02703584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996599|NCT00968682|Trastuzumab|trastuzumab|mesh-list
92996600|NCT00968682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996601|NCT00968682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996602|NCT00968760|Cytarabine|cytarabine|mesh-list
92996603|NCT00968760|Etoposide|etoposide|mesh-list
92996604|NCT00968760|Melphalan|melphalan|mesh-list
92996605|NCT00968760|Interleukin-2|interleukin-2|mesh-list
92996606|NCT00968760|Carmustine|carmustine|mesh-list
92996607|NCT00968760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996608|NCT00968760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996609|NCT00968760|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92996610|NCT00968760|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92996611|NCT00968760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996612|NCT00968760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996613|NCT00968760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92996614|NCT00968760|Antimetabolites|antimetabolites|mesh-ancestor
92996615|NCT00968760|Antiviral Agents|antiviral agents|mesh-ancestor
92996616|NCT00968760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996617|NCT00968760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996618|NCT00968760|Immunologic Factors|immunologic factors|mesh-ancestor
92996619|NCT00968760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996620|NCT00968760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92996621|NCT00968760|Alkylating Agents|alkylating agents|mesh-ancestor
92996622|NCT00968760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92996623|NCT00968760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92996624|NCT00968760|Analgesics|analgesics|mesh-ancestor
92996625|NCT00968760|Sensory System Agents|sensory system agents|mesh-ancestor
92996626|NCT00968760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996627|NCT02465138|Ketorolac|ketorolac|mesh-list
92996628|NCT02465138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92996629|NCT02465138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92996630|NCT02465138|Analgesics|analgesics|mesh-ancestor
92996631|NCT02465138|Sensory System Agents|sensory system agents|mesh-ancestor
92996632|NCT02465138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996633|NCT02465138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996634|NCT02465138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92996635|NCT02465138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996636|NCT02465138|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92996637|NCT02465138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996638|NCT02465138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996639|NCT00968994|Petrolatum|petrolatum|mesh-list
92996640|NCT00968994|Emollients|emollients|mesh-ancestor
92996641|NCT00968994|Dermatologic Agents|dermatologic agents|mesh-ancestor
92996642|NCT00969072|Dutasteride|dutasteride|mesh-list
92996643|NCT00969072|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92996644|NCT00969072|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92996645|NCT00969072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996646|NCT00969072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996647|NCT00969072|Hormone Antagonists|hormone antagonists|mesh-ancestor
92996648|NCT00969072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92996649|NCT00969072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996650|NCT00094861|Paclitaxel|paclitaxel|mesh-list
92996651|NCT00094861|Carboplatin|carboplatin|mesh-list
92996652|NCT00094861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996653|NCT00094861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996654|NCT00094861|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996655|NCT00094861|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996656|NCT00094861|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996657|NCT00094861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996658|NCT00963534|Rituximab|rituximab|mesh-list
92996659|NCT00963534|Lenalidomide|lenalidomide|mesh-list
92996660|NCT00963534|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92996661|NCT00963534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996662|NCT00963534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996663|NCT00963534|Immunologic Factors|immunologic factors|mesh-ancestor
92996664|NCT00963534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996665|NCT00963534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996666|NCT00963534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92996667|NCT00963534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92996668|NCT00963534|Growth Substances|growth substances|mesh-ancestor
92996669|NCT00963534|Growth Inhibitors|growth inhibitors|mesh-ancestor
92996670|NCT00963534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92996671|NCT00963534|Alkylating Agents|alkylating agents|mesh-ancestor
92996672|NCT00963534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996673|NCT00963690|Hemostatics|hemostatics|mesh-list
92996674|NCT00963690|Coagulants|coagulants|mesh-ancestor
92996676|NCT01079767|Temsirolimus|temsirolimus|mesh-list
92996677|NCT01079767|MTOR Inhibitors|mtor inhibitors|mesh-list
92996678|NCT01079767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996679|NCT01079767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996680|NCT01079767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996681|NCT01079767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996682|NCT01079767|Immunologic Factors|immunologic factors|mesh-ancestor
92996683|NCT01079767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996684|NCT01079767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996685|NCT01079767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996686|NCT01079767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996687|NCT01079767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92996688|NCT01079767|Antifungal Agents|antifungal agents|mesh-ancestor
92996689|NCT00969306|Chloroquine|chloroquine|mesh-list
92996690|NCT00969306|Amebicides|amebicides|mesh-ancestor
92996691|NCT00969306|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92996692|NCT00969306|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92996693|NCT00969306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996694|NCT00969306|Antimalarials|antimalarials|mesh-ancestor
92996695|NCT00969306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996696|NCT00963768|Canagliflozin|canagliflozin|mesh-list
92996697|NCT00963768|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92996698|NCT00963768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996699|NCT00963768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92996700|NCT00963768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996701|NCT00969462|Doxorubicin|doxorubicin|mesh-list
92996702|NCT00969462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92996703|NCT00969462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996704|NCT00969462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92996705|NCT00969462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92996706|NCT00969462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996707|NCT00969462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996708|NCT00963846|Huperzine A|huperzine a|mesh-list
92996709|NCT00963846|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92996710|NCT00963846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996711|NCT00963846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996712|NCT00963846|Cholinergic Agents|cholinergic agents|mesh-ancestor
92996713|NCT00963846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996714|NCT00963846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996715|NCT00963846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92996716|NCT00963846|Protective Agents|protective agents|mesh-ancestor
92996717|NCT00969696|Galantamine|galantamine|mesh-list
92996718|NCT00969696|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92996719|NCT00969696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996720|NCT00969696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996721|NCT00969696|Cholinergic Agents|cholinergic agents|mesh-ancestor
92996722|NCT00969696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996723|NCT00969696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996724|NCT00969696|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92996725|NCT00969696|Autonomic Agents|autonomic agents|mesh-ancestor
92996726|NCT00969696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996727|NCT00969696|Nootropic Agents|nootropic agents|mesh-ancestor
92996728|NCT00958854|Thalidomide|thalidomide|mesh-list
92996729|NCT00958854|Cyclophosphamide|cyclophosphamide|mesh-list
92996730|NCT00958854|Fludarabine|fludarabine|mesh-list
92996731|NCT00958854|Fludarabine phosphate|fludarabine phosphate|mesh-list
92996732|NCT00958854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996733|NCT00958854|Immunologic Factors|immunologic factors|mesh-ancestor
92996734|NCT00958854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996735|NCT00958854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92996736|NCT00958854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92996737|NCT00958854|Alkylating Agents|alkylating agents|mesh-ancestor
92996738|NCT00958854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996739|NCT00958854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996740|NCT00958854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92996741|NCT00958854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92996742|NCT00958854|Antimetabolites|antimetabolites|mesh-ancestor
92996743|NCT00958854|Leprostatic Agents|leprostatic agents|mesh-ancestor
92996744|NCT00958854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996745|NCT00958854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996746|NCT00958854|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92996747|NCT00958854|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92996748|NCT00958854|Growth Substances|growth substances|mesh-ancestor
92996750|NCT00964080|Leucovorin|leucovorin|mesh-list
92996751|NCT00964080|Fluorouracil|fluorouracil|mesh-list
92996752|NCT00964080|Oxaliplatin|oxaliplatin|mesh-list
92996753|NCT00964080|Antimetabolites|antimetabolites|mesh-ancestor
92996754|NCT00964080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996755|NCT00964080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92996756|NCT00964080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996757|NCT00964080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996758|NCT00964080|Immunologic Factors|immunologic factors|mesh-ancestor
92996759|NCT00964080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996760|NCT00964080|Antidotes|antidotes|mesh-ancestor
92996761|NCT00964080|Protective Agents|protective agents|mesh-ancestor
92996762|NCT00964080|Vitamin B Complex|vitamin b complex|mesh-ancestor
92996763|NCT00964080|Vitamins|vitamins|mesh-ancestor
92996764|NCT00964080|Micronutrients|micronutrients|mesh-ancestor
92996765|NCT00969852|Sertraline|sertraline|mesh-list
92996766|NCT00969852|Antidepressive Agents|antidepressive agents|mesh-ancestor
92996767|NCT00969852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92996768|NCT00969852|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92996769|NCT00969852|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92996770|NCT00969852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996771|NCT00969852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996772|NCT00969852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996773|NCT00969852|Serotonin Agents|serotonin agents|mesh-ancestor
92996774|NCT00969852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996775|NCT00426556|Paclitaxel|paclitaxel|mesh-list
92996776|NCT00426556|Trastuzumab|trastuzumab|mesh-list
92996777|NCT00426556|Everolimus|everolimus|mesh-list
92996778|NCT00426556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996779|NCT00426556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996780|NCT00426556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996781|NCT00426556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996782|NCT00426556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996783|NCT00426556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996784|NCT00426556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996785|NCT00426556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92996786|NCT00426556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996787|NCT00426556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996788|NCT00426556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996789|NCT00426556|Immunologic Factors|immunologic factors|mesh-ancestor
92996790|NCT00426556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996791|NCT00107653|Ribavirin|ribavirin|mesh-list
92996792|NCT00107653|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92996793|NCT00107653|Interferon-alpha|interferon-alpha|mesh-list
92996794|NCT00107653|Antimetabolites|antimetabolites|mesh-ancestor
92996795|NCT00107653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996796|NCT00107653|Antiviral Agents|antiviral agents|mesh-ancestor
92996797|NCT00107653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996798|NCT00107653|Immunologic Factors|immunologic factors|mesh-ancestor
92996799|NCT00107653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996800|NCT03950856|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92996801|NCT03950856|Immunologic Factors|immunologic factors|mesh-ancestor
92996802|NCT03950856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996803|NCT00970008|CD59 Antigens|cd59 antigens|mesh-list
92996804|NCT00970008|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92996805|NCT00970008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92996806|NCT00970008|Immunologic Factors|immunologic factors|mesh-ancestor
92996807|NCT00970008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996808|NCT00970086|Bupivacaine|bupivacaine|mesh-list
92996809|NCT00970086|Levobupivacaine|levobupivacaine|mesh-list
92996810|NCT00970086|Anesthetics, Local|anesthetics, local|mesh-ancestor
92996811|NCT00970086|Anesthetics|anesthetics|mesh-ancestor
92996812|NCT00970086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996813|NCT00970086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996814|NCT00970086|Sensory System Agents|sensory system agents|mesh-ancestor
92996815|NCT00970086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996816|NCT00689351|Vaccines|vaccines|mesh-list
92996817|NCT00689351|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92996818|NCT00689351|Immunologic Factors|immunologic factors|mesh-ancestor
92996819|NCT00689351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996820|NCT03950622|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92996821|NCT03950622|Immunologic Factors|immunologic factors|mesh-ancestor
92996822|NCT03950622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996823|NCT02563847|Erythritol|erythritol|mesh-list
92996825|NCT02563847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92996826|NCT02563847|Antidepressive Agents|antidepressive agents|mesh-ancestor
92996827|NCT02563847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92996828|NCT02563847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92996829|NCT00746681|Pregabalin|pregabalin|mesh-list
92996830|NCT00746681|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92996831|NCT00746681|Analgesics|analgesics|mesh-ancestor
92996832|NCT00746681|Sensory System Agents|sensory system agents|mesh-ancestor
92996833|NCT00746681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996834|NCT00746681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996835|NCT00746681|Anticonvulsants|anticonvulsants|mesh-ancestor
92996836|NCT00746681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92996837|NCT00746681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996838|NCT00746681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996840|NCT00746681|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92996841|NCT00746681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92996842|NCT00746681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996843|NCT00746681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92996844|NCT00746681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92996845|NCT00746681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92996846|NCT00746681|Cholinergic Agents|cholinergic agents|mesh-ancestor
92996847|NCT00746681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996848|NCT00746681|Urological Agents|urological agents|mesh-ancestor
92996849|NCT00746837|N-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|n-(1-(3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-n-ethyl-2-(4-methanesulfonylphenyl)acetamide|mesh-list
92996850|NCT00746837|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92996851|NCT00746837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996852|NCT00746837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92996853|NCT00746837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92996854|NCT00746837|Antiviral Agents|antiviral agents|mesh-ancestor
92996855|NCT00746837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996856|NCT00749099|Pancrelipase|pancrelipase|mesh-list
92996857|NCT00749099|Pancreatin|pancreatin|mesh-list
92996858|NCT00749099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92996859|NCT00959400|Fentanyl|fentanyl|mesh-list
92996860|NCT00959400|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92996861|NCT00959400|Narcotics|narcotics|mesh-ancestor
92996862|NCT00959400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996863|NCT00959400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996864|NCT00959400|Analgesics|analgesics|mesh-ancestor
92996865|NCT00959400|Sensory System Agents|sensory system agents|mesh-ancestor
92996866|NCT00959400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996867|NCT00959400|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92996868|NCT00959400|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92996869|NCT00959400|Anesthetics, General|anesthetics, general|mesh-ancestor
92996870|NCT00959400|Anesthetics|anesthetics|mesh-ancestor
92996871|NCT02563769|Clavulanic Acids|clavulanic acids|mesh-list
92996872|NCT02563769|Clavulanic Acid|clavulanic acid|mesh-list
92996873|NCT02563769|Cocaine|cocaine|mesh-list
92996874|NCT02563769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92996875|NCT02563769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996876|NCT02563769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996877|NCT02563769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996878|NCT02563769|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92996879|NCT02563769|Anesthetics, Local|anesthetics, local|mesh-ancestor
92996880|NCT02563769|Anesthetics|anesthetics|mesh-ancestor
92996881|NCT02563769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996882|NCT02563769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996883|NCT02563769|Sensory System Agents|sensory system agents|mesh-ancestor
92996884|NCT02563769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996885|NCT02563769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92996886|NCT02563769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92996887|NCT02563769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92996888|NCT02563769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996889|NCT02563769|Dopamine Agents|dopamine agents|mesh-ancestor
92996890|NCT02563769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996891|NCT00959478|Carbon Monoxide|carbon monoxide|mesh-list
92996892|NCT00959478|Antimetabolites|antimetabolites|mesh-ancestor
92996893|NCT00959478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996894|NCT00959478|Gasotransmitters|gasotransmitters|mesh-ancestor
92996895|NCT00959478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996896|NCT00959478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996897|NCT00964626|Paclitaxel|paclitaxel|mesh-list
92996898|NCT00964626|Cisplatin|cisplatin|mesh-list
92996899|NCT00964626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996900|NCT00964626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996901|NCT00964626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996902|NCT00964626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996903|NCT00964626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996904|NCT00964626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996905|NCT02562287|Olanzapine|olanzapine|mesh-list
92996906|NCT02562287|Risperidone|risperidone|mesh-list
92996907|NCT02562287|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92996908|NCT02562287|Clozapine|clozapine|mesh-list
92996909|NCT02562287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92996910|NCT02562287|Serotonin Agents|serotonin agents|mesh-ancestor
92996911|NCT02562287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642258|NCT00209885|Analgesics|analgesics|mesh-ancestor
92996912|NCT02562287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996913|NCT02562287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996915|NCT02562287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92996916|NCT02562287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92996917|NCT02562287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92996918|NCT02562287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92996919|NCT02562287|Dopamine Agents|dopamine agents|mesh-ancestor
92996920|NCT02562287|Antiemetics|antiemetics|mesh-ancestor
92996921|NCT02562287|Autonomic Agents|autonomic agents|mesh-ancestor
92996922|NCT02562287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92996923|NCT02562287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92996924|NCT02562287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92996925|NCT02562287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92996926|NCT02562287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996927|NCT02562287|Antidepressive Agents|antidepressive agents|mesh-ancestor
92996928|NCT02562287|GABA Antagonists|gaba antagonists|mesh-ancestor
92996929|NCT02562287|GABA Agents|gaba agents|mesh-ancestor
92996930|NCT02562053|Fluoxetine|fluoxetine|mesh-list
92996931|NCT02562053|Contraceptive Agents|contraceptive agents|mesh-list
92996932|NCT02562053|Contraceptives, Oral|contraceptives, oral|mesh-list
92996933|NCT02562053|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92996934|NCT02562053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92996935|NCT02562053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92996936|NCT02562053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92996937|NCT02562053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996938|NCT02562053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92996939|NCT02562053|Serotonin Agents|serotonin agents|mesh-ancestor
92996940|NCT02562053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996941|NCT02562053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92996942|NCT02562053|Antidepressive Agents|antidepressive agents|mesh-ancestor
92996943|NCT02562053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92996944|NCT02562053|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92996945|NCT02562053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92996946|NCT02562053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996947|NCT02562053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92996948|NCT02562053|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92996949|NCT00746993|Contraceptive Agents|contraceptive agents|mesh-list
92996950|NCT00746993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92996951|NCT00746993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92996952|NCT04060043|Goserelin|goserelin|mesh-list
92996953|NCT04060043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92996954|NCT04060043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996955|NCT00553358|Paclitaxel|paclitaxel|mesh-list
92996956|NCT00553358|Trastuzumab|trastuzumab|mesh-list
92996957|NCT00553358|Lapatinib|lapatinib|mesh-list
92996958|NCT00553358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92996959|NCT00553358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996960|NCT00553358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92996961|NCT00553358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92996962|NCT00553358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92996963|NCT00553358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996964|NCT00553358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92996965|NCT00553358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92996966|NCT00553358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996967|NCT00744809|Moxifloxacin|moxifloxacin|mesh-list
92996968|NCT00744809|Efavirenz|efavirenz|mesh-list
92996969|NCT00744809|Rilpivirine|rilpivirine|mesh-list
92996970|NCT00744809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528371|NCT02971306|Protective Agents|protective agents|mesh-ancestor
92996971|NCT00744809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996972|NCT00744809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92996973|NCT00744809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92996974|NCT00744809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996975|NCT00744809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996976|NCT00744809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92996977|NCT00744809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92996978|NCT00744809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92996979|NCT00744809|Antiviral Agents|antiviral agents|mesh-ancestor
92996980|NCT00744809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92996981|NCT00744809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92996982|NCT00744809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92996983|NCT00744809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92996984|NCT00744809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92996985|NCT00744809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92996986|NCT00744809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92996987|NCT00744809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92996989|NCT00744887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92996990|NCT00744887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92996991|NCT00744887|Protease Inhibitors|protease inhibitors|mesh-ancestor
92996992|NCT00744887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92996993|NCT00744887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92996994|NCT00744887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92996995|NCT00744887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92996996|NCT00744887|Antiviral Agents|antiviral agents|mesh-ancestor
92996997|NCT00744887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92996998|NCT02286830|Zoledronic Acid|zoledronic acid|mesh-list
92996999|NCT02286830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92997000|NCT02286830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997001|NCT00749567|Bevacizumab|bevacizumab|mesh-list
92997002|NCT00749567|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92997003|NCT00749567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997004|NCT00749567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997005|NCT00749567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997006|NCT00749567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997007|NCT00749567|Growth Substances|growth substances|mesh-ancestor
92997008|NCT00749567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997009|NCT00749567|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997010|NCT00749567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997011|NCT00749567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997012|NCT00749567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997013|NCT04010942|Metformin|metformin|mesh-list
92997014|NCT04010942|Clomiphene|clomiphene|mesh-list
92997015|NCT04010942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997016|NCT04010942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997017|NCT04010942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92997018|NCT04010942|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997019|NCT04010942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997020|NCT04010942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92997021|NCT04010942|Fertility Agents|fertility agents|mesh-ancestor
92997022|NCT04010942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92168232|NCT05579730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92997023|NCT04010942|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92997024|NCT04010942|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92997025|NCT00949364|Pomalidomide|pomalidomide|mesh-list
92997026|NCT00949364|Immunologic Factors|immunologic factors|mesh-ancestor
92997027|NCT00949364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997028|NCT00949364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997029|NCT00949364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997030|NCT00949364|Growth Substances|growth substances|mesh-ancestor
92997031|NCT00949364|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997032|NCT00949364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997033|NCT00689117|Clindamycin|clindamycin|mesh-list
92997034|NCT00689117|Clindamycin palmitate|clindamycin palmitate|mesh-list
92997035|NCT00689117|Clindamycin phosphate|clindamycin phosphate|mesh-list
92997036|NCT00689117|Tretinoin|tretinoin|mesh-list
92997037|NCT00689117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997038|NCT00689117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997039|NCT00689117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92997040|NCT00689117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997041|NCT00689117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997042|NCT00689117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342522|NCT00004043|Vitamins|vitamins|mesh-ancestor
92997043|NCT00689117|Keratolytic Agents|keratolytic agents|mesh-ancestor
92997044|NCT00689117|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997045|NCT00949442|Insulin|insulin|mesh-list
92997046|NCT00949442|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92997047|NCT00949442|Insulin Glargine|insulin glargine|mesh-list
92997048|NCT00949442|Glimepiride|glimepiride|mesh-list
92997049|NCT00949442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997050|NCT00949442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997051|NCT00949442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92997052|NCT00949442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997053|NCT00949442|Immunologic Factors|immunologic factors|mesh-ancestor
92997054|NCT00749723|Carboplatin|carboplatin|mesh-list
92997055|NCT00749723|Etoposide|etoposide|mesh-list
92997056|NCT00749723|Etoposide phosphate|etoposide phosphate|mesh-list
92997057|NCT00749723|Temozolomide|temozolomide|mesh-list
92997058|NCT00749723|Thiotepa|thiotepa|mesh-list
92997059|NCT00749723|Trofosfamide|trofosfamide|mesh-list
92997060|NCT00749723|Cyclophosphamide|cyclophosphamide|mesh-list
92997061|NCT00749723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997062|NCT00749723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92997063|NCT00749723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92997064|NCT00749723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92997065|NCT00749723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997066|NCT00749723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997067|NCT00749723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92997068|NCT00749723|Alkylating Agents|alkylating agents|mesh-ancestor
92997069|NCT00749723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92997070|NCT00749723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997071|NCT00749723|Immunologic Factors|immunologic factors|mesh-ancestor
92997072|NCT00749723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997073|NCT00749723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997074|NCT00547248|Vaccines|vaccines|mesh-list
92997075|NCT00547248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92997076|NCT00547248|Immunologic Factors|immunologic factors|mesh-ancestor
92997077|NCT00547248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997078|NCT00688103|Etanercept|etanercept|mesh-list
92997079|NCT00688103|Methotrexate|methotrexate|mesh-list
92997080|NCT00688103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92997081|NCT00688103|Abortifacient Agents|abortifacient agents|mesh-ancestor
92997082|NCT00688103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92997083|NCT00688103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997084|NCT00688103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92997085|NCT00688103|Antimetabolites|antimetabolites|mesh-ancestor
92997086|NCT00688103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997087|NCT00688103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997088|NCT00688103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997089|NCT00688103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997090|NCT00688103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92997091|NCT00688103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997092|NCT00688103|Immunologic Factors|immunologic factors|mesh-ancestor
92997093|NCT00688103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997094|NCT00688103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92997095|NCT00688103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92997096|NCT00688103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92997097|NCT00688103|Analgesics|analgesics|mesh-ancestor
92997098|NCT00688103|Sensory System Agents|sensory system agents|mesh-ancestor
92997099|NCT00688103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997100|NCT00688103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997101|NCT00688103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997102|NCT00949598|Tamoxifen|tamoxifen|mesh-list
92997103|NCT00949598|Letrozole|letrozole|mesh-list
92997104|NCT00949598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997105|NCT00949598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997106|NCT00949598|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92997107|NCT00949598|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92997108|NCT00949598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997109|NCT00949598|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92997110|NCT00949598|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997111|NCT00949598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997112|NCT00949598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997113|NCT00949598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997114|NCT00949598|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92997115|NCT00949598|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92997116|NCT00949598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92997117|NCT00964704|Bevacizumab|bevacizumab|mesh-list
92997118|NCT00964704|Trastuzumab|trastuzumab|mesh-list
92997120|NCT00964704|Capecitabine|capecitabine|mesh-list
92997121|NCT00964704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997122|NCT00964704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997123|NCT00964704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997124|NCT00964704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997125|NCT00964704|Growth Substances|growth substances|mesh-ancestor
92997126|NCT00964704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997127|NCT00964704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997128|NCT00964704|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997129|NCT00964704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997130|NCT00964704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997131|NCT00964704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997132|NCT00964704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642486|NCT00210587|Epoetin Alfa|epoetin alfa|mesh-list
92997133|NCT00964704|Antimetabolites|antimetabolites|mesh-ancestor
92997134|NCT00686855|Dexamethasone|dexamethasone|mesh-list
92997135|NCT00686855|Tacrolimus|tacrolimus|mesh-list
92997136|NCT00686855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997137|NCT00686855|Antiemetics|antiemetics|mesh-ancestor
92997138|NCT00686855|Autonomic Agents|autonomic agents|mesh-ancestor
92997139|NCT00686855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997140|NCT00686855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997141|NCT00686855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997142|NCT00686855|Glucocorticoids|glucocorticoids|mesh-ancestor
92997143|NCT00686855|Hormones|hormones|mesh-ancestor
92997144|NCT00686855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997145|NCT00686855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997146|NCT00686855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997147|NCT00686855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997148|NCT00686855|Immunologic Factors|immunologic factors|mesh-ancestor
92997149|NCT00686855|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92997150|NCT00686855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997151|NCT00686855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997152|NCT00745043|Bronchodilator Agents|bronchodilator agents|mesh-list
92997153|NCT00745043|Autonomic Agents|autonomic agents|mesh-ancestor
92997154|NCT00745043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997155|NCT00745043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997156|NCT00745043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92997157|NCT00745043|Respiratory System Agents|respiratory system agents|mesh-ancestor
92997158|NCT00949832|Calcium, Dietary|calcium, dietary|mesh-list
92997159|NCT00949832|Vitamin D|vitamin d|mesh-list
92997160|NCT00949832|Ergocalciferols|ergocalciferols|mesh-list
92997161|NCT00949832|Cholecalciferol|cholecalciferol|mesh-list
92997162|NCT00949832|Vitamins|vitamins|mesh-list
92997163|NCT00949832|Calcium|calcium|mesh-list
92997164|NCT00949832|Micronutrients|micronutrients|mesh-ancestor
92997165|NCT00949832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997166|NCT00949832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92997167|NCT00949832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92997168|NCT00745199|Cromolyn Sodium|cromolyn sodium|mesh-list
92997169|NCT00745199|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92997170|NCT00745199|Immunologic Factors|immunologic factors|mesh-ancestor
92997171|NCT00745199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997172|NCT00745199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92997173|NCT00745199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997174|NCT00745199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92997175|NCT00745199|Respiratory System Agents|respiratory system agents|mesh-ancestor
92997176|NCT00961844|Temozolomide|temozolomide|mesh-list
92997177|NCT00961844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92997178|NCT00961844|Alkylating Agents|alkylating agents|mesh-ancestor
92997179|NCT00961844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997180|NCT00961844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997181|NCT00686777|Interferons|interferons|mesh-list
92997182|NCT00686777|Ribavirin|ribavirin|mesh-list
92997183|NCT00686777|Interferon-alpha|interferon-alpha|mesh-list
92997184|NCT00686777|Interferon alpha-2|interferon alpha-2|mesh-list
92997185|NCT00686777|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92997186|NCT00686777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997187|NCT00686777|Antiviral Agents|antiviral agents|mesh-ancestor
92997188|NCT00686777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997189|NCT00686777|Antimetabolites|antimetabolites|mesh-ancestor
92997190|NCT00686777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997191|NCT00686777|Immunologic Factors|immunologic factors|mesh-ancestor
92997192|NCT00686777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997193|NCT04009772|Metronidazole|metronidazole|mesh-list
92997194|NCT04009772|Cefuroxime|cefuroxime|mesh-list
92997195|NCT04009772|Cefuroxime axetil|cefuroxime axetil|mesh-list
92997196|NCT04009772|Cefepime|cefepime|mesh-list
92997197|NCT04009772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997198|NCT04009772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997199|NCT04009772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92997200|NCT04009772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92997201|NCT00959582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92997202|NCT00959582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92997203|NCT00959582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997204|NCT00962156|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92997205|NCT00962156|Plasma Substitutes|plasma substitutes|mesh-ancestor
92997206|NCT00962156|Blood Substitutes|blood substitutes|mesh-ancestor
92997207|NCT01563068|Calcipotriene|calcipotriene|mesh-list
92997208|NCT01563068|Dermatologic Agents|dermatologic agents|mesh-ancestor
92642559|NCT04569916|Irinotecan|irinotecan|mesh-list
92997209|NCT00747305|Sunitinib|sunitinib|mesh-list
92997211|NCT00747305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997212|NCT00747305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997213|NCT00747305|Growth Substances|growth substances|mesh-ancestor
92997214|NCT00747305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997215|NCT00747305|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997216|NCT00747305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997217|NCT00747305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997218|NCT00747305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997219|NCT05254106|Paclitaxel|paclitaxel|mesh-list
92997220|NCT05254106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92997221|NCT05254106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997222|NCT05254106|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997223|NCT05254106|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997224|NCT05254106|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997225|NCT05254106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997226|NCT00747383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92997227|NCT00747383|Glimepiride|glimepiride|mesh-list
92997228|NCT00747383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997229|NCT00747383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997230|NCT00747383|Incretins|incretins|mesh-ancestor
92997231|NCT00747383|Hormones|hormones|mesh-ancestor
92997232|NCT00747383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997233|NCT00747383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92997234|NCT00747383|Protease Inhibitors|protease inhibitors|mesh-ancestor
92997235|NCT00747383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997236|NCT00747383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997237|NCT00747383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92997238|NCT00747383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997239|NCT00747383|Immunologic Factors|immunologic factors|mesh-ancestor
92997240|NCT00106639|Tacrolimus|tacrolimus|mesh-list
92997241|NCT00106639|Tofacitinib|tofacitinib|mesh-list
92997242|NCT00106639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997243|NCT00106639|Immunologic Factors|immunologic factors|mesh-ancestor
92997244|NCT00106639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997245|NCT00106639|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92997246|NCT00106639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997247|NCT00106639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997248|NCT00106639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92997249|NCT00106639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997250|NCT00747539|Interferons|interferons|mesh-list
92997251|NCT00747539|Ribavirin|ribavirin|mesh-list
92997252|NCT00747539|Interferon-alpha|interferon-alpha|mesh-list
92997253|NCT00747539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997254|NCT00747539|Antiviral Agents|antiviral agents|mesh-ancestor
92997255|NCT00747539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997256|NCT00747539|Antimetabolites|antimetabolites|mesh-ancestor
92997257|NCT00747539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997258|NCT00747539|Immunologic Factors|immunologic factors|mesh-ancestor
92997259|NCT00747539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997261|NCT00745433|Repaglinide|repaglinide|mesh-list
92997262|NCT00745433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997263|NCT00745433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997264|NCT00962234|Deuterium Oxide|deuterium oxide|mesh-list
92997265|NCT00962234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997266|NCT00962234|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92997267|NCT00962234|Protective Agents|protective agents|mesh-ancestor
92997268|NCT00962234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997269|NCT00747695|Rabeprazole|rabeprazole|mesh-list
92997270|NCT00747695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92997271|NCT00747695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997272|NCT00747695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92997273|NCT00747695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997274|NCT00747695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997275|NCT00959972|Nicotine|nicotine|mesh-list
92997276|NCT00959972|Varenicline|varenicline|mesh-list
92997277|NCT00959972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92997278|NCT00959972|Autonomic Agents|autonomic agents|mesh-ancestor
92997279|NCT00959972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997280|NCT00959972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997281|NCT00959972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92997282|NCT00959972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92997283|NCT00959972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92997284|NCT00959972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997285|NCT00959972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997286|NCT04009616|Chlorhexidine|chlorhexidine|mesh-list
92997287|NCT04009616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92997288|NCT04009616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997289|NCT04009616|Disinfectants|disinfectants|mesh-ancestor
92997290|NCT00960284|Gemcitabine|gemcitabine|mesh-list
92997291|NCT00960284|Fluorouracil|fluorouracil|mesh-list
92997292|NCT00960284|Capecitabine|capecitabine|mesh-list
92997293|NCT00960284|Epirubicin|epirubicin|mesh-list
92997294|NCT00960284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997295|NCT00960284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92997296|NCT00960284|Antimetabolites|antimetabolites|mesh-ancestor
92997297|NCT00960284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997298|NCT00960284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997299|NCT00960284|Immunologic Factors|immunologic factors|mesh-ancestor
92997300|NCT00960284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997301|NCT00960284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92997302|NCT00960284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92997303|NCT00960284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92997304|NCT00960284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997305|NCT00105469|Tobramycin|tobramycin|mesh-list
92997306|NCT00105469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997307|NCT00105469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997308|NCT00962312|Capecitabine|capecitabine|mesh-list
92997309|NCT00962312|Lapatinib|lapatinib|mesh-list
92997310|NCT00962312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92997311|NCT00962312|Antimetabolites|antimetabolites|mesh-ancestor
92997312|NCT00962312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997313|NCT00962312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997314|NCT00962312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997315|NCT00962312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997316|NCT00960518|Adefovir|adefovir|mesh-list
92997317|NCT00960518|Antiviral Agents|antiviral agents|mesh-ancestor
92997318|NCT00960518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997319|NCT00960518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92997320|NCT00960518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92997321|NCT00960518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997322|NCT00960518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997323|NCT00960830|Mirtazapine|mirtazapine|mesh-list
92997324|NCT00960830|Antidepressive Agents|antidepressive agents|mesh-ancestor
92997325|NCT00960830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92997326|NCT00960830|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92997327|NCT00960830|Histamine Antagonists|histamine antagonists|mesh-ancestor
92997328|NCT00960830|Histamine Agents|histamine agents|mesh-ancestor
92997329|NCT00960830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997330|NCT00960830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997331|NCT00960830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997332|NCT00960830|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92997333|NCT00960830|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92997334|NCT00960830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997335|NCT00960830|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92997336|NCT00960830|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92997337|NCT00960830|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92997338|NCT00960830|Adrenergic Agents|adrenergic agents|mesh-ancestor
92997339|NCT00960830|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92997340|NCT00960830|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92997341|NCT00960830|Serotonin Agents|serotonin agents|mesh-ancestor
92997342|NCT00960830|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92997343|NCT00962624|Vaccines|vaccines|mesh-list
92997344|NCT00962624|Immunologic Factors|immunologic factors|mesh-ancestor
92997345|NCT00962624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997346|NCT00105235|Cyclosporine|cyclosporine|mesh-list
92997347|NCT00105235|Mycophenolic Acid|mycophenolic acid|mesh-list
92997348|NCT00105235|Alemtuzumab|alemtuzumab|mesh-list
92997349|NCT00105235|Tacrolimus|tacrolimus|mesh-list
92997350|NCT00105235|Cyclosporins|cyclosporins|mesh-list
92997351|NCT00105235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997352|NCT00105235|Immunologic Factors|immunologic factors|mesh-ancestor
92997353|NCT00105235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997354|NCT00105235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92997355|NCT00105235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997356|NCT00105235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997357|NCT00105235|Antifungal Agents|antifungal agents|mesh-ancestor
92997358|NCT00105235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997359|NCT00105235|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997360|NCT00105235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997361|NCT00105235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92997362|NCT00105235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997363|NCT00105235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92997364|NCT00105235|Antitubercular Agents|antitubercular agents|mesh-ancestor
92997365|NCT00105235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997366|NCT00105235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997367|NCT03962803|Vaccines|vaccines|mesh-list
92997368|NCT03962803|Immunologic Factors|immunologic factors|mesh-ancestor
92997369|NCT03962803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997370|NCT00547118|Rimonabant|rimonabant|mesh-list
92997371|NCT00547118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92997372|NCT00547118|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92997373|NCT00547118|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92997374|NCT00547118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997375|NCT00547118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997376|NCT00547118|Hormones|hormones|mesh-ancestor
92997377|NCT00547118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997378|NCT00547118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997379|NCT00962936|Pidilizumab|pidilizumab|mesh-list
92997380|NCT00962936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997381|NCT00962936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997382|NCT01087099|Albendazole|albendazole|mesh-list
92997383|NCT01087099|Anthelmintics|anthelmintics|mesh-ancestor
92997384|NCT01087099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92997385|NCT01087099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997386|NCT01087099|Anticestodal Agents|anticestodal agents|mesh-ancestor
92997387|NCT01087099|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92997388|NCT01087099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92997389|NCT01087099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997390|NCT01087099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997391|NCT01087099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997392|NCT01087099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997393|NCT01087099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997394|NCT00686543|Posaconazole|posaconazole|mesh-list
92997395|NCT00686543|Antifungal Agents|antifungal agents|mesh-ancestor
92997396|NCT00686543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997397|NCT00686543|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92997398|NCT00686543|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92997399|NCT00686543|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92997400|NCT00686543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92997401|NCT00686543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92997402|NCT00686543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997403|NCT00686543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997404|NCT00686543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92997405|NCT00686543|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997406|NCT00686543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997407|NCT00686543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997408|NCT00750113|Telmisartan|telmisartan|mesh-list
92997410|NCT00750113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92997411|NCT00750113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92997412|NCT00750113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92997413|NCT00750113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997414|NCT00750113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92997415|NCT00750113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92997416|NCT00750113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92997417|NCT00750113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997418|NCT00750113|Vasodilator Agents|vasodilator agents|mesh-ancestor
92997419|NCT00750113|Tocolytic Agents|tocolytic agents|mesh-ancestor
92997420|NCT00750113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92997421|NCT00745511|Bevacizumab|bevacizumab|mesh-list
92997422|NCT00745511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997423|NCT00745511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997424|NCT00745511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997425|NCT00745511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997426|NCT00745511|Growth Substances|growth substances|mesh-ancestor
92997427|NCT00745511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997428|NCT00745511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997429|NCT00545688|Docetaxel|docetaxel|mesh-list
92997430|NCT00545688|Trastuzumab|trastuzumab|mesh-list
92997431|NCT00545688|Pertuzumab|pertuzumab|mesh-list
92997432|NCT00545688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997433|NCT00545688|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997434|NCT00545688|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997435|NCT00545688|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997436|NCT00545688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997437|NCT00545688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997439|NCT00502203|Carboplatin|carboplatin|mesh-list
92997440|NCT00502203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92997441|NCT00502203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997442|NCT00502203|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997443|NCT00502203|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997444|NCT00502203|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997445|NCT00502203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997446|NCT00546078|Vaccines|vaccines|mesh-list
92997447|NCT00546078|Immunologic Factors|immunologic factors|mesh-ancestor
92997448|NCT00546078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997449|NCT00967772|Naftopidil|naftopidil|mesh-list
92997450|NCT00967772|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92997451|NCT00967772|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92997452|NCT00967772|Adrenergic Agents|adrenergic agents|mesh-ancestor
92997453|NCT00967772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997454|NCT00967772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997455|NCT00967772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997456|NCT00967772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92997457|NCT00967772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92997458|NCT00967772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92997459|NCT00967772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92997460|NCT00967772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92997461|NCT00967850|Verteporfin|verteporfin|mesh-list
92997462|NCT00967850|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92997463|NCT00967850|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997464|NCT00967928|Everolimus|everolimus|mesh-list
92997465|NCT00967928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997466|NCT00967928|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92997467|NCT00967928|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997468|NCT00967928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997469|NCT00967928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997470|NCT00967928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997471|NCT00967928|Immunologic Factors|immunologic factors|mesh-ancestor
92997472|NCT00967928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997473|NCT00546000|Fluticasone|fluticasone|mesh-list
92997474|NCT00546000|Xhance|xhance|mesh-list
92997475|NCT00546000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997476|NCT00546000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92997477|NCT00546000|Autonomic Agents|autonomic agents|mesh-ancestor
92997478|NCT00546000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997479|NCT00546000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997480|NCT00546000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92997481|NCT00546000|Respiratory System Agents|respiratory system agents|mesh-ancestor
92997482|NCT00546000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997483|NCT00546000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92997484|NCT00968006|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92997485|NCT00968006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997486|NCT00968006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997487|NCT00968006|Incretins|incretins|mesh-ancestor
92997488|NCT00968006|Hormones|hormones|mesh-ancestor
92997489|NCT00968006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997490|NCT00968006|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92997491|NCT00968006|Protease Inhibitors|protease inhibitors|mesh-ancestor
92997492|NCT00968006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997493|NCT00968006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997494|NCT00968162|Fludarabine|fludarabine|mesh-list
92997495|NCT00968162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997496|NCT00968240|Bevacizumab|bevacizumab|mesh-list
92997497|NCT00968240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997498|NCT00968240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997499|NCT00968240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997500|NCT00968240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997501|NCT00968240|Growth Substances|growth substances|mesh-ancestor
92997502|NCT00968240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997503|NCT00968240|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997504|NCT00501969|Rotigotine|rotigotine|mesh-list
92997505|NCT00501969|Dopamine Agonists|dopamine agonists|mesh-ancestor
92997506|NCT00501969|Dopamine Agents|dopamine agents|mesh-ancestor
92997507|NCT00501969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997508|NCT00501969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997509|NCT00501969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997510|NCT03942042|Ixekizumab|ixekizumab|mesh-list
92997511|NCT03942042|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997512|NCT00968396|Melphalan|melphalan|mesh-list
92997513|NCT00968396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92997514|NCT00968396|Alkylating Agents|alkylating agents|mesh-ancestor
92997515|NCT00968396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997516|NCT00968396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997517|NCT00968396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92997518|NCT00968396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997519|NCT00968396|Immunologic Factors|immunologic factors|mesh-ancestor
92997520|NCT00968396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997521|NCT04008732|Nitroglycerin|nitroglycerin|mesh-list
92997522|NCT04008732|Vasodilator Agents|vasodilator agents|mesh-ancestor
92997523|NCT01013727|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
92997524|NCT01013727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92997525|NCT01013727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997526|NCT05299580|Trametinib|trametinib|mesh-list
92997527|NCT05299580|Dabrafenib|dabrafenib|mesh-list
92997528|NCT05299580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997529|NCT05299580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997530|NCT05299580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997531|NCT05299580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997532|NCT01013805|Leucovorin|leucovorin|mesh-list
92997533|NCT01013805|Fluorouracil|fluorouracil|mesh-list
92997534|NCT01013805|Oxaliplatin|oxaliplatin|mesh-list
92997535|NCT01013805|Antimetabolites|antimetabolites|mesh-ancestor
92997536|NCT01013805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997537|NCT01013805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92997538|NCT01013805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997539|NCT01013805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997540|NCT01013805|Immunologic Factors|immunologic factors|mesh-ancestor
92997541|NCT01013805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997542|NCT01013805|Antidotes|antidotes|mesh-ancestor
92997543|NCT01013805|Protective Agents|protective agents|mesh-ancestor
92997544|NCT01013805|Vitamin B Complex|vitamin b complex|mesh-ancestor
92997545|NCT01013805|Vitamins|vitamins|mesh-ancestor
92997546|NCT01013805|Micronutrients|micronutrients|mesh-ancestor
92997547|NCT00104299|Prednisone|prednisone|mesh-list
92997548|NCT00104299|Methylprednisolone|methylprednisolone|mesh-list
92997549|NCT00104299|Cyclophosphamide|cyclophosphamide|mesh-list
92997550|NCT00104299|Rituximab|rituximab|mesh-list
92997551|NCT00104299|Azathioprine|azathioprine|mesh-list
92997552|NCT00104299|Glucocorticoids|glucocorticoids|mesh-list
92997553|NCT00104299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997554|NCT00104299|Immunologic Factors|immunologic factors|mesh-ancestor
92997555|NCT00104299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997556|NCT00104299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997557|NCT00104299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92997558|NCT00104299|Alkylating Agents|alkylating agents|mesh-ancestor
92997559|NCT00104299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997560|NCT00104299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997561|NCT00104299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92997562|NCT00104299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997563|NCT00104299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997565|NCT00104299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997566|NCT00104299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997567|NCT00104299|Antiemetics|antiemetics|mesh-ancestor
92997568|NCT00104299|Autonomic Agents|autonomic agents|mesh-ancestor
92997569|NCT00104299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997570|NCT00104299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997571|NCT00104299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92997572|NCT00104299|Protective Agents|protective agents|mesh-ancestor
92997573|NCT00104299|Antimetabolites|antimetabolites|mesh-ancestor
92997574|NCT00104299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92997575|NCT05196308|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92997576|NCT05196308|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92997577|NCT05196308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997578|NCT05196308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997579|NCT05196308|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92997580|NCT05196308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92997581|NCT05196308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997582|NCT05196308|Cholinergic Agents|cholinergic agents|mesh-ancestor
92997583|NCT05196308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997584|NCT00082381|Insulin Glargine|insulin glargine|mesh-list
92997586|NCT00082381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997587|NCT00082381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997588|NCT00082381|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92997589|NCT00082381|Incretins|incretins|mesh-ancestor
92997590|NCT00082381|Hormones|hormones|mesh-ancestor
92997591|NCT00082381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997592|NCT00964106|Rosiglitazone|rosiglitazone|mesh-list
92997593|NCT00964106|Rifampin|rifampin|mesh-list
92997594|NCT00964106|Fluconazole|fluconazole|mesh-list
92997595|NCT00964106|Ketoconazole|ketoconazole|mesh-list
92997596|NCT00964106|Flurbiprofen|flurbiprofen|mesh-list
92997597|NCT00964106|Midazolam|midazolam|mesh-list
92997598|NCT00964106|Dextromethorphan|dextromethorphan|mesh-list
92997599|NCT00964106|Caffeine|caffeine|mesh-list
92997600|NCT00964106|Omeprazole|omeprazole|mesh-list
92997601|NCT00964106|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92997602|NCT00964106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92997603|NCT00964106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92997604|NCT00964106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997605|NCT00964106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997606|NCT00964106|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92997607|NCT00964106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92997608|NCT00964106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92997609|NCT00964106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92997610|NCT00964106|Anesthetics, General|anesthetics, general|mesh-ancestor
92997611|NCT00964106|Anesthetics|anesthetics|mesh-ancestor
92997612|NCT00964106|GABA Modulators|gaba modulators|mesh-ancestor
92997613|NCT00964106|GABA Agents|gaba agents|mesh-ancestor
92997614|NCT00964106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997615|NCT00964106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997616|NCT00964106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92997617|NCT00964106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92997618|NCT00964106|Antimetabolites|antimetabolites|mesh-ancestor
92997619|NCT00964106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92997620|NCT00964106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92997621|NCT00964106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997622|NCT00964106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92997623|NCT00964106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92997624|NCT00964106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92997625|NCT00964106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92997626|NCT00964106|Purinergic Agents|purinergic agents|mesh-ancestor
92997627|NCT00964106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92997628|NCT00964106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997629|NCT00964106|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92997630|NCT00964106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92997631|NCT00964106|Antitubercular Agents|antitubercular agents|mesh-ancestor
92997632|NCT00964106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997633|NCT00964106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997634|NCT00964106|Leprostatic Agents|leprostatic agents|mesh-ancestor
92997635|NCT00964106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92997636|NCT00964106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92997637|NCT00964106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92997638|NCT00964106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92997639|NCT00964106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92997640|NCT00964106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92997641|NCT00964106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92997642|NCT00964106|Antifungal Agents|antifungal agents|mesh-ancestor
92997643|NCT00964106|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92997644|NCT00964106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92997645|NCT00964106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92997646|NCT00964106|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997647|NCT00964106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997648|NCT00964106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92997649|NCT00964106|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92997650|NCT00964106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997651|NCT00964106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92997652|NCT00964106|Antitussive Agents|antitussive agents|mesh-ancestor
92997653|NCT00964106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92997654|NCT00964106|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92997655|NCT00964106|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92997656|NCT00964106|Analgesics|analgesics|mesh-ancestor
92997657|NCT00964106|Sensory System Agents|sensory system agents|mesh-ancestor
92997658|NCT00964106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997659|NCT00964106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92997660|NCT00964106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92997661|NCT00964106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997662|NCT00964106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997663|NCT00964106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92997664|NCT00960336|Doxorubicin|doxorubicin|mesh-list
92997665|NCT00960336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92997666|NCT00960336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92997667|NCT00960336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997668|NCT00960336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92997669|NCT00960336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92997670|NCT00960336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997671|NCT00960336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997672|NCT00965172|Calcium|calcium|mesh-list
92997673|NCT00965172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92997674|NCT00965172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997675|NCT01084837|Bortezomib|bortezomib|mesh-list
92997676|NCT01084837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997677|NCT00545844|Montelukast|montelukast|mesh-list
92997678|NCT00545844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92997679|NCT00545844|Respiratory System Agents|respiratory system agents|mesh-ancestor
92997680|NCT00545844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92997681|NCT00545844|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997682|NCT00545844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997683|NCT00545844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997684|NCT00545844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92997685|NCT00545844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92997686|NCT00545844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997687|NCT01084993|Heparin|heparin|mesh-list
92997688|NCT01084993|Bivalirudin|bivalirudin|mesh-list
92997689|NCT01084993|Anticoagulants|anticoagulants|mesh-ancestor
92997690|NCT01084993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92997691|NCT01084993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92997692|NCT01084993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997693|NCT01084993|Antithrombins|antithrombins|mesh-ancestor
92997694|NCT01084993|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92997695|NCT01084993|Protease Inhibitors|protease inhibitors|mesh-ancestor
92997696|NCT01084993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997697|NCT00492063|Vaccines|vaccines|mesh-list
92997698|NCT00492063|Immunologic Factors|immunologic factors|mesh-ancestor
92997699|NCT00492063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997700|NCT00960492|Temozolomide|temozolomide|mesh-list
92997701|NCT00960492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92997702|NCT00960492|Alkylating Agents|alkylating agents|mesh-ancestor
92997703|NCT00960492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997704|NCT00960492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997705|NCT00971724|Prednisolone|prednisolone|mesh-list
92997706|NCT00971724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997707|NCT00971724|Glucocorticoids|glucocorticoids|mesh-ancestor
92997708|NCT00971724|Hormones|hormones|mesh-ancestor
92997709|NCT00971724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997710|NCT00971724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997711|NCT00971724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997712|NCT00971724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997713|NCT02976909|Paclitaxel|paclitaxel|mesh-list
92997714|NCT02976909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92997715|NCT02976909|Cisplatin|cisplatin|mesh-list
92997716|NCT02976909|Fluorouracil|fluorouracil|mesh-list
92997717|NCT02976909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92997718|NCT02976909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997719|NCT02976909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997720|NCT02976909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997721|NCT02976909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997722|NCT02976909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997723|NCT02976909|Antimetabolites|antimetabolites|mesh-ancestor
92997724|NCT02976909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92997725|NCT02976909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997726|NCT02976909|Immunologic Factors|immunologic factors|mesh-ancestor
92997727|NCT02976909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997728|NCT02878083|Adalimumab|adalimumab|mesh-list
92997729|NCT02878083|Vedolizumab|vedolizumab|mesh-list
92997730|NCT02878083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92997731|NCT02878083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997732|NCT02878083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643081|NCT05426044|Metformin|metformin|mesh-list
92997734|NCT00093145|Paclitaxel|paclitaxel|mesh-list
92997735|NCT00093145|Carboplatin|carboplatin|mesh-list
92997736|NCT00093145|Trastuzumab|trastuzumab|mesh-list
92997737|NCT00093145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92997738|NCT00093145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92997739|NCT00093145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997740|NCT00093145|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997741|NCT00093145|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997742|NCT00093145|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997743|NCT00093145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997744|NCT00093145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997745|NCT00965406|Insulin|insulin|mesh-list
92997746|NCT00965406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92997747|NCT00965406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997748|NCT00513357|Melatonin|melatonin|mesh-list
92997749|NCT00513357|Antioxidants|antioxidants|mesh-ancestor
92997750|NCT00513357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997751|NCT00513357|Protective Agents|protective agents|mesh-ancestor
92997752|NCT00513357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997753|NCT00513357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997754|NCT00960960|Paclitaxel|paclitaxel|mesh-list
92997755|NCT00960960|Bevacizumab|bevacizumab|mesh-list
92997756|NCT00960960|Trastuzumab|trastuzumab|mesh-list
92997757|NCT00960960|Letrozole|letrozole|mesh-list
92997758|NCT00960960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92997759|NCT00960960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997760|NCT00960960|Tubulin Modulators|tubulin modulators|mesh-ancestor
92997761|NCT00960960|Antimitotic Agents|antimitotic agents|mesh-ancestor
92997762|NCT00960960|Mitosis Modulators|mitosis modulators|mesh-ancestor
92997763|NCT00960960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997764|NCT00960960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92997765|NCT00960960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92997766|NCT00960960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92997767|NCT00960960|Growth Substances|growth substances|mesh-ancestor
92997768|NCT00960960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997769|NCT00960960|Growth Inhibitors|growth inhibitors|mesh-ancestor
92997770|NCT00960960|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92997771|NCT00960960|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92997772|NCT00960960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997773|NCT00960960|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92997774|NCT00960960|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997775|NCT00960960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997776|NCT00965640|Botulinum Toxins|botulinum toxins|mesh-list
92997777|NCT00965640|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92997778|NCT00965640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92997779|NCT00965640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997780|NCT00965640|Cholinergic Agents|cholinergic agents|mesh-ancestor
92997781|NCT00965640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997782|NCT00965640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997783|NCT00961038|Ciprofloxacin|ciprofloxacin|mesh-list
92997784|NCT00961038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997785|NCT00961038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997786|NCT00961038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92997787|NCT00961038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92997788|NCT00961038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997789|NCT00961038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997790|NCT00961038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997791|NCT00961038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92997792|NCT00961038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92997793|NCT00961194|Ketamine|ketamine|mesh-list
92997794|NCT00961194|Analgesics|analgesics|mesh-ancestor
92997795|NCT00961194|Sensory System Agents|sensory system agents|mesh-ancestor
92997796|NCT00961194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997797|NCT00961194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168291|NCT05294588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997798|NCT00961194|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92997799|NCT00961194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92997800|NCT00961194|Anesthetics, General|anesthetics, general|mesh-ancestor
92997801|NCT00961194|Anesthetics|anesthetics|mesh-ancestor
92997802|NCT00961194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997803|NCT00961194|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92997804|NCT00961194|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92997805|NCT00961194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997806|NCT00961194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997807|NCT05279586|Colistin|colistin|mesh-list
92997808|NCT05279586|Lactulose|lactulose|mesh-list
92997809|NCT05279586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997810|NCT05279586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997811|NCT05279586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997812|NCT00965796|Lidocaine|lidocaine|mesh-list
92997813|NCT00965796|Anesthetics, Local|anesthetics, local|mesh-ancestor
92997814|NCT00965796|Anesthetics|anesthetics|mesh-ancestor
92997815|NCT00965796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997816|NCT00965796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997817|NCT00965796|Sensory System Agents|sensory system agents|mesh-ancestor
92997818|NCT00965796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997819|NCT00965796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92997820|NCT00965796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92997821|NCT00965796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92997822|NCT00965796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92997823|NCT00965796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997824|NCT00415636|Pemetrexed|pemetrexed|mesh-list
92997825|NCT00415636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997826|NCT00415636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997827|NCT00415636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997828|NCT00415636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92997829|NCT00415636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92997830|NCT00965874|Magnesium Sulfate|magnesium sulfate|mesh-list
92997831|NCT00965874|Analgesics|analgesics|mesh-ancestor
92997832|NCT00965874|Sensory System Agents|sensory system agents|mesh-ancestor
92997833|NCT00965874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997834|NCT00965874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997835|NCT00965874|Anesthetics|anesthetics|mesh-ancestor
92997836|NCT00965874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92997837|NCT00965874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92997838|NCT00965874|Anticonvulsants|anticonvulsants|mesh-ancestor
92997839|NCT00965874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92997840|NCT00965874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92997841|NCT00965874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997842|NCT00965874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92997843|NCT00965874|Tocolytic Agents|tocolytic agents|mesh-ancestor
92997844|NCT00965874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92997845|NCT00972426|Timolol|timolol|mesh-list
92997846|NCT00972426|Carteolol|carteolol|mesh-list
92997847|NCT00972426|Latanoprost|latanoprost|mesh-list
92997848|NCT00972426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92997849|NCT00972426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92997850|NCT00972426|Adrenergic Agents|adrenergic agents|mesh-ancestor
92997851|NCT00972426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997852|NCT00972426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997853|NCT00972426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997854|NCT00972426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92997855|NCT00972426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92997856|NCT00972426|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92997857|NCT00972426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92997858|NCT00972426|Sympatholytics|sympatholytics|mesh-ancestor
92997859|NCT00972426|Autonomic Agents|autonomic agents|mesh-ancestor
92997860|NCT00972426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997861|NCT00972660|Cyclosporine|cyclosporine|mesh-list
92997862|NCT00972660|Mycophenolic Acid|mycophenolic acid|mesh-list
92997863|NCT00972660|Prednisone|prednisone|mesh-list
92997864|NCT00972660|Cyclosporins|cyclosporins|mesh-list
92997865|NCT00972660|Tacrolimus|tacrolimus|mesh-list
92997866|NCT00972660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997867|NCT00972660|Glucocorticoids|glucocorticoids|mesh-ancestor
92997868|NCT00972660|Hormones|hormones|mesh-ancestor
92168293|NCT05294588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92997869|NCT00972660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997870|NCT00972660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997871|NCT00972660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997872|NCT00972660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997873|NCT00972660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997874|NCT00972660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997875|NCT00972660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997876|NCT00972660|Immunologic Factors|immunologic factors|mesh-ancestor
92997877|NCT00972660|Antifungal Agents|antifungal agents|mesh-ancestor
92997878|NCT00972660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997879|NCT00972660|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997880|NCT00972660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997881|NCT00972660|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92997882|NCT00972660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92997883|NCT00972660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92997884|NCT00972660|Antitubercular Agents|antitubercular agents|mesh-ancestor
92997885|NCT00972660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997886|NCT04008966|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92997887|NCT04008966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92997888|NCT04008966|Cetrorelix|cetrorelix|mesh-list
92997889|NCT04008966|Progesterone|progesterone|mesh-list
92997890|NCT04008966|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92997891|NCT04008966|Progestins|progestins|mesh-ancestor
92997892|NCT04008966|Hormones|hormones|mesh-ancestor
92997893|NCT04008966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997894|NCT04008966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997895|NCT04008966|Luteolytic Agents|luteolytic agents|mesh-ancestor
92997896|NCT04008966|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92997897|NCT04008966|Contraceptive Agents|contraceptive agents|mesh-ancestor
92997898|NCT04008966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92997899|NCT04008966|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92997900|NCT04008966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997901|NCT04008966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997902|NCT04008966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92997903|NCT04008966|Fertility Agents|fertility agents|mesh-ancestor
92997904|NCT04008966|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997905|NCT00425854|Afatinib|afatinib|mesh-list
92997906|NCT00425854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997907|NCT00425854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997908|NCT00425854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997909|NCT00425854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997910|NCT00425698|Epoetin Alfa|epoetin alfa|mesh-list
92997911|NCT00425698|Hematinics|hematinics|mesh-ancestor
92997912|NCT01037530|Ramipril|ramipril|mesh-list
92997913|NCT01037530|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92997914|NCT01037530|Protease Inhibitors|protease inhibitors|mesh-ancestor
92997915|NCT01037530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997916|NCT01037530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997917|NCT01037530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92997918|NCT00973050|Bicalutamide|bicalutamide|mesh-list
92997919|NCT00973050|Androgen Antagonists|androgen antagonists|mesh-ancestor
92997920|NCT00973050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92997921|NCT00973050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997922|NCT00973050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997923|NCT00973050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997924|NCT00973128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92997925|NCT00973128|Sargramostim|sargramostim|mesh-list
92997926|NCT00973128|Immunologic Factors|immunologic factors|mesh-ancestor
92997927|NCT00973128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997928|NCT00973128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92997929|NCT00973128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92997930|NCT00973128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997931|NCT00973986|Atorvastatin|atorvastatin|mesh-list
92997932|NCT00973986|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92997933|NCT00973986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92997934|NCT00973986|Antimetabolites|antimetabolites|mesh-ancestor
92997935|NCT00973986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997936|NCT00973986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92997937|NCT00973986|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92997938|NCT00973986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997939|NCT00966576|Timolol|timolol|mesh-list
92997940|NCT00966576|Brinzolamide|brinzolamide|mesh-list
92997941|NCT00966576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997942|NCT00966576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997943|NCT00966576|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92997944|NCT00966576|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92997945|NCT00966576|Adrenergic Agents|adrenergic agents|mesh-ancestor
92997946|NCT00966576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92997947|NCT00966576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997948|NCT00966576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92997949|NCT00966576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92997950|NCT00966576|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92997951|NCT00425308|Cyclosporine|cyclosporine|mesh-list
92997952|NCT00425308|Mycophenolic Acid|mycophenolic acid|mesh-list
92997953|NCT00425308|Everolimus|everolimus|mesh-list
92997954|NCT00425308|Cyclosporins|cyclosporins|mesh-list
92643315|NCT00212186|Selenium|selenium|mesh-list
92997955|NCT00425308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997956|NCT00425308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997957|NCT00425308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997958|NCT00425308|Immunologic Factors|immunologic factors|mesh-ancestor
92997959|NCT00425308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997960|NCT00425308|Antifungal Agents|antifungal agents|mesh-ancestor
92997961|NCT00425308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92997962|NCT00425308|Dermatologic Agents|dermatologic agents|mesh-ancestor
92997963|NCT00425308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92997964|NCT00425308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92997966|NCT00425308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92997967|NCT00425308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997968|NCT00425308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92997969|NCT00425308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92997970|NCT00425308|Antitubercular Agents|antitubercular agents|mesh-ancestor
92997971|NCT00425308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92997972|NCT04008888|Dexamethasone|dexamethasone|mesh-list
92997973|NCT04008888|Dexamethasone acetate|dexamethasone acetate|mesh-list
92997974|NCT04008888|Fludarabine|fludarabine|mesh-list
92997975|NCT04008888|Melphalan|melphalan|mesh-list
92997976|NCT04008888|BB 1101|bb 1101|mesh-list
92997977|NCT04008888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92997978|NCT04008888|Antiemetics|antiemetics|mesh-ancestor
92997979|NCT04008888|Autonomic Agents|autonomic agents|mesh-ancestor
92997980|NCT04008888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92997981|NCT04008888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92997982|NCT04008888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92997983|NCT04008888|Glucocorticoids|glucocorticoids|mesh-ancestor
92997984|NCT04008888|Hormones|hormones|mesh-ancestor
92997985|NCT04008888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92997986|NCT04008888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92997987|NCT04008888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92997988|NCT04008888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92997989|NCT04008888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92997990|NCT04008888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92997991|NCT04008888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92997992|NCT04008888|Immunologic Factors|immunologic factors|mesh-ancestor
92997993|NCT04008888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92997994|NCT04008888|Alkylating Agents|alkylating agents|mesh-ancestor
92997995|NCT04008888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92997996|NCT01033084|Sertraline|sertraline|mesh-list
92997997|NCT01033084|Antidepressive Agents|antidepressive agents|mesh-ancestor
92997998|NCT01033084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92528389|NCT04732390|Anesthetics, Local|anesthetics, local|mesh-ancestor
92997999|NCT01033084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92998000|NCT01033084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92998001|NCT01033084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998002|NCT01033084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998003|NCT01033084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998004|NCT01033084|Serotonin Agents|serotonin agents|mesh-ancestor
92998005|NCT01033084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998006|NCT00979758|Atorvastatin|atorvastatin|mesh-list
92998007|NCT00979758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92998008|NCT00979758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998009|NCT00979758|Antimetabolites|antimetabolites|mesh-ancestor
92998010|NCT00979758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998011|NCT00979758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92998012|NCT00979758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92998013|NCT00979758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998014|NCT00545064|Timolol|timolol|mesh-list
92998015|NCT00545064|Dorzolamide|dorzolamide|mesh-list
92998016|NCT00545064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998017|NCT00545064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998018|NCT00545064|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92998019|NCT00545064|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92998020|NCT00545064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998021|NCT00545064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998022|NCT00545064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998023|NCT00545064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998024|NCT00545064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92998025|NCT00545064|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92998026|NCT00979836|Calcium Dobesilate|calcium dobesilate|mesh-list
92998027|NCT00979836|Calcium|calcium|mesh-list
92998028|NCT00979836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92643383|NCT00239421|Fluticasone|fluticasone|mesh-list
92998029|NCT00979836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998030|NCT00979836|Hemostatics|hemostatics|mesh-ancestor
92998031|NCT00979836|Coagulants|coagulants|mesh-ancestor
92998032|NCT01588912|Tenofovir|tenofovir|mesh-list
92998033|NCT01588912|Entecavir|entecavir|mesh-list
92998034|NCT01588912|Telbivudine|telbivudine|mesh-list
92998035|NCT01588912|Antiviral Agents|antiviral agents|mesh-ancestor
92998036|NCT01588912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998037|NCT01588912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92998038|NCT01588912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92998039|NCT01588912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998040|NCT01588912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998041|NCT01588912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92998042|NCT01588912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92998043|NCT01589068|Nicotine|nicotine|mesh-list
92998044|NCT01589068|Progesterone|progesterone|mesh-list
92998045|NCT01589068|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92998046|NCT01589068|Autonomic Agents|autonomic agents|mesh-ancestor
92998047|NCT01589068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998048|NCT01589068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998049|NCT01589068|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92998050|NCT01589068|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92998051|NCT01589068|Cholinergic Agents|cholinergic agents|mesh-ancestor
92998052|NCT01589068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998053|NCT01589068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998054|NCT01589068|Progestins|progestins|mesh-ancestor
92998055|NCT01589068|Hormones|hormones|mesh-ancestor
92998056|NCT01589068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998057|NCT00432562|Vinorelbine|vinorelbine|mesh-list
92998058|NCT00432562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92998059|NCT00432562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998060|NCT00432562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92998061|NCT00432562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92998062|NCT00432562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92998063|NCT00432562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998064|NCT00966966|Gemfibrozil|gemfibrozil|mesh-list
92998065|NCT00966966|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998066|NCT00966966|Antimetabolites|antimetabolites|mesh-ancestor
92998067|NCT00966966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998068|NCT00966966|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92998069|NCT00966966|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92998070|NCT00966966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92998071|NCT00966966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998072|NCT00974532|Calcium, Dietary|calcium, dietary|mesh-list
92998074|NCT00974532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92998075|NCT00974532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998076|NCT00974532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92998077|NCT00432172|Cyclophosphamide|cyclophosphamide|mesh-list
92998078|NCT00432172|Carboplatin|carboplatin|mesh-list
92998079|NCT00432172|Docetaxel|docetaxel|mesh-list
92998080|NCT00432172|Epirubicin|epirubicin|mesh-list
92998081|NCT00432172|Exemestane|exemestane|mesh-list
92998082|NCT00432172|Goserelin|goserelin|mesh-list
92998083|NCT00432172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998084|NCT00432172|Immunologic Factors|immunologic factors|mesh-ancestor
92998085|NCT00432172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998086|NCT00432172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998087|NCT00432172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92998088|NCT00432172|Alkylating Agents|alkylating agents|mesh-ancestor
92998089|NCT00432172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998090|NCT00432172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998091|NCT00432172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92998092|NCT00432172|Tubulin Modulators|tubulin modulators|mesh-ancestor
92998093|NCT00432172|Antimitotic Agents|antimitotic agents|mesh-ancestor
92998094|NCT00432172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92998095|NCT00432172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92998096|NCT00432172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92998097|NCT00432172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92998098|NCT00432172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998099|NCT00432172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92998100|NCT00432172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92998101|NCT00432172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92998102|NCT00432172|Hormone Antagonists|hormone antagonists|mesh-ancestor
92998103|NCT00432172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998104|NCT00432172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998105|NCT01034410|Cytarabine|cytarabine|mesh-list
92998106|NCT01034410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92998107|NCT01034410|Antimetabolites|antimetabolites|mesh-ancestor
92998108|NCT01034410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998109|NCT01034410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998110|NCT01034410|Antiviral Agents|antiviral agents|mesh-ancestor
92998111|NCT01034410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998112|NCT01034410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998113|NCT01034410|Immunologic Factors|immunologic factors|mesh-ancestor
92998114|NCT01034410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998115|NCT00415168|Pemetrexed|pemetrexed|mesh-list
92998116|NCT00415168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998117|NCT00415168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998118|NCT00415168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998119|NCT00415168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92998120|NCT00415168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92998121|NCT00424762|Rosiglitazone|rosiglitazone|mesh-list
92998122|NCT00424762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92998123|NCT00424762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998124|NCT00980304|Rituximab|rituximab|mesh-list
92998125|NCT00980304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92998126|NCT00980304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998127|NCT00980304|Immunologic Factors|immunologic factors|mesh-ancestor
92998128|NCT00980304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998129|NCT00980304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998130|NCT00974766|Glucocorticoids|glucocorticoids|mesh-list
92998131|NCT00974766|Hormones|hormones|mesh-ancestor
92998132|NCT00974766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998133|NCT00974766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998134|NCT00980382|Docetaxel|docetaxel|mesh-list
92998135|NCT00980382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998136|NCT00980382|Tubulin Modulators|tubulin modulators|mesh-ancestor
92998137|NCT00980382|Antimitotic Agents|antimitotic agents|mesh-ancestor
92998138|NCT00980382|Mitosis Modulators|mitosis modulators|mesh-ancestor
92998139|NCT00980382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998140|NCT00967434|Atorvastatin|atorvastatin|mesh-list
92998141|NCT00967434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92998142|NCT00967434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998143|NCT00967434|Antimetabolites|antimetabolites|mesh-ancestor
92998144|NCT00967434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998145|NCT00967434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92998146|NCT00967434|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92998147|NCT00967434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998149|NCT00967512|Idarubicin|idarubicin|mesh-list
92998150|NCT00967512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92998151|NCT00967512|Antimetabolites|antimetabolites|mesh-ancestor
92998152|NCT00967512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998153|NCT00967512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998154|NCT00967512|Antiviral Agents|antiviral agents|mesh-ancestor
92998155|NCT00967512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298790|NCT05467748|Pembrolizumab|pembrolizumab|mesh-list
92998156|NCT00967512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998157|NCT00967512|Immunologic Factors|immunologic factors|mesh-ancestor
92998158|NCT00967512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998159|NCT00967512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92998160|NCT00967512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92998161|NCT00967512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92998162|NCT00967512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998163|NCT04082910|Infliximab|infliximab|mesh-list
92998164|NCT04082910|Etanercept|etanercept|mesh-list
92998165|NCT04082910|Metoprolol|metoprolol|mesh-list
92998166|NCT04082910|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92998167|NCT04082910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998168|NCT04082910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92998169|NCT04082910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998170|NCT04082910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998171|NCT04082910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92998172|NCT04082910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92998173|NCT04082910|Analgesics|analgesics|mesh-ancestor
92998174|NCT04082910|Sensory System Agents|sensory system agents|mesh-ancestor
92998175|NCT04082910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998176|NCT04082910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998177|NCT04082910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998178|NCT04082910|Immunologic Factors|immunologic factors|mesh-ancestor
92998179|NCT04082910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998180|NCT04082910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92998181|NCT04082910|Sympatholytics|sympatholytics|mesh-ancestor
92998182|NCT04082910|Autonomic Agents|autonomic agents|mesh-ancestor
92998183|NCT04082910|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92998184|NCT04082910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92998185|NCT04082910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92998186|NCT04082910|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998187|NCT04082910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998188|NCT04082910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998189|NCT00975078|Prednisone|prednisone|mesh-list
92998190|NCT00975078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998191|NCT00975078|Glucocorticoids|glucocorticoids|mesh-ancestor
92998192|NCT00975078|Hormones|hormones|mesh-ancestor
92998193|NCT00975078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998194|NCT00975078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998195|NCT00975078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998196|NCT00975078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998197|NCT00980616|Ropivacaine|ropivacaine|mesh-list
92998198|NCT00980616|Anesthetics, Local|anesthetics, local|mesh-ancestor
92998199|NCT00980616|Anesthetics|anesthetics|mesh-ancestor
92998200|NCT00980616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998201|NCT00980616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998202|NCT00980616|Sensory System Agents|sensory system agents|mesh-ancestor
92998203|NCT00980616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998204|NCT00980850|Vaccines|vaccines|mesh-list
92998205|NCT00980850|Immunologic Factors|immunologic factors|mesh-ancestor
92998206|NCT00980850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998207|NCT00414466|Gabapentin|gabapentin|mesh-list
92998208|NCT00414466|Analgesics|analgesics|mesh-ancestor
92998209|NCT00414466|Sensory System Agents|sensory system agents|mesh-ancestor
92998210|NCT00414466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998211|NCT00414466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998212|NCT00414466|Anticonvulsants|anticonvulsants|mesh-ancestor
92998213|NCT00414466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92998214|NCT00414466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998215|NCT00414466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998216|NCT00414466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998217|NCT00414466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92998218|NCT00414466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92998219|NCT00414466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998220|NCT00414466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998221|NCT00414466|Antimanic Agents|antimanic agents|mesh-ancestor
92998222|NCT00984750|Acetylcarnitine|acetylcarnitine|mesh-list
92998223|NCT00984750|Simvastatin|simvastatin|mesh-list
92998224|NCT00984750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92998225|NCT00984750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998226|NCT00984750|Antimetabolites|antimetabolites|mesh-ancestor
92998227|NCT00984750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148621|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
92998228|NCT00984750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92998229|NCT00984750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92998230|NCT00984750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998231|NCT00984750|Vitamin B Complex|vitamin b complex|mesh-ancestor
92998232|NCT00984750|Vitamins|vitamins|mesh-ancestor
92998233|NCT00984750|Micronutrients|micronutrients|mesh-ancestor
92998234|NCT00984750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998235|NCT00984750|Nootropic Agents|nootropic agents|mesh-ancestor
92998236|NCT00975312|Tretinoin|tretinoin|mesh-list
92998237|NCT00975312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998238|NCT00975312|Keratolytic Agents|keratolytic agents|mesh-ancestor
92998239|NCT00975312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92998240|NCT00424528|Tiotropium Bromide|tiotropium bromide|mesh-list
92998241|NCT00424528|Formoterol Fumarate|formoterol fumarate|mesh-list
92998242|NCT00424528|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92998243|NCT00424528|Autonomic Agents|autonomic agents|mesh-ancestor
92998244|NCT00424528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998245|NCT00424528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998246|NCT00424528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92998247|NCT00424528|Respiratory System Agents|respiratory system agents|mesh-ancestor
92998248|NCT00424528|Parasympatholytics|parasympatholytics|mesh-ancestor
92998249|NCT00424528|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92998250|NCT00424528|Cholinergic Agents|cholinergic agents|mesh-ancestor
92998251|NCT00424528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998252|NCT00424528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998253|NCT00424528|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92998254|NCT00424528|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92998255|NCT00424528|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92998256|NCT00424528|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998257|NCT04974996|Prednisone|prednisone|mesh-list
92998258|NCT04974996|Cyclophosphamide|cyclophosphamide|mesh-list
92998259|NCT04974996|Rituximab|rituximab|mesh-list
92998260|NCT04974996|Doxorubicin|doxorubicin|mesh-list
92998261|NCT04974996|Vincristine|vincristine|mesh-list
92998262|NCT04974996|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92998263|NCT04974996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998264|NCT04974996|Immunologic Factors|immunologic factors|mesh-ancestor
92998265|NCT04974996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998266|NCT04974996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998267|NCT04974996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92998268|NCT04974996|Alkylating Agents|alkylating agents|mesh-ancestor
92998269|NCT04974996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998270|NCT04974996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998271|NCT04974996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92998272|NCT04974996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92998273|NCT04974996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92998274|NCT04974996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92998275|NCT04974996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92998276|NCT04974996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998277|NCT04974996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998278|NCT04974996|Glucocorticoids|glucocorticoids|mesh-ancestor
92998279|NCT04974996|Hormones|hormones|mesh-ancestor
92998280|NCT04974996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998281|NCT04974996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998282|NCT04974996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92998283|NCT04974996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92998284|NCT04974996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92998285|NCT04974996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92998286|NCT00981006|Mitogens|mitogens|mesh-list
92998287|NCT00981006|Mitosis Modulators|mitosis modulators|mesh-ancestor
92998288|NCT00981006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998289|NCT00975390|Caffeine|caffeine|mesh-list
92998290|NCT00975390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92998291|NCT00975390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998292|NCT00975390|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92998293|NCT00975390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998294|NCT00975390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998295|NCT00975390|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92998296|NCT00975390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92998297|NCT00975390|Purinergic Agents|purinergic agents|mesh-ancestor
92998298|NCT00975390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998299|NCT00981318|Ritonavir|ritonavir|mesh-list
92998300|NCT00981318|Lopinavir|lopinavir|mesh-list
92998301|NCT00981318|Maraviroc|maraviroc|mesh-list
92998302|NCT00981318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92998303|NCT00981318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92998304|NCT00981318|Protease Inhibitors|protease inhibitors|mesh-ancestor
92998305|NCT00981318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998306|NCT00981318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998307|NCT00981318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92998308|NCT00981318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92998309|NCT00981318|Antiviral Agents|antiviral agents|mesh-ancestor
92998310|NCT00981318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998311|NCT00981318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92998312|NCT00981318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92998313|NCT00981318|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92998314|NCT00981318|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92998315|NCT00981318|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92998316|NCT00984984|Methylprednisolone|methylprednisolone|mesh-list
92998317|NCT00984984|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92998318|NCT00984984|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92998319|NCT00984984|Prednisolone|prednisolone|mesh-list
92998320|NCT00984984|Prednisolone acetate|prednisolone acetate|mesh-list
92998321|NCT00984984|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92998322|NCT00984984|Prednisolone phosphate|prednisolone phosphate|mesh-list
92998323|NCT00984984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998324|NCT00984984|Antiemetics|antiemetics|mesh-ancestor
92998325|NCT00984984|Autonomic Agents|autonomic agents|mesh-ancestor
92998326|NCT00984984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998327|NCT00984984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998328|NCT00984984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998329|NCT00984984|Glucocorticoids|glucocorticoids|mesh-ancestor
92998330|NCT00984984|Hormones|hormones|mesh-ancestor
92998331|NCT00984984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998332|NCT00984984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92998333|NCT00984984|Protective Agents|protective agents|mesh-ancestor
92998334|NCT00984984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998335|NCT00984984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998336|NCT00545532|Oseltamivir|oseltamivir|mesh-list
92998337|NCT00545532|Antiviral Agents|antiviral agents|mesh-ancestor
92998338|NCT00545532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998339|NCT00545532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998340|NCT00545532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998341|NCT00544440|Prednisone|prednisone|mesh-list
92998342|NCT00544440|Abiraterone Acetate|abiraterone acetate|mesh-list
92998343|NCT00544440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998344|NCT00544440|Glucocorticoids|glucocorticoids|mesh-ancestor
92998345|NCT00544440|Hormones|hormones|mesh-ancestor
92998346|NCT00544440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998347|NCT00544440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998348|NCT00544440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998349|NCT00544440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998350|NCT00544440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92998351|NCT00544440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998352|NCT00544440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998353|NCT00544440|Hormone Antagonists|hormone antagonists|mesh-ancestor
92998354|NCT00544440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92998355|NCT00981708|Dexamethasone|dexamethasone|mesh-list
92998356|NCT00981708|Dexamethasone acetate|dexamethasone acetate|mesh-list
92998357|NCT00981708|Cyclophosphamide|cyclophosphamide|mesh-list
92998358|NCT00981708|Lenalidomide|lenalidomide|mesh-list
92998359|NCT00981708|BB 1101|bb 1101|mesh-list
92998360|NCT00981708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998361|NCT00981708|Immunologic Factors|immunologic factors|mesh-ancestor
92998362|NCT00981708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998363|NCT00981708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998364|NCT00981708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92998365|NCT00981708|Alkylating Agents|alkylating agents|mesh-ancestor
92998366|NCT00981708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998367|NCT00981708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998368|NCT00981708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92998369|NCT00981708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998370|NCT00981708|Antiemetics|antiemetics|mesh-ancestor
92998371|NCT00981708|Autonomic Agents|autonomic agents|mesh-ancestor
92998372|NCT00981708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168311|NCT05170139|Caffeine|caffeine|mesh-list
92998373|NCT00981708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998374|NCT00981708|Glucocorticoids|glucocorticoids|mesh-ancestor
92998375|NCT00981708|Hormones|hormones|mesh-ancestor
92998376|NCT00981708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998377|NCT00981708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998378|NCT00981708|Protease Inhibitors|protease inhibitors|mesh-ancestor
92998379|NCT00981708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998380|NCT00981708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92998381|NCT00981708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92998382|NCT00981708|Growth Substances|growth substances|mesh-ancestor
92998383|NCT00981708|Growth Inhibitors|growth inhibitors|mesh-ancestor
92998384|NCT00981786|Timolol|timolol|mesh-list
92998385|NCT00981786|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92998386|NCT00981786|Travoprost|travoprost|mesh-list
92998387|NCT00981786|Brinzolamide|brinzolamide|mesh-list
92998388|NCT00981786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92998389|NCT00981786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92998390|NCT00981786|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998391|NCT00981786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998392|NCT00981786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998393|NCT00981786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998394|NCT00981786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998395|NCT00981786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92998396|NCT00981786|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92998397|NCT00981786|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92998398|NCT00981786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92998399|NCT00981786|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92998400|NCT00981786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998401|NCT04007562|Hydroxychloroquine|hydroxychloroquine|mesh-list
92998402|NCT04007562|Antimalarials|antimalarials|mesh-ancestor
92998403|NCT04007562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92998404|NCT04007562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92998405|NCT04007562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998406|NCT04007562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998407|NCT04007562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998408|NCT04007562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998409|NCT00985374|Everolimus|everolimus|mesh-list
92998410|NCT00985374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92998411|NCT00985374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92998412|NCT00985374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998413|NCT00985374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998414|NCT00985374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998415|NCT00985374|Immunologic Factors|immunologic factors|mesh-ancestor
92998416|NCT00985374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998417|NCT00985374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998418|NCT00975936|Ketoconazole|ketoconazole|mesh-list
92998419|NCT00975936|Antifungal Agents|antifungal agents|mesh-ancestor
92998420|NCT00975936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998421|NCT00975936|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92998422|NCT00975936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92998423|NCT00975936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998424|NCT00975936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998425|NCT00975936|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92998426|NCT00975936|Hormone Antagonists|hormone antagonists|mesh-ancestor
92998427|NCT00975936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998428|NCT00975936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998429|NCT00975936|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92998430|NCT00976092|Heparin|heparin|mesh-list
92998431|NCT00976092|Calcium heparin|calcium heparin|mesh-list
92998432|NCT00976092|Bivalirudin|bivalirudin|mesh-list
92998433|NCT00976092|Clopidogrel|clopidogrel|mesh-list
92998434|NCT00976092|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92998435|NCT00976092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92998436|NCT00976092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92998437|NCT00976092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92998438|NCT00976092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92998439|NCT00976092|Purinergic Agents|purinergic agents|mesh-ancestor
92998440|NCT00976092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998441|NCT00976092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998442|NCT00976092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998443|NCT00976092|Anticoagulants|anticoagulants|mesh-ancestor
92998444|NCT00976092|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92998445|NCT00976092|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92998446|NCT00976092|Antithrombins|antithrombins|mesh-ancestor
92998447|NCT00976092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92998448|NCT00976092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92998449|NCT00976092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998450|NCT00985530|Arsenic Trioxide|arsenic trioxide|mesh-list
92998451|NCT00985530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998452|NCT04006470|Fluorides|fluorides|mesh-list
92998453|NCT04006470|Tin Fluorides|tin fluorides|mesh-list
92998454|NCT04006470|Cariostatic Agents|cariostatic agents|mesh-ancestor
92998455|NCT04006470|Protective Agents|protective agents|mesh-ancestor
92998456|NCT04006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998457|NCT01323712|Vitamin D|vitamin d|mesh-list
92998458|NCT01323712|Cholecalciferol|cholecalciferol|mesh-list
92998459|NCT01323712|Vitamins|vitamins|mesh-ancestor
92998460|NCT01323712|Micronutrients|micronutrients|mesh-ancestor
92998461|NCT01323712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998462|NCT01323712|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92998463|NCT01323712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92998464|NCT00981942|Imatinib Mesylate|imatinib mesylate|mesh-list
92998465|NCT00981942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998466|NCT00981942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92998467|NCT00981942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998468|NCT00981942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998469|NCT03927144|Erenumab|erenumab|mesh-list
92998470|NCT03927144|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92998471|NCT03927144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998472|NCT03927144|Analgesics|analgesics|mesh-ancestor
92998473|NCT03927144|Sensory System Agents|sensory system agents|mesh-ancestor
92998474|NCT03927144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998475|NCT03927144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998476|NCT00976170|Sorafenib|sorafenib|mesh-list
92998477|NCT00976170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998478|NCT00976170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92998479|NCT00976170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998480|NCT00976170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998481|NCT00982254|Insulin|insulin|mesh-list
92998482|NCT00982254|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92998483|NCT00982254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92998484|NCT00982254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998485|NCT00985608|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92998486|NCT00985608|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92998487|NCT00985608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998488|NCT00985608|Antitubercular Agents|antitubercular agents|mesh-ancestor
92998489|NCT00976326|Insulin|insulin|mesh-list
92998490|NCT00976326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92998491|NCT00976326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998492|NCT00982332|Betamethasone|betamethasone|mesh-list
92998493|NCT00982332|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
92998494|NCT00982332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998495|NCT00982332|Glucocorticoids|glucocorticoids|mesh-ancestor
92998496|NCT00982332|Hormones|hormones|mesh-ancestor
92998497|NCT00982332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998498|NCT00982332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998499|NCT00982332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92998500|NCT00982332|Respiratory System Agents|respiratory system agents|mesh-ancestor
92998501|NCT04007328|Methylprednisolone|methylprednisolone|mesh-list
92998502|NCT04007328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92998503|NCT04007328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92998504|NCT04007328|Prednisolone|prednisolone|mesh-list
92998505|NCT04007328|Prednisolone acetate|prednisolone acetate|mesh-list
92998506|NCT04007328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92998507|NCT04007328|Prednisolone phosphate|prednisolone phosphate|mesh-list
92998508|NCT04007328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998509|NCT04007328|Antiemetics|antiemetics|mesh-ancestor
92998510|NCT04007328|Autonomic Agents|autonomic agents|mesh-ancestor
92998511|NCT04007328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998512|NCT04007328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998513|NCT04007328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998514|NCT04007328|Glucocorticoids|glucocorticoids|mesh-ancestor
92998515|NCT04007328|Hormones|hormones|mesh-ancestor
92998516|NCT04007328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998517|NCT04007328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92998518|NCT04007328|Protective Agents|protective agents|mesh-ancestor
92998519|NCT04007328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998520|NCT04007328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998521|NCT00985920|Tranexamic Acid|tranexamic acid|mesh-list
92998522|NCT00985920|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92998523|NCT00985920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92998524|NCT00985920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998525|NCT00985920|Hemostatics|hemostatics|mesh-ancestor
92998526|NCT00985920|Coagulants|coagulants|mesh-ancestor
92998527|NCT00976794|Carbamazepine|carbamazepine|mesh-list
92998528|NCT00976794|Valproic Acid|valproic acid|mesh-list
92998529|NCT00976794|Lithium Carbonate|lithium carbonate|mesh-list
92998530|NCT00976794|Antidepressive Agents|antidepressive agents|mesh-ancestor
92998531|NCT00976794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998532|NCT00976794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998533|NCT00976794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998534|NCT00976794|Antimanic Agents|antimanic agents|mesh-ancestor
92998535|NCT00976794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998536|NCT00976794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998537|NCT00976794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998538|NCT00976794|Anticonvulsants|anticonvulsants|mesh-ancestor
92998539|NCT00976794|GABA Agents|gaba agents|mesh-ancestor
92998540|NCT00976794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998541|NCT00976794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92998542|NCT00976794|Analgesics|analgesics|mesh-ancestor
92998543|NCT00976794|Sensory System Agents|sensory system agents|mesh-ancestor
92998544|NCT00976794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998545|NCT00976794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92998546|NCT00976794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998547|NCT00976794|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92998548|NCT00976794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92998549|NCT00985998|Nimotuzumab|nimotuzumab|mesh-list
92998550|NCT00985998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92998551|NCT00985998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998552|NCT04008186|Metformin|metformin|mesh-list
92998553|NCT04008186|Repaglinide|repaglinide|mesh-list
92998554|NCT04008186|Itraconazole|itraconazole|mesh-list
92998555|NCT04008186|Digoxin|digoxin|mesh-list
92998557|NCT04008186|Midazolam|midazolam|mesh-list
92998558|NCT04008186|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92998559|NCT04008186|Gemfibrozil|gemfibrozil|mesh-list
92998560|NCT04008186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92998561|NCT04008186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998562|NCT04008186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92998563|NCT04008186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92998564|NCT04008186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998565|NCT04008186|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92998566|NCT04008186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998567|NCT04008186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998568|NCT04008186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92998569|NCT04008186|Anesthetics, General|anesthetics, general|mesh-ancestor
92998570|NCT04008186|Anesthetics|anesthetics|mesh-ancestor
92998571|NCT04008186|GABA Modulators|gaba modulators|mesh-ancestor
92998572|NCT04008186|GABA Agents|gaba agents|mesh-ancestor
92998573|NCT04008186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998574|NCT04008186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998575|NCT04008186|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92998576|NCT04008186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998577|NCT04008186|Antimetabolites|antimetabolites|mesh-ancestor
92998578|NCT04008186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92998579|NCT04008186|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92998580|NCT04008186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998581|NCT04008186|Antifungal Agents|antifungal agents|mesh-ancestor
92998582|NCT04008186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998583|NCT04008186|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92998584|NCT04008186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92998585|NCT04008186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92998586|NCT04008186|Hormone Antagonists|hormone antagonists|mesh-ancestor
92998587|NCT04008186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998588|NCT04008186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92299219|NCT05062889|Antidotes|antidotes|mesh-ancestor
92998589|NCT04008186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998590|NCT04008186|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92998591|NCT04008186|Protective Agents|protective agents|mesh-ancestor
92998592|NCT04008186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92998593|NCT04008186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998594|NCT04008186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92998595|NCT04008186|Vasodilator Agents|vasodilator agents|mesh-ancestor
92998596|NCT04008186|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92998597|NCT00982566|Navitoclax|navitoclax|mesh-list
92998598|NCT00982566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998599|NCT00977028|Lidocaine|lidocaine|mesh-list
92998600|NCT00977028|Epinephrine|epinephrine|mesh-list
92998601|NCT00977028|Racepinephrine|racepinephrine|mesh-list
92998602|NCT00977028|Anesthetics|anesthetics|mesh-list
92998603|NCT00977028|Epinephryl borate|epinephryl borate|mesh-list
92998604|NCT00977028|Anesthetics, Local|anesthetics, local|mesh-ancestor
92998605|NCT00977028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998606|NCT00977028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998607|NCT00977028|Sensory System Agents|sensory system agents|mesh-ancestor
92998608|NCT00977028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998609|NCT00977028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998610|NCT00977028|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92998611|NCT00977028|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92998612|NCT00977028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998613|NCT00977028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998614|NCT00977028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92998615|NCT00977028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92998616|NCT00977028|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998617|NCT00977028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998618|NCT00977028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92998619|NCT00977028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92998620|NCT00977028|Autonomic Agents|autonomic agents|mesh-ancestor
92998621|NCT00977028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92998622|NCT00977028|Respiratory System Agents|respiratory system agents|mesh-ancestor
92998623|NCT00977028|Mydriatics|mydriatics|mesh-ancestor
92998624|NCT00977028|Sympathomimetics|sympathomimetics|mesh-ancestor
92998625|NCT00977028|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92998626|NCT00982722|Calcium, Dietary|calcium, dietary|mesh-list
92998627|NCT00982722|Cholecalciferol|cholecalciferol|mesh-list
92998628|NCT00982722|Vitamin D|vitamin d|mesh-list
92998629|NCT00982722|Calcium Carbonate|calcium carbonate|mesh-list
92643975|NCT00215501|Fluorouracil|fluorouracil|mesh-list
92998630|NCT00982722|Calcium|calcium|mesh-list
92998631|NCT00982722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92998632|NCT00982722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998633|NCT00982722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92998635|NCT00982722|Micronutrients|micronutrients|mesh-ancestor
92998636|NCT00982722|Antacids|antacids|mesh-ancestor
92998637|NCT00982722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998638|NCT00982722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998639|NCT00982800|Gabapentin|gabapentin|mesh-list
92998640|NCT00982800|Analgesics|analgesics|mesh-ancestor
92998641|NCT00982800|Sensory System Agents|sensory system agents|mesh-ancestor
92998642|NCT00982800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998643|NCT00982800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998644|NCT00982800|Anticonvulsants|anticonvulsants|mesh-ancestor
92998645|NCT00982800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92998646|NCT00982800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998647|NCT00982800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998648|NCT00982800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998649|NCT00982800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92998650|NCT00982800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92998651|NCT00982800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998652|NCT00982800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998653|NCT00982800|Antimanic Agents|antimanic agents|mesh-ancestor
92998654|NCT00986076|Enoxaparin|enoxaparin|mesh-list
92998655|NCT00986076|Anticoagulants|anticoagulants|mesh-ancestor
92998656|NCT00986076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92998657|NCT00986076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92998658|NCT00986076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998659|NCT00984828|Bortezomib|bortezomib|mesh-list
92168321|NCT05140811|Azacitidine|azacitidine|mesh-list
92998660|NCT00984828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998661|NCT00983034|Amoxicillin|amoxicillin|mesh-list
92998662|NCT00983034|Clarithromycin|clarithromycin|mesh-list
92998663|NCT00983034|Lansoprazole|lansoprazole|mesh-list
92998664|NCT00983034|Dexlansoprazole|dexlansoprazole|mesh-list
92998665|NCT00983034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92998666|NCT00983034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998667|NCT00983034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92998668|NCT00983034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998669|NCT00983034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998670|NCT00983034|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92998671|NCT00983034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92998672|NCT00983034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92998673|NCT00983034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998674|NCT00983034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92998675|NCT00983112|Thrombin|thrombin|mesh-list
92998676|NCT00983112|Hemostatics|hemostatics|mesh-ancestor
92998677|NCT00983112|Coagulants|coagulants|mesh-ancestor
92998678|NCT00986466|Vitamin D|vitamin d|mesh-list
92998679|NCT00986466|Ergocalciferols|ergocalciferols|mesh-list
92998680|NCT00986466|Cholecalciferol|cholecalciferol|mesh-list
92998681|NCT00986466|Vitamins|vitamins|mesh-list
92998682|NCT00986466|Micronutrients|micronutrients|mesh-ancestor
92998683|NCT00986466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998684|NCT00986466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92998685|NCT00986466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92998686|NCT00545298|Nitric Oxide|nitric oxide|mesh-list
92998687|NCT00545298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92998688|NCT00545298|Autonomic Agents|autonomic agents|mesh-ancestor
92998689|NCT00545298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998690|NCT00545298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998691|NCT00545298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92998692|NCT00545298|Respiratory System Agents|respiratory system agents|mesh-ancestor
92998693|NCT00545298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92998694|NCT00545298|Antioxidants|antioxidants|mesh-ancestor
92998695|NCT00545298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998696|NCT00545298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998697|NCT00545298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92998698|NCT00545298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92998699|NCT00545298|Gasotransmitters|gasotransmitters|mesh-ancestor
92998700|NCT00545298|Protective Agents|protective agents|mesh-ancestor
92998701|NCT00983268|Capecitabine|capecitabine|mesh-list
92998702|NCT00983268|Vorinostat|vorinostat|mesh-list
92998703|NCT00983268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92998704|NCT00983268|Antimetabolites|antimetabolites|mesh-ancestor
92998705|NCT00983268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644051|NCT04667299|Antacids|antacids|mesh-ancestor
92998706|NCT00983268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998707|NCT00983268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92998708|NCT00983268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998709|NCT00977964|Caseins|caseins|mesh-list
92998710|NCT00977964|Chelating Agents|chelating agents|mesh-ancestor
92998711|NCT00977964|Sequestering Agents|sequestering agents|mesh-ancestor
92998712|NCT00977964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998713|NCT00983424|Cyclosporine|cyclosporine|mesh-list
92998714|NCT00983424|Paclitaxel|paclitaxel|mesh-list
92998715|NCT00983424|Cyclosporins|cyclosporins|mesh-list
92998716|NCT00983424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92998717|NCT00983424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998718|NCT00983424|Tubulin Modulators|tubulin modulators|mesh-ancestor
92998719|NCT00983424|Antimitotic Agents|antimitotic agents|mesh-ancestor
92998720|NCT00983424|Mitosis Modulators|mitosis modulators|mesh-ancestor
92998721|NCT00983424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998722|NCT00983424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998723|NCT00983424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998724|NCT00983424|Immunologic Factors|immunologic factors|mesh-ancestor
92998725|NCT00983424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998726|NCT00983424|Antifungal Agents|antifungal agents|mesh-ancestor
92998727|NCT00983424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998728|NCT00983424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92998729|NCT00983424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998730|NCT00983424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92998731|NCT00983736|Tramadol|tramadol|mesh-list
92998732|NCT00983736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92998733|NCT00983736|Narcotics|narcotics|mesh-ancestor
92998734|NCT00983736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998735|NCT00983736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998736|NCT00983736|Analgesics|analgesics|mesh-ancestor
92998737|NCT00983736|Sensory System Agents|sensory system agents|mesh-ancestor
92998738|NCT00983736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998739|NCT00986778|Lamivudine|lamivudine|mesh-list
92998740|NCT00986778|Adefovir|adefovir|mesh-list
92998741|NCT00986778|Entecavir|entecavir|mesh-list
92998742|NCT00986778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92998743|NCT00986778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92998744|NCT00986778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998745|NCT00986778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998746|NCT00986778|Antiviral Agents|antiviral agents|mesh-ancestor
92998747|NCT00986778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998748|NCT00986778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92998749|NCT00986778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92998751|NCT00429364|Atenolol|atenolol|mesh-list
92998752|NCT00429364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998753|NCT00429364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92998754|NCT00429364|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92998755|NCT00429364|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92998756|NCT00429364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998757|NCT00429364|Sympatholytics|sympatholytics|mesh-ancestor
92998758|NCT00429364|Autonomic Agents|autonomic agents|mesh-ancestor
92998759|NCT00429364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998760|NCT00429364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998761|NCT00429364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92998762|NCT00429364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92998763|NCT00429364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92998764|NCT00429364|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998765|NCT00429364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998766|NCT00978354|Furosemide|furosemide|mesh-list
92998767|NCT00978354|Diuretics|diuretics|mesh-ancestor
92998768|NCT00978354|Natriuretic Agents|natriuretic agents|mesh-ancestor
92998769|NCT00978354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998770|NCT00978354|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92998771|NCT00978354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998772|NCT00978354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998773|NCT00984360|Naltrexone|naltrexone|mesh-list
92998774|NCT00984360|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92998775|NCT00984360|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92998776|NCT00984360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998777|NCT00984360|Sensory System Agents|sensory system agents|mesh-ancestor
92998778|NCT00984360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998779|NCT00414388|Sorafenib|sorafenib|mesh-list
92998780|NCT00414388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998781|NCT00414388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92998782|NCT00414388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998783|NCT00414388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998784|NCT00978588|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92998785|NCT00978588|Plasma Substitutes|plasma substitutes|mesh-ancestor
92998786|NCT00978588|Blood Substitutes|blood substitutes|mesh-ancestor
92998788|NCT01037608|Analgesics|analgesics|mesh-ancestor
92998789|NCT01037608|Sensory System Agents|sensory system agents|mesh-ancestor
92998790|NCT01037608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998791|NCT01037608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998792|NCT04006080|Vedolizumab|vedolizumab|mesh-list
92998793|NCT04006080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998794|NCT00984438|Bevacizumab|bevacizumab|mesh-list
92998795|NCT00984438|Irinotecan|irinotecan|mesh-list
92998796|NCT00984438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92998797|NCT00984438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998798|NCT00984438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92998799|NCT00984438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92998800|NCT00984438|Growth Substances|growth substances|mesh-ancestor
92998801|NCT00984438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998802|NCT00984438|Growth Inhibitors|growth inhibitors|mesh-ancestor
92998803|NCT00984438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92998804|NCT00984438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92998805|NCT00984438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998806|NCT00984438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998807|NCT00424372|Pregabalin|pregabalin|mesh-list
92998808|NCT00424372|Analgesics|analgesics|mesh-ancestor
92998809|NCT00424372|Sensory System Agents|sensory system agents|mesh-ancestor
92998810|NCT00424372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998811|NCT00424372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998812|NCT00424372|Anticonvulsants|anticonvulsants|mesh-ancestor
92998813|NCT00424372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92998814|NCT00424372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998815|NCT00424372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998816|NCT00424372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92998817|NCT00424372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92998818|NCT00424372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998819|NCT00424372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998820|NCT00424372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998821|NCT00987168|Octreotide|octreotide|mesh-list
92998822|NCT00987168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998823|NCT00987168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92998824|NCT00987168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998825|NCT00978978|Fentanyl|fentanyl|mesh-list
92998826|NCT00978978|Midazolam|midazolam|mesh-list
92998827|NCT00978978|Propofol|propofol|mesh-list
92998828|NCT00978978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92998829|NCT00978978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998830|NCT00978978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998831|NCT00978978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92998832|NCT00978978|Anesthetics, General|anesthetics, general|mesh-ancestor
92998833|NCT00978978|Anesthetics|anesthetics|mesh-ancestor
92998834|NCT00978978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92998835|NCT00978978|Narcotics|narcotics|mesh-ancestor
92998836|NCT00978978|Analgesics|analgesics|mesh-ancestor
92998837|NCT00978978|Sensory System Agents|sensory system agents|mesh-ancestor
92998838|NCT00978978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998839|NCT00978978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92998840|NCT00978978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92998841|NCT00978978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998842|NCT00978978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998843|NCT00978978|GABA Modulators|gaba modulators|mesh-ancestor
92998844|NCT00978978|GABA Agents|gaba agents|mesh-ancestor
92998845|NCT00978978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998846|NCT00978978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998847|NCT00414310|Decitabine|decitabine|mesh-list
92998848|NCT00414310|Valproic Acid|valproic acid|mesh-list
92998849|NCT00414310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92998850|NCT00414310|Antimetabolites|antimetabolites|mesh-ancestor
92998851|NCT00414310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998852|NCT00414310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998853|NCT00414310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998854|NCT00414310|Anticonvulsants|anticonvulsants|mesh-ancestor
92998855|NCT00414310|GABA Agents|gaba agents|mesh-ancestor
92998856|NCT00414310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998857|NCT00414310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998858|NCT00414310|Antimanic Agents|antimanic agents|mesh-ancestor
92998859|NCT00414310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998860|NCT00414310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998861|NCT00414310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998862|NCT00542880|Fluticasone|fluticasone|mesh-list
92998863|NCT00542880|Budesonide|budesonide|mesh-list
92998864|NCT00542880|Formoterol Fumarate|formoterol fumarate|mesh-list
92998865|NCT00542880|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92998866|NCT00542880|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92998867|NCT00542880|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92998868|NCT00542880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998869|NCT00542880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92998870|NCT00542880|Autonomic Agents|autonomic agents|mesh-ancestor
92998871|NCT00542880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998872|NCT00542880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998873|NCT00542880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92998874|NCT00542880|Respiratory System Agents|respiratory system agents|mesh-ancestor
92998875|NCT00542880|Dermatologic Agents|dermatologic agents|mesh-ancestor
92998876|NCT00542880|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92998877|NCT00542880|Glucocorticoids|glucocorticoids|mesh-ancestor
92998878|NCT00542880|Hormones|hormones|mesh-ancestor
92998879|NCT00542880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998880|NCT00542880|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92998881|NCT00542880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92998882|NCT00542880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92998883|NCT00542880|Adrenergic Agents|adrenergic agents|mesh-ancestor
92998884|NCT00542880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998885|NCT00542880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998886|NCT00542880|Sympathomimetics|sympathomimetics|mesh-ancestor
92998887|NCT00414076|Letrozole|letrozole|mesh-list
92998888|NCT00414076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998889|NCT00414076|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92998890|NCT00414076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92998891|NCT00414076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998892|NCT00414076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998893|NCT00414076|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92998894|NCT00414076|Hormone Antagonists|hormone antagonists|mesh-ancestor
92998895|NCT00414076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92998896|NCT00414076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998897|NCT01033318|Losartan|losartan|mesh-list
92998898|NCT01033318|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92998899|NCT01033318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92998900|NCT01033318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92998901|NCT01033318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92998902|NCT01033318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998903|NCT01033396|Fexofenadine|fexofenadine|mesh-list
92998904|NCT01033396|Terfenadine|terfenadine|mesh-list
92998905|NCT01033396|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92998906|NCT01033396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92998907|NCT01033396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92998908|NCT01033396|Histamine Antagonists|histamine antagonists|mesh-ancestor
92998909|NCT01033396|Histamine Agents|histamine agents|mesh-ancestor
92998910|NCT01033396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998911|NCT01033396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998912|NCT01033396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998913|NCT00979056|Rifaximin|rifaximin|mesh-list
92998914|NCT00979056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92998915|NCT00979056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92998916|NCT00979056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998917|NCT00092677|Simvastatin|simvastatin|mesh-list
92998918|NCT00092677|Ezetimibe|ezetimibe|mesh-list
92998919|NCT00092677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92998920|NCT00092677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998921|NCT00092677|Antimetabolites|antimetabolites|mesh-ancestor
92998922|NCT00092677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998923|NCT00092677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168336|NCT05096169|Zuclomiphene|zuclomiphene|mesh-list
92998924|NCT00092677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92998925|NCT00092677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998926|NCT00542178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92998927|NCT00542178|Simvastatin|simvastatin|mesh-list
92998928|NCT00542178|Fenofibrate|fenofibrate|mesh-list
92998929|NCT00542178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92998930|NCT00542178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92998931|NCT00542178|Antimetabolites|antimetabolites|mesh-ancestor
92998932|NCT00542178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998933|NCT00542178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92998934|NCT00542178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92998935|NCT00542178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998936|NCT00542178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998938|NCT00987636|Diphosphonates|diphosphonates|mesh-list
92998939|NCT00987636|Busulfan|busulfan|mesh-list
92998940|NCT00987636|Treosulfan|treosulfan|mesh-list
92998941|NCT00987636|Alkylating Agents|alkylating agents|mesh-ancestor
92998942|NCT00987636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998943|NCT00987636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998944|NCT00987636|Immunologic Factors|immunologic factors|mesh-ancestor
92998945|NCT00987636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998946|NCT00987636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92998947|NCT00987636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998948|NCT00987636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92998949|NCT00987636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92998950|NCT00424294|Celecoxib|celecoxib|mesh-list
92998951|NCT00424294|Methotrexate|methotrexate|mesh-list
92998952|NCT00424294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92998953|NCT00424294|Abortifacient Agents|abortifacient agents|mesh-ancestor
92998954|NCT00424294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92998955|NCT00424294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998956|NCT00424294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92998957|NCT00424294|Antimetabolites|antimetabolites|mesh-ancestor
92998958|NCT00424294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998959|NCT00424294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92998960|NCT00424294|Dermatologic Agents|dermatologic agents|mesh-ancestor
92998961|NCT00424294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998962|NCT00424294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92998963|NCT00424294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92998964|NCT00424294|Immunologic Factors|immunologic factors|mesh-ancestor
92998965|NCT00424294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92998966|NCT00424294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92998967|NCT00424294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92998968|NCT00424294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92998969|NCT00424294|Analgesics|analgesics|mesh-ancestor
92998970|NCT00424294|Sensory System Agents|sensory system agents|mesh-ancestor
92998971|NCT00424294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998972|NCT00424294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92998973|NCT00424294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92998974|NCT00424294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92998975|NCT00988728|Olanzapine|olanzapine|mesh-list
92998976|NCT00988728|Antiemetics|antiemetics|mesh-ancestor
92998977|NCT00988728|Autonomic Agents|autonomic agents|mesh-ancestor
92998978|NCT00988728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92998979|NCT00988728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92998980|NCT00988728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92998981|NCT00988728|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92998982|NCT00988728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92998983|NCT00988728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92998984|NCT00988728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92998985|NCT00988728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92998986|NCT00988728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92998987|NCT00988728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92998988|NCT00988728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998989|NCT00988728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92998990|NCT00988728|Serotonin Agents|serotonin agents|mesh-ancestor
92998991|NCT00988806|Simendan|simendan|mesh-list
92998992|NCT00988806|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92998993|NCT00988806|Vasodilator Agents|vasodilator agents|mesh-ancestor
92998994|NCT00988806|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92998995|NCT00988806|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92998996|NCT00988806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92998997|NCT00988806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92998998|NCT00988806|Protective Agents|protective agents|mesh-ancestor
92998999|NCT00988806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999000|NCT04005768|Hydroxychloroquine|hydroxychloroquine|mesh-list
92999001|NCT04005768|Antimalarials|antimalarials|mesh-ancestor
92999002|NCT04005768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92999003|NCT04005768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92999004|NCT04005768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999005|NCT04005768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999006|NCT04005768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999007|NCT04005768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999008|NCT00987792|Moxifloxacin|moxifloxacin|mesh-list
92999009|NCT00987792|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92999010|NCT00987792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999011|NCT00987792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999012|NCT00987792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92999013|NCT00987792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92999014|NCT00987792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999015|NCT00987792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999016|NCT00987792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999017|NCT00987792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92999018|NCT00987792|Contraceptive Agents|contraceptive agents|mesh-ancestor
92999019|NCT00987792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92999020|NCT00987792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999021|NCT00987792|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92999022|NCT00987792|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92999023|NCT00987792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92999024|NCT00987870|Betamethasone|betamethasone|mesh-list
92999025|NCT00987870|Calcipotriene|calcipotriene|mesh-list
92999026|NCT00987870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999027|NCT00987870|Glucocorticoids|glucocorticoids|mesh-ancestor
92999028|NCT00987870|Hormones|hormones|mesh-ancestor
92999029|NCT00987870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999030|NCT00987870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999031|NCT00987870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92999032|NCT00987870|Respiratory System Agents|respiratory system agents|mesh-ancestor
92999033|NCT00987870|Dermatologic Agents|dermatologic agents|mesh-ancestor
92999034|NCT00988026|Minocycline|minocycline|mesh-list
92999036|NCT00988026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999037|NCT00988026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999038|NCT05578170|Pembrolizumab|pembrolizumab|mesh-list
92999039|NCT05578170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999040|NCT05578170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999041|NCT05578170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999042|NCT05578170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999043|NCT00989274|Vaccines|vaccines|mesh-list
92999044|NCT00989274|Immunologic Factors|immunologic factors|mesh-ancestor
92999045|NCT00989274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999046|NCT03310944|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92999047|NCT03310944|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92999048|NCT03310944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999049|NCT03310944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92999050|NCT03310944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999051|NCT05712642|Bevacizumab|bevacizumab|mesh-list
92999052|NCT05712642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999053|NCT05712642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168377|NCT05033522|Sorafenib|sorafenib|mesh-list
92999054|NCT05712642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92999055|NCT05712642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92999056|NCT05712642|Growth Substances|growth substances|mesh-ancestor
92999057|NCT05712642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999058|NCT05712642|Growth Inhibitors|growth inhibitors|mesh-ancestor
92999059|NCT05492682|Cyclophosphamide|cyclophosphamide|mesh-list
92999060|NCT05492682|Pembrolizumab|pembrolizumab|mesh-list
92999061|NCT05492682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999062|NCT05492682|Immunologic Factors|immunologic factors|mesh-ancestor
92999063|NCT05492682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999064|NCT05492682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999065|NCT05492682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92999066|NCT05492682|Alkylating Agents|alkylating agents|mesh-ancestor
92999067|NCT05492682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999068|NCT05492682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999069|NCT05492682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92999070|NCT05492682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999071|NCT05492682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999072|NCT01085149|Simvastatin|simvastatin|mesh-list
92999073|NCT01085149|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92999074|NCT01085149|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92999075|NCT01085149|Antimetabolites|antimetabolites|mesh-ancestor
92644425|NCT00241254|Prednisolone|prednisolone|mesh-list
92999076|NCT01085149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999077|NCT01085149|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92999078|NCT01085149|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92999079|NCT01085149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999081|NCT04005612|Ergocalciferols|ergocalciferols|mesh-list
92999082|NCT04005612|Cholecalciferol|cholecalciferol|mesh-list
92999083|NCT04005612|Vitamins|vitamins|mesh-list
92999084|NCT04005612|Micronutrients|micronutrients|mesh-ancestor
92999085|NCT04005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999086|NCT04005612|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92999087|NCT04005612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92999088|NCT00413920|Mycophenolic Acid|mycophenolic acid|mesh-list
92999089|NCT00413920|Prednisone|prednisone|mesh-list
92999090|NCT00413920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999091|NCT00413920|Glucocorticoids|glucocorticoids|mesh-ancestor
92999092|NCT00413920|Hormones|hormones|mesh-ancestor
92999093|NCT00413920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999094|NCT00413920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999095|NCT00413920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92999096|NCT00413920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999097|NCT00413920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92999098|NCT00413920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92999099|NCT00413920|Antitubercular Agents|antitubercular agents|mesh-ancestor
92999100|NCT00413920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999101|NCT00413920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999102|NCT00413920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999103|NCT00413920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999104|NCT00091819|Vancomycin|vancomycin|mesh-list
92999105|NCT00091819|Telavancin|telavancin|mesh-list
92999106|NCT00091819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999107|NCT00091819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999108|NCT01326871|Gemcitabine|gemcitabine|mesh-list
92999109|NCT01326871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999110|NCT01326871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92999111|NCT01326871|Antimetabolites|antimetabolites|mesh-ancestor
92999112|NCT01326871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999113|NCT01081561|Riboflavin|riboflavin|mesh-list
92999114|NCT01081561|Vitamin B Complex|vitamin b complex|mesh-ancestor
92999115|NCT01081561|Vitamins|vitamins|mesh-ancestor
92999116|NCT01081561|Micronutrients|micronutrients|mesh-ancestor
92999117|NCT01081561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999118|NCT01081561|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92999119|NCT01081561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92999120|NCT04004754|Miltefosine|miltefosine|mesh-list
92999121|NCT04004754|Antifungal Agents|antifungal agents|mesh-ancestor
92999122|NCT04004754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999123|NCT04004754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999124|NCT04004754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92999125|NCT04004754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92999126|NCT05919797|Naltrexone|naltrexone|mesh-list
92999127|NCT05919797|Bupropion|bupropion|mesh-list
92999128|NCT05919797|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92999129|NCT05919797|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92999130|NCT05919797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999131|NCT05919797|Sensory System Agents|sensory system agents|mesh-ancestor
92999132|NCT05919797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999133|NCT05919797|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92999134|NCT05919797|Antidepressive Agents|antidepressive agents|mesh-ancestor
92999135|NCT05919797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92999136|NCT05919797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92999137|NCT05919797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92999138|NCT05919797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92999139|NCT05919797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999140|NCT05919797|Dopamine Agents|dopamine agents|mesh-ancestor
92999141|NCT05919797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999142|NCT05919797|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92999143|NCT05919797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92999144|NCT05919797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999145|NCT05919732|Epinephrine|epinephrine|mesh-list
92999146|NCT05919732|Bupivacaine|bupivacaine|mesh-list
92999147|NCT05919732|Anesthetics, Local|anesthetics, local|mesh-ancestor
92999148|NCT05919732|Anesthetics|anesthetics|mesh-ancestor
92999149|NCT05919732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999150|NCT05919732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999151|NCT05919732|Sensory System Agents|sensory system agents|mesh-ancestor
92999152|NCT05919732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999153|NCT05919732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92999154|NCT05919732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92999155|NCT05919732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92999156|NCT05919732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999157|NCT05919732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999158|NCT05919732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92999159|NCT05919732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92999160|NCT05919732|Autonomic Agents|autonomic agents|mesh-ancestor
92999161|NCT05919732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92999162|NCT05919732|Respiratory System Agents|respiratory system agents|mesh-ancestor
92999163|NCT05919732|Mydriatics|mydriatics|mesh-ancestor
92999164|NCT05919732|Sympathomimetics|sympathomimetics|mesh-ancestor
92999165|NCT05919732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92999166|NCT05919615|Tranexamic Acid|tranexamic acid|mesh-list
92999167|NCT05919615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92528404|NCT00035854|Linezolid|linezolid|mesh-list
92999168|NCT05919615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92999169|NCT05919615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999171|NCT05919615|Coagulants|coagulants|mesh-ancestor
92999172|NCT05919550|Clozapine|clozapine|mesh-list
92999173|NCT05919550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92999174|NCT05919550|Serotonin Agents|serotonin agents|mesh-ancestor
92999175|NCT05919550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999176|NCT05919550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999177|NCT05919550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999178|NCT05919550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92999179|NCT05919550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92999180|NCT05919550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999181|NCT05919550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92999182|NCT05919550|GABA Antagonists|gaba antagonists|mesh-ancestor
92999183|NCT05919550|GABA Agents|gaba agents|mesh-ancestor
92999184|NCT05919537|Paclitaxel|paclitaxel|mesh-list
92999185|NCT05919537|Docetaxel|docetaxel|mesh-list
92999186|NCT05919537|Gemcitabine|gemcitabine|mesh-list
92999187|NCT05919537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92999188|NCT05919537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999189|NCT05919537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92999190|NCT05919537|Antimitotic Agents|antimitotic agents|mesh-ancestor
92999191|NCT05919537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92999192|NCT05919537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999193|NCT05919537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92999194|NCT05919537|Antimetabolites|antimetabolites|mesh-ancestor
92999195|NCT05919472|Iron|iron|mesh-list
92999196|NCT05919472|Vaccines|vaccines|mesh-list
92999197|NCT05919472|Immunologic Factors|immunologic factors|mesh-ancestor
92999198|NCT05919472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999199|NCT05919472|Trace Elements|trace elements|mesh-ancestor
92999200|NCT05919472|Micronutrients|micronutrients|mesh-ancestor
92999201|NCT05919407|Amifampridine|amifampridine|mesh-list
92999202|NCT05919407|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92999203|NCT05919407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92999204|NCT05919407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999205|NCT05919407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999206|NCT05919407|Cholinergic Agents|cholinergic agents|mesh-ancestor
92999207|NCT05919407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999208|NCT05919407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999209|NCT05919407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92999210|NCT05919407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999211|NCT05919407|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92999212|NCT05919407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92999213|NCT05919277|Antibodies|antibodies|mesh-list
92999214|NCT05919277|Immunoglobulins|immunoglobulins|mesh-list
92999215|NCT05919277|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92999216|NCT05919277|Immunoglobulin G|immunoglobulin g|mesh-list
92999217|NCT05919277|Immunologic Factors|immunologic factors|mesh-ancestor
92999218|NCT05919277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999219|NCT05919121|Hydrocortisone|hydrocortisone|mesh-list
92999220|NCT05919121|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92999221|NCT05919121|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92999222|NCT05919121|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92999223|NCT05919121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999224|NCT05919017|Naltrexone|naltrexone|mesh-list
92999225|NCT05919017|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92999226|NCT05919017|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92999227|NCT05919017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999228|NCT05919017|Sensory System Agents|sensory system agents|mesh-ancestor
92999229|NCT05919017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999230|NCT05918952|Antibodies|antibodies|mesh-list
92999231|NCT05918952|Immunologic Factors|immunologic factors|mesh-ancestor
92999232|NCT05918952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999233|NCT05918861|Dalcetrapib|dalcetrapib|mesh-list
92999234|NCT05918861|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92999235|NCT05918861|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92999236|NCT05918861|Antimetabolites|antimetabolites|mesh-ancestor
92999237|NCT05918861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999238|NCT05918861|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92999239|NCT05918822|Maribavir|maribavir|mesh-list
92999240|NCT05918822|Rabeprazole|rabeprazole|mesh-list
92999241|NCT05918822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92999242|NCT05918822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999243|NCT05918822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92999244|NCT05918822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999245|NCT05918822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999246|NCT05918822|Antiviral Agents|antiviral agents|mesh-ancestor
92999247|NCT05918822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999248|NCT05918796|Dexamethasone|dexamethasone|mesh-list
92999249|NCT05918796|Bupivacaine|bupivacaine|mesh-list
92999250|NCT05918796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999251|NCT05918796|Antiemetics|antiemetics|mesh-ancestor
92999252|NCT05918796|Autonomic Agents|autonomic agents|mesh-ancestor
92999253|NCT05918796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999254|NCT05918796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999255|NCT05918796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999256|NCT05918796|Glucocorticoids|glucocorticoids|mesh-ancestor
92999257|NCT05918796|Hormones|hormones|mesh-ancestor
92999258|NCT05918796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999259|NCT05918796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92999260|NCT05918796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999261|NCT05918796|Anesthetics, Local|anesthetics, local|mesh-ancestor
92999262|NCT05918796|Anesthetics|anesthetics|mesh-ancestor
92999263|NCT05918796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999264|NCT05918796|Sensory System Agents|sensory system agents|mesh-ancestor
92999265|NCT05918718|Methotrexate|methotrexate|mesh-list
92999266|NCT05918718|Letrozole|letrozole|mesh-list
92999267|NCT05918718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92999268|NCT05918718|Abortifacient Agents|abortifacient agents|mesh-ancestor
92999269|NCT05918718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92999270|NCT05918718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999271|NCT05918718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92999272|NCT05918718|Antimetabolites|antimetabolites|mesh-ancestor
92999273|NCT05918718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999274|NCT05918718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999275|NCT05918718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92999276|NCT05918718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999277|NCT05918718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92999278|NCT05918718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999279|NCT05918718|Immunologic Factors|immunologic factors|mesh-ancestor
92999280|NCT05918718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999281|NCT05918718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92999282|NCT05918718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92999283|NCT05918718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92999284|NCT05918718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92999285|NCT05918718|Hormone Antagonists|hormone antagonists|mesh-ancestor
92999286|NCT05918718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999287|NCT05918627|Belumosudil|belumosudil|mesh-list
92999288|NCT05918627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999289|NCT05918627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999290|NCT05918627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999291|NCT05918614|Belumosudil|belumosudil|mesh-list
92999292|NCT05918614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999293|NCT05918614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999294|NCT05918614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999295|NCT05918588|Belumosudil|belumosudil|mesh-list
92999296|NCT05918588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999297|NCT05918588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999298|NCT05918588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999299|NCT05918341|Piracetam|piracetam|mesh-list
92999300|NCT05918341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92999301|NCT05918341|Protective Agents|protective agents|mesh-ancestor
92999302|NCT05918341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999303|NCT05918341|Nootropic Agents|nootropic agents|mesh-ancestor
92999304|NCT05918328|Paclitaxel|paclitaxel|mesh-list
92999305|NCT05918328|Docetaxel|docetaxel|mesh-list
92999306|NCT05918328|Carboplatin|carboplatin|mesh-list
92999307|NCT05918328|Trastuzumab|trastuzumab|mesh-list
92999308|NCT05918328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92999309|NCT05918328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999310|NCT05918328|Tubulin Modulators|tubulin modulators|mesh-ancestor
92999311|NCT05918328|Antimitotic Agents|antimitotic agents|mesh-ancestor
92999312|NCT05918328|Mitosis Modulators|mitosis modulators|mesh-ancestor
92999313|NCT05918328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999314|NCT05918328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999315|NCT05918302|Everolimus|everolimus|mesh-list
92999316|NCT05918302|Edotreotide|edotreotide|mesh-list
92999317|NCT05918302|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
92999318|NCT05918302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92999320|NCT05918302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999321|NCT05918302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999322|NCT05918302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999323|NCT05918302|Immunologic Factors|immunologic factors|mesh-ancestor
92999324|NCT05918302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999325|NCT05918302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999326|NCT05918302|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92999327|NCT05918211|Udenafil|udenafil|mesh-list
92999328|NCT05918211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92999329|NCT05918211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92999330|NCT05918211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999331|NCT05918211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999332|NCT05918198|Venetoclax|venetoclax|mesh-list
92999333|NCT05918198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999334|NCT05918094|Fluorouracil|fluorouracil|mesh-list
92999335|NCT05918094|Antimetabolites|antimetabolites|mesh-ancestor
92999336|NCT05918094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999337|NCT05918094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92999338|NCT05918094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999339|NCT05918094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999340|NCT05918094|Immunologic Factors|immunologic factors|mesh-ancestor
92999341|NCT05918094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999342|NCT05918068|Vitamin B 6|vitamin b 6|mesh-list
92999343|NCT05918068|Pyridoxal|pyridoxal|mesh-list
92999344|NCT05918068|Pyridoxine|pyridoxine|mesh-list
92999345|NCT05918068|Metformin|metformin|mesh-list
92999346|NCT05918068|Vitamins|vitamins|mesh-ancestor
92999347|NCT05918068|Micronutrients|micronutrients|mesh-ancestor
92999348|NCT05918068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999349|NCT05918068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92999350|NCT05918068|Vitamin B Complex|vitamin b complex|mesh-ancestor
92999351|NCT05918029|Potassium Citrate|potassium citrate|mesh-list
92999352|NCT05918029|Diuretics|diuretics|mesh-ancestor
92999353|NCT05918029|Natriuretic Agents|natriuretic agents|mesh-ancestor
92999354|NCT05918029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999355|NCT05918029|Expectorants|expectorants|mesh-ancestor
92999356|NCT05918029|Respiratory System Agents|respiratory system agents|mesh-ancestor
92999357|NCT05917691|Anesthetics|anesthetics|mesh-list
92999358|NCT05917691|Anesthetics, General|anesthetics, general|mesh-list
92999359|NCT05917691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999360|NCT05917691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999361|NCT05917587|Metformin|metformin|mesh-list
92999362|NCT05917587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92999363|NCT05917587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999364|NCT05917522|Abatacept|abatacept|mesh-list
92999365|NCT05917522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999366|NCT05917522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999367|NCT05917522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999368|NCT05917522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999369|NCT05917522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999370|NCT05917522|Immunologic Factors|immunologic factors|mesh-ancestor
92999371|NCT05917522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999372|NCT05917522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999373|NCT05914506|Xenon|xenon|mesh-list
92999374|NCT05914506|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92999375|NCT05914506|Anesthetics, General|anesthetics, general|mesh-ancestor
92999376|NCT05914506|Anesthetics|anesthetics|mesh-ancestor
92999377|NCT05914506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999378|NCT05914506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999379|NCT05913817|Adalimumab|adalimumab|mesh-list
92999380|NCT05913817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92999381|NCT05913817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999382|NCT05913817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999383|NCT05912244|Nivolumab|nivolumab|mesh-list
92999384|NCT05912244|Relatlimab|relatlimab|mesh-list
92999385|NCT05912244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999386|NCT05912244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999387|NCT05912244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999388|NCT05912244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999389|NCT05909683|Anti-Infective Agents|anti-infective agents|mesh-list
92999390|NCT05909683|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92999391|NCT05907993|Ibuprofen|ibuprofen|mesh-list
92999392|NCT05907993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92999393|NCT05907993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999394|NCT05907993|Analgesics|analgesics|mesh-ancestor
92999395|NCT05907993|Sensory System Agents|sensory system agents|mesh-ancestor
92999396|NCT05907993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999397|NCT05907993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999398|NCT05907993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999399|NCT05907993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999400|NCT05907993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92999401|NCT05907993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999402|NCT05907993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999403|NCT05900427|Bupivacaine|bupivacaine|mesh-list
92999404|NCT05900427|Anesthetics, Local|anesthetics, local|mesh-ancestor
92999405|NCT05900427|Anesthetics|anesthetics|mesh-ancestor
92999406|NCT05900427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999407|NCT05900427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999408|NCT05900427|Sensory System Agents|sensory system agents|mesh-ancestor
92999409|NCT05900427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999410|NCT05888831|Nivolumab|nivolumab|mesh-list
92999411|NCT05888831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999412|NCT05888831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999413|NCT05888831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999414|NCT05888831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999415|NCT05883241|Diclofenac|diclofenac|mesh-list
92999416|NCT05883241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92999417|NCT05883241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999418|NCT05883241|Analgesics|analgesics|mesh-ancestor
92999419|NCT05883241|Sensory System Agents|sensory system agents|mesh-ancestor
92999420|NCT05883241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999421|NCT05883241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999422|NCT05883241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999423|NCT05883241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999424|NCT05883241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92999425|NCT05883241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999426|NCT05883241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999427|NCT05882812|Diclofenac|diclofenac|mesh-list
92999428|NCT05882812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92999429|NCT05882812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999430|NCT05882812|Analgesics|analgesics|mesh-ancestor
92999431|NCT05882812|Sensory System Agents|sensory system agents|mesh-ancestor
92999432|NCT05882812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999433|NCT05882812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999434|NCT05882812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999435|NCT05882812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999436|NCT05882812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92999437|NCT05882812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999438|NCT05882812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999439|NCT05879107|Vaccines|vaccines|mesh-list
92999440|NCT05879107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92999441|NCT05879107|Immunologic Factors|immunologic factors|mesh-ancestor
92999442|NCT05879107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999443|NCT05874245|Midazolam|midazolam|mesh-list
92999444|NCT05874245|Dexmedetomidine|dexmedetomidine|mesh-list
92999445|NCT05874245|Ketamine|ketamine|mesh-list
92999446|NCT05874245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92999447|NCT05874245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999448|NCT05874245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999449|NCT05874245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999450|NCT05874245|Analgesics|analgesics|mesh-ancestor
92999451|NCT05874245|Sensory System Agents|sensory system agents|mesh-ancestor
92999452|NCT05874245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999453|NCT05874245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92999454|NCT05874245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92999455|NCT05874245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92999456|NCT05874245|Adrenergic Agents|adrenergic agents|mesh-ancestor
92999457|NCT05874245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999458|NCT05874245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999459|NCT05874245|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92999460|NCT05874245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92999461|NCT05874245|Anesthetics, General|anesthetics, general|mesh-ancestor
92999462|NCT05874245|Anesthetics|anesthetics|mesh-ancestor
92999463|NCT05874245|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92999464|NCT05874245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92999465|NCT05874245|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92999466|NCT05874245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92999467|NCT05874245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92999468|NCT05874245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92999469|NCT05874245|GABA Modulators|gaba modulators|mesh-ancestor
92999470|NCT05874245|GABA Agents|gaba agents|mesh-ancestor
92999471|NCT05824351|Propolis|propolis|mesh-list
92999472|NCT05824351|Pycnogenols|pycnogenols|mesh-list
92999473|NCT05824351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92999474|NCT05824351|Immunologic Factors|immunologic factors|mesh-ancestor
92999475|NCT05824351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999476|NCT05824351|Antioxidants|antioxidants|mesh-ancestor
92999477|NCT05824351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999478|NCT05824351|Protective Agents|protective agents|mesh-ancestor
92999479|NCT05824351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92999480|NCT05824351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999481|NCT05824143|Carbamazepine|carbamazepine|mesh-list
92999482|NCT05824143|Anticonvulsants|anticonvulsants|mesh-ancestor
92999483|NCT05824143|Antimanic Agents|antimanic agents|mesh-ancestor
92999484|NCT05824143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92999485|NCT05824143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999486|NCT05824143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999487|NCT05824143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92999488|NCT05824143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999489|NCT05824143|Analgesics|analgesics|mesh-ancestor
92999490|NCT05824143|Sensory System Agents|sensory system agents|mesh-ancestor
92999491|NCT05824143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999492|NCT05824143|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92999493|NCT05824143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92999494|NCT05824143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999495|NCT05824143|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92999496|NCT05824143|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92999497|NCT05730712|Trastuzumab|trastuzumab|mesh-list
92999498|NCT05730712|Pertuzumab|pertuzumab|mesh-list
92999499|NCT05730712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999500|NCT05730712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999501|NCT05687136|Peposertib|peposertib|mesh-list
92999502|NCT05687136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999503|NCT05687136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999504|NCT05687136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999505|NCT05687032|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92999506|NCT05687032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999507|NCT05687032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999508|NCT05687032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92999509|NCT05687032|Immunotoxins|immunotoxins|mesh-ancestor
92999510|NCT05687032|Immunoconjugates|immunoconjugates|mesh-ancestor
92999511|NCT05687032|Immunologic Factors|immunologic factors|mesh-ancestor
92999512|NCT05687032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999513|NCT05664568|Amoxicillin|amoxicillin|mesh-list
92999514|NCT05664568|Clavulanic Acid|clavulanic acid|mesh-list
92999515|NCT05664568|Clavulanic Acids|clavulanic acids|mesh-list
92999516|NCT05664568|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92999517|NCT05664568|Cephalexin|cephalexin|mesh-list
92999518|NCT05664568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999519|NCT05664568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999520|NCT05664568|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92999521|NCT05664568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999522|NCT05664568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999523|NCT05525858|Bevacizumab|bevacizumab|mesh-list
92999524|NCT05525858|Trastuzumab|trastuzumab|mesh-list
92999525|NCT05525858|Atezolizumab|atezolizumab|mesh-list
92999526|NCT05525858|Pertuzumab|pertuzumab|mesh-list
92999527|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92999528|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92999529|NCT05525858|Vemurafenib|vemurafenib|mesh-list
92999530|NCT05525858|Maytansine|maytansine|mesh-list
92999531|NCT05525858|Pralsetinib|pralsetinib|mesh-list
92999533|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999534|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999535|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92999536|NCT05525858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92999537|NCT05525858|Growth Substances|growth substances|mesh-ancestor
92999538|NCT05525858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999539|NCT05525858|Growth Inhibitors|growth inhibitors|mesh-ancestor
92999540|NCT05525858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999541|NCT05525858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999542|NCT05525858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528420|NCT00035893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999543|NCT05525858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999544|NCT05525858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92999545|NCT05525858|Tubulin Modulators|tubulin modulators|mesh-ancestor
92999546|NCT05525858|Antimitotic Agents|antimitotic agents|mesh-ancestor
92999547|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
92999548|NCT05525858|Immunotoxins|immunotoxins|mesh-ancestor
92999549|NCT05525858|Immunoconjugates|immunoconjugates|mesh-ancestor
92999550|NCT05525858|Immunologic Factors|immunologic factors|mesh-ancestor
92999551|NCT05524584|Fulvestrant|fulvestrant|mesh-list
92999552|NCT05524584|Anastrozole|anastrozole|mesh-list
92999553|NCT05524584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92999554|NCT05524584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999555|NCT05524584|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92999556|NCT05524584|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92999557|NCT05524584|Hormone Antagonists|hormone antagonists|mesh-ancestor
92999558|NCT05524584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999559|NCT05524584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999560|NCT05524584|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92999561|NCT05524584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92999562|NCT05524584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168394|NCT04976868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92999563|NCT05524584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999564|NCT05507541|Pembrolizumab|pembrolizumab|mesh-list
92999565|NCT05507541|Immunoglobulin G|immunoglobulin g|mesh-list
92999566|NCT05507541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999567|NCT05507541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999568|NCT05507541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999569|NCT05507541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999570|NCT05507541|Immunologic Factors|immunologic factors|mesh-ancestor
92999571|NCT05507541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999572|NCT05498220|Dexamethasone|dexamethasone|mesh-list
92999573|NCT05498220|Rituximab|rituximab|mesh-list
92999574|NCT05498220|Gemcitabine|gemcitabine|mesh-list
92999575|NCT05498220|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92999576|NCT05498220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999577|NCT05498220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999578|NCT05498220|Immunologic Factors|immunologic factors|mesh-ancestor
92999579|NCT05498220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999580|NCT05498220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999581|NCT05498220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999582|NCT05498220|Antiemetics|antiemetics|mesh-ancestor
92999583|NCT05498220|Autonomic Agents|autonomic agents|mesh-ancestor
92999584|NCT05498220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999585|NCT05498220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999586|NCT05498220|Glucocorticoids|glucocorticoids|mesh-ancestor
92999587|NCT05498220|Hormones|hormones|mesh-ancestor
92999588|NCT05498220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999589|NCT05498220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92999590|NCT05498220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92999591|NCT05498220|Antimetabolites|antimetabolites|mesh-ancestor
92999592|NCT05498220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999593|NCT05498220|Immunoconjugates|immunoconjugates|mesh-ancestor
92999594|NCT05494437|Gabapentin|gabapentin|mesh-list
92999595|NCT05494437|Nabilone|nabilone|mesh-list
92999596|NCT05494437|Analgesics|analgesics|mesh-ancestor
92999597|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
92999598|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999599|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999600|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
92999601|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92999602|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92999603|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999604|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644955|NCT04642846|Cariostatic Agents|cariostatic agents|mesh-ancestor
92999605|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92999606|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92999607|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999608|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999609|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
92999610|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
92999611|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
92999612|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999613|NCT05440708|Bevacizumab|bevacizumab|mesh-list
92999614|NCT05440708|Pembrolizumab|pembrolizumab|mesh-list
92999615|NCT05440708|Atezolizumab|atezolizumab|mesh-list
92999616|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999617|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999618|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92999619|NCT05440708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92999620|NCT05440708|Growth Substances|growth substances|mesh-ancestor
92999621|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999622|NCT05440708|Growth Inhibitors|growth inhibitors|mesh-ancestor
92999623|NCT05440708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999624|NCT05440708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999625|NCT05428488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92999626|NCT05428488|Abatacept|abatacept|mesh-list
92999627|NCT05428488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999628|NCT05428488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999629|NCT05428488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999630|NCT05428488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999631|NCT05428488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999632|NCT05428488|Immunologic Factors|immunologic factors|mesh-ancestor
92999633|NCT05428488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999634|NCT05428488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999635|NCT05428488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999636|NCT05414201|Adalimumab|adalimumab|mesh-list
92999637|NCT05414201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92999638|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999639|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999640|NCT05412004|Tirzepatide|tirzepatide|mesh-list
92999641|NCT05412004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92999642|NCT05412004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999643|NCT05412004|Incretins|incretins|mesh-ancestor
92999644|NCT05412004|Hormones|hormones|mesh-ancestor
92999645|NCT05412004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999646|NCT05405751|Tenofovir|tenofovir|mesh-list
92999647|NCT05405751|Emtricitabine|emtricitabine|mesh-list
92999648|NCT05405751|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92999649|NCT05405751|Antiviral Agents|antiviral agents|mesh-ancestor
92999650|NCT05405751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999651|NCT05405751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92999652|NCT05405751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92999653|NCT05405751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999654|NCT05405751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999655|NCT05405751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92999656|NCT05405751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92999657|NCT05405309|Olaparib|olaparib|mesh-list
92999658|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92999659|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999660|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999661|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999662|NCT05392452|Insulin|insulin|mesh-list
92999663|NCT05392452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92999664|NCT05392452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999665|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
92999666|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92999667|NCT05387187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999668|NCT05387187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999669|NCT05387187|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92999670|NCT05387187|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92999671|NCT05387187|Protective Agents|protective agents|mesh-ancestor
92999672|NCT05387187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999673|NCT05387187|Vasodilator Agents|vasodilator agents|mesh-ancestor
92999674|NCT05387187|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92999675|NCT05387187|Antioxidants|antioxidants|mesh-ancestor
92999676|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
92999677|NCT05365893|Losartan|losartan|mesh-list
92999678|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
92999679|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92999680|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92999681|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999682|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999683|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999684|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999685|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92999686|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92999687|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92999688|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92999689|NCT05364073|Aflutinib|aflutinib|mesh-list
92999690|NCT05364073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999691|NCT05364073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999692|NCT05364073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999693|NCT05312671|Cisplatin|cisplatin|mesh-list
92999694|NCT05312671|Carboplatin|carboplatin|mesh-list
92999695|NCT05312671|Etoposide|etoposide|mesh-list
92999696|NCT05312671|Atezolizumab|atezolizumab|mesh-list
92999697|NCT05312671|Podophyllotoxin|podophyllotoxin|mesh-list
92999698|NCT05312671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999699|NCT05312671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92999700|NCT05312671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92999701|NCT05312671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92999702|NCT05312671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999703|NCT05312671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999704|NCT05312671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999705|NCT05312671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999706|NCT05312671|Keratolytic Agents|keratolytic agents|mesh-ancestor
92999707|NCT05312671|Dermatologic Agents|dermatologic agents|mesh-ancestor
92999708|NCT05312671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92999709|NCT05312671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92999710|NCT05312671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92999711|NCT05262270|Naltrexone|naltrexone|mesh-list
92999712|NCT05262270|Buprenorphine|buprenorphine|mesh-list
92999713|NCT05262270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92999714|NCT05262270|Narcotics|narcotics|mesh-ancestor
92999715|NCT05262270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999716|NCT05262270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999717|NCT05262270|Analgesics|analgesics|mesh-ancestor
92999718|NCT05262270|Sensory System Agents|sensory system agents|mesh-ancestor
92999719|NCT05262270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999720|NCT05262270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92999721|NCT05262270|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92999722|NCT05254574|Diclofenac|diclofenac|mesh-list
92999723|NCT05254574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92999724|NCT05254574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999725|NCT05254574|Analgesics|analgesics|mesh-ancestor
92999726|NCT05254574|Sensory System Agents|sensory system agents|mesh-ancestor
92999727|NCT05254574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999728|NCT05254574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999729|NCT05254574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999730|NCT05254574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999731|NCT05254574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92999732|NCT05254574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999733|NCT05254574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999734|NCT05219929|Tetracycline|tetracycline|mesh-list
92999735|NCT05219929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999736|NCT05219929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999737|NCT05219929|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92999738|NCT05219929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999739|NCT05219929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999740|NCT05205382|Nicotine|nicotine|mesh-list
92999741|NCT05205382|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92999742|NCT05205382|Autonomic Agents|autonomic agents|mesh-ancestor
92999743|NCT05205382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999744|NCT05205382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999745|NCT05205382|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92999746|NCT05205382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92999747|NCT05205382|Cholinergic Agents|cholinergic agents|mesh-ancestor
92999748|NCT05205382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999749|NCT05205382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999750|NCT05198843|Dasatinib|dasatinib|mesh-list
92999751|NCT05198843|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92999752|NCT05198843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999753|NCT05198843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999754|NCT05198843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999755|NCT05198843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999756|NCT05198843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92999757|NCT05198843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92999758|NCT05139225|Daratumumab|daratumumab|mesh-list
92999759|NCT05139225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999760|NCT05132829|Azithromycin|azithromycin|mesh-list
92999761|NCT05132829|Cefazolin|cefazolin|mesh-list
92999762|NCT05132829|Indomethacin|indomethacin|mesh-list
92999763|NCT05132829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92999764|NCT05132829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999765|NCT05132829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92999766|NCT05132829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999767|NCT05132829|Analgesics|analgesics|mesh-ancestor
92999768|NCT05132829|Sensory System Agents|sensory system agents|mesh-ancestor
92999769|NCT05132829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999770|NCT05132829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999771|NCT05132829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999772|NCT05132829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999773|NCT05132829|Gout Suppressants|gout suppressants|mesh-ancestor
92999774|NCT05132829|Tocolytic Agents|tocolytic agents|mesh-ancestor
92999775|NCT05132829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92999776|NCT05132829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92999777|NCT05132829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999778|NCT05132829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999779|NCT05117450|Heparin|heparin|mesh-list
92999780|NCT05117450|Anticoagulants|anticoagulants|mesh-ancestor
92999781|NCT05117450|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92999782|NCT05117450|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92999783|NCT05117450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999784|NCT05102669|Antibodies|antibodies|mesh-list
92999785|NCT05102669|Immunologic Factors|immunologic factors|mesh-ancestor
92999786|NCT05102669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999787|NCT05090566|Dexamethasone|dexamethasone|mesh-list
92999788|NCT05090566|Lenalidomide|lenalidomide|mesh-list
92999789|NCT05090566|Nirogacestat|nirogacestat|mesh-list
92999790|NCT05090566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999791|NCT05090566|Antiemetics|antiemetics|mesh-ancestor
92999792|NCT05090566|Autonomic Agents|autonomic agents|mesh-ancestor
92999793|NCT05090566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999794|NCT05090566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999795|NCT05090566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999796|NCT05090566|Glucocorticoids|glucocorticoids|mesh-ancestor
92999797|NCT05090566|Hormones|hormones|mesh-ancestor
92999798|NCT05090566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999799|NCT05090566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92999800|NCT05090566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999801|NCT05090566|Immunologic Factors|immunologic factors|mesh-ancestor
92999802|NCT05090566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92999803|NCT05090566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92999804|NCT05090566|Growth Substances|growth substances|mesh-ancestor
92999805|NCT05090566|Growth Inhibitors|growth inhibitors|mesh-ancestor
92999806|NCT05090566|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92999807|NCT05090566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999808|NCT05090566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999809|NCT05050448|Diclofenac|diclofenac|mesh-list
92999810|NCT05050448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92999811|NCT05050448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999812|NCT05050448|Analgesics|analgesics|mesh-ancestor
92999813|NCT05050448|Sensory System Agents|sensory system agents|mesh-ancestor
92999814|NCT05050448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999815|NCT05050448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999816|NCT05050448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999817|NCT05050448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92999818|NCT05050448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92999819|NCT05050448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999820|NCT05050448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999821|NCT04919226|Leucovorin|leucovorin|mesh-list
92999822|NCT04919226|Folic Acid|folic acid|mesh-list
92999823|NCT04919226|Fluorouracil|fluorouracil|mesh-list
92999824|NCT04919226|Capecitabine|capecitabine|mesh-list
92999825|NCT04919226|Oxaliplatin|oxaliplatin|mesh-list
92999826|NCT04919226|Everolimus|everolimus|mesh-list
92999827|NCT04919226|Temozolomide|temozolomide|mesh-list
92999828|NCT04919226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92999829|NCT04919226|Levoleucovorin|levoleucovorin|mesh-list
92999830|NCT04919226|Edotreotide|edotreotide|mesh-list
92999831|NCT04919226|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
92999832|NCT04919226|Antimetabolites|antimetabolites|mesh-ancestor
92999833|NCT04919226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999834|NCT04919226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92999835|NCT04919226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999836|NCT04919226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92999837|NCT04919226|Immunologic Factors|immunologic factors|mesh-ancestor
92999838|NCT04919226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999839|NCT04919226|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92999840|NCT04919226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999841|NCT04919226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999842|NCT04919226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92999843|NCT04919226|Alkylating Agents|alkylating agents|mesh-ancestor
92999844|NCT04919226|Antidotes|antidotes|mesh-ancestor
92999845|NCT04919226|Protective Agents|protective agents|mesh-ancestor
92999846|NCT04919226|Vitamin B Complex|vitamin b complex|mesh-ancestor
92999847|NCT04919226|Vitamins|vitamins|mesh-ancestor
92999848|NCT04919226|Micronutrients|micronutrients|mesh-ancestor
92999849|NCT04919226|Hematinics|hematinics|mesh-ancestor
92999850|NCT04919226|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92999851|NCT04899388|Fentanyl|fentanyl|mesh-list
92999852|NCT04899388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92999853|NCT04899388|Narcotics|narcotics|mesh-ancestor
92999854|NCT04899388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999855|NCT04899388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999856|NCT04899388|Analgesics|analgesics|mesh-ancestor
92999857|NCT04899388|Sensory System Agents|sensory system agents|mesh-ancestor
92999858|NCT04899388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999859|NCT04899388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92999860|NCT04899388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92999861|NCT04899388|Anesthetics, General|anesthetics, general|mesh-ancestor
92999862|NCT04899388|Anesthetics|anesthetics|mesh-ancestor
92999863|NCT04880785|Lamivudine|lamivudine|mesh-list
92999864|NCT04880785|Dolutegravir|dolutegravir|mesh-list
92999865|NCT04880785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92999866|NCT04880785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92999867|NCT04880785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999868|NCT04880785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999869|NCT04880785|Antiviral Agents|antiviral agents|mesh-ancestor
92999870|NCT04880785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999871|NCT04880785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92999872|NCT04880785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92999873|NCT04880785|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92999874|NCT04880785|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92999875|NCT04874246|Vasopressins|vasopressins|mesh-list
92999876|NCT04874246|Arginine Vasopressin|arginine vasopressin|mesh-list
92999877|NCT04874246|Hemostatics|hemostatics|mesh-ancestor
92999878|NCT04874246|Coagulants|coagulants|mesh-ancestor
92999879|NCT04874246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92999880|NCT04874246|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92999881|NCT04874246|Natriuretic Agents|natriuretic agents|mesh-ancestor
92999882|NCT04874246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999883|NCT04865731|Esomeprazole|esomeprazole|mesh-list
92999884|NCT04865731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92999885|NCT04865731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999886|NCT04865731|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92999887|NCT04865731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999888|NCT04865731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999889|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
92999890|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999891|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999892|NCT04847466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999893|NCT04847466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999894|NCT04793958|Cetuximab|cetuximab|mesh-list
92999895|NCT04793958|Adagrasib|adagrasib|mesh-list
92999896|NCT04793958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999897|NCT04793958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999898|NCT04781088|Paclitaxel|paclitaxel|mesh-list
92999899|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
92999900|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92999901|NCT04781088|Lenvatinib|lenvatinib|mesh-list
92999902|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92999903|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999904|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92999905|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92999906|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92999907|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999908|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999909|NCT04781088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999910|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92999911|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999912|NCT04777006|Amitriptyline|amitriptyline|mesh-list
92999913|NCT04777006|Fluoxetine|fluoxetine|mesh-list
92999914|NCT04777006|Antidepressive Agents|antidepressive agents|mesh-list
92999915|NCT04777006|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92999916|NCT04777006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92999917|NCT04777006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92999918|NCT04777006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999919|NCT04777006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92999921|NCT04777006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999922|NCT04777006|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92999923|NCT04777006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92999924|NCT04777006|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92999925|NCT04777006|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92999926|NCT04777006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999927|NCT04777006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92999928|NCT04777006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92999929|NCT04777006|Analgesics|analgesics|mesh-ancestor
92999930|NCT04777006|Sensory System Agents|sensory system agents|mesh-ancestor
92999931|NCT04777006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999932|NCT04777006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92999933|NCT04777006|Adrenergic Agents|adrenergic agents|mesh-ancestor
92999934|NCT04766086|Vaccines|vaccines|mesh-list
92999935|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
92999936|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999937|NCT04733547|Furosemide|furosemide|mesh-list
92999938|NCT04733547|Diuretics|diuretics|mesh-ancestor
92999939|NCT04733547|Natriuretic Agents|natriuretic agents|mesh-ancestor
92999940|NCT04733547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999941|NCT04733547|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92999942|NCT04733547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92999943|NCT04733547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999944|NCT04717986|Dapagliflozin|dapagliflozin|mesh-list
92999945|NCT04717986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92999946|NCT04717986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999947|NCT04717986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92999948|NCT04717986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999949|NCT04680910|Propofol|propofol|mesh-list
92999950|NCT04680910|Anesthetics|anesthetics|mesh-list
92999951|NCT04680910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92999952|NCT04680910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92999953|NCT04680910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999954|NCT04680910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92999955|NCT04680910|Anesthetics, General|anesthetics, general|mesh-ancestor
92999956|NCT04678102|PHI-101|phi-101|mesh-list
92999957|NCT04678102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92999958|NCT04678102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999959|NCT04678102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92999960|NCT04678102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999961|NCT04653246|Dexamethasone|dexamethasone|mesh-list
92999962|NCT04653246|Lenalidomide|lenalidomide|mesh-list
92999963|NCT04653246|Bortezomib|bortezomib|mesh-list
92999964|NCT04653246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92999965|NCT04653246|Antiemetics|antiemetics|mesh-ancestor
92999966|NCT04653246|Autonomic Agents|autonomic agents|mesh-ancestor
92999967|NCT04653246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92999968|NCT04653246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92999969|NCT04653246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92999970|NCT04653246|Glucocorticoids|glucocorticoids|mesh-ancestor
92999971|NCT04653246|Hormones|hormones|mesh-ancestor
92999972|NCT04653246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92999973|NCT04653246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92999974|NCT04653246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999975|NCT04653246|Immunologic Factors|immunologic factors|mesh-ancestor
92999976|NCT04653246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92999977|NCT04653246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92999978|NCT04653246|Growth Substances|growth substances|mesh-ancestor
92999979|NCT04653246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92645326|NCT00246636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92999980|NCT04643106|Hemostatics|hemostatics|mesh-list
92999981|NCT04643106|Coagulants|coagulants|mesh-ancestor
92999983|NCT04636437|Lamivudine|lamivudine|mesh-list
92999984|NCT04636437|Emtricitabine|emtricitabine|mesh-list
92999985|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
92999986|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
92999987|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92999988|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92999989|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345486|NCT04568603|Islatravir|islatravir|mesh-list
92999990|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92999991|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92999992|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92999993|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92999994|NCT04606914|Maytansine|maytansine|mesh-list
92999995|NCT04606914|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92999996|NCT04606914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92999997|NCT04606914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92999998|NCT04606914|Tubulin Modulators|tubulin modulators|mesh-ancestor
92999999|NCT04606914|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000000|NCT04606914|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000001|NCT04606914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000002|NCT04606914|Immunoconjugates|immunoconjugates|mesh-ancestor
93000003|NCT04606914|Immunologic Factors|immunologic factors|mesh-ancestor
93000004|NCT04606914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000005|NCT04600648|Insulin|insulin|mesh-list
93000006|NCT04600648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93000007|NCT04600648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000008|NCT04564885|Meloxicam|meloxicam|mesh-list
93000009|NCT04564885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93000010|NCT04564885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93000011|NCT04564885|Analgesics|analgesics|mesh-ancestor
93000012|NCT04564885|Sensory System Agents|sensory system agents|mesh-ancestor
93000013|NCT04564885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000014|NCT04564885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000015|NCT04564885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000016|NCT04564885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93000017|NCT04564885|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93000018|NCT04564885|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93000019|NCT04564885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000020|NCT04564885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000021|NCT04564157|Paclitaxel|paclitaxel|mesh-list
93000022|NCT04564157|Carboplatin|carboplatin|mesh-list
93000023|NCT04564157|Nivolumab|nivolumab|mesh-list
93000024|NCT04564157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000025|NCT04564157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000026|NCT04564157|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000027|NCT04564157|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000028|NCT04564157|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000029|NCT04564157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000030|NCT04564157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000031|NCT04564157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93000032|NCT04555577|Temozolomide|temozolomide|mesh-list
93000033|NCT04555577|Peposertib|peposertib|mesh-list
93000034|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93000035|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
93000036|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000037|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000038|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000039|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000040|NCT04509791|Immunoglobulins|immunoglobulins|mesh-list
93000041|NCT04509791|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93000042|NCT04509791|Antibodies|antibodies|mesh-list
93000043|NCT04509791|Thymoglobulin|thymoglobulin|mesh-list
93000044|NCT04509791|Immunologic Factors|immunologic factors|mesh-ancestor
93000045|NCT04509791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000046|NCT04509791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000047|NCT04504812|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93000048|NCT04504812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93000049|NCT04504812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93000050|NCT04504812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93000051|NCT04504812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000052|NCT04504812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000053|NCT04504812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000054|NCT04504812|Analgesics|analgesics|mesh-ancestor
93000055|NCT04504812|Sensory System Agents|sensory system agents|mesh-ancestor
93000056|NCT04504812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000057|NCT04504812|Antidepressive Agents|antidepressive agents|mesh-ancestor
93000058|NCT04504812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93000059|NCT04504812|Dopamine Agents|dopamine agents|mesh-ancestor
93000060|NCT04497584|Prednisone|prednisone|mesh-list
93000061|NCT04497584|Afatinib|afatinib|mesh-list
93000062|NCT04497584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000063|NCT04497584|Glucocorticoids|glucocorticoids|mesh-ancestor
93000065|NCT04497584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000066|NCT04497584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000067|NCT04497584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000068|NCT04497584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000069|NCT04497584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000070|NCT04497584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000071|NCT04497584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000072|NCT04484623|Dexamethasone|dexamethasone|mesh-list
93000073|NCT04484623|Bortezomib|bortezomib|mesh-list
93000074|NCT04484623|Pomalidomide|pomalidomide|mesh-list
93000075|NCT04484623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000076|NCT04484623|Antiemetics|antiemetics|mesh-ancestor
93000077|NCT04484623|Autonomic Agents|autonomic agents|mesh-ancestor
93000078|NCT04484623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000079|NCT04484623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000080|NCT04484623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000081|NCT04484623|Glucocorticoids|glucocorticoids|mesh-ancestor
93000082|NCT04484623|Hormones|hormones|mesh-ancestor
93000083|NCT04484623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000084|NCT04484623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000085|NCT04484623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000086|NCT04484623|Immunologic Factors|immunologic factors|mesh-ancestor
93000087|NCT04484623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93000088|NCT04484623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93000089|NCT04484623|Growth Substances|growth substances|mesh-ancestor
93000090|NCT04484623|Growth Inhibitors|growth inhibitors|mesh-ancestor
93000091|NCT04469595|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93000092|NCT04469595|Aflibercept|aflibercept|mesh-list
93000093|NCT04469595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93000094|NCT04469595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93000095|NCT04469595|Growth Substances|growth substances|mesh-ancestor
93000096|NCT04469595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000097|NCT04469595|Growth Inhibitors|growth inhibitors|mesh-ancestor
93000098|NCT04469595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000099|NCT04469595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000100|NCT04469595|Glucocorticoids|glucocorticoids|mesh-ancestor
93000101|NCT04469595|Hormones|hormones|mesh-ancestor
93000102|NCT04469595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000103|NCT04374877|Pembrolizumab|pembrolizumab|mesh-list
93000104|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000105|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000106|NCT04374877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93000107|NCT04374877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000108|NCT04266795|Azacitidine|azacitidine|mesh-list
93000109|NCT04266795|Venetoclax|venetoclax|mesh-list
93000110|NCT04266795|Pevonedistat|pevonedistat|mesh-list
93000111|NCT04266795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000112|NCT04266795|Antimetabolites|antimetabolites|mesh-ancestor
93000113|NCT04266795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000114|NCT04266795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000115|NCT04266795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000116|NCT04250636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93000117|NCT04250636|Antibodies|antibodies|mesh-list
93000118|NCT04250636|Immunoglobulins|immunoglobulins|mesh-list
93000119|NCT04250636|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93000120|NCT04250636|Immunologic Factors|immunologic factors|mesh-ancestor
93000121|NCT04250636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000122|NCT04250636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000123|NCT04233749|Tranexamic Acid|tranexamic acid|mesh-list
93000124|NCT04233749|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93000125|NCT04233749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93000126|NCT04233749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000127|NCT04233749|Hemostatics|hemostatics|mesh-ancestor
93000128|NCT04233749|Coagulants|coagulants|mesh-ancestor
93000129|NCT04231851|Cytarabine|cytarabine|mesh-list
93000130|NCT04231851|Daunorubicin|daunorubicin|mesh-list
93000131|NCT04231851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000133|NCT04231851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000134|NCT04231851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000135|NCT04231851|Antiviral Agents|antiviral agents|mesh-ancestor
93000136|NCT04231851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000137|NCT04231851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000138|NCT04231851|Immunologic Factors|immunologic factors|mesh-ancestor
93000139|NCT04231851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000140|NCT04231851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93000141|NCT04231851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93000142|NCT04231851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93000143|NCT04231851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000144|NCT04201561|Selenious Acid|selenious acid|mesh-list
93000145|NCT04201561|Sodium Selenite|sodium selenite|mesh-list
93000146|NCT04201561|Paclitaxel|paclitaxel|mesh-list
93000147|NCT04201561|Carboplatin|carboplatin|mesh-list
93000148|NCT04201561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000149|NCT04201561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000150|NCT04201561|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000151|NCT04201561|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000152|NCT04201561|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000153|NCT04201561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000154|NCT04201561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000155|NCT04201561|Trace Elements|trace elements|mesh-ancestor
93000156|NCT04201561|Micronutrients|micronutrients|mesh-ancestor
93000157|NCT04184609|Albuterol|albuterol|mesh-list
93000158|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93000159|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
93000160|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000161|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000162|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93000163|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
93000164|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
93000165|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93000166|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93000167|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93000168|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93000169|NCT04184609|Adrenergic Agents|adrenergic agents|mesh-ancestor
93000170|NCT04184609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000171|NCT04184609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000172|NCT04180215|Pembrolizumab|pembrolizumab|mesh-list
93000173|NCT04180215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000174|NCT04180215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000175|NCT04180215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93000176|NCT04180215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000177|NCT04162873|Celecoxib|celecoxib|mesh-list
93000178|NCT04162873|Benzenesulfonamide|benzenesulfonamide|mesh-list
93000179|NCT04162873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93000180|NCT04162873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93000181|NCT04162873|Analgesics|analgesics|mesh-ancestor
93000182|NCT04162873|Sensory System Agents|sensory system agents|mesh-ancestor
93000183|NCT04162873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000184|NCT04162873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000185|NCT04162873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000186|NCT04162873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93000187|NCT04162873|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93000188|NCT04162873|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93000189|NCT04162873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000190|NCT04162873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000191|NCT04162873|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93000192|NCT04157348|Benralizumab|benralizumab|mesh-list
93000193|NCT04157348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93000194|NCT04157348|Respiratory System Agents|respiratory system agents|mesh-ancestor
93000195|NCT04100018|Prednisone|prednisone|mesh-list
93000196|NCT04100018|Docetaxel|docetaxel|mesh-list
93000197|NCT04100018|Nivolumab|nivolumab|mesh-list
93000198|NCT04100018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000199|NCT04100018|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000200|NCT04100018|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000201|NCT04100018|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000202|NCT04100018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000203|NCT04100018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000204|NCT04100018|Glucocorticoids|glucocorticoids|mesh-ancestor
93000205|NCT04100018|Hormones|hormones|mesh-ancestor
92645555|NCT00220064|Leucovorin|leucovorin|mesh-list
93000206|NCT04100018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000207|NCT04100018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000208|NCT04100018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000209|NCT04100018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000210|NCT04100018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93000212|NCT04061421|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93000213|NCT04061421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000214|NCT04061421|Antimetabolites|antimetabolites|mesh-ancestor
93000215|NCT04061421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000216|NCT04061421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000217|NCT04061421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000218|NCT04046900|Metronidazole|metronidazole|mesh-list
93000219|NCT04046900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000220|NCT04046900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93000221|NCT04046900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93000222|NCT04046900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93000223|NCT03989115|Osimertinib|osimertinib|mesh-list
93000224|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000225|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000226|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000227|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000228|NCT03971071|Erenumab|erenumab|mesh-list
93000229|NCT03971071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93000230|NCT03971071|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93000231|NCT03971071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000232|NCT03971071|Analgesics|analgesics|mesh-ancestor
93000233|NCT03971071|Sensory System Agents|sensory system agents|mesh-ancestor
93000234|NCT03971071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000235|NCT03971071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000236|NCT03971071|Immunologic Factors|immunologic factors|mesh-ancestor
93000237|NCT03939897|Fulvestrant|fulvestrant|mesh-list
93000238|NCT03939897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000239|NCT03939897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000240|NCT03939897|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93000241|NCT03939897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93000242|NCT03939897|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000243|NCT03939897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000244|NCT03939897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000245|NCT03937843|Carboplatin|carboplatin|mesh-list
93000246|NCT03937843|Etoposide|etoposide|mesh-list
93000247|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000248|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000249|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93000250|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93000251|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000252|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000253|NCT03839823|Paclitaxel|paclitaxel|mesh-list
93000254|NCT03839823|Vinorelbine|vinorelbine|mesh-list
93000255|NCT03839823|Docetaxel|docetaxel|mesh-list
93000256|NCT03839823|Gemcitabine|gemcitabine|mesh-list
93000257|NCT03839823|Capecitabine|capecitabine|mesh-list
93000258|NCT03839823|Letrozole|letrozole|mesh-list
93000259|NCT03839823|Anastrozole|anastrozole|mesh-list
93000260|NCT03839823|Goserelin|goserelin|mesh-list
93000261|NCT03839823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000262|NCT03839823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000263|NCT03839823|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000264|NCT03839823|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000265|NCT03839823|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000266|NCT03839823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000267|NCT03839823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000268|NCT03839823|Antimetabolites|antimetabolites|mesh-ancestor
93000269|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93000270|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93000271|NCT03839823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000272|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93000273|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000274|NCT03839823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000275|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000276|NCT03839823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000277|NCT03787680|Olaparib|olaparib|mesh-list
93000278|NCT03787680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93000279|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000280|NCT03787680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000281|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000283|NCT03743636|Niacin|niacin|mesh-list
93000284|NCT03743636|Nicotinic Acids|nicotinic acids|mesh-list
93000285|NCT03743636|Resveratrol|resveratrol|mesh-list
93000286|NCT03743636|Antioxidants|antioxidants|mesh-ancestor
93000287|NCT03743636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000288|NCT03743636|Protective Agents|protective agents|mesh-ancestor
93000289|NCT03743636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000290|NCT03743636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000291|NCT03743636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93000292|NCT03743636|Vitamin B Complex|vitamin b complex|mesh-ancestor
93000293|NCT03743636|Vitamins|vitamins|mesh-ancestor
93000294|NCT03743636|Micronutrients|micronutrients|mesh-ancestor
93000295|NCT03743636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93000296|NCT03743636|Antimetabolites|antimetabolites|mesh-ancestor
93000297|NCT03743636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93000298|NCT03743636|Vasodilator Agents|vasodilator agents|mesh-ancestor
93000299|NCT03726775|Durvalumab|durvalumab|mesh-list
93000300|NCT03726775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000301|NCT03726775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000302|NCT03718039|Aprepitant|aprepitant|mesh-list
93000303|NCT03718039|Antiemetics|antiemetics|mesh-ancestor
93000304|NCT03718039|Autonomic Agents|autonomic agents|mesh-ancestor
93000305|NCT03718039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000306|NCT03718039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000307|NCT03718039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000308|NCT03718039|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93000309|NCT03718039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000310|NCT03718039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000311|NCT03672292|Voriconazole|voriconazole|mesh-list
93000312|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
93000313|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
93000314|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000315|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93000316|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93000317|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000318|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000319|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93000320|NCT03672292|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000321|NCT03672292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000322|NCT03672292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000323|NCT03672292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93000324|NCT03635164|Durvalumab|durvalumab|mesh-list
93000325|NCT03635164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000326|NCT03635164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000327|NCT03602014|Droxidopa|droxidopa|mesh-list
93000328|NCT03602014|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93000329|NCT03602014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93000330|NCT03559868|Digoxin|digoxin|mesh-list
93000331|NCT03559868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93000332|NCT03559868|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93000333|NCT03559868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000334|NCT03559868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000335|NCT03559868|Protective Agents|protective agents|mesh-ancestor
93000336|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000337|NCT03559192|Aticaprant|aticaprant|mesh-list
93000338|NCT03559192|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93000339|NCT03559192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000340|NCT03559192|Sensory System Agents|sensory system agents|mesh-ancestor
93000341|NCT03559192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000342|NCT03552471|Rucaparib|rucaparib|mesh-list
93000343|NCT03552471|Maytansine|maytansine|mesh-list
93000344|NCT03552471|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
93000345|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93000346|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000347|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000348|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000349|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000350|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000351|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000352|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000353|NCT03552471|Immunoconjugates|immunoconjugates|mesh-ancestor
93000354|NCT03552471|Immunologic Factors|immunologic factors|mesh-ancestor
93000355|NCT03552471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000356|NCT03533946|Rucaparib|rucaparib|mesh-list
93000357|NCT03533946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93000359|NCT03533946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000360|NCT03533946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000361|NCT03523585|Capecitabine|capecitabine|mesh-list
93000362|NCT03523585|Trastuzumab|trastuzumab|mesh-list
93000363|NCT03523585|Lapatinib|lapatinib|mesh-list
93000364|NCT03523585|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93000365|NCT03523585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000366|NCT03523585|Antimetabolites|antimetabolites|mesh-ancestor
93000367|NCT03523585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000368|NCT03523585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000369|NCT03523585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000370|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000371|NCT03523585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000372|NCT03523585|Immunoconjugates|immunoconjugates|mesh-ancestor
93000373|NCT03523585|Immunologic Factors|immunologic factors|mesh-ancestor
93000374|NCT03523585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000375|NCT03485911|Berotralstat|berotralstat|mesh-list
93000376|NCT03485911|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93000377|NCT03485911|Protease Inhibitors|protease inhibitors|mesh-ancestor
93000378|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000379|NCT03485911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000380|NCT03435250|Paclitaxel|paclitaxel|mesh-list
93000381|NCT03435250|Docetaxel|docetaxel|mesh-list
93000382|NCT03435250|Gemcitabine|gemcitabine|mesh-list
93000383|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000384|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000385|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000386|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000387|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000388|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000389|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000390|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
93000391|NCT03416153|Paclitaxel|paclitaxel|mesh-list
93000392|NCT03416153|Carboplatin|carboplatin|mesh-list
93000393|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000394|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000395|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000396|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000397|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000398|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000399|NCT03409718|Cimetidine|cimetidine|mesh-list
93000400|NCT03409718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93000401|NCT03409718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000402|NCT03409718|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93000403|NCT03409718|Histamine Antagonists|histamine antagonists|mesh-ancestor
93000404|NCT03409718|Histamine Agents|histamine agents|mesh-ancestor
93000405|NCT03409718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000406|NCT03409718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000407|NCT03409718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000408|NCT03409718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93000409|NCT03409718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93000410|NCT03409718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000411|NCT03395314|Midazolam|midazolam|mesh-list
93000412|NCT03395314|Ketamine|ketamine|mesh-list
93000413|NCT03395314|Analgesics|analgesics|mesh-ancestor
93000414|NCT03395314|Sensory System Agents|sensory system agents|mesh-ancestor
93000415|NCT03395314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000416|NCT03395314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000417|NCT03395314|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93000418|NCT03395314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93000419|NCT03395314|Anesthetics, General|anesthetics, general|mesh-ancestor
93000420|NCT03395314|Anesthetics|anesthetics|mesh-ancestor
93000421|NCT03395314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93000422|NCT03395314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93000423|NCT03395314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93000424|NCT03395314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000425|NCT03395314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000426|NCT03395314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93000427|NCT03395314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92645774|NCT04621513|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000428|NCT03395314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93000430|NCT03395314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93000431|NCT03395314|GABA Modulators|gaba modulators|mesh-ancestor
93000432|NCT03395314|GABA Agents|gaba agents|mesh-ancestor
93000433|NCT03386500|Manganese|manganese|mesh-list
93000434|NCT03386500|Trace Elements|trace elements|mesh-ancestor
93000435|NCT03386500|Micronutrients|micronutrients|mesh-ancestor
93000436|NCT03386500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000437|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
93000438|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000439|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000440|NCT03293680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93000441|NCT03293680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000442|NCT03245541|Durvalumab|durvalumab|mesh-list
93000443|NCT03245541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000444|NCT03245541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000445|NCT03239340|Osimertinib|osimertinib|mesh-list
93000446|NCT03239340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000447|NCT03239340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000448|NCT03239340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000449|NCT03239340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000450|NCT03187106|Metronidazole|metronidazole|mesh-list
93000451|NCT03187106|Cephalexin|cephalexin|mesh-list
93000452|NCT03187106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000453|NCT03187106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93000454|NCT03187106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93000455|NCT03187106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93000456|NCT03172975|Albendazole|albendazole|mesh-list
93000457|NCT03172975|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93000458|NCT03172975|Anthelmintics|anthelmintics|mesh-ancestor
93000459|NCT03172975|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93000460|NCT03172975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000461|NCT03172975|Anticestodal Agents|anticestodal agents|mesh-ancestor
93000462|NCT03172975|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93000463|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93000464|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000465|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000466|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000467|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000468|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000469|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93000470|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
93000471|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000472|NCT03172975|Antacids|antacids|mesh-ancestor
93000473|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000474|NCT03114527|Everolimus|everolimus|mesh-list
93000475|NCT03114527|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93000476|NCT03114527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000477|NCT03114527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000478|NCT03114527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000479|NCT03114527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000480|NCT03114527|Immunologic Factors|immunologic factors|mesh-ancestor
93000481|NCT03114527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000482|NCT03114527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000483|NCT03073785|Zoledronic Acid|zoledronic acid|mesh-list
93000484|NCT03073785|Fluorouracil|fluorouracil|mesh-list
93000485|NCT03073785|Capecitabine|capecitabine|mesh-list
93000486|NCT03073785|Imidazole|imidazole|mesh-list
93000487|NCT03073785|Antimetabolites|antimetabolites|mesh-ancestor
93000488|NCT03073785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000489|NCT03073785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000490|NCT03073785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000491|NCT03073785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000492|NCT03073785|Immunologic Factors|immunologic factors|mesh-ancestor
93000493|NCT03073785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000494|NCT03073785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93000495|NCT03073785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000496|NCT03028103|Repaglinide|repaglinide|mesh-list
93000497|NCT03028103|Fluconazole|fluconazole|mesh-list
93000498|NCT03028103|Omeprazole|omeprazole|mesh-list
93000499|NCT03028103|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93000500|NCT03028103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000501|NCT03028103|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93000502|NCT03028103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645849|NCT00220649|Antimetabolites|antimetabolites|mesh-ancestor
93000503|NCT03028103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000504|NCT03028103|Antifungal Agents|antifungal agents|mesh-ancestor
93000505|NCT03028103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000506|NCT03028103|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93000507|NCT03028103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93000508|NCT03028103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93000509|NCT03028103|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000510|NCT03028103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000511|NCT03028103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000512|NCT03028103|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93000513|NCT03028103|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93000514|NCT03028103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93000515|NCT03020589|Tacrolimus|tacrolimus|mesh-list
93000516|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000517|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
93000518|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000519|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93000520|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000521|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000522|NCT02932475|Metformin|metformin|mesh-list
93000523|NCT02932475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93000524|NCT02932475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000525|NCT02919917|Midodrine|midodrine|mesh-list
93000526|NCT02919917|Sympathomimetics|sympathomimetics|mesh-ancestor
93000527|NCT02919917|Autonomic Agents|autonomic agents|mesh-ancestor
93000528|NCT02919917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000529|NCT02919917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000530|NCT02919917|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93000531|NCT02919917|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93000532|NCT02919917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93000533|NCT02919917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93000534|NCT02919917|Adrenergic Agents|adrenergic agents|mesh-ancestor
93000535|NCT02919917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000536|NCT02919917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000537|NCT02915198|Metformin|metformin|mesh-list
93000538|NCT02915198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93000539|NCT02915198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000540|NCT02893553|Midodrine|midodrine|mesh-list
93000541|NCT02893553|Bromides|bromides|mesh-list
93000542|NCT02893553|Mirabegron|mirabegron|mesh-list
93000543|NCT02893553|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
93000544|NCT02893553|Anticonvulsants|anticonvulsants|mesh-ancestor
93000545|NCT02893553|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93000546|NCT02893553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93000547|NCT02893553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93000548|NCT02893553|Adrenergic Agents|adrenergic agents|mesh-ancestor
93000549|NCT02893553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000550|NCT02893553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000551|NCT02893553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000552|NCT02893553|Urological Agents|urological agents|mesh-ancestor
93000553|NCT02893553|Sympathomimetics|sympathomimetics|mesh-ancestor
93000554|NCT02893553|Autonomic Agents|autonomic agents|mesh-ancestor
93000555|NCT02893553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000556|NCT02893553|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93000557|NCT02893553|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93000558|NCT02893553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93000559|NCT02893553|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93000560|NCT02893553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000561|NCT02893553|Cholinergic Agents|cholinergic agents|mesh-ancestor
93000562|NCT02755272|Carboplatin|carboplatin|mesh-list
93000563|NCT02755272|Gemcitabine|gemcitabine|mesh-list
93000564|NCT02755272|Pembrolizumab|pembrolizumab|mesh-list
93000565|NCT02755272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000566|NCT02755272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000567|NCT02755272|Antimetabolites|antimetabolites|mesh-ancestor
93000568|NCT02755272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000569|NCT02755272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000570|NCT02755272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93000571|NCT02629120|Sirolimus|sirolimus|mesh-list
93000572|NCT02629120|Cyclophosphamide|cyclophosphamide|mesh-list
93000573|NCT02629120|Busulfan|busulfan|mesh-list
93000574|NCT02629120|Alemtuzumab|alemtuzumab|mesh-list
93000575|NCT02629120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000576|NCT02629120|Immunologic Factors|immunologic factors|mesh-ancestor
93000577|NCT02629120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000578|NCT02629120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93000579|NCT02629120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93000580|NCT02629120|Alkylating Agents|alkylating agents|mesh-ancestor
93000581|NCT02629120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000582|NCT02629120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000583|NCT02629120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93000584|NCT02629120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93000585|NCT02629120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000586|NCT02629120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93000587|NCT02629120|Antifungal Agents|antifungal agents|mesh-ancestor
93000588|NCT02629120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000589|NCT02542293|Paclitaxel|paclitaxel|mesh-list
93000590|NCT02542293|Cisplatin|cisplatin|mesh-list
93000591|NCT02542293|Carboplatin|carboplatin|mesh-list
93000592|NCT02542293|Gemcitabine|gemcitabine|mesh-list
93000593|NCT02542293|Pemetrexed|pemetrexed|mesh-list
93000594|NCT02542293|Durvalumab|durvalumab|mesh-list
93000595|NCT02542293|Tremelimumab|tremelimumab|mesh-list
93000596|NCT02542293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000597|NCT02542293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000598|NCT02542293|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000599|NCT02542293|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000600|NCT02542293|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000601|NCT02542293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000602|NCT02542293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000603|NCT02542293|Antimetabolites|antimetabolites|mesh-ancestor
93000604|NCT02542293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000605|NCT02542293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93000606|NCT02542293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93000607|NCT02542293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000608|NCT02507687|Bimatoprost|bimatoprost|mesh-list
93000609|NCT02507687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93000610|NCT02466971|Cisplatin|cisplatin|mesh-list
93000611|NCT02466971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000612|NCT02321501|Everolimus|everolimus|mesh-list
93000613|NCT02321501|Ceritinib|ceritinib|mesh-list
93000614|NCT02321501|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93000615|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000616|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000617|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000618|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000619|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
93000620|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000621|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000622|NCT02242942|Venetoclax|venetoclax|mesh-list
93000623|NCT02242942|Obinutuzumab|obinutuzumab|mesh-list
93000624|NCT02242942|Chlorambucil|chlorambucil|mesh-list
93000625|NCT02242942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000626|NCT02242942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000627|NCT02242942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93000628|NCT02242942|Alkylating Agents|alkylating agents|mesh-ancestor
93000629|NCT02242942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000630|NCT02237079|Bazedoxifene|bazedoxifene|mesh-list
93000631|NCT02237079|Estrogens|estrogens|mesh-list
93000632|NCT02237079|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93000633|NCT02237079|Hormones|hormones|mesh-ancestor
93000634|NCT02237079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000635|NCT02237079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000636|NCT02237079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93000637|NCT02237079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93000638|NCT02237079|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000639|NCT02237079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93000640|NCT02233829|Dopamine|dopamine|mesh-list
93000641|NCT02233829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93000642|NCT02233829|Sympathomimetics|sympathomimetics|mesh-ancestor
93000643|NCT02233829|Autonomic Agents|autonomic agents|mesh-ancestor
93000644|NCT02233829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000645|NCT02233829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000646|NCT02233829|Dopamine Agents|dopamine agents|mesh-ancestor
93000647|NCT02233829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000648|NCT02233829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000649|NCT02233829|Protective Agents|protective agents|mesh-ancestor
93000650|NCT01992861|Deoxyglucose|deoxyglucose|mesh-list
93000651|NCT01992861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93000652|NCT01992861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93000653|NCT01992861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000654|NCT01992861|Antimetabolites|antimetabolites|mesh-ancestor
93000655|NCT01992861|Antiviral Agents|antiviral agents|mesh-ancestor
93000656|NCT01992861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000657|NCT01799538|Albuterol|albuterol|mesh-list
93000658|NCT01799538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93000659|NCT01799538|Autonomic Agents|autonomic agents|mesh-ancestor
93000660|NCT01799538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000661|NCT01799538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000662|NCT01799538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93000663|NCT01799538|Respiratory System Agents|respiratory system agents|mesh-ancestor
93000664|NCT01799538|Tocolytic Agents|tocolytic agents|mesh-ancestor
93000665|NCT01799538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93000666|NCT01799538|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93000667|NCT01799538|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93000668|NCT01799538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93000669|NCT01799538|Adrenergic Agents|adrenergic agents|mesh-ancestor
93000670|NCT01799538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000671|NCT01799538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000672|NCT01267448|Metformin|metformin|mesh-list
93000673|NCT01267448|Saxagliptin|saxagliptin|mesh-list
93000674|NCT01267448|Glipizide|glipizide|mesh-list
93000675|NCT01267448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93000676|NCT01267448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000677|NCT01267448|Incretins|incretins|mesh-ancestor
93000678|NCT01267448|Hormones|hormones|mesh-ancestor
93000679|NCT01267448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000680|NCT01267448|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93000681|NCT01267448|Protease Inhibitors|protease inhibitors|mesh-ancestor
93000682|NCT01267448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000683|NCT01267448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000684|NCT01265030|Sirolimus|sirolimus|mesh-list
93000685|NCT01265030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93000686|NCT01265030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000687|NCT01265030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93000688|NCT01265030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000689|NCT01265030|Antifungal Agents|antifungal agents|mesh-ancestor
93000690|NCT01265030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000691|NCT01265030|Immunologic Factors|immunologic factors|mesh-ancestor
93000692|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000693|NCT00901511|Sargramostim|sargramostim|mesh-list
93000694|NCT00901511|Immunologic Factors|immunologic factors|mesh-ancestor
93000695|NCT00901511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000696|NCT00775476|Acetylcysteine|acetylcysteine|mesh-list
93000697|NCT00775476|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93000698|NCT00775476|Antiviral Agents|antiviral agents|mesh-ancestor
93000699|NCT00775476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000700|NCT00775476|Expectorants|expectorants|mesh-ancestor
93000701|NCT00775476|Respiratory System Agents|respiratory system agents|mesh-ancestor
93000702|NCT00775476|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93000703|NCT00775476|Antioxidants|antioxidants|mesh-ancestor
92168458|NCT04789499|Autonomic Agents|autonomic agents|mesh-ancestor
93000704|NCT00775476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000705|NCT00775476|Protective Agents|protective agents|mesh-ancestor
93000706|NCT00775476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000707|NCT00775476|Antidotes|antidotes|mesh-ancestor
93000708|NCT00353158|Doxycycline|doxycycline|mesh-list
93000709|NCT00353158|Voriconazole|voriconazole|mesh-list
93000710|NCT00353158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93000711|NCT00353158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000712|NCT00353158|Antimalarials|antimalarials|mesh-ancestor
93000713|NCT00353158|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93000714|NCT00353158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93000715|NCT00353158|Antifungal Agents|antifungal agents|mesh-ancestor
93000716|NCT00353158|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93000717|NCT00353158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93000718|NCT00353158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000719|NCT00353158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000720|NCT00353158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93000721|NCT00353158|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000722|NCT00353158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000723|NCT00353158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000724|NCT00353158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93000725|NCT00202813|Anti-Infective Agents|anti-infective agents|mesh-list
93000726|NCT00202813|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93000727|NCT00004180|Rosiglitazone|rosiglitazone|mesh-list
93000728|NCT00004180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93000729|NCT00004180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000730|NCT00001521|Hydrocortisone|hydrocortisone|mesh-list
93000731|NCT00001521|Fludrocortisone|fludrocortisone|mesh-list
93000732|NCT00001521|Letrozole|letrozole|mesh-list
93000733|NCT00001521|Flutamide|flutamide|mesh-list
93000734|NCT00001521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000735|NCT00001521|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93000736|NCT00001521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93000737|NCT00001521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000738|NCT00001521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000739|NCT00001521|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93000740|NCT00001521|Hormone Antagonists|hormone antagonists|mesh-ancestor
93000741|NCT00001521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000742|NCT00001521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000743|NCT00001521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000744|NCT00001521|Androgen Antagonists|androgen antagonists|mesh-ancestor
93000745|NCT00001521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000746|NCT00988494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93000747|NCT00988494|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93000748|NCT00539994|Retapamulin|retapamulin|mesh-list
93000749|NCT00539994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93000750|NCT00539994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000751|NCT04508790|Dexamethasone|dexamethasone|mesh-list
93000752|NCT04508790|Dexamethasone acetate|dexamethasone acetate|mesh-list
93000753|NCT04508790|Pomalidomide|pomalidomide|mesh-list
93000754|NCT04508790|Ichthammol|ichthammol|mesh-list
93000755|NCT04508790|BB 1101|bb 1101|mesh-list
93000756|NCT04508790|Leflunomide|leflunomide|mesh-list
93000757|NCT04508790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000758|NCT04508790|Antiemetics|antiemetics|mesh-ancestor
93000759|NCT04508790|Autonomic Agents|autonomic agents|mesh-ancestor
93000760|NCT04508790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000761|NCT04508790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000762|NCT04508790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000763|NCT04508790|Glucocorticoids|glucocorticoids|mesh-ancestor
93000764|NCT04508790|Hormones|hormones|mesh-ancestor
93000765|NCT04508790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000766|NCT04508790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000767|NCT04508790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000768|NCT04508790|Protease Inhibitors|protease inhibitors|mesh-ancestor
93000769|NCT04508790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000770|NCT04508790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000771|NCT04508790|Immunologic Factors|immunologic factors|mesh-ancestor
93000772|NCT04508790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93000773|NCT04508790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93000774|NCT04508790|Growth Substances|growth substances|mesh-ancestor
93000775|NCT04508790|Growth Inhibitors|growth inhibitors|mesh-ancestor
93000776|NCT04508790|Dermatologic Agents|dermatologic agents|mesh-ancestor
93000777|NCT04508790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000778|NCT04005222|Selenium|selenium|mesh-list
93000779|NCT04005222|Melatonin|melatonin|mesh-list
93000780|NCT04005222|Antioxidants|antioxidants|mesh-ancestor
93000781|NCT04005222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000782|NCT04005222|Protective Agents|protective agents|mesh-ancestor
93000783|NCT04005222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000784|NCT04005222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93000785|NCT04005222|Trace Elements|trace elements|mesh-ancestor
93000786|NCT04005222|Micronutrients|micronutrients|mesh-ancestor
93000787|NCT00098839|Leucovorin|leucovorin|mesh-list
93000788|NCT00098839|Cytarabine|cytarabine|mesh-list
93000789|NCT00098839|Prednisone|prednisone|mesh-list
93000790|NCT00098839|Hydrocortisone|hydrocortisone|mesh-list
93000791|NCT00098839|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93000792|NCT00098839|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93000793|NCT00098839|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93000794|NCT00098839|Cyclophosphamide|cyclophosphamide|mesh-list
93000795|NCT00098839|Doxorubicin|doxorubicin|mesh-list
93000796|NCT00098839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93000797|NCT00098839|Methotrexate|methotrexate|mesh-list
93000799|NCT00098839|Vincristine|vincristine|mesh-list
93000800|NCT00098839|Etoposide phosphate|etoposide phosphate|mesh-list
93000801|NCT00098839|Asparaginase|asparaginase|mesh-list
93000802|NCT00098839|Pegaspargase|pegaspargase|mesh-list
93000803|NCT00098839|Epratuzumab|epratuzumab|mesh-list
93000804|NCT00098839|Dexrazoxane|dexrazoxane|mesh-list
93000805|NCT00098839|Razoxane|razoxane|mesh-list
93000806|NCT00098839|Levoleucovorin|levoleucovorin|mesh-list
93000807|NCT00098839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000808|NCT00098839|Immunologic Factors|immunologic factors|mesh-ancestor
93000809|NCT00098839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646144|NCT00221702|Antiviral Agents|antiviral agents|mesh-ancestor
93000810|NCT00098839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93000811|NCT00098839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93000812|NCT00098839|Alkylating Agents|alkylating agents|mesh-ancestor
93000813|NCT00098839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000814|NCT00098839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000815|NCT00098839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93000816|NCT00098839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93000817|NCT00098839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93000818|NCT00098839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93000819|NCT00098839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000820|NCT00098839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000821|NCT00098839|Glucocorticoids|glucocorticoids|mesh-ancestor
93000822|NCT00098839|Hormones|hormones|mesh-ancestor
93000823|NCT00098839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000824|NCT00098839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93000825|NCT00098839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93000826|NCT00098839|Abortifacient Agents|abortifacient agents|mesh-ancestor
93000827|NCT00098839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93000828|NCT00098839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000829|NCT00098839|Antimetabolites|antimetabolites|mesh-ancestor
93000830|NCT00098839|Dermatologic Agents|dermatologic agents|mesh-ancestor
93000831|NCT00098839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93000832|NCT00098839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93000833|NCT00098839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93000834|NCT00098839|Antiviral Agents|antiviral agents|mesh-ancestor
93000835|NCT00098839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000836|NCT00098839|Antidotes|antidotes|mesh-ancestor
93000837|NCT00098839|Protective Agents|protective agents|mesh-ancestor
93000838|NCT00098839|Vitamin B Complex|vitamin b complex|mesh-ancestor
93000839|NCT00098839|Vitamins|vitamins|mesh-ancestor
93000840|NCT00098839|Micronutrients|micronutrients|mesh-ancestor
93000841|NCT00098839|Tubulin Modulators|tubulin modulators|mesh-ancestor
93000842|NCT00098839|Antimitotic Agents|antimitotic agents|mesh-ancestor
93000843|NCT00098839|Mitosis Modulators|mitosis modulators|mesh-ancestor
93000844|NCT00098839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93000845|NCT00098839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93000846|NCT05268744|Micronutrients|micronutrients|mesh-list
93000847|NCT05268744|Trace Elements|trace elements|mesh-list
93000848|NCT05268744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000849|NCT02531191|Peficitinib|peficitinib|mesh-list
93000850|NCT02531191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000851|NCT02531191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000852|NCT02531191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000853|NCT02531191|Immunologic Factors|immunologic factors|mesh-ancestor
93000854|NCT02531191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000855|NCT01081639|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93000856|NCT01081639|Hormones|hormones|mesh-ancestor
93000857|NCT01081639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000858|NCT01081639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000859|NCT01081717|Golimumab|golimumab|mesh-list
93000860|NCT01081717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93000861|NCT01081717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000862|NCT01081717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000863|NCT01081717|Immunologic Factors|immunologic factors|mesh-ancestor
93000864|NCT01081717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000865|NCT01085383|Aripiprazole|aripiprazole|mesh-list
93000866|NCT01085383|Antidepressive Agents|antidepressive agents|mesh-ancestor
93000867|NCT01085383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93000868|NCT01085383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93000869|NCT01085383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93000870|NCT01085383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93000871|NCT01085383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000872|NCT01085383|Dopamine Agonists|dopamine agonists|mesh-ancestor
93000873|NCT01085383|Dopamine Agents|dopamine agents|mesh-ancestor
93000874|NCT01085383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000875|NCT01085383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000876|NCT01085383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93000877|NCT01085383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93000878|NCT01085383|Serotonin Agents|serotonin agents|mesh-ancestor
93000879|NCT01085383|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93000880|NCT01085383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93000881|NCT01085383|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93000882|NCT01085383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93000883|NCT00485589|Methotrexate|methotrexate|mesh-list
92646226|NCT00251277|Rituximab|rituximab|mesh-list
93000884|NCT00485589|Ocrelizumab|ocrelizumab|mesh-list
93000885|NCT00485589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93000886|NCT00485589|Abortifacient Agents|abortifacient agents|mesh-ancestor
93000887|NCT00485589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93000888|NCT00485589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000889|NCT00485589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000890|NCT00485589|Antimetabolites|antimetabolites|mesh-ancestor
93000891|NCT00485589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000892|NCT00485589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000893|NCT00485589|Dermatologic Agents|dermatologic agents|mesh-ancestor
93000894|NCT00485589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000895|NCT00485589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93000896|NCT00485589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93000897|NCT00485589|Immunologic Factors|immunologic factors|mesh-ancestor
93000898|NCT00485589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93000899|NCT00485589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93000900|NCT00490971|Olanzapine|olanzapine|mesh-list
93000901|NCT00490971|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93000902|NCT00490971|Antiemetics|antiemetics|mesh-ancestor
93000903|NCT00490971|Autonomic Agents|autonomic agents|mesh-ancestor
93000904|NCT00490971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000905|NCT00490971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000906|NCT00490971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93000907|NCT00490971|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93000908|NCT00490971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93000909|NCT00490971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93000910|NCT00490971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93000911|NCT00490971|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93000912|NCT00490971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93000913|NCT00490971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93000914|NCT00490971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000915|NCT00490971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000916|NCT00490971|Serotonin Agents|serotonin agents|mesh-ancestor
93000917|NCT00490971|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93000918|NCT00490971|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93000919|NCT00490971|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93000920|NCT00490971|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93000921|NCT00490971|Dopamine Agents|dopamine agents|mesh-ancestor
93000922|NCT04286295|Nicotine|nicotine|mesh-list
93000923|NCT04286295|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93000924|NCT04286295|Autonomic Agents|autonomic agents|mesh-ancestor
93000925|NCT04286295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000926|NCT04286295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000927|NCT04286295|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93000928|NCT04286295|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93000929|NCT04286295|Cholinergic Agents|cholinergic agents|mesh-ancestor
93000930|NCT04286295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000931|NCT04286295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000932|NCT00750347|Acetaminophen|acetaminophen|mesh-list
93000933|NCT00750347|Rimonabant|rimonabant|mesh-list
93000934|NCT00750347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93000935|NCT00750347|Analgesics|analgesics|mesh-ancestor
93000936|NCT00750347|Sensory System Agents|sensory system agents|mesh-ancestor
93000937|NCT00750347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000938|NCT00750347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000939|NCT00750347|Antipyretics|antipyretics|mesh-ancestor
93000940|NCT00750347|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93000941|NCT00750347|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93000942|NCT00750347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93000943|NCT00750347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93000944|NCT00750347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000945|NCT00750347|Hormones|hormones|mesh-ancestor
93000946|NCT00750347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93000947|NCT00750425|Cediranib|cediranib|mesh-list
93000948|NCT00750425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000949|NCT00750425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93000950|NCT00750425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000951|NCT00750425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000952|NCT00745589|Sevelamer|sevelamer|mesh-list
93000953|NCT00745589|Chelating Agents|chelating agents|mesh-ancestor
93000954|NCT00745589|Sequestering Agents|sequestering agents|mesh-ancestor
93000955|NCT00745589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000956|NCT00750581|Indomethacin|indomethacin|mesh-list
92646302|NCT00248118|Bupropion|bupropion|mesh-list
93000957|NCT00750581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93000958|NCT00750581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93000959|NCT00750581|Analgesics|analgesics|mesh-ancestor
93000960|NCT00750581|Sensory System Agents|sensory system agents|mesh-ancestor
93000961|NCT00750581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93000962|NCT00750581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93000963|NCT00750581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93000964|NCT00750581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93000965|NCT00750581|Gout Suppressants|gout suppressants|mesh-ancestor
93000966|NCT00750581|Tocolytic Agents|tocolytic agents|mesh-ancestor
93000967|NCT00750581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93000968|NCT00750581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93000969|NCT00750581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000970|NCT00750581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000971|NCT00685763|Gemcitabine|gemcitabine|mesh-list
93000972|NCT00685763|Capecitabine|capecitabine|mesh-list
93000973|NCT00685763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93000974|NCT00685763|Antimetabolites|antimetabolites|mesh-ancestor
93000975|NCT00685763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000976|NCT00685763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93000977|NCT00098293|Lamivudine|lamivudine|mesh-list
93000978|NCT00098293|Zidovudine|zidovudine|mesh-list
93000979|NCT00098293|Efavirenz|efavirenz|mesh-list
93000980|NCT00098293|Maraviroc|maraviroc|mesh-list
93000981|NCT00098293|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93000982|NCT00098293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93000983|NCT00098293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93000984|NCT00098293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93000985|NCT00098293|Antiviral Agents|antiviral agents|mesh-ancestor
93000986|NCT00098293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93000987|NCT00098293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93000988|NCT00098293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93000989|NCT00098293|Antimetabolites|antimetabolites|mesh-ancestor
93000990|NCT00098293|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93000991|NCT00098293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93000992|NCT00098293|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93000993|NCT00098293|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93000994|NCT00098293|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93000995|NCT00098293|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93000996|NCT00098293|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93000997|NCT00098293|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93000998|NCT00098293|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93000999|NCT00923741|Talactoferrin alfa|talactoferrin alfa|mesh-list
93001000|NCT00923741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001001|NCT00685685|Lovastatin|lovastatin|mesh-list
93001002|NCT00685685|L 647318|l 647318|mesh-list
93001003|NCT00685685|Dihydromevinolin|dihydromevinolin|mesh-list
93001004|NCT00685685|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93001005|NCT00685685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93001006|NCT00685685|Antimetabolites|antimetabolites|mesh-ancestor
93001007|NCT00685685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001008|NCT00685685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93001009|NCT00685685|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93001010|NCT00685685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001011|NCT01087567|Insulin|insulin|mesh-list
93001012|NCT01087567|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93001013|NCT01087567|Metformin|metformin|mesh-list
93001014|NCT01087567|Pioglitazone|pioglitazone|mesh-list
93001015|NCT01087567|Glimepiride|glimepiride|mesh-list
92528444|NCT02971345|Trace Elements|trace elements|mesh-ancestor
93001016|NCT01087567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93001017|NCT01087567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001018|NCT01087567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001019|NCT01087567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001020|NCT01087567|Immunologic Factors|immunologic factors|mesh-ancestor
93001021|NCT00751049|Timolol|timolol|mesh-list
93001022|NCT00751049|Latanoprost|latanoprost|mesh-list
93001023|NCT00751049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93001024|NCT00751049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93001025|NCT00751049|Adrenergic Agents|adrenergic agents|mesh-ancestor
93001026|NCT00751049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001027|NCT00751049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001028|NCT00751049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001029|NCT00751049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001030|NCT00751049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93001031|NCT00751049|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92646409|NCT04611724|Folfirinox|folfirinox|mesh-list
93001032|NCT00751049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93001033|NCT00500331|Pioglitazone|pioglitazone|mesh-list
93001034|NCT00500331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93001035|NCT00500331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001037|NCT01019109|Trace Elements|trace elements|mesh-ancestor
93001038|NCT01019109|Micronutrients|micronutrients|mesh-ancestor
93001039|NCT01019109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001040|NCT00499863|Methylphenidate|methylphenidate|mesh-list
93001041|NCT00499863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93001042|NCT00499863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001043|NCT00499863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93001044|NCT00499863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93001045|NCT00499863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001046|NCT00499863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001047|NCT00499863|Dopamine Agents|dopamine agents|mesh-ancestor
93001048|NCT00499863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001049|NCT04475835|Heparin|heparin|mesh-list
93001050|NCT04475835|Bivalirudin|bivalirudin|mesh-list
93001051|NCT04475835|Anticoagulants|anticoagulants|mesh-ancestor
93001052|NCT04475835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93001053|NCT04475835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93001054|NCT04475835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001055|NCT04475835|Antithrombins|antithrombins|mesh-ancestor
93001056|NCT04475835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93001057|NCT04475835|Protease Inhibitors|protease inhibitors|mesh-ancestor
93001058|NCT04475835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001059|NCT01014507|Goserelin|goserelin|mesh-list
93001060|NCT01014507|Contraceptive Agents|contraceptive agents|mesh-list
93001061|NCT01014507|Contraceptives, Oral|contraceptives, oral|mesh-list
93001062|NCT01014507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001063|NCT01014507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001064|NCT01014507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001065|NCT01014507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001066|NCT01014507|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93001067|NCT00097981|Thalidomide|thalidomide|mesh-list
93001068|NCT00097981|Dexamethasone|dexamethasone|mesh-list
93001069|NCT00097981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001070|NCT00097981|Antiemetics|antiemetics|mesh-ancestor
93001071|NCT00097981|Autonomic Agents|autonomic agents|mesh-ancestor
93001072|NCT00097981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001073|NCT00097981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001074|NCT00097981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93001075|NCT00097981|Glucocorticoids|glucocorticoids|mesh-ancestor
93001076|NCT00097981|Hormones|hormones|mesh-ancestor
93001077|NCT00097981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001078|NCT00097981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001079|NCT00097981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001080|NCT00097981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001081|NCT00097981|Immunologic Factors|immunologic factors|mesh-ancestor
93001082|NCT00097981|Leprostatic Agents|leprostatic agents|mesh-ancestor
93001083|NCT00097981|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93001084|NCT00097981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001085|NCT00097981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93001086|NCT00097981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93001087|NCT00097981|Growth Substances|growth substances|mesh-ancestor
93001088|NCT00097981|Growth Inhibitors|growth inhibitors|mesh-ancestor
93001089|NCT01016145|Antipsychotic Agents|antipsychotic agents|mesh-list
93001090|NCT01016145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93001091|NCT01016145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93001092|NCT01016145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93001093|NCT01016145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001094|NCT01016223|Beclomethasone|beclomethasone|mesh-list
93001095|NCT01016223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001096|NCT01016223|Glucocorticoids|glucocorticoids|mesh-ancestor
93001097|NCT01016223|Hormones|hormones|mesh-ancestor
93001098|NCT01016223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001099|NCT01016223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001100|NCT01016223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93001101|NCT01016223|Respiratory System Agents|respiratory system agents|mesh-ancestor
93001102|NCT04151017|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93001103|NCT04151017|Hemostatics|hemostatics|mesh-ancestor
93001104|NCT04151017|Coagulants|coagulants|mesh-ancestor
93001105|NCT01019265|Buprenorphine|buprenorphine|mesh-list
93001106|NCT01019265|Tramadol|tramadol|mesh-list
93001107|NCT01019265|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93001108|NCT01019265|Narcotics|narcotics|mesh-ancestor
93001109|NCT01019265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93001111|NCT01019265|Analgesics|analgesics|mesh-ancestor
93001112|NCT01019265|Sensory System Agents|sensory system agents|mesh-ancestor
93001113|NCT01019265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001114|NCT01019265|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93001115|NCT01085617|Cytarabine|cytarabine|mesh-list
93001116|NCT01085617|Cyclophosphamide|cyclophosphamide|mesh-list
93001117|NCT01085617|Melphalan|melphalan|mesh-list
93001118|NCT01085617|Rituximab|rituximab|mesh-list
93001119|NCT01085617|Methotrexate|methotrexate|mesh-list
93001120|NCT01085617|Fludarabine|fludarabine|mesh-list
93001121|NCT01085617|Fludarabine phosphate|fludarabine phosphate|mesh-list
93001122|NCT01085617|Etoposide|etoposide|mesh-list
93001123|NCT01085617|Vincristine|vincristine|mesh-list
93001124|NCT01085617|Imatinib Mesylate|imatinib mesylate|mesh-list
93001125|NCT01085617|Daunorubicin|daunorubicin|mesh-list
93001126|NCT01085617|Mercaptopurine|mercaptopurine|mesh-list
93001127|NCT01085617|Pegaspargase|pegaspargase|mesh-list
93001128|NCT01085617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001129|NCT01085617|Immunologic Factors|immunologic factors|mesh-ancestor
93001130|NCT01085617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001131|NCT01085617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001132|NCT01085617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93001133|NCT01085617|Alkylating Agents|alkylating agents|mesh-ancestor
93001134|NCT01085617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001135|NCT01085617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001136|NCT01085617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93001137|NCT01085617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93001138|NCT01085617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93001139|NCT01085617|Abortifacient Agents|abortifacient agents|mesh-ancestor
93001140|NCT01085617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001141|NCT01085617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93001142|NCT01085617|Antimetabolites|antimetabolites|mesh-ancestor
93001143|NCT01085617|Dermatologic Agents|dermatologic agents|mesh-ancestor
93001144|NCT01085617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001145|NCT01085617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93001146|NCT01085617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93001147|NCT01085617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93001148|NCT01085617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93001149|NCT01085617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93001150|NCT01085617|Antiviral Agents|antiviral agents|mesh-ancestor
93001151|NCT01085617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001152|NCT01085617|Tubulin Modulators|tubulin modulators|mesh-ancestor
93001153|NCT01085617|Antimitotic Agents|antimitotic agents|mesh-ancestor
93001154|NCT01085617|Mitosis Modulators|mitosis modulators|mesh-ancestor
93001155|NCT01085617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001156|NCT01085617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93001157|NCT00499083|Tamoxifen|tamoxifen|mesh-list
93001158|NCT00499083|Paclitaxel|paclitaxel|mesh-list
93001159|NCT00499083|Cyclophosphamide|cyclophosphamide|mesh-list
93001160|NCT00499083|Doxorubicin|doxorubicin|mesh-list
93001161|NCT00499083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93001162|NCT00499083|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93001163|NCT00499083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93001164|NCT00499083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001165|NCT00499083|Tubulin Modulators|tubulin modulators|mesh-ancestor
93001166|NCT00499083|Antimitotic Agents|antimitotic agents|mesh-ancestor
93001167|NCT00499083|Mitosis Modulators|mitosis modulators|mesh-ancestor
93001168|NCT00499083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001169|NCT00499083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001170|NCT00499083|Immunologic Factors|immunologic factors|mesh-ancestor
93001171|NCT00499083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001172|NCT00499083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001173|NCT00499083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93001174|NCT00499083|Alkylating Agents|alkylating agents|mesh-ancestor
93001175|NCT00499083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93001176|NCT00499083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93001177|NCT00499083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93001178|NCT00499083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93001179|NCT00499083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001180|NCT00499083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92646520|NCT04610164|Coagulants|coagulants|mesh-ancestor
93001181|NCT00499083|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001182|NCT00499083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001183|NCT00499083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001184|NCT00499083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92168509|NCT04675827|Immunotoxins|immunotoxins|mesh-ancestor
93001185|NCT00499083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93001186|NCT00499083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93001187|NCT00499083|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93001188|NCT01087879|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93001189|NCT01087879|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93001190|NCT01087879|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93001191|NCT01087879|Etonogestrel|etonogestrel|mesh-list
93001192|NCT01087879|Desogestrel|desogestrel|mesh-list
93001193|NCT01087879|NuvaRing|nuvaring|mesh-list
93001194|NCT01087879|Norelgestromin|norelgestromin|mesh-list
93001195|NCT01087879|Contraceptive Agents|contraceptive agents|mesh-list
93001196|NCT01087879|Estradiol|estradiol|mesh-list
93001197|NCT01087879|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93001198|NCT01087879|Estrogens|estrogens|mesh-ancestor
93001199|NCT01087879|Hormones|hormones|mesh-ancestor
93001200|NCT01087879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001201|NCT01087879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001202|NCT01087879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93001203|NCT01087879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001204|NCT01087879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93001205|NCT01087879|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93001206|NCT01087879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93001207|NCT01087879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93001208|NCT01087879|Progestins|progestins|mesh-ancestor
93001209|NCT01019421|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
93001210|NCT01019421|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93001211|NCT01019421|Serotonin Agents|serotonin agents|mesh-ancestor
93001212|NCT01019421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001213|NCT01019421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001214|NCT01019421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001215|NCT01085695|Rabeprazole|rabeprazole|mesh-list
93001216|NCT01085695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93001217|NCT01085695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93001218|NCT01085695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93001219|NCT01085695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001220|NCT01085695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001221|NCT01088035|Carboplatin|carboplatin|mesh-list
93001222|NCT01088035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001223|NCT01085851|Chlorpheniramine|chlorpheniramine|mesh-list
93001224|NCT01085851|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93001225|NCT01085851|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93001226|NCT01085851|Histamine Antagonists|histamine antagonists|mesh-ancestor
93001227|NCT01085851|Histamine Agents|histamine agents|mesh-ancestor
93001228|NCT01085851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001229|NCT01085851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001230|NCT01085851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001231|NCT01085851|Antipruritics|antipruritics|mesh-ancestor
93001232|NCT01085851|Dermatologic Agents|dermatologic agents|mesh-ancestor
93001233|NCT01085851|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93001234|NCT00751127|Timolol|timolol|mesh-list
93001235|NCT00751127|Latanoprost|latanoprost|mesh-list
93001236|NCT00751127|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93001237|NCT00751127|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93001238|NCT00751127|Adrenergic Agents|adrenergic agents|mesh-ancestor
93001239|NCT00751127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001240|NCT00751127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001241|NCT00751127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001242|NCT00751127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001243|NCT00751127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93001244|NCT00751127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93001245|NCT00751127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93001246|NCT00751205|Acetylcarnitine|acetylcarnitine|mesh-list
93001248|NCT00751205|Prednisolone|prednisolone|mesh-list
93001249|NCT00751205|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93001250|NCT00751205|Methylprednisolone|methylprednisolone|mesh-list
93001251|NCT00751205|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93001252|NCT00751205|Prednisolone acetate|prednisolone acetate|mesh-list
93001253|NCT00751205|Sagopilone|sagopilone|mesh-list
93001254|NCT00751205|Epothilones|epothilones|mesh-list
93001255|NCT00751205|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93001256|NCT00751205|Prednisolone phosphate|prednisolone phosphate|mesh-list
93001257|NCT00751205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001258|NCT00751205|Glucocorticoids|glucocorticoids|mesh-ancestor
93001259|NCT00751205|Hormones|hormones|mesh-ancestor
93001260|NCT00751205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001261|NCT00751205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001262|NCT00751205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001263|NCT00751205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001264|NCT00751205|Antiemetics|antiemetics|mesh-ancestor
93001265|NCT00751205|Autonomic Agents|autonomic agents|mesh-ancestor
93001266|NCT00751205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001267|NCT00751205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93001268|NCT00751205|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93001269|NCT00751205|Protective Agents|protective agents|mesh-ancestor
93001270|NCT00751205|Vitamin B Complex|vitamin b complex|mesh-ancestor
93001271|NCT00751205|Vitamins|vitamins|mesh-ancestor
93001272|NCT00751205|Micronutrients|micronutrients|mesh-ancestor
93001273|NCT00751205|Nootropic Agents|nootropic agents|mesh-ancestor
93001274|NCT00751205|Tubulin Modulators|tubulin modulators|mesh-ancestor
93001275|NCT00751205|Antimitotic Agents|antimitotic agents|mesh-ancestor
93001276|NCT00751205|Mitosis Modulators|mitosis modulators|mesh-ancestor
93001277|NCT00751205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001278|NCT00752063|Capecitabine|capecitabine|mesh-list
93001279|NCT00752063|Oxaliplatin|oxaliplatin|mesh-list
93001280|NCT00752063|Sorafenib|sorafenib|mesh-list
93001281|NCT00752063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93001282|NCT00752063|Antimetabolites|antimetabolites|mesh-ancestor
93001283|NCT00752063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001284|NCT00752063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001285|NCT00752063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001286|NCT00752063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001287|NCT00752141|Mandelic Acids|mandelic acids|mesh-list
93001288|NCT00752141|Oxybutynin|oxybutynin|mesh-list
93001289|NCT00752141|Parasympatholytics|parasympatholytics|mesh-ancestor
93001290|NCT00752141|Autonomic Agents|autonomic agents|mesh-ancestor
93001291|NCT00752141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001292|NCT00752141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001293|NCT00752141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93001294|NCT00752141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93001295|NCT00752141|Cholinergic Agents|cholinergic agents|mesh-ancestor
93001296|NCT00752141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001297|NCT00752141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001298|NCT00752141|Urological Agents|urological agents|mesh-ancestor
93001299|NCT00752141|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93001300|NCT00752141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001301|NCT00752375|Trimethoprim|trimethoprim|mesh-list
93001302|NCT00752375|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93001303|NCT00752375|Sulfamethoxazole|sulfamethoxazole|mesh-list
93001304|NCT00752375|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93001305|NCT00752375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001306|NCT00752375|Antimalarials|antimalarials|mesh-ancestor
93001307|NCT00752375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93001308|NCT00752375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93001309|NCT00752375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93001310|NCT00752375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001311|NCT00752375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001312|NCT00752375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93001313|NCT00752375|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93001314|NCT00752375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93001315|NCT00752375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93001316|NCT00751517|Cyclophosphamide|cyclophosphamide|mesh-list
93001317|NCT00751517|Methotrexate|methotrexate|mesh-list
93001318|NCT00751517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001319|NCT00751517|Immunologic Factors|immunologic factors|mesh-ancestor
93001320|NCT00751517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001321|NCT00751517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001322|NCT00751517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93001323|NCT00751517|Alkylating Agents|alkylating agents|mesh-ancestor
93001324|NCT00751517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001325|NCT00751517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001326|NCT00751517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93001327|NCT00751517|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93001328|NCT00751517|Abortifacient Agents|abortifacient agents|mesh-ancestor
93001329|NCT00751517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001330|NCT00751517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93001331|NCT00751517|Antimetabolites|antimetabolites|mesh-ancestor
92646666|NCT00222833|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93001332|NCT00751517|Dermatologic Agents|dermatologic agents|mesh-ancestor
93001333|NCT00751517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001334|NCT00751517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93001335|NCT00751517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93001337|NCT02561117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001338|NCT02561117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93001339|NCT02561117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93001340|NCT02561117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93001341|NCT00684515|Aspirin|aspirin|mesh-list
93001342|NCT00684515|Vorapaxar|vorapaxar|mesh-list
93001343|NCT00684515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001344|NCT00684515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001345|NCT00684515|Analgesics|analgesics|mesh-ancestor
93001346|NCT00684515|Sensory System Agents|sensory system agents|mesh-ancestor
93001347|NCT00684515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001348|NCT00684515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001349|NCT00684515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001350|NCT00684515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001351|NCT00684515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93001352|NCT00684515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93001353|NCT00684515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001354|NCT00684515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93001355|NCT00684515|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93001356|NCT00684515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001357|NCT00684515|Antipyretics|antipyretics|mesh-ancestor
93001358|NCT00751751|Losartan|losartan|mesh-list
93001359|NCT00751751|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93001360|NCT00751751|Olmesartan|olmesartan|mesh-list
93001361|NCT00751751|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93001362|NCT00751751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001363|NCT00751751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93001364|NCT00751751|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93001365|NCT00751751|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93001366|NCT00751751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001367|NCT00751751|Diuretics|diuretics|mesh-ancestor
93001368|NCT00751751|Natriuretic Agents|natriuretic agents|mesh-ancestor
93001369|NCT00751751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001370|NCT00751751|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93001371|NCT00751751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001372|NCT00490815|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93001373|NCT00490815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001374|NCT00490815|Glucocorticoids|glucocorticoids|mesh-ancestor
93001375|NCT00490815|Hormones|hormones|mesh-ancestor
93001376|NCT00490815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001377|NCT00490815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001378|NCT04453137|Adalimumab|adalimumab|mesh-list
93001379|NCT04453137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93001380|NCT04453137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001381|NCT04453137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001382|NCT03855189|Mometasone Furoate|mometasone furoate|mesh-list
93001383|NCT03855189|Beclomethasone|beclomethasone|mesh-list
93001384|NCT03855189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001385|NCT03855189|Dermatologic Agents|dermatologic agents|mesh-ancestor
93001386|NCT03855189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93001387|NCT03855189|Glucocorticoids|glucocorticoids|mesh-ancestor
93001388|NCT03855189|Hormones|hormones|mesh-ancestor
93001389|NCT03855189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001390|NCT03855189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001391|NCT03855189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93001392|NCT03855189|Respiratory System Agents|respiratory system agents|mesh-ancestor
93001393|NCT03853551|Osimertinib|osimertinib|mesh-list
93001394|NCT03853551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001395|NCT03853551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001396|NCT03853551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001397|NCT03853551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001398|NCT00423670|Ribavirin|ribavirin|mesh-list
93001399|NCT00423670|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93001400|NCT00423670|Antimetabolites|antimetabolites|mesh-ancestor
93001401|NCT00423670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001402|NCT00423670|Antiviral Agents|antiviral agents|mesh-ancestor
93001403|NCT00423670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001404|NCT01019655|Nadroparin|nadroparin|mesh-list
93001405|NCT01019655|Calcium|calcium|mesh-list
93001406|NCT01019655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93001407|NCT01019655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001408|NCT01019655|Anticoagulants|anticoagulants|mesh-ancestor
93001409|NCT01019655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93001410|NCT01019655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93001411|NCT01019655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001413|NCT00483717|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93001414|NCT00483717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001415|NCT00483717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001416|NCT00483717|Analgesics|analgesics|mesh-ancestor
93001417|NCT00483717|Sensory System Agents|sensory system agents|mesh-ancestor
93001418|NCT00483717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001419|NCT00483717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001420|NCT00483717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001421|NCT00483717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001422|NCT00483717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93001423|NCT00483717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001424|NCT00483717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001425|NCT00406354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93001426|NCT00406354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93001427|NCT00406354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93001428|NCT00406354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001429|NCT00406354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001430|NCT00406354|Adrenergic Agents|adrenergic agents|mesh-ancestor
93001431|NCT00406354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001432|NCT00406354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001433|NCT01037842|Mitiglinide|mitiglinide|mesh-list
93001434|NCT01037842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93001435|NCT01037842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001436|NCT00483405|Capecitabine|capecitabine|mesh-list
93001437|NCT00483405|Oxaliplatin|oxaliplatin|mesh-list
93001438|NCT00483405|Cetuximab|cetuximab|mesh-list
93001439|NCT00483405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93001440|NCT00483405|Antimetabolites|antimetabolites|mesh-ancestor
93001441|NCT00483405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001442|NCT00483405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001443|NCT00483405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93001444|NCT00483327|Megestrol|megestrol|mesh-list
93001445|NCT00483327|Megestrol Acetate|megestrol acetate|mesh-list
93001446|NCT00483327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93001447|NCT00483327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93001448|NCT00483327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93001449|NCT00483327|Contraceptive Agents|contraceptive agents|mesh-ancestor
93001450|NCT00483327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001451|NCT00483327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001452|NCT00483327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93001453|NCT00483327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93001454|NCT00483327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001455|NCT00483327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001456|NCT00483327|Appetite Stimulants|appetite stimulants|mesh-ancestor
93001457|NCT00483327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93001458|NCT00684203|Aspirin|aspirin|mesh-list
93001459|NCT00684203|Clopidogrel|clopidogrel|mesh-list
93001460|NCT00684203|Vorapaxar|vorapaxar|mesh-list
93001461|NCT00684203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001462|NCT00684203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001463|NCT00684203|Analgesics|analgesics|mesh-ancestor
93001464|NCT00684203|Sensory System Agents|sensory system agents|mesh-ancestor
93001465|NCT00684203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001466|NCT00684203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001467|NCT00684203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001468|NCT00684203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001469|NCT00684203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93001470|NCT00684203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93001471|NCT00684203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001472|NCT00684203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93001473|NCT00684203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93001474|NCT00684203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001475|NCT00684203|Antipyretics|antipyretics|mesh-ancestor
93001476|NCT00684203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93001477|NCT00684203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93001478|NCT00684203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93001479|NCT00684203|Purinergic Agents|purinergic agents|mesh-ancestor
93001480|NCT00684203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001481|NCT00423592|Ambrisentan|ambrisentan|mesh-list
93001482|NCT00423592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93001483|NCT01037998|Gefitinib|gefitinib|mesh-list
93001484|NCT01037998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001485|NCT01037998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001486|NCT01037998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001487|NCT01037998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001488|NCT00751907|Atorvastatin|atorvastatin|mesh-list
93001489|NCT00751907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93001490|NCT00751907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93001491|NCT00751907|Antimetabolites|antimetabolites|mesh-ancestor
93001492|NCT00751907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001493|NCT00751907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93001494|NCT00751907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93001495|NCT00751907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001496|NCT00752843|Mifepristone|mifepristone|mesh-list
93001497|NCT00752843|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93001498|NCT00752843|Abortifacient Agents|abortifacient agents|mesh-ancestor
93001499|NCT00752843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001500|NCT00752843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001501|NCT00752843|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93001502|NCT00752843|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93001503|NCT00752843|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93001504|NCT00752843|Contraceptive Agents|contraceptive agents|mesh-ancestor
93001505|NCT00752843|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93001506|NCT00752843|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93001507|NCT00752843|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001508|NCT00752843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001509|NCT00752843|Luteolytic Agents|luteolytic agents|mesh-ancestor
93001510|NCT00752843|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93001511|NCT00752843|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93001512|NCT00752921|Etoricoxib|etoricoxib|mesh-list
93001513|NCT00752921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001514|NCT00752921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001515|NCT00752921|Analgesics|analgesics|mesh-ancestor
93001516|NCT00752921|Sensory System Agents|sensory system agents|mesh-ancestor
93001517|NCT00752921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001518|NCT00752921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001519|NCT00752921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001520|NCT00752921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001521|NCT00752921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93001522|NCT00752921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93001523|NCT00752921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001524|NCT00752921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001525|NCT00683657|Saxagliptin|saxagliptin|mesh-list
93001526|NCT00683657|Incretins|incretins|mesh-ancestor
93001527|NCT00683657|Hormones|hormones|mesh-ancestor
93001528|NCT00683657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001529|NCT00683657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001530|NCT00683657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93001531|NCT00683657|Protease Inhibitors|protease inhibitors|mesh-ancestor
93001532|NCT00683657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001533|NCT00683657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001534|NCT00683657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93001535|NCT00755885|Abiraterone Acetate|abiraterone acetate|mesh-list
93001536|NCT00755885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001537|NCT00755885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93001538|NCT00755885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001539|NCT00755885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001540|NCT00755885|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001541|NCT00755885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001542|NCT00755885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001543|NCT00755885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93001544|NCT00755963|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93001545|NCT00755963|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93001546|NCT00755963|Estradiol|estradiol|mesh-list
93001547|NCT00755963|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93001548|NCT00755963|Progesterone|progesterone|mesh-list
93001549|NCT00755963|Estrogens|estrogens|mesh-ancestor
93001550|NCT00755963|Hormones|hormones|mesh-ancestor
93001551|NCT00755963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646896|NCT04604509|Bupropion|bupropion|mesh-list
93001553|NCT00755963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93001554|NCT00755963|Contraceptive Agents|contraceptive agents|mesh-ancestor
93001555|NCT00755963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001556|NCT00755963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93001557|NCT00755963|Progestins|progestins|mesh-ancestor
93001558|NCT00753311|Rizatriptan|rizatriptan|mesh-list
93001559|NCT00753311|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93001560|NCT00753311|Serotonin Agents|serotonin agents|mesh-ancestor
93001561|NCT00753311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001562|NCT00753311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001563|NCT00753311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001564|NCT00753389|Anesthetics|anesthetics|mesh-list
93001565|NCT00753389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93001566|NCT00753389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001567|NCT00753467|Interferons|interferons|mesh-list
93001568|NCT00753467|Adefovir|adefovir|mesh-list
93001569|NCT00753467|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93001570|NCT00753467|Interferon-gamma|interferon-gamma|mesh-list
93001571|NCT00753467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001572|NCT00753467|Antiviral Agents|antiviral agents|mesh-ancestor
93001573|NCT00753467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001574|NCT00753467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93001575|NCT00753467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93001576|NCT00753467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001577|NCT00753467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001578|NCT00482703|Dasatinib|dasatinib|mesh-list
93001579|NCT00482703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001580|NCT00482703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001581|NCT00482703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001582|NCT00482703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001583|NCT04052867|Lidocaine|lidocaine|mesh-list
93001584|NCT04052867|Anesthetics, Local|anesthetics, local|mesh-ancestor
93001585|NCT04052867|Anesthetics|anesthetics|mesh-ancestor
93001586|NCT04052867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93001587|NCT04052867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001588|NCT04052867|Sensory System Agents|sensory system agents|mesh-ancestor
93001589|NCT04052867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001590|NCT04052867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001591|NCT04052867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93001592|NCT04052867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93001593|NCT04052867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001594|NCT04052867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001595|NCT00482391|Paclitaxel|paclitaxel|mesh-list
93001596|NCT00482391|Cyclophosphamide|cyclophosphamide|mesh-list
93001597|NCT00482391|Doxorubicin|doxorubicin|mesh-list
93001598|NCT00482391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93001599|NCT00482391|Trastuzumab|trastuzumab|mesh-list
93001600|NCT00482391|Lapatinib|lapatinib|mesh-list
93001601|NCT00482391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93001602|NCT00482391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001603|NCT00482391|Tubulin Modulators|tubulin modulators|mesh-ancestor
93001604|NCT00482391|Antimitotic Agents|antimitotic agents|mesh-ancestor
93001605|NCT00482391|Mitosis Modulators|mitosis modulators|mesh-ancestor
93001606|NCT00482391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001607|NCT00482391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001608|NCT00482391|Immunologic Factors|immunologic factors|mesh-ancestor
93001609|NCT00482391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001610|NCT00482391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001611|NCT00482391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93001612|NCT00482391|Alkylating Agents|alkylating agents|mesh-ancestor
93001613|NCT00482391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93001614|NCT00482391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93001615|NCT00482391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93001616|NCT00482391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93001617|NCT00482391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001618|NCT00482391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93001619|NCT00482391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001620|NCT00753779|Simvastatin|simvastatin|mesh-list
93001621|NCT00753779|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93001622|NCT00753779|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93001623|NCT00753779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93001624|NCT00753779|Antimetabolites|antimetabolites|mesh-ancestor
92646961|NCT05361824|Analgesics|analgesics|mesh-ancestor
93001625|NCT00753779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001626|NCT00753779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93001627|NCT00753779|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93001628|NCT00753779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001629|NCT00757523|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
93001630|NCT00757523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001631|NCT00757523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001632|NCT00757523|Analgesics|analgesics|mesh-ancestor
93001633|NCT00757523|Sensory System Agents|sensory system agents|mesh-ancestor
93001634|NCT00757523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001635|NCT00757523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001636|NCT00757523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001637|NCT00757523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001638|NCT00757523|Dermatologic Agents|dermatologic agents|mesh-ancestor
93001639|NCT00757679|Milnacipran|milnacipran|mesh-list
93001640|NCT00757679|Levomilnacipran|levomilnacipran|mesh-list
93001641|NCT00757679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93001642|NCT00757679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93001643|NCT00757679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001644|NCT00757679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001645|NCT00757679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001646|NCT00757679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001647|NCT00757679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001648|NCT00757679|Analgesics|analgesics|mesh-ancestor
93001649|NCT00757679|Sensory System Agents|sensory system agents|mesh-ancestor
93001650|NCT00757679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001651|NCT00757679|Antidepressive Agents|antidepressive agents|mesh-ancestor
93001652|NCT00757679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93001653|NCT00496587|Bevacizumab|bevacizumab|mesh-list
93001654|NCT00496587|Gemcitabine|gemcitabine|mesh-list
93001655|NCT00496587|Capecitabine|capecitabine|mesh-list
93001656|NCT00496587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93001657|NCT00496587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001658|NCT00496587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93001659|NCT00496587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93001660|NCT00496587|Growth Substances|growth substances|mesh-ancestor
93001661|NCT00496587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001662|NCT00496587|Growth Inhibitors|growth inhibitors|mesh-ancestor
93001663|NCT00496587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93001664|NCT00496587|Antimetabolites|antimetabolites|mesh-ancestor
93001665|NCT00496587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001666|NCT00757835|Timolol|timolol|mesh-list
93001667|NCT00757835|Latanoprost|latanoprost|mesh-list
93001668|NCT00757835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93001669|NCT00757835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93001670|NCT00757835|Adrenergic Agents|adrenergic agents|mesh-ancestor
93001671|NCT00757835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001672|NCT00757835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001673|NCT00757835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001674|NCT00757835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001675|NCT00757835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93001676|NCT00757835|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93001677|NCT00757835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93001678|NCT01038154|Pravastatin|pravastatin|mesh-list
93001679|NCT01038154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93001680|NCT01038154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93001681|NCT01038154|Antimetabolites|antimetabolites|mesh-ancestor
93001682|NCT01038154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001683|NCT01038154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93001684|NCT01038154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93001685|NCT01038154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001686|NCT00405652|Mycophenolic Acid|mycophenolic acid|mesh-list
93001687|NCT00405652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93001688|NCT00405652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001689|NCT00405652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93001690|NCT00405652|Antitubercular Agents|antitubercular agents|mesh-ancestor
93001691|NCT00405652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93001692|NCT00405652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001693|NCT00405652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001694|NCT00405652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001695|NCT01324180|Metformin|metformin|mesh-list
93001696|NCT01324180|Dexamethasone|dexamethasone|mesh-list
93001697|NCT01324180|Doxorubicin|doxorubicin|mesh-list
93001698|NCT01324180|Vincristine|vincristine|mesh-list
93001699|NCT01324180|Asparaginase|asparaginase|mesh-list
93001700|NCT01324180|Pegaspargase|pegaspargase|mesh-list
93001701|NCT01324180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001702|NCT01324180|Antiemetics|antiemetics|mesh-ancestor
93001703|NCT01324180|Autonomic Agents|autonomic agents|mesh-ancestor
93001704|NCT01324180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001705|NCT01324180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001706|NCT01324180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93001707|NCT01324180|Glucocorticoids|glucocorticoids|mesh-ancestor
93001708|NCT01324180|Hormones|hormones|mesh-ancestor
93001709|NCT01324180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001710|NCT01324180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001711|NCT01324180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001712|NCT01324180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93001713|NCT01324180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93001714|NCT01324180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93001715|NCT01324180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93001716|NCT01324180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001717|NCT01324180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001718|NCT01324180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93001719|NCT01324180|Tubulin Modulators|tubulin modulators|mesh-ancestor
93001720|NCT01324180|Antimitotic Agents|antimitotic agents|mesh-ancestor
93001721|NCT01324180|Mitosis Modulators|mitosis modulators|mesh-ancestor
93001722|NCT02560649|Tenofovir|tenofovir|mesh-list
93001723|NCT02560649|Lamivudine|lamivudine|mesh-list
93001724|NCT02560649|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93001725|NCT02560649|Interferon-alpha|interferon-alpha|mesh-list
93001726|NCT02560649|Entecavir|entecavir|mesh-list
93001727|NCT02560649|Adefovir|adefovir|mesh-list
93001728|NCT02560649|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93001729|NCT02560649|Antiviral Agents|antiviral agents|mesh-ancestor
93001730|NCT02560649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001731|NCT02560649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93001732|NCT02560649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93001733|NCT02560649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001734|NCT02560649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001735|NCT02560649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93001736|NCT02560649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93001737|NCT02560649|Immunologic Factors|immunologic factors|mesh-ancestor
93001738|NCT02560649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001739|NCT00754403|Metformin|metformin|mesh-list
93001740|NCT00754403|Pioglitazone|pioglitazone|mesh-list
93001741|NCT00754403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93001742|NCT00754403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001743|NCT00758225|Idebenone|idebenone|mesh-list
93001744|NCT00758225|Antioxidants|antioxidants|mesh-ancestor
93001745|NCT00758225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001746|NCT00758225|Protective Agents|protective agents|mesh-ancestor
93001747|NCT00758225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001748|NCT02561039|Ibandronic Acid|ibandronic acid|mesh-list
93001749|NCT02561039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93001750|NCT02561039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001751|NCT00422734|Tadalafil|tadalafil|mesh-list
93001752|NCT00422734|Vasodilator Agents|vasodilator agents|mesh-ancestor
93001753|NCT00422734|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93001754|NCT00422734|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93001755|NCT00422734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001756|NCT00422734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001757|NCT00422734|Urological Agents|urological agents|mesh-ancestor
93001758|NCT00422422|Brivaracetam|brivaracetam|mesh-list
93001759|NCT00422422|Anticonvulsants|anticonvulsants|mesh-ancestor
93001760|NCT00413374|Enoxaparin|enoxaparin|mesh-list
93001761|NCT00413374|Anticoagulants|anticoagulants|mesh-ancestor
93001762|NCT00413374|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93001763|NCT00413374|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93001764|NCT00413374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001765|NCT00682643|Fluticasone|fluticasone|mesh-list
93001766|NCT00682643|Xhance|xhance|mesh-list
93001767|NCT00682643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001768|NCT00682643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93001769|NCT00682643|Autonomic Agents|autonomic agents|mesh-ancestor
93001770|NCT00682643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001771|NCT00682643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647111|NCT04601389|Omalizumab|omalizumab|mesh-list
93001772|NCT00682643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93001773|NCT00682643|Respiratory System Agents|respiratory system agents|mesh-ancestor
93001774|NCT00682643|Dermatologic Agents|dermatologic agents|mesh-ancestor
93001776|NCT00758381|Sorafenib|sorafenib|mesh-list
93001777|NCT00758381|Cisplatin|cisplatin|mesh-list
93001778|NCT00758381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001779|NCT00758381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93001780|NCT00758381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001781|NCT00758381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001782|NCT00754871|Dienogest|dienogest|mesh-list
93001783|NCT00754871|Nandrolone|nandrolone|mesh-list
93001784|NCT00754871|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93001785|NCT00754871|Contraceptive Agents|contraceptive agents|mesh-ancestor
93001786|NCT00754871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93001787|NCT00754871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001788|NCT00754871|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93001789|NCT00754871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93001790|NCT00754871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93001791|NCT00754871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93001792|NCT00754871|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001793|NCT00754871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001794|NCT00754871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001795|NCT00754871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001796|NCT00754871|Androgens|androgens|mesh-ancestor
93001797|NCT00754871|Hormones|hormones|mesh-ancestor
93001798|NCT00754871|Anabolic Agents|anabolic agents|mesh-ancestor
93001799|NCT00755027|Rasagiline|rasagiline|mesh-list
93001800|NCT00755027|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93001801|NCT00755027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001802|NCT00755027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001803|NCT00755027|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93001804|NCT00755027|Protective Agents|protective agents|mesh-ancestor
93001805|NCT00755027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001806|NCT05435729|Levodopa|levodopa|mesh-list
93001807|NCT05435729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93001808|NCT05435729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93001809|NCT05435729|Dopamine Agents|dopamine agents|mesh-ancestor
93001810|NCT05435729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001811|NCT05435729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001812|NCT05435729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001813|NCT01038388|Dexamethasone|dexamethasone|mesh-list
93001814|NCT01038388|Lenalidomide|lenalidomide|mesh-list
93001815|NCT01038388|Bortezomib|bortezomib|mesh-list
93001816|NCT01038388|Vorinostat|vorinostat|mesh-list
93001817|NCT01038388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001818|NCT01038388|Antiemetics|antiemetics|mesh-ancestor
93001819|NCT01038388|Autonomic Agents|autonomic agents|mesh-ancestor
93001820|NCT01038388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001821|NCT01038388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001822|NCT01038388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93001823|NCT01038388|Glucocorticoids|glucocorticoids|mesh-ancestor
93001824|NCT01038388|Hormones|hormones|mesh-ancestor
93001825|NCT01038388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001826|NCT01038388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93001827|NCT01038388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001828|NCT01038388|Immunologic Factors|immunologic factors|mesh-ancestor
93001829|NCT01038388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93001830|NCT01038388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93001831|NCT01038388|Growth Substances|growth substances|mesh-ancestor
93001832|NCT01038388|Growth Inhibitors|growth inhibitors|mesh-ancestor
93001833|NCT01038388|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93001834|NCT01038388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001835|NCT01038388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001837|NCT04050059|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93001838|NCT04050059|Anesthetics, Local|anesthetics, local|mesh-ancestor
93001839|NCT04050059|Anesthetics|anesthetics|mesh-ancestor
93001840|NCT04050059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93001841|NCT04050059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001842|NCT04050059|Sensory System Agents|sensory system agents|mesh-ancestor
93001843|NCT04050059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001844|NCT04050059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93001845|NCT04050059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93001846|NCT04050059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93001847|NCT04050059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001848|NCT04050059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001849|NCT04050059|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93001851|NCT00482001|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93001852|NCT00482001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001853|NCT00482001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001854|NCT00482001|Cholinergic Agents|cholinergic agents|mesh-ancestor
93001855|NCT00482001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001856|NCT00482001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001857|NCT00482001|Nootropic Agents|nootropic agents|mesh-ancestor
93001858|NCT00490035|Brivaracetam|brivaracetam|mesh-list
93001859|NCT00490035|Anticonvulsants|anticonvulsants|mesh-ancestor
93001860|NCT00421174|Methylprednisolone|methylprednisolone|mesh-list
93001861|NCT00421174|Etanercept|etanercept|mesh-list
93001862|NCT00421174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001863|NCT00421174|Antiemetics|antiemetics|mesh-ancestor
93001864|NCT00421174|Autonomic Agents|autonomic agents|mesh-ancestor
93001865|NCT00421174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001866|NCT00421174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001867|NCT00421174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93001868|NCT00421174|Glucocorticoids|glucocorticoids|mesh-ancestor
93001869|NCT00421174|Hormones|hormones|mesh-ancestor
93001870|NCT00421174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001871|NCT00421174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93001872|NCT00421174|Protective Agents|protective agents|mesh-ancestor
93001873|NCT00421174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001874|NCT00421174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001875|NCT00421174|Analgesics|analgesics|mesh-ancestor
93001876|NCT00421174|Sensory System Agents|sensory system agents|mesh-ancestor
93001877|NCT00421174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001878|NCT00421174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001879|NCT00421174|Immunologic Factors|immunologic factors|mesh-ancestor
93001880|NCT00496197|Fluconazole|fluconazole|mesh-list
93001881|NCT00496197|Voriconazole|voriconazole|mesh-list
93001882|NCT00496197|Anidulafungin|anidulafungin|mesh-list
93001883|NCT00496197|Antifungal Agents|antifungal agents|mesh-ancestor
93001884|NCT00496197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001885|NCT00496197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93001886|NCT00496197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93001887|NCT00496197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001888|NCT00496197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001889|NCT00496197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92168560|NCT04560010|Hemostatics|hemostatics|mesh-ancestor
93001890|NCT00496197|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001891|NCT00496197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001892|NCT00496197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001893|NCT00496197|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93001894|NCT00496197|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93001895|NCT00496197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93001896|NCT03996993|Bicalutamide|bicalutamide|mesh-list
93001897|NCT03996993|Androgen Antagonists|androgen antagonists|mesh-ancestor
92528454|NCT00036088|Antiemetics|antiemetics|mesh-ancestor
93001898|NCT03996993|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001899|NCT03996993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001900|NCT03996993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001901|NCT03996993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001902|NCT01015053|Ropivacaine|ropivacaine|mesh-list
93001903|NCT01015053|Anesthetics, Local|anesthetics, local|mesh-ancestor
93001904|NCT01015053|Anesthetics|anesthetics|mesh-ancestor
93001905|NCT01015053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93001906|NCT01015053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001907|NCT01015053|Sensory System Agents|sensory system agents|mesh-ancestor
93001908|NCT01015053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001909|NCT00404092|Caspofungin|caspofungin|mesh-list
93001910|NCT00404092|Antifungal Agents|antifungal agents|mesh-ancestor
93001911|NCT00404092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001912|NCT00404092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001913|NCT00404092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001914|NCT00481767|Vaccines|vaccines|mesh-list
93001915|NCT00481767|Immunologic Factors|immunologic factors|mesh-ancestor
93001916|NCT00481767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001917|NCT00489489|Interferons|interferons|mesh-list
93001918|NCT00489489|Interferon-beta|interferon-beta|mesh-list
93001919|NCT00489489|Teriflunomide|teriflunomide|mesh-list
93001920|NCT00489489|Interferon beta-1b|interferon beta-1b|mesh-list
93001921|NCT00489489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001922|NCT00489489|Antiviral Agents|antiviral agents|mesh-ancestor
93001923|NCT00489489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001924|NCT00489489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93001925|NCT00489489|Immunologic Factors|immunologic factors|mesh-ancestor
93001926|NCT00489489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001927|NCT00489489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001928|NCT00489489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001929|NCT00489489|Analgesics|analgesics|mesh-ancestor
93001930|NCT00489489|Sensory System Agents|sensory system agents|mesh-ancestor
93001931|NCT00489489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001932|NCT00489489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001933|NCT00489489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001934|NCT00489489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001935|NCT00489411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93001936|NCT00489411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93001937|NCT00489411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93001938|NCT00489411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93001939|NCT00489411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001940|NCT00489411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93001941|NCT00489411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001942|NCT00489411|Analgesics|analgesics|mesh-ancestor
93001943|NCT00489411|Sensory System Agents|sensory system agents|mesh-ancestor
93001944|NCT00489411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001945|NCT00489411|Antidepressive Agents|antidepressive agents|mesh-ancestor
93001946|NCT00489411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93001947|NCT00489411|Dopamine Agents|dopamine agents|mesh-ancestor
93001948|NCT00420784|Interferons|interferons|mesh-list
93001949|NCT00420784|Ribavirin|ribavirin|mesh-list
93001950|NCT00420784|Interferon-alpha|interferon-alpha|mesh-list
93001951|NCT00420784|Interferon alpha-2|interferon alpha-2|mesh-list
93001952|NCT00420784|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93001953|NCT00420784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93001954|NCT00420784|Antiviral Agents|antiviral agents|mesh-ancestor
93001955|NCT00420784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001956|NCT00420784|Antimetabolites|antimetabolites|mesh-ancestor
93001957|NCT00420784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001958|NCT00420784|Immunologic Factors|immunologic factors|mesh-ancestor
92168562|NCT04558866|Methyltestosterone|methyltestosterone|mesh-list
93001959|NCT00420784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001960|NCT00420628|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93001961|NCT00420628|Tobramycin|tobramycin|mesh-list
93001962|NCT00420628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93001963|NCT00420628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001964|NCT00420628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93001965|NCT00413218|Voriconazole|voriconazole|mesh-list
93001966|NCT00413218|Caspofungin|caspofungin|mesh-list
93001967|NCT00413218|Isavuconazole|isavuconazole|mesh-list
93001968|NCT00413218|Antifungal Agents|antifungal agents|mesh-ancestor
93001969|NCT00413218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93001970|NCT00413218|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93001971|NCT00413218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93001972|NCT00413218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001973|NCT00413218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001974|NCT00413218|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93001975|NCT00413218|Hormone Antagonists|hormone antagonists|mesh-ancestor
93001976|NCT00413218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93001977|NCT00413218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001978|NCT00413218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93001980|NCT00494871|Rivaroxaban|rivaroxaban|mesh-list
93001981|NCT00494871|Anticoagulants|anticoagulants|mesh-ancestor
93001982|NCT00494871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93001983|NCT00494871|Antithrombins|antithrombins|mesh-ancestor
93001984|NCT00494871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93001985|NCT00494871|Protease Inhibitors|protease inhibitors|mesh-ancestor
93001986|NCT00494871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93001987|NCT00494871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93001988|NCT00420238|Etanercept|etanercept|mesh-list
93001989|NCT00420238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93001990|NCT00420238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93001991|NCT00420238|Analgesics|analgesics|mesh-ancestor
93001992|NCT00420238|Sensory System Agents|sensory system agents|mesh-ancestor
93001993|NCT00420238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93001994|NCT00420238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93001995|NCT00420238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93001996|NCT00420238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93001997|NCT00420238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647375|NCT00252798|Paclitaxel|paclitaxel|mesh-list
93001998|NCT00420238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93001999|NCT00420238|Immunologic Factors|immunologic factors|mesh-ancestor
93002000|NCT00420004|Escitalopram|escitalopram|mesh-list
93002001|NCT00420004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93002002|NCT00420004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93002003|NCT00420004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002004|NCT00420004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002005|NCT00420004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002006|NCT00420004|Serotonin Agents|serotonin agents|mesh-ancestor
93002007|NCT00420004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002008|NCT00494481|Docetaxel|docetaxel|mesh-list
93002009|NCT00494481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002010|NCT00494481|Tubulin Modulators|tubulin modulators|mesh-ancestor
93002011|NCT00494481|Antimitotic Agents|antimitotic agents|mesh-ancestor
93002012|NCT00494481|Mitosis Modulators|mitosis modulators|mesh-ancestor
93002013|NCT00494481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002014|NCT00097591|Clopidogrel|clopidogrel|mesh-list
93002015|NCT00097591|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93002016|NCT00097591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93002017|NCT00097591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93002018|NCT00097591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93002019|NCT00097591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93002020|NCT00097591|Purinergic Agents|purinergic agents|mesh-ancestor
93002021|NCT00097591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002022|NCT00097591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002023|NCT00097591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002024|NCT01082029|Lansoprazole|lansoprazole|mesh-list
93002025|NCT01082029|Dexlansoprazole|dexlansoprazole|mesh-list
93002026|NCT01082029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93002027|NCT01082029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93002028|NCT01082029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93002029|NCT01082029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168567|NCT04558866|Androgens|androgens|mesh-ancestor
93002030|NCT01082029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002031|NCT00419926|Cyclosporine|cyclosporine|mesh-list
93002032|NCT00419926|Mycophenolic Acid|mycophenolic acid|mesh-list
93002033|NCT00419926|Prednisone|prednisone|mesh-list
93002034|NCT00419926|Cyclosporins|cyclosporins|mesh-list
93002035|NCT00419926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002036|NCT00419926|Glucocorticoids|glucocorticoids|mesh-ancestor
93002037|NCT00419926|Hormones|hormones|mesh-ancestor
93002038|NCT00419926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002039|NCT00419926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002040|NCT00419926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93002042|NCT00419926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002043|NCT00419926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002044|NCT00419926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002045|NCT00419926|Immunologic Factors|immunologic factors|mesh-ancestor
93002046|NCT00419926|Antifungal Agents|antifungal agents|mesh-ancestor
93002047|NCT00419926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002048|NCT00419926|Dermatologic Agents|dermatologic agents|mesh-ancestor
93002049|NCT00419926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002050|NCT00419926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93002051|NCT00419926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93002052|NCT00419926|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93002053|NCT00419926|Antitubercular Agents|antitubercular agents|mesh-ancestor
93002054|NCT00419926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002055|NCT00419770|Amphotericin B|amphotericin b|mesh-list
93002056|NCT00419770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93002057|NCT00419770|Deferasirox|deferasirox|mesh-list
93002058|NCT00419770|Amebicides|amebicides|mesh-ancestor
93002059|NCT00419770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93002060|NCT00419770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93002061|NCT00419770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002062|NCT00419770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002063|NCT00419770|Antifungal Agents|antifungal agents|mesh-ancestor
93002064|NCT00419770|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93002065|NCT00419770|Chelating Agents|chelating agents|mesh-ancestor
93002066|NCT00419770|Sequestering Agents|sequestering agents|mesh-ancestor
93002067|NCT00419770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002068|NCT00080119|Isoniazid|isoniazid|mesh-list
93002069|NCT00080119|Trimethoprim|trimethoprim|mesh-list
93002070|NCT00080119|Sulfamethoxazole|sulfamethoxazole|mesh-list
93002071|NCT00080119|Antitubercular Agents|antitubercular agents|mesh-ancestor
92647407|NCT00566371|Adrenergic Agents|adrenergic agents|mesh-ancestor
93002072|NCT00080119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002073|NCT00080119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002074|NCT00080119|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93002075|NCT00080119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93002076|NCT00080119|Antimetabolites|antimetabolites|mesh-ancestor
93002077|NCT00080119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002078|NCT00080119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93002079|NCT00080119|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93002080|NCT00080119|Antimalarials|antimalarials|mesh-ancestor
93002081|NCT00080119|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93002082|NCT00080119|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93002083|NCT00080119|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93002084|NCT00080119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002085|NCT00080119|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93002086|NCT00080119|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93002087|NCT00080119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93002088|NCT01034878|Sunitinib|sunitinib|mesh-list
93002089|NCT01034878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002090|NCT01034878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002091|NCT01034878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002092|NCT01034878|Growth Substances|growth substances|mesh-ancestor
93002093|NCT01034878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002094|NCT01034878|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002095|NCT01034878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93002096|NCT01034878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002097|NCT01034878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002098|NCT01082263|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93002099|NCT01082263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93002100|NCT01082263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93002101|NCT01082263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002102|NCT01082263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002103|NCT01082263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93002104|NCT01082263|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93002105|NCT01082263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93002106|NCT01082263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93002107|NCT01082263|Adrenergic Agents|adrenergic agents|mesh-ancestor
93002108|NCT01082263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002109|NCT01082263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002110|NCT01082263|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93002111|NCT01082263|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93002112|NCT01082263|Serotonin Agents|serotonin agents|mesh-ancestor
92528460|NCT00036088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93002114|NCT01082263|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93002115|NCT01082263|Dopamine Agents|dopamine agents|mesh-ancestor
93002116|NCT02208544|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93002117|NCT02208544|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93002118|NCT02208544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002119|NCT00494091|Sirolimus|sirolimus|mesh-list
93002120|NCT00494091|Temsirolimus|temsirolimus|mesh-list
93002121|NCT00494091|MTOR Inhibitors|mtor inhibitors|mesh-list
93002122|NCT00494091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93002123|NCT00494091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002124|NCT00494091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002125|NCT00494091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002126|NCT00494091|Immunologic Factors|immunologic factors|mesh-ancestor
93002127|NCT00494091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002128|NCT00494091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002129|NCT00494091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002130|NCT00494091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002131|NCT00494091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93002132|NCT00494091|Antifungal Agents|antifungal agents|mesh-ancestor
93002133|NCT01017159|Immunoglobulins|immunoglobulins|mesh-list
93002134|NCT01017159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93002135|NCT01017159|Antibodies|antibodies|mesh-list
93002136|NCT01017159|Immunologic Factors|immunologic factors|mesh-ancestor
93002137|NCT01017159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002138|NCT00494013|Insulin Lispro|insulin lispro|mesh-list
93002139|NCT00494013|Protamines|protamines|mesh-list
93002140|NCT00494013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002141|NCT00494013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002142|NCT00494013|Heparin Antagonists|heparin antagonists|mesh-ancestor
93002143|NCT00494013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002144|NCT00494013|Coagulants|coagulants|mesh-ancestor
93002145|NCT00079339|Tipifarnib|tipifarnib|mesh-list
93002146|NCT00079339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002147|NCT01088191|Hyaluronic Acid|hyaluronic acid|mesh-list
93002148|NCT01088191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93002149|NCT01088191|Immunologic Factors|immunologic factors|mesh-ancestor
93002150|NCT01088191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002151|NCT01088191|Viscosupplements|viscosupplements|mesh-ancestor
93002152|NCT01088191|Protective Agents|protective agents|mesh-ancestor
93002153|NCT01082341|Vaccines|vaccines|mesh-list
93002154|NCT01082341|Immunologic Factors|immunologic factors|mesh-ancestor
93002155|NCT01082341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002156|NCT00541866|Cytarabine|cytarabine|mesh-list
93002157|NCT00541866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93002158|NCT00541866|Antimetabolites|antimetabolites|mesh-ancestor
93002159|NCT00541866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002160|NCT00541866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002161|NCT00541866|Antiviral Agents|antiviral agents|mesh-ancestor
93002162|NCT00541866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002163|NCT00541866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002164|NCT00541866|Immunologic Factors|immunologic factors|mesh-ancestor
93002165|NCT00541866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002166|NCT00493467|Rituximab|rituximab|mesh-list
93002167|NCT00493467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002168|NCT00493467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002169|NCT00493467|Immunologic Factors|immunologic factors|mesh-ancestor
93002170|NCT00493467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002171|NCT00493467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002172|NCT00090493|Immunomodulating Agents|immunomodulating agents|mesh-list
93002173|NCT00090493|Immunologic Factors|immunologic factors|mesh-ancestor
93002174|NCT00090493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002175|NCT01088347|Mapatumumab|mapatumumab|mesh-list
93002176|NCT01088347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002177|NCT04221828|Paclitaxel|paclitaxel|mesh-list
93002178|NCT04221828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93002179|NCT04221828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93002180|NCT04221828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002181|NCT04221828|Tubulin Modulators|tubulin modulators|mesh-ancestor
93002182|NCT04221828|Antimitotic Agents|antimitotic agents|mesh-ancestor
93002183|NCT04221828|Mitosis Modulators|mitosis modulators|mesh-ancestor
93002184|NCT04221828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002185|NCT04221750|Metformin|metformin|mesh-list
93002186|NCT04221750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002187|NCT04221750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002188|NCT04198428|Analgesics, Opioid|analgesics, opioid|mesh-list
93002190|NCT04198428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002191|NCT04198428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002192|NCT04198428|Analgesics|analgesics|mesh-ancestor
93002193|NCT04198428|Sensory System Agents|sensory system agents|mesh-ancestor
93002194|NCT04198428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002195|NCT00481065|MF59 oil emulsion|mf59 oil emulsion|mesh-list
93002196|NCT00481065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93002197|NCT00481065|Immunologic Factors|immunologic factors|mesh-ancestor
93002198|NCT00481065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002199|NCT01017393|Ketamine|ketamine|mesh-list
93002200|NCT01017393|Analgesics|analgesics|mesh-ancestor
93002201|NCT01017393|Sensory System Agents|sensory system agents|mesh-ancestor
93002202|NCT01017393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002203|NCT01017393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002204|NCT01017393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93002205|NCT01017393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93002206|NCT01017393|Anesthetics, General|anesthetics, general|mesh-ancestor
93002207|NCT01017393|Anesthetics|anesthetics|mesh-ancestor
93002208|NCT01017393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002209|NCT01017393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93002210|NCT01017393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93002211|NCT01017393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002212|NCT01017393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002213|NCT00493311|Acetaminophen|acetaminophen|mesh-list
93002214|NCT00493311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93002215|NCT00493311|Analgesics|analgesics|mesh-ancestor
93002216|NCT00493311|Sensory System Agents|sensory system agents|mesh-ancestor
93002217|NCT00493311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002218|NCT00493311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002219|NCT00493311|Antipyretics|antipyretics|mesh-ancestor
93002220|NCT00571649|Enoxaparin|enoxaparin|mesh-list
93002221|NCT00571649|Rivaroxaban|rivaroxaban|mesh-list
93002222|NCT00571649|Enoxaparin sodium|enoxaparin sodium|mesh-list
93002223|NCT00571649|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93002224|NCT00571649|Antithrombins|antithrombins|mesh-ancestor
93002225|NCT00571649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93002226|NCT00571649|Protease Inhibitors|protease inhibitors|mesh-ancestor
93002227|NCT00571649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002228|NCT00571649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002229|NCT00571649|Anticoagulants|anticoagulants|mesh-ancestor
93002230|NCT00571649|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93002231|NCT00571649|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93002232|NCT00546572|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93002233|NCT00546572|Immunologic Factors|immunologic factors|mesh-ancestor
93002234|NCT00546572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002235|NCT03917472|Aflibercept|aflibercept|mesh-list
93002236|NCT03917472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002237|NCT03917472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002238|NCT03917472|Growth Substances|growth substances|mesh-ancestor
93002239|NCT03917472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002240|NCT03917472|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002241|NCT03917472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002242|NCT00681863|Pramipexole|pramipexole|mesh-list
93002243|NCT00681863|Antioxidants|antioxidants|mesh-ancestor
93002244|NCT00681863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002245|NCT00681863|Protective Agents|protective agents|mesh-ancestor
93002246|NCT00681863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002247|NCT00681863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93002248|NCT00681863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93002249|NCT00681863|Dopamine Agonists|dopamine agonists|mesh-ancestor
93002250|NCT00681863|Dopamine Agents|dopamine agents|mesh-ancestor
92168573|NCT04558866|Anabolic Agents|anabolic agents|mesh-ancestor
93002251|NCT00681863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002252|NCT02559791|Reslizumab|reslizumab|mesh-list
93002253|NCT02559791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93002254|NCT02559791|Respiratory System Agents|respiratory system agents|mesh-ancestor
93002255|NCT05677620|Propofol|propofol|mesh-list
93002256|NCT05677620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93002257|NCT05677620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002258|NCT05677620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002259|NCT05677620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93002260|NCT05677620|Anesthetics, General|anesthetics, general|mesh-ancestor
93002261|NCT05677620|Anesthetics|anesthetics|mesh-ancestor
93002262|NCT00681629|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93002263|NCT00681629|Antidepressive Agents|antidepressive agents|mesh-ancestor
93002265|NCT00681629|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93002266|NCT00681629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93002267|NCT00681629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002268|NCT00681629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002269|NCT00969176|Acetaminophen|acetaminophen|mesh-list
93002270|NCT00969176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93002271|NCT00969176|Analgesics|analgesics|mesh-ancestor
93002272|NCT00969176|Sensory System Agents|sensory system agents|mesh-ancestor
93002273|NCT00969176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002274|NCT00969176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002275|NCT00969176|Antipyretics|antipyretics|mesh-ancestor
93002276|NCT04503252|Cefazolin|cefazolin|mesh-list
93002277|NCT04503252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002278|NCT04503252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002279|NCT00679367|Dexamethasone|dexamethasone|mesh-list
93002280|NCT00679367|Lenalidomide|lenalidomide|mesh-list
93002281|NCT00679367|Melphalan|melphalan|mesh-list
93002282|NCT00679367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002283|NCT00679367|Antiemetics|antiemetics|mesh-ancestor
93002284|NCT00679367|Autonomic Agents|autonomic agents|mesh-ancestor
93002285|NCT00679367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002286|NCT00679367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002287|NCT00679367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93002288|NCT00679367|Glucocorticoids|glucocorticoids|mesh-ancestor
93002289|NCT00679367|Hormones|hormones|mesh-ancestor
93002290|NCT00679367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002291|NCT00679367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93002292|NCT00679367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002293|NCT00679367|Immunologic Factors|immunologic factors|mesh-ancestor
92647645|NCT00567034|Naltrexone|naltrexone|mesh-list
93002294|NCT00679367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002295|NCT00679367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002296|NCT00679367|Growth Substances|growth substances|mesh-ancestor
93002297|NCT00679367|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002298|NCT00679367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93002299|NCT00679367|Alkylating Agents|alkylating agents|mesh-ancestor
93002300|NCT00679367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002301|NCT00679367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93002302|NCT00679367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002303|NCT00969566|Metformin|metformin|mesh-list
93002304|NCT00969566|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93002305|NCT00969566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002306|NCT00969566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002307|NCT00969566|Incretins|incretins|mesh-ancestor
93002308|NCT00969566|Hormones|hormones|mesh-ancestor
93002309|NCT00969566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002310|NCT00969566|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93002311|NCT00969566|Protease Inhibitors|protease inhibitors|mesh-ancestor
93002312|NCT00969566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002313|NCT00969566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002314|NCT00755495|Doxepin|doxepin|mesh-list
93002315|NCT00755495|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93002316|NCT00755495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93002317|NCT00755495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002318|NCT00755495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002319|NCT00755495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93002320|NCT00755495|Antidepressive Agents|antidepressive agents|mesh-ancestor
93002321|NCT00755495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93002322|NCT00755495|Histamine Antagonists|histamine antagonists|mesh-ancestor
93002323|NCT00755495|Histamine Agents|histamine agents|mesh-ancestor
93002324|NCT00755495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002325|NCT00755495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002326|NCT00964184|Metformin|metformin|mesh-list
93002327|NCT00964184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002328|NCT00964184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002329|NCT00969800|Chlorine dioxide|chlorine dioxide|mesh-list
93002330|NCT00969800|Dental Disinfectants|dental disinfectants|mesh-ancestor
93002331|NCT00969800|Disinfectants|disinfectants|mesh-ancestor
93002332|NCT00969800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002333|NCT00964262|Exenatide|exenatide|mesh-list
93002334|NCT00964262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002335|NCT00964262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002336|NCT00964262|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93002337|NCT00964262|Incretins|incretins|mesh-ancestor
93002338|NCT00964262|Hormones|hormones|mesh-ancestor
93002339|NCT00964262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002340|NCT00973778|Capecitabine|capecitabine|mesh-list
93002341|NCT00973778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93002342|NCT00973778|Antimetabolites|antimetabolites|mesh-ancestor
93002343|NCT00973778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002344|NCT00973778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002345|NCT05623410|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93002346|NCT05623410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93002347|NCT05623410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002348|NCT05623410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002349|NCT05623410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93002350|NCT05623410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002351|NCT05623410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002352|NCT05623410|Cholinergic Agents|cholinergic agents|mesh-ancestor
93002353|NCT05623410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002354|NCT00964418|Insulin|insulin|mesh-list
93002355|NCT00964418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93002356|NCT00964418|Insulin Glargine|insulin glargine|mesh-list
93002357|NCT00964418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002358|NCT00964418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002359|NCT00974012|Valproic Acid|valproic acid|mesh-list
93002360|NCT00974012|Anticonvulsants|anticonvulsants|mesh-ancestor
93002361|NCT00974012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002362|NCT00974012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002363|NCT00974012|GABA Agents|gaba agents|mesh-ancestor
93002364|NCT00974012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002365|NCT00974012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002366|NCT00974012|Antimanic Agents|antimanic agents|mesh-ancestor
93002367|NCT00974012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93002368|NCT00974012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002369|NCT00974012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93002370|NCT00964574|Insulin|insulin|mesh-list
93002371|NCT00964574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93002372|NCT00964574|Insulin Glargine|insulin glargine|mesh-list
93002373|NCT00964574|Insulin glulisine|insulin glulisine|mesh-list
93002374|NCT00964574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002375|NCT00964574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002377|NCT00970580|Carboplatin|carboplatin|mesh-list
93002378|NCT00970580|Alkylating Agents|alkylating agents|mesh-list
93002379|NCT00970580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93002380|NCT00970580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002381|NCT00970580|Tubulin Modulators|tubulin modulators|mesh-ancestor
93002382|NCT00970580|Antimitotic Agents|antimitotic agents|mesh-ancestor
93002383|NCT00970580|Mitosis Modulators|mitosis modulators|mesh-ancestor
93002384|NCT00970580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002385|NCT00974324|Endostar protein|endostar protein|mesh-list
93002386|NCT00974324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002387|NCT00974324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002388|NCT00974324|Growth Substances|growth substances|mesh-ancestor
93002389|NCT00974324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002390|NCT00974324|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002391|NCT00974324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002392|NCT00545714|Cyclophosphamide|cyclophosphamide|mesh-list
93002393|NCT00545714|Rituximab|rituximab|mesh-list
93002394|NCT00545714|Fludarabine|fludarabine|mesh-list
93002395|NCT00545714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002396|NCT00545714|Immunologic Factors|immunologic factors|mesh-ancestor
93002397|NCT00545714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002398|NCT00545714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002399|NCT00545714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92303064|NCT00361244|Cetuximab|cetuximab|mesh-list
93002400|NCT00545714|Alkylating Agents|alkylating agents|mesh-ancestor
93002401|NCT00545714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002402|NCT00545714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002403|NCT00545714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93002404|NCT00545714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002405|NCT00964730|Moxifloxacin|moxifloxacin|mesh-list
93002406|NCT00964730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002407|NCT00964730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002408|NCT00964730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93002409|NCT00964730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93002410|NCT00964730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002411|NCT00964730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002412|NCT00964730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002413|NCT00539838|Mycophenolic Acid|mycophenolic acid|mesh-list
93002415|NCT00539838|Methylprednisolone|methylprednisolone|mesh-list
93002416|NCT00539838|Methotrexate|methotrexate|mesh-list
93002417|NCT00539838|Azathioprine|azathioprine|mesh-list
93002418|NCT00539838|Immunosuppressive Agents|immunosuppressive agents|mesh-list
93002419|NCT00539838|Ocrelizumab|ocrelizumab|mesh-list
93002420|NCT00539838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002421|NCT00539838|Glucocorticoids|glucocorticoids|mesh-ancestor
93002422|NCT00539838|Hormones|hormones|mesh-ancestor
93002423|NCT00539838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002424|NCT00539838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002425|NCT00539838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93002426|NCT00539838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002427|NCT00539838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93002428|NCT00539838|Abortifacient Agents|abortifacient agents|mesh-ancestor
93002429|NCT00539838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93002430|NCT00539838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93002431|NCT00539838|Antimetabolites|antimetabolites|mesh-ancestor
93002432|NCT00539838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002433|NCT00539838|Dermatologic Agents|dermatologic agents|mesh-ancestor
93002434|NCT00539838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002435|NCT00539838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93002436|NCT00539838|Immunologic Factors|immunologic factors|mesh-ancestor
93002437|NCT00539838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002438|NCT00539838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93002439|NCT00539838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93002440|NCT00539838|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93002441|NCT00539838|Antitubercular Agents|antitubercular agents|mesh-ancestor
93002442|NCT00539838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002443|NCT00539838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002444|NCT00539838|Antiemetics|antiemetics|mesh-ancestor
93002445|NCT00539838|Autonomic Agents|autonomic agents|mesh-ancestor
93002446|NCT00539838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002447|NCT00539838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93002448|NCT00539838|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93002449|NCT00539838|Protective Agents|protective agents|mesh-ancestor
93002451|NCT00970892|Anticoagulants|anticoagulants|mesh-ancestor
93002452|NCT00964808|Oxycodone|oxycodone|mesh-list
93002453|NCT00964808|Buprenorphine|buprenorphine|mesh-list
93002454|NCT00964808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93002455|NCT00964808|Narcotics|narcotics|mesh-ancestor
93002456|NCT00964808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002457|NCT00964808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002458|NCT00964808|Analgesics|analgesics|mesh-ancestor
93002459|NCT00964808|Sensory System Agents|sensory system agents|mesh-ancestor
93002460|NCT00964808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002461|NCT00964808|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93002462|NCT00970970|Bevacizumab|bevacizumab|mesh-list
93002463|NCT00970970|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
93002464|NCT00970970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002465|NCT00970970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002466|NCT00970970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002467|NCT00970970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002468|NCT00970970|Growth Substances|growth substances|mesh-ancestor
93002469|NCT00970970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002470|NCT00970970|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002471|NCT00970970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93002472|NCT00970970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002473|NCT03765450|Infliximab|infliximab|mesh-list
93002474|NCT03765450|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93002475|NCT03765450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002476|NCT03765450|Dermatologic Agents|dermatologic agents|mesh-ancestor
93002477|NCT03765450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93002478|NCT03765450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002479|NCT00971126|Thalidomide|thalidomide|mesh-list
93002480|NCT00971126|Sorafenib|sorafenib|mesh-list
93002481|NCT00971126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002482|NCT00971126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93002483|NCT00971126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002484|NCT00971126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002485|NCT00971126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002486|NCT00971126|Immunologic Factors|immunologic factors|mesh-ancestor
93002487|NCT00971126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002488|NCT00971126|Leprostatic Agents|leprostatic agents|mesh-ancestor
93002489|NCT00971126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002490|NCT00971126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002491|NCT00971126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002492|NCT00971126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002493|NCT00971126|Growth Substances|growth substances|mesh-ancestor
93002494|NCT00971126|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002495|NCT00964964|Insulin|insulin|mesh-list
93002496|NCT00964964|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93002497|NCT00964964|Insulin, Long-Acting|insulin, long-acting|mesh-list
93002498|NCT00964964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002499|NCT00964964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002500|NCT00965042|Ceftobiprole|ceftobiprole|mesh-list
93002501|NCT00965042|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93002502|NCT00965042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002503|NCT00965042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002504|NCT03676764|Azithromycin|azithromycin|mesh-list
93002505|NCT03676764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002506|NCT03676764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002507|NCT00974792|Leucovorin|leucovorin|mesh-list
93002508|NCT00974792|Cytarabine|cytarabine|mesh-list
93002509|NCT00974792|Cyclophosphamide|cyclophosphamide|mesh-list
93002510|NCT00974792|Ifosfamide|ifosfamide|mesh-list
93002511|NCT00974792|Rituximab|rituximab|mesh-list
93002512|NCT00974792|Doxorubicin|doxorubicin|mesh-list
93002513|NCT00974792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93002514|NCT00974792|Methotrexate|methotrexate|mesh-list
93002515|NCT00974792|Etoposide|etoposide|mesh-list
93002516|NCT00974792|Vincristine|vincristine|mesh-list
93002517|NCT00974792|Etoposide phosphate|etoposide phosphate|mesh-list
93002518|NCT00974792|Levoleucovorin|levoleucovorin|mesh-list
93002519|NCT00974792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002520|NCT00974792|Immunologic Factors|immunologic factors|mesh-ancestor
93002521|NCT00974792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002522|NCT00974792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002523|NCT00974792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93002524|NCT00974792|Alkylating Agents|alkylating agents|mesh-ancestor
93002525|NCT00974792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002526|NCT00974792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002527|NCT00974792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93002528|NCT00974792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002529|NCT00974792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93002530|NCT00974792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93002531|NCT00974792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93002532|NCT00974792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002533|NCT00974792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93002534|NCT00974792|Abortifacient Agents|abortifacient agents|mesh-ancestor
93002535|NCT00974792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93002536|NCT00974792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93002537|NCT00974792|Antimetabolites|antimetabolites|mesh-ancestor
93002538|NCT00974792|Dermatologic Agents|dermatologic agents|mesh-ancestor
93002539|NCT00974792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93002540|NCT00974792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93002541|NCT00974792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93002542|NCT00974792|Antiviral Agents|antiviral agents|mesh-ancestor
93002543|NCT00974792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002544|NCT00974792|Antidotes|antidotes|mesh-ancestor
93002545|NCT00974792|Protective Agents|protective agents|mesh-ancestor
93002546|NCT00974792|Vitamin B Complex|vitamin b complex|mesh-ancestor
93002547|NCT00974792|Vitamins|vitamins|mesh-ancestor
93002548|NCT00974792|Micronutrients|micronutrients|mesh-ancestor
93002549|NCT00974792|Tubulin Modulators|tubulin modulators|mesh-ancestor
93002550|NCT00974792|Antimitotic Agents|antimitotic agents|mesh-ancestor
93002551|NCT00974792|Mitosis Modulators|mitosis modulators|mesh-ancestor
93002552|NCT00965120|Bradykinin|bradykinin|mesh-list
93002553|NCT00965120|Kininogens|kininogens|mesh-list
93002554|NCT00965120|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
93002555|NCT00965120|Vasodilator Agents|vasodilator agents|mesh-ancestor
93002556|NCT00965120|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93002557|NCT00965120|Protease Inhibitors|protease inhibitors|mesh-ancestor
93002558|NCT00965120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002559|NCT00965120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002560|NCT00679289|Interferons|interferons|mesh-list
93002561|NCT00679289|Ecromeximab|ecromeximab|mesh-list
93002562|NCT00679289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002563|NCT00679289|Antiviral Agents|antiviral agents|mesh-ancestor
93002564|NCT00679289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002565|NCT00679289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002566|NCT00679211|Trastuzumab|trastuzumab|mesh-list
93002567|NCT00679211|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93002568|NCT00679211|Maytansine|maytansine|mesh-list
93002569|NCT00679211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002570|NCT00679211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002571|NCT00679211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93002572|NCT00679211|Tubulin Modulators|tubulin modulators|mesh-ancestor
93002573|NCT00679211|Antimitotic Agents|antimitotic agents|mesh-ancestor
93002574|NCT00679211|Mitosis Modulators|mitosis modulators|mesh-ancestor
93002575|NCT00679211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002576|NCT00679211|Immunotoxins|immunotoxins|mesh-ancestor
93002577|NCT00679211|Immunoconjugates|immunoconjugates|mesh-ancestor
93002578|NCT00679211|Immunologic Factors|immunologic factors|mesh-ancestor
93002579|NCT00679211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002580|NCT00545948|Cisplatin|cisplatin|mesh-list
93002581|NCT00545948|Pemetrexed|pemetrexed|mesh-list
93002582|NCT00545948|Vinorelbine|vinorelbine|mesh-list
93002583|NCT00545948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002584|NCT00545948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002585|NCT00545948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002586|NCT00545948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93002587|NCT00545948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93002588|NCT00545948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93002589|NCT00545948|Tubulin Modulators|tubulin modulators|mesh-ancestor
93002590|NCT00545948|Antimitotic Agents|antimitotic agents|mesh-ancestor
93002591|NCT00545948|Mitosis Modulators|mitosis modulators|mesh-ancestor
93002592|NCT00755573|Pregabalin|pregabalin|mesh-list
93002593|NCT00755573|Analgesics|analgesics|mesh-ancestor
93002594|NCT00755573|Sensory System Agents|sensory system agents|mesh-ancestor
93002595|NCT00755573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002596|NCT00755573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002597|NCT00755573|Anticonvulsants|anticonvulsants|mesh-ancestor
93002598|NCT00755573|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93002599|NCT00755573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002600|NCT00755573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002601|NCT00755573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93002602|NCT00755573|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93002603|NCT00755573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93002604|NCT00755573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002605|NCT00755573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93002606|NCT00975104|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
93002607|NCT00975104|Immunologic Factors|immunologic factors|mesh-ancestor
93002608|NCT00975104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002609|NCT04008290|Liraglutide|liraglutide|mesh-list
93002610|NCT04008290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002611|NCT04008290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002612|NCT04008290|Incretins|incretins|mesh-ancestor
93002613|NCT04008290|Hormones|hormones|mesh-ancestor
93002614|NCT04008290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002615|NCT02559167|Cannabidiol|cannabidiol|mesh-list
93002616|NCT02559167|Anticonvulsants|anticonvulsants|mesh-ancestor
93002617|NCT00975182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93002618|NCT00975182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002619|NCT00975182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93002620|NCT00975182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002621|NCT00975182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002622|NCT05271071|Lidocaine|lidocaine|mesh-list
93002623|NCT05271071|Anesthetics, Local|anesthetics, local|mesh-ancestor
93002624|NCT05271071|Anesthetics|anesthetics|mesh-ancestor
93002625|NCT05271071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002626|NCT05271071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002627|NCT05271071|Sensory System Agents|sensory system agents|mesh-ancestor
93002628|NCT05271071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002629|NCT05271071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93002630|NCT05271071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93002631|NCT05271071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93002632|NCT05271071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002633|NCT05271071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002634|NCT00972140|Formoterol Fumarate|formoterol fumarate|mesh-list
93002635|NCT00972140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93002636|NCT00972140|Autonomic Agents|autonomic agents|mesh-ancestor
93002637|NCT00972140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002638|NCT00972140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002639|NCT00972140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93002640|NCT00972140|Respiratory System Agents|respiratory system agents|mesh-ancestor
93002641|NCT00972140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93002642|NCT00972140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93002644|NCT00972140|Adrenergic Agents|adrenergic agents|mesh-ancestor
93002645|NCT00972140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002646|NCT00972140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002647|NCT00972218|Adalimumab|adalimumab|mesh-list
93002648|NCT00972218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93002649|NCT00972218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002650|NCT00972218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002651|NCT05230901|Dihydralazine|dihydralazine|mesh-list
93002652|NCT05230901|Spironolactone|spironolactone|mesh-list
93002653|NCT05230901|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93002654|NCT05230901|Hormone Antagonists|hormone antagonists|mesh-ancestor
93002655|NCT05230901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002656|NCT05230901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002657|NCT05230901|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93002658|NCT05230901|Diuretics|diuretics|mesh-ancestor
93002659|NCT05230901|Natriuretic Agents|natriuretic agents|mesh-ancestor
93002660|NCT05230901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93002661|NCT00972296|Carbon Fiber|carbon fiber|mesh-list
93002662|NCT00972296|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93002663|NCT00972296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002664|NCT03927950|Bupropion|bupropion|mesh-list
93002665|NCT03927950|Escitalopram|escitalopram|mesh-list
93002666|NCT03927950|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93002667|NCT03927950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93002668|NCT03927950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002669|NCT03927950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002670|NCT03927950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002671|NCT03927950|Serotonin Agents|serotonin agents|mesh-ancestor
93002672|NCT03927950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002673|NCT03927950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93002674|NCT03927950|Antidepressive Agents|antidepressive agents|mesh-ancestor
93002675|NCT03927950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93002676|NCT03927950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93002677|NCT03927950|Dopamine Agents|dopamine agents|mesh-ancestor
93002678|NCT03927950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93002679|NCT03927950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93002680|NCT03927950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002681|NCT00972842|Lenalidomide|lenalidomide|mesh-list
93002682|NCT00972842|Vorinostat|vorinostat|mesh-list
93002683|NCT00972842|Immunologic Factors|immunologic factors|mesh-ancestor
93002684|NCT00972842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002685|NCT00972842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93002686|NCT00972842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93002687|NCT00972842|Growth Substances|growth substances|mesh-ancestor
93002688|NCT00972842|Growth Inhibitors|growth inhibitors|mesh-ancestor
93002689|NCT00972842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002690|NCT00972842|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93002691|NCT00972842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002692|NCT00972842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002693|NCT00975494|Sildenafil Citrate|sildenafil citrate|mesh-list
93002694|NCT00975494|Vasodilator Agents|vasodilator agents|mesh-ancestor
93002695|NCT00975494|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93002696|NCT00975494|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93002697|NCT00975494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002698|NCT00975494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002699|NCT00975494|Urological Agents|urological agents|mesh-ancestor
93002700|NCT00975572|Vaccines|vaccines|mesh-list
93002701|NCT00975572|Immunologic Factors|immunologic factors|mesh-ancestor
93002702|NCT00975572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002703|NCT00965666|Etanercept|etanercept|mesh-list
93002704|NCT00965666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93002705|NCT00965666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93002706|NCT00965666|Analgesics|analgesics|mesh-ancestor
93002707|NCT00965666|Sensory System Agents|sensory system agents|mesh-ancestor
93002708|NCT00965666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002709|NCT00965666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002710|NCT00965666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002711|NCT00965666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002712|NCT00965666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93002713|NCT00965666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002714|NCT00965666|Immunologic Factors|immunologic factors|mesh-ancestor
93002715|NCT00975728|Antioxidants|antioxidants|mesh-list
93002716|NCT00975728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002717|NCT00975728|Protective Agents|protective agents|mesh-ancestor
93002718|NCT00975728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002719|NCT04049747|Bicalutamide|bicalutamide|mesh-list
93002720|NCT04049747|Finasteride|finasteride|mesh-list
93002721|NCT04049747|Androgen Antagonists|androgen antagonists|mesh-ancestor
93002722|NCT04049747|Hormone Antagonists|hormone antagonists|mesh-ancestor
93002723|NCT04049747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002724|NCT04049747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002725|NCT04049747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002726|NCT04049747|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93002727|NCT04049747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93002728|NCT04049747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002729|NCT04049747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002730|NCT04049747|Urological Agents|urological agents|mesh-ancestor
93002731|NCT00973154|Prednisone|prednisone|mesh-list
93002732|NCT00973154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002733|NCT00973154|Glucocorticoids|glucocorticoids|mesh-ancestor
93002734|NCT00973154|Hormones|hormones|mesh-ancestor
93002735|NCT00973154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002736|NCT00973154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002737|NCT00973154|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93002738|NCT00973154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002739|NCT00965900|Propranolol|propranolol|mesh-list
93002740|NCT00965900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93002741|NCT00965900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93002742|NCT00965900|Adrenergic Agents|adrenergic agents|mesh-ancestor
93002743|NCT00965900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002744|NCT00965900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002745|NCT00965900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002746|NCT00965900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93002747|NCT00965900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93002748|NCT00965900|Vasodilator Agents|vasodilator agents|mesh-ancestor
93002749|NCT03486197|Pembrolizumab|pembrolizumab|mesh-list
93002750|NCT03486197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002751|NCT03486197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002752|NCT03486197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93002753|NCT03486197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002754|NCT00973232|Acetaminophen|acetaminophen|mesh-list
93002755|NCT00973232|Tramadol|tramadol|mesh-list
93002756|NCT00973232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93002757|NCT00973232|Analgesics|analgesics|mesh-ancestor
93002758|NCT00973232|Sensory System Agents|sensory system agents|mesh-ancestor
93002759|NCT00973232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002760|NCT00973232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002761|NCT00973232|Antipyretics|antipyretics|mesh-ancestor
93002762|NCT00973232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93002763|NCT00973232|Narcotics|narcotics|mesh-ancestor
93002764|NCT00973232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002765|NCT00973310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93002766|NCT00973310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002767|NCT00973310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93002768|NCT00973310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002769|NCT00973310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002770|NCT00973388|Moxifloxacin|moxifloxacin|mesh-list
93002771|NCT00973388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002772|NCT00973388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002773|NCT00973388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93002774|NCT00973388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93002775|NCT00973388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002776|NCT00973388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002777|NCT00973388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002778|NCT00975962|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93002779|NCT00975962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93002780|NCT00975962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93002781|NCT00975962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002782|NCT00966056|Mitomycins|mitomycins|mesh-list
93002783|NCT00966056|Mitomycin|mitomycin|mesh-list
93002784|NCT00966056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93002785|NCT00966056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002786|NCT00966056|Alkylating Agents|alkylating agents|mesh-ancestor
93002787|NCT00966056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002788|NCT00966056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93002789|NCT00966056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002790|NCT00976040|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93002791|NCT00976040|Antiviral Agents|antiviral agents|mesh-ancestor
93002792|NCT00976040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002793|NCT03523728|Venglustat|venglustat|mesh-list
93002794|NCT03523728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002795|NCT03523728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002796|NCT00979706|Cyclosporine|cyclosporine|mesh-list
93002797|NCT00979706|Interleukin-2|interleukin-2|mesh-list
93002798|NCT00979706|Cyclosporins|cyclosporins|mesh-list
93002799|NCT00979706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002800|NCT00979706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002801|NCT00979706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93002802|NCT00979706|Immunologic Factors|immunologic factors|mesh-ancestor
93002803|NCT00979706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002804|NCT00979706|Antifungal Agents|antifungal agents|mesh-ancestor
93002805|NCT00979706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002806|NCT00979706|Dermatologic Agents|dermatologic agents|mesh-ancestor
93002807|NCT00979706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002808|NCT00979706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93002809|NCT00979706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002810|NCT00979706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93002811|NCT00979706|Analgesics|analgesics|mesh-ancestor
93002812|NCT00979706|Sensory System Agents|sensory system agents|mesh-ancestor
93002813|NCT00979706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002814|NCT00979862|Cediranib|cediranib|mesh-list
93002815|NCT00979862|Maleic acid|maleic acid|mesh-list
93002816|NCT00979862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002817|NCT00979862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002818|NCT00979862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002819|NCT00979862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93002820|NCT00966290|Warfarin|warfarin|mesh-list
93002821|NCT00966290|Anticoagulants|anticoagulants|mesh-list
93002822|NCT00966290|Acenocoumarol|acenocoumarol|mesh-list
93002823|NCT00966290|Fluindione|fluindione|mesh-list
93002824|NCT00966290|Phenindione|phenindione|mesh-list
93002825|NCT00966368|Insulin|insulin|mesh-list
93002826|NCT00966368|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93002827|NCT00966368|Insulin, Long-Acting|insulin, long-acting|mesh-list
93002828|NCT00966368|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002829|NCT00966368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002830|NCT00980408|Cycloserine|cycloserine|mesh-list
93002831|NCT00980408|Memantine|memantine|mesh-list
93002832|NCT00980408|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93002833|NCT00980408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93002834|NCT00980408|Dopamine Agents|dopamine agents|mesh-ancestor
93002835|NCT00980408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93002836|NCT00980408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002837|NCT00980408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002838|NCT00980408|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93002839|NCT00980408|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93002840|NCT00980408|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93002841|NCT00980408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002842|NCT00980408|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93002843|NCT00980408|Antitubercular Agents|antitubercular agents|mesh-ancestor
93002844|NCT00980408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002845|NCT00980408|Antimetabolites|antimetabolites|mesh-ancestor
93002846|NCT00980876|Ciprofloxacin|ciprofloxacin|mesh-list
93002847|NCT00980876|Hydrocortisone|hydrocortisone|mesh-list
93002848|NCT00980876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002849|NCT00980876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002850|NCT00980876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002851|NCT00980876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93002852|NCT00980876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93002853|NCT00980876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002854|NCT00980876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002855|NCT00980876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002856|NCT00980876|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93002857|NCT00980876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93002858|NCT05279040|Ivacaftor|ivacaftor|mesh-list
93002859|NCT05279040|Elexacaftor|elexacaftor|mesh-list
93002860|NCT05279040|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93002861|NCT05279040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002862|NCT05279040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002863|NCT00989898|Insulin|insulin|mesh-list
93002864|NCT00989898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002865|NCT00989898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002866|NCT00990054|Plerixafor|plerixafor|mesh-list
93002867|NCT00990054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93002868|NCT00990054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93002869|NCT00990054|Antiviral Agents|antiviral agents|mesh-ancestor
93002870|NCT00990054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002871|NCT03388632|Nivolumab|nivolumab|mesh-list
93002872|NCT03388632|Ipilimumab|ipilimumab|mesh-list
93002873|NCT03388632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002874|NCT03388632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002875|NCT03388632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93002876|NCT03388632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002877|NCT05361408|Zoledronic Acid|zoledronic acid|mesh-list
93002878|NCT05361408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93002879|NCT05361408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002880|NCT05590572|Etoposide|etoposide|mesh-list
93002881|NCT05590572|Ifosfamide|ifosfamide|mesh-list
93002882|NCT05590572|Isophosphamide mustard|isophosphamide mustard|mesh-list
93002883|NCT05590572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93002884|NCT05590572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002885|NCT05590572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93002886|NCT05590572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93002887|NCT05590572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002888|NCT05590572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002889|NCT05590572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93002890|NCT05590572|Alkylating Agents|alkylating agents|mesh-ancestor
93002891|NCT03069378|Pembrolizumab|pembrolizumab|mesh-list
93002892|NCT03069378|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93002893|NCT03069378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93002894|NCT03069378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002895|NCT03069378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93002896|NCT03069378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002897|NCT05590416|Adalimumab|adalimumab|mesh-list
93002898|NCT05590416|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93002899|NCT05590416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002900|NCT05590416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002901|NCT00990444|Insulin|insulin|mesh-list
93002902|NCT00990444|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93002903|NCT00990444|Dextrans|dextrans|mesh-list
93002904|NCT00990444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93002905|NCT00990444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002906|NCT00990444|Anticoagulants|anticoagulants|mesh-ancestor
93002907|NCT00990444|Plasma Substitutes|plasma substitutes|mesh-ancestor
93002908|NCT00990444|Blood Substitutes|blood substitutes|mesh-ancestor
93002909|NCT00990600|Tenofovir|tenofovir|mesh-list
93002910|NCT00990600|Emtricitabine|emtricitabine|mesh-list
93002911|NCT00990600|Efavirenz|efavirenz|mesh-list
93002912|NCT00990600|Antiviral Agents|antiviral agents|mesh-ancestor
93002913|NCT00990600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002914|NCT00990600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93002915|NCT00990600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93002916|NCT00990600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002917|NCT00990600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002918|NCT00990600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93002919|NCT00990600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93002920|NCT00990600|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93002921|NCT00990600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93002922|NCT00990600|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93002923|NCT00990600|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93002924|NCT00990600|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93002925|NCT00990600|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93002926|NCT02897076|Betamethasone|betamethasone|mesh-list
93002927|NCT02897076|Betamethasone Valerate|betamethasone valerate|mesh-list
93002928|NCT02897076|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93002929|NCT02897076|Betamethasone benzoate|betamethasone benzoate|mesh-list
93002930|NCT02897076|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93002931|NCT02897076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002932|NCT02897076|Glucocorticoids|glucocorticoids|mesh-ancestor
93002933|NCT02897076|Hormones|hormones|mesh-ancestor
93002934|NCT02897076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93002935|NCT02897076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002936|NCT02897076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93002937|NCT02897076|Respiratory System Agents|respiratory system agents|mesh-ancestor
93002938|NCT02797548|Aspirin|aspirin|mesh-list
93002939|NCT02797548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93002940|NCT02797548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93002941|NCT02797548|Analgesics|analgesics|mesh-ancestor
93002942|NCT02797548|Sensory System Agents|sensory system agents|mesh-ancestor
93002943|NCT02797548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002944|NCT02797548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002945|NCT02797548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93002946|NCT02797548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93002947|NCT02797548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93002948|NCT02797548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93002949|NCT02797548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002950|NCT02797548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93002951|NCT02797548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93002952|NCT02797548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002953|NCT02797548|Antipyretics|antipyretics|mesh-ancestor
93002954|NCT00990678|Vitamin D|vitamin d|mesh-list
93002955|NCT00990678|Calcitriol|calcitriol|mesh-list
93002956|NCT00990678|Calcium|calcium|mesh-list
93002957|NCT00990678|Vitamins|vitamins|mesh-ancestor
93002958|NCT00990678|Micronutrients|micronutrients|mesh-ancestor
93002959|NCT00990678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002960|NCT00990678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93002961|NCT00990678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93002962|NCT00990678|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93002963|NCT00990678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93002964|NCT00990678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002965|NCT00990678|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93002966|NCT00538590|Mitomycins|mitomycins|mesh-list
93002967|NCT00538590|Mitomycin|mitomycin|mesh-list
93002968|NCT00538590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93002969|NCT00538590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93002970|NCT00538590|Alkylating Agents|alkylating agents|mesh-ancestor
93002971|NCT00538590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002972|NCT00538590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93002973|NCT00538590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002974|NCT00990834|Simvastatin|simvastatin|mesh-list
93002975|NCT00990834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93002976|NCT00990834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93002977|NCT00990834|Antimetabolites|antimetabolites|mesh-ancestor
93002978|NCT00990834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002979|NCT00990834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93002980|NCT00990834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93002981|NCT00990834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002983|NCT00990990|Oxazolidinones|oxazolidinones|mesh-list
93002984|NCT00990990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93002985|NCT00990990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93002986|NCT00990990|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93002987|NCT00990990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93002988|NCT00990990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93002989|NCT05589402|Lidocaine|lidocaine|mesh-list
93002990|NCT05589402|Anesthetics, Local|anesthetics, local|mesh-ancestor
93002991|NCT05589402|Anesthetics|anesthetics|mesh-ancestor
93002992|NCT05589402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93002993|NCT05589402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93002994|NCT05589402|Sensory System Agents|sensory system agents|mesh-ancestor
93002995|NCT05589402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93002996|NCT05589402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93002997|NCT05589402|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93002998|NCT05589402|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93002999|NCT05589402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003000|NCT05589402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003001|NCT00466947|Vaccines|vaccines|mesh-list
93003002|NCT00466947|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93003003|NCT00466947|Immunologic Factors|immunologic factors|mesh-ancestor
93003004|NCT00466947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003005|NCT00537810|Sibutramine|sibutramine|mesh-list
93003006|NCT00537810|Antidepressive Agents|antidepressive agents|mesh-ancestor
93003007|NCT00537810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003008|NCT00537810|Appetite Depressants|appetite depressants|mesh-ancestor
93003009|NCT00537810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93003010|NCT01829568|Rituximab|rituximab|mesh-list
93003011|NCT01829568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93003012|NCT01829568|Lenalidomide|lenalidomide|mesh-list
93003013|NCT01829568|Antibodies|antibodies|mesh-list
93003014|NCT01829568|Immunoglobulins|immunoglobulins|mesh-list
93003015|NCT01829568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93003016|NCT01829568|Immunologic Factors|immunologic factors|mesh-ancestor
93003017|NCT01829568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003018|NCT01829568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003019|NCT01829568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003020|NCT01829568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003021|NCT01829568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003022|NCT01829568|Growth Substances|growth substances|mesh-ancestor
93003023|NCT01829568|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003024|NCT00848328|Rituximab|rituximab|mesh-list
93003025|NCT00848328|Lenalidomide|lenalidomide|mesh-list
93003026|NCT00848328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003027|NCT00848328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003028|NCT00848328|Immunologic Factors|immunologic factors|mesh-ancestor
93003029|NCT00848328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003030|NCT00848328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003031|NCT00848328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003032|NCT00848328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003033|NCT00848328|Growth Substances|growth substances|mesh-ancestor
93003034|NCT00848328|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003035|NCT00989352|Rituximab|rituximab|mesh-list
93003036|NCT00989352|Methotrexate|methotrexate|mesh-list
93003037|NCT00989352|Lomustine|lomustine|mesh-list
93003038|NCT00989352|Procarbazine|procarbazine|mesh-list
93003039|NCT00989352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003040|NCT00989352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003041|NCT00989352|Immunologic Factors|immunologic factors|mesh-ancestor
93003042|NCT00989352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003043|NCT00989352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003044|NCT00989352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93003045|NCT00989352|Abortifacient Agents|abortifacient agents|mesh-ancestor
93003046|NCT00989352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93003047|NCT00989352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003048|NCT00989352|Antimetabolites|antimetabolites|mesh-ancestor
93003049|NCT00989352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003050|NCT00989352|Dermatologic Agents|dermatologic agents|mesh-ancestor
93003051|NCT00989352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003052|NCT00989352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93003053|NCT00989352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003054|NCT00989352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003055|NCT00989352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003056|NCT00989352|Alkylating Agents|alkylating agents|mesh-ancestor
93003057|NCT05566626|Tropicamide|tropicamide|mesh-list
93003058|NCT05566626|Mydriatics|mydriatics|mesh-ancestor
93003059|NCT05566626|Autonomic Agents|autonomic agents|mesh-ancestor
93003060|NCT05566626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003061|NCT05566626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003062|NCT05566626|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93003063|NCT05566626|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93003064|NCT05566626|Cholinergic Agents|cholinergic agents|mesh-ancestor
93003065|NCT05566626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003066|NCT05566626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003067|NCT00989508|Perhexiline|perhexiline|mesh-list
93003068|NCT00989508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93003069|NCT00989508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003070|NCT00989508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003071|NCT00989508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93003072|NCT00989508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003073|NCT00989508|Vasodilator Agents|vasodilator agents|mesh-ancestor
93003074|NCT05360394|Paclitaxel|paclitaxel|mesh-list
93003075|NCT05360394|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93003076|NCT05360394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93003077|NCT05360394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003078|NCT05360394|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003079|NCT05360394|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003080|NCT05360394|Mitosis Modulators|mitosis modulators|mesh-ancestor
93003081|NCT05360394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003082|NCT00090259|Losartan|losartan|mesh-list
93003083|NCT00090259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93003084|NCT00090259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93003085|NCT00090259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93003086|NCT00090259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93003087|NCT00090259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003088|NCT00079183|Sirolimus|sirolimus|mesh-list
93003089|NCT00079183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003090|NCT00079183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003091|NCT00079183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93003092|NCT00079183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003093|NCT00079183|Antifungal Agents|antifungal agents|mesh-ancestor
93003094|NCT00079183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003095|NCT00079183|Immunologic Factors|immunologic factors|mesh-ancestor
93003096|NCT00079183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003097|NCT01086085|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93003098|NCT01086085|Interferon-alpha|interferon-alpha|mesh-list
93003099|NCT01086085|Adefovir|adefovir|mesh-list
93003100|NCT01086085|Antiviral Agents|antiviral agents|mesh-ancestor
93003101|NCT01086085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003102|NCT01086085|Immunologic Factors|immunologic factors|mesh-ancestor
93003103|NCT01086085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003104|NCT01086085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93003105|NCT01086085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003106|NCT01086085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003107|NCT01086085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003108|NCT01589419|Capecitabine|capecitabine|mesh-list
93003109|NCT01589419|Veliparib|veliparib|mesh-list
93003110|NCT01589419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003111|NCT01589419|Antimetabolites|antimetabolites|mesh-ancestor
93003112|NCT01589419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003113|NCT01589419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003114|NCT01589419|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93003115|NCT01589419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003116|NCT00676403|Pregabalin|pregabalin|mesh-list
93003117|NCT00676403|Analgesics|analgesics|mesh-ancestor
93003118|NCT00676403|Sensory System Agents|sensory system agents|mesh-ancestor
93003119|NCT00676403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003120|NCT00676403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003121|NCT00676403|Anticonvulsants|anticonvulsants|mesh-ancestor
93003122|NCT00676403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93003123|NCT00676403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003124|NCT00676403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003125|NCT00676403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93003127|NCT00676403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93003128|NCT00676403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003129|NCT00676403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003130|NCT00078325|Modafinil|modafinil|mesh-list
93003131|NCT00078325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93003132|NCT00078325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003133|NCT00078325|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93003134|NCT00078325|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93003135|NCT00078325|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93003136|NCT00078325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003137|NCT03963193|Cisplatin|cisplatin|mesh-list
93003138|NCT03963193|Irinotecan|irinotecan|mesh-list
93003139|NCT03963193|Etoposide|etoposide|mesh-list
93003140|NCT03963193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003141|NCT03963193|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93003142|NCT03963193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93003143|NCT03963193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003144|NCT03963193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003145|NCT03963193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93003146|NCT03963193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93003147|NCT03961867|Docetaxel|docetaxel|mesh-list
93003148|NCT03961867|Oxaliplatin|oxaliplatin|mesh-list
93003149|NCT03961867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003150|NCT03961867|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003151|NCT03961867|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003152|NCT03961867|Mitosis Modulators|mitosis modulators|mesh-ancestor
93003153|NCT03961867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003155|NCT00077857|Capecitabine|capecitabine|mesh-list
93003156|NCT00077857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003157|NCT00077857|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003158|NCT00077857|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003159|NCT00077857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92168647|NCT04211987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93003160|NCT00077857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003161|NCT00077857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003162|NCT00077857|Antimetabolites|antimetabolites|mesh-ancestor
93003163|NCT00545402|Mycophenolic Acid|mycophenolic acid|mesh-list
93003164|NCT00545402|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93003165|NCT00545402|Tacrolimus|tacrolimus|mesh-list
93003166|NCT00545402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003167|NCT00545402|Immunologic Factors|immunologic factors|mesh-ancestor
93003168|NCT00545402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003169|NCT00545402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93003170|NCT00545402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003171|NCT00545402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003172|NCT00545402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93003173|NCT00545402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003174|NCT00545402|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93003175|NCT00545402|Antitubercular Agents|antitubercular agents|mesh-ancestor
93003176|NCT00545402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003177|NCT00545402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003178|NCT00545402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003179|NCT00545402|Glucocorticoids|glucocorticoids|mesh-ancestor
93003180|NCT00545402|Hormones|hormones|mesh-ancestor
93003181|NCT00545402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003182|NCT00545402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93003183|NCT00545402|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93003184|NCT00545402|Protective Agents|protective agents|mesh-ancestor
93003185|NCT03963115|Epinephrine|epinephrine|mesh-list
93003186|NCT03963115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93003187|NCT03963115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93003188|NCT03963115|Adrenergic Agents|adrenergic agents|mesh-ancestor
93003189|NCT03963115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003190|NCT03963115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003191|NCT03963115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003192|NCT03963115|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93003193|NCT03963115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93003194|NCT03963115|Autonomic Agents|autonomic agents|mesh-ancestor
93003195|NCT03963115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003196|NCT03963115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93003197|NCT03963115|Respiratory System Agents|respiratory system agents|mesh-ancestor
93003198|NCT03963115|Mydriatics|mydriatics|mesh-ancestor
93003199|NCT03963115|Sympathomimetics|sympathomimetics|mesh-ancestor
93003200|NCT03963115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93003201|NCT01583023|Bupropion|bupropion|mesh-list
93003202|NCT01583023|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93003203|NCT01583023|Antidepressive Agents|antidepressive agents|mesh-ancestor
93003204|NCT01583023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003205|NCT01583023|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93003206|NCT01583023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93003207|NCT01583023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003208|NCT01583023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003209|NCT01583023|Dopamine Agents|dopamine agents|mesh-ancestor
93003210|NCT01583023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003211|NCT01583023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003212|NCT01583023|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93003213|NCT01583023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93003214|NCT01583023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003215|NCT00976976|Cisplatin|cisplatin|mesh-list
93003216|NCT00976976|Docetaxel|docetaxel|mesh-list
93003217|NCT00976976|Capecitabine|capecitabine|mesh-list
93003218|NCT00976976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003219|NCT00976976|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003220|NCT00976976|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003221|NCT00976976|Mitosis Modulators|mitosis modulators|mesh-ancestor
93003222|NCT00976976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003223|NCT00976976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003224|NCT00976976|Antimetabolites|antimetabolites|mesh-ancestor
93003225|NCT00977054|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93003226|NCT00977054|Interferon-alpha|interferon-alpha|mesh-list
93003227|NCT00977054|Ribavirin|ribavirin|mesh-list
93003228|NCT00977054|Interferon alpha-2|interferon alpha-2|mesh-list
93003229|NCT00977054|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93003230|NCT00977054|Antiviral Agents|antiviral agents|mesh-ancestor
93003231|NCT00977054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003232|NCT00977054|Immunologic Factors|immunologic factors|mesh-ancestor
93003233|NCT00977054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003234|NCT00977054|Antimetabolites|antimetabolites|mesh-ancestor
93003235|NCT00977054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003236|NCT00977054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003237|NCT00977132|Lenalidomide|lenalidomide|mesh-list
93003238|NCT00977132|Immunologic Factors|immunologic factors|mesh-ancestor
93003239|NCT00977132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003240|NCT00977132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003241|NCT00977132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003242|NCT00977132|Growth Substances|growth substances|mesh-ancestor
93003243|NCT00977132|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003244|NCT00977132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003245|NCT00545792|Bevacizumab|bevacizumab|mesh-list
93003246|NCT00545792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003247|NCT00545792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003248|NCT00545792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003249|NCT00545792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003250|NCT00545792|Growth Substances|growth substances|mesh-ancestor
93003251|NCT00545792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003252|NCT00545792|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003253|NCT00977288|Atorvastatin|atorvastatin|mesh-list
93003254|NCT00977288|Anacetrapib|anacetrapib|mesh-list
93003255|NCT00977288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93003256|NCT00977288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93003257|NCT00977288|Antimetabolites|antimetabolites|mesh-ancestor
93003258|NCT00977288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003259|NCT00977288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93003260|NCT00977288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93003261|NCT00977288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003262|NCT00966602|Ivacaftor|ivacaftor|mesh-list
93003263|NCT00966602|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93003264|NCT00966602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003265|NCT00966602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003266|NCT00966680|Anesthetics|anesthetics|mesh-list
93003267|NCT00966680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003268|NCT00966680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003269|NCT00977444|Prednisolone|prednisolone|mesh-list
93003270|NCT00977444|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93003271|NCT00977444|Methylprednisolone|methylprednisolone|mesh-list
93003272|NCT00977444|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93003273|NCT00977444|Prednisolone acetate|prednisolone acetate|mesh-list
93003274|NCT00977444|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93003275|NCT00977444|Prednisolone phosphate|prednisolone phosphate|mesh-list
93003276|NCT00977444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003277|NCT00977444|Glucocorticoids|glucocorticoids|mesh-ancestor
93003278|NCT00977444|Hormones|hormones|mesh-ancestor
93003279|NCT00977444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003280|NCT00977444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003281|NCT00977444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93003282|NCT00977444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003283|NCT00977444|Antiemetics|antiemetics|mesh-ancestor
93003284|NCT00977444|Autonomic Agents|autonomic agents|mesh-ancestor
93003285|NCT00977444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003286|NCT00977444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003287|NCT00977444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93003288|NCT00977444|Protective Agents|protective agents|mesh-ancestor
93003289|NCT00977600|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93003290|NCT00977600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003291|NCT00966836|Mycophenolic Acid|mycophenolic acid|mesh-list
93003292|NCT00966836|Valganciclovir|valganciclovir|mesh-list
93003293|NCT00966836|Everolimus|everolimus|mesh-list
93003294|NCT00966836|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93003295|NCT00966836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93003296|NCT00966836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003297|NCT00966836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003298|NCT00966836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003299|NCT00966836|Immunologic Factors|immunologic factors|mesh-ancestor
92168655|NCT04190433|Lisinopril|lisinopril|mesh-list
93003300|NCT00966836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003301|NCT00966836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003302|NCT00966836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93003303|NCT00966836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93003304|NCT00966836|Antitubercular Agents|antitubercular agents|mesh-ancestor
93003305|NCT00966836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003306|NCT00966836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003307|NCT00966836|Antiviral Agents|antiviral agents|mesh-ancestor
93003308|NCT00967070|Nicotine|nicotine|mesh-list
93003309|NCT00967070|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93003310|NCT00967070|Autonomic Agents|autonomic agents|mesh-ancestor
93003311|NCT00967070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003312|NCT00967070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003313|NCT00967070|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93003314|NCT00967070|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93003315|NCT00967070|Cholinergic Agents|cholinergic agents|mesh-ancestor
93003316|NCT00967070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003317|NCT00967070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003318|NCT00977756|Ritonavir|ritonavir|mesh-list
93003319|NCT00977756|Lopinavir|lopinavir|mesh-list
93003320|NCT00977756|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93003321|NCT00977756|Darunavir|darunavir|mesh-list
93003322|NCT00977756|Tenofovir|tenofovir|mesh-list
93003323|NCT00977756|Raltegravir Potassium|raltegravir potassium|mesh-list
93003324|NCT00977756|Maraviroc|maraviroc|mesh-list
93003325|NCT00977756|Etravirine|etravirine|mesh-list
93003326|NCT00977756|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93003327|NCT00977756|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93003328|NCT00977756|Protease Inhibitors|protease inhibitors|mesh-ancestor
93003329|NCT00977756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003330|NCT00977756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003331|NCT00977756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93003332|NCT00977756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93003333|NCT00977756|Antiviral Agents|antiviral agents|mesh-ancestor
93003334|NCT00977756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003335|NCT00977756|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93003336|NCT00977756|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93003337|NCT00977756|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93003338|NCT00977756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003339|NCT00977756|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93003340|NCT00977756|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93003341|NCT00977756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93003342|NCT00977756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93003343|NCT00977756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93003344|NCT00967148|Tinzaparin|tinzaparin|mesh-list
93003345|NCT00967148|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93003346|NCT00967148|Dalteparin|dalteparin|mesh-list
93003347|NCT00967148|Anticoagulants|anticoagulants|mesh-ancestor
93003348|NCT00967148|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93003349|NCT00967148|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93003350|NCT00967148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003351|NCT04007588|Nivolumab|nivolumab|mesh-list
93003352|NCT04007588|Ipilimumab|ipilimumab|mesh-list
93003353|NCT04007588|Linrodostat|linrodostat|mesh-list
93003354|NCT04007588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003355|NCT04007588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003356|NCT04007588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93003357|NCT04007588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003358|NCT04007588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003359|NCT00978146|Hydroxyurea|hydroxyurea|mesh-list
93003360|NCT00978146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003361|NCT00978146|Antisickling Agents|antisickling agents|mesh-ancestor
93003362|NCT00978146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003363|NCT00978146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003364|NCT00978146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003365|NCT00981968|Sitaxsentan|sitaxsentan|mesh-list
93003366|NCT00981968|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93003367|NCT00981968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003368|NCT00982046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93003369|NCT00967382|Dalteparin|dalteparin|mesh-list
93003370|NCT00967382|Tinzaparin|tinzaparin|mesh-list
93003371|NCT00967382|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93003372|NCT00967382|Anticoagulants|anticoagulants|mesh-ancestor
93003373|NCT00967382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93003374|NCT00967382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92348877|NCT01516008|Analgesics|analgesics|mesh-ancestor
93003375|NCT00967382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003376|NCT00982124|Zoledronic Acid|zoledronic acid|mesh-list
93003377|NCT00982124|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93003378|NCT00982124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003379|NCT00982202|Pioglitazone|pioglitazone|mesh-list
93003380|NCT00982202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93003381|NCT00982202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003382|NCT00967538|Etanercept|etanercept|mesh-list
93003383|NCT00967538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93003384|NCT00967538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93003385|NCT00967538|Analgesics|analgesics|mesh-ancestor
93003386|NCT00967538|Sensory System Agents|sensory system agents|mesh-ancestor
93003387|NCT00967538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003388|NCT00967538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003389|NCT00967538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003390|NCT00967538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003391|NCT00967538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003392|NCT00967538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003393|NCT00967538|Immunologic Factors|immunologic factors|mesh-ancestor
93003394|NCT00982358|Valsartan|valsartan|mesh-list
93003395|NCT00982358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93003396|NCT00982358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93003397|NCT00982358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93003398|NCT00982358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003399|NCT00982436|Carboplatin|carboplatin|mesh-list
93003400|NCT00982436|Docetaxel|docetaxel|mesh-list
93003401|NCT00982436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003402|NCT00982436|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003403|NCT00982436|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003404|NCT00982436|Mitosis Modulators|mitosis modulators|mesh-ancestor
93003405|NCT00982436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003406|NCT00545168|Permethrin|permethrin|mesh-list
93003407|NCT00545168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003408|NCT00545168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003409|NCT00984932|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93003410|NCT00984932|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93003411|NCT00984932|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93003412|NCT00984932|Antimetabolites|antimetabolites|mesh-ancestor
93003413|NCT00984932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003414|NCT00984932|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93003415|NCT00984932|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93003416|NCT00984932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003417|NCT00983138|Asparaginase|asparaginase|mesh-list
93003418|NCT00983138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003419|NCT00544544|Riluzole|riluzole|mesh-list
93003420|NCT00544544|Anticonvulsants|anticonvulsants|mesh-ancestor
93003421|NCT00544544|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93003422|NCT00544544|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93003423|NCT00544544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003424|NCT00544544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003425|NCT00544544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003426|NCT00544544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93003427|NCT00544544|Protective Agents|protective agents|mesh-ancestor
93003429|NCT00979160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003430|NCT00979160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93003431|NCT00979160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003432|NCT00979160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003433|NCT00979316|Moxifloxacin|moxifloxacin|mesh-list
93003434|NCT00979316|BMS 708163|bms 708163|mesh-list
93003435|NCT00979316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003436|NCT00979316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003437|NCT00979316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93003438|NCT00979316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93003439|NCT00979316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003440|NCT00979316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003441|NCT00979316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003442|NCT00979316|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93003443|NCT00983450|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93003444|NCT00983450|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
93003445|NCT00983450|beta-Endorphin|beta-endorphin|mesh-list
93003446|NCT00983450|Hormones|hormones|mesh-ancestor
93003447|NCT00983450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003449|NCT00983450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003450|NCT00983450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003451|NCT00983996|Alendronate|alendronate|mesh-list
93003452|NCT00983996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93003453|NCT00983996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003454|NCT00985244|Azithromycin|azithromycin|mesh-list
93003455|NCT00985244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003456|NCT00985244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003457|NCT00979472|Solifenacin Succinate|solifenacin succinate|mesh-list
93003458|NCT00979472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93003459|NCT00979472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93003460|NCT00979472|Cholinergic Agents|cholinergic agents|mesh-ancestor
93003461|NCT00979472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003462|NCT00979472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003463|NCT00979472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003464|NCT00979472|Urological Agents|urological agents|mesh-ancestor
93003465|NCT00984152|Efavirenz|efavirenz|mesh-list
93003466|NCT00984152|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93003467|NCT00984152|Raltegravir Potassium|raltegravir potassium|mesh-list
93003468|NCT00984152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93003469|NCT00984152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003470|NCT00984152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003471|NCT00984152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003472|NCT00984152|Antiviral Agents|antiviral agents|mesh-ancestor
93003473|NCT00984152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003474|NCT00984152|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93003475|NCT00984152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93003476|NCT00984152|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93003477|NCT00984152|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93003478|NCT00984152|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93003479|NCT00984152|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93003480|NCT00984152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93003481|NCT00984152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93003482|NCT00984152|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93003483|NCT00984152|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93003484|NCT00985322|Ramipril|ramipril|mesh-list
93003485|NCT00985322|Antihypertensive Agents|antihypertensive agents|mesh-list
93003486|NCT00985322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93003487|NCT00985322|Protease Inhibitors|protease inhibitors|mesh-ancestor
93003488|NCT00985322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168689|NCT04177810|Cemiplimab|cemiplimab|mesh-list
93003489|NCT00985322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003490|NCT00984230|Lactoferrin|lactoferrin|mesh-list
93003491|NCT00984230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003492|NCT00984386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93003493|NCT00984386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93003494|NCT00984386|Estradiol|estradiol|mesh-list
93003495|NCT00984386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93003496|NCT00984386|Estrogens|estrogens|mesh-ancestor
93003497|NCT00984386|Hormones|hormones|mesh-ancestor
93003498|NCT00984386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003499|NCT00984386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003500|NCT00984386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93003501|NCT00984386|Contraceptive Agents|contraceptive agents|mesh-ancestor
93003502|NCT00984386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93003503|NCT00984386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93003504|NCT00984464|Paclitaxel|paclitaxel|mesh-list
93003505|NCT00984464|Carboplatin|carboplatin|mesh-list
93003506|NCT00984464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93003507|NCT00984464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003508|NCT00984464|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003509|NCT00984464|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003510|NCT00984464|Mitosis Modulators|mitosis modulators|mesh-ancestor
93003511|NCT00984464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003512|NCT00985556|Capecitabine|capecitabine|mesh-list
93003513|NCT00985556|Tegafur|tegafur|mesh-list
93003514|NCT00985556|Oxaliplatin|oxaliplatin|mesh-list
93003515|NCT00985556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003516|NCT00985556|Antimetabolites|antimetabolites|mesh-ancestor
93003517|NCT00985556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003518|NCT00985556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003519|NCT05537402|Bevacizumab|bevacizumab|mesh-list
93003521|NCT05537402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003522|NCT05537402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003523|NCT05537402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003524|NCT05537402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003525|NCT05537402|Growth Substances|growth substances|mesh-ancestor
93003526|NCT05537402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003527|NCT05537402|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003528|NCT05537402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93003529|NCT05537402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003530|NCT04445246|Iloprost|iloprost|mesh-list
93003531|NCT04445246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93003532|NCT04445246|Vasodilator Agents|vasodilator agents|mesh-ancestor
93003533|NCT00541346|Methylphenidate|methylphenidate|mesh-list
93003534|NCT00541346|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93003535|NCT00541346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003536|NCT00541346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93003537|NCT00541346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93003538|NCT00541346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003539|NCT00541346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003540|NCT00541346|Dopamine Agents|dopamine agents|mesh-ancestor
93003541|NCT00541346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003542|NCT00988520|Bromides|bromides|mesh-list
93003543|NCT00988520|Propofol|propofol|mesh-list
93003544|NCT00988520|Sevoflurane|sevoflurane|mesh-list
93003545|NCT00988520|Rocuronium|rocuronium|mesh-list
93003546|NCT00988520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93003547|NCT00988520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003548|NCT00988520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003549|NCT00988520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93003550|NCT00988520|Anesthetics, General|anesthetics, general|mesh-ancestor
93003551|NCT00988520|Anesthetics|anesthetics|mesh-ancestor
93003552|NCT00988520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93003553|NCT00988520|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93003554|NCT00988520|Anticonvulsants|anticonvulsants|mesh-ancestor
93003555|NCT00988520|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93003556|NCT00988520|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93003557|NCT00988520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92168691|NCT04177810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93003558|NCT00988520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003559|NCT05498090|Fenofibrate|fenofibrate|mesh-list
93003560|NCT05498090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93003561|NCT05498090|Antimetabolites|antimetabolites|mesh-ancestor
93003562|NCT05498090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003563|NCT05498090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93003564|NCT00077623|Epoetin Alfa|epoetin alfa|mesh-list
93003565|NCT00077623|Hematinics|hematinics|mesh-ancestor
93003566|NCT00541034|Cyclophosphamide|cyclophosphamide|mesh-list
93003567|NCT00541034|Rituximab|rituximab|mesh-list
93003568|NCT00541034|Pentostatin|pentostatin|mesh-list
93003569|NCT00541034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003570|NCT00541034|Immunologic Factors|immunologic factors|mesh-ancestor
93003571|NCT00541034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003572|NCT00541034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003573|NCT00541034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003574|NCT00541034|Alkylating Agents|alkylating agents|mesh-ancestor
93003575|NCT00541034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003576|NCT00541034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003577|NCT00541034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93003578|NCT00541034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003579|NCT00541034|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93003580|NCT00541034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003581|NCT00540644|Prednisone|prednisone|mesh-list
93003582|NCT00540644|Cyclophosphamide|cyclophosphamide|mesh-list
93003583|NCT00540644|Lenalidomide|lenalidomide|mesh-list
93003584|NCT00540644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003585|NCT00540644|Immunologic Factors|immunologic factors|mesh-ancestor
93003586|NCT00540644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003587|NCT00540644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003588|NCT00540644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003589|NCT00540644|Alkylating Agents|alkylating agents|mesh-ancestor
93003590|NCT00540644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003591|NCT00540644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003592|NCT00540644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93003593|NCT00540644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003595|NCT00540644|Hormones|hormones|mesh-ancestor
93003596|NCT00540644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003597|NCT00540644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93003598|NCT00540644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003599|NCT00540644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003600|NCT00540644|Growth Substances|growth substances|mesh-ancestor
93003601|NCT00540644|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003602|NCT05470400|Vaccines|vaccines|mesh-list
93003603|NCT05470400|Immunologic Factors|immunologic factors|mesh-ancestor
93003604|NCT05470400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003605|NCT05450900|Biotin|biotin|mesh-list
93003606|NCT05450900|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93003607|NCT05450900|Vitamins|vitamins|mesh-ancestor
93003608|NCT05450900|Micronutrients|micronutrients|mesh-ancestor
93003609|NCT05450900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003610|NCT05450900|Vitamin B Complex|vitamin b complex|mesh-ancestor
93003611|NCT05450900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93003612|NCT00988910|Contraceptive Agents|contraceptive agents|mesh-list
93003613|NCT00988910|Contraceptives, Oral|contraceptives, oral|mesh-list
93003614|NCT00988910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93003615|NCT00988910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93003616|NCT00988910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003617|NCT00988910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93003618|NCT00986336|Topiramate|topiramate|mesh-list
93003619|NCT00986336|Risperidone|risperidone|mesh-list
93003620|NCT00986336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93003621|NCT00986336|Serotonin Agents|serotonin agents|mesh-ancestor
93003622|NCT00986336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003623|NCT00986336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003624|NCT00986336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003625|NCT00986336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93003626|NCT00986336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93003627|NCT00986336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003628|NCT00986336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92168705|NCT04146038|Venetoclax|venetoclax|mesh-list
93003629|NCT00986336|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93003630|NCT00986336|Dopamine Agents|dopamine agents|mesh-ancestor
93003631|NCT00986336|Anticonvulsants|anticonvulsants|mesh-ancestor
93003632|NCT00986336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93003633|NCT00989300|Omeprazole|omeprazole|mesh-list
93003634|NCT00989300|Rabeprazole|rabeprazole|mesh-list
93003635|NCT00989300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93003636|NCT00989300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003637|NCT00989300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93003638|NCT00989300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003639|NCT00989300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003640|NCT01563614|Cytarabine|cytarabine|mesh-list
93003641|NCT01563614|Lomustine|lomustine|mesh-list
93003642|NCT01563614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003643|NCT01563614|Antimetabolites|antimetabolites|mesh-ancestor
93003644|NCT01563614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003645|NCT01563614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003646|NCT01563614|Antiviral Agents|antiviral agents|mesh-ancestor
93003647|NCT01563614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003648|NCT01563614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003650|NCT01563614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003651|NCT01563614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003652|NCT01563614|Alkylating Agents|alkylating agents|mesh-ancestor
93003653|NCT00543296|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93003654|NCT00543296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003655|NCT00543296|Glucocorticoids|glucocorticoids|mesh-ancestor
93003656|NCT00543296|Hormones|hormones|mesh-ancestor
93003657|NCT00543296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003658|NCT00543296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003659|NCT00543062|Moxifloxacin|moxifloxacin|mesh-list
93003660|NCT00543062|Prochlorperazine|prochlorperazine|mesh-list
93003661|NCT00543062|Loxapine|loxapine|mesh-list
93003662|NCT00543062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003663|NCT00543062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003664|NCT00543062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93003665|NCT00543062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93003666|NCT00543062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003667|NCT00543062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003668|NCT00543062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003669|NCT00543062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003671|NCT00543062|Autonomic Agents|autonomic agents|mesh-ancestor
93003672|NCT00543062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003673|NCT00543062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003674|NCT00543062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93003675|NCT00543062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93003676|NCT00543062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003677|NCT00543062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003678|NCT00543062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93003679|NCT00543062|Dopamine Agents|dopamine agents|mesh-ancestor
93003680|NCT00543062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003681|NCT05221580|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93003682|NCT05221580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93003683|NCT05221580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003684|NCT00986804|Decitabine|decitabine|mesh-list
93003685|NCT00986804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003686|NCT00986804|Antimetabolites|antimetabolites|mesh-ancestor
93003687|NCT00986804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003688|NCT00986804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003689|NCT00986804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003690|NCT00676091|Vaccines|vaccines|mesh-list
93003691|NCT00676091|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93003692|NCT00676091|Immunologic Factors|immunologic factors|mesh-ancestor
93003693|NCT00676091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003694|NCT02558933|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93003695|NCT02558933|Antioxidants|antioxidants|mesh-ancestor
93003696|NCT02558933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003697|NCT02558933|Protective Agents|protective agents|mesh-ancestor
93003698|NCT02558933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003699|NCT02558933|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93003700|NCT02558933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93003701|NCT02558933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003702|NCT02558933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93003703|NCT00678041|Nitrofurantoin|nitrofurantoin|mesh-list
93003704|NCT00678041|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93003705|NCT00678041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003706|NCT00678041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003707|NCT03903822|PF-06700841|pf-06700841|mesh-list
93003708|NCT03903822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93003709|NCT03903822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003710|NCT03903822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003711|NCT04003350|Acetaminophen|acetaminophen|mesh-list
93003712|NCT04003350|Meloxicam|meloxicam|mesh-list
93003713|NCT04003350|Oxycodone|oxycodone|mesh-list
93003714|NCT04003350|Tramadol|tramadol|mesh-list
93003715|NCT04003350|Gabapentin|gabapentin|mesh-list
93003716|NCT04003350|Esomeprazole|esomeprazole|mesh-list
93003717|NCT04003350|Metaxalone|metaxalone|mesh-list
93003718|NCT04003350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93003719|NCT04003350|Narcotics|narcotics|mesh-ancestor
93003720|NCT04003350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003721|NCT04003350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649075|NCT00225173|Hormones|hormones|mesh-ancestor
93003722|NCT04003350|Analgesics|analgesics|mesh-ancestor
93003723|NCT04003350|Sensory System Agents|sensory system agents|mesh-ancestor
93003724|NCT04003350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003726|NCT04003350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93003727|NCT04003350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93003728|NCT04003350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003729|NCT04003350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93003730|NCT04003350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93003731|NCT04003350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003732|NCT04003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003733|NCT04003350|Antimanic Agents|antimanic agents|mesh-ancestor
93003734|NCT04003350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93003735|NCT04003350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003736|NCT04003350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93003737|NCT04003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003738|NCT04003350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93003739|NCT04003350|Antipyretics|antipyretics|mesh-ancestor
93003740|NCT04003350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93003741|NCT04003350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003742|NCT04003350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528477|NCT00036127|Dopamine Agents|dopamine agents|mesh-ancestor
93003743|NCT04003350|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93003744|NCT04003350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93003745|NCT04003350|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93003746|NCT00748007|Rivastigmine|rivastigmine|mesh-list
93003747|NCT00748007|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
93003748|NCT00748007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003749|NCT00748007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003750|NCT00748007|Cholinergic Agents|cholinergic agents|mesh-ancestor
93003751|NCT00748007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003752|NCT00748007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003753|NCT00748007|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93003754|NCT00748007|Protective Agents|protective agents|mesh-ancestor
93003755|NCT00748163|Paclitaxel|paclitaxel|mesh-list
93003756|NCT00748163|Sunitinib|sunitinib|mesh-list
93003757|NCT00748163|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93003758|NCT00748163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93003759|NCT00748163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003760|NCT00748163|Tubulin Modulators|tubulin modulators|mesh-ancestor
93003761|NCT00748163|Antimitotic Agents|antimitotic agents|mesh-ancestor
93003762|NCT00748163|Mitosis Modulators|mitosis modulators|mesh-ancestor
93003763|NCT00748163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003764|NCT00748163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003765|NCT00748163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003766|NCT00748163|Growth Substances|growth substances|mesh-ancestor
93003767|NCT00748163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003768|NCT00748163|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003769|NCT00748163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93003770|NCT00748163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003771|NCT00687401|Infliximab|infliximab|mesh-list
93003772|NCT00687401|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93003773|NCT00687401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003774|NCT00687401|Dermatologic Agents|dermatologic agents|mesh-ancestor
93003775|NCT00687401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003776|NCT00687401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003777|NCT00485693|Epinephrine|epinephrine|mesh-list
93003778|NCT00485693|Bupivacaine|bupivacaine|mesh-list
93003779|NCT00485693|Anesthetics, Local|anesthetics, local|mesh-ancestor
93003780|NCT00485693|Anesthetics|anesthetics|mesh-ancestor
93003781|NCT00485693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003782|NCT00485693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003783|NCT00485693|Sensory System Agents|sensory system agents|mesh-ancestor
93003784|NCT00485693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003785|NCT00485693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93003786|NCT00485693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93003787|NCT00485693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93003788|NCT00485693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003789|NCT00485693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003790|NCT00485693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93003791|NCT00485693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93003792|NCT00485693|Autonomic Agents|autonomic agents|mesh-ancestor
93003793|NCT00485693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93003794|NCT00485693|Respiratory System Agents|respiratory system agents|mesh-ancestor
93003795|NCT00485693|Mydriatics|mydriatics|mesh-ancestor
93003796|NCT00485693|Sympathomimetics|sympathomimetics|mesh-ancestor
93003797|NCT00485693|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93003798|NCT00538902|Adalimumab|adalimumab|mesh-list
93003799|NCT00538902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93003800|NCT00538902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003801|NCT00538902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003803|NCT00541970|Immunologic Factors|immunologic factors|mesh-ancestor
93003804|NCT00541970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003805|NCT00687323|Temozolomide|temozolomide|mesh-list
93003806|NCT00687323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003807|NCT00687323|Alkylating Agents|alkylating agents|mesh-ancestor
93003808|NCT00687323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003809|NCT00687323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003810|NCT00989742|Doxycycline|doxycycline|mesh-list
93003811|NCT00989742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003812|NCT00989742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003813|NCT00989742|Antimalarials|antimalarials|mesh-ancestor
93003814|NCT00989742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93003815|NCT00989742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93003816|NCT05408208|Triamcinolone|triamcinolone|mesh-list
93003817|NCT05408208|Methotrexate|methotrexate|mesh-list
93003818|NCT05408208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93003819|NCT05408208|Abortifacient Agents|abortifacient agents|mesh-ancestor
93003820|NCT05408208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93003821|NCT05408208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003822|NCT05408208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93003823|NCT05408208|Antimetabolites|antimetabolites|mesh-ancestor
93003824|NCT05408208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003825|NCT05408208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003826|NCT05408208|Dermatologic Agents|dermatologic agents|mesh-ancestor
93003827|NCT05408208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003828|NCT05408208|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93003829|NCT05408208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93003830|NCT05408208|Immunologic Factors|immunologic factors|mesh-ancestor
93003831|NCT05408208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003832|NCT05408208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003833|NCT05408208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003834|NCT05408208|Glucocorticoids|glucocorticoids|mesh-ancestor
93003835|NCT05408208|Hormones|hormones|mesh-ancestor
93003836|NCT05408208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003837|NCT00758693|Rituximab|rituximab|mesh-list
93003838|NCT00758693|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93003839|NCT00758693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93003840|NCT00758693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003841|NCT00758693|Immunologic Factors|immunologic factors|mesh-ancestor
93003842|NCT00758693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003843|NCT00758693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93003844|NCT00758693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93003845|NCT00758693|Alkylating Agents|alkylating agents|mesh-ancestor
93003846|NCT00758693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003847|NCT00989820|Coal Tar|coal tar|mesh-list
93003848|NCT00989820|Keratolytic Agents|keratolytic agents|mesh-ancestor
93003849|NCT00989820|Dermatologic Agents|dermatologic agents|mesh-ancestor
93003850|NCT05357820|Itraconazole|itraconazole|mesh-list
93003851|NCT05357820|Rifampin|rifampin|mesh-list
93003852|NCT05357820|Antifungal Agents|antifungal agents|mesh-ancestor
93003853|NCT05357820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003854|NCT05357820|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93003855|NCT05357820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93003856|NCT05357820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003857|NCT05357820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003858|NCT05357820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93003859|NCT05357820|Hormone Antagonists|hormone antagonists|mesh-ancestor
93003860|NCT05357820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003861|NCT05357820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003862|NCT05357820|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93003863|NCT05357820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93003864|NCT05357820|Antitubercular Agents|antitubercular agents|mesh-ancestor
93003865|NCT05357820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93003866|NCT05357820|Leprostatic Agents|leprostatic agents|mesh-ancestor
93003867|NCT05357820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93003868|NCT05357820|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93003869|NCT05357820|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93003870|NCT05357820|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92649220|NCT00574093|Ranibizumab|ranibizumab|mesh-list
93003871|NCT05357820|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93003872|NCT05357820|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93003873|NCT05357820|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93003874|NCT00748787|Psyllium|psyllium|mesh-list
93003875|NCT00748787|Calcium polycarbophil|calcium polycarbophil|mesh-list
93003876|NCT00748787|Cathartics|cathartics|mesh-ancestor
93003877|NCT00748787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003878|NCT00748787|Antidiarrheals|antidiarrheals|mesh-ancestor
93003879|NCT05712044|Folic Acid|folic acid|mesh-list
93003880|NCT05712044|Vitamin B Complex|vitamin b complex|mesh-list
93003881|NCT05712044|Hematinics|hematinics|mesh-ancestor
93003882|NCT05712044|Vitamins|vitamins|mesh-ancestor
93003883|NCT05712044|Micronutrients|micronutrients|mesh-ancestor
93003884|NCT05712044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003885|NCT00986960|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93003886|NCT00986960|Hormones|hormones|mesh-ancestor
93003887|NCT00986960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93003888|NCT00986960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003889|NCT05711966|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93003890|NCT05711966|Respiratory System Agents|respiratory system agents|mesh-ancestor
93003891|NCT00759005|Hydrocortisone|hydrocortisone|mesh-list
93003892|NCT00759005|Propranolol|propranolol|mesh-list
93003893|NCT00759005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93003894|NCT00759005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93003895|NCT00759005|Adrenergic Agents|adrenergic agents|mesh-ancestor
93003896|NCT00759005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003897|NCT00759005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003898|NCT00759005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003899|NCT00759005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93003900|NCT00759005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93003901|NCT00759005|Vasodilator Agents|vasodilator agents|mesh-ancestor
93003902|NCT00759005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93003903|NCT04360070|Ketamine|ketamine|mesh-list
93003904|NCT04360070|Analgesics|analgesics|mesh-ancestor
93003905|NCT04360070|Sensory System Agents|sensory system agents|mesh-ancestor
93003906|NCT04360070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003907|NCT04360070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003908|NCT04360070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93003909|NCT04360070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93003910|NCT04360070|Anesthetics, General|anesthetics, general|mesh-ancestor
93003911|NCT04360070|Anesthetics|anesthetics|mesh-ancestor
93003912|NCT04360070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003913|NCT04360070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93003914|NCT04360070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93003915|NCT04360070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003916|NCT04360070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003917|NCT00748943|Chlorine dioxide|chlorine dioxide|mesh-list
93003918|NCT00748943|Dental Disinfectants|dental disinfectants|mesh-ancestor
93003919|NCT00748943|Disinfectants|disinfectants|mesh-ancestor
93003920|NCT00748943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93003921|NCT00749021|Ranibizumab|ranibizumab|mesh-list
93003922|NCT00749021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93003923|NCT00749021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93003924|NCT00749021|Growth Substances|growth substances|mesh-ancestor
93003925|NCT00749021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003926|NCT00749021|Growth Inhibitors|growth inhibitors|mesh-ancestor
93003927|NCT00749021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93003928|NCT04048889|Ropivacaine|ropivacaine|mesh-list
93003929|NCT04048889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93003930|NCT04048889|Anesthetics, Local|anesthetics, local|mesh-ancestor
93003931|NCT04048889|Anesthetics|anesthetics|mesh-ancestor
93003932|NCT04048889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003933|NCT04048889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003934|NCT04048889|Sensory System Agents|sensory system agents|mesh-ancestor
93003935|NCT04048889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003936|NCT00987038|Midazolam|midazolam|mesh-list
93003937|NCT00987038|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93003938|NCT00987038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93003939|NCT00987038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93003940|NCT00987038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003941|NCT00987038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93003942|NCT00987038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93003943|NCT00987038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003944|NCT00987038|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93003945|NCT00987038|Anesthetics, General|anesthetics, general|mesh-ancestor
92649288|NCT00574639|GABA Agents|gaba agents|mesh-ancestor
93003947|NCT00987038|GABA Modulators|gaba modulators|mesh-ancestor
93003948|NCT00987038|GABA Agents|gaba agents|mesh-ancestor
93003949|NCT00987038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003950|NCT00987038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003951|NCT05711810|Ubiquinone|ubiquinone|mesh-list
93003952|NCT05711810|Coenzyme Q10|coenzyme q10|mesh-list
93003953|NCT05711810|Tocopherols|tocopherols|mesh-list
93003954|NCT05711810|Vitamin E|vitamin e|mesh-list
93003955|NCT05711810|alpha-Tocopherol|alpha-tocopherol|mesh-list
93003956|NCT05711810|Metoprolol|metoprolol|mesh-list
93003957|NCT05711810|Enalapril|enalapril|mesh-list
93003958|NCT05711810|Enalaprilat|enalaprilat|mesh-list
93003959|NCT05711810|Nifedipine|nifedipine|mesh-list
93003960|NCT05711810|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93003961|NCT05711810|Lansoprazole|lansoprazole|mesh-list
93003962|NCT05711810|Superoxide Dismutase|superoxide dismutase|mesh-list
93003963|NCT05711810|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93003964|NCT05711810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93003965|NCT05711810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93003966|NCT05711810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93003967|NCT05711810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93003968|NCT05711810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93003969|NCT05711810|Analgesics|analgesics|mesh-ancestor
93003970|NCT05711810|Sensory System Agents|sensory system agents|mesh-ancestor
93003971|NCT05711810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93003972|NCT05711810|Antidepressive Agents|antidepressive agents|mesh-ancestor
93003973|NCT05711810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93003974|NCT05711810|Dopamine Agents|dopamine agents|mesh-ancestor
93003975|NCT05711810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93003976|NCT05711810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93003977|NCT05711810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93003978|NCT05711810|Sympatholytics|sympatholytics|mesh-ancestor
93003979|NCT05711810|Autonomic Agents|autonomic agents|mesh-ancestor
93003980|NCT05711810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93003981|NCT05711810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93003982|NCT05711810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93003983|NCT05711810|Adrenergic Agents|adrenergic agents|mesh-ancestor
93003984|NCT05711810|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93003985|NCT05711810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93003986|NCT05711810|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93003987|NCT05711810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93003988|NCT05711810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93003989|NCT05711810|Vasodilator Agents|vasodilator agents|mesh-ancestor
93003990|NCT05711810|Tocolytic Agents|tocolytic agents|mesh-ancestor
93003991|NCT05711810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93003992|NCT05711810|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93003993|NCT05711810|Protease Inhibitors|protease inhibitors|mesh-ancestor
93003994|NCT05711810|Micronutrients|micronutrients|mesh-ancestor
93003995|NCT05711810|Vitamins|vitamins|mesh-ancestor
93003996|NCT05711810|Antioxidants|antioxidants|mesh-ancestor
93003997|NCT05711810|Protective Agents|protective agents|mesh-ancestor
93003998|NCT05711810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93003999|NCT00759083|Bivalirudin|bivalirudin|mesh-list
93004000|NCT00759083|Antithrombins|antithrombins|mesh-ancestor
93004001|NCT00759083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93004002|NCT00759083|Protease Inhibitors|protease inhibitors|mesh-ancestor
93004003|NCT00759083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004004|NCT00759083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004005|NCT00759083|Anticoagulants|anticoagulants|mesh-ancestor
93004006|NCT00759239|Timolol|timolol|mesh-list
93004007|NCT00759239|Travoprost|travoprost|mesh-list
93004008|NCT00759239|Maleic acid|maleic acid|mesh-list
93004009|NCT00759239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004010|NCT00759239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004011|NCT00759239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93004012|NCT00759239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93004013|NCT00759239|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004014|NCT00759239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004015|NCT00759239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004016|NCT00759239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93004017|NCT00759239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93004018|NCT03742908|Clindamycin|clindamycin|mesh-list
93004019|NCT03742908|Clindamycin palmitate|clindamycin palmitate|mesh-list
93004020|NCT03742908|Clindamycin phosphate|clindamycin phosphate|mesh-list
93004021|NCT03742908|Cefazolin|cefazolin|mesh-list
93004022|NCT03742908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004023|NCT03742908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004024|NCT03742908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93004025|NCT03742908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004026|NCT03742908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004027|NCT05357196|Gemcitabine|gemcitabine|mesh-list
93004028|NCT05357196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004029|NCT05357196|Antimetabolites|antimetabolites|mesh-ancestor
93004030|NCT05357196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004031|NCT05357196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004032|NCT05232630|Fenfluramine|fenfluramine|mesh-list
93004033|NCT05232630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93004034|NCT05232630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93004035|NCT05232630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004036|NCT05232630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004037|NCT05232630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004038|NCT05232630|Serotonin Agents|serotonin agents|mesh-ancestor
93004039|NCT05232630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004040|NCT03902574|Brexpiprazole|brexpiprazole|mesh-list
93004041|NCT03902574|Serotonin Agents|serotonin agents|mesh-ancestor
93004042|NCT03902574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004043|NCT03902574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004044|NCT03902574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004045|NCT03902574|Dopamine Agonists|dopamine agonists|mesh-ancestor
93004046|NCT03902574|Dopamine Agents|dopamine agents|mesh-ancestor
93004047|NCT01004874|Bevacizumab|bevacizumab|mesh-list
93004048|NCT01004874|Temozolomide|temozolomide|mesh-list
93004049|NCT01004874|Topotecan|topotecan|mesh-list
93004050|NCT01004874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004051|NCT01004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004052|NCT01004874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93004053|NCT01004874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93004054|NCT01004874|Growth Substances|growth substances|mesh-ancestor
93004055|NCT01004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004056|NCT01004874|Growth Inhibitors|growth inhibitors|mesh-ancestor
93004057|NCT01004874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93004058|NCT01004874|Alkylating Agents|alkylating agents|mesh-ancestor
93004059|NCT01004874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004060|NCT01004874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93004061|NCT01004874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93004062|NCT01004874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004063|NCT00987116|Prednisone|prednisone|mesh-list
93004064|NCT00987116|Azathioprine|azathioprine|mesh-list
93004065|NCT00987116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004066|NCT00987116|Glucocorticoids|glucocorticoids|mesh-ancestor
93004067|NCT00987116|Hormones|hormones|mesh-ancestor
93004068|NCT00987116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004069|NCT00987116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004070|NCT00987116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93004071|NCT00987116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004072|NCT00987116|Antimetabolites|antimetabolites|mesh-ancestor
93004073|NCT00987116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004074|NCT00987116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004075|NCT00987116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004076|NCT00987116|Immunologic Factors|immunologic factors|mesh-ancestor
93004077|NCT00987116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004078|NCT05711732|Busulfan|busulfan|mesh-list
93004079|NCT05711732|Alkylating Agents|alkylating agents|mesh-ancestor
93004080|NCT05711732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004081|NCT05711732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004082|NCT05711732|Immunologic Factors|immunologic factors|mesh-ancestor
93004083|NCT05711732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004084|NCT05711732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93004085|NCT05711732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004086|NCT05711732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93004087|NCT04004702|Levetiracetam|levetiracetam|mesh-list
93004088|NCT04004702|Anticonvulsants|anticonvulsants|mesh-ancestor
93004089|NCT04004702|Nootropic Agents|nootropic agents|mesh-ancestor
93004090|NCT00542828|Immunoglobulins|immunoglobulins|mesh-list
93004091|NCT00542828|Thymoglobulin|thymoglobulin|mesh-list
93004092|NCT00542828|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93004093|NCT00542828|Immunologic Factors|immunologic factors|mesh-ancestor
93004094|NCT00542828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004095|NCT00542828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004096|NCT04731974|Melatonin|melatonin|mesh-list
92649434|NCT04573855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93004097|NCT04731974|Antioxidants|antioxidants|mesh-ancestor
93004098|NCT04731974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004099|NCT04731974|Protective Agents|protective agents|mesh-ancestor
93004100|NCT04731974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004101|NCT04731974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004102|NCT00987662|Amlodipine|amlodipine|mesh-list
93004103|NCT00987662|Irbesartan|irbesartan|mesh-list
93004104|NCT00987662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93004105|NCT00987662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93004106|NCT00987662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004107|NCT00987662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004108|NCT00987662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93004109|NCT00987662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004110|NCT00987662|Vasodilator Agents|vasodilator agents|mesh-ancestor
93004111|NCT00987662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93004112|NCT00987662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93004114|NCT04430426|Keratolytic Agents|keratolytic agents|mesh-ancestor
93004115|NCT04430426|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004116|NCT00090103|Tamsulosin|tamsulosin|mesh-list
93004117|NCT00090103|Dutasteride|dutasteride|mesh-list
93004118|NCT00090103|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93004119|NCT00090103|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93004120|NCT00090103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93004121|NCT00090103|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004122|NCT00090103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004123|NCT00090103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004124|NCT00090103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004125|NCT00090103|Urological Agents|urological agents|mesh-ancestor
93004126|NCT00090103|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93004127|NCT00090103|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93004128|NCT00090103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004129|NCT00090103|Hormone Antagonists|hormone antagonists|mesh-ancestor
93004130|NCT00090103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004131|NCT01088659|Tenofovir|tenofovir|mesh-list
93004132|NCT01088659|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93004133|NCT01088659|Antiviral Agents|antiviral agents|mesh-ancestor
93004134|NCT01088659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004135|NCT01088659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93004136|NCT01088659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93004137|NCT01088659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004138|NCT01088659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004139|NCT01088659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93004140|NCT01088659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93004141|NCT00087607|Ribavirin|ribavirin|mesh-list
93004142|NCT00087607|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93004143|NCT00087607|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93004144|NCT00087607|Antimetabolites|antimetabolites|mesh-ancestor
93004145|NCT00087607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004146|NCT00087607|Antiviral Agents|antiviral agents|mesh-ancestor
93004147|NCT00087607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004148|NCT01088737|Imiquimod|imiquimod|mesh-list
93004149|NCT01088737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93004150|NCT01088737|Immunologic Factors|immunologic factors|mesh-ancestor
93004151|NCT01088737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004152|NCT01088737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004153|NCT01088737|Interferon Inducers|interferon inducers|mesh-ancestor
93004154|NCT00069823|Esomeprazole|esomeprazole|mesh-list
93004155|NCT00069823|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93004156|NCT00069823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93004157|NCT00069823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93004158|NCT00069823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004159|NCT00069823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004160|NCT01088815|Paclitaxel|paclitaxel|mesh-list
93004161|NCT01088815|Gemcitabine|gemcitabine|mesh-list
93004162|NCT01088815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93004163|NCT01088815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004164|NCT01088815|Tubulin Modulators|tubulin modulators|mesh-ancestor
93004165|NCT01088815|Antimitotic Agents|antimitotic agents|mesh-ancestor
93004166|NCT01088815|Mitosis Modulators|mitosis modulators|mesh-ancestor
93004167|NCT01088815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004168|NCT01088815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004169|NCT01088815|Antimetabolites|antimetabolites|mesh-ancestor
93004170|NCT00086515|Metformin|metformin|mesh-list
93004172|NCT00086515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93004173|NCT00086515|Glipizide|glipizide|mesh-list
93004174|NCT00086515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93004175|NCT00086515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004176|NCT00086515|Incretins|incretins|mesh-ancestor
93004177|NCT00086515|Hormones|hormones|mesh-ancestor
93004178|NCT00086515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004179|NCT00086515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93004180|NCT00086515|Protease Inhibitors|protease inhibitors|mesh-ancestor
93004181|NCT00086515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004182|NCT00086515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004183|NCT00541658|Risedronic Acid|risedronic acid|mesh-list
93004184|NCT00541658|Etidronic Acid|etidronic acid|mesh-list
93004185|NCT00541658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93004186|NCT00541658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004187|NCT00541658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004188|NCT00541658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93004189|NCT00541658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004190|NCT00541658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93004191|NCT04334174|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93004192|NCT04334174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004193|NCT04334174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004195|NCT04334174|Immunoconjugates|immunoconjugates|mesh-ancestor
93004196|NCT04334174|Immunologic Factors|immunologic factors|mesh-ancestor
93004197|NCT04334174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004198|NCT04333706|Capecitabine|capecitabine|mesh-list
93004199|NCT04333706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004200|NCT04333706|Antimetabolites|antimetabolites|mesh-ancestor
93004201|NCT04333706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004202|NCT04333706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004203|NCT00987974|Atorvastatin|atorvastatin|mesh-list
93004204|NCT00987974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93004205|NCT00987974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93004206|NCT00987974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93004207|NCT00987974|Antimetabolites|antimetabolites|mesh-ancestor
93004208|NCT00987974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004209|NCT00987974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93004210|NCT00987974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93004211|NCT00987974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004212|NCT03519074|Cisplatin|cisplatin|mesh-list
93004213|NCT03519074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004214|NCT03767582|Nivolumab|nivolumab|mesh-list
93004215|NCT03767582|Vaccines|vaccines|mesh-list
93004216|NCT03767582|Immunologic Factors|immunologic factors|mesh-ancestor
93004217|NCT03767582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004218|NCT03767582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004219|NCT03767582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004220|NCT03767582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93004221|NCT03767582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004222|NCT03905642|Amikacin|amikacin|mesh-list
93004223|NCT03905642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004224|NCT03905642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004225|NCT04126538|Pirfenidone|pirfenidone|mesh-list
93004226|NCT04126538|Analgesics|analgesics|mesh-ancestor
93004227|NCT04126538|Sensory System Agents|sensory system agents|mesh-ancestor
93004228|NCT04126538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004229|NCT04126538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004230|NCT04126538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93004231|NCT04126538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93004232|NCT04126538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004233|NCT04126538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004234|NCT04126538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004235|NCT04004234|Manganese|manganese|mesh-list
93004236|NCT04004234|Paclitaxel|paclitaxel|mesh-list
93004237|NCT04004234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93004238|NCT04004234|Gemcitabine|gemcitabine|mesh-list
93004239|NCT04004234|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93004240|NCT04004234|Antibodies|antibodies|mesh-list
93004241|NCT04004234|Immunoglobulins|immunoglobulins|mesh-list
93004242|NCT04004234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93004243|NCT04004234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004244|NCT04004234|Tubulin Modulators|tubulin modulators|mesh-ancestor
93004245|NCT04004234|Antimitotic Agents|antimitotic agents|mesh-ancestor
93004246|NCT04004234|Mitosis Modulators|mitosis modulators|mesh-ancestor
93004247|NCT04004234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004248|NCT04004234|Immunologic Factors|immunologic factors|mesh-ancestor
93004249|NCT04004234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004250|NCT04004234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004251|NCT04004234|Antimetabolites|antimetabolites|mesh-ancestor
93004252|NCT04004234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004253|NCT04004234|Trace Elements|trace elements|mesh-ancestor
93004254|NCT04004234|Micronutrients|micronutrients|mesh-ancestor
93004255|NCT00990158|Vitamin K|vitamin k|mesh-list
93004256|NCT00990158|Vitamin K 1|vitamin k 1|mesh-list
93004257|NCT00990158|Vitamins|vitamins|mesh-ancestor
93004258|NCT00990158|Micronutrients|micronutrients|mesh-ancestor
93004259|NCT00990158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004260|NCT00990158|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93004261|NCT00990158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93004262|NCT00990158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004263|NCT00990158|Hemostatics|hemostatics|mesh-ancestor
93004264|NCT00990158|Coagulants|coagulants|mesh-ancestor
93004265|NCT00412984|Warfarin|warfarin|mesh-list
93004266|NCT00412984|Apixaban|apixaban|mesh-list
93004267|NCT00412984|Anticoagulants|anticoagulants|mesh-ancestor
93004268|NCT00412984|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93004269|NCT00412984|Antithrombins|antithrombins|mesh-ancestor
93004270|NCT00412984|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93004271|NCT00412984|Protease Inhibitors|protease inhibitors|mesh-ancestor
93004272|NCT00412984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004273|NCT00412984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004274|NCT03471182|Cocaine|cocaine|mesh-list
93004275|NCT03471182|Anesthetics, Local|anesthetics, local|mesh-ancestor
93004276|NCT03471182|Anesthetics|anesthetics|mesh-ancestor
93004277|NCT03471182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004278|NCT03471182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004279|NCT03471182|Sensory System Agents|sensory system agents|mesh-ancestor
93004280|NCT03471182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004281|NCT03471182|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93004282|NCT03471182|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93004283|NCT03471182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93004284|NCT03471182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004285|NCT03471182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004286|NCT03471182|Dopamine Agents|dopamine agents|mesh-ancestor
93004287|NCT03471182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004288|NCT00539864|Hemagglutinins|hemagglutinins|mesh-list
93004289|NCT00539864|Agglutinins|agglutinins|mesh-ancestor
93004290|NCT00539864|Immunologic Factors|immunologic factors|mesh-ancestor
93004291|NCT00539864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004292|NCT00539864|Coagulants|coagulants|mesh-ancestor
93004293|NCT04003376|Vitamin D|vitamin d|mesh-list
93004294|NCT04003376|Triamcinolone|triamcinolone|mesh-list
93004295|NCT04003376|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93004296|NCT04003376|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93004297|NCT04003376|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93004298|NCT04003376|Vitamins|vitamins|mesh-ancestor
93004299|NCT04003376|Micronutrients|micronutrients|mesh-ancestor
93004300|NCT04003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004301|NCT04003376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93004302|NCT04003376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004303|NCT04003376|Glucocorticoids|glucocorticoids|mesh-ancestor
93004304|NCT04003376|Hormones|hormones|mesh-ancestor
93004305|NCT04003376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004306|NCT04003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004307|NCT04003376|Immunologic Factors|immunologic factors|mesh-ancestor
93004308|NCT04003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004309|NCT04003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004310|NCT04086212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93004311|NCT04086212|Icodextrin|icodextrin|mesh-list
93004312|NCT04086212|Dialysis Solutions|dialysis solutions|mesh-list
93004313|NCT05404490|Bupivacaine|bupivacaine|mesh-list
93004314|NCT05404490|Anesthetics, Local|anesthetics, local|mesh-ancestor
93004315|NCT05404490|Anesthetics|anesthetics|mesh-ancestor
93004316|NCT05404490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004317|NCT05404490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004318|NCT05404490|Sensory System Agents|sensory system agents|mesh-ancestor
93004319|NCT05404490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004320|NCT05359874|Bevacizumab|bevacizumab|mesh-list
93004321|NCT05359874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004322|NCT05359874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004323|NCT05359874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93004324|NCT05359874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93004325|NCT05359874|Growth Substances|growth substances|mesh-ancestor
93004326|NCT05359874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004327|NCT05359874|Growth Inhibitors|growth inhibitors|mesh-ancestor
93004328|NCT00990392|Polymyxins|polymyxins|mesh-list
93004329|NCT00990392|Bacitracin|bacitracin|mesh-list
93004330|NCT00990392|Polymyxin B|polymyxin b|mesh-list
93004331|NCT00990392|Gramicidin|gramicidin|mesh-list
93004332|NCT00990392|Petrolatum|petrolatum|mesh-list
93004333|NCT00990392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004334|NCT00990392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004335|NCT00990392|Emollients|emollients|mesh-ancestor
92528487|NCT00000788|Fluconazole|fluconazole|mesh-list
93004336|NCT00990392|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004337|NCT00990392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93004338|NCT03367754|Pembrolizumab|pembrolizumab|mesh-list
93004339|NCT03367754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004340|NCT03367754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004341|NCT03367754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93004342|NCT03367754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004343|NCT03335072|Azithromycin|azithromycin|mesh-list
93004344|NCT03335072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004345|NCT03335072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004347|NCT01034956|Hyaluronic Acid|hyaluronic acid|mesh-list
93004348|NCT01034956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93004349|NCT01034956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004350|NCT01034956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93004351|NCT01034956|Immunologic Factors|immunologic factors|mesh-ancestor
93004352|NCT01034956|Viscosupplements|viscosupplements|mesh-ancestor
93004353|NCT01034956|Protective Agents|protective agents|mesh-ancestor
93004354|NCT01580878|Butenafine|butenafine|mesh-list
93004355|NCT01580878|Clotrimazole|clotrimazole|mesh-list
93004356|NCT01580878|Antifungal Agents|antifungal agents|mesh-ancestor
93004357|NCT01580878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004358|NCT01580878|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93004359|NCT01580878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93004360|NCT01580878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93004361|NCT01580878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004362|NCT01580878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004363|NCT01580878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93004364|NCT01580878|Hormone Antagonists|hormone antagonists|mesh-ancestor
93004365|NCT01580878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004366|NCT01580878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004367|NCT05589974|Verteporfin|verteporfin|mesh-list
93004368|NCT05589974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93004369|NCT05589974|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004370|NCT05589896|Mycophenolic Acid|mycophenolic acid|mesh-list
93004371|NCT05589896|Cyclophosphamide|cyclophosphamide|mesh-list
93004372|NCT05589896|Busulfan|busulfan|mesh-list
93004373|NCT05589896|Fludarabine|fludarabine|mesh-list
93004374|NCT05589896|Tacrolimus|tacrolimus|mesh-list
93004375|NCT05589896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004376|NCT05589896|Immunologic Factors|immunologic factors|mesh-ancestor
93004377|NCT05589896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004378|NCT05589896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004379|NCT05589896|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93004380|NCT05589896|Alkylating Agents|alkylating agents|mesh-ancestor
93004381|NCT05589896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004382|NCT05589896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004383|NCT05589896|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93004384|NCT05589896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93004385|NCT05589896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004386|NCT05589896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93004387|NCT05589896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93004388|NCT05589896|Antitubercular Agents|antitubercular agents|mesh-ancestor
93004389|NCT05589896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004390|NCT05589896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004391|NCT00673049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93004392|NCT00673049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004393|NCT00673049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93004394|NCT00673049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004395|NCT00673049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004396|NCT04003844|Aspirin|aspirin|mesh-list
93004397|NCT04003844|Immunoglobulins|immunoglobulins|mesh-list
93004398|NCT04003844|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93004399|NCT04003844|Antibodies|antibodies|mesh-list
93004400|NCT04003844|Immunoglobulin G|immunoglobulin g|mesh-list
93004401|NCT04003844|Immunologic Factors|immunologic factors|mesh-ancestor
93004402|NCT04003844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004403|NCT04003844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93004404|NCT04003844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93004405|NCT04003844|Analgesics|analgesics|mesh-ancestor
93004406|NCT04003844|Sensory System Agents|sensory system agents|mesh-ancestor
93004407|NCT04003844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004408|NCT04003844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004409|NCT04003844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528490|NCT00000788|Narcotics|narcotics|mesh-ancestor
93004411|NCT04003844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93004412|NCT04003844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004413|NCT04003844|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93004414|NCT04003844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93004415|NCT04003844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004416|NCT04003844|Antipyretics|antipyretics|mesh-ancestor
93004417|NCT05589584|Acetylcysteine|acetylcysteine|mesh-list
93004418|NCT05589584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93004419|NCT05589584|Antiviral Agents|antiviral agents|mesh-ancestor
93004420|NCT05589584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004421|NCT05589584|Expectorants|expectorants|mesh-ancestor
93004422|NCT05589584|Respiratory System Agents|respiratory system agents|mesh-ancestor
93004423|NCT05589584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93004424|NCT05589584|Antioxidants|antioxidants|mesh-ancestor
93004425|NCT05589584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004426|NCT05589584|Protective Agents|protective agents|mesh-ancestor
93004427|NCT05589584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004428|NCT05589584|Antidotes|antidotes|mesh-ancestor
93004429|NCT00412750|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93004430|NCT00412750|Telbivudine|telbivudine|mesh-list
93004431|NCT00412750|Antiviral Agents|antiviral agents|mesh-ancestor
93004432|NCT00412750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004433|NCT00412750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93004434|NCT00412750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004435|NCT00412750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004436|NCT05361278|Chlorhexidine|chlorhexidine|mesh-list
93004437|NCT05361278|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93004438|NCT05361278|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93004440|NCT05361278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93004441|NCT05361278|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93004442|NCT05361278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004443|NCT05361278|Disinfectants|disinfectants|mesh-ancestor
93004444|NCT05361278|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004445|NCT00764855|Propofol|propofol|mesh-list
93004446|NCT00764855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93004447|NCT00764855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004448|NCT00764855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004449|NCT00764855|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93004450|NCT00764855|Anesthetics, General|anesthetics, general|mesh-ancestor
93004451|NCT00764855|Anesthetics|anesthetics|mesh-ancestor
93004452|NCT00759317|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93004453|NCT00759317|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93004454|NCT00759317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93004455|NCT00759317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004456|NCT00759317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004457|NCT00759317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004458|NCT00759317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004459|NCT00759317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93004460|NCT00759317|Antidepressive Agents|antidepressive agents|mesh-ancestor
93004461|NCT00759317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93004462|NCT00076999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93004463|NCT01041040|Gemtuzumab|gemtuzumab|mesh-list
93004464|NCT01041040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004465|NCT01041040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004466|NCT01041040|Immunotoxins|immunotoxins|mesh-ancestor
93004467|NCT01041040|Immunoconjugates|immunoconjugates|mesh-ancestor
93004468|NCT01041040|Immunologic Factors|immunologic factors|mesh-ancestor
93004469|NCT01041040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004470|NCT00765011|Cetuximab|cetuximab|mesh-list
93004471|NCT00765011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004472|NCT00765011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649804|NCT00227318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93004473|NCT00765167|Chlorhexidine|chlorhexidine|mesh-list
93004474|NCT00765167|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93004475|NCT00765167|Triclosan|triclosan|mesh-list
93004476|NCT00765167|Fluorides|fluorides|mesh-list
93004477|NCT00765167|Cariostatic Agents|cariostatic agents|mesh-ancestor
93004478|NCT00765167|Protective Agents|protective agents|mesh-ancestor
93004479|NCT00765167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004480|NCT00765167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93004481|NCT00765167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004482|NCT00765167|Disinfectants|disinfectants|mesh-ancestor
93004483|NCT00765167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004484|NCT00765167|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93004485|NCT00765167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93004486|NCT00765167|Antimetabolites|antimetabolites|mesh-ancestor
93004487|NCT00765167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004488|NCT00765167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93004489|NCT00759551|Olmesartan|olmesartan|mesh-list
93004490|NCT00759551|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93004491|NCT00759551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93004492|NCT00759551|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93004493|NCT00759551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93004494|NCT00759551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004495|NCT03905096|Donepezil|donepezil|mesh-list
93004496|NCT03905096|BI 425809|bi 425809|mesh-list
93004497|NCT03905096|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93004498|NCT03905096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004499|NCT03905096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004500|NCT03905096|Cholinergic Agents|cholinergic agents|mesh-ancestor
93004501|NCT03905096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004502|NCT03905096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004503|NCT03905096|Nootropic Agents|nootropic agents|mesh-ancestor
93004504|NCT00412360|Cyclosporine|cyclosporine|mesh-list
93004505|NCT00412360|Mycophenolic Acid|mycophenolic acid|mesh-list
93004506|NCT00412360|Cyclophosphamide|cyclophosphamide|mesh-list
93004507|NCT00412360|Fludarabine|fludarabine|mesh-list
93004508|NCT00412360|Cyclosporins|cyclosporins|mesh-list
93004509|NCT00412360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004510|NCT00412360|Immunologic Factors|immunologic factors|mesh-ancestor
93004511|NCT00412360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004512|NCT00412360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004513|NCT00412360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93004514|NCT00412360|Alkylating Agents|alkylating agents|mesh-ancestor
93004515|NCT00412360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004516|NCT00412360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004517|NCT00412360|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93004518|NCT00412360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004519|NCT00412360|Antifungal Agents|antifungal agents|mesh-ancestor
93004520|NCT00412360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004521|NCT00412360|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004522|NCT00412360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93004523|NCT00412360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93004524|NCT00412360|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93004525|NCT00412360|Antitubercular Agents|antitubercular agents|mesh-ancestor
93004526|NCT00412360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004527|NCT00761501|Naproxen|naproxen|mesh-list
93004528|NCT00761501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93004529|NCT00761501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93004530|NCT00761501|Analgesics|analgesics|mesh-ancestor
93004531|NCT00761501|Sensory System Agents|sensory system agents|mesh-ancestor
93004532|NCT00761501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004533|NCT00761501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004534|NCT00761501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004535|NCT00761501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004536|NCT00761501|Gout Suppressants|gout suppressants|mesh-ancestor
93004537|NCT00761501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93004538|NCT00761501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004539|NCT00761501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004540|NCT01088893|Everolimus|everolimus|mesh-list
93004541|NCT01088893|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93004542|NCT01088893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93004543|NCT01088893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004544|NCT01088893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004545|NCT01088893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004546|NCT01088893|Immunologic Factors|immunologic factors|mesh-ancestor
93004547|NCT01088893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004548|NCT01088893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004549|NCT03026036|Raclopride|raclopride|mesh-list
93004551|NCT03026036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93004552|NCT03026036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004553|NCT03026036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004554|NCT03026036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93004555|NCT03026036|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93004556|NCT03026036|Dopamine Agents|dopamine agents|mesh-ancestor
93004557|NCT03026036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004558|NCT03026036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004559|NCT00990860|Doxorubicin|doxorubicin|mesh-list
93004560|NCT00990860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93004561|NCT00990860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004562|NCT00990860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93004563|NCT00990860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93004564|NCT00990860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004565|NCT00990860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004566|NCT01035190|Budesonide|budesonide|mesh-list
93004567|NCT01035190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004568|NCT01035190|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93004569|NCT01035190|Autonomic Agents|autonomic agents|mesh-ancestor
93004570|NCT01035190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004571|NCT01035190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004572|NCT01035190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93004573|NCT01035190|Respiratory System Agents|respiratory system agents|mesh-ancestor
93004574|NCT01035190|Glucocorticoids|glucocorticoids|mesh-ancestor
93004575|NCT01035190|Hormones|hormones|mesh-ancestor
93004576|NCT01035190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004577|NCT00571103|Acamprosate|acamprosate|mesh-list
93004578|NCT00571103|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93004579|NCT00084799|Antibodies|antibodies|mesh-list
93004580|NCT00084799|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93004581|NCT00084799|Immunologic Factors|immunologic factors|mesh-ancestor
93004582|NCT00084799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004583|NCT00765557|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93004584|NCT00765557|Laxatives|laxatives|mesh-ancestor
93004585|NCT00765557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93004586|NCT01086553|Budesonide|budesonide|mesh-list
93004587|NCT01086553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004588|NCT01086553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93004589|NCT01086553|Autonomic Agents|autonomic agents|mesh-ancestor
93004590|NCT01086553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004591|NCT01086553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004592|NCT01086553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93004593|NCT01086553|Respiratory System Agents|respiratory system agents|mesh-ancestor
93004594|NCT01086553|Glucocorticoids|glucocorticoids|mesh-ancestor
93004595|NCT01086553|Hormones|hormones|mesh-ancestor
93004596|NCT01086553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93004597|NCT01041508|Cyclosporine|cyclosporine|mesh-list
93004598|NCT01041508|Mycophenolic Acid|mycophenolic acid|mesh-list
93004599|NCT01041508|Clofarabine|clofarabine|mesh-list
93004600|NCT01041508|Cyclosporins|cyclosporins|mesh-list
93004601|NCT01041508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004602|NCT01041508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004603|NCT01041508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004604|NCT01041508|Immunologic Factors|immunologic factors|mesh-ancestor
93004605|NCT01041508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004606|NCT01041508|Antifungal Agents|antifungal agents|mesh-ancestor
93004607|NCT01041508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004608|NCT01041508|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004609|NCT01041508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004610|NCT01041508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93004611|NCT01041508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93004612|NCT01041508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004613|NCT01041508|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93004614|NCT01041508|Antitubercular Agents|antitubercular agents|mesh-ancestor
93004615|NCT01041508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004616|NCT01041508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004617|NCT01041508|Antimetabolites|antimetabolites|mesh-ancestor
93004618|NCT00766025|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93004619|NCT00766025|Calcium|calcium|mesh-list
93004620|NCT00766025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93004621|NCT00766025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004622|NCT00766025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93004623|NCT00766025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93004624|NCT00766025|Antimetabolites|antimetabolites|mesh-ancestor
93004625|NCT00766025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004626|NCT00766025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93004627|NCT00766025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93004628|NCT00766025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004630|NCT00766181|Anesthetics, Local|anesthetics, local|mesh-ancestor
93004631|NCT00766181|Anesthetics|anesthetics|mesh-ancestor
93004632|NCT00766181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004633|NCT00766181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004634|NCT00766181|Sensory System Agents|sensory system agents|mesh-ancestor
93004635|NCT00766181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004636|NCT00766181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93004637|NCT00766181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93004638|NCT00766181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93004639|NCT00766181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004640|NCT00766181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004641|NCT04048577|Natalizumab|natalizumab|mesh-list
93004642|NCT04048577|Immunologic Factors|immunologic factors|mesh-ancestor
93004643|NCT04048577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004644|NCT00991250|Temozolomide|temozolomide|mesh-list
93004645|NCT00991250|Dacarbazine|dacarbazine|mesh-list
93004646|NCT00991250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93004647|NCT00991250|Alkylating Agents|alkylating agents|mesh-ancestor
93004648|NCT00991250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004649|NCT00991250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004650|NCT00418522|Insulin|insulin|mesh-list
93004651|NCT00418522|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93004652|NCT00418522|Insulin Glargine|insulin glargine|mesh-list
93004653|NCT00418522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93004654|NCT00418522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004655|NCT00760175|Vaccines|vaccines|mesh-list
93004656|NCT00760175|Immunologic Factors|immunologic factors|mesh-ancestor
93004657|NCT00760175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004658|NCT00766337|Sirolimus|sirolimus|mesh-list
93004659|NCT00766337|Temsirolimus|temsirolimus|mesh-list
93004660|NCT00766337|Ranibizumab|ranibizumab|mesh-list
93004661|NCT00766337|MTOR Inhibitors|mtor inhibitors|mesh-list
93004662|NCT00766337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004663|NCT00766337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004664|NCT00766337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93004665|NCT00766337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004666|NCT00766337|Antifungal Agents|antifungal agents|mesh-ancestor
93004667|NCT00766337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004668|NCT00766337|Immunologic Factors|immunologic factors|mesh-ancestor
93004669|NCT00766337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004670|NCT00766337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93004671|NCT00766337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004672|NCT00766337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004673|NCT00766337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93004674|NCT00766337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93004675|NCT00766337|Growth Substances|growth substances|mesh-ancestor
93004676|NCT00766337|Growth Inhibitors|growth inhibitors|mesh-ancestor
93004677|NCT00991562|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
93004678|NCT00991562|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93004679|NCT00991562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004680|NCT00991562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004681|NCT00991562|Immunotoxins|immunotoxins|mesh-ancestor
93004682|NCT00991562|Immunoconjugates|immunoconjugates|mesh-ancestor
93004683|NCT00991562|Immunologic Factors|immunologic factors|mesh-ancestor
93004684|NCT00991562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004685|NCT00991562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93004686|NCT00991562|Tubulin Modulators|tubulin modulators|mesh-ancestor
93004687|NCT00991562|Antimitotic Agents|antimitotic agents|mesh-ancestor
93004688|NCT00991562|Mitosis Modulators|mitosis modulators|mesh-ancestor
93004689|NCT00991562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004690|NCT00762671|Ebselen|ebselen|mesh-list
93004691|NCT00762671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93004692|NCT00762671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93004693|NCT00762671|Analgesics|analgesics|mesh-ancestor
93004694|NCT00762671|Sensory System Agents|sensory system agents|mesh-ancestor
93004695|NCT00762671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004696|NCT00762671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004697|NCT00762671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650035|NCT00236145|Fentanyl|fentanyl|mesh-list
93004698|NCT00762671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004699|NCT00762671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93004700|NCT00762671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93004701|NCT00762671|Antioxidants|antioxidants|mesh-ancestor
92168772|NCT03942419|Atropine|atropine|mesh-list
93004702|NCT00762671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004703|NCT00762671|Protective Agents|protective agents|mesh-ancestor
93004705|NCT00762671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004706|NCT00762671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93004707|NCT02558387|Nintedanib|nintedanib|mesh-list
93004708|NCT02558387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004709|NCT02558387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93004710|NCT02558387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004711|NCT02558387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004712|NCT00766805|Propranolol|propranolol|mesh-list
93004713|NCT00766805|Isosorbide|isosorbide|mesh-list
93004714|NCT00766805|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93004715|NCT00766805|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93004716|NCT00766805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93004717|NCT00766805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93004718|NCT00766805|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004719|NCT00766805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004720|NCT00766805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004721|NCT00766805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004722|NCT00766805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93004723|NCT00766805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93004724|NCT00766805|Vasodilator Agents|vasodilator agents|mesh-ancestor
93004725|NCT00766805|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93004726|NCT00766805|Diuretics|diuretics|mesh-ancestor
93004727|NCT00766805|Natriuretic Agents|natriuretic agents|mesh-ancestor
93004728|NCT00766805|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93004729|NCT00762749|Diphenhydramine|diphenhydramine|mesh-list
93004730|NCT00762749|Promethazine|promethazine|mesh-list
93004731|NCT00762749|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93004732|NCT00762749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93004733|NCT00762749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004734|NCT00762749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004735|NCT00762749|Anesthetics, Local|anesthetics, local|mesh-ancestor
93004736|NCT00762749|Anesthetics|anesthetics|mesh-ancestor
93004737|NCT00762749|Sensory System Agents|sensory system agents|mesh-ancestor
93004738|NCT00762749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004739|NCT00762749|Antiemetics|antiemetics|mesh-ancestor
93004740|NCT00762749|Autonomic Agents|autonomic agents|mesh-ancestor
93004741|NCT00762749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93004742|NCT00762749|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93004743|NCT00762749|Histamine Antagonists|histamine antagonists|mesh-ancestor
93004744|NCT00762749|Histamine Agents|histamine agents|mesh-ancestor
93004745|NCT00762749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004746|NCT00762749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004747|NCT00762749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93004748|NCT00762749|Antipruritics|antipruritics|mesh-ancestor
93004749|NCT00762749|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004750|NCT00403546|Ziprasidone|ziprasidone|mesh-list
93004751|NCT00403546|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93004752|NCT00403546|Serotonin Agents|serotonin agents|mesh-ancestor
93004753|NCT00403546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004754|NCT00403546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004755|NCT00403546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004756|NCT00403546|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93004757|NCT00403546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93004758|NCT00403546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004759|NCT00403546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93004760|NCT00403546|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93004761|NCT00403546|Dopamine Agents|dopamine agents|mesh-ancestor
93004762|NCT00767117|Ritonavir|ritonavir|mesh-list
93004763|NCT00767117|Lopinavir|lopinavir|mesh-list
93004764|NCT00767117|Etravirine|etravirine|mesh-list
93004765|NCT00767117|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93004766|NCT00767117|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93004767|NCT00767117|Protease Inhibitors|protease inhibitors|mesh-ancestor
93004768|NCT00767117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004769|NCT00767117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004770|NCT00767117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93004771|NCT00767117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93004772|NCT00767117|Antiviral Agents|antiviral agents|mesh-ancestor
93004773|NCT00767117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650103|NCT00228488|Gefitinib|gefitinib|mesh-list
93004774|NCT00767117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93004775|NCT00767117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93004776|NCT00767117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528498|NCT00000788|Antifungal Agents|antifungal agents|mesh-ancestor
93004777|NCT00767117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93004780|NCT00762983|Dermatologic Agents|dermatologic agents|mesh-ancestor
93004781|NCT00762983|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93004782|NCT00762983|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93004783|NCT00762983|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93004784|NCT00762983|Histamine Antagonists|histamine antagonists|mesh-ancestor
93004785|NCT00762983|Histamine Agents|histamine agents|mesh-ancestor
93004786|NCT00762983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004787|NCT00762983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004788|NCT00762983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004789|NCT00403234|Buprenorphine|buprenorphine|mesh-list
93004790|NCT00403234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93004791|NCT00403234|Narcotics|narcotics|mesh-ancestor
93004792|NCT00403234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004793|NCT00403234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004794|NCT00403234|Analgesics|analgesics|mesh-ancestor
93004795|NCT00403234|Sensory System Agents|sensory system agents|mesh-ancestor
93004796|NCT00403234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004797|NCT00403234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93004798|NCT04049201|Midazolam|midazolam|mesh-list
93004799|NCT04049201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93004800|NCT04049201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93004801|NCT04049201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93004802|NCT04049201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004803|NCT04049201|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93004804|NCT04049201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93004805|NCT04049201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93004806|NCT04049201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93004807|NCT04049201|Anesthetics, General|anesthetics, general|mesh-ancestor
93004808|NCT04049201|Anesthetics|anesthetics|mesh-ancestor
93004809|NCT04049201|GABA Modulators|gaba modulators|mesh-ancestor
93004810|NCT04049201|GABA Agents|gaba agents|mesh-ancestor
93004811|NCT04049201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004812|NCT04049201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004813|NCT00767663|Dipyridamole|dipyridamole|mesh-list
93004814|NCT00767663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93004815|NCT00767663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004816|NCT00767663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004817|NCT00767663|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93004818|NCT00767663|Vasodilator Agents|vasodilator agents|mesh-ancestor
93004819|NCT00402688|Levofloxacin|levofloxacin|mesh-list
93004820|NCT00402688|Ofloxacin|ofloxacin|mesh-list
93004821|NCT00402688|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93004822|NCT00402688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004823|NCT00402688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004824|NCT00402688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93004825|NCT00402688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93004826|NCT00402688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004827|NCT00402688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004828|NCT00402688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004829|NCT00402688|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93004830|NCT00402688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93004831|NCT04049045|Empagliflozin|empagliflozin|mesh-list
93004832|NCT04049045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93004833|NCT04049045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004834|NCT04049045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93004835|NCT04049045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004836|NCT00763373|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93004837|NCT00763373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93004838|NCT00763373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004839|NCT00763373|Antitubercular Agents|antitubercular agents|mesh-ancestor
93004840|NCT01035580|Curcumin|curcumin|mesh-list
93004841|NCT01035580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93004842|NCT01035580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93004843|NCT01035580|Analgesics|analgesics|mesh-ancestor
93004844|NCT01035580|Sensory System Agents|sensory system agents|mesh-ancestor
93004845|NCT01035580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004846|NCT01035580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004847|NCT01035580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93004848|NCT01035580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93004849|NCT01035580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004850|NCT01035580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004851|NCT01035580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004852|NCT00671879|Carisoprodol|carisoprodol|mesh-list
93004853|NCT00671879|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93004854|NCT00671879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004855|NCT00671879|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93004856|NCT00671879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004857|NCT00402298|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93004858|NCT00402298|Hallucinogens|hallucinogens|mesh-ancestor
93004859|NCT00402298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004860|NCT00402298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93004861|NCT00402298|Serotonin Agents|serotonin agents|mesh-ancestor
93004862|NCT00402298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004863|NCT00402298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004864|NCT00402298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93004865|NCT00402298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93004866|NCT00402298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004867|NCT00402298|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004868|NCT00767975|Rifampin|rifampin|mesh-list
93004869|NCT00767975|Isoniazid|isoniazid|mesh-list
93004870|NCT00767975|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93004871|NCT00767975|Antitubercular Agents|antitubercular agents|mesh-ancestor
93004872|NCT00767975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93004873|NCT00767975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93004874|NCT00767975|Leprostatic Agents|leprostatic agents|mesh-ancestor
93004875|NCT00767975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93004876|NCT00767975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004877|NCT00767975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004878|NCT00767975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93004879|NCT00767975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93004880|NCT00767975|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93004881|NCT00767975|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93004882|NCT00767975|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93004883|NCT00767975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93004884|NCT00767975|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93004885|NCT00767975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93004886|NCT00767975|Antimetabolites|antimetabolites|mesh-ancestor
93004887|NCT00767975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93004888|NCT00768131|Paclitaxel|paclitaxel|mesh-list
93004889|NCT00768131|Carboplatin|carboplatin|mesh-list
93004890|NCT00768131|Cetuximab|cetuximab|mesh-list
93004891|NCT00768131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93004892|NCT00768131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004893|NCT00768131|Tubulin Modulators|tubulin modulators|mesh-ancestor
93004894|NCT00768131|Antimitotic Agents|antimitotic agents|mesh-ancestor
93004895|NCT00768131|Mitosis Modulators|mitosis modulators|mesh-ancestor
93004896|NCT00768131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004897|NCT00768131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004898|NCT00401830|Lacosamide|lacosamide|mesh-list
93004899|NCT00401830|Anticonvulsants|anticonvulsants|mesh-ancestor
93004900|NCT00401830|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93004901|NCT00401830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93004902|NCT00401830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004903|NCT00401830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004904|NCT00768209|Topiramate|topiramate|mesh-list
93004905|NCT00768209|Phentermine|phentermine|mesh-list
93004906|NCT00768209|Anticonvulsants|anticonvulsants|mesh-ancestor
93004907|NCT00768209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93004908|NCT00768209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004909|NCT00768209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93004910|NCT00768209|Appetite Depressants|appetite depressants|mesh-ancestor
93004911|NCT00768209|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93004912|NCT00768209|Sympathomimetics|sympathomimetics|mesh-ancestor
93004913|NCT00768209|Autonomic Agents|autonomic agents|mesh-ancestor
93004914|NCT00768209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93004915|NCT00768209|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004916|NCT00768209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004917|NCT00768209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004918|NCT00401752|Esomeprazole|esomeprazole|mesh-list
93004919|NCT00401752|Ranitidine|ranitidine|mesh-list
92650252|NCT00229424|Famotidine|famotidine|mesh-list
93004920|NCT00401752|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93004921|NCT00401752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93004922|NCT00401752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93004923|NCT00401752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93004924|NCT00401752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004925|NCT00401752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004926|NCT00401752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93004927|NCT00401752|Histamine Antagonists|histamine antagonists|mesh-ancestor
93004928|NCT00401752|Histamine Agents|histamine agents|mesh-ancestor
93004929|NCT00401752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004930|NCT00401752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004931|NCT00770471|Temozolomide|temozolomide|mesh-list
93004932|NCT00770471|Veliparib|veliparib|mesh-list
93004933|NCT00770471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93004934|NCT00770471|Alkylating Agents|alkylating agents|mesh-ancestor
93004935|NCT00770471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004936|NCT00770471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004937|NCT00770471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93004938|NCT00770471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004939|NCT00539240|Antidepressive Agents|antidepressive agents|mesh-list
93004940|NCT00539240|Nortriptyline|nortriptyline|mesh-list
93004941|NCT00539240|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
93004942|NCT00539240|Rabeprazole|rabeprazole|mesh-list
93004943|NCT00539240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93004944|NCT00539240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93004945|NCT00539240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93004946|NCT00539240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93004947|NCT00539240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004948|NCT00539240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93004949|NCT00539240|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93004950|NCT00539240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93004951|NCT00539240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93004952|NCT00539240|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004953|NCT00539240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004954|NCT00539240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004955|NCT00417976|Bevacizumab|bevacizumab|mesh-list
93004956|NCT00417976|Gemcitabine|gemcitabine|mesh-list
93004957|NCT00417976|Fluorouracil|fluorouracil|mesh-list
93004958|NCT00417976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004959|NCT00417976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004960|NCT00417976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93004961|NCT00417976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93004962|NCT00417976|Growth Substances|growth substances|mesh-ancestor
93004963|NCT00417976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004964|NCT00417976|Growth Inhibitors|growth inhibitors|mesh-ancestor
93004965|NCT00417976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004966|NCT00417976|Antimetabolites|antimetabolites|mesh-ancestor
93004967|NCT00417976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004968|NCT00417976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93004969|NCT00417976|Immunologic Factors|immunologic factors|mesh-ancestor
93004970|NCT00770705|Phenoxybenzamine|phenoxybenzamine|mesh-list
93004971|NCT00770705|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93004972|NCT00770705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93004973|NCT00770705|Adrenergic Agents|adrenergic agents|mesh-ancestor
93004974|NCT00770705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93004975|NCT00770705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004976|NCT00770705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004977|NCT00770705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93004978|NCT00770705|Vasodilator Agents|vasodilator agents|mesh-ancestor
93004979|NCT00991796|Paclitaxel|paclitaxel|mesh-list
93004980|NCT00991796|Carboplatin|carboplatin|mesh-list
92168790|NCT03878095|Olaparib|olaparib|mesh-list
93004981|NCT00991796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93004982|NCT00991796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004983|NCT00991796|Tubulin Modulators|tubulin modulators|mesh-ancestor
93004984|NCT00991796|Antimitotic Agents|antimitotic agents|mesh-ancestor
93004985|NCT00991796|Mitosis Modulators|mitosis modulators|mesh-ancestor
93004986|NCT00991796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004987|NCT00673673|Bevacizumab|bevacizumab|mesh-list
93004988|NCT00673673|Fluorouracil|fluorouracil|mesh-list
93004989|NCT00673673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93004990|NCT00673673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93004991|NCT00673673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93004992|NCT00673673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93004993|NCT00673673|Growth Substances|growth substances|mesh-ancestor
93004994|NCT00673673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93004995|NCT00673673|Growth Inhibitors|growth inhibitors|mesh-ancestor
93004996|NCT00673673|Antimetabolites|antimetabolites|mesh-ancestor
93004997|NCT00673673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93004998|NCT00673673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93004999|NCT00673673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005000|NCT00673673|Immunologic Factors|immunologic factors|mesh-ancestor
93005002|NCT00763685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93005003|NCT00763685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005004|NCT00763685|Analgesics|analgesics|mesh-ancestor
93005005|NCT00763685|Sensory System Agents|sensory system agents|mesh-ancestor
93005006|NCT00763685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005007|NCT00763685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005008|NCT00763685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005009|NCT00763685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005010|NCT00763685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93005011|NCT00763685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93005012|NCT00763685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005013|NCT00763685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005014|NCT04048655|Neostigmine|neostigmine|mesh-list
93005015|NCT04048655|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93005016|NCT04048655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005017|NCT04048655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005018|NCT04048655|Cholinergic Agents|cholinergic agents|mesh-ancestor
93005019|NCT04048655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005020|NCT04048655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005021|NCT04048655|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93005022|NCT04048655|Autonomic Agents|autonomic agents|mesh-ancestor
93005023|NCT04048655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005024|NCT00768677|Topiramate|topiramate|mesh-list
93005025|NCT00768677|Anticonvulsants|anticonvulsants|mesh-ancestor
93005026|NCT00768677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93005027|NCT00768677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005028|NCT02557451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
93005029|NCT02557451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93005030|NCT02557451|Growth Substances|growth substances|mesh-ancestor
93005031|NCT02557451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005032|NCT02557451|Growth Inhibitors|growth inhibitors|mesh-ancestor
93005033|NCT02557451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005034|NCT05408936|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93005035|NCT05408936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005036|NCT05408936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93005037|NCT05408936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005038|NCT02558153|Paclitaxel|paclitaxel|mesh-list
93005039|NCT02558153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93005040|NCT02558153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005041|NCT02558153|Tubulin Modulators|tubulin modulators|mesh-ancestor
93005042|NCT02558153|Antimitotic Agents|antimitotic agents|mesh-ancestor
93005043|NCT02558153|Mitosis Modulators|mitosis modulators|mesh-ancestor
93005044|NCT02558153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005045|NCT00763763|Interferons|interferons|mesh-list
93005046|NCT00763763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93005047|NCT00763763|Interferon-alpha|interferon-alpha|mesh-list
93005048|NCT00763763|Dexamethasone|dexamethasone|mesh-list
93005049|NCT00763763|Vincristine|vincristine|mesh-list
93005050|NCT00763763|Imatinib Mesylate|imatinib mesylate|mesh-list
93005051|NCT00763763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005052|NCT00763763|Antiemetics|antiemetics|mesh-ancestor
93005053|NCT00763763|Autonomic Agents|autonomic agents|mesh-ancestor
93005054|NCT00763763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005055|NCT00763763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005056|NCT00763763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93005057|NCT00763763|Glucocorticoids|glucocorticoids|mesh-ancestor
93005058|NCT00763763|Hormones|hormones|mesh-ancestor
93005059|NCT00763763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005060|NCT00763763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93005061|NCT00763763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005062|NCT00763763|Antiviral Agents|antiviral agents|mesh-ancestor
93005063|NCT00763763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005064|NCT00763763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93005065|NCT00763763|Tubulin Modulators|tubulin modulators|mesh-ancestor
93005066|NCT00763763|Antimitotic Agents|antimitotic agents|mesh-ancestor
92350573|NCT05632692|Menthol|menthol|mesh-list
93005067|NCT00763763|Mitosis Modulators|mitosis modulators|mesh-ancestor
93005068|NCT00763763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005069|NCT00763763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005070|NCT00763763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005071|NCT00763763|Immunologic Factors|immunologic factors|mesh-ancestor
93005073|NCT01037140|Cholecalciferol|cholecalciferol|mesh-list
93005075|NCT01037140|Micronutrients|micronutrients|mesh-ancestor
93005076|NCT01037140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005077|NCT01037140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93005078|NCT01037140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93005079|NCT05357456|Epinephrine|epinephrine|mesh-list
93005080|NCT05357456|Racepinephrine|racepinephrine|mesh-list
93005081|NCT05357456|Epinephryl borate|epinephryl borate|mesh-list
93005082|NCT05357456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93005083|NCT05357456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93005084|NCT05357456|Adrenergic Agents|adrenergic agents|mesh-ancestor
93005085|NCT05357456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005086|NCT05357456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005087|NCT05357456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005088|NCT05357456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93005089|NCT05357456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93005090|NCT05357456|Autonomic Agents|autonomic agents|mesh-ancestor
93005091|NCT05357456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005092|NCT05357456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93005093|NCT05357456|Respiratory System Agents|respiratory system agents|mesh-ancestor
93005094|NCT05357456|Mydriatics|mydriatics|mesh-ancestor
93005095|NCT05357456|Sympathomimetics|sympathomimetics|mesh-ancestor
93005096|NCT05357456|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93005097|NCT00069121|Leucovorin|leucovorin|mesh-list
93005098|NCT00069121|Fluorouracil|fluorouracil|mesh-list
93005099|NCT00069121|Capecitabine|capecitabine|mesh-list
93005100|NCT00069121|Oxaliplatin|oxaliplatin|mesh-list
93005101|NCT00069121|Antimetabolites|antimetabolites|mesh-ancestor
93005102|NCT00069121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005103|NCT00069121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93005104|NCT00069121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005105|NCT00069121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005106|NCT00069121|Immunologic Factors|immunologic factors|mesh-ancestor
93005107|NCT00069121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005108|NCT00069121|Antidotes|antidotes|mesh-ancestor
93005109|NCT00069121|Protective Agents|protective agents|mesh-ancestor
93005110|NCT00069121|Vitamin B Complex|vitamin b complex|mesh-ancestor
93005111|NCT00069121|Vitamins|vitamins|mesh-ancestor
93005112|NCT00069121|Micronutrients|micronutrients|mesh-ancestor
93005113|NCT00768911|Temozolomide|temozolomide|mesh-list
93005114|NCT00768911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005115|NCT00768911|Alkylating Agents|alkylating agents|mesh-ancestor
93005116|NCT00768911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005117|NCT00768911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005118|NCT00769145|Ranibizumab|ranibizumab|mesh-list
93005119|NCT00769145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93005120|NCT00769145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93005121|NCT00769145|Growth Substances|growth substances|mesh-ancestor
93005122|NCT00769145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005123|NCT00769145|Growth Inhibitors|growth inhibitors|mesh-ancestor
93005124|NCT00769145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005125|NCT00763997|Acetaminophen|acetaminophen|mesh-list
93005126|NCT00763997|Dipyrone|dipyrone|mesh-list
93005127|NCT00763997|Ibuprofen|ibuprofen|mesh-list
93005128|NCT00763997|Parecoxib|parecoxib|mesh-list
93005129|NCT00763997|Valdecoxib|valdecoxib|mesh-list
93005130|NCT00763997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005131|NCT00763997|Analgesics|analgesics|mesh-ancestor
93005132|NCT00763997|Sensory System Agents|sensory system agents|mesh-ancestor
93005133|NCT00763997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005134|NCT00763997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005135|NCT00763997|Antipyretics|antipyretics|mesh-ancestor
93005136|NCT00763997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93005137|NCT00763997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005138|NCT00763997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005139|NCT00763997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93005140|NCT00763997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005141|NCT00763997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005142|NCT00763997|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93005143|NCT00771251|Golimumab|golimumab|mesh-list
93005144|NCT00771251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93005145|NCT00771251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005146|NCT00771251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005147|NCT00771251|Immunologic Factors|immunologic factors|mesh-ancestor
93005148|NCT00771251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005149|NCT01420250|Bicalutamide|bicalutamide|mesh-list
93005151|NCT01420250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93005152|NCT01420250|Androgens|androgens|mesh-list
93005153|NCT01420250|Androgen Antagonists|androgen antagonists|mesh-list
93005154|NCT01420250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005155|NCT01420250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005156|NCT01420250|Hormone Antagonists|hormone antagonists|mesh-ancestor
93005157|NCT01420250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005158|NCT00399568|Acetaminophen|acetaminophen|mesh-list
93005159|NCT00399568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005160|NCT00399568|Analgesics|analgesics|mesh-ancestor
93005161|NCT00399568|Sensory System Agents|sensory system agents|mesh-ancestor
93005162|NCT00399568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005163|NCT00399568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005164|NCT00399568|Antipyretics|antipyretics|mesh-ancestor
93005165|NCT05088356|Plerixafor|plerixafor|mesh-list
93005166|NCT05088356|Cyclophosphamide|cyclophosphamide|mesh-list
93005167|NCT05088356|Melphalan|melphalan|mesh-list
93005168|NCT05088356|Fludarabine|fludarabine|mesh-list
93005169|NCT05088356|Fludarabine phosphate|fludarabine phosphate|mesh-list
93005170|NCT05088356|Tacrolimus|tacrolimus|mesh-list
93005171|NCT05088356|Alkylating Agents|alkylating agents|mesh-list
93005172|NCT05088356|Lenograstim|lenograstim|mesh-list
93005173|NCT05088356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005174|NCT05088356|Immunologic Factors|immunologic factors|mesh-ancestor
93005175|NCT05088356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005176|NCT05088356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005177|NCT05088356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005178|NCT05088356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005179|NCT05088356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005180|NCT05088356|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93005181|NCT05088356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93005182|NCT05088356|Antimetabolites|antimetabolites|mesh-ancestor
93005183|NCT05088356|Antiviral Agents|antiviral agents|mesh-ancestor
93005184|NCT05088356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005185|NCT05088356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93005186|NCT05088356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93005187|NCT05088356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005188|NCT05088356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93005189|NCT05088356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93005190|NCT01039558|Ecabet|ecabet|mesh-list
93005191|NCT01039558|Lansoprazole|lansoprazole|mesh-list
93005192|NCT01039558|Dexlansoprazole|dexlansoprazole|mesh-list
93005193|NCT01039558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93005194|NCT01039558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93005195|NCT01039558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93005196|NCT01039558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005197|NCT01039558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005198|NCT01039558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005199|NCT01039558|Protease Inhibitors|protease inhibitors|mesh-ancestor
93005200|NCT01039558|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93005201|NCT01039558|Protective Agents|protective agents|mesh-ancestor
93005202|NCT01039558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005203|NCT01039558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005204|NCT01324258|Gemcitabine|gemcitabine|mesh-list
93005205|NCT01324258|Trametinib|trametinib|mesh-list
93005206|NCT01324258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93005207|NCT01324258|Antimetabolites|antimetabolites|mesh-ancestor
93005208|NCT01324258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005209|NCT01324258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005210|NCT01324258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005211|NCT01324258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005212|NCT01415882|Dexamethasone|dexamethasone|mesh-list
93005213|NCT01415882|Dexamethasone acetate|dexamethasone acetate|mesh-list
93005214|NCT01415882|Cyclophosphamide|cyclophosphamide|mesh-list
93005215|NCT01415882|Daratumumab|daratumumab|mesh-list
93005216|NCT01415882|Ixazomib|ixazomib|mesh-list
93005217|NCT01415882|Ichthammol|ichthammol|mesh-list
93005218|NCT01415882|BB 1101|bb 1101|mesh-list
93005219|NCT01415882|Glycine|glycine|mesh-list
93005220|NCT01415882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005221|NCT01415882|Immunologic Factors|immunologic factors|mesh-ancestor
93005222|NCT01415882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005223|NCT01415882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005224|NCT01415882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005225|NCT01415882|Alkylating Agents|alkylating agents|mesh-ancestor
93005226|NCT01415882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005227|NCT01415882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005228|NCT01415882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93005229|NCT01415882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005231|NCT01415882|Autonomic Agents|autonomic agents|mesh-ancestor
93005232|NCT01415882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005233|NCT01415882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93005234|NCT01415882|Glucocorticoids|glucocorticoids|mesh-ancestor
93005235|NCT01415882|Hormones|hormones|mesh-ancestor
93005236|NCT01415882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005237|NCT01415882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93005238|NCT01415882|Protease Inhibitors|protease inhibitors|mesh-ancestor
93005239|NCT01415882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005240|NCT01415882|Dermatologic Agents|dermatologic agents|mesh-ancestor
93005241|NCT01415882|Glycine Agents|glycine agents|mesh-ancestor
93005242|NCT01415882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005243|NCT00068419|Tamoxifen|tamoxifen|mesh-list
93005244|NCT00068419|Sulindac|sulindac|mesh-list
93005245|NCT00068419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005246|NCT00068419|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93005247|NCT00068419|Hormone Antagonists|hormone antagonists|mesh-ancestor
93005248|NCT00068419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005249|NCT00068419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005250|NCT00068419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93005251|NCT00068419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005252|NCT00068419|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93005253|NCT00068419|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93005254|NCT00068419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93005255|NCT00068419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93005256|NCT00068419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005257|NCT00068419|Analgesics|analgesics|mesh-ancestor
93005258|NCT00068419|Sensory System Agents|sensory system agents|mesh-ancestor
93005259|NCT00068419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005260|NCT00068419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005261|NCT00068419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005262|NCT00068419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93005263|NCT00068419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005264|NCT02557373|Vitamins|vitamins|mesh-list
93005265|NCT02557373|Vitamin A|vitamin a|mesh-list
93005266|NCT02557373|Retinol palmitate|retinol palmitate|mesh-list
93005267|NCT02557373|Micronutrients|micronutrients|mesh-ancestor
93005268|NCT02557373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005269|NCT02557373|Antioxidants|antioxidants|mesh-ancestor
93005270|NCT02557373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005271|NCT02557373|Protective Agents|protective agents|mesh-ancestor
93005272|NCT02557373|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93005273|NCT02557373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005274|NCT01757626|Molgramostim|molgramostim|mesh-list
93005275|NCT01757626|Sargramostim|sargramostim|mesh-list
92305964|NCT00004029|Sargramostim|sargramostim|mesh-list
93005276|NCT01757626|Immunologic Factors|immunologic factors|mesh-ancestor
93005277|NCT01757626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005278|NCT01757626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005279|NCT04048811|Propofol|propofol|mesh-list
93005280|NCT04048811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93005281|NCT04048811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005282|NCT04048811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005283|NCT04048811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93005284|NCT04048811|Anesthetics, General|anesthetics, general|mesh-ancestor
93005285|NCT04048811|Anesthetics|anesthetics|mesh-ancestor
93005286|NCT01086631|Rituximab|rituximab|mesh-list
93005287|NCT01086631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93005288|NCT01086631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005289|NCT01086631|Immunologic Factors|immunologic factors|mesh-ancestor
93005290|NCT01086631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005291|NCT01086631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005292|NCT00399490|Tanezumab|tanezumab|mesh-list
93005293|NCT00399490|Analgesics|analgesics|mesh-ancestor
93005294|NCT00399490|Sensory System Agents|sensory system agents|mesh-ancestor
93005295|NCT00399490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350794|NCT03598374|Vitamins|vitamins|mesh-ancestor
93005296|NCT00399490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005297|NCT00398866|Triamcinolone|triamcinolone|mesh-list
93005298|NCT00398866|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93005299|NCT00398866|Bupivacaine|bupivacaine|mesh-list
93005300|NCT00398866|Hyaluronic Acid|hyaluronic acid|mesh-list
93005302|NCT00398866|Anesthetics, Local|anesthetics, local|mesh-ancestor
93005303|NCT00398866|Anesthetics|anesthetics|mesh-ancestor
93005304|NCT00398866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005305|NCT00398866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005306|NCT00398866|Sensory System Agents|sensory system agents|mesh-ancestor
93005307|NCT00398866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005308|NCT00398866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005309|NCT00398866|Glucocorticoids|glucocorticoids|mesh-ancestor
93005310|NCT00398866|Hormones|hormones|mesh-ancestor
93005311|NCT00398866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005312|NCT00398866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005313|NCT00398866|Immunologic Factors|immunologic factors|mesh-ancestor
93005314|NCT00398866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93005315|NCT00398866|Viscosupplements|viscosupplements|mesh-ancestor
93005316|NCT00398866|Protective Agents|protective agents|mesh-ancestor
93005317|NCT00771563|Cisplatin|cisplatin|mesh-list
93005318|NCT00771563|Docetaxel|docetaxel|mesh-list
93005319|NCT00771563|Enoxaparin|enoxaparin|mesh-list
93005320|NCT00771563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005321|NCT00771563|Tubulin Modulators|tubulin modulators|mesh-ancestor
93005322|NCT00771563|Antimitotic Agents|antimitotic agents|mesh-ancestor
93005323|NCT00771563|Mitosis Modulators|mitosis modulators|mesh-ancestor
93005324|NCT00771563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005325|NCT00771563|Anticoagulants|anticoagulants|mesh-ancestor
93005326|NCT00771563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93005327|NCT00771563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93005328|NCT00775073|Bevacizumab|bevacizumab|mesh-list
93005329|NCT00775073|Everolimus|everolimus|mesh-list
93005330|NCT00775073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93005331|NCT00775073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005332|NCT00775073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93005333|NCT00775073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93005334|NCT00775073|Growth Substances|growth substances|mesh-ancestor
93005335|NCT00775073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005336|NCT00775073|Growth Inhibitors|growth inhibitors|mesh-ancestor
93005337|NCT00775073|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93005338|NCT00775073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005339|NCT00775073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005340|NCT00775073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005341|NCT00775073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005342|NCT00775073|Immunologic Factors|immunologic factors|mesh-ancestor
93005343|NCT00398632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93005344|NCT00398632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93005345|NCT00398632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93005346|NCT00398632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005347|NCT00398632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005348|NCT00398632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005349|NCT00398632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005350|NCT00398632|Analgesics|analgesics|mesh-ancestor
93005351|NCT00398632|Sensory System Agents|sensory system agents|mesh-ancestor
93005352|NCT00398632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005353|NCT00398632|Antidepressive Agents|antidepressive agents|mesh-ancestor
93005354|NCT00398632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93005355|NCT00398632|Dopamine Agents|dopamine agents|mesh-ancestor
93005356|NCT01589146|Heparin|heparin|mesh-list
93005357|NCT01589146|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93005358|NCT01589146|Tinzaparin|tinzaparin|mesh-list
93005359|NCT01589146|Dalteparin|dalteparin|mesh-list
93005360|NCT01589146|Anticoagulants|anticoagulants|mesh-ancestor
93005361|NCT01589146|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93005362|NCT01589146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93005363|NCT01589146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005364|NCT00775151|Amlodipine|amlodipine|mesh-list
93005365|NCT00775151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93005366|NCT00775151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93005367|NCT00775151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005368|NCT00775151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005369|NCT00775151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93005370|NCT00775151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005371|NCT00775151|Vasodilator Agents|vasodilator agents|mesh-ancestor
93005372|NCT04694300|Acetaminophen|acetaminophen|mesh-list
93005373|NCT04694300|Naproxen|naproxen|mesh-list
93005374|NCT04694300|Tramadol|tramadol|mesh-list
92650708|NCT00236886|Topiramate|topiramate|mesh-list
93005375|NCT04694300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005376|NCT04694300|Analgesics|analgesics|mesh-ancestor
93005377|NCT04694300|Sensory System Agents|sensory system agents|mesh-ancestor
93005378|NCT04694300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005379|NCT04694300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005380|NCT04694300|Antipyretics|antipyretics|mesh-ancestor
93005381|NCT04694300|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93005382|NCT04694300|Narcotics|narcotics|mesh-ancestor
93005383|NCT04694300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005384|NCT04694300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93005385|NCT04694300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005386|NCT04694300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005387|NCT04694300|Gout Suppressants|gout suppressants|mesh-ancestor
93005388|NCT04694300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93005389|NCT04694300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005390|NCT04694300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005391|NCT04642820|Methamphetamine|methamphetamine|mesh-list
93005392|NCT04642820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93005393|NCT04642820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005394|NCT04642820|Sympathomimetics|sympathomimetics|mesh-ancestor
93005395|NCT04642820|Autonomic Agents|autonomic agents|mesh-ancestor
93005396|NCT04642820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005397|NCT04642820|Dopamine Agents|dopamine agents|mesh-ancestor
93005398|NCT04642820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005399|NCT04642820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005400|NCT04642820|Adrenergic Agents|adrenergic agents|mesh-ancestor
93005401|NCT04642820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93005402|NCT04642820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93005403|NCT04642820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005404|NCT04642820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93005406|NCT00771641|Trace Elements|trace elements|mesh-ancestor
93005407|NCT00771641|Micronutrients|micronutrients|mesh-ancestor
93005408|NCT00771641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005409|NCT05408000|Propofol|propofol|mesh-list
93005410|NCT05408000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93005411|NCT05408000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005412|NCT05408000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005413|NCT05408000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93005414|NCT05408000|Anesthetics, General|anesthetics, general|mesh-ancestor
93005415|NCT05408000|Anesthetics|anesthetics|mesh-ancestor
93005416|NCT00771719|Ceftobiprole|ceftobiprole|mesh-list
93005417|NCT00771719|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93005418|NCT00771719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93005419|NCT00771719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005420|NCT00673361|Temozolomide|temozolomide|mesh-list
93005421|NCT00673361|Sorafenib|sorafenib|mesh-list
93005422|NCT00673361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005423|NCT00673361|Alkylating Agents|alkylating agents|mesh-ancestor
93005424|NCT00673361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005425|NCT00673361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005426|NCT00673361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005427|NCT00673361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005428|NCT00393718|Liraglutide|liraglutide|mesh-list
93005429|NCT00393718|Glyburide|glyburide|mesh-list
93005430|NCT00393718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93005431|NCT00393718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005432|NCT00393718|Incretins|incretins|mesh-ancestor
93005433|NCT00393718|Hormones|hormones|mesh-ancestor
93005434|NCT00393718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005435|NCT00669071|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93005436|NCT00669071|Tretinoin|tretinoin|mesh-list
93005437|NCT00669071|Hydroquinone|hydroquinone|mesh-list
93005438|NCT00669071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005439|NCT00669071|Keratolytic Agents|keratolytic agents|mesh-ancestor
93005440|NCT00669071|Dermatologic Agents|dermatologic agents|mesh-ancestor
93005441|NCT00669071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005442|NCT00669071|Glucocorticoids|glucocorticoids|mesh-ancestor
93005443|NCT00669071|Hormones|hormones|mesh-ancestor
93005444|NCT00669071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005445|NCT00669071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005446|NCT00669071|Antioxidants|antioxidants|mesh-ancestor
93005447|NCT00669071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005449|NCT00669071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92650786|NCT00176488|Vinorelbine|vinorelbine|mesh-list
93005450|NCT00398320|Bevacizumab|bevacizumab|mesh-list
93005451|NCT00398320|Capecitabine|capecitabine|mesh-list
93005452|NCT00398320|Oxaliplatin|oxaliplatin|mesh-list
93005453|NCT00398320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93005454|NCT00398320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005455|NCT00398320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93005456|NCT00398320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93005457|NCT00398320|Growth Substances|growth substances|mesh-ancestor
93005458|NCT00398320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005459|NCT00398320|Growth Inhibitors|growth inhibitors|mesh-ancestor
93005460|NCT00398320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93005461|NCT00398320|Antimetabolites|antimetabolites|mesh-ancestor
93005462|NCT00398320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005463|NCT00670007|Protease Inhibitors|protease inhibitors|mesh-list
93005464|NCT00670007|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93005465|NCT00670007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005466|NCT00670007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005467|NCT00670007|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93005468|NCT00670007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93005469|NCT04003688|Magnesium Sulfate|magnesium sulfate|mesh-list
93005470|NCT04003688|Analgesics|analgesics|mesh-ancestor
93005471|NCT04003688|Sensory System Agents|sensory system agents|mesh-ancestor
93005472|NCT04003688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005473|NCT04003688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005474|NCT04003688|Anesthetics|anesthetics|mesh-ancestor
93005475|NCT04003688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005476|NCT04003688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93005477|NCT04003688|Anticonvulsants|anticonvulsants|mesh-ancestor
93005478|NCT04003688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93005479|NCT04003688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005480|NCT04003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005481|NCT04003688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93005482|NCT04003688|Tocolytic Agents|tocolytic agents|mesh-ancestor
93005483|NCT04003688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93005484|NCT00779129|Cyclophosphamide|cyclophosphamide|mesh-list
93005485|NCT00779129|Doxorubicin|doxorubicin|mesh-list
93005486|NCT00779129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005487|NCT00779129|Immunologic Factors|immunologic factors|mesh-ancestor
93005488|NCT00779129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005489|NCT00779129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005490|NCT00779129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005491|NCT00779129|Alkylating Agents|alkylating agents|mesh-ancestor
93005492|NCT00779129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005493|NCT00779129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005494|NCT00779129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93005495|NCT00779129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93005496|NCT00779129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93005497|NCT00779129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93005498|NCT00779129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005500|NCT00772187|Morphine|morphine|mesh-list
93005501|NCT00772187|Anesthetics|anesthetics|mesh-ancestor
93005502|NCT00772187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005503|NCT00772187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005504|NCT00772187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93005505|NCT00772187|Narcotics|narcotics|mesh-ancestor
93005506|NCT00772187|Analgesics|analgesics|mesh-ancestor
93005507|NCT00772187|Sensory System Agents|sensory system agents|mesh-ancestor
93005508|NCT00772187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005509|NCT00772187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93005510|NCT00772187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93005511|NCT00772187|Anesthetics, General|anesthetics, general|mesh-ancestor
93005512|NCT00772265|Insulin|insulin|mesh-list
93005513|NCT00772265|Isophane Insulin, Human|isophane insulin, human|mesh-list
93005514|NCT00772265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93005515|NCT00772265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005516|NCT00779441|Zolpidem|zolpidem|mesh-list
93005517|NCT00779441|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93005518|NCT00779441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93005519|NCT00779441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005520|NCT00779441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005521|NCT00779441|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93005522|NCT00779441|GABA Agonists|gaba agonists|mesh-ancestor
93005523|NCT00779441|GABA Agents|gaba agents|mesh-ancestor
93005524|NCT00779441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005525|NCT00779441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005526|NCT02556437|Immunoglobulins|immunoglobulins|mesh-list
93005527|NCT02556437|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93005529|NCT02556437|Immunologic Factors|immunologic factors|mesh-ancestor
93005530|NCT02556437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005531|NCT04946006|Oxytocin|oxytocin|mesh-list
93005532|NCT04946006|Oxytocics|oxytocics|mesh-ancestor
93005533|NCT04946006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93005534|NCT04946006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005535|NCT00775619|Carvedilol|carvedilol|mesh-list
93005536|NCT00775619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93005537|NCT00775619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93005538|NCT00775619|Adrenergic Agents|adrenergic agents|mesh-ancestor
93005539|NCT00775619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005540|NCT00775619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005541|NCT00775619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005542|NCT00775619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93005543|NCT00775619|Antioxidants|antioxidants|mesh-ancestor
93005544|NCT00775619|Protective Agents|protective agents|mesh-ancestor
93005545|NCT00775619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93005546|NCT00775619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005547|NCT00775619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93005548|NCT00775619|Vasodilator Agents|vasodilator agents|mesh-ancestor
93005549|NCT00775619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93005550|NCT00775619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93005551|NCT00775697|Montelukast|montelukast|mesh-list
93005552|NCT00775697|Leukotriene Antagonists|leukotriene antagonists|mesh-list
93005553|NCT00775697|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93005554|NCT00775697|Respiratory System Agents|respiratory system agents|mesh-ancestor
93005555|NCT00775697|Hormone Antagonists|hormone antagonists|mesh-ancestor
93005556|NCT00775697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005557|NCT00775697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005558|NCT00775697|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93005559|NCT00775697|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92148699|NCT04382625|Antimalarials|antimalarials|mesh-ancestor
93005560|NCT00775697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005561|NCT05357066|Nitrous Oxide|nitrous oxide|mesh-list
93005562|NCT05357066|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93005563|NCT05357066|Anesthetics, General|anesthetics, general|mesh-ancestor
93005564|NCT05357066|Anesthetics|anesthetics|mesh-ancestor
93005565|NCT05357066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005566|NCT05357066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005567|NCT05357066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005568|NCT05357066|Analgesics|analgesics|mesh-ancestor
93005569|NCT05357066|Sensory System Agents|sensory system agents|mesh-ancestor
93005570|NCT05357066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005571|NCT02556905|Dexamethasone|dexamethasone|mesh-list
93005572|NCT02556905|Lenalidomide|lenalidomide|mesh-list
93005573|NCT02556905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005574|NCT02556905|Antiemetics|antiemetics|mesh-ancestor
93005575|NCT02556905|Autonomic Agents|autonomic agents|mesh-ancestor
93005576|NCT02556905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005577|NCT02556905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005578|NCT02556905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93005579|NCT02556905|Glucocorticoids|glucocorticoids|mesh-ancestor
93005580|NCT02556905|Hormones|hormones|mesh-ancestor
93005581|NCT02556905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93005582|NCT02556905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93005583|NCT02556905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005584|NCT02556905|Immunologic Factors|immunologic factors|mesh-ancestor
93005585|NCT02556905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93005586|NCT02556905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93005587|NCT02556905|Growth Substances|growth substances|mesh-ancestor
93005588|NCT02556905|Growth Inhibitors|growth inhibitors|mesh-ancestor
93005589|NCT00539006|Fluticasone|fluticasone|mesh-list
93005590|NCT00539006|Xhance|xhance|mesh-list
93005591|NCT00539006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005592|NCT00539006|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93005593|NCT00539006|Autonomic Agents|autonomic agents|mesh-ancestor
93005594|NCT00539006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005595|NCT00539006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005596|NCT00539006|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93005597|NCT00539006|Respiratory System Agents|respiratory system agents|mesh-ancestor
92650929|NCT00171925|Zoledronic Acid|zoledronic acid|mesh-list
93005598|NCT00539006|Dermatologic Agents|dermatologic agents|mesh-ancestor
93005599|NCT00539006|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93005600|NCT04047329|Anesthetics|anesthetics|mesh-list
93005601|NCT04047329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005602|NCT04047329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005603|NCT00779753|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
93005604|NCT00779753|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93005605|NCT00779753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93005606|NCT00537056|Sunitinib|sunitinib|mesh-list
93005607|NCT00537056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93005608|NCT00537056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005609|NCT00537056|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93005610|NCT00537056|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93005611|NCT00537056|Growth Substances|growth substances|mesh-ancestor
93005612|NCT00537056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005613|NCT00537056|Growth Inhibitors|growth inhibitors|mesh-ancestor
93005614|NCT00537056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005615|NCT00537056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005616|NCT00537056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005617|NCT00537056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93005618|NCT00779831|Pseudoephedrine|pseudoephedrine|mesh-list
93005619|NCT00779831|Ephedrine|ephedrine|mesh-list
93005620|NCT00779831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93005621|NCT00779831|Autonomic Agents|autonomic agents|mesh-ancestor
93005622|NCT00779831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005623|NCT00779831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005624|NCT00779831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93005625|NCT00779831|Respiratory System Agents|respiratory system agents|mesh-ancestor
93005626|NCT00779831|Nasal Decongestants|nasal decongestants|mesh-ancestor
93005627|NCT00779831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93005628|NCT00779831|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93005629|NCT00779831|Sympathomimetics|sympathomimetics|mesh-ancestor
93005630|NCT00779831|Adrenergic Agents|adrenergic agents|mesh-ancestor
93005631|NCT00779831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005632|NCT00779831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005633|NCT00535262|Selegiline|selegiline|mesh-list
93005634|NCT00535262|Antidepressive Agents|antidepressive agents|mesh-ancestor
93005635|NCT00535262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93005636|NCT00535262|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93005637|NCT00535262|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93005638|NCT00535262|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93005639|NCT00535262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005640|NCT00535262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005641|NCT00535262|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93005642|NCT00535262|Protective Agents|protective agents|mesh-ancestor
93005643|NCT00535262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005644|NCT00772499|Atenolol|atenolol|mesh-list
93005645|NCT00772499|Amlodipine|amlodipine|mesh-list
93005646|NCT00772499|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93005647|NCT00772499|Olmesartan|olmesartan|mesh-list
93005648|NCT00772499|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93005649|NCT00772499|Hydralazine|hydralazine|mesh-list
93005650|NCT00772499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93005651|NCT00772499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93005652|NCT00772499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005653|NCT00772499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005654|NCT00772499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93005655|NCT00772499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005656|NCT00772499|Vasodilator Agents|vasodilator agents|mesh-ancestor
93005657|NCT00772499|Diuretics|diuretics|mesh-ancestor
93005658|NCT00772499|Natriuretic Agents|natriuretic agents|mesh-ancestor
93005659|NCT00772499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93005660|NCT00772499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93005661|NCT00772499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93005662|NCT00772499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93005663|NCT00772499|Sympatholytics|sympatholytics|mesh-ancestor
93005664|NCT00772499|Autonomic Agents|autonomic agents|mesh-ancestor
92351170|NCT04192032|Autonomic Agents|autonomic agents|mesh-ancestor
93005665|NCT00772499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005666|NCT00772499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93005667|NCT00772499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93005668|NCT00772499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93005669|NCT00772499|Adrenergic Agents|adrenergic agents|mesh-ancestor
93005670|NCT00772499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005671|NCT00989690|Docetaxel|docetaxel|mesh-list
93005672|NCT00989690|Pemetrexed|pemetrexed|mesh-list
93005673|NCT00989690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93005674|NCT00989690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005675|NCT00989690|Tubulin Modulators|tubulin modulators|mesh-ancestor
93005676|NCT00989690|Antimitotic Agents|antimitotic agents|mesh-ancestor
93005677|NCT00989690|Mitosis Modulators|mitosis modulators|mesh-ancestor
93005678|NCT00989690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005679|NCT00989690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005680|NCT00989690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93005681|NCT00989690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93005682|NCT00989690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005683|NCT00074581|Ritonavir|ritonavir|mesh-list
93005684|NCT00074581|Lopinavir|lopinavir|mesh-list
93005685|NCT00074581|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93005686|NCT00074581|Tenofovir|tenofovir|mesh-list
93005687|NCT00074581|Lamivudine|lamivudine|mesh-list
93005688|NCT00074581|Emtricitabine|emtricitabine|mesh-list
93005689|NCT00074581|Zidovudine|zidovudine|mesh-list
93005690|NCT00074581|Nevirapine|nevirapine|mesh-list
93005691|NCT00074581|Didanosine|didanosine|mesh-list
93005692|NCT00074581|Stavudine|stavudine|mesh-list
93005693|NCT00074581|Efavirenz|efavirenz|mesh-list
93005694|NCT00074581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93005695|NCT00074581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93005696|NCT00074581|Protease Inhibitors|protease inhibitors|mesh-ancestor
93005697|NCT00074581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005698|NCT00074581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005699|NCT00074581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93005700|NCT00074581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93005701|NCT00074581|Antiviral Agents|antiviral agents|mesh-ancestor
93005702|NCT00074581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005703|NCT00074581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93005704|NCT00074581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93005705|NCT00074581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93005706|NCT00074581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93005707|NCT00074581|Antimetabolites|antimetabolites|mesh-ancestor
93005708|NCT00074581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93005709|NCT00074581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93005710|NCT00074581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93005711|NCT00074581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93005712|NCT00074581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93005713|NCT00776477|Aspirin|aspirin|mesh-list
93005714|NCT00776477|Clopidogrel|clopidogrel|mesh-list
93005715|NCT00776477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93005716|NCT00776477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005717|NCT00776477|Analgesics|analgesics|mesh-ancestor
93005718|NCT00776477|Sensory System Agents|sensory system agents|mesh-ancestor
93005719|NCT00776477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005720|NCT00776477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005721|NCT00776477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005722|NCT00776477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005723|NCT00776477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93005724|NCT00776477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93005725|NCT00776477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005726|NCT00776477|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93005727|NCT00776477|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93005728|NCT00776477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005729|NCT00776477|Antipyretics|antipyretics|mesh-ancestor
93005730|NCT00776477|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93005731|NCT00776477|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93005732|NCT00776477|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93005733|NCT00776477|Purinergic Agents|purinergic agents|mesh-ancestor
93005734|NCT00776477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005735|NCT00772655|Rituximab|rituximab|mesh-list
93005736|NCT00772655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93005737|NCT00772655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005738|NCT00772655|Immunologic Factors|immunologic factors|mesh-ancestor
93005739|NCT00772655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005740|NCT00772655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005741|NCT04272086|Bupivacaine|bupivacaine|mesh-list
93005742|NCT04272086|Anesthetics, Local|anesthetics, local|mesh-ancestor
93005743|NCT04272086|Anesthetics|anesthetics|mesh-ancestor
93005744|NCT04272086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005745|NCT04272086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005746|NCT04272086|Sensory System Agents|sensory system agents|mesh-ancestor
93005747|NCT04272086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651083|NCT00258765|Docetaxel|docetaxel|mesh-list
93005749|NCT00776633|Clopidogrel|clopidogrel|mesh-list
93005750|NCT00776633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93005751|NCT00776633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005752|NCT00776633|Analgesics|analgesics|mesh-ancestor
93005753|NCT00776633|Sensory System Agents|sensory system agents|mesh-ancestor
93005754|NCT00776633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005755|NCT00776633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005756|NCT00776633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005757|NCT00776633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005758|NCT00776633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93005759|NCT00776633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93005760|NCT00776633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005761|NCT00776633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93005762|NCT00776633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93005763|NCT00776633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005764|NCT00776633|Antipyretics|antipyretics|mesh-ancestor
93005765|NCT00776633|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93005766|NCT00776633|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93005767|NCT00776633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93005768|NCT00776633|Purinergic Agents|purinergic agents|mesh-ancestor
93005769|NCT00776633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005770|NCT01093963|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93005771|NCT01093963|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93005772|NCT01093963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168829|NCT03746106|Trimethoprim|trimethoprim|mesh-list
93005773|NCT01093963|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93005774|NCT01093963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93005775|NCT01093963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005776|NCT01093963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005777|NCT01093963|Dopamine Agents|dopamine agents|mesh-ancestor
93005778|NCT01093963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005779|NCT04256018|Mogamulizumab|mogamulizumab|mesh-list
93005780|NCT04256018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005781|NCT03961087|Ubiquinone|ubiquinone|mesh-list
93005782|NCT03961087|Coenzyme Q10|coenzyme q10|mesh-list
93005783|NCT03961087|Meclofenoxate|meclofenoxate|mesh-list
93005784|NCT03961087|Micronutrients|micronutrients|mesh-ancestor
93005785|NCT03961087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005786|NCT03961087|Vitamins|vitamins|mesh-ancestor
93005787|NCT03961087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93005788|NCT03961087|Protective Agents|protective agents|mesh-ancestor
93005789|NCT03961087|Nootropic Agents|nootropic agents|mesh-ancestor
93005790|NCT03960775|Dexmedetomidine|dexmedetomidine|mesh-list
93005791|NCT03960775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93005792|NCT03960775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93005793|NCT03960775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005794|NCT03960775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93005795|NCT03960775|Analgesics|analgesics|mesh-ancestor
93005796|NCT03960775|Sensory System Agents|sensory system agents|mesh-ancestor
93005797|NCT03960775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93005798|NCT03960775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93005799|NCT03960775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93005800|NCT03960775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93005801|NCT03960775|Adrenergic Agents|adrenergic agents|mesh-ancestor
93005802|NCT03960775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005803|NCT03960775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005804|NCT00536978|Cytarabine|cytarabine|mesh-list
93005805|NCT00536978|Cyclophosphamide|cyclophosphamide|mesh-list
93005806|NCT00536978|Melphalan|melphalan|mesh-list
93005807|NCT00536978|Carmustine|carmustine|mesh-list
93005808|NCT00536978|Rituximab|rituximab|mesh-list
93005809|NCT00536978|Methotrexate|methotrexate|mesh-list
93005810|NCT00536978|Fludarabine|fludarabine|mesh-list
93005811|NCT00536978|Fludarabine phosphate|fludarabine phosphate|mesh-list
93005812|NCT00536978|Etoposide|etoposide|mesh-list
93005813|NCT00536978|Alemtuzumab|alemtuzumab|mesh-list
93005814|NCT00536978|Tacrolimus|tacrolimus|mesh-list
93005815|NCT00536978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005816|NCT00536978|Immunologic Factors|immunologic factors|mesh-ancestor
93005817|NCT00536978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005818|NCT00536978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005819|NCT00536978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005820|NCT00536978|Alkylating Agents|alkylating agents|mesh-ancestor
92651158|NCT04709094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005821|NCT00536978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005822|NCT00536978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005824|NCT00536978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93005825|NCT00536978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93005826|NCT00536978|Abortifacient Agents|abortifacient agents|mesh-ancestor
93005827|NCT00536978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93005828|NCT00536978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93005829|NCT00536978|Antimetabolites|antimetabolites|mesh-ancestor
93005830|NCT00536978|Dermatologic Agents|dermatologic agents|mesh-ancestor
93005831|NCT00536978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005832|NCT00536978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93005833|NCT00536978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93005834|NCT00536978|Antiviral Agents|antiviral agents|mesh-ancestor
93005835|NCT00536978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005836|NCT00536978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93005837|NCT00536978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93005838|NCT00536978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93005839|NCT00536978|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93005840|NCT03809611|Choline|choline|mesh-list
93005841|NCT03809611|Lipotropic Agents|lipotropic agents|mesh-ancestor
93005842|NCT03809611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93005843|NCT03809611|Antimetabolites|antimetabolites|mesh-ancestor
93005844|NCT03809611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005845|NCT03809611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93005846|NCT03809611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93005847|NCT03809611|Nootropic Agents|nootropic agents|mesh-ancestor
93005848|NCT05360342|Vitamins|vitamins|mesh-list
93005849|NCT05360342|Vitamin K|vitamin k|mesh-list
93005850|NCT05360342|Vitamin K 1|vitamin k 1|mesh-list
93005851|NCT05360342|Micronutrients|micronutrients|mesh-ancestor
93005852|NCT05360342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005853|NCT05360342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93005854|NCT05360342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93005855|NCT05360342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005856|NCT05360342|Hemostatics|hemostatics|mesh-ancestor
93005857|NCT05360342|Coagulants|coagulants|mesh-ancestor
93005858|NCT05290220|Lenvatinib|lenvatinib|mesh-list
93005859|NCT05290220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005860|NCT05290220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93005861|NCT05290220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005862|NCT05290220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005863|NCT04026230|Atorvastatin|atorvastatin|mesh-list
93005864|NCT04026230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93005865|NCT04026230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93005866|NCT04026230|Antimetabolites|antimetabolites|mesh-ancestor
93005867|NCT04026230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005868|NCT04026230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93005869|NCT04026230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93005870|NCT04026230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005871|NCT00536510|Niacin|niacin|mesh-list
93005872|NCT00536510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93005873|NCT00536510|Antimetabolites|antimetabolites|mesh-ancestor
93005874|NCT00536510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005875|NCT00536510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93005876|NCT00536510|Vasodilator Agents|vasodilator agents|mesh-ancestor
93005877|NCT00536510|Vitamin B Complex|vitamin b complex|mesh-ancestor
93005878|NCT00536510|Vitamins|vitamins|mesh-ancestor
93005879|NCT00536510|Micronutrients|micronutrients|mesh-ancestor
93005880|NCT00536510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005881|NCT04424264|Tenofovir|tenofovir|mesh-list
93005882|NCT04424264|Lamivudine|lamivudine|mesh-list
93005883|NCT04424264|Emtricitabine|emtricitabine|mesh-list
93005884|NCT04424264|Efavirenz|efavirenz|mesh-list
93005885|NCT04424264|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93005886|NCT04424264|Rifampin|rifampin|mesh-list
93005887|NCT04424264|Isoniazid|isoniazid|mesh-list
93005888|NCT04424264|Antiviral Agents|antiviral agents|mesh-ancestor
93005889|NCT04424264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005890|NCT04424264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93005891|NCT04424264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93005892|NCT04424264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005893|NCT04424264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005894|NCT04424264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93005895|NCT04424264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93005896|NCT04424264|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93005897|NCT04424264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93005898|NCT04424264|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93005899|NCT04424264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93005900|NCT04424264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93005901|NCT04424264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93005902|NCT04424264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93005903|NCT04424264|Antitubercular Agents|antitubercular agents|mesh-ancestor
93005904|NCT04424264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93005905|NCT04424264|Leprostatic Agents|leprostatic agents|mesh-ancestor
93005906|NCT04424264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93005907|NCT04424264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93005908|NCT04424264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93005909|NCT04424264|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93005910|NCT04424264|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93005911|NCT04424264|Antimetabolites|antimetabolites|mesh-ancestor
93005912|NCT04424264|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93005913|NCT00398086|Paclitaxel|paclitaxel|mesh-list
93005914|NCT00398086|Gemcitabine|gemcitabine|mesh-list
93005915|NCT00398086|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93005916|NCT00398086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93005917|NCT00398086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005918|NCT00398086|Tubulin Modulators|tubulin modulators|mesh-ancestor
93005919|NCT00398086|Antimitotic Agents|antimitotic agents|mesh-ancestor
93005920|NCT00398086|Mitosis Modulators|mitosis modulators|mesh-ancestor
93005921|NCT00398086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005922|NCT00398086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93005923|NCT00398086|Antimetabolites|antimetabolites|mesh-ancestor
93005924|NCT04364360|Sulforaphane|sulforaphane|mesh-list
93005925|NCT04364360|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93005926|NCT04364360|Protective Agents|protective agents|mesh-ancestor
93005927|NCT04364360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005928|NCT04364360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005929|NCT00536198|Sertraline|sertraline|mesh-list
93005930|NCT00536198|Antidepressive Agents|antidepressive agents|mesh-ancestor
93005931|NCT00536198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93005932|NCT00536198|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93005933|NCT00536198|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93005934|NCT00536198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93005935|NCT00536198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005936|NCT00536198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93005937|NCT00536198|Serotonin Agents|serotonin agents|mesh-ancestor
93005938|NCT00536198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005939|NCT00393484|Lamivudine|lamivudine|mesh-list
93005940|NCT00393484|Entecavir|entecavir|mesh-list
93005941|NCT00393484|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93005942|NCT00393484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93005943|NCT00393484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005944|NCT00393484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005945|NCT00393484|Antiviral Agents|antiviral agents|mesh-ancestor
93005946|NCT00393484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93005947|NCT00393484|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93005948|NCT00393484|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93005949|NCT00667823|Macitentan|macitentan|mesh-list
93005950|NCT00667823|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93005951|NCT00667823|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93005952|NCT00667823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005953|NCT00667823|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93005954|NCT00536120|Natalizumab|natalizumab|mesh-list
93005955|NCT00536120|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93005956|NCT00536120|Immunologic Factors|immunologic factors|mesh-ancestor
93005957|NCT00536120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005958|NCT00536120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93005960|NCT00057811|Cytarabine|cytarabine|mesh-list
93005961|NCT00057811|Prednisone|prednisone|mesh-list
93005962|NCT00057811|Methylprednisolone|methylprednisolone|mesh-list
93005963|NCT00057811|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93005964|NCT00057811|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93005965|NCT00057811|Prednisolone|prednisolone|mesh-list
93005966|NCT00057811|Prednisolone acetate|prednisolone acetate|mesh-list
93005967|NCT00057811|Hydrocortisone|hydrocortisone|mesh-list
93005968|NCT00057811|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93005969|NCT00057811|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93005970|NCT00057811|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93005971|NCT00057811|Cyclophosphamide|cyclophosphamide|mesh-list
93005972|NCT00057811|Rituximab|rituximab|mesh-list
93005974|NCT00057811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93005975|NCT00057811|Methotrexate|methotrexate|mesh-list
93005976|NCT00057811|Etoposide|etoposide|mesh-list
93005977|NCT00057811|Vincristine|vincristine|mesh-list
93005978|NCT00057811|Etoposide phosphate|etoposide phosphate|mesh-list
93005979|NCT00057811|Rasburicase|rasburicase|mesh-list
93005980|NCT00057811|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93005981|NCT00057811|Prednisolone phosphate|prednisolone phosphate|mesh-list
93005982|NCT00057811|Levoleucovorin|levoleucovorin|mesh-list
93005983|NCT00057811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93005984|NCT00057811|Immunologic Factors|immunologic factors|mesh-ancestor
93005985|NCT00057811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93005986|NCT00057811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93005987|NCT00057811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93005988|NCT00057811|Alkylating Agents|alkylating agents|mesh-ancestor
93005989|NCT00057811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93005990|NCT00057811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93005991|NCT00057811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92168837|NCT03746106|Antimalarials|antimalarials|mesh-ancestor
93005992|NCT00057811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93005993|NCT00057811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93005994|NCT00057811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93005995|NCT00057811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93005996|NCT00057811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93005997|NCT00057811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93005998|NCT00057811|Glucocorticoids|glucocorticoids|mesh-ancestor
93005999|NCT00057811|Hormones|hormones|mesh-ancestor
93006000|NCT00057811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93006001|NCT00057811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93006002|NCT00057811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93006003|NCT00057811|Abortifacient Agents|abortifacient agents|mesh-ancestor
93006004|NCT00057811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93006005|NCT00057811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93006006|NCT00057811|Antimetabolites|antimetabolites|mesh-ancestor
93006007|NCT00057811|Dermatologic Agents|dermatologic agents|mesh-ancestor
93006008|NCT00057811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93006009|NCT00057811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93006010|NCT00057811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93006011|NCT00057811|Antiviral Agents|antiviral agents|mesh-ancestor
93006012|NCT00057811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006013|NCT00057811|Antidotes|antidotes|mesh-ancestor
93006014|NCT00057811|Protective Agents|protective agents|mesh-ancestor
93006015|NCT00057811|Vitamin B Complex|vitamin b complex|mesh-ancestor
93006016|NCT00057811|Vitamins|vitamins|mesh-ancestor
93006017|NCT00057811|Micronutrients|micronutrients|mesh-ancestor
93006018|NCT00057811|Tubulin Modulators|tubulin modulators|mesh-ancestor
93006019|NCT00057811|Antimitotic Agents|antimitotic agents|mesh-ancestor
93006020|NCT00057811|Mitosis Modulators|mitosis modulators|mesh-ancestor
93006021|NCT00057811|Antiemetics|antiemetics|mesh-ancestor
93006022|NCT00057811|Autonomic Agents|autonomic agents|mesh-ancestor
93006023|NCT00057811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006024|NCT00057811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006025|NCT00057811|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93006026|NCT00057811|Gout Suppressants|gout suppressants|mesh-ancestor
93006027|NCT03502148|Cisplatin|cisplatin|mesh-list
93006028|NCT03502148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006029|NCT02530801|Bevacizumab|bevacizumab|mesh-list
93006030|NCT02530801|Fluorouracil|fluorouracil|mesh-list
93006031|NCT02530801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006032|NCT02530801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006033|NCT02530801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93006034|NCT02530801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006035|NCT02530801|Growth Substances|growth substances|mesh-ancestor
93006036|NCT02530801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006037|NCT02530801|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006038|NCT02530801|Antimetabolites|antimetabolites|mesh-ancestor
93006039|NCT02530801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006040|NCT02530801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93006041|NCT02530801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006042|NCT02530801|Immunologic Factors|immunologic factors|mesh-ancestor
93006044|NCT01091077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93006045|NCT01091077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006046|NCT01091077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93006047|NCT01091077|Hormone Antagonists|hormone antagonists|mesh-ancestor
93006048|NCT01091077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93006049|NCT01091077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006051|NCT01094275|Clopidogrel|clopidogrel|mesh-list
93006052|NCT01094275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93006053|NCT01094275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93006054|NCT01094275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93006055|NCT01094275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93006056|NCT01094275|Purinergic Agents|purinergic agents|mesh-ancestor
93006057|NCT01094275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006058|NCT01094275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006059|NCT01094275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006060|NCT01094275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93006061|NCT01094275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006062|NCT01094275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93006063|NCT01094275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006064|NCT01089205|Metformin|metformin|mesh-list
93006065|NCT01089205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006066|NCT01089205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006067|NCT02866682|Tacrolimus|tacrolimus|mesh-list
93006068|NCT02866682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006069|NCT02866682|Immunologic Factors|immunologic factors|mesh-ancestor
93006070|NCT02866682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006071|NCT02866682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93006072|NCT02866682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006073|NCT02866682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006074|NCT01089439|Nitric Oxide|nitric oxide|mesh-list
93006075|NCT01089439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93006076|NCT01089439|Autonomic Agents|autonomic agents|mesh-ancestor
93006077|NCT01089439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006078|NCT01089439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006079|NCT01089439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93006080|NCT01089439|Respiratory System Agents|respiratory system agents|mesh-ancestor
93006081|NCT01089439|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93006082|NCT01089439|Antioxidants|antioxidants|mesh-ancestor
93006083|NCT01089439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006084|NCT01089439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006085|NCT01089439|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93006086|NCT01089439|Vasodilator Agents|vasodilator agents|mesh-ancestor
93006087|NCT01089439|Gasotransmitters|gasotransmitters|mesh-ancestor
93006088|NCT01089439|Protective Agents|protective agents|mesh-ancestor
93006089|NCT00992030|Rituximab|rituximab|mesh-list
93006090|NCT00992030|Doxorubicin|doxorubicin|mesh-list
93006091|NCT00992030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93006092|NCT00992030|Dacarbazine|dacarbazine|mesh-list
93006093|NCT00992030|Bleomycin|bleomycin|mesh-list
93006094|NCT00992030|Vinblastine|vinblastine|mesh-list
93006095|NCT00992030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006096|NCT00992030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006097|NCT00992030|Immunologic Factors|immunologic factors|mesh-ancestor
93006098|NCT00992030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006099|NCT00992030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006100|NCT00992030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006101|NCT00992030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93006102|NCT00992030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93006103|NCT00992030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006104|NCT00992030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006105|NCT00992030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93006106|NCT00992030|Alkylating Agents|alkylating agents|mesh-ancestor
93006107|NCT00992030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93006108|NCT00992030|Tubulin Modulators|tubulin modulators|mesh-ancestor
93006109|NCT00992030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92528517|NCT00000794|Calcium|calcium|mesh-list
93006110|NCT00992030|Mitosis Modulators|mitosis modulators|mesh-ancestor
93006111|NCT01976390|Sirolimus|sirolimus|mesh-list
93006112|NCT01976390|Everolimus|everolimus|mesh-list
93006113|NCT01976390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93006114|NCT01976390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006115|NCT01976390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006116|NCT01976390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006117|NCT01976390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006118|NCT01976390|Immunologic Factors|immunologic factors|mesh-ancestor
93006119|NCT01976390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006120|NCT01976390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006121|NCT01976390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006122|NCT01976390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651460|NCT00266487|Vitamins|vitamins|mesh-list
93006123|NCT01976390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006124|NCT01976390|Antifungal Agents|antifungal agents|mesh-ancestor
93006125|NCT00570713|Gemcitabine|gemcitabine|mesh-list
93006126|NCT00570713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93006127|NCT00570713|Antimetabolites|antimetabolites|mesh-ancestor
93006128|NCT00570713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006129|NCT00570713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006130|NCT04002440|Candesartan cilexetil|candesartan cilexetil|mesh-list
93006131|NCT04002440|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93006132|NCT04002440|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93006133|NCT04002440|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93006134|NCT04002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006135|NCT00780377|Bradykinin|bradykinin|mesh-list
93006136|NCT00780377|Kininogens|kininogens|mesh-list
93006137|NCT00780377|Vasodilator Agents|vasodilator agents|mesh-ancestor
93006138|NCT00780377|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93006139|NCT00780377|Protease Inhibitors|protease inhibitors|mesh-ancestor
93006140|NCT00780377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006141|NCT00780377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006142|NCT05219942|Insulin|insulin|mesh-list
93006143|NCT05219942|Insulin Glargine|insulin glargine|mesh-list
93006144|NCT05219942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006145|NCT05219942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006146|NCT00669617|Fluticasone|fluticasone|mesh-list
93006147|NCT00669617|Xhance|xhance|mesh-list
93006148|NCT00669617|Albuterol|albuterol|mesh-list
93006149|NCT00669617|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93006150|NCT00669617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006151|NCT00669617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93006152|NCT00669617|Autonomic Agents|autonomic agents|mesh-ancestor
93006153|NCT00669617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006154|NCT00669617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006155|NCT00669617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93006156|NCT00669617|Respiratory System Agents|respiratory system agents|mesh-ancestor
93006157|NCT00669617|Dermatologic Agents|dermatologic agents|mesh-ancestor
93006158|NCT00669617|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93006159|NCT00669617|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93006160|NCT00669617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93006161|NCT00669617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93006162|NCT00669617|Adrenergic Agents|adrenergic agents|mesh-ancestor
93006163|NCT00669617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006164|NCT00669617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006165|NCT00669617|Tocolytic Agents|tocolytic agents|mesh-ancestor
93006166|NCT00669617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93006167|NCT03979352|Empagliflozin|empagliflozin|mesh-list
93006168|NCT03979352|Pancrelipase|pancrelipase|mesh-list
93006169|NCT03979352|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93006170|NCT03979352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006171|NCT03979352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006172|NCT03979352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006173|NCT03979352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006174|NCT00773201|Sotalol|sotalol|mesh-list
93006175|NCT00773201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93006176|NCT00773201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93006177|NCT00773201|Adrenergic Agents|adrenergic agents|mesh-ancestor
93006178|NCT00773201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006179|NCT00773201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006180|NCT00773201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006181|NCT00773201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93006182|NCT00773201|Sympatholytics|sympatholytics|mesh-ancestor
93006183|NCT00773201|Autonomic Agents|autonomic agents|mesh-ancestor
93006184|NCT00773201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006185|NCT00777413|Minocycline|minocycline|mesh-list
93006186|NCT00777413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006187|NCT00777413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006188|NCT05162690|Dapagliflozin|dapagliflozin|mesh-list
93006189|NCT05162690|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93006190|NCT05162690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006191|NCT05162690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006192|NCT05162690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006193|NCT00992576|Hydromorphone|hydromorphone|mesh-list
93006194|NCT00992576|Naloxone|naloxone|mesh-list
93006195|NCT00992576|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93006196|NCT00992576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006197|NCT00992576|Sensory System Agents|sensory system agents|mesh-ancestor
93006198|NCT00992576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006199|NCT00992576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93006200|NCT00992576|Narcotics|narcotics|mesh-ancestor
93006201|NCT00992576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006202|NCT00992576|Analgesics|analgesics|mesh-ancestor
93006203|NCT00777569|Nicotine|nicotine|mesh-list
93006204|NCT00777569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93006205|NCT00777569|Autonomic Agents|autonomic agents|mesh-ancestor
93006206|NCT00777569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006207|NCT00777569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006208|NCT00777569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93006209|NCT00777569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93006210|NCT00777569|Cholinergic Agents|cholinergic agents|mesh-ancestor
93006211|NCT00777569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006212|NCT00777569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006213|NCT02556593|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93006214|NCT02556593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006215|NCT02556593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006216|NCT02556593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006217|NCT02556593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006218|NCT00535730|Vaccines|vaccines|mesh-list
93006219|NCT00535730|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93006220|NCT00535730|Immunologic Factors|immunologic factors|mesh-ancestor
93006221|NCT00535730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006222|NCT00992654|Maraviroc|maraviroc|mesh-list
93006223|NCT00992654|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93006224|NCT00992654|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93006225|NCT00992654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006226|NCT00992654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93006227|NCT00992654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93006228|NCT00992654|Antiviral Agents|antiviral agents|mesh-ancestor
93006229|NCT00992654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006230|NCT00992654|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93006231|NCT00773591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93006232|NCT00773591|Botulinum Toxins|botulinum toxins|mesh-list
93006233|NCT00773591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93006234|NCT00773591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93006235|NCT00773591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006236|NCT00773591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006237|NCT00773591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93006238|NCT00773591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006239|NCT00773591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006240|NCT00773591|Cholinergic Agents|cholinergic agents|mesh-ancestor
93006241|NCT00773591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006242|NCT00995306|Capsaicin|capsaicin|mesh-list
93006243|NCT00995306|Antipruritics|antipruritics|mesh-ancestor
93006244|NCT00995306|Dermatologic Agents|dermatologic agents|mesh-ancestor
93006245|NCT00995306|Sensory System Agents|sensory system agents|mesh-ancestor
93006246|NCT00995306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006247|NCT00995306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006248|NCT00666965|Rotigotine|rotigotine|mesh-list
93006249|NCT00666965|Dopamine Agonists|dopamine agonists|mesh-ancestor
93006250|NCT00666965|Dopamine Agents|dopamine agents|mesh-ancestor
93006251|NCT00666965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006252|NCT00666965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006253|NCT00666965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006254|NCT00781157|Phenylephrine|phenylephrine|mesh-list
93006255|NCT00781157|Oxymetazoline|oxymetazoline|mesh-list
93006256|NCT00781157|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93006257|NCT00781157|Mydriatics|mydriatics|mesh-ancestor
93006258|NCT00781157|Autonomic Agents|autonomic agents|mesh-ancestor
93006259|NCT00781157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006260|NCT00781157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006261|NCT00781157|Sympathomimetics|sympathomimetics|mesh-ancestor
93006262|NCT00781157|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93006263|NCT00781157|Nasal Decongestants|nasal decongestants|mesh-ancestor
93006264|NCT00781157|Respiratory System Agents|respiratory system agents|mesh-ancestor
93006265|NCT00781157|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93006266|NCT00781157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93006267|NCT00781157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93006268|NCT00781157|Adrenergic Agents|adrenergic agents|mesh-ancestor
93006269|NCT00781157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006270|NCT00781157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006271|NCT00781157|Protective Agents|protective agents|mesh-ancestor
93006272|NCT00777959|Sirolimus|sirolimus|mesh-list
93006273|NCT00777959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006274|NCT00777959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006275|NCT00777959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006276|NCT00777959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006277|NCT00777959|Antifungal Agents|antifungal agents|mesh-ancestor
93006278|NCT00777959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006279|NCT00777959|Immunologic Factors|immunologic factors|mesh-ancestor
92168853|NCT03651882|Oxytocics|oxytocics|mesh-ancestor
93006280|NCT00777959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006281|NCT00778037|Cyclobenzaprine|cyclobenzaprine|mesh-list
93006282|NCT00778037|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93006283|NCT00778037|Antidepressive Agents|antidepressive agents|mesh-ancestor
93006284|NCT00778037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006285|NCT00778037|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93006286|NCT00778037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006287|NCT00778037|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93006288|NCT00778037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006289|NCT00778037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93006290|NCT00778037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006291|NCT00778115|Simethicone|simethicone|mesh-list
93006292|NCT00778115|Loperamide|loperamide|mesh-list
93006293|NCT00778115|Antidiarrheals|antidiarrheals|mesh-list
93006294|NCT00778115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006295|NCT00778115|Antifoaming Agents|antifoaming agents|mesh-ancestor
93006296|NCT00778115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006297|NCT00778115|Emollients|emollients|mesh-ancestor
93006298|NCT00778115|Dermatologic Agents|dermatologic agents|mesh-ancestor
93006299|NCT00993122|Ribavirin|ribavirin|mesh-list
93006300|NCT00993122|Antimetabolites|antimetabolites|mesh-ancestor
93006301|NCT00993122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006302|NCT00993122|Antiviral Agents|antiviral agents|mesh-ancestor
93006303|NCT00993122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006304|NCT00778193|Aspirin|aspirin|mesh-list
93006305|NCT00778193|Celecoxib|celecoxib|mesh-list
93006306|NCT00778193|Naproxen|naproxen|mesh-list
93006307|NCT00778193|Clopidogrel|clopidogrel|mesh-list
93006308|NCT00778193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93006309|NCT00778193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93006310|NCT00778193|Analgesics|analgesics|mesh-ancestor
93006311|NCT00778193|Sensory System Agents|sensory system agents|mesh-ancestor
93006312|NCT00778193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006313|NCT00778193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006314|NCT00778193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006315|NCT00778193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006316|NCT00778193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93006317|NCT00778193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93006318|NCT00778193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006319|NCT00778193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93006320|NCT00778193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93006321|NCT00778193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006322|NCT00778193|Antipyretics|antipyretics|mesh-ancestor
93006323|NCT00778193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93006324|NCT00778193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93006325|NCT00778193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93006326|NCT00778193|Purinergic Agents|purinergic agents|mesh-ancestor
93006327|NCT00778193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006328|NCT00778193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93006329|NCT00778193|Gout Suppressants|gout suppressants|mesh-ancestor
93006330|NCT00778271|Gabapentin|gabapentin|mesh-list
93006331|NCT00778271|Analgesics|analgesics|mesh-ancestor
93006332|NCT00778271|Sensory System Agents|sensory system agents|mesh-ancestor
93006333|NCT00778271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006334|NCT00778271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006335|NCT00778271|Anticonvulsants|anticonvulsants|mesh-ancestor
93006336|NCT00778271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93006337|NCT00778271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93006338|NCT00778271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006339|NCT00778271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006340|NCT00778271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93006341|NCT00778271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93006342|NCT00778271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006343|NCT00778271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006344|NCT00778271|Antimanic Agents|antimanic agents|mesh-ancestor
93006345|NCT00778349|Metformin|metformin|mesh-list
93006346|NCT00778349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006347|NCT00778349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006348|NCT00995618|Tranilast|tranilast|mesh-list
93006349|NCT00995618|Febuxostat|febuxostat|mesh-list
93006350|NCT00995618|Gout Suppressants|gout suppressants|mesh-ancestor
93006351|NCT00995618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006352|NCT00995618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93006353|NCT00995618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93006354|NCT00995618|Analgesics|analgesics|mesh-ancestor
93006355|NCT00995618|Sensory System Agents|sensory system agents|mesh-ancestor
93006356|NCT00995618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006357|NCT00995618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006358|NCT00995618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006359|NCT00995618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93006360|NCT00995618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006361|NCT00995618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006362|NCT00995618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93006363|NCT00995618|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93006364|NCT00995618|Histamine Antagonists|histamine antagonists|mesh-ancestor
93006365|NCT00995618|Histamine Agents|histamine agents|mesh-ancestor
93006366|NCT00995618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006367|NCT00995618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93006368|NCT00995618|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93006369|NCT00778427|Metformin|metformin|mesh-list
93006370|NCT00778427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006371|NCT00778427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006372|NCT03889886|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93006373|NCT03889886|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93006374|NCT00667355|Adalimumab|adalimumab|mesh-list
93006375|NCT00667355|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93006376|NCT00667355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006377|NCT00667355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006378|NCT00778505|Remifentanil|remifentanil|mesh-list
93006379|NCT00778505|Propofol|propofol|mesh-list
93006380|NCT00778505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93006381|NCT00778505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006382|NCT00778505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006383|NCT00778505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93006384|NCT00778505|Anesthetics, General|anesthetics, general|mesh-ancestor
93006385|NCT00778505|Anesthetics|anesthetics|mesh-ancestor
93006386|NCT00778505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93006387|NCT00778505|Narcotics|narcotics|mesh-ancestor
93006388|NCT00778505|Analgesics|analgesics|mesh-ancestor
93006389|NCT00778505|Sensory System Agents|sensory system agents|mesh-ancestor
93006390|NCT00778505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006391|NCT00532844|Vitamins|vitamins|mesh-list
93006392|NCT00532844|Ascorbic Acid|ascorbic acid|mesh-list
93006393|NCT00532844|Verapamil|verapamil|mesh-list
93006394|NCT00532844|Micronutrients|micronutrients|mesh-ancestor
93006395|NCT00532844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006396|NCT00532844|Antioxidants|antioxidants|mesh-ancestor
93006397|NCT00532844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006398|NCT00532844|Protective Agents|protective agents|mesh-ancestor
93006399|NCT00532844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93006400|NCT00532844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93006401|NCT00532844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006402|NCT00532844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93006403|NCT00532844|Vasodilator Agents|vasodilator agents|mesh-ancestor
93006404|NCT00778583|Nitrofurantoin|nitrofurantoin|mesh-list
93006405|NCT00778583|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93006406|NCT00778583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006407|NCT00778583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006408|NCT00778661|Amoxicillin|amoxicillin|mesh-list
93006409|NCT00778661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006410|NCT00778661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006411|NCT00993356|Lanreotide|lanreotide|mesh-list
93006412|NCT00993356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006413|NCT00781547|Hormones|hormones|mesh-list
93006414|NCT00781547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93006415|NCT00781547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006416|NCT00778739|Cefprozil|cefprozil|mesh-list
93006417|NCT00778739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006418|NCT00778739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006419|NCT00781625|Methenamine hippurate|methenamine hippurate|mesh-list
93006420|NCT00781625|Methenamine|methenamine|mesh-list
93006421|NCT00781625|Methenamine mandelate|methenamine mandelate|mesh-list
93006422|NCT00781625|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93006423|NCT00781625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006424|NCT00781625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006425|NCT00781781|Alemtuzumab|alemtuzumab|mesh-list
93006426|NCT00781781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006427|NCT00781781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006428|NCT00666263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93006429|NCT00666263|Immunoglobulins|immunoglobulins|mesh-list
93006430|NCT00666263|Antibodies|antibodies|mesh-list
93006431|NCT00666263|gamma-Globulins|gamma-globulins|mesh-list
93006432|NCT00666263|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93006433|NCT00666263|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93006434|NCT00666263|Immunologic Factors|immunologic factors|mesh-ancestor
93006435|NCT00666263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006436|NCT00667277|Bevacizumab|bevacizumab|mesh-list
93006437|NCT00667277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006438|NCT00667277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006439|NCT00667277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93006440|NCT00667277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006441|NCT00667277|Growth Substances|growth substances|mesh-ancestor
93006442|NCT00667277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006443|NCT00667277|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006444|NCT00774527|Cyclophosphamide|cyclophosphamide|mesh-list
93006445|NCT00774527|Fludarabine|fludarabine|mesh-list
93006446|NCT00774527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93006447|NCT00774527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006448|NCT00774527|Immunologic Factors|immunologic factors|mesh-ancestor
93006449|NCT00774527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006450|NCT00774527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006451|NCT00774527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93006452|NCT00774527|Alkylating Agents|alkylating agents|mesh-ancestor
93006453|NCT00774527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006454|NCT00774527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006455|NCT00774527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93006456|NCT00778973|Sertraline|sertraline|mesh-list
93006457|NCT00778973|Antidepressive Agents|antidepressive agents|mesh-ancestor
93006458|NCT00778973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006459|NCT00778973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93006460|NCT00778973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93006461|NCT00778973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006462|NCT00778973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006463|NCT00778973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006464|NCT00778973|Serotonin Agents|serotonin agents|mesh-ancestor
93006465|NCT00778973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006466|NCT00774605|Varenicline|varenicline|mesh-list
93006467|NCT00774605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93006468|NCT00774605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93006469|NCT00774605|Cholinergic Agents|cholinergic agents|mesh-ancestor
93006470|NCT00774605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006471|NCT00774605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006472|NCT00774605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006473|NCT00779051|Zolpidem|zolpidem|mesh-list
93006474|NCT00779051|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93006475|NCT00779051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93006476|NCT00779051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006477|NCT00779051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006478|NCT00779051|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93006479|NCT00779051|GABA Agonists|gaba agonists|mesh-ancestor
93006480|NCT00779051|GABA Agents|gaba agents|mesh-ancestor
93006481|NCT00779051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006482|NCT00779051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006483|NCT00774683|Raltegravir Potassium|raltegravir potassium|mesh-list
93006484|NCT00774683|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93006485|NCT00774683|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93006486|NCT00774683|Antiviral Agents|antiviral agents|mesh-ancestor
93006487|NCT00774683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006488|NCT00774683|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93006489|NCT00774683|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93006490|NCT00774683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006491|NCT00774683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006492|NCT00782093|Volociximab|volociximab|mesh-list
93006493|NCT00782093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93006494|NCT00782093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006495|NCT00782093|Growth Substances|growth substances|mesh-ancestor
92168862|NCT03636932|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93006496|NCT00782093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006497|NCT00782093|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006498|NCT00782093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006500|NCT00784511|Ergocalciferols|ergocalciferols|mesh-list
93006501|NCT00784511|Cholecalciferol|cholecalciferol|mesh-list
93006502|NCT00784511|Vitamins|vitamins|mesh-list
93006503|NCT00784511|Micronutrients|micronutrients|mesh-ancestor
93006504|NCT00784511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006505|NCT00784511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93006506|NCT00784511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93006507|NCT00784589|Rituximab|rituximab|mesh-list
93006508|NCT00784589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006509|NCT00784589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006510|NCT00784589|Immunologic Factors|immunologic factors|mesh-ancestor
93006511|NCT00784589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006512|NCT00784589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006513|NCT00784667|Cetuximab|cetuximab|mesh-list
93006514|NCT00784667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93006515|NCT00784667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006516|NCT00784667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006517|NCT00784667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006518|NCT00784667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006519|NCT00784667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006520|NCT00784745|Dexamethasone|dexamethasone|mesh-list
93006521|NCT00784745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006522|NCT00784745|Antiemetics|antiemetics|mesh-ancestor
93006523|NCT00784745|Autonomic Agents|autonomic agents|mesh-ancestor
93006524|NCT00784745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006525|NCT00784745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006526|NCT00784745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006527|NCT00784745|Glucocorticoids|glucocorticoids|mesh-ancestor
93006528|NCT00784745|Hormones|hormones|mesh-ancestor
93006529|NCT00784745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93006530|NCT00784745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93006531|NCT00784745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006532|NCT00993512|Bleomycin|bleomycin|mesh-list
93006533|NCT00993512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006534|NCT00993512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006535|NCT00662129|Paclitaxel|paclitaxel|mesh-list
93006536|NCT00662129|Bevacizumab|bevacizumab|mesh-list
93006537|NCT00662129|Gemcitabine|gemcitabine|mesh-list
93006538|NCT00662129|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93006539|NCT00662129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93006540|NCT00662129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006541|NCT00662129|Tubulin Modulators|tubulin modulators|mesh-ancestor
93006542|NCT00662129|Antimitotic Agents|antimitotic agents|mesh-ancestor
93006543|NCT00662129|Mitosis Modulators|mitosis modulators|mesh-ancestor
93006544|NCT00662129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006545|NCT00662129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006546|NCT00662129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93006547|NCT00662129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006548|NCT00662129|Growth Substances|growth substances|mesh-ancestor
93006549|NCT00662129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006550|NCT00662129|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006551|NCT00662129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93006552|NCT00662129|Antimetabolites|antimetabolites|mesh-ancestor
93006554|NCT05346224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006555|NCT05346224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006556|NCT00993746|Lidocaine|lidocaine|mesh-list
93006557|NCT00993746|Bupivacaine|bupivacaine|mesh-list
93006558|NCT00993746|Anesthetics, Local|anesthetics, local|mesh-ancestor
93006559|NCT00993746|Anesthetics|anesthetics|mesh-ancestor
93006560|NCT00993746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006561|NCT00993746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006562|NCT00993746|Sensory System Agents|sensory system agents|mesh-ancestor
93006563|NCT00993746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006564|NCT00993746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93006565|NCT00993746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93006566|NCT00993746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93006567|NCT00993746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92168867|NCT03636932|Antidotes|antidotes|mesh-ancestor
93006568|NCT00993746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006569|NCT00789971|Triamcinolone|triamcinolone|mesh-list
93006570|NCT00789971|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93006571|NCT00789971|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93006572|NCT00789971|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93006573|NCT00789971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006574|NCT00789971|Glucocorticoids|glucocorticoids|mesh-ancestor
93006575|NCT00789971|Hormones|hormones|mesh-ancestor
93006576|NCT00789971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93006577|NCT00789971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006578|NCT00789971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006579|NCT00789971|Immunologic Factors|immunologic factors|mesh-ancestor
93006580|NCT00789971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006581|NCT00789971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006582|NCT00782405|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93006584|NCT00782405|Antidepressive Agents|antidepressive agents|mesh-ancestor
93006585|NCT00782405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006586|NCT00782405|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93006587|NCT00782405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93006588|NCT00782405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006589|NCT00782405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006590|NCT00782405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93006591|NCT00782405|Histamine Antagonists|histamine antagonists|mesh-ancestor
93006592|NCT00782405|Histamine Agents|histamine agents|mesh-ancestor
93006593|NCT00782405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006594|NCT00782405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006595|NCT00782405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93006596|NCT00782405|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93006597|NCT00782405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93006598|NCT00782405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93006599|NCT00782405|Adrenergic Agents|adrenergic agents|mesh-ancestor
93006600|NCT00782405|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93006601|NCT00782405|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93006602|NCT00782405|Serotonin Agents|serotonin agents|mesh-ancestor
93006603|NCT00782405|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93006604|NCT05343260|Propofol|propofol|mesh-list
93006605|NCT05343260|Sevoflurane|sevoflurane|mesh-list
93006606|NCT05343260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93006607|NCT05343260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006608|NCT05343260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006609|NCT05343260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93006610|NCT05343260|Anesthetics, General|anesthetics, general|mesh-ancestor
93006611|NCT05343260|Anesthetics|anesthetics|mesh-ancestor
93006612|NCT05343260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93006613|NCT05343260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93006614|NCT00664859|Atorvastatin|atorvastatin|mesh-list
93006615|NCT00664859|Fenofibrate|fenofibrate|mesh-list
93006616|NCT00664859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93006617|NCT00664859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93006618|NCT00664859|Antimetabolites|antimetabolites|mesh-ancestor
93006619|NCT00664859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006620|NCT00664859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93006621|NCT00664859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93006622|NCT00664859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006623|NCT00996788|Rebamipide|rebamipide|mesh-list
93006624|NCT00996788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93006625|NCT00996788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006626|NCT00996788|Antioxidants|antioxidants|mesh-ancestor
93006627|NCT00996788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006628|NCT00996788|Protective Agents|protective agents|mesh-ancestor
93006629|NCT00996788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006630|NCT00996788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006631|NCT01564550|Insulin|insulin|mesh-list
93006632|NCT01564550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93006633|NCT01564550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93006634|NCT01564550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006635|NCT00790439|Cyclosporine|cyclosporine|mesh-list
93006636|NCT00790439|Sirolimus|sirolimus|mesh-list
93006637|NCT00790439|Mycophenolic Acid|mycophenolic acid|mesh-list
93006638|NCT00790439|Heparin|heparin|mesh-list
93006639|NCT00790439|Calcium heparin|calcium heparin|mesh-list
93006640|NCT00790439|Dextrans|dextrans|mesh-list
93006641|NCT00790439|Tacrolimus|tacrolimus|mesh-list
93006642|NCT00790439|Cyclosporins|cyclosporins|mesh-list
93006643|NCT00790439|Basiliximab|basiliximab|mesh-list
93006644|NCT00790439|Daclizumab|daclizumab|mesh-list
93006645|NCT00790439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006646|NCT00790439|Immunologic Factors|immunologic factors|mesh-ancestor
93006647|NCT00790439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006648|NCT00790439|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93006649|NCT00790439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006650|NCT00790439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651989|NCT00259896|Exenatide|exenatide|mesh-list
93006651|NCT00790439|Antifungal Agents|antifungal agents|mesh-ancestor
93006652|NCT00790439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006653|NCT00790439|Dermatologic Agents|dermatologic agents|mesh-ancestor
93006654|NCT00790439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006655|NCT00790439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006656|NCT00790439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006657|NCT00790439|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93006658|NCT00790439|Antitubercular Agents|antitubercular agents|mesh-ancestor
93006659|NCT00790439|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006660|NCT00790439|Anticoagulants|anticoagulants|mesh-ancestor
93006661|NCT00790439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93006662|NCT00790439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93006663|NCT00790439|Plasma Substitutes|plasma substitutes|mesh-ancestor
93006664|NCT00790439|Blood Substitutes|blood substitutes|mesh-ancestor
93006665|NCT00785603|Tramadol|tramadol|mesh-list
93006666|NCT00785603|Paroxetine|paroxetine|mesh-list
93006667|NCT00785603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93006668|NCT00785603|Narcotics|narcotics|mesh-ancestor
93006669|NCT00785603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006670|NCT00785603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006671|NCT00785603|Analgesics|analgesics|mesh-ancestor
93006672|NCT00785603|Sensory System Agents|sensory system agents|mesh-ancestor
93006673|NCT00785603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006674|NCT00785603|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93006675|NCT00785603|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93006676|NCT00785603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006677|NCT00785603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006678|NCT00785603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006679|NCT00785603|Serotonin Agents|serotonin agents|mesh-ancestor
93006680|NCT00785603|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93006681|NCT00785603|Antidepressive Agents|antidepressive agents|mesh-ancestor
93006682|NCT00785603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006683|NCT00785603|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93006684|NCT00785603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93006685|NCT00785603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006686|NCT00570401|Dasatinib|dasatinib|mesh-list
93006687|NCT00570401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006688|NCT00570401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006689|NCT00570401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006690|NCT00570401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006691|NCT00532298|Vaccines|vaccines|mesh-list
93006692|NCT00532298|Immunologic Factors|immunologic factors|mesh-ancestor
93006693|NCT00532298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006694|NCT04047017|Apatinib|apatinib|mesh-list
93006695|NCT04047017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006696|NCT04047017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006697|NCT04047017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006698|NCT04047017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006699|NCT00997022|Sorafenib|sorafenib|mesh-list
93006700|NCT00997022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006701|NCT00997022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006702|NCT00997022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006703|NCT00997022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006705|NCT00786149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93006706|NCT00786149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93006707|NCT00786149|Cholinergic Agents|cholinergic agents|mesh-ancestor
93006708|NCT00786149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006709|NCT00786149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006710|NCT00786149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006711|NCT00410410|Abatacept|abatacept|mesh-list
93006712|NCT00410410|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168874|NCT05910476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93006713|NCT00410410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006714|NCT00410410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006715|NCT00410410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006716|NCT00410410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006717|NCT00410410|Immunologic Factors|immunologic factors|mesh-ancestor
93006718|NCT00410410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006719|NCT00410410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006720|NCT00782951|Morphine|morphine|mesh-list
93006721|NCT00782951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93006722|NCT00782951|Narcotics|narcotics|mesh-ancestor
93006723|NCT00782951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652057|NCT00232895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006724|NCT00782951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006725|NCT00782951|Analgesics|analgesics|mesh-ancestor
93006726|NCT00782951|Sensory System Agents|sensory system agents|mesh-ancestor
93006727|NCT00782951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006728|NCT02555813|Paclitaxel|paclitaxel|mesh-list
93006729|NCT02555813|Gemcitabine|gemcitabine|mesh-list
93006730|NCT02555813|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93006731|NCT02555813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93006732|NCT02555813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006733|NCT02555813|Tubulin Modulators|tubulin modulators|mesh-ancestor
93006734|NCT02555813|Antimitotic Agents|antimitotic agents|mesh-ancestor
93006735|NCT02555813|Mitosis Modulators|mitosis modulators|mesh-ancestor
93006736|NCT02555813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006737|NCT02555813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93006738|NCT02555813|Antimetabolites|antimetabolites|mesh-ancestor
93006739|NCT00997412|Mycophenolic Acid|mycophenolic acid|mesh-list
93006740|NCT00997412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006741|NCT00997412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006742|NCT00997412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93006743|NCT00997412|Antitubercular Agents|antitubercular agents|mesh-ancestor
93006744|NCT00997412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006745|NCT00997412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006746|NCT00997412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006747|NCT00997412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006748|NCT00783107|Cyclosporine|cyclosporine|mesh-list
93006749|NCT00783107|Cyclosporins|cyclosporins|mesh-list
93006750|NCT00783107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006751|NCT00783107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006752|NCT00783107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006753|NCT00783107|Immunologic Factors|immunologic factors|mesh-ancestor
93006754|NCT00783107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006755|NCT00783107|Antifungal Agents|antifungal agents|mesh-ancestor
93006756|NCT00783107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006757|NCT00783107|Dermatologic Agents|dermatologic agents|mesh-ancestor
93006758|NCT00783107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006759|NCT00783107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93006760|NCT00534404|Nicotine|nicotine|mesh-list
93006761|NCT00534404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93006762|NCT00534404|Autonomic Agents|autonomic agents|mesh-ancestor
93006763|NCT00534404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006764|NCT00534404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006765|NCT00534404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93006766|NCT00534404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93006767|NCT00534404|Cholinergic Agents|cholinergic agents|mesh-ancestor
93006768|NCT00534404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006769|NCT00534404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006770|NCT00393094|Bevacizumab|bevacizumab|mesh-list
93006771|NCT00393094|Irinotecan|irinotecan|mesh-list
93006772|NCT00393094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93006773|NCT00393094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006774|NCT00393094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92528523|NCT00000794|Vitamin B Complex|vitamin b complex|mesh-ancestor
93006775|NCT00393094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006776|NCT00393094|Growth Substances|growth substances|mesh-ancestor
93006777|NCT00393094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006778|NCT00393094|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006779|NCT00393094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93006780|NCT00393094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93006781|NCT00393094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006782|NCT00393094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006783|NCT00783653|Sunitinib|sunitinib|mesh-list
93006784|NCT00783653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006785|NCT00783653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93006786|NCT00783653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006787|NCT00783653|Growth Substances|growth substances|mesh-ancestor
93006788|NCT00783653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006789|NCT00783653|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006790|NCT00783653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006791|NCT00783653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006792|NCT00783653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006793|NCT00786305|Amikacin|amikacin|mesh-list
93006794|NCT00786305|Ceftazidime|ceftazidime|mesh-list
93006795|NCT00786305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006796|NCT00786305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006797|NCT01044004|Modafinil|modafinil|mesh-list
93006798|NCT01044004|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93006799|NCT01044004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006800|NCT01044004|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93006801|NCT01044004|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93006802|NCT01044004|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93006803|NCT01044004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006805|NCT00786383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006806|NCT00790595|Sunitinib|sunitinib|mesh-list
93006807|NCT00790595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006808|NCT00790595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93006809|NCT00790595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93006810|NCT00790595|Growth Substances|growth substances|mesh-ancestor
93006811|NCT00790595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006812|NCT00790595|Growth Inhibitors|growth inhibitors|mesh-ancestor
93006813|NCT00790595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006814|NCT00790595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006815|NCT00790595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006816|NCT00783731|Midazolam|midazolam|mesh-list
93006817|NCT00783731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93006818|NCT00783731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93006819|NCT00783731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006820|NCT00783731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006821|NCT00783731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93006822|NCT00783731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93006823|NCT00783731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006824|NCT00783731|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93006825|NCT00783731|Anesthetics, General|anesthetics, general|mesh-ancestor
93006826|NCT00783731|Anesthetics|anesthetics|mesh-ancestor
93006827|NCT00783731|GABA Modulators|gaba modulators|mesh-ancestor
93006828|NCT00783731|GABA Agents|gaba agents|mesh-ancestor
93006829|NCT00783731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006830|NCT00783731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006831|NCT00409708|Methylphenidate|methylphenidate|mesh-list
93006832|NCT00409708|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93006833|NCT00409708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006834|NCT00409708|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93006835|NCT00409708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93006836|NCT00409708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006837|NCT00409708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006838|NCT00409708|Dopamine Agents|dopamine agents|mesh-ancestor
93006839|NCT00409708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006840|NCT00790985|Naproxen|naproxen|mesh-list
93006841|NCT00790985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93006842|NCT00790985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93006843|NCT00790985|Analgesics|analgesics|mesh-ancestor
93006844|NCT00790985|Sensory System Agents|sensory system agents|mesh-ancestor
93006845|NCT00790985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006846|NCT00790985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528524|NCT00000794|Vitamins|vitamins|mesh-ancestor
93006847|NCT00790985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93006848|NCT00790985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93006849|NCT00790985|Gout Suppressants|gout suppressants|mesh-ancestor
93006850|NCT00790985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93006851|NCT00790985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006852|NCT00790985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006853|NCT01324336|Mercaptopurine|mercaptopurine|mesh-list
93006854|NCT01324336|Antimetabolites|antimetabolites|mesh-ancestor
93006855|NCT01324336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006856|NCT01324336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93006857|NCT01324336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006858|NCT01324336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006859|NCT01324336|Immunologic Factors|immunologic factors|mesh-ancestor
93006860|NCT01324336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006861|NCT01324336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93006862|NCT01324336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006863|NCT01324492|Everolimus|everolimus|mesh-list
93006864|NCT01324492|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93006865|NCT01324492|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006866|NCT01324492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006867|NCT01324492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006868|NCT01324492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006869|NCT01324492|Immunologic Factors|immunologic factors|mesh-ancestor
92652207|NCT00233558|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93006870|NCT01324492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006871|NCT01324492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006873|NCT01039948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006874|NCT01039948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006875|NCT01039948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006876|NCT01039948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006877|NCT00391846|Metoprolol|metoprolol|mesh-list
93006878|NCT00391846|Valsartan|valsartan|mesh-list
93006879|NCT00391846|Carvedilol|carvedilol|mesh-list
93006880|NCT00391846|Candesartan|candesartan|mesh-list
93006881|NCT00391846|Ramipril|ramipril|mesh-list
93006882|NCT00391846|Enalapril|enalapril|mesh-list
93006883|NCT00391846|Lisinopril|lisinopril|mesh-list
93006884|NCT00391846|Eplerenone|eplerenone|mesh-list
93006885|NCT00391846|Bisoprolol|bisoprolol|mesh-list
93006886|NCT00391846|Captopril|captopril|mesh-list
93006887|NCT00391846|Trandolapril|trandolapril|mesh-list
93006888|NCT00391846|Spironolactone|spironolactone|mesh-list
93006889|NCT00391846|Diuretics|diuretics|mesh-list
93006890|NCT00391846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93006891|NCT00391846|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93006892|NCT00391846|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93006893|NCT00391846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006894|NCT00391846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93006895|NCT00391846|Sympatholytics|sympatholytics|mesh-ancestor
93006896|NCT00391846|Autonomic Agents|autonomic agents|mesh-ancestor
93006897|NCT00391846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006898|NCT00391846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006899|NCT00391846|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93006900|NCT00391846|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93006901|NCT00391846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93006902|NCT00391846|Adrenergic Agents|adrenergic agents|mesh-ancestor
93006903|NCT00391846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006904|NCT00391846|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93006905|NCT00391846|Hormone Antagonists|hormone antagonists|mesh-ancestor
93006906|NCT00391846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93006907|NCT00391846|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93006908|NCT00391846|Natriuretic Agents|natriuretic agents|mesh-ancestor
93006909|NCT00391846|Antioxidants|antioxidants|mesh-ancestor
93006910|NCT00391846|Protective Agents|protective agents|mesh-ancestor
93006911|NCT00391846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93006912|NCT00391846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006913|NCT00391846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93006914|NCT00391846|Vasodilator Agents|vasodilator agents|mesh-ancestor
93006915|NCT00391846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93006916|NCT00391846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93006917|NCT00391846|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93006918|NCT00391846|Protease Inhibitors|protease inhibitors|mesh-ancestor
93006919|NCT00391846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006920|NCT00391846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93006921|NCT00391768|Oseltamivir|oseltamivir|mesh-list
93006922|NCT00391768|Antiviral Agents|antiviral agents|mesh-ancestor
93006923|NCT00391768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006924|NCT00391768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006925|NCT00391768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006926|NCT00391222|Olanzapine|olanzapine|mesh-list
93006927|NCT00391222|Risperidone|risperidone|mesh-list
93006928|NCT00391222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93006929|NCT00391222|Serotonin Agents|serotonin agents|mesh-ancestor
93006930|NCT00391222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93006931|NCT00391222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006932|NCT00391222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006933|NCT00391222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93006934|NCT00391222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93006935|NCT00391222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93006936|NCT00391222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93006937|NCT00391222|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93006938|NCT00391222|Dopamine Agents|dopamine agents|mesh-ancestor
93006939|NCT00391222|Antiemetics|antiemetics|mesh-ancestor
93006940|NCT00391222|Autonomic Agents|autonomic agents|mesh-ancestor
93006941|NCT00391222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93006942|NCT00391222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93006943|NCT00391222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92652295|NCT00233792|Sirolimus|sirolimus|mesh-list
93006944|NCT00391222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93006945|NCT00391222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93006946|NCT00409006|Pemetrexed|pemetrexed|mesh-list
93006947|NCT00409006|Gefitinib|gefitinib|mesh-list
93006948|NCT00409006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006949|NCT00409006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006950|NCT00409006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006951|NCT00409006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93006952|NCT00409006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93006953|NCT00409006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006954|NCT00997880|Calcium, Dietary|calcium, dietary|mesh-list
93006955|NCT00997880|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93006956|NCT00997880|Calcium|calcium|mesh-list
93006957|NCT00997880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93006958|NCT00997880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006959|NCT00997880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93006960|NCT00997880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93006961|NCT00997880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93006962|NCT00997880|Antimetabolites|antimetabolites|mesh-ancestor
93006963|NCT00997880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006964|NCT00997880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93006965|NCT00997880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93006966|NCT00997880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006967|NCT00408928|Bortezomib|bortezomib|mesh-list
93006968|NCT00408928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006969|NCT00997958|Mycophenolic Acid|mycophenolic acid|mesh-list
93006970|NCT00997958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006971|NCT00997958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006972|NCT00997958|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93006973|NCT00997958|Antitubercular Agents|antitubercular agents|mesh-ancestor
93006974|NCT00997958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006975|NCT00997958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006976|NCT00997958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006977|NCT00997958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006978|NCT00998036|Sirolimus|sirolimus|mesh-list
93006979|NCT00998036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93006980|NCT00998036|Temsirolimus|temsirolimus|mesh-list
93006981|NCT00998036|MTOR Inhibitors|mtor inhibitors|mesh-list
93006982|NCT00998036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93006983|NCT00998036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93006984|NCT00998036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93006985|NCT00998036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93006986|NCT00998036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93006987|NCT00998036|Immunologic Factors|immunologic factors|mesh-ancestor
93006988|NCT00998036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93006989|NCT00998036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006990|NCT00998036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006991|NCT00998036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93006992|NCT00998036|Antifungal Agents|antifungal agents|mesh-ancestor
93006993|NCT05254808|Fosfomycin|fosfomycin|mesh-list
93006994|NCT05254808|Nitrofurantoin|nitrofurantoin|mesh-list
93006995|NCT05254808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93006996|NCT05254808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93006997|NCT05254808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93006998|NCT02275286|Trabectedin|trabectedin|mesh-list
93006999|NCT02275286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007000|NCT02275286|Alkylating Agents|alkylating agents|mesh-ancestor
93007001|NCT02275286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007002|NCT02275286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007003|NCT00998192|Paclitaxel|paclitaxel|mesh-list
93007004|NCT00998192|Carboplatin|carboplatin|mesh-list
93007005|NCT00998192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93007006|NCT00998192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007007|NCT00998192|Tubulin Modulators|tubulin modulators|mesh-ancestor
93007008|NCT00998192|Antimitotic Agents|antimitotic agents|mesh-ancestor
93007009|NCT00998192|Mitosis Modulators|mitosis modulators|mesh-ancestor
93007010|NCT00998192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007011|NCT00994526|Vitamin E|vitamin e|mesh-list
93007012|NCT00994526|Calcium|calcium|mesh-list
93007013|NCT00994526|Vitamins|vitamins|mesh-ancestor
93007014|NCT00994526|Micronutrients|micronutrients|mesh-ancestor
93007015|NCT00994526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007016|NCT00994526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93007017|NCT00994526|Antioxidants|antioxidants|mesh-ancestor
93007018|NCT00994526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007019|NCT00994526|Protective Agents|protective agents|mesh-ancestor
93007020|NCT00998504|Resveratrol|resveratrol|mesh-list
93007021|NCT00998504|Antioxidants|antioxidants|mesh-ancestor
93007022|NCT00998504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007023|NCT00998504|Protective Agents|protective agents|mesh-ancestor
93007024|NCT00998504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007025|NCT00998504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007026|NCT00998504|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93007027|NCT00788684|Rituximab|rituximab|mesh-list
93007028|NCT00788684|Navitoclax|navitoclax|mesh-list
93007029|NCT00788684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007030|NCT00788684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007031|NCT00788684|Immunologic Factors|immunologic factors|mesh-ancestor
93007032|NCT00788684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007033|NCT00788684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007034|NCT00998972|Acetylcysteine|acetylcysteine|mesh-list
93007035|NCT00998972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93007036|NCT00998972|Antiviral Agents|antiviral agents|mesh-ancestor
93007037|NCT00998972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007038|NCT00998972|Expectorants|expectorants|mesh-ancestor
93007039|NCT00998972|Respiratory System Agents|respiratory system agents|mesh-ancestor
93007040|NCT00998972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93007041|NCT00998972|Antioxidants|antioxidants|mesh-ancestor
93007042|NCT00998972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007043|NCT00998972|Protective Agents|protective agents|mesh-ancestor
93007044|NCT00998972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007045|NCT00998972|Antidotes|antidotes|mesh-ancestor
93007046|NCT00390910|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93007047|NCT00390910|Immunologic Factors|immunologic factors|mesh-ancestor
93007048|NCT00390910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007049|NCT00998816|Pregabalin|pregabalin|mesh-list
93007050|NCT00998816|Analgesics|analgesics|mesh-ancestor
93007051|NCT00998816|Sensory System Agents|sensory system agents|mesh-ancestor
93007052|NCT00998816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007053|NCT00998816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007054|NCT00998816|Anticonvulsants|anticonvulsants|mesh-ancestor
93007055|NCT00998816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93007056|NCT00998816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007057|NCT00998816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007058|NCT00998816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93007059|NCT00998816|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93007060|NCT00998816|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93007061|NCT00998816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007062|NCT00998816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007063|NCT00533702|Dacarbazine|dacarbazine|mesh-list
93007064|NCT00533702|Ramucirumab|ramucirumab|mesh-list
93007065|NCT00533702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93007066|NCT00533702|Imidazole|imidazole|mesh-list
93007067|NCT00533702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007068|NCT00533702|Alkylating Agents|alkylating agents|mesh-ancestor
92168886|NCT05910125|Aspirin|aspirin|mesh-list
93007069|NCT00533702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007070|NCT00533702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007071|NCT00533702|Immunologic Factors|immunologic factors|mesh-ancestor
93007072|NCT00533702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007073|NCT00533702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007074|NCT00408694|Bevacizumab|bevacizumab|mesh-list
93007075|NCT00408694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93007076|NCT00408694|Cisplatin|cisplatin|mesh-list
93007077|NCT00408694|Fluorouracil|fluorouracil|mesh-list
93007078|NCT00408694|Endothelial Growth Factors|endothelial growth factors|mesh-list
93007079|NCT00408694|Antibodies|antibodies|mesh-list
93007080|NCT00408694|Immunoglobulins|immunoglobulins|mesh-list
93007081|NCT00408694|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93007082|NCT00408694|Immunoglobulin G|immunoglobulin g|mesh-list
93007083|NCT00408694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007084|NCT00408694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93007085|NCT00408694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93007086|NCT00408694|Growth Substances|growth substances|mesh-ancestor
93007087|NCT00408694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007088|NCT00408694|Growth Inhibitors|growth inhibitors|mesh-ancestor
93007089|NCT00408694|Immunologic Factors|immunologic factors|mesh-ancestor
93007090|NCT00408694|Antimetabolites|antimetabolites|mesh-ancestor
93007091|NCT00408694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007092|NCT00408694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93007093|NCT00408694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93007094|NCT00999128|Rabeprazole|rabeprazole|mesh-list
93007095|NCT00999128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93007096|NCT00999128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007097|NCT00999128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93007098|NCT00999128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007099|NCT00999128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007101|NCT00999206|Immunologic Factors|immunologic factors|mesh-ancestor
93007102|NCT00999206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007103|NCT01043224|Clobetasol|clobetasol|mesh-list
93007104|NCT01043224|Calcipotriene|calcipotriene|mesh-list
93007105|NCT01043224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007106|NCT01043224|Glucocorticoids|glucocorticoids|mesh-ancestor
93007107|NCT01043224|Hormones|hormones|mesh-ancestor
93007108|NCT01043224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007109|NCT01043224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007110|NCT01043224|Dermatologic Agents|dermatologic agents|mesh-ancestor
93007111|NCT01044238|Methylphenidate|methylphenidate|mesh-list
93007112|NCT01044238|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93007113|NCT01044238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007114|NCT01044238|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93007115|NCT01044238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93007116|NCT01044238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007117|NCT01044238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007118|NCT01044238|Dopamine Agents|dopamine agents|mesh-ancestor
93007119|NCT01044238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007120|NCT01043380|Atorvastatin|atorvastatin|mesh-list
93007121|NCT01043380|Ezetimibe|ezetimibe|mesh-list
93007122|NCT01043380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93007123|NCT01043380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93007124|NCT01043380|Antimetabolites|antimetabolites|mesh-ancestor
93007125|NCT01043380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007126|NCT01043380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168888|NCT05910125|Clopidogrel|clopidogrel|mesh-list
93007127|NCT01043380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93007128|NCT01043380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007129|NCT01044394|Bisacodyl|bisacodyl|mesh-list
93007130|NCT01044394|Cathartics|cathartics|mesh-ancestor
93007131|NCT01044394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007132|NCT01044394|Laxatives|laxatives|mesh-ancestor
93007133|NCT03474094|Atezolizumab|atezolizumab|mesh-list
93007134|NCT03474094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93007135|NCT03474094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93007136|NCT03474094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007137|NCT03474094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007138|NCT03474094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007139|NCT03474094|Immunologic Factors|immunologic factors|mesh-ancestor
93007140|NCT03474094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007141|NCT01043536|Temozolomide|temozolomide|mesh-list
93007142|NCT01043536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007143|NCT01043536|Alkylating Agents|alkylating agents|mesh-ancestor
93007144|NCT01043536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007145|NCT01043536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007146|NCT01004198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93007147|NCT00056407|Dutasteride|dutasteride|mesh-list
93007148|NCT00056407|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93007149|NCT00056407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93007150|NCT00056407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007151|NCT00056407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007152|NCT00056407|Hormone Antagonists|hormone antagonists|mesh-ancestor
93007153|NCT00056407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007154|NCT00056407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007155|NCT00387790|Motexafin gadolinium|motexafin gadolinium|mesh-list
93007156|NCT00387790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007157|NCT00387790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93007158|NCT00387790|Dermatologic Agents|dermatologic agents|mesh-ancestor
93007159|NCT00073021|Mesalamine|mesalamine|mesh-list
93007160|NCT00073021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93007161|NCT00073021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93007162|NCT00073021|Analgesics|analgesics|mesh-ancestor
93007163|NCT00073021|Sensory System Agents|sensory system agents|mesh-ancestor
93007164|NCT00073021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007165|NCT00073021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007166|NCT00073021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007167|NCT00073021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007168|NCT01584115|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
93007169|NCT01584115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93007170|NCT01584115|Immunologic Factors|immunologic factors|mesh-ancestor
93007171|NCT01584115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007172|NCT00395746|Liraglutide|liraglutide|mesh-list
93007173|NCT00395746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93007174|NCT00395746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007175|NCT00395746|Incretins|incretins|mesh-ancestor
93007176|NCT00395746|Hormones|hormones|mesh-ancestor
93007177|NCT00395746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007178|NCT01004900|Timolol|timolol|mesh-list
93007179|NCT01004900|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93007180|NCT01004900|Travoprost|travoprost|mesh-list
93007181|NCT01004900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93007182|NCT01004900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93007183|NCT01004900|Adrenergic Agents|adrenergic agents|mesh-ancestor
93007184|NCT01004900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007185|NCT01004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007186|NCT01004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007187|NCT01004900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93007188|NCT01004900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93007189|NCT01004900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93007190|NCT01004900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93007191|NCT01004900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93007192|NCT04001348|Diazepam|diazepam|mesh-list
93007193|NCT04001348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93007194|NCT04001348|Anticonvulsants|anticonvulsants|mesh-ancestor
93007195|NCT04001348|Antiemetics|antiemetics|mesh-ancestor
93007196|NCT04001348|Autonomic Agents|autonomic agents|mesh-ancestor
93007197|NCT04001348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007198|NCT04001348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007199|NCT04001348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007200|NCT04001348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93007201|NCT04001348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007202|NCT04001348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93007203|NCT04001348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93007204|NCT04001348|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93007205|NCT04001348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93007206|NCT04001348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007207|NCT04001348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93007208|NCT04001348|Anesthetics, General|anesthetics, general|mesh-ancestor
93007209|NCT04001348|Anesthetics|anesthetics|mesh-ancestor
93007210|NCT04001348|GABA Modulators|gaba modulators|mesh-ancestor
93007211|NCT04001348|GABA Agents|gaba agents|mesh-ancestor
93007212|NCT04001348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007213|NCT04001348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007214|NCT00395512|Pioglitazone|pioglitazone|mesh-list
93007215|NCT00395512|Alogliptin|alogliptin|mesh-list
93007216|NCT00395512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93007217|NCT00395512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007218|NCT00395512|Incretins|incretins|mesh-ancestor
93007219|NCT00395512|Hormones|hormones|mesh-ancestor
93007220|NCT00395512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007221|NCT00395512|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93007222|NCT00395512|Protease Inhibitors|protease inhibitors|mesh-ancestor
93007223|NCT00395512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007224|NCT00395512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007225|NCT03956017|Ubiquinone|ubiquinone|mesh-list
93007226|NCT03956017|Coenzyme Q10|coenzyme q10|mesh-list
93007227|NCT03956017|Micronutrients|micronutrients|mesh-ancestor
93007228|NCT03956017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007229|NCT03956017|Vitamins|vitamins|mesh-ancestor
93007230|NCT00994916|Amifampridine|amifampridine|mesh-list
93007231|NCT00994916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93007232|NCT00994916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007233|NCT00994916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007234|NCT00994916|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93007235|NCT00994916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007236|NCT00994916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007237|NCT00999440|Methadone|methadone|mesh-list
93007238|NCT00999440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93007239|NCT00999440|Narcotics|narcotics|mesh-ancestor
93007240|NCT00999440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007241|NCT00999440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007242|NCT00999440|Analgesics|analgesics|mesh-ancestor
93007243|NCT00999440|Sensory System Agents|sensory system agents|mesh-ancestor
93007244|NCT00999440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007245|NCT00999440|Antitussive Agents|antitussive agents|mesh-ancestor
93007246|NCT00999440|Respiratory System Agents|respiratory system agents|mesh-ancestor
93007247|NCT00054691|Gefitinib|gefitinib|mesh-list
93007248|NCT00054691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007249|NCT00054691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007250|NCT00054691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007251|NCT00054691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007252|NCT02530879|Esomeprazole|esomeprazole|mesh-list
93007253|NCT02530879|Omeprazole|omeprazole|mesh-list
93007254|NCT02530879|Lansoprazole|lansoprazole|mesh-list
93007255|NCT02530879|Dexlansoprazole|dexlansoprazole|mesh-list
93007256|NCT02530879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93007257|NCT02530879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007258|NCT02530879|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93007259|NCT02530879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007260|NCT02530879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007261|NCT03957499|Dexamethasone|dexamethasone|mesh-list
93007262|NCT03957499|Magnesium Sulfate|magnesium sulfate|mesh-list
93007263|NCT03957499|Bupivacaine|bupivacaine|mesh-list
93007264|NCT03957499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007265|NCT03957499|Antiemetics|antiemetics|mesh-ancestor
93007266|NCT03957499|Autonomic Agents|autonomic agents|mesh-ancestor
93007267|NCT03957499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007268|NCT03957499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007269|NCT03957499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007270|NCT03957499|Glucocorticoids|glucocorticoids|mesh-ancestor
93007271|NCT03957499|Hormones|hormones|mesh-ancestor
93007272|NCT03957499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007273|NCT03957499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007274|NCT03957499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007275|NCT03957499|Anesthetics, Local|anesthetics, local|mesh-ancestor
93007276|NCT03957499|Anesthetics|anesthetics|mesh-ancestor
93007277|NCT03957499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007278|NCT03957499|Sensory System Agents|sensory system agents|mesh-ancestor
93007279|NCT03957499|Analgesics|analgesics|mesh-ancestor
93007280|NCT03957499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93007281|NCT03957499|Anticonvulsants|anticonvulsants|mesh-ancestor
93007282|NCT03957499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93007283|NCT03957499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007284|NCT03957499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007285|NCT03957499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93007286|NCT03957499|Tocolytic Agents|tocolytic agents|mesh-ancestor
93007287|NCT03957499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93007288|NCT01040338|Nicotine|nicotine|mesh-list
93007289|NCT01040338|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93007290|NCT01040338|Autonomic Agents|autonomic agents|mesh-ancestor
93007291|NCT01040338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007292|NCT01040338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007293|NCT01040338|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93007294|NCT01040338|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93007295|NCT01040338|Cholinergic Agents|cholinergic agents|mesh-ancestor
93007296|NCT01040338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007297|NCT01040338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007299|NCT00066703|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93007300|NCT00066703|Exemestane|exemestane|mesh-list
93007301|NCT00066703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93007302|NCT00066703|Hormone Antagonists|hormone antagonists|mesh-ancestor
93007303|NCT00066703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007304|NCT00066703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007305|NCT00066703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007306|NCT00066703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007307|NCT00066703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93007308|NCT00066703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93007309|NCT00066703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93007310|NCT00066703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93007311|NCT00066703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93007312|NCT00066703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007313|NCT00066703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007314|NCT00066703|Luteolytic Agents|luteolytic agents|mesh-ancestor
93007315|NCT00066703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93007316|NCT00066703|Contraceptive Agents|contraceptive agents|mesh-ancestor
93007317|NCT00066703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93007318|NCT00066703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93007319|NCT03955939|Midazolam|midazolam|mesh-list
93007320|NCT03955939|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93007321|NCT03955939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93007322|NCT03955939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007323|NCT03955939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007324|NCT03955939|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93007325|NCT03955939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93007326|NCT03955939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007327|NCT03955939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93007328|NCT03955939|Anesthetics, General|anesthetics, general|mesh-ancestor
93007329|NCT03955939|Anesthetics|anesthetics|mesh-ancestor
93007330|NCT03955939|GABA Modulators|gaba modulators|mesh-ancestor
93007331|NCT03955939|GABA Agents|gaba agents|mesh-ancestor
93007332|NCT03955939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007333|NCT03955939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007334|NCT01094821|ATI 7505|ati 7505|mesh-list
93007335|NCT01094821|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93007336|NCT01094821|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93007337|NCT01094821|Serotonin Agents|serotonin agents|mesh-ancestor
93007338|NCT01094821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007339|NCT01094821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007340|NCT01094821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007341|NCT00072475|Vatalanib|vatalanib|mesh-list
93007342|NCT00072475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007343|NCT00072475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007344|NCT00072475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007345|NCT01091701|Plasma-lyte 148|plasma-lyte 148|mesh-list
93007346|NCT01091701|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93007347|NCT01091701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93007348|NCT00066469|Prednisone|prednisone|mesh-list
93007349|NCT00066469|Methylprednisolone|methylprednisolone|mesh-list
93007350|NCT00066469|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93007351|NCT00066469|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93007352|NCT00066469|Prednisolone|prednisolone|mesh-list
93007353|NCT00066469|Prednisolone acetate|prednisolone acetate|mesh-list
93007354|NCT00066469|Cyclophosphamide|cyclophosphamide|mesh-list
93007355|NCT00066469|Rituximab|rituximab|mesh-list
93007356|NCT00066469|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93007357|NCT00066469|Prednisolone phosphate|prednisolone phosphate|mesh-list
93007358|NCT00066469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93007359|NCT00066469|Immunologic Factors|immunologic factors|mesh-ancestor
93007360|NCT00066469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007361|NCT00066469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007362|NCT00066469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007363|NCT00066469|Alkylating Agents|alkylating agents|mesh-ancestor
93007364|NCT00066469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007365|NCT00066469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007366|NCT00066469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93007367|NCT00066469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007368|NCT00066469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007369|NCT00066469|Glucocorticoids|glucocorticoids|mesh-ancestor
93007370|NCT00066469|Hormones|hormones|mesh-ancestor
93007371|NCT00066469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007372|NCT00066469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007373|NCT00066469|Antiemetics|antiemetics|mesh-ancestor
93007374|NCT00066469|Autonomic Agents|autonomic agents|mesh-ancestor
93007375|NCT00066469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007376|NCT00066469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007377|NCT00066469|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93007378|NCT00066469|Protective Agents|protective agents|mesh-ancestor
93007379|NCT01094977|Tranexamic Acid|tranexamic acid|mesh-list
93007380|NCT01094977|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93007381|NCT01094977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93007382|NCT01094977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007383|NCT01094977|Hemostatics|hemostatics|mesh-ancestor
93007384|NCT01094977|Coagulants|coagulants|mesh-ancestor
93007385|NCT01095133|Amiloride|amiloride|mesh-list
93007386|NCT01095133|Diuretics|diuretics|mesh-ancestor
93007387|NCT01095133|Natriuretic Agents|natriuretic agents|mesh-ancestor
93007388|NCT01095133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007389|NCT01095133|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93007390|NCT01095133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93007391|NCT01095133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007392|NCT01095133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007393|NCT01095133|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92652731|NCT04550338|Hemostatics|hemostatics|mesh-ancestor
93007394|NCT01095133|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93007395|NCT00387088|Tiotropium Bromide|tiotropium bromide|mesh-list
93007396|NCT00387088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93007397|NCT00387088|Autonomic Agents|autonomic agents|mesh-ancestor
93007398|NCT00387088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007399|NCT00387088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007400|NCT00387088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93007401|NCT00387088|Respiratory System Agents|respiratory system agents|mesh-ancestor
93007402|NCT00387088|Parasympatholytics|parasympatholytics|mesh-ancestor
93007403|NCT00387088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93007404|NCT00387088|Cholinergic Agents|cholinergic agents|mesh-ancestor
93007405|NCT00387088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007406|NCT00387088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007407|NCT01095211|Vitamin B Complex|vitamin b complex|mesh-list
93007408|NCT01095211|Vitamins|vitamins|mesh-ancestor
93007409|NCT01095211|Micronutrients|micronutrients|mesh-ancestor
93007410|NCT01095211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007411|NCT01089985|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93007412|NCT01089985|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93007413|NCT00053365|Irofulven|irofulven|mesh-list
93007414|NCT00053365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007415|NCT00053365|Alkylating Agents|alkylating agents|mesh-ancestor
93007416|NCT00053365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007417|NCT00053365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007418|NCT00387010|Fentanyl|fentanyl|mesh-list
93007419|NCT00387010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93007420|NCT00387010|Narcotics|narcotics|mesh-ancestor
93007421|NCT00387010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007422|NCT00387010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007423|NCT00387010|Analgesics|analgesics|mesh-ancestor
93007424|NCT00387010|Sensory System Agents|sensory system agents|mesh-ancestor
93007425|NCT00387010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007426|NCT00387010|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93007427|NCT00387010|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93007428|NCT00387010|Anesthetics, General|anesthetics, general|mesh-ancestor
93007429|NCT00387010|Anesthetics|anesthetics|mesh-ancestor
93007430|NCT01092091|BCT-100|bct-100|mesh-list
93007431|NCT01092091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007432|NCT00065065|Rosiglitazone|rosiglitazone|mesh-list
93007433|NCT00065065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93007434|NCT00065065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007435|NCT00386308|Tranexamic Acid|tranexamic acid|mesh-list
93007436|NCT00386308|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93007437|NCT00386308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93007438|NCT00386308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007439|NCT00386308|Hemostatics|hemostatics|mesh-ancestor
93007440|NCT00386308|Coagulants|coagulants|mesh-ancestor
93007441|NCT00064987|Hormones|hormones|mesh-list
93007442|NCT00064987|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93007443|NCT00064987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007444|NCT00064987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007445|NCT00374140|Everolimus|everolimus|mesh-list
93007446|NCT00374140|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93007447|NCT00374140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007448|NCT00374140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007449|NCT00374140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007450|NCT00374140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93007451|NCT00374140|Immunologic Factors|immunologic factors|mesh-ancestor
93007452|NCT00374140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007453|NCT00374140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007454|NCT00665561|Maraviroc|maraviroc|mesh-list
93007455|NCT00665561|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93007456|NCT00665561|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93007457|NCT00665561|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93007458|NCT00665561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007459|NCT00665561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93007460|NCT00665561|Antiviral Agents|antiviral agents|mesh-ancestor
93007461|NCT00665561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007462|NCT00665561|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93007463|NCT03955705|Nefopam|nefopam|mesh-list
93007464|NCT03955705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93007465|NCT03955705|Analgesics|analgesics|mesh-ancestor
93007466|NCT03955705|Sensory System Agents|sensory system agents|mesh-ancestor
93007467|NCT03955705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007468|NCT03955705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652805|NCT00268398|Immunologic Factors|immunologic factors|mesh-ancestor
93007469|NCT00786461|Silver Nitrate|silver nitrate|mesh-list
93007470|NCT00786461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93007471|NCT00786461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007472|NCT00786695|Esomeprazole|esomeprazole|mesh-list
93007473|NCT00786695|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93007474|NCT00786695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007475|NCT00786695|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93007476|NCT00786695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007477|NCT00786695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007478|NCT00786851|Lenalidomide|lenalidomide|mesh-list
93007479|NCT00786851|Immunologic Factors|immunologic factors|mesh-ancestor
93007480|NCT00786851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007481|NCT00786851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93007482|NCT00786851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93007483|NCT00786851|Growth Substances|growth substances|mesh-ancestor
93007484|NCT00786851|Growth Inhibitors|growth inhibitors|mesh-ancestor
93007485|NCT00786851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007487|NCT00787007|Phytoestrogens|phytoestrogens|mesh-ancestor
93007488|NCT00787007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93007489|NCT00787007|Estrogens|estrogens|mesh-ancestor
93007490|NCT00787007|Hormones|hormones|mesh-ancestor
93007491|NCT00787007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007492|NCT00787007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007493|NCT00791141|Cetuximab|cetuximab|mesh-list
93007494|NCT00791141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007495|NCT00791141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007496|NCT00386152|Epoetin Alfa|epoetin alfa|mesh-list
93007497|NCT00386152|Darbepoetin alfa|darbepoetin alfa|mesh-list
93007498|NCT00386152|Hematinics|hematinics|mesh-ancestor
93007499|NCT00787553|Cefazolin|cefazolin|mesh-list
93007500|NCT00787553|Tinidazole|tinidazole|mesh-list
93007501|NCT00787553|Imidazole|imidazole|mesh-list
93007502|NCT00787553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93007503|NCT00787553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007504|NCT00787553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007505|NCT00787553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007506|NCT00787553|Alkylating Agents|alkylating agents|mesh-ancestor
93007507|NCT00787553|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93007508|NCT00787553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93007509|NCT00787553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93007510|NCT00795353|Alefacept|alefacept|mesh-list
93007511|NCT00795353|Dermatologic Agents|dermatologic agents|mesh-ancestor
93007512|NCT00795353|Immunologic Factors|immunologic factors|mesh-ancestor
93007513|NCT00795353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007514|NCT00791297|Ulipristal acetate|ulipristal acetate|mesh-list
93007515|NCT00791297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93007516|NCT00791297|Contraceptive Agents|contraceptive agents|mesh-ancestor
93007517|NCT00791297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93007518|NCT00791297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007519|NCT00791297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93007521|NCT01045876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007522|NCT01045876|Antiemetics|antiemetics|mesh-ancestor
93007523|NCT01045876|Autonomic Agents|autonomic agents|mesh-ancestor
93007524|NCT01045876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007525|NCT01045876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007526|NCT01045876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007527|NCT01045876|Glucocorticoids|glucocorticoids|mesh-ancestor
93007528|NCT01045876|Hormones|hormones|mesh-ancestor
93007529|NCT01045876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007530|NCT01045876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007531|NCT01045876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007532|NCT00385762|Paroxetine|paroxetine|mesh-list
93007533|NCT00385762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93007534|NCT00385762|Serotonin|serotonin|mesh-list
93007535|NCT00385762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93007536|NCT00385762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007537|NCT00385762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007538|NCT00385762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007539|NCT00385762|Serotonin Agents|serotonin agents|mesh-ancestor
93007540|NCT00385762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007541|NCT00385762|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93007542|NCT00385762|Antidepressive Agents|antidepressive agents|mesh-ancestor
93007543|NCT00385762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007544|NCT00385762|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93007545|NCT00385762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93007547|NCT00385762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93007548|NCT00385684|Acetaminophen|acetaminophen|mesh-list
93007549|NCT00385684|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93007550|NCT00385684|Hydrocodone|hydrocodone|mesh-list
93007551|NCT00385684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93007552|NCT00385684|Narcotics|narcotics|mesh-ancestor
93007553|NCT00385684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007554|NCT00385684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007555|NCT00385684|Analgesics|analgesics|mesh-ancestor
93007556|NCT00385684|Sensory System Agents|sensory system agents|mesh-ancestor
93007557|NCT00385684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007558|NCT00385684|Antitussive Agents|antitussive agents|mesh-ancestor
92168923|NCT05909852|Adalimumab|adalimumab|mesh-list
93007559|NCT00385684|Respiratory System Agents|respiratory system agents|mesh-ancestor
93007560|NCT00385684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93007561|NCT00385684|Antipyretics|antipyretics|mesh-ancestor
93007562|NCT00385684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93007563|NCT00385684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007564|NCT00385684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007565|NCT00661661|Tofacitinib|tofacitinib|mesh-list
93007566|NCT00661661|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93007567|NCT00661661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007568|NCT00661661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007569|NCT00661661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007570|NCT00038467|Tamoxifen|tamoxifen|mesh-list
93007571|NCT00038467|Exemestane|exemestane|mesh-list
93007572|NCT00038467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93007573|NCT00038467|Hormone Antagonists|hormone antagonists|mesh-ancestor
93007574|NCT00038467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007575|NCT00038467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007576|NCT00038467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007577|NCT00038467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007578|NCT00038467|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93007579|NCT00038467|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93007580|NCT00038467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93007581|NCT00038467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93007582|NCT00038467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93007583|NCT00038467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007584|NCT00038467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007585|NCT01095445|Ribavirin|ribavirin|mesh-list
93007586|NCT01095445|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93007587|NCT01095445|Antimetabolites|antimetabolites|mesh-ancestor
93007588|NCT01095445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007589|NCT01095445|Antiviral Agents|antiviral agents|mesh-ancestor
93007590|NCT01095445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007591|NCT00660179|Macitentan|macitentan|mesh-list
93007592|NCT00660179|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93007593|NCT00660179|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93007594|NCT00660179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007595|NCT00660179|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
93007596|NCT00050167|Paclitaxel|paclitaxel|mesh-list
93007597|NCT00050167|Docetaxel|docetaxel|mesh-list
93007598|NCT00050167|Capecitabine|capecitabine|mesh-list
93007599|NCT00050167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93007600|NCT00050167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007601|NCT00050167|Tubulin Modulators|tubulin modulators|mesh-ancestor
93007602|NCT00050167|Antimitotic Agents|antimitotic agents|mesh-ancestor
93007603|NCT00050167|Mitosis Modulators|mitosis modulators|mesh-ancestor
93007604|NCT00050167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007605|NCT00050167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93007606|NCT00050167|Antimetabolites|antimetabolites|mesh-ancestor
93007607|NCT01096927|Amoxicillin|amoxicillin|mesh-list
93007608|NCT01096927|Clavulanic Acids|clavulanic acids|mesh-list
93007609|NCT01096927|Clavulanic Acid|clavulanic acid|mesh-list
93007610|NCT01096927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93007611|NCT01096927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007612|NCT01096927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007613|NCT01096927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007614|NCT01096927|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93007615|NCT00660023|Epoetin Alfa|epoetin alfa|mesh-list
93007616|NCT00660023|Hematinics|hematinics|mesh-ancestor
93007617|NCT02554955|Mycophenolic Acid|mycophenolic acid|mesh-list
93007618|NCT02554955|Daclizumab|daclizumab|mesh-list
93007619|NCT02554955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93007620|NCT02554955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007621|NCT02554955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93007622|NCT02554955|Antitubercular Agents|antitubercular agents|mesh-ancestor
93007623|NCT02554955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93007624|NCT02554955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007625|NCT02554955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007626|NCT02554955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007627|NCT02554955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93007628|NCT02554955|Immunologic Factors|immunologic factors|mesh-ancestor
93007629|NCT02554955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007630|NCT00062647|Vancomycin|vancomycin|mesh-list
93007631|NCT00062647|Cloxacillin|cloxacillin|mesh-list
93007632|NCT00062647|Oxacillin|oxacillin|mesh-list
93007633|NCT00062647|Nafcillin|nafcillin|mesh-list
93007634|NCT00062647|Telavancin|telavancin|mesh-list
93007635|NCT00062647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93007636|NCT00062647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007637|NCT00570323|Fulvestrant|fulvestrant|mesh-list
93007638|NCT00570323|Anastrozole|anastrozole|mesh-list
93007639|NCT00570323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007640|NCT00570323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007641|NCT00570323|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93007642|NCT00570323|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93007643|NCT00570323|Hormone Antagonists|hormone antagonists|mesh-ancestor
93007644|NCT00570323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007645|NCT00570323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007646|NCT00570323|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93007647|NCT00570323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93007648|NCT00570323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007649|NCT00570323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007650|NCT00791531|Methotrexate|methotrexate|mesh-list
93007651|NCT00791531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93007652|NCT00791531|Abortifacient Agents|abortifacient agents|mesh-ancestor
93007653|NCT00791531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93007654|NCT00791531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007655|NCT00791531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93007656|NCT00791531|Antimetabolites|antimetabolites|mesh-ancestor
93007657|NCT00791531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007658|NCT00791531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007659|NCT00791531|Dermatologic Agents|dermatologic agents|mesh-ancestor
93007660|NCT00791531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007661|NCT00791531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93007663|NCT00791531|Immunologic Factors|immunologic factors|mesh-ancestor
93007664|NCT00791531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007665|NCT00791531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93007666|NCT00788099|Gemcitabine|gemcitabine|mesh-list
93007667|NCT00788099|Sorafenib|sorafenib|mesh-list
93007668|NCT00788099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93007669|NCT00788099|Antimetabolites|antimetabolites|mesh-ancestor
93007670|NCT00788099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007671|NCT00788099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007672|NCT00788099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007673|NCT00788099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007674|NCT00795587|Mannitol|mannitol|mesh-list
93007675|NCT00795587|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93007676|NCT00795587|Diuretics|diuretics|mesh-ancestor
93007677|NCT00795587|Natriuretic Agents|natriuretic agents|mesh-ancestor
93007678|NCT00795587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007679|NCT00661505|Epoetin Alfa|epoetin alfa|mesh-list
93007680|NCT00661505|Hematinics|hematinics|mesh-ancestor
93007681|NCT00788333|Trastuzumab|trastuzumab|mesh-list
93007682|NCT00788333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007683|NCT00788333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007684|NCT00795899|Paclitaxel|paclitaxel|mesh-list
93007685|NCT00795899|Cyclophosphamide|cyclophosphamide|mesh-list
93007686|NCT00795899|Trastuzumab|trastuzumab|mesh-list
93007687|NCT00795899|Epirubicin|epirubicin|mesh-list
93007688|NCT00795899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93007689|NCT00795899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007690|NCT00795899|Tubulin Modulators|tubulin modulators|mesh-ancestor
93007691|NCT00795899|Antimitotic Agents|antimitotic agents|mesh-ancestor
93007692|NCT00795899|Mitosis Modulators|mitosis modulators|mesh-ancestor
93007693|NCT00795899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007694|NCT00795899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93007695|NCT00795899|Immunologic Factors|immunologic factors|mesh-ancestor
93007696|NCT00795899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007697|NCT00795899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007698|NCT00795899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007699|NCT00795899|Alkylating Agents|alkylating agents|mesh-ancestor
93007700|NCT00795899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93007701|NCT00795899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007702|NCT00795899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93007703|NCT00795899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93007704|NCT00795899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93007705|NCT00795899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007706|NCT00795977|Picibanil|picibanil|mesh-list
93007707|NCT00795977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007708|NCT00796211|Nortriptyline|nortriptyline|mesh-list
93007709|NCT00796211|Calcipotriene|calcipotriene|mesh-list
93007710|NCT00796211|Dermatologic Agents|dermatologic agents|mesh-ancestor
93007711|NCT00796211|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93007712|NCT00796211|Antidepressive Agents|antidepressive agents|mesh-ancestor
93007713|NCT00796211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007714|NCT00796211|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93007715|NCT00796211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93007716|NCT00796211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007717|NCT00796211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007718|NCT00796211|Adrenergic Agents|adrenergic agents|mesh-ancestor
93007719|NCT00796211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007720|NCT00796211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007721|NCT00788567|Mycophenolic Acid|mycophenolic acid|mesh-list
93007722|NCT00788567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93007723|NCT00788567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007724|NCT00788567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93007725|NCT00788567|Antitubercular Agents|antitubercular agents|mesh-ancestor
93007726|NCT00788567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93007727|NCT00788567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007728|NCT00788567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007729|NCT00788567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007730|NCT00662909|Mirabegron|mirabegron|mesh-list
93007731|NCT00662909|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93007732|NCT00662909|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93007733|NCT00662909|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93007734|NCT00662909|Adrenergic Agents|adrenergic agents|mesh-ancestor
93007735|NCT00662909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353257|NCT00081510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007736|NCT00662909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007737|NCT00662909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007738|NCT00662909|Urological Agents|urological agents|mesh-ancestor
93007739|NCT00050011|Zoledronic Acid|zoledronic acid|mesh-list
93007740|NCT00050011|Letrozole|letrozole|mesh-list
93007741|NCT00050011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007742|NCT00050011|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93007743|NCT00050011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93007744|NCT00050011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007745|NCT00050011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007746|NCT00050011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93007747|NCT00050011|Hormone Antagonists|hormone antagonists|mesh-ancestor
93007748|NCT00050011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007749|NCT00050011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007750|NCT00050011|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93007751|NCT00661427|Cetuximab|cetuximab|mesh-list
93007752|NCT00661427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007753|NCT00661427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007754|NCT00049543|Gefitinib|gefitinib|mesh-list
93007755|NCT00049543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007756|NCT00049543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007757|NCT00049543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007758|NCT00049543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007759|NCT03955393|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93007760|NCT03955393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93007761|NCT03955393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007762|NCT01092481|Oxaliplatin|oxaliplatin|mesh-list
93007763|NCT01092481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007764|NCT00035815|Mitogens|mitogens|mesh-list
93007765|NCT00035815|Mitosis Modulators|mitosis modulators|mesh-ancestor
93007766|NCT00035815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007767|NCT00662831|Dalteparin|dalteparin|mesh-list
93007768|NCT00662831|Tinzaparin|tinzaparin|mesh-list
93007769|NCT00662831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93007770|NCT00662831|Anticoagulants|anticoagulants|mesh-ancestor
93007771|NCT00662831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93007772|NCT00662831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93007773|NCT00662831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007774|NCT02555423|Anesthetics|anesthetics|mesh-list
93007775|NCT02555423|Levobupivacaine|levobupivacaine|mesh-list
93007776|NCT02555423|Anesthetics, Local|anesthetics, local|mesh-list
93007777|NCT02555423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007778|NCT02555423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007779|NCT02555423|Sensory System Agents|sensory system agents|mesh-ancestor
93007780|NCT02555423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007781|NCT00792779|Propofol|propofol|mesh-list
93007782|NCT00792779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93007783|NCT00792779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007784|NCT00792779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007785|NCT00792779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93007786|NCT00792779|Anesthetics, General|anesthetics, general|mesh-ancestor
93007787|NCT00792779|Anesthetics|anesthetics|mesh-ancestor
93007788|NCT00662363|Lubiprostone|lubiprostone|mesh-list
93007789|NCT00662363|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93007790|NCT00662363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007791|NCT00662363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007792|NCT00796835|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93007793|NCT00796835|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93007794|NCT00796835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93007795|NCT00796835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007796|NCT00796835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007797|NCT00796835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007798|NCT00796835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93007799|NCT00796835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93007800|NCT00796835|Serotonin Agents|serotonin agents|mesh-ancestor
93007801|NCT00796835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007802|NCT00796835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007803|NCT00796835|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93007804|NCT00796835|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93007805|NCT00796835|Dopamine Agents|dopamine agents|mesh-ancestor
93007806|NCT00792857|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
93007808|NCT00792857|Micronutrients|micronutrients|mesh-ancestor
93007809|NCT00792857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007810|NCT00792857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93007811|NCT02554175|Propofol|propofol|mesh-list
93007812|NCT02554175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93007813|NCT02554175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007814|NCT02554175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007815|NCT02554175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93007816|NCT02554175|Anesthetics, General|anesthetics, general|mesh-ancestor
93007817|NCT02554175|Anesthetics|anesthetics|mesh-ancestor
93007818|NCT00793091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93007819|NCT00793091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93007820|NCT00789503|Vitamin D|vitamin d|mesh-list
93007821|NCT00789503|Cholecalciferol|cholecalciferol|mesh-list
93007822|NCT00789503|Calcium|calcium|mesh-list
93007823|NCT00789503|Vitamins|vitamins|mesh-ancestor
93007824|NCT00789503|Micronutrients|micronutrients|mesh-ancestor
93007825|NCT00789503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007826|NCT00789503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93007827|NCT00789503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93007828|NCT00797303|Bevacizumab|bevacizumab|mesh-list
93007829|NCT00797303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007830|NCT00797303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007831|NCT00797303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93007832|NCT00797303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93007833|NCT00797303|Growth Substances|growth substances|mesh-ancestor
93007834|NCT00797303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007835|NCT00797303|Growth Inhibitors|growth inhibitors|mesh-ancestor
93007836|NCT00661193|Paclitaxel|paclitaxel|mesh-list
93007837|NCT00661193|Carboplatin|carboplatin|mesh-list
93007838|NCT00661193|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93007839|NCT00661193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93007840|NCT00661193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007841|NCT00661193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92653179|NCT00236015|Tiagabine|tiagabine|mesh-list
93007842|NCT00661193|Antimitotic Agents|antimitotic agents|mesh-ancestor
93007843|NCT00661193|Mitosis Modulators|mitosis modulators|mesh-ancestor
93007844|NCT00661193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007845|NCT00661193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93007846|NCT00661193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007847|NCT00801047|Remifentanil|remifentanil|mesh-list
93007848|NCT00801047|Bupivacaine|bupivacaine|mesh-list
93007849|NCT00801047|Anesthetics, Local|anesthetics, local|mesh-ancestor
93007850|NCT00801047|Anesthetics|anesthetics|mesh-ancestor
93007851|NCT00801047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007852|NCT00801047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007853|NCT00801047|Sensory System Agents|sensory system agents|mesh-ancestor
93007854|NCT00801047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007855|NCT00801047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93007856|NCT00801047|Narcotics|narcotics|mesh-ancestor
93007857|NCT00801047|Analgesics|analgesics|mesh-ancestor
93007858|NCT00801125|Natalizumab|natalizumab|mesh-list
93007859|NCT00801125|Immunologic Factors|immunologic factors|mesh-ancestor
93007860|NCT00801125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007862|NCT00801281|Cyclophosphamide|cyclophosphamide|mesh-list
93007863|NCT00801281|Rituximab|rituximab|mesh-list
93007864|NCT00801281|Doxorubicin|doxorubicin|mesh-list
93007865|NCT00801281|Vincristine|vincristine|mesh-list
93007866|NCT00801281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93007867|NCT00801281|Immunologic Factors|immunologic factors|mesh-ancestor
93007868|NCT00801281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007869|NCT00801281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007870|NCT00801281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93007871|NCT00801281|Alkylating Agents|alkylating agents|mesh-ancestor
93007872|NCT00801281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007873|NCT00801281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93007874|NCT00801281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93007875|NCT00801281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93007876|NCT00801281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93007877|NCT00801281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93007878|NCT00801281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93007879|NCT00801281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93007880|NCT00801281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007881|NCT00801281|Glucocorticoids|glucocorticoids|mesh-ancestor
93007882|NCT00801281|Hormones|hormones|mesh-ancestor
93007883|NCT00801281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93007884|NCT00801281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93007885|NCT00801281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93007886|NCT00801281|Tubulin Modulators|tubulin modulators|mesh-ancestor
93007887|NCT00801281|Antimitotic Agents|antimitotic agents|mesh-ancestor
93007888|NCT00801281|Mitosis Modulators|mitosis modulators|mesh-ancestor
93007889|NCT00801359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93007890|NCT00801515|Maraviroc|maraviroc|mesh-list
93007891|NCT00801515|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93007892|NCT00801515|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93007893|NCT00801515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007894|NCT00801515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93007895|NCT00801515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93007896|NCT00801515|Antiviral Agents|antiviral agents|mesh-ancestor
93007897|NCT00801515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93007898|NCT00801515|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93007899|NCT00797693|Misoprostol|misoprostol|mesh-list
93007900|NCT00797693|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93007901|NCT00797693|Abortifacient Agents|abortifacient agents|mesh-ancestor
93007902|NCT00797693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93007903|NCT00797693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007904|NCT00797693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93007905|NCT00797693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93007906|NCT00797693|Oxytocics|oxytocics|mesh-ancestor
93007907|NCT00797771|Insulin|insulin|mesh-list
93007908|NCT00797771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93007909|NCT00797771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007910|NCT00793559|Terlipressin|terlipressin|mesh-list
93007911|NCT00793559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93007912|NCT00793559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93007913|NCT00797927|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93007914|NCT00797927|Antipsychotic Agents|antipsychotic agents|mesh-list
93007915|NCT00797927|Antidepressive Agents|antidepressive agents|mesh-ancestor
93007916|NCT00797927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007917|NCT00797927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93007918|NCT00797927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007919|NCT00797927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007920|NCT00798083|Lidocaine|lidocaine|mesh-list
93007921|NCT00798083|Ketamine|ketamine|mesh-list
93007922|NCT00798083|Amitriptyline|amitriptyline|mesh-list
93007923|NCT00798083|Anesthetics, Local|anesthetics, local|mesh-ancestor
93007924|NCT00798083|Anesthetics|anesthetics|mesh-ancestor
93007925|NCT00798083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007926|NCT00798083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007927|NCT00798083|Sensory System Agents|sensory system agents|mesh-ancestor
93007928|NCT00798083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007929|NCT00798083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93007930|NCT00798083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93007931|NCT00798083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93007932|NCT00798083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93007933|NCT00798083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007934|NCT00798083|Analgesics|analgesics|mesh-ancestor
93007935|NCT00798083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93007936|NCT00798083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93007937|NCT00798083|Anesthetics, General|anesthetics, general|mesh-ancestor
93007938|NCT00798083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93007939|NCT00798083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93007940|NCT00798083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007941|NCT00798083|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93007942|NCT00798083|Antidepressive Agents|antidepressive agents|mesh-ancestor
93007943|NCT00798083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007944|NCT00798083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93007945|NCT00798083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93007946|NCT00798083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93007947|NCT00798083|Adrenergic Agents|adrenergic agents|mesh-ancestor
93007948|NCT00798395|Zopiclone|zopiclone|mesh-list
93007949|NCT00798395|Mirtazapine|mirtazapine|mesh-list
93007950|NCT00798395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93007951|NCT00798395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007952|NCT00798395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007953|NCT00798395|Antidepressive Agents|antidepressive agents|mesh-ancestor
93007954|NCT00798395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93007955|NCT00798395|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93007956|NCT00798395|Histamine Antagonists|histamine antagonists|mesh-ancestor
93007957|NCT00798395|Histamine Agents|histamine agents|mesh-ancestor
93007958|NCT00798395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007959|NCT00798395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007960|NCT00798395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93007961|NCT00798395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93007962|NCT00798395|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93007963|NCT00798395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93007964|NCT00798395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93007965|NCT00798395|Adrenergic Agents|adrenergic agents|mesh-ancestor
93007966|NCT00798395|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93007967|NCT00798395|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93007968|NCT00798395|Serotonin Agents|serotonin agents|mesh-ancestor
93007969|NCT00798395|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93007970|NCT00801905|Nepafenac|nepafenac|mesh-list
93007971|NCT00801905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93007972|NCT00801905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93007973|NCT00801905|Analgesics|analgesics|mesh-ancestor
93007974|NCT00801905|Sensory System Agents|sensory system agents|mesh-ancestor
93007975|NCT00801905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93007976|NCT00801905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007977|NCT00801905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93007978|NCT00801905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93007979|NCT00658541|Zolpidem|zolpidem|mesh-list
93007980|NCT00658541|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93007981|NCT00658541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93007982|NCT00658541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93007983|NCT00658541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007984|NCT00658541|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93007985|NCT00658541|GABA Agonists|gaba agonists|mesh-ancestor
93007986|NCT00658541|GABA Agents|gaba agents|mesh-ancestor
93007987|NCT00658541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93007988|NCT00658541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93007989|NCT00048061|Vitamin D|vitamin d|mesh-list
93007990|NCT00048061|Ibandronic Acid|ibandronic acid|mesh-list
93007991|NCT00048061|Calcium|calcium|mesh-list
93007992|NCT00048061|Vitamins|vitamins|mesh-ancestor
93007993|NCT00048061|Micronutrients|micronutrients|mesh-ancestor
93007994|NCT00048061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93007995|NCT00048061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93007996|NCT00048061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93007997|NCT00802139|Iron|iron|mesh-list
93007998|NCT00802139|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93007999|NCT00802139|Trace Elements|trace elements|mesh-ancestor
93008000|NCT00802139|Micronutrients|micronutrients|mesh-ancestor
93008001|NCT00802139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008002|NCT00802139|Hematinics|hematinics|mesh-ancestor
93008003|NCT00802217|Capsaicin|capsaicin|mesh-list
93008004|NCT00802217|Antipruritics|antipruritics|mesh-ancestor
93008005|NCT00802217|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008006|NCT00802217|Sensory System Agents|sensory system agents|mesh-ancestor
93008007|NCT00802217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008008|NCT00802217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008009|NCT00802373|Solifenacin Succinate|solifenacin succinate|mesh-list
93008010|NCT00802373|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93008011|NCT00802373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93008012|NCT00802373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93008013|NCT00802373|Cholinergic Agents|cholinergic agents|mesh-ancestor
93008014|NCT00802373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008015|NCT00802373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008016|NCT00802373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008017|NCT00802373|Urological Agents|urological agents|mesh-ancestor
93008018|NCT03957109|Anesthetics|anesthetics|mesh-list
93008019|NCT03957109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008020|NCT03957109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008021|NCT00802451|Mesalamine|mesalamine|mesh-list
93008022|NCT00802451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93008023|NCT00802451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93008024|NCT00802451|Analgesics|analgesics|mesh-ancestor
93008025|NCT00802451|Sensory System Agents|sensory system agents|mesh-ancestor
93008026|NCT00802451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528535|NCT00000794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008027|NCT00802451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008028|NCT00802451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008029|NCT00802451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008030|NCT03956953|Deucravacitinib|deucravacitinib|mesh-list
93008031|NCT03956953|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008032|NCT03956953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008033|NCT03956953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008034|NCT03956953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008035|NCT00798473|Zoledronic Acid|zoledronic acid|mesh-list
93008036|NCT00798473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93008037|NCT00798473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008038|NCT04045769|Moxifloxacin|moxifloxacin|mesh-list
93008039|NCT04045769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93008040|NCT04045769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008041|NCT04045769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93008042|NCT04045769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93008043|NCT04045769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008044|NCT04045769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008045|NCT04045769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008046|NCT01097317|Carboplatin|carboplatin|mesh-list
93008047|NCT01097317|Vinorelbine|vinorelbine|mesh-list
93008048|NCT01097317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008049|NCT01097317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93008050|NCT01097317|Tubulin Modulators|tubulin modulators|mesh-ancestor
93008051|NCT01097317|Antimitotic Agents|antimitotic agents|mesh-ancestor
93008052|NCT01097317|Mitosis Modulators|mitosis modulators|mesh-ancestor
93008053|NCT01097317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008054|NCT01095679|Baclofen|baclofen|mesh-list
93008055|NCT01095679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93008056|NCT01095679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008057|NCT01095679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93008058|NCT01095679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008059|NCT01095679|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93008060|NCT01095679|GABA Agonists|gaba agonists|mesh-ancestor
93008061|NCT01095679|GABA Agents|gaba agents|mesh-ancestor
93008062|NCT01095679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008063|NCT01095679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008064|NCT00794261|Lenograstim|lenograstim|mesh-list
93008065|NCT00794261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93008066|NCT00794261|Immunologic Factors|immunologic factors|mesh-ancestor
93008067|NCT00794261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008068|NCT03953287|Acetaminophen|acetaminophen|mesh-list
93008070|NCT03953287|Analgesics|analgesics|mesh-ancestor
93008071|NCT03953287|Sensory System Agents|sensory system agents|mesh-ancestor
93008072|NCT03953287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008073|NCT03953287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008074|NCT03953287|Antipyretics|antipyretics|mesh-ancestor
93008075|NCT01097551|Phenylephrine|phenylephrine|mesh-list
93008076|NCT01097551|Acetylcholine|acetylcholine|mesh-list
93008077|NCT01097551|Nitroglycerin|nitroglycerin|mesh-list
93008078|NCT01097551|Vasodilator Agents|vasodilator agents|mesh-ancestor
93008079|NCT01097551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93008080|NCT01097551|Cholinergic Agents|cholinergic agents|mesh-ancestor
93008081|NCT01097551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008082|NCT01097551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008083|NCT01097551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008084|NCT01097551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93008085|NCT01097551|Mydriatics|mydriatics|mesh-ancestor
93008086|NCT01097551|Autonomic Agents|autonomic agents|mesh-ancestor
93008087|NCT01097551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008088|NCT01097551|Sympathomimetics|sympathomimetics|mesh-ancestor
93008089|NCT01097551|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93008090|NCT01097551|Nasal Decongestants|nasal decongestants|mesh-ancestor
93008091|NCT01097551|Respiratory System Agents|respiratory system agents|mesh-ancestor
93008092|NCT01097551|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93008093|NCT01097551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93008094|NCT01097551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93008095|NCT01097551|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008096|NCT01097551|Protective Agents|protective agents|mesh-ancestor
93008097|NCT00803309|Interferons|interferons|mesh-list
93008098|NCT00803309|Ribavirin|ribavirin|mesh-list
93008099|NCT00803309|Interferon-alpha|interferon-alpha|mesh-list
93008100|NCT00803309|Interferon alpha-2|interferon alpha-2|mesh-list
93008101|NCT00803309|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93008102|NCT00803309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008103|NCT00803309|Antiviral Agents|antiviral agents|mesh-ancestor
93008104|NCT00803309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008105|NCT00803309|Antimetabolites|antimetabolites|mesh-ancestor
93008106|NCT00803309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008107|NCT00803309|Immunologic Factors|immunologic factors|mesh-ancestor
93008108|NCT00803309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008109|NCT03953209|Spironolactone|spironolactone|mesh-list
93008110|NCT03953209|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93008111|NCT03953209|Hormone Antagonists|hormone antagonists|mesh-ancestor
93008112|NCT03953209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008113|NCT03953209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008114|NCT03953209|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93008115|NCT03953209|Diuretics|diuretics|mesh-ancestor
93008116|NCT03953209|Natriuretic Agents|natriuretic agents|mesh-ancestor
93008117|NCT01583959|Folic Acid|folic acid|mesh-list
93008118|NCT01583959|Hematinics|hematinics|mesh-ancestor
93008119|NCT01583959|Vitamin B Complex|vitamin b complex|mesh-ancestor
93008120|NCT01583959|Vitamins|vitamins|mesh-ancestor
93008121|NCT01583959|Micronutrients|micronutrients|mesh-ancestor
93008122|NCT01583959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008123|NCT00803387|Travoprost|travoprost|mesh-list
93008124|NCT00803387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93008125|NCT02553551|Vitamins|vitamins|mesh-list
93008126|NCT02553551|Micronutrients|micronutrients|mesh-ancestor
93008127|NCT02553551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008128|NCT00803465|Fluticasone|fluticasone|mesh-list
93008129|NCT00803465|Xhance|xhance|mesh-list
93008130|NCT00803465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008131|NCT00803465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93008132|NCT00803465|Autonomic Agents|autonomic agents|mesh-ancestor
93008133|NCT00803465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008134|NCT00803465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008135|NCT00803465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93008136|NCT00803465|Respiratory System Agents|respiratory system agents|mesh-ancestor
92168947|NCT05909800|Fenofibrate|fenofibrate|mesh-list
93008137|NCT00803465|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008138|NCT00803465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93008139|NCT00803699|Selenium|selenium|mesh-list
93008140|NCT00803699|Antioxidants|antioxidants|mesh-ancestor
93008141|NCT00803699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008142|NCT00803699|Protective Agents|protective agents|mesh-ancestor
93008143|NCT00803699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008144|NCT00803699|Trace Elements|trace elements|mesh-ancestor
93008145|NCT00803699|Micronutrients|micronutrients|mesh-ancestor
93008146|NCT00798785|Rituximab|rituximab|mesh-list
93008147|NCT00798785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008148|NCT00798785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008149|NCT00798785|Immunologic Factors|immunologic factors|mesh-ancestor
93008150|NCT00798785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008151|NCT00798785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008152|NCT01095991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93008153|NCT01095991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93008154|NCT01095991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008155|NCT01095991|Incretins|incretins|mesh-ancestor
93008156|NCT01095991|Hormones|hormones|mesh-ancestor
93008157|NCT01095991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008158|NCT01095991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93008159|NCT01095991|Protease Inhibitors|protease inhibitors|mesh-ancestor
93008160|NCT01095991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008161|NCT01095991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008162|NCT00794807|Alefacept|alefacept|mesh-list
93008163|NCT00794807|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008164|NCT00794807|Immunologic Factors|immunologic factors|mesh-ancestor
93008165|NCT00794807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008166|NCT00794885|Folic Acid|folic acid|mesh-list
93008167|NCT00794885|Vitamin B Complex|vitamin b complex|mesh-list
93008168|NCT00794885|Enalapril|enalapril|mesh-list
93008169|NCT00794885|Enalaprilat|enalaprilat|mesh-list
93008170|NCT00794885|Maleic acid|maleic acid|mesh-list
93008171|NCT00794885|Hematinics|hematinics|mesh-ancestor
93008172|NCT00794885|Vitamins|vitamins|mesh-ancestor
93008173|NCT00794885|Micronutrients|micronutrients|mesh-ancestor
93008174|NCT00794885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008175|NCT00794885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008176|NCT00794885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008177|NCT00794885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93008178|NCT00794885|Protease Inhibitors|protease inhibitors|mesh-ancestor
93008179|NCT00794885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93008180|NCT00803933|Pentamidine|pentamidine|mesh-list
93008181|NCT00803933|Pafuramidine|pafuramidine|mesh-list
93008182|NCT00803933|Antifungal Agents|antifungal agents|mesh-ancestor
93008183|NCT00803933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008184|NCT00803933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008185|NCT00803933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008186|NCT00803933|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93008187|NCT02553707|Ibandronic Acid|ibandronic acid|mesh-list
93008188|NCT02553707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93008189|NCT02553707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008190|NCT00799175|Ketorolac|ketorolac|mesh-list
93008191|NCT00799175|Epinephrine|epinephrine|mesh-list
93008192|NCT00799175|Ropivacaine|ropivacaine|mesh-list
93008193|NCT00799175|Anesthetics, Local|anesthetics, local|mesh-ancestor
93008194|NCT00799175|Anesthetics|anesthetics|mesh-ancestor
93008195|NCT00799175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008196|NCT00799175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008197|NCT00799175|Sensory System Agents|sensory system agents|mesh-ancestor
93008198|NCT00799175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008199|NCT00799175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93008200|NCT00799175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93008201|NCT00799175|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008202|NCT00799175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008203|NCT00799175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008204|NCT00799175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93008205|NCT00799175|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93008206|NCT00799175|Autonomic Agents|autonomic agents|mesh-ancestor
93008207|NCT00799175|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93008208|NCT00799175|Respiratory System Agents|respiratory system agents|mesh-ancestor
93008209|NCT00799175|Mydriatics|mydriatics|mesh-ancestor
93008210|NCT00799175|Sympathomimetics|sympathomimetics|mesh-ancestor
93008211|NCT00799175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93008212|NCT00799175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93008213|NCT00799175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93008214|NCT00799175|Analgesics|analgesics|mesh-ancestor
93008215|NCT00799175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008216|NCT00799175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008217|NCT00799175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93008218|NCT00799175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008219|NCT00656513|Pilocarpine|pilocarpine|mesh-list
93008220|NCT00656513|Miotics|miotics|mesh-ancestor
93008221|NCT00656513|Autonomic Agents|autonomic agents|mesh-ancestor
92653559|NCT04541251|Paclitaxel|paclitaxel|mesh-list
93008222|NCT00656513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008223|NCT00656513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008225|NCT00656513|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93008226|NCT00656513|Cholinergic Agents|cholinergic agents|mesh-ancestor
93008227|NCT00656513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008228|NCT00656513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008229|NCT04017221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93008230|NCT04017221|Protease Inhibitors|protease inhibitors|mesh-ancestor
93008231|NCT04017221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008232|NCT04017221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008233|NCT04017221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93008234|NCT04017221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008235|NCT00804245|Choline|choline|mesh-list
93008236|NCT00804245|Lipotropic Agents|lipotropic agents|mesh-ancestor
93008237|NCT00804245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93008238|NCT00804245|Antimetabolites|antimetabolites|mesh-ancestor
93008239|NCT00804245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008240|NCT00804245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008241|NCT00804245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93008242|NCT00804245|Nootropic Agents|nootropic agents|mesh-ancestor
93008243|NCT00804401|Naproxen|naproxen|mesh-list
93008244|NCT00804401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93008245|NCT00804401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93008246|NCT00804401|Analgesics|analgesics|mesh-ancestor
93008247|NCT00804401|Sensory System Agents|sensory system agents|mesh-ancestor
93008248|NCT00804401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008249|NCT00804401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008250|NCT00804401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008251|NCT00804401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008252|NCT00804401|Gout Suppressants|gout suppressants|mesh-ancestor
93008253|NCT00804401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93008254|NCT00804401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008255|NCT00804401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008256|NCT00804791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93008258|NCT00804791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93008259|NCT02553083|Amoxicillin|amoxicillin|mesh-list
93008260|NCT02553083|Doxycycline|doxycycline|mesh-list
93008261|NCT02553083|Esomeprazole|esomeprazole|mesh-list
93008262|NCT02553083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93008263|NCT02553083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008264|NCT02553083|Antimalarials|antimalarials|mesh-ancestor
93008265|NCT02553083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008266|NCT02553083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008267|NCT02553083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93008268|NCT02553083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008269|NCT02553083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93008270|NCT02553083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008271|NCT02553083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008272|NCT00804947|Melphalan|melphalan|mesh-list
93008273|NCT00804947|Busulfan|busulfan|mesh-list
93008274|NCT00804947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93008275|NCT00804947|Alkylating Agents|alkylating agents|mesh-ancestor
93008276|NCT00804947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008277|NCT00804947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008278|NCT00804947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93008279|NCT00804947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008280|NCT00804947|Immunologic Factors|immunologic factors|mesh-ancestor
93008281|NCT00804947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008282|NCT00806663|Sunitinib|sunitinib|mesh-list
93008283|NCT00806663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008284|NCT00806663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93008285|NCT00806663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93008286|NCT00806663|Growth Substances|growth substances|mesh-ancestor
93008287|NCT00806663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008288|NCT00806663|Growth Inhibitors|growth inhibitors|mesh-ancestor
93008289|NCT00806663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008290|NCT00806663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008291|NCT00806663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008292|NCT00806741|Phenylephrine|phenylephrine|mesh-list
93008293|NCT00806741|Oxymetazoline|oxymetazoline|mesh-list
93008294|NCT00806741|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
93008295|NCT00806741|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93008296|NCT00806741|Mydriatics|mydriatics|mesh-ancestor
93008297|NCT00806741|Autonomic Agents|autonomic agents|mesh-ancestor
93008298|NCT00806741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008299|NCT00806741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008300|NCT00806741|Sympathomimetics|sympathomimetics|mesh-ancestor
93008301|NCT00806741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93008302|NCT00806741|Nasal Decongestants|nasal decongestants|mesh-ancestor
93008303|NCT00806741|Respiratory System Agents|respiratory system agents|mesh-ancestor
93008304|NCT00806741|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93008305|NCT00806741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93008306|NCT00806741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93008307|NCT00806741|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008308|NCT00806741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008309|NCT00806741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008310|NCT00806741|Protective Agents|protective agents|mesh-ancestor
93008311|NCT00806741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008312|NCT00806897|Insulin Detemir|insulin detemir|mesh-list
93008313|NCT00806897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93008314|NCT00806897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008315|NCT00805649|Dexamethasone|dexamethasone|mesh-list
93008316|NCT00805649|Bevacizumab|bevacizumab|mesh-list
93008317|NCT00805649|Temazepam|temazepam|mesh-list
93008318|NCT00805649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008319|NCT00805649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008320|NCT00805649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93008321|NCT00805649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93008322|NCT00805649|Growth Substances|growth substances|mesh-ancestor
93008323|NCT00805649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008324|NCT00805649|Growth Inhibitors|growth inhibitors|mesh-ancestor
93008325|NCT00805649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008326|NCT00805649|Antiemetics|antiemetics|mesh-ancestor
93008327|NCT00805649|Autonomic Agents|autonomic agents|mesh-ancestor
93008328|NCT00805649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008329|NCT00805649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008330|NCT00805649|Glucocorticoids|glucocorticoids|mesh-ancestor
93008332|NCT00805649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008333|NCT00805649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008334|NCT00805649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93008335|NCT00805649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008336|NCT00805649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93008337|NCT00805649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93008338|NCT00805649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93008339|NCT00805649|GABA Modulators|gaba modulators|mesh-ancestor
93008340|NCT00805649|GABA Agents|gaba agents|mesh-ancestor
93008341|NCT00805649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008342|NCT00805649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168970|NCT05909462|Hormones|hormones|mesh-ancestor
93008343|NCT00807053|Ciclesonide|ciclesonide|mesh-list
93008344|NCT00807053|Glucocorticoids|glucocorticoids|mesh-ancestor
93008345|NCT00807053|Hormones|hormones|mesh-ancestor
93008346|NCT00807053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008347|NCT00807053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008348|NCT00807053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93008349|NCT00809393|Tranexamic Acid|tranexamic acid|mesh-list
93008350|NCT00809393|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93008351|NCT00809393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93008352|NCT00809393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008353|NCT00809393|Hemostatics|hemostatics|mesh-ancestor
93008354|NCT00809393|Coagulants|coagulants|mesh-ancestor
93008355|NCT00658775|Esomeprazole|esomeprazole|mesh-list
93008356|NCT00658775|Rabeprazole|rabeprazole|mesh-list
93008357|NCT00658775|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93008358|NCT00658775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008359|NCT00658775|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93008360|NCT00658775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008361|NCT00658775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008362|NCT00488631|Golimumab|golimumab|mesh-list
93008363|NCT00488631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93008364|NCT00488631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93008365|NCT00488631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008366|NCT00488631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008367|NCT00488631|Immunologic Factors|immunologic factors|mesh-ancestor
93008368|NCT00488631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008369|NCT00809549|Lenograstim|lenograstim|mesh-list
93008370|NCT00809549|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93008371|NCT00809549|Immunologic Factors|immunologic factors|mesh-ancestor
93008372|NCT00809549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008373|NCT00809627|Caffeine|caffeine|mesh-list
92528550|NCT00036283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008374|NCT00809627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93008375|NCT00809627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008376|NCT00809627|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93008377|NCT00809627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008378|NCT00809627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008379|NCT00809627|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93008380|NCT00809627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93008381|NCT00809627|Purinergic Agents|purinergic agents|mesh-ancestor
93008382|NCT00809627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008383|NCT00809705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93008384|NCT00809705|Incretins|incretins|mesh-ancestor
93008385|NCT00809705|Hormones|hormones|mesh-ancestor
93008386|NCT00809705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008387|NCT00809705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008388|NCT00655499|Irinotecan|irinotecan|mesh-list
93008389|NCT00655499|Panitumumab|panitumumab|mesh-list
93008390|NCT00655499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93008391|NCT00655499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93008392|NCT00655499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008393|NCT00655499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008394|NCT00655499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008395|NCT00655499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008396|NCT00800267|Timolol|timolol|mesh-list
93008397|NCT00800267|Latanoprost|latanoprost|mesh-list
93008398|NCT00800267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93008399|NCT00800267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93008400|NCT00800267|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008401|NCT00800267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008402|NCT00800267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008403|NCT00800267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008404|NCT00800267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93008405|NCT00800267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93008406|NCT00800267|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93008407|NCT00800267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93008408|NCT00809939|Progesterone|progesterone|mesh-list
93008409|NCT00809939|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93008410|NCT00809939|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93008411|NCT00809939|Progestins|progestins|mesh-ancestor
93008412|NCT00809939|Hormones|hormones|mesh-ancestor
93008413|NCT00809939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008414|NCT00809939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008415|NCT00809939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93008416|NCT00809939|Hormone Antagonists|hormone antagonists|mesh-ancestor
93008417|NCT00807443|Raltegravir Potassium|raltegravir potassium|mesh-list
93008418|NCT00807443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93008419|NCT00807443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93008420|NCT00807443|Antiviral Agents|antiviral agents|mesh-ancestor
93008421|NCT00807443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008422|NCT00807443|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93008423|NCT00807443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93008424|NCT00807443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008425|NCT00807443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008426|NCT00807521|Dexamethasone|dexamethasone|mesh-list
93008427|NCT00807521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008428|NCT00807521|Antiemetics|antiemetics|mesh-ancestor
93008429|NCT00807521|Autonomic Agents|autonomic agents|mesh-ancestor
93008430|NCT00807521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008431|NCT00807521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008432|NCT00807521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008433|NCT00807521|Glucocorticoids|glucocorticoids|mesh-ancestor
93008434|NCT00807521|Hormones|hormones|mesh-ancestor
93008435|NCT00807521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008436|NCT00807521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008437|NCT00807521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008438|NCT00800423|Timolol|timolol|mesh-list
93008439|NCT00800423|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93008440|NCT00800423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008441|NCT00800423|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93008442|NCT00800423|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93008443|NCT00800423|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008444|NCT00800423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008445|NCT00800423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008446|NCT00800423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93008447|NCT00800423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93008448|NCT00800423|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93008450|NCT00800423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93008451|NCT00651755|Prednisone|prednisone|mesh-list
93008452|NCT00651755|Cyclophosphamide|cyclophosphamide|mesh-list
93008453|NCT00651755|Rituximab|rituximab|mesh-list
93008454|NCT00651755|Doxorubicin|doxorubicin|mesh-list
93008455|NCT00651755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93008456|NCT00651755|Vincristine|vincristine|mesh-list
93008457|NCT00651755|Ondansetron|ondansetron|mesh-list
93008458|NCT00651755|Aprepitant|aprepitant|mesh-list
93008459|NCT00651755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008460|NCT00651755|Immunologic Factors|immunologic factors|mesh-ancestor
93008461|NCT00651755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008462|NCT00651755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008463|NCT00651755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93008464|NCT00651755|Alkylating Agents|alkylating agents|mesh-ancestor
93008465|NCT00651755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008466|NCT00651755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008467|NCT00651755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93008468|NCT00651755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008469|NCT00651755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93008470|NCT00651755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93008471|NCT00651755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93008472|NCT00651755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008473|NCT00651755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008474|NCT00651755|Glucocorticoids|glucocorticoids|mesh-ancestor
93008475|NCT00651755|Hormones|hormones|mesh-ancestor
93008476|NCT00651755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008477|NCT00651755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92168977|NCT05909423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008478|NCT00651755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93008479|NCT00651755|Tubulin Modulators|tubulin modulators|mesh-ancestor
93008480|NCT00651755|Antimitotic Agents|antimitotic agents|mesh-ancestor
93008481|NCT00651755|Mitosis Modulators|mitosis modulators|mesh-ancestor
93008482|NCT00651755|Antiemetics|antiemetics|mesh-ancestor
93008483|NCT00651755|Autonomic Agents|autonomic agents|mesh-ancestor
93008484|NCT00651755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008485|NCT00651755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008486|NCT00651755|Antipruritics|antipruritics|mesh-ancestor
93008487|NCT00651755|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008488|NCT00651755|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93008489|NCT00651755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93008490|NCT00651755|Serotonin Agents|serotonin agents|mesh-ancestor
93008491|NCT00651755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008492|NCT00651755|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93008493|NCT00807755|Carboplatin|carboplatin|mesh-list
93008494|NCT00807755|Etoposide|etoposide|mesh-list
93008495|NCT00807755|Everolimus|everolimus|mesh-list
93008496|NCT00807755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008497|NCT00807755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93008498|NCT00807755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93008499|NCT00807755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93008500|NCT00807755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008501|NCT00807755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008502|NCT00807755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93008503|NCT00807755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008504|NCT00807755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008505|NCT00807755|Immunologic Factors|immunologic factors|mesh-ancestor
93008506|NCT00807755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008507|NCT00813527|Fenofibrate|fenofibrate|mesh-list
93008508|NCT00813527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93008509|NCT00813527|Antimetabolites|antimetabolites|mesh-ancestor
93008510|NCT00813527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008511|NCT00813527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93008512|NCT00810563|Bupivacaine|bupivacaine|mesh-list
93008513|NCT00810563|Anesthetics, Local|anesthetics, local|mesh-ancestor
93008514|NCT00810563|Anesthetics|anesthetics|mesh-ancestor
93008515|NCT00810563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008516|NCT00810563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008517|NCT00810563|Sensory System Agents|sensory system agents|mesh-ancestor
93008518|NCT00810563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008520|NCT00808145|Gemcitabine|gemcitabine|mesh-list
93008521|NCT00808145|Sorafenib|sorafenib|mesh-list
93008522|NCT00808145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008523|NCT00808145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93008524|NCT00808145|Antimetabolites|antimetabolites|mesh-ancestor
93008525|NCT00808145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008526|NCT00808145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008527|NCT00808145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008529|NCT02552459|Dexmedetomidine|dexmedetomidine|mesh-list
93008530|NCT02552459|Dsuvia|dsuvia|mesh-list
93008531|NCT02552459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93008532|NCT02552459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008533|NCT02552459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008534|NCT02552459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93008535|NCT02552459|Analgesics|analgesics|mesh-ancestor
93008536|NCT02552459|Sensory System Agents|sensory system agents|mesh-ancestor
93008537|NCT02552459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008538|NCT02552459|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93008539|NCT02552459|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93008540|NCT02552459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93008541|NCT02552459|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008542|NCT02552459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008543|NCT02552459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008544|NCT02552459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93008545|NCT02552459|Narcotics|narcotics|mesh-ancestor
93008546|NCT02552459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93008547|NCT02552459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93008548|NCT02552459|Anesthetics, General|anesthetics, general|mesh-ancestor
93008549|NCT02552459|Anesthetics|anesthetics|mesh-ancestor
93008550|NCT00810953|Pentamidine|pentamidine|mesh-list
93008551|NCT00810953|Antifungal Agents|antifungal agents|mesh-ancestor
93008552|NCT00810953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008553|NCT00810953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008554|NCT00810953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008555|NCT00810953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93008556|NCT00811031|Prednisone|prednisone|mesh-list
93008557|NCT00811031|Docetaxel|docetaxel|mesh-list
93008558|NCT00811031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008559|NCT00811031|Tubulin Modulators|tubulin modulators|mesh-ancestor
93008560|NCT00811031|Antimitotic Agents|antimitotic agents|mesh-ancestor
93008561|NCT00811031|Mitosis Modulators|mitosis modulators|mesh-ancestor
93008562|NCT00811031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008563|NCT00811031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008564|NCT00811031|Glucocorticoids|glucocorticoids|mesh-ancestor
93008565|NCT00811031|Hormones|hormones|mesh-ancestor
93008566|NCT00811031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008567|NCT00811031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008568|NCT00811031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008569|NCT02552537|Mannitol|mannitol|mesh-list
93008570|NCT02552537|Omeprazole|omeprazole|mesh-list
93008571|NCT02552537|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93008572|NCT02552537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008573|NCT02552537|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93008574|NCT02552537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008575|NCT02552537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008576|NCT02552537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93008577|NCT02552537|Diuretics|diuretics|mesh-ancestor
93008578|NCT02552537|Natriuretic Agents|natriuretic agents|mesh-ancestor
93008579|NCT02552537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008580|NCT00808223|Alefacept|alefacept|mesh-list
93008581|NCT00808223|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008582|NCT00808223|Immunologic Factors|immunologic factors|mesh-ancestor
93008583|NCT00808223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008584|NCT00811421|Pyrimethamine|pyrimethamine|mesh-list
93008585|NCT00811421|Sulfadoxine|sulfadoxine|mesh-list
93008586|NCT00811421|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93008587|NCT00811421|Mefloquine|mefloquine|mesh-list
93008588|NCT00811421|Antimalarials|antimalarials|mesh-ancestor
93008589|NCT00811421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008590|NCT00811421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008591|NCT00811421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008592|NCT00811421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93008593|NCT00811421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008594|NCT00811421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008595|NCT00811421|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93008596|NCT00569777|Ketotifen|ketotifen|mesh-list
93008597|NCT00569777|Antipruritics|antipruritics|mesh-ancestor
93008598|NCT00569777|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008599|NCT00569777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93008600|NCT00569777|Histamine Antagonists|histamine antagonists|mesh-ancestor
93008601|NCT00569777|Histamine Agents|histamine agents|mesh-ancestor
93008602|NCT00569777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008603|NCT00569777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008604|NCT00569777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008605|NCT00569777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93008606|NCT00654095|Atorvastatin|atorvastatin|mesh-list
93008607|NCT00654095|Ezetimibe|ezetimibe|mesh-list
93008608|NCT00654095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93008609|NCT00654095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93008610|NCT00654095|Antimetabolites|antimetabolites|mesh-ancestor
93008611|NCT00654095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008612|NCT00654095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93008613|NCT00654095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93008614|NCT00654095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008615|NCT00811967|Ribavirin|ribavirin|mesh-list
93008616|NCT00811967|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93008617|NCT00811967|Interferon-alpha|interferon-alpha|mesh-list
93008618|NCT00811967|Antimetabolites|antimetabolites|mesh-ancestor
93008619|NCT00811967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008620|NCT00811967|Antiviral Agents|antiviral agents|mesh-ancestor
93008621|NCT00811967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008622|NCT00811967|Immunologic Factors|immunologic factors|mesh-ancestor
93008623|NCT00811967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008624|NCT04046159|Tamoxifen|tamoxifen|mesh-list
93008625|NCT04046159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92168989|NCT05909293|Autonomic Agents|autonomic agents|mesh-ancestor
93008626|NCT04046159|Hormone Antagonists|hormone antagonists|mesh-ancestor
93008627|NCT04046159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008628|NCT04046159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008629|NCT04046159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008630|NCT04046159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008631|NCT04046159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93008632|NCT04046159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93008633|NCT04046159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93008634|NCT00653939|Paclitaxel|paclitaxel|mesh-list
93008635|NCT00653939|Fosbretabulin|fosbretabulin|mesh-list
93008636|NCT00653939|Combretastatin|combretastatin|mesh-list
93008637|NCT00653939|Bevacizumab|bevacizumab|mesh-list
93008638|NCT00653939|Carboplatin|carboplatin|mesh-list
93008639|NCT00653939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93008640|NCT00653939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008641|NCT00653939|Tubulin Modulators|tubulin modulators|mesh-ancestor
93008642|NCT00653939|Antimitotic Agents|antimitotic agents|mesh-ancestor
93008643|NCT00653939|Mitosis Modulators|mitosis modulators|mesh-ancestor
93008644|NCT00653939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008645|NCT00653939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008646|NCT00653939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93008647|NCT00653939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93008648|NCT00653939|Growth Substances|growth substances|mesh-ancestor
93008649|NCT00653939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008650|NCT00653939|Growth Inhibitors|growth inhibitors|mesh-ancestor
93008651|NCT00812123|Cyclosporine|cyclosporine|mesh-list
93008652|NCT00812123|Sirolimus|sirolimus|mesh-list
93008653|NCT00812123|Mycophenolic Acid|mycophenolic acid|mesh-list
93008654|NCT00812123|Prednisone|prednisone|mesh-list
93008655|NCT00812123|Cyclosporins|cyclosporins|mesh-list
93008656|NCT00812123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008657|NCT00812123|Glucocorticoids|glucocorticoids|mesh-ancestor
93008658|NCT00812123|Hormones|hormones|mesh-ancestor
93008659|NCT00812123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008660|NCT00812123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008661|NCT00812123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008662|NCT00812123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008663|NCT00812123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008664|NCT00812123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008665|NCT00812123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008666|NCT00812123|Immunologic Factors|immunologic factors|mesh-ancestor
93008667|NCT00812123|Antifungal Agents|antifungal agents|mesh-ancestor
93008668|NCT00812123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008669|NCT00812123|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008670|NCT00812123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008671|NCT00812123|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93008672|NCT00812123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93008673|NCT00812123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93008674|NCT00812123|Antitubercular Agents|antitubercular agents|mesh-ancestor
93008675|NCT00812123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654004|NCT04538365|Triclosan|triclosan|mesh-list
93008676|NCT00646451|Pregabalin|pregabalin|mesh-list
93008677|NCT00646451|Analgesics|analgesics|mesh-ancestor
93008678|NCT00646451|Sensory System Agents|sensory system agents|mesh-ancestor
93008679|NCT00646451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008680|NCT00646451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008681|NCT00646451|Anticonvulsants|anticonvulsants|mesh-ancestor
93008682|NCT00646451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93008683|NCT00646451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93008684|NCT00646451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008685|NCT00646451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93008686|NCT00646451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93008687|NCT00646451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93008688|NCT00646451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008689|NCT00646451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93008690|NCT00809237|Hydroxychloroquine|hydroxychloroquine|mesh-list
93008691|NCT00809237|Gefitinib|gefitinib|mesh-list
93008692|NCT00809237|Antimalarials|antimalarials|mesh-ancestor
93008693|NCT00809237|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008694|NCT00809237|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008695|NCT00809237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008696|NCT00809237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008697|NCT00809237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008698|NCT00809237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008699|NCT00809237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008700|NCT00809237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008701|NCT00817583|Docetaxel|docetaxel|mesh-list
93008702|NCT00817583|Fluorouracil|fluorouracil|mesh-list
93008703|NCT00817583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008704|NCT00817583|Tubulin Modulators|tubulin modulators|mesh-ancestor
93008705|NCT00817583|Antimitotic Agents|antimitotic agents|mesh-ancestor
93008706|NCT00817583|Mitosis Modulators|mitosis modulators|mesh-ancestor
93008707|NCT00817583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008708|NCT00817583|Antimetabolites|antimetabolites|mesh-ancestor
93008709|NCT00817583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93008710|NCT00817583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008711|NCT00817583|Immunologic Factors|immunologic factors|mesh-ancestor
93008712|NCT00817583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008713|NCT00817661|Vitamin A|vitamin a|mesh-list
93008714|NCT00817661|Vitamins|vitamins|mesh-ancestor
93008715|NCT00817661|Micronutrients|micronutrients|mesh-ancestor
93008716|NCT00817661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008717|NCT00642707|Leronlimab|leronlimab|mesh-list
93008718|NCT00642707|Antibodies|antibodies|mesh-list
93008719|NCT00642707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93008720|NCT00642707|Immunologic Factors|immunologic factors|mesh-ancestor
93008721|NCT00642707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008722|NCT00642707|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93008723|NCT00642707|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93008724|NCT00642707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008725|NCT00642707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93008726|NCT00642707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93008727|NCT00642707|Antiviral Agents|antiviral agents|mesh-ancestor
93008728|NCT00642707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008729|NCT02551523|Dolutegravir|dolutegravir|mesh-list
93008730|NCT02551523|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93008731|NCT02551523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93008732|NCT02551523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93008734|NCT02551523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008735|NCT02551523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93008736|NCT02551523|Antiviral Agents|antiviral agents|mesh-ancestor
93008737|NCT02551523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008738|NCT00817739|Leuprolide|leuprolide|mesh-list
93008739|NCT00817739|Flutamide|flutamide|mesh-list
93008740|NCT00817739|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93008741|NCT00817739|Fertility Agents|fertility agents|mesh-ancestor
93008742|NCT00817739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93008743|NCT00817739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008744|NCT00817739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008745|NCT00817739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008746|NCT00817739|Androgen Antagonists|androgen antagonists|mesh-ancestor
93008747|NCT00817739|Hormone Antagonists|hormone antagonists|mesh-ancestor
93008748|NCT00817739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008749|NCT00817895|Cisplatin|cisplatin|mesh-list
93008750|NCT00817895|Fluorouracil|fluorouracil|mesh-list
93008751|NCT00817895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008752|NCT00817895|Antimetabolites|antimetabolites|mesh-ancestor
93008753|NCT00817895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008754|NCT00817895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93008755|NCT00817895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008756|NCT00817895|Immunologic Factors|immunologic factors|mesh-ancestor
93008757|NCT00817895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008758|NCT00814229|Vaccines|vaccines|mesh-list
93008759|NCT00814229|Aluminum sulfate|aluminum sulfate|mesh-list
93008760|NCT00814229|Immunologic Factors|immunologic factors|mesh-ancestor
93008761|NCT00814229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008762|NCT00814229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93008763|NCT00568685|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93008764|NCT00568685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93008765|NCT00568685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93008766|NCT00568685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93008767|NCT00568685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008768|NCT00568685|Adrenergic Agents|adrenergic agents|mesh-ancestor
93008769|NCT00568685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008770|NCT00568685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008771|NCT00061945|Leucovorin|leucovorin|mesh-list
93008772|NCT00061945|Cytarabine|cytarabine|mesh-list
93008773|NCT00061945|Acyclovir|acyclovir|mesh-list
93008774|NCT00061945|Trimethoprim|trimethoprim|mesh-list
93008775|NCT00061945|Sulfamethoxazole|sulfamethoxazole|mesh-list
93008776|NCT00061945|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93008777|NCT00061945|Dexamethasone|dexamethasone|mesh-list
93008778|NCT00061945|Cyclophosphamide|cyclophosphamide|mesh-list
93008779|NCT00061945|Methotrexate|methotrexate|mesh-list
93008780|NCT00061945|Vincristine|vincristine|mesh-list
93008781|NCT00061945|Imatinib Mesylate|imatinib mesylate|mesh-list
93008782|NCT00061945|Daunorubicin|daunorubicin|mesh-list
93008783|NCT00061945|Asparaginase|asparaginase|mesh-list
93008784|NCT00061945|Mercaptopurine|mercaptopurine|mesh-list
93008785|NCT00061945|Alemtuzumab|alemtuzumab|mesh-list
93008786|NCT00061945|Allopurinol|allopurinol|mesh-list
93008787|NCT00061945|Levoleucovorin|levoleucovorin|mesh-list
93008788|NCT00061945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008789|NCT00061945|Immunologic Factors|immunologic factors|mesh-ancestor
93008790|NCT00061945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008791|NCT00061945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008792|NCT00061945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93008793|NCT00061945|Alkylating Agents|alkylating agents|mesh-ancestor
93008794|NCT00061945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008795|NCT00061945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008796|NCT00061945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93008797|NCT00061945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008798|NCT00061945|Antiemetics|antiemetics|mesh-ancestor
93008799|NCT00061945|Autonomic Agents|autonomic agents|mesh-ancestor
93008800|NCT00061945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008801|NCT00061945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008802|NCT00061945|Glucocorticoids|glucocorticoids|mesh-ancestor
93008803|NCT00061945|Hormones|hormones|mesh-ancestor
93008804|NCT00061945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008805|NCT00061945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008806|NCT00061945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93008807|NCT00061945|Abortifacient Agents|abortifacient agents|mesh-ancestor
93008809|NCT00061945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93008810|NCT00061945|Antimetabolites|antimetabolites|mesh-ancestor
93008811|NCT00061945|Dermatologic Agents|dermatologic agents|mesh-ancestor
93008812|NCT00061945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008813|NCT00061945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93008814|NCT00061945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93008815|NCT00061945|Antiviral Agents|antiviral agents|mesh-ancestor
93008816|NCT00061945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008817|NCT00061945|Antidotes|antidotes|mesh-ancestor
93008818|NCT00061945|Protective Agents|protective agents|mesh-ancestor
93008819|NCT00061945|Vitamin B Complex|vitamin b complex|mesh-ancestor
93008820|NCT00061945|Vitamins|vitamins|mesh-ancestor
93008821|NCT00061945|Micronutrients|micronutrients|mesh-ancestor
93008822|NCT00061945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93008823|NCT00061945|Tubulin Modulators|tubulin modulators|mesh-ancestor
93008824|NCT00061945|Antimitotic Agents|antimitotic agents|mesh-ancestor
92654150|NCT04536961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93008825|NCT00061945|Mitosis Modulators|mitosis modulators|mesh-ancestor
93008826|NCT00061945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008827|NCT00061945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93008828|NCT00061945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93008829|NCT00061945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93008830|NCT00061945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008831|NCT00061945|Gout Suppressants|gout suppressants|mesh-ancestor
93008832|NCT00061945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93008834|NCT00061945|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93008835|NCT00061945|Antimalarials|antimalarials|mesh-ancestor
93008836|NCT00061945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008837|NCT00061945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008838|NCT00061945|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93008839|NCT00061945|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93008840|NCT00061945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93008841|NCT00061945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93008842|NCT00817973|Caseins|caseins|mesh-list
93008843|NCT00817973|Chelating Agents|chelating agents|mesh-ancestor
93008844|NCT00817973|Sequestering Agents|sequestering agents|mesh-ancestor
93008845|NCT00817973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008846|NCT01097941|Vaccines|vaccines|mesh-list
93008847|NCT01097941|Immunologic Factors|immunologic factors|mesh-ancestor
93008848|NCT01097941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008849|NCT00642473|Metronidazole|metronidazole|mesh-list
93008850|NCT00642473|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93008851|NCT00642473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008852|NCT00642473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008853|NCT00642473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008854|NCT00642473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008855|NCT00642473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008856|NCT00642473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93008857|NCT00642473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93008858|NCT00642473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93008859|NCT00645671|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93008860|NCT00645671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93008861|NCT00366340|Vaccines|vaccines|mesh-list
93008862|NCT00366340|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93008863|NCT00366340|Immunologic Factors|immunologic factors|mesh-ancestor
93008864|NCT00366340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008865|NCT03992326|Cyclophosphamide|cyclophosphamide|mesh-list
93008866|NCT03992326|Fludarabine|fludarabine|mesh-list
93008867|NCT03992326|Interleukin-2|interleukin-2|mesh-list
93008868|NCT03992326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008869|NCT03992326|Immunologic Factors|immunologic factors|mesh-ancestor
93008870|NCT03992326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008871|NCT03992326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008872|NCT03992326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93008873|NCT03992326|Alkylating Agents|alkylating agents|mesh-ancestor
93008874|NCT03992326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008875|NCT03992326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008876|NCT03992326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93008877|NCT03992326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93008878|NCT03992326|Analgesics|analgesics|mesh-ancestor
93008879|NCT03992326|Sensory System Agents|sensory system agents|mesh-ancestor
93008880|NCT03992326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008881|NCT01045954|Insulin|insulin|mesh-list
93008882|NCT01045954|Insulin Glargine|insulin glargine|mesh-list
93008883|NCT01045954|Insulin Lispro|insulin lispro|mesh-list
93008884|NCT01045954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93008885|NCT01045954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008887|NCT01046032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93008888|NCT01046032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008889|NCT00061633|Vancomycin|vancomycin|mesh-list
93008890|NCT00061633|Penicillins|penicillins|mesh-list
93008891|NCT00061633|Telavancin|telavancin|mesh-list
93008892|NCT00061633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93008893|NCT00061633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93008894|NCT00645593|Gemcitabine|gemcitabine|mesh-list
93008895|NCT00645593|Cetuximab|cetuximab|mesh-list
93008896|NCT00645593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008897|NCT00645593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93008898|NCT00645593|Antimetabolites|antimetabolites|mesh-ancestor
93008899|NCT00645593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008900|NCT00645593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008901|NCT01093261|Hydrocortisone|hydrocortisone|mesh-list
93008902|NCT01093261|Fludrocortisone|fludrocortisone|mesh-list
93008903|NCT01093261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008904|NCT02550977|Gestodene|gestodene|mesh-list
93008905|NCT02550977|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93008906|NCT02550977|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93008907|NCT02550977|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93008908|NCT02550977|Contraceptive Agents|contraceptive agents|mesh-ancestor
93008909|NCT02550977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93008910|NCT02550977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008911|NCT02550977|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93008912|NCT02550977|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93008913|NCT02550977|Progestins|progestins|mesh-ancestor
93008914|NCT02550977|Hormones|hormones|mesh-ancestor
93008915|NCT02550977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008916|NCT01045018|Mesalamine|mesalamine|mesh-list
93008917|NCT01045018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93008918|NCT01045018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93008919|NCT01045018|Analgesics|analgesics|mesh-ancestor
93008920|NCT01045018|Sensory System Agents|sensory system agents|mesh-ancestor
93008921|NCT01045018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008922|NCT01045018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008923|NCT01045018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008924|NCT01045018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93008925|NCT01049464|Magnesium Sulfate|magnesium sulfate|mesh-list
93008926|NCT01049464|Analgesics|analgesics|mesh-ancestor
93008927|NCT01049464|Sensory System Agents|sensory system agents|mesh-ancestor
93008928|NCT01049464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008929|NCT01049464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008930|NCT01049464|Anesthetics|anesthetics|mesh-ancestor
93008931|NCT01049464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93008932|NCT01049464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93008933|NCT01049464|Anticonvulsants|anticonvulsants|mesh-ancestor
93008934|NCT01049464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93008935|NCT01049464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93008936|NCT01049464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008937|NCT01049464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93008938|NCT01049464|Tocolytic Agents|tocolytic agents|mesh-ancestor
93008939|NCT01049464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93008940|NCT01046266|Cetuximab|cetuximab|mesh-list
93008941|NCT01046266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93008942|NCT01046266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008943|NCT00365794|Testosterone|testosterone|mesh-list
93008944|NCT00365794|Androgens|androgens|mesh-ancestor
93008945|NCT00365794|Hormones|hormones|mesh-ancestor
93008946|NCT00365794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008947|NCT00365794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008948|NCT01098019|Botulinum Toxins|botulinum toxins|mesh-list
93008949|NCT01098019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93008950|NCT01098019|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93008951|NCT01098019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93008952|NCT01098019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93008953|NCT01098019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008954|NCT01098019|Cholinergic Agents|cholinergic agents|mesh-ancestor
93008955|NCT01098019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93008956|NCT01098019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008958|NCT01098019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93008959|NCT00365716|Vaccines|vaccines|mesh-list
93008960|NCT00365716|Immunologic Factors|immunologic factors|mesh-ancestor
93008961|NCT00365716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008962|NCT01049542|Astressin|astressin|mesh-list
93008963|NCT01049542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93008964|NCT01049542|Protective Agents|protective agents|mesh-ancestor
93008965|NCT01049542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008966|NCT01049620|Capecitabine|capecitabine|mesh-list
93008967|NCT01049620|Oxaliplatin|oxaliplatin|mesh-list
93008968|NCT01049620|Everolimus|everolimus|mesh-list
93008969|NCT01049620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93008970|NCT01049620|Antimetabolites|antimetabolites|mesh-ancestor
93008971|NCT01049620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008972|NCT01049620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008973|NCT01049620|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93008974|NCT01049620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93008975|NCT01049620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008976|NCT01049620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93008977|NCT01049620|Immunologic Factors|immunologic factors|mesh-ancestor
93008978|NCT01049620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008979|NCT00059839|Prednisone|prednisone|mesh-list
93008980|NCT00059839|Doxorubicin|doxorubicin|mesh-list
93008981|NCT00059839|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93008983|NCT00059839|Vincristine|vincristine|mesh-list
93008984|NCT00059839|Mercaptopurine|mercaptopurine|mesh-list
93008985|NCT00059839|Vinblastine|vinblastine|mesh-list
93008986|NCT00059839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93008987|NCT00059839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93008988|NCT00059839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93008989|NCT00059839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93008990|NCT00059839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93008991|NCT00059839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93008992|NCT00059839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93008993|NCT00059839|Glucocorticoids|glucocorticoids|mesh-ancestor
93008994|NCT00059839|Hormones|hormones|mesh-ancestor
93008995|NCT00059839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93008996|NCT00059839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93008997|NCT00059839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93008998|NCT00059839|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93008999|NCT00059839|Abortifacient Agents|abortifacient agents|mesh-ancestor
93009000|NCT00059839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93009001|NCT00059839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009002|NCT00059839|Antimetabolites|antimetabolites|mesh-ancestor
93009003|NCT00059839|Dermatologic Agents|dermatologic agents|mesh-ancestor
93009004|NCT00059839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93009005|NCT00059839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009006|NCT00059839|Immunologic Factors|immunologic factors|mesh-ancestor
93009007|NCT00059839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009008|NCT00059839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93009009|NCT00059839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93009010|NCT00059839|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009011|NCT00059839|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009012|NCT00059839|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009013|NCT00059215|Clopidogrel|clopidogrel|mesh-list
93009014|NCT00059215|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93009015|NCT00059215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93009016|NCT00059215|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93009017|NCT00059215|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93009018|NCT00059215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93009019|NCT00059215|Purinergic Agents|purinergic agents|mesh-ancestor
93009020|NCT00059215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009021|NCT00059215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009022|NCT00059215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009023|NCT00058825|Cyclosporine|cyclosporine|mesh-list
93009024|NCT00058825|Fludarabine|fludarabine|mesh-list
93009025|NCT00058825|Alemtuzumab|alemtuzumab|mesh-list
93009026|NCT00058825|Tacrolimus|tacrolimus|mesh-list
93009027|NCT00058825|Cyclosporins|cyclosporins|mesh-list
93009028|NCT00058825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009029|NCT00058825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009030|NCT00058825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009031|NCT00058825|Immunologic Factors|immunologic factors|mesh-ancestor
93009032|NCT00058825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009033|NCT00058825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93009034|NCT00058825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009035|NCT00058825|Antifungal Agents|antifungal agents|mesh-ancestor
93009036|NCT00058825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009037|NCT00058825|Dermatologic Agents|dermatologic agents|mesh-ancestor
93009038|NCT00058825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009039|NCT00058825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009040|NCT02535052|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93009041|NCT02535052|Immunologic Factors|immunologic factors|mesh-ancestor
93009042|NCT02535052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009043|NCT03953989|Ranolazine|ranolazine|mesh-list
93009044|NCT03953989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93009045|NCT03953989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009046|NCT03953989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009047|NCT01096225|Vaccines|vaccines|mesh-list
93009048|NCT01096225|Immunologic Factors|immunologic factors|mesh-ancestor
93009049|NCT01096225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009050|NCT02535130|Amikacin|amikacin|mesh-list
93009051|NCT02535130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009052|NCT02535130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009053|NCT01046500|Inositol|inositol|mesh-list
93009054|NCT01046500|Metformin|metformin|mesh-list
93009055|NCT01046500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93009056|NCT01046500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009057|NCT01046500|Vitamin B Complex|vitamin b complex|mesh-ancestor
93009058|NCT01046500|Vitamins|vitamins|mesh-ancestor
93009059|NCT01046500|Micronutrients|micronutrients|mesh-ancestor
93009060|NCT01046578|Letrozole|letrozole|mesh-list
93009061|NCT01046578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009062|NCT01046578|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93009063|NCT01046578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93009064|NCT01046578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009065|NCT01046578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009066|NCT01046578|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93009067|NCT01046578|Hormone Antagonists|hormone antagonists|mesh-ancestor
93009068|NCT01046578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009069|NCT01046578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009070|NCT00372424|Docetaxel|docetaxel|mesh-list
93009071|NCT00372424|Trastuzumab|trastuzumab|mesh-list
93009072|NCT00372424|Sunitinib|sunitinib|mesh-list
93009073|NCT00372424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009074|NCT00372424|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009075|NCT00372424|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009076|NCT00372424|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009077|NCT00372424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009078|NCT00372424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009079|NCT00372424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009080|NCT00372424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93009081|NCT00372424|Growth Substances|growth substances|mesh-ancestor
93009082|NCT00372424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009083|NCT00372424|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009084|NCT00372424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93009085|NCT00372424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009086|NCT02530411|Fulvestrant|fulvestrant|mesh-list
93009087|NCT02530411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93009088|NCT02530411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009089|NCT02530411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93009090|NCT02530411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93009091|NCT02530411|Hormone Antagonists|hormone antagonists|mesh-ancestor
93009092|NCT02530411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009093|NCT02530411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009094|NCT01327027|Vasopressins|vasopressins|mesh-list
93009095|NCT01327027|Arginine Vasopressin|arginine vasopressin|mesh-list
93009096|NCT01327027|Hemostatics|hemostatics|mesh-ancestor
93009097|NCT01327027|Coagulants|coagulants|mesh-ancestor
93009098|NCT01327027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93009099|NCT01327027|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93009100|NCT01327027|Natriuretic Agents|natriuretic agents|mesh-ancestor
93009101|NCT01327027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009103|NCT01093807|Enalaprilat|enalaprilat|mesh-list
93009104|NCT01093807|Lercanidipine|lercanidipine|mesh-list
93009105|NCT01093807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93009106|NCT01093807|Protease Inhibitors|protease inhibitors|mesh-ancestor
93009107|NCT01093807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009108|NCT01093807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009109|NCT01093807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93009110|NCT01093807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93009111|NCT01093807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009112|NCT01093807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93009113|NCT01093807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009114|NCT00044083|Tolcapone|tolcapone|mesh-list
93009115|NCT00044083|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93009116|NCT00044083|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93009117|NCT00044083|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93009118|NCT00044083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009119|NCT00044083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009120|NCT00058123|Poly ICLC|poly iclc|mesh-list
93009121|NCT00058123|Interferon Inducers|interferon inducers|mesh-ancestor
93009122|NCT00058123|Immunologic Factors|immunologic factors|mesh-ancestor
93009123|NCT00058123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009124|NCT00022633|Paclitaxel|paclitaxel|mesh-list
93009125|NCT00022633|Gemcitabine|gemcitabine|mesh-list
93009126|NCT00022633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93009127|NCT00022633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654454|NCT00263094|Rofecoxib|rofecoxib|mesh-list
93009128|NCT00022633|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009129|NCT00022633|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009130|NCT00022633|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009131|NCT00022633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009132|NCT00022633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009133|NCT00022633|Antimetabolites|antimetabolites|mesh-ancestor
93009134|NCT00021541|Tipifarnib|tipifarnib|mesh-list
93009135|NCT00021541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009136|NCT00021229|Imatinib Mesylate|imatinib mesylate|mesh-list
93009137|NCT00021229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009138|NCT00021229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93009139|NCT00021229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009140|NCT00021229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009141|NCT02688790|Dalbavancin|dalbavancin|mesh-list
93009142|NCT02688790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009143|NCT02688790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009144|NCT00488475|Etanercept|etanercept|mesh-list
93009145|NCT00488475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93009146|NCT00488475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93009147|NCT00488475|Analgesics|analgesics|mesh-ancestor
93009148|NCT00488475|Sensory System Agents|sensory system agents|mesh-ancestor
93009149|NCT00488475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009150|NCT00488475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009151|NCT00488475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009152|NCT00488475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009153|NCT00488475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93009154|NCT00488475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009155|NCT00488475|Immunologic Factors|immunologic factors|mesh-ancestor
93009156|NCT01020279|Celecoxib|celecoxib|mesh-list
93009157|NCT01020279|Ketoprofen|ketoprofen|mesh-list
93009158|NCT01020279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93009159|NCT01020279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93009160|NCT01020279|Analgesics|analgesics|mesh-ancestor
93009161|NCT01020279|Sensory System Agents|sensory system agents|mesh-ancestor
93009162|NCT01020279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009163|NCT01020279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009164|NCT01020279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009165|NCT01020279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009166|NCT01020279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93009167|NCT01020279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93009168|NCT01020279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009169|NCT01020279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009170|NCT01020357|Caffeine|caffeine|mesh-list
93009171|NCT01020357|Caffeine citrate|caffeine citrate|mesh-list
93009172|NCT01020357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009173|NCT01020357|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93009174|NCT01020357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009175|NCT01020357|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93009177|NCT01020357|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93009178|NCT01020357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93009179|NCT01020357|Purinergic Agents|purinergic agents|mesh-ancestor
93009180|NCT01020357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009181|NCT00042991|Gefitinib|gefitinib|mesh-list
93009182|NCT00042991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009183|NCT00042991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93009184|NCT00042991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009185|NCT00042991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009186|NCT00466167|Pramipexole|pramipexole|mesh-list
93009187|NCT00466167|Antioxidants|antioxidants|mesh-ancestor
93009188|NCT00466167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009189|NCT00466167|Protective Agents|protective agents|mesh-ancestor
93009190|NCT00466167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009191|NCT00466167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93009192|NCT00466167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93009193|NCT00466167|Dopamine Agonists|dopamine agonists|mesh-ancestor
93009194|NCT00466167|Dopamine Agents|dopamine agents|mesh-ancestor
93009195|NCT00466167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009196|NCT01017939|Prednisone|prednisone|mesh-list
93009197|NCT01017939|Abiraterone Acetate|abiraterone acetate|mesh-list
93009198|NCT01017939|Theophylline|theophylline|mesh-list
93009199|NCT01017939|Dextromethorphan|dextromethorphan|mesh-list
93009200|NCT01017939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009201|NCT01017939|Glucocorticoids|glucocorticoids|mesh-ancestor
93009202|NCT01017939|Hormones|hormones|mesh-ancestor
93009203|NCT01017939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009204|NCT01017939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009205|NCT01017939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93009206|NCT01017939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009207|NCT01017939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93009208|NCT01017939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009209|NCT01017939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009210|NCT01017939|Hormone Antagonists|hormone antagonists|mesh-ancestor
93009211|NCT01017939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93009212|NCT01017939|Antitussive Agents|antitussive agents|mesh-ancestor
93009213|NCT01017939|Respiratory System Agents|respiratory system agents|mesh-ancestor
93009214|NCT01017939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93009215|NCT01017939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93009216|NCT01017939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009217|NCT01017939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93009218|NCT01017939|Autonomic Agents|autonomic agents|mesh-ancestor
93009219|NCT01017939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009220|NCT01017939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93009221|NCT01017939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93009222|NCT01017939|Vasodilator Agents|vasodilator agents|mesh-ancestor
93009223|NCT01017939|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93009224|NCT01017939|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93009225|NCT01017939|Purinergic Agents|purinergic agents|mesh-ancestor
93009226|NCT00480441|Dronabinol|dronabinol|mesh-list
93009227|NCT00480441|Hallucinogens|hallucinogens|mesh-ancestor
93009228|NCT00480441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009229|NCT00480441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93009230|NCT00480441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93009231|NCT00480441|Analgesics|analgesics|mesh-ancestor
93009232|NCT00480441|Sensory System Agents|sensory system agents|mesh-ancestor
93009233|NCT00480441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009234|NCT00480441|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93009235|NCT00480441|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93009236|NCT00480441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009237|NCT00480441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009238|NCT00480441|Hormones|hormones|mesh-ancestor
93009239|NCT00480441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009240|NCT01022463|Atenolol|atenolol|mesh-list
93009241|NCT01022463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93009242|NCT01022463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93009243|NCT01022463|Sympatholytics|sympatholytics|mesh-ancestor
93009244|NCT01022463|Autonomic Agents|autonomic agents|mesh-ancestor
93009245|NCT01022463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009246|NCT01022463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009247|NCT01022463|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93009248|NCT01022463|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93009249|NCT01022463|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93009250|NCT01022463|Adrenergic Agents|adrenergic agents|mesh-ancestor
93009251|NCT01022463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009252|NCT01022463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009253|NCT00488319|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93009254|NCT00488319|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93009255|NCT00488319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93009256|NCT00488319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009257|NCT00488319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009258|NCT00488319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93009259|NCT00488319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93009260|NCT00488319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93009261|NCT00488319|Serotonin Agents|serotonin agents|mesh-ancestor
93009262|NCT00488319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009263|NCT00488319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009264|NCT00488319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93009265|NCT00488319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93009266|NCT00488319|Dopamine Agents|dopamine agents|mesh-ancestor
93009267|NCT01018251|Alovudine|alovudine|mesh-list
93009268|NCT01018251|Antiviral Agents|antiviral agents|mesh-ancestor
93009269|NCT01018251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009270|NCT00463047|Fentanyl|fentanyl|mesh-list
93009271|NCT00463047|Oxycodone|oxycodone|mesh-list
93009272|NCT00463047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93009273|NCT00463047|Narcotics|narcotics|mesh-ancestor
93009274|NCT00463047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009275|NCT00463047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009276|NCT00463047|Analgesics|analgesics|mesh-ancestor
93009277|NCT00463047|Sensory System Agents|sensory system agents|mesh-ancestor
93009278|NCT00463047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654622|NCT05896930|Rifampin|rifampin|mesh-list
93009279|NCT00463047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93009280|NCT00463047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93009281|NCT00463047|Anesthetics, General|anesthetics, general|mesh-ancestor
93009282|NCT00463047|Anesthetics|anesthetics|mesh-ancestor
93009283|NCT00487539|Golimumab|golimumab|mesh-list
93009284|NCT00487539|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93009285|NCT00487539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93009286|NCT00487539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009287|NCT00487539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009288|NCT00487539|Immunologic Factors|immunologic factors|mesh-ancestor
93009289|NCT00487539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009290|NCT00486837|Protease Inhibitors|protease inhibitors|mesh-list
93009291|NCT00486837|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93009292|NCT00486837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009293|NCT00486837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009294|NCT00486837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93009295|NCT00486837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93009296|NCT00486759|Bevacizumab|bevacizumab|mesh-list
93009297|NCT00486759|Rituximab|rituximab|mesh-list
93009298|NCT00486759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009299|NCT00486759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009300|NCT00486759|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009301|NCT00486759|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93009302|NCT00486759|Growth Substances|growth substances|mesh-ancestor
93009303|NCT00486759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009304|NCT00486759|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009305|NCT00486759|Immunologic Factors|immunologic factors|mesh-ancestor
93009306|NCT00486759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009307|NCT00486603|Hydroxychloroquine|hydroxychloroquine|mesh-list
93009308|NCT00486603|Temozolomide|temozolomide|mesh-list
93009309|NCT00486603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93009310|NCT00486603|Alkylating Agents|alkylating agents|mesh-ancestor
93009311|NCT00486603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009312|NCT00486603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009313|NCT00486603|Antimalarials|antimalarials|mesh-ancestor
93009314|NCT00486603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93009315|NCT00486603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93009316|NCT00486603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009317|NCT00486603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009318|NCT00486603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009320|NCT00474045|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93009321|NCT00474045|Insulin Aspart|insulin aspart|mesh-list
93009322|NCT00474045|Insulin Detemir|insulin detemir|mesh-list
93009323|NCT00474045|Insulin, Isophane|insulin, isophane|mesh-list
93009324|NCT00474045|Isophane Insulin, Human|isophane insulin, human|mesh-list
93009325|NCT00474045|Isophane insulin, beef|isophane insulin, beef|mesh-list
93009326|NCT00474045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93009327|NCT00474045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009328|NCT01020825|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93009329|NCT01020825|Hemostatics|hemostatics|mesh-ancestor
93009330|NCT01020825|Coagulants|coagulants|mesh-ancestor
93009331|NCT01018485|Botulinum Toxins|botulinum toxins|mesh-list
93009332|NCT01018485|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93009333|NCT01018485|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93009334|NCT01018485|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93009335|NCT01018485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009336|NCT01018485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009337|NCT01018485|Cholinergic Agents|cholinergic agents|mesh-ancestor
93009338|NCT01018485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009339|NCT01018485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009340|NCT01018485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93009341|NCT01018485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009342|NCT00462501|Leucovorin|leucovorin|mesh-list
93009343|NCT00462501|Bevacizumab|bevacizumab|mesh-list
93009344|NCT00462501|Fluorouracil|fluorouracil|mesh-list
93009345|NCT00462501|Oxaliplatin|oxaliplatin|mesh-list
93009346|NCT00462501|Calcium|calcium|mesh-list
93009347|NCT00462501|Levoleucovorin|levoleucovorin|mesh-list
93009348|NCT00462501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009349|NCT00462501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009350|NCT00462501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009351|NCT00462501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93009352|NCT00462501|Growth Substances|growth substances|mesh-ancestor
93009353|NCT00462501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009354|NCT00462501|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009355|NCT00462501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93009356|NCT00462501|Antimetabolites|antimetabolites|mesh-ancestor
93009357|NCT00462501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009358|NCT00462501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009359|NCT00462501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009360|NCT00462501|Immunologic Factors|immunologic factors|mesh-ancestor
93009361|NCT00462501|Antidotes|antidotes|mesh-ancestor
92169058|NCT05908851|Morphine|morphine|mesh-list
93009362|NCT00462501|Protective Agents|protective agents|mesh-ancestor
93009363|NCT00462501|Vitamin B Complex|vitamin b complex|mesh-ancestor
93009364|NCT00462501|Vitamins|vitamins|mesh-ancestor
93009365|NCT00462501|Micronutrients|micronutrients|mesh-ancestor
93009366|NCT03996603|Estrogens|estrogens|mesh-list
93009367|NCT03996603|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93009368|NCT03996603|Hormones|hormones|mesh-ancestor
93009369|NCT03996603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009370|NCT03996603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009371|NCT00462345|Rituximab|rituximab|mesh-list
93009372|NCT00462345|Methotrexate|methotrexate|mesh-list
93009373|NCT00462345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009374|NCT00462345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009375|NCT00462345|Immunologic Factors|immunologic factors|mesh-ancestor
93009376|NCT00462345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009377|NCT00462345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009378|NCT00462345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93009379|NCT00462345|Abortifacient Agents|abortifacient agents|mesh-ancestor
93009380|NCT00462345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93009381|NCT00462345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009382|NCT00462345|Antimetabolites|antimetabolites|mesh-ancestor
93009383|NCT00462345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009384|NCT00462345|Dermatologic Agents|dermatologic agents|mesh-ancestor
93009385|NCT00462345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009386|NCT00462345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93009387|NCT00462345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009388|NCT00462345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93009389|NCT01022541|Bevacizumab|bevacizumab|mesh-list
93009390|NCT01022541|Capecitabine|capecitabine|mesh-list
93009391|NCT01022541|Oxaliplatin|oxaliplatin|mesh-list
93009392|NCT01022541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009393|NCT01022541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354915|NCT01926132|Vitamins|vitamins|mesh-ancestor
93009394|NCT01022541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009395|NCT01022541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93009396|NCT01022541|Growth Substances|growth substances|mesh-ancestor
93009397|NCT01022541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009398|NCT01022541|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009399|NCT01022541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009400|NCT01022541|Antimetabolites|antimetabolites|mesh-ancestor
93009401|NCT01022541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009402|NCT01047202|Vaccines|vaccines|mesh-list
93009403|NCT01047202|Immunologic Factors|immunologic factors|mesh-ancestor
93009404|NCT01047202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009405|NCT01049854|Vidarabine|vidarabine|mesh-list
93009406|NCT01049854|Cyclophosphamide|cyclophosphamide|mesh-list
93009407|NCT01049854|Thiotepa|thiotepa|mesh-list
93009408|NCT01049854|Busulfan|busulfan|mesh-list
93009409|NCT01049854|Fludarabine phosphate|fludarabine phosphate|mesh-list
93009410|NCT01049854|Fludarabine|fludarabine|mesh-list
93009411|NCT01049854|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93009412|NCT01049854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009413|NCT01049854|Immunologic Factors|immunologic factors|mesh-ancestor
93009414|NCT01049854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009415|NCT01049854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009416|NCT01049854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93009417|NCT01049854|Alkylating Agents|alkylating agents|mesh-ancestor
93009418|NCT01049854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009419|NCT01049854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009420|NCT01049854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93009421|NCT01049854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009422|NCT01049854|Antimetabolites|antimetabolites|mesh-ancestor
93009423|NCT01049854|Antiviral Agents|antiviral agents|mesh-ancestor
93009424|NCT01049854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009425|NCT00453999|Oseltamivir|oseltamivir|mesh-list
93009426|NCT00453999|Peramivir|peramivir|mesh-list
93009427|NCT00453999|Antiviral Agents|antiviral agents|mesh-ancestor
93009428|NCT00453999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009429|NCT00453999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009430|NCT00453999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009431|NCT00453921|Methylphenidate|methylphenidate|mesh-list
93009432|NCT00453921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93009433|NCT00453921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009434|NCT00453921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93009435|NCT00453921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93009436|NCT00453921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009437|NCT00453921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009438|NCT00453921|Dopamine Agents|dopamine agents|mesh-ancestor
93009439|NCT00453921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009440|NCT00382720|Docetaxel|docetaxel|mesh-list
93009441|NCT00382720|Capecitabine|capecitabine|mesh-list
93009442|NCT00382720|Oxaliplatin|oxaliplatin|mesh-list
93009443|NCT00382720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169127|NCT05904470|Ruzasvir|ruzasvir|mesh-list
93009444|NCT00382720|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009445|NCT00382720|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009446|NCT00382720|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009447|NCT00382720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009448|NCT00382720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009449|NCT00382720|Antimetabolites|antimetabolites|mesh-ancestor
93009450|NCT01025349|Bevacizumab|bevacizumab|mesh-list
93009451|NCT01025349|Docetaxel|docetaxel|mesh-list
93009452|NCT01025349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009453|NCT01025349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009454|NCT01025349|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009455|NCT01025349|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93009456|NCT01025349|Growth Substances|growth substances|mesh-ancestor
93009457|NCT01025349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009458|NCT01025349|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009459|NCT01025349|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009460|NCT01025349|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009461|NCT01025349|Mitosis Modulators|mitosis modulators|mesh-ancestor
92528608|NCT00000827|Immunologic Factors|immunologic factors|mesh-ancestor
93009462|NCT01025349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009463|NCT02473276|Morphine|morphine|mesh-list
93009464|NCT02473276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93009465|NCT02473276|Narcotics|narcotics|mesh-ancestor
93009466|NCT02473276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009467|NCT02473276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009468|NCT02473276|Analgesics|analgesics|mesh-ancestor
93009469|NCT02473276|Sensory System Agents|sensory system agents|mesh-ancestor
93009470|NCT02473276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009471|NCT00453063|Mometasone Furoate|mometasone furoate|mesh-list
93009472|NCT00453063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009473|NCT00453063|Dermatologic Agents|dermatologic agents|mesh-ancestor
93009474|NCT00453063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93009475|NCT00371566|Lapatinib|lapatinib|mesh-list
93009476|NCT00371566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009477|NCT00371566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93009478|NCT00371566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009479|NCT00371566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009480|NCT00371254|Dasatinib|dasatinib|mesh-list
93009481|NCT00371254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009482|NCT00371254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93009483|NCT00371254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009484|NCT00371254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009485|NCT00452673|Capecitabine|capecitabine|mesh-list
93009486|NCT00452673|Dasatinib|dasatinib|mesh-list
93009487|NCT00452673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009488|NCT00452673|Antimetabolites|antimetabolites|mesh-ancestor
93009489|NCT00452673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009490|NCT00452673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009491|NCT00452673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93009492|NCT00452673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009494|NCT00461253|Levonorgestrel|levonorgestrel|mesh-list
93009495|NCT00461253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93009496|NCT00461253|Contraceptive Agents|contraceptive agents|mesh-ancestor
93009497|NCT00461253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93009498|NCT00461253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009499|NCT00461253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93009500|NCT00461253|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93009501|NCT00461253|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93009502|NCT00461253|Trace Elements|trace elements|mesh-ancestor
93009503|NCT00461253|Micronutrients|micronutrients|mesh-ancestor
93009504|NCT00469833|Insulin|insulin|mesh-list
93009505|NCT00469833|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93009506|NCT00469833|Insulin Glargine|insulin glargine|mesh-list
93009507|NCT00469833|Insulin, Long-Acting|insulin, long-acting|mesh-list
93009508|NCT00469833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93009509|NCT00469833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009510|NCT00641537|Cladribine|cladribine|mesh-list
93009511|NCT00641537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009512|NCT00641537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009513|NCT00641537|Immunologic Factors|immunologic factors|mesh-ancestor
93009514|NCT00641537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009515|NCT01025583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93009516|NCT00814541|Dexamethasone|dexamethasone|mesh-list
93009517|NCT00814541|Doxorubicin|doxorubicin|mesh-list
93009518|NCT00814541|Bortezomib|bortezomib|mesh-list
93009519|NCT00814541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009520|NCT00814541|Antiemetics|antiemetics|mesh-ancestor
93009521|NCT00814541|Autonomic Agents|autonomic agents|mesh-ancestor
93009522|NCT00814541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169204|NCT05904002|Hormones|hormones|mesh-ancestor
93009523|NCT00814541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009524|NCT00814541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93009525|NCT00814541|Glucocorticoids|glucocorticoids|mesh-ancestor
93009526|NCT00814541|Hormones|hormones|mesh-ancestor
93009527|NCT00814541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009528|NCT00814541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93009529|NCT00814541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009530|NCT00814541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93009531|NCT00814541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93009532|NCT00814541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93009533|NCT00814541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009534|NCT00814541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009535|NCT00814619|Capecitabine|capecitabine|mesh-list
93009536|NCT00814619|Panitumumab|panitumumab|mesh-list
93009537|NCT00814619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009538|NCT00814619|Antimetabolites|antimetabolites|mesh-ancestor
93009539|NCT00814619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009540|NCT00814619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009541|NCT00814619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009542|NCT00641147|Curcumin|curcumin|mesh-list
93009543|NCT00641147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93009544|NCT00641147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93009545|NCT00641147|Analgesics|analgesics|mesh-ancestor
93009546|NCT00641147|Sensory System Agents|sensory system agents|mesh-ancestor
93009547|NCT00641147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009548|NCT00641147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009549|NCT00641147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009550|NCT00641147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009551|NCT00641147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009552|NCT00641147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009553|NCT00641147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009554|NCT00460239|Morphine|morphine|mesh-list
93009555|NCT00460239|Buprenorphine|buprenorphine|mesh-list
93009556|NCT00460239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93009557|NCT00460239|Narcotics|narcotics|mesh-ancestor
93009558|NCT00460239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009559|NCT00460239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009560|NCT00460239|Analgesics|analgesics|mesh-ancestor
93009561|NCT00460239|Sensory System Agents|sensory system agents|mesh-ancestor
92169241|NCT05903937|Analgesics|analgesics|mesh-ancestor
93009562|NCT00460239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009563|NCT00460239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93009564|NCT00640835|Buprenorphine|buprenorphine|mesh-list
93009565|NCT00640835|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93009566|NCT00640835|Naloxone|naloxone|mesh-list
93009567|NCT00640835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93009568|NCT00640835|Narcotics|narcotics|mesh-ancestor
93009569|NCT00640835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009570|NCT00640835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009571|NCT00640835|Analgesics|analgesics|mesh-ancestor
93009572|NCT00640835|Sensory System Agents|sensory system agents|mesh-ancestor
93009573|NCT00640835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009574|NCT00640835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93009575|NCT03839355|Warfarin|warfarin|mesh-list
93009576|NCT03839355|Apixaban|apixaban|mesh-list
93009577|NCT03839355|Anticoagulants|anticoagulants|mesh-ancestor
93009578|NCT03839355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93009579|NCT03839355|Antithrombins|antithrombins|mesh-ancestor
93009580|NCT03839355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93009581|NCT03839355|Protease Inhibitors|protease inhibitors|mesh-ancestor
93009582|NCT03839355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009583|NCT03839355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009584|NCT00640601|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93009585|NCT00640601|Antidepressive Agents|antidepressive agents|mesh-ancestor
93009586|NCT00640601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93009587|NCT00640601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93009588|NCT00640601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93009589|NCT00640601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009590|NCT00640601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009592|NCT02551133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009593|NCT02551133|Antiemetics|antiemetics|mesh-ancestor
93009594|NCT02551133|Autonomic Agents|autonomic agents|mesh-ancestor
93009595|NCT02551133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009596|NCT02551133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009597|NCT02551133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93009598|NCT02551133|Glucocorticoids|glucocorticoids|mesh-ancestor
93009599|NCT02551133|Hormones|hormones|mesh-ancestor
93009600|NCT02551133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93009601|NCT02551133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93009602|NCT02551133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009603|NCT00818285|Psychotropic Drugs|psychotropic drugs|mesh-list
93009604|NCT00452439|Vitamin D|vitamin d|mesh-list
93009605|NCT00452439|Risedronic Acid|risedronic acid|mesh-list
93009606|NCT00452439|Etidronic Acid|etidronic acid|mesh-list
93009607|NCT00452439|Calcium|calcium|mesh-list
93009608|NCT00452439|Vitamins|vitamins|mesh-ancestor
93009609|NCT00452439|Micronutrients|micronutrients|mesh-ancestor
93009610|NCT00452439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009611|NCT00452439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93009612|NCT00452439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93009613|NCT00452439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92355131|NCT03238248|Azacitidine|azacitidine|mesh-list
93009615|NCT00452439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009616|NCT01023087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93009617|NCT01023087|Colistin|colistin|mesh-list
93009618|NCT01023087|Polymyxins|polymyxins|mesh-list
93009619|NCT01023087|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93009620|NCT01023087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009621|NCT01023087|Antitubercular Agents|antitubercular agents|mesh-ancestor
93009622|NCT00381940|Bortezomib|bortezomib|mesh-list
93009623|NCT00381940|Vinorelbine|vinorelbine|mesh-list
93009624|NCT00381940|Ifosfamide|ifosfamide|mesh-list
93009625|NCT00381940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009626|NCT00381940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93009627|NCT00381940|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009628|NCT00381940|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009629|NCT00381940|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009630|NCT00381940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009631|NCT00381940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93009632|NCT00381940|Alkylating Agents|alkylating agents|mesh-ancestor
93009633|NCT00818675|Sirolimus|sirolimus|mesh-list
93009634|NCT00818675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009635|NCT00818675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009636|NCT00818675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93009637|NCT00818675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009638|NCT00818675|Antifungal Agents|antifungal agents|mesh-ancestor
93009639|NCT00818675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009640|NCT00818675|Immunologic Factors|immunologic factors|mesh-ancestor
93009641|NCT00818675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009642|NCT00364156|Nicotine|nicotine|mesh-list
93009643|NCT00364156|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93009644|NCT00364156|Autonomic Agents|autonomic agents|mesh-ancestor
93009645|NCT00364156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009646|NCT00364156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009647|NCT00364156|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93009648|NCT00364156|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93009649|NCT00364156|Cholinergic Agents|cholinergic agents|mesh-ancestor
93009650|NCT00364156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009651|NCT00364156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009652|NCT00452361|Cyclosporine|cyclosporine|mesh-list
93009653|NCT00452361|Sirolimus|sirolimus|mesh-list
93009654|NCT00452361|Tacrolimus|tacrolimus|mesh-list
93009655|NCT00452361|Cyclosporins|cyclosporins|mesh-list
93009656|NCT00452361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93009657|NCT00452361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654974|NCT05400122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009658|NCT00452361|Immunologic Factors|immunologic factors|mesh-ancestor
93009659|NCT00452361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009660|NCT00452361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009661|NCT00452361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009662|NCT00452361|Antifungal Agents|antifungal agents|mesh-ancestor
93009663|NCT00452361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009664|NCT00452361|Dermatologic Agents|dermatologic agents|mesh-ancestor
93009665|NCT00452361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009666|NCT00452361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009667|NCT00452361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93009668|NCT00452361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009669|NCT03334318|Allopurinol|allopurinol|mesh-list
93009670|NCT03334318|Antimetabolites|antimetabolites|mesh-ancestor
93009671|NCT03334318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009672|NCT03334318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009673|NCT03334318|Gout Suppressants|gout suppressants|mesh-ancestor
93009674|NCT03334318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009675|NCT03334318|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93009676|NCT03334318|Antioxidants|antioxidants|mesh-ancestor
93009677|NCT03334318|Protective Agents|protective agents|mesh-ancestor
93009678|NCT03334318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009679|NCT00640289|Fibrinolysin|fibrinolysin|mesh-list
93009680|NCT00640289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93009681|NCT00640289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93009682|NCT00640289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009683|NCT03877809|Sirolimus|sirolimus|mesh-list
93009684|NCT03877809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009685|NCT03877809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009686|NCT03877809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93009687|NCT03877809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009688|NCT03877809|Antifungal Agents|antifungal agents|mesh-ancestor
93009689|NCT03877809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009690|NCT03877809|Immunologic Factors|immunologic factors|mesh-ancestor
93009691|NCT03877809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009692|NCT01049932|Rilpivirine|rilpivirine|mesh-list
93009693|NCT01049932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93009694|NCT01049932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93009695|NCT01049932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009696|NCT01049932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009697|NCT01049932|Antiviral Agents|antiviral agents|mesh-ancestor
93009698|NCT01049932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009699|NCT01049932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93009700|NCT01049932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93009701|NCT01047670|Hydrocortisone|hydrocortisone|mesh-list
93009702|NCT01047670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009703|NCT00819065|Botulinum Toxins|botulinum toxins|mesh-list
93009704|NCT00819065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93009705|NCT00819065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93009706|NCT00819065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93009707|NCT00819065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009708|NCT00819065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009709|NCT00819065|Cholinergic Agents|cholinergic agents|mesh-ancestor
93009710|NCT00819065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009711|NCT00819065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009712|NCT00819065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93009713|NCT00819065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009714|NCT01047748|Digoxin|digoxin|mesh-list
93009715|NCT01047748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93009716|NCT01047748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93009717|NCT01047748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009718|NCT01047748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009719|NCT01047748|Protective Agents|protective agents|mesh-ancestor
93009720|NCT01047748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009721|NCT00568451|Paclitaxel|paclitaxel|mesh-list
93009722|NCT00568451|Carboplatin|carboplatin|mesh-list
93009723|NCT00568451|Temozolomide|temozolomide|mesh-list
93009724|NCT00568451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93009725|NCT00568451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009726|NCT00568451|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009727|NCT00568451|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009728|NCT00568451|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009729|NCT00568451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009730|NCT00568451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93009731|NCT00568451|Alkylating Agents|alkylating agents|mesh-ancestor
93009732|NCT00459537|Terbinafine|terbinafine|mesh-list
93009733|NCT00459537|Amorolfine|amorolfine|mesh-list
93009734|NCT00459537|Antifungal Agents|antifungal agents|mesh-ancestor
93009735|NCT00459537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655057|NCT05145764|Suvorexant|suvorexant|mesh-list
93009736|NCT00459537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009737|NCT00459537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009738|NCT03866421|Liver Extracts|liver extracts|mesh-list
93009739|NCT03866421|Hematinics|hematinics|mesh-ancestor
93009740|NCT00819377|Milrinone|milrinone|mesh-list
93009741|NCT00819377|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93009742|NCT00819377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93009743|NCT00819377|Vasodilator Agents|vasodilator agents|mesh-ancestor
93009744|NCT00819377|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93009745|NCT00819377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93009746|NCT00819377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009747|NCT00819377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009748|NCT00819377|Protective Agents|protective agents|mesh-ancestor
93009749|NCT00819377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009750|NCT01023165|Insulin Lispro|insulin lispro|mesh-list
93009751|NCT01023165|Insulin Aspart|insulin aspart|mesh-list
93009752|NCT01023165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93009753|NCT01023165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009754|NCT01023243|Aspirin|aspirin|mesh-list
93009755|NCT01023243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93009756|NCT01023243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93009757|NCT01023243|Analgesics|analgesics|mesh-ancestor
93009758|NCT01023243|Sensory System Agents|sensory system agents|mesh-ancestor
93009759|NCT01023243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009760|NCT01023243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009761|NCT01023243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93009762|NCT01023243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009763|NCT01023243|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93009764|NCT01023243|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93009765|NCT01023243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009766|NCT01023243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93009767|NCT01023243|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93009768|NCT01023243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009770|NCT03762915|Minocycline|minocycline|mesh-list
93009771|NCT03762915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009772|NCT03762915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009773|NCT00469209|Ascorbic Acid|ascorbic acid|mesh-list
93009774|NCT00469209|Bortezomib|bortezomib|mesh-list
93009775|NCT00469209|Melphalan|melphalan|mesh-list
93009776|NCT00469209|Arsenic Trioxide|arsenic trioxide|mesh-list
93009777|NCT00469209|Vitamins|vitamins|mesh-ancestor
93009778|NCT00469209|Micronutrients|micronutrients|mesh-ancestor
93009779|NCT00469209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009780|NCT00469209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009781|NCT00469209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93009782|NCT00469209|Alkylating Agents|alkylating agents|mesh-ancestor
93009783|NCT00469209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009784|NCT00469209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93009785|NCT00469209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009786|NCT00469209|Immunologic Factors|immunologic factors|mesh-ancestor
93009787|NCT00469209|Antioxidants|antioxidants|mesh-ancestor
93009788|NCT00469209|Protective Agents|protective agents|mesh-ancestor
93009789|NCT00635219|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93009790|NCT00635219|Vortioxetine|vortioxetine|mesh-list
93009791|NCT00635219|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93009792|NCT00635219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93009793|NCT00635219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009794|NCT00635219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009795|NCT00635219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009796|NCT00635219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009797|NCT00635219|Analgesics|analgesics|mesh-ancestor
93009798|NCT00635219|Sensory System Agents|sensory system agents|mesh-ancestor
93009799|NCT00635219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009800|NCT00635219|Antidepressive Agents|antidepressive agents|mesh-ancestor
93009801|NCT00635219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93009802|NCT00635219|Dopamine Agents|dopamine agents|mesh-ancestor
93009803|NCT00635219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93009804|NCT00635219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93009805|NCT00635219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009806|NCT00635219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93009807|NCT00635219|Serotonin Agents|serotonin agents|mesh-ancestor
93009808|NCT00635219|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93009809|NCT00635219|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93009810|NCT00635219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93009811|NCT00635219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93009812|NCT01026129|Lidocaine|lidocaine|mesh-list
93009813|NCT01026129|Remifentanil|remifentanil|mesh-list
93009814|NCT01026129|Anesthetics, Local|anesthetics, local|mesh-ancestor
93009815|NCT01026129|Anesthetics|anesthetics|mesh-ancestor
93009816|NCT01026129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009817|NCT01026129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009818|NCT01026129|Sensory System Agents|sensory system agents|mesh-ancestor
93009819|NCT01026129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009820|NCT01026129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93009821|NCT01026129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93009822|NCT01026129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93009823|NCT01026129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009824|NCT01026129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009825|NCT01026129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93009826|NCT01026129|Narcotics|narcotics|mesh-ancestor
93009827|NCT01026129|Analgesics|analgesics|mesh-ancestor
93009828|NCT01026285|Risperidone|risperidone|mesh-list
93009829|NCT01026285|Antipsychotic Agents|antipsychotic agents|mesh-list
93009830|NCT01026285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93009831|NCT01026285|Serotonin Agents|serotonin agents|mesh-ancestor
93009832|NCT01026285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009833|NCT01026285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009834|NCT01026285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528617|NCT00036634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93009835|NCT01026285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93009836|NCT01026285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009837|NCT01026285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93009838|NCT01026285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93009839|NCT01026285|Dopamine Agents|dopamine agents|mesh-ancestor
93009840|NCT01026363|Vitamin D|vitamin d|mesh-list
93009841|NCT01026363|Ergocalciferols|ergocalciferols|mesh-list
93009842|NCT01026363|Cholecalciferol|cholecalciferol|mesh-list
93009843|NCT01026363|Calcitriol|calcitriol|mesh-list
93009844|NCT01026363|Vitamins|vitamins|mesh-list
93009845|NCT01026363|Micronutrients|micronutrients|mesh-ancestor
93009846|NCT01026363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009847|NCT01026363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93009848|NCT01026363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93009849|NCT01026363|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93009850|NCT01026363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009851|NCT01026363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009852|NCT01026363|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93009853|NCT01023399|Artesunate|artesunate|mesh-list
93009854|NCT01023399|Amodiaquine|amodiaquine|mesh-list
93009855|NCT01023399|Antimalarials|antimalarials|mesh-ancestor
93009856|NCT01023399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93009857|NCT01023399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93009858|NCT01023399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009859|NCT01023399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009860|NCT01023399|Antiviral Agents|antiviral agents|mesh-ancestor
93009861|NCT01023399|Schistosomicides|schistosomicides|mesh-ancestor
93009862|NCT01023399|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93009863|NCT01023399|Anthelmintics|anthelmintics|mesh-ancestor
93009864|NCT00451191|Botulinum Toxins|botulinum toxins|mesh-list
93009865|NCT00451191|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93009866|NCT00451191|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93009867|NCT00451191|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93009868|NCT00451191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93009869|NCT00451191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009870|NCT00451191|Cholinergic Agents|cholinergic agents|mesh-ancestor
93009871|NCT00451191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009872|NCT00451191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009873|NCT00451191|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93009874|NCT00451191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009875|NCT00451035|Panobinostat|panobinostat|mesh-list
93009876|NCT00451035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009877|NCT00451035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93009878|NCT00451035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009879|NCT00451035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009880|NCT00468585|Bevacizumab|bevacizumab|mesh-list
93009881|NCT00468585|Capecitabine|capecitabine|mesh-list
93009882|NCT00468585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009883|NCT00468585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009884|NCT00468585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009885|NCT00468585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655202|NCT04898894|Cytarabine|cytarabine|mesh-list
93009886|NCT00468585|Growth Substances|growth substances|mesh-ancestor
93009887|NCT00468585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009888|NCT00468585|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009889|NCT00468585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009890|NCT00468585|Antimetabolites|antimetabolites|mesh-ancestor
93009891|NCT00468585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009893|NCT01026597|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93009894|NCT01026597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93009895|NCT01026597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93009896|NCT01026597|Antimetabolites|antimetabolites|mesh-ancestor
93009897|NCT01026597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009898|NCT01026597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93009899|NCT01026597|Protease Inhibitors|protease inhibitors|mesh-ancestor
93009900|NCT01026597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009901|NCT01026597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93009902|NCT00450801|Leucovorin|leucovorin|mesh-list
93009903|NCT00450801|Cytarabine|cytarabine|mesh-list
93009904|NCT00450801|Thalidomide|thalidomide|mesh-list
93009905|NCT00450801|Cyclophosphamide|cyclophosphamide|mesh-list
93009906|NCT00450801|Ifosfamide|ifosfamide|mesh-list
93009907|NCT00450801|Rituximab|rituximab|mesh-list
93009908|NCT00450801|Doxorubicin|doxorubicin|mesh-list
93009909|NCT00450801|Methotrexate|methotrexate|mesh-list
93009910|NCT00450801|Etoposide|etoposide|mesh-list
92528619|NCT00000851|Didanosine|didanosine|mesh-list
93009911|NCT00450801|Vincristine|vincristine|mesh-list
93009912|NCT00450801|Granisetron|granisetron|mesh-list
93009913|NCT00450801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93009914|NCT00450801|Immunologic Factors|immunologic factors|mesh-ancestor
93009915|NCT00450801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009916|NCT00450801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93009917|NCT00450801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93009918|NCT00450801|Alkylating Agents|alkylating agents|mesh-ancestor
93009919|NCT00450801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009920|NCT00450801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009921|NCT00450801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93009922|NCT00450801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93009923|NCT00450801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93009924|NCT00450801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93009925|NCT00450801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93009926|NCT00450801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009927|NCT00450801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93009928|NCT00450801|Abortifacient Agents|abortifacient agents|mesh-ancestor
93009929|NCT00450801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93009930|NCT00450801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93009931|NCT00450801|Antimetabolites|antimetabolites|mesh-ancestor
93009932|NCT00450801|Dermatologic Agents|dermatologic agents|mesh-ancestor
93009933|NCT00450801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93009934|NCT00450801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93009935|NCT00450801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93009936|NCT00450801|Antiviral Agents|antiviral agents|mesh-ancestor
93009937|NCT00450801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93009938|NCT00450801|Antidotes|antidotes|mesh-ancestor
93009939|NCT00450801|Protective Agents|protective agents|mesh-ancestor
93009940|NCT00450801|Vitamin B Complex|vitamin b complex|mesh-ancestor
93009941|NCT00450801|Vitamins|vitamins|mesh-ancestor
93009942|NCT00450801|Micronutrients|micronutrients|mesh-ancestor
93009943|NCT00450801|Tubulin Modulators|tubulin modulators|mesh-ancestor
93009944|NCT00450801|Antimitotic Agents|antimitotic agents|mesh-ancestor
93009945|NCT00450801|Mitosis Modulators|mitosis modulators|mesh-ancestor
93009946|NCT00450801|Antiemetics|antiemetics|mesh-ancestor
93009947|NCT00450801|Autonomic Agents|autonomic agents|mesh-ancestor
93009948|NCT00450801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93009949|NCT00450801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93009950|NCT00450801|Leprostatic Agents|leprostatic agents|mesh-ancestor
93009951|NCT00450801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93009952|NCT00450801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93009953|NCT00450801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93009954|NCT00450801|Growth Substances|growth substances|mesh-ancestor
93009955|NCT00450801|Growth Inhibitors|growth inhibitors|mesh-ancestor
93009956|NCT00450801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93009957|NCT00450801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93009958|NCT00450801|Serotonin Agents|serotonin agents|mesh-ancestor
93009959|NCT00450801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009960|NCT01023633|Oxaliplatin|oxaliplatin|mesh-list
92655282|NCT04589845|Immunotoxins|immunotoxins|mesh-ancestor
93009961|NCT01023633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93009962|NCT00458211|Ziprasidone|ziprasidone|mesh-list
93009964|NCT00458211|Serotonin Agents|serotonin agents|mesh-ancestor
93009965|NCT00458211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009966|NCT00458211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009967|NCT00458211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009968|NCT00458211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93009969|NCT00458211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93009970|NCT00458211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93009971|NCT00458211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93009972|NCT00458211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93009973|NCT00458211|Dopamine Agents|dopamine agents|mesh-ancestor
93009974|NCT00450723|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
93009975|NCT00450723|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93009976|NCT00450723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009977|NCT00457821|Ivacaftor|ivacaftor|mesh-list
93009978|NCT00457821|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93009979|NCT00457821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169508|NCT05861570|Viscosupplements|viscosupplements|mesh-ancestor
93009980|NCT00457821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009981|NCT00633893|Apixaban|apixaban|mesh-list
93009982|NCT00633893|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93009983|NCT00633893|Antithrombins|antithrombins|mesh-ancestor
93009984|NCT00633893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93009985|NCT00633893|Protease Inhibitors|protease inhibitors|mesh-ancestor
93009986|NCT00633893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009987|NCT00633893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009988|NCT00633893|Anticoagulants|anticoagulants|mesh-ancestor
93009990|NCT02550665|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93009991|NCT02550665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93009992|NCT02550665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93009993|NCT02550665|Cholinergic Agents|cholinergic agents|mesh-ancestor
93009994|NCT02550665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93009995|NCT02550665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93009996|NCT02550665|Nootropic Agents|nootropic agents|mesh-ancestor
93009997|NCT00819845|Carvedilol|carvedilol|mesh-list
93009998|NCT00819845|Ramipril|ramipril|mesh-list
93009999|NCT00819845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93010000|NCT00819845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93010001|NCT00819845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93010002|NCT00819845|Adrenergic Agents|adrenergic agents|mesh-ancestor
93010003|NCT00819845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010004|NCT00819845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010005|NCT00819845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010006|NCT00819845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93010007|NCT00819845|Antioxidants|antioxidants|mesh-ancestor
93010008|NCT00819845|Protective Agents|protective agents|mesh-ancestor
93010009|NCT00819845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93010010|NCT00819845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010011|NCT00819845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93010012|NCT00819845|Vasodilator Agents|vasodilator agents|mesh-ancestor
93010013|NCT00819845|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93010014|NCT00819845|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93010015|NCT00819845|Protease Inhibitors|protease inhibitors|mesh-ancestor
93010016|NCT00819845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010017|NCT00457743|Sunitinib|sunitinib|mesh-list
93010018|NCT00457743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010019|NCT00457743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010020|NCT00457743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010021|NCT00457743|Growth Substances|growth substances|mesh-ancestor
93010022|NCT00457743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010023|NCT00457743|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010024|NCT00457743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93010025|NCT00457743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010026|NCT00457743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010027|NCT01023867|Donepezil|donepezil|mesh-list
93010028|NCT01023867|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93010029|NCT01023867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010030|NCT01023867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010031|NCT01023867|Cholinergic Agents|cholinergic agents|mesh-ancestor
93010032|NCT01023867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010033|NCT01023867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010034|NCT01023867|Nootropic Agents|nootropic agents|mesh-ancestor
93010035|NCT00820469|Rituximab|rituximab|mesh-list
93010036|NCT00820469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010037|NCT00820469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010038|NCT00820469|Immunologic Factors|immunologic factors|mesh-ancestor
93010039|NCT00820469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010040|NCT00820469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010042|NCT00815399|Pioglitazone|pioglitazone|mesh-list
93010043|NCT00815399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93010044|NCT00815399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010045|NCT00644969|Varenicline|varenicline|mesh-list
93010046|NCT00644969|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93010047|NCT00644969|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93010048|NCT00644969|Cholinergic Agents|cholinergic agents|mesh-ancestor
93010049|NCT00644969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010050|NCT00644969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010051|NCT00644969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010052|NCT00812435|Eptifibatide|eptifibatide|mesh-list
93010053|NCT00812435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93010054|NCT00812513|Becaplermin|becaplermin|mesh-list
93010055|NCT00812513|Anticoagulants|anticoagulants|mesh-ancestor
93010056|NCT00812513|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93010057|NCT00812513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010058|NCT00812513|Growth Substances|growth substances|mesh-ancestor
93010059|NCT00812513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010060|NCT00820547|Cyclophosphamide|cyclophosphamide|mesh-list
93010061|NCT00820547|Bevacizumab|bevacizumab|mesh-list
93010062|NCT00820547|Docetaxel|docetaxel|mesh-list
93010063|NCT00820547|Fluorouracil|fluorouracil|mesh-list
93010064|NCT00820547|Epirubicin|epirubicin|mesh-list
93010065|NCT00820547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010066|NCT00820547|Immunologic Factors|immunologic factors|mesh-ancestor
93010067|NCT00820547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010068|NCT00820547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010069|NCT00820547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93010070|NCT00820547|Alkylating Agents|alkylating agents|mesh-ancestor
93010071|NCT00820547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010072|NCT00820547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010073|NCT00820547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93010074|NCT00820547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010075|NCT00820547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010076|NCT00820547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010077|NCT00820547|Growth Substances|growth substances|mesh-ancestor
93010078|NCT00820547|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010079|NCT00820547|Tubulin Modulators|tubulin modulators|mesh-ancestor
93010080|NCT00820547|Antimitotic Agents|antimitotic agents|mesh-ancestor
93010081|NCT00820547|Mitosis Modulators|mitosis modulators|mesh-ancestor
93010082|NCT00820547|Antimetabolites|antimetabolites|mesh-ancestor
93010083|NCT00820547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010084|NCT00820547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010085|NCT00820547|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93010086|NCT00820547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010087|NCT00820547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010088|NCT00815867|Epoetin Alfa|epoetin alfa|mesh-list
93010089|NCT00815867|Hematinics|hematinics|mesh-ancestor
93010090|NCT00815945|Carboplatin|carboplatin|mesh-list
93010091|NCT00815945|Doxorubicin|doxorubicin|mesh-list
93010092|NCT00815945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010093|NCT00815945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010094|NCT00815945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93010095|NCT00815945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010096|NCT00815945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010097|NCT00815945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010098|NCT00812825|Prednisolone|prednisolone|mesh-list
93010099|NCT00812825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010100|NCT00812825|Glucocorticoids|glucocorticoids|mesh-ancestor
93010101|NCT00812825|Hormones|hormones|mesh-ancestor
93010102|NCT00812825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010103|NCT00812825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010104|NCT00812825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93010105|NCT00812825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010106|NCT00628355|Lidocaine|lidocaine|mesh-list
93010107|NCT00628355|Anesthetics, Local|anesthetics, local|mesh-ancestor
93010108|NCT00628355|Anesthetics|anesthetics|mesh-ancestor
93010109|NCT00628355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010110|NCT00628355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655427|NCT04101877|Bevacizumab|bevacizumab|mesh-list
93010111|NCT00628355|Sensory System Agents|sensory system agents|mesh-ancestor
93010112|NCT00628355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010113|NCT00628355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93010114|NCT00628355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93010115|NCT00628355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93010116|NCT00628355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010117|NCT00628355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010119|NCT00647699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93010120|NCT00647699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93010121|NCT00647699|Vitamin B Complex|vitamin b complex|mesh-ancestor
93010122|NCT00647699|Vitamins|vitamins|mesh-ancestor
93010123|NCT00647699|Micronutrients|micronutrients|mesh-ancestor
93010124|NCT00647699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010125|NCT00647699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93010126|NCT00647699|Dermatologic Agents|dermatologic agents|mesh-ancestor
93010127|NCT00813059|Bevacizumab|bevacizumab|mesh-list
93010128|NCT00813059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010129|NCT00813059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010130|NCT00813059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010131|NCT00813059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010132|NCT00813059|Growth Substances|growth substances|mesh-ancestor
93010133|NCT00813059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010134|NCT00813059|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010135|NCT00467649|Insulin|insulin|mesh-list
93010136|NCT00467649|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93010137|NCT00467649|Insulin Glargine|insulin glargine|mesh-list
93010138|NCT00467649|Insulin Aspart|insulin aspart|mesh-list
93010139|NCT00467649|Insulin Lispro|insulin lispro|mesh-list
93010140|NCT00467649|Insulin Detemir|insulin detemir|mesh-list
93010141|NCT00467649|Insulin glulisine|insulin glulisine|mesh-list
93010142|NCT00467649|Pramlintide|pramlintide|mesh-list
93010143|NCT00467649|Insulin, Short-Acting|insulin, short-acting|mesh-list
93010144|NCT00467649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93010145|NCT00467649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010146|NCT01023945|Ipragliflozin|ipragliflozin|mesh-list
93010147|NCT01023945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93010148|NCT01023945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010149|NCT01023945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93010150|NCT01023945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010151|NCT00450333|Epoetin Alfa|epoetin alfa|mesh-list
93010152|NCT00450333|Hematinics|hematinics|mesh-ancestor
93010153|NCT00643565|Bevacizumab|bevacizumab|mesh-list
93010154|NCT00643565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010155|NCT00643565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010156|NCT00643565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010157|NCT00643565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010158|NCT00643565|Growth Substances|growth substances|mesh-ancestor
93010159|NCT00643565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010160|NCT00643565|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010161|NCT00450255|Aflibercept|aflibercept|mesh-list
93010162|NCT00450255|Endothelial Growth Factors|endothelial growth factors|mesh-list
93010163|NCT00450255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010164|NCT00450255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010165|NCT00450255|Growth Substances|growth substances|mesh-ancestor
93010166|NCT00450255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010167|NCT00450255|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010168|NCT00450255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010169|NCT00816335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93010170|NCT00816335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93010171|NCT00816335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010172|NCT00816413|Cyclosporine|cyclosporine|mesh-list
93010173|NCT00816413|Mycophenolic Acid|mycophenolic acid|mesh-list
93010174|NCT00816413|Pentostatin|pentostatin|mesh-list
93010175|NCT00816413|Cyclosporins|cyclosporins|mesh-list
93010176|NCT00816413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010177|NCT00816413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010178|NCT00816413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010179|NCT00816413|Immunologic Factors|immunologic factors|mesh-ancestor
93010180|NCT00816413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010181|NCT00816413|Antifungal Agents|antifungal agents|mesh-ancestor
93010182|NCT00816413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010183|NCT00816413|Dermatologic Agents|dermatologic agents|mesh-ancestor
93010184|NCT00816413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010185|NCT00816413|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93010186|NCT00816413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010187|NCT00816413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010188|NCT00816413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93010189|NCT00816413|Antitubercular Agents|antitubercular agents|mesh-ancestor
93010190|NCT00816413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93010191|NCT00816413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93010192|NCT00813137|Endostar protein|endostar protein|mesh-list
93010193|NCT00813137|Endostatins|endostatins|mesh-list
93010194|NCT00813137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010195|NCT00813137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010196|NCT00813137|Growth Substances|growth substances|mesh-ancestor
93010197|NCT00813137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010198|NCT00813137|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010199|NCT00813137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010200|NCT01024179|Sirolimus|sirolimus|mesh-list
93010201|NCT01024179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93010202|NCT01024179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010203|NCT01024179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010204|NCT01024179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010205|NCT01024179|Antifungal Agents|antifungal agents|mesh-ancestor
93010206|NCT01024179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010207|NCT01024179|Immunologic Factors|immunologic factors|mesh-ancestor
93010208|NCT01024179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010209|NCT00821483|Frovatriptan|frovatriptan|mesh-list
93010210|NCT00821483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93010211|NCT00821483|Serotonin Agents|serotonin agents|mesh-ancestor
93010212|NCT00821483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010213|NCT00821483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010214|NCT00821483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010216|NCT02551367|Clomiphene|clomiphene|mesh-list
93010217|NCT02551367|Enclomiphene|enclomiphene|mesh-list
93010218|NCT02551367|Zuclomiphene|zuclomiphene|mesh-list
93010219|NCT02551367|Hormones|hormones|mesh-list
93010220|NCT02551367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010221|NCT02551367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010222|NCT02551367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010223|NCT02551367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010224|NCT02551367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93010225|NCT02551367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93010226|NCT02551367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010227|NCT02551367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93010228|NCT02551367|Hormone Antagonists|hormone antagonists|mesh-ancestor
93010229|NCT02551367|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93010230|NCT02551367|Fertility Agents|fertility agents|mesh-ancestor
93010231|NCT02551367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93010232|NCT02551367|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93010233|NCT02551367|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93010234|NCT00813449|Dacarbazine|dacarbazine|mesh-list
93010235|NCT00813449|Endostar protein|endostar protein|mesh-list
93010236|NCT00813449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93010237|NCT00813449|Alkylating Agents|alkylating agents|mesh-ancestor
93010238|NCT00813449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010239|NCT00813449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010240|NCT00813449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010241|NCT00813449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010242|NCT00813449|Growth Substances|growth substances|mesh-ancestor
93010243|NCT00813449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010244|NCT00813449|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010245|NCT00822029|Alendronate|alendronate|mesh-list
93010246|NCT00822029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93010247|NCT00822029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010248|NCT00467259|Testosterone|testosterone|mesh-list
93010249|NCT00467259|Androgens|androgens|mesh-ancestor
93010250|NCT00467259|Hormones|hormones|mesh-ancestor
93010251|NCT00467259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010252|NCT00467259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010253|NCT01022151|Aminophylline|aminophylline|mesh-list
93010254|NCT01022151|Doxapram|doxapram|mesh-list
93010255|NCT01022151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93010256|NCT01022151|Autonomic Agents|autonomic agents|mesh-ancestor
93010257|NCT01022151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010258|NCT01022151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010259|NCT01022151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93010260|NCT01022151|Respiratory System Agents|respiratory system agents|mesh-ancestor
93010261|NCT01022151|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93010262|NCT01022151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93010263|NCT01022151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010264|NCT01022151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010265|NCT01022151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93010266|NCT01022151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93010267|NCT01022151|Purinergic Agents|purinergic agents|mesh-ancestor
93010268|NCT01022151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010269|NCT01022151|Protective Agents|protective agents|mesh-ancestor
93010270|NCT01022151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93010272|NCT01022229|Vitamin B 6|vitamin b 6|mesh-list
93010273|NCT01022229|Micronutrients|micronutrients|mesh-ancestor
93010274|NCT01022229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010275|NCT01022229|Vitamin B Complex|vitamin b complex|mesh-ancestor
93010276|NCT00449787|Naproxen|naproxen|mesh-list
93010277|NCT00449787|Sumatriptan|sumatriptan|mesh-list
93010278|NCT00449787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93010279|NCT00449787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93010280|NCT00449787|Analgesics|analgesics|mesh-ancestor
93010281|NCT00449787|Sensory System Agents|sensory system agents|mesh-ancestor
93010282|NCT00449787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169750|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
93010283|NCT00449787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010284|NCT00449787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010285|NCT00449787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010286|NCT00449787|Gout Suppressants|gout suppressants|mesh-ancestor
93010287|NCT00449787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93010288|NCT00449787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010289|NCT00449787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010290|NCT00449787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93010291|NCT00449787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93010292|NCT00449787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93010293|NCT00449787|Serotonin Agents|serotonin agents|mesh-ancestor
93010294|NCT00449787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010295|NCT01566201|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93010296|NCT01566201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010297|NCT01566279|Everolimus|everolimus|mesh-list
93010298|NCT01566279|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93010299|NCT01566279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93010300|NCT01566279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010301|NCT01566279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010302|NCT01566279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010303|NCT01566279|Immunologic Factors|immunologic factors|mesh-ancestor
93010304|NCT01566279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010305|NCT01566279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010306|NCT00449163|Leucovorin|leucovorin|mesh-list
93010307|NCT00449163|Bevacizumab|bevacizumab|mesh-list
93010308|NCT00449163|Irinotecan|irinotecan|mesh-list
93010309|NCT00449163|Floxuridine|floxuridine|mesh-list
93010310|NCT00449163|Levoleucovorin|levoleucovorin|mesh-list
93010311|NCT00449163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010312|NCT00449163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010313|NCT00449163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010314|NCT00449163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010315|NCT00449163|Growth Substances|growth substances|mesh-ancestor
93010316|NCT00449163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010317|NCT00449163|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010318|NCT00449163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93010319|NCT00449163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010320|NCT00449163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010321|NCT00449163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010322|NCT00449163|Antidotes|antidotes|mesh-ancestor
93010323|NCT00449163|Protective Agents|protective agents|mesh-ancestor
93010324|NCT00449163|Vitamin B Complex|vitamin b complex|mesh-ancestor
93010325|NCT00449163|Vitamins|vitamins|mesh-ancestor
93010326|NCT00449163|Micronutrients|micronutrients|mesh-ancestor
93010327|NCT00449163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010328|NCT00449163|Antimetabolites|antimetabolites|mesh-ancestor
93010329|NCT01026987|Plerixafor|plerixafor|mesh-list
93010330|NCT01026987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93010331|NCT01026987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010332|NCT01026987|Antiviral Agents|antiviral agents|mesh-ancestor
93010333|NCT01026987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010334|NCT00448539|Rufinamide|rufinamide|mesh-list
93010335|NCT00448539|Anticonvulsants|anticonvulsants|mesh-ancestor
93010336|NCT00448539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93010337|NCT00448539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93010338|NCT00448539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010339|NCT00448539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010340|NCT00457665|Efavirenz|efavirenz|mesh-list
93010341|NCT00457665|Nelfinavir|nelfinavir|mesh-list
93010342|NCT00457665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93010343|NCT00457665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93010344|NCT00457665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010345|NCT00457665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010346|NCT00457665|Antiviral Agents|antiviral agents|mesh-ancestor
93010347|NCT00457665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010348|NCT00457665|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93010349|NCT00457665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93010350|NCT00457665|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92528631|NCT00036751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010351|NCT00457665|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93010352|NCT00457665|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93010353|NCT00457665|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93010354|NCT00457665|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93010355|NCT00457665|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93010356|NCT00457665|Protease Inhibitors|protease inhibitors|mesh-ancestor
93010357|NCT00457665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93010358|NCT00457665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010360|NCT00447603|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93010361|NCT00447603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93010362|NCT00447603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93010363|NCT00447603|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93010364|NCT00447603|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93010365|NCT00447603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010366|NCT00447603|Diuretics|diuretics|mesh-ancestor
93010367|NCT00447603|Natriuretic Agents|natriuretic agents|mesh-ancestor
93010368|NCT00447603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010369|NCT00447603|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93010370|NCT00447603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010371|NCT00447057|Pemetrexed|pemetrexed|mesh-list
93010372|NCT00447057|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93010373|NCT00447057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010374|NCT00447057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010375|NCT00447057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010376|NCT00447057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93010377|NCT00447057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93010378|NCT00447057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93010379|NCT01027611|Lidocaine|lidocaine|mesh-list
93010380|NCT01027611|Proxymetacaine|proxymetacaine|mesh-list
93010381|NCT01027611|Propoxycaine|propoxycaine|mesh-list
93010382|NCT01027611|Anesthetics, Local|anesthetics, local|mesh-ancestor
93010383|NCT01027611|Anesthetics|anesthetics|mesh-ancestor
93010384|NCT01027611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010385|NCT01027611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010386|NCT01027611|Sensory System Agents|sensory system agents|mesh-ancestor
93010387|NCT01027611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010388|NCT01027611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93010389|NCT01027611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93010390|NCT01027611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93010391|NCT01027611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010392|NCT01027611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010393|NCT01024413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93010394|NCT01024413|Gefitinib|gefitinib|mesh-list
93010395|NCT01024413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010396|NCT01024413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93010397|NCT01024413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010398|NCT01024413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010399|NCT00446511|Valsartan|valsartan|mesh-list
93010400|NCT00446511|Enalapril|enalapril|mesh-list
93010401|NCT00446511|Enalaprilat|enalaprilat|mesh-list
93010402|NCT00446511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93010403|NCT00446511|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93010404|NCT00446511|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93010405|NCT00446511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010406|NCT00446511|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93010407|NCT00446511|Protease Inhibitors|protease inhibitors|mesh-ancestor
93010408|NCT00446511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010409|NCT01024491|Paroxetine|paroxetine|mesh-list
92169868|NCT05463367|Narcotics|narcotics|mesh-ancestor
93010410|NCT01024491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93010411|NCT01024491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93010412|NCT01024491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010413|NCT01024491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010414|NCT01024491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010415|NCT01024491|Serotonin Agents|serotonin agents|mesh-ancestor
93010416|NCT01024491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010417|NCT01024491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93010418|NCT01024491|Antidepressive Agents|antidepressive agents|mesh-ancestor
93010419|NCT01024491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355944|NCT03822546|Nicotine|nicotine|mesh-list
93010420|NCT01024491|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93010421|NCT01024491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93010422|NCT01024491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010423|NCT00446199|Drospirenone|drospirenone|mesh-list
93010424|NCT00446199|Estradiol|estradiol|mesh-list
93010425|NCT00446199|Estrogens|estrogens|mesh-ancestor
93010426|NCT00446199|Hormones|hormones|mesh-ancestor
93010427|NCT00446199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010428|NCT00446199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010429|NCT00446199|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93010430|NCT00446199|Hormone Antagonists|hormone antagonists|mesh-ancestor
93010431|NCT00446199|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93010432|NCT00446199|Diuretics|diuretics|mesh-ancestor
93010433|NCT00446199|Natriuretic Agents|natriuretic agents|mesh-ancestor
93010434|NCT01027689|Alprazolam|alprazolam|mesh-list
93010435|NCT01027689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93010436|NCT01027689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010437|NCT01027689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010438|NCT01027689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93010439|NCT01027689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93010440|NCT01027689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93010441|NCT01027689|GABA Modulators|gaba modulators|mesh-ancestor
93010442|NCT01027689|GABA Agents|gaba agents|mesh-ancestor
93010443|NCT01027689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010444|NCT01027689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010445|NCT01024647|Certolizumab Pegol|certolizumab pegol|mesh-list
93010446|NCT01024647|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93010447|NCT01024647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010448|NCT01024647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010449|NCT01024647|Immunologic Factors|immunologic factors|mesh-ancestor
93010450|NCT01024647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010451|NCT01024647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010452|NCT01027923|Cytarabine|cytarabine|mesh-list
93010453|NCT01027923|Plerixafor|plerixafor|mesh-list
93010454|NCT01027923|Etoposide|etoposide|mesh-list
93010455|NCT01027923|Mitoxantrone|mitoxantrone|mesh-list
93010456|NCT01027923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93010457|NCT01027923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010458|NCT01027923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93010459|NCT01027923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010460|NCT01027923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010461|NCT01027923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010462|NCT01027923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010463|NCT01027923|Antimetabolites|antimetabolites|mesh-ancestor
93010464|NCT01027923|Antiviral Agents|antiviral agents|mesh-ancestor
92169894|NCT05436535|Triamcinolone|triamcinolone|mesh-list
93010465|NCT01027923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010466|NCT01027923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010467|NCT01027923|Immunologic Factors|immunologic factors|mesh-ancestor
93010468|NCT01027923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010469|NCT01027923|Analgesics|analgesics|mesh-ancestor
93010470|NCT01027923|Sensory System Agents|sensory system agents|mesh-ancestor
93010471|NCT01027923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010472|NCT01027923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93010473|NCT01027923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010474|NCT01565733|Insulin Aspart|insulin aspart|mesh-list
93010475|NCT01565733|Biphasic Insulins|biphasic insulins|mesh-list
93010476|NCT01565733|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93010477|NCT01565733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93010478|NCT01565733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010479|NCT01027065|Tenofovir|tenofovir|mesh-list
93010480|NCT01027065|Entecavir|entecavir|mesh-list
93010481|NCT01027065|Antiviral Agents|antiviral agents|mesh-ancestor
93010482|NCT01027065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010483|NCT01027065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92655808|NCT02580305|Serotonin Agents|serotonin agents|mesh-ancestor
93010484|NCT01027065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93010485|NCT01027065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010486|NCT01027065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010487|NCT01027065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93010488|NCT01027065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010489|NCT00456495|Ranibizumab|ranibizumab|mesh-list
93010490|NCT00456495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010491|NCT00456495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010492|NCT00456495|Growth Substances|growth substances|mesh-ancestor
93010493|NCT00456495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010494|NCT00456495|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010495|NCT00456495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010496|NCT00445341|Alvocidib|alvocidib|mesh-list
93010497|NCT00445341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010498|NCT00445341|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010499|NCT00445341|Growth Substances|growth substances|mesh-ancestor
93010500|NCT00445341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010501|NCT00445341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93010502|NCT00445341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010503|NCT00445341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010504|NCT03846453|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93010505|NCT03846453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93010506|NCT00444951|Vaccines|vaccines|mesh-list
93010507|NCT00444951|Immunologic Factors|immunologic factors|mesh-ancestor
93010508|NCT00444951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010509|NCT00444795|Sunitinib|sunitinib|mesh-list
93010510|NCT00444795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010511|NCT00444795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010512|NCT00444795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010513|NCT00444795|Growth Substances|growth substances|mesh-ancestor
93010514|NCT00444795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010515|NCT00444795|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010516|NCT00444795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93010517|NCT00444795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010518|NCT00444795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010519|NCT03846219|Calcium, Dietary|calcium, dietary|mesh-list
93010520|NCT03846219|Calcium|calcium|mesh-list
93010521|NCT03846219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93010522|NCT03846219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010523|NCT03846219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93010524|NCT00455325|Chloroquine|chloroquine|mesh-list
93010525|NCT00455325|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93010526|NCT00455325|Amebicides|amebicides|mesh-ancestor
93010527|NCT00455325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93010528|NCT00455325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93010529|NCT00455325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010530|NCT00455325|Antimalarials|antimalarials|mesh-ancestor
93010531|NCT00455325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010532|NCT00455325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93010533|NCT00455325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93010534|NCT00455325|Analgesics|analgesics|mesh-ancestor
93010535|NCT00455325|Sensory System Agents|sensory system agents|mesh-ancestor
93010536|NCT00455325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010537|NCT00455325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010538|NCT00455325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010539|NCT00455325|Filaricides|filaricides|mesh-ancestor
93010540|NCT00455325|Antinematodal Agents|antinematodal agents|mesh-ancestor
93010541|NCT00455325|Anthelmintics|anthelmintics|mesh-ancestor
93010542|NCT01028079|Aspirin|aspirin|mesh-list
93010543|NCT01028079|Ibuprofen|ibuprofen|mesh-list
93010544|NCT01028079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93010545|NCT01028079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93010546|NCT01028079|Analgesics|analgesics|mesh-ancestor
93010547|NCT01028079|Sensory System Agents|sensory system agents|mesh-ancestor
93010548|NCT01028079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010549|NCT01028079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010550|NCT01028079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010551|NCT01028079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010552|NCT01028079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93010553|NCT01028079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93010554|NCT01028079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169941|NCT05382871|Vaccines|vaccines|mesh-list
93010555|NCT01028079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93010556|NCT01028079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93010557|NCT01028079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010558|NCT01028079|Antipyretics|antipyretics|mesh-ancestor
93010559|NCT00443781|Anesthetics|anesthetics|mesh-list
93010560|NCT00443781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010561|NCT00443781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010562|NCT00443703|Ritonavir|ritonavir|mesh-list
93010563|NCT00443703|Lopinavir|lopinavir|mesh-list
93010564|NCT00443703|Raltegravir Potassium|raltegravir potassium|mesh-list
93010565|NCT00443703|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93010566|NCT00443703|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93010567|NCT00443703|Protease Inhibitors|protease inhibitors|mesh-ancestor
93010568|NCT00443703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010569|NCT00443703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010571|NCT00443703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010572|NCT00443703|Antiviral Agents|antiviral agents|mesh-ancestor
93010573|NCT00443703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010574|NCT00443703|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93010575|NCT00443703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93010576|NCT00443703|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93010577|NCT00443703|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93010578|NCT00381706|Leucovorin|leucovorin|mesh-list
93010579|NCT00381706|Cisplatin|cisplatin|mesh-list
93010580|NCT00381706|Fluorouracil|fluorouracil|mesh-list
93010581|NCT00381706|Oxaliplatin|oxaliplatin|mesh-list
93010582|NCT00381706|Irinotecan|irinotecan|mesh-list
93010583|NCT00381706|Cetuximab|cetuximab|mesh-list
93010584|NCT00381706|Epirubicin|epirubicin|mesh-list
93010585|NCT00381706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010586|NCT00381706|Antimetabolites|antimetabolites|mesh-ancestor
93010587|NCT00381706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010588|NCT00381706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010589|NCT00381706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010590|NCT00381706|Immunologic Factors|immunologic factors|mesh-ancestor
93010591|NCT00381706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010592|NCT00381706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93010593|NCT00381706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010594|NCT00381706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010595|NCT00381706|Antidotes|antidotes|mesh-ancestor
93010596|NCT00381706|Protective Agents|protective agents|mesh-ancestor
93010597|NCT00381706|Vitamin B Complex|vitamin b complex|mesh-ancestor
93010598|NCT00381706|Vitamins|vitamins|mesh-ancestor
93010599|NCT00381706|Micronutrients|micronutrients|mesh-ancestor
93010600|NCT00381706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010601|NCT00381706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010602|NCT00381706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93010603|NCT01045642|Omeprazole|omeprazole|mesh-list
93010604|NCT01045642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93010605|NCT01045642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93010606|NCT01045642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93010607|NCT01045642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010608|NCT01045642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010609|NCT05357430|Propofol|propofol|mesh-list
93010610|NCT05357430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93010611|NCT05357430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010612|NCT05357430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010613|NCT05357430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93010614|NCT05357430|Anesthetics, General|anesthetics, general|mesh-ancestor
93010615|NCT05357430|Anesthetics|anesthetics|mesh-ancestor
93010616|NCT00370552|Paclitaxel|paclitaxel|mesh-list
93010617|NCT00370552|Epothilones|epothilones|mesh-list
93010618|NCT00370552|Bevacizumab|bevacizumab|mesh-list
93010619|NCT00370552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93010620|NCT00370552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010621|NCT00370552|Tubulin Modulators|tubulin modulators|mesh-ancestor
93010622|NCT00370552|Antimitotic Agents|antimitotic agents|mesh-ancestor
93010623|NCT00370552|Mitosis Modulators|mitosis modulators|mesh-ancestor
93010624|NCT00370552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010625|NCT00370552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010626|NCT00370552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93010627|NCT00370552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93010628|NCT00370552|Growth Substances|growth substances|mesh-ancestor
93010629|NCT00370552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010630|NCT00370552|Growth Inhibitors|growth inhibitors|mesh-ancestor
93010631|NCT00537030|Asparaginase|asparaginase|mesh-list
93010632|NCT00537030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655951|NCT04531423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010633|NCT00381238|Rosiglitazone|rosiglitazone|mesh-list
93010634|NCT00381238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93010635|NCT00381238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010636|NCT04400994|Rituximab|rituximab|mesh-list
93010637|NCT04400994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010638|NCT04400994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010639|NCT04400994|Immunologic Factors|immunologic factors|mesh-ancestor
93010640|NCT04400994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010641|NCT04400994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010642|NCT04928820|Edetic Acid|edetic acid|mesh-list
93010643|NCT04928820|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93010644|NCT04928820|Chelating Agents|chelating agents|mesh-ancestor
93010645|NCT04928820|Sequestering Agents|sequestering agents|mesh-ancestor
93010646|NCT04928820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010647|NCT04928820|Anticoagulants|anticoagulants|mesh-ancestor
93010648|NCT04928820|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93010649|NCT04928820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93010650|NCT04429152|Tenofovir|tenofovir|mesh-list
93010651|NCT04429152|Lamivudine|lamivudine|mesh-list
93010652|NCT04429152|Antiviral Agents|antiviral agents|mesh-ancestor
93010653|NCT04429152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010654|NCT04429152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93010655|NCT04429152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93010656|NCT04429152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010657|NCT04429152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010658|NCT04429152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93010659|NCT04429152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010660|NCT04001400|Rabeprazole|rabeprazole|mesh-list
93010661|NCT04001400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93010662|NCT04001400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93010663|NCT04001400|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93010664|NCT04001400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010665|NCT04001400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010666|NCT00380692|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93010667|NCT00380692|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93010668|NCT00380692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93010669|NCT00380692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010670|NCT00380692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010671|NCT00380692|Adrenergic Agents|adrenergic agents|mesh-ancestor
93010672|NCT00380692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010673|NCT00380692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010674|NCT04285866|Durvalumab|durvalumab|mesh-list
93010675|NCT04285866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010676|NCT04285866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010677|NCT01047982|Folic Acid|folic acid|mesh-list
93010678|NCT01047982|Inositol|inositol|mesh-list
93010679|NCT01047982|Hematinics|hematinics|mesh-ancestor
93010680|NCT01047982|Vitamin B Complex|vitamin b complex|mesh-ancestor
93010681|NCT01047982|Vitamins|vitamins|mesh-ancestor
93010682|NCT01047982|Micronutrients|micronutrients|mesh-ancestor
93010683|NCT01047982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010684|NCT00536874|Gemcitabine|gemcitabine|mesh-list
93010685|NCT00536874|Oxaliplatin|oxaliplatin|mesh-list
93010686|NCT00536874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010687|NCT00536874|Antimetabolites|antimetabolites|mesh-ancestor
93010688|NCT00536874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010689|NCT00536874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010690|NCT00991848|Lidocaine|lidocaine|mesh-list
93010691|NCT00991848|Anesthetics, Local|anesthetics, local|mesh-ancestor
93010692|NCT00991848|Anesthetics|anesthetics|mesh-ancestor
93010693|NCT00991848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010694|NCT00991848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010695|NCT00991848|Sensory System Agents|sensory system agents|mesh-ancestor
93010696|NCT00991848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010697|NCT00991848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93010698|NCT00991848|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93010699|NCT00991848|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93010700|NCT00991848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170017|NCT05346159|Androgens|androgens|mesh-list
93010701|NCT00991848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010702|NCT05281068|Danazol|danazol|mesh-list
93010703|NCT05281068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93010704|NCT05281068|Hormone Antagonists|hormone antagonists|mesh-ancestor
93010705|NCT05281068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010706|NCT05281068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010707|NCT00380068|Ambrisentan|ambrisentan|mesh-list
93010708|NCT00380068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93010709|NCT00991926|Orlistat|orlistat|mesh-list
93010710|NCT00991926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010711|NCT00991926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010713|NCT00991926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93010714|NCT04230954|Pembrolizumab|pembrolizumab|mesh-list
93010715|NCT04230954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010716|NCT04230954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010717|NCT04230954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93010718|NCT04230954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010720|NCT00536484|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93010721|NCT00536484|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93010722|NCT00536484|Cholinergic Agents|cholinergic agents|mesh-ancestor
93010723|NCT00536484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010724|NCT00536484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010725|NCT00536484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010726|NCT00536484|Urological Agents|urological agents|mesh-ancestor
93010727|NCT00370396|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93010728|NCT00370396|Immunologic Factors|immunologic factors|mesh-ancestor
93010729|NCT00370396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010730|NCT00992004|Turmeric extract|turmeric extract|mesh-list
93010731|NCT00992004|Antioxidants|antioxidants|mesh-ancestor
93010732|NCT00992004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010733|NCT00992004|Protective Agents|protective agents|mesh-ancestor
93010734|NCT00992004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010735|NCT03862716|Insulin|insulin|mesh-list
93010736|NCT03862716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93010737|NCT03862716|Metformin|metformin|mesh-list
93010738|NCT03862716|Liraglutide|liraglutide|mesh-list
93010739|NCT03862716|Insulin, Long-Acting|insulin, long-acting|mesh-list
93010740|NCT03862716|Xultophy|xultophy|mesh-list
93010741|NCT03862716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93010742|NCT03862716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010743|NCT03862716|Incretins|incretins|mesh-ancestor
93010744|NCT03862716|Hormones|hormones|mesh-ancestor
93010745|NCT03862716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010746|NCT00992082|Ketorolac|ketorolac|mesh-list
93010747|NCT00992082|Epinephrine|epinephrine|mesh-list
93010748|NCT00992082|Morphine|morphine|mesh-list
93010749|NCT00992082|Ropivacaine|ropivacaine|mesh-list
93010750|NCT00992082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93010751|NCT00992082|Narcotics|narcotics|mesh-ancestor
93010752|NCT00992082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010753|NCT00992082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010754|NCT00992082|Analgesics|analgesics|mesh-ancestor
93010755|NCT00992082|Sensory System Agents|sensory system agents|mesh-ancestor
93010756|NCT00992082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010757|NCT00992082|Anesthetics, Local|anesthetics, local|mesh-ancestor
93010758|NCT00992082|Anesthetics|anesthetics|mesh-ancestor
93010759|NCT00992082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93010760|NCT00992082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93010761|NCT00992082|Adrenergic Agents|adrenergic agents|mesh-ancestor
93010762|NCT00992082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010763|NCT00992082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010764|NCT00992082|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93010765|NCT00992082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93010766|NCT00992082|Autonomic Agents|autonomic agents|mesh-ancestor
93010767|NCT00992082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93010768|NCT00992082|Respiratory System Agents|respiratory system agents|mesh-ancestor
93010769|NCT00992082|Mydriatics|mydriatics|mesh-ancestor
93010770|NCT00992082|Sympathomimetics|sympathomimetics|mesh-ancestor
93010771|NCT00992082|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93010772|NCT00992082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93010773|NCT00992082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93010774|NCT00992082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010775|NCT00992082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010776|NCT00992082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93010777|NCT00992082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010778|NCT00455013|Mycophenolic Acid|mycophenolic acid|mesh-list
93010779|NCT00455013|Sirolimus|sirolimus|mesh-list
93010780|NCT00455013|Abatacept|abatacept|mesh-list
93010781|NCT00455013|Tacrolimus|tacrolimus|mesh-list
93010782|NCT00455013|Thymoglobulin|thymoglobulin|mesh-list
93010783|NCT00455013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93010784|NCT00455013|Immunologic Factors|immunologic factors|mesh-ancestor
93010785|NCT00455013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010786|NCT00455013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92656101|NCT00239330|Atorvastatin|atorvastatin|mesh-list
93010787|NCT00455013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010788|NCT00455013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010789|NCT00455013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010790|NCT00455013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010791|NCT00455013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93010792|NCT00455013|Antitubercular Agents|antitubercular agents|mesh-ancestor
92356304|NCT04346004|Hematinics|hematinics|mesh-ancestor
93010793|NCT00455013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93010794|NCT00455013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010795|NCT00455013|Antifungal Agents|antifungal agents|mesh-ancestor
93010796|NCT00455013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93010797|NCT00455013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93010798|NCT00455013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010800|NCT00363298|Amphetamine|amphetamine|mesh-list
93010801|NCT00363298|Dextroamphetamine|dextroamphetamine|mesh-list
93010802|NCT00363298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93010803|NCT00363298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010804|NCT00363298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93010805|NCT00363298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010806|NCT00363298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010807|NCT00363298|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93010808|NCT00363298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93010809|NCT00363298|Purinergic Agents|purinergic agents|mesh-ancestor
93010810|NCT00363298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010811|NCT00363298|Sympathomimetics|sympathomimetics|mesh-ancestor
93010812|NCT00363298|Autonomic Agents|autonomic agents|mesh-ancestor
93010813|NCT00363298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010814|NCT00363298|Dopamine Agents|dopamine agents|mesh-ancestor
93010815|NCT00363298|Adrenergic Agents|adrenergic agents|mesh-ancestor
93010816|NCT00363298|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93010817|NCT00363298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93010818|NCT00363298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93010819|NCT00363298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93010820|NCT05254548|Flurbiprofen|flurbiprofen|mesh-list
93010821|NCT05254548|Midazolam|midazolam|mesh-list
93010822|NCT05254548|Omeprazole|omeprazole|mesh-list
93010823|NCT05254548|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93010824|NCT05254548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93010825|NCT05254548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010826|NCT05254548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010827|NCT05254548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93010828|NCT05254548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93010829|NCT05254548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93010830|NCT05254548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93010831|NCT05254548|Anesthetics, General|anesthetics, general|mesh-ancestor
93010832|NCT05254548|Anesthetics|anesthetics|mesh-ancestor
93010833|NCT05254548|GABA Modulators|gaba modulators|mesh-ancestor
93010834|NCT05254548|GABA Agents|gaba agents|mesh-ancestor
93010835|NCT05254548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010836|NCT05254548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010837|NCT05254548|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93010838|NCT05254548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93010839|NCT05254548|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93010840|NCT05254548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010841|NCT05254548|Analgesics|analgesics|mesh-ancestor
93010842|NCT05254548|Sensory System Agents|sensory system agents|mesh-ancestor
93010843|NCT05254548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010844|NCT05254548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93010845|NCT05254548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93010846|NCT05254548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010847|NCT05254548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010848|NCT05254548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93010849|NCT00363142|Ritonavir|ritonavir|mesh-list
93010850|NCT00363142|Fosamprenavir|fosamprenavir|mesh-list
93010851|NCT00363142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93010852|NCT00363142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93010853|NCT00363142|Protease Inhibitors|protease inhibitors|mesh-ancestor
93010854|NCT00363142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010855|NCT00363142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010856|NCT00363142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93010857|NCT00363142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93010858|NCT00363142|Antiviral Agents|antiviral agents|mesh-ancestor
93010859|NCT00363142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010860|NCT00363142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93010861|NCT00363142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93010862|NCT05246982|Capecitabine|capecitabine|mesh-list
93010863|NCT05246982|Oxaliplatin|oxaliplatin|mesh-list
93010864|NCT05246982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010865|NCT05246982|Antimetabolites|antimetabolites|mesh-ancestor
92528638|NCT00036790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010866|NCT05246982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010868|NCT04002024|Salicylic Acid|salicylic acid|mesh-list
93010869|NCT04002024|Salicylates|salicylates|mesh-list
93010870|NCT04002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010871|NCT04002024|Antifungal Agents|antifungal agents|mesh-ancestor
93010872|NCT04002024|Keratolytic Agents|keratolytic agents|mesh-ancestor
93010873|NCT04002024|Dermatologic Agents|dermatologic agents|mesh-ancestor
93010874|NCT04002024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93010875|NCT04002024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93010876|NCT04002024|Analgesics|analgesics|mesh-ancestor
93010877|NCT04002024|Sensory System Agents|sensory system agents|mesh-ancestor
93010878|NCT04002024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010879|NCT04002024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010880|NCT04002024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010881|NCT04002024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93010882|NCT04002024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93010883|NCT04002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010884|NCT04002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010885|NCT01028313|Methylprednisolone|methylprednisolone|mesh-list
93010886|NCT01028313|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93010887|NCT01028313|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93010888|NCT01028313|Prednisolone|prednisolone|mesh-list
93010889|NCT01028313|Prednisolone acetate|prednisolone acetate|mesh-list
93010890|NCT01028313|Panobinostat|panobinostat|mesh-list
93010891|NCT01028313|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93010892|NCT01028313|Prednisolone phosphate|prednisolone phosphate|mesh-list
93010893|NCT01028313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93010894|NCT01028313|Antiemetics|antiemetics|mesh-ancestor
93010895|NCT01028313|Autonomic Agents|autonomic agents|mesh-ancestor
93010896|NCT01028313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010897|NCT01028313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010898|NCT01028313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93010899|NCT01028313|Glucocorticoids|glucocorticoids|mesh-ancestor
93010900|NCT01028313|Hormones|hormones|mesh-ancestor
93010901|NCT01028313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93010902|NCT01028313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93010903|NCT01028313|Protective Agents|protective agents|mesh-ancestor
93010904|NCT01028313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93010905|NCT01028313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010906|NCT01028313|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93010907|NCT01028313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010908|NCT01028313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010909|NCT04001712|Caffeine|caffeine|mesh-list
93010910|NCT04001712|Caffeine citrate|caffeine citrate|mesh-list
93010911|NCT04001712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010912|NCT04001712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93010913|NCT04001712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010914|NCT04001712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93010915|NCT04001712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010916|NCT04001712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93010917|NCT04001712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93010918|NCT04001712|Purinergic Agents|purinergic agents|mesh-ancestor
93010919|NCT04001712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010920|NCT01027377|Factor VIII|factor viii|mesh-list
93010921|NCT01027377|Coagulants|coagulants|mesh-ancestor
93010922|NCT00992160|Vestipitant|vestipitant|mesh-list
93010923|NCT00992160|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93010924|NCT00992160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010925|NCT00992160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010926|NCT00992160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010927|NCT00379912|Azacitidine|azacitidine|mesh-list
93010928|NCT00379912|Epoetin Alfa|epoetin alfa|mesh-list
93010929|NCT00379912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93010930|NCT00379912|Antimetabolites|antimetabolites|mesh-ancestor
93010931|NCT00379912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010932|NCT00379912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010933|NCT00379912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010934|NCT00379912|Hematinics|hematinics|mesh-ancestor
93010935|NCT00379834|Timolol|timolol|mesh-list
93010936|NCT00379834|Dorzolamide|dorzolamide|mesh-list
93010937|NCT00379834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93010939|NCT00379834|Adrenergic Agents|adrenergic agents|mesh-ancestor
93010940|NCT00379834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010941|NCT00379834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010942|NCT00379834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010943|NCT00379834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93010944|NCT00379834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93010945|NCT00379834|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93010946|NCT00379834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010947|NCT02292706|Sofosbuvir|sofosbuvir|mesh-list
93010948|NCT02292706|Antiviral Agents|antiviral agents|mesh-ancestor
93010949|NCT02292706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010950|NCT00992472|Prochlorperazine|prochlorperazine|mesh-list
93010951|NCT00992472|Antiemetics|antiemetics|mesh-ancestor
93010952|NCT00992472|Autonomic Agents|autonomic agents|mesh-ancestor
93010953|NCT00992472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93010954|NCT00992472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010955|NCT00992472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93010956|NCT00992472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93010957|NCT00992472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93010958|NCT00992472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93010959|NCT00992472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93010960|NCT00992472|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93010961|NCT00992472|Dopamine Agents|dopamine agents|mesh-ancestor
93010962|NCT00992472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010963|NCT00992472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010964|NCT03453840|Lumefantrine|lumefantrine|mesh-list
93010965|NCT03453840|Artemether|artemether|mesh-list
93010966|NCT03453840|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93010967|NCT03453840|Antimalarials|antimalarials|mesh-ancestor
93010968|NCT03453840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93010969|NCT03453840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93010970|NCT03453840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93010971|NCT03439254|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
93010972|NCT03439254|Cathartics|cathartics|mesh-ancestor
93010973|NCT03439254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93010974|NCT05354700|Carboplatin|carboplatin|mesh-list
93010975|NCT05354700|Etoposide|etoposide|mesh-list
93010976|NCT05354700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170229|NCT05089370|Antimetabolites|antimetabolites|mesh-ancestor
93010977|NCT05354700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93010978|NCT05354700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93010979|NCT05354700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010980|NCT05354700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010981|NCT05354700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010982|NCT03339258|Doxazosin|doxazosin|mesh-list
93010983|NCT03339258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93010984|NCT03339258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93010985|NCT03339258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93010986|NCT03339258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93010987|NCT03339258|Adrenergic Agents|adrenergic agents|mesh-ancestor
93010988|NCT03339258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93010989|NCT03339258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010990|NCT03339258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93010991|NCT00992706|Doxorubicin|doxorubicin|mesh-list
93010992|NCT00992706|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93010993|NCT00992706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93010994|NCT00992706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93010995|NCT00992706|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93010996|NCT00992706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93010997|NCT00992706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93010998|NCT00992706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93010999|NCT00454779|Cisplatin|cisplatin|mesh-list
93011000|NCT00454779|Docetaxel|docetaxel|mesh-list
93011001|NCT00454779|Panitumumab|panitumumab|mesh-list
93011002|NCT00454779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011003|NCT00454779|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011004|NCT00454779|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011005|NCT00454779|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011006|NCT00454779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011007|NCT00454779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011008|NCT00992862|Moexipril|moexipril|mesh-list
93011009|NCT00992862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93011010|NCT00992862|Protease Inhibitors|protease inhibitors|mesh-ancestor
93011011|NCT00992862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656324|NCT01644838|Histamine Agents|histamine agents|mesh-ancestor
93011012|NCT00992862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011013|NCT00992862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011015|NCT00993096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93011016|NCT00993096|Insulin Aspart|insulin aspart|mesh-list
93011017|NCT00993096|Insulin, Long-Acting|insulin, long-acting|mesh-list
93011018|NCT00993096|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93011019|NCT00993096|Biphasic Insulins|biphasic insulins|mesh-list
93011020|NCT00993096|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93011021|NCT00993096|Insulin, Isophane|insulin, isophane|mesh-list
93011022|NCT00993096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93011023|NCT00993096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011024|NCT00439569|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93011025|NCT00439569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011026|NCT00993408|Selexipag|selexipag|mesh-list
93011027|NCT00993408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011028|NCT03994107|Paclitaxel|paclitaxel|mesh-list
93011029|NCT03994107|Doxorubicin|doxorubicin|mesh-list
93011030|NCT03994107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93011031|NCT03994107|Trastuzumab|trastuzumab|mesh-list
93011032|NCT03994107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93011033|NCT03994107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011034|NCT03994107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011035|NCT03994107|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011036|NCT03994107|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011037|NCT03994107|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011038|NCT03994107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011039|NCT03994107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011040|NCT03994107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93011041|NCT03994107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93011042|NCT03994107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011043|NCT03994107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011044|NCT03469713|Nivolumab|nivolumab|mesh-list
93011045|NCT03469713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011046|NCT03469713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011047|NCT03469713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93011048|NCT03469713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011049|NCT00427635|Esomeprazole|esomeprazole|mesh-list
93011050|NCT00427635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93011051|NCT00427635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93011052|NCT00427635|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93011053|NCT00427635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011054|NCT00427635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011055|NCT00993642|Panobinostat|panobinostat|mesh-list
93011056|NCT00993642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011057|NCT00993642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93011058|NCT00993642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011059|NCT00993642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011060|NCT01028547|Dexamethasone|dexamethasone|mesh-list
93011061|NCT01028547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011062|NCT01028547|Antiemetics|antiemetics|mesh-ancestor
93011063|NCT01028547|Autonomic Agents|autonomic agents|mesh-ancestor
93011064|NCT01028547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011065|NCT01028547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011066|NCT01028547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93011067|NCT01028547|Glucocorticoids|glucocorticoids|mesh-ancestor
93011068|NCT01028547|Hormones|hormones|mesh-ancestor
93011069|NCT01028547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011070|NCT01028547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93011071|NCT01028547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011072|NCT01031355|Calcium, Dietary|calcium, dietary|mesh-list
93011073|NCT01031355|Tetrahydrofolates|tetrahydrofolates|mesh-list
93011074|NCT01031355|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93011075|NCT01031355|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93011076|NCT01031355|Calcium|calcium|mesh-list
93011077|NCT01031355|Estradiol|estradiol|mesh-list
93011078|NCT01031355|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93011079|NCT01031355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93011080|NCT01031355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011081|NCT01031355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93011082|NCT01031355|Estrogens|estrogens|mesh-ancestor
93011083|NCT01031355|Hormones|hormones|mesh-ancestor
92170271|NCT05075993|Alkylating Agents|alkylating agents|mesh-ancestor
93011084|NCT01031355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656396|NCT01645774|Nasal Decongestants|nasal decongestants|mesh-ancestor
93011085|NCT01031355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93011086|NCT01031355|Contraceptive Agents|contraceptive agents|mesh-ancestor
93011087|NCT01031355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93011088|NCT01031355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93011089|NCT01031355|Vitamin B Complex|vitamin b complex|mesh-ancestor
93011090|NCT01031355|Vitamins|vitamins|mesh-ancestor
93011091|NCT01031355|Micronutrients|micronutrients|mesh-ancestor
93011092|NCT00993720|Liraglutide|liraglutide|mesh-list
93011093|NCT00993720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93011094|NCT00993720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011095|NCT00993720|Incretins|incretins|mesh-ancestor
93011096|NCT00993720|Hormones|hormones|mesh-ancestor
93011097|NCT00993720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011098|NCT03891264|Cannabidiol|cannabidiol|mesh-list
93011099|NCT03891264|Anticonvulsants|anticonvulsants|mesh-ancestor
93011100|NCT00425607|Lonafarnib|lonafarnib|mesh-list
93011101|NCT00425607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011102|NCT00425607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011103|NCT00437073|Capecitabine|capecitabine|mesh-list
93011104|NCT00437073|Topotecan|topotecan|mesh-list
93011105|NCT00437073|Lapatinib|lapatinib|mesh-list
93011106|NCT00437073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011107|NCT00437073|Antimetabolites|antimetabolites|mesh-ancestor
93011108|NCT00437073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011109|NCT00437073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011110|NCT00437073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93011111|NCT00437073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93011112|NCT00437073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011113|NCT00437073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011114|NCT00425373|Amlodipine|amlodipine|mesh-list
93011115|NCT00425373|Valsartan|valsartan|mesh-list
93011116|NCT00425373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011117|NCT00425373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93011118|NCT00425373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011119|NCT00425373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011120|NCT00425373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92170294|NCT05027308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93011121|NCT00425373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011122|NCT00425373|Vasodilator Agents|vasodilator agents|mesh-ancestor
93011123|NCT00425373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93011124|NCT00425373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93011125|NCT01031589|Rilpivirine|rilpivirine|mesh-list
93011126|NCT01031589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93011127|NCT01031589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93011128|NCT01031589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011129|NCT01031589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011130|NCT01031589|Antiviral Agents|antiviral agents|mesh-ancestor
93011131|NCT01031589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011132|NCT01031589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93011133|NCT01031589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93011134|NCT03894540|Paclitaxel|paclitaxel|mesh-list
93011135|NCT03894540|Pembrolizumab|pembrolizumab|mesh-list
93011136|NCT03894540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011137|NCT03894540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011138|NCT03894540|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011139|NCT03894540|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011140|NCT03894540|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011141|NCT03894540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011142|NCT03894540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011143|NCT03894540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93011144|NCT00993876|Citalopram|citalopram|mesh-list
93011145|NCT00993876|Reboxetine|reboxetine|mesh-list
93011146|NCT00993876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93011147|NCT00993876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93011148|NCT00993876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011149|NCT00993876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011150|NCT00993876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011151|NCT00993876|Serotonin Agents|serotonin agents|mesh-ancestor
93011152|NCT00993876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011153|NCT00993876|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93011154|NCT00993876|Antidepressive Agents|antidepressive agents|mesh-ancestor
93011155|NCT00993876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93011156|NCT00993876|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93011157|NCT00993876|Adrenergic Agents|adrenergic agents|mesh-ancestor
93011158|NCT05129358|Furosemide|furosemide|mesh-list
93011159|NCT05129358|Diuretics|diuretics|mesh-ancestor
93011160|NCT05129358|Natriuretic Agents|natriuretic agents|mesh-ancestor
93011161|NCT05129358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011162|NCT05129358|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93011163|NCT05129358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011164|NCT05129358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011165|NCT01646814|Aspirin|aspirin|mesh-list
93011166|NCT01646814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93011167|NCT01646814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93011168|NCT01646814|Analgesics|analgesics|mesh-ancestor
93011169|NCT01646814|Sensory System Agents|sensory system agents|mesh-ancestor
93011170|NCT01646814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011171|NCT01646814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011172|NCT01646814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011173|NCT01646814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011174|NCT01646814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93011175|NCT01646814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93011176|NCT01646814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011177|NCT01646814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93011178|NCT01646814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93011179|NCT01646814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011180|NCT01646814|Antipyretics|antipyretics|mesh-ancestor
93011181|NCT00994344|Ritonavir|ritonavir|mesh-list
93011182|NCT00994344|Lopinavir|lopinavir|mesh-list
93011183|NCT00994344|Darunavir|darunavir|mesh-list
93011184|NCT00994344|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93011185|NCT00994344|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93011186|NCT00994344|Protease Inhibitors|protease inhibitors|mesh-ancestor
93011187|NCT00994344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011188|NCT00994344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011189|NCT00994344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93011190|NCT00994344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93011191|NCT00994344|Antiviral Agents|antiviral agents|mesh-ancestor
93011192|NCT00994344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011193|NCT00994344|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93011194|NCT00994344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93011195|NCT00994500|Bortezomib|bortezomib|mesh-list
93011196|NCT00994500|Vorinostat|vorinostat|mesh-list
93011197|NCT00994500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011198|NCT00994500|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93011199|NCT00994500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011200|NCT00994500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011201|NCT01416636|Treprostinil|treprostinil|mesh-list
93011202|NCT01416636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011203|NCT00999180|Botulinum Toxins|botulinum toxins|mesh-list
93011204|NCT00999180|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93011205|NCT00999180|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93011206|NCT00999180|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92170365|NCT04978675|Fluorides|fluorides|mesh-list
93011207|NCT00999180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011208|NCT00999180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011209|NCT00999180|Cholinergic Agents|cholinergic agents|mesh-ancestor
93011210|NCT00999180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011211|NCT00999180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011212|NCT00999180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93011213|NCT00999180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011214|NCT05280132|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93011215|NCT05280132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93011216|NCT05280132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011217|NCT05280132|Antitubercular Agents|antitubercular agents|mesh-ancestor
93011218|NCT00999258|Sirolimus|sirolimus|mesh-list
93011219|NCT00999258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93011220|NCT00999258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011221|NCT00999258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011222|NCT00999258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011223|NCT00999258|Antifungal Agents|antifungal agents|mesh-ancestor
93011224|NCT00999258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011225|NCT00999258|Immunologic Factors|immunologic factors|mesh-ancestor
93011226|NCT00999258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011227|NCT00994734|Mifepristone|mifepristone|mesh-list
93011228|NCT00994734|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93011229|NCT00994734|Abortifacient Agents|abortifacient agents|mesh-ancestor
93011230|NCT00994734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93011231|NCT00994734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011232|NCT00994734|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93011233|NCT00994734|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93011234|NCT00994734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93011235|NCT00994734|Contraceptive Agents|contraceptive agents|mesh-ancestor
93011236|NCT00994734|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93011237|NCT00994734|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93011238|NCT00994734|Hormone Antagonists|hormone antagonists|mesh-ancestor
93011239|NCT00994734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011240|NCT00994734|Luteolytic Agents|luteolytic agents|mesh-ancestor
93011241|NCT00994734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93011242|NCT00994734|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93011243|NCT00999336|Betrixaban|betrixaban|mesh-list
93011244|NCT00999336|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93011245|NCT00999336|Antithrombins|antithrombins|mesh-ancestor
93011246|NCT00999336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93011247|NCT00999336|Protease Inhibitors|protease inhibitors|mesh-ancestor
93011248|NCT00999336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011249|NCT00999336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011250|NCT00999336|Anticoagulants|anticoagulants|mesh-ancestor
93011251|NCT00995826|Laninamivir|laninamivir|mesh-list
93011252|NCT00995826|Antiviral Agents|antiviral agents|mesh-ancestor
93011253|NCT00995826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011254|NCT00994812|Metformin|metformin|mesh-list
93011255|NCT00994812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93011256|NCT00994812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011257|NCT00994968|Cyclophosphamide|cyclophosphamide|mesh-list
93011258|NCT00994968|Docetaxel|docetaxel|mesh-list
93011259|NCT00994968|Doxorubicin|doxorubicin|mesh-list
93011260|NCT00994968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93011261|NCT00994968|Tegafur|tegafur|mesh-list
93011262|NCT00994968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011263|NCT00994968|Immunologic Factors|immunologic factors|mesh-ancestor
93011264|NCT00994968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011265|NCT00994968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011266|NCT00994968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93011267|NCT00994968|Alkylating Agents|alkylating agents|mesh-ancestor
93011268|NCT00994968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011269|NCT00994968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011270|NCT00994968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93011271|NCT00994968|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011272|NCT00994968|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011273|NCT00994968|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011274|NCT00994968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011275|NCT00994968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93011276|NCT00994968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93011277|NCT00994968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011278|NCT00994968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011279|NCT00994968|Antimetabolites|antimetabolites|mesh-ancestor
93011280|NCT03887442|Paclitaxel|paclitaxel|mesh-list
93011281|NCT03887442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93011282|NCT03887442|Cetuximab|cetuximab|mesh-list
93011283|NCT03887442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011284|NCT03887442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011285|NCT03887442|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011286|NCT03887442|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011287|NCT03887442|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011288|NCT03887442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011289|NCT03887442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011290|NCT00996060|Hydralazine|hydralazine|mesh-list
93011291|NCT00996060|Valproic Acid|valproic acid|mesh-list
93011292|NCT00996060|Anticonvulsants|anticonvulsants|mesh-ancestor
93011293|NCT00996060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011294|NCT00996060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011295|NCT00996060|GABA Agents|gaba agents|mesh-ancestor
93011296|NCT00996060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011297|NCT00996060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011298|NCT00996060|Antimanic Agents|antimanic agents|mesh-ancestor
93011299|NCT00996060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93011300|NCT00996060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011301|NCT00996060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93011302|NCT00996060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011303|NCT00996060|Vasodilator Agents|vasodilator agents|mesh-ancestor
93011304|NCT00995046|Factor VIII|factor viii|mesh-list
93011305|NCT00995046|Coagulants|coagulants|mesh-ancestor
93011306|NCT00995124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92528644|NCT00036790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93011307|NCT04000932|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
93011308|NCT04000932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011309|NCT04000932|Glucocorticoids|glucocorticoids|mesh-ancestor
93011310|NCT04000932|Hormones|hormones|mesh-ancestor
93011311|NCT04000932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011312|NCT04000932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011313|NCT05170230|Terlipressin|terlipressin|mesh-list
93011314|NCT05170230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011315|NCT05170230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93011316|NCT01000116|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93011317|NCT01000116|Hemostatics|hemostatics|mesh-ancestor
93011318|NCT01000116|Coagulants|coagulants|mesh-ancestor
93011319|NCT00996684|Plasminogen|plasminogen|mesh-list
93011320|NCT00996684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93011321|NCT00996684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93011322|NCT00996684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011323|NCT00996762|Lapatinib|lapatinib|mesh-list
93011324|NCT00996762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011325|NCT00996762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011326|NCT00996762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011327|NCT00996762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011328|NCT05162196|Niraparib|niraparib|mesh-list
93011329|NCT05162196|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93011330|NCT05162196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011331|NCT05162196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011332|NCT05162196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011333|NCT00997074|Ibuprofen|ibuprofen|mesh-list
93011334|NCT00997074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93011335|NCT00997074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93011336|NCT00997074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93011337|NCT00997074|Analgesics|analgesics|mesh-ancestor
93011338|NCT00997074|Sensory System Agents|sensory system agents|mesh-ancestor
93011339|NCT00997074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011340|NCT00997074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011341|NCT00997074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011342|NCT00997074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93011343|NCT00997074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011344|NCT00997074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011345|NCT05249712|Androgens|androgens|mesh-list
93011346|NCT05249712|Hormones|hormones|mesh-ancestor
93011347|NCT05249712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327621|NCT00003092|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011348|NCT05249712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011349|NCT01000896|Paclitaxel|paclitaxel|mesh-list
93011350|NCT01000896|Carboplatin|carboplatin|mesh-list
93011351|NCT01000896|Saracatinib|saracatinib|mesh-list
93011352|NCT01000896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011353|NCT01000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011354|NCT01000896|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011355|NCT01000896|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011356|NCT01000896|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011357|NCT01000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011358|NCT01000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011359|NCT00997542|Allopurinol|allopurinol|mesh-list
93011360|NCT00997542|Antimetabolites|antimetabolites|mesh-ancestor
93011361|NCT00997542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011362|NCT00997542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011363|NCT00997542|Gout Suppressants|gout suppressants|mesh-ancestor
93011364|NCT00997542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011365|NCT00997542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93011366|NCT00997542|Antioxidants|antioxidants|mesh-ancestor
93011367|NCT00997542|Protective Agents|protective agents|mesh-ancestor
93011368|NCT00997542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011369|NCT01001130|Fluticasone|fluticasone|mesh-list
93011370|NCT01001130|Xhance|xhance|mesh-list
93011371|NCT01001130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011372|NCT01001130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93011373|NCT01001130|Autonomic Agents|autonomic agents|mesh-ancestor
93011374|NCT01001130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011375|NCT01001130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011376|NCT01001130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93011377|NCT01001130|Respiratory System Agents|respiratory system agents|mesh-ancestor
93011378|NCT01001130|Dermatologic Agents|dermatologic agents|mesh-ancestor
93011379|NCT01001130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93011380|NCT00424827|Gemcitabine|gemcitabine|mesh-list
93011381|NCT00424827|Fluorouracil|fluorouracil|mesh-list
93011382|NCT00424827|Cetuximab|cetuximab|mesh-list
93011383|NCT00424827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011384|NCT00424827|Antimetabolites|antimetabolites|mesh-ancestor
93011385|NCT00424827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011386|NCT00424827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011387|NCT00424827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011388|NCT00424827|Immunologic Factors|immunologic factors|mesh-ancestor
93011389|NCT00424827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011390|NCT00424827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011392|NCT01001364|Formoterol Fumarate|formoterol fumarate|mesh-list
93011393|NCT01001364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011394|NCT01001364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93011395|NCT01001364|Autonomic Agents|autonomic agents|mesh-ancestor
93011396|NCT01001364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011397|NCT01001364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011398|NCT01001364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93011399|NCT01001364|Respiratory System Agents|respiratory system agents|mesh-ancestor
93011400|NCT01001364|Glucocorticoids|glucocorticoids|mesh-ancestor
93011401|NCT01001364|Hormones|hormones|mesh-ancestor
93011402|NCT01001364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011403|NCT01001364|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93011404|NCT01001364|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93011405|NCT01001364|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93011406|NCT01001364|Adrenergic Agents|adrenergic agents|mesh-ancestor
93011407|NCT01001364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011408|NCT01001364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011409|NCT01031667|Cilostazol|cilostazol|mesh-list
93011410|NCT01031667|Probucol|probucol|mesh-list
93011411|NCT01031667|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93011412|NCT01031667|Autonomic Agents|autonomic agents|mesh-ancestor
93011413|NCT01031667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011414|NCT01031667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011415|NCT01031667|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93011416|NCT01031667|Respiratory System Agents|respiratory system agents|mesh-ancestor
93011417|NCT01031667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93011418|NCT01031667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93011419|NCT01031667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011420|NCT01031667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93011421|NCT01031667|Vasodilator Agents|vasodilator agents|mesh-ancestor
93011422|NCT01031667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93011423|NCT01031667|Protective Agents|protective agents|mesh-ancestor
93011424|NCT01031667|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93011425|NCT01031667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93011426|NCT01031667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011427|NCT01031667|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93011428|NCT01031667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93011429|NCT01031667|Antimetabolites|antimetabolites|mesh-ancestor
93011430|NCT01031667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93011431|NCT01031667|Antioxidants|antioxidants|mesh-ancestor
93011432|NCT03995277|Biotin|biotin|mesh-list
93011433|NCT03995277|Vitamin B Complex|vitamin b complex|mesh-ancestor
93011434|NCT03995277|Vitamins|vitamins|mesh-ancestor
93011435|NCT03995277|Micronutrients|micronutrients|mesh-ancestor
93011436|NCT03995277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011437|NCT04000386|Zinc Oxide|zinc oxide|mesh-list
93011438|NCT04000386|Dermatologic Agents|dermatologic agents|mesh-ancestor
93011439|NCT04000386|Sunscreening Agents|sunscreening agents|mesh-ancestor
93011440|NCT04000386|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93011441|NCT04000386|Protective Agents|protective agents|mesh-ancestor
93011442|NCT04000386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011443|NCT00998088|Epoetin Alfa|epoetin alfa|mesh-list
93011444|NCT00998088|Hematinics|hematinics|mesh-ancestor
93011445|NCT00377962|Mycophenolic Acid|mycophenolic acid|mesh-list
93011446|NCT00377962|Everolimus|everolimus|mesh-list
93011447|NCT00377962|Azathioprine|azathioprine|mesh-list
93011448|NCT00377962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93011449|NCT00377962|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93011450|NCT00377962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011451|NCT00377962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011452|NCT00377962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011453|NCT00377962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011454|NCT00377962|Immunologic Factors|immunologic factors|mesh-ancestor
93011455|NCT00377962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011456|NCT00377962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011457|NCT00377962|Antimetabolites|antimetabolites|mesh-ancestor
93011458|NCT00377962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011459|NCT00377962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011460|NCT00377962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011461|NCT00377962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93011462|NCT00377962|Antitubercular Agents|antitubercular agents|mesh-ancestor
93011463|NCT00377962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93011464|NCT00377962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011466|NCT00424749|Rituximab|rituximab|mesh-list
93011467|NCT00424749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011468|NCT00424749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011469|NCT00424749|Immunologic Factors|immunologic factors|mesh-ancestor
93011470|NCT00424749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011471|NCT00424749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011472|NCT00424749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011473|NCT00424749|Glucocorticoids|glucocorticoids|mesh-ancestor
93011474|NCT00424749|Hormones|hormones|mesh-ancestor
93011475|NCT00424749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011476|NCT00424749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93011477|NCT00424593|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93011478|NCT00424593|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93011479|NCT00424593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93011480|NCT00424593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011481|NCT00424593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011482|NCT00424593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011483|NCT00424593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011484|NCT00424593|Analgesics|analgesics|mesh-ancestor
93011485|NCT00424593|Sensory System Agents|sensory system agents|mesh-ancestor
93011486|NCT00424593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011487|NCT00424593|Antidepressive Agents|antidepressive agents|mesh-ancestor
93011488|NCT00424593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93011489|NCT00424593|Dopamine Agents|dopamine agents|mesh-ancestor
93011490|NCT00369382|Cyclosporine|cyclosporine|mesh-list
93011491|NCT00369382|Sirolimus|sirolimus|mesh-list
93011492|NCT00369382|Tacrolimus|tacrolimus|mesh-list
93011493|NCT00369382|Cyclosporins|cyclosporins|mesh-list
93011494|NCT00369382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011495|NCT00369382|Immunologic Factors|immunologic factors|mesh-ancestor
93011496|NCT00369382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011497|NCT00369382|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93011498|NCT00369382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011499|NCT00369382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011500|NCT00369382|Antifungal Agents|antifungal agents|mesh-ancestor
93011501|NCT00369382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011502|NCT00369382|Dermatologic Agents|dermatologic agents|mesh-ancestor
93011503|NCT00369382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011504|NCT00369382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93011505|NCT00369382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011506|NCT00369382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011507|NCT00424515|Imatinib Mesylate|imatinib mesylate|mesh-list
93011508|NCT00424515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011509|NCT00424515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011510|NCT00424515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011511|NCT00424515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011512|NCT05131204|Eculizumab|eculizumab|mesh-list
93011513|NCT05131204|Ravulizumab|ravulizumab|mesh-list
93011514|NCT05131204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93011515|NCT05131204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011516|NCT05131204|Immunologic Factors|immunologic factors|mesh-ancestor
93011517|NCT05131204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011518|NCT00377260|Amoxicillin|amoxicillin|mesh-list
93011519|NCT00377260|Clavulanic Acid|clavulanic acid|mesh-list
93011520|NCT00377260|Clavulanic Acids|clavulanic acids|mesh-list
93011521|NCT00377260|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93011522|NCT00377260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93011523|NCT00377260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011524|NCT00377260|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93011525|NCT00377260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011526|NCT00377260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011527|NCT00441441|Fluticasone|fluticasone|mesh-list
93011528|NCT00441441|Xhance|xhance|mesh-list
93011529|NCT00441441|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93011530|NCT00441441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011531|NCT00441441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93011532|NCT00441441|Autonomic Agents|autonomic agents|mesh-ancestor
93011533|NCT00441441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011534|NCT00441441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011535|NCT00441441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93011536|NCT00441441|Respiratory System Agents|respiratory system agents|mesh-ancestor
93011537|NCT00441441|Dermatologic Agents|dermatologic agents|mesh-ancestor
93011538|NCT00441441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93011539|NCT00441441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93011540|NCT00441441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93011541|NCT00441441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93011542|NCT00441441|Adrenergic Agents|adrenergic agents|mesh-ancestor
93011543|NCT00441441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011544|NCT00441441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011545|NCT00436917|Zoledronic Acid|zoledronic acid|mesh-list
93011546|NCT00436917|Letrozole|letrozole|mesh-list
93011547|NCT00436917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011548|NCT00436917|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93011549|NCT00436917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93011550|NCT00436917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011551|NCT00436917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011552|NCT00436917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93011553|NCT00436917|Hormone Antagonists|hormone antagonists|mesh-ancestor
93011554|NCT00436917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011555|NCT00436917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011556|NCT00436917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93011557|NCT00436605|Dasatinib|dasatinib|mesh-list
93011558|NCT00436605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011559|NCT00436605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011560|NCT00436605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011561|NCT00436605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011562|NCT01034787|Tremelimumab|tremelimumab|mesh-list
93011563|NCT01034787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011564|NCT01028781|Thalidomide|thalidomide|mesh-list
93011565|NCT01028781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011566|NCT01028781|Immunologic Factors|immunologic factors|mesh-ancestor
93011567|NCT01028781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170651|NCT04294225|Letrozole|letrozole|mesh-list
93011568|NCT01028781|Leprostatic Agents|leprostatic agents|mesh-ancestor
93011569|NCT01028781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93011570|NCT01028781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011571|NCT01028781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93011572|NCT01028781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93011573|NCT01028781|Growth Substances|growth substances|mesh-ancestor
93011574|NCT01028781|Growth Inhibitors|growth inhibitors|mesh-ancestor
93011575|NCT01028781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011576|NCT01031901|Sirolimus|sirolimus|mesh-list
93011577|NCT01031901|Temsirolimus|temsirolimus|mesh-list
93011578|NCT01031901|MTOR Inhibitors|mtor inhibitors|mesh-list
93011579|NCT01031901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93011580|NCT01031901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011581|NCT01031901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011582|NCT01031901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011583|NCT01031901|Antifungal Agents|antifungal agents|mesh-ancestor
93011584|NCT01031901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011585|NCT01031901|Immunologic Factors|immunologic factors|mesh-ancestor
93011586|NCT01031901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011587|NCT01031901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011588|NCT01031901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011589|NCT01031901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011590|NCT00368992|Paclitaxel|paclitaxel|mesh-list
93011591|NCT00368992|Bevacizumab|bevacizumab|mesh-list
93011592|NCT00368992|Cetuximab|cetuximab|mesh-list
93011593|NCT00368992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93011594|NCT00368992|Antibodies|antibodies|mesh-list
93011595|NCT00368992|Immunoglobulins|immunoglobulins|mesh-list
93011596|NCT00368992|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93011597|NCT00368992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011598|NCT00368992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011599|NCT00368992|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011600|NCT00368992|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011601|NCT00368992|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011602|NCT00368992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011603|NCT00368992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93011605|NCT00368992|Growth Substances|growth substances|mesh-ancestor
93011606|NCT00368992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011607|NCT00368992|Growth Inhibitors|growth inhibitors|mesh-ancestor
93011608|NCT00368992|Immunologic Factors|immunologic factors|mesh-ancestor
93011609|NCT00376246|Ezetimibe|ezetimibe|mesh-list
93011610|NCT00376246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93011611|NCT00376246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93011612|NCT00376246|Antimetabolites|antimetabolites|mesh-ancestor
92170656|NCT04294225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011613|NCT00376246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011614|NCT00376246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93011615|NCT01050088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93011616|NCT00375934|Diclofenac|diclofenac|mesh-list
93011617|NCT00375934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93011618|NCT00375934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93011619|NCT00375934|Analgesics|analgesics|mesh-ancestor
93011620|NCT00375934|Sensory System Agents|sensory system agents|mesh-ancestor
93011621|NCT00375934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011622|NCT00375934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011623|NCT00375934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011624|NCT00375934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011625|NCT00375934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93011626|NCT00375934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011627|NCT00375934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011628|NCT01052584|Lumefantrine|lumefantrine|mesh-list
93011629|NCT01052584|Chloroquine|chloroquine|mesh-list
93011630|NCT01052584|Artemether|artemether|mesh-list
93011631|NCT01052584|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93011632|NCT01052584|Antimalarials|antimalarials|mesh-ancestor
93011633|NCT01052584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93011634|NCT01052584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93011635|NCT01052584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011636|NCT01052584|Amebicides|amebicides|mesh-ancestor
93011637|NCT01052584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011638|NCT02534506|Nivolumab|nivolumab|mesh-list
93011639|NCT02534506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011640|NCT02534506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011641|NCT02534506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93011642|NCT02534506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011643|NCT01050322|Gemcitabine|gemcitabine|mesh-list
93011644|NCT01050322|Capecitabine|capecitabine|mesh-list
93011645|NCT01050322|Vinorelbine|vinorelbine|mesh-list
93011646|NCT01050322|Lapatinib|lapatinib|mesh-list
93011647|NCT01050322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011648|NCT01050322|Antimetabolites|antimetabolites|mesh-ancestor
93011649|NCT01050322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011650|NCT01050322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011651|NCT01050322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011652|NCT01050322|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011653|NCT01050322|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011654|NCT01050322|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011655|NCT01050322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011656|NCT01050322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011657|NCT00531960|Bevacizumab|bevacizumab|mesh-list
93011658|NCT00531960|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93011659|NCT00531960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011660|NCT00531960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011661|NCT00531960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93011662|NCT00531960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93011663|NCT00531960|Growth Substances|growth substances|mesh-ancestor
93011664|NCT00531960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011665|NCT00531960|Growth Inhibitors|growth inhibitors|mesh-ancestor
93011666|NCT00531960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93011667|NCT00531960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011668|NCT00531960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011669|NCT01001676|Paclitaxel|paclitaxel|mesh-list
93011670|NCT01001676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011671|NCT01001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011672|NCT01001676|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011673|NCT01001676|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011674|NCT01001676|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011675|NCT01001676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011676|NCT00816959|Bleomycin|bleomycin|mesh-list
93011677|NCT00816959|Dacarbazine|dacarbazine|mesh-list
93011678|NCT00816959|Vinblastine|vinblastine|mesh-list
93011679|NCT00816959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93011680|NCT00816959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011681|NCT00816959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011682|NCT00816959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93011683|NCT00816959|Alkylating Agents|alkylating agents|mesh-ancestor
93011684|NCT00816959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011685|NCT00816959|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011686|NCT00816959|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011687|NCT00816959|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011688|NCT01001754|Ribavirin|ribavirin|mesh-list
93011689|NCT01001754|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93011690|NCT01001754|Antimetabolites|antimetabolites|mesh-ancestor
93011691|NCT01001754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011692|NCT01001754|Antiviral Agents|antiviral agents|mesh-ancestor
93011693|NCT01001754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011694|NCT00825851|Nicotine|nicotine|mesh-list
93011695|NCT00825851|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93011696|NCT00825851|Autonomic Agents|autonomic agents|mesh-ancestor
93011697|NCT00825851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011698|NCT00825851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011699|NCT00825851|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93011700|NCT00825851|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93011701|NCT00825851|Cholinergic Agents|cholinergic agents|mesh-ancestor
93011702|NCT00825851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011703|NCT00825851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011704|NCT00361504|Oxycodone|oxycodone|mesh-list
93011705|NCT00361504|Tapentadol|tapentadol|mesh-list
93011706|NCT00361504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93011707|NCT00361504|Narcotics|narcotics|mesh-ancestor
93011708|NCT00361504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011709|NCT00361504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011710|NCT00361504|Analgesics|analgesics|mesh-ancestor
93011711|NCT00361504|Sensory System Agents|sensory system agents|mesh-ancestor
93011712|NCT00361504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011713|NCT00361504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93011714|NCT00361504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93011715|NCT00361504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011716|NCT00361504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011717|NCT00361504|Adrenergic Agents|adrenergic agents|mesh-ancestor
93011718|NCT00361504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011719|NCT00361270|Complement Factor H|complement factor h|mesh-list
93011720|NCT00361270|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93011721|NCT00361270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93011722|NCT00361270|Immunologic Factors|immunologic factors|mesh-ancestor
93011723|NCT00361270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011724|NCT00826163|Budesonide|budesonide|mesh-list
93011725|NCT00826163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011726|NCT00826163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93011727|NCT00826163|Autonomic Agents|autonomic agents|mesh-ancestor
93011728|NCT00826163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011729|NCT00826163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011730|NCT00826163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93011731|NCT00826163|Respiratory System Agents|respiratory system agents|mesh-ancestor
93011732|NCT00826163|Glucocorticoids|glucocorticoids|mesh-ancestor
93011733|NCT00826163|Hormones|hormones|mesh-ancestor
93011734|NCT00826163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011735|NCT00998166|Bevacizumab|bevacizumab|mesh-list
93011736|NCT00998166|Pemetrexed|pemetrexed|mesh-list
93011737|NCT00998166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93011738|NCT00998166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011739|NCT00998166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93011740|NCT00998166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93011741|NCT00998166|Growth Substances|growth substances|mesh-ancestor
93011742|NCT00998166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011743|NCT00998166|Growth Inhibitors|growth inhibitors|mesh-ancestor
93011744|NCT00998166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011745|NCT00998166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011746|NCT00998166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93011747|NCT00998166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93011748|NCT03990922|Morphine|morphine|mesh-list
93011749|NCT03990922|Ropivacaine|ropivacaine|mesh-list
93011750|NCT03990922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93011752|NCT03990922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011753|NCT03990922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011754|NCT03990922|Analgesics|analgesics|mesh-ancestor
93011755|NCT03990922|Sensory System Agents|sensory system agents|mesh-ancestor
93011756|NCT03990922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011757|NCT03990922|Anesthetics, Local|anesthetics, local|mesh-ancestor
93011758|NCT03990922|Anesthetics|anesthetics|mesh-ancestor
93011759|NCT00822263|Acetylcysteine|acetylcysteine|mesh-list
93011760|NCT00822263|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93011761|NCT00822263|Antiviral Agents|antiviral agents|mesh-ancestor
93011762|NCT00822263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93011763|NCT00822263|Expectorants|expectorants|mesh-ancestor
93011764|NCT00822263|Respiratory System Agents|respiratory system agents|mesh-ancestor
93011765|NCT00822263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93011766|NCT00822263|Antioxidants|antioxidants|mesh-ancestor
93011767|NCT00822263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011768|NCT00822263|Protective Agents|protective agents|mesh-ancestor
93011769|NCT00822263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011770|NCT00822263|Antidotes|antidotes|mesh-ancestor
93011771|NCT03992170|Daratumumab|daratumumab|mesh-list
93011772|NCT03992170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011773|NCT00817037|Nifedipine|nifedipine|mesh-list
93011774|NCT00817037|Sitaxsentan|sitaxsentan|mesh-list
93011775|NCT00817037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93011776|NCT00817037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011777|NCT00817037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011778|NCT00817037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93011779|NCT00817037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011780|NCT00817037|Vasodilator Agents|vasodilator agents|mesh-ancestor
93011781|NCT00817037|Tocolytic Agents|tocolytic agents|mesh-ancestor
93011782|NCT00817037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93011783|NCT00817037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93011784|NCT00998322|Gemcitabine|gemcitabine|mesh-list
93011785|NCT00998322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011786|NCT00998322|Antimetabolites|antimetabolites|mesh-ancestor
93011787|NCT00998322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011788|NCT00998322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011789|NCT00367744|Rosiglitazone|rosiglitazone|mesh-list
93011790|NCT00367744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93011791|NCT00367744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011792|NCT01002300|Oxytocin|oxytocin|mesh-list
93011793|NCT01002300|Oxytocics|oxytocics|mesh-ancestor
93011794|NCT01002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93011795|NCT01002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011796|NCT00822419|Lidocaine|lidocaine|mesh-list
93011797|NCT00822419|Ketamine|ketamine|mesh-list
93011798|NCT00822419|Anesthetics, Local|anesthetics, local|mesh-ancestor
93011799|NCT00822419|Anesthetics|anesthetics|mesh-ancestor
93011800|NCT00822419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011801|NCT00822419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011802|NCT00822419|Sensory System Agents|sensory system agents|mesh-ancestor
93011803|NCT00822419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011804|NCT00822419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93011805|NCT00822419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93011806|NCT00822419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93011807|NCT00822419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011808|NCT00822419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011809|NCT00822419|Analgesics|analgesics|mesh-ancestor
93011810|NCT00822419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93011811|NCT00822419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93011812|NCT00822419|Anesthetics, General|anesthetics, general|mesh-ancestor
93011813|NCT00822419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93011814|NCT00822419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93011815|NCT00822419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011816|NCT01002534|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93011817|NCT01002534|Vasodilator Agents|vasodilator agents|mesh-ancestor
93011818|NCT01002534|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93011819|NCT01002534|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93011820|NCT01002534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011821|NCT01002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011822|NCT01002534|Urological Agents|urological agents|mesh-ancestor
93011823|NCT00817271|Glucagon|glucagon|mesh-list
93011824|NCT00817271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93011826|NCT00817271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011827|NCT00817271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011829|NCT01052896|Analgesics|analgesics|mesh-ancestor
93011830|NCT01052896|Sensory System Agents|sensory system agents|mesh-ancestor
93011831|NCT01052896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011832|NCT01052896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011833|NCT01052896|Anticonvulsants|anticonvulsants|mesh-ancestor
93011834|NCT01052896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93011835|NCT01052896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93011836|NCT01052896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011837|NCT01052896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93011838|NCT01052896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93011839|NCT01052896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93011840|NCT01052896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011841|NCT01052896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011842|NCT01052896|Antimanic Agents|antimanic agents|mesh-ancestor
93011843|NCT01002690|Etoricoxib|etoricoxib|mesh-list
93011844|NCT01002690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93011845|NCT01002690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93011846|NCT01002690|Analgesics|analgesics|mesh-ancestor
93011847|NCT01002690|Sensory System Agents|sensory system agents|mesh-ancestor
93011848|NCT01002690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011849|NCT01002690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011850|NCT01002690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011851|NCT01002690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93011852|NCT01002690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93011853|NCT01002690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93011854|NCT01002690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011855|NCT01002690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011856|NCT01048684|Mannitol|mannitol|mesh-list
93011857|NCT01048684|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93011858|NCT01048684|Diuretics|diuretics|mesh-ancestor
93011859|NCT01048684|Natriuretic Agents|natriuretic agents|mesh-ancestor
93011860|NCT01048684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011861|NCT01002768|Insulin|insulin|mesh-list
93011862|NCT01002768|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93011863|NCT01002768|Insulin Glargine|insulin glargine|mesh-list
93011864|NCT01002768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93011865|NCT01002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011866|NCT01050478|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93011867|NCT01050478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93011868|NCT01050478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93011869|NCT01050478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011870|NCT01050478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011871|NCT01050478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93011872|NCT01050478|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93011873|NCT01050478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93011874|NCT01050478|Serotonin Agents|serotonin agents|mesh-ancestor
93011875|NCT01050478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011876|NCT01050478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011877|NCT01050478|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93011878|NCT01050478|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93011879|NCT01050478|Dopamine Agents|dopamine agents|mesh-ancestor
93011880|NCT00998556|Bromocriptine|bromocriptine|mesh-list
93011881|NCT00998556|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93011882|NCT00998556|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93011883|NCT00998556|Hormone Antagonists|hormone antagonists|mesh-ancestor
93011884|NCT00998556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011885|NCT00998556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011886|NCT00998556|Dopamine Agonists|dopamine agonists|mesh-ancestor
93011887|NCT00998556|Dopamine Agents|dopamine agents|mesh-ancestor
93011888|NCT00998556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011889|NCT00998556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011890|NCT01052974|Ropivacaine|ropivacaine|mesh-list
93011891|NCT01052974|Anesthetics, Local|anesthetics, local|mesh-ancestor
93011892|NCT01052974|Anesthetics|anesthetics|mesh-ancestor
93011893|NCT01052974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011894|NCT01052974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011895|NCT01052974|Sensory System Agents|sensory system agents|mesh-ancestor
93011896|NCT01052974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011897|NCT00998634|Lithium Carbonate|lithium carbonate|mesh-list
93011898|NCT00998634|Antidepressive Agents|antidepressive agents|mesh-ancestor
93011899|NCT00998634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93011900|NCT00998634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011901|NCT00998634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011902|NCT00998634|Antimanic Agents|antimanic agents|mesh-ancestor
93011903|NCT00998634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93011904|NCT00998634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011905|NCT00998634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011906|NCT01003002|Levodopa|levodopa|mesh-list
93011907|NCT01003002|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93011908|NCT01003002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93011909|NCT01003002|Dopamine Agents|dopamine agents|mesh-ancestor
93011910|NCT01003002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011911|NCT01003002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011912|NCT01003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011913|NCT01003158|Paclitaxel|paclitaxel|mesh-list
93011914|NCT01003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93011915|NCT01003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011916|NCT01003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
93011917|NCT01003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
93011918|NCT01003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
93011919|NCT01003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011920|NCT03883386|Loratadine|loratadine|mesh-list
93011921|NCT03883386|Antipruritics|antipruritics|mesh-ancestor
93011922|NCT03883386|Dermatologic Agents|dermatologic agents|mesh-ancestor
93011923|NCT03883386|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93011924|NCT03883386|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93011925|NCT03883386|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93011926|NCT03883386|Histamine Antagonists|histamine antagonists|mesh-ancestor
93011927|NCT03883386|Histamine Agents|histamine agents|mesh-ancestor
93011928|NCT03883386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011929|NCT03883386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011930|NCT03883386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011931|NCT00530946|Amlodipine|amlodipine|mesh-list
93011932|NCT00530946|Atorvastatin|atorvastatin|mesh-list
93011933|NCT00530946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93011934|NCT00530946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93011935|NCT00530946|Antimetabolites|antimetabolites|mesh-ancestor
93011936|NCT00530946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011937|NCT00530946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93011938|NCT00530946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93011939|NCT00530946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011940|NCT00530946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93011941|NCT00530946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93011942|NCT00530946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93011943|NCT00530946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93011944|NCT00530946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011945|NCT00530946|Vasodilator Agents|vasodilator agents|mesh-ancestor
93011946|NCT00424047|Dexamethasone|dexamethasone|mesh-list
93011947|NCT00424047|Dexamethasone acetate|dexamethasone acetate|mesh-list
93011948|NCT00424047|Lenalidomide|lenalidomide|mesh-list
93011949|NCT00424047|BB 1101|bb 1101|mesh-list
93011950|NCT00424047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93011951|NCT00424047|Antiemetics|antiemetics|mesh-ancestor
93011952|NCT00424047|Autonomic Agents|autonomic agents|mesh-ancestor
93011953|NCT00424047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93011954|NCT00424047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011955|NCT00424047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93011956|NCT00424047|Glucocorticoids|glucocorticoids|mesh-ancestor
93011957|NCT00424047|Hormones|hormones|mesh-ancestor
93011958|NCT00424047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93011959|NCT00424047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93011960|NCT00424047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011961|NCT00424047|Protease Inhibitors|protease inhibitors|mesh-ancestor
93011962|NCT00424047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93011963|NCT00424047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011964|NCT00424047|Immunologic Factors|immunologic factors|mesh-ancestor
93011965|NCT00424047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93011966|NCT00424047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93011967|NCT00424047|Growth Substances|growth substances|mesh-ancestor
93011968|NCT00424047|Growth Inhibitors|growth inhibitors|mesh-ancestor
93011969|NCT00530790|Ropinirole|ropinirole|mesh-list
93011970|NCT00530790|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93011971|NCT00530790|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93011972|NCT00530790|Dopamine Agonists|dopamine agonists|mesh-ancestor
93011973|NCT00530790|Dopamine Agents|dopamine agents|mesh-ancestor
93011974|NCT00530790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93011975|NCT00530790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011976|NCT00530790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011977|NCT01032057|Gemcitabine|gemcitabine|mesh-list
93011978|NCT01032057|Capecitabine|capecitabine|mesh-list
93011979|NCT01032057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93011980|NCT01032057|Antimetabolites|antimetabolites|mesh-ancestor
93011981|NCT01032057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93011982|NCT01032057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011983|NCT01003314|Vaccines|vaccines|mesh-list
93011984|NCT01003314|Immunologic Factors|immunologic factors|mesh-ancestor
93011985|NCT01003314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011986|NCT00530088|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
93011987|NCT00530088|Trioxsalen|trioxsalen|mesh-list
93011988|NCT00530088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93011989|NCT00530088|Dermatologic Agents|dermatologic agents|mesh-ancestor
93011990|NCT00530088|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93011991|NCT01006668|Propofol|propofol|mesh-list
93011992|NCT01006668|Sevoflurane|sevoflurane|mesh-list
93011993|NCT01006668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93011994|NCT01006668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93011995|NCT01006668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93011996|NCT01006668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93011997|NCT01006668|Anesthetics, General|anesthetics, general|mesh-ancestor
93011998|NCT01006668|Anesthetics|anesthetics|mesh-ancestor
93011999|NCT01006668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93012000|NCT01006668|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93012001|NCT00360568|Levodopa|levodopa|mesh-list
93012002|NCT00360568|Carbidopa|carbidopa|mesh-list
93012003|NCT00360568|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93012004|NCT00360568|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93012005|NCT00360568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93012006|NCT00360568|Dopamine Agents|dopamine agents|mesh-ancestor
93012007|NCT00360568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012008|NCT00360568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012009|NCT00360568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012010|NCT00360568|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93012011|NCT00360568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012012|NCT00360568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93012013|NCT00360568|Immunologic Factors|immunologic factors|mesh-ancestor
93012014|NCT00360568|Dopamine Agonists|dopamine agonists|mesh-ancestor
93012015|NCT00436215|Bevacizumab|bevacizumab|mesh-list
93012016|NCT00436215|Sorafenib|sorafenib|mesh-list
93012017|NCT00436215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012018|NCT00436215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012019|NCT00436215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93012020|NCT00436215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93012021|NCT00436215|Growth Substances|growth substances|mesh-ancestor
92170931|NCT03983850|Antitubercular Agents|antitubercular agents|mesh-ancestor
93012022|NCT00436215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012023|NCT00436215|Growth Inhibitors|growth inhibitors|mesh-ancestor
93012024|NCT00436215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012025|NCT00436215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012026|NCT00436215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012027|NCT05734248|Hyaluronic Acid|hyaluronic acid|mesh-list
93012028|NCT05734248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93012029|NCT05734248|Immunologic Factors|immunologic factors|mesh-ancestor
93012030|NCT05734248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012031|NCT05734248|Viscosupplements|viscosupplements|mesh-ancestor
93012032|NCT05734248|Protective Agents|protective agents|mesh-ancestor
93012033|NCT00441363|Bromocriptine|bromocriptine|mesh-list
93012034|NCT00441363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93012035|NCT00441363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93012036|NCT00441363|Hormone Antagonists|hormone antagonists|mesh-ancestor
93012037|NCT00441363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012038|NCT00441363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012039|NCT00441363|Dopamine Agonists|dopamine agonists|mesh-ancestor
93012040|NCT00441363|Dopamine Agents|dopamine agents|mesh-ancestor
93012041|NCT00441363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528658|NCT00036868|Trastuzumab|trastuzumab|mesh-list
93012042|NCT00441363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012044|NCT00626795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93012045|NCT00626795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012046|NCT00626795|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93012047|NCT00626795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012048|NCT00626795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012049|NCT00826553|Midazolam|midazolam|mesh-list
93012050|NCT00826553|Dexmedetomidine|dexmedetomidine|mesh-list
93012051|NCT00826553|Lorazepam|lorazepam|mesh-list
93012052|NCT00826553|Propofol|propofol|mesh-list
93012053|NCT00826553|GABA Agonists|gaba agonists|mesh-list
93012054|NCT00826553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93012055|NCT00826553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012056|NCT00826553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012057|NCT00826553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93012058|NCT00826553|Analgesics|analgesics|mesh-ancestor
93012059|NCT00826553|Sensory System Agents|sensory system agents|mesh-ancestor
93012060|NCT00826553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012061|NCT00826553|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93012062|NCT00826553|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93012063|NCT00826553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93012064|NCT00826553|Adrenergic Agents|adrenergic agents|mesh-ancestor
93012065|NCT00826553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012066|NCT00826553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012067|NCT00826553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93012068|NCT00826553|Anesthetics, General|anesthetics, general|mesh-ancestor
93012070|NCT00826553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93012071|NCT00826553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93012072|NCT00826553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93012073|NCT00826553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93012074|NCT00826553|GABA Modulators|gaba modulators|mesh-ancestor
93012075|NCT00826553|GABA Agents|gaba agents|mesh-ancestor
93012076|NCT00826553|Anticonvulsants|anticonvulsants|mesh-ancestor
93012077|NCT00826553|Antiemetics|antiemetics|mesh-ancestor
92170965|NCT03917082|Tamoxifen|tamoxifen|mesh-list
93012078|NCT00826553|Autonomic Agents|autonomic agents|mesh-ancestor
93012079|NCT00826553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93012080|NCT00626639|Cisplatin|cisplatin|mesh-list
93012081|NCT00626639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012082|NCT00626561|Paclitaxel|paclitaxel|mesh-list
93012083|NCT00626561|Bevacizumab|bevacizumab|mesh-list
93012084|NCT00626561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012085|NCT00626561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012086|NCT00626561|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012087|NCT00626561|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012088|NCT00626561|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012089|NCT00626561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012090|NCT00626561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012091|NCT00626561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93012092|NCT00626561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93012093|NCT00626561|Growth Substances|growth substances|mesh-ancestor
93012094|NCT00626561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012095|NCT00626561|Growth Inhibitors|growth inhibitors|mesh-ancestor
93012096|NCT03880266|Glycopyrrolate|glycopyrrolate|mesh-list
93012097|NCT03880266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93012098|NCT03880266|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93012099|NCT03880266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93012100|NCT03880266|Cholinergic Agents|cholinergic agents|mesh-ancestor
93012101|NCT03880266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012102|NCT03880266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012103|NCT03880266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012104|NCT00423891|Entecavir|entecavir|mesh-list
93012105|NCT00423891|Antiviral Agents|antiviral agents|mesh-ancestor
93012106|NCT00423891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012107|NCT00830609|Ribavirin|ribavirin|mesh-list
93012108|NCT00830609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93012109|NCT00830609|Interferon-alpha|interferon-alpha|mesh-list
93012110|NCT00830609|Antimetabolites|antimetabolites|mesh-ancestor
93012111|NCT00830609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012112|NCT00830609|Antiviral Agents|antiviral agents|mesh-ancestor
93012113|NCT00830609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012114|NCT00830609|Immunologic Factors|immunologic factors|mesh-ancestor
93012115|NCT00830609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012116|NCT00822809|Prednisolone|prednisolone|mesh-list
93012117|NCT00822809|Catumaxomab|catumaxomab|mesh-list
93012118|NCT00822809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012119|NCT00822809|Glucocorticoids|glucocorticoids|mesh-ancestor
93012120|NCT00822809|Hormones|hormones|mesh-ancestor
93012121|NCT00822809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012122|NCT00822809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012123|NCT00822809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012124|NCT00822809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012125|NCT00822809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93012126|NCT02549651|Durvalumab|durvalumab|mesh-list
93012127|NCT02549651|Tremelimumab|tremelimumab|mesh-list
93012128|NCT02549651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012129|NCT02549651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012130|NCT03999372|Hyaluronic Acid|hyaluronic acid|mesh-list
93012131|NCT03999372|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93012132|NCT03999372|Immunologic Factors|immunologic factors|mesh-ancestor
93012133|NCT03999372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012134|NCT03999372|Viscosupplements|viscosupplements|mesh-ancestor
93012135|NCT03999372|Protective Agents|protective agents|mesh-ancestor
93012136|NCT05733468|Calcium, Dietary|calcium, dietary|mesh-list
93012137|NCT05733468|Calcium|calcium|mesh-list
93012138|NCT05733468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93012139|NCT05733468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012140|NCT05733468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93012142|NCT00830843|Isoflurane|isoflurane|mesh-list
93012143|NCT00830843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93012144|NCT00830843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012145|NCT00830843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012146|NCT00830843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93012147|NCT00830843|Anesthetics, General|anesthetics, general|mesh-ancestor
93012148|NCT00830843|Anesthetics|anesthetics|mesh-ancestor
93012149|NCT00830843|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93012150|NCT00826787|Levetiracetam|levetiracetam|mesh-list
93012151|NCT00826787|Anticonvulsants|anticonvulsants|mesh-ancestor
93012152|NCT00826787|Nootropic Agents|nootropic agents|mesh-ancestor
93012153|NCT00823121|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93012154|NCT00823121|Buserelin|buserelin|mesh-list
93012155|NCT00823121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93012156|NCT00823121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012157|NCT00823121|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93012158|NCT00823121|Fertility Agents|fertility agents|mesh-ancestor
93012159|NCT03687372|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93012160|NCT03687372|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93012161|NCT03687372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012162|NCT00626405|Paclitaxel|paclitaxel|mesh-list
93012163|NCT00626405|Bevacizumab|bevacizumab|mesh-list
93012164|NCT00626405|Carboplatin|carboplatin|mesh-list
93012165|NCT00626405|Temozolomide|temozolomide|mesh-list
93012166|NCT00626405|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93012167|NCT00626405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012168|NCT00626405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012169|NCT00626405|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012170|NCT00626405|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012171|NCT00626405|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012172|NCT00626405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012173|NCT00626405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012174|NCT00626405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93012175|NCT00626405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93012176|NCT00626405|Growth Substances|growth substances|mesh-ancestor
93012177|NCT00626405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012178|NCT00626405|Growth Inhibitors|growth inhibitors|mesh-ancestor
93012179|NCT00626405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93012180|NCT00626405|Alkylating Agents|alkylating agents|mesh-ancestor
93012181|NCT00826865|Levetiracetam|levetiracetam|mesh-list
93012182|NCT00826865|Anticonvulsants|anticonvulsants|mesh-ancestor
93012183|NCT00826865|Nootropic Agents|nootropic agents|mesh-ancestor
93012184|NCT00358150|Eliglustat|eliglustat|mesh-list
93012185|NCT00358150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012186|NCT00358150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012187|NCT05427630|Dronabinol|dronabinol|mesh-list
93012188|NCT05427630|Hallucinogens|hallucinogens|mesh-ancestor
93012189|NCT05427630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012190|NCT05427630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93012191|NCT05427630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93012192|NCT05427630|Analgesics|analgesics|mesh-ancestor
93012193|NCT05427630|Sensory System Agents|sensory system agents|mesh-ancestor
93012194|NCT05427630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012195|NCT05427630|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93012196|NCT05427630|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93012197|NCT05427630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012198|NCT05427630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012199|NCT05427630|Hormones|hormones|mesh-ancestor
93012200|NCT05427630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012201|NCT01050556|Folic Acid|folic acid|mesh-list
93012202|NCT01050556|Vitamin B Complex|vitamin b complex|mesh-list
93012203|NCT01050556|Hematinics|hematinics|mesh-ancestor
93012204|NCT01050556|Vitamins|vitamins|mesh-ancestor
93012205|NCT01050556|Micronutrients|micronutrients|mesh-ancestor
93012206|NCT01050556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012207|NCT05889871|Apatinib|apatinib|mesh-list
93012208|NCT05889871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012209|NCT05889871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012210|NCT05889871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012211|NCT05889871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012212|NCT05889624|Amitriptyline|amitriptyline|mesh-list
93012213|NCT05889624|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93012214|NCT05889624|Antidepressive Agents|antidepressive agents|mesh-ancestor
93012215|NCT05889624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93012216|NCT05889624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93012217|NCT05889624|Analgesics|analgesics|mesh-ancestor
93012218|NCT05889624|Sensory System Agents|sensory system agents|mesh-ancestor
93012219|NCT05889624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012220|NCT05889624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012221|NCT05889624|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93012222|NCT05889624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93012223|NCT05889624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93012224|NCT05889624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012225|NCT05889624|Adrenergic Agents|adrenergic agents|mesh-ancestor
93012226|NCT05889624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012227|NCT05889455|Sildenafil Citrate|sildenafil citrate|mesh-list
93012228|NCT05889455|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012229|NCT05889455|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93012230|NCT05889455|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93012231|NCT05889455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012232|NCT05889455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012233|NCT05889455|Urological Agents|urological agents|mesh-ancestor
93012234|NCT05889442|Cromakalim|cromakalim|mesh-list
93012235|NCT05889442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93012236|NCT05889442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93012237|NCT05889442|Autonomic Agents|autonomic agents|mesh-ancestor
93012238|NCT05889442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012239|NCT05889442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012240|NCT05889442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93012241|NCT05889442|Respiratory System Agents|respiratory system agents|mesh-ancestor
93012242|NCT05889442|Parasympatholytics|parasympatholytics|mesh-ancestor
93012243|NCT05889442|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012244|NCT05889390|Paclitaxel|paclitaxel|mesh-list
93012245|NCT05889390|Cyclophosphamide|cyclophosphamide|mesh-list
93012246|NCT05889390|Carboplatin|carboplatin|mesh-list
93012247|NCT05889390|Doxorubicin|doxorubicin|mesh-list
93012248|NCT05889390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012249|NCT05889390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012250|NCT05889390|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012251|NCT05889390|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012252|NCT05889390|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012253|NCT05889390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012254|NCT05889390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012255|NCT05889390|Immunologic Factors|immunologic factors|mesh-ancestor
93012256|NCT05889390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012257|NCT05889390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93012258|NCT05889390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93012259|NCT05889390|Alkylating Agents|alkylating agents|mesh-ancestor
93012260|NCT05889390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93012261|NCT05889390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012262|NCT05889390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93012263|NCT05889390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93012264|NCT05889390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012265|NCT05889338|Adalimumab|adalimumab|mesh-list
93012267|NCT05889338|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93012268|NCT05889338|Abortifacient Agents|abortifacient agents|mesh-ancestor
93012269|NCT05889338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93012270|NCT05889338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012271|NCT05889338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93012272|NCT05889338|Antimetabolites|antimetabolites|mesh-ancestor
93012273|NCT05889338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012274|NCT05889338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012275|NCT05889338|Dermatologic Agents|dermatologic agents|mesh-ancestor
93012276|NCT05889338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012277|NCT05889338|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93012278|NCT05889338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012279|NCT05889338|Immunologic Factors|immunologic factors|mesh-ancestor
93012280|NCT05889338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93012281|NCT05889338|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93012282|NCT05889338|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93012283|NCT05889338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012284|NCT05889143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93012285|NCT05889143|Ezetimibe|ezetimibe|mesh-list
93012286|NCT05889143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93012287|NCT05889143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93012288|NCT05889143|Antimetabolites|antimetabolites|mesh-ancestor
93012289|NCT05889143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012290|NCT05889143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93012291|NCT05889143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93012292|NCT05889143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012293|NCT05889052|Pyrimethamine|pyrimethamine|mesh-list
93012294|NCT05889052|Sulfadoxine|sulfadoxine|mesh-list
93012295|NCT05889052|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93012296|NCT05889052|Antimalarials|antimalarials|mesh-ancestor
93012297|NCT05889052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93012298|NCT05889052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93012299|NCT05889052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012300|NCT05889052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93012301|NCT05889052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012302|NCT05889052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012303|NCT05889052|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93012304|NCT05889026|Botulinum Toxins|botulinum toxins|mesh-list
93012305|NCT05889026|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93012306|NCT05889026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93012307|NCT05889026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012308|NCT05889026|Cholinergic Agents|cholinergic agents|mesh-ancestor
93012309|NCT05889026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012310|NCT05889026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012311|NCT05889013|Nitric Oxide|nitric oxide|mesh-list
93012312|NCT05889013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93012313|NCT05889013|Autonomic Agents|autonomic agents|mesh-ancestor
93012314|NCT05889013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012315|NCT05889013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012316|NCT05889013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93012317|NCT05889013|Respiratory System Agents|respiratory system agents|mesh-ancestor
93012318|NCT05889013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93012319|NCT05889013|Antioxidants|antioxidants|mesh-ancestor
93012320|NCT05889013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012321|NCT05889013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012322|NCT05889013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93012323|NCT05889013|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012324|NCT05889013|Gasotransmitters|gasotransmitters|mesh-ancestor
93012325|NCT05889013|Protective Agents|protective agents|mesh-ancestor
93012327|NCT05888922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93012328|NCT05888922|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012329|NCT05888597|Menthol|menthol|mesh-list
93012330|NCT05888597|Antipruritics|antipruritics|mesh-ancestor
93012331|NCT05888597|Dermatologic Agents|dermatologic agents|mesh-ancestor
93012332|NCT05888493|Prednisone|prednisone|mesh-list
93012333|NCT05888493|Prednisolone|prednisolone|mesh-list
93012334|NCT05888493|Cyclophosphamide|cyclophosphamide|mesh-list
93012335|NCT05888493|Rituximab|rituximab|mesh-list
93012336|NCT05888493|Doxorubicin|doxorubicin|mesh-list
93012337|NCT05888493|Vincristine|vincristine|mesh-list
93012338|NCT05888493|Lenalidomide|lenalidomide|mesh-list
93012339|NCT05888493|Tisagenlecleucel|tisagenlecleucel|mesh-list
93012340|NCT05888493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012341|NCT05888493|Immunologic Factors|immunologic factors|mesh-ancestor
93012342|NCT05888493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012344|NCT05888493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93012345|NCT05888493|Alkylating Agents|alkylating agents|mesh-ancestor
93012346|NCT05888493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012347|NCT05888493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012348|NCT05888493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93012349|NCT05888493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012350|NCT05888493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012351|NCT05888493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93012352|NCT05888493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93012353|NCT05888493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012354|NCT05888493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012355|NCT05888493|Glucocorticoids|glucocorticoids|mesh-ancestor
93012356|NCT05888493|Hormones|hormones|mesh-ancestor
92171129|NCT03774446|Roscovitine|roscovitine|mesh-list
93012357|NCT05888493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012358|NCT05888493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012359|NCT05888493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012360|NCT05888493|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012361|NCT05888493|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012362|NCT05888493|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012363|NCT05888493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93012364|NCT05888493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93012365|NCT05888493|Growth Substances|growth substances|mesh-ancestor
93012366|NCT05888493|Growth Inhibitors|growth inhibitors|mesh-ancestor
93012367|NCT05887947|Nicotine|nicotine|mesh-list
93012368|NCT05887947|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93012369|NCT05887947|Autonomic Agents|autonomic agents|mesh-ancestor
93012370|NCT05887947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012371|NCT05887947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012372|NCT05887947|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93012373|NCT05887947|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93012374|NCT05887947|Cholinergic Agents|cholinergic agents|mesh-ancestor
93012375|NCT05887947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012376|NCT05887947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012377|NCT05887908|Imipenem|imipenem|mesh-list
93012378|NCT05887908|Cefepime|cefepime|mesh-list
93012379|NCT05887908|Aztreonam|aztreonam|mesh-list
93012380|NCT05887908|Cilastatin|cilastatin|mesh-list
93012381|NCT05887908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93012382|NCT05887908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012383|NCT05887908|Protease Inhibitors|protease inhibitors|mesh-ancestor
93012384|NCT05887908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012385|NCT05887908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012386|NCT05887882|Mitogens|mitogens|mesh-list
93012387|NCT05887882|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012388|NCT05887882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012389|NCT05887778|Dexamethasone|dexamethasone|mesh-list
93012390|NCT05887778|Dexamethasone acetate|dexamethasone acetate|mesh-list
93012391|NCT05887778|BB 1101|bb 1101|mesh-list
93012392|NCT05887778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012393|NCT05887778|Antiemetics|antiemetics|mesh-ancestor
93012394|NCT05887778|Autonomic Agents|autonomic agents|mesh-ancestor
93012395|NCT05887778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012396|NCT05887778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012397|NCT05887778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93012398|NCT05887778|Glucocorticoids|glucocorticoids|mesh-ancestor
93012399|NCT05887778|Hormones|hormones|mesh-ancestor
93012400|NCT05887778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012401|NCT05887778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012402|NCT05887778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012403|NCT05887778|Protease Inhibitors|protease inhibitors|mesh-ancestor
93012404|NCT05887778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012405|NCT05887778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012406|NCT05887765|Dexamethasone|dexamethasone|mesh-list
93012407|NCT05887765|Dexamethasone acetate|dexamethasone acetate|mesh-list
93012408|NCT05887765|BB 1101|bb 1101|mesh-list
93012409|NCT05887765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012410|NCT05887765|Antiemetics|antiemetics|mesh-ancestor
93012411|NCT05887765|Autonomic Agents|autonomic agents|mesh-ancestor
93012412|NCT05887765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012413|NCT05887765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012414|NCT05887765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93012415|NCT05887765|Glucocorticoids|glucocorticoids|mesh-ancestor
93012416|NCT05887765|Hormones|hormones|mesh-ancestor
93012417|NCT05887765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012418|NCT05887765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012419|NCT05887765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012420|NCT05887765|Protease Inhibitors|protease inhibitors|mesh-ancestor
93012421|NCT05887765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012422|NCT05887765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012423|NCT05886712|Naloxone|naloxone|mesh-list
93012424|NCT05886712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93012425|NCT05886712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012426|NCT05886712|Sensory System Agents|sensory system agents|mesh-ancestor
93012427|NCT05886712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012428|NCT05881382|Lenograstim|lenograstim|mesh-list
93012429|NCT05881382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93012430|NCT05881382|Immunologic Factors|immunologic factors|mesh-ancestor
93012431|NCT05881382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012432|NCT05874414|Trametinib|trametinib|mesh-list
93012433|NCT05874414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012434|NCT05874414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012435|NCT05874414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012436|NCT05874414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012437|NCT05851677|Disitamab vedotin|disitamab vedotin|mesh-list
93012438|NCT05851677|Immunoconjugates|immunoconjugates|mesh-ancestor
92657743|NCT00244517|Narcotics|narcotics|mesh-ancestor
93012439|NCT05851677|Immunologic Factors|immunologic factors|mesh-ancestor
93012440|NCT05851677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012441|NCT05843708|Ciprofloxacin|ciprofloxacin|mesh-list
93012442|NCT05843708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93012443|NCT05843708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012444|NCT05843708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93012445|NCT05843708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93012446|NCT05843708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012447|NCT05843708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012448|NCT05843708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012449|NCT05843708|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93012450|NCT05843708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93012451|NCT05836584|Calcium, Dietary|calcium, dietary|mesh-list
93012452|NCT05836584|Leucovorin|leucovorin|mesh-list
93012453|NCT05836584|Folic Acid|folic acid|mesh-list
93012454|NCT05836584|Docetaxel|docetaxel|mesh-list
93012455|NCT05836584|Fluorouracil|fluorouracil|mesh-list
93012456|NCT05836584|Capecitabine|capecitabine|mesh-list
93012457|NCT05836584|Oxaliplatin|oxaliplatin|mesh-list
93012458|NCT05836584|Atezolizumab|atezolizumab|mesh-list
93012459|NCT05836584|Calcium|calcium|mesh-list
93012460|NCT05836584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93012461|NCT05836584|Levoleucovorin|levoleucovorin|mesh-list
93012462|NCT05836584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012463|NCT05836584|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012464|NCT05836584|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012465|NCT05836584|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012466|NCT05836584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012467|NCT05836584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93012468|NCT05836584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012469|NCT05836584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93012470|NCT05836584|Antimetabolites|antimetabolites|mesh-ancestor
93012471|NCT05836584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93012472|NCT05836584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012473|NCT05836584|Immunologic Factors|immunologic factors|mesh-ancestor
93012474|NCT05836584|Antidotes|antidotes|mesh-ancestor
93012475|NCT05836584|Protective Agents|protective agents|mesh-ancestor
93012476|NCT05836584|Vitamin B Complex|vitamin b complex|mesh-ancestor
93012477|NCT05836584|Vitamins|vitamins|mesh-ancestor
93012478|NCT05836584|Micronutrients|micronutrients|mesh-ancestor
93012479|NCT05836584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012480|NCT05836584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012481|NCT05836584|Hematinics|hematinics|mesh-ancestor
93012482|NCT05805826|Vaccines|vaccines|mesh-list
93012483|NCT05805826|Immunologic Factors|immunologic factors|mesh-ancestor
93012484|NCT05805826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012485|NCT05802693|Mitogens|mitogens|mesh-list
93012486|NCT05802693|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012487|NCT05802693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012488|NCT05779020|Vaccines|vaccines|mesh-list
93012489|NCT05779020|Immunologic Factors|immunologic factors|mesh-ancestor
93012490|NCT05779020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012491|NCT05774899|Venetoclax|venetoclax|mesh-list
93012492|NCT05774899|Lenvatinib|lenvatinib|mesh-list
93012493|NCT05774899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012494|NCT05774899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012495|NCT05774899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012496|NCT05774899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012497|NCT05759949|Fulvestrant|fulvestrant|mesh-list
93012498|NCT05759949|Palbociclib|palbociclib|mesh-list
93012499|NCT05759949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012500|NCT05759949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012501|NCT05759949|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93012502|NCT05759949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93012503|NCT05759949|Hormone Antagonists|hormone antagonists|mesh-ancestor
93012504|NCT05759949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012505|NCT05759949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171233|NCT03710772|Antiemetics|antiemetics|mesh-ancestor
93012506|NCT05759949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012507|NCT05759949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012508|NCT05759949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012509|NCT05754073|Oxytocin|oxytocin|mesh-list
93012510|NCT05754073|Oxytocics|oxytocics|mesh-ancestor
93012511|NCT05754073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93012512|NCT05754073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012513|NCT05743946|Ivacaftor|ivacaftor|mesh-list
93012514|NCT05743946|Elexacaftor|elexacaftor|mesh-list
92657812|NCT00244907|Protective Agents|protective agents|mesh-ancestor
93012515|NCT05743946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93012516|NCT05743946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93012517|NCT05743946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012518|NCT05742789|Propofol|propofol|mesh-list
93012519|NCT05742789|Sevoflurane|sevoflurane|mesh-list
93012520|NCT05742789|Isoflurane|isoflurane|mesh-list
93012521|NCT05742789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93012522|NCT05742789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012523|NCT05742789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012524|NCT05742789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93012525|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
93012526|NCT05742789|Anesthetics|anesthetics|mesh-ancestor
93012527|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93012528|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93012529|NCT05741385|Metoprolol|metoprolol|mesh-list
93012530|NCT05741385|Midazolam|midazolam|mesh-list
93012531|NCT05741385|Caffeine|caffeine|mesh-list
93012532|NCT05741385|Omeprazole|omeprazole|mesh-list
93012533|NCT05741385|Warfarin|warfarin|mesh-list
93012534|NCT05741385|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93012535|NCT05741385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93012536|NCT05741385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012537|NCT05741385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012538|NCT05741385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93012539|NCT05741385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93012540|NCT05741385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93012541|NCT05741385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93012542|NCT05741385|Anesthetics, General|anesthetics, general|mesh-ancestor
93012543|NCT05741385|Anesthetics|anesthetics|mesh-ancestor
93012544|NCT05741385|GABA Modulators|gaba modulators|mesh-ancestor
93012545|NCT05741385|GABA Agents|gaba agents|mesh-ancestor
93012546|NCT05741385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012547|NCT05741385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012548|NCT05741385|Anticoagulants|anticoagulants|mesh-ancestor
93012549|NCT05741385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93012550|NCT05741385|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93012551|NCT05741385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012552|NCT05741385|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93012553|NCT05741385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93012554|NCT05741385|Purinergic Agents|purinergic agents|mesh-ancestor
93012555|NCT05741385|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93012556|NCT05741385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93012557|NCT05741385|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93012558|NCT05741385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93012559|NCT05741385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93012560|NCT05741385|Sympatholytics|sympatholytics|mesh-ancestor
93012561|NCT05741385|Autonomic Agents|autonomic agents|mesh-ancestor
93012562|NCT05741385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012563|NCT05741385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93012564|NCT05741385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93012565|NCT05741385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93012566|NCT05741385|Adrenergic Agents|adrenergic agents|mesh-ancestor
93012567|NCT05731895|BI 425809|bi 425809|mesh-list
93012568|NCT05731895|Nootropic Agents|nootropic agents|mesh-ancestor
93012569|NCT05721846|Nivolumab|nivolumab|mesh-list
93012570|NCT05721846|Ipilimumab|ipilimumab|mesh-list
93012571|NCT05721846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012572|NCT05721846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012573|NCT05721846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012574|NCT05721846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012575|NCT05704049|Dexamethasone|dexamethasone|mesh-list
93012576|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
93012577|NCT05704049|BB 1101|bb 1101|mesh-list
93012578|NCT05704049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012579|NCT05704049|Antiemetics|antiemetics|mesh-ancestor
93012580|NCT05704049|Autonomic Agents|autonomic agents|mesh-ancestor
93012581|NCT05704049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012582|NCT05704049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012583|NCT05704049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93012584|NCT05704049|Glucocorticoids|glucocorticoids|mesh-ancestor
93012585|NCT05704049|Hormones|hormones|mesh-ancestor
93012586|NCT05704049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012587|NCT05704049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012588|NCT05704049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012589|NCT05704049|Protease Inhibitors|protease inhibitors|mesh-ancestor
93012590|NCT05704049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012591|NCT05704049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012592|NCT05696782|Durvalumab|durvalumab|mesh-list
93012593|NCT05696782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012594|NCT05696782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012595|NCT05696613|Rituximab|rituximab|mesh-list
93012596|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93012597|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012598|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012599|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
93012600|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012601|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93012603|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012604|NCT05669833|Golimumab|golimumab|mesh-list
93012605|NCT05669833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93012606|NCT05669833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93012607|NCT05669833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012608|NCT05669833|Immunologic Factors|immunologic factors|mesh-ancestor
93012609|NCT05669833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012610|NCT05645146|Nicotine|nicotine|mesh-list
93012611|NCT05645146|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93012612|NCT05645146|Autonomic Agents|autonomic agents|mesh-ancestor
93012613|NCT05645146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012614|NCT05645146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012615|NCT05645146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93012616|NCT05645146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93012617|NCT05645146|Cholinergic Agents|cholinergic agents|mesh-ancestor
93012618|NCT05645146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012619|NCT05645146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012620|NCT05636111|Paclitaxel|paclitaxel|mesh-list
93012621|NCT05636111|Bevacizumab|bevacizumab|mesh-list
93012622|NCT05636111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012623|NCT05636111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012624|NCT05636111|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012625|NCT05636111|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012626|NCT05636111|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012627|NCT05636111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012628|NCT05636111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012629|NCT05636111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93012630|NCT05636111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93012631|NCT05636111|Growth Substances|growth substances|mesh-ancestor
92528678|NCT00036946|Aflibercept|aflibercept|mesh-list
93012632|NCT05636111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012633|NCT05636111|Growth Inhibitors|growth inhibitors|mesh-ancestor
93012635|NCT05631236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93012636|NCT05631236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012637|NCT05631236|Sympathomimetics|sympathomimetics|mesh-ancestor
93012638|NCT05631236|Autonomic Agents|autonomic agents|mesh-ancestor
93012639|NCT05631236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012640|NCT05631236|Dopamine Agents|dopamine agents|mesh-ancestor
93012641|NCT05631236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012642|NCT05631236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012643|NCT05631236|Adrenergic Agents|adrenergic agents|mesh-ancestor
93012644|NCT05631236|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93012645|NCT05631236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93012646|NCT05631236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93012647|NCT05631236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93012648|NCT05610072|Acetylcysteine|acetylcysteine|mesh-list
93012649|NCT05610072|Hydromorphone|hydromorphone|mesh-list
93012650|NCT05610072|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93012651|NCT05610072|Antiviral Agents|antiviral agents|mesh-ancestor
93012652|NCT05610072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012653|NCT05610072|Expectorants|expectorants|mesh-ancestor
93012654|NCT05610072|Respiratory System Agents|respiratory system agents|mesh-ancestor
93012655|NCT05610072|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93012656|NCT05610072|Antioxidants|antioxidants|mesh-ancestor
93012657|NCT05610072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012658|NCT05610072|Protective Agents|protective agents|mesh-ancestor
93012659|NCT05610072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012660|NCT05610072|Antidotes|antidotes|mesh-ancestor
93012661|NCT05610072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93012662|NCT05610072|Narcotics|narcotics|mesh-ancestor
93012663|NCT05610072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012664|NCT05610072|Analgesics|analgesics|mesh-ancestor
93012665|NCT05610072|Sensory System Agents|sensory system agents|mesh-ancestor
93012666|NCT05610072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012667|NCT05597085|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92657960|NCT00274560|Autonomic Agents|autonomic agents|mesh-ancestor
93012668|NCT05597085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012669|NCT05597085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012670|NCT05597085|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012671|NCT05597085|Immunotoxins|immunotoxins|mesh-ancestor
93012672|NCT05597085|Immunoconjugates|immunoconjugates|mesh-ancestor
93012673|NCT05597085|Immunologic Factors|immunologic factors|mesh-ancestor
93012674|NCT05597085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012675|NCT05577481|Antidepressive Agents|antidepressive agents|mesh-list
93012676|NCT05577481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93012677|NCT05538208|Mycophenolic Acid|mycophenolic acid|mesh-list
93012678|NCT05538208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012679|NCT05538208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012680|NCT05538208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93012681|NCT05538208|Antitubercular Agents|antitubercular agents|mesh-ancestor
92171360|NCT03579446|Analgesics|analgesics|mesh-ancestor
93012682|NCT05538208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93012683|NCT05538208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012684|NCT05538208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012685|NCT05538208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012686|NCT05484622|Pembrolizumab|pembrolizumab|mesh-list
93012687|NCT05484622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012688|NCT05484622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012689|NCT05484622|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012690|NCT05484622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012691|NCT05465135|Artenimol|artenimol|mesh-list
93012692|NCT05465135|Antimalarials|antimalarials|mesh-ancestor
93012693|NCT05465135|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93012694|NCT05465135|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93012695|NCT05465135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012696|NCT05425732|Vaccines|vaccines|mesh-list
93012697|NCT05425732|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93012698|NCT05425732|Immunologic Factors|immunologic factors|mesh-ancestor
93012699|NCT05425732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012700|NCT05389514|Cyclophosphamide|cyclophosphamide|mesh-list
93012701|NCT05389514|Gemcitabine|gemcitabine|mesh-list
93012702|NCT05389514|Pembrolizumab|pembrolizumab|mesh-list
93012703|NCT05389514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012704|NCT05389514|Immunologic Factors|immunologic factors|mesh-ancestor
93012705|NCT05389514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012706|NCT05389514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93012707|NCT05389514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93012708|NCT05389514|Alkylating Agents|alkylating agents|mesh-ancestor
93012709|NCT05389514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012710|NCT05389514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012711|NCT05389514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93012712|NCT05389514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93012713|NCT05389514|Antimetabolites|antimetabolites|mesh-ancestor
93012714|NCT05389514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012715|NCT05389514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012717|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93012718|NCT05327777|Narcotics|narcotics|mesh-ancestor
93012719|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012720|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012721|NCT05327777|Analgesics|analgesics|mesh-ancestor
93012722|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
93012723|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012724|NCT05741372|Metformin|metformin|mesh-list
93012725|NCT05741372|Digoxin|digoxin|mesh-list
93012726|NCT05741372|Furosemide|furosemide|mesh-list
93012727|NCT05741372|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93012728|NCT05741372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93012729|NCT05741372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012730|NCT05741372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93012731|NCT05741372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93012732|NCT05741372|Antimetabolites|antimetabolites|mesh-ancestor
93012733|NCT05741372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012734|NCT05741372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93012735|NCT05741372|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93012736|NCT05741372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012737|NCT05741372|Diuretics|diuretics|mesh-ancestor
93012738|NCT05741372|Natriuretic Agents|natriuretic agents|mesh-ancestor
93012739|NCT05741372|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93012740|NCT05741372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93012741|NCT05741372|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93012742|NCT05741372|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93012743|NCT05741372|Protective Agents|protective agents|mesh-ancestor
93012744|NCT05309187|Pembrolizumab|pembrolizumab|mesh-list
93012745|NCT05309187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012746|NCT05309187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012747|NCT05309187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012748|NCT05309187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012750|NCT05304546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012751|NCT05304546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012752|NCT05304546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012753|NCT05304546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012754|NCT05261490|Doxorubicin|doxorubicin|mesh-list
93012755|NCT05261490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93012756|NCT05261490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012757|NCT05261490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012758|NCT05261490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93012759|NCT05261490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93012760|NCT05261490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012761|NCT05261490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012762|NCT05234099|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93012763|NCT05234099|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93012764|NCT05234099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012765|NCT05180773|Bromocriptine|bromocriptine|mesh-list
93012766|NCT05180773|Rivaroxaban|rivaroxaban|mesh-list
93012767|NCT05180773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93012768|NCT05180773|Antithrombins|antithrombins|mesh-ancestor
93012769|NCT05180773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93012770|NCT05180773|Protease Inhibitors|protease inhibitors|mesh-ancestor
93012771|NCT05180773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012772|NCT05180773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012773|NCT05180773|Anticoagulants|anticoagulants|mesh-ancestor
93012774|NCT05180773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93012775|NCT05180773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93012776|NCT05180773|Hormone Antagonists|hormone antagonists|mesh-ancestor
93012777|NCT05180773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012778|NCT05180773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012779|NCT05180773|Dopamine Agonists|dopamine agonists|mesh-ancestor
93012780|NCT05180773|Dopamine Agents|dopamine agents|mesh-ancestor
93012781|NCT05180773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012782|NCT05092360|Paclitaxel|paclitaxel|mesh-list
93012783|NCT05092360|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93012784|NCT05092360|Gemcitabine|gemcitabine|mesh-list
93012785|NCT05092360|Doxorubicin|doxorubicin|mesh-list
93012786|NCT05092360|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93012787|NCT05092360|Pembrolizumab|pembrolizumab|mesh-list
93012788|NCT05092360|Topotecan|topotecan|mesh-list
93012789|NCT05092360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012790|NCT05092360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012791|NCT05092360|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012792|NCT05092360|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012793|NCT05092360|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012794|NCT05092360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012795|NCT05092360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93012796|NCT05092360|Antimetabolites|antimetabolites|mesh-ancestor
93012797|NCT05092360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012798|NCT05092360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93012799|NCT05092360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93012800|NCT05092360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012801|NCT05092360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012802|NCT05092360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012803|NCT05092360|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93012804|NCT05019430|Cocaine|cocaine|mesh-list
93012805|NCT05019430|Zolmitriptan|zolmitriptan|mesh-list
93012806|NCT05019430|Anesthetics, Local|anesthetics, local|mesh-ancestor
93012807|NCT05019430|Anesthetics|anesthetics|mesh-ancestor
93012808|NCT05019430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012809|NCT05019430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012810|NCT05019430|Sensory System Agents|sensory system agents|mesh-ancestor
93012811|NCT05019430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012812|NCT05019430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93012813|NCT05019430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93012814|NCT05019430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93012815|NCT05019430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93012816|NCT05019430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012817|NCT05019430|Dopamine Agents|dopamine agents|mesh-ancestor
93012818|NCT05019430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012819|NCT05019430|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93012820|NCT05019430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93012822|NCT05011058|Valganciclovir|valganciclovir|mesh-list
93012823|NCT05011058|Antiviral Agents|antiviral agents|mesh-ancestor
93012824|NCT05011058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012825|NCT04957758|Varenicline|varenicline|mesh-list
93012826|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93012827|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93012828|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
93012829|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012830|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012831|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012832|NCT04934722|Pembrolizumab|pembrolizumab|mesh-list
93012833|NCT04934722|Androgens|androgens|mesh-list
93012834|NCT04934722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012835|NCT04934722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171443|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012836|NCT04934722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012837|NCT04934722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012838|NCT04934722|Hormones|hormones|mesh-ancestor
93012839|NCT04934722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012840|NCT04934722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012841|NCT04924660|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
93012842|NCT04924660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93012843|NCT04924660|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012844|NCT04920383|Pembrolizumab|pembrolizumab|mesh-list
93012845|NCT04920383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012846|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012847|NCT04920383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012848|NCT04920383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012850|NCT04899349|Dapagliflozin|dapagliflozin|mesh-list
93012851|NCT04899349|Fulvestrant|fulvestrant|mesh-list
93012852|NCT04899349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93012853|NCT04899349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012854|NCT04899349|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93012855|NCT04899349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012856|NCT04899349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93012857|NCT04899349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012858|NCT04899349|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93012859|NCT04899349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93012860|NCT04899349|Hormone Antagonists|hormone antagonists|mesh-ancestor
93012861|NCT04899349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93012862|NCT04897841|Bupivacaine|bupivacaine|mesh-list
93012863|NCT04897841|Anesthetics, Local|anesthetics, local|mesh-ancestor
93012864|NCT04897841|Anesthetics|anesthetics|mesh-ancestor
93012865|NCT04897841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012866|NCT04897841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012867|NCT04897841|Sensory System Agents|sensory system agents|mesh-ancestor
93012868|NCT04897841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012869|NCT04850599|Pomalidomide|pomalidomide|mesh-list
93012870|NCT04850599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93012871|NCT04850599|Immunologic Factors|immunologic factors|mesh-ancestor
93012872|NCT04850599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012873|NCT04850599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92171463|NCT03298451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012874|NCT04850599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93012875|NCT04850599|Growth Substances|growth substances|mesh-ancestor
93012876|NCT04850599|Growth Inhibitors|growth inhibitors|mesh-ancestor
93012877|NCT04850599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012878|NCT04827134|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
93012879|NCT04827134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93012880|NCT04827134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93012881|NCT04827134|Antiviral Agents|antiviral agents|mesh-ancestor
93012882|NCT04827134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012883|NCT04792073|Avelumab|avelumab|mesh-list
93012884|NCT04792073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012885|NCT04792073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012886|NCT04765059|Cisplatin|cisplatin|mesh-list
93012887|NCT04765059|Carboplatin|carboplatin|mesh-list
93012888|NCT04765059|Pemetrexed|pemetrexed|mesh-list
93012889|NCT04765059|Osimertinib|osimertinib|mesh-list
93012890|NCT04765059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012891|NCT04765059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012892|NCT04765059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012893|NCT04765059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93012894|NCT04765059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93012895|NCT04765059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012897|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93012898|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012899|NCT04736953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93012900|NCT04736953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012901|NCT04736953|Antifungal Agents|antifungal agents|mesh-ancestor
93012902|NCT04736953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93012903|NCT04736953|Immunologic Factors|immunologic factors|mesh-ancestor
93012904|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012905|NCT04725617|Varenicline|varenicline|mesh-list
93012906|NCT04725617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93012907|NCT04725617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93012908|NCT04725617|Cholinergic Agents|cholinergic agents|mesh-ancestor
93012909|NCT04725617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012910|NCT04725617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012911|NCT04725617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012912|NCT04707391|Vaccines|vaccines|mesh-list
93012913|NCT04707391|Immunologic Factors|immunologic factors|mesh-ancestor
93012914|NCT04707391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012915|NCT04703075|Rifapentine|rifapentine|mesh-list
93012916|NCT04703075|Rifampin|rifampin|mesh-list
93012917|NCT04703075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93012918|NCT04703075|Antitubercular Agents|antitubercular agents|mesh-ancestor
93012919|NCT04703075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93012920|NCT04703075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93012921|NCT04703075|Leprostatic Agents|leprostatic agents|mesh-ancestor
93012922|NCT04703075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528686|NCT00036985|Doxorubicin|doxorubicin|mesh-list
93012923|NCT04703075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012924|NCT04703075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012925|NCT04703075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93012926|NCT04703075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93012927|NCT04703075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93012928|NCT04703075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93012929|NCT04703075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93012930|NCT04703075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93012931|NCT04702737|AMG 757|amg 757|mesh-list
93012932|NCT04702737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012933|NCT04691986|Niacinamide|niacinamide|mesh-list
93012934|NCT04691986|Niacin|niacin|mesh-list
93012935|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
93012936|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
93012937|NCT04691986|Vitamins|vitamins|mesh-ancestor
93012938|NCT04691986|Micronutrients|micronutrients|mesh-ancestor
93012939|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012940|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93012941|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
93012942|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012943|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93012944|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012945|NCT04685421|Bupivacaine|bupivacaine|mesh-list
93012946|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
93012947|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
93012948|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93012949|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93012950|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
93012951|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93012952|NCT04682158|Paclitaxel|paclitaxel|mesh-list
93012953|NCT04682158|Carboplatin|carboplatin|mesh-list
93012954|NCT04682158|Propranolol|propranolol|mesh-list
93012955|NCT04682158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012956|NCT04682158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012957|NCT04682158|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012958|NCT04682158|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012959|NCT04682158|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012960|NCT04682158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012961|NCT04682158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93012962|NCT04682158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93012963|NCT04682158|Adrenergic Agents|adrenergic agents|mesh-ancestor
93012964|NCT04682158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93012965|NCT04682158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658261|NCT00277602|Riluzole|riluzole|mesh-list
93012966|NCT04682158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93012967|NCT04682158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93012968|NCT04682158|Vasodilator Agents|vasodilator agents|mesh-ancestor
93012969|NCT04680975|Belumosudil|belumosudil|mesh-list
93012970|NCT04680975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93012971|NCT04680975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012972|NCT04680975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012973|NCT04673786|Ustekinumab|ustekinumab|mesh-list
93012974|NCT04673786|Dermatologic Agents|dermatologic agents|mesh-ancestor
93012975|NCT04623775|Paclitaxel|paclitaxel|mesh-list
93012976|NCT04623775|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93012977|NCT04623775|Carboplatin|carboplatin|mesh-list
93012978|NCT04623775|Nivolumab|nivolumab|mesh-list
93012979|NCT04623775|Pemetrexed|pemetrexed|mesh-list
93012980|NCT04623775|Relatlimab|relatlimab|mesh-list
93012981|NCT04623775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93012982|NCT04623775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012983|NCT04623775|Tubulin Modulators|tubulin modulators|mesh-ancestor
93012984|NCT04623775|Antimitotic Agents|antimitotic agents|mesh-ancestor
93012985|NCT04623775|Mitosis Modulators|mitosis modulators|mesh-ancestor
93012986|NCT04623775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93012987|NCT04623775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93012988|NCT04623775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93012989|NCT04623775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93012990|NCT04623775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93012991|NCT04623775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93012992|NCT04606446|Letrozole|letrozole|mesh-list
93012993|NCT04606446|Fulvestrant|fulvestrant|mesh-list
93012994|NCT04606446|Palbociclib|palbociclib|mesh-list
93012995|NCT04606446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93012996|NCT04606446|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93012997|NCT04606446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93012999|NCT04606446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013000|NCT04606446|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93013001|NCT04606446|Hormone Antagonists|hormone antagonists|mesh-ancestor
93013002|NCT04606446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013003|NCT04606446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013004|NCT04606446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93013005|NCT04606446|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93013006|NCT04606446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013007|NCT04605978|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93013008|NCT04602533|Durvalumab|durvalumab|mesh-list
93013009|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013010|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013011|NCT04597671|Durvalumab|durvalumab|mesh-list
93013012|NCT04597671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013013|NCT04597671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013014|NCT04583969|Remdesivir|remdesivir|mesh-list
93013015|NCT04583969|Lenzilumab|lenzilumab|mesh-list
93013016|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
92171621|NCT03089983|Isoniazid|isoniazid|mesh-list
93013017|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013018|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
93013019|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013020|NCT04583969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013021|NCT04575857|Atorvastatin|atorvastatin|mesh-list
93013022|NCT04575857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93013023|NCT04575857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93013024|NCT04575857|Antimetabolites|antimetabolites|mesh-ancestor
93013025|NCT04575857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013026|NCT04575857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93013027|NCT04575857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93013028|NCT04575857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013029|NCT04561115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93013030|NCT04561115|Immunologic Factors|immunologic factors|mesh-ancestor
93013031|NCT04561115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013032|NCT04546425|Vaccines|vaccines|mesh-list
93013033|NCT04546425|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93013034|NCT04546425|Immunologic Factors|immunologic factors|mesh-ancestor
93013035|NCT04546425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013036|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
93013037|NCT04520711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013038|NCT04520711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013039|NCT04520711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013040|NCT04520711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013041|NCT04502706|Rituximab|rituximab|mesh-list
93013042|NCT04502706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013043|NCT04502706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013044|NCT04502706|Immunologic Factors|immunologic factors|mesh-ancestor
93013045|NCT04502706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013046|NCT04502706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013047|NCT04486833|Cisplatin|cisplatin|mesh-list
93013048|NCT04486833|Carboplatin|carboplatin|mesh-list
93013049|NCT04486833|Osimertinib|osimertinib|mesh-list
93013050|NCT04486833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013051|NCT04486833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013052|NCT04486833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013053|NCT04486833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013054|NCT04468776|Zolpidem|zolpidem|mesh-list
93013055|NCT04468776|Trazodone|trazodone|mesh-list
93013056|NCT04468776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93013057|NCT04468776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93013058|NCT04468776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013059|NCT04468776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013060|NCT04468776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93013061|NCT04468776|GABA Agonists|gaba agonists|mesh-ancestor
93013062|NCT04468776|GABA Agents|gaba agents|mesh-ancestor
93013063|NCT04468776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013064|NCT04468776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013065|NCT04468776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93013066|NCT04468776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93013067|NCT04468776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93013068|NCT04468776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93013069|NCT04468776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93013070|NCT04468776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93013071|NCT04468776|Serotonin Agents|serotonin agents|mesh-ancestor
93013072|NCT04468776|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93013073|NCT04468776|Antidepressive Agents|antidepressive agents|mesh-ancestor
93013074|NCT04461639|Factor VIII|factor viii|mesh-list
93013075|NCT04461639|Coagulants|coagulants|mesh-ancestor
93013076|NCT04456673|Cholinergic Agents|cholinergic agents|mesh-list
93013077|NCT04456673|Muscarinic Antagonists|muscarinic antagonists|mesh-list
93013078|NCT04456673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013079|NCT04456673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013080|NCT04456673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013081|NCT04456673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93013082|NCT04416269|Insulin|insulin|mesh-list
93013083|NCT04416269|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93013084|NCT04416269|Metformin|metformin|mesh-list
93013085|NCT04416269|Pioglitazone|pioglitazone|mesh-list
93013086|NCT04416269|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93013087|NCT04416269|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93013088|NCT04416269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013089|NCT04416269|Protease Inhibitors|protease inhibitors|mesh-ancestor
93013090|NCT04416269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013091|NCT04416269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013092|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
93013093|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
93013094|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013095|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
93013096|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93013097|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
93013098|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013099|NCT04374461|Expectorants|expectorants|mesh-ancestor
93013100|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
93013101|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93013102|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
93013103|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013104|NCT04374461|Protective Agents|protective agents|mesh-ancestor
93013105|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013106|NCT04374461|Antidotes|antidotes|mesh-ancestor
93013107|NCT04344860|Tranexamic Acid|tranexamic acid|mesh-list
93013108|NCT04344860|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93013109|NCT04344860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93013110|NCT04344860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013111|NCT04344860|Hemostatics|hemostatics|mesh-ancestor
93013112|NCT04344860|Coagulants|coagulants|mesh-ancestor
93013113|NCT04333420|Vilobelimab|vilobelimab|mesh-list
93013114|NCT04333420|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92658414|NCT00247715|Antacids|antacids|mesh-ancestor
93013115|NCT04333420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013116|NCT04333420|Immunologic Factors|immunologic factors|mesh-ancestor
93013117|NCT04333420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013118|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
93013119|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013120|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013121|NCT04317534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013122|NCT04317534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013123|NCT04247165|Paclitaxel|paclitaxel|mesh-list
93013124|NCT04247165|Gemcitabine|gemcitabine|mesh-list
93013125|NCT04247165|Nivolumab|nivolumab|mesh-list
93013126|NCT04247165|Ipilimumab|ipilimumab|mesh-list
93013127|NCT04247165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93013128|NCT04247165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013129|NCT04247165|Tubulin Modulators|tubulin modulators|mesh-ancestor
93013130|NCT04247165|Antimitotic Agents|antimitotic agents|mesh-ancestor
93013131|NCT04247165|Mitosis Modulators|mitosis modulators|mesh-ancestor
93013132|NCT04247165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013133|NCT04247165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93013134|NCT04247165|Antimetabolites|antimetabolites|mesh-ancestor
93013135|NCT04247165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013136|NCT04247165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013137|NCT04245865|Leucovorin|leucovorin|mesh-list
93013138|NCT04245865|Tocotrienols|tocotrienols|mesh-list
93013139|NCT04245865|Vitamin E|vitamin e|mesh-list
93013140|NCT04245865|Tocopherols|tocopherols|mesh-list
93013141|NCT04245865|Bevacizumab|bevacizumab|mesh-list
93013142|NCT04245865|Fluorouracil|fluorouracil|mesh-list
93013143|NCT04245865|Capecitabine|capecitabine|mesh-list
93013144|NCT04245865|Oxaliplatin|oxaliplatin|mesh-list
93013146|NCT04245865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013147|NCT04245865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013148|NCT04245865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93013149|NCT04245865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93013150|NCT04245865|Growth Substances|growth substances|mesh-ancestor
93013151|NCT04245865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013152|NCT04245865|Growth Inhibitors|growth inhibitors|mesh-ancestor
93013153|NCT04245865|Antimetabolites|antimetabolites|mesh-ancestor
93013154|NCT04245865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013155|NCT04245865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93013156|NCT04245865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013157|NCT04245865|Immunologic Factors|immunologic factors|mesh-ancestor
93013158|NCT04245865|Antidotes|antidotes|mesh-ancestor
93013159|NCT04245865|Protective Agents|protective agents|mesh-ancestor
93013160|NCT04245865|Vitamin B Complex|vitamin b complex|mesh-ancestor
93013161|NCT04245865|Vitamins|vitamins|mesh-ancestor
93013162|NCT04245865|Micronutrients|micronutrients|mesh-ancestor
93013163|NCT04245865|Antioxidants|antioxidants|mesh-ancestor
93013164|NCT04234867|Dapagliflozin|dapagliflozin|mesh-list
93013165|NCT04234867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93013166|NCT04234867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013167|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93013168|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013169|NCT04234048|Fenretinide|fenretinide|mesh-list
93013170|NCT04234048|Retinamide|retinamide|mesh-list
93013171|NCT04234048|Tretinoin|tretinoin|mesh-list
93013172|NCT04234048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013173|NCT04234048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93013174|NCT04234048|Protective Agents|protective agents|mesh-ancestor
93013175|NCT04234048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013176|NCT04234048|Keratolytic Agents|keratolytic agents|mesh-ancestor
93013177|NCT04234048|Dermatologic Agents|dermatologic agents|mesh-ancestor
93013178|NCT04219280|Methylphenidate|methylphenidate|mesh-list
93013179|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93013180|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013181|NCT04219280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93013182|NCT04219280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93013183|NCT04219280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93013184|NCT04219280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013185|NCT04219280|Dopamine Agents|dopamine agents|mesh-ancestor
93013186|NCT04219280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013187|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
93013188|NCT04191096|Androgens|androgens|mesh-list
93013189|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013190|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013191|NCT04191096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013192|NCT04191096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013193|NCT04191096|Hormones|hormones|mesh-ancestor
93013194|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013195|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013196|NCT04177693|Letrozole|letrozole|mesh-list
93013197|NCT04177693|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93013198|NCT04177693|Clomiphene|clomiphene|mesh-list
93013199|NCT04177693|Enclomiphene|enclomiphene|mesh-list
93013200|NCT04177693|Zuclomiphene|zuclomiphene|mesh-list
93013201|NCT04177693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013202|NCT04177693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013203|NCT04177693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93013204|NCT04177693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93013205|NCT04177693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013206|NCT04177693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93013207|NCT04177693|Hormone Antagonists|hormone antagonists|mesh-ancestor
93013208|NCT04177693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013209|NCT04177693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013210|NCT04177693|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93013211|NCT04177693|Fertility Agents|fertility agents|mesh-ancestor
93013212|NCT04177693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93013213|NCT04177693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93013214|NCT04177693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93013215|NCT04177693|Antioxidants|antioxidants|mesh-ancestor
93013216|NCT04177693|Protective Agents|protective agents|mesh-ancestor
93013217|NCT04177693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93013218|NCT04177693|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93013219|NCT04177693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93013220|NCT04118387|Acetazolamide|acetazolamide|mesh-list
93013221|NCT04118387|Zolpidem|zolpidem|mesh-list
93013222|NCT04118387|Buspirone|buspirone|mesh-list
93013223|NCT04118387|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93013224|NCT04118387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93013225|NCT04118387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013226|NCT04118387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013227|NCT04118387|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93013228|NCT04118387|GABA Agonists|gaba agonists|mesh-ancestor
93013229|NCT04118387|GABA Agents|gaba agents|mesh-ancestor
93013230|NCT04118387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013231|NCT04118387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013232|NCT04118387|Anticonvulsants|anticonvulsants|mesh-ancestor
93013233|NCT04118387|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93013234|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013235|NCT04118387|Diuretics|diuretics|mesh-ancestor
93013236|NCT04118387|Natriuretic Agents|natriuretic agents|mesh-ancestor
93013237|NCT04118387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93013238|NCT04118387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93013239|NCT04118387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93013240|NCT04118387|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93013241|NCT04118387|Serotonin Agents|serotonin agents|mesh-ancestor
93013242|NCT04105335|Pembrolizumab|pembrolizumab|mesh-list
93013243|NCT04105335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013244|NCT04105335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013245|NCT04105335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013246|NCT04105335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013247|NCT04072952|Palbociclib|palbociclib|mesh-list
93013248|NCT04072952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013249|NCT04072952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013250|NCT04072952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013251|NCT04072952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013252|NCT04068194|Avelumab|avelumab|mesh-list
93013253|NCT04068194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93013254|NCT04068194|Peposertib|peposertib|mesh-list
93013255|NCT04068194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013256|NCT04068194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013257|NCT04068194|Immunologic Factors|immunologic factors|mesh-ancestor
93013258|NCT04068194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013259|NCT04068194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013260|NCT04068194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013261|NCT04068194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013262|NCT04032418|Pembrolizumab|pembrolizumab|mesh-list
93013263|NCT04032418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013264|NCT04032418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013265|NCT04032418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013266|NCT04032418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013267|NCT04026412|Nivolumab|nivolumab|mesh-list
93013268|NCT04026412|Ipilimumab|ipilimumab|mesh-list
93013270|NCT04026412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013271|NCT04026412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013272|NCT04026412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013273|NCT04026412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013274|NCT04006522|Atezolizumab|atezolizumab|mesh-list
93013275|NCT04006522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013276|NCT04006522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013277|NCT04006522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013278|NCT04006522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013279|NCT03971734|Regadenoson|regadenoson|mesh-list
93013280|NCT03971734|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93013281|NCT03971734|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93013282|NCT03971734|Purinergic Agonists|purinergic agonists|mesh-ancestor
93013283|NCT03971734|Purinergic Agents|purinergic agents|mesh-ancestor
93013284|NCT03971734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013285|NCT03971734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013286|NCT03971734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013287|NCT03964727|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93013288|NCT03964727|Immunoconjugates|immunoconjugates|mesh-ancestor
93013289|NCT03964727|Immunologic Factors|immunologic factors|mesh-ancestor
93013290|NCT03964727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013292|NCT03922048|Anesthetics, Local|anesthetics, local|mesh-ancestor
93013293|NCT03922048|Anesthetics|anesthetics|mesh-ancestor
92171787|NCT02877303|Antiemetics|antiemetics|mesh-ancestor
93013294|NCT03922048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013295|NCT03922048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013296|NCT03922048|Sensory System Agents|sensory system agents|mesh-ancestor
93013297|NCT03922048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013298|NCT03914742|Temozolomide|temozolomide|mesh-list
93013299|NCT03914742|Pamiparib|pamiparib|mesh-list
93013300|NCT03914742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93013301|NCT03914742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93013302|NCT03914742|Alkylating Agents|alkylating agents|mesh-ancestor
93013303|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013304|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013305|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013306|NCT03907475|Paclitaxel|paclitaxel|mesh-list
93013307|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93013308|NCT03907475|Carboplatin|carboplatin|mesh-list
93013309|NCT03907475|Gemcitabine|gemcitabine|mesh-list
93013310|NCT03907475|Doxorubicin|doxorubicin|mesh-list
93013311|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93013312|NCT03907475|Capecitabine|capecitabine|mesh-list
93013313|NCT03907475|Durvalumab|durvalumab|mesh-list
93013314|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
93013315|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93013316|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
93013317|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93013318|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013319|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
93013320|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
93013321|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
93013322|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013323|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93013324|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
93013325|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93013326|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93013327|NCT03907475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93013328|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013329|NCT03907475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013330|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
93013331|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013332|NCT03891667|Disulfiram|disulfiram|mesh-list
93013333|NCT03891667|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93013334|NCT03891667|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93013335|NCT03891667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013336|NCT03891667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013337|NCT03866174|Niacin|niacin|mesh-list
93013338|NCT03866174|Psilocybin|psilocybin|mesh-list
93013339|NCT03866174|Vitamins|vitamins|mesh-ancestor
93013340|NCT03866174|Micronutrients|micronutrients|mesh-ancestor
92658632|NCT00249041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93013341|NCT03866174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013342|NCT03866174|Vitamin B Complex|vitamin b complex|mesh-ancestor
93013343|NCT03866174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93013344|NCT03866174|Antimetabolites|antimetabolites|mesh-ancestor
93013345|NCT03866174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013346|NCT03866174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93013347|NCT03866174|Vasodilator Agents|vasodilator agents|mesh-ancestor
93013348|NCT03866174|Hallucinogens|hallucinogens|mesh-ancestor
93013349|NCT03866174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93013350|NCT03859869|Pancrelipase|pancrelipase|mesh-list
93013351|NCT03859869|Pancreatin|pancreatin|mesh-list
93013352|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93013353|NCT03831932|Osimertinib|osimertinib|mesh-list
93013354|NCT03831932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013355|NCT03831932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013356|NCT03831932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013357|NCT03831932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013358|NCT03764098|Guanfacine|guanfacine|mesh-list
93013359|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93013360|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93013361|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93013362|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93013363|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
93013364|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358888|NCT00250926|Antiemetics|antiemetics|mesh-ancestor
93013365|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013366|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013367|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93013368|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93013369|NCT03740204|Estradiol|estradiol|mesh-list
93013370|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93013371|NCT03740204|Progesterone|progesterone|mesh-list
93013372|NCT03740204|Estrogens|estrogens|mesh-ancestor
93013373|NCT03740204|Hormones|hormones|mesh-ancestor
93013374|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013375|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013376|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93013377|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
93013378|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93013379|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93013380|NCT03740204|Progestins|progestins|mesh-ancestor
93013381|NCT03735563|Fentanyl|fentanyl|mesh-list
93013382|NCT03735563|Ketamine|ketamine|mesh-list
93013383|NCT03735563|Analgesics|analgesics|mesh-ancestor
93013384|NCT03735563|Sensory System Agents|sensory system agents|mesh-ancestor
93013385|NCT03735563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013386|NCT03735563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013387|NCT03735563|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93013388|NCT03735563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93013389|NCT03735563|Anesthetics, General|anesthetics, general|mesh-ancestor
93013390|NCT03735563|Anesthetics|anesthetics|mesh-ancestor
93013391|NCT03735563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013392|NCT03735563|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93013393|NCT03735563|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93013394|NCT03735563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013395|NCT03735563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013396|NCT03735563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93013397|NCT03735563|Narcotics|narcotics|mesh-ancestor
93013398|NCT03735563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93013399|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
93013400|NCT03735095|Trioxsalen|trioxsalen|mesh-list
93013401|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013402|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
93013403|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93013404|NCT03715153|Bumetanide|bumetanide|mesh-list
93013405|NCT03715153|Diuretics|diuretics|mesh-ancestor
93013406|NCT03715153|Natriuretic Agents|natriuretic agents|mesh-ancestor
93013407|NCT03715153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013408|NCT03715153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93013409|NCT03715153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93013410|NCT03715153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013412|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
93013413|NCT03685773|Niacinamide|niacinamide|mesh-list
93013414|NCT03685773|Diazoxide|diazoxide|mesh-list
92658712|NCT00249236|Dopamine Agents|dopamine agents|mesh-ancestor
93013415|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93013416|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
93013417|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013418|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93013419|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
93013420|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
93013421|NCT03685773|Vitamins|vitamins|mesh-ancestor
93013422|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
93013423|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013424|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93013425|NCT03683277|Dexamethasone|dexamethasone|mesh-list
93013426|NCT03683277|Pomalidomide|pomalidomide|mesh-list
93013427|NCT03683277|Ixazomib|ixazomib|mesh-list
93013428|NCT03683277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013429|NCT03683277|Antiemetics|antiemetics|mesh-ancestor
93013430|NCT03683277|Autonomic Agents|autonomic agents|mesh-ancestor
93013431|NCT03683277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013432|NCT03683277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013433|NCT03683277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93013434|NCT03683277|Glucocorticoids|glucocorticoids|mesh-ancestor
93013435|NCT03683277|Hormones|hormones|mesh-ancestor
93013436|NCT03683277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013437|NCT03683277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93013438|NCT03683277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013439|NCT03683277|Immunologic Factors|immunologic factors|mesh-ancestor
93013440|NCT03683277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93013441|NCT03683277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93013442|NCT03683277|Growth Substances|growth substances|mesh-ancestor
93013443|NCT03683277|Growth Inhibitors|growth inhibitors|mesh-ancestor
93013444|NCT03683277|Protease Inhibitors|protease inhibitors|mesh-ancestor
93013445|NCT03683277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013446|NCT03683277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013447|NCT03665207|Insulin|insulin|mesh-list
93013448|NCT03665207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93013449|NCT03665207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013450|NCT03660683|Dapagliflozin|dapagliflozin|mesh-list
93013451|NCT03660683|Saxagliptin|saxagliptin|mesh-list
93013452|NCT03660683|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93013453|NCT03660683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013454|NCT03660683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93013455|NCT03660683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013456|NCT03660683|Incretins|incretins|mesh-ancestor
93013457|NCT03660683|Hormones|hormones|mesh-ancestor
93013458|NCT03660683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013459|NCT03660683|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93013460|NCT03660683|Protease Inhibitors|protease inhibitors|mesh-ancestor
93013461|NCT03660683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013462|NCT03569293|Upadacitinib|upadacitinib|mesh-list
93013463|NCT03569293|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93013464|NCT03569293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013465|NCT03569293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013466|NCT03569293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013467|NCT03569293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013468|NCT03566511|Diazoxide|diazoxide|mesh-list
93013469|NCT03566511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93013470|NCT03566511|Vasodilator Agents|vasodilator agents|mesh-ancestor
93013471|NCT03464136|Adalimumab|adalimumab|mesh-list
93013472|NCT03464136|Ustekinumab|ustekinumab|mesh-list
93013473|NCT03464136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93013474|NCT03464136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013475|NCT03464136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013476|NCT03464136|Dermatologic Agents|dermatologic agents|mesh-ancestor
93013477|NCT03397706|Valganciclovir|valganciclovir|mesh-list
93013478|NCT03397706|Antiviral Agents|antiviral agents|mesh-ancestor
93013479|NCT03397706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013480|NCT03382587|Aflibercept|aflibercept|mesh-list
93013481|NCT03382587|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93013482|NCT03382587|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93013483|NCT03382587|Growth Substances|growth substances|mesh-ancestor
93013484|NCT03382587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013485|NCT03382587|Growth Inhibitors|growth inhibitors|mesh-ancestor
93013486|NCT03382587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013487|NCT03325972|Dexmedetomidine|dexmedetomidine|mesh-list
93013488|NCT03325972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93013489|NCT03325972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013490|NCT03325972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013491|NCT03325972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93013492|NCT03325972|Analgesics|analgesics|mesh-ancestor
93013493|NCT03325972|Sensory System Agents|sensory system agents|mesh-ancestor
93013494|NCT03325972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013495|NCT03325972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93013496|NCT03325972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93013497|NCT03325972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93013498|NCT03325972|Adrenergic Agents|adrenergic agents|mesh-ancestor
93013499|NCT03325972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013500|NCT03325972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013501|NCT03274492|Prednisone|prednisone|mesh-list
93013502|NCT03274492|Cyclophosphamide|cyclophosphamide|mesh-list
93013503|NCT03274492|Rituximab|rituximab|mesh-list
93013504|NCT03274492|Doxorubicin|doxorubicin|mesh-list
93013505|NCT03274492|Vincristine|vincristine|mesh-list
93013506|NCT03274492|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93013507|NCT03274492|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
93013508|NCT03274492|Immunoconjugates|immunoconjugates|mesh-list
93013509|NCT03274492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013510|NCT03274492|Immunologic Factors|immunologic factors|mesh-ancestor
93013511|NCT03274492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013512|NCT03274492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013513|NCT03274492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93013514|NCT03274492|Alkylating Agents|alkylating agents|mesh-ancestor
93013515|NCT03274492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013516|NCT03274492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013517|NCT03274492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93013518|NCT03274492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013519|NCT03274492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93013520|NCT03274492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93013521|NCT03274492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93013522|NCT03274492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013523|NCT03274492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013524|NCT03274492|Glucocorticoids|glucocorticoids|mesh-ancestor
93013525|NCT03274492|Hormones|hormones|mesh-ancestor
93013526|NCT03274492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013527|NCT03274492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93013528|NCT03274492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93013529|NCT03274492|Tubulin Modulators|tubulin modulators|mesh-ancestor
93013530|NCT03274492|Antimitotic Agents|antimitotic agents|mesh-ancestor
93013531|NCT03274492|Mitosis Modulators|mitosis modulators|mesh-ancestor
93013532|NCT03247712|Nivolumab|nivolumab|mesh-list
93013533|NCT03247712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013534|NCT03247712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013535|NCT03247712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013536|NCT03247712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013537|NCT03198026|Obinutuzumab|obinutuzumab|mesh-list
93013538|NCT03198026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013539|NCT03198026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013540|NCT03125642|Cytarabine|cytarabine|mesh-list
93013541|NCT03125642|Cyclophosphamide|cyclophosphamide|mesh-list
93013542|NCT03125642|Melphalan|melphalan|mesh-list
93013543|NCT03125642|Carmustine|carmustine|mesh-list
93013544|NCT03125642|Etoposide|etoposide|mesh-list
93013545|NCT03125642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013546|NCT03125642|Immunologic Factors|immunologic factors|mesh-ancestor
93013547|NCT03125642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013548|NCT03125642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013549|NCT03125642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93013550|NCT03125642|Alkylating Agents|alkylating agents|mesh-ancestor
93013551|NCT03125642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013552|NCT03125642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013553|NCT03125642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93013554|NCT03125642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93013555|NCT03125642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93013556|NCT03125642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93013557|NCT03125642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013558|NCT03125642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93013559|NCT03125642|Antimetabolites|antimetabolites|mesh-ancestor
93013560|NCT03125642|Antiviral Agents|antiviral agents|mesh-ancestor
93013561|NCT03125642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013562|NCT03048825|Colchicine|colchicine|mesh-list
93013563|NCT03048825|Spironolactone|spironolactone|mesh-list
93013564|NCT03048825|Gout Suppressants|gout suppressants|mesh-ancestor
93013565|NCT03048825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013566|NCT03048825|Tubulin Modulators|tubulin modulators|mesh-ancestor
93013567|NCT03048825|Antimitotic Agents|antimitotic agents|mesh-ancestor
93013568|NCT03048825|Mitosis Modulators|mitosis modulators|mesh-ancestor
93013569|NCT03048825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013570|NCT03048825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013571|NCT03048825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93013572|NCT03048825|Hormone Antagonists|hormone antagonists|mesh-ancestor
93013573|NCT03048825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013574|NCT03048825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013575|NCT03048825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93013576|NCT03048825|Diuretics|diuretics|mesh-ancestor
93013577|NCT03048825|Natriuretic Agents|natriuretic agents|mesh-ancestor
93013579|NCT03039413|Trace Elements|trace elements|mesh-ancestor
93013580|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
93013581|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013582|NCT03026790|Buprenorphine|buprenorphine|mesh-list
93013583|NCT03026790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93013584|NCT03026790|Naloxone|naloxone|mesh-list
93013585|NCT03026790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93013586|NCT03026790|Narcotics|narcotics|mesh-ancestor
93013587|NCT03026790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013588|NCT03026790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013589|NCT03026790|Analgesics|analgesics|mesh-ancestor
93013590|NCT03026790|Sensory System Agents|sensory system agents|mesh-ancestor
93013591|NCT03026790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013592|NCT03026790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93013593|NCT02974725|Trametinib|trametinib|mesh-list
93013594|NCT02974725|Naporafenib|naporafenib|mesh-list
93013595|NCT02974725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013596|NCT02974725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013597|NCT02974725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013598|NCT02974725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013599|NCT02955290|Pembrolizumab|pembrolizumab|mesh-list
93013600|NCT02955290|Nivolumab|nivolumab|mesh-list
93013601|NCT02955290|Vaccines|vaccines|mesh-list
93013602|NCT02955290|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93013603|NCT02955290|Mitogens|mitogens|mesh-list
93013604|NCT02955290|Immunologic Factors|immunologic factors|mesh-ancestor
93013605|NCT02955290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013606|NCT02955290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013607|NCT02955290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013608|NCT02955290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93013609|NCT02955290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013610|NCT02955290|Mitosis Modulators|mitosis modulators|mesh-ancestor
93013611|NCT02955290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93013612|NCT02735707|Aspirin|aspirin|mesh-list
93013613|NCT02735707|Vitamins|vitamins|mesh-list
93013614|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
93013615|NCT02735707|Interferons|interferons|mesh-list
93013616|NCT02735707|Ritonavir|ritonavir|mesh-list
93013617|NCT02735707|Lopinavir|lopinavir|mesh-list
93013618|NCT02735707|Interferon-beta|interferon-beta|mesh-list
93013619|NCT02735707|Oseltamivir|oseltamivir|mesh-list
93013620|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
93013621|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
93013622|NCT02735707|Baloxavir|baloxavir|mesh-list
93013623|NCT02735707|Amoxicillin|amoxicillin|mesh-list
93013624|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
93013625|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
93013626|NCT02735707|Levofloxacin|levofloxacin|mesh-list
93013627|NCT02735707|Ivermectin|ivermectin|mesh-list
93013628|NCT02735707|Ceftriaxone|ceftriaxone|mesh-list
93013629|NCT02735707|Tazobactam|tazobactam|mesh-list
93013630|NCT02735707|Piperacillin|piperacillin|mesh-list
93013631|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
93013632|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93013633|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93013634|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93013635|NCT02735707|Dexamethasone|dexamethasone|mesh-list
93013636|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
93013637|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93013638|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93013639|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93013640|NCT02735707|Apremilast|apremilast|mesh-list
93013641|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93013642|NCT02735707|Losartan|losartan|mesh-list
93013643|NCT02735707|Valsartan|valsartan|mesh-list
93013644|NCT02735707|Telmisartan|telmisartan|mesh-list
93013645|NCT02735707|Candesartan|candesartan|mesh-list
93013646|NCT02735707|Ramipril|ramipril|mesh-list
93013647|NCT02735707|Olmesartan|olmesartan|mesh-list
93013648|NCT02735707|Enalapril|enalapril|mesh-list
93013649|NCT02735707|Lisinopril|lisinopril|mesh-list
93013650|NCT02735707|Irbesartan|irbesartan|mesh-list
93013651|NCT02735707|Perindopril|perindopril|mesh-list
93013652|NCT02735707|Captopril|captopril|mesh-list
93013653|NCT02735707|Trandolapril|trandolapril|mesh-list
93013654|NCT02735707|Clopidogrel|clopidogrel|mesh-list
93013655|NCT02735707|Ticagrelor|ticagrelor|mesh-list
93013656|NCT02735707|Simvastatin|simvastatin|mesh-list
93013657|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93013658|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
93013659|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93013660|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93013661|NCT02735707|Cysteamine|cysteamine|mesh-list
93013662|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
93013663|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013664|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013665|NCT02735707|Antiemetics|antiemetics|mesh-ancestor
93013666|NCT02735707|Autonomic Agents|autonomic agents|mesh-ancestor
93013667|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013668|NCT02735707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93013669|NCT02735707|Glucocorticoids|glucocorticoids|mesh-ancestor
93013670|NCT02735707|Hormones|hormones|mesh-ancestor
93013671|NCT02735707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013672|NCT02735707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93013673|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013674|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013675|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93013676|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93013677|NCT02735707|Analgesics|analgesics|mesh-ancestor
93013678|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
93013679|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013680|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93013681|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93013682|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013683|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93013684|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93013685|NCT02735707|Antipyretics|antipyretics|mesh-ancestor
93013686|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93013687|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93013688|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
93013689|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93013690|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93013691|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93013692|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93013693|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93013694|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93013695|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93013696|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
93013697|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013698|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93013699|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93013700|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93013701|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
93013702|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93013703|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93013704|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93013705|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93013706|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
93013707|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93013708|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93013709|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
93013710|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93013711|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93013712|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93013713|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
93013714|NCT02735707|Protective Agents|protective agents|mesh-ancestor
93013715|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93013716|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93013717|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93013718|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93013719|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93013720|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93013721|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93013722|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
93013723|NCT02697448|Propofol|propofol|mesh-list
93013724|NCT02697448|Sevoflurane|sevoflurane|mesh-list
93013725|NCT02697448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93013726|NCT02697448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013727|NCT02697448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013728|NCT02697448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93013730|NCT02697448|Anesthetics|anesthetics|mesh-ancestor
93013731|NCT02697448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93013732|NCT02697448|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93013733|NCT02647203|Fluorides|fluorides|mesh-list
93013734|NCT02647203|Cariostatic Agents|cariostatic agents|mesh-ancestor
93013735|NCT02647203|Protective Agents|protective agents|mesh-ancestor
93013736|NCT02647203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013737|NCT02637973|Empagliflozin|empagliflozin|mesh-list
93013738|NCT02637973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93013739|NCT02637973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013740|NCT02637973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93013741|NCT02637973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013742|NCT02575794|Masoprocol|masoprocol|mesh-list
93013743|NCT02575794|Antioxidants|antioxidants|mesh-ancestor
92172103|NCT01991873|Vitamins|vitamins|mesh-ancestor
93013744|NCT02575794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013745|NCT02575794|Protective Agents|protective agents|mesh-ancestor
93013746|NCT02575794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013747|NCT02575794|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93013748|NCT02575794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013749|NCT02575794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93013750|NCT02575794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93013751|NCT02575794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93013752|NCT02575794|Analgesics|analgesics|mesh-ancestor
93013753|NCT02575794|Sensory System Agents|sensory system agents|mesh-ancestor
93013754|NCT02575794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013755|NCT02575794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013756|NCT02575794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013757|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
93013758|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
93013759|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013760|NCT02527681|Ceftobiprole|ceftobiprole|mesh-list
93013761|NCT02527681|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93013762|NCT02527681|Cephalosporins|cephalosporins|mesh-list
93013763|NCT02527681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93013764|NCT02527681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013765|NCT02516696|Clarithromycin|clarithromycin|mesh-list
93013766|NCT02516696|Dexamethasone|dexamethasone|mesh-list
93013767|NCT02516696|Lenalidomide|lenalidomide|mesh-list
93013768|NCT02516696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013769|NCT02516696|Antiemetics|antiemetics|mesh-ancestor
93013770|NCT02516696|Autonomic Agents|autonomic agents|mesh-ancestor
93013771|NCT02516696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013772|NCT02516696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013773|NCT02516696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93013774|NCT02516696|Glucocorticoids|glucocorticoids|mesh-ancestor
93013775|NCT02516696|Hormones|hormones|mesh-ancestor
93013776|NCT02516696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013777|NCT02516696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93013778|NCT02516696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013779|NCT02516696|Immunologic Factors|immunologic factors|mesh-ancestor
93013780|NCT02516696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93013781|NCT02516696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93013782|NCT02516696|Growth Substances|growth substances|mesh-ancestor
93013783|NCT02516696|Growth Inhibitors|growth inhibitors|mesh-ancestor
93013784|NCT02516696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93013785|NCT02516696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013786|NCT02516696|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93013787|NCT02516696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172140|NCT01927744|Docetaxel|docetaxel|mesh-list
93013788|NCT02516696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013789|NCT02516696|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93013790|NCT02516696|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93013791|NCT02513329|Bupivacaine|bupivacaine|mesh-list
93013792|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
93013793|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
93013794|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013795|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013796|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
93013797|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013798|NCT02425826|Thalidomide|thalidomide|mesh-list
93013799|NCT02425826|Apremilast|apremilast|mesh-list
93013800|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93013801|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93013802|NCT02425826|Analgesics|analgesics|mesh-ancestor
93013803|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
93013804|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013805|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013806|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93013807|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013808|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93013809|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93013810|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013811|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013812|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013813|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
93013814|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
93013815|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93013816|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013817|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93013818|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93013819|NCT02425826|Growth Substances|growth substances|mesh-ancestor
93013820|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
93013821|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013822|NCT02386774|Benoxinate|benoxinate|mesh-list
93013823|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93013825|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
93013826|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
93013827|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013828|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013829|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
93013830|NCT02386774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013831|NCT02278120|Tamoxifen|tamoxifen|mesh-list
93013832|NCT02278120|Letrozole|letrozole|mesh-list
93013833|NCT02278120|Anastrozole|anastrozole|mesh-list
93013834|NCT02278120|Goserelin|goserelin|mesh-list
93013835|NCT02278120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013836|NCT02278120|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93013837|NCT02278120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93013838|NCT02278120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013839|NCT02278120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013840|NCT02278120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93013841|NCT02278120|Hormone Antagonists|hormone antagonists|mesh-ancestor
93013842|NCT02278120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93013843|NCT02278120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013844|NCT02278120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93013845|NCT02278120|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93013846|NCT02278120|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93013847|NCT02278120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93013848|NCT02274155|Antibodies|antibodies|mesh-list
93013849|NCT02274155|Immunologic Factors|immunologic factors|mesh-ancestor
93013850|NCT02274155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013851|NCT02255357|Oxytocin|oxytocin|mesh-list
93013852|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
93013853|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93013854|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013855|NCT02211131|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93013856|NCT02211131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013857|NCT02211131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013858|NCT02155647|Avelumab|avelumab|mesh-list
93013859|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013860|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013861|NCT02125786|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93013862|NCT02125786|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93013863|NCT02125786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013864|NCT02057107|Docetaxel|docetaxel|mesh-list
93013865|NCT02057107|Cetuximab|cetuximab|mesh-list
93013866|NCT02057107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013867|NCT02057107|Tubulin Modulators|tubulin modulators|mesh-ancestor
93013868|NCT02057107|Antimitotic Agents|antimitotic agents|mesh-ancestor
93013869|NCT02057107|Mitosis Modulators|mitosis modulators|mesh-ancestor
93013870|NCT02057107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013871|NCT02057107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013872|NCT01861106|Mycophenolic Acid|mycophenolic acid|mesh-list
93013873|NCT01861106|Cyclophosphamide|cyclophosphamide|mesh-list
93013874|NCT01861106|Busulfan|busulfan|mesh-list
93013875|NCT01861106|Fludarabine|fludarabine|mesh-list
93013876|NCT01861106|Fludarabine phosphate|fludarabine phosphate|mesh-list
93013877|NCT01861106|Tacrolimus|tacrolimus|mesh-list
93013878|NCT01861106|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93013879|NCT01861106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013880|NCT01861106|Immunologic Factors|immunologic factors|mesh-ancestor
93013881|NCT01861106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013882|NCT01861106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013883|NCT01861106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93013884|NCT01861106|Alkylating Agents|alkylating agents|mesh-ancestor
93013885|NCT01861106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013886|NCT01861106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013887|NCT01861106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93013888|NCT01861106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93013889|NCT01861106|Antimetabolites|antimetabolites|mesh-ancestor
93013890|NCT01861106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93013891|NCT01861106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013892|NCT01861106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93013893|NCT01861106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93013894|NCT01861106|Antitubercular Agents|antitubercular agents|mesh-ancestor
93013895|NCT01861106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93013896|NCT01861106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013897|NCT01479075|Insulin|insulin|mesh-list
93013898|NCT01479075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93013899|NCT01479075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93013900|NCT01479075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013902|NCT01082679|Methadone|methadone|mesh-list
93013903|NCT01082679|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93013904|NCT01082679|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93013905|NCT01082679|Narcotics|narcotics|mesh-ancestor
93013906|NCT01082679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013907|NCT01082679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013908|NCT01082679|Analgesics|analgesics|mesh-ancestor
93013909|NCT01082679|Sensory System Agents|sensory system agents|mesh-ancestor
93013910|NCT01082679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013911|NCT01082679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93013912|NCT01082679|Antitussive Agents|antitussive agents|mesh-ancestor
93013913|NCT01082679|Respiratory System Agents|respiratory system agents|mesh-ancestor
93013914|NCT00976963|Fosfomycin|fosfomycin|mesh-list
93013915|NCT00976963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93013916|NCT00976963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013917|NCT00958633|Bupropion|bupropion|mesh-list
93013918|NCT00958633|Escitalopram|escitalopram|mesh-list
93013919|NCT00958633|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93013920|NCT00958633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93013921|NCT00958633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93013922|NCT00958633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013923|NCT00958633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013924|NCT00958633|Serotonin Agents|serotonin agents|mesh-ancestor
93013925|NCT00958633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013926|NCT00958633|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93013927|NCT00958633|Antidepressive Agents|antidepressive agents|mesh-ancestor
93013928|NCT00958633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93013929|NCT00958633|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93013930|NCT00958633|Dopamine Agents|dopamine agents|mesh-ancestor
93013931|NCT00958633|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93013932|NCT00958633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93013933|NCT00958633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013934|NCT00393783|Trastuzumab|trastuzumab|mesh-list
93013935|NCT00393783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93013936|NCT00393783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013937|NCT00074269|Cyclosporine|cyclosporine|mesh-list
93013938|NCT00074269|Methotrexate|methotrexate|mesh-list
93013939|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
93013940|NCT00074269|Fludarabine|fludarabine|mesh-list
93013941|NCT00074269|Melphalan|melphalan|mesh-list
93013942|NCT00074269|Cyclosporins|cyclosporins|mesh-list
93013943|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93013944|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93013945|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
93013946|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93013947|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013948|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93013949|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
93013950|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013951|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013952|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
93013953|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013954|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93013955|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93013956|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
93013957|NCT00074269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93013958|NCT00074269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93013959|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
93013960|NCT00074269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93013961|NCT00074269|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93013962|NCT00074269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93013963|NCT00074269|Alkylating Agents|alkylating agents|mesh-ancestor
93013964|NCT00074269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93013965|NCT00423735|Dasatinib|dasatinib|mesh-list
93013966|NCT00423735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93013967|NCT00423735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93013968|NCT00423735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013969|NCT00423735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013970|NCT01032213|Magnesium Sulfate|magnesium sulfate|mesh-list
93013971|NCT01032213|Analgesics|analgesics|mesh-ancestor
92359500|NCT00549978|Antioxidants|antioxidants|mesh-ancestor
93013972|NCT01032213|Sensory System Agents|sensory system agents|mesh-ancestor
93013973|NCT01032213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93013974|NCT01032213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013975|NCT01032213|Anesthetics|anesthetics|mesh-ancestor
93013976|NCT01032213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93013977|NCT01032213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93013978|NCT01032213|Anticonvulsants|anticonvulsants|mesh-ancestor
93013979|NCT01032213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93013980|NCT01032213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93013981|NCT01032213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013982|NCT01032213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93013983|NCT01032213|Tocolytic Agents|tocolytic agents|mesh-ancestor
93013984|NCT01032213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93013985|NCT00357994|Levodopa|levodopa|mesh-list
93013986|NCT00357994|Carbidopa|carbidopa|mesh-list
93013987|NCT00357994|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93013988|NCT00357994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93013989|NCT00357994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93013990|NCT00357994|Dopamine Agents|dopamine agents|mesh-ancestor
93013991|NCT00357994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93013992|NCT00357994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93013993|NCT00357994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93013994|NCT00357994|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93013995|NCT00357994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93013996|NCT00357994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93013997|NCT00357994|Immunologic Factors|immunologic factors|mesh-ancestor
93013998|NCT00357994|Dopamine Agonists|dopamine agonists|mesh-ancestor
93013999|NCT00823433|Penicillins|penicillins|mesh-list
93014000|NCT00823433|Penicillin V|penicillin v|mesh-list
93014001|NCT00823433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014002|NCT00823433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014003|NCT00423657|Vancomycin|vancomycin|mesh-list
93014004|NCT00423657|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93014005|NCT00423657|Aztreonam|aztreonam|mesh-list
93014006|NCT00423657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014007|NCT00423657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014008|NCT00831155|Nicotine|nicotine|mesh-list
93014009|NCT00831155|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93014010|NCT00831155|Autonomic Agents|autonomic agents|mesh-ancestor
93014011|NCT00831155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014012|NCT00831155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014013|NCT00831155|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93014014|NCT00831155|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93014015|NCT00831155|Cholinergic Agents|cholinergic agents|mesh-ancestor
93014016|NCT00831155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014017|NCT00831155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014018|NCT00827021|Epoetin Alfa|epoetin alfa|mesh-list
93014019|NCT00827021|Hematinics|hematinics|mesh-list
93014020|NCT01050712|Carbon Monoxide|carbon monoxide|mesh-list
93014021|NCT01050712|Antimetabolites|antimetabolites|mesh-ancestor
93014022|NCT01050712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014023|NCT01050712|Gasotransmitters|gasotransmitters|mesh-ancestor
93014024|NCT01050712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014025|NCT01050712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014026|NCT02550119|Dexamethasone|dexamethasone|mesh-list
93014027|NCT02550119|Dexamethasone acetate|dexamethasone acetate|mesh-list
92659310|NCT02271334|Tocolytic Agents|tocolytic agents|mesh-ancestor
93014028|NCT02550119|Aprepitant|aprepitant|mesh-list
93014029|NCT02550119|Dolasetron|dolasetron|mesh-list
93014030|NCT02550119|Ichthammol|ichthammol|mesh-list
93014032|NCT02550119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014033|NCT02550119|Antiemetics|antiemetics|mesh-ancestor
93014034|NCT02550119|Autonomic Agents|autonomic agents|mesh-ancestor
93014035|NCT02550119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014036|NCT02550119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014037|NCT02550119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014038|NCT02550119|Glucocorticoids|glucocorticoids|mesh-ancestor
93014039|NCT02550119|Hormones|hormones|mesh-ancestor
93014040|NCT02550119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014041|NCT02550119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93014042|NCT02550119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014043|NCT02550119|Protease Inhibitors|protease inhibitors|mesh-ancestor
93014044|NCT02550119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014045|NCT02550119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014046|NCT02550119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93014047|NCT02550119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014048|NCT02550119|Dermatologic Agents|dermatologic agents|mesh-ancestor
93014049|NCT02550119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93014050|NCT02550119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93014052|NCT02548403|Simethicone|simethicone|mesh-list
93014053|NCT02548403|Antifoaming Agents|antifoaming agents|mesh-ancestor
93014054|NCT02548403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014055|NCT02548403|Emollients|emollients|mesh-ancestor
93014056|NCT02548403|Dermatologic Agents|dermatologic agents|mesh-ancestor
93014057|NCT00367432|Levetiracetam|levetiracetam|mesh-list
93014058|NCT00367432|Anticonvulsants|anticonvulsants|mesh-ancestor
93014059|NCT00367432|Nootropic Agents|nootropic agents|mesh-ancestor
93014060|NCT00623363|Piclozotan|piclozotan|mesh-list
93014061|NCT00623363|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93014062|NCT00623363|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93014063|NCT00623363|Serotonin Agents|serotonin agents|mesh-ancestor
93014064|NCT00623363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014065|NCT00623363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014066|NCT00623363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014067|NCT00827177|Sorafenib|sorafenib|mesh-list
93014068|NCT00827177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014069|NCT00827177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014070|NCT00827177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014071|NCT00827177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014072|NCT00423267|Fluconazole|fluconazole|mesh-list
93014073|NCT00423267|Posaconazole|posaconazole|mesh-list
93014074|NCT00423267|Antifungal Agents|antifungal agents|mesh-ancestor
93014075|NCT00423267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014076|NCT00423267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93014077|NCT00423267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93014078|NCT00423267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014079|NCT00423267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014080|NCT00423267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93014081|NCT00423267|Hormone Antagonists|hormone antagonists|mesh-ancestor
93014082|NCT00423267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014083|NCT00423267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014084|NCT00423267|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93014085|NCT00423267|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93014086|NCT00423267|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93014087|NCT00423267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93014088|NCT00423267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93014089|NCT02549261|Etoposide|etoposide|mesh-list
93014090|NCT02549261|Nimotuzumab|nimotuzumab|mesh-list
92172254|NCT01328171|Vitamins|vitamins|mesh-ancestor
93014091|NCT02549261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014092|NCT02549261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93014093|NCT02549261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93014094|NCT02549261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93014095|NCT02549261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014096|NCT02549261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014097|NCT02549261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014098|NCT00357760|Aflibercept|aflibercept|mesh-list
93014099|NCT00357760|Endothelial Growth Factors|endothelial growth factors|mesh-list
93014100|NCT00357760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93014101|NCT00357760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93014102|NCT00357760|Growth Substances|growth substances|mesh-ancestor
93014103|NCT00357760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014104|NCT00357760|Growth Inhibitors|growth inhibitors|mesh-ancestor
93014105|NCT00357760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014106|NCT00622739|Ziprasidone|ziprasidone|mesh-list
93014107|NCT00622739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93014108|NCT00622739|Serotonin Agents|serotonin agents|mesh-ancestor
93014109|NCT00622739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014110|NCT00622739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014111|NCT00622739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014112|NCT00622739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93014113|NCT00622739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014114|NCT00622739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014115|NCT00622739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014116|NCT00622739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93014117|NCT00622739|Dopamine Agents|dopamine agents|mesh-ancestor
93014118|NCT03742336|Dabigatran|dabigatran|mesh-list
93014119|NCT03742336|Abrocitinib|abrocitinib|mesh-list
93014120|NCT03742336|Antithrombins|antithrombins|mesh-ancestor
93014121|NCT03742336|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93014122|NCT03742336|Protease Inhibitors|protease inhibitors|mesh-ancestor
93014123|NCT03742336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014124|NCT03742336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014125|NCT03742336|Anticoagulants|anticoagulants|mesh-ancestor
93014126|NCT03742336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014127|NCT00435825|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93014128|NCT00435825|Antiviral Agents|antiviral agents|mesh-ancestor
93014129|NCT00435825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014131|NCT00824057|Caffeine|caffeine|mesh-list
93014132|NCT00824057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93014133|NCT00824057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93014134|NCT00824057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014135|NCT00824057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014136|NCT00824057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93014137|NCT00824057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014138|NCT00824057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014139|NCT00824057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93014140|NCT00824057|Anesthetics, General|anesthetics, general|mesh-ancestor
93014141|NCT00824057|Anesthetics|anesthetics|mesh-ancestor
93014142|NCT00824057|GABA Modulators|gaba modulators|mesh-ancestor
93014143|NCT00824057|GABA Agents|gaba agents|mesh-ancestor
93014144|NCT00824057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014145|NCT00824057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014146|NCT00824057|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93014147|NCT00824057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93014148|NCT00824057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014149|NCT00824057|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93014150|NCT00824057|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93014151|NCT00824057|Purinergic Agents|purinergic agents|mesh-ancestor
93014152|NCT01053208|Diphenhydramine|diphenhydramine|mesh-list
93014153|NCT01053208|Promethazine|promethazine|mesh-list
93014154|NCT01053208|Ibuprofen|ibuprofen|mesh-list
93014155|NCT01053208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014156|NCT01053208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93014157|NCT01053208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93014158|NCT01053208|Analgesics|analgesics|mesh-ancestor
93014159|NCT01053208|Sensory System Agents|sensory system agents|mesh-ancestor
93014160|NCT01053208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014161|NCT01053208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014162|NCT01053208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014163|NCT01053208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014164|NCT01053208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93014165|NCT01053208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014166|NCT01053208|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93014167|NCT01053208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93014168|NCT01053208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014169|NCT01053208|Anesthetics, Local|anesthetics, local|mesh-ancestor
93014170|NCT01053208|Anesthetics|anesthetics|mesh-ancestor
93014171|NCT01053208|Antiemetics|antiemetics|mesh-ancestor
93014172|NCT01053208|Autonomic Agents|autonomic agents|mesh-ancestor
93014173|NCT01053208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014174|NCT01053208|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93014175|NCT01053208|Histamine Antagonists|histamine antagonists|mesh-ancestor
93014176|NCT01053208|Histamine Agents|histamine agents|mesh-ancestor
92659458|NCT00287157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93014177|NCT01053208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014178|NCT01053208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93014179|NCT01053208|Antipruritics|antipruritics|mesh-ancestor
93014180|NCT01053208|Dermatologic Agents|dermatologic agents|mesh-ancestor
93014181|NCT00423189|Ranibizumab|ranibizumab|mesh-list
93014182|NCT00423189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93014183|NCT00423189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93014184|NCT00423189|Growth Substances|growth substances|mesh-ancestor
93014185|NCT00423189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014186|NCT00423189|Growth Inhibitors|growth inhibitors|mesh-ancestor
93014187|NCT00423189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014188|NCT00831545|Temozolomide|temozolomide|mesh-list
93014189|NCT00831545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93014190|NCT00831545|Alkylating Agents|alkylating agents|mesh-ancestor
93014191|NCT00831545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014192|NCT00831545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014193|NCT00824135|Mycophenolic Acid|mycophenolic acid|mesh-list
93014194|NCT00824135|Rituximab|rituximab|mesh-list
93014195|NCT00824135|Melphalan|melphalan|mesh-list
93014196|NCT00824135|Thiotepa|thiotepa|mesh-list
93014197|NCT00824135|Clofarabine|clofarabine|mesh-list
93014198|NCT00824135|Muromonab-CD3|muromonab-cd3|mesh-list
93014199|NCT00824135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014200|NCT00824135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014201|NCT00824135|Immunologic Factors|immunologic factors|mesh-ancestor
93014202|NCT00824135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014203|NCT00824135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014204|NCT00824135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93014205|NCT00824135|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93014206|NCT00824135|Antitubercular Agents|antitubercular agents|mesh-ancestor
93014207|NCT00824135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014208|NCT00824135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014209|NCT00824135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014210|NCT00824135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014211|NCT00824135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93014212|NCT00824135|Alkylating Agents|alkylating agents|mesh-ancestor
93014213|NCT00824135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93014214|NCT00824135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014215|NCT00824135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93014216|NCT00824135|Antimetabolites|antimetabolites|mesh-ancestor
93014217|NCT00422799|Rituximab|rituximab|mesh-list
93014218|NCT00422799|Bortezomib|bortezomib|mesh-list
93014219|NCT00422799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014220|NCT00422799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014221|NCT00422799|Immunologic Factors|immunologic factors|mesh-ancestor
93014222|NCT00422799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014223|NCT00422799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014224|NCT00827411|Aspirin|aspirin|mesh-list
93014225|NCT00827411|Clopidogrel|clopidogrel|mesh-list
93014226|NCT00827411|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93014227|NCT00827411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93014228|NCT00827411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93014229|NCT00827411|Analgesics|analgesics|mesh-ancestor
93014230|NCT00827411|Sensory System Agents|sensory system agents|mesh-ancestor
93014231|NCT00827411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014232|NCT00827411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014233|NCT00827411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014234|NCT00827411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014235|NCT00827411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93014236|NCT00827411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93014237|NCT00827411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014238|NCT00827411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93014239|NCT00827411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93014240|NCT00827411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014241|NCT00827411|Antipyretics|antipyretics|mesh-ancestor
93014242|NCT00827411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93014243|NCT00827411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93014244|NCT00827411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93014245|NCT00827411|Purinergic Agents|purinergic agents|mesh-ancestor
93014246|NCT00827411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014247|NCT00435045|Atorvastatin|atorvastatin|mesh-list
93014248|NCT00435045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93014249|NCT00435045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93014250|NCT00435045|Antimetabolites|antimetabolites|mesh-ancestor
93014251|NCT00435045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014252|NCT00435045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93014253|NCT00435045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93014254|NCT00435045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014255|NCT00441129|Insulin|insulin|mesh-list
93014256|NCT00441129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014257|NCT00441129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014258|NCT00622505|Zoledronic Acid|zoledronic acid|mesh-list
93014259|NCT00622505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93014260|NCT00622505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014261|NCT00831857|Bevacizumab|bevacizumab|mesh-list
93014262|NCT00831857|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
93014263|NCT00831857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014264|NCT00831857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014265|NCT00831857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93014266|NCT00831857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93014267|NCT00831857|Growth Substances|growth substances|mesh-ancestor
93014268|NCT00831857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014269|NCT00831857|Growth Inhibitors|growth inhibitors|mesh-ancestor
93014270|NCT00831857|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93014271|NCT00831857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014272|NCT00832013|Propofol|propofol|mesh-list
93014273|NCT00832013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93014274|NCT00832013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014275|NCT00832013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014276|NCT00832013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93014277|NCT00832013|Anesthetics, General|anesthetics, general|mesh-ancestor
93014278|NCT00832013|Anesthetics|anesthetics|mesh-ancestor
93014279|NCT00832481|Metformin|metformin|mesh-list
93014280|NCT00832481|Repaglinide|repaglinide|mesh-list
93014281|NCT00832481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014282|NCT00832481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014283|NCT00350272|Tenofovir|tenofovir|mesh-list
93014284|NCT00350272|Lamivudine|lamivudine|mesh-list
93014285|NCT00350272|Efavirenz|efavirenz|mesh-list
93014286|NCT00350272|Dexelvucitabine|dexelvucitabine|mesh-list
93014287|NCT00350272|Antiviral Agents|antiviral agents|mesh-ancestor
93014288|NCT00350272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014289|NCT00350272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93014290|NCT00350272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93014291|NCT00350272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014292|NCT00350272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014293|NCT00350272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93014294|NCT00350272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93014295|NCT00350272|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93014296|NCT00350272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93014297|NCT00350272|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93014298|NCT00350272|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93014299|NCT00350272|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93014300|NCT00350272|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93014301|NCT04044287|Misoprostol|misoprostol|mesh-list
93014302|NCT04044287|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93014303|NCT04044287|Abortifacient Agents|abortifacient agents|mesh-ancestor
93014304|NCT04044287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93014305|NCT04044287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014306|NCT04044287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93014307|NCT04044287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014308|NCT04044287|Oxytocics|oxytocics|mesh-ancestor
93014309|NCT00357370|Dapagliflozin|dapagliflozin|mesh-list
93014310|NCT00357370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93014311|NCT00357370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014312|NCT00357370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014313|NCT00357370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014314|NCT00825071|Dexamethasone|dexamethasone|mesh-list
93014315|NCT00825071|Ondansetron|ondansetron|mesh-list
93014316|NCT00825071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014317|NCT00825071|Antiemetics|antiemetics|mesh-ancestor
93014318|NCT00825071|Autonomic Agents|autonomic agents|mesh-ancestor
93014319|NCT00825071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014320|NCT00825071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014321|NCT00825071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014322|NCT00825071|Glucocorticoids|glucocorticoids|mesh-ancestor
93014323|NCT00825071|Hormones|hormones|mesh-ancestor
93014324|NCT00825071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014325|NCT00825071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93014326|NCT00825071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014327|NCT00825071|Antipruritics|antipruritics|mesh-ancestor
93014328|NCT00825071|Dermatologic Agents|dermatologic agents|mesh-ancestor
93014329|NCT00825071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93014330|NCT00825071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93014331|NCT00825071|Serotonin Agents|serotonin agents|mesh-ancestor
93014332|NCT00825071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014333|NCT00825071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014334|NCT00574847|Escitalopram|escitalopram|mesh-list
93014335|NCT00574847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93014336|NCT00574847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93014337|NCT00574847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93014338|NCT00574847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014339|NCT00574847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014340|NCT00574847|Serotonin Agents|serotonin agents|mesh-ancestor
93014341|NCT00574847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014342|NCT00348790|Vatalanib|vatalanib|mesh-list
93014343|NCT00348790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014344|NCT00348790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014345|NCT00348790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014346|NCT00825149|Prednisone|prednisone|mesh-list
93014347|NCT00825149|Cyclophosphamide|cyclophosphamide|mesh-list
93014348|NCT00825149|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93014349|NCT00825149|Doxorubicin|doxorubicin|mesh-list
93014350|NCT00825149|Fludarabine|fludarabine|mesh-list
93014351|NCT00825149|Vincristine|vincristine|mesh-list
93014352|NCT00825149|Obinutuzumab|obinutuzumab|mesh-list
93014353|NCT00825149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014354|NCT00825149|Immunologic Factors|immunologic factors|mesh-ancestor
93014355|NCT00825149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014356|NCT00825149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014357|NCT00825149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93014358|NCT00825149|Alkylating Agents|alkylating agents|mesh-ancestor
93014359|NCT00825149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014360|NCT00825149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014361|NCT00825149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93014362|NCT00825149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172479|NCT00359684|Cysteamine|cysteamine|mesh-list
93014363|NCT00825149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93014364|NCT00825149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93014365|NCT00825149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014366|NCT00825149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014367|NCT00825149|Glucocorticoids|glucocorticoids|mesh-ancestor
93014368|NCT00825149|Hormones|hormones|mesh-ancestor
93014369|NCT00825149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014370|NCT00825149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93014371|NCT00825149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93014372|NCT00825149|Tubulin Modulators|tubulin modulators|mesh-ancestor
93014373|NCT00825149|Antimitotic Agents|antimitotic agents|mesh-ancestor
93014374|NCT00825149|Mitosis Modulators|mitosis modulators|mesh-ancestor
93014375|NCT00825149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014376|NCT00360490|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93014377|NCT00360490|Levonorgestrel|levonorgestrel|mesh-list
93014378|NCT00360490|Medroxyprogesterone|medroxyprogesterone|mesh-list
93014379|NCT00360490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93014380|NCT00360490|Contraceptive Agents|contraceptive agents|mesh-ancestor
93014381|NCT00360490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93014382|NCT00360490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014383|NCT00360490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93014384|NCT00360490|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93014385|NCT00360490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93014386|NCT00360490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93014387|NCT00360490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93014388|NCT00360490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93014389|NCT00360490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014390|NCT02549105|Lidocaine|lidocaine|mesh-list
93014391|NCT02549105|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93014392|NCT02549105|Anesthetics, Local|anesthetics, local|mesh-ancestor
93014393|NCT02549105|Anesthetics|anesthetics|mesh-ancestor
93014394|NCT02549105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014395|NCT02549105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014396|NCT02549105|Sensory System Agents|sensory system agents|mesh-ancestor
93014397|NCT02549105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014398|NCT02549105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93014399|NCT02549105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93014400|NCT02549105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93014401|NCT02549105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659683|NCT00287391|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93014402|NCT02549105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014403|NCT02549105|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93014404|NCT00624377|Tiotropium Bromide|tiotropium bromide|mesh-list
93014405|NCT00624377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93014406|NCT00624377|Autonomic Agents|autonomic agents|mesh-ancestor
93014407|NCT00624377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014408|NCT00624377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014409|NCT00624377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93014410|NCT00624377|Respiratory System Agents|respiratory system agents|mesh-ancestor
93014411|NCT00624377|Parasympatholytics|parasympatholytics|mesh-ancestor
93014412|NCT00624377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93014413|NCT00624377|Cholinergic Agents|cholinergic agents|mesh-ancestor
93014414|NCT00624377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014415|NCT00624377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014416|NCT02549963|Rivaroxaban|rivaroxaban|mesh-list
93014417|NCT02549963|Anticoagulants|anticoagulants|mesh-list
93014418|NCT02549963|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93014419|NCT02549963|Antithrombins|antithrombins|mesh-ancestor
93014420|NCT02549963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93014421|NCT02549963|Protease Inhibitors|protease inhibitors|mesh-ancestor
93014422|NCT02549963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014423|NCT02549963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014424|NCT00624065|Carvedilol|carvedilol|mesh-list
93014425|NCT00624065|Lisinopril|lisinopril|mesh-list
93014426|NCT00624065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93014427|NCT00624065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93014428|NCT00624065|Adrenergic Agents|adrenergic agents|mesh-ancestor
93014429|NCT00624065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014430|NCT00624065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014431|NCT00624065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014432|NCT00624065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93014433|NCT00624065|Antioxidants|antioxidants|mesh-ancestor
93014434|NCT00624065|Protective Agents|protective agents|mesh-ancestor
93014435|NCT00624065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93014436|NCT00624065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93014437|NCT00624065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93014438|NCT00624065|Vasodilator Agents|vasodilator agents|mesh-ancestor
93014439|NCT00624065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93014440|NCT00624065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93014441|NCT00624065|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93014442|NCT00624065|Protease Inhibitors|protease inhibitors|mesh-ancestor
93014443|NCT00624065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014444|NCT00624065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93014445|NCT00833339|Mifepristone|mifepristone|mesh-list
93014446|NCT00833339|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93014447|NCT00833339|Abortifacient Agents|abortifacient agents|mesh-ancestor
93014448|NCT00833339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93014449|NCT00833339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014450|NCT00833339|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93014451|NCT00833339|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93014452|NCT00833339|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93014453|NCT00833339|Contraceptive Agents|contraceptive agents|mesh-ancestor
93014454|NCT00833339|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93014455|NCT00833339|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93014456|NCT00833339|Hormone Antagonists|hormone antagonists|mesh-ancestor
93014457|NCT00833339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014458|NCT00833339|Luteolytic Agents|luteolytic agents|mesh-ancestor
93014459|NCT00833339|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93014460|NCT00833339|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93014461|NCT00825617|Hormones|hormones|mesh-list
93014462|NCT00825617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014463|NCT00825617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014464|NCT00360334|Insulin Glargine|insulin glargine|mesh-list
93014465|NCT00360334|Exenatide|exenatide|mesh-list
93014466|NCT00360334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014467|NCT00360334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014468|NCT00360334|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93014469|NCT00360334|Incretins|incretins|mesh-ancestor
93014470|NCT00360334|Hormones|hormones|mesh-ancestor
93014471|NCT00360334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93014472|NCT00422097|Epothilones|epothilones|mesh-list
93014473|NCT00422097|Famotidine|famotidine|mesh-list
93014474|NCT00422097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659763|NCT01680913|Anesthetics|anesthetics|mesh-list
93014475|NCT00422097|Antimitotic Agents|antimitotic agents|mesh-ancestor
93014476|NCT00422097|Mitosis Modulators|mitosis modulators|mesh-ancestor
93014477|NCT00422097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014478|NCT00422097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014479|NCT00422097|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93014480|NCT00422097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014481|NCT00422097|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93014482|NCT00422097|Histamine Antagonists|histamine antagonists|mesh-ancestor
93014483|NCT00422097|Histamine Agents|histamine agents|mesh-ancestor
93014484|NCT00422097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014485|NCT00422097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014486|NCT01051102|Insulin|insulin|mesh-list
93014487|NCT01051102|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93014488|NCT01051102|Insulin Aspart|insulin aspart|mesh-list
93014489|NCT01051102|Insulin, Long-Acting|insulin, long-acting|mesh-list
93014490|NCT01051102|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93014491|NCT01051102|Biphasic Insulins|biphasic insulins|mesh-list
93014492|NCT01051102|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93014493|NCT01051102|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014494|NCT01051102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014495|NCT00348556|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93014496|NCT00348556|Natriuretic Agents|natriuretic agents|mesh-ancestor
93014497|NCT00348556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014498|NCT00434967|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93014499|NCT00434967|Candesartan|candesartan|mesh-list
93014500|NCT00434967|Candesartan cilexetil|candesartan cilexetil|mesh-list
93014501|NCT00434967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93014502|NCT00434967|Diuretics|diuretics|mesh-ancestor
93014503|NCT00434967|Natriuretic Agents|natriuretic agents|mesh-ancestor
93014504|NCT00434967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014505|NCT00434967|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93014506|NCT00434967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93014507|NCT00434967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014508|NCT00434967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93014509|NCT00434967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93014510|NCT00833729|Etanercept|etanercept|mesh-list
93014511|NCT00833729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93014512|NCT00833729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93014513|NCT00833729|Analgesics|analgesics|mesh-ancestor
93014514|NCT00833729|Sensory System Agents|sensory system agents|mesh-ancestor
93014515|NCT00833729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014516|NCT00833729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014517|NCT00833729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014518|NCT00833729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014519|NCT00833729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014520|NCT00833729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014521|NCT00833729|Immunologic Factors|immunologic factors|mesh-ancestor
93014522|NCT00837239|Gemcitabine|gemcitabine|mesh-list
93014523|NCT00837239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93014524|NCT00837239|Antimetabolites|antimetabolites|mesh-ancestor
93014525|NCT00837239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014526|NCT00837239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014527|NCT00833807|Paclitaxel|paclitaxel|mesh-list
93014528|NCT00833807|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93014529|NCT00833807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93014530|NCT00833807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014531|NCT00833807|Tubulin Modulators|tubulin modulators|mesh-ancestor
93014532|NCT00833807|Antimitotic Agents|antimitotic agents|mesh-ancestor
93014533|NCT00833807|Mitosis Modulators|mitosis modulators|mesh-ancestor
93014534|NCT00833807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014535|NCT00833963|Trastuzumab|trastuzumab|mesh-list
93014536|NCT00833963|Pertuzumab|pertuzumab|mesh-list
93014537|NCT00833963|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93014538|NCT00833963|Maytansine|maytansine|mesh-list
93014539|NCT00833963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014540|NCT00833963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014541|NCT00833963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93014542|NCT00833963|Tubulin Modulators|tubulin modulators|mesh-ancestor
93014543|NCT00833963|Antimitotic Agents|antimitotic agents|mesh-ancestor
93014544|NCT00833963|Mitosis Modulators|mitosis modulators|mesh-ancestor
93014545|NCT00833963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014546|NCT00833963|Immunotoxins|immunotoxins|mesh-ancestor
93014547|NCT00833963|Immunoconjugates|immunoconjugates|mesh-ancestor
93014548|NCT00833963|Immunologic Factors|immunologic factors|mesh-ancestor
93014549|NCT00833963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014550|NCT00837317|Phenol|phenol|mesh-list
93014551|NCT00837317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93014552|NCT00837317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014553|NCT00837317|Disinfectants|disinfectants|mesh-ancestor
93014554|NCT00837317|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
93014555|NCT00837317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93014556|NCT04043897|Rifaximin|rifaximin|mesh-list
93014557|NCT04043897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014558|NCT04043897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014559|NCT04043897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014561|NCT00356590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93014562|NCT00356590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93014563|NCT00356590|Analgesics|analgesics|mesh-ancestor
93014564|NCT00356590|Sensory System Agents|sensory system agents|mesh-ancestor
93014565|NCT00356590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014566|NCT00356590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014567|NCT00356590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014568|NCT00356590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014569|NCT00356590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014570|NCT00356590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014571|NCT00356590|Immunologic Factors|immunologic factors|mesh-ancestor
93014572|NCT00828503|Valganciclovir|valganciclovir|mesh-list
93014573|NCT00828503|Everolimus|everolimus|mesh-list
93014574|NCT00828503|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93014575|NCT00828503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014576|NCT00828503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014577|NCT00828503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014578|NCT00828503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014579|NCT00828503|Immunologic Factors|immunologic factors|mesh-ancestor
93014580|NCT00828503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014581|NCT00828503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014582|NCT00828503|Antiviral Agents|antiviral agents|mesh-ancestor
93014583|NCT00828503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014584|NCT00834665|Molgramostim|molgramostim|mesh-list
93014585|NCT00834665|Sargramostim|sargramostim|mesh-list
93014586|NCT00834665|Immunologic Factors|immunologic factors|mesh-ancestor
93014587|NCT00834665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014588|NCT00834665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014589|NCT00837707|Aripiprazole|aripiprazole|mesh-list
93014590|NCT00837707|Antidepressive Agents|antidepressive agents|mesh-ancestor
93014591|NCT00837707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014592|NCT00837707|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93014593|NCT00837707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014594|NCT00837707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014595|NCT00837707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014596|NCT00837707|Dopamine Agonists|dopamine agonists|mesh-ancestor
93014597|NCT00837707|Dopamine Agents|dopamine agents|mesh-ancestor
93014598|NCT00837707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014599|NCT00837707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014600|NCT00837707|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93014601|NCT00837707|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93014602|NCT00837707|Serotonin Agents|serotonin agents|mesh-ancestor
93014603|NCT00837707|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93014604|NCT00837707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93014605|NCT00837707|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93014606|NCT00837707|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93014607|NCT01055938|Valproic Acid|valproic acid|mesh-list
93014608|NCT01055938|Anticonvulsants|anticonvulsants|mesh-ancestor
93014609|NCT01055938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014610|NCT01055938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014611|NCT01055938|GABA Agents|gaba agents|mesh-ancestor
93014612|NCT01055938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014613|NCT01055938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014614|NCT01055938|Antimanic Agents|antimanic agents|mesh-ancestor
93014615|NCT01055938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014616|NCT01055938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014617|NCT01055938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014618|NCT00837785|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93014619|NCT00837785|Dermatologic Agents|dermatologic agents|mesh-ancestor
93014620|NCT00837785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014621|NCT00837785|Immunologic Factors|immunologic factors|mesh-ancestor
93014622|NCT00837785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014623|NCT00356278|Cycloserine|cycloserine|mesh-list
93014624|NCT00356278|Alprazolam|alprazolam|mesh-list
93014625|NCT00356278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93014626|NCT00356278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014627|NCT00356278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93014628|NCT00356278|Antitubercular Agents|antitubercular agents|mesh-ancestor
93014629|NCT00356278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014631|NCT00356278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014632|NCT00356278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93014633|NCT00356278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014634|NCT00356278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014635|NCT00356278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93014636|NCT00356278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014637|NCT00356278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014638|NCT00356278|GABA Modulators|gaba modulators|mesh-ancestor
93014639|NCT00356278|GABA Agents|gaba agents|mesh-ancestor
93014640|NCT00356278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014641|NCT03991780|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93014642|NCT03991780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014643|NCT03991780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014644|NCT03991780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014645|NCT00837941|Diphenhydramine|diphenhydramine|mesh-list
93014646|NCT00837941|Promethazine|promethazine|mesh-list
93014647|NCT00837941|Pregabalin|pregabalin|mesh-list
93014648|NCT00837941|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93014649|NCT00837941|Analgesics|analgesics|mesh-ancestor
93014650|NCT00837941|Sensory System Agents|sensory system agents|mesh-ancestor
93014651|NCT00837941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014652|NCT00837941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014653|NCT00837941|Anticonvulsants|anticonvulsants|mesh-ancestor
93014654|NCT00837941|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93014655|NCT00837941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93014656|NCT00837941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014657|NCT00837941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93014658|NCT00837941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93014659|NCT00837941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014660|NCT00837941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014661|NCT00837941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014662|NCT00837941|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93014663|NCT00837941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93014664|NCT00837941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014665|NCT00837941|Antidepressive Agents|antidepressive agents|mesh-ancestor
93014666|NCT00837941|Dopamine Agents|dopamine agents|mesh-ancestor
93014667|NCT00837941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93014668|NCT00837941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93014669|NCT00837941|Anesthetics, Local|anesthetics, local|mesh-ancestor
93014670|NCT00837941|Anesthetics|anesthetics|mesh-ancestor
93014671|NCT00837941|Antiemetics|antiemetics|mesh-ancestor
93014672|NCT00837941|Autonomic Agents|autonomic agents|mesh-ancestor
93014673|NCT00837941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93014674|NCT00837941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93014675|NCT00837941|Histamine Antagonists|histamine antagonists|mesh-ancestor
93014676|NCT00837941|Histamine Agents|histamine agents|mesh-ancestor
93014677|NCT00837941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93014678|NCT00837941|Antipruritics|antipruritics|mesh-ancestor
93014679|NCT00837941|Dermatologic Agents|dermatologic agents|mesh-ancestor
93014680|NCT01053442|Fe(III)-EDTA|fe(iii)-edta|mesh-list
93014681|NCT01053442|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93014682|NCT01053442|Chelating Agents|chelating agents|mesh-ancestor
93014683|NCT01053442|Sequestering Agents|sequestering agents|mesh-ancestor
93014684|NCT01053442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014685|NCT00356200|Fluphenazine|fluphenazine|mesh-list
93014686|NCT00356200|Fluphenazine depot|fluphenazine depot|mesh-list
93014687|NCT00356200|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
93014688|NCT00356200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93014689|NCT00356200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93014690|NCT00356200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172656|NCT03452865|Esomeprazole|esomeprazole|mesh-list
93014691|NCT00356200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014692|NCT00356200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014693|NCT00356200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93014694|NCT00356200|Dopamine Agents|dopamine agents|mesh-ancestor
93014695|NCT00356200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014696|NCT00356200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014697|NCT00356122|Bevacizumab|bevacizumab|mesh-list
93014698|NCT00356122|Docetaxel|docetaxel|mesh-list
93014699|NCT00356122|Oxaliplatin|oxaliplatin|mesh-list
93014700|NCT00356122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014701|NCT00356122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014702|NCT00356122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93014703|NCT00356122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93014704|NCT00356122|Growth Substances|growth substances|mesh-ancestor
93014705|NCT00356122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014706|NCT00356122|Growth Inhibitors|growth inhibitors|mesh-ancestor
93014707|NCT00356122|Tubulin Modulators|tubulin modulators|mesh-ancestor
93014708|NCT00356122|Antimitotic Agents|antimitotic agents|mesh-ancestor
93014709|NCT00356122|Mitosis Modulators|mitosis modulators|mesh-ancestor
93014710|NCT00356122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014712|NCT00828815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93014713|NCT00828815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93014714|NCT00828815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014715|NCT00828815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014716|NCT00828815|Antiviral Agents|antiviral agents|mesh-ancestor
93014717|NCT00828815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014718|NCT01053520|Navitoclax|navitoclax|mesh-list
93014719|NCT01053520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014720|NCT00347932|Besifloxacin|besifloxacin|mesh-list
93014721|NCT00347932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014722|NCT00347932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014723|NCT00347932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93014724|NCT00347932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93014725|NCT00347932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014726|NCT00347932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014727|NCT00347932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014728|NCT00828971|Amoxicillin|amoxicillin|mesh-list
93014729|NCT00828971|Moxifloxacin|moxifloxacin|mesh-list
93014730|NCT00828971|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93014731|NCT00828971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014732|NCT00828971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014733|NCT00828971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93014734|NCT00828971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93014735|NCT00828971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014736|NCT00828971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014737|NCT00828971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014738|NCT00828971|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93014739|NCT00828971|Contraceptive Agents|contraceptive agents|mesh-ancestor
93014740|NCT00828971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93014741|NCT00828971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014742|NCT00828971|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93014743|NCT00828971|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93014744|NCT00828971|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93014745|NCT00528996|Bromides|bromides|mesh-list
92172680|NCT03449108|Analgesics|analgesics|mesh-ancestor
93014746|NCT00528996|Tiotropium Bromide|tiotropium bromide|mesh-list
93014747|NCT00528996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93014748|NCT00528996|Autonomic Agents|autonomic agents|mesh-ancestor
93014749|NCT00528996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014750|NCT00528996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014751|NCT00528996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93014752|NCT00528996|Respiratory System Agents|respiratory system agents|mesh-ancestor
93014753|NCT00528996|Parasympatholytics|parasympatholytics|mesh-ancestor
93014754|NCT00528996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93014755|NCT00528996|Cholinergic Agents|cholinergic agents|mesh-ancestor
93014756|NCT00528996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014757|NCT00528996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014758|NCT00528996|Anticonvulsants|anticonvulsants|mesh-ancestor
93014759|NCT00359788|Albuterol|albuterol|mesh-list
93014760|NCT00359788|Tiotropium Bromide|tiotropium bromide|mesh-list
93014761|NCT00359788|Ipratropium|ipratropium|mesh-list
93014762|NCT00359788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93014763|NCT00359788|Autonomic Agents|autonomic agents|mesh-ancestor
93014764|NCT00359788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014765|NCT00359788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014766|NCT00359788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93014767|NCT00359788|Respiratory System Agents|respiratory system agents|mesh-ancestor
93014768|NCT00359788|Parasympatholytics|parasympatholytics|mesh-ancestor
93014769|NCT00359788|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93014770|NCT00359788|Cholinergic Agents|cholinergic agents|mesh-ancestor
93014771|NCT00359788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014772|NCT00359788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014773|NCT00359788|Tocolytic Agents|tocolytic agents|mesh-ancestor
93014774|NCT00359788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93014775|NCT00359788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93014776|NCT00359788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93014777|NCT00359788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93014778|NCT00359788|Adrenergic Agents|adrenergic agents|mesh-ancestor
93014779|NCT05416476|Anisodine|anisodine|mesh-list
93014780|NCT05416476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93014781|NCT05416476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93014782|NCT05416476|Analgesics|analgesics|mesh-ancestor
93014783|NCT05416476|Sensory System Agents|sensory system agents|mesh-ancestor
93014784|NCT05416476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014785|NCT05416476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014786|NCT05416476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93014787|NCT05416476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014788|NCT05416476|Parasympatholytics|parasympatholytics|mesh-ancestor
93014789|NCT05416476|Autonomic Agents|autonomic agents|mesh-ancestor
93014790|NCT00623597|Ritonavir|ritonavir|mesh-list
93014791|NCT00623597|Saquinavir|saquinavir|mesh-list
93014792|NCT00623597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93014793|NCT00623597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93014794|NCT00623597|Protease Inhibitors|protease inhibitors|mesh-ancestor
92172697|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
93014795|NCT00623597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014796|NCT00623597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014797|NCT00623597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93014798|NCT00623597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93014799|NCT00623597|Antiviral Agents|antiviral agents|mesh-ancestor
93014800|NCT00623597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014801|NCT00623597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93014802|NCT00623597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93014803|NCT01056172|Ribavirin|ribavirin|mesh-list
93014804|NCT01056172|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93014805|NCT01056172|Interferon-alpha|interferon-alpha|mesh-list
93014806|NCT01056172|Antimetabolites|antimetabolites|mesh-ancestor
93014807|NCT01056172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014808|NCT01056172|Antiviral Agents|antiviral agents|mesh-ancestor
93014809|NCT01056172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014810|NCT01056172|Immunologic Factors|immunologic factors|mesh-ancestor
93014811|NCT01056172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014812|NCT00838955|Sirolimus|sirolimus|mesh-list
93014813|NCT00838955|Temsirolimus|temsirolimus|mesh-list
93014814|NCT00838955|MTOR Inhibitors|mtor inhibitors|mesh-list
93014815|NCT00838955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014816|NCT00838955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014817|NCT00838955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014818|NCT00838955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93014819|NCT00838955|Immunologic Factors|immunologic factors|mesh-ancestor
93014820|NCT00838955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014821|NCT00838955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014822|NCT00838955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014823|NCT00838955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014824|NCT00838955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93014825|NCT00838955|Antifungal Agents|antifungal agents|mesh-ancestor
93014826|NCT00347776|Azithromycin|azithromycin|mesh-list
93014827|NCT00347776|Tetracycline|tetracycline|mesh-list
93014828|NCT00347776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93014829|NCT00347776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014830|NCT00347776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93014831|NCT00347776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014832|NCT00347776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014833|NCT04452136|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93014834|NCT04452136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93014835|NCT04452136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014836|NCT00829205|Rituximab|rituximab|mesh-list
93014837|NCT00829205|Carboplatin|carboplatin|mesh-list
93014838|NCT00829205|Etoposide|etoposide|mesh-list
93014839|NCT00829205|Ifosfamide|ifosfamide|mesh-list
93014840|NCT00829205|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
93014841|NCT00829205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014842|NCT00829205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014843|NCT00829205|Immunologic Factors|immunologic factors|mesh-ancestor
93014844|NCT00829205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014845|NCT00829205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93014846|NCT00829205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93014847|NCT00829205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93014848|NCT00829205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93014849|NCT00829205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014850|NCT00829205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014851|NCT00829205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172725|NCT03248570|Pembrolizumab|pembrolizumab|mesh-list
93014852|NCT00829205|Alkylating Agents|alkylating agents|mesh-ancestor
93014853|NCT00829205|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93014854|NCT00829205|Protective Agents|protective agents|mesh-ancestor
93014855|NCT04944888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93014856|NCT04944888|Eliglustat|eliglustat|mesh-list
93014857|NCT04944888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014858|NCT04944888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014859|NCT04944888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014860|NCT04944888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014861|NCT00839111|Irinotecan|irinotecan|mesh-list
93014862|NCT00839111|Sorafenib|sorafenib|mesh-list
93014863|NCT00839111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93014864|NCT00839111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93014865|NCT00839111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014866|NCT00839111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014867|NCT00839111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014868|NCT00839111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014869|NCT00836381|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93014870|NCT00836381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93014871|NCT00836381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93014872|NCT00836381|Cholinergic Agents|cholinergic agents|mesh-ancestor
93014873|NCT00836381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014874|NCT00836381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014875|NCT00836381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014876|NCT00836381|Urological Agents|urological agents|mesh-ancestor
93014877|NCT02533336|Abamectin|abamectin|mesh-list
93014878|NCT02533336|Anthelmintics|anthelmintics|mesh-ancestor
93014879|NCT02533336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93014880|NCT02533336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014881|NCT05367960|BPN14770|bpn14770|mesh-list
93014882|NCT05367960|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93014883|NCT05367960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93014884|NCT05367960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014885|NCT05367960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014886|NCT01053910|Ramipril|ramipril|mesh-list
93014887|NCT01053910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93014888|NCT01053910|Protease Inhibitors|protease inhibitors|mesh-ancestor
93014889|NCT01053910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014890|NCT01053910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014891|NCT01053910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93014892|NCT00829595|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93014893|NCT00829595|Immunologic Factors|immunologic factors|mesh-ancestor
93014894|NCT00829595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014895|NCT01008384|Vitamin D|vitamin d|mesh-list
93014896|NCT01008384|Cholecalciferol|cholecalciferol|mesh-list
93014897|NCT01008384|Vitamins|vitamins|mesh-ancestor
93014898|NCT01008384|Micronutrients|micronutrients|mesh-ancestor
93014899|NCT01008384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014900|NCT01008384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93014901|NCT01008384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93014902|NCT02547155|Anesthetics|anesthetics|mesh-list
93014903|NCT02547155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93014904|NCT02547155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014905|NCT00836849|Sertraline|sertraline|mesh-list
93014906|NCT00836849|Antidepressive Agents|antidepressive agents|mesh-ancestor
93014907|NCT00836849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93014908|NCT00836849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93014909|NCT00836849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93014910|NCT00836849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93014911|NCT00836849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014912|NCT00836849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014913|NCT00836849|Serotonin Agents|serotonin agents|mesh-ancestor
93014914|NCT00836849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014915|NCT00839345|Clopidogrel|clopidogrel|mesh-list
93014916|NCT00839345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93014917|NCT00839345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93014918|NCT00839345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93014919|NCT00839345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93014920|NCT00839345|Purinergic Agents|purinergic agents|mesh-ancestor
93014921|NCT00839345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014922|NCT00839345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660209|NCT01685515|Antimetabolites|antimetabolites|mesh-ancestor
93014923|NCT00839345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014924|NCT00839501|Acetazolamide|acetazolamide|mesh-list
93014925|NCT00839501|Anticonvulsants|anticonvulsants|mesh-ancestor
93014926|NCT00839501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93014927|NCT00839501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014928|NCT00839501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014929|NCT00839501|Diuretics|diuretics|mesh-ancestor
93014930|NCT00839501|Natriuretic Agents|natriuretic agents|mesh-ancestor
93014931|NCT00839501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014932|NCT00529542|Atorvastatin|atorvastatin|mesh-list
93014933|NCT00529542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93014934|NCT00529542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93014935|NCT00529542|Antimetabolites|antimetabolites|mesh-ancestor
93014936|NCT00529542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014937|NCT00529542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93014938|NCT00529542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93014939|NCT00529542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014940|NCT04043741|Sulfamethazine|sulfamethazine|mesh-list
93014941|NCT04043741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93014942|NCT00621959|Levocetirizine|levocetirizine|mesh-list
93014943|NCT00621959|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93014944|NCT00621959|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93014945|NCT00621959|Histamine Antagonists|histamine antagonists|mesh-ancestor
93014946|NCT00621959|Histamine Agents|histamine agents|mesh-ancestor
93014947|NCT00621959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93014948|NCT00621959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014949|NCT00621959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014950|NCT00839657|Warfarin|warfarin|mesh-list
93014951|NCT00839657|Anticoagulants|anticoagulants|mesh-ancestor
93014952|NCT05259696|Cemiplimab|cemiplimab|mesh-list
92172767|NCT02994784|Melphalan|melphalan|mesh-list
93014953|NCT05259696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93014954|NCT05259696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014955|NCT00830297|Isophane Insulin, Human|isophane insulin, human|mesh-list
93014956|NCT00830297|Insulin, Isophane|insulin, isophane|mesh-list
93014957|NCT00830297|Isophane insulin, beef|isophane insulin, beef|mesh-list
93014958|NCT00830297|Insulin, Long-Acting|insulin, long-acting|mesh-list
93014959|NCT00830297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014960|NCT00830297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014961|NCT03877224|Dapagliflozin|dapagliflozin|mesh-list
93014962|NCT03877224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93014963|NCT03877224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014964|NCT03877224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93014965|NCT03877224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014966|NCT00840125|Docetaxel|docetaxel|mesh-list
93014967|NCT00840125|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93014968|NCT00840125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014969|NCT00840125|Tubulin Modulators|tubulin modulators|mesh-ancestor
93014970|NCT00840125|Antimitotic Agents|antimitotic agents|mesh-ancestor
93014971|NCT00840125|Mitosis Modulators|mitosis modulators|mesh-ancestor
93014972|NCT00840125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014973|NCT00840125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93014974|NCT00840125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014975|NCT00830531|Bumetanide|bumetanide|mesh-list
93014976|NCT00830531|Diuretics|diuretics|mesh-ancestor
93014977|NCT00830531|Natriuretic Agents|natriuretic agents|mesh-ancestor
93014978|NCT00830531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014979|NCT00830531|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93014980|NCT00830531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93014981|NCT00830531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014982|NCT05014542|Analgesics|analgesics|mesh-list
93014983|NCT05014542|Sensory System Agents|sensory system agents|mesh-ancestor
93014984|NCT05014542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93014985|NCT05014542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014986|NCT04926324|Niraparib|niraparib|mesh-list
93014987|NCT04926324|Dostarlimab|dostarlimab|mesh-list
93014988|NCT04926324|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93014989|NCT04926324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93014990|NCT04926324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93014991|NCT04926324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93014992|NCT00621257|Vitamin D|vitamin d|mesh-list
93014993|NCT00621257|Ergocalciferols|ergocalciferols|mesh-list
93014994|NCT00621257|Cholecalciferol|cholecalciferol|mesh-list
93014995|NCT00621257|Vitamins|vitamins|mesh-list
93014997|NCT00621257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93014998|NCT00621257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93014999|NCT00621257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93015000|NCT00840671|Cerebrolysin|cerebrolysin|mesh-list
93015001|NCT00840671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93015002|NCT00840671|Protective Agents|protective agents|mesh-ancestor
93015003|NCT00840671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015004|NCT00840671|Nootropic Agents|nootropic agents|mesh-ancestor
93015005|NCT02546531|Gemcitabine|gemcitabine|mesh-list
93015006|NCT02546531|Pembrolizumab|pembrolizumab|mesh-list
93015007|NCT02546531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93015008|NCT02546531|Antimetabolites|antimetabolites|mesh-ancestor
93015009|NCT02546531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015010|NCT02546531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015011|NCT02546531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93015012|NCT02546531|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93015013|NCT05205720|Ropivacaine|ropivacaine|mesh-list
93015014|NCT05205720|Anesthetics, Local|anesthetics, local|mesh-ancestor
93015015|NCT05205720|Anesthetics|anesthetics|mesh-ancestor
93015016|NCT05205720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015017|NCT05205720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015018|NCT05205720|Sensory System Agents|sensory system agents|mesh-ancestor
93015019|NCT05205720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015020|NCT04043195|Oxaliplatin|oxaliplatin|mesh-list
93015021|NCT04043195|Nivolumab|nivolumab|mesh-list
93015022|NCT04043195|Ipilimumab|ipilimumab|mesh-list
93015023|NCT04043195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015024|NCT04043195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93015025|NCT04043195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93015026|NCT04043195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015027|NCT00841061|Ferrous fumarate|ferrous fumarate|mesh-list
93015028|NCT00841061|Trace Elements|trace elements|mesh-ancestor
93015029|NCT00841061|Micronutrients|micronutrients|mesh-ancestor
93015030|NCT00841061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015031|NCT04042805|Lenvatinib|lenvatinib|mesh-list
93015032|NCT04042805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015033|NCT04042805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015034|NCT04042805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015035|NCT04042805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015036|NCT05643846|Bupivacaine|bupivacaine|mesh-list
93015037|NCT05643846|Anesthetics, Local|anesthetics, local|mesh-list
93015038|NCT05643846|Anesthetics|anesthetics|mesh-list
93015039|NCT05643846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015040|NCT05643846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015041|NCT05643846|Sensory System Agents|sensory system agents|mesh-ancestor
93015042|NCT05643846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015043|NCT00841139|Perhexiline|perhexiline|mesh-list
93015044|NCT00841139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93015045|NCT00841139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015046|NCT00841139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015047|NCT00841139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93015048|NCT00841139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015049|NCT00841139|Vasodilator Agents|vasodilator agents|mesh-ancestor
93015050|NCT00844337|Amoxicillin|amoxicillin|mesh-list
93015051|NCT00844337|Gentamicins|gentamicins|mesh-list
93015052|NCT00844337|Penicillins|penicillins|mesh-list
93015053|NCT00844337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93015054|NCT00844337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015055|NCT00844337|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93015056|NCT00844337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015057|NCT00844337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015058|NCT00841373|Ranibizumab|ranibizumab|mesh-list
93015059|NCT00841373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93015060|NCT00841373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93015061|NCT00841373|Growth Substances|growth substances|mesh-ancestor
93015062|NCT00841373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015063|NCT00841373|Growth Inhibitors|growth inhibitors|mesh-ancestor
93015064|NCT00841373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015065|NCT00851513|Lidocaine|lidocaine|mesh-list
93015066|NCT00851513|Anesthetics, Local|anesthetics, local|mesh-ancestor
93015067|NCT00851513|Anesthetics|anesthetics|mesh-ancestor
93015068|NCT00851513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015069|NCT00851513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015071|NCT00851513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015072|NCT00851513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93015073|NCT00851513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93015074|NCT00851513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93015075|NCT00851513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015076|NCT00851513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015077|NCT00841841|Acetaminophen|acetaminophen|mesh-list
93015079|NCT00841841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015080|NCT00841841|Analgesics|analgesics|mesh-ancestor
93015081|NCT00841841|Sensory System Agents|sensory system agents|mesh-ancestor
93015082|NCT00841841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015083|NCT00841841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015084|NCT00841841|Antipyretics|antipyretics|mesh-ancestor
93015085|NCT00841841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015086|NCT00841841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015087|NCT00841841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015088|NCT02545751|Thymalfasin|thymalfasin|mesh-list
93015089|NCT02545751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93015090|NCT02545751|Immunologic Factors|immunologic factors|mesh-ancestor
93015091|NCT02545751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015092|NCT00841919|Insulin|insulin|mesh-list
93015093|NCT00841919|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93015094|NCT00841919|Insulin Glargine|insulin glargine|mesh-list
93015095|NCT00841919|Insulin, Isophane|insulin, isophane|mesh-list
93015096|NCT00841919|Isophane Insulin, Human|isophane insulin, human|mesh-list
93015097|NCT00841919|Isophane insulin, beef|isophane insulin, beef|mesh-list
93015098|NCT00841919|Insulin Lispro|insulin lispro|mesh-list
93015099|NCT00841919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93015100|NCT00841919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015101|NCT00852059|Methylphenidate|methylphenidate|mesh-list
93015102|NCT00852059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93015103|NCT00852059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015104|NCT00852059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93015105|NCT00852059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93015106|NCT00852059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015107|NCT00852059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015108|NCT00852059|Dopamine Agents|dopamine agents|mesh-ancestor
93015109|NCT00852059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015110|NCT00844727|Rofecoxib|rofecoxib|mesh-list
93015111|NCT00844727|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93015112|NCT00844727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93015113|NCT00844727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015114|NCT00844727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015115|NCT00844727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015116|NCT00844727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015117|NCT00844727|Analgesics|analgesics|mesh-ancestor
93015118|NCT00844727|Sensory System Agents|sensory system agents|mesh-ancestor
93015119|NCT00844727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015120|NCT00844727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015121|NCT00844727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015122|NCT00844727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015123|NCT00528528|Ribavirin|ribavirin|mesh-list
93015124|NCT00528528|Interferon-alpha|interferon-alpha|mesh-list
93015125|NCT00528528|Interferon alpha-2|interferon alpha-2|mesh-list
93015126|NCT00528528|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93015127|NCT00528528|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93015128|NCT00528528|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93015129|NCT00528528|Antimetabolites|antimetabolites|mesh-ancestor
93015130|NCT00528528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015131|NCT00528528|Antiviral Agents|antiviral agents|mesh-ancestor
93015132|NCT00528528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015133|NCT00528528|Immunologic Factors|immunologic factors|mesh-ancestor
93015134|NCT00528528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015135|NCT00528528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015136|NCT00620555|Gabapentin|gabapentin|mesh-list
93015137|NCT00620555|Analgesics|analgesics|mesh-ancestor
93015138|NCT00620555|Sensory System Agents|sensory system agents|mesh-ancestor
93015139|NCT00620555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015140|NCT00620555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015141|NCT00620555|Anticonvulsants|anticonvulsants|mesh-ancestor
93015142|NCT00620555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93015143|NCT00620555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93015144|NCT00620555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015145|NCT00620555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660435|NCT01687894|Hemostatics|hemostatics|mesh-ancestor
93015146|NCT00620555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93015147|NCT00620555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93015149|NCT00620555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015150|NCT00620555|Antimanic Agents|antimanic agents|mesh-ancestor
93015151|NCT00845351|Bexarotene|bexarotene|mesh-list
93015152|NCT00845351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015153|NCT02546141|Caseins|caseins|mesh-list
93015154|NCT02546141|Chelating Agents|chelating agents|mesh-ancestor
93015155|NCT02546141|Sequestering Agents|sequestering agents|mesh-ancestor
92172856|NCT02103361|Ustekinumab|ustekinumab|mesh-list
93015156|NCT02546141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015157|NCT00845819|Iodine|iodine|mesh-list
93015158|NCT00845819|Chlorhexidine|chlorhexidine|mesh-list
93015159|NCT00845819|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93015160|NCT00845819|Cadexomer iodine|cadexomer iodine|mesh-list
93015161|NCT00845819|Povidone-Iodine|povidone-iodine|mesh-list
93015162|NCT00845819|Nystatin|nystatin|mesh-list
93015163|NCT00845819|Povidone|povidone|mesh-list
93015164|NCT00845819|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93015165|NCT00845819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015166|NCT00845819|Disinfectants|disinfectants|mesh-ancestor
93015167|NCT00845819|Dermatologic Agents|dermatologic agents|mesh-ancestor
93015168|NCT00845819|Trace Elements|trace elements|mesh-ancestor
93015169|NCT00845819|Micronutrients|micronutrients|mesh-ancestor
93015170|NCT00845819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015171|NCT00845819|Plasma Substitutes|plasma substitutes|mesh-ancestor
93015172|NCT00845819|Blood Substitutes|blood substitutes|mesh-ancestor
93015173|NCT00845819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93015174|NCT00845819|Antifungal Agents|antifungal agents|mesh-ancestor
93015175|NCT00845819|Ionophores|ionophores|mesh-ancestor
93015176|NCT00845819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015177|NCT00845819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015178|NCT02546843|Rocuronium|rocuronium|mesh-list
93015179|NCT02546843|Atracurium|atracurium|mesh-list
93015180|NCT02546843|Cisatracurium|cisatracurium|mesh-list
93015181|NCT02546843|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93015182|NCT02546843|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93015183|NCT02546843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93015184|NCT02546843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015185|NCT02546843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015186|NCT02546843|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
93015187|NCT02546843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93015188|NCT02546843|Cholinergic Agents|cholinergic agents|mesh-ancestor
93015189|NCT02546843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015190|NCT02546843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015191|NCT03998982|Dexamethasone|dexamethasone|mesh-list
93015192|NCT03998982|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
93015193|NCT03998982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015194|NCT03998982|Antiemetics|antiemetics|mesh-ancestor
93015195|NCT03998982|Autonomic Agents|autonomic agents|mesh-ancestor
93015196|NCT03998982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015197|NCT03998982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015198|NCT03998982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015199|NCT03998982|Glucocorticoids|glucocorticoids|mesh-ancestor
93015200|NCT03998982|Hormones|hormones|mesh-ancestor
93015201|NCT03998982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015202|NCT03998982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93015203|NCT03998982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015204|NCT00620321|Cytarabine|cytarabine|mesh-list
93015205|NCT00620321|Idarubicin|idarubicin|mesh-list
93015206|NCT00620321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93015207|NCT00620321|Antimetabolites|antimetabolites|mesh-ancestor
93015208|NCT00620321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015209|NCT00620321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015210|NCT00620321|Antiviral Agents|antiviral agents|mesh-ancestor
93015211|NCT00620321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015212|NCT00620321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015213|NCT00620321|Immunologic Factors|immunologic factors|mesh-ancestor
93015214|NCT00620321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015215|NCT00620321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93015216|NCT00620321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93015217|NCT00620321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93015218|NCT00620321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015219|NCT00621023|Ascorbic Acid|ascorbic acid|mesh-list
93015221|NCT00621023|Arsenic Trioxide|arsenic trioxide|mesh-list
93015222|NCT00621023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93015223|NCT00621023|Antimetabolites|antimetabolites|mesh-ancestor
93015224|NCT00621023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015225|NCT00621023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015226|NCT00621023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015227|NCT00621023|Antioxidants|antioxidants|mesh-ancestor
93015228|NCT00621023|Protective Agents|protective agents|mesh-ancestor
93015229|NCT00621023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015230|NCT00621023|Vitamins|vitamins|mesh-ancestor
93015231|NCT00621023|Micronutrients|micronutrients|mesh-ancestor
93015232|NCT00848861|Midazolam|midazolam|mesh-list
93015233|NCT00848861|Meperidine|meperidine|mesh-list
93015234|NCT00848861|Propofol|propofol|mesh-list
93015235|NCT00848861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93015236|NCT00848861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015237|NCT00848861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015238|NCT00848861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93015239|NCT00848861|Anesthetics, General|anesthetics, general|mesh-ancestor
93015240|NCT00848861|Anesthetics|anesthetics|mesh-ancestor
93015241|NCT00848861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93015242|NCT00848861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93015243|NCT00848861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93015244|NCT00848861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93015245|NCT00848861|GABA Modulators|gaba modulators|mesh-ancestor
93015246|NCT00848861|GABA Agents|gaba agents|mesh-ancestor
93015247|NCT00848861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015248|NCT00848861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015249|NCT00848861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93015250|NCT00848861|Narcotics|narcotics|mesh-ancestor
93015251|NCT00848861|Analgesics|analgesics|mesh-ancestor
93015252|NCT00848861|Sensory System Agents|sensory system agents|mesh-ancestor
93015253|NCT00848861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015254|NCT00852371|Pyrimethamine|pyrimethamine|mesh-list
93015255|NCT00852371|Piperaquine|piperaquine|mesh-list
93015256|NCT00852371|Sulfadoxine|sulfadoxine|mesh-list
93015257|NCT00852371|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93015258|NCT00852371|Amodiaquine|amodiaquine|mesh-list
93015259|NCT00852371|Artenimol|artenimol|mesh-list
93015260|NCT00852371|Antimalarials|antimalarials|mesh-ancestor
93015261|NCT00852371|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93015262|NCT00852371|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93015263|NCT00852371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015264|NCT00852371|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93015265|NCT00852371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015266|NCT00852371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015267|NCT00852371|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93015268|NCT00528372|Metformin|metformin|mesh-list
93015269|NCT00528372|Dapagliflozin|dapagliflozin|mesh-list
93015270|NCT00528372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93015271|NCT00528372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015272|NCT00528372|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93015273|NCT00528372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015274|NCT01564680|Acetaminophen|acetaminophen|mesh-list
93015275|NCT01564680|Lornoxicam|lornoxicam|mesh-list
93015276|NCT01564680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015277|NCT01564680|Analgesics|analgesics|mesh-ancestor
93015278|NCT01564680|Sensory System Agents|sensory system agents|mesh-ancestor
93015279|NCT01564680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015280|NCT01564680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015281|NCT01564680|Antipyretics|antipyretics|mesh-ancestor
93015282|NCT01564680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015283|NCT01564680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015284|NCT01564680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015285|NCT01564836|Imatinib Mesylate|imatinib mesylate|mesh-list
93015286|NCT01564836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015287|NCT01564836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015288|NCT01564836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015289|NCT01564836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015290|NCT00527982|Celecoxib|celecoxib|mesh-list
93015291|NCT00527982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015292|NCT00527982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015293|NCT00527982|Analgesics|analgesics|mesh-ancestor
93015294|NCT00527982|Sensory System Agents|sensory system agents|mesh-ancestor
93015295|NCT00527982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015296|NCT00527982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015297|NCT00527982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015298|NCT00527982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015299|NCT00527982|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93015300|NCT00527982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93015301|NCT00527982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015302|NCT00527982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015304|NCT00527904|Esomeprazole|esomeprazole|mesh-list
93015305|NCT00527904|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93015306|NCT00527904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015307|NCT00527904|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93015308|NCT00527904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015309|NCT00527904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015310|NCT00527904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015311|NCT00527904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015312|NCT00527904|Analgesics|analgesics|mesh-ancestor
93015313|NCT00527904|Sensory System Agents|sensory system agents|mesh-ancestor
93015314|NCT00527904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015315|NCT00527904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015316|NCT00527904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015317|NCT00527904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015318|NCT00527904|Gout Suppressants|gout suppressants|mesh-ancestor
93015319|NCT00527904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93015320|NCT00619619|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93015321|NCT00619619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93015322|NCT00619619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93015323|NCT00619619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015324|NCT00619619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015325|NCT00619619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015326|NCT00619619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015327|NCT00619619|Antidepressive Agents|antidepressive agents|mesh-ancestor
93015328|NCT00619619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93015329|NCT00848939|Treprostinil|treprostinil|mesh-list
93015330|NCT00848939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93015331|NCT00842933|Prednisone|prednisone|mesh-list
93015332|NCT00842933|Methylprednisolone|methylprednisolone|mesh-list
93015333|NCT00842933|Hydrocortisone|hydrocortisone|mesh-list
93015334|NCT00842933|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93015335|NCT00842933|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93015336|NCT00842933|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93015337|NCT00842933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015338|NCT00842933|Glucocorticoids|glucocorticoids|mesh-ancestor
93015339|NCT00842933|Hormones|hormones|mesh-ancestor
93015340|NCT00842933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015341|NCT00842933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015342|NCT00842933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93015343|NCT00842933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015344|NCT00842933|Antiemetics|antiemetics|mesh-ancestor
93015345|NCT00842933|Autonomic Agents|autonomic agents|mesh-ancestor
93015346|NCT00842933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015347|NCT00842933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015348|NCT00842933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93015349|NCT00842933|Protective Agents|protective agents|mesh-ancestor
93015350|NCT00849095|Budesonide|budesonide|mesh-list
93015351|NCT00849095|Terbutaline|terbutaline|mesh-list
93015352|NCT00849095|Formoterol Fumarate|formoterol fumarate|mesh-list
93015353|NCT00849095|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93015354|NCT00849095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015355|NCT00849095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93015356|NCT00849095|Autonomic Agents|autonomic agents|mesh-ancestor
93015357|NCT00849095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015358|NCT00849095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015359|NCT00849095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93015360|NCT00849095|Respiratory System Agents|respiratory system agents|mesh-ancestor
93015361|NCT00849095|Glucocorticoids|glucocorticoids|mesh-ancestor
93015362|NCT00849095|Hormones|hormones|mesh-ancestor
93015363|NCT00849095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015364|NCT00849095|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93015365|NCT00849095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93015366|NCT00849095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92528721|NCT00000869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93015367|NCT00849095|Adrenergic Agents|adrenergic agents|mesh-ancestor
93015368|NCT00849095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015369|NCT00849095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015370|NCT00849095|Sympathomimetics|sympathomimetics|mesh-ancestor
93015371|NCT00849095|Tocolytic Agents|tocolytic agents|mesh-ancestor
93015372|NCT00849095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93015373|NCT00527826|Fluticasone|fluticasone|mesh-list
93015374|NCT00527826|Xhance|xhance|mesh-list
93015375|NCT00527826|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93015376|NCT00527826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015377|NCT00527826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93015378|NCT00527826|Autonomic Agents|autonomic agents|mesh-ancestor
93015379|NCT00527826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015380|NCT00527826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015381|NCT00527826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93015382|NCT00527826|Respiratory System Agents|respiratory system agents|mesh-ancestor
93015383|NCT00527826|Dermatologic Agents|dermatologic agents|mesh-ancestor
93015384|NCT00527826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93015385|NCT00527826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93015386|NCT00527826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93015387|NCT00527826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93015388|NCT00527826|Adrenergic Agents|adrenergic agents|mesh-ancestor
93015389|NCT00527826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015390|NCT00527826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015391|NCT00849329|Lapatinib|lapatinib|mesh-list
93015392|NCT00849329|Esomeprazole|esomeprazole|mesh-list
93015393|NCT00849329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93015394|NCT00849329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015395|NCT00849329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93015396|NCT00849329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015397|NCT00849329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015398|NCT00849329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015399|NCT00849329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015400|NCT03998670|Methamphetamine|methamphetamine|mesh-list
93015401|NCT03998670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93015402|NCT03998670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015403|NCT03998670|Sympathomimetics|sympathomimetics|mesh-ancestor
93015404|NCT03998670|Autonomic Agents|autonomic agents|mesh-ancestor
93015405|NCT03998670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015406|NCT03998670|Dopamine Agents|dopamine agents|mesh-ancestor
93015407|NCT03998670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015408|NCT03998670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015409|NCT03998670|Adrenergic Agents|adrenergic agents|mesh-ancestor
93015410|NCT03998670|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93015411|NCT03998670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93015412|NCT03998670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015413|NCT03998670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93015414|NCT00852683|Pregabalin|pregabalin|mesh-list
93015415|NCT00852683|Analgesics|analgesics|mesh-ancestor
93015416|NCT00852683|Sensory System Agents|sensory system agents|mesh-ancestor
93015417|NCT00852683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015418|NCT00852683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015419|NCT00852683|Anticonvulsants|anticonvulsants|mesh-ancestor
92172980|NCT04914936|Rifampin|rifampin|mesh-list
93015420|NCT00852683|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93015421|NCT00852683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015422|NCT00852683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015423|NCT00852683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93015424|NCT00852683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93015425|NCT00852683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93015426|NCT00852683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015427|NCT00852683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93015428|NCT00619307|Interferon beta-1a|interferon beta-1a|mesh-list
93015429|NCT00619307|Ibuprofen|ibuprofen|mesh-list
93015430|NCT00619307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015431|NCT00619307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015432|NCT00619307|Analgesics|analgesics|mesh-ancestor
93015433|NCT00619307|Sensory System Agents|sensory system agents|mesh-ancestor
93015434|NCT00619307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015435|NCT00619307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015436|NCT00619307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015437|NCT00619307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015438|NCT00619307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93015439|NCT00619307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015440|NCT00619307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015441|NCT00619307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93015442|NCT00619307|Immunologic Factors|immunologic factors|mesh-ancestor
93015443|NCT00619307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015444|NCT00619307|Antiviral Agents|antiviral agents|mesh-ancestor
93015445|NCT00619307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015447|NCT00855881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93015448|NCT00855881|Antimetabolites|antimetabolites|mesh-ancestor
93015449|NCT00855881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015450|NCT00855881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015451|NCT00619229|Alprostadil|alprostadil|mesh-list
93015452|NCT00619229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93015453|NCT00619229|Vasodilator Agents|vasodilator agents|mesh-ancestor
93015454|NCT00619229|Urological Agents|urological agents|mesh-ancestor
93015455|NCT02546297|Budesonide|budesonide|mesh-list
93015456|NCT02546297|Bromides|bromides|mesh-list
93015457|NCT02546297|Formoterol Fumarate|formoterol fumarate|mesh-list
93015458|NCT02546297|Tiotropium Bromide|tiotropium bromide|mesh-list
93015459|NCT02546297|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93015460|NCT02546297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015461|NCT02546297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93015462|NCT02546297|Autonomic Agents|autonomic agents|mesh-ancestor
93015463|NCT02546297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015464|NCT02546297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015465|NCT02546297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93015466|NCT02546297|Respiratory System Agents|respiratory system agents|mesh-ancestor
93015467|NCT02546297|Glucocorticoids|glucocorticoids|mesh-ancestor
93015468|NCT02546297|Hormones|hormones|mesh-ancestor
93015469|NCT02546297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015470|NCT02546297|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93015471|NCT02546297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93015472|NCT02546297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93015473|NCT02546297|Adrenergic Agents|adrenergic agents|mesh-ancestor
93015474|NCT02546297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015475|NCT02546297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015476|NCT02546297|Parasympatholytics|parasympatholytics|mesh-ancestor
93015477|NCT02546297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93015478|NCT02546297|Cholinergic Agents|cholinergic agents|mesh-ancestor
93015479|NCT02546297|Anticonvulsants|anticonvulsants|mesh-ancestor
93015480|NCT00618995|Niacin|niacin|mesh-list
93015481|NCT00618995|Niacinamide|niacinamide|mesh-list
93015482|NCT00618995|Nicotinic Acids|nicotinic acids|mesh-list
93015483|NCT00618995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93015484|NCT00618995|Antimetabolites|antimetabolites|mesh-ancestor
93015485|NCT00618995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015486|NCT00618995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93015487|NCT00618995|Vasodilator Agents|vasodilator agents|mesh-ancestor
93015488|NCT00618995|Vitamin B Complex|vitamin b complex|mesh-ancestor
93015489|NCT00618995|Vitamins|vitamins|mesh-ancestor
93015490|NCT00618995|Micronutrients|micronutrients|mesh-ancestor
93015491|NCT00618995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015492|NCT03685344|Durvalumab|durvalumab|mesh-list
93015493|NCT03685344|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93015494|NCT03685344|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93015495|NCT03685344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93015496|NCT03685344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015497|NCT03685344|Immunologic Factors|immunologic factors|mesh-ancestor
93015498|NCT03685344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015499|NCT00856037|Doxorubicin|doxorubicin|mesh-list
93015500|NCT00856037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93015501|NCT00856037|Topotecan|topotecan|mesh-list
93015502|NCT00856037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93015503|NCT00856037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015504|NCT00856037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93015505|NCT00856037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93015506|NCT00856037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015507|NCT00856037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015508|NCT00856037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93015509|NCT00856271|Losartan|losartan|mesh-list
93015510|NCT00856271|Olmesartan|olmesartan|mesh-list
93015511|NCT00856271|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93015512|NCT00856271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93015513|NCT00856271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93015514|NCT00856271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93015516|NCT00856271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015517|NCT00856505|Mycophenolic Acid|mycophenolic acid|mesh-list
93015518|NCT00856505|Everolimus|everolimus|mesh-list
93015519|NCT00856505|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93015520|NCT00856505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015521|NCT00856505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015522|NCT00856505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015523|NCT00856505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015524|NCT00856505|Immunologic Factors|immunologic factors|mesh-ancestor
93015525|NCT00856505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015526|NCT00856505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015527|NCT00856505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93015528|NCT00856505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93015529|NCT00856505|Antitubercular Agents|antitubercular agents|mesh-ancestor
93015530|NCT00856505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93015531|NCT00856505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015532|NCT02544893|Dexmedetomidine|dexmedetomidine|mesh-list
93015533|NCT02544893|Bupivacaine|bupivacaine|mesh-list
93015534|NCT02544893|Anesthetics, Local|anesthetics, local|mesh-ancestor
93015535|NCT02544893|Anesthetics|anesthetics|mesh-ancestor
93015536|NCT02544893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015537|NCT02544893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015538|NCT02544893|Sensory System Agents|sensory system agents|mesh-ancestor
93015539|NCT02544893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015540|NCT02544893|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93015541|NCT02544893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015542|NCT02544893|Analgesics|analgesics|mesh-ancestor
93015543|NCT02544893|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93015544|NCT02544893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93015545|NCT02544893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93015546|NCT02544893|Adrenergic Agents|adrenergic agents|mesh-ancestor
93015547|NCT02544893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015548|NCT02544893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015549|NCT00520572|Etanercept|etanercept|mesh-list
93015550|NCT00520572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015551|NCT00520572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015552|NCT00520572|Analgesics|analgesics|mesh-ancestor
93015553|NCT00520572|Sensory System Agents|sensory system agents|mesh-ancestor
93015554|NCT00520572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015555|NCT00520572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015556|NCT00520572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015557|NCT00520572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015558|NCT00520572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015559|NCT00520572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015560|NCT00520572|Immunologic Factors|immunologic factors|mesh-ancestor
93015561|NCT00853697|Methyltestosterone|methyltestosterone|mesh-list
93015562|NCT00853697|Testosterone|testosterone|mesh-list
93015563|NCT00853697|Testosterone undecanoate|testosterone undecanoate|mesh-list
93015564|NCT00853697|Testosterone enanthate|testosterone enanthate|mesh-list
93015565|NCT00853697|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93015566|NCT00853697|Dutasteride|dutasteride|mesh-list
93015567|NCT00853697|Androgens|androgens|mesh-ancestor
93015568|NCT00853697|Hormones|hormones|mesh-ancestor
93015569|NCT00853697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015570|NCT00853697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015571|NCT00853697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93015572|NCT00853697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015573|NCT00853697|Anabolic Agents|anabolic agents|mesh-ancestor
93015574|NCT00853697|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93015575|NCT00853697|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93015576|NCT00853697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015577|NCT00853697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015578|NCT00853697|Hormone Antagonists|hormone antagonists|mesh-ancestor
93015579|NCT00861419|Niacinamide|niacinamide|mesh-list
93015580|NCT00861419|Bevacizumab|bevacizumab|mesh-list
93015581|NCT00861419|Sunitinib|sunitinib|mesh-list
93015582|NCT00861419|Trebananib|trebananib|mesh-list
93015583|NCT00861419|Sorafenib|sorafenib|mesh-list
93015584|NCT00861419|Motesanib diphosphate|motesanib diphosphate|mesh-list
93015585|NCT00861419|Imetelstat|imetelstat|mesh-list
93015586|NCT00861419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93015587|NCT00861419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015588|NCT00861419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93015589|NCT00861419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93015590|NCT00861419|Growth Substances|growth substances|mesh-ancestor
93015591|NCT00861419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015592|NCT00861419|Growth Inhibitors|growth inhibitors|mesh-ancestor
93015593|NCT00861419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015594|NCT00861419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015595|NCT00861419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015596|NCT00861419|Vitamin B Complex|vitamin b complex|mesh-ancestor
93015597|NCT00861419|Vitamins|vitamins|mesh-ancestor
93015598|NCT00861419|Micronutrients|micronutrients|mesh-ancestor
92660880|NCT01588756|Mechlorethamine|mechlorethamine|mesh-list
93015599|NCT00527514|Amlodipine|amlodipine|mesh-list
93015600|NCT00527514|Olmesartan|olmesartan|mesh-list
93015601|NCT00527514|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93015602|NCT00527514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93015603|NCT00527514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93015604|NCT00527514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015605|NCT00527514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015606|NCT00527514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93015607|NCT00527514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015608|NCT00527514|Vasodilator Agents|vasodilator agents|mesh-ancestor
93015609|NCT00527514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93015610|NCT00527514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93015611|NCT03998826|Piroxicam|piroxicam|mesh-list
93015612|NCT03998826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93015613|NCT03998826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93015614|NCT03998826|Analgesics|analgesics|mesh-ancestor
93015615|NCT03998826|Sensory System Agents|sensory system agents|mesh-ancestor
93015616|NCT03998826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015617|NCT03998826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015618|NCT03998826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015619|NCT03998826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015620|NCT03998826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93015621|NCT03998826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015622|NCT03998826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015623|NCT00853931|Panitumumab|panitumumab|mesh-list
93015624|NCT00853931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93015625|NCT00853931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015626|NCT00854009|BLI-489|bli-489|mesh-list
93015627|NCT00854009|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93015628|NCT00854009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015629|NCT00854009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015630|NCT00854009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93015631|NCT00854009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015632|NCT03998592|Vaccines|vaccines|mesh-list
93015633|NCT03998592|Immunologic Factors|immunologic factors|mesh-ancestor
93015634|NCT03998592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015635|NCT00861731|Simvastatin|simvastatin|mesh-list
93015636|NCT00861731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93015637|NCT00861731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93015638|NCT00861731|Antimetabolites|antimetabolites|mesh-ancestor
93015639|NCT00861731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015640|NCT00861731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93015641|NCT00861731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93015642|NCT00861731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015643|NCT02544659|Pamidronate|pamidronate|mesh-list
93015644|NCT02544659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93015645|NCT02544659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015646|NCT00861887|Vancomycin|vancomycin|mesh-list
93015647|NCT00861887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93015648|NCT00861887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015649|NCT00857519|Carboplatin|carboplatin|mesh-list
93015650|NCT00857519|Melphalan|melphalan|mesh-list
93015651|NCT00857519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015652|NCT00857519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93015653|NCT00857519|Alkylating Agents|alkylating agents|mesh-ancestor
93015654|NCT00857519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015655|NCT00857519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93015656|NCT00857519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015657|NCT00857519|Immunologic Factors|immunologic factors|mesh-ancestor
93015658|NCT00857519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015659|NCT00618449|Azithromycin|azithromycin|mesh-list
92528727|NCT00037102|Interferon beta-1a|interferon beta-1a|mesh-list
93015660|NCT00618449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93015661|NCT00618449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015662|NCT00857597|Esomeprazole|esomeprazole|mesh-list
93015664|NCT00857597|Rabeprazole|rabeprazole|mesh-list
93015665|NCT00857597|Pantoprazole|pantoprazole|mesh-list
93015666|NCT00857597|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93015667|NCT00857597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93015668|NCT00857597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015669|NCT00857597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015670|NCT00857597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015671|NCT00857753|Fentanyl|fentanyl|mesh-list
93015672|NCT00857753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93015673|NCT00857753|Narcotics|narcotics|mesh-ancestor
93015674|NCT00857753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660959|NCT04050085|Nivolumab|nivolumab|mesh-list
93015675|NCT00857753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015677|NCT00857753|Sensory System Agents|sensory system agents|mesh-ancestor
93015678|NCT00857753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015679|NCT00857753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93015680|NCT00857753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93015681|NCT00857753|Anesthetics, General|anesthetics, general|mesh-ancestor
93015682|NCT00857753|Anesthetics|anesthetics|mesh-ancestor
93015683|NCT00854321|Rituximab|rituximab|mesh-list
93015684|NCT00854321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93015685|NCT00854321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015686|NCT00854321|Immunologic Factors|immunologic factors|mesh-ancestor
93015687|NCT00854321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015688|NCT00854321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93015689|NCT03684642|Metformin|metformin|mesh-list
93015690|NCT03684642|Dulaglutide|dulaglutide|mesh-list
93015691|NCT03684642|Efpeglenatide|efpeglenatide|mesh-list
93015692|NCT03684642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93015693|NCT03684642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015694|NCT00857831|Vitamin D|vitamin d|mesh-list
93015695|NCT00857831|Calcium|calcium|mesh-list
93015696|NCT00857831|Vitamins|vitamins|mesh-ancestor
93015697|NCT00857831|Micronutrients|micronutrients|mesh-ancestor
93015698|NCT00857831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015699|NCT00857831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93015700|NCT00857831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93015701|NCT00862043|Sildenafil Citrate|sildenafil citrate|mesh-list
93015702|NCT00862043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015703|NCT00862043|Vasodilator Agents|vasodilator agents|mesh-ancestor
93015704|NCT00862043|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93015705|NCT00862043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93015706|NCT00862043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015707|NCT00862043|Urological Agents|urological agents|mesh-ancestor
93015708|NCT00519636|Fluticasone|fluticasone|mesh-list
93015709|NCT00519636|Xhance|xhance|mesh-list
93015710|NCT00519636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015711|NCT00519636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93015712|NCT00519636|Autonomic Agents|autonomic agents|mesh-ancestor
93015713|NCT00519636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173196|NCT02394769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015714|NCT00519636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015715|NCT00519636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93015716|NCT00519636|Respiratory System Agents|respiratory system agents|mesh-ancestor
93015717|NCT00519636|Dermatologic Agents|dermatologic agents|mesh-ancestor
93015718|NCT00519636|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93015719|NCT00857909|Amiloride|amiloride|mesh-list
93015720|NCT00857909|Spironolactone|spironolactone|mesh-list
93015721|NCT00857909|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93015722|NCT00857909|Hormone Antagonists|hormone antagonists|mesh-ancestor
93015723|NCT00857909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015724|NCT00857909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015725|NCT00857909|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93015726|NCT00857909|Diuretics|diuretics|mesh-ancestor
93015727|NCT00857909|Natriuretic Agents|natriuretic agents|mesh-ancestor
93015728|NCT00857909|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93015729|NCT00857909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93015730|NCT00857909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015731|NCT00857909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015732|NCT00857909|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93015733|NCT00857987|Expectorants|expectorants|mesh-list
93015734|NCT00857987|Respiratory System Agents|respiratory system agents|mesh-ancestor
93015735|NCT00854477|Capecitabine|capecitabine|mesh-list
92528728|NCT00037102|Methotrexate|methotrexate|mesh-list
93015736|NCT00854477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93015737|NCT00854477|Antimetabolites|antimetabolites|mesh-ancestor
93015738|NCT00854477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015739|NCT00854477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015740|NCT00854633|Lactoferrin|lactoferrin|mesh-list
93015741|NCT00854633|Talactoferrin alfa|talactoferrin alfa|mesh-list
93015742|NCT00854633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015743|NCT00854633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015744|NCT00618371|Raltegravir Potassium|raltegravir potassium|mesh-list
93015745|NCT00618371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93015746|NCT00618371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93015747|NCT00618371|Antiviral Agents|antiviral agents|mesh-ancestor
93015748|NCT00618371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661032|NCT00289419|Autonomic Agents|autonomic agents|mesh-ancestor
93015749|NCT00618371|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93015750|NCT00618371|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93015751|NCT00618371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015752|NCT00618371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015754|NCT00858299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93015755|NCT00858299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93015756|NCT00858299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93015757|NCT00858299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015758|NCT00526890|Selenium|selenium|mesh-list
93015759|NCT00526890|Paclitaxel|paclitaxel|mesh-list
93015760|NCT00526890|Carboplatin|carboplatin|mesh-list
93015761|NCT00526890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93015762|NCT00526890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015763|NCT00526890|Tubulin Modulators|tubulin modulators|mesh-ancestor
93015764|NCT00526890|Antimitotic Agents|antimitotic agents|mesh-ancestor
93015765|NCT00526890|Mitosis Modulators|mitosis modulators|mesh-ancestor
93015766|NCT00526890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015767|NCT00526890|Antioxidants|antioxidants|mesh-ancestor
93015768|NCT00526890|Protective Agents|protective agents|mesh-ancestor
93015769|NCT00526890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015770|NCT00526890|Trace Elements|trace elements|mesh-ancestor
93015771|NCT00526890|Micronutrients|micronutrients|mesh-ancestor
93015772|NCT04041167|Thioctic Acid|thioctic acid|mesh-list
93015773|NCT04041167|Antioxidants|antioxidants|mesh-ancestor
93015774|NCT04041167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015775|NCT04041167|Protective Agents|protective agents|mesh-ancestor
93015776|NCT04041167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015777|NCT04041167|Vitamin B Complex|vitamin b complex|mesh-ancestor
93015778|NCT04041167|Vitamins|vitamins|mesh-ancestor
93015779|NCT04041167|Micronutrients|micronutrients|mesh-ancestor
93015780|NCT00858377|Complement Factor H|complement factor h|mesh-list
93015781|NCT00858377|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93015782|NCT00858377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015783|NCT00858377|Immunologic Factors|immunologic factors|mesh-ancestor
93015784|NCT00858377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015785|NCT00854711|Nitric Oxide|nitric oxide|mesh-list
93015786|NCT00854711|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93015787|NCT00854711|Autonomic Agents|autonomic agents|mesh-ancestor
93015788|NCT00854711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015789|NCT00854711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015790|NCT00854711|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93015791|NCT00854711|Respiratory System Agents|respiratory system agents|mesh-ancestor
93015792|NCT00854711|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93015793|NCT00854711|Antioxidants|antioxidants|mesh-ancestor
93015794|NCT00854711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015795|NCT00854711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015796|NCT00854711|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93015797|NCT00854711|Vasodilator Agents|vasodilator agents|mesh-ancestor
93015798|NCT00854711|Gasotransmitters|gasotransmitters|mesh-ancestor
93015799|NCT00854711|Protective Agents|protective agents|mesh-ancestor
93015800|NCT00858455|Dolutegravir|dolutegravir|mesh-list
93015801|NCT00858455|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93015802|NCT00858455|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93015803|NCT00858455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015804|NCT00858455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015805|NCT00858455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93015806|NCT00858455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93015807|NCT00858455|Antiviral Agents|antiviral agents|mesh-ancestor
93015808|NCT00858455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015810|NCT02544737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015811|NCT02544737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015812|NCT02544737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015813|NCT02544737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015814|NCT00526656|Sunitinib|sunitinib|mesh-list
93015815|NCT00526656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015816|NCT00526656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93015817|NCT00526656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93015818|NCT00526656|Growth Substances|growth substances|mesh-ancestor
93015819|NCT00526656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015820|NCT00526656|Growth Inhibitors|growth inhibitors|mesh-ancestor
93015821|NCT00526656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015822|NCT00526656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015823|NCT00526656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015824|NCT00858767|Vitamin K 2|vitamin k 2|mesh-list
93015825|NCT00858767|Vitamin K|vitamin k|mesh-list
93015826|NCT00858767|Menaquinone 7|menaquinone 7|mesh-list
93015827|NCT00858767|Caseins|caseins|mesh-list
93015828|NCT00858767|Chelating Agents|chelating agents|mesh-ancestor
93015829|NCT00858767|Sequestering Agents|sequestering agents|mesh-ancestor
93015830|NCT00858767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015831|NCT00858767|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93015832|NCT00858767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93015833|NCT00858767|Hemostatics|hemostatics|mesh-ancestor
93015834|NCT00858767|Coagulants|coagulants|mesh-ancestor
93015835|NCT00858767|Vitamins|vitamins|mesh-ancestor
93015836|NCT00858767|Micronutrients|micronutrients|mesh-ancestor
93015837|NCT00858767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015838|NCT00617903|Azelaic acid|azelaic acid|mesh-list
93015839|NCT00617903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015840|NCT00617903|Dermatologic Agents|dermatologic agents|mesh-ancestor
93015841|NCT00526110|Docetaxel|docetaxel|mesh-list
93015842|NCT00526110|Fluorouracil|fluorouracil|mesh-list
93015843|NCT00526110|Oxaliplatin|oxaliplatin|mesh-list
93015844|NCT00526110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015845|NCT00526110|Tubulin Modulators|tubulin modulators|mesh-ancestor
93015846|NCT00526110|Antimitotic Agents|antimitotic agents|mesh-ancestor
93015847|NCT00526110|Mitosis Modulators|mitosis modulators|mesh-ancestor
93015848|NCT00526110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015849|NCT00526110|Antimetabolites|antimetabolites|mesh-ancestor
92173280|NCT01390233|Oxytocics|oxytocics|mesh-ancestor
93015850|NCT00526110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93015851|NCT00526110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015852|NCT00526110|Immunologic Factors|immunologic factors|mesh-ancestor
93015853|NCT00526110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015854|NCT04565730|Anesthetics|anesthetics|mesh-list
93015855|NCT04565730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015856|NCT04565730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015857|NCT00859079|Insulin|insulin|mesh-list
93015858|NCT00859079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93015859|NCT00859079|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93015860|NCT00859079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93015861|NCT00859079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015862|NCT00859079|Incretins|incretins|mesh-ancestor
93015863|NCT00859079|Hormones|hormones|mesh-ancestor
93015864|NCT00859079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015865|NCT02544425|Dexamethasone|dexamethasone|mesh-list
93015866|NCT02544425|Etoposide|etoposide|mesh-list
93015867|NCT02544425|Melphalan|melphalan|mesh-list
93015868|NCT02544425|Busulfan|busulfan|mesh-list
93015869|NCT02544425|Asparaginase|asparaginase|mesh-list
93015870|NCT02544425|Ifosfamide|ifosfamide|mesh-list
93015871|NCT02544425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93015872|NCT02544425|Antiemetics|antiemetics|mesh-ancestor
93015873|NCT02544425|Autonomic Agents|autonomic agents|mesh-ancestor
93015874|NCT02544425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015875|NCT02544425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015876|NCT02544425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93015877|NCT02544425|Glucocorticoids|glucocorticoids|mesh-ancestor
93015878|NCT02544425|Hormones|hormones|mesh-ancestor
93015879|NCT02544425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015880|NCT02544425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93015881|NCT02544425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015882|NCT02544425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93015883|NCT02544425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93015884|NCT02544425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93015885|NCT02544425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015886|NCT02544425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015887|NCT02544425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93015889|NCT02544425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93015890|NCT02544425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93015891|NCT02544425|Immunologic Factors|immunologic factors|mesh-ancestor
93015892|NCT00859235|Chlorhexidine|chlorhexidine|mesh-list
93015893|NCT00859235|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93015894|NCT00859235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93015895|NCT00859235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015896|NCT00859235|Disinfectants|disinfectants|mesh-ancestor
93015897|NCT00859235|Dermatologic Agents|dermatologic agents|mesh-ancestor
93015898|NCT04523688|Temozolomide|temozolomide|mesh-list
93015899|NCT04523688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93015900|NCT04523688|Alkylating Agents|alkylating agents|mesh-ancestor
93015901|NCT04523688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015902|NCT04523688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015903|NCT00511836|Naltrexone|naltrexone|mesh-list
93015904|NCT00511836|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93015905|NCT00511836|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93015906|NCT00511836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015907|NCT00511836|Sensory System Agents|sensory system agents|mesh-ancestor
93015908|NCT00511836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015909|NCT00859703|Risedronic Acid|risedronic acid|mesh-list
93015910|NCT00859703|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93015911|NCT00859703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015912|NCT00859703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015913|NCT00859703|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93015914|NCT00859703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015915|NCT00859703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93015916|NCT03998436|Esmolol|esmolol|mesh-list
93015917|NCT03998436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93015918|NCT03998436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93015919|NCT03998436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93015920|NCT03998436|Adrenergic Agents|adrenergic agents|mesh-ancestor
93015921|NCT03998436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015922|NCT03998436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015923|NCT03998436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015924|NCT00855101|Voriconazole|voriconazole|mesh-list
93015925|NCT00855101|Antifungal Agents|antifungal agents|mesh-ancestor
93015926|NCT00855101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93015927|NCT00855101|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93015928|NCT00855101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93015929|NCT00855101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015930|NCT00855101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015931|NCT00855101|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93015932|NCT00855101|Hormone Antagonists|hormone antagonists|mesh-ancestor
93015933|NCT00855101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015934|NCT00855101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015935|NCT00855101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93015936|NCT00573755|Sorafenib|sorafenib|mesh-list
93015937|NCT00573755|Letrozole|letrozole|mesh-list
93015938|NCT00573755|Anastrozole|anastrozole|mesh-list
93015939|NCT00573755|Exemestane|exemestane|mesh-list
93015940|NCT00573755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015941|NCT00573755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015942|NCT00573755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015943|NCT00573755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015944|NCT00573755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93015945|NCT00573755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93015946|NCT00573755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93015947|NCT00573755|Hormone Antagonists|hormone antagonists|mesh-ancestor
93015948|NCT00573755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93015949|NCT00573755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015950|NCT00573755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93015951|NCT02544191|Goserelin|goserelin|mesh-list
93015952|NCT02544191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93015953|NCT02544191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015954|NCT00524316|Doxorubicin|doxorubicin|mesh-list
93015955|NCT00524316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93015957|NCT00524316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93015958|NCT00524316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93015959|NCT00524316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93015960|NCT00524316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93015961|NCT00524316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93015962|NCT00524316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015963|NCT00524316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93015964|NCT00524316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93015965|NCT00524316|Growth Substances|growth substances|mesh-ancestor
93015966|NCT00524316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015967|NCT00524316|Growth Inhibitors|growth inhibitors|mesh-ancestor
93015968|NCT00524316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93015969|NCT03861936|Botulinum Toxins|botulinum toxins|mesh-list
93015970|NCT03861936|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93015971|NCT03861936|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93015972|NCT03861936|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93015973|NCT03861936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015974|NCT03861936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015975|NCT03861936|Cholinergic Agents|cholinergic agents|mesh-ancestor
93015976|NCT03861936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015977|NCT03861936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015978|NCT03861936|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93015979|NCT03861936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015980|NCT02544269|Bupivacaine|bupivacaine|mesh-list
93015981|NCT02544269|Ropivacaine|ropivacaine|mesh-list
93015982|NCT02544269|Anesthetics, Local|anesthetics, local|mesh-ancestor
93015983|NCT02544269|Anesthetics|anesthetics|mesh-ancestor
93015984|NCT02544269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93015985|NCT02544269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015986|NCT02544269|Sensory System Agents|sensory system agents|mesh-ancestor
93015987|NCT02544269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93015988|NCT00434577|Vaccines|vaccines|mesh-list
93015989|NCT00434577|Immunologic Factors|immunologic factors|mesh-ancestor
93015990|NCT00434577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93015991|NCT00865085|Dexetimide|dexetimide|mesh-list
93015992|NCT00865085|Citalopram|citalopram|mesh-list
93015993|NCT00865085|Escitalopram|escitalopram|mesh-list
93015994|NCT00865085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93015995|NCT00865085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93015996|NCT00865085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93015997|NCT00865085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93015998|NCT00865085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93015999|NCT00865085|Serotonin Agents|serotonin agents|mesh-ancestor
93016000|NCT00865085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016001|NCT00865085|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93016002|NCT00865085|Antidepressive Agents|antidepressive agents|mesh-ancestor
93016003|NCT00865085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016004|NCT00865085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93016005|NCT00865085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93016006|NCT00865085|Parasympatholytics|parasympatholytics|mesh-ancestor
93016007|NCT00865085|Autonomic Agents|autonomic agents|mesh-ancestor
93016008|NCT00865085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016009|NCT00865085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93016010|NCT00865085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93016011|NCT00865085|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016012|NCT00796068|Cyclosporine|cyclosporine|mesh-list
93016013|NCT00796068|Mycophenolic Acid|mycophenolic acid|mesh-list
93016014|NCT00796068|Fludarabine|fludarabine|mesh-list
93016015|NCT00796068|Fludarabine phosphate|fludarabine phosphate|mesh-list
93016016|NCT00796068|Treosulfan|treosulfan|mesh-list
93016017|NCT00796068|Busulfan|busulfan|mesh-list
93016018|NCT00796068|Cyclosporins|cyclosporins|mesh-list
93016019|NCT00796068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016020|NCT00796068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93016021|NCT00796068|Antimetabolites|antimetabolites|mesh-ancestor
93016022|NCT00796068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016023|NCT00796068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93016024|NCT00796068|Immunologic Factors|immunologic factors|mesh-ancestor
93016025|NCT00796068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016026|NCT00796068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016027|NCT00796068|Antifungal Agents|antifungal agents|mesh-ancestor
93016028|NCT00796068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016029|NCT00796068|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016030|NCT00796068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016031|NCT00796068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93016032|NCT00796068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93016033|NCT00796068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93016034|NCT00796068|Antitubercular Agents|antitubercular agents|mesh-ancestor
93016035|NCT00796068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93016036|NCT00796068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93016037|NCT00796068|Alkylating Agents|alkylating agents|mesh-ancestor
93016038|NCT00796068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93016039|NCT04732182|Donepezil|donepezil|mesh-list
93016040|NCT04732182|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93016041|NCT04732182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016042|NCT04732182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016043|NCT04732182|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016044|NCT04732182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016045|NCT04732182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016046|NCT04732182|Nootropic Agents|nootropic agents|mesh-ancestor
93016047|NCT03783078|Pembrolizumab|pembrolizumab|mesh-list
93016048|NCT03783078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93016049|NCT03783078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661335|NCT02270437|Mydriatics|mydriatics|mesh-ancestor
93016050|NCT03783078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93016051|NCT03783078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016053|NCT01009476|Piracetam|piracetam|mesh-list
93016054|NCT01009476|Galantamine|galantamine|mesh-list
93016055|NCT01009476|Nootropic Agents|nootropic agents|mesh-list
93016056|NCT01009476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93016057|NCT01009476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016058|NCT01009476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016059|NCT01009476|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016060|NCT01009476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016061|NCT01009476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016062|NCT01009476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93016063|NCT01009476|Autonomic Agents|autonomic agents|mesh-ancestor
93016064|NCT01009476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016065|NCT01009476|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93016066|NCT01009476|Protective Agents|protective agents|mesh-ancestor
93016067|NCT01009476|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93016068|NCT01009476|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93016069|NCT01009476|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016070|NCT01009476|Vasodilator Agents|vasodilator agents|mesh-ancestor
93016071|NCT00517296|Adalimumab|adalimumab|mesh-list
93016072|NCT00517296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93016073|NCT00517296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016074|NCT00517296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016075|NCT00516906|Chlorhexidine|chlorhexidine|mesh-list
93016076|NCT00516906|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93016077|NCT00516906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93016078|NCT00516906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016079|NCT00516906|Disinfectants|disinfectants|mesh-ancestor
93016080|NCT00516906|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016081|NCT00523848|Thalidomide|thalidomide|mesh-list
93016082|NCT00523848|Doxorubicin|doxorubicin|mesh-list
93016083|NCT00523848|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93016084|NCT00523848|Bortezomib|bortezomib|mesh-list
93016085|NCT00523848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93016086|NCT00523848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016087|NCT00523848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93016088|NCT00523848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93016089|NCT00523848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016090|NCT00523848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016091|NCT00523848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93016092|NCT00523848|Immunologic Factors|immunologic factors|mesh-ancestor
93016093|NCT00523848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016094|NCT00523848|Leprostatic Agents|leprostatic agents|mesh-ancestor
93016095|NCT00523848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93016096|NCT00523848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016097|NCT00523848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016098|NCT00523848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016099|NCT00523848|Growth Substances|growth substances|mesh-ancestor
93016100|NCT00523848|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016101|NCT04414722|Amoxicillin|amoxicillin|mesh-list
93016102|NCT04414722|Clavulanic Acid|clavulanic acid|mesh-list
93016103|NCT04414722|Clavulanic Acids|clavulanic acids|mesh-list
93016104|NCT04414722|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93016105|NCT04414722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93016106|NCT04414722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016107|NCT04414722|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93016108|NCT04414722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016109|NCT04414722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016110|NCT00617669|Docetaxel|docetaxel|mesh-list
93016111|NCT00617669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016112|NCT00617669|Tubulin Modulators|tubulin modulators|mesh-ancestor
93016113|NCT00617669|Antimitotic Agents|antimitotic agents|mesh-ancestor
93016114|NCT00617669|Mitosis Modulators|mitosis modulators|mesh-ancestor
93016115|NCT00617669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016116|NCT04018157|Dexmedetomidine|dexmedetomidine|mesh-list
93016117|NCT04018157|Ketamine|ketamine|mesh-list
93016118|NCT04018157|Propofol|propofol|mesh-list
93016119|NCT04018157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93016120|NCT04018157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016121|NCT04018157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016122|NCT04018157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016123|NCT04018157|Analgesics|analgesics|mesh-ancestor
93016124|NCT04018157|Sensory System Agents|sensory system agents|mesh-ancestor
93016125|NCT04018157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016126|NCT04018157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93016127|NCT04018157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93016128|NCT04018157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93016129|NCT04018157|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016130|NCT04018157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016131|NCT04018157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016132|NCT04018157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93016133|NCT04018157|Anesthetics, General|anesthetics, general|mesh-ancestor
93016134|NCT04018157|Anesthetics|anesthetics|mesh-ancestor
93016135|NCT04018157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92173459|NCT03008655|Coagulants|coagulants|mesh-ancestor
93016136|NCT04018157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93016137|NCT04018157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93016138|NCT00865241|Metformin|metformin|mesh-list
93016139|NCT00865241|Glyburide|glyburide|mesh-list
93016140|NCT00865241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93016141|NCT00865241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016142|NCT00863213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93016143|NCT00860639|Gemtuzumab|gemtuzumab|mesh-list
93016144|NCT00860639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93016145|NCT00860639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016146|NCT00860639|Immunotoxins|immunotoxins|mesh-ancestor
93016147|NCT00860639|Immunoconjugates|immunoconjugates|mesh-ancestor
93016148|NCT00860639|Immunologic Factors|immunologic factors|mesh-ancestor
93016149|NCT00860639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016150|NCT00863291|Buprenorphine|buprenorphine|mesh-list
93016151|NCT00863291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93016152|NCT00863291|Narcotics|narcotics|mesh-ancestor
93016153|NCT00863291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016154|NCT00863291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016155|NCT00863291|Analgesics|analgesics|mesh-ancestor
93016156|NCT00863291|Sensory System Agents|sensory system agents|mesh-ancestor
93016157|NCT00863291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016158|NCT00863291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93016159|NCT00865319|Deoxyglucose|deoxyglucose|mesh-list
93016160|NCT00865319|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93016161|NCT00865319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93016162|NCT00865319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016163|NCT00865319|Antimetabolites|antimetabolites|mesh-ancestor
93016164|NCT00865319|Antiviral Agents|antiviral agents|mesh-ancestor
93016165|NCT00865319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016166|NCT03639714|Nivolumab|nivolumab|mesh-list
93016167|NCT03639714|Ipilimumab|ipilimumab|mesh-list
93016168|NCT03639714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93016169|NCT03639714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016170|NCT03639714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93016171|NCT03639714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016172|NCT00861029|Moxifloxacin|moxifloxacin|mesh-list
93016173|NCT00861029|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93016174|NCT00861029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93016175|NCT00861029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016176|NCT00861029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93016177|NCT00861029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93016178|NCT00861029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016179|NCT00861029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016180|NCT00861029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016181|NCT00861029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93016182|NCT00861029|Contraceptive Agents|contraceptive agents|mesh-ancestor
93016183|NCT00861029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93016184|NCT00861029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016185|NCT00861029|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93016186|NCT00861029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93016187|NCT00861029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93016188|NCT00865397|Insulin Detemir|insulin detemir|mesh-list
93016189|NCT00865397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93016190|NCT00865397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016191|NCT00861107|Vaccines|vaccines|mesh-list
93016192|NCT00861107|Immunologic Factors|immunologic factors|mesh-ancestor
93016193|NCT00861107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016194|NCT00510510|Glycopyrrolate|glycopyrrolate|mesh-list
93016195|NCT00510510|Bromides|bromides|mesh-list
93016196|NCT00510510|Anticonvulsants|anticonvulsants|mesh-ancestor
93016197|NCT00510510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93016198|NCT00510510|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93016199|NCT00510510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92661483|NCT00257075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016200|NCT00510510|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016201|NCT00510510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016202|NCT00510510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016203|NCT00510510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016204|NCT04685694|Misoprostol|misoprostol|mesh-list
93016205|NCT04685694|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93016206|NCT04685694|Abortifacient Agents|abortifacient agents|mesh-ancestor
93016207|NCT04685694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93016208|NCT04685694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016209|NCT04685694|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93016210|NCT04685694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016211|NCT04685694|Oxytocics|oxytocics|mesh-ancestor
93016212|NCT00870311|Lithium Carbonate|lithium carbonate|mesh-list
93016213|NCT00870311|Antidepressive Agents|antidepressive agents|mesh-ancestor
93016214|NCT00870311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016215|NCT00870311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016216|NCT00870311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016217|NCT00870311|Antimanic Agents|antimanic agents|mesh-ancestor
93016218|NCT00870311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93016219|NCT00870311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016220|NCT00870311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016221|NCT00865631|Gabapentin|gabapentin|mesh-list
93016222|NCT00865631|Analgesics|analgesics|mesh-ancestor
93016223|NCT00865631|Sensory System Agents|sensory system agents|mesh-ancestor
93016224|NCT00865631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016225|NCT00865631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016226|NCT00865631|Anticonvulsants|anticonvulsants|mesh-ancestor
93016227|NCT00865631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93016228|NCT00865631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93016229|NCT00865631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016230|NCT00865631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016231|NCT00865631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93016232|NCT00865631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93016233|NCT00865631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016234|NCT00865631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016235|NCT00865631|Antimanic Agents|antimanic agents|mesh-ancestor
93016236|NCT00863837|Terlipressin|terlipressin|mesh-list
93016237|NCT00863837|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93016238|NCT00863837|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93016239|NCT00863837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016240|NCT00863837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016241|NCT00863837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016242|NCT00863915|Ramipril|ramipril|mesh-list
93016243|NCT00863915|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93016244|NCT00863915|Protease Inhibitors|protease inhibitors|mesh-ancestor
93016245|NCT00863915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016246|NCT00863915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016247|NCT00863915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016248|NCT01009944|Atenolol|atenolol|mesh-list
93016249|NCT01009944|Lisinopril|lisinopril|mesh-list
93016250|NCT01009944|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93016251|NCT01009944|Protease Inhibitors|protease inhibitors|mesh-ancestor
93016252|NCT01009944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016253|NCT01009944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016254|NCT01009944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016255|NCT01009944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93016256|NCT01009944|Protective Agents|protective agents|mesh-ancestor
93016257|NCT01009944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016258|NCT01009944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93016259|NCT01009944|Sympatholytics|sympatholytics|mesh-ancestor
93016260|NCT01009944|Autonomic Agents|autonomic agents|mesh-ancestor
93016261|NCT01009944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016262|NCT01009944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93016263|NCT01009944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93016264|NCT01009944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93016265|NCT01009944|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016266|NCT01009944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016267|NCT01010022|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93016268|NCT01010022|Plasma Substitutes|plasma substitutes|mesh-ancestor
93016269|NCT01010022|Blood Substitutes|blood substitutes|mesh-ancestor
93016270|NCT00864071|Griseofulvin|griseofulvin|mesh-list
93016271|NCT00864071|Antifungal Agents|antifungal agents|mesh-ancestor
93016272|NCT00864071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016273|NCT04264026|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93016274|NCT04264026|Hallucinogens|hallucinogens|mesh-ancestor
93016275|NCT04264026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016276|NCT04264026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016277|NCT04264026|Serotonin Agents|serotonin agents|mesh-ancestor
93016278|NCT04264026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016279|NCT04264026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016280|NCT04264026|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93016281|NCT04264026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93016282|NCT04264026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016283|NCT04264026|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016284|NCT00864149|Carvedilol|carvedilol|mesh-list
93016285|NCT00864149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93016286|NCT00864149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93016287|NCT00864149|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016288|NCT00864149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016289|NCT00864149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016290|NCT00864149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016291|NCT00864149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016292|NCT00864149|Antioxidants|antioxidants|mesh-ancestor
93016293|NCT00864149|Protective Agents|protective agents|mesh-ancestor
93016294|NCT00864149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93016295|NCT00864149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016296|NCT00864149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93016297|NCT00864149|Vasodilator Agents|vasodilator agents|mesh-ancestor
93016298|NCT00864149|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93016299|NCT00864149|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93016300|NCT01010100|Acarbose|acarbose|mesh-list
93016301|NCT01010100|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93016302|NCT01010100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016303|NCT01010100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016304|NCT01010100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93016305|NCT01010100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016306|NCT00870779|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93016307|NCT00870779|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93016308|NCT00870779|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016309|NCT01010178|Theophylline|theophylline|mesh-list
93016310|NCT01010178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93016311|NCT01010178|Autonomic Agents|autonomic agents|mesh-ancestor
93016312|NCT01010178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016313|NCT01010178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016314|NCT01010178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93016315|NCT01010178|Respiratory System Agents|respiratory system agents|mesh-ancestor
93016316|NCT01010178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93016317|NCT01010178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016318|NCT01010178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016319|NCT01010178|Vasodilator Agents|vasodilator agents|mesh-ancestor
93016320|NCT01010178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93016321|NCT01010178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93016322|NCT01010178|Purinergic Agents|purinergic agents|mesh-ancestor
93016323|NCT01010178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016324|NCT00617591|Dexamethasone|dexamethasone|mesh-list
93016325|NCT00617591|Doxorubicin|doxorubicin|mesh-list
93016326|NCT00617591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93016327|NCT00617591|Lenalidomide|lenalidomide|mesh-list
93016328|NCT00617591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016329|NCT00617591|Antiemetics|antiemetics|mesh-ancestor
93016330|NCT00617591|Autonomic Agents|autonomic agents|mesh-ancestor
93016331|NCT00617591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016332|NCT00617591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016333|NCT00617591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016334|NCT00617591|Glucocorticoids|glucocorticoids|mesh-ancestor
93016335|NCT00617591|Hormones|hormones|mesh-ancestor
93016336|NCT00617591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016337|NCT00617591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93016338|NCT00617591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016339|NCT00617591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93016340|NCT00617591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93016341|NCT00617591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93016342|NCT00617591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016343|NCT00617591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016344|NCT00617591|Immunologic Factors|immunologic factors|mesh-ancestor
93016345|NCT00617591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016346|NCT00617591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016347|NCT00617591|Growth Substances|growth substances|mesh-ancestor
93016348|NCT00617591|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016349|NCT00864305|Gabapentin|gabapentin|mesh-list
93016350|NCT00864305|Analgesics|analgesics|mesh-ancestor
93016351|NCT00864305|Sensory System Agents|sensory system agents|mesh-ancestor
93016352|NCT00864305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016353|NCT00864305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016354|NCT00864305|Anticonvulsants|anticonvulsants|mesh-ancestor
93016355|NCT00864305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93016356|NCT00864305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93016357|NCT00864305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016358|NCT00864305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016359|NCT00864305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93016360|NCT00864305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93016361|NCT00864305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016362|NCT00864305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016363|NCT00864305|Antimanic Agents|antimanic agents|mesh-ancestor
93016364|NCT00510276|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93016365|NCT00510276|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93016366|NCT00510276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93016367|NCT00510276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016368|NCT00510276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016369|NCT00510276|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016370|NCT00510276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016371|NCT00510276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016372|NCT00864617|Nifedipine|nifedipine|mesh-list
93016373|NCT00864617|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93016374|NCT00864617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016375|NCT00864617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016376|NCT00864617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93016377|NCT00864617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016378|NCT00864617|Vasodilator Agents|vasodilator agents|mesh-ancestor
93016379|NCT00864617|Tocolytic Agents|tocolytic agents|mesh-ancestor
93016380|NCT00864617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93016381|NCT00865943|Dexetimide|dexetimide|mesh-list
93016382|NCT00865943|Citalopram|citalopram|mesh-list
92173662|NCT04881474|Ibuprofen|ibuprofen|mesh-list
93016383|NCT00865943|Escitalopram|escitalopram|mesh-list
93016384|NCT00865943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93016385|NCT00865943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93016386|NCT00865943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016387|NCT00865943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016388|NCT00865943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016389|NCT00865943|Serotonin Agents|serotonin agents|mesh-ancestor
93016390|NCT00865943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016391|NCT00865943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93016392|NCT00865943|Antidepressive Agents|antidepressive agents|mesh-ancestor
93016393|NCT00865943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016394|NCT00865943|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93016395|NCT00865943|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93016396|NCT00865943|Parasympatholytics|parasympatholytics|mesh-ancestor
93016397|NCT00865943|Autonomic Agents|autonomic agents|mesh-ancestor
93016398|NCT00865943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016399|NCT00865943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93016400|NCT00865943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93016401|NCT00865943|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016402|NCT00866021|Ritonavir|ritonavir|mesh-list
93016403|NCT00866021|Lopinavir|lopinavir|mesh-list
93016404|NCT00866021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93016405|NCT00866021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93016406|NCT00866021|Protease Inhibitors|protease inhibitors|mesh-ancestor
93016407|NCT00866021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016408|NCT00866021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016409|NCT00866021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93016410|NCT00866021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93016411|NCT00866021|Antiviral Agents|antiviral agents|mesh-ancestor
93016412|NCT00866021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016413|NCT00866021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93016414|NCT00866021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93016415|NCT00871247|Finasteride|finasteride|mesh-list
93016416|NCT00871247|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93016417|NCT00871247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93016418|NCT00871247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016419|NCT00871247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661721|NCT00290628|Antiemetics|antiemetics|mesh-ancestor
93016420|NCT00871247|Hormone Antagonists|hormone antagonists|mesh-ancestor
93016421|NCT00871247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016422|NCT00871247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016423|NCT00871247|Urological Agents|urological agents|mesh-ancestor
93016424|NCT02543879|Azacitidine|azacitidine|mesh-list
93016425|NCT02543879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93016426|NCT02543879|Antimetabolites|antimetabolites|mesh-ancestor
93016427|NCT02543879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016428|NCT02543879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016429|NCT02543879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016430|NCT04137120|Aflibercept|aflibercept|mesh-list
93016431|NCT04137120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92173687|NCT04881006|Dapagliflozin|dapagliflozin|mesh-list
93016432|NCT04137120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016433|NCT04137120|Growth Substances|growth substances|mesh-ancestor
93016434|NCT04137120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016435|NCT04137120|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016436|NCT04137120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016437|NCT00616655|Eszopiclone|eszopiclone|mesh-list
93016438|NCT00616655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93016439|NCT00616655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016440|NCT00616655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016441|NCT00864773|Endothelial Growth Factors|endothelial growth factors|mesh-list
93016442|NCT00864773|Growth Substances|growth substances|mesh-ancestor
93016443|NCT00864773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016444|NCT01010490|Dipivefrin|dipivefrin|mesh-list
93016445|NCT01010490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93016446|NCT01010490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016447|NCT01010490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016448|NCT01010490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016449|NCT01010490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016451|NCT00516048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93016452|NCT00516048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016453|NCT00516048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93016454|NCT00516048|Incretins|incretins|mesh-ancestor
93016455|NCT00516048|Hormones|hormones|mesh-ancestor
93016456|NCT00516048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016457|NCT00871949|Oxazolidinones|oxazolidinones|mesh-list
93016458|NCT00871949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016459|NCT00871949|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93016460|NCT00871949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016461|NCT00871949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016462|NCT00865007|Ritonavir|ritonavir|mesh-list
93016463|NCT00865007|Lopinavir|lopinavir|mesh-list
93016464|NCT00865007|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93016465|NCT00865007|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93016466|NCT00865007|Protease Inhibitors|protease inhibitors|mesh-ancestor
93016467|NCT00865007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016468|NCT00865007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016469|NCT00865007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93016470|NCT00865007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93016471|NCT00865007|Antiviral Agents|antiviral agents|mesh-ancestor
93016472|NCT00865007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016473|NCT00865007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93016474|NCT00865007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93016475|NCT00872417|Lamivudine|lamivudine|mesh-list
93016476|NCT00872417|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93016477|NCT00872417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93016478|NCT00872417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016479|NCT00872417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016480|NCT00872417|Antiviral Agents|antiviral agents|mesh-ancestor
93016481|NCT00872417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016482|NCT00872417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93016483|NCT00872417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93016484|NCT00876317|Etoricoxib|etoricoxib|mesh-list
92173710|NCT01395537|Antimitotic Agents|antimitotic agents|mesh-ancestor
93016485|NCT00876317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93016486|NCT00876317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016487|NCT00876317|Analgesics|analgesics|mesh-ancestor
93016488|NCT00876317|Sensory System Agents|sensory system agents|mesh-ancestor
93016489|NCT00876317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016490|NCT00876317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016491|NCT00876317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016492|NCT00876317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016493|NCT00876317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93016494|NCT00876317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93016495|NCT00876317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016496|NCT00876317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016497|NCT00866645|Haloperidol|haloperidol|mesh-list
93016498|NCT00866645|Haloperidol decanoate|haloperidol decanoate|mesh-list
93016499|NCT00866645|Sulpiride|sulpiride|mesh-list
93016500|NCT00866645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93016501|NCT00866645|Antiemetics|antiemetics|mesh-ancestor
93016502|NCT00866645|Autonomic Agents|autonomic agents|mesh-ancestor
93016503|NCT00866645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016504|NCT00866645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016505|NCT00866645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016506|NCT00866645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93016507|NCT00866645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93016508|NCT00866645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016509|NCT00866645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016510|NCT00866645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93016511|NCT00866645|Dopamine Agents|dopamine agents|mesh-ancestor
93016512|NCT00866645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016513|NCT00866645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016514|NCT00866645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93016515|NCT00866645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93016516|NCT00866645|Antidepressive Agents|antidepressive agents|mesh-ancestor
93016517|NCT00872651|Timolol|timolol|mesh-list
93016518|NCT00872651|Travoprost|travoprost|mesh-list
93016519|NCT00872651|Latanoprost|latanoprost|mesh-list
93016520|NCT00872651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93016521|NCT00872651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93016522|NCT00872651|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016523|NCT00872651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016524|NCT00872651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016525|NCT00872651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016526|NCT00872651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93016527|NCT00872651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016528|NCT00872651|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93016529|NCT00872651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93016530|NCT00872963|Vaccines|vaccines|mesh-list
93016531|NCT00872963|Immunologic Factors|immunologic factors|mesh-ancestor
93016532|NCT00872963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016533|NCT00873197|Granisetron|granisetron|mesh-list
93016534|NCT00873197|Antiemetics|antiemetics|mesh-ancestor
93016535|NCT00873197|Autonomic Agents|autonomic agents|mesh-ancestor
93016536|NCT00873197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016537|NCT00873197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016538|NCT00873197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016539|NCT00873197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93016540|NCT00873197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93016541|NCT00873197|Serotonin Agents|serotonin agents|mesh-ancestor
93016542|NCT00873197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016543|NCT00873197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016544|NCT00873353|Capecitabine|capecitabine|mesh-list
93016545|NCT00873353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93016546|NCT00873353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93016547|NCT00873353|Antimetabolites|antimetabolites|mesh-ancestor
93016548|NCT00873353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016549|NCT00873353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016550|NCT00873353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93016551|NCT00873353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016552|NCT00877097|Clodronic Acid|clodronic acid|mesh-list
93016553|NCT00877097|Trisequens|trisequens|mesh-list
93016554|NCT00877097|Norethindrone|norethindrone|mesh-list
93016555|NCT00877097|Estradiol|estradiol|mesh-list
93016556|NCT00877097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93016557|NCT00877097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016558|NCT00877097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93016559|NCT00877097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93016560|NCT00877097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93016561|NCT00877097|Contraceptive Agents|contraceptive agents|mesh-ancestor
93016562|NCT00877097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93016563|NCT00877097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93016564|NCT00877097|Estrogens|estrogens|mesh-ancestor
93016565|NCT00877097|Hormones|hormones|mesh-ancestor
93016566|NCT00877097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016567|NCT00877097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93016568|NCT00877175|Phenylephrine|phenylephrine|mesh-list
93016569|NCT00877175|Oxymetazoline|oxymetazoline|mesh-list
93016570|NCT00877175|Tropicamide|tropicamide|mesh-list
93016571|NCT00877175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93016572|NCT00877175|Mydriatics|mydriatics|mesh-ancestor
93016573|NCT00877175|Autonomic Agents|autonomic agents|mesh-ancestor
93016574|NCT00877175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016575|NCT00877175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016576|NCT00877175|Sympathomimetics|sympathomimetics|mesh-ancestor
93016577|NCT00877175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93016578|NCT00877175|Nasal Decongestants|nasal decongestants|mesh-ancestor
93016579|NCT00877175|Respiratory System Agents|respiratory system agents|mesh-ancestor
93016580|NCT00877175|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93016581|NCT00877175|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93016582|NCT00877175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93016583|NCT00877175|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016584|NCT00877175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016585|NCT00877175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016586|NCT00877175|Protective Agents|protective agents|mesh-ancestor
93016587|NCT00877175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93016588|NCT00877175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93016589|NCT00877175|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016591|NCT00420927|Methotrexate|methotrexate|mesh-list
92528762|NCT00037180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016592|NCT00420927|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93016593|NCT00420927|Abortifacient Agents|abortifacient agents|mesh-ancestor
93016594|NCT00420927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93016595|NCT00420927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016596|NCT00420927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93016597|NCT00420927|Antimetabolites|antimetabolites|mesh-ancestor
93016598|NCT00420927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016599|NCT00420927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016600|NCT00420927|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016601|NCT00420927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016602|NCT00420927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93016603|NCT00420927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93016604|NCT00420927|Immunologic Factors|immunologic factors|mesh-ancestor
93016605|NCT00420927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016606|NCT00420927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93016607|NCT00420927|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93016608|NCT00420927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016610|NCT00573443|Quinidine gluconate|quinidine gluconate|mesh-list
93016611|NCT00573443|Dextromethorphan|dextromethorphan|mesh-list
93016612|NCT00573443|Antitussive Agents|antitussive agents|mesh-ancestor
93016613|NCT00573443|Respiratory System Agents|respiratory system agents|mesh-ancestor
93016614|NCT00573443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93016615|NCT00573443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93016616|NCT00573443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016617|NCT00573443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016618|NCT00573443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016619|NCT00573443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93016620|NCT00573443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93016621|NCT00573443|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016622|NCT00573443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93016623|NCT00573443|Antimalarials|antimalarials|mesh-ancestor
93016624|NCT00573443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93016625|NCT00573443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93016626|NCT00573443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016627|NCT00573443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016628|NCT00573443|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93016629|NCT00573443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93016630|NCT00573443|Cholinergic Agents|cholinergic agents|mesh-ancestor
93016631|NCT00573443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93016632|NCT00573443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93016633|NCT00573443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016634|NCT00573443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93016635|NCT00573443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93016636|NCT05225831|Cyclophosphamide|cyclophosphamide|mesh-list
93016637|NCT05225831|Fludarabine|fludarabine|mesh-list
93016638|NCT05225831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93016639|NCT05225831|Immunologic Factors|immunologic factors|mesh-ancestor
93016640|NCT05225831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016641|NCT05225831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016642|NCT05225831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93016643|NCT05225831|Alkylating Agents|alkylating agents|mesh-ancestor
93016644|NCT05225831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016645|NCT05225831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016646|NCT05225831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93016647|NCT00873509|Buspirone|buspirone|mesh-list
93016648|NCT00873509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93016649|NCT00873509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93016650|NCT00873509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016651|NCT00873509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016652|NCT00873509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016653|NCT00873509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93016654|NCT00873509|Serotonin Agents|serotonin agents|mesh-ancestor
93016655|NCT00873509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016656|NCT00873509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016657|NCT00877253|Carboplatin|carboplatin|mesh-list
93016658|NCT00877253|genexol-PM|genexol-pm|mesh-list
93016659|NCT00877253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016660|NCT00877253|Tubulin Modulators|tubulin modulators|mesh-ancestor
93016661|NCT00877253|Antimitotic Agents|antimitotic agents|mesh-ancestor
93016662|NCT00877253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92528764|NCT00037180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93016663|NCT00877253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016665|NCT05225753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93016666|NCT05225753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016667|NCT05225753|Analgesics|analgesics|mesh-ancestor
93016668|NCT05225753|Sensory System Agents|sensory system agents|mesh-ancestor
93016669|NCT05225753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016670|NCT05225753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016671|NCT05225753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016672|NCT05225753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016673|NCT00877409|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93016674|NCT00877409|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016675|NCT00874133|Domperidone|domperidone|mesh-list
93016676|NCT00874133|Antiemetics|antiemetics|mesh-ancestor
93016677|NCT00874133|Autonomic Agents|autonomic agents|mesh-ancestor
93016678|NCT00874133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016679|NCT00874133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016680|NCT00874133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016681|NCT00874133|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93016682|NCT00874133|Dopamine Agents|dopamine agents|mesh-ancestor
93016683|NCT00874133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016684|NCT00874133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016685|NCT00867737|Fluticasone|fluticasone|mesh-list
93016686|NCT00867737|Budesonide|budesonide|mesh-list
93016687|NCT00867737|Formoterol Fumarate|formoterol fumarate|mesh-list
93016688|NCT00867737|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93016689|NCT00867737|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93016690|NCT00867737|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93016691|NCT00867737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016692|NCT00867737|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93016693|NCT00867737|Autonomic Agents|autonomic agents|mesh-ancestor
93016694|NCT00867737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016695|NCT00867737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016696|NCT00867737|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93016697|NCT00867737|Respiratory System Agents|respiratory system agents|mesh-ancestor
93016698|NCT00867737|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016699|NCT00867737|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93016700|NCT00867737|Glucocorticoids|glucocorticoids|mesh-ancestor
93016701|NCT00867737|Hormones|hormones|mesh-ancestor
93016702|NCT00867737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016703|NCT00867737|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93016704|NCT00867737|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93016705|NCT00867737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93016706|NCT00867737|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016707|NCT00867737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016708|NCT00867737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016709|NCT00867737|Sympathomimetics|sympathomimetics|mesh-ancestor
93016710|NCT04551677|Vaccines|vaccines|mesh-list
93016711|NCT04551677|Immunologic Factors|immunologic factors|mesh-ancestor
93016712|NCT04551677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016713|NCT04040465|Aspirin|aspirin|mesh-list
93016714|NCT04040465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93016715|NCT04040465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016716|NCT04040465|Analgesics|analgesics|mesh-ancestor
93016717|NCT04040465|Sensory System Agents|sensory system agents|mesh-ancestor
93016718|NCT04040465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016719|NCT04040465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016720|NCT04040465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016721|NCT04040465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016722|NCT04040465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93016723|NCT04040465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93016724|NCT04040465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016725|NCT04040465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93016726|NCT04040465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93016727|NCT04040465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016729|NCT00420849|Dexamethasone|dexamethasone|mesh-list
93016730|NCT00420849|Lenalidomide|lenalidomide|mesh-list
93016731|NCT00420849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016732|NCT00420849|Antiemetics|antiemetics|mesh-ancestor
93016733|NCT00420849|Autonomic Agents|autonomic agents|mesh-ancestor
93016734|NCT00420849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016735|NCT00420849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173904|NCT01895023|Anesthetics|anesthetics|mesh-ancestor
93016737|NCT00420849|Glucocorticoids|glucocorticoids|mesh-ancestor
93016738|NCT00420849|Hormones|hormones|mesh-ancestor
93016739|NCT00420849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016740|NCT00420849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93016741|NCT00420849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016742|NCT00420849|Immunologic Factors|immunologic factors|mesh-ancestor
93016743|NCT00420849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016744|NCT00420849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016745|NCT00420849|Growth Substances|growth substances|mesh-ancestor
93016746|NCT00420849|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016747|NCT00874523|Raltegravir Potassium|raltegravir potassium|mesh-list
93016748|NCT00874523|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93016749|NCT00874523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93016750|NCT00874523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93016751|NCT00874523|Antiviral Agents|antiviral agents|mesh-ancestor
93016752|NCT00874523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016753|NCT00874523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93016754|NCT00874523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93016755|NCT00874523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016756|NCT00874523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016757|NCT00874523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93016758|NCT00874523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93016759|NCT00874523|Protease Inhibitors|protease inhibitors|mesh-ancestor
93016760|NCT00874601|Valsartan|valsartan|mesh-list
93016761|NCT00874601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016762|NCT00874601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93016763|NCT00874601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93016764|NCT00874601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016765|NCT00874679|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93016766|NCT00874679|Vasodilator Agents|vasodilator agents|mesh-ancestor
93016767|NCT00874679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93016768|NCT00874679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93016769|NCT00874679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016770|NCT00874679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016771|NCT00874679|Urological Agents|urological agents|mesh-ancestor
93016772|NCT00617201|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93016773|NCT00617201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93016774|NCT00617201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93016775|NCT00617201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173932|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
93016776|NCT00617201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016777|NCT00617201|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016778|NCT00617201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016779|NCT00617201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016780|NCT00420303|Etanercept|etanercept|mesh-list
93016781|NCT00420303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93016782|NCT00420303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016783|NCT00420303|Analgesics|analgesics|mesh-ancestor
93016784|NCT00420303|Sensory System Agents|sensory system agents|mesh-ancestor
93016785|NCT00420303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016786|NCT00420303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016787|NCT00420303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016788|NCT00420303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016789|NCT00420303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016790|NCT00420303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662083|NCT00258245|BB 1101|bb 1101|mesh-list
93016791|NCT00420303|Immunologic Factors|immunologic factors|mesh-ancestor
93016792|NCT00617123|Vorapaxar|vorapaxar|mesh-list
93016793|NCT00617123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93016794|NCT00877955|Alprazolam|alprazolam|mesh-list
93016795|NCT00877955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93016796|NCT00877955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016797|NCT00877955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016798|NCT00877955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93016799|NCT00877955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93016800|NCT00877955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93016801|NCT00877955|GABA Modulators|gaba modulators|mesh-ancestor
93016802|NCT00877955|GABA Agents|gaba agents|mesh-ancestor
93016803|NCT00877955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016804|NCT00877955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016805|NCT00419757|Budesonide|budesonide|mesh-list
93016806|NCT00419757|Formoterol Fumarate|formoterol fumarate|mesh-list
93016807|NCT00419757|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93016808|NCT00419757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016809|NCT00419757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93016810|NCT00419757|Autonomic Agents|autonomic agents|mesh-ancestor
93016811|NCT00419757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016812|NCT00419757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016813|NCT00419757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93016814|NCT00419757|Respiratory System Agents|respiratory system agents|mesh-ancestor
93016815|NCT00419757|Glucocorticoids|glucocorticoids|mesh-ancestor
93016816|NCT00419757|Hormones|hormones|mesh-ancestor
92173966|NCT01475643|Prednisolone phosphate|prednisolone phosphate|mesh-list
93016817|NCT00419757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93016818|NCT00419757|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93016819|NCT00419757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93016820|NCT00419757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93016821|NCT00419757|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016822|NCT00419757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016823|NCT00419757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016824|NCT00434109|Sunitinib|sunitinib|mesh-list
93016825|NCT00434109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016826|NCT00434109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016827|NCT00434109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016828|NCT00434109|Growth Substances|growth substances|mesh-ancestor
93016829|NCT00434109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016830|NCT00434109|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016831|NCT00434109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93016832|NCT00434109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016833|NCT00434109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016834|NCT00875069|Ethanol|ethanol|mesh-list
93016835|NCT00875069|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93016836|NCT00875069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016837|NCT00875069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016838|NCT00875069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016839|NCT01029639|Insulin|insulin|mesh-list
93016840|NCT01029639|Insulin Aspart|insulin aspart|mesh-list
93016841|NCT01029639|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93016842|NCT01029639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93016843|NCT01029639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016844|NCT00875147|Bevacizumab|bevacizumab|mesh-list
93016845|NCT00875147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93016846|NCT00875147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016847|NCT00875147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016848|NCT00875147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016849|NCT00875147|Growth Substances|growth substances|mesh-ancestor
93016850|NCT00875147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016851|NCT00875147|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016852|NCT00433329|Bosentan|bosentan|mesh-list
93016853|NCT00433329|Sildenafil Citrate|sildenafil citrate|mesh-list
92174001|NCT04395222|Melphalan|melphalan|mesh-list
93016854|NCT00433329|Vasodilator Agents|vasodilator agents|mesh-ancestor
93016855|NCT00433329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93016856|NCT00433329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93016857|NCT00433329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016858|NCT00433329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016859|NCT00433329|Urological Agents|urological agents|mesh-ancestor
93016860|NCT00433329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93016861|NCT00433329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93016862|NCT01035021|Rocuronium|rocuronium|mesh-list
93016863|NCT01035021|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93016864|NCT01035021|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93016865|NCT01035021|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93016866|NCT01035021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016867|NCT01035021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016869|NCT00878345|Dexmedetomidine|dexmedetomidine|mesh-list
93016870|NCT00878345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93016871|NCT00878345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93016872|NCT00878345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016873|NCT00878345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016874|NCT00878345|Analgesics|analgesics|mesh-ancestor
93016875|NCT00878345|Sensory System Agents|sensory system agents|mesh-ancestor
93016876|NCT00878345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016877|NCT00878345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93016878|NCT00878345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93016879|NCT00878345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93016880|NCT00878345|Adrenergic Agents|adrenergic agents|mesh-ancestor
93016881|NCT00878345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93016882|NCT00878345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016883|NCT00878345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93016884|NCT00878345|GABA Modulators|gaba modulators|mesh-ancestor
93016885|NCT00878345|GABA Agents|gaba agents|mesh-ancestor
93016886|NCT00433017|Ranibizumab|ranibizumab|mesh-list
93016887|NCT00433017|Verteporfin|verteporfin|mesh-list
93016888|NCT00433017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016889|NCT00433017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016890|NCT00433017|Growth Substances|growth substances|mesh-ancestor
93016891|NCT00433017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016892|NCT00433017|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016893|NCT00433017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016894|NCT00433017|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93016895|NCT00433017|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016896|NCT03726671|Choline|choline|mesh-list
93016897|NCT03726671|Lipotropic Agents|lipotropic agents|mesh-ancestor
93016898|NCT03726671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93016899|NCT03726671|Antimetabolites|antimetabolites|mesh-ancestor
93016900|NCT03726671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016901|NCT03726671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016902|NCT03726671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93016903|NCT03726671|Nootropic Agents|nootropic agents|mesh-ancestor
93016904|NCT00868283|Cerebrolysin|cerebrolysin|mesh-list
93016905|NCT00868283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93016906|NCT00868283|Protective Agents|protective agents|mesh-ancestor
93016907|NCT00868283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016908|NCT00868283|Nootropic Agents|nootropic agents|mesh-ancestor
93016909|NCT04039373|Mycophenolic Acid|mycophenolic acid|mesh-list
93016910|NCT04039373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93016911|NCT04039373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016912|NCT04039373|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93016913|NCT04039373|Antitubercular Agents|antitubercular agents|mesh-ancestor
93016914|NCT04039373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93016915|NCT04039373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016916|NCT04039373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016917|NCT04039373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016918|NCT00875537|Capsaicin|capsaicin|mesh-list
93016919|NCT00875537|Antipruritics|antipruritics|mesh-ancestor
93016920|NCT00875537|Dermatologic Agents|dermatologic agents|mesh-ancestor
93016921|NCT00875537|Sensory System Agents|sensory system agents|mesh-ancestor
93016922|NCT00875537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016923|NCT00875537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016924|NCT00875771|Bevacizumab|bevacizumab|mesh-list
93016925|NCT00875771|Capecitabine|capecitabine|mesh-list
93016926|NCT00875771|Irinotecan|irinotecan|mesh-list
93016927|NCT00875771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93016928|NCT00875771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016929|NCT00875771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93016930|NCT00875771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93016931|NCT00875771|Growth Substances|growth substances|mesh-ancestor
93016932|NCT00875771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016933|NCT00875771|Growth Inhibitors|growth inhibitors|mesh-ancestor
93016934|NCT00875771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93016935|NCT00875771|Antimetabolites|antimetabolites|mesh-ancestor
93016936|NCT00875771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016937|NCT00875771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93016938|NCT00875771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92662237|NCT01339273|Sensory System Agents|sensory system agents|mesh-ancestor
93016939|NCT00875771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016940|NCT00875849|Cetuximab|cetuximab|mesh-list
93016941|NCT00875849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016942|NCT00875849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93016943|NCT00875927|Zinc|zinc|mesh-list
93016944|NCT00875927|Propolis|propolis|mesh-list
93016945|NCT00875927|Trace Elements|trace elements|mesh-ancestor
93016946|NCT00875927|Micronutrients|micronutrients|mesh-ancestor
93016947|NCT00875927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016948|NCT00875927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016949|NCT00878657|Gemcitabine|gemcitabine|mesh-list
93016950|NCT00878657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93016951|NCT00878657|Antimetabolites|antimetabolites|mesh-ancestor
93016952|NCT00878657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016953|NCT00878657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016954|NCT00868829|Chromium|chromium|mesh-list
93016956|NCT00868829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93016957|NCT00868829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93016958|NCT00868829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93016959|NCT00868829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93016960|NCT00868829|Antifungal Agents|antifungal agents|mesh-ancestor
93016961|NCT00868829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93016962|NCT00868829|Immunologic Factors|immunologic factors|mesh-ancestor
93016963|NCT00868829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016964|NCT00868829|Trace Elements|trace elements|mesh-ancestor
93016965|NCT00868829|Micronutrients|micronutrients|mesh-ancestor
93016966|NCT00868907|Risedronic Acid|risedronic acid|mesh-list
93016967|NCT00868907|Etidronic Acid|etidronic acid|mesh-list
93016968|NCT00868907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93016969|NCT00868907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93016970|NCT00868907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016971|NCT00868907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93016972|NCT00868907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016973|NCT00868907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93016974|NCT00868985|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93016975|NCT00868985|Laxatives|laxatives|mesh-ancestor
93016976|NCT00868985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93016977|NCT00869063|Diclofenac|diclofenac|mesh-list
93016978|NCT00869063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93016979|NCT00869063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016980|NCT00869063|Analgesics|analgesics|mesh-ancestor
93016981|NCT00869063|Sensory System Agents|sensory system agents|mesh-ancestor
93016982|NCT00869063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016983|NCT00869063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016984|NCT00869063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016985|NCT00869063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016986|NCT00869063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93016987|NCT00869063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93016988|NCT00869063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93016989|NCT00869219|Nepafenac|nepafenac|mesh-list
93016990|NCT00869219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93016991|NCT00869219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93016992|NCT00869219|Analgesics|analgesics|mesh-ancestor
93016993|NCT00869219|Sensory System Agents|sensory system agents|mesh-ancestor
93016994|NCT00869219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93016995|NCT00869219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93016996|NCT00869219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93016997|NCT00869219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93016998|NCT03994965|Pimavanserin|pimavanserin|mesh-list
93016999|NCT03994965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93017000|NCT03994965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93017001|NCT03994965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93017002|NCT03994965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93017003|NCT03994965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017004|NCT03994965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017005|NCT03994965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017006|NCT03994965|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93017007|NCT03994965|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93017008|NCT03994965|Serotonin Agents|serotonin agents|mesh-ancestor
93017009|NCT03994965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017010|NCT03994965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017011|NCT00531284|Dexamethasone|dexamethasone|mesh-list
93017012|NCT00531284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017013|NCT00531284|Antiemetics|antiemetics|mesh-ancestor
92662314|NCT00291369|Analgesics|analgesics|mesh-ancestor
93017015|NCT00531284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017016|NCT00531284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017017|NCT00531284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017018|NCT00531284|Glucocorticoids|glucocorticoids|mesh-ancestor
93017019|NCT00531284|Hormones|hormones|mesh-ancestor
93017020|NCT00531284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017021|NCT00531284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93017022|NCT00531284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017023|NCT00531206|Ritonavir|ritonavir|mesh-list
93017024|NCT00531206|Tipranavir|tipranavir|mesh-list
93017025|NCT00531206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93017026|NCT00531206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93017027|NCT00531206|Protease Inhibitors|protease inhibitors|mesh-ancestor
93017028|NCT00531206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362658|NCT05028075|Cobalt|cobalt|mesh-list
93017029|NCT00531206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017031|NCT00531206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93017032|NCT00531206|Antiviral Agents|antiviral agents|mesh-ancestor
93017033|NCT00531206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017034|NCT00531206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93017035|NCT00531206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93017036|NCT00994994|Tranylcypromine|tranylcypromine|mesh-list
93017037|NCT00994994|Tranexamic Acid|tranexamic acid|mesh-list
93017038|NCT00994994|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
93017039|NCT00994994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93017040|NCT00994994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017041|NCT00994994|Hemostatics|hemostatics|mesh-ancestor
93017042|NCT00994994|Coagulants|coagulants|mesh-ancestor
93017043|NCT00994994|Antidepressive Agents|antidepressive agents|mesh-ancestor
93017044|NCT00994994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017045|NCT00994994|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93017046|NCT00994994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174189|NCT04392102|Niraparib|niraparib|mesh-list
93017047|NCT00994994|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93017048|NCT00994994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93017049|NCT00994994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017050|NCT00994994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017051|NCT00999752|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93017052|NCT00999752|Nebivolol|nebivolol|mesh-list
93017053|NCT00999752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93017054|NCT00999752|Diuretics|diuretics|mesh-ancestor
93017055|NCT00999752|Natriuretic Agents|natriuretic agents|mesh-ancestor
93017056|NCT00999752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017057|NCT00999752|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93017058|NCT00999752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017059|NCT00999752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017060|NCT00999752|Vasodilator Agents|vasodilator agents|mesh-ancestor
93017061|NCT00999752|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93017062|NCT00999752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93017063|NCT00999752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93017064|NCT00999752|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017065|NCT00999752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017066|NCT01005758|Cytarabine|cytarabine|mesh-list
93017067|NCT01005758|Dexamethasone|dexamethasone|mesh-list
93017068|NCT01005758|Prednisone|prednisone|mesh-list
93017069|NCT01005758|Methylprednisolone|methylprednisolone|mesh-list
93017070|NCT01005758|Prednisolone|prednisolone|mesh-list
93017071|NCT01005758|Hydrocortisone|hydrocortisone|mesh-list
93017072|NCT01005758|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93017073|NCT01005758|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93017074|NCT01005758|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93017075|NCT01005758|Cyclophosphamide|cyclophosphamide|mesh-list
93017076|NCT01005758|Doxorubicin|doxorubicin|mesh-list
93017077|NCT01005758|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92174228|NCT02117167|Pemetrexed|pemetrexed|mesh-list
93017078|NCT01005758|Methotrexate|methotrexate|mesh-list
93017079|NCT01005758|Etoposide|etoposide|mesh-list
93017080|NCT01005758|Vincristine|vincristine|mesh-list
93017081|NCT01005758|Imatinib Mesylate|imatinib mesylate|mesh-list
93017082|NCT01005758|Mercaptopurine|mercaptopurine|mesh-list
93017083|NCT01005758|Pegaspargase|pegaspargase|mesh-list
93017084|NCT01005758|Etoposide phosphate|etoposide phosphate|mesh-list
92662387|NCT00259181|Dermatologic Agents|dermatologic agents|mesh-ancestor
93017085|NCT01005758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93017086|NCT01005758|Immunologic Factors|immunologic factors|mesh-ancestor
93017087|NCT01005758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017088|NCT01005758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017089|NCT01005758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93017090|NCT01005758|Alkylating Agents|alkylating agents|mesh-ancestor
93017091|NCT01005758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017092|NCT01005758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017093|NCT01005758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93017094|NCT01005758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017095|NCT01005758|Antiemetics|antiemetics|mesh-ancestor
93017096|NCT01005758|Autonomic Agents|autonomic agents|mesh-ancestor
93017097|NCT01005758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017098|NCT01005758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017099|NCT01005758|Glucocorticoids|glucocorticoids|mesh-ancestor
93017100|NCT01005758|Hormones|hormones|mesh-ancestor
93017101|NCT01005758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017102|NCT01005758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93017103|NCT01005758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93017104|NCT01005758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93017105|NCT01005758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93017106|NCT01005758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017107|NCT01005758|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93017108|NCT01005758|Abortifacient Agents|abortifacient agents|mesh-ancestor
93017109|NCT01005758|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93017110|NCT01005758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93017111|NCT01005758|Antimetabolites|antimetabolites|mesh-ancestor
93017112|NCT01005758|Dermatologic Agents|dermatologic agents|mesh-ancestor
93017113|NCT01005758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93017114|NCT01005758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93017115|NCT01005758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93017116|NCT01005758|Antiviral Agents|antiviral agents|mesh-ancestor
93017117|NCT01005758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017118|NCT01005758|Tubulin Modulators|tubulin modulators|mesh-ancestor
93017119|NCT01005758|Antimitotic Agents|antimitotic agents|mesh-ancestor
93017120|NCT01005758|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174267|NCT04885764|Vaccines|vaccines|mesh-list
93017121|NCT01005758|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93017122|NCT01005758|Protective Agents|protective agents|mesh-ancestor
93017123|NCT01005758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93017124|NCT00879047|Ethanol|ethanol|mesh-list
93017125|NCT00879047|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93017126|NCT00879047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017127|NCT00879047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017128|NCT00879047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017129|NCT00999986|Cyclophosphamide|cyclophosphamide|mesh-list
93017130|NCT00999986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93017131|NCT00999986|Immunologic Factors|immunologic factors|mesh-ancestor
93017132|NCT00999986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017133|NCT00999986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017134|NCT00999986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93017135|NCT00999986|Alkylating Agents|alkylating agents|mesh-ancestor
93017136|NCT00999986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017137|NCT00999986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017138|NCT00999986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93017139|NCT01000220|Omeprazole|omeprazole|mesh-list
93017140|NCT01000220|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93017141|NCT01000220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017142|NCT01000220|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93017143|NCT01000220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017144|NCT01000220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017145|NCT01006694|Antidepressive Agents|antidepressive agents|mesh-list
93017146|NCT01006694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017147|NCT01000298|Amoxicillin|amoxicillin|mesh-list
93017148|NCT01000298|Cefdinir|cefdinir|mesh-list
93017149|NCT01000298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93017150|NCT01000298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017151|NCT00614939|Saxagliptin|saxagliptin|mesh-list
93017152|NCT00614939|Incretins|incretins|mesh-ancestor
93017153|NCT00614939|Hormones|hormones|mesh-ancestor
93017154|NCT00614939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017155|NCT00614939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017156|NCT00614939|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93017157|NCT00614939|Protease Inhibitors|protease inhibitors|mesh-ancestor
93017158|NCT00614939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174304|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
93017159|NCT00614939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017160|NCT00614939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93017161|NCT05176964|Capecitabine|capecitabine|mesh-list
93017162|NCT05176964|Oxaliplatin|oxaliplatin|mesh-list
93017163|NCT05176964|Tislelizumab|tislelizumab|mesh-list
92662460|NCT04709081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93017164|NCT05176964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93017165|NCT05176964|Antimetabolites|antimetabolites|mesh-ancestor
93017166|NCT05176964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017167|NCT05176964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017168|NCT05176964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017169|NCT00879827|PENTA|penta|mesh-list
93017170|NCT00879827|Anticoagulants|anticoagulants|mesh-ancestor
93017171|NCT00879827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93017172|NCT00879827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93017173|NCT00879827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017174|NCT01007084|Propranolol|propranolol|mesh-list
93017175|NCT01007084|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93017176|NCT01007084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93017177|NCT01007084|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017178|NCT01007084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017179|NCT01007084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017180|NCT01007084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017181|NCT01007084|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93017182|NCT01007084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93017183|NCT01007084|Vasodilator Agents|vasodilator agents|mesh-ancestor
93017185|NCT04040309|Anesthetics, Local|anesthetics, local|mesh-ancestor
93017186|NCT04040309|Anesthetics|anesthetics|mesh-ancestor
93017187|NCT04040309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017188|NCT04040309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017189|NCT04040309|Sensory System Agents|sensory system agents|mesh-ancestor
93017190|NCT04040309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017191|NCT04040309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93017192|NCT04040309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93017193|NCT04040309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93017194|NCT04040309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017195|NCT04040309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017196|NCT01000688|Vildagliptin|vildagliptin|mesh-list
93017197|NCT01000688|Acarbose|acarbose|mesh-list
93017198|NCT01000688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93017199|NCT01000688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017200|NCT01000688|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93017201|NCT01000688|Protease Inhibitors|protease inhibitors|mesh-ancestor
93017202|NCT01000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017203|NCT01000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017204|NCT01000688|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93017205|NCT00879983|Azithromycin|azithromycin|mesh-list
93017206|NCT00879983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93017207|NCT00879983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017208|NCT00880061|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
93017209|NCT00880061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017210|NCT00869765|Cycloserine|cycloserine|mesh-list
93017211|NCT00869765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93017212|NCT00869765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017213|NCT00869765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93017214|NCT00869765|Antitubercular Agents|antitubercular agents|mesh-ancestor
93017215|NCT00869765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93017216|NCT00869765|Antimetabolites|antimetabolites|mesh-ancestor
93017217|NCT00869765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017218|NCT00880373|Ibuprofen|ibuprofen|mesh-list
93017219|NCT00880373|Morphine|morphine|mesh-list
93017220|NCT00880373|Heroin|heroin|mesh-list
93017221|NCT00880373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93017222|NCT00880373|Narcotics|narcotics|mesh-ancestor
93017223|NCT00880373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017224|NCT00880373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017225|NCT00880373|Analgesics|analgesics|mesh-ancestor
93017226|NCT00880373|Sensory System Agents|sensory system agents|mesh-ancestor
93017227|NCT00880373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017228|NCT00880373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93017229|NCT00880373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93017230|NCT00880373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017231|NCT00880373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017232|NCT00880373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93017233|NCT00880373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017234|NCT00880373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017235|NCT01007630|Rasagiline|rasagiline|mesh-list
93017236|NCT01007630|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93017237|NCT01007630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017238|NCT01007630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017239|NCT01007630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93017240|NCT01007630|Protective Agents|protective agents|mesh-ancestor
93017241|NCT01007630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017242|NCT05883384|Caseins|caseins|mesh-list
93017243|NCT05883384|Chelating Agents|chelating agents|mesh-ancestor
93017244|NCT05883384|Sequestering Agents|sequestering agents|mesh-ancestor
93017245|NCT05883384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017246|NCT05883358|Clonidine|clonidine|mesh-list
93017247|NCT05883358|Buprenorphine|buprenorphine|mesh-list
93017248|NCT05883358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93017250|NCT05883358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017251|NCT05883358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017252|NCT05883358|Analgesics|analgesics|mesh-ancestor
93017253|NCT05883358|Sensory System Agents|sensory system agents|mesh-ancestor
93017254|NCT05883358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017255|NCT05883358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93017256|NCT05883358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93017257|NCT05883358|Sympatholytics|sympatholytics|mesh-ancestor
93017258|NCT05883358|Autonomic Agents|autonomic agents|mesh-ancestor
93017259|NCT05883358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93017260|NCT05883358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93017261|NCT05883358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93017262|NCT05883358|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017263|NCT05883358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017264|NCT05883358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017265|NCT05883345|Immunoglobulins|immunoglobulins|mesh-list
93017266|NCT05883345|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93017267|NCT05883345|Antibodies|antibodies|mesh-list
93017268|NCT05883345|Immunoglobulin G|immunoglobulin g|mesh-list
93017269|NCT05883345|Gastrins|gastrins|mesh-list
93017270|NCT05883345|Immunologic Factors|immunologic factors|mesh-ancestor
93017271|NCT05883345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017272|NCT05883345|Hormones|hormones|mesh-ancestor
93017273|NCT05883345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017274|NCT05883332|Nitrous Oxide|nitrous oxide|mesh-list
93017275|NCT05883332|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93017276|NCT05883332|Anesthetics, General|anesthetics, general|mesh-ancestor
93017277|NCT05883332|Anesthetics|anesthetics|mesh-ancestor
93017278|NCT05883332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017279|NCT05883332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017280|NCT05883332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93017281|NCT05883332|Analgesics|analgesics|mesh-ancestor
93017282|NCT05883332|Sensory System Agents|sensory system agents|mesh-ancestor
93017283|NCT05883332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017284|NCT05883176|Bevacizumab|bevacizumab|mesh-list
93017285|NCT05883176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017286|NCT05883176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017287|NCT05883176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93017288|NCT05883176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93017289|NCT05883176|Growth Substances|growth substances|mesh-ancestor
93017290|NCT05883176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017291|NCT05883176|Growth Inhibitors|growth inhibitors|mesh-ancestor
93017292|NCT05883150|Midazolam|midazolam|mesh-list
93017293|NCT05883150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93017294|NCT05883150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93017295|NCT05883150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017296|NCT05883150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017297|NCT05883150|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93017298|NCT05883150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93017299|NCT05883150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017300|NCT05883150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93017301|NCT05883150|Anesthetics, General|anesthetics, general|mesh-ancestor
93017302|NCT05883150|Anesthetics|anesthetics|mesh-ancestor
93017303|NCT05883150|GABA Modulators|gaba modulators|mesh-ancestor
93017304|NCT05883150|GABA Agents|gaba agents|mesh-ancestor
93017305|NCT05883150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017306|NCT05883150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017307|NCT05883124|Rivastigmine|rivastigmine|mesh-list
93017308|NCT05883124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93017309|NCT05883124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017310|NCT05883124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017311|NCT05883124|Cholinergic Agents|cholinergic agents|mesh-ancestor
93017312|NCT05883124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017313|NCT05883124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017314|NCT05883124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93017315|NCT05883124|Protective Agents|protective agents|mesh-ancestor
93017316|NCT05883046|Performance-Enhancing Substances|performance-enhancing substances|mesh-list
93017317|NCT05883046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017318|NCT05882903|Betamethasone|betamethasone|mesh-list
93017319|NCT05882903|Betamethasone Valerate|betamethasone valerate|mesh-list
93017320|NCT05882903|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93017321|NCT05882903|Betamethasone benzoate|betamethasone benzoate|mesh-list
93017322|NCT05882903|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93017323|NCT05882903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017324|NCT05882903|Glucocorticoids|glucocorticoids|mesh-ancestor
93017325|NCT05882903|Hormones|hormones|mesh-ancestor
93017326|NCT05882903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017327|NCT05882903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017328|NCT05882903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93017329|NCT05882903|Respiratory System Agents|respiratory system agents|mesh-ancestor
93017330|NCT05882864|Triamcinolone|triamcinolone|mesh-list
93017331|NCT05882864|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93017332|NCT05882864|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93017333|NCT05882864|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93017334|NCT05882864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017335|NCT05882864|Glucocorticoids|glucocorticoids|mesh-ancestor
93017336|NCT05882864|Hormones|hormones|mesh-ancestor
93017337|NCT05882864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017338|NCT05882864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017339|NCT05882864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93017340|NCT05882864|Immunologic Factors|immunologic factors|mesh-ancestor
93017341|NCT05882864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017342|NCT05882864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017343|NCT05882734|Cemiplimab|cemiplimab|mesh-list
93017344|NCT05882734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017345|NCT05882734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017346|NCT05882630|Carboplatin|carboplatin|mesh-list
93017347|NCT05882630|Etoposide|etoposide|mesh-list
93017348|NCT05882630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017349|NCT05882630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93017350|NCT05882630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93017351|NCT05882630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93017352|NCT05882630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017353|NCT05882630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017354|NCT05882604|Mesna|mesna|mesh-list
93017355|NCT05882604|Protective Agents|protective agents|mesh-ancestor
93017356|NCT05882604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017357|NCT05881980|Itraconazole|itraconazole|mesh-list
93017358|NCT05881980|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
93017359|NCT05881980|Terbinafine|terbinafine|mesh-list
93017360|NCT05881980|Antifungal Agents|antifungal agents|mesh-ancestor
93017361|NCT05881980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017362|NCT05881980|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93017363|NCT05881980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93017364|NCT05881980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017365|NCT05881980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017366|NCT05881980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93017367|NCT05881980|Hormone Antagonists|hormone antagonists|mesh-ancestor
93017368|NCT05881980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017369|NCT05881980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017370|NCT05881980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93017371|NCT05881915|Phenylephrine|phenylephrine|mesh-list
93017372|NCT05881915|Epinephrine|epinephrine|mesh-list
93017373|NCT05881915|Oxymetazoline|oxymetazoline|mesh-list
93017374|NCT05881915|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93017375|NCT05881915|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93017376|NCT05881915|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017377|NCT05881915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017378|NCT05881915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017379|NCT05881915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017380|NCT05881915|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93017381|NCT05881915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93017382|NCT05881915|Autonomic Agents|autonomic agents|mesh-ancestor
93017383|NCT05881915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017384|NCT05881915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93017385|NCT05881915|Respiratory System Agents|respiratory system agents|mesh-ancestor
93017386|NCT05881915|Mydriatics|mydriatics|mesh-ancestor
93017387|NCT05881915|Sympathomimetics|sympathomimetics|mesh-ancestor
93017388|NCT05881915|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93017389|NCT05881915|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93017390|NCT05881915|Nasal Decongestants|nasal decongestants|mesh-ancestor
93017391|NCT05881915|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93017392|NCT05881915|Protective Agents|protective agents|mesh-ancestor
93017393|NCT05881746|Liver Extracts|liver extracts|mesh-list
93017394|NCT05881746|Hematinics|hematinics|mesh-ancestor
93017395|NCT05881525|Paclitaxel|paclitaxel|mesh-list
93017396|NCT05881525|Cyclophosphamide|cyclophosphamide|mesh-list
93017397|NCT05881525|Fludarabine|fludarabine|mesh-list
93017398|NCT05881525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93017399|NCT05881525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017400|NCT05881525|Tubulin Modulators|tubulin modulators|mesh-ancestor
93017401|NCT05881525|Antimitotic Agents|antimitotic agents|mesh-ancestor
93017402|NCT05881525|Mitosis Modulators|mitosis modulators|mesh-ancestor
93017403|NCT05881525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017404|NCT05881525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93017405|NCT05881525|Immunologic Factors|immunologic factors|mesh-ancestor
93017406|NCT05881525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017407|NCT05881525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017408|NCT05881525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93017409|NCT05881525|Alkylating Agents|alkylating agents|mesh-ancestor
93017410|NCT05881525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93017411|NCT05881265|Venetoclax|venetoclax|mesh-list
93017412|NCT05881265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017413|NCT05881187|Riboflavin|riboflavin|mesh-list
93017414|NCT05881187|Antifungal Agents|antifungal agents|mesh-list
93017415|NCT05881187|Clotrimazole|clotrimazole|mesh-list
93017416|NCT05881187|Miconazole|miconazole|mesh-list
93017417|NCT05881187|Vitamin B Complex|vitamin b complex|mesh-ancestor
93017418|NCT05881187|Vitamins|vitamins|mesh-ancestor
93017419|NCT05881187|Micronutrients|micronutrients|mesh-ancestor
93017420|NCT05881187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017421|NCT05881187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93017422|NCT05881187|Dermatologic Agents|dermatologic agents|mesh-ancestor
93017423|NCT05881187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017424|NCT05881187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93017425|NCT05881187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93017426|NCT05881187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93017427|NCT05881187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017428|NCT05881187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017429|NCT05881187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93017430|NCT05881187|Hormone Antagonists|hormone antagonists|mesh-ancestor
93017431|NCT05881187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017432|NCT05881187|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93017433|NCT05881187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93017434|NCT05881135|Choline|choline|mesh-list
93017435|NCT05881135|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93017436|NCT05881135|Lipotropic Agents|lipotropic agents|mesh-ancestor
93017437|NCT05881135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93017438|NCT05881135|Antimetabolites|antimetabolites|mesh-ancestor
93017439|NCT05881135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017440|NCT05881135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017441|NCT05881135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93017442|NCT05881135|Nootropic Agents|nootropic agents|mesh-ancestor
93017443|NCT05880732|Magnesium Sulfate|magnesium sulfate|mesh-list
93017444|NCT05880732|Analgesics|analgesics|mesh-ancestor
93017445|NCT05880732|Sensory System Agents|sensory system agents|mesh-ancestor
93017446|NCT05880732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017447|NCT05880732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017448|NCT05880732|Anesthetics|anesthetics|mesh-ancestor
93017449|NCT05880732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017450|NCT05880732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93017451|NCT05880732|Anticonvulsants|anticonvulsants|mesh-ancestor
93017452|NCT05880732|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93017453|NCT05880732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017454|NCT05880732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017455|NCT05880732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93017456|NCT05880732|Tocolytic Agents|tocolytic agents|mesh-ancestor
93017457|NCT05880732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93017458|NCT05880706|Osimertinib|osimertinib|mesh-list
93017459|NCT05880706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017460|NCT05880706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93017461|NCT05880706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017462|NCT05880706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017463|NCT05880693|Magnesium Sulfate|magnesium sulfate|mesh-list
93017464|NCT05880693|Dexmedetomidine|dexmedetomidine|mesh-list
93017465|NCT05880693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93017466|NCT05880693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017467|NCT05880693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017468|NCT05880693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93017469|NCT05880693|Analgesics|analgesics|mesh-ancestor
93017470|NCT05880693|Sensory System Agents|sensory system agents|mesh-ancestor
93017471|NCT05880693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017472|NCT05880693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93017473|NCT05880693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93017474|NCT05880693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93017475|NCT05880693|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017476|NCT05880693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017477|NCT05880693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017478|NCT05880693|Anesthetics|anesthetics|mesh-ancestor
93017479|NCT05880693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93017480|NCT05880693|Anticonvulsants|anticonvulsants|mesh-ancestor
93017481|NCT05880693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93017482|NCT05880693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017483|NCT05880693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93017484|NCT05880693|Tocolytic Agents|tocolytic agents|mesh-ancestor
93017485|NCT05880693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93017486|NCT05880459|Magnesium Sulfate|magnesium sulfate|mesh-list
93017487|NCT05880459|Nalbuphine|nalbuphine|mesh-list
93017488|NCT05880459|Propofol|propofol|mesh-list
93017489|NCT05880459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93017490|NCT05880459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017491|NCT05880459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017492|NCT05880459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93017493|NCT05880459|Anesthetics, General|anesthetics, general|mesh-ancestor
93017494|NCT05880459|Anesthetics|anesthetics|mesh-ancestor
93017495|NCT05880459|Analgesics|analgesics|mesh-ancestor
93017496|NCT05880459|Sensory System Agents|sensory system agents|mesh-ancestor
93017497|NCT05880459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017498|NCT05880459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93017499|NCT05880459|Anticonvulsants|anticonvulsants|mesh-ancestor
93017500|NCT05880459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93017501|NCT05880459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017502|NCT05880459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017503|NCT05880459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93017504|NCT05880459|Tocolytic Agents|tocolytic agents|mesh-ancestor
93017505|NCT05880459|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93017506|NCT05880459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93017507|NCT05880459|Narcotics|narcotics|mesh-ancestor
93017508|NCT05880355|Dapansutrile|dapansutrile|mesh-list
93017509|NCT05880355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017510|NCT05880342|Methylphenidate|methylphenidate|mesh-list
93017511|NCT05880342|Reboxetine|reboxetine|mesh-list
93017512|NCT05880342|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93017513|NCT05880342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017514|NCT05880342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93017515|NCT05880342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93017516|NCT05880342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017517|NCT05880342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017518|NCT05880342|Dopamine Agents|dopamine agents|mesh-ancestor
93017519|NCT05880342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017520|NCT05880342|Antidepressive Agents|antidepressive agents|mesh-ancestor
93017521|NCT05880342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017522|NCT05880342|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93017523|NCT05880342|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017524|NCT05880186|Caffeine|caffeine|mesh-list
93017525|NCT05880186|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93017526|NCT05880186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017527|NCT05880186|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93017528|NCT05880186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017529|NCT05880186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017530|NCT05880186|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93017531|NCT05880186|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93017532|NCT05880186|Purinergic Agents|purinergic agents|mesh-ancestor
93017533|NCT05880186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017534|NCT05880082|Cisplatin|cisplatin|mesh-list
93017535|NCT05880082|Carboplatin|carboplatin|mesh-list
92662892|NCT00293163|Hylan|hylan|mesh-list
93017536|NCT05880082|Tislelizumab|tislelizumab|mesh-list
93017537|NCT05880082|Nedaplatin|nedaplatin|mesh-list
93017538|NCT05880082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017539|NCT05880082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017540|NCT05880030|Vitamin D|vitamin d|mesh-list
93017541|NCT05880030|Cholecalciferol|cholecalciferol|mesh-list
93017542|NCT05880030|Vitamins|vitamins|mesh-ancestor
93017543|NCT05880030|Micronutrients|micronutrients|mesh-ancestor
93017544|NCT05880030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017545|NCT05880030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93017546|NCT05880030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93017548|NCT05880017|Bupivacaine|bupivacaine|mesh-list
93017549|NCT05880017|Anesthetics, Local|anesthetics, local|mesh-ancestor
93017550|NCT05880017|Anesthetics|anesthetics|mesh-ancestor
93017551|NCT05880017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017552|NCT05880017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017553|NCT05880017|Sensory System Agents|sensory system agents|mesh-ancestor
93017554|NCT05880017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017555|NCT05880017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93017556|NCT05880017|Narcotics|narcotics|mesh-ancestor
93017557|NCT05880017|Analgesics|analgesics|mesh-ancestor
93017558|NCT05879926|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93017559|NCT05879926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93017560|NCT05879926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017561|NCT05879926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017562|NCT05879926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93017563|NCT05879926|Hormone Antagonists|hormone antagonists|mesh-ancestor
93017564|NCT05879926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017565|NCT05879926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017566|NCT05879796|Cisplatin|cisplatin|mesh-list
93017567|NCT05879796|Endostatins|endostatins|mesh-list
93017568|NCT05879796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017569|NCT05879796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93017570|NCT05879796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93017571|NCT05879796|Growth Substances|growth substances|mesh-ancestor
93017572|NCT05879796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017573|NCT05879796|Growth Inhibitors|growth inhibitors|mesh-ancestor
93017574|NCT05879653|Pembrolizumab|pembrolizumab|mesh-list
93017575|NCT05879653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017576|NCT05879653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017577|NCT05879653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93017578|NCT05879653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017579|NCT05879627|Exatecan|exatecan|mesh-list
93017580|NCT05879627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93017581|NCT05879627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93017582|NCT05879627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017583|NCT05879627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017584|NCT05879627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017585|NCT05879536|Tramadol|tramadol|mesh-list
93017586|NCT05879536|Ondansetron|ondansetron|mesh-list
93017587|NCT05879536|Ropivacaine|ropivacaine|mesh-list
93017588|NCT05879536|Anesthetics, Local|anesthetics, local|mesh-ancestor
93017589|NCT05879536|Anesthetics|anesthetics|mesh-ancestor
93017590|NCT05879536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017591|NCT05879536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017592|NCT05879536|Sensory System Agents|sensory system agents|mesh-ancestor
93017593|NCT05879536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017594|NCT05879536|Antiemetics|antiemetics|mesh-ancestor
93017595|NCT05879536|Autonomic Agents|autonomic agents|mesh-ancestor
93017596|NCT05879536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017597|NCT05879536|Antipruritics|antipruritics|mesh-ancestor
93017598|NCT05879536|Dermatologic Agents|dermatologic agents|mesh-ancestor
93017599|NCT05879536|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93017600|NCT05879536|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93017601|NCT05879536|Serotonin Agents|serotonin agents|mesh-ancestor
93017602|NCT05879536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017603|NCT05879536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017604|NCT05879536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93017605|NCT05879536|Narcotics|narcotics|mesh-ancestor
93017606|NCT05879536|Analgesics|analgesics|mesh-ancestor
93017607|NCT05879367|Eflornithine|eflornithine|mesh-list
93017608|NCT05879367|Temozolomide|temozolomide|mesh-list
93017609|NCT05879367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93017610|NCT05879367|Alkylating Agents|alkylating agents|mesh-ancestor
93017611|NCT05879367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017612|NCT05879367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017613|NCT05879367|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93017614|NCT05879367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93017615|NCT05879367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93017616|NCT05879367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017617|NCT05879367|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
93017618|NCT05879367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017619|NCT05879276|Empagliflozin|empagliflozin|mesh-list
93017620|NCT05879276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93017621|NCT05879276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017622|NCT05879276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93017623|NCT05879276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017624|NCT05879237|Vitamin D|vitamin d|mesh-list
93017625|NCT05879237|Cholecalciferol|cholecalciferol|mesh-list
93017626|NCT05879237|Vitamins|vitamins|mesh-ancestor
93017627|NCT05879237|Micronutrients|micronutrients|mesh-ancestor
93017628|NCT05879237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017629|NCT05879237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93017630|NCT05879237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93017631|NCT05879146|Nirogacestat|nirogacestat|mesh-list
93017632|NCT05879146|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93017633|NCT05879146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017634|NCT05879146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017635|NCT05879068|Paclitaxel|paclitaxel|mesh-list
93017636|NCT05879068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93017637|NCT05879068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017638|NCT05879068|Tubulin Modulators|tubulin modulators|mesh-ancestor
93017639|NCT05879068|Antimitotic Agents|antimitotic agents|mesh-ancestor
93017640|NCT05879068|Mitosis Modulators|mitosis modulators|mesh-ancestor
93017641|NCT05879068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017642|NCT05879029|Rabeprazole|rabeprazole|mesh-list
93017643|NCT05879029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93017644|NCT05879029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017645|NCT05879029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93017646|NCT05879029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017647|NCT05879029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017648|NCT05878977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93017649|NCT05878977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017650|NCT05878977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017651|NCT05878977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017652|NCT05878964|Mitogens|mitogens|mesh-list
93017653|NCT05878964|Mitosis Modulators|mitosis modulators|mesh-ancestor
93017654|NCT05878964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017655|NCT05878951|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93017656|NCT05878951|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93017657|NCT05878951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93017658|NCT05878951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017659|NCT05878951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017660|NCT05878951|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93017661|NCT05878951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017662|NCT05878951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017663|NCT05878951|Cholinergic Agents|cholinergic agents|mesh-ancestor
93017664|NCT05878951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017665|NCT05878535|Metformin|metformin|mesh-list
93017666|NCT05878535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93017667|NCT05878535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017668|NCT05876806|Trametinib|trametinib|mesh-list
93017669|NCT05876806|Dabrafenib|dabrafenib|mesh-list
93017670|NCT05876806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017671|NCT05876806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93017672|NCT05876806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017673|NCT05876806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017674|NCT05876273|Pancrelipase|pancrelipase|mesh-list
93017675|NCT05876273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017676|NCT05875506|Doxycycline|doxycycline|mesh-list
93017677|NCT05875506|Chitosan|chitosan|mesh-list
93017678|NCT05875506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93017679|NCT05875506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017680|NCT05875506|Antimalarials|antimalarials|mesh-ancestor
93017681|NCT05875506|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93017682|NCT05875506|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93017683|NCT05875506|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93017684|NCT05875506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93017685|NCT05875506|Antimetabolites|antimetabolites|mesh-ancestor
93017686|NCT05875506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017687|NCT05875506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93017688|NCT05875506|Chelating Agents|chelating agents|mesh-ancestor
93017689|NCT05875506|Sequestering Agents|sequestering agents|mesh-ancestor
93017690|NCT05875506|Hemostatics|hemostatics|mesh-ancestor
93017691|NCT05875506|Coagulants|coagulants|mesh-ancestor
93017692|NCT05875441|Moxidectin|moxidectin|mesh-list
93017693|NCT05875441|Anthelmintics|anthelmintics|mesh-ancestor
93017694|NCT05875441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93017695|NCT05875441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017696|NCT05875441|Antinematodal Agents|antinematodal agents|mesh-ancestor
93017697|NCT05875350|Anesthetics|anesthetics|mesh-list
93017698|NCT05875350|Anesthetics, Local|anesthetics, local|mesh-list
93017699|NCT05875350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017700|NCT05875350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017701|NCT05875350|Sensory System Agents|sensory system agents|mesh-ancestor
93017702|NCT05875350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017703|NCT05874037|Fluvoxamine|fluvoxamine|mesh-list
93017704|NCT05874037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93017705|NCT05874037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93017706|NCT05874037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017707|NCT05874037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017708|NCT05874037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017709|NCT05874037|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93017710|NCT05874037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93017711|NCT05874037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017712|NCT05874037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017713|NCT05874037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017714|NCT05874037|Serotonin Agents|serotonin agents|mesh-ancestor
93017715|NCT05874037|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93017716|NCT05874037|Antidepressive Agents|antidepressive agents|mesh-ancestor
93017717|NCT05874037|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93017718|NCT05874037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93017719|NCT05874037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017720|NCT05874037|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93017721|NCT05871086|Ubiquinone|ubiquinone|mesh-list
93017722|NCT05871086|Coenzyme Q10|coenzyme q10|mesh-list
93017723|NCT05871086|Micronutrients|micronutrients|mesh-ancestor
93017724|NCT05871086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017725|NCT05871086|Vitamins|vitamins|mesh-ancestor
93017726|NCT05868837|Rituximab|rituximab|mesh-list
93017727|NCT05868837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017728|NCT05868837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017729|NCT05868837|Immunologic Factors|immunologic factors|mesh-ancestor
93017730|NCT05868837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017731|NCT05868837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017732|NCT05866536|BCG Vaccine|bcg vaccine|mesh-list
93017733|NCT05866536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93017734|NCT05866536|Immunologic Factors|immunologic factors|mesh-ancestor
93017735|NCT05866536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017736|NCT05864755|Bevacizumab|bevacizumab|mesh-list
93017737|NCT05864755|Durvalumab|durvalumab|mesh-list
93017738|NCT05864755|Tremelimumab|tremelimumab|mesh-list
93017739|NCT05864755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017740|NCT05864755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017741|NCT05864755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93017742|NCT05864755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93017743|NCT05864755|Growth Substances|growth substances|mesh-ancestor
93017744|NCT05864755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017745|NCT05864755|Growth Inhibitors|growth inhibitors|mesh-ancestor
93017746|NCT05864404|Dexmedetomidine|dexmedetomidine|mesh-list
93017747|NCT05864404|Remifentanil|remifentanil|mesh-list
93017748|NCT05864404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93017749|NCT05864404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017750|NCT05864404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017751|NCT05864404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93017752|NCT05864404|Analgesics|analgesics|mesh-ancestor
93017753|NCT05864404|Sensory System Agents|sensory system agents|mesh-ancestor
93017754|NCT05864404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017755|NCT05864404|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93017756|NCT05864404|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93017757|NCT05864404|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93017758|NCT05864404|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017759|NCT05864404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017760|NCT05864404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017761|NCT05864404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92663064|NCT00299013|Prednisolone|prednisolone|mesh-list
93017762|NCT05864404|Narcotics|narcotics|mesh-ancestor
93017763|NCT05856981|Pembrolizumab|pembrolizumab|mesh-list
93017764|NCT05856981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017765|NCT05856981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017766|NCT05856981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93017767|NCT05856981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017768|NCT05856357|Pyrimethamine|pyrimethamine|mesh-list
93017769|NCT05856357|Sulfadoxine|sulfadoxine|mesh-list
93017770|NCT05856357|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93017771|NCT05856357|Antimalarials|antimalarials|mesh-ancestor
93017772|NCT05856357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93017773|NCT05856357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93017774|NCT05856357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017775|NCT05856357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93017776|NCT05856357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017777|NCT05856357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017778|NCT05856357|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93017779|NCT05846906|Sildenafil Citrate|sildenafil citrate|mesh-list
93017780|NCT05846906|Citric Acid|citric acid|mesh-list
93017781|NCT05846906|Sodium Citrate|sodium citrate|mesh-list
93017782|NCT05846906|Clomiphene|clomiphene|mesh-list
93017783|NCT05846906|Enclomiphene|enclomiphene|mesh-list
93017784|NCT05846906|Zuclomiphene|zuclomiphene|mesh-list
93017785|NCT05846906|Anticoagulants|anticoagulants|mesh-ancestor
93017786|NCT05846906|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93017787|NCT05846906|Chelating Agents|chelating agents|mesh-ancestor
93017788|NCT05846906|Sequestering Agents|sequestering agents|mesh-ancestor
93017789|NCT05846906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017790|NCT05846906|Vasodilator Agents|vasodilator agents|mesh-ancestor
93017791|NCT05846906|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93017792|NCT05846906|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93017793|NCT05846906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017794|NCT05846906|Urological Agents|urological agents|mesh-ancestor
93017795|NCT05846906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93017796|NCT05846906|Hormone Antagonists|hormone antagonists|mesh-ancestor
93017797|NCT05846906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017798|NCT05846906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017799|NCT05846906|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93017800|NCT05846906|Fertility Agents|fertility agents|mesh-ancestor
93017801|NCT05846906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93017802|NCT05846906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93017803|NCT05846906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93017804|NCT05844735|Ciprofloxacin|ciprofloxacin|mesh-list
93017805|NCT05844735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93017806|NCT05844735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017807|NCT05844735|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93017808|NCT05844735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93017809|NCT05844735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174847|NCT03047772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017810|NCT05844735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017811|NCT05844735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017812|NCT05844735|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93017813|NCT05844735|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93017814|NCT05844462|Tadalafil|tadalafil|mesh-list
93017815|NCT05844462|Vasodilator Agents|vasodilator agents|mesh-ancestor
93017816|NCT05844462|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93017817|NCT05844462|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93017818|NCT05844462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017819|NCT05844462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017820|NCT05844462|Urological Agents|urological agents|mesh-ancestor
93017821|NCT05838521|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93017822|NCT05838521|Immunoconjugates|immunoconjugates|mesh-ancestor
93017823|NCT05838521|Immunologic Factors|immunologic factors|mesh-ancestor
93017824|NCT05838521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017825|NCT05835245|Lenvatinib|lenvatinib|mesh-list
93017826|NCT05835245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017827|NCT05835245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93017828|NCT05835245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017829|NCT05835245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017830|NCT05832255|Psilocybin|psilocybin|mesh-list
93017831|NCT05832255|Hallucinogens|hallucinogens|mesh-ancestor
93017832|NCT05832255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017833|NCT05832255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017834|NCT05826327|Sufentanil|sufentanil|mesh-list
93017835|NCT05826327|Esketamine|esketamine|mesh-list
93017836|NCT05826327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93017837|NCT05826327|Narcotics|narcotics|mesh-ancestor
93017838|NCT05826327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017839|NCT05826327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017840|NCT05826327|Analgesics|analgesics|mesh-ancestor
93017841|NCT05826327|Sensory System Agents|sensory system agents|mesh-ancestor
93017842|NCT05826327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017843|NCT05826327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93017844|NCT05826327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93017845|NCT05826327|Anesthetics, General|anesthetics, general|mesh-ancestor
93017846|NCT05826327|Anesthetics|anesthetics|mesh-ancestor
93017847|NCT05826327|Antidepressive Agents|antidepressive agents|mesh-ancestor
93017848|NCT05826327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93017849|NCT05823116|Vancomycin|vancomycin|mesh-list
93017850|NCT05823116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93017851|NCT05823116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93017852|NCT05817721|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93017853|NCT05817721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017854|NCT05817721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017855|NCT05814991|Nitroglycerin|nitroglycerin|mesh-list
93017856|NCT05814991|Vasodilator Agents|vasodilator agents|mesh-ancestor
93017857|NCT05814367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93017858|NCT05814367|Lubricant Eye Drops|lubricant eye drops|mesh-list
93017859|NCT05814367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93017860|NCT05809011|Dexamethasone|dexamethasone|mesh-list
93017861|NCT05809011|Prednisone|prednisone|mesh-list
93017862|NCT05809011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017863|NCT05809011|Antiemetics|antiemetics|mesh-ancestor
93017864|NCT05809011|Autonomic Agents|autonomic agents|mesh-ancestor
93017865|NCT05809011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017866|NCT05809011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017867|NCT05809011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93017868|NCT05809011|Glucocorticoids|glucocorticoids|mesh-ancestor
93017869|NCT05809011|Hormones|hormones|mesh-ancestor
93017870|NCT05809011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93017871|NCT05809011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93017872|NCT05809011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017873|NCT05801757|Propofol|propofol|mesh-list
93017874|NCT05801757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93017875|NCT05801757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017876|NCT05801757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017877|NCT05801757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93017878|NCT05801757|Anesthetics, General|anesthetics, general|mesh-ancestor
93017879|NCT05801757|Anesthetics|anesthetics|mesh-ancestor
93017880|NCT05801146|Botulinum Toxins|botulinum toxins|mesh-list
93017881|NCT05801146|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93017882|NCT05801146|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93017883|NCT05801146|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93017884|NCT05801146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93017885|NCT05801146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017886|NCT05801146|Cholinergic Agents|cholinergic agents|mesh-ancestor
93017887|NCT05801146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017888|NCT05801146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017889|NCT05801146|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93017890|NCT05801146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017891|NCT05795647|Tocopherols|tocopherols|mesh-list
93017892|NCT05795647|Vitamin E|vitamin e|mesh-list
93017893|NCT05795647|Tocotrienols|tocotrienols|mesh-list
93017894|NCT05795647|alpha-Tocopherol|alpha-tocopherol|mesh-list
93017895|NCT05795647|Pentoxifylline|pentoxifylline|mesh-list
93017896|NCT05795647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93017897|NCT05795647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017898|NCT05795647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017899|NCT05795647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93017900|NCT05795647|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93017901|NCT05795647|Protective Agents|protective agents|mesh-ancestor
93017902|NCT05795647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017903|NCT05795647|Vasodilator Agents|vasodilator agents|mesh-ancestor
93017904|NCT05795647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93017905|NCT05795647|Antioxidants|antioxidants|mesh-ancestor
93017906|NCT05795647|Vitamins|vitamins|mesh-ancestor
93017907|NCT05795647|Micronutrients|micronutrients|mesh-ancestor
93017908|NCT05794399|Warfarin|warfarin|mesh-list
93017909|NCT05794399|Rivaroxaban|rivaroxaban|mesh-list
93017910|NCT05794399|Anticoagulants|anticoagulants|mesh-ancestor
92174909|NCT03820193|Ketorolac|ketorolac|mesh-list
93017911|NCT05794399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93017912|NCT05794399|Antithrombins|antithrombins|mesh-ancestor
93017913|NCT05794399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93017914|NCT05794399|Protease Inhibitors|protease inhibitors|mesh-ancestor
93017915|NCT05794399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017916|NCT05794399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017917|NCT05788510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93017918|NCT05788510|Immunologic Factors|immunologic factors|mesh-ancestor
93017919|NCT05788510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017920|NCT05781035|Dexmedetomidine|dexmedetomidine|mesh-list
93017921|NCT05781035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93017922|NCT05781035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017923|NCT05781035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93017924|NCT05781035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93017925|NCT05781035|Analgesics|analgesics|mesh-ancestor
93017926|NCT05781035|Sensory System Agents|sensory system agents|mesh-ancestor
93017927|NCT05781035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017928|NCT05781035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93017929|NCT05781035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93017930|NCT05781035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93017931|NCT05781035|Adrenergic Agents|adrenergic agents|mesh-ancestor
93017932|NCT05781035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017933|NCT05781035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017934|NCT05774704|Curcumin|curcumin|mesh-list
93017935|NCT05774704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93017936|NCT05774704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93017937|NCT05774704|Analgesics|analgesics|mesh-ancestor
93017938|NCT05774704|Sensory System Agents|sensory system agents|mesh-ancestor
93017939|NCT05774704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017940|NCT05774704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017941|NCT05774704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93017942|NCT05774704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017943|NCT05774704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017944|NCT05774704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017945|NCT05774704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017946|NCT05771480|Paclitaxel|paclitaxel|mesh-list
93017947|NCT05771480|Cisplatin|cisplatin|mesh-list
93017948|NCT05771480|Carboplatin|carboplatin|mesh-list
93017949|NCT05771480|Gemcitabine|gemcitabine|mesh-list
93017950|NCT05771480|Oxaliplatin|oxaliplatin|mesh-list
93017951|NCT05771480|Durvalumab|durvalumab|mesh-list
93017952|NCT05771480|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93017953|NCT05771480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93017954|NCT05771480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017955|NCT05771480|Tubulin Modulators|tubulin modulators|mesh-ancestor
93017956|NCT05771480|Antimitotic Agents|antimitotic agents|mesh-ancestor
93017957|NCT05771480|Mitosis Modulators|mitosis modulators|mesh-ancestor
93017958|NCT05771480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017959|NCT05771480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93017960|NCT05771480|Antimetabolites|antimetabolites|mesh-ancestor
93017961|NCT05771480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017962|NCT05764395|Pembrolizumab|pembrolizumab|mesh-list
93017963|NCT05764395|ON 01910|on 01910|mesh-list
93017964|NCT05764395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93017965|NCT05764395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017966|NCT05764395|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93017967|NCT05764395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017968|NCT05764395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93017969|NCT05764395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93017971|NCT05746546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93017972|NCT05746546|Autonomic Agents|autonomic agents|mesh-ancestor
93017973|NCT05746546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93017974|NCT05746546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017975|NCT05746546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93017976|NCT05746546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93017977|NCT05746546|Cholinergic Agents|cholinergic agents|mesh-ancestor
93017978|NCT05746546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93017979|NCT05746546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017981|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
93017982|NCT05727371|Protective Agents|protective agents|mesh-ancestor
93017983|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017984|NCT05714306|Cyclophosphamide|cyclophosphamide|mesh-list
93017985|NCT05714306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93017986|NCT05714306|Immunologic Factors|immunologic factors|mesh-ancestor
93017987|NCT05714306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93017988|NCT05714306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93017989|NCT05714306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93017990|NCT05714306|Alkylating Agents|alkylating agents|mesh-ancestor
93017991|NCT05714306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93017992|NCT05714306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93017993|NCT05714306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93017994|NCT05706259|Vitamin D|vitamin d|mesh-list
93017995|NCT05706259|Ergocalciferols|ergocalciferols|mesh-list
93017996|NCT05706259|Cholecalciferol|cholecalciferol|mesh-list
93017997|NCT05706259|Vitamins|vitamins|mesh-list
93017998|NCT05706259|Micronutrients|micronutrients|mesh-ancestor
93017999|NCT05706259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018000|NCT05706259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93018001|NCT05706259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93018002|NCT05704374|Pregabalin|pregabalin|mesh-list
93018003|NCT05704374|Analgesics|analgesics|mesh-ancestor
93018004|NCT05704374|Sensory System Agents|sensory system agents|mesh-ancestor
93018005|NCT05704374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018006|NCT05704374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018007|NCT05704374|Anticonvulsants|anticonvulsants|mesh-ancestor
93018008|NCT05704374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93018009|NCT05704374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93018010|NCT05704374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018011|NCT05704374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93018012|NCT05704374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93018013|NCT05704374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93018014|NCT05704374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018015|NCT05704374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93018016|NCT05704166|Pirfenidone|pirfenidone|mesh-list
93018017|NCT05704166|Analgesics|analgesics|mesh-ancestor
93018018|NCT05704166|Sensory System Agents|sensory system agents|mesh-ancestor
93018019|NCT05704166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018020|NCT05704166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018021|NCT05704166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93018022|NCT05704166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018023|NCT05704166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018024|NCT05704166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018025|NCT05704166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018026|NCT05687266|Paclitaxel|paclitaxel|mesh-list
93018027|NCT05687266|Carboplatin|carboplatin|mesh-list
93018028|NCT05687266|Pembrolizumab|pembrolizumab|mesh-list
93018029|NCT05687266|Pemetrexed|pemetrexed|mesh-list
93018030|NCT05687266|Durvalumab|durvalumab|mesh-list
93018031|NCT05687266|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93018032|NCT05687266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018033|NCT05687266|Tubulin Modulators|tubulin modulators|mesh-ancestor
93018034|NCT05687266|Antimitotic Agents|antimitotic agents|mesh-ancestor
93018035|NCT05687266|Mitosis Modulators|mitosis modulators|mesh-ancestor
93018036|NCT05687266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018037|NCT05687266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018038|NCT05687266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018039|NCT05687266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018040|NCT05687266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93018041|NCT05687266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93018042|NCT05680558|Methoxsalen|methoxsalen|mesh-list
93018043|NCT05680558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93018044|NCT05680558|Dermatologic Agents|dermatologic agents|mesh-ancestor
93018045|NCT05672251|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
93018046|NCT05672251|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93018047|NCT05672251|Immunologic Factors|immunologic factors|mesh-ancestor
93018048|NCT05672251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018049|NCT05672251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018050|NCT05672251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018052|NCT05667324|Ropivacaine|ropivacaine|mesh-list
93018053|NCT05667324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018054|NCT05667324|Antiemetics|antiemetics|mesh-ancestor
93018055|NCT05667324|Autonomic Agents|autonomic agents|mesh-ancestor
93018056|NCT05667324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018057|NCT05667324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018058|NCT05667324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018059|NCT05667324|Glucocorticoids|glucocorticoids|mesh-ancestor
93018060|NCT05667324|Hormones|hormones|mesh-ancestor
93018061|NCT05667324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018062|NCT05667324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018063|NCT05667324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663383|NCT00425594|Bisacodyl|bisacodyl|mesh-list
93018064|NCT05667324|Anesthetics, Local|anesthetics, local|mesh-ancestor
93018065|NCT05667324|Anesthetics|anesthetics|mesh-ancestor
93018066|NCT05667324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018067|NCT05667324|Sensory System Agents|sensory system agents|mesh-ancestor
93018068|NCT05665595|Pembrolizumab|pembrolizumab|mesh-list
93018069|NCT05665595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018070|NCT05665595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018071|NCT05665595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018072|NCT05665595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018073|NCT05663242|Anesthetics|anesthetics|mesh-list
93018074|NCT05663242|Propofol|propofol|mesh-list
93018075|NCT05663242|Sevoflurane|sevoflurane|mesh-list
93018076|NCT05663242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018077|NCT05663242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018078|NCT05663242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93018079|NCT05663242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93018080|NCT05663242|Anesthetics, General|anesthetics, general|mesh-ancestor
93018081|NCT05663242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93018082|NCT05663242|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93018083|NCT05661851|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93018084|NCT05661851|Lubricant Eye Drops|lubricant eye drops|mesh-list
93018085|NCT05661851|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93018086|NCT05656521|Dexamethasone|dexamethasone|mesh-list
93018087|NCT05656521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018088|NCT05656521|Antiemetics|antiemetics|mesh-ancestor
93018089|NCT05656521|Autonomic Agents|autonomic agents|mesh-ancestor
93018090|NCT05656521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018091|NCT05656521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018092|NCT05656521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018093|NCT05656521|Glucocorticoids|glucocorticoids|mesh-ancestor
93018094|NCT05656521|Hormones|hormones|mesh-ancestor
93018095|NCT05656521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018096|NCT05656521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018097|NCT05656521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018098|NCT05655013|Zoledronic Acid|zoledronic acid|mesh-list
93018099|NCT05655013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93018100|NCT05655013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018101|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
93018102|NCT05653271|Fludarabine|fludarabine|mesh-list
93018103|NCT05653271|Obinutuzumab|obinutuzumab|mesh-list
93018104|NCT05653271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93018105|NCT05653271|Immunologic Factors|immunologic factors|mesh-ancestor
93018106|NCT05653271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018107|NCT05653271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018108|NCT05653271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93018109|NCT05653271|Alkylating Agents|alkylating agents|mesh-ancestor
93018110|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018111|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175007|NCT01669122|Nicotine|nicotine|mesh-list
93018112|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93018113|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018114|NCT05644184|Vaccines|vaccines|mesh-list
93018115|NCT05644184|Immunologic Factors|immunologic factors|mesh-ancestor
93018116|NCT05644184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018117|NCT05644041|Gemcitabine|gemcitabine|mesh-list
93018118|NCT05644041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018119|NCT05644041|Antimetabolites|antimetabolites|mesh-ancestor
93018120|NCT05644041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018121|NCT05644041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018122|NCT05633992|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93018123|NCT05633992|Immunologic Factors|immunologic factors|mesh-ancestor
93018124|NCT05633992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018126|NCT05628623|Azacitidine|azacitidine|mesh-list
93018127|NCT05628623|Daunorubicin|daunorubicin|mesh-list
93018128|NCT05628623|Venetoclax|venetoclax|mesh-list
93018129|NCT05628623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018130|NCT05628623|Antimetabolites|antimetabolites|mesh-ancestor
93018131|NCT05628623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018132|NCT05628623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018133|NCT05628623|Antiviral Agents|antiviral agents|mesh-ancestor
93018134|NCT05628623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018135|NCT05628623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92663439|NCT00264134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93018136|NCT05628623|Immunologic Factors|immunologic factors|mesh-ancestor
93018137|NCT05628623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018138|NCT05628623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018139|NCT05628623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93018140|NCT05628623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93018141|NCT05628623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93018143|NCT05616923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018144|NCT05616923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018145|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018146|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018147|NCT05616013|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93018148|NCT05616013|Antibodies, Blocking|antibodies, blocking|mesh-list
93018149|NCT05616013|Immunologic Factors|immunologic factors|mesh-ancestor
93018150|NCT05616013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018151|NCT05608200|Lenvatinib|lenvatinib|mesh-list
93018152|NCT05608200|Chlorotrianisene|chlorotrianisene|mesh-list
93018153|NCT05608200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018154|NCT05608200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018155|NCT05608200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018156|NCT05608200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018157|NCT05608200|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93018158|NCT05608200|Estrogens|estrogens|mesh-ancestor
93018159|NCT05608200|Hormones|hormones|mesh-ancestor
92175039|NCT04873284|Antiemetics|antiemetics|mesh-ancestor
93018160|NCT05608200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018161|NCT05608200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018162|NCT05608200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018163|NCT05606692|Propofol|propofol|mesh-list
93018164|NCT05606692|Sevoflurane|sevoflurane|mesh-list
93018165|NCT05606692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93018166|NCT05606692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018167|NCT05606692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018168|NCT05606692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93018169|NCT05606692|Anesthetics, General|anesthetics, general|mesh-ancestor
93018170|NCT05606692|Anesthetics|anesthetics|mesh-ancestor
93018171|NCT05606692|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93018172|NCT05606692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93018173|NCT05601336|Metformin|metformin|mesh-list
93018174|NCT05601336|Dapagliflozin|dapagliflozin|mesh-list
93018175|NCT05601336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93018176|NCT05601336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018177|NCT05601336|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93018178|NCT05601336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018179|NCT05599243|Dutasteride|dutasteride|mesh-list
93018180|NCT05599243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93018181|NCT05599243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93018182|NCT05599243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018183|NCT05599243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018184|NCT05599243|Hormone Antagonists|hormone antagonists|mesh-ancestor
93018185|NCT05599243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018186|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018187|NCT05595083|Dexmedetomidine|dexmedetomidine|mesh-list
93018188|NCT05595083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93018189|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92528802|NCT00396526|Amoxicillin|amoxicillin|mesh-list
93018190|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018191|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018192|NCT05595083|Analgesics|analgesics|mesh-ancestor
93018193|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
93018194|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018195|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93018196|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93018197|NCT05595083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93018198|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
93018199|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018200|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018201|NCT05580666|Azithromycin|azithromycin|mesh-list
93018202|NCT05580666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93018203|NCT05580666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018204|NCT05567406|Belumosudil|belumosudil|mesh-list
93018205|NCT05567406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018206|NCT05567406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018207|NCT05567406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018208|NCT05557110|Blinatumomab|blinatumomab|mesh-list
93018209|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018210|NCT05556889|Iodine|iodine|mesh-list
93018211|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93018212|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018213|NCT05556889|Trace Elements|trace elements|mesh-ancestor
93018214|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
93018215|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018216|NCT05544136|Carboplatin|carboplatin|mesh-list
93018217|NCT05544136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018218|NCT05541471|Digoxin|digoxin|mesh-list
93018219|NCT05541471|Midazolam|midazolam|mesh-list
93018220|NCT05541471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93018221|NCT05541471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93018222|NCT05541471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018223|NCT05541471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018224|NCT05541471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93018225|NCT05541471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93018226|NCT05541471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93018227|NCT05541471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93018228|NCT05541471|Anesthetics, General|anesthetics, general|mesh-ancestor
93018229|NCT05541471|Anesthetics|anesthetics|mesh-ancestor
93018230|NCT05541471|GABA Modulators|gaba modulators|mesh-ancestor
93018231|NCT05541471|GABA Agents|gaba agents|mesh-ancestor
93018232|NCT05541471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018233|NCT05541471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018234|NCT05541471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93018235|NCT05541471|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93018236|NCT05541471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018237|NCT05541471|Protective Agents|protective agents|mesh-ancestor
93018238|NCT05516914|Cisplatin|cisplatin|mesh-list
93018239|NCT05516914|Gemcitabine|gemcitabine|mesh-list
93018240|NCT05516914|Docetaxel|docetaxel|mesh-list
93018241|NCT05516914|Tislelizumab|tislelizumab|mesh-list
93018242|NCT05516914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018243|NCT05516914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018244|NCT05516914|Antimetabolites|antimetabolites|mesh-ancestor
93018245|NCT05516914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018246|NCT05516914|Tubulin Modulators|tubulin modulators|mesh-ancestor
93018247|NCT05516914|Antimitotic Agents|antimitotic agents|mesh-ancestor
93018248|NCT05516914|Mitosis Modulators|mitosis modulators|mesh-ancestor
93018249|NCT05516914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018250|NCT05513027|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93018251|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93018252|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018253|NCT05504278|Carboplatin|carboplatin|mesh-list
93018254|NCT05504278|Pemetrexed|pemetrexed|mesh-list
93018255|NCT05504278|Cisplatin|cisplatin|mesh-list
93018256|NCT05504278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018257|NCT05504278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018258|NCT05504278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018259|NCT05504278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93018260|NCT05504278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93018262|NCT05498792|Ipilimumab|ipilimumab|mesh-list
93018263|NCT05498792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018264|NCT05498792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018265|NCT05498792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018266|NCT05498792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018267|NCT05490134|Naloxone|naloxone|mesh-list
93018268|NCT05490134|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93018269|NCT05490134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018270|NCT05490134|Sensory System Agents|sensory system agents|mesh-ancestor
93018271|NCT05490134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018272|NCT05479812|Pembrolizumab|pembrolizumab|mesh-list
93018273|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018274|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018275|NCT05479812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018276|NCT05479812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018277|NCT05475613|Immunomodulating Agents|immunomodulating agents|mesh-list
93018278|NCT05475613|Immunologic Factors|immunologic factors|mesh-ancestor
93018279|NCT05475613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018280|NCT05453968|Berotralstat|berotralstat|mesh-list
93018281|NCT05453968|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93018282|NCT05453968|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018283|NCT05453968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018284|NCT05453968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018285|NCT05443035|Anti-Infective Agents|anti-infective agents|mesh-list
93018286|NCT05443035|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93018287|NCT05440201|Enoxaparin|enoxaparin|mesh-list
93018288|NCT05440201|Anticoagulants|anticoagulants|mesh-list
93018290|NCT05440201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93018291|NCT05440201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018292|NCT05422885|Dasatinib|dasatinib|mesh-list
93018293|NCT05422885|Quercetin|quercetin|mesh-list
93018294|NCT05422885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018295|NCT05422885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018296|NCT05422885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018297|NCT05422885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018298|NCT05422885|Antioxidants|antioxidants|mesh-ancestor
93018299|NCT05422885|Protective Agents|protective agents|mesh-ancestor
93018300|NCT05422885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018301|NCT05418049|Memantine|memantine|mesh-list
93018302|NCT05418049|Baclofen|baclofen|mesh-list
93018303|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93018304|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93018305|NCT05418049|Dopamine Agents|dopamine agents|mesh-ancestor
93018306|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018307|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018308|NCT05418049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018309|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93018310|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93018311|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93018312|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93018313|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018314|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93018315|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
93018316|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
93018317|NCT05414500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93018318|NCT05414500|Mogamulizumab|mogamulizumab|mesh-list
93018319|NCT05414500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018320|NCT05414500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018321|NCT05414500|Immunotoxins|immunotoxins|mesh-ancestor
93018322|NCT05414500|Immunoconjugates|immunoconjugates|mesh-ancestor
93018323|NCT05414500|Immunologic Factors|immunologic factors|mesh-ancestor
93018324|NCT05414500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018325|NCT05411484|Doxycycline|doxycycline|mesh-list
93018326|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93018327|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018328|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
93018329|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93018330|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93018331|NCT05403450|Decitabine|decitabine|mesh-list
92528808|NCT00396526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93018332|NCT05403450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018334|NCT05403450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175173|NCT02022709|Serotonin Agents|serotonin agents|mesh-ancestor
93018335|NCT05403450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018336|NCT05403450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018337|NCT05369676|Ritonavir|ritonavir|mesh-list
93018338|NCT05369676|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93018339|NCT05369676|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93018340|NCT05369676|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018341|NCT05369676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018342|NCT05369676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018343|NCT05369676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93018344|NCT05369676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93018345|NCT05369676|Antiviral Agents|antiviral agents|mesh-ancestor
93018346|NCT05369676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018347|NCT05369676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93018348|NCT05369676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93018349|NCT05327010|Talazoparib|talazoparib|mesh-list
93018350|NCT05327010|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93018351|NCT05327010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018352|NCT05327010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018353|NCT05327010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018354|NCT05316493|Megestrol|megestrol|mesh-list
93018355|NCT05316493|Megestrol Acetate|megestrol acetate|mesh-list
93018356|NCT05316493|Levonorgestrel|levonorgestrel|mesh-list
93018357|NCT05316493|Contraceptive Agents|contraceptive agents|mesh-list
93018358|NCT05316493|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93018359|NCT05316493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93018360|NCT05316493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018361|NCT05316493|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93018362|NCT05316493|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93018363|NCT05316493|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93018364|NCT05316493|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93018365|NCT05316493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018366|NCT05316493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018367|NCT05316493|Appetite Stimulants|appetite stimulants|mesh-ancestor
93018368|NCT05316493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93018369|NCT05316467|Megestrol|megestrol|mesh-list
93018370|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
93018371|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93018372|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93018373|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93018374|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
93018375|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93018376|NCT05316467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018377|NCT05316467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93018378|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93018379|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018380|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018381|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
93018382|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93018383|NCT05309928|Amoxicillin|amoxicillin|mesh-list
93018384|NCT05309928|Probenecid|probenecid|mesh-list
93018385|NCT05309928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93018386|NCT05309928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018387|NCT05309928|Uricosuric Agents|uricosuric agents|mesh-ancestor
93018388|NCT05309928|Gout Suppressants|gout suppressants|mesh-ancestor
93018389|NCT05309928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018390|NCT05304949|Ranibizumab|ranibizumab|mesh-list
93018391|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93018392|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93018393|NCT05304949|Growth Substances|growth substances|mesh-ancestor
93018394|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018395|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
93018396|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018397|NCT05294341|Norethindrone|norethindrone|mesh-list
93018398|NCT05294341|Norethindrone Acetate|norethindrone acetate|mesh-list
93018399|NCT05294341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93018400|NCT05294341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93018401|NCT05294341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93018402|NCT05294341|Contraceptive Agents|contraceptive agents|mesh-ancestor
92363991|NCT04355052|Azithromycin|azithromycin|mesh-list
93018403|NCT05294341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93018404|NCT05294341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018405|NCT05294341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93018406|NCT05294341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93018407|NCT05293964|Everolimus|everolimus|mesh-list
93018408|NCT05293964|Palbociclib|palbociclib|mesh-list
93018409|NCT05293964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93018410|NCT05293964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018411|NCT05293964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018412|NCT05293964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018413|NCT05293964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93018414|NCT05293964|Immunologic Factors|immunologic factors|mesh-ancestor
93018415|NCT05293964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018416|NCT05293964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018417|NCT05290207|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93018418|NCT05290207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018419|NCT05275010|Trastuzumab|trastuzumab|mesh-list
93018420|NCT05275010|Pertuzumab|pertuzumab|mesh-list
93018421|NCT05275010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018422|NCT05275010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018423|NCT05274269|Ivacaftor|ivacaftor|mesh-list
93018424|NCT05274269|Elexacaftor|elexacaftor|mesh-list
93018425|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93018426|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93018427|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018428|NCT05271240|Bevacizumab|bevacizumab|mesh-list
93018429|NCT05271240|Temozolomide|temozolomide|mesh-list
93018430|NCT05271240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018431|NCT05271240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018432|NCT05271240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93018433|NCT05271240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93018434|NCT05271240|Growth Substances|growth substances|mesh-ancestor
93018435|NCT05271240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018436|NCT05271240|Growth Inhibitors|growth inhibitors|mesh-ancestor
93018437|NCT05271240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92663735|NCT00265304|Analgesics|analgesics|mesh-ancestor
93018438|NCT05271240|Alkylating Agents|alkylating agents|mesh-ancestor
93018439|NCT05271240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018440|NCT05269459|Cannabidiol|cannabidiol|mesh-list
93018441|NCT05269459|Anticonvulsants|anticonvulsants|mesh-ancestor
93018442|NCT05264883|Azacitidine|azacitidine|mesh-list
93018444|NCT05264883|Venetoclax|venetoclax|mesh-list
93018445|NCT05264883|Aclarubicin|aclarubicin|mesh-list
93018446|NCT05264883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018447|NCT05264883|Antimetabolites|antimetabolites|mesh-ancestor
93018448|NCT05264883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018449|NCT05264883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018450|NCT05264883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018451|NCT05264883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93018452|NCT05264883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93018453|NCT05264883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93018454|NCT05263453|Vemurafenib|vemurafenib|mesh-list
93018455|NCT05263453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018456|NCT05263453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018457|NCT05263453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175266|NCT00595933|Muramidase|muramidase|mesh-list
93018458|NCT05263453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018459|NCT05257629|Nicotine|nicotine|mesh-list
93018460|NCT05257629|Varenicline|varenicline|mesh-list
93018461|NCT05257629|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93018462|NCT05257629|Autonomic Agents|autonomic agents|mesh-ancestor
93018463|NCT05257629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018464|NCT05257629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018465|NCT05257629|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93018466|NCT05257629|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93018467|NCT05257629|Cholinergic Agents|cholinergic agents|mesh-ancestor
93018468|NCT05257629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018469|NCT05257629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018470|NCT05245669|Denosumab|denosumab|mesh-list
93018471|NCT05245669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93018472|NCT05245669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018473|NCT05233332|Vemurafenib|vemurafenib|mesh-list
93018474|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018475|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018476|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018477|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018478|NCT05232084|Fentanyl|fentanyl|mesh-list
93018479|NCT05232084|Bupivacaine|bupivacaine|mesh-list
93018480|NCT05232084|Anesthetics, Local|anesthetics, local|mesh-ancestor
93018481|NCT05232084|Anesthetics|anesthetics|mesh-ancestor
93018482|NCT05232084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018483|NCT05232084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018484|NCT05232084|Sensory System Agents|sensory system agents|mesh-ancestor
93018485|NCT05232084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018486|NCT05232084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93018487|NCT05232084|Narcotics|narcotics|mesh-ancestor
93018488|NCT05232084|Analgesics|analgesics|mesh-ancestor
93018489|NCT05232084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93018490|NCT05232084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93018491|NCT05232084|Anesthetics, General|anesthetics, general|mesh-ancestor
93018492|NCT05195619|Cyclophosphamide|cyclophosphamide|mesh-list
93018493|NCT05195619|Vaccines|vaccines|mesh-list
93018494|NCT05195619|Immunologic Factors|immunologic factors|mesh-ancestor
93018495|NCT05195619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018496|NCT05195619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93018497|NCT05195619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018498|NCT05195619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93018499|NCT05195619|Alkylating Agents|alkylating agents|mesh-ancestor
93018500|NCT05195619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018501|NCT05195619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018502|NCT05195619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93018503|NCT05158517|Vedolizumab|vedolizumab|mesh-list
93018504|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018505|NCT05139914|Dapagliflozin|dapagliflozin|mesh-list
93018506|NCT05139914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93018507|NCT05139914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018508|NCT05139914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93018509|NCT05139914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663808|NCT00265928|Rituximab|rituximab|mesh-list
93018510|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93018511|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93018512|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93018513|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018514|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018515|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93018516|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93018517|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018518|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
93018519|NCT05138835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018520|NCT05132231|Brodalumab|brodalumab|mesh-list
93018521|NCT05132231|Dermatologic Agents|dermatologic agents|mesh-ancestor
93018522|NCT05114421|Pembrolizumab|pembrolizumab|mesh-list
93018523|NCT05114421|Lenvatinib|lenvatinib|mesh-list
93018524|NCT05114421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018525|NCT05114421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018526|NCT05114421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018527|NCT05114421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018528|NCT05114421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018529|NCT05114421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018530|NCT05099107|Albuterol|albuterol|mesh-list
93018531|NCT05099107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93018532|NCT05099107|Autonomic Agents|autonomic agents|mesh-ancestor
93018533|NCT05099107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018534|NCT05099107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018535|NCT05099107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93018536|NCT05099107|Respiratory System Agents|respiratory system agents|mesh-ancestor
93018537|NCT05099107|Tocolytic Agents|tocolytic agents|mesh-ancestor
93018538|NCT05099107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93018539|NCT05099107|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93018540|NCT05099107|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93018541|NCT05099107|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93018542|NCT05099107|Adrenergic Agents|adrenergic agents|mesh-ancestor
93018543|NCT05099107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018544|NCT05099107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018545|NCT05090280|Nafamostat|nafamostat|mesh-list
93018546|NCT05090280|Naltrexone|naltrexone|mesh-list
93018547|NCT05090280|Oxycodone|oxycodone|mesh-list
93018548|NCT05090280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93018549|NCT05090280|Narcotics|narcotics|mesh-ancestor
93018550|NCT05090280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018551|NCT05090280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018553|NCT05090280|Sensory System Agents|sensory system agents|mesh-ancestor
93018554|NCT05090280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018555|NCT05090280|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93018556|NCT05090280|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93018557|NCT05090280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93018558|NCT05090280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018559|NCT05090280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018560|NCT05090280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018561|NCT05090280|Anticoagulants|anticoagulants|mesh-ancestor
93018562|NCT05090280|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018563|NCT05090280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018564|NCT05090280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018565|NCT05090280|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93018566|NCT05090280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93018567|NCT05090280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93018568|NCT05090280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93018569|NCT05090280|Immunologic Factors|immunologic factors|mesh-ancestor
93018570|NCT05078866|Vaccines|vaccines|mesh-list
93018571|NCT05078866|Immunologic Factors|immunologic factors|mesh-ancestor
93018572|NCT05078866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018573|NCT05065970|Felzartamab|felzartamab|mesh-list
93018574|NCT05065970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018575|NCT05065970|Immunologic Factors|immunologic factors|mesh-ancestor
93018576|NCT05065970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018577|NCT05029063|Rivaroxaban|rivaroxaban|mesh-list
93018578|NCT05029063|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93018579|NCT05029063|Antithrombins|antithrombins|mesh-ancestor
93018580|NCT05029063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93018581|NCT05029063|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018582|NCT05029063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018583|NCT05029063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018584|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
93018585|NCT04998786|Dexamethasone|dexamethasone|mesh-list
93018586|NCT04998786|Ixazomib|ixazomib|mesh-list
93018587|NCT04998786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018588|NCT04998786|Antiemetics|antiemetics|mesh-ancestor
93018590|NCT04998786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018591|NCT04998786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018592|NCT04998786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018593|NCT04998786|Glucocorticoids|glucocorticoids|mesh-ancestor
93018594|NCT04998786|Hormones|hormones|mesh-ancestor
93018595|NCT04998786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018596|NCT04998786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018597|NCT04998786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018598|NCT04998786|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018599|NCT04998786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018600|NCT04998786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018601|NCT04998500|Hormones|hormones|mesh-list
93018602|NCT04998500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018603|NCT04998500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018604|NCT04992624|Dronabinol|dronabinol|mesh-list
93018605|NCT04992624|Cannabidiol|cannabidiol|mesh-list
93018606|NCT04992624|Anticonvulsants|anticonvulsants|mesh-ancestor
93018607|NCT04992624|Hallucinogens|hallucinogens|mesh-ancestor
93018608|NCT04992624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018609|NCT04992624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93018610|NCT04992624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018611|NCT04992624|Analgesics|analgesics|mesh-ancestor
93018612|NCT04992624|Sensory System Agents|sensory system agents|mesh-ancestor
93018613|NCT04992624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018614|NCT04992624|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93018615|NCT04992624|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93018616|NCT04992624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018617|NCT04992624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018618|NCT04992624|Hormones|hormones|mesh-ancestor
93018619|NCT04992624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018620|NCT04990258|Infliximab|infliximab|mesh-list
93018621|NCT04990258|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93018622|NCT04990258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018623|NCT04990258|Dermatologic Agents|dermatologic agents|mesh-ancestor
93018624|NCT04990258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018625|NCT04990258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018626|NCT04988295|Carboplatin|carboplatin|mesh-list
93018627|NCT04988295|Pemetrexed|pemetrexed|mesh-list
93018628|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
93018629|NCT04988295|Lazertinib|lazertinib|mesh-list
93018630|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018631|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018632|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018633|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93018634|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93018635|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018636|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018637|NCT04965493|Rituximab|rituximab|mesh-list
93018638|NCT04965493|Venetoclax|venetoclax|mesh-list
93018639|NCT04965493|Pirtobrutinib|pirtobrutinib|mesh-list
93018640|NCT04965493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018641|NCT04965493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018642|NCT04965493|Immunologic Factors|immunologic factors|mesh-ancestor
93018643|NCT04965493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018644|NCT04965493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018645|NCT04965493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018646|NCT04965493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018647|NCT04965493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018648|NCT04964089|Aflibercept|aflibercept|mesh-list
93018649|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93018650|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93018651|NCT04964089|Growth Substances|growth substances|mesh-ancestor
93018652|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018653|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
93018654|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018655|NCT04940299|Nivolumab|nivolumab|mesh-list
93018656|NCT04940299|Ipilimumab|ipilimumab|mesh-list
93018657|NCT04940299|Immunoglobulins|immunoglobulins|mesh-list
93018658|NCT04940299|Immunoglobulin G|immunoglobulin g|mesh-list
93018659|NCT04940299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018660|NCT04940299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018661|NCT04940299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92663954|NCT00295542|Vasodilator Agents|vasodilator agents|mesh-ancestor
93018662|NCT04940299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018663|NCT04940299|Immunologic Factors|immunologic factors|mesh-ancestor
93018664|NCT04940299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018666|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018667|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018668|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93018669|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
93018670|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93018671|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
93018672|NCT04924374|Pembrolizumab|pembrolizumab|mesh-list
93018673|NCT04924374|Atezolizumab|atezolizumab|mesh-list
93018674|NCT04924374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93018675|NCT04924374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018676|NCT04924374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018677|NCT04924374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018678|NCT04924374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018679|NCT04924374|Immunologic Factors|immunologic factors|mesh-ancestor
93018680|NCT04924374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018681|NCT04918147|Acetaminophen|acetaminophen|mesh-list
93018682|NCT04918147|Diphenhydramine|diphenhydramine|mesh-list
93018683|NCT04918147|Promethazine|promethazine|mesh-list
93018684|NCT04918147|Prednisone|prednisone|mesh-list
93018685|NCT04918147|Methylprednisolone|methylprednisolone|mesh-list
93018686|NCT04918147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93018687|NCT04918147|Elotuzumab|elotuzumab|mesh-list
93018688|NCT04918147|Famotidine|famotidine|mesh-list
93018689|NCT04918147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018690|NCT04918147|Glucocorticoids|glucocorticoids|mesh-ancestor
93018691|NCT04918147|Hormones|hormones|mesh-ancestor
93018692|NCT04918147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018693|NCT04918147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018694|NCT04918147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018695|NCT04918147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018696|NCT04918147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018697|NCT04918147|Analgesics|analgesics|mesh-ancestor
93018698|NCT04918147|Sensory System Agents|sensory system agents|mesh-ancestor
93018699|NCT04918147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018700|NCT04918147|Antipyretics|antipyretics|mesh-ancestor
93018701|NCT04918147|Antiemetics|antiemetics|mesh-ancestor
93018702|NCT04918147|Autonomic Agents|autonomic agents|mesh-ancestor
93018703|NCT04918147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018704|NCT04918147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93018705|NCT04918147|Protective Agents|protective agents|mesh-ancestor
93018706|NCT04918147|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93018707|NCT04918147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93018708|NCT04918147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018709|NCT04918147|Anesthetics, Local|anesthetics, local|mesh-ancestor
93018710|NCT04918147|Anesthetics|anesthetics|mesh-ancestor
93018711|NCT04918147|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93018712|NCT04918147|Histamine Antagonists|histamine antagonists|mesh-ancestor
93018713|NCT04918147|Histamine Agents|histamine agents|mesh-ancestor
93018714|NCT04918147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018715|NCT04918147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018716|NCT04918147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93018717|NCT04918147|Antipruritics|antipruritics|mesh-ancestor
93018718|NCT04918147|Dermatologic Agents|dermatologic agents|mesh-ancestor
93018719|NCT04918147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93018720|NCT04918147|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93018721|NCT04916197|Dexmedetomidine|dexmedetomidine|mesh-list
93018722|NCT04916197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93018723|NCT04916197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018724|NCT04916197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018725|NCT04916197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018726|NCT04916197|Analgesics|analgesics|mesh-ancestor
93018727|NCT04916197|Sensory System Agents|sensory system agents|mesh-ancestor
93018728|NCT04916197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018729|NCT04916197|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93018730|NCT04916197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93018731|NCT04916197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93018732|NCT04916197|Adrenergic Agents|adrenergic agents|mesh-ancestor
93018733|NCT04916197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018734|NCT04916197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018735|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93018736|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93018737|NCT04915768|Immunologic Factors|immunologic factors|mesh-ancestor
93018738|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018739|NCT04915768|Antacids|antacids|mesh-ancestor
93018740|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018741|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018742|NCT04902625|Naltrexone|naltrexone|mesh-list
93018743|NCT04902625|Bupropion|bupropion|mesh-list
93018744|NCT04902625|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93018745|NCT04902625|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93018746|NCT04902625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018747|NCT04902625|Sensory System Agents|sensory system agents|mesh-ancestor
93018748|NCT04902625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018749|NCT04902625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93018750|NCT04902625|Antidepressive Agents|antidepressive agents|mesh-ancestor
93018751|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92175497|NCT00332605|Antiviral Agents|antiviral agents|mesh-ancestor
93018752|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93018753|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93018754|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93018755|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018756|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
93018757|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018758|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93018759|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93018760|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018761|NCT04892303|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
93018762|NCT04892303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018763|NCT04848792|Sulforaphane|sulforaphane|mesh-list
93018764|NCT04848792|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93018765|NCT04848792|Protective Agents|protective agents|mesh-ancestor
93018766|NCT04848792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018767|NCT04848792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018768|NCT04805775|Desflurane|desflurane|mesh-list
93018769|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93018770|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
93018771|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
92528818|NCT00037531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018772|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018774|NCT04796194|Pembrolizumab|pembrolizumab|mesh-list
93018775|NCT04796194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018776|NCT04796194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018777|NCT04796194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93018778|NCT04796194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018779|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
93018780|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93018781|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93018782|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
93018783|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018784|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018785|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93018786|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
93018787|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93018788|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
93018789|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018790|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018791|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93018792|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
93018793|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
93018794|NCT04755647|Protective Agents|protective agents|mesh-ancestor
93018795|NCT04739761|Trastuzumab|trastuzumab|mesh-list
93018796|NCT04739761|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
93018797|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018798|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018799|NCT04739761|Immunoconjugates|immunoconjugates|mesh-ancestor
93018800|NCT04739761|Immunologic Factors|immunologic factors|mesh-ancestor
93018801|NCT04739761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018802|NCT04733040|Felzartamab|felzartamab|mesh-list
93018803|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018804|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
93018805|NCT04733040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018806|NCT04699123|Pembrolizumab|pembrolizumab|mesh-list
93018807|NCT04699123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018808|NCT04699123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018809|NCT04699123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92664103|NCT00295971|Thiotepa|thiotepa|mesh-list
93018810|NCT04699123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018812|NCT04677972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93018813|NCT04677972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93018814|NCT04677972|Analgesics|analgesics|mesh-ancestor
93018815|NCT04677972|Sensory System Agents|sensory system agents|mesh-ancestor
93018816|NCT04677972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018817|NCT04677972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018818|NCT04677972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018819|NCT04677972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018820|NCT04677972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93018821|NCT04677972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93018822|NCT04677972|Antioxidants|antioxidants|mesh-ancestor
93018823|NCT04677972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018824|NCT04677972|Protective Agents|protective agents|mesh-ancestor
93018825|NCT04677972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93018826|NCT04677972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175578|NCT00198991|Cytarabine|cytarabine|mesh-list
93018827|NCT04677972|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93018828|NCT04648046|Cyclophosphamide|cyclophosphamide|mesh-list
93018829|NCT04648046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93018830|NCT04648046|Immunologic Factors|immunologic factors|mesh-ancestor
93018831|NCT04648046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018832|NCT04648046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018833|NCT04648046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93018834|NCT04648046|Alkylating Agents|alkylating agents|mesh-ancestor
93018835|NCT04648046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018836|NCT04648046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018837|NCT04648046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93018838|NCT04648020|Clonidine|clonidine|mesh-list
93018839|NCT04648020|Analgesics|analgesics|mesh-ancestor
93018840|NCT04648020|Sensory System Agents|sensory system agents|mesh-ancestor
93018841|NCT04648020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93018842|NCT04648020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018843|NCT04648020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93018844|NCT04648020|Sympatholytics|sympatholytics|mesh-ancestor
93018845|NCT04648020|Autonomic Agents|autonomic agents|mesh-ancestor
93018846|NCT04648020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93018847|NCT04648020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93018848|NCT04648020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93018849|NCT04648020|Adrenergic Agents|adrenergic agents|mesh-ancestor
93018850|NCT04648020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93018851|NCT04648020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018852|NCT04630145|Clarithromycin|clarithromycin|mesh-list
93018853|NCT04630145|Rifampin|rifampin|mesh-list
93018854|NCT04630145|Ethambutol|ethambutol|mesh-list
93018855|NCT04630145|Rifabutin|rifabutin|mesh-list
93018856|NCT04630145|Bedaquiline|bedaquiline|mesh-list
93018857|NCT04630145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93018858|NCT04630145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93018859|NCT04630145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93018860|NCT04630145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018861|NCT04630145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018862|NCT04630145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93018863|NCT04630145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93018864|NCT04630145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93018865|NCT04630145|Antitubercular Agents|antitubercular agents|mesh-ancestor
93018866|NCT04630145|Leprostatic Agents|leprostatic agents|mesh-ancestor
93018867|NCT04630145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93018868|NCT04630145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93018869|NCT04630145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93018870|NCT04630145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93018871|NCT04630145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93018872|NCT04630145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93018873|NCT04630145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93018874|NCT04629651|Captopril|captopril|mesh-list
93018875|NCT04629651|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93018876|NCT04629651|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018877|NCT04629651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018878|NCT04629651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018879|NCT04629651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93018880|NCT04627870|Paclitaxel|paclitaxel|mesh-list
93018881|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664181|NCT00301782|Etoposide|etoposide|mesh-list
93018882|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018883|NCT04627870|Tubulin Modulators|tubulin modulators|mesh-ancestor
93018884|NCT04627870|Antimitotic Agents|antimitotic agents|mesh-ancestor
93018885|NCT04627870|Mitosis Modulators|mitosis modulators|mesh-ancestor
93018886|NCT04627870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018887|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
93018888|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
93018889|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93018890|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018891|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018892|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
93018893|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93018894|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93018895|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018896|NCT04614194|Letrozole|letrozole|mesh-list
93018897|NCT04614194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018898|NCT04614194|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93018899|NCT04614194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93018900|NCT04614194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018901|NCT04614194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018902|NCT04614194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93018903|NCT04614194|Hormone Antagonists|hormone antagonists|mesh-ancestor
93018904|NCT04614194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018905|NCT04614194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018906|NCT04603001|Azacitidine|azacitidine|mesh-list
93018907|NCT04603001|Venetoclax|venetoclax|mesh-list
93018908|NCT04603001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018909|NCT04603001|Antimetabolites|antimetabolites|mesh-ancestor
93018910|NCT04603001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018911|NCT04603001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018912|NCT04603001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018913|NCT04593654|Dalteparin|dalteparin|mesh-list
93018914|NCT04593654|Tinzaparin|tinzaparin|mesh-list
93018915|NCT04593654|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93018916|NCT04593654|Anticoagulants|anticoagulants|mesh-ancestor
93018917|NCT04593654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93018918|NCT04593654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93018919|NCT04593654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018920|NCT04591210|Angiotensin II|angiotensin ii|mesh-list
93018921|NCT04591210|Giapreza|giapreza|mesh-list
93018922|NCT04591210|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93018923|NCT04591210|Angiotensinogen|angiotensinogen|mesh-list
93018924|NCT04591210|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93018925|NCT04591210|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93018926|NCT04591210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018927|NCT04591210|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93018928|NCT04591210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93018929|NCT04591210|Protease Inhibitors|protease inhibitors|mesh-ancestor
93018930|NCT04585893|Rituximab|rituximab|mesh-list
93018931|NCT04585893|Etoposide|etoposide|mesh-list
93018932|NCT04585893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018933|NCT04585893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018934|NCT04585893|Immunologic Factors|immunologic factors|mesh-ancestor
93018935|NCT04585893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018936|NCT04585893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018937|NCT04585893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93018938|NCT04585893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93018939|NCT04585893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93018940|NCT04585893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018941|NCT04585893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018942|NCT04573478|Atrasentan|atrasentan|mesh-list
93018943|NCT04573478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018944|NCT04573478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93018945|NCT04573478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93018946|NCT04573478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018947|NCT04547946|Trametinib|trametinib|mesh-list
93018948|NCT04547946|Dabrafenib|dabrafenib|mesh-list
93018949|NCT04547946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018950|NCT04547946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018951|NCT04547946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018952|NCT04547946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018953|NCT04546009|Letrozole|letrozole|mesh-list
93018954|NCT04546009|Palbociclib|palbociclib|mesh-list
93018955|NCT04546009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018957|NCT04546009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93018958|NCT04546009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018959|NCT04546009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018960|NCT04546009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93018961|NCT04546009|Hormone Antagonists|hormone antagonists|mesh-ancestor
93018962|NCT04546009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018963|NCT04546009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018964|NCT04546009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93018965|NCT04542824|Prednisone|prednisone|mesh-list
93018966|NCT04542824|Cyclophosphamide|cyclophosphamide|mesh-list
93018967|NCT04542824|Rituximab|rituximab|mesh-list
93018968|NCT04542824|Gemcitabine|gemcitabine|mesh-list
93018969|NCT04542824|Doxorubicin|doxorubicin|mesh-list
93018970|NCT04542824|Oxaliplatin|oxaliplatin|mesh-list
93018971|NCT04542824|Vincristine|vincristine|mesh-list
93018972|NCT04542824|Lenalidomide|lenalidomide|mesh-list
93018973|NCT04542824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175732|NCT04776655|Antidotes|antidotes|mesh-ancestor
93018974|NCT04542824|Immunologic Factors|immunologic factors|mesh-ancestor
93018975|NCT04542824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93018976|NCT04542824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93018977|NCT04542824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93018978|NCT04542824|Alkylating Agents|alkylating agents|mesh-ancestor
93018979|NCT04542824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93018980|NCT04542824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93018981|NCT04542824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93018982|NCT04542824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93018983|NCT04542824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93018984|NCT04542824|Antimetabolites|antimetabolites|mesh-ancestor
93018985|NCT04542824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93018986|NCT04542824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93018987|NCT04542824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93018988|NCT04542824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93018989|NCT04542824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93018990|NCT04542824|Glucocorticoids|glucocorticoids|mesh-ancestor
93018991|NCT04542824|Hormones|hormones|mesh-ancestor
93018992|NCT04542824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93018993|NCT04542824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93018994|NCT04542824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93018995|NCT04542824|Tubulin Modulators|tubulin modulators|mesh-ancestor
93018996|NCT04542824|Antimitotic Agents|antimitotic agents|mesh-ancestor
93018997|NCT04542824|Mitosis Modulators|mitosis modulators|mesh-ancestor
92175770|NCT01455857|Exenatide|exenatide|mesh-list
93018998|NCT04542824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93018999|NCT04542824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93019000|NCT04542824|Growth Substances|growth substances|mesh-ancestor
93019001|NCT04542824|Growth Inhibitors|growth inhibitors|mesh-ancestor
93019002|NCT04535700|Pioglitazone|pioglitazone|mesh-list
93019003|NCT04535700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93019004|NCT04535700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019005|NCT04526795|Cytarabine|cytarabine|mesh-list
93019006|NCT04526795|Fludarabine|fludarabine|mesh-list
93019007|NCT04526795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019008|NCT04526795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019009|NCT04526795|Antimetabolites|antimetabolites|mesh-ancestor
93019010|NCT04526795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019011|NCT04526795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019012|NCT04526795|Immunologic Factors|immunologic factors|mesh-ancestor
93019013|NCT04526795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019014|NCT04526795|Antiviral Agents|antiviral agents|mesh-ancestor
93019015|NCT04526795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019016|NCT04521686|Gemcitabine|gemcitabine|mesh-list
93019017|NCT04521686|Durvalumab|durvalumab|mesh-list
93019018|NCT04521686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019019|NCT04521686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019020|NCT04521686|Antimetabolites|antimetabolites|mesh-ancestor
93019021|NCT04521686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019022|NCT04521686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019023|NCT04512911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93019024|NCT04510051|Cyclophosphamide|cyclophosphamide|mesh-list
93019025|NCT04510051|Fludarabine|fludarabine|mesh-list
93019026|NCT04510051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019027|NCT04510051|Immunologic Factors|immunologic factors|mesh-ancestor
93019028|NCT04510051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664325|NCT00415961|Paclitaxel|paclitaxel|mesh-list
93019029|NCT04510051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019030|NCT04510051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92175814|NCT04849715|Rituximab|rituximab|mesh-list
93019031|NCT04510051|Alkylating Agents|alkylating agents|mesh-ancestor
93019032|NCT04510051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019033|NCT04510051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019034|NCT04510051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93019035|NCT04503551|Ranibizumab|ranibizumab|mesh-list
93019036|NCT04503551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93019037|NCT04503551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93019038|NCT04503551|Growth Substances|growth substances|mesh-ancestor
93019039|NCT04503551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019040|NCT04503551|Growth Inhibitors|growth inhibitors|mesh-ancestor
93019041|NCT04503551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019042|NCT04478279|Temozolomide|temozolomide|mesh-list
93019043|NCT04478279|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019044|NCT04478279|Alkylating Agents|alkylating agents|mesh-ancestor
93019045|NCT04478279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019046|NCT04478279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019048|NCT04471428|Atezolizumab|atezolizumab|mesh-list
93019049|NCT04471428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019050|NCT04471428|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019051|NCT04471428|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019052|NCT04471428|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019053|NCT04471428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019054|NCT04471428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019055|NCT04471428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019056|NCT04437225|Glycolic acid|glycolic acid|mesh-list
93019057|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
93019058|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
93019059|NCT04429555|Ibudilast|ibudilast|mesh-list
93019060|NCT04429555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93019061|NCT04429555|Autonomic Agents|autonomic agents|mesh-ancestor
92364656|NCT03030300|Pioglitazone|pioglitazone|mesh-list
93019062|NCT04429555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019063|NCT04429555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019065|NCT04429555|Respiratory System Agents|respiratory system agents|mesh-ancestor
93019066|NCT04429555|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93019067|NCT04429555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019068|NCT04429555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019069|NCT04429555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93019070|NCT04429555|Vasodilator Agents|vasodilator agents|mesh-ancestor
93019071|NCT04421378|Bevacizumab|bevacizumab|mesh-list
93019072|NCT04421378|Temozolomide|temozolomide|mesh-list
93019073|NCT04421378|Carmustine|carmustine|mesh-list
93019074|NCT04421378|Lomustine|lomustine|mesh-list
93019075|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019076|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019077|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93019078|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93019079|NCT04421378|Growth Substances|growth substances|mesh-ancestor
93019080|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019081|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
93019082|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019083|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
93019084|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019085|NCT04400474|Atezolizumab|atezolizumab|mesh-list
93019086|NCT04400474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019087|NCT04400474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019088|NCT04400474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019089|NCT04400474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019090|NCT04393389|Paclitaxel|paclitaxel|mesh-list
93019091|NCT04393389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019092|NCT04393389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019093|NCT04393389|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019094|NCT04393389|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019095|NCT04393389|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019096|NCT04393389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019097|NCT04390763|Paclitaxel|paclitaxel|mesh-list
93019098|NCT04390763|Gemcitabine|gemcitabine|mesh-list
93019099|NCT04390763|Spartalizumab|spartalizumab|mesh-list
93019100|NCT04390763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019101|NCT04390763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019102|NCT04390763|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664400|NCT00268619|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019103|NCT04390763|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019104|NCT04390763|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019105|NCT04390763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019106|NCT04390763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019107|NCT04390763|Antimetabolites|antimetabolites|mesh-ancestor
93019108|NCT04390763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019109|NCT04390763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019110|NCT04328337|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93019111|NCT04328337|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93019112|NCT04328337|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93019113|NCT04328337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93019114|NCT04319627|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93019115|NCT04319627|Calcium|calcium|mesh-list
93019116|NCT04319627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93019117|NCT04319627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019118|NCT04319627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93019119|NCT04319627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93019120|NCT04319627|Antimetabolites|antimetabolites|mesh-ancestor
93019121|NCT04319627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019122|NCT04319627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93019123|NCT04319627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93019124|NCT04319627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019125|NCT04307576|Dexamethasone|dexamethasone|mesh-list
93019126|NCT04307576|Doxorubicin|doxorubicin|mesh-list
93019127|NCT04307576|Vincristine|vincristine|mesh-list
93019128|NCT04307576|Imatinib Mesylate|imatinib mesylate|mesh-list
93019129|NCT04307576|Blinatumomab|blinatumomab|mesh-list
93019130|NCT04307576|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93019131|NCT04307576|Thioguanine|thioguanine|mesh-list
93019132|NCT04307576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019133|NCT04307576|Antiemetics|antiemetics|mesh-ancestor
93019134|NCT04307576|Autonomic Agents|autonomic agents|mesh-ancestor
93019135|NCT04307576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019136|NCT04307576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019137|NCT04307576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019138|NCT04307576|Glucocorticoids|glucocorticoids|mesh-ancestor
93019139|NCT04307576|Hormones|hormones|mesh-ancestor
93019140|NCT04307576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019141|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019142|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019143|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93019144|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93019145|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019146|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019147|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019148|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019149|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019150|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019151|NCT04307576|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019152|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019153|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019154|NCT04307576|Immunotoxins|immunotoxins|mesh-ancestor
93019155|NCT04307576|Immunoconjugates|immunoconjugates|mesh-ancestor
93019156|NCT04307576|Immunologic Factors|immunologic factors|mesh-ancestor
93019157|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019158|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
93019159|NCT04305496|Fulvestrant|fulvestrant|mesh-list
93019160|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019161|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019162|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93019163|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93019164|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
93019165|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019166|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019167|NCT04301934|Estradiol|estradiol|mesh-list
93019168|NCT04301934|Estrogens|estrogens|mesh-list
93019169|NCT04301934|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93019170|NCT04301934|Hormones|hormones|mesh-ancestor
93019171|NCT04301934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019172|NCT04301934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019173|NCT04281017|Anesthetics|anesthetics|mesh-list
93019174|NCT04281017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019175|NCT04281017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019176|NCT04261036|Ascorbic Acid|ascorbic acid|mesh-list
93019177|NCT04261036|Antioxidants|antioxidants|mesh-ancestor
93019178|NCT04261036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019179|NCT04261036|Protective Agents|protective agents|mesh-ancestor
93019180|NCT04261036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019181|NCT04261036|Vitamins|vitamins|mesh-ancestor
93019182|NCT04261036|Micronutrients|micronutrients|mesh-ancestor
93019183|NCT04256707|Docetaxel|docetaxel|mesh-list
93019184|NCT04256707|Pembrolizumab|pembrolizumab|mesh-list
93019185|NCT04256707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019186|NCT04256707|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019187|NCT04256707|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019188|NCT04256707|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019189|NCT04256707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019190|NCT04256707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019191|NCT04256707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019192|NCT04255407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93019193|NCT04155190|Veratrum Alkaloids|veratrum alkaloids|mesh-list
93019194|NCT04155190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93019195|NCT04145440|Felzartamab|felzartamab|mesh-list
93019196|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019197|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
93019198|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019199|NCT04095832|Anesthetics|anesthetics|mesh-list
93019200|NCT04095832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019201|NCT04095832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019202|NCT04083365|Capecitabine|capecitabine|mesh-list
93019203|NCT04083365|Durvalumab|durvalumab|mesh-list
93019204|NCT04083365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019205|NCT04083365|Antimetabolites|antimetabolites|mesh-ancestor
93019206|NCT04083365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019207|NCT04083365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019208|NCT04083365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019209|NCT04072068|Edoxaban|edoxaban|mesh-list
93019210|NCT04072068|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93019211|NCT04072068|Antithrombins|antithrombins|mesh-ancestor
93019212|NCT04072068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93019213|NCT04072068|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019214|NCT04072068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019215|NCT04072068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019216|NCT04072068|Anticoagulants|anticoagulants|mesh-ancestor
93019217|NCT04036305|Lidocaine|lidocaine|mesh-list
93019218|NCT04036305|Bupivacaine|bupivacaine|mesh-list
93019219|NCT04036305|Anesthetics, Local|anesthetics, local|mesh-ancestor
93019220|NCT04036305|Anesthetics|anesthetics|mesh-ancestor
93019221|NCT04036305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019222|NCT04036305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019223|NCT04036305|Sensory System Agents|sensory system agents|mesh-ancestor
93019224|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019225|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93019226|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93019227|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93019228|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93019229|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019230|NCT04021108|Nivolumab|nivolumab|mesh-list
93019231|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019232|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019233|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019234|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019235|NCT04019327|Temozolomide|temozolomide|mesh-list
93019236|NCT04019327|Talazoparib|talazoparib|mesh-list
93019237|NCT04019327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019238|NCT04019327|Alkylating Agents|alkylating agents|mesh-ancestor
93019239|NCT04019327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019240|NCT04019327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019241|NCT04019327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93019242|NCT04019327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019243|NCT03989466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93019244|NCT03989466|Alemtuzumab|alemtuzumab|mesh-list
93019245|NCT03989466|Antibodies|antibodies|mesh-list
93019246|NCT03989466|Immunoglobulins|immunoglobulins|mesh-list
93019247|NCT03989466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93019248|NCT03989466|Immunologic Factors|immunologic factors|mesh-ancestor
93019249|NCT03989466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019250|NCT03989466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019251|NCT03970655|Dexamethasone|dexamethasone|mesh-list
93019252|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
93019253|NCT03970655|Epinephrine|epinephrine|mesh-list
93019254|NCT03970655|Racepinephrine|racepinephrine|mesh-list
93019255|NCT03970655|Bupivacaine|bupivacaine|mesh-list
93019256|NCT03970655|Ropivacaine|ropivacaine|mesh-list
93019257|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
93019258|NCT03970655|BB 1101|bb 1101|mesh-list
93019259|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019260|NCT03970655|Antiemetics|antiemetics|mesh-ancestor
93019261|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
93019262|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019263|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019264|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019265|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
93019266|NCT03970655|Hormones|hormones|mesh-ancestor
93019267|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019268|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019269|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019270|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019271|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019272|NCT03970655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019273|NCT03970655|Anesthetics, Local|anesthetics, local|mesh-ancestor
93019274|NCT03970655|Anesthetics|anesthetics|mesh-ancestor
93019275|NCT03970655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019276|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
93019277|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93019278|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93019279|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
92176034|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019280|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93019281|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93019282|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93019283|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93019284|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
93019285|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
93019286|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
93019287|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93019288|NCT03967977|Carboplatin|carboplatin|mesh-list
93019289|NCT03967977|Gemcitabine|gemcitabine|mesh-list
93019290|NCT03967977|Tislelizumab|tislelizumab|mesh-list
93019291|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019292|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019293|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
93019294|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019295|NCT03967977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019296|NCT03956056|Poly I-C|poly i-c|mesh-list
93019297|NCT03956056|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93019298|NCT03956056|Poly ICLC|poly iclc|mesh-list
93019299|NCT03956056|Interferon Inducers|interferon inducers|mesh-ancestor
93019300|NCT03956056|Immunologic Factors|immunologic factors|mesh-ancestor
93019301|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019302|NCT03956056|Laxatives|laxatives|mesh-ancestor
93019303|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019304|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
93019305|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019306|NCT03916627|Cemiplimab|cemiplimab|mesh-list
93019307|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019308|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019309|NCT03912064|Ipilimumab|ipilimumab|mesh-list
93019310|NCT03912064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019311|NCT03912064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019312|NCT03912064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019313|NCT03912064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019314|NCT03911453|Rucaparib|rucaparib|mesh-list
93019315|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93019316|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019317|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019318|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019319|NCT03897127|Cytarabine|cytarabine|mesh-list
93019320|NCT03897127|Daunorubicin|daunorubicin|mesh-list
93019321|NCT03897127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019322|NCT03897127|Antimetabolites|antimetabolites|mesh-ancestor
93019323|NCT03897127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019324|NCT03897127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019325|NCT03897127|Antiviral Agents|antiviral agents|mesh-ancestor
93019326|NCT03897127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019327|NCT03897127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019328|NCT03897127|Immunologic Factors|immunologic factors|mesh-ancestor
93019329|NCT03897127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019330|NCT03897127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93019331|NCT03897127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93019332|NCT03897127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019333|NCT03897127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019334|NCT03870919|Palbociclib|palbociclib|mesh-list
93019335|NCT03870919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019336|NCT03870919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019337|NCT03870919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019338|NCT03870919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019339|NCT03865290|Ondansetron|ondansetron|mesh-list
93019340|NCT03865290|Antiemetics|antiemetics|mesh-ancestor
93019341|NCT03865290|Autonomic Agents|autonomic agents|mesh-ancestor
93019342|NCT03865290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019343|NCT03865290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019344|NCT03865290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019345|NCT03865290|Antipruritics|antipruritics|mesh-ancestor
93019346|NCT03865290|Dermatologic Agents|dermatologic agents|mesh-ancestor
93019347|NCT03865290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93019348|NCT03865290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93019349|NCT03865290|Serotonin Agents|serotonin agents|mesh-ancestor
93019350|NCT03865290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93019351|NCT03865290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019352|NCT03843359|Dostarlimab|dostarlimab|mesh-list
93019353|NCT03843359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019354|NCT03840291|Edoxaban|edoxaban|mesh-list
93019355|NCT03840291|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93019356|NCT03840291|Antithrombins|antithrombins|mesh-ancestor
93019357|NCT03840291|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93019358|NCT03840291|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019359|NCT03840291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019360|NCT03840291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019361|NCT03840291|Anticoagulants|anticoagulants|mesh-ancestor
93019362|NCT03837626|Amiloride|amiloride|mesh-list
93019363|NCT03837626|Diuretics|diuretics|mesh-ancestor
93019364|NCT03837626|Natriuretic Agents|natriuretic agents|mesh-ancestor
93019365|NCT03837626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019366|NCT03837626|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93019367|NCT03837626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93019368|NCT03837626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93019369|NCT03837626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019370|NCT03837626|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93019371|NCT03837626|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93019372|NCT03781219|Vemurafenib|vemurafenib|mesh-list
93019373|NCT03781219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019374|NCT03781219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019375|NCT03781219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019376|NCT03781219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019377|NCT03773237|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
93019378|NCT03773237|SMOFlipid|smoflipid|mesh-list
93019379|NCT03773237|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
93019380|NCT03773237|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93019381|NCT03773237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93019382|NCT03754725|Deferiprone|deferiprone|mesh-list
93019383|NCT03754725|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93019384|NCT03754725|Chelating Agents|chelating agents|mesh-ancestor
93019385|NCT03754725|Sequestering Agents|sequestering agents|mesh-ancestor
93019386|NCT03754725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019387|NCT03747484|Interferons|interferons|mesh-list
93019388|NCT03747484|Interferon-gamma|interferon-gamma|mesh-list
93019389|NCT03747484|Pembrolizumab|pembrolizumab|mesh-list
93019390|NCT03747484|Avelumab|avelumab|mesh-list
93019391|NCT03747484|Immunoglobulins|immunoglobulins|mesh-list
93019392|NCT03747484|Immunoglobulin G|immunoglobulin g|mesh-list
93019393|NCT03747484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93019394|NCT03747484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019395|NCT03747484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019396|NCT03747484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019397|NCT03747484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019398|NCT03747484|Antiviral Agents|antiviral agents|mesh-ancestor
93019399|NCT03747484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019400|NCT03747484|Immunologic Factors|immunologic factors|mesh-ancestor
93019401|NCT03747484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019402|NCT03745950|Olaparib|olaparib|mesh-list
93019403|NCT03745950|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93019404|NCT03745950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019405|NCT03745950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019406|NCT03745950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019407|NCT03694808|Vaccines|vaccines|mesh-list
93019408|NCT03694808|Immunologic Factors|immunologic factors|mesh-ancestor
93019409|NCT03694808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019410|NCT03677973|Quemliclustat|quemliclustat|mesh-list
93019411|NCT03677973|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019412|NCT03677973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019413|NCT03677973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019414|NCT03677973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019415|NCT03659539|Propofol|propofol|mesh-list
93019416|NCT03659539|Desflurane|desflurane|mesh-list
93019417|NCT03659539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93019418|NCT03659539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019419|NCT03659539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019420|NCT03659539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93019421|NCT03659539|Anesthetics, General|anesthetics, general|mesh-ancestor
93019422|NCT03659539|Anesthetics|anesthetics|mesh-ancestor
93019423|NCT03659539|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93019424|NCT03659136|Everolimus|everolimus|mesh-list
93019425|NCT03659136|Exemestane|exemestane|mesh-list
93019426|NCT03659136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93019427|NCT03659136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019429|NCT03659136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019430|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019431|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
93019432|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019433|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019434|NCT03659136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93019435|NCT03659136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93019436|NCT03659136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93019437|NCT03659136|Hormone Antagonists|hormone antagonists|mesh-ancestor
93019438|NCT03659136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019439|NCT03632044|Ropivacaine|ropivacaine|mesh-list
93019440|NCT03632044|Anesthetics, Local|anesthetics, local|mesh-ancestor
93019441|NCT03632044|Anesthetics|anesthetics|mesh-ancestor
93019442|NCT03632044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019443|NCT03632044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019444|NCT03632044|Sensory System Agents|sensory system agents|mesh-ancestor
93019445|NCT03632044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019446|NCT03629418|Phenylephrine|phenylephrine|mesh-list
93019447|NCT03629418|Norepinephrine|norepinephrine|mesh-list
93019448|NCT03629418|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93019449|NCT03629418|Mydriatics|mydriatics|mesh-ancestor
93019450|NCT03629418|Autonomic Agents|autonomic agents|mesh-ancestor
93019451|NCT03629418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019452|NCT03629418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019453|NCT03629418|Sympathomimetics|sympathomimetics|mesh-ancestor
93019454|NCT03629418|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93019455|NCT03629418|Nasal Decongestants|nasal decongestants|mesh-ancestor
93019456|NCT03629418|Respiratory System Agents|respiratory system agents|mesh-ancestor
93019457|NCT03629418|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93019458|NCT03629418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93019459|NCT03629418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93019460|NCT03629418|Adrenergic Agents|adrenergic agents|mesh-ancestor
93019461|NCT03629418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93019462|NCT03629418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019463|NCT03629418|Protective Agents|protective agents|mesh-ancestor
93019464|NCT03606213|Vaccines|vaccines|mesh-list
93019465|NCT03606213|Immunologic Factors|immunologic factors|mesh-ancestor
93019466|NCT03606213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019467|NCT03605719|Dexamethasone|dexamethasone|mesh-list
93019468|NCT03605719|Nivolumab|nivolumab|mesh-list
93019469|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019470|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
93019471|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
93019472|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019473|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019474|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019475|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
93019476|NCT03605719|Hormones|hormones|mesh-ancestor
93019477|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019478|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019479|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019480|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019481|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019482|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019483|NCT03529422|Durvalumab|durvalumab|mesh-list
93019484|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019485|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019486|NCT03518203|Eculizumab|eculizumab|mesh-list
93019487|NCT03518203|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93019488|NCT03518203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019489|NCT03518203|Immunologic Factors|immunologic factors|mesh-ancestor
93019490|NCT03518203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019491|NCT03514108|Metformin|metformin|mesh-list
93019492|NCT03514108|Hydralazine|hydralazine|mesh-list
93019493|NCT03514108|Isosorbide|isosorbide|mesh-list
93019494|NCT03514108|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
93019495|NCT03514108|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
93019496|NCT03514108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93019497|NCT03514108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019498|NCT03514108|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93019499|NCT03514108|Diuretics|diuretics|mesh-ancestor
93019500|NCT03514108|Natriuretic Agents|natriuretic agents|mesh-ancestor
93019501|NCT03514108|Vasodilator Agents|vasodilator agents|mesh-ancestor
93019502|NCT03514108|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93019503|NCT03514108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019504|NCT03514108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93019505|NCT03390036|Triamcinolone|triamcinolone|mesh-list
93019506|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93019507|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93019508|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93019509|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019510|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
93019511|NCT03390036|Hormones|hormones|mesh-ancestor
92176177|NCT04859556|Dipivefrin|dipivefrin|mesh-list
93019512|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019513|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019514|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019515|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
93019516|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019517|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019518|NCT03379506|Grazoprevir|grazoprevir|mesh-list
93019519|NCT03379506|Antiviral Agents|antiviral agents|mesh-ancestor
93019520|NCT03379506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019521|NCT03375788|Hormones|hormones|mesh-list
93019522|NCT03375788|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
93019523|NCT03375788|Tesamorelin|tesamorelin|mesh-list
93019524|NCT03375788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019525|NCT03375788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019526|NCT03375788|Growth Substances|growth substances|mesh-ancestor
93019527|NCT03366844|Pembrolizumab|pembrolizumab|mesh-list
93019528|NCT03366844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019529|NCT03366844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019530|NCT03366844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019531|NCT03366844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019532|NCT03348969|Mitomycins|mitomycins|mesh-list
93019533|NCT03348969|Mitomycin|mitomycin|mesh-list
93019534|NCT03348969|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93019535|NCT03348969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019536|NCT03348969|Alkylating Agents|alkylating agents|mesh-ancestor
93019537|NCT03348969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019538|NCT03348969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93019539|NCT03348969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019540|NCT03341936|Nivolumab|nivolumab|mesh-list
93019541|NCT03341936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019542|NCT03341936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019543|NCT03341936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019544|NCT03341936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019545|NCT03318900|Aldesleukin|aldesleukin|mesh-list
93019546|NCT03318900|Cyclophosphamide|cyclophosphamide|mesh-list
93019547|NCT03318900|Interleukin-2|interleukin-2|mesh-list
93019548|NCT03318900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93019549|NCT03318900|Immunoglobulin G|immunoglobulin g|mesh-list
93019550|NCT03318900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019551|NCT03318900|Immunologic Factors|immunologic factors|mesh-ancestor
93019552|NCT03318900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019553|NCT03318900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019554|NCT03318900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019555|NCT03318900|Alkylating Agents|alkylating agents|mesh-ancestor
93019556|NCT03318900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019557|NCT03318900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019558|NCT03318900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93019559|NCT03318900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93019560|NCT03318900|Analgesics|analgesics|mesh-ancestor
93019561|NCT03318900|Sensory System Agents|sensory system agents|mesh-ancestor
93019562|NCT03318900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019563|NCT03318900|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93019564|NCT03318900|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93019565|NCT03318900|Antiviral Agents|antiviral agents|mesh-ancestor
93019566|NCT03318900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019568|NCT03306446|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93019569|NCT03306446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019570|NCT03306446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019571|NCT03306264|Decitabine|decitabine|mesh-list
93019572|NCT03306264|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
93019573|NCT03306264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019574|NCT03306264|Antimetabolites|antimetabolites|mesh-ancestor
93019575|NCT03306264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019576|NCT03306264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019577|NCT03306264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019578|NCT03292133|Gefitinib|gefitinib|mesh-list
93019579|NCT03292133|Nazartinib|nazartinib|mesh-list
93019580|NCT03292133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019581|NCT03292133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019582|NCT03292133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019583|NCT03292133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019584|NCT03289728|Dobutamine|dobutamine|mesh-list
93019585|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93019586|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
93019587|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
93019588|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019589|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019590|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93019591|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93019592|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93019593|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
93019594|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93019595|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019596|NCT03289728|Protective Agents|protective agents|mesh-ancestor
92176243|NCT04779853|Antibodies|antibodies|mesh-list
93019597|NCT03283917|Dexamethasone|dexamethasone|mesh-list
93019598|NCT03283917|Dexamethasone acetate|dexamethasone acetate|mesh-list
93019599|NCT03283917|Daratumumab|daratumumab|mesh-list
93019600|NCT03283917|Ixazomib|ixazomib|mesh-list
93019601|NCT03283917|Ichthammol|ichthammol|mesh-list
93019602|NCT03283917|BB 1101|bb 1101|mesh-list
93019603|NCT03283917|Glycine|glycine|mesh-list
93019604|NCT03283917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019605|NCT03283917|Antiemetics|antiemetics|mesh-ancestor
93019606|NCT03283917|Autonomic Agents|autonomic agents|mesh-ancestor
93019607|NCT03283917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019608|NCT03283917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019609|NCT03283917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019610|NCT03283917|Glucocorticoids|glucocorticoids|mesh-ancestor
93019611|NCT03283917|Hormones|hormones|mesh-ancestor
93019612|NCT03283917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019613|NCT03283917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019614|NCT03283917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019615|NCT03283917|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019616|NCT03283917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019617|NCT03283917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019618|NCT03283917|Dermatologic Agents|dermatologic agents|mesh-ancestor
93019619|NCT03283917|Glycine Agents|glycine agents|mesh-ancestor
93019620|NCT03283917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93019621|NCT03275415|Budesonide|budesonide|mesh-list
93019622|NCT03275415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019623|NCT03275415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93019624|NCT03275415|Autonomic Agents|autonomic agents|mesh-ancestor
93019625|NCT03275415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019626|NCT03275415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019627|NCT03275415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93019628|NCT03275415|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664956|NCT00271349|Budesonide|budesonide|mesh-list
93019629|NCT03275415|Glucocorticoids|glucocorticoids|mesh-ancestor
93019630|NCT03275415|Hormones|hormones|mesh-ancestor
93019631|NCT03275415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019632|NCT03233724|Pembrolizumab|pembrolizumab|mesh-list
93019633|NCT03233724|Decitabine|decitabine|mesh-list
93019634|NCT03233724|Tetrahydrouridine|tetrahydrouridine|mesh-list
93019635|NCT03233724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019636|NCT03233724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019637|NCT03233724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019638|NCT03233724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019639|NCT03233724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019640|NCT03233724|Antimetabolites|antimetabolites|mesh-ancestor
93019641|NCT03233724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019642|NCT03230734|Docetaxel|docetaxel|mesh-list
93019643|NCT03230734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019644|NCT03230734|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019645|NCT03230734|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019646|NCT03230734|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019647|NCT03230734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019648|NCT03229408|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
93019649|NCT03229408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93019650|NCT03229408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93019651|NCT03229408|Analgesics|analgesics|mesh-ancestor
93019652|NCT03229408|Sensory System Agents|sensory system agents|mesh-ancestor
93019653|NCT03229408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019654|NCT03229408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019655|NCT03229408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019656|NCT03229408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019657|NCT03182244|Cytarabine|cytarabine|mesh-list
93019658|NCT03182244|Fludarabine|fludarabine|mesh-list
93019659|NCT03182244|Etoposide|etoposide|mesh-list
93019660|NCT03182244|Mitoxantrone|mitoxantrone|mesh-list
93019661|NCT03182244|Lenograstim|lenograstim|mesh-list
93019662|NCT03182244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019663|NCT03182244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019664|NCT03182244|Antimetabolites|antimetabolites|mesh-ancestor
93019665|NCT03182244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019666|NCT03182244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019667|NCT03182244|Immunologic Factors|immunologic factors|mesh-ancestor
93019668|NCT03182244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019669|NCT03182244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019670|NCT03182244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93019671|NCT03182244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019672|NCT03182244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019673|NCT03182244|Antiviral Agents|antiviral agents|mesh-ancestor
93019674|NCT03182244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019675|NCT03182244|Analgesics|analgesics|mesh-ancestor
93019676|NCT03182244|Sensory System Agents|sensory system agents|mesh-ancestor
93019677|NCT03182244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019678|NCT03182244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93019679|NCT03174197|Temozolomide|temozolomide|mesh-list
93019680|NCT03174197|Atezolizumab|atezolizumab|mesh-list
93019681|NCT03174197|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93019682|NCT03174197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019683|NCT03174197|Alkylating Agents|alkylating agents|mesh-ancestor
93019684|NCT03174197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019685|NCT03174197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019686|NCT03174197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019687|NCT03174197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019688|NCT03174197|Immunologic Factors|immunologic factors|mesh-ancestor
92176298|NCT01890005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93019689|NCT03174197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019690|NCT03164928|Denosumab|denosumab|mesh-list
93019691|NCT03164928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93019692|NCT03164928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019693|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
93019694|NCT03146962|Vitamins|vitamins|mesh-ancestor
93019695|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
93019696|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019697|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
93019698|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019699|NCT03146962|Protective Agents|protective agents|mesh-ancestor
93019700|NCT03110978|Nivolumab|nivolumab|mesh-list
93019701|NCT03110978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019702|NCT03110978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019703|NCT03110978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019704|NCT03110978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019705|NCT03085810|Ocrelizumab|ocrelizumab|mesh-list
93019706|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
93019707|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019708|NCT03077451|Nelfinavir|nelfinavir|mesh-list
93019709|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93019710|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93019711|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019712|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019713|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019714|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93019715|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93019716|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
93019717|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019718|NCT02998268|Paclitaxel|paclitaxel|mesh-list
93019719|NCT02998268|Carboplatin|carboplatin|mesh-list
93019720|NCT02998268|Pembrolizumab|pembrolizumab|mesh-list
93019721|NCT02998268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019722|NCT02998268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019723|NCT02998268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019724|NCT02998268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019725|NCT02998268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019726|NCT02998268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019727|NCT02998268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019729|NCT02947685|Trastuzumab|trastuzumab|mesh-list
93019730|NCT02947685|Pertuzumab|pertuzumab|mesh-list
93019731|NCT02947685|Letrozole|letrozole|mesh-list
93019732|NCT02947685|Fulvestrant|fulvestrant|mesh-list
93019733|NCT02947685|Palbociclib|palbociclib|mesh-list
93019734|NCT02947685|Anastrozole|anastrozole|mesh-list
93019735|NCT02947685|Exemestane|exemestane|mesh-list
93019736|NCT02947685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019737|NCT02947685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019738|NCT02947685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93019739|NCT02947685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93019740|NCT02947685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019741|NCT02947685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019742|NCT02947685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93019743|NCT02947685|Hormone Antagonists|hormone antagonists|mesh-ancestor
93019744|NCT02947685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019745|NCT02947685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019746|NCT02947685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019747|NCT02947685|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93019748|NCT02947685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019749|NCT02879695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93019750|NCT02879695|Nivolumab|nivolumab|mesh-list
93019751|NCT02879695|Ipilimumab|ipilimumab|mesh-list
93019752|NCT02879695|Blinatumomab|blinatumomab|mesh-list
93019753|NCT02879695|Antibodies|antibodies|mesh-list
93019754|NCT02879695|Immunoglobulins|immunoglobulins|mesh-list
93019755|NCT02879695|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93019756|NCT02879695|Muromonab-CD3|muromonab-cd3|mesh-list
93019757|NCT02879695|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93019758|NCT02879695|Immunologic Factors|immunologic factors|mesh-ancestor
93019759|NCT02879695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019760|NCT02879695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019761|NCT02879695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019762|NCT02879695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019763|NCT02879695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019764|NCT02871882|Bile Acids and Salts|bile acids and salts|mesh-list
93019765|NCT02871882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019766|NCT02824276|Morphine|morphine|mesh-list
93019767|NCT02824276|Oxycodone|oxycodone|mesh-list
93019768|NCT02824276|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93019769|NCT02824276|Narcotics|narcotics|mesh-ancestor
93019770|NCT02824276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019771|NCT02824276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019772|NCT02824276|Analgesics|analgesics|mesh-ancestor
93019773|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
93019774|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019775|NCT02813135|Cytarabine|cytarabine|mesh-list
93019776|NCT02813135|Dexamethasone|dexamethasone|mesh-list
93019777|NCT02813135|Cyclophosphamide|cyclophosphamide|mesh-list
93019778|NCT02813135|Temozolomide|temozolomide|mesh-list
93019779|NCT02813135|Carboplatin|carboplatin|mesh-list
93019780|NCT02813135|Nivolumab|nivolumab|mesh-list
93019781|NCT02813135|Irinotecan|irinotecan|mesh-list
93019782|NCT02813135|Everolimus|everolimus|mesh-list
93019783|NCT02813135|Topotecan|topotecan|mesh-list
93019784|NCT02813135|Olaparib|olaparib|mesh-list
93019785|NCT02813135|Futibatinib|futibatinib|mesh-list
93019787|NCT02813135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019788|NCT02813135|Immunologic Factors|immunologic factors|mesh-ancestor
93019789|NCT02813135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019790|NCT02813135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019791|NCT02813135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019792|NCT02813135|Alkylating Agents|alkylating agents|mesh-ancestor
93019793|NCT02813135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019794|NCT02813135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019795|NCT02813135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93019796|NCT02813135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019797|NCT02813135|Antiemetics|antiemetics|mesh-ancestor
93019798|NCT02813135|Autonomic Agents|autonomic agents|mesh-ancestor
93019799|NCT02813135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019800|NCT02813135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019801|NCT02813135|Glucocorticoids|glucocorticoids|mesh-ancestor
93019802|NCT02813135|Hormones|hormones|mesh-ancestor
93019803|NCT02813135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019804|NCT02813135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019805|NCT02813135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93019806|NCT02813135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93019807|NCT02813135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93019808|NCT02813135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019809|NCT02813135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019810|NCT02813135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019811|NCT02813135|Antimetabolites|antimetabolites|mesh-ancestor
93019812|NCT02813135|Antiviral Agents|antiviral agents|mesh-ancestor
93019813|NCT02813135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019814|NCT02813135|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93019815|NCT02813135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019816|NCT02813135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93019817|NCT02732288|Melatonin|melatonin|mesh-list
93019818|NCT02732288|Antioxidants|antioxidants|mesh-ancestor
93019819|NCT02732288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019820|NCT02732288|Protective Agents|protective agents|mesh-ancestor
93019821|NCT02732288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019822|NCT02732288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93019823|NCT02687958|Everolimus|everolimus|mesh-list
93019824|NCT02687958|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93019825|NCT02687958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019826|NCT02687958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019827|NCT02687958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019828|NCT02687958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019829|NCT02687958|Immunologic Factors|immunologic factors|mesh-ancestor
93019830|NCT02687958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019831|NCT02687958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019832|NCT02478710|Vancomycin|vancomycin|mesh-list
93019833|NCT02478710|Tobramycin|tobramycin|mesh-list
93019834|NCT02478710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93019835|NCT02478710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93019836|NCT02476279|Indomethacin|indomethacin|mesh-list
93019837|NCT02476279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93019838|NCT02476279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93019839|NCT02476279|Analgesics|analgesics|mesh-ancestor
93019840|NCT02476279|Sensory System Agents|sensory system agents|mesh-ancestor
93019841|NCT02476279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019842|NCT02476279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019843|NCT02476279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019844|NCT02476279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019845|NCT02476279|Gout Suppressants|gout suppressants|mesh-ancestor
93019846|NCT02476279|Tocolytic Agents|tocolytic agents|mesh-ancestor
93019847|NCT02476279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93019848|NCT02476279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93019849|NCT02476279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019850|NCT02476279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019851|NCT02425865|Golimumab|golimumab|mesh-list
93019852|NCT02425865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93019853|NCT02425865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019854|NCT02425865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019855|NCT02425865|Immunologic Factors|immunologic factors|mesh-ancestor
93019856|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019857|NCT02425852|Prednisolone|prednisolone|mesh-list
93019858|NCT02425852|Hydrocortisone|hydrocortisone|mesh-list
93019859|NCT02425852|Infliximab|infliximab|mesh-list
93019860|NCT02425852|Azathioprine|azathioprine|mesh-list
93019861|NCT02425852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019863|NCT02425852|Hormones|hormones|mesh-ancestor
93019864|NCT02425852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019865|NCT02425852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019866|NCT02425852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019867|NCT02425852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019868|NCT02425852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019869|NCT02425852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93019870|NCT02425852|Dermatologic Agents|dermatologic agents|mesh-ancestor
93019871|NCT02425852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019872|NCT02425852|Antimetabolites|antimetabolites|mesh-ancestor
93019873|NCT02425852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019874|NCT02425852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019875|NCT02425852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019876|NCT02425852|Immunologic Factors|immunologic factors|mesh-ancestor
93019877|NCT02382549|Vaccines|vaccines|mesh-list
93019878|NCT02382549|Immunologic Factors|immunologic factors|mesh-ancestor
93019879|NCT02382549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019880|NCT02333188|Leucovorin|leucovorin|mesh-list
93019881|NCT02333188|Paclitaxel|paclitaxel|mesh-list
93019882|NCT02333188|Fluorouracil|fluorouracil|mesh-list
93019883|NCT02333188|Irinotecan|irinotecan|mesh-list
93019884|NCT02333188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93019885|NCT02333188|Calcium|calcium|mesh-list
93019886|NCT02333188|Levoleucovorin|levoleucovorin|mesh-list
93019887|NCT02333188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019888|NCT02333188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176503|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
93019889|NCT02333188|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019890|NCT02333188|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019891|NCT02333188|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019892|NCT02333188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019893|NCT02333188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93019894|NCT02333188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019895|NCT02333188|Antimetabolites|antimetabolites|mesh-ancestor
93019896|NCT02333188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93019897|NCT02333188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019898|NCT02333188|Immunologic Factors|immunologic factors|mesh-ancestor
93019899|NCT02333188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93019900|NCT02333188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019901|NCT02333188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019902|NCT02333188|Antidotes|antidotes|mesh-ancestor
93019903|NCT02333188|Protective Agents|protective agents|mesh-ancestor
93019904|NCT02333188|Vitamin B Complex|vitamin b complex|mesh-ancestor
93019905|NCT02333188|Vitamins|vitamins|mesh-ancestor
93019906|NCT02333188|Micronutrients|micronutrients|mesh-ancestor
93019907|NCT02282358|Mocetinostat|mocetinostat|mesh-list
93019908|NCT02282358|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93019909|NCT02282358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019910|NCT02282358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019911|NCT02177578|Temozolomide|temozolomide|mesh-list
93019912|NCT02177578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019913|NCT02177578|Alkylating Agents|alkylating agents|mesh-ancestor
93019914|NCT02177578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019915|NCT02177578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019916|NCT02166463|Prednisone|prednisone|mesh-list
93019917|NCT02166463|Methylprednisolone|methylprednisolone|mesh-list
93019918|NCT02166463|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93019919|NCT02166463|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93019920|NCT02166463|Prednisolone|prednisolone|mesh-list
93019921|NCT02166463|Prednisolone acetate|prednisolone acetate|mesh-list
93019922|NCT02166463|Cortisone|cortisone|mesh-list
93019923|NCT02166463|Cyclophosphamide|cyclophosphamide|mesh-list
93019924|NCT02166463|Doxorubicin|doxorubicin|mesh-list
93019925|NCT02166463|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93019926|NCT02166463|Etoposide|etoposide|mesh-list
93019927|NCT02166463|Vincristine|vincristine|mesh-list
93019928|NCT02166463|Etoposide phosphate|etoposide phosphate|mesh-list
93019929|NCT02166463|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93019930|NCT02166463|Bleomycin|bleomycin|mesh-list
93019931|NCT02166463|Podophyllotoxin|podophyllotoxin|mesh-list
93019932|NCT02166463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93019933|NCT02166463|Antibodies|antibodies|mesh-list
93019934|NCT02166463|Immunoglobulins|immunoglobulins|mesh-list
93019935|NCT02166463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93019936|NCT02166463|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93019937|NCT02166463|Prednisolone phosphate|prednisolone phosphate|mesh-list
93019938|NCT02166463|Immunoconjugates|immunoconjugates|mesh-list
93019940|NCT02166463|Immunologic Factors|immunologic factors|mesh-ancestor
93019941|NCT02166463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019942|NCT02166463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019943|NCT02166463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019944|NCT02166463|Alkylating Agents|alkylating agents|mesh-ancestor
93019945|NCT02166463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019946|NCT02166463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019947|NCT02166463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93019948|NCT02166463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93019949|NCT02166463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93019950|NCT02166463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019951|NCT02166463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019952|NCT02166463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93019953|NCT02166463|Glucocorticoids|glucocorticoids|mesh-ancestor
93019954|NCT02166463|Hormones|hormones|mesh-ancestor
93019955|NCT02166463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93019956|NCT02166463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93019957|NCT02166463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019958|NCT02166463|Tubulin Modulators|tubulin modulators|mesh-ancestor
93019959|NCT02166463|Antimitotic Agents|antimitotic agents|mesh-ancestor
93019960|NCT02166463|Mitosis Modulators|mitosis modulators|mesh-ancestor
93019961|NCT02166463|Antiemetics|antiemetics|mesh-ancestor
93019962|NCT02166463|Autonomic Agents|autonomic agents|mesh-ancestor
93019963|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93019964|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93019965|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93019966|NCT02166463|Protective Agents|protective agents|mesh-ancestor
93019967|NCT02166463|Immunotoxins|immunotoxins|mesh-ancestor
93019968|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
93019969|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
93019970|NCT02112526|Acalabrutinib|acalabrutinib|mesh-list
93019971|NCT02112526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019972|NCT02094794|Cyclophosphamide|cyclophosphamide|mesh-list
93019973|NCT02094794|Etoposide|etoposide|mesh-list
93019974|NCT02094794|Etoposide phosphate|etoposide phosphate|mesh-list
93019975|NCT02094794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93019976|NCT02094794|Immunologic Factors|immunologic factors|mesh-ancestor
93019977|NCT02094794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019978|NCT02094794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93019979|NCT02094794|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93019980|NCT02094794|Alkylating Agents|alkylating agents|mesh-ancestor
93019981|NCT02094794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019982|NCT02094794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019983|NCT02094794|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92176545|NCT04753489|Protease Inhibitors|protease inhibitors|mesh-ancestor
93019984|NCT02094794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93019985|NCT02094794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93019986|NCT02094794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93019987|NCT02094794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019988|NCT01902173|Trametinib|trametinib|mesh-list
93019989|NCT01902173|Dabrafenib|dabrafenib|mesh-list
93019990|NCT01902173|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93019991|NCT01902173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93019992|NCT01902173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93019993|NCT01902173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93019994|NCT01902173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93019995|NCT01902173|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93019996|NCT01902173|Protective Agents|protective agents|mesh-ancestor
93019997|NCT01902173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93019998|NCT01902173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93019999|NCT01902173|Antioxidants|antioxidants|mesh-ancestor
93020000|NCT01892709|Hydromorphone|hydromorphone|mesh-list
93020001|NCT01892709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93020002|NCT01892709|Narcotics|narcotics|mesh-ancestor
93020003|NCT01892709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020004|NCT01892709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020005|NCT01892709|Analgesics|analgesics|mesh-ancestor
93020006|NCT01892709|Sensory System Agents|sensory system agents|mesh-ancestor
93020007|NCT01892709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020008|NCT01860937|Cyclophosphamide|cyclophosphamide|mesh-list
93020009|NCT01860937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020010|NCT01860937|Immunologic Factors|immunologic factors|mesh-ancestor
93020011|NCT01860937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665298|NCT00272831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020012|NCT01860937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020013|NCT01860937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020014|NCT01860937|Alkylating Agents|alkylating agents|mesh-ancestor
93020015|NCT01860937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020016|NCT01860937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020017|NCT01860937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020019|NCT01806571|Daunorubicin|daunorubicin|mesh-list
93020020|NCT01806571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020021|NCT01806571|Antimetabolites|antimetabolites|mesh-ancestor
93020022|NCT01806571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020023|NCT01806571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020024|NCT01806571|Antiviral Agents|antiviral agents|mesh-ancestor
93020025|NCT01806571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020026|NCT01806571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020027|NCT01806571|Immunologic Factors|immunologic factors|mesh-ancestor
93020028|NCT01806571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176583|NCT02213289|Nivolumab|nivolumab|mesh-list
93020029|NCT01806571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93020030|NCT01806571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93020031|NCT01806571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93020032|NCT01806571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020033|NCT01772472|Trastuzumab|trastuzumab|mesh-list
93020034|NCT01772472|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93020035|NCT01772472|Maytansine|maytansine|mesh-list
93020036|NCT01772472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020037|NCT01772472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020038|NCT01772472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93020039|NCT01772472|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020040|NCT01772472|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020041|NCT01772472|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020042|NCT01772472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020043|NCT01772472|Immunotoxins|immunotoxins|mesh-ancestor
93020044|NCT01772472|Immunoconjugates|immunoconjugates|mesh-ancestor
93020045|NCT01772472|Immunologic Factors|immunologic factors|mesh-ancestor
93020046|NCT01772472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020047|NCT01633177|Vitamin D|vitamin d|mesh-list
93020048|NCT01633177|Ergocalciferols|ergocalciferols|mesh-list
93020049|NCT01633177|Cholecalciferol|cholecalciferol|mesh-list
93020050|NCT01633177|Vitamins|vitamins|mesh-list
93020051|NCT01633177|Micronutrients|micronutrients|mesh-ancestor
93020052|NCT01633177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020053|NCT01633177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93020054|NCT01633177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93020055|NCT01522976|Lenalidomide|lenalidomide|mesh-list
93020056|NCT01522976|Azacitidine|azacitidine|mesh-list
93020057|NCT01522976|Vorinostat|vorinostat|mesh-list
93020058|NCT01522976|Immunologic Factors|immunologic factors|mesh-ancestor
93020059|NCT01522976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020060|NCT01522976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93020061|NCT01522976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93020062|NCT01522976|Growth Substances|growth substances|mesh-ancestor
93020063|NCT01522976|Growth Inhibitors|growth inhibitors|mesh-ancestor
93020064|NCT01522976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020065|NCT01522976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020066|NCT01522976|Antimetabolites|antimetabolites|mesh-ancestor
93020067|NCT01522976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020068|NCT01522976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020069|NCT01522976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93020070|NCT01517451|Androgens|androgens|mesh-list
93020071|NCT01517451|Hormones|hormones|mesh-ancestor
93020072|NCT01517451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020073|NCT01517451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020074|NCT01409200|Ascorbic Acid|ascorbic acid|mesh-list
93020075|NCT01409200|Methyltestosterone|methyltestosterone|mesh-list
93020076|NCT01409200|Axitinib|axitinib|mesh-list
93020077|NCT01409200|Hormones|hormones|mesh-list
93020078|NCT01409200|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93020079|NCT01409200|Androgens|androgens|mesh-list
93020080|NCT01409200|Androgen Antagonists|androgen antagonists|mesh-list
93020081|NCT01409200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020082|NCT01409200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020083|NCT01409200|Antioxidants|antioxidants|mesh-ancestor
93020084|NCT01409200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020085|NCT01409200|Protective Agents|protective agents|mesh-ancestor
93020086|NCT01409200|Vitamins|vitamins|mesh-ancestor
93020087|NCT01409200|Micronutrients|micronutrients|mesh-ancestor
93020088|NCT01409200|Estrogens|estrogens|mesh-ancestor
93020089|NCT01409200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020090|NCT01409200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020091|NCT01409200|Anabolic Agents|anabolic agents|mesh-ancestor
93020092|NCT01409200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93020093|NCT01409200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020094|NCT01409200|Hormone Antagonists|hormone antagonists|mesh-ancestor
93020095|NCT01204216|Biotin|biotin|mesh-list
93020096|NCT01204216|Vitamin B Complex|vitamin b complex|mesh-ancestor
93020097|NCT01204216|Vitamins|vitamins|mesh-ancestor
93020098|NCT01204216|Micronutrients|micronutrients|mesh-ancestor
93020099|NCT01204216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020100|NCT01104350|Gemcitabine|gemcitabine|mesh-list
93020101|NCT01104350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020102|NCT01104350|Antimetabolites|antimetabolites|mesh-ancestor
93020103|NCT01104350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020104|NCT01104350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020105|NCT01100892|Insulin Detemir|insulin detemir|mesh-list
93020106|NCT01100892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93020107|NCT01100892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020108|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
93020109|NCT01025089|Doxorubicin|doxorubicin|mesh-list
93020110|NCT01025089|Cetuximab|cetuximab|mesh-list
93020111|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020112|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
93020113|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020114|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020115|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020116|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
93020117|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020118|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020119|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020120|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93020121|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93020122|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93020123|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020124|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020125|NCT00999037|Sevelamer|sevelamer|mesh-list
93020126|NCT00999037|Chelating Agents|chelating agents|mesh-ancestor
93020127|NCT00999037|Sequestering Agents|sequestering agents|mesh-ancestor
93020128|NCT00999037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020129|NCT00921856|Acetylcholine|acetylcholine|mesh-list
93020130|NCT00921856|Vasodilator Agents|vasodilator agents|mesh-ancestor
93020131|NCT00921856|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93020132|NCT00921856|Cholinergic Agents|cholinergic agents|mesh-ancestor
93020133|NCT00921856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020134|NCT00921856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020135|NCT00921856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020136|NCT00861705|Paclitaxel|paclitaxel|mesh-list
93020137|NCT00861705|Cyclophosphamide|cyclophosphamide|mesh-list
93020138|NCT00861705|Bevacizumab|bevacizumab|mesh-list
93020139|NCT00861705|Carboplatin|carboplatin|mesh-list
93020140|NCT00861705|Doxorubicin|doxorubicin|mesh-list
93020141|NCT00861705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93020142|NCT00861705|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93020143|NCT00861705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93020144|NCT00861705|Antibodies|antibodies|mesh-list
93020145|NCT00861705|Immunoglobulins|immunoglobulins|mesh-list
93020146|NCT00861705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93020147|NCT00861705|Immunoglobulin G|immunoglobulin g|mesh-list
93020148|NCT00861705|Endothelial Growth Factors|endothelial growth factors|mesh-list
93020149|NCT00861705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93020150|NCT00861705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020151|NCT00861705|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020152|NCT00861705|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020153|NCT00861705|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020154|NCT00861705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020155|NCT00861705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020156|NCT00861705|Immunologic Factors|immunologic factors|mesh-ancestor
93020157|NCT00861705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020158|NCT00861705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020159|NCT00861705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020160|NCT00861705|Alkylating Agents|alkylating agents|mesh-ancestor
93020161|NCT00861705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020162|NCT00861705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93020163|NCT00861705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93020164|NCT00861705|Growth Substances|growth substances|mesh-ancestor
93020165|NCT00861705|Growth Inhibitors|growth inhibitors|mesh-ancestor
93020166|NCT00861705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93020167|NCT00861705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93020168|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93020169|NCT00861705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020170|NCT00833664|Terbinafine|terbinafine|mesh-list
93020171|NCT00833664|Antifungal Agents|antifungal agents|mesh-ancestor
93020172|NCT00833664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020173|NCT00833664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020174|NCT00833664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020175|NCT00696111|Leuprolide|leuprolide|mesh-list
93020176|NCT00696111|Progesterone|progesterone|mesh-list
93020177|NCT00696111|Estrogens|estrogens|mesh-list
93020178|NCT00696111|Progestins|progestins|mesh-ancestor
93020179|NCT00696111|Hormones|hormones|mesh-ancestor
93020180|NCT00696111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020181|NCT00696111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020182|NCT00696111|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93020183|NCT00696111|Fertility Agents|fertility agents|mesh-ancestor
93020184|NCT00696111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93020185|NCT00696111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020186|NCT00696111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020187|NCT00354393|Methotrexate|methotrexate|mesh-list
93020188|NCT00354393|Vinorelbine|vinorelbine|mesh-list
93020189|NCT00354393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020190|NCT00354393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93020191|NCT00354393|Abortifacient Agents|abortifacient agents|mesh-ancestor
93020192|NCT00354393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93020193|NCT00354393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020194|NCT00354393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020195|NCT00354393|Antimetabolites|antimetabolites|mesh-ancestor
93020196|NCT00354393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020197|NCT00354393|Dermatologic Agents|dermatologic agents|mesh-ancestor
93020198|NCT00354393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020199|NCT00354393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93020200|NCT00354393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020201|NCT00354393|Immunologic Factors|immunologic factors|mesh-ancestor
93020202|NCT00354393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020203|NCT00354393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93020204|NCT00354393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93020205|NCT00354393|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020206|NCT00354393|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020207|NCT00354393|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020209|NCT00224393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93020210|NCT00224393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020211|NCT00224393|Analgesics|analgesics|mesh-ancestor
93020212|NCT00224393|Sensory System Agents|sensory system agents|mesh-ancestor
93020213|NCT00224393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020214|NCT00224393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020215|NCT00224393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020216|NCT00224393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020217|NCT00224393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020218|NCT00224393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020219|NCT00224393|Immunologic Factors|immunologic factors|mesh-ancestor
93020220|NCT00199862|Antibodies|antibodies|mesh-list
93020221|NCT00199862|Immunologic Factors|immunologic factors|mesh-ancestor
93020222|NCT00199862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020223|NCT00128310|Gemcitabine|gemcitabine|mesh-list
93020224|NCT00128310|Vinorelbine|vinorelbine|mesh-list
93020225|NCT00128310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020226|NCT00128310|Antimetabolites|antimetabolites|mesh-ancestor
93020227|NCT00128310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020228|NCT00128310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020229|NCT00128310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93020230|NCT00128310|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020231|NCT00128310|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020232|NCT00128310|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020233|NCT00885443|Propofol|propofol|mesh-list
93020234|NCT00885443|Sevoflurane|sevoflurane|mesh-list
93020235|NCT00885443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93020236|NCT00885443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020237|NCT00885443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020238|NCT00885443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93020239|NCT00885443|Anesthetics, General|anesthetics, general|mesh-ancestor
93020240|NCT00885443|Anesthetics|anesthetics|mesh-ancestor
93020241|NCT00885443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93020242|NCT00885443|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93020243|NCT00882869|Sorafenib|sorafenib|mesh-list
93020244|NCT00882869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020245|NCT00882869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93020246|NCT00882869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020247|NCT00882869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020248|NCT00882947|Iloprost|iloprost|mesh-list
93020249|NCT00882947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93020250|NCT00882947|Vasodilator Agents|vasodilator agents|mesh-ancestor
93020251|NCT00531050|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93020252|NCT00531050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93020253|NCT00531050|Autonomic Agents|autonomic agents|mesh-ancestor
92528840|NCT00000899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020254|NCT00531050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020255|NCT00531050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020257|NCT00531050|Respiratory System Agents|respiratory system agents|mesh-ancestor
93020258|NCT00531050|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93020259|NCT00531050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93020260|NCT00531050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93020261|NCT00531050|Adrenergic Agents|adrenergic agents|mesh-ancestor
93020262|NCT00531050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020263|NCT00531050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020264|NCT00530348|Interferons|interferons|mesh-list
93020265|NCT00530348|Interferon-beta|interferon-beta|mesh-list
93020266|NCT00530348|Interferon beta-1a|interferon beta-1a|mesh-list
93020267|NCT00530348|Alemtuzumab|alemtuzumab|mesh-list
93020268|NCT00530348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020269|NCT00530348|Antiviral Agents|antiviral agents|mesh-ancestor
93020270|NCT00530348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020271|NCT00530348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020272|NCT00530348|Immunologic Factors|immunologic factors|mesh-ancestor
93020273|NCT00530348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020274|NCT00530348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93020275|NCT01007864|Pramipexole|pramipexole|mesh-list
93020276|NCT01007864|Ropinirole|ropinirole|mesh-list
93020277|NCT01007864|Piribedil|piribedil|mesh-list
93020278|NCT01007864|Antioxidants|antioxidants|mesh-ancestor
93020279|NCT01007864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020280|NCT01007864|Protective Agents|protective agents|mesh-ancestor
93020281|NCT01007864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020282|NCT01007864|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93020283|NCT01007864|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93020284|NCT01007864|Dopamine Agonists|dopamine agonists|mesh-ancestor
93020285|NCT01007864|Dopamine Agents|dopamine agents|mesh-ancestor
93020286|NCT01007864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020287|NCT01008020|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93020288|NCT01008020|Antioxidants|antioxidants|mesh-ancestor
93020289|NCT01008020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020290|NCT01008020|Protective Agents|protective agents|mesh-ancestor
93020291|NCT01008020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020292|NCT01008020|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93020293|NCT01008020|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93020294|NCT01008020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020295|NCT01008020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93020296|NCT01008098|Escitalopram|escitalopram|mesh-list
93020297|NCT01008098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93020298|NCT01008098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93020299|NCT01008098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93020300|NCT01008098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020301|NCT01008098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020302|NCT01008098|Serotonin Agents|serotonin agents|mesh-ancestor
93020303|NCT01008098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020304|NCT00530270|Dexamethasone|dexamethasone|mesh-list
93020305|NCT00530270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020306|NCT00530270|Antiemetics|antiemetics|mesh-ancestor
93020307|NCT00530270|Autonomic Agents|autonomic agents|mesh-ancestor
93020308|NCT00530270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020309|NCT00530270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020310|NCT00530270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020311|NCT00530270|Glucocorticoids|glucocorticoids|mesh-ancestor
93020312|NCT00530270|Hormones|hormones|mesh-ancestor
93020313|NCT00530270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020314|NCT00530270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020315|NCT00530270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665611|NCT00274118|Enalapril|enalapril|mesh-list
93020316|NCT01008488|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93020317|NCT01008488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020318|NCT01001624|Hydroquinone|hydroquinone|mesh-list
93020319|NCT01001624|Antioxidants|antioxidants|mesh-ancestor
93020320|NCT01001624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020321|NCT01001624|Protective Agents|protective agents|mesh-ancestor
93020322|NCT01001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020323|NCT01001624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93020324|NCT01001780|Cyclophosphamide|cyclophosphamide|mesh-list
93020325|NCT01001780|Rituximab|rituximab|mesh-list
93020326|NCT01001780|Pentostatin|pentostatin|mesh-list
93020327|NCT01001780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020328|NCT01001780|Immunologic Factors|immunologic factors|mesh-ancestor
93020329|NCT01001780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020330|NCT01001780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020331|NCT01001780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020332|NCT01001780|Alkylating Agents|alkylating agents|mesh-ancestor
93020333|NCT01001780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020334|NCT01001780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020335|NCT01001780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020336|NCT01001780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020337|NCT01001780|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93020338|NCT01001780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020340|NCT01008566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93020341|NCT01008566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020342|NCT01008566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93020343|NCT01008566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020344|NCT01008566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020345|NCT01008566|Immunologic Factors|immunologic factors|mesh-ancestor
93020346|NCT01008566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020347|NCT03885596|Acetaminophen|acetaminophen|mesh-list
93020348|NCT03885596|Celecoxib|celecoxib|mesh-list
93020349|NCT03885596|Ketorolac|ketorolac|mesh-list
93020350|NCT03885596|Lidocaine|lidocaine|mesh-list
93020351|NCT03885596|Fentanyl|fentanyl|mesh-list
93020352|NCT03885596|Bupivacaine|bupivacaine|mesh-list
93020353|NCT03885596|Anesthetics, Local|anesthetics, local|mesh-ancestor
93020354|NCT03885596|Anesthetics|anesthetics|mesh-ancestor
93020355|NCT03885596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020356|NCT03885596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020357|NCT03885596|Sensory System Agents|sensory system agents|mesh-ancestor
93020358|NCT03885596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020359|NCT03885596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93020360|NCT03885596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93020361|NCT03885596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93020362|NCT03885596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93020363|NCT03885596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020364|NCT03885596|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93020365|NCT03885596|Narcotics|narcotics|mesh-ancestor
93020366|NCT03885596|Analgesics|analgesics|mesh-ancestor
93020367|NCT03885596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93020368|NCT03885596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93020369|NCT03885596|Anesthetics, General|anesthetics, general|mesh-ancestor
93020370|NCT03885596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020371|NCT03885596|Antipyretics|antipyretics|mesh-ancestor
93020372|NCT03885596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93020373|NCT03885596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020374|NCT03885596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020375|NCT03885596|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93020376|NCT03885596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93020377|NCT03885596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020378|NCT01002092|Endostar protein|endostar protein|mesh-list
93020379|NCT01002092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93020380|NCT01002092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93020381|NCT01002092|Growth Substances|growth substances|mesh-ancestor
93020382|NCT01002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020383|NCT01002092|Growth Inhibitors|growth inhibitors|mesh-ancestor
93020384|NCT01002092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020385|NCT03999866|Pyrithione zinc|pyrithione zinc|mesh-list
93020386|NCT03999866|Keratolytic Agents|keratolytic agents|mesh-ancestor
93020387|NCT03999866|Dermatologic Agents|dermatologic agents|mesh-ancestor
93020388|NCT00529100|Cisplatin|cisplatin|mesh-list
93020389|NCT00529100|Pemetrexed|pemetrexed|mesh-list
92665671|NCT00308607|Alkylating Agents|alkylating agents|mesh-ancestor
93020390|NCT00529100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020391|NCT00529100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020392|NCT00529100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020393|NCT00529100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93020394|NCT00529100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93020395|NCT05732948|Cyclophosphamide|cyclophosphamide|mesh-list
93020396|NCT05732948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020397|NCT05732948|Immunologic Factors|immunologic factors|mesh-ancestor
93020398|NCT05732948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020399|NCT05732948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020400|NCT05732948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020401|NCT05732948|Alkylating Agents|alkylating agents|mesh-ancestor
93020402|NCT05732948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020403|NCT05732948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020404|NCT05732948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020405|NCT00529802|Everolimus|everolimus|mesh-list
93020406|NCT00529802|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93020407|NCT00529802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93020408|NCT00529802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020409|NCT00529802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020410|NCT00529802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020411|NCT00529802|Immunologic Factors|immunologic factors|mesh-ancestor
93020412|NCT00529802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020413|NCT00529802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020414|NCT00528866|Docetaxel|docetaxel|mesh-list
93020415|NCT00528866|Bicalutamide|bicalutamide|mesh-list
93020416|NCT00528866|Flutamide|flutamide|mesh-list
93020417|NCT00528866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020418|NCT00528866|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020419|NCT00528866|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020420|NCT00528866|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020421|NCT00528866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020422|NCT00528866|Androgen Antagonists|androgen antagonists|mesh-ancestor
93020423|NCT00528866|Hormone Antagonists|hormone antagonists|mesh-ancestor
93020424|NCT00528866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020425|NCT00528866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020426|NCT00528866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020427|NCT05730920|Methadone|methadone|mesh-list
93020428|NCT05730920|Bupivacaine|bupivacaine|mesh-list
93020429|NCT05730920|Anesthetics, Local|anesthetics, local|mesh-ancestor
93020430|NCT05730920|Anesthetics|anesthetics|mesh-ancestor
93020431|NCT05730920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020432|NCT05730920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020433|NCT05730920|Sensory System Agents|sensory system agents|mesh-ancestor
93020434|NCT05730920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020435|NCT05730920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93020436|NCT05730920|Narcotics|narcotics|mesh-ancestor
93020437|NCT05730920|Analgesics|analgesics|mesh-ancestor
93020438|NCT05730920|Antitussive Agents|antitussive agents|mesh-ancestor
93020439|NCT05730920|Respiratory System Agents|respiratory system agents|mesh-ancestor
93020440|NCT03999008|Budesonide|budesonide|mesh-list
93020441|NCT03999008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020442|NCT03999008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93020443|NCT03999008|Autonomic Agents|autonomic agents|mesh-ancestor
93020444|NCT03999008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020445|NCT03999008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020446|NCT03999008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93020447|NCT03999008|Respiratory System Agents|respiratory system agents|mesh-ancestor
93020448|NCT03999008|Glucocorticoids|glucocorticoids|mesh-ancestor
93020449|NCT03999008|Hormones|hormones|mesh-ancestor
93020450|NCT03999008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020451|NCT05140148|Amantadine|amantadine|mesh-list
93020452|NCT05140148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93020453|NCT05140148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93020454|NCT05140148|Antiviral Agents|antiviral agents|mesh-ancestor
93020455|NCT05140148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020456|NCT05140148|Dopamine Agents|dopamine agents|mesh-ancestor
93020457|NCT05140148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020458|NCT05140148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020459|NCT05140148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020460|NCT05140148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020461|NCT05140148|Analgesics|analgesics|mesh-ancestor
93020462|NCT05140148|Sensory System Agents|sensory system agents|mesh-ancestor
93020463|NCT05140148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020464|NCT04932746|Dexmedetomidine|dexmedetomidine|mesh-list
93020465|NCT04932746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93020466|NCT04932746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020467|NCT04932746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020468|NCT04932746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020469|NCT04932746|Analgesics|analgesics|mesh-ancestor
93020470|NCT04932746|Sensory System Agents|sensory system agents|mesh-ancestor
93020471|NCT04932746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020472|NCT04932746|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93020473|NCT04932746|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93020474|NCT04932746|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93020475|NCT04932746|Adrenergic Agents|adrenergic agents|mesh-ancestor
93020476|NCT04932746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020477|NCT04932746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020478|NCT00614393|Irinotecan|irinotecan|mesh-list
93020479|NCT00614393|Cetuximab|cetuximab|mesh-list
93020480|NCT00614393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93020481|NCT00614393|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93020482|NCT00614393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93020483|NCT00614393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020484|NCT00614393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020485|NCT00614393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020486|NCT00614393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020487|NCT00614393|Immunologic Factors|immunologic factors|mesh-ancestor
93020488|NCT00614393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020489|NCT00880529|Morphine|morphine|mesh-list
93020490|NCT00880529|Bupivacaine|bupivacaine|mesh-list
93020491|NCT00880529|Anesthetics, Local|anesthetics, local|mesh-ancestor
93020492|NCT00880529|Anesthetics|anesthetics|mesh-ancestor
93020493|NCT00880529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020494|NCT00880529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020495|NCT00880529|Sensory System Agents|sensory system agents|mesh-ancestor
93020496|NCT00880529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020497|NCT00880529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93020498|NCT00880529|Narcotics|narcotics|mesh-ancestor
93020499|NCT00880529|Analgesics|analgesics|mesh-ancestor
93020500|NCT00880841|Buprenorphine|buprenorphine|mesh-list
93020501|NCT00880841|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93020502|NCT00880841|Naloxone|naloxone|mesh-list
93020503|NCT00880841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93020504|NCT00880841|Narcotics|narcotics|mesh-ancestor
93020505|NCT00880841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020506|NCT00880841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020507|NCT00880841|Analgesics|analgesics|mesh-ancestor
93020508|NCT00880841|Sensory System Agents|sensory system agents|mesh-ancestor
93020509|NCT00880841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020510|NCT00880841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93020511|NCT00883259|Metformin|metformin|mesh-list
93020512|NCT00883259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93020513|NCT00883259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020514|NCT00885599|Listerine|listerine|mesh-list
93020515|NCT00885599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93020516|NCT00885599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020517|NCT04366115|Dexamethasone|dexamethasone|mesh-list
93020518|NCT04366115|Dexamethasone acetate|dexamethasone acetate|mesh-list
93020519|NCT04366115|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93020520|NCT04366115|BB 1101|bb 1101|mesh-list
93020521|NCT04366115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020522|NCT04366115|Antiemetics|antiemetics|mesh-ancestor
93020523|NCT04366115|Autonomic Agents|autonomic agents|mesh-ancestor
93020524|NCT04366115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020525|NCT04366115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020526|NCT04366115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020527|NCT04366115|Glucocorticoids|glucocorticoids|mesh-ancestor
93020528|NCT04366115|Hormones|hormones|mesh-ancestor
93020529|NCT04366115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020530|NCT04366115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020531|NCT04366115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020532|NCT04366115|Protease Inhibitors|protease inhibitors|mesh-ancestor
93020533|NCT04366115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020534|NCT04366115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020535|NCT04038125|Dexamethasone|dexamethasone|mesh-list
93020536|NCT04038125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020537|NCT04038125|Antiemetics|antiemetics|mesh-ancestor
93020538|NCT04038125|Autonomic Agents|autonomic agents|mesh-ancestor
93020539|NCT04038125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020540|NCT04038125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020541|NCT04038125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020542|NCT04038125|Glucocorticoids|glucocorticoids|mesh-ancestor
93020543|NCT04038125|Hormones|hormones|mesh-ancestor
93020544|NCT04038125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020545|NCT04038125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020546|NCT04038125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020547|NCT00881153|Cefprozil|cefprozil|mesh-list
93020548|NCT00881153|Cephalosporins|cephalosporins|mesh-list
93020549|NCT00881153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93020550|NCT00881153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020551|NCT00885833|Fludarabine|fludarabine|mesh-list
93020552|NCT00885833|Busulfan|busulfan|mesh-list
93020553|NCT00885833|Thymoglobulin|thymoglobulin|mesh-list
93020554|NCT00885833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020555|NCT00885833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020556|NCT00885833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020557|NCT00885833|Immunologic Factors|immunologic factors|mesh-ancestor
93020558|NCT00885833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020559|NCT00885833|Alkylating Agents|alkylating agents|mesh-ancestor
93020560|NCT00885833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020561|NCT00885833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020562|NCT00612677|Oxaliplatin|oxaliplatin|mesh-list
93020563|NCT00612677|Pemetrexed|pemetrexed|mesh-list
93020564|NCT00612677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020565|NCT00612677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020566|NCT00612677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020567|NCT00612677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93020568|NCT00612677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93020569|NCT04038749|Cabergoline|cabergoline|mesh-list
93020570|NCT04038749|Bromocriptine|bromocriptine|mesh-list
93020571|NCT04038749|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93020572|NCT04038749|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93020573|NCT04038749|Dopamine Agonists|dopamine agonists|mesh-ancestor
93020574|NCT04038749|Dopamine Agents|dopamine agents|mesh-ancestor
93020575|NCT04038749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020576|NCT04038749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020577|NCT04038749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020578|NCT04038749|Hormone Antagonists|hormone antagonists|mesh-ancestor
93020579|NCT04038749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020580|NCT00881231|Cilostazol|cilostazol|mesh-list
93020581|NCT00881231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93020582|NCT00881231|Autonomic Agents|autonomic agents|mesh-ancestor
93020583|NCT00881231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020584|NCT00881231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020585|NCT00881231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93020586|NCT00881231|Respiratory System Agents|respiratory system agents|mesh-ancestor
93020587|NCT00881231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93020588|NCT00881231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93020589|NCT00881231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020590|NCT00881231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93020591|NCT00881231|Vasodilator Agents|vasodilator agents|mesh-ancestor
93020592|NCT00881231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93020593|NCT00881231|Protective Agents|protective agents|mesh-ancestor
93020594|NCT00881231|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93020595|NCT00881231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93020596|NCT00881231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020597|NCT00883727|Plasma-lyte 148|plasma-lyte 148|mesh-list
93020598|NCT00883727|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93020599|NCT00883727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93020600|NCT00881387|Rituximab|rituximab|mesh-list
93020601|NCT00881387|Gemcitabine|gemcitabine|mesh-list
93020602|NCT00881387|Vinorelbine|vinorelbine|mesh-list
93020603|NCT00881387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020604|NCT00881387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020605|NCT00881387|Immunologic Factors|immunologic factors|mesh-ancestor
93020606|NCT00881387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020607|NCT00881387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020608|NCT00881387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020609|NCT00881387|Antimetabolites|antimetabolites|mesh-ancestor
93020610|NCT00881387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020611|NCT00881387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93020612|NCT00881387|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020613|NCT00881387|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020614|NCT00881387|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020615|NCT00883883|Cefdinir|cefdinir|mesh-list
93020616|NCT00883883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93020617|NCT00883883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177189|NCT02268695|Docetaxel|docetaxel|mesh-list
92665892|NCT00277589|Micronutrients|micronutrients|mesh-ancestor
93020618|NCT00881543|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93020619|NCT00881543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93020620|NCT00881543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93020621|NCT00881543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020623|NCT00881543|Hormones|hormones|mesh-ancestor
93020624|NCT00881543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020625|NCT00881543|Protease Inhibitors|protease inhibitors|mesh-ancestor
93020626|NCT00881543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020627|NCT00881543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020628|NCT00881855|Cefprozil|cefprozil|mesh-list
93020629|NCT00881855|Cephalosporins|cephalosporins|mesh-list
93020630|NCT00881855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93020631|NCT00881855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020632|NCT04015115|Analgesics, Opioid|analgesics, opioid|mesh-list
93020633|NCT04015115|Narcotics|narcotics|mesh-ancestor
93020634|NCT04015115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020635|NCT04015115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020636|NCT04015115|Analgesics|analgesics|mesh-ancestor
93020637|NCT04015115|Sensory System Agents|sensory system agents|mesh-ancestor
93020638|NCT04015115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020639|NCT02543645|Atezolizumab|atezolizumab|mesh-list
93020640|NCT02543645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93020641|NCT02543645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020642|NCT02543645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020643|NCT02543645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020644|NCT02543411|Lidocaine|lidocaine|mesh-list
93020645|NCT02543411|Anesthetics, Local|anesthetics, local|mesh-ancestor
93020646|NCT02543411|Anesthetics|anesthetics|mesh-ancestor
93020647|NCT02543411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020648|NCT02543411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020649|NCT02543411|Sensory System Agents|sensory system agents|mesh-ancestor
93020650|NCT02543411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020651|NCT02543411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93020652|NCT02543411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93020653|NCT02543411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93020654|NCT02543411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93020655|NCT02543411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020656|NCT00882323|Cyclophosphamide|cyclophosphamide|mesh-list
93020657|NCT00882323|Fludarabine|fludarabine|mesh-list
93020658|NCT00882323|Thymoglobulin|thymoglobulin|mesh-list
93020659|NCT00882323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020660|NCT00882323|Immunologic Factors|immunologic factors|mesh-ancestor
93020661|NCT00882323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020662|NCT00882323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020663|NCT00882323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93020664|NCT00882323|Alkylating Agents|alkylating agents|mesh-ancestor
93020665|NCT00882323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020666|NCT00882323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020667|NCT00882323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93020668|NCT00882401|Vitamin D|vitamin d|mesh-list
93020669|NCT00882401|Ergocalciferols|ergocalciferols|mesh-list
93020670|NCT00882401|Vitamins|vitamins|mesh-ancestor
93020671|NCT00882401|Micronutrients|micronutrients|mesh-ancestor
93020672|NCT00882401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020673|NCT00882401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93020674|NCT00882401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93020675|NCT00886457|Interferons|interferons|mesh-list
93020676|NCT00886457|Interferon-alpha|interferon-alpha|mesh-list
93020677|NCT00886457|Interferon alpha-2|interferon alpha-2|mesh-list
93020678|NCT00886457|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93020679|NCT00886457|Decitabine|decitabine|mesh-list
93020680|NCT00886457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020681|NCT00886457|Antiviral Agents|antiviral agents|mesh-ancestor
93020682|NCT00886457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020683|NCT00886457|Immunologic Factors|immunologic factors|mesh-ancestor
93020684|NCT00886457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020685|NCT00886457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020686|NCT00886457|Antimetabolites|antimetabolites|mesh-ancestor
93020687|NCT00886457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020688|NCT00886457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020689|NCT04038671|Anti-Infective Agents|anti-infective agents|mesh-list
93020690|NCT04038671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93020691|NCT04038671|Charcoal|charcoal|mesh-list
93020692|NCT04038671|Antidotes|antidotes|mesh-ancestor
93020693|NCT04038671|Protective Agents|protective agents|mesh-ancestor
93020694|NCT04038671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020696|NCT02543099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93020698|NCT02543099|Antimetabolites|antimetabolites|mesh-ancestor
93020699|NCT02543099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020700|NCT02543099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93020701|NCT02543099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93020702|NCT00882635|Heparin|heparin|mesh-list
93020703|NCT00882635|Enoxaparin|enoxaparin|mesh-list
93020704|NCT00882635|Calcium heparin|calcium heparin|mesh-list
93020705|NCT00882635|Anticoagulants|anticoagulants|mesh-ancestor
93020706|NCT00882635|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93020707|NCT00882635|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93020708|NCT00882635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020709|NCT00609869|Rituximab|rituximab|mesh-list
93020710|NCT00609869|Lenalidomide|lenalidomide|mesh-list
93020711|NCT00609869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93020712|NCT00609869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020713|NCT00609869|Immunologic Factors|immunologic factors|mesh-ancestor
93020714|NCT00609869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020715|NCT00609869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020716|NCT00609869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93020717|NCT00609869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93020718|NCT00609869|Growth Substances|growth substances|mesh-ancestor
93020719|NCT00609869|Growth Inhibitors|growth inhibitors|mesh-ancestor
93020720|NCT00888797|Etodolac|etodolac|mesh-list
93020721|NCT00888797|Propranolol|propranolol|mesh-list
93020722|NCT00888797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93020723|NCT00888797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93020724|NCT00888797|Adrenergic Agents|adrenergic agents|mesh-ancestor
93020725|NCT00888797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020726|NCT00888797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020727|NCT00888797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020728|NCT00888797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93020729|NCT00888797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93020730|NCT00888797|Vasodilator Agents|vasodilator agents|mesh-ancestor
93020731|NCT00888797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93020732|NCT00888797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020733|NCT00888797|Analgesics|analgesics|mesh-ancestor
93020734|NCT00888797|Sensory System Agents|sensory system agents|mesh-ancestor
93020735|NCT00888797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020736|NCT00888797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020737|NCT00888797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020738|NCT00888797|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93020739|NCT00888797|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93020740|NCT00888797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020741|NCT00884663|Propranolol|propranolol|mesh-list
93020742|NCT00884663|Candesartan|candesartan|mesh-list
93020743|NCT00884663|Candesartan cilexetil|candesartan cilexetil|mesh-list
93020744|NCT00884663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93020745|NCT00884663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93020746|NCT00884663|Adrenergic Agents|adrenergic agents|mesh-ancestor
93020747|NCT00884663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020748|NCT00884663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020749|NCT00884663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020750|NCT00884663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93020751|NCT00884663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93020752|NCT00884663|Vasodilator Agents|vasodilator agents|mesh-ancestor
92177369|NCT02117297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020753|NCT00884663|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93020754|NCT00884663|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93020755|NCT00887003|Methylprednisolone|methylprednisolone|mesh-list
93020756|NCT00887003|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93020757|NCT00887003|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93020758|NCT00887003|Prednisolone|prednisolone|mesh-list
93020759|NCT00887003|Prednisolone acetate|prednisolone acetate|mesh-list
93020760|NCT00887003|Bupivacaine|bupivacaine|mesh-list
93020761|NCT00887003|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93020762|NCT00887003|Prednisolone phosphate|prednisolone phosphate|mesh-list
93020763|NCT00887003|Anesthetics, Local|anesthetics, local|mesh-ancestor
93020764|NCT00887003|Anesthetics|anesthetics|mesh-ancestor
93020765|NCT00887003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020766|NCT00887003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020767|NCT00887003|Sensory System Agents|sensory system agents|mesh-ancestor
93020768|NCT00887003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020769|NCT00887003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020770|NCT00887003|Antiemetics|antiemetics|mesh-ancestor
93020771|NCT00887003|Autonomic Agents|autonomic agents|mesh-ancestor
93020772|NCT00887003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020773|NCT00887003|Glucocorticoids|glucocorticoids|mesh-ancestor
93020774|NCT00887003|Hormones|hormones|mesh-ancestor
93020775|NCT00887003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020776|NCT00887003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93020777|NCT00887003|Protective Agents|protective agents|mesh-ancestor
93020778|NCT00887003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020779|NCT00887003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020780|NCT00887081|Ribavirin|ribavirin|mesh-list
93020781|NCT00887081|Interferon-alpha|interferon-alpha|mesh-list
93020782|NCT00887081|Interferon alpha-2|interferon alpha-2|mesh-list
93020783|NCT00887081|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93020784|NCT00887081|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93020785|NCT00887081|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93020786|NCT00887081|Antimetabolites|antimetabolites|mesh-ancestor
93020787|NCT00887081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020788|NCT00887081|Antiviral Agents|antiviral agents|mesh-ancestor
93020789|NCT00887081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020790|NCT00887081|Immunologic Factors|immunologic factors|mesh-ancestor
93020791|NCT00887081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020792|NCT00887081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020793|NCT03998696|Cisplatin|cisplatin|mesh-list
93020794|NCT03998696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020795|NCT00611975|Bupropion|bupropion|mesh-list
93020796|NCT00611975|Fluoxetine|fluoxetine|mesh-list
93020797|NCT00611975|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93020798|NCT00611975|Antidepressive Agents|antidepressive agents|mesh-ancestor
93020799|NCT00611975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93020800|NCT00611975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93020801|NCT00611975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93020802|NCT00611975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93020803|NCT00611975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020804|NCT00611975|Dopamine Agents|dopamine agents|mesh-ancestor
93020805|NCT00611975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020806|NCT00611975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020807|NCT00611975|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93020808|NCT00611975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93020809|NCT00611975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020810|NCT00611975|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93020811|NCT00611975|Serotonin Agents|serotonin agents|mesh-ancestor
93020812|NCT05695352|Meloxicam|meloxicam|mesh-list
93020813|NCT05695352|Levonorgestrel|levonorgestrel|mesh-list
93020814|NCT05695352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93020815|NCT05695352|Contraceptive Agents|contraceptive agents|mesh-ancestor
93020816|NCT05695352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93020817|NCT05695352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020818|NCT05695352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93020819|NCT05695352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93020820|NCT05695352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93020821|NCT05695352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93020822|NCT05695352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020823|NCT05695352|Analgesics|analgesics|mesh-ancestor
93020824|NCT05695352|Sensory System Agents|sensory system agents|mesh-ancestor
93020825|NCT05695352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020826|NCT05695352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020827|NCT05695352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020828|NCT05695352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93020829|NCT05695352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93020830|NCT05695352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020831|NCT05695352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020832|NCT04895306|Methyltestosterone|methyltestosterone|mesh-list
93020833|NCT04895306|Testosterone|testosterone|mesh-list
93020834|NCT04895306|Testosterone undecanoate|testosterone undecanoate|mesh-list
93020835|NCT04895306|Testosterone enanthate|testosterone enanthate|mesh-list
93020836|NCT04895306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93020837|NCT04895306|Androgens|androgens|mesh-ancestor
93020838|NCT04895306|Hormones|hormones|mesh-ancestor
93020839|NCT04895306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93020840|NCT04895306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020841|NCT04895306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93020842|NCT04895306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666120|NCT00315900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93020843|NCT04895306|Anabolic Agents|anabolic agents|mesh-ancestor
93020844|NCT02542241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93020845|NCT00889343|Leucovorin|leucovorin|mesh-list
93020846|NCT00889343|Fluorouracil|fluorouracil|mesh-list
93020847|NCT00889343|Oxaliplatin|oxaliplatin|mesh-list
93020848|NCT00889343|Irinotecan|irinotecan|mesh-list
93020849|NCT00889343|Sorafenib|sorafenib|mesh-list
93020850|NCT00889343|Antimetabolites|antimetabolites|mesh-ancestor
93020851|NCT00889343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020852|NCT00889343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93020853|NCT00889343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020854|NCT00889343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020855|NCT00889343|Immunologic Factors|immunologic factors|mesh-ancestor
93020856|NCT00889343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020857|NCT00889343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93020858|NCT00889343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93020859|NCT00889343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020860|NCT00889343|Antidotes|antidotes|mesh-ancestor
93020861|NCT00889343|Protective Agents|protective agents|mesh-ancestor
93020862|NCT00889343|Vitamin B Complex|vitamin b complex|mesh-ancestor
93020863|NCT00889343|Vitamins|vitamins|mesh-ancestor
93020864|NCT00889343|Micronutrients|micronutrients|mesh-ancestor
93020865|NCT00889343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93020866|NCT00884819|Fenofibrate|fenofibrate|mesh-list
93020867|NCT00884819|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93020868|NCT00884819|Antimetabolites|antimetabolites|mesh-ancestor
93020869|NCT00884819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020870|NCT00884819|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93020871|NCT00573131|Paclitaxel|paclitaxel|mesh-list
93020872|NCT00573131|Cisplatin|cisplatin|mesh-list
93020873|NCT00573131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93020874|NCT00573131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020875|NCT00573131|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020876|NCT00573131|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020877|NCT00573131|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020878|NCT00573131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020879|NCT01565018|Rotigotine|rotigotine|mesh-list
93020880|NCT01565018|Dopamine Agonists|dopamine agonists|mesh-ancestor
93020881|NCT01565018|Dopamine Agents|dopamine agents|mesh-ancestor
93020882|NCT01565018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020883|NCT01565018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020884|NCT01565018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020885|NCT01565096|Metformin|metformin|mesh-list
93020886|NCT01565096|Glimepiride|glimepiride|mesh-list
93020887|NCT01565096|Vildagliptin|vildagliptin|mesh-list
93020888|NCT01565096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93020889|NCT01565096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020890|NCT01565096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93020891|NCT01565096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020892|NCT01565096|Immunologic Factors|immunologic factors|mesh-ancestor
93020893|NCT01565096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93020894|NCT01565096|Protease Inhibitors|protease inhibitors|mesh-ancestor
93020895|NCT01565096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020896|NCT01565096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020897|NCT00889499|Tropisetron|tropisetron|mesh-list
93020898|NCT00889499|Antiemetics|antiemetics|mesh-ancestor
93020899|NCT00889499|Autonomic Agents|autonomic agents|mesh-ancestor
93020900|NCT00889499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020901|NCT00889499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020902|NCT00889499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020903|NCT00889499|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93020904|NCT00889499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93020905|NCT00889499|Serotonin Agents|serotonin agents|mesh-ancestor
93020906|NCT00889499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020907|NCT00889499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020908|NCT00889655|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93020909|NCT00889655|Laxatives|laxatives|mesh-ancestor
93020910|NCT00889655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93020911|NCT05002946|Naltrexone|naltrexone|mesh-list
93020912|NCT05002946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93020913|NCT05002946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93020914|NCT05002946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020915|NCT05002946|Sensory System Agents|sensory system agents|mesh-ancestor
93020916|NCT05002946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020917|NCT04641338|Dipyrone|dipyrone|mesh-list
93020918|NCT04641338|Codeine|codeine|mesh-list
93020919|NCT04641338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93020920|NCT04641338|Narcotics|narcotics|mesh-ancestor
93020921|NCT04641338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020922|NCT04641338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020923|NCT04641338|Analgesics|analgesics|mesh-ancestor
93020924|NCT04641338|Sensory System Agents|sensory system agents|mesh-ancestor
93020925|NCT04641338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020926|NCT04641338|Antitussive Agents|antitussive agents|mesh-ancestor
93020927|NCT04641338|Respiratory System Agents|respiratory system agents|mesh-ancestor
93020928|NCT04641338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93020929|NCT04641338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020930|NCT04641338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93020931|NCT04641338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93020932|NCT04641338|Antipyretics|antipyretics|mesh-ancestor
93020933|NCT04635098|Dexmedetomidine|dexmedetomidine|mesh-list
93020934|NCT04635098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93020935|NCT04635098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020936|NCT04635098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020937|NCT04635098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93020938|NCT04635098|Analgesics|analgesics|mesh-ancestor
93020939|NCT04635098|Sensory System Agents|sensory system agents|mesh-ancestor
93020940|NCT04635098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93020941|NCT04635098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93020942|NCT04635098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93020943|NCT04635098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93020944|NCT04635098|Adrenergic Agents|adrenergic agents|mesh-ancestor
93020945|NCT04635098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93020946|NCT04635098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020948|NCT00521144|Obatoclax|obatoclax|mesh-list
93020949|NCT00521144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93020950|NCT00521144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93020951|NCT00521144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020952|NCT00521144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020953|NCT00521144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020954|NCT00520676|Carboplatin|carboplatin|mesh-list
93020955|NCT00520676|Docetaxel|docetaxel|mesh-list
93020956|NCT00520676|Pemetrexed|pemetrexed|mesh-list
93020957|NCT00520676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020958|NCT00520676|Tubulin Modulators|tubulin modulators|mesh-ancestor
93020959|NCT00520676|Antimitotic Agents|antimitotic agents|mesh-ancestor
93020960|NCT00520676|Mitosis Modulators|mitosis modulators|mesh-ancestor
93020961|NCT00520676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020962|NCT00520676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020963|NCT00520676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93020964|NCT00520676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93020965|NCT00889733|Cisplatin|cisplatin|mesh-list
93020966|NCT00889733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020967|NCT00887627|Conivaptan|conivaptan|mesh-list
93020968|NCT00887627|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93020969|NCT00887627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020970|NCT00887627|Natriuretic Agents|natriuretic agents|mesh-ancestor
93020971|NCT00887627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020972|NCT00885287|Lumefantrine|lumefantrine|mesh-list
93020973|NCT00885287|Artemether|artemether|mesh-list
93020974|NCT00885287|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93020975|NCT00885287|Antimalarials|antimalarials|mesh-ancestor
93020976|NCT00885287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93020977|NCT00885287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93020978|NCT00885287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020979|NCT02542007|Sirolimus|sirolimus|mesh-list
93020980|NCT02542007|Temsirolimus|temsirolimus|mesh-list
92177680|NCT02318303|Analgesics|analgesics|mesh-ancestor
93020981|NCT02542007|MTOR Inhibitors|mtor inhibitors|mesh-list
93020982|NCT02542007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93020983|NCT02542007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93020984|NCT02542007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93020985|NCT02542007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93020986|NCT02542007|Antifungal Agents|antifungal agents|mesh-ancestor
93020987|NCT02542007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93020988|NCT02542007|Immunologic Factors|immunologic factors|mesh-ancestor
93020989|NCT02542007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020990|NCT02542007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93020991|NCT02542007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93020992|NCT02542007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93020993|NCT00892541|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92666270|NCT00316329|Schistosomicides|schistosomicides|mesh-ancestor
93020995|NCT00892541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93020996|NCT00892541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93020997|NCT00892541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93020998|NCT00892541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93020999|NCT00892541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93021000|NCT00892541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93021001|NCT00892541|Serotonin Agents|serotonin agents|mesh-ancestor
93021002|NCT00892541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021003|NCT00892541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021004|NCT00892541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93021005|NCT00892541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93021006|NCT00892541|Dopamine Agents|dopamine agents|mesh-ancestor
93021007|NCT00890279|Imidapril|imidapril|mesh-list
93021008|NCT00890279|Cilnidipine|cilnidipine|mesh-list
93021009|NCT00890279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93021010|NCT00890279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021011|NCT00890279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021012|NCT00890279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93021013|NCT00890279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021014|NCT00890279|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93021015|NCT00890279|Protease Inhibitors|protease inhibitors|mesh-ancestor
93021016|NCT00890279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021017|NCT00890279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93021018|NCT00608543|Aripiprazole|aripiprazole|mesh-list
93021019|NCT00608543|Antidepressive Agents|antidepressive agents|mesh-ancestor
93021020|NCT00608543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93021021|NCT00608543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93021022|NCT00608543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93021023|NCT00608543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021024|NCT00608543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021025|NCT00608543|Dopamine Agonists|dopamine agonists|mesh-ancestor
93021026|NCT00608543|Dopamine Agents|dopamine agents|mesh-ancestor
93021027|NCT00608543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021028|NCT00608543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021029|NCT00608543|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93021030|NCT00608543|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93021031|NCT00608543|Serotonin Agents|serotonin agents|mesh-ancestor
93021032|NCT00608543|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93021033|NCT00608543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93021034|NCT00608543|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93021035|NCT00608543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93021036|NCT02541383|Thalidomide|thalidomide|mesh-list
93021037|NCT02541383|Dexamethasone|dexamethasone|mesh-list
93021038|NCT02541383|Dexamethasone acetate|dexamethasone acetate|mesh-list
93021039|NCT02541383|Bortezomib|bortezomib|mesh-list
93021040|NCT02541383|Daratumumab|daratumumab|mesh-list
93021041|NCT02541383|BB 1101|bb 1101|mesh-list
93021042|NCT02541383|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93021043|NCT02541383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021044|NCT02541383|Antiemetics|antiemetics|mesh-ancestor
93021045|NCT02541383|Autonomic Agents|autonomic agents|mesh-ancestor
93021046|NCT02541383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021047|NCT02541383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021048|NCT02541383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021049|NCT02541383|Glucocorticoids|glucocorticoids|mesh-ancestor
93021050|NCT02541383|Hormones|hormones|mesh-ancestor
93021051|NCT02541383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021052|NCT02541383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93021053|NCT02541383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021054|NCT02541383|Protease Inhibitors|protease inhibitors|mesh-ancestor
93021055|NCT02541383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021056|NCT02541383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021057|NCT02541383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021058|NCT02541383|Immunologic Factors|immunologic factors|mesh-ancestor
93021059|NCT02541383|Leprostatic Agents|leprostatic agents|mesh-ancestor
93021060|NCT02541383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021061|NCT02541383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021062|NCT02541383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021063|NCT02541383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021064|NCT02541383|Growth Substances|growth substances|mesh-ancestor
93021065|NCT02541383|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021066|NCT04036487|Propofol|propofol|mesh-list
93021068|NCT04036487|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93021069|NCT04036487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021070|NCT04036487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021071|NCT04036487|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93021072|NCT04036487|Anesthetics, General|anesthetics, general|mesh-ancestor
93021073|NCT04036487|Anesthetics|anesthetics|mesh-ancestor
93021074|NCT04036487|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93021075|NCT05278793|Ferrous fumarate|ferrous fumarate|mesh-list
93021076|NCT05278793|Trace Elements|trace elements|mesh-ancestor
93021077|NCT05278793|Micronutrients|micronutrients|mesh-ancestor
93021078|NCT05278793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021079|NCT04037657|Propofol|propofol|mesh-list
93021080|NCT04037657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93021081|NCT04037657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021082|NCT04037657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021083|NCT04037657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93021084|NCT04037657|Anesthetics, General|anesthetics, general|mesh-ancestor
93021085|NCT04037657|Anesthetics|anesthetics|mesh-ancestor
93021086|NCT00893009|Theophylline|theophylline|mesh-list
93021087|NCT00893009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93021088|NCT00893009|Autonomic Agents|autonomic agents|mesh-ancestor
92177782|NCT00158743|Digoxin|digoxin|mesh-list
93021089|NCT00893009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021090|NCT00893009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021091|NCT00893009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93021092|NCT00893009|Respiratory System Agents|respiratory system agents|mesh-ancestor
93021093|NCT00893009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93021094|NCT00893009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021095|NCT00893009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021096|NCT00893009|Vasodilator Agents|vasodilator agents|mesh-ancestor
93021097|NCT00893009|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93021098|NCT00893009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93021099|NCT00893009|Purinergic Agents|purinergic agents|mesh-ancestor
93021100|NCT00893009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021101|NCT00890747|Sunitinib|sunitinib|mesh-list
93021102|NCT00890747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021103|NCT00890747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021104|NCT00890747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021105|NCT00890747|Growth Substances|growth substances|mesh-ancestor
93021106|NCT00890747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021107|NCT00890747|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021108|NCT00890747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93021109|NCT00890747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021110|NCT00890747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021111|NCT04017845|Tribenoside|tribenoside|mesh-list
93021112|NCT04017845|Lidocaine|lidocaine|mesh-list
93021113|NCT04017845|Diltiazem|diltiazem|mesh-list
93021114|NCT04017845|Calcium Channel Blockers|calcium channel blockers|mesh-list
93021115|NCT04017845|Nitroglycerin|nitroglycerin|mesh-list
93021116|NCT04017845|Bisacodyl|bisacodyl|mesh-list
93021117|NCT04017845|Anesthetics, Local|anesthetics, local|mesh-ancestor
93021118|NCT04017845|Anesthetics|anesthetics|mesh-ancestor
93021119|NCT04017845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021120|NCT04017845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021121|NCT04017845|Sensory System Agents|sensory system agents|mesh-ancestor
93021122|NCT04017845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021123|NCT04017845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93021124|NCT04017845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93021125|NCT04017845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93021126|NCT04017845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021127|NCT04017845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021128|NCT04017845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93021129|NCT04017845|Vasodilator Agents|vasodilator agents|mesh-ancestor
93021130|NCT04017845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93021131|NCT04017845|Cathartics|cathartics|mesh-ancestor
93021132|NCT04017845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021133|NCT04017845|Laxatives|laxatives|mesh-ancestor
93021134|NCT04017845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93021135|NCT04017845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021136|NCT04017845|Analgesics|analgesics|mesh-ancestor
93021137|NCT04017845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021138|NCT04017845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021139|NCT00520130|Cytarabine|cytarabine|mesh-list
93021140|NCT00520130|Cyclosporine|cyclosporine|mesh-list
93021141|NCT00520130|Rituximab|rituximab|mesh-list
93021142|NCT00520130|Alemtuzumab|alemtuzumab|mesh-list
93021144|NCT00520130|Cyclosporins|cyclosporins|mesh-list
93021145|NCT00520130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93021146|NCT00520130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021147|NCT00520130|Immunologic Factors|immunologic factors|mesh-ancestor
93021148|NCT00520130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021149|NCT00520130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021150|NCT00520130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021151|NCT00520130|Antimetabolites|antimetabolites|mesh-ancestor
93021152|NCT00520130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021153|NCT00520130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021154|NCT00520130|Antiviral Agents|antiviral agents|mesh-ancestor
93021155|NCT00520130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021156|NCT00520130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021157|NCT00520130|Antifungal Agents|antifungal agents|mesh-ancestor
93021158|NCT00520130|Dermatologic Agents|dermatologic agents|mesh-ancestor
93021159|NCT00520130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93021160|NCT00519896|Sunitinib|sunitinib|mesh-list
93021161|NCT00519896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021162|NCT00519896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021163|NCT00519896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021164|NCT00519896|Growth Substances|growth substances|mesh-ancestor
93021165|NCT00519896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021166|NCT00519896|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021167|NCT00519896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93021168|NCT00519896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021169|NCT00519896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021170|NCT00527618|Valacyclovir|valacyclovir|mesh-list
93021171|NCT00527618|Acyclovir|acyclovir|mesh-list
93021172|NCT00527618|Antiviral Agents|antiviral agents|mesh-ancestor
93021173|NCT00527618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021174|NCT00527072|Infliximab|infliximab|mesh-list
93021175|NCT00527072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93021176|NCT00527072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021177|NCT00527072|Dermatologic Agents|dermatologic agents|mesh-ancestor
93021178|NCT00527072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021179|NCT00527072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021180|NCT00519428|Dexetimide|dexetimide|mesh-list
93021181|NCT00519428|Citalopram|citalopram|mesh-list
93021182|NCT00519428|Bupropion|bupropion|mesh-list
93021183|NCT00519428|Escitalopram|escitalopram|mesh-list
93021184|NCT00519428|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93021185|NCT00519428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93021186|NCT00519428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021187|NCT00519428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021188|NCT00519428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021189|NCT00519428|Serotonin Agents|serotonin agents|mesh-ancestor
93021190|NCT00519428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021191|NCT00519428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93021192|NCT00519428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93021193|NCT00519428|Parasympatholytics|parasympatholytics|mesh-ancestor
93021194|NCT00519428|Autonomic Agents|autonomic agents|mesh-ancestor
93021195|NCT00519428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021196|NCT00519428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93021197|NCT00519428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93021198|NCT00519428|Cholinergic Agents|cholinergic agents|mesh-ancestor
93021199|NCT00519428|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93021200|NCT00519428|Antidepressive Agents|antidepressive agents|mesh-ancestor
93021201|NCT00519428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93021202|NCT00519428|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93021203|NCT00519428|Dopamine Agents|dopamine agents|mesh-ancestor
93021204|NCT00519428|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93021205|NCT00519428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93021206|NCT00519428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021207|NCT00431847|Anesthetics|anesthetics|mesh-list
93021208|NCT00431847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021209|NCT00431847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021210|NCT00431067|Afatinib|afatinib|mesh-list
93021211|NCT00431067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021212|NCT00431067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93021213|NCT00431067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021214|NCT00431067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021215|NCT00430989|Nitrous Oxide|nitrous oxide|mesh-list
92366809|NCT00766116|Immunotoxins|immunotoxins|mesh-ancestor
93021216|NCT00430989|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93021218|NCT00430989|Anesthetics|anesthetics|mesh-ancestor
93021219|NCT00430989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021220|NCT00430989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021221|NCT00430989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021222|NCT00430989|Analgesics|analgesics|mesh-ancestor
93021223|NCT00430989|Sensory System Agents|sensory system agents|mesh-ancestor
93021224|NCT00430989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021225|NCT00518882|Liraglutide|liraglutide|mesh-list
93021227|NCT00518882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93021228|NCT00518882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021229|NCT00518882|Incretins|incretins|mesh-ancestor
93021230|NCT00518882|Hormones|hormones|mesh-ancestor
93021231|NCT00518882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021232|NCT00518882|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93021233|NCT00518180|Lactitol|lactitol|mesh-list
93021234|NCT00518180|Vaccines|vaccines|mesh-list
93021235|NCT00518180|Immunologic Factors|immunologic factors|mesh-ancestor
93021236|NCT00518180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021237|NCT00518180|Cathartics|cathartics|mesh-ancestor
93021238|NCT00518180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021239|NCT00525902|Adalimumab|adalimumab|mesh-list
93021240|NCT00525902|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93021241|NCT00525902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021242|NCT00525902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021243|NCT00525824|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93021244|NCT00525824|Simvastatin|simvastatin|mesh-list
93021245|NCT00525824|Ezetimibe|ezetimibe|mesh-list
93021246|NCT00525824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93021247|NCT00525824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93021248|NCT00525824|Antimetabolites|antimetabolites|mesh-ancestor
93021249|NCT00525824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021250|NCT00525824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93021251|NCT00525824|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93021252|NCT00525824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021253|NCT00525590|Carmustine|carmustine|mesh-list
93021254|NCT00525590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93021255|NCT00525590|Alkylating Agents|alkylating agents|mesh-ancestor
93021256|NCT00525590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021257|NCT00525590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021258|NCT00430677|Mycophenolic Acid|mycophenolic acid|mesh-list
93021259|NCT00430677|Prednisone|prednisone|mesh-list
93021260|NCT00430677|Prednisolone|prednisolone|mesh-list
93021261|NCT00430677|Abatacept|abatacept|mesh-list
93021262|NCT00430677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021263|NCT00430677|Glucocorticoids|glucocorticoids|mesh-ancestor
93021264|NCT00430677|Hormones|hormones|mesh-ancestor
93021265|NCT00430677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021266|NCT00430677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021267|NCT00430677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93021268|NCT00430677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021269|NCT00430677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93021270|NCT00430677|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93021271|NCT00430677|Antitubercular Agents|antitubercular agents|mesh-ancestor
93021272|NCT00430677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021273|NCT00430677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021274|NCT00430677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021275|NCT00430677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021276|NCT00430677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93021277|NCT00430677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93021278|NCT00430677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021279|NCT00430677|Immunologic Factors|immunologic factors|mesh-ancestor
93021280|NCT00430677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021281|NCT02631759|Levetiracetam|levetiracetam|mesh-list
93021282|NCT02631759|Anticonvulsants|anticonvulsants|mesh-ancestor
93021283|NCT02631759|Nootropic Agents|nootropic agents|mesh-ancestor
93021284|NCT01035801|Insulin Lispro|insulin lispro|mesh-list
93021285|NCT01035801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93021286|NCT01035801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021287|NCT00525512|Tiotropium Bromide|tiotropium bromide|mesh-list
93021288|NCT00525512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93021289|NCT00525512|Autonomic Agents|autonomic agents|mesh-ancestor
93021290|NCT00525512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021291|NCT00525512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021292|NCT00525512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93021293|NCT00525512|Respiratory System Agents|respiratory system agents|mesh-ancestor
93021294|NCT00525512|Parasympatholytics|parasympatholytics|mesh-ancestor
93021295|NCT00525512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92178048|NCT00068341|Docetaxel|docetaxel|mesh-list
93021296|NCT00525512|Cholinergic Agents|cholinergic agents|mesh-ancestor
93021297|NCT00525512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021298|NCT00525512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021300|NCT04501406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93021301|NCT04501406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021302|NCT03656666|Thalidomide|thalidomide|mesh-list
93021303|NCT03656666|Apremilast|apremilast|mesh-list
93021304|NCT03656666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93021305|NCT03656666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021306|NCT03656666|Analgesics|analgesics|mesh-ancestor
93021307|NCT03656666|Sensory System Agents|sensory system agents|mesh-ancestor
93021308|NCT03656666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021309|NCT03656666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021310|NCT03656666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021311|NCT03656666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021312|NCT03656666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93021313|NCT03656666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93021314|NCT03656666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021315|NCT03656666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021316|NCT03656666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021317|NCT03656666|Immunologic Factors|immunologic factors|mesh-ancestor
93021318|NCT03656666|Leprostatic Agents|leprostatic agents|mesh-ancestor
93021319|NCT03656666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021320|NCT03656666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021321|NCT03656666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021322|NCT03656666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021323|NCT03656666|Growth Substances|growth substances|mesh-ancestor
93021324|NCT03656666|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021325|NCT03656666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021326|NCT00430521|Vaccines|vaccines|mesh-list
93021327|NCT00430521|Immunologic Factors|immunologic factors|mesh-ancestor
93021328|NCT00430521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021329|NCT01036035|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93021330|NCT01036035|Pilocarpine|pilocarpine|mesh-list
93021331|NCT01036035|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93021332|NCT01036035|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93021333|NCT01036035|Cholinergic Agents|cholinergic agents|mesh-ancestor
93021334|NCT01036035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021335|NCT01036035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021336|NCT01036035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021337|NCT01036035|Urological Agents|urological agents|mesh-ancestor
93021338|NCT01036035|Miotics|miotics|mesh-ancestor
93021339|NCT01036035|Autonomic Agents|autonomic agents|mesh-ancestor
93021340|NCT01036035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021341|NCT01036035|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93021342|NCT01036035|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93021343|NCT01036659|Ecallantide|ecallantide|mesh-list
93021344|NCT01036659|Bradykinin|bradykinin|mesh-list
93021345|NCT01036659|Kallikreins|kallikreins|mesh-list
93021346|NCT01036659|Kininogens|kininogens|mesh-list
93021347|NCT01036659|Vasodilator Agents|vasodilator agents|mesh-ancestor
93021348|NCT01036659|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93021349|NCT01036659|Protease Inhibitors|protease inhibitors|mesh-ancestor
93021350|NCT01036659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021351|NCT01036659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021352|NCT01036659|Analgesics|analgesics|mesh-ancestor
93021353|NCT01036659|Sensory System Agents|sensory system agents|mesh-ancestor
93021354|NCT01036659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021355|NCT01036659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021356|NCT01036659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93021357|NCT01036659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021358|NCT01036659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021359|NCT01036659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021360|NCT01036659|Coagulants|coagulants|mesh-ancestor
93021361|NCT01036659|Fertility Agents, Male|fertility agents, male|mesh-ancestor
93021362|NCT01036659|Fertility Agents|fertility agents|mesh-ancestor
93021363|NCT01036659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93021364|NCT01033149|Acetylcysteine|acetylcysteine|mesh-list
93021365|NCT01033149|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93021366|NCT01033149|Antiviral Agents|antiviral agents|mesh-ancestor
93021367|NCT01033149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021368|NCT01033149|Expectorants|expectorants|mesh-ancestor
93021369|NCT01033149|Respiratory System Agents|respiratory system agents|mesh-ancestor
93021370|NCT01033149|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93021371|NCT01033149|Antioxidants|antioxidants|mesh-ancestor
93021372|NCT01033149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666649|NCT00416858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021373|NCT01033149|Protective Agents|protective agents|mesh-ancestor
93021374|NCT01033149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021375|NCT01033149|Antidotes|antidotes|mesh-ancestor
93021376|NCT00440271|Ritonavir|ritonavir|mesh-list
93021377|NCT00440271|Raltegravir Potassium|raltegravir potassium|mesh-list
93021378|NCT00440271|Maraviroc|maraviroc|mesh-list
93021379|NCT00440271|Tipranavir|tipranavir|mesh-list
93021380|NCT00440271|Enfuvirtide|enfuvirtide|mesh-list
93021381|NCT00440271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93021382|NCT00440271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93021383|NCT00440271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93021384|NCT00440271|Protease Inhibitors|protease inhibitors|mesh-ancestor
93021385|NCT00440271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021386|NCT00440271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021387|NCT00440271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93021388|NCT00440271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93021389|NCT00440271|Antiviral Agents|antiviral agents|mesh-ancestor
93021390|NCT00440271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021391|NCT00440271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93021392|NCT00440271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93021393|NCT00440271|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93021394|NCT00440271|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93021395|NCT00440271|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93021396|NCT00440271|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93021397|NCT00440271|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93021398|NCT00440271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93021399|NCT00346216|Ibuprofen|ibuprofen|mesh-list
93021400|NCT00346216|Celecoxib|celecoxib|mesh-list
93021401|NCT00346216|Naproxen|naproxen|mesh-list
93021402|NCT00346216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93021403|NCT00346216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021404|NCT00346216|Analgesics|analgesics|mesh-ancestor
93021405|NCT00346216|Sensory System Agents|sensory system agents|mesh-ancestor
93021406|NCT00346216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021407|NCT00346216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021408|NCT00346216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021409|NCT00346216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021410|NCT00346216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93021411|NCT00346216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021412|NCT00346216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021413|NCT00346216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93021414|NCT00346216|Gout Suppressants|gout suppressants|mesh-ancestor
93021415|NCT01051648|Triamcinolone|triamcinolone|mesh-list
93021416|NCT01051648|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93021417|NCT01051648|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93021418|NCT01051648|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93021419|NCT01051648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021420|NCT01051648|Glucocorticoids|glucocorticoids|mesh-ancestor
93021421|NCT01051648|Hormones|hormones|mesh-ancestor
93021422|NCT01051648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021423|NCT01051648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021424|NCT01051648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021425|NCT01051648|Immunologic Factors|immunologic factors|mesh-ancestor
93021426|NCT01051648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021427|NCT01051648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021428|NCT00429273|Guanfacine|guanfacine|mesh-list
93021429|NCT00429273|Methylphenidate|methylphenidate|mesh-list
93021430|NCT00429273|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
93021431|NCT00429273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93021432|NCT00429273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021433|NCT00429273|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93021434|NCT00429273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93021435|NCT00429273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021436|NCT00429273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021437|NCT00429273|Dopamine Agents|dopamine agents|mesh-ancestor
93021438|NCT00429273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021439|NCT00429273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93021440|NCT00429273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93021441|NCT00429273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93021442|NCT00429273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93021443|NCT00429273|Adrenergic Agents|adrenergic agents|mesh-ancestor
93021444|NCT00359632|Linezolid|linezolid|mesh-list
93021445|NCT00359632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021446|NCT00359632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021447|NCT00359632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92666725|NCT00317499|Etanercept|etanercept|mesh-list
93021448|NCT00359632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178199|NCT04834752|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93021449|NCT00359632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021450|NCT01324960|Aldesleukin|aldesleukin|mesh-list
93021451|NCT01324960|Azacitidine|azacitidine|mesh-list
93021452|NCT01324960|Histamine|histamine|mesh-list
93021453|NCT01324960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021454|NCT01324960|Antimetabolites|antimetabolites|mesh-ancestor
93021455|NCT01324960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021456|NCT01324960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021457|NCT01324960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021458|NCT01324960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021459|NCT01324960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93021460|NCT01324960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93021461|NCT01324960|Antiviral Agents|antiviral agents|mesh-ancestor
93021462|NCT01324960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021463|NCT01324960|Histamine Agonists|histamine agonists|mesh-ancestor
93021464|NCT01324960|Histamine Agents|histamine agents|mesh-ancestor
93021465|NCT01324960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021466|NCT00417885|Sunitinib|sunitinib|mesh-list
93021467|NCT00417885|Exemestane|exemestane|mesh-list
93021468|NCT00417885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021469|NCT00417885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021470|NCT00417885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021471|NCT00417885|Growth Substances|growth substances|mesh-ancestor
93021472|NCT00417885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021473|NCT00417885|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021474|NCT00417885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93021475|NCT00417885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021476|NCT00417885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021477|NCT00417885|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93021478|NCT00417885|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93021479|NCT00417885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93021480|NCT00417885|Hormone Antagonists|hormone antagonists|mesh-ancestor
93021481|NCT00417885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021482|NCT01036893|Prucalopride|prucalopride|mesh-list
93021483|NCT01036893|Laxatives|laxatives|mesh-ancestor
93021484|NCT01036893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021485|NCT01036893|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
93021486|NCT01036893|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93021487|NCT01036893|Serotonin Agents|serotonin agents|mesh-ancestor
93021488|NCT01036893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021489|NCT01036893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021490|NCT01036893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021491|NCT00525044|Ambroxol|ambroxol|mesh-list
93021492|NCT00525044|Expectorants|expectorants|mesh-ancestor
93021493|NCT00525044|Respiratory System Agents|respiratory system agents|mesh-ancestor
93021494|NCT00355342|Fluticasone|fluticasone|mesh-list
93021495|NCT00355342|Xhance|xhance|mesh-list
93021496|NCT00355342|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93021497|NCT00355342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021498|NCT00355342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93021499|NCT00355342|Autonomic Agents|autonomic agents|mesh-ancestor
93021500|NCT00355342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021501|NCT00355342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021502|NCT00355342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93021503|NCT00355342|Respiratory System Agents|respiratory system agents|mesh-ancestor
93021504|NCT00355342|Dermatologic Agents|dermatologic agents|mesh-ancestor
93021505|NCT00355342|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93021506|NCT00355342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93021507|NCT00355342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93021508|NCT00355342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93021509|NCT00355342|Adrenergic Agents|adrenergic agents|mesh-ancestor
93021510|NCT00355342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021511|NCT00355342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021512|NCT01051804|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93021514|NCT01051804|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93021515|NCT01573754|Hydroxychloroquine|hydroxychloroquine|mesh-list
93021516|NCT01573754|Antimalarials|antimalarials|mesh-ancestor
93021517|NCT01573754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93021518|NCT01573754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93021519|NCT01573754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021520|NCT01573754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021521|NCT01573754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021522|NCT01573754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021523|NCT03989830|Endostatins|endostatins|mesh-list
93021524|NCT03989830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021525|NCT03989830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021526|NCT03989830|Growth Substances|growth substances|mesh-ancestor
93021527|NCT03989830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021528|NCT03989830|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021529|NCT03989830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021530|NCT02533648|Allopurinol|allopurinol|mesh-list
93021531|NCT02533648|Antimetabolites|antimetabolites|mesh-ancestor
93021532|NCT02533648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021533|NCT02533648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021534|NCT02533648|Gout Suppressants|gout suppressants|mesh-ancestor
93021535|NCT02533648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021536|NCT02533648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93021537|NCT02533648|Antioxidants|antioxidants|mesh-ancestor
93021538|NCT02533648|Protective Agents|protective agents|mesh-ancestor
93021539|NCT02533648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021540|NCT02533492|Triclosan|triclosan|mesh-list
93021541|NCT02533492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93021542|NCT02533492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021543|NCT02533492|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93021544|NCT02533492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93021545|NCT02533492|Antimetabolites|antimetabolites|mesh-ancestor
93021546|NCT02533492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021547|NCT02533492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93021548|NCT01056874|Maraviroc|maraviroc|mesh-list
93021549|NCT01056874|Digoxin|digoxin|mesh-list
93021550|NCT01056874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93021551|NCT01056874|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93021552|NCT01056874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021553|NCT01056874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021554|NCT01056874|Protective Agents|protective agents|mesh-ancestor
93021555|NCT01056874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021556|NCT01056874|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93021557|NCT01056874|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93021558|NCT01056874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93021559|NCT01056874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93021560|NCT01056874|Antiviral Agents|antiviral agents|mesh-ancestor
93021561|NCT01056874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021562|NCT01056874|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93021563|NCT00355030|Leuprolide|leuprolide|mesh-list
93021564|NCT00355030|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93021565|NCT00355030|Fertility Agents|fertility agents|mesh-ancestor
93021566|NCT00355030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93021567|NCT00355030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021568|NCT00355030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93021569|NCT00355030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021570|NCT01057030|BMS 708163|bms 708163|mesh-list
93021571|NCT01057030|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93021572|NCT01057030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021573|NCT01057030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021574|NCT01057186|Alfacalcidol|alfacalcidol|mesh-list
93021575|NCT01057186|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93021576|NCT01057186|Sevelamer|sevelamer|mesh-list
93021577|NCT01057186|Chelating Agents|chelating agents|mesh-ancestor
93021578|NCT01057186|Sequestering Agents|sequestering agents|mesh-ancestor
93021579|NCT01057186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021580|NCT01057186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93021581|NCT01057186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021582|NCT01057186|Vitamins|vitamins|mesh-ancestor
93021583|NCT01057186|Micronutrients|micronutrients|mesh-ancestor
93021584|NCT01057264|Paclitaxel|paclitaxel|mesh-list
93021585|NCT01057264|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93021586|NCT01057264|Bevacizumab|bevacizumab|mesh-list
93021587|NCT01057264|Gemcitabine|gemcitabine|mesh-list
93021588|NCT01057264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93021589|NCT01057264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021590|NCT01057264|Tubulin Modulators|tubulin modulators|mesh-ancestor
93021591|NCT01057264|Antimitotic Agents|antimitotic agents|mesh-ancestor
93021592|NCT01057264|Mitosis Modulators|mitosis modulators|mesh-ancestor
93021593|NCT01057264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021594|NCT01057264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93021595|NCT01057264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021596|NCT01057264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021597|NCT01057264|Growth Substances|growth substances|mesh-ancestor
93021598|NCT01057264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021599|NCT01057264|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021600|NCT01057264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021601|NCT01057264|Antimetabolites|antimetabolites|mesh-ancestor
93021602|NCT03991312|Itraconazole|itraconazole|mesh-list
93021603|NCT03991312|Rifampin|rifampin|mesh-list
93021604|NCT03991312|Mitapivat|mitapivat|mesh-list
93021605|NCT03991312|Antifungal Agents|antifungal agents|mesh-ancestor
93021606|NCT03991312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021607|NCT03991312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93021608|NCT03991312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93021609|NCT03991312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021610|NCT03991312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021611|NCT03991312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93021612|NCT03991312|Hormone Antagonists|hormone antagonists|mesh-ancestor
93021613|NCT03991312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021614|NCT03991312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021615|NCT03991312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93021616|NCT03991312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93021617|NCT03991312|Antitubercular Agents|antitubercular agents|mesh-ancestor
93021618|NCT03991312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021619|NCT03991312|Leprostatic Agents|leprostatic agents|mesh-ancestor
93021620|NCT03991312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93021621|NCT03991312|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93021622|NCT03991312|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93021623|NCT03991312|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93021624|NCT03991312|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93021625|NCT03991312|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93021626|NCT03991312|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93021627|NCT03991312|Enzyme Activators|enzyme activators|mesh-ancestor
93021628|NCT01057342|Paclitaxel|paclitaxel|mesh-list
93021629|NCT01057342|Carboplatin|carboplatin|mesh-list
93021630|NCT01057342|Vadimezan|vadimezan|mesh-list
93021631|NCT01057342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93021632|NCT01057342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021633|NCT01057342|Tubulin Modulators|tubulin modulators|mesh-ancestor
93021634|NCT01057342|Antimitotic Agents|antimitotic agents|mesh-ancestor
93021635|NCT01057342|Mitosis Modulators|mitosis modulators|mesh-ancestor
93021636|NCT01057342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021638|NCT01057498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93021639|NCT01057498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021640|NCT01057498|Analgesics|analgesics|mesh-ancestor
93021641|NCT01057498|Sensory System Agents|sensory system agents|mesh-ancestor
93021642|NCT01057498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021643|NCT01057498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021644|NCT01057498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021645|NCT01057498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021646|NCT01057498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93021647|NCT03742258|Prednisone|prednisone|mesh-list
93021648|NCT03742258|Cortisone|cortisone|mesh-list
93021649|NCT03742258|Cyclophosphamide|cyclophosphamide|mesh-list
93021650|NCT03742258|Rituximab|rituximab|mesh-list
93021651|NCT03742258|Doxorubicin|doxorubicin|mesh-list
93021652|NCT03742258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93021653|NCT03742258|Vincristine|vincristine|mesh-list
93021654|NCT03742258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93021655|NCT03742258|Antibodies|antibodies|mesh-list
93021656|NCT03742258|Immunoglobulins|immunoglobulins|mesh-list
93021657|NCT03742258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93021658|NCT03742258|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93021659|NCT03742258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021660|NCT03742258|Immunologic Factors|immunologic factors|mesh-ancestor
93021661|NCT03742258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021662|NCT03742258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021663|NCT03742258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93021664|NCT03742258|Alkylating Agents|alkylating agents|mesh-ancestor
93021665|NCT03742258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021666|NCT03742258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021667|NCT03742258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93021668|NCT03742258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93021669|NCT03742258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93021670|NCT03742258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93021671|NCT03742258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021672|NCT03742258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021673|NCT03742258|Glucocorticoids|glucocorticoids|mesh-ancestor
93021674|NCT03742258|Hormones|hormones|mesh-ancestor
93021675|NCT03742258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021676|NCT03742258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93021677|NCT03742258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93021678|NCT03742258|Tubulin Modulators|tubulin modulators|mesh-ancestor
93021679|NCT03742258|Antimitotic Agents|antimitotic agents|mesh-ancestor
93021680|NCT03742258|Mitosis Modulators|mitosis modulators|mesh-ancestor
93021681|NCT03742258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93021683|NCT00354172|Mycophenolic Acid|mycophenolic acid|mesh-list
93021684|NCT00354172|Aldesleukin|aldesleukin|mesh-list
93021685|NCT00354172|Methylprednisolone|methylprednisolone|mesh-list
93021686|NCT00354172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93021687|NCT00354172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93021688|NCT00354172|Prednisolone|prednisolone|mesh-list
93021689|NCT00354172|Prednisolone acetate|prednisolone acetate|mesh-list
93021690|NCT00354172|Cyclophosphamide|cyclophosphamide|mesh-list
93021691|NCT00354172|Fludarabine|fludarabine|mesh-list
93021692|NCT00354172|Fludarabine phosphate|fludarabine phosphate|mesh-list
93021693|NCT00354172|Interleukin-2|interleukin-2|mesh-list
93021694|NCT00354172|Cyclosporins|cyclosporins|mesh-list
93021695|NCT00354172|Lenograstim|lenograstim|mesh-list
93021696|NCT00354172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93021697|NCT00354172|Prednisolone phosphate|prednisolone phosphate|mesh-list
93021698|NCT00354172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021699|NCT00354172|Immunologic Factors|immunologic factors|mesh-ancestor
93021700|NCT00354172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021701|NCT00354172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021702|NCT00354172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93021703|NCT00354172|Alkylating Agents|alkylating agents|mesh-ancestor
93021704|NCT00354172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021705|NCT00354172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021706|NCT00354172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93021707|NCT00354172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021708|NCT00354172|Antimetabolites|antimetabolites|mesh-ancestor
93021709|NCT00354172|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93021710|NCT00354172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021711|NCT00354172|Antifungal Agents|antifungal agents|mesh-ancestor
93021712|NCT00354172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021713|NCT00354172|Dermatologic Agents|dermatologic agents|mesh-ancestor
93021714|NCT00354172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93021715|NCT00354172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93021716|NCT00354172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93021717|NCT00354172|Antitubercular Agents|antitubercular agents|mesh-ancestor
93021718|NCT00354172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021719|NCT00354172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021720|NCT00354172|Antiemetics|antiemetics|mesh-ancestor
93021721|NCT00354172|Autonomic Agents|autonomic agents|mesh-ancestor
93021722|NCT00354172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021723|NCT00354172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021724|NCT00354172|Glucocorticoids|glucocorticoids|mesh-ancestor
93021725|NCT00354172|Hormones|hormones|mesh-ancestor
92178446|NCT01472445|Vitamin D|vitamin d|mesh-list
93021726|NCT00354172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021727|NCT00354172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93021728|NCT00354172|Protective Agents|protective agents|mesh-ancestor
93021729|NCT00354172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93021730|NCT00354172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021731|NCT00354172|Analgesics|analgesics|mesh-ancestor
93021732|NCT00354172|Sensory System Agents|sensory system agents|mesh-ancestor
93021733|NCT00354172|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93021734|NCT00354172|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93021735|NCT00354172|Antiviral Agents|antiviral agents|mesh-ancestor
93021736|NCT00353704|Pregabalin|pregabalin|mesh-list
93021737|NCT00353704|Morphine|morphine|mesh-list
93021738|NCT00353704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93021739|NCT00353704|Narcotics|narcotics|mesh-ancestor
93021740|NCT00353704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021741|NCT00353704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021742|NCT00353704|Analgesics|analgesics|mesh-ancestor
93021743|NCT00353704|Sensory System Agents|sensory system agents|mesh-ancestor
93021744|NCT00353704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021745|NCT00353704|Anticonvulsants|anticonvulsants|mesh-ancestor
93021746|NCT00353704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93021747|NCT00353704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021748|NCT00353704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178481|NCT01586091|Fexofenadine|fexofenadine|mesh-list
93021749|NCT00353704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93021750|NCT00353704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93021751|NCT00353704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93021752|NCT00353704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93021753|NCT03742180|Ketorolac|ketorolac|mesh-list
93021754|NCT03742180|Dexmedetomidine|dexmedetomidine|mesh-list
93021755|NCT03742180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93021756|NCT03742180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021757|NCT03742180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021758|NCT03742180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93021759|NCT03742180|Analgesics|analgesics|mesh-ancestor
93021760|NCT03742180|Sensory System Agents|sensory system agents|mesh-ancestor
93021761|NCT03742180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021762|NCT03742180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93021763|NCT03742180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93021764|NCT03742180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93021765|NCT03742180|Adrenergic Agents|adrenergic agents|mesh-ancestor
93021766|NCT03742180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021767|NCT03742180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021768|NCT03742180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93021769|NCT03742180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021770|NCT03742180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021771|NCT03742180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93021772|NCT03742180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021773|NCT00512252|Cytarabine|cytarabine|mesh-list
93021774|NCT00512252|Plerixafor|plerixafor|mesh-list
93021775|NCT00512252|Etoposide|etoposide|mesh-list
93021776|NCT00512252|Mitoxantrone|mitoxantrone|mesh-list
93021777|NCT00512252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93021778|NCT00512252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021779|NCT00512252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93021780|NCT00512252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93021781|NCT00512252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021782|NCT00512252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021783|NCT00512252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021784|NCT00512252|Antimetabolites|antimetabolites|mesh-ancestor
93021785|NCT00512252|Antiviral Agents|antiviral agents|mesh-ancestor
93021786|NCT00512252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021787|NCT00512252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021788|NCT00512252|Immunologic Factors|immunologic factors|mesh-ancestor
93021789|NCT00512252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021790|NCT00512252|Analgesics|analgesics|mesh-ancestor
93021791|NCT00512252|Sensory System Agents|sensory system agents|mesh-ancestor
93021792|NCT00512252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021793|NCT00512252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93021794|NCT00512252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93021795|NCT00516386|Mecasermin|mecasermin|mesh-list
93021796|NCT00516386|Growth Substances|growth substances|mesh-ancestor
93021797|NCT00516386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021798|NCT00512096|Paclitaxel|paclitaxel|mesh-list
93021799|NCT00512096|Cisplatin|cisplatin|mesh-list
93021800|NCT00512096|Ifosfamide|ifosfamide|mesh-list
93021801|NCT00512096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93021802|NCT00512096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021803|NCT00512096|Tubulin Modulators|tubulin modulators|mesh-ancestor
93021804|NCT00512096|Antimitotic Agents|antimitotic agents|mesh-ancestor
93021805|NCT00512096|Mitosis Modulators|mitosis modulators|mesh-ancestor
93021806|NCT00512096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021807|NCT00512096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93021808|NCT00512096|Alkylating Agents|alkylating agents|mesh-ancestor
93021809|NCT04462796|Magnesium citrate|magnesium citrate|mesh-list
93021810|NCT04462796|Cathartics|cathartics|mesh-ancestor
93021811|NCT04462796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021812|NCT00524030|Pregabalin|pregabalin|mesh-list
93021813|NCT00524030|Analgesics|analgesics|mesh-ancestor
93021815|NCT00524030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021816|NCT00524030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021817|NCT00524030|Anticonvulsants|anticonvulsants|mesh-ancestor
93021818|NCT00524030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93021819|NCT00524030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021820|NCT00524030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021821|NCT00524030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93021822|NCT00524030|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93021823|NCT00524030|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93021824|NCT00524030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93021825|NCT00524030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667102|NCT00419250|Lenalidomide|lenalidomide|mesh-list
93021826|NCT00523718|Riluzole|riluzole|mesh-list
93021827|NCT00523718|Anticonvulsants|anticonvulsants|mesh-ancestor
93021828|NCT00523718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93021829|NCT00523718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93021830|NCT00523718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021831|NCT00523718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021832|NCT00523718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021833|NCT00523718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93021834|NCT00523718|Protective Agents|protective agents|mesh-ancestor
93021835|NCT00523640|Bevacizumab|bevacizumab|mesh-list
93021836|NCT00523640|Gemcitabine|gemcitabine|mesh-list
93021837|NCT00523640|Capecitabine|capecitabine|mesh-list
93021838|NCT00523640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93021839|NCT00523640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021840|NCT00523640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93021841|NCT00523640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93021842|NCT00523640|Growth Substances|growth substances|mesh-ancestor
93021843|NCT00523640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021844|NCT00523640|Growth Inhibitors|growth inhibitors|mesh-ancestor
93021845|NCT00523640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021846|NCT00523640|Antimetabolites|antimetabolites|mesh-ancestor
93021847|NCT00523640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021848|NCT00345358|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93021849|NCT00345358|Immunologic Factors|immunologic factors|mesh-ancestor
93021850|NCT00345358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021851|NCT00516074|Exenatide|exenatide|mesh-list
93021852|NCT00516074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93021853|NCT00516074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021854|NCT00516074|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93021855|NCT00516074|Incretins|incretins|mesh-ancestor
93021856|NCT00516074|Hormones|hormones|mesh-ancestor
93021857|NCT00516074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021858|NCT01057654|Pravastatin|pravastatin|mesh-list
93021859|NCT01057654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93021860|NCT01057654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93021861|NCT01057654|Antimetabolites|antimetabolites|mesh-ancestor
93021862|NCT01057654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021863|NCT01057654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93021864|NCT01057654|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93021865|NCT01057654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021866|NCT00515294|Caffeine|caffeine|mesh-list
93021867|NCT00515294|Methamphetamine|methamphetamine|mesh-list
93021868|NCT00515294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93021869|NCT00515294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021870|NCT00515294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93021871|NCT00515294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021872|NCT00515294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021873|NCT00515294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93021874|NCT00515294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93021875|NCT00515294|Purinergic Agents|purinergic agents|mesh-ancestor
93021876|NCT00515294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021877|NCT00515294|Sympathomimetics|sympathomimetics|mesh-ancestor
93021878|NCT00515294|Autonomic Agents|autonomic agents|mesh-ancestor
93021879|NCT00515294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021880|NCT00515294|Dopamine Agents|dopamine agents|mesh-ancestor
93021881|NCT00515294|Adrenergic Agents|adrenergic agents|mesh-ancestor
93021882|NCT00515294|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93021883|NCT00515294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93021884|NCT00515294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021885|NCT00515294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93021887|NCT00345046|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93021888|NCT00345046|Methylprednisolone|methylprednisolone|mesh-list
93021889|NCT00345046|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93021890|NCT00345046|Prednisolone acetate|prednisolone acetate|mesh-list
93021891|NCT00345046|Prednisone|prednisone|mesh-list
93021892|NCT00345046|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93021893|NCT00345046|Prednisolone phosphate|prednisolone phosphate|mesh-list
93021894|NCT00345046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93021895|NCT00345046|Glucocorticoids|glucocorticoids|mesh-ancestor
93021896|NCT00345046|Hormones|hormones|mesh-ancestor
93021897|NCT00345046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93021898|NCT00345046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667175|NCT00284531|Daclizumab|daclizumab|mesh-list
93021899|NCT00345046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93021900|NCT00345046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021901|NCT00345046|Antiemetics|antiemetics|mesh-ancestor
93021902|NCT00345046|Autonomic Agents|autonomic agents|mesh-ancestor
93021903|NCT00345046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021904|NCT00345046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93021905|NCT00345046|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93021906|NCT00345046|Protective Agents|protective agents|mesh-ancestor
93021908|NCT00515216|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
93021909|NCT00515216|Tetrahydrofolates|tetrahydrofolates|mesh-list
93021910|NCT00515216|Fluorouracil|fluorouracil|mesh-list
93021911|NCT00515216|Oxaliplatin|oxaliplatin|mesh-list
93021912|NCT00515216|Levoleucovorin|levoleucovorin|mesh-list
93021913|NCT00515216|Antimetabolites|antimetabolites|mesh-ancestor
93021914|NCT00515216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021915|NCT00515216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93021916|NCT00515216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021917|NCT00515216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021918|NCT00515216|Immunologic Factors|immunologic factors|mesh-ancestor
93021919|NCT00515216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021920|NCT00515216|Antidotes|antidotes|mesh-ancestor
93021921|NCT00515216|Protective Agents|protective agents|mesh-ancestor
93021922|NCT00515216|Vitamin B Complex|vitamin b complex|mesh-ancestor
93021923|NCT00515216|Vitamins|vitamins|mesh-ancestor
93021924|NCT00515216|Micronutrients|micronutrients|mesh-ancestor
93021925|NCT01004978|Cisplatin|cisplatin|mesh-list
93021926|NCT01004978|Doxorubicin|doxorubicin|mesh-list
93021927|NCT01004978|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93021928|NCT01004978|Sorafenib|sorafenib|mesh-list
93021929|NCT01004978|Mitomycins|mitomycins|mesh-list
93021930|NCT01004978|Mitomycin|mitomycin|mesh-list
93021931|NCT01004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93021932|NCT01004978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93021933|NCT01004978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93021934|NCT01004978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93021935|NCT01004978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021936|NCT01004978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021937|NCT01004978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93021938|NCT01004978|Alkylating Agents|alkylating agents|mesh-ancestor
93021939|NCT01004978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93021940|NCT00440193|Enoxaparin|enoxaparin|mesh-list
93021941|NCT00440193|Rivaroxaban|rivaroxaban|mesh-list
93021942|NCT00440193|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93021943|NCT00440193|Antithrombins|antithrombins|mesh-ancestor
93021944|NCT00440193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93021945|NCT00440193|Protease Inhibitors|protease inhibitors|mesh-ancestor
93021946|NCT00440193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021947|NCT00440193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021948|NCT00440193|Anticoagulants|anticoagulants|mesh-ancestor
93021949|NCT00440193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93021950|NCT00440193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93021951|NCT00511472|Insulin Glargine|insulin glargine|mesh-list
93021952|NCT00511472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93021953|NCT00511472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021954|NCT01033305|Cyclosporine|cyclosporine|mesh-list
93021955|NCT01033305|Cyclosporins|cyclosporins|mesh-list
93021956|NCT01033305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021957|NCT01033305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021958|NCT01033305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93021959|NCT01033305|Immunologic Factors|immunologic factors|mesh-ancestor
93021960|NCT01033305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021961|NCT01033305|Antifungal Agents|antifungal agents|mesh-ancestor
93021962|NCT01033305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021963|NCT01033305|Dermatologic Agents|dermatologic agents|mesh-ancestor
93021964|NCT01033305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93021965|NCT01033305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93021967|NCT00514904|Immunologic Factors|immunologic factors|mesh-ancestor
93021968|NCT00514904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021969|NCT00440115|Bupropion|bupropion|mesh-list
93021970|NCT00440115|Nicotine|nicotine|mesh-list
93021971|NCT00440115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93021972|NCT00440115|Autonomic Agents|autonomic agents|mesh-ancestor
93021973|NCT00440115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93021974|NCT00440115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021975|NCT00440115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93021976|NCT00440115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93021977|NCT00440115|Cholinergic Agents|cholinergic agents|mesh-ancestor
93021978|NCT00440115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93021979|NCT00440115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93021980|NCT00440115|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93021981|NCT00440115|Antidepressive Agents|antidepressive agents|mesh-ancestor
93021982|NCT00440115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93021983|NCT00440115|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93021984|NCT00440115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93021985|NCT00440115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93021986|NCT00440115|Dopamine Agents|dopamine agents|mesh-ancestor
93021987|NCT00440115|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93021988|NCT00440115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93021989|NCT00440115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93021990|NCT01033461|Calcium|calcium|mesh-list
93021991|NCT01033461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93021992|NCT01033461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93021993|NCT01030731|Ceftobiprole|ceftobiprole|mesh-list
93021994|NCT01030731|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93021995|NCT01030731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93021996|NCT01030731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93021997|NCT00416715|Calcium, Dietary|calcium, dietary|mesh-list
93021998|NCT00416715|Vitamin D|vitamin d|mesh-list
93021999|NCT00416715|Cholecalciferol|cholecalciferol|mesh-list
93022000|NCT00416715|Letrozole|letrozole|mesh-list
93022001|NCT00416715|Calcium Carbonate|calcium carbonate|mesh-list
93022002|NCT00416715|Citric Acid|citric acid|mesh-list
93022003|NCT00416715|Sodium Citrate|sodium citrate|mesh-list
93022004|NCT00416715|Calcium|calcium|mesh-list
93022005|NCT00416715|Vitamins|vitamins|mesh-ancestor
93022006|NCT00416715|Micronutrients|micronutrients|mesh-ancestor
93022007|NCT00416715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022008|NCT00416715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022009|NCT00416715|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022010|NCT00416715|Anticoagulants|anticoagulants|mesh-ancestor
93022011|NCT00416715|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93022012|NCT00416715|Chelating Agents|chelating agents|mesh-ancestor
93022013|NCT00416715|Sequestering Agents|sequestering agents|mesh-ancestor
93022014|NCT00416715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022015|NCT00416715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022016|NCT00416715|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93022017|NCT00416715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93022018|NCT00416715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022019|NCT00416715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93022020|NCT00416715|Hormone Antagonists|hormone antagonists|mesh-ancestor
93022021|NCT00416715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022022|NCT00416715|Antacids|antacids|mesh-ancestor
93022023|NCT00416715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022024|NCT01037517|Plerixafor|plerixafor|mesh-list
93022025|NCT01037517|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93022026|NCT01037517|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93022027|NCT01037517|Antiviral Agents|antiviral agents|mesh-ancestor
93022028|NCT01037517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022029|NCT00406029|Levodopa|levodopa|mesh-list
93022030|NCT00406029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93022031|NCT00406029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93022032|NCT00406029|Dopamine Agents|dopamine agents|mesh-ancestor
93022033|NCT00406029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022034|NCT00406029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022035|NCT00406029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022037|NCT00514514|Mycophenolic Acid|mycophenolic acid|mesh-list
93022038|NCT00514514|Everolimus|everolimus|mesh-list
93022039|NCT00514514|Cyclosporins|cyclosporins|mesh-list
93022040|NCT00514514|Basiliximab|basiliximab|mesh-list
93022041|NCT00514514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022042|NCT00514514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022043|NCT00514514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022044|NCT00514514|Immunologic Factors|immunologic factors|mesh-ancestor
93022045|NCT00514514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022046|NCT00514514|Antifungal Agents|antifungal agents|mesh-ancestor
93022047|NCT00514514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022048|NCT00514514|Dermatologic Agents|dermatologic agents|mesh-ancestor
93022049|NCT00514514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022050|NCT00514514|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93022051|NCT00514514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93022052|NCT00514514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93022053|NCT00514514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667321|NCT00285389|Antiemetics|antiemetics|mesh-ancestor
93022054|NCT00514514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93022055|NCT00514514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93022056|NCT00514514|Antitubercular Agents|antitubercular agents|mesh-ancestor
93022057|NCT00514514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93022058|NCT00405639|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93022059|NCT00405639|Natriuretic Agents|natriuretic agents|mesh-ancestor
93022060|NCT00405639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022061|NCT00439725|Rivaroxaban|rivaroxaban|mesh-list
93022062|NCT00439725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93022063|NCT00439725|Antithrombins|antithrombins|mesh-ancestor
93022064|NCT00439725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93022065|NCT00439725|Protease Inhibitors|protease inhibitors|mesh-ancestor
93022066|NCT00439725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022067|NCT00439725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022068|NCT00439725|Anticoagulants|anticoagulants|mesh-ancestor
93022069|NCT00521586|Vaccines|vaccines|mesh-list
93022070|NCT00521586|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93022071|NCT00521586|Immunologic Factors|immunologic factors|mesh-ancestor
93022072|NCT00521586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022073|NCT00515502|Tiotropium Bromide|tiotropium bromide|mesh-list
93022074|NCT00515502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93022075|NCT00515502|Autonomic Agents|autonomic agents|mesh-ancestor
93022076|NCT00515502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022077|NCT00515502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022078|NCT00515502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93022079|NCT00515502|Respiratory System Agents|respiratory system agents|mesh-ancestor
93022080|NCT00515502|Parasympatholytics|parasympatholytics|mesh-ancestor
93022081|NCT00515502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93022082|NCT00515502|Cholinergic Agents|cholinergic agents|mesh-ancestor
93022083|NCT00515502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022084|NCT00515502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022085|NCT01010646|Ribavirin|ribavirin|mesh-list
93022086|NCT01010646|Interferon-alpha|interferon-alpha|mesh-list
93022087|NCT01010646|Interferon alpha-2|interferon alpha-2|mesh-list
93022088|NCT01010646|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
93022089|NCT01010646|Antimetabolites|antimetabolites|mesh-ancestor
93022090|NCT01010646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022091|NCT01010646|Antiviral Agents|antiviral agents|mesh-ancestor
93022092|NCT01010646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022093|NCT01010646|Immunologic Factors|immunologic factors|mesh-ancestor
93022094|NCT01010646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022095|NCT01010646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022096|NCT00439647|Zoledronic Acid|zoledronic acid|mesh-list
93022097|NCT00439647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022098|NCT00439647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022099|NCT00515112|Testosterone|testosterone|mesh-list
93022100|NCT00515112|Androgens|androgens|mesh-ancestor
93022101|NCT00515112|Hormones|hormones|mesh-ancestor
93022102|NCT00515112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022103|NCT00515112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022104|NCT03742557|Ketamine|ketamine|mesh-list
93022105|NCT03742557|Analgesics|analgesics|mesh-ancestor
93022106|NCT03742557|Sensory System Agents|sensory system agents|mesh-ancestor
93022107|NCT03742557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022108|NCT03742557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022109|NCT03742557|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93022110|NCT03742557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93022111|NCT03742557|Anesthetics, General|anesthetics, general|mesh-ancestor
93022112|NCT03742557|Anesthetics|anesthetics|mesh-ancestor
93022113|NCT03742557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022114|NCT03742557|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93022115|NCT03742557|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93022116|NCT03742557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022117|NCT03742557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022118|NCT01324089|Resveratrol|resveratrol|mesh-list
93022119|NCT01324089|Piperine|piperine|mesh-list
93022120|NCT01324089|Antioxidants|antioxidants|mesh-ancestor
93022121|NCT01324089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022122|NCT01324089|Protective Agents|protective agents|mesh-ancestor
93022123|NCT01324089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022124|NCT01324089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022125|NCT01324089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93022126|NCT01324089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93022127|NCT00404547|Ciclesonide|ciclesonide|mesh-list
92667397|NCT00319566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93022128|NCT00404547|Glucocorticoids|glucocorticoids|mesh-ancestor
92179003|NCT01896739|Vaccines|vaccines|mesh-list
92179007|NCT00176839|Melphalan|melphalan|mesh-list
93022130|NCT00404547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022131|NCT00404547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022132|NCT00404547|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93022133|NCT00515034|Imipenem|imipenem|mesh-list
93022134|NCT00515034|Doripenem|doripenem|mesh-list
93022135|NCT00515034|Cilastatin|cilastatin|mesh-list
93022136|NCT00515034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93022137|NCT00515034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022138|NCT00515034|Protease Inhibitors|protease inhibitors|mesh-ancestor
93022139|NCT00515034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022140|NCT00515034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022141|NCT00404235|Paclitaxel|paclitaxel|mesh-list
93022142|NCT00404235|Carboplatin|carboplatin|mesh-list
93022143|NCT00404235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93022144|NCT00404235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022145|NCT00404235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022146|NCT00404235|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022147|NCT00404235|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022148|NCT00404235|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022149|NCT00404235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022150|NCT00509262|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93022151|NCT00509262|Glipizide|glipizide|mesh-list
93022152|NCT00509262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93022153|NCT00509262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022154|NCT00509262|Incretins|incretins|mesh-ancestor
93022155|NCT00509262|Hormones|hormones|mesh-ancestor
93022156|NCT00509262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022157|NCT00509262|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93022158|NCT00509262|Protease Inhibitors|protease inhibitors|mesh-ancestor
93022159|NCT00509262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022160|NCT00509262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022161|NCT00509106|Ceftriaxone|ceftriaxone|mesh-list
93022162|NCT00509106|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93022163|NCT00509106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93022164|NCT00509106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022165|NCT00607919|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93022166|NCT00607919|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93022167|NCT00607919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93022168|NCT00607919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93022169|NCT00607919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022170|NCT00607919|Adrenergic Agents|adrenergic agents|mesh-ancestor
93022171|NCT00607919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022172|NCT00607919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022173|NCT00344968|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
93022174|NCT00344968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022175|NCT00344968|Glucocorticoids|glucocorticoids|mesh-ancestor
93022176|NCT00344968|Hormones|hormones|mesh-ancestor
93022177|NCT00344968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022178|NCT00344968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022179|NCT00509028|Budesonide|budesonide|mesh-list
93022180|NCT00509028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022181|NCT00509028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93022182|NCT00509028|Autonomic Agents|autonomic agents|mesh-ancestor
93022183|NCT00509028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022184|NCT00509028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022185|NCT00509028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93022186|NCT00509028|Respiratory System Agents|respiratory system agents|mesh-ancestor
92179113|NCT01855607|Menthol|menthol|mesh-list
93022187|NCT00509028|Glucocorticoids|glucocorticoids|mesh-ancestor
93022189|NCT00509028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022190|NCT00352846|Vitamin D|vitamin d|mesh-list
93022191|NCT00352846|Zoledronic Acid|zoledronic acid|mesh-list
93022192|NCT00352846|Calcium Carbonate|calcium carbonate|mesh-list
93022193|NCT00352846|Calcium|calcium|mesh-list
93022194|NCT00352846|Vitamins|vitamins|mesh-ancestor
93022195|NCT00352846|Micronutrients|micronutrients|mesh-ancestor
93022196|NCT00352846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022197|NCT00352846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022198|NCT00352846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022199|NCT00352846|Antacids|antacids|mesh-ancestor
93022200|NCT00352846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022201|NCT00352846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022202|NCT00508872|Leucovorin|leucovorin|mesh-list
93022203|NCT00508872|Bevacizumab|bevacizumab|mesh-list
93022204|NCT00508872|Fluorouracil|fluorouracil|mesh-list
93022205|NCT00508872|Oxaliplatin|oxaliplatin|mesh-list
93022206|NCT00508872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022207|NCT00508872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022208|NCT00508872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93022209|NCT00508872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93022210|NCT00508872|Growth Substances|growth substances|mesh-ancestor
93022211|NCT00508872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022212|NCT00508872|Growth Inhibitors|growth inhibitors|mesh-ancestor
93022213|NCT00508872|Antimetabolites|antimetabolites|mesh-ancestor
93022214|NCT00508872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022215|NCT00508872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93022216|NCT00508872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022217|NCT00508872|Immunologic Factors|immunologic factors|mesh-ancestor
93022218|NCT00508872|Antidotes|antidotes|mesh-ancestor
93022219|NCT00508872|Protective Agents|protective agents|mesh-ancestor
93022220|NCT00508872|Vitamin B Complex|vitamin b complex|mesh-ancestor
93022221|NCT00508872|Vitamins|vitamins|mesh-ancestor
93022222|NCT00508872|Micronutrients|micronutrients|mesh-ancestor
93022223|NCT00508482|Lactulose|lactulose|mesh-list
93022224|NCT00508482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022225|NCT00344032|Vaccines|vaccines|mesh-list
93022226|NCT00344032|Immunologic Factors|immunologic factors|mesh-ancestor
93022227|NCT00344032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022228|NCT00607373|Mipomersen|mipomersen|mesh-list
93022229|NCT00607373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93022230|NCT00607373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93022231|NCT00607373|Antimetabolites|antimetabolites|mesh-ancestor
93022232|NCT00607373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022233|NCT00607373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93022234|NCT00508404|Panitumumab|panitumumab|mesh-list
93022235|NCT00508404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022236|NCT00508404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022237|NCT00352690|Paclitaxel|paclitaxel|mesh-list
93022238|NCT00352690|Carboplatin|carboplatin|mesh-list
93022239|NCT00352690|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
93022240|NCT00352690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022241|NCT00352690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022242|NCT00352690|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022243|NCT00352690|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022244|NCT00352690|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022245|NCT00352690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022246|NCT00895505|Warfarin|warfarin|mesh-list
93022247|NCT00895505|Phenprocoumon|phenprocoumon|mesh-list
93022248|NCT00895505|Anticoagulants|anticoagulants|mesh-ancestor
93022249|NCT03502577|Cyclophosphamide|cyclophosphamide|mesh-list
93022250|NCT03502577|Fludarabine|fludarabine|mesh-list
93022251|NCT03502577|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93022252|NCT03502577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022253|NCT03502577|Immunologic Factors|immunologic factors|mesh-ancestor
93022254|NCT03502577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022255|NCT03502577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022256|NCT03502577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022257|NCT03502577|Alkylating Agents|alkylating agents|mesh-ancestor
93022258|NCT03502577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022259|NCT03502577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022260|NCT03502577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93022261|NCT03502577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022262|NCT03249012|Calcium, Dietary|calcium, dietary|mesh-list
93022264|NCT03249012|Calcium Carbonate|calcium carbonate|mesh-list
93022265|NCT03249012|Calcium|calcium|mesh-list
93022266|NCT03249012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022267|NCT03249012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022268|NCT03249012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022269|NCT03249012|Antacids|antacids|mesh-ancestor
93022270|NCT03249012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022271|NCT03249012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022272|NCT03249012|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93022273|NCT03249012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93022274|NCT03249012|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93022275|NCT03249012|Vitamins|vitamins|mesh-ancestor
93022276|NCT03249012|Micronutrients|micronutrients|mesh-ancestor
92667545|NCT00319917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022277|NCT03477539|Lenalidomide|lenalidomide|mesh-list
93022278|NCT03477539|Daratumumab|daratumumab|mesh-list
93022279|NCT03477539|Immunologic Factors|immunologic factors|mesh-ancestor
93022280|NCT03477539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022281|NCT03477539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93022282|NCT03477539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93022283|NCT03477539|Growth Substances|growth substances|mesh-ancestor
93022284|NCT03477539|Growth Inhibitors|growth inhibitors|mesh-ancestor
93022285|NCT03477539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022287|NCT00893477|Sargramostim|sargramostim|mesh-list
93022288|NCT00893477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022289|NCT00893477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022290|NCT00893477|Immunologic Factors|immunologic factors|mesh-ancestor
93022291|NCT00893477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022292|NCT00893477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022293|NCT00609245|Valproic Acid|valproic acid|mesh-list
93022294|NCT00609245|Anticonvulsants|anticonvulsants|mesh-ancestor
93022295|NCT00609245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022296|NCT00609245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022297|NCT00609245|GABA Agents|gaba agents|mesh-ancestor
93022298|NCT00609245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022299|NCT00609245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022300|NCT00609245|Antimanic Agents|antimanic agents|mesh-ancestor
93022301|NCT00609245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022302|NCT00609245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022303|NCT00609245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022304|NCT01010802|Epoetin Alfa|epoetin alfa|mesh-list
93022305|NCT01010802|Hematinics|hematinics|mesh-ancestor
93022306|NCT04036253|Epoetin Alfa|epoetin alfa|mesh-list
93022307|NCT04036253|Hematinics|hematinics|mesh-ancestor
93022308|NCT00893555|Voriconazole|voriconazole|mesh-list
93022309|NCT00893555|Antifungal Agents|antifungal agents|mesh-ancestor
93022310|NCT00893555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022311|NCT00893555|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93022312|NCT00893555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93022313|NCT00893555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022314|NCT00893555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022315|NCT00893555|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93022316|NCT00893555|Hormone Antagonists|hormone antagonists|mesh-ancestor
93022317|NCT00893555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022318|NCT00893555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022319|NCT00893555|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93022320|NCT02541071|Clonidine|clonidine|mesh-list
93022321|NCT02541071|Yohimbine|yohimbine|mesh-list
93022322|NCT02541071|Analgesics|analgesics|mesh-ancestor
93022323|NCT02541071|Sensory System Agents|sensory system agents|mesh-ancestor
93022324|NCT02541071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022325|NCT02541071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022326|NCT02541071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93022327|NCT02541071|Sympatholytics|sympatholytics|mesh-ancestor
93022328|NCT02541071|Autonomic Agents|autonomic agents|mesh-ancestor
93022329|NCT02541071|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93022330|NCT02541071|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93022331|NCT02541071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93022332|NCT02541071|Adrenergic Agents|adrenergic agents|mesh-ancestor
93022333|NCT02541071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022334|NCT02541071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022335|NCT02541071|Mydriatics|mydriatics|mesh-ancestor
93022336|NCT02541071|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93022337|NCT02541071|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93022338|NCT02541071|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93022339|NCT02541071|Urological Agents|urological agents|mesh-ancestor
93022340|NCT01058824|Lincomycin|lincomycin|mesh-list
93022341|NCT01058824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93022342|NCT01058824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022343|NCT01058824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93022344|NCT01058824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022345|NCT01058824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022346|NCT00895739|Cyclosporine|cyclosporine|mesh-list
93022347|NCT00895739|Alemtuzumab|alemtuzumab|mesh-list
93022348|NCT00895739|Cyclosporins|cyclosporins|mesh-list
93022349|NCT00895739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022350|NCT00895739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022351|NCT00895739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022352|NCT00895739|Immunologic Factors|immunologic factors|mesh-ancestor
93022353|NCT00895739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022354|NCT00895739|Antifungal Agents|antifungal agents|mesh-ancestor
93022355|NCT00895739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022356|NCT00895739|Dermatologic Agents|dermatologic agents|mesh-ancestor
93022357|NCT00895739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022358|NCT00895739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93022359|NCT00895739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022360|NCT00895739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022362|NCT01058902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93022363|NCT01058902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93022364|NCT01058902|Analgesics|analgesics|mesh-ancestor
93022365|NCT01058902|Sensory System Agents|sensory system agents|mesh-ancestor
93022366|NCT01058902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022367|NCT01058902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022368|NCT01058902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022369|NCT01058902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022370|NCT01058902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93022371|NCT01058902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93022372|NCT01058902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022373|NCT01058902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93022374|NCT01058902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93022375|NCT01058902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022376|NCT01058902|Antipyretics|antipyretics|mesh-ancestor
93022377|NCT00609167|Dexamethasone|dexamethasone|mesh-list
93022378|NCT00609167|Cyclophosphamide|cyclophosphamide|mesh-list
93022379|NCT00609167|Bortezomib|bortezomib|mesh-list
93022380|NCT00609167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022381|NCT00609167|Immunologic Factors|immunologic factors|mesh-ancestor
93022382|NCT00609167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022383|NCT00609167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022384|NCT00609167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022385|NCT00609167|Alkylating Agents|alkylating agents|mesh-ancestor
93022386|NCT00609167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022387|NCT00609167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022388|NCT00609167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93022389|NCT00609167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022390|NCT00609167|Antiemetics|antiemetics|mesh-ancestor
93022391|NCT00609167|Autonomic Agents|autonomic agents|mesh-ancestor
93022392|NCT00609167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022393|NCT00609167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022394|NCT00609167|Glucocorticoids|glucocorticoids|mesh-ancestor
93022395|NCT00609167|Hormones|hormones|mesh-ancestor
93022396|NCT00609167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022397|NCT00609167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93022398|NCT01055236|Hydroxyzine|hydroxyzine|mesh-list
93022399|NCT01055236|Antipruritics|antipruritics|mesh-ancestor
93022400|NCT01055236|Dermatologic Agents|dermatologic agents|mesh-ancestor
93022401|NCT01055236|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93022402|NCT01055236|Histamine Antagonists|histamine antagonists|mesh-ancestor
93022403|NCT01055236|Histamine Agents|histamine agents|mesh-ancestor
93022404|NCT01055236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022405|NCT01055236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022406|NCT01055236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022407|NCT00606281|Aripiprazole|aripiprazole|mesh-list
93022408|NCT00606281|Antidepressive Agents|antidepressive agents|mesh-ancestor
93022409|NCT00606281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022410|NCT00606281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93022411|NCT00606281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022412|NCT00606281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022413|NCT00606281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022414|NCT00606281|Dopamine Agonists|dopamine agonists|mesh-ancestor
93022416|NCT00606281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022417|NCT00606281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022418|NCT00606281|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93022419|NCT00606281|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93022420|NCT00606281|Serotonin Agents|serotonin agents|mesh-ancestor
93022421|NCT00606281|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93022422|NCT00606281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93022423|NCT00606281|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93022424|NCT00606281|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93022425|NCT00506142|Vincristine|vincristine|mesh-list
93022426|NCT00506142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022427|NCT00506142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667702|NCT00313599|Paclitaxel|paclitaxel|mesh-list
93022428|NCT00506142|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022429|NCT00506142|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022430|NCT00506142|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022431|NCT00506142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022433|NCT00891605|Navitoclax|navitoclax|mesh-list
93022434|NCT00891605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022435|NCT00891605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022436|NCT00891605|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022437|NCT00891605|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022438|NCT00891605|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022439|NCT00891605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022440|NCT00893711|Vitamin D|vitamin d|mesh-list
93022441|NCT00893711|Vitamins|vitamins|mesh-ancestor
93022442|NCT00893711|Micronutrients|micronutrients|mesh-ancestor
93022443|NCT00893711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022444|NCT00893711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022445|NCT00514020|Leucovorin|leucovorin|mesh-list
93022446|NCT00514020|Fluorouracil|fluorouracil|mesh-list
93022447|NCT00514020|Oxaliplatin|oxaliplatin|mesh-list
93022448|NCT00514020|Calcium|calcium|mesh-list
93022449|NCT00514020|Levoleucovorin|levoleucovorin|mesh-list
93022450|NCT00514020|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022451|NCT00514020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022452|NCT00514020|Antimetabolites|antimetabolites|mesh-ancestor
93022453|NCT00514020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022454|NCT00514020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93022455|NCT00514020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022456|NCT00514020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022457|NCT00514020|Immunologic Factors|immunologic factors|mesh-ancestor
93022458|NCT00514020|Antidotes|antidotes|mesh-ancestor
93022459|NCT00514020|Protective Agents|protective agents|mesh-ancestor
93022460|NCT00514020|Vitamin B Complex|vitamin b complex|mesh-ancestor
93022461|NCT00514020|Vitamins|vitamins|mesh-ancestor
93022462|NCT00514020|Micronutrients|micronutrients|mesh-ancestor
93022463|NCT03570827|Ascorbic Acid|ascorbic acid|mesh-list
93022464|NCT03570827|Methyltestosterone|methyltestosterone|mesh-list
93022465|NCT03570827|Androgens|androgens|mesh-list
93022466|NCT03570827|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93022467|NCT03570827|Hormones|hormones|mesh-ancestor
93022468|NCT03570827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022469|NCT03570827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022470|NCT03570827|Antioxidants|antioxidants|mesh-ancestor
93022471|NCT03570827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022472|NCT03570827|Protective Agents|protective agents|mesh-ancestor
93022473|NCT03570827|Vitamins|vitamins|mesh-ancestor
93022474|NCT03570827|Micronutrients|micronutrients|mesh-ancestor
93022475|NCT03570827|Estrogens|estrogens|mesh-ancestor
93022476|NCT03570827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93022477|NCT03570827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022478|NCT03570827|Anabolic Agents|anabolic agents|mesh-ancestor
93022479|NCT03560531|Palbociclib|palbociclib|mesh-list
93022480|NCT03560531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022481|NCT03560531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93022482|NCT03560531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022483|NCT03560531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022484|NCT00896285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
93022486|NCT00896285|Opiate Alkaloids|opiate alkaloids|mesh-list
93022487|NCT00896285|Sensory System Agents|sensory system agents|mesh-ancestor
93022488|NCT00896285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022489|NCT00896285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022490|NCT00896285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93022491|NCT00896285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022492|NCT00896285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022493|NCT00896285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93022494|NCT00896285|Narcotics|narcotics|mesh-ancestor
93022495|NCT00896285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022496|NCT00891761|Dexamethasone|dexamethasone|mesh-list
93022497|NCT00891761|Dexamethasone acetate|dexamethasone acetate|mesh-list
93022498|NCT00891761|Ondansetron|ondansetron|mesh-list
93022499|NCT00891761|Casopitant|casopitant|mesh-list
93022500|NCT00891761|BB 1101|bb 1101|mesh-list
93022501|NCT00891761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022502|NCT00891761|Antiemetics|antiemetics|mesh-ancestor
93022503|NCT00891761|Autonomic Agents|autonomic agents|mesh-ancestor
93022504|NCT00891761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022505|NCT00891761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022506|NCT00891761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022507|NCT00891761|Glucocorticoids|glucocorticoids|mesh-ancestor
93022508|NCT00891761|Hormones|hormones|mesh-ancestor
93022509|NCT00891761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022510|NCT00891761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93022511|NCT00891761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022512|NCT00891761|Protease Inhibitors|protease inhibitors|mesh-ancestor
93022513|NCT00891761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022514|NCT00891761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022515|NCT00891761|Antipruritics|antipruritics|mesh-ancestor
93022516|NCT00891761|Dermatologic Agents|dermatologic agents|mesh-ancestor
93022517|NCT00891761|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93022518|NCT00891761|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93022519|NCT00891761|Serotonin Agents|serotonin agents|mesh-ancestor
93022520|NCT00891761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022521|NCT00891761|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93022522|NCT01012830|Huperzine A|huperzine a|mesh-list
93022523|NCT01012830|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93022524|NCT01012830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022525|NCT01012830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022526|NCT01012830|Cholinergic Agents|cholinergic agents|mesh-ancestor
93022527|NCT01012830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022528|NCT01012830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022529|NCT01012830|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93022530|NCT01012830|Protective Agents|protective agents|mesh-ancestor
93022531|NCT00513474|Cyclosporine|cyclosporine|mesh-list
93022532|NCT00513474|Sirolimus|sirolimus|mesh-list
93022533|NCT00513474|Cyclophosphamide|cyclophosphamide|mesh-list
93022534|NCT00513474|Busulfan|busulfan|mesh-list
93022535|NCT00513474|Methotrexate|methotrexate|mesh-list
93022536|NCT00513474|Fludarabine|fludarabine|mesh-list
93022537|NCT00513474|Etoposide|etoposide|mesh-list
93022538|NCT00513474|Allopurinol|allopurinol|mesh-list
93022539|NCT00513474|Rasburicase|rasburicase|mesh-list
93022540|NCT00513474|Tacrolimus|tacrolimus|mesh-list
93022541|NCT00513474|Cyclosporins|cyclosporins|mesh-list
93022542|NCT00513474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022543|NCT00513474|Immunologic Factors|immunologic factors|mesh-ancestor
93022544|NCT00513474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022545|NCT00513474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022546|NCT00513474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022547|NCT00513474|Alkylating Agents|alkylating agents|mesh-ancestor
93022548|NCT00513474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022549|NCT00513474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022550|NCT00513474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93022551|NCT00513474|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93022552|NCT00513474|Abortifacient Agents|abortifacient agents|mesh-ancestor
93022553|NCT00513474|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93022554|NCT00513474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93022555|NCT00513474|Antimetabolites|antimetabolites|mesh-ancestor
93022556|NCT00513474|Dermatologic Agents|dermatologic agents|mesh-ancestor
93022557|NCT00513474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022558|NCT00513474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92368146|NCT00943800|Vidarabine|vidarabine|mesh-list
93022559|NCT00513474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93022560|NCT00513474|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022561|NCT00513474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93022562|NCT00513474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93022563|NCT00513474|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93022564|NCT00513474|Antifungal Agents|antifungal agents|mesh-ancestor
93022565|NCT00513474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022566|NCT00513474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93022567|NCT00513474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93022568|NCT00513474|Gout Suppressants|gout suppressants|mesh-ancestor
93022569|NCT00513474|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93022570|NCT00513474|Antioxidants|antioxidants|mesh-ancestor
93022571|NCT00513474|Protective Agents|protective agents|mesh-ancestor
93022572|NCT01010958|Valproic Acid|valproic acid|mesh-list
93022573|NCT01010958|Anticonvulsants|anticonvulsants|mesh-ancestor
93022574|NCT01010958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022575|NCT01010958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022576|NCT01010958|GABA Agents|gaba agents|mesh-ancestor
93022577|NCT01010958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022578|NCT01010958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022579|NCT01010958|Antimanic Agents|antimanic agents|mesh-ancestor
93022580|NCT01010958|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022581|NCT01010958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022582|NCT01010958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022583|NCT00896519|Prednisone|prednisone|mesh-list
93022584|NCT00896519|Cyclophosphamide|cyclophosphamide|mesh-list
93022585|NCT00896519|Rituximab|rituximab|mesh-list
93022586|NCT00896519|Doxorubicin|doxorubicin|mesh-list
93022587|NCT00896519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93022588|NCT00896519|Vincristine|vincristine|mesh-list
93022589|NCT00896519|Sargramostim|sargramostim|mesh-list
93022590|NCT00896519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022591|NCT00896519|Immunologic Factors|immunologic factors|mesh-ancestor
93022592|NCT00896519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022593|NCT00896519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022594|NCT00896519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022595|NCT00896519|Alkylating Agents|alkylating agents|mesh-ancestor
93022596|NCT00896519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022597|NCT00896519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022598|NCT00896519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93022599|NCT00896519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022600|NCT00896519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93022601|NCT00896519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93022602|NCT00896519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93022603|NCT00896519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022604|NCT00896519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022605|NCT00896519|Glucocorticoids|glucocorticoids|mesh-ancestor
93022606|NCT00896519|Hormones|hormones|mesh-ancestor
93022607|NCT00896519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022608|NCT00896519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93022609|NCT00896519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022610|NCT00896519|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022611|NCT00896519|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022612|NCT00896519|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022613|NCT00505752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93022614|NCT00505752|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93022615|NCT00505752|Hormones|hormones|mesh-ancestor
93022616|NCT00505752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022617|NCT00505752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022618|NCT00505752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93022619|NCT01011036|Clonazepam|clonazepam|mesh-list
93022620|NCT01011036|Clobazam|clobazam|mesh-list
93022621|NCT01011036|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93022622|NCT01011036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93022623|NCT01011036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93022624|NCT01011036|Cholinergic Agents|cholinergic agents|mesh-ancestor
93022625|NCT01011036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022626|NCT01011036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022627|NCT01011036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022628|NCT01011036|Urological Agents|urological agents|mesh-ancestor
93022629|NCT01011036|Anticonvulsants|anticonvulsants|mesh-ancestor
93022630|NCT01011036|GABA Modulators|gaba modulators|mesh-ancestor
93022631|NCT01011036|GABA Agents|gaba agents|mesh-ancestor
93022632|NCT01011036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93022633|NCT01011036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022634|NCT01011036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022635|NCT01011036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022636|NCT01011036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93022637|NCT01011036|GABA Agonists|gaba agonists|mesh-ancestor
93022638|NCT03601637|Ivacaftor|ivacaftor|mesh-list
93022639|NCT03601637|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93022640|NCT03601637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93022641|NCT03601637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022642|NCT00894023|Abciximab|abciximab|mesh-list
93022643|NCT00894023|Anticoagulants|anticoagulants|mesh-ancestor
93022644|NCT00894023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93022645|NCT00892073|Metformin|metformin|mesh-list
93022646|NCT00892073|Diazoxide|diazoxide|mesh-list
93022647|NCT00892073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93022648|NCT00892073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022649|NCT00892073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93022650|NCT00892073|Vasodilator Agents|vasodilator agents|mesh-ancestor
93022651|NCT00896831|N-Methylaspartate|n-methylaspartate|mesh-list
93022652|NCT00896831|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93022653|NCT00896831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93022654|NCT00896831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022655|NCT00896831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022656|NCT00896831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667941|NCT00322569|Paclitaxel|paclitaxel|mesh-list
93022657|NCT02541227|Cerebrolysin|cerebrolysin|mesh-list
93022658|NCT02541227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93022659|NCT02541227|Protective Agents|protective agents|mesh-ancestor
93022660|NCT02541227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022661|NCT02541227|Nootropic Agents|nootropic agents|mesh-ancestor
93022662|NCT00896987|Lamotrigine|lamotrigine|mesh-list
93022663|NCT00896987|Carbamazepine|carbamazepine|mesh-list
93022664|NCT00896987|Anticonvulsants|anticonvulsants|mesh-ancestor
93022665|NCT00896987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93022666|NCT00896987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93022667|NCT00896987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022668|NCT00896987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022669|NCT00896987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022670|NCT00896987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93022671|NCT00896987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022672|NCT00896987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022673|NCT00896987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022674|NCT00896987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93022675|NCT00896987|Antimanic Agents|antimanic agents|mesh-ancestor
93022676|NCT00896987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93022677|NCT00896987|Analgesics|analgesics|mesh-ancestor
93022678|NCT00896987|Sensory System Agents|sensory system agents|mesh-ancestor
93022679|NCT00896987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022680|NCT00896987|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93022681|NCT00896987|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93022682|NCT00897065|Antibodies|antibodies|mesh-list
93022683|NCT00897065|Immunologic Factors|immunologic factors|mesh-ancestor
93022684|NCT00897065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022685|NCT00343252|Teriparatide|teriparatide|mesh-list
93022686|NCT00343252|Risedronic Acid|risedronic acid|mesh-list
93022687|NCT00343252|Etidronic Acid|etidronic acid|mesh-list
93022688|NCT00343252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022689|NCT00343252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022690|NCT00343252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022691|NCT00343252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93022692|NCT00343252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93022693|NCT00343252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022694|NCT00892229|Misoprostol|misoprostol|mesh-list
93022695|NCT00892229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93022696|NCT00892229|Abortifacient Agents|abortifacient agents|mesh-ancestor
93022697|NCT00892229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93022698|NCT00892229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022699|NCT00892229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93022700|NCT00892229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022701|NCT00892229|Oxytocics|oxytocics|mesh-ancestor
93022702|NCT00897221|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93022703|NCT00897221|Deferiprone|deferiprone|mesh-list
93022704|NCT00897221|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93022705|NCT00897221|Chelating Agents|chelating agents|mesh-ancestor
93022706|NCT00897221|Sequestering Agents|sequestering agents|mesh-ancestor
93022707|NCT00897221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022708|NCT00892307|Adenosine|adenosine|mesh-list
93022709|NCT00892307|Analgesics|analgesics|mesh-ancestor
93022710|NCT00892307|Sensory System Agents|sensory system agents|mesh-ancestor
93022711|NCT00892307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022712|NCT00892307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022713|NCT00892307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93022714|NCT00892307|Vasodilator Agents|vasodilator agents|mesh-ancestor
93022715|NCT00892307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93022716|NCT00892307|Purinergic Agonists|purinergic agonists|mesh-ancestor
93022717|NCT00892307|Purinergic Agents|purinergic agents|mesh-ancestor
93022718|NCT00892307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022719|NCT00892307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022720|NCT00342628|Vaccines|vaccines|mesh-list
93022721|NCT00342628|Immunologic Factors|immunologic factors|mesh-ancestor
93022722|NCT00342628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022723|NCT00897377|Temozolomide|temozolomide|mesh-list
93022724|NCT00897377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022725|NCT00897377|Alkylating Agents|alkylating agents|mesh-ancestor
93022726|NCT00897377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022727|NCT00897377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022728|NCT00894569|Paclitaxel|paclitaxel|mesh-list
93022729|NCT00894569|Carboplatin|carboplatin|mesh-list
93022730|NCT00894569|Cetuximab|cetuximab|mesh-list
93022731|NCT00894569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022732|NCT00894569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022733|NCT00894569|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022734|NCT00894569|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022735|NCT00894569|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022736|NCT00894569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022737|NCT00894569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022738|NCT00337168|Cytarabine|cytarabine|mesh-list
93022739|NCT00337168|Clofarabine|clofarabine|mesh-list
93022740|NCT00337168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93022741|NCT00337168|Antimetabolites|antimetabolites|mesh-ancestor
93022742|NCT00337168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022743|NCT00337168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022744|NCT00337168|Antiviral Agents|antiviral agents|mesh-ancestor
92179624|NCT04803162|Omeprazole|omeprazole|mesh-list
93022745|NCT00337168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022746|NCT00337168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022747|NCT00337168|Immunologic Factors|immunologic factors|mesh-ancestor
93022748|NCT00337168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022749|NCT00892385|Temozolomide|temozolomide|mesh-list
93022750|NCT00892385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022751|NCT00892385|Alkylating Agents|alkylating agents|mesh-ancestor
93022752|NCT00892385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022753|NCT00892385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022754|NCT00892463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93022755|NCT00892463|Antidepressive Agents|antidepressive agents|mesh-ancestor
93022756|NCT00892463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022757|NCT00892463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93022758|NCT00892463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022759|NCT00892463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022760|NCT00892463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022761|NCT01011114|Cinacalcet|cinacalcet|mesh-list
93022762|NCT01011114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93022763|NCT01011114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022764|NCT01011114|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93022765|NCT01011114|Hormone Antagonists|hormone antagonists|mesh-ancestor
93022766|NCT01011114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022767|NCT00606905|Immunoglobulins|immunoglobulins|mesh-list
93022768|NCT00606905|gamma-Globulins|gamma-globulins|mesh-list
93022769|NCT00606905|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93022770|NCT00606905|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93022771|NCT00606905|Immunologic Factors|immunologic factors|mesh-ancestor
93022772|NCT00606905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022773|NCT01055392|Lithium Carbonate|lithium carbonate|mesh-list
93022774|NCT01055392|Antidepressive Agents|antidepressive agents|mesh-ancestor
93022775|NCT01055392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93022776|NCT01055392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022777|NCT01055392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022778|NCT01055392|Antimanic Agents|antimanic agents|mesh-ancestor
93022779|NCT01055392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93022780|NCT01055392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022781|NCT01055392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022782|NCT03063762|Bevacizumab|bevacizumab|mesh-list
93022783|NCT03063762|Atezolizumab|atezolizumab|mesh-list
92179670|NCT01538745|Sensory System Agents|sensory system agents|mesh-ancestor
93022784|NCT03063762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93022785|NCT03063762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022786|NCT03063762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93022787|NCT03063762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93022788|NCT03063762|Growth Substances|growth substances|mesh-ancestor
93022789|NCT03063762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022790|NCT03063762|Growth Inhibitors|growth inhibitors|mesh-ancestor
93022791|NCT03063762|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93022792|NCT03063762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022793|NCT05278637|Aspirin|aspirin|mesh-list
93022794|NCT05278637|Ticagrelor|ticagrelor|mesh-list
93022795|NCT05278637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93022796|NCT05278637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93022797|NCT05278637|Analgesics|analgesics|mesh-ancestor
93022798|NCT05278637|Sensory System Agents|sensory system agents|mesh-ancestor
93022799|NCT05278637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022800|NCT05278637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022801|NCT05278637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022802|NCT05278637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93022803|NCT05278637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93022804|NCT05278637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92668105|NCT00288470|Hylan|hylan|mesh-list
93022805|NCT05278637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022806|NCT05278637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93022807|NCT05278637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93022808|NCT05278637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022809|NCT05278637|Antipyretics|antipyretics|mesh-ancestor
93022810|NCT05278637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93022811|NCT05278637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93022812|NCT05278637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93022813|NCT05278637|Purinergic Agents|purinergic agents|mesh-ancestor
93022814|NCT05278637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022815|NCT04017377|Paclitaxel|paclitaxel|mesh-list
93022816|NCT04017377|Cisplatin|cisplatin|mesh-list
93022817|NCT04017377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93022818|NCT04017377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022819|NCT04017377|Tubulin Modulators|tubulin modulators|mesh-ancestor
93022820|NCT04017377|Antimitotic Agents|antimitotic agents|mesh-ancestor
93022821|NCT04017377|Mitosis Modulators|mitosis modulators|mesh-ancestor
93022822|NCT04017377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022823|NCT04035785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93022824|NCT04035707|Rocuronium|rocuronium|mesh-list
93022825|NCT04035707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022826|NCT04035707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93022827|NCT04035707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93022828|NCT04035707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93022829|NCT04035707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022830|NCT02539745|Vitamin D|vitamin d|mesh-list
93022831|NCT02539745|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93022832|NCT02539745|Vitamins|vitamins|mesh-ancestor
93022833|NCT02539745|Micronutrients|micronutrients|mesh-ancestor
93022834|NCT02539745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022835|NCT02539745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022836|NCT00894959|Heparin|heparin|mesh-list
93022837|NCT00894959|Calcium heparin|calcium heparin|mesh-list
93022838|NCT00894959|Anticoagulants|anticoagulants|mesh-ancestor
93022839|NCT00894959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93022840|NCT00894959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93022841|NCT00894959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022842|NCT00895115|Vitamin E|vitamin e|mesh-list
93022843|NCT00895115|Vitamins|vitamins|mesh-ancestor
93022844|NCT00895115|Micronutrients|micronutrients|mesh-ancestor
92528879|NCT00037882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022845|NCT00895115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022846|NCT00895115|Antioxidants|antioxidants|mesh-ancestor
93022847|NCT00895115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022848|NCT00895115|Protective Agents|protective agents|mesh-ancestor
93022849|NCT00901745|Norepinephrine|norepinephrine|mesh-list
93022850|NCT00901745|Angiotensin II|angiotensin ii|mesh-list
93022851|NCT00901745|Giapreza|giapreza|mesh-list
93022852|NCT00901745|Angiotensinogen|angiotensinogen|mesh-list
93022853|NCT00901745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93022854|NCT00901745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93022855|NCT00901745|Adrenergic Agents|adrenergic agents|mesh-ancestor
93022856|NCT00901745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022857|NCT00901745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022858|NCT00901745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022859|NCT00901745|Sympathomimetics|sympathomimetics|mesh-ancestor
93022860|NCT00901745|Autonomic Agents|autonomic agents|mesh-ancestor
93022861|NCT00901745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022862|NCT00901745|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93022863|NCT00901745|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93022864|NCT00901745|Protease Inhibitors|protease inhibitors|mesh-ancestor
93022865|NCT00901745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022866|NCT02540837|Bupivacaine|bupivacaine|mesh-list
93022867|NCT02540837|Anesthetics, Local|anesthetics, local|mesh-ancestor
93022868|NCT02540837|Anesthetics|anesthetics|mesh-ancestor
93022869|NCT02540837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022870|NCT02540837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022871|NCT02540837|Sensory System Agents|sensory system agents|mesh-ancestor
93022872|NCT02540837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022873|NCT00901823|Diazoxide|diazoxide|mesh-list
93022874|NCT00901823|Choline|choline|mesh-list
93022875|NCT00901823|Lipotropic Agents|lipotropic agents|mesh-ancestor
93022876|NCT00901823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93022877|NCT00901823|Antimetabolites|antimetabolites|mesh-ancestor
92668156|NCT00288743|Insulin|insulin|mesh-list
93022878|NCT00901823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022879|NCT00901823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022880|NCT00901823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93022881|NCT00901823|Nootropic Agents|nootropic agents|mesh-ancestor
93022882|NCT00901823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93022883|NCT00901823|Vasodilator Agents|vasodilator agents|mesh-ancestor
93022884|NCT00902057|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93022885|NCT00902057|Hemostatics|hemostatics|mesh-ancestor
93022886|NCT00902057|Coagulants|coagulants|mesh-ancestor
93022887|NCT00902057|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93022888|NCT00902057|Natriuretic Agents|natriuretic agents|mesh-ancestor
93022889|NCT00902057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022890|NCT00902135|Interferons|interferons|mesh-list
93022891|NCT00902135|Interferon-beta|interferon-beta|mesh-list
93022892|NCT00902135|Interferon beta-1b|interferon beta-1b|mesh-list
93022893|NCT00902135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022894|NCT00902135|Antiviral Agents|antiviral agents|mesh-ancestor
93022895|NCT00902135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93022896|NCT00902135|Immunologic Factors|immunologic factors|mesh-ancestor
93022897|NCT00902135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022898|NCT00902135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93022899|NCT02540369|Aflibercept|aflibercept|mesh-list
93022900|NCT02540369|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93022901|NCT02540369|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93022902|NCT02540369|Growth Substances|growth substances|mesh-ancestor
93022903|NCT02540369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022904|NCT02540369|Growth Inhibitors|growth inhibitors|mesh-ancestor
93022905|NCT02540369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022906|NCT00605267|Tamoxifen|tamoxifen|mesh-list
93022907|NCT00605267|Goserelin|goserelin|mesh-list
93022908|NCT00605267|Anastrozole|anastrozole|mesh-list
93022909|NCT00605267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93022910|NCT00605267|Hormone Antagonists|hormone antagonists|mesh-ancestor
93022911|NCT00605267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022912|NCT00605267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022913|NCT00605267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93022914|NCT00605267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022915|NCT00605267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93022916|NCT00605267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93022917|NCT00605267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93022918|NCT00605267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93022919|NCT00605267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93022920|NCT00605267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022921|NCT00605267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022922|NCT00902525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93022923|NCT00902525|Immunologic Factors|immunologic factors|mesh-ancestor
93022924|NCT00902525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022926|NCT00902603|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93022927|NCT00902603|Vasodilator Agents|vasodilator agents|mesh-ancestor
93022928|NCT00902681|Fesoterodine|fesoterodine|mesh-list
93022929|NCT00902681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93022930|NCT00902681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93022931|NCT00902681|Cholinergic Agents|cholinergic agents|mesh-ancestor
93022932|NCT00902681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022933|NCT00902681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022934|NCT00902681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022935|NCT00902681|Urological Agents|urological agents|mesh-ancestor
93022936|NCT00906113|Melphalan|melphalan|mesh-list
93022937|NCT00906113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93022938|NCT00906113|Alkylating Agents|alkylating agents|mesh-ancestor
93022939|NCT00906113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022940|NCT00906113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022941|NCT00906113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93022942|NCT00906113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93022943|NCT00906113|Immunologic Factors|immunologic factors|mesh-ancestor
93022944|NCT00906113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022945|NCT00902837|Oxycodone|oxycodone|mesh-list
93022946|NCT00902837|Naloxone|naloxone|mesh-list
93022947|NCT00902837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93022948|NCT00902837|Narcotics|narcotics|mesh-ancestor
93022949|NCT00902837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022950|NCT00902837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022951|NCT00902837|Analgesics|analgesics|mesh-ancestor
93022952|NCT00902837|Sensory System Agents|sensory system agents|mesh-ancestor
93022953|NCT00902837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022954|NCT00902837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93022955|NCT00605813|Sertraline|sertraline|mesh-list
93022956|NCT00605813|Antidepressive Agents|antidepressive agents|mesh-ancestor
93022958|NCT00605813|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93022959|NCT00605813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93022960|NCT00605813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93022961|NCT00605813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022962|NCT00605813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93022963|NCT00605813|Serotonin Agents|serotonin agents|mesh-ancestor
93022964|NCT00605813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022965|NCT00906269|Sildenafil Citrate|sildenafil citrate|mesh-list
93022966|NCT00906269|Vasodilator Agents|vasodilator agents|mesh-ancestor
93022967|NCT00906269|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93022968|NCT00906269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93022969|NCT00906269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93022970|NCT00906269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93022971|NCT00906269|Urological Agents|urological agents|mesh-ancestor
93022972|NCT00902915|Dexamethasone|dexamethasone|mesh-list
93022973|NCT00902915|Lenalidomide|lenalidomide|mesh-list
93022974|NCT00902915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93022975|NCT00902915|Antiemetics|antiemetics|mesh-ancestor
93022976|NCT00902915|Autonomic Agents|autonomic agents|mesh-ancestor
93022977|NCT00902915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93022978|NCT00902915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022979|NCT00902915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93022980|NCT00902915|Glucocorticoids|glucocorticoids|mesh-ancestor
93022981|NCT00902915|Hormones|hormones|mesh-ancestor
93022982|NCT00902915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93022983|NCT00902915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93022984|NCT00902915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93022985|NCT00902915|Immunologic Factors|immunologic factors|mesh-ancestor
93022986|NCT00902915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93022987|NCT00902915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93022988|NCT00902915|Growth Substances|growth substances|mesh-ancestor
93022989|NCT00902915|Growth Inhibitors|growth inhibitors|mesh-ancestor
93022990|NCT04034771|Propofol|propofol|mesh-list
93022991|NCT04034771|Melatonin|melatonin|mesh-list
93022992|NCT04034771|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93022993|NCT04034771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93022994|NCT04034771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93022995|NCT04034771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93022996|NCT04034771|Anesthetics, General|anesthetics, general|mesh-ancestor
93022997|NCT04034771|Anesthetics|anesthetics|mesh-ancestor
93022998|NCT04034771|Antioxidants|antioxidants|mesh-ancestor
93022999|NCT04034771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023000|NCT04034771|Protective Agents|protective agents|mesh-ancestor
93023001|NCT00899483|Insulin|insulin|mesh-list
93023002|NCT00899483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93023003|NCT00899483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023004|NCT02539199|Misoprostol|misoprostol|mesh-list
93023005|NCT02539199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93023006|NCT02539199|Abortifacient Agents|abortifacient agents|mesh-ancestor
93023007|NCT02539199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93023008|NCT02539199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023009|NCT02539199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93023010|NCT02539199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93023011|NCT02539199|Oxytocics|oxytocics|mesh-ancestor
93023012|NCT00903227|Fluticasone|fluticasone|mesh-list
93023013|NCT00903227|Xhance|xhance|mesh-list
93023014|NCT00903227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023015|NCT00903227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93023016|NCT00903227|Autonomic Agents|autonomic agents|mesh-ancestor
93023017|NCT00903227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023018|NCT00903227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023019|NCT00903227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93023020|NCT00903227|Respiratory System Agents|respiratory system agents|mesh-ancestor
93023021|NCT00903227|Dermatologic Agents|dermatologic agents|mesh-ancestor
93023022|NCT00903227|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93023023|NCT00605657|Valproic Acid|valproic acid|mesh-list
93023024|NCT00605657|Anticonvulsants|anticonvulsants|mesh-ancestor
93023025|NCT00605657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023026|NCT00605657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023027|NCT00605657|GABA Agents|gaba agents|mesh-ancestor
93023028|NCT00605657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023029|NCT00605657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023030|NCT00605657|Antimanic Agents|antimanic agents|mesh-ancestor
93023031|NCT00605657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93023032|NCT00605657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023034|NCT00899951|Fentanyl|fentanyl|mesh-list
93023035|NCT00899951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93023036|NCT00899951|Narcotics|narcotics|mesh-ancestor
93023037|NCT00899951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023038|NCT00899951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023039|NCT00899951|Analgesics|analgesics|mesh-ancestor
93023040|NCT00899951|Sensory System Agents|sensory system agents|mesh-ancestor
93023041|NCT00899951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023042|NCT00899951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93023043|NCT00899951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93023044|NCT00899951|Anesthetics, General|anesthetics, general|mesh-ancestor
93023045|NCT00899951|Anesthetics|anesthetics|mesh-ancestor
93023046|NCT02539979|Acetaminophen|acetaminophen|mesh-list
93023047|NCT02539979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023048|NCT02539979|Analgesics|analgesics|mesh-ancestor
93023049|NCT02539979|Sensory System Agents|sensory system agents|mesh-ancestor
93023050|NCT02539979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023051|NCT02539979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023052|NCT02539979|Antipyretics|antipyretics|mesh-ancestor
93023053|NCT05277701|Lazertinib|lazertinib|mesh-list
93023054|NCT05277701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023055|NCT05277701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023056|NCT05277701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023057|NCT00605345|Darbepoetin alfa|darbepoetin alfa|mesh-list
93023058|NCT00605345|Hematinics|hematinics|mesh-ancestor
93023059|NCT00903851|Lidocaine|lidocaine|mesh-list
93023060|NCT00903851|Anesthetics, Local|anesthetics, local|mesh-ancestor
93023062|NCT00903851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023063|NCT00903851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023064|NCT00903851|Sensory System Agents|sensory system agents|mesh-ancestor
93023065|NCT00903851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023066|NCT00903851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023067|NCT00903851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93023068|NCT00903851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023069|NCT00903851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023070|NCT00903851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023071|NCT00900887|Ketorolac|ketorolac|mesh-list
93023072|NCT00900887|Nepafenac|nepafenac|mesh-list
93023073|NCT00900887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93023074|NCT00900887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023075|NCT00900887|Analgesics|analgesics|mesh-ancestor
93023076|NCT00900887|Sensory System Agents|sensory system agents|mesh-ancestor
93023077|NCT00900887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023078|NCT00900887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023079|NCT00900887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023080|NCT00900887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023081|NCT00900887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93023082|NCT00900887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023083|NCT00900887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023084|NCT00904085|Oxymorphone|oxymorphone|mesh-list
93023085|NCT00904085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93023086|NCT00904085|Narcotics|narcotics|mesh-ancestor
93023087|NCT00904085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023088|NCT00904085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023089|NCT00904085|Analgesics|analgesics|mesh-ancestor
93023090|NCT00904085|Sensory System Agents|sensory system agents|mesh-ancestor
93023091|NCT00904085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023092|NCT00904085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93023093|NCT00908453|Fosphenytoin|fosphenytoin|mesh-list
93023094|NCT00908453|Anticonvulsants|anticonvulsants|mesh-ancestor
93023095|NCT00908453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023096|NCT00908453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023097|NCT00908453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023098|NCT00908531|Letrozole|letrozole|mesh-list
93023099|NCT00908531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023100|NCT00908531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93023101|NCT00908531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93023102|NCT00908531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179791|NCT04792398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023103|NCT00908531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023104|NCT00908531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93023105|NCT00908531|Hormone Antagonists|hormone antagonists|mesh-ancestor
92668376|NCT04718259|Midazolam|midazolam|mesh-list
93023106|NCT00908531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023107|NCT00908531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023109|NCT00904397|Lidocaine|lidocaine|mesh-list
93023110|NCT00904397|Anesthetics, Local|anesthetics, local|mesh-ancestor
93023111|NCT00904397|Anesthetics|anesthetics|mesh-ancestor
93023112|NCT00904397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023113|NCT00904397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023114|NCT00904397|Sensory System Agents|sensory system agents|mesh-ancestor
93023115|NCT00904397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023116|NCT00904397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023117|NCT00904397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93023118|NCT00904397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023119|NCT00904397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023120|NCT00904397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023121|NCT00904397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93023122|NCT00904397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023123|NCT00904397|Analgesics|analgesics|mesh-ancestor
93023124|NCT00904397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023125|NCT00904397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023126|NCT00904397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93023127|NCT00904397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93023128|NCT00904397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023129|NCT00904475|Lidocaine|lidocaine|mesh-list
93023130|NCT00904475|Anesthetics, Local|anesthetics, local|mesh-ancestor
93023131|NCT00904475|Anesthetics|anesthetics|mesh-ancestor
93023132|NCT00904475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023133|NCT00904475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023134|NCT00904475|Sensory System Agents|sensory system agents|mesh-ancestor
93023135|NCT00904475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023136|NCT00904475|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023137|NCT00904475|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93023138|NCT00904475|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023139|NCT00904475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023140|NCT00904475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023141|NCT00908921|Glimepiride|glimepiride|mesh-list
93023142|NCT00908921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023143|NCT00908921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93023144|NCT00908921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023145|NCT00908921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023146|NCT00908921|Immunologic Factors|immunologic factors|mesh-ancestor
93023147|NCT00904631|Salicylic Acid|salicylic acid|mesh-list
93023148|NCT00904631|Salicylates|salicylates|mesh-list
93023149|NCT00904631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023150|NCT00904631|Antifungal Agents|antifungal agents|mesh-ancestor
93023151|NCT00904631|Keratolytic Agents|keratolytic agents|mesh-ancestor
93023152|NCT00904631|Dermatologic Agents|dermatologic agents|mesh-ancestor
93023153|NCT00904631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93023154|NCT00904631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023155|NCT00904631|Analgesics|analgesics|mesh-ancestor
93023156|NCT00904631|Sensory System Agents|sensory system agents|mesh-ancestor
93023157|NCT00904631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023158|NCT00904631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023159|NCT00904631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023160|NCT00904631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023161|NCT00904631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93023162|NCT00904631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023163|NCT00904631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023164|NCT00909077|Dexamethasone|dexamethasone|mesh-list
93023165|NCT00909077|Dexamethasone acetate|dexamethasone acetate|mesh-list
93023166|NCT00909077|Rituximab|rituximab|mesh-list
93023167|NCT00909077|BB 1101|bb 1101|mesh-list
93023168|NCT00909077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023169|NCT00909077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023170|NCT00909077|Immunologic Factors|immunologic factors|mesh-ancestor
93023171|NCT00909077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023172|NCT00909077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023173|NCT00909077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023174|NCT00909077|Antiemetics|antiemetics|mesh-ancestor
93023175|NCT00909077|Autonomic Agents|autonomic agents|mesh-ancestor
93023176|NCT00909077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023177|NCT00909077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93023178|NCT00909077|Glucocorticoids|glucocorticoids|mesh-ancestor
93023179|NCT00909077|Hormones|hormones|mesh-ancestor
93023180|NCT00909077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023181|NCT00909077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93023182|NCT00909077|Protease Inhibitors|protease inhibitors|mesh-ancestor
93023183|NCT00909077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023184|NCT00909077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023185|NCT00904709|Tranexamic Acid|tranexamic acid|mesh-list
93023186|NCT00904709|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93023187|NCT00904709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93023188|NCT00904709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023189|NCT00904709|Hemostatics|hemostatics|mesh-ancestor
93023190|NCT00904709|Coagulants|coagulants|mesh-ancestor
93023191|NCT00340834|Interferons|interferons|mesh-list
93023192|NCT00340834|Interferon-beta|interferon-beta|mesh-list
93023193|NCT00340834|Interferon beta-1a|interferon beta-1a|mesh-list
93023194|NCT00340834|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93023195|NCT00340834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023196|NCT00340834|Antiviral Agents|antiviral agents|mesh-ancestor
93023197|NCT00340834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023198|NCT00340834|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93023199|NCT00340834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023200|NCT00340834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023201|NCT00340834|Immunologic Factors|immunologic factors|mesh-ancestor
93023202|NCT00340834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023203|NCT00340834|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93023205|NCT01057966|Micronutrients|micronutrients|mesh-ancestor
93023206|NCT01057966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023207|NCT00603941|Paclitaxel|paclitaxel|mesh-list
93023208|NCT00603941|Efatutazone|efatutazone|mesh-list
93023209|NCT00603941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93023210|NCT00603941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023211|NCT00603941|Tubulin Modulators|tubulin modulators|mesh-ancestor
93023212|NCT00603941|Antimitotic Agents|antimitotic agents|mesh-ancestor
93023213|NCT00603941|Mitosis Modulators|mitosis modulators|mesh-ancestor
93023214|NCT00603941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023215|NCT00340678|Losartan|losartan|mesh-list
93023216|NCT00340678|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023217|NCT00340678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93023218|NCT00340678|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93023219|NCT00340678|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93023220|NCT00340678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023221|NCT01055470|Diclofenac|diclofenac|mesh-list
93023222|NCT01055470|Lornoxicam|lornoxicam|mesh-list
92179925|NCT05571345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93023223|NCT01055470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93023224|NCT01055470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023225|NCT01055470|Analgesics|analgesics|mesh-ancestor
93023226|NCT01055470|Sensory System Agents|sensory system agents|mesh-ancestor
93023227|NCT01055470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023228|NCT01055470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023229|NCT01055470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023230|NCT01055470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023231|NCT01055470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93023232|NCT01055470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023233|NCT01055470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023234|NCT03986008|Liraglutide|liraglutide|mesh-list
93023235|NCT03986008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93023236|NCT03986008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023237|NCT03986008|Incretins|incretins|mesh-ancestor
93023238|NCT03986008|Hormones|hormones|mesh-ancestor
93023239|NCT03986008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023240|NCT00909233|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
93023241|NCT00909233|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023242|NCT00909233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93023243|NCT00909233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93023244|NCT00909233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023245|NCT00909233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023246|NCT00909233|Urological Agents|urological agents|mesh-ancestor
93023247|NCT00909311|Ritonavir|ritonavir|mesh-list
93023248|NCT00909311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93023249|NCT00909311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93023250|NCT00909311|Protease Inhibitors|protease inhibitors|mesh-ancestor
93023251|NCT00909311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023252|NCT00909311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023254|NCT00909311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93023255|NCT00909311|Antiviral Agents|antiviral agents|mesh-ancestor
93023256|NCT00909311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023257|NCT00909311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93023258|NCT00909311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93023259|NCT00907751|Rituximab|rituximab|mesh-list
93023260|NCT00907751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023261|NCT00907751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023262|NCT00907751|Immunologic Factors|immunologic factors|mesh-ancestor
93023263|NCT00907751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023264|NCT00907751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023265|NCT00905333|Felodipine|felodipine|mesh-list
93023266|NCT00905333|Candesartan|candesartan|mesh-list
93023267|NCT00905333|Candesartan cilexetil|candesartan cilexetil|mesh-list
93023268|NCT00905333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93023269|NCT00905333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93023270|NCT00905333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93023271|NCT00905333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023272|NCT00905333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023273|NCT00905333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93023274|NCT00905333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023275|NCT00905333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93023276|NCT00905333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023277|NCT00905333|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023278|NCT00907829|Lidocaine|lidocaine|mesh-list
93023279|NCT00907829|Anesthetics, Local|anesthetics, local|mesh-ancestor
93023280|NCT00907829|Anesthetics|anesthetics|mesh-ancestor
93023281|NCT00907829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023282|NCT00907829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023283|NCT00907829|Sensory System Agents|sensory system agents|mesh-ancestor
93023284|NCT00907829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023285|NCT00907829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023286|NCT00907829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93023287|NCT00907829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023288|NCT00907829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023289|NCT00907829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023290|NCT00336544|Clarithromycin|clarithromycin|mesh-list
93023291|NCT00336544|Cethromycin|cethromycin|mesh-list
93023292|NCT00336544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93023293|NCT00336544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023294|NCT00336544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93023295|NCT00336544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023296|NCT00336544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023297|NCT00336544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93023298|NCT00336544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93023299|NCT01059058|Fluorides|fluorides|mesh-list
93023300|NCT01059058|Fluorides, Topical|fluorides, topical|mesh-list
93023301|NCT01059058|Cariostatic Agents|cariostatic agents|mesh-ancestor
93023302|NCT01059058|Protective Agents|protective agents|mesh-ancestor
93023303|NCT01059058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023304|NCT00605033|Buprenorphine|buprenorphine|mesh-list
93023305|NCT00605033|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93023306|NCT00605033|Naloxone|naloxone|mesh-list
93023307|NCT00605033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93023308|NCT00605033|Narcotics|narcotics|mesh-ancestor
93023309|NCT00605033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023310|NCT00605033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023311|NCT00605033|Analgesics|analgesics|mesh-ancestor
93023312|NCT00605033|Sensory System Agents|sensory system agents|mesh-ancestor
93023313|NCT00605033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023314|NCT00605033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93023315|NCT03988114|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93023316|NCT03988114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93023317|NCT03988114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023318|NCT03988114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023319|NCT03988114|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93023320|NCT03988114|Hormone Antagonists|hormone antagonists|mesh-ancestor
93023321|NCT03988114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023322|NCT03988114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023323|NCT00905723|Estradiol|estradiol|mesh-list
93023324|NCT00905723|Estrogens|estrogens|mesh-ancestor
93023325|NCT00905723|Hormones|hormones|mesh-ancestor
93023326|NCT00905723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023327|NCT00905723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023328|NCT00907985|Lamotrigine|lamotrigine|mesh-list
93023329|NCT00907985|Vofopitant|vofopitant|mesh-list
93023330|NCT00907985|Anticonvulsants|anticonvulsants|mesh-ancestor
93023331|NCT00907985|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93023332|NCT00907985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023333|NCT00907985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023334|NCT00907985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93023335|NCT00907985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023336|NCT00907985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93023337|NCT00907985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93023338|NCT00907985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023339|NCT00907985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93023340|NCT00907985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023341|NCT00907985|Antiemetics|antiemetics|mesh-ancestor
93023342|NCT00907985|Autonomic Agents|autonomic agents|mesh-ancestor
93023343|NCT00907985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023344|NCT00907985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93023345|NCT00907985|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93023346|NCT00907985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023347|NCT01325194|Cytarabine|cytarabine|mesh-list
93023348|NCT01325194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93023349|NCT01325194|Antimetabolites|antimetabolites|mesh-ancestor
93023350|NCT01325194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023352|NCT01325194|Antiviral Agents|antiviral agents|mesh-ancestor
93023353|NCT01325194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023354|NCT01325194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023355|NCT01325194|Immunologic Factors|immunologic factors|mesh-ancestor
93023356|NCT01325194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023357|NCT00908219|Bevacizumab|bevacizumab|mesh-list
93023358|NCT00908219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023359|NCT00908219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023360|NCT00908219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93023361|NCT00908219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93023362|NCT00908219|Growth Substances|growth substances|mesh-ancestor
93023363|NCT00908219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023364|NCT00908219|Growth Inhibitors|growth inhibitors|mesh-ancestor
93023365|NCT00908297|Ubiquinone|ubiquinone|mesh-list
93023366|NCT00908297|Coenzyme Q10|coenzyme q10|mesh-list
93023367|NCT00908297|Micronutrients|micronutrients|mesh-ancestor
93023368|NCT00908297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023369|NCT00908297|Vitamins|vitamins|mesh-ancestor
93023370|NCT00927407|Malathion|malathion|mesh-list
93023371|NCT00927407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93023372|NCT00927407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023373|NCT00927407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023374|NCT00927407|Cholinergic Agents|cholinergic agents|mesh-ancestor
93023375|NCT00927407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023376|NCT00927407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023377|NCT00931697|Mefloquine|mefloquine|mesh-list
93023378|NCT00931697|Antimalarials|antimalarials|mesh-ancestor
93023379|NCT00931697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93023380|NCT00931697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93023381|NCT00931697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180131|NCT04785768|Hydromorphone|hydromorphone|mesh-list
93023382|NCT00927797|Cyclophosphamide|cyclophosphamide|mesh-list
93023383|NCT00927797|Rituximab|rituximab|mesh-list
93023384|NCT00927797|Pentostatin|pentostatin|mesh-list
93023385|NCT00927797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023386|NCT00927797|Immunologic Factors|immunologic factors|mesh-ancestor
93023387|NCT00927797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023388|NCT00927797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023389|NCT00927797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93023390|NCT00927797|Alkylating Agents|alkylating agents|mesh-ancestor
93023391|NCT00927797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023392|NCT00927797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023393|NCT00927797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93023394|NCT00927797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023395|NCT00927797|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93023396|NCT00927797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023397|NCT00338962|Naltrexone|naltrexone|mesh-list
93023398|NCT00338962|Paroxetine|paroxetine|mesh-list
93023399|NCT00338962|Desipramine|desipramine|mesh-list
93023400|NCT00338962|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92668675|NCT00291785|Vitamins|vitamins|mesh-ancestor
93023401|NCT00338962|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93023402|NCT00338962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023403|NCT00338962|Sensory System Agents|sensory system agents|mesh-ancestor
93023404|NCT00338962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023405|NCT00338962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93023406|NCT00338962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93023407|NCT00338962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023408|NCT00338962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023409|NCT00338962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023410|NCT00338962|Serotonin Agents|serotonin agents|mesh-ancestor
93023411|NCT00338962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93023412|NCT00338962|Antidepressive Agents|antidepressive agents|mesh-ancestor
93023413|NCT00338962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93023414|NCT00338962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93023415|NCT00338962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93023416|NCT00338962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023417|NCT00338962|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93023418|NCT00338962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93023419|NCT00338962|Adrenergic Agents|adrenergic agents|mesh-ancestor
93023420|NCT00931775|Pindolol|pindolol|mesh-list
93023421|NCT00931775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93023422|NCT00931775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93023423|NCT00931775|Adrenergic Agents|adrenergic agents|mesh-ancestor
93023424|NCT00931775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023425|NCT00931775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023426|NCT00931775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023427|NCT00931775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93023428|NCT00931775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93023429|NCT00931775|Serotonin Agents|serotonin agents|mesh-ancestor
93023430|NCT00931775|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023432|NCT00927875|Etoposide|etoposide|mesh-list
93023433|NCT00927875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023434|NCT00927875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93023435|NCT00927875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92180223|NCT01625013|Hylan|hylan|mesh-list
93023436|NCT00927875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93023437|NCT00927875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023438|NCT00927875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023439|NCT00568061|Nitric Oxide|nitric oxide|mesh-list
93023440|NCT00568061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93023441|NCT00568061|Autonomic Agents|autonomic agents|mesh-ancestor
93023442|NCT00568061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023443|NCT00568061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023444|NCT00568061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93023445|NCT00568061|Respiratory System Agents|respiratory system agents|mesh-ancestor
93023446|NCT00568061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93023447|NCT00568061|Antioxidants|antioxidants|mesh-ancestor
93023448|NCT00568061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023449|NCT00568061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023450|NCT00568061|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93023451|NCT00568061|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023452|NCT00568061|Gasotransmitters|gasotransmitters|mesh-ancestor
93023453|NCT00568061|Protective Agents|protective agents|mesh-ancestor
93023454|NCT03547427|Acetaminophen|acetaminophen|mesh-list
93023455|NCT03547427|Insulin|insulin|mesh-list
93023456|NCT03547427|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93023457|NCT03547427|Pramlintide|pramlintide|mesh-list
93023458|NCT03547427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93023459|NCT03547427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023460|NCT03547427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023461|NCT03547427|Analgesics|analgesics|mesh-ancestor
93023462|NCT03547427|Sensory System Agents|sensory system agents|mesh-ancestor
93023463|NCT03547427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023464|NCT03547427|Antipyretics|antipyretics|mesh-ancestor
93023465|NCT00338884|Sunitinib|sunitinib|mesh-list
93023466|NCT00338884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023467|NCT00338884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93023468|NCT00338884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93023469|NCT00338884|Growth Substances|growth substances|mesh-ancestor
93023470|NCT00338884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023471|NCT00338884|Growth Inhibitors|growth inhibitors|mesh-ancestor
93023472|NCT00338884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023473|NCT00338884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668751|NCT00324831|Immunoglobulins|immunoglobulins|mesh-list
93023474|NCT00338884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023475|NCT03038100|Paclitaxel|paclitaxel|mesh-list
93023476|NCT03038100|Bevacizumab|bevacizumab|mesh-list
93023477|NCT03038100|Carboplatin|carboplatin|mesh-list
93023478|NCT03038100|Atezolizumab|atezolizumab|mesh-list
93023479|NCT03038100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93023480|NCT03038100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93023481|NCT03038100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023482|NCT03038100|Tubulin Modulators|tubulin modulators|mesh-ancestor
93023483|NCT03038100|Antimitotic Agents|antimitotic agents|mesh-ancestor
93023484|NCT03038100|Mitosis Modulators|mitosis modulators|mesh-ancestor
93023485|NCT03038100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023486|NCT03038100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023487|NCT03038100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93023488|NCT03038100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93023489|NCT03038100|Growth Substances|growth substances|mesh-ancestor
93023490|NCT03038100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023491|NCT03038100|Growth Inhibitors|growth inhibitors|mesh-ancestor
93023492|NCT03038100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93023493|NCT03038100|Immunologic Factors|immunologic factors|mesh-ancestor
93023494|NCT00338728|Letrozole|letrozole|mesh-list
93023495|NCT00338728|Imatinib Mesylate|imatinib mesylate|mesh-list
92369087|NCT05821192|Hormones|hormones|mesh-ancestor
93023496|NCT00338728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023497|NCT00338728|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93023498|NCT00338728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93023499|NCT00338728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023500|NCT00338728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023501|NCT00338728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93023502|NCT00338728|Hormone Antagonists|hormone antagonists|mesh-ancestor
93023503|NCT00338728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023504|NCT00338728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023505|NCT00338728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023506|NCT01059136|Spironolactone|spironolactone|mesh-list
93023507|NCT01059136|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93023508|NCT01059136|Hormone Antagonists|hormone antagonists|mesh-ancestor
93023509|NCT01059136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023510|NCT01059136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023511|NCT01059136|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93023512|NCT01059136|Diuretics|diuretics|mesh-ancestor
93023513|NCT01059136|Natriuretic Agents|natriuretic agents|mesh-ancestor
93023514|NCT00336856|Irinotecan|irinotecan|mesh-list
93023515|NCT00336856|Cetuximab|cetuximab|mesh-list
93023516|NCT00336856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93023517|NCT00336856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93023518|NCT00336856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023519|NCT00336856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023520|NCT00336856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023521|NCT00336856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023522|NCT00566501|Donepezil|donepezil|mesh-list
93023523|NCT00566501|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93023524|NCT00566501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023525|NCT00566501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023526|NCT00566501|Cholinergic Agents|cholinergic agents|mesh-ancestor
93023527|NCT00566501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023528|NCT00566501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023529|NCT00566501|Nootropic Agents|nootropic agents|mesh-ancestor
93023530|NCT00504894|Thiopental|thiopental|mesh-list
93023531|NCT00504894|Propofol|propofol|mesh-list
93023532|NCT00504894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93023533|NCT00504894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023534|NCT00504894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023535|NCT00504894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93023536|NCT00504894|Anesthetics, General|anesthetics, general|mesh-ancestor
93023537|NCT00504894|Anesthetics|anesthetics|mesh-ancestor
93023538|NCT00504894|Anticonvulsants|anticonvulsants|mesh-ancestor
93023539|NCT00504894|GABA Modulators|gaba modulators|mesh-ancestor
93023540|NCT00504894|GABA Agents|gaba agents|mesh-ancestor
93023541|NCT00504894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023542|NCT00504894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023543|NCT00924755|Caffeine|caffeine|mesh-list
93023544|NCT00924755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93023545|NCT00924755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023546|NCT00924755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93023547|NCT00924755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023548|NCT00924755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023549|NCT00924755|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93023550|NCT00924755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93023551|NCT00924755|Purinergic Agents|purinergic agents|mesh-ancestor
93023552|NCT00924755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023553|NCT01011348|Ubiquinone|ubiquinone|mesh-list
93023554|NCT01011348|Coenzyme Q10|coenzyme q10|mesh-list
93023555|NCT01011348|Micronutrients|micronutrients|mesh-ancestor
93023556|NCT01011348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023557|NCT01011348|Vitamins|vitamins|mesh-ancestor
93023558|NCT00928655|Acetazolamide|acetazolamide|mesh-list
93023559|NCT00928655|Anticonvulsants|anticonvulsants|mesh-ancestor
93023560|NCT00928655|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93023561|NCT00928655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023562|NCT00928655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023563|NCT00928655|Diuretics|diuretics|mesh-ancestor
93023564|NCT00928655|Natriuretic Agents|natriuretic agents|mesh-ancestor
93023565|NCT00928655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023566|NCT01011426|Bisacodyl|bisacodyl|mesh-list
93023567|NCT01011426|Cathartics|cathartics|mesh-ancestor
93023568|NCT01011426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93023569|NCT01011426|Laxatives|laxatives|mesh-ancestor
93023570|NCT00932555|Factor VIII|factor viii|mesh-list
93023571|NCT00932555|Coagulants|coagulants|mesh-ancestor
93023572|NCT04722575|Atezolizumab|atezolizumab|mesh-list
93023573|NCT04722575|Vemurafenib|vemurafenib|mesh-list
93023574|NCT04722575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93023575|NCT04722575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023576|NCT04722575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023577|NCT04722575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023578|NCT04722575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023579|NCT04722575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023580|NCT00513240|Epoetin Alfa|epoetin alfa|mesh-list
93023581|NCT00513240|Hematinics|hematinics|mesh-ancestor
93023582|NCT00928811|Basiliximab|basiliximab|mesh-list
93023583|NCT00928811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023584|NCT00928811|Immunologic Factors|immunologic factors|mesh-ancestor
93023585|NCT00928811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023586|NCT00932867|Telmisartan|telmisartan|mesh-list
93023587|NCT00932867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93023588|NCT00932867|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93023589|NCT00932867|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93023590|NCT00932867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023591|NCT00928967|Interferons|interferons|mesh-list
93023592|NCT00928967|Interferon-beta|interferon-beta|mesh-list
93023593|NCT00928967|Interferon beta-1b|interferon beta-1b|mesh-list
93023594|NCT00928967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023595|NCT00928967|Antiviral Agents|antiviral agents|mesh-ancestor
93023596|NCT00928967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023597|NCT00928967|Immunologic Factors|immunologic factors|mesh-ancestor
93023598|NCT00928967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023599|NCT00928967|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93023600|NCT00933023|Hydrocortisone|hydrocortisone|mesh-list
93023601|NCT00933023|Betamethasone|betamethasone|mesh-list
93023602|NCT00933023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023603|NCT00933023|Glucocorticoids|glucocorticoids|mesh-ancestor
93023604|NCT00933023|Hormones|hormones|mesh-ancestor
93023605|NCT00933023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023606|NCT00933023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023607|NCT00933023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93023608|NCT00933023|Respiratory System Agents|respiratory system agents|mesh-ancestor
93023609|NCT00933179|Levonorgestrel|levonorgestrel|mesh-list
93023610|NCT00933179|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93023611|NCT00933179|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
93023612|NCT00933179|Gestodene|gestodene|mesh-list
93023613|NCT00933179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93023614|NCT00933179|Contraceptive Agents|contraceptive agents|mesh-ancestor
92180371|NCT03794388|Anticonvulsants|anticonvulsants|mesh-ancestor
93023615|NCT00933179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93023616|NCT00933179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023617|NCT00933179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93023618|NCT00933179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93023619|NCT00933179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93023620|NCT00933179|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93023621|NCT00933179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93023622|NCT00933179|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
93023623|NCT00933179|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93023624|NCT00933179|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93023625|NCT00933179|Progestins|progestins|mesh-ancestor
93023626|NCT00933179|Hormones|hormones|mesh-ancestor
93023627|NCT00933179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023628|NCT00504348|Tacrolimus|tacrolimus|mesh-list
93023629|NCT00504348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023630|NCT00504348|Immunologic Factors|immunologic factors|mesh-ancestor
93023631|NCT00504348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023632|NCT00504348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93023633|NCT00504348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023634|NCT00504348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023635|NCT00929045|Hormones|hormones|mesh-list
93023636|NCT00929045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023637|NCT00929045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023638|NCT00925457|Domperidone|domperidone|mesh-list
93023639|NCT00925457|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93023640|NCT00925457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023641|NCT00925457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023643|NCT00925457|Autonomic Agents|autonomic agents|mesh-ancestor
93023644|NCT00925457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023645|NCT00925457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023646|NCT00925457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93023647|NCT00925457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93023648|NCT00925457|Dopamine Agents|dopamine agents|mesh-ancestor
93023649|NCT00925457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023650|NCT00929279|Abciximab|abciximab|mesh-list
93023651|NCT00929279|Anticoagulants|anticoagulants|mesh-ancestor
93023652|NCT00929279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93023653|NCT00567593|Rosiglitazone|rosiglitazone|mesh-list
93023654|NCT00567593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93023655|NCT00567593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023656|NCT00335764|Sirolimus|sirolimus|mesh-list
93023657|NCT00335764|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93023658|NCT00335764|Sorafenib|sorafenib|mesh-list
93023659|NCT00335764|Temsirolimus|temsirolimus|mesh-list
93023660|NCT00335764|Tipifarnib|tipifarnib|mesh-list
93023661|NCT00335764|MTOR Inhibitors|mtor inhibitors|mesh-list
93023662|NCT00335764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023663|NCT00335764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023664|NCT00335764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023665|NCT00335764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023666|NCT00335764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023667|NCT00335764|Immunologic Factors|immunologic factors|mesh-ancestor
93023668|NCT00335764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023669|NCT00335764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93023670|NCT00335764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023671|NCT00335764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93023672|NCT00335764|Antifungal Agents|antifungal agents|mesh-ancestor
93023673|NCT03743285|Insulin Lispro|insulin lispro|mesh-list
93023674|NCT03743285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93023675|NCT03743285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023676|NCT03981484|Thrombin|thrombin|mesh-list
93023677|NCT03981484|Hemostatics|hemostatics|mesh-ancestor
93023678|NCT03981484|Coagulants|coagulants|mesh-ancestor
93023679|NCT00567359|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93023680|NCT00567359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023681|NCT00567359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023682|NCT00567359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023683|NCT00567359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023684|NCT01063660|Treosulfan|treosulfan|mesh-list
93023685|NCT01063660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93023686|NCT01063660|Alkylating Agents|alkylating agents|mesh-ancestor
93023687|NCT01063660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023688|NCT01063660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023689|NCT00925847|Lithium Carbonate|lithium carbonate|mesh-list
93023690|NCT00925847|Antidepressive Agents|antidepressive agents|mesh-ancestor
93023691|NCT00925847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93023692|NCT00925847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023693|NCT00925847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023694|NCT00925847|Antimanic Agents|antimanic agents|mesh-ancestor
93023695|NCT00925847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93023696|NCT00925847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668975|NCT00293228|Antimetabolites|antimetabolites|mesh-ancestor
93023697|NCT00925847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023698|NCT00492726|Moxifloxacin|moxifloxacin|mesh-list
93023699|NCT00492726|Ertapenem|ertapenem|mesh-list
93023700|NCT00492726|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93023701|NCT00492726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93023702|NCT00492726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180420|NCT01469546|Axitinib|axitinib|mesh-list
93023703|NCT00492726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93023704|NCT00492726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93023705|NCT00492726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023706|NCT00492726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023707|NCT00492726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023708|NCT00492726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93023709|NCT00492726|Contraceptive Agents|contraceptive agents|mesh-ancestor
93023710|NCT00492726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93023711|NCT00492726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023712|NCT00492726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93023713|NCT00492726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93023714|NCT00492726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93023715|NCT00309946|Cediranib|cediranib|mesh-list
93023716|NCT00309946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023717|NCT00309946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023718|NCT00309946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023719|NCT00309946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023720|NCT00929591|Tamoxifen|tamoxifen|mesh-list
93023721|NCT00929591|Cyclophosphamide|cyclophosphamide|mesh-list
93023722|NCT00929591|Doxorubicin|doxorubicin|mesh-list
93023723|NCT00929591|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93023724|NCT00929591|Fluorouracil|fluorouracil|mesh-list
93023725|NCT00929591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023726|NCT00929591|Immunologic Factors|immunologic factors|mesh-ancestor
93023727|NCT00929591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023728|NCT00929591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023729|NCT00929591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93023730|NCT00929591|Alkylating Agents|alkylating agents|mesh-ancestor
93023731|NCT00929591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023732|NCT00929591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023733|NCT00929591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93023734|NCT00929591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93023735|NCT00929591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93023736|NCT00929591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93023737|NCT00929591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023738|NCT00929591|Antimetabolites|antimetabolites|mesh-ancestor
93023739|NCT00929591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93023740|NCT00929591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93023741|NCT00929591|Hormone Antagonists|hormone antagonists|mesh-ancestor
93023742|NCT00929591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023743|NCT00929591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93023744|NCT00929591|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93023745|NCT00929591|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93023746|NCT00929591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93023747|NCT03997500|Norepinephrine|norepinephrine|mesh-list
93023748|NCT03997500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93023749|NCT03997500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93023750|NCT03997500|Adrenergic Agents|adrenergic agents|mesh-ancestor
93023751|NCT03997500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023752|NCT03997500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023753|NCT03997500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023754|NCT03997500|Sympathomimetics|sympathomimetics|mesh-ancestor
93023755|NCT03997500|Autonomic Agents|autonomic agents|mesh-ancestor
93023756|NCT03997500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023757|NCT03997500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93023758|NCT01011660|Amlodipine|amlodipine|mesh-list
93023759|NCT01011660|Telmisartan|telmisartan|mesh-list
93023760|NCT01011660|Amiloride|amiloride|mesh-list
93023761|NCT01011660|Simvastatin|simvastatin|mesh-list
93023762|NCT01011660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93023763|NCT01011660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93023764|NCT01011660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023765|NCT01011660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023766|NCT01011660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93023767|NCT01011660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023768|NCT01011660|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023769|NCT01011660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93023770|NCT01011660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92669051|NCT00293930|Tacrolimus|tacrolimus|mesh-list
93023771|NCT01011660|Antimetabolites|antimetabolites|mesh-ancestor
93023772|NCT01011660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93023773|NCT01011660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93023774|NCT01011660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023775|NCT01011660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93023776|NCT01011660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93023777|NCT01011660|Diuretics|diuretics|mesh-ancestor
93023778|NCT01011660|Natriuretic Agents|natriuretic agents|mesh-ancestor
93023779|NCT01011660|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93023780|NCT01011660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93023781|NCT01011660|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93023782|NCT01011660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93023783|NCT01015248|Rituximab|rituximab|mesh-list
93023784|NCT01015248|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93023785|NCT01015248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93023786|NCT01015248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023787|NCT01015248|Immunologic Factors|immunologic factors|mesh-ancestor
93023788|NCT01015248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023789|NCT01015248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023790|NCT01015248|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93023791|NCT01015248|Alkylating Agents|alkylating agents|mesh-ancestor
93023792|NCT01015248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023793|NCT00506922|Methotrexate|methotrexate|mesh-list
93023794|NCT00506922|Pentostatin|pentostatin|mesh-list
93023795|NCT00506922|Tacrolimus|tacrolimus|mesh-list
93023796|NCT00506922|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93023797|NCT00506922|Abortifacient Agents|abortifacient agents|mesh-ancestor
93023798|NCT00506922|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93023799|NCT00506922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023800|NCT00506922|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93023801|NCT00506922|Antimetabolites|antimetabolites|mesh-ancestor
93023802|NCT00506922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023803|NCT00506922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023804|NCT00506922|Dermatologic Agents|dermatologic agents|mesh-ancestor
93023805|NCT00506922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023806|NCT00506922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93023807|NCT00506922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023808|NCT00506922|Immunologic Factors|immunologic factors|mesh-ancestor
93023809|NCT00506922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023810|NCT00506922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93023811|NCT00506922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93023812|NCT00506922|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93023813|NCT00934193|Gabapentin|gabapentin|mesh-list
93023814|NCT00934193|Analgesics|analgesics|mesh-ancestor
93023815|NCT00934193|Sensory System Agents|sensory system agents|mesh-ancestor
93023816|NCT00934193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023817|NCT00934193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023818|NCT00934193|Anticonvulsants|anticonvulsants|mesh-ancestor
93023819|NCT00934193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93023820|NCT00934193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93023821|NCT00934193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023822|NCT00934193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93023823|NCT00934193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93023824|NCT00934193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93023825|NCT00934193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023826|NCT00934193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023827|NCT00934193|Antimanic Agents|antimanic agents|mesh-ancestor
93023828|NCT00492024|Moxifloxacin|moxifloxacin|mesh-list
93023829|NCT00492024|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93023830|NCT00492024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93023831|NCT00492024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023832|NCT00492024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93023833|NCT00492024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93023834|NCT00492024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023835|NCT00492024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023836|NCT00492024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023837|NCT00492024|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93023838|NCT00492024|Contraceptive Agents|contraceptive agents|mesh-ancestor
93023839|NCT00492024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93023840|NCT00492024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023841|NCT00492024|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93023842|NCT00492024|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93023843|NCT00492024|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93023844|NCT00934427|Nitroglycerin|nitroglycerin|mesh-list
93023845|NCT00934427|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023846|NCT00926315|Calcitriol|calcitriol|mesh-list
93023847|NCT00926315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93023848|NCT00926315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023849|NCT00926315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92180558|NCT05611242|Cangrelor|cangrelor|mesh-list
93023850|NCT00926315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93023851|NCT00926315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023852|NCT00926315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93023853|NCT00926315|Vitamins|vitamins|mesh-ancestor
93023854|NCT00926315|Micronutrients|micronutrients|mesh-ancestor
93023855|NCT00926315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93023857|NCT01013454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93023858|NCT01013454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93023859|NCT01013454|Cholinergic Agents|cholinergic agents|mesh-ancestor
93023860|NCT01013454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023861|NCT01013454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023862|NCT01013454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023863|NCT00491556|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93023864|NCT00491556|Antiviral Agents|antiviral agents|mesh-ancestor
93023865|NCT00491556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023866|NCT00926627|Bosentan|bosentan|mesh-list
93023867|NCT00926627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93023868|NCT00926627|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93023869|NCT00926627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023870|NCT00934739|Thalidomide|thalidomide|mesh-list
93023871|NCT00934739|Dexamethasone|dexamethasone|mesh-list
93023872|NCT00934739|Celecoxib|celecoxib|mesh-list
93023873|NCT00934739|Cyclophosphamide|cyclophosphamide|mesh-list
93023874|NCT00934739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023875|NCT00934739|Immunologic Factors|immunologic factors|mesh-ancestor
93023876|NCT00934739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023877|NCT00934739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023878|NCT00934739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93023879|NCT00934739|Alkylating Agents|alkylating agents|mesh-ancestor
93023880|NCT00934739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023881|NCT00934739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180599|NCT03849534|Salicylic Acid|salicylic acid|mesh-list
93023882|NCT00934739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93023883|NCT00934739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023884|NCT00934739|Antiemetics|antiemetics|mesh-ancestor
93023885|NCT00934739|Autonomic Agents|autonomic agents|mesh-ancestor
93023886|NCT00934739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023887|NCT00934739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93023888|NCT00934739|Glucocorticoids|glucocorticoids|mesh-ancestor
93023889|NCT00934739|Hormones|hormones|mesh-ancestor
93023890|NCT00934739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93023891|NCT00934739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93023892|NCT00934739|Leprostatic Agents|leprostatic agents|mesh-ancestor
93023893|NCT00934739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93023894|NCT00934739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023895|NCT00934739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93023896|NCT00934739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93023897|NCT00934739|Growth Substances|growth substances|mesh-ancestor
93023898|NCT00934739|Growth Inhibitors|growth inhibitors|mesh-ancestor
93023899|NCT00934739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93023900|NCT00934739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023901|NCT00934739|Analgesics|analgesics|mesh-ancestor
93023902|NCT00934739|Sensory System Agents|sensory system agents|mesh-ancestor
93023903|NCT00934739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93023904|NCT00934739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93023905|NCT00934739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023906|NCT01015482|Midazolam|midazolam|mesh-list
93023907|NCT01015482|Remifentanil|remifentanil|mesh-list
93023908|NCT01015482|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93023909|NCT01015482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93023910|NCT01015482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023911|NCT01015482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023912|NCT01015482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93023913|NCT01015482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93023914|NCT01015482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93023915|NCT01015482|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93023916|NCT01015482|Anesthetics, General|anesthetics, general|mesh-ancestor
93023917|NCT01015482|Anesthetics|anesthetics|mesh-ancestor
93023918|NCT01015482|GABA Modulators|gaba modulators|mesh-ancestor
92669204|NCT00325806|Ramipril|ramipril|mesh-list
93023920|NCT01015482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023921|NCT01015482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023922|NCT01015482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93023923|NCT01015482|Narcotics|narcotics|mesh-ancestor
93023924|NCT01015482|Analgesics|analgesics|mesh-ancestor
93023925|NCT01015482|Sensory System Agents|sensory system agents|mesh-ancestor
93023926|NCT01015482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023927|NCT03760679|Chlorhexidine|chlorhexidine|mesh-list
93023928|NCT03760679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93023929|NCT03760679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93023931|NCT00934817|Metformin|metformin|mesh-list
93023932|NCT00934817|Glimepiride|glimepiride|mesh-list
93023933|NCT00934817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92180640|NCT00088621|Serotonin Agents|serotonin agents|mesh-ancestor
93023934|NCT00934817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023935|NCT00934817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93023936|NCT00934817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023937|NCT00934817|Immunologic Factors|immunologic factors|mesh-ancestor
93023938|NCT01013532|Aspirin|aspirin|mesh-list
93023939|NCT01013532|Cilostazol|cilostazol|mesh-list
93023940|NCT01013532|Probucol|probucol|mesh-list
93023941|NCT01013532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93023942|NCT01013532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023943|NCT01013532|Analgesics|analgesics|mesh-ancestor
93023944|NCT01013532|Sensory System Agents|sensory system agents|mesh-ancestor
93023945|NCT01013532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023946|NCT01013532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023947|NCT01013532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93023948|NCT01013532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93023949|NCT01013532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93023950|NCT01013532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93023951|NCT01013532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023952|NCT01013532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93023953|NCT01013532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93023954|NCT01013532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023955|NCT01013532|Antipyretics|antipyretics|mesh-ancestor
93023956|NCT01013532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93023957|NCT01013532|Autonomic Agents|autonomic agents|mesh-ancestor
93023958|NCT01013532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93023959|NCT01013532|Respiratory System Agents|respiratory system agents|mesh-ancestor
93023960|NCT01013532|Vasodilator Agents|vasodilator agents|mesh-ancestor
93023961|NCT01013532|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93023962|NCT01013532|Protective Agents|protective agents|mesh-ancestor
93023963|NCT01013532|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93023964|NCT01013532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93023965|NCT01013532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93023966|NCT01013532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93023967|NCT01013532|Antimetabolites|antimetabolites|mesh-ancestor
93023968|NCT01013532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93023969|NCT01013532|Antioxidants|antioxidants|mesh-ancestor
93023970|NCT00934895|Paclitaxel|paclitaxel|mesh-list
93023971|NCT00934895|Everolimus|everolimus|mesh-list
93023972|NCT00934895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93023973|NCT00934895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93023974|NCT00934895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93023975|NCT00934895|Tubulin Modulators|tubulin modulators|mesh-ancestor
93023976|NCT00934895|Antimitotic Agents|antimitotic agents|mesh-ancestor
93023977|NCT00934895|Mitosis Modulators|mitosis modulators|mesh-ancestor
93023978|NCT00934895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93023979|NCT00934895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93023980|NCT00934895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93023981|NCT00934895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93023982|NCT00934895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93023983|NCT00934895|Immunologic Factors|immunologic factors|mesh-ancestor
93023984|NCT00934895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023985|NCT00926705|Fentanyl|fentanyl|mesh-list
93023986|NCT00926705|Dexmedetomidine|dexmedetomidine|mesh-list
93023987|NCT00926705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93023988|NCT00926705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93023989|NCT00926705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93023990|NCT00926705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93023991|NCT00926705|Analgesics|analgesics|mesh-ancestor
93023992|NCT00926705|Sensory System Agents|sensory system agents|mesh-ancestor
92669277|NCT00326235|Buspirone|buspirone|mesh-list
93023993|NCT00926705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93023994|NCT00926705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93023995|NCT00926705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93023996|NCT00926705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93023997|NCT00926705|Adrenergic Agents|adrenergic agents|mesh-ancestor
93023998|NCT00926705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93023999|NCT00926705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024000|NCT00926705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93024001|NCT00926705|Narcotics|narcotics|mesh-ancestor
93024002|NCT00926705|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93024003|NCT00926705|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93024004|NCT00926705|Anesthetics, General|anesthetics, general|mesh-ancestor
93024005|NCT00926705|Anesthetics|anesthetics|mesh-ancestor
93024006|NCT01012284|Bedaquiline|bedaquiline|mesh-list
93024007|NCT01012284|Antitubercular Agents|antitubercular agents|mesh-ancestor
93024008|NCT01012284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024009|NCT01012284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024010|NCT00934973|Mebeverine|mebeverine|mesh-list
93024011|NCT00934973|Alverine|alverine|mesh-list
93024012|NCT00934973|Anticonvulsants|anticonvulsants|mesh-ancestor
93024013|NCT00934973|Parasympatholytics|parasympatholytics|mesh-ancestor
93024014|NCT00934973|Autonomic Agents|autonomic agents|mesh-ancestor
93024015|NCT00934973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024016|NCT00934973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024017|NCT00485472|Lacosamide|lacosamide|mesh-list
93024018|NCT00485472|Anticonvulsants|anticonvulsants|mesh-ancestor
93024019|NCT00485472|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93024020|NCT00485472|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93024021|NCT00485472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024022|NCT00485472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024023|NCT00930605|Alemtuzumab|alemtuzumab|mesh-list
93024024|NCT00930605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93024025|NCT00930605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024026|NCT01018836|Riluzole|riluzole|mesh-list
93024027|NCT01018836|Anticonvulsants|anticonvulsants|mesh-ancestor
93024028|NCT01018836|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93024029|NCT01018836|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93024030|NCT01018836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024031|NCT01018836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024032|NCT01018836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024033|NCT01018836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93024034|NCT01018836|Protective Agents|protective agents|mesh-ancestor
93024035|NCT04015661|Paclitaxel|paclitaxel|mesh-list
93024036|NCT04015661|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93024037|NCT04015661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93024038|NCT04015661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024039|NCT04015661|Tubulin Modulators|tubulin modulators|mesh-ancestor
93024040|NCT04015661|Antimitotic Agents|antimitotic agents|mesh-ancestor
93024041|NCT04015661|Mitosis Modulators|mitosis modulators|mesh-ancestor
93024042|NCT04015661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024043|NCT00491400|Atorvastatin|atorvastatin|mesh-list
93024044|NCT00491400|Fenofibrate|fenofibrate|mesh-list
93024045|NCT00491400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93024046|NCT00491400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93024047|NCT00491400|Antimetabolites|antimetabolites|mesh-ancestor
93024048|NCT00491400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024049|NCT00491400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93024050|NCT00491400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92180750|NCT03693807|Gemcitabine|gemcitabine|mesh-list
93024051|NCT00491400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024052|NCT00491322|Ergocalciferols|ergocalciferols|mesh-list
93024053|NCT00491322|Vitamin D|vitamin d|mesh-list
93024054|NCT00491322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93024055|NCT00491322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024056|NCT00491322|Vitamins|vitamins|mesh-ancestor
93024057|NCT00491322|Micronutrients|micronutrients|mesh-ancestor
93024058|NCT00491322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024059|NCT00930683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93024060|NCT00930683|Immunologic Factors|immunologic factors|mesh-ancestor
93024061|NCT00930683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024062|NCT00930839|Aspirin|aspirin|mesh-list
93024063|NCT00930839|Niacin|niacin|mesh-list
93024064|NCT00930839|Nicotinic Acids|nicotinic acids|mesh-list
93024065|NCT00930839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93024066|NCT00930839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024067|NCT00930839|Analgesics|analgesics|mesh-ancestor
93024068|NCT00930839|Sensory System Agents|sensory system agents|mesh-ancestor
93024069|NCT00930839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024070|NCT00930839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024071|NCT00930839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024072|NCT00930839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024073|NCT00930839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93024074|NCT00930839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93024075|NCT00930839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024076|NCT00930839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93024077|NCT00930839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93024078|NCT00930839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024080|NCT00930839|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93024081|NCT00930839|Antimetabolites|antimetabolites|mesh-ancestor
93024082|NCT00930839|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93024083|NCT00930839|Vasodilator Agents|vasodilator agents|mesh-ancestor
93024084|NCT00930839|Vitamin B Complex|vitamin b complex|mesh-ancestor
93024086|NCT00930839|Micronutrients|micronutrients|mesh-ancestor
93024087|NCT01015794|Ephedrine|ephedrine|mesh-list
93024088|NCT01015794|Pseudoephedrine|pseudoephedrine|mesh-list
93024089|NCT01015794|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93024090|NCT01015794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024091|NCT01015794|Sympathomimetics|sympathomimetics|mesh-ancestor
93024092|NCT01015794|Autonomic Agents|autonomic agents|mesh-ancestor
93024093|NCT01015794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024094|NCT01015794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93024095|NCT01015794|Adrenergic Agents|adrenergic agents|mesh-ancestor
93024096|NCT01015794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024097|NCT01015794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024098|NCT01015794|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93024099|NCT01015794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93024100|NCT01015794|Respiratory System Agents|respiratory system agents|mesh-ancestor
93024101|NCT01015794|Nasal Decongestants|nasal decongestants|mesh-ancestor
93024102|NCT00935363|Glyburide|glyburide|mesh-list
93024103|NCT00935363|Rifampin|rifampin|mesh-list
93024104|NCT00935363|Fluconazole|fluconazole|mesh-list
93024105|NCT00935363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93024106|NCT00935363|Antitubercular Agents|antitubercular agents|mesh-ancestor
93024107|NCT00935363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024108|NCT00935363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024109|NCT00935363|Leprostatic Agents|leprostatic agents|mesh-ancestor
93024110|NCT00935363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93024111|NCT00935363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024112|NCT00935363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024113|NCT00935363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93024114|NCT00935363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93024115|NCT00935363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93024116|NCT00935363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93024117|NCT00935363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93024118|NCT00935363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93024119|NCT00935363|Antifungal Agents|antifungal agents|mesh-ancestor
93024120|NCT00935363|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93024121|NCT00935363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93024122|NCT00935363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93024123|NCT00935363|Hormone Antagonists|hormone antagonists|mesh-ancestor
93024124|NCT00935363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024125|NCT00935363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024126|NCT00935363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93024127|NCT00935363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93024128|NCT00935363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024129|NCT00930995|Candesartan|candesartan|mesh-list
93024130|NCT00930995|Candesartan cilexetil|candesartan cilexetil|mesh-list
93024131|NCT00930995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92180817|NCT00089011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024132|NCT00930995|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93024133|NCT00930995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93024134|NCT00930995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024135|NCT00931073|Ketoconazole|ketoconazole|mesh-list
93024136|NCT00931073|Omeprazole|omeprazole|mesh-list
93024137|NCT00931073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93024138|NCT00931073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93024139|NCT00931073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93024140|NCT00931073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024141|NCT00931073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024142|NCT00931073|Antifungal Agents|antifungal agents|mesh-ancestor
92669438|NCT00295997|Busulfan|busulfan|mesh-list
93024143|NCT00931073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024144|NCT00931073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93024145|NCT00931073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93024146|NCT00931073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93024147|NCT00931073|Hormone Antagonists|hormone antagonists|mesh-ancestor
93024148|NCT00931073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024149|NCT00931073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024150|NCT00931073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93024152|NCT00936689|Chlorotrianisene|chlorotrianisene|mesh-list
93024153|NCT00936689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93024154|NCT00936689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024155|NCT00936689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93024156|NCT00936689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93024157|NCT00936689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024158|NCT00936689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024159|NCT00936689|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93024160|NCT00936689|Estrogens|estrogens|mesh-ancestor
93024161|NCT00936689|Hormones|hormones|mesh-ancestor
93024162|NCT00936689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024163|NCT00936689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024164|NCT00936689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024165|NCT01018914|Mycophenolic Acid|mycophenolic acid|mesh-list
93024166|NCT01018914|Tacrolimus|tacrolimus|mesh-list
93024167|NCT01018914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024168|NCT01018914|Immunologic Factors|immunologic factors|mesh-ancestor
93024169|NCT01018914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024170|NCT01018914|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93024171|NCT01018914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024172|NCT01018914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024173|NCT01018914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93024174|NCT01018914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024175|NCT01018914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93024176|NCT01018914|Antitubercular Agents|antitubercular agents|mesh-ancestor
93024177|NCT01018914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024178|NCT01018914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024179|NCT01019070|Asunaprevir|asunaprevir|mesh-list
93024180|NCT01019070|Protease Inhibitors|protease inhibitors|mesh-ancestor
93024181|NCT01019070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024182|NCT01019070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024183|NCT00936767|Artesunate|artesunate|mesh-list
93024184|NCT00936767|Mefloquine|mefloquine|mesh-list
93024185|NCT00936767|Antimalarials|antimalarials|mesh-ancestor
93024186|NCT00936767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93024187|NCT00936767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93024188|NCT00936767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024189|NCT00936767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024190|NCT00936767|Antiviral Agents|antiviral agents|mesh-ancestor
93024191|NCT00936767|Schistosomicides|schistosomicides|mesh-ancestor
93024192|NCT00936767|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93024193|NCT00936767|Anthelmintics|anthelmintics|mesh-ancestor
93024194|NCT00931229|Entecavir|entecavir|mesh-list
93024195|NCT00931229|Antiviral Agents|antiviral agents|mesh-ancestor
93024196|NCT00931229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024197|NCT00936923|Furosemide|furosemide|mesh-list
93024198|NCT00936923|Diuretics|diuretics|mesh-list
93024199|NCT00936923|Natriuretic Agents|natriuretic agents|mesh-ancestor
93024200|NCT00936923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024201|NCT00936923|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93024202|NCT00936923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024203|NCT00936923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024204|NCT01019382|Gemcitabine|gemcitabine|mesh-list
93024205|NCT01019382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93024206|NCT01019382|Antimetabolites|antimetabolites|mesh-ancestor
93024207|NCT01019382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024208|NCT01019382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024209|NCT00935675|Escitalopram|escitalopram|mesh-list
93024210|NCT00935675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93024211|NCT00935675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93024212|NCT00935675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024213|NCT00935675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024214|NCT00935675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669505|NCT00296387|Atorvastatin|atorvastatin|mesh-list
93024215|NCT00935675|Serotonin Agents|serotonin agents|mesh-ancestor
93024216|NCT00935675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024217|NCT01016184|Vitamin D|vitamin d|mesh-list
93024218|NCT01016184|Vitamins|vitamins|mesh-ancestor
93024219|NCT01016184|Micronutrients|micronutrients|mesh-ancestor
93024220|NCT01016184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024221|NCT01016184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024222|NCT02567825|Amoxicillin|amoxicillin|mesh-list
93024223|NCT02567825|Ceftriaxone|ceftriaxone|mesh-list
93024224|NCT02567825|Clavulanic Acid|clavulanic acid|mesh-list
93024225|NCT02567825|Clavulanic Acids|clavulanic acids|mesh-list
93024226|NCT02567825|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93024227|NCT02567825|Ofloxacin|ofloxacin|mesh-list
93024228|NCT02567825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024229|NCT02567825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024230|NCT02567825|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93024231|NCT02567825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024232|NCT02567825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024233|NCT02567825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92180938|NCT00194779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024234|NCT02567825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93024235|NCT02567825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93024236|NCT02567825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024237|NCT02567825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93024238|NCT02567825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93024239|NCT00490776|Panobinostat|panobinostat|mesh-list
93024240|NCT00490776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024241|NCT00490776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93024242|NCT00490776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024243|NCT00490776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024244|NCT00566735|Galantamine|galantamine|mesh-list
93024245|NCT00566735|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93024246|NCT00566735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024247|NCT00566735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024248|NCT00566735|Cholinergic Agents|cholinergic agents|mesh-ancestor
93024249|NCT00566735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024250|NCT00566735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024251|NCT00566735|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93024252|NCT00566735|Autonomic Agents|autonomic agents|mesh-ancestor
93024253|NCT00566735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024254|NCT00566735|Nootropic Agents|nootropic agents|mesh-ancestor
93024255|NCT00936143|Infliximab|infliximab|mesh-list
93024256|NCT00936143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93024257|NCT00936143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024258|NCT00936143|Dermatologic Agents|dermatologic agents|mesh-ancestor
93024259|NCT00936143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93024260|NCT00936143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024261|NCT00937079|Exenatide|exenatide|mesh-list
93024262|NCT00937079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024263|NCT00937079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024264|NCT00937079|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93024265|NCT00937079|Incretins|incretins|mesh-ancestor
93024266|NCT00937079|Hormones|hormones|mesh-ancestor
93024267|NCT00937079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024268|NCT00566111|Ceftriaxone|ceftriaxone|mesh-list
93024269|NCT00566111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024270|NCT00566111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024271|NCT00937625|Cyclophosphamide|cyclophosphamide|mesh-list
93024272|NCT00937625|Fludarabine|fludarabine|mesh-list
93024273|NCT00937625|Fludarabine phosphate|fludarabine phosphate|mesh-list
93024274|NCT00937625|Interleukin-2|interleukin-2|mesh-list
93024275|NCT00937625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024276|NCT00937625|Immunologic Factors|immunologic factors|mesh-ancestor
92180971|NCT05474664|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93024277|NCT00937625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024278|NCT00937625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024279|NCT00937625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93024280|NCT00937625|Alkylating Agents|alkylating agents|mesh-ancestor
93024281|NCT00937625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024282|NCT00937625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024283|NCT00937625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93024284|NCT00937625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93024285|NCT00937625|Antimetabolites|antimetabolites|mesh-ancestor
93024286|NCT00937625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024287|NCT00937625|Analgesics|analgesics|mesh-ancestor
93024288|NCT00937625|Sensory System Agents|sensory system agents|mesh-ancestor
93024289|NCT00937625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024290|NCT04014101|Apatinib|apatinib|mesh-list
93024291|NCT04014101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024292|NCT04014101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93024293|NCT04014101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024294|NCT04014101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024295|NCT00936533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93024296|NCT00936533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93024297|NCT00936533|Botulinum Toxins|botulinum toxins|mesh-list
93024298|NCT00936533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93024299|NCT00936533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024300|NCT00936533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024301|NCT00936533|Cholinergic Agents|cholinergic agents|mesh-ancestor
93024302|NCT00936533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024303|NCT00936533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024304|NCT00936533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93024305|NCT00936533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024306|NCT00564629|Acetaminophen|acetaminophen|mesh-list
93024307|NCT00564629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024308|NCT00564629|Analgesics|analgesics|mesh-ancestor
93024309|NCT00564629|Sensory System Agents|sensory system agents|mesh-ancestor
93024310|NCT00564629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024311|NCT00564629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024312|NCT00564629|Antipyretics|antipyretics|mesh-ancestor
93024313|NCT00564395|Insulin|insulin|mesh-list
93024314|NCT00564395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93024315|NCT00564395|Insulin Detemir|insulin detemir|mesh-list
93024316|NCT00564395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024317|NCT00564395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024318|NCT04013243|Magnesium Sulfate|magnesium sulfate|mesh-list
93024319|NCT04013243|Analgesics|analgesics|mesh-ancestor
93024320|NCT04013243|Sensory System Agents|sensory system agents|mesh-ancestor
93024321|NCT04013243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024322|NCT04013243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024323|NCT04013243|Anesthetics|anesthetics|mesh-ancestor
93024324|NCT04013243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024325|NCT04013243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93024326|NCT04013243|Anticonvulsants|anticonvulsants|mesh-ancestor
93024327|NCT04013243|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93024328|NCT04013243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024329|NCT04013243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024330|NCT04013243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93024331|NCT04013243|Tocolytic Agents|tocolytic agents|mesh-ancestor
93024332|NCT04013243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93024333|NCT00938171|Anesthetics|anesthetics|mesh-list
93024334|NCT00938171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024335|NCT00938171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024336|NCT05280275|Dexamethasone|dexamethasone|mesh-list
93024337|NCT05280275|Lenalidomide|lenalidomide|mesh-list
93024338|NCT05280275|Daratumumab|daratumumab|mesh-list
93024339|NCT05280275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024340|NCT05280275|Antiemetics|antiemetics|mesh-ancestor
93024341|NCT05280275|Autonomic Agents|autonomic agents|mesh-ancestor
93024342|NCT05280275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024343|NCT05280275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024344|NCT05280275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93024345|NCT05280275|Glucocorticoids|glucocorticoids|mesh-ancestor
93024346|NCT05280275|Hormones|hormones|mesh-ancestor
93024347|NCT05280275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024348|NCT05280275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024349|NCT05280275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024350|NCT05280275|Immunologic Factors|immunologic factors|mesh-ancestor
93024351|NCT05280275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93024352|NCT05280275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93024353|NCT05280275|Growth Substances|growth substances|mesh-ancestor
93024354|NCT05280275|Growth Inhibitors|growth inhibitors|mesh-ancestor
93024355|NCT00939497|Risperidone|risperidone|mesh-list
93024356|NCT00939497|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93024357|NCT00939497|Serotonin Agents|serotonin agents|mesh-ancestor
93024358|NCT00939497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181036|NCT00195403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024359|NCT00939497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024360|NCT00939497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024361|NCT00939497|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93024362|NCT00939497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93024363|NCT00939497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024364|NCT00939497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93024365|NCT00939497|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93024366|NCT00939497|Dopamine Agents|dopamine agents|mesh-ancestor
93024367|NCT00502242|Ramipril|ramipril|mesh-list
93024368|NCT00502242|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93024369|NCT00502242|Protease Inhibitors|protease inhibitors|mesh-ancestor
93024371|NCT00502242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024372|NCT00502242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93024373|NCT00938405|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93024374|NCT00938405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93024375|NCT00938405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93024376|NCT00938405|Antimetabolites|antimetabolites|mesh-ancestor
93024377|NCT00938405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024378|NCT00938405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93024379|NCT03045653|Tamoxifen|tamoxifen|mesh-list
93024380|NCT03045653|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93024381|NCT03045653|Hormone Antagonists|hormone antagonists|mesh-ancestor
93024382|NCT03045653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024383|NCT03045653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024384|NCT03045653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024385|NCT03045653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024386|NCT03045653|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93024387|NCT03045653|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93024388|NCT03045653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024389|NCT02991365|Insulin|insulin|mesh-list
93024390|NCT02991365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024391|NCT02991365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024392|NCT03972137|Nicotine|nicotine|mesh-list
93024393|NCT03972137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93024394|NCT03972137|Autonomic Agents|autonomic agents|mesh-ancestor
93024395|NCT03972137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024396|NCT03972137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024397|NCT03972137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93024398|NCT03972137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93024399|NCT03972137|Cholinergic Agents|cholinergic agents|mesh-ancestor
93024400|NCT03972137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024401|NCT03972137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024402|NCT00490698|Zoledronic Acid|zoledronic acid|mesh-list
93024403|NCT00490698|Atorvastatin|atorvastatin|mesh-list
93024404|NCT00490698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93024405|NCT00490698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93024406|NCT00490698|Antimetabolites|antimetabolites|mesh-ancestor
93024407|NCT00490698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024408|NCT00490698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93024409|NCT00490698|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93024410|NCT00490698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024411|NCT00490698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024412|NCT00490698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024413|NCT04492254|Enoxaparin|enoxaparin|mesh-list
93024414|NCT04492254|Anticoagulants|anticoagulants|mesh-ancestor
93024415|NCT04492254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93024416|NCT04492254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93024417|NCT04492254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024418|NCT03855228|Mometasone Furoate|mometasone furoate|mesh-list
93024419|NCT03855228|Loratadine|loratadine|mesh-list
93024420|NCT03855228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024421|NCT03855228|Dermatologic Agents|dermatologic agents|mesh-ancestor
93024422|NCT03855228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93024423|NCT03855228|Antipruritics|antipruritics|mesh-ancestor
93024424|NCT03855228|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93024425|NCT03855228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93024426|NCT03855228|Histamine Antagonists|histamine antagonists|mesh-ancestor
93024427|NCT03855228|Histamine Agents|histamine agents|mesh-ancestor
93024428|NCT03855228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024429|NCT03855228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024430|NCT03855228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024431|NCT04013477|Donepezil|donepezil|mesh-list
93024432|NCT04013477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93024433|NCT04013477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024434|NCT04013477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024435|NCT04013477|Cholinergic Agents|cholinergic agents|mesh-ancestor
93024436|NCT04013477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024437|NCT04013477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024438|NCT04013477|Nootropic Agents|nootropic agents|mesh-ancestor
93024439|NCT00940667|Losartan|losartan|mesh-list
92528930|NCT00038233|Growth Substances|growth substances|mesh-ancestor
93024441|NCT00940667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93024442|NCT00940667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93024443|NCT00940667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024444|NCT00940667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024445|NCT00940667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92181107|NCT00097669|Folic Acid|folic acid|mesh-list
93024446|NCT00940667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024447|NCT00940667|Vasodilator Agents|vasodilator agents|mesh-ancestor
93024448|NCT00940667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93024449|NCT00940667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93024450|NCT00940667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93024451|NCT01019772|Vaccines|vaccines|mesh-list
93024452|NCT01019772|Immunologic Factors|immunologic factors|mesh-ancestor
93024453|NCT01019772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024454|NCT00513500|Amoxicillin|amoxicillin|mesh-list
93024455|NCT00513500|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93024456|NCT00513500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024457|NCT00513500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024458|NCT00513500|Antimalarials|antimalarials|mesh-ancestor
93024459|NCT00513500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93024460|NCT00513500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93024461|NCT00511004|Albendazole|albendazole|mesh-list
93024462|NCT00511004|Diethylcarbamazine|diethylcarbamazine|mesh-list
93024463|NCT00511004|Anthelmintics|anthelmintics|mesh-ancestor
93024464|NCT00511004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93024465|NCT00511004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024466|NCT00511004|Anticestodal Agents|anticestodal agents|mesh-ancestor
93024467|NCT00511004|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93024468|NCT00511004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93024469|NCT00511004|Tubulin Modulators|tubulin modulators|mesh-ancestor
93024470|NCT00511004|Antimitotic Agents|antimitotic agents|mesh-ancestor
93024471|NCT00511004|Mitosis Modulators|mitosis modulators|mesh-ancestor
93024472|NCT00511004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024473|NCT00511004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024474|NCT00511004|Filaricides|filaricides|mesh-ancestor
93024475|NCT00511004|Antinematodal Agents|antinematodal agents|mesh-ancestor
93024476|NCT00511004|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93024477|NCT00511004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024478|NCT02550197|Vaccines|vaccines|mesh-list
93024479|NCT02550197|Immunologic Factors|immunologic factors|mesh-ancestor
93024480|NCT02550197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024481|NCT00939965|Isotretinoin|isotretinoin|mesh-list
93024482|NCT00939965|Dermatologic Agents|dermatologic agents|mesh-ancestor
93024483|NCT04012541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
93024484|NCT02877134|Ustekinumab|ustekinumab|mesh-list
93024485|NCT02877134|Dermatologic Agents|dermatologic agents|mesh-ancestor
93024486|NCT00563381|Bromides|bromides|mesh-list
93024487|NCT00563381|Tiotropium Bromide|tiotropium bromide|mesh-list
93024488|NCT00563381|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93024489|NCT00563381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93024490|NCT00563381|Autonomic Agents|autonomic agents|mesh-ancestor
93024491|NCT00563381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024492|NCT00563381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024493|NCT00563381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93024494|NCT00563381|Respiratory System Agents|respiratory system agents|mesh-ancestor
93024495|NCT00563381|Parasympatholytics|parasympatholytics|mesh-ancestor
93024496|NCT00563381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93024497|NCT00563381|Cholinergic Agents|cholinergic agents|mesh-ancestor
93024498|NCT00563381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024499|NCT00563381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024500|NCT00563381|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93024501|NCT00563381|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93024502|NCT00563381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93024503|NCT00563381|Adrenergic Agents|adrenergic agents|mesh-ancestor
93024504|NCT00563381|Anticonvulsants|anticonvulsants|mesh-ancestor
93024505|NCT00512798|Temozolomide|temozolomide|mesh-list
93024506|NCT00512798|Bortezomib|bortezomib|mesh-list
93024507|NCT00512798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93024508|NCT00512798|Alkylating Agents|alkylating agents|mesh-ancestor
93024509|NCT00512798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024510|NCT00512798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024511|NCT00940121|Mirabegron|mirabegron|mesh-list
93024512|NCT00940121|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93024513|NCT00940121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93024514|NCT00940121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92669793|NCT00298181|Antiviral Agents|antiviral agents|mesh-ancestor
93024515|NCT00940121|Adrenergic Agents|adrenergic agents|mesh-ancestor
93024516|NCT00940121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024517|NCT00940121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024518|NCT00940121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024519|NCT00940121|Urological Agents|urological agents|mesh-ancestor
93024520|NCT04012619|Cisplatin|cisplatin|mesh-list
93024521|NCT04012619|Carboplatin|carboplatin|mesh-list
93024522|NCT04012619|Pemetrexed|pemetrexed|mesh-list
93024523|NCT04012619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024524|NCT04012619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024525|NCT04012619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024526|NCT04012619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93024527|NCT04012619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93024528|NCT00941057|Calcium, Dietary|calcium, dietary|mesh-list
93024529|NCT00941057|Tetrahydrofolates|tetrahydrofolates|mesh-list
93024530|NCT00941057|Dienogest|dienogest|mesh-list
93024531|NCT00941057|Calcium|calcium|mesh-list
93024532|NCT00941057|Nandrolone|nandrolone|mesh-list
93024533|NCT00941057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93024534|NCT00941057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024535|NCT00941057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024536|NCT00941057|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93024537|NCT00941057|Contraceptive Agents|contraceptive agents|mesh-ancestor
93024538|NCT00941057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93024539|NCT00941057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93024540|NCT00941057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93024541|NCT00941057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93024542|NCT00941057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93024543|NCT00941057|Hormone Antagonists|hormone antagonists|mesh-ancestor
93024544|NCT00941057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024545|NCT00941057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024546|NCT00941057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024547|NCT00941057|Androgens|androgens|mesh-ancestor
93024548|NCT00941057|Hormones|hormones|mesh-ancestor
93024549|NCT00941057|Anabolic Agents|anabolic agents|mesh-ancestor
93024550|NCT00941057|Vitamin B Complex|vitamin b complex|mesh-ancestor
93024551|NCT00941057|Vitamins|vitamins|mesh-ancestor
93024552|NCT00941057|Micronutrients|micronutrients|mesh-ancestor
93024553|NCT00561821|Mirtazapine|mirtazapine|mesh-list
93024554|NCT00561821|Antidepressive Agents|antidepressive agents|mesh-ancestor
93024555|NCT00561821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93024556|NCT00561821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93024557|NCT00561821|Histamine Antagonists|histamine antagonists|mesh-ancestor
93024558|NCT00561821|Histamine Agents|histamine agents|mesh-ancestor
93024559|NCT00561821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024560|NCT00561821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024561|NCT00561821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024562|NCT00561821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93024563|NCT00561821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93024564|NCT00561821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024565|NCT00561821|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93024566|NCT00561821|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93024567|NCT00561821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93024568|NCT00561821|Adrenergic Agents|adrenergic agents|mesh-ancestor
93024569|NCT00561821|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93024570|NCT00561821|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93024571|NCT00561821|Serotonin Agents|serotonin agents|mesh-ancestor
93024572|NCT00561821|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93024573|NCT03684044|Baloxavir|baloxavir|mesh-list
93024574|NCT03684044|Antiviral Agents|antiviral agents|mesh-ancestor
93024575|NCT03684044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024576|NCT03684044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024577|NCT03684044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024578|NCT01009502|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
93024579|NCT01009502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93024580|NCT01009502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93024581|NCT01009502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024582|NCT01009502|Schistosomicides|schistosomicides|mesh-ancestor
93024583|NCT01009502|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93024584|NCT01009502|Anthelmintics|anthelmintics|mesh-ancestor
93024585|NCT00335452|Clopidogrel|clopidogrel|mesh-list
93024586|NCT00335452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93024587|NCT00335452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93024588|NCT00335452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92370184|NCT01083732|Dabigatran|dabigatran|mesh-list
93024589|NCT00335452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93024590|NCT00335452|Purinergic Agents|purinergic agents|mesh-ancestor
93024591|NCT00335452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024592|NCT00335452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024593|NCT00335452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024594|NCT00522548|Mycophenolic Acid|mycophenolic acid|mesh-list
93024595|NCT00522548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93024596|NCT00522548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024597|NCT00522548|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93024598|NCT00522548|Antitubercular Agents|antitubercular agents|mesh-ancestor
93024599|NCT00522548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024600|NCT00522548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024601|NCT00522548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024602|NCT00522548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024603|NCT00522392|Dexamethasone|dexamethasone|mesh-list
93024604|NCT00522392|Lenalidomide|lenalidomide|mesh-list
93024606|NCT00522392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024607|NCT00522392|Antiemetics|antiemetics|mesh-ancestor
93024608|NCT00522392|Autonomic Agents|autonomic agents|mesh-ancestor
93024609|NCT00522392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024610|NCT00522392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024611|NCT00522392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93024612|NCT00522392|Glucocorticoids|glucocorticoids|mesh-ancestor
93024613|NCT00522392|Hormones|hormones|mesh-ancestor
93024614|NCT00522392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024615|NCT00522392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024616|NCT00522392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024617|NCT00522392|Immunologic Factors|immunologic factors|mesh-ancestor
93024618|NCT00522392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93024619|NCT00522392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93024620|NCT00522392|Growth Substances|growth substances|mesh-ancestor
93024621|NCT00522392|Growth Inhibitors|growth inhibitors|mesh-ancestor
93024622|NCT01061320|Tocopherols|tocopherols|mesh-list
93024623|NCT01061320|Vitamin E|vitamin e|mesh-list
93024624|NCT01061320|Tocotrienols|tocotrienols|mesh-list
93024625|NCT01061320|alpha-Tocopherol|alpha-tocopherol|mesh-list
93024626|NCT01061320|Vitamins|vitamins|mesh-ancestor
93024627|NCT01061320|Micronutrients|micronutrients|mesh-ancestor
93024628|NCT01061320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024629|NCT01061320|Antioxidants|antioxidants|mesh-ancestor
93024630|NCT01061320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024631|NCT01061320|Protective Agents|protective agents|mesh-ancestor
93024632|NCT01012544|Clopidogrel|clopidogrel|mesh-list
93024633|NCT01012544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93024634|NCT01012544|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93024635|NCT01012544|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93024636|NCT01012544|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93024637|NCT01012544|Purinergic Agents|purinergic agents|mesh-ancestor
93024638|NCT01012544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024639|NCT01012544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024640|NCT01012544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024641|NCT01012700|Poly ICLC|poly iclc|mesh-list
93024642|NCT01012700|Interferon Inducers|interferon inducers|mesh-ancestor
93024643|NCT01012700|Immunologic Factors|immunologic factors|mesh-ancestor
93024644|NCT01012700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024645|NCT01565720|Moxifloxacin|moxifloxacin|mesh-list
93024646|NCT01565720|Isavuconazole|isavuconazole|mesh-list
93024647|NCT01565720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024648|NCT01565720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024649|NCT01565720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93024650|NCT01565720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93024651|NCT01565720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024652|NCT01565720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024653|NCT01565720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024654|NCT01565720|Antifungal Agents|antifungal agents|mesh-ancestor
93024655|NCT00309244|Insulin|insulin|mesh-list
93024656|NCT00309244|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93024657|NCT00309244|Insulin Aspart|insulin aspart|mesh-list
93024658|NCT00309244|Protamines|protamines|mesh-list
93024659|NCT00309244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024660|NCT00309244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024661|NCT00309244|Heparin Antagonists|heparin antagonists|mesh-ancestor
92181266|NCT00201877|Immunologic Factors|immunologic factors|mesh-ancestor
93024662|NCT00309244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024663|NCT00309244|Coagulants|coagulants|mesh-ancestor
92669940|NCT00299936|Antimetabolites|antimetabolites|mesh-ancestor
93024664|NCT00483756|Cyclosporine|cyclosporine|mesh-list
93024665|NCT00483756|Cyclosporins|cyclosporins|mesh-list
93024666|NCT00483756|Tofacitinib|tofacitinib|mesh-list
93024667|NCT00483756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024668|NCT00483756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024669|NCT00483756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024670|NCT00483756|Immunologic Factors|immunologic factors|mesh-ancestor
93024671|NCT00483756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024672|NCT00483756|Antifungal Agents|antifungal agents|mesh-ancestor
93024673|NCT00483756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024674|NCT00483756|Dermatologic Agents|dermatologic agents|mesh-ancestor
93024675|NCT00483756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024676|NCT00483756|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93024677|NCT00483756|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93024678|NCT00483756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93024679|NCT00309166|Vaccines|vaccines|mesh-list
93024680|NCT00309166|Immunologic Factors|immunologic factors|mesh-ancestor
93024681|NCT00309166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024682|NCT01063816|Carboplatin|carboplatin|mesh-list
93024683|NCT01063816|Gemcitabine|gemcitabine|mesh-list
93024684|NCT01063816|Veliparib|veliparib|mesh-list
93024685|NCT01063816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024686|NCT01063816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93024687|NCT01063816|Antimetabolites|antimetabolites|mesh-ancestor
93024688|NCT01063816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024689|NCT01063816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93024690|NCT01063816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024691|NCT00501852|Glycopyrrolate|glycopyrrolate|mesh-list
93024692|NCT00501852|Tiotropium Bromide|tiotropium bromide|mesh-list
93024693|NCT00501852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93024694|NCT00501852|Autonomic Agents|autonomic agents|mesh-ancestor
93024695|NCT00501852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024696|NCT00501852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024697|NCT00501852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93024698|NCT00501852|Respiratory System Agents|respiratory system agents|mesh-ancestor
93024699|NCT00501852|Parasympatholytics|parasympatholytics|mesh-ancestor
93024700|NCT00501852|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93024701|NCT00501852|Cholinergic Agents|cholinergic agents|mesh-ancestor
93024702|NCT00501852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024703|NCT00501852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024704|NCT00501852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93024705|NCT00501852|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93024706|NCT00482274|Docetaxel|docetaxel|mesh-list
93024707|NCT00482274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024708|NCT00482274|Tubulin Modulators|tubulin modulators|mesh-ancestor
93024709|NCT00482274|Antimitotic Agents|antimitotic agents|mesh-ancestor
93024710|NCT00482274|Mitosis Modulators|mitosis modulators|mesh-ancestor
93024711|NCT00482274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024712|NCT00490542|Ziprasidone|ziprasidone|mesh-list
93024713|NCT00490542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93024714|NCT00490542|Serotonin Agents|serotonin agents|mesh-ancestor
93024715|NCT00490542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024716|NCT00490542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024717|NCT00490542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024718|NCT00490542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93024719|NCT00490542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93024720|NCT00490542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024721|NCT00490542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93024722|NCT00490542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93024723|NCT00490542|Dopamine Agents|dopamine agents|mesh-ancestor
93024724|NCT01059604|Naproxen|naproxen|mesh-list
93024725|NCT01059604|Sumatriptan|sumatriptan|mesh-list
93024726|NCT01059604|Naratriptan|naratriptan|mesh-list
93024727|NCT01059604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93024728|NCT01059604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024729|NCT01059604|Analgesics|analgesics|mesh-ancestor
93024730|NCT01059604|Sensory System Agents|sensory system agents|mesh-ancestor
93024731|NCT01059604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024732|NCT01059604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024733|NCT01059604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024734|NCT01059604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024735|NCT01059604|Gout Suppressants|gout suppressants|mesh-ancestor
93024736|NCT01059604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93024737|NCT01059604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024738|NCT01059604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024739|NCT01059604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93024740|NCT01059604|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93024741|NCT01059604|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93024743|NCT01059604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024744|NCT02532634|Dexamethasone|dexamethasone|mesh-list
93024745|NCT02532634|Dexamethasone acetate|dexamethasone acetate|mesh-list
93024746|NCT02532634|Aprepitant|aprepitant|mesh-list
93024747|NCT02532634|Fosaprepitant|fosaprepitant|mesh-list
93024748|NCT02532634|Palonosetron|palonosetron|mesh-list
93024749|NCT02532634|Ramosetron|ramosetron|mesh-list
93024750|NCT02532634|BB 1101|bb 1101|mesh-list
93024751|NCT02532634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024752|NCT02532634|Antiemetics|antiemetics|mesh-ancestor
93024753|NCT02532634|Autonomic Agents|autonomic agents|mesh-ancestor
93024754|NCT02532634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024755|NCT02532634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024756|NCT02532634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93024757|NCT02532634|Glucocorticoids|glucocorticoids|mesh-ancestor
93024758|NCT02532634|Hormones|hormones|mesh-ancestor
93024759|NCT02532634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024760|NCT02532634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024761|NCT02532634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024762|NCT02532634|Protease Inhibitors|protease inhibitors|mesh-ancestor
93024763|NCT02532634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024764|NCT02532634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024765|NCT02532634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93024766|NCT02532634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024767|NCT02532634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93024768|NCT02532634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93024769|NCT02532634|Serotonin Agents|serotonin agents|mesh-ancestor
93024770|NCT00501540|Lithium Carbonate|lithium carbonate|mesh-list
93024771|NCT00501540|Antidepressive Agents|antidepressive agents|mesh-ancestor
93024772|NCT00501540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93024773|NCT00501540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024774|NCT00501540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024775|NCT00501540|Antimanic Agents|antimanic agents|mesh-ancestor
93024776|NCT00501540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93024777|NCT00501540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024778|NCT00501540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024779|NCT01014156|Epoprostenol|epoprostenol|mesh-list
93024780|NCT01014156|Tezosentan|tezosentan|mesh-list
93024781|NCT01014156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93024782|NCT01014156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93024783|NCT01014156|Vasodilator Agents|vasodilator agents|mesh-ancestor
93024784|NCT00322348|Goserelin|goserelin|mesh-list
93024785|NCT00322348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024786|NCT00322348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024787|NCT01014234|Cyclosporine|cyclosporine|mesh-list
93024788|NCT01014234|Sirolimus|sirolimus|mesh-list
93024789|NCT01014234|Cyclosporins|cyclosporins|mesh-list
93024790|NCT01014234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024791|NCT01014234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024792|NCT01014234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024793|NCT01014234|Immunologic Factors|immunologic factors|mesh-ancestor
93024794|NCT01014234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024795|NCT01014234|Antifungal Agents|antifungal agents|mesh-ancestor
93024796|NCT01014234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024797|NCT01014234|Dermatologic Agents|dermatologic agents|mesh-ancestor
93024798|NCT01014234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024799|NCT01014234|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93024800|NCT01014234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024801|NCT01014234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93024802|NCT01014234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024803|NCT00501228|Lenograstim|lenograstim|mesh-list
93024804|NCT00501228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93024805|NCT00501228|Immunologic Factors|immunologic factors|mesh-ancestor
93024806|NCT00501228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024807|NCT00308620|Chloroquine|chloroquine|mesh-list
93024808|NCT00308620|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93024809|NCT00308620|Amebicides|amebicides|mesh-ancestor
93024810|NCT00308620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93024811|NCT00308620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93024812|NCT00308620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024813|NCT00308620|Antimalarials|antimalarials|mesh-ancestor
93024814|NCT00308620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024815|NCT00308620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93024816|NCT00308620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024817|NCT00308620|Analgesics|analgesics|mesh-ancestor
93024818|NCT00308620|Sensory System Agents|sensory system agents|mesh-ancestor
93024819|NCT00308620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024820|NCT00308620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024821|NCT00308620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024822|NCT00308620|Filaricides|filaricides|mesh-ancestor
93024823|NCT00308620|Antinematodal Agents|antinematodal agents|mesh-ancestor
93024824|NCT00308620|Anthelmintics|anthelmintics|mesh-ancestor
93024825|NCT00492752|Sorafenib|sorafenib|mesh-list
93024826|NCT00492752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024827|NCT00492752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93024828|NCT00492752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024829|NCT00492752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024830|NCT00308308|Insulin|insulin|mesh-list
93024831|NCT00308308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024832|NCT00308308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024833|NCT00505934|Levetiracetam|levetiracetam|mesh-list
93024834|NCT00505934|Anticonvulsants|anticonvulsants|mesh-ancestor
93024835|NCT00505934|Nootropic Agents|nootropic agents|mesh-ancestor
93024836|NCT02532790|Prednisone|prednisone|mesh-list
93024837|NCT02532790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024838|NCT02532790|Glucocorticoids|glucocorticoids|mesh-ancestor
93024839|NCT02532790|Hormones|hormones|mesh-ancestor
93024840|NCT02532790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024841|NCT02532790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024842|NCT02532790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024843|NCT02532790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024844|NCT00505778|Mesalamine|mesalamine|mesh-list
93024845|NCT00505778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93024846|NCT00505778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024847|NCT00505778|Analgesics|analgesics|mesh-ancestor
93024848|NCT00505778|Sensory System Agents|sensory system agents|mesh-ancestor
93024849|NCT00505778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024850|NCT00505778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024851|NCT00505778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024852|NCT00505778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024853|NCT00308074|Aripiprazole|aripiprazole|mesh-list
93024854|NCT00308074|Antidepressive Agents|antidepressive agents|mesh-ancestor
93024855|NCT00308074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93024856|NCT00308074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93024857|NCT00308074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93024858|NCT00308074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024859|NCT00308074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024860|NCT00308074|Dopamine Agonists|dopamine agonists|mesh-ancestor
93024861|NCT00308074|Dopamine Agents|dopamine agents|mesh-ancestor
93024862|NCT00308074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024863|NCT00308074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024864|NCT00308074|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93024865|NCT00308074|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93024866|NCT00308074|Serotonin Agents|serotonin agents|mesh-ancestor
93024867|NCT00308074|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93024868|NCT00308074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93024869|NCT00308074|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93024870|NCT00308074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93024871|NCT03997058|Estazolam|estazolam|mesh-list
93024872|NCT03997058|Anticonvulsants|anticonvulsants|mesh-ancestor
93024873|NCT03997058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93024874|NCT03997058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93024875|NCT03997058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024876|NCT03997058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024877|NCT03997058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93024878|NCT03997058|GABA Modulators|gaba modulators|mesh-ancestor
93024879|NCT03997058|GABA Agents|gaba agents|mesh-ancestor
93024880|NCT03997058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024881|NCT03997058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024882|NCT00500760|Panitumumab|panitumumab|mesh-list
93024883|NCT00500760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024884|NCT00500760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93024885|NCT01016730|Bortezomib|bortezomib|mesh-list
93024886|NCT01016730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024887|NCT01012934|Alendronate|alendronate|mesh-list
93024888|NCT01012934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024889|NCT01012934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024890|NCT04334330|Trastuzumab|trastuzumab|mesh-list
93024891|NCT04334330|Fulvestrant|fulvestrant|mesh-list
93024892|NCT04334330|Palbociclib|palbociclib|mesh-list
93024893|NCT04334330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93024894|NCT04334330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024895|NCT04334330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93024896|NCT04334330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93024898|NCT04334330|Hormone Antagonists|hormone antagonists|mesh-ancestor
93024899|NCT04334330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93024900|NCT04334330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024901|NCT04334330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93024902|NCT04334330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024903|NCT04334330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024904|NCT01015196|Daunorubicin|daunorubicin|mesh-list
93024905|NCT01015196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93024906|NCT01015196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024907|NCT01015196|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93024908|NCT01015196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93024909|NCT01015196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024910|NCT01015196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024911|NCT01009892|Codeine|codeine|mesh-list
93024912|NCT01009892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93024913|NCT01009892|Narcotics|narcotics|mesh-ancestor
93024914|NCT01009892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93024915|NCT01009892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024916|NCT01009892|Analgesics|analgesics|mesh-ancestor
93024917|NCT01009892|Sensory System Agents|sensory system agents|mesh-ancestor
93024918|NCT01009892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024919|NCT01009892|Antitussive Agents|antitussive agents|mesh-ancestor
93024920|NCT01009892|Respiratory System Agents|respiratory system agents|mesh-ancestor
93024921|NCT00307684|Methylphenidate|methylphenidate|mesh-list
93024922|NCT00307684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93024923|NCT00307684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024924|NCT00307684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93024925|NCT00307684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93024926|NCT00307684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93024927|NCT00307684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024928|NCT00307684|Dopamine Agents|dopamine agents|mesh-ancestor
92181454|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024929|NCT00307684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93024930|NCT00489918|Teriparatide|teriparatide|mesh-list
93024931|NCT00489918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93024932|NCT00489918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024933|NCT00489918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93024934|NCT01061788|Everolimus|everolimus|mesh-list
93024935|NCT01061788|Panitumumab|panitumumab|mesh-list
93024936|NCT01061788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93024937|NCT01061788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93024938|NCT01061788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024939|NCT01061788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024940|NCT01061788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024941|NCT01061788|Immunologic Factors|immunologic factors|mesh-ancestor
93024942|NCT01061788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024943|NCT01061788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024944|NCT01061788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93024945|NCT00307294|Thalidomide|thalidomide|mesh-list
93024946|NCT00307294|Doxorubicin|doxorubicin|mesh-list
93024947|NCT00307294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93024948|NCT00307294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024949|NCT00307294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93024950|NCT00307294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93024951|NCT00307294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024952|NCT00307294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024953|NCT00307294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024954|NCT00307294|Immunologic Factors|immunologic factors|mesh-ancestor
93024955|NCT00307294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024956|NCT00307294|Leprostatic Agents|leprostatic agents|mesh-ancestor
93024957|NCT00307294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93024958|NCT00307294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93024959|NCT00307294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93024960|NCT00307294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93024961|NCT00307294|Growth Substances|growth substances|mesh-ancestor
93024962|NCT00307294|Growth Inhibitors|growth inhibitors|mesh-ancestor
93024963|NCT03981094|Pirfenidone|pirfenidone|mesh-list
93024964|NCT03981094|Analgesics|analgesics|mesh-ancestor
93024965|NCT03981094|Sensory System Agents|sensory system agents|mesh-ancestor
93024966|NCT03981094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024967|NCT03981094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024968|NCT03981094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93024969|NCT03981094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024970|NCT03981094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181488|NCT01660893|Mydriatics|mydriatics|mesh-ancestor
93024971|NCT03981094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024972|NCT03981094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93024973|NCT03963401|PF-06700841|pf-06700841|mesh-list
93024974|NCT03963401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93024975|NCT03963401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93024976|NCT03963401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93024977|NCT04410965|Teriflunomide|teriflunomide|mesh-list
93024978|NCT04410965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93024979|NCT04410965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93024980|NCT04410965|Analgesics|analgesics|mesh-ancestor
93024981|NCT04410965|Sensory System Agents|sensory system agents|mesh-ancestor
93024982|NCT04410965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93024983|NCT04410965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024984|NCT04410965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93024985|NCT04410965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93024986|NCT04410965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93024987|NCT04410965|Immunologic Factors|immunologic factors|mesh-ancestor
93024988|NCT04012775|Insulin|insulin|mesh-list
93024989|NCT04012775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93024990|NCT04012775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93024991|NCT04012775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024992|NCT00944723|Vitamins|vitamins|mesh-list
93024993|NCT00944723|Zinc|zinc|mesh-list
93024994|NCT00944723|Vitamin B Complex|vitamin b complex|mesh-list
93024995|NCT00944723|Zinc Sulfate|zinc sulfate|mesh-list
93024996|NCT00944723|Micronutrients|micronutrients|mesh-ancestor
93024997|NCT00944723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93024998|NCT00944723|Trace Elements|trace elements|mesh-ancestor
93024999|NCT00944723|Astringents|astringents|mesh-ancestor
93025000|NCT00944723|Dermatologic Agents|dermatologic agents|mesh-ancestor
93025001|NCT00944801|Doxorubicin|doxorubicin|mesh-list
93025002|NCT00944801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93025003|NCT00944801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025004|NCT00944801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025005|NCT00944801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93025006|NCT00944801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93025007|NCT00944801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025008|NCT00944801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025009|NCT01060228|Valproic Acid|valproic acid|mesh-list
93025010|NCT01060228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93025011|NCT01060228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93025012|NCT01060228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93025013|NCT01060228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025014|NCT01060228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025015|NCT01060228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025016|NCT01060228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93025017|NCT01060228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93025018|NCT01060228|Serotonin Agents|serotonin agents|mesh-ancestor
93025019|NCT01060228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025020|NCT01060228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025021|NCT01060228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93025022|NCT01060228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93025023|NCT01060228|Dopamine Agents|dopamine agents|mesh-ancestor
93025024|NCT01060228|Anticonvulsants|anticonvulsants|mesh-ancestor
93025025|NCT01060228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025026|NCT01060228|GABA Agents|gaba agents|mesh-ancestor
93025027|NCT01060228|Antimanic Agents|antimanic agents|mesh-ancestor
93025028|NCT00306670|Prednisone|prednisone|mesh-list
93025029|NCT00306670|Rituximab|rituximab|mesh-list
93025030|NCT00306670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025031|NCT00306670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025032|NCT00306670|Immunologic Factors|immunologic factors|mesh-ancestor
93025033|NCT00306670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025034|NCT00306670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025035|NCT00306670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025036|NCT00306670|Glucocorticoids|glucocorticoids|mesh-ancestor
93025037|NCT00306670|Hormones|hormones|mesh-ancestor
93025038|NCT00306670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025039|NCT00306670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025040|NCT00306592|Natalizumab|natalizumab|mesh-list
93025041|NCT00306592|Immunologic Factors|immunologic factors|mesh-ancestor
93025042|NCT00306592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025043|NCT00321646|Bevacizumab|bevacizumab|mesh-list
93025045|NCT00321646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025046|NCT00321646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025047|NCT00321646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025048|NCT00321646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025049|NCT00321646|Growth Substances|growth substances|mesh-ancestor
93025050|NCT00321646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025051|NCT00321646|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025052|NCT00321646|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025053|NCT00321646|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025054|NCT00321646|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025055|NCT00321646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025056|NCT00403767|Warfarin|warfarin|mesh-list
93025057|NCT00403767|Rivaroxaban|rivaroxaban|mesh-list
93025058|NCT00403767|Anticoagulants|anticoagulants|mesh-ancestor
93025059|NCT00403767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93025060|NCT00403767|Antithrombins|antithrombins|mesh-ancestor
93025061|NCT00403767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93025062|NCT00403767|Protease Inhibitors|protease inhibitors|mesh-ancestor
93025063|NCT00403767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025064|NCT00403767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025065|NCT00492284|Dexamethasone|dexamethasone|mesh-list
93025066|NCT00492284|Ranibizumab|ranibizumab|mesh-list
93025067|NCT00492284|Verteporfin|verteporfin|mesh-list
93025068|NCT00492284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025069|NCT00492284|Antiemetics|antiemetics|mesh-ancestor
93025070|NCT00492284|Autonomic Agents|autonomic agents|mesh-ancestor
93025071|NCT00492284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025072|NCT00492284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025073|NCT00492284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025074|NCT00492284|Glucocorticoids|glucocorticoids|mesh-ancestor
93025075|NCT00492284|Hormones|hormones|mesh-ancestor
93025076|NCT00492284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025077|NCT00492284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025078|NCT00492284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025079|NCT00492284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025080|NCT00492284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025081|NCT00492284|Growth Substances|growth substances|mesh-ancestor
93025082|NCT00492284|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025083|NCT00492284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93025084|NCT00492284|Dermatologic Agents|dermatologic agents|mesh-ancestor
93025085|NCT01013012|Dexamethasone|dexamethasone|mesh-list
93025086|NCT01013012|Ramosetron|ramosetron|mesh-list
93025087|NCT01013012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025088|NCT01013012|Antiemetics|antiemetics|mesh-ancestor
93025089|NCT01013012|Autonomic Agents|autonomic agents|mesh-ancestor
93025090|NCT01013012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025091|NCT01013012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025092|NCT01013012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025093|NCT01013012|Glucocorticoids|glucocorticoids|mesh-ancestor
93025094|NCT01013012|Hormones|hormones|mesh-ancestor
93025095|NCT01013012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025096|NCT01013012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025097|NCT01013012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025098|NCT01013012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93025099|NCT01013012|Serotonin Agents|serotonin agents|mesh-ancestor
93025100|NCT01013012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025101|NCT01013012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025102|NCT01009970|Prednisone|prednisone|mesh-list
93025103|NCT01009970|Cyclophosphamide|cyclophosphamide|mesh-list
93025104|NCT01009970|Rituximab|rituximab|mesh-list
93025105|NCT01009970|Doxorubicin|doxorubicin|mesh-list
93025106|NCT01009970|Vincristine|vincristine|mesh-list
93025107|NCT01009970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025108|NCT01009970|Immunologic Factors|immunologic factors|mesh-ancestor
93025109|NCT01009970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025110|NCT01009970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025111|NCT01009970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93025113|NCT01009970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025114|NCT01009970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025115|NCT01009970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93025116|NCT01009970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670391|NCT00302705|Valsartan|valsartan|mesh-list
93025117|NCT01009970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025118|NCT01009970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93025119|NCT01009970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93025120|NCT01009970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025121|NCT01009970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025122|NCT01009970|Glucocorticoids|glucocorticoids|mesh-ancestor
93025124|NCT01009970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025125|NCT01009970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025126|NCT01009970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93025127|NCT01009970|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025128|NCT01009970|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025129|NCT01009970|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025130|NCT01015352|Azacitidine|azacitidine|mesh-list
93025131|NCT01015352|Epoetin Alfa|epoetin alfa|mesh-list
93025132|NCT01015352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025133|NCT01015352|Antimetabolites|antimetabolites|mesh-ancestor
93025134|NCT01015352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025135|NCT01015352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025136|NCT01015352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025137|NCT01015352|Hematinics|hematinics|mesh-ancestor
93025138|NCT03563157|Leucovorin|leucovorin|mesh-list
93025139|NCT03563157|Paclitaxel|paclitaxel|mesh-list
93025140|NCT03563157|Cyclophosphamide|cyclophosphamide|mesh-list
93025141|NCT03563157|Fluorouracil|fluorouracil|mesh-list
93025142|NCT03563157|Capecitabine|capecitabine|mesh-list
93025143|NCT03563157|Oxaliplatin|oxaliplatin|mesh-list
93025144|NCT03563157|Cetuximab|cetuximab|mesh-list
93025145|NCT03563157|Avelumab|avelumab|mesh-list
93025146|NCT03563157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93025147|NCT03563157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025148|NCT03563157|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025149|NCT03563157|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025150|NCT03563157|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025151|NCT03563157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025152|NCT03563157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181619|NCT01664559|Ketorolac|ketorolac|mesh-list
93025153|NCT03563157|Immunologic Factors|immunologic factors|mesh-ancestor
93025154|NCT03563157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025155|NCT03563157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025156|NCT03563157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93025157|NCT03563157|Alkylating Agents|alkylating agents|mesh-ancestor
93025158|NCT03563157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93025159|NCT03563157|Antimetabolites|antimetabolites|mesh-ancestor
93025160|NCT03563157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025161|NCT03563157|Antidotes|antidotes|mesh-ancestor
93025162|NCT03563157|Protective Agents|protective agents|mesh-ancestor
93025163|NCT03563157|Vitamin B Complex|vitamin b complex|mesh-ancestor
93025164|NCT03563157|Vitamins|vitamins|mesh-ancestor
93025165|NCT03563157|Micronutrients|micronutrients|mesh-ancestor
93025166|NCT03563157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025167|NCT01010048|Nifedipine|nifedipine|mesh-list
93025168|NCT01010048|Bromides|bromides|mesh-list
93025169|NCT01010048|Propantheline|propantheline|mesh-list
93025170|NCT01010048|Tamsulosin|tamsulosin|mesh-list
93025171|NCT01010048|Progesterone|progesterone|mesh-list
93025172|NCT01010048|Progestins|progestins|mesh-ancestor
93025173|NCT01010048|Hormones|hormones|mesh-ancestor
93025174|NCT01010048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025175|NCT01010048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025176|NCT01010048|Anticonvulsants|anticonvulsants|mesh-ancestor
93025177|NCT01010048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93025178|NCT01010048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93025179|NCT01010048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93025180|NCT01010048|Adrenergic Agents|adrenergic agents|mesh-ancestor
93025181|NCT01010048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025182|NCT01010048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025183|NCT01010048|Urological Agents|urological agents|mesh-ancestor
93025184|NCT01010048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93025185|NCT01010048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92528939|NCT00000926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93025186|NCT01010048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93025188|NCT01010048|Tocolytic Agents|tocolytic agents|mesh-ancestor
93025189|NCT01010048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93025190|NCT01010048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93025191|NCT01010048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025192|NCT01010048|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93025193|NCT01010048|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92670474|NCT00303290|Cytarabine|cytarabine|mesh-list
93025194|NCT01010048|Cholinergic Agents|cholinergic agents|mesh-ancestor
93025195|NCT01589055|Nicotine|nicotine|mesh-list
92181646|NCT01894685|Analgesics|analgesics|mesh-ancestor
93025196|NCT01589055|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93025197|NCT01589055|Autonomic Agents|autonomic agents|mesh-ancestor
93025198|NCT01589055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025199|NCT01589055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025200|NCT01589055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93025201|NCT01589055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93025202|NCT01589055|Cholinergic Agents|cholinergic agents|mesh-ancestor
93025203|NCT01589055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025204|NCT01589055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025205|NCT00414765|Aldesleukin|aldesleukin|mesh-list
93025206|NCT00414765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025207|NCT00414765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93025208|NCT00414765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93025209|NCT00414765|Antiviral Agents|antiviral agents|mesh-ancestor
93025210|NCT00414765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025211|NCT03997292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93025212|NCT03997292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93025213|NCT03997292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93025214|NCT03997292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025215|NCT01013402|Insulin|insulin|mesh-list
93025216|NCT01013402|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93025217|NCT01013402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93025218|NCT01013402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025219|NCT01013480|Baclofen|baclofen|mesh-list
93025220|NCT01013480|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93025221|NCT01013480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025222|NCT01013480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93025223|NCT01013480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025224|NCT01013480|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93025225|NCT01013480|GABA Agonists|gaba agonists|mesh-ancestor
93025226|NCT01013480|GABA Agents|gaba agents|mesh-ancestor
93025227|NCT01013480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025228|NCT01013480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025229|NCT00500370|Exenatide|exenatide|mesh-list
93025230|NCT00500370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93025231|NCT00500370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025232|NCT00500370|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93025233|NCT00500370|Incretins|incretins|mesh-ancestor
93025234|NCT00500370|Hormones|hormones|mesh-ancestor
93025235|NCT00500370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025236|NCT00320788|Aflibercept|aflibercept|mesh-list
93025237|NCT00320788|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025238|NCT00320788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025239|NCT00320788|Growth Substances|growth substances|mesh-ancestor
93025240|NCT00320788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025241|NCT00320788|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025242|NCT00320788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025243|NCT03996486|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
93025244|NCT03996486|Immunoglobulins|immunoglobulins|mesh-list
93025245|NCT03996486|Immunoglobulin G|immunoglobulin g|mesh-list
93025246|NCT03996486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93025247|NCT03996486|Myeloma Proteins|myeloma proteins|mesh-list
93025248|NCT03996486|Paraproteins|paraproteins|mesh-list
93025249|NCT03996486|Immunologic Factors|immunologic factors|mesh-ancestor
93025250|NCT03996486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025251|NCT03996486|Anticoagulants|anticoagulants|mesh-ancestor
93025252|NCT03996486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93025253|NCT03996486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93025254|NCT03996486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025255|NCT03996486|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93025256|NCT03996486|Protease Inhibitors|protease inhibitors|mesh-ancestor
93025257|NCT03996486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025258|NCT03996486|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93025259|NCT03996486|Antithrombins|antithrombins|mesh-ancestor
93025260|NCT01014468|Bevacizumab|bevacizumab|mesh-list
93025261|NCT01014468|Ranibizumab|ranibizumab|mesh-list
93025262|NCT01014468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025263|NCT01014468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025264|NCT01014468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025265|NCT01014468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025266|NCT01014468|Growth Substances|growth substances|mesh-ancestor
93025267|NCT01014468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025268|NCT01014468|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025270|NCT00503984|Docetaxel|docetaxel|mesh-list
93025271|NCT00503984|Azacitidine|azacitidine|mesh-list
92670538|NCT00303758|Gemcitabine|gemcitabine|mesh-list
93025272|NCT00503984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025273|NCT00503984|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025274|NCT00503984|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025275|NCT00503984|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025276|NCT00503984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025277|NCT00503984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025279|NCT00503984|Hormones|hormones|mesh-ancestor
93025280|NCT00503984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025281|NCT00503984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181713|NCT01605903|Analgesics|analgesics|mesh-ancestor
93025282|NCT00503984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025283|NCT00503984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025284|NCT00503984|Antimetabolites|antimetabolites|mesh-ancestor
93025285|NCT00503984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025286|NCT03996564|Acetaminophen|acetaminophen|mesh-list
93025287|NCT03996564|Diclofenac|diclofenac|mesh-list
93025288|NCT03996564|Ketorolac|ketorolac|mesh-list
93025289|NCT03996564|Diazepam|diazepam|mesh-list
93025290|NCT03996564|Hydrocodone|hydrocodone|mesh-list
93025291|NCT03996564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025292|NCT03996564|Analgesics|analgesics|mesh-ancestor
93025293|NCT03996564|Sensory System Agents|sensory system agents|mesh-ancestor
93025294|NCT03996564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025295|NCT03996564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025296|NCT03996564|Antipyretics|antipyretics|mesh-ancestor
93025297|NCT03996564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93025298|NCT03996564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025299|NCT03996564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025300|NCT03996564|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93025301|NCT03996564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025302|NCT03996564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025303|NCT03996564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93025304|NCT03996564|Narcotics|narcotics|mesh-ancestor
93025305|NCT03996564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025306|NCT03996564|Antitussive Agents|antitussive agents|mesh-ancestor
93025307|NCT03996564|Respiratory System Agents|respiratory system agents|mesh-ancestor
93025308|NCT03996564|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93025309|NCT03996564|Anticonvulsants|anticonvulsants|mesh-ancestor
93025310|NCT03996564|Antiemetics|antiemetics|mesh-ancestor
93025311|NCT03996564|Autonomic Agents|autonomic agents|mesh-ancestor
93025312|NCT03996564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025313|NCT03996564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93025314|NCT03996564|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93025315|NCT03996564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93025316|NCT03996564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93025317|NCT03996564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93025318|NCT03996564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025319|NCT03996564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93025320|NCT03996564|Anesthetics, General|anesthetics, general|mesh-ancestor
93025321|NCT03996564|Anesthetics|anesthetics|mesh-ancestor
93025322|NCT03996564|GABA Modulators|gaba modulators|mesh-ancestor
93025323|NCT03996564|GABA Agents|gaba agents|mesh-ancestor
93025324|NCT03996564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025325|NCT00565409|Etanercept|etanercept|mesh-list
93025326|NCT00565409|Methotrexate|methotrexate|mesh-list
93025327|NCT00565409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93025328|NCT00565409|Abortifacient Agents|abortifacient agents|mesh-ancestor
93025329|NCT00565409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93025330|NCT00565409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025331|NCT00565409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025332|NCT00565409|Antimetabolites|antimetabolites|mesh-ancestor
93025333|NCT00565409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025334|NCT00565409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025335|NCT00565409|Dermatologic Agents|dermatologic agents|mesh-ancestor
93025336|NCT00565409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025337|NCT00565409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93025338|NCT00565409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025339|NCT00565409|Immunologic Factors|immunologic factors|mesh-ancestor
93025340|NCT00565409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025341|NCT00565409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93025342|NCT00565409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93025343|NCT00565409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025344|NCT00565409|Analgesics|analgesics|mesh-ancestor
93025345|NCT00565409|Sensory System Agents|sensory system agents|mesh-ancestor
93025346|NCT00565409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025347|NCT00565409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025348|NCT00565409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025349|NCT00394251|Paclitaxel|paclitaxel|mesh-list
93025350|NCT00394251|Cyclophosphamide|cyclophosphamide|mesh-list
93025351|NCT00394251|Bevacizumab|bevacizumab|mesh-list
93025352|NCT00394251|Doxorubicin|doxorubicin|mesh-list
93025353|NCT00394251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93025354|NCT00394251|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93025355|NCT00394251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93025356|NCT00394251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025357|NCT00394251|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025358|NCT00394251|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025359|NCT00394251|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025360|NCT00394251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025361|NCT00394251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025362|NCT00394251|Immunologic Factors|immunologic factors|mesh-ancestor
93025363|NCT00394251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025364|NCT00394251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025365|NCT00394251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93025366|NCT00394251|Alkylating Agents|alkylating agents|mesh-ancestor
93025367|NCT00394251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93025368|NCT00394251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025369|NCT00394251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025370|NCT00394251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025371|NCT00394251|Growth Substances|growth substances|mesh-ancestor
93025372|NCT00394251|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025373|NCT00394251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025374|NCT00394251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93025375|NCT00394251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93025376|NCT00394251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025377|NCT02532400|Goserelin|goserelin|mesh-list
93025378|NCT02532400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025379|NCT02532400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025380|NCT00394095|Topiramate|topiramate|mesh-list
93025381|NCT00394095|Anticonvulsants|anticonvulsants|mesh-ancestor
93025382|NCT00394095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93025383|NCT00394095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025384|NCT00503906|Paclitaxel|paclitaxel|mesh-list
93025385|NCT00503906|Bevacizumab|bevacizumab|mesh-list
93025386|NCT00503906|Gemcitabine|gemcitabine|mesh-list
93025387|NCT00503906|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93025388|NCT00503906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93025389|NCT00503906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025390|NCT00503906|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025391|NCT00503906|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025392|NCT00503906|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025393|NCT00503906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025394|NCT00503906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025395|NCT00503906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025396|NCT00503906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025397|NCT00503906|Growth Substances|growth substances|mesh-ancestor
93025398|NCT00503906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025399|NCT00503906|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025400|NCT00503906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025401|NCT00503906|Antimetabolites|antimetabolites|mesh-ancestor
93025402|NCT00305110|Hydromorphone|hydromorphone|mesh-list
93025403|NCT00305110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93025404|NCT00305110|Narcotics|narcotics|mesh-ancestor
93025405|NCT00305110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025406|NCT00305110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025407|NCT00305110|Analgesics|analgesics|mesh-ancestor
93025408|NCT00305110|Sensory System Agents|sensory system agents|mesh-ancestor
93025409|NCT00305110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025410|NCT03984760|Sevelamer|sevelamer|mesh-list
93025411|NCT03984760|Chelating Agents|chelating agents|mesh-ancestor
93025412|NCT03984760|Sequestering Agents|sequestering agents|mesh-ancestor
93025413|NCT03984760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025414|NCT00491894|Glycopyrrolate|glycopyrrolate|mesh-list
93025415|NCT00491894|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93025416|NCT00491894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93025417|NCT00491894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93025418|NCT00491894|Cholinergic Agents|cholinergic agents|mesh-ancestor
93025419|NCT00491894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025420|NCT00491894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025421|NCT00491894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025422|NCT01060618|Maraviroc|maraviroc|mesh-list
93025423|NCT01060618|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93025424|NCT01060618|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93025425|NCT01060618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025426|NCT01060618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93025427|NCT01060618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93025428|NCT01060618|Antiviral Agents|antiviral agents|mesh-ancestor
93025429|NCT01060618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025430|NCT01060618|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93025431|NCT00491504|Mometasone Furoate|mometasone furoate|mesh-list
93025432|NCT00491504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025433|NCT00491504|Dermatologic Agents|dermatologic agents|mesh-ancestor
93025434|NCT00491504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93025435|NCT00500292|Leucovorin|leucovorin|mesh-list
93025436|NCT00500292|Folic Acid|folic acid|mesh-list
93025437|NCT00500292|Fluorouracil|fluorouracil|mesh-list
93025438|NCT00500292|Oxaliplatin|oxaliplatin|mesh-list
93025439|NCT00500292|Levoleucovorin|levoleucovorin|mesh-list
93025440|NCT00500292|Antimetabolites|antimetabolites|mesh-ancestor
93025441|NCT00500292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025442|NCT00500292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025443|NCT00500292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025444|NCT00500292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025445|NCT00500292|Immunologic Factors|immunologic factors|mesh-ancestor
93025446|NCT00500292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025447|NCT00500292|Antidotes|antidotes|mesh-ancestor
93025448|NCT00500292|Protective Agents|protective agents|mesh-ancestor
93025449|NCT00500292|Vitamin B Complex|vitamin b complex|mesh-ancestor
93025450|NCT00500292|Vitamins|vitamins|mesh-ancestor
93025451|NCT00500292|Micronutrients|micronutrients|mesh-ancestor
93025452|NCT00500292|Hematinics|hematinics|mesh-ancestor
93025453|NCT01013558|Remifentanil|remifentanil|mesh-list
93025454|NCT01013558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93025455|NCT01013558|Narcotics|narcotics|mesh-ancestor
93025456|NCT01013558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025457|NCT01013558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025458|NCT01013558|Analgesics|analgesics|mesh-ancestor
93025459|NCT01013558|Sensory System Agents|sensory system agents|mesh-ancestor
93025460|NCT01013558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025461|NCT00499746|Tramadol|tramadol|mesh-list
93025462|NCT00499746|Hydromorphone|hydromorphone|mesh-list
93025463|NCT00499746|Methylphenidate|methylphenidate|mesh-list
93025464|NCT00499746|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93025465|NCT00499746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025466|NCT00499746|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93025467|NCT00499746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93025468|NCT00499746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93025469|NCT00499746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025470|NCT00499746|Dopamine Agents|dopamine agents|mesh-ancestor
93025471|NCT00499746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025472|NCT00499746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93025473|NCT00499746|Narcotics|narcotics|mesh-ancestor
92181905|NCT05556408|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93025474|NCT00499746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025475|NCT00499746|Analgesics|analgesics|mesh-ancestor
93025476|NCT00499746|Sensory System Agents|sensory system agents|mesh-ancestor
93025477|NCT00499746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025479|NCT01010516|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93025480|NCT01010516|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
93025481|NCT01010516|Fenofibrate|fenofibrate|mesh-list
93025482|NCT01010516|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93025483|NCT01010516|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93025484|NCT01010516|Antimetabolites|antimetabolites|mesh-ancestor
93025485|NCT01010516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025486|NCT01010516|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93025487|NCT01010516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025488|NCT01010516|Vasodilator Agents|vasodilator agents|mesh-ancestor
93025489|NCT01010516|Vitamin B Complex|vitamin b complex|mesh-ancestor
93025490|NCT01010516|Vitamins|vitamins|mesh-ancestor
93025491|NCT01010516|Micronutrients|micronutrients|mesh-ancestor
93025492|NCT01010516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025493|NCT01020162|Gabapentin|gabapentin|mesh-list
93025494|NCT01020162|Amitriptyline|amitriptyline|mesh-list
93025495|NCT01020162|Analgesics|analgesics|mesh-ancestor
93025496|NCT01020162|Sensory System Agents|sensory system agents|mesh-ancestor
93025497|NCT01020162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025498|NCT01020162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025499|NCT01020162|Anticonvulsants|anticonvulsants|mesh-ancestor
93025500|NCT01020162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93025501|NCT01020162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93025502|NCT01020162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025503|NCT01020162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025504|NCT01020162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93025505|NCT01020162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93025506|NCT01020162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025507|NCT01020162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025508|NCT01020162|Antimanic Agents|antimanic agents|mesh-ancestor
93025509|NCT01020162|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93025510|NCT01020162|Antidepressive Agents|antidepressive agents|mesh-ancestor
93025511|NCT01020162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025512|NCT01020162|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93025513|NCT01020162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93025514|NCT01020162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93025515|NCT01020162|Adrenergic Agents|adrenergic agents|mesh-ancestor
93025516|NCT01016886|Bisoprolol|bisoprolol|mesh-list
93025517|NCT01016886|Perindopril|perindopril|mesh-list
93025518|NCT01016886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93025519|NCT01016886|Sympatholytics|sympatholytics|mesh-ancestor
93025520|NCT01016886|Autonomic Agents|autonomic agents|mesh-ancestor
93025521|NCT01016886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025522|NCT01016886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025523|NCT01016886|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93025524|NCT01016886|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93025525|NCT01016886|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93025526|NCT01016886|Adrenergic Agents|adrenergic agents|mesh-ancestor
93025527|NCT01016886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025528|NCT01016886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025529|NCT01016886|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93025530|NCT01016886|Protease Inhibitors|protease inhibitors|mesh-ancestor
93025531|NCT01016886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025532|NCT00499590|Ranibizumab|ranibizumab|mesh-list
93025533|NCT00499590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025534|NCT00499590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025535|NCT00499590|Growth Substances|growth substances|mesh-ancestor
93025536|NCT00499590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025537|NCT00499590|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025538|NCT00499590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025539|NCT00510146|Olanzapine|olanzapine|mesh-list
93025540|NCT00510146|Antiemetics|antiemetics|mesh-ancestor
93025541|NCT00510146|Autonomic Agents|autonomic agents|mesh-ancestor
93025542|NCT00510146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025543|NCT00510146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025544|NCT00510146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025545|NCT00510146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93025546|NCT00510146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93025547|NCT00510146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025548|NCT00510146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025549|NCT00510146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93025550|NCT00510146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93025551|NCT00510146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93025552|NCT00510146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025553|NCT00510146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025554|NCT00510146|Serotonin Agents|serotonin agents|mesh-ancestor
93025555|NCT04250064|Bevacizumab|bevacizumab|mesh-list
93025556|NCT04250064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025557|NCT04250064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025558|NCT04250064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025559|NCT04250064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025560|NCT04250064|Growth Substances|growth substances|mesh-ancestor
93025561|NCT04250064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025562|NCT04250064|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025564|NCT00480636|Tinzaparin|tinzaparin|mesh-list
93025565|NCT00480636|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93025566|NCT00480636|Anticoagulants|anticoagulants|mesh-ancestor
93025567|NCT00480636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93025568|NCT00480636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93025569|NCT00480636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025570|NCT01017198|Antacids|antacids|mesh-list
93025571|NCT01017198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025572|NCT01017198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025573|NCT00499122|Cyclophosphamide|cyclophosphamide|mesh-list
93025574|NCT00499122|Docetaxel|docetaxel|mesh-list
92670834|NCT00329316|Progesterone|progesterone|mesh-list
93025575|NCT00499122|Doxorubicin|doxorubicin|mesh-list
93025576|NCT00499122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025577|NCT00499122|Immunologic Factors|immunologic factors|mesh-ancestor
93025578|NCT00499122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025579|NCT00499122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025580|NCT00499122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93025581|NCT00499122|Alkylating Agents|alkylating agents|mesh-ancestor
93025582|NCT00499122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025583|NCT00499122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025584|NCT00499122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93025585|NCT00499122|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025586|NCT00499122|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025587|NCT00499122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182012|NCT04739670|Bevacizumab|bevacizumab|mesh-list
93025588|NCT00499122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025589|NCT00499122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93025590|NCT00499122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93025591|NCT00499122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025592|NCT00393939|Docetaxel|docetaxel|mesh-list
93025593|NCT00393939|Sunitinib|sunitinib|mesh-list
93025594|NCT00393939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025595|NCT00393939|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025596|NCT00393939|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025597|NCT00393939|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025598|NCT00393939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025599|NCT00393939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025600|NCT00393939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025601|NCT00393939|Growth Substances|growth substances|mesh-ancestor
93025602|NCT00393939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025603|NCT00393939|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025604|NCT00393939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93025605|NCT00393939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025606|NCT00488982|Docetaxel|docetaxel|mesh-list
93025607|NCT00488982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025608|NCT00488982|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025609|NCT00488982|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025610|NCT00488982|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025611|NCT00488982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025612|NCT00488826|Vaccines|vaccines|mesh-list
93025613|NCT00488826|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93025614|NCT00488826|Immunologic Factors|immunologic factors|mesh-ancestor
93025615|NCT00488826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025616|NCT01017354|Calcifediol|calcifediol|mesh-list
93025617|NCT01017354|Vitamins|vitamins|mesh-ancestor
93025618|NCT01017354|Micronutrients|micronutrients|mesh-ancestor
93025619|NCT01017354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025620|NCT01017354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93025621|NCT00393861|Bevacizumab|bevacizumab|mesh-list
93025622|NCT00393861|Oxaliplatin|oxaliplatin|mesh-list
93025623|NCT00393861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025624|NCT00393861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025625|NCT00393861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025626|NCT00393861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025627|NCT00393861|Growth Substances|growth substances|mesh-ancestor
93025628|NCT00393861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025629|NCT00393861|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025630|NCT01040559|Idarubicin|idarubicin|mesh-list
93025631|NCT01040559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025633|NCT01040559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93025634|NCT01040559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93025635|NCT01040559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025636|NCT01040559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025637|NCT01020396|Metronidazole|metronidazole|mesh-list
93025638|NCT01020396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025639|NCT01020396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93025640|NCT01020396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93025641|NCT01020396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93025642|NCT00488592|Molgramostim|molgramostim|mesh-list
93025643|NCT00488592|Sargramostim|sargramostim|mesh-list
93025644|NCT00488592|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93025645|NCT00488592|Immunologic Factors|immunologic factors|mesh-ancestor
93025646|NCT00488592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025647|NCT00488592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025648|NCT00488592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93025649|NCT00488514|Naproxen|naproxen|mesh-list
93025650|NCT00488514|Sumatriptan|sumatriptan|mesh-list
92670904|NCT00305396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025651|NCT00488514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93025652|NCT00488514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025654|NCT00488514|Sensory System Agents|sensory system agents|mesh-ancestor
93025655|NCT00488514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025656|NCT00488514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025657|NCT00488514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025658|NCT00488514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025659|NCT00488514|Gout Suppressants|gout suppressants|mesh-ancestor
93025660|NCT00488514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93025661|NCT00488514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025662|NCT00488514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025663|NCT00488514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93025664|NCT00488514|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93025665|NCT00488514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93025666|NCT00488514|Serotonin Agents|serotonin agents|mesh-ancestor
93025667|NCT00488514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025668|NCT00320710|Zoledronic Acid|zoledronic acid|mesh-list
93025669|NCT00320710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93025670|NCT00320710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025671|NCT00320398|PENTA|penta|mesh-list
93025672|NCT00320398|Fondaparinux|fondaparinux|mesh-list
93025673|NCT00320398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93025674|NCT00320398|Antithrombins|antithrombins|mesh-ancestor
93025675|NCT00320398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93025676|NCT00320398|Protease Inhibitors|protease inhibitors|mesh-ancestor
93025677|NCT00320398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025678|NCT00320398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025679|NCT00320398|Anticoagulants|anticoagulants|mesh-ancestor
93025680|NCT00320398|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93025681|NCT00320398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93025682|NCT00498186|Rotigotine|rotigotine|mesh-list
93025683|NCT00498186|Dopamine Agonists|dopamine agonists|mesh-ancestor
93025684|NCT00498186|Dopamine Agents|dopamine agents|mesh-ancestor
93025685|NCT00498186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025686|NCT00498186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025687|NCT00498186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025688|NCT03984526|Atropine|atropine|mesh-list
93025689|NCT03984526|Ephedrine|ephedrine|mesh-list
93025690|NCT03984526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93025691|NCT03984526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93025692|NCT03984526|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93025693|NCT03984526|Autonomic Agents|autonomic agents|mesh-ancestor
93025694|NCT03984526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025695|NCT03984526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025696|NCT03984526|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93025697|NCT03984526|Respiratory System Agents|respiratory system agents|mesh-ancestor
93025698|NCT03984526|Mydriatics|mydriatics|mesh-ancestor
93025699|NCT03984526|Parasympatholytics|parasympatholytics|mesh-ancestor
93025700|NCT03984526|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93025701|NCT03984526|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93025702|NCT03984526|Cholinergic Agents|cholinergic agents|mesh-ancestor
93025703|NCT03984526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025704|NCT03984526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025705|NCT03984526|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93025706|NCT03984526|Sympathomimetics|sympathomimetics|mesh-ancestor
93025707|NCT03984526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93025708|NCT03984526|Adrenergic Agents|adrenergic agents|mesh-ancestor
93025709|NCT01017666|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
93025710|NCT01017666|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93025711|NCT01017666|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93025712|NCT01017666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93025713|NCT01017666|Purinergic Agents|purinergic agents|mesh-ancestor
93025714|NCT01017666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025715|NCT01017666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025716|NCT01017666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025717|NCT01017744|Anesthetics|anesthetics|mesh-list
93025718|NCT01017744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025719|NCT01017744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025720|NCT00477594|Mipomersen|mipomersen|mesh-list
93025721|NCT00477594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93025722|NCT00477594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93025723|NCT00477594|Antimetabolites|antimetabolites|mesh-ancestor
93025724|NCT00477594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025725|NCT00477594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93025726|NCT00304954|Sirolimus|sirolimus|mesh-list
93025727|NCT00304954|Infliximab|infliximab|mesh-list
93025728|NCT00304954|Daclizumab|daclizumab|mesh-list
93025729|NCT00304954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93025730|NCT00304954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025731|NCT00304954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025732|NCT00304954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025733|NCT00304954|Antifungal Agents|antifungal agents|mesh-ancestor
93025734|NCT00304954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025735|NCT00304954|Immunologic Factors|immunologic factors|mesh-ancestor
93025736|NCT00304954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025737|NCT00304954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93025738|NCT00304954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025739|NCT00304954|Dermatologic Agents|dermatologic agents|mesh-ancestor
93025740|NCT00304954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025741|NCT00304954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025742|NCT00475176|Ribavirin|ribavirin|mesh-list
93025743|NCT00475176|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93025744|NCT00475176|Antimetabolites|antimetabolites|mesh-ancestor
93025745|NCT00475176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025746|NCT00475176|Antiviral Agents|antiviral agents|mesh-ancestor
93025747|NCT00475176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025748|NCT00393705|Insulin|insulin|mesh-list
93025749|NCT00393705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93025750|NCT00393705|Insulin Lispro|insulin lispro|mesh-list
93025751|NCT00393705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93025752|NCT00393705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025753|NCT00303628|Leucovorin|leucovorin|mesh-list
93025754|NCT00303628|Bevacizumab|bevacizumab|mesh-list
93025755|NCT00303628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93025756|NCT00303628|Fluorouracil|fluorouracil|mesh-list
93025757|NCT00303628|Oxaliplatin|oxaliplatin|mesh-list
93025758|NCT00303628|Antibodies|antibodies|mesh-list
93025759|NCT00303628|Immunoglobulins|immunoglobulins|mesh-list
93025760|NCT00303628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93025761|NCT00303628|Levoleucovorin|levoleucovorin|mesh-list
93025762|NCT00303628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025763|NCT00303628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93025764|NCT00303628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025765|NCT00303628|Growth Substances|growth substances|mesh-ancestor
93025766|NCT00303628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025767|NCT00303628|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025768|NCT00303628|Immunologic Factors|immunologic factors|mesh-ancestor
93025769|NCT00303628|Antimetabolites|antimetabolites|mesh-ancestor
93025770|NCT00303628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025771|NCT00303628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93025772|NCT00303628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025773|NCT00303628|Antidotes|antidotes|mesh-ancestor
93025774|NCT00303628|Protective Agents|protective agents|mesh-ancestor
93025775|NCT00303628|Vitamin B Complex|vitamin b complex|mesh-ancestor
93025776|NCT00303628|Vitamins|vitamins|mesh-ancestor
93025777|NCT00303628|Micronutrients|micronutrients|mesh-ancestor
93025778|NCT00414453|Lidocaine|lidocaine|mesh-list
93025779|NCT00414453|Oxycodone|oxycodone|mesh-list
93025780|NCT00414453|Anesthetics, Local|anesthetics, local|mesh-ancestor
93025781|NCT00414453|Anesthetics|anesthetics|mesh-ancestor
93025782|NCT00414453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93025783|NCT00414453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025784|NCT00414453|Sensory System Agents|sensory system agents|mesh-ancestor
93025785|NCT00414453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025786|NCT00414453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93025787|NCT00414453|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93025788|NCT00414453|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93025789|NCT00414453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93025790|NCT00414453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025791|NCT00414453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93025792|NCT00414453|Narcotics|narcotics|mesh-ancestor
93025793|NCT00414453|Analgesics|analgesics|mesh-ancestor
93025794|NCT01037595|Turmeric extract|turmeric extract|mesh-list
93025795|NCT01037595|Antioxidants|antioxidants|mesh-ancestor
93025796|NCT01037595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025797|NCT01037595|Protective Agents|protective agents|mesh-ancestor
93025798|NCT01037595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025799|NCT01041027|Paclitaxel|paclitaxel|mesh-list
93025800|NCT01041027|Carboplatin|carboplatin|mesh-list
93025801|NCT01041027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93025802|NCT01041027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025803|NCT01041027|Tubulin Modulators|tubulin modulators|mesh-ancestor
93025804|NCT01041027|Antimitotic Agents|antimitotic agents|mesh-ancestor
93025805|NCT01041027|Mitosis Modulators|mitosis modulators|mesh-ancestor
93025806|NCT01041027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025807|NCT00332488|Insulin|insulin|mesh-list
93025808|NCT00332488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93025809|NCT00332488|Metformin|metformin|mesh-list
93025810|NCT00332488|Secretagogues|secretagogues|mesh-list
93025811|NCT00332488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182179|NCT05554848|Magnesium Sulfate|magnesium sulfate|mesh-list
93025812|NCT00332488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025813|NCT00332332|Etanercept|etanercept|mesh-list
93025814|NCT00332332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93025815|NCT00332332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025816|NCT00332332|Analgesics|analgesics|mesh-ancestor
93025817|NCT00332332|Sensory System Agents|sensory system agents|mesh-ancestor
93025818|NCT00332332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025819|NCT00332332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025820|NCT00332332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025821|NCT00332332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025822|NCT00332332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025823|NCT00332332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025824|NCT00332332|Immunologic Factors|immunologic factors|mesh-ancestor
93025825|NCT00392925|Pramlintide|pramlintide|mesh-list
93025826|NCT00392925|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
93025827|NCT00392925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93025828|NCT00392925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025829|NCT00392925|Appetite Depressants|appetite depressants|mesh-ancestor
93025830|NCT00392925|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93025831|NCT00392925|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
93025832|NCT00392925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025833|NCT00474786|Sirolimus|sirolimus|mesh-list
93025834|NCT00474786|Sorafenib|sorafenib|mesh-list
93025835|NCT00474786|Temsirolimus|temsirolimus|mesh-list
93025836|NCT00474786|MTOR Inhibitors|mtor inhibitors|mesh-list
93025837|NCT00474786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025838|NCT00474786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93025839|NCT00474786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025840|NCT00474786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025841|NCT00474786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025842|NCT00474786|Immunologic Factors|immunologic factors|mesh-ancestor
93025843|NCT00474786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025844|NCT00474786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93025845|NCT00474786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025846|NCT00474786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93025847|NCT00474786|Antifungal Agents|antifungal agents|mesh-ancestor
93025848|NCT00392769|Cetuximab|cetuximab|mesh-list
93025849|NCT00392769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025850|NCT00392769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025851|NCT01041183|Ramosetron|ramosetron|mesh-list
93025852|NCT01041183|Antiemetics|antiemetics|mesh-ancestor
93025853|NCT01041183|Autonomic Agents|autonomic agents|mesh-ancestor
93025854|NCT01041183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025855|NCT01041183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025856|NCT01041183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025857|NCT01041183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93025858|NCT01041183|Serotonin Agents|serotonin agents|mesh-ancestor
93025859|NCT01041183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025860|NCT01041183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025862|NCT00319696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93025863|NCT00319696|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93025864|NCT00319696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025865|NCT00474630|Naltrexone|naltrexone|mesh-list
93025866|NCT00474630|Bupropion|bupropion|mesh-list
93025867|NCT00474630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93025868|NCT00474630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93025869|NCT00474630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025870|NCT00474630|Sensory System Agents|sensory system agents|mesh-ancestor
93025871|NCT00474630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025872|NCT00474630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93025873|NCT00474630|Antidepressive Agents|antidepressive agents|mesh-ancestor
93025874|NCT00474630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025875|NCT00474630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93025876|NCT00474630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93025877|NCT00474630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93025878|NCT00474630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025879|NCT00474630|Dopamine Agents|dopamine agents|mesh-ancestor
93025880|NCT00474630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025881|NCT00474630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93025882|NCT00474630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93025883|NCT00474630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025884|NCT01064752|Minocycline|minocycline|mesh-list
93025885|NCT01064752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93025886|NCT01064752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025887|NCT00392379|Nicotine|nicotine|mesh-list
93025888|NCT00392379|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93025889|NCT00392379|Autonomic Agents|autonomic agents|mesh-ancestor
93025890|NCT00392379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025891|NCT00392379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025892|NCT00392379|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93025893|NCT00392379|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93025894|NCT00392379|Cholinergic Agents|cholinergic agents|mesh-ancestor
93025895|NCT00392379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025896|NCT00392379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025897|NCT01038063|Lumefantrine|lumefantrine|mesh-list
93025898|NCT01038063|Artemether|artemether|mesh-list
93025899|NCT01038063|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93025900|NCT01038063|Antimalarials|antimalarials|mesh-ancestor
93025901|NCT01038063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93025902|NCT01038063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93025903|NCT01038063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93025904|NCT01043991|Darbepoetin alfa|darbepoetin alfa|mesh-list
93025905|NCT01043991|Hematinics|hematinics|mesh-ancestor
93025906|NCT01020630|Sunitinib|sunitinib|mesh-list
93025907|NCT01020630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025908|NCT01020630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92182241|NCT00110461|Serotonin Agents|serotonin agents|mesh-ancestor
93025909|NCT01020630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93025910|NCT01020630|Growth Substances|growth substances|mesh-ancestor
93025911|NCT01020630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025912|NCT01020630|Growth Inhibitors|growth inhibitors|mesh-ancestor
93025913|NCT01020630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93025914|NCT01020630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025915|NCT01020630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025916|NCT00403455|Paroxetine|paroxetine|mesh-list
93025917|NCT00403455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93025918|NCT00403455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93025919|NCT00403455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93025920|NCT00403455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025921|NCT00403455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93025922|NCT00403455|Serotonin Agents|serotonin agents|mesh-ancestor
93025923|NCT00403455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025924|NCT00403455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93025925|NCT00403455|Antidepressive Agents|antidepressive agents|mesh-ancestor
93025926|NCT00403455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93025927|NCT00403455|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93025928|NCT00403455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93025929|NCT00403455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371505|NCT01295112|BB 1101|bb 1101|mesh-list
93025931|NCT00318370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025932|NCT00510068|Everolimus|everolimus|mesh-list
93025933|NCT00510068|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93025934|NCT00510068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93025935|NCT00510068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025936|NCT00510068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025937|NCT00510068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025938|NCT00510068|Immunologic Factors|immunologic factors|mesh-ancestor
93025939|NCT00510068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025940|NCT00510068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025941|NCT00509600|Etanercept|etanercept|mesh-list
93025942|NCT00509600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93025943|NCT00509600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025944|NCT00509600|Analgesics|analgesics|mesh-ancestor
93025945|NCT00509600|Sensory System Agents|sensory system agents|mesh-ancestor
93025946|NCT00509600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025947|NCT00509600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025948|NCT00509600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025949|NCT00509600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025950|NCT00509600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671199|NCT00333645|Caspofungin|caspofungin|mesh-list
93025951|NCT00509600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025952|NCT00509600|Immunologic Factors|immunologic factors|mesh-ancestor
93025953|NCT01014104|Methylprednisolone|methylprednisolone|mesh-list
93025954|NCT01014104|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93025955|NCT01014104|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93025956|NCT01014104|Prednisolone|prednisolone|mesh-list
93025957|NCT01014104|Prednisolone acetate|prednisolone acetate|mesh-list
93025958|NCT01014104|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93025959|NCT01014104|Prednisolone phosphate|prednisolone phosphate|mesh-list
93025960|NCT01014104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025961|NCT01014104|Antiemetics|antiemetics|mesh-ancestor
93025962|NCT01014104|Autonomic Agents|autonomic agents|mesh-ancestor
93025963|NCT01014104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025964|NCT01014104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025965|NCT01014104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93025966|NCT01014104|Glucocorticoids|glucocorticoids|mesh-ancestor
93025967|NCT01014104|Hormones|hormones|mesh-ancestor
93025968|NCT01014104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93025969|NCT01014104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93025970|NCT01014104|Protective Agents|protective agents|mesh-ancestor
93025971|NCT01014104|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93025972|NCT01014104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025973|NCT00402987|Celecoxib|celecoxib|mesh-list
93025974|NCT00402987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93025975|NCT00402987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93025976|NCT00402987|Analgesics|analgesics|mesh-ancestor
93025977|NCT00402987|Sensory System Agents|sensory system agents|mesh-ancestor
93025978|NCT00402987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93025979|NCT00402987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025980|NCT00402987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93025981|NCT00402987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93025982|NCT00402987|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93025983|NCT00402987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93025984|NCT00402987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025985|NCT00402987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025986|NCT01015664|Sirolimus|sirolimus|mesh-list
93025987|NCT01015664|Cetuximab|cetuximab|mesh-list
93025988|NCT01015664|Temsirolimus|temsirolimus|mesh-list
93025989|NCT01015664|MTOR Inhibitors|mtor inhibitors|mesh-list
93025990|NCT01015664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93025991|NCT01015664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93025992|NCT01015664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93025993|NCT01015664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93025994|NCT01015664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93025995|NCT01015664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93025996|NCT01015664|Immunologic Factors|immunologic factors|mesh-ancestor
93025997|NCT01015664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93025998|NCT01015664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93025999|NCT01015664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026000|NCT01015664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93026001|NCT01015664|Antifungal Agents|antifungal agents|mesh-ancestor
93026002|NCT00501644|Interferons|interferons|mesh-list
93026003|NCT00501644|Interferon-gamma|interferon-gamma|mesh-list
93026004|NCT00501644|Carboplatin|carboplatin|mesh-list
93026005|NCT00501644|Molgramostim|molgramostim|mesh-list
93026006|NCT00501644|Sargramostim|sargramostim|mesh-list
93026007|NCT00501644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026008|NCT00501644|Antiviral Agents|antiviral agents|mesh-ancestor
93026009|NCT00501644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026010|NCT00501644|Immunologic Factors|immunologic factors|mesh-ancestor
93026011|NCT00501644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026012|NCT01014260|Doxycycline|doxycycline|mesh-list
93026013|NCT01014260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93026014|NCT01014260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026015|NCT01014260|Antimalarials|antimalarials|mesh-ancestor
93026016|NCT01014260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93026017|NCT01014260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93026018|NCT01010672|Sirolimus|sirolimus|mesh-list
93026019|NCT01010672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93026020|NCT01010672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026021|NCT01010672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93026022|NCT01010672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026023|NCT01010672|Antifungal Agents|antifungal agents|mesh-ancestor
93026024|NCT01010672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671279|NCT00451490|Agomelatine|agomelatine|mesh-list
93026025|NCT01010672|Immunologic Factors|immunologic factors|mesh-ancestor
93026026|NCT01010672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026027|NCT01014338|Fosinopril|fosinopril|mesh-list
93026028|NCT01014338|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93026029|NCT01014338|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026030|NCT01014338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026031|NCT01014338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026032|NCT01014338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026033|NCT01014416|Tolvaptan|tolvaptan|mesh-list
93026034|NCT01014416|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93026035|NCT01014416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026036|NCT01014416|Natriuretic Agents|natriuretic agents|mesh-ancestor
93026037|NCT01014416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026038|NCT00497796|Ganciclovir|ganciclovir|mesh-list
93026039|NCT00497796|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93026040|NCT00497796|Maribavir|maribavir|mesh-list
93026041|NCT00497796|Antiviral Agents|antiviral agents|mesh-ancestor
93026042|NCT00497796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026043|NCT00497796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026044|NCT00497796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026045|NCT00497796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026046|NCT01017822|Gemcitabine|gemcitabine|mesh-list
93026047|NCT01017822|Capecitabine|capecitabine|mesh-list
93026048|NCT01017822|Conatumumab|conatumumab|mesh-list
93026049|NCT01017822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026050|NCT01017822|Antimetabolites|antimetabolites|mesh-ancestor
93026051|NCT01017822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026052|NCT01017822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026053|NCT01017822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026054|NCT00496782|Maraviroc|maraviroc|mesh-list
93026055|NCT00496782|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93026056|NCT00496782|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93026057|NCT00496782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026058|NCT00496782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93026059|NCT00496782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93026060|NCT00496782|Antiviral Agents|antiviral agents|mesh-ancestor
93026061|NCT00496782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026062|NCT00496782|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93026063|NCT01020708|Acetylcysteine|acetylcysteine|mesh-list
93026064|NCT01020708|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93026065|NCT01020708|Mesalamine|mesalamine|mesh-list
93026066|NCT01020708|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93026067|NCT01020708|Antiviral Agents|antiviral agents|mesh-ancestor
93026068|NCT01020708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026069|NCT01020708|Expectorants|expectorants|mesh-ancestor
93026070|NCT01020708|Respiratory System Agents|respiratory system agents|mesh-ancestor
93026071|NCT01020708|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93026072|NCT01020708|Antioxidants|antioxidants|mesh-ancestor
93026073|NCT01020708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026074|NCT01020708|Protective Agents|protective agents|mesh-ancestor
93026075|NCT01020708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026076|NCT01020708|Antidotes|antidotes|mesh-ancestor
93026077|NCT01020708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93026078|NCT01020708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93026079|NCT01020708|Analgesics|analgesics|mesh-ancestor
93026080|NCT01020708|Sensory System Agents|sensory system agents|mesh-ancestor
93026081|NCT01020708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026082|NCT01020708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026083|NCT01020708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026084|NCT01020708|Antitubercular Agents|antitubercular agents|mesh-ancestor
93026085|NCT01020708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93026086|NCT01020864|Carboplatin|carboplatin|mesh-list
93026087|NCT01020864|Cetuximab|cetuximab|mesh-list
93026088|NCT01020864|Vinorelbine|vinorelbine|mesh-list
93026089|NCT01020864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026090|NCT01020864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026091|NCT01020864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93026092|NCT01020864|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026093|NCT01020864|Antimitotic Agents|antimitotic agents|mesh-ancestor
93026094|NCT01020864|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026095|NCT01020864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026096|NCT04428372|Mannitol|mannitol|mesh-list
93026097|NCT04428372|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93026098|NCT04428372|Diuretics|diuretics|mesh-ancestor
93026099|NCT04428372|Natriuretic Agents|natriuretic agents|mesh-ancestor
92671351|NCT00451997|Imatinib Mesylate|imatinib mesylate|mesh-list
92182326|NCT01672983|Ritonavir|ritonavir|mesh-list
93026100|NCT04428372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026101|NCT01014858|Donepezil|donepezil|mesh-list
93026102|NCT01014858|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93026103|NCT01014858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026104|NCT01014858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026105|NCT01014858|Cholinergic Agents|cholinergic agents|mesh-ancestor
93026106|NCT01014858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026107|NCT01014858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026108|NCT01014858|Nootropic Agents|nootropic agents|mesh-ancestor
93026109|NCT00471276|Sunitinib|sunitinib|mesh-list
93026110|NCT00471276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026111|NCT00471276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93026112|NCT00471276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93026113|NCT00471276|Growth Substances|growth substances|mesh-ancestor
93026114|NCT00471276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026115|NCT00471276|Growth Inhibitors|growth inhibitors|mesh-ancestor
93026116|NCT00471276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026117|NCT00471276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026118|NCT00471276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026119|NCT00470262|Pioglitazone|pioglitazone|mesh-list
93026120|NCT00470262|Fenofibrate|fenofibrate|mesh-list
93026121|NCT00470262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93026122|NCT00470262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026123|NCT00470262|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93026124|NCT00470262|Antimetabolites|antimetabolites|mesh-ancestor
93026125|NCT00470262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026126|NCT00470262|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93026127|NCT04034862|Lamivudine|lamivudine|mesh-list
93026128|NCT04034862|Dolutegravir|dolutegravir|mesh-list
93026129|NCT04034862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93026130|NCT04034862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026131|NCT04034862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026132|NCT04034862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026133|NCT04034862|Antiviral Agents|antiviral agents|mesh-ancestor
93026134|NCT04034862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026135|NCT04034862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93026136|NCT04034862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93026137|NCT04034862|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93026138|NCT04034862|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93026139|NCT00496470|Budesonide|budesonide|mesh-list
93026140|NCT00496470|Bromides|bromides|mesh-list
93026141|NCT00496470|Formoterol Fumarate|formoterol fumarate|mesh-list
93026142|NCT00496470|Tiotropium Bromide|tiotropium bromide|mesh-list
93026143|NCT00496470|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93026144|NCT00496470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026145|NCT00496470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93026146|NCT00496470|Autonomic Agents|autonomic agents|mesh-ancestor
93026147|NCT00496470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026148|NCT00496470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026149|NCT00496470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93026150|NCT00496470|Respiratory System Agents|respiratory system agents|mesh-ancestor
93026151|NCT00496470|Glucocorticoids|glucocorticoids|mesh-ancestor
93026152|NCT00496470|Hormones|hormones|mesh-ancestor
93026153|NCT00496470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026154|NCT00496470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92182364|NCT01879085|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026155|NCT00496470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93026156|NCT00496470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93026157|NCT00496470|Adrenergic Agents|adrenergic agents|mesh-ancestor
93026158|NCT00496470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026159|NCT00496470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026160|NCT00496470|Parasympatholytics|parasympatholytics|mesh-ancestor
93026161|NCT00496470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93026162|NCT00496470|Cholinergic Agents|cholinergic agents|mesh-ancestor
93026163|NCT00496470|Anticonvulsants|anticonvulsants|mesh-ancestor
93026164|NCT01021176|Diltiazem|diltiazem|mesh-list
93026165|NCT01021176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026166|NCT01021176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93026167|NCT01021176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026168|NCT01021176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026169|NCT01021176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93026170|NCT01021176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026171|NCT01021176|Vasodilator Agents|vasodilator agents|mesh-ancestor
93026172|NCT01018368|Rifampin|rifampin|mesh-list
93026173|NCT01018368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93026174|NCT01018368|Antitubercular Agents|antitubercular agents|mesh-ancestor
93026175|NCT01018368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92671425|NCT00334152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93026176|NCT01018368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026177|NCT01018368|Leprostatic Agents|leprostatic agents|mesh-ancestor
93026178|NCT01018368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026179|NCT01018368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026180|NCT01018368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026181|NCT01018368|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93026182|NCT01018368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93026183|NCT01018368|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93026184|NCT01018368|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93026185|NCT01018368|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93026186|NCT01018368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93026187|NCT00487578|Naratriptan|naratriptan|mesh-list
93026188|NCT00487578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93026189|NCT00487578|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93026190|NCT00487578|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93026191|NCT00487578|Serotonin Agents|serotonin agents|mesh-ancestor
93026192|NCT00487578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026193|NCT00487578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026194|NCT00487578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026195|NCT00495612|Omalizumab|omalizumab|mesh-list
93026196|NCT00495612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93026197|NCT00495612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93026198|NCT00495612|Respiratory System Agents|respiratory system agents|mesh-ancestor
93026199|NCT01021488|Enoxaparin|enoxaparin|mesh-list
93026200|NCT01021488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93026201|NCT01021488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93026202|NCT01021488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93026203|NCT01021488|Antimetabolites|antimetabolites|mesh-ancestor
93026204|NCT01021488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026205|NCT01021488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93026206|NCT01021488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93026207|NCT01021488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026208|NCT01021488|Anticoagulants|anticoagulants|mesh-ancestor
93026209|NCT01021488|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93026210|NCT01021488|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92182387|NCT01439126|Clonidine|clonidine|mesh-list
93026211|NCT00487188|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93026212|NCT00487188|Enfuvirtide|enfuvirtide|mesh-list
93026213|NCT00487188|Antiviral Agents|antiviral agents|mesh-ancestor
93026214|NCT00487188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026215|NCT00487188|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93026216|NCT00487188|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92528961|NCT00000941|Antimetabolites|antimetabolites|mesh-ancestor
93026217|NCT00487188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026218|NCT00487188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93026219|NCT00509366|Cisplatin|cisplatin|mesh-list
93026220|NCT00509366|Gemcitabine|gemcitabine|mesh-list
93026221|NCT00509366|Docetaxel|docetaxel|mesh-list
93026222|NCT00509366|Pemetrexed|pemetrexed|mesh-list
93026223|NCT00509366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026224|NCT00509366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026225|NCT00509366|Antimetabolites|antimetabolites|mesh-ancestor
93026226|NCT00509366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026227|NCT00509366|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026228|NCT00509366|Antimitotic Agents|antimitotic agents|mesh-ancestor
93026229|NCT00509366|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026230|NCT00509366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026231|NCT00509366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93026232|NCT00509366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026233|NCT01016054|Carboplatin|carboplatin|mesh-list
93026234|NCT01016054|Gemcitabine|gemcitabine|mesh-list
93026235|NCT01016054|Doxorubicin|doxorubicin|mesh-list
93026236|NCT01016054|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93026237|NCT01016054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026238|NCT01016054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026239|NCT01016054|Antimetabolites|antimetabolites|mesh-ancestor
93026240|NCT01016054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026241|NCT01016054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93026242|NCT01016054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93026243|NCT01016054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93026244|NCT01016054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026245|NCT00500318|Bromides|bromides|mesh-list
93026246|NCT00500318|Anticonvulsants|anticonvulsants|mesh-ancestor
93026247|NCT00499694|Bevacizumab|bevacizumab|mesh-list
93026248|NCT00499694|Satraplatin|satraplatin|mesh-list
93026249|NCT00499694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026250|NCT00499694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026251|NCT00499694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93026252|NCT00499694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93026253|NCT00499694|Growth Substances|growth substances|mesh-ancestor
93026254|NCT00499694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026255|NCT00499694|Growth Inhibitors|growth inhibitors|mesh-ancestor
93026256|NCT00486954|Paclitaxel|paclitaxel|mesh-list
93026257|NCT00486954|Lapatinib|lapatinib|mesh-list
93026258|NCT00486954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93026259|NCT00486954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026260|NCT00486954|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026261|NCT00486954|Antimitotic Agents|antimitotic agents|mesh-ancestor
93026262|NCT00486954|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026263|NCT00486954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026264|NCT00486954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026265|NCT00486954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026266|NCT00494676|Methamphetamine|methamphetamine|mesh-list
93026267|NCT00494676|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93026268|NCT00494676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026269|NCT00494676|Sympathomimetics|sympathomimetics|mesh-ancestor
93026270|NCT00494676|Autonomic Agents|autonomic agents|mesh-ancestor
93026271|NCT00494676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026272|NCT00494676|Dopamine Agents|dopamine agents|mesh-ancestor
93026273|NCT00494676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026274|NCT00494676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026275|NCT00494676|Adrenergic Agents|adrenergic agents|mesh-ancestor
93026276|NCT00494676|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93026277|NCT00494676|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93026278|NCT00494676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026279|NCT00494676|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93026280|NCT00486720|Vorinostat|vorinostat|mesh-list
93026281|NCT00486720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026282|NCT00486720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93026283|NCT00486720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026284|NCT00486720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026285|NCT00486330|Ritonavir|ritonavir|mesh-list
93026286|NCT00486330|Tipranavir|tipranavir|mesh-list
93026287|NCT00486330|Buprenorphine|buprenorphine|mesh-list
93026288|NCT00486330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93026289|NCT00486330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93026290|NCT00486330|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026291|NCT00486330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026292|NCT00486330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026293|NCT00486330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93026294|NCT00486330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93026295|NCT00486330|Antiviral Agents|antiviral agents|mesh-ancestor
93026296|NCT00486330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026297|NCT00486330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93026298|NCT00486330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93026299|NCT00486330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93026300|NCT00486330|Narcotics|narcotics|mesh-ancestor
93026301|NCT00486330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93026302|NCT00486330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026303|NCT00486330|Analgesics|analgesics|mesh-ancestor
93026304|NCT00486330|Sensory System Agents|sensory system agents|mesh-ancestor
93026305|NCT00486330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026306|NCT00486330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93026307|NCT01021566|Methadone|methadone|mesh-list
93026308|NCT01021566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93026309|NCT01021566|Narcotics|narcotics|mesh-ancestor
93026310|NCT01021566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93026311|NCT01021566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026312|NCT01021566|Analgesics|analgesics|mesh-ancestor
93026313|NCT01021566|Sensory System Agents|sensory system agents|mesh-ancestor
93026314|NCT01021566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026315|NCT01021566|Antitussive Agents|antitussive agents|mesh-ancestor
93026316|NCT01021566|Respiratory System Agents|respiratory system agents|mesh-ancestor
93026317|NCT00494442|Olaparib|olaparib|mesh-list
93026318|NCT00494442|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
93026319|NCT00494442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026320|NCT00494442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026321|NCT00494442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026322|NCT00493974|Zileuton|zileuton|mesh-list
93026323|NCT00493974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93026324|NCT00493974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671598|NCT00335088|Iodine|iodine|mesh-list
93026325|NCT00493974|Analgesics|analgesics|mesh-ancestor
93026326|NCT00493974|Sensory System Agents|sensory system agents|mesh-ancestor
93026327|NCT00493974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026328|NCT00493974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026329|NCT00493974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026330|NCT00493974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026331|NCT00493974|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93026332|NCT00493974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026333|NCT00493974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026334|NCT00493974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93026335|NCT00493974|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026336|NCT00493974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026337|NCT01018446|Busulfan|busulfan|mesh-list
93026338|NCT01018446|Alkylating Agents|alkylating agents|mesh-ancestor
93026339|NCT01018446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026340|NCT01018446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026341|NCT01018446|Immunologic Factors|immunologic factors|mesh-ancestor
93026342|NCT01018446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026343|NCT01018446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93026344|NCT01018446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026345|NCT01018446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93026346|NCT01018602|Vildagliptin|vildagliptin|mesh-list
93026347|NCT01018602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93026348|NCT01018602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026349|NCT01018602|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93026350|NCT01018602|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026351|NCT01018602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026352|NCT01018602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026353|NCT01018758|Palonosetron|palonosetron|mesh-list
93026354|NCT01018758|Antiemetics|antiemetics|mesh-ancestor
93026355|NCT01018758|Autonomic Agents|autonomic agents|mesh-ancestor
93026356|NCT01018758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026357|NCT01018758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026358|NCT01018758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93026359|NCT01018758|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93026360|NCT01018758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93026361|NCT01018758|Serotonin Agents|serotonin agents|mesh-ancestor
93026362|NCT01018758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371946|NCT01353144|Aspirin|aspirin|mesh-list
93026363|NCT01018758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026364|NCT00469092|Insulin|insulin|mesh-list
93026365|NCT00469092|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93026366|NCT00469092|Metformin|metformin|mesh-list
93026367|NCT00469092|Insulin Glargine|insulin glargine|mesh-list
93026368|NCT00469092|Insulin Aspart|insulin aspart|mesh-list
93026369|NCT00469092|Glimepiride|glimepiride|mesh-list
93026370|NCT00469092|Biphasic Insulins|biphasic insulins|mesh-list
93026371|NCT00469092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93026372|NCT00469092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026373|NCT00469092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93026374|NCT00469092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026375|NCT00469092|Immunologic Factors|immunologic factors|mesh-ancestor
93026376|NCT00499616|Cyclophosphamide|cyclophosphamide|mesh-list
93026377|NCT00499616|Carboplatin|carboplatin|mesh-list
93026378|NCT00499616|Doxorubicin|doxorubicin|mesh-list
93026379|NCT00499616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93026380|NCT00499616|Etoposide|etoposide|mesh-list
93026381|NCT00499616|Topotecan|topotecan|mesh-list
93026382|NCT00499616|Isotretinoin|isotretinoin|mesh-list
93026383|NCT00499616|Lenograstim|lenograstim|mesh-list
93026384|NCT00499616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026385|NCT00499616|Immunologic Factors|immunologic factors|mesh-ancestor
93026386|NCT00499616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026387|NCT00499616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026388|NCT00499616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93026389|NCT00499616|Alkylating Agents|alkylating agents|mesh-ancestor
92182481|NCT05547516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93026390|NCT00499616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026391|NCT00499616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026392|NCT00499616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93026393|NCT00499616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93026394|NCT00499616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93026395|NCT00499616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93026396|NCT00499616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026397|NCT00499616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93026398|NCT00499616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93026399|NCT00499616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93026400|NCT00499616|Dermatologic Agents|dermatologic agents|mesh-ancestor
93026401|NCT00402597|Rivaroxaban|rivaroxaban|mesh-list
93026402|NCT00402597|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93026403|NCT00402597|Antithrombins|antithrombins|mesh-ancestor
93026404|NCT00402597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93026405|NCT00402597|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026406|NCT00402597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026407|NCT00402597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026408|NCT00402597|Anticoagulants|anticoagulants|mesh-ancestor
93026409|NCT00469014|Fludarabine|fludarabine|mesh-list
93026410|NCT00469014|Fludarabine phosphate|fludarabine phosphate|mesh-list
93026411|NCT00469014|Busulfan|busulfan|mesh-list
93026412|NCT00469014|Clofarabine|clofarabine|mesh-list
93026413|NCT00469014|Thymoglobulin|thymoglobulin|mesh-list
93026414|NCT00469014|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93026415|NCT00469014|Lenograstim|lenograstim|mesh-list
93026416|NCT00469014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026417|NCT00469014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026418|NCT00469014|Antimetabolites|antimetabolites|mesh-ancestor
93026419|NCT00469014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026420|NCT00469014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026421|NCT00469014|Immunologic Factors|immunologic factors|mesh-ancestor
93026422|NCT00469014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026423|NCT00469014|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93026424|NCT00469014|Alkylating Agents|alkylating agents|mesh-ancestor
93026425|NCT00469014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93026426|NCT00469014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93026427|NCT00493038|Amoxicillin|amoxicillin|mesh-list
93026428|NCT00493038|Moxifloxacin|moxifloxacin|mesh-list
93026429|NCT00493038|Clavulanic Acid|clavulanic acid|mesh-list
93026430|NCT00493038|Clavulanic Acids|clavulanic acids|mesh-list
93026431|NCT00493038|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93026492|NCT00401973|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93026493|NCT00401973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93026494|NCT00401973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026495|NCT00401973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026496|NCT00401973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026497|NCT00401973|Serotonin Agents|serotonin agents|mesh-ancestor
93026498|NCT00401973|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93026499|NCT00401973|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93026500|NCT00401973|Antiviral Agents|antiviral agents|mesh-ancestor
93026501|NCT00401973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026502|NCT00401973|Dopamine Agents|dopamine agents|mesh-ancestor
93026503|NCT00401973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93026504|NCT00401973|Analgesics|analgesics|mesh-ancestor
93026505|NCT00401973|Sensory System Agents|sensory system agents|mesh-ancestor
93026506|NCT00401973|Anticonvulsants|anticonvulsants|mesh-ancestor
93026507|NCT00401973|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93026508|NCT00401973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93026509|NCT01038453|Vitamin D|vitamin d|mesh-list
93026510|NCT01038453|Cholecalciferol|cholecalciferol|mesh-list
93026511|NCT01038453|Vitamins|vitamins|mesh-ancestor
93026512|NCT01038453|Micronutrients|micronutrients|mesh-ancestor
93026513|NCT01038453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026514|NCT01038453|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93026515|NCT01038453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93026516|NCT00401193|Tranexamic Acid|tranexamic acid|mesh-list
93026517|NCT00401193|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93026518|NCT00401193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93026519|NCT00401193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026520|NCT00401193|Hemostatics|hemostatics|mesh-ancestor
93026521|NCT00401193|Coagulants|coagulants|mesh-ancestor
93026523|NCT00400569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026524|NCT00400569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93026525|NCT00400569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93026526|NCT00400569|Growth Substances|growth substances|mesh-ancestor
93026527|NCT00400569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026528|NCT00400569|Growth Inhibitors|growth inhibitors|mesh-ancestor
93026529|NCT00400569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026530|NCT00400569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026531|NCT00400569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026532|NCT00413049|Amlodipine|amlodipine|mesh-list
93026533|NCT00413049|Valsartan|valsartan|mesh-list
93026534|NCT00413049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026535|NCT00413049|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93026536|NCT00413049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026537|NCT00413049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026538|NCT00413049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93026539|NCT00413049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026540|NCT00413049|Vasodilator Agents|vasodilator agents|mesh-ancestor
93026541|NCT00413049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93026542|NCT00413049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93026543|NCT03732495|Denosumab|denosumab|mesh-list
93026544|NCT03732495|Lenvatinib|lenvatinib|mesh-list
93026545|NCT03732495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026546|NCT03732495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026547|NCT03732495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026548|NCT03732495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026549|NCT03732495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93026550|NCT03732495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026551|NCT01041729|Atorvastatin|atorvastatin|mesh-list
93026552|NCT01041729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93026553|NCT01041729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93026555|NCT01041729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026556|NCT01041729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93026557|NCT01041729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93026558|NCT01041729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026559|NCT01324245|Fenoldopam|fenoldopam|mesh-list
93026560|NCT01324245|Enalaprilat|enalaprilat|mesh-list
93026561|NCT01324245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026562|NCT01324245|Vasodilator Agents|vasodilator agents|mesh-ancestor
93026563|NCT01324245|Dopamine Agonists|dopamine agonists|mesh-ancestor
93026564|NCT01324245|Dopamine Agents|dopamine agents|mesh-ancestor
93026565|NCT01324245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026566|NCT01324245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026567|NCT01324245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026568|NCT01324245|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93026569|NCT01324245|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026570|NCT01324245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026571|NCT00454194|Pemetrexed|pemetrexed|mesh-list
93026572|NCT00454194|Sorafenib|sorafenib|mesh-list
93026573|NCT00454194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026574|NCT00454194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026575|NCT00454194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026576|NCT00454194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93026577|NCT00454194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026578|NCT00454194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026579|NCT00468546|Methotrexate|methotrexate|mesh-list
93026580|NCT00468546|Rituximab|rituximab|mesh-list
93026581|NCT00468546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93026582|NCT00468546|Abortifacient Agents|abortifacient agents|mesh-ancestor
93026583|NCT00468546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93026584|NCT00468546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026585|NCT00468546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026586|NCT00468546|Antimetabolites|antimetabolites|mesh-ancestor
93026587|NCT00468546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026588|NCT00468546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026589|NCT00468546|Dermatologic Agents|dermatologic agents|mesh-ancestor
93026590|NCT00468546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026591|NCT00468546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93026592|NCT00468546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026593|NCT00468546|Immunologic Factors|immunologic factors|mesh-ancestor
93026594|NCT00468546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026595|NCT00468546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026596|NCT00468546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026597|NCT00303316|Vaccines|vaccines|mesh-list
93026598|NCT00303316|Immunologic Factors|immunologic factors|mesh-ancestor
93026599|NCT00303316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026600|NCT01064986|Hydrocortisone|hydrocortisone|mesh-list
93026601|NCT01064986|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93026602|NCT01064986|Epinephrine|epinephrine|mesh-list
93026603|NCT01064986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93026604|NCT01064986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93026605|NCT01064986|Adrenergic Agents|adrenergic agents|mesh-ancestor
93026606|NCT01064986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026607|NCT01064986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026608|NCT01064986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026609|NCT01064986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93026610|NCT01064986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93026611|NCT01064986|Autonomic Agents|autonomic agents|mesh-ancestor
93026612|NCT01064986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026613|NCT01064986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93026614|NCT01064986|Respiratory System Agents|respiratory system agents|mesh-ancestor
93026615|NCT01064986|Mydriatics|mydriatics|mesh-ancestor
93026616|NCT01064986|Sympathomimetics|sympathomimetics|mesh-ancestor
93026617|NCT01064986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93026618|NCT01064986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026619|NCT00468312|Mometasone Furoate|mometasone furoate|mesh-list
93026620|NCT00468312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026621|NCT00468312|Dermatologic Agents|dermatologic agents|mesh-ancestor
93026622|NCT00468312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93026623|NCT03980002|Thalidomide|thalidomide|mesh-list
93026624|NCT03980002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026625|NCT03980002|Immunologic Factors|immunologic factors|mesh-ancestor
92671876|NCT00336765|XL647|xl647|mesh-list
93026626|NCT03980002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026627|NCT03980002|Leprostatic Agents|leprostatic agents|mesh-ancestor
93026628|NCT03980002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93026629|NCT03980002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026630|NCT03980002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93026631|NCT03980002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93026632|NCT03980002|Growth Substances|growth substances|mesh-ancestor
93026633|NCT03980002|Growth Inhibitors|growth inhibitors|mesh-ancestor
93026634|NCT03980002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026635|NCT00331864|Ranibizumab|ranibizumab|mesh-list
93026636|NCT00331864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93026637|NCT00331864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93026638|NCT00331864|Growth Substances|growth substances|mesh-ancestor
93026639|NCT00331864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026640|NCT00331864|Growth Inhibitors|growth inhibitors|mesh-ancestor
93026641|NCT00331864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026642|NCT00331630|Paclitaxel|paclitaxel|mesh-list
93026643|NCT00331630|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93026644|NCT00331630|Lapatinib|lapatinib|mesh-list
93026645|NCT00331630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93026646|NCT00331630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026647|NCT00331630|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026648|NCT00331630|Antimitotic Agents|antimitotic agents|mesh-ancestor
93026649|NCT00331630|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026650|NCT00331630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026651|NCT00331630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026652|NCT00331630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026653|NCT00331552|Cyclophosphamide|cyclophosphamide|mesh-list
93026654|NCT00331552|Doxorubicin|doxorubicin|mesh-list
93026655|NCT00331552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93026656|NCT00331552|Trastuzumab|trastuzumab|mesh-list
93026657|NCT00331552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93026658|NCT00331552|Antibodies|antibodies|mesh-list
93026659|NCT00331552|Immunoglobulins|immunoglobulins|mesh-list
93026660|NCT00331552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93026661|NCT00331552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026662|NCT00331552|Immunologic Factors|immunologic factors|mesh-ancestor
93026663|NCT00331552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026664|NCT00331552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026665|NCT00331552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93026666|NCT00331552|Alkylating Agents|alkylating agents|mesh-ancestor
93026667|NCT00331552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026668|NCT00331552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026669|NCT00331552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93026670|NCT00331552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93026671|NCT00331552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93026672|NCT00331552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93026673|NCT00331552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026674|NCT04320628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93026675|NCT04320628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026676|NCT00331006|Rituximab|rituximab|mesh-list
93026677|NCT00331006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026678|NCT00331006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026679|NCT00331006|Immunologic Factors|immunologic factors|mesh-ancestor
93026680|NCT00331006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026681|NCT00331006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026682|NCT00302458|Methylphenidate|methylphenidate|mesh-list
93026683|NCT00302458|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93026684|NCT00302458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026685|NCT00302458|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93026686|NCT00302458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93026687|NCT00302458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026688|NCT00302458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026689|NCT00302458|Dopamine Agents|dopamine agents|mesh-ancestor
93026690|NCT00302458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026691|NCT00391053|Vaccines|vaccines|mesh-list
93026692|NCT00391053|Immunologic Factors|immunologic factors|mesh-ancestor
93026693|NCT00391053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026694|NCT00317044|Esomeprazole|esomeprazole|mesh-list
93026695|NCT00317044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93026696|NCT00317044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93026697|NCT00317044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93026698|NCT00317044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026699|NCT00317044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026700|NCT00301834|Cyclosporine|cyclosporine|mesh-list
93026701|NCT00301834|Methylprednisolone|methylprednisolone|mesh-list
93026702|NCT00301834|Methotrexate|methotrexate|mesh-list
93026703|NCT00301834|Fludarabine phosphate|fludarabine phosphate|mesh-list
93026704|NCT00301834|Fludarabine|fludarabine|mesh-list
93026705|NCT00301834|Busulfan|busulfan|mesh-list
93026706|NCT00301834|Alemtuzumab|alemtuzumab|mesh-list
93026707|NCT00301834|Cyclosporins|cyclosporins|mesh-list
93026708|NCT00301834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93026709|NCT00301834|Abortifacient Agents|abortifacient agents|mesh-ancestor
93026710|NCT00301834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93026711|NCT00301834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026712|NCT00301834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026713|NCT00301834|Antimetabolites|antimetabolites|mesh-ancestor
93026714|NCT00301834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026715|NCT00301834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026716|NCT00301834|Dermatologic Agents|dermatologic agents|mesh-ancestor
93026717|NCT00301834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026718|NCT00301834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93026719|NCT00301834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93026720|NCT00301834|Immunologic Factors|immunologic factors|mesh-ancestor
93026721|NCT00301834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026722|NCT00301834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026723|NCT00301834|Antifungal Agents|antifungal agents|mesh-ancestor
93026724|NCT00301834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026725|NCT00301834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93026726|NCT00301834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026727|NCT00301834|Antiemetics|antiemetics|mesh-ancestor
93026728|NCT00301834|Autonomic Agents|autonomic agents|mesh-ancestor
93026729|NCT00301834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026730|NCT00301834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93026731|NCT00301834|Glucocorticoids|glucocorticoids|mesh-ancestor
93026732|NCT00301834|Hormones|hormones|mesh-ancestor
93026733|NCT00301834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026734|NCT00301834|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93026735|NCT00301834|Protective Agents|protective agents|mesh-ancestor
93026736|NCT00301834|Alkylating Agents|alkylating agents|mesh-ancestor
93026737|NCT00301834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93026738|NCT00301834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93026739|NCT00301834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026740|NCT00301366|Protease Inhibitors|protease inhibitors|mesh-list
93026741|NCT00301366|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93026742|NCT00301366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026743|NCT00301366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026744|NCT00301366|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93026745|NCT00301366|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93026746|NCT00466440|Prednisone|prednisone|mesh-list
93026747|NCT00466440|Docetaxel|docetaxel|mesh-list
93026748|NCT00466440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026749|NCT00466440|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026750|NCT00466440|Antimitotic Agents|antimitotic agents|mesh-ancestor
93026751|NCT00466440|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026752|NCT00466440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026753|NCT00466440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026754|NCT00466440|Glucocorticoids|glucocorticoids|mesh-ancestor
93026755|NCT00466440|Hormones|hormones|mesh-ancestor
93026756|NCT00466440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026757|NCT00466440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026758|NCT00466440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93026759|NCT00465972|Doxepin|doxepin|mesh-list
93026760|NCT00465972|Temazepam|temazepam|mesh-list
93026761|NCT00465972|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93026762|NCT00465972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93026763|NCT00465972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93026764|NCT00465972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026765|NCT00465972|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93026766|NCT00465972|Antidepressive Agents|antidepressive agents|mesh-ancestor
93026767|NCT00465972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93026768|NCT00465972|Histamine Antagonists|histamine antagonists|mesh-ancestor
93026769|NCT00465972|Histamine Agents|histamine agents|mesh-ancestor
93026770|NCT00465972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026771|NCT00465972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026772|NCT00465972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93026773|NCT00465972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93026774|NCT00465972|GABA Modulators|gaba modulators|mesh-ancestor
93026775|NCT00465972|GABA Agents|gaba agents|mesh-ancestor
92672022|NCT00307307|Niacin|niacin|mesh-list
92182611|NCT01466192|Antimetabolites|antimetabolites|mesh-ancestor
93026777|NCT03926754|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93026778|NCT03926754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93026779|NCT03926754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93026780|NCT03926754|Adrenergic Agents|adrenergic agents|mesh-ancestor
93026781|NCT03926754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026782|NCT03926754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026783|NCT03926754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026784|NCT03926754|Urological Agents|urological agents|mesh-ancestor
93026785|NCT00465894|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93026786|NCT00465894|Estradiol|estradiol|mesh-list
93026787|NCT00465894|Estrogens|estrogens|mesh-ancestor
93026788|NCT00465894|Hormones|hormones|mesh-ancestor
93026789|NCT00465894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026790|NCT00465894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026791|NCT00465894|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93026792|NCT00465894|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93026793|NCT00465894|Cholinergic Agents|cholinergic agents|mesh-ancestor
93026794|NCT00465894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026795|NCT00465894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026796|NCT00465894|Urological Agents|urological agents|mesh-ancestor
93026797|NCT00330460|Denosumab|denosumab|mesh-list
93026798|NCT00330460|Alendronate|alendronate|mesh-list
93026799|NCT00330460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93026800|NCT00330460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026801|NCT01062490|Treosulfan|treosulfan|mesh-list
93026802|NCT01062490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93026803|NCT01062490|Alkylating Agents|alkylating agents|mesh-ancestor
93026804|NCT01062490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026805|NCT01062490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026806|NCT00465738|Botulinum Toxins|botulinum toxins|mesh-list
93026807|NCT00465738|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93026808|NCT00465738|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93026809|NCT00465738|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93026810|NCT00465738|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93026811|NCT00465738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026812|NCT00465738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026813|NCT00465738|Cholinergic Agents|cholinergic agents|mesh-ancestor
93026814|NCT00465738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026815|NCT00465738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026816|NCT00465738|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93026817|NCT00465738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026818|NCT00400179|Cisplatin|cisplatin|mesh-list
93026819|NCT00400179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026820|NCT00464568|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
93026821|NCT00464568|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93026822|NCT00464568|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93026823|NCT00464568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026824|NCT00464568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026825|NCT00464490|Dexmedetomidine|dexmedetomidine|mesh-list
93026826|NCT00464490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93026827|NCT00464490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93026828|NCT00464490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026829|NCT00464490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93026830|NCT00464490|Analgesics|analgesics|mesh-ancestor
93026831|NCT00464490|Sensory System Agents|sensory system agents|mesh-ancestor
93026832|NCT00464490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026833|NCT00464490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93026834|NCT00464490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93026835|NCT00464490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93026836|NCT00464490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93026837|NCT00464490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026838|NCT00464490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026839|NCT00412893|Voriconazole|voriconazole|mesh-list
93026840|NCT00412893|Isavuconazole|isavuconazole|mesh-list
93026841|NCT00412893|Antifungal Agents|antifungal agents|mesh-ancestor
93026842|NCT00412893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026843|NCT00412893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93026844|NCT00412893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93026845|NCT00412893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026846|NCT00412893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026847|NCT00412893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93026848|NCT00412893|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026849|NCT00412893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026850|NCT00412893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026851|NCT00412893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93026852|NCT00412737|Oseltamivir|oseltamivir|mesh-list
93026853|NCT00412737|Antiviral Agents|antiviral agents|mesh-ancestor
93026854|NCT00412737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026855|NCT00412737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026856|NCT00412737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026857|NCT00508742|Vaccines|vaccines|mesh-list
93026858|NCT00508742|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93026859|NCT00508742|Immunologic Factors|immunologic factors|mesh-ancestor
93026860|NCT00508742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026861|NCT01041963|Losartan|losartan|mesh-list
93026862|NCT01041963|Enalapril|enalapril|mesh-list
93026863|NCT01041963|Enalaprilat|enalaprilat|mesh-list
93026864|NCT01041963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93026865|NCT01041963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026866|NCT01041963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93026867|NCT01041963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93026868|NCT01041963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026869|NCT01041963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93026870|NCT01041963|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026871|NCT01041963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026872|NCT01044225|Cetuximab|cetuximab|mesh-list
93026873|NCT01044225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026874|NCT01044225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026875|NCT00508274|Capecitabine|capecitabine|mesh-list
93026876|NCT00508274|Lapatinib|lapatinib|mesh-list
93026877|NCT00508274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026879|NCT00508274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026880|NCT00508274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026881|NCT00508274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026882|NCT00508274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026883|NCT01042041|Doxorubicin|doxorubicin|mesh-list
93026884|NCT01042041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93026885|NCT01042041|Sorafenib|sorafenib|mesh-list
93026886|NCT01042041|Mitomycins|mitomycins|mesh-list
93026887|NCT01042041|Mitomycin|mitomycin|mesh-list
93026888|NCT01042041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026889|NCT01042041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93026890|NCT01042041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93026891|NCT01042041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93026892|NCT01042041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026893|NCT01042041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026894|NCT01042041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93026895|NCT01042041|Alkylating Agents|alkylating agents|mesh-ancestor
93026896|NCT01042041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93026897|NCT00499460|Oxycodone|oxycodone|mesh-list
93026898|NCT00499460|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93026899|NCT00499460|Narcotics|narcotics|mesh-ancestor
93026900|NCT00499460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93026901|NCT00499460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026902|NCT00499460|Analgesics|analgesics|mesh-ancestor
93026903|NCT00499460|Sensory System Agents|sensory system agents|mesh-ancestor
93026904|NCT00499460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026905|NCT00412113|Calcium, Dietary|calcium, dietary|mesh-list
93026906|NCT00412113|Amlodipine|amlodipine|mesh-list
93026907|NCT00412113|Atorvastatin|atorvastatin|mesh-list
93026908|NCT00412113|Calcium|calcium|mesh-list
93026909|NCT00412113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93026910|NCT00412113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026911|NCT00412113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93026912|NCT00412113|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93026913|NCT00412113|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93026914|NCT00412113|Antimetabolites|antimetabolites|mesh-ancestor
93026915|NCT00412113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026916|NCT00412113|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93026917|NCT00412113|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93026918|NCT00412113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026919|NCT00412113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93026920|NCT00412113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92672175|NCT00308165|Topotecan|topotecan|mesh-list
93026921|NCT00412113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93026922|NCT00412113|Vasodilator Agents|vasodilator agents|mesh-ancestor
93026923|NCT01014650|Glycine|glycine|mesh-list
93026924|NCT01014650|Glycine Agents|glycine agents|mesh-ancestor
93026925|NCT01014650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93026926|NCT01014650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026927|NCT01014650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026928|NCT00411645|Maribavir|maribavir|mesh-list
93026929|NCT00411645|Antiviral Agents|antiviral agents|mesh-ancestor
93026930|NCT00411645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026931|NCT00490724|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93026932|NCT00490724|Natriuretic Agents|natriuretic agents|mesh-ancestor
93026933|NCT00490724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026934|NCT01039155|Oxaliplatin|oxaliplatin|mesh-list
93026935|NCT01039155|Azacitidine|azacitidine|mesh-list
93026936|NCT01039155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026937|NCT01039155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93026938|NCT01039155|Antimetabolites|antimetabolites|mesh-ancestor
93026939|NCT01039155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026940|NCT01039155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026941|NCT01039233|Bicalutamide|bicalutamide|mesh-list
93026942|NCT01039233|Androgen Antagonists|androgen antagonists|mesh-ancestor
93026943|NCT01039233|Hormone Antagonists|hormone antagonists|mesh-ancestor
93026944|NCT01039233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026945|NCT01039233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026946|NCT01039233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026947|NCT00490646|Docetaxel|docetaxel|mesh-list
93026948|NCT00490646|Trastuzumab|trastuzumab|mesh-list
93026949|NCT00490646|Epothilones|epothilones|mesh-list
93026950|NCT00490646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372548|NCT01508832|Lidocaine|lidocaine|mesh-list
93026951|NCT00490646|Tubulin Modulators|tubulin modulators|mesh-ancestor
93026952|NCT00490646|Antimitotic Agents|antimitotic agents|mesh-ancestor
93026953|NCT00490646|Mitosis Modulators|mitosis modulators|mesh-ancestor
93026954|NCT00490646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026955|NCT00490646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93026956|NCT03992937|Levonorgestrel|levonorgestrel|mesh-list
93026957|NCT03992937|Progesterone|progesterone|mesh-list
93026958|NCT03992937|Progestins|progestins|mesh-ancestor
93026959|NCT03992937|Hormones|hormones|mesh-ancestor
93026960|NCT03992937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93026961|NCT03992937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026962|NCT03992937|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93026963|NCT03992937|Contraceptive Agents|contraceptive agents|mesh-ancestor
93026964|NCT03992937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93026965|NCT03992937|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93026966|NCT03992937|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93026967|NCT03992937|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93026968|NCT01039545|Norfloxacin|norfloxacin|mesh-list
93026969|NCT01039545|Diclofenac|diclofenac|mesh-list
93026970|NCT01039545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93026971|NCT01039545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93026972|NCT01039545|Analgesics|analgesics|mesh-ancestor
93026973|NCT01039545|Sensory System Agents|sensory system agents|mesh-ancestor
93026974|NCT01039545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93026975|NCT01039545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026976|NCT01039545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93026977|NCT01039545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93026978|NCT01039545|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93026979|NCT01039545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93026980|NCT01039545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93026981|NCT01039545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93026982|NCT01039545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026983|NCT01039545|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93026984|NCT01039545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93026985|NCT01039545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93026986|NCT01039545|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93026987|NCT01039545|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93026988|NCT00490568|Rosiglitazone|rosiglitazone|mesh-list
93026989|NCT00490568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93026990|NCT00490568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93026991|NCT00561353|Ribavirin|ribavirin|mesh-list
93026992|NCT00561353|Simeprevir|simeprevir|mesh-list
93026993|NCT00561353|Antimetabolites|antimetabolites|mesh-ancestor
93026994|NCT00561353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672251|NCT00308594|Dexamethasone|dexamethasone|mesh-list
93026995|NCT00561353|Antiviral Agents|antiviral agents|mesh-ancestor
93026996|NCT00561353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93026997|NCT00561353|Protease Inhibitors|protease inhibitors|mesh-ancestor
93026998|NCT00561353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027000|NCT00944957|Raltegravir Potassium|raltegravir potassium|mesh-list
93027001|NCT00944957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93027002|NCT00944957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027003|NCT00944957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027004|NCT00944957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027005|NCT00944957|Antiviral Agents|antiviral agents|mesh-ancestor
93027006|NCT00944957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027007|NCT00944957|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93027008|NCT00944957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93027009|NCT00944957|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93027010|NCT00944957|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93027011|NCT00944957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93027012|NCT00944957|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93027013|NCT00944957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93027014|NCT00944957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93027015|NCT00944957|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93027016|NCT00944957|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93027017|NCT00945347|Miglustat|miglustat|mesh-list
93027018|NCT00945347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027019|NCT00945347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027020|NCT00945347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93027021|NCT00945347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93027022|NCT00945347|Antiviral Agents|antiviral agents|mesh-ancestor
93027023|NCT00945347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027024|NCT00945347|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93027025|NCT00945347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93027026|NCT00945347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027027|NCT00941135|Docetaxel|docetaxel|mesh-list
93027028|NCT00941135|Cetuximab|cetuximab|mesh-list
93027029|NCT00941135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027030|NCT00941135|Tubulin Modulators|tubulin modulators|mesh-ancestor
93027031|NCT00941135|Antimitotic Agents|antimitotic agents|mesh-ancestor
93027032|NCT00941135|Mitosis Modulators|mitosis modulators|mesh-ancestor
93027033|NCT00941135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027034|NCT00941135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027035|NCT00556439|Abatacept|abatacept|mesh-list
93027036|NCT00556439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93027037|NCT00556439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027038|NCT00556439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027039|NCT00556439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027040|NCT00556439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93027041|NCT00556439|Immunologic Factors|immunologic factors|mesh-ancestor
93027042|NCT00556439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027043|NCT00556439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027044|NCT04012307|Candesartan|candesartan|mesh-list
93027045|NCT04012307|Candesartan cilexetil|candesartan cilexetil|mesh-list
93027046|NCT04012307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93027047|NCT04012307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93027048|NCT04012307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93027049|NCT04012307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027050|NCT00387465|Azacitidine|azacitidine|mesh-list
93027051|NCT00387465|Entinostat|entinostat|mesh-list
93027052|NCT00387465|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93027053|NCT00387465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93027054|NCT00387465|Antimetabolites|antimetabolites|mesh-ancestor
93027055|NCT00387465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027056|NCT00387465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027057|NCT00387465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027058|NCT01042665|Latanoprost|latanoprost|mesh-list
93027059|NCT01042665|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93027060|NCT01042665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93027061|NCT00949949|Gemcitabine|gemcitabine|mesh-list
93027062|NCT00949949|Everolimus|everolimus|mesh-list
93027063|NCT00949949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027064|NCT00949949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93027065|NCT00949949|Antimetabolites|antimetabolites|mesh-ancestor
93027066|NCT00949949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027067|NCT00949949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92672356|NCT00309569|Epirubicin|epirubicin|mesh-list
93027068|NCT00949949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93027069|NCT00949949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027070|NCT00949949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93027071|NCT00949949|Immunologic Factors|immunologic factors|mesh-ancestor
93027072|NCT00949949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027073|NCT00941369|Insulin|insulin|mesh-list
93027074|NCT00941369|Insulin Glargine|insulin glargine|mesh-list
93027075|NCT00941369|Insulin, Isophane|insulin, isophane|mesh-list
93027076|NCT00941369|Isophane Insulin, Human|isophane insulin, human|mesh-list
93027077|NCT00941369|Isophane insulin, beef|isophane insulin, beef|mesh-list
93027078|NCT00941369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93027079|NCT00941369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027080|NCT00950027|Povidone-Iodine|povidone-iodine|mesh-list
93027081|NCT00950027|Povidone|povidone|mesh-list
93027082|NCT00950027|Plasma Substitutes|plasma substitutes|mesh-ancestor
93027083|NCT00950027|Blood Substitutes|blood substitutes|mesh-ancestor
93027084|NCT00950027|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93027085|NCT00950027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027086|NCT00941525|Latanoprost|latanoprost|mesh-list
93027087|NCT00941525|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93027088|NCT00941525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93027089|NCT00456261|Bevacizumab|bevacizumab|mesh-list
93027090|NCT00456261|Carboplatin|carboplatin|mesh-list
93027091|NCT00456261|Gemcitabine|gemcitabine|mesh-list
93027092|NCT00456261|Pemetrexed|pemetrexed|mesh-list
93027093|NCT00456261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027094|NCT00456261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027095|NCT00456261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93027096|NCT00456261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93027098|NCT00456261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027099|NCT00456261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92182655|NCT05134987|Insulin Detemir|insulin detemir|mesh-list
93027100|NCT00456261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93027101|NCT00456261|Antimetabolites|antimetabolites|mesh-ancestor
93027102|NCT00456261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027103|NCT00456261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027104|NCT00456261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93027105|NCT00456261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027106|NCT00386607|Valsartan|valsartan|mesh-list
93027107|NCT00386607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93027108|NCT00386607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93027109|NCT00386607|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93027110|NCT00386607|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93027111|NCT00386607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027112|NCT00386607|Diuretics|diuretics|mesh-ancestor
93027113|NCT00386607|Natriuretic Agents|natriuretic agents|mesh-ancestor
93027114|NCT00386607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027115|NCT00386607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93027116|NCT00386607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027117|NCT00410163|Cyclophosphamide|cyclophosphamide|mesh-list
93027118|NCT00410163|Fludarabine|fludarabine|mesh-list
93027119|NCT00410163|Ofatumumab|ofatumumab|mesh-list
93027120|NCT00410163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93027121|NCT00410163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93027122|NCT00410163|Immunologic Factors|immunologic factors|mesh-ancestor
93027123|NCT00410163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027124|NCT00410163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027125|NCT00410163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93027126|NCT00410163|Alkylating Agents|alkylating agents|mesh-ancestor
93027127|NCT00410163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027128|NCT00410163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027129|NCT00410163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93027130|NCT03617523|Vaccines|vaccines|mesh-list
93027131|NCT03617523|Immunologic Factors|immunologic factors|mesh-ancestor
93027132|NCT03617523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027133|NCT00409617|Adalimumab|adalimumab|mesh-list
93027134|NCT00409617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93027135|NCT00409617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027136|NCT00409617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027137|NCT00300274|Cyclosporine|cyclosporine|mesh-list
93027138|NCT00300274|Mycophenolic Acid|mycophenolic acid|mesh-list
93027139|NCT00300274|Everolimus|everolimus|mesh-list
93027140|NCT00300274|Cyclosporins|cyclosporins|mesh-list
93027141|NCT00300274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027142|NCT00300274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027143|NCT00300274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672400|NCT00309725|Autonomic Agents|autonomic agents|mesh-ancestor
93027144|NCT00300274|Immunologic Factors|immunologic factors|mesh-ancestor
93027145|NCT00300274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027146|NCT00300274|Antifungal Agents|antifungal agents|mesh-ancestor
93027147|NCT00300274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027148|NCT00300274|Dermatologic Agents|dermatologic agents|mesh-ancestor
93027149|NCT00300274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027150|NCT00300274|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93027152|NCT00300274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93027153|NCT00300274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027154|NCT00300274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93027155|NCT00300274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93027156|NCT00300274|Antitubercular Agents|antitubercular agents|mesh-ancestor
93027157|NCT00300274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93027158|NCT01043211|Lidocaine|lidocaine|mesh-list
93027159|NCT01043211|Epinephrine|epinephrine|mesh-list
93027160|NCT01043211|Anesthetics, Local|anesthetics, local|mesh-ancestor
93027161|NCT01043211|Anesthetics|anesthetics|mesh-ancestor
93027162|NCT01043211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027163|NCT01043211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027164|NCT01043211|Sensory System Agents|sensory system agents|mesh-ancestor
93027165|NCT01043211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027166|NCT01043211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93027167|NCT01043211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93027168|NCT01043211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93027169|NCT01043211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372760|NCT01542372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027170|NCT01043211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182659|NCT05545800|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93027171|NCT01043211|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93027172|NCT01043211|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93027173|NCT01043211|Adrenergic Agents|adrenergic agents|mesh-ancestor
93027174|NCT01043211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027175|NCT01043211|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93027176|NCT01043211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93027177|NCT01043211|Autonomic Agents|autonomic agents|mesh-ancestor
93027178|NCT01043211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93027179|NCT01043211|Respiratory System Agents|respiratory system agents|mesh-ancestor
93027180|NCT01043211|Mydriatics|mydriatics|mesh-ancestor
93027181|NCT01043211|Sympathomimetics|sympathomimetics|mesh-ancestor
93027182|NCT01043211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93027183|NCT01043445|Glycerol|glycerol|mesh-list
93027184|NCT01043445|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93027185|NCT01043445|Protective Agents|protective agents|mesh-ancestor
93027186|NCT01043445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027187|NCT00396591|Aflibercept|aflibercept|mesh-list
93027188|NCT00396591|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93027189|NCT00396591|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93027190|NCT00396591|Growth Substances|growth substances|mesh-ancestor
93027191|NCT00396591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027192|NCT00396591|Growth Inhibitors|growth inhibitors|mesh-ancestor
93027193|NCT00396591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027194|NCT00316264|Palivizumab|palivizumab|mesh-list
93027195|NCT00316264|Antiviral Agents|antiviral agents|mesh-ancestor
93027196|NCT00316264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027197|NCT00385827|Prednisone|prednisone|mesh-list
93027198|NCT00385827|Mitoxantrone|mitoxantrone|mesh-list
93027199|NCT00385827|Siltuximab|siltuximab|mesh-list
93027200|NCT00385827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027201|NCT00385827|Glucocorticoids|glucocorticoids|mesh-ancestor
93027202|NCT00385827|Hormones|hormones|mesh-ancestor
93027203|NCT00385827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027204|NCT00385827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027205|NCT00385827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93027206|NCT00385827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027207|NCT00385827|Analgesics|analgesics|mesh-ancestor
93027208|NCT00385827|Sensory System Agents|sensory system agents|mesh-ancestor
93027209|NCT00385827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027210|NCT00385827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93027211|NCT00385827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93027212|NCT00385827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027213|NCT00385827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027214|NCT00498602|Saponin QA-21V1|saponin qa-21v1|mesh-list
93027215|NCT00498602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93027216|NCT00498602|Immunologic Factors|immunologic factors|mesh-ancestor
93027217|NCT00498602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027218|NCT00507728|Bupropion|bupropion|mesh-list
93027219|NCT00507728|Varenicline|varenicline|mesh-list
93027220|NCT00507728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93027221|NCT00507728|Antidepressive Agents|antidepressive agents|mesh-ancestor
93027222|NCT00507728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027223|NCT00507728|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93027224|NCT00507728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93027225|NCT00507728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027226|NCT00507728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027227|NCT00507728|Dopamine Agents|dopamine agents|mesh-ancestor
93027228|NCT00507728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027229|NCT00507728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027230|NCT00507728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93027231|NCT00507728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93027232|NCT00507728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027233|NCT00507728|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93027234|NCT00507728|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93027235|NCT00507728|Cholinergic Agents|cholinergic agents|mesh-ancestor
93027236|NCT00498368|Rituximab|rituximab|mesh-list
93027237|NCT00498368|Angiotensin II|angiotensin ii|mesh-list
93027238|NCT00498368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027239|NCT00498368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027240|NCT00498368|Immunologic Factors|immunologic factors|mesh-ancestor
93027241|NCT00498368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027242|NCT00498368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027243|NCT00498368|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93027244|NCT04460066|Paclitaxel|paclitaxel|mesh-list
93027245|NCT04460066|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93027246|NCT04460066|Antibodies|antibodies|mesh-list
93027247|NCT04460066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93027248|NCT04460066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027249|NCT04460066|Tubulin Modulators|tubulin modulators|mesh-ancestor
93027250|NCT04460066|Antimitotic Agents|antimitotic agents|mesh-ancestor
93027251|NCT04460066|Mitosis Modulators|mitosis modulators|mesh-ancestor
93027252|NCT04460066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027253|NCT04460066|Immunologic Factors|immunologic factors|mesh-ancestor
93027254|NCT04460066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027255|NCT00385671|Pregabalin|pregabalin|mesh-list
93027256|NCT00385671|Gabapentin|gabapentin|mesh-list
93027257|NCT00385671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93027258|NCT00385671|Analgesics|analgesics|mesh-ancestor
93027259|NCT00385671|Sensory System Agents|sensory system agents|mesh-ancestor
93027260|NCT00385671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027261|NCT00385671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027262|NCT00385671|Anticonvulsants|anticonvulsants|mesh-ancestor
93027263|NCT00385671|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93027264|NCT00385671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027265|NCT00385671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027266|NCT00385671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93027267|NCT00385671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93027268|NCT00385671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027269|NCT00385671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027270|NCT00385671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027271|NCT00385671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93027272|NCT00385671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93027273|NCT00385671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027274|NCT00385671|Antimanic Agents|antimanic agents|mesh-ancestor
93027275|NCT00385671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93027276|NCT00385671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93027277|NCT00385671|Antidepressive Agents|antidepressive agents|mesh-ancestor
93027278|NCT00385671|Dopamine Agents|dopamine agents|mesh-ancestor
93027279|NCT00497198|Bile Acids and Salts|bile acids and salts|mesh-list
93027280|NCT00497198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93027281|NCT00496964|Botulinum Toxins|botulinum toxins|mesh-list
93027282|NCT00496964|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93027283|NCT00496964|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93027284|NCT00496964|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93027285|NCT00496964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027286|NCT00496964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027287|NCT00496964|Cholinergic Agents|cholinergic agents|mesh-ancestor
93027288|NCT00496964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027289|NCT00496964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027290|NCT00496964|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93027291|NCT00496964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027292|NCT01011062|Losartan|losartan|mesh-list
93027293|NCT01011062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93027294|NCT01011062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93027295|NCT01011062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93027296|NCT01011062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93027297|NCT01011062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027298|NCT00490490|Iodine|iodine|mesh-list
93027299|NCT00490490|Lugol's solution|lugol's solution|mesh-list
93027300|NCT00490490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93027301|NCT00490490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93027302|NCT00490490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027303|NCT00490490|Trace Elements|trace elements|mesh-ancestor
93027304|NCT00490490|Micronutrients|micronutrients|mesh-ancestor
93027305|NCT00490490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027306|NCT00490490|Hemostatics|hemostatics|mesh-ancestor
93027307|NCT00490490|Coagulants|coagulants|mesh-ancestor
93027308|NCT05049980|Mifepristone|mifepristone|mesh-list
93027309|NCT05049980|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93027310|NCT05049980|Abortifacient Agents|abortifacient agents|mesh-ancestor
93027311|NCT05049980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93027312|NCT05049980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027313|NCT05049980|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93027314|NCT05049980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93027315|NCT05049980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93027316|NCT05049980|Contraceptive Agents|contraceptive agents|mesh-ancestor
93027317|NCT05049980|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93027318|NCT05049980|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93027319|NCT05049980|Hormone Antagonists|hormone antagonists|mesh-ancestor
93027320|NCT05049980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027321|NCT05049980|Luteolytic Agents|luteolytic agents|mesh-ancestor
93027322|NCT05049980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93027323|NCT05049980|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93027324|NCT05176418|Nicotine|nicotine|mesh-list
93027325|NCT05176418|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93027326|NCT05176418|Autonomic Agents|autonomic agents|mesh-ancestor
93027327|NCT05176418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027328|NCT05176418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027329|NCT05176418|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93027330|NCT05176418|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93027331|NCT05176418|Cholinergic Agents|cholinergic agents|mesh-ancestor
93027332|NCT05176418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027333|NCT05176418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027334|NCT00385593|Budesonide|budesonide|mesh-list
93027335|NCT00385593|Formoterol Fumarate|formoterol fumarate|mesh-list
93027336|NCT00385593|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93027337|NCT00385593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027338|NCT00385593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93027339|NCT00385593|Autonomic Agents|autonomic agents|mesh-ancestor
93027340|NCT00385593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027341|NCT00385593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027342|NCT00385593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93027343|NCT00385593|Respiratory System Agents|respiratory system agents|mesh-ancestor
93027344|NCT00385593|Glucocorticoids|glucocorticoids|mesh-ancestor
93027345|NCT00385593|Hormones|hormones|mesh-ancestor
93027346|NCT00385593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027347|NCT00385593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93027348|NCT00385593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93027349|NCT00385593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93027350|NCT00385593|Adrenergic Agents|adrenergic agents|mesh-ancestor
93027351|NCT00385593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027352|NCT00385593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027353|NCT01015040|Solifenacin Succinate|solifenacin succinate|mesh-list
93027354|NCT01015040|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93027355|NCT01015040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93027356|NCT01015040|Cholinergic Agents|cholinergic agents|mesh-ancestor
93027357|NCT01015040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027358|NCT01015040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027359|NCT01015040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027360|NCT01015040|Urological Agents|urological agents|mesh-ancestor
93027361|NCT00495170|Paclitaxel|paclitaxel|mesh-list
93027362|NCT00495170|Carboplatin|carboplatin|mesh-list
93027363|NCT00495170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93027364|NCT00495170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027365|NCT00495170|Tubulin Modulators|tubulin modulators|mesh-ancestor
93027366|NCT00495170|Antimitotic Agents|antimitotic agents|mesh-ancestor
93027367|NCT00495170|Mitosis Modulators|mitosis modulators|mesh-ancestor
93027368|NCT00495170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027369|NCT01011374|Ranibizumab|ranibizumab|mesh-list
93027370|NCT01011374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93027371|NCT01011374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93027372|NCT01011374|Growth Substances|growth substances|mesh-ancestor
93027373|NCT01011374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027374|NCT01011374|Growth Inhibitors|growth inhibitors|mesh-ancestor
93027375|NCT01011374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027376|NCT00385203|Cediranib|cediranib|mesh-list
93027377|NCT00385203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027378|NCT00385203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93027379|NCT00385203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027380|NCT00385203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027381|NCT01043601|Formoterol Fumarate|formoterol fumarate|mesh-list
93027382|NCT01043601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93027383|NCT01043601|Autonomic Agents|autonomic agents|mesh-ancestor
93027384|NCT01043601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027385|NCT01043601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528977|NCT00014937|Lamivudine|lamivudine|mesh-list
93027386|NCT01043601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93027387|NCT01043601|Respiratory System Agents|respiratory system agents|mesh-ancestor
93027388|NCT01043601|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93027389|NCT01043601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93027390|NCT01043601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93027391|NCT01043601|Adrenergic Agents|adrenergic agents|mesh-ancestor
93027392|NCT01043601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027393|NCT01043601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027394|NCT01043679|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93027395|NCT01043679|Antidepressive Agents|antidepressive agents|mesh-ancestor
93027396|NCT01043679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027397|NCT01043679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93027398|NCT01043679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027399|NCT01043679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027400|NCT01043679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027401|NCT00408993|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93027402|NCT00408993|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93027403|NCT00408993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93027404|NCT00408993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027405|NCT00408993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027406|NCT00408993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027407|NCT00408993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027408|NCT00408993|Analgesics|analgesics|mesh-ancestor
93027409|NCT00408993|Sensory System Agents|sensory system agents|mesh-ancestor
93027410|NCT00408993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027411|NCT00408993|Antidepressive Agents|antidepressive agents|mesh-ancestor
93027412|NCT00408993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027413|NCT00408993|Dopamine Agents|dopamine agents|mesh-ancestor
92182696|NCT00235573|Vitamins|vitamins|mesh-ancestor
93027415|NCT00395967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93027416|NCT00395967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93027417|NCT00395967|Antiviral Agents|antiviral agents|mesh-ancestor
93027418|NCT00395967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027419|NCT00395343|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93027420|NCT00395343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93027421|NCT00395343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027422|NCT00395343|Incretins|incretins|mesh-ancestor
93027423|NCT00395343|Hormones|hormones|mesh-ancestor
93027424|NCT00395343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027425|NCT00395343|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93027426|NCT00395343|Protease Inhibitors|protease inhibitors|mesh-ancestor
93027427|NCT00395343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027428|NCT00395343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027429|NCT00560573|Gemcitabine|gemcitabine|mesh-list
93027430|NCT00560573|Pemetrexed|pemetrexed|mesh-list
93027431|NCT00560573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027432|NCT00560573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93027433|NCT00560573|Antimetabolites|antimetabolites|mesh-ancestor
93027434|NCT00560573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027435|NCT00560573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027436|NCT00560573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93027437|NCT00560573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027438|NCT00950105|Semapimod|semapimod|mesh-list
93027439|NCT00950105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93027440|NCT00950105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93027441|NCT00950105|Analgesics|analgesics|mesh-ancestor
93027442|NCT00950105|Sensory System Agents|sensory system agents|mesh-ancestor
93027443|NCT00950105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027444|NCT00950105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027445|NCT00950105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027446|NCT00950105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027447|NCT00950105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93027448|NCT00950105|Immunologic Factors|immunologic factors|mesh-ancestor
93027449|NCT00950261|Cisplatin|cisplatin|mesh-list
93027450|NCT00950261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027451|NCT05280197|Bupivacaine|bupivacaine|mesh-list
93027452|NCT05280197|Anesthetics, Local|anesthetics, local|mesh-ancestor
93027453|NCT05280197|Anesthetics|anesthetics|mesh-ancestor
93027454|NCT05280197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027455|NCT05280197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027456|NCT05280197|Sensory System Agents|sensory system agents|mesh-ancestor
93027457|NCT05280197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027458|NCT00946595|Ritonavir|ritonavir|mesh-list
93027459|NCT00946595|Lopinavir|lopinavir|mesh-list
93027460|NCT00946595|Tenofovir|tenofovir|mesh-list
93027461|NCT00946595|Efavirenz|efavirenz|mesh-list
93027462|NCT00946595|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93027463|NCT00946595|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93027464|NCT00946595|Protease Inhibitors|protease inhibitors|mesh-ancestor
93027465|NCT00946595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027466|NCT00946595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027467|NCT00946595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93027468|NCT00946595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93027469|NCT00946595|Antiviral Agents|antiviral agents|mesh-ancestor
93027470|NCT00946595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027471|NCT00946595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93027472|NCT00946595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93027473|NCT00946595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93027474|NCT00946595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027475|NCT00946595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93027476|NCT00946595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93027477|NCT00946595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93027478|NCT00946595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93027479|NCT00946595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93027480|NCT00494780|Prednisone|prednisone|mesh-list
93027481|NCT00494780|Prednisolone|prednisolone|mesh-list
93027482|NCT00494780|Cyclophosphamide|cyclophosphamide|mesh-list
93027483|NCT00494780|Doxorubicin|doxorubicin|mesh-list
93027484|NCT00494780|Vincristine|vincristine|mesh-list
93027485|NCT00494780|Ofatumumab|ofatumumab|mesh-list
93027486|NCT00494780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93027487|NCT00494780|Immunologic Factors|immunologic factors|mesh-ancestor
93027488|NCT00494780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027489|NCT00494780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027490|NCT00494780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93027491|NCT00494780|Alkylating Agents|alkylating agents|mesh-ancestor
93027492|NCT00494780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027493|NCT00494780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027494|NCT00494780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93027495|NCT00494780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93027496|NCT00494780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93027497|NCT00494780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93027498|NCT00494780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027499|NCT00494780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027500|NCT00494780|Glucocorticoids|glucocorticoids|mesh-ancestor
93027501|NCT00494780|Hormones|hormones|mesh-ancestor
93027502|NCT00494780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027503|NCT00494780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93027504|NCT00494780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93027505|NCT00494780|Tubulin Modulators|tubulin modulators|mesh-ancestor
93027506|NCT00494780|Antimitotic Agents|antimitotic agents|mesh-ancestor
93027507|NCT00494780|Mitosis Modulators|mitosis modulators|mesh-ancestor
93027508|NCT01011452|Montelukast|montelukast|mesh-list
93027509|NCT01011452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93027510|NCT01011452|Respiratory System Agents|respiratory system agents|mesh-ancestor
93027511|NCT01011452|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93027512|NCT01011452|Hormone Antagonists|hormone antagonists|mesh-ancestor
93027513|NCT01011452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027514|NCT01011452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027515|NCT01011452|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93027516|NCT01011452|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93027517|NCT01011452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027518|NCT00490022|Dihydrotestosterone|dihydrotestosterone|mesh-list
93027520|NCT00490022|Hormones|hormones|mesh-ancestor
93027521|NCT00490022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027522|NCT00490022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027523|NCT01011530|Pevonedistat|pevonedistat|mesh-list
93027524|NCT01011530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027525|NCT01011530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027526|NCT00493454|Rituximab|rituximab|mesh-list
93027527|NCT00493454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93027528|NCT00493454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027529|NCT00493454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027530|NCT00493454|Immunologic Factors|immunologic factors|mesh-ancestor
93027531|NCT00493454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027533|NCT00493220|Ceftriaxone|ceftriaxone|mesh-list
93027534|NCT00493220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93027535|NCT00493220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027536|NCT00950339|Omeprazole|omeprazole|mesh-list
93027537|NCT00950339|Pantoprazole|pantoprazole|mesh-list
93027538|NCT00950339|Famotidine|famotidine|mesh-list
93027539|NCT00950339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93027540|NCT00950339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93027541|NCT00950339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93027542|NCT00950339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027543|NCT00950339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027544|NCT00950339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92182730|NCT00124579|Hormones|hormones|mesh-ancestor
93027545|NCT00950339|Histamine Antagonists|histamine antagonists|mesh-ancestor
93027546|NCT00950339|Histamine Agents|histamine agents|mesh-ancestor
93027547|NCT00950339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027548|NCT00950339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027549|NCT00950417|Nimotuzumab|nimotuzumab|mesh-list
93027550|NCT00950417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027551|NCT00950417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027552|NCT00946673|Vorinostat|vorinostat|mesh-list
93027553|NCT00946673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027554|NCT00946673|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93027555|NCT00946673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027556|NCT00946673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027557|NCT00394953|Darbepoetin alfa|darbepoetin alfa|mesh-list
93027558|NCT00394953|Hematinics|hematinics|mesh-ancestor
93027559|NCT00946751|Levetiracetam|levetiracetam|mesh-list
93027560|NCT00946751|Anticonvulsants|anticonvulsants|mesh-ancestor
93027561|NCT00946751|Nootropic Agents|nootropic agents|mesh-ancestor
93027562|NCT00485732|Vaccines|vaccines|mesh-list
93027563|NCT00485732|Immunologic Factors|immunologic factors|mesh-ancestor
93027564|NCT00485732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027565|NCT00946829|Telmisartan|telmisartan|mesh-list
93027566|NCT00946829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93027567|NCT00946829|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93027568|NCT00946829|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93027569|NCT00946829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027570|NCT00489554|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93027571|NCT00489554|Immunologic Factors|immunologic factors|mesh-ancestor
93027572|NCT00489554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027573|NCT00408681|Lithium Carbonate|lithium carbonate|mesh-list
93027574|NCT00408681|Antidepressive Agents|antidepressive agents|mesh-ancestor
93027575|NCT00408681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027576|NCT00408681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027577|NCT00408681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027578|NCT00408681|Antimanic Agents|antimanic agents|mesh-ancestor
93027579|NCT00408681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027580|NCT00408681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027581|NCT00408681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027582|NCT00560417|Insulin|insulin|mesh-list
93027583|NCT00560417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93027584|NCT00560417|Insulin Glargine|insulin glargine|mesh-list
93027585|NCT00560417|Insulin Lispro|insulin lispro|mesh-list
93027586|NCT00560417|Protamines|protamines|mesh-list
93027587|NCT00560417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93027588|NCT00560417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027589|NCT00560417|Heparin Antagonists|heparin antagonists|mesh-ancestor
93027590|NCT00560417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027592|NCT01040091|Tenofovir|tenofovir|mesh-list
93027593|NCT01040091|Emtricitabine|emtricitabine|mesh-list
93027594|NCT01040091|Efavirenz|efavirenz|mesh-list
93027595|NCT01040091|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93027596|NCT01040091|Antiviral Agents|antiviral agents|mesh-ancestor
93027597|NCT01040091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027598|NCT01040091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93027599|NCT01040091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027600|NCT01040091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027601|NCT01040091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027602|NCT01040091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93027603|NCT01040091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93027604|NCT01040091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93027605|NCT01040091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528982|NCT00014937|Efavirenz|efavirenz|mesh-list
93027606|NCT01040091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93027608|NCT01040091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93027609|NCT01040091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93027610|NCT00946907|Aspirin|aspirin|mesh-list
93027611|NCT00946907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93027612|NCT00946907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93027613|NCT00946907|Analgesics|analgesics|mesh-ancestor
93027614|NCT00946907|Sensory System Agents|sensory system agents|mesh-ancestor
93027615|NCT00946907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027616|NCT00946907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182736|NCT00124579|Leprostatic Agents|leprostatic agents|mesh-ancestor
93027617|NCT00946907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027618|NCT00946907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027619|NCT00946907|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93027620|NCT00946907|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93027621|NCT00946907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027622|NCT00946907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93027623|NCT00946907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93027624|NCT00946907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027625|NCT00946907|Antipyretics|antipyretics|mesh-ancestor
93027626|NCT00942539|Midazolam|midazolam|mesh-list
93027627|NCT00942539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93027628|NCT00942539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93027629|NCT00942539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027630|NCT00942539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027631|NCT00942539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93027632|NCT00942539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027633|NCT00942539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027634|NCT00942539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93027635|NCT00942539|Anesthetics, General|anesthetics, general|mesh-ancestor
93027636|NCT00942539|Anesthetics|anesthetics|mesh-ancestor
93027637|NCT00942539|GABA Modulators|gaba modulators|mesh-ancestor
93027638|NCT00942539|GABA Agents|gaba agents|mesh-ancestor
93027639|NCT00942539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027640|NCT00942539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027641|NCT00947063|Promethazine|promethazine|mesh-list
93027642|NCT00947063|Diphenhydramine|diphenhydramine|mesh-list
93027643|NCT00947063|Antipruritics|antipruritics|mesh-ancestor
93027644|NCT00947063|Dermatologic Agents|dermatologic agents|mesh-ancestor
93027645|NCT00947063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93027646|NCT00947063|Histamine Antagonists|histamine antagonists|mesh-ancestor
93027647|NCT00947063|Histamine Agents|histamine agents|mesh-ancestor
93027648|NCT00947063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027649|NCT00947063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027650|NCT00947063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027651|NCT00947063|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93027652|NCT00947063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93027653|NCT00947063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93027654|NCT00947063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027655|NCT00947063|Anesthetics, Local|anesthetics, local|mesh-ancestor
93027656|NCT00947063|Anesthetics|anesthetics|mesh-ancestor
93027657|NCT00947063|Sensory System Agents|sensory system agents|mesh-ancestor
93027658|NCT00947063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027659|NCT00947063|Antiemetics|antiemetics|mesh-ancestor
93027660|NCT00947063|Autonomic Agents|autonomic agents|mesh-ancestor
93027661|NCT00947063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93027662|NCT00942617|Aspirin|aspirin|mesh-list
93027663|NCT00942617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93027664|NCT00942617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93027665|NCT00942617|Analgesics|analgesics|mesh-ancestor
93027666|NCT00942617|Sensory System Agents|sensory system agents|mesh-ancestor
93027667|NCT00942617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027668|NCT00942617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027669|NCT00942617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027670|NCT00942617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027671|NCT00942617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93027672|NCT00942617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93027673|NCT00942617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027674|NCT00942617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93027675|NCT00942617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93027676|NCT00942617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027677|NCT00942617|Antipyretics|antipyretics|mesh-ancestor
93027678|NCT00345345|Alemtuzumab|alemtuzumab|mesh-list
93027679|NCT00345345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027680|NCT00345345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027681|NCT03968159|Pimavanserin|pimavanserin|mesh-list
93027682|NCT03968159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93027683|NCT03968159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93027684|NCT03968159|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93027685|NCT03968159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027686|NCT03968159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027687|NCT03968159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027688|NCT03968159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027689|NCT03968159|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93027690|NCT03968159|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93027691|NCT03968159|Serotonin Agents|serotonin agents|mesh-ancestor
93027692|NCT03968159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027693|NCT03968159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027694|NCT00947141|Valganciclovir|valganciclovir|mesh-list
93027695|NCT00947141|Ganciclovir|ganciclovir|mesh-list
93027696|NCT00947141|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
93027697|NCT00947141|Foscarnet|foscarnet|mesh-list
93027698|NCT00947141|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
93027699|NCT00947141|Antiviral Agents|antiviral agents|mesh-ancestor
93027700|NCT00947141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027701|NCT00947141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027702|NCT00947141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027703|NCT00947141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027704|NCT00947141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93027705|NCT03966365|Timolol|timolol|mesh-list
93027706|NCT03966365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93027707|NCT03966365|Dorzolamide|dorzolamide|mesh-list
93027708|NCT03966365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93027709|NCT03966365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93027710|NCT03966365|Adrenergic Agents|adrenergic agents|mesh-ancestor
93027711|NCT03966365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027712|NCT03966365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027713|NCT03966365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027714|NCT03966365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93027715|NCT03966365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93027716|NCT03966365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93027717|NCT03966365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93027718|NCT03966365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93027719|NCT03966365|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93027720|NCT03966365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027721|NCT00375219|Homoharringtonine|homoharringtonine|mesh-list
93027722|NCT00375219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93027723|NCT00375219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027724|NCT00375219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93027725|NCT00375219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027726|NCT00375219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027727|NCT03965351|Probenecid|probenecid|mesh-list
93027728|NCT03965351|Uricosuric Agents|uricosuric agents|mesh-ancestor
93027729|NCT03965351|Gout Suppressants|gout suppressants|mesh-ancestor
93027730|NCT03965351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027731|NCT00947375|Lamotrigine|lamotrigine|mesh-list
93027732|NCT00947375|Haloperidol|haloperidol|mesh-list
93027733|NCT00947375|Haloperidol decanoate|haloperidol decanoate|mesh-list
93027734|NCT00947375|Antiemetics|antiemetics|mesh-ancestor
93027735|NCT00947375|Autonomic Agents|autonomic agents|mesh-ancestor
93027736|NCT00947375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027737|NCT00947375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027738|NCT00947375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93027739|NCT00947375|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93027740|NCT00947375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027741|NCT00947375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027742|NCT00947375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027743|NCT00947375|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93027744|NCT00947375|Dopamine Agents|dopamine agents|mesh-ancestor
93027745|NCT00947375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027746|NCT00947375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027747|NCT00947375|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93027748|NCT00947375|Anticonvulsants|anticonvulsants|mesh-ancestor
93027749|NCT00947375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93027750|NCT00947375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027751|NCT00947375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93027752|NCT00947375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93027753|NCT00947453|Montelukast|montelukast|mesh-list
93027755|NCT00947453|Respiratory System Agents|respiratory system agents|mesh-ancestor
93027756|NCT00947453|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93027757|NCT00947453|Hormone Antagonists|hormone antagonists|mesh-ancestor
93027758|NCT00947453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027759|NCT00947453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027760|NCT00947453|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93027761|NCT00947453|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93027762|NCT00947453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027763|NCT00942773|Voriconazole|voriconazole|mesh-list
93027764|NCT00942773|Antifungal Agents|antifungal agents|mesh-ancestor
93027765|NCT00942773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027766|NCT00942773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93027767|NCT00942773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93027768|NCT00942773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027769|NCT00942773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027770|NCT00942773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93027771|NCT00942773|Hormone Antagonists|hormone antagonists|mesh-ancestor
93027772|NCT00942773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027773|NCT00942773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027774|NCT00942773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93027775|NCT04364555|Clobetasol|clobetasol|mesh-list
93027776|NCT04364555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027777|NCT04364555|Glucocorticoids|glucocorticoids|mesh-ancestor
93027778|NCT04364555|Hormones|hormones|mesh-ancestor
93027779|NCT04364555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027780|NCT04364555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027781|NCT00374907|Metformin|metformin|mesh-list
93027782|NCT00374907|Saxagliptin|saxagliptin|mesh-list
93027783|NCT00374907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93027784|NCT00374907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027785|NCT00374907|Incretins|incretins|mesh-ancestor
93027786|NCT00374907|Hormones|hormones|mesh-ancestor
93027787|NCT00374907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027788|NCT00374907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93027789|NCT00374907|Protease Inhibitors|protease inhibitors|mesh-ancestor
93027790|NCT00374907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027791|NCT00374907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027792|NCT01045083|Methylphenidate|methylphenidate|mesh-list
93027793|NCT01045083|Escitalopram|escitalopram|mesh-list
93027794|NCT01045083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93027795|NCT01045083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93027796|NCT01045083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027797|NCT01045083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027798|NCT01045083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027799|NCT01045083|Serotonin Agents|serotonin agents|mesh-ancestor
93027800|NCT01045083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027801|NCT01045083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93027802|NCT01045083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93027803|NCT01045083|Dopamine Agents|dopamine agents|mesh-ancestor
93027804|NCT01040325|Vaccines|vaccines|mesh-list
93027805|NCT01040325|Immunologic Factors|immunologic factors|mesh-ancestor
93027806|NCT01040325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027807|NCT00947843|Aspirin|aspirin|mesh-list
93027808|NCT00947843|Clopidogrel|clopidogrel|mesh-list
92673078|NCT00348153|Adalimumab|adalimumab|mesh-list
93027809|NCT00947843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93027810|NCT00947843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93027811|NCT00947843|Analgesics|analgesics|mesh-ancestor
93027812|NCT00947843|Sensory System Agents|sensory system agents|mesh-ancestor
93027813|NCT00947843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027814|NCT00947843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027815|NCT00947843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027816|NCT00947843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027817|NCT00947843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93027818|NCT00947843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93027819|NCT00947843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027820|NCT00947843|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93027821|NCT00947843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93027822|NCT00947843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027823|NCT00947843|Antipyretics|antipyretics|mesh-ancestor
93027824|NCT00947843|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93027825|NCT00947843|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93027826|NCT00947843|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93027827|NCT00947843|Purinergic Agents|purinergic agents|mesh-ancestor
93027828|NCT00947843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93027829|NCT00948077|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
93027830|NCT00948077|Antitubercular Agents|antitubercular agents|mesh-ancestor
93027831|NCT00948077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93027832|NCT00948077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027833|NCT00407745|Pregabalin|pregabalin|mesh-list
93027834|NCT00407745|Analgesics|analgesics|mesh-ancestor
93027835|NCT00407745|Sensory System Agents|sensory system agents|mesh-ancestor
93027836|NCT00407745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027837|NCT00407745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027838|NCT00407745|Anticonvulsants|anticonvulsants|mesh-ancestor
93027839|NCT00407745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93027840|NCT00407745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93027841|NCT00407745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027842|NCT00407745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93027843|NCT00407745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93027844|NCT00407745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93027845|NCT00407745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93027846|NCT00407745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93027847|NCT00951431|Esomeprazole|esomeprazole|mesh-list
93027848|NCT00951431|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93027849|NCT00951431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93027850|NCT00951431|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93027851|NCT00951431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027852|NCT00951431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027853|NCT00299494|Rituximab|rituximab|mesh-list
93027854|NCT00299494|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
93027855|NCT00299494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027856|NCT00299494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027857|NCT00299494|Immunologic Factors|immunologic factors|mesh-ancestor
93027858|NCT00299494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027859|NCT00299494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027860|NCT00299494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93027861|NCT00299494|Immunotoxins|immunotoxins|mesh-ancestor
93027862|NCT00299494|Immunoconjugates|immunoconjugates|mesh-ancestor
93027863|NCT00943553|Decitabine|decitabine|mesh-list
93027864|NCT00943553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93027865|NCT00943553|Antimetabolites|antimetabolites|mesh-ancestor
93027866|NCT00943553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027867|NCT00943553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027868|NCT00943553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027869|NCT00453180|Acetylcysteine|acetylcysteine|mesh-list
93027870|NCT00453180|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93027871|NCT00453180|Antiviral Agents|antiviral agents|mesh-ancestor
93027872|NCT00453180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027873|NCT00453180|Expectorants|expectorants|mesh-ancestor
93027874|NCT00453180|Respiratory System Agents|respiratory system agents|mesh-ancestor
93027875|NCT00453180|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93027876|NCT00453180|Antioxidants|antioxidants|mesh-ancestor
93027877|NCT00453180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027878|NCT00453180|Protective Agents|protective agents|mesh-ancestor
93027879|NCT00453180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027880|NCT00453180|Antidotes|antidotes|mesh-ancestor
93027881|NCT00943709|Insulin|insulin|mesh-list
93027882|NCT00943709|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93027883|NCT00943709|Insulin Glargine|insulin glargine|mesh-list
93027884|NCT00943709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93027885|NCT00943709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027886|NCT00464178|Bortezomib|bortezomib|mesh-list
93027887|NCT00464178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027888|NCT00316186|Carboplatin|carboplatin|mesh-list
93027889|NCT00316186|Topotecan|topotecan|mesh-list
93027890|NCT00316186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027891|NCT00316186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93027892|NCT00316186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93027893|NCT00316186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027894|NCT00316186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027895|NCT01065220|Cyproterone Acetate|cyproterone acetate|mesh-list
93027896|NCT01065220|Testolactone|testolactone|mesh-list
93027897|NCT01065220|Lynestrenol|lynestrenol|mesh-list
93027898|NCT01065220|Estradiol|estradiol|mesh-list
93027899|NCT01065220|Cyproterone|cyproterone|mesh-list
93027900|NCT01065220|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
93027901|NCT01065220|Estrogens|estrogens|mesh-ancestor
93027902|NCT01065220|Hormones|hormones|mesh-ancestor
93027903|NCT01065220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027904|NCT01065220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027905|NCT01065220|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93027906|NCT01065220|Contraceptive Agents|contraceptive agents|mesh-ancestor
93027907|NCT01065220|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93027908|NCT01065220|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93027909|NCT01065220|Androgen Antagonists|androgen antagonists|mesh-ancestor
93027910|NCT01065220|Hormone Antagonists|hormone antagonists|mesh-ancestor
93027911|NCT01065220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027912|NCT01065220|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93027913|NCT01065220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93027914|NCT01065220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027915|NCT01065220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027916|NCT01065220|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93027917|NCT01065220|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93027918|NCT01065220|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93027919|NCT01065220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93027920|NCT00943943|Plerixafor|plerixafor|mesh-list
93027921|NCT00943943|Sorafenib|sorafenib|mesh-list
93027922|NCT00943943|Lenograstim|lenograstim|mesh-list
93027923|NCT00943943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027924|NCT00943943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92182790|NCT01689441|Vitamins|vitamins|mesh-ancestor
93027925|NCT00943943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027926|NCT00943943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027927|NCT00943943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93027928|NCT00943943|Immunologic Factors|immunologic factors|mesh-ancestor
93027929|NCT00943943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027930|NCT00943943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93027931|NCT00943943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93027932|NCT00943943|Antiviral Agents|antiviral agents|mesh-ancestor
93027933|NCT00943943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027934|NCT00948779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93027935|NCT00948779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93027936|NCT00948779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027937|NCT00948779|Antitubercular Agents|antitubercular agents|mesh-ancestor
93027938|NCT00453102|Rituximab|rituximab|mesh-list
93027939|NCT00453102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027940|NCT00453102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027941|NCT00453102|Immunologic Factors|immunologic factors|mesh-ancestor
93027942|NCT00453102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027943|NCT00453102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027944|NCT00299182|Cytarabine|cytarabine|mesh-list
93027945|NCT00299182|Dexamethasone|dexamethasone|mesh-list
93027946|NCT00299182|Cyclophosphamide|cyclophosphamide|mesh-list
93027947|NCT00299182|Rituximab|rituximab|mesh-list
93027948|NCT00299182|Doxorubicin|doxorubicin|mesh-list
93027949|NCT00299182|Methotrexate|methotrexate|mesh-list
93027950|NCT00299182|Vincristine|vincristine|mesh-list
93027951|NCT00299182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93027952|NCT00299182|Immunologic Factors|immunologic factors|mesh-ancestor
93027953|NCT00299182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93027954|NCT00299182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93027955|NCT00299182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93027956|NCT00299182|Alkylating Agents|alkylating agents|mesh-ancestor
93027957|NCT00299182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93027958|NCT00299182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027959|NCT00299182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93027960|NCT00299182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027961|NCT00299182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93027962|NCT00299182|Antiemetics|antiemetics|mesh-ancestor
93027963|NCT00299182|Autonomic Agents|autonomic agents|mesh-ancestor
93027964|NCT00299182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93027965|NCT00299182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93027966|NCT00299182|Glucocorticoids|glucocorticoids|mesh-ancestor
93027967|NCT00299182|Hormones|hormones|mesh-ancestor
93027968|NCT00299182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93027969|NCT00299182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93027970|NCT00299182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93027971|NCT00299182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528985|NCT00014937|Protease Inhibitors|protease inhibitors|mesh-ancestor
93027972|NCT00299182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93027973|NCT00299182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93027974|NCT00299182|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93027975|NCT00299182|Abortifacient Agents|abortifacient agents|mesh-ancestor
93027976|NCT00299182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93027977|NCT00299182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93027978|NCT00299182|Antimetabolites|antimetabolites|mesh-ancestor
93027979|NCT00299182|Dermatologic Agents|dermatologic agents|mesh-ancestor
93027980|NCT00299182|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93027981|NCT00299182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93027982|NCT00299182|Antiviral Agents|antiviral agents|mesh-ancestor
93027983|NCT00299182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93027984|NCT00299182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93027985|NCT00299182|Tubulin Modulators|tubulin modulators|mesh-ancestor
93027986|NCT00299182|Antimitotic Agents|antimitotic agents|mesh-ancestor
93027987|NCT00299182|Mitosis Modulators|mitosis modulators|mesh-ancestor
93027988|NCT00467142|Leucovorin|leucovorin|mesh-list
93027989|NCT00467142|Bevacizumab|bevacizumab|mesh-list
93027990|NCT00467142|Fluorouracil|fluorouracil|mesh-list
93027991|NCT00467142|Irinotecan|irinotecan|mesh-list
93027992|NCT00467142|Calcium|calcium|mesh-list
93027993|NCT00467142|Levoleucovorin|levoleucovorin|mesh-list
93027994|NCT00467142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93027995|NCT00467142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93027996|NCT00467142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93027997|NCT00467142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93027998|NCT00467142|Growth Substances|growth substances|mesh-ancestor
93027999|NCT00467142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028000|NCT00467142|Growth Inhibitors|growth inhibitors|mesh-ancestor
93028001|NCT00467142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93028002|NCT00467142|Antimetabolites|antimetabolites|mesh-ancestor
93028003|NCT00467142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028004|NCT00467142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028005|NCT00467142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028006|NCT00467142|Immunologic Factors|immunologic factors|mesh-ancestor
93028007|NCT00467142|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93028008|NCT00467142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028009|NCT00467142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028010|NCT00467142|Antidotes|antidotes|mesh-ancestor
93028011|NCT00467142|Protective Agents|protective agents|mesh-ancestor
93028012|NCT00467142|Vitamin B Complex|vitamin b complex|mesh-ancestor
93028013|NCT00467142|Vitamins|vitamins|mesh-ancestor
93028014|NCT00467142|Micronutrients|micronutrients|mesh-ancestor
93028015|NCT01065376|Cabergoline|cabergoline|mesh-list
93028016|NCT01065376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93028017|NCT01065376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93028018|NCT01065376|Dopamine Agonists|dopamine agonists|mesh-ancestor
93028019|NCT01065376|Dopamine Agents|dopamine agents|mesh-ancestor
93028020|NCT01065376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028021|NCT01065376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028022|NCT01065376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028023|NCT00944177|Metformin|metformin|mesh-list
93028024|NCT00944177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93028025|NCT00944177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028026|NCT00553475|Pregabalin|pregabalin|mesh-list
93028027|NCT00553475|Analgesics|analgesics|mesh-ancestor
93028028|NCT00553475|Sensory System Agents|sensory system agents|mesh-ancestor
93028029|NCT00553475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028030|NCT00553475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028031|NCT00553475|Anticonvulsants|anticonvulsants|mesh-ancestor
93028032|NCT00553475|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93028033|NCT00553475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028034|NCT00553475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028035|NCT00553475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93028036|NCT00553475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93028037|NCT00553475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93028038|NCT00553475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028039|NCT00553475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028040|NCT00329602|Ropinirole|ropinirole|mesh-list
93028041|NCT00329602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93028042|NCT00329602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93028043|NCT00329602|Dopamine Agonists|dopamine agonists|mesh-ancestor
93028044|NCT00329602|Dopamine Agents|dopamine agents|mesh-ancestor
93028045|NCT00329602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028046|NCT00329602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028047|NCT00329602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028048|NCT01060696|Mefenamic Acid|mefenamic acid|mesh-list
93028049|NCT01060696|Scopolamine|scopolamine|mesh-list
93028050|NCT01060696|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93028051|NCT01060696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93028052|NCT01060696|Antiemetics|antiemetics|mesh-ancestor
93028053|NCT01060696|Autonomic Agents|autonomic agents|mesh-ancestor
93028054|NCT01060696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028055|NCT01060696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028056|NCT01060696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028057|NCT01060696|Mydriatics|mydriatics|mesh-ancestor
93028058|NCT01060696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93028059|NCT01060696|Cholinergic Agents|cholinergic agents|mesh-ancestor
93028060|NCT01060696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028061|NCT01060696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028062|NCT01060696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93028063|NCT01060696|Parasympatholytics|parasympatholytics|mesh-ancestor
93028064|NCT01060696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93028065|NCT01060696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93028066|NCT01060696|Analgesics|analgesics|mesh-ancestor
93028067|NCT01060696|Sensory System Agents|sensory system agents|mesh-ancestor
93028068|NCT01060696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028069|NCT01060696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028070|NCT01060696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93028071|NCT01060696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028072|NCT01065610|Oxytocin|oxytocin|mesh-list
93028073|NCT01065610|Oxytocics|oxytocics|mesh-ancestor
93028074|NCT01065610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93028075|NCT01065610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028076|NCT00463866|Budesonide|budesonide|mesh-list
93028077|NCT00463866|Formoterol Fumarate|formoterol fumarate|mesh-list
93028078|NCT00463866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028079|NCT00463866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93028080|NCT00463866|Autonomic Agents|autonomic agents|mesh-ancestor
93028081|NCT00463866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028082|NCT00463866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028083|NCT00463866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93028084|NCT00463866|Respiratory System Agents|respiratory system agents|mesh-ancestor
93028085|NCT00463866|Glucocorticoids|glucocorticoids|mesh-ancestor
93028086|NCT00463866|Hormones|hormones|mesh-ancestor
93028087|NCT00463866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028088|NCT00463866|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93028089|NCT00463866|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93028090|NCT00463866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93028091|NCT00463866|Adrenergic Agents|adrenergic agents|mesh-ancestor
93028092|NCT00463866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028093|NCT00463866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028094|NCT00313846|Buprenorphine|buprenorphine|mesh-list
93028095|NCT00313846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93028096|NCT00313846|Narcotics|narcotics|mesh-ancestor
93028097|NCT00313846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028098|NCT00313846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028099|NCT00313846|Analgesics|analgesics|mesh-ancestor
93028100|NCT00313846|Sensory System Agents|sensory system agents|mesh-ancestor
93028101|NCT00313846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028102|NCT00313846|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93028103|NCT00949247|Bevacizumab|bevacizumab|mesh-list
93028104|NCT00949247|Trastuzumab|trastuzumab|mesh-list
93028105|NCT00949247|Carboplatin|carboplatin|mesh-list
93028106|NCT00949247|Docetaxel|docetaxel|mesh-list
93028107|NCT00949247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028108|NCT00949247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028109|NCT00949247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93028110|NCT00949247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93028111|NCT00949247|Growth Substances|growth substances|mesh-ancestor
93028112|NCT00949247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028113|NCT00949247|Growth Inhibitors|growth inhibitors|mesh-ancestor
93028114|NCT00949247|Tubulin Modulators|tubulin modulators|mesh-ancestor
93028115|NCT00949247|Antimitotic Agents|antimitotic agents|mesh-ancestor
93028116|NCT00949247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92494468|NCT01975454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028117|NCT00949247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028118|NCT00551135|Pregabalin|pregabalin|mesh-list
93028119|NCT00551135|Analgesics|analgesics|mesh-ancestor
93028120|NCT00551135|Sensory System Agents|sensory system agents|mesh-ancestor
93028121|NCT00551135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028122|NCT00551135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028123|NCT00551135|Anticonvulsants|anticonvulsants|mesh-ancestor
93028124|NCT00551135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93028125|NCT00551135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028126|NCT00551135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028127|NCT00551135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93028128|NCT00551135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93028129|NCT00551135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93028130|NCT00551135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028131|NCT00551135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028132|NCT00944333|Clopidogrel|clopidogrel|mesh-list
93028133|NCT00944333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93028134|NCT00944333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93028135|NCT00944333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93028136|NCT00944333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93028137|NCT00944333|Purinergic Agents|purinergic agents|mesh-ancestor
93028138|NCT00944333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028139|NCT00944333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028140|NCT00944333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028141|NCT00299104|Methylprednisolone|methylprednisolone|mesh-list
93028142|NCT00299104|Rituximab|rituximab|mesh-list
93028143|NCT00299104|Methotrexate|methotrexate|mesh-list
93028144|NCT00299104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028145|NCT00299104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028146|NCT00299104|Immunologic Factors|immunologic factors|mesh-ancestor
93028147|NCT00299104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028148|NCT00299104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028149|NCT00299104|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93028150|NCT00299104|Abortifacient Agents|abortifacient agents|mesh-ancestor
93028151|NCT00299104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93028152|NCT00299104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028153|NCT00299104|Antimetabolites|antimetabolites|mesh-ancestor
93028154|NCT00299104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028155|NCT00299104|Dermatologic Agents|dermatologic agents|mesh-ancestor
93028156|NCT00299104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028157|NCT00299104|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93028158|NCT00299104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028159|NCT00299104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028160|NCT00299104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028161|NCT00299104|Antiemetics|antiemetics|mesh-ancestor
93028162|NCT00299104|Autonomic Agents|autonomic agents|mesh-ancestor
93028163|NCT00299104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028164|NCT00299104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028165|NCT00299104|Glucocorticoids|glucocorticoids|mesh-ancestor
93028166|NCT00299104|Hormones|hormones|mesh-ancestor
93028167|NCT00299104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028168|NCT00299104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93028169|NCT00299104|Protective Agents|protective agents|mesh-ancestor
93028170|NCT03979456|Rituximab|rituximab|mesh-list
93028171|NCT03979456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028172|NCT03979456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028173|NCT03979456|Immunologic Factors|immunologic factors|mesh-ancestor
93028174|NCT03979456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028175|NCT03979456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028176|NCT00313612|Oxaliplatin|oxaliplatin|mesh-list
93028177|NCT00313612|Topotecan|topotecan|mesh-list
93028178|NCT00313612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028179|NCT00313612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93028180|NCT00313612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028181|NCT00313612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028182|NCT00313612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028183|NCT00507416|Thalidomide|thalidomide|mesh-list
93028184|NCT00507416|Dexamethasone|dexamethasone|mesh-list
93028185|NCT00507416|Prednisone|prednisone|mesh-list
93028186|NCT00507416|Bortezomib|bortezomib|mesh-list
93028187|NCT00507416|Melphalan|melphalan|mesh-list
93028188|NCT00507416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028189|NCT00507416|Antiemetics|antiemetics|mesh-ancestor
93028190|NCT00507416|Autonomic Agents|autonomic agents|mesh-ancestor
93028191|NCT00507416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028192|NCT00507416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028193|NCT00507416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028194|NCT00507416|Glucocorticoids|glucocorticoids|mesh-ancestor
93028195|NCT00507416|Hormones|hormones|mesh-ancestor
93028196|NCT00507416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028197|NCT00507416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93028198|NCT00507416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028199|NCT00507416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93028200|NCT00507416|Alkylating Agents|alkylating agents|mesh-ancestor
93028201|NCT00507416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028202|NCT00507416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93028203|NCT00507416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028204|NCT00507416|Immunologic Factors|immunologic factors|mesh-ancestor
93028205|NCT00507416|Leprostatic Agents|leprostatic agents|mesh-ancestor
93028206|NCT00507416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028207|NCT00507416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028208|NCT00507416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93028209|NCT00507416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93028210|NCT00507416|Growth Substances|growth substances|mesh-ancestor
93028211|NCT00507416|Growth Inhibitors|growth inhibitors|mesh-ancestor
93028212|NCT00489476|Loxapine|loxapine|mesh-list
93028213|NCT00489476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93028214|NCT00489476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93028215|NCT00489476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028216|NCT00489476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028217|NCT00489476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028218|NCT00489476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93028219|NCT00489476|Dopamine Agents|dopamine agents|mesh-ancestor
93028220|NCT00489476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028221|NCT00489476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028222|NCT04216043|Caseins|caseins|mesh-list
93028223|NCT04216043|Chelating Agents|chelating agents|mesh-ancestor
93028224|NCT04216043|Sequestering Agents|sequestering agents|mesh-ancestor
93028225|NCT04216043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028226|NCT00957125|Bevacizumab|bevacizumab|mesh-list
93028227|NCT00957125|Docetaxel|docetaxel|mesh-list
93028228|NCT00957125|Epirubicin|epirubicin|mesh-list
93028229|NCT00957125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028230|NCT00957125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028231|NCT00957125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93028232|NCT00957125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93028233|NCT00957125|Growth Substances|growth substances|mesh-ancestor
93028234|NCT00957125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028235|NCT00957125|Growth Inhibitors|growth inhibitors|mesh-ancestor
93028236|NCT00957125|Tubulin Modulators|tubulin modulators|mesh-ancestor
93028237|NCT00957125|Antimitotic Agents|antimitotic agents|mesh-ancestor
93028238|NCT00957125|Mitosis Modulators|mitosis modulators|mesh-ancestor
93028239|NCT00957125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028240|NCT00957125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93028241|NCT00957125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93028242|NCT00957125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028243|NCT00957125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028244|NCT00957203|Istradefylline|istradefylline|mesh-list
93028245|NCT00957203|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93028246|NCT00957203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93028247|NCT00957203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93028248|NCT00957203|Purinergic Agents|purinergic agents|mesh-ancestor
93028249|NCT00957203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028250|NCT00957203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494469|NCT01975454|Antimetabolites|antimetabolites|mesh-ancestor
93028251|NCT00957203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028252|NCT00952913|Lansoprazole|lansoprazole|mesh-list
93028253|NCT00952913|Dexlansoprazole|dexlansoprazole|mesh-list
93028254|NCT00952913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93028255|NCT00952913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028256|NCT00952913|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93028257|NCT00952913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028258|NCT00952913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028259|NCT00952991|Vildagliptin|vildagliptin|mesh-list
93028260|NCT00952991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93028261|NCT00952991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028262|NCT00952991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93028263|NCT00952991|Protease Inhibitors|protease inhibitors|mesh-ancestor
93028264|NCT00952991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028265|NCT00952991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028266|NCT00953303|Dexamethasone|dexamethasone|mesh-list
93028267|NCT00953303|Dexamethasone acetate|dexamethasone acetate|mesh-list
93028268|NCT00953303|Prednisone|prednisone|mesh-list
93028269|NCT00953303|Torsemide|torsemide|mesh-list
93028270|NCT00953303|Dobutamine|dobutamine|mesh-list
93028271|NCT00953303|Dopamine|dopamine|mesh-list
93028272|NCT00953303|Furosemide|furosemide|mesh-list
93028273|NCT00953303|Nitroglycerin|nitroglycerin|mesh-list
93028274|NCT00953303|Glucocorticoids|glucocorticoids|mesh-list
93028275|NCT00953303|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93028276|NCT00953303|BB 1101|bb 1101|mesh-list
93028277|NCT00953303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028278|NCT00953303|Antiemetics|antiemetics|mesh-ancestor
93028279|NCT00953303|Autonomic Agents|autonomic agents|mesh-ancestor
93028280|NCT00953303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028281|NCT00953303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028282|NCT00953303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028283|NCT00953303|Hormones|hormones|mesh-ancestor
93028284|NCT00953303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028285|NCT00953303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93028286|NCT00953303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028287|NCT00953303|Protease Inhibitors|protease inhibitors|mesh-ancestor
93028288|NCT00953303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028289|NCT00953303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028290|NCT00953303|Diuretics|diuretics|mesh-ancestor
93028291|NCT00953303|Natriuretic Agents|natriuretic agents|mesh-ancestor
93028292|NCT00953303|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93028293|NCT00953303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028294|NCT00953303|Vasodilator Agents|vasodilator agents|mesh-ancestor
93028295|NCT00953303|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93028296|NCT00953303|Sympathomimetics|sympathomimetics|mesh-ancestor
93028297|NCT00953303|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93028298|NCT00953303|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93028299|NCT00953303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93028300|NCT00953303|Adrenergic Agents|adrenergic agents|mesh-ancestor
93028301|NCT00953303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028302|NCT00953303|Protective Agents|protective agents|mesh-ancestor
93028303|NCT00953303|Dopamine Agents|dopamine agents|mesh-ancestor
92182850|NCT05234307|Nivolumab|nivolumab|mesh-list
93028304|NCT00953303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93028305|NCT05300555|Warfarin|warfarin|mesh-list
93028306|NCT05300555|Rivaroxaban|rivaroxaban|mesh-list
93028307|NCT05300555|Anticoagulants|anticoagulants|mesh-ancestor
93028308|NCT05300555|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93028309|NCT05300555|Antithrombins|antithrombins|mesh-ancestor
93028310|NCT05300555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93028311|NCT05300555|Protease Inhibitors|protease inhibitors|mesh-ancestor
93028312|NCT05300555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028313|NCT05300555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028314|NCT04010669|Somatostatin|somatostatin|mesh-list
93028315|NCT04010669|Hormones|hormones|mesh-ancestor
93028316|NCT04010669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028317|NCT04010669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028318|NCT00452790|Vaccines|vaccines|mesh-list
93028319|NCT00452790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93028320|NCT00452790|Immunologic Factors|immunologic factors|mesh-ancestor
93028321|NCT00452790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028322|NCT00953381|Omeprazole|omeprazole|mesh-list
93028323|NCT00953381|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93028324|NCT00953381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028325|NCT00953381|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93028326|NCT00953381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028327|NCT00953381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028328|NCT05300477|Acetazolamide|acetazolamide|mesh-list
93028329|NCT05300477|Epoetin Alfa|epoetin alfa|mesh-list
93028330|NCT05300477|Hematinics|hematinics|mesh-ancestor
93028331|NCT05300477|Anticonvulsants|anticonvulsants|mesh-ancestor
93028332|NCT05300477|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93028333|NCT05300477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028334|NCT05300477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028335|NCT05300477|Diuretics|diuretics|mesh-ancestor
93028336|NCT05300477|Natriuretic Agents|natriuretic agents|mesh-ancestor
92673601|NCT00316238|Serotonin Agents|serotonin agents|mesh-ancestor
93028337|NCT05300477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028338|NCT00953459|Sunitinib|sunitinib|mesh-list
93028339|NCT00953459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93028340|NCT00953459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028341|NCT00953459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93028342|NCT00953459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93028343|NCT00953459|Growth Substances|growth substances|mesh-ancestor
93028344|NCT00953459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028345|NCT00953459|Growth Inhibitors|growth inhibitors|mesh-ancestor
93028346|NCT00953459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028347|NCT00953459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028348|NCT00953459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028349|NCT00953459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93028351|NCT00953537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028352|NCT00953537|Antimetabolites|antimetabolites|mesh-ancestor
93028353|NCT00953537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028354|NCT00953537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028355|NCT00463788|Cisplatin|cisplatin|mesh-list
93028356|NCT00463788|Cetuximab|cetuximab|mesh-list
93028357|NCT00463788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028358|NCT00463788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028359|NCT00548249|Iron|iron|mesh-list
93028360|NCT00548249|Trace Elements|trace elements|mesh-ancestor
93028361|NCT00548249|Micronutrients|micronutrients|mesh-ancestor
93028362|NCT00548249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028363|NCT01025466|Memantine|memantine|mesh-list
93028364|NCT01025466|Rivastigmine|rivastigmine|mesh-list
93028365|NCT01025466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93028366|NCT01025466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93028367|NCT01025466|Dopamine Agents|dopamine agents|mesh-ancestor
93028368|NCT01025466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028369|NCT01025466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028370|NCT01025466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028371|NCT01025466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93028372|NCT01025466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93028373|NCT01025466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93028374|NCT01025466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028375|NCT01025466|Cholinergic Agents|cholinergic agents|mesh-ancestor
93028376|NCT01025466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93028377|NCT01025466|Protective Agents|protective agents|mesh-ancestor
93028378|NCT01025544|Vaccines|vaccines|mesh-list
93028379|NCT01025544|Immunologic Factors|immunologic factors|mesh-ancestor
93028380|NCT01025544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028381|NCT03839940|Dexamethasone|dexamethasone|mesh-list
93028382|NCT03839940|Everolimus|everolimus|mesh-list
93028383|NCT03839940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028384|NCT03839940|Antiemetics|antiemetics|mesh-ancestor
93028385|NCT03839940|Autonomic Agents|autonomic agents|mesh-ancestor
93028386|NCT03839940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028387|NCT03839940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028388|NCT03839940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028389|NCT03839940|Glucocorticoids|glucocorticoids|mesh-ancestor
93028390|NCT03839940|Hormones|hormones|mesh-ancestor
93028391|NCT03839940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028392|NCT03839940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93028393|NCT03839940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028394|NCT03839940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93028395|NCT03839940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028396|NCT03839940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028397|NCT03839940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028398|NCT03839940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028399|NCT03839940|Immunologic Factors|immunologic factors|mesh-ancestor
93028400|NCT03905928|Nicotine|nicotine|mesh-list
93028401|NCT03905928|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93028402|NCT03905928|Autonomic Agents|autonomic agents|mesh-ancestor
93028403|NCT03905928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028404|NCT03905928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028405|NCT03905928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93028406|NCT03905928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93028407|NCT03905928|Cholinergic Agents|cholinergic agents|mesh-ancestor
93028408|NCT03905928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028409|NCT03905928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028410|NCT01027494|Ciprofloxacin|ciprofloxacin|mesh-list
93028411|NCT01027494|Dexamethasone|dexamethasone|mesh-list
93028412|NCT01027494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028413|NCT01027494|Antiemetics|antiemetics|mesh-ancestor
93028414|NCT01027494|Autonomic Agents|autonomic agents|mesh-ancestor
93028415|NCT01027494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028416|NCT01027494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028419|NCT01027494|Hormones|hormones|mesh-ancestor
93028420|NCT01027494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028421|NCT01027494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93028422|NCT01027494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028423|NCT01027494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028424|NCT01027494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028425|NCT01027494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93028426|NCT01027494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028427|NCT01027494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028428|NCT01027494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028429|NCT01027494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93028430|NCT01027494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93028431|NCT01025700|Nabilone|nabilone|mesh-list
93028432|NCT01025700|Antiemetics|antiemetics|mesh-ancestor
93028433|NCT01025700|Autonomic Agents|autonomic agents|mesh-ancestor
93028434|NCT01025700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028435|NCT01025700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028436|NCT01025700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028437|NCT01025700|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93028438|NCT01025700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93028439|NCT01025700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028440|NCT01025700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028441|NCT00462462|Ethanol|ethanol|mesh-list
93028442|NCT00462462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93028443|NCT00462462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028444|NCT00462462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028445|NCT00462462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028446|NCT00462384|Epoetin Alfa|epoetin alfa|mesh-list
93028447|NCT00462384|Hematinics|hematinics|mesh-ancestor
93028448|NCT00452400|Olodaterol|olodaterol|mesh-list
93028449|NCT00452400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93028450|NCT00452400|Autonomic Agents|autonomic agents|mesh-ancestor
93028451|NCT00452400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028452|NCT00452400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028453|NCT00452400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93028454|NCT00452400|Respiratory System Agents|respiratory system agents|mesh-ancestor
93028455|NCT01566474|Melatonin|melatonin|mesh-list
93028456|NCT01566474|Omeprazole|omeprazole|mesh-list
93028457|NCT01566474|Antioxidants|antioxidants|mesh-ancestor
93028458|NCT01566474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028459|NCT01566474|Protective Agents|protective agents|mesh-ancestor
93028460|NCT01566474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028461|NCT01566474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028462|NCT01566474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93028463|NCT01566474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028464|NCT01566474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93028465|NCT01566474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028466|NCT01025778|Cyclophosphamide|cyclophosphamide|mesh-list
93028467|NCT01025778|Thiotepa|thiotepa|mesh-list
93028468|NCT01025778|Etoposide|etoposide|mesh-list
93028469|NCT01025778|Clofarabine|clofarabine|mesh-list
93028470|NCT01025778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028471|NCT01025778|Immunologic Factors|immunologic factors|mesh-ancestor
93028472|NCT01025778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028473|NCT01025778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028474|NCT01025778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93028475|NCT01025778|Alkylating Agents|alkylating agents|mesh-ancestor
93028476|NCT01025778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028477|NCT01025778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028478|NCT01025778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93028479|NCT01025778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93028480|NCT01025778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93028481|NCT01025778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028482|NCT01025778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028483|NCT01025778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028484|NCT01025778|Antimetabolites|antimetabolites|mesh-ancestor
93028485|NCT00443430|Prednisone|prednisone|mesh-list
93028486|NCT00443430|Prednisolone|prednisolone|mesh-list
93028487|NCT00443430|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93028488|NCT00443430|Methylprednisolone|methylprednisolone|mesh-list
92673755|NCT00317096|Rituximab|rituximab|mesh-list
93028489|NCT00443430|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93028491|NCT00443430|Etanercept|etanercept|mesh-list
93028492|NCT00443430|Methotrexate|methotrexate|mesh-list
93028493|NCT00443430|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93028494|NCT00443430|Prednisolone phosphate|prednisolone phosphate|mesh-list
93028495|NCT00443430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028496|NCT00443430|Glucocorticoids|glucocorticoids|mesh-ancestor
93028497|NCT00443430|Hormones|hormones|mesh-ancestor
93028498|NCT00443430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028499|NCT00443430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028500|NCT00443430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93028501|NCT00443430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028502|NCT00443430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93028503|NCT00443430|Abortifacient Agents|abortifacient agents|mesh-ancestor
93028504|NCT00443430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93028505|NCT00443430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028506|NCT00443430|Antimetabolites|antimetabolites|mesh-ancestor
93028507|NCT00443430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028508|NCT00443430|Dermatologic Agents|dermatologic agents|mesh-ancestor
93028509|NCT00443430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028510|NCT00443430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93028511|NCT00443430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028512|NCT00443430|Immunologic Factors|immunologic factors|mesh-ancestor
93028513|NCT00443430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028514|NCT00443430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028515|NCT00443430|Antiemetics|antiemetics|mesh-ancestor
93028516|NCT00443430|Autonomic Agents|autonomic agents|mesh-ancestor
93028517|NCT00443430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028518|NCT00443430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028519|NCT00443430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93028520|NCT00443430|Protective Agents|protective agents|mesh-ancestor
93028521|NCT00443430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93028522|NCT00443430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93028523|NCT00443430|Analgesics|analgesics|mesh-ancestor
93028524|NCT00443430|Sensory System Agents|sensory system agents|mesh-ancestor
93028525|NCT03898986|Vaccines|vaccines|mesh-list
93028526|NCT03898986|Immunologic Factors|immunologic factors|mesh-ancestor
93028527|NCT03898986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028528|NCT01022658|Insulin|insulin|mesh-list
93028529|NCT01022658|Insulin Detemir|insulin detemir|mesh-list
93028530|NCT01022658|Insulin Aspart|insulin aspart|mesh-list
93028531|NCT01022658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93028532|NCT01022658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028533|NCT01022736|Gabapentin|gabapentin|mesh-list
93028534|NCT01022736|Analgesics|analgesics|mesh-ancestor
93028535|NCT01022736|Sensory System Agents|sensory system agents|mesh-ancestor
93028536|NCT01022736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028537|NCT01022736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028538|NCT01022736|Anticonvulsants|anticonvulsants|mesh-ancestor
93028539|NCT01022736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93028540|NCT01022736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93028541|NCT01022736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93028542|NCT01022736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028543|NCT01022736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93028544|NCT01022736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93028545|NCT01022736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028546|NCT01022736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028547|NCT01022736|Antimanic Agents|antimanic agents|mesh-ancestor
93028548|NCT01025934|Bevacizumab|bevacizumab|mesh-list
93028549|NCT01025934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028550|NCT01025934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028551|NCT01025934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93028552|NCT01025934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93028554|NCT01025934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028555|NCT01025934|Growth Inhibitors|growth inhibitors|mesh-ancestor
93028556|NCT01026090|Dronedarone|dronedarone|mesh-list
93028557|NCT01026090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93028558|NCT00460746|Ritonavir|ritonavir|mesh-list
93028559|NCT00460746|Darunavir|darunavir|mesh-list
93028560|NCT00460746|Etravirine|etravirine|mesh-list
93028561|NCT00460746|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93028562|NCT00460746|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93028563|NCT00460746|Protease Inhibitors|protease inhibitors|mesh-ancestor
93028564|NCT00460746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673846|NCT00317408|Antidotes|antidotes|mesh-ancestor
93028565|NCT00460746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028566|NCT00460746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93028567|NCT00460746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93028568|NCT00460746|Antiviral Agents|antiviral agents|mesh-ancestor
93028569|NCT00460746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028570|NCT00460746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93028571|NCT00460746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93028572|NCT00460746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93028573|NCT00460746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028575|NCT01026558|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93028576|NCT01026558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028577|NCT01026558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028578|NCT00373425|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93028579|NCT00373425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028580|NCT00373425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028581|NCT00373425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028582|NCT00373425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028583|NCT00459342|Dasatinib|dasatinib|mesh-list
92182890|NCT00131677|Antiviral Agents|antiviral agents|mesh-ancestor
93028584|NCT00459342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028585|NCT00459342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028586|NCT00459342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028587|NCT00459342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028588|NCT00442962|Tenofovir|tenofovir|mesh-list
93028589|NCT00442962|Emtricitabine|emtricitabine|mesh-list
93028590|NCT00442962|Efavirenz|efavirenz|mesh-list
93028591|NCT00442962|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93028592|NCT00442962|Antiviral Agents|antiviral agents|mesh-ancestor
93028593|NCT00442962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028594|NCT00442962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93028595|NCT00442962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028596|NCT00442962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028597|NCT00442962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028598|NCT00442962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93028599|NCT00442962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93028600|NCT00442962|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93028601|NCT00442962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93028602|NCT00442962|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93028603|NCT00442962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93028604|NCT00442962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93028605|NCT00442962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93028606|NCT01028508|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93028607|NCT01028508|Antidepressive Agents|antidepressive agents|mesh-ancestor
93028608|NCT01028508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028609|NCT01028508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028610|NCT01028508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028611|NCT01028508|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93028612|NCT01028508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93028613|NCT01028508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028614|NCT01028508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028615|NCT01028508|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93028616|NCT01026636|Ceftobiprole|ceftobiprole|mesh-list
93028617|NCT01026636|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93028618|NCT01026636|Cephalosporins|cephalosporins|mesh-list
93028619|NCT01026636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028620|NCT01026636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028621|NCT00313300|Apixaban|apixaban|mesh-list
93028622|NCT00313300|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93028623|NCT00313300|Antithrombins|antithrombins|mesh-ancestor
93028624|NCT00313300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93028625|NCT00313300|Protease Inhibitors|protease inhibitors|mesh-ancestor
93028626|NCT00313300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028627|NCT00313300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028628|NCT00313300|Anticoagulants|anticoagulants|mesh-ancestor
93028629|NCT00459186|Prednisone|prednisone|mesh-list
93028630|NCT00459186|Docetaxel|docetaxel|mesh-list
93028631|NCT00459186|Everolimus|everolimus|mesh-list
93028632|NCT00459186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028633|NCT00459186|Tubulin Modulators|tubulin modulators|mesh-ancestor
93028634|NCT00459186|Antimitotic Agents|antimitotic agents|mesh-ancestor
93028635|NCT00459186|Mitosis Modulators|mitosis modulators|mesh-ancestor
93028636|NCT00459186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028637|NCT00459186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028638|NCT00459186|Glucocorticoids|glucocorticoids|mesh-ancestor
93028639|NCT00459186|Hormones|hormones|mesh-ancestor
93028640|NCT00459186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028641|NCT00459186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028642|NCT00459186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93028643|NCT00459186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93028644|NCT00459186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028645|NCT00459186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028646|NCT00459186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028647|NCT00459186|Immunologic Factors|immunologic factors|mesh-ancestor
93028648|NCT01026714|Fluconazole|fluconazole|mesh-list
93028649|NCT01026714|Rifampin|rifampin|mesh-list
93028650|NCT01026714|Flurbiprofen|flurbiprofen|mesh-list
93028651|NCT01026714|Antifungal Agents|antifungal agents|mesh-ancestor
93028652|NCT01026714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028653|NCT01026714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93028654|NCT01026714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93028655|NCT01026714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028656|NCT01026714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028657|NCT01026714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93028658|NCT01026714|Hormone Antagonists|hormone antagonists|mesh-ancestor
93028659|NCT01026714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028660|NCT01026714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028661|NCT01026714|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93028662|NCT01026714|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93028663|NCT01026714|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93028664|NCT01026714|Antitubercular Agents|antitubercular agents|mesh-ancestor
93028665|NCT01026714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028666|NCT01026714|Leprostatic Agents|leprostatic agents|mesh-ancestor
93028667|NCT01026714|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028668|NCT01026714|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93028669|NCT01026714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93028670|NCT01026714|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93028671|NCT01026714|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93028672|NCT01026714|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93028673|NCT01026714|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93028674|NCT01026714|Analgesics|analgesics|mesh-ancestor
93028675|NCT01026714|Sensory System Agents|sensory system agents|mesh-ancestor
93028676|NCT01026714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028677|NCT01026714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93028678|NCT01026714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93028679|NCT01026714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028680|NCT01026714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028681|NCT01026714|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93028682|NCT03996252|Calcitriol|calcitriol|mesh-list
93028683|NCT03996252|Fluorouracil|fluorouracil|mesh-list
93028684|NCT03996252|Calcipotriene|calcipotriene|mesh-list
93028685|NCT03996252|Antimetabolites|antimetabolites|mesh-ancestor
93028686|NCT03996252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028687|NCT03996252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028688|NCT03996252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028689|NCT03996252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028690|NCT03996252|Immunologic Factors|immunologic factors|mesh-ancestor
93028691|NCT03996252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028692|NCT03996252|Dermatologic Agents|dermatologic agents|mesh-ancestor
93028693|NCT03996252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93028694|NCT03996252|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93028695|NCT03996252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028696|NCT03996252|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93028697|NCT03996252|Vitamins|vitamins|mesh-ancestor
93028698|NCT03996252|Micronutrients|micronutrients|mesh-ancestor
93028699|NCT03996252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93028700|NCT00313144|Protease Inhibitors|protease inhibitors|mesh-list
93028701|NCT00313144|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93028702|NCT00313144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028703|NCT00313144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028704|NCT00313144|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93028705|NCT00313144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93028706|NCT00459108|Dasatinib|dasatinib|mesh-list
93028707|NCT00459108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028708|NCT00459108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028709|NCT00459108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028710|NCT00459108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028711|NCT00328198|Alemtuzumab|alemtuzumab|mesh-list
93028712|NCT00328198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028713|NCT00328198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028714|NCT00450450|Lenograstim|lenograstim|mesh-list
93028715|NCT00450450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93028716|NCT00450450|Immunologic Factors|immunologic factors|mesh-ancestor
93028717|NCT00450450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028718|NCT03440892|Sulfasalazine|sulfasalazine|mesh-list
93028719|NCT03440892|Methotrexate|methotrexate|mesh-list
93028720|NCT03440892|Abatacept|abatacept|mesh-list
93028721|NCT03440892|Tofacitinib|tofacitinib|mesh-list
92182898|NCT00240487|Nitric Oxide|nitric oxide|mesh-list
93028722|NCT03440892|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93028723|NCT03440892|Abortifacient Agents|abortifacient agents|mesh-ancestor
93028724|NCT03440892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93028725|NCT03440892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028726|NCT03440892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028727|NCT03440892|Antimetabolites|antimetabolites|mesh-ancestor
93028728|NCT03440892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028729|NCT03440892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028730|NCT03440892|Dermatologic Agents|dermatologic agents|mesh-ancestor
93028731|NCT03440892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028732|NCT03440892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93028733|NCT03440892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028734|NCT03440892|Immunologic Factors|immunologic factors|mesh-ancestor
93028735|NCT03440892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028736|NCT03440892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028737|NCT03440892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93028738|NCT03440892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028739|NCT03440892|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93028740|NCT03440892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028741|NCT03440892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028742|NCT03440892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93028743|NCT03440892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93028744|NCT03440892|Analgesics|analgesics|mesh-ancestor
93028745|NCT03440892|Sensory System Agents|sensory system agents|mesh-ancestor
93028746|NCT03440892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028747|NCT03440892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028748|NCT03440892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028749|NCT00442572|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93028750|NCT00442572|Antiviral Agents|antiviral agents|mesh-ancestor
93028751|NCT00442572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028752|NCT01023360|Esomeprazole|esomeprazole|mesh-list
93028753|NCT01023360|Rabeprazole|rabeprazole|mesh-list
93028754|NCT01023360|Pantoprazole|pantoprazole|mesh-list
93028755|NCT01023360|Clopidogrel|clopidogrel|mesh-list
93028756|NCT01023360|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93028757|NCT01023360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93028758|NCT01023360|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93028759|NCT01023360|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93028760|NCT01023360|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93028761|NCT01023360|Purinergic Agents|purinergic agents|mesh-ancestor
93028762|NCT01023360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028763|NCT01023360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028764|NCT01023360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028765|NCT01023360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93028766|NCT01023360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92529014|NCT00000959|Vitamins|vitamins|mesh-ancestor
93028767|NCT01023360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028768|NCT03685890|Nivolumab|nivolumab|mesh-list
93028769|NCT03685890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028770|NCT03685890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028771|NCT03685890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93028772|NCT03685890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028773|NCT00442416|Epoetin Alfa|epoetin alfa|mesh-list
93028774|NCT00442416|Hematinics|hematinics|mesh-ancestor
93028775|NCT03674424|Avelumab|avelumab|mesh-list
93028776|NCT03674424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028777|NCT03674424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028778|NCT00441792|Midazolam|midazolam|mesh-list
93028779|NCT00441792|Etomidate|etomidate|mesh-list
93028780|NCT00441792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93028781|NCT00441792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93028782|NCT00441792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182903|NCT00240487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93028783|NCT00441792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674056|NCT00345735|Analgesics|analgesics|mesh-ancestor
93028784|NCT00441792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93028785|NCT00441792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93028786|NCT00441792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028787|NCT00441792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93028788|NCT00441792|Anesthetics, General|anesthetics, general|mesh-ancestor
93028789|NCT00441792|Anesthetics|anesthetics|mesh-ancestor
93028790|NCT00441792|GABA Modulators|gaba modulators|mesh-ancestor
93028791|NCT00441792|GABA Agents|gaba agents|mesh-ancestor
93028792|NCT00441792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028793|NCT00441792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028794|NCT00312208|Cyclophosphamide|cyclophosphamide|mesh-list
93028795|NCT00312208|Docetaxel|docetaxel|mesh-list
93028796|NCT00312208|Doxorubicin|doxorubicin|mesh-list
93028797|NCT00312208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93028798|NCT00312208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028799|NCT00312208|Immunologic Factors|immunologic factors|mesh-ancestor
93028800|NCT00312208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028801|NCT00312208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028802|NCT00312208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93028803|NCT00312208|Alkylating Agents|alkylating agents|mesh-ancestor
93028804|NCT00312208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028805|NCT00312208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028806|NCT00312208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93028807|NCT00312208|Tubulin Modulators|tubulin modulators|mesh-ancestor
93028808|NCT00312208|Antimitotic Agents|antimitotic agents|mesh-ancestor
93028809|NCT00312208|Mitosis Modulators|mitosis modulators|mesh-ancestor
93028810|NCT00312208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93028811|NCT00312208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93028812|NCT00312208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028813|NCT00312208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028814|NCT00297778|Pramipexole|pramipexole|mesh-list
93028815|NCT00297778|Antioxidants|antioxidants|mesh-ancestor
93028816|NCT00297778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028817|NCT00297778|Protective Agents|protective agents|mesh-ancestor
93028818|NCT00297778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028819|NCT00297778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93028820|NCT00297778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93028821|NCT00297778|Dopamine Agonists|dopamine agonists|mesh-ancestor
93028822|NCT00297778|Dopamine Agents|dopamine agents|mesh-ancestor
93028823|NCT00297778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028824|NCT03848832|Cannabidiol|cannabidiol|mesh-list
93028825|NCT03848832|Anticonvulsants|anticonvulsants|mesh-ancestor
93028826|NCT00327340|Docetaxel|docetaxel|mesh-list
93028827|NCT00327340|Mitoxantrone|mitoxantrone|mesh-list
93028828|NCT00327340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028829|NCT00327340|Tubulin Modulators|tubulin modulators|mesh-ancestor
93028830|NCT00327340|Antimitotic Agents|antimitotic agents|mesh-ancestor
93028831|NCT00327340|Mitosis Modulators|mitosis modulators|mesh-ancestor
93028832|NCT00327340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028833|NCT00327340|Analgesics|analgesics|mesh-ancestor
93028834|NCT00327340|Sensory System Agents|sensory system agents|mesh-ancestor
93028835|NCT00327340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028836|NCT00327340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028837|NCT00327340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93028838|NCT00327340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93028839|NCT00327340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028840|NCT00958139|Permethrin|permethrin|mesh-list
93028841|NCT00958139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028842|NCT00958139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028843|NCT00450216|Ibuprofen|ibuprofen|mesh-list
93028844|NCT00450216|Famotidine|famotidine|mesh-list
93028845|NCT00450216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93028846|NCT00450216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93028847|NCT00450216|Analgesics|analgesics|mesh-ancestor
93028848|NCT00450216|Sensory System Agents|sensory system agents|mesh-ancestor
92182914|NCT02126917|Hydrocodone|hydrocodone|mesh-list
93028849|NCT00450216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93028850|NCT00450216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028851|NCT00450216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028852|NCT00450216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028853|NCT00450216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93028854|NCT00450216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028855|NCT00450216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028856|NCT00450216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93028857|NCT00450216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93028858|NCT00450216|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93028859|NCT00450216|Histamine Antagonists|histamine antagonists|mesh-ancestor
93028860|NCT00450216|Histamine Agents|histamine agents|mesh-ancestor
93028861|NCT00450216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028863|NCT00953771|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93028864|NCT00953771|Hormone Antagonists|hormone antagonists|mesh-ancestor
93028865|NCT00953771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028866|NCT00953771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028867|NCT01566006|Mycophenolic Acid|mycophenolic acid|mesh-list
93028868|NCT01566006|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
93028869|NCT01566006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93028870|NCT01566006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028871|NCT01566006|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93028872|NCT01566006|Antitubercular Agents|antitubercular agents|mesh-ancestor
93028873|NCT01566006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93028874|NCT01566006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93028875|NCT01566006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028876|NCT01566006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028877|NCT01566006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93028878|NCT00958451|Ergocalciferols|ergocalciferols|mesh-list
93028879|NCT00958451|Vitamin D|vitamin d|mesh-list
93028880|NCT00958451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93028881|NCT00958451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028882|NCT00958451|Vitamins|vitamins|mesh-ancestor
93028883|NCT00958451|Micronutrients|micronutrients|mesh-ancestor
93028884|NCT00958451|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93028885|NCT05352191|Beclomethasone|beclomethasone|mesh-list
93028886|NCT05352191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93028887|NCT05352191|Glucocorticoids|glucocorticoids|mesh-ancestor
93028888|NCT05352191|Hormones|hormones|mesh-ancestor
93028889|NCT05352191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93028890|NCT05352191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028891|NCT05352191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93028892|NCT05352191|Respiratory System Agents|respiratory system agents|mesh-ancestor
93028893|NCT00954005|Rituximab|rituximab|mesh-list
93028894|NCT00954005|Gemcitabine|gemcitabine|mesh-list
93028895|NCT00954005|Oxaliplatin|oxaliplatin|mesh-list
93028896|NCT00954005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028897|NCT00954005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028898|NCT00954005|Immunologic Factors|immunologic factors|mesh-ancestor
93028899|NCT00954005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028900|NCT00954005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028901|NCT00954005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028902|NCT00954005|Antimetabolites|antimetabolites|mesh-ancestor
93028903|NCT00954005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028904|NCT01023750|Fenofibrate|fenofibrate|mesh-list
93028905|NCT01023750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93028906|NCT01023750|Antimetabolites|antimetabolites|mesh-ancestor
93028907|NCT01023750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028908|NCT01023750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93028909|NCT05300009|Methotrexate|methotrexate|mesh-list
93028910|NCT05300009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93028911|NCT05300009|Abortifacient Agents|abortifacient agents|mesh-ancestor
93028912|NCT05300009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93028913|NCT05300009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028914|NCT05300009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93028915|NCT05300009|Antimetabolites|antimetabolites|mesh-ancestor
93028916|NCT05300009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028917|NCT05300009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028918|NCT05300009|Dermatologic Agents|dermatologic agents|mesh-ancestor
93028919|NCT05300009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028920|NCT05300009|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93028921|NCT05300009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93028922|NCT05300009|Immunologic Factors|immunologic factors|mesh-ancestor
93028923|NCT05300009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93028924|NCT05300009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93028925|NCT05352113|Antidepressive Agents|antidepressive agents|mesh-list
93028926|NCT05352113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93028927|NCT05352113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028928|NCT05352113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93028929|NCT05352113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028930|NCT05352113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028931|NCT05352113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028932|NCT05352113|Serotonin Agents|serotonin agents|mesh-ancestor
92674204|NCT00319319|Mecamylamine|mecamylamine|mesh-list
93028933|NCT05352113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028934|NCT00547703|Nortriptyline|nortriptyline|mesh-list
93028935|NCT00547703|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93028936|NCT00547703|Antidepressive Agents|antidepressive agents|mesh-ancestor
93028937|NCT00547703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93028938|NCT00547703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93028939|NCT00547703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93028940|NCT00547703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93028941|NCT00547703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028942|NCT00547703|Adrenergic Agents|adrenergic agents|mesh-ancestor
93028943|NCT00547703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93028944|NCT00547703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028945|NCT00297232|Natalizumab|natalizumab|mesh-list
93028946|NCT00297232|Immunologic Factors|immunologic factors|mesh-ancestor
93028947|NCT00297232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028948|NCT01062802|Atorvastatin|atorvastatin|mesh-list
93028949|NCT01062802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93028950|NCT01062802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93028951|NCT01062802|Antimetabolites|antimetabolites|mesh-ancestor
93028952|NCT01062802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028953|NCT01062802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93028954|NCT01062802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93028955|NCT01062802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028956|NCT03867383|Calcium, Dietary|calcium, dietary|mesh-list
93028957|NCT03867383|Calcium|calcium|mesh-list
93028958|NCT03867383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93028959|NCT03867383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028960|NCT03867383|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93028961|NCT00954395|Fibrin Fibrinogen Degradation Products|fibrin fibrinogen degradation products|mesh-list
93028962|NCT00954395|Fibrin fragment D|fibrin fragment d|mesh-list
93028963|NCT00954395|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93028964|NCT00954395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93028965|NCT00954395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028966|NCT00954395|Hemostatics|hemostatics|mesh-ancestor
93028967|NCT00954395|Coagulants|coagulants|mesh-ancestor
93028968|NCT00954395|Anticoagulants|anticoagulants|mesh-ancestor
93028969|NCT03741101|Trametinib|trametinib|mesh-list
93028970|NCT03741101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028971|NCT03741101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93028972|NCT03741101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028973|NCT03741101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028974|NCT00449670|Vaccines|vaccines|mesh-list
93028975|NCT00449670|Immunologic Factors|immunologic factors|mesh-ancestor
93028976|NCT00449670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028977|NCT04010903|Insulin|insulin|mesh-list
93028978|NCT04010903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93028979|NCT04010903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93028980|NCT05299931|Ustekinumab|ustekinumab|mesh-list
93028981|NCT05299931|Dermatologic Agents|dermatologic agents|mesh-ancestor
93028982|NCT00296374|Atorvastatin|atorvastatin|mesh-list
93028983|NCT00296374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93028984|NCT00296374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93028985|NCT00296374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93028986|NCT00296374|Antimetabolites|antimetabolites|mesh-ancestor
93028987|NCT00296374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028988|NCT00296374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93028989|NCT00296374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93028990|NCT00296374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93028991|NCT03387761|Nivolumab|nivolumab|mesh-list
93028992|NCT03387761|Ipilimumab|ipilimumab|mesh-list
93028993|NCT03387761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93028994|NCT03387761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93028995|NCT03387761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93028996|NCT03387761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93028997|NCT01060774|Lidocaine|lidocaine|mesh-list
93028998|NCT01060774|Bupivacaine|bupivacaine|mesh-list
93028999|NCT01060774|Anesthetics, Local|anesthetics, local|mesh-ancestor
93029000|NCT01060774|Anesthetics|anesthetics|mesh-ancestor
93029001|NCT01060774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93029002|NCT01060774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029003|NCT01060774|Sensory System Agents|sensory system agents|mesh-ancestor
93029004|NCT01060774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029005|NCT01060774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93029006|NCT01060774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93029007|NCT01060774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93029008|NCT01060774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029009|NCT01060774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029010|NCT00954785|Diclofenac|diclofenac|mesh-list
93029011|NCT00954785|Etoricoxib|etoricoxib|mesh-list
93029012|NCT00954785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029013|NCT00954785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029014|NCT00954785|Analgesics|analgesics|mesh-ancestor
93029015|NCT00954785|Sensory System Agents|sensory system agents|mesh-ancestor
93029016|NCT00954785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029017|NCT00954785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029018|NCT00954785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029019|NCT00954785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029020|NCT00954785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029021|NCT00954785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029022|NCT00954785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029023|NCT00954785|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93029024|NCT00548717|Mycophenolic Acid|mycophenolic acid|mesh-list
93029025|NCT00548717|Sirolimus|sirolimus|mesh-list
93029026|NCT00548717|Bortezomib|bortezomib|mesh-list
93029027|NCT00548717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93029028|NCT00548717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029029|NCT00548717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93029030|NCT00548717|Antitubercular Agents|antitubercular agents|mesh-ancestor
93029031|NCT00548717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93029032|NCT00548717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029033|NCT00548717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029034|NCT00548717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029035|NCT00548717|Antifungal Agents|antifungal agents|mesh-ancestor
93029036|NCT00548717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029037|NCT00548717|Immunologic Factors|immunologic factors|mesh-ancestor
93029038|NCT00548717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029039|NCT00441168|Dexamethasone|dexamethasone|mesh-list
93029040|NCT00441168|Vincristine|vincristine|mesh-list
93029041|NCT00441168|Doxorubicin|doxorubicin|mesh-list
93029042|NCT00441168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93029043|NCT00441168|Bortezomib|bortezomib|mesh-list
93029044|NCT00441168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029045|NCT00441168|Antiemetics|antiemetics|mesh-ancestor
93029046|NCT00441168|Autonomic Agents|autonomic agents|mesh-ancestor
93029047|NCT00441168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029048|NCT00441168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029049|NCT00441168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93029050|NCT00441168|Glucocorticoids|glucocorticoids|mesh-ancestor
93029051|NCT00441168|Hormones|hormones|mesh-ancestor
93029052|NCT00441168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029053|NCT00441168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93029054|NCT00441168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330198|NCT00004232|Prednisone|prednisone|mesh-list
93029055|NCT00441168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93029056|NCT00441168|Tubulin Modulators|tubulin modulators|mesh-ancestor
93029057|NCT00441168|Antimitotic Agents|antimitotic agents|mesh-ancestor
93029058|NCT00441168|Mitosis Modulators|mitosis modulators|mesh-ancestor
93029059|NCT00441168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029060|NCT00441168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93029061|NCT00441168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93029062|NCT00441168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93029063|NCT00441168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029065|NCT01062958|Folic Acid|folic acid|mesh-list
93029066|NCT01062958|Vitamin B 12|vitamin b 12|mesh-list
93029067|NCT01062958|Hydroxocobalamin|hydroxocobalamin|mesh-list
93029068|NCT01062958|Micronutrients|micronutrients|mesh-ancestor
93029069|NCT01062958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029070|NCT01062958|Hematinics|hematinics|mesh-ancestor
93029071|NCT01062958|Vitamin B Complex|vitamin b complex|mesh-ancestor
93029072|NCT01028976|Ascorbic Acid|ascorbic acid|mesh-list
93029073|NCT01028976|Vitamins|vitamins|mesh-ancestor
93029074|NCT01028976|Micronutrients|micronutrients|mesh-ancestor
93029075|NCT01028976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029076|NCT01028976|Antioxidants|antioxidants|mesh-ancestor
93029077|NCT01028976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029078|NCT01028976|Protective Agents|protective agents|mesh-ancestor
92674354|NCT00351507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029079|NCT01024140|Escitalopram|escitalopram|mesh-list
93029080|NCT01024140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93029081|NCT01024140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93029082|NCT01024140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029083|NCT01024140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029084|NCT01024140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029085|NCT01024140|Serotonin Agents|serotonin agents|mesh-ancestor
93029086|NCT01024140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029087|NCT00457626|Valsartan|valsartan|mesh-list
93029088|NCT00457626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93029089|NCT00457626|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93029090|NCT00457626|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93029091|NCT00457626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029092|NCT02748707|Celecoxib|celecoxib|mesh-list
93029093|NCT02748707|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93029094|NCT02748707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029095|NCT02748707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93029096|NCT02748707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029097|NCT02748707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029098|NCT02748707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029099|NCT02748707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029100|NCT02748707|Analgesics|analgesics|mesh-ancestor
93029101|NCT02748707|Sensory System Agents|sensory system agents|mesh-ancestor
93029102|NCT02748707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029103|NCT02748707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029104|NCT02748707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029105|NCT02748707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029106|NCT02748707|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93029107|NCT02748707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029108|NCT05014061|Adenosine|adenosine|mesh-list
93029109|NCT05014061|Analgesics|analgesics|mesh-ancestor
93029110|NCT05014061|Sensory System Agents|sensory system agents|mesh-ancestor
93029111|NCT05014061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029112|NCT05014061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029113|NCT05014061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93029114|NCT05014061|Vasodilator Agents|vasodilator agents|mesh-ancestor
93029115|NCT05014061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93029116|NCT05014061|Purinergic Agonists|purinergic agonists|mesh-ancestor
93029117|NCT05014061|Purinergic Agents|purinergic agents|mesh-ancestor
93029118|NCT05014061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029119|NCT05014061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029120|NCT00373113|Capecitabine|capecitabine|mesh-list
93029121|NCT00373113|Sunitinib|sunitinib|mesh-list
93029122|NCT00373113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029123|NCT00373113|Antimetabolites|antimetabolites|mesh-ancestor
93029124|NCT00373113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029125|NCT00373113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029126|NCT00373113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93029127|NCT00373113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93029128|NCT00373113|Growth Substances|growth substances|mesh-ancestor
93029129|NCT00373113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029130|NCT00373113|Growth Inhibitors|growth inhibitors|mesh-ancestor
93029131|NCT00373113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93029132|NCT00373113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029133|NCT01045941|Gemcitabine|gemcitabine|mesh-list
93029134|NCT01045941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029135|NCT01045941|Antimetabolites|antimetabolites|mesh-ancestor
93029136|NCT01045941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029137|NCT01045941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029138|NCT00407511|Pregabalin|pregabalin|mesh-list
93029139|NCT00407511|Analgesics|analgesics|mesh-ancestor
93029140|NCT00407511|Sensory System Agents|sensory system agents|mesh-ancestor
93029141|NCT00407511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029142|NCT00407511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029143|NCT00407511|Anticonvulsants|anticonvulsants|mesh-ancestor
93029144|NCT00407511|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93029145|NCT00407511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029146|NCT00407511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029147|NCT00407511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93029148|NCT00407511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93029149|NCT00407511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93029150|NCT00407511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93029151|NCT00407511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93029152|NCT00384189|Ciclesonide|ciclesonide|mesh-list
93029153|NCT00384189|Albuterol|albuterol|mesh-list
93029154|NCT00384189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93029155|NCT00384189|Autonomic Agents|autonomic agents|mesh-ancestor
93029156|NCT00384189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029157|NCT00384189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029158|NCT00384189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93029159|NCT00384189|Respiratory System Agents|respiratory system agents|mesh-ancestor
93029160|NCT00384189|Tocolytic Agents|tocolytic agents|mesh-ancestor
93029161|NCT00384189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93029162|NCT00384189|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93029163|NCT00384189|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93029164|NCT00384189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93029165|NCT00384189|Adrenergic Agents|adrenergic agents|mesh-ancestor
93029166|NCT00384189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029167|NCT00384189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029168|NCT00384189|Glucocorticoids|glucocorticoids|mesh-ancestor
93029169|NCT00384189|Hormones|hormones|mesh-ancestor
93029170|NCT00384189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029171|NCT00384189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93029172|NCT00326716|Ritonavir|ritonavir|mesh-list
93029173|NCT00326716|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93029174|NCT00326716|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93029175|NCT00326716|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93029176|NCT00326716|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93029177|NCT00326716|Protease Inhibitors|protease inhibitors|mesh-ancestor
93029178|NCT00326716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029179|NCT00326716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029180|NCT00326716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93029181|NCT00326716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93029182|NCT00326716|Antiviral Agents|antiviral agents|mesh-ancestor
93029183|NCT00326716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029184|NCT00326716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93029185|NCT00326716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93029186|NCT00326716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93029187|NCT00326716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93029188|NCT01063192|Leucovorin|leucovorin|mesh-list
93029189|NCT01063192|Gemcitabine|gemcitabine|mesh-list
93029190|NCT01063192|Fluorouracil|fluorouracil|mesh-list
93029191|NCT01063192|Oxaliplatin|oxaliplatin|mesh-list
93029192|NCT01063192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029193|NCT01063192|Antimetabolites|antimetabolites|mesh-ancestor
93029194|NCT01063192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029195|NCT01063192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029196|NCT01063192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029197|NCT01063192|Immunologic Factors|immunologic factors|mesh-ancestor
93029198|NCT01063192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029199|NCT01063192|Antidotes|antidotes|mesh-ancestor
93029200|NCT01063192|Protective Agents|protective agents|mesh-ancestor
93029201|NCT01063192|Vitamin B Complex|vitamin b complex|mesh-ancestor
93029202|NCT01063192|Vitamins|vitamins|mesh-ancestor
93029203|NCT01063192|Micronutrients|micronutrients|mesh-ancestor
93029204|NCT03978988|Aspirin|aspirin|mesh-list
93029205|NCT03978988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029206|NCT03978988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029207|NCT03978988|Analgesics|analgesics|mesh-ancestor
93029208|NCT03978988|Sensory System Agents|sensory system agents|mesh-ancestor
93029209|NCT03978988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029210|NCT03978988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029211|NCT03978988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029212|NCT03978988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029213|NCT03978988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93029214|NCT03978988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93029215|NCT03978988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029216|NCT03978988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93029217|NCT03978988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029218|NCT03978988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029219|NCT03978988|Antipyretics|antipyretics|mesh-ancestor
93029220|NCT01063426|Enoxaparin|enoxaparin|mesh-list
93029221|NCT01063426|Enoxaparin sodium|enoxaparin sodium|mesh-list
93029222|NCT01063426|Atorvastatin|atorvastatin|mesh-list
93029223|NCT01063426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93029224|NCT01063426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93029225|NCT01063426|Antimetabolites|antimetabolites|mesh-ancestor
93029226|NCT01063426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029227|NCT01063426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93029228|NCT01063426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92674506|NCT00351663|Enoxaparin|enoxaparin|mesh-list
93029229|NCT01063426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029230|NCT01063426|Anticoagulants|anticoagulants|mesh-ancestor
93029231|NCT01063426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93029232|NCT01063426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93029233|NCT00548405|Interferons|interferons|mesh-list
93029234|NCT00548405|Interferon-beta|interferon-beta|mesh-list
93029235|NCT00548405|Interferon beta-1a|interferon beta-1a|mesh-list
93029236|NCT00548405|Alemtuzumab|alemtuzumab|mesh-list
93029237|NCT00548405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029238|NCT00548405|Antiviral Agents|antiviral agents|mesh-ancestor
93029239|NCT00548405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029240|NCT00548405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029241|NCT00548405|Immunologic Factors|immunologic factors|mesh-ancestor
93029242|NCT00548405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029243|NCT00548405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93029244|NCT04919369|Vitamins|vitamins|mesh-list
93029245|NCT04919369|Vitamin A|vitamin a|mesh-list
93029246|NCT04919369|Atezolizumab|atezolizumab|mesh-list
93029247|NCT04919369|Tretinoin|tretinoin|mesh-list
93029248|NCT04919369|Retinol palmitate|retinol palmitate|mesh-list
93029249|NCT04919369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93029250|NCT04919369|Micronutrients|micronutrients|mesh-ancestor
93029251|NCT04919369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029252|NCT04919369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93029253|NCT04919369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029254|NCT04919369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029255|NCT04919369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029256|NCT04919369|Immunologic Factors|immunologic factors|mesh-ancestor
93029257|NCT04919369|Keratolytic Agents|keratolytic agents|mesh-ancestor
93029258|NCT04919369|Dermatologic Agents|dermatologic agents|mesh-ancestor
93029259|NCT04919369|Antioxidants|antioxidants|mesh-ancestor
93029260|NCT04919369|Protective Agents|protective agents|mesh-ancestor
93029261|NCT04919369|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93029262|NCT00959075|Thiamine|thiamine|mesh-list
93029263|NCT00959075|Vitamins|vitamins|mesh-ancestor
93029264|NCT00959075|Micronutrients|micronutrients|mesh-ancestor
93029265|NCT00959075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029266|NCT00959075|Vitamin B Complex|vitamin b complex|mesh-ancestor
93029267|NCT00295750|Leuprolide|leuprolide|mesh-list
93029268|NCT00295750|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93029269|NCT00295750|Fertility Agents|fertility agents|mesh-ancestor
93029270|NCT00295750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93029271|NCT00295750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029272|NCT00295750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93029273|NCT00295750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029274|NCT00959231|Cyclosporine|cyclosporine|mesh-list
93029275|NCT00959231|Mycophenolic Acid|mycophenolic acid|mesh-list
93029276|NCT00959231|Cyclophosphamide|cyclophosphamide|mesh-list
93029277|NCT00959231|Fludarabine|fludarabine|mesh-list
93029278|NCT00959231|Fludarabine phosphate|fludarabine phosphate|mesh-list
93029280|NCT00959231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029281|NCT00959231|Immunologic Factors|immunologic factors|mesh-ancestor
93029282|NCT00959231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029283|NCT00959231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029284|NCT00959231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93029285|NCT00959231|Alkylating Agents|alkylating agents|mesh-ancestor
93029286|NCT00959231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029287|NCT00959231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029288|NCT00959231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93029289|NCT00959231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029290|NCT00959231|Antimetabolites|antimetabolites|mesh-ancestor
93029291|NCT00959231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029292|NCT00959231|Antifungal Agents|antifungal agents|mesh-ancestor
93029293|NCT00959231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029294|NCT00959231|Dermatologic Agents|dermatologic agents|mesh-ancestor
93029295|NCT00959231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93029296|NCT00959231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93029297|NCT00959231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93029298|NCT00959231|Antitubercular Agents|antitubercular agents|mesh-ancestor
93029299|NCT00959231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93029300|NCT03948581|Vedolizumab|vedolizumab|mesh-list
93029301|NCT03948581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93029302|NCT00548327|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93029303|NCT00548327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93029304|NCT00548327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93029305|NCT00548327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029306|NCT00548327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029307|NCT00548327|Adrenergic Agents|adrenergic agents|mesh-ancestor
93029308|NCT00548327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029309|NCT00548327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029310|NCT04720547|Zolpidem|zolpidem|mesh-list
93029311|NCT04720547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93029312|NCT04720547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93029313|NCT04720547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93029314|NCT04720547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029315|NCT04720547|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93029316|NCT04720547|GABA Agonists|gaba agonists|mesh-ancestor
93029317|NCT04720547|GABA Agents|gaba agents|mesh-ancestor
93029318|NCT04720547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029319|NCT04720547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029320|NCT00959387|Paclitaxel|paclitaxel|mesh-list
93029321|NCT00959387|Cisplatin|cisplatin|mesh-list
93029322|NCT00959387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93029323|NCT00959387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029324|NCT00959387|Tubulin Modulators|tubulin modulators|mesh-ancestor
93029325|NCT00959387|Antimitotic Agents|antimitotic agents|mesh-ancestor
93029326|NCT00959387|Mitosis Modulators|mitosis modulators|mesh-ancestor
93029327|NCT00959387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029328|NCT04718285|Favipiravir|favipiravir|mesh-list
93029329|NCT04718285|Montelukast|montelukast|mesh-list
93029330|NCT04718285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93029331|NCT04718285|Respiratory System Agents|respiratory system agents|mesh-ancestor
93029332|NCT04718285|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93029333|NCT04718285|Hormone Antagonists|hormone antagonists|mesh-ancestor
93029334|NCT04718285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029335|NCT04718285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029336|NCT04718285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93029337|NCT04718285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93029338|NCT04718285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029339|NCT04718285|Antiviral Agents|antiviral agents|mesh-ancestor
93029340|NCT04718285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029341|NCT00959621|Aspirin|aspirin|mesh-list
93029342|NCT00959621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029343|NCT00959621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029344|NCT00959621|Analgesics|analgesics|mesh-ancestor
93029345|NCT00959621|Sensory System Agents|sensory system agents|mesh-ancestor
93029346|NCT00959621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029347|NCT00959621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529024|NCT00000962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93029348|NCT00959621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029349|NCT00959621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029350|NCT00959621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93029351|NCT00959621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93029352|NCT00959621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029353|NCT00959621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93029354|NCT00959621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029355|NCT00959621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029356|NCT00959621|Antipyretics|antipyretics|mesh-ancestor
93029357|NCT00959777|Lenograstim|lenograstim|mesh-list
93029358|NCT00959777|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93029359|NCT00959777|Immunologic Factors|immunologic factors|mesh-ancestor
93029360|NCT00959777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029361|NCT00959933|Ribavirin|ribavirin|mesh-list
93029362|NCT00959933|Antimetabolites|antimetabolites|mesh-ancestor
93029363|NCT00959933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029364|NCT00959933|Antiviral Agents|antiviral agents|mesh-ancestor
93029365|NCT00959933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029366|NCT00960245|Nadolol|nadolol|mesh-list
93029367|NCT00960245|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93029368|NCT00960245|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93029369|NCT00960245|Adrenergic Agents|adrenergic agents|mesh-ancestor
93029370|NCT00960245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029371|NCT00960245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029372|NCT00960245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029373|NCT00960245|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93029374|NCT00960245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93029375|NCT00960245|Sympatholytics|sympatholytics|mesh-ancestor
93029376|NCT00960245|Autonomic Agents|autonomic agents|mesh-ancestor
93029377|NCT00960245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029378|NCT00406653|Abatacept|abatacept|mesh-list
93029379|NCT00406653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93029380|NCT00406653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029381|NCT00406653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029382|NCT00406653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029383|NCT00406653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029384|NCT00406653|Immunologic Factors|immunologic factors|mesh-ancestor
93029385|NCT00406653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029386|NCT00406653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029387|NCT00547157|Cisplatin|cisplatin|mesh-list
93029388|NCT00547157|Panitumumab|panitumumab|mesh-list
93029389|NCT00547157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029390|NCT00547157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029391|NCT00960479|Ribavirin|ribavirin|mesh-list
93029392|NCT00960479|Antimetabolites|antimetabolites|mesh-ancestor
93029393|NCT00960479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029394|NCT00960479|Antiviral Agents|antiviral agents|mesh-ancestor
93029395|NCT00960479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029396|NCT00960557|Combretastatin|combretastatin|mesh-list
93029397|NCT00960557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93029398|NCT00960557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029399|NCT00960557|Tubulin Modulators|tubulin modulators|mesh-ancestor
93029400|NCT00960557|Antimitotic Agents|antimitotic agents|mesh-ancestor
93029401|NCT00960557|Mitosis Modulators|mitosis modulators|mesh-ancestor
93029402|NCT00960557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029403|NCT00960635|Vitamin D|vitamin d|mesh-list
93029404|NCT00960635|Cholecalciferol|cholecalciferol|mesh-list
93029405|NCT00960635|Calcitriol|calcitriol|mesh-list
93029406|NCT00960635|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
93029407|NCT00960635|Vitamins|vitamins|mesh-ancestor
93029408|NCT00960635|Micronutrients|micronutrients|mesh-ancestor
93029409|NCT00960635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029410|NCT00960635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93029411|NCT00960635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93029412|NCT00960635|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93029413|NCT00960635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029414|NCT00960635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029415|NCT00960635|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93029416|NCT00960713|Rituximab|rituximab|mesh-list
93029417|NCT00960713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029418|NCT00960713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029419|NCT00960713|Immunologic Factors|immunologic factors|mesh-ancestor
93029420|NCT00960713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029421|NCT00960713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029422|NCT04009889|Silicon|silicon|mesh-list
93029423|NCT04009889|Trace Elements|trace elements|mesh-ancestor
93029424|NCT04009889|Micronutrients|micronutrients|mesh-ancestor
93029425|NCT04009889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029426|NCT00962507|Everolimus|everolimus|mesh-list
93029427|NCT00962507|Panobinostat|panobinostat|mesh-list
93029428|NCT00962507|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93029429|NCT00962507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93029430|NCT00962507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029431|NCT00962507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029432|NCT00962507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029433|NCT00962507|Immunologic Factors|immunologic factors|mesh-ancestor
93029434|NCT00962507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029435|NCT00962507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029436|NCT00962507|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93029437|NCT00384033|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93029438|NCT00384033|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93029439|NCT00384033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93029440|NCT00384033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93029441|NCT00384033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029442|NCT00384033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029443|NCT00384033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029444|NCT00384033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029445|NCT00384033|Analgesics|analgesics|mesh-ancestor
93029446|NCT00384033|Sensory System Agents|sensory system agents|mesh-ancestor
93029447|NCT00384033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029448|NCT00384033|Antidepressive Agents|antidepressive agents|mesh-ancestor
93029449|NCT00384033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93029450|NCT00384033|Dopamine Agents|dopamine agents|mesh-ancestor
93029451|NCT00962663|Ibuprofen|ibuprofen|mesh-list
93029452|NCT00962663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029453|NCT00962663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029454|NCT00962663|Analgesics|analgesics|mesh-ancestor
93029455|NCT00962663|Sensory System Agents|sensory system agents|mesh-ancestor
93029456|NCT00962663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029457|NCT00962663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029458|NCT00962663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029459|NCT00962663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029460|NCT00962663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029461|NCT00962663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029462|NCT00962663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029463|NCT00962975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93029464|NCT00962975|Antiviral Agents|antiviral agents|mesh-ancestor
93029465|NCT00962975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029466|NCT00075387|Sodium thiosulfate|sodium thiosulfate|mesh-list
93029467|NCT00075387|Cyclophosphamide|cyclophosphamide|mesh-list
93029468|NCT00075387|Carboplatin|carboplatin|mesh-list
93029469|NCT00075387|Etoposide|etoposide|mesh-list
93029470|NCT00075387|Etoposide phosphate|etoposide phosphate|mesh-list
93029471|NCT00075387|Antidotes|antidotes|mesh-list
93029472|NCT00075387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029473|NCT00075387|Immunologic Factors|immunologic factors|mesh-ancestor
93029474|NCT00075387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029475|NCT00075387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029476|NCT00075387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93029477|NCT00075387|Alkylating Agents|alkylating agents|mesh-ancestor
93029478|NCT00075387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029479|NCT00075387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029480|NCT00075387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93029481|NCT00075387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93029482|NCT00075387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93029483|NCT00075387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93029484|NCT00075387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029485|NCT00075387|Protective Agents|protective agents|mesh-ancestor
93029486|NCT00075387|Antioxidants|antioxidants|mesh-ancestor
93029487|NCT00075387|Antitubercular Agents|antitubercular agents|mesh-ancestor
93029488|NCT00075387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93029489|NCT00075387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029490|NCT00075387|Chelating Agents|chelating agents|mesh-ancestor
93029491|NCT00075387|Sequestering Agents|sequestering agents|mesh-ancestor
93029492|NCT00963131|Antioxidants|antioxidants|mesh-list
93029493|NCT00963131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029494|NCT00963131|Protective Agents|protective agents|mesh-ancestor
93029495|NCT00963131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029496|NCT00963209|Tamoxifen|tamoxifen|mesh-list
93029497|NCT00963209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93029498|NCT00963209|Hormone Antagonists|hormone antagonists|mesh-ancestor
93029499|NCT00963209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029500|NCT00963209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029501|NCT00963209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93029502|NCT00963209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029503|NCT00963209|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93029504|NCT00963209|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93029505|NCT00963209|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93029506|NCT00963443|Aspirin|aspirin|mesh-list
93029507|NCT00963443|Pseudoephedrine|pseudoephedrine|mesh-list
93029508|NCT00963443|Ephedrine|ephedrine|mesh-list
93029509|NCT00963443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029510|NCT00963443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029511|NCT00963443|Analgesics|analgesics|mesh-ancestor
93029512|NCT00963443|Sensory System Agents|sensory system agents|mesh-ancestor
93029513|NCT00963443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029514|NCT00963443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029515|NCT00963443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029516|NCT00963443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029517|NCT00963443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93029518|NCT00963443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93029519|NCT00963443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029520|NCT00963443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93029521|NCT00963443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029522|NCT00963443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029523|NCT00963443|Antipyretics|antipyretics|mesh-ancestor
93029524|NCT00963443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93029525|NCT00963443|Autonomic Agents|autonomic agents|mesh-ancestor
93029526|NCT00963443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93029527|NCT00963443|Respiratory System Agents|respiratory system agents|mesh-ancestor
93029528|NCT00963443|Nasal Decongestants|nasal decongestants|mesh-ancestor
93029529|NCT00963443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92674809|NCT00323687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029530|NCT00963443|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93029531|NCT00963443|Sympathomimetics|sympathomimetics|mesh-ancestor
93029532|NCT00963443|Adrenergic Agents|adrenergic agents|mesh-ancestor
93029533|NCT00963443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029534|NCT00963833|Interferons|interferons|mesh-list
93029535|NCT00963833|Interferon-beta|interferon-beta|mesh-list
93029536|NCT00963833|Interferon beta-1b|interferon beta-1b|mesh-list
93029537|NCT00963833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029538|NCT00963833|Antiviral Agents|antiviral agents|mesh-ancestor
93029539|NCT00963833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029540|NCT00963833|Immunologic Factors|immunologic factors|mesh-ancestor
93029541|NCT00963833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029542|NCT00963833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93029543|NCT00967655|Capecitabine|capecitabine|mesh-list
93029544|NCT00967655|Irinotecan|irinotecan|mesh-list
93029545|NCT00967655|Panitumumab|panitumumab|mesh-list
93029546|NCT00967655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029547|NCT00967655|Antimetabolites|antimetabolites|mesh-ancestor
93029548|NCT00967655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029549|NCT00967655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029550|NCT00967655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93029551|NCT00967655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93029552|NCT00967655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029553|NCT00967655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029554|NCT00546377|Cyclophosphamide|cyclophosphamide|mesh-list
93029555|NCT00546377|Rituximab|rituximab|mesh-list
93029556|NCT00546377|Mitoxantrone|mitoxantrone|mesh-list
93029557|NCT00546377|Pentostatin|pentostatin|mesh-list
93029558|NCT00546377|Sargramostim|sargramostim|mesh-list
93029559|NCT00546377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029560|NCT00546377|Immunologic Factors|immunologic factors|mesh-ancestor
93029561|NCT00546377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029562|NCT00546377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029563|NCT00546377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93029564|NCT00546377|Alkylating Agents|alkylating agents|mesh-ancestor
93029565|NCT00546377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029566|NCT00546377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029567|NCT00546377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93029568|NCT00546377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029570|NCT00546377|Sensory System Agents|sensory system agents|mesh-ancestor
93029571|NCT00546377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029572|NCT00546377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93029573|NCT00546377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93029574|NCT00546377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029575|NCT00546377|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93029576|NCT00967967|Mometasone Furoate|mometasone furoate|mesh-list
93029577|NCT00967967|Desloratadine|desloratadine|mesh-list
93029578|NCT00967967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029579|NCT00967967|Dermatologic Agents|dermatologic agents|mesh-ancestor
93029580|NCT00967967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93029581|NCT00967967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93029582|NCT00967967|Cholinergic Agents|cholinergic agents|mesh-ancestor
93029583|NCT00967967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029584|NCT00967967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029585|NCT00967967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029586|NCT00967967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93029587|NCT00967967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93029588|NCT00967967|Histamine Antagonists|histamine antagonists|mesh-ancestor
93029589|NCT00967967|Histamine Agents|histamine agents|mesh-ancestor
93029590|NCT00964457|Cetuximab|cetuximab|mesh-list
93029591|NCT00964457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029592|NCT00964457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029593|NCT00964535|Budesonide|budesonide|mesh-list
93029594|NCT00964535|Formoterol Fumarate|formoterol fumarate|mesh-list
93029595|NCT00964535|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93029596|NCT00964535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029597|NCT00964535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93029598|NCT00964535|Autonomic Agents|autonomic agents|mesh-ancestor
93029599|NCT00964535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029600|NCT00964535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029601|NCT00964535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93029602|NCT00964535|Respiratory System Agents|respiratory system agents|mesh-ancestor
93029603|NCT00964535|Glucocorticoids|glucocorticoids|mesh-ancestor
93029604|NCT00964535|Hormones|hormones|mesh-ancestor
93029605|NCT00964535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029607|NCT00964535|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93029608|NCT00964535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93029609|NCT00964535|Adrenergic Agents|adrenergic agents|mesh-ancestor
93029610|NCT00964535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029611|NCT00964535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029612|NCT00964691|Chloroquine|chloroquine|mesh-list
93029613|NCT00964691|Pyrimethamine|pyrimethamine|mesh-list
93029614|NCT00964691|Sulfadoxine|sulfadoxine|mesh-list
93029615|NCT00964691|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93029616|NCT00964691|Amebicides|amebicides|mesh-ancestor
93029617|NCT00964691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93029618|NCT00964691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93029619|NCT00964691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029620|NCT00964691|Antimalarials|antimalarials|mesh-ancestor
93029621|NCT00964691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029622|NCT00964691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93029623|NCT00964691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029624|NCT00964691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029625|NCT00964691|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93029626|NCT00964769|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93029627|NCT00964769|Immunologic Factors|immunologic factors|mesh-ancestor
93029628|NCT00964769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029629|NCT00968435|Bevacizumab|bevacizumab|mesh-list
93029630|NCT00968435|Cetuximab|cetuximab|mesh-list
93029631|NCT00968435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029632|NCT00968435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029633|NCT00968435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93029634|NCT00968435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93029635|NCT00968435|Growth Substances|growth substances|mesh-ancestor
93029636|NCT00968435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029637|NCT00968435|Growth Inhibitors|growth inhibitors|mesh-ancestor
93029638|NCT05253287|Hormones|hormones|mesh-list
93029639|NCT05253287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029640|NCT05253287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029641|NCT00968591|Everolimus|everolimus|mesh-list
93029642|NCT00968591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93029643|NCT00968591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93029644|NCT00968591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029645|NCT00968591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029646|NCT00968591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029647|NCT00968591|Immunologic Factors|immunologic factors|mesh-ancestor
93029648|NCT00968591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029649|NCT00968591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029650|NCT00968903|Methylprednisolone|methylprednisolone|mesh-list
93029651|NCT00968903|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93029652|NCT00968903|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93029653|NCT00968903|Prednisolone|prednisolone|mesh-list
93029654|NCT00968903|Prednisolone acetate|prednisolone acetate|mesh-list
93029655|NCT00968903|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93029656|NCT00968903|Prednisolone phosphate|prednisolone phosphate|mesh-list
93029657|NCT00968903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029658|NCT00968903|Antiemetics|antiemetics|mesh-ancestor
93029659|NCT00968903|Autonomic Agents|autonomic agents|mesh-ancestor
93029660|NCT00968903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029661|NCT00968903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029662|NCT00968903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93029663|NCT00968903|Glucocorticoids|glucocorticoids|mesh-ancestor
93029664|NCT00968903|Hormones|hormones|mesh-ancestor
93029665|NCT00968903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029666|NCT00968903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93029667|NCT00968903|Protective Agents|protective agents|mesh-ancestor
93029668|NCT00968903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93029669|NCT00968903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029670|NCT00969137|Nicotine|nicotine|mesh-list
93029671|NCT00969137|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93029672|NCT00969137|Autonomic Agents|autonomic agents|mesh-ancestor
93029673|NCT00969137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029674|NCT00969137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029675|NCT00969137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92182986|NCT00084149|Antiviral Agents|antiviral agents|mesh-ancestor
93029676|NCT00969137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93029677|NCT00969137|Cholinergic Agents|cholinergic agents|mesh-ancestor
93029678|NCT00969137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674953|NCT00324467|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93029679|NCT00969137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029680|NCT00965315|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93029681|NCT00965315|Fenofibrate|fenofibrate|mesh-list
93029682|NCT00965315|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93029683|NCT00965315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93029684|NCT00965315|Antimetabolites|antimetabolites|mesh-ancestor
93029685|NCT00965315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029686|NCT00965315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93029687|NCT00965315|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93029688|NCT00965315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029689|NCT00969293|Ecallantide|ecallantide|mesh-list
93029690|NCT00969293|Analgesics|analgesics|mesh-ancestor
93029691|NCT00969293|Sensory System Agents|sensory system agents|mesh-ancestor
93029692|NCT00969293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029693|NCT00969293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029694|NCT00969293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029695|NCT00969293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029696|NCT00969293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029697|NCT00969293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029698|NCT00969449|Naproxen|naproxen|mesh-list
93029699|NCT00969449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029700|NCT00969449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029701|NCT00969449|Analgesics|analgesics|mesh-ancestor
93029702|NCT00969449|Sensory System Agents|sensory system agents|mesh-ancestor
93029703|NCT00969449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029704|NCT00969449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029705|NCT00969449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029706|NCT00969449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029707|NCT00969449|Gout Suppressants|gout suppressants|mesh-ancestor
93029708|NCT00969449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93029709|NCT00969449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029710|NCT00969449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029711|NCT00965393|Bradykinin|bradykinin|mesh-list
93029712|NCT00965393|Kininogens|kininogens|mesh-list
93029713|NCT00965393|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-list
93029714|NCT00965393|Vasodilator Agents|vasodilator agents|mesh-ancestor
93029715|NCT00965393|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
93029716|NCT00965393|Protease Inhibitors|protease inhibitors|mesh-ancestor
93029717|NCT00965393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029718|NCT00965393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029719|NCT00965549|Insulin|insulin|mesh-list
93029720|NCT00965549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93029721|NCT00965549|Insulin Glargine|insulin glargine|mesh-list
93029722|NCT00965549|Insulin Aspart|insulin aspart|mesh-list
93029723|NCT00965549|Insulin glulisine|insulin glulisine|mesh-list
93029724|NCT00965549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93029725|NCT00965549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029726|NCT00966251|Pidilizumab|pidilizumab|mesh-list
93029727|NCT00966251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029728|NCT00966251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029729|NCT00966329|Maraviroc|maraviroc|mesh-list
93029730|NCT00966329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93029731|NCT00966329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93029732|NCT00966329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029733|NCT00966329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93029734|NCT00966329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93029735|NCT00966329|Antiviral Agents|antiviral agents|mesh-ancestor
93029736|NCT00966329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029737|NCT00966329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93029738|NCT00970697|Becaplermin|becaplermin|mesh-list
93029739|NCT00970697|Anticoagulants|anticoagulants|mesh-ancestor
93029740|NCT00970697|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93029741|NCT00970697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93029742|NCT00970697|Growth Substances|growth substances|mesh-ancestor
93029743|NCT00970697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029744|NCT00967031|Capecitabine|capecitabine|mesh-list
93029745|NCT00967031|Lapatinib|lapatinib|mesh-list
93029746|NCT00967031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029747|NCT00967031|Antimetabolites|antimetabolites|mesh-ancestor
93029748|NCT00967031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029749|NCT00967031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029750|NCT00967031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93029751|NCT00967031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029752|NCT00967109|Chrysarobin|chrysarobin|mesh-list
93029753|NCT00967109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93029754|NCT00967109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93029755|NCT00967109|Analgesics|analgesics|mesh-ancestor
93029756|NCT00967109|Sensory System Agents|sensory system agents|mesh-ancestor
93029757|NCT00967109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029758|NCT00967109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029759|NCT00967109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93029760|NCT00967109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029761|NCT00545753|Permethrin|permethrin|mesh-list
93029762|NCT00545753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029763|NCT00545753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029764|NCT00970931|Chlorthalidone|chlorthalidone|mesh-list
93029765|NCT00970931|Amiloride|amiloride|mesh-list
93029766|NCT00970931|Diuretics|diuretics|mesh-list
93029767|NCT00970931|Natriuretic Agents|natriuretic agents|mesh-ancestor
93029768|NCT00970931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029769|NCT00970931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93029770|NCT00970931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93029771|NCT00970931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029772|NCT00970931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029773|NCT00970931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92529038|NCT00396721|Sirolimus|sirolimus|mesh-list
93029774|NCT00970931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93029775|NCT00970931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93029776|NCT00970931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93029777|NCT00406419|Methotrexate|methotrexate|mesh-list
93029778|NCT00406419|Ocrelizumab|ocrelizumab|mesh-list
93029779|NCT00406419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93029780|NCT00406419|Abortifacient Agents|abortifacient agents|mesh-ancestor
93029781|NCT00406419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93029782|NCT00406419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029783|NCT00406419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029784|NCT00406419|Antimetabolites|antimetabolites|mesh-ancestor
93029785|NCT00406419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029786|NCT00406419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029787|NCT00406419|Dermatologic Agents|dermatologic agents|mesh-ancestor
93029788|NCT00406419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029789|NCT00406419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93029790|NCT00406419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029791|NCT00406419|Immunologic Factors|immunologic factors|mesh-ancestor
93029792|NCT00406419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029793|NCT00406419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93029794|NCT00967421|Ethanol|ethanol|mesh-list
93029795|NCT00967421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93029796|NCT00967421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029797|NCT00967421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93029798|NCT00967421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029799|NCT00971165|Losartan|losartan|mesh-list
93029800|NCT00971165|Chlorthalidone|chlorthalidone|mesh-list
93029801|NCT00971165|Amiloride|amiloride|mesh-list
93029802|NCT00971165|Diuretics|diuretics|mesh-list
93029803|NCT00971165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93029804|NCT00971165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93029805|NCT00971165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93029806|NCT00971165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93029807|NCT00971165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029808|NCT00971165|Natriuretic Agents|natriuretic agents|mesh-ancestor
93029809|NCT00971165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029810|NCT00971165|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93029811|NCT00971165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182999|NCT02959905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029812|NCT00971165|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
93029813|NCT00971165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93029814|NCT00971165|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
93029815|NCT00971165|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93029816|NCT00971399|Ondansetron|ondansetron|mesh-list
93029817|NCT00971399|Ramosetron|ramosetron|mesh-list
93029818|NCT00971399|Antiemetics|antiemetics|mesh-ancestor
93029819|NCT00971399|Autonomic Agents|autonomic agents|mesh-ancestor
93029820|NCT00971399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029821|NCT00971399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029822|NCT00971399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93029823|NCT00971399|Antipruritics|antipruritics|mesh-ancestor
93029824|NCT00971399|Dermatologic Agents|dermatologic agents|mesh-ancestor
93029825|NCT00971399|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93029826|NCT00971399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93029827|NCT00971399|Serotonin Agents|serotonin agents|mesh-ancestor
93029828|NCT00971399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029829|NCT00971399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029830|NCT00973505|Anastrozole|anastrozole|mesh-list
93029831|NCT00973505|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93029832|NCT00973505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029833|NCT00973505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93029834|NCT00973505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029835|NCT00973505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029836|NCT00973505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93029837|NCT00973505|Hormone Antagonists|hormone antagonists|mesh-ancestor
93029838|NCT00973505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93029839|NCT00973505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029840|NCT00973505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93029841|NCT00973583|Vitamin D|vitamin d|mesh-list
93029842|NCT00973583|Vitamins|vitamins|mesh-ancestor
93029843|NCT00973583|Micronutrients|micronutrients|mesh-ancestor
93029844|NCT00973583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529047|NCT00396721|Immunologic Factors|immunologic factors|mesh-ancestor
93029845|NCT00973583|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93029846|NCT00972101|Mycophenolic Acid|mycophenolic acid|mesh-list
93029847|NCT00972101|Rituximab|rituximab|mesh-list
93029848|NCT00972101|Fludarabine|fludarabine|mesh-list
93029849|NCT00972101|Fludarabine phosphate|fludarabine phosphate|mesh-list
93029850|NCT00972101|Etoposide|etoposide|mesh-list
93029851|NCT00972101|Melphalan|melphalan|mesh-list
93029852|NCT00972101|Thiotepa|thiotepa|mesh-list
93029853|NCT00972101|Tacrolimus|tacrolimus|mesh-list
93029854|NCT00972101|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93029855|NCT00972101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93029856|NCT00972101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029857|NCT00972101|Immunologic Factors|immunologic factors|mesh-ancestor
93029858|NCT00972101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029859|NCT00972101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029860|NCT00972101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029861|NCT00972101|Antimetabolites|antimetabolites|mesh-ancestor
93029862|NCT00972101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029863|NCT00972101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029864|NCT00972101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029865|NCT00972101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93029866|NCT00972101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93029867|NCT00972101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93029868|NCT00972101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029869|NCT00972101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93029870|NCT00972101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93029871|NCT00972101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93029872|NCT00972101|Antitubercular Agents|antitubercular agents|mesh-ancestor
93029873|NCT00972101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93029874|NCT00972101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93029875|NCT00972101|Alkylating Agents|alkylating agents|mesh-ancestor
93029876|NCT00972101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93029877|NCT00325468|Denosumab|denosumab|mesh-list
93029878|NCT00325468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93029879|NCT00325468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029880|NCT00972257|Timolol|timolol|mesh-list
93029881|NCT00972257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93029882|NCT00972257|Dorzolamide|dorzolamide|mesh-list
93029883|NCT00972257|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93029884|NCT00972257|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93029885|NCT00972257|Adrenergic Agents|adrenergic agents|mesh-ancestor
93029886|NCT00972257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029887|NCT00972257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029888|NCT00972257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029889|NCT00972257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93029890|NCT00972257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93029891|NCT00972257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93029892|NCT00972257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93029893|NCT00972257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93029894|NCT00972257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93029895|NCT00972257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029896|NCT00311584|Irinotecan|irinotecan|mesh-list
93029897|NCT00311584|Temozolomide|temozolomide|mesh-list
93029898|NCT00311584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93029899|NCT00311584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93029900|NCT00311584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029901|NCT00311584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029902|NCT00311584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029903|NCT00311584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93029904|NCT00311584|Alkylating Agents|alkylating agents|mesh-ancestor
93029905|NCT00383331|Gemcitabine|gemcitabine|mesh-list
93029906|NCT00383331|Pemetrexed|pemetrexed|mesh-list
93029907|NCT00383331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029908|NCT00383331|Antimetabolites|antimetabolites|mesh-ancestor
93029909|NCT00383331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029910|NCT00383331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029911|NCT00383331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029912|NCT00383331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93029913|NCT00383331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93029914|NCT03934541|Vaccines|vaccines|mesh-list
93029915|NCT03934541|Immunologic Factors|immunologic factors|mesh-ancestor
93029916|NCT03934541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029917|NCT00325234|Carboplatin|carboplatin|mesh-list
93029918|NCT00325234|Gemcitabine|gemcitabine|mesh-list
93029919|NCT00325234|Pemetrexed|pemetrexed|mesh-list
93029920|NCT00325234|Vinorelbine|vinorelbine|mesh-list
93029921|NCT00325234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029922|NCT00325234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029923|NCT00325234|Antimetabolites|antimetabolites|mesh-ancestor
93029924|NCT00325234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029925|NCT00325234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029926|NCT00325234|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93029927|NCT00325234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93029928|NCT00325234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93029929|NCT00325234|Tubulin Modulators|tubulin modulators|mesh-ancestor
93029930|NCT00325234|Antimitotic Agents|antimitotic agents|mesh-ancestor
93029931|NCT00325234|Mitosis Modulators|mitosis modulators|mesh-ancestor
93029932|NCT01063504|Teriparatide|teriparatide|mesh-list
93029933|NCT01063504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93029934|NCT01063504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029935|NCT01063504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93029936|NCT00366249|Ertapenem|ertapenem|mesh-list
93029937|NCT00366249|Tigecycline|tigecycline|mesh-list
93029938|NCT00366249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93029939|NCT00366249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93029940|NCT00366249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93029941|NCT00366249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029942|NCT00366249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029943|NCT03927911|Bupivacaine|bupivacaine|mesh-list
93029944|NCT03927911|Anesthetics, Local|anesthetics, local|mesh-ancestor
93029945|NCT03927911|Anesthetics|anesthetics|mesh-ancestor
93029946|NCT03927911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93029947|NCT03927911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029948|NCT03927911|Sensory System Agents|sensory system agents|mesh-ancestor
93029949|NCT03927911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93029950|NCT00383019|Latanoprost|latanoprost|mesh-list
93029951|NCT00383019|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93029952|NCT00383019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93029953|NCT00310804|Vaccines|vaccines|mesh-list
93029954|NCT00310804|Immunologic Factors|immunologic factors|mesh-ancestor
93029955|NCT00310804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029956|NCT00590187|Sapacitabine|sapacitabine|mesh-list
93029957|NCT00590187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029958|NCT03978364|Azacitidine|azacitidine|mesh-list
93029959|NCT03978364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93029960|NCT03978364|Antimetabolites|antimetabolites|mesh-ancestor
93029961|NCT03978364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029962|NCT03978364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029963|NCT03978364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029964|NCT01046487|Cyclophosphamide|cyclophosphamide|mesh-list
93029965|NCT01046487|Imatinib Mesylate|imatinib mesylate|mesh-list
93029966|NCT01046487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93029967|NCT01046487|Immunologic Factors|immunologic factors|mesh-ancestor
93029968|NCT01046487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029969|NCT01046487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93029970|NCT01046487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93029971|NCT01046487|Alkylating Agents|alkylating agents|mesh-ancestor
93029972|NCT01046487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029973|NCT01046487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93029974|NCT01046487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93029975|NCT01046487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93029976|NCT01046487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93029977|NCT03978286|Vortioxetine|vortioxetine|mesh-list
92675256|NCT00325910|Metformin|metformin|mesh-list
93029979|NCT03978286|Antidepressive Agents|antidepressive agents|mesh-ancestor
93029980|NCT03978286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93029981|NCT03978286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93029982|NCT03978286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93029983|NCT03978286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93029984|NCT03978286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93029985|NCT03978286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93029986|NCT03978286|Serotonin Agents|serotonin agents|mesh-ancestor
93029987|NCT03978286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93029988|NCT03978286|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93029989|NCT03978286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93029990|NCT03978286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93029991|NCT03978286|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93029992|NCT03978286|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93029993|NCT03978286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93029994|NCT03978286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93029995|NCT03933449|Paclitaxel|paclitaxel|mesh-list
93029996|NCT03933449|Docetaxel|docetaxel|mesh-list
93029997|NCT03933449|Pembrolizumab|pembrolizumab|mesh-list
93029998|NCT03933449|Irinotecan|irinotecan|mesh-list
93029999|NCT03933449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93030000|NCT03933449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030001|NCT03933449|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030002|NCT03933449|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030003|NCT03933449|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030004|NCT03933449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030005|NCT03933449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030006|NCT03933449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93030007|NCT03933449|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93030008|NCT03933449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93030009|NCT03933449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030010|NCT00974441|Valproic Acid|valproic acid|mesh-list
93030011|NCT00974441|Anticonvulsants|anticonvulsants|mesh-ancestor
93030012|NCT00974441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030013|NCT00974441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030014|NCT00974441|GABA Agents|gaba agents|mesh-ancestor
93030015|NCT00974441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030016|NCT00974441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030017|NCT00974441|Antimanic Agents|antimanic agents|mesh-ancestor
93030018|NCT00974441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93030019|NCT00974441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93030020|NCT00974441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93030021|NCT01049451|Methylprednisolone|methylprednisolone|mesh-list
93030022|NCT01049451|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93030023|NCT01049451|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93030024|NCT01049451|Prednisolone|prednisolone|mesh-list
93030025|NCT01049451|Prednisolone acetate|prednisolone acetate|mesh-list
93030026|NCT01049451|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93030027|NCT01049451|Prednisolone phosphate|prednisolone phosphate|mesh-list
93030028|NCT01049451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030029|NCT01049451|Antiemetics|antiemetics|mesh-ancestor
93030030|NCT01049451|Autonomic Agents|autonomic agents|mesh-ancestor
93030031|NCT01049451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030032|NCT01049451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030033|NCT01049451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93030034|NCT01049451|Glucocorticoids|glucocorticoids|mesh-ancestor
93030035|NCT01049451|Hormones|hormones|mesh-ancestor
93030036|NCT01049451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030037|NCT01049451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93030038|NCT01049451|Protective Agents|protective agents|mesh-ancestor
93030039|NCT01049451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93030040|NCT01049451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030041|NCT00972569|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93030042|NCT00972569|Natriuretic Agents|natriuretic agents|mesh-ancestor
93030043|NCT00972569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030044|NCT00974753|Ketorolac|ketorolac|mesh-list
93030045|NCT00974753|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93030046|NCT00974753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93030047|NCT00974753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93030048|NCT00974753|Analgesics|analgesics|mesh-ancestor
93030049|NCT00974753|Sensory System Agents|sensory system agents|mesh-ancestor
93030050|NCT00974753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030051|NCT00974753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030052|NCT00974753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030053|NCT00974753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030054|NCT00974753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93030055|NCT00974753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030056|NCT00974753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030058|NCT00972803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93030059|NCT00972803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030060|NCT00972803|Disinfectants|disinfectants|mesh-ancestor
93030061|NCT02908269|Vaccines|vaccines|mesh-list
93030062|NCT02908269|Immunologic Factors|immunologic factors|mesh-ancestor
93030063|NCT02908269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030064|NCT00974987|Temozolomide|temozolomide|mesh-list
93030065|NCT00974987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93030066|NCT00974987|Alkylating Agents|alkylating agents|mesh-ancestor
93030067|NCT00974987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030068|NCT00974987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030070|NCT00975065|Vildagliptin|vildagliptin|mesh-list
93030071|NCT00975065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030072|NCT00975065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030073|NCT00975065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93030074|NCT00975065|Protease Inhibitors|protease inhibitors|mesh-ancestor
93030075|NCT00975065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030076|NCT00975065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030077|NCT00972881|Capecitabine|capecitabine|mesh-list
93030078|NCT00972881|Irinotecan|irinotecan|mesh-list
93030079|NCT00972881|Cetuximab|cetuximab|mesh-list
93030080|NCT00972881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93030081|NCT00972881|Antimetabolites|antimetabolites|mesh-ancestor
93030082|NCT00972881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030083|NCT00972881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030084|NCT00972881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93030085|NCT00972881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93030086|NCT00972881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030087|NCT00972881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030088|NCT00290758|Genistein|genistein|mesh-list
93030089|NCT00290758|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93030090|NCT00290758|Protective Agents|protective agents|mesh-ancestor
93030091|NCT00290758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030092|NCT00290758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030093|NCT00290758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030094|NCT00290758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030095|NCT00290758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030096|NCT00290758|Phytoestrogens|phytoestrogens|mesh-ancestor
93030097|NCT00290758|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93030098|NCT00290758|Estrogens|estrogens|mesh-ancestor
93030099|NCT00290758|Hormones|hormones|mesh-ancestor
93030100|NCT00290758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030101|NCT00975299|Bombesin|bombesin|mesh-list
93030102|NCT00975299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030103|NCT00975299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030104|NCT00975299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030105|NCT01060930|Epinephrine|epinephrine|mesh-list
93030106|NCT01060930|Norepinephrine|norepinephrine|mesh-list
93030107|NCT01060930|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
93030108|NCT01060930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93030109|NCT01060930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93030110|NCT01060930|Adrenergic Agents|adrenergic agents|mesh-ancestor
93030111|NCT01060930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030112|NCT01060930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030113|NCT01060930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030114|NCT01060930|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93030115|NCT01060930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93030116|NCT01060930|Autonomic Agents|autonomic agents|mesh-ancestor
93030117|NCT01060930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030118|NCT01060930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93030119|NCT01060930|Respiratory System Agents|respiratory system agents|mesh-ancestor
93030120|NCT01060930|Mydriatics|mydriatics|mesh-ancestor
93030121|NCT01060930|Sympathomimetics|sympathomimetics|mesh-ancestor
93030122|NCT01060930|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93030123|NCT01060930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030124|NCT00973037|Tamoxifen|tamoxifen|mesh-list
93030125|NCT00973037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93030126|NCT00973037|Hormone Antagonists|hormone antagonists|mesh-ancestor
93030127|NCT00973037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030128|NCT00973037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030129|NCT00973037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93030130|NCT00973037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030131|NCT00973037|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93030132|NCT00973037|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93030133|NCT00973037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93030134|NCT00973115|Simvastatin|simvastatin|mesh-list
93030135|NCT00973115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93030136|NCT00973115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93030137|NCT00973115|Antimetabolites|antimetabolites|mesh-ancestor
93030138|NCT00973115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030139|NCT00973115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93030140|NCT00973115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93030141|NCT00973115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030142|NCT00973193|Panitumumab|panitumumab|mesh-list
93030143|NCT00973193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030144|NCT00973193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030145|NCT00975533|Insulin|insulin|mesh-list
93030146|NCT00975533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030147|NCT00975533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030148|NCT00372567|Sunitinib|sunitinib|mesh-list
93030149|NCT00372567|Imatinib Mesylate|imatinib mesylate|mesh-list
93030150|NCT00372567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030151|NCT00372567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030152|NCT00372567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030153|NCT00372567|Growth Substances|growth substances|mesh-ancestor
93030154|NCT00372567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030155|NCT00372567|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030156|NCT00372567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030157|NCT00372567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030158|NCT00372567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030159|NCT00973271|Atorvastatin|atorvastatin|mesh-list
93030160|NCT00973271|Fenofibric acid|fenofibric acid|mesh-list
93030161|NCT00973271|Fenofibrate|fenofibrate|mesh-list
93030162|NCT00973271|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93030163|NCT00973271|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93030164|NCT00973271|Antimetabolites|antimetabolites|mesh-ancestor
93030165|NCT00973271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030166|NCT00973271|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93030167|NCT00973271|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93030168|NCT00973271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030169|NCT00975767|Docetaxel|docetaxel|mesh-list
93030170|NCT00975767|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93030171|NCT00975767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030172|NCT00975767|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030173|NCT00975767|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030174|NCT00975767|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030175|NCT00975767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030176|NCT00975767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030177|NCT00975767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030178|NCT00365547|Bevacizumab|bevacizumab|mesh-list
93030179|NCT00365547|Topotecan|topotecan|mesh-list
93030180|NCT00365547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030181|NCT00365547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030182|NCT00365547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030183|NCT00365547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030184|NCT00365547|Growth Substances|growth substances|mesh-ancestor
93030185|NCT00365547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030186|NCT00365547|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030187|NCT00365547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93030188|NCT00365547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93030189|NCT00365547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030190|NCT00365547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030191|NCT00979589|Aspirin|aspirin|mesh-list
93030192|NCT00979589|Clopidogrel|clopidogrel|mesh-list
93030193|NCT00979589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93030194|NCT00979589|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93030195|NCT00979589|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93030196|NCT00979589|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93030197|NCT00979589|Purinergic Agents|purinergic agents|mesh-ancestor
93030198|NCT00979589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675470|NCT00327197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93030199|NCT00979589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030200|NCT00979589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030201|NCT00979589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93030202|NCT00979589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93030203|NCT00979589|Analgesics|analgesics|mesh-ancestor
93030204|NCT00979589|Sensory System Agents|sensory system agents|mesh-ancestor
93030205|NCT00979589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030206|NCT00979589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030207|NCT00979589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030208|NCT00979589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93030209|NCT00979589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93030210|NCT00979589|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93030211|NCT00979589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030213|NCT00294658|Prednisone|prednisone|mesh-list
93030214|NCT00294658|Prednisolone|prednisolone|mesh-list
93030215|NCT00294658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030216|NCT00294658|Glucocorticoids|glucocorticoids|mesh-ancestor
93030217|NCT00294658|Hormones|hormones|mesh-ancestor
93030218|NCT00294658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030219|NCT00294658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030220|NCT00294658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93030221|NCT00294658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030222|NCT00979667|Oseltamivir|oseltamivir|mesh-list
93030223|NCT00979667|Zanamivir|zanamivir|mesh-list
93030224|NCT00979667|Antiviral Agents|antiviral agents|mesh-ancestor
93030225|NCT00979667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030226|NCT00979667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030227|NCT00979667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030228|NCT03978052|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
93030229|NCT03978052|Antioxidants|antioxidants|mesh-ancestor
93030230|NCT03978052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030231|NCT03978052|Protective Agents|protective agents|mesh-ancestor
93030232|NCT03978052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030233|NCT03978052|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93030234|NCT03978052|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93030235|NCT03978052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030236|NCT03978052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93030237|NCT03923933|Chlorthalidone|chlorthalidone|mesh-list
93030238|NCT03923933|Bumetanide|bumetanide|mesh-list
93030239|NCT03923933|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93030240|NCT03923933|Diuretics|diuretics|mesh-ancestor
93030241|NCT03923933|Natriuretic Agents|natriuretic agents|mesh-ancestor
93030242|NCT03923933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030243|NCT03923933|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93030244|NCT03923933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93030245|NCT03923933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030246|NCT03923933|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93030247|NCT01066468|Imatinib Mesylate|imatinib mesylate|mesh-list
93030248|NCT01066468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030249|NCT01066468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030250|NCT01066468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030251|NCT01066468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030252|NCT00980135|Hydrocortisone|hydrocortisone|mesh-list
93030253|NCT00980135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030254|NCT00980213|Sunitinib|sunitinib|mesh-list
93030255|NCT00980213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030256|NCT00980213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030257|NCT00980213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030258|NCT00980213|Growth Substances|growth substances|mesh-ancestor
93030259|NCT00980213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030260|NCT00980213|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030261|NCT00980213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030262|NCT00980213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030263|NCT00980213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030264|NCT00976469|Vaccines|vaccines|mesh-list
93030265|NCT00976469|Immunologic Factors|immunologic factors|mesh-ancestor
93030266|NCT00976469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030267|NCT00980603|Docetaxel|docetaxel|mesh-list
93030268|NCT00980603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030269|NCT00980603|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030270|NCT00980603|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030271|NCT00980603|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030272|NCT00980603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030273|NCT00274456|Paclitaxel|paclitaxel|mesh-list
93030274|NCT00274456|Docetaxel|docetaxel|mesh-list
93030275|NCT00274456|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93030276|NCT00274456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93030277|NCT00274456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030278|NCT00274456|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030279|NCT00274456|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030280|NCT00274456|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030281|NCT00274456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030282|NCT00977093|Pentetic Acid|pentetic acid|mesh-list
93030283|NCT00977093|Antidotes|antidotes|mesh-ancestor
93030284|NCT00977093|Protective Agents|protective agents|mesh-ancestor
92529052|NCT00396721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93030285|NCT00977093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030287|NCT00977093|Sequestering Agents|sequestering agents|mesh-ancestor
93030288|NCT00977093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030289|NCT00977093|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93030290|NCT00977249|Varenicline|varenicline|mesh-list
93030291|NCT00977249|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93030292|NCT00977249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93030293|NCT00977249|Cholinergic Agents|cholinergic agents|mesh-ancestor
93030294|NCT00977249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030295|NCT00977249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030296|NCT00977249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030297|NCT01069822|Midazolam|midazolam|mesh-list
93030298|NCT01069822|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93030299|NCT01069822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93030300|NCT01069822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93030301|NCT01069822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030302|NCT01069822|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93030303|NCT01069822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93030304|NCT01069822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93030305|NCT01069822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93030306|NCT01069822|Anesthetics, General|anesthetics, general|mesh-ancestor
93030307|NCT01069822|Anesthetics|anesthetics|mesh-ancestor
93030308|NCT01069822|GABA Modulators|gaba modulators|mesh-ancestor
93030309|NCT01069822|GABA Agents|gaba agents|mesh-ancestor
93030310|NCT01069822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030311|NCT01069822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030312|NCT00364923|10-deazaaminopterin|10-deazaaminopterin|mesh-list
93030313|NCT00364923|Aminopterin|aminopterin|mesh-list
93030314|NCT00364923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93030315|NCT00364923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030316|NCT00364923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030317|NCT00364923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030318|NCT00273052|Metoprolol|metoprolol|mesh-list
93030319|NCT00273052|Carvedilol|carvedilol|mesh-list
93030320|NCT00273052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93030321|NCT00273052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93030322|NCT00273052|Sympatholytics|sympatholytics|mesh-ancestor
93030323|NCT00273052|Autonomic Agents|autonomic agents|mesh-ancestor
93030324|NCT00273052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030325|NCT00273052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030326|NCT00273052|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93030327|NCT00273052|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93030328|NCT00273052|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93030329|NCT00273052|Adrenergic Agents|adrenergic agents|mesh-ancestor
93030330|NCT00273052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030331|NCT00273052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030332|NCT00273052|Antioxidants|antioxidants|mesh-ancestor
93030333|NCT00273052|Protective Agents|protective agents|mesh-ancestor
93030334|NCT00273052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93030335|NCT00273052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93030336|NCT00273052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93030337|NCT00273052|Vasodilator Agents|vasodilator agents|mesh-ancestor
93030338|NCT00273052|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93030339|NCT00273052|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93030340|NCT01046721|Exenatide|exenatide|mesh-list
93030341|NCT01046721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030342|NCT01046721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030343|NCT01046721|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93030344|NCT01046721|Incretins|incretins|mesh-ancestor
93030345|NCT01046721|Hormones|hormones|mesh-ancestor
92675618|NCT00432393|Levodopa|levodopa|mesh-list
93030346|NCT01046721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030347|NCT01046799|Entecavir|entecavir|mesh-list
93030348|NCT01046799|Antiviral Agents|antiviral agents|mesh-ancestor
93030349|NCT01046799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030350|NCT00290290|Chlorhexidine|chlorhexidine|mesh-list
93030351|NCT00290290|Povidone-Iodine|povidone-iodine|mesh-list
93030352|NCT00290290|Povidone|povidone|mesh-list
93030353|NCT00290290|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93030354|NCT00290290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030355|NCT00290290|Disinfectants|disinfectants|mesh-ancestor
93030356|NCT00290290|Plasma Substitutes|plasma substitutes|mesh-ancestor
93030357|NCT00290290|Blood Substitutes|blood substitutes|mesh-ancestor
93030358|NCT01049685|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93030359|NCT01049685|Antiviral Agents|antiviral agents|mesh-ancestor
93030360|NCT01049685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030361|NCT01580943|Chlorhexidine|chlorhexidine|mesh-list
93030362|NCT01580943|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93030363|NCT01580943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93030364|NCT01580943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030365|NCT01580943|Disinfectants|disinfectants|mesh-ancestor
93030366|NCT01580943|Dermatologic Agents|dermatologic agents|mesh-ancestor
93030367|NCT02534961|Cefazolin|cefazolin|mesh-list
93030368|NCT02534961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030369|NCT02534961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030370|NCT01046955|Alemtuzumab|alemtuzumab|mesh-list
93030371|NCT01046955|Thymoglobulin|thymoglobulin|mesh-list
93030372|NCT01046955|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93030373|NCT01046955|Daclizumab|daclizumab|mesh-list
93030374|NCT01046955|Immunologic Factors|immunologic factors|mesh-ancestor
93030375|NCT01046955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030376|NCT01046955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030377|NCT01046955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030378|NCT01046955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030379|NCT00272038|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93030380|NCT00272038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030381|NCT00272038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030382|NCT00272038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030383|NCT00272038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030384|NCT00271024|Naltrexone|naltrexone|mesh-list
93030385|NCT00271024|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93030386|NCT00271024|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93030387|NCT00271024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030388|NCT00271024|Sensory System Agents|sensory system agents|mesh-ancestor
93030389|NCT00271024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030390|NCT00381693|Azacitidine|azacitidine|mesh-list
93030391|NCT00381693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93030392|NCT00381693|Antimetabolites|antimetabolites|mesh-ancestor
93030393|NCT00381693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030394|NCT00381693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030395|NCT00381693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030396|NCT00545363|Ibandronic Acid|ibandronic acid|mesh-list
93030397|NCT00545363|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93030398|NCT00545363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030399|NCT00977405|Gentamicins|gentamicins|mesh-list
93030400|NCT00977405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030401|NCT00977405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030402|NCT00977405|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93030403|NCT00977405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030404|NCT00977405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030405|NCT00977795|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93030406|NCT00977795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93030407|NCT00977795|Dermatologic Agents|dermatologic agents|mesh-ancestor
93030408|NCT00977873|Cholecalciferol|cholecalciferol|mesh-list
93030409|NCT00977873|Vitamin D|vitamin d|mesh-list
93030410|NCT00977873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93030411|NCT00977873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030412|NCT00977873|Vitamins|vitamins|mesh-ancestor
93030413|NCT00977873|Micronutrients|micronutrients|mesh-ancestor
93030414|NCT00977873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93030415|NCT00457392|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93030416|NCT00457392|Sunitinib|sunitinib|mesh-list
93030417|NCT00457392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030418|NCT00457392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030419|NCT00457392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030420|NCT00457392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675694|NCT05354258|Anthelmintics|anthelmintics|mesh-ancestor
93030421|NCT00457392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030422|NCT00457392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030423|NCT00457392|Growth Substances|growth substances|mesh-ancestor
93030424|NCT00457392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030425|NCT00457392|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030426|NCT00545051|Ibandronic Acid|ibandronic acid|mesh-list
93030427|NCT00545051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92183051|NCT00245635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030428|NCT00545051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030429|NCT00381615|Vaccines|vaccines|mesh-list
93030430|NCT00381615|Immunologic Factors|immunologic factors|mesh-ancestor
93030431|NCT00381615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030432|NCT00978107|Flucytosine|flucytosine|mesh-list
92376058|NCT02002650|Indomethacin|indomethacin|mesh-list
93030433|NCT00978107|Antifungal Agents|antifungal agents|mesh-ancestor
93030434|NCT00978107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030436|NCT00978107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030437|NCT01029132|Galantamine|galantamine|mesh-list
93030438|NCT01029132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93030439|NCT01029132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030440|NCT01029132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030441|NCT01029132|Cholinergic Agents|cholinergic agents|mesh-ancestor
93030442|NCT01029132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030443|NCT01029132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030444|NCT01029132|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93030445|NCT01029132|Autonomic Agents|autonomic agents|mesh-ancestor
93030446|NCT01029132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030447|NCT01029132|Nootropic Agents|nootropic agents|mesh-ancestor
93030448|NCT04008017|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
93030449|NCT04008017|Immunologic Factors|immunologic factors|mesh-ancestor
93030450|NCT04008017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030451|NCT01049763|Oseltamivir|oseltamivir|mesh-list
93030452|NCT01049763|Antiviral Agents|antiviral agents|mesh-ancestor
93030453|NCT01049763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030454|NCT01049763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030455|NCT01049763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030456|NCT00981773|Maraviroc|maraviroc|mesh-list
93030457|NCT00981773|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93030458|NCT00981773|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93030459|NCT00981773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030460|NCT00981773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93030461|NCT00981773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93030462|NCT00981773|Antiviral Agents|antiviral agents|mesh-ancestor
93030463|NCT00981773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030464|NCT00981773|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93030465|NCT01049841|Sirolimus|sirolimus|mesh-list
93030466|NCT01049841|Temsirolimus|temsirolimus|mesh-list
93030467|NCT01049841|MTOR Inhibitors|mtor inhibitors|mesh-list
93030468|NCT01049841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030469|NCT01049841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030470|NCT01049841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030471|NCT01049841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030472|NCT01049841|Immunologic Factors|immunologic factors|mesh-ancestor
93030473|NCT01049841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030474|NCT01049841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030475|NCT01049841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030476|NCT01049841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030477|NCT01049841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93030478|NCT01049841|Antifungal Agents|antifungal agents|mesh-ancestor
93030479|NCT00978263|Metformin|metformin|mesh-list
93030480|NCT00978263|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93030481|NCT00978263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030482|NCT00981851|Albuterol|albuterol|mesh-list
93030483|NCT00981851|Tiotropium Bromide|tiotropium bromide|mesh-list
93030484|NCT00981851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93030485|NCT00981851|Autonomic Agents|autonomic agents|mesh-ancestor
93030486|NCT00981851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030487|NCT00981851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030488|NCT00981851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93030489|NCT00981851|Respiratory System Agents|respiratory system agents|mesh-ancestor
93030490|NCT00981851|Parasympatholytics|parasympatholytics|mesh-ancestor
93030491|NCT00981851|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93030492|NCT00981851|Cholinergic Agents|cholinergic agents|mesh-ancestor
93030493|NCT00981851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030494|NCT00981851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030495|NCT00981851|Tocolytic Agents|tocolytic agents|mesh-ancestor
92183060|NCT00141115|Levetiracetam|levetiracetam|mesh-list
93030496|NCT00981851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93030497|NCT00981851|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92675768|NCT05198960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030498|NCT00981851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93030499|NCT00981851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93030500|NCT00981851|Adrenergic Agents|adrenergic agents|mesh-ancestor
93030501|NCT00981929|Losartan|losartan|mesh-list
93030502|NCT00981929|Tramadol|tramadol|mesh-list
93030503|NCT00981929|Caffeine|caffeine|mesh-list
93030504|NCT00981929|Omeprazole|omeprazole|mesh-list
93030505|NCT00981929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93030506|NCT00981929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376125|NCT02024724|Dexamethasone|dexamethasone|mesh-list
93030507|NCT00981929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93030508|NCT00981929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93030509|NCT00981929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030510|NCT00981929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93030511|NCT00981929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030512|NCT00981929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93030513|NCT00981929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030514|NCT00981929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93030515|NCT00981929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93030516|NCT00981929|Purinergic Agents|purinergic agents|mesh-ancestor
93030517|NCT00981929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030518|NCT00981929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93030519|NCT00981929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93030520|NCT00981929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93030521|NCT00981929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93030523|NCT00981929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93030524|NCT00981929|Analgesics|analgesics|mesh-ancestor
93030525|NCT00981929|Sensory System Agents|sensory system agents|mesh-ancestor
93030526|NCT00981929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030527|NCT00364845|Darbepoetin alfa|darbepoetin alfa|mesh-list
93030528|NCT00364845|Hematinics|hematinics|mesh-ancestor
93030529|NCT00978653|Allopurinol|allopurinol|mesh-list
93030530|NCT00978653|Antimetabolites|antimetabolites|mesh-ancestor
93030531|NCT00978653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030532|NCT00978653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030533|NCT00978653|Gout Suppressants|gout suppressants|mesh-ancestor
93030534|NCT00978653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030535|NCT00978653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93030536|NCT00978653|Antioxidants|antioxidants|mesh-ancestor
93030537|NCT00978653|Protective Agents|protective agents|mesh-ancestor
93030538|NCT00978653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030539|NCT00293722|Etanercept|etanercept|mesh-list
93030540|NCT00293722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93030541|NCT00293722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93030542|NCT00293722|Analgesics|analgesics|mesh-ancestor
93030543|NCT00293722|Sensory System Agents|sensory system agents|mesh-ancestor
93030544|NCT00293722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030545|NCT00293722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030546|NCT00293722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030547|NCT00293722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030548|NCT00293722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93030549|NCT00293722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030550|NCT00293722|Immunologic Factors|immunologic factors|mesh-ancestor
93030551|NCT00381303|Ritonavir|ritonavir|mesh-list
93030552|NCT00381303|Darunavir|darunavir|mesh-list
93030553|NCT00381303|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93030554|NCT00381303|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93030555|NCT00381303|Protease Inhibitors|protease inhibitors|mesh-ancestor
93030556|NCT00381303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030557|NCT00381303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030558|NCT00381303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93030559|NCT00381303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93030560|NCT00381303|Antiviral Agents|antiviral agents|mesh-ancestor
93030561|NCT00381303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030562|NCT00381303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93030563|NCT00381303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93030564|NCT00364689|Rifaximin|rifaximin|mesh-list
93030565|NCT00364689|Lactulose|lactulose|mesh-list
93030566|NCT00364689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030567|NCT00364689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030568|NCT00364689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93030569|NCT00545129|Tanezumab|tanezumab|mesh-list
93030570|NCT00545129|Analgesics|analgesics|mesh-ancestor
92675839|NCT00419783|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93030571|NCT00545129|Sensory System Agents|sensory system agents|mesh-ancestor
93030572|NCT00545129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030573|NCT00545129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030574|NCT00956111|Vaccines|vaccines|mesh-list
93030575|NCT00956111|Immunologic Factors|immunologic factors|mesh-ancestor
93030576|NCT00956111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030577|NCT00982631|Sirolimus|sirolimus|mesh-list
93030578|NCT00982631|Temsirolimus|temsirolimus|mesh-list
93030579|NCT00982631|MTOR Inhibitors|mtor inhibitors|mesh-list
93030580|NCT00982631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030581|NCT00982631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030582|NCT00982631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030583|NCT00982631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030584|NCT00982631|Immunologic Factors|immunologic factors|mesh-ancestor
93030585|NCT00982631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030586|NCT00982631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030587|NCT00982631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030588|NCT00982631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030589|NCT00982631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93030590|NCT00982631|Antifungal Agents|antifungal agents|mesh-ancestor
93030591|NCT00364611|Bevacizumab|bevacizumab|mesh-list
93030592|NCT00364611|Trastuzumab|trastuzumab|mesh-list
93030593|NCT00364611|Docetaxel|docetaxel|mesh-list
93030594|NCT00364611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030595|NCT00364611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030596|NCT00364611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030597|NCT00364611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030598|NCT00364611|Growth Substances|growth substances|mesh-ancestor
93030599|NCT00364611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030600|NCT00364611|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030601|NCT00364611|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030602|NCT00364611|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030603|NCT00364611|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030604|NCT00364611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030605|NCT00956189|Aripiprazole|aripiprazole|mesh-list
93030606|NCT00956189|Amisulpride|amisulpride|mesh-list
93030607|NCT00956189|Antidepressive Agents|antidepressive agents|mesh-ancestor
93030608|NCT00956189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93030609|NCT00956189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93030610|NCT00956189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93030611|NCT00956189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93030612|NCT00956189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030613|NCT00956189|Dopamine Agonists|dopamine agonists|mesh-ancestor
93030614|NCT00956189|Dopamine Agents|dopamine agents|mesh-ancestor
93030615|NCT00956189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030616|NCT00956189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030617|NCT00956189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93030618|NCT00956189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93030619|NCT00956189|Serotonin Agents|serotonin agents|mesh-ancestor
93030620|NCT00956189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93030621|NCT00956189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93030622|NCT00956189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93030623|NCT00956189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93030624|NCT00956189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93030625|NCT00956267|Letrozole|letrozole|mesh-list
93030626|NCT00956267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030627|NCT00956267|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93030628|NCT00956267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93030629|NCT00956267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030630|NCT00956267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030631|NCT00956267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93030632|NCT00956267|Hormone Antagonists|hormone antagonists|mesh-ancestor
93030633|NCT00956267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030634|NCT00956267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030635|NCT04007003|Insulin|insulin|mesh-list
93030636|NCT04007003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030637|NCT04007003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030638|NCT00364533|Oxycodone|oxycodone|mesh-list
93030639|NCT00364533|Tapentadol|tapentadol|mesh-list
93030640|NCT00364533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93030641|NCT00364533|Narcotics|narcotics|mesh-ancestor
93030642|NCT00364533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93030643|NCT00364533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030644|NCT00364533|Analgesics|analgesics|mesh-ancestor
93030645|NCT00364533|Sensory System Agents|sensory system agents|mesh-ancestor
93030646|NCT00364533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030647|NCT00364533|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93030648|NCT00364533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93030649|NCT00364533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93030650|NCT00364533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030651|NCT00364533|Adrenergic Agents|adrenergic agents|mesh-ancestor
93030652|NCT00364533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030653|NCT01047423|Simvastatin|simvastatin|mesh-list
93030654|NCT01047423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93030655|NCT01047423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93030656|NCT01047423|Antimetabolites|antimetabolites|mesh-ancestor
93030657|NCT01047423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030658|NCT01047423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93030659|NCT01047423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93030660|NCT01047423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030661|NCT00984737|Insulin|insulin|mesh-list
93030662|NCT00984737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030663|NCT00984737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030664|NCT01047579|Rivastigmine|rivastigmine|mesh-list
93030665|NCT01047579|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93030666|NCT01047579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030667|NCT01047579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030668|NCT01047579|Cholinergic Agents|cholinergic agents|mesh-ancestor
93030669|NCT01047579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030670|NCT01047579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030671|NCT01047579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93030672|NCT01047579|Protective Agents|protective agents|mesh-ancestor
93030673|NCT04006847|Dasatinib|dasatinib|mesh-list
93030674|NCT04006847|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93030675|NCT04006847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030676|NCT04006847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030677|NCT04006847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030678|NCT04006847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030679|NCT00984893|Zoledronic Acid|zoledronic acid|mesh-list
93030680|NCT00984893|Diphosphonates|diphosphonates|mesh-list
93030681|NCT00984893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93030682|NCT00984893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030683|NCT00983021|Insulin|insulin|mesh-list
93030684|NCT00983021|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93030685|NCT00983021|Liraglutide|liraglutide|mesh-list
93030686|NCT00983021|Insulin, Long-Acting|insulin, long-acting|mesh-list
93030687|NCT00983021|Xultophy|xultophy|mesh-list
93030688|NCT00983021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030689|NCT00983021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030690|NCT00983021|Incretins|incretins|mesh-ancestor
93030691|NCT00983021|Hormones|hormones|mesh-ancestor
93030692|NCT00983021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030693|NCT00984971|Tenofovir|tenofovir|mesh-list
93030694|NCT00984971|Antiviral Agents|antiviral agents|mesh-ancestor
93030695|NCT00984971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030696|NCT00984971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93030697|NCT00984971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93030698|NCT00984971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030699|NCT00984971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030700|NCT00984971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93030701|NCT00984971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93030702|NCT00544817|Temozolomide|temozolomide|mesh-list
93030703|NCT00544817|Sorafenib|sorafenib|mesh-list
93030704|NCT00544817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93030705|NCT00544817|Alkylating Agents|alkylating agents|mesh-ancestor
93030706|NCT00544817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030707|NCT00544817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030708|NCT00544817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030709|NCT00544817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030710|NCT00289978|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93030711|NCT00289978|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93030712|NCT00289978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030713|NCT00289978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030714|NCT00289978|Immunologic Factors|immunologic factors|mesh-ancestor
93030715|NCT00289978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030716|NCT00983177|Colchicine|colchicine|mesh-list
93030717|NCT00983177|Gout Suppressants|gout suppressants|mesh-ancestor
93030718|NCT00983177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030719|NCT00983177|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030720|NCT00983177|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030721|NCT00983177|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030722|NCT00983177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030723|NCT00983177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030724|NCT00983255|Tedizolid phosphate|tedizolid phosphate|mesh-list
93030725|NCT00983255|Tedizolid|tedizolid|mesh-list
93030726|NCT00983255|Oxazolidinones|oxazolidinones|mesh-list
93030727|NCT00983255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030728|NCT00983255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030729|NCT00983255|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93030730|NCT00983255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030731|NCT00983255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030732|NCT00988403|Levan|levan|mesh-list
93030733|NCT00988403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030734|NCT00988481|Topiramate|topiramate|mesh-list
93030735|NCT00988481|Anticonvulsants|anticonvulsants|mesh-ancestor
93030736|NCT00988481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93030737|NCT00988481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030738|NCT00289900|Atorvastatin|atorvastatin|mesh-list
93030739|NCT00289900|Simvastatin|simvastatin|mesh-list
93030740|NCT00289900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93030741|NCT00289900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93030742|NCT00289900|Antimetabolites|antimetabolites|mesh-ancestor
93030743|NCT00289900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030744|NCT00289900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93030745|NCT00289900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93030746|NCT00289900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030747|NCT00543725|Efavirenz|efavirenz|mesh-list
93030748|NCT00543725|Rilpivirine|rilpivirine|mesh-list
93030749|NCT00543725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93030750|NCT00543725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93030751|NCT00543725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030752|NCT00543725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030753|NCT00543725|Antiviral Agents|antiviral agents|mesh-ancestor
93030754|NCT00543725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030755|NCT00543725|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93030756|NCT00543725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93030757|NCT00543725|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93030758|NCT00543725|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93030759|NCT00543725|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93030760|NCT00543725|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93030761|NCT00543725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93030762|NCT00543725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93030763|NCT00985361|Vitamin D|vitamin d|mesh-list
93030764|NCT00985361|Cholecalciferol|cholecalciferol|mesh-list
93030765|NCT00985361|Vitamins|vitamins|mesh-list
93030766|NCT00985361|Micronutrients|micronutrients|mesh-ancestor
93030767|NCT00985361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030768|NCT00985361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93030769|NCT00985361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93030770|NCT00269152|Carboplatin|carboplatin|mesh-list
93030771|NCT00269152|Pemetrexed|pemetrexed|mesh-list
93030772|NCT00269152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030773|NCT00269152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030774|NCT00269152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030775|NCT00269152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93030776|NCT00269152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93030777|NCT00988715|Cyclosporine|cyclosporine|mesh-list
93030778|NCT00988715|Mycophenolic Acid|mycophenolic acid|mesh-list
93030779|NCT00988715|Fludarabine|fludarabine|mesh-list
93030780|NCT00988715|Fludarabine phosphate|fludarabine phosphate|mesh-list
93030781|NCT00988715|Cyclosporins|cyclosporins|mesh-list
93030782|NCT00988715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030783|NCT00988715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93030784|NCT00988715|Antimetabolites|antimetabolites|mesh-ancestor
93030785|NCT00988715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030786|NCT00988715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030787|NCT00988715|Immunologic Factors|immunologic factors|mesh-ancestor
93030788|NCT00988715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030789|NCT00988715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030790|NCT00988715|Antifungal Agents|antifungal agents|mesh-ancestor
93030791|NCT00988715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030792|NCT00988715|Dermatologic Agents|dermatologic agents|mesh-ancestor
93030793|NCT00988715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030794|NCT00988715|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93030795|NCT00988715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93030796|NCT00988715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93030797|NCT00988715|Antitubercular Agents|antitubercular agents|mesh-ancestor
93030798|NCT00988715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030799|NCT03975166|Fluticasone|fluticasone|mesh-list
93030801|NCT03975166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93030802|NCT03975166|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93030803|NCT03975166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030804|NCT03975166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93030805|NCT03975166|Autonomic Agents|autonomic agents|mesh-ancestor
93030806|NCT03975166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030807|NCT03975166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030808|NCT03975166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93030809|NCT03975166|Respiratory System Agents|respiratory system agents|mesh-ancestor
93030810|NCT03975166|Dermatologic Agents|dermatologic agents|mesh-ancestor
93030811|NCT03975166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93030812|NCT03975166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93030813|NCT03975166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93030814|NCT03975166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93030815|NCT03975166|Adrenergic Agents|adrenergic agents|mesh-ancestor
93030816|NCT03975166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030817|NCT03975166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030818|NCT03975166|Glucocorticoids|glucocorticoids|mesh-ancestor
93030819|NCT03975166|Hormones|hormones|mesh-ancestor
93030820|NCT03975166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030821|NCT03975166|Sympathomimetics|sympathomimetics|mesh-ancestor
93030822|NCT01325818|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93030823|NCT01325818|Pravastatin|pravastatin|mesh-list
93030824|NCT01325818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93030825|NCT01325818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93030826|NCT01325818|Antimetabolites|antimetabolites|mesh-ancestor
93030827|NCT01325818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030828|NCT01325818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93030829|NCT01325818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93030830|NCT01325818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030831|NCT00379899|Vitamin D|vitamin d|mesh-list
93030832|NCT00379899|Cinacalcet|cinacalcet|mesh-list
93030833|NCT00379899|Vitamins|vitamins|mesh-ancestor
93030834|NCT00379899|Micronutrients|micronutrients|mesh-ancestor
93030835|NCT00379899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030836|NCT00379899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93030837|NCT00379899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93030838|NCT00379899|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93030839|NCT00379899|Hormone Antagonists|hormone antagonists|mesh-ancestor
93030840|NCT00379899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030841|NCT02535039|Methylprednisolone|methylprednisolone|mesh-list
93030842|NCT02535039|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93030843|NCT02535039|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93030844|NCT02535039|Prednisolone|prednisolone|mesh-list
93030845|NCT02535039|Prednisolone acetate|prednisolone acetate|mesh-list
93030846|NCT02535039|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93030847|NCT02535039|Prednisolone phosphate|prednisolone phosphate|mesh-list
93030848|NCT02535039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93030849|NCT02535039|Antiemetics|antiemetics|mesh-ancestor
93030850|NCT02535039|Autonomic Agents|autonomic agents|mesh-ancestor
93030851|NCT02535039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030852|NCT02535039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030853|NCT02535039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93030854|NCT02535039|Glucocorticoids|glucocorticoids|mesh-ancestor
93030855|NCT02535039|Hormones|hormones|mesh-ancestor
93030856|NCT02535039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93030857|NCT02535039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93030858|NCT02535039|Protective Agents|protective agents|mesh-ancestor
93030859|NCT02535039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93030860|NCT02535039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030861|NCT00363129|Vitamin E|vitamin e|mesh-list
93030862|NCT00363129|Vitamins|vitamins|mesh-ancestor
93030863|NCT00363129|Micronutrients|micronutrients|mesh-ancestor
93030864|NCT00363129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030865|NCT00363129|Antioxidants|antioxidants|mesh-ancestor
93030866|NCT00363129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030867|NCT00363129|Protective Agents|protective agents|mesh-ancestor
93030868|NCT00268996|Darapladib|darapladib|mesh-list
93030869|NCT00268996|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
93030870|NCT00268996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030871|NCT00268996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030872|NCT00379587|Rituximab|rituximab|mesh-list
93030873|NCT00379587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030874|NCT00379587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030875|NCT00379587|Immunologic Factors|immunologic factors|mesh-ancestor
93030876|NCT00379587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030877|NCT00379587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93030878|NCT00363051|Everolimus|everolimus|mesh-list
93030879|NCT00363051|Octreotide|octreotide|mesh-list
93030880|NCT00363051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93030881|NCT00363051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030882|NCT00363051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030883|NCT00363051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030884|NCT00363051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030885|NCT00363051|Immunologic Factors|immunologic factors|mesh-ancestor
93030886|NCT00363051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030887|NCT00363051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030888|NCT00363051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93030889|NCT00363051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93030890|NCT00379353|Thalidomide|thalidomide|mesh-list
93030891|NCT00379353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93030892|NCT00379353|Immunologic Factors|immunologic factors|mesh-ancestor
93030893|NCT00379353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030894|NCT00379353|Leprostatic Agents|leprostatic agents|mesh-ancestor
93030895|NCT00379353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93030896|NCT00379353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030897|NCT00379353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030898|NCT00379353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030899|NCT00379353|Growth Substances|growth substances|mesh-ancestor
93030900|NCT00379353|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030901|NCT00379353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030902|NCT01047657|Orlistat|orlistat|mesh-list
93030903|NCT01047657|Sibutramine|sibutramine|mesh-list
93030904|NCT01047657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030905|NCT01047657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030906|NCT01047657|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93030907|NCT01047657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93030908|NCT01047657|Antidepressive Agents|antidepressive agents|mesh-ancestor
93030909|NCT01047657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93030910|NCT01047657|Appetite Depressants|appetite depressants|mesh-ancestor
93030911|NCT00378573|Bevacizumab|bevacizumab|mesh-list
93030912|NCT00378573|Gemcitabine|gemcitabine|mesh-list
93030913|NCT00378573|Docetaxel|docetaxel|mesh-list
93030914|NCT00378573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93030915|NCT00378573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030916|NCT00378573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93030917|NCT00378573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93030918|NCT00378573|Growth Substances|growth substances|mesh-ancestor
93030919|NCT00378573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030920|NCT00378573|Growth Inhibitors|growth inhibitors|mesh-ancestor
93030921|NCT00378573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93030922|NCT00378573|Antimetabolites|antimetabolites|mesh-ancestor
93030923|NCT00378573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030924|NCT00378573|Tubulin Modulators|tubulin modulators|mesh-ancestor
93030925|NCT00378573|Antimitotic Agents|antimitotic agents|mesh-ancestor
93030926|NCT00378573|Mitosis Modulators|mitosis modulators|mesh-ancestor
93030927|NCT01047891|Sorafenib|sorafenib|mesh-list
93030928|NCT01047891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93030929|NCT01047891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93030930|NCT01047891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030931|NCT01047891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030932|NCT02534571|Epinephrine|epinephrine|mesh-list
93030933|NCT02534571|Hemostatics|hemostatics|mesh-list
93030934|NCT02534571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93030935|NCT02534571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93030936|NCT02534571|Adrenergic Agents|adrenergic agents|mesh-ancestor
93030937|NCT02534571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93030938|NCT02534571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030939|NCT02534571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030940|NCT02534571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93030941|NCT02534571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93030942|NCT02534571|Autonomic Agents|autonomic agents|mesh-ancestor
93030943|NCT02534571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030944|NCT02534571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93030945|NCT02534571|Respiratory System Agents|respiratory system agents|mesh-ancestor
93030946|NCT02534571|Mydriatics|mydriatics|mesh-ancestor
93030947|NCT02534571|Sympathomimetics|sympathomimetics|mesh-ancestor
93030948|NCT02534571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93030949|NCT02534571|Coagulants|coagulants|mesh-ancestor
93030950|NCT00457002|Enoxaparin|enoxaparin|mesh-list
93030951|NCT00457002|Apixaban|apixaban|mesh-list
93030952|NCT00457002|Anticoagulants|anticoagulants|mesh-ancestor
93030953|NCT00457002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93030954|NCT00457002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93030955|NCT00457002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030956|NCT00457002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93030957|NCT00457002|Antithrombins|antithrombins|mesh-ancestor
93030958|NCT00457002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93030959|NCT00457002|Protease Inhibitors|protease inhibitors|mesh-ancestor
93030960|NCT00457002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030961|NCT00362115|Olmesartan|olmesartan|mesh-list
93030962|NCT00362115|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93030963|NCT00362115|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93030964|NCT00362115|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93030965|NCT00362115|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93030966|NCT00362115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030967|NCT00485264|Raltegravir Potassium|raltegravir potassium|mesh-list
93030968|NCT00485264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93030969|NCT00485264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93030970|NCT00485264|Antiviral Agents|antiviral agents|mesh-ancestor
93030971|NCT00485264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030972|NCT00485264|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93030973|NCT00485264|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93030974|NCT00485264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030975|NCT00485264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030976|NCT00293254|Raltegravir Potassium|raltegravir potassium|mesh-list
93030977|NCT00293254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93030978|NCT00293254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93030979|NCT00293254|Antiviral Agents|antiviral agents|mesh-ancestor
93030980|NCT00293254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93030981|NCT00293254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93030982|NCT00293254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93030983|NCT00293254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030984|NCT00293254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93030985|NCT03975010|Naltrexone|naltrexone|mesh-list
93030986|NCT03975010|Buprenorphine|buprenorphine|mesh-list
93030987|NCT03975010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93030988|NCT03975010|Narcotics|narcotics|mesh-ancestor
93030989|NCT03975010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93030990|NCT03975010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93030991|NCT03975010|Analgesics|analgesics|mesh-ancestor
93030992|NCT03975010|Sensory System Agents|sensory system agents|mesh-ancestor
93030993|NCT03975010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93030994|NCT03975010|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93030995|NCT03975010|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93030996|NCT01016990|Valproic Acid|valproic acid|mesh-list
93030997|NCT01016990|Anticonvulsants|anticonvulsants|mesh-ancestor
93030998|NCT01016990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93030999|NCT01016990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031000|NCT01016990|GABA Agents|gaba agents|mesh-ancestor
93031001|NCT01016990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031002|NCT01016990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031003|NCT01016990|Antimanic Agents|antimanic agents|mesh-ancestor
93031004|NCT01016990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031005|NCT01016990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031006|NCT01016990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031007|NCT01048047|Amlodipine|amlodipine|mesh-list
93031008|NCT01048047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93031009|NCT01048047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93031010|NCT01048047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93031011|NCT01048047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031012|NCT01048047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93031013|NCT01048047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031014|NCT01048047|Vasodilator Agents|vasodilator agents|mesh-ancestor
93031015|NCT01324635|Panobinostat|panobinostat|mesh-list
93031016|NCT01324635|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93031017|NCT01324635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031018|NCT01324635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031019|NCT01324635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031020|NCT00456846|Paclitaxel|paclitaxel|mesh-list
93031021|NCT00456846|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93031022|NCT00456846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031023|NCT00456846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676290|NCT02957643|Iron|iron|mesh-list
93031024|NCT00456846|Tubulin Modulators|tubulin modulators|mesh-ancestor
93031025|NCT00456846|Antimitotic Agents|antimitotic agents|mesh-ancestor
93031026|NCT00456846|Mitosis Modulators|mitosis modulators|mesh-ancestor
93031027|NCT00456846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031028|NCT03324282|Avelumab|avelumab|mesh-list
93031029|NCT03324282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031030|NCT03324282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031031|NCT00484094|Sirolimus|sirolimus|mesh-list
93031032|NCT00484094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031033|NCT00484094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031034|NCT00484094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031035|NCT00484094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031036|NCT00484094|Antifungal Agents|antifungal agents|mesh-ancestor
93031037|NCT00484094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031038|NCT00484094|Immunologic Factors|immunologic factors|mesh-ancestor
93031039|NCT00484094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031040|NCT01029288|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93031041|NCT01029288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031042|NCT01029444|Insulin Aspart|insulin aspart|mesh-list
93031043|NCT01029444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93031044|NCT01029444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031045|NCT01029522|Atorvastatin|atorvastatin|mesh-list
93031046|NCT01029522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93031047|NCT01029522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93031048|NCT01029522|Antimetabolites|antimetabolites|mesh-ancestor
93031049|NCT01029522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031050|NCT01029522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93031051|NCT01029522|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93031052|NCT01029522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031053|NCT00447876|Botulinum Toxins|botulinum toxins|mesh-list
93031054|NCT00447876|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93031055|NCT00447876|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93031056|NCT00447876|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93031057|NCT00447876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93031058|NCT00447876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031059|NCT00447876|Cholinergic Agents|cholinergic agents|mesh-ancestor
93031060|NCT00447876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031061|NCT00447876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031062|NCT00447876|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93031063|NCT00447876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031064|NCT01565772|Etoposide|etoposide|mesh-list
93031065|NCT01565772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031066|NCT01565772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031067|NCT01565772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93031068|NCT01565772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93031069|NCT01565772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031070|NCT01565772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031071|NCT00456300|Exenatide|exenatide|mesh-list
93031072|NCT00456300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93031073|NCT00456300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031074|NCT00456300|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93031075|NCT00456300|Incretins|incretins|mesh-ancestor
93031076|NCT00456300|Hormones|hormones|mesh-ancestor
93031077|NCT00456300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031078|NCT00267748|Sunitinib|sunitinib|mesh-list
93031079|NCT00267748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031080|NCT00267748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031081|NCT00267748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93031082|NCT00267748|Growth Substances|growth substances|mesh-ancestor
93031083|NCT00267748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031084|NCT00267748|Growth Inhibitors|growth inhibitors|mesh-ancestor
93031085|NCT00267748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93031086|NCT00267748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031087|NCT00267748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031088|NCT00267202|Omalizumab|omalizumab|mesh-list
93031089|NCT00267202|Immunomodulating Agents|immunomodulating agents|mesh-list
93031090|NCT00267202|Immunologic Factors|immunologic factors|mesh-list
93031091|NCT00267202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031092|NCT00267202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93031093|NCT00267202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93031094|NCT00267202|Respiratory System Agents|respiratory system agents|mesh-ancestor
93031095|NCT01067638|Tranexamic Acid|tranexamic acid|mesh-list
93031097|NCT01067638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93031098|NCT01067638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031099|NCT01067638|Hemostatics|hemostatics|mesh-ancestor
93031100|NCT01067638|Coagulants|coagulants|mesh-ancestor
93031101|NCT00267046|Doxorubicin|doxorubicin|mesh-list
93031102|NCT00267046|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93031103|NCT00267046|Vincristine|vincristine|mesh-list
93031104|NCT00267046|Ifosfamide|ifosfamide|mesh-list
93031105|NCT00267046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031106|NCT00267046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031107|NCT00267046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93031108|NCT00267046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93031109|NCT00267046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031110|NCT00267046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031111|NCT00267046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031112|NCT00267046|Tubulin Modulators|tubulin modulators|mesh-ancestor
93031113|NCT00267046|Antimitotic Agents|antimitotic agents|mesh-ancestor
93031114|NCT00267046|Mitosis Modulators|mitosis modulators|mesh-ancestor
93031115|NCT00267046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031116|NCT00267046|Alkylating Agents|alkylating agents|mesh-ancestor
93031117|NCT01029678|Vinorelbine|vinorelbine|mesh-list
93031118|NCT01029678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031119|NCT01029678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031120|NCT01029678|Tubulin Modulators|tubulin modulators|mesh-ancestor
93031121|NCT01029678|Antimitotic Agents|antimitotic agents|mesh-ancestor
93031122|NCT01029678|Mitosis Modulators|mitosis modulators|mesh-ancestor
93031123|NCT01029678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031124|NCT00286468|Alogliptin|alogliptin|mesh-list
93031125|NCT00286468|Glyburide|glyburide|mesh-list
93031126|NCT00286468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93031127|NCT00286468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031128|NCT00286468|Incretins|incretins|mesh-ancestor
93031129|NCT00286468|Hormones|hormones|mesh-ancestor
93031130|NCT00286468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031131|NCT00286468|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93031132|NCT00286468|Protease Inhibitors|protease inhibitors|mesh-ancestor
93031133|NCT00286468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031134|NCT00286468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031135|NCT00507026|Diclofenac|diclofenac|mesh-list
93031136|NCT00507026|Ketorolac|ketorolac|mesh-list
93031137|NCT00507026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93031138|NCT00507026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031139|NCT00507026|Analgesics|analgesics|mesh-ancestor
93031140|NCT00507026|Sensory System Agents|sensory system agents|mesh-ancestor
93031141|NCT00507026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031142|NCT00507026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031143|NCT00507026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031144|NCT00507026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031145|NCT00507026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93031146|NCT00507026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031147|NCT00507026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031148|NCT01019174|Cyclophosphamide|cyclophosphamide|mesh-list
93031149|NCT01019174|Lenalidomide|lenalidomide|mesh-list
93031150|NCT01019174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031151|NCT01019174|Immunologic Factors|immunologic factors|mesh-ancestor
93031152|NCT01019174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031153|NCT01019174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031154|NCT01019174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031155|NCT01019174|Alkylating Agents|alkylating agents|mesh-ancestor
93031156|NCT01019174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031157|NCT01019174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031158|NCT01019174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93031159|NCT01019174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031160|NCT01019174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93031161|NCT01019174|Growth Substances|growth substances|mesh-ancestor
93031162|NCT01019174|Growth Inhibitors|growth inhibitors|mesh-ancestor
93031163|NCT01017224|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
93031164|NCT01017224|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93031165|NCT01017224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031166|NCT01011920|Cytarabine|cytarabine|mesh-list
93031167|NCT01011920|Rituximab|rituximab|mesh-list
93031168|NCT01011920|Methotrexate|methotrexate|mesh-list
93031169|NCT01011920|Thiotepa|thiotepa|mesh-list
93031170|NCT01011920|Carmustine|carmustine|mesh-list
93031171|NCT01011920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031172|NCT01011920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031173|NCT01011920|Immunologic Factors|immunologic factors|mesh-ancestor
93031174|NCT01011920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031175|NCT01011920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031176|NCT01011920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92183128|NCT00088985|Trastuzumab|trastuzumab|mesh-list
93031177|NCT01011920|Abortifacient Agents|abortifacient agents|mesh-ancestor
93031178|NCT01011920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93031179|NCT01011920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93031180|NCT01011920|Antimetabolites|antimetabolites|mesh-ancestor
93031181|NCT01011920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031182|NCT01011920|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031183|NCT01011920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031184|NCT01011920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93031185|NCT01011920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031186|NCT01011920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93031187|NCT01011920|Antiviral Agents|antiviral agents|mesh-ancestor
93031188|NCT01011920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031189|NCT01011920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031190|NCT01011920|Alkylating Agents|alkylating agents|mesh-ancestor
93031191|NCT01011920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93031192|NCT03976102|Rituximab|rituximab|mesh-list
93031193|NCT03976102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031194|NCT03976102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031195|NCT03976102|Immunologic Factors|immunologic factors|mesh-ancestor
93031196|NCT03976102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031197|NCT03976102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031198|NCT00506948|Mycophenolic Acid|mycophenolic acid|mesh-list
93031199|NCT00506948|Sirolimus|sirolimus|mesh-list
93031200|NCT00506948|Thymoglobulin|thymoglobulin|mesh-list
93031201|NCT00506948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93031202|NCT00506948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031203|NCT00506948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031204|NCT00506948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93031205|NCT00506948|Antitubercular Agents|antitubercular agents|mesh-ancestor
93031206|NCT00506948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031207|NCT00506948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031208|NCT00506948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031209|NCT00506948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031210|NCT00506948|Antifungal Agents|antifungal agents|mesh-ancestor
93031211|NCT00506948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031212|NCT00506948|Immunologic Factors|immunologic factors|mesh-ancestor
93031213|NCT00506948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031215|NCT00286234|Nicotinic Acids|nicotinic acids|mesh-list
93031216|NCT00286234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93031217|NCT00286234|Antimetabolites|antimetabolites|mesh-ancestor
93031218|NCT00286234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031219|NCT00286234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93031220|NCT00286234|Vasodilator Agents|vasodilator agents|mesh-ancestor
93031221|NCT00286234|Vitamin B Complex|vitamin b complex|mesh-ancestor
93031222|NCT00286234|Vitamins|vitamins|mesh-ancestor
93031223|NCT00286234|Micronutrients|micronutrients|mesh-ancestor
93031224|NCT00286234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031225|NCT01019408|Chloroquine|chloroquine|mesh-list
93031226|NCT01019408|Amebicides|amebicides|mesh-ancestor
93031227|NCT01019408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93031228|NCT01019408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93031229|NCT01019408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031230|NCT01019408|Antimalarials|antimalarials|mesh-ancestor
93031231|NCT01019408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031232|NCT01067950|Pancrelipase|pancrelipase|mesh-list
93031233|NCT01067950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031234|NCT00445848|Bevacizumab|bevacizumab|mesh-list
93031235|NCT00445848|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93031236|NCT00445848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031237|NCT00445848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031238|NCT00445848|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031239|NCT00445848|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93031240|NCT00445848|Growth Substances|growth substances|mesh-ancestor
93031241|NCT00445848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031242|NCT00445848|Growth Inhibitors|growth inhibitors|mesh-ancestor
93031243|NCT00445848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93031244|NCT00445848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031245|NCT00445848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031246|NCT00286156|Sirolimus|sirolimus|mesh-list
93031247|NCT00286156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031248|NCT00286156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031249|NCT00286156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031250|NCT00286156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031251|NCT00286156|Antifungal Agents|antifungal agents|mesh-ancestor
93031252|NCT00286156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031253|NCT00286156|Immunologic Factors|immunologic factors|mesh-ancestor
93031254|NCT00286156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031255|NCT00455520|Tapentadol|tapentadol|mesh-list
93031256|NCT00455520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93031257|NCT00455520|Narcotics|narcotics|mesh-ancestor
93031258|NCT00455520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031259|NCT00455520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031260|NCT00455520|Analgesics|analgesics|mesh-ancestor
93031261|NCT00455520|Sensory System Agents|sensory system agents|mesh-ancestor
93031262|NCT00455520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031263|NCT00455520|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93031264|NCT00455520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93031265|NCT00455520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93031266|NCT00455520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031267|NCT00455520|Adrenergic Agents|adrenergic agents|mesh-ancestor
93031268|NCT00455520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031269|NCT00284050|Ranibizumab|ranibizumab|mesh-list
93031270|NCT00284050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031271|NCT00284050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93031272|NCT00284050|Growth Substances|growth substances|mesh-ancestor
93031273|NCT00284050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031274|NCT00284050|Growth Inhibitors|growth inhibitors|mesh-ancestor
93031275|NCT00284050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031276|NCT00293020|Fentanyl|fentanyl|mesh-list
93031277|NCT00293020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93031278|NCT00293020|Narcotics|narcotics|mesh-ancestor
93031279|NCT00293020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031280|NCT00293020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031281|NCT00293020|Analgesics|analgesics|mesh-ancestor
93031282|NCT00293020|Sensory System Agents|sensory system agents|mesh-ancestor
93031283|NCT00293020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031284|NCT00293020|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93031285|NCT00293020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93031286|NCT00293020|Anesthetics, General|anesthetics, general|mesh-ancestor
93031287|NCT00293020|Anesthetics|anesthetics|mesh-ancestor
93031288|NCT00377637|Mycophenolic Acid|mycophenolic acid|mesh-list
93031289|NCT00377637|Cyclophosphamide|cyclophosphamide|mesh-list
93031290|NCT00377637|Azathioprine|azathioprine|mesh-list
93031291|NCT00377637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031292|NCT00377637|Immunologic Factors|immunologic factors|mesh-ancestor
93031293|NCT00377637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031294|NCT00377637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031295|NCT00377637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031296|NCT00377637|Alkylating Agents|alkylating agents|mesh-ancestor
93031297|NCT00377637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031298|NCT00377637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031299|NCT00377637|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93031300|NCT00377637|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031301|NCT00377637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93031302|NCT00377637|Antitubercular Agents|antitubercular agents|mesh-ancestor
93031303|NCT00377637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031304|NCT00377637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031305|NCT00377637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031306|NCT00377637|Antimetabolites|antimetabolites|mesh-ancestor
93031307|NCT00377637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93031308|NCT00377403|Acetaminophen|acetaminophen|mesh-list
93031309|NCT00377403|Amoxicillin|amoxicillin|mesh-list
93031310|NCT00377403|Phenylpropanolamine|phenylpropanolamine|mesh-list
93031311|NCT00377403|Pseudoephedrine|pseudoephedrine|mesh-list
93031312|NCT00377403|Ephedrine|ephedrine|mesh-list
93031313|NCT00377403|Dextromethorphan|dextromethorphan|mesh-list
93031314|NCT00377403|Guaifenesin|guaifenesin|mesh-list
93031315|NCT00377403|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
93031316|NCT00377403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031317|NCT00377403|Analgesics|analgesics|mesh-ancestor
93031319|NCT00377403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031320|NCT00377403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031321|NCT00377403|Antipyretics|antipyretics|mesh-ancestor
93031322|NCT00377403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031323|NCT00377403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031324|NCT00377403|Antitussive Agents|antitussive agents|mesh-ancestor
93031325|NCT00377403|Respiratory System Agents|respiratory system agents|mesh-ancestor
93031326|NCT00377403|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93031327|NCT00377403|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93031328|NCT00377403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031329|NCT00377403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031330|NCT00377403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93031331|NCT00377403|Autonomic Agents|autonomic agents|mesh-ancestor
93031332|NCT00377403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93031333|NCT00377403|Nasal Decongestants|nasal decongestants|mesh-ancestor
93031334|NCT00377403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93031335|NCT00377403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93031336|NCT00377403|Sympathomimetics|sympathomimetics|mesh-ancestor
93031337|NCT00377403|Adrenergic Agents|adrenergic agents|mesh-ancestor
93031339|NCT00377403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93031340|NCT00377403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93031341|NCT00377403|Appetite Depressants|appetite depressants|mesh-ancestor
93031342|NCT00377403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93031343|NCT00370149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93031344|NCT00370149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031345|NCT00292942|Artesunate|artesunate|mesh-list
93031346|NCT00292942|Mannitol|mannitol|mesh-list
93031347|NCT00292942|Antimalarials|antimalarials|mesh-ancestor
93031348|NCT00292942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93031349|NCT00292942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93031350|NCT00292942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031351|NCT00292942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031352|NCT00292942|Antiviral Agents|antiviral agents|mesh-ancestor
93031353|NCT00292942|Schistosomicides|schistosomicides|mesh-ancestor
93031354|NCT00292942|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93031355|NCT00292942|Anthelmintics|anthelmintics|mesh-ancestor
93031356|NCT00292942|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93031357|NCT00292942|Diuretics|diuretics|mesh-ancestor
93031358|NCT00292942|Natriuretic Agents|natriuretic agents|mesh-ancestor
93031359|NCT00292942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031360|NCT00483938|Interferons|interferons|mesh-list
93031361|NCT00483938|Ribavirin|ribavirin|mesh-list
93031362|NCT00483938|Interferon-alpha|interferon-alpha|mesh-list
93031363|NCT00483938|Interferon alpha-2|interferon alpha-2|mesh-list
93031364|NCT00483938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93031365|NCT00483938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031366|NCT00483938|Antiviral Agents|antiviral agents|mesh-ancestor
93031367|NCT00483938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031368|NCT00483938|Antimetabolites|antimetabolites|mesh-ancestor
93031369|NCT00483938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031370|NCT00483938|Immunologic Factors|immunologic factors|mesh-ancestor
93031371|NCT00483938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031372|NCT00370071|Interferons|interferons|mesh-list
93031373|NCT00370071|Interferon-beta|interferon-beta|mesh-list
93031374|NCT00370071|Interferon beta-1b|interferon beta-1b|mesh-list
93031375|NCT00370071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031376|NCT00370071|Antiviral Agents|antiviral agents|mesh-ancestor
93031377|NCT00370071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031378|NCT00370071|Immunologic Factors|immunologic factors|mesh-ancestor
93031379|NCT00370071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031380|NCT00370071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93031381|NCT00369915|Scopolamine|scopolamine|mesh-list
93031382|NCT00369915|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93031383|NCT00369915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93031384|NCT00369915|Antiemetics|antiemetics|mesh-ancestor
93031385|NCT00369915|Autonomic Agents|autonomic agents|mesh-ancestor
93031386|NCT00369915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031387|NCT00369915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031388|NCT00369915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031389|NCT00369915|Mydriatics|mydriatics|mesh-ancestor
93031390|NCT00369915|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93031391|NCT00369915|Cholinergic Agents|cholinergic agents|mesh-ancestor
93031392|NCT00369915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183147|NCT00158249|Nootropic Agents|nootropic agents|mesh-ancestor
93031393|NCT00369915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031394|NCT00369915|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93031395|NCT00369915|Parasympatholytics|parasympatholytics|mesh-ancestor
93031396|NCT03991845|Levocetirizine|levocetirizine|mesh-list
93031397|NCT03991845|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93031398|NCT03991845|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93031399|NCT03991845|Histamine Antagonists|histamine antagonists|mesh-ancestor
93031400|NCT03991845|Histamine Agents|histamine agents|mesh-ancestor
93031401|NCT03991845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031402|NCT03991845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031403|NCT03991845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031404|NCT01017380|Celecoxib|celecoxib|mesh-list
93031405|NCT01017380|Etoricoxib|etoricoxib|mesh-list
93031406|NCT01017380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93031407|NCT01017380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031408|NCT01017380|Analgesics|analgesics|mesh-ancestor
93031409|NCT01017380|Sensory System Agents|sensory system agents|mesh-ancestor
93031410|NCT01017380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031411|NCT01017380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031412|NCT01017380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031413|NCT01017380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031414|NCT01017380|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93031415|NCT01017380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93031416|NCT01017380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031417|NCT01017380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031418|NCT00369681|Rituximab|rituximab|mesh-list
93031419|NCT00369681|Doxorubicin|doxorubicin|mesh-list
93031420|NCT00369681|Dacarbazine|dacarbazine|mesh-list
93031421|NCT00369681|Bleomycin|bleomycin|mesh-list
93031422|NCT00369681|Vinblastine|vinblastine|mesh-list
93031423|NCT00369681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031424|NCT00369681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031425|NCT00369681|Immunologic Factors|immunologic factors|mesh-ancestor
93031426|NCT00369681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031427|NCT00369681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031428|NCT00369681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031429|NCT00369681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93031430|NCT00369681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93031431|NCT00369681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031432|NCT00369681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031433|NCT00369681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031434|NCT00369681|Alkylating Agents|alkylating agents|mesh-ancestor
93031435|NCT00369681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031436|NCT00369681|Tubulin Modulators|tubulin modulators|mesh-ancestor
93031437|NCT00369681|Antimitotic Agents|antimitotic agents|mesh-ancestor
93031438|NCT00369681|Mitosis Modulators|mitosis modulators|mesh-ancestor
93031439|NCT00266812|Temozolomide|temozolomide|mesh-list
93031440|NCT00266812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031441|NCT00266812|Alkylating Agents|alkylating agents|mesh-ancestor
93031442|NCT00266812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031443|NCT00266812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031444|NCT04249544|Pramipexole|pramipexole|mesh-list
93031445|NCT04249544|Antioxidants|antioxidants|mesh-ancestor
93031446|NCT04249544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031447|NCT04249544|Protective Agents|protective agents|mesh-ancestor
93031448|NCT04249544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031449|NCT04249544|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93031450|NCT04249544|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93031451|NCT04249544|Dopamine Agonists|dopamine agonists|mesh-ancestor
93031452|NCT04249544|Dopamine Agents|dopamine agents|mesh-ancestor
93031453|NCT04249544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031454|NCT00488774|Golimumab|golimumab|mesh-list
93031455|NCT00488774|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93031456|NCT00488774|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93031457|NCT00488774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031458|NCT00488774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031459|NCT00488774|Immunologic Factors|immunologic factors|mesh-ancestor
93031460|NCT00488774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031461|NCT00361569|Estrogens|estrogens|mesh-list
93031462|NCT00361569|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93031463|NCT00361569|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
93031464|NCT00361569|Hormones|hormones|mesh-ancestor
93031465|NCT00361569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031466|NCT00361569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031467|NCT01011998|Imatinib Mesylate|imatinib mesylate|mesh-list
93031468|NCT01011998|Valproic Acid|valproic acid|mesh-list
93031469|NCT01011998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031470|NCT01011998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93031471|NCT01011998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031472|NCT01011998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031473|NCT01011998|Anticonvulsants|anticonvulsants|mesh-ancestor
93031474|NCT01011998|GABA Agents|gaba agents|mesh-ancestor
93031475|NCT01011998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031476|NCT01011998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031477|NCT01011998|Antimanic Agents|antimanic agents|mesh-ancestor
93031478|NCT01011998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031479|NCT01011998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676744|NCT00331097|Antimetabolites|antimetabolites|mesh-ancestor
93031480|NCT01011998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031481|NCT01017458|Methyltestosterone|methyltestosterone|mesh-list
93031482|NCT01017458|Testosterone|testosterone|mesh-list
93031483|NCT01017458|Testosterone undecanoate|testosterone undecanoate|mesh-list
93031484|NCT01017458|Testosterone enanthate|testosterone enanthate|mesh-list
93031485|NCT01017458|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93031486|NCT01017458|Androgens|androgens|mesh-ancestor
93031487|NCT01017458|Hormones|hormones|mesh-ancestor
93031488|NCT01017458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031489|NCT01017458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031490|NCT01017458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93031491|NCT01017458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031492|NCT01017458|Anabolic Agents|anabolic agents|mesh-ancestor
93031493|NCT02534415|Hyaluronic Acid|hyaluronic acid|mesh-list
93031494|NCT02534415|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93031495|NCT02534415|Immunologic Factors|immunologic factors|mesh-ancestor
93031496|NCT02534415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031497|NCT02534415|Viscosupplements|viscosupplements|mesh-ancestor
93031498|NCT02534415|Protective Agents|protective agents|mesh-ancestor
93031499|NCT00488618|Cariprazine|cariprazine|mesh-list
93031500|NCT00488618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93031501|NCT00488618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031502|NCT00488618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031503|NCT00488618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031504|NCT00488618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031505|NCT01019642|Cholecalciferol|cholecalciferol|mesh-list
93031506|NCT01019642|Vitamin D|vitamin d|mesh-list
93031507|NCT01019642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93031508|NCT01019642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031509|NCT01019642|Vitamins|vitamins|mesh-ancestor
93031510|NCT01019642|Micronutrients|micronutrients|mesh-ancestor
93031511|NCT01019642|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93031512|NCT00266656|Hormones|hormones|mesh-list
93031513|NCT00266656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031514|NCT00266656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031515|NCT00483548|Ziprasidone|ziprasidone|mesh-list
93031516|NCT00483548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93031517|NCT00483548|Serotonin Agents|serotonin agents|mesh-ancestor
93031518|NCT00483548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031519|NCT00483548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031520|NCT00483548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031521|NCT00483548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93031522|NCT00483548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031523|NCT00483548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031524|NCT00483548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031525|NCT00483548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93031526|NCT00483548|Dopamine Agents|dopamine agents|mesh-ancestor
93031527|NCT00445770|Etanercept|etanercept|mesh-list
93031528|NCT00445770|Methotrexate|methotrexate|mesh-list
93031529|NCT00445770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93031530|NCT00445770|Abortifacient Agents|abortifacient agents|mesh-ancestor
93031531|NCT00445770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93031532|NCT00445770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031533|NCT00445770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93031534|NCT00445770|Antimetabolites|antimetabolites|mesh-ancestor
93031535|NCT00445770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031536|NCT00445770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031537|NCT00445770|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031538|NCT00445770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031539|NCT00445770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93031540|NCT00445770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031541|NCT00445770|Immunologic Factors|immunologic factors|mesh-ancestor
93031542|NCT00445770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031543|NCT00445770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93031544|NCT00445770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93031545|NCT00445770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031546|NCT00445770|Analgesics|analgesics|mesh-ancestor
93031547|NCT00445770|Sensory System Agents|sensory system agents|mesh-ancestor
93031548|NCT00445770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031549|NCT00445770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031550|NCT00445770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031551|NCT00266032|Drospirenone|drospirenone|mesh-list
93031552|NCT00266032|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93031553|NCT00266032|Hormone Antagonists|hormone antagonists|mesh-ancestor
93031554|NCT00266032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031555|NCT00266032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031556|NCT00266032|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93031557|NCT00266032|Diuretics|diuretics|mesh-ancestor
93031558|NCT00266032|Natriuretic Agents|natriuretic agents|mesh-ancestor
93031559|NCT01019798|Docetaxel|docetaxel|mesh-list
93031560|NCT01019798|Sunitinib|sunitinib|mesh-list
93031561|NCT01019798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031562|NCT01019798|Tubulin Modulators|tubulin modulators|mesh-ancestor
93031563|NCT01019798|Antimitotic Agents|antimitotic agents|mesh-ancestor
93031564|NCT01019798|Mitosis Modulators|mitosis modulators|mesh-ancestor
93031565|NCT01019798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031566|NCT01019798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031567|NCT01019798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93031568|NCT01019798|Growth Substances|growth substances|mesh-ancestor
93031569|NCT01019798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031570|NCT01019798|Growth Inhibitors|growth inhibitors|mesh-ancestor
93031571|NCT01019798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93031572|NCT01019798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031573|NCT00483002|Varenicline|varenicline|mesh-list
93031574|NCT00483002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93031575|NCT00483002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93031576|NCT00483002|Cholinergic Agents|cholinergic agents|mesh-ancestor
93031577|NCT00483002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031578|NCT00483002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031579|NCT00483002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031580|NCT00482612|Mirtazapine|mirtazapine|mesh-list
93031581|NCT00482612|Antidepressive Agents|antidepressive agents|mesh-ancestor
93031582|NCT00482612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031583|NCT00482612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93031584|NCT00482612|Histamine Antagonists|histamine antagonists|mesh-ancestor
93031585|NCT00482612|Histamine Agents|histamine agents|mesh-ancestor
93031586|NCT00482612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031587|NCT00482612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031588|NCT00482612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031589|NCT00482612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93031590|NCT00482612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031591|NCT00482612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031592|NCT00482612|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93031593|NCT00482612|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93031594|NCT00482612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93031595|NCT00482612|Adrenergic Agents|adrenergic agents|mesh-ancestor
93031596|NCT00482612|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93031597|NCT00482612|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93031598|NCT00482612|Serotonin Agents|serotonin agents|mesh-ancestor
93031599|NCT00482612|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93031600|NCT00282568|Tacrolimus|tacrolimus|mesh-list
93031601|NCT00282568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031602|NCT00282568|Immunologic Factors|immunologic factors|mesh-ancestor
93031603|NCT00282568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031604|NCT00282568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93031605|NCT00282568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031606|NCT00282568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031607|NCT02532322|Acetaminophen|acetaminophen|mesh-list
93031608|NCT02532322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031609|NCT02532322|Analgesics|analgesics|mesh-ancestor
93031610|NCT02532322|Sensory System Agents|sensory system agents|mesh-ancestor
93031611|NCT02532322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031612|NCT02532322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031613|NCT02532322|Antipyretics|antipyretics|mesh-ancestor
93031614|NCT00445692|Clarithromycin|clarithromycin|mesh-list
93031615|NCT00445692|Dexamethasone|dexamethasone|mesh-list
93031616|NCT00445692|Dexamethasone acetate|dexamethasone acetate|mesh-list
93031617|NCT00445692|Lenalidomide|lenalidomide|mesh-list
93031618|NCT00445692|Ichthammol|ichthammol|mesh-list
93031619|NCT00445692|BB 1101|bb 1101|mesh-list
93031620|NCT00445692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031621|NCT00445692|Antiemetics|antiemetics|mesh-ancestor
93031622|NCT00445692|Autonomic Agents|autonomic agents|mesh-ancestor
93031623|NCT00445692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031624|NCT00445692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031625|NCT00445692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031626|NCT00445692|Glucocorticoids|glucocorticoids|mesh-ancestor
93031627|NCT00445692|Hormones|hormones|mesh-ancestor
93031628|NCT00445692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031629|NCT00445692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93031630|NCT00445692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031632|NCT00445692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93031633|NCT00445692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93031634|NCT00445692|Growth Substances|growth substances|mesh-ancestor
93031635|NCT00445692|Growth Inhibitors|growth inhibitors|mesh-ancestor
93031636|NCT00445692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031637|NCT00445692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031638|NCT00445692|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93031639|NCT00445692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031640|NCT00445692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031641|NCT00445692|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93031642|NCT00445692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93031643|NCT00445692|Protease Inhibitors|protease inhibitors|mesh-ancestor
93031644|NCT00445692|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031645|NCT00282412|Cyclosporine|cyclosporine|mesh-list
93031646|NCT00282412|Mycophenolic Acid|mycophenolic acid|mesh-list
93031647|NCT00282412|Cyclophosphamide|cyclophosphamide|mesh-list
93031648|NCT00282412|Fludarabine|fludarabine|mesh-list
93031649|NCT00282412|Alemtuzumab|alemtuzumab|mesh-list
93031650|NCT00282412|Cyclosporins|cyclosporins|mesh-list
93031651|NCT00282412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031652|NCT00282412|Immunologic Factors|immunologic factors|mesh-ancestor
93031653|NCT00282412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031654|NCT00282412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031655|NCT00282412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031656|NCT00282412|Alkylating Agents|alkylating agents|mesh-ancestor
93031657|NCT00282412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031658|NCT00282412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031659|NCT00282412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93031660|NCT00282412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031661|NCT00282412|Antifungal Agents|antifungal agents|mesh-ancestor
93031662|NCT00282412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031663|NCT00282412|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031664|NCT00282412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93031665|NCT00282412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031666|NCT00282412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93031667|NCT00282412|Antitubercular Agents|antitubercular agents|mesh-ancestor
93031668|NCT00282412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031669|NCT00282412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031670|NCT03974932|Acetaminophen|acetaminophen|mesh-list
93031671|NCT03974932|Ibuprofen|ibuprofen|mesh-list
93031672|NCT03974932|Celecoxib|celecoxib|mesh-list
93031673|NCT03974932|Bupivacaine|bupivacaine|mesh-list
93031674|NCT03974932|Anesthetics, Local|anesthetics, local|mesh-ancestor
93031675|NCT03974932|Anesthetics|anesthetics|mesh-ancestor
93031676|NCT03974932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031677|NCT03974932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031678|NCT03974932|Sensory System Agents|sensory system agents|mesh-ancestor
93031679|NCT03974932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031680|NCT03974932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031681|NCT03974932|Analgesics|analgesics|mesh-ancestor
93031682|NCT03974932|Antipyretics|antipyretics|mesh-ancestor
93031683|NCT03974932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93031684|NCT03974932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031685|NCT03974932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031686|NCT03974932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93031687|NCT03974932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031688|NCT03974932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031689|NCT03974932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93031690|NCT00282256|Tacrolimus|tacrolimus|mesh-list
93031692|NCT00282256|Immunologic Factors|immunologic factors|mesh-ancestor
93031693|NCT00282256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031694|NCT00282256|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93031695|NCT00282256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031696|NCT00282256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031697|NCT00265330|Ziprasidone|ziprasidone|mesh-list
93031698|NCT00265330|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93031699|NCT00265330|Serotonin Agents|serotonin agents|mesh-ancestor
93031700|NCT00265330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031701|NCT00265330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031702|NCT00265330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031703|NCT00265330|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93031704|NCT00265330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92676958|NCT00332384|Timolol|timolol|mesh-list
93031705|NCT00265330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031706|NCT00265330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031707|NCT00265330|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93031708|NCT00265330|Dopamine Agents|dopamine agents|mesh-ancestor
93031709|NCT00543569|Mycophenolic Acid|mycophenolic acid|mesh-list
93031710|NCT00543569|Alefacept|alefacept|mesh-list
93031711|NCT00543569|Tacrolimus|tacrolimus|mesh-list
93031712|NCT00543569|Basiliximab|basiliximab|mesh-list
93031713|NCT00543569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031714|NCT00543569|Immunologic Factors|immunologic factors|mesh-ancestor
93031715|NCT00543569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031716|NCT00543569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93031717|NCT00543569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031718|NCT00543569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031719|NCT00543569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031720|NCT00543569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031721|NCT00543569|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93031722|NCT00543569|Antitubercular Agents|antitubercular agents|mesh-ancestor
93031723|NCT00543569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031724|NCT00543569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031725|NCT00543569|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031726|NCT00984347|Oxytocin|oxytocin|mesh-list
93031727|NCT00984347|Oxytocics|oxytocics|mesh-ancestor
93031728|NCT00984347|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93031729|NCT00984347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031730|NCT00984425|Sorafenib|sorafenib|mesh-list
93031731|NCT00984425|Lapatinib|lapatinib|mesh-list
93031732|NCT00984425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031733|NCT00984425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93031734|NCT00984425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031735|NCT00984425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031736|NCT05596955|Naltrexone|naltrexone|mesh-list
93031737|NCT05596955|Buprenorphine|buprenorphine|mesh-list
93031738|NCT05596955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93031739|NCT05596955|Narcotics|narcotics|mesh-ancestor
93031740|NCT05596955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031741|NCT05596955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031742|NCT05596955|Analgesics|analgesics|mesh-ancestor
93031743|NCT05596955|Sensory System Agents|sensory system agents|mesh-ancestor
93031744|NCT05596955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031745|NCT05596955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93031746|NCT05596955|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93031747|NCT00445458|Paclitaxel|paclitaxel|mesh-list
93031748|NCT00445458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031749|NCT00445458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031750|NCT00445458|Tubulin Modulators|tubulin modulators|mesh-ancestor
93031751|NCT00445458|Antimitotic Agents|antimitotic agents|mesh-ancestor
93031752|NCT00445458|Mitosis Modulators|mitosis modulators|mesh-ancestor
93031753|NCT00445458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031754|NCT03914417|Imiquimod|imiquimod|mesh-list
93031755|NCT03914417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93031756|NCT03914417|Immunologic Factors|immunologic factors|mesh-ancestor
93031757|NCT03914417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031758|NCT03914417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031759|NCT03914417|Interferon Inducers|interferon inducers|mesh-ancestor
93031760|NCT05586113|Bismuth|bismuth|mesh-list
93031761|NCT05586113|Antacids|antacids|mesh-ancestor
93031762|NCT05586113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031763|NCT05586113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031764|NCT00541385|Artesunate|artesunate|mesh-list
93031765|NCT00541385|Lumefantrine|lumefantrine|mesh-list
93031766|NCT00541385|Pyronaridine|pyronaridine|mesh-list
93031767|NCT00541385|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93031768|NCT00541385|Antimalarials|antimalarials|mesh-ancestor
93031769|NCT00541385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93031770|NCT00541385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93031771|NCT00541385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031772|NCT00541385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031773|NCT00541385|Antiviral Agents|antiviral agents|mesh-ancestor
93031774|NCT00541385|Schistosomicides|schistosomicides|mesh-ancestor
93031775|NCT00541385|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93031776|NCT00541385|Anthelmintics|anthelmintics|mesh-ancestor
93031777|NCT00988949|Spiradoline|spiradoline|mesh-list
93031778|NCT00988949|Analgesics|analgesics|mesh-ancestor
93031779|NCT00988949|Sensory System Agents|sensory system agents|mesh-ancestor
93031780|NCT00988949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031781|NCT00988949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031782|NCT00988949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93031784|NCT00988949|Natriuretic Agents|natriuretic agents|mesh-ancestor
93031785|NCT00989027|Oxytocin|oxytocin|mesh-list
93031786|NCT00989027|Carboprost|carboprost|mesh-list
93031787|NCT00989027|Carboprost tromethamine|carboprost tromethamine|mesh-list
93031788|NCT00989027|Ergonovine|ergonovine|mesh-list
93031789|NCT00989027|Oxytocics|oxytocics|mesh-ancestor
93031790|NCT00989027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93031791|NCT00989027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031792|NCT00989027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93031793|NCT00989027|Abortifacient Agents|abortifacient agents|mesh-ancestor
93031794|NCT00265096|Golimumab|golimumab|mesh-list
93031795|NCT00265096|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93031796|NCT00265096|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93031797|NCT00265096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031798|NCT00265096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031799|NCT00265096|Immunologic Factors|immunologic factors|mesh-ancestor
93031800|NCT00265096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031801|NCT02201108|Teriflunomide|teriflunomide|mesh-list
93031802|NCT02201108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93031803|NCT02201108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031804|NCT02201108|Analgesics|analgesics|mesh-ancestor
93031805|NCT02201108|Sensory System Agents|sensory system agents|mesh-ancestor
93031806|NCT02201108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031807|NCT02201108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031808|NCT02201108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031809|NCT02201108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031810|NCT02201108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031811|NCT02201108|Immunologic Factors|immunologic factors|mesh-ancestor
93031812|NCT00986609|Poly I-C|poly i-c|mesh-list
92183183|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
93031813|NCT00986609|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93031814|NCT00986609|Vaccines|vaccines|mesh-list
93031815|NCT00986609|Poly ICLC|poly iclc|mesh-list
93031816|NCT00986609|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
93031817|NCT00986609|Immunologic Factors|immunologic factors|mesh-ancestor
93031818|NCT00986609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031819|NCT00986609|Interferon Inducers|interferon inducers|mesh-ancestor
93031820|NCT00986609|Laxatives|laxatives|mesh-ancestor
93031821|NCT00986609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031822|NCT00986609|Antiviral Agents|antiviral agents|mesh-ancestor
93031823|NCT00986609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031824|NCT00986609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93031825|NCT00281320|Asenapine|asenapine|mesh-list
93031826|NCT00281320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93031827|NCT00281320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031828|NCT00281320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031829|NCT00281320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031830|NCT00281320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031831|NCT00541307|Heparin|heparin|mesh-list
93031832|NCT00541307|Anticoagulants|anticoagulants|mesh-ancestor
93031833|NCT00541307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93031834|NCT00541307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93031835|NCT00541307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031836|NCT05003258|Dexamethasone|dexamethasone|mesh-list
93031837|NCT05003258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031838|NCT05003258|Antiemetics|antiemetics|mesh-ancestor
93031839|NCT05003258|Autonomic Agents|autonomic agents|mesh-ancestor
93031840|NCT05003258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031841|NCT05003258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031842|NCT05003258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031843|NCT05003258|Glucocorticoids|glucocorticoids|mesh-ancestor
93031844|NCT05003258|Hormones|hormones|mesh-ancestor
93031845|NCT05003258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031846|NCT05003258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93031847|NCT05003258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031848|NCT05499689|Bupivacaine|bupivacaine|mesh-list
93031849|NCT05499689|Anesthetics, Local|anesthetics, local|mesh-ancestor
93031850|NCT05499689|Anesthetics|anesthetics|mesh-ancestor
93031851|NCT05499689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031852|NCT05499689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031853|NCT05499689|Sensory System Agents|sensory system agents|mesh-ancestor
93031854|NCT05499689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677116|NCT00333164|Cilostazol|cilostazol|mesh-list
93031855|NCT01012232|Ropivacaine|ropivacaine|mesh-list
93031856|NCT01012232|Anesthetics, Local|anesthetics, local|mesh-ancestor
93031857|NCT01012232|Anesthetics|anesthetics|mesh-ancestor
93031858|NCT01012232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031859|NCT01012232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031860|NCT01012232|Sensory System Agents|sensory system agents|mesh-ancestor
93031861|NCT01012232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031862|NCT00541229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93031863|NCT00541229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93031864|NCT00541229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031865|NCT00541229|Incretins|incretins|mesh-ancestor
93031866|NCT00541229|Hormones|hormones|mesh-ancestor
93031867|NCT00541229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93031868|NCT00541229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93031869|NCT00541229|Protease Inhibitors|protease inhibitors|mesh-ancestor
93031870|NCT00541229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031871|NCT00541229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031872|NCT04006691|Mitomycins|mitomycins|mesh-list
93031873|NCT04006691|Mitomycin|mitomycin|mesh-list
93031874|NCT04006691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031875|NCT04006691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031876|NCT04006691|Alkylating Agents|alkylating agents|mesh-ancestor
93031877|NCT04006691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031878|NCT04006691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93031879|NCT04006691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031880|NCT00986765|Aspirin|aspirin|mesh-list
93031881|NCT00986765|Enoxaparin|enoxaparin|mesh-list
93031882|NCT00986765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93031883|NCT00986765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93031884|NCT00986765|Analgesics|analgesics|mesh-ancestor
93031885|NCT00986765|Sensory System Agents|sensory system agents|mesh-ancestor
93031886|NCT00986765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031887|NCT00986765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031888|NCT00986765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031889|NCT00986765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031890|NCT00986765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93031891|NCT00986765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93031892|NCT00986765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031893|NCT00986765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93031894|NCT00986765|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93031895|NCT00986765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031896|NCT00986765|Antipyretics|antipyretics|mesh-ancestor
93031897|NCT00986765|Anticoagulants|anticoagulants|mesh-ancestor
93031898|NCT00986843|Irinotecan|irinotecan|mesh-list
93031899|NCT00986843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93031900|NCT00986843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93031901|NCT00986843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031902|NCT00986843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031903|NCT00986843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031904|NCT01019876|Cyclophosphamide|cyclophosphamide|mesh-list
93031905|NCT01019876|Fludarabine|fludarabine|mesh-list
93031906|NCT01019876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031907|NCT01019876|Immunologic Factors|immunologic factors|mesh-ancestor
93031908|NCT01019876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031909|NCT01019876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031910|NCT01019876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031911|NCT01019876|Alkylating Agents|alkylating agents|mesh-ancestor
93031912|NCT01019876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031913|NCT01019876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031914|NCT01019876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93031915|NCT05463419|Vaccines|vaccines|mesh-list
93031916|NCT05463419|Immunologic Factors|immunologic factors|mesh-ancestor
93031917|NCT05463419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031919|NCT01017770|Lumefantrine|lumefantrine|mesh-list
93031920|NCT01017770|Artemether|artemether|mesh-list
93031921|NCT01017770|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93031922|NCT01017770|Amodiaquine|amodiaquine|mesh-list
93031923|NCT01017770|Antimalarials|antimalarials|mesh-ancestor
93031924|NCT01017770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93031925|NCT01017770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93031926|NCT01017770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031927|NCT01017770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031928|NCT01017770|Antiviral Agents|antiviral agents|mesh-ancestor
93031929|NCT01017770|Schistosomicides|schistosomicides|mesh-ancestor
93031930|NCT01017770|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93031931|NCT01017770|Anthelmintics|anthelmintics|mesh-ancestor
93031932|NCT05712707|Lofexidine|lofexidine|mesh-list
93031933|NCT05712707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93031934|NCT05712707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93031935|NCT05712707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031937|NCT05712707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031938|NCT05712707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93031939|NCT05712707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93031940|NCT05712707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93031941|NCT05712707|Adrenergic Agents|adrenergic agents|mesh-ancestor
93031942|NCT05712707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031943|NCT05712707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031944|NCT01017926|Triazolam|triazolam|mesh-list
93031945|NCT01017926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93031946|NCT01017926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93031947|NCT01017926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93031948|NCT01017926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93031949|NCT01017926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031950|NCT01017926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93031951|NCT01017926|GABA Modulators|gaba modulators|mesh-ancestor
93031952|NCT01017926|GABA Agents|gaba agents|mesh-ancestor
93031953|NCT01017926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93031954|NCT01017926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031955|NCT00481832|Cyclosporine|cyclosporine|mesh-list
93031956|NCT00481832|Mycophenolic Acid|mycophenolic acid|mesh-list
93031957|NCT00481832|Methylprednisolone|methylprednisolone|mesh-list
93031958|NCT00481832|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93031959|NCT00481832|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93031960|NCT00481832|Prednisolone|prednisolone|mesh-list
93031961|NCT00481832|Prednisolone acetate|prednisolone acetate|mesh-list
93031962|NCT00481832|Cyclophosphamide|cyclophosphamide|mesh-list
93031963|NCT00481832|Carmustine|carmustine|mesh-list
93031964|NCT00481832|Rituximab|rituximab|mesh-list
93031965|NCT00481832|Etoposide|etoposide|mesh-list
93031966|NCT00481832|Cyclosporins|cyclosporins|mesh-list
93031967|NCT00481832|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93031968|NCT00481832|Lenograstim|lenograstim|mesh-list
93031969|NCT00481832|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93031970|NCT00481832|Prednisolone phosphate|prednisolone phosphate|mesh-list
93031971|NCT00481832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93031972|NCT00481832|Immunologic Factors|immunologic factors|mesh-ancestor
93031973|NCT00481832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93031974|NCT00481832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93031975|NCT00481832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93031976|NCT00481832|Alkylating Agents|alkylating agents|mesh-ancestor
93031977|NCT00481832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93031978|NCT00481832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93031979|NCT00481832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93031980|NCT00481832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93031981|NCT00481832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93031982|NCT00481832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93031983|NCT00481832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93031984|NCT00481832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93031985|NCT00481832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93031986|NCT00481832|Antifungal Agents|antifungal agents|mesh-ancestor
93031987|NCT00481832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93031988|NCT00481832|Dermatologic Agents|dermatologic agents|mesh-ancestor
93031989|NCT00481832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93031990|NCT00481832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93031991|NCT00481832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93031992|NCT00481832|Antitubercular Agents|antitubercular agents|mesh-ancestor
93031993|NCT00481832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93031994|NCT00481832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93031995|NCT00481832|Antiemetics|antiemetics|mesh-ancestor
93031996|NCT00481832|Autonomic Agents|autonomic agents|mesh-ancestor
93031997|NCT00481832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93031998|NCT00481832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93031999|NCT00481832|Glucocorticoids|glucocorticoids|mesh-ancestor
93032000|NCT00481832|Hormones|hormones|mesh-ancestor
93032001|NCT00481832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032002|NCT00481832|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93032003|NCT00481832|Protective Agents|protective agents|mesh-ancestor
93032004|NCT00481832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93032005|NCT00481676|Omalizumab|omalizumab|mesh-list
93032006|NCT00481676|Loratadine|loratadine|mesh-list
93032007|NCT00481676|Clemastine|clemastine|mesh-list
93032008|NCT00481676|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92677252|NCT00420563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93032009|NCT00481676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93032010|NCT00481676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93032012|NCT00481676|Immunologic Factors|immunologic factors|mesh-ancestor
93032013|NCT00481676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032014|NCT00481676|Antipruritics|antipruritics|mesh-ancestor
93032015|NCT00481676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92183294|NCT00253513|Alkylating Agents|alkylating agents|mesh-ancestor
93032016|NCT00481676|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93032017|NCT00481676|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93032018|NCT00481676|Histamine Antagonists|histamine antagonists|mesh-ancestor
93032019|NCT00481676|Histamine Agents|histamine agents|mesh-ancestor
93032020|NCT00481676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032021|NCT00481676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032022|NCT00987233|Triamcinolone|triamcinolone|mesh-list
93032023|NCT00987233|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93032024|NCT00987233|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93032025|NCT00987233|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93032026|NCT00987233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032027|NCT00987233|Glucocorticoids|glucocorticoids|mesh-ancestor
93032028|NCT00987233|Hormones|hormones|mesh-ancestor
93032029|NCT00987233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032030|NCT00987233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032031|NCT00987233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032032|NCT00987233|Immunologic Factors|immunologic factors|mesh-ancestor
93032033|NCT00987233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032034|NCT00987233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032035|NCT04377503|Methylprednisolone|methylprednisolone|mesh-list
92183651|NCT00018031|Ribavirin|ribavirin|mesh-list
93032036|NCT04377503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93032037|NCT04377503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93032038|NCT04377503|Prednisolone|prednisolone|mesh-list
93032039|NCT04377503|Prednisolone acetate|prednisolone acetate|mesh-list
93032040|NCT04377503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93032041|NCT04377503|Prednisolone phosphate|prednisolone phosphate|mesh-list
93032042|NCT04377503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032043|NCT04377503|Antiemetics|antiemetics|mesh-ancestor
93032044|NCT04377503|Autonomic Agents|autonomic agents|mesh-ancestor
93032045|NCT04377503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032046|NCT04377503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032047|NCT04377503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032048|NCT04377503|Glucocorticoids|glucocorticoids|mesh-ancestor
93032049|NCT04377503|Hormones|hormones|mesh-ancestor
93032050|NCT04377503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032051|NCT04377503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93032052|NCT04377503|Protective Agents|protective agents|mesh-ancestor
93032053|NCT04377503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93032054|NCT04377503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032055|NCT00542789|Esomeprazole|esomeprazole|mesh-list
93032056|NCT00542789|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92183872|NCT02584452|Fentanyl|fentanyl|mesh-list
93032057|NCT00542789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032058|NCT00542789|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93032059|NCT00542789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183930|NCT03520491|Ipilimumab|ipilimumab|mesh-list
93032060|NCT00542789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032061|NCT00464672|Vaccines|vaccines|mesh-list
93032062|NCT00464672|Immunologic Factors|immunologic factors|mesh-ancestor
93032063|NCT00464672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032064|NCT03996434|Cetrorelix|cetrorelix|mesh-list
93032065|NCT03996434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93032066|NCT03996434|Fertility Agents|fertility agents|mesh-ancestor
93032067|NCT03996434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93032068|NCT03996434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032069|NCT03996434|Hormone Antagonists|hormone antagonists|mesh-ancestor
93032070|NCT03996434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032071|NCT00987779|Gabapentin|gabapentin|mesh-list
93032072|NCT00987779|Analgesics|analgesics|mesh-ancestor
93032073|NCT00987779|Sensory System Agents|sensory system agents|mesh-ancestor
93032074|NCT00987779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032075|NCT00987779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032076|NCT00987779|Anticonvulsants|anticonvulsants|mesh-ancestor
93032077|NCT00987779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93032078|NCT00987779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93032079|NCT00987779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032080|NCT00987779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93032081|NCT00987779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93032082|NCT00987779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93032083|NCT00987779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677327|NCT00438048|Miotics|miotics|mesh-ancestor
92184008|NCT01736865|Vitamin D|vitamin d|mesh-list
93032084|NCT00987779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032085|NCT00987779|Antimanic Agents|antimanic agents|mesh-ancestor
93032086|NCT01018160|Rabeprazole|rabeprazole|mesh-list
93032087|NCT01018160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93032088|NCT01018160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032089|NCT01018160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93032090|NCT01018160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184053|NCT01745055|Tofacitinib|tofacitinib|mesh-list
93032091|NCT01018160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032092|NCT00473876|Metformin|metformin|mesh-list
93032093|NCT00473876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032094|NCT00473876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032095|NCT00463580|Infliximab|infliximab|mesh-list
93032096|NCT00463580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93032097|NCT00463580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032098|NCT00463580|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032099|NCT00463580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032100|NCT00463580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032101|NCT01020734|Cyclosporine|cyclosporine|mesh-list
93032102|NCT01020734|Cyclophosphamide|cyclophosphamide|mesh-list
93032103|NCT01020734|Busulfan|busulfan|mesh-list
93032104|NCT01020734|Methotrexate|methotrexate|mesh-list
93032105|NCT01020734|Fludarabine|fludarabine|mesh-list
93032106|NCT01020734|Fludarabine phosphate|fludarabine phosphate|mesh-list
93032107|NCT01020734|Cyclosporins|cyclosporins|mesh-list
93032108|NCT01020734|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93032109|NCT01020734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032110|NCT01020734|Immunologic Factors|immunologic factors|mesh-ancestor
93032111|NCT01020734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032112|NCT01020734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032113|NCT01020734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93032114|NCT01020734|Alkylating Agents|alkylating agents|mesh-ancestor
93032115|NCT01020734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032116|NCT01020734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032117|NCT01020734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93032118|NCT01020734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93032119|NCT01020734|Abortifacient Agents|abortifacient agents|mesh-ancestor
93032120|NCT01020734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93032121|NCT01020734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93032122|NCT01020734|Antimetabolites|antimetabolites|mesh-ancestor
93032123|NCT01020734|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032124|NCT01020734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032125|NCT01020734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93032126|NCT01020734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93032127|NCT01020734|Antifungal Agents|antifungal agents|mesh-ancestor
93032128|NCT01020734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032129|NCT01020734|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93032130|NCT00540449|Efavirenz|efavirenz|mesh-list
93032131|NCT00540449|Rilpivirine|rilpivirine|mesh-list
93032132|NCT00540449|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93032133|NCT00540449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93032134|NCT00540449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032135|NCT00540449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032136|NCT00540449|Antiviral Agents|antiviral agents|mesh-ancestor
93032137|NCT00540449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032138|NCT00540449|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93032139|NCT00540449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93032140|NCT00540449|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93032141|NCT00540449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93032142|NCT00540449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93032143|NCT00540449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93032144|NCT00540449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92184715|NCT00186017|Olanzapine|olanzapine|mesh-list
93032145|NCT00540449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93032146|NCT03911843|Vitamin D|vitamin d|mesh-list
93032147|NCT03911843|Vitamins|vitamins|mesh-ancestor
93032148|NCT03911843|Micronutrients|micronutrients|mesh-ancestor
93032149|NCT03911843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032150|NCT03911843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93032151|NCT00361335|Golimumab|golimumab|mesh-list
93032152|NCT00361335|Methotrexate|methotrexate|mesh-list
93032153|NCT00361335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93032154|NCT00361335|Abortifacient Agents|abortifacient agents|mesh-ancestor
93032155|NCT00361335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93032156|NCT00361335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032157|NCT00361335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92677408|NCT00334646|Antiemetics|antiemetics|mesh-ancestor
93032158|NCT00361335|Antimetabolites|antimetabolites|mesh-ancestor
93032159|NCT00361335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032160|NCT00361335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032161|NCT00361335|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032162|NCT00361335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032163|NCT00361335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93032164|NCT00361335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032165|NCT00361335|Immunologic Factors|immunologic factors|mesh-ancestor
93032166|NCT00361335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032167|NCT00361335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93032168|NCT00361335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93032169|NCT00361335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032171|NCT00264550|Methotrexate|methotrexate|mesh-list
93032172|NCT00264550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93032173|NCT00264550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93032174|NCT00264550|Abortifacient Agents|abortifacient agents|mesh-ancestor
93032175|NCT00264550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93032176|NCT00264550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032177|NCT00264550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93032178|NCT00264550|Antimetabolites|antimetabolites|mesh-ancestor
93032179|NCT00264550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032180|NCT00264550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032181|NCT00264550|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032182|NCT00264550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032183|NCT00264550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93032184|NCT00264550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032185|NCT00264550|Immunologic Factors|immunologic factors|mesh-ancestor
93032186|NCT00264550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032187|NCT00264550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93032188|NCT00264550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93032189|NCT00264550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032190|NCT04004507|Phentolamine|phentolamine|mesh-list
93032191|NCT04004507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93032192|NCT04004507|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93032193|NCT04004507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93032194|NCT04004507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93032195|NCT04004507|Adrenergic Agents|adrenergic agents|mesh-ancestor
93032196|NCT04004507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032197|NCT04004507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032198|NCT04004507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032199|NCT04004507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93032200|NCT01070290|Capecitabine|capecitabine|mesh-list
93032201|NCT01070290|Oxaliplatin|oxaliplatin|mesh-list
93032202|NCT01070290|Irinotecan|irinotecan|mesh-list
92185397|NCT00256451|Ethanol|ethanol|mesh-list
93032203|NCT01070290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93032204|NCT01070290|Antimetabolites|antimetabolites|mesh-ancestor
93032205|NCT01070290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032206|NCT01070290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032207|NCT01070290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93032208|NCT01070290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93032209|NCT01070290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032210|NCT01070446|Choline|choline|mesh-list
93032211|NCT01070446|Lipotropic Agents|lipotropic agents|mesh-ancestor
93032212|NCT01070446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93032213|NCT01070446|Antimetabolites|antimetabolites|mesh-ancestor
93032214|NCT01070446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032215|NCT01070446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032216|NCT01070446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93032217|NCT01070446|Nootropic Agents|nootropic agents|mesh-ancestor
93032218|NCT01050387|Vitamin D|vitamin d|mesh-list
93032219|NCT01050387|Vitamins|vitamins|mesh-ancestor
93032220|NCT01050387|Micronutrients|micronutrients|mesh-ancestor
93032221|NCT01050387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032222|NCT01050387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93032223|NCT01070524|Budesonide|budesonide|mesh-list
93032224|NCT01070524|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93032225|NCT01070524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032226|NCT01070524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93032227|NCT01070524|Autonomic Agents|autonomic agents|mesh-ancestor
93032228|NCT01070524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032229|NCT01070524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032230|NCT01070524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93032231|NCT01070524|Respiratory System Agents|respiratory system agents|mesh-ancestor
93032232|NCT01070524|Glucocorticoids|glucocorticoids|mesh-ancestor
93032233|NCT01070524|Hormones|hormones|mesh-ancestor
93032234|NCT01070524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032235|NCT01070524|Sympathomimetics|sympathomimetics|mesh-ancestor
93032236|NCT01071304|Midazolam|midazolam|mesh-list
93032237|NCT01071304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93032238|NCT01071304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93032239|NCT01071304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032240|NCT01071304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032241|NCT01071304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92185949|NCT00281021|Digoxin|digoxin|mesh-list
93032242|NCT01071304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93032243|NCT01071304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93032244|NCT01071304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93032245|NCT01071304|Anesthetics, General|anesthetics, general|mesh-ancestor
93032246|NCT01071304|Anesthetics|anesthetics|mesh-ancestor
93032247|NCT01071304|GABA Modulators|gaba modulators|mesh-ancestor
93032248|NCT01071304|GABA Agents|gaba agents|mesh-ancestor
93032249|NCT01071304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032250|NCT01071304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032251|NCT01069042|Enalapril|enalapril|mesh-list
93032252|NCT01069042|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93032253|NCT01069042|Protease Inhibitors|protease inhibitors|mesh-ancestor
93032254|NCT01069042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032255|NCT01069042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032256|NCT01069042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93032257|NCT00368979|Dutasteride|dutasteride|mesh-list
93032258|NCT00368979|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93032259|NCT00368979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93032260|NCT00368979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032261|NCT00368979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032262|NCT00368979|Hormone Antagonists|hormone antagonists|mesh-ancestor
93032263|NCT00368979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032264|NCT00368979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032265|NCT00264238|Memantine|memantine|mesh-list
93032266|NCT00264238|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93032267|NCT00264238|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93032268|NCT00264238|Dopamine Agents|dopamine agents|mesh-ancestor
93032269|NCT00264238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032270|NCT00264238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032271|NCT00264238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032272|NCT00264238|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93032273|NCT00264238|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93032274|NCT00540293|Atorvastatin|atorvastatin|mesh-list
93032275|NCT00540293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93032276|NCT00540293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93032277|NCT00540293|Antimetabolites|antimetabolites|mesh-ancestor
93032278|NCT00540293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032279|NCT00540293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93032280|NCT00540293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93032281|NCT00540293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032282|NCT00375609|Enoxaparin|enoxaparin|mesh-list
93032283|NCT00375609|Betrixaban|betrixaban|mesh-list
93032284|NCT00375609|Anticoagulants|anticoagulants|mesh-ancestor
93032285|NCT00375609|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93032286|NCT00375609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93032287|NCT00375609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032288|NCT00375609|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93032289|NCT00375609|Antithrombins|antithrombins|mesh-ancestor
93032290|NCT00375609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93032291|NCT00375609|Protease Inhibitors|protease inhibitors|mesh-ancestor
93032292|NCT00375609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032293|NCT01050621|Ascorbic Acid|ascorbic acid|mesh-list
93032294|NCT01050621|Vitamins|vitamins|mesh-ancestor
93032295|NCT01050621|Micronutrients|micronutrients|mesh-ancestor
93032296|NCT01050621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032297|NCT01050621|Antioxidants|antioxidants|mesh-ancestor
93032298|NCT01050621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032299|NCT01050621|Protective Agents|protective agents|mesh-ancestor
93032300|NCT00359073|Montelukast|montelukast|mesh-list
93032301|NCT00359073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93032302|NCT00359073|Respiratory System Agents|respiratory system agents|mesh-ancestor
93032303|NCT00359073|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93032304|NCT00359073|Hormone Antagonists|hormone antagonists|mesh-ancestor
93032305|NCT00359073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032306|NCT00359073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677550|NCT00436995|Darbepoetin alfa|darbepoetin alfa|mesh-list
93032307|NCT00359073|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93032308|NCT00359073|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93032309|NCT00359073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032310|NCT00368745|Pregabalin|pregabalin|mesh-list
93032311|NCT00368745|Analgesics|analgesics|mesh-ancestor
93032312|NCT00368745|Sensory System Agents|sensory system agents|mesh-ancestor
93032313|NCT00368745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032314|NCT00368745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032315|NCT00368745|Anticonvulsants|anticonvulsants|mesh-ancestor
93032316|NCT00368745|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93032317|NCT00368745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93032318|NCT00368745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032319|NCT00368745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93032320|NCT00368745|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93032321|NCT00368745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93032322|NCT00368745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032323|NCT00368745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93032324|NCT03235739|Naloxegol|naloxegol|mesh-list
93032325|NCT03235739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93032326|NCT03235739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032327|NCT03235739|Sensory System Agents|sensory system agents|mesh-ancestor
93032328|NCT03235739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032329|NCT04573673|Emodin|emodin|mesh-list
93032330|NCT04573673|Cathartics|cathartics|mesh-ancestor
93032331|NCT04573673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032332|NCT04573673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93032333|NCT04573673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032334|NCT04573673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032335|NCT01050699|Fentanyl|fentanyl|mesh-list
93032336|NCT01050699|Midazolam|midazolam|mesh-list
92186182|NCT04085419|Denosumab|denosumab|mesh-list
93032337|NCT01050699|Dexmedetomidine|dexmedetomidine|mesh-list
93032338|NCT01050699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93032339|NCT01050699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032340|NCT01050699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032341|NCT01050699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93032342|NCT01050699|Analgesics|analgesics|mesh-ancestor
93032343|NCT01050699|Sensory System Agents|sensory system agents|mesh-ancestor
93032344|NCT01050699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032345|NCT01050699|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93032346|NCT01050699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93032347|NCT01050699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93032348|NCT01050699|Adrenergic Agents|adrenergic agents|mesh-ancestor
93032349|NCT01050699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032350|NCT01050699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032351|NCT01050699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93032352|NCT01050699|Narcotics|narcotics|mesh-ancestor
93032353|NCT01050699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93032354|NCT01050699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93032355|NCT01050699|Anesthetics, General|anesthetics, general|mesh-ancestor
93032356|NCT01050699|Anesthetics|anesthetics|mesh-ancestor
93032357|NCT01050699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93032358|NCT01050699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93032359|NCT01050699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93032360|NCT01050699|GABA Modulators|gaba modulators|mesh-ancestor
93032361|NCT01050699|GABA Agents|gaba agents|mesh-ancestor
93032362|NCT02408315|Misoprostol|misoprostol|mesh-list
93032363|NCT02408315|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93032364|NCT02408315|Abortifacient Agents|abortifacient agents|mesh-ancestor
93032365|NCT02408315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93032366|NCT02408315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032367|NCT02408315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93032368|NCT02408315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032369|NCT02408315|Oxytocics|oxytocics|mesh-ancestor
93032370|NCT05711693|Bepridil|bepridil|mesh-list
93032371|NCT05711693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93032372|NCT05711693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93032373|NCT05711693|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93032374|NCT05711693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93032375|NCT05711693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032376|NCT05711693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93032377|NCT05711693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032378|NCT05711693|Vasodilator Agents|vasodilator agents|mesh-ancestor
93032379|NCT04005365|Propranolol|propranolol|mesh-list
93032380|NCT04005365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93032381|NCT04005365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93032383|NCT04005365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032384|NCT04005365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032385|NCT04005365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032386|NCT04005365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93032387|NCT04005365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93032388|NCT04005365|Vasodilator Agents|vasodilator agents|mesh-ancestor
93032389|NCT01027182|Raltegravir Potassium|raltegravir potassium|mesh-list
93032390|NCT01027182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93032391|NCT01027182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93032392|NCT01027182|Antiviral Agents|antiviral agents|mesh-ancestor
93032393|NCT01027182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032394|NCT01027182|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93032395|NCT01027182|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93032396|NCT01027182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032397|NCT01027182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032398|NCT00358917|Ritonavir|ritonavir|mesh-list
93032399|NCT00358917|Lopinavir|lopinavir|mesh-list
93032400|NCT00358917|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93032401|NCT00358917|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93032402|NCT00358917|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93032403|NCT00358917|Protease Inhibitors|protease inhibitors|mesh-ancestor
93032404|NCT00358917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032405|NCT00358917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032406|NCT00358917|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93032407|NCT00358917|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93032408|NCT00358917|Antiviral Agents|antiviral agents|mesh-ancestor
93032409|NCT00358917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032410|NCT00358917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93032411|NCT00358917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93032412|NCT00358917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93032413|NCT01048515|Caffeine|caffeine|mesh-list
93032414|NCT01048515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93032415|NCT01048515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032416|NCT01048515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93032417|NCT01048515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032418|NCT01048515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032419|NCT01048515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93032420|NCT01048515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93032421|NCT01048515|Purinergic Agents|purinergic agents|mesh-ancestor
93032422|NCT01048515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032423|NCT01050777|Paromomycin|paromomycin|mesh-list
93032424|NCT01050777|Meglumine Antimoniate|meglumine antimoniate|mesh-list
93032425|NCT01050777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93032426|NCT01050777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032427|NCT01050777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93032428|NCT01050777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93032429|NCT00264004|Cediranib|cediranib|mesh-list
93032430|NCT00264004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032431|NCT00264004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93032432|NCT00264004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032433|NCT00264004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032434|NCT01069198|Vitamin A|vitamin a|mesh-list
93032435|NCT01069198|Albendazole|albendazole|mesh-list
93032436|NCT01069198|Vitamins|vitamins|mesh-ancestor
93032437|NCT01069198|Micronutrients|micronutrients|mesh-ancestor
93032438|NCT01069198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032439|NCT01069198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032440|NCT01069198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032441|NCT01069198|Anthelmintics|anthelmintics|mesh-ancestor
93032442|NCT01069198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93032443|NCT01069198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032444|NCT01069198|Anticestodal Agents|anticestodal agents|mesh-ancestor
93032445|NCT01069198|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93032446|NCT01069198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93032447|NCT01069198|Tubulin Modulators|tubulin modulators|mesh-ancestor
93032448|NCT01069198|Antimitotic Agents|antimitotic agents|mesh-ancestor
93032449|NCT01069198|Mitosis Modulators|mitosis modulators|mesh-ancestor
93032450|NCT00368355|Cytarabine|cytarabine|mesh-list
93032451|NCT00368355|Cyclophosphamide|cyclophosphamide|mesh-list
93032452|NCT00368355|Alemtuzumab|alemtuzumab|mesh-list
93032453|NCT00368355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032454|NCT00368355|Immunologic Factors|immunologic factors|mesh-ancestor
93032455|NCT00368355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032456|NCT00368355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032457|NCT00368355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93032458|NCT00368355|Alkylating Agents|alkylating agents|mesh-ancestor
93032459|NCT00368355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032460|NCT00368355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032461|NCT00368355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93032462|NCT00368355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93032463|NCT00368355|Antimetabolites|antimetabolites|mesh-ancestor
93032464|NCT00368355|Antiviral Agents|antiviral agents|mesh-ancestor
93032465|NCT00368355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032466|NCT00368355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93032467|NCT01070680|Dexmedetomidine|dexmedetomidine|mesh-list
93032468|NCT01070680|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93032469|NCT01070680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032470|NCT01070680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032471|NCT01070680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93032473|NCT01070680|Sensory System Agents|sensory system agents|mesh-ancestor
93032474|NCT01070680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032475|NCT01070680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93032476|NCT01070680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93032477|NCT01070680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93032478|NCT01070680|Adrenergic Agents|adrenergic agents|mesh-ancestor
93032479|NCT01070680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032480|NCT01070680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032481|NCT00445146|Elvitegravir|elvitegravir|mesh-list
93032482|NCT00445146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92186278|NCT00285779|Etanercept|etanercept|mesh-list
93032483|NCT00445146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93032484|NCT00445146|Antiviral Agents|antiviral agents|mesh-ancestor
93032485|NCT00445146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032486|NCT00445146|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93032487|NCT00445146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032488|NCT00445146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032489|NCT01581736|Insulin|insulin|mesh-list
93032490|NCT01581736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93032491|NCT01581736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032492|NCT01581736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032493|NCT01030302|Bortezomib|bortezomib|mesh-list
93032494|NCT01030302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032495|NCT00368277|Amlodipine|amlodipine|mesh-list
93032496|NCT00368277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93032497|NCT00368277|Ramipril|ramipril|mesh-list
93032498|NCT00368277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93032499|NCT00368277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93032500|NCT00368277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93032501|NCT00368277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032502|NCT00368277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93032503|NCT00368277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032504|NCT00368277|Vasodilator Agents|vasodilator agents|mesh-ancestor
93032505|NCT00368277|Diuretics|diuretics|mesh-ancestor
93032506|NCT00368277|Natriuretic Agents|natriuretic agents|mesh-ancestor
93032507|NCT00368277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93032508|NCT00368277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93032509|NCT00368277|Protease Inhibitors|protease inhibitors|mesh-ancestor
93032510|NCT00368277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032512|NCT00280150|Bevacizumab|bevacizumab|mesh-list
93032513|NCT00280150|Carboplatin|carboplatin|mesh-list
93032514|NCT00280150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93032515|NCT00280150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93032516|NCT00280150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032517|NCT00280150|Tubulin Modulators|tubulin modulators|mesh-ancestor
93032518|NCT00280150|Antimitotic Agents|antimitotic agents|mesh-ancestor
93032519|NCT00280150|Mitosis Modulators|mitosis modulators|mesh-ancestor
93032520|NCT00280150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032521|NCT00280150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93032522|NCT00280150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93032523|NCT00280150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93032524|NCT00280150|Growth Substances|growth substances|mesh-ancestor
93032525|NCT00280150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032526|NCT00280150|Growth Inhibitors|growth inhibitors|mesh-ancestor
93032527|NCT00280150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93032528|NCT00280150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032529|NCT00279916|Triamcinolone|triamcinolone|mesh-list
93032530|NCT00279916|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93032531|NCT00279916|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93032532|NCT00279916|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93032533|NCT00279916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032534|NCT00279916|Glucocorticoids|glucocorticoids|mesh-ancestor
93032535|NCT00279916|Hormones|hormones|mesh-ancestor
93032536|NCT00279916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032537|NCT00279916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032538|NCT00279916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032539|NCT00279916|Immunologic Factors|immunologic factors|mesh-ancestor
93032540|NCT00279916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032541|NCT00279916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032542|NCT02534337|Leucovorin|leucovorin|mesh-list
93032543|NCT02534337|Gemcitabine|gemcitabine|mesh-list
93032544|NCT02534337|Fluorouracil|fluorouracil|mesh-list
93032545|NCT02534337|Oxaliplatin|oxaliplatin|mesh-list
93032546|NCT02534337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93032547|NCT02534337|Antimetabolites|antimetabolites|mesh-ancestor
93032548|NCT02534337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032549|NCT02534337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032550|NCT02534337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032551|NCT02534337|Immunologic Factors|immunologic factors|mesh-ancestor
93032552|NCT02534337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032553|NCT02534337|Antidotes|antidotes|mesh-ancestor
93032554|NCT02534337|Protective Agents|protective agents|mesh-ancestor
93032555|NCT02534337|Vitamin B Complex|vitamin b complex|mesh-ancestor
93032556|NCT02534337|Vitamins|vitamins|mesh-ancestor
93032557|NCT02534337|Micronutrients|micronutrients|mesh-ancestor
93032558|NCT01325896|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93032559|NCT01325896|Antiviral Agents|antiviral agents|mesh-ancestor
93032560|NCT01325896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032561|NCT01050933|Carbon Monoxide|carbon monoxide|mesh-list
93032562|NCT01050933|Antimetabolites|antimetabolites|mesh-ancestor
93032563|NCT01050933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032564|NCT01050933|Gasotransmitters|gasotransmitters|mesh-ancestor
93032565|NCT01050933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032566|NCT01050933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032567|NCT00358527|Mometasone Furoate|mometasone furoate|mesh-list
93032568|NCT00358527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032569|NCT00358527|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032570|NCT00358527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93032571|NCT00251758|Dexlansoprazole|dexlansoprazole|mesh-list
93032572|NCT00251758|Lansoprazole|lansoprazole|mesh-list
93032573|NCT00251758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93032574|NCT00251758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032575|NCT00251758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93032576|NCT00251758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032577|NCT00251758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032578|NCT00279214|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
93032579|NCT00279214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032580|NCT00262834|Vorinostat|vorinostat|mesh-list
93032581|NCT00262834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032582|NCT00262834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93032583|NCT00262834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032584|NCT00262834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032585|NCT04417361|Erenumab|erenumab|mesh-list
93032586|NCT04417361|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93032587|NCT04417361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032588|NCT04417361|Analgesics|analgesics|mesh-ancestor
93032589|NCT04417361|Sensory System Agents|sensory system agents|mesh-ancestor
93032590|NCT04417361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032591|NCT04417361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032592|NCT00541775|Metformin|metformin|mesh-list
93032593|NCT00541775|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93032594|NCT00541775|Rosiglitazone|rosiglitazone|mesh-list
93032595|NCT00541775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032596|NCT00541775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032597|NCT00541775|Incretins|incretins|mesh-ancestor
93032598|NCT00541775|Hormones|hormones|mesh-ancestor
93032599|NCT00541775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032600|NCT00541775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93032601|NCT00541775|Protease Inhibitors|protease inhibitors|mesh-ancestor
93032602|NCT00541775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032603|NCT00541775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032604|NCT04004117|Fentanyl|fentanyl|mesh-list
93032605|NCT04004117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93032606|NCT04004117|Narcotics|narcotics|mesh-ancestor
93032607|NCT04004117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032608|NCT04004117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032609|NCT04004117|Analgesics|analgesics|mesh-ancestor
93032610|NCT04004117|Sensory System Agents|sensory system agents|mesh-ancestor
93032611|NCT04004117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032612|NCT04004117|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93032613|NCT04004117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93032614|NCT04004117|Anesthetics, General|anesthetics, general|mesh-ancestor
93032615|NCT04004117|Anesthetics|anesthetics|mesh-ancestor
93032616|NCT00539513|Acetylcysteine|acetylcysteine|mesh-list
93032617|NCT00539513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93032618|NCT00539513|Antiviral Agents|antiviral agents|mesh-ancestor
93032619|NCT00539513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032620|NCT00539513|Expectorants|expectorants|mesh-ancestor
93032621|NCT00539513|Respiratory System Agents|respiratory system agents|mesh-ancestor
93032622|NCT00539513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93032623|NCT00539513|Antioxidants|antioxidants|mesh-ancestor
93032624|NCT00539513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032625|NCT00539513|Protective Agents|protective agents|mesh-ancestor
93032626|NCT00539513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032627|NCT00539513|Antidotes|antidotes|mesh-ancestor
93032628|NCT02997761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93032629|NCT02997761|Blinatumomab|blinatumomab|mesh-list
93032630|NCT02997761|Antibodies|antibodies|mesh-list
93032631|NCT02997761|Immunoglobulins|immunoglobulins|mesh-list
93032632|NCT02997761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93032633|NCT02997761|Muromonab-CD3|muromonab-cd3|mesh-list
93032634|NCT02997761|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93032635|NCT02997761|Immunologic Factors|immunologic factors|mesh-ancestor
93032636|NCT02997761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032637|NCT02997761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032638|NCT02997761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032639|NCT00454584|Etanercept|etanercept|mesh-list
93032640|NCT00454584|Ustekinumab|ustekinumab|mesh-list
93032641|NCT00454584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93032642|NCT00454584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93032643|NCT00454584|Analgesics|analgesics|mesh-ancestor
93032644|NCT00454584|Sensory System Agents|sensory system agents|mesh-ancestor
93032645|NCT00454584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032646|NCT00454584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032647|NCT00454584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032648|NCT00454584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032649|NCT00454584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032650|NCT00454584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032651|NCT00454584|Immunologic Factors|immunologic factors|mesh-ancestor
93032652|NCT00454584|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032653|NCT04221191|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93032654|NCT04221191|Dermatologic Agents|dermatologic agents|mesh-ancestor
93032655|NCT04221191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032656|NCT04221191|Immunologic Factors|immunologic factors|mesh-ancestor
93032657|NCT04221191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032659|NCT04204343|Anesthetics, Local|anesthetics, local|mesh-ancestor
93032660|NCT04204343|Anesthetics|anesthetics|mesh-ancestor
93032661|NCT04204343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032662|NCT04204343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032663|NCT04204343|Sensory System Agents|sensory system agents|mesh-ancestor
93032664|NCT04204343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032665|NCT02845271|Acetaminophen|acetaminophen|mesh-list
93032666|NCT02845271|Tramadol|tramadol|mesh-list
93032667|NCT02845271|Codeine|codeine|mesh-list
93032668|NCT02845271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93032669|NCT02845271|Analgesics|analgesics|mesh-ancestor
93032670|NCT02845271|Sensory System Agents|sensory system agents|mesh-ancestor
93032671|NCT02845271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032672|NCT02845271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032673|NCT02845271|Antipyretics|antipyretics|mesh-ancestor
93032674|NCT02845271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93032675|NCT02845271|Narcotics|narcotics|mesh-ancestor
93032676|NCT02845271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032677|NCT02845271|Antitussive Agents|antitussive agents|mesh-ancestor
93032678|NCT02845271|Respiratory System Agents|respiratory system agents|mesh-ancestor
93032679|NCT00445068|Panobinostat|panobinostat|mesh-list
93032680|NCT00445068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677925|NCT00337259|Gemcitabine|gemcitabine|mesh-list
93032681|NCT00445068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93032682|NCT00445068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032683|NCT00445068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032684|NCT02404337|Betaine|betaine|mesh-list
93032685|NCT02404337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032686|NCT02404337|Lipotropic Agents|lipotropic agents|mesh-ancestor
93032687|NCT02404337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93032688|NCT02404337|Antimetabolites|antimetabolites|mesh-ancestor
93032689|NCT02404337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032690|NCT02404337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93032691|NCT05360147|Metformin|metformin|mesh-list
93032692|NCT05360147|Liraglutide|liraglutide|mesh-list
93032693|NCT05360147|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93032694|NCT05360147|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
93032695|NCT05360147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032696|NCT05360147|Incretins|incretins|mesh-ancestor
93032697|NCT05360147|Hormones|hormones|mesh-ancestor
93032698|NCT05360147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032699|NCT00444912|Plerixafor|plerixafor|mesh-list
93032700|NCT00444912|Rituximab|rituximab|mesh-list
93032701|NCT00444912|Lenograstim|lenograstim|mesh-list
93032702|NCT00444912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93032703|NCT00444912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032704|NCT00444912|Immunologic Factors|immunologic factors|mesh-ancestor
93032705|NCT00444912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032706|NCT00444912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032707|NCT00444912|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93032708|NCT00444912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93032709|NCT00444912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93032710|NCT00444912|Antiviral Agents|antiviral agents|mesh-ancestor
93032711|NCT00444912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032712|NCT00538733|Clarithromycin|clarithromycin|mesh-list
93032713|NCT00538733|Thalidomide|thalidomide|mesh-list
93032714|NCT00538733|Dexamethasone|dexamethasone|mesh-list
93032715|NCT00538733|Lenalidomide|lenalidomide|mesh-list
93032716|NCT00538733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032717|NCT00538733|Antiemetics|antiemetics|mesh-ancestor
93032718|NCT00538733|Autonomic Agents|autonomic agents|mesh-ancestor
93032719|NCT00538733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032720|NCT00538733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032721|NCT00538733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032722|NCT00538733|Glucocorticoids|glucocorticoids|mesh-ancestor
93032723|NCT00538733|Hormones|hormones|mesh-ancestor
93032724|NCT00538733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032725|NCT00538733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93032726|NCT00538733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032727|NCT00538733|Immunologic Factors|immunologic factors|mesh-ancestor
93032728|NCT00538733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93032729|NCT00538733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93032730|NCT00538733|Growth Substances|growth substances|mesh-ancestor
92378326|NCT02025036|Capecitabine|capecitabine|mesh-list
93032731|NCT00538733|Growth Inhibitors|growth inhibitors|mesh-ancestor
93032732|NCT00538733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93032733|NCT00538733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032734|NCT00538733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93032735|NCT00538733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186396|NCT01846455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93032736|NCT00538733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032737|NCT00538733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93032738|NCT00538733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93032739|NCT00538733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032740|NCT00538733|Leprostatic Agents|leprostatic agents|mesh-ancestor
93032741|NCT00444678|Capecitabine|capecitabine|mesh-list
93032742|NCT00444678|Oxaliplatin|oxaliplatin|mesh-list
93032744|NCT00444678|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93032745|NCT00444678|Antimetabolites|antimetabolites|mesh-ancestor
93032746|NCT00444678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032747|NCT00444678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032748|NCT00444678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93032749|NCT00539981|Hemagglutinins|hemagglutinins|mesh-list
93032750|NCT00539981|Immunologic Factors|immunologic factors|mesh-ancestor
93032751|NCT00539981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032752|NCT00539981|Agglutinins|agglutinins|mesh-ancestor
93032753|NCT00539981|Coagulants|coagulants|mesh-ancestor
93032754|NCT00990197|Nicotine|nicotine|mesh-list
93032755|NCT00990197|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93032756|NCT00990197|Autonomic Agents|autonomic agents|mesh-ancestor
93032757|NCT00990197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032758|NCT00990197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032759|NCT00990197|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93032760|NCT00990197|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93032761|NCT00990197|Cholinergic Agents|cholinergic agents|mesh-ancestor
93032762|NCT00990197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032763|NCT00990197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032764|NCT01051011|Metformin|metformin|mesh-list
93032765|NCT01051011|Insulin Glargine|insulin glargine|mesh-list
93032766|NCT01051011|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93032767|NCT01051011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032768|NCT01051011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032769|NCT01051011|Incretins|incretins|mesh-ancestor
93032770|NCT01051011|Hormones|hormones|mesh-ancestor
93032771|NCT01051011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032772|NCT01048827|Busulfan|busulfan|mesh-list
93032773|NCT01048827|Alkylating Agents|alkylating agents|mesh-ancestor
93032774|NCT01048827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032775|NCT01048827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032776|NCT01048827|Immunologic Factors|immunologic factors|mesh-ancestor
93032777|NCT01048827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032778|NCT01048827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93032779|NCT01048827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032780|NCT01048827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93032781|NCT02023463|Leuprolide|leuprolide|mesh-list
93032782|NCT02023463|Goserelin|goserelin|mesh-list
93032783|NCT02023463|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93032784|NCT02023463|Fertility Agents|fertility agents|mesh-ancestor
93032785|NCT02023463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93032786|NCT02023463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032787|NCT02023463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93032788|NCT02023463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032789|NCT01302327|Exenatide|exenatide|mesh-list
93032790|NCT01302327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032791|NCT01302327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032792|NCT01302327|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93032793|NCT01302327|Incretins|incretins|mesh-ancestor
93032794|NCT01302327|Hormones|hormones|mesh-ancestor
93032795|NCT01302327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032796|NCT01048983|Minocycline|minocycline|mesh-list
93032797|NCT01048983|Curcumin|curcumin|mesh-list
93032798|NCT01048983|Modafinil|modafinil|mesh-list
93032799|NCT01048983|Bupropion|bupropion|mesh-list
93032800|NCT01048983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93032801|NCT01048983|Antidepressive Agents|antidepressive agents|mesh-ancestor
93032802|NCT01048983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93032803|NCT01048983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93032804|NCT01048983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93032805|NCT01048983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378408|NCT02417844|Tamsulosin|tamsulosin|mesh-list
93032806|NCT01048983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032807|NCT01048983|Dopamine Agents|dopamine agents|mesh-ancestor
93032808|NCT01048983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032809|NCT01048983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032810|NCT01048983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93032811|NCT01048983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93032812|NCT01048983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032813|NCT01048983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93032814|NCT01048983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032815|NCT01048983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93032816|NCT01048983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93032818|NCT01048983|Sensory System Agents|sensory system agents|mesh-ancestor
93032819|NCT01048983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032820|NCT01048983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032821|NCT01048983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032822|NCT01048983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032823|NCT01048983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93032824|NCT01048983|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92187031|NCT05949762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032825|NCT01048983|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93032826|NCT01048983|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93032827|NCT00990275|Ethanol|ethanol|mesh-list
93032828|NCT00990275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93032829|NCT00990275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032830|NCT00990275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032831|NCT00990275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032832|NCT01340417|Melatonin|melatonin|mesh-list
93032833|NCT01340417|Antioxidants|antioxidants|mesh-ancestor
93032834|NCT01340417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032835|NCT01340417|Protective Agents|protective agents|mesh-ancestor
93032836|NCT01340417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032837|NCT01340417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032838|NCT01049061|Farletuzumab|farletuzumab|mesh-list
93032839|NCT01049061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032840|NCT00367341|Escitalopram|escitalopram|mesh-list
93032841|NCT00367341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93032842|NCT00367341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93032843|NCT00367341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187326|NCT05605093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93032844|NCT00367341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032845|NCT00367341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032846|NCT00367341|Serotonin Agents|serotonin agents|mesh-ancestor
93032847|NCT00367341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032848|NCT01052961|Oseltamivir|oseltamivir|mesh-list
93032849|NCT01052961|Antiviral Agents|antiviral agents|mesh-ancestor
93032850|NCT01052961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032851|NCT01052961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032852|NCT01052961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032853|NCT00440466|Epoetin Alfa|epoetin alfa|mesh-list
93032854|NCT00440466|Hematinics|hematinics|mesh-ancestor
93032856|NCT01051167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93032857|NCT01051167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032858|NCT01325441|Paclitaxel|paclitaxel|mesh-list
93032859|NCT01325441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93032860|NCT01325441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032861|NCT01325441|Tubulin Modulators|tubulin modulators|mesh-ancestor
93032862|NCT01325441|Antimitotic Agents|antimitotic agents|mesh-ancestor
93032863|NCT01325441|Mitosis Modulators|mitosis modulators|mesh-ancestor
93032864|NCT01325441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032865|NCT00616967|Paclitaxel|paclitaxel|mesh-list
93032866|NCT00616967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93032867|NCT00616967|Carboplatin|carboplatin|mesh-list
93032868|NCT00616967|Vorinostat|vorinostat|mesh-list
93032869|NCT00616967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93032870|NCT00616967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032871|NCT00616967|Tubulin Modulators|tubulin modulators|mesh-ancestor
93032872|NCT00616967|Antimitotic Agents|antimitotic agents|mesh-ancestor
93032873|NCT00616967|Mitosis Modulators|mitosis modulators|mesh-ancestor
93032874|NCT00616967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032875|NCT00616967|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93032876|NCT00616967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032877|NCT05360537|Insulin Glargine|insulin glargine|mesh-list
93032878|NCT05360537|Liraglutide|liraglutide|mesh-list
93032879|NCT05360537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032880|NCT05360537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032881|NCT05360537|Incretins|incretins|mesh-ancestor
93032883|NCT05360537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032884|NCT05590637|Pimavanserin|pimavanserin|mesh-list
93032885|NCT05590637|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93032886|NCT05590637|Antidepressive Agents|antidepressive agents|mesh-ancestor
92187802|NCT04750616|Niacin|niacin|mesh-list
93032887|NCT05590637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93032888|NCT05590637|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93032889|NCT05590637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93032890|NCT05590637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032891|NCT05590637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032892|NCT05590637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93032893|NCT05590637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93032894|NCT05590637|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93032895|NCT05590637|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93032896|NCT05590637|Serotonin Agents|serotonin agents|mesh-ancestor
93032897|NCT05590637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93032898|NCT05590637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032899|NCT00989651|Paclitaxel|paclitaxel|mesh-list
93032900|NCT00989651|Bevacizumab|bevacizumab|mesh-list
93032901|NCT00989651|Cisplatin|cisplatin|mesh-list
93032902|NCT00989651|Carboplatin|carboplatin|mesh-list
93032903|NCT00989651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93032904|NCT00989651|Veliparib|veliparib|mesh-list
93032905|NCT00989651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93032906|NCT00989651|Endothelial Growth Factors|endothelial growth factors|mesh-list
93032907|NCT00989651|Antibodies|antibodies|mesh-list
93032908|NCT00989651|Immunoglobulins|immunoglobulins|mesh-list
93032909|NCT00989651|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93032910|NCT00989651|Immunoglobulin G|immunoglobulin g|mesh-list
93032911|NCT00989651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93032912|NCT00989651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032913|NCT00989651|Tubulin Modulators|tubulin modulators|mesh-ancestor
93032914|NCT00989651|Antimitotic Agents|antimitotic agents|mesh-ancestor
93032915|NCT00989651|Mitosis Modulators|mitosis modulators|mesh-ancestor
93032916|NCT00989651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188149|NCT04065399|Cobicistat|cobicistat|mesh-list
93032917|NCT00989651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93032918|NCT00989651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93032919|NCT00989651|Growth Substances|growth substances|mesh-ancestor
93032920|NCT00989651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188216|NCT03901339|Immunoconjugates|immunoconjugates|mesh-ancestor
93032921|NCT00989651|Growth Inhibitors|growth inhibitors|mesh-ancestor
93032922|NCT00989651|Immunologic Factors|immunologic factors|mesh-ancestor
93032923|NCT00989651|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93032924|NCT00989651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032925|NCT05590559|Morphine|morphine|mesh-list
93032926|NCT05590559|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93032927|NCT05590559|Narcotics|narcotics|mesh-ancestor
93032928|NCT05590559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93032929|NCT05590559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032930|NCT05590559|Analgesics|analgesics|mesh-ancestor
93032931|NCT05590559|Sensory System Agents|sensory system agents|mesh-ancestor
93032932|NCT05590559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032933|NCT05590325|Dolutegravir|dolutegravir|mesh-list
93032934|NCT05590325|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93032935|NCT05590325|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93032936|NCT05590325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188498|NCT03112603|Methotrexate|methotrexate|mesh-list
92188567|NCT02752035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032937|NCT05590325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032938|NCT05590325|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93032939|NCT05590325|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93032940|NCT05590325|Antiviral Agents|antiviral agents|mesh-ancestor
93032941|NCT05590325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032942|NCT00989729|Methylprednisolone|methylprednisolone|mesh-list
93032943|NCT00989729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93032944|NCT00989729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93032945|NCT00989729|Prednisolone|prednisolone|mesh-list
93032946|NCT00989729|Prednisolone acetate|prednisolone acetate|mesh-list
93032947|NCT00989729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93032948|NCT00989729|Prednisolone phosphate|prednisolone phosphate|mesh-list
93032949|NCT00989729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93032950|NCT00989729|Antiemetics|antiemetics|mesh-ancestor
93032951|NCT00989729|Autonomic Agents|autonomic agents|mesh-ancestor
93032952|NCT00989729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93032953|NCT00989729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032954|NCT00989729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93032956|NCT00989729|Hormones|hormones|mesh-ancestor
93032957|NCT00989729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93032958|NCT00989729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93032959|NCT00989729|Protective Agents|protective agents|mesh-ancestor
93032960|NCT00989729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93032961|NCT00989729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032962|NCT00989807|Aztreonam|aztreonam|mesh-list
93032963|NCT00989807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93032964|NCT00989807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032965|NCT00990587|Ciclopirox|ciclopirox|mesh-list
93032966|NCT00990587|Antifungal Agents|antifungal agents|mesh-ancestor
93032967|NCT00990587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032968|NCT00537329|Anidulafungin|anidulafungin|mesh-list
93032969|NCT00537329|Antifungal Agents|antifungal agents|mesh-ancestor
93032970|NCT00537329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93032971|NCT03905135|Avelumab|avelumab|mesh-list
93032972|NCT03905135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93032973|NCT03905135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032974|NCT00991055|Pioglitazone|pioglitazone|mesh-list
93032975|NCT00991055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93032976|NCT00991055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032977|NCT00991133|Clofarabine|clofarabine|mesh-list
93032978|NCT00991133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032979|NCT00991133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032980|NCT00991133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92678221|NCT00445575|Risedronic Acid|risedronic acid|mesh-list
93032981|NCT00991133|Antimetabolites|antimetabolites|mesh-ancestor
93032982|NCT00991211|Cyclophosphamide|cyclophosphamide|mesh-list
93032983|NCT00991211|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93032984|NCT00991211|Doxorubicin|doxorubicin|mesh-list
93032985|NCT00991211|Vincristine|vincristine|mesh-list
93032986|NCT00991211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93032987|NCT00991211|Immunologic Factors|immunologic factors|mesh-ancestor
93032988|NCT00991211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93032989|NCT00991211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93032990|NCT00991211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93032991|NCT00991211|Alkylating Agents|alkylating agents|mesh-ancestor
93032992|NCT00991211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93032993|NCT00991211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93032994|NCT00991211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93032995|NCT00991211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93032996|NCT00991211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93032997|NCT00991211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93032998|NCT00991211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93032999|NCT00991211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93033000|NCT00991211|Tubulin Modulators|tubulin modulators|mesh-ancestor
93033001|NCT00991211|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033002|NCT00991211|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033003|NCT00357903|Etanercept|etanercept|mesh-list
93033004|NCT00357903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93033005|NCT00357903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93033006|NCT00357903|Analgesics|analgesics|mesh-ancestor
93033007|NCT00357903|Sensory System Agents|sensory system agents|mesh-ancestor
93033008|NCT00357903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189334|NCT04971187|Cisplatin|cisplatin|mesh-list
93033009|NCT00357903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033010|NCT00357903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033011|NCT00357903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033012|NCT00357903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033013|NCT00357903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93033014|NCT00357903|Immunologic Factors|immunologic factors|mesh-ancestor
93033015|NCT01053039|Morphine|morphine|mesh-list
93033016|NCT01053039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93033017|NCT01053039|Narcotics|narcotics|mesh-ancestor
93033018|NCT01053039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033019|NCT01053039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033020|NCT01053039|Analgesics|analgesics|mesh-ancestor
93033021|NCT01053039|Sensory System Agents|sensory system agents|mesh-ancestor
93033022|NCT01053039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033023|NCT01051401|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93033024|NCT01051401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93033025|NCT01051401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93033026|NCT01051401|Antimetabolites|antimetabolites|mesh-ancestor
93033027|NCT01051401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378621|NCT02486016|Fentanyl|fentanyl|mesh-list
93033028|NCT01051401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93033029|NCT01051401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93033030|NCT01051401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033031|NCT00348933|Vitamin B 12|vitamin b 12|mesh-list
93033032|NCT00348933|Hydroxocobalamin|hydroxocobalamin|mesh-list
93033033|NCT00348933|Betaine|betaine|mesh-list
93033034|NCT00348933|Vitamins|vitamins|mesh-ancestor
93033035|NCT00348933|Micronutrients|micronutrients|mesh-ancestor
93033036|NCT00348933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033037|NCT00348933|Vitamin B Complex|vitamin b complex|mesh-ancestor
93033038|NCT00348933|Hematinics|hematinics|mesh-ancestor
93033039|NCT00348933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033040|NCT00348933|Lipotropic Agents|lipotropic agents|mesh-ancestor
93033041|NCT00348933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93033042|NCT00348933|Antimetabolites|antimetabolites|mesh-ancestor
93033043|NCT00348933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033044|NCT00348933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93033045|NCT01051479|Choline|choline|mesh-list
93033046|NCT01051479|Lipotropic Agents|lipotropic agents|mesh-ancestor
93033047|NCT01051479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93033048|NCT01051479|Antimetabolites|antimetabolites|mesh-ancestor
93033049|NCT01051479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033050|NCT01051479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033051|NCT01051479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93033052|NCT01051479|Nootropic Agents|nootropic agents|mesh-ancestor
93033053|NCT01055691|Metformin|metformin|mesh-list
93033054|NCT01055691|Dapagliflozin|dapagliflozin|mesh-list
93033055|NCT01055691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033056|NCT01055691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033057|NCT01055691|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93033058|NCT01055691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033059|NCT03896477|Vaccines|vaccines|mesh-list
93033060|NCT03896477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93033061|NCT03896477|Immunologic Factors|immunologic factors|mesh-ancestor
93033062|NCT03896477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033063|NCT00444600|Triamcinolone|triamcinolone|mesh-list
93033064|NCT00444600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93033065|NCT00444600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93033066|NCT00444600|Ranibizumab|ranibizumab|mesh-list
93033067|NCT00444600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93033068|NCT00444600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033069|NCT00444600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033070|NCT00444600|Growth Substances|growth substances|mesh-ancestor
93033071|NCT00444600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033072|NCT00444600|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033073|NCT00444600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033074|NCT00444600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033075|NCT00444600|Glucocorticoids|glucocorticoids|mesh-ancestor
93033076|NCT00444600|Hormones|hormones|mesh-ancestor
93033077|NCT00444600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033078|NCT00444600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189665|NCT01390220|Midazolam|midazolam|mesh-list
93033079|NCT00444600|Immunologic Factors|immunologic factors|mesh-ancestor
93033080|NCT00444600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033081|NCT00444600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033082|NCT05357027|Cyclophosphamide|cyclophosphamide|mesh-list
93033083|NCT05357027|Fludarabine|fludarabine|mesh-list
93033084|NCT05357027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93033085|NCT05357027|Immunologic Factors|immunologic factors|mesh-ancestor
93033086|NCT05357027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033087|NCT05357027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033088|NCT05357027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93033089|NCT05357027|Alkylating Agents|alkylating agents|mesh-ancestor
92189799|NCT00398983|Decitabine|decitabine|mesh-list
93033090|NCT05357027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033091|NCT05357027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033092|NCT05357027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93033093|NCT00443898|Terbinafine|terbinafine|mesh-list
93033094|NCT00443898|Antifungal Agents|antifungal agents|mesh-ancestor
92189936|NCT00350363|Gatifloxacin|gatifloxacin|mesh-list
93033095|NCT00443898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033096|NCT00443898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033097|NCT00443898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033098|NCT00537017|Levodopa|levodopa|mesh-list
93033099|NCT00537017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93033100|NCT00537017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93033101|NCT00537017|Dopamine Agents|dopamine agents|mesh-ancestor
93033102|NCT00537017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033103|NCT00537017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033104|NCT00537017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033105|NCT00348309|Rosiglitazone|rosiglitazone|mesh-list
93033106|NCT00348309|Donepezil|donepezil|mesh-list
93033107|NCT00348309|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93033108|NCT00348309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033109|NCT00348309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033110|NCT00348309|Cholinergic Agents|cholinergic agents|mesh-ancestor
93033111|NCT00348309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190082|NCT00403117|Naltrexone|naltrexone|mesh-list
93033112|NCT00348309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033113|NCT00348309|Nootropic Agents|nootropic agents|mesh-ancestor
93033114|NCT00348309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033115|NCT04451837|Dapagliflozin|dapagliflozin|mesh-list
93033116|NCT04451837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93033117|NCT04451837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033118|NCT04451837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033119|NCT04451837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033120|NCT05493683|Tislelizumab|tislelizumab|mesh-list
93033121|NCT05493683|Disitamab vedotin|disitamab vedotin|mesh-list
93033122|NCT05493683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93033123|NCT05493683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033124|NCT05493683|Immunoconjugates|immunoconjugates|mesh-ancestor
93033125|NCT05493683|Immunologic Factors|immunologic factors|mesh-ancestor
93033126|NCT05493683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033127|NCT05440487|Chelating Agents|chelating agents|mesh-list
93033128|NCT05440487|Sequestering Agents|sequestering agents|mesh-ancestor
93033129|NCT05440487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033130|NCT00440310|Talaporfin|talaporfin|mesh-list
93033131|NCT00440310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033132|NCT00440310|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93033133|NCT00440310|Dermatologic Agents|dermatologic agents|mesh-ancestor
93033134|NCT01055847|Aztreonam|aztreonam|mesh-list
93033135|NCT01055847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93033136|NCT01055847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033137|NCT02533791|Vaccines|vaccines|mesh-list
93033138|NCT02533791|Immunologic Factors|immunologic factors|mesh-ancestor
93033139|NCT02533791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033140|NCT05426681|Glyburide|glyburide|mesh-list
93033141|NCT05426681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033142|NCT05426681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033143|NCT01055925|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
93033144|NCT01055925|Laxatives|laxatives|mesh-ancestor
93033145|NCT01055925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033146|NCT00440232|Frovatriptan|frovatriptan|mesh-list
93033147|NCT00440232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93033148|NCT00440232|Serotonin Agents|serotonin agents|mesh-ancestor
93033149|NCT00440232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033150|NCT00440232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033151|NCT00440232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033152|NCT01564199|Fluticasone|fluticasone|mesh-list
93033154|NCT01564199|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93033155|NCT01564199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033156|NCT01564199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93033157|NCT01564199|Autonomic Agents|autonomic agents|mesh-ancestor
93033158|NCT01564199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033159|NCT01564199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033160|NCT01564199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93033161|NCT01564199|Respiratory System Agents|respiratory system agents|mesh-ancestor
93033162|NCT01564199|Dermatologic Agents|dermatologic agents|mesh-ancestor
93033163|NCT01564199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93033164|NCT01564199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93033165|NCT01564199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93033166|NCT01564199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93033167|NCT01564199|Adrenergic Agents|adrenergic agents|mesh-ancestor
93033168|NCT01564199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033169|NCT01564199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033170|NCT02533323|Gemcitabine|gemcitabine|mesh-list
93033171|NCT02533323|Oxaliplatin|oxaliplatin|mesh-list
93033172|NCT02533323|Pegaspargase|pegaspargase|mesh-list
93033173|NCT02533323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93033174|NCT02533323|Antimetabolites|antimetabolites|mesh-ancestor
93033175|NCT02533323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033176|NCT02533323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033177|NCT05379959|Methamphetamine|methamphetamine|mesh-list
93033178|NCT05379959|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93033179|NCT05379959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033180|NCT05379959|Sympathomimetics|sympathomimetics|mesh-ancestor
93033181|NCT05379959|Autonomic Agents|autonomic agents|mesh-ancestor
93033182|NCT05379959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033183|NCT05379959|Dopamine Agents|dopamine agents|mesh-ancestor
93033184|NCT05379959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033185|NCT05379959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033186|NCT05379959|Adrenergic Agents|adrenergic agents|mesh-ancestor
93033187|NCT05379959|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93033188|NCT05379959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93033189|NCT05379959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033190|NCT05379959|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93033191|NCT04791228|Doxorubicin|doxorubicin|mesh-list
93033192|NCT04791228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92190439|NCT00315341|Naloxone|naloxone|mesh-list
93033193|NCT04791228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93033194|NCT04791228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033195|NCT04791228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93033196|NCT04791228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93033197|NCT04791228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190512|NCT01730833|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033198|NCT04791228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033199|NCT05357885|Antibodies|antibodies|mesh-list
93033200|NCT05357885|Immunologic Factors|immunologic factors|mesh-ancestor
93033201|NCT05357885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033202|NCT04003181|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93033203|NCT04003181|Bile Acids and Salts|bile acids and salts|mesh-list
93033204|NCT04003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033205|NCT04003181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033206|NCT00356889|Bevacizumab|bevacizumab|mesh-list
93033207|NCT00356889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93033208|NCT00356889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93033209|NCT00356889|Antibodies|antibodies|mesh-list
93033210|NCT00356889|Immunoglobulins|immunoglobulins|mesh-list
93033211|NCT00356889|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93033212|NCT00356889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678439|NCT00452634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93033213|NCT00356889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033214|NCT00356889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033215|NCT00356889|Growth Substances|growth substances|mesh-ancestor
93033216|NCT00356889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033217|NCT00356889|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033218|NCT00356889|Immunologic Factors|immunologic factors|mesh-ancestor
93033219|NCT00356889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033220|NCT00356889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033221|NCT00356889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033222|NCT05186363|Pyrimethamine|pyrimethamine|mesh-list
93033223|NCT05186363|Sulfadoxine|sulfadoxine|mesh-list
93033224|NCT05186363|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93033225|NCT05186363|Amodiaquine|amodiaquine|mesh-list
93033226|NCT05186363|Antimalarials|antimalarials|mesh-ancestor
92190650|NCT03855371|Decitabine|decitabine|mesh-list
93033227|NCT05186363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93033228|NCT05186363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93033229|NCT05186363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033230|NCT05186363|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92190762|NCT00426283|Xhance|xhance|mesh-list
93033231|NCT05186363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033232|NCT05186363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033233|NCT05186363|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93033234|NCT03742323|Idelalisib|idelalisib|mesh-list
93033235|NCT03742323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033236|NCT03742323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190775|NCT00322439|Analgesics|analgesics|mesh-ancestor
93033237|NCT03742323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033238|NCT04715022|Ascorbic Acid|ascorbic acid|mesh-list
93033239|NCT04715022|Antioxidants|antioxidants|mesh-ancestor
93033240|NCT04715022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033241|NCT04715022|Protective Agents|protective agents|mesh-ancestor
93033242|NCT04715022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033243|NCT04715022|Vitamins|vitamins|mesh-ancestor
93033244|NCT04715022|Micronutrients|micronutrients|mesh-ancestor
93033245|NCT00356811|Paclitaxel|paclitaxel|mesh-list
93033246|NCT00356811|Lapatinib|lapatinib|mesh-list
93033247|NCT00356811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93033248|NCT00356811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033249|NCT00356811|Tubulin Modulators|tubulin modulators|mesh-ancestor
93033250|NCT00356811|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033251|NCT00356811|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033252|NCT00356811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033253|NCT00356811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033254|NCT00356811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033255|NCT00439218|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
93033256|NCT00439218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033257|NCT01030614|Dexamethasone|dexamethasone|mesh-list
93033258|NCT01030614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033259|NCT01030614|Antiemetics|antiemetics|mesh-ancestor
93033260|NCT01030614|Autonomic Agents|autonomic agents|mesh-ancestor
93033261|NCT01030614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033262|NCT01030614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033263|NCT01030614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033264|NCT01030614|Glucocorticoids|glucocorticoids|mesh-ancestor
93033265|NCT01030614|Hormones|hormones|mesh-ancestor
93033266|NCT01030614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033267|NCT01030614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93033268|NCT01030614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033269|NCT01030692|Rivastigmine|rivastigmine|mesh-list
93033270|NCT01030692|Huperzine A|huperzine a|mesh-list
93033271|NCT01030692|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93033272|NCT01030692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033273|NCT01030692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033274|NCT01030692|Cholinergic Agents|cholinergic agents|mesh-ancestor
93033275|NCT01030692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033276|NCT01030692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033277|NCT01030692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93033278|NCT01030692|Protective Agents|protective agents|mesh-ancestor
93033279|NCT03138252|Oxytocin|oxytocin|mesh-list
93033280|NCT03138252|Oxytocics|oxytocics|mesh-ancestor
93033281|NCT03138252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93033282|NCT03138252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033283|NCT04994561|Niacinamide|niacinamide|mesh-list
93033284|NCT04994561|Metformin|metformin|mesh-list
93033285|NCT04994561|Dasatinib|dasatinib|mesh-list
93033286|NCT04994561|Resveratrol|resveratrol|mesh-list
93033287|NCT04994561|Quercetin|quercetin|mesh-list
93033288|NCT04994561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033289|NCT04994561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033290|NCT04994561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033291|NCT04994561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033292|NCT04994561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033293|NCT04994561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033294|NCT04994561|Antioxidants|antioxidants|mesh-ancestor
93033295|NCT04994561|Protective Agents|protective agents|mesh-ancestor
93033296|NCT04994561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93033297|NCT04994561|Vitamin B Complex|vitamin b complex|mesh-ancestor
93033298|NCT04994561|Vitamins|vitamins|mesh-ancestor
93033299|NCT04994561|Micronutrients|micronutrients|mesh-ancestor
93033300|NCT01030770|Ranibizumab|ranibizumab|mesh-list
93033301|NCT01030770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033302|NCT01030770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033303|NCT01030770|Growth Substances|growth substances|mesh-ancestor
93033304|NCT01030770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033305|NCT01030770|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033306|NCT01030770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033307|NCT04941443|Ibuprofen|ibuprofen|mesh-list
93033308|NCT04941443|Methadone|methadone|mesh-list
93033309|NCT04941443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93033310|NCT04941443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93033311|NCT04941443|Analgesics|analgesics|mesh-ancestor
93033312|NCT04941443|Sensory System Agents|sensory system agents|mesh-ancestor
93033313|NCT04941443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033314|NCT04941443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033315|NCT04941443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033316|NCT04941443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033317|NCT04941443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93033318|NCT04941443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033319|NCT04941443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033320|NCT04941443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93033321|NCT04941443|Narcotics|narcotics|mesh-ancestor
93033322|NCT04941443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033324|NCT04941443|Respiratory System Agents|respiratory system agents|mesh-ancestor
93033325|NCT03994692|Ether|ether|mesh-list
93033326|NCT03994692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93033327|NCT03994692|Anesthetics, General|anesthetics, general|mesh-ancestor
93033328|NCT03994692|Anesthetics|anesthetics|mesh-ancestor
93033329|NCT03994692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191070|NCT01424228|Serotonin Agents|serotonin agents|mesh-ancestor
93033330|NCT03994692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033331|NCT01030926|Insulin|insulin|mesh-list
93033332|NCT01030926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93033333|NCT01030926|Insulin Glargine|insulin glargine|mesh-list
93033334|NCT01030926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033335|NCT01030926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033336|NCT00536939|Paclitaxel|paclitaxel|mesh-list
93033337|NCT00536939|Bevacizumab|bevacizumab|mesh-list
93033338|NCT00536939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93033339|NCT00536939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033340|NCT00536939|Tubulin Modulators|tubulin modulators|mesh-ancestor
93033341|NCT00536939|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033342|NCT00536939|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033343|NCT00536939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033344|NCT00536939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93033345|NCT00536939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033346|NCT00536939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033347|NCT00536939|Growth Substances|growth substances|mesh-ancestor
93033348|NCT00536939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033349|NCT00536939|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033350|NCT04597697|Insulin|insulin|mesh-list
93033351|NCT04597697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033352|NCT04597697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033353|NCT00347919|Lapatinib|lapatinib|mesh-list
93033354|NCT00347919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033355|NCT00347919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033356|NCT00347919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033357|NCT00347919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033358|NCT00439140|Botulinum Toxins|botulinum toxins|mesh-list
93033359|NCT00439140|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93033360|NCT00439140|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93033361|NCT00439140|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93033362|NCT00439140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033363|NCT00439140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033364|NCT00439140|Cholinergic Agents|cholinergic agents|mesh-ancestor
93033365|NCT00439140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033366|NCT00439140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033367|NCT00439140|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93033368|NCT00439140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033369|NCT00356421|Insulin|insulin|mesh-list
93033370|NCT00356421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93033371|NCT00356421|Insulin Lispro|insulin lispro|mesh-list
93033372|NCT00356421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033373|NCT00356421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033374|NCT03990129|Dipyrone|dipyrone|mesh-list
93033375|NCT03990129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93033376|NCT03990129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93033377|NCT03990129|Analgesics|analgesics|mesh-ancestor
93033378|NCT03990129|Sensory System Agents|sensory system agents|mesh-ancestor
93033379|NCT03990129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033380|NCT03990129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033381|NCT03990129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033382|NCT03990129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033383|NCT03990129|Antipyretics|antipyretics|mesh-ancestor
93033384|NCT01051947|Metoprolol|metoprolol|mesh-list
93033385|NCT01051947|Nebivolol|nebivolol|mesh-list
93033386|NCT01051947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93033387|NCT01051947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93033388|NCT01051947|Sympatholytics|sympatholytics|mesh-ancestor
93033389|NCT01051947|Autonomic Agents|autonomic agents|mesh-ancestor
93033390|NCT01051947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033391|NCT01051947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033392|NCT01051947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93033394|NCT01051947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93033395|NCT01051947|Adrenergic Agents|adrenergic agents|mesh-ancestor
93033396|NCT01051947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033397|NCT01051947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033398|NCT01051947|Vasodilator Agents|vasodilator agents|mesh-ancestor
93033399|NCT01051947|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93033400|NCT01051947|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93033401|NCT01051947|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93033402|NCT01052025|Curcumin|curcumin|mesh-list
93033403|NCT01052025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93033404|NCT01052025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93033405|NCT01052025|Analgesics|analgesics|mesh-ancestor
93033406|NCT01052025|Sensory System Agents|sensory system agents|mesh-ancestor
93033407|NCT01052025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033408|NCT01052025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033409|NCT01052025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033410|NCT01052025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033411|NCT01052025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033412|NCT01052025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033413|NCT01052025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033414|NCT00443820|Terbinafine|terbinafine|mesh-list
93033415|NCT00443820|Antifungal Agents|antifungal agents|mesh-ancestor
93033416|NCT00443820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033417|NCT00443820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033418|NCT00443820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033419|NCT00438672|Dexamethasone|dexamethasone|mesh-list
93033420|NCT00438672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033421|NCT00438672|Antiemetics|antiemetics|mesh-ancestor
93033422|NCT00438672|Autonomic Agents|autonomic agents|mesh-ancestor
93033423|NCT00438672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033424|NCT00438672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033425|NCT00438672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033426|NCT00438672|Glucocorticoids|glucocorticoids|mesh-ancestor
93033427|NCT00438672|Hormones|hormones|mesh-ancestor
93033428|NCT00438672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033429|NCT00438672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93033430|NCT00438672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033431|NCT00438360|Cyclosporine|cyclosporine|mesh-list
93033432|NCT00438360|Cyclosporins|cyclosporins|mesh-list
93033433|NCT00438360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033434|NCT00438360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033435|NCT00438360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93033436|NCT00438360|Immunologic Factors|immunologic factors|mesh-ancestor
93033437|NCT00438360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033438|NCT00438360|Antifungal Agents|antifungal agents|mesh-ancestor
93033439|NCT00438360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033440|NCT00438360|Dermatologic Agents|dermatologic agents|mesh-ancestor
93033441|NCT00438360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033442|NCT00438360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93033443|NCT00536471|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93033444|NCT00536471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93033445|NCT00536471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93033446|NCT00536471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033447|NCT00536471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033448|NCT00536471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033449|NCT00536471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033450|NCT00536471|Analgesics|analgesics|mesh-ancestor
93033451|NCT00536471|Sensory System Agents|sensory system agents|mesh-ancestor
93033452|NCT00536471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033453|NCT00536471|Antidepressive Agents|antidepressive agents|mesh-ancestor
93033454|NCT00536471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93033455|NCT00536471|Dopamine Agents|dopamine agents|mesh-ancestor
93033456|NCT00437658|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93033457|NCT00437658|Medroxyprogesterone|medroxyprogesterone|mesh-list
93033458|NCT00437658|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93033459|NCT00437658|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93033460|NCT00437658|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93033461|NCT00437658|Contraceptive Agents|contraceptive agents|mesh-ancestor
93033462|NCT00437658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93033463|NCT00437658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033464|NCT00437658|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93033465|NCT00437658|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93033466|NCT00437658|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93033467|NCT00437658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93033468|NCT00437658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033469|NCT04002635|Letrozole|letrozole|mesh-list
93033470|NCT04002635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93033471|NCT04002635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93033472|NCT04002635|Estradiol|estradiol|mesh-list
93033473|NCT04002635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93033474|NCT04002635|Progesterone|progesterone|mesh-list
93033475|NCT04002635|Estrogens|estrogens|mesh-ancestor
93033476|NCT04002635|Hormones|hormones|mesh-ancestor
92191536|NCT00386243|Analgesics|analgesics|mesh-list
93033477|NCT04002635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033478|NCT04002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033479|NCT04002635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93033480|NCT04002635|Contraceptive Agents|contraceptive agents|mesh-ancestor
93033481|NCT04002635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93033482|NCT04002635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93033483|NCT04002635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033484|NCT04002635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93033485|NCT04002635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93033486|NCT04002635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033487|NCT04002635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033488|NCT04002635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93033489|NCT04002635|Hormone Antagonists|hormone antagonists|mesh-ancestor
93033490|NCT04002635|Progestins|progestins|mesh-ancestor
93033491|NCT01052181|Cholecalciferol|cholecalciferol|mesh-list
93033492|NCT01052181|Vitamin D|vitamin d|mesh-list
93033493|NCT01052181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93033494|NCT01052181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033495|NCT01052181|Vitamins|vitamins|mesh-ancestor
93033496|NCT01052181|Micronutrients|micronutrients|mesh-ancestor
93033497|NCT01052181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93033498|NCT01056237|Mycophenolic Acid|mycophenolic acid|mesh-list
93033499|NCT01056237|Azathioprine|azathioprine|mesh-list
93033500|NCT01056237|Tacrolimus|tacrolimus|mesh-list
93033501|NCT01056237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93033502|NCT01056237|Immunologic Factors|immunologic factors|mesh-ancestor
93033503|NCT01056237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033504|NCT01056237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93033505|NCT01056237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033506|NCT01056237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033507|NCT01056237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93033508|NCT01056237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033509|NCT01056237|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93033510|NCT01056237|Antitubercular Agents|antitubercular agents|mesh-ancestor
93033511|NCT01056237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191868|NCT01381562|Meropenem|meropenem|mesh-list
93033512|NCT01056237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033513|NCT01056237|Antimetabolites|antimetabolites|mesh-ancestor
93033514|NCT01056237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93033515|NCT01056237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93033516|NCT02533557|Lidocaine|lidocaine|mesh-list
93033517|NCT02533557|Epinephrine|epinephrine|mesh-list
93033518|NCT02533557|Racepinephrine|racepinephrine|mesh-list
93033519|NCT02533557|Epinephryl borate|epinephryl borate|mesh-list
93033520|NCT02533557|Anesthetics, Local|anesthetics, local|mesh-ancestor
93033521|NCT02533557|Anesthetics|anesthetics|mesh-ancestor
93033522|NCT02533557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033523|NCT02533557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033524|NCT02533557|Sensory System Agents|sensory system agents|mesh-ancestor
93033525|NCT02533557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033526|NCT02533557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93033527|NCT02533557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93033528|NCT02533557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93033529|NCT02533557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033530|NCT02533557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033531|NCT02533557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93033532|NCT02533557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93033533|NCT02533557|Adrenergic Agents|adrenergic agents|mesh-ancestor
93033534|NCT02533557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033535|NCT02533557|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93033536|NCT02533557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93033537|NCT02533557|Autonomic Agents|autonomic agents|mesh-ancestor
93033538|NCT02533557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93033539|NCT02533557|Respiratory System Agents|respiratory system agents|mesh-ancestor
93033540|NCT02533557|Mydriatics|mydriatics|mesh-ancestor
93033541|NCT02533557|Sympathomimetics|sympathomimetics|mesh-ancestor
93033542|NCT02533557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93033543|NCT00356265|Phenylephrine|phenylephrine|mesh-list
93033544|NCT00356265|Oxymetazoline|oxymetazoline|mesh-list
93033545|NCT00356265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93033546|NCT00356265|Mydriatics|mydriatics|mesh-ancestor
93033547|NCT00356265|Autonomic Agents|autonomic agents|mesh-ancestor
93033548|NCT00356265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033549|NCT00356265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033550|NCT00356265|Sympathomimetics|sympathomimetics|mesh-ancestor
93033551|NCT00356265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93033552|NCT00356265|Nasal Decongestants|nasal decongestants|mesh-ancestor
93033553|NCT00356265|Respiratory System Agents|respiratory system agents|mesh-ancestor
93033554|NCT00356265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93033555|NCT00356265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93033556|NCT00356265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93033557|NCT00356265|Adrenergic Agents|adrenergic agents|mesh-ancestor
93033558|NCT00356265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033559|NCT00356265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033560|NCT00356265|Protective Agents|protective agents|mesh-ancestor
93033561|NCT01052259|Gusperimus|gusperimus|mesh-list
93033562|NCT01052259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93033563|NCT01052259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033564|NCT01052259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033565|NCT01052259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033566|NCT01052259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93033567|NCT01052259|Immunologic Factors|immunologic factors|mesh-ancestor
93033568|NCT01052259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93033569|NCT01052259|Protective Agents|protective agents|mesh-ancestor
93033570|NCT01056549|Exenatide|exenatide|mesh-list
93033571|NCT01056549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033572|NCT01056549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033573|NCT01056549|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93033574|NCT01056549|Incretins|incretins|mesh-ancestor
93033575|NCT01056549|Hormones|hormones|mesh-ancestor
93033576|NCT01056549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033577|NCT01052337|Anesthetics|anesthetics|mesh-list
93033578|NCT01052337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033579|NCT01052337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033580|NCT00535145|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93033581|NCT00535145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93033582|NCT00535145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93033583|NCT00535145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033584|NCT00535145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033585|NCT00535145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93033586|NCT00535145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93033587|NCT00535145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93033588|NCT00535145|Serotonin Agents|serotonin agents|mesh-ancestor
93033589|NCT00535145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678825|NCT00344552|Paclitaxel|paclitaxel|mesh-list
93033590|NCT00535145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033591|NCT00535145|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93033592|NCT00535145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93033593|NCT00535145|Dopamine Agents|dopamine agents|mesh-ancestor
93033594|NCT01056627|Valproic Acid|valproic acid|mesh-list
93033595|NCT01056627|Anticonvulsants|anticonvulsants|mesh-ancestor
93033596|NCT01056627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033597|NCT01056627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033598|NCT01056627|GABA Agents|gaba agents|mesh-ancestor
93033599|NCT01056627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033600|NCT01056627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033601|NCT01056627|Antimanic Agents|antimanic agents|mesh-ancestor
93033602|NCT01056627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93033603|NCT01056627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033604|NCT01056627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93033605|NCT04273061|Atezolizumab|atezolizumab|mesh-list
93033606|NCT04273061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93033607|NCT04273061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033608|NCT04273061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93033609|NCT04273061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033610|NCT01053585|Baclofen|baclofen|mesh-list
93033611|NCT01053585|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93033612|NCT01053585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033614|NCT01053585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033615|NCT01053585|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93033616|NCT01053585|GABA Agonists|gaba agonists|mesh-ancestor
93033617|NCT01053585|GABA Agents|gaba agents|mesh-ancestor
93033618|NCT01053585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033619|NCT01053585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033620|NCT01564355|Triamcinolone|triamcinolone|mesh-list
93033621|NCT01564355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93033622|NCT01564355|Glucocorticoids|glucocorticoids|mesh-ancestor
93033623|NCT01564355|Hormones|hormones|mesh-ancestor
93033624|NCT01564355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033625|NCT01564355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033626|NCT01056705|Vaccines|vaccines|mesh-list
93033627|NCT01056705|Immunologic Factors|immunologic factors|mesh-ancestor
93033628|NCT01056705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033629|NCT00437268|Irinotecan|irinotecan|mesh-list
93033630|NCT00437268|Cetuximab|cetuximab|mesh-list
93033631|NCT00437268|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93033632|NCT00437268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93033633|NCT00437268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033634|NCT00437268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033635|NCT00437268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033636|NCT00437268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93033637|NCT04002089|Bupivacaine|bupivacaine|mesh-list
93033638|NCT04002089|Anesthetics, Local|anesthetics, local|mesh-ancestor
93033639|NCT04002089|Anesthetics|anesthetics|mesh-ancestor
93033640|NCT04002089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033641|NCT04002089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192564|NCT01796093|Digoxin|digoxin|mesh-list
93033642|NCT04002089|Sensory System Agents|sensory system agents|mesh-ancestor
93033643|NCT04002089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033644|NCT04002245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
93033645|NCT04002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033646|NCT01056861|Botulinum Toxins|botulinum toxins|mesh-list
93033647|NCT01056861|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93033648|NCT01056861|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92192647|NCT03595514|Mydriatics|mydriatics|mesh-ancestor
93033649|NCT01056861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93033650|NCT01056861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033651|NCT01056861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033652|NCT01056861|Cholinergic Agents|cholinergic agents|mesh-ancestor
92192746|NCT00490477|Polymyxins|polymyxins|mesh-list
93033653|NCT01056861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033654|NCT01056861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033655|NCT01056861|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93033656|NCT01056861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033657|NCT05355467|Tenofovir|tenofovir|mesh-list
93033658|NCT05355467|Antiviral Agents|antiviral agents|mesh-ancestor
93033659|NCT05355467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033660|NCT05355467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92192813|NCT05630222|Morphine|morphine|mesh-list
93033661|NCT05355467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93033662|NCT05355467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678901|NCT00448149|Everolimus|everolimus|mesh-list
93033663|NCT05355467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033664|NCT05355467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92192856|NCT03590210|Nivolumab|nivolumab|mesh-list
93033665|NCT05355467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93033667|NCT04139525|Calcium heparin|calcium heparin|mesh-list
93033668|NCT04139525|Citric Acid|citric acid|mesh-list
93033669|NCT04139525|Sodium Citrate|sodium citrate|mesh-list
93033670|NCT04139525|Anticoagulants|anticoagulants|mesh-ancestor
93033671|NCT04139525|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93033672|NCT04139525|Chelating Agents|chelating agents|mesh-ancestor
93033673|NCT04139525|Sequestering Agents|sequestering agents|mesh-ancestor
93033674|NCT04139525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033675|NCT04139525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93033676|NCT04139525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93033677|NCT00437034|Aflibercept|aflibercept|mesh-list
93033678|NCT00437034|Endothelial Growth Factors|endothelial growth factors|mesh-list
93033679|NCT00437034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033680|NCT00437034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033681|NCT00437034|Growth Substances|growth substances|mesh-ancestor
93033682|NCT00437034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192991|NCT05631704|Anesthetics|anesthetics|mesh-ancestor
93033683|NCT00437034|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033684|NCT00437034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033685|NCT00337467|Ritonavir|ritonavir|mesh-list
93033686|NCT00337467|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92193056|NCT03590912|Glucocorticoids|glucocorticoids|mesh-ancestor
93033687|NCT00337467|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93033688|NCT00337467|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93033689|NCT00337467|Protease Inhibitors|protease inhibitors|mesh-ancestor
93033690|NCT00337467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033691|NCT00337467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033692|NCT00337467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93033693|NCT00337467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93033694|NCT00337467|Antiviral Agents|antiviral agents|mesh-ancestor
92193127|NCT01013779|Carboplatin|carboplatin|mesh-list
93033695|NCT00337467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033696|NCT00337467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93033697|NCT00337467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93033698|NCT00428220|Sunitinib|sunitinib|mesh-list
93033699|NCT00428220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033700|NCT00428220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033701|NCT00428220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033702|NCT00428220|Growth Substances|growth substances|mesh-ancestor
93033703|NCT00428220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033704|NCT00428220|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033705|NCT00428220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033706|NCT00428220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033707|NCT00428220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033708|NCT01057329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93033709|NCT01057329|Olanzapine|olanzapine|mesh-list
93033710|NCT01057329|Aripiprazole|aripiprazole|mesh-list
93033711|NCT01057329|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93033712|NCT01057329|Antiemetics|antiemetics|mesh-ancestor
93033713|NCT01057329|Autonomic Agents|autonomic agents|mesh-ancestor
93033714|NCT01057329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033715|NCT01057329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033716|NCT01057329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033717|NCT01057329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92193411|NCT00509665|Gemcitabine|gemcitabine|mesh-list
93033718|NCT01057329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93033719|NCT01057329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033720|NCT01057329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93033721|NCT01057329|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93033722|NCT01057329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93033723|NCT01057329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033724|NCT01057329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033725|NCT01057329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033726|NCT01057329|Serotonin Agents|serotonin agents|mesh-ancestor
93033727|NCT01057329|Antidepressive Agents|antidepressive agents|mesh-ancestor
93033728|NCT01057329|Dopamine Agonists|dopamine agonists|mesh-ancestor
93033729|NCT01057329|Dopamine Agents|dopamine agents|mesh-ancestor
93033730|NCT01057329|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93033731|NCT01057329|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93033732|NCT01057329|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93033733|NCT01057329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93033734|NCT01057329|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93033735|NCT01057329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93033736|NCT01057329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93033737|NCT01057329|Analgesics|analgesics|mesh-ancestor
93033738|NCT01057329|Sensory System Agents|sensory system agents|mesh-ancestor
93033739|NCT01057329|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93033740|NCT01057329|Adrenergic Agents|adrenergic agents|mesh-ancestor
93033741|NCT01057407|Sevelamer|sevelamer|mesh-list
93033742|NCT01057407|Chelating Agents|chelating agents|mesh-ancestor
93033743|NCT01057407|Sequestering Agents|sequestering agents|mesh-ancestor
93033744|NCT01057407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033745|NCT02873975|Prexasertib|prexasertib|mesh-list
93033746|NCT02873975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033747|NCT02873975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033748|NCT02873975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033749|NCT01057563|Paclitaxel|paclitaxel|mesh-list
93033750|NCT01057563|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93033751|NCT01057563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92193757|NCT04028024|Urinastatin|urinastatin|mesh-list
93033752|NCT01057563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033753|NCT01057563|Tubulin Modulators|tubulin modulators|mesh-ancestor
93033754|NCT01057563|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033755|NCT01057563|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033756|NCT01057563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033757|NCT00345579|PENTA|penta|mesh-list
93033758|NCT00345579|Anticoagulants|anticoagulants|mesh-ancestor
93033759|NCT00345579|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93033760|NCT00345579|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93033761|NCT00345579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033762|NCT04002323|Lamivudine|lamivudine|mesh-list
93033763|NCT04002323|Dolutegravir|dolutegravir|mesh-list
93033764|NCT04002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93033765|NCT04002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93033766|NCT04002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033767|NCT04002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033768|NCT04002323|Antiviral Agents|antiviral agents|mesh-ancestor
93033769|NCT04002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033770|NCT04002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93033771|NCT04002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93033772|NCT04002323|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93033773|NCT04002323|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93033774|NCT04001855|Acetic Acid|acetic acid|mesh-list
93033775|NCT04001855|Retinol acetate|retinol acetate|mesh-list
93033776|NCT04001855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93033777|NCT04001855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033778|NCT04001855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93033779|NCT04001855|Immunologic Factors|immunologic factors|mesh-ancestor
93033780|NCT04001855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033781|NCT04001855|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93033782|NCT04001855|Protective Agents|protective agents|mesh-ancestor
93033783|NCT04001855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033784|NCT00335829|Bevacizumab|bevacizumab|mesh-list
93033785|NCT00335829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93033786|NCT00335829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033787|NCT00335829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93033788|NCT00335829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93033789|NCT00335829|Growth Substances|growth substances|mesh-ancestor
92194247|NCT03988387|Tenofovir|tenofovir|mesh-list
93033790|NCT00335829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033791|NCT00335829|Growth Inhibitors|growth inhibitors|mesh-ancestor
93033792|NCT02533011|Heparin|heparin|mesh-list
93033793|NCT02533011|Anticoagulants|anticoagulants|mesh-ancestor
93033794|NCT02533011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93033795|NCT02533011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93033796|NCT02533011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033797|NCT05262257|Metformin|metformin|mesh-list
93033798|NCT05262257|Dapagliflozin|dapagliflozin|mesh-list
93033799|NCT05262257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194462|NCT00452387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93033800|NCT05262257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033801|NCT05262257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93033802|NCT05262257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033803|NCT03989817|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
93033804|NCT03989817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93033805|NCT03989817|Vasodilator Agents|vasodilator agents|mesh-ancestor
93033806|NCT03989817|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93033807|NCT03989817|Protective Agents|protective agents|mesh-ancestor
93033808|NCT03989817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033809|NCT01059123|Amoxicillin|amoxicillin|mesh-list
93033810|NCT01059123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93033811|NCT01059123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033812|NCT03986385|Capecitabine|capecitabine|mesh-list
93033813|NCT03986385|Oxaliplatin|oxaliplatin|mesh-list
93033814|NCT03986385|Apatinib|apatinib|mesh-list
93033815|NCT03986385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93033816|NCT03986385|Antimetabolites|antimetabolites|mesh-ancestor
93033817|NCT03986385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033818|NCT03986385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033819|NCT03986385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93033820|NCT03986385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033821|NCT00344019|Atorvastatin|atorvastatin|mesh-list
93033822|NCT00344019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93033823|NCT00344019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93033824|NCT00344019|Antimetabolites|antimetabolites|mesh-ancestor
93033825|NCT00344019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033826|NCT00344019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93033827|NCT00344019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93033828|NCT00344019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033829|NCT00535847|Interferons|interferons|mesh-list
93033830|NCT00535847|Ribavirin|ribavirin|mesh-list
93033831|NCT00535847|Interferon-alpha|interferon-alpha|mesh-list
93033832|NCT00535847|Interferon alpha-2|interferon alpha-2|mesh-list
93033833|NCT00535847|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93033834|NCT00535847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033835|NCT00535847|Antiviral Agents|antiviral agents|mesh-ancestor
92194960|NCT01796951|Analgesics|analgesics|mesh-ancestor
93033836|NCT00535847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033837|NCT00535847|Antimetabolites|antimetabolites|mesh-ancestor
93033838|NCT00535847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033839|NCT00535847|Immunologic Factors|immunologic factors|mesh-ancestor
93033840|NCT00535847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033841|NCT03606785|Tranexamic Acid|tranexamic acid|mesh-list
93033842|NCT03606785|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93033843|NCT03606785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93033844|NCT03606785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033845|NCT03606785|Hemostatics|hemostatics|mesh-ancestor
93033846|NCT03606785|Coagulants|coagulants|mesh-ancestor
93033847|NCT05356169|Venetoclax|venetoclax|mesh-list
93033848|NCT05356169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033849|NCT01057875|Caffeine|caffeine|mesh-list
93033850|NCT01057875|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93033851|NCT01057875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033852|NCT01057875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93033853|NCT01057875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033854|NCT01057875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033855|NCT01057875|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93033856|NCT01057875|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93033857|NCT01057875|Purinergic Agents|purinergic agents|mesh-ancestor
93033858|NCT01057875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033859|NCT04001387|Anesthetics|anesthetics|mesh-list
93033860|NCT04001387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033861|NCT04001387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033862|NCT00334737|Epoetin Alfa|epoetin alfa|mesh-list
93033863|NCT00334737|Darbepoetin alfa|darbepoetin alfa|mesh-list
93033864|NCT00334737|Hematinics|hematinics|mesh-ancestor
93033865|NCT03986073|Linagliptin|linagliptin|mesh-list
92195236|NCT00609739|Cytarabine|cytarabine|mesh-list
93033866|NCT03986073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033867|NCT03986073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033868|NCT03986073|Incretins|incretins|mesh-ancestor
93033869|NCT03986073|Hormones|hormones|mesh-ancestor
93033870|NCT03986073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93033871|NCT03986073|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93033872|NCT03986073|Protease Inhibitors|protease inhibitors|mesh-ancestor
93033873|NCT03986073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033874|NCT03986073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033875|NCT05347199|Amisulpride|amisulpride|mesh-list
93033876|NCT05347199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93033877|NCT05347199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93033878|NCT05347199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033879|NCT05347199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033880|NCT05347199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93033881|NCT05347199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93033882|NCT05347199|Dopamine Agents|dopamine agents|mesh-ancestor
93033883|NCT05347199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033884|NCT05347199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033885|NCT05347199|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93033886|NCT05347199|Antidepressive Agents|antidepressive agents|mesh-ancestor
93033887|NCT01060137|Fentanyl|fentanyl|mesh-list
93033888|NCT01060137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93033889|NCT01060137|Narcotics|narcotics|mesh-ancestor
93033890|NCT01060137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033891|NCT01060137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033892|NCT01060137|Analgesics|analgesics|mesh-ancestor
93033893|NCT01060137|Sensory System Agents|sensory system agents|mesh-ancestor
93033894|NCT01060137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033895|NCT01060137|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93033896|NCT01060137|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93033897|NCT01060137|Anesthetics, General|anesthetics, general|mesh-ancestor
93033898|NCT01060137|Anesthetics|anesthetics|mesh-ancestor
93033899|NCT01058109|Calcium, Dietary|calcium, dietary|mesh-list
93033900|NCT01058109|Calcium|calcium|mesh-list
93033901|NCT01058109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93033902|NCT01058109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033903|NCT01058109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93033904|NCT00992069|Efavirenz|efavirenz|mesh-list
93033905|NCT00992069|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93033906|NCT00992069|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93033907|NCT00992069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529114|NCT00015210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93033908|NCT00992069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033910|NCT00992069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033911|NCT00992069|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93033912|NCT00992069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92195727|NCT03583424|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033913|NCT00992069|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93033914|NCT00992069|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93033915|NCT00992069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93033916|NCT00992069|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93033917|NCT01060293|Dopamine|dopamine|mesh-list
93033918|NCT01060293|Furosemide|furosemide|mesh-list
93033919|NCT01060293|Diuretics|diuretics|mesh-ancestor
93033920|NCT01060293|Natriuretic Agents|natriuretic agents|mesh-ancestor
93033921|NCT01060293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033922|NCT01060293|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93033923|NCT01060293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93033924|NCT01060293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033925|NCT01060293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93033926|NCT01060293|Sympathomimetics|sympathomimetics|mesh-ancestor
93033927|NCT01060293|Autonomic Agents|autonomic agents|mesh-ancestor
93033928|NCT01060293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033929|NCT01060293|Dopamine Agents|dopamine agents|mesh-ancestor
93033930|NCT01060293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033931|NCT01060293|Protective Agents|protective agents|mesh-ancestor
93033932|NCT05343767|Metformin|metformin|mesh-list
93033933|NCT05343767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93033934|NCT05343767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033935|NCT01054677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93033936|NCT01054677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033937|NCT03989037|Carboplatin|carboplatin|mesh-list
93033938|NCT03989037|Docetaxel|docetaxel|mesh-list
93033939|NCT03989037|Trastuzumab|trastuzumab|mesh-list
93033940|NCT03989037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033941|NCT03989037|Tubulin Modulators|tubulin modulators|mesh-ancestor
93033942|NCT03989037|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033943|NCT03989037|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033944|NCT03989037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033945|NCT03989037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93033946|NCT00416598|Cytarabine|cytarabine|mesh-list
93033947|NCT00416598|Etoposide|etoposide|mesh-list
93033948|NCT00416598|Podophyllotoxin|podophyllotoxin|mesh-list
93033949|NCT00416598|Daunorubicin|daunorubicin|mesh-list
93033950|NCT00416598|Etoposide phosphate|etoposide phosphate|mesh-list
93033951|NCT00416598|Busulfan|busulfan|mesh-list
93033952|NCT00416598|Decitabine|decitabine|mesh-list
93033953|NCT00416598|Lenograstim|lenograstim|mesh-list
93033954|NCT00416598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93033955|NCT00416598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93033956|NCT00416598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93033957|NCT00416598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93033958|NCT00416598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93033959|NCT00416598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033960|NCT00416598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93033961|NCT00416598|Antimetabolites|antimetabolites|mesh-ancestor
93033962|NCT00416598|Antiviral Agents|antiviral agents|mesh-ancestor
93033963|NCT00416598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93033964|NCT00416598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93033965|NCT00416598|Immunologic Factors|immunologic factors|mesh-ancestor
93033966|NCT00416598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033967|NCT00416598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93033968|NCT00416598|Alkylating Agents|alkylating agents|mesh-ancestor
93033969|NCT00416598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93033970|NCT00416598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93033971|NCT00416598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93033972|NCT00416598|Keratolytic Agents|keratolytic agents|mesh-ancestor
93033973|NCT00416598|Dermatologic Agents|dermatologic agents|mesh-ancestor
93033974|NCT00416598|Tubulin Modulators|tubulin modulators|mesh-ancestor
93033975|NCT00416598|Antimitotic Agents|antimitotic agents|mesh-ancestor
93033976|NCT00416598|Mitosis Modulators|mitosis modulators|mesh-ancestor
93033977|NCT00534599|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93033978|NCT00534599|Antidepressive Agents|antidepressive agents|mesh-ancestor
93033979|NCT00534599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93033980|NCT00534599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93033981|NCT00534599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92379582|NCT05150652|Letrozole|letrozole|mesh-list
93033982|NCT00534599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93033983|NCT00534599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033985|NCT04001465|Miotics|miotics|mesh-ancestor
93033986|NCT04001465|Autonomic Agents|autonomic agents|mesh-ancestor
93033987|NCT04001465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93033988|NCT04001465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93033989|NCT04001465|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93033990|NCT04001465|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
93033991|NCT04001465|Respiratory System Agents|respiratory system agents|mesh-ancestor
93033992|NCT04001465|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93033993|NCT04001465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93033994|NCT04001465|Cholinergic Agents|cholinergic agents|mesh-ancestor
93033995|NCT04001465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93033996|NCT04001465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93033997|NCT00992381|Naproxen|naproxen|mesh-list
92196483|NCT03158246|Calcium|calcium|mesh-list
93033998|NCT00992381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93033999|NCT00992381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034000|NCT00992381|Analgesics|analgesics|mesh-ancestor
93034001|NCT00992381|Sensory System Agents|sensory system agents|mesh-ancestor
93034002|NCT00992381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034003|NCT00992381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034004|NCT00992381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034005|NCT00992381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034006|NCT00992381|Gout Suppressants|gout suppressants|mesh-ancestor
93034007|NCT00992381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93034008|NCT00992381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034009|NCT00992381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034010|NCT00992537|Insulin|insulin|mesh-list
93034011|NCT00992537|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93034012|NCT00992537|Insulin Aspart|insulin aspart|mesh-list
93034013|NCT00992537|Insulin, Long-Acting|insulin, long-acting|mesh-list
93034014|NCT00992537|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93034015|NCT00992537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93034016|NCT00992537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034017|NCT00992693|Ribavirin|ribavirin|mesh-list
93034018|NCT00992693|Antimetabolites|antimetabolites|mesh-ancestor
93034019|NCT00992693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034020|NCT00992693|Antiviral Agents|antiviral agents|mesh-ancestor
93034021|NCT00992693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034022|NCT00992771|Varenicline|varenicline|mesh-list
93034023|NCT00992771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93034024|NCT00992771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93034025|NCT00992771|Cholinergic Agents|cholinergic agents|mesh-ancestor
93034026|NCT00992771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034027|NCT00992771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034028|NCT00992771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034029|NCT00992849|Bevacizumab|bevacizumab|mesh-list
93034030|NCT00992849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034031|NCT00992849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034032|NCT00992849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034033|NCT00992849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034034|NCT00992849|Growth Substances|growth substances|mesh-ancestor
93034035|NCT00992849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034036|NCT00992849|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034037|NCT04001231|Exenatide|exenatide|mesh-list
93034038|NCT04001231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93034039|NCT04001231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034040|NCT04001231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93034041|NCT04001231|Incretins|incretins|mesh-ancestor
93034042|NCT04001231|Hormones|hormones|mesh-ancestor
93034043|NCT04001231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034044|NCT03892889|Aripiprazole|aripiprazole|mesh-list
92196640|NCT03156920|Sumatriptan|sumatriptan|mesh-list
93034045|NCT03892889|Antidepressive Agents|antidepressive agents|mesh-ancestor
93034046|NCT03892889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034047|NCT03892889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93034048|NCT03892889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93034049|NCT03892889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93034050|NCT03892889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034051|NCT03892889|Dopamine Agonists|dopamine agonists|mesh-ancestor
93034052|NCT03892889|Dopamine Agents|dopamine agents|mesh-ancestor
93034053|NCT03892889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034054|NCT03892889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379655|NCT02369406|Antiviral Agents|antiviral agents|mesh-ancestor
93034055|NCT03892889|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93034056|NCT03892889|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93034058|NCT03892889|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93034059|NCT03892889|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93034060|NCT03892889|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93034061|NCT03892889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93034062|NCT00993707|Hyaluronic Acid|hyaluronic acid|mesh-list
93034063|NCT00993707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93034064|NCT00993707|Immunologic Factors|immunologic factors|mesh-ancestor
92196933|NCT04120766|Vitamins|vitamins|mesh-ancestor
93034065|NCT00993707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034066|NCT00993707|Viscosupplements|viscosupplements|mesh-ancestor
93034067|NCT00993707|Protective Agents|protective agents|mesh-ancestor
93034068|NCT00473330|Ranibizumab|ranibizumab|mesh-list
93034069|NCT00473330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034070|NCT00473330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034071|NCT00473330|Growth Substances|growth substances|mesh-ancestor
93034072|NCT00473330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034073|NCT00473330|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034074|NCT00473330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034075|NCT00416520|Sevelamer|sevelamer|mesh-list
93034076|NCT00416520|Chelating Agents|chelating agents|mesh-ancestor
93034077|NCT00416520|Sequestering Agents|sequestering agents|mesh-ancestor
93034078|NCT00416520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034079|NCT00533429|Bevacizumab|bevacizumab|mesh-list
93034080|NCT00533429|Carboplatin|carboplatin|mesh-list
93034081|NCT00533429|Pemetrexed|pemetrexed|mesh-list
93034082|NCT00533429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034083|NCT00533429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034084|NCT00533429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034085|NCT00533429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92197136|NCT02115074|Celecoxib|celecoxib|mesh-list
93034086|NCT00533429|Growth Substances|growth substances|mesh-ancestor
93034087|NCT00533429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034088|NCT00533429|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034089|NCT00533429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034090|NCT00533429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034091|NCT00533429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93034092|NCT00533429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034093|NCT01034124|Vitamin K|vitamin k|mesh-list
93034094|NCT01034124|Midazolam|midazolam|mesh-list
93034095|NCT01034124|Warfarin|warfarin|mesh-list
93034096|NCT01034124|Vitamins|vitamins|mesh-ancestor
93034097|NCT01034124|Micronutrients|micronutrients|mesh-ancestor
93034098|NCT01034124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034099|NCT01034124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93034100|NCT01034124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93034101|NCT01034124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93034102|NCT01034124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93034103|NCT01034124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93034104|NCT01034124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034105|NCT01034124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93034106|NCT01034124|Anesthetics, General|anesthetics, general|mesh-ancestor
93034107|NCT01034124|Anesthetics|anesthetics|mesh-ancestor
93034108|NCT01034124|GABA Modulators|gaba modulators|mesh-ancestor
93034109|NCT01034124|GABA Agents|gaba agents|mesh-ancestor
92197362|NCT00557193|Antiemetics|antiemetics|mesh-ancestor
93034110|NCT01034124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034111|NCT01034124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034112|NCT01034124|Anticoagulants|anticoagulants|mesh-ancestor
93034113|NCT01034124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93034114|NCT01034124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93034115|NCT01034124|Hemostatics|hemostatics|mesh-ancestor
93034116|NCT01034124|Coagulants|coagulants|mesh-ancestor
93034117|NCT00339183|Panitumumab|panitumumab|mesh-list
93034118|NCT00339183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034119|NCT00339183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034120|NCT01060605|Sirolimus|sirolimus|mesh-list
93034121|NCT01060605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034122|NCT01060605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034123|NCT01060605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93034124|NCT01060605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034125|NCT01060605|Antifungal Agents|antifungal agents|mesh-ancestor
93034126|NCT01060605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034127|NCT01060605|Immunologic Factors|immunologic factors|mesh-ancestor
93034128|NCT01060605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034129|NCT00532883|Hydroxyurea|hydroxyurea|mesh-list
93034130|NCT00532883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034131|NCT00532883|Antisickling Agents|antisickling agents|mesh-ancestor
93034132|NCT00532883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034133|NCT00532883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034134|NCT00532883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034135|NCT00993863|Ibuprofen|ibuprofen|mesh-list
93034136|NCT00993863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93034137|NCT00993863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034138|NCT00993863|Analgesics|analgesics|mesh-ancestor
93034139|NCT00993863|Sensory System Agents|sensory system agents|mesh-ancestor
93034140|NCT00993863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034141|NCT00993863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034142|NCT00993863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034143|NCT00993863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197860|NCT00662155|Zolpidem|zolpidem|mesh-list
93034144|NCT00993863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93034145|NCT00993863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034146|NCT00993863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034147|NCT00995423|Paclitaxel|paclitaxel|mesh-list
93034148|NCT00995423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034149|NCT00995423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034150|NCT00995423|Tubulin Modulators|tubulin modulators|mesh-ancestor
93034151|NCT00995423|Antimitotic Agents|antimitotic agents|mesh-ancestor
93034152|NCT00995423|Mitosis Modulators|mitosis modulators|mesh-ancestor
93034153|NCT00995423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034154|NCT00995657|Fluticasone|fluticasone|mesh-list
93034155|NCT00995657|Xhance|xhance|mesh-list
93034156|NCT00995657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034157|NCT00995657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93034158|NCT00995657|Autonomic Agents|autonomic agents|mesh-ancestor
93034159|NCT00995657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034160|NCT00995657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034161|NCT00995657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93034162|NCT00995657|Respiratory System Agents|respiratory system agents|mesh-ancestor
93034163|NCT00995657|Dermatologic Agents|dermatologic agents|mesh-ancestor
93034164|NCT00995657|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93034165|NCT00994097|Gemcitabine|gemcitabine|mesh-list
93034166|NCT00994097|Pemetrexed|pemetrexed|mesh-list
93034167|NCT00994097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034168|NCT00994097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93034169|NCT00994097|Antimetabolites|antimetabolites|mesh-ancestor
93034170|NCT00994097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034171|NCT00994097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034172|NCT00994097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93034173|NCT00994097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034174|NCT04000919|Carbidopa|carbidopa|mesh-list
93034175|NCT04000919|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92198290|NCT00590863|Histamine Agents|histamine agents|mesh-ancestor
93034176|NCT04000919|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93034177|NCT04000919|Dopamine Agents|dopamine agents|mesh-ancestor
93034178|NCT04000919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034179|NCT04000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034180|NCT04000919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034181|NCT04000919|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93034182|NCT04000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034183|NCT00994253|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93034184|NCT00994253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93034185|NCT00994253|Diuretics|diuretics|mesh-ancestor
93034186|NCT00994253|Natriuretic Agents|natriuretic agents|mesh-ancestor
93034187|NCT00994253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034188|NCT00994253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93034189|NCT00994253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93034190|NCT00994253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034191|NCT00338949|Olanzapine|olanzapine|mesh-list
93034192|NCT00338949|Risperidone|risperidone|mesh-list
93034193|NCT00338949|Ziprasidone|ziprasidone|mesh-list
93034194|NCT00338949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93034195|NCT00338949|Serotonin Agents|serotonin agents|mesh-ancestor
93034196|NCT00338949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034197|NCT00338949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034198|NCT00338949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034199|NCT00338949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93034200|NCT00338949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93034201|NCT00338949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93034202|NCT00338949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034203|NCT00338949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93034204|NCT00338949|Dopamine Agents|dopamine agents|mesh-ancestor
93034205|NCT00338949|Antiemetics|antiemetics|mesh-ancestor
93034206|NCT00338949|Autonomic Agents|autonomic agents|mesh-ancestor
93034207|NCT00338949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034208|NCT00338949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93034209|NCT00338949|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93034210|NCT00338949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93034211|NCT00338949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93034212|NCT01325259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93034213|NCT01325259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93034214|NCT01325259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034215|NCT00332709|Zoledronic Acid|zoledronic acid|mesh-list
93034216|NCT00332709|Letrozole|letrozole|mesh-list
93034217|NCT00332709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034218|NCT00332709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93034219|NCT00332709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93034220|NCT00332709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034221|NCT00332709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034222|NCT00332709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93034223|NCT00332709|Hormone Antagonists|hormone antagonists|mesh-ancestor
92199057|NCT02994433|Sensory System Agents|sensory system agents|mesh-ancestor
93034224|NCT00332709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034225|NCT00332709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199129|NCT00086996|Fluorouracil|fluorouracil|mesh-list
93034226|NCT00332709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93034227|NCT03988725|Vitamin E|vitamin e|mesh-list
93034228|NCT03988725|Vitamins|vitamins|mesh-ancestor
93034229|NCT03988725|Micronutrients|micronutrients|mesh-ancestor
93034230|NCT03988725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034231|NCT03988725|Antioxidants|antioxidants|mesh-ancestor
92199200|NCT03309137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199270|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
93034232|NCT03988725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034233|NCT03988725|Protective Agents|protective agents|mesh-ancestor
93034234|NCT00332241|Aripiprazole|aripiprazole|mesh-list
93034235|NCT00332241|Antidepressive Agents|antidepressive agents|mesh-ancestor
93034236|NCT00332241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034237|NCT00332241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93034238|NCT00332241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93034239|NCT00332241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199414|NCT02990455|Autonomic Agents|autonomic agents|mesh-ancestor
93034240|NCT00332241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034241|NCT00332241|Dopamine Agonists|dopamine agonists|mesh-ancestor
93034242|NCT00332241|Dopamine Agents|dopamine agents|mesh-ancestor
93034243|NCT00332241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034244|NCT00332241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199498|NCT01893801|Paclitaxel|paclitaxel|mesh-list
93034245|NCT00332241|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93034246|NCT00332241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93034247|NCT00332241|Serotonin Agents|serotonin agents|mesh-ancestor
93034248|NCT00332241|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93034249|NCT00332241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93034250|NCT00332241|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93034251|NCT00332241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93034252|NCT01058577|Somatostatin|somatostatin|mesh-list
93034253|NCT01058577|Hormones|hormones|mesh-ancestor
93034254|NCT01058577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199629|NCT00572897|Fludarabine|fludarabine|mesh-list
93034255|NCT01058577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034256|NCT03983889|Fentanyl|fentanyl|mesh-list
93034257|NCT03983889|Midazolam|midazolam|mesh-list
93034258|NCT03983889|Dexmedetomidine|dexmedetomidine|mesh-list
93034259|NCT03983889|Remifentanil|remifentanil|mesh-list
93034260|NCT03983889|Propofol|propofol|mesh-list
93034261|NCT03983889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93034262|NCT03983889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679491|NCT00348413|Prednisolone|prednisolone|mesh-list
92199700|NCT02991937|Tazobactam|tazobactam|mesh-list
93034263|NCT03983889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034264|NCT03983889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034265|NCT03983889|Analgesics|analgesics|mesh-ancestor
93034266|NCT03983889|Sensory System Agents|sensory system agents|mesh-ancestor
93034267|NCT03983889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034268|NCT03983889|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93034269|NCT03983889|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93034270|NCT03983889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93034271|NCT03983889|Adrenergic Agents|adrenergic agents|mesh-ancestor
93034272|NCT03983889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034273|NCT03983889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034274|NCT03983889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93034275|NCT03983889|Anesthetics, General|anesthetics, general|mesh-ancestor
93034276|NCT03983889|Anesthetics|anesthetics|mesh-ancestor
93034277|NCT03983889|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93034278|NCT03983889|Narcotics|narcotics|mesh-ancestor
93034279|NCT03983889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93034280|NCT03983889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93034281|NCT03983889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93034282|NCT03983889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034283|NCT03983889|GABA Modulators|gaba modulators|mesh-ancestor
93034284|NCT03983889|GABA Agents|gaba agents|mesh-ancestor
93034285|NCT00337935|Epoetin Alfa|epoetin alfa|mesh-list
93034286|NCT00337935|Hematinics|hematinics|mesh-ancestor
93034287|NCT00337779|Glatiramer Acetate|glatiramer acetate|mesh-list
93034288|NCT00337779|(T,G)-A-L|(t,g)-a-l|mesh-list
93034289|NCT00337779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93034290|NCT00337779|Immunologic Factors|immunologic factors|mesh-ancestor
93034291|NCT00337779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034292|NCT00337779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034293|NCT00337779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034294|NCT00352755|Leucovorin|leucovorin|mesh-list
93034295|NCT00352755|Fluorouracil|fluorouracil|mesh-list
93034296|NCT00352755|Oxaliplatin|oxaliplatin|mesh-list
93034297|NCT00352755|Antimetabolites|antimetabolites|mesh-ancestor
93034298|NCT00352755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034299|NCT00352755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93034300|NCT00352755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034301|NCT00352755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034302|NCT00352755|Immunologic Factors|immunologic factors|mesh-ancestor
93034303|NCT00352755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034304|NCT00352755|Antidotes|antidotes|mesh-ancestor
93034305|NCT00352755|Protective Agents|protective agents|mesh-ancestor
93034306|NCT00352755|Vitamin B Complex|vitamin b complex|mesh-ancestor
93034307|NCT00352755|Vitamins|vitamins|mesh-ancestor
93034308|NCT00352755|Micronutrients|micronutrients|mesh-ancestor
93034309|NCT00533897|Abatacept|abatacept|mesh-list
93034310|NCT00533897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93034311|NCT00533897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034312|NCT00533897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034313|NCT00533897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034314|NCT00533897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034315|NCT00533897|Immunologic Factors|immunologic factors|mesh-ancestor
93034316|NCT00533897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034317|NCT00533897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034318|NCT00426660|Maraviroc|maraviroc|mesh-list
93034319|NCT00426660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93034320|NCT00426660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93034321|NCT00426660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034322|NCT00426660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93034323|NCT00426660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93034324|NCT00426660|Antiviral Agents|antiviral agents|mesh-ancestor
93034325|NCT00426660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034326|NCT00426660|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93034327|NCT00426270|Immunoglobulins|immunoglobulins|mesh-list
93034328|NCT00426270|Immunologic Factors|immunologic factors|mesh-ancestor
93034329|NCT00426270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034330|NCT00330681|Edaravone|edaravone|mesh-list
93034331|NCT00330681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93034332|NCT00330681|Antioxidants|antioxidants|mesh-ancestor
93034333|NCT00330681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034334|NCT00330681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93034335|NCT00330681|Protective Agents|protective agents|mesh-ancestor
93034336|NCT00330681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034337|NCT00329901|Vaccines|vaccines|mesh-list
93034338|NCT00329901|Immunologic Factors|immunologic factors|mesh-ancestor
93034339|NCT00329901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034340|NCT00436956|Prednisone|prednisone|mesh-list
93034341|NCT00436956|Cediranib|cediranib|mesh-list
93034342|NCT00436956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034343|NCT00436956|Glucocorticoids|glucocorticoids|mesh-ancestor
93034344|NCT00436956|Hormones|hormones|mesh-ancestor
93034345|NCT00436956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034346|NCT00436956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034347|NCT00436956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93034348|NCT00436956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034349|NCT00436956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034350|NCT00436956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034351|NCT00436956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034353|NCT00436644|Lapatinib|lapatinib|mesh-list
93034354|NCT00436644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93034355|NCT00436644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034356|NCT00436644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034357|NCT00436644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034358|NCT00436644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034359|NCT00436644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034360|NCT00324987|Bevacizumab|bevacizumab|mesh-list
93034361|NCT00324987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93034362|NCT00324987|Imatinib Mesylate|imatinib mesylate|mesh-list
93034363|NCT00324987|Endothelial Growth Factors|endothelial growth factors|mesh-list
93034364|NCT00324987|Antibodies|antibodies|mesh-list
93034365|NCT00324987|Immunoglobulins|immunoglobulins|mesh-list
93034366|NCT00324987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93034367|NCT00324987|Immunoglobulin G|immunoglobulin g|mesh-list
93034368|NCT00324987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034369|NCT00324987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034370|NCT00324987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034371|NCT00324987|Growth Substances|growth substances|mesh-ancestor
92322353|NCT00000512|Vitamin B Complex|vitamin b complex|mesh-ancestor
93034372|NCT00324987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034373|NCT00324987|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034374|NCT00324987|Immunologic Factors|immunologic factors|mesh-ancestor
93034375|NCT00324987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034376|NCT00324987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034377|NCT00324987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034378|NCT00324675|Rosiglitazone|rosiglitazone|mesh-list
93034379|NCT00324675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93034380|NCT00324675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034381|NCT01055145|Moxifloxacin|moxifloxacin|mesh-list
93034382|NCT01055145|Levofloxacin|levofloxacin|mesh-list
93034383|NCT01055145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034384|NCT01055145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034385|NCT01055145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93034386|NCT01055145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034387|NCT01055145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034388|NCT01055145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034389|NCT01055145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034390|NCT01055145|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93034391|NCT01055145|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93034392|NCT01055145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93034393|NCT00436566|Paclitaxel|paclitaxel|mesh-list
93034394|NCT00436566|Cyclophosphamide|cyclophosphamide|mesh-list
93034395|NCT00436566|Doxorubicin|doxorubicin|mesh-list
93034396|NCT00436566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93034397|NCT00436566|Trastuzumab|trastuzumab|mesh-list
93034398|NCT00436566|Lapatinib|lapatinib|mesh-list
93034399|NCT00436566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034400|NCT00436566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034401|NCT00436566|Tubulin Modulators|tubulin modulators|mesh-ancestor
93034402|NCT00436566|Antimitotic Agents|antimitotic agents|mesh-ancestor
93034403|NCT00436566|Mitosis Modulators|mitosis modulators|mesh-ancestor
92200104|NCT00604019|Dopamine|dopamine|mesh-list
93034404|NCT00436566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034405|NCT00436566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034406|NCT00436566|Immunologic Factors|immunologic factors|mesh-ancestor
93034407|NCT00436566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034408|NCT00436566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034409|NCT00436566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93034410|NCT00436566|Alkylating Agents|alkylating agents|mesh-ancestor
93034411|NCT00436566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93034412|NCT00436566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93034413|NCT00436566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93034414|NCT00436566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034415|NCT00436566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034416|NCT00436566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034418|NCT01060683|Chrysarobin|chrysarobin|mesh-list
93034419|NCT01060683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93034420|NCT01060683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034421|NCT01060683|Analgesics|analgesics|mesh-ancestor
93034422|NCT01060683|Sensory System Agents|sensory system agents|mesh-ancestor
93034423|NCT01060683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034424|NCT01060683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034425|NCT01060683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034426|NCT01060683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034427|NCT01055301|Thalidomide|thalidomide|mesh-list
93034428|NCT01055301|Dexamethasone|dexamethasone|mesh-list
93034429|NCT01055301|Cyclophosphamide|cyclophosphamide|mesh-list
93034431|NCT01055301|Doxorubicin|doxorubicin|mesh-list
93034432|NCT01055301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93034433|NCT01055301|Etoposide|etoposide|mesh-list
93034434|NCT01055301|Lenalidomide|lenalidomide|mesh-list
93034435|NCT01055301|Bortezomib|bortezomib|mesh-list
93034436|NCT01055301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034437|NCT01055301|Immunologic Factors|immunologic factors|mesh-ancestor
93034438|NCT01055301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034439|NCT01055301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034440|NCT01055301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93034441|NCT01055301|Alkylating Agents|alkylating agents|mesh-ancestor
93034442|NCT01055301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034443|NCT01055301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034444|NCT01055301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93034445|NCT01055301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034446|NCT01055301|Antiemetics|antiemetics|mesh-ancestor
93034447|NCT01055301|Autonomic Agents|autonomic agents|mesh-ancestor
93034448|NCT01055301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034449|NCT01055301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93034450|NCT01055301|Glucocorticoids|glucocorticoids|mesh-ancestor
93034451|NCT01055301|Hormones|hormones|mesh-ancestor
93034452|NCT01055301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034453|NCT01055301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93034454|NCT01055301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93034455|NCT01055301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93034456|NCT01055301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034457|NCT01055301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034458|NCT01055301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034459|NCT01055301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034460|NCT01055301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034461|NCT01055301|Growth Substances|growth substances|mesh-ancestor
93034462|NCT01055301|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034463|NCT01055301|Leprostatic Agents|leprostatic agents|mesh-ancestor
93034464|NCT01055301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034465|NCT01055301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034466|NCT01055379|Rasagiline|rasagiline|mesh-list
93034467|NCT01055379|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93034468|NCT01055379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034469|NCT01055379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034470|NCT01055379|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93034471|NCT01055379|Protective Agents|protective agents|mesh-ancestor
93034472|NCT01055379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034473|NCT03988101|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93034474|NCT03988101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93034475|NCT03988101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93034476|NCT03988101|Antimetabolites|antimetabolites|mesh-ancestor
93034477|NCT03988101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034478|NCT03988101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93034479|NCT03988101|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93034480|NCT03988101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034481|NCT00352365|Lenalidomide|lenalidomide|mesh-list
93034482|NCT00352365|Immunologic Factors|immunologic factors|mesh-ancestor
93034483|NCT00352365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034484|NCT00352365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034485|NCT00352365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034486|NCT00352365|Growth Substances|growth substances|mesh-ancestor
93034487|NCT00352365|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034488|NCT00352365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034489|NCT01055535|Plasminogen|plasminogen|mesh-list
93034490|NCT01055535|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93034491|NCT01055535|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93034492|NCT01055535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034493|NCT03987867|Paclitaxel|paclitaxel|mesh-list
93034494|NCT03987867|Carboplatin|carboplatin|mesh-list
93034495|NCT03987867|Pemetrexed|pemetrexed|mesh-list
93034496|NCT03987867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93034497|NCT03987867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034498|NCT03987867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034499|NCT03987867|Tubulin Modulators|tubulin modulators|mesh-ancestor
93034500|NCT03987867|Antimitotic Agents|antimitotic agents|mesh-ancestor
93034502|NCT03987867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034503|NCT03987867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034504|NCT03987867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93034505|NCT03987867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034506|NCT03987867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034507|NCT00532493|Prazosin|prazosin|mesh-list
93034508|NCT00532493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93034509|NCT00532493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93034510|NCT00532493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93034511|NCT00532493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93034512|NCT00532493|Adrenergic Agents|adrenergic agents|mesh-ancestor
93034513|NCT00532493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034514|NCT00532493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034515|NCT00532493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034516|NCT00996515|Azacitidine|azacitidine|mesh-list
93034517|NCT00996515|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93034518|NCT00996515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93034519|NCT00996515|Antimetabolites|antimetabolites|mesh-ancestor
93034520|NCT00996515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034521|NCT00996515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034522|NCT00996515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034523|NCT00996515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034524|NCT00994799|Ranibizumab|ranibizumab|mesh-list
93034525|NCT00994799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034526|NCT00994799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034527|NCT00994799|Growth Substances|growth substances|mesh-ancestor
93034528|NCT00994799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034529|NCT00994799|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034530|NCT00994799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034531|NCT00533507|Vaccines|vaccines|mesh-list
93034532|NCT00533507|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93034533|NCT00533507|Immunologic Factors|immunologic factors|mesh-ancestor
93034534|NCT00533507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034535|NCT00352053|Tenofovir|tenofovir|mesh-list
93034536|NCT00352053|Antiviral Agents|antiviral agents|mesh-ancestor
93034537|NCT00352053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034538|NCT00352053|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93034539|NCT00352053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034540|NCT00352053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034541|NCT00352053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034542|NCT00352053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93034543|NCT00352053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93034544|NCT00995033|Varenicline|varenicline|mesh-list
93034545|NCT00995033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93034546|NCT00995033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93034547|NCT00995033|Cholinergic Agents|cholinergic agents|mesh-ancestor
92200195|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
93034548|NCT00995033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034549|NCT00995033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034550|NCT00995033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034551|NCT00997061|Topotecan|topotecan|mesh-list
93034552|NCT00997061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93034553|NCT00997061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034554|NCT00997061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034555|NCT00997061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034556|NCT00997061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034557|NCT00351819|Testosterone|testosterone|mesh-list
93034558|NCT00351819|Androgens|androgens|mesh-ancestor
93034559|NCT00351819|Hormones|hormones|mesh-ancestor
93034560|NCT00351819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034561|NCT00351819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034562|NCT00998933|Testosterone|testosterone|mesh-list
93034563|NCT00998933|Androgens|androgens|mesh-ancestor
92679795|NCT04699110|Vasodilator Agents|vasodilator agents|mesh-ancestor
93034564|NCT00998933|Hormones|hormones|mesh-ancestor
93034565|NCT00998933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034566|NCT00998933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034567|NCT00323115|Temozolomide|temozolomide|mesh-list
93034568|NCT00323115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93034569|NCT00323115|Alkylating Agents|alkylating agents|mesh-ancestor
93034570|NCT00323115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034571|NCT00323115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034573|NCT00322881|Carboplatin|carboplatin|mesh-list
93034574|NCT00322881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034575|NCT00322881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034576|NCT00322881|Tubulin Modulators|tubulin modulators|mesh-ancestor
93034577|NCT00322881|Antimitotic Agents|antimitotic agents|mesh-ancestor
93034578|NCT00322881|Mitosis Modulators|mitosis modulators|mesh-ancestor
93034579|NCT00322881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034580|NCT00415194|Pemetrexed|pemetrexed|mesh-list
93034581|NCT00415194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034582|NCT00415194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034583|NCT00415194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034584|NCT00415194|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93034585|NCT00415194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034586|NCT00436332|Bevacizumab|bevacizumab|mesh-list
93034587|NCT00436332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93034588|NCT00436332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034589|NCT00436332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034590|NCT00436332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034591|NCT00436332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034592|NCT00436332|Growth Substances|growth substances|mesh-ancestor
93034593|NCT00436332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034594|NCT00436332|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034595|NCT00436332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034596|NCT00436332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034597|NCT00436332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034598|NCT00532259|Pidilizumab|pidilizumab|mesh-list
93034599|NCT00532259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034600|NCT00532259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034601|NCT00322491|Plerixafor|plerixafor|mesh-list
93034602|NCT00322491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93034603|NCT00322491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93034604|NCT00322491|Antiviral Agents|antiviral agents|mesh-ancestor
93034605|NCT00322491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034606|NCT01034514|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
93034607|NCT01034514|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93034608|NCT01034514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034609|NCT00997607|Vaccines|vaccines|mesh-list
93034610|NCT00997607|Immunologic Factors|immunologic factors|mesh-ancestor
93034611|NCT00997607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034612|NCT00997685|Capecitabine|capecitabine|mesh-list
93034613|NCT00997685|Oxaliplatin|oxaliplatin|mesh-list
93034614|NCT00997685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93034615|NCT00997685|Antimetabolites|antimetabolites|mesh-ancestor
93034616|NCT00997685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034617|NCT00997685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034618|NCT00997919|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93034619|NCT00997919|Immunologic Factors|immunologic factors|mesh-ancestor
93034620|NCT00997919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034621|NCT00997997|Moxifloxacin|moxifloxacin|mesh-list
93034622|NCT00997997|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93034623|NCT00997997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034624|NCT00997997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034625|NCT00997997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93034626|NCT00997997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034627|NCT00997997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034628|NCT00997997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034629|NCT00997997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034630|NCT00997997|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93034631|NCT00997997|Contraceptive Agents|contraceptive agents|mesh-ancestor
93034632|NCT00997997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92322406|NCT00002120|Antidotes|antidotes|mesh-ancestor
93034633|NCT00997997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034634|NCT00997997|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93034635|NCT00997997|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93034636|NCT00997997|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92679871|NCT00457119|Everolimus|everolimus|mesh-list
93034637|NCT00998075|Esomeprazole|esomeprazole|mesh-list
93034638|NCT00998075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034639|NCT00998075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034640|NCT00998075|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93034641|NCT00998075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93034642|NCT00998075|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93034644|NCT00531947|Antidepressive Agents|antidepressive agents|mesh-ancestor
93034645|NCT00531947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034646|NCT00531947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93034647|NCT00531947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93034648|NCT00531947|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93034649|NCT00531947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034650|NCT00531947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034651|NCT00531947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93034652|NCT00531947|Protective Agents|protective agents|mesh-ancestor
93034653|NCT00531947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034654|NCT01003847|Fenofibrate|fenofibrate|mesh-list
93034655|NCT01003847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93034656|NCT01003847|Antimetabolites|antimetabolites|mesh-ancestor
93034657|NCT01003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034658|NCT01003847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93034659|NCT00530855|Lacosamide|lacosamide|mesh-list
93034660|NCT00530855|Anticonvulsants|anticonvulsants|mesh-ancestor
93034661|NCT00530855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93034662|NCT00530855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93034663|NCT00530855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93034664|NCT00530855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034665|NCT01004237|Valsartan|valsartan|mesh-list
93034666|NCT01004237|Pravastatin|pravastatin|mesh-list
93034667|NCT01004237|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93034668|NCT01004237|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93034669|NCT01004237|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93034670|NCT01004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034671|NCT01004237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93034672|NCT01004237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93034673|NCT01004237|Antimetabolites|antimetabolites|mesh-ancestor
93034674|NCT01004237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93034675|NCT01004237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93034676|NCT01004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034677|NCT01004315|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93034678|NCT01004315|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93034679|NCT01004315|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93034680|NCT01004315|Cholinergic Agents|cholinergic agents|mesh-ancestor
93034681|NCT01004315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034682|NCT01004315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034683|NCT01004315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034684|NCT01004315|Urological Agents|urological agents|mesh-ancestor
93034685|NCT05239637|Heparin|heparin|mesh-list
93034686|NCT05239637|Calcium heparin|calcium heparin|mesh-list
93034687|NCT05239637|Anticoagulants|anticoagulants|mesh-ancestor
93034688|NCT05239637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93034689|NCT05239637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93034690|NCT05239637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034691|NCT01005095|Vitamin D|vitamin d|mesh-list
93034692|NCT01005095|Ergocalciferols|ergocalciferols|mesh-list
93034693|NCT01005095|Cholecalciferol|cholecalciferol|mesh-list
93034694|NCT01005095|Vitamins|vitamins|mesh-list
93034695|NCT01005095|Micronutrients|micronutrients|mesh-ancestor
93034696|NCT01005095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322493|NCT03774745|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93034697|NCT01005095|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93034698|NCT01005095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93034699|NCT01005641|Lapatinib|lapatinib|mesh-list
93034700|NCT01005641|Exemestane|exemestane|mesh-list
93034701|NCT01005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034702|NCT01005641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034703|NCT01005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034704|NCT01005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034705|NCT01005641|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93034706|NCT01005641|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93034707|NCT01005641|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93034708|NCT01005641|Hormone Antagonists|hormone antagonists|mesh-ancestor
93034709|NCT01005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034710|NCT01005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034712|NCT01005797|Panobinostat|panobinostat|mesh-list
93034713|NCT01005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034714|NCT01005797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034715|NCT01005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380310|NCT04128540|Analgesics|analgesics|mesh-ancestor
93034716|NCT01005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034717|NCT01005797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93034718|NCT01006031|Interferons|interferons|mesh-list
93034719|NCT01006031|Ribavirin|ribavirin|mesh-list
93034720|NCT01006031|Interferon-alpha|interferon-alpha|mesh-list
93034721|NCT01006031|Interferon alpha-2|interferon alpha-2|mesh-list
93034722|NCT01006031|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93034723|NCT01006031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034724|NCT01006031|Antiviral Agents|antiviral agents|mesh-ancestor
93034725|NCT01006031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034726|NCT01006031|Antimetabolites|antimetabolites|mesh-ancestor
93034727|NCT01006031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034728|NCT01006031|Immunologic Factors|immunologic factors|mesh-ancestor
93034729|NCT01006031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034730|NCT01006187|Lidocaine|lidocaine|mesh-list
93034731|NCT01006187|Anesthetics, Local|anesthetics, local|mesh-ancestor
93034732|NCT01006187|Anesthetics|anesthetics|mesh-ancestor
93034733|NCT01006187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92322525|NCT00000626|Dacarbazine|dacarbazine|mesh-list
93034734|NCT01006187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034735|NCT01006187|Sensory System Agents|sensory system agents|mesh-ancestor
93034736|NCT01006187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034737|NCT01006187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93034738|NCT01006187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93034739|NCT01006187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93034740|NCT01006187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93034741|NCT01006187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034742|NCT00530777|Valacyclovir|valacyclovir|mesh-list
93034743|NCT00530777|Antiviral Agents|antiviral agents|mesh-ancestor
93034744|NCT00530777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034745|NCT01006499|Pentoxifylline|pentoxifylline|mesh-list
93034746|NCT01006499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93034747|NCT01006499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034748|NCT01006499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034749|NCT01006499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93034750|NCT01006499|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93034751|NCT01006499|Protective Agents|protective agents|mesh-ancestor
93034752|NCT01006499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034753|NCT01006499|Vasodilator Agents|vasodilator agents|mesh-ancestor
93034754|NCT01006499|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93034755|NCT01006499|Antioxidants|antioxidants|mesh-ancestor
93034756|NCT03882047|Fluticasone|fluticasone|mesh-list
93034758|NCT03882047|Mometasone Furoate|mometasone furoate|mesh-list
93034759|NCT03882047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034760|NCT03882047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93034761|NCT03882047|Autonomic Agents|autonomic agents|mesh-ancestor
93034762|NCT03882047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034763|NCT03882047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034764|NCT03882047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93034765|NCT03882047|Respiratory System Agents|respiratory system agents|mesh-ancestor
93034766|NCT03882047|Dermatologic Agents|dermatologic agents|mesh-ancestor
93034767|NCT03882047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93034768|NCT01007279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93034769|NCT01007279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93034770|NCT01007279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93034771|NCT01007279|Antimetabolites|antimetabolites|mesh-ancestor
93034772|NCT01007279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034773|NCT01007279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93034774|NCT01007279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93034775|NCT01007279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034776|NCT00530621|Pemetrexed|pemetrexed|mesh-list
93034777|NCT00530621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034778|NCT00530621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034779|NCT00530621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034780|NCT00530621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93034781|NCT00530621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93034782|NCT00531479|Voriconazole|voriconazole|mesh-list
93034783|NCT00531479|Anidulafungin|anidulafungin|mesh-list
93034784|NCT00531479|Antifungal Agents|antifungal agents|mesh-ancestor
93034785|NCT00531479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034786|NCT00531479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93034787|NCT00531479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93034788|NCT00531479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034789|NCT00531479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034790|NCT00531479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93034791|NCT00531479|Hormone Antagonists|hormone antagonists|mesh-ancestor
93034792|NCT00531479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034793|NCT00531479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034794|NCT00531479|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93034795|NCT00999479|Ferrous fumarate|ferrous fumarate|mesh-list
93034796|NCT00999479|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93034797|NCT00999479|Norethindrone|norethindrone|mesh-list
93034798|NCT00999479|Norethindrone Acetate|norethindrone acetate|mesh-list
93034799|NCT00999479|Estradiol|estradiol|mesh-list
93034800|NCT00999479|Estrogens|estrogens|mesh-ancestor
93034801|NCT00999479|Hormones|hormones|mesh-ancestor
93034802|NCT00999479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034803|NCT00999479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034804|NCT00999479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93034805|NCT00999479|Contraceptive Agents|contraceptive agents|mesh-ancestor
93034806|NCT00999479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93034807|NCT00999479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93034808|NCT00999479|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93034809|NCT00999479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93034810|NCT00999479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93034811|NCT00999479|Trace Elements|trace elements|mesh-ancestor
93034812|NCT00999479|Micronutrients|micronutrients|mesh-ancestor
93034813|NCT00999557|Bimatoprost|bimatoprost|mesh-list
93034814|NCT00999557|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93034815|NCT00999557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93034816|NCT00999557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93034817|NCT01008137|Vaccines|vaccines|mesh-list
93034818|NCT01008137|Immunologic Factors|immunologic factors|mesh-ancestor
93034819|NCT01008137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034820|NCT00999791|Diclofenac|diclofenac|mesh-list
93034821|NCT00999791|Bevacizumab|bevacizumab|mesh-list
93034822|NCT00999791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93034823|NCT00999791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034824|NCT00999791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93034825|NCT00999791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93034826|NCT00999791|Growth Substances|growth substances|mesh-ancestor
93034827|NCT00999791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034828|NCT00999791|Growth Inhibitors|growth inhibitors|mesh-ancestor
93034829|NCT00999791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93034830|NCT00999791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034831|NCT00999791|Analgesics|analgesics|mesh-ancestor
93034832|NCT00999791|Sensory System Agents|sensory system agents|mesh-ancestor
93034833|NCT00999791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034834|NCT00999791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034835|NCT00999791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034836|NCT00999791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93034837|NCT00999791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034838|NCT00999791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034839|NCT00999869|Triamcinolone|triamcinolone|mesh-list
93034840|NCT00999869|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93034841|NCT00999869|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93034842|NCT00999869|Botulinum Toxins|botulinum toxins|mesh-list
93034843|NCT00999869|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93034844|NCT00999869|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93034845|NCT00999869|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93034846|NCT00999869|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93034847|NCT00999869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93034848|NCT00999869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034849|NCT00999869|Cholinergic Agents|cholinergic agents|mesh-ancestor
93034850|NCT00999869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93034851|NCT00999869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034852|NCT00999869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034853|NCT00999869|Glucocorticoids|glucocorticoids|mesh-ancestor
93034854|NCT00999869|Hormones|hormones|mesh-ancestor
93034855|NCT00999869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93034856|NCT00999869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034857|NCT00999869|Immunologic Factors|immunologic factors|mesh-ancestor
93034858|NCT00999869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034859|NCT00999869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93034860|NCT00999869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034861|NCT01008293|Lactulose|lactulose|mesh-list
93034862|NCT01008293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93034863|NCT01008527|Poly ICLC|poly iclc|mesh-list
93034864|NCT01008527|Interferon Inducers|interferon inducers|mesh-ancestor
93034865|NCT01008527|Immunologic Factors|immunologic factors|mesh-ancestor
93034866|NCT01008527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034867|NCT01000415|Cisplatin|cisplatin|mesh-list
93034868|NCT01000415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034869|NCT01008761|Azithromycin|azithromycin|mesh-list
93034870|NCT01008761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034871|NCT01008761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034872|NCT01008917|Sirolimus|sirolimus|mesh-list
93034873|NCT01008917|Sorafenib|sorafenib|mesh-list
93034874|NCT01008917|Temsirolimus|temsirolimus|mesh-list
93034875|NCT01008917|MTOR Inhibitors|mtor inhibitors|mesh-list
93034876|NCT01008917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034877|NCT01008917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034878|NCT01008917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034879|NCT01008917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034880|NCT01008917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034881|NCT01008917|Immunologic Factors|immunologic factors|mesh-ancestor
93034882|NCT01008917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034883|NCT01008917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034884|NCT01008917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034885|NCT01008917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93034886|NCT01008917|Antifungal Agents|antifungal agents|mesh-ancestor
93034887|NCT01009073|Irinotecan|irinotecan|mesh-list
93034888|NCT01009073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93034889|NCT01009073|Navitoclax|navitoclax|mesh-list
93034890|NCT01009073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93034891|NCT01009073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034892|NCT01009073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034893|NCT01009073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034894|NCT01009073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034895|NCT01009073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034896|NCT00530075|Gusperimus|gusperimus|mesh-list
93034897|NCT00530075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93034898|NCT00530075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034899|NCT00530075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93034900|NCT00530075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034901|NCT00530075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034902|NCT00530075|Immunologic Factors|immunologic factors|mesh-ancestor
93034903|NCT00530075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93034904|NCT00530075|Protective Agents|protective agents|mesh-ancestor
93034905|NCT01001585|Sevoflurane|sevoflurane|mesh-list
93034906|NCT01001585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93034907|NCT01001585|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93034908|NCT01001585|Anesthetics, General|anesthetics, general|mesh-ancestor
93034909|NCT01001585|Anesthetics|anesthetics|mesh-ancestor
93034910|NCT01001585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93034911|NCT01001585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034912|NCT01001897|Misoprostol|misoprostol|mesh-list
93034913|NCT01001897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93034914|NCT01001897|Abortifacient Agents|abortifacient agents|mesh-ancestor
93034915|NCT01001897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93034916|NCT01001897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034917|NCT01001897|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93034918|NCT01001897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93034919|NCT01001897|Oxytocics|oxytocics|mesh-ancestor
93034920|NCT05734001|Hemostatics|hemostatics|mesh-list
93034921|NCT05734001|Coagulants|coagulants|mesh-ancestor
93034922|NCT01002911|Cefazolin|cefazolin|mesh-list
93034923|NCT01002911|Cephalexin|cephalexin|mesh-list
93034924|NCT01002911|Bacitracin|bacitracin|mesh-list
93034925|NCT01002911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93034926|NCT01002911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034927|NCT01002911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93034928|NCT05059535|Acetaminophen|acetaminophen|mesh-list
93034929|NCT05059535|Analgesics|analgesics|mesh-list
92200447|NCT03402152|Serotonin Agents|serotonin agents|mesh-ancestor
93034930|NCT05059535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034931|NCT05059535|Sensory System Agents|sensory system agents|mesh-ancestor
93034932|NCT05059535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680168|NCT00466401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034933|NCT05059535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034934|NCT05059535|Antipyretics|antipyretics|mesh-ancestor
93034935|NCT00531011|Paclitaxel|paclitaxel|mesh-list
93034936|NCT00531011|Everolimus|everolimus|mesh-list
93034937|NCT00531011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034939|NCT00531011|Tubulin Modulators|tubulin modulators|mesh-ancestor
93034940|NCT00531011|Antimitotic Agents|antimitotic agents|mesh-ancestor
93034941|NCT00531011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92529125|NCT00000986|Zidovudine|zidovudine|mesh-list
93034942|NCT00531011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034943|NCT00531011|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93034944|NCT00531011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034945|NCT00531011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034946|NCT00531011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93034947|NCT00531011|Immunologic Factors|immunologic factors|mesh-ancestor
93034948|NCT00531011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034949|NCT04000295|Paclitaxel|paclitaxel|mesh-list
93034950|NCT04000295|Etoposide|etoposide|mesh-list
93034951|NCT04000295|Apatinib|apatinib|mesh-list
92200459|NCT05346146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92200461|NCT00613379|Leronlimab|leronlimab|mesh-list
92200462|NCT00613379|HIV Antibodies|hiv antibodies|mesh-list
92200463|NCT00613379|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92200464|NCT00613379|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92200465|NCT00613379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200466|NCT00613379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92200467|NCT00613379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92200468|NCT00613379|Antiviral Agents|antiviral agents|mesh-ancestor
92200469|NCT00613379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200470|NCT00613379|Immunologic Factors|immunologic factors|mesh-ancestor
92200471|NCT00613379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200472|NCT01271725|Paclitaxel|paclitaxel|mesh-list
92200473|NCT01271725|Vinorelbine|vinorelbine|mesh-list
92200474|NCT01271725|Afatinib|afatinib|mesh-list
92200483|NCT00587483|Lidocaine|lidocaine|mesh-list
93034952|NCT04000295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93034953|NCT04000295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034954|NCT04000295|Tubulin Modulators|tubulin modulators|mesh-ancestor
93034955|NCT04000295|Antimitotic Agents|antimitotic agents|mesh-ancestor
93034956|NCT04000295|Mitosis Modulators|mitosis modulators|mesh-ancestor
93034957|NCT04000295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034958|NCT04000295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92200499|NCT00587483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92200500|NCT00587483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200501|NCT00587483|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92200502|NCT00587483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92200503|NCT00587483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92200504|NCT03401060|Denosumab|denosumab|mesh-list
92200505|NCT03401060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91912356|NCT02086019|Ramipril|ramipril|mesh-list
93034959|NCT04000295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93034960|NCT04000295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034961|NCT04000295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034962|NCT01003613|Tranilast|tranilast|mesh-list
91917673|NCT03660488|Cefixime|cefixime|mesh-list
93034963|NCT01003613|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91924394|NCT02688387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034964|NCT01003613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93034965|NCT01003613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93034966|NCT01003613|Analgesics|analgesics|mesh-ancestor
93034967|NCT01003613|Sensory System Agents|sensory system agents|mesh-ancestor
93034968|NCT01003613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93034969|NCT01003613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93034970|NCT01003613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93034971|NCT01003613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93034972|NCT01003613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93034973|NCT01003613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93034974|NCT01003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034975|NCT01003613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93034976|NCT01003613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93034977|NCT01003613|Histamine Antagonists|histamine antagonists|mesh-ancestor
93034978|NCT01003613|Histamine Agents|histamine agents|mesh-ancestor
93034979|NCT01003613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200705|NCT00668525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93034980|NCT01003613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93034981|NCT01003613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93034982|NCT01003613|Hemostatics|hemostatics|mesh-ancestor
93034983|NCT01003613|Coagulants|coagulants|mesh-ancestor
93034984|NCT00471146|Gemcitabine|gemcitabine|mesh-list
93034985|NCT00471146|Axitinib|axitinib|mesh-list
93034986|NCT00471146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93034987|NCT00471146|Antimetabolites|antimetabolites|mesh-ancestor
93034988|NCT00471146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93034989|NCT00471146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93034990|NCT00471146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93034991|NCT00471146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93034992|NCT01021358|Ketoconazole|ketoconazole|mesh-list
93034993|NCT01021358|Navitoclax|navitoclax|mesh-list
93034994|NCT01021358|Antifungal Agents|antifungal agents|mesh-ancestor
93034995|NCT01021358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93034996|NCT01021358|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93034997|NCT01021358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93034998|NCT01021358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200840|NCT02285283|Hormone Antagonists|hormone antagonists|mesh-ancestor
93034999|NCT01021358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035000|NCT01021358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93035001|NCT01021358|Hormone Antagonists|hormone antagonists|mesh-ancestor
93035002|NCT01021358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035003|NCT01021358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035004|NCT01021358|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93035005|NCT01021358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035006|NCT00469898|Carboplatin|carboplatin|mesh-list
93035007|NCT00469898|Irinotecan|irinotecan|mesh-list
93035008|NCT00469898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035009|NCT00469898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93035010|NCT00469898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93035011|NCT00469898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035012|NCT00469898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035013|NCT01021436|Amikacin|amikacin|mesh-list
93035014|NCT01021436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92200904|NCT05688020|Mydriatics|mydriatics|mesh-ancestor
93035015|NCT01021436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035017|NCT00529763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035018|NCT00529763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93035019|NCT00529763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200962|NCT00670241|Hormones|hormones|mesh-ancestor
93035020|NCT00529763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035021|NCT00486902|Ketamine|ketamine|mesh-list
93035022|NCT00486902|N-Methylaspartate|n-methylaspartate|mesh-list
93035023|NCT00486902|Analgesics|analgesics|mesh-ancestor
93035024|NCT00486902|Sensory System Agents|sensory system agents|mesh-ancestor
92201030|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035025|NCT00486902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201106|NCT03029013|Apatinib|apatinib|mesh-list
93035026|NCT00486902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035027|NCT00486902|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93035028|NCT00486902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93035029|NCT00486902|Anesthetics, General|anesthetics, general|mesh-ancestor
93035030|NCT00486902|Anesthetics|anesthetics|mesh-ancestor
93035031|NCT00486902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93035032|NCT00486902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93035033|NCT00486902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93035034|NCT00486902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035035|NCT00486902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035036|NCT00486902|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
93035037|NCT03687827|Insulin|insulin|mesh-list
93035038|NCT03687827|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93035039|NCT03687827|Insulin Glargine|insulin glargine|mesh-list
93035040|NCT03687827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035041|NCT03687827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035042|NCT00529529|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93035043|NCT00529529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93035044|NCT00529529|Autonomic Agents|autonomic agents|mesh-ancestor
93035045|NCT00529529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035046|NCT00529529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035047|NCT00529529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93035048|NCT00529529|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035049|NCT00529529|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93035050|NCT00529529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93035051|NCT00529529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93035052|NCT00529529|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035053|NCT00529529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035054|NCT00529529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035055|NCT05685953|Vaccines|vaccines|mesh-list
93035056|NCT05685953|Immunologic Factors|immunologic factors|mesh-ancestor
92201252|NCT00755755|Iron|iron|mesh-list
93035057|NCT05685953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035058|NCT00486434|Calcitonin|calcitonin|mesh-list
93035059|NCT00486434|Salmon calcitonin|salmon calcitonin|mesh-list
93035060|NCT00486434|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
93035061|NCT00486434|Katacalcin|katacalcin|mesh-list
93035062|NCT00486434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035063|NCT00486434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035064|NCT00486434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93035065|NCT00486434|Vasodilator Agents|vasodilator agents|mesh-ancestor
93035066|NCT00529451|Ramipril|ramipril|mesh-list
93035067|NCT00529451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93035068|NCT00529451|Protease Inhibitors|protease inhibitors|mesh-ancestor
93035069|NCT00529451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035070|NCT00529451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035071|NCT00529451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93035072|NCT05641259|Azacitidine|azacitidine|mesh-list
93035073|NCT05641259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93035074|NCT05641259|Antimetabolites|antimetabolites|mesh-ancestor
93035075|NCT05641259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035076|NCT05641259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035077|NCT05641259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035078|NCT05405387|Budesonide|budesonide|mesh-list
93035079|NCT05405387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035080|NCT05405387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93035081|NCT05405387|Autonomic Agents|autonomic agents|mesh-ancestor
93035082|NCT05405387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035083|NCT05405387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035084|NCT05405387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92680320|NCT00458367|Dopamine Agents|dopamine agents|mesh-ancestor
93035085|NCT05405387|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035086|NCT05405387|Glucocorticoids|glucocorticoids|mesh-ancestor
93035087|NCT05405387|Hormones|hormones|mesh-ancestor
93035088|NCT05405387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035089|NCT03999437|Terbinafine|terbinafine|mesh-list
93035090|NCT03999437|Butenafine|butenafine|mesh-list
93035091|NCT03999437|Antifungal Agents|antifungal agents|mesh-ancestor
93035092|NCT03999437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035093|NCT03999437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201487|NCT00634283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93035094|NCT03999437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035095|NCT05638217|Listerine|listerine|mesh-list
93035096|NCT05638217|Fluorides|fluorides|mesh-list
93035097|NCT05638217|Sodium Fluoride|sodium fluoride|mesh-list
93035098|NCT05638217|Fluorides, Topical|fluorides, topical|mesh-list
93035099|NCT05638217|Cariostatic Agents|cariostatic agents|mesh-ancestor
93035100|NCT05638217|Protective Agents|protective agents|mesh-ancestor
93035101|NCT05638217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035102|NCT05638217|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93035103|NCT05638217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035104|NCT05637281|Indomethacin|indomethacin|mesh-list
93035105|NCT05637281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93035106|NCT05637281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93035107|NCT05637281|Analgesics|analgesics|mesh-ancestor
93035108|NCT05637281|Sensory System Agents|sensory system agents|mesh-ancestor
92201704|NCT04725591|Insulin|insulin|mesh-list
93035109|NCT05637281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035110|NCT05637281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035111|NCT05637281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035112|NCT05637281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93035113|NCT05637281|Gout Suppressants|gout suppressants|mesh-ancestor
93035114|NCT05637281|Tocolytic Agents|tocolytic agents|mesh-ancestor
93035115|NCT05637281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93035116|NCT05637281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93035117|NCT05637281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035118|NCT05637281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035119|NCT00321711|Azacitidine|azacitidine|mesh-list
93035120|NCT00321711|Decitabine|decitabine|mesh-list
92201844|NCT03333668|Dopamine Agents|dopamine agents|mesh-ancestor
93035121|NCT00321711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93035122|NCT00321711|Antimetabolites|antimetabolites|mesh-ancestor
93035123|NCT00321711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035124|NCT00321711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035125|NCT00321711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035126|NCT00486044|Simvastatin|simvastatin|mesh-list
93035127|NCT00486044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93035128|NCT00486044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93035129|NCT00486044|Antimetabolites|antimetabolites|mesh-ancestor
92201911|NCT03793439|Glucocorticoids|glucocorticoids|mesh-ancestor
93035130|NCT00486044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035131|NCT00486044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93035132|NCT00486044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93035133|NCT00486044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035134|NCT00351273|Azithromycin|azithromycin|mesh-list
93035135|NCT00351273|Doxycycline|doxycycline|mesh-list
93035136|NCT00351273|Rifampin|rifampin|mesh-list
93035137|NCT00351273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035138|NCT00351273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035139|NCT00351273|Antimalarials|antimalarials|mesh-ancestor
93035140|NCT00351273|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93035141|NCT00351273|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93035142|NCT00351273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93035143|NCT00351273|Antitubercular Agents|antitubercular agents|mesh-ancestor
93035144|NCT00351273|Leprostatic Agents|leprostatic agents|mesh-ancestor
93035145|NCT00351273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93035146|NCT00351273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035147|NCT00351273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035148|NCT00351273|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93035149|NCT00351273|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93035150|NCT00351273|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93035151|NCT00351273|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93035152|NCT00351273|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93035153|NCT00351273|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93035154|NCT00327717|Zonisamide|zonisamide|mesh-list
93035155|NCT00327717|Anticonvulsants|anticonvulsants|mesh-ancestor
93035156|NCT00327717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93035157|NCT00327717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035158|NCT00327717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680391|NCT00354458|Rolofylline|rolofylline|mesh-list
93035159|NCT00327717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035160|NCT00327717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035163|NCT01022528|Dexamethasone|dexamethasone|mesh-list
93035164|NCT01022528|Dexamethasone acetate|dexamethasone acetate|mesh-list
93035165|NCT01022528|BB 1101|bb 1101|mesh-list
93035166|NCT01022528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035167|NCT01022528|Antiemetics|antiemetics|mesh-ancestor
93035168|NCT01022528|Autonomic Agents|autonomic agents|mesh-ancestor
93035169|NCT01022528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035170|NCT01022528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035171|NCT01022528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93035172|NCT01022528|Glucocorticoids|glucocorticoids|mesh-ancestor
93035173|NCT01022528|Hormones|hormones|mesh-ancestor
93035174|NCT01022528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035175|NCT01022528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92202028|NCT00644657|Clopidogrel|clopidogrel|mesh-list
93035176|NCT01022528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035177|NCT01022528|Protease Inhibitors|protease inhibitors|mesh-ancestor
93035178|NCT01022528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035179|NCT01022528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035180|NCT01025102|Sufentanil|sufentanil|mesh-list
93035181|NCT01025102|Ropivacaine|ropivacaine|mesh-list
93035182|NCT01025102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93035183|NCT01025102|Narcotics|narcotics|mesh-ancestor
93035184|NCT01025102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93035185|NCT01025102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035186|NCT01025102|Analgesics|analgesics|mesh-ancestor
93035187|NCT01025102|Sensory System Agents|sensory system agents|mesh-ancestor
93035188|NCT01025102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035189|NCT01025102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93035190|NCT01025102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93035191|NCT01025102|Anesthetics, General|anesthetics, general|mesh-ancestor
93035192|NCT01025102|Anesthetics|anesthetics|mesh-ancestor
93035193|NCT01025102|Anesthetics, Local|anesthetics, local|mesh-ancestor
93035194|NCT00424476|Belimumab|belimumab|mesh-list
93035195|NCT00424476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93035196|NCT00424476|Immunologic Factors|immunologic factors|mesh-ancestor
93035197|NCT00424476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035198|NCT01037634|Oseltamivir|oseltamivir|mesh-list
93035199|NCT01037634|Antiviral Agents|antiviral agents|mesh-ancestor
93035200|NCT01037634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035201|NCT01037634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035202|NCT01037634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035203|NCT01037712|Valacyclovir|valacyclovir|mesh-list
92202293|NCT01790165|Terbinafine|terbinafine|mesh-list
93035204|NCT01037712|Antiviral Agents|antiviral agents|mesh-ancestor
93035205|NCT01037712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035206|NCT00453362|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93035207|NCT00453362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035208|NCT00453362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93035209|NCT00453362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035210|NCT00453362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035211|NCT00424398|Bepotastine besilate|bepotastine besilate|mesh-list
93035212|NCT00424398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93035213|NCT00461786|Pemetrexed|pemetrexed|mesh-list
93035214|NCT00461786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035215|NCT00461786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035216|NCT00461786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035217|NCT00461786|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93035218|NCT00461786|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93035219|NCT01021592|Bortezomib|bortezomib|mesh-list
93035220|NCT01021592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035221|NCT00435162|Valsartan|valsartan|mesh-list
93035222|NCT00435162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93035223|NCT00435162|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93035224|NCT00435162|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93035225|NCT00435162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035226|NCT03836664|Timolol|timolol|mesh-list
92202561|NCT00699803|Antiemetics|antiemetics|mesh-ancestor
93035227|NCT03836664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93035228|NCT03836664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93035229|NCT03836664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93035230|NCT03836664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93035231|NCT03836664|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035232|NCT03836664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035233|NCT03836664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035235|NCT03836664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93035236|NCT03836664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93035237|NCT00350727|Lapatinib|lapatinib|mesh-list
93035238|NCT00350727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035239|NCT00350727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93035240|NCT00350727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035241|NCT00350727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035242|NCT01032486|Rasagiline|rasagiline|mesh-list
92202772|NCT00242489|Diclofenac|diclofenac|mesh-list
93035243|NCT01032486|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93035244|NCT01032486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035245|NCT01032486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035246|NCT01032486|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93035247|NCT01032486|Protective Agents|protective agents|mesh-ancestor
93035248|NCT01032486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035249|NCT01061697|Pregabalin|pregabalin|mesh-list
93035250|NCT01061697|Analgesics|analgesics|mesh-ancestor
93035251|NCT01061697|Sensory System Agents|sensory system agents|mesh-ancestor
93035252|NCT01061697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035253|NCT01061697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035254|NCT01061697|Anticonvulsants|anticonvulsants|mesh-ancestor
93035255|NCT01061697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93035256|NCT01061697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035257|NCT01061697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202984|NCT01973205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035258|NCT01061697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035259|NCT01061697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93035260|NCT01061697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93035261|NCT01061697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93035262|NCT01061697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93035263|NCT00434304|Ropinirole|ropinirole|mesh-list
93035264|NCT00434304|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93035265|NCT00434304|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93035266|NCT00434304|Dopamine Agonists|dopamine agonists|mesh-ancestor
93035267|NCT00434304|Dopamine Agents|dopamine agents|mesh-ancestor
93035268|NCT00434304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035269|NCT00434304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035270|NCT00434304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035271|NCT00424008|Fluticasone|fluticasone|mesh-list
93035272|NCT00424008|Xhance|xhance|mesh-list
93035273|NCT00424008|Mometasone Furoate|mometasone furoate|mesh-list
93035274|NCT00424008|Formoterol Fumarate|formoterol fumarate|mesh-list
93035275|NCT00424008|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93035276|NCT00424008|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93035277|NCT00424008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035278|NCT00424008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93035279|NCT00424008|Autonomic Agents|autonomic agents|mesh-ancestor
93035280|NCT00424008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035281|NCT00424008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035282|NCT00424008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93035283|NCT00424008|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035284|NCT00424008|Dermatologic Agents|dermatologic agents|mesh-ancestor
93035285|NCT00424008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93035286|NCT00424008|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93035287|NCT00424008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93035288|NCT00424008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93035289|NCT00424008|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035290|NCT00424008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035291|NCT00424008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035292|NCT00424008|Glucocorticoids|glucocorticoids|mesh-ancestor
93035293|NCT00424008|Hormones|hormones|mesh-ancestor
93035294|NCT00424008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035295|NCT00424008|Sympathomimetics|sympathomimetics|mesh-ancestor
93035296|NCT00423930|Bevacizumab|bevacizumab|mesh-list
93035297|NCT00423930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203552|NCT00759811|Methotrexate|methotrexate|mesh-list
93035298|NCT00423930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035299|NCT00423930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93035300|NCT00423930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93035301|NCT00423930|Growth Substances|growth substances|mesh-ancestor
93035302|NCT00423930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035303|NCT00423930|Growth Inhibitors|growth inhibitors|mesh-ancestor
93035304|NCT00423852|Paclitaxel|paclitaxel|mesh-list
93035305|NCT00423852|Carboplatin|carboplatin|mesh-list
93035306|NCT00423852|Ifosfamide|ifosfamide|mesh-list
92529131|NCT00000986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203687|NCT01279681|Calcium|calcium|mesh-list
93035307|NCT00423852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92680540|NCT00467571|Amoxicillin|amoxicillin|mesh-list
93035308|NCT00423852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035309|NCT00423852|Tubulin Modulators|tubulin modulators|mesh-ancestor
93035310|NCT00423852|Antimitotic Agents|antimitotic agents|mesh-ancestor
93035311|NCT00423852|Mitosis Modulators|mitosis modulators|mesh-ancestor
93035312|NCT00423852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035313|NCT00423852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93035314|NCT00423852|Alkylating Agents|alkylating agents|mesh-ancestor
93035315|NCT00461708|Gemcitabine|gemcitabine|mesh-list
93035316|NCT00461708|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93035317|NCT00461708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93035318|NCT00461708|Antimetabolites|antimetabolites|mesh-ancestor
93035319|NCT00461708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035320|NCT00461708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203844|NCT01277627|Efavirenz|efavirenz|mesh-list
93035321|NCT00461708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93035322|NCT00461708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035323|NCT00327171|Aflibercept|aflibercept|mesh-list
93035324|NCT00327171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93035325|NCT00327171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93035326|NCT00327171|Growth Substances|growth substances|mesh-ancestor
93035327|NCT00327171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035328|NCT00327171|Growth Inhibitors|growth inhibitors|mesh-ancestor
93035329|NCT00327171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035330|NCT01038024|Antioxidants|antioxidants|mesh-list
93035331|NCT01038024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035332|NCT01038024|Protective Agents|protective agents|mesh-ancestor
93035333|NCT01038024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035334|NCT00461630|Niacin|niacin|mesh-list
93035335|NCT00461630|Simvastatin|simvastatin|mesh-list
93035336|NCT00461630|Ezetimibe|ezetimibe|mesh-list
93035337|NCT00461630|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
93035338|NCT00461630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93035339|NCT00461630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93035340|NCT00461630|Antimetabolites|antimetabolites|mesh-ancestor
93035341|NCT00461630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035342|NCT00461630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93035343|NCT00461630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93035344|NCT00461630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035345|NCT00461630|Vasodilator Agents|vasodilator agents|mesh-ancestor
93035346|NCT00461630|Vitamin B Complex|vitamin b complex|mesh-ancestor
93035347|NCT00461630|Vitamins|vitamins|mesh-ancestor
93035348|NCT00461630|Micronutrients|micronutrients|mesh-ancestor
92204108|NCT01276327|Hormones|hormones|mesh-ancestor
93035349|NCT00461630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035350|NCT01061853|Sirolimus|sirolimus|mesh-list
93035351|NCT01061853|Betamethasone|betamethasone|mesh-list
93035352|NCT01061853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035353|NCT01061853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035354|NCT01061853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93035355|NCT01061853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035356|NCT01061853|Antifungal Agents|antifungal agents|mesh-ancestor
93035357|NCT01061853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93035358|NCT01061853|Immunologic Factors|immunologic factors|mesh-ancestor
93035359|NCT01061853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035360|NCT01061853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035361|NCT01061853|Glucocorticoids|glucocorticoids|mesh-ancestor
93035362|NCT01061853|Hormones|hormones|mesh-ancestor
92204397|NCT01273727|Dexamethasone|dexamethasone|mesh-list
93035363|NCT01061853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035364|NCT01061853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93035365|NCT01061853|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035366|NCT01325415|Moxifloxacin|moxifloxacin|mesh-list
93035367|NCT01325415|Naloxegol|naloxegol|mesh-list
93035368|NCT01325415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035369|NCT01325415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035370|NCT01325415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93035371|NCT01325415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93035372|NCT01325415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035373|NCT01325415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035374|NCT01325415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035375|NCT01325415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035376|NCT01325415|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93035377|NCT01325415|Sensory System Agents|sensory system agents|mesh-ancestor
93035378|NCT01325415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035379|NCT01022840|Ketamine|ketamine|mesh-list
93035380|NCT01022840|Esketamine|esketamine|mesh-list
93035381|NCT01022840|Analgesics|analgesics|mesh-ancestor
93035382|NCT01022840|Sensory System Agents|sensory system agents|mesh-ancestor
93035383|NCT01022840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035384|NCT01022840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035385|NCT01022840|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93035386|NCT01022840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93035387|NCT01022840|Anesthetics, General|anesthetics, general|mesh-ancestor
93035388|NCT01022840|Anesthetics|anesthetics|mesh-ancestor
92204761|NCT01276223|Difluprednate|difluprednate|mesh-list
93035389|NCT01022840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93035390|NCT01022840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93035391|NCT01022840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93035392|NCT01022840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035393|NCT01022840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035394|NCT01022840|Antidepressive Agents|antidepressive agents|mesh-ancestor
93035395|NCT01022840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93035396|NCT01025570|Gemcitabine|gemcitabine|mesh-list
93035397|NCT01025570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93035398|NCT01025570|Antimetabolites|antimetabolites|mesh-ancestor
93035399|NCT01025570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035400|NCT01025570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035401|NCT03983876|Adalimumab|adalimumab|mesh-list
93035402|NCT03983876|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93035403|NCT03983876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035404|NCT03983876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93035405|NCT00327015|Metformin|metformin|mesh-list
93035406|NCT00327015|Pioglitazone|pioglitazone|mesh-list
93035407|NCT00327015|Saxagliptin|saxagliptin|mesh-list
93035408|NCT00327015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035409|NCT00327015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035410|NCT00327015|Incretins|incretins|mesh-ancestor
93035411|NCT00327015|Hormones|hormones|mesh-ancestor
93035412|NCT00327015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035413|NCT00327015|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93035414|NCT00327015|Protease Inhibitors|protease inhibitors|mesh-ancestor
93035415|NCT00327015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205032|NCT03804931|Prednisone|prednisone|mesh-list
93035416|NCT00327015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035417|NCT00434148|Pasireotide|pasireotide|mesh-list
93035418|NCT00434148|Hormones|hormones|mesh-ancestor
93035419|NCT00434148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035420|NCT00434148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035421|NCT01063569|Hydrocortisone|hydrocortisone|mesh-list
93035422|NCT01063569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93035423|NCT01063569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93035424|NCT01063569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93035425|NCT01063569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035426|NCT01063647|Treosulfan|treosulfan|mesh-list
93035427|NCT01063647|Busulfan|busulfan|mesh-list
93035428|NCT01063647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93035429|NCT01063647|Alkylating Agents|alkylating agents|mesh-ancestor
93035430|NCT01063647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035431|NCT01063647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035432|NCT01063647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93035433|NCT01063647|Immunologic Factors|immunologic factors|mesh-ancestor
93035434|NCT01063647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035435|NCT01063647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93035436|NCT00468728|Vancomycin|vancomycin|mesh-list
93035437|NCT00468728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035438|NCT00468728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035439|NCT00433914|Vaccines|vaccines|mesh-list
93035440|NCT00433914|Immunologic Factors|immunologic factors|mesh-ancestor
92205392|NCT03801499|Lenvatinib|lenvatinib|mesh-list
93035441|NCT00433914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035442|NCT00468650|Sildenafil Citrate|sildenafil citrate|mesh-list
93035443|NCT00468650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035444|NCT00468650|Vasodilator Agents|vasodilator agents|mesh-ancestor
93035445|NCT00468650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93035446|NCT00468650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93035447|NCT00468650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035448|NCT00468650|Urological Agents|urological agents|mesh-ancestor
93035449|NCT00423150|Temozolomide|temozolomide|mesh-list
93035450|NCT00423150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93035451|NCT00423150|Alkylating Agents|alkylating agents|mesh-ancestor
93035452|NCT00423150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035453|NCT00423150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035454|NCT00433836|Valsartan|valsartan|mesh-list
93035455|NCT00433836|Enalapril|enalapril|mesh-list
93035456|NCT00433836|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93035457|NCT00433836|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93035458|NCT00433836|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93035459|NCT00433836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035460|NCT00433836|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93035462|NCT00433836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035463|NCT01022918|Bevacizumab|bevacizumab|mesh-list
93035464|NCT01022918|Temozolomide|temozolomide|mesh-list
93035465|NCT01022918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93035466|NCT01022918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035467|NCT01022918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93035468|NCT01022918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93035469|NCT01022918|Growth Substances|growth substances|mesh-ancestor
93035470|NCT01022918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035471|NCT01022918|Growth Inhibitors|growth inhibitors|mesh-ancestor
93035472|NCT01022918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93035473|NCT01022918|Alkylating Agents|alkylating agents|mesh-ancestor
93035474|NCT01022918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035475|NCT03996044|Anti-Infective Agents|anti-infective agents|mesh-list
93035476|NCT03996044|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93035477|NCT00433446|Siltuximab|siltuximab|mesh-list
93035478|NCT00433446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035479|NCT00468104|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93035480|NCT00468104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93035481|NCT00468104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93035482|NCT00468104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035483|NCT00326625|Glatiramer Acetate|glatiramer acetate|mesh-list
93035484|NCT00326625|(T,G)-A-L|(t,g)-a-l|mesh-list
93035485|NCT00326625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93035486|NCT00326625|Immunologic Factors|immunologic factors|mesh-ancestor
93035487|NCT00326625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035488|NCT00326625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93035489|NCT00326625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93035490|NCT00433290|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93035491|NCT00433290|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93035492|NCT00433290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93035493|NCT00433290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035494|NCT00433290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035495|NCT00433290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035496|NCT00433290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035497|NCT00433290|Analgesics|analgesics|mesh-ancestor
93035498|NCT00433290|Sensory System Agents|sensory system agents|mesh-ancestor
93035499|NCT00433290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035500|NCT00433290|Antidepressive Agents|antidepressive agents|mesh-ancestor
93035501|NCT00433290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93035502|NCT00433290|Dopamine Agents|dopamine agents|mesh-ancestor
93035503|NCT00467870|Methyltestosterone|methyltestosterone|mesh-list
93035504|NCT00467870|Testosterone|testosterone|mesh-list
93035505|NCT00467870|Testosterone undecanoate|testosterone undecanoate|mesh-list
93035506|NCT00467870|Testosterone enanthate|testosterone enanthate|mesh-list
93035507|NCT00467870|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93035508|NCT00467870|Androgens|androgens|mesh-ancestor
93035509|NCT00467870|Hormones|hormones|mesh-ancestor
93035510|NCT00467870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035511|NCT00467870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035512|NCT00467870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93035513|NCT00467870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035514|NCT00467870|Anabolic Agents|anabolic agents|mesh-ancestor
93035515|NCT00467558|Naltrexone|naltrexone|mesh-list
93035516|NCT00467558|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93035517|NCT00467558|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93035518|NCT00467558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035519|NCT00467558|Sensory System Agents|sensory system agents|mesh-ancestor
93035520|NCT00467558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035521|NCT00422292|Vaccines|vaccines|mesh-list
93035522|NCT00422292|Immunologic Factors|immunologic factors|mesh-ancestor
93035523|NCT00422292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035524|NCT00452348|Fluticasone|fluticasone|mesh-list
93035526|NCT00452348|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93035527|NCT00452348|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93035528|NCT00452348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035529|NCT00452348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93035530|NCT00452348|Autonomic Agents|autonomic agents|mesh-ancestor
92680803|NCT00427232|BQ 788|bq 788|mesh-list
93035531|NCT00452348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035532|NCT00452348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035533|NCT00452348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93035534|NCT00452348|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035535|NCT00452348|Dermatologic Agents|dermatologic agents|mesh-ancestor
93035536|NCT00452348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93035537|NCT00452348|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93035538|NCT00452348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93035539|NCT00452348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93035540|NCT00452348|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035541|NCT00452348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206199|NCT03839251|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93035542|NCT00452348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035543|NCT00452348|Glucocorticoids|glucocorticoids|mesh-ancestor
93035544|NCT00452348|Hormones|hormones|mesh-ancestor
93035545|NCT00452348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035546|NCT00452348|Sympathomimetics|sympathomimetics|mesh-ancestor
93035547|NCT01323062|Bavituximab|bavituximab|mesh-list
93035548|NCT01323062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93035549|NCT01323062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035550|NCT00320541|Paclitaxel|paclitaxel|mesh-list
93035551|NCT00320541|Bevacizumab|bevacizumab|mesh-list
93035552|NCT00320541|Gemcitabine|gemcitabine|mesh-list
93035553|NCT00320541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93035554|NCT00320541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035555|NCT00320541|Tubulin Modulators|tubulin modulators|mesh-ancestor
93035556|NCT00320541|Antimitotic Agents|antimitotic agents|mesh-ancestor
93035557|NCT00320541|Mitosis Modulators|mitosis modulators|mesh-ancestor
93035558|NCT00320541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035559|NCT00320541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93035560|NCT00320541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92206478|NCT02410707|Nitrous Oxide|nitrous oxide|mesh-list
93035561|NCT00320541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93035562|NCT00320541|Growth Substances|growth substances|mesh-ancestor
93035563|NCT00320541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035564|NCT00320541|Growth Inhibitors|growth inhibitors|mesh-ancestor
93035565|NCT00320541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93035566|NCT00320541|Antimetabolites|antimetabolites|mesh-ancestor
93035567|NCT00320385|Trastuzumab|trastuzumab|mesh-list
93035568|NCT00320385|Lapatinib|lapatinib|mesh-list
93035569|NCT00320385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93035570|NCT00320385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035571|NCT00320385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93035572|NCT00320385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035573|NCT00320385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206666|NCT00241631|Xhance|xhance|mesh-list
93035574|NCT00309777|Simvastatin|simvastatin|mesh-list
93035575|NCT00309777|Pitavastatin|pitavastatin|mesh-list
93035576|NCT00309777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93035577|NCT00309777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93035578|NCT00309777|Antimetabolites|antimetabolites|mesh-ancestor
93035579|NCT00309777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035580|NCT00309777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206691|NCT00240071|Tamoxifen|tamoxifen|mesh-list
93035581|NCT00309777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93035582|NCT00309777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035583|NCT00325143|Edetic Acid|edetic acid|mesh-list
93035584|NCT00325143|Pentetic Acid|pentetic acid|mesh-list
93035585|NCT00325143|Antidotes|antidotes|mesh-ancestor
92206759|NCT02353299|GABA Agonists|gaba agonists|mesh-ancestor
93035586|NCT00325143|Protective Agents|protective agents|mesh-ancestor
93035587|NCT00325143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035588|NCT00325143|Chelating Agents|chelating agents|mesh-ancestor
93035589|NCT00325143|Sequestering Agents|sequestering agents|mesh-ancestor
92206828|NCT02312739|Analgesics|analgesics|mesh-list
93035590|NCT00325143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035591|NCT00325143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93035592|NCT00325143|Anticoagulants|anticoagulants|mesh-ancestor
93035593|NCT00325143|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93035594|NCT00319839|Paclitaxel|paclitaxel|mesh-list
93035595|NCT00319839|Cetuximab|cetuximab|mesh-list
93035596|NCT00319839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93035597|NCT00319839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93035598|NCT00319839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035599|NCT00319839|Tubulin Modulators|tubulin modulators|mesh-ancestor
93035600|NCT00319839|Antimitotic Agents|antimitotic agents|mesh-ancestor
93035601|NCT00319839|Mitosis Modulators|mitosis modulators|mesh-ancestor
93035602|NCT00319839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035603|NCT00319839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93035604|NCT01062087|Lidocaine|lidocaine|mesh-list
93035605|NCT01062087|Bupivacaine|bupivacaine|mesh-list
93035606|NCT01062087|Anesthetics, Local|anesthetics, local|mesh-ancestor
93035607|NCT01062087|Anesthetics|anesthetics|mesh-ancestor
92207040|NCT00768599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035608|NCT01062087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93035609|NCT01062087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035610|NCT01062087|Sensory System Agents|sensory system agents|mesh-ancestor
93035611|NCT01062087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035612|NCT01062087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93035613|NCT01062087|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93035614|NCT01062087|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93035615|NCT01062087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035616|NCT01062087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035617|NCT00319449|Atorvastatin|atorvastatin|mesh-list
93035618|NCT00319449|Ezetimibe|ezetimibe|mesh-list
93035619|NCT00319449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92207259|NCT02388321|Fentanyl|fentanyl|mesh-list
93035620|NCT00319449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93035621|NCT00319449|Antimetabolites|antimetabolites|mesh-ancestor
93035622|NCT00319449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035623|NCT00319449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93035624|NCT00319449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93035625|NCT00319449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035626|NCT00308685|Albuterol|albuterol|mesh-list
93035627|NCT00308685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93035628|NCT00308685|Autonomic Agents|autonomic agents|mesh-ancestor
93035629|NCT00308685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035630|NCT00308685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035631|NCT00308685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93035632|NCT00308685|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035633|NCT00308685|Tocolytic Agents|tocolytic agents|mesh-ancestor
93035634|NCT00308685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93035635|NCT00308685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93035636|NCT00308685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93035637|NCT00308685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93035638|NCT00308685|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035639|NCT00308685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035640|NCT00308685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035641|NCT01060917|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93035642|NCT01060917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035643|NCT03981081|Prednisone|prednisone|mesh-list
93035644|NCT03981081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035645|NCT03981081|Glucocorticoids|glucocorticoids|mesh-ancestor
93035646|NCT03981081|Hormones|hormones|mesh-ancestor
93035647|NCT03981081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035648|NCT03981081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035649|NCT03981081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93035650|NCT03981081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035651|NCT03979209|Mometasone Furoate|mometasone furoate|mesh-list
93035652|NCT03979209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035653|NCT03979209|Dermatologic Agents|dermatologic agents|mesh-ancestor
93035654|NCT03979209|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93035655|NCT00316719|Lamivudine|lamivudine|mesh-list
93035656|NCT00316719|Adefovir|adefovir|mesh-list
93035657|NCT00316719|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93035658|NCT00316719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93035659|NCT00316719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93035660|NCT00316719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035661|NCT00316719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035662|NCT00316719|Antiviral Agents|antiviral agents|mesh-ancestor
93035663|NCT00316719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035664|NCT00316719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93035665|NCT00316719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93035666|NCT01065987|Tizanidine|tizanidine|mesh-list
93035667|NCT01065987|Analgesics|analgesics|mesh-ancestor
93035668|NCT01065987|Sensory System Agents|sensory system agents|mesh-ancestor
93035669|NCT01065987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035670|NCT01065987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035671|NCT01065987|Anticonvulsants|anticonvulsants|mesh-ancestor
93035672|NCT01065987|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93035673|NCT01065987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93035674|NCT01065987|Parasympatholytics|parasympatholytics|mesh-ancestor
93035675|NCT01065987|Autonomic Agents|autonomic agents|mesh-ancestor
92207672|NCT03835013|Exenatide|exenatide|mesh-list
93035676|NCT01065987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93035677|NCT01065987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93035678|NCT01065987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92680919|NCT00469131|Tacrolimus|tacrolimus|mesh-list
93035679|NCT01065987|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035680|NCT01065987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035681|NCT01065987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035683|NCT01064115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93035684|NCT01064115|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93035685|NCT01064115|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93035686|NCT01064115|Histamine Antagonists|histamine antagonists|mesh-ancestor
93035687|NCT01064115|Histamine Agents|histamine agents|mesh-ancestor
93035688|NCT01064115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035689|NCT01064115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035690|NCT01064115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035691|NCT00422058|Liraglutide|liraglutide|mesh-list
93035692|NCT00422058|Orlistat|orlistat|mesh-list
93035693|NCT00422058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035694|NCT00422058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035695|NCT00422058|Incretins|incretins|mesh-ancestor
93035696|NCT00422058|Hormones|hormones|mesh-ancestor
93035697|NCT00422058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035698|NCT00422058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035699|NCT00422058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035700|NCT00422058|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93035701|NCT00422058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93035702|NCT01032798|Mepivacaine|mepivacaine|mesh-list
93035703|NCT01032798|Anesthetics, Local|anesthetics, local|mesh-ancestor
93035704|NCT01032798|Anesthetics|anesthetics|mesh-ancestor
93035705|NCT01032798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208083|NCT00845507|Exenatide|exenatide|mesh-list
93035706|NCT01032798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035707|NCT01032798|Sensory System Agents|sensory system agents|mesh-ancestor
93035708|NCT01032798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035709|NCT00413244|Testosterone|testosterone|mesh-list
93035710|NCT00413244|Androgens|androgens|mesh-ancestor
93035711|NCT00413244|Hormones|hormones|mesh-ancestor
92208220|NCT00850889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93035712|NCT00413244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208300|NCT00365950|Warfarin|warfarin|mesh-list
92208364|NCT00828841|Tubulin Modulators|tubulin modulators|mesh-ancestor
93035713|NCT00413244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035714|NCT01033032|Amrubicin|amrubicin|mesh-list
93035715|NCT01033032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035716|NCT01038570|Oxytocin|oxytocin|mesh-list
93035717|NCT01038570|Oxytocics|oxytocics|mesh-ancestor
93035718|NCT01038570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93035719|NCT01038570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035720|NCT00420342|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93035721|NCT00420342|Drospirenone|drospirenone|mesh-list
93035722|NCT00420342|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93035723|NCT00420342|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93035724|NCT00420342|Medroxyprogesterone|medroxyprogesterone|mesh-list
93035725|NCT00420342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93035726|NCT00420342|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93035727|NCT00420342|Estradiol|estradiol|mesh-list
93035728|NCT00420342|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93035729|NCT00420342|Estrogens|estrogens|mesh-ancestor
93035730|NCT00420342|Hormones|hormones|mesh-ancestor
93035731|NCT00420342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208656|NCT00366652|Analgesics|analgesics|mesh-ancestor
93035732|NCT00420342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035733|NCT00420342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93035734|NCT00420342|Contraceptive Agents|contraceptive agents|mesh-ancestor
92208735|NCT02834247|Nivolumab|nivolumab|mesh-list
93035735|NCT00420342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93035736|NCT00420342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93035737|NCT00420342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93035738|NCT00420342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93035739|NCT00420342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93035740|NCT00420342|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93035741|NCT00420342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93035742|NCT00420342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529140|NCT00015249|Antiviral Agents|antiviral agents|mesh-ancestor
93035743|NCT00420342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93035744|NCT00420342|Hormone Antagonists|hormone antagonists|mesh-ancestor
93035745|NCT00420342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93035746|NCT00420342|Diuretics|diuretics|mesh-ancestor
93035747|NCT00420342|Natriuretic Agents|natriuretic agents|mesh-ancestor
93035748|NCT01038648|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93035749|NCT01038648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035750|NCT01038648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035751|NCT01038648|Incretins|incretins|mesh-ancestor
93035752|NCT01038648|Hormones|hormones|mesh-ancestor
93035753|NCT01038648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035754|NCT01038648|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93035756|NCT01038648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035757|NCT01038648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035758|NCT00432666|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93035759|NCT00432666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93035760|NCT00432666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035761|NCT00432666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035762|NCT00432666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93035763|NCT00432666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035764|NCT00432666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035765|NCT00432666|Cholinergic Agents|cholinergic agents|mesh-ancestor
93035766|NCT00432666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035767|NCT00451958|Leuprolide|leuprolide|mesh-list
93035768|NCT00451958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93035769|NCT00451958|Fertility Agents|fertility agents|mesh-ancestor
93035770|NCT00451958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93035771|NCT00451958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035772|NCT00451958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93035773|NCT00451958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035774|NCT01025882|Gemcitabine|gemcitabine|mesh-list
93035775|NCT01025882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93035776|NCT01025882|Antimetabolites|antimetabolites|mesh-ancestor
93035777|NCT01025882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209283|NCT03215875|Torsemide|torsemide|mesh-list
93035778|NCT01025882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035779|NCT01026116|Paclitaxel|paclitaxel|mesh-list
93035780|NCT01026116|Cyclophosphamide|cyclophosphamide|mesh-list
93035781|NCT01026116|Epirubicin|epirubicin|mesh-list
93035782|NCT01026116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93035783|NCT01026116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035784|NCT01026116|Tubulin Modulators|tubulin modulators|mesh-ancestor
93035785|NCT01026116|Antimitotic Agents|antimitotic agents|mesh-ancestor
93035786|NCT01026116|Mitosis Modulators|mitosis modulators|mesh-ancestor
93035787|NCT01026116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035788|NCT01026116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93035789|NCT01026116|Immunologic Factors|immunologic factors|mesh-ancestor
93035790|NCT01026116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035791|NCT01026116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93035792|NCT01026116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93035793|NCT01026116|Alkylating Agents|alkylating agents|mesh-ancestor
93035794|NCT01026116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93035795|NCT01026116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93035796|NCT01026116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93035797|NCT01026116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93035798|NCT01026116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035799|NCT00432276|Metformin|metformin|mesh-list
93035800|NCT00432276|Pioglitazone|pioglitazone|mesh-list
93035801|NCT00432276|Alogliptin|alogliptin|mesh-list
93035802|NCT00432276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035803|NCT00432276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035804|NCT00432276|Incretins|incretins|mesh-ancestor
93035805|NCT00432276|Hormones|hormones|mesh-ancestor
92209644|NCT05444998|Antimitotic Agents|antimitotic agents|mesh-ancestor
93035806|NCT00432276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035807|NCT00432276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93035808|NCT00432276|Protease Inhibitors|protease inhibitors|mesh-ancestor
93035809|NCT00432276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209716|NCT05443282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035810|NCT00432276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035811|NCT01027520|Monensin|monensin|mesh-list
93035812|NCT01027520|Antifungal Agents|antifungal agents|mesh-ancestor
93035813|NCT01027520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035814|NCT01027520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93035815|NCT01027520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93035816|NCT01027520|Coccidiostats|coccidiostats|mesh-ancestor
93035817|NCT01027520|Proton Ionophores|proton ionophores|mesh-ancestor
93035818|NCT01027520|Uncoupling Agents|uncoupling agents|mesh-ancestor
93035820|NCT01027520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035821|NCT01027520|Ionophores|ionophores|mesh-ancestor
93035822|NCT01027520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035823|NCT01027520|Sodium Ionophores|sodium ionophores|mesh-ancestor
93035824|NCT01023230|Entecavir|entecavir|mesh-list
93035825|NCT01023230|Antiviral Agents|antiviral agents|mesh-ancestor
93035826|NCT01023230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035827|NCT01027832|Tazobactam|tazobactam|mesh-list
93035828|NCT01027832|Piperacillin|piperacillin|mesh-list
93035829|NCT01027832|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
93035830|NCT01027832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035831|NCT01027832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035832|NCT01027832|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93035833|NCT01027832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035834|NCT01027832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035835|NCT00413010|Pregabalin|pregabalin|mesh-list
93035836|NCT00413010|Analgesics|analgesics|mesh-ancestor
93035837|NCT00413010|Sensory System Agents|sensory system agents|mesh-ancestor
93035838|NCT00413010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210141|NCT04380103|Irinotecan|irinotecan|mesh-list
93035839|NCT00413010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035840|NCT00413010|Anticonvulsants|anticonvulsants|mesh-ancestor
93035841|NCT00413010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92210213|NCT01839253|Atenolol|atenolol|mesh-list
93035842|NCT00413010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035843|NCT00413010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035844|NCT00413010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035845|NCT00413010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93035846|NCT00413010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93035847|NCT00413010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93035848|NCT00413010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93035849|NCT00459290|Mifepristone|mifepristone|mesh-list
92210282|NCT02489734|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93035850|NCT00459290|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93035851|NCT00459290|Abortifacient Agents|abortifacient agents|mesh-ancestor
93035852|NCT00459290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93035853|NCT00459290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035854|NCT00459290|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93035855|NCT00459290|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93035856|NCT00459290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93035857|NCT00459290|Contraceptive Agents|contraceptive agents|mesh-ancestor
93035858|NCT00459290|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93035859|NCT00459290|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93035860|NCT00459290|Hormone Antagonists|hormone antagonists|mesh-ancestor
93035861|NCT00459290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035862|NCT00459290|Luteolytic Agents|luteolytic agents|mesh-ancestor
93035863|NCT00459290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93035864|NCT00459290|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93035865|NCT00443534|Sunitinib|sunitinib|mesh-list
93035866|NCT00443534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035867|NCT00443534|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93035868|NCT00443534|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93035869|NCT00443534|Growth Substances|growth substances|mesh-ancestor
93035870|NCT00443534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035871|NCT00443534|Growth Inhibitors|growth inhibitors|mesh-ancestor
93035872|NCT00443534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93035873|NCT00443534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035874|NCT00443534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035875|NCT00419952|Budesonide|budesonide|mesh-list
92210635|NCT04850638|Furosemide|furosemide|mesh-list
93035876|NCT00419952|Formoterol Fumarate|formoterol fumarate|mesh-list
93035877|NCT00419952|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93035878|NCT00419952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93035879|NCT00419952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93035880|NCT00419952|Autonomic Agents|autonomic agents|mesh-ancestor
93035881|NCT00419952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93035882|NCT00419952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035883|NCT00419952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93035884|NCT00419952|Respiratory System Agents|respiratory system agents|mesh-ancestor
93035885|NCT00419952|Glucocorticoids|glucocorticoids|mesh-ancestor
93035886|NCT00419952|Hormones|hormones|mesh-ancestor
93035887|NCT00419952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035888|NCT00419952|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93035889|NCT00419952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93035890|NCT00419952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93035891|NCT00419952|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035892|NCT00419952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035893|NCT00419952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035894|NCT00443456|Amlodipine|amlodipine|mesh-list
92210837|NCT02153489|Anticonvulsants|anticonvulsants|mesh-ancestor
93035895|NCT00443456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93035896|NCT00443456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92210915|NCT00829049|Adapalene|adapalene|mesh-list
93035897|NCT00443456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035898|NCT00443456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035899|NCT00443456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035900|NCT00443456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035902|NCT00419562|Insulin|insulin|mesh-list
93035903|NCT00419562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035904|NCT00419562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035905|NCT03557294|Varenicline|varenicline|mesh-list
93035906|NCT03557294|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93035907|NCT03557294|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93035908|NCT03557294|Cholinergic Agents|cholinergic agents|mesh-ancestor
93035909|NCT03557294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035910|NCT03557294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035911|NCT03557294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035912|NCT01026350|Antibodies|antibodies|mesh-list
93035913|NCT01026350|Immunologic Factors|immunologic factors|mesh-ancestor
93035914|NCT01026350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035915|NCT01026428|Levodopa|levodopa|mesh-list
93035916|NCT01026428|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93035917|NCT01026428|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93035918|NCT01026428|Dopamine Agents|dopamine agents|mesh-ancestor
93035919|NCT01026428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035920|NCT01026428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035921|NCT01026428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035922|NCT00308139|Exenatide|exenatide|mesh-list
93035923|NCT00308139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93035924|NCT00308139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035925|NCT00308139|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93035926|NCT00308139|Incretins|incretins|mesh-ancestor
93035927|NCT00308139|Hormones|hormones|mesh-ancestor
93035928|NCT00308139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035929|NCT00459056|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93035930|NCT00459056|Carvedilol|carvedilol|mesh-list
93035931|NCT00459056|Lisinopril|lisinopril|mesh-list
93035932|NCT00459056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93035933|NCT00459056|Diuretics|diuretics|mesh-ancestor
93035934|NCT00459056|Natriuretic Agents|natriuretic agents|mesh-ancestor
93035935|NCT00459056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035936|NCT00459056|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93035937|NCT00459056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93035938|NCT00459056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035939|NCT00459056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93035940|NCT00459056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93035941|NCT00459056|Adrenergic Agents|adrenergic agents|mesh-ancestor
93035942|NCT00459056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035943|NCT00459056|Antioxidants|antioxidants|mesh-ancestor
93035944|NCT00459056|Protective Agents|protective agents|mesh-ancestor
92211483|NCT04996134|Domperidone|domperidone|mesh-list
93035945|NCT00459056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93035946|NCT00459056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035947|NCT00459056|Vasodilator Agents|vasodilator agents|mesh-ancestor
93035948|NCT00459056|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93035949|NCT00459056|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93035950|NCT00459056|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93035951|NCT00459056|Protease Inhibitors|protease inhibitors|mesh-ancestor
93035952|NCT00459056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035953|NCT00459056|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93035954|NCT01062477|Vaccines|vaccines|mesh-list
93035955|NCT01062477|Immunologic Factors|immunologic factors|mesh-ancestor
93035956|NCT01062477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035957|NCT01323374|Carbidopa|carbidopa|mesh-list
93035958|NCT01323374|Droxidopa|droxidopa|mesh-list
93035959|NCT01323374|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93035960|NCT01323374|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92211617|NCT05521152|Norepinephrine|norepinephrine|mesh-list
93035961|NCT01323374|Dopamine Agents|dopamine agents|mesh-ancestor
93035962|NCT01323374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93035963|NCT01323374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035964|NCT01323374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035965|NCT01323374|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93035966|NCT01323374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035968|NCT00431964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035969|NCT00431964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035970|NCT00431496|Cinacalcet|cinacalcet|mesh-list
93035971|NCT00431496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93035972|NCT00431496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035973|NCT00431496|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93035974|NCT00431496|Hormone Antagonists|hormone antagonists|mesh-ancestor
93035975|NCT00431496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93035977|NCT00316173|Topotecan|topotecan|mesh-list
93035978|NCT00316173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93035979|NCT00316173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93035980|NCT00316173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93035981|NCT00316173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035982|NCT00316173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035983|NCT00412542|Thalidomide|thalidomide|mesh-list
93035984|NCT00412542|Irinotecan|irinotecan|mesh-list
93035985|NCT00412542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93035986|NCT00412542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93035987|NCT00412542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93035988|NCT00412542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93035989|NCT00412542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211960|NCT01048333|Autonomic Agents|autonomic agents|mesh-ancestor
93035990|NCT00412542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93035991|NCT00412542|Immunologic Factors|immunologic factors|mesh-ancestor
93035992|NCT00412542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93035993|NCT00412542|Leprostatic Agents|leprostatic agents|mesh-ancestor
93035994|NCT00412542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93035995|NCT00412542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93035996|NCT00412542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93035997|NCT00412542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93035998|NCT00412542|Growth Substances|growth substances|mesh-ancestor
93035999|NCT00412542|Growth Inhibitors|growth inhibitors|mesh-ancestor
93036000|NCT00316017|Dextrans|dextrans|mesh-list
93036001|NCT00316017|Anticoagulants|anticoagulants|mesh-ancestor
93036002|NCT00316017|Plasma Substitutes|plasma substitutes|mesh-ancestor
93036003|NCT00316017|Blood Substitutes|blood substitutes|mesh-ancestor
93036004|NCT00451178|Prednisone|prednisone|mesh-list
93036005|NCT00451178|Cyclophosphamide|cyclophosphamide|mesh-list
93036006|NCT00451178|Rituximab|rituximab|mesh-list
93036007|NCT00451178|Doxorubicin|doxorubicin|mesh-list
93036008|NCT00451178|Vincristine|vincristine|mesh-list
93036009|NCT00451178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036010|NCT00451178|Immunologic Factors|immunologic factors|mesh-ancestor
93036011|NCT00451178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036012|NCT00451178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036013|NCT00451178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93036014|NCT00451178|Alkylating Agents|alkylating agents|mesh-ancestor
93036015|NCT00451178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036016|NCT00451178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036017|NCT00451178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93036018|NCT00451178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036019|NCT00451178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93036020|NCT00451178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93036021|NCT00451178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93036022|NCT00451178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036023|NCT00451178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036024|NCT00451178|Glucocorticoids|glucocorticoids|mesh-ancestor
93036025|NCT00451178|Hormones|hormones|mesh-ancestor
93036026|NCT00451178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036027|NCT00451178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93036028|NCT00451178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93036029|NCT00451178|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036030|NCT00451178|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036031|NCT00451178|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036032|NCT00450866|Epothilones|epothilones|mesh-list
93036033|NCT00450866|Epothilone B|epothilone b|mesh-list
93036034|NCT00450866|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036035|NCT00450866|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036036|NCT00450866|Mitosis Modulators|mitosis modulators|mesh-ancestor
92212363|NCT04282954|Esomeprazole|esomeprazole|mesh-list
93036037|NCT00450866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036038|NCT00450866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036039|NCT01026584|Aripiprazole|aripiprazole|mesh-list
93036040|NCT01026584|Antidepressive Agents|antidepressive agents|mesh-ancestor
93036041|NCT01026584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93036042|NCT01026584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93036043|NCT01026584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93036044|NCT01026584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036045|NCT01026584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036046|NCT01026584|Dopamine Agonists|dopamine agonists|mesh-ancestor
93036047|NCT01026584|Dopamine Agents|dopamine agents|mesh-ancestor
93036048|NCT01026584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036049|NCT01026584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036050|NCT01026584|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93036051|NCT01026584|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93036053|NCT01026584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93036054|NCT01026584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93036055|NCT01026584|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93036056|NCT01026584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93036057|NCT01023464|Emollients|emollients|mesh-list
93036058|NCT01023464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93036059|NCT01023464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93036060|NCT01023464|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036061|NCT01023542|Everolimus|everolimus|mesh-list
93036062|NCT01023542|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93036063|NCT01023542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93036064|NCT01023542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036065|NCT01023542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036066|NCT01023542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036067|NCT01023542|Immunologic Factors|immunologic factors|mesh-ancestor
93036068|NCT01023542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212733|NCT01831505|Hormones|hormones|mesh-ancestor
93036069|NCT01023542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036070|NCT01026740|Ceftobiprole|ceftobiprole|mesh-list
93036071|NCT01026740|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
93036072|NCT01026740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93036073|NCT01026740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036074|NCT01028534|Olmesartan|olmesartan|mesh-list
93036075|NCT01028534|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93036076|NCT01028534|Calcium Channel Blockers|calcium channel blockers|mesh-list
93036077|NCT01028534|Angiotensin II|angiotensin ii|mesh-list
93036078|NCT01028534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
93036079|NCT01028534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93036080|NCT01028534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036081|NCT01028534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93036082|NCT01028534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93036083|NCT01028534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036084|NCT01028534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93036085|NCT01028534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93036086|NCT00441974|Adefovir|adefovir|mesh-list
93036087|NCT00441974|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93036088|NCT00441974|Antiviral Agents|antiviral agents|mesh-ancestor
93036089|NCT00441974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036090|NCT00441974|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93036091|NCT00441974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93036092|NCT00441974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036093|NCT00441974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036094|NCT00441584|Ribavirin|ribavirin|mesh-list
93036095|NCT00441584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93036096|NCT00441584|Interferon-alpha|interferon-alpha|mesh-list
93036097|NCT00441584|Antimetabolites|antimetabolites|mesh-ancestor
93036098|NCT00441584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036099|NCT00441584|Antiviral Agents|antiviral agents|mesh-ancestor
93036100|NCT00441584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036101|NCT00441584|Immunologic Factors|immunologic factors|mesh-ancestor
93036102|NCT00441584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036103|NCT00430716|Sildenafil Citrate|sildenafil citrate|mesh-list
93036104|NCT00430716|Citric Acid|citric acid|mesh-list
93036105|NCT00430716|Sodium Citrate|sodium citrate|mesh-list
93036106|NCT00430716|Anticoagulants|anticoagulants|mesh-ancestor
93036107|NCT00430716|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93036108|NCT00430716|Chelating Agents|chelating agents|mesh-ancestor
93036109|NCT00430716|Sequestering Agents|sequestering agents|mesh-ancestor
93036110|NCT00430716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036111|NCT00430716|Vasodilator Agents|vasodilator agents|mesh-ancestor
93036112|NCT00430716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93036113|NCT00430716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92213046|NCT03404479|Analgesics|analgesics|mesh-ancestor
93036114|NCT00430716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036115|NCT00430716|Urological Agents|urological agents|mesh-ancestor
93036116|NCT01028768|Teduglutide|teduglutide|mesh-list
93036117|NCT01028768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036118|NCT01028768|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93036119|NCT01028768|Protective Agents|protective agents|mesh-ancestor
93036120|NCT01028768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036121|NCT00441272|Pioglitazone|pioglitazone|mesh-list
93036122|NCT00441272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93036123|NCT00441272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036124|NCT01566552|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93036125|NCT01566552|Antifungal Agents|antifungal agents|mesh-ancestor
93036126|NCT01566552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036127|NCT01566552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93036128|NCT01566552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93036130|NCT01028924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036131|NCT01028924|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93036132|NCT01028924|Protective Agents|protective agents|mesh-ancestor
93036133|NCT01028924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036134|NCT01029002|Vitamin D|vitamin d|mesh-list
93036135|NCT01029002|Vitamins|vitamins|mesh-ancestor
93036136|NCT01029002|Micronutrients|micronutrients|mesh-ancestor
93036137|NCT01029002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036138|NCT01029002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93036139|NCT00430638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93036140|NCT00430638|Olmesartan|olmesartan|mesh-list
93036141|NCT00430638|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93036142|NCT00430638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93036143|NCT00430638|Diuretics|diuretics|mesh-ancestor
93036144|NCT00430638|Natriuretic Agents|natriuretic agents|mesh-ancestor
93036145|NCT00430638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036146|NCT00430638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93036147|NCT00430638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93036148|NCT00430638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213119|NCT02240953|Warfarin|warfarin|mesh-list
93036149|NCT00430638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93036150|NCT00430638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93036151|NCT03671330|Letrozole|letrozole|mesh-list
93036152|NCT03671330|Goserelin|goserelin|mesh-list
93036153|NCT03671330|Anastrozole|anastrozole|mesh-list
93036154|NCT03671330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036155|NCT03671330|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93036156|NCT03671330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93036157|NCT03671330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036158|NCT03671330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036159|NCT03671330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93036160|NCT03671330|Hormone Antagonists|hormone antagonists|mesh-ancestor
93036161|NCT03671330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036162|NCT03671330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036163|NCT03671330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93036164|NCT01038882|Midazolam|midazolam|mesh-list
93036165|NCT01038882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93036166|NCT01038882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93036167|NCT01038882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036168|NCT01038882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036169|NCT01038882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93036170|NCT01038882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93036171|NCT01038882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93036172|NCT01038882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93036173|NCT01038882|Anesthetics, General|anesthetics, general|mesh-ancestor
93036174|NCT01038882|Anesthetics|anesthetics|mesh-ancestor
93036175|NCT01038882|GABA Modulators|gaba modulators|mesh-ancestor
93036176|NCT01038882|GABA Agents|gaba agents|mesh-ancestor
93036177|NCT01038882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036178|NCT01038882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036179|NCT00449930|Metformin|metformin|mesh-list
93036180|NCT00449930|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93036181|NCT00449930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93036182|NCT00449930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036183|NCT00449930|Incretins|incretins|mesh-ancestor
93036184|NCT00449930|Hormones|hormones|mesh-ancestor
93036185|NCT00449930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036186|NCT00449930|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93036188|NCT00449930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036189|NCT00449930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036190|NCT00441116|Dutasteride|dutasteride|mesh-list
93036191|NCT00441116|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93036192|NCT00441116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93036193|NCT00441116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036194|NCT00441116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036195|NCT00441116|Hormone Antagonists|hormone antagonists|mesh-ancestor
93036196|NCT00441116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036197|NCT00441116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036198|NCT01024322|Diclofenac|diclofenac|mesh-list
93036199|NCT01024322|Prednisolone acetate|prednisolone acetate|mesh-list
93036200|NCT01024322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93036201|NCT01024322|Methylprednisolone|methylprednisolone|mesh-list
93036202|NCT01024322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93036203|NCT01024322|Prednisolone|prednisolone|mesh-list
93036204|NCT01024322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93036205|NCT01024322|Prednisolone phosphate|prednisolone phosphate|mesh-list
93036206|NCT01024322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93036207|NCT01024322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93036208|NCT01024322|Analgesics|analgesics|mesh-ancestor
93036209|NCT01024322|Sensory System Agents|sensory system agents|mesh-ancestor
93036210|NCT01024322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036211|NCT01024322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036212|NCT01024322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036213|NCT01024322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036214|NCT01024322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93036215|NCT01024322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036216|NCT01024322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036217|NCT01024322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036218|NCT01024322|Antiemetics|antiemetics|mesh-ancestor
93036219|NCT01024322|Autonomic Agents|autonomic agents|mesh-ancestor
93036220|NCT01024322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036221|NCT01024322|Glucocorticoids|glucocorticoids|mesh-ancestor
93036222|NCT01024322|Hormones|hormones|mesh-ancestor
93036223|NCT01024322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036224|NCT01024322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93036225|NCT01024322|Protective Agents|protective agents|mesh-ancestor
93036226|NCT01024322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93036227|NCT03320642|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93036228|NCT03320642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036229|NCT03320642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036230|NCT01566266|Amoxicillin|amoxicillin|mesh-list
93036231|NCT01566266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93036232|NCT01566266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036233|NCT00430248|Allopurinol|allopurinol|mesh-list
93036234|NCT00430248|Febuxostat|febuxostat|mesh-list
93036235|NCT00430248|Antimetabolites|antimetabolites|mesh-ancestor
93036236|NCT00430248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036237|NCT00430248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036238|NCT00430248|Gout Suppressants|gout suppressants|mesh-ancestor
93036239|NCT00430248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036240|NCT00430248|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93036241|NCT00430248|Antioxidants|antioxidants|mesh-ancestor
93036242|NCT00430248|Protective Agents|protective agents|mesh-ancestor
93036243|NCT00430248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036244|NCT00411762|Capecitabine|capecitabine|mesh-list
93036245|NCT00411762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036246|NCT00411762|Antimetabolites|antimetabolites|mesh-ancestor
93036247|NCT00411762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036248|NCT00411762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036249|NCT00429858|Gemcitabine|gemcitabine|mesh-list
93036250|NCT00429858|Tegafur|tegafur|mesh-list
93036251|NCT00429858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036252|NCT00429858|Antimetabolites|antimetabolites|mesh-ancestor
92214205|NCT00373126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036253|NCT00429858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036254|NCT00429858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036255|NCT01035216|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
93036256|NCT01035216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93036257|NCT01035216|Immunologic Factors|immunologic factors|mesh-ancestor
93036258|NCT01035216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036259|NCT00449150|Cetrorelix|cetrorelix|mesh-list
92214282|NCT02793154|Exenatide|exenatide|mesh-list
93036260|NCT00449150|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93036261|NCT00449150|Fertility Agents|fertility agents|mesh-ancestor
93036262|NCT00449150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93036263|NCT00449150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036264|NCT00449150|Hormone Antagonists|hormone antagonists|mesh-ancestor
92214343|NCT02793856|Cyclophosphamide|cyclophosphamide|mesh-list
93036265|NCT00449150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036266|NCT00428844|Vancomycin|vancomycin|mesh-list
93036267|NCT00428844|Daptomycin|daptomycin|mesh-list
93036268|NCT00428844|Teicoplanin|teicoplanin|mesh-list
93036269|NCT00428844|Floxacillin|floxacillin|mesh-list
93036270|NCT00428844|Oxacillin|oxacillin|mesh-list
93036271|NCT00428844|Nafcillin|nafcillin|mesh-list
92214410|NCT00913913|Growth Substances|growth substances|mesh-ancestor
93036272|NCT00428844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93036273|NCT00428844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036274|NCT00457418|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93036275|NCT00457418|Antiviral Agents|antiviral agents|mesh-ancestor
93036276|NCT00457418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036277|NCT01039194|Galantamine|galantamine|mesh-list
93036279|NCT01039194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93036280|NCT01039194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036281|NCT01039194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036282|NCT01039194|Cholinergic Agents|cholinergic agents|mesh-ancestor
93036283|NCT01039194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036284|NCT01039194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036285|NCT01039194|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93036286|NCT01039194|Autonomic Agents|autonomic agents|mesh-ancestor
93036287|NCT01039194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036288|NCT01039194|Nootropic Agents|nootropic agents|mesh-ancestor
93036289|NCT01039194|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93036290|NCT00449072|Loratadine|loratadine|mesh-list
93036291|NCT00449072|Antipruritics|antipruritics|mesh-ancestor
93036292|NCT00449072|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036293|NCT00449072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93036294|NCT00449072|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93036295|NCT00449072|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93036296|NCT00449072|Histamine Antagonists|histamine antagonists|mesh-ancestor
93036297|NCT00449072|Histamine Agents|histamine agents|mesh-ancestor
93036298|NCT00449072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036299|NCT00449072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036300|NCT00449072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036301|NCT00419094|Levetiracetam|levetiracetam|mesh-list
93036302|NCT00419094|Anticonvulsants|anticonvulsants|mesh-ancestor
93036303|NCT00419094|Nootropic Agents|nootropic agents|mesh-ancestor
93036304|NCT00448916|Pregabalin|pregabalin|mesh-list
93036305|NCT00448916|Analgesics|analgesics|mesh-ancestor
93036306|NCT00448916|Sensory System Agents|sensory system agents|mesh-ancestor
93036307|NCT00448916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036308|NCT00448916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036309|NCT00448916|Anticonvulsants|anticonvulsants|mesh-ancestor
93036310|NCT00448916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93036311|NCT00448916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93036312|NCT00448916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036313|NCT00448916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93036314|NCT00448916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93036315|NCT00448916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92214822|NCT04362241|Methylprednisolone|methylprednisolone|mesh-list
93036316|NCT00448916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036317|NCT00448916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93036318|NCT00418938|Leucovorin|leucovorin|mesh-list
93036319|NCT00418938|Bevacizumab|bevacizumab|mesh-list
93036320|NCT00418938|Panitumumab|panitumumab|mesh-list
93036321|NCT00418938|Fluorouracil|fluorouracil|mesh-list
93036322|NCT00418938|Irinotecan|irinotecan|mesh-list
93036323|NCT00418938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036324|NCT00418938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036325|NCT00418938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93036326|NCT00418938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93036327|NCT00418938|Growth Substances|growth substances|mesh-ancestor
93036328|NCT00418938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036329|NCT00418938|Growth Inhibitors|growth inhibitors|mesh-ancestor
93036330|NCT00418938|Antimetabolites|antimetabolites|mesh-ancestor
92215031|NCT03033355|Cholinergic Agents|cholinergic agents|mesh-ancestor
93036331|NCT00418938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036332|NCT00418938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036333|NCT00418938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036334|NCT00418938|Immunologic Factors|immunologic factors|mesh-ancestor
93036335|NCT00418938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93036336|NCT00418938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93036337|NCT00418938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036338|NCT00418938|Antidotes|antidotes|mesh-ancestor
93036339|NCT00418938|Protective Agents|protective agents|mesh-ancestor
93036340|NCT00418938|Vitamin B Complex|vitamin b complex|mesh-ancestor
93036341|NCT00418938|Vitamins|vitamins|mesh-ancestor
93036342|NCT00418938|Micronutrients|micronutrients|mesh-ancestor
93036343|NCT00448760|Leucovorin|leucovorin|mesh-list
93036344|NCT00448760|Docetaxel|docetaxel|mesh-list
93036345|NCT00448760|Oxaliplatin|oxaliplatin|mesh-list
93036346|NCT00448760|Floxuridine|floxuridine|mesh-list
93036347|NCT00448760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036348|NCT00448760|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036349|NCT00448760|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036350|NCT00448760|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036351|NCT00448760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036352|NCT00448760|Antidotes|antidotes|mesh-ancestor
93036353|NCT00448760|Protective Agents|protective agents|mesh-ancestor
93036354|NCT00448760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036355|NCT00448760|Vitamin B Complex|vitamin b complex|mesh-ancestor
93036357|NCT00448760|Micronutrients|micronutrients|mesh-ancestor
93036358|NCT00448760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036359|NCT00448760|Antimetabolites|antimetabolites|mesh-ancestor
93036360|NCT01039350|Darbepoetin alfa|darbepoetin alfa|mesh-list
93036361|NCT01039350|Hematinics|hematinics|mesh-ancestor
93036362|NCT01039506|Irinotecan|irinotecan|mesh-list
93036363|NCT01039506|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93036364|NCT01039506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93036365|NCT01039506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036366|NCT01039506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036367|NCT01039506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036368|NCT01033500|Abatacept|abatacept|mesh-list
93036369|NCT01033500|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93036370|NCT01033500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036371|NCT01033500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036372|NCT01033500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215369|NCT00950365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036373|NCT01033500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036374|NCT01033500|Immunologic Factors|immunologic factors|mesh-ancestor
93036375|NCT01033500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036376|NCT01033500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036377|NCT01035450|Sirolimus|sirolimus|mesh-list
93036378|NCT01035450|Everolimus|everolimus|mesh-list
93036379|NCT01035450|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93036380|NCT01035450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93036381|NCT01035450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036382|NCT01035450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036383|NCT01035450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036384|NCT01035450|Immunologic Factors|immunologic factors|mesh-ancestor
93036385|NCT01035450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036386|NCT01035450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036387|NCT01035450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93036388|NCT01035450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036389|NCT01035450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93036390|NCT01035450|Antifungal Agents|antifungal agents|mesh-ancestor
93036391|NCT01035528|Metformin|metformin|mesh-list
93036392|NCT01035528|Insulin Glargine|insulin glargine|mesh-list
93036393|NCT01035528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93036394|NCT01035528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036395|NCT01033656|Methotrexate|methotrexate|mesh-list
93036396|NCT01033656|Azathioprine|azathioprine|mesh-list
93036397|NCT01033656|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93036398|NCT01033656|Leflunomide|leflunomide|mesh-list
93036399|NCT01033656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93036400|NCT01033656|Abortifacient Agents|abortifacient agents|mesh-ancestor
93036401|NCT01033656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93036402|NCT01033656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036403|NCT01033656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036404|NCT01033656|Antimetabolites|antimetabolites|mesh-ancestor
93036405|NCT01033656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036406|NCT01033656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036407|NCT01033656|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036408|NCT01033656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036409|NCT01033656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93036410|NCT01033656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92215781|NCT04347005|Allopurinol|allopurinol|mesh-list
93036411|NCT01033656|Immunologic Factors|immunologic factors|mesh-ancestor
93036412|NCT01033656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036413|NCT01033656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93036415|NCT01039740|Antidepressive Agents|antidepressive agents|mesh-ancestor
93036416|NCT01039740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93036417|NCT01039740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93036418|NCT01039740|Histamine Antagonists|histamine antagonists|mesh-ancestor
93036419|NCT01039740|Histamine Agents|histamine agents|mesh-ancestor
93036420|NCT01039740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036421|NCT01039740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036422|NCT01039740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036423|NCT01039740|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92681659|NCT00463086|Isoniazid|isoniazid|mesh-list
93036424|NCT01039740|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93036425|NCT01039740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036426|NCT01039740|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93036427|NCT01039740|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93036428|NCT01039740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93036429|NCT01039740|Adrenergic Agents|adrenergic agents|mesh-ancestor
93036430|NCT01039740|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93036431|NCT01039740|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93036432|NCT01039740|Serotonin Agents|serotonin agents|mesh-ancestor
93036433|NCT01039740|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93036434|NCT00448136|Bevacizumab|bevacizumab|mesh-list
93036435|NCT00448136|Streptozocin|streptozocin|mesh-list
93036436|NCT00448136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036437|NCT00448136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036438|NCT00448136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93036439|NCT00448136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93036440|NCT00448136|Growth Substances|growth substances|mesh-ancestor
92215980|NCT02242253|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93036441|NCT00448136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036442|NCT00448136|Growth Inhibitors|growth inhibitors|mesh-ancestor
93036443|NCT00448136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93036444|NCT00447902|Ritonavir|ritonavir|mesh-list
93036445|NCT00447902|Tipranavir|tipranavir|mesh-list
93036446|NCT00447902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93036447|NCT00447902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93036448|NCT00447902|Protease Inhibitors|protease inhibitors|mesh-ancestor
93036449|NCT00447902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036450|NCT00447902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036451|NCT00447902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93036452|NCT00447902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93036453|NCT00447902|Antiviral Agents|antiviral agents|mesh-ancestor
93036454|NCT00447902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036455|NCT00447902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93036456|NCT00447902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93036457|NCT00307437|Ustekinumab|ustekinumab|mesh-list
93036458|NCT00307437|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036459|NCT00440726|Cytarabine|cytarabine|mesh-list
93036460|NCT00440726|Dexamethasone|dexamethasone|mesh-list
93036461|NCT00440726|Doxorubicin|doxorubicin|mesh-list
92216200|NCT04368377|PENTA|penta|mesh-list
93036462|NCT00440726|Methotrexate|methotrexate|mesh-list
93036463|NCT00440726|Vincristine|vincristine|mesh-list
93036464|NCT00440726|Bortezomib|bortezomib|mesh-list
93036465|NCT00440726|Asparaginase|asparaginase|mesh-list
93036466|NCT00440726|Pegaspargase|pegaspargase|mesh-list
93036467|NCT00440726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036468|NCT00440726|Antiemetics|antiemetics|mesh-ancestor
93036469|NCT00440726|Autonomic Agents|autonomic agents|mesh-ancestor
93036470|NCT00440726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036471|NCT00440726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036472|NCT00440726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036473|NCT00440726|Glucocorticoids|glucocorticoids|mesh-ancestor
93036474|NCT00440726|Hormones|hormones|mesh-ancestor
93036475|NCT00440726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036476|NCT00440726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93036477|NCT00440726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036478|NCT00440726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93036479|NCT00440726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93036480|NCT00440726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93036481|NCT00440726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036482|NCT00440726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216470|NCT04367051|Natriuretic Agents|natriuretic agents|mesh-ancestor
93036483|NCT00440726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93036484|NCT00440726|Abortifacient Agents|abortifacient agents|mesh-ancestor
93036485|NCT00440726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93036486|NCT00440726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036487|NCT00440726|Antimetabolites|antimetabolites|mesh-ancestor
93036488|NCT00440726|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036489|NCT00440726|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93036490|NCT00440726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92216552|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
93036491|NCT00440726|Immunologic Factors|immunologic factors|mesh-ancestor
93036492|NCT00440726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036493|NCT00440726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93036494|NCT00440726|Antiviral Agents|antiviral agents|mesh-ancestor
93036495|NCT00440726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036496|NCT00440726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93036497|NCT00440726|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036498|NCT00440726|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036499|NCT00440726|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036500|NCT01030016|Atenolol|atenolol|mesh-list
93036501|NCT01030016|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93036502|NCT01030016|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92681733|NCT00432653|Rituximab|rituximab|mesh-list
93036503|NCT01030016|Adrenergic Agents|adrenergic agents|mesh-ancestor
93036504|NCT01030016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036505|NCT01030016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036506|NCT01030016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036507|NCT01030016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93036508|NCT01030016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93036509|NCT01030016|Sympatholytics|sympatholytics|mesh-ancestor
93036510|NCT01030016|Autonomic Agents|autonomic agents|mesh-ancestor
93036511|NCT01030016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036512|NCT01030016|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93036513|NCT03996278|Thymoglobulin|thymoglobulin|mesh-list
93036514|NCT03996278|Immunologic Factors|immunologic factors|mesh-ancestor
93036515|NCT03996278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036516|NCT03996278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036517|NCT00447278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93036518|NCT00447278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93036519|NCT00447278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93036520|NCT00447278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93036521|NCT00447278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216738|NCT00937235|Varenicline|varenicline|mesh-list
93036522|NCT00447278|Adrenergic Agents|adrenergic agents|mesh-ancestor
93036523|NCT00447278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036524|NCT00447278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036525|NCT01030094|Topiramate|topiramate|mesh-list
93036526|NCT01030094|Carbamazepine|carbamazepine|mesh-list
93036527|NCT01030094|Valproic Acid|valproic acid|mesh-list
93036528|NCT01030094|Anticonvulsants|anticonvulsants|mesh-ancestor
93036529|NCT01030094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92216817|NCT01575925|BB 1101|bb 1101|mesh-list
93036530|NCT01030094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036531|NCT01030094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036532|NCT01030094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036533|NCT01030094|GABA Agents|gaba agents|mesh-ancestor
93036534|NCT01030094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036535|NCT01030094|Antimanic Agents|antimanic agents|mesh-ancestor
93036536|NCT01030094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93036537|NCT01030094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036538|NCT01030094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93036539|NCT01030094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93036540|NCT01030094|Analgesics|analgesics|mesh-ancestor
93036541|NCT01030094|Sensory System Agents|sensory system agents|mesh-ancestor
93036542|NCT01030094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036543|NCT01030094|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93036544|NCT01030094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93036545|NCT01030094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93036546|NCT01030094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93036547|NCT01565798|Copper|copper|mesh-list
93036548|NCT01565798|Trace Elements|trace elements|mesh-ancestor
93036549|NCT01565798|Micronutrients|micronutrients|mesh-ancestor
93036550|NCT01565798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036551|NCT01030328|Fenofibrate|fenofibrate|mesh-list
93036552|NCT01030328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93036553|NCT01030328|Antimetabolites|antimetabolites|mesh-ancestor
93036554|NCT01030328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036555|NCT01030328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93036556|NCT00405756|Aspirin|aspirin|mesh-list
93036557|NCT00405756|Prednisone|prednisone|mesh-list
93036558|NCT00405756|Lenalidomide|lenalidomide|mesh-list
93036559|NCT00405756|Melphalan|melphalan|mesh-list
93036560|NCT00405756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036561|NCT00405756|Glucocorticoids|glucocorticoids|mesh-ancestor
93036562|NCT00405756|Hormones|hormones|mesh-ancestor
93036563|NCT00405756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036564|NCT00405756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036565|NCT00405756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93036566|NCT00405756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036567|NCT00405756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93036568|NCT00405756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93036569|NCT00405756|Analgesics|analgesics|mesh-ancestor
93036570|NCT00405756|Sensory System Agents|sensory system agents|mesh-ancestor
93036571|NCT00405756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036572|NCT00405756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036573|NCT00405756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93036574|NCT00405756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92681803|NCT00433043|Antioxidants|antioxidants|mesh-ancestor
93036575|NCT00405756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217283|NCT04707118|Paclitaxel|paclitaxel|mesh-list
93036576|NCT00405756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93036577|NCT00405756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93036578|NCT00405756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036579|NCT00405756|Antipyretics|antipyretics|mesh-ancestor
93036580|NCT00405756|Immunologic Factors|immunologic factors|mesh-ancestor
93036581|NCT00405756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93036582|NCT00405756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93036583|NCT00405756|Growth Substances|growth substances|mesh-ancestor
93036584|NCT00405756|Growth Inhibitors|growth inhibitors|mesh-ancestor
93036585|NCT00405756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93036586|NCT00405756|Alkylating Agents|alkylating agents|mesh-ancestor
93036587|NCT00405756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93036588|NCT00405756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036589|NCT00456092|Apremilast|apremilast|mesh-list
93036590|NCT00456092|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93036591|NCT00456092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93036592|NCT00456092|Analgesics|analgesics|mesh-ancestor
93036593|NCT00456092|Sensory System Agents|sensory system agents|mesh-ancestor
93036594|NCT00456092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036595|NCT00456092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036596|NCT00456092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036597|NCT00456092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036598|NCT00456092|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93036599|NCT00456092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93036600|NCT00456092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036601|NCT00456092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036602|NCT01030640|Tanezumab|tanezumab|mesh-list
93036603|NCT01030640|Analgesics|analgesics|mesh-ancestor
93036604|NCT01030640|Sensory System Agents|sensory system agents|mesh-ancestor
93036605|NCT01030640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036606|NCT01030640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036607|NCT00411450|Panitumumab|panitumumab|mesh-list
92217696|NCT04049266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036608|NCT00411450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036609|NCT00411450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036610|NCT00404820|Vitamin D|vitamin d|mesh-list
93036611|NCT00404820|Zoledronic Acid|zoledronic acid|mesh-list
93036612|NCT00404820|Alendronate|alendronate|mesh-list
93036613|NCT00404820|Calcium|calcium|mesh-list
93036614|NCT00404820|Vitamins|vitamins|mesh-ancestor
93036615|NCT00404820|Micronutrients|micronutrients|mesh-ancestor
93036616|NCT00404820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036617|NCT00404820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93036618|NCT00404820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93036619|NCT00446030|Cyclophosphamide|cyclophosphamide|mesh-list
93036620|NCT00446030|Bevacizumab|bevacizumab|mesh-list
93036621|NCT00446030|Carboplatin|carboplatin|mesh-list
93036622|NCT00446030|Docetaxel|docetaxel|mesh-list
93036623|NCT00446030|Doxorubicin|doxorubicin|mesh-list
93036624|NCT00446030|Trastuzumab|trastuzumab|mesh-list
92217905|NCT03127137|Anesthetics, Local|anesthetics, local|mesh-ancestor
93036625|NCT00446030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036626|NCT00446030|Immunologic Factors|immunologic factors|mesh-ancestor
93036627|NCT00446030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036628|NCT00446030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036629|NCT00446030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93036630|NCT00446030|Alkylating Agents|alkylating agents|mesh-ancestor
93036631|NCT00446030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036632|NCT00446030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036633|NCT00446030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92382237|NCT04204200|Vitamins|vitamins|mesh-list
93036635|NCT00446030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92217977|NCT03505762|Prednisone|prednisone|mesh-list
93036636|NCT00446030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93036637|NCT00446030|Growth Substances|growth substances|mesh-ancestor
93036638|NCT00446030|Growth Inhibitors|growth inhibitors|mesh-ancestor
93036639|NCT00446030|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036640|NCT00446030|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036641|NCT00446030|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036642|NCT00446030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93036643|NCT00446030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93036644|NCT00446030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92218120|NCT03574779|Paclitaxel|paclitaxel|mesh-list
93036645|NCT00446030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036646|NCT00410514|Mirabegron|mirabegron|mesh-list
93036647|NCT00410514|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92218184|NCT00635102|Antimetabolites|antimetabolites|mesh-ancestor
93036648|NCT00410514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93036649|NCT00410514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93036650|NCT00410514|Adrenergic Agents|adrenergic agents|mesh-ancestor
93036651|NCT00410514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036652|NCT00410514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036653|NCT00410514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036654|NCT00410514|Urological Agents|urological agents|mesh-ancestor
93036655|NCT03847610|Penicillins|penicillins|mesh-list
93036656|NCT03847610|Penicillin V|penicillin v|mesh-list
93036657|NCT03847610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93036658|NCT03847610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036659|NCT01036854|Ondansetron|ondansetron|mesh-list
93036660|NCT01036854|Antiemetics|antiemetics|mesh-ancestor
93036661|NCT01036854|Autonomic Agents|autonomic agents|mesh-ancestor
93036662|NCT01036854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218325|NCT03421210|Nicotine|nicotine|mesh-list
93036663|NCT01036854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036664|NCT01036854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036665|NCT01036854|Antipruritics|antipruritics|mesh-ancestor
93036666|NCT01036854|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036667|NCT01036854|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93036668|NCT01036854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93036669|NCT01036854|Serotonin Agents|serotonin agents|mesh-ancestor
93036670|NCT01036854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036671|NCT01036854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036672|NCT01030796|Caffeine|caffeine|mesh-list
92218395|NCT03296800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036673|NCT01030796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93036674|NCT01030796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036675|NCT01030796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93036676|NCT01030796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036677|NCT01030796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036678|NCT01030796|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93036679|NCT01030796|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93036680|NCT01030796|Purinergic Agents|purinergic agents|mesh-ancestor
93036681|NCT01030796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93036682|NCT00455858|Insulin Detemir|insulin detemir|mesh-list
93036683|NCT00455858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93036684|NCT00455858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036685|NCT00439556|Cytarabine|cytarabine|mesh-list
93036686|NCT00439556|Rituximab|rituximab|mesh-list
93036687|NCT00439556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93036688|NCT00439556|Methotrexate|methotrexate|mesh-list
93036689|NCT00439556|Etoposide|etoposide|mesh-list
93036690|NCT00439556|Etoposide phosphate|etoposide phosphate|mesh-list
93036691|NCT00439556|Bortezomib|bortezomib|mesh-list
93036692|NCT00439556|Melphalan|melphalan|mesh-list
93036693|NCT00439556|Mechlorethamine|mechlorethamine|mesh-list
93036694|NCT00439556|Carmustine|carmustine|mesh-list
93036695|NCT00439556|Podophyllotoxin|podophyllotoxin|mesh-list
93036696|NCT00439556|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93036697|NCT00439556|Antibodies|antibodies|mesh-list
93036698|NCT00439556|Immunoglobulins|immunoglobulins|mesh-list
93036699|NCT00439556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93036700|NCT00439556|Lenograstim|lenograstim|mesh-list
93036701|NCT00439556|Tacrolimus|tacrolimus|mesh-list
93036702|NCT00439556|Thymoglobulin|thymoglobulin|mesh-list
93036703|NCT00439556|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93036704|NCT00439556|Immunologic Factors|immunologic factors|mesh-ancestor
93036705|NCT00439556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036706|NCT00439556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036707|NCT00439556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036708|NCT00439556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93036709|NCT00439556|Abortifacient Agents|abortifacient agents|mesh-ancestor
93036710|NCT00439556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93036712|NCT00439556|Antimetabolites|antimetabolites|mesh-ancestor
93036713|NCT00439556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036714|NCT00439556|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036715|NCT00439556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036716|NCT00439556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93036717|NCT00439556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036718|NCT00439556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93036719|NCT00439556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93036720|NCT00439556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93036721|NCT00439556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93036722|NCT00439556|Antiviral Agents|antiviral agents|mesh-ancestor
93036723|NCT00439556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036724|NCT00439556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93036725|NCT00439556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93036726|NCT00439556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93036727|NCT00439556|Alkylating Agents|alkylating agents|mesh-ancestor
93036728|NCT00439556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93036729|NCT00439556|Keratolytic Agents|keratolytic agents|mesh-ancestor
93036730|NCT00439556|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036731|NCT00439556|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036732|NCT00439556|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036733|NCT00410202|Tenofovir|tenofovir|mesh-list
93036734|NCT00410202|Lamivudine|lamivudine|mesh-list
93036735|NCT00410202|Entecavir|entecavir|mesh-list
93036736|NCT00410202|Adefovir|adefovir|mesh-list
93036737|NCT00410202|Antiviral Agents|antiviral agents|mesh-ancestor
93036738|NCT00410202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036739|NCT00410202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93036740|NCT00410202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93036741|NCT00410202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036742|NCT00410202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036743|NCT00410202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93036744|NCT00410202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93036745|NCT03802058|Paclitaxel|paclitaxel|mesh-list
93036746|NCT03802058|Carboplatin|carboplatin|mesh-list
93036747|NCT03802058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92218934|NCT00986180|Oxycodone|oxycodone|mesh-list
93036748|NCT03802058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036749|NCT03802058|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036750|NCT03802058|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036751|NCT03802058|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036752|NCT03802058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036753|NCT00445328|Heparin|heparin|mesh-list
93036754|NCT00445328|Calcium heparin|calcium heparin|mesh-list
93036755|NCT00445328|Dalteparin|dalteparin|mesh-list
93036756|NCT00445328|Tinzaparin|tinzaparin|mesh-list
93036757|NCT00445328|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93036758|NCT00445328|Anticoagulants|anticoagulants|mesh-ancestor
93036759|NCT00445328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93036760|NCT00445328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93036761|NCT00445328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036762|NCT00455312|Methylprednisolone|methylprednisolone|mesh-list
93036763|NCT00455312|Cyclophosphamide|cyclophosphamide|mesh-list
93036764|NCT00455312|Fludarabine|fludarabine|mesh-list
93036765|NCT00455312|Alemtuzumab|alemtuzumab|mesh-list
93036766|NCT00455312|Thymoglobulin|thymoglobulin|mesh-list
93036767|NCT00455312|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93036768|NCT00455312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036769|NCT00455312|Immunologic Factors|immunologic factors|mesh-ancestor
93036770|NCT00455312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036771|NCT00455312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036772|NCT00455312|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93036773|NCT00455312|Alkylating Agents|alkylating agents|mesh-ancestor
93036774|NCT00455312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036775|NCT00455312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036776|NCT00455312|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93036777|NCT00455312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036778|NCT00455312|Antiemetics|antiemetics|mesh-ancestor
93036779|NCT00455312|Autonomic Agents|autonomic agents|mesh-ancestor
93036780|NCT00455312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036781|NCT00455312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036782|NCT00455312|Glucocorticoids|glucocorticoids|mesh-ancestor
93036783|NCT00455312|Hormones|hormones|mesh-ancestor
93036784|NCT00455312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036785|NCT00455312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93036786|NCT00455312|Protective Agents|protective agents|mesh-ancestor
93036787|NCT00455312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93036788|NCT01031030|Cyclophosphamide|cyclophosphamide|mesh-list
93036790|NCT01031030|Methotrexate|methotrexate|mesh-list
93036791|NCT01031030|Epirubicin|epirubicin|mesh-list
93036792|NCT01031030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036793|NCT01031030|Immunologic Factors|immunologic factors|mesh-ancestor
93036794|NCT01031030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036795|NCT01031030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036796|NCT01031030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93036797|NCT01031030|Alkylating Agents|alkylating agents|mesh-ancestor
93036798|NCT01031030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036799|NCT01031030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036800|NCT01031030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93036801|NCT01031030|Antimetabolites|antimetabolites|mesh-ancestor
93036802|NCT01031030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036803|NCT01031030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92682030|NCT00464373|Botulinum Toxins|botulinum toxins|mesh-list
93036804|NCT01031030|Abortifacient Agents|abortifacient agents|mesh-ancestor
93036805|NCT01031030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93036806|NCT01031030|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036807|NCT01031030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036808|NCT01031030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93036809|NCT01031030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92219559|NCT03503578|Ketamine|ketamine|mesh-list
93036810|NCT01031030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93036811|NCT01031030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93036812|NCT01031030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93036813|NCT01024712|Paclitaxel|paclitaxel|mesh-list
92219626|NCT01078363|Ramipril|ramipril|mesh-list
93036814|NCT01024712|Carboplatin|carboplatin|mesh-list
93036815|NCT01024712|Gefitinib|gefitinib|mesh-list
93036816|NCT01024712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93036817|NCT01024712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036818|NCT01024712|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036819|NCT01024712|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036820|NCT01024712|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036821|NCT01024712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036822|NCT01024712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93036823|NCT01024712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036824|NCT01323452|Entecavir|entecavir|mesh-list
93036825|NCT01323452|Antiviral Agents|antiviral agents|mesh-ancestor
93036826|NCT01323452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036827|NCT00444626|Lidocaine|lidocaine|mesh-list
93036828|NCT00444626|Prilocaine|prilocaine|mesh-list
93036829|NCT00444626|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93036830|NCT00444626|Hyaluronic Acid|hyaluronic acid|mesh-list
93036831|NCT00444626|Anesthetics, Local|anesthetics, local|mesh-ancestor
93036832|NCT00444626|Anesthetics|anesthetics|mesh-ancestor
93036833|NCT00444626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036834|NCT00444626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036835|NCT00444626|Sensory System Agents|sensory system agents|mesh-ancestor
92219832|NCT01084759|Androgens|androgens|mesh-ancestor
93036836|NCT00444626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036837|NCT00444626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93036838|NCT00444626|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93036839|NCT00444626|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93036840|NCT00444626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93036841|NCT00444626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036842|NCT00444626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93036843|NCT00444626|Immunologic Factors|immunologic factors|mesh-ancestor
93036844|NCT00444626|Viscosupplements|viscosupplements|mesh-ancestor
93036845|NCT00444626|Protective Agents|protective agents|mesh-ancestor
93036846|NCT00444626|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
93036847|NCT01024868|Ropivacaine|ropivacaine|mesh-list
93036848|NCT01024868|Anesthetics, Local|anesthetics, local|mesh-ancestor
93036849|NCT01024868|Anesthetics|anesthetics|mesh-ancestor
93036850|NCT01024868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93036851|NCT01024868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036852|NCT01024868|Sensory System Agents|sensory system agents|mesh-ancestor
93036853|NCT01024868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036854|NCT03795194|Clavulanic Acid|clavulanic acid|mesh-list
93036855|NCT03795194|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93036856|NCT03795194|Clavulanic Acids|clavulanic acids|mesh-list
93036857|NCT03795194|Ampicillin|ampicillin|mesh-list
93036858|NCT03795194|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92219977|NCT02245529|Tamsulosin|tamsulosin|mesh-list
93036859|NCT03795194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036860|NCT03795194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036861|NCT03795194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93036862|NCT03795194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036863|NCT00404352|Interferon beta-1a|interferon beta-1a|mesh-list
93036864|NCT00404352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93036865|NCT00404352|Immunologic Factors|immunologic factors|mesh-ancestor
93036866|NCT00404352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036867|NCT00404352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036868|NCT00404352|Antiviral Agents|antiviral agents|mesh-ancestor
93036869|NCT00404352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036870|NCT00439244|Zoledronic Acid|zoledronic acid|mesh-list
92220040|NCT03032315|Amlodipine|amlodipine|mesh-list
93036871|NCT00439244|Teriparatide|teriparatide|mesh-list
93036872|NCT00439244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93036873|NCT00439244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036874|NCT00439244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93036875|NCT04844762|Menthol|menthol|mesh-list
93036876|NCT04844762|Antipruritics|antipruritics|mesh-ancestor
93036877|NCT04844762|Dermatologic Agents|dermatologic agents|mesh-ancestor
93036878|NCT01323218|Vitamin D|vitamin d|mesh-list
93036879|NCT01323218|Vitamins|vitamins|mesh-ancestor
93036880|NCT01323218|Micronutrients|micronutrients|mesh-ancestor
93036881|NCT01323218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036882|NCT01323218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93036883|NCT01323296|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93036884|NCT01323296|Hematinics|hematinics|mesh-ancestor
93036885|NCT01323296|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93036886|NCT01323296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93036887|NCT00438464|Finasteride|finasteride|mesh-list
93036888|NCT00438464|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93036889|NCT00438464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93036890|NCT00438464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036891|NCT00438464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036892|NCT00438464|Hormone Antagonists|hormone antagonists|mesh-ancestor
93036893|NCT00438464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93036894|NCT00438464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036895|NCT00438464|Urological Agents|urological agents|mesh-ancestor
93036896|NCT00437294|Capecitabine|capecitabine|mesh-list
93036897|NCT00437294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93036898|NCT00437294|Antimetabolites|antimetabolites|mesh-ancestor
93036899|NCT00437294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036900|NCT00437294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036901|NCT01033760|Ritonavir|ritonavir|mesh-list
93036902|NCT01033760|Darunavir|darunavir|mesh-list
93036903|NCT01033760|Tenofovir|tenofovir|mesh-list
93036904|NCT01033760|Emtricitabine|emtricitabine|mesh-list
93036905|NCT01033760|Raltegravir Potassium|raltegravir potassium|mesh-list
93036906|NCT01033760|Maraviroc|maraviroc|mesh-list
93036907|NCT01033760|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93036908|NCT01033760|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93036909|NCT01033760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93036910|NCT01033760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036911|NCT01033760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036912|NCT01033760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93036913|NCT01033760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93036914|NCT01033760|Antiviral Agents|antiviral agents|mesh-ancestor
93036915|NCT01033760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220373|NCT01118845|Rituximab|rituximab|mesh-list
93036916|NCT01033760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93036917|NCT01033760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93036918|NCT01033760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93036919|NCT01033760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93036920|NCT01033760|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93036921|NCT01033760|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93036922|NCT01033760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93036923|NCT01033760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93036924|NCT01033760|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93036925|NCT01031732|Tacrine|tacrine|mesh-list
93036926|NCT01031732|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93036927|NCT01031732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93036928|NCT01031732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036929|NCT01031732|Cholinergic Agents|cholinergic agents|mesh-ancestor
93036930|NCT01031732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220567|NCT03035357|Daratumumab|daratumumab|mesh-list
93036931|NCT01031732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036932|NCT01031732|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93036933|NCT01031732|Autonomic Agents|autonomic agents|mesh-ancestor
93036934|NCT01031732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036935|NCT01031732|Nootropic Agents|nootropic agents|mesh-ancestor
93036936|NCT01033994|Mitogens|mitogens|mesh-list
93036937|NCT01033994|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036938|NCT01033994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036939|NCT01031888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93036940|NCT01031888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93036941|NCT00436826|Interferons|interferons|mesh-list
93036942|NCT00436826|Interferon-beta|interferon-beta|mesh-list
93036943|NCT00436826|Cladribine|cladribine|mesh-list
93036944|NCT00436826|Interferon beta-1b|interferon beta-1b|mesh-list
93036945|NCT00436826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036946|NCT00436826|Antiviral Agents|antiviral agents|mesh-ancestor
93036947|NCT00436826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93036948|NCT00436826|Immunologic Factors|immunologic factors|mesh-ancestor
93036949|NCT00436826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036950|NCT00436826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036951|NCT00436826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93036952|NCT00410124|Everolimus|everolimus|mesh-list
93036953|NCT00410124|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93036954|NCT00410124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93036955|NCT00410124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682192|NCT00464919|Sorafenib|sorafenib|mesh-list
93036956|NCT00410124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036957|NCT00410124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036958|NCT00410124|Immunologic Factors|immunologic factors|mesh-ancestor
93036959|NCT00410124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036960|NCT00410124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036961|NCT01036932|Lenograstim|lenograstim|mesh-list
93036962|NCT01036932|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93036963|NCT01036932|Immunologic Factors|immunologic factors|mesh-ancestor
93036964|NCT01036932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036965|NCT00410046|Etanercept|etanercept|mesh-list
93036966|NCT00410046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93036967|NCT00410046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93036968|NCT00410046|Analgesics|analgesics|mesh-ancestor
93036969|NCT00410046|Sensory System Agents|sensory system agents|mesh-ancestor
93036970|NCT00410046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93036971|NCT00410046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93036972|NCT00410046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93036973|NCT00410046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93036974|NCT00410046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93036975|NCT00410046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93036976|NCT00410046|Immunologic Factors|immunologic factors|mesh-ancestor
93036977|NCT00416624|Epoetin Alfa|epoetin alfa|mesh-list
93036978|NCT00416624|Darbepoetin alfa|darbepoetin alfa|mesh-list
93036979|NCT00416624|Hematinics|hematinics|mesh-ancestor
93036980|NCT02501954|Paclitaxel|paclitaxel|mesh-list
92221024|NCT03633526|VX-659|vx-659|mesh-list
93036981|NCT02501954|Carboplatin|carboplatin|mesh-list
93036982|NCT02501954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93036983|NCT02501954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93036984|NCT02501954|Tubulin Modulators|tubulin modulators|mesh-ancestor
93036985|NCT02501954|Antimitotic Agents|antimitotic agents|mesh-ancestor
93036986|NCT02501954|Mitosis Modulators|mitosis modulators|mesh-ancestor
93036987|NCT02501954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036988|NCT00262600|Warfarin|warfarin|mesh-list
93036989|NCT00262600|Dabigatran|dabigatran|mesh-list
93036990|NCT00262600|Anticoagulants|anticoagulants|mesh-ancestor
93036991|NCT00262600|Antithrombins|antithrombins|mesh-ancestor
93036992|NCT00262600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93036993|NCT00262600|Protease Inhibitors|protease inhibitors|mesh-ancestor
93036994|NCT00262600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221190|NCT04425850|Ivermectin|ivermectin|mesh-list
93036995|NCT00262600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93036996|NCT00409578|Valsartan|valsartan|mesh-list
93036997|NCT00409578|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93036998|NCT00409578|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93036999|NCT00409578|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92221260|NCT01104025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037000|NCT00409578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037001|NCT01037322|Cannabidiol|cannabidiol|mesh-list
93037002|NCT01037322|Anticonvulsants|anticonvulsants|mesh-ancestor
93037003|NCT01070758|Lanreotide|lanreotide|mesh-list
93037004|NCT01070758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037005|NCT00428090|Rosiglitazone|rosiglitazone|mesh-list
93037006|NCT00428090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037007|NCT00428090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037008|NCT01031966|Thymalfasin|thymalfasin|mesh-list
93037009|NCT01031966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93037010|NCT01031966|Immunologic Factors|immunologic factors|mesh-ancestor
93037011|NCT01031966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037013|NCT00436436|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
93037014|NCT00436436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037015|NCT00436436|Alkylating Agents|alkylating agents|mesh-ancestor
93037016|NCT00436436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037017|NCT00436436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037018|NCT00436436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037019|NCT00262522|Ritonavir|ritonavir|mesh-list
93037020|NCT00262522|Lopinavir|lopinavir|mesh-list
93037021|NCT00262522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93037022|NCT00262522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93037023|NCT00262522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93037024|NCT00262522|Protease Inhibitors|protease inhibitors|mesh-ancestor
92221464|NCT03866434|Anagrelide|anagrelide|mesh-list
93037025|NCT00262522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037026|NCT00262522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037027|NCT00262522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93037028|NCT00262522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93037029|NCT00262522|Antiviral Agents|antiviral agents|mesh-ancestor
93037030|NCT00262522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037031|NCT00262522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93037032|NCT00262522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93037033|NCT00262522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93037034|NCT00436280|Rituximab|rituximab|mesh-list
93037035|NCT00436280|Gemcitabine|gemcitabine|mesh-list
93037036|NCT00436280|Oxaliplatin|oxaliplatin|mesh-list
93037037|NCT00436280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037038|NCT00436280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037039|NCT00436280|Immunologic Factors|immunologic factors|mesh-ancestor
93037040|NCT00436280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037041|NCT00436280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037042|NCT00436280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037043|NCT00436280|Antimetabolites|antimetabolites|mesh-ancestor
93037044|NCT00436280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037045|NCT00394836|Ofatumumab|ofatumumab|mesh-list
93037046|NCT00394836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93037047|NCT00394836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037048|NCT00394836|Immunologic Factors|immunologic factors|mesh-ancestor
93037049|NCT00394836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037050|NCT01040598|Omalizumab|omalizumab|mesh-list
93037051|NCT01040598|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93037052|NCT01040598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93037053|NCT01040598|Respiratory System Agents|respiratory system agents|mesh-ancestor
93037054|NCT01039974|Ketoconazole|ketoconazole|mesh-list
93037055|NCT01039974|Antifungal Agents|antifungal agents|mesh-ancestor
93037056|NCT01039974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037057|NCT01039974|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93037058|NCT01039974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93037059|NCT01039974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037060|NCT01039974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221812|NCT03797872|Prednisolone|prednisolone|mesh-list
93037061|NCT01039974|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93037062|NCT01039974|Hormone Antagonists|hormone antagonists|mesh-ancestor
93037063|NCT01039974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037064|NCT01039974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037065|NCT01039974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93037066|NCT01032122|Rituximab|rituximab|mesh-list
93037067|NCT01032122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037068|NCT01032122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037069|NCT01032122|Immunologic Factors|immunologic factors|mesh-ancestor
93037070|NCT01032122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037071|NCT01032122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037072|NCT03819660|Amifampridine|amifampridine|mesh-list
93037073|NCT03819660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93037074|NCT03819660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037075|NCT03819660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037076|NCT03819660|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93037077|NCT03819660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037078|NCT03819660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037079|NCT00394524|Insulin|insulin|mesh-list
93037080|NCT00394524|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92222092|NCT03011905|Antipyretics|antipyretics|mesh-ancestor
93037081|NCT00394524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037082|NCT00409344|Dexmedetomidine|dexmedetomidine|mesh-list
93037083|NCT00409344|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93037084|NCT00409344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037085|NCT00409344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037086|NCT00409344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93037087|NCT00409344|Analgesics|analgesics|mesh-ancestor
93037088|NCT00409344|Sensory System Agents|sensory system agents|mesh-ancestor
92222162|NCT01178827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037089|NCT00409344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037090|NCT00409344|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93037091|NCT00409344|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93037092|NCT00409344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93037093|NCT00409344|Adrenergic Agents|adrenergic agents|mesh-ancestor
93037094|NCT00409344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222232|NCT00980330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037095|NCT00409344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037096|NCT00415610|Nicardipine|nicardipine|mesh-list
93037097|NCT00415610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93037098|NCT00415610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93037099|NCT00415610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037100|NCT00415610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037101|NCT00415610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93037102|NCT00415610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037103|NCT00415610|Vasodilator Agents|vasodilator agents|mesh-ancestor
93037104|NCT01722812|Cromolyn Sodium|cromolyn sodium|mesh-list
93037105|NCT01722812|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
93037106|NCT01722812|Immunologic Factors|immunologic factors|mesh-ancestor
92682318|NCT00434681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037107|NCT01722812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037108|NCT01722812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93037109|NCT01722812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93037110|NCT01722812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93037111|NCT01722812|Respiratory System Agents|respiratory system agents|mesh-ancestor
93037112|NCT00250432|Caspofungin|caspofungin|mesh-list
93037113|NCT00250432|Antifungal Agents|antifungal agents|mesh-ancestor
93037114|NCT00250432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037115|NCT00250432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222447|NCT01928888|Histamine Agents|histamine agents|mesh-ancestor
93037116|NCT00250432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037117|NCT00249808|Antibodies|antibodies|mesh-list
93037118|NCT00249808|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93037119|NCT00249808|Immunologic Factors|immunologic factors|mesh-ancestor
93037120|NCT00249808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037121|NCT00278512|Cyclophosphamide|cyclophosphamide|mesh-list
93037122|NCT00278512|Fludarabine|fludarabine|mesh-list
93037123|NCT00278512|Alemtuzumab|alemtuzumab|mesh-list
93037124|NCT00278512|Tacrolimus|tacrolimus|mesh-list
93037125|NCT00278512|Thymoglobulin|thymoglobulin|mesh-list
93037126|NCT00278512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037127|NCT00278512|Immunologic Factors|immunologic factors|mesh-ancestor
93037128|NCT00278512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037129|NCT00278512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037130|NCT00278512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037131|NCT00278512|Alkylating Agents|alkylating agents|mesh-ancestor
93037132|NCT00278512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037133|NCT00278512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037134|NCT00278512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93037135|NCT00278512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93037136|NCT00278512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037137|NCT00278512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037138|NCT01072240|Rituximab|rituximab|mesh-list
93037139|NCT01072240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037140|NCT01072240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037141|NCT01072240|Immunologic Factors|immunologic factors|mesh-ancestor
93037142|NCT01072240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037143|NCT01072240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037144|NCT00427934|Maraviroc|maraviroc|mesh-list
93037145|NCT00427934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93037146|NCT00427934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93037147|NCT00427934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037148|NCT00427934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93037149|NCT00427934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93037150|NCT00427934|Antiviral Agents|antiviral agents|mesh-ancestor
93037151|NCT00427934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037152|NCT00427934|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93037153|NCT00427700|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93037154|NCT00427700|Clomiphene|clomiphene|mesh-list
93037155|NCT00427700|Enclomiphene|enclomiphene|mesh-list
93037156|NCT00427700|Zuclomiphene|zuclomiphene|mesh-list
93037157|NCT00427700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93037158|NCT00427700|Hormone Antagonists|hormone antagonists|mesh-ancestor
93037159|NCT00427700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037160|NCT00427700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037161|NCT00427700|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93037162|NCT00427700|Fertility Agents|fertility agents|mesh-ancestor
93037163|NCT00427700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93037164|NCT00427700|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93037165|NCT00427700|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93037166|NCT00427700|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037167|NCT01324076|Doxorubicin|doxorubicin|mesh-list
93037168|NCT01324076|Sorafenib|sorafenib|mesh-list
93037169|NCT01324076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93037170|NCT01324076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037171|NCT01324076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93037172|NCT01324076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93037173|NCT01324076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037174|NCT01324076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037175|NCT01324076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93037176|NCT00409188|Cyclophosphamide|cyclophosphamide|mesh-list
93037177|NCT00409188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037178|NCT00409188|Immunologic Factors|immunologic factors|mesh-ancestor
93037179|NCT00409188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037180|NCT00409188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037181|NCT00409188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037183|NCT00409188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037184|NCT00409188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037185|NCT00409188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93037186|NCT00434954|Insulin Aspart|insulin aspart|mesh-list
93037187|NCT00434954|Exenatide|exenatide|mesh-list
93037188|NCT00434954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037189|NCT00434954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037190|NCT00434954|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93037191|NCT00434954|Incretins|incretins|mesh-ancestor
93037192|NCT00434954|Hormones|hormones|mesh-ancestor
93037193|NCT00434954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037194|NCT00276484|Atorvastatin|atorvastatin|mesh-list
93037195|NCT00276484|Ezetimibe|ezetimibe|mesh-list
93037196|NCT00276484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93037197|NCT00276484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93037198|NCT00276484|Antimetabolites|antimetabolites|mesh-ancestor
93037199|NCT00276484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037200|NCT00276484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93037201|NCT00276484|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93037202|NCT00276484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037203|NCT00426842|Midodrine|midodrine|mesh-list
93037204|NCT00426842|Sympathomimetics|sympathomimetics|mesh-ancestor
93037205|NCT00426842|Autonomic Agents|autonomic agents|mesh-ancestor
93037206|NCT00426842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037207|NCT00426842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037208|NCT00426842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93037209|NCT00426842|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93037210|NCT00426842|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93037211|NCT00426842|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93037212|NCT00426842|Adrenergic Agents|adrenergic agents|mesh-ancestor
93037213|NCT00426842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223114|NCT03820466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93037214|NCT00426842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037215|NCT00434876|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93037216|NCT00434876|Antidepressive Agents|antidepressive agents|mesh-ancestor
93037217|NCT00434876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93037218|NCT00434876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93037219|NCT00434876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93037220|NCT00434876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223196|NCT02972294|Iron|iron|mesh-list
93037221|NCT00434876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037222|NCT01072318|Letrozole|letrozole|mesh-list
93037223|NCT01072318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037224|NCT01072318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93037225|NCT01072318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93037226|NCT01072318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382834|NCT01166724|Sirolimus|sirolimus|mesh-list
93037227|NCT01072318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037228|NCT01072318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93037229|NCT01072318|Hormone Antagonists|hormone antagonists|mesh-ancestor
93037230|NCT01072318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037231|NCT01072318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037232|NCT00276094|Tamoxifen|tamoxifen|mesh-list
93037233|NCT00276094|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93037234|NCT00276094|Hormone Antagonists|hormone antagonists|mesh-ancestor
93037235|NCT00276094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037236|NCT00276094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037237|NCT00276094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93037238|NCT00276094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037239|NCT00276094|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93037240|NCT00276094|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93037241|NCT00276094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037242|NCT03975088|Ranibizumab|ranibizumab|mesh-list
93037243|NCT03975088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93037244|NCT03975088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037245|NCT03975088|Growth Substances|growth substances|mesh-ancestor
93037246|NCT03975088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037247|NCT03975088|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037248|NCT03975088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037249|NCT00276016|Phenylephrine|phenylephrine|mesh-list
93037250|NCT00276016|Oxymetazoline|oxymetazoline|mesh-list
93037251|NCT00276016|Pseudoephedrine|pseudoephedrine|mesh-list
93037252|NCT00276016|Ephedrine|ephedrine|mesh-list
93037253|NCT00276016|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93037254|NCT00276016|Mydriatics|mydriatics|mesh-ancestor
93037255|NCT00276016|Autonomic Agents|autonomic agents|mesh-ancestor
93037256|NCT00276016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223435|NCT04124822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037257|NCT00276016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037258|NCT00276016|Sympathomimetics|sympathomimetics|mesh-ancestor
93037259|NCT00276016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93037260|NCT00276016|Nasal Decongestants|nasal decongestants|mesh-ancestor
93037261|NCT00276016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223510|NCT01454180|Leucovorin|leucovorin|mesh-list
93037262|NCT00276016|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93037263|NCT00276016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93037264|NCT00276016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93037265|NCT00276016|Adrenergic Agents|adrenergic agents|mesh-ancestor
93037266|NCT00276016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223578|NCT03820622|Mitosis Modulators|mitosis modulators|mesh-ancestor
93037267|NCT00276016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037268|NCT00276016|Protective Agents|protective agents|mesh-ancestor
93037269|NCT00276016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93037270|NCT00276016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93037271|NCT00276016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93037272|NCT00434642|Bevacizumab|bevacizumab|mesh-list
93037273|NCT00434642|Carboplatin|carboplatin|mesh-list
93037274|NCT00434642|Gemcitabine|gemcitabine|mesh-list
93037275|NCT00434642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037276|NCT00434642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037277|NCT00434642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93037278|NCT00434642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037279|NCT00434642|Growth Substances|growth substances|mesh-ancestor
93037280|NCT00434642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037281|NCT00434642|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037282|NCT00434642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037283|NCT00434642|Antimetabolites|antimetabolites|mesh-ancestor
93037284|NCT00434642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037285|NCT01032434|Sertraline|sertraline|mesh-list
93037286|NCT01032434|Antidepressive Agents|antidepressive agents|mesh-ancestor
93037287|NCT01032434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92223788|NCT03827018|Mavrilimumab|mavrilimumab|mesh-list
93037288|NCT01032434|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93037289|NCT01032434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93037290|NCT01032434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92223858|NCT03765502|Incretins|incretins|mesh-ancestor
93037291|NCT01032434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037292|NCT01032434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037293|NCT01032434|Serotonin Agents|serotonin agents|mesh-ancestor
93037294|NCT01032434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037295|NCT00426764|Romidepsin|romidepsin|mesh-list
93037296|NCT00426764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93037297|NCT00426764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037298|NCT00426764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93037300|NCT00426764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037301|NCT01032668|Clopidogrel|clopidogrel|mesh-list
93037302|NCT01032668|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93037303|NCT01032668|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93037304|NCT01032668|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93037305|NCT01032668|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93037306|NCT01032668|Purinergic Agents|purinergic agents|mesh-ancestor
93037307|NCT01032668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037308|NCT01032668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037309|NCT01032668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037310|NCT00434252|Paclitaxel|paclitaxel|mesh-list
93037311|NCT00434252|Bevacizumab|bevacizumab|mesh-list
93037312|NCT00434252|Carboplatin|carboplatin|mesh-list
93037313|NCT00434252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93037314|NCT00434252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037315|NCT00434252|Tubulin Modulators|tubulin modulators|mesh-ancestor
93037316|NCT00434252|Antimitotic Agents|antimitotic agents|mesh-ancestor
93037317|NCT00434252|Mitosis Modulators|mitosis modulators|mesh-ancestor
93037318|NCT00434252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037319|NCT00434252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037320|NCT00434252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92224209|NCT04011592|Ketamine|ketamine|mesh-list
93037321|NCT00434252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037322|NCT00434252|Growth Substances|growth substances|mesh-ancestor
93037323|NCT00434252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037324|NCT00434252|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037325|NCT00425750|Docetaxel|docetaxel|mesh-list
93037326|NCT00425750|Bortezomib|bortezomib|mesh-list
93037327|NCT00425750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037328|NCT00425750|Tubulin Modulators|tubulin modulators|mesh-ancestor
93037329|NCT00425750|Antimitotic Agents|antimitotic agents|mesh-ancestor
93037330|NCT00425750|Mitosis Modulators|mitosis modulators|mesh-ancestor
93037331|NCT00425750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037333|NCT00414908|Pancreatin|pancreatin|mesh-list
93037334|NCT00414908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037335|NCT00242710|Bazedoxifene|bazedoxifene|mesh-list
93037336|NCT00242710|Estrogens|estrogens|mesh-list
93037337|NCT00242710|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93037338|NCT00242710|Hormones|hormones|mesh-ancestor
93037339|NCT00242710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037340|NCT00242710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037341|NCT00242710|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93037342|NCT00242710|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93037343|NCT00242710|Hormone Antagonists|hormone antagonists|mesh-ancestor
93037344|NCT00242710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037345|NCT00408876|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93037346|NCT00408876|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93037347|NCT00408876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93037348|NCT00408876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037349|NCT00408876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037350|NCT00408876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037351|NCT00408876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037352|NCT00408876|Analgesics|analgesics|mesh-ancestor
93037353|NCT00408876|Sensory System Agents|sensory system agents|mesh-ancestor
93037354|NCT00408876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037355|NCT00408876|Antidepressive Agents|antidepressive agents|mesh-ancestor
93037356|NCT00408876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93037357|NCT00408876|Dopamine Agents|dopamine agents|mesh-ancestor
93037358|NCT00240994|Mycophenolic Acid|mycophenolic acid|mesh-list
93037359|NCT00240994|Sirolimus|sirolimus|mesh-list
93037360|NCT00240994|Alemtuzumab|alemtuzumab|mesh-list
93037361|NCT00240994|Tacrolimus|tacrolimus|mesh-list
93037362|NCT00240994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037363|NCT00240994|Immunologic Factors|immunologic factors|mesh-ancestor
93037364|NCT00240994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037365|NCT00240994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93037366|NCT00240994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037367|NCT00240994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037368|NCT00240994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93037369|NCT00240994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037370|NCT00240994|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93037371|NCT00240994|Antitubercular Agents|antitubercular agents|mesh-ancestor
92382970|NCT00726180|Trastuzumab|trastuzumab|mesh-list
93037372|NCT00240994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93037373|NCT00240994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037374|NCT00240994|Antifungal Agents|antifungal agents|mesh-ancestor
93037375|NCT00240994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037376|NCT01070836|Natalizumab|natalizumab|mesh-list
93037377|NCT01070836|Immunologic Factors|immunologic factors|mesh-ancestor
93037378|NCT01070836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224834|NCT01891916|Caseins|caseins|mesh-list
93037379|NCT00239590|Methyltestosterone|methyltestosterone|mesh-list
93037380|NCT00239590|Testosterone|testosterone|mesh-list
93037381|NCT00239590|Testosterone undecanoate|testosterone undecanoate|mesh-list
93037382|NCT00239590|Testosterone enanthate|testosterone enanthate|mesh-list
93037383|NCT00239590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93037384|NCT00239590|Androgens|androgens|mesh-ancestor
93037385|NCT00239590|Hormones|hormones|mesh-ancestor
93037386|NCT00239590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037387|NCT00239590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037388|NCT00239590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93037389|NCT00239590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037390|NCT00239590|Anabolic Agents|anabolic agents|mesh-ancestor
93037391|NCT00433160|Teriparatide|teriparatide|mesh-list
93037392|NCT00433160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93037393|NCT00433160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037394|NCT00433160|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037395|NCT00239356|Aripiprazole|aripiprazole|mesh-list
93037396|NCT00239356|Antidepressive Agents|antidepressive agents|mesh-ancestor
93037397|NCT00239356|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93037398|NCT00239356|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93037399|NCT00239356|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93037400|NCT00239356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037401|NCT00239356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682619|NCT00437333|Metformin|metformin|mesh-list
93037402|NCT00239356|Dopamine Agonists|dopamine agonists|mesh-ancestor
93037403|NCT00239356|Dopamine Agents|dopamine agents|mesh-ancestor
93037404|NCT00239356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037405|NCT00239356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037406|NCT00239356|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93037407|NCT00239356|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93037408|NCT00239356|Serotonin Agents|serotonin agents|mesh-ancestor
93037409|NCT00239356|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93037410|NCT00239356|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93037411|NCT00239356|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93037412|NCT00239356|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93037413|NCT00425438|Mycophenolic Acid|mycophenolic acid|mesh-list
93037414|NCT00425438|Prednisolone|prednisolone|mesh-list
93037415|NCT00425438|Cyclophosphamide|cyclophosphamide|mesh-list
93037416|NCT00425438|Azathioprine|azathioprine|mesh-list
93037417|NCT00425438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037418|NCT00425438|Immunologic Factors|immunologic factors|mesh-ancestor
93037419|NCT00425438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037420|NCT00425438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037421|NCT00425438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037422|NCT00425438|Alkylating Agents|alkylating agents|mesh-ancestor
93037423|NCT00425438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037424|NCT00425438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037425|NCT00425438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93037426|NCT00425438|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93037427|NCT00425438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93037428|NCT00425438|Antitubercular Agents|antitubercular agents|mesh-ancestor
93037429|NCT00425438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93037430|NCT00425438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037431|NCT00425438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037432|NCT00425438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93037433|NCT00425438|Glucocorticoids|glucocorticoids|mesh-ancestor
93037434|NCT00425438|Hormones|hormones|mesh-ancestor
93037435|NCT00425438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225156|NCT05507398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037436|NCT00425438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93037437|NCT00425438|Antimetabolites|antimetabolites|mesh-ancestor
93037438|NCT00425438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037439|NCT01041066|Labetalol|labetalol|mesh-list
93037440|NCT01041066|Nicardipine|nicardipine|mesh-list
93037441|NCT01041066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93037442|NCT01041066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93037443|NCT01041066|Adrenergic Agents|adrenergic agents|mesh-ancestor
93037444|NCT01041066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037445|NCT01041066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037446|NCT01041066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037447|NCT01041066|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93037448|NCT01041066|Sympathomimetics|sympathomimetics|mesh-ancestor
93037449|NCT01041066|Autonomic Agents|autonomic agents|mesh-ancestor
93037450|NCT01041066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037451|NCT01041066|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93037452|NCT01041066|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93037453|NCT01041066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93037454|NCT01041066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037455|NCT01041066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93037456|NCT01041066|Vasodilator Agents|vasodilator agents|mesh-ancestor
93037457|NCT01323608|Vitamin D|vitamin d|mesh-list
93037458|NCT01323608|Cholecalciferol|cholecalciferol|mesh-list
93037459|NCT01323608|Vitamins|vitamins|mesh-ancestor
93037460|NCT01323608|Micronutrients|micronutrients|mesh-ancestor
93037461|NCT01323608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037462|NCT01323608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037463|NCT01323608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93037464|NCT00275002|Temozolomide|temozolomide|mesh-list
93037465|NCT00275002|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92225427|NCT00996502|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037466|NCT00275002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037467|NCT00275002|Alkylating Agents|alkylating agents|mesh-ancestor
93037468|NCT00275002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037469|NCT00275002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037470|NCT00275002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037471|NCT00433004|Levonorgestrel|levonorgestrel|mesh-list
93037472|NCT00433004|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93037473|NCT00433004|Contraceptive Agents|contraceptive agents|mesh-ancestor
93037474|NCT00433004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92682689|NCT00437918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037475|NCT00433004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037476|NCT00433004|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93037477|NCT00433004|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93037478|NCT00433004|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93037479|NCT00393042|Amphetamine|amphetamine|mesh-list
93037480|NCT00393042|Adderall|adderall|mesh-list
93037481|NCT00393042|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
93037482|NCT00393042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93037483|NCT00393042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037484|NCT00393042|Sympathomimetics|sympathomimetics|mesh-ancestor
93037485|NCT00393042|Autonomic Agents|autonomic agents|mesh-ancestor
93037486|NCT00393042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037487|NCT00393042|Dopamine Agents|dopamine agents|mesh-ancestor
93037488|NCT00393042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037489|NCT00393042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037490|NCT00393042|Adrenergic Agents|adrenergic agents|mesh-ancestor
93037491|NCT00393042|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93037492|NCT00393042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93037493|NCT00393042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225776|NCT01675960|Anticonvulsants|anticonvulsants|mesh-ancestor
93037494|NCT00393042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93037495|NCT01040286|Chlorhexidine|chlorhexidine|mesh-list
93037496|NCT01040286|Flurbiprofen|flurbiprofen|mesh-list
93037497|NCT01040286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93037498|NCT01040286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037499|NCT01040286|Disinfectants|disinfectants|mesh-ancestor
93037500|NCT01040286|Analgesics|analgesics|mesh-ancestor
93037501|NCT01040286|Sensory System Agents|sensory system agents|mesh-ancestor
93037502|NCT01040286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037503|NCT01040286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037504|NCT01040286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92225915|NCT05482464|Sequestering Agents|sequestering agents|mesh-ancestor
93037505|NCT01040286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93037506|NCT01040286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93037507|NCT01040286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226017|NCT02598778|Listerine|listerine|mesh-list
93037508|NCT01040286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93037509|NCT01040286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037510|NCT01040286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037511|NCT01041378|Dexamethasone|dexamethasone|mesh-list
93037512|NCT01041378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93037513|NCT01041378|Antiemetics|antiemetics|mesh-ancestor
93037514|NCT01041378|Autonomic Agents|autonomic agents|mesh-ancestor
92226060|NCT00623974|Teriparatide|teriparatide|mesh-list
93037515|NCT01041378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037516|NCT01041378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037517|NCT01041378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037518|NCT01041378|Glucocorticoids|glucocorticoids|mesh-ancestor
93037519|NCT01041378|Hormones|hormones|mesh-ancestor
92226126|NCT00000736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93037520|NCT01041378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037521|NCT01041378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93037522|NCT01041378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037523|NCT03546192|Vaccines|vaccines|mesh-list
93037524|NCT03546192|Immunologic Factors|immunologic factors|mesh-ancestor
93037525|NCT03546192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037526|NCT01043952|Remifentanil|remifentanil|mesh-list
93037527|NCT01043952|Propofol|propofol|mesh-list
93037528|NCT01043952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93037529|NCT01043952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037530|NCT01043952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037531|NCT01043952|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93037532|NCT01043952|Anesthetics, General|anesthetics, general|mesh-ancestor
93037533|NCT01043952|Anesthetics|anesthetics|mesh-ancestor
93037534|NCT01043952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93037535|NCT01043952|Narcotics|narcotics|mesh-ancestor
93037536|NCT01043952|Analgesics|analgesics|mesh-ancestor
92226282|NCT00268450|Paclitaxel|paclitaxel|mesh-list
93037537|NCT01043952|Sensory System Agents|sensory system agents|mesh-ancestor
93037538|NCT01043952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037539|NCT00274846|Aldesleukin|aldesleukin|mesh-list
93037540|NCT00274846|Cyclophosphamide|cyclophosphamide|mesh-list
93037541|NCT00274846|Fludarabine|fludarabine|mesh-list
93037542|NCT00274846|Fludarabine phosphate|fludarabine phosphate|mesh-list
93037543|NCT00274846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037544|NCT00274846|Immunologic Factors|immunologic factors|mesh-ancestor
92226479|NCT00000850|Protease Inhibitors|protease inhibitors|mesh-ancestor
93037545|NCT00274846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037546|NCT00274846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037547|NCT00274846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037548|NCT00274846|Alkylating Agents|alkylating agents|mesh-ancestor
93037549|NCT00274846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037550|NCT00274846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037551|NCT00274846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93037552|NCT00274846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037553|NCT00274846|Antimetabolites|antimetabolites|mesh-ancestor
93037554|NCT00274846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93037555|NCT00274846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93037556|NCT00274846|Antiviral Agents|antiviral agents|mesh-ancestor
93037557|NCT00274846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037558|NCT01072786|Vaccines|vaccines|mesh-list
92226629|NCT02308280|Bortezomib|bortezomib|mesh-list
93037559|NCT01072786|Immunologic Factors|immunologic factors|mesh-ancestor
93037560|NCT01072786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037561|NCT03970798|Midazolam|midazolam|mesh-list
93037562|NCT03970798|Caffeine|caffeine|mesh-list
93037563|NCT03970798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93037564|NCT03970798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93037565|NCT03970798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93037566|NCT03970798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037567|NCT03970798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037568|NCT03970798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93037569|NCT03970798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92226689|NCT00001870|Acetylcholine|acetylcholine|mesh-list
93037570|NCT03970798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93037571|NCT03970798|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93037572|NCT03970798|Anesthetics, General|anesthetics, general|mesh-ancestor
93037573|NCT03970798|Anesthetics|anesthetics|mesh-ancestor
93037574|NCT03970798|GABA Modulators|gaba modulators|mesh-ancestor
93037575|NCT03970798|GABA Agents|gaba agents|mesh-ancestor
93037576|NCT03970798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226837|NCT02543346|Cetirizine|cetirizine|mesh-list
93037577|NCT03970798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037578|NCT03970798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93037579|NCT03970798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93037580|NCT03970798|Antimetabolites|antimetabolites|mesh-ancestor
93037581|NCT03970798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93037582|NCT03970798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93037583|NCT03970798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037584|NCT03970798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93037585|NCT03970798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92226910|NCT00000976|Antiviral Agents|antiviral agents|mesh-ancestor
93037586|NCT03970798|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93037587|NCT03970798|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93037588|NCT03970798|Purinergic Agents|purinergic agents|mesh-ancestor
93037589|NCT00414440|Everolimus|everolimus|mesh-list
93037590|NCT00414440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93037591|NCT00414440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93037592|NCT00414440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037593|NCT00414440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037594|NCT00414440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037595|NCT00414440|Immunologic Factors|immunologic factors|mesh-ancestor
93037596|NCT00414440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037597|NCT00414440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037598|NCT00209560|Fospropofol|fospropofol|mesh-list
93037599|NCT00209560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93037600|NCT00209560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037601|NCT00209560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037602|NCT01073800|Atorvastatin|atorvastatin|mesh-list
93037603|NCT01073800|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93037604|NCT01073800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93037605|NCT01073800|Antimetabolites|antimetabolites|mesh-ancestor
93037606|NCT01073800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037607|NCT01073800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93037608|NCT01073800|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93037609|NCT01073800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037610|NCT01037660|Metformin|metformin|mesh-list
93037611|NCT01037660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037612|NCT01037660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037613|NCT00236080|Modafinil|modafinil|mesh-list
93037614|NCT00236080|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93037615|NCT00236080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037616|NCT00236080|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93037617|NCT00236080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93037618|NCT00236080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92227332|NCT02548650|Clopidogrel|clopidogrel|mesh-list
93037619|NCT00236080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037620|NCT01033058|Atorvastatin|atorvastatin|mesh-list
93037621|NCT01033058|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93037622|NCT01033058|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93037623|NCT01033058|Antimetabolites|antimetabolites|mesh-ancestor
93037624|NCT01033058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037625|NCT01033058|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93037626|NCT01033058|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93037627|NCT01033058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037628|NCT03973138|Ranibizumab|ranibizumab|mesh-list
93037629|NCT03973138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93037630|NCT03973138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037631|NCT03973138|Growth Substances|growth substances|mesh-ancestor
93037632|NCT03973138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037633|NCT03973138|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037634|NCT03973138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037635|NCT01072942|Ciprofloxacin|ciprofloxacin|mesh-list
93037636|NCT01072942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93037637|NCT01072942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227535|NCT02535000|Analgesics|analgesics|mesh-ancestor
93037638|NCT01072942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93037639|NCT01072942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93037640|NCT01072942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037641|NCT01072942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037642|NCT01072942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037643|NCT01072942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92227673|NCT02723162|Antiviral Agents|antiviral agents|mesh-ancestor
93037644|NCT01072942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93037645|NCT00234052|Bevacizumab|bevacizumab|mesh-list
93037646|NCT00234052|Carboplatin|carboplatin|mesh-list
93037648|NCT00234052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037649|NCT00234052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037650|NCT00234052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93037651|NCT00234052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037652|NCT00234052|Growth Substances|growth substances|mesh-ancestor
92227812|NCT01195597|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93037653|NCT00234052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037654|NCT00234052|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037655|NCT00234052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037656|NCT00234052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037657|NCT00234052|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93037658|NCT00234052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93037659|NCT00408408|Cyclophosphamide|cyclophosphamide|mesh-list
93037660|NCT00408408|Bevacizumab|bevacizumab|mesh-list
93037661|NCT00408408|Gemcitabine|gemcitabine|mesh-list
93037662|NCT00408408|Docetaxel|docetaxel|mesh-list
93037663|NCT00408408|Doxorubicin|doxorubicin|mesh-list
93037664|NCT00408408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93037665|NCT00408408|Capecitabine|capecitabine|mesh-list
93037666|NCT00408408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037667|NCT00408408|Immunologic Factors|immunologic factors|mesh-ancestor
93037668|NCT00408408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037669|NCT00408408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037670|NCT00408408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037671|NCT00408408|Alkylating Agents|alkylating agents|mesh-ancestor
93037672|NCT00408408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037673|NCT00408408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228099|NCT00002092|Cimetidine|cimetidine|mesh-list
93037674|NCT00408408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93037675|NCT00408408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037676|NCT00408408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93037677|NCT00408408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037678|NCT00408408|Growth Substances|growth substances|mesh-ancestor
92228195|NCT00001438|Tretinoin|tretinoin|mesh-list
93037679|NCT00408408|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037680|NCT00408408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037681|NCT00408408|Antimetabolites|antimetabolites|mesh-ancestor
93037682|NCT00408408|Tubulin Modulators|tubulin modulators|mesh-ancestor
93037683|NCT00408408|Antimitotic Agents|antimitotic agents|mesh-ancestor
93037684|NCT00408408|Mitosis Modulators|mitosis modulators|mesh-ancestor
93037685|NCT00408408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93037686|NCT00408408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93037687|NCT00408408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93037688|NCT00408408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037689|NCT00414050|Vaccines|vaccines|mesh-list
93037690|NCT00414050|Immunologic Factors|immunologic factors|mesh-ancestor
93037691|NCT00414050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037692|NCT03973840|Methyltestosterone|methyltestosterone|mesh-list
93037693|NCT03973840|Testosterone|testosterone|mesh-list
93037694|NCT03973840|Testosterone undecanoate|testosterone undecanoate|mesh-list
93037695|NCT03973840|Testosterone enanthate|testosterone enanthate|mesh-list
93037696|NCT03973840|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93037697|NCT03973840|Androgens|androgens|mesh-ancestor
93037698|NCT03973840|Hormones|hormones|mesh-ancestor
93037699|NCT03973840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037701|NCT03973840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93037702|NCT03973840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037703|NCT03973840|Anabolic Agents|anabolic agents|mesh-ancestor
93037704|NCT00413972|Simvastatin|simvastatin|mesh-list
93037705|NCT00413972|Ezetimibe|ezetimibe|mesh-list
93037706|NCT00413972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93037707|NCT00413972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93037708|NCT00413972|Antimetabolites|antimetabolites|mesh-ancestor
93037709|NCT00413972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037710|NCT00413972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93037711|NCT00413972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93037712|NCT00413972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037713|NCT00259012|Pantoprazole|pantoprazole|mesh-list
93037714|NCT00259012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93037715|NCT00259012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037716|NCT00259012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93037717|NCT00259012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037718|NCT00259012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037719|NCT01044186|Deferasirox|deferasirox|mesh-list
93037720|NCT01044186|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93037721|NCT01044186|Chelating Agents|chelating agents|mesh-ancestor
92228667|NCT00002170|Antiviral Agents|antiviral agents|mesh-ancestor
93037722|NCT01044186|Sequestering Agents|sequestering agents|mesh-ancestor
93037723|NCT01044186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037724|NCT00209170|Escitalopram|escitalopram|mesh-list
93037725|NCT00209170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93037726|NCT00209170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93037727|NCT00209170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037728|NCT00209170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037729|NCT00209170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037730|NCT00209170|Serotonin Agents|serotonin agents|mesh-ancestor
93037731|NCT00209170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037732|NCT01071694|Interferons|interferons|mesh-list
93037733|NCT01071694|Interferon-beta|interferon-beta|mesh-list
93037734|NCT01071694|Interferon beta-1b|interferon beta-1b|mesh-list
93037735|NCT01071694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037736|NCT01071694|Antiviral Agents|antiviral agents|mesh-ancestor
93037737|NCT01071694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037738|NCT01071694|Immunologic Factors|immunologic factors|mesh-ancestor
93037739|NCT01071694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037741|NCT00413894|Epoetin Alfa|epoetin alfa|mesh-list
93037742|NCT00413894|Hematinics|hematinics|mesh-ancestor
93037743|NCT03972748|Itraconazole|itraconazole|mesh-list
93037744|NCT03972748|Antifungal Agents|antifungal agents|mesh-ancestor
92228968|NCT02168309|Labetalol|labetalol|mesh-list
93037745|NCT03972748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037746|NCT03972748|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93037747|NCT03972748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93037748|NCT03972748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037749|NCT03972748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037750|NCT03972748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93037751|NCT03972748|Hormone Antagonists|hormone antagonists|mesh-ancestor
93037752|NCT03972748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229026|NCT00995501|Hormones|hormones|mesh-ancestor
93037753|NCT03972748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037754|NCT03972748|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93037755|NCT01581814|Metformin|metformin|mesh-list
93037756|NCT01581814|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93037757|NCT01581814|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93037758|NCT01581814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037759|NCT01581814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037760|NCT01581814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93037761|NCT01581814|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93037762|NCT01581814|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93037763|NCT01581814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93037764|NCT01581814|Contraceptive Agents|contraceptive agents|mesh-ancestor
93037765|NCT01581814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93037766|NCT01581814|Estrogens|estrogens|mesh-ancestor
93037767|NCT01581814|Hormones|hormones|mesh-ancestor
93037768|NCT01581814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037769|NCT00407550|Gemcitabine|gemcitabine|mesh-list
93037770|NCT00407550|Pemetrexed|pemetrexed|mesh-list
93037771|NCT00407550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037772|NCT00407550|Antimetabolites|antimetabolites|mesh-ancestor
93037773|NCT00407550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037774|NCT00407550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037775|NCT00407550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037776|NCT00407550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93037777|NCT00407550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93037779|NCT00209092|Capecitabine|capecitabine|mesh-list
93037780|NCT00209092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037781|NCT00209092|Tubulin Modulators|tubulin modulators|mesh-ancestor
93037782|NCT00209092|Antimitotic Agents|antimitotic agents|mesh-ancestor
93037783|NCT00209092|Mitosis Modulators|mitosis modulators|mesh-ancestor
93037784|NCT00209092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037785|NCT00209092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037786|NCT00209092|Antimetabolites|antimetabolites|mesh-ancestor
93037787|NCT03972982|Insulin|insulin|mesh-list
93037788|NCT03972982|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93037789|NCT03972982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037790|NCT03972982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037791|NCT00403494|Verapamil|verapamil|mesh-list
93037792|NCT00403494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93037793|NCT00403494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93037794|NCT00403494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037795|NCT00403494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037796|NCT00403494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93037797|NCT00403494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229592|NCT00002440|Nelfinavir|nelfinavir|mesh-list
93037798|NCT00403494|Vasodilator Agents|vasodilator agents|mesh-ancestor
93037799|NCT00403260|Artesunate|artesunate|mesh-list
93037800|NCT00403260|Mefloquine|mefloquine|mesh-list
93037801|NCT00403260|Pyronaridine|pyronaridine|mesh-list
93037802|NCT00403260|Antimalarials|antimalarials|mesh-ancestor
93037803|NCT00403260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93037804|NCT00403260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93037805|NCT00403260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037806|NCT00403260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037807|NCT00403260|Antiviral Agents|antiviral agents|mesh-ancestor
93037808|NCT00403260|Schistosomicides|schistosomicides|mesh-ancestor
93037809|NCT00403260|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92229744|NCT00002476|Cobalt|cobalt|mesh-list
93037810|NCT00403260|Anthelmintics|anthelmintics|mesh-ancestor
93037811|NCT00406848|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92529168|NCT00015288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037812|NCT00406848|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92229804|NCT01004705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037813|NCT00406848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93037814|NCT00406848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037815|NCT00406848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037816|NCT00406848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037817|NCT00406848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037818|NCT00406848|Analgesics|analgesics|mesh-ancestor
93037819|NCT00406848|Sensory System Agents|sensory system agents|mesh-ancestor
93037820|NCT00406848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037821|NCT00406848|Antidepressive Agents|antidepressive agents|mesh-ancestor
93037822|NCT00406848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93037823|NCT00406848|Dopamine Agents|dopamine agents|mesh-ancestor
93037824|NCT00406692|Zonisamide|zonisamide|mesh-list
93037825|NCT00406692|Anticonvulsants|anticonvulsants|mesh-ancestor
93037826|NCT00406692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93037827|NCT00406692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037828|NCT00406692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037829|NCT00406692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93037830|NCT00406692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037831|NCT00004494|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
93037832|NCT00004494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037833|NCT00004494|Vasodilator Agents|vasodilator agents|mesh-ancestor
93037834|NCT00004494|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93037835|NCT00004494|Protective Agents|protective agents|mesh-ancestor
93037836|NCT00004494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037837|NCT00315705|Cyclophosphamide|cyclophosphamide|mesh-list
93037838|NCT00315705|Etoposide|etoposide|mesh-list
93037839|NCT00315705|Clofarabine|clofarabine|mesh-list
93037840|NCT00315705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037841|NCT00315705|Immunologic Factors|immunologic factors|mesh-ancestor
93037842|NCT00315705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037843|NCT00315705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037844|NCT00315705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93037845|NCT00315705|Alkylating Agents|alkylating agents|mesh-ancestor
93037846|NCT00315705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037847|NCT00315705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037848|NCT00315705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93037849|NCT00315705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93037850|NCT00315705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93037851|NCT00315705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93037853|NCT00315705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037854|NCT00315705|Antimetabolites|antimetabolites|mesh-ancestor
93037855|NCT03982173|Durvalumab|durvalumab|mesh-list
93037856|NCT03982173|Tremelimumab|tremelimumab|mesh-list
93037857|NCT03982173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92230180|NCT01823198|Busulfan|busulfan|mesh-list
93037858|NCT03982173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037859|NCT01062633|Erythritol|erythritol|mesh-list
93037860|NCT01062633|Sorbitol|sorbitol|mesh-list
93037861|NCT01062633|Vasodilator Agents|vasodilator agents|mesh-ancestor
93037862|NCT01062633|Cathartics|cathartics|mesh-ancestor
93037863|NCT01062633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037864|NCT00307125|Rituximab|rituximab|mesh-list
93037865|NCT00307125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93037866|NCT00307125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037867|NCT00307125|Immunologic Factors|immunologic factors|mesh-ancestor
93037868|NCT00307125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037869|NCT00307125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93037870|NCT01066299|Oxytocin|oxytocin|mesh-list
93037871|NCT01066299|Oxytocics|oxytocics|mesh-ancestor
93037872|NCT01066299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93037873|NCT01066299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037874|NCT00307047|Paclitaxel|paclitaxel|mesh-list
93037875|NCT00307047|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93037876|NCT00307047|Everolimus|everolimus|mesh-list
93037877|NCT00307047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93037878|NCT00307047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037879|NCT00307047|Tubulin Modulators|tubulin modulators|mesh-ancestor
93037880|NCT00307047|Antimitotic Agents|antimitotic agents|mesh-ancestor
93037881|NCT00307047|Mitosis Modulators|mitosis modulators|mesh-ancestor
93037882|NCT00307047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037883|NCT00307047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93037884|NCT00307047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93037885|NCT00307047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037886|NCT00307047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037887|NCT00307047|Immunologic Factors|immunologic factors|mesh-ancestor
93037888|NCT00307047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037889|NCT01066377|Sulfalene|sulfalene|mesh-list
93037890|NCT01066377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93037891|NCT01066377|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92230360|NCT05276219|Isosorbide|isosorbide|mesh-list
93037892|NCT01066377|Antimalarials|antimalarials|mesh-ancestor
93037893|NCT01066377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93037894|NCT01066377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93037895|NCT00306891|Cediranib|cediranib|mesh-list
93037896|NCT00306891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037897|NCT00306891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93037898|NCT00306891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037899|NCT00306891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037900|NCT03980847|Alendronate|alendronate|mesh-list
93037901|NCT03980847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037902|NCT03980847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037903|NCT00391872|Clopidogrel|clopidogrel|mesh-list
93037904|NCT00391872|Ticagrelor|ticagrelor|mesh-list
93037905|NCT00391872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93037906|NCT00391872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93037907|NCT00391872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93037908|NCT00391872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93037909|NCT00391872|Purinergic Agents|purinergic agents|mesh-ancestor
93037910|NCT00391872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037911|NCT00391872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037912|NCT00391872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037913|NCT00391170|Dexamethasone|dexamethasone|mesh-list
93037914|NCT00391170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93037915|NCT00391170|Antiemetics|antiemetics|mesh-ancestor
93037916|NCT00391170|Autonomic Agents|autonomic agents|mesh-ancestor
93037917|NCT00391170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037918|NCT00391170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037919|NCT00391170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037920|NCT00391170|Glucocorticoids|glucocorticoids|mesh-ancestor
93037921|NCT00391170|Hormones|hormones|mesh-ancestor
93037922|NCT00391170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230414|NCT01313702|Protease Inhibitors|protease inhibitors|mesh-ancestor
93037923|NCT00391170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93037924|NCT00391170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037925|NCT00402324|Valproic Acid|valproic acid|mesh-list
93037926|NCT00402324|Olanzapine|olanzapine|mesh-list
93037927|NCT00402324|Antiemetics|antiemetics|mesh-ancestor
93037928|NCT00402324|Autonomic Agents|autonomic agents|mesh-ancestor
93037929|NCT00402324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037930|NCT00402324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037931|NCT00402324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93037932|NCT00402324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93037933|NCT00402324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93037934|NCT00402324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037935|NCT00402324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93037936|NCT00402324|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93037937|NCT00402324|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93037938|NCT00402324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93037939|NCT00402324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037940|NCT00402324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93037941|NCT00402324|Serotonin Agents|serotonin agents|mesh-ancestor
93037942|NCT00402324|Anticonvulsants|anticonvulsants|mesh-ancestor
93037943|NCT00402324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93037944|NCT00402324|GABA Agents|gaba agents|mesh-ancestor
93037945|NCT00402324|Antimanic Agents|antimanic agents|mesh-ancestor
93037946|NCT00294723|Liraglutide|liraglutide|mesh-list
93037947|NCT00294723|Glimepiride|glimepiride|mesh-list
93037948|NCT00294723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037949|NCT00294723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037950|NCT00294723|Incretins|incretins|mesh-ancestor
93037951|NCT00294723|Hormones|hormones|mesh-ancestor
93037952|NCT00294723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037953|NCT00294723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93037954|NCT00294723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93037955|NCT00294723|Immunologic Factors|immunologic factors|mesh-ancestor
93037956|NCT00375492|Exenatide|exenatide|mesh-list
93037957|NCT00375492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93037958|NCT00375492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037959|NCT00375492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93037960|NCT00375492|Incretins|incretins|mesh-ancestor
93037961|NCT00375492|Hormones|hormones|mesh-ancestor
93037962|NCT00375492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93037964|NCT00306189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93037965|NCT00306189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037966|NCT00305877|Bevacizumab|bevacizumab|mesh-list
93037967|NCT00305877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93037968|NCT00305877|Cetuximab|cetuximab|mesh-list
93037969|NCT00305877|Gemcitabine|gemcitabine|mesh-list
93037970|NCT00305877|Capecitabine|capecitabine|mesh-list
93037971|NCT00305877|Antibodies|antibodies|mesh-list
93037972|NCT00305877|Immunoglobulins|immunoglobulins|mesh-list
93037973|NCT00305877|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93037974|NCT00305877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93037975|NCT00305877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93037976|NCT00305877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93037977|NCT00305877|Growth Substances|growth substances|mesh-ancestor
93037978|NCT00305877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230562|NCT00254384|Cisplatin|cisplatin|mesh-list
93037979|NCT00305877|Growth Inhibitors|growth inhibitors|mesh-ancestor
93037980|NCT00305877|Immunologic Factors|immunologic factors|mesh-ancestor
93037981|NCT00305877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93037982|NCT00305877|Antimetabolites|antimetabolites|mesh-ancestor
92230634|NCT00002590|Prednisone|prednisone|mesh-list
93037983|NCT00305877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93037984|NCT00312195|Buprenorphine|buprenorphine|mesh-list
93037985|NCT00312195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93037986|NCT00312195|Narcotics|narcotics|mesh-ancestor
93037987|NCT00312195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93037988|NCT00312195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93037989|NCT00312195|Analgesics|analgesics|mesh-ancestor
92230710|NCT00199082|Vindesine|vindesine|mesh-list
93037990|NCT00312195|Sensory System Agents|sensory system agents|mesh-ancestor
93037991|NCT00312195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93037992|NCT00312195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93037993|NCT02532777|Mycophenolic Acid|mycophenolic acid|mesh-list
93037994|NCT02532777|Prednisone|prednisone|mesh-list
93037995|NCT02532777|Methylprednisolone|methylprednisolone|mesh-list
93037996|NCT02532777|Cyclophosphamide|cyclophosphamide|mesh-list
93037997|NCT02532777|Leflunomide|leflunomide|mesh-list
93037998|NCT02532777|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93037999|NCT02532777|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93038000|NCT02532777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038001|NCT02532777|Immunologic Factors|immunologic factors|mesh-ancestor
93038002|NCT02532777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038003|NCT02532777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038004|NCT02532777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038005|NCT02532777|Alkylating Agents|alkylating agents|mesh-ancestor
93038006|NCT02532777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038007|NCT02532777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038008|NCT02532777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038009|NCT02532777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93038010|NCT02532777|Glucocorticoids|glucocorticoids|mesh-ancestor
93038012|NCT02532777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038013|NCT02532777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038014|NCT02532777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93038015|NCT02532777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93038016|NCT02532777|Antitubercular Agents|antitubercular agents|mesh-ancestor
93038017|NCT02532777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93038018|NCT02532777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038019|NCT02532777|Antiemetics|antiemetics|mesh-ancestor
93038020|NCT02532777|Autonomic Agents|autonomic agents|mesh-ancestor
93038021|NCT02532777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038022|NCT02532777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038023|NCT02532777|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93038024|NCT02532777|Protective Agents|protective agents|mesh-ancestor
93038025|NCT02532777|Protease Inhibitors|protease inhibitors|mesh-ancestor
93038026|NCT01062945|Doxazosin|doxazosin|mesh-list
93038027|NCT01062945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92230971|NCT05073718|Aspirin|aspirin|mesh-list
93038028|NCT01062945|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93038029|NCT01062945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93038030|NCT01062945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93038031|NCT01062945|Adrenergic Agents|adrenergic agents|mesh-ancestor
93038032|NCT01062945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038033|NCT01062945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038034|NCT01062945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038035|NCT01063023|Moxifloxacin|moxifloxacin|mesh-list
92231116|NCT00002716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038036|NCT01063023|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93038038|NCT01063023|Protease Inhibitors|protease inhibitors|mesh-ancestor
93038039|NCT01063023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038040|NCT01063023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038041|NCT01063023|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93038042|NCT01063023|Contraceptive Agents|contraceptive agents|mesh-ancestor
93038043|NCT01063023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93038044|NCT01063023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038045|NCT01063023|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93038046|NCT01063023|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93038047|NCT01063023|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93038048|NCT01063023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93038049|NCT01063023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038050|NCT01063023|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038051|NCT01063023|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231265|NCT00002764|Ifosfamide|ifosfamide|mesh-list
93038052|NCT01063023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038053|NCT01063101|Fucoidan|fucoidan|mesh-list
93038054|NCT01063101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93038055|NCT01063101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038056|NCT01063101|Anticoagulants|anticoagulants|mesh-ancestor
93038057|NCT01063101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038058|NCT01066689|Rituximab|rituximab|mesh-list
93038059|NCT01066689|Citric Acid|citric acid|mesh-list
93038060|NCT01066689|Sodium Citrate|sodium citrate|mesh-list
93038061|NCT01066689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038062|NCT01066689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038063|NCT01066689|Immunologic Factors|immunologic factors|mesh-ancestor
93038064|NCT01066689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038065|NCT01066689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038066|NCT01066689|Anticoagulants|anticoagulants|mesh-ancestor
93038067|NCT01066689|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93038068|NCT01066689|Chelating Agents|chelating agents|mesh-ancestor
93038069|NCT01066689|Sequestering Agents|sequestering agents|mesh-ancestor
93038070|NCT01066689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038071|NCT00293709|Etanercept|etanercept|mesh-list
93038072|NCT00293709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93038073|NCT00293709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93038074|NCT00293709|Analgesics|analgesics|mesh-ancestor
93038075|NCT00293709|Sensory System Agents|sensory system agents|mesh-ancestor
93038076|NCT00293709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038077|NCT00293709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038078|NCT00293709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93038079|NCT00293709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038080|NCT00293709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038081|NCT00293709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038082|NCT00293709|Immunologic Factors|immunologic factors|mesh-ancestor
93038083|NCT01063257|Clofarabine|clofarabine|mesh-list
93038084|NCT01063257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93038085|NCT01063257|Antimetabolites|antimetabolites|mesh-ancestor
93038086|NCT01063257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038087|NCT01063257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038088|NCT03977649|Erenumab|erenumab|mesh-list
93038089|NCT03977649|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93038090|NCT03977649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038091|NCT03977649|Analgesics|analgesics|mesh-ancestor
93038092|NCT03977649|Sensory System Agents|sensory system agents|mesh-ancestor
93038093|NCT03977649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038094|NCT03977649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038095|NCT01066767|Fexofenadine|fexofenadine|mesh-list
93038096|NCT01066767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93038097|NCT01066767|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93038098|NCT01066767|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93038099|NCT01066767|Histamine Antagonists|histamine antagonists|mesh-ancestor
93038100|NCT01066767|Histamine Agents|histamine agents|mesh-ancestor
93038101|NCT01066767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038102|NCT01066767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038103|NCT01066767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038104|NCT03980379|Rituximab|rituximab|mesh-list
93038105|NCT03980379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038106|NCT03980379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038107|NCT03980379|Immunologic Factors|immunologic factors|mesh-ancestor
93038108|NCT03980379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038109|NCT03980379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038110|NCT01064271|Risperidone|risperidone|mesh-list
93038112|NCT01064271|Serotonin Agents|serotonin agents|mesh-ancestor
93038113|NCT01064271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038114|NCT01064271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038115|NCT01064271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038116|NCT01064271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93038117|NCT01064271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93038118|NCT01064271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038119|NCT01064271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038120|NCT01064271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93038121|NCT01064271|Dopamine Agents|dopamine agents|mesh-ancestor
93038122|NCT01066845|Tadalafil|tadalafil|mesh-list
93038123|NCT01066845|Vasodilator Agents|vasodilator agents|mesh-ancestor
93038124|NCT01066845|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93038125|NCT01066845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92231876|NCT05426304|Agomelatine|agomelatine|mesh-list
93038126|NCT01066845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038127|NCT01066845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038128|NCT01066845|Urological Agents|urological agents|mesh-ancestor
93038129|NCT01064349|Trastuzumab|trastuzumab|mesh-list
93038130|NCT01064349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038131|NCT01064349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038132|NCT00293397|Doxorubicin|doxorubicin|mesh-list
93038133|NCT00293397|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93038134|NCT00293397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93038135|NCT00293397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038136|NCT00293397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038137|NCT00293397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038138|NCT00293397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038139|NCT00293397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038140|NCT03981627|Insulin Aspart|insulin aspart|mesh-list
93038141|NCT03981627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93038142|NCT03981627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038143|NCT01069263|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93038144|NCT01069263|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93038145|NCT01069263|Protective Agents|protective agents|mesh-ancestor
93038146|NCT01069263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232077|NCT00002896|Antimetabolites|antimetabolites|mesh-ancestor
93038147|NCT01069263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93038148|NCT01069263|Antioxidants|antioxidants|mesh-ancestor
93038149|NCT01069263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038151|NCT01067235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93038152|NCT01067235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038153|NCT01067235|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93038154|NCT01067235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93038155|NCT01067235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93038156|NCT01067235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038157|NCT00290745|Tamoxifen|tamoxifen|mesh-list
93038158|NCT00290745|Letrozole|letrozole|mesh-list
93038159|NCT00290745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038160|NCT00290745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038161|NCT00290745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92232286|NCT00002926|Antimetabolites|antimetabolites|mesh-ancestor
93038162|NCT00290745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93038163|NCT00290745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038164|NCT00290745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93038165|NCT00290745|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038166|NCT00290745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038167|NCT00290745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232368|NCT01555268|Cytarabine|cytarabine|mesh-list
93038168|NCT00290745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038169|NCT00290745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93038170|NCT00290745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93038171|NCT00290745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93038172|NCT03980223|Doxycycline|doxycycline|mesh-list
93038173|NCT03980223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93038174|NCT03980223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038175|NCT03980223|Antimalarials|antimalarials|mesh-ancestor
93038176|NCT03980223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93038177|NCT03980223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93038178|NCT01067391|Tadalafil|tadalafil|mesh-list
92232507|NCT04780412|Oxytocics|oxytocics|mesh-ancestor
93038179|NCT01067391|Vasodilator Agents|vasodilator agents|mesh-ancestor
93038180|NCT01067391|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93038181|NCT01067391|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93038182|NCT01067391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038183|NCT01067391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038184|NCT01067391|Urological Agents|urological agents|mesh-ancestor
93038185|NCT00402168|Cyclosporine|cyclosporine|mesh-list
93038186|NCT00402168|Abatacept|abatacept|mesh-list
93038187|NCT00402168|Tacrolimus|tacrolimus|mesh-list
93038188|NCT00402168|Cyclosporins|cyclosporins|mesh-list
93038189|NCT00402168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038190|NCT00402168|Immunologic Factors|immunologic factors|mesh-ancestor
93038191|NCT00402168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038192|NCT00402168|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93038193|NCT00402168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038194|NCT00402168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038195|NCT00402168|Antifungal Agents|antifungal agents|mesh-ancestor
92232715|NCT00003490|Prednisone|prednisone|mesh-list
93038196|NCT00402168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038197|NCT00402168|Dermatologic Agents|dermatologic agents|mesh-ancestor
93038198|NCT00402168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038199|NCT00402168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93038200|NCT00402168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038201|NCT00402168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038202|NCT00290589|Methylprednisolone|methylprednisolone|mesh-list
93038203|NCT00290589|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93038204|NCT00290589|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93038205|NCT00290589|Prednisolone|prednisolone|mesh-list
93038206|NCT00290589|Prednisolone acetate|prednisolone acetate|mesh-list
93038207|NCT00290589|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93038208|NCT00290589|Prednisolone phosphate|prednisolone phosphate|mesh-list
93038209|NCT00290589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93038210|NCT00290589|Antiemetics|antiemetics|mesh-ancestor
92232851|NCT00384436|Escitalopram|escitalopram|mesh-list
93038211|NCT00290589|Autonomic Agents|autonomic agents|mesh-ancestor
93038212|NCT00290589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038213|NCT00290589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038214|NCT00290589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038215|NCT00290589|Glucocorticoids|glucocorticoids|mesh-ancestor
93038216|NCT00290589|Hormones|hormones|mesh-ancestor
93038217|NCT00290589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038218|NCT00290589|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93038219|NCT00290589|Protective Agents|protective agents|mesh-ancestor
93038220|NCT00290589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038221|NCT00290589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038222|NCT01067547|Iron|iron|mesh-list
93038223|NCT01067547|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93038224|NCT01067547|Trace Elements|trace elements|mesh-ancestor
93038225|NCT01067547|Micronutrients|micronutrients|mesh-ancestor
93038226|NCT01067547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038227|NCT01067547|Hematinics|hematinics|mesh-ancestor
93038228|NCT00290511|Dexamethasone|dexamethasone|mesh-list
93038229|NCT00290511|Rituximab|rituximab|mesh-list
93038230|NCT00290511|Fludarabine|fludarabine|mesh-list
93038231|NCT00290511|Fludarabine phosphate|fludarabine phosphate|mesh-list
93038232|NCT00290511|Mitoxantrone|mitoxantrone|mesh-list
93038233|NCT00290511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038234|NCT00290511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038235|NCT00290511|Immunologic Factors|immunologic factors|mesh-ancestor
93038236|NCT00290511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038237|NCT00290511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038238|NCT00290511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93038239|NCT00290511|Antiemetics|antiemetics|mesh-ancestor
93038240|NCT00290511|Autonomic Agents|autonomic agents|mesh-ancestor
93038241|NCT00290511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038242|NCT00290511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038243|NCT00290511|Glucocorticoids|glucocorticoids|mesh-ancestor
93038244|NCT00290511|Hormones|hormones|mesh-ancestor
93038245|NCT00290511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038246|NCT00290511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038247|NCT00290511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93038248|NCT00290511|Antimetabolites|antimetabolites|mesh-ancestor
93038249|NCT00290511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038250|NCT00290511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038251|NCT00290511|Analgesics|analgesics|mesh-ancestor
93038252|NCT00290511|Sensory System Agents|sensory system agents|mesh-ancestor
93038253|NCT00290511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038254|NCT00290511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038255|NCT00290511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038256|NCT00290433|Cytarabine|cytarabine|mesh-list
93038257|NCT00290433|Dexamethasone|dexamethasone|mesh-list
93038258|NCT00290433|Cyclophosphamide|cyclophosphamide|mesh-list
93038259|NCT00290433|Doxorubicin|doxorubicin|mesh-list
93038260|NCT00290433|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93038261|NCT00290433|Methotrexate|methotrexate|mesh-list
93038262|NCT00290433|Vincristine|vincristine|mesh-list
93038263|NCT00290433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038264|NCT00290433|Immunologic Factors|immunologic factors|mesh-ancestor
93038265|NCT00290433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038266|NCT00290433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038267|NCT00290433|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038268|NCT00290433|Alkylating Agents|alkylating agents|mesh-ancestor
93038269|NCT00290433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038270|NCT00290433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038271|NCT00290433|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038272|NCT00290433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93038273|NCT00290433|Antiemetics|antiemetics|mesh-ancestor
92233627|NCT00003214|Paclitaxel|paclitaxel|mesh-list
93038274|NCT00290433|Autonomic Agents|autonomic agents|mesh-ancestor
93038275|NCT00290433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038276|NCT00290433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038277|NCT00290433|Glucocorticoids|glucocorticoids|mesh-ancestor
93038278|NCT00290433|Hormones|hormones|mesh-ancestor
92233694|NCT00002884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494470|NCT01975454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038279|NCT00290433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038280|NCT00290433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038281|NCT00290433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93038282|NCT00290433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038283|NCT00290433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038284|NCT00290433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038285|NCT00290433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93038286|NCT00290433|Abortifacient Agents|abortifacient agents|mesh-ancestor
93038287|NCT00290433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93038288|NCT00290433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93038289|NCT00290433|Antimetabolites|antimetabolites|mesh-ancestor
93038290|NCT00290433|Dermatologic Agents|dermatologic agents|mesh-ancestor
93038291|NCT00290433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93038292|NCT00290433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93038293|NCT00290433|Antiviral Agents|antiviral agents|mesh-ancestor
93038294|NCT00290433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038295|NCT00290433|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93038296|NCT00290433|Tubulin Modulators|tubulin modulators|mesh-ancestor
93038297|NCT00290433|Antimitotic Agents|antimitotic agents|mesh-ancestor
92683512|NCT00441662|Hormones|hormones|mesh-ancestor
93038298|NCT00290433|Mitosis Modulators|mitosis modulators|mesh-ancestor
93038299|NCT00304083|Doxorubicin|doxorubicin|mesh-list
93038300|NCT00304083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93038301|NCT00304083|Etoposide|etoposide|mesh-list
93038302|NCT00304083|Ifosfamide|ifosfamide|mesh-list
93038303|NCT00304083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93038304|NCT00304083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038305|NCT00304083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038306|NCT00304083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038307|NCT00304083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038308|NCT00304083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038309|NCT00304083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93038310|NCT00304083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234194|NCT00003754|Thalidomide|thalidomide|mesh-list
93038311|NCT00304083|Alkylating Agents|alkylating agents|mesh-ancestor
93038312|NCT01069965|BGP 15|bgp 15|mesh-list
93038313|NCT01069965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038314|NCT01069965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038315|NCT00391092|Bevacizumab|bevacizumab|mesh-list
93038316|NCT00391092|Trastuzumab|trastuzumab|mesh-list
93038317|NCT00391092|Docetaxel|docetaxel|mesh-list
93038318|NCT00391092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038319|NCT00391092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038320|NCT00391092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93038321|NCT00391092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93038322|NCT00391092|Growth Substances|growth substances|mesh-ancestor
93038323|NCT00391092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038324|NCT00391092|Growth Inhibitors|growth inhibitors|mesh-ancestor
92234331|NCT00003346|Antioxidants|antioxidants|mesh-ancestor
93038325|NCT00391092|Tubulin Modulators|tubulin modulators|mesh-ancestor
93038326|NCT00391092|Antimitotic Agents|antimitotic agents|mesh-ancestor
93038327|NCT00391092|Mitosis Modulators|mitosis modulators|mesh-ancestor
93038328|NCT00391092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038329|NCT00374868|Pemetrexed|pemetrexed|mesh-list
93038330|NCT00374868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038331|NCT00374868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038332|NCT00374868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038333|NCT00374868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93038334|NCT00374868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93038335|NCT01044342|Donepezil|donepezil|mesh-list
93038336|NCT01044342|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93038337|NCT01044342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038338|NCT01044342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038339|NCT01044342|Cholinergic Agents|cholinergic agents|mesh-ancestor
93038340|NCT01044342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038341|NCT01044342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038342|NCT01044342|Nootropic Agents|nootropic agents|mesh-ancestor
93038343|NCT00374556|Eszopiclone|eszopiclone|mesh-list
93038344|NCT00374556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93038345|NCT00374556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038346|NCT00374556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038347|NCT01064973|Baclofen|baclofen|mesh-list
93038348|NCT01064973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93038349|NCT01064973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038350|NCT01064973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93038351|NCT01064973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038352|NCT01064973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93038353|NCT01064973|GABA Agonists|gaba agonists|mesh-ancestor
93038354|NCT01064973|GABA Agents|gaba agents|mesh-ancestor
93038355|NCT01064973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038356|NCT01064973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038357|NCT00374322|Lapatinib|lapatinib|mesh-list
93038358|NCT00374322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038359|NCT00374322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93038360|NCT00374322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038361|NCT00374322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038362|NCT00303459|Bosentan|bosentan|mesh-list
93038363|NCT00303459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93038364|NCT00303459|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93038365|NCT00303459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038366|NCT00289887|Losartan|losartan|mesh-list
93038367|NCT00289887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92234667|NCT00003862|Calcium|calcium|mesh-list
93038368|NCT00289887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93038369|NCT00289887|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93038370|NCT00289887|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93038371|NCT00289887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038372|NCT01068093|Ezetimibe|ezetimibe|mesh-list
93038373|NCT01068093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93038374|NCT01068093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93038375|NCT01068093|Antimetabolites|antimetabolites|mesh-ancestor
93038376|NCT01068093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038377|NCT01068093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93038378|NCT00401544|Dextrans|dextrans|mesh-list
93038379|NCT00401544|Darbepoetin alfa|darbepoetin alfa|mesh-list
93038380|NCT00401544|Iron-Dextran Complex|iron-dextran complex|mesh-list
93038381|NCT00401544|Hematinics|hematinics|mesh-ancestor
93038382|NCT00401544|Anticoagulants|anticoagulants|mesh-ancestor
93038383|NCT00401544|Plasma Substitutes|plasma substitutes|mesh-ancestor
93038384|NCT00401544|Blood Substitutes|blood substitutes|mesh-ancestor
93038385|NCT00292461|Lamotrigine|lamotrigine|mesh-list
93038386|NCT00292461|Zonisamide|zonisamide|mesh-list
93038387|NCT00292461|Anticonvulsants|anticonvulsants|mesh-ancestor
93038388|NCT00292461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93038389|NCT00292461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038390|NCT00292461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234944|NCT05775965|Sensory System Agents|sensory system agents|mesh-ancestor
93038391|NCT00292461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93038392|NCT00292461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038393|NCT00292461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93038394|NCT00292461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93038395|NCT00292461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038396|NCT00292461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038397|NCT00292461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93038398|NCT00288639|Pregabalin|pregabalin|mesh-list
93038399|NCT00288639|Analgesics|analgesics|mesh-ancestor
93038400|NCT00288639|Sensory System Agents|sensory system agents|mesh-ancestor
93038401|NCT00288639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038402|NCT00288639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038403|NCT00288639|Anticonvulsants|anticonvulsants|mesh-ancestor
93038404|NCT00288639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92235166|NCT05463341|Anesthetics|anesthetics|mesh-ancestor
93038405|NCT00288639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038406|NCT00288639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384017|NCT00000960|Zidovudine|zidovudine|mesh-list
93038407|NCT00288639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93038408|NCT00288639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93038409|NCT00288639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93038410|NCT00288639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038411|NCT00288639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038412|NCT00390858|Deferasirox|deferasirox|mesh-list
93038413|NCT00390858|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93038414|NCT00390858|Chelating Agents|chelating agents|mesh-ancestor
93038415|NCT00390858|Sequestering Agents|sequestering agents|mesh-ancestor
93038416|NCT00390858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038417|NCT00390780|Clotrimazole|clotrimazole|mesh-list
93038418|NCT00390780|Miconazole|miconazole|mesh-list
93038419|NCT00390780|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93038420|NCT00390780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038421|NCT00390780|Antifungal Agents|antifungal agents|mesh-ancestor
93038422|NCT00390780|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93038423|NCT00390780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93038424|NCT00390780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235445|NCT04569747|Tamoxifen|tamoxifen|mesh-list
93038425|NCT00390780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038426|NCT00390780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93038427|NCT00390780|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038428|NCT00390780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038429|NCT00390780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235515|NCT04273165|Antiviral Agents|antiviral agents|mesh-ancestor
93038430|NCT00390780|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93038431|NCT00390780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93038432|NCT00390546|Propranolol|propranolol|mesh-list
93038433|NCT00390546|Digoxin|digoxin|mesh-list
93038434|NCT00390546|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93038435|NCT00390546|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93038436|NCT00390546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92235584|NCT03493490|Diclofenac|diclofenac|mesh-list
93038437|NCT00390546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038438|NCT00390546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038439|NCT00390546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038440|NCT00390546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93038441|NCT00390546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93038442|NCT00390546|Vasodilator Agents|vasodilator agents|mesh-ancestor
93038443|NCT00390546|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93038444|NCT00390546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038445|NCT00390546|Protective Agents|protective agents|mesh-ancestor
92683662|NCT00477789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038447|NCT00400764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038448|NCT00400764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038449|NCT00400764|Immunologic Factors|immunologic factors|mesh-ancestor
93038450|NCT00400764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038451|NCT00400764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038452|NCT00302211|Bosentan|bosentan|mesh-list
93038453|NCT00302211|Sildenafil Citrate|sildenafil citrate|mesh-list
93038454|NCT00302211|Iloprost|iloprost|mesh-list
93038455|NCT00302211|Vasodilator Agents|vasodilator agents|mesh-ancestor
93038456|NCT00302211|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93038457|NCT00302211|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93038458|NCT00302211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038459|NCT00302211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235789|NCT00199095|Hormones|hormones|mesh-ancestor
93038460|NCT00302211|Urological Agents|urological agents|mesh-ancestor
93038461|NCT00302211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93038462|NCT00302211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93038463|NCT00302211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93038464|NCT01045902|Moxifloxacin|moxifloxacin|mesh-list
93038465|NCT01045902|Ampicillin|ampicillin|mesh-list
93038466|NCT01045902|Sulbactam|sulbactam|mesh-list
93038467|NCT01045902|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93038468|NCT01045902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93038469|NCT01045902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038470|NCT01045902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038471|NCT01045902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038472|NCT01045902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235930|NCT00109395|GABA Agents|gaba agents|mesh-ancestor
93038473|NCT01045902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038474|NCT01045902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038475|NCT01045902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93038476|NCT01045902|Contraceptive Agents|contraceptive agents|mesh-ancestor
92236003|NCT00004162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038477|NCT01045902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93038478|NCT01045902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038479|NCT01045902|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93038480|NCT01045902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93038481|NCT01045902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93038482|NCT01045902|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93038483|NCT01041690|Bevacizumab|bevacizumab|mesh-list
93038484|NCT01041690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038485|NCT01041690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038486|NCT01041690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93038487|NCT01041690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93038488|NCT01041690|Growth Substances|growth substances|mesh-ancestor
93038489|NCT01041690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038490|NCT01041690|Growth Inhibitors|growth inhibitors|mesh-ancestor
93038491|NCT00288015|Bevacizumab|bevacizumab|mesh-list
93038492|NCT00288015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038493|NCT00288015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038494|NCT00288015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93038495|NCT00288015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93038496|NCT00288015|Growth Substances|growth substances|mesh-ancestor
93038497|NCT00288015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038498|NCT00288015|Growth Inhibitors|growth inhibitors|mesh-ancestor
93038499|NCT00389064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93038500|NCT00389064|Antidepressive Agents|antidepressive agents|mesh-ancestor
93038501|NCT00389064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038502|NCT00389064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93038503|NCT00389064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93038504|NCT00389064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038505|NCT00389064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038507|NCT01068327|Nelfinavir|nelfinavir|mesh-list
93038508|NCT01068327|Gemcitabine|gemcitabine|mesh-list
93038509|NCT01068327|Fluorouracil|fluorouracil|mesh-list
93038510|NCT01068327|Calcium|calcium|mesh-list
92236369|NCT00028262|Cysteamine|cysteamine|mesh-list
93038511|NCT01068327|Levoleucovorin|levoleucovorin|mesh-list
93038512|NCT01068327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93038513|NCT01068327|Antimetabolites|antimetabolites|mesh-ancestor
93038514|NCT01068327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236426|NCT00005596|Antiemetics|antiemetics|mesh-ancestor
93038515|NCT01068327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038516|NCT01068327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93038517|NCT01068327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038518|NCT01068327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038519|NCT01068327|Immunologic Factors|immunologic factors|mesh-ancestor
93038520|NCT01068327|Antidotes|antidotes|mesh-ancestor
93038522|NCT01068327|Vitamin B Complex|vitamin b complex|mesh-ancestor
93038523|NCT01068327|Vitamins|vitamins|mesh-ancestor
93038524|NCT01068327|Micronutrients|micronutrients|mesh-ancestor
93038525|NCT01068327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93038526|NCT01068327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93038527|NCT01068327|Protease Inhibitors|protease inhibitors|mesh-ancestor
93038528|NCT01068327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038529|NCT01068327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93038530|NCT01068327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93038531|NCT01068327|Antiviral Agents|antiviral agents|mesh-ancestor
93038532|NCT01068327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038533|NCT01045980|Vitamin D|vitamin d|mesh-list
93038534|NCT01045980|Ergocalciferols|ergocalciferols|mesh-list
93038535|NCT01045980|Cholecalciferol|cholecalciferol|mesh-list
93038536|NCT01045980|Vitamins|vitamins|mesh-list
93038537|NCT01045980|Micronutrients|micronutrients|mesh-ancestor
93038538|NCT01045980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038539|NCT01045980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93038540|NCT01045980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93038541|NCT00388674|Entecavir|entecavir|mesh-list
93038542|NCT00388674|Antiviral Agents|antiviral agents|mesh-ancestor
93038543|NCT00388674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038544|NCT00388362|Sirolimus|sirolimus|mesh-list
93038545|NCT00388362|Prednisone|prednisone|mesh-list
93038546|NCT00388362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93038547|NCT00388362|Glucocorticoids|glucocorticoids|mesh-ancestor
93038548|NCT00388362|Hormones|hormones|mesh-ancestor
93038549|NCT00388362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038550|NCT00388362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038551|NCT00388362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038552|NCT00388362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038553|NCT00388362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93038554|NCT00388362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038555|NCT00388362|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93038556|NCT00388362|Antifungal Agents|antifungal agents|mesh-ancestor
93038557|NCT00388362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038558|NCT00388362|Immunologic Factors|immunologic factors|mesh-ancestor
93038560|NCT01046058|Antiviral Agents|antiviral agents|mesh-ancestor
93038561|NCT01046058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038562|NCT01046058|Protease Inhibitors|protease inhibitors|mesh-ancestor
93038563|NCT01046058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038564|NCT01046058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038565|NCT01046214|Bupropion|bupropion|mesh-list
93038566|NCT01046214|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93038567|NCT01046214|Antidepressive Agents|antidepressive agents|mesh-ancestor
93038568|NCT01046214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038569|NCT01046214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93038570|NCT01046214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92236748|NCT00004438|Leuprolide|leuprolide|mesh-list
93038571|NCT01046214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038572|NCT01046214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038573|NCT01046214|Dopamine Agents|dopamine agents|mesh-ancestor
93038574|NCT01046214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038575|NCT01046214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038576|NCT01046214|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93038577|NCT01046214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93038578|NCT01046214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038579|NCT01324284|Lubiprostone|lubiprostone|mesh-list
92236892|NCT00004486|Serotonin Agents|serotonin agents|mesh-ancestor
93038580|NCT01324284|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93038581|NCT01324284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038582|NCT01324284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038583|NCT00387894|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93038584|NCT00387894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038585|NCT00387894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93038586|NCT00387894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494471|NCT01975454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038587|NCT00387894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038588|NCT00387426|Sunitinib|sunitinib|mesh-list
93038589|NCT00387426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038590|NCT00387426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93038591|NCT00387426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93038592|NCT00387426|Growth Substances|growth substances|mesh-ancestor
93038593|NCT00387426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038594|NCT00387426|Growth Inhibitors|growth inhibitors|mesh-ancestor
92683812|NCT00440427|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93038595|NCT00387426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93038596|NCT00387426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038597|NCT00387426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038598|NCT00387348|Dexetimide|dexetimide|mesh-list
93038599|NCT00387348|Citalopram|citalopram|mesh-list
93038600|NCT00387348|Escitalopram|escitalopram|mesh-list
93038601|NCT00387348|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93038602|NCT00387348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93038603|NCT00387348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038604|NCT00387348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038605|NCT00387348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038606|NCT00387348|Serotonin Agents|serotonin agents|mesh-ancestor
93038607|NCT00387348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038608|NCT00387348|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93038609|NCT00387348|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93038610|NCT00387348|Parasympatholytics|parasympatholytics|mesh-ancestor
93038611|NCT00387348|Autonomic Agents|autonomic agents|mesh-ancestor
93038612|NCT00387348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038613|NCT00387348|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93038614|NCT00387348|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93038615|NCT00387348|Cholinergic Agents|cholinergic agents|mesh-ancestor
92237081|NCT00004804|Interferons|interferons|mesh-list
93038616|NCT00387348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93038617|NCT00387348|Antidepressive Agents|antidepressive agents|mesh-ancestor
93038618|NCT00387348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038619|NCT03992820|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
93038620|NCT03992820|Anesthetics, Local|anesthetics, local|mesh-ancestor
93038621|NCT03992820|Anesthetics|anesthetics|mesh-ancestor
93038622|NCT03992820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038623|NCT03992820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038624|NCT03992820|Sensory System Agents|sensory system agents|mesh-ancestor
93038625|NCT03992820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038626|NCT03992820|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92237216|NCT01349491|Ranolazine|ranolazine|mesh-list
93038628|NCT00413660|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93038629|NCT00413660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93038630|NCT00413660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038631|NCT00413660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038632|NCT01234532|Anastrozole|anastrozole|mesh-list
93038633|NCT01234532|Entinostat|entinostat|mesh-list
93038634|NCT01234532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038635|NCT01234532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038636|NCT01234532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93038637|NCT01234532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93038638|NCT01234532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038639|NCT01234532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038640|NCT01234532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93038641|NCT01234532|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038642|NCT01234532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237442|NCT00052910|Leucovorin|leucovorin|mesh-list
93038643|NCT01234532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038644|NCT01234532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93038645|NCT00431444|Zoledronic Acid|zoledronic acid|mesh-list
93038646|NCT00431444|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93038647|NCT00431444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93038648|NCT00431444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038649|NCT00431444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93038650|NCT00431444|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038651|NCT00431444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038652|NCT00431444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93038653|NCT00431444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93038654|NCT00430352|Rituximab|rituximab|mesh-list
93038655|NCT00430352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038656|NCT00430352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038657|NCT00430352|Immunologic Factors|immunologic factors|mesh-ancestor
93038658|NCT00430352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038659|NCT00430352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038660|NCT01068405|Methotrexate|methotrexate|mesh-list
93038661|NCT01068405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93038662|NCT01068405|Abortifacient Agents|abortifacient agents|mesh-ancestor
93038663|NCT01068405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93038664|NCT01068405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237723|NCT00166166|Bradykinin|bradykinin|mesh-list
93038665|NCT01068405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683888|NCT00443690|Rolofylline|rolofylline|mesh-list
93038666|NCT01068405|Antimetabolites|antimetabolites|mesh-ancestor
93038667|NCT01068405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038668|NCT01068405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038669|NCT01068405|Dermatologic Agents|dermatologic agents|mesh-ancestor
93038670|NCT01068405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038671|NCT01068405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93038672|NCT01068405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237799|NCT01795313|Imiquimod|imiquimod|mesh-list
93038673|NCT01068405|Immunologic Factors|immunologic factors|mesh-ancestor
93038674|NCT01068405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038675|NCT01068405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93038676|NCT00429572|Fludarabine|fludarabine|mesh-list
93038677|NCT00429572|Melphalan|melphalan|mesh-list
93038678|NCT00429572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237865|NCT01034111|Incretins|incretins|mesh-ancestor
93038679|NCT00429572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038680|NCT00429572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038681|NCT00429572|Immunologic Factors|immunologic factors|mesh-ancestor
93038682|NCT00429572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038683|NCT00429572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038684|NCT00429572|Alkylating Agents|alkylating agents|mesh-ancestor
93038685|NCT00429572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038686|NCT00429494|Leuprolide|leuprolide|mesh-list
93038687|NCT00429494|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93038688|NCT00429494|Fertility Agents|fertility agents|mesh-ancestor
93038689|NCT00429494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93038690|NCT00429494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038691|NCT00429494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038692|NCT00429494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038693|NCT00429416|Cytarabine|cytarabine|mesh-list
93038694|NCT00429416|Cyclophosphamide|cyclophosphamide|mesh-list
93038695|NCT00429416|Fludarabine|fludarabine|mesh-list
93038696|NCT00429416|Fludarabine phosphate|fludarabine phosphate|mesh-list
93038697|NCT00429416|Molgramostim|molgramostim|mesh-list
93038698|NCT00429416|Tacrolimus|tacrolimus|mesh-list
93038699|NCT00429416|Sargramostim|sargramostim|mesh-list
93038700|NCT00429416|Mesna|mesna|mesh-list
93038701|NCT00429416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038702|NCT00429416|Immunologic Factors|immunologic factors|mesh-ancestor
93038703|NCT00429416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038704|NCT00429416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038705|NCT00429416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038706|NCT00429416|Alkylating Agents|alkylating agents|mesh-ancestor
93038707|NCT00429416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038708|NCT00429416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038709|NCT00429416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038710|NCT00429416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93038711|NCT00429416|Antimetabolites|antimetabolites|mesh-ancestor
93038712|NCT00429416|Antiviral Agents|antiviral agents|mesh-ancestor
93038713|NCT00429416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038714|NCT00429416|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93038715|NCT00429416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038716|NCT00429416|Protective Agents|protective agents|mesh-ancestor
93038717|NCT00429182|Cyclophosphamide|cyclophosphamide|mesh-list
93038718|NCT00429182|Thiotepa|thiotepa|mesh-list
93038719|NCT00429182|Carboplatin|carboplatin|mesh-list
93038720|NCT00429182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038721|NCT00429182|Immunologic Factors|immunologic factors|mesh-ancestor
93038722|NCT00429182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038723|NCT00429182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038724|NCT00429182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038725|NCT00429182|Alkylating Agents|alkylating agents|mesh-ancestor
93038726|NCT00429182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038727|NCT00429182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038728|NCT00429182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038729|NCT00429104|Trastuzumab|trastuzumab|mesh-list
93038730|NCT00429104|Sargramostim|sargramostim|mesh-list
93038731|NCT00429104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93038732|NCT00429104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238333|NCT01116401|Leuprolide|leuprolide|mesh-list
93038733|NCT00429104|Immunologic Factors|immunologic factors|mesh-ancestor
93038734|NCT00429104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038735|NCT00429026|Cyclophosphamide|cyclophosphamide|mesh-list
93038736|NCT00429026|Melphalan|melphalan|mesh-list
93038737|NCT00429026|Fludarabine|fludarabine|mesh-list
93038738|NCT00429026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038739|NCT00429026|Immunologic Factors|immunologic factors|mesh-ancestor
93038740|NCT00429026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038741|NCT00429026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038742|NCT00429026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038743|NCT00429026|Alkylating Agents|alkylating agents|mesh-ancestor
93038744|NCT00429026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038745|NCT00429026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038746|NCT00429026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038747|NCT00301821|Prednisone|prednisone|mesh-list
93038748|NCT00301821|Cyclophosphamide|cyclophosphamide|mesh-list
93038749|NCT00301821|Rituximab|rituximab|mesh-list
93038750|NCT00301821|Doxorubicin|doxorubicin|mesh-list
92238545|NCT00265850|Antimetabolites|antimetabolites|mesh-ancestor
93038751|NCT00301821|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93038752|NCT00301821|Vincristine|vincristine|mesh-list
93038753|NCT00301821|Epratuzumab|epratuzumab|mesh-list
93038754|NCT00301821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038755|NCT00301821|Immunologic Factors|immunologic factors|mesh-ancestor
93038756|NCT00301821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038757|NCT00301821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93038758|NCT00301821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93038759|NCT00301821|Alkylating Agents|alkylating agents|mesh-ancestor
93038760|NCT00301821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038761|NCT00301821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038762|NCT00301821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93038763|NCT00301821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238626|NCT01336933|Hormones|hormones|mesh-ancestor
93038764|NCT00301821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93038765|NCT00301821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038766|NCT00301821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038767|NCT00301821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038768|NCT00301821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238700|NCT01089569|Exenatide|exenatide|mesh-list
93038769|NCT00301821|Glucocorticoids|glucocorticoids|mesh-ancestor
93038770|NCT00301821|Hormones|hormones|mesh-ancestor
93038771|NCT00301821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238819|NCT00183092|Quinacrine|quinacrine|mesh-list
93038772|NCT00301821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038773|NCT00301821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93038774|NCT00301821|Tubulin Modulators|tubulin modulators|mesh-ancestor
93038775|NCT00301821|Antimitotic Agents|antimitotic agents|mesh-ancestor
93038776|NCT00301821|Mitosis Modulators|mitosis modulators|mesh-ancestor
93038777|NCT03976713|Bromides|bromides|mesh-list
93038778|NCT03976713|Tiotropium Bromide|tiotropium bromide|mesh-list
93038779|NCT03976713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93038780|NCT03976713|Autonomic Agents|autonomic agents|mesh-ancestor
92238892|NCT01049243|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93038781|NCT03976713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038782|NCT03976713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038783|NCT03976713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93038784|NCT03976713|Respiratory System Agents|respiratory system agents|mesh-ancestor
93038785|NCT03976713|Parasympatholytics|parasympatholytics|mesh-ancestor
93038786|NCT03976713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93038787|NCT03976713|Cholinergic Agents|cholinergic agents|mesh-ancestor
93038788|NCT03976713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038789|NCT03976713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038790|NCT03976713|Anticonvulsants|anticonvulsants|mesh-ancestor
93038791|NCT00372996|Fulvestrant|fulvestrant|mesh-list
93038792|NCT00372996|Exemestane|exemestane|mesh-list
93038793|NCT00372996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93038794|NCT00372996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038795|NCT00372996|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93038796|NCT00372996|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93038797|NCT00372996|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038798|NCT00372996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239203|NCT01474915|Aprepitant|aprepitant|mesh-list
93038799|NCT00372996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038800|NCT00372996|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93038801|NCT00372996|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93038802|NCT00372996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038803|NCT00372996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038804|NCT00399360|Metformin|metformin|mesh-list
93038805|NCT00399360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93038806|NCT00399360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038807|NCT00428948|Tolvaptan|tolvaptan|mesh-list
93038808|NCT00428948|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93038809|NCT00428948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038810|NCT00428948|Natriuretic Agents|natriuretic agents|mesh-ancestor
93038811|NCT00428948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038812|NCT00428792|Methylphenidate|methylphenidate|mesh-list
92239305|NCT05156060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93038813|NCT00428792|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93038814|NCT00428792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038815|NCT00428792|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93038816|NCT00428792|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93038817|NCT00428792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038818|NCT00428792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038820|NCT00428792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038821|NCT00300885|Paclitaxel|paclitaxel|mesh-list
93038822|NCT00300885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93038823|NCT00300885|Carboplatin|carboplatin|mesh-list
93038824|NCT00300885|Sorafenib|sorafenib|mesh-list
93038825|NCT00300885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93038826|NCT00300885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038827|NCT00300885|Tubulin Modulators|tubulin modulators|mesh-ancestor
93038828|NCT00300885|Antimitotic Agents|antimitotic agents|mesh-ancestor
93038829|NCT00300885|Mitosis Modulators|mitosis modulators|mesh-ancestor
93038830|NCT00300885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038831|NCT00300885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93038832|NCT00300885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038833|NCT00386334|Eszopiclone|eszopiclone|mesh-list
93038834|NCT00386334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93038835|NCT00386334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038836|NCT00386334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038837|NCT01143116|Silver Nitrate|silver nitrate|mesh-list
93038838|NCT01143116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93038839|NCT01143116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038840|NCT00292227|Moxifloxacin|moxifloxacin|mesh-list
93038841|NCT00292227|Rotigotine|rotigotine|mesh-list
93038842|NCT00292227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93038843|NCT00292227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038844|NCT00292227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93038845|NCT00292227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93038846|NCT00292227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038847|NCT00292227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038848|NCT00292227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038849|NCT00292227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038850|NCT00292227|Dopamine Agonists|dopamine agonists|mesh-ancestor
93038851|NCT00292227|Dopamine Agents|dopamine agents|mesh-ancestor
93038852|NCT00292227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038853|NCT00386100|Metformin|metformin|mesh-list
93038854|NCT00386100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92239438|NCT00287222|Bevacizumab|bevacizumab|mesh-list
93038855|NCT00386100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038856|NCT00300495|Amiodarone|amiodarone|mesh-list
93038857|NCT00300495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93038858|NCT00300495|Vasodilator Agents|vasodilator agents|mesh-ancestor
93038859|NCT00300495|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93038860|NCT00300495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038861|NCT00300495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038862|NCT00300495|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93038863|NCT00300495|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93038864|NCT00300495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93038865|NCT00300495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038866|NCT00300495|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93038867|NCT00300495|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93038868|NCT00300495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93038869|NCT03979989|Tapentadol|tapentadol|mesh-list
93038870|NCT03979989|Omeprazole|omeprazole|mesh-list
93038871|NCT03979989|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93038872|NCT03979989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93038873|NCT03979989|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93038874|NCT03979989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038875|NCT03979989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038876|NCT03979989|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93038877|NCT03979989|Narcotics|narcotics|mesh-ancestor
93038878|NCT03979989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038879|NCT03979989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038880|NCT03979989|Analgesics|analgesics|mesh-ancestor
93038881|NCT03979989|Sensory System Agents|sensory system agents|mesh-ancestor
93038882|NCT03979989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038883|NCT03979989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93038884|NCT03979989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93038885|NCT03979989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038886|NCT03979989|Adrenergic Agents|adrenergic agents|mesh-ancestor
93038887|NCT03979989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038888|NCT01325571|Tacrolimus|tacrolimus|mesh-list
93038889|NCT01325571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93038890|NCT01325571|Immunologic Factors|immunologic factors|mesh-ancestor
93038892|NCT01325571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93038893|NCT01325571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038894|NCT01325571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038895|NCT00386022|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93038896|NCT00386022|Estrogens|estrogens|mesh-list
93038897|NCT00386022|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
93038898|NCT00386022|Hormones|hormones|mesh-ancestor
93038899|NCT00386022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038900|NCT00386022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038901|NCT00386022|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038902|NCT01068795|Enoxaparin|enoxaparin|mesh-list
93038903|NCT01068795|Anticoagulants|anticoagulants|mesh-ancestor
93038904|NCT01068795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93038905|NCT01068795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93038906|NCT01068795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038907|NCT00286455|Alogliptin|alogliptin|mesh-list
93038908|NCT00286455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93038909|NCT00286455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038910|NCT00286455|Incretins|incretins|mesh-ancestor
93038911|NCT00286455|Hormones|hormones|mesh-ancestor
93038912|NCT00286455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038913|NCT00286455|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93038914|NCT00286455|Protease Inhibitors|protease inhibitors|mesh-ancestor
93038915|NCT00286455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038916|NCT00286455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038917|NCT00385944|Clopidogrel|clopidogrel|mesh-list
93038918|NCT00385944|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93038919|NCT00385944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93038920|NCT00385944|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93038921|NCT00385944|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93038922|NCT00385944|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93038923|NCT00385944|Purinergic Agents|purinergic agents|mesh-ancestor
93038924|NCT00385944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038925|NCT00385944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038926|NCT00385944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038927|NCT00286221|Fentanyl|fentanyl|mesh-list
93038928|NCT00286221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93038929|NCT00286221|Narcotics|narcotics|mesh-ancestor
93038930|NCT00286221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038931|NCT00286221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038932|NCT00286221|Analgesics|analgesics|mesh-ancestor
93038933|NCT00286221|Sensory System Agents|sensory system agents|mesh-ancestor
93038934|NCT00286221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038935|NCT00286221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93038936|NCT00286221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93038937|NCT00286221|Anesthetics, General|anesthetics, general|mesh-ancestor
93038938|NCT00286221|Anesthetics|anesthetics|mesh-ancestor
93038939|NCT00398112|Sunitinib|sunitinib|mesh-list
93038940|NCT00398112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038941|NCT00398112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93038942|NCT00398112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93038943|NCT00398112|Growth Substances|growth substances|mesh-ancestor
93038944|NCT00398112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038945|NCT00398112|Growth Inhibitors|growth inhibitors|mesh-ancestor
93038946|NCT00398112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93038947|NCT00398112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038948|NCT00398112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038949|NCT01065129|Plerixafor|plerixafor|mesh-list
93038950|NCT01065129|Azacitidine|azacitidine|mesh-list
93038951|NCT01065129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93038952|NCT01065129|Antimetabolites|antimetabolites|mesh-ancestor
93038953|NCT01065129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038954|NCT01065129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038955|NCT01065129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038956|NCT01065129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93038957|NCT01065129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93038958|NCT01065129|Antiviral Agents|antiviral agents|mesh-ancestor
93038959|NCT01065129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93038960|NCT01042314|Donepezil|donepezil|mesh-list
93038961|NCT01042314|BMS 708163|bms 708163|mesh-list
93038962|NCT01042314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93038963|NCT01042314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038964|NCT01042314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038965|NCT01042314|Cholinergic Agents|cholinergic agents|mesh-ancestor
93038966|NCT01042314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93038967|NCT01042314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038968|NCT01042314|Nootropic Agents|nootropic agents|mesh-ancestor
93038969|NCT01042314|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93038970|NCT00372528|Pregabalin|pregabalin|mesh-list
93038971|NCT00372528|Analgesics|analgesics|mesh-ancestor
93038972|NCT00372528|Sensory System Agents|sensory system agents|mesh-ancestor
93038973|NCT00372528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93038974|NCT00372528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038975|NCT00372528|Anticonvulsants|anticonvulsants|mesh-ancestor
93038976|NCT00372528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93038977|NCT00372528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93038978|NCT00372528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038979|NCT00372528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93038980|NCT00372528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93038981|NCT00372528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93038982|NCT00372528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93038983|NCT00372528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93038984|NCT00283803|Sulindac sulfone|sulindac sulfone|mesh-list
93038985|NCT00283803|Hormones|hormones|mesh-list
93038986|NCT00283803|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93038987|NCT00283803|Androgen Antagonists|androgen antagonists|mesh-list
93038988|NCT00283803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93038989|NCT00283803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93038990|NCT00283803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93038991|NCT00283803|Hormone Antagonists|hormone antagonists|mesh-ancestor
93038992|NCT00283803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93038993|NCT00283803|Protective Agents|protective agents|mesh-ancestor
93038994|NCT00283803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93038995|NCT00283803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93038996|NCT00283803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93038997|NCT00283803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93038998|NCT00283803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93038999|NCT00283803|Analgesics|analgesics|mesh-ancestor
93039000|NCT00283803|Sensory System Agents|sensory system agents|mesh-ancestor
93039001|NCT00283803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039002|NCT00283803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039003|NCT00283803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039004|NCT01044810|Efavirenz|efavirenz|mesh-list
93039005|NCT01044810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93039006|NCT01044810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93039007|NCT01044810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039008|NCT01044810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039009|NCT01044810|Antiviral Agents|antiviral agents|mesh-ancestor
93039010|NCT01044810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039011|NCT01044810|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93039012|NCT01044810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93039013|NCT01044810|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93039014|NCT01044810|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93039015|NCT01044810|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93039016|NCT01044810|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93039017|NCT01033370|Clevidipine|clevidipine|mesh-list
93039018|NCT01033370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93039019|NCT01033370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039020|NCT01033370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039021|NCT01033370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93039022|NCT01033370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039023|NCT01044888|Heparin|heparin|mesh-list
93039024|NCT01044888|Anticoagulants|anticoagulants|mesh-ancestor
93039025|NCT01044888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039026|NCT01044888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93039027|NCT01044888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039028|NCT03742466|Methylprednisolone|methylprednisolone|mesh-list
93039029|NCT03742466|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93039030|NCT03742466|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93039031|NCT03742466|Prednisolone|prednisolone|mesh-list
93039032|NCT03742466|Prednisolone acetate|prednisolone acetate|mesh-list
93039033|NCT03742466|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92684277|NCT00454259|Fentanyl|fentanyl|mesh-list
93039034|NCT03742466|Prednisolone phosphate|prednisolone phosphate|mesh-list
93039035|NCT03742466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039036|NCT03742466|Antiemetics|antiemetics|mesh-ancestor
93039037|NCT03742466|Autonomic Agents|autonomic agents|mesh-ancestor
93039038|NCT03742466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039039|NCT03742466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039040|NCT03742466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039041|NCT03742466|Glucocorticoids|glucocorticoids|mesh-ancestor
93039042|NCT03742466|Hormones|hormones|mesh-ancestor
93039043|NCT03742466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039044|NCT03742466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93039045|NCT03742466|Protective Agents|protective agents|mesh-ancestor
93039046|NCT03742466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93039047|NCT03742466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039048|NCT01065285|Vaccines|vaccines|mesh-list
93039049|NCT01065285|Immunologic Factors|immunologic factors|mesh-ancestor
93039050|NCT01065285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039051|NCT01033526|Aspirin|aspirin|mesh-list
93039052|NCT01033526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93039053|NCT01033526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93039054|NCT01033526|Analgesics|analgesics|mesh-ancestor
93039055|NCT01033526|Sensory System Agents|sensory system agents|mesh-ancestor
93039056|NCT01033526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039057|NCT01033526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039058|NCT01033526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039059|NCT01033526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039060|NCT01033526|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039061|NCT01033526|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93039062|NCT01033526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039063|NCT01033526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93039064|NCT01033526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93039065|NCT01033526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039066|NCT01033526|Antipyretics|antipyretics|mesh-ancestor
93039068|NCT00397488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039069|NCT00397488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93039070|NCT00397488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039071|NCT00397488|Growth Substances|growth substances|mesh-ancestor
93039072|NCT00397488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039073|NCT00397488|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039074|NCT00397488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039075|NCT00397488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039076|NCT00397488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039077|NCT01581411|Plasminogen|plasminogen|mesh-list
93039078|NCT01581411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93039079|NCT01581411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039080|NCT01581411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93039081|NCT01581411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039082|NCT02900664|Trametinib|trametinib|mesh-list
93039083|NCT02900664|Spartalizumab|spartalizumab|mesh-list
93039084|NCT02900664|Nazartinib|nazartinib|mesh-list
93039085|NCT02900664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039086|NCT02900664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039087|NCT02900664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039088|NCT02900664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039089|NCT02900664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93039090|NCT02900664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039091|NCT01324596|Prednisolone|prednisolone|mesh-list
93039092|NCT01324596|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93039093|NCT01324596|Methylprednisolone|methylprednisolone|mesh-list
93039094|NCT01324596|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93039095|NCT01324596|Prednisolone acetate|prednisolone acetate|mesh-list
93039096|NCT01324596|Cyclophosphamide|cyclophosphamide|mesh-list
93039097|NCT01324596|Rituximab|rituximab|mesh-list
93039098|NCT01324596|Doxorubicin|doxorubicin|mesh-list
93039099|NCT01324596|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93039100|NCT01324596|Vincristine|vincristine|mesh-list
93039101|NCT01324596|Bortezomib|bortezomib|mesh-list
93039102|NCT01324596|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93039103|NCT01324596|Prednisolone phosphate|prednisolone phosphate|mesh-list
93039104|NCT01324596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039105|NCT01324596|Immunologic Factors|immunologic factors|mesh-ancestor
93039106|NCT01324596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039107|NCT01324596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039108|NCT01324596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92684334|NCT00454883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039109|NCT01324596|Alkylating Agents|alkylating agents|mesh-ancestor
93039110|NCT01324596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039111|NCT01324596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039112|NCT01324596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93039113|NCT01324596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039114|NCT01324596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039115|NCT01324596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93039116|NCT01324596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93039117|NCT01324596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039118|NCT01324596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93039119|NCT01324596|Tubulin Modulators|tubulin modulators|mesh-ancestor
93039120|NCT01324596|Antimitotic Agents|antimitotic agents|mesh-ancestor
93039121|NCT01324596|Mitosis Modulators|mitosis modulators|mesh-ancestor
93039122|NCT01324596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039123|NCT01324596|Glucocorticoids|glucocorticoids|mesh-ancestor
93039124|NCT01324596|Hormones|hormones|mesh-ancestor
93039125|NCT01324596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039126|NCT01324596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93039127|NCT01324596|Antiemetics|antiemetics|mesh-ancestor
93039128|NCT01324596|Autonomic Agents|autonomic agents|mesh-ancestor
93039129|NCT01324596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039130|NCT01324596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039131|NCT01324596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93039132|NCT01324596|Protective Agents|protective agents|mesh-ancestor
93039134|NCT00424190|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
93039135|NCT00424190|Aztreonam|aztreonam|mesh-list
93039136|NCT00424190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039137|NCT00424190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039138|NCT02859012|Axitinib|axitinib|mesh-list
93039139|NCT02859012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039140|NCT02859012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039141|NCT02859012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039142|NCT02859012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039143|NCT00274287|Sargramostim|sargramostim|mesh-list
93039144|NCT00274287|Immunologic Factors|immunologic factors|mesh-ancestor
93039145|NCT00274287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039146|NCT01045278|Interferons|interferons|mesh-list
93039147|NCT01045278|Ribavirin|ribavirin|mesh-list
93039148|NCT01045278|Interferon-alpha|interferon-alpha|mesh-list
93039149|NCT01045278|Interferon alpha-2|interferon alpha-2|mesh-list
93039150|NCT01045278|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93039151|NCT01045278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039152|NCT01045278|Antiviral Agents|antiviral agents|mesh-ancestor
93039153|NCT01045278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039154|NCT01045278|Antimetabolites|antimetabolites|mesh-ancestor
93039155|NCT01045278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039156|NCT01045278|Immunologic Factors|immunologic factors|mesh-ancestor
93039157|NCT01045278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039158|NCT00423800|Interferons|interferons|mesh-list
93039159|NCT00423800|Ribavirin|ribavirin|mesh-list
93039160|NCT00423800|Interferon-alpha|interferon-alpha|mesh-list
93039161|NCT00423800|Interferon alpha-2|interferon alpha-2|mesh-list
92239734|NCT03011645|Ziprasidone|ziprasidone|mesh-list
93039162|NCT00423800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93039163|NCT00423800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039164|NCT00423800|Antiviral Agents|antiviral agents|mesh-ancestor
93039165|NCT00423800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039166|NCT00423800|Antimetabolites|antimetabolites|mesh-ancestor
93039167|NCT00423800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039168|NCT00423800|Immunologic Factors|immunologic factors|mesh-ancestor
93039169|NCT00423800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039170|NCT00405548|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
93039171|NCT00405548|Natriuretic Agents|natriuretic agents|mesh-ancestor
93039172|NCT00405548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039173|NCT00405392|Ibandronic Acid|ibandronic acid|mesh-list
93039174|NCT00405392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93039175|NCT00405392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039176|NCT00282243|Tacrolimus|tacrolimus|mesh-list
93039177|NCT00282243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039178|NCT00282243|Immunologic Factors|immunologic factors|mesh-ancestor
93039179|NCT00282243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039180|NCT00282243|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93039181|NCT00282243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039182|NCT00282243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039183|NCT00272961|N-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|n-(2-acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide|mesh-list
93039184|NCT00272961|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
93039185|NCT00272961|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93039186|NCT00272961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039187|NCT00282087|Gemcitabine|gemcitabine|mesh-list
93039188|NCT00282087|Docetaxel|docetaxel|mesh-list
93039189|NCT00282087|Doxorubicin|doxorubicin|mesh-list
93039190|NCT00282087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039191|NCT00282087|Antimetabolites|antimetabolites|mesh-ancestor
93039192|NCT00282087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039193|NCT00282087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039194|NCT00282087|Tubulin Modulators|tubulin modulators|mesh-ancestor
93039195|NCT00282087|Antimitotic Agents|antimitotic agents|mesh-ancestor
93039196|NCT00282087|Mitosis Modulators|mitosis modulators|mesh-ancestor
93039197|NCT00282087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039198|NCT00282087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93039199|NCT00282087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93039200|NCT00282087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039201|NCT00281697|Bevacizumab|bevacizumab|mesh-list
93039202|NCT00281697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039203|NCT00281697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039204|NCT00281697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92384821|NCT00002352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93039205|NCT00281697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039206|NCT00281697|Growth Substances|growth substances|mesh-ancestor
93039207|NCT00281697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039208|NCT00281697|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039209|NCT00232180|Eplerenone|eplerenone|mesh-list
93039210|NCT00232180|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93039211|NCT00232180|Hormone Antagonists|hormone antagonists|mesh-ancestor
93039212|NCT00232180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239907|NCT01602666|Etoposide|etoposide|mesh-list
93039213|NCT00232180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039214|NCT00232180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93039215|NCT00232180|Diuretics|diuretics|mesh-ancestor
93039216|NCT00232180|Natriuretic Agents|natriuretic agents|mesh-ancestor
93039217|NCT00232180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93039218|NCT01070277|Albendazole|albendazole|mesh-list
93039219|NCT01070277|Tinidazole|tinidazole|mesh-list
93039220|NCT01070277|Anthelmintics|anthelmintics|mesh-ancestor
93039221|NCT01070277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93039222|NCT01070277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039223|NCT01070277|Anticestodal Agents|anticestodal agents|mesh-ancestor
93039224|NCT01070277|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92239934|NCT05441592|Hemostatics|hemostatics|mesh-ancestor
93039225|NCT01070277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93039226|NCT01070277|Tubulin Modulators|tubulin modulators|mesh-ancestor
93039227|NCT01070277|Antimitotic Agents|antimitotic agents|mesh-ancestor
93039228|NCT01070277|Mitosis Modulators|mitosis modulators|mesh-ancestor
93039229|NCT01070277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039230|NCT01070277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039231|NCT01070277|Alkylating Agents|alkylating agents|mesh-ancestor
93039232|NCT01070277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039233|NCT01070277|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93039234|NCT00270231|Naltrexone|naltrexone|mesh-list
93039235|NCT00270231|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93039236|NCT00270231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93039237|NCT00270231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039238|NCT00270231|Sensory System Agents|sensory system agents|mesh-ancestor
93039239|NCT00270231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039240|NCT02532309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93039241|NCT02532309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93039242|NCT02532309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93039243|NCT02532309|Antimetabolites|antimetabolites|mesh-ancestor
93039244|NCT02532309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039245|NCT02532309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93039246|NCT02532309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93039247|NCT02532309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039248|NCT00258856|Vaccines|vaccines|mesh-list
93039249|NCT00258856|Immunologic Factors|immunologic factors|mesh-ancestor
93039250|NCT00258856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039251|NCT00269919|Risperidone|risperidone|mesh-list
93039252|NCT00269919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93039253|NCT00269919|Serotonin Agents|serotonin agents|mesh-ancestor
93039254|NCT00269919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039255|NCT00269919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039256|NCT00269919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039257|NCT00269919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92684485|NCT00455897|Immunologic Factors|immunologic factors|mesh-ancestor
93039258|NCT00269919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93039259|NCT00269919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93039260|NCT00269919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039261|NCT00269919|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93039262|NCT00269919|Dopamine Agents|dopamine agents|mesh-ancestor
93039263|NCT00257920|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
93039264|NCT00257920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039265|NCT00257920|Vitamins|vitamins|mesh-ancestor
93039266|NCT00257920|Micronutrients|micronutrients|mesh-ancestor
93039267|NCT00257920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93039268|NCT00268983|Iodine|iodine|mesh-list
93039269|NCT00268983|Rituximab|rituximab|mesh-list
93039270|NCT00268983|Tositumomab I-131|tositumomab i-131|mesh-list
93039271|NCT00268983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93039272|NCT00268983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039273|NCT00268983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039274|NCT00268983|Immunologic Factors|immunologic factors|mesh-ancestor
93039275|NCT00268983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039276|NCT00268983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039277|NCT00268983|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93039278|NCT00268983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039279|NCT00268983|Trace Elements|trace elements|mesh-ancestor
93039280|NCT00268983|Micronutrients|micronutrients|mesh-ancestor
93039281|NCT01070511|Tadalafil|tadalafil|mesh-list
93039282|NCT01070511|Vasodilator Agents|vasodilator agents|mesh-ancestor
93039283|NCT01070511|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93039284|NCT01070511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93039285|NCT01070511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039286|NCT01070511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039287|NCT01070511|Urological Agents|urological agents|mesh-ancestor
93039288|NCT01070667|Dronedarone|dronedarone|mesh-list
93039289|NCT01070667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93039290|NCT00257608|Bevacizumab|bevacizumab|mesh-list
93039291|NCT00257608|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93039292|NCT00257608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039293|NCT00257608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039294|NCT00257608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93039295|NCT00257608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039296|NCT00257608|Growth Substances|growth substances|mesh-ancestor
93039297|NCT00257608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039298|NCT00257608|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039299|NCT00257608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039300|NCT00257608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039301|NCT00257608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039302|NCT00231478|Granisetron|granisetron|mesh-list
93039303|NCT00231478|Antiemetics|antiemetics|mesh-ancestor
93039304|NCT00231478|Autonomic Agents|autonomic agents|mesh-ancestor
93039305|NCT00231478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039306|NCT00231478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039307|NCT00231478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039308|NCT00231478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93039309|NCT00231478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93039310|NCT00231478|Serotonin Agents|serotonin agents|mesh-ancestor
93039311|NCT00231478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039312|NCT00231478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039313|NCT00207142|Ritonavir|ritonavir|mesh-list
93039314|NCT00207142|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93039315|NCT00207142|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93039316|NCT00207142|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93039317|NCT00207142|Protease Inhibitors|protease inhibitors|mesh-ancestor
93039318|NCT00207142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039319|NCT00207142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039320|NCT00207142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93039321|NCT00207142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93039322|NCT00207142|Antiviral Agents|antiviral agents|mesh-ancestor
93039323|NCT00207142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240079|NCT01479127|Carbidopa|carbidopa|mesh-list
93039324|NCT00207142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93039325|NCT00207142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93039326|NCT00268905|Carboplatin|carboplatin|mesh-list
93039327|NCT00268905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039328|NCT00206518|Docetaxel|docetaxel|mesh-list
93039329|NCT00206518|Doxorubicin|doxorubicin|mesh-list
93039330|NCT00206518|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93039331|NCT00206518|Cyclophosphamide|cyclophosphamide|mesh-list
93039332|NCT00206518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039333|NCT00206518|Tubulin Modulators|tubulin modulators|mesh-ancestor
93039334|NCT00206518|Antimitotic Agents|antimitotic agents|mesh-ancestor
93039336|NCT00206518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039337|NCT00206518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039338|NCT00206518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93039339|NCT00206518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93039340|NCT00206518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039341|NCT00206518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039342|NCT00206518|Immunologic Factors|immunologic factors|mesh-ancestor
93039343|NCT00206518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039344|NCT00206518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039345|NCT00206518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93039346|NCT00206518|Alkylating Agents|alkylating agents|mesh-ancestor
93039347|NCT00206518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93039348|NCT00206440|Esomeprazole|esomeprazole|mesh-list
93039349|NCT00206440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93039350|NCT00206440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039351|NCT00206440|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93039352|NCT00206440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039353|NCT00206440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039354|NCT00268437|Carboplatin|carboplatin|mesh-list
93039355|NCT00268437|Pemetrexed|pemetrexed|mesh-list
93039356|NCT00268437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039357|NCT00268437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039358|NCT00268437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039359|NCT00268437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93039360|NCT00268437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93039361|NCT00423488|Simvastatin|simvastatin|mesh-list
93039362|NCT00423488|Ezetimibe|ezetimibe|mesh-list
93039363|NCT00423488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93039364|NCT00423488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93039365|NCT00423488|Antimetabolites|antimetabolites|mesh-ancestor
93039366|NCT00423488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039367|NCT00423488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93039368|NCT00423488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93039369|NCT00423488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039370|NCT00404066|Dexamethasone|dexamethasone|mesh-list
93039371|NCT00404066|Cyclophosphamide|cyclophosphamide|mesh-list
93039372|NCT00404066|Docetaxel|docetaxel|mesh-list
93039373|NCT00404066|Doxorubicin|doxorubicin|mesh-list
93039374|NCT00404066|Trastuzumab|trastuzumab|mesh-list
93039375|NCT00404066|Lapatinib|lapatinib|mesh-list
93039376|NCT00404066|Lenograstim|lenograstim|mesh-list
93039377|NCT00404066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039378|NCT00404066|Immunologic Factors|immunologic factors|mesh-ancestor
93039379|NCT00404066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039380|NCT00404066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039381|NCT00404066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93039382|NCT00404066|Alkylating Agents|alkylating agents|mesh-ancestor
93039383|NCT00404066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039384|NCT00404066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039385|NCT00404066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93039386|NCT00404066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039387|NCT00404066|Antiemetics|antiemetics|mesh-ancestor
93039388|NCT00404066|Autonomic Agents|autonomic agents|mesh-ancestor
93039389|NCT00404066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039390|NCT00404066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039391|NCT00404066|Glucocorticoids|glucocorticoids|mesh-ancestor
93039392|NCT00404066|Hormones|hormones|mesh-ancestor
93039393|NCT00404066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039394|NCT00404066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93039395|NCT00404066|Tubulin Modulators|tubulin modulators|mesh-ancestor
93039396|NCT00404066|Antimitotic Agents|antimitotic agents|mesh-ancestor
93039397|NCT00404066|Mitosis Modulators|mitosis modulators|mesh-ancestor
93039398|NCT00404066|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039399|NCT00404066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93039400|NCT00404066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93039401|NCT00404066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039402|NCT00404066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039403|NCT00404066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93039404|NCT00404066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039405|NCT00423332|Cediranib|cediranib|mesh-list
92684634|NCT00456794|Istradefylline|istradefylline|mesh-list
93039406|NCT00423332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039407|NCT00423332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039408|NCT00423332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039409|NCT00423332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039410|NCT00413036|Lenalidomide|lenalidomide|mesh-list
93039411|NCT00413036|Immunologic Factors|immunologic factors|mesh-ancestor
93039412|NCT00413036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039413|NCT00413036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93039414|NCT00413036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039415|NCT00413036|Growth Substances|growth substances|mesh-ancestor
93039416|NCT00413036|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039417|NCT00413036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039418|NCT00412958|Plasminogen|plasminogen|mesh-list
93039419|NCT00412958|Fibrinolysin|fibrinolysin|mesh-list
93039420|NCT00412958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039421|NCT00412958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93039422|NCT00412958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039423|NCT00423176|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93039424|NCT00423176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93039425|NCT00423176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039426|NCT00423176|Antitubercular Agents|antitubercular agents|mesh-ancestor
93039428|NCT01040702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93039429|NCT01040702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039430|NCT01040702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93039431|NCT01040702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93039432|NCT01040702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039433|NCT01040702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039434|NCT01040702|Dopamine Agents|dopamine agents|mesh-ancestor
93039435|NCT01040702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039436|NCT00268203|Tositumomab I-131|tositumomab i-131|mesh-list
93039437|NCT00268203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039438|NCT00384930|Tadalafil|tadalafil|mesh-list
93039439|NCT00384930|Vasodilator Agents|vasodilator agents|mesh-ancestor
93039440|NCT00384930|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93039441|NCT00384930|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93039442|NCT00384930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039443|NCT00384930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039444|NCT00384930|Urological Agents|urological agents|mesh-ancestor
93039445|NCT00423098|Mycophenolic Acid|mycophenolic acid|mesh-list
93039446|NCT00423098|Prednisone|prednisone|mesh-list
93039447|NCT00423098|Methylprednisolone|methylprednisolone|mesh-list
93039448|NCT00423098|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93039449|NCT00423098|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93039450|NCT00423098|Prednisolone|prednisolone|mesh-list
93039451|NCT00423098|Prednisolone acetate|prednisolone acetate|mesh-list
93039452|NCT00423098|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93039453|NCT00423098|Prednisolone phosphate|prednisolone phosphate|mesh-list
93039454|NCT00423098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039455|NCT00423098|Glucocorticoids|glucocorticoids|mesh-ancestor
93039456|NCT00423098|Hormones|hormones|mesh-ancestor
93039457|NCT00423098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039458|NCT00423098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039459|NCT00423098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93039460|NCT00423098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039461|NCT00423098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039462|NCT00423098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93039463|NCT00423098|Antitubercular Agents|antitubercular agents|mesh-ancestor
93039464|NCT00423098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039465|NCT00423098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039466|NCT00423098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039467|NCT00423098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039468|NCT00423098|Antiemetics|antiemetics|mesh-ancestor
93039469|NCT00423098|Autonomic Agents|autonomic agents|mesh-ancestor
93039470|NCT00423098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039471|NCT00423098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039472|NCT00423098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93039473|NCT00423098|Protective Agents|protective agents|mesh-ancestor
93039474|NCT01042704|Aspirin|aspirin|mesh-list
93039475|NCT01042704|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93039476|NCT01042704|Dexamethasone|dexamethasone|mesh-list
93039477|NCT01042704|Lenalidomide|lenalidomide|mesh-list
93039478|NCT01042704|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93039479|NCT01042704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039480|NCT01042704|Antiemetics|antiemetics|mesh-ancestor
93039481|NCT01042704|Autonomic Agents|autonomic agents|mesh-ancestor
93039482|NCT01042704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039483|NCT01042704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039484|NCT01042704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039485|NCT01042704|Glucocorticoids|glucocorticoids|mesh-ancestor
93039486|NCT01042704|Hormones|hormones|mesh-ancestor
93039487|NCT01042704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039488|NCT01042704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93039489|NCT01042704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039490|NCT01042704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93039491|NCT01042704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93039492|NCT01042704|Analgesics|analgesics|mesh-ancestor
93039493|NCT01042704|Sensory System Agents|sensory system agents|mesh-ancestor
93039494|NCT01042704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039495|NCT01042704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039496|NCT01042704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93039497|NCT01042704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039498|NCT01042704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93039500|NCT01042704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039501|NCT01042704|Antipyretics|antipyretics|mesh-ancestor
93039502|NCT01042704|Immunologic Factors|immunologic factors|mesh-ancestor
93039503|NCT01042704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93039504|NCT01042704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039505|NCT01042704|Growth Substances|growth substances|mesh-ancestor
93039506|NCT01042704|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039507|NCT01042704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039508|NCT01042704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93039509|NCT01042704|Alkylating Agents|alkylating agents|mesh-ancestor
93039510|NCT00750698|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93039511|NCT00750698|Entinostat|entinostat|mesh-list
93039512|NCT00750698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039513|NCT00750698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039514|NCT00750698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039515|NCT00750698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039516|NCT00750698|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93039517|NCT01046838|Sildenafil Citrate|sildenafil citrate|mesh-list
93039518|NCT01046838|Vasodilator Agents|vasodilator agents|mesh-ancestor
93039519|NCT01046838|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93039520|NCT01046838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93039521|NCT01046838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494472|NCT01975480|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93039522|NCT01046838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039523|NCT01046838|Urological Agents|urological agents|mesh-ancestor
93039524|NCT01042782|Everolimus|everolimus|mesh-list
93039525|NCT01042782|Mitomycin|mitomycin|mesh-list
93039526|NCT01042782|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93039527|NCT01042782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039528|NCT01042782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039529|NCT01042782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039530|NCT01042782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039531|NCT01042782|Immunologic Factors|immunologic factors|mesh-ancestor
93039532|NCT01042782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039533|NCT01042782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039534|NCT01042782|Alkylating Agents|alkylating agents|mesh-ancestor
93039535|NCT01042782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039536|NCT01042782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93039537|NCT00411788|Sirolimus|sirolimus|mesh-list
93039538|NCT00411788|Trastuzumab|trastuzumab|mesh-list
93039539|NCT00411788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039540|NCT00411788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039541|NCT00411788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039542|NCT00411788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039543|NCT00411788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039544|NCT00411788|Antifungal Agents|antifungal agents|mesh-ancestor
93039545|NCT00411788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039546|NCT00411788|Immunologic Factors|immunologic factors|mesh-ancestor
93039547|NCT00411788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039548|NCT01046994|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93039549|NCT01046994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039550|NCT01040936|Atorvastatin|atorvastatin|mesh-list
93039551|NCT01040936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93039552|NCT01040936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93039553|NCT01040936|Antimetabolites|antimetabolites|mesh-ancestor
93039554|NCT01040936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039555|NCT01040936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93039556|NCT01040936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93039557|NCT01040936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039558|NCT01041092|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93039559|NCT01041092|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93039560|NCT01041092|Hormone Antagonists|hormone antagonists|mesh-ancestor
93039561|NCT01041092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039562|NCT01041092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039563|NCT01041092|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93039564|NCT01041092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93039565|NCT01041092|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93039567|NCT01041170|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93039568|NCT01041170|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93039569|NCT01041170|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93039570|NCT01041170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039571|NCT01041170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039573|NCT01041170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039574|NCT01041170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039575|NCT01041482|Sorafenib|sorafenib|mesh-list
93039576|NCT01041482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039577|NCT01041482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039578|NCT01041482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039579|NCT01041482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039580|NCT00422942|Rituximab|rituximab|mesh-list
93039581|NCT00422942|Methotrexate|methotrexate|mesh-list
93039582|NCT00422942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039583|NCT00422942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039584|NCT00422942|Immunologic Factors|immunologic factors|mesh-ancestor
93039585|NCT00422942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039586|NCT00422942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240357|NCT01481545|Growth Substances|growth substances|mesh-ancestor
93039587|NCT00422942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93039588|NCT00422942|Abortifacient Agents|abortifacient agents|mesh-ancestor
93039589|NCT00422942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93039590|NCT00422942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039591|NCT00422942|Antimetabolites|antimetabolites|mesh-ancestor
93039592|NCT00422942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039593|NCT00422942|Dermatologic Agents|dermatologic agents|mesh-ancestor
93039594|NCT00422942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039595|NCT00422942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93039596|NCT00422942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039597|NCT00422942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93039598|NCT01039142|Acitretin|acitretin|mesh-list
93039599|NCT01039142|Keratolytic Agents|keratolytic agents|mesh-ancestor
93039600|NCT01039142|Dermatologic Agents|dermatologic agents|mesh-ancestor
93039601|NCT00422162|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93039602|NCT00422162|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93039603|NCT00422162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93039604|NCT00422162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039605|NCT00422162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039606|NCT00422162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039607|NCT00422162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039608|NCT00422162|Analgesics|analgesics|mesh-ancestor
93039609|NCT00422162|Sensory System Agents|sensory system agents|mesh-ancestor
93039610|NCT00422162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039611|NCT00422162|Antidepressive Agents|antidepressive agents|mesh-ancestor
93039612|NCT00422162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039613|NCT00422162|Dopamine Agents|dopamine agents|mesh-ancestor
93039614|NCT00411632|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93039615|NCT00411632|Bexarotene|bexarotene|mesh-list
93039616|NCT00411632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039617|NCT00411632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039618|NCT00411632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039619|NCT00411632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039620|NCT00422084|Artesunate|artesunate|mesh-list
93039621|NCT00422084|Lumefantrine|lumefantrine|mesh-list
93039622|NCT00422084|Artemether|artemether|mesh-list
93039623|NCT00422084|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93039624|NCT00422084|Pyronaridine|pyronaridine|mesh-list
93039625|NCT00422084|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93039626|NCT00422084|Antimalarials|antimalarials|mesh-ancestor
93039627|NCT00422084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93039628|NCT00422084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93039629|NCT00422084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039630|NCT00422084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039631|NCT00422084|Antiviral Agents|antiviral agents|mesh-ancestor
93039632|NCT00422084|Schistosomicides|schistosomicides|mesh-ancestor
93039633|NCT00422084|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93039634|NCT00422084|Anthelmintics|anthelmintics|mesh-ancestor
93039635|NCT00421928|Oxycodone|oxycodone|mesh-list
93039636|NCT00421928|Tapentadol|tapentadol|mesh-list
93039637|NCT00421928|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93039638|NCT00421928|Narcotics|narcotics|mesh-ancestor
93039639|NCT00421928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93039640|NCT00421928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039641|NCT00421928|Analgesics|analgesics|mesh-ancestor
93039642|NCT00421928|Sensory System Agents|sensory system agents|mesh-ancestor
93039643|NCT00421928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039644|NCT00421928|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93039645|NCT00421928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93039646|NCT00421928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039647|NCT00421928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039648|NCT00421928|Adrenergic Agents|adrenergic agents|mesh-ancestor
93039649|NCT00421928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039650|NCT01047072|Mycophenolic Acid|mycophenolic acid|mesh-list
93039651|NCT01047072|Cyclophosphamide|cyclophosphamide|mesh-list
93039652|NCT01047072|Rituximab|rituximab|mesh-list
93039653|NCT01047072|Fludarabine|fludarabine|mesh-list
93039654|NCT01047072|Fludarabine phosphate|fludarabine phosphate|mesh-list
93039655|NCT01047072|Tacrolimus|tacrolimus|mesh-list
93039656|NCT01047072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039657|NCT01047072|Immunologic Factors|immunologic factors|mesh-ancestor
93039658|NCT01047072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039659|NCT01047072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039660|NCT01047072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93039661|NCT01047072|Alkylating Agents|alkylating agents|mesh-ancestor
93039662|NCT01047072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039663|NCT01047072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039664|NCT01047072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93039665|NCT01047072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039666|NCT01047072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039667|NCT01047072|Antimetabolites|antimetabolites|mesh-ancestor
93039668|NCT01047072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93039669|NCT01047072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039670|NCT01047072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039671|NCT01047072|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93039672|NCT01047072|Antitubercular Agents|antitubercular agents|mesh-ancestor
93039673|NCT01047072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039674|NCT01047072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039675|NCT00372060|Pioglitazone|pioglitazone|mesh-list
93039676|NCT00372060|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93039677|NCT00372060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93039678|NCT00372060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039679|NCT00372060|Incretins|incretins|mesh-ancestor
93039680|NCT00372060|Hormones|hormones|mesh-ancestor
93039681|NCT00372060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039682|NCT00372060|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93039683|NCT00372060|Protease Inhibitors|protease inhibitors|mesh-ancestor
93039684|NCT00372060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039685|NCT00372060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039686|NCT01043172|Gemcitabine|gemcitabine|mesh-list
93039687|NCT01043172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039688|NCT01043172|Antimetabolites|antimetabolites|mesh-ancestor
93039689|NCT01043172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039690|NCT01043172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039691|NCT01045434|Omeprazole|omeprazole|mesh-list
93039692|NCT01045434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93039693|NCT01045434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93039694|NCT01045434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93039695|NCT01045434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039696|NCT01045434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039697|NCT01043484|Bevacizumab|bevacizumab|mesh-list
93039698|NCT01043484|Capecitabine|capecitabine|mesh-list
93039699|NCT01043484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039700|NCT01043484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039701|NCT01043484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93039702|NCT01043484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039703|NCT01043484|Growth Substances|growth substances|mesh-ancestor
93039704|NCT01043484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039705|NCT01043484|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039706|NCT01043484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039707|NCT01043484|Antimetabolites|antimetabolites|mesh-ancestor
93039708|NCT01043484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039709|NCT00396318|Tenecteplase|tenecteplase|mesh-list
93039710|NCT00396318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039711|NCT00396318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92240465|NCT00335504|Atorvastatin|atorvastatin|mesh-list
93039712|NCT00396318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039713|NCT00381888|PENTA|penta|mesh-list
93039714|NCT00381888|Fondaparinux|fondaparinux|mesh-list
93039715|NCT00381888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93039716|NCT00381888|Antithrombins|antithrombins|mesh-ancestor
93039717|NCT00381888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93039718|NCT00381888|Protease Inhibitors|protease inhibitors|mesh-ancestor
93039720|NCT00381888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039721|NCT00381888|Anticoagulants|anticoagulants|mesh-ancestor
93039722|NCT00381888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93039723|NCT00381888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93039724|NCT00267969|Ustekinumab|ustekinumab|mesh-list
93039725|NCT00267969|Dermatologic Agents|dermatologic agents|mesh-ancestor
93039726|NCT00280293|Lamotrigine|lamotrigine|mesh-list
93039727|NCT00280293|Anticonvulsants|anticonvulsants|mesh-ancestor
93039728|NCT00280293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93039729|NCT00280293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039730|NCT00280293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039731|NCT00280293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93039732|NCT00280293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039733|NCT00280293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93039734|NCT00280293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93039735|NCT00280293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93039736|NCT00280293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039737|NCT00280293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93039738|NCT00421148|Bromides|bromides|mesh-list
93039739|NCT00421148|Rocuronium|rocuronium|mesh-list
93039740|NCT00421148|Anticonvulsants|anticonvulsants|mesh-ancestor
93039741|NCT00421148|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93039742|NCT00421148|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93039743|NCT00421148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93039744|NCT00421148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039745|NCT00421148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039746|NCT00403754|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93039747|NCT00403754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93039748|NCT00403754|Autonomic Agents|autonomic agents|mesh-ancestor
93039749|NCT00403754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039750|NCT00403754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039751|NCT00403754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93039752|NCT00403754|Respiratory System Agents|respiratory system agents|mesh-ancestor
93039753|NCT00403754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93039754|NCT00403754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93039755|NCT00403754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93039756|NCT00403754|Adrenergic Agents|adrenergic agents|mesh-ancestor
93039757|NCT00403754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039758|NCT00403754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039759|NCT00280059|Pregabalin|pregabalin|mesh-list
93039760|NCT00280059|Lamotrigine|lamotrigine|mesh-list
93039761|NCT00280059|Analgesics|analgesics|mesh-ancestor
93039762|NCT00280059|Sensory System Agents|sensory system agents|mesh-ancestor
93039763|NCT00280059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039764|NCT00280059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039765|NCT00280059|Anticonvulsants|anticonvulsants|mesh-ancestor
93039766|NCT00280059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93039767|NCT00280059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039768|NCT00280059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039769|NCT00280059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93039770|NCT00280059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93039771|NCT00280059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93039772|NCT00280059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93039773|NCT00280059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039774|NCT00280059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93039775|NCT00280059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93039776|NCT00403130|Paclitaxel|paclitaxel|mesh-list
93039777|NCT00403130|Bevacizumab|bevacizumab|mesh-list
92340463|NCT00002567|Etoposide|etoposide|mesh-list
92685003|NCT00459836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039778|NCT00403130|Gemcitabine|gemcitabine|mesh-list
93039779|NCT00403130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93039780|NCT00403130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039781|NCT00403130|Tubulin Modulators|tubulin modulators|mesh-ancestor
93039782|NCT00403130|Antimitotic Agents|antimitotic agents|mesh-ancestor
93039783|NCT00403130|Mitosis Modulators|mitosis modulators|mesh-ancestor
93039784|NCT00403130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039785|NCT00403130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93039786|NCT00403130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93039787|NCT00403130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93039788|NCT00403130|Growth Substances|growth substances|mesh-ancestor
93039789|NCT00403130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039790|NCT00403130|Growth Inhibitors|growth inhibitors|mesh-ancestor
93039791|NCT00403130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039793|NCT01039610|Moxifloxacin|moxifloxacin|mesh-list
93039794|NCT01039610|Linezolid|linezolid|mesh-list
93039795|NCT01039610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039796|NCT01039610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039797|NCT01039610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93039798|NCT01039610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93039799|NCT01039610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039800|NCT01039610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039801|NCT01039610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039802|NCT01039610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93039803|NCT00420290|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93039804|NCT00420290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039805|NCT00267189|Cyclosporine|cyclosporine|mesh-list
93039806|NCT00267189|Everolimus|everolimus|mesh-list
93039807|NCT00267189|Azathioprine|azathioprine|mesh-list
93039808|NCT00267189|Tacrolimus|tacrolimus|mesh-list
93039809|NCT00267189|Cyclosporins|cyclosporins|mesh-list
93039810|NCT00267189|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93039811|NCT00267189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92240574|NCT01184885|Sirolimus|sirolimus|mesh-list
93039812|NCT00267189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039813|NCT00267189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039814|NCT00267189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039815|NCT00267189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039816|NCT00267189|Immunologic Factors|immunologic factors|mesh-ancestor
93039817|NCT00267189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039818|NCT00267189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039819|NCT00267189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039820|NCT00267189|Antimetabolites|antimetabolites|mesh-ancestor
93039821|NCT00267189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93039822|NCT00267189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039823|NCT00267189|Antifungal Agents|antifungal agents|mesh-ancestor
93039824|NCT00267189|Dermatologic Agents|dermatologic agents|mesh-ancestor
93039825|NCT00402116|Temozolomide|temozolomide|mesh-list
93039826|NCT00402116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93039827|NCT00402116|Alkylating Agents|alkylating agents|mesh-ancestor
93039828|NCT00402116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039829|NCT00402116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039830|NCT00401960|Daptomycin|daptomycin|mesh-list
93039831|NCT00401960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039832|NCT00401960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039833|NCT00401726|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93039834|NCT00401726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93039835|NCT00401726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93039836|NCT00401726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039837|NCT00401726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039838|NCT00401726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039839|NCT00401726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039840|NCT00401726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93039841|NCT00401726|Antidepressive Agents|antidepressive agents|mesh-ancestor
93039842|NCT00401726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039843|NCT00371826|Cyclosporine|cyclosporine|mesh-list
93039844|NCT00371826|Mycophenolic Acid|mycophenolic acid|mesh-list
93039845|NCT00371826|Prednisone|prednisone|mesh-list
93039846|NCT00371826|Everolimus|everolimus|mesh-list
93039847|NCT00371826|Cyclosporins|cyclosporins|mesh-list
93039848|NCT00371826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93039849|NCT00371826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039850|NCT00371826|Glucocorticoids|glucocorticoids|mesh-ancestor
93039851|NCT00371826|Hormones|hormones|mesh-ancestor
93039852|NCT00371826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039853|NCT00371826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039854|NCT00371826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93039855|NCT00371826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039856|NCT00371826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039857|NCT00371826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039858|NCT00371826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039859|NCT00371826|Immunologic Factors|immunologic factors|mesh-ancestor
93039860|NCT00371826|Antifungal Agents|antifungal agents|mesh-ancestor
93039861|NCT00371826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039862|NCT00371826|Dermatologic Agents|dermatologic agents|mesh-ancestor
93039863|NCT00371826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93039864|NCT00371826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92385501|NCT00002670|Trace Elements|trace elements|mesh-ancestor
93039865|NCT00371826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039866|NCT00371826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039867|NCT00371826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93039868|NCT00371826|Antitubercular Agents|antitubercular agents|mesh-ancestor
93039869|NCT00371826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039870|NCT03993366|Pramlintide|pramlintide|mesh-list
93039871|NCT03993366|Insulin Aspart|insulin aspart|mesh-list
93039872|NCT03993366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93039873|NCT03993366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039874|NCT02457702|Glycerol|glycerol|mesh-list
93039875|NCT02457702|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93039876|NCT02457702|Protective Agents|protective agents|mesh-ancestor
93039877|NCT02457702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039878|NCT00396084|Moxifloxacin|moxifloxacin|mesh-list
93039879|NCT00396084|Levofloxacin|levofloxacin|mesh-list
93039880|NCT00396084|Isoniazid|isoniazid|mesh-list
93039881|NCT00396084|Linezolid|linezolid|mesh-list
93039882|NCT00396084|Gatifloxacin|gatifloxacin|mesh-list
93039883|NCT00396084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039884|NCT00396084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039885|NCT00396084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93039886|NCT00396084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93039887|NCT00396084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039888|NCT00396084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039889|NCT00396084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039890|NCT00396084|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93039891|NCT00396084|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93039892|NCT00396084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93039893|NCT00396084|Antitubercular Agents|antitubercular agents|mesh-ancestor
92240713|NCT01283555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93039894|NCT00396084|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93039895|NCT00396084|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93039896|NCT00396084|Antimetabolites|antimetabolites|mesh-ancestor
93039897|NCT00396084|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93039898|NCT00396084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93039899|NCT00396084|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93039900|NCT00396084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93039901|NCT00395850|Disulfiram|disulfiram|mesh-list
93039902|NCT00395850|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93039903|NCT00395850|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93039904|NCT00395850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039905|NCT00395850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039906|NCT00420212|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93039907|NCT00420212|Dermatologic Agents|dermatologic agents|mesh-ancestor
93039908|NCT00420212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93039909|NCT00420212|Immunologic Factors|immunologic factors|mesh-ancestor
93039910|NCT00420212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039911|NCT00401258|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93039912|NCT00401258|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93039913|NCT00401258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93039914|NCT00401258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039915|NCT00401258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039916|NCT00401258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93039917|NCT00401258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039918|NCT00401258|Analgesics|analgesics|mesh-ancestor
93039919|NCT00401258|Sensory System Agents|sensory system agents|mesh-ancestor
93039920|NCT00401258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039921|NCT00401258|Antidepressive Agents|antidepressive agents|mesh-ancestor
93039922|NCT00401258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039923|NCT00401258|Dopamine Agents|dopamine agents|mesh-ancestor
93039924|NCT00380874|Pregabalin|pregabalin|mesh-list
93039925|NCT00380874|Analgesics|analgesics|mesh-ancestor
93039926|NCT00380874|Sensory System Agents|sensory system agents|mesh-ancestor
93039927|NCT00380874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039928|NCT00380874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039929|NCT00380874|Anticonvulsants|anticonvulsants|mesh-ancestor
93039930|NCT00380874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93039931|NCT00380874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039932|NCT00380874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039933|NCT00380874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93039934|NCT00380874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93039935|NCT00380874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93039936|NCT00380874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93039937|NCT00380874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039938|NCT00420056|Palbociclib|palbociclib|mesh-list
93039939|NCT00420056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039940|NCT00420056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93039941|NCT00420056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039942|NCT00420056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039943|NCT00411554|Inositol|inositol|mesh-list
93039944|NCT00411554|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93039945|NCT00411554|Voglibose|voglibose|mesh-list
93039946|NCT00411554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93039947|NCT00411554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039948|NCT00411554|Incretins|incretins|mesh-ancestor
93039949|NCT00411554|Hormones|hormones|mesh-ancestor
93039950|NCT00411554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93039951|NCT00411554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93039952|NCT00411554|Protease Inhibitors|protease inhibitors|mesh-ancestor
93039953|NCT00411554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039954|NCT00411554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039955|NCT00411554|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93039956|NCT00411554|Vitamin B Complex|vitamin b complex|mesh-ancestor
93039957|NCT00411554|Vitamins|vitamins|mesh-ancestor
93039958|NCT00411554|Micronutrients|micronutrients|mesh-ancestor
93039959|NCT00380718|Pemetrexed|pemetrexed|mesh-list
93039960|NCT00380718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039961|NCT00380718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039962|NCT00380718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039963|NCT00380718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93039964|NCT00380718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93039965|NCT00380250|Lubiprostone|lubiprostone|mesh-list
93039966|NCT00380250|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93039967|NCT00380250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039968|NCT00380250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039969|NCT00400400|Mycophenolic Acid|mycophenolic acid|mesh-list
93039970|NCT00400400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93039971|NCT00400400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93039972|NCT00400400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93039973|NCT00400400|Antitubercular Agents|antitubercular agents|mesh-ancestor
93039974|NCT00400400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93039975|NCT00400400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93039976|NCT00400400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93039977|NCT00400400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039978|NCT00395694|Lamotrigine|lamotrigine|mesh-list
93039979|NCT00395694|Anticonvulsants|anticonvulsants|mesh-ancestor
93039980|NCT00395694|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93039981|NCT00395694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93039982|NCT00395694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93039983|NCT00395694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93039984|NCT00395694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039985|NCT00395694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93039986|NCT00395694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93039987|NCT00395694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93039988|NCT00395694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93039989|NCT00395694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93039990|NCT00419744|Budesonide|budesonide|mesh-list
93039991|NCT00419744|Formoterol Fumarate|formoterol fumarate|mesh-list
93039992|NCT00419744|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93039993|NCT00419744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93039994|NCT00419744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93039995|NCT00419744|Autonomic Agents|autonomic agents|mesh-ancestor
93039996|NCT00419744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93039997|NCT00419744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93039998|NCT00419744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93039999|NCT00419744|Respiratory System Agents|respiratory system agents|mesh-ancestor
93040000|NCT00419744|Glucocorticoids|glucocorticoids|mesh-ancestor
92685236|NCT00496275|Cisplatin|cisplatin|mesh-list
93040001|NCT00419744|Hormones|hormones|mesh-ancestor
93040002|NCT00419744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93040003|NCT00419744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93040004|NCT00419744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93040005|NCT00419744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93040006|NCT00419744|Adrenergic Agents|adrenergic agents|mesh-ancestor
93040007|NCT00419744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040008|NCT00419744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040009|NCT01047774|Caseins|caseins|mesh-list
93040010|NCT01047774|Chelating Agents|chelating agents|mesh-ancestor
93040011|NCT01047774|Sequestering Agents|sequestering agents|mesh-ancestor
93040012|NCT01047774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040013|NCT00395304|Fluticasone|fluticasone|mesh-list
93040014|NCT00395304|Xhance|xhance|mesh-list
93040015|NCT00395304|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93040016|NCT00395304|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93040017|NCT00395304|Montelukast|montelukast|mesh-list
93040018|NCT00395304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93040019|NCT00395304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93040020|NCT00395304|Autonomic Agents|autonomic agents|mesh-ancestor
93040021|NCT00395304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040022|NCT00395304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040023|NCT00395304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93040024|NCT00395304|Respiratory System Agents|respiratory system agents|mesh-ancestor
93040025|NCT00395304|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040026|NCT00395304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93040027|NCT00395304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93040028|NCT00395304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93040029|NCT00395304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93040030|NCT00395304|Adrenergic Agents|adrenergic agents|mesh-ancestor
93040031|NCT00395304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040032|NCT00395304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040033|NCT00395304|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93040034|NCT00395304|Hormone Antagonists|hormone antagonists|mesh-ancestor
93040035|NCT00395304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93040036|NCT00395304|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93040037|NCT00395304|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93040038|NCT00395304|Glucocorticoids|glucocorticoids|mesh-ancestor
93040039|NCT00395304|Hormones|hormones|mesh-ancestor
93040040|NCT00395304|Sympathomimetics|sympathomimetics|mesh-ancestor
93040041|NCT00395226|Zinc Sulfate|zinc sulfate|mesh-list
93040042|NCT00395226|Astringents|astringents|mesh-ancestor
93040043|NCT00395226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040044|NCT00395226|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040045|NCT00394914|Pleconaril|pleconaril|mesh-list
93040046|NCT00394914|Antiviral Agents|antiviral agents|mesh-ancestor
93040047|NCT00394914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040048|NCT00366444|Diclofenac|diclofenac|mesh-list
93040049|NCT00366444|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93040050|NCT00366444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93040051|NCT00366444|Analgesics|analgesics|mesh-ancestor
93040052|NCT00366444|Sensory System Agents|sensory system agents|mesh-ancestor
93040053|NCT00366444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040054|NCT00366444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040055|NCT00366444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93040056|NCT00366444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040057|NCT00366444|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93040058|NCT00366444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040059|NCT00366444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040060|NCT00365976|Eszopiclone|eszopiclone|mesh-list
93040061|NCT00365976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93040062|NCT00365976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040063|NCT00365976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040064|NCT00378534|Cyclosporine|cyclosporine|mesh-list
93040065|NCT00378534|Cyclophosphamide|cyclophosphamide|mesh-list
93040066|NCT00378534|Fludarabine|fludarabine|mesh-list
93040067|NCT00378534|Cyclosporins|cyclosporins|mesh-list
93040068|NCT00378534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040069|NCT00378534|Immunologic Factors|immunologic factors|mesh-ancestor
93040070|NCT00378534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040071|NCT00378534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040072|NCT00378534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93040073|NCT00378534|Alkylating Agents|alkylating agents|mesh-ancestor
93040074|NCT00378534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040075|NCT00378534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040076|NCT00378534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93040077|NCT00378534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040078|NCT00378534|Antifungal Agents|antifungal agents|mesh-ancestor
93040079|NCT00378534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040080|NCT00378534|Dermatologic Agents|dermatologic agents|mesh-ancestor
92240979|NCT00315302|Mydriatics|mydriatics|mesh-ancestor
93040081|NCT00378534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93040082|NCT00377676|Bromocriptine|bromocriptine|mesh-list
93040083|NCT00377676|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93040084|NCT00377676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93040086|NCT00377676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93040087|NCT00377676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040088|NCT00377676|Dopamine Agonists|dopamine agonists|mesh-ancestor
93040089|NCT00377676|Dopamine Agents|dopamine agents|mesh-ancestor
93040090|NCT00377676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040091|NCT00377676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040092|NCT00377520|Pemetrexed|pemetrexed|mesh-list
93040093|NCT00377520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040094|NCT00377520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040095|NCT00377520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040096|NCT00377520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93040097|NCT00377520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93040098|NCT00377364|Acetaminophen|acetaminophen|mesh-list
93040099|NCT00377364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93040100|NCT00377364|Analgesics|analgesics|mesh-ancestor
93040101|NCT00377364|Sensory System Agents|sensory system agents|mesh-ancestor
93040102|NCT00377364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040103|NCT00377364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040104|NCT00377364|Antipyretics|antipyretics|mesh-ancestor
93040105|NCT00365508|Nicotine|nicotine|mesh-list
93040106|NCT00365508|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93040107|NCT00365508|Autonomic Agents|autonomic agents|mesh-ancestor
93040108|NCT00365508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040109|NCT00365508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040110|NCT00365508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93040111|NCT00365508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93040112|NCT00365508|Cholinergic Agents|cholinergic agents|mesh-ancestor
93040113|NCT00365508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040114|NCT00365508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040115|NCT00365352|Gabapentin|gabapentin|mesh-list
93040116|NCT00365352|Analgesics|analgesics|mesh-ancestor
93040117|NCT00365352|Sensory System Agents|sensory system agents|mesh-ancestor
93040118|NCT00365352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040119|NCT00365352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040120|NCT00365352|Anticonvulsants|anticonvulsants|mesh-ancestor
93040121|NCT00365352|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93040122|NCT00365352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93040123|NCT00365352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040124|NCT00365352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040125|NCT00365352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93040126|NCT00365352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93040127|NCT00365352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040128|NCT00365352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040129|NCT00365352|Antimanic Agents|antimanic agents|mesh-ancestor
93040130|NCT00410384|Belimumab|belimumab|mesh-list
93040131|NCT00410384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040132|NCT00410384|Immunologic Factors|immunologic factors|mesh-ancestor
93040133|NCT00410384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040134|NCT00370032|Alosetron|alosetron|mesh-list
93040135|NCT00370032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93040136|NCT00370032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93040137|NCT00370032|Serotonin Agents|serotonin agents|mesh-ancestor
93040138|NCT00370032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040139|NCT00370032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040140|NCT00370032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040141|NCT00410072|Tenofovir|tenofovir|mesh-list
93040142|NCT00410072|Entecavir|entecavir|mesh-list
93040143|NCT00410072|Antiviral Agents|antiviral agents|mesh-ancestor
93040144|NCT00410072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040145|NCT00410072|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93040146|NCT00410072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93040147|NCT00410072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040148|NCT00410072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040149|NCT00410072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93040150|NCT00410072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93040151|NCT00409838|Methotrexate|methotrexate|mesh-list
93040152|NCT00409838|Abatacept|abatacept|mesh-list
93040153|NCT00409838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93040154|NCT00409838|Abortifacient Agents|abortifacient agents|mesh-ancestor
93040155|NCT00409838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93040156|NCT00409838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241051|NCT04422678|Imatinib Mesylate|imatinib mesylate|mesh-list
93040157|NCT00409838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040158|NCT00409838|Antimetabolites|antimetabolites|mesh-ancestor
93040159|NCT00409838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040160|NCT00409838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040161|NCT00409838|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040162|NCT00409838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040163|NCT00409838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93040164|NCT00409838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040165|NCT00409838|Immunologic Factors|immunologic factors|mesh-ancestor
93040166|NCT00409838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040167|NCT00409838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93040168|NCT00409838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93040169|NCT00409838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040170|NCT01041872|Lidocaine|lidocaine|mesh-list
93040171|NCT01041872|Propofol|propofol|mesh-list
93040172|NCT01041872|Anesthetics, Local|anesthetics, local|mesh-ancestor
93040173|NCT01041872|Anesthetics|anesthetics|mesh-ancestor
93040174|NCT01041872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040175|NCT01041872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040176|NCT01041872|Sensory System Agents|sensory system agents|mesh-ancestor
93040177|NCT01041872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040178|NCT01041872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93040179|NCT01041872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93040180|NCT01041872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93040181|NCT01041872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040182|NCT01041872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040183|NCT01041872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93040184|NCT01041872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93040185|NCT01041872|Anesthetics, General|anesthetics, general|mesh-ancestor
93040186|NCT00399542|Lubiprostone|lubiprostone|mesh-list
93040187|NCT00399542|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93040188|NCT00399542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040189|NCT00399542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040190|NCT01039766|Oxytocin|oxytocin|mesh-list
93040191|NCT01039766|Oxytocics|oxytocics|mesh-ancestor
93040192|NCT01039766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92241559|NCT05810597|Hormones|hormones|mesh-ancestor
93040193|NCT01039766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040194|NCT00409682|Adalimumab|adalimumab|mesh-list
93040195|NCT00409682|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93040196|NCT00409682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93040197|NCT00409682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040198|NCT01039844|Paclitaxel|paclitaxel|mesh-list
93040199|NCT01039844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93040200|NCT01039844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040201|NCT01039844|Tubulin Modulators|tubulin modulators|mesh-ancestor
93040202|NCT01039844|Antimitotic Agents|antimitotic agents|mesh-ancestor
93040203|NCT01039844|Mitosis Modulators|mitosis modulators|mesh-ancestor
93040204|NCT01039844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040205|NCT01042028|Capecitabine|capecitabine|mesh-list
93040206|NCT01042028|Irinotecan|irinotecan|mesh-list
93040207|NCT01042028|Cetuximab|cetuximab|mesh-list
93040208|NCT01042028|Everolimus|everolimus|mesh-list
93040209|NCT01042028|Oxaliplatin|oxaliplatin|mesh-list
93040210|NCT01042028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040211|NCT01042028|Antimetabolites|antimetabolites|mesh-ancestor
93040212|NCT01042028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040213|NCT01042028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040214|NCT01042028|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93040215|NCT01042028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93040216|NCT01042028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040217|NCT01042028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040218|NCT01042028|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93040219|NCT01042028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93040220|NCT01042028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040221|NCT01042028|Immunologic Factors|immunologic factors|mesh-ancestor
93040222|NCT01042028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040223|NCT03993626|Nivolumab|nivolumab|mesh-list
93040224|NCT03993626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040225|NCT03993626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040226|NCT03993626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93040227|NCT03993626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040229|NCT00398216|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
93040230|NCT00398216|Antithrombins|antithrombins|mesh-ancestor
93040231|NCT00398216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93040232|NCT00398216|Protease Inhibitors|protease inhibitors|mesh-ancestor
93040233|NCT00398216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040234|NCT00398216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040235|NCT00398216|Anticoagulants|anticoagulants|mesh-ancestor
93040236|NCT00398138|Sargramostim|sargramostim|mesh-list
93040237|NCT00398138|Freund's Adjuvant|freund's adjuvant|mesh-list
93040238|NCT00398138|Immunologic Factors|immunologic factors|mesh-ancestor
93040239|NCT00398138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040240|NCT00398138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93040241|NCT04566380|Bevacizumab|bevacizumab|mesh-list
93040242|NCT04566380|Nivolumab|nivolumab|mesh-list
93040243|NCT04566380|Capecitabine|capecitabine|mesh-list
93040244|NCT04566380|Oxaliplatin|oxaliplatin|mesh-list
93040245|NCT04566380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040246|NCT04566380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242076|NCT04623541|Glucocorticoids|glucocorticoids|mesh-ancestor
93040247|NCT04566380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93040248|NCT04566380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93040249|NCT04566380|Growth Substances|growth substances|mesh-ancestor
93040250|NCT04566380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040251|NCT04566380|Growth Inhibitors|growth inhibitors|mesh-ancestor
93040252|NCT04566380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040253|NCT04566380|Antimetabolites|antimetabolites|mesh-ancestor
93040254|NCT04566380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040255|NCT04566380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93040256|NCT00397982|Sirolimus|sirolimus|mesh-list
93040257|NCT00397982|Bevacizumab|bevacizumab|mesh-list
93040258|NCT00397982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93040259|NCT00397982|Temsirolimus|temsirolimus|mesh-list
93040260|NCT00397982|MTOR Inhibitors|mtor inhibitors|mesh-list
93040261|NCT00397982|Endothelial Growth Factors|endothelial growth factors|mesh-list
93040262|NCT00397982|Antibodies|antibodies|mesh-list
93040263|NCT00397982|Immunoglobulins|immunoglobulins|mesh-list
93040264|NCT00397982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93040265|NCT00397982|Immunoglobulin G|immunoglobulin g|mesh-list
93040266|NCT00397982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040267|NCT00397982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93040268|NCT00397982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93040269|NCT00397982|Growth Substances|growth substances|mesh-ancestor
93040270|NCT00397982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040271|NCT00397982|Growth Inhibitors|growth inhibitors|mesh-ancestor
93040272|NCT00397982|Immunologic Factors|immunologic factors|mesh-ancestor
93040273|NCT00397982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93040274|NCT00397982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040275|NCT00397982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93040276|NCT00397982|Antifungal Agents|antifungal agents|mesh-ancestor
93040277|NCT00397982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040278|NCT00397982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93040279|NCT00397982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040280|NCT00397982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040281|NCT03715166|Bumetanide|bumetanide|mesh-list
93040282|NCT03715166|Diuretics|diuretics|mesh-ancestor
93040283|NCT03715166|Natriuretic Agents|natriuretic agents|mesh-ancestor
93040284|NCT03715166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040285|NCT03715166|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93040286|NCT03715166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040287|NCT03715166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040288|NCT01042574|Clevidipine|clevidipine|mesh-list
93040289|NCT01042574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93040290|NCT01042574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92242331|NCT04100824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040291|NCT01042574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040292|NCT01042574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93040293|NCT01042574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040294|NCT01042652|Raltegravir Potassium|raltegravir potassium|mesh-list
93040295|NCT01042652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93040296|NCT01042652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93040297|NCT01042652|Antiviral Agents|antiviral agents|mesh-ancestor
93040298|NCT01042652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040299|NCT01042652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93040300|NCT01042652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93040301|NCT01042652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040302|NCT01042652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040303|NCT01040078|Vaccines|vaccines|mesh-list
93040304|NCT01040078|Immunologic Factors|immunologic factors|mesh-ancestor
93040305|NCT01040078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040306|NCT01035320|Simvastatin|simvastatin|mesh-list
93040307|NCT01035320|Ezetimibe|ezetimibe|mesh-list
93040308|NCT01035320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93040309|NCT01035320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93040310|NCT01035320|Antimetabolites|antimetabolites|mesh-ancestor
93040311|NCT01035320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040312|NCT01035320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93040313|NCT01035320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93040314|NCT01035320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040315|NCT01042730|Pitavastatin|pitavastatin|mesh-list
93040316|NCT01042730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93040317|NCT01042730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93040318|NCT01042730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93040319|NCT01042730|Antimetabolites|antimetabolites|mesh-ancestor
93040320|NCT01042730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040321|NCT01042730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040322|NCT01042730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93040323|NCT00396812|Rituximab|rituximab|mesh-list
93040324|NCT00396812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040325|NCT00396812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040326|NCT00396812|Immunologic Factors|immunologic factors|mesh-ancestor
93040327|NCT00396812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040328|NCT00396812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040329|NCT01566578|Mitogens|mitogens|mesh-list
93040330|NCT01566578|Mitosis Modulators|mitosis modulators|mesh-ancestor
93040331|NCT01566578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040332|NCT01040234|Bupivacaine|bupivacaine|mesh-list
93040333|NCT01040234|Anesthetics, Local|anesthetics, local|mesh-ancestor
93040334|NCT01040234|Anesthetics|anesthetics|mesh-ancestor
93040335|NCT01040234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040336|NCT01040234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040337|NCT01040234|Sensory System Agents|sensory system agents|mesh-ancestor
93040338|NCT01040234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040339|NCT00396656|Atenolol|atenolol|mesh-list
93040340|NCT00396656|Valsartan|valsartan|mesh-list
93040341|NCT00396656|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93040342|NCT00396656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93040343|NCT00396656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93040344|NCT00396656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93040345|NCT00396656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040346|NCT00396656|Diuretics|diuretics|mesh-ancestor
93040347|NCT00396656|Natriuretic Agents|natriuretic agents|mesh-ancestor
93040348|NCT00396656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040349|NCT00396656|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93040350|NCT00396656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040351|NCT00396656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93040352|NCT00396656|Sympatholytics|sympatholytics|mesh-ancestor
93040353|NCT00396656|Autonomic Agents|autonomic agents|mesh-ancestor
93040354|NCT00396656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040355|NCT00396656|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93040356|NCT00396656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93040357|NCT00396656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93040358|NCT00396656|Adrenergic Agents|adrenergic agents|mesh-ancestor
93040359|NCT00396656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040360|NCT00408434|Efatutazone|efatutazone|mesh-list
93040361|NCT00408434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040362|NCT00418886|Pemetrexed|pemetrexed|mesh-list
93040363|NCT00418886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040364|NCT00418886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040365|NCT00418886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040366|NCT00418886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93040367|NCT00418886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93040368|NCT01040312|Cisplatin|cisplatin|mesh-list
93040369|NCT01040312|Carboplatin|carboplatin|mesh-list
93040370|NCT01040312|Nedaplatin|nedaplatin|mesh-list
93040371|NCT01040312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040372|NCT00407030|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92529208|NCT05076877|Metformin|metformin|mesh-list
93040373|NCT00407030|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93040374|NCT00407030|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93040375|NCT00407030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040376|NCT00407030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040377|NCT00407030|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93040378|NCT00407030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040379|NCT00407030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040380|NCT00407030|Cholinergic Agents|cholinergic agents|mesh-ancestor
93040381|NCT00407030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040382|NCT00406640|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93040384|NCT00406640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93040385|NCT00406640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93040386|NCT00406640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040387|NCT00406640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040388|NCT00406640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040390|NCT00406640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040391|NCT00406640|Antidepressive Agents|antidepressive agents|mesh-ancestor
93040392|NCT00406640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040393|NCT00406640|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93040394|NCT01043510|Insulin|insulin|mesh-list
93040395|NCT01043510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93040396|NCT01043510|Insulin Detemir|insulin detemir|mesh-list
93040397|NCT01043510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93040398|NCT01043510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040399|NCT01043666|Mirabegron|mirabegron|mesh-list
93040400|NCT01043666|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93040401|NCT01043666|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93040402|NCT01043666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93040403|NCT01043666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93040404|NCT01043666|Adrenergic Agents|adrenergic agents|mesh-ancestor
93040405|NCT01043666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040406|NCT01043666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040407|NCT01043666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242836|NCT00392834|Antidotes|antidotes|mesh-ancestor
93040408|NCT01043666|Urological Agents|urological agents|mesh-ancestor
93040409|NCT01043666|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93040410|NCT01043666|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93040411|NCT01043666|Cholinergic Agents|cholinergic agents|mesh-ancestor
93040412|NCT00394472|Lesogaberan|lesogaberan|mesh-list
93040413|NCT00394472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93040414|NCT00394472|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93040415|NCT00394472|GABA Agonists|gaba agonists|mesh-ancestor
93040416|NCT00394472|GABA Agents|gaba agents|mesh-ancestor
93040417|NCT00394472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242885|NCT02662634|Tubulin Modulators|tubulin modulators|mesh-ancestor
93040418|NCT00394472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040419|NCT00394472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040420|NCT00395486|Atorvastatin|atorvastatin|mesh-list
93040421|NCT00395486|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93040422|NCT00395486|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93040423|NCT00395486|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93040424|NCT00395486|Antimetabolites|antimetabolites|mesh-ancestor
93040425|NCT00395486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242953|NCT05514990|Protease Inhibitors|protease inhibitors|mesh-ancestor
93040426|NCT00395486|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93040427|NCT00395486|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93040428|NCT00395486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040429|NCT01043744|Lumefantrine|lumefantrine|mesh-list
93040430|NCT01043744|Artemether|artemether|mesh-list
93040431|NCT01043744|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93040432|NCT01043744|Antimalarials|antimalarials|mesh-ancestor
93040433|NCT01043744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93040434|NCT01043744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92243090|NCT04749914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040435|NCT01043744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040436|NCT00395018|Entecavir|entecavir|mesh-list
93040437|NCT00395018|Antiviral Agents|antiviral agents|mesh-ancestor
93040438|NCT00395018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040439|NCT01036412|Chlorhexidine|chlorhexidine|mesh-list
93040440|NCT01036412|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
93040441|NCT01036412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93040442|NCT01036412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040443|NCT01036412|Disinfectants|disinfectants|mesh-ancestor
93040444|NCT01036412|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040445|NCT00375518|Atorvastatin|atorvastatin|mesh-list
93040446|NCT00375518|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93040447|NCT00375518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93040448|NCT00375518|Antimetabolites|antimetabolites|mesh-ancestor
93040449|NCT00375518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040450|NCT00375518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93040451|NCT00375518|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93040452|NCT00375518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040453|NCT01045772|Rilonacept|rilonacept|mesh-list
93040454|NCT01045772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93040455|NCT01045928|Rituximab|rituximab|mesh-list
93040456|NCT01045928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93040457|NCT01045928|Lenalidomide|lenalidomide|mesh-list
93040458|NCT01045928|Antibodies|antibodies|mesh-list
93040459|NCT01045928|Immunoglobulins|immunoglobulins|mesh-list
93040460|NCT01045928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93040461|NCT01045928|Immunologic Factors|immunologic factors|mesh-ancestor
93040462|NCT01045928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040463|NCT01045928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040464|NCT01045928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040465|NCT01045928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93040466|NCT01045928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93040467|NCT01045928|Growth Substances|growth substances|mesh-ancestor
93040468|NCT01045928|Growth Inhibitors|growth inhibitors|mesh-ancestor
93040469|NCT00256750|Cyclosporine|cyclosporine|mesh-list
93040470|NCT00256750|Abatacept|abatacept|mesh-list
93040471|NCT00256750|Cyclosporins|cyclosporins|mesh-list
93040472|NCT00256750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040473|NCT00256750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040474|NCT00256750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040475|NCT00256750|Immunologic Factors|immunologic factors|mesh-ancestor
93040476|NCT00256750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040477|NCT00256750|Antifungal Agents|antifungal agents|mesh-ancestor
93040478|NCT00256750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040479|NCT00256750|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040480|NCT00256750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040481|NCT00256750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93040482|NCT00256750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93040483|NCT00256750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040484|NCT00256750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040485|NCT00279201|Insulin Glargine|insulin glargine|mesh-list
93040486|NCT00279201|Insulin Lispro|insulin lispro|mesh-list
93040487|NCT00279201|Insulin, Isophane|insulin, isophane|mesh-list
93040488|NCT00279201|Biphasic Insulins|biphasic insulins|mesh-list
93040489|NCT00279201|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
93040490|NCT00279201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92243563|NCT02111798|Bupropion|bupropion|mesh-list
93040491|NCT00279201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040492|NCT00203476|Niacin|niacin|mesh-list
93040493|NCT00203476|Ezetimibe|ezetimibe|mesh-list
93040494|NCT00203476|Colestipol|colestipol|mesh-list
93040495|NCT00203476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93040496|NCT00203476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93040497|NCT00203476|Antimetabolites|antimetabolites|mesh-ancestor
93040498|NCT00203476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040499|NCT00203476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93040500|NCT00203476|Vasodilator Agents|vasodilator agents|mesh-ancestor
93040501|NCT00203476|Vitamin B Complex|vitamin b complex|mesh-ancestor
93040502|NCT00203476|Vitamins|vitamins|mesh-ancestor
93040503|NCT00203476|Micronutrients|micronutrients|mesh-ancestor
93040504|NCT00203476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040505|NCT00203476|Sequestering Agents|sequestering agents|mesh-ancestor
93040506|NCT00203242|Valproic Acid|valproic acid|mesh-list
93040507|NCT00203242|Anticonvulsants|anticonvulsants|mesh-ancestor
93040508|NCT00203242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040509|NCT00203242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040510|NCT00203242|GABA Agents|gaba agents|mesh-ancestor
93040511|NCT00203242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040512|NCT00203242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040513|NCT00203242|Antimanic Agents|antimanic agents|mesh-ancestor
93040514|NCT00203242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93040515|NCT00203242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040516|NCT00203242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040517|NCT00200356|Ozagrel|ozagrel|mesh-list
93040518|NCT00200356|Edaravone|edaravone|mesh-list
93040519|NCT00200356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93040520|NCT00200356|Antioxidants|antioxidants|mesh-ancestor
93040521|NCT00200356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040522|NCT00200356|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92529211|NCT05076877|Lazertinib|lazertinib|mesh-list
93040524|NCT00200356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040525|NCT00200356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040526|NCT00200356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93040527|NCT00200356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93040528|NCT00200356|Histamine Antagonists|histamine antagonists|mesh-ancestor
93040529|NCT00200356|Histamine Agents|histamine agents|mesh-ancestor
93040530|NCT00200356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040531|NCT00227344|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93040532|NCT00227266|Valproic Acid|valproic acid|mesh-list
93040533|NCT00227266|Anticonvulsants|anticonvulsants|mesh-ancestor
93040534|NCT00227266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243912|NCT05480046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040535|NCT00227266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040536|NCT00227266|GABA Agents|gaba agents|mesh-ancestor
93040537|NCT00227266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040538|NCT00227266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040539|NCT00227266|Antimanic Agents|antimanic agents|mesh-ancestor
93040540|NCT00227266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93040541|NCT00227266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040542|NCT00227266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040543|NCT00256282|Docetaxel|docetaxel|mesh-list
93040544|NCT00256282|Vinorelbine|vinorelbine|mesh-list
93040545|NCT00256282|Sargramostim|sargramostim|mesh-list
93040546|NCT00256282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040547|NCT00256282|Tubulin Modulators|tubulin modulators|mesh-ancestor
93040548|NCT00256282|Antimitotic Agents|antimitotic agents|mesh-ancestor
93040549|NCT00256282|Mitosis Modulators|mitosis modulators|mesh-ancestor
93040550|NCT00256282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040551|NCT00256282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93040552|NCT00256282|Immunologic Factors|immunologic factors|mesh-ancestor
93040553|NCT00256282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040554|NCT00256204|Rasagiline|rasagiline|mesh-list
93040555|NCT00256204|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93040556|NCT00256204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040557|NCT00256204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040558|NCT00256204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93040559|NCT00256204|Protective Agents|protective agents|mesh-ancestor
93040560|NCT00256204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040561|NCT03972358|Misoprostol|misoprostol|mesh-list
93040562|NCT03972358|Mifepristone|mifepristone|mesh-list
93040563|NCT03972358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93040564|NCT03972358|Abortifacient Agents|abortifacient agents|mesh-ancestor
93040565|NCT03972358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93040566|NCT03972358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040567|NCT03972358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93040568|NCT03972358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93040569|NCT03972358|Oxytocics|oxytocics|mesh-ancestor
93040570|NCT03972358|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93040571|NCT03972358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93040572|NCT03972358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93040573|NCT03972358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93040574|NCT03972358|Contraceptive Agents|contraceptive agents|mesh-ancestor
93040575|NCT03972358|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93040576|NCT03972358|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93040577|NCT03972358|Hormone Antagonists|hormone antagonists|mesh-ancestor
93040578|NCT03972358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93040579|NCT03972358|Luteolytic Agents|luteolytic agents|mesh-ancestor
93040580|NCT03972358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93040581|NCT03972358|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93040582|NCT01073332|Antioxidants|antioxidants|mesh-list
93040583|NCT01073332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040584|NCT01073332|Protective Agents|protective agents|mesh-ancestor
93040585|NCT01073332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040586|NCT03972046|Trametinib|trametinib|mesh-list
93040587|NCT03972046|Dabrafenib|dabrafenib|mesh-list
93040588|NCT03972046|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93040589|NCT03972046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040590|NCT03972046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93040591|NCT03972046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040592|NCT03972046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040593|NCT03972046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040594|NCT01071772|Insulin|insulin|mesh-list
93040595|NCT01071772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93040596|NCT01071772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040597|NCT01074346|Interferons|interferons|mesh-list
93040598|NCT01074346|Interferon-beta|interferon-beta|mesh-list
93040599|NCT01074346|Interferon beta-1a|interferon beta-1a|mesh-list
93040600|NCT01074346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040601|NCT01074346|Antiviral Agents|antiviral agents|mesh-ancestor
93040602|NCT01074346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040604|NCT01074346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040605|NCT01074346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93040606|NCT00278889|Leucovorin|leucovorin|mesh-list
93040607|NCT00278889|Bevacizumab|bevacizumab|mesh-list
93040608|NCT00278889|Fluorouracil|fluorouracil|mesh-list
93040609|NCT00278889|Oxaliplatin|oxaliplatin|mesh-list
93040610|NCT00278889|Cediranib|cediranib|mesh-list
93040611|NCT00278889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93040612|NCT00278889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040613|NCT00278889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93040614|NCT00278889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93040615|NCT00278889|Growth Substances|growth substances|mesh-ancestor
93040616|NCT00278889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040617|NCT00278889|Growth Inhibitors|growth inhibitors|mesh-ancestor
93040618|NCT00278889|Antimetabolites|antimetabolites|mesh-ancestor
93040619|NCT00278889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040620|NCT00278889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040621|NCT00278889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040622|NCT00278889|Immunologic Factors|immunologic factors|mesh-ancestor
93040623|NCT00278889|Antidotes|antidotes|mesh-ancestor
93040624|NCT00278889|Protective Agents|protective agents|mesh-ancestor
93040625|NCT00278889|Vitamin B Complex|vitamin b complex|mesh-ancestor
93040626|NCT00278889|Vitamins|vitamins|mesh-ancestor
93040627|NCT00278889|Micronutrients|micronutrients|mesh-ancestor
93040628|NCT00278889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93040629|NCT00278889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040630|NCT01070745|Ibuprofen|ibuprofen|mesh-list
93040631|NCT01070745|Indomethacin|indomethacin|mesh-list
93040632|NCT01070745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93040633|NCT01070745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93040634|NCT01070745|Analgesics|analgesics|mesh-ancestor
93040635|NCT01070745|Sensory System Agents|sensory system agents|mesh-ancestor
93040636|NCT01070745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040637|NCT01070745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040638|NCT01070745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93040639|NCT01070745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040640|NCT01070745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93040641|NCT01070745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040642|NCT01070745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040643|NCT01070745|Gout Suppressants|gout suppressants|mesh-ancestor
93040644|NCT01070745|Tocolytic Agents|tocolytic agents|mesh-ancestor
93040645|NCT01070745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93040646|NCT01071057|Morphine|morphine|mesh-list
93040647|NCT01071057|Naloxone|naloxone|mesh-list
93040648|NCT01071057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93040649|NCT01071057|Narcotics|narcotics|mesh-ancestor
93040650|NCT01071057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040651|NCT01071057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040652|NCT01071057|Analgesics|analgesics|mesh-ancestor
93040653|NCT01071057|Sensory System Agents|sensory system agents|mesh-ancestor
93040654|NCT01071057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040655|NCT01071057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93040656|NCT00278109|Cyclophosphamide|cyclophosphamide|mesh-list
93040657|NCT00278109|Doxorubicin|doxorubicin|mesh-list
93040658|NCT00278109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040659|NCT00278109|Immunologic Factors|immunologic factors|mesh-ancestor
93040660|NCT00278109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040661|NCT00278109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93040662|NCT00278109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93040663|NCT00278109|Alkylating Agents|alkylating agents|mesh-ancestor
93040664|NCT00278109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040665|NCT00278109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040666|NCT00278109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93040667|NCT00278109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93040668|NCT00278109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93040669|NCT00278109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93040670|NCT00278109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040671|NCT00296517|Bupropion|bupropion|mesh-list
93040672|NCT00296517|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93040673|NCT00296517|Antidepressive Agents|antidepressive agents|mesh-ancestor
93040674|NCT00296517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040675|NCT00296517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93040676|NCT00296517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93040677|NCT00296517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040678|NCT00296517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040679|NCT00296517|Dopamine Agents|dopamine agents|mesh-ancestor
93040680|NCT00296517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040681|NCT00296517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151793|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
93040682|NCT00296517|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93040683|NCT00296517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93040684|NCT00296517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040685|NCT00224770|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93040686|NCT00224770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93040687|NCT00224770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93040688|NCT00224770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040689|NCT00266409|Alprazolam|alprazolam|mesh-list
93040690|NCT00266409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93040691|NCT00266409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040692|NCT00266409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040693|NCT00266409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93040694|NCT00266409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93040695|NCT00266409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040696|NCT00266409|GABA Modulators|gaba modulators|mesh-ancestor
93040697|NCT00266409|GABA Agents|gaba agents|mesh-ancestor
93040698|NCT00266409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040699|NCT00266409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040700|NCT00265785|Pemetrexed|pemetrexed|mesh-list
93040701|NCT00265785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040702|NCT00265785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040703|NCT00265785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040704|NCT00265785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93040705|NCT00265785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93040706|NCT02532153|Ketamine|ketamine|mesh-list
93040707|NCT02532153|Analgesics|analgesics|mesh-ancestor
93040708|NCT02532153|Sensory System Agents|sensory system agents|mesh-ancestor
93040709|NCT02532153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040710|NCT02532153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040711|NCT02532153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93040712|NCT02532153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93040713|NCT02532153|Anesthetics, General|anesthetics, general|mesh-ancestor
93040714|NCT02532153|Anesthetics|anesthetics|mesh-ancestor
93040715|NCT02532153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040716|NCT02532153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93040717|NCT02532153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93040718|NCT02532153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040719|NCT02532153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040720|NCT00265395|Interferons|interferons|mesh-list
93040721|NCT00265395|Ribavirin|ribavirin|mesh-list
93040722|NCT00265395|Interferon-alpha|interferon-alpha|mesh-list
93040723|NCT00265395|Interferon alpha-2|interferon alpha-2|mesh-list
93040724|NCT00265395|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93040725|NCT00265395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040726|NCT00265395|Antiviral Agents|antiviral agents|mesh-ancestor
93040727|NCT00265395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040728|NCT00265395|Antimetabolites|antimetabolites|mesh-ancestor
93040729|NCT00265395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040730|NCT00265395|Immunologic Factors|immunologic factors|mesh-ancestor
93040731|NCT00265395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040732|NCT01582113|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93040733|NCT01582113|Nootropic Agents|nootropic agents|mesh-ancestor
93040734|NCT00195442|Factor VIII|factor viii|mesh-list
93040735|NCT00195442|Coagulants|coagulants|mesh-ancestor
93040736|NCT01070823|Natalizumab|natalizumab|mesh-list
93040737|NCT01070823|Immunologic Factors|immunologic factors|mesh-ancestor
93040738|NCT01070823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040739|NCT01071135|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93040740|NCT01071135|Antidepressive Agents|antidepressive agents|mesh-ancestor
93040741|NCT01071135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040742|NCT01071135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93040743|NCT01071135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93040744|NCT01071135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040745|NCT01071135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040746|NCT00275301|Olanzapine|olanzapine|mesh-list
93040747|NCT00275301|Antiemetics|antiemetics|mesh-ancestor
93040748|NCT00275301|Autonomic Agents|autonomic agents|mesh-ancestor
93040749|NCT00275301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040750|NCT00275301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040751|NCT00275301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93040752|NCT00275301|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93040753|NCT00275301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93040754|NCT00275301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040755|NCT00275301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93040756|NCT00275301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93040757|NCT00275301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93040758|NCT00275301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040759|NCT00275301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040760|NCT00275301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040761|NCT00275301|Serotonin Agents|serotonin agents|mesh-ancestor
93040762|NCT02531997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93040763|NCT02531997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040764|NCT02531997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040765|NCT00251745|Dexlansoprazole|dexlansoprazole|mesh-list
93040766|NCT00251745|Lansoprazole|lansoprazole|mesh-list
93040767|NCT00251745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93040768|NCT00251745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93040769|NCT00251745|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93040770|NCT00251745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040771|NCT00251745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040772|NCT00255190|Dexlansoprazole|dexlansoprazole|mesh-list
93040773|NCT00255190|Lansoprazole|lansoprazole|mesh-list
93040774|NCT00255190|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93040775|NCT00255190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93040776|NCT00255190|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93040777|NCT00255190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040778|NCT00255190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040779|NCT00359424|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93040780|NCT00359424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93040781|NCT00359424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93040782|NCT00359424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040783|NCT01049646|Angiotensin II|angiotensin ii|mesh-list
93040784|NCT01049646|Giapreza|giapreza|mesh-list
93040785|NCT01049646|Angiotensinogen|angiotensinogen|mesh-list
93040786|NCT01049646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93040787|NCT01049646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93040788|NCT01049646|Protease Inhibitors|protease inhibitors|mesh-ancestor
93040789|NCT01049646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040790|NCT01049646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040791|NCT02286414|Vitamins|vitamins|mesh-list
93040792|NCT02286414|Vitamin K|vitamin k|mesh-list
93040793|NCT02286414|Warfarin|warfarin|mesh-list
93040794|NCT02286414|Rivaroxaban|rivaroxaban|mesh-list
93040795|NCT02286414|Dabigatran|dabigatran|mesh-list
93040796|NCT02286414|Apixaban|apixaban|mesh-list
93040797|NCT02286414|Acenocoumarol|acenocoumarol|mesh-list
93040798|NCT02286414|Fluindione|fluindione|mesh-list
93040799|NCT02286414|Micronutrients|micronutrients|mesh-ancestor
93040800|NCT02286414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040801|NCT02286414|Anticoagulants|anticoagulants|mesh-ancestor
93040802|NCT02286414|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93040803|NCT02286414|Antithrombins|antithrombins|mesh-ancestor
93040804|NCT02286414|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93040805|NCT02286414|Protease Inhibitors|protease inhibitors|mesh-ancestor
93040806|NCT02286414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040807|NCT02286414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040808|NCT02286414|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93040809|NCT02286414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93040810|NCT02286414|Hemostatics|hemostatics|mesh-ancestor
93040811|NCT02286414|Coagulants|coagulants|mesh-ancestor
93040812|NCT00255034|Ribavirin|ribavirin|mesh-list
93040813|NCT00255034|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93040814|NCT00255034|Interferon-alpha|interferon-alpha|mesh-list
93040815|NCT00255034|Antimetabolites|antimetabolites|mesh-ancestor
93040816|NCT00255034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040817|NCT00255034|Antiviral Agents|antiviral agents|mesh-ancestor
93040818|NCT00255034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040819|NCT00255034|Immunologic Factors|immunologic factors|mesh-ancestor
93040820|NCT00255034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040821|NCT03991104|Oxaliplatin|oxaliplatin|mesh-list
93040822|NCT03991104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040823|NCT00254566|Azithromycin|azithromycin|mesh-list
93040824|NCT00254566|Moxifloxacin|moxifloxacin|mesh-list
93040825|NCT00254566|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93040826|NCT00254566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93040827|NCT00254566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93040828|NCT00254566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93040829|NCT00254566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93040831|NCT00254566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040832|NCT00254566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040833|NCT00254566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93040834|NCT00254566|Contraceptive Agents|contraceptive agents|mesh-ancestor
93040835|NCT00254566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93040836|NCT00254566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040837|NCT00254566|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93040838|NCT00254566|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93040839|NCT00254566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93040840|NCT02531854|Pemetrexed|pemetrexed|mesh-list
93040841|NCT02531854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040842|NCT02531854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040843|NCT02531854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040844|NCT02531854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93040845|NCT02531854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93040846|NCT01048086|Tretinoin|tretinoin|mesh-list
93040847|NCT01048086|Isotretinoin|isotretinoin|mesh-list
93040848|NCT01048086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040849|NCT01048086|Keratolytic Agents|keratolytic agents|mesh-ancestor
93040850|NCT01048086|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040851|NCT03830892|Nicotine|nicotine|mesh-list
93040852|NCT03830892|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93040853|NCT03830892|Autonomic Agents|autonomic agents|mesh-ancestor
93040854|NCT03830892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040855|NCT03830892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040856|NCT03830892|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93040857|NCT03830892|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93040858|NCT03830892|Cholinergic Agents|cholinergic agents|mesh-ancestor
93040859|NCT03830892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040860|NCT03830892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040861|NCT01049880|Ascorbic Acid|ascorbic acid|mesh-list
93040862|NCT01049880|Gemcitabine|gemcitabine|mesh-list
93040863|NCT01049880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040864|NCT01049880|Antimetabolites|antimetabolites|mesh-ancestor
93040865|NCT01049880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040866|NCT01049880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040867|NCT01049880|Antioxidants|antioxidants|mesh-ancestor
93040868|NCT01049880|Protective Agents|protective agents|mesh-ancestor
93040869|NCT01049880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040870|NCT01049880|Vitamins|vitamins|mesh-ancestor
93040871|NCT01049880|Micronutrients|micronutrients|mesh-ancestor
93040872|NCT00253630|Vorinostat|vorinostat|mesh-list
93040873|NCT00253630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040874|NCT00253630|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93040875|NCT00253630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040876|NCT00253630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040877|NCT00358644|Decitabine|decitabine|mesh-list
93040878|NCT00358644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040879|NCT00358644|Antimetabolites|antimetabolites|mesh-ancestor
93040880|NCT00358644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040881|NCT00358644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040882|NCT00358644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040883|NCT01048320|Gemcitabine|gemcitabine|mesh-list
93040884|NCT01048320|Oxaliplatin|oxaliplatin|mesh-list
93040885|NCT01048320|Imatinib Mesylate|imatinib mesylate|mesh-list
93040886|NCT01048320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93040887|NCT01048320|Antimetabolites|antimetabolites|mesh-ancestor
93040888|NCT01048320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040889|NCT01048320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040890|NCT01048320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93040891|NCT01048320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040892|NCT03990480|Amlodipine|amlodipine|mesh-list
93040893|NCT03990480|Valsartan|valsartan|mesh-list
93040894|NCT03990480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93040895|NCT03990480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93040896|NCT03990480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040897|NCT03990480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040898|NCT03990480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93040899|NCT03990480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040900|NCT03990480|Vasodilator Agents|vasodilator agents|mesh-ancestor
93040901|NCT03990480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93040902|NCT03990480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93040903|NCT00369486|Triamcinolone|triamcinolone|mesh-list
93040905|NCT00369486|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93040906|NCT00369486|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93040907|NCT00369486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93040908|NCT00369486|Glucocorticoids|glucocorticoids|mesh-ancestor
93040909|NCT00369486|Hormones|hormones|mesh-ancestor
93040910|NCT00369486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93040911|NCT00369486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040912|NCT00369486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040913|NCT00369486|Immunologic Factors|immunologic factors|mesh-ancestor
93040914|NCT00369486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040915|NCT00369486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040916|NCT00363480|Fluticasone|fluticasone|mesh-list
93040917|NCT00363480|Albuterol|albuterol|mesh-list
93040918|NCT00363480|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93040919|NCT00363480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244664|NCT00433550|Capecitabine|capecitabine|mesh-list
93040920|NCT00363480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93040921|NCT00363480|Autonomic Agents|autonomic agents|mesh-ancestor
93040922|NCT00363480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040923|NCT00363480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040924|NCT00363480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93040925|NCT00363480|Respiratory System Agents|respiratory system agents|mesh-ancestor
93040926|NCT00363480|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040927|NCT00363480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93040928|NCT00363480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93040929|NCT00363480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93040930|NCT00363480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93040931|NCT00363480|Adrenergic Agents|adrenergic agents|mesh-ancestor
93040932|NCT00363480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040933|NCT00363480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040934|NCT00363480|Tocolytic Agents|tocolytic agents|mesh-ancestor
93040935|NCT00363480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93040936|NCT03990636|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93040937|NCT03990636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93040938|NCT03990636|Dermatologic Agents|dermatologic agents|mesh-ancestor
93040939|NCT01048398|Acetaminophen|acetaminophen|mesh-list
93040940|NCT01048398|Remifentanil|remifentanil|mesh-list
93040941|NCT01048398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93040942|NCT01048398|Analgesics|analgesics|mesh-ancestor
93040943|NCT01048398|Sensory System Agents|sensory system agents|mesh-ancestor
93040944|NCT01048398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040945|NCT01048398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040946|NCT01048398|Antipyretics|antipyretics|mesh-ancestor
93040947|NCT01048398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93040948|NCT01048398|Narcotics|narcotics|mesh-ancestor
92244855|NCT01462279|Vitamin B Complex|vitamin b complex|mesh-ancestor
93040949|NCT01048398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93040950|NCT01073644|Sunitinib|sunitinib|mesh-list
93040951|NCT01073644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040952|NCT01073644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93040953|NCT01073644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93040954|NCT01073644|Growth Substances|growth substances|mesh-ancestor
93040955|NCT01073644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040956|NCT01073644|Growth Inhibitors|growth inhibitors|mesh-ancestor
93040957|NCT01073644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93040958|NCT01073644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040959|NCT01073644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040960|NCT03992586|Methamphetamine|methamphetamine|mesh-list
93040961|NCT03992586|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93040962|NCT03992586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040963|NCT03992586|Sympathomimetics|sympathomimetics|mesh-ancestor
93040964|NCT03992586|Autonomic Agents|autonomic agents|mesh-ancestor
93040965|NCT03992586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93040966|NCT03992586|Dopamine Agents|dopamine agents|mesh-ancestor
92529221|NCT05076877|Anesthetics, General|anesthetics, general|mesh-ancestor
93040967|NCT03992586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93040968|NCT03992586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040969|NCT03992586|Adrenergic Agents|adrenergic agents|mesh-ancestor
93040970|NCT03992586|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93040971|NCT03992586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93040972|NCT03992586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93040973|NCT03992586|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93040975|NCT00221104|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93040976|NCT00221104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93040977|NCT00221104|Antimetabolites|antimetabolites|mesh-ancestor
93040978|NCT00221104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245163|NCT05021094|Estradiol|estradiol|mesh-list
93040980|NCT00221104|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93040981|NCT00221104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93040982|NCT00189202|Sirolimus|sirolimus|mesh-list
93040983|NCT00189202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93040984|NCT00189202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245210|NCT04421742|Hormones|hormones|mesh-ancestor
93040985|NCT00189202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93040986|NCT00189202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040987|NCT00189202|Antifungal Agents|antifungal agents|mesh-ancestor
93040988|NCT00189202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93040989|NCT00189202|Immunologic Factors|immunologic factors|mesh-ancestor
93040990|NCT00189202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93040991|NCT01071928|Docetaxel|docetaxel|mesh-list
93040992|NCT01071928|Vadimezan|vadimezan|mesh-list
93040993|NCT01071928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93040994|NCT01071928|Tubulin Modulators|tubulin modulators|mesh-ancestor
93040995|NCT01071928|Antimitotic Agents|antimitotic agents|mesh-ancestor
93040996|NCT01071928|Mitosis Modulators|mitosis modulators|mesh-ancestor
93040997|NCT01071928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93040998|NCT00187486|Temozolomide|temozolomide|mesh-list
93040999|NCT00187486|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93041000|NCT00187486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041001|NCT00187486|Alkylating Agents|alkylating agents|mesh-ancestor
93041002|NCT00187486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041003|NCT00187486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041004|NCT00187486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93041005|NCT00187486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041006|NCT00220636|Aripiprazole|aripiprazole|mesh-list
93041007|NCT00220636|Antidepressive Agents|antidepressive agents|mesh-ancestor
93041008|NCT00220636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041009|NCT00220636|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93041010|NCT00220636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93041011|NCT00220636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041012|NCT00220636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041013|NCT00220636|Dopamine Agonists|dopamine agonists|mesh-ancestor
93041014|NCT00220636|Dopamine Agents|dopamine agents|mesh-ancestor
93041015|NCT00220636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041016|NCT00220636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041017|NCT00220636|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93041018|NCT00220636|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93041019|NCT00220636|Serotonin Agents|serotonin agents|mesh-ancestor
93041020|NCT00220636|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93041021|NCT00220636|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93041022|NCT00220636|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93041023|NCT00220636|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93041024|NCT00362232|Enoxaparin|enoxaparin|mesh-list
93041025|NCT00362232|Rivaroxaban|rivaroxaban|mesh-list
93041026|NCT00362232|Enoxaparin sodium|enoxaparin sodium|mesh-list
93041027|NCT00362232|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93041028|NCT00362232|Antithrombins|antithrombins|mesh-ancestor
93041029|NCT00362232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93041030|NCT00362232|Protease Inhibitors|protease inhibitors|mesh-ancestor
93041031|NCT00362232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041032|NCT00362232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041033|NCT00362232|Anticoagulants|anticoagulants|mesh-ancestor
93041034|NCT00362232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93041035|NCT00362232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93041036|NCT01048554|Bevacizumab|bevacizumab|mesh-list
93041037|NCT01048554|Temozolomide|temozolomide|mesh-list
92245701|NCT01653912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041038|NCT01048554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041039|NCT01048554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041040|NCT01048554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93041041|NCT01048554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93041042|NCT01048554|Growth Substances|growth substances|mesh-ancestor
93041043|NCT01048554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041044|NCT01048554|Growth Inhibitors|growth inhibitors|mesh-ancestor
93041045|NCT01048554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041046|NCT01048554|Alkylating Agents|alkylating agents|mesh-ancestor
93041047|NCT01048554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041049|NCT00219544|Analgesics|analgesics|mesh-ancestor
93041050|NCT00219544|Sensory System Agents|sensory system agents|mesh-ancestor
93041051|NCT00219544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041052|NCT00219544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041053|NCT00219544|Anticonvulsants|anticonvulsants|mesh-ancestor
93041054|NCT00219544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93041055|NCT00219544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041056|NCT00219544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041057|NCT00219544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93041058|NCT00219544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93041059|NCT00219544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93041060|NCT00219544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041061|NCT00219544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041063|NCT00357552|Lopinavir|lopinavir|mesh-list
93041064|NCT00357552|Tenofovir|tenofovir|mesh-list
93041065|NCT00357552|Emtricitabine|emtricitabine|mesh-list
93041066|NCT00357552|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93041067|NCT00357552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93041068|NCT00357552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93041069|NCT00357552|Protease Inhibitors|protease inhibitors|mesh-ancestor
93041070|NCT00357552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041071|NCT00357552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041072|NCT00357552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93041073|NCT00357552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93041074|NCT00357552|Antiviral Agents|antiviral agents|mesh-ancestor
93041075|NCT00357552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041076|NCT00357552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93041077|NCT00357552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93041078|NCT00357552|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93041079|NCT00357552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93041080|NCT00187096|Cyclophosphamide|cyclophosphamide|mesh-list
93041081|NCT00187096|Fludarabine|fludarabine|mesh-list
93041082|NCT00187096|Etoposide|etoposide|mesh-list
93041083|NCT00187096|Interleukin-2|interleukin-2|mesh-list
93041084|NCT00187096|Clofarabine|clofarabine|mesh-list
93041085|NCT00187096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041086|NCT00187096|Immunologic Factors|immunologic factors|mesh-ancestor
93041087|NCT00187096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041088|NCT00187096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041089|NCT00187096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041090|NCT00187096|Alkylating Agents|alkylating agents|mesh-ancestor
93041091|NCT00187096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041092|NCT00187096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041093|NCT00187096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93041094|NCT00187096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93041095|NCT00187096|Antimetabolites|antimetabolites|mesh-ancestor
93041096|NCT00187096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93041097|NCT00187096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93041098|NCT00187096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041099|NCT00187096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041100|NCT00187096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93041101|NCT00187096|Analgesics|analgesics|mesh-ancestor
93041102|NCT00187096|Sensory System Agents|sensory system agents|mesh-ancestor
93041103|NCT00187096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041104|NCT00357396|Melphalan|melphalan|mesh-list
93041105|NCT00357396|Busulfan|busulfan|mesh-list
93041106|NCT00357396|Thiotepa|thiotepa|mesh-list
93041107|NCT00357396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041108|NCT00357396|Alkylating Agents|alkylating agents|mesh-ancestor
93041109|NCT00357396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041110|NCT00357396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041111|NCT00357396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93041112|NCT00357396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041113|NCT00357396|Immunologic Factors|immunologic factors|mesh-ancestor
93041114|NCT00357396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041115|NCT00186628|Acetaminophen|acetaminophen|mesh-list
93041116|NCT00186628|Diphenhydramine|diphenhydramine|mesh-list
93041117|NCT00186628|Promethazine|promethazine|mesh-list
93041118|NCT00186628|Cyclosporine|cyclosporine|mesh-list
93041119|NCT00186628|Hydrocortisone|hydrocortisone|mesh-list
93041120|NCT00186628|Methylprednisolone|methylprednisolone|mesh-list
93041121|NCT00186628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93041122|NCT00186628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93041123|NCT00186628|Prednisolone|prednisolone|mesh-list
93041124|NCT00186628|Prednisolone acetate|prednisolone acetate|mesh-list
93041126|NCT00186628|Granisetron|granisetron|mesh-list
92686355|NCT00592618|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93041127|NCT00186628|Lenograstim|lenograstim|mesh-list
93041128|NCT00186628|Cyclosporins|cyclosporins|mesh-list
93041129|NCT00186628|Thymoglobulin|thymoglobulin|mesh-list
93041130|NCT00186628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93041131|NCT00186628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93041132|NCT00186628|Prednisolone phosphate|prednisolone phosphate|mesh-list
93041133|NCT00186628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041134|NCT00186628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041135|NCT00186628|Immunologic Factors|immunologic factors|mesh-ancestor
93041136|NCT00186628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041137|NCT00186628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041138|NCT00186628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93041139|NCT00186628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041140|NCT00186628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041141|NCT00186628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041142|NCT00186628|Antifungal Agents|antifungal agents|mesh-ancestor
93041143|NCT00186628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041144|NCT00186628|Dermatologic Agents|dermatologic agents|mesh-ancestor
93041145|NCT00186628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93041146|NCT00186628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93041147|NCT00186628|Analgesics|analgesics|mesh-ancestor
93041148|NCT00186628|Sensory System Agents|sensory system agents|mesh-ancestor
93041149|NCT00186628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041150|NCT00186628|Antipyretics|antipyretics|mesh-ancestor
93041151|NCT00186628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93041152|NCT00186628|Antiemetics|antiemetics|mesh-ancestor
93041153|NCT00186628|Autonomic Agents|autonomic agents|mesh-ancestor
93041154|NCT00186628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93041155|NCT00186628|Glucocorticoids|glucocorticoids|mesh-ancestor
93041157|NCT00186628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041158|NCT00186628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93041159|NCT00186628|Protective Agents|protective agents|mesh-ancestor
93041160|NCT00186628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93041161|NCT00186628|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93041162|NCT00186628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92246485|NCT00574340|Hypoglycemic Agents|hypoglycemic agents|mesh-list
93041163|NCT00186628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041164|NCT00186628|Anesthetics, Local|anesthetics, local|mesh-ancestor
93041165|NCT00186628|Anesthetics|anesthetics|mesh-ancestor
93041166|NCT00186628|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93041167|NCT00186628|Histamine Antagonists|histamine antagonists|mesh-ancestor
93041168|NCT00186628|Histamine Agents|histamine agents|mesh-ancestor
93041169|NCT00186628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041170|NCT00186628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93041171|NCT00186628|Antipruritics|antipruritics|mesh-ancestor
93041172|NCT00186628|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93041173|NCT00186628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93041174|NCT00186628|Serotonin Agents|serotonin agents|mesh-ancestor
93041175|NCT00368550|Sertraline|sertraline|mesh-list
93041176|NCT00368550|Antidepressive Agents|antidepressive agents|mesh-ancestor
93041177|NCT00368550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041178|NCT00368550|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93041179|NCT00368550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93041180|NCT00368550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041181|NCT00368550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041182|NCT00368550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041183|NCT00368550|Serotonin Agents|serotonin agents|mesh-ancestor
93041184|NCT00368550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041185|NCT01050036|Busulfan|busulfan|mesh-list
93041186|NCT01050036|Alkylating Agents|alkylating agents|mesh-ancestor
93041187|NCT01050036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041188|NCT01050036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041189|NCT01050036|Immunologic Factors|immunologic factors|mesh-ancestor
93041190|NCT01050036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041191|NCT01050036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041193|NCT01050036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93041194|NCT00357006|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93041195|NCT00357006|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93041196|NCT00357006|Estradiol|estradiol|mesh-list
93041197|NCT00357006|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93041198|NCT00357006|Estrogens|estrogens|mesh-ancestor
93041199|NCT00357006|Hormones|hormones|mesh-ancestor
93041200|NCT00357006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041201|NCT00357006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041202|NCT00357006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93041203|NCT00357006|Contraceptive Agents|contraceptive agents|mesh-ancestor
93041204|NCT00357006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93041205|NCT00357006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93041207|NCT01050114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93041208|NCT01050114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92246745|NCT00583700|Antioxidants|antioxidants|mesh-ancestor
93041209|NCT01050114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041210|NCT01050114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041211|NCT01050114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93041212|NCT01050114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041213|NCT01050114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041214|NCT01050114|Cholinergic Agents|cholinergic agents|mesh-ancestor
93041215|NCT01050114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041216|NCT01050114|Parasympatholytics|parasympatholytics|mesh-ancestor
93041217|NCT01050114|Autonomic Agents|autonomic agents|mesh-ancestor
93041218|NCT01050114|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93041219|NCT01050114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93041220|NCT01050114|Urological Agents|urological agents|mesh-ancestor
93041221|NCT01048632|Oxandrolone|oxandrolone|mesh-list
93041222|NCT01048632|Androgens|androgens|mesh-ancestor
93041223|NCT01048632|Hormones|hormones|mesh-ancestor
93041224|NCT01048632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041225|NCT01048632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041226|NCT01048632|Anabolic Agents|anabolic agents|mesh-ancestor
93041227|NCT00165646|Rabeprazole|rabeprazole|mesh-list
93041228|NCT00165646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93041229|NCT00165646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93041230|NCT00165646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93041231|NCT00165646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041232|NCT00165646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041233|NCT01050270|Acetylcysteine|acetylcysteine|mesh-list
93041234|NCT01050270|Ondansetron|ondansetron|mesh-list
93041235|NCT01050270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93041236|NCT01050270|Antiemetics|antiemetics|mesh-ancestor
93041237|NCT01050270|Autonomic Agents|autonomic agents|mesh-ancestor
92247044|NCT00612716|Busulfan|busulfan|mesh-list
93041238|NCT01050270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041239|NCT01050270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041240|NCT01050270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93041241|NCT01050270|Antipruritics|antipruritics|mesh-ancestor
93041242|NCT01050270|Dermatologic Agents|dermatologic agents|mesh-ancestor
93041243|NCT01050270|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93041244|NCT01050270|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93041245|NCT01050270|Serotonin Agents|serotonin agents|mesh-ancestor
93041246|NCT01050270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041247|NCT01050270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041248|NCT01050270|Antiviral Agents|antiviral agents|mesh-ancestor
93041249|NCT01050270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041250|NCT01050270|Expectorants|expectorants|mesh-ancestor
93041251|NCT01050270|Respiratory System Agents|respiratory system agents|mesh-ancestor
93041252|NCT01050270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93041253|NCT01050270|Antioxidants|antioxidants|mesh-ancestor
93041254|NCT01050270|Protective Agents|protective agents|mesh-ancestor
93041255|NCT01050270|Antidotes|antidotes|mesh-ancestor
93041256|NCT00367770|Bosentan|bosentan|mesh-list
92247288|NCT00619970|Rifaximin|rifaximin|mesh-list
93041257|NCT00367770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93041258|NCT00367770|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93041259|NCT00367770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041260|NCT00185614|Cyclosporine|cyclosporine|mesh-list
93041261|NCT00185614|Mycophenolic Acid|mycophenolic acid|mesh-list
93041262|NCT00185614|Cyclophosphamide|cyclophosphamide|mesh-list
93041263|NCT00185614|Melphalan|melphalan|mesh-list
93041264|NCT00185614|Cyclosporins|cyclosporins|mesh-list
93041265|NCT00185614|Lenograstim|lenograstim|mesh-list
93041266|NCT00185614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041267|NCT00185614|Immunologic Factors|immunologic factors|mesh-ancestor
92386911|NCT00003276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041268|NCT00185614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041269|NCT00185614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041270|NCT00185614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041271|NCT00185614|Alkylating Agents|alkylating agents|mesh-ancestor
93041272|NCT00185614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041273|NCT00185614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041274|NCT00185614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93041275|NCT00185614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93041276|NCT00185614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041277|NCT00185614|Antifungal Agents|antifungal agents|mesh-ancestor
93041278|NCT00185614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041279|NCT00185614|Dermatologic Agents|dermatologic agents|mesh-ancestor
93041280|NCT00185614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93041281|NCT00185614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93041282|NCT00185614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93041283|NCT00185614|Antitubercular Agents|antitubercular agents|mesh-ancestor
93041284|NCT00185614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93041286|NCT01075438|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93041287|NCT01075438|Immunologic Factors|immunologic factors|mesh-ancestor
92247559|NCT02999815|Immunoglobulins|immunoglobulins|mesh-list
93041288|NCT01075438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041289|NCT00361842|Irinotecan|irinotecan|mesh-list
93041290|NCT00361842|Floxuridine|floxuridine|mesh-list
93041291|NCT00361842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93041292|NCT00361842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041293|NCT00361842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247632|NCT04707625|Aflibercept|aflibercept|mesh-list
93041294|NCT00361842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041295|NCT00361842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041296|NCT00361842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93041297|NCT00361842|Antimetabolites|antimetabolites|mesh-ancestor
93041298|NCT01324752|Losartan|losartan|mesh-list
93041299|NCT01324752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93041300|NCT01324752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93041301|NCT01324752|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93041302|NCT01324752|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93041303|NCT01324752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041304|NCT01050348|Atorvastatin|atorvastatin|mesh-list
93041305|NCT01050348|Calcium|calcium|mesh-list
93041306|NCT01050348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93041307|NCT01050348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041308|NCT01050348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93041309|NCT01050348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93041310|NCT01050348|Antimetabolites|antimetabolites|mesh-ancestor
93041311|NCT01050348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041312|NCT01050348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93041313|NCT01050348|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93041314|NCT01050348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041315|NCT01053390|Leucovorin|leucovorin|mesh-list
93041316|NCT01053390|Fluorouracil|fluorouracil|mesh-list
93041317|NCT01053390|Epirubicin|epirubicin|mesh-list
93041318|NCT01053390|Somatostatin|somatostatin|mesh-list
93041319|NCT01053390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041320|NCT01053390|Antimetabolites|antimetabolites|mesh-ancestor
93041321|NCT01053390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041322|NCT01053390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93041323|NCT01053390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041324|NCT01053390|Immunologic Factors|immunologic factors|mesh-ancestor
93041325|NCT01053390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041326|NCT01053390|Antidotes|antidotes|mesh-ancestor
93041327|NCT01053390|Protective Agents|protective agents|mesh-ancestor
93041328|NCT01053390|Vitamin B Complex|vitamin b complex|mesh-ancestor
93041329|NCT01053390|Vitamins|vitamins|mesh-ancestor
93041330|NCT01053390|Micronutrients|micronutrients|mesh-ancestor
93041331|NCT01053390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93041332|NCT01053390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93041333|NCT01053390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041334|NCT01053390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041335|NCT01053390|Hormones|hormones|mesh-ancestor
93041336|NCT01053390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041337|NCT00356148|Ampicillin|ampicillin|mesh-list
93041338|NCT00356148|Sulbactam|sulbactam|mesh-list
93041339|NCT00356148|Sultamicillin|sultamicillin|mesh-list
93041340|NCT00356148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93041341|NCT00356148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041343|NCT00356148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041344|NCT00356148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041345|NCT00361218|Citalopram|citalopram|mesh-list
93041346|NCT00361218|Escitalopram|escitalopram|mesh-list
93041347|NCT00361218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
93041348|NCT00361218|Serotonin|serotonin|mesh-list
93041349|NCT00361218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93041350|NCT00361218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041351|NCT00361218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041352|NCT00361218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041353|NCT00361218|Serotonin Agents|serotonin agents|mesh-ancestor
93041354|NCT00361218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041355|NCT00361218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93041356|NCT00361218|Antidepressive Agents|antidepressive agents|mesh-ancestor
93041357|NCT00361218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041358|NCT00361218|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93041359|NCT01049022|Moxifloxacin|moxifloxacin|mesh-list
93041360|NCT01049022|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93041361|NCT01049022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93041362|NCT01049022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041363|NCT01049022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93041364|NCT01049022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041365|NCT01049022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041366|NCT01049022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041367|NCT01049022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041368|NCT01049022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93041369|NCT01049022|Contraceptive Agents|contraceptive agents|mesh-ancestor
93041370|NCT01049022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93041371|NCT01049022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041372|NCT01049022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93041373|NCT01049022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93041374|NCT01049022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93041375|NCT02534610|Etoricoxib|etoricoxib|mesh-list
93041376|NCT02534610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93041377|NCT02534610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93041378|NCT02534610|Analgesics|analgesics|mesh-ancestor
93041379|NCT02534610|Sensory System Agents|sensory system agents|mesh-ancestor
93041380|NCT02534610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041381|NCT02534610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041382|NCT02534610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93041383|NCT02534610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041384|NCT02534610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93041385|NCT02534610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93041386|NCT02534610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041387|NCT02534610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041388|NCT01050426|Leucovorin|leucovorin|mesh-list
93041389|NCT01050426|Cetuximab|cetuximab|mesh-list
93041390|NCT01050426|Levoleucovorin|levoleucovorin|mesh-list
93041391|NCT01050426|Antidotes|antidotes|mesh-ancestor
93041392|NCT01050426|Protective Agents|protective agents|mesh-ancestor
93041393|NCT01050426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041394|NCT01050426|Vitamin B Complex|vitamin b complex|mesh-ancestor
93041395|NCT01050426|Vitamins|vitamins|mesh-ancestor
93041396|NCT01050426|Micronutrients|micronutrients|mesh-ancestor
93041397|NCT01050426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041398|NCT01050426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041399|NCT00367458|Atorvastatin|atorvastatin|mesh-list
92248590|NCT01199237|Autonomic Agents|autonomic agents|mesh-ancestor
93041400|NCT00367458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93041401|NCT00367458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93041402|NCT00367458|Antimetabolites|antimetabolites|mesh-ancestor
93041403|NCT00367458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041404|NCT00367458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92248660|NCT01238471|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93041405|NCT00367458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93041406|NCT00367458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041407|NCT00252694|Candesartan|candesartan|mesh-list
93041408|NCT00252694|Candesartan cilexetil|candesartan cilexetil|mesh-list
93041409|NCT00252694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93041410|NCT00252694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93041411|NCT00252694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93041412|NCT00252694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041414|NCT00185380|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93041415|NCT00185380|Contraceptive Agents|contraceptive agents|mesh-ancestor
93041416|NCT00185380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93041417|NCT00185380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041418|NCT00185380|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93041419|NCT00185380|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93041420|NCT00185380|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93041421|NCT01077466|Natalizumab|natalizumab|mesh-list
93041422|NCT01077466|Immunologic Factors|immunologic factors|mesh-ancestor
93041423|NCT01077466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041424|NCT00160654|Levetiracetam|levetiracetam|mesh-list
93041425|NCT00160654|Anticonvulsants|anticonvulsants|mesh-ancestor
93041426|NCT00160654|Nootropic Agents|nootropic agents|mesh-ancestor
93041428|NCT01582672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041429|NCT01582672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93041430|NCT01582672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93041431|NCT01582672|Growth Substances|growth substances|mesh-ancestor
93041432|NCT01582672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041433|NCT01582672|Growth Inhibitors|growth inhibitors|mesh-ancestor
93041434|NCT01582672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93041435|NCT01582672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041436|NCT01582672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041437|NCT00366678|Vaccines|vaccines|mesh-list
93041438|NCT00366678|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93041439|NCT00366678|Immunologic Factors|immunologic factors|mesh-ancestor
93041440|NCT00366678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041441|NCT01049178|Silymarin|silymarin|mesh-list
93041442|NCT01049178|Antioxidants|antioxidants|mesh-ancestor
93041443|NCT01049178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041444|NCT01049178|Protective Agents|protective agents|mesh-ancestor
93041445|NCT01049178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041446|NCT02534454|Nicotine|nicotine|mesh-list
93041447|NCT02534454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93041448|NCT02534454|Autonomic Agents|autonomic agents|mesh-ancestor
93041449|NCT02534454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041450|NCT02534454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041451|NCT02534454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92249055|NCT01276730|Tretinoin|tretinoin|mesh-list
93041452|NCT02534454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93041453|NCT02534454|Cholinergic Agents|cholinergic agents|mesh-ancestor
93041454|NCT02534454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041455|NCT02534454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041456|NCT00355368|Rocuronium|rocuronium|mesh-list
93041457|NCT00355368|Succinylcholine|succinylcholine|mesh-list
93041458|NCT00355368|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93041459|NCT00355368|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93041460|NCT00355368|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93041461|NCT00355368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041462|NCT00355368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041463|NCT00355368|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
93041464|NCT01054092|Ipragliflozin|ipragliflozin|mesh-list
93041465|NCT01054092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93041466|NCT01054092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041467|NCT01054092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92249265|NCT00712244|Viscosupplements|viscosupplements|mesh-ancestor
93041468|NCT01054092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041469|NCT00360282|Rizatriptan|rizatriptan|mesh-list
93041470|NCT00360282|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93041471|NCT00360282|Serotonin Agents|serotonin agents|mesh-ancestor
93041472|NCT00360282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041473|NCT00360282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041474|NCT00360282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041475|NCT00373958|Vaccines|vaccines|mesh-list
93041476|NCT00373958|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93041477|NCT00373958|Immunologic Factors|immunologic factors|mesh-ancestor
93041478|NCT00373958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041479|NCT00373880|Cocaine|cocaine|mesh-list
93041480|NCT00373880|Aripiprazole|aripiprazole|mesh-list
93041481|NCT00373880|Antidepressive Agents|antidepressive agents|mesh-ancestor
93041482|NCT00373880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249407|NCT04385654|Axitinib|axitinib|mesh-list
93041483|NCT00373880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93041484|NCT00373880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93041485|NCT00373880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041486|NCT00373880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041488|NCT00373880|Dopamine Agents|dopamine agents|mesh-ancestor
93041489|NCT00373880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041490|NCT00373880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041491|NCT00373880|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93041492|NCT00373880|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93041493|NCT00373880|Serotonin Agents|serotonin agents|mesh-ancestor
93041494|NCT00373880|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93041495|NCT00373880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92249539|NCT00744380|Midazolam|midazolam|mesh-list
93041496|NCT00373880|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93041497|NCT00373880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93041498|NCT00373880|Anesthetics, Local|anesthetics, local|mesh-ancestor
92686729|NCT00474110|Anesthetics|anesthetics|mesh-ancestor
93041499|NCT00373880|Anesthetics|anesthetics|mesh-ancestor
93041500|NCT00373880|Sensory System Agents|sensory system agents|mesh-ancestor
93041501|NCT00373880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249606|NCT01278134|Ritonavir|ritonavir|mesh-list
93041502|NCT00373880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93041503|NCT00373880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93041504|NCT00373880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93041505|NCT00373880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041506|NCT00184600|Insulin|insulin|mesh-list
93041507|NCT00184600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93041508|NCT00184600|Insulin Aspart|insulin aspart|mesh-list
93041509|NCT00184600|Insulin, Long-Acting|insulin, long-acting|mesh-list
93041510|NCT00184600|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
93041511|NCT00184600|Insulin Detemir|insulin detemir|mesh-list
93041512|NCT00184600|Biphasic Insulins|biphasic insulins|mesh-list
93041513|NCT00184600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93041514|NCT00184600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041515|NCT00265317|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93041516|NCT00265317|Sunitinib|sunitinib|mesh-list
93041517|NCT00265317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041518|NCT00265317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93041519|NCT00265317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041520|NCT00265317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041521|NCT00265317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93041522|NCT00265317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93041523|NCT00265317|Growth Substances|growth substances|mesh-ancestor
93041524|NCT00265317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041525|NCT00265317|Growth Inhibitors|growth inhibitors|mesh-ancestor
93041526|NCT00373490|Vorinostat|vorinostat|mesh-list
93041527|NCT00373490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041528|NCT00373490|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93041529|NCT00373490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249961|NCT00778310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93041530|NCT00373490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041531|NCT00251589|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93041532|NCT00251589|Vorinostat|vorinostat|mesh-list
93041533|NCT00251589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041534|NCT00251589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92250032|NCT01213199|Adapalene|adapalene|mesh-list
93041535|NCT00251589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041536|NCT00251589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041537|NCT00251589|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93041538|NCT00265239|Edaravone|edaravone|mesh-list
93041539|NCT00265239|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93041540|NCT00265239|Antioxidants|antioxidants|mesh-ancestor
92250097|NCT03809546|Sensory System Agents|sensory system agents|mesh-ancestor
93041541|NCT00265239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041542|NCT00265239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93041543|NCT00265239|Protective Agents|protective agents|mesh-ancestor
93041544|NCT00265239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041545|NCT00159874|Sildenafil Citrate|sildenafil citrate|mesh-list
93041546|NCT00159874|Citric Acid|citric acid|mesh-list
93041547|NCT00159874|Sodium Citrate|sodium citrate|mesh-list
93041548|NCT00159874|Anticoagulants|anticoagulants|mesh-ancestor
93041549|NCT00159874|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93041550|NCT00159874|Chelating Agents|chelating agents|mesh-ancestor
93041551|NCT00159874|Sequestering Agents|sequestering agents|mesh-ancestor
93041552|NCT00159874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041553|NCT00159874|Vasodilator Agents|vasodilator agents|mesh-ancestor
93041554|NCT00159874|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93041555|NCT00159874|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93041556|NCT00159874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041557|NCT00159874|Urological Agents|urological agents|mesh-ancestor
93041558|NCT00184054|Ascorbic Acid|ascorbic acid|mesh-list
93041559|NCT00184054|Arsenic Trioxide|arsenic trioxide|mesh-list
93041561|NCT00184054|Micronutrients|micronutrients|mesh-ancestor
93041562|NCT00184054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041563|NCT00184054|Antioxidants|antioxidants|mesh-ancestor
93041564|NCT00184054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041565|NCT00184054|Protective Agents|protective agents|mesh-ancestor
93041566|NCT00184054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041568|NCT02533908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93041569|NCT02533908|Narcotics|narcotics|mesh-ancestor
93041570|NCT02533908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041571|NCT02533908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041572|NCT02533908|Analgesics|analgesics|mesh-ancestor
93041573|NCT02533908|Sensory System Agents|sensory system agents|mesh-ancestor
92686808|NCT01605721|Everolimus|everolimus|mesh-list
93041574|NCT02533908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041575|NCT02533908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93041576|NCT02533908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93041577|NCT02533908|Anesthetics, General|anesthetics, general|mesh-ancestor
93041578|NCT02533908|Anesthetics|anesthetics|mesh-ancestor
93041579|NCT00183430|Prazosin|prazosin|mesh-list
93041580|NCT00183430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93041581|NCT00183430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93041582|NCT00183430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93041583|NCT00183430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93041584|NCT00183430|Adrenergic Agents|adrenergic agents|mesh-ancestor
93041585|NCT00183430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041586|NCT00183430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041587|NCT00183430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041588|NCT00183274|Norepinephrine|norepinephrine|mesh-list
93041589|NCT00183274|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93041590|NCT00183274|Serotonin|serotonin|mesh-list
93041591|NCT00183274|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
93041592|NCT00183274|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93041593|NCT00183274|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93041594|NCT00183274|Adrenergic Agents|adrenergic agents|mesh-ancestor
93041595|NCT00183274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041596|NCT00183274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041597|NCT00183274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041598|NCT00183274|Sympathomimetics|sympathomimetics|mesh-ancestor
93041599|NCT00183274|Autonomic Agents|autonomic agents|mesh-ancestor
93041600|NCT00183274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041601|NCT00183274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93041602|NCT00183274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92250707|NCT00772772|Ergocalciferols|ergocalciferols|mesh-list
93041603|NCT00183274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041604|NCT00183274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93041605|NCT00183274|Antidepressive Agents|antidepressive agents|mesh-ancestor
93041606|NCT00183274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041607|NCT00183274|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93041608|NCT00183274|Serotonin Agents|serotonin agents|mesh-ancestor
93041609|NCT00183196|Naltrexone|naltrexone|mesh-list
93041610|NCT00183196|Gabapentin|gabapentin|mesh-list
93041611|NCT00183196|Analgesics|analgesics|mesh-ancestor
93041612|NCT00183196|Sensory System Agents|sensory system agents|mesh-ancestor
93041613|NCT00183196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041614|NCT00183196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041615|NCT00183196|Anticonvulsants|anticonvulsants|mesh-ancestor
92250849|NCT00789776|Fludarabine|fludarabine|mesh-list
93041616|NCT00183196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93041617|NCT00183196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93041618|NCT00183196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041619|NCT00183196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041620|NCT00183196|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93041621|NCT00183196|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93041622|NCT00183196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250917|NCT04383548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041623|NCT00183196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041624|NCT00183196|Antimanic Agents|antimanic agents|mesh-ancestor
93041625|NCT00183196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93041626|NCT00183196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93041627|NCT00349752|Certolizumab Pegol|certolizumab pegol|mesh-list
93041628|NCT00349752|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93041629|NCT00349752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93041630|NCT00349752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041631|NCT00349752|Immunologic Factors|immunologic factors|mesh-ancestor
93041632|NCT00349752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041633|NCT00349752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041635|NCT01055652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93041636|NCT01055652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041637|NCT01055652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251122|NCT05287724|Antioxidants|antioxidants|mesh-ancestor
93041638|NCT01055652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041639|NCT00348816|Prednisone|prednisone|mesh-list
93041640|NCT00348816|Docetaxel|docetaxel|mesh-list
93041641|NCT00348816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041642|NCT00348816|Tubulin Modulators|tubulin modulators|mesh-ancestor
93041643|NCT00348816|Antimitotic Agents|antimitotic agents|mesh-ancestor
93041644|NCT00348816|Mitosis Modulators|mitosis modulators|mesh-ancestor
93041645|NCT00348816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041646|NCT00348816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251268|NCT00802412|Topiramate|topiramate|mesh-list
93041647|NCT00348816|Glucocorticoids|glucocorticoids|mesh-ancestor
93041649|NCT00348816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251337|NCT03839888|Mydriatics|mydriatics|mesh-ancestor
93041650|NCT00348816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041651|NCT00348816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93041652|NCT03989310|Manganese|manganese|mesh-list
93041653|NCT03989310|Paclitaxel|paclitaxel|mesh-list
93041654|NCT03989310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93041655|NCT03989310|Gemcitabine|gemcitabine|mesh-list
93041656|NCT03989310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93041657|NCT03989310|Antibodies|antibodies|mesh-list
93041658|NCT03989310|Immunoglobulins|immunoglobulins|mesh-list
93041659|NCT03989310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93041660|NCT03989310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041661|NCT03989310|Tubulin Modulators|tubulin modulators|mesh-ancestor
93041662|NCT03989310|Antimitotic Agents|antimitotic agents|mesh-ancestor
93041663|NCT03989310|Mitosis Modulators|mitosis modulators|mesh-ancestor
93041664|NCT03989310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041665|NCT03989310|Immunologic Factors|immunologic factors|mesh-ancestor
93041666|NCT03989310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041667|NCT03989310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93041668|NCT03989310|Antimetabolites|antimetabolites|mesh-ancestor
93041669|NCT03989310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041670|NCT03989310|Trace Elements|trace elements|mesh-ancestor
93041671|NCT03989310|Micronutrients|micronutrients|mesh-ancestor
93041672|NCT03966898|Letrozole|letrozole|mesh-list
93041673|NCT03966898|Anastrozole|anastrozole|mesh-list
93041674|NCT03966898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041675|NCT03966898|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92251540|NCT01276301|Verapamil|verapamil|mesh-list
93041676|NCT03966898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93041677|NCT03966898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041678|NCT03966898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041679|NCT03966898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93041680|NCT03966898|Hormone Antagonists|hormone antagonists|mesh-ancestor
92251697|NCT01279187|Teriparatide|teriparatide|mesh-list
93041681|NCT03966898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041682|NCT03966898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041683|NCT03966898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93041684|NCT03989700|Thiamine|thiamine|mesh-list
93041685|NCT03989700|Vitamins|vitamins|mesh-ancestor
93041686|NCT03989700|Micronutrients|micronutrients|mesh-ancestor
93041687|NCT03989700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041688|NCT03989700|Vitamin B Complex|vitamin b complex|mesh-ancestor
93041689|NCT01051284|Gemcitabine|gemcitabine|mesh-list
93041690|NCT01051284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93041691|NCT01051284|Antimetabolites|antimetabolites|mesh-ancestor
93041692|NCT01051284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041693|NCT01051284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041694|NCT01051362|Carboplatin|carboplatin|mesh-list
93041695|NCT01051362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041696|NCT01055808|Insulin|insulin|mesh-list
93041697|NCT01055808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93041698|NCT01055808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041699|NCT00265083|Golimumab|golimumab|mesh-list
93041700|NCT00265083|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93041701|NCT00265083|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93041702|NCT00265083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93041703|NCT00265083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041704|NCT00265083|Immunologic Factors|immunologic factors|mesh-ancestor
92251828|NCT00815360|Hormones|hormones|mesh-ancestor
93041705|NCT00265083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041706|NCT00264849|Omalizumab|omalizumab|mesh-list
93041707|NCT00264849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93041708|NCT00264849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93041709|NCT00264849|Respiratory System Agents|respiratory system agents|mesh-ancestor
93041710|NCT01073709|Acetaminophen|acetaminophen|mesh-list
92251895|NCT01475513|Moxifloxacin|moxifloxacin|mesh-list
92251955|NCT00858962|Raltegravir Potassium|raltegravir potassium|mesh-list
93041711|NCT01073709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93041712|NCT01073709|Analgesics|analgesics|mesh-ancestor
93041713|NCT01073709|Sensory System Agents|sensory system agents|mesh-ancestor
93041714|NCT01073709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252029|NCT02348762|Antidotes|antidotes|mesh-ancestor
93041715|NCT01073709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041716|NCT01073709|Antipyretics|antipyretics|mesh-ancestor
93041717|NCT00211809|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93041718|NCT00211809|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93041719|NCT00211809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93041720|NCT00211809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686954|NCT00469547|Ethanol|ethanol|mesh-list
93041721|NCT00211809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041722|NCT00211809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041723|NCT00211809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041724|NCT00211809|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93041725|NCT00211809|Antidepressive Agents|antidepressive agents|mesh-ancestor
93041726|NCT00211809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041728|NCT01071291|Nicotinic Acids|nicotinic acids|mesh-list
93041729|NCT01071291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93041730|NCT01071291|Antimetabolites|antimetabolites|mesh-ancestor
93041731|NCT01071291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041732|NCT01071291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93041733|NCT01071291|Vasodilator Agents|vasodilator agents|mesh-ancestor
93041734|NCT01071291|Vitamin B Complex|vitamin b complex|mesh-ancestor
93041735|NCT01071291|Vitamins|vitamins|mesh-ancestor
93041736|NCT01071291|Micronutrients|micronutrients|mesh-ancestor
93041737|NCT01071291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041738|NCT00129766|Palivizumab|palivizumab|mesh-list
93041739|NCT00129766|Antiviral Agents|antiviral agents|mesh-ancestor
93041740|NCT00129766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041741|NCT00150592|Guanfacine|guanfacine|mesh-list
93041742|NCT00150592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93041743|NCT00150592|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93041744|NCT00150592|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93041745|NCT00150592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93041746|NCT00150592|Adrenergic Agents|adrenergic agents|mesh-ancestor
93041747|NCT00150592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041748|NCT00150592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041749|NCT00150592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041750|NCT00149890|Cyclosporine|cyclosporine|mesh-list
93041751|NCT00149890|Cyclosporins|cyclosporins|mesh-list
93041752|NCT00149890|Basiliximab|basiliximab|mesh-list
93041753|NCT00149890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041754|NCT00149890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041755|NCT00149890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041756|NCT00149890|Immunologic Factors|immunologic factors|mesh-ancestor
93041757|NCT00149890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041758|NCT00149890|Antifungal Agents|antifungal agents|mesh-ancestor
93041759|NCT00149890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041760|NCT00149890|Dermatologic Agents|dermatologic agents|mesh-ancestor
93041761|NCT00149890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041762|NCT00149890|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93041763|NCT00174382|Donepezil|donepezil|mesh-list
93041764|NCT00174382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93041765|NCT00174382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041766|NCT00174382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041767|NCT00174382|Cholinergic Agents|cholinergic agents|mesh-ancestor
93041768|NCT00174382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041769|NCT00174382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041770|NCT00174382|Nootropic Agents|nootropic agents|mesh-ancestor
93041771|NCT00355134|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
93041772|NCT00355134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93041773|NCT00355134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041774|NCT00355134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041775|NCT00355134|Immunologic Factors|immunologic factors|mesh-ancestor
93041776|NCT00355134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041777|NCT00171730|Pasireotide|pasireotide|mesh-list
93041778|NCT00171730|Hormones|hormones|mesh-ancestor
93041779|NCT00171730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041780|NCT00171730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041781|NCT00348348|Moxifloxacin|moxifloxacin|mesh-list
93041782|NCT00348348|Besifloxacin|besifloxacin|mesh-list
93041783|NCT00348348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93041784|NCT00348348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041785|NCT00348348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93041786|NCT00348348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041787|NCT00348348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041788|NCT00348348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041789|NCT00348348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041790|NCT00354744|Dactinomycin|dactinomycin|mesh-list
93041791|NCT00354744|Cyclophosphamide|cyclophosphamide|mesh-list
93041792|NCT00354744|Ifosfamide|ifosfamide|mesh-list
93041793|NCT00354744|Isophosphamide mustard|isophosphamide mustard|mesh-list
93041794|NCT00354744|Doxorubicin|doxorubicin|mesh-list
93041795|NCT00354744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92687029|NCT01342510|Analgesics|analgesics|mesh-ancestor
93041796|NCT00354744|Irinotecan|irinotecan|mesh-list
93041797|NCT00354744|Etoposide|etoposide|mesh-list
93041798|NCT00354744|Vincristine|vincristine|mesh-list
93041799|NCT00354744|Camptothecin|camptothecin|mesh-list
93041800|NCT00354744|Lenograstim|lenograstim|mesh-list
93041801|NCT00354744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041802|NCT00354744|Immunologic Factors|immunologic factors|mesh-ancestor
93041803|NCT00354744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041804|NCT00354744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041805|NCT00354744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93041806|NCT00354744|Alkylating Agents|alkylating agents|mesh-ancestor
93041807|NCT00354744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041808|NCT00354744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041809|NCT00354744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92252689|NCT02478372|Sensory System Agents|sensory system agents|mesh-ancestor
93041810|NCT00354744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93041811|NCT00354744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93041812|NCT00354744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041813|NCT00354744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041814|NCT00354744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93041815|NCT00354744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93041816|NCT00354744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93041817|NCT00354744|Tubulin Modulators|tubulin modulators|mesh-ancestor
93041818|NCT00354744|Antimitotic Agents|antimitotic agents|mesh-ancestor
93041819|NCT00354744|Mitosis Modulators|mitosis modulators|mesh-ancestor
93041820|NCT00354744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93041821|NCT00354744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041822|NCT00354744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93041823|NCT00354744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93041824|NCT01055964|Tacrolimus|tacrolimus|mesh-list
93041825|NCT01055964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93041826|NCT01055964|Immunologic Factors|immunologic factors|mesh-ancestor
93041827|NCT01055964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041828|NCT01055964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93041829|NCT01055964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041830|NCT01055964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041831|NCT01056042|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93041832|NCT01056042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93041833|NCT01056042|Medroxyprogesterone|medroxyprogesterone|mesh-list
93041834|NCT01056042|Gestodene|gestodene|mesh-list
93041835|NCT01056042|Estradiol|estradiol|mesh-list
93041836|NCT01056042|Estrogens|estrogens|mesh-ancestor
93041837|NCT01056042|Hormones|hormones|mesh-ancestor
93041838|NCT01056042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041839|NCT01056042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041840|NCT01056042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93041841|NCT01056042|Contraceptive Agents|contraceptive agents|mesh-ancestor
93041842|NCT01056042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93041843|NCT01056042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93041844|NCT01056042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93041845|NCT01056042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92253034|NCT01432145|Antimetabolites|antimetabolites|mesh-ancestor
93041846|NCT01056042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93041847|NCT01056042|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93041848|NCT01056042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93041849|NCT01056042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041850|NCT01056042|Progestins|progestins|mesh-ancestor
93041851|NCT00373256|Paclitaxel|paclitaxel|mesh-list
93041852|NCT00373256|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93041853|NCT00373256|Bevacizumab|bevacizumab|mesh-list
93041854|NCT00373256|Sunitinib|sunitinib|mesh-list
92387509|NCT00003876|Carmustine|carmustine|mesh-list
92253251|NCT05945875|Panitumumab|panitumumab|mesh-list
93041855|NCT00373256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93041856|NCT00373256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041857|NCT00373256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92253336|NCT05945342|Fluoxetine|fluoxetine|mesh-list
93041858|NCT00373256|Antimitotic Agents|antimitotic agents|mesh-ancestor
93041859|NCT00373256|Mitosis Modulators|mitosis modulators|mesh-ancestor
93041860|NCT00373256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041861|NCT00373256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041862|NCT00373256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93041863|NCT00373256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93041864|NCT00373256|Growth Substances|growth substances|mesh-ancestor
93041865|NCT00373256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041866|NCT00373256|Growth Inhibitors|growth inhibitors|mesh-ancestor
93041867|NCT00373256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93041868|NCT00373256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041869|NCT01324544|Buprenorphine|buprenorphine|mesh-list
93041870|NCT01324544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93041871|NCT01324544|Narcotics|narcotics|mesh-ancestor
93041872|NCT01324544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041873|NCT01324544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041874|NCT01324544|Analgesics|analgesics|mesh-ancestor
93041875|NCT01324544|Sensory System Agents|sensory system agents|mesh-ancestor
93041876|NCT01324544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041877|NCT01324544|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93041878|NCT00394082|Paclitaxel|paclitaxel|mesh-list
93041879|NCT00394082|Bevacizumab|bevacizumab|mesh-list
93041880|NCT00394082|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92253536|NCT05753189|Miotics|miotics|mesh-ancestor
93041881|NCT00394082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93041882|NCT00394082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041883|NCT00394082|Tubulin Modulators|tubulin modulators|mesh-ancestor
93041884|NCT00394082|Antimitotic Agents|antimitotic agents|mesh-ancestor
93041885|NCT00394082|Mitosis Modulators|mitosis modulators|mesh-ancestor
93041886|NCT00394082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041887|NCT00394082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041888|NCT00394082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93041889|NCT00394082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93041890|NCT00394082|Growth Substances|growth substances|mesh-ancestor
93041891|NCT00394082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041892|NCT00394082|Growth Inhibitors|growth inhibitors|mesh-ancestor
93041893|NCT00393848|Ketoconazole|ketoconazole|mesh-list
93041894|NCT00393848|Antifungal Agents|antifungal agents|mesh-ancestor
93041895|NCT00393848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93041896|NCT00393848|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93041897|NCT00393848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93041898|NCT00393848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041899|NCT00393848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041900|NCT00393848|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93041901|NCT00393848|Hormone Antagonists|hormone antagonists|mesh-ancestor
93041902|NCT00393848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041903|NCT00393848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041904|NCT00393848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93041905|NCT00393458|Formoterol Fumarate|formoterol fumarate|mesh-list
93041906|NCT00393458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93041907|NCT00393458|Autonomic Agents|autonomic agents|mesh-ancestor
93041908|NCT00393458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041909|NCT00393458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041910|NCT00393458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93041911|NCT00393458|Respiratory System Agents|respiratory system agents|mesh-ancestor
93041912|NCT00393458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93041913|NCT00393458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93041914|NCT00393458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93041915|NCT00393458|Adrenergic Agents|adrenergic agents|mesh-ancestor
93041916|NCT00393458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041917|NCT00393458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041918|NCT01046006|Dexamethasone|dexamethasone|mesh-list
93041919|NCT01046006|Rituximab|rituximab|mesh-list
93041920|NCT01046006|Bortezomib|bortezomib|mesh-list
93041921|NCT01046006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93041922|NCT01046006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041923|NCT01046006|Immunologic Factors|immunologic factors|mesh-ancestor
93041924|NCT01046006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041925|NCT01046006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93041926|NCT01046006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93041927|NCT01046006|Antiemetics|antiemetics|mesh-ancestor
93041928|NCT01046006|Autonomic Agents|autonomic agents|mesh-ancestor
93041929|NCT01046006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254230|NCT04184622|Tirzepatide|tirzepatide|mesh-list
93041930|NCT01046006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93041931|NCT01046006|Glucocorticoids|glucocorticoids|mesh-ancestor
93041932|NCT01046006|Hormones|hormones|mesh-ancestor
92254295|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041933|NCT01046006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041934|NCT01046006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93041935|NCT01046162|Alprazolam|alprazolam|mesh-list
93041936|NCT01046162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93041937|NCT01046162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041938|NCT01046162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041939|NCT01046162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93041940|NCT01046162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93041941|NCT01046162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041942|NCT01046162|GABA Modulators|gaba modulators|mesh-ancestor
93041943|NCT01046162|GABA Agents|gaba agents|mesh-ancestor
93041944|NCT01046162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041945|NCT01046162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041946|NCT00417482|Risperidone|risperidone|mesh-list
93041947|NCT00417482|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93041948|NCT00417482|Serotonin Agents|serotonin agents|mesh-ancestor
93041949|NCT00417482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041950|NCT00417482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041951|NCT00417482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041952|NCT00417482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93041953|NCT00417482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93041954|NCT00417482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93041955|NCT00417482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93041956|NCT00417482|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93041957|NCT00417482|Dopamine Agents|dopamine agents|mesh-ancestor
93041958|NCT00417248|Etoposide|etoposide|mesh-list
93041959|NCT00417248|Sorafenib|sorafenib|mesh-list
93041960|NCT00417248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93041961|NCT00417248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93041962|NCT00417248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93041963|NCT00417248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93041964|NCT00417248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93041965|NCT00417248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041966|NCT00417248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93041967|NCT01046240|Palonosetron|palonosetron|mesh-list
93041968|NCT01046240|Antiemetics|antiemetics|mesh-ancestor
93041969|NCT01046240|Autonomic Agents|autonomic agents|mesh-ancestor
93041970|NCT01046240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93041971|NCT01046240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041972|NCT01046240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92254796|NCT01750073|Antibodies|antibodies|mesh-list
93041973|NCT01046240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93041974|NCT01046240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93041975|NCT01046240|Serotonin Agents|serotonin agents|mesh-ancestor
93041976|NCT01046240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93041977|NCT01046240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041978|NCT00392288|Ciclesonide|ciclesonide|mesh-list
93041979|NCT00392288|Glucocorticoids|glucocorticoids|mesh-ancestor
93041980|NCT00392288|Hormones|hormones|mesh-ancestor
93041981|NCT00392288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93041982|NCT00392288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041983|NCT00392288|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93041984|NCT00417170|Amlodipine|amlodipine|mesh-list
93041985|NCT00417170|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93041986|NCT00417170|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93041987|NCT00417170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93041988|NCT00417170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93041989|NCT00417170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93041990|NCT00417170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93041991|NCT00417170|Vasodilator Agents|vasodilator agents|mesh-ancestor
93041992|NCT00392990|Cytarabine|cytarabine|mesh-list
93041993|NCT00392990|Cyclophosphamide|cyclophosphamide|mesh-list
93041994|NCT00392990|Ifosfamide|ifosfamide|mesh-list
93041995|NCT00392990|Rituximab|rituximab|mesh-list
93041996|NCT00392990|Doxorubicin|doxorubicin|mesh-list
93041997|NCT00392990|Methotrexate|methotrexate|mesh-list
93041998|NCT00392990|Etoposide|etoposide|mesh-list
93041999|NCT00392990|Vincristine|vincristine|mesh-list
93042000|NCT00392990|Etoposide phosphate|etoposide phosphate|mesh-list
93042001|NCT00392990|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93042002|NCT00392990|Podophyllotoxin|podophyllotoxin|mesh-list
93042003|NCT00392990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93042004|NCT00392990|Immunologic Factors|immunologic factors|mesh-ancestor
93042005|NCT00392990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042006|NCT00392990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042007|NCT00392990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93042008|NCT00392990|Alkylating Agents|alkylating agents|mesh-ancestor
92255068|NCT01437605|Poly I-C|poly i-c|mesh-list
93042009|NCT00392990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042010|NCT00392990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042011|NCT00392990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93042012|NCT00392990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255135|NCT03216668|Silymarin|silymarin|mesh-list
93042013|NCT00392990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93042014|NCT00392990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93042015|NCT00392990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93042016|NCT00392990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042017|NCT00392990|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93042018|NCT00392990|Abortifacient Agents|abortifacient agents|mesh-ancestor
93042019|NCT00392990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93042020|NCT00392990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93042021|NCT00392990|Antimetabolites|antimetabolites|mesh-ancestor
93042022|NCT00392990|Dermatologic Agents|dermatologic agents|mesh-ancestor
93042023|NCT00392990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93042024|NCT00392990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92255267|NCT00895934|Immunotoxins|immunotoxins|mesh-ancestor
93042025|NCT00392990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93042026|NCT00392990|Antiviral Agents|antiviral agents|mesh-ancestor
93042027|NCT00392990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042028|NCT00392990|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042029|NCT00392990|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042030|NCT00392990|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042031|NCT00392990|Keratolytic Agents|keratolytic agents|mesh-ancestor
93042032|NCT00249873|Clopidogrel|clopidogrel|mesh-list
92255334|NCT01831622|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93042033|NCT00249873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93042034|NCT00249873|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93042035|NCT00249873|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93042036|NCT00249873|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93042037|NCT00249873|Purinergic Agents|purinergic agents|mesh-ancestor
93042038|NCT00249873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255471|NCT02476422|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042039|NCT00249873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042040|NCT00249873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042041|NCT01037348|Ranibizumab|ranibizumab|mesh-list
93042042|NCT01037348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93042043|NCT01037348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93042044|NCT01037348|Growth Substances|growth substances|mesh-ancestor
93042045|NCT01037348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042046|NCT01037348|Growth Inhibitors|growth inhibitors|mesh-ancestor
93042047|NCT01037348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042049|NCT03490292|Carboplatin|carboplatin|mesh-list
93042050|NCT03490292|Avelumab|avelumab|mesh-list
93042051|NCT03490292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93042052|NCT03490292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042053|NCT03490292|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042054|NCT03490292|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042055|NCT03490292|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042056|NCT03490292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042057|NCT03490292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93042058|NCT01046630|Ketamine|ketamine|mesh-list
93042059|NCT01046630|Analgesics|analgesics|mesh-ancestor
92255754|NCT03212456|Anesthetics|anesthetics|mesh-ancestor
93042060|NCT01046630|Sensory System Agents|sensory system agents|mesh-ancestor
93042061|NCT01046630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042062|NCT01046630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042063|NCT01046630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93042064|NCT01046630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93042065|NCT01046630|Anesthetics, General|anesthetics, general|mesh-ancestor
93042066|NCT01046630|Anesthetics|anesthetics|mesh-ancestor
93042067|NCT01046630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042068|NCT01046630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93042069|NCT01046630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93042070|NCT01046630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042071|NCT01046630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042072|NCT01046708|Progesterone|progesterone|mesh-list
93042073|NCT01046708|Progestins|progestins|mesh-ancestor
93042074|NCT01046708|Hormones|hormones|mesh-ancestor
92255892|NCT01561469|Vancomycin|vancomycin|mesh-list
93042075|NCT01046708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93042076|NCT01046708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042077|NCT01046786|Methylprednisolone|methylprednisolone|mesh-list
93042078|NCT01046786|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93042079|NCT01046786|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93042080|NCT01046786|Prednisolone|prednisolone|mesh-list
93042081|NCT01046786|Prednisolone acetate|prednisolone acetate|mesh-list
93042082|NCT01046786|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93042083|NCT01046786|Prednisolone phosphate|prednisolone phosphate|mesh-list
93042084|NCT01046786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042085|NCT01046786|Antiemetics|antiemetics|mesh-ancestor
93042086|NCT01046786|Autonomic Agents|autonomic agents|mesh-ancestor
93042087|NCT01046786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042088|NCT01046786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042089|NCT01046786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042090|NCT01046786|Glucocorticoids|glucocorticoids|mesh-ancestor
93042091|NCT01046786|Hormones|hormones|mesh-ancestor
93042092|NCT01046786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93042093|NCT01046786|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93042094|NCT01046786|Protective Agents|protective agents|mesh-ancestor
93042095|NCT01046786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93042096|NCT01046786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042097|NCT00391976|Tobramycin|tobramycin|mesh-list
93042098|NCT00391976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93042099|NCT00391976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042100|NCT00762554|Fentanyl|fentanyl|mesh-list
93042101|NCT00762554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93042102|NCT00762554|Narcotics|narcotics|mesh-ancestor
93042103|NCT00762554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042104|NCT00762554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042105|NCT00762554|Analgesics|analgesics|mesh-ancestor
93042106|NCT00762554|Sensory System Agents|sensory system agents|mesh-ancestor
93042107|NCT00762554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042108|NCT00762554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93042109|NCT00762554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93042110|NCT00762554|Anesthetics, General|anesthetics, general|mesh-ancestor
93042111|NCT00762554|Anesthetics|anesthetics|mesh-ancestor
93042112|NCT00391898|Levodopa|levodopa|mesh-list
93042113|NCT00391898|Carbidopa|carbidopa|mesh-list
93042114|NCT00391898|Entacapone|entacapone|mesh-list
93042115|NCT00391898|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93042116|NCT00391898|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93042117|NCT00391898|Dopamine Agents|dopamine agents|mesh-ancestor
93042118|NCT00391898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042119|NCT00391898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256230|NCT01830296|Narcotics|narcotics|mesh-ancestor
93042120|NCT00391898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042121|NCT00391898|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93042122|NCT00391898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042123|NCT00391898|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93042124|NCT01046864|Leucovorin|leucovorin|mesh-list
93042125|NCT01046864|Fluorouracil|fluorouracil|mesh-list
93042126|NCT01046864|Irinotecan|irinotecan|mesh-list
93042127|NCT01046864|Antimetabolites|antimetabolites|mesh-ancestor
93042128|NCT01046864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256370|NCT02497404|Melphalan|melphalan|mesh-list
93042129|NCT01046864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93042130|NCT01046864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042131|NCT01046864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93042132|NCT01046864|Immunologic Factors|immunologic factors|mesh-ancestor
93042133|NCT01046864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042134|NCT01046864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93042135|NCT01046864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93042136|NCT01046864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042137|NCT01046864|Antidotes|antidotes|mesh-ancestor
93042138|NCT01046864|Protective Agents|protective agents|mesh-ancestor
93042139|NCT01046864|Vitamin B Complex|vitamin b complex|mesh-ancestor
93042140|NCT01046864|Vitamins|vitamins|mesh-ancestor
93042141|NCT01046864|Micronutrients|micronutrients|mesh-ancestor
93042142|NCT01046942|Aspirin|aspirin|mesh-list
93042143|NCT01046942|Clopidogrel|clopidogrel|mesh-list
93042144|NCT01046942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93042145|NCT01046942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93042146|NCT01046942|Analgesics|analgesics|mesh-ancestor
93042147|NCT01046942|Sensory System Agents|sensory system agents|mesh-ancestor
93042148|NCT01046942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042149|NCT01046942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042150|NCT01046942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042151|NCT01046942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042152|NCT01046942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93042153|NCT01046942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93042154|NCT01046942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042155|NCT01046942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92256580|NCT03830216|Insulin|insulin|mesh-list
93042156|NCT01046942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042157|NCT01046942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042158|NCT01046942|Antipyretics|antipyretics|mesh-ancestor
93042159|NCT01046942|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92256637|NCT03835442|GABA Agents|gaba agents|mesh-ancestor
93042160|NCT01046942|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93042161|NCT01046942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92256712|NCT03006809|Metronidazole|metronidazole|mesh-list
93042162|NCT01046942|Purinergic Agents|purinergic agents|mesh-ancestor
93042163|NCT01046942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042164|NCT01049438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93042165|NCT01049438|Doxycycline|doxycycline|mesh-list
93042166|NCT01049438|Minocycline|minocycline|mesh-list
93042167|NCT01049438|Mupirocin|mupirocin|mesh-list
93042168|NCT01049438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93042169|NCT01049438|Trimethoprim|trimethoprim|mesh-list
93042170|NCT01049438|Sulfamethoxazole|sulfamethoxazole|mesh-list
93042171|NCT01049438|Hexachlorophene|hexachlorophene|mesh-list
93042172|NCT01049438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042173|NCT01049438|Antimalarials|antimalarials|mesh-ancestor
93042174|NCT01049438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93042175|NCT01049438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93042176|NCT01049438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93042177|NCT01049438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93042178|NCT01049438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042179|NCT01049438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042180|NCT01049438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92256920|NCT01586975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93042181|NCT01049438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93042182|NCT01049438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93042183|NCT01049438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93042184|NCT01049438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93042185|NCT01047098|Iron|iron|mesh-list
93042186|NCT01047098|Trace Elements|trace elements|mesh-ancestor
93042187|NCT01047098|Micronutrients|micronutrients|mesh-ancestor
93042188|NCT01047098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042189|NCT00391586|Paclitaxel|paclitaxel|mesh-list
93042190|NCT00391586|Etoposide|etoposide|mesh-list
93042191|NCT00391586|Vinorelbine|vinorelbine|mesh-list
93042192|NCT00391586|Docetaxel|docetaxel|mesh-list
93042193|NCT00391586|Gemcitabine|gemcitabine|mesh-list
93042194|NCT00391586|Irinotecan|irinotecan|mesh-list
93042195|NCT00391586|Pemetrexed|pemetrexed|mesh-list
93042196|NCT00391586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93042197|NCT00391586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93042198|NCT00391586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042199|NCT00391586|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042200|NCT00391586|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042201|NCT00391586|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042202|NCT00391586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042203|NCT00391586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93042204|NCT00391586|Antimetabolites|antimetabolites|mesh-ancestor
93042205|NCT00391586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93042206|NCT00391586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93042207|NCT00391586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042208|NCT00391586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93042209|NCT00391586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93042210|NCT00391586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93042211|NCT00391586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93042212|NCT00391430|Sertraline|sertraline|mesh-list
93042213|NCT00391430|Antidepressive Agents|antidepressive agents|mesh-ancestor
93042214|NCT00391430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93042215|NCT00391430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93042216|NCT00391430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93042217|NCT00391430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042218|NCT00391430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042219|NCT00391430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042220|NCT00391430|Serotonin Agents|serotonin agents|mesh-ancestor
93042221|NCT00391430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042223|NCT00391274|Pemetrexed|pemetrexed|mesh-list
93042224|NCT00391274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042225|NCT00391274|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042226|NCT00391274|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042227|NCT00391274|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042228|NCT00391274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042229|NCT00391274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042230|NCT00391274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93042231|NCT00391274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93042232|NCT00391118|Paclitaxel|paclitaxel|mesh-list
93042233|NCT00391118|Carboplatin|carboplatin|mesh-list
93042234|NCT00391118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93042235|NCT00391118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042236|NCT00391118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042237|NCT00391118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042238|NCT00391118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042239|NCT00391118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042240|NCT00390884|Vaccines|vaccines|mesh-list
93042241|NCT00390884|Immunologic Factors|immunologic factors|mesh-ancestor
93042242|NCT00390884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042243|NCT01047488|Pregabalin|pregabalin|mesh-list
93042244|NCT01047488|Imipramine|imipramine|mesh-list
92687473|NCT00623116|Estrogens|estrogens|mesh-list
93042245|NCT01047488|Analgesics|analgesics|mesh-ancestor
93042246|NCT01047488|Sensory System Agents|sensory system agents|mesh-ancestor
92257395|NCT02246270|Calcium heparin|calcium heparin|mesh-list
93042247|NCT01047488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042248|NCT01047488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042249|NCT01047488|Anticonvulsants|anticonvulsants|mesh-ancestor
93042250|NCT01047488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93042251|NCT01047488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042252|NCT01047488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042253|NCT01047488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042254|NCT01047488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93042255|NCT01047488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92257448|NCT02516592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042256|NCT01047488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042257|NCT01047488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93042258|NCT01047488|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92257513|NCT04716335|Harmine|harmine|mesh-list
93042259|NCT01047488|Antidepressive Agents|antidepressive agents|mesh-ancestor
93042260|NCT01047488|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92257595|NCT04594733|Minocycline|minocycline|mesh-list
93042261|NCT01047488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93042262|NCT01047488|Adrenergic Agents|adrenergic agents|mesh-ancestor
93042263|NCT01047488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042264|NCT01047566|Digoxin|digoxin|mesh-list
93042265|NCT01047566|Dronedarone|dronedarone|mesh-list
93042266|NCT01047566|Calcium Channel Blockers|calcium channel blockers|mesh-list
93042267|NCT01047566|Calcium|calcium|mesh-list
93042268|NCT01047566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93042269|NCT01047566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042270|NCT01047566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042271|NCT01047566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93042272|NCT01047566|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93042273|NCT01047566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042274|NCT01047566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042275|NCT01047566|Protective Agents|protective agents|mesh-ancestor
93042276|NCT01047566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93042277|NCT01047566|Adrenergic Agents|adrenergic agents|mesh-ancestor
93042278|NCT01047566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257872|NCT02243618|Rebamipide|rebamipide|mesh-list
93042279|NCT01047566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042280|NCT00365846|Alemtuzumab|alemtuzumab|mesh-list
93042281|NCT00365846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93042282|NCT00365846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042283|NCT00264537|Golimumab|golimumab|mesh-list
93042284|NCT00264537|Methotrexate|methotrexate|mesh-list
93042285|NCT00264537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93042286|NCT00264537|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93042287|NCT00264537|Abortifacient Agents|abortifacient agents|mesh-ancestor
93042288|NCT00264537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93042289|NCT00264537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042290|NCT00264537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93042291|NCT00264537|Antimetabolites|antimetabolites|mesh-ancestor
93042292|NCT00264537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042293|NCT00264537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042294|NCT00264537|Dermatologic Agents|dermatologic agents|mesh-ancestor
93042295|NCT00264537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042297|NCT00264537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93042298|NCT00264537|Immunologic Factors|immunologic factors|mesh-ancestor
93042299|NCT00264537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042300|NCT00264537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93042301|NCT00264537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93042302|NCT00264537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042303|NCT00371150|Entecavir|entecavir|mesh-list
93042304|NCT00371150|Antiviral Agents|antiviral agents|mesh-ancestor
93042305|NCT00371150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042306|NCT00264303|Levocetirizine|levocetirizine|mesh-list
93042307|NCT00264303|Desloratadine|desloratadine|mesh-list
93042308|NCT00264303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93042309|NCT00264303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93042310|NCT00264303|Histamine Antagonists|histamine antagonists|mesh-ancestor
92258143|NCT02459964|Fentanyl|fentanyl|mesh-list
93042311|NCT00264303|Histamine Agents|histamine agents|mesh-ancestor
93042312|NCT00264303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042313|NCT00264303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042314|NCT00264303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042315|NCT00264303|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93042316|NCT00264303|Cholinergic Agents|cholinergic agents|mesh-ancestor
93042317|NCT01071369|Betamethasone|betamethasone|mesh-list
93042318|NCT01071369|Betamethasone Valerate|betamethasone valerate|mesh-list
93042319|NCT01071369|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93042320|NCT01071369|Betamethasone benzoate|betamethasone benzoate|mesh-list
93042321|NCT01071369|Lidocaine|lidocaine|mesh-list
93042322|NCT01071369|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92687551|NCT00601042|Lobeline|lobeline|mesh-list
93042323|NCT01071369|Anesthetics, Local|anesthetics, local|mesh-ancestor
93042324|NCT01071369|Anesthetics|anesthetics|mesh-ancestor
93042325|NCT01071369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042326|NCT01071369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042327|NCT01071369|Sensory System Agents|sensory system agents|mesh-ancestor
93042328|NCT01071369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042329|NCT01071369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93042330|NCT01071369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93042331|NCT01071369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93042332|NCT01071369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042333|NCT01071369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042334|NCT01071369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042335|NCT01071369|Glucocorticoids|glucocorticoids|mesh-ancestor
93042336|NCT01071369|Hormones|hormones|mesh-ancestor
93042337|NCT01071369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93042338|NCT01071369|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92258564|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93042339|NCT01071369|Respiratory System Agents|respiratory system agents|mesh-ancestor
93042340|NCT00370682|Vaccines|vaccines|mesh-list
93042341|NCT00370682|Immunologic Factors|immunologic factors|mesh-ancestor
93042342|NCT00370682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042343|NCT00264147|Diclofenac|diclofenac|mesh-list
93042344|NCT00264147|Etoricoxib|etoricoxib|mesh-list
93042345|NCT00264147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93042346|NCT00264147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93042347|NCT00264147|Analgesics|analgesics|mesh-ancestor
93042348|NCT00264147|Sensory System Agents|sensory system agents|mesh-ancestor
93042349|NCT00264147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042350|NCT00264147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042351|NCT00264147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042352|NCT00264147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042353|NCT00264147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042354|NCT00264147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042355|NCT00264147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042356|NCT00264147|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93042357|NCT01044446|Dialysis Solutions|dialysis solutions|mesh-list
93042358|NCT01044446|Icodextrin|icodextrin|mesh-list
93042359|NCT01044446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93042360|NCT03971019|Calcium, Dietary|calcium, dietary|mesh-list
93042361|NCT03971019|Atorvastatin|atorvastatin|mesh-list
93042362|NCT03971019|Simvastatin|simvastatin|mesh-list
93042363|NCT03971019|Calcium|calcium|mesh-list
93042364|NCT03971019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042365|NCT03971019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042366|NCT03971019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93042367|NCT03971019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93042368|NCT03971019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93042369|NCT03971019|Antimetabolites|antimetabolites|mesh-ancestor
93042370|NCT03971019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042371|NCT03971019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93042372|NCT03971019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93042373|NCT03971019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042374|NCT03974685|Niacinamide|niacinamide|mesh-list
93042375|NCT03974685|Niacin|niacin|mesh-list
93042376|NCT03974685|Nicotinic Acids|nicotinic acids|mesh-list
93042377|NCT03974685|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
93042378|NCT03974685|Vitamin B Complex|vitamin b complex|mesh-ancestor
93042379|NCT03974685|Vitamins|vitamins|mesh-ancestor
93042380|NCT03974685|Micronutrients|micronutrients|mesh-ancestor
93042381|NCT03974685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042382|NCT03974685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93042383|NCT03974685|Antimetabolites|antimetabolites|mesh-ancestor
93042384|NCT03974685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258897|NCT04359524|Vitamin D|vitamin d|mesh-list
93042385|NCT03974685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93042386|NCT03974685|Vasodilator Agents|vasodilator agents|mesh-ancestor
93042387|NCT03974685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042388|NCT00263211|Aspirin|aspirin|mesh-list
93042389|NCT00263211|Clopidogrel|clopidogrel|mesh-list
93042390|NCT00263211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93042391|NCT00263211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93042392|NCT00263211|Analgesics|analgesics|mesh-ancestor
92687622|NCT00601432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042393|NCT00263211|Sensory System Agents|sensory system agents|mesh-ancestor
93042394|NCT00263211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259122|NCT03031808|Lidocaine|lidocaine|mesh-list
93042395|NCT00263211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042396|NCT00263211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042397|NCT00263211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042398|NCT00263211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93042399|NCT00263211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93042400|NCT00263211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042401|NCT00263211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93042402|NCT00263211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042403|NCT00263211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042404|NCT00263211|Antipyretics|antipyretics|mesh-ancestor
93042405|NCT00263211|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93042406|NCT00263211|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93042407|NCT00263211|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93042408|NCT00263211|Purinergic Agents|purinergic agents|mesh-ancestor
93042409|NCT00263211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042410|NCT00248625|Acetylcysteine|acetylcysteine|mesh-list
93042411|NCT00248625|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93042412|NCT00248625|Antiviral Agents|antiviral agents|mesh-ancestor
93042413|NCT00248625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042414|NCT00248625|Expectorants|expectorants|mesh-ancestor
93042415|NCT00248625|Respiratory System Agents|respiratory system agents|mesh-ancestor
93042416|NCT00248625|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93042417|NCT00248625|Antioxidants|antioxidants|mesh-ancestor
93042418|NCT00248625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042419|NCT00248625|Protective Agents|protective agents|mesh-ancestor
93042420|NCT00248625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042421|NCT00248625|Antidotes|antidotes|mesh-ancestor
93042422|NCT00262821|Tirapazamine|tirapazamine|mesh-list
93042423|NCT00262821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042424|NCT01326117|Tadalafil|tadalafil|mesh-list
93042425|NCT01326117|Vasodilator Agents|vasodilator agents|mesh-ancestor
93042426|NCT01326117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93042427|NCT01326117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93042428|NCT01326117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042429|NCT01326117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042430|NCT01326117|Urological Agents|urological agents|mesh-ancestor
93042431|NCT03970239|Ketanserin|ketanserin|mesh-list
93042432|NCT03970239|Fluorides|fluorides|mesh-list
93042433|NCT03970239|Altanserin|altanserin|mesh-list
93042434|NCT03970239|Cariostatic Agents|cariostatic agents|mesh-ancestor
93042435|NCT03970239|Protective Agents|protective agents|mesh-ancestor
93042436|NCT03970239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042437|NCT03970239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93042438|NCT03970239|Serotonin Agents|serotonin agents|mesh-ancestor
93042439|NCT03970239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042440|NCT03970239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042441|NCT03970239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93042442|NCT03970239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93042443|NCT00170950|Amlodipine|amlodipine|mesh-list
93042444|NCT00170950|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93042445|NCT00170950|Benazepril|benazepril|mesh-list
93042446|NCT00170950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93042447|NCT00170950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93042448|NCT00170950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042449|NCT00170950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042450|NCT00170950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042451|NCT00170950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042452|NCT00170950|Vasodilator Agents|vasodilator agents|mesh-ancestor
93042453|NCT00170950|Diuretics|diuretics|mesh-ancestor
93042454|NCT00170950|Natriuretic Agents|natriuretic agents|mesh-ancestor
93042455|NCT00170950|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93042456|NCT00170950|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93042457|NCT00170950|Protease Inhibitors|protease inhibitors|mesh-ancestor
93042458|NCT00170950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042459|NCT00262041|Vaccines|vaccines|mesh-list
93042460|NCT00262041|Immunologic Factors|immunologic factors|mesh-ancestor
93042461|NCT00262041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042462|NCT00208767|Valsartan|valsartan|mesh-list
93042463|NCT00208767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93042464|NCT00208767|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93042465|NCT00208767|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93042466|NCT00208767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042467|NCT02531529|Fentanyl|fentanyl|mesh-list
93042468|NCT02531529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93042469|NCT02531529|Narcotics|narcotics|mesh-ancestor
93042470|NCT02531529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042471|NCT02531529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042472|NCT02531529|Analgesics|analgesics|mesh-ancestor
93042473|NCT02531529|Sensory System Agents|sensory system agents|mesh-ancestor
93042474|NCT02531529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042475|NCT02531529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93042476|NCT02531529|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93042477|NCT02531529|Anesthetics, General|anesthetics, general|mesh-ancestor
93042478|NCT02531529|Anesthetics|anesthetics|mesh-ancestor
93042479|NCT01071525|Niacin|niacin|mesh-list
93042480|NCT01071525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93042481|NCT01071525|Antimetabolites|antimetabolites|mesh-ancestor
93042482|NCT01071525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042483|NCT01071525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93042484|NCT01071525|Vasodilator Agents|vasodilator agents|mesh-ancestor
93042485|NCT01071525|Vitamin B Complex|vitamin b complex|mesh-ancestor
93042486|NCT01071525|Vitamins|vitamins|mesh-ancestor
93042487|NCT01071525|Micronutrients|micronutrients|mesh-ancestor
93042488|NCT01071525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042489|NCT01072695|Ribavirin|ribavirin|mesh-list
93042490|NCT01072695|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93042491|NCT01072695|Antimetabolites|antimetabolites|mesh-ancestor
92260145|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93042492|NCT01072695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042493|NCT01072695|Antiviral Agents|antiviral agents|mesh-ancestor
93042494|NCT01072695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042495|NCT00390806|Topotecan|topotecan|mesh-list
93042496|NCT00390806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93042497|NCT00390806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93042498|NCT00390806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042499|NCT00390806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042500|NCT00390806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042501|NCT00135200|Tositumomab I-131|tositumomab i-131|mesh-list
93042502|NCT00135200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042503|NCT01047722|Aspirin|aspirin|mesh-list
93042504|NCT01047722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93042505|NCT01047722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93042506|NCT01047722|Analgesics|analgesics|mesh-ancestor
93042507|NCT01047722|Sensory System Agents|sensory system agents|mesh-ancestor
93042508|NCT01047722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260350|NCT01051778|Heparin|heparin|mesh-list
93042509|NCT01047722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042510|NCT01047722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042511|NCT01047722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042512|NCT01047722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93042513|NCT01047722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93042514|NCT01047722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042515|NCT01047722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92260426|NCT02170532|Tocolytic Agents|tocolytic agents|mesh-ancestor
93042516|NCT01047722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042517|NCT01047722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042519|NCT00390416|Leucovorin|leucovorin|mesh-list
93042520|NCT00390416|Bevacizumab|bevacizumab|mesh-list
93042521|NCT00390416|Docetaxel|docetaxel|mesh-list
93042522|NCT00390416|Fluorouracil|fluorouracil|mesh-list
93042523|NCT00390416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93042524|NCT00390416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042525|NCT00390416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93042526|NCT00390416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91995728|NCT02642159|Niacin|niacin|mesh-list
93042527|NCT00390416|Growth Substances|growth substances|mesh-ancestor
93042528|NCT00390416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042529|NCT00390416|Growth Inhibitors|growth inhibitors|mesh-ancestor
93042530|NCT00390416|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042531|NCT00390416|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042532|NCT00390416|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042533|NCT00390416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042534|NCT00390416|Antimetabolites|antimetabolites|mesh-ancestor
93042535|NCT00390416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92260681|NCT02740868|Xenon|xenon|mesh-list
93042536|NCT00390416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93042537|NCT00390416|Immunologic Factors|immunologic factors|mesh-ancestor
93042538|NCT00390416|Antidotes|antidotes|mesh-ancestor
93042539|NCT00390416|Protective Agents|protective agents|mesh-ancestor
93042540|NCT00390416|Vitamin B Complex|vitamin b complex|mesh-ancestor
93042541|NCT00390416|Vitamins|vitamins|mesh-ancestor
93042542|NCT00390416|Micronutrients|micronutrients|mesh-ancestor
93042543|NCT00261495|Oxycodone|oxycodone|mesh-list
93042544|NCT00261495|Hydromorphone|hydromorphone|mesh-list
93042545|NCT00261495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93042546|NCT00261495|Narcotics|narcotics|mesh-ancestor
92687780|NCT00470522|Hematinics|hematinics|mesh-ancestor
93042547|NCT00261495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042548|NCT00261495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042550|NCT00261495|Sensory System Agents|sensory system agents|mesh-ancestor
93042551|NCT00261495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260838|NCT01036802|Warfarin|warfarin|mesh-list
93042552|NCT00168844|Tiotropium Bromide|tiotropium bromide|mesh-list
93042553|NCT00168844|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93042554|NCT00168844|Autonomic Agents|autonomic agents|mesh-ancestor
93042555|NCT00168844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042556|NCT00168844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042557|NCT00168844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93042558|NCT00168844|Respiratory System Agents|respiratory system agents|mesh-ancestor
93042559|NCT00168844|Parasympatholytics|parasympatholytics|mesh-ancestor
93042560|NCT00168844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93042561|NCT00168844|Cholinergic Agents|cholinergic agents|mesh-ancestor
92260992|NCT00585195|Itraconazole|itraconazole|mesh-list
93042562|NCT00168844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042563|NCT00168844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042564|NCT00365456|Risedronic Acid|risedronic acid|mesh-list
93042565|NCT00365456|Hormones|hormones|mesh-list
93042566|NCT00365456|Parathyroid Hormone|parathyroid hormone|mesh-list
93042567|NCT00365456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93042568|NCT00365456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042569|NCT00365456|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93042570|NCT00365456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042571|NCT00365456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042572|NCT00365456|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042573|NCT00365456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93042574|NCT01047956|Methadone|methadone|mesh-list
93042575|NCT01047956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93042576|NCT01047956|Narcotics|narcotics|mesh-ancestor
93042577|NCT01047956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042578|NCT01047956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042579|NCT01047956|Analgesics|analgesics|mesh-ancestor
93042580|NCT01047956|Sensory System Agents|sensory system agents|mesh-ancestor
93042581|NCT01047956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042582|NCT01047956|Antitussive Agents|antitussive agents|mesh-ancestor
92261262|NCT02926196|Avelumab|avelumab|mesh-list
93042583|NCT01047956|Respiratory System Agents|respiratory system agents|mesh-ancestor
93042584|NCT03480698|Cerebrolysin|cerebrolysin|mesh-list
93042585|NCT03480698|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93042586|NCT03480698|Protective Agents|protective agents|mesh-ancestor
93042587|NCT03480698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042588|NCT03480698|Nootropic Agents|nootropic agents|mesh-ancestor
93042589|NCT00206427|Lapatinib|lapatinib|mesh-list
93042590|NCT00206427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042591|NCT00206427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92388262|NCT00004578|Ritonavir|ritonavir|mesh-list
93042592|NCT00206427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042593|NCT00206427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042594|NCT00389324|Immunoglobulins|immunoglobulins|mesh-list
93042595|NCT00389324|Antibodies|antibodies|mesh-list
93042596|NCT00389324|gamma-Globulins|gamma-globulins|mesh-list
93042597|NCT00389324|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93042598|NCT00389324|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93042599|NCT00389324|Immunoglobulin G|immunoglobulin g|mesh-list
93042600|NCT00389324|Immunologic Factors|immunologic factors|mesh-ancestor
93042601|NCT00389324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042602|NCT00365300|Pantoprazole|pantoprazole|mesh-list
93042603|NCT00365300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93042604|NCT00365300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042605|NCT00365300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93042606|NCT00365300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042607|NCT00365300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042608|NCT01048034|Azacitidine|azacitidine|mesh-list
93042609|NCT01048034|Epoetin Alfa|epoetin alfa|mesh-list
93042610|NCT01048034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93042611|NCT01048034|Antimetabolites|antimetabolites|mesh-ancestor
92261451|NCT02481219|Bisacodyl|bisacodyl|mesh-list
93042612|NCT01048034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042613|NCT01048034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042614|NCT01048034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042615|NCT01048034|Hematinics|hematinics|mesh-ancestor
93042616|NCT00370292|Pemetrexed|pemetrexed|mesh-list
93042617|NCT00370292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042618|NCT00370292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042619|NCT00370292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042620|NCT00370292|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93042621|NCT00370292|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93042622|NCT01049672|Alfentanil|alfentanil|mesh-list
93042623|NCT01049672|Heroin|heroin|mesh-list
93042624|NCT01049672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93042625|NCT01049672|Narcotics|narcotics|mesh-ancestor
93042626|NCT01049672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042627|NCT01049672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042628|NCT01049672|Analgesics|analgesics|mesh-ancestor
93042629|NCT01049672|Sensory System Agents|sensory system agents|mesh-ancestor
93042630|NCT01049672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042631|NCT01049672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93042632|NCT01049672|Anesthetics, General|anesthetics, general|mesh-ancestor
93042633|NCT01049672|Anesthetics|anesthetics|mesh-ancestor
93042635|NCT01048190|Immunologic Factors|immunologic factors|mesh-ancestor
92261680|NCT01171118|Miotics|miotics|mesh-ancestor
93042636|NCT01048190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042637|NCT01048268|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
93042638|NCT01048268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042639|NCT01048268|Incretins|incretins|mesh-ancestor
93042640|NCT01048268|Hormones|hormones|mesh-ancestor
93042641|NCT01048268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93042642|NCT01048268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042643|NCT03993236|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93042644|NCT03993236|Ezetimibe|ezetimibe|mesh-list
93042645|NCT03993236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93042646|NCT03993236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93042647|NCT03993236|Antimetabolites|antimetabolites|mesh-ancestor
93042648|NCT03993236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042649|NCT03993236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93042650|NCT03993236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93042651|NCT03993236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042652|NCT00388154|Cisplatin|cisplatin|mesh-list
93042653|NCT00388154|Gemcitabine|gemcitabine|mesh-list
93042654|NCT00388154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042655|NCT00388154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93042656|NCT00388154|Antimetabolites|antimetabolites|mesh-ancestor
93042657|NCT00388154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042658|NCT02535104|Ranpirnase|ranpirnase|mesh-list
92529246|NCT00396760|Aprotinin|aprotinin|mesh-list
93042659|NCT02535104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042660|NCT02535104|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93042661|NCT02535104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042662|NCT02535104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042663|NCT00386360|Risedronic Acid|risedronic acid|mesh-list
93042664|NCT00386360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92261787|NCT02561481|Sulforaphane|sulforaphane|mesh-list
93042665|NCT00386360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042666|NCT00386360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042667|NCT00386360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042668|NCT00386360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261847|NCT01178216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042669|NCT00386360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93042670|NCT00369278|Mycophenolic Acid|mycophenolic acid|mesh-list
93042671|NCT00369278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93042672|NCT00369278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042673|NCT00369278|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92261923|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
93042674|NCT00369278|Antitubercular Agents|antitubercular agents|mesh-ancestor
93042675|NCT00369278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93042676|NCT00369278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042677|NCT00369278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042678|NCT00369278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042679|NCT00529373|Calcium, Dietary|calcium, dietary|mesh-list
93042680|NCT00529373|Vitamin D|vitamin d|mesh-list
93042681|NCT00529373|Cholecalciferol|cholecalciferol|mesh-list
93042682|NCT00529373|Calcium Carbonate|calcium carbonate|mesh-list
93042683|NCT00529373|Calcium|calcium|mesh-list
93042684|NCT00529373|Vitamins|vitamins|mesh-ancestor
93042685|NCT00529373|Micronutrients|micronutrients|mesh-ancestor
93042686|NCT00529373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042687|NCT00529373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93042688|NCT00529373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93042689|NCT00529373|Antacids|antacids|mesh-ancestor
93042690|NCT00529373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262206|NCT01186562|Incretins|incretins|mesh-ancestor
93042691|NCT00529373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042692|NCT00369122|Bevacizumab|bevacizumab|mesh-list
93042693|NCT00369122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93042694|NCT00369122|Cisplatin|cisplatin|mesh-list
93042695|NCT00369122|Endothelial Growth Factors|endothelial growth factors|mesh-list
93042696|NCT00369122|Antibodies|antibodies|mesh-list
93042697|NCT00369122|Immunoglobulins|immunoglobulins|mesh-list
93042698|NCT00369122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93042699|NCT00369122|Immunoglobulin G|immunoglobulin g|mesh-list
93042700|NCT00369122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042701|NCT00369122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93042702|NCT00369122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93042703|NCT00369122|Growth Substances|growth substances|mesh-ancestor
93042704|NCT00369122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042705|NCT00369122|Growth Inhibitors|growth inhibitors|mesh-ancestor
93042706|NCT00369122|Immunologic Factors|immunologic factors|mesh-ancestor
93042707|NCT03999203|Nitric Oxide|nitric oxide|mesh-list
93042708|NCT03999203|Citric Acid|citric acid|mesh-list
93042709|NCT03999203|Sodium Citrate|sodium citrate|mesh-list
93042710|NCT03999203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93042711|NCT03999203|Autonomic Agents|autonomic agents|mesh-ancestor
93042712|NCT03999203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042713|NCT03999203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042714|NCT03999203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93042715|NCT03999203|Respiratory System Agents|respiratory system agents|mesh-ancestor
93042716|NCT03999203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93042717|NCT03999203|Antioxidants|antioxidants|mesh-ancestor
93042718|NCT03999203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042719|NCT03999203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042720|NCT03999203|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93042721|NCT03999203|Vasodilator Agents|vasodilator agents|mesh-ancestor
93042722|NCT03999203|Gasotransmitters|gasotransmitters|mesh-ancestor
93042723|NCT03999203|Protective Agents|protective agents|mesh-ancestor
93042724|NCT03999203|Anticoagulants|anticoagulants|mesh-ancestor
93042725|NCT03999203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93042726|NCT03999203|Chelating Agents|chelating agents|mesh-ancestor
93042727|NCT03999203|Sequestering Agents|sequestering agents|mesh-ancestor
93042728|NCT04854395|Bupivacaine|bupivacaine|mesh-list
93042729|NCT04854395|Anesthetics, Local|anesthetics, local|mesh-ancestor
93042730|NCT04854395|Anesthetics|anesthetics|mesh-ancestor
93042731|NCT04854395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042732|NCT04854395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042733|NCT04854395|Sensory System Agents|sensory system agents|mesh-ancestor
93042734|NCT04854395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042735|NCT05173493|Amoxicillin|amoxicillin|mesh-list
93042736|NCT05173493|Levofloxacin|levofloxacin|mesh-list
93042737|NCT05173493|Tetracycline|tetracycline|mesh-list
93042738|NCT05173493|Furazolidone|furazolidone|mesh-list
93042739|NCT05173493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93042740|NCT05173493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042741|NCT05173493|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93042742|NCT05173493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93042743|NCT05173493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93042744|NCT05173493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262595|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
93042745|NCT05173493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042746|NCT05173493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042747|NCT05173493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93042748|NCT05173493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93042749|NCT05173493|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93042750|NCT05173493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93042751|NCT05173493|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93042752|NCT05173493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93042753|NCT05173493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93042754|NCT05173493|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
93042755|NCT03872843|Ibuprofen|ibuprofen|mesh-list
93042756|NCT03872843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93042757|NCT03872843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93042758|NCT03872843|Analgesics|analgesics|mesh-ancestor
93042759|NCT03872843|Sensory System Agents|sensory system agents|mesh-ancestor
93042760|NCT03872843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042761|NCT03872843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042762|NCT03872843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042763|NCT03872843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042764|NCT03872843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042765|NCT03872843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262953|NCT05535166|Alkylating Agents|alkylating agents|mesh-ancestor
93042766|NCT03872843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042767|NCT03966040|Vaccines|vaccines|mesh-list
93042768|NCT03966040|Immunologic Factors|immunologic factors|mesh-ancestor
93042769|NCT03966040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042770|NCT03999125|Dexamethasone|dexamethasone|mesh-list
93042771|NCT03999125|Dexamethasone acetate|dexamethasone acetate|mesh-list
92687992|NCT04325698|Bevacizumab|bevacizumab|mesh-list
92263033|NCT05233202|Simendan|simendan|mesh-list
93042772|NCT03999125|Ranibizumab|ranibizumab|mesh-list
93042773|NCT03999125|Aflibercept|aflibercept|mesh-list
93042774|NCT03999125|BB 1101|bb 1101|mesh-list
93042775|NCT03999125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042776|NCT03999125|Antiemetics|antiemetics|mesh-ancestor
93042777|NCT03999125|Autonomic Agents|autonomic agents|mesh-ancestor
93042778|NCT03999125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042779|NCT03999125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042780|NCT03999125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042781|NCT03999125|Glucocorticoids|glucocorticoids|mesh-ancestor
93042782|NCT03999125|Hormones|hormones|mesh-ancestor
93042783|NCT03999125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263183|NCT04717765|Vitamin E|vitamin e|mesh-list
93042784|NCT03999125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93042785|NCT03999125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042786|NCT03999125|Protease Inhibitors|protease inhibitors|mesh-ancestor
93042787|NCT03999125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042788|NCT03999125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042789|NCT03999125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93042790|NCT03999125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93042791|NCT03999125|Growth Substances|growth substances|mesh-ancestor
93042792|NCT03999125|Growth Inhibitors|growth inhibitors|mesh-ancestor
93042793|NCT00168064|Mechlorethamine|mechlorethamine|mesh-list
93042794|NCT00168064|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93042795|NCT00168064|Alkylating Agents|alkylating agents|mesh-ancestor
93042796|NCT00168064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042797|NCT00168064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92263306|NCT04207060|Tocolytic Agents|tocolytic agents|mesh-ancestor
93042798|NCT00168064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042799|NCT00166114|Desipramine|desipramine|mesh-list
93042800|NCT00166114|Escitalopram|escitalopram|mesh-list
93042801|NCT00166114|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93042802|NCT00166114|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92263376|NCT03899987|Aspirin|aspirin|mesh-list
93042803|NCT00166114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042804|NCT00166114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042805|NCT00166114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042806|NCT00166114|Serotonin Agents|serotonin agents|mesh-ancestor
93042807|NCT00166114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042808|NCT00166114|Antidepressive Agents|antidepressive agents|mesh-ancestor
93042809|NCT00166114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93042810|NCT00166114|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93042811|NCT00166114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042812|NCT00166114|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93042813|NCT00166114|Adrenergic Agents|adrenergic agents|mesh-ancestor
93042814|NCT05032781|Minocycline|minocycline|mesh-list
93042815|NCT05032781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93042816|NCT05032781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042817|NCT00129376|Cyclophosphamide|cyclophosphamide|mesh-list
93042818|NCT00129376|Docetaxel|docetaxel|mesh-list
93042819|NCT00129376|Doxorubicin|doxorubicin|mesh-list
93042820|NCT00129376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93042821|NCT00129376|Immunologic Factors|immunologic factors|mesh-ancestor
93042822|NCT00129376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042823|NCT00129376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042824|NCT00129376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93042825|NCT00129376|Alkylating Agents|alkylating agents|mesh-ancestor
93042826|NCT00129376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042827|NCT00129376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042828|NCT00129376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93042829|NCT00129376|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042830|NCT00129376|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042831|NCT00129376|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042832|NCT00129376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93042833|NCT00129376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92263797|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
93042834|NCT00129376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93042835|NCT00129376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042836|NCT04878107|Docetaxel|docetaxel|mesh-list
93042837|NCT04878107|Apatinib|apatinib|mesh-list
93042838|NCT04878107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042839|NCT04878107|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042840|NCT04878107|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042841|NCT04878107|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042842|NCT04878107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042843|NCT04878107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93042844|NCT04878107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042845|NCT03998969|Pantoprazole|pantoprazole|mesh-list
93042846|NCT03998969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93042847|NCT03998969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042848|NCT03998969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92688069|NCT00503451|Panobinostat|panobinostat|mesh-list
93042849|NCT03998969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042850|NCT03998969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042851|NCT00129220|Haloperidol|haloperidol|mesh-list
93042852|NCT00129220|Olanzapine|olanzapine|mesh-list
93042853|NCT00129220|Haloperidol decanoate|haloperidol decanoate|mesh-list
93042854|NCT00129220|Antiemetics|antiemetics|mesh-ancestor
93042855|NCT00129220|Autonomic Agents|autonomic agents|mesh-ancestor
93042856|NCT00129220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042857|NCT00129220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042858|NCT00129220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93042859|NCT00129220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93042860|NCT00129220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93042861|NCT00129220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042862|NCT00129220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93042863|NCT00129220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93042864|NCT00129220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93042865|NCT00129220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93042866|NCT00129220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042867|NCT00129220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042868|NCT00129220|Serotonin Agents|serotonin agents|mesh-ancestor
93042869|NCT00129220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93042870|NCT00129220|Dopamine Agents|dopamine agents|mesh-ancestor
93042871|NCT00129220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93042872|NCT03686813|Sildenafil Citrate|sildenafil citrate|mesh-list
92264436|NCT01720277|Vaccines|vaccines|mesh-list
93042873|NCT03686813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042874|NCT03686813|Vasodilator Agents|vasodilator agents|mesh-ancestor
93042875|NCT03686813|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93042876|NCT03686813|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93042877|NCT03686813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264506|NCT01234922|Lisinopril|lisinopril|mesh-list
93042878|NCT03686813|Urological Agents|urological agents|mesh-ancestor
93042879|NCT00128830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93042880|NCT00128830|Etravirine|etravirine|mesh-list
93042881|NCT00128830|Enfuvirtide|enfuvirtide|mesh-list
93042882|NCT00128830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93042883|NCT00128830|Protease Inhibitors|protease inhibitors|mesh-list
93042884|NCT00128830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93042885|NCT00128830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042886|NCT00128830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042887|NCT00128830|Antiviral Agents|antiviral agents|mesh-ancestor
93042888|NCT00128830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042889|NCT00128830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93042890|NCT00128830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92264723|NCT01742117|Clopidogrel|clopidogrel|mesh-list
93042891|NCT00128830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93042892|NCT00128830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93042893|NCT00128830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93042894|NCT01074892|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93042895|NCT01074892|Levonorgestrel|levonorgestrel|mesh-list
93042896|NCT01074892|Medroxyprogesterone|medroxyprogesterone|mesh-list
93042897|NCT01074892|Progestins|progestins|mesh-list
93042898|NCT01074892|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93042899|NCT01074892|Contraceptive Agents|contraceptive agents|mesh-ancestor
93042900|NCT01074892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93042901|NCT01074892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042902|NCT01074892|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93042903|NCT01074892|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93042904|NCT01074892|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93042905|NCT01074892|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93042906|NCT01074892|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93042907|NCT01074892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93042908|NCT01074892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042909|NCT01074892|Hormones|hormones|mesh-ancestor
93042910|NCT01074892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93042911|NCT00128206|Rifampin|rifampin|mesh-list
93042912|NCT00128206|Isoniazid|isoniazid|mesh-list
93042913|NCT00128206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93042914|NCT00128206|Antitubercular Agents|antitubercular agents|mesh-ancestor
93042915|NCT00128206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93042916|NCT00128206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93042917|NCT00128206|Leprostatic Agents|leprostatic agents|mesh-ancestor
93042918|NCT00128206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93042919|NCT00128206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042920|NCT00128206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042921|NCT00128206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92688144|NCT00494715|Valsartan|valsartan|mesh-list
92265068|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93042922|NCT00128206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93042923|NCT00128206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92265140|NCT04522167|Growth Substances|growth substances|mesh-ancestor
93042924|NCT00128206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93042925|NCT00128206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93042926|NCT00128206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93042927|NCT00128206|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93042928|NCT00128206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93042929|NCT00128206|Antimetabolites|antimetabolites|mesh-ancestor
92265212|NCT01750931|Meloxicam|meloxicam|mesh-list
93042930|NCT00128206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93042931|NCT01075828|Cetuximab|cetuximab|mesh-list
93042932|NCT01075828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93042933|NCT01075828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042934|NCT01074970|Cisplatin|cisplatin|mesh-list
93042935|NCT01074970|Rucaparib|rucaparib|mesh-list
93042936|NCT01074970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042937|NCT01074970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93042938|NCT01074970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265275|NCT01250834|Atorvastatin|atorvastatin|mesh-list
93042939|NCT01074970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042940|NCT03968146|Acetaminophen|acetaminophen|mesh-list
93042941|NCT03968146|Ketorolac|ketorolac|mesh-list
93042942|NCT03968146|Fentanyl|fentanyl|mesh-list
93042943|NCT03968146|Meperidine|meperidine|mesh-list
93042944|NCT03968146|Morphine|morphine|mesh-list
93042945|NCT03968146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93042946|NCT03968146|Narcotics|narcotics|mesh-ancestor
92265343|NCT01754909|Enalapril|enalapril|mesh-list
93042947|NCT03968146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042948|NCT03968146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042949|NCT03968146|Analgesics|analgesics|mesh-ancestor
93042950|NCT03968146|Sensory System Agents|sensory system agents|mesh-ancestor
93042951|NCT03968146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93042952|NCT03968146|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92265421|NCT01757561|Propofol|propofol|mesh-list
93042953|NCT03968146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93042954|NCT03968146|Anesthetics, General|anesthetics, general|mesh-ancestor
93042955|NCT03968146|Anesthetics|anesthetics|mesh-ancestor
93042956|NCT03968146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93042957|NCT03968146|Antipyretics|antipyretics|mesh-ancestor
93042958|NCT03968146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93042959|NCT03968146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93042960|NCT03968146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042961|NCT03968146|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93042962|NCT03968146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042963|NCT03968146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042964|NCT03966118|Paclitaxel|paclitaxel|mesh-list
93042965|NCT03966118|Avelumab|avelumab|mesh-list
93042966|NCT03966118|Ramucirumab|ramucirumab|mesh-list
93042967|NCT03966118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93042968|NCT03966118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93042969|NCT03966118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93042970|NCT03966118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93042971|NCT03966118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93042972|NCT03966118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042973|NCT03966118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93042974|NCT03968224|Metformin|metformin|mesh-list
93042975|NCT03968224|Dapagliflozin|dapagliflozin|mesh-list
93042976|NCT03968224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93042977|NCT03968224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042978|NCT03968224|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93042979|NCT03968224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042980|NCT01075126|Valproic Acid|valproic acid|mesh-list
93042981|NCT01075126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93042982|NCT01075126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042983|NCT01075126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93042984|NCT01075126|Antimanic Agents|antimanic agents|mesh-ancestor
93042985|NCT01075126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93042986|NCT01075126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93042987|NCT01075126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93042988|NCT01075126|Anticonvulsants|anticonvulsants|mesh-ancestor
93042989|NCT01075126|GABA Agents|gaba agents|mesh-ancestor
93042990|NCT01075126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93042991|NCT03823378|Upadacitinib|upadacitinib|mesh-list
93042992|NCT03823378|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93042993|NCT03823378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93042994|NCT03823378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93042995|NCT03823378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688221|NCT00494832|Dexmedetomidine|dexmedetomidine|mesh-list
93042996|NCT03823378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93042997|NCT00141778|Ramipril|ramipril|mesh-list
93042998|NCT00141778|Spironolactone|spironolactone|mesh-list
93042999|NCT00141778|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
93043000|NCT00141778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92265961|NCT02631525|Propofol|propofol|mesh-list
93043001|NCT00141778|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93043002|NCT00141778|Mineralocorticoids|mineralocorticoids|mesh-list
93043003|NCT00141778|Hormone Antagonists|hormone antagonists|mesh-ancestor
93043004|NCT00141778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043005|NCT00141778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043006|NCT00141778|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93043007|NCT00141778|Diuretics|diuretics|mesh-ancestor
93043008|NCT00141778|Natriuretic Agents|natriuretic agents|mesh-ancestor
93043009|NCT00141778|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043010|NCT00141778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043011|NCT00141778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93043012|NCT00141778|Hormones|hormones|mesh-ancestor
93043013|NCT01079884|Esomeprazole|esomeprazole|mesh-list
93043014|NCT01079884|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93043015|NCT01079884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266251|NCT01267136|Acetaminophen|acetaminophen|mesh-list
93043016|NCT01079884|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93043017|NCT01079884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043018|NCT01079884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043019|NCT01075906|Colchicine|colchicine|mesh-list
93043020|NCT01075906|Gout Suppressants|gout suppressants|mesh-ancestor
93043021|NCT01075906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043022|NCT01075906|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043023|NCT01075906|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043024|NCT01075906|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043025|NCT01075906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266464|NCT01332578|Vitamins|vitamins|mesh-ancestor
93043026|NCT01075906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043027|NCT01076062|Misoprostol|misoprostol|mesh-list
93043028|NCT01076062|Oxytocin|oxytocin|mesh-list
93043029|NCT01076062|Oxytocics|oxytocics|mesh-ancestor
93043030|NCT01076062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93043031|NCT01076062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043032|NCT01076062|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93043033|NCT01076062|Abortifacient Agents|abortifacient agents|mesh-ancestor
93043034|NCT01076062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93043035|NCT01076062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93043036|NCT00115336|Ibuprofen|ibuprofen|mesh-list
93043037|NCT00115336|Ketorolac|ketorolac|mesh-list
93043038|NCT00115336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93043039|NCT00115336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93043040|NCT00115336|Analgesics|analgesics|mesh-ancestor
93043041|NCT00115336|Sensory System Agents|sensory system agents|mesh-ancestor
93043042|NCT00115336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043043|NCT00115336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043044|NCT00115336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043045|NCT00115336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043046|NCT00115336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93043047|NCT00115336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043048|NCT00115336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043049|NCT01076140|Lisinopril|lisinopril|mesh-list
93043050|NCT01076140|Nebivolol|nebivolol|mesh-list
93043051|NCT01076140|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93043052|NCT01076140|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043053|NCT01076140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043054|NCT01076140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043055|NCT01076140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93043056|NCT01076140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93043057|NCT01076140|Protective Agents|protective agents|mesh-ancestor
93043058|NCT01076140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043059|NCT01076140|Vasodilator Agents|vasodilator agents|mesh-ancestor
93043060|NCT01076140|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93043061|NCT01076140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93043062|NCT01076140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93043063|NCT01076140|Adrenergic Agents|adrenergic agents|mesh-ancestor
93043064|NCT01076140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043065|NCT00205803|Vaccines|vaccines|mesh-list
93043066|NCT00205803|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92267107|NCT05327309|Bleomycin|bleomycin|mesh-list
93043067|NCT00205803|Immunologic Factors|immunologic factors|mesh-ancestor
93043068|NCT00205803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043069|NCT00127192|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93043070|NCT00127192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93043071|NCT00127192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043072|NCT00127192|Incretins|incretins|mesh-ancestor
92267246|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92267318|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
93043074|NCT00127192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043075|NCT00127192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93043076|NCT00127192|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043077|NCT00127192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043078|NCT00127192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043079|NCT00127036|Bevacizumab|bevacizumab|mesh-list
93043080|NCT00127036|Capecitabine|capecitabine|mesh-list
93043081|NCT00127036|Oxaliplatin|oxaliplatin|mesh-list
93043082|NCT00127036|Irinotecan|irinotecan|mesh-list
92267540|NCT02731833|Fluorides|fluorides|mesh-list
93043083|NCT00127036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043084|NCT00127036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043085|NCT00127036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93043086|NCT00127036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043087|NCT00127036|Growth Substances|growth substances|mesh-ancestor
93043088|NCT00127036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043089|NCT00127036|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043090|NCT00127036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043091|NCT00127036|Antimetabolites|antimetabolites|mesh-ancestor
93043092|NCT00127036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043093|NCT00127036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93043094|NCT00127036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043095|NCT00127036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043096|NCT00259857|Alendronate|alendronate|mesh-list
93043097|NCT00259857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93043098|NCT00259857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043099|NCT01071681|Telmisartan|telmisartan|mesh-list
93043100|NCT01071681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92529254|NCT00396760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043101|NCT01071681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93043102|NCT01071681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93043103|NCT01071681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043104|NCT00203307|Olanzapine|olanzapine|mesh-list
93043105|NCT00203307|Antiemetics|antiemetics|mesh-ancestor
93043106|NCT00203307|Autonomic Agents|autonomic agents|mesh-ancestor
92267890|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
93043107|NCT00203307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043108|NCT00203307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043109|NCT00203307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93043110|NCT00203307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93043111|NCT00203307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93043112|NCT00203307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93043113|NCT00203307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043114|NCT00203307|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93043115|NCT00203307|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93043116|NCT00203307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93043117|NCT00203307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043118|NCT00203307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043119|NCT00203307|Serotonin Agents|serotonin agents|mesh-ancestor
93043120|NCT00126568|Sorafenib|sorafenib|mesh-list
93043121|NCT00126568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043122|NCT00126568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93043123|NCT00126568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268098|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043124|NCT00126568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043125|NCT00202839|Ribavirin|ribavirin|mesh-list
93043126|NCT00202839|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93043127|NCT00202839|Interferon-alpha|interferon-alpha|mesh-list
93043128|NCT00202839|Antimetabolites|antimetabolites|mesh-ancestor
93043129|NCT00202839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043130|NCT00202839|Antiviral Agents|antiviral agents|mesh-ancestor
93043131|NCT00202839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043132|NCT00202839|Immunologic Factors|immunologic factors|mesh-ancestor
93043133|NCT00202839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043134|NCT00126490|Aldesleukin|aldesleukin|mesh-list
93043135|NCT00126490|Bevacizumab|bevacizumab|mesh-list
93043136|NCT00126490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93043137|NCT00126490|Interleukin-2|interleukin-2|mesh-list
93043138|NCT00126490|Endothelial Growth Factors|endothelial growth factors|mesh-list
93043139|NCT00126490|Antibodies|antibodies|mesh-list
93043140|NCT00126490|Immunoglobulins|immunoglobulins|mesh-list
93043141|NCT00126490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93043142|NCT00126490|Immunoglobulin G|immunoglobulin g|mesh-list
93043143|NCT00126490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043144|NCT00126490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93043145|NCT00126490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043146|NCT00126490|Growth Substances|growth substances|mesh-ancestor
93043147|NCT00126490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043148|NCT00126490|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043149|NCT00126490|Immunologic Factors|immunologic factors|mesh-ancestor
93043150|NCT00126490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92268603|NCT02213900|Haloperidol|haloperidol|mesh-list
93043152|NCT00126490|Sensory System Agents|sensory system agents|mesh-ancestor
93043153|NCT00126490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043154|NCT00126490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93043155|NCT00126490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93043156|NCT00126490|Antiviral Agents|antiviral agents|mesh-ancestor
93043157|NCT00126490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043158|NCT00200967|Beclomethasone|beclomethasone|mesh-list
93043159|NCT00200967|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93043160|NCT00200967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93043161|NCT00200967|Autonomic Agents|autonomic agents|mesh-ancestor
93043162|NCT00200967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043163|NCT00200967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043164|NCT00200967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93043165|NCT00200967|Respiratory System Agents|respiratory system agents|mesh-ancestor
93043166|NCT00200967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93043167|NCT00200967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93043168|NCT00200967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93043169|NCT00200967|Adrenergic Agents|adrenergic agents|mesh-ancestor
93043170|NCT00200967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043171|NCT00200967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043172|NCT00200967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043173|NCT00200967|Glucocorticoids|glucocorticoids|mesh-ancestor
93043174|NCT00200967|Hormones|hormones|mesh-ancestor
92529255|NCT00396760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043175|NCT00200967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043176|NCT02533440|Anesthetics|anesthetics|mesh-list
93043177|NCT02533440|Anesthetics, Local|anesthetics, local|mesh-list
92268928|NCT00370539|Hormones|hormones|mesh-ancestor
93043178|NCT02533440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93043179|NCT02533440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043180|NCT02533440|Sensory System Agents|sensory system agents|mesh-ancestor
93043181|NCT02533440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043182|NCT00354432|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93043183|NCT00354432|Caseins|caseins|mesh-list
93043184|NCT00354432|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93043185|NCT00354432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93043186|NCT00354432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93043187|NCT00354432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043188|NCT00354432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043189|NCT00354432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043190|NCT00354432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93043191|NCT00354432|Antidepressive Agents|antidepressive agents|mesh-ancestor
93043192|NCT00354432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043193|NCT00354432|Chelating Agents|chelating agents|mesh-ancestor
93043194|NCT00354432|Sequestering Agents|sequestering agents|mesh-ancestor
93043195|NCT00140140|Paclitaxel|paclitaxel|mesh-list
93043196|NCT00140140|Vinorelbine|vinorelbine|mesh-list
93043197|NCT00140140|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93043198|NCT00140140|Trastuzumab|trastuzumab|mesh-list
93043199|NCT00140140|Lenograstim|lenograstim|mesh-list
92269077|NCT02347332|Dermatologic Agents|dermatologic agents|mesh-ancestor
93043200|NCT00140140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043201|NCT00140140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043202|NCT00140140|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043203|NCT00140140|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043204|NCT00140140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269144|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043205|NCT00140140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043206|NCT00140140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043207|NCT00140140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93043208|NCT00140140|Immunologic Factors|immunologic factors|mesh-ancestor
93043209|NCT00140140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043210|NCT00346398|Immunomodulating Agents|immunomodulating agents|mesh-list
93043211|NCT00346398|Immunologic Factors|immunologic factors|mesh-ancestor
93043212|NCT00346398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043213|NCT00346164|Doxorubicin|doxorubicin|mesh-list
92269290|NCT01558700|Analgesics|analgesics|mesh-ancestor
93043214|NCT00346164|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93043215|NCT00346164|Ifosfamide|ifosfamide|mesh-list
93043216|NCT00346164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93043217|NCT00346164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043218|NCT00346164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043219|NCT00346164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043220|NCT00346164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043221|NCT00346164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269360|NCT02762331|Vitamins|vitamins|mesh-ancestor
93043222|NCT00346164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93043223|NCT00346164|Alkylating Agents|alkylating agents|mesh-ancestor
92529256|NCT00001007|Zidovudine|zidovudine|mesh-list
93043224|NCT01052298|Ciprofloxacin|ciprofloxacin|mesh-list
93043225|NCT01052298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93043226|NCT01052298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043227|NCT01052298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043228|NCT01052298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043229|NCT01052298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043230|NCT01052298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043231|NCT01052298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043232|NCT01052298|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93043233|NCT01052298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93043234|NCT00114244|Gemcitabine|gemcitabine|mesh-list
93043235|NCT00114244|Sorafenib|sorafenib|mesh-list
92269633|NCT04080843|Capecitabine|capecitabine|mesh-list
93043236|NCT00114244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043237|NCT00114244|Antimetabolites|antimetabolites|mesh-ancestor
93043238|NCT00114244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043239|NCT00114244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043240|NCT00114244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92269773|NCT01516268|Sufentanil|sufentanil|mesh-list
93043241|NCT00114244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043242|NCT01054872|Vaccines|vaccines|mesh-list
93043243|NCT01054872|Immunologic Factors|immunologic factors|mesh-ancestor
93043244|NCT01054872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043245|NCT00337662|Olanzapine|olanzapine|mesh-list
93043246|NCT00337662|Risperidone|risperidone|mesh-list
93043247|NCT00337662|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93043248|NCT00337662|Serotonin Agents|serotonin agents|mesh-ancestor
93043249|NCT00337662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043250|NCT00337662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043251|NCT00337662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043252|NCT00337662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93043253|NCT00337662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93043254|NCT00337662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93043255|NCT00337662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043256|NCT00337662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93043257|NCT00337662|Dopamine Agents|dopamine agents|mesh-ancestor
93043258|NCT00337662|Antiemetics|antiemetics|mesh-ancestor
93043259|NCT00337662|Autonomic Agents|autonomic agents|mesh-ancestor
93043260|NCT00337662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043261|NCT00337662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93043262|NCT00337662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93043263|NCT00337662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92270071|NCT01576952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043264|NCT00337662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93043265|NCT00138424|Cidofovir|cidofovir|mesh-list
93043266|NCT00138424|Antiviral Agents|antiviral agents|mesh-ancestor
93043267|NCT00138424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043268|NCT00138424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043269|NCT00138424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043270|NCT00368966|Vaccines|vaccines|mesh-list
92270131|NCT02803749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043271|NCT00368966|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93043272|NCT00368966|Immunologic Factors|immunologic factors|mesh-ancestor
93043273|NCT00368966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043274|NCT00114166|Topotecan|topotecan|mesh-list
93043275|NCT00114166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93043276|NCT00114166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043277|NCT00114166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043278|NCT00114166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043279|NCT00114166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043280|NCT00337428|Vaccines|vaccines|mesh-list
93043281|NCT00337428|Immunologic Factors|immunologic factors|mesh-ancestor
93043282|NCT00337428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043283|NCT00235989|Interferons|interferons|mesh-list
93043284|NCT00235989|Interferon-beta|interferon-beta|mesh-list
93043285|NCT00235989|Interferon beta-1b|interferon beta-1b|mesh-list
93043286|NCT00235989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043287|NCT00235989|Antiviral Agents|antiviral agents|mesh-ancestor
92270478|NCT01536938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93043288|NCT00235989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043289|NCT00235989|Immunologic Factors|immunologic factors|mesh-ancestor
93043290|NCT00235989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043291|NCT00235989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93043292|NCT00113386|Docetaxel|docetaxel|mesh-list
93043293|NCT00113386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043294|NCT00113386|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688517|NCT01247493|Antimetabolites|antimetabolites|mesh-ancestor
93043295|NCT00113386|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043296|NCT00113386|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043297|NCT00113386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043299|NCT00353262|Oxaliplatin|oxaliplatin|mesh-list
93043300|NCT00353262|Bevacizumab|bevacizumab|mesh-list
93043301|NCT00353262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043302|NCT00353262|Antimetabolites|antimetabolites|mesh-ancestor
93043303|NCT00353262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043304|NCT00353262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043305|NCT00353262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043306|NCT00353262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92270634|NCT00551291|Hematinics|hematinics|mesh-ancestor
93043307|NCT00353262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043308|NCT00353262|Growth Substances|growth substances|mesh-ancestor
93043309|NCT00353262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043310|NCT00353262|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043311|NCT00125164|Mecasermin|mecasermin|mesh-list
93043312|NCT00125164|Growth Substances|growth substances|mesh-ancestor
93043313|NCT00125164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043314|NCT03985410|Moxifloxacin|moxifloxacin|mesh-list
93043315|NCT03985410|Durlobactam|durlobactam|mesh-list
93043316|NCT03985410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92270758|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
93043317|NCT03985410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043318|NCT03985410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043319|NCT03985410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043320|NCT03985410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043321|NCT03985410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043322|NCT03985410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043323|NCT03985410|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93043324|NCT00136318|Ribavirin|ribavirin|mesh-list
93043325|NCT00136318|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93043326|NCT00136318|Escitalopram|escitalopram|mesh-list
93043327|NCT00136318|Antimetabolites|antimetabolites|mesh-ancestor
93043328|NCT00136318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043329|NCT00136318|Antiviral Agents|antiviral agents|mesh-ancestor
93043330|NCT00136318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043331|NCT00136318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93043332|NCT00136318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92271118|NCT01880723|Adrenergic Agents|adrenergic agents|mesh-ancestor
93043333|NCT00136318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93043334|NCT00136318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043335|NCT00136318|Serotonin Agents|serotonin agents|mesh-ancestor
93043336|NCT00136318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043337|NCT01058850|Rindopepimut|rindopepimut|mesh-list
93043338|NCT01058850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271194|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
93043339|NCT01058850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043340|NCT00136084|Cytarabine|cytarabine|mesh-list
93043341|NCT00136084|Dexamethasone|dexamethasone|mesh-list
93043342|NCT00136084|Prednisone|prednisone|mesh-list
93043343|NCT00136084|Cyclophosphamide|cyclophosphamide|mesh-list
93043344|NCT00136084|Methotrexate|methotrexate|mesh-list
93043345|NCT00136084|Etoposide|etoposide|mesh-list
93043346|NCT00136084|Vincristine|vincristine|mesh-list
93043347|NCT00136084|Daunorubicin|daunorubicin|mesh-list
93043348|NCT00136084|Asparaginase|asparaginase|mesh-list
93043349|NCT00136084|Mitoxantrone|mitoxantrone|mesh-list
93043350|NCT00136084|Mercaptopurine|mercaptopurine|mesh-list
93043351|NCT00136084|Cladribine|cladribine|mesh-list
93043352|NCT00136084|Gemtuzumab|gemtuzumab|mesh-list
93043353|NCT00136084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043354|NCT00136084|Immunologic Factors|immunologic factors|mesh-ancestor
93043355|NCT00136084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043356|NCT00136084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043357|NCT00136084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93043358|NCT00136084|Alkylating Agents|alkylating agents|mesh-ancestor
93043359|NCT00136084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043360|NCT00136084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043361|NCT00136084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93043362|NCT00136084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043363|NCT00136084|Antiemetics|antiemetics|mesh-ancestor
93043364|NCT00136084|Autonomic Agents|autonomic agents|mesh-ancestor
93043365|NCT00136084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043366|NCT00136084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93043367|NCT00136084|Glucocorticoids|glucocorticoids|mesh-ancestor
93043368|NCT00136084|Hormones|hormones|mesh-ancestor
93043369|NCT00136084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271687|NCT04976777|Dexamethasone|dexamethasone|mesh-list
93043370|NCT00136084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92688595|NCT00478907|GABA Agents|gaba agents|mesh-ancestor
93043371|NCT00136084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93043372|NCT00136084|Abortifacient Agents|abortifacient agents|mesh-ancestor
92271759|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93043373|NCT00136084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93043374|NCT00136084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043375|NCT00136084|Antimetabolites|antimetabolites|mesh-ancestor
93043376|NCT00136084|Dermatologic Agents|dermatologic agents|mesh-ancestor
93043377|NCT00136084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043378|NCT00136084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93043379|NCT00136084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93043380|NCT00136084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043381|NCT00136084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043382|NCT00136084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043383|NCT00136084|Antiviral Agents|antiviral agents|mesh-ancestor
93043384|NCT00136084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043385|NCT00136084|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043386|NCT00136084|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043387|NCT00136084|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043388|NCT00136084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93043389|NCT00136084|Analgesics|analgesics|mesh-ancestor
93043390|NCT00136084|Sensory System Agents|sensory system agents|mesh-ancestor
93043391|NCT00136084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043392|NCT00136084|Immunotoxins|immunotoxins|mesh-ancestor
93043393|NCT00136084|Immunoconjugates|immunoconjugates|mesh-ancestor
93043394|NCT00364832|Epoetin Alfa|epoetin alfa|mesh-list
93043395|NCT00364832|Hematinics|hematinics|mesh-ancestor
93043396|NCT00235755|Ezogabine|ezogabine|mesh-list
93043397|NCT00235755|Anticonvulsants|anticonvulsants|mesh-ancestor
93043398|NCT00235755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93043399|NCT00235755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043400|NCT01581879|Ziprasidone|ziprasidone|mesh-list
93043401|NCT01581879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93043402|NCT01581879|Serotonin Agents|serotonin agents|mesh-ancestor
93043403|NCT01581879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043404|NCT01581879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043405|NCT01581879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043406|NCT01581879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93043407|NCT01581879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93043408|NCT01581879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93043409|NCT01581879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043410|NCT01581879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93043411|NCT01581879|Dopamine Agents|dopamine agents|mesh-ancestor
93043412|NCT00337194|Gemcitabine|gemcitabine|mesh-list
93043413|NCT00337194|Doxorubicin|doxorubicin|mesh-list
93043414|NCT00337194|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93043415|NCT00337194|Vinorelbine|vinorelbine|mesh-list
93043416|NCT00337194|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93043417|NCT00337194|Antibodies|antibodies|mesh-list
93043418|NCT00337194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93043419|NCT00337194|Immunologic Factors|immunologic factors|mesh-ancestor
93043420|NCT00337194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043421|NCT00337194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043422|NCT00337194|Antimetabolites|antimetabolites|mesh-ancestor
93043423|NCT00337194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043424|NCT00337194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043425|NCT00337194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93043426|NCT00337194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043427|NCT00337194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043428|NCT00337194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043429|NCT00337194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043430|NCT00337194|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043431|NCT00337194|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043432|NCT00337194|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043433|NCT00337194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043434|NCT00337194|Immunotoxins|immunotoxins|mesh-ancestor
93043435|NCT00337194|Immunoconjugates|immunoconjugates|mesh-ancestor
93043436|NCT01074021|Nimotuzumab|nimotuzumab|mesh-list
93043437|NCT01074021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043438|NCT01074021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043439|NCT01074333|Cetuximab|cetuximab|mesh-list
93043440|NCT01074333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043441|NCT01074333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043442|NCT00385736|Adalimumab|adalimumab|mesh-list
93043443|NCT00385736|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93043444|NCT00385736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043445|NCT00385736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043446|NCT01057212|Bevacizumab|bevacizumab|mesh-list
93043447|NCT01057212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043448|NCT01057212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043449|NCT01057212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93043450|NCT01057212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043451|NCT01057212|Growth Substances|growth substances|mesh-ancestor
93043452|NCT01057212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043453|NCT01057212|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043455|NCT03988452|Darunavir|darunavir|mesh-list
93043456|NCT03988452|Tenofovir|tenofovir|mesh-list
93043457|NCT03988452|Lamivudine|lamivudine|mesh-list
93043458|NCT03988452|Zidovudine|zidovudine|mesh-list
93043459|NCT03988452|Dolutegravir|dolutegravir|mesh-list
93043460|NCT03988452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93043461|NCT03988452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93043462|NCT03988452|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043463|NCT03988452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043464|NCT03988452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043465|NCT03988452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93043466|NCT03988452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93043467|NCT03988452|Antiviral Agents|antiviral agents|mesh-ancestor
92273035|NCT05316935|Letrozole|letrozole|mesh-list
93043468|NCT03988452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043469|NCT03988452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93043470|NCT03988452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93043471|NCT03988452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93043472|NCT03988452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93043473|NCT03988452|Antimetabolites|antimetabolites|mesh-ancestor
93043474|NCT03988452|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93043475|NCT03988452|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93043476|NCT01048580|Capecitabine|capecitabine|mesh-list
93043477|NCT01048580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043478|NCT01048580|Antimetabolites|antimetabolites|mesh-ancestor
93043479|NCT01048580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043480|NCT01048580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043481|NCT00195819|Adalimumab|adalimumab|mesh-list
93043482|NCT00195819|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92273247|NCT01619774|Trametinib|trametinib|mesh-list
93043483|NCT00195819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043484|NCT00195819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043485|NCT00527735|Paclitaxel|paclitaxel|mesh-list
93043486|NCT00527735|Carboplatin|carboplatin|mesh-list
93043487|NCT00527735|Ipilimumab|ipilimumab|mesh-list
93043488|NCT00527735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043489|NCT00527735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043490|NCT00527735|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043491|NCT00527735|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043492|NCT00527735|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043493|NCT00527735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043494|NCT00527735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043495|NCT00527735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93043496|NCT00336492|Infliximab|infliximab|mesh-list
93043497|NCT00336492|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93043498|NCT00336492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043499|NCT00336492|Dermatologic Agents|dermatologic agents|mesh-ancestor
93043500|NCT00336492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93043501|NCT00336492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043502|NCT00194025|Valproic Acid|valproic acid|mesh-list
93043503|NCT00194025|Anticonvulsants|anticonvulsants|mesh-ancestor
93043504|NCT00194025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043505|NCT00194025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043506|NCT00194025|GABA Agents|gaba agents|mesh-ancestor
93043507|NCT00194025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043508|NCT00194025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043509|NCT00194025|Antimanic Agents|antimanic agents|mesh-ancestor
92273519|NCT03471663|Palbociclib|palbociclib|mesh-list
93043510|NCT00194025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93043511|NCT00194025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93043512|NCT00194025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93043513|NCT00521339|Apremilast|apremilast|mesh-list
92273601|NCT03282669|Morphine|morphine|mesh-list
93043514|NCT00521339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93043515|NCT00521339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93043516|NCT00521339|Analgesics|analgesics|mesh-ancestor
93043517|NCT00521339|Sensory System Agents|sensory system agents|mesh-ancestor
93043518|NCT00521339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043519|NCT00521339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043520|NCT00521339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043521|NCT00521339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043522|NCT00521339|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93043523|NCT00521339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92273802|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
93043524|NCT00521339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043525|NCT00521339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043526|NCT00363896|Bromides|bromides|mesh-list
93043527|NCT00363896|Anticonvulsants|anticonvulsants|mesh-ancestor
93043528|NCT00527423|Aflibercept|aflibercept|mesh-list
93043529|NCT00527423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93043530|NCT00527423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043531|NCT00527423|Growth Substances|growth substances|mesh-ancestor
93043532|NCT00527423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043533|NCT00527423|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043534|NCT00527423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043535|NCT00527111|Fluorouracil|fluorouracil|mesh-list
93043536|NCT00527111|Cetuximab|cetuximab|mesh-list
93043537|NCT00527111|Antimetabolites|antimetabolites|mesh-ancestor
93043538|NCT00527111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043539|NCT00527111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043540|NCT00527111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043541|NCT00527111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043542|NCT00527111|Immunologic Factors|immunologic factors|mesh-ancestor
93043543|NCT00527111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043544|NCT00527111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043545|NCT00336024|Leucovorin|leucovorin|mesh-list
93043546|NCT00336024|Cyclophosphamide|cyclophosphamide|mesh-list
93043547|NCT00336024|Thiotepa|thiotepa|mesh-list
93043548|NCT00336024|Carboplatin|carboplatin|mesh-list
93043549|NCT00336024|Methotrexate|methotrexate|mesh-list
93043550|NCT00336024|Etoposide|etoposide|mesh-list
93043551|NCT00336024|Vincristine|vincristine|mesh-list
93043552|NCT00336024|Etoposide phosphate|etoposide phosphate|mesh-list
93043553|NCT00336024|Levoleucovorin|levoleucovorin|mesh-list
93043554|NCT00336024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043555|NCT00336024|Immunologic Factors|immunologic factors|mesh-ancestor
92274225|NCT03226899|Colchicine|colchicine|mesh-list
93043556|NCT00336024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043557|NCT00336024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043558|NCT00336024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93043559|NCT00336024|Alkylating Agents|alkylating agents|mesh-ancestor
93043560|NCT00336024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043561|NCT00336024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043562|NCT00336024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93043563|NCT00336024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93043564|NCT00336024|Abortifacient Agents|abortifacient agents|mesh-ancestor
93043565|NCT00336024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93043566|NCT00336024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043567|NCT00336024|Antimetabolites|antimetabolites|mesh-ancestor
93043568|NCT00336024|Dermatologic Agents|dermatologic agents|mesh-ancestor
93043569|NCT00336024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043570|NCT00336024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93043571|NCT00336024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93043572|NCT00336024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043573|NCT00336024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043574|NCT00336024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043575|NCT00336024|Antidotes|antidotes|mesh-ancestor
93043576|NCT00336024|Protective Agents|protective agents|mesh-ancestor
93043577|NCT00336024|Vitamin B Complex|vitamin b complex|mesh-ancestor
93043578|NCT00336024|Vitamins|vitamins|mesh-ancestor
93043579|NCT00336024|Micronutrients|micronutrients|mesh-ancestor
93043580|NCT00336024|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043581|NCT00336024|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043582|NCT00336024|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043583|NCT00384956|Azacitidine|azacitidine|mesh-list
93043584|NCT00384956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043585|NCT00384956|Antimetabolites|antimetabolites|mesh-ancestor
93043586|NCT00384956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043587|NCT00384956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043588|NCT00384956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043589|NCT04090697|Oxandrolone|oxandrolone|mesh-list
93043590|NCT04090697|Androgens|androgens|mesh-ancestor
93043591|NCT04090697|Hormones|hormones|mesh-ancestor
93043592|NCT04090697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043593|NCT04090697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043594|NCT04090697|Anabolic Agents|anabolic agents|mesh-ancestor
93043595|NCT00367640|Immunomodulating Agents|immunomodulating agents|mesh-list
93043596|NCT00367640|Immunologic Factors|immunologic factors|mesh-list
93043597|NCT00367640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043598|NCT01325220|Baclofen|baclofen|mesh-list
93043599|NCT01325220|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93043600|NCT01325220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043601|NCT01325220|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92274781|NCT02013245|Vaccines|vaccines|mesh-list
93043602|NCT01325220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043603|NCT01325220|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93043604|NCT01325220|GABA Agonists|gaba agonists|mesh-ancestor
93043605|NCT01325220|GABA Agents|gaba agents|mesh-ancestor
92274850|NCT01717742|Plasminogen|plasminogen|mesh-list
93043606|NCT01325220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043607|NCT01325220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043608|NCT00367484|Interferons|interferons|mesh-list
93043609|NCT00367484|Interferon-beta|interferon-beta|mesh-list
93043610|NCT00367484|Interferon beta-1a|interferon beta-1a|mesh-list
93043611|NCT00367484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043612|NCT00367484|Antiviral Agents|antiviral agents|mesh-ancestor
93043613|NCT00367484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043614|NCT00367484|Immunologic Factors|immunologic factors|mesh-ancestor
93043615|NCT00367484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043616|NCT00367484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93043617|NCT00526799|Sorafenib|sorafenib|mesh-list
93043618|NCT00526799|Topotecan|topotecan|mesh-list
93043619|NCT00526799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043620|NCT00526799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93043621|NCT00526799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043622|NCT00526799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043623|NCT00526799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93043624|NCT00526799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043625|NCT01059084|Valacyclovir|valacyclovir|mesh-list
93043626|NCT01059084|Antiviral Agents|antiviral agents|mesh-ancestor
93043627|NCT01059084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043628|NCT03992144|Amoxicillin|amoxicillin|mesh-list
93043629|NCT03992144|Metronidazole|metronidazole|mesh-list
93043630|NCT03992144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93043631|NCT03992144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043632|NCT03992144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93043633|NCT03992144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93043634|NCT02534870|Ritonavir|ritonavir|mesh-list
92275125|NCT02044367|Dabigatran|dabigatran|mesh-list
93043635|NCT02534870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93043636|NCT02534870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93043637|NCT02534870|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043638|NCT02534870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043639|NCT02534870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043640|NCT02534870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92275202|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
93043641|NCT02534870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93043642|NCT02534870|Antiviral Agents|antiviral agents|mesh-ancestor
93043643|NCT02534870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043644|NCT02534870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93043645|NCT02534870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93043646|NCT03992066|Epoetin Alfa|epoetin alfa|mesh-list
93043647|NCT03992066|Darbepoetin alfa|darbepoetin alfa|mesh-list
93043648|NCT03992066|Hematinics|hematinics|mesh-ancestor
93043649|NCT03986268|Vitamin D|vitamin d|mesh-list
93043650|NCT03986268|Cholecalciferol|cholecalciferol|mesh-list
93043651|NCT03986268|Vitamins|vitamins|mesh-ancestor
93043652|NCT03986268|Micronutrients|micronutrients|mesh-ancestor
93043653|NCT03986268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043654|NCT03986268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92275336|NCT02052635|Purinergic Agents|purinergic agents|mesh-ancestor
93043655|NCT03986268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93043656|NCT01048892|Cyclophosphamide|cyclophosphamide|mesh-list
92275404|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
93043657|NCT01048892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043658|NCT01048892|Immunologic Factors|immunologic factors|mesh-ancestor
93043659|NCT01048892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043660|NCT01048892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043661|NCT01048892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93043662|NCT01048892|Alkylating Agents|alkylating agents|mesh-ancestor
93043663|NCT01048892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043664|NCT01048892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043665|NCT01048892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93043666|NCT01259648|Remifentanil|remifentanil|mesh-list
93043667|NCT01259648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93043668|NCT01259648|Narcotics|narcotics|mesh-ancestor
93043669|NCT01259648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93043670|NCT01259648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043671|NCT01259648|Analgesics|analgesics|mesh-ancestor
92275547|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
93043672|NCT01259648|Sensory System Agents|sensory system agents|mesh-ancestor
93043673|NCT01259648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93043675|NCT01049048|Cholecalciferol|cholecalciferol|mesh-list
93043676|NCT01049048|Vitamins|vitamins|mesh-ancestor
93043677|NCT01049048|Micronutrients|micronutrients|mesh-ancestor
93043678|NCT01049048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928532|NCT02742649|Timolol|timolol|mesh-list
93043679|NCT01049048|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93043680|NCT01049048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93043681|NCT00520481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93043682|NCT00520481|Immunologic Factors|immunologic factors|mesh-ancestor
93043683|NCT00520481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043684|NCT01044992|Levodopa|levodopa|mesh-list
93043685|NCT01044992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93043686|NCT01044992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93043687|NCT01044992|Dopamine Agents|dopamine agents|mesh-ancestor
93043688|NCT01044992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93043689|NCT01044992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043690|NCT01044992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043691|NCT00520403|Interferons|interferons|mesh-list
93043692|NCT00520403|Interferon-alpha|interferon-alpha|mesh-list
93043693|NCT00520403|Interferon alpha-2|interferon alpha-2|mesh-list
93043694|NCT00520403|Bevacizumab|bevacizumab|mesh-list
93043695|NCT00520403|Vinblastine|vinblastine|mesh-list
93043696|NCT00520403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043697|NCT00520403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043698|NCT00520403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93043699|NCT00520403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043700|NCT00520403|Growth Substances|growth substances|mesh-ancestor
93043701|NCT00520403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043702|NCT00520403|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043703|NCT00520403|Antiviral Agents|antiviral agents|mesh-ancestor
93043704|NCT00520403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043705|NCT00520403|Immunologic Factors|immunologic factors|mesh-ancestor
93043706|NCT00520403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043707|NCT00520403|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043708|NCT00520403|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043709|NCT00520403|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043710|NCT00520403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043711|NCT00520013|Paclitaxel|paclitaxel|mesh-list
93043712|NCT00520013|Bevacizumab|bevacizumab|mesh-list
93043713|NCT00520013|Carboplatin|carboplatin|mesh-list
93043714|NCT00520013|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93043715|NCT00520013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043716|NCT00520013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043717|NCT00520013|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043718|NCT00520013|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043719|NCT00520013|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043720|NCT00520013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043721|NCT00520013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043722|NCT00520013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92276099|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
93043723|NCT00520013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93043724|NCT00520013|Growth Substances|growth substances|mesh-ancestor
93043725|NCT00520013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276182|NCT03974789|Hormones|hormones|mesh-ancestor
93043726|NCT00520013|Growth Inhibitors|growth inhibitors|mesh-ancestor
93043727|NCT00520013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93043728|NCT00520013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043729|NCT00526097|Bisacodyl|bisacodyl|mesh-list
93043730|NCT00526097|Cathartics|cathartics|mesh-ancestor
93043731|NCT00526097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93043732|NCT00526097|Laxatives|laxatives|mesh-ancestor
93043733|NCT00525785|Leucovorin|leucovorin|mesh-list
93043734|NCT00525785|Folic Acid|folic acid|mesh-list
93043735|NCT00525785|Fluorouracil|fluorouracil|mesh-list
93043736|NCT00525785|Oxaliplatin|oxaliplatin|mesh-list
93043737|NCT00525785|Levoleucovorin|levoleucovorin|mesh-list
93043738|NCT00525785|Antimetabolites|antimetabolites|mesh-ancestor
93043739|NCT00525785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043740|NCT00525785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93043741|NCT00525785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276386|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
93043742|NCT00525785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043743|NCT00525785|Immunologic Factors|immunologic factors|mesh-ancestor
93043744|NCT00525785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043745|NCT00525785|Antidotes|antidotes|mesh-ancestor
93043746|NCT00525785|Protective Agents|protective agents|mesh-ancestor
93043747|NCT00525785|Vitamin B Complex|vitamin b complex|mesh-ancestor
93043748|NCT00525785|Vitamins|vitamins|mesh-ancestor
93043749|NCT00525785|Micronutrients|micronutrients|mesh-ancestor
93043750|NCT00525785|Hematinics|hematinics|mesh-ancestor
93043751|NCT00525161|Sorafenib|sorafenib|mesh-list
93043752|NCT00525161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276608|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
93043753|NCT00525161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93043755|NCT00525161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043756|NCT00135694|Prednisone|prednisone|mesh-list
93043757|NCT00135694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93043758|NCT00135694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043759|NCT00135694|Glucocorticoids|glucocorticoids|mesh-ancestor
93043760|NCT00135694|Hormones|hormones|mesh-ancestor
93043761|NCT00135694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043762|NCT00135694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043763|NCT00135694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93043764|NCT00135694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043765|NCT00135694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043766|NCT00135694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043767|NCT00524459|Docetaxel|docetaxel|mesh-list
93043768|NCT00524459|Doxorubicin|doxorubicin|mesh-list
93043769|NCT00524459|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93043770|NCT00524459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276814|NCT03383523|Praziquantel|praziquantel|mesh-list
93043771|NCT00524459|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043772|NCT00524459|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043773|NCT00524459|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043774|NCT00524459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276890|NCT01839110|Ranolazine|ranolazine|mesh-list
93043775|NCT00524459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93043776|NCT00524459|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043777|NCT00524459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043778|NCT00524459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043779|NCT00519623|Insulin|insulin|mesh-list
93043780|NCT00519623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93043781|NCT00519623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043782|NCT01076530|Temozolomide|temozolomide|mesh-list
93043783|NCT01076530|Vorinostat|vorinostat|mesh-list
93043784|NCT01076530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93043785|NCT01076530|Alkylating Agents|alkylating agents|mesh-ancestor
93043786|NCT01076530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043787|NCT01076530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043788|NCT01076530|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93043789|NCT01076530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043790|NCT00519077|Gefitinib|gefitinib|mesh-list
93043791|NCT00519077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043792|NCT00519077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93043793|NCT00519077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043794|NCT00519077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043795|NCT00124618|Cetuximab|cetuximab|mesh-list
92277096|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
93043796|NCT00124618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93043797|NCT00124618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043798|NCT00124072|Folic Acid|folic acid|mesh-list
93043799|NCT00124072|Vitamin B 12|vitamin b 12|mesh-list
93043800|NCT00124072|Hydroxocobalamin|hydroxocobalamin|mesh-list
93043801|NCT00124072|Simvastatin|simvastatin|mesh-list
93043802|NCT00124072|Vitamins|vitamins|mesh-ancestor
93043803|NCT00124072|Micronutrients|micronutrients|mesh-ancestor
93043804|NCT00124072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043805|NCT00124072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93043806|NCT00124072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93043807|NCT00124072|Antimetabolites|antimetabolites|mesh-ancestor
92277228|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
93043808|NCT00124072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043809|NCT00124072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93043810|NCT00124072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93043811|NCT00124072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043812|NCT00124072|Hematinics|hematinics|mesh-ancestor
93043813|NCT00124072|Vitamin B Complex|vitamin b complex|mesh-ancestor
93043814|NCT01080352|Ascorbic Acid|ascorbic acid|mesh-list
93043815|NCT01080352|Vitamins|vitamins|mesh-ancestor
93043816|NCT01080352|Micronutrients|micronutrients|mesh-ancestor
93043817|NCT01080352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043818|NCT01080352|Antioxidants|antioxidants|mesh-ancestor
93043819|NCT01080352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043820|NCT01080352|Protective Agents|protective agents|mesh-ancestor
93043821|NCT00524303|Paclitaxel|paclitaxel|mesh-list
93043822|NCT00524303|Trastuzumab|trastuzumab|mesh-list
93043823|NCT00524303|Lapatinib|lapatinib|mesh-list
93043824|NCT00524303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92277508|NCT02353572|Melphalan|melphalan|mesh-list
93043825|NCT00524303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043827|NCT00524303|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043828|NCT00524303|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277584|NCT04032327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043829|NCT00524303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689039|NCT01313182|Mupirocin|mupirocin|mesh-list
93043830|NCT00524303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689040|NCT01313182|Povidone|povidone|mesh-list
93043831|NCT00524303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93043832|NCT00524303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043833|NCT04461041|Empagliflozin|empagliflozin|mesh-list
93043834|NCT04461041|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92277730|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043835|NCT04461041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043836|NCT04461041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93043837|NCT04461041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043838|NCT00335556|Dactinomycin|dactinomycin|mesh-list
93043839|NCT00335556|Cyclophosphamide|cyclophosphamide|mesh-list
93043840|NCT00335556|Carboplatin|carboplatin|mesh-list
93043841|NCT00335556|Doxorubicin|doxorubicin|mesh-list
93043842|NCT00335556|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93043843|NCT00335556|Irinotecan|irinotecan|mesh-list
93043844|NCT00335556|Etoposide|etoposide|mesh-list
93043845|NCT00335556|Vincristine|vincristine|mesh-list
93043846|NCT00335556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93043847|NCT00335556|Immunologic Factors|immunologic factors|mesh-ancestor
93043848|NCT00335556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043849|NCT00335556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93043850|NCT00335556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93043851|NCT00335556|Alkylating Agents|alkylating agents|mesh-ancestor
93043852|NCT00335556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043853|NCT00335556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043854|NCT00335556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93043855|NCT00335556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93043856|NCT00335556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93043857|NCT00335556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93043858|NCT00335556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043859|NCT00335556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93043860|NCT00335556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93043861|NCT00335556|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043862|NCT00335556|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043863|NCT00335556|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043864|NCT00335556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278085|NCT02300610|Gemcitabine|gemcitabine|mesh-list
93043865|NCT00335556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043866|NCT00335556|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93043867|NCT00335556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93043868|NCT00518687|Vaccines|vaccines|mesh-list
93043869|NCT00518687|Immunologic Factors|immunologic factors|mesh-ancestor
93043870|NCT00518687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043871|NCT00134056|Prednisone|prednisone|mesh-list
93043872|NCT00134056|Docetaxel|docetaxel|mesh-list
93043873|NCT00134056|Atrasentan|atrasentan|mesh-list
93043874|NCT00134056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043875|NCT00134056|Tubulin Modulators|tubulin modulators|mesh-ancestor
93043876|NCT00134056|Antimitotic Agents|antimitotic agents|mesh-ancestor
93043877|NCT00134056|Mitosis Modulators|mitosis modulators|mesh-ancestor
93043878|NCT00134056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043879|NCT00134056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93043880|NCT00134056|Glucocorticoids|glucocorticoids|mesh-ancestor
93043881|NCT00134056|Hormones|hormones|mesh-ancestor
92278369|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93043882|NCT00134056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043883|NCT00134056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043884|NCT00134056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93043885|NCT00134056|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92278440|NCT01118013|Methotrexate|methotrexate|mesh-list
93043886|NCT00134056|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93043887|NCT00518531|Denosumab|denosumab|mesh-list
93043888|NCT00518531|Alendronate|alendronate|mesh-list
93043889|NCT00518531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92278508|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
92278578|NCT01048125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93043890|NCT00518531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043891|NCT01326442|Vitamin D|vitamin d|mesh-list
93043892|NCT01326442|Vitamins|vitamins|mesh-ancestor
93043893|NCT01326442|Micronutrients|micronutrients|mesh-ancestor
93043894|NCT01326442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043895|NCT01326442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93043896|NCT00523991|Tiotropium Bromide|tiotropium bromide|mesh-list
93043897|NCT00523991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93043898|NCT00523991|Autonomic Agents|autonomic agents|mesh-ancestor
92389576|NCT00370656|Dopamine Agents|dopamine agents|mesh-ancestor
93043900|NCT00523991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043901|NCT00523991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93043902|NCT00523991|Respiratory System Agents|respiratory system agents|mesh-ancestor
93043903|NCT00523991|Parasympatholytics|parasympatholytics|mesh-ancestor
93043904|NCT00523991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93043905|NCT00523991|Cholinergic Agents|cholinergic agents|mesh-ancestor
93043906|NCT00523991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278866|NCT00823095|Nitric Oxide|nitric oxide|mesh-list
92689116|NCT00482066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278941|NCT01901679|Analgesics|analgesics|mesh-ancestor
93043907|NCT00523991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043908|NCT00350844|Hydroxyurea|hydroxyurea|mesh-list
93043909|NCT00350844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043910|NCT00350844|Antisickling Agents|antisickling agents|mesh-ancestor
93043911|NCT00350844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279007|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
93043912|NCT00350844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043913|NCT00350844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93043914|NCT00345540|Carboplatin|carboplatin|mesh-list
93043915|NCT00345540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043916|NCT00335322|Ritonavir|ritonavir|mesh-list
93043917|NCT00335322|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93043918|NCT00335322|Tenofovir|tenofovir|mesh-list
93043919|NCT00335322|Emtricitabine|emtricitabine|mesh-list
93043920|NCT00335322|Zidovudine|zidovudine|mesh-list
92494473|NCT01975480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93043921|NCT00335322|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93043922|NCT00335322|Abacavir|abacavir|mesh-list
93043923|NCT00335322|Efavirenz|efavirenz|mesh-list
92279243|NCT05722301|Hormones|hormones|mesh-ancestor
93043924|NCT00335322|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93043925|NCT00335322|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93043926|NCT00335322|Protease Inhibitors|protease inhibitors|mesh-ancestor
93043927|NCT00335322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279292|NCT00570531|Paclitaxel|paclitaxel|mesh-list
93043928|NCT00335322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043929|NCT00335322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93043930|NCT00335322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93043931|NCT00335322|Antiviral Agents|antiviral agents|mesh-ancestor
93043932|NCT00335322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043933|NCT00335322|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93043934|NCT00335322|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93043935|NCT00335322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93043936|NCT00335322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93043937|NCT00335322|Antimetabolites|antimetabolites|mesh-ancestor
93043938|NCT00335322|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93043939|NCT00335322|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93043940|NCT00335322|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93043941|NCT00335322|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92279505|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043942|NCT00335322|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93043943|NCT01059396|Propranolol|propranolol|mesh-list
93043944|NCT01059396|Carvedilol|carvedilol|mesh-list
93043945|NCT01059396|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93043946|NCT01059396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93043947|NCT01059396|Adrenergic Agents|adrenergic agents|mesh-ancestor
93043948|NCT01059396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279650|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
93043949|NCT01059396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043950|NCT01059396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043951|NCT01059396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93043952|NCT01059396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93043953|NCT01059396|Vasodilator Agents|vasodilator agents|mesh-ancestor
93043954|NCT01059396|Antioxidants|antioxidants|mesh-ancestor
93043955|NCT01059396|Protective Agents|protective agents|mesh-ancestor
93043956|NCT01059396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93043957|NCT01059396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93043958|NCT01059396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93043959|NCT01059396|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93043960|NCT01059396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93043961|NCT01059552|Vorinostat|vorinostat|mesh-list
93043962|NCT01059552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93043963|NCT01059552|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93043964|NCT01059552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043965|NCT01059552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043966|NCT03741894|Chlorhexidine|chlorhexidine|mesh-list
93043967|NCT03741894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93043968|NCT03741894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043969|NCT03741894|Disinfectants|disinfectants|mesh-ancestor
93043970|NCT03755765|Amoxicillin|amoxicillin|mesh-list
93043972|NCT03755765|Clavulanic Acids|clavulanic acids|mesh-list
93043973|NCT03755765|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93043974|NCT03755765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93043975|NCT03755765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043976|NCT03755765|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93043977|NCT03755765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93043978|NCT03755765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043979|NCT01061112|Tolbutamide|tolbutamide|mesh-list
93043980|NCT01061112|Fluconazole|fluconazole|mesh-list
93043982|NCT01061112|Flurbiprofen|flurbiprofen|mesh-list
93043983|NCT01061112|Antifungal Agents|antifungal agents|mesh-ancestor
93043984|NCT01061112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93043985|NCT01061112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93043986|NCT01061112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93043987|NCT01061112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280142|NCT05362487|Bromides|bromides|mesh-list
93043988|NCT01061112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93043989|NCT01061112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93043990|NCT01061112|Hormone Antagonists|hormone antagonists|mesh-ancestor
93043991|NCT01061112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93043992|NCT01061112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93043993|NCT01061112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93043994|NCT01061112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93043995|NCT01061112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93043996|NCT01061112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93043997|NCT01061112|Analgesics|analgesics|mesh-ancestor
93043998|NCT01061112|Sensory System Agents|sensory system agents|mesh-ancestor
92280211|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
93043999|NCT01061112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044000|NCT01061112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93044001|NCT01061112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044002|NCT01061112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93044003|NCT01061112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93044004|NCT01061190|Propranolol|propranolol|mesh-list
93044005|NCT01061190|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93044006|NCT01061190|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93044007|NCT01061190|Adrenergic Agents|adrenergic agents|mesh-ancestor
93044008|NCT01061190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044009|NCT01061190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044010|NCT01061190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044011|NCT01061190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93044012|NCT01061190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93044013|NCT01061190|Vasodilator Agents|vasodilator agents|mesh-ancestor
93044014|NCT00324168|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93044015|NCT00324168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044016|NCT00517829|Docetaxel|docetaxel|mesh-list
93044017|NCT00517829|Oxaliplatin|oxaliplatin|mesh-list
93044018|NCT00517829|Cetuximab|cetuximab|mesh-list
93044019|NCT00517829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044020|NCT00517829|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044021|NCT00517829|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044022|NCT00517829|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044023|NCT00517829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044024|NCT00517829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044025|NCT00343512|Docetaxel|docetaxel|mesh-list
93044026|NCT00343512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044027|NCT00343512|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280790|NCT00002037|Trifluridine|trifluridine|mesh-list
93044028|NCT00343512|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044029|NCT00343512|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280864|NCT00002049|Thymopentin|thymopentin|mesh-list
93044030|NCT00343512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044031|NCT00334542|Simvastatin|simvastatin|mesh-list
93044032|NCT00334542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93044033|NCT00334542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93044034|NCT00334542|Antimetabolites|antimetabolites|mesh-ancestor
92280927|NCT00002061|Immunologic Factors|immunologic factors|mesh-ancestor
93044035|NCT00334542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044036|NCT00334542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92280998|NCT00001383|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044037|NCT00334542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93044038|NCT00334542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044039|NCT00112294|Paclitaxel|paclitaxel|mesh-list
93044040|NCT00112294|Docetaxel|docetaxel|mesh-list
93044041|NCT00112294|Carboplatin|carboplatin|mesh-list
93044042|NCT00112294|Cetuximab|cetuximab|mesh-list
93044043|NCT00112294|Taxane|taxane|mesh-list
93044044|NCT00112294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044045|NCT00112294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044046|NCT00112294|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044047|NCT00112294|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281230|NCT00001629|Giapreza|giapreza|mesh-list
93044048|NCT00112294|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044049|NCT00112294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044050|NCT00112294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044051|NCT00235443|Lacosamide|lacosamide|mesh-list
93044052|NCT00235443|Anticonvulsants|anticonvulsants|mesh-ancestor
93044053|NCT00235443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93044054|NCT00235443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93044055|NCT00235443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044056|NCT00235443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044057|NCT00234039|Gemcitabine|gemcitabine|mesh-list
93044058|NCT00234039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93044059|NCT00234039|Antimetabolites|antimetabolites|mesh-ancestor
93044060|NCT00234039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044061|NCT00234039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044062|NCT02531451|Aspirin|aspirin|mesh-list
93044063|NCT02531451|Ibuprofen|ibuprofen|mesh-list
92494474|NCT01975480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93044064|NCT02531451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93044065|NCT02531451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93044066|NCT02531451|Analgesics|analgesics|mesh-ancestor
93044067|NCT02531451|Sensory System Agents|sensory system agents|mesh-ancestor
93044068|NCT02531451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044069|NCT02531451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044070|NCT02531451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93044071|NCT02531451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044072|NCT02531451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93044073|NCT02531451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281571|NCT00002205|Abacavir|abacavir|mesh-list
93044074|NCT02531451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044075|NCT02531451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93044076|NCT02531451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93044077|NCT02531451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93044078|NCT02531451|Antipyretics|antipyretics|mesh-ancestor
93044079|NCT01073007|Simvastatin|simvastatin|mesh-list
93044080|NCT01073007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93044081|NCT01073007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93044082|NCT01073007|Antimetabolites|antimetabolites|mesh-ancestor
93044083|NCT01073007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044084|NCT01073007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93044085|NCT01073007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93044086|NCT01073007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044087|NCT03741621|Psyllium|psyllium|mesh-list
93044088|NCT03741621|Cathartics|cathartics|mesh-ancestor
93044089|NCT03741621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044090|NCT00323622|Pyrimethamine|pyrimethamine|mesh-list
93044091|NCT00323622|Sulfadoxine|sulfadoxine|mesh-list
93044092|NCT00323622|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93044093|NCT00323622|Amodiaquine|amodiaquine|mesh-list
93044094|NCT00323622|Vaccines|vaccines|mesh-list
93044095|NCT00323622|Immunologic Factors|immunologic factors|mesh-ancestor
92281931|NCT00002493|Doxorubicin|doxorubicin|mesh-list
93044096|NCT00323622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044097|NCT00323622|Antimalarials|antimalarials|mesh-ancestor
93044098|NCT00323622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93044099|NCT00323622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92282007|NCT04933331|Silver Nitrate|silver nitrate|mesh-list
93044100|NCT00323622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044101|NCT00323622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93044102|NCT00323622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044103|NCT00323622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044104|NCT00323622|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93044105|NCT01326039|Bupivacaine|bupivacaine|mesh-list
93044106|NCT01326039|Anesthetics, Local|anesthetics, local|mesh-ancestor
93044107|NCT01326039|Anesthetics|anesthetics|mesh-ancestor
93044108|NCT01326039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044109|NCT01326039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282149|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
93044110|NCT01326039|Sensory System Agents|sensory system agents|mesh-ancestor
93044111|NCT01326039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044112|NCT01057758|Simvastatin|simvastatin|mesh-list
93044113|NCT01057758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93044114|NCT01057758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93044115|NCT01057758|Antimetabolites|antimetabolites|mesh-ancestor
93044116|NCT01057758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044117|NCT01057758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93044118|NCT01057758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93044119|NCT01057758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044121|NCT00186537|Fenofibrate|fenofibrate|mesh-list
93044122|NCT00186537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92282292|NCT00002565|Idarubicin|idarubicin|mesh-list
93044123|NCT00186537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044124|NCT00186537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93044125|NCT00186537|Antimetabolites|antimetabolites|mesh-ancestor
93044126|NCT00186537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044127|NCT00186537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93044128|NCT03968835|Bacitracin|bacitracin|mesh-list
93044129|NCT03968835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93044131|NCT03968835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93044132|NCT00322842|Plerixafor|plerixafor|mesh-list
93044133|NCT00322842|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044134|NCT00322842|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044135|NCT00322842|Antiviral Agents|antiviral agents|mesh-ancestor
93044136|NCT00322842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044137|NCT04726085|Ibuprofen|ibuprofen|mesh-list
93044138|NCT04726085|Indomethacin|indomethacin|mesh-list
92494475|NCT01975480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044139|NCT04726085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93044140|NCT04726085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93044141|NCT04726085|Analgesics|analgesics|mesh-ancestor
93044142|NCT04726085|Sensory System Agents|sensory system agents|mesh-ancestor
93044143|NCT04726085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044144|NCT04726085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044145|NCT04726085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282847|NCT05492851|Hylan|hylan|mesh-list
93044146|NCT04726085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044147|NCT04726085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93044148|NCT04726085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044149|NCT04726085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044150|NCT04726085|Gout Suppressants|gout suppressants|mesh-ancestor
93044151|NCT04726085|Tocolytic Agents|tocolytic agents|mesh-ancestor
93044152|NCT04726085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93044153|NCT00255723|Carboplatin|carboplatin|mesh-list
93044154|NCT00255723|Etoposide|etoposide|mesh-list
93044155|NCT00255723|Ifosfamide|ifosfamide|mesh-list
93044156|NCT00255723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282947|NCT04860011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93044157|NCT00255723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044158|NCT00255723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044159|NCT00255723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93044160|NCT00255723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044161|NCT00255723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044162|NCT00255723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93044163|NCT00255723|Alkylating Agents|alkylating agents|mesh-ancestor
93044164|NCT01060176|Tranexamic Acid|tranexamic acid|mesh-list
93044165|NCT01060176|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93044166|NCT01060176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93044167|NCT01060176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044168|NCT01060176|Hemostatics|hemostatics|mesh-ancestor
93044169|NCT01060176|Coagulants|coagulants|mesh-ancestor
93044170|NCT00132808|Zoledronic Acid|zoledronic acid|mesh-list
93044171|NCT00132808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93044172|NCT00132808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044173|NCT03982992|Blinatumomab|blinatumomab|mesh-list
93044174|NCT03982992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044175|NCT03695471|Pembrolizumab|pembrolizumab|mesh-list
93044176|NCT03695471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044177|NCT03695471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044178|NCT03695471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93044179|NCT03695471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044180|NCT01061268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93044181|NCT01061268|Lubricant Eye Drops|lubricant eye drops|mesh-list
93044182|NCT01061268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93044183|NCT00517361|Bevacizumab|bevacizumab|mesh-list
93044184|NCT00517361|Carboplatin|carboplatin|mesh-list
93044185|NCT00517361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044186|NCT00517361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044187|NCT00517361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93044188|NCT00517361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93044189|NCT00517361|Growth Substances|growth substances|mesh-ancestor
93044190|NCT00517361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044191|NCT00517361|Growth Inhibitors|growth inhibitors|mesh-ancestor
93044193|NCT00516893|Immunologic Factors|immunologic factors|mesh-ancestor
92283598|NCT01169259|Vitamin D|vitamin d|mesh-list
93044194|NCT00516893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044195|NCT03657641|Pembrolizumab|pembrolizumab|mesh-list
93044196|NCT03657641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044197|NCT03657641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044198|NCT03657641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93044199|NCT03657641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044200|NCT03649841|Ascorbic Acid|ascorbic acid|mesh-list
93044201|NCT03649841|Prednisone|prednisone|mesh-list
93044202|NCT03649841|Cortisone|cortisone|mesh-list
93044203|NCT03649841|Methyltestosterone|methyltestosterone|mesh-list
93044204|NCT03649841|Abiraterone Acetate|abiraterone acetate|mesh-list
93044205|NCT03649841|Hormones|hormones|mesh-list
93044206|NCT03649841|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93044207|NCT03649841|Androgens|androgens|mesh-list
93044208|NCT03649841|Androgen Antagonists|androgen antagonists|mesh-list
93044209|NCT03649841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93044210|NCT03649841|Glucocorticoids|glucocorticoids|mesh-ancestor
93044211|NCT03649841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283807|NCT00002691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044212|NCT03649841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044213|NCT03649841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93044214|NCT03649841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044215|NCT03649841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93044216|NCT03649841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044217|NCT03649841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044218|NCT03649841|Hormone Antagonists|hormone antagonists|mesh-ancestor
93044219|NCT03649841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93044220|NCT03649841|Antioxidants|antioxidants|mesh-ancestor
93044221|NCT03649841|Protective Agents|protective agents|mesh-ancestor
93044222|NCT03649841|Vitamins|vitamins|mesh-ancestor
93044223|NCT03649841|Micronutrients|micronutrients|mesh-ancestor
93044224|NCT03649841|Estrogens|estrogens|mesh-ancestor
93044225|NCT03649841|Anabolic Agents|anabolic agents|mesh-ancestor
93044226|NCT00522431|Testosterone|testosterone|mesh-list
93044227|NCT00522431|Androgens|androgens|mesh-ancestor
93044228|NCT00522431|Hormones|hormones|mesh-ancestor
93044229|NCT00522431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044230|NCT00522431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044231|NCT00185211|Interferons|interferons|mesh-list
93044232|NCT00185211|Interferon-beta|interferon-beta|mesh-list
93044233|NCT00185211|Interferon beta-1b|interferon beta-1b|mesh-list
93044234|NCT00185211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044235|NCT00185211|Antiviral Agents|antiviral agents|mesh-ancestor
93044236|NCT00185211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044237|NCT00185211|Immunologic Factors|immunologic factors|mesh-ancestor
93044238|NCT00185211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044239|NCT00185211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93044240|NCT00516737|Rizatriptan|rizatriptan|mesh-list
93044241|NCT00516737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93044242|NCT00516737|Serotonin Agents|serotonin agents|mesh-ancestor
93044243|NCT00516737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044244|NCT00516737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044245|NCT00516737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044246|NCT03540485|Melatonin|melatonin|mesh-list
93044247|NCT03540485|Antioxidants|antioxidants|mesh-ancestor
93044248|NCT03540485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044249|NCT03540485|Protective Agents|protective agents|mesh-ancestor
93044250|NCT03540485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284226|NCT04343963|Cholinergic Agents|cholinergic agents|mesh-ancestor
93044251|NCT03540485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044252|NCT00132730|MK 0873|mk 0873|mesh-list
93044253|NCT00132730|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93044254|NCT00132730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93044255|NCT00132730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044256|NCT00132730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044257|NCT02531841|Dexamethasone acetate|dexamethasone acetate|mesh-list
93044258|NCT02531841|Dexamethasone|dexamethasone|mesh-list
93044259|NCT02531841|Etoposide phosphate|etoposide phosphate|mesh-list
93044260|NCT02531841|Etoposide|etoposide|mesh-list
93044261|NCT02531841|Ifosfamide|ifosfamide|mesh-list
93044262|NCT02531841|Isophosphamide mustard|isophosphamide mustard|mesh-list
93044263|NCT02531841|Thiotepa|thiotepa|mesh-list
93044264|NCT02531841|Carmustine|carmustine|mesh-list
93044265|NCT02531841|Busulfan|busulfan|mesh-list
93044266|NCT02531841|BB 1101|bb 1101|mesh-list
93044267|NCT02531841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93044268|NCT02531841|Antiemetics|antiemetics|mesh-ancestor
93044269|NCT02531841|Autonomic Agents|autonomic agents|mesh-ancestor
93044270|NCT02531841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044271|NCT02531841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044272|NCT02531841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044273|NCT02531841|Glucocorticoids|glucocorticoids|mesh-ancestor
93044274|NCT02531841|Hormones|hormones|mesh-ancestor
93044275|NCT02531841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689484|NCT04517214|Antimetabolites|antimetabolites|mesh-ancestor
93044276|NCT02531841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93044277|NCT02531841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044278|NCT02531841|Protease Inhibitors|protease inhibitors|mesh-ancestor
93044279|NCT02531841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044280|NCT02531841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044281|NCT02531841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044282|NCT02531841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044283|NCT02531841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93044284|NCT02531841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93044285|NCT02531841|Alkylating Agents|alkylating agents|mesh-ancestor
93044286|NCT02531841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93044287|NCT02531841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044288|NCT02531841|Immunologic Factors|immunologic factors|mesh-ancestor
93044289|NCT01074411|Carboplatin|carboplatin|mesh-list
93044290|NCT01074411|Bortezomib|bortezomib|mesh-list
93044291|NCT01074411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044292|NCT03973047|Ondansetron|ondansetron|mesh-list
93044293|NCT03973047|Antiemetics|antiemetics|mesh-ancestor
93044294|NCT03973047|Autonomic Agents|autonomic agents|mesh-ancestor
93044295|NCT03973047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044296|NCT03973047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044297|NCT03973047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044298|NCT03973047|Antipruritics|antipruritics|mesh-ancestor
93044299|NCT03973047|Dermatologic Agents|dermatologic agents|mesh-ancestor
93044300|NCT03973047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93044301|NCT03973047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93044302|NCT03973047|Serotonin Agents|serotonin agents|mesh-ancestor
93044303|NCT03973047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284697|NCT02987348|Hormones|hormones|mesh-ancestor
93044304|NCT03973047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044305|NCT00522275|Lacosamide|lacosamide|mesh-list
93044306|NCT00522275|Anticonvulsants|anticonvulsants|mesh-ancestor
93044307|NCT00522275|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93044308|NCT00522275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93044309|NCT00522275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044310|NCT00522275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044311|NCT01074567|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
93044312|NCT01074567|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93044313|NCT01074567|Protective Agents|protective agents|mesh-ancestor
93044314|NCT01074567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044315|NCT01074567|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93044316|NCT01074567|Antioxidants|antioxidants|mesh-ancestor
93044317|NCT01074567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044318|NCT00522041|Nitroglycerin|nitroglycerin|mesh-list
93044319|NCT00522041|Vasodilator Agents|vasodilator agents|mesh-ancestor
93044320|NCT03519971|Paclitaxel|paclitaxel|mesh-list
93044321|NCT03519971|Etoposide|etoposide|mesh-list
93044322|NCT03519971|Cisplatin|cisplatin|mesh-list
93044323|NCT03519971|Carboplatin|carboplatin|mesh-list
93044324|NCT03519971|Pemetrexed|pemetrexed|mesh-list
93044325|NCT03519971|Durvalumab|durvalumab|mesh-list
93044326|NCT03519971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044327|NCT03519971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044328|NCT03519971|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044329|NCT03519971|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044330|NCT03519971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92285117|NCT00000447|Naltrexone|naltrexone|mesh-list
93044331|NCT03519971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044332|NCT03519971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044333|NCT03519971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93044334|NCT03519971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044335|NCT03519971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93044336|NCT03519971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93044337|NCT03519971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044338|NCT00122980|Hydroxyurea|hydroxyurea|mesh-list
93044339|NCT00122980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044340|NCT00122980|Antisickling Agents|antisickling agents|mesh-ancestor
93044341|NCT00122980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044342|NCT00122980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044343|NCT00122980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93044345|NCT00340704|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93044346|NCT00340704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93044347|NCT00340704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93044348|NCT00340704|Adrenergic Agents|adrenergic agents|mesh-ancestor
93044349|NCT00340704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044350|NCT00340704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044351|NCT00340704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044352|NCT00340704|Urological Agents|urological agents|mesh-ancestor
93044353|NCT00132496|Rabeprazole|rabeprazole|mesh-list
93044354|NCT00132496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92689563|NCT01241019|Topiramate|topiramate|mesh-list
93044355|NCT00132496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044356|NCT00132496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93044357|NCT00132496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044358|NCT00132496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044359|NCT01080586|Cyclosporine|cyclosporine|mesh-list
93044360|NCT01080586|Cyclosporins|cyclosporins|mesh-list
93044361|NCT01080586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285619|NCT04750395|Olanzapine|olanzapine|mesh-list
93044362|NCT01080586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044363|NCT01080586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044364|NCT01080586|Immunologic Factors|immunologic factors|mesh-ancestor
93044365|NCT01080586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285691|NCT05700266|Aspirin|aspirin|mesh-list
93044366|NCT01080586|Antifungal Agents|antifungal agents|mesh-ancestor
93044367|NCT01080586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044368|NCT01080586|Dermatologic Agents|dermatologic agents|mesh-ancestor
93044369|NCT01080586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044370|NCT01080586|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93044371|NCT00231777|Ondansetron|ondansetron|mesh-list
93044372|NCT00231777|Aprepitant|aprepitant|mesh-list
93044373|NCT00231777|Antiemetics|antiemetics|mesh-ancestor
93044374|NCT00231777|Autonomic Agents|autonomic agents|mesh-ancestor
93044375|NCT00231777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044376|NCT00231777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044377|NCT00231777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044378|NCT00231777|Antipruritics|antipruritics|mesh-ancestor
93044379|NCT00231777|Dermatologic Agents|dermatologic agents|mesh-ancestor
93044380|NCT00231777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93044381|NCT00231777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93044382|NCT00231777|Serotonin Agents|serotonin agents|mesh-ancestor
93044383|NCT00231777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044384|NCT00231777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044385|NCT00231777|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93044386|NCT01076842|Insulin|insulin|mesh-list
93044387|NCT01076842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93044388|NCT01076842|Exenatide|exenatide|mesh-list
93044389|NCT01076842|Insulin Detemir|insulin detemir|mesh-list
93044390|NCT01076842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93044391|NCT01076842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044392|NCT01076842|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93044393|NCT01076842|Incretins|incretins|mesh-ancestor
93044394|NCT01076842|Hormones|hormones|mesh-ancestor
93044395|NCT01076842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044396|NCT01060410|Cyclophosphamide|cyclophosphamide|mesh-list
93044397|NCT01060410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044398|NCT01060410|Immunologic Factors|immunologic factors|mesh-ancestor
93044399|NCT01060410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044400|NCT01060410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044401|NCT01060410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93044402|NCT01060410|Alkylating Agents|alkylating agents|mesh-ancestor
93044403|NCT01060410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044404|NCT01060410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044405|NCT01060410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93044406|NCT00231465|Docetaxel|docetaxel|mesh-list
93044407|NCT00231465|Gefitinib|gefitinib|mesh-list
93044408|NCT00231465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044409|NCT00231465|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044410|NCT00231465|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044411|NCT00231465|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044412|NCT00231465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044413|NCT00231465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93044414|NCT00231465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044415|NCT00254397|Leuprolide|leuprolide|mesh-list
93044416|NCT00254397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93044417|NCT00254397|Fertility Agents|fertility agents|mesh-ancestor
93044418|NCT00254397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93044419|NCT00254397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044420|NCT00254397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93044421|NCT00254397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044422|NCT00254163|Cyclophosphamide|cyclophosphamide|mesh-list
93044423|NCT00254163|Rituximab|rituximab|mesh-list
93044424|NCT00254163|Fludarabine|fludarabine|mesh-list
93044425|NCT00254163|Pentostatin|pentostatin|mesh-list
93044426|NCT00254163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044427|NCT00254163|Immunologic Factors|immunologic factors|mesh-ancestor
93044428|NCT00254163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044429|NCT00254163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044430|NCT00254163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93044431|NCT00254163|Alkylating Agents|alkylating agents|mesh-ancestor
93044432|NCT00254163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044434|NCT00254163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93044435|NCT00254163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044436|NCT00254163|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93044437|NCT00254163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044438|NCT00110890|Cinacalcet|cinacalcet|mesh-list
93044439|NCT00110890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93044440|NCT00110890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044441|NCT00110890|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93044442|NCT00110890|Hormone Antagonists|hormone antagonists|mesh-ancestor
93044443|NCT00110890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044444|NCT00182637|Bortezomib|bortezomib|mesh-list
93044445|NCT00182637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044446|NCT01076998|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93044447|NCT01076998|Lubricant Eye Drops|lubricant eye drops|mesh-list
93044448|NCT01076998|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93044449|NCT00122278|Dexamethasone|dexamethasone|mesh-list
93044450|NCT00122278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93044451|NCT00122278|Antiemetics|antiemetics|mesh-ancestor
93044452|NCT00122278|Autonomic Agents|autonomic agents|mesh-ancestor
93044453|NCT00122278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044454|NCT00122278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044455|NCT00122278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044456|NCT00122278|Glucocorticoids|glucocorticoids|mesh-ancestor
93044457|NCT00122278|Hormones|hormones|mesh-ancestor
93044458|NCT00122278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044459|NCT00122278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93044460|NCT00122278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044461|NCT00182091|Hormones|hormones|mesh-list
93044462|NCT00182091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044463|NCT00182091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044464|NCT03398135|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93044465|NCT03398135|Immunologic Factors|immunologic factors|mesh-ancestor
92286564|NCT02795858|Lanreotide|lanreotide|mesh-list
93044466|NCT03398135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044467|NCT01072071|Furosemide|furosemide|mesh-list
93044468|NCT01072071|Diuretics|diuretics|mesh-ancestor
93044469|NCT01072071|Natriuretic Agents|natriuretic agents|mesh-ancestor
93044470|NCT01072071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044471|NCT01072071|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93044472|NCT01072071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044473|NCT01072071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044474|NCT00181155|Allopurinol|allopurinol|mesh-list
93044475|NCT00181155|Antimetabolites|antimetabolites|mesh-ancestor
93044476|NCT00181155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044477|NCT00181155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044478|NCT00181155|Gout Suppressants|gout suppressants|mesh-ancestor
93044479|NCT00181155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044480|NCT00181155|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93044481|NCT00181155|Antioxidants|antioxidants|mesh-ancestor
93044482|NCT00181155|Protective Agents|protective agents|mesh-ancestor
92286762|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044483|NCT00181155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044484|NCT00322452|Paclitaxel|paclitaxel|mesh-list
93044485|NCT00322452|Carboplatin|carboplatin|mesh-list
93044486|NCT00322452|Gefitinib|gefitinib|mesh-list
93044487|NCT00322452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044488|NCT00322452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044489|NCT00322452|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044490|NCT00322452|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044491|NCT00322452|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286911|NCT02918955|Cisplatin|cisplatin|mesh-list
93044492|NCT00322452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044493|NCT00322452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93044494|NCT00322452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044495|NCT00110812|Aldesleukin|aldesleukin|mesh-list
93044496|NCT00110812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044497|NCT00110812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044498|NCT00110812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044499|NCT00110812|Antiviral Agents|antiviral agents|mesh-ancestor
93044500|NCT00110812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044501|NCT00516269|Methylphenidate|methylphenidate|mesh-list
93044502|NCT00516269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93044503|NCT00516269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044504|NCT00516269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93044505|NCT00516269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92689706|NCT05644210|Aspirin|aspirin|mesh-list
93044506|NCT00516269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044507|NCT00516269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044508|NCT00516269|Dopamine Agents|dopamine agents|mesh-ancestor
93044509|NCT00516269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044510|NCT04639037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92287195|NCT00003087|Paclitaxel|paclitaxel|mesh-list
93044511|NCT00228813|Lenograstim|lenograstim|mesh-list
93044512|NCT00228813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93044513|NCT00228813|Immunologic Factors|immunologic factors|mesh-ancestor
93044514|NCT00228813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044515|NCT00322374|Epirubicin|epirubicin|mesh-list
93044516|NCT00322374|Epothilones|epothilones|mesh-list
92287337|NCT03962725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93044517|NCT00322374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93044518|NCT00322374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044519|NCT00322374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044520|NCT00322374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93044521|NCT00322374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044522|NCT00322374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044523|NCT00322374|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044524|NCT00322374|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044525|NCT00322374|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044526|NCT00174447|Ziprasidone|ziprasidone|mesh-list
93044527|NCT00174447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93044528|NCT00174447|Serotonin Agents|serotonin agents|mesh-ancestor
93044529|NCT00174447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044530|NCT00174447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044531|NCT00174447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044532|NCT00174447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93044533|NCT00174447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93044534|NCT00174447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044535|NCT00174447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93044536|NCT00174447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93044537|NCT00174447|Dopamine Agents|dopamine agents|mesh-ancestor
93044538|NCT00321984|Dexlansoprazole|dexlansoprazole|mesh-list
93044539|NCT00321984|Lansoprazole|lansoprazole|mesh-list
93044540|NCT00321984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93044541|NCT00321984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044542|NCT00321984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93044543|NCT00321984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044544|NCT00321984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044545|NCT01060488|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
93044546|NCT01060488|Hormones|hormones|mesh-ancestor
93044547|NCT01060488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044548|NCT01060488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044549|NCT01060566|Ivacaftor|ivacaftor|mesh-list
93044550|NCT01060566|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93044551|NCT01060566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92287719|NCT01771627|Nicotine|nicotine|mesh-list
93044552|NCT01060566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044553|NCT02533284|Magnesium Sulfate|magnesium sulfate|mesh-list
93044554|NCT02533284|Analgesics|analgesics|mesh-ancestor
93044555|NCT02533284|Sensory System Agents|sensory system agents|mesh-ancestor
93044556|NCT02533284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044557|NCT02533284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044558|NCT02533284|Anesthetics|anesthetics|mesh-ancestor
93044559|NCT02533284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044560|NCT02533284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93044561|NCT02533284|Anticonvulsants|anticonvulsants|mesh-ancestor
93044562|NCT02533284|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93044563|NCT02533284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044564|NCT02533284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287822|NCT04744727|Acetaminophen|acetaminophen|mesh-list
93044565|NCT02533284|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93044566|NCT02533284|Tocolytic Agents|tocolytic agents|mesh-ancestor
93044567|NCT02533284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93044568|NCT00515099|Thymoglobulin|thymoglobulin|mesh-list
93044569|NCT00515099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93044570|NCT00515099|Immunologic Factors|immunologic factors|mesh-ancestor
93044571|NCT00515099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044572|NCT00515099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044573|NCT00110266|Deferasirox|deferasirox|mesh-list
93044574|NCT00110266|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93044575|NCT00110266|Chelating Agents|chelating agents|mesh-ancestor
93044576|NCT00110266|Sequestering Agents|sequestering agents|mesh-ancestor
93044577|NCT00110266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044578|NCT00366548|Vaccines|vaccines|mesh-list
93044579|NCT00366548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93044580|NCT00366548|Immunologic Factors|immunologic factors|mesh-ancestor
93044581|NCT00366548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044583|NCT01074645|Antiviral Agents|antiviral agents|mesh-ancestor
93044584|NCT01074645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044585|NCT01074645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93044586|NCT01074645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93044587|NCT01074645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044588|NCT01074645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044589|NCT01074645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044590|NCT01074645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044591|NCT00132028|Vorinostat|vorinostat|mesh-list
93044592|NCT00132028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044593|NCT00132028|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93044594|NCT00132028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044595|NCT00132028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044596|NCT01045304|Carboplatin|carboplatin|mesh-list
93044597|NCT01045304|Gemcitabine|gemcitabine|mesh-list
93044598|NCT01045304|Iniparib|iniparib|mesh-list
93044599|NCT01045304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044600|NCT01045304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93044601|NCT01045304|Antimetabolites|antimetabolites|mesh-ancestor
93044602|NCT01045304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044603|NCT01045304|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93044604|NCT01045304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044605|NCT01080742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93044606|NCT01080742|Bisoprolol|bisoprolol|mesh-list
93044607|NCT01080742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93044608|NCT01080742|Diuretics|diuretics|mesh-ancestor
93044609|NCT01080742|Natriuretic Agents|natriuretic agents|mesh-ancestor
93044610|NCT01080742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044611|NCT01080742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93044612|NCT01080742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92287971|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93044613|NCT01080742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044614|NCT01080742|Sympatholytics|sympatholytics|mesh-ancestor
93044615|NCT01080742|Autonomic Agents|autonomic agents|mesh-ancestor
93044616|NCT01080742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044617|NCT01080742|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93044618|NCT01080742|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93044619|NCT01080742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93044620|NCT01080742|Adrenergic Agents|adrenergic agents|mesh-ancestor
93044621|NCT01080742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044622|NCT00131248|Metoclopramide|metoclopramide|mesh-list
93044623|NCT00131248|Ranitidine|ranitidine|mesh-list
93044624|NCT00131248|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
93044625|NCT00131248|Antiemetics|antiemetics|mesh-ancestor
93044626|NCT00131248|Autonomic Agents|autonomic agents|mesh-ancestor
93044627|NCT00131248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044628|NCT00131248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044629|NCT00131248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044630|NCT00131248|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93044631|NCT00131248|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93044632|NCT00131248|Dopamine Agents|dopamine agents|mesh-ancestor
93044633|NCT00131248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044634|NCT00131248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044635|NCT00131248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93044636|NCT00131248|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93044637|NCT00131248|Histamine Antagonists|histamine antagonists|mesh-ancestor
93044638|NCT00131248|Histamine Agents|histamine agents|mesh-ancestor
93044639|NCT00362414|Mitogens|mitogens|mesh-list
93044640|NCT00362414|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044641|NCT00362414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044642|NCT01080820|Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine|mesh-list
93044643|NCT01080820|Antiviral Agents|antiviral agents|mesh-ancestor
93044644|NCT01080820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044645|NCT01080820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044646|NCT01080820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044647|NCT01049204|Maraviroc|maraviroc|mesh-list
93044648|NCT01049204|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93044649|NCT01049204|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93044650|NCT01049204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044651|NCT01049204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044652|NCT01049204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044653|NCT01049204|Antiviral Agents|antiviral agents|mesh-ancestor
93044654|NCT01049204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044655|NCT01049204|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93044656|NCT00096382|Aldesleukin|aldesleukin|mesh-list
93044657|NCT00096382|Cyclophosphamide|cyclophosphamide|mesh-list
93044658|NCT00096382|Fludarabine|fludarabine|mesh-list
93044659|NCT00096382|Fludarabine phosphate|fludarabine phosphate|mesh-list
93044660|NCT00096382|Interleukin-2|interleukin-2|mesh-list
93044661|NCT00096382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044662|NCT00096382|Immunologic Factors|immunologic factors|mesh-ancestor
93044663|NCT00096382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044664|NCT00096382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044665|NCT00096382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93044666|NCT00096382|Alkylating Agents|alkylating agents|mesh-ancestor
93044667|NCT00096382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044668|NCT00096382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044669|NCT00096382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93044670|NCT00096382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93044671|NCT00096382|Antimetabolites|antimetabolites|mesh-ancestor
93044672|NCT00096382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93044673|NCT00096382|Analgesics|analgesics|mesh-ancestor
93044674|NCT00096382|Sensory System Agents|sensory system agents|mesh-ancestor
93044675|NCT00096382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044676|NCT00096382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044677|NCT00096382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044678|NCT00096382|Antiviral Agents|antiviral agents|mesh-ancestor
93044679|NCT00096382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044680|NCT00384332|Olanzapine|olanzapine|mesh-list
93044681|NCT00384332|Antiemetics|antiemetics|mesh-ancestor
93044682|NCT00384332|Autonomic Agents|autonomic agents|mesh-ancestor
93044683|NCT00384332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044684|NCT00384332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044685|NCT00384332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044686|NCT00384332|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93044687|NCT00384332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93044688|NCT00384332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044689|NCT00384332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93044690|NCT00384332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93044691|NCT00384332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93044692|NCT00384332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044693|NCT00384332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044694|NCT00384332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044695|NCT00384332|Serotonin Agents|serotonin agents|mesh-ancestor
93044696|NCT00096226|Paclitaxel|paclitaxel|mesh-list
93044697|NCT00096226|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93044698|NCT00096226|Carboplatin|carboplatin|mesh-list
93044699|NCT00096226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044700|NCT00096226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044701|NCT00096226|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044702|NCT00096226|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044703|NCT00096226|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044704|NCT00096226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044705|NCT01078714|Bumetanide|bumetanide|mesh-list
93044706|NCT01078714|Diuretics|diuretics|mesh-ancestor
93044707|NCT01078714|Natriuretic Agents|natriuretic agents|mesh-ancestor
93044708|NCT01078714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044709|NCT01078714|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93044710|NCT01078714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044711|NCT01078714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044712|NCT03964324|Nitric Oxide|nitric oxide|mesh-list
93044713|NCT03964324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93044714|NCT03964324|Autonomic Agents|autonomic agents|mesh-ancestor
93044715|NCT03964324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044716|NCT03964324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044717|NCT03964324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93044718|NCT03964324|Respiratory System Agents|respiratory system agents|mesh-ancestor
93044719|NCT03964324|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93044720|NCT03964324|Antioxidants|antioxidants|mesh-ancestor
93044721|NCT03964324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044722|NCT03964324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044723|NCT03964324|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93044724|NCT03964324|Vasodilator Agents|vasodilator agents|mesh-ancestor
92689929|NCT01241175|Anesthetics|anesthetics|mesh-ancestor
93044725|NCT03964324|Gasotransmitters|gasotransmitters|mesh-ancestor
93044726|NCT03964324|Protective Agents|protective agents|mesh-ancestor
93044727|NCT01082848|Aripiprazole|aripiprazole|mesh-list
93044728|NCT01082848|Antidepressive Agents|antidepressive agents|mesh-ancestor
93044729|NCT01082848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93044730|NCT01082848|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93044731|NCT01082848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93044732|NCT01082848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044733|NCT01082848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044734|NCT01082848|Dopamine Agonists|dopamine agonists|mesh-ancestor
93044736|NCT01082848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044737|NCT01082848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044738|NCT01082848|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93044739|NCT01082848|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93044740|NCT01082848|Serotonin Agents|serotonin agents|mesh-ancestor
93044741|NCT01082848|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93044742|NCT01082848|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93044743|NCT01082848|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93044744|NCT01082848|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93044745|NCT01082926|Aldesleukin|aldesleukin|mesh-list
93044746|NCT01082926|Interleukin-2|interleukin-2|mesh-list
93044747|NCT01082926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044748|NCT01082926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93044749|NCT01082926|Analgesics|analgesics|mesh-ancestor
93044750|NCT01082926|Sensory System Agents|sensory system agents|mesh-ancestor
93044751|NCT01082926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044752|NCT01082926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044753|NCT01082926|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93044754|NCT01082926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93044755|NCT01082926|Antiviral Agents|antiviral agents|mesh-ancestor
93044756|NCT01082926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044757|NCT03962920|Tigecycline|tigecycline|mesh-list
93044758|NCT03962920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93044759|NCT03962920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044760|NCT03962920|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93044761|NCT03962920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044762|NCT03962920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044763|NCT01078870|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93044764|NCT01078870|Escitalopram|escitalopram|mesh-list
93044765|NCT01078870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93044766|NCT01078870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93044767|NCT01078870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044768|NCT01078870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044769|NCT01078870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044770|NCT01078870|Serotonin Agents|serotonin agents|mesh-ancestor
93044771|NCT01078870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044772|NCT01078870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044773|NCT01078870|Antidepressive Agents|antidepressive agents|mesh-ancestor
93044774|NCT01078870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93044775|NCT01078870|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93044776|NCT01078870|Analgesics|analgesics|mesh-ancestor
93044777|NCT01078870|Sensory System Agents|sensory system agents|mesh-ancestor
93044778|NCT01078870|Dopamine Agents|dopamine agents|mesh-ancestor
93044779|NCT00105196|Aripiprazole|aripiprazole|mesh-list
93044780|NCT00105196|Antidepressive Agents|antidepressive agents|mesh-ancestor
93044781|NCT00105196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93044782|NCT00105196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93044783|NCT00105196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93044784|NCT00105196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044785|NCT00105196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044786|NCT00105196|Dopamine Agonists|dopamine agonists|mesh-ancestor
93044788|NCT00105196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044789|NCT00105196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044790|NCT00105196|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93044791|NCT00105196|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93044792|NCT00105196|Serotonin Agents|serotonin agents|mesh-ancestor
93044793|NCT00105196|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93044794|NCT00105196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93044795|NCT00105196|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93044796|NCT00105196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93044797|NCT00104572|Vitamin D|vitamin d|mesh-list
93044798|NCT00104572|Anastrozole|anastrozole|mesh-list
93044799|NCT00104572|Calcium|calcium|mesh-list
93044800|NCT00104572|Testosterone|testosterone|mesh-list
92690007|NCT01241162|Decitabine|decitabine|mesh-list
93044801|NCT00104572|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93044802|NCT00104572|Vitamins|vitamins|mesh-ancestor
93044803|NCT00104572|Micronutrients|micronutrients|mesh-ancestor
93044804|NCT00104572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044805|NCT00104572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93044806|NCT00104572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93044807|NCT00104572|Androgens|androgens|mesh-ancestor
93044808|NCT00104572|Hormones|hormones|mesh-ancestor
93044809|NCT00104572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044810|NCT00104572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93044811|NCT00104572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044812|NCT00104572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93044813|NCT00104572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044814|NCT00104572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044815|NCT00104572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93044816|NCT00104572|Hormone Antagonists|hormone antagonists|mesh-ancestor
93044817|NCT00514943|Cetuximab|cetuximab|mesh-list
93044818|NCT00514943|Afatinib|afatinib|mesh-list
93044819|NCT00514943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044820|NCT00514943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044821|NCT00514943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93044822|NCT00514943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044823|NCT00514943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044824|NCT00103402|Alfuzosin|alfuzosin|mesh-list
93044825|NCT00103402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93044826|NCT00103402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93044827|NCT00103402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93044828|NCT00103402|Adrenergic Agents|adrenergic agents|mesh-ancestor
93044829|NCT00103402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044830|NCT00103402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044831|NCT00103402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044832|NCT00103402|Urological Agents|urological agents|mesh-ancestor
93044833|NCT00095836|Gefitinib|gefitinib|mesh-list
93044834|NCT00095836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044835|NCT00095836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93044836|NCT00095836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044837|NCT00095836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044838|NCT00168831|Tiotropium Bromide|tiotropium bromide|mesh-list
93044839|NCT00168831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93044840|NCT00168831|Autonomic Agents|autonomic agents|mesh-ancestor
93044841|NCT00168831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044842|NCT00168831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044843|NCT00168831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93044844|NCT00168831|Respiratory System Agents|respiratory system agents|mesh-ancestor
93044845|NCT00168831|Parasympatholytics|parasympatholytics|mesh-ancestor
93044846|NCT00168831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93044847|NCT00168831|Cholinergic Agents|cholinergic agents|mesh-ancestor
93044848|NCT00168831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044849|NCT00168831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044850|NCT03330821|Cytarabine|cytarabine|mesh-list
93044851|NCT03330821|Idarubicin|idarubicin|mesh-list
93044852|NCT03330821|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93044853|NCT03330821|Pevonedistat|pevonedistat|mesh-list
93044854|NCT03330821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93044855|NCT03330821|Antimetabolites|antimetabolites|mesh-ancestor
93044856|NCT03330821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044857|NCT03330821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044858|NCT03330821|Antiviral Agents|antiviral agents|mesh-ancestor
93044859|NCT03330821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93044860|NCT03330821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044861|NCT03330821|Immunologic Factors|immunologic factors|mesh-ancestor
93044862|NCT03330821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044863|NCT03330821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93044864|NCT03330821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044865|NCT03330821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93044866|NCT00512135|Botulinum Toxins|botulinum toxins|mesh-list
93044867|NCT00512135|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93044868|NCT00512135|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93044869|NCT00512135|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93044870|NCT00512135|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93044871|NCT00512135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93044872|NCT00512135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044873|NCT00512135|Cholinergic Agents|cholinergic agents|mesh-ancestor
92690076|NCT00488891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93044874|NCT00512135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288497|NCT02537873|Cocaine|cocaine|mesh-list
93044875|NCT00512135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044876|NCT00512135|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93044877|NCT00512135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044878|NCT03235505|Nicotine|nicotine|mesh-list
93044879|NCT03235505|Varenicline|varenicline|mesh-list
93044880|NCT03235505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93044881|NCT03235505|Autonomic Agents|autonomic agents|mesh-ancestor
92288560|NCT02489357|Pembrolizumab|pembrolizumab|mesh-list
93044882|NCT03235505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93044883|NCT03235505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044884|NCT03235505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93044885|NCT03235505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93044886|NCT03235505|Cholinergic Agents|cholinergic agents|mesh-ancestor
93044887|NCT03235505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288698|NCT01826851|Sensory System Agents|sensory system agents|mesh-ancestor
93044888|NCT03235505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044889|NCT00251979|Esomeprazole|esomeprazole|mesh-list
93044890|NCT00251979|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93044891|NCT00251979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93044892|NCT00251979|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92288776|NCT02504723|Carvedilol|carvedilol|mesh-list
93044893|NCT00251979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044894|NCT00251979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044895|NCT00511901|Epoetin Alfa|epoetin alfa|mesh-list
93044896|NCT00511901|Hematinics|hematinics|mesh-ancestor
93044897|NCT04580147|Aflibercept|aflibercept|mesh-list
93044898|NCT04580147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93044899|NCT04580147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93044900|NCT04580147|Growth Substances|growth substances|mesh-ancestor
93044901|NCT04580147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288919|NCT02561897|Antithrombins|antithrombins|mesh-ancestor
93044902|NCT04580147|Growth Inhibitors|growth inhibitors|mesh-ancestor
93044903|NCT04580147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044904|NCT03147287|Fulvestrant|fulvestrant|mesh-list
93044905|NCT03147287|Palbociclib|palbociclib|mesh-list
93044906|NCT03147287|Avelumab|avelumab|mesh-list
93044907|NCT03147287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93044908|NCT03147287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044909|NCT03147287|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93044910|NCT03147287|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93044911|NCT03147287|Hormone Antagonists|hormone antagonists|mesh-ancestor
93044912|NCT03147287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044913|NCT03147287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044914|NCT03147287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93044915|NCT03147287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044916|NCT03147287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044917|NCT03147287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93044918|NCT00228423|Clopidogrel|clopidogrel|mesh-list
93044919|NCT00228423|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93044920|NCT00228423|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93044921|NCT00228423|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93044922|NCT00228423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93044923|NCT00228423|Purinergic Agents|purinergic agents|mesh-ancestor
93044924|NCT00228423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044925|NCT00228423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044926|NCT00228423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044927|NCT00513695|Paclitaxel|paclitaxel|mesh-list
93044928|NCT00513695|Cyclophosphamide|cyclophosphamide|mesh-list
93044929|NCT00513695|Doxorubicin|doxorubicin|mesh-list
93044930|NCT00513695|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93044931|NCT00513695|Sunitinib|sunitinib|mesh-list
93044932|NCT00513695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93044933|NCT00513695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93044934|NCT00513695|Tubulin Modulators|tubulin modulators|mesh-ancestor
93044935|NCT00513695|Antimitotic Agents|antimitotic agents|mesh-ancestor
93044936|NCT00513695|Mitosis Modulators|mitosis modulators|mesh-ancestor
93044937|NCT00513695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289488|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
93044938|NCT00513695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93044939|NCT00513695|Immunologic Factors|immunologic factors|mesh-ancestor
93044940|NCT00513695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044941|NCT00513695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93044942|NCT00513695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93044943|NCT00513695|Alkylating Agents|alkylating agents|mesh-ancestor
93044944|NCT00513695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93044945|NCT00513695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93044946|NCT00513695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93044947|NCT00513695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92289625|NCT01847131|Phenylephrine|phenylephrine|mesh-list
93044948|NCT00513695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044949|NCT00513695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93044950|NCT00513695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93044951|NCT00513695|Growth Substances|growth substances|mesh-ancestor
93044952|NCT00513695|Growth Inhibitors|growth inhibitors|mesh-ancestor
93044953|NCT00513695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93044954|NCT00162981|Clobazam|clobazam|mesh-list
93044955|NCT00162981|Anticonvulsants|anticonvulsants|mesh-ancestor
93044956|NCT00162981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93044957|NCT00162981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93044958|NCT00162981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93044959|NCT00162981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044960|NCT00162981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93044961|NCT00162981|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93044962|NCT00162981|GABA Agonists|gaba agonists|mesh-ancestor
93044963|NCT00162981|GABA Agents|gaba agents|mesh-ancestor
93044964|NCT00162981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93044965|NCT00162981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044966|NCT00099268|Levodopa|levodopa|mesh-list
93044967|NCT00099268|Carbidopa|carbidopa|mesh-list
93044968|NCT00099268|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93044969|NCT00099268|Entacapone|entacapone|mesh-list
93044970|NCT00099268|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93044971|NCT00099268|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93044972|NCT00099268|Dopamine Agents|dopamine agents|mesh-ancestor
93044973|NCT00099268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289762|NCT00550771|Cyclophosphamide|cyclophosphamide|mesh-list
93044974|NCT00099268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93044975|NCT00099268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044976|NCT00099268|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93044977|NCT00099268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93044978|NCT00099268|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93044979|NCT00099268|Immunologic Factors|immunologic factors|mesh-ancestor
93044980|NCT00099268|Dopamine Agonists|dopamine agonists|mesh-ancestor
93044981|NCT00099268|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93044982|NCT00511355|Levonorgestrel|levonorgestrel|mesh-list
93044983|NCT00511355|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93044984|NCT00511355|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
93044985|NCT00511355|Estradiol|estradiol|mesh-list
93044986|NCT00511355|Estrogens|estrogens|mesh-ancestor
93044987|NCT00511355|Hormones|hormones|mesh-ancestor
93044988|NCT00511355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93044989|NCT00511355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93044990|NCT00511355|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93044991|NCT00511355|Contraceptive Agents|contraceptive agents|mesh-ancestor
93044992|NCT00511355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93044993|NCT00511355|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93044994|NCT00511355|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93044995|NCT00511355|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93044996|NCT00511355|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93044997|NCT00511355|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93044998|NCT01083784|Valproic Acid|valproic acid|mesh-list
93044999|NCT01083784|Clonazepam|clonazepam|mesh-list
93045000|NCT01083784|Anticonvulsants|anticonvulsants|mesh-list
93045001|NCT01083784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045002|NCT01083784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045003|NCT01083784|GABA Agents|gaba agents|mesh-ancestor
93045004|NCT01083784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290171|NCT02641691|Leucovorin|leucovorin|mesh-list
93045005|NCT01083784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045006|NCT01083784|Antimanic Agents|antimanic agents|mesh-ancestor
92290239|NCT03635567|Carboplatin|carboplatin|mesh-list
93045007|NCT01083784|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93045008|NCT01083784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045009|NCT01083784|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93045010|NCT01083784|GABA Modulators|gaba modulators|mesh-ancestor
93045011|NCT00095212|Testosterone|testosterone|mesh-list
93045012|NCT00095212|Androgens|androgens|mesh-ancestor
93045013|NCT00095212|Hormones|hormones|mesh-ancestor
93045014|NCT00095212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045015|NCT00095212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045016|NCT02834975|Paclitaxel|paclitaxel|mesh-list
93045017|NCT02834975|Carboplatin|carboplatin|mesh-list
93045018|NCT02834975|Pembrolizumab|pembrolizumab|mesh-list
93045019|NCT02834975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93045020|NCT02834975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045021|NCT02834975|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045022|NCT02834975|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045023|NCT02834975|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045024|NCT02834975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045025|NCT02834975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045026|NCT02834975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93045027|NCT00120874|Memantine|memantine|mesh-list
93045028|NCT00120874|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93045029|NCT00120874|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93045030|NCT00120874|Dopamine Agents|dopamine agents|mesh-ancestor
93045031|NCT00120874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045032|NCT00120874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045033|NCT00120874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045034|NCT00120874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93045035|NCT00120874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93045036|NCT00120250|Eszopiclone|eszopiclone|mesh-list
93045037|NCT00120250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93045038|NCT00120250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045039|NCT00120250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045040|NCT01081600|Trastuzumab|trastuzumab|mesh-list
93045041|NCT01081600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045042|NCT01081600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045043|NCT01079338|Caffeine|caffeine|mesh-list
93045044|NCT01079338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93045045|NCT01079338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045046|NCT01079338|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93045047|NCT01079338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290950|NCT05544786|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93045048|NCT01079338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291024|NCT01947907|Hormones|hormones|mesh-list
93045049|NCT01079338|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93045050|NCT01079338|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93045051|NCT01079338|Purinergic Agents|purinergic agents|mesh-ancestor
93045052|NCT01079338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045053|NCT00384176|Leucovorin|leucovorin|mesh-list
93045054|NCT00384176|Bevacizumab|bevacizumab|mesh-list
93045055|NCT00384176|Fluorouracil|fluorouracil|mesh-list
93045056|NCT00384176|Oxaliplatin|oxaliplatin|mesh-list
93045057|NCT00384176|Cediranib|cediranib|mesh-list
93045058|NCT00384176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045059|NCT00384176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045060|NCT00384176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93045061|NCT00384176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93045062|NCT00384176|Growth Substances|growth substances|mesh-ancestor
93045063|NCT00384176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045064|NCT00384176|Growth Inhibitors|growth inhibitors|mesh-ancestor
93045065|NCT00384176|Antimetabolites|antimetabolites|mesh-ancestor
93045066|NCT00384176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045067|NCT00384176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045068|NCT00384176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045069|NCT00384176|Immunologic Factors|immunologic factors|mesh-ancestor
93045070|NCT00384176|Antidotes|antidotes|mesh-ancestor
93045071|NCT00384176|Protective Agents|protective agents|mesh-ancestor
93045072|NCT00384176|Vitamin B Complex|vitamin b complex|mesh-ancestor
93045073|NCT00384176|Vitamins|vitamins|mesh-ancestor
93045074|NCT00384176|Micronutrients|micronutrients|mesh-ancestor
93045075|NCT00384176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045076|NCT00384176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045077|NCT00513305|Cytarabine|cytarabine|mesh-list
93045078|NCT00513305|Arsenic Trioxide|arsenic trioxide|mesh-list
92291103|NCT04739111|Antibodies|antibodies|mesh-list
93045079|NCT00513305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045081|NCT00513305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045082|NCT00513305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045083|NCT00513305|Antiviral Agents|antiviral agents|mesh-ancestor
93045084|NCT00513305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045085|NCT00513305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045086|NCT00513305|Immunologic Factors|immunologic factors|mesh-ancestor
93045087|NCT00513305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045088|NCT00513071|Saracatinib|saracatinib|mesh-list
93045089|NCT00513071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045090|NCT00513071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045091|NCT00513071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045092|NCT00510887|Dexamethasone|dexamethasone|mesh-list
93045093|NCT00510887|Rituximab|rituximab|mesh-list
93045094|NCT00510887|Fludarabine|fludarabine|mesh-list
93045095|NCT00510887|Bortezomib|bortezomib|mesh-list
93045096|NCT00510887|Mitoxantrone|mitoxantrone|mesh-list
93045097|NCT00510887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045098|NCT00510887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690298|NCT04513821|Minocycline|minocycline|mesh-list
93045099|NCT00510887|Immunologic Factors|immunologic factors|mesh-ancestor
93045100|NCT00510887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045101|NCT00510887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045102|NCT00510887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045103|NCT00510887|Antiemetics|antiemetics|mesh-ancestor
93045104|NCT00510887|Autonomic Agents|autonomic agents|mesh-ancestor
93045105|NCT00510887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045106|NCT00510887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045107|NCT00510887|Glucocorticoids|glucocorticoids|mesh-ancestor
93045108|NCT00510887|Hormones|hormones|mesh-ancestor
93045109|NCT00510887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045110|NCT00510887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93045111|NCT00510887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045112|NCT00510887|Analgesics|analgesics|mesh-ancestor
93045113|NCT00510887|Sensory System Agents|sensory system agents|mesh-ancestor
93045114|NCT00510887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93045115|NCT00510887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93045116|NCT00510887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045117|NCT01012349|Aspirin|aspirin|mesh-list
93045118|NCT01012349|Citric Acid|citric acid|mesh-list
93045119|NCT01012349|Sodium Citrate|sodium citrate|mesh-list
93045120|NCT01012349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045121|NCT01012349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045122|NCT01012349|Analgesics|analgesics|mesh-ancestor
93045123|NCT01012349|Sensory System Agents|sensory system agents|mesh-ancestor
93045124|NCT01012349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045125|NCT01012349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045126|NCT01012349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045127|NCT01012349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045128|NCT01012349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93045129|NCT01012349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93045130|NCT01012349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045131|NCT01012349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93045132|NCT01012349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93045133|NCT01012349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045134|NCT01012349|Antipyretics|antipyretics|mesh-ancestor
93045135|NCT01012349|Anticoagulants|anticoagulants|mesh-ancestor
93045136|NCT01012349|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93045137|NCT01012349|Chelating Agents|chelating agents|mesh-ancestor
93045138|NCT01012349|Sequestering Agents|sequestering agents|mesh-ancestor
93045139|NCT00358826|Atreleuton|atreleuton|mesh-list
93045140|NCT00358826|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93045141|NCT00358826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045142|NCT00358826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045143|NCT01009541|Pregabalin|pregabalin|mesh-list
93045144|NCT01009541|Analgesics|analgesics|mesh-ancestor
93045145|NCT01009541|Sensory System Agents|sensory system agents|mesh-ancestor
93045146|NCT01009541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045147|NCT01009541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045148|NCT01009541|Anticonvulsants|anticonvulsants|mesh-ancestor
93045149|NCT01009541|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93045150|NCT01009541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93045151|NCT01009541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045152|NCT01009541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93045154|NCT01009541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93045155|NCT01009541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045156|NCT01009541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93045157|NCT00510653|Imatinib Mesylate|imatinib mesylate|mesh-list
93045158|NCT00510653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045159|NCT00510653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045160|NCT00510653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045161|NCT00510653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045162|NCT01009697|Codeine|codeine|mesh-list
93045163|NCT01009697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93045164|NCT01009697|Narcotics|narcotics|mesh-ancestor
93045165|NCT01009697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045166|NCT01009697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045167|NCT01009697|Analgesics|analgesics|mesh-ancestor
93045168|NCT01009697|Sensory System Agents|sensory system agents|mesh-ancestor
93045169|NCT01009697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045170|NCT01009697|Antitussive Agents|antitussive agents|mesh-ancestor
93045171|NCT01009697|Respiratory System Agents|respiratory system agents|mesh-ancestor
93045172|NCT01009853|Codeine|codeine|mesh-list
93045173|NCT01009853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93045174|NCT01009853|Narcotics|narcotics|mesh-ancestor
93045175|NCT01009853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045176|NCT01009853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045177|NCT01009853|Analgesics|analgesics|mesh-ancestor
93045178|NCT01009853|Sensory System Agents|sensory system agents|mesh-ancestor
93045179|NCT01009853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045180|NCT01009853|Antitussive Agents|antitussive agents|mesh-ancestor
93045181|NCT01009853|Respiratory System Agents|respiratory system agents|mesh-ancestor
93045182|NCT00506285|Methylphenidate|methylphenidate|mesh-list
93045183|NCT00506285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93045184|NCT00506285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045185|NCT00506285|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93045186|NCT00506285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93045187|NCT00506285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93045188|NCT00506285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045189|NCT00506285|Dopamine Agents|dopamine agents|mesh-ancestor
93045190|NCT00506285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045191|NCT00506129|Fludarabine|fludarabine|mesh-list
93045192|NCT00506129|Fludarabine phosphate|fludarabine phosphate|mesh-list
93045194|NCT00506129|Thymoglobulin|thymoglobulin|mesh-list
93045195|NCT00506129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93045196|NCT00506129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045197|NCT00506129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045198|NCT00506129|Antimetabolites|antimetabolites|mesh-ancestor
93045199|NCT00506129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045200|NCT00506129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045201|NCT00506129|Immunologic Factors|immunologic factors|mesh-ancestor
93045202|NCT00506129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045203|NCT00506129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93045204|NCT00506129|Alkylating Agents|alkylating agents|mesh-ancestor
93045205|NCT00506129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93045206|NCT00358670|Infliximab|infliximab|mesh-list
93045207|NCT00358670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93045208|NCT00358670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045209|NCT00358670|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045210|NCT00358670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045211|NCT00358670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045212|NCT01010087|Oseltamivir|oseltamivir|mesh-list
93045213|NCT01010087|Antiviral Agents|antiviral agents|mesh-ancestor
93045214|NCT01010087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045215|NCT01010087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045216|NCT01010087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045217|NCT00505661|Letrozole|letrozole|mesh-list
93045218|NCT00505661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045219|NCT00505661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93045220|NCT00505661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93045221|NCT00505661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045222|NCT00505661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045223|NCT00505661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93045224|NCT00505661|Hormone Antagonists|hormone antagonists|mesh-ancestor
93045225|NCT00505661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045226|NCT00505661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045227|NCT00383786|Vofopitant|vofopitant|mesh-list
93045228|NCT00383786|Antiemetics|antiemetics|mesh-ancestor
93045229|NCT00383786|Autonomic Agents|autonomic agents|mesh-ancestor
93045230|NCT00383786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045231|NCT00383786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045232|NCT00383786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045233|NCT00383786|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93045234|NCT00383786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045235|NCT00383786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045236|NCT05358977|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93045237|NCT05358977|Hemostatics|hemostatics|mesh-ancestor
93045238|NCT05358977|Coagulants|coagulants|mesh-ancestor
93045239|NCT01010243|Pioglitazone|pioglitazone|mesh-list
93045240|NCT01010243|Dexamethasone|dexamethasone|mesh-list
93045241|NCT01010243|Lenalidomide|lenalidomide|mesh-list
93045242|NCT01010243|Treosulfan|treosulfan|mesh-list
93045243|NCT01010243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045244|NCT01010243|Antiemetics|antiemetics|mesh-ancestor
93045245|NCT01010243|Autonomic Agents|autonomic agents|mesh-ancestor
93045246|NCT01010243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045247|NCT01010243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045248|NCT01010243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045249|NCT01010243|Glucocorticoids|glucocorticoids|mesh-ancestor
93045251|NCT01010243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045252|NCT01010243|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93045253|NCT01010243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045254|NCT01010243|Immunologic Factors|immunologic factors|mesh-ancestor
93045255|NCT01010243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93045256|NCT01010243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93045257|NCT01010243|Growth Substances|growth substances|mesh-ancestor
93045258|NCT01010243|Growth Inhibitors|growth inhibitors|mesh-ancestor
93045259|NCT01010243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93045260|NCT01010243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93045261|NCT01010243|Alkylating Agents|alkylating agents|mesh-ancestor
93045262|NCT01010243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045263|NCT00383708|Lanreotide|lanreotide|mesh-list
93045264|NCT00383708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045265|NCT00504881|Brivaracetam|brivaracetam|mesh-list
93045266|NCT00504881|Anticonvulsants|anticonvulsants|mesh-ancestor
93045267|NCT00504725|Ketamine|ketamine|mesh-list
93045268|NCT00504725|Analgesics|analgesics|mesh-ancestor
93045269|NCT00504725|Sensory System Agents|sensory system agents|mesh-ancestor
93045270|NCT00504725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045271|NCT00504725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045272|NCT00504725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93045273|NCT00504725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93045274|NCT00504725|Anesthetics, General|anesthetics, general|mesh-ancestor
93045275|NCT00504725|Anesthetics|anesthetics|mesh-ancestor
93045276|NCT00504725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045277|NCT00504725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93045278|NCT00504725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93045279|NCT00504725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045280|NCT00504725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045281|NCT00383240|Mometasone Furoate|mometasone furoate|mesh-list
93045282|NCT00383240|Formoterol Fumarate|formoterol fumarate|mesh-list
93045283|NCT00383240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93045284|NCT00383240|Autonomic Agents|autonomic agents|mesh-ancestor
93045285|NCT00383240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045286|NCT00383240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045287|NCT00383240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93045288|NCT00383240|Respiratory System Agents|respiratory system agents|mesh-ancestor
93045289|NCT00383240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93045290|NCT00383240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93045291|NCT00383240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93045292|NCT00383240|Adrenergic Agents|adrenergic agents|mesh-ancestor
93045293|NCT00383240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045294|NCT00383240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045295|NCT00383240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045296|NCT00383240|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045297|NCT00383240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93045298|NCT05130788|Nicotine|nicotine|mesh-list
93045299|NCT05130788|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93045300|NCT05130788|Autonomic Agents|autonomic agents|mesh-ancestor
93045301|NCT05130788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291344|NCT02466581|Antiemetics|antiemetics|mesh-ancestor
93045302|NCT05130788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045303|NCT05130788|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93045304|NCT05130788|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93045305|NCT05130788|Cholinergic Agents|cholinergic agents|mesh-ancestor
93045306|NCT05130788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045307|NCT05130788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045309|NCT00362180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93045310|NCT00362180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93045311|NCT00362180|Antimetabolites|antimetabolites|mesh-ancestor
93045312|NCT00362180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045313|NCT00362180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93045314|NCT00383162|Naproxen|naproxen|mesh-list
93045315|NCT00383162|Sumatriptan|sumatriptan|mesh-list
93045316|NCT00383162|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045317|NCT00383162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045318|NCT00383162|Analgesics|analgesics|mesh-ancestor
93045319|NCT00383162|Sensory System Agents|sensory system agents|mesh-ancestor
93045320|NCT00383162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045321|NCT00383162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045322|NCT00383162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045323|NCT00383162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045324|NCT00383162|Gout Suppressants|gout suppressants|mesh-ancestor
93045325|NCT00383162|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93045326|NCT00383162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045327|NCT00383162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045328|NCT00383162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93045329|NCT00383162|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93045330|NCT00383162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93045331|NCT00383162|Serotonin Agents|serotonin agents|mesh-ancestor
93045332|NCT00383162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045333|NCT01052792|Naproxen|naproxen|mesh-list
93045334|NCT01052792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045335|NCT01052792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045336|NCT01052792|Analgesics|analgesics|mesh-ancestor
93045337|NCT01052792|Sensory System Agents|sensory system agents|mesh-ancestor
93045338|NCT01052792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045339|NCT01052792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045340|NCT01052792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045341|NCT01052792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045342|NCT01052792|Gout Suppressants|gout suppressants|mesh-ancestor
93045343|NCT01052792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93045344|NCT01052792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045345|NCT01052792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045346|NCT01052870|Finasteride|finasteride|mesh-list
93045347|NCT01052870|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93045348|NCT01052870|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93045349|NCT01052870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045350|NCT01052870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045351|NCT01052870|Hormone Antagonists|hormone antagonists|mesh-ancestor
93045352|NCT01052870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045353|NCT01052870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045354|NCT01052870|Urological Agents|urological agents|mesh-ancestor
93045355|NCT00358436|Bromides|bromides|mesh-list
93045356|NCT00358436|Anticonvulsants|anticonvulsants|mesh-ancestor
93045357|NCT01053026|Olmesartan|olmesartan|mesh-list
93045358|NCT01053026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93045359|NCT01053026|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93045360|NCT01053026|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93045361|NCT01053026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045362|NCT01045538|Capecitabine|capecitabine|mesh-list
93045363|NCT01045538|Vorinostat|vorinostat|mesh-list
93045364|NCT01045538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045365|NCT01045538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045366|NCT01045538|Antimetabolites|antimetabolites|mesh-ancestor
93045367|NCT01045538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045368|NCT01045538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93045369|NCT01045538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045370|NCT00361634|Etanercept|etanercept|mesh-list
93045371|NCT00361634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045372|NCT00361634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045374|NCT00361634|Sensory System Agents|sensory system agents|mesh-ancestor
93045375|NCT00361634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045376|NCT00361634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045377|NCT00361634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045378|NCT00361634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045379|NCT00361634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045380|NCT00361634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045381|NCT00361634|Immunologic Factors|immunologic factors|mesh-ancestor
93045382|NCT00357968|Clopidogrel|clopidogrel|mesh-list
93045383|NCT00357968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93045384|NCT00357968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93045385|NCT00357968|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93045386|NCT00357968|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93045387|NCT00357968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93045388|NCT00357968|Purinergic Agents|purinergic agents|mesh-ancestor
93045389|NCT00357968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045390|NCT00357968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045391|NCT00357968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045392|NCT00357656|Factor VIII|factor viii|mesh-list
93045393|NCT00357656|Coagulants|coagulants|mesh-ancestor
93045394|NCT00357500|Thalidomide|thalidomide|mesh-list
93045395|NCT00357500|Celecoxib|celecoxib|mesh-list
93045396|NCT00357500|Cyclophosphamide|cyclophosphamide|mesh-list
93045398|NCT00357500|Fenofibrate|fenofibrate|mesh-list
93045399|NCT00357500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045400|NCT00357500|Immunologic Factors|immunologic factors|mesh-ancestor
93045401|NCT00357500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045402|NCT00357500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045403|NCT00357500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93045404|NCT00357500|Alkylating Agents|alkylating agents|mesh-ancestor
93045405|NCT00357500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291665|NCT00370019|Estrogens|estrogens|mesh-ancestor
93045406|NCT00357500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045407|NCT00357500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93045408|NCT00357500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93045409|NCT00357500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93045410|NCT00357500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93045411|NCT00357500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045412|NCT00357500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045413|NCT00357500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045414|NCT00357500|Analgesics|analgesics|mesh-ancestor
93045415|NCT00357500|Sensory System Agents|sensory system agents|mesh-ancestor
93045416|NCT00357500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045417|NCT00357500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045418|NCT00357500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93045419|NCT00357500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92291865|NCT01911169|Vitamin D|vitamin d|mesh-list
93045420|NCT00357500|Leprostatic Agents|leprostatic agents|mesh-ancestor
93045421|NCT00357500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93045422|NCT00357500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045423|NCT00357500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93045424|NCT00357500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93045425|NCT00357500|Growth Substances|growth substances|mesh-ancestor
92291936|NCT03251651|Propofol|propofol|mesh-list
93045426|NCT00357500|Growth Inhibitors|growth inhibitors|mesh-ancestor
93045427|NCT00357500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93045428|NCT00357500|Antimetabolites|antimetabolites|mesh-ancestor
93045429|NCT00357500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93045430|NCT00357110|Fulvestrant|fulvestrant|mesh-list
93045431|NCT00357110|Anastrozole|anastrozole|mesh-list
93045432|NCT00357110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93045433|NCT00357110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045434|NCT00357110|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93045435|NCT00357110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93045436|NCT00357110|Hormone Antagonists|hormone antagonists|mesh-ancestor
93045437|NCT00357110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045438|NCT00357110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045439|NCT00357110|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92292062|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
93045440|NCT00357110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93045441|NCT00357110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045442|NCT00357110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045443|NCT03337646|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
93045444|NCT03337646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93045445|NCT03337646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045446|NCT03337646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93045447|NCT03337646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93045448|NCT03337646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93045449|NCT03337646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045450|NCT03337646|Dopamine Agents|dopamine agents|mesh-ancestor
93045451|NCT03337646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045452|NCT00098722|Maraviroc|maraviroc|mesh-list
93045453|NCT00098722|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93045454|NCT00098722|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92292277|NCT02748785|Methotrexate|methotrexate|mesh-list
93045455|NCT00098722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045456|NCT00098722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93045457|NCT00098722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93045458|NCT00098722|Antiviral Agents|antiviral agents|mesh-ancestor
93045459|NCT00098722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045460|NCT00098722|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93045461|NCT02531152|Latanoprost|latanoprost|mesh-list
93045462|NCT02531152|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93045463|NCT02531152|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93045464|NCT01084408|Paclitaxel|paclitaxel|mesh-list
93045465|NCT01084408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93045466|NCT01084408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93045467|NCT01084408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045468|NCT01084408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92690673|NCT00485901|Olanzapine|olanzapine|mesh-list
93045469|NCT01084408|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045470|NCT01084408|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045471|NCT01084408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045472|NCT00098254|Sorafenib|sorafenib|mesh-list
93045473|NCT00098254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045474|NCT00098254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292572|NCT02917993|Osimertinib|osimertinib|mesh-list
93045475|NCT00098254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045476|NCT00098254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045477|NCT00095056|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93045478|NCT00095056|Glipizide|glipizide|mesh-list
93045479|NCT00095056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93045480|NCT00095056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045481|NCT00095056|Incretins|incretins|mesh-ancestor
93045482|NCT00095056|Hormones|hormones|mesh-ancestor
93045483|NCT00095056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045484|NCT00095056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93045485|NCT00095056|Protease Inhibitors|protease inhibitors|mesh-ancestor
93045486|NCT00095056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045487|NCT00095056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045488|NCT00098020|Isotretinoin|isotretinoin|mesh-list
93045489|NCT00098020|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045490|NCT00381680|Leucovorin|leucovorin|mesh-list
93045491|NCT00381680|Cytarabine|cytarabine|mesh-list
93045492|NCT00381680|Dexamethasone|dexamethasone|mesh-list
93045493|NCT00381680|Prednisone|prednisone|mesh-list
93045494|NCT00381680|Cyclophosphamide|cyclophosphamide|mesh-list
93045495|NCT00381680|Doxorubicin|doxorubicin|mesh-list
93045496|NCT00381680|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93045497|NCT00381680|Methotrexate|methotrexate|mesh-list
93045498|NCT00381680|Etoposide|etoposide|mesh-list
93045499|NCT00381680|Vincristine|vincristine|mesh-list
93045500|NCT00381680|Etoposide phosphate|etoposide phosphate|mesh-list
93045501|NCT00381680|Asparaginase|asparaginase|mesh-list
93045502|NCT00381680|Mercaptopurine|mercaptopurine|mesh-list
93045503|NCT00381680|Pegaspargase|pegaspargase|mesh-list
93045504|NCT00381680|Levoleucovorin|levoleucovorin|mesh-list
93045505|NCT00381680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045506|NCT00381680|Immunologic Factors|immunologic factors|mesh-ancestor
93045507|NCT00381680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045508|NCT00381680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045509|NCT00381680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93045510|NCT00381680|Alkylating Agents|alkylating agents|mesh-ancestor
93045511|NCT00381680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293067|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
93045512|NCT00381680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045513|NCT00381680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93045514|NCT00381680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045515|NCT00381680|Antiemetics|antiemetics|mesh-ancestor
93045516|NCT00381680|Autonomic Agents|autonomic agents|mesh-ancestor
93045517|NCT00381680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045518|NCT00381680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045519|NCT00381680|Glucocorticoids|glucocorticoids|mesh-ancestor
93045520|NCT00381680|Hormones|hormones|mesh-ancestor
92529310|NCT00001013|Protective Agents|protective agents|mesh-ancestor
93045521|NCT00381680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045522|NCT00381680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93045523|NCT00381680|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93045524|NCT00381680|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93045525|NCT00381680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93045526|NCT00381680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045527|NCT00381680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93045528|NCT00381680|Abortifacient Agents|abortifacient agents|mesh-ancestor
93045529|NCT00381680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93045530|NCT00381680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045532|NCT00381680|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045533|NCT00381680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93045534|NCT00381680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93045535|NCT00381680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93045536|NCT00381680|Antiviral Agents|antiviral agents|mesh-ancestor
93045537|NCT00381680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045538|NCT00381680|Antidotes|antidotes|mesh-ancestor
93045539|NCT00381680|Protective Agents|protective agents|mesh-ancestor
93045540|NCT00381680|Vitamin B Complex|vitamin b complex|mesh-ancestor
93045541|NCT00381680|Vitamins|vitamins|mesh-ancestor
93045542|NCT00381680|Micronutrients|micronutrients|mesh-ancestor
93045543|NCT00381680|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045544|NCT00381680|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045545|NCT00381680|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045546|NCT03292250|Durvalumab|durvalumab|mesh-list
93045547|NCT03292250|Tremelimumab|tremelimumab|mesh-list
93045548|NCT03292250|Nintedanib|nintedanib|mesh-list
93045549|NCT03292250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045550|NCT03292250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293620|NCT01973348|Adrenergic Agents|adrenergic agents|mesh-ancestor
93045551|NCT03292250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045552|NCT03292250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045553|NCT03292250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045554|NCT01053338|Diphenhydramine|diphenhydramine|mesh-list
93045555|NCT01053338|Promethazine|promethazine|mesh-list
93045556|NCT01053338|Ibuprofen|ibuprofen|mesh-list
93045557|NCT01053338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045558|NCT01053338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045559|NCT01053338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045560|NCT01053338|Analgesics|analgesics|mesh-ancestor
93045561|NCT01053338|Sensory System Agents|sensory system agents|mesh-ancestor
93045562|NCT01053338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293764|NCT02938949|Alirocumab|alirocumab|mesh-list
93045563|NCT01053338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045564|NCT01053338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045565|NCT01053338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045566|NCT01053338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93045567|NCT01053338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045568|NCT01053338|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93045569|NCT01053338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93045570|NCT01053338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045571|NCT01053338|Anesthetics, Local|anesthetics, local|mesh-ancestor
93045572|NCT01053338|Anesthetics|anesthetics|mesh-ancestor
93045573|NCT01053338|Antiemetics|antiemetics|mesh-ancestor
93045574|NCT01053338|Autonomic Agents|autonomic agents|mesh-ancestor
93045575|NCT01053338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045576|NCT01053338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93045577|NCT01053338|Histamine Antagonists|histamine antagonists|mesh-ancestor
93045578|NCT01053338|Histamine Agents|histamine agents|mesh-ancestor
93045579|NCT01053338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045580|NCT01053338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93045581|NCT01053338|Antipruritics|antipruritics|mesh-ancestor
93045582|NCT01053338|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045583|NCT01050374|Albendazole|albendazole|mesh-list
92294052|NCT02024204|Xhance|xhance|mesh-list
93045584|NCT01050374|Praziquantel|praziquantel|mesh-list
93045585|NCT01050374|Mebendazole|mebendazole|mesh-list
93045586|NCT01050374|Piperazine|piperazine|mesh-list
93045587|NCT01050374|Piperazine citrate|piperazine citrate|mesh-list
93045588|NCT01050374|DMP 777|dmp 777|mesh-list
93045589|NCT01050374|Anthelmintics|anthelmintics|mesh-ancestor
93045590|NCT01050374|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93045591|NCT01050374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045592|NCT01050374|Anticestodal Agents|anticestodal agents|mesh-ancestor
93045593|NCT01050374|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92294261|NCT02061397|Antimetabolites|antimetabolites|mesh-ancestor
93045594|NCT01050374|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93045595|NCT01050374|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045597|NCT01050374|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045598|NCT01050374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045599|NCT01050374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045600|NCT01050374|Antinematodal Agents|antinematodal agents|mesh-ancestor
93045601|NCT01050374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045602|NCT00360698|Insulin|insulin|mesh-list
93045603|NCT00360698|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93045604|NCT00360698|Metformin|metformin|mesh-list
93045605|NCT00360698|Insulin Glargine|insulin glargine|mesh-list
93045606|NCT00360698|Glimepiride|glimepiride|mesh-list
93045607|NCT00360698|Insulin glulisine|insulin glulisine|mesh-list
93045608|NCT00360698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93045609|NCT00360698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045610|NCT00360698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93045611|NCT00360698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045612|NCT00360698|Immunologic Factors|immunologic factors|mesh-ancestor
93045613|NCT03990194|Leuprolide|leuprolide|mesh-list
93045614|NCT03990194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93045615|NCT03990194|Fertility Agents|fertility agents|mesh-ancestor
93045616|NCT03990194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93045617|NCT03990194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045618|NCT03990194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93045619|NCT03990194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045620|NCT00380978|Narcotics|narcotics|mesh-list
93045621|NCT00380978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045622|NCT00380978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045623|NCT00380978|Analgesics|analgesics|mesh-ancestor
93045624|NCT00380978|Sensory System Agents|sensory system agents|mesh-ancestor
93045625|NCT00380978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294605|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045627|NCT00162123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045628|NCT00162123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045629|NCT00162123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92294670|NCT04737473|Anesthetics|anesthetics|mesh-list
93045630|NCT00162123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045631|NCT00227721|Gemcitabine|gemcitabine|mesh-list
93045632|NCT00227721|Docetaxel|docetaxel|mesh-list
93045633|NCT00227721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045634|NCT00227721|Antimetabolites|antimetabolites|mesh-ancestor
93045635|NCT00227721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045636|NCT00227721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045637|NCT00227721|Tubulin Modulators|tubulin modulators|mesh-ancestor
92294813|NCT03066947|Interferons|interferons|mesh-list
93045638|NCT00227721|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045639|NCT00227721|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045640|NCT01074723|Carotenoids|carotenoids|mesh-list
93045641|NCT01074723|Antioxidants|antioxidants|mesh-ancestor
93045642|NCT01074723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045643|NCT01074723|Protective Agents|protective agents|mesh-ancestor
93045644|NCT01074723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045645|NCT01074801|Insulin|insulin|mesh-list
93045646|NCT01074801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93045647|NCT01074801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93045648|NCT01074801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045649|NCT01074879|Caseins|caseins|mesh-list
93045650|NCT01074879|Chelating Agents|chelating agents|mesh-ancestor
93045651|NCT01074879|Sequestering Agents|sequestering agents|mesh-ancestor
93045652|NCT01074879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045653|NCT00226941|Diphenhydramine|diphenhydramine|mesh-list
93045654|NCT00226941|Promethazine|promethazine|mesh-list
93045655|NCT00226941|Capecitabine|capecitabine|mesh-list
93045656|NCT00226941|Oxaliplatin|oxaliplatin|mesh-list
93045657|NCT00226941|Cetuximab|cetuximab|mesh-list
92294950|NCT02044393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93045658|NCT00226941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045659|NCT00226941|Antimetabolites|antimetabolites|mesh-ancestor
93045660|NCT00226941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045661|NCT00226941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045662|NCT00226941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045663|NCT00226941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92295042|NCT03086213|Dsuvia|dsuvia|mesh-list
93045664|NCT00226941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93045665|NCT00226941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045666|NCT00226941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045667|NCT00226941|Anesthetics, Local|anesthetics, local|mesh-ancestor
93045668|NCT00226941|Anesthetics|anesthetics|mesh-ancestor
92295082|NCT03091673|Incretins|incretins|mesh-ancestor
93045669|NCT00226941|Sensory System Agents|sensory system agents|mesh-ancestor
93045670|NCT00226941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045671|NCT00226941|Antiemetics|antiemetics|mesh-ancestor
93045672|NCT00226941|Autonomic Agents|autonomic agents|mesh-ancestor
93045673|NCT00226941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045674|NCT00226941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93045675|NCT00226941|Histamine Antagonists|histamine antagonists|mesh-ancestor
93045676|NCT00226941|Histamine Agents|histamine agents|mesh-ancestor
93045677|NCT00226941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045678|NCT00226941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93045679|NCT00226941|Antipruritics|antipruritics|mesh-ancestor
93045680|NCT00226941|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045681|NCT01075503|Ropivacaine|ropivacaine|mesh-list
93045682|NCT01075503|Anesthetics, Local|anesthetics, local|mesh-ancestor
93045683|NCT01075503|Anesthetics|anesthetics|mesh-ancestor
92295294|NCT03101033|Glucocorticoids|glucocorticoids|mesh-ancestor
93045684|NCT01075503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045685|NCT01075503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045686|NCT01075503|Sensory System Agents|sensory system agents|mesh-ancestor
93045687|NCT01075503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045688|NCT01075581|Epinephrine|epinephrine|mesh-list
93045689|NCT01075581|Racepinephrine|racepinephrine|mesh-list
93045690|NCT01075581|Epinephryl borate|epinephryl borate|mesh-list
93045691|NCT01075581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93045692|NCT01075581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93045693|NCT01075581|Adrenergic Agents|adrenergic agents|mesh-ancestor
93045694|NCT01075581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045695|NCT01075581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045696|NCT01075581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045697|NCT01075581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93045698|NCT01075581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93045699|NCT01075581|Autonomic Agents|autonomic agents|mesh-ancestor
93045700|NCT01075581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045701|NCT01075581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93045702|NCT01075581|Respiratory System Agents|respiratory system agents|mesh-ancestor
93045703|NCT01075581|Mydriatics|mydriatics|mesh-ancestor
93045704|NCT01075581|Sympathomimetics|sympathomimetics|mesh-ancestor
93045705|NCT01075581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93045706|NCT00356408|Certolizumab Pegol|certolizumab pegol|mesh-list
93045707|NCT00356408|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93045708|NCT00356408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045709|NCT00356408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045710|NCT00356408|Immunologic Factors|immunologic factors|mesh-ancestor
93045711|NCT00356408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045712|NCT00356408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045713|NCT00509795|Ranibizumab|ranibizumab|mesh-list
93045714|NCT00509795|Aflibercept|aflibercept|mesh-list
93045715|NCT00509795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93045716|NCT00509795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93045717|NCT00509795|Growth Substances|growth substances|mesh-ancestor
93045718|NCT00509795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045719|NCT00509795|Growth Inhibitors|growth inhibitors|mesh-ancestor
93045720|NCT00509795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045721|NCT00504257|Bevacizumab|bevacizumab|mesh-list
93045723|NCT00504257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93045724|NCT00504257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045725|NCT00504257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93045726|NCT00504257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93045727|NCT00504257|Growth Substances|growth substances|mesh-ancestor
93045728|NCT00504257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045729|NCT00504257|Growth Inhibitors|growth inhibitors|mesh-ancestor
93045730|NCT00504257|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045731|NCT00504257|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045732|NCT00504257|Mitosis Modulators|mitosis modulators|mesh-ancestor
92295607|NCT04652414|Hormones|hormones|mesh-ancestor
93045733|NCT00504257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045734|NCT00509093|Imatinib Mesylate|imatinib mesylate|mesh-list
93045735|NCT00509093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045736|NCT00509093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045737|NCT00509093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045738|NCT00509093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045739|NCT05358509|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
93045740|NCT05358509|Ferric Compounds|ferric compounds|mesh-list
93045741|NCT05358509|Hematinics|hematinics|mesh-ancestor
93045742|NCT00160641|Certolizumab Pegol|certolizumab pegol|mesh-list
93045743|NCT00160641|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93045744|NCT00160641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045745|NCT00160641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045746|NCT00160641|Immunologic Factors|immunologic factors|mesh-ancestor
93045747|NCT00160641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295697|NCT03308669|Topiramate|topiramate|mesh-list
93045748|NCT00160641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045750|NCT00493025|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93045751|NCT00493025|Cisplatin|cisplatin|mesh-list
93045752|NCT00493025|Gefitinib|gefitinib|mesh-list
93045753|NCT00493025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93045754|NCT00493025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045755|NCT00493025|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045756|NCT00493025|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045757|NCT00493025|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045758|NCT00493025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045759|NCT00493025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045760|NCT00493025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045761|NCT01075113|Sorafenib|sorafenib|mesh-list
93045762|NCT01075113|Vorinostat|vorinostat|mesh-list
93045763|NCT01075113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045764|NCT01075113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045765|NCT01075113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295981|NCT03220022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045766|NCT01075113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045767|NCT01075113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93045768|NCT01073319|Rivastigmine|rivastigmine|mesh-list
93045769|NCT01073319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93045770|NCT01073319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296053|NCT02802566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045771|NCT01073319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045772|NCT01073319|Cholinergic Agents|cholinergic agents|mesh-ancestor
93045773|NCT01073319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296135|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
93045774|NCT01073319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045775|NCT01073319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92690961|NCT01242098|Fluticasone|fluticasone|mesh-list
93045776|NCT01073319|Protective Agents|protective agents|mesh-ancestor
93045777|NCT00160563|Levocetirizine|levocetirizine|mesh-list
92296192|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045778|NCT00160563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93045779|NCT00160563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93045780|NCT00160563|Histamine Antagonists|histamine antagonists|mesh-ancestor
93045781|NCT00160563|Histamine Agents|histamine agents|mesh-ancestor
93045782|NCT00160563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045783|NCT00160563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045784|NCT00160563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045785|NCT01050452|Ivermectin|ivermectin|mesh-list
93045786|NCT01050452|Albendazole|albendazole|mesh-list
93045787|NCT01050452|Mebendazole|mebendazole|mesh-list
93045788|NCT01050452|Piperazine|piperazine|mesh-list
93045789|NCT01050452|Piperazine citrate|piperazine citrate|mesh-list
93045790|NCT01050452|DMP 777|dmp 777|mesh-list
93045791|NCT01050452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93045792|NCT01050452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045793|NCT01050452|Anthelmintics|anthelmintics|mesh-ancestor
93045794|NCT01050452|Anticestodal Agents|anticestodal agents|mesh-ancestor
92296432|NCT03226457|Furosemide|furosemide|mesh-list
93045795|NCT01050452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93045796|NCT01050452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93045797|NCT01050452|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045798|NCT01050452|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296484|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
93045799|NCT01050452|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045800|NCT01050452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045801|NCT01050452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045802|NCT01050452|Antinematodal Agents|antinematodal agents|mesh-ancestor
93045803|NCT01050452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045804|NCT00380588|Gemcitabine|gemcitabine|mesh-list
93045805|NCT00380588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045806|NCT00380588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045807|NCT00380588|Antimetabolites|antimetabolites|mesh-ancestor
92296619|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93045808|NCT00380588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045809|NCT00379808|Montelukast|montelukast|mesh-list
93045810|NCT00379808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93045811|NCT00379808|Respiratory System Agents|respiratory system agents|mesh-ancestor
93045812|NCT00379808|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93045813|NCT00379808|Hormone Antagonists|hormone antagonists|mesh-ancestor
93045814|NCT00379808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045815|NCT00379808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045816|NCT00379808|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92296766|NCT00003399|Hormones|hormones|mesh-ancestor
93045817|NCT00379808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93045818|NCT00379808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045819|NCT03990038|Ropivacaine|ropivacaine|mesh-list
93045820|NCT03990038|Anesthetics, Local|anesthetics, local|mesh-ancestor
93045821|NCT03990038|Anesthetics|anesthetics|mesh-ancestor
93045822|NCT03990038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93045823|NCT03990038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045824|NCT03990038|Sensory System Agents|sensory system agents|mesh-ancestor
92296902|NCT02265510|Immunologic Factors|immunologic factors|mesh-ancestor
93045825|NCT03990038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045826|NCT00355784|Hormones|hormones|mesh-list
93045827|NCT00355784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93045828|NCT00355784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045829|NCT02534636|Interferons|interferons|mesh-list
93045830|NCT02534636|Interferon-alpha|interferon-alpha|mesh-list
93045831|NCT02534636|Interferon alpha-2|interferon alpha-2|mesh-list
93045832|NCT02534636|Deucravacitinib|deucravacitinib|mesh-list
93045833|NCT02534636|Famotidine|famotidine|mesh-list
93045834|NCT02534636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045835|NCT02534636|Antiviral Agents|antiviral agents|mesh-ancestor
93045836|NCT02534636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045837|NCT02534636|Immunologic Factors|immunologic factors|mesh-ancestor
93045838|NCT02534636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045839|NCT02534636|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93045840|NCT02534636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045841|NCT02534636|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93045842|NCT02534636|Histamine Antagonists|histamine antagonists|mesh-ancestor
93045843|NCT02534636|Histamine Agents|histamine agents|mesh-ancestor
93045844|NCT02534636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297258|NCT05071352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045845|NCT02534636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045846|NCT02534636|Dermatologic Agents|dermatologic agents|mesh-ancestor
93045847|NCT02534636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045848|NCT02534636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045849|NCT01053650|Acetaminophen|acetaminophen|mesh-list
93045850|NCT01053650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93045851|NCT01053650|Analgesics|analgesics|mesh-ancestor
93045852|NCT01053650|Sensory System Agents|sensory system agents|mesh-ancestor
93045853|NCT01053650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045854|NCT01053650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045855|NCT01053650|Antipyretics|antipyretics|mesh-ancestor
93045856|NCT01053728|Insulin Glargine|insulin glargine|mesh-list
93045857|NCT01053728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93045858|NCT01053728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045859|NCT01050608|Ethanol|ethanol|mesh-list
93045860|NCT01050608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93045861|NCT01050608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045862|NCT01050608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297473|NCT00360386|Clopidogrel|clopidogrel|mesh-list
93045863|NCT01050608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045864|NCT01053806|Lenalidomide|lenalidomide|mesh-list
93045865|NCT01053806|Azacitidine|azacitidine|mesh-list
93045866|NCT01053806|Immunologic Factors|immunologic factors|mesh-ancestor
93045867|NCT01053806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045868|NCT01053806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93045869|NCT01053806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93045870|NCT01053806|Growth Substances|growth substances|mesh-ancestor
93045871|NCT01053806|Growth Inhibitors|growth inhibitors|mesh-ancestor
93045872|NCT01053806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045873|NCT01053806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045874|NCT01053806|Antimetabolites|antimetabolites|mesh-ancestor
93045875|NCT01053806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045876|NCT01053806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045877|NCT00355472|Mogamulizumab|mogamulizumab|mesh-list
93045878|NCT00355472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045879|NCT01053884|Anidulafungin|anidulafungin|mesh-list
93045880|NCT01053884|Antifungal Agents|antifungal agents|mesh-ancestor
93045881|NCT01053884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93045882|NCT00492557|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93045883|NCT00492557|Immunologic Factors|immunologic factors|mesh-ancestor
93045884|NCT00492557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045885|NCT01010789|Modafinil|modafinil|mesh-list
93045886|NCT01010789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92297830|NCT05922605|Ketamine|ketamine|mesh-list
93045887|NCT01010789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045888|NCT01010789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93045889|NCT01010789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93045890|NCT01010789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92297899|NCT05922306|Antiviral Agents|antiviral agents|mesh-ancestor
93045891|NCT01010789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045892|NCT01015235|Ketorolac|ketorolac|mesh-list
93045893|NCT01015235|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93045894|NCT01015235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93045896|NCT01015235|Analgesics|analgesics|mesh-ancestor
93045897|NCT01015235|Sensory System Agents|sensory system agents|mesh-ancestor
93045898|NCT01015235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93045899|NCT01015235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045900|NCT01015235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93045901|NCT01015235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298039|NCT05920512|GABA Agents|gaba agents|mesh-ancestor
93045902|NCT01015235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93045903|NCT01015235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298109|NCT05919316|Mometasone Furoate|mometasone furoate|mesh-list
93045904|NCT01015235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045905|NCT00508157|Olanzapine|olanzapine|mesh-list
93045906|NCT00508157|Risperidone|risperidone|mesh-list
93045907|NCT00508157|Aripiprazole|aripiprazole|mesh-list
93045908|NCT00508157|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93045909|NCT00508157|Antipsychotic Agents|antipsychotic agents|mesh-list
93045910|NCT00508157|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93045911|NCT00508157|Serotonin Agents|serotonin agents|mesh-ancestor
93045912|NCT00508157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045913|NCT00508157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045914|NCT00508157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045915|NCT00508157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93045916|NCT00508157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298182|NCT05888311|Charcoal|charcoal|mesh-list
93045917|NCT00508157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93045918|NCT00508157|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93045919|NCT00508157|Dopamine Agents|dopamine agents|mesh-ancestor
93045920|NCT00508157|Antiemetics|antiemetics|mesh-ancestor
93045921|NCT00508157|Autonomic Agents|autonomic agents|mesh-ancestor
93045922|NCT00508157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298325|NCT05832398|Antidotes|antidotes|mesh-ancestor
93045923|NCT00508157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93045924|NCT00508157|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93045925|NCT00508157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92298391|NCT05803551|Anesthetics|anesthetics|mesh-ancestor
93045926|NCT00508157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93045927|NCT00508157|Antidepressive Agents|antidepressive agents|mesh-ancestor
93045928|NCT00508157|Dopamine Agonists|dopamine agonists|mesh-ancestor
93045929|NCT00508157|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93045930|NCT00508157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93045931|NCT00508157|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93045932|NCT00508157|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93045933|NCT04331717|Leuprolide|leuprolide|mesh-list
93045934|NCT04331717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93045935|NCT04331717|Fertility Agents|fertility agents|mesh-ancestor
93045936|NCT04331717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93045937|NCT04331717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045938|NCT04331717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93045939|NCT04331717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045940|NCT01015391|Azathioprine|azathioprine|mesh-list
93045941|NCT01015391|Antimetabolites|antimetabolites|mesh-ancestor
93045942|NCT01015391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045943|NCT01015391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045944|NCT01015391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045945|NCT01015391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93045946|NCT01015391|Immunologic Factors|immunologic factors|mesh-ancestor
93045947|NCT01015391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045948|NCT01015391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93045949|NCT01010945|Paclitaxel|paclitaxel|mesh-list
93045950|NCT01010945|Gemcitabine|gemcitabine|mesh-list
93045951|NCT01010945|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93045952|NCT01010945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93045953|NCT01010945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93045954|NCT01010945|Tubulin Modulators|tubulin modulators|mesh-ancestor
93045955|NCT01010945|Antimitotic Agents|antimitotic agents|mesh-ancestor
93045956|NCT01010945|Mitosis Modulators|mitosis modulators|mesh-ancestor
93045957|NCT01010945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045958|NCT01010945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045959|NCT01010945|Antimetabolites|antimetabolites|mesh-ancestor
93045960|NCT01010945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93045961|NCT01010945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93045962|NCT00507689|Immunoglobulins|immunoglobulins|mesh-list
93045963|NCT00507689|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93045964|NCT00507689|Antibodies|antibodies|mesh-list
93045965|NCT00507689|Immunologic Factors|immunologic factors|mesh-ancestor
93045966|NCT00507689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045968|NCT00491387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93045969|NCT00491387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93045970|NCT00491387|Sympatholytics|sympatholytics|mesh-ancestor
93045971|NCT00491387|Autonomic Agents|autonomic agents|mesh-ancestor
93045972|NCT00491387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299023|NCT05213676|Gasotransmitters|gasotransmitters|mesh-ancestor
93045973|NCT00491387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045974|NCT00491387|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93045975|NCT00491387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93045976|NCT00491387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93045977|NCT00491387|Adrenergic Agents|adrenergic agents|mesh-ancestor
93045978|NCT00491387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93045979|NCT00491387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045980|NCT01011257|Clopidogrel|clopidogrel|mesh-list
93045981|NCT01011257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93045982|NCT01011257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93045983|NCT01011257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93045984|NCT01011257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93045985|NCT01011257|Purinergic Agents|purinergic agents|mesh-ancestor
93045986|NCT01011257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299090|NCT05155293|Growth Substances|growth substances|mesh-ancestor
93045987|NCT01011257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93045988|NCT01011257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045989|NCT01015547|Sulfasalazine|sulfasalazine|mesh-list
93045991|NCT01015547|Methotrexate|methotrexate|mesh-list
93045992|NCT01015547|Naltrexone|naltrexone|mesh-list
93045993|NCT01015547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93045994|NCT01015547|Abortifacient Agents|abortifacient agents|mesh-ancestor
93045995|NCT01015547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93045996|NCT01015547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93045997|NCT01015547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93045998|NCT01015547|Antimetabolites|antimetabolites|mesh-ancestor
93045999|NCT01015547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046000|NCT01015547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046001|NCT01015547|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046002|NCT01015547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046003|NCT01015547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93046004|NCT01015547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046005|NCT01015547|Immunologic Factors|immunologic factors|mesh-ancestor
93046006|NCT01015547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046007|NCT01015547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93046008|NCT01015547|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93046009|NCT01015547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046010|NCT01015547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92299369|NCT04807517|Buspirone|buspirone|mesh-list
93046011|NCT01015547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046012|NCT01015547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93046013|NCT01015547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93046015|NCT01015547|Sensory System Agents|sensory system agents|mesh-ancestor
93046016|NCT01015547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299441|NCT04730544|Nivolumab|nivolumab|mesh-list
93046017|NCT01015547|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93046018|NCT01015547|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93046019|NCT00491075|Gemcitabine|gemcitabine|mesh-list
93046020|NCT00491075|Pemetrexed|pemetrexed|mesh-list
93046021|NCT00491075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046022|NCT00491075|Antimetabolites|antimetabolites|mesh-ancestor
93046023|NCT00491075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046024|NCT00491075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046025|NCT00491075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046026|NCT00491075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93046027|NCT00491075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93046028|NCT00507455|Tamsulosin|tamsulosin|mesh-list
93046029|NCT00507455|Solifenacin Succinate|solifenacin succinate|mesh-list
93046030|NCT00507455|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93046031|NCT00507455|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93046032|NCT00507455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93046033|NCT00507455|Adrenergic Agents|adrenergic agents|mesh-ancestor
93046034|NCT00507455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046035|NCT00507455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046036|NCT00507455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046037|NCT00507455|Urological Agents|urological agents|mesh-ancestor
93046038|NCT00507455|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93046039|NCT00507455|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93046040|NCT00507455|Cholinergic Agents|cholinergic agents|mesh-ancestor
93046042|NCT04275713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046043|NCT04275713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046044|NCT00506831|Imatinib Mesylate|imatinib mesylate|mesh-list
93046045|NCT00506831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046046|NCT00506831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046047|NCT00506831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046048|NCT00506831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046049|NCT00490919|Buprenorphine|buprenorphine|mesh-list
93046050|NCT00490919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93046051|NCT00490919|Narcotics|narcotics|mesh-ancestor
93046052|NCT00490919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93046053|NCT00490919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046054|NCT00490919|Analgesics|analgesics|mesh-ancestor
93046055|NCT00490919|Sensory System Agents|sensory system agents|mesh-ancestor
93046056|NCT00490919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046057|NCT00490919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93046058|NCT01015937|Losartan|losartan|mesh-list
93046059|NCT01015937|Enalapril|enalapril|mesh-list
93046060|NCT01015937|Angiotensin II|angiotensin ii|mesh-list
93046061|NCT01015937|Giapreza|giapreza|mesh-list
93046062|NCT01015937|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93046063|NCT01015937|Angiotensinogen|angiotensinogen|mesh-list
93046064|NCT01015937|Turmeric extract|turmeric extract|mesh-list
93046065|NCT01015937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93046066|NCT01015937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93046067|NCT01015937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92300064|NCT04172675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046068|NCT01015937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93046069|NCT01015937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046070|NCT01015937|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046071|NCT01015937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046072|NCT01015937|Antioxidants|antioxidants|mesh-ancestor
93046073|NCT01015937|Protective Agents|protective agents|mesh-ancestor
93046074|NCT01015937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046075|NCT01015937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93046076|NCT01015937|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93046077|NCT01012193|Cilostazol|cilostazol|mesh-list
93046078|NCT01012193|Clopidogrel|clopidogrel|mesh-list
93046079|NCT01012193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93046080|NCT01012193|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93046081|NCT01012193|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93046082|NCT01012193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93046083|NCT01012193|Purinergic Agents|purinergic agents|mesh-ancestor
93046084|NCT01012193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046085|NCT01012193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046086|NCT01012193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046087|NCT01012193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93046088|NCT01012193|Autonomic Agents|autonomic agents|mesh-ancestor
93046089|NCT01012193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046090|NCT01012193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93046091|NCT01012193|Respiratory System Agents|respiratory system agents|mesh-ancestor
93046092|NCT01012193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93046093|NCT01012193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93046094|NCT01012193|Vasodilator Agents|vasodilator agents|mesh-ancestor
93046095|NCT01012193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93046096|NCT01012193|Protective Agents|protective agents|mesh-ancestor
93046097|NCT01012193|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93046098|NCT01012193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93046099|NCT01012193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046100|NCT00503399|Teriparatide|teriparatide|mesh-list
93046101|NCT00503399|Risedronic Acid|risedronic acid|mesh-list
93046102|NCT00503399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046103|NCT00503399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046104|NCT00503399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93046105|NCT00503399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93046106|NCT00503399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046107|NCT00503399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046108|NCT00506519|Antithrombins|antithrombins|mesh-list
93046109|NCT00506519|Antithrombin III|antithrombin iii|mesh-list
93046110|NCT00506519|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93046111|NCT00506519|Protease Inhibitors|protease inhibitors|mesh-ancestor
92300418|NCT03841617|Hormones|hormones|mesh-list
93046112|NCT00506519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046113|NCT00506519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046114|NCT00506519|Anticoagulants|anticoagulants|mesh-ancestor
93046115|NCT00503009|Fluticasone|fluticasone|mesh-list
93046116|NCT00503009|Xhance|xhance|mesh-list
93046117|NCT00503009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93046118|NCT00503009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046119|NCT00503009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93046120|NCT00503009|Autonomic Agents|autonomic agents|mesh-ancestor
93046121|NCT00503009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046122|NCT00503009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046123|NCT00503009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93046124|NCT00503009|Respiratory System Agents|respiratory system agents|mesh-ancestor
93046125|NCT00503009|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046126|NCT00503009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93046127|NCT00503009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93046128|NCT00503009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93046129|NCT00503009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93046130|NCT00503009|Adrenergic Agents|adrenergic agents|mesh-ancestor
93046131|NCT00503009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046132|NCT00503009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046133|NCT01016093|Zoledronic Acid|zoledronic acid|mesh-list
93046134|NCT01016093|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93046135|NCT01016093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046136|NCT00160251|Ribavirin|ribavirin|mesh-list
93046137|NCT00160251|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93046138|NCT00160251|Antimetabolites|antimetabolites|mesh-ancestor
93046139|NCT00160251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046140|NCT00160251|Antiviral Agents|antiviral agents|mesh-ancestor
93046141|NCT00160251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046142|NCT01075425|Bortezomib|bortezomib|mesh-list
93046143|NCT01075425|Belinostat|belinostat|mesh-list
93046144|NCT01075425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046145|NCT01075425|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93046146|NCT01075425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300695|NCT03439865|Ivacaftor|ivacaftor|mesh-list
93046147|NCT01075425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046148|NCT00378014|Everolimus|everolimus|mesh-list
93046149|NCT00378014|Basiliximab|basiliximab|mesh-list
93046150|NCT00378014|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93046151|NCT00378014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046152|NCT00378014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046153|NCT00378014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046154|NCT00378014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046155|NCT00378014|Immunologic Factors|immunologic factors|mesh-ancestor
93046156|NCT00378014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046157|NCT00378014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046158|NCT00485303|Prednisone|prednisone|mesh-list
93046159|NCT00485303|Abiraterone Acetate|abiraterone acetate|mesh-list
93046160|NCT00485303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046161|NCT00485303|Glucocorticoids|glucocorticoids|mesh-ancestor
93046162|NCT00485303|Hormones|hormones|mesh-ancestor
93046163|NCT00485303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046164|NCT00485303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046165|NCT00485303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93046166|NCT00485303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046167|NCT00485303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93046168|NCT00485303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046169|NCT00485303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046170|NCT00485303|Hormone Antagonists|hormone antagonists|mesh-ancestor
93046171|NCT00485303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93046172|NCT01018823|Ertugliflozin|ertugliflozin|mesh-list
93046173|NCT01018823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93046174|NCT01018823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046175|NCT01018823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046176|NCT01018823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046177|NCT01016249|Epinephrine|epinephrine|mesh-list
93046178|NCT01016249|Racepinephrine|racepinephrine|mesh-list
93046179|NCT01016249|Epinephryl borate|epinephryl borate|mesh-list
92301020|NCT02667587|Nivolumab|nivolumab|mesh-list
93046180|NCT01016249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93046181|NCT01016249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93046182|NCT01016249|Adrenergic Agents|adrenergic agents|mesh-ancestor
93046183|NCT01016249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046184|NCT01016249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046185|NCT01016249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046186|NCT01016249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93046187|NCT01016249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93046188|NCT01016249|Autonomic Agents|autonomic agents|mesh-ancestor
92301157|NCT02359175|Acetaminophen|acetaminophen|mesh-list
93046189|NCT01016249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046190|NCT01016249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93046191|NCT01016249|Respiratory System Agents|respiratory system agents|mesh-ancestor
93046192|NCT01016249|Mydriatics|mydriatics|mesh-ancestor
93046193|NCT01016249|Sympathomimetics|sympathomimetics|mesh-ancestor
93046194|NCT01016249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93046195|NCT00377858|Insulin|insulin|mesh-list
93046196|NCT00377858|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93046197|NCT00377858|Insulin Glargine|insulin glargine|mesh-list
93046198|NCT00377858|Insulin Lispro|insulin lispro|mesh-list
93046199|NCT00377858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046200|NCT00377858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046201|NCT00502775|Fluticasone|fluticasone|mesh-list
93046202|NCT00502775|Xhance|xhance|mesh-list
93046203|NCT00502775|Fexofenadine|fexofenadine|mesh-list
93046204|NCT00502775|Terfenadine|terfenadine|mesh-list
93046205|NCT00502775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046206|NCT00502775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93046207|NCT00502775|Autonomic Agents|autonomic agents|mesh-ancestor
93046208|NCT00502775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046209|NCT00502775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046210|NCT00502775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93046211|NCT00502775|Respiratory System Agents|respiratory system agents|mesh-ancestor
93046212|NCT00502775|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046213|NCT00502775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93046214|NCT00502775|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93046215|NCT00502775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93046216|NCT00502775|Histamine Antagonists|histamine antagonists|mesh-ancestor
93046217|NCT00502775|Histamine Agents|histamine agents|mesh-ancestor
93046218|NCT00502775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046219|NCT00502775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046220|NCT01013675|Vaccines|vaccines|mesh-list
93046221|NCT01013675|Immunologic Factors|immunologic factors|mesh-ancestor
93046222|NCT01013675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046223|NCT01054118|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93046224|NCT01054118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046225|NCT01054118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046227|NCT01054118|Hormones|hormones|mesh-ancestor
93046228|NCT01054118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046229|NCT01054118|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93046230|NCT01054118|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046231|NCT01054118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046232|NCT01054118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046233|NCT01050842|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93046234|NCT01050842|Bicalutamide|bicalutamide|mesh-list
93046235|NCT01050842|Androgen Antagonists|androgen antagonists|mesh-ancestor
93046236|NCT01050842|Hormone Antagonists|hormone antagonists|mesh-ancestor
93046237|NCT01050842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046238|NCT01050842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046239|NCT01050842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046240|NCT01050842|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93046241|NCT01050842|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93046242|NCT01050842|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93046243|NCT01050842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93046244|NCT00485069|Levodopa|levodopa|mesh-list
93046245|NCT00485069|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93046246|NCT00485069|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93046247|NCT00485069|Dopamine Agents|dopamine agents|mesh-ancestor
93046248|NCT00485069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046249|NCT00485069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046250|NCT00485069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046251|NCT03989336|Manganese|manganese|mesh-list
93046252|NCT03989336|Paclitaxel|paclitaxel|mesh-list
93046253|NCT03989336|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93046254|NCT03989336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93046255|NCT03989336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93046256|NCT03989336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046257|NCT03989336|Tubulin Modulators|tubulin modulators|mesh-ancestor
93046258|NCT03989336|Antimitotic Agents|antimitotic agents|mesh-ancestor
93046259|NCT03989336|Mitosis Modulators|mitosis modulators|mesh-ancestor
93046260|NCT03989336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046261|NCT03989336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046262|NCT03989336|Trace Elements|trace elements|mesh-ancestor
93046263|NCT03989336|Micronutrients|micronutrients|mesh-ancestor
93046264|NCT03989336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046265|NCT00355082|Lamotrigine|lamotrigine|mesh-list
93046266|NCT00355082|Anticonvulsants|anticonvulsants|mesh-list
93046267|NCT00355082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93046268|NCT00355082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046269|NCT00355082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046270|NCT00355082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046271|NCT00355082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046272|NCT00355082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93046273|NCT00355082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93046274|NCT00355082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93046275|NCT00355082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93046276|NCT00355082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93046277|NCT00502307|Tivozanib|tivozanib|mesh-list
93046278|NCT00502307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046279|NCT00502307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046280|NCT00502307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046281|NCT00484679|Triamcinolone|triamcinolone|mesh-list
93046282|NCT00484679|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93046283|NCT00484679|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93046284|NCT00484679|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93046285|NCT00484679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046286|NCT00484679|Glucocorticoids|glucocorticoids|mesh-ancestor
93046287|NCT00484679|Hormones|hormones|mesh-ancestor
93046288|NCT00484679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046289|NCT00484679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046290|NCT00484679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046291|NCT00484679|Immunologic Factors|immunologic factors|mesh-ancestor
93046292|NCT00484679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046293|NCT00484679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046294|NCT00377312|Hormones|hormones|mesh-list
93046295|NCT00377312|Parathyroid Hormone|parathyroid hormone|mesh-list
93046296|NCT00377312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691469|NCT00487682|Valacyclovir|valacyclovir|mesh-list
93046297|NCT00377312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046298|NCT00377312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046299|NCT00377234|Risedronic Acid|risedronic acid|mesh-list
93046300|NCT00377234|Ibandronic Acid|ibandronic acid|mesh-list
93046301|NCT00377234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92301736|NCT00070291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046302|NCT00377234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046303|NCT00377234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046304|NCT00377234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046305|NCT00377234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046306|NCT00377234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93046307|NCT00376688|Sirolimus|sirolimus|mesh-list
93046308|NCT00376688|Temsirolimus|temsirolimus|mesh-list
93046309|NCT00376688|MTOR Inhibitors|mtor inhibitors|mesh-list
93046310|NCT00376688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93046311|NCT00376688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046312|NCT00376688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93046313|NCT00376688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046314|NCT00376688|Antifungal Agents|antifungal agents|mesh-ancestor
93046315|NCT00376688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046316|NCT00376688|Immunologic Factors|immunologic factors|mesh-ancestor
93046317|NCT00376688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046318|NCT00376688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046319|NCT00376688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301862|NCT00003389|Etoposide phosphate|etoposide phosphate|mesh-list
93046320|NCT00376688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046321|NCT00376220|Riluzole|riluzole|mesh-list
93046322|NCT00376220|Anticonvulsants|anticonvulsants|mesh-ancestor
93046323|NCT00376220|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93046324|NCT00376220|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93046325|NCT00376220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046326|NCT00376220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046327|NCT00376220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046328|NCT00376220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93046329|NCT00376220|Protective Agents|protective agents|mesh-ancestor
93046330|NCT00375752|Letrozole|letrozole|mesh-list
93046331|NCT00375752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046332|NCT00375752|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93046333|NCT00375752|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93046334|NCT00375752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046335|NCT00375752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046336|NCT00375752|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93046337|NCT00375752|Hormone Antagonists|hormone antagonists|mesh-ancestor
93046338|NCT00375752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046339|NCT00375752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046340|NCT00484289|Abatacept|abatacept|mesh-list
93046341|NCT00484289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93046342|NCT00484289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046343|NCT00484289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046344|NCT00484289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046345|NCT00484289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046346|NCT00484289|Immunologic Factors|immunologic factors|mesh-ancestor
93046347|NCT00484289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046348|NCT00484289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046349|NCT01013831|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93046350|NCT01013831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046351|NCT01013831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046352|NCT01013831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046353|NCT01013831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046354|NCT01013909|Terbinafine|terbinafine|mesh-list
93046355|NCT01013909|Bifonazole|bifonazole|mesh-list
93046356|NCT01013909|Antifungal Agents|antifungal agents|mesh-ancestor
93046357|NCT01013909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046358|NCT01013909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302132|NCT02959112|Indomethacin|indomethacin|mesh-list
93046359|NCT01013909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046360|NCT01013987|Ritonavir|ritonavir|mesh-list
93046361|NCT01013987|Darunavir|darunavir|mesh-list
92302219|NCT04486352|Letrozole|letrozole|mesh-list
93046362|NCT01013987|Raltegravir Potassium|raltegravir potassium|mesh-list
93046363|NCT01013987|Maraviroc|maraviroc|mesh-list
93046364|NCT01013987|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93046365|NCT01013987|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93046366|NCT01013987|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046367|NCT01013987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046368|NCT01013987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691545|NCT00492479|Kinetin|kinetin|mesh-list
93046369|NCT01013987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93046370|NCT01013987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93046371|NCT01013987|Antiviral Agents|antiviral agents|mesh-ancestor
93046372|NCT01013987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046373|NCT01013987|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93046374|NCT01013987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93046375|NCT01013987|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93046376|NCT01013987|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93046377|NCT01013987|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93046378|NCT01013987|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93046379|NCT01013987|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93046380|NCT01019291|Formaldehyde|formaldehyde|mesh-list
93046381|NCT01019291|Disinfectants|disinfectants|mesh-ancestor
93046382|NCT01019291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046383|NCT01019447|Anti-Infective Agents|anti-infective agents|mesh-list
93046384|NCT01019447|Triclosan|triclosan|mesh-list
93046385|NCT01019447|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93046386|NCT01019447|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93046387|NCT01019447|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93046388|NCT01019447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93046389|NCT01019447|Antimetabolites|antimetabolites|mesh-ancestor
92302566|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
93046390|NCT01019447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046391|NCT01019447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93046392|NCT00490529|Cyclophosphamide|cyclophosphamide|mesh-list
93046393|NCT00490529|Rituximab|rituximab|mesh-list
93046394|NCT00490529|Vaccines|vaccines|mesh-list
93046395|NCT00490529|Immunologic Factors|immunologic factors|mesh-ancestor
93046396|NCT00490529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046397|NCT00490529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046398|NCT00490529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046399|NCT00490529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93046400|NCT00490529|Alkylating Agents|alkylating agents|mesh-ancestor
93046401|NCT00490529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046402|NCT00490529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046403|NCT00490529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92302761|NCT05122026|Antimetabolites|antimetabolites|mesh-ancestor
93046404|NCT00490529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046405|NCT00333840|Interferons|interferons|mesh-list
93046406|NCT00333840|Cytarabine|cytarabine|mesh-list
93046407|NCT00333840|Interferon-alpha|interferon-alpha|mesh-list
93046408|NCT00333840|Interferon alpha-2|interferon alpha-2|mesh-list
93046409|NCT00333840|Imatinib Mesylate|imatinib mesylate|mesh-list
93046410|NCT00333840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046411|NCT00333840|Antiviral Agents|antiviral agents|mesh-ancestor
93046412|NCT00333840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046413|NCT00333840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046414|NCT00333840|Antimetabolites|antimetabolites|mesh-ancestor
93046415|NCT00333840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046416|NCT00333840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046417|NCT00333840|Immunologic Factors|immunologic factors|mesh-ancestor
93046418|NCT00333840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046419|NCT00333840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046420|NCT00333840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046421|NCT01019603|Nicotinic Acids|nicotinic acids|mesh-list
93046422|NCT01019603|Tazarotene|tazarotene|mesh-list
91999688|NCT05856305|Copper|copper|mesh-list
93046423|NCT01019603|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046424|NCT01019603|Keratolytic Agents|keratolytic agents|mesh-ancestor
93046425|NCT01019603|Vitamin B Complex|vitamin b complex|mesh-ancestor
93046426|NCT01019603|Vitamins|vitamins|mesh-ancestor
93046427|NCT01019603|Micronutrients|micronutrients|mesh-ancestor
93046428|NCT01019603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046429|NCT00321906|Sirolimus|sirolimus|mesh-list
93046430|NCT00321906|Azathioprine|azathioprine|mesh-list
93046431|NCT00321906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93046432|NCT00321906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046433|NCT00321906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93046434|NCT00321906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046435|NCT00321906|Antifungal Agents|antifungal agents|mesh-ancestor
93046436|NCT00321906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046437|NCT00321906|Immunologic Factors|immunologic factors|mesh-ancestor
93046438|NCT00321906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303117|NCT02974712|Fentanyl|fentanyl|mesh-list
93046439|NCT00321906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303186|NCT04841148|Avelumab|avelumab|mesh-list
93046440|NCT00321906|Antimetabolites|antimetabolites|mesh-ancestor
93046441|NCT00321906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046442|NCT00321906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046443|NCT00339144|Dasatinib|dasatinib|mesh-list
93046444|NCT00339144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046445|NCT00339144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046446|NCT00339144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046447|NCT00339144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046449|NCT00321828|Bevacizumab|bevacizumab|mesh-list
93046450|NCT00321828|Fluorouracil|fluorouracil|mesh-list
93046451|NCT00321828|Oxaliplatin|oxaliplatin|mesh-list
93046452|NCT00321828|Levoleucovorin|levoleucovorin|mesh-list
93046453|NCT00321828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046454|NCT00321828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046455|NCT00321828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93046456|NCT00321828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93046457|NCT00321828|Growth Substances|growth substances|mesh-ancestor
93046458|NCT00321828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046459|NCT00321828|Growth Inhibitors|growth inhibitors|mesh-ancestor
93046460|NCT00321828|Antimetabolites|antimetabolites|mesh-ancestor
93046461|NCT00321828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046462|NCT00321828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046463|NCT00321828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046464|NCT00321828|Immunologic Factors|immunologic factors|mesh-ancestor
93046465|NCT00321828|Antidotes|antidotes|mesh-ancestor
93046466|NCT00321828|Protective Agents|protective agents|mesh-ancestor
93046467|NCT00321828|Vitamin B Complex|vitamin b complex|mesh-ancestor
93046468|NCT00321828|Vitamins|vitamins|mesh-ancestor
93046469|NCT00321828|Micronutrients|micronutrients|mesh-ancestor
93046470|NCT00333138|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92303454|NCT02521753|Metformin|metformin|mesh-list
93046471|NCT00333138|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
93046472|NCT00333138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046473|NCT00333138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046474|NCT00333138|Immunologic Factors|immunologic factors|mesh-ancestor
92529334|NCT04680442|Maytansine|maytansine|mesh-list
93046475|NCT00333138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046476|NCT01061658|Vaccines|vaccines|mesh-list
93046477|NCT01061658|Immunologic Factors|immunologic factors|mesh-ancestor
93046478|NCT01061658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046479|NCT01058382|Progesterone|progesterone|mesh-list
93046480|NCT01058382|Progestins|progestins|mesh-ancestor
93046481|NCT01058382|Hormones|hormones|mesh-ancestor
92303657|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046482|NCT01058382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046483|NCT01058382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046484|NCT01061814|Mipomersen|mipomersen|mesh-list
93046485|NCT01061814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93046486|NCT01061814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93046487|NCT01061814|Antimetabolites|antimetabolites|mesh-ancestor
93046488|NCT01061814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046489|NCT01061814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93046490|NCT00331422|Paclitaxel|paclitaxel|mesh-list
93046491|NCT00331422|Carboplatin|carboplatin|mesh-list
93046492|NCT00331422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92303874|NCT05716867|Cystatins|cystatins|mesh-list
93046493|NCT00331422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046494|NCT00331422|Tubulin Modulators|tubulin modulators|mesh-ancestor
93046495|NCT00331422|Antimitotic Agents|antimitotic agents|mesh-ancestor
93046496|NCT00331422|Mitosis Modulators|mitosis modulators|mesh-ancestor
93046497|NCT00331422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046498|NCT00331344|Prednisone|prednisone|mesh-list
93046499|NCT00331344|Mitoxantrone|mitoxantrone|mesh-list
93046500|NCT00331344|Epothilone B|epothilone b|mesh-list
93046501|NCT00331344|Epothilones|epothilones|mesh-list
92304016|NCT04450836|Trifluridine|trifluridine|mesh-list
93046502|NCT00331344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046503|NCT00331344|Glucocorticoids|glucocorticoids|mesh-ancestor
93046504|NCT00331344|Hormones|hormones|mesh-ancestor
92304083|NCT00359359|Sagopilone|sagopilone|mesh-list
93046505|NCT00331344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046506|NCT00331344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046507|NCT00331344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93046508|NCT00331344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046509|NCT00331344|Analgesics|analgesics|mesh-ancestor
93046510|NCT00331344|Sensory System Agents|sensory system agents|mesh-ancestor
93046511|NCT00331344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046512|NCT00331344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93046513|NCT00331344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93046514|NCT00331344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046515|NCT00331344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046516|NCT00331344|Tubulin Modulators|tubulin modulators|mesh-ancestor
93046517|NCT00331344|Antimitotic Agents|antimitotic agents|mesh-ancestor
93046518|NCT00331344|Mitosis Modulators|mitosis modulators|mesh-ancestor
93046519|NCT00321672|Capsaicin|capsaicin|mesh-list
93046520|NCT00321672|Antipruritics|antipruritics|mesh-ancestor
93046521|NCT00321672|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046522|NCT00321672|Sensory System Agents|sensory system agents|mesh-ancestor
93046523|NCT00321672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046524|NCT00321672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046525|NCT00330174|Acamprosate|acamprosate|mesh-list
93046526|NCT00330174|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93046527|NCT00320424|PENTA|penta|mesh-list
93046528|NCT00320424|Fondaparinux|fondaparinux|mesh-list
93046529|NCT00320424|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93046530|NCT00320424|Antithrombins|antithrombins|mesh-ancestor
93046531|NCT00320424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93046532|NCT00320424|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046533|NCT00320424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046534|NCT00320424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046535|NCT00320424|Anticoagulants|anticoagulants|mesh-ancestor
93046536|NCT00320424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93046537|NCT00320424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93046538|NCT00338286|Epoetin Alfa|epoetin alfa|mesh-list
93046539|NCT00338286|Hematinics|hematinics|mesh-ancestor
93046540|NCT00329550|Certolizumab Pegol|certolizumab pegol|mesh-list
93046541|NCT00329550|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93046542|NCT00329550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304513|NCT03875911|Mitomycins|mitomycins|mesh-list
93046543|NCT00329550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046544|NCT00329550|Immunologic Factors|immunologic factors|mesh-ancestor
93046545|NCT00329550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046546|NCT00329550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046547|NCT00375674|Sunitinib|sunitinib|mesh-list
93046548|NCT00375674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046549|NCT00375674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93046550|NCT00375674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92304650|NCT05195034|Analgesics|analgesics|mesh-ancestor
93046551|NCT00375674|Growth Substances|growth substances|mesh-ancestor
93046552|NCT00375674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046554|NCT00375674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046555|NCT00375674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046556|NCT00375674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046557|NCT03991910|Ramipril|ramipril|mesh-list
93046558|NCT03991910|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93046559|NCT03991910|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046560|NCT03991910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046561|NCT03991910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046562|NCT03991910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93046563|NCT00320190|Imatinib Mesylate|imatinib mesylate|mesh-list
93046564|NCT00320190|Dasatinib|dasatinib|mesh-list
93046565|NCT00320190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046566|NCT00320190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046567|NCT00320190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046568|NCT00320190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046569|NCT02534402|Prednisone|prednisone|mesh-list
93046570|NCT02534402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046571|NCT02534402|Glucocorticoids|glucocorticoids|mesh-ancestor
93046572|NCT02534402|Hormones|hormones|mesh-ancestor
93046573|NCT02534402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046574|NCT02534402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046575|NCT02534402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93046576|NCT02534402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046577|NCT00319956|Azithromycin|azithromycin|mesh-list
93046578|NCT00319956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93046579|NCT00319956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046580|NCT01062048|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93046581|NCT01062048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046582|NCT01062048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046583|NCT01062048|Incretins|incretins|mesh-ancestor
93046584|NCT01062048|Hormones|hormones|mesh-ancestor
92304856|NCT04329429|Trastuzumab|trastuzumab|mesh-list
93046585|NCT01062048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046586|NCT01062048|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93046587|NCT01062048|Protease Inhibitors|protease inhibitors|mesh-ancestor
92304912|NCT00003273|Etoposide|etoposide|mesh-list
93046588|NCT01062048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046589|NCT01062048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046590|NCT00349622|Ceftriaxone|ceftriaxone|mesh-list
93046591|NCT00349622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93046592|NCT00349622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046593|NCT03987698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92304985|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
93046594|NCT03987698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046595|NCT03987698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046596|NCT03987698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046597|NCT01054508|Nicotinic Acids|nicotinic acids|mesh-list
93046599|NCT01054508|Niacinamide|niacinamide|mesh-list
93046600|NCT01054508|Vitamin B Complex|vitamin b complex|mesh-ancestor
93046601|NCT01054508|Vitamins|vitamins|mesh-ancestor
93046602|NCT01054508|Micronutrients|micronutrients|mesh-ancestor
93046603|NCT01054508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046604|NCT01054508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93046605|NCT01054508|Antimetabolites|antimetabolites|mesh-ancestor
93046606|NCT01054508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046607|NCT01054508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93046608|NCT01054508|Vasodilator Agents|vasodilator agents|mesh-ancestor
93046609|NCT00348686|Felodipine|felodipine|mesh-list
93046610|NCT00348686|Candesartan|candesartan|mesh-list
93046611|NCT00348686|Candesartan cilexetil|candesartan cilexetil|mesh-list
93046612|NCT00348686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93046613|NCT00348686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93046614|NCT00348686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92305350|NCT00002865|Antiviral Agents|antiviral agents|mesh-ancestor
93046615|NCT00348686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046616|NCT00348686|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93046617|NCT00348686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93046618|NCT00348686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046619|NCT00348686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046620|NCT00348686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046621|NCT00348686|Vasodilator Agents|vasodilator agents|mesh-ancestor
93046622|NCT00360230|Vaccines|vaccines|mesh-list
93046623|NCT00360230|Immunologic Factors|immunologic factors|mesh-ancestor
92305492|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93046624|NCT00360230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046625|NCT03989024|Clomiphene|clomiphene|mesh-list
93046626|NCT03989024|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
93046627|NCT03989024|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93046628|NCT03989024|Hormone Antagonists|hormone antagonists|mesh-ancestor
93046629|NCT03989024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046630|NCT03989024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046631|NCT03989024|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93046632|NCT03989024|Fertility Agents|fertility agents|mesh-ancestor
93046633|NCT03989024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93046634|NCT03989024|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92305638|NCT00003555|Paclitaxel|paclitaxel|mesh-list
93046635|NCT03989024|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93046637|NCT03987308|Insulin Aspart|insulin aspart|mesh-list
93046638|NCT03987308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046639|NCT03987308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046640|NCT00348374|Insulin Lispro|insulin lispro|mesh-list
93046641|NCT00348374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92305702|NCT03476239|Blinatumomab|blinatumomab|mesh-list
93046642|NCT00348374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046643|NCT03742232|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93046644|NCT03742232|Laxatives|laxatives|mesh-ancestor
93046645|NCT03742232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93046646|NCT03988478|Psychotropic Drugs|psychotropic drugs|mesh-list
93046647|NCT00352664|Donepezil|donepezil|mesh-list
93046648|NCT00352664|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93046649|NCT00352664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046650|NCT00352664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046651|NCT00352664|Cholinergic Agents|cholinergic agents|mesh-ancestor
93046652|NCT00352664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046653|NCT00352664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046654|NCT00352664|Nootropic Agents|nootropic agents|mesh-ancestor
93046655|NCT03991442|Amlodipine|amlodipine|mesh-list
93046656|NCT03991442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93046657|NCT03991442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93046658|NCT03991442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046659|NCT03991442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046660|NCT03991442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046661|NCT03991442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046662|NCT03991442|Vasodilator Agents|vasodilator agents|mesh-ancestor
93046663|NCT03742310|Vitamin D|vitamin d|mesh-list
93046664|NCT03742310|Calcitriol|calcitriol|mesh-list
93046665|NCT03742310|Vitamins|vitamins|mesh-ancestor
93046666|NCT03742310|Micronutrients|micronutrients|mesh-ancestor
93046667|NCT03742310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046668|NCT03742310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93046669|NCT03742310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93046670|NCT03742310|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93046671|NCT03742310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046672|NCT03742310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046673|NCT03742310|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93046674|NCT00490139|Trastuzumab|trastuzumab|mesh-list
93046675|NCT00490139|Lapatinib|lapatinib|mesh-list
93046676|NCT00490139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93046677|NCT00490139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046678|NCT00490139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046679|NCT00490139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046680|NCT00490139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046681|NCT00348140|Rosiglitazone|rosiglitazone|mesh-list
93046682|NCT00348140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046683|NCT00348140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046684|NCT01051388|Rabeprazole|rabeprazole|mesh-list
93046685|NCT01051388|Gefarnate|gefarnate|mesh-list
93046686|NCT01051388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93046687|NCT01051388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93046688|NCT01051388|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93046689|NCT01051388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046690|NCT01051388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046691|NCT00490061|Lapatinib|lapatinib|mesh-list
93046692|NCT00490061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046693|NCT00490061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93046694|NCT00490061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046695|NCT00490061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046696|NCT00483119|Cyclophosphamide|cyclophosphamide|mesh-list
93046697|NCT00483119|Immunoglobulins|immunoglobulins|mesh-list
92306345|NCT00004197|Hormones|hormones|mesh-ancestor
93046698|NCT00483119|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93046699|NCT00483119|Antibodies|antibodies|mesh-list
93046700|NCT00483119|gamma-Globulins|gamma-globulins|mesh-list
93046701|NCT00483119|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93046702|NCT00483119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046703|NCT00483119|Immunologic Factors|immunologic factors|mesh-ancestor
92306406|NCT00004215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93046704|NCT00483119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046705|NCT00483119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93046706|NCT00483119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93046707|NCT00483119|Alkylating Agents|alkylating agents|mesh-ancestor
93046708|NCT00483119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046709|NCT00483119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046710|NCT00483119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93046711|NCT01016639|Capecitabine|capecitabine|mesh-list
93046712|NCT01016639|Oxaliplatin|oxaliplatin|mesh-list
93046713|NCT01016639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046714|NCT01016639|Antimetabolites|antimetabolites|mesh-ancestor
93046715|NCT01016639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306618|NCT00004317|Vitamins|vitamins|mesh-ancestor
93046716|NCT01016639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046717|NCT00501293|Methylphenidate|methylphenidate|mesh-list
93046718|NCT00501293|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93046719|NCT00501293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046720|NCT00501293|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93046721|NCT00501293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93046722|NCT00501293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046723|NCT00501293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046724|NCT00501293|Dopamine Agents|dopamine agents|mesh-ancestor
93046725|NCT00501293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046726|NCT01014221|Prednisolone|prednisolone|mesh-list
93046727|NCT01014221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93046728|NCT01014221|Glucocorticoids|glucocorticoids|mesh-ancestor
93046729|NCT01014221|Hormones|hormones|mesh-ancestor
92306760|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
93046730|NCT01014221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046731|NCT01014221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046732|NCT01014221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93046733|NCT01014221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046734|NCT00482729|Metformin|metformin|mesh-list
93046735|NCT00482729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93046736|NCT00482729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92306829|NCT00384969|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93046737|NCT00482729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046738|NCT00482729|Incretins|incretins|mesh-ancestor
93046739|NCT00482729|Hormones|hormones|mesh-ancestor
93046740|NCT00482729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306897|NCT00385125|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93046741|NCT00482729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93046742|NCT00482729|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046743|NCT00482729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046744|NCT00482729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046745|NCT00359762|Exenatide|exenatide|mesh-list
93046747|NCT00359762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93046748|NCT00359762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046749|NCT00359762|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93046750|NCT00359762|Incretins|incretins|mesh-ancestor
93046751|NCT00359762|Hormones|hormones|mesh-ancestor
93046752|NCT00359762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046753|NCT00359762|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93046754|NCT00359762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046755|NCT00359762|Immunologic Factors|immunologic factors|mesh-ancestor
93046756|NCT03988010|Amantadine|amantadine|mesh-list
93046757|NCT03988010|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93046758|NCT03988010|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93046759|NCT03988010|Antiviral Agents|antiviral agents|mesh-ancestor
93046760|NCT03988010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046761|NCT03988010|Dopamine Agents|dopamine agents|mesh-ancestor
93046762|NCT03988010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046763|NCT03988010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307175|NCT00005583|Epirubicin|epirubicin|mesh-list
93046764|NCT03988010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046765|NCT03988010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93046766|NCT03988010|Analgesics|analgesics|mesh-ancestor
93046767|NCT03988010|Sensory System Agents|sensory system agents|mesh-ancestor
93046768|NCT03988010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046769|NCT01055522|Interleukin-2|interleukin-2|mesh-list
93046770|NCT01055522|Dacarbazine|dacarbazine|mesh-list
92307248|NCT00005607|Vitamin B Complex|vitamin b complex|mesh-ancestor
93046771|NCT01055522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046772|NCT01055522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93046773|NCT01055522|Analgesics|analgesics|mesh-ancestor
93046774|NCT01055522|Sensory System Agents|sensory system agents|mesh-ancestor
92307321|NCT02247349|Nivolumab|nivolumab|mesh-list
93046775|NCT01055522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046776|NCT01055522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046777|NCT01055522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93046778|NCT01055522|Alkylating Agents|alkylating agents|mesh-ancestor
93046779|NCT01055522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046780|NCT03987152|Sirolimus|sirolimus|mesh-list
93046781|NCT03987152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93046782|NCT03987152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93046783|NCT03987152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93046784|NCT03987152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046785|NCT03987152|Antifungal Agents|antifungal agents|mesh-ancestor
93046786|NCT03987152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046787|NCT03987152|Immunologic Factors|immunologic factors|mesh-ancestor
93046788|NCT03987152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046789|NCT00347438|Capecitabine|capecitabine|mesh-list
93046790|NCT00347438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046791|NCT00347438|Antimetabolites|antimetabolites|mesh-ancestor
93046792|NCT00347438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046793|NCT00347438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046794|NCT00329238|Warfarin|warfarin|mesh-list
93046795|NCT00329238|Dabigatran|dabigatran|mesh-list
93046796|NCT00329238|Anticoagulants|anticoagulants|mesh-ancestor
93046797|NCT00329238|Antithrombins|antithrombins|mesh-ancestor
93046798|NCT00329238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93046799|NCT00329238|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046800|NCT00329238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046801|NCT00329238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046802|NCT00329160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93046803|NCT00329160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93046804|NCT00329160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93046805|NCT00329160|Antimetabolites|antimetabolites|mesh-ancestor
93046806|NCT00329160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046807|NCT00329160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93046808|NCT00329160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93046809|NCT00329160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046810|NCT00328926|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93046811|NCT00328926|Hormones|hormones|mesh-list
93046812|NCT00328926|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93046813|NCT00328926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93046814|NCT00328926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046815|NCT00328926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93046816|NCT00347360|Carvedilol|carvedilol|mesh-list
93046817|NCT00347360|Lisinopril|lisinopril|mesh-list
93046818|NCT00347360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93046819|NCT00347360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93046820|NCT00347360|Adrenergic Agents|adrenergic agents|mesh-ancestor
93046821|NCT00347360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93046822|NCT00347360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046823|NCT00347360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046824|NCT00347360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93046825|NCT00347360|Antioxidants|antioxidants|mesh-ancestor
93046826|NCT00347360|Protective Agents|protective agents|mesh-ancestor
93046827|NCT00347360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93046828|NCT00347360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93046829|NCT00347360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92307808|NCT02492750|Dexamethasone|dexamethasone|mesh-list
93046830|NCT00347360|Vasodilator Agents|vasodilator agents|mesh-ancestor
93046831|NCT00347360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93046832|NCT00347360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93046833|NCT00347360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93046834|NCT00347360|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046835|NCT00347360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93046836|NCT00347360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93046837|NCT00319020|Bosentan|bosentan|mesh-list
93046838|NCT00319020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93046839|NCT00319020|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93046840|NCT00319020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046841|NCT01056224|Remifentanil|remifentanil|mesh-list
93046842|NCT01056224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93046843|NCT01056224|Narcotics|narcotics|mesh-ancestor
93046844|NCT01056224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308006|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
93046845|NCT01056224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046846|NCT01056224|Analgesics|analgesics|mesh-ancestor
93046847|NCT01056224|Sensory System Agents|sensory system agents|mesh-ancestor
93046848|NCT01056224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93046849|NCT03982680|Gemcitabine|gemcitabine|mesh-list
93046850|NCT03982680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046851|NCT03982680|Antimetabolites|antimetabolites|mesh-ancestor
93046852|NCT03982680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046853|NCT03982680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046854|NCT00352118|Docetaxel|docetaxel|mesh-list
93046855|NCT00352118|Fluorouracil|fluorouracil|mesh-list
93046856|NCT00352118|Lenograstim|lenograstim|mesh-list
93046857|NCT00352118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046858|NCT00352118|Tubulin Modulators|tubulin modulators|mesh-ancestor
93046859|NCT00352118|Antimitotic Agents|antimitotic agents|mesh-ancestor
93046860|NCT00352118|Mitosis Modulators|mitosis modulators|mesh-ancestor
93046861|NCT00352118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046862|NCT00352118|Antimetabolites|antimetabolites|mesh-ancestor
93046863|NCT00352118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93046864|NCT00352118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93046865|NCT00352118|Immunologic Factors|immunologic factors|mesh-ancestor
93046866|NCT00352118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93046867|NCT00352118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93046868|NCT00318474|Mycophenolic Acid|mycophenolic acid|mesh-list
93046869|NCT00318474|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93046870|NCT00318474|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93046871|NCT00318474|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93046872|NCT00318474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93046873|NCT00318474|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93046874|NCT00318474|Antitubercular Agents|antitubercular agents|mesh-ancestor
93046875|NCT00318474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93046876|NCT00318474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308433|NCT02555228|Dermatologic Agents|dermatologic agents|mesh-ancestor
93046877|NCT00318474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93046878|NCT00318474|Protease Inhibitors|protease inhibitors|mesh-ancestor
93046879|NCT00350870|Disulfiram|disulfiram|mesh-list
93046880|NCT00350870|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93046881|NCT00350870|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93046882|NCT00350870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308578|NCT02541565|Tubulin Modulators|tubulin modulators|mesh-ancestor
93046883|NCT00350870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047065|NCT03983460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047066|NCT03983460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047067|NCT03983460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92308648|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047068|NCT03983460|Respiratory System Agents|respiratory system agents|mesh-ancestor
93047069|NCT01056614|Methotrexate|methotrexate|mesh-list
93047070|NCT01056614|Fludarabine phosphate|fludarabine phosphate|mesh-list
93047071|NCT01056614|Fludarabine|fludarabine|mesh-list
93047072|NCT01056614|Busulfan|busulfan|mesh-list
93047073|NCT01056614|Tacrolimus|tacrolimus|mesh-list
93047074|NCT01056614|Thymoglobulin|thymoglobulin|mesh-list
92692074|NCT00494624|Hormones|hormones|mesh-ancestor
93047075|NCT01056614|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93047076|NCT01056614|Immunoglobulins|immunoglobulins|mesh-list
93047077|NCT01056614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93047078|NCT01056614|Abortifacient Agents|abortifacient agents|mesh-ancestor
93047079|NCT01056614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93047080|NCT01056614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047081|NCT01056614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93047082|NCT01056614|Antimetabolites|antimetabolites|mesh-ancestor
93047083|NCT01056614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047084|NCT01056614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047085|NCT01056614|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047086|NCT01056614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047087|NCT01056614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93047088|NCT01056614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047089|NCT01056614|Immunologic Factors|immunologic factors|mesh-ancestor
93047090|NCT01056614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047091|NCT01056614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93047092|NCT01056614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93047093|NCT01056614|Alkylating Agents|alkylating agents|mesh-ancestor
93047094|NCT01056614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93047095|NCT01056614|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93047096|NCT00346034|Pregabalin|pregabalin|mesh-list
93047097|NCT00346034|Analgesics|analgesics|mesh-ancestor
93047098|NCT00346034|Sensory System Agents|sensory system agents|mesh-ancestor
93047099|NCT00346034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047100|NCT00346034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047101|NCT00346034|Anticonvulsants|anticonvulsants|mesh-ancestor
93047102|NCT00346034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93047103|NCT00346034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047104|NCT00346034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047105|NCT00346034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93047106|NCT00346034|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93047107|NCT00346034|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93047108|NCT00346034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047109|NCT00346034|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93047110|NCT00345878|Vaccines|vaccines|mesh-list
93047111|NCT00345878|Immunologic Factors|immunologic factors|mesh-ancestor
92309279|NCT02243202|Canagliflozin|canagliflozin|mesh-list
93047112|NCT00345878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047113|NCT01059110|Salicylates|salicylates|mesh-list
93047114|NCT01059110|Imiquimod|imiquimod|mesh-list
93047115|NCT01059110|Fluorouracil|fluorouracil|mesh-list
93047116|NCT01059110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93047117|NCT01059110|Immunologic Factors|immunologic factors|mesh-ancestor
92309346|NCT03786770|Cholinergic Agents|cholinergic agents|mesh-ancestor
93047118|NCT01059110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047119|NCT01059110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047120|NCT01059110|Interferon Inducers|interferon inducers|mesh-ancestor
93047121|NCT01059110|Antimetabolites|antimetabolites|mesh-ancestor
93047122|NCT01059110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047123|NCT01059110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93047124|NCT01059110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047125|NCT01059110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93047126|NCT01059110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047127|NCT01059110|Analgesics|analgesics|mesh-ancestor
93047128|NCT01059110|Sensory System Agents|sensory system agents|mesh-ancestor
93047129|NCT01059110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047130|NCT01059110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047131|NCT01059110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309488|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93047132|NCT01059110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93047133|NCT01059110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047134|NCT03991364|Methamphetamine|methamphetamine|mesh-list
92309556|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
93047135|NCT03991364|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93047136|NCT03991364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047137|NCT03991364|Sympathomimetics|sympathomimetics|mesh-ancestor
93047138|NCT03991364|Autonomic Agents|autonomic agents|mesh-ancestor
93047139|NCT03991364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047140|NCT03991364|Dopamine Agents|dopamine agents|mesh-ancestor
93047141|NCT03991364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047142|NCT03991364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047143|NCT03991364|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047144|NCT03991364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93047145|NCT03991364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93047146|NCT03991364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047147|NCT03991364|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92692165|NCT05148546|Nivolumab|nivolumab|mesh-list
93047148|NCT00335738|Carboplatin|carboplatin|mesh-list
93047149|NCT00335738|Etoposide|etoposide|mesh-list
93047150|NCT00335738|Vincristine|vincristine|mesh-list
93047151|NCT00335738|Etoposide phosphate|etoposide phosphate|mesh-list
93047152|NCT00335738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047153|NCT00335738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93047154|NCT00335738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93047155|NCT00335738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93047156|NCT00335738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047157|NCT00335738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047158|NCT00335738|Tubulin Modulators|tubulin modulators|mesh-ancestor
93047159|NCT00335738|Antimitotic Agents|antimitotic agents|mesh-ancestor
93047160|NCT00335738|Mitosis Modulators|mitosis modulators|mesh-ancestor
93047161|NCT02533076|Capsaicin|capsaicin|mesh-list
93047162|NCT02533076|Antipruritics|antipruritics|mesh-ancestor
93047163|NCT02533076|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047164|NCT02533076|Sensory System Agents|sensory system agents|mesh-ancestor
93047165|NCT02533076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047166|NCT02533076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047167|NCT03991520|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93047168|NCT03991520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047169|NCT01056926|Nicotine|nicotine|mesh-list
93047170|NCT01056926|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93047171|NCT01056926|Autonomic Agents|autonomic agents|mesh-ancestor
93047172|NCT01056926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047173|NCT01056926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047174|NCT01056926|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93047175|NCT01056926|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93047176|NCT01056926|Cholinergic Agents|cholinergic agents|mesh-ancestor
93047177|NCT01056926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047178|NCT01056926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047179|NCT01059422|Lamivudine|lamivudine|mesh-list
93047180|NCT01059422|Abacavir|abacavir|mesh-list
93047181|NCT01059422|Raltegravir Potassium|raltegravir potassium|mesh-list
93047182|NCT01059422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93047183|NCT01059422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93047184|NCT01059422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309891|NCT02507011|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047185|NCT01059422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047186|NCT01059422|Antiviral Agents|antiviral agents|mesh-ancestor
93047187|NCT01059422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047188|NCT01059422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93047189|NCT01059422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93047190|NCT01059422|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93047191|NCT01059422|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93047192|NCT01052246|Clindamycin|clindamycin|mesh-list
93047193|NCT01052246|Clindamycin palmitate|clindamycin palmitate|mesh-list
93047194|NCT01052246|Clindamycin phosphate|clindamycin phosphate|mesh-list
93047195|NCT01052246|Benzoyl Peroxide|benzoyl peroxide|mesh-list
93047196|NCT01052246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93047197|NCT01052246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047198|NCT01052246|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93047199|NCT01052246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047200|NCT01052246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047201|NCT01052246|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047202|NCT00334958|Rufinamide|rufinamide|mesh-list
93047203|NCT00334958|Anticonvulsants|anticonvulsants|mesh-ancestor
93047204|NCT00334958|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93047205|NCT00334958|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93047206|NCT00334958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047207|NCT00334958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047208|NCT00326898|Sorafenib|sorafenib|mesh-list
93047209|NCT00326898|Sunitinib|sunitinib|mesh-list
93047210|NCT00326898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047211|NCT00326898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93047212|NCT00326898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047213|NCT00326898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047214|NCT00326898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92310243|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93047215|NCT00326898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93047216|NCT00326898|Growth Substances|growth substances|mesh-ancestor
93047217|NCT00326898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047218|NCT00326898|Growth Inhibitors|growth inhibitors|mesh-ancestor
93047219|NCT01062360|Aspirin|aspirin|mesh-list
93047220|NCT01062360|Pseudoephedrine|pseudoephedrine|mesh-list
93047221|NCT01062360|Ephedrine|ephedrine|mesh-list
93047222|NCT01062360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92692224|NCT00497744|Cefepime|cefepime|mesh-list
93047223|NCT01062360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047224|NCT01062360|Analgesics|analgesics|mesh-ancestor
93047225|NCT01062360|Sensory System Agents|sensory system agents|mesh-ancestor
93047226|NCT01062360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047227|NCT01062360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047228|NCT01062360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047229|NCT01062360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047230|NCT01062360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93047231|NCT01062360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92310466|NCT02625181|Hormones|hormones|mesh-ancestor
93047232|NCT01062360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047233|NCT01062360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92310533|NCT04979377|Insulin|insulin|mesh-list
93047234|NCT01062360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93047235|NCT01062360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047236|NCT01062360|Antipyretics|antipyretics|mesh-ancestor
93047237|NCT01062360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93047238|NCT01062360|Autonomic Agents|autonomic agents|mesh-ancestor
93047239|NCT01062360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93047240|NCT01062360|Respiratory System Agents|respiratory system agents|mesh-ancestor
93047241|NCT01062360|Nasal Decongestants|nasal decongestants|mesh-ancestor
93047242|NCT01062360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93047243|NCT01062360|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93047244|NCT01062360|Sympathomimetics|sympathomimetics|mesh-ancestor
93047245|NCT01062360|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047246|NCT01062360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047247|NCT01063842|Acetaminophen|acetaminophen|mesh-list
93047248|NCT01063842|Tramadol|tramadol|mesh-list
93047249|NCT01063842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047250|NCT01063842|Analgesics|analgesics|mesh-ancestor
93047251|NCT01063842|Sensory System Agents|sensory system agents|mesh-ancestor
93047252|NCT01063842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047253|NCT01063842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047254|NCT01063842|Antipyretics|antipyretics|mesh-ancestor
93047255|NCT01063842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047256|NCT01063842|Narcotics|narcotics|mesh-ancestor
93047257|NCT01063842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047258|NCT01063920|Naproxen|naproxen|mesh-list
93047259|NCT01063920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93047260|NCT01063920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047261|NCT01063920|Analgesics|analgesics|mesh-ancestor
92310810|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
93047262|NCT01063920|Sensory System Agents|sensory system agents|mesh-ancestor
93047263|NCT01063920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047264|NCT01063920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047265|NCT01063920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047266|NCT01063920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047267|NCT01063920|Gout Suppressants|gout suppressants|mesh-ancestor
93047268|NCT01063920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93047269|NCT01063920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047270|NCT01063920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047271|NCT01062516|Esomeprazole|esomeprazole|mesh-list
93047272|NCT01062516|Famotidine|famotidine|mesh-list
93047273|NCT01062516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93047274|NCT01062516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93047275|NCT01062516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93047276|NCT01062516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047277|NCT01062516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047278|NCT01062516|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93047279|NCT01062516|Histamine Antagonists|histamine antagonists|mesh-ancestor
92311020|NCT02244164|Exenatide|exenatide|mesh-list
93047280|NCT01062516|Histamine Agents|histamine agents|mesh-ancestor
93047281|NCT01062516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047282|NCT01062516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047283|NCT00334802|Paclitaxel|paclitaxel|mesh-list
93047284|NCT00334802|Gemcitabine|gemcitabine|mesh-list
93047285|NCT00334802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93047286|NCT00334802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047287|NCT00334802|Tubulin Modulators|tubulin modulators|mesh-ancestor
93047288|NCT00334802|Antimitotic Agents|antimitotic agents|mesh-ancestor
93047289|NCT00334802|Mitosis Modulators|mitosis modulators|mesh-ancestor
92311156|NCT05441761|Antimetabolites|antimetabolites|mesh-ancestor
93047290|NCT00334802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047291|NCT00334802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93047292|NCT00334802|Antimetabolites|antimetabolites|mesh-ancestor
93047293|NCT03985358|Analgesics, Opioid|analgesics, opioid|mesh-list
93047294|NCT03985358|Narcotics|narcotics|mesh-ancestor
93047295|NCT03985358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047296|NCT03985358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047297|NCT03985358|Analgesics|analgesics|mesh-ancestor
93047298|NCT03985358|Sensory System Agents|sensory system agents|mesh-ancestor
93047299|NCT03985358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047300|NCT01052324|Remifentanil|remifentanil|mesh-list
93047301|NCT01052324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047302|NCT01052324|Narcotics|narcotics|mesh-ancestor
92311298|NCT02691416|Propofol|propofol|mesh-list
93047303|NCT01052324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047304|NCT01052324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047305|NCT01052324|Analgesics|analgesics|mesh-ancestor
93047306|NCT01052324|Sensory System Agents|sensory system agents|mesh-ancestor
93047307|NCT01052324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047308|NCT01059890|Metronidazole|metronidazole|mesh-list
93047309|NCT01059890|Ciprofloxacin|ciprofloxacin|mesh-list
93047310|NCT01059890|Cefotaxime|cefotaxime|mesh-list
93047311|NCT01059890|Cefoxitin|cefoxitin|mesh-list
92311363|NCT02653183|Laxatives|laxatives|mesh-ancestor
93047312|NCT01059890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047313|NCT01059890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93047314|NCT01059890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93047315|NCT01059890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93047316|NCT01059890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93047317|NCT01059890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93047318|NCT01059890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047319|NCT01059890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047320|NCT01059890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047321|NCT01059890|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93047322|NCT01059890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93047323|NCT01057160|Rizatriptan|rizatriptan|mesh-list
92311580|NCT05261672|Midazolam|midazolam|mesh-list
93047324|NCT01057160|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93047325|NCT01057160|Serotonin Agents|serotonin agents|mesh-ancestor
93047326|NCT01057160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047327|NCT01057160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047328|NCT01057160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047329|NCT03990974|Anti-Infective Agents|anti-infective agents|mesh-list
93047330|NCT03990974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93047331|NCT00307086|Bortezomib|bortezomib|mesh-list
93047332|NCT00307086|Melphalan|melphalan|mesh-list
93047333|NCT00307086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047334|NCT00307086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93047335|NCT00307086|Alkylating Agents|alkylating agents|mesh-ancestor
93047336|NCT00307086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047337|NCT00307086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93047338|NCT00307086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047339|NCT00307086|Immunologic Factors|immunologic factors|mesh-ancestor
93047340|NCT00307086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047341|NCT02533544|Tenofovir|tenofovir|mesh-list
93047342|NCT02533544|Antiviral Agents|antiviral agents|mesh-ancestor
93047343|NCT02533544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047344|NCT02533544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93047345|NCT02533544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93047346|NCT02533544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047347|NCT02533544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047348|NCT02533544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92311851|NCT05424523|Omalizumab|omalizumab|mesh-list
93047349|NCT02533544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92311923|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047350|NCT03991208|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
93047351|NCT03991208|Antimalarials|antimalarials|mesh-ancestor
93047352|NCT03991208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93047353|NCT03991208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93047354|NCT03991208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047355|NCT00325416|Melphalan|melphalan|mesh-list
93047356|NCT00325416|Topotecan|topotecan|mesh-list
93047357|NCT00325416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93047358|NCT00325416|Alkylating Agents|alkylating agents|mesh-ancestor
93047359|NCT00325416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047360|NCT00325416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047361|NCT00325416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93047362|NCT00325416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047363|NCT00325416|Immunologic Factors|immunologic factors|mesh-ancestor
93047364|NCT00325416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047365|NCT00325416|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93047366|NCT00325416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93047367|NCT00325416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047368|NCT00314808|Dronabinol|dronabinol|mesh-list
93047369|NCT00314808|Hallucinogens|hallucinogens|mesh-ancestor
93047370|NCT00314808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047371|NCT00314808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93047372|NCT00314808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047373|NCT00314808|Analgesics|analgesics|mesh-ancestor
93047374|NCT00314808|Sensory System Agents|sensory system agents|mesh-ancestor
93047375|NCT00314808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312138|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93047376|NCT00314808|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93047377|NCT00314808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93047378|NCT00314808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047379|NCT00314808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047381|NCT00314808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047382|NCT01060514|Vinorelbine|vinorelbine|mesh-list
93047383|NCT01060514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93047384|NCT01060514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047385|NCT01060514|Tubulin Modulators|tubulin modulators|mesh-ancestor
93047386|NCT01060514|Antimitotic Agents|antimitotic agents|mesh-ancestor
93047387|NCT01060514|Mitosis Modulators|mitosis modulators|mesh-ancestor
93047388|NCT01060514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047389|NCT01061216|Insulin|insulin|mesh-list
93047390|NCT01061216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93047391|NCT01061216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93047392|NCT01061216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047394|NCT00314574|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93047395|NCT00314574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93047396|NCT00314574|Respiratory System Agents|respiratory system agents|mesh-ancestor
93047397|NCT01064154|Carvedilol|carvedilol|mesh-list
93047398|NCT01064154|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93047399|NCT01064154|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93047400|NCT01064154|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047401|NCT01064154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047402|NCT01064154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047403|NCT01064154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047404|NCT01064154|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93047405|NCT01064154|Antioxidants|antioxidants|mesh-ancestor
93047406|NCT01064154|Protective Agents|protective agents|mesh-ancestor
93047407|NCT01064154|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92312401|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
93047408|NCT01064154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047409|NCT01064154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93047410|NCT01064154|Vasodilator Agents|vasodilator agents|mesh-ancestor
93047411|NCT01064154|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93047412|NCT01064154|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93047413|NCT00314340|Acetaminophen|acetaminophen|mesh-list
93047414|NCT00314340|Morphine|morphine|mesh-list
93047415|NCT00314340|Hydrocodone|hydrocodone|mesh-list
93047416|NCT00314340|Phenobarbital|phenobarbital|mesh-list
93047417|NCT00314340|Amphetamine|amphetamine|mesh-list
93047418|NCT00314340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047419|NCT00314340|Narcotics|narcotics|mesh-ancestor
93047420|NCT00314340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047421|NCT00314340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047422|NCT00314340|Analgesics|analgesics|mesh-ancestor
93047423|NCT00314340|Sensory System Agents|sensory system agents|mesh-ancestor
93047424|NCT00314340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047425|NCT00314340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047426|NCT00314340|Antipyretics|antipyretics|mesh-ancestor
93047427|NCT00314340|Antitussive Agents|antitussive agents|mesh-ancestor
93047428|NCT00314340|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312752|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
93047429|NCT00314340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93047430|NCT00314340|Sympathomimetics|sympathomimetics|mesh-ancestor
93047431|NCT00314340|Autonomic Agents|autonomic agents|mesh-ancestor
93047432|NCT00314340|Dopamine Agents|dopamine agents|mesh-ancestor
92312821|NCT04809662|Imiquimod|imiquimod|mesh-list
93047433|NCT00314340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047434|NCT00314340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047435|NCT00314340|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047436|NCT00314340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93047437|NCT00314340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93047438|NCT00314340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047439|NCT00314340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93047440|NCT00314340|Anticonvulsants|anticonvulsants|mesh-ancestor
93047441|NCT00314340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93047442|NCT00314340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93047443|NCT00314340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93047444|NCT00314340|GABA Modulators|gaba modulators|mesh-ancestor
93047445|NCT00314340|GABA Agents|gaba agents|mesh-ancestor
93047446|NCT00314340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93047447|NCT00314340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92692450|NCT00498992|Antioxidants|antioxidants|mesh-ancestor
93047448|NCT00314340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93047449|NCT00306852|Mitomycins|mitomycins|mesh-list
93047450|NCT00306852|Mitomycin|mitomycin|mesh-list
93047451|NCT00306852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93047452|NCT00306852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047453|NCT00306852|Alkylating Agents|alkylating agents|mesh-ancestor
93047454|NCT00306852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047455|NCT00306852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93047456|NCT00306852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047457|NCT00314262|Celecoxib|celecoxib|mesh-list
93047458|NCT00314262|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93047459|NCT00314262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047460|NCT00314262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93047461|NCT00314262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529348|NCT00015834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92313243|NCT02767934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93047462|NCT00314262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047463|NCT00314262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93047464|NCT00314262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047465|NCT00314262|Analgesics|analgesics|mesh-ancestor
92313315|NCT04336891|Estrogens|estrogens|mesh-ancestor
93047466|NCT00314262|Sensory System Agents|sensory system agents|mesh-ancestor
93047467|NCT00314262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313382|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
93047468|NCT00314262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047469|NCT00314262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047470|NCT00314262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047471|NCT00314262|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93047472|NCT00314262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93047473|NCT00333866|Pregabalin|pregabalin|mesh-list
93047474|NCT00333866|Analgesics|analgesics|mesh-ancestor
93047475|NCT00333866|Sensory System Agents|sensory system agents|mesh-ancestor
93047476|NCT00333866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047477|NCT00333866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047478|NCT00333866|Anticonvulsants|anticonvulsants|mesh-ancestor
93047479|NCT00333866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93047480|NCT00333866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047481|NCT00333866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047482|NCT00333866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93047483|NCT00333866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93047484|NCT00333866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93047485|NCT00333866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047486|NCT00333866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93047487|NCT00324740|Vorinostat|vorinostat|mesh-list
93047488|NCT00324740|Isotretinoin|isotretinoin|mesh-list
93047489|NCT00324740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047490|NCT00324740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93047491|NCT00324740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047492|NCT00324740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047493|NCT00324740|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047494|NCT00333788|Certolizumab Pegol|certolizumab pegol|mesh-list
93047495|NCT00333788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92313815|NCT02885636|Albuterol|albuterol|mesh-list
93047496|NCT00333788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047497|NCT00333788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047498|NCT00333788|Immunologic Factors|immunologic factors|mesh-ancestor
93047499|NCT00333788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047500|NCT00333788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047501|NCT00332696|Methylprednisolone|methylprednisolone|mesh-list
93047502|NCT00332696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93047503|NCT00332696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93047504|NCT00332696|Prednisolone|prednisolone|mesh-list
93047505|NCT00332696|Prednisolone acetate|prednisolone acetate|mesh-list
93047506|NCT00332696|Octreotide|octreotide|mesh-list
93047507|NCT00332696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93047508|NCT00332696|Prednisolone phosphate|prednisolone phosphate|mesh-list
92313949|NCT02911844|Fulvestrant|fulvestrant|mesh-list
93047509|NCT00332696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047510|NCT00332696|Antiemetics|antiemetics|mesh-ancestor
93047511|NCT00332696|Autonomic Agents|autonomic agents|mesh-ancestor
93047512|NCT00332696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047513|NCT00332696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047514|NCT00332696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93047515|NCT00332696|Glucocorticoids|glucocorticoids|mesh-ancestor
93047516|NCT00332696|Hormones|hormones|mesh-ancestor
93047517|NCT00332696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047518|NCT00332696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93047519|NCT00332696|Protective Agents|protective agents|mesh-ancestor
93047520|NCT00332696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93047521|NCT00332696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047522|NCT00313716|Epoetin Alfa|epoetin alfa|mesh-list
93047523|NCT00313716|Hematinics|hematinics|mesh-ancestor
93047524|NCT00313170|Fulvestrant|fulvestrant|mesh-list
92314088|NCT03001843|Anesthetics|anesthetics|mesh-ancestor
93047525|NCT00313170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93047526|NCT00313170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047527|NCT00313170|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93047528|NCT00313170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93047529|NCT00313170|Hormone Antagonists|hormone antagonists|mesh-ancestor
93047530|NCT00313170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047531|NCT00313170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047532|NCT00332462|Cyclosporine|cyclosporine|mesh-list
93047533|NCT00332462|Cyclosporins|cyclosporins|mesh-list
93047534|NCT00332462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047535|NCT00332462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047536|NCT00332462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047537|NCT00332462|Immunologic Factors|immunologic factors|mesh-ancestor
93047538|NCT00332462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047539|NCT00332462|Antifungal Agents|antifungal agents|mesh-ancestor
93047540|NCT00332462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047541|NCT00332462|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047542|NCT00332462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047543|NCT00332462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93047544|NCT00324038|Acetaminophen|acetaminophen|mesh-list
93047545|NCT00324038|Buprenorphine|buprenorphine|mesh-list
93047546|NCT00324038|Codeine|codeine|mesh-list
93047547|NCT00324038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047548|NCT00324038|Analgesics|analgesics|mesh-ancestor
93047549|NCT00324038|Sensory System Agents|sensory system agents|mesh-ancestor
93047550|NCT00324038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047551|NCT00324038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047552|NCT00324038|Antipyretics|antipyretics|mesh-ancestor
93047553|NCT00324038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047554|NCT00324038|Narcotics|narcotics|mesh-ancestor
93047555|NCT00324038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047556|NCT00324038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93047557|NCT00324038|Antitussive Agents|antitussive agents|mesh-ancestor
93047558|NCT00324038|Respiratory System Agents|respiratory system agents|mesh-ancestor
93047559|NCT03984110|Dexamethasone|dexamethasone|mesh-list
93047560|NCT03984110|Aflibercept|aflibercept|mesh-list
92314447|NCT02945150|Grazoprevir|grazoprevir|mesh-list
93047561|NCT03984110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047562|NCT03984110|Antiemetics|antiemetics|mesh-ancestor
93047563|NCT03984110|Autonomic Agents|autonomic agents|mesh-ancestor
93047564|NCT03984110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314506|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047565|NCT03984110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047566|NCT03984110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93047567|NCT03984110|Glucocorticoids|glucocorticoids|mesh-ancestor
93047568|NCT03984110|Hormones|hormones|mesh-ancestor
92314578|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047569|NCT03984110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314648|NCT05829603|Harmine|harmine|mesh-list
93047570|NCT03984110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93047571|NCT03984110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047572|NCT03984110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93047573|NCT03984110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93047574|NCT03984110|Growth Substances|growth substances|mesh-ancestor
93047575|NCT03984110|Growth Inhibitors|growth inhibitors|mesh-ancestor
93047576|NCT00159861|Sildenafil Citrate|sildenafil citrate|mesh-list
92314796|NCT05827991|Vasodilator Agents|vasodilator agents|mesh-ancestor
93047577|NCT00159861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047578|NCT00159861|Vasodilator Agents|vasodilator agents|mesh-ancestor
93047579|NCT00159861|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93047580|NCT00159861|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93047581|NCT00159861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047582|NCT00159861|Urological Agents|urological agents|mesh-ancestor
93047583|NCT01057628|Ipragliflozin|ipragliflozin|mesh-list
93047584|NCT01057628|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93047585|NCT01057628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047586|NCT01057628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93047587|NCT01057628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047588|NCT00331760|Cisplatin|cisplatin|mesh-list
93047589|NCT00331760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047590|NCT00225147|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93047591|NCT00225147|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93047592|NCT00225147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047593|NCT00225147|Immunologic Factors|immunologic factors|mesh-ancestor
93047594|NCT00225147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047595|NCT00313014|Oxycodone|oxycodone|mesh-list
93047596|NCT00313014|Buprenorphine|buprenorphine|mesh-list
93047597|NCT00313014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047598|NCT00313014|Narcotics|narcotics|mesh-ancestor
93047599|NCT00313014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047600|NCT00313014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047601|NCT00313014|Analgesics|analgesics|mesh-ancestor
93047602|NCT00313014|Sensory System Agents|sensory system agents|mesh-ancestor
93047603|NCT00313014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047604|NCT00313014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93047605|NCT01075659|Nicotine|nicotine|mesh-list
93047606|NCT01075659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93047607|NCT01075659|Autonomic Agents|autonomic agents|mesh-ancestor
93047608|NCT01075659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047609|NCT01075659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047610|NCT01075659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93047611|NCT01075659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93047612|NCT01075659|Cholinergic Agents|cholinergic agents|mesh-ancestor
93047613|NCT01075659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047614|NCT01075659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047615|NCT01077453|Letrozole|letrozole|mesh-list
93047616|NCT01077453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047617|NCT01077453|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93047618|NCT01077453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93047619|NCT01077453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315365|NCT04966702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93047620|NCT01077453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047621|NCT01077453|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93047622|NCT01077453|Hormone Antagonists|hormone antagonists|mesh-ancestor
93047623|NCT01077453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047624|NCT01077453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047625|NCT00157209|Cyclophosphamide|cyclophosphamide|mesh-list
93047626|NCT00157209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047627|NCT00157209|Immunologic Factors|immunologic factors|mesh-ancestor
93047628|NCT00157209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047629|NCT00157209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047630|NCT00157209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93047631|NCT00157209|Alkylating Agents|alkylating agents|mesh-ancestor
93047632|NCT00157209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047633|NCT00157209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047634|NCT00157209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93047635|NCT00312858|Vaccines|vaccines|mesh-list
93047636|NCT00312858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93047637|NCT00312858|Immunologic Factors|immunologic factors|mesh-ancestor
93047638|NCT00312858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047639|NCT00156819|Fluticasone|fluticasone|mesh-list
93047640|NCT00156819|Xhance|xhance|mesh-list
93047641|NCT00156819|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93047642|NCT00156819|Montelukast|montelukast|mesh-list
93047643|NCT00156819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047644|NCT00156819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93047645|NCT00156819|Autonomic Agents|autonomic agents|mesh-ancestor
93047646|NCT00156819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047647|NCT00156819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315437|NCT04724148|Anesthetics|anesthetics|mesh-ancestor
93047648|NCT00156819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93047649|NCT00156819|Respiratory System Agents|respiratory system agents|mesh-ancestor
93047650|NCT00156819|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047651|NCT00156819|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93047652|NCT00156819|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93047653|NCT00156819|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93047654|NCT00156819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93047655|NCT00156819|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047656|NCT00156819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047657|NCT00156819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047658|NCT00156819|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93047659|NCT00156819|Hormone Antagonists|hormone antagonists|mesh-ancestor
93047660|NCT00156819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047661|NCT00156819|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93047662|NCT00156819|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93047663|NCT00224133|Silodosin|silodosin|mesh-list
93047664|NCT00224133|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93047665|NCT00224133|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93047666|NCT00224133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93047667|NCT00224133|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047668|NCT00224133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047669|NCT00224133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047670|NCT00224133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692703|NCT05146713|Eusol|eusol|mesh-list
93047671|NCT00224133|Urological Agents|urological agents|mesh-ancestor
93047672|NCT00224055|Ferric gluconate|ferric gluconate|mesh-list
93047673|NCT00224055|Hematinics|hematinics|mesh-ancestor
93047674|NCT00150969|Vitamin K|vitamin k|mesh-list
93047675|NCT00150969|Vitamin K 1|vitamin k 1|mesh-list
93047676|NCT00150969|Vitamins|vitamins|mesh-ancestor
93047677|NCT00150969|Micronutrients|micronutrients|mesh-ancestor
93047678|NCT00150969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047679|NCT00150969|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93047680|NCT00150969|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93047681|NCT00150969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047683|NCT00150969|Coagulants|coagulants|mesh-ancestor
93047684|NCT00150345|Voriconazole|voriconazole|mesh-list
93047685|NCT00150345|Antifungal Agents|antifungal agents|mesh-ancestor
93047686|NCT00150345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047687|NCT00150345|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93047688|NCT00150345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93047689|NCT00150345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047690|NCT00150345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047691|NCT00150345|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93047692|NCT00150345|Hormone Antagonists|hormone antagonists|mesh-ancestor
93047693|NCT00150345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316057|NCT02964416|Tramadol|tramadol|mesh-list
93047694|NCT00150345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047695|NCT00150345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93047696|NCT01077609|Fluticasone|fluticasone|mesh-list
93047697|NCT01077609|Xhance|xhance|mesh-list
93047698|NCT01077609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047699|NCT01077609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93047700|NCT01077609|Autonomic Agents|autonomic agents|mesh-ancestor
93047701|NCT01077609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047702|NCT01077609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047703|NCT01077609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93047704|NCT01077609|Respiratory System Agents|respiratory system agents|mesh-ancestor
93047705|NCT01077609|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047706|NCT01077609|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93047707|NCT00223977|Ferric gluconate|ferric gluconate|mesh-list
93047708|NCT00223977|Ferric Compounds|ferric compounds|mesh-list
93047709|NCT00223977|Hematinics|hematinics|mesh-ancestor
93047710|NCT00148941|Vaccines|vaccines|mesh-list
93047711|NCT00148941|Immunologic Factors|immunologic factors|mesh-ancestor
93047712|NCT00148941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047713|NCT01073553|Cephalexin|cephalexin|mesh-list
93047714|NCT01073553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93047715|NCT01073553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047716|NCT00148317|Dexamethasone|dexamethasone|mesh-list
93047717|NCT00148317|Doxorubicin|doxorubicin|mesh-list
93047718|NCT00148317|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93047719|NCT00148317|Bortezomib|bortezomib|mesh-list
93047720|NCT00148317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047721|NCT00148317|Antiemetics|antiemetics|mesh-ancestor
93047722|NCT00148317|Autonomic Agents|autonomic agents|mesh-ancestor
93047723|NCT00148317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047724|NCT00148317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047725|NCT00148317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93047726|NCT00148317|Glucocorticoids|glucocorticoids|mesh-ancestor
93047727|NCT00148317|Hormones|hormones|mesh-ancestor
93047728|NCT00148317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047729|NCT00148317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93047730|NCT00148317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047731|NCT00148317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93047732|NCT00148317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93047733|NCT00148317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93047734|NCT00148317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047735|NCT00148317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047736|NCT00323882|Ipilimumab|ipilimumab|mesh-list
93047737|NCT00323882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93047738|NCT00323882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047739|NCT00323882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93047740|NCT00323882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047741|NCT00331682|Docetaxel|docetaxel|mesh-list
93047742|NCT00331682|Alvocidib|alvocidib|mesh-list
93047743|NCT00331682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047744|NCT00331682|Tubulin Modulators|tubulin modulators|mesh-ancestor
93047745|NCT00331682|Antimitotic Agents|antimitotic agents|mesh-ancestor
93047746|NCT00331682|Mitosis Modulators|mitosis modulators|mesh-ancestor
93047747|NCT00331682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047748|NCT00331682|Growth Inhibitors|growth inhibitors|mesh-ancestor
93047749|NCT00331682|Growth Substances|growth substances|mesh-ancestor
93047750|NCT00331682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529355|NCT00015834|Immunologic Factors|immunologic factors|mesh-ancestor
93047751|NCT00331682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93047752|NCT00331682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047753|NCT00323492|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93047754|NCT00323492|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93047755|NCT00323492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93047756|NCT00323492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047757|NCT00323492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047758|NCT00323492|Antiviral Agents|antiviral agents|mesh-ancestor
93047759|NCT00323492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047760|NCT00323492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93047761|NCT00323492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93047762|NCT00331136|Artesunate|artesunate|mesh-list
93047763|NCT00331136|Pyronaridine|pyronaridine|mesh-list
93047764|NCT00331136|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93047765|NCT00331136|Antimalarials|antimalarials|mesh-ancestor
93047766|NCT00331136|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93047767|NCT00331136|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93047768|NCT00331136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93047769|NCT00331136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316741|NCT03090620|Miotics|miotics|mesh-ancestor
93047770|NCT00331136|Antiviral Agents|antiviral agents|mesh-ancestor
93047771|NCT00331136|Schistosomicides|schistosomicides|mesh-ancestor
93047772|NCT00331136|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93047773|NCT00331136|Anthelmintics|anthelmintics|mesh-ancestor
93047774|NCT00330668|Mecasermin|mecasermin|mesh-list
93047775|NCT00330668|Growth Substances|growth substances|mesh-ancestor
93047776|NCT00330668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047777|NCT00306384|Alogliptin|alogliptin|mesh-list
93047778|NCT00306384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93047779|NCT00306384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047780|NCT00306384|Incretins|incretins|mesh-ancestor
93047781|NCT00306384|Hormones|hormones|mesh-ancestor
92316877|NCT03098420|Hormones|hormones|mesh-ancestor
93047782|NCT00306384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047783|NCT00306384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93047784|NCT00306384|Protease Inhibitors|protease inhibitors|mesh-ancestor
93047785|NCT00306384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047786|NCT00306384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047787|NCT01062906|Lidocaine|lidocaine|mesh-list
93047788|NCT01062906|Fentanyl|fentanyl|mesh-list
93047789|NCT01062906|Anesthetics, Local|anesthetics, local|mesh-ancestor
93047790|NCT01062906|Anesthetics|anesthetics|mesh-ancestor
93047791|NCT01062906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047792|NCT01062906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047793|NCT01062906|Sensory System Agents|sensory system agents|mesh-ancestor
93047794|NCT01062906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047795|NCT01062906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93047796|NCT01062906|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93047797|NCT01062906|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93047798|NCT01062906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317085|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
93047799|NCT01062906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047800|NCT01062906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047801|NCT01062906|Narcotics|narcotics|mesh-ancestor
93047802|NCT01062906|Analgesics|analgesics|mesh-ancestor
93047803|NCT01062906|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93047804|NCT01062906|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93047805|NCT01062906|Anesthetics, General|anesthetics, general|mesh-ancestor
93047806|NCT00305604|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92317163|NCT03132571|Naltrexone|naltrexone|mesh-list
93047807|NCT00305604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93047808|NCT00305604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047809|NCT00305604|Incretins|incretins|mesh-ancestor
93047810|NCT00305604|Hormones|hormones|mesh-ancestor
93047811|NCT00305604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047812|NCT00305604|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93047813|NCT00305604|Protease Inhibitors|protease inhibitors|mesh-ancestor
93047814|NCT00305604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047815|NCT00305604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047816|NCT01064232|Risperidone|risperidone|mesh-list
93047817|NCT01064232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91936625|NCT02262533|Atenolol|atenolol|mesh-list
93047818|NCT01064232|Serotonin Agents|serotonin agents|mesh-ancestor
93047819|NCT01064232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047820|NCT01064232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047821|NCT01064232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047823|NCT01064232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92317361|NCT03865615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93047824|NCT01064232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047825|NCT01064232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93047826|NCT01064232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93047827|NCT01064232|Dopamine Agents|dopamine agents|mesh-ancestor
93047828|NCT00501059|Aspirin|aspirin|mesh-list
93047829|NCT00501059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92317434|NCT05357911|Digoxin|digoxin|mesh-list
93047830|NCT00501059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93047831|NCT00501059|Analgesics|analgesics|mesh-ancestor
93047832|NCT00501059|Sensory System Agents|sensory system agents|mesh-ancestor
92317497|NCT04736108|Hormones|hormones|mesh-ancestor
93047833|NCT00501059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047834|NCT00501059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047835|NCT00501059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93047836|NCT00501059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047837|NCT00501059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93047838|NCT00501059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93047839|NCT00501059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047840|NCT00501059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93047841|NCT00501059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93047842|NCT00501059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047843|NCT00501059|Antipyretics|antipyretics|mesh-ancestor
93047844|NCT00344318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93047845|NCT00344318|Immunologic Factors|immunologic factors|mesh-ancestor
92317639|NCT00392821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047846|NCT00344318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047847|NCT00322868|Pioglitazone|pioglitazone|mesh-list
93047848|NCT00322868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93047849|NCT00322868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047850|NCT01016717|Omeprazole|omeprazole|mesh-list
93047851|NCT01016717|Pantoprazole|pantoprazole|mesh-list
93047852|NCT01016717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93047853|NCT01016717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93047854|NCT01016717|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93047855|NCT01016717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047856|NCT01016717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047857|NCT01016795|Lenograstim|lenograstim|mesh-list
93047858|NCT01016795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93047859|NCT01016795|Immunologic Factors|immunologic factors|mesh-ancestor
93047860|NCT01016795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047861|NCT00343382|Pilocarpine|pilocarpine|mesh-list
93047862|NCT00343382|Miotics|miotics|mesh-ancestor
93047863|NCT00343382|Autonomic Agents|autonomic agents|mesh-ancestor
93047864|NCT00343382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047865|NCT00343382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047866|NCT00343382|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93047867|NCT00343382|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93047868|NCT00343382|Cholinergic Agents|cholinergic agents|mesh-ancestor
93047869|NCT00343382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047870|NCT00343382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047871|NCT00481871|Vitamins|vitamins|mesh-list
93047872|NCT00481871|Folic Acid|folic acid|mesh-list
93047873|NCT00481871|Vitamin B 12|vitamin b 12|mesh-list
93047874|NCT00481871|Vitamin B Complex|vitamin b complex|mesh-list
93047875|NCT00481871|Gemcitabine|gemcitabine|mesh-list
93047876|NCT00481871|10-deazaaminopterin|10-deazaaminopterin|mesh-list
93047877|NCT00481871|Aminopterin|aminopterin|mesh-list
93047878|NCT00481871|Micronutrients|micronutrients|mesh-ancestor
93047879|NCT00481871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047880|NCT00481871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92317915|NCT02182830|Empagliflozin|empagliflozin|mesh-list
93047881|NCT00481871|Antimetabolites|antimetabolites|mesh-ancestor
93047882|NCT00481871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047883|NCT00481871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047884|NCT00481871|Hematinics|hematinics|mesh-ancestor
93047885|NCT00481871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93047886|NCT00481871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047887|NCT00329420|Certolizumab Pegol|certolizumab pegol|mesh-list
92318029|NCT03306589|Molgramostim|molgramostim|mesh-list
93047888|NCT00329420|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93047889|NCT00329420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318098|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
93047890|NCT00329420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93047891|NCT00329420|Immunologic Factors|immunologic factors|mesh-ancestor
93047892|NCT00329420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047893|NCT00329420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047894|NCT00329108|Olanzapine|olanzapine|mesh-list
93047895|NCT00329108|Ziprasidone|ziprasidone|mesh-list
92692882|NCT00508365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047896|NCT00329108|Antiemetics|antiemetics|mesh-ancestor
93047897|NCT00329108|Autonomic Agents|autonomic agents|mesh-ancestor
93047898|NCT00329108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047900|NCT00329108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93047902|NCT00329108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93047903|NCT00329108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047904|NCT00329108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93047905|NCT00329108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93047906|NCT00329108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92318311|NCT03581084|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93047907|NCT00329108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047908|NCT00329108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047909|NCT00329108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047910|NCT00329108|Serotonin Agents|serotonin agents|mesh-ancestor
93047911|NCT00329108|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93047912|NCT00329108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93047913|NCT00329108|Dopamine Agents|dopamine agents|mesh-ancestor
93047914|NCT00329030|Rituximab|rituximab|mesh-list
93047915|NCT00329030|Tositumomab I-131|tositumomab i-131|mesh-list
93047916|NCT00329030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93047917|NCT00329030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047918|NCT00329030|Immunologic Factors|immunologic factors|mesh-ancestor
93047919|NCT00329030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047920|NCT00329030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047921|NCT00328562|Gefitinib|gefitinib|mesh-list
93047922|NCT00328562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318450|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93047923|NCT00328562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93047924|NCT00328562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047925|NCT00328562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047926|NCT00328172|Metformin|metformin|mesh-list
93047927|NCT00328172|Linagliptin|linagliptin|mesh-list
93047928|NCT00328172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92318522|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
93047929|NCT00328172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047930|NCT00328172|Incretins|incretins|mesh-ancestor
93047931|NCT00328172|Hormones|hormones|mesh-ancestor
92494476|NCT01975480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047932|NCT00328172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047933|NCT00328172|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93047934|NCT00328172|Protease Inhibitors|protease inhibitors|mesh-ancestor
93047935|NCT00328172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93047936|NCT00328172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047937|NCT01061372|Pregabalin|pregabalin|mesh-list
93047938|NCT01061372|Analgesics|analgesics|mesh-ancestor
93047939|NCT01061372|Sensory System Agents|sensory system agents|mesh-ancestor
93047940|NCT01061372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047941|NCT01061372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047942|NCT01061372|Anticonvulsants|anticonvulsants|mesh-ancestor
92318741|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
93047943|NCT01061372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93047944|NCT01061372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93047945|NCT01061372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047946|NCT01061372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93047947|NCT01061372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93047948|NCT01061372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93047949|NCT01061372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93047950|NCT01061372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93047951|NCT00328094|Insulin|insulin|mesh-list
93047952|NCT00328094|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93047953|NCT00328094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93047954|NCT00328094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047955|NCT00295932|Prednisone|prednisone|mesh-list
93047956|NCT00295932|Cyclophosphamide|cyclophosphamide|mesh-list
93047957|NCT00295932|Rituximab|rituximab|mesh-list
93047958|NCT00295932|Bortezomib|bortezomib|mesh-list
93047959|NCT00295932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92318819|NCT03336853|Hybenx|hybenx|mesh-list
93047960|NCT00295932|Immunologic Factors|immunologic factors|mesh-ancestor
93047961|NCT00295932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047962|NCT00295932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93047963|NCT00295932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93047964|NCT00295932|Alkylating Agents|alkylating agents|mesh-ancestor
93047965|NCT00295932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93047966|NCT00295932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93047967|NCT00295932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93047968|NCT00295932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93047969|NCT00295932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318877|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
93047970|NCT00295932|Glucocorticoids|glucocorticoids|mesh-ancestor
93047971|NCT00295932|Hormones|hormones|mesh-ancestor
92529361|NCT00001040|Saquinavir|saquinavir|mesh-list
93047972|NCT00295932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047975|NCT01063140|Immunologic Factors|immunologic factors|mesh-ancestor
93047976|NCT01063140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047977|NCT00305448|Fulvestrant|fulvestrant|mesh-list
93047978|NCT00305448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93047979|NCT00305448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318930|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
93047980|NCT00305448|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93047981|NCT00305448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93047982|NCT00305448|Hormone Antagonists|hormone antagonists|mesh-ancestor
92494477|NCT01975480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93047983|NCT00305448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93047984|NCT00305448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047985|NCT01063218|Emollients|emollients|mesh-list
93047986|NCT01063218|Dermatologic Agents|dermatologic agents|mesh-ancestor
93047987|NCT00305058|Morphine|morphine|mesh-list
93047988|NCT00305058|Hydromorphone|hydromorphone|mesh-list
93047989|NCT00305058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93047990|NCT00305058|Narcotics|narcotics|mesh-ancestor
93047991|NCT00305058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319069|NCT04121078|Rifampin|rifampin|mesh-list
93047992|NCT00305058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93047993|NCT00305058|Analgesics|analgesics|mesh-ancestor
93047994|NCT00305058|Sensory System Agents|sensory system agents|mesh-ancestor
93047995|NCT00305058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93047996|NCT01061450|Simvastatin|simvastatin|mesh-list
93047997|NCT01061450|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93047998|NCT01061450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93047999|NCT01061450|Antimetabolites|antimetabolites|mesh-ancestor
92494478|NCT01975480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048000|NCT01061450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048001|NCT01061450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93048002|NCT01061450|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93048003|NCT01061450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048004|NCT03986294|Leucovorin|leucovorin|mesh-list
93048005|NCT03986294|Antidotes|antidotes|mesh-ancestor
93048006|NCT03986294|Protective Agents|protective agents|mesh-ancestor
93048007|NCT03986294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048008|NCT03986294|Vitamin B Complex|vitamin b complex|mesh-ancestor
93048009|NCT03986294|Vitamins|vitamins|mesh-ancestor
93048010|NCT03986294|Micronutrients|micronutrients|mesh-ancestor
93048011|NCT00322556|Immunoglobulins|immunoglobulins|mesh-list
93048012|NCT00322556|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93048013|NCT00322556|Antibodies|antibodies|mesh-list
93048014|NCT00322556|Immunologic Factors|immunologic factors|mesh-ancestor
93048015|NCT00322556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048016|NCT00321932|Calcium, Dietary|calcium, dietary|mesh-list
93048017|NCT00321932|Cholecalciferol|cholecalciferol|mesh-list
93048018|NCT00321932|Zoledronic Acid|zoledronic acid|mesh-list
93048019|NCT00321932|Calcium Carbonate|calcium carbonate|mesh-list
93048020|NCT00321932|Calcium|calcium|mesh-list
93048021|NCT00321932|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93048022|NCT00321932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048023|NCT00321932|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93048024|NCT00321932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048025|NCT00321932|Vitamins|vitamins|mesh-ancestor
93048026|NCT00321932|Micronutrients|micronutrients|mesh-ancestor
93048027|NCT00321932|Antacids|antacids|mesh-ancestor
93048028|NCT00321932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048029|NCT00326612|Midazolam|midazolam|mesh-list
93048030|NCT00326612|Diazepam|diazepam|mesh-list
93048031|NCT00326612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93048032|NCT00326612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93048033|NCT00326612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048034|NCT00326612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048035|NCT00326612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93048036|NCT00326612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93048037|NCT00326612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93048038|NCT00326612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93048039|NCT00326612|Anesthetics, General|anesthetics, general|mesh-ancestor
93048040|NCT00326612|Anesthetics|anesthetics|mesh-ancestor
93048041|NCT00326612|GABA Modulators|gaba modulators|mesh-ancestor
93048042|NCT00326612|GABA Agents|gaba agents|mesh-ancestor
93048043|NCT00326612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048044|NCT00326612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048045|NCT00326612|Anticonvulsants|anticonvulsants|mesh-ancestor
93048046|NCT00326612|Antiemetics|antiemetics|mesh-ancestor
93048047|NCT00326612|Autonomic Agents|autonomic agents|mesh-ancestor
93048048|NCT00326612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048050|NCT00326612|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93048051|NCT00326612|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93048052|NCT01060826|Somatostatin|somatostatin|mesh-list
93048053|NCT01060826|Hormones|hormones|mesh-ancestor
93048054|NCT01060826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048055|NCT01060826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319462|NCT03513757|Propofol|propofol|mesh-list
93048056|NCT00321854|Pramipexole|pramipexole|mesh-list
93048057|NCT00321854|Antioxidants|antioxidants|mesh-ancestor
93048058|NCT00321854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048059|NCT00321854|Protective Agents|protective agents|mesh-ancestor
93048060|NCT00321854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048061|NCT00321854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93048062|NCT00321854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93048063|NCT00321854|Dopamine Agonists|dopamine agonists|mesh-ancestor
93048064|NCT00321854|Dopamine Agents|dopamine agents|mesh-ancestor
93048065|NCT00321854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048066|NCT03982862|Triamcinolone|triamcinolone|mesh-list
93048067|NCT03982862|Lidocaine|lidocaine|mesh-list
93048068|NCT03982862|Botulinum Toxins|botulinum toxins|mesh-list
93048069|NCT03982862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93048070|NCT03982862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93048071|NCT03982862|Anesthetics, Local|anesthetics, local|mesh-ancestor
93048072|NCT03982862|Anesthetics|anesthetics|mesh-ancestor
93048073|NCT03982862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048074|NCT03982862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048075|NCT03982862|Sensory System Agents|sensory system agents|mesh-ancestor
93048076|NCT03982862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048077|NCT03982862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92319593|NCT00378872|Coagulants|coagulants|mesh-ancestor
93048078|NCT03982862|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93048079|NCT03982862|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93048080|NCT03982862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048081|NCT03982862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048082|NCT03982862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93048083|NCT03982862|Cholinergic Agents|cholinergic agents|mesh-ancestor
93048084|NCT03982862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048085|NCT03982862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048086|NCT03982862|Glucocorticoids|glucocorticoids|mesh-ancestor
93048087|NCT03982862|Hormones|hormones|mesh-ancestor
93048088|NCT03982862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048089|NCT03982862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93048090|NCT01060904|Doxorubicin|doxorubicin|mesh-list
93048091|NCT01060904|Bleomycin|bleomycin|mesh-list
93048092|NCT01060904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93048093|NCT01060904|Dacarbazine|dacarbazine|mesh-list
93048094|NCT01060904|Vinblastine|vinblastine|mesh-list
93048095|NCT01060904|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93048096|NCT01060904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93048097|NCT01060904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319725|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93048098|NCT01060904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93048099|NCT01060904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93048100|NCT01060904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048101|NCT01060904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048102|NCT01060904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93048103|NCT01060904|Immunotoxins|immunotoxins|mesh-ancestor
93048104|NCT01060904|Immunoconjugates|immunoconjugates|mesh-ancestor
93048105|NCT01060904|Immunologic Factors|immunologic factors|mesh-ancestor
93048106|NCT01060904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048107|NCT01060904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93048108|NCT01060904|Alkylating Agents|alkylating agents|mesh-ancestor
93048109|NCT01060904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93048110|NCT01060904|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048111|NCT01060904|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048112|NCT01060904|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048113|NCT01058174|Fluconazole|fluconazole|mesh-list
93048114|NCT01058174|Amphotericin B|amphotericin b|mesh-list
93048115|NCT01058174|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
93048116|NCT01058174|Caspofungin|caspofungin|mesh-list
93048117|NCT01058174|Micafungin|micafungin|mesh-list
93048118|NCT01058174|Antifungal Agents|antifungal agents|mesh-ancestor
93048119|NCT01058174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048120|NCT01058174|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93048121|NCT01058174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93048122|NCT01058174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319788|NCT03490916|Diuretics|diuretics|mesh-ancestor
93048123|NCT01058174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048124|NCT01058174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93048125|NCT01058174|Hormone Antagonists|hormone antagonists|mesh-ancestor
93048126|NCT01058174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048127|NCT01058174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048128|NCT01058174|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93048129|NCT01058174|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93048130|NCT01058174|Amebicides|amebicides|mesh-ancestor
93048131|NCT01058174|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93048132|NCT01058174|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93048133|NCT01058174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93048134|NCT01058252|Indomethacin|indomethacin|mesh-list
93048135|NCT01058252|Letrozole|letrozole|mesh-list
93048136|NCT01058252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048137|NCT01058252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93048138|NCT01058252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93048139|NCT01058252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048140|NCT01058252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048141|NCT01058252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93048142|NCT01058252|Hormone Antagonists|hormone antagonists|mesh-ancestor
93048143|NCT01058252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048144|NCT01058252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048145|NCT01058252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93048146|NCT01058252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93048147|NCT01058252|Analgesics|analgesics|mesh-ancestor
93048148|NCT01058252|Sensory System Agents|sensory system agents|mesh-ancestor
93048149|NCT01058252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048150|NCT01058252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048151|NCT01058252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93048152|NCT01058252|Gout Suppressants|gout suppressants|mesh-ancestor
93048153|NCT01058252|Tocolytic Agents|tocolytic agents|mesh-ancestor
93048154|NCT01058252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93048155|NCT01058252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93048156|NCT01058408|Cisplatin|cisplatin|mesh-list
93048157|NCT01058408|Everolimus|everolimus|mesh-list
93048158|NCT01058408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048159|NCT01058408|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93048160|NCT01058408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048161|NCT01058408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320029|NCT02043860|Melphalan|melphalan|mesh-list
93048162|NCT01058408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048163|NCT01058408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048164|NCT01058408|Immunologic Factors|immunologic factors|mesh-ancestor
93048165|NCT01058408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048166|NCT01061060|Epoprostenol|epoprostenol|mesh-list
93048167|NCT01061060|Beraprost|beraprost|mesh-list
93048168|NCT01061060|Tezosentan|tezosentan|mesh-list
93048169|NCT01061060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93048170|NCT01061060|Vasodilator Agents|vasodilator agents|mesh-ancestor
93048171|NCT01061060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048172|NCT00310388|Ezogabine|ezogabine|mesh-list
93048173|NCT00310388|Anticonvulsants|anticonvulsants|mesh-ancestor
93048174|NCT00310388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048175|NCT00310388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048176|NCT03981770|Anesthetics|anesthetics|mesh-list
93048177|NCT03981770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048178|NCT03981770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048179|NCT00500357|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93048180|NCT00500357|Immunologic Factors|immunologic factors|mesh-ancestor
93048181|NCT00500357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048182|NCT01063556|Donepezil|donepezil|mesh-list
93048183|NCT01063556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93048184|NCT01063556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048185|NCT01063556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048186|NCT01063556|Cholinergic Agents|cholinergic agents|mesh-ancestor
93048187|NCT01063556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048188|NCT01063556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048189|NCT01063556|Nootropic Agents|nootropic agents|mesh-ancestor
93048190|NCT03981458|Hyaluronic Acid|hyaluronic acid|mesh-list
93048191|NCT03981458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93048192|NCT03981458|Immunologic Factors|immunologic factors|mesh-ancestor
93048193|NCT03981458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048194|NCT03981458|Viscosupplements|viscosupplements|mesh-ancestor
93048195|NCT03981458|Protective Agents|protective agents|mesh-ancestor
92393781|NCT03959423|Insulin|insulin|mesh-list
93048196|NCT00309842|Cyclosporine|cyclosporine|mesh-list
93048197|NCT00309842|Mycophenolic Acid|mycophenolic acid|mesh-list
93048198|NCT00309842|Cyclophosphamide|cyclophosphamide|mesh-list
93048199|NCT00309842|Fludarabine|fludarabine|mesh-list
93048200|NCT00309842|Fludarabine phosphate|fludarabine phosphate|mesh-list
93048201|NCT00309842|Cyclosporins|cyclosporins|mesh-list
93048202|NCT00309842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048203|NCT00309842|Immunologic Factors|immunologic factors|mesh-ancestor
93048204|NCT00309842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048205|NCT00309842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93048206|NCT00309842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93048207|NCT00309842|Alkylating Agents|alkylating agents|mesh-ancestor
93048208|NCT00309842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048209|NCT00309842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048210|NCT00309842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93048211|NCT00309842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93048212|NCT00309842|Antimetabolites|antimetabolites|mesh-ancestor
93048213|NCT00309842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048214|NCT00309842|Antifungal Agents|antifungal agents|mesh-ancestor
93048215|NCT00309842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048216|NCT00309842|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048217|NCT00309842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93048218|NCT00309842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93048219|NCT00309842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93048220|NCT00309842|Antitubercular Agents|antitubercular agents|mesh-ancestor
93048221|NCT00309842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93048222|NCT03985982|Botulinum Toxins|botulinum toxins|mesh-list
93048223|NCT03985982|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93048224|NCT03985982|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93048225|NCT03985982|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93048226|NCT03985982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048227|NCT03985982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048228|NCT03985982|Cholinergic Agents|cholinergic agents|mesh-ancestor
93048229|NCT03985982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048230|NCT03985982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048231|NCT03985982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93048232|NCT03985982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048233|NCT00499889|Vidarabine|vidarabine|mesh-list
93048234|NCT00499889|Methotrexate|methotrexate|mesh-list
93048235|NCT00499889|Fludarabine phosphate|fludarabine phosphate|mesh-list
93048236|NCT00499889|Fludarabine|fludarabine|mesh-list
93048237|NCT00499889|Busulfan|busulfan|mesh-list
93048238|NCT00499889|Imatinib Mesylate|imatinib mesylate|mesh-list
93048239|NCT00499889|Tacrolimus|tacrolimus|mesh-list
93048240|NCT00499889|Thymoglobulin|thymoglobulin|mesh-list
93048241|NCT00499889|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93048242|NCT00499889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93048243|NCT00499889|Abortifacient Agents|abortifacient agents|mesh-ancestor
93048244|NCT00499889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93048245|NCT00499889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048246|NCT00499889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93048247|NCT00499889|Antimetabolites|antimetabolites|mesh-ancestor
92320707|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
93048248|NCT00499889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048249|NCT00499889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048250|NCT00499889|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048251|NCT00499889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048252|NCT00499889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93048253|NCT00499889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320778|NCT00521924|Cyclosporine|cyclosporine|mesh-list
93048254|NCT00499889|Immunologic Factors|immunologic factors|mesh-ancestor
93048255|NCT00499889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93048256|NCT00499889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93048257|NCT00499889|Antiviral Agents|antiviral agents|mesh-ancestor
93048258|NCT00499889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048259|NCT00499889|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93048260|NCT00499889|Alkylating Agents|alkylating agents|mesh-ancestor
92320842|NCT04713644|Propofol|propofol|mesh-list
93048261|NCT00499889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93048262|NCT00499889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93048263|NCT00499889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048264|NCT00309608|Glimepiride|glimepiride|mesh-list
93048265|NCT00309608|Linagliptin|linagliptin|mesh-list
93048266|NCT00309608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93048267|NCT00309608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048268|NCT00309608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048269|NCT00309608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048270|NCT00309608|Immunologic Factors|immunologic factors|mesh-ancestor
93048271|NCT00309608|Incretins|incretins|mesh-ancestor
93048272|NCT00309608|Hormones|hormones|mesh-ancestor
93048273|NCT00309608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048274|NCT00309608|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93048275|NCT00309608|Protease Inhibitors|protease inhibitors|mesh-ancestor
93048276|NCT00309608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320979|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048277|NCT00309608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048278|NCT00308750|Carboplatin|carboplatin|mesh-list
93048279|NCT00308750|Docetaxel|docetaxel|mesh-list
93048280|NCT00308750|Pemetrexed|pemetrexed|mesh-list
93048281|NCT00308750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048282|NCT00308750|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048283|NCT00308750|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048284|NCT00308750|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048285|NCT00308750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048286|NCT00308750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048287|NCT00308750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93048288|NCT00308750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93048289|NCT00489359|Carboplatin|carboplatin|mesh-list
93048290|NCT00489359|Pemetrexed|pemetrexed|mesh-list
93048291|NCT00489359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048292|NCT00489359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048293|NCT00489359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048294|NCT00489359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93048295|NCT00489359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93048296|NCT00481247|Imatinib Mesylate|imatinib mesylate|mesh-list
93048297|NCT00481247|Dasatinib|dasatinib|mesh-list
93048298|NCT00481247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048299|NCT00481247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048300|NCT00481247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048301|NCT00481247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048302|NCT04101461|Iron|iron|mesh-list
93048303|NCT04101461|Hepcidins|hepcidins|mesh-list
93048304|NCT04101461|Trace Elements|trace elements|mesh-ancestor
93048305|NCT04101461|Micronutrients|micronutrients|mesh-ancestor
93048306|NCT04101461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048307|NCT04101461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048308|NCT01017107|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
93048309|NCT01017107|Protein C|protein c|mesh-list
93048310|NCT01017107|Anticoagulants|anticoagulants|mesh-ancestor
93048311|NCT01017107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93048312|NCT01017107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93048313|NCT01017107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048314|NCT01017107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048315|NCT03997019|Analgesics, Opioid|analgesics, opioid|mesh-list
93048316|NCT03997019|Narcotics|narcotics|mesh-ancestor
93048317|NCT03997019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048318|NCT03997019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048319|NCT03997019|Analgesics|analgesics|mesh-ancestor
93048320|NCT03997019|Sensory System Agents|sensory system agents|mesh-ancestor
93048321|NCT03997019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048322|NCT00480857|Docetaxel|docetaxel|mesh-list
93048323|NCT00480857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048324|NCT00480857|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048325|NCT00480857|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048326|NCT00480857|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048327|NCT00480857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048328|NCT00499031|Cetuximab|cetuximab|mesh-list
93048329|NCT00499031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92321384|NCT04331600|Filaricides|filaricides|mesh-ancestor
93048330|NCT00499031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048331|NCT00498797|Prednisolone|prednisolone|mesh-list
93048332|NCT00498797|Docetaxel|docetaxel|mesh-list
93048333|NCT00498797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048334|NCT00498797|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048335|NCT00498797|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048336|NCT00498797|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048337|NCT00498797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048338|NCT00498797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048339|NCT00498797|Glucocorticoids|glucocorticoids|mesh-ancestor
93048340|NCT00498797|Hormones|hormones|mesh-ancestor
93048341|NCT00498797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048342|NCT00498797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048343|NCT00498797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93048344|NCT00498485|Sodium Oxybate|sodium oxybate|mesh-list
93048345|NCT00498485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93048346|NCT00498485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93048347|NCT00498485|Anesthetics, General|anesthetics, general|mesh-ancestor
93048348|NCT00498485|Anesthetics|anesthetics|mesh-ancestor
92321593|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93048349|NCT00498485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048350|NCT00498485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693332|NCT00510666|Tramadol|tramadol|mesh-list
93048351|NCT04242329|Immunomodulating Agents|immunomodulating agents|mesh-list
93048352|NCT04242329|Immunologic Factors|immunologic factors|mesh-ancestor
93048353|NCT04242329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048354|NCT00498173|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93048355|NCT00498173|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92321671|NCT03811951|Insulin|insulin|mesh-list
93048356|NCT00498173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93048357|NCT00498173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048358|NCT00498173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048359|NCT00498173|Adrenergic Agents|adrenergic agents|mesh-ancestor
93048360|NCT00498173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048361|NCT00498173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048362|NCT00295620|Anastrozole|anastrozole|mesh-list
93048363|NCT00295620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93048364|NCT00295620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048365|NCT00295620|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93048366|NCT00295620|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93048367|NCT00295620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048368|NCT00295620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321816|NCT00001052|Antacids|antacids|mesh-ancestor
93048369|NCT00295620|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93048370|NCT00295620|Hormone Antagonists|hormone antagonists|mesh-ancestor
93048371|NCT00295620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048372|NCT00295620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048373|NCT03980496|Omeprazole|omeprazole|mesh-list
93048374|NCT03980496|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93048375|NCT03980496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048376|NCT03980496|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93048377|NCT03980496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048378|NCT03980496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048379|NCT01063530|Fluorides|fluorides|mesh-list
93048380|NCT01063530|Cariostatic Agents|cariostatic agents|mesh-ancestor
93048381|NCT01063530|Protective Agents|protective agents|mesh-ancestor
93048382|NCT01063530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048383|NCT00304356|Nitazoxanide|nitazoxanide|mesh-list
93048384|NCT00304356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93048385|NCT00304356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048386|NCT01069302|Clopidogrel|clopidogrel|mesh-list
93048387|NCT01069302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93048388|NCT01069302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92322007|NCT00000338|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93048389|NCT01069302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93048390|NCT01069302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93048391|NCT01069302|Purinergic Agents|purinergic agents|mesh-ancestor
93048392|NCT01069302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048393|NCT01069302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048394|NCT01069302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048395|NCT00321620|Zoledronic Acid|zoledronic acid|mesh-list
93048396|NCT00321620|Denosumab|denosumab|mesh-list
93048397|NCT00321620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93048398|NCT00321620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048399|NCT00304278|Cisplatin|cisplatin|mesh-list
93048400|NCT00304278|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93048401|NCT00304278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048402|NCT00304278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048403|NCT00304278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529369|NCT00001040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93048404|NCT00304278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048405|NCT03981068|Nimorazole|nimorazole|mesh-list
93048406|NCT03981068|Cisplatin|cisplatin|mesh-list
93048407|NCT03981068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048408|NCT03981068|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
93048409|NCT03981068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93048410|NCT03981068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93048411|NCT03981068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048412|NCT01064102|Cetirizine|cetirizine|mesh-list
93048413|NCT01064102|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93048414|NCT01064102|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93048415|NCT01064102|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93048416|NCT01064102|Histamine Antagonists|histamine antagonists|mesh-ancestor
93048417|NCT01064102|Histamine Agents|histamine agents|mesh-ancestor
93048418|NCT01064102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048419|NCT01064102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048420|NCT01064102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048421|NCT02532114|Niclosamide|niclosamide|mesh-list
93048422|NCT02532114|Anticestodal Agents|anticestodal agents|mesh-ancestor
93048423|NCT02532114|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93048424|NCT02532114|Anthelmintics|anthelmintics|mesh-ancestor
93048425|NCT02532114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93048426|NCT02532114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048427|NCT02532114|Antinematodal Agents|antinematodal agents|mesh-ancestor
93048429|NCT00307736|Fluorouracil|fluorouracil|mesh-list
93048430|NCT00307736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93048431|NCT00307736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93048432|NCT00307736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048433|NCT00307736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93048434|NCT00307736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93048435|NCT00307736|Growth Substances|growth substances|mesh-ancestor
93048436|NCT00307736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048437|NCT00307736|Growth Inhibitors|growth inhibitors|mesh-ancestor
93048438|NCT00307736|Antimetabolites|antimetabolites|mesh-ancestor
92494479|NCT01975480|Antidepressive Agents|antidepressive agents|mesh-ancestor
93048439|NCT00307736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048440|NCT00307736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93048441|NCT00307736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048442|NCT00307736|Immunologic Factors|immunologic factors|mesh-ancestor
93048443|NCT00307736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048444|NCT00307736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048445|NCT00320528|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93048446|NCT00320528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93048447|NCT00320528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93048448|NCT00320528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048449|NCT00320528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048450|NCT00320528|Adrenergic Agents|adrenergic agents|mesh-ancestor
93048451|NCT00320528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322852|NCT00002300|Megestrol|megestrol|mesh-list
93048452|NCT00320528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048453|NCT03979586|Hyaluronic Acid|hyaluronic acid|mesh-list
93048454|NCT03979586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93048455|NCT03979586|Immunologic Factors|immunologic factors|mesh-ancestor
92494480|NCT01975480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93048456|NCT03979586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048457|NCT03979586|Viscosupplements|viscosupplements|mesh-ancestor
93048458|NCT03979586|Protective Agents|protective agents|mesh-ancestor
93048459|NCT00294762|Paclitaxel|paclitaxel|mesh-list
93048460|NCT00294762|Carboplatin|carboplatin|mesh-list
93048461|NCT00294762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93048462|NCT00294762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93048463|NCT00294762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048464|NCT00294762|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048465|NCT00294762|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048466|NCT00294762|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048467|NCT00294762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048468|NCT00294762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048469|NCT00294762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048470|NCT00294684|Methylprednisolone|methylprednisolone|mesh-list
93048471|NCT00294684|Prednisolone|prednisolone|mesh-list
93048472|NCT00294684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048473|NCT00294684|Antiemetics|antiemetics|mesh-ancestor
93048474|NCT00294684|Autonomic Agents|autonomic agents|mesh-ancestor
93048475|NCT00294684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048476|NCT00294684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048477|NCT00294684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048478|NCT00294684|Glucocorticoids|glucocorticoids|mesh-ancestor
93048479|NCT00294684|Hormones|hormones|mesh-ancestor
93048480|NCT00294684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048481|NCT00294684|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93048482|NCT00294684|Protective Agents|protective agents|mesh-ancestor
93048483|NCT00294684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494481|NCT01975662|Vancomycin|vancomycin|mesh-list
93048484|NCT00294684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048485|NCT00307034|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93048486|NCT00307034|Immunologic Factors|immunologic factors|mesh-ancestor
93048487|NCT00307034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048488|NCT01061996|Basiliximab|basiliximab|mesh-list
93048489|NCT01061996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323115|NCT00002276|Zidovudine|zidovudine|mesh-list
93048490|NCT01061996|Immunologic Factors|immunologic factors|mesh-ancestor
93048491|NCT01061996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048492|NCT01064180|Carvedilol|carvedilol|mesh-list
93048493|NCT01064180|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93048494|NCT01064180|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93048495|NCT01064180|Adrenergic Agents|adrenergic agents|mesh-ancestor
93048496|NCT01064180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048497|NCT01064180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693490|NCT00502541|Glucocorticoids|glucocorticoids|mesh-ancestor
93048498|NCT01064180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048499|NCT01064180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048500|NCT01064180|Antioxidants|antioxidants|mesh-ancestor
93048501|NCT01064180|Protective Agents|protective agents|mesh-ancestor
93048502|NCT01064180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93048503|NCT01064180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048504|NCT01064180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93048505|NCT01064180|Vasodilator Agents|vasodilator agents|mesh-ancestor
93048506|NCT01064180|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93048507|NCT01064180|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93048508|NCT01069536|Metoclopramide|metoclopramide|mesh-list
93048509|NCT01069536|Antiemetics|antiemetics|mesh-ancestor
93048510|NCT01069536|Autonomic Agents|autonomic agents|mesh-ancestor
93048511|NCT01069536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048512|NCT01069536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048513|NCT01069536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048514|NCT01069536|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93048515|NCT01069536|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93048516|NCT01069536|Dopamine Agents|dopamine agents|mesh-ancestor
93048517|NCT01069536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048518|NCT01069536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048519|NCT00320216|Ustekinumab|ustekinumab|mesh-list
93048520|NCT00320216|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048521|NCT00290706|Gemcitabine|gemcitabine|mesh-list
93048522|NCT00290706|Bortezomib|bortezomib|mesh-list
93048523|NCT00290706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93048524|NCT00290706|Antimetabolites|antimetabolites|mesh-ancestor
93048525|NCT00290706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048526|NCT00290706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048527|NCT03978156|Dronabinol|dronabinol|mesh-list
93048528|NCT03978156|Hallucinogens|hallucinogens|mesh-ancestor
93048529|NCT03978156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048530|NCT03978156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93048531|NCT03978156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93048532|NCT03978156|Analgesics|analgesics|mesh-ancestor
93048533|NCT03978156|Sensory System Agents|sensory system agents|mesh-ancestor
93048534|NCT03978156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048535|NCT03978156|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93048536|NCT03978156|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93048537|NCT03978156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048538|NCT03978156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048539|NCT03978156|Hormones|hormones|mesh-ancestor
93048540|NCT03978156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048541|NCT03978234|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93048542|NCT03978234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93048543|NCT03978234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93048544|NCT03978234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048545|NCT03978234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048546|NCT03978234|Cholinergic Agents|cholinergic agents|mesh-ancestor
93048547|NCT03978234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048548|NCT03978234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048549|NCT03978234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93048550|NCT03978234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048552|NCT01066494|Amonafide|amonafide|mesh-list
93048553|NCT01066494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93048554|NCT01066494|Antimetabolites|antimetabolites|mesh-ancestor
93048555|NCT01066494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048556|NCT01066494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048557|NCT01066494|Antiviral Agents|antiviral agents|mesh-ancestor
93048558|NCT01066494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048559|NCT01066494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048560|NCT01066494|Immunologic Factors|immunologic factors|mesh-ancestor
93048561|NCT01066494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048562|NCT01066494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048563|NCT01069770|Sunitinib|sunitinib|mesh-list
93048564|NCT01069770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048565|NCT01069770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93048566|NCT01069770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93048567|NCT01069770|Growth Substances|growth substances|mesh-ancestor
93048568|NCT01069770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048569|NCT01069770|Growth Inhibitors|growth inhibitors|mesh-ancestor
93048570|NCT01069770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048571|NCT01069770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048572|NCT01069770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048573|NCT00303108|Carboplatin|carboplatin|mesh-list
93048574|NCT00303108|Doxorubicin|doxorubicin|mesh-list
93048575|NCT00303108|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93048576|NCT00303108|Trastuzumab|trastuzumab|mesh-list
93048577|NCT00303108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048578|NCT00303108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93048579|NCT00303108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93048580|NCT00303108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93048581|NCT00303108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048582|NCT00303108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048583|NCT00303108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93048584|NCT00302952|Lovastatin|lovastatin|mesh-list
93048585|NCT00302952|L 647318|l 647318|mesh-list
93048586|NCT00302952|Dihydromevinolin|dihydromevinolin|mesh-list
93048587|NCT00302952|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93048588|NCT00302952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93048589|NCT00302952|Antimetabolites|antimetabolites|mesh-ancestor
93048590|NCT00302952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048591|NCT00302952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93048592|NCT00302952|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93048593|NCT00302952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048594|NCT01066572|Lisinopril|lisinopril|mesh-list
93048595|NCT01066572|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93048596|NCT01066572|Protease Inhibitors|protease inhibitors|mesh-ancestor
93048597|NCT01066572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048598|NCT01066572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048599|NCT01066572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048600|NCT01066572|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93048601|NCT01066572|Protective Agents|protective agents|mesh-ancestor
93048602|NCT01066572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048603|NCT01066650|Everolimus|everolimus|mesh-list
92324066|NCT02145169|Nitrous Oxide|nitrous oxide|mesh-list
93048604|NCT01066650|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93048605|NCT01066650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048606|NCT01066650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048607|NCT01066650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048608|NCT01066650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048609|NCT01066650|Immunologic Factors|immunologic factors|mesh-ancestor
93048610|NCT01066650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048611|NCT01066650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048612|NCT01066728|Theophylline|theophylline|mesh-list
93048613|NCT01066728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93048614|NCT01066728|Autonomic Agents|autonomic agents|mesh-ancestor
93048615|NCT01066728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324137|NCT00002654|Cobalt|cobalt|mesh-list
93048616|NCT01066728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048617|NCT01066728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93048618|NCT01066728|Respiratory System Agents|respiratory system agents|mesh-ancestor
93048619|NCT01066728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93048620|NCT01066728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048621|NCT01066728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494482|NCT01975662|Daptomycin|daptomycin|mesh-list
93048623|NCT01066728|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93048624|NCT01066728|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93048625|NCT01066728|Purinergic Agents|purinergic agents|mesh-ancestor
93048626|NCT01066728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048627|NCT01325610|Cholecalciferol|cholecalciferol|mesh-list
93048628|NCT01325610|Vitamin D|vitamin d|mesh-list
93048629|NCT01325610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92324278|NCT01315873|Bortezomib|bortezomib|mesh-list
93048630|NCT01325610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048631|NCT01325610|Vitamins|vitamins|mesh-ancestor
93048632|NCT01325610|Micronutrients|micronutrients|mesh-ancestor
93048633|NCT01325610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93048634|NCT00301080|Cycloserine|cycloserine|mesh-list
93048635|NCT00301080|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93048636|NCT00301080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048637|NCT00301080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93048638|NCT00301080|Antitubercular Agents|antitubercular agents|mesh-ancestor
93048639|NCT00301080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93048640|NCT00301080|Antimetabolites|antimetabolites|mesh-ancestor
93048641|NCT00301080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048642|NCT01066806|Calcium|calcium|mesh-list
93048643|NCT01066806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93048644|NCT01066806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048645|NCT03977610|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93048646|NCT03977610|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92494483|NCT01975662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93048647|NCT03977610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048648|NCT01066884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93048649|NCT01066884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048650|NCT01066884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048651|NCT01066884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324542|NCT00002756|Antimetabolites|antimetabolites|mesh-ancestor
93048652|NCT01066884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048654|NCT02532270|Oxymetazoline|oxymetazoline|mesh-list
93048655|NCT02532270|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93048656|NCT02532270|Mydriatics|mydriatics|mesh-ancestor
93048657|NCT02532270|Autonomic Agents|autonomic agents|mesh-ancestor
93048658|NCT02532270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048659|NCT02532270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048660|NCT02532270|Sympathomimetics|sympathomimetics|mesh-ancestor
93048661|NCT02532270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93048662|NCT02532270|Nasal Decongestants|nasal decongestants|mesh-ancestor
93048663|NCT02532270|Respiratory System Agents|respiratory system agents|mesh-ancestor
93048664|NCT02532270|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93048665|NCT02532270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93048666|NCT02532270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93048667|NCT02532270|Adrenergic Agents|adrenergic agents|mesh-ancestor
93048668|NCT02532270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048669|NCT02532270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048670|NCT02532270|Protective Agents|protective agents|mesh-ancestor
93048671|NCT01581450|Nitrous Oxide|nitrous oxide|mesh-list
93048672|NCT01581450|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93048673|NCT01581450|Anesthetics, General|anesthetics, general|mesh-ancestor
93048674|NCT01581450|Anesthetics|anesthetics|mesh-ancestor
93048675|NCT01581450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048676|NCT01581450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048677|NCT01581450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93048678|NCT01581450|Analgesics|analgesics|mesh-ancestor
93048679|NCT01581450|Sensory System Agents|sensory system agents|mesh-ancestor
93048680|NCT01581450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048681|NCT00289848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93048682|NCT00289848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048683|NCT00289848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048684|NCT00289848|Incretins|incretins|mesh-ancestor
93048685|NCT00289848|Hormones|hormones|mesh-ancestor
93048686|NCT00289848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048687|NCT00289848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93048688|NCT00289848|Protease Inhibitors|protease inhibitors|mesh-ancestor
93048689|NCT00289848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048690|NCT00289848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048691|NCT00289536|Factor VIII|factor viii|mesh-list
93048692|NCT00289536|Coagulants|coagulants|mesh-ancestor
93048693|NCT01066962|Ritonavir|ritonavir|mesh-list
93048694|NCT01066962|Darunavir|darunavir|mesh-list
93048695|NCT01066962|Tenofovir|tenofovir|mesh-list
93048696|NCT01066962|Emtricitabine|emtricitabine|mesh-list
93048698|NCT01066962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93048699|NCT01066962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93048700|NCT01066962|Protease Inhibitors|protease inhibitors|mesh-ancestor
93048701|NCT01066962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048702|NCT01066962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048703|NCT01066962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93048704|NCT01066962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93048705|NCT01066962|Antiviral Agents|antiviral agents|mesh-ancestor
93048706|NCT01066962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048707|NCT01066962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93048708|NCT01066962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93048709|NCT01066962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93048710|NCT01066962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92325259|NCT00801931|Melphalan|melphalan|mesh-list
93048711|NCT01066962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93048712|NCT01066962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93048713|NCT01067118|Insulin|insulin|mesh-list
93048714|NCT01067118|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93048715|NCT01067118|Insulin Lispro|insulin lispro|mesh-list
93048716|NCT01067118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048717|NCT01067118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048718|NCT01067274|Cytarabine|cytarabine|mesh-list
93048719|NCT01067274|Azacitidine|azacitidine|mesh-list
93048720|NCT01067274|Tretinoin|tretinoin|mesh-list
92693721|NCT02951793|Psychotropic Drugs|psychotropic drugs|mesh-list
93048721|NCT01067274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325404|NCT00728845|Paclitaxel|paclitaxel|mesh-list
93048722|NCT01067274|Antimetabolites|antimetabolites|mesh-ancestor
93048723|NCT01067274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048724|NCT01067274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048725|NCT01067274|Antiviral Agents|antiviral agents|mesh-ancestor
93048726|NCT01067274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048727|NCT01067274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048728|NCT01067274|Immunologic Factors|immunologic factors|mesh-ancestor
93048729|NCT01067274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048730|NCT01067274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048731|NCT01067274|Keratolytic Agents|keratolytic agents|mesh-ancestor
93048732|NCT01067274|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048733|NCT01065246|Catumaxomab|catumaxomab|mesh-list
93048734|NCT01065246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048735|NCT01325844|Anesthetics|anesthetics|mesh-list
93048736|NCT01325844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048737|NCT01325844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048738|NCT01067430|Diclofenac|diclofenac|mesh-list
93048739|NCT01067430|Etoricoxib|etoricoxib|mesh-list
93048740|NCT01067430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93048741|NCT01067430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93048742|NCT01067430|Analgesics|analgesics|mesh-ancestor
93048743|NCT01067430|Sensory System Agents|sensory system agents|mesh-ancestor
93048744|NCT01067430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048745|NCT01067430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048746|NCT01067430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048747|NCT01067430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93048748|NCT01067430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93048749|NCT01067430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048750|NCT01067430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048751|NCT01067430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93048752|NCT00305864|Temozolomide|temozolomide|mesh-list
93048753|NCT00305864|Motexafin gadolinium|motexafin gadolinium|mesh-list
93048754|NCT00305864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93048755|NCT00305864|Alkylating Agents|alkylating agents|mesh-ancestor
93048756|NCT00305864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048757|NCT00305864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325754|NCT00000319|Narcotics|narcotics|mesh-ancestor
93048758|NCT00305864|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93048759|NCT00305864|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048760|NCT03982784|Morphine|morphine|mesh-list
93048761|NCT03982784|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93048762|NCT03982784|Narcotics|narcotics|mesh-ancestor
93048763|NCT03982784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048764|NCT03982784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048765|NCT03982784|Analgesics|analgesics|mesh-ancestor
93048766|NCT03982784|Sensory System Agents|sensory system agents|mesh-ancestor
93048767|NCT03982784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048768|NCT03978884|Losartan|losartan|mesh-list
93048769|NCT03978884|Amlodipine|amlodipine|mesh-list
93048770|NCT03978884|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92529387|NCT00015873|Antimetabolites|antimetabolites|mesh-ancestor
93048771|NCT03978884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048772|NCT03978884|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93048773|NCT03978884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92326025|NCT00000415|Calcium|calcium|mesh-list
93048774|NCT03978884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048775|NCT03978884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93048776|NCT03978884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048777|NCT03978884|Vasodilator Agents|vasodilator agents|mesh-ancestor
93048778|NCT03978884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93048779|NCT03978884|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93048780|NCT03978884|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93048782|NCT03978884|Natriuretic Agents|natriuretic agents|mesh-ancestor
93048783|NCT03978884|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93048784|NCT00319982|Diltiazem|diltiazem|mesh-list
93048785|NCT00319982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048786|NCT00319982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93048787|NCT00319982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92326187|NCT00000547|Enalapril|enalapril|mesh-list
93048788|NCT00319982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048789|NCT00319982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93048790|NCT00319982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048791|NCT00319982|Vasodilator Agents|vasodilator agents|mesh-ancestor
93048792|NCT00319592|Vaccines|vaccines|mesh-list
93048793|NCT00319592|Immunologic Factors|immunologic factors|mesh-ancestor
93048794|NCT00319592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048795|NCT03980990|Metformin|metformin|mesh-list
93048796|NCT03980990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048797|NCT03980990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048798|NCT03980756|Esomeprazole|esomeprazole|mesh-list
93048799|NCT03980756|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93048800|NCT03980756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048801|NCT03980756|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93048802|NCT03980756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326460|NCT00000997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048803|NCT03980756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048804|NCT03978494|Tacrolimus|tacrolimus|mesh-list
93048805|NCT03978494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048806|NCT03978494|Immunologic Factors|immunologic factors|mesh-ancestor
93048807|NCT03978494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048808|NCT03978494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93048809|NCT03978494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048810|NCT03978494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048811|NCT01064570|Tretinoin|tretinoin|mesh-list
93048812|NCT01064570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048813|NCT01064570|Keratolytic Agents|keratolytic agents|mesh-ancestor
93048814|NCT01064570|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048815|NCT01581164|Vaccines|vaccines|mesh-list
93048816|NCT01581164|Immunologic Factors|immunologic factors|mesh-ancestor
93048817|NCT01581164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048818|NCT00319046|Miglustat|miglustat|mesh-list
93048819|NCT00319046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048820|NCT00319046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048821|NCT00319046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93048822|NCT00319046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93048823|NCT00319046|Antiviral Agents|antiviral agents|mesh-ancestor
93048824|NCT00319046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048825|NCT00319046|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93048826|NCT00319046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048827|NCT00319046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048828|NCT00303602|Olanzapine|olanzapine|mesh-list
93048829|NCT00303602|Antiemetics|antiemetics|mesh-ancestor
93048830|NCT00303602|Autonomic Agents|autonomic agents|mesh-ancestor
93048831|NCT00303602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048832|NCT00303602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048833|NCT00303602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048834|NCT00303602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93048835|NCT00303602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93048836|NCT00303602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93048837|NCT00303602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93048838|NCT00303602|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93048839|NCT00303602|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93048840|NCT00303602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93048841|NCT00303602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048842|NCT00303602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048844|NCT03979976|Ramipril|ramipril|mesh-list
93048845|NCT03979976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93048846|NCT03979976|Enzyme Inhibitors|enzyme inhibitors|mesh-list
93048847|NCT03979976|Protease Inhibitors|protease inhibitors|mesh-ancestor
93048848|NCT03979976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048849|NCT03979976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93048850|NCT00299130|Methylprednisolone|methylprednisolone|mesh-list
93048851|NCT00299130|Rituximab|rituximab|mesh-list
93048852|NCT00299130|Methotrexate|methotrexate|mesh-list
93048853|NCT00299130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93048854|NCT00299130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048855|NCT00299130|Immunologic Factors|immunologic factors|mesh-ancestor
93048856|NCT00299130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048857|NCT00299130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93048858|NCT00299130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93048859|NCT00299130|Abortifacient Agents|abortifacient agents|mesh-ancestor
93048860|NCT00299130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92327105|NCT00002089|Azithromycin|azithromycin|mesh-list
93048861|NCT00299130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93048862|NCT00299130|Antimetabolites|antimetabolites|mesh-ancestor
93048863|NCT00299130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048864|NCT00299130|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048865|NCT00299130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048866|NCT00299130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93048867|NCT00299130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327162|NCT04329650|Methylprednisolone|methylprednisolone|mesh-list
93048868|NCT00299130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93048869|NCT00299130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048870|NCT00299130|Antiemetics|antiemetics|mesh-ancestor
93048871|NCT00299130|Autonomic Agents|autonomic agents|mesh-ancestor
93048872|NCT00299130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048873|NCT00299130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048874|NCT00299130|Glucocorticoids|glucocorticoids|mesh-ancestor
93048875|NCT00299130|Hormones|hormones|mesh-ancestor
93048876|NCT00299130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048877|NCT00299130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93048878|NCT00299130|Protective Agents|protective agents|mesh-ancestor
93048879|NCT00288054|Docetaxel|docetaxel|mesh-list
93048880|NCT00288054|Cetuximab|cetuximab|mesh-list
93048881|NCT00288054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048882|NCT00288054|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048883|NCT00288054|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048884|NCT00288054|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048885|NCT00288054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048886|NCT00288054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93048887|NCT00287586|Testosterone|testosterone|mesh-list
93048888|NCT00287586|Androgens|androgens|mesh-ancestor
93048889|NCT00287586|Hormones|hormones|mesh-ancestor
93048890|NCT00287586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048891|NCT00287586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048892|NCT01070160|Metformin|metformin|mesh-list
93048893|NCT01070160|Progesterone|progesterone|mesh-list
93048894|NCT01070160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048895|NCT01070160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048896|NCT01070160|Progestins|progestins|mesh-ancestor
93048897|NCT01070160|Hormones|hormones|mesh-ancestor
93048898|NCT01070160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048899|NCT03977298|Chlorhexidine|chlorhexidine|mesh-list
93048900|NCT03977298|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93048901|NCT03977298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048902|NCT03977298|Disinfectants|disinfectants|mesh-ancestor
93048903|NCT03977220|Paclitaxel|paclitaxel|mesh-list
93048904|NCT03977220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91980072|NCT02437721|Folic Acid|folic acid|mesh-list
93048905|NCT03977220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048906|NCT03977220|Tubulin Modulators|tubulin modulators|mesh-ancestor
93048907|NCT03977220|Antimitotic Agents|antimitotic agents|mesh-ancestor
93048908|NCT03977220|Mitosis Modulators|mitosis modulators|mesh-ancestor
93048909|NCT03977220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048910|NCT00293202|Etanercept|etanercept|mesh-list
93048911|NCT00293202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93048912|NCT00293202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93048913|NCT00293202|Analgesics|analgesics|mesh-ancestor
93048914|NCT00293202|Sensory System Agents|sensory system agents|mesh-ancestor
93048915|NCT00293202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048916|NCT00293202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048917|NCT00293202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048918|NCT00293202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93048919|NCT00293202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048920|NCT00293202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048921|NCT00293202|Immunologic Factors|immunologic factors|mesh-ancestor
93048923|NCT00286494|Alogliptin|alogliptin|mesh-list
93048924|NCT00286494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93048925|NCT00286494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048926|NCT00286494|Incretins|incretins|mesh-ancestor
93048927|NCT00286494|Hormones|hormones|mesh-ancestor
92494484|NCT01975662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048928|NCT00286494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048929|NCT00286494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93048930|NCT00286494|Protease Inhibitors|protease inhibitors|mesh-ancestor
93048931|NCT00286494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048932|NCT00286494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048933|NCT00298740|Insulin|insulin|mesh-list
93048934|NCT00298740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92327817|NCT00002239|Efavirenz|efavirenz|mesh-list
93048935|NCT00298740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048936|NCT01067898|Vitamin D|vitamin d|mesh-list
93048937|NCT01067898|Ergocalciferols|ergocalciferols|mesh-list
93048938|NCT01067898|Cholecalciferol|cholecalciferol|mesh-list
93048939|NCT01067898|Vitamins|vitamins|mesh-list
93048940|NCT01067898|Calcium Carbonate|calcium carbonate|mesh-list
93048941|NCT01067898|Micronutrients|micronutrients|mesh-ancestor
93048942|NCT01067898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048943|NCT01067898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93048944|NCT01067898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93048945|NCT01067898|Antacids|antacids|mesh-ancestor
93048946|NCT01067898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048948|NCT03979248|Deucravacitinib|deucravacitinib|mesh-list
93048949|NCT03979248|Rabeprazole|rabeprazole|mesh-list
93048950|NCT03979248|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93048951|NCT03979248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93048952|NCT03979248|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93048953|NCT03979248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048954|NCT03979248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048955|NCT03979248|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048956|NCT03979248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93048957|NCT00285012|Varenicline|varenicline|mesh-list
93048958|NCT00285012|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93048959|NCT00285012|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93048960|NCT00285012|Cholinergic Agents|cholinergic agents|mesh-ancestor
93048961|NCT00285012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93048962|NCT00285012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048963|NCT00285012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048964|NCT00284934|Mycophenolic Acid|mycophenolic acid|mesh-list
93048965|NCT00284934|Prednisone|prednisone|mesh-list
93048966|NCT00284934|Tacrolimus|tacrolimus|mesh-list
93048967|NCT00284934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93048968|NCT00284934|Glucocorticoids|glucocorticoids|mesh-ancestor
93048969|NCT00284934|Hormones|hormones|mesh-ancestor
93048970|NCT00284934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048971|NCT00284934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048972|NCT00284934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93048973|NCT00284934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93048974|NCT00284934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93048975|NCT00284934|Immunologic Factors|immunologic factors|mesh-ancestor
93048976|NCT00284934|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93048977|NCT00284934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93048978|NCT00284934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93048979|NCT00284934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93048980|NCT00284934|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93048981|NCT00284934|Antitubercular Agents|antitubercular agents|mesh-ancestor
92328245|NCT00002281|Zidovudine|zidovudine|mesh-list
93048982|NCT00284934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93048983|NCT00284934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93048984|NCT00284856|Fluticasone|fluticasone|mesh-list
93048985|NCT00284856|Montelukast|montelukast|mesh-list
93048986|NCT00284856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328320|NCT00002557|Antimetabolites|antimetabolites|mesh-ancestor
93048987|NCT00284856|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93048988|NCT00284856|Autonomic Agents|autonomic agents|mesh-ancestor
93048989|NCT00284856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93048990|NCT00284856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93048991|NCT00284856|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93048992|NCT00284856|Respiratory System Agents|respiratory system agents|mesh-ancestor
93048993|NCT00284856|Dermatologic Agents|dermatologic agents|mesh-ancestor
93048994|NCT00284856|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93048995|NCT00284856|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93048996|NCT00284856|Hormone Antagonists|hormone antagonists|mesh-ancestor
93048997|NCT00284856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93048998|NCT00284856|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93048999|NCT00284856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93049000|NCT00284856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049001|NCT00298272|Methylprednisolone|methylprednisolone|mesh-list
93049002|NCT00298272|Adalimumab|adalimumab|mesh-list
93049003|NCT00298272|Etanercept|etanercept|mesh-list
93049004|NCT00298272|Rituximab|rituximab|mesh-list
93049005|NCT00298272|Methotrexate|methotrexate|mesh-list
93049006|NCT00298272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049007|NCT00298272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049008|NCT00298272|Immunologic Factors|immunologic factors|mesh-ancestor
93049009|NCT00298272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049010|NCT00298272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049011|NCT00298272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93049012|NCT00298272|Abortifacient Agents|abortifacient agents|mesh-ancestor
93049013|NCT00298272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93049014|NCT00298272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049015|NCT00298272|Antimetabolites|antimetabolites|mesh-ancestor
93049016|NCT00298272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049017|NCT00298272|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049018|NCT00298272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049019|NCT00298272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93049020|NCT00298272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049021|NCT00298272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93049022|NCT00298272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049023|NCT00298272|Antiemetics|antiemetics|mesh-ancestor
93049024|NCT00298272|Autonomic Agents|autonomic agents|mesh-ancestor
93049025|NCT00298272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049026|NCT00298272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049027|NCT00298272|Glucocorticoids|glucocorticoids|mesh-ancestor
93049028|NCT00298272|Hormones|hormones|mesh-ancestor
93049029|NCT00298272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049030|NCT00298272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93049031|NCT00298272|Protective Agents|protective agents|mesh-ancestor
93049032|NCT00298272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93049033|NCT00298272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93049034|NCT00298272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93049035|NCT00298272|Analgesics|analgesics|mesh-ancestor
93049036|NCT00298272|Sensory System Agents|sensory system agents|mesh-ancestor
93049037|NCT01068054|Cyclosporine|cyclosporine|mesh-list
93049038|NCT01068054|Tacrolimus|tacrolimus|mesh-list
93049039|NCT01068054|Cyclosporins|cyclosporins|mesh-list
93049040|NCT01068054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049041|NCT01068054|Immunologic Factors|immunologic factors|mesh-ancestor
93049042|NCT01068054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049043|NCT01068054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93049044|NCT01068054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049045|NCT01068054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049046|NCT01068054|Antifungal Agents|antifungal agents|mesh-ancestor
93049047|NCT01068054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328718|NCT00003446|Vitamins|vitamins|mesh-ancestor
93049048|NCT01068054|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049049|NCT01068054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049050|NCT00298038|Rifaximin|rifaximin|mesh-list
93049051|NCT00298038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049052|NCT00298038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049053|NCT00298038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049054|NCT00283686|Telmisartan|telmisartan|mesh-list
93049055|NCT00283686|Lisinopril|lisinopril|mesh-list
93049056|NCT00283686|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93049057|NCT00283686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93049058|NCT00283686|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93049059|NCT00283686|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93049060|NCT00283686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049061|NCT00283686|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049062|NCT00283686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049063|NCT00283686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93049064|NCT00283686|Protective Agents|protective agents|mesh-ancestor
93049065|NCT00283686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049066|NCT00297882|Artesunate|artesunate|mesh-list
93049067|NCT00297882|Lumefantrine|lumefantrine|mesh-list
93049068|NCT00297882|Artemether|artemether|mesh-list
93049069|NCT00297882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93049070|NCT00297882|Amodiaquine|amodiaquine|mesh-list
93049071|NCT00297882|Antimalarials|antimalarials|mesh-ancestor
93049072|NCT00297882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93049073|NCT00297882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93049074|NCT00297882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049075|NCT00297882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049076|NCT00297882|Antiviral Agents|antiviral agents|mesh-ancestor
93049077|NCT00297882|Schistosomicides|schistosomicides|mesh-ancestor
93049078|NCT00297882|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93049079|NCT00297882|Anthelmintics|anthelmintics|mesh-ancestor
93049080|NCT01065870|Gemcitabine|gemcitabine|mesh-list
93049081|NCT01065870|Capecitabine|capecitabine|mesh-list
93049082|NCT01065870|Docetaxel|docetaxel|mesh-list
93049083|NCT01065870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049084|NCT01065870|Antimetabolites|antimetabolites|mesh-ancestor
93049085|NCT01065870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049086|NCT01065870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049087|NCT01065870|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049088|NCT01065870|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049089|NCT01065870|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049090|NCT00297648|Certolizumab Pegol|certolizumab pegol|mesh-list
93049091|NCT00297648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93049092|NCT00297648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049093|NCT00297648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049094|NCT00297648|Immunologic Factors|immunologic factors|mesh-ancestor
93049095|NCT00297648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694082|NCT00515151|Ethanol|ethanol|mesh-list
93049096|NCT00297648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049097|NCT01068132|Cetuximab|cetuximab|mesh-list
93049098|NCT01068132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049099|NCT01068132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049100|NCT00297492|Nicotine|nicotine|mesh-list
93049101|NCT00297492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93049102|NCT00297492|Autonomic Agents|autonomic agents|mesh-ancestor
93049103|NCT00297492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049104|NCT00297492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049105|NCT00297492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93049106|NCT00297492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93049107|NCT00297492|Cholinergic Agents|cholinergic agents|mesh-ancestor
93049108|NCT00297492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049109|NCT00297492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049110|NCT00496769|Aspirin|aspirin|mesh-list
93049111|NCT00496769|Apixaban|apixaban|mesh-list
93049112|NCT00496769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93049113|NCT00496769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93049114|NCT00496769|Analgesics|analgesics|mesh-ancestor
93049115|NCT00496769|Sensory System Agents|sensory system agents|mesh-ancestor
93049116|NCT00496769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049117|NCT00496769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049118|NCT00496769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049119|NCT00496769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049120|NCT00496769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93049121|NCT00496769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93049122|NCT00496769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049123|NCT00496769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93049124|NCT00496769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93049125|NCT00496769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049126|NCT00496769|Antipyretics|antipyretics|mesh-ancestor
93049127|NCT00496769|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93049128|NCT00496769|Antithrombins|antithrombins|mesh-ancestor
93049129|NCT00496769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93049130|NCT00496769|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049131|NCT00496769|Anticoagulants|anticoagulants|mesh-ancestor
93049132|NCT01014845|Vaccines|vaccines|mesh-list
93049133|NCT01014845|Immunologic Factors|immunologic factors|mesh-ancestor
93049134|NCT01014845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049135|NCT00488345|Tigecycline|tigecycline|mesh-list
93049136|NCT00488345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049137|NCT00488345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049138|NCT00488345|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93049139|NCT00488345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049140|NCT00488345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049142|NCT00283062|Leuprolide|leuprolide|mesh-list
93049143|NCT00283062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049144|NCT00283062|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049145|NCT00283062|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049146|NCT00283062|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049147|NCT00283062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049148|NCT00283062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93049149|NCT00283062|Fertility Agents|fertility agents|mesh-ancestor
93049150|NCT00283062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93049151|NCT00283062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049152|NCT00283062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049153|NCT00282984|Varenicline|varenicline|mesh-list
93049154|NCT00282984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93049155|NCT00282984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93049156|NCT00282984|Cholinergic Agents|cholinergic agents|mesh-ancestor
93049157|NCT00282984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049158|NCT00282984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049159|NCT00282984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049160|NCT00296400|Atorvastatin|atorvastatin|mesh-list
93049161|NCT00296400|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93049162|NCT00296400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93049163|NCT00296400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93049164|NCT00296400|Antimetabolites|antimetabolites|mesh-ancestor
93049165|NCT00296400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049166|NCT00296400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93049167|NCT00296400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93049168|NCT00296400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049169|NCT00296244|Mycophenolic Acid|mycophenolic acid|mesh-list
93049170|NCT00296244|Prednisone|prednisone|mesh-list
93049171|NCT00296244|Methylprednisolone|methylprednisolone|mesh-list
93049172|NCT00296244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92694163|NCT01240811|Copper|copper|mesh-list
93049173|NCT00296244|Tacrolimus|tacrolimus|mesh-list
93049174|NCT00296244|Basiliximab|basiliximab|mesh-list
93049175|NCT00296244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049176|NCT00296244|Glucocorticoids|glucocorticoids|mesh-ancestor
93049177|NCT00296244|Hormones|hormones|mesh-ancestor
93049178|NCT00296244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049179|NCT00296244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049180|NCT00296244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049181|NCT00296244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049182|NCT00296244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049183|NCT00296244|Immunologic Factors|immunologic factors|mesh-ancestor
93049184|NCT00296244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93049185|NCT00296244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049186|NCT00296244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049187|NCT00296244|Antiemetics|antiemetics|mesh-ancestor
93049188|NCT00296244|Autonomic Agents|autonomic agents|mesh-ancestor
93049189|NCT00296244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049190|NCT00296244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049191|NCT00296244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93049192|NCT00296244|Protective Agents|protective agents|mesh-ancestor
93049193|NCT00296244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049194|NCT00296244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93049195|NCT00296244|Antitubercular Agents|antitubercular agents|mesh-ancestor
93049196|NCT00296244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049197|NCT00296244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049198|NCT01068444|Pioglitazone|pioglitazone|mesh-list
93049199|NCT01068444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049200|NCT01068444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049201|NCT00282048|Axitinib|axitinib|mesh-list
93049202|NCT00282048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049203|NCT00282048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93049204|NCT00282048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049205|NCT00282048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049206|NCT00474539|Vaccines|vaccines|mesh-list
93049207|NCT00474539|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93049208|NCT00474539|Immunologic Factors|immunologic factors|mesh-ancestor
93049209|NCT00474539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049210|NCT01017809|Aprepitant|aprepitant|mesh-list
93049211|NCT01017809|Antiemetics|antiemetics|mesh-ancestor
93049212|NCT01017809|Autonomic Agents|autonomic agents|mesh-ancestor
93049213|NCT01017809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049214|NCT01017809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049215|NCT01017809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049216|NCT01017809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93049217|NCT01017809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049218|NCT01017809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049219|NCT01020539|Fludarabine|fludarabine|mesh-list
93049220|NCT01020539|Busulfan|busulfan|mesh-list
93049221|NCT01020539|Gemtuzumab|gemtuzumab|mesh-list
93049222|NCT01020539|Isotretinoin|isotretinoin|mesh-list
93049223|NCT01020539|Thymoglobulin|thymoglobulin|mesh-list
93049224|NCT01020539|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93049225|NCT01020539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049226|NCT01020539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049227|NCT01020539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049228|NCT01020539|Immunologic Factors|immunologic factors|mesh-ancestor
93049229|NCT01020539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049230|NCT01020539|Alkylating Agents|alkylating agents|mesh-ancestor
93049231|NCT01020539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93049232|NCT01020539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93049233|NCT01020539|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049234|NCT01020539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049235|NCT01020539|Immunotoxins|immunotoxins|mesh-ancestor
93049236|NCT01020539|Immunoconjugates|immunoconjugates|mesh-ancestor
93049237|NCT00281580|Amlodipine|amlodipine|mesh-list
93049238|NCT00281580|Telmisartan|telmisartan|mesh-list
93049239|NCT00281580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93049240|NCT00281580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93049241|NCT00281580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93049242|NCT00281580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049243|NCT00281580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93049244|NCT00281580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049245|NCT00281580|Vasodilator Agents|vasodilator agents|mesh-ancestor
92694230|NCT00516243|Antioxidants|antioxidants|mesh-ancestor
93049246|NCT00281580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93049247|NCT00281580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93049249|NCT00495755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049250|NCT00495755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049251|NCT01070862|Thalidomide|thalidomide|mesh-list
93049252|NCT01070862|Dexamethasone|dexamethasone|mesh-list
93049253|NCT01070862|Dexamethasone acetate|dexamethasone acetate|mesh-list
93049254|NCT01070862|Doxorubicin|doxorubicin|mesh-list
93049255|NCT01070862|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93049256|NCT01070862|Melphalan|melphalan|mesh-list
93049257|NCT01070862|Cyclophosphamide|cyclophosphamide|mesh-list
93049258|NCT01070862|Vincristine|vincristine|mesh-list
93049259|NCT01070862|BB 1101|bb 1101|mesh-list
93049260|NCT01070862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049261|NCT01070862|Antiemetics|antiemetics|mesh-ancestor
93049262|NCT01070862|Autonomic Agents|autonomic agents|mesh-ancestor
93049263|NCT01070862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049264|NCT01070862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049265|NCT01070862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049266|NCT01070862|Glucocorticoids|glucocorticoids|mesh-ancestor
93049267|NCT01070862|Hormones|hormones|mesh-ancestor
93049268|NCT01070862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049269|NCT01070862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049270|NCT01070862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049271|NCT01070862|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049272|NCT01070862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049273|NCT01070862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049274|NCT01070862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049275|NCT01070862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93049276|NCT01070862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93049277|NCT01070862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93049278|NCT01070862|Alkylating Agents|alkylating agents|mesh-ancestor
93049279|NCT01070862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93049280|NCT01070862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049281|NCT01070862|Immunologic Factors|immunologic factors|mesh-ancestor
93049282|NCT01070862|Leprostatic Agents|leprostatic agents|mesh-ancestor
93049283|NCT01070862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049284|NCT01070862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049285|NCT01070862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93049286|NCT01070862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93049287|NCT01070862|Growth Substances|growth substances|mesh-ancestor
93049288|NCT01070862|Growth Inhibitors|growth inhibitors|mesh-ancestor
93049289|NCT01070862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328978|NCT00002653|Glucocorticoids|glucocorticoids|mesh-ancestor
93049290|NCT01070862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93049291|NCT01070862|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049292|NCT01070862|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049293|NCT01070862|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049294|NCT00495677|PF 232798|pf 232798|mesh-list
93049295|NCT00495677|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93049296|NCT00495677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049297|NCT00495677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93049298|NCT00495677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93049299|NCT00495677|Antiviral Agents|antiviral agents|mesh-ancestor
93049300|NCT00495677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049301|NCT00495521|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93049302|NCT00495521|Antitubercular Agents|antitubercular agents|mesh-ancestor
93049303|NCT00495521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049304|NCT00495521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049305|NCT00494507|Dichlorphenamide|dichlorphenamide|mesh-list
93049306|NCT00494507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93049307|NCT00494507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049308|NCT00494507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049309|NCT00292188|Pregabalin|pregabalin|mesh-list
93049310|NCT00292188|Analgesics|analgesics|mesh-ancestor
93049311|NCT00292188|Sensory System Agents|sensory system agents|mesh-ancestor
93049312|NCT00292188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049313|NCT00292188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049314|NCT00292188|Anticonvulsants|anticonvulsants|mesh-ancestor
93049315|NCT00292188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93049316|NCT00292188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93049317|NCT00292188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049318|NCT00292188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93049319|NCT00292188|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93049320|NCT00292188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049321|NCT00292188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049322|NCT00292188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049323|NCT00271596|Citalopram|citalopram|mesh-list
93049324|NCT00271596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93049325|NCT00271596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93049326|NCT00271596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93049327|NCT00271596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049328|NCT00271596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049329|NCT00271596|Serotonin Agents|serotonin agents|mesh-ancestor
93049330|NCT00271596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049331|NCT00271596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93049332|NCT00271596|Antidepressive Agents|antidepressive agents|mesh-ancestor
93049333|NCT00271596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049334|NCT01068756|Dapagliflozin|dapagliflozin|mesh-list
93049335|NCT01068756|Rifampin|rifampin|mesh-list
93049336|NCT01068756|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93049337|NCT01068756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049338|NCT01068756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049339|NCT01068756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049340|NCT01068756|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93049341|NCT01068756|Antitubercular Agents|antitubercular agents|mesh-ancestor
93049342|NCT01068756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049343|NCT01068756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049344|NCT01068756|Leprostatic Agents|leprostatic agents|mesh-ancestor
93049345|NCT01068756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93049346|NCT01068756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049347|NCT01068756|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93049348|NCT01068756|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93049349|NCT01068756|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93049350|NCT01068756|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93049351|NCT01068756|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93049352|NCT01068756|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93049353|NCT00291642|Cetirizine|cetirizine|mesh-list
93049354|NCT00291642|Levocetirizine|levocetirizine|mesh-list
93049356|NCT00291642|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93049357|NCT00291642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93049358|NCT00291642|Histamine Antagonists|histamine antagonists|mesh-ancestor
93049359|NCT00291642|Histamine Agents|histamine agents|mesh-ancestor
93049360|NCT00291642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049361|NCT00291642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049362|NCT00291642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049363|NCT01070472|Misoprostol|misoprostol|mesh-list
93049364|NCT01070472|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93049365|NCT01070472|Abortifacient Agents|abortifacient agents|mesh-ancestor
93049366|NCT01070472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93049367|NCT01070472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049368|NCT01070472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93049369|NCT01070472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049370|NCT01070472|Oxytocics|oxytocics|mesh-ancestor
93049371|NCT00280566|Ziprasidone|ziprasidone|mesh-list
93049372|NCT00280566|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93049373|NCT00280566|Serotonin Agents|serotonin agents|mesh-ancestor
93049374|NCT00280566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049375|NCT00280566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049376|NCT00280566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049377|NCT00280566|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93049378|NCT00280566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049379|NCT00280566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049380|NCT00280566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049381|NCT00280566|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93049382|NCT00280566|Dopamine Agents|dopamine agents|mesh-ancestor
93049383|NCT00270894|Cyclophosphamide|cyclophosphamide|mesh-list
93049384|NCT00270894|Docetaxel|docetaxel|mesh-list
93049385|NCT00270894|Trastuzumab|trastuzumab|mesh-list
93049386|NCT00270894|Epirubicin|epirubicin|mesh-list
93049387|NCT00270894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049388|NCT00270894|Immunologic Factors|immunologic factors|mesh-ancestor
93049389|NCT00270894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049390|NCT00270894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049391|NCT00270894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93049392|NCT00270894|Alkylating Agents|alkylating agents|mesh-ancestor
93049393|NCT00270894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049394|NCT00270894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049395|NCT00270894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93049396|NCT00270894|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049397|NCT00270894|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049398|NCT00270894|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049399|NCT00270894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049400|NCT00270894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049401|NCT00270894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93049402|NCT00270894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93049403|NCT00270894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049404|NCT01070628|Levodopa|levodopa|mesh-list
93049405|NCT01070628|Carbidopa|carbidopa|mesh-list
93049406|NCT01070628|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93049407|NCT01070628|Entacapone|entacapone|mesh-list
93049408|NCT01070628|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93049409|NCT01070628|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93049410|NCT01070628|Dopamine Agents|dopamine agents|mesh-ancestor
93049411|NCT01070628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049412|NCT01070628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049413|NCT01070628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049414|NCT01070628|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93049415|NCT01070628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049416|NCT01070628|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93049417|NCT01070628|Immunologic Factors|immunologic factors|mesh-ancestor
93049418|NCT01070628|Dopamine Agonists|dopamine agonists|mesh-ancestor
93049419|NCT01070628|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
93049420|NCT01070940|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
93049421|NCT01070940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049422|NCT01070940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049423|NCT00317642|Cytarabine|cytarabine|mesh-list
93049424|NCT00317642|Clofarabine|clofarabine|mesh-list
93049425|NCT00317642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049426|NCT00317642|Antimetabolites|antimetabolites|mesh-ancestor
93049427|NCT00317642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049428|NCT00317642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049429|NCT00317642|Antiviral Agents|antiviral agents|mesh-ancestor
93049430|NCT00317642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049431|NCT00317642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049432|NCT00317642|Immunologic Factors|immunologic factors|mesh-ancestor
93049433|NCT00317642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049434|NCT01064726|Fluticasone|fluticasone|mesh-list
93049435|NCT01064726|Xhance|xhance|mesh-list
93049436|NCT01064726|Ibuprofen|ibuprofen|mesh-list
93049437|NCT01064726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93049438|NCT01064726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93049439|NCT01064726|Analgesics|analgesics|mesh-ancestor
93049440|NCT01064726|Sensory System Agents|sensory system agents|mesh-ancestor
93049441|NCT01064726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049442|NCT01064726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049443|NCT01064726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049444|NCT01064726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049445|NCT01064726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93049446|NCT01064726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049447|NCT01064726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049448|NCT01064726|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93049449|NCT01064726|Autonomic Agents|autonomic agents|mesh-ancestor
93049450|NCT01064726|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93049451|NCT01064726|Respiratory System Agents|respiratory system agents|mesh-ancestor
93049452|NCT01064726|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049453|NCT01064726|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93049454|NCT00295022|Montelukast|montelukast|mesh-list
93049455|NCT00295022|Levocetirizine|levocetirizine|mesh-list
93049456|NCT00295022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93049457|NCT00295022|Respiratory System Agents|respiratory system agents|mesh-ancestor
93049458|NCT00295022|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93049459|NCT00295022|Hormone Antagonists|hormone antagonists|mesh-ancestor
93049460|NCT00295022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049461|NCT00295022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049462|NCT00295022|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93049463|NCT00295022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93049464|NCT00295022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049465|NCT00295022|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93049466|NCT00295022|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93049467|NCT00295022|Histamine Antagonists|histamine antagonists|mesh-ancestor
92694451|NCT01248468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93049468|NCT00295022|Histamine Agents|histamine agents|mesh-ancestor
93049469|NCT00295022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049470|NCT01062152|Lenalidomide|lenalidomide|mesh-list
93049471|NCT01062152|Immunologic Factors|immunologic factors|mesh-ancestor
93049472|NCT01062152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049473|NCT01062152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93049474|NCT01062152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93049475|NCT01062152|Growth Substances|growth substances|mesh-ancestor
93049476|NCT01062152|Growth Inhibitors|growth inhibitors|mesh-ancestor
93049477|NCT01062152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049478|NCT00303446|Dutasteride|dutasteride|mesh-list
93049479|NCT00303446|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
93049480|NCT00303446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93049481|NCT00303446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049482|NCT00303446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049483|NCT00303446|Hormone Antagonists|hormone antagonists|mesh-ancestor
93049484|NCT00303446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049485|NCT00303446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049486|NCT01065038|Hydroxyurea|hydroxyurea|mesh-list
93049487|NCT01065038|Anagrelide|anagrelide|mesh-list
93049488|NCT01065038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049489|NCT01065038|Antisickling Agents|antisickling agents|mesh-ancestor
93049490|NCT01065038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049491|NCT01065038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049492|NCT01065038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93049493|NCT01065038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93049494|NCT01065038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93049495|NCT01065038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93049496|NCT00291486|Capecitabine|capecitabine|mesh-list
93049497|NCT00291486|Antibodies|antibodies|mesh-list
93049498|NCT00291486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93049499|NCT00291486|Immunologic Factors|immunologic factors|mesh-ancestor
93049500|NCT00291486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049501|NCT00291486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049502|NCT00291486|Antimetabolites|antimetabolites|mesh-ancestor
93049503|NCT00291486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049504|NCT00291486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049505|NCT00301964|Bevacizumab|bevacizumab|mesh-list
93049506|NCT00301964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93049507|NCT00301964|Antibodies|antibodies|mesh-list
93049508|NCT00301964|Immunoglobulins|immunoglobulins|mesh-list
93049509|NCT00301964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93049510|NCT00301964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049511|NCT00301964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93049512|NCT00301964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93049513|NCT00301964|Growth Substances|growth substances|mesh-ancestor
93049514|NCT00301964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049515|NCT00301964|Growth Inhibitors|growth inhibitors|mesh-ancestor
93049516|NCT00301964|Immunologic Factors|immunologic factors|mesh-ancestor
93049517|NCT01070706|Paclitaxel|paclitaxel|mesh-list
93049518|NCT01070706|Gemcitabine|gemcitabine|mesh-list
93049519|NCT01070706|Sunitinib|sunitinib|mesh-list
93049520|NCT01070706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93049521|NCT01070706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049522|NCT01070706|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049523|NCT01070706|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049524|NCT01070706|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049525|NCT01070706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049526|NCT01070706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049527|NCT01070706|Antimetabolites|antimetabolites|mesh-ancestor
93049528|NCT01070706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93049529|NCT01070706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93049530|NCT01070706|Growth Substances|growth substances|mesh-ancestor
93049531|NCT01070706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049532|NCT01070706|Growth Inhibitors|growth inhibitors|mesh-ancestor
93049533|NCT01070706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93049534|NCT01070706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049535|NCT00268242|Gemcitabine|gemcitabine|mesh-list
93049536|NCT00268242|Mitoxantrone|mitoxantrone|mesh-list
93049537|NCT00268242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049538|NCT00268242|Antimetabolites|antimetabolites|mesh-ancestor
93049539|NCT00268242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049540|NCT00268242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049541|NCT00268242|Analgesics|analgesics|mesh-ancestor
92694540|NCT00516399|Natamycin|natamycin|mesh-list
92329027|NCT00002665|Leucovorin|leucovorin|mesh-list
93049542|NCT00268242|Sensory System Agents|sensory system agents|mesh-ancestor
93049543|NCT00268242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049544|NCT00268242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049545|NCT00268242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93049546|NCT00268242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93049547|NCT00268242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049549|NCT00294554|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93049550|NCT00294554|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93049551|NCT00294554|Dopamine Agents|dopamine agents|mesh-ancestor
93049552|NCT00294554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049553|NCT00294554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049554|NCT00294554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049555|NCT00294554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93049556|NCT00294554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93049557|NCT00294398|Fluticasone|fluticasone|mesh-list
93049558|NCT00294398|Xhance|xhance|mesh-list
93049559|NCT00294398|Budesonide|budesonide|mesh-list
93049560|NCT00294398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049561|NCT00294398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93049562|NCT00294398|Autonomic Agents|autonomic agents|mesh-ancestor
93049563|NCT00294398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049564|NCT00294398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049565|NCT00294398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93049566|NCT00294398|Respiratory System Agents|respiratory system agents|mesh-ancestor
93049567|NCT00294398|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049568|NCT00294398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93049569|NCT00294398|Glucocorticoids|glucocorticoids|mesh-ancestor
93049570|NCT00294398|Hormones|hormones|mesh-ancestor
93049571|NCT00294398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049572|NCT00279708|Atorvastatin|atorvastatin|mesh-list
93049573|NCT00279708|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93049574|NCT00279708|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93049575|NCT00279708|Antimetabolites|antimetabolites|mesh-ancestor
93049576|NCT00279708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049577|NCT00279708|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93049578|NCT00279708|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93049579|NCT00279708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049580|NCT00299702|Aripiprazole|aripiprazole|mesh-list
93049581|NCT00299702|Risperidone|risperidone|mesh-list
93049582|NCT00299702|Antidepressive Agents|antidepressive agents|mesh-ancestor
93049583|NCT00299702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049584|NCT00299702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93049585|NCT00299702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049586|NCT00299702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049587|NCT00299702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049588|NCT00299702|Dopamine Agonists|dopamine agonists|mesh-ancestor
93049589|NCT00299702|Dopamine Agents|dopamine agents|mesh-ancestor
93049590|NCT00299702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049591|NCT00299702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049592|NCT00299702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93049593|NCT00299702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93049594|NCT00299702|Serotonin Agents|serotonin agents|mesh-ancestor
93049595|NCT00299702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93049596|NCT00299702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93049597|NCT00299702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93049598|NCT00299702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93049599|NCT00291330|Warfarin|warfarin|mesh-list
93049600|NCT00291330|Dabigatran|dabigatran|mesh-list
93049601|NCT00291330|Anticoagulants|anticoagulants|mesh-ancestor
93049602|NCT00291330|Antithrombins|antithrombins|mesh-ancestor
93049603|NCT00291330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93049604|NCT00291330|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049605|NCT00291330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049606|NCT00291330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049607|NCT03975036|Antibodies|antibodies|mesh-list
93049608|NCT03975036|Immunologic Factors|immunologic factors|mesh-ancestor
93049609|NCT03975036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049610|NCT00267150|Mycophenolic Acid|mycophenolic acid|mesh-list
93049611|NCT00267150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049612|NCT00267150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049613|NCT00267150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93049614|NCT00267150|Antitubercular Agents|antitubercular agents|mesh-ancestor
93049615|NCT00267150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049616|NCT00267150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049617|NCT00267150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049618|NCT00267150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049619|NCT01582230|Vildagliptin|vildagliptin|mesh-list
93049620|NCT01582230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049621|NCT01582230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049622|NCT01582230|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93049623|NCT01582230|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049624|NCT01582230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049625|NCT01582230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049626|NCT00278148|Paclitaxel|paclitaxel|mesh-list
93049627|NCT00278148|Carboplatin|carboplatin|mesh-list
93049628|NCT00278148|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93049629|NCT00278148|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93049630|NCT00278148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049631|NCT00278148|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049632|NCT00278148|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049633|NCT00278148|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049634|NCT00278148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049635|NCT00278148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93049636|NCT00278148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049637|NCT00299546|Golimumab|golimumab|mesh-list
93049638|NCT00299546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93049639|NCT00299546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93049640|NCT00299546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049641|NCT00299546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049642|NCT00299546|Immunologic Factors|immunologic factors|mesh-ancestor
93049643|NCT00299546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049644|NCT03975270|Paclitaxel|paclitaxel|mesh-list
93049645|NCT03975270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93049646|NCT03975270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049647|NCT03975270|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049648|NCT03975270|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049649|NCT03975270|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049650|NCT03975270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049651|NCT01065116|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93049652|NCT01065116|Antimalarials|antimalarials|mesh-ancestor
93049653|NCT01065116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93049654|NCT01065116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93049655|NCT01065116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049656|NCT03977792|Docosanol|docosanol|mesh-list
93049657|NCT03977792|Antiviral Agents|antiviral agents|mesh-ancestor
93049658|NCT03977792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049659|NCT01066598|Rituximab|rituximab|mesh-list
93049660|NCT01066598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049661|NCT01066598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049662|NCT01066598|Immunologic Factors|immunologic factors|mesh-ancestor
93049663|NCT01066598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049664|NCT01066598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049665|NCT01066676|Ibuprofen|ibuprofen|mesh-list
93049666|NCT01066676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93049667|NCT01066676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93049668|NCT01066676|Analgesics|analgesics|mesh-ancestor
93049669|NCT01066676|Sensory System Agents|sensory system agents|mesh-ancestor
93049670|NCT01066676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049671|NCT01066676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049672|NCT01066676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049673|NCT01066676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049674|NCT01066676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93049675|NCT01066676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049676|NCT01066676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049677|NCT01065194|Simendan|simendan|mesh-list
93049678|NCT01065194|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93049679|NCT01065194|Vasodilator Agents|vasodilator agents|mesh-ancestor
93049680|NCT01065194|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93049681|NCT01065194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93049682|NCT01065194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049683|NCT01065194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049684|NCT01065194|Protective Agents|protective agents|mesh-ancestor
93049685|NCT01065194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049686|NCT01065272|Dexamethasone|dexamethasone|mesh-list
93049687|NCT01065272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049688|NCT01065272|Antiemetics|antiemetics|mesh-ancestor
93049689|NCT01065272|Autonomic Agents|autonomic agents|mesh-ancestor
93049690|NCT01065272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049691|NCT01065272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049692|NCT01065272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049693|NCT01065272|Glucocorticoids|glucocorticoids|mesh-ancestor
93049694|NCT01065272|Hormones|hormones|mesh-ancestor
93049695|NCT01065272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049696|NCT01065272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049697|NCT01065272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049698|NCT00299156|Clofarabine|clofarabine|mesh-list
93049699|NCT00299156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049700|NCT00299156|Antimetabolites|antimetabolites|mesh-ancestor
93049701|NCT00299156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049702|NCT00299156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049703|NCT00277212|Lamotrigine|lamotrigine|mesh-list
93049704|NCT00277212|Anticonvulsants|anticonvulsants|mesh-list
93049705|NCT00277212|Aripiprazole|aripiprazole|mesh-list
93049706|NCT00277212|Antidepressive Agents|antidepressive agents|mesh-ancestor
93049707|NCT00277212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049708|NCT00277212|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93049709|NCT00277212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049710|NCT00277212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049711|NCT00277212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049712|NCT00277212|Dopamine Agonists|dopamine agonists|mesh-ancestor
93049713|NCT00277212|Dopamine Agents|dopamine agents|mesh-ancestor
93049714|NCT00277212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049715|NCT00277212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049716|NCT00277212|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93049717|NCT00277212|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93049718|NCT00277212|Serotonin Agents|serotonin agents|mesh-ancestor
93049719|NCT00277212|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93049720|NCT00277212|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93049721|NCT00277212|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93049722|NCT00277212|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93049723|NCT00277212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93049724|NCT00277212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93049725|NCT00277212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93049726|NCT00277212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93049727|NCT01066754|Fexofenadine|fexofenadine|mesh-list
93049728|NCT01066754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93049729|NCT01066754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93049730|NCT01066754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93049731|NCT01066754|Histamine Antagonists|histamine antagonists|mesh-ancestor
93049732|NCT01066754|Histamine Agents|histamine agents|mesh-ancestor
93049733|NCT01066754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049734|NCT01066754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049735|NCT01066754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049737|NCT00276744|Gemcitabine|gemcitabine|mesh-list
93049738|NCT00276744|Capecitabine|capecitabine|mesh-list
93049739|NCT00276744|Docetaxel|docetaxel|mesh-list
93049740|NCT00276744|Irinotecan|irinotecan|mesh-list
93049741|NCT00276744|Cetuximab|cetuximab|mesh-list
93049742|NCT00276744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93049743|NCT00276744|Mitomycins|mitomycins|mesh-list
93049744|NCT00276744|Mitomycin|mitomycin|mesh-list
93049745|NCT00276744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049746|NCT00276744|Antimetabolites|antimetabolites|mesh-ancestor
93049747|NCT00276744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049748|NCT00276744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049749|NCT00276744|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049750|NCT00276744|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049751|NCT00276744|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049752|NCT00276744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93049753|NCT00276744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93049754|NCT00276744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049755|NCT00276744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049756|NCT00276744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93049757|NCT00276744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049758|NCT00276744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049759|NCT00276744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049760|NCT00276744|Antifungal Agents|antifungal agents|mesh-ancestor
93049761|NCT00276744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049762|NCT00276744|Immunologic Factors|immunologic factors|mesh-ancestor
93049763|NCT00276744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049764|NCT00276744|Alkylating Agents|alkylating agents|mesh-ancestor
93049765|NCT00276744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93049766|NCT00251316|Lithium Carbonate|lithium carbonate|mesh-list
93049767|NCT00251316|Antidepressive Agents|antidepressive agents|mesh-ancestor
93049768|NCT00251316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049769|NCT00251316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049770|NCT00251316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049771|NCT00251316|Antimanic Agents|antimanic agents|mesh-ancestor
93049772|NCT00251316|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049773|NCT00251316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049774|NCT00251316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049775|NCT02532192|Cytarabine|cytarabine|mesh-list
93049776|NCT02532192|Ciprofloxacin|ciprofloxacin|mesh-list
93049777|NCT02532192|Fluconazole|fluconazole|mesh-list
93049778|NCT02532192|Dexamethasone|dexamethasone|mesh-list
93049779|NCT02532192|Rituximab|rituximab|mesh-list
93049780|NCT02532192|Cisplatin|cisplatin|mesh-list
93049781|NCT02532192|Belinostat|belinostat|mesh-list
93049782|NCT02532192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049783|NCT02532192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049784|NCT02532192|Immunologic Factors|immunologic factors|mesh-ancestor
93049785|NCT02532192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049786|NCT02532192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049787|NCT02532192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049788|NCT02532192|Antiemetics|antiemetics|mesh-ancestor
93049789|NCT02532192|Autonomic Agents|autonomic agents|mesh-ancestor
93049790|NCT02532192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049791|NCT02532192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049792|NCT02532192|Glucocorticoids|glucocorticoids|mesh-ancestor
93049793|NCT02532192|Hormones|hormones|mesh-ancestor
93049794|NCT02532192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049795|NCT02532192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049796|NCT02532192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049797|NCT02532192|Antimetabolites|antimetabolites|mesh-ancestor
93049798|NCT02532192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049799|NCT02532192|Antiviral Agents|antiviral agents|mesh-ancestor
93049800|NCT02532192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049801|NCT02532192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049802|NCT02532192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049803|NCT02532192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93049804|NCT02532192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93049805|NCT02532192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049806|NCT02532192|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93049807|NCT02532192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93049808|NCT02532192|Antifungal Agents|antifungal agents|mesh-ancestor
93049809|NCT02532192|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93049810|NCT02532192|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93049811|NCT02532192|Hormone Antagonists|hormone antagonists|mesh-ancestor
93049812|NCT02532192|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93049813|NCT02532192|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93049814|NCT02532192|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93049815|NCT00293462|Sargramostim|sargramostim|mesh-list
93049816|NCT00293462|Immunologic Factors|immunologic factors|mesh-ancestor
93049817|NCT00293462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049818|NCT00316082|Metformin|metformin|mesh-list
93049819|NCT00316082|Saxagliptin|saxagliptin|mesh-list
93049820|NCT00316082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049821|NCT00316082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049822|NCT00316082|Incretins|incretins|mesh-ancestor
93049823|NCT00316082|Hormones|hormones|mesh-ancestor
93049824|NCT00316082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049825|NCT00316082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93049826|NCT00316082|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049827|NCT00316082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049828|NCT00316082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049829|NCT00316004|Dextrans|dextrans|mesh-list
93049830|NCT00316004|Anticoagulants|anticoagulants|mesh-ancestor
93049831|NCT00316004|Plasma Substitutes|plasma substitutes|mesh-ancestor
93049832|NCT00316004|Blood Substitutes|blood substitutes|mesh-ancestor
93049833|NCT01066832|Paclitaxel|paclitaxel|mesh-list
93049834|NCT01066832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93049835|NCT01066832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049836|NCT01066832|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049837|NCT01066832|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049838|NCT01066832|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049839|NCT01066832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049840|NCT00298766|Bortezomib|bortezomib|mesh-list
93049841|NCT00298766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694824|NCT01242930|Niacinamide|niacinamide|mesh-list
93049842|NCT03979664|Dexamethasone|dexamethasone|mesh-list
93049843|NCT03979664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049845|NCT03979664|Autonomic Agents|autonomic agents|mesh-ancestor
93049846|NCT03979664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049847|NCT03979664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049848|NCT03979664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049849|NCT03979664|Glucocorticoids|glucocorticoids|mesh-ancestor
93049850|NCT03979664|Hormones|hormones|mesh-ancestor
93049851|NCT03979664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049852|NCT03979664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049853|NCT03979664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049854|NCT01325558|Gemcitabine|gemcitabine|mesh-list
93049855|NCT01325558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93049856|NCT01325558|Antimetabolites|antimetabolites|mesh-ancestor
93049857|NCT01325558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049858|NCT01325558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049859|NCT00315458|Buprenorphine|buprenorphine|mesh-list
93049860|NCT00315458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93049861|NCT00315458|Narcotics|narcotics|mesh-ancestor
93049862|NCT00315458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049863|NCT00315458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049864|NCT00315458|Analgesics|analgesics|mesh-ancestor
93049865|NCT00315458|Sensory System Agents|sensory system agents|mesh-ancestor
93049866|NCT00315458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049867|NCT00315458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93049868|NCT01065662|Sirolimus|sirolimus|mesh-list
93049869|NCT01065662|Temsirolimus|temsirolimus|mesh-list
93049870|NCT01065662|MTOR Inhibitors|mtor inhibitors|mesh-list
93049871|NCT01065662|Cediranib|cediranib|mesh-list
93049872|NCT01065662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93049873|NCT01065662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049874|NCT01065662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049875|NCT01065662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049876|NCT01065662|Immunologic Factors|immunologic factors|mesh-ancestor
93049877|NCT01065662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049878|NCT01065662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049879|NCT01065662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93049880|NCT01065662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049881|NCT01065662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93049882|NCT01065662|Antifungal Agents|antifungal agents|mesh-ancestor
93049883|NCT01581242|Adefovir|adefovir|mesh-list
93049884|NCT01581242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93049885|NCT01581242|Clevudine|clevudine|mesh-list
93049886|NCT01581242|Antiviral Agents|antiviral agents|mesh-ancestor
93049887|NCT01581242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93049888|NCT01581242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93049889|NCT01581242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93049890|NCT01581242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049891|NCT01581242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049892|NCT03982238|Metformin|metformin|mesh-list
93049893|NCT03982238|Dapagliflozin|dapagliflozin|mesh-list
93049894|NCT03982238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049895|NCT03982238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049896|NCT03982238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93049897|NCT03982238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049898|NCT00293384|Dexamethasone|dexamethasone|mesh-list
93049899|NCT00293384|Dexamethasone acetate|dexamethasone acetate|mesh-list
93049900|NCT00293384|Cyclophosphamide|cyclophosphamide|mesh-list
93049901|NCT00293384|Aprepitant|aprepitant|mesh-list
93049902|NCT00293384|Granisetron|granisetron|mesh-list
93049903|NCT00293384|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93049904|NCT00293384|BB 1101|bb 1101|mesh-list
93049905|NCT00293384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93049906|NCT00293384|Immunologic Factors|immunologic factors|mesh-ancestor
93049907|NCT00293384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049908|NCT00293384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93049909|NCT00293384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93049910|NCT00293384|Alkylating Agents|alkylating agents|mesh-ancestor
93049911|NCT00293384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049912|NCT00293384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049913|NCT00293384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93049914|NCT00293384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93049915|NCT00293384|Antiemetics|antiemetics|mesh-ancestor
93049916|NCT00293384|Autonomic Agents|autonomic agents|mesh-ancestor
93049917|NCT00293384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694897|NCT00518466|Topiramate|topiramate|mesh-list
93049918|NCT00293384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93049919|NCT00293384|Glucocorticoids|glucocorticoids|mesh-ancestor
93049920|NCT00293384|Hormones|hormones|mesh-ancestor
93049921|NCT00293384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93049922|NCT00293384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93049923|NCT00293384|Protease Inhibitors|protease inhibitors|mesh-ancestor
93049924|NCT00293384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93049925|NCT00293384|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93049926|NCT00293384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049927|NCT00293384|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93049928|NCT00293384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93049929|NCT00293384|Serotonin Agents|serotonin agents|mesh-ancestor
93049930|NCT00297830|Zoledronic Acid|zoledronic acid|mesh-list
93049931|NCT00297830|Alendronate|alendronate|mesh-list
93049932|NCT00297830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93049933|NCT00297830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049934|NCT00296816|Bevacizumab|bevacizumab|mesh-list
93049935|NCT00296816|Docetaxel|docetaxel|mesh-list
93049936|NCT00296816|Oxaliplatin|oxaliplatin|mesh-list
93049937|NCT00296816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93049938|NCT00296816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93049939|NCT00296816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93049940|NCT00296816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93049941|NCT00296816|Growth Substances|growth substances|mesh-ancestor
93049942|NCT00296816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049943|NCT00296816|Growth Inhibitors|growth inhibitors|mesh-ancestor
93049944|NCT00296816|Tubulin Modulators|tubulin modulators|mesh-ancestor
93049945|NCT00296816|Antimitotic Agents|antimitotic agents|mesh-ancestor
93049946|NCT00296816|Mitosis Modulators|mitosis modulators|mesh-ancestor
93049947|NCT00296816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049949|NCT01066988|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93049950|NCT01066988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93049951|NCT01066988|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049952|NCT00097786|Nateglinide|nateglinide|mesh-list
93049953|NCT00097786|Valsartan|valsartan|mesh-list
93049954|NCT00097786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93049955|NCT00097786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93049956|NCT00097786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93049957|NCT00097786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049958|NCT00097786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049959|NCT00097786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049960|NCT01081756|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93049961|NCT01081756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93049962|NCT01081756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049963|NCT01081990|Cyclobenzaprine|cyclobenzaprine|mesh-list
93049964|NCT01081990|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93049965|NCT01081990|Antidepressive Agents|antidepressive agents|mesh-ancestor
93049966|NCT01081990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049967|NCT01081990|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93049968|NCT01081990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049969|NCT01081990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93049970|NCT01081990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93049971|NCT01081990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049972|NCT01081990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049973|NCT01084486|Metformin|metformin|mesh-list
93049974|NCT01084486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93049975|NCT01084486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049976|NCT01082146|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93049977|NCT01082146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93049978|NCT01082146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93049979|NCT01082146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93049980|NCT01082146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93049981|NCT01082146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93049982|NCT01082146|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93049983|NCT01082146|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93049984|NCT01082146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93049985|NCT01082146|Adrenergic Agents|adrenergic agents|mesh-ancestor
93049986|NCT01082146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93049987|NCT01082146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93049988|NCT01082146|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93049989|NCT01082146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93049990|NCT01082146|Serotonin Agents|serotonin agents|mesh-ancestor
93049991|NCT01082146|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93049992|NCT01082146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93049994|NCT01084720|V0034CR|v0034cr|mesh-list
93049995|NCT01084720|Emollients|emollients|mesh-ancestor
93049996|NCT01084720|Dermatologic Agents|dermatologic agents|mesh-ancestor
93049997|NCT03963466|Tranexamic Acid|tranexamic acid|mesh-list
93049998|NCT03963466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93049999|NCT03963466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93050000|NCT03963466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050001|NCT03963466|Hemostatics|hemostatics|mesh-ancestor
93050002|NCT03963466|Coagulants|coagulants|mesh-ancestor
93050003|NCT01084876|Paclitaxel|paclitaxel|mesh-list
93050004|NCT01084876|Trastuzumab|trastuzumab|mesh-list
93050005|NCT01084876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050006|NCT01084876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050007|NCT01084876|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050008|NCT01084876|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050009|NCT01084876|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329099|NCT00003542|Interferons|interferons|mesh-list
93050010|NCT01084876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050011|NCT01084876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050012|NCT00117676|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93050013|NCT00117676|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93050014|NCT00117676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93050015|NCT00117676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93050016|NCT00117676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050017|NCT00117676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050018|NCT00117676|Antiviral Agents|antiviral agents|mesh-ancestor
93050019|NCT00117676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050020|NCT00117676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93050021|NCT00117676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93050022|NCT00251004|Cyclosporine|cyclosporine|mesh-list
93050023|NCT00251004|Mycophenolic Acid|mycophenolic acid|mesh-list
93050024|NCT00251004|Everolimus|everolimus|mesh-list
93050025|NCT00251004|Cyclosporins|cyclosporins|mesh-list
93050026|NCT00251004|Basiliximab|basiliximab|mesh-list
93050027|NCT00251004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050028|NCT00251004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050029|NCT00251004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050030|NCT00251004|Immunologic Factors|immunologic factors|mesh-ancestor
93050031|NCT00251004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050032|NCT00251004|Antifungal Agents|antifungal agents|mesh-ancestor
93050033|NCT00251004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050034|NCT00251004|Dermatologic Agents|dermatologic agents|mesh-ancestor
93050035|NCT00251004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050036|NCT00251004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93050037|NCT00251004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93050038|NCT00251004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050039|NCT00251004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050040|NCT00251004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93050041|NCT00251004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93050042|NCT00251004|Antitubercular Agents|antitubercular agents|mesh-ancestor
93050043|NCT00251004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93050044|NCT00275262|Leuprolide|leuprolide|mesh-list
93050045|NCT00275262|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93050046|NCT00275262|Fertility Agents|fertility agents|mesh-ancestor
93050047|NCT00275262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93050048|NCT00275262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050049|NCT00275262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93050050|NCT00275262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050051|NCT00275028|Cediranib|cediranib|mesh-list
93050052|NCT00275028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050053|NCT00275028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050054|NCT00275028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050055|NCT00275028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050056|NCT00471497|Imatinib Mesylate|imatinib mesylate|mesh-list
93050057|NCT00471497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050058|NCT00471497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050059|NCT00471497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050060|NCT00471497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050061|NCT04357457|Almitrine|almitrine|mesh-list
93050062|NCT04357457|Respiratory System Agents|respiratory system agents|mesh-ancestor
93050063|NCT00493649|Cyclophosphamide|cyclophosphamide|mesh-list
93050064|NCT00493649|Docetaxel|docetaxel|mesh-list
93050065|NCT00493649|Trastuzumab|trastuzumab|mesh-list
93050066|NCT00493649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050067|NCT00493649|Immunologic Factors|immunologic factors|mesh-ancestor
93050068|NCT00493649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050069|NCT00493649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050070|NCT00493649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050071|NCT00493649|Alkylating Agents|alkylating agents|mesh-ancestor
93050072|NCT00493649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050073|NCT00493649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050074|NCT00493649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93050075|NCT00493649|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050076|NCT00493649|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050077|NCT00493649|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050078|NCT00493649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050079|NCT01021163|Acetylcysteine|acetylcysteine|mesh-list
93050080|NCT01021163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93050081|NCT01021163|Antiviral Agents|antiviral agents|mesh-ancestor
93050082|NCT01021163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050083|NCT01021163|Expectorants|expectorants|mesh-ancestor
93050084|NCT01021163|Respiratory System Agents|respiratory system agents|mesh-ancestor
93050085|NCT01021163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93050086|NCT01021163|Antioxidants|antioxidants|mesh-ancestor
93050087|NCT01021163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050088|NCT01021163|Protective Agents|protective agents|mesh-ancestor
93050089|NCT01021163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050090|NCT01021163|Antidotes|antidotes|mesh-ancestor
93050091|NCT01022333|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
93050092|NCT01022333|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93050093|NCT01022333|Protective Agents|protective agents|mesh-ancestor
93050094|NCT01022333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050095|NCT01022333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050096|NCT00117598|Sirolimus|sirolimus|mesh-list
93050097|NCT00117598|Temsirolimus|temsirolimus|mesh-list
93050098|NCT00117598|MTOR Inhibitors|mtor inhibitors|mesh-list
93050099|NCT00117598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050100|NCT00117598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050101|NCT00117598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050102|NCT00117598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050103|NCT00117598|Immunologic Factors|immunologic factors|mesh-ancestor
93050104|NCT00117598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050105|NCT00117598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050106|NCT00117598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93050107|NCT00117598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050108|NCT00117598|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93050109|NCT00117598|Antifungal Agents|antifungal agents|mesh-ancestor
93050110|NCT01082458|Lidocaine|lidocaine|mesh-list
93050111|NCT01082458|Remifentanil|remifentanil|mesh-list
93050112|NCT01082458|Anesthetics, Local|anesthetics, local|mesh-ancestor
93050113|NCT01082458|Anesthetics|anesthetics|mesh-ancestor
93050114|NCT01082458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050115|NCT01082458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050116|NCT01082458|Sensory System Agents|sensory system agents|mesh-ancestor
93050117|NCT01082458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050118|NCT01082458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93050119|NCT01082458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93050120|NCT01082458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93050121|NCT01082458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93050122|NCT01082458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050123|NCT01082458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93050124|NCT01082458|Narcotics|narcotics|mesh-ancestor
93050125|NCT01082458|Analgesics|analgesics|mesh-ancestor
93050126|NCT00469859|Cytarabine|cytarabine|mesh-list
93050127|NCT00469859|Idarubicin|idarubicin|mesh-list
93050128|NCT00469859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050129|NCT00469859|Antimetabolites|antimetabolites|mesh-ancestor
93050130|NCT00469859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050131|NCT00469859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050132|NCT00469859|Antiviral Agents|antiviral agents|mesh-ancestor
93050133|NCT00469859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050134|NCT00469859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050135|NCT00469859|Immunologic Factors|immunologic factors|mesh-ancestor
93050136|NCT00469859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050137|NCT00469859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93050138|NCT00469859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93050139|NCT00469859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93050140|NCT00469859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050141|NCT01021475|Domperidone|domperidone|mesh-list
93050142|NCT01021475|Antiemetics|antiemetics|mesh-ancestor
93050143|NCT01021475|Autonomic Agents|autonomic agents|mesh-ancestor
93050144|NCT01021475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050145|NCT01021475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050146|NCT01021475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050147|NCT01021475|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93050148|NCT01021475|Dopamine Agents|dopamine agents|mesh-ancestor
93050149|NCT01021475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050150|NCT01021475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050152|NCT01085032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93050153|NCT01085032|Autonomic Agents|autonomic agents|mesh-ancestor
93050154|NCT01085032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050155|NCT01085032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050156|NCT01085032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93050157|NCT01085032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93050158|NCT01085032|Cholinergic Agents|cholinergic agents|mesh-ancestor
93050159|NCT01085032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050160|NCT01085032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050161|NCT01021787|Titanium dioxide|titanium dioxide|mesh-list
93050162|NCT01021787|Sunscreening Agents|sunscreening agents|mesh-ancestor
93050163|NCT01021787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93050164|NCT01021787|Protective Agents|protective agents|mesh-ancestor
93050165|NCT01021787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050167|NCT01021787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93050168|NCT00093808|Capecitabine|capecitabine|mesh-list
93050169|NCT00093808|Trastuzumab|trastuzumab|mesh-list
93050170|NCT00093808|Vinorelbine|vinorelbine|mesh-list
93050171|NCT00093808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050172|NCT00093808|Antimetabolites|antimetabolites|mesh-ancestor
93050173|NCT00093808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050174|NCT00093808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050175|NCT00093808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050176|NCT00093808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050177|NCT00093808|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050178|NCT00093808|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050179|NCT00093808|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050180|NCT00469079|Nicotine|nicotine|mesh-list
93050181|NCT00469079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93050182|NCT00469079|Autonomic Agents|autonomic agents|mesh-ancestor
93050183|NCT00469079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050184|NCT00469079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050185|NCT00469079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93050186|NCT00469079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93050187|NCT00469079|Cholinergic Agents|cholinergic agents|mesh-ancestor
93050188|NCT00469079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050189|NCT00469079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050190|NCT01326754|Artesunate|artesunate|mesh-list
93050191|NCT01326754|Lumefantrine|lumefantrine|mesh-list
93050192|NCT01326754|Artemether|artemether|mesh-list
93050193|NCT01326754|Piperaquine|piperaquine|mesh-list
93050194|NCT01326754|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
93050195|NCT01326754|Amodiaquine|amodiaquine|mesh-list
93050196|NCT01326754|Artenimol|artenimol|mesh-list
93050197|NCT01326754|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
93050198|NCT01326754|Antimalarials|antimalarials|mesh-ancestor
93050199|NCT01326754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93050200|NCT01326754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93050201|NCT01326754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050202|NCT01326754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050203|NCT01326754|Antiviral Agents|antiviral agents|mesh-ancestor
93050204|NCT01326754|Schistosomicides|schistosomicides|mesh-ancestor
93050205|NCT01326754|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93050206|NCT01326754|Anthelmintics|anthelmintics|mesh-ancestor
93050207|NCT00093496|Gemcitabine|gemcitabine|mesh-list
93050208|NCT00093496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050209|NCT00093496|Antimetabolites|antimetabolites|mesh-ancestor
93050210|NCT00093496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050211|NCT00093496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050212|NCT00265122|Ustekinumab|ustekinumab|mesh-list
93050213|NCT00265122|Dermatologic Agents|dermatologic agents|mesh-ancestor
93050214|NCT00096538|Valganciclovir|valganciclovir|mesh-list
93050215|NCT00096538|Antiviral Agents|antiviral agents|mesh-ancestor
93050216|NCT00096538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050217|NCT00116428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
93050218|NCT03971214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93050219|NCT03971214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050220|NCT03971214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050221|NCT03971214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050223|NCT01073748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93050224|NCT01073748|Analgesics|analgesics|mesh-ancestor
93050225|NCT01073748|Sensory System Agents|sensory system agents|mesh-ancestor
93050226|NCT01073748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050227|NCT01073748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050228|NCT01073748|Antipyretics|antipyretics|mesh-ancestor
93050229|NCT00468845|Pregabalin|pregabalin|mesh-list
93050230|NCT00468845|Analgesics|analgesics|mesh-ancestor
93050231|NCT00468845|Sensory System Agents|sensory system agents|mesh-ancestor
93050232|NCT00468845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050233|NCT00468845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050234|NCT00468845|Anticonvulsants|anticonvulsants|mesh-ancestor
93050235|NCT00468845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93050236|NCT00468845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93050237|NCT00468845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050238|NCT00468845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93050239|NCT00468845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93050240|NCT00468845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92529413|NCT00015912|Antiviral Agents|antiviral agents|mesh-ancestor
93050241|NCT00468845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050242|NCT00468845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93050243|NCT00468299|Misoprostol|misoprostol|mesh-list
93050244|NCT00468299|Mifepristone|mifepristone|mesh-list
93050245|NCT00468299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93050246|NCT00468299|Abortifacient Agents|abortifacient agents|mesh-ancestor
93050247|NCT00468299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93050248|NCT00468299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050249|NCT00468299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93050250|NCT00468299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050251|NCT00468299|Oxytocics|oxytocics|mesh-ancestor
93050252|NCT00468299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93050253|NCT00468299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93050254|NCT00468299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93050255|NCT00468299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93050256|NCT00468299|Contraceptive Agents|contraceptive agents|mesh-ancestor
93050257|NCT00468299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93050258|NCT00468299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93050259|NCT00468299|Hormone Antagonists|hormone antagonists|mesh-ancestor
93050260|NCT00468299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050261|NCT00468299|Luteolytic Agents|luteolytic agents|mesh-ancestor
93050262|NCT00468299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93050263|NCT00468299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93050264|NCT01021865|Glucagon|glucagon|mesh-list
93050265|NCT01021865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93050266|NCT01021865|Regadenoson|regadenoson|mesh-list
93050267|NCT01021865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050268|NCT01021865|Hormones|hormones|mesh-ancestor
93050269|NCT01021865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050270|NCT01021865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050271|NCT01021865|Incretins|incretins|mesh-ancestor
93050272|NCT01021865|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
93050273|NCT01021865|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
93050274|NCT01021865|Purinergic Agonists|purinergic agonists|mesh-ancestor
93050275|NCT01021865|Purinergic Agents|purinergic agents|mesh-ancestor
93050276|NCT01021865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050277|NCT01021865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050278|NCT00468143|Adderall|adderall|mesh-list
93050279|NCT00468143|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93050280|NCT00468143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050281|NCT00467831|Acetylcysteine|acetylcysteine|mesh-list
93050282|NCT00467831|Erythromycin|erythromycin|mesh-list
93050283|NCT00467831|Erythromycin Estolate|erythromycin estolate|mesh-list
93050284|NCT00467831|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93050285|NCT00467831|Erythromycin stearate|erythromycin stearate|mesh-list
93050286|NCT00467831|Zileuton|zileuton|mesh-list
93050287|NCT00467831|Losartan|losartan|mesh-list
93050288|NCT00467831|Pravastatin|pravastatin|mesh-list
93050289|NCT00467831|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93050290|NCT00467831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93050291|NCT00467831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93050292|NCT00467831|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93050293|NCT00467831|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93050294|NCT00467831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050295|NCT00467831|Antiviral Agents|antiviral agents|mesh-ancestor
93050296|NCT00467831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050297|NCT00467831|Expectorants|expectorants|mesh-ancestor
93050298|NCT00467831|Respiratory System Agents|respiratory system agents|mesh-ancestor
93050299|NCT00467831|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93050300|NCT00467831|Antioxidants|antioxidants|mesh-ancestor
93050301|NCT00467831|Protective Agents|protective agents|mesh-ancestor
93050302|NCT00467831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050303|NCT00467831|Antidotes|antidotes|mesh-ancestor
93050304|NCT00467831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93050305|NCT00467831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93050306|NCT00467831|Antimetabolites|antimetabolites|mesh-ancestor
93050307|NCT00467831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93050308|NCT00467831|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93050309|NCT00467831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050310|NCT00467831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93050311|NCT00467831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050312|NCT00467831|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93050313|NCT00467831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93050314|NCT00467831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93050315|NCT00467831|Analgesics|analgesics|mesh-ancestor
93050316|NCT00467831|Sensory System Agents|sensory system agents|mesh-ancestor
93050317|NCT00467831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050318|NCT00467831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050319|NCT00467831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050320|NCT00467831|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93050321|NCT00467831|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93050322|NCT00467831|Hormone Antagonists|hormone antagonists|mesh-ancestor
93050323|NCT00467831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050324|NCT00467753|Oxcarbazepine|oxcarbazepine|mesh-list
93050325|NCT00467753|Anticonvulsants|anticonvulsants|mesh-ancestor
93050326|NCT00467753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93050327|NCT00467753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93050328|NCT00467753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93050329|NCT00467753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050330|NCT00467753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93050331|NCT00467753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93050332|NCT01021943|Spironolactone|spironolactone|mesh-list
93050333|NCT01021943|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93050334|NCT01021943|Hormone Antagonists|hormone antagonists|mesh-ancestor
93050335|NCT01021943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050336|NCT01021943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050337|NCT01021943|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93050338|NCT01021943|Diuretics|diuretics|mesh-ancestor
93050339|NCT01021943|Natriuretic Agents|natriuretic agents|mesh-ancestor
93050341|NCT00116272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93050342|NCT00116272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93050343|NCT00116272|Analgesics|analgesics|mesh-ancestor
93050344|NCT00116272|Sensory System Agents|sensory system agents|mesh-ancestor
93050345|NCT00116272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050346|NCT00116272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050347|NCT00116272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050348|NCT00116272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050349|NCT00116272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050350|NCT00116272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050351|NCT00116272|Immunologic Factors|immunologic factors|mesh-ancestor
93050352|NCT01022021|Rituximab|rituximab|mesh-list
93050353|NCT01022021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93050354|NCT01022021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050355|NCT01022021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050356|NCT01022021|Immunologic Factors|immunologic factors|mesh-ancestor
93050357|NCT01022021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050358|NCT01022021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050359|NCT01022021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050360|NCT01022021|Alkylating Agents|alkylating agents|mesh-ancestor
93050361|NCT01022021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050362|NCT00467597|Levodopa|levodopa|mesh-list
93050363|NCT00467597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93050364|NCT00467597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93050365|NCT00467597|Dopamine Agents|dopamine agents|mesh-ancestor
93050366|NCT00467597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050367|NCT00467597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050368|NCT00467597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050369|NCT00115804|Fluoxetine|fluoxetine|mesh-list
93050370|NCT00115804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93050371|NCT00115804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93050372|NCT00115804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93050373|NCT00115804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050374|NCT00115804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050375|NCT00115804|Serotonin Agents|serotonin agents|mesh-ancestor
93050376|NCT00115804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050377|NCT00115804|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93050378|NCT00115804|Antidepressive Agents|antidepressive agents|mesh-ancestor
93050379|NCT00115804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93050380|NCT00115804|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93050381|NCT00115804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93050382|NCT00115804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050384|NCT00467363|Folic Acid|folic acid|mesh-list
93050385|NCT00467363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93050386|NCT00467363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93050387|NCT00467363|Analgesics|analgesics|mesh-ancestor
93050388|NCT00467363|Sensory System Agents|sensory system agents|mesh-ancestor
93050389|NCT00467363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050390|NCT00467363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050391|NCT00467363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050392|NCT00467363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050393|NCT00467363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92329153|NCT00381901|Trastuzumab|trastuzumab|mesh-list
93050394|NCT00467363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93050395|NCT00467363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050396|NCT00467363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93050397|NCT00467363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93050398|NCT00467363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050399|NCT00467363|Antipyretics|antipyretics|mesh-ancestor
93050400|NCT00467363|Hematinics|hematinics|mesh-ancestor
93050401|NCT00467363|Vitamin B Complex|vitamin b complex|mesh-ancestor
93050402|NCT00467363|Vitamins|vitamins|mesh-ancestor
93050403|NCT00467363|Micronutrients|micronutrients|mesh-ancestor
93050404|NCT01071174|Dapivirine|dapivirine|mesh-list
93050405|NCT01071174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93050406|NCT01071174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93050407|NCT01071174|Antiviral Agents|antiviral agents|mesh-ancestor
93050408|NCT01071174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050409|NCT00466505|Celecoxib|celecoxib|mesh-list
93050410|NCT00466505|Cetuximab|cetuximab|mesh-list
93050411|NCT00466505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050412|NCT00466505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050413|NCT00466505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93050414|NCT00466505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93050415|NCT00466505|Analgesics|analgesics|mesh-ancestor
93050416|NCT00466505|Sensory System Agents|sensory system agents|mesh-ancestor
93050417|NCT00466505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050418|NCT00466505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050419|NCT00466505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050420|NCT00466505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050421|NCT00466505|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93050422|NCT00466505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93050423|NCT00466505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050424|NCT00466505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050425|NCT02531568|Warfarin|warfarin|mesh-list
93050426|NCT02531568|Anticoagulants|anticoagulants|mesh-ancestor
93050427|NCT00467051|Paclitaxel|paclitaxel|mesh-list
93050428|NCT00467051|Carboplatin|carboplatin|mesh-list
93050429|NCT00467051|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93050430|NCT00467051|Ifosfamide|ifosfamide|mesh-list
93050431|NCT00467051|Isophosphamide mustard|isophosphamide mustard|mesh-list
93050432|NCT00467051|Lenograstim|lenograstim|mesh-list
93050433|NCT00467051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050434|NCT00467051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050435|NCT00467051|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050436|NCT00467051|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050437|NCT00467051|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050438|NCT00467051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050439|NCT00467051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93050440|NCT00467051|Immunologic Factors|immunologic factors|mesh-ancestor
93050441|NCT00467051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050442|NCT00467051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050443|NCT00467051|Alkylating Agents|alkylating agents|mesh-ancestor
93050444|NCT00264498|Carboplatin|carboplatin|mesh-list
93050445|NCT00264498|Gemcitabine|gemcitabine|mesh-list
93050446|NCT00264498|Gefitinib|gefitinib|mesh-list
93050447|NCT00264498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050448|NCT00264498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050449|NCT00264498|Antimetabolites|antimetabolites|mesh-ancestor
93050450|NCT00264498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050451|NCT00264498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050452|NCT00264498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050453|NCT00466193|Zolpidem|zolpidem|mesh-list
93050454|NCT00466193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93050455|NCT00466193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93050456|NCT00466193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050457|NCT00466193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537640|NCT00141700|Rituximab|rituximab|mesh-list
93050458|NCT00466193|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93050459|NCT00466193|GABA Agonists|gaba agonists|mesh-ancestor
93050460|NCT00466193|GABA Agents|gaba agents|mesh-ancestor
93050461|NCT00466193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050462|NCT00466193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050463|NCT01072578|Dapagliflozin|dapagliflozin|mesh-list
93050464|NCT01072578|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93050465|NCT01072578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050466|NCT01072578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93050467|NCT01072578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050468|NCT01072734|Vaccines|vaccines|mesh-list
93050469|NCT01072734|Immunologic Factors|immunologic factors|mesh-ancestor
93050470|NCT01072734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050471|NCT03970668|Insulin|insulin|mesh-list
93050472|NCT03970668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93050473|NCT03970668|Linagliptin|linagliptin|mesh-list
93050474|NCT03970668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93050475|NCT03970668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050476|NCT03970668|Incretins|incretins|mesh-ancestor
93050477|NCT03970668|Hormones|hormones|mesh-ancestor
93050478|NCT03970668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050479|NCT03970668|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93050480|NCT03970668|Protease Inhibitors|protease inhibitors|mesh-ancestor
93050481|NCT03970668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050482|NCT03970668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050483|NCT00454181|Interferons|interferons|mesh-list
93050484|NCT00454181|Interferon-alpha|interferon-alpha|mesh-list
93050485|NCT00454181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050486|NCT00454181|Antiviral Agents|antiviral agents|mesh-ancestor
93050487|NCT00454181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050488|NCT00454181|Immunologic Factors|immunologic factors|mesh-ancestor
93050489|NCT00454181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050490|NCT01073826|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93050491|NCT01073826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93050492|NCT01073826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050493|NCT01073826|Incretins|incretins|mesh-ancestor
93050494|NCT01073826|Hormones|hormones|mesh-ancestor
93050495|NCT01073826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050496|NCT01073826|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93050497|NCT01073826|Protease Inhibitors|protease inhibitors|mesh-ancestor
93050498|NCT01073826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050499|NCT01073826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050500|NCT01072812|Phenserine|phenserine|mesh-list
93050501|NCT01072812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93050502|NCT01072812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050503|NCT01072812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050504|NCT01072812|Cholinergic Agents|cholinergic agents|mesh-ancestor
93050505|NCT01072812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050506|NCT01072812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050507|NCT00237042|Levonorgestrel|levonorgestrel|mesh-list
93050508|NCT00237042|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93050509|NCT00237042|Estradiol|estradiol|mesh-list
93050510|NCT00237042|Estrogens|estrogens|mesh-ancestor
93050511|NCT00237042|Hormones|hormones|mesh-ancestor
93050512|NCT00237042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050513|NCT00237042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050514|NCT00237042|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93050515|NCT00237042|Contraceptive Agents|contraceptive agents|mesh-ancestor
93050516|NCT00237042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93050517|NCT00237042|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93050518|NCT00237042|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93050519|NCT00237042|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93050520|NCT00237042|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93050521|NCT00465647|Hydromorphone|hydromorphone|mesh-list
93050522|NCT00465647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93050523|NCT00465647|Narcotics|narcotics|mesh-ancestor
93050524|NCT00465647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050525|NCT00465647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050526|NCT00465647|Analgesics|analgesics|mesh-ancestor
93050527|NCT00465647|Sensory System Agents|sensory system agents|mesh-ancestor
93050528|NCT00465647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050529|NCT00090766|Valganciclovir|valganciclovir|mesh-list
93050530|NCT00090766|Antiviral Agents|antiviral agents|mesh-ancestor
93050531|NCT00090766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050532|NCT03961828|Sofosbuvir|sofosbuvir|mesh-list
93050533|NCT03961828|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93050534|NCT03961828|Ledipasvir|ledipasvir|mesh-list
93050535|NCT03961828|Antiviral Agents|antiviral agents|mesh-ancestor
93050536|NCT03961828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050537|NCT00465179|Sunitinib|sunitinib|mesh-list
93050538|NCT00465179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050539|NCT00465179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93050540|NCT00465179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93050541|NCT00465179|Growth Substances|growth substances|mesh-ancestor
93050542|NCT00465179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050543|NCT00465179|Growth Inhibitors|growth inhibitors|mesh-ancestor
93050544|NCT00465179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050545|NCT00465179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050546|NCT00465179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050547|NCT00084136|Tenofovir|tenofovir|mesh-list
93050548|NCT00084136|Lamivudine|lamivudine|mesh-list
93050549|NCT00084136|Emtricitabine|emtricitabine|mesh-list
93050550|NCT00084136|Zidovudine|zidovudine|mesh-list
93050551|NCT00084136|Efavirenz|efavirenz|mesh-list
93050552|NCT00084136|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93050553|NCT00084136|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93050554|NCT00084136|Didanosine|didanosine|mesh-list
93050555|NCT00084136|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93050556|NCT00084136|Antiviral Agents|antiviral agents|mesh-ancestor
93050557|NCT00084136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050558|NCT00084136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93050559|NCT00084136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93050560|NCT00084136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050561|NCT00084136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050562|NCT00084136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93050563|NCT00084136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93050564|NCT00084136|Antimetabolites|antimetabolites|mesh-ancestor
93050565|NCT00084136|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93050566|NCT00084136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93050567|NCT00084136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93050568|NCT00084136|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93050569|NCT00084136|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93050570|NCT00084136|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93050571|NCT00084136|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93050572|NCT00084136|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93050573|NCT00084136|Protease Inhibitors|protease inhibitors|mesh-ancestor
93050574|NCT03812380|Magnesium citrate|magnesium citrate|mesh-list
93050575|NCT03812380|Cathartics|cathartics|mesh-ancestor
93050576|NCT03812380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050577|NCT01085422|Temozolomide|temozolomide|mesh-list
93050578|NCT01085422|Veliparib|veliparib|mesh-list
93050579|NCT01085422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050580|NCT01085422|Alkylating Agents|alkylating agents|mesh-ancestor
93050581|NCT01085422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050582|NCT01085422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050583|NCT01085422|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93050584|NCT01085422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050585|NCT01085656|Combretastatin|combretastatin|mesh-list
93050586|NCT01085656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050587|NCT01085656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050588|NCT01085656|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050589|NCT01085656|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050590|NCT01085656|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050591|NCT01085656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050592|NCT01087138|Calcium|calcium|mesh-list
93050593|NCT01087138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93050594|NCT01087138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050595|NCT00464945|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93050596|NCT00464945|Immunologic Factors|immunologic factors|mesh-ancestor
93050597|NCT00464945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050598|NCT00464087|Heparin|heparin|mesh-list
93050599|NCT00464087|Calcium heparin|calcium heparin|mesh-list
93050601|NCT00464087|Bivalirudin|bivalirudin|mesh-list
93050602|NCT00464087|Fondaparinux|fondaparinux|mesh-list
93050603|NCT00464087|Anticoagulants|anticoagulants|mesh-ancestor
93050604|NCT00464087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93050605|NCT00464087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93050606|NCT00464087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050607|NCT00464087|Antithrombins|antithrombins|mesh-ancestor
93050608|NCT00464087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93050609|NCT00464087|Protease Inhibitors|protease inhibitors|mesh-ancestor
93050610|NCT00464087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050611|NCT00464087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93050613|NCT00452699|Xhance|xhance|mesh-list
93050614|NCT00452699|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93050615|NCT00452699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050616|NCT00452699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93050617|NCT00452699|Autonomic Agents|autonomic agents|mesh-ancestor
93050618|NCT00452699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050619|NCT00452699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050620|NCT00452699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93050621|NCT00452699|Respiratory System Agents|respiratory system agents|mesh-ancestor
93050622|NCT00452699|Dermatologic Agents|dermatologic agents|mesh-ancestor
93050623|NCT00452699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93050624|NCT00452699|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93050625|NCT00452699|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93050626|NCT00452699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93050627|NCT00452699|Adrenergic Agents|adrenergic agents|mesh-ancestor
93050628|NCT00452699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050629|NCT00452699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050630|NCT00069784|Insulin|insulin|mesh-list
93050631|NCT00069784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93050632|NCT00069784|Insulin Glargine|insulin glargine|mesh-list
93050633|NCT00069784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93050634|NCT00069784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050635|NCT00090610|Carboplatin|carboplatin|mesh-list
93050636|NCT00090610|Docetaxel|docetaxel|mesh-list
93050637|NCT00090610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050638|NCT00090610|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050639|NCT00090610|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050640|NCT00090610|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050641|NCT00090610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050642|NCT01326988|Anesthetics|anesthetics|mesh-list
93050643|NCT01326988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050644|NCT01326988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050645|NCT03962296|Calcium Dobesilate|calcium dobesilate|mesh-list
93050646|NCT03962296|Calcium|calcium|mesh-list
93050647|NCT03962296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93050648|NCT03962296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050649|NCT03962296|Hemostatics|hemostatics|mesh-ancestor
93050650|NCT03962296|Coagulants|coagulants|mesh-ancestor
93050651|NCT01086046|Heparin|heparin|mesh-list
93050652|NCT01086046|Enoxaparin|enoxaparin|mesh-list
93050653|NCT01086046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93050654|NCT01086046|Tinzaparin|tinzaparin|mesh-list
93050655|NCT01086046|Dalteparin|dalteparin|mesh-list
93050656|NCT01086046|Anticoagulants|anticoagulants|mesh-ancestor
93050657|NCT01086046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93050658|NCT01086046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93050659|NCT01086046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050660|NCT01090648|Etravirine|etravirine|mesh-list
93050661|NCT01090648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93050662|NCT01090648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93050663|NCT01090648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050664|NCT01090648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050665|NCT01090648|Antiviral Agents|antiviral agents|mesh-ancestor
93050666|NCT01090648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050667|NCT03741244|Temozolomide|temozolomide|mesh-list
93050668|NCT03741244|Apatinib|apatinib|mesh-list
93050669|NCT03741244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050670|NCT03741244|Alkylating Agents|alkylating agents|mesh-ancestor
93050671|NCT03741244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050672|NCT03741244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050673|NCT03741244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050674|NCT03741244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050675|NCT00463385|Thalidomide|thalidomide|mesh-list
93050676|NCT00463385|Prednisone|prednisone|mesh-list
93050677|NCT00463385|Pomalidomide|pomalidomide|mesh-list
93050678|NCT00463385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050679|NCT00463385|Glucocorticoids|glucocorticoids|mesh-ancestor
93050680|NCT00463385|Hormones|hormones|mesh-ancestor
93050681|NCT00463385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050682|NCT00463385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050683|NCT00463385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93050685|NCT00463385|Immunologic Factors|immunologic factors|mesh-ancestor
93050686|NCT00463385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93050687|NCT00463385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93050688|NCT00463385|Growth Substances|growth substances|mesh-ancestor
93050689|NCT00463385|Growth Inhibitors|growth inhibitors|mesh-ancestor
93050690|NCT00463385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050691|NCT00463385|Leprostatic Agents|leprostatic agents|mesh-ancestor
93050692|NCT00463385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93050693|NCT00463385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050694|NCT03839693|Botulinum Toxins|botulinum toxins|mesh-list
93050695|NCT03839693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93050696|NCT03839693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93050697|NCT03839693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93050698|NCT03839693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93050699|NCT03839693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050700|NCT03839693|Cholinergic Agents|cholinergic agents|mesh-ancestor
93050701|NCT03839693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050702|NCT03839693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050703|NCT03839693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93050704|NCT03839693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050705|NCT00068692|Leucovorin|leucovorin|mesh-list
93050706|NCT00068692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
93050707|NCT00068692|Tetrahydrofolates|tetrahydrofolates|mesh-list
93050708|NCT00068692|Fluorouracil|fluorouracil|mesh-list
93050709|NCT00068692|Oxaliplatin|oxaliplatin|mesh-list
93050710|NCT00068692|Irinotecan|irinotecan|mesh-list
93050711|NCT00068692|Camptothecin|camptothecin|mesh-list
93050712|NCT00068692|Levoleucovorin|levoleucovorin|mesh-list
93050713|NCT00068692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050714|NCT00068692|Antimetabolites|antimetabolites|mesh-ancestor
93050715|NCT00068692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050716|NCT00068692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050717|NCT00068692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050718|NCT00068692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050719|NCT00068692|Immunologic Factors|immunologic factors|mesh-ancestor
93050720|NCT00068692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93050721|NCT00068692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93050722|NCT00068692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050723|NCT00068692|Antidotes|antidotes|mesh-ancestor
93050724|NCT00068692|Protective Agents|protective agents|mesh-ancestor
93050725|NCT00068692|Vitamin B Complex|vitamin b complex|mesh-ancestor
93050726|NCT00068692|Vitamins|vitamins|mesh-ancestor
93050727|NCT00068692|Micronutrients|micronutrients|mesh-ancestor
93050728|NCT00068692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050729|NCT00463151|Rebamipide|rebamipide|mesh-list
93050730|NCT00463151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93050731|NCT00463151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050732|NCT00463151|Antioxidants|antioxidants|mesh-ancestor
93050733|NCT00463151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050734|NCT00463151|Protective Agents|protective agents|mesh-ancestor
93050735|NCT00463151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050736|NCT00463151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050737|NCT00068380|Imatinib Mesylate|imatinib mesylate|mesh-list
93050738|NCT00068380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050739|NCT00068380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050740|NCT00068380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050741|NCT00068380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050742|NCT00067990|Losartan|losartan|mesh-list
93050743|NCT00067990|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93050744|NCT00067990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93050745|NCT00067990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93050746|NCT00067990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93050747|NCT00067990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050748|NCT00263328|Tacrolimus|tacrolimus|mesh-list
93050749|NCT00263328|Tofacitinib|tofacitinib|mesh-list
93050750|NCT00263328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050751|NCT00263328|Immunologic Factors|immunologic factors|mesh-ancestor
93050752|NCT00263328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050753|NCT00263328|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93050754|NCT00263328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050755|NCT00263328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050756|NCT00263328|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93050757|NCT00263328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050758|NCT03741660|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93050760|NCT03741660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050761|NCT00262860|Gemcitabine|gemcitabine|mesh-list
93050762|NCT00262860|Bortezomib|bortezomib|mesh-list
93050763|NCT00262860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050764|NCT00262860|Antimetabolites|antimetabolites|mesh-ancestor
93050765|NCT00262860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050766|NCT00262860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050767|NCT00236184|Rabeprazole|rabeprazole|mesh-list
93050768|NCT00236184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93050769|NCT00236184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050770|NCT00236184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93050771|NCT00236184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050772|NCT00236184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050773|NCT00296504|Ritonavir|ritonavir|mesh-list
93050774|NCT00296504|Fosamprenavir|fosamprenavir|mesh-list
93050775|NCT00296504|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93050776|NCT00296504|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93050777|NCT00296504|Protease Inhibitors|protease inhibitors|mesh-ancestor
93050778|NCT00296504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050779|NCT00296504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050780|NCT00296504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93050781|NCT00296504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93050782|NCT00296504|Antiviral Agents|antiviral agents|mesh-ancestor
93050783|NCT00296504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050784|NCT00296504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93050785|NCT00296504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93050786|NCT00313820|Pregabalin|pregabalin|mesh-list
93050787|NCT00313820|Analgesics|analgesics|mesh-ancestor
93050788|NCT00313820|Sensory System Agents|sensory system agents|mesh-ancestor
93050789|NCT00313820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050790|NCT00313820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050791|NCT00313820|Anticonvulsants|anticonvulsants|mesh-ancestor
93050792|NCT00313820|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93050793|NCT00313820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93050794|NCT00313820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050795|NCT00313820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93050796|NCT00313820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93050797|NCT00313820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93050798|NCT00313820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050799|NCT00313820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93050800|NCT00235872|Adalimumab|adalimumab|mesh-list
93050801|NCT00235872|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93050802|NCT00235872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050803|NCT00235872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050804|NCT00461981|Vaccines|vaccines|mesh-list
93050805|NCT00461981|Immunologic Factors|immunologic factors|mesh-ancestor
93050806|NCT00461981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050807|NCT00296036|Pyridoxine|pyridoxine|mesh-list
93050808|NCT00296036|Vitamin B 6|vitamin b 6|mesh-list
93050809|NCT00296036|Vitamin B Complex|vitamin b complex|mesh-ancestor
93050810|NCT00296036|Vitamins|vitamins|mesh-ancestor
93050811|NCT00296036|Micronutrients|micronutrients|mesh-ancestor
93050812|NCT00296036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050813|NCT01072890|Sirolimus|sirolimus|mesh-list
93050814|NCT01072890|Temsirolimus|temsirolimus|mesh-list
93050815|NCT01072890|MTOR Inhibitors|mtor inhibitors|mesh-list
93050816|NCT01072890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050817|NCT01072890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050818|NCT01072890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050819|NCT01072890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050820|NCT01072890|Immunologic Factors|immunologic factors|mesh-ancestor
93050821|NCT01072890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050822|NCT01072890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050823|NCT01072890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93050824|NCT01072890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050825|NCT01072890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93050827|NCT00089674|Denosumab|denosumab|mesh-list
93050828|NCT00089674|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93050829|NCT00089674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050830|NCT01090882|Bupivacaine|bupivacaine|mesh-list
93050831|NCT01090882|Anesthetics, Local|anesthetics, local|mesh-ancestor
93050832|NCT01090882|Anesthetics|anesthetics|mesh-ancestor
93050833|NCT01090882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050834|NCT01090882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050835|NCT01090882|Sensory System Agents|sensory system agents|mesh-ancestor
93050836|NCT01090882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050837|NCT01090960|Ipatasertib|ipatasertib|mesh-list
93050838|NCT01090960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050839|NCT01090960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050840|NCT01090960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050841|NCT01090960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050842|NCT01067066|Temozolomide|temozolomide|mesh-list
93050843|NCT01067066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050844|NCT01067066|Alkylating Agents|alkylating agents|mesh-ancestor
93050845|NCT01067066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050846|NCT01067066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050847|NCT00313586|Azacitidine|azacitidine|mesh-list
93050848|NCT00313586|Entinostat|entinostat|mesh-list
93050849|NCT00313586|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93050850|NCT00313586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050851|NCT00313586|Antimetabolites|antimetabolites|mesh-ancestor
93050852|NCT00313586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050853|NCT00313586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050854|NCT00313586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050855|NCT01069328|Paclitaxel|paclitaxel|mesh-list
93050856|NCT01069328|Bevacizumab|bevacizumab|mesh-list
93050857|NCT01069328|Carboplatin|carboplatin|mesh-list
93050858|NCT01069328|Sorafenib|sorafenib|mesh-list
93050859|NCT01069328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050860|NCT01069328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050861|NCT01069328|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050862|NCT01069328|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050863|NCT01069328|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050864|NCT01069328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050865|NCT01069328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050866|NCT01069328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93050867|NCT01069328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93050868|NCT01069328|Growth Substances|growth substances|mesh-ancestor
93050869|NCT01069328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050870|NCT01069328|Growth Inhibitors|growth inhibitors|mesh-ancestor
93050871|NCT01069328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93050872|NCT01069328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050873|NCT01067222|Modafinil|modafinil|mesh-list
93050874|NCT01067222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93050875|NCT01067222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050876|NCT01067222|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93050877|NCT01067222|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93050878|NCT01067222|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93050879|NCT01067222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050880|NCT00312572|Buprenorphine|buprenorphine|mesh-list
93050881|NCT00312572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93050882|NCT00312572|Narcotics|narcotics|mesh-ancestor
93050883|NCT00312572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050884|NCT00312572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050885|NCT00312572|Analgesics|analgesics|mesh-ancestor
93050886|NCT00312572|Sensory System Agents|sensory system agents|mesh-ancestor
93050887|NCT00312572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050888|NCT00312572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93050889|NCT00290732|Doxorubicin|doxorubicin|mesh-list
93050890|NCT00290732|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93050891|NCT00290732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93050892|NCT00290732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050893|NCT00290732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93050894|NCT00290732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93050895|NCT00290732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050896|NCT00290732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050898|NCT00312494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93050899|NCT00312494|Serotonin Agents|serotonin agents|mesh-ancestor
93050900|NCT00312494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93050901|NCT00312494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050902|NCT00312494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050903|NCT00312494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93050904|NCT00312494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93050905|NCT00312494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93050906|NCT00312494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93050907|NCT00312494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93050908|NCT00312494|Dopamine Agents|dopamine agents|mesh-ancestor
93050909|NCT00312338|Moxifloxacin|moxifloxacin|mesh-list
93050910|NCT00312338|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93050911|NCT00312338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93050912|NCT00312338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050913|NCT00312338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93050914|NCT00312338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93050915|NCT00312338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050916|NCT00312338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050917|NCT00312338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050918|NCT00312338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93050919|NCT00312338|Contraceptive Agents|contraceptive agents|mesh-ancestor
93050920|NCT00312338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93050921|NCT00312338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050922|NCT00312338|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93050923|NCT00312338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93050924|NCT00312338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93050925|NCT00290498|Cytarabine|cytarabine|mesh-list
93050926|NCT00290498|Dexamethasone|dexamethasone|mesh-list
93050927|NCT00290498|Prednisone|prednisone|mesh-list
93050928|NCT00290498|Cyclophosphamide|cyclophosphamide|mesh-list
93050929|NCT00290498|Rituximab|rituximab|mesh-list
93050930|NCT00290498|Doxorubicin|doxorubicin|mesh-list
93050931|NCT00290498|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93050932|NCT00290498|Methotrexate|methotrexate|mesh-list
93050933|NCT00290498|Vincristine|vincristine|mesh-list
93050934|NCT00290498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93050935|NCT00290498|Immunologic Factors|immunologic factors|mesh-ancestor
93050936|NCT00290498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050937|NCT00290498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93050938|NCT00290498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93050939|NCT00290498|Alkylating Agents|alkylating agents|mesh-ancestor
93050940|NCT00290498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050941|NCT00290498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050942|NCT00290498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93050943|NCT00290498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050944|NCT00290498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93050945|NCT00290498|Antiemetics|antiemetics|mesh-ancestor
93050946|NCT00290498|Autonomic Agents|autonomic agents|mesh-ancestor
93050947|NCT00290498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050948|NCT00290498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93050949|NCT00290498|Glucocorticoids|glucocorticoids|mesh-ancestor
93050950|NCT00290498|Hormones|hormones|mesh-ancestor
92494485|NCT01975688|Nabiximols|nabiximols|mesh-list
93050951|NCT00290498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93050952|NCT00290498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93050953|NCT00290498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93050954|NCT00290498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93050955|NCT00290498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93050956|NCT00290498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93050957|NCT00290498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93050958|NCT00290498|Abortifacient Agents|abortifacient agents|mesh-ancestor
93050959|NCT00290498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93050960|NCT00290498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050961|NCT00290498|Antimetabolites|antimetabolites|mesh-ancestor
93050962|NCT00290498|Dermatologic Agents|dermatologic agents|mesh-ancestor
93050963|NCT00290498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93050964|NCT00290498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93050965|NCT00290498|Antiviral Agents|antiviral agents|mesh-ancestor
93050966|NCT00290498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93050967|NCT00290498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050968|NCT00290498|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050969|NCT00290498|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050971|NCT01069796|Paclitaxel|paclitaxel|mesh-list
93050972|NCT01069796|Bevacizumab|bevacizumab|mesh-list
93050973|NCT01069796|Capecitabine|capecitabine|mesh-list
93050974|NCT01069796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93050975|NCT01069796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93050976|NCT01069796|Tubulin Modulators|tubulin modulators|mesh-ancestor
93050977|NCT01069796|Antimitotic Agents|antimitotic agents|mesh-ancestor
93050978|NCT01069796|Mitosis Modulators|mitosis modulators|mesh-ancestor
93050979|NCT01069796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93050980|NCT01069796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93050981|NCT01069796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93050982|NCT01069796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93050983|NCT01069796|Growth Substances|growth substances|mesh-ancestor
93050984|NCT01069796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050985|NCT01069796|Growth Inhibitors|growth inhibitors|mesh-ancestor
93050986|NCT01069796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93050988|NCT01067534|Albuterol|albuterol|mesh-list
93050989|NCT01067534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93050990|NCT01067534|Autonomic Agents|autonomic agents|mesh-ancestor
93050991|NCT01067534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93050992|NCT01067534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93050993|NCT01067534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93050994|NCT01067534|Respiratory System Agents|respiratory system agents|mesh-ancestor
93050995|NCT01067534|Tocolytic Agents|tocolytic agents|mesh-ancestor
93050996|NCT01067534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93050997|NCT01067534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93050998|NCT01067534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93050999|NCT01067534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93051000|NCT01067534|Adrenergic Agents|adrenergic agents|mesh-ancestor
93051001|NCT01067534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051002|NCT01067534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051003|NCT00451451|Glatiramer Acetate|glatiramer acetate|mesh-list
93051004|NCT00451451|Dimethyl Fumarate|dimethyl fumarate|mesh-list
93051005|NCT00451451|(T,G)-A-L|(t,g)-a-l|mesh-list
93051006|NCT00451451|Dermatologic Agents|dermatologic agents|mesh-ancestor
93051007|NCT00451451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051008|NCT00451451|Immunologic Factors|immunologic factors|mesh-ancestor
93051009|NCT00451451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051010|NCT00451451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93051011|NCT00451451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051012|NCT01062698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93051013|NCT01062698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93051014|NCT01062698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93051015|NCT01062698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051016|NCT03977324|Chlorhexidine|chlorhexidine|mesh-list
93051017|NCT03977324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93051018|NCT03977324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051019|NCT03977324|Disinfectants|disinfectants|mesh-ancestor
93051020|NCT01069874|Vitamin D|vitamin d|mesh-list
93051021|NCT01069874|Cholecalciferol|cholecalciferol|mesh-list
93051022|NCT01069874|Vitamins|vitamins|mesh-ancestor
93051023|NCT01069874|Micronutrients|micronutrients|mesh-ancestor
93051024|NCT01069874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051025|NCT01069874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93051026|NCT01069874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93051027|NCT01022645|Copper|copper|mesh-list
93051028|NCT01022645|Levonorgestrel|levonorgestrel|mesh-list
93051029|NCT01022645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93051030|NCT01022645|Contraceptive Agents|contraceptive agents|mesh-ancestor
93051031|NCT01022645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93051032|NCT01022645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051033|NCT01022645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93051034|NCT01022645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93051035|NCT01022645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93051036|NCT01022645|Trace Elements|trace elements|mesh-ancestor
93051037|NCT01022645|Micronutrients|micronutrients|mesh-ancestor
93051038|NCT01025765|Metformin|metformin|mesh-list
93051039|NCT01025765|Pioglitazone|pioglitazone|mesh-list
93051040|NCT01025765|Acarbose|acarbose|mesh-list
93051041|NCT01025765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93051042|NCT01025765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051043|NCT01025765|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93051044|NCT01025765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696017|NCT05149274|Fexuprazan|fexuprazan|mesh-list
93051045|NCT01025765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051046|NCT03824912|Ketoconazole|ketoconazole|mesh-list
93051047|NCT03824912|Antifungal Agents|antifungal agents|mesh-ancestor
93051048|NCT03824912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051049|NCT03824912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93051050|NCT03824912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93051051|NCT03824912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051052|NCT03824912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051053|NCT03824912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93051054|NCT03824912|Hormone Antagonists|hormone antagonists|mesh-ancestor
93051055|NCT03824912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051056|NCT03824912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051057|NCT03824912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93051059|NCT01062776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93051060|NCT01062776|Diuretics|diuretics|mesh-ancestor
93051061|NCT01062776|Natriuretic Agents|natriuretic agents|mesh-ancestor
93051062|NCT01062776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051063|NCT01062776|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93051064|NCT01062776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93051065|NCT01062776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051066|NCT01025921|Colistin|colistin|mesh-list
93051067|NCT01025921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051068|NCT01025921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051069|NCT01070030|Amlodipine|amlodipine|mesh-list
93051070|NCT01070030|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93051071|NCT01070030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93051072|NCT01070030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93051073|NCT01070030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93051074|NCT01070030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051075|NCT01070030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93051076|NCT01070030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051077|NCT01070030|Vasodilator Agents|vasodilator agents|mesh-ancestor
93051078|NCT01070030|Diuretics|diuretics|mesh-ancestor
93051079|NCT01070030|Natriuretic Agents|natriuretic agents|mesh-ancestor
93051080|NCT01070030|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93051081|NCT00461123|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92329305|NCT00003578|Cytarabine|cytarabine|mesh-list
93051082|NCT00461123|Vasodilator Agents|vasodilator agents|mesh-ancestor
93051083|NCT00461123|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93051084|NCT00461123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93051085|NCT00461123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051086|NCT00461123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051087|NCT00461123|Urological Agents|urological agents|mesh-ancestor
93051088|NCT00290342|Edetic Acid|edetic acid|mesh-list
93051089|NCT00290342|Pentetic Acid|pentetic acid|mesh-list
93051090|NCT00290342|Antidotes|antidotes|mesh-ancestor
93051091|NCT00290342|Protective Agents|protective agents|mesh-ancestor
93051092|NCT00290342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051093|NCT00290342|Chelating Agents|chelating agents|mesh-ancestor
93051094|NCT00290342|Sequestering Agents|sequestering agents|mesh-ancestor
93051095|NCT00290342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051096|NCT00290342|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93051097|NCT00290342|Anticoagulants|anticoagulants|mesh-ancestor
93051098|NCT00290342|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93051099|NCT00460811|Linaclotide|linaclotide|mesh-list
93051100|NCT00460811|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
93051101|NCT00460811|Enzyme Activators|enzyme activators|mesh-ancestor
93051102|NCT00460811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051103|NCT00460811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051104|NCT01070108|Ketamine|ketamine|mesh-list
93051105|NCT01070108|Analgesics|analgesics|mesh-ancestor
93051106|NCT01070108|Sensory System Agents|sensory system agents|mesh-ancestor
93051107|NCT01070108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051108|NCT01070108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051109|NCT01070108|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93051110|NCT01070108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93051111|NCT01070108|Anesthetics, General|anesthetics, general|mesh-ancestor
93051112|NCT01070108|Anesthetics|anesthetics|mesh-ancestor
93051113|NCT01070108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93051114|NCT01070108|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93051115|NCT01070108|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93051116|NCT01070108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051117|NCT01070108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051118|NCT01067690|Indinavir|indinavir|mesh-list
93051119|NCT01067690|Bleomycin|bleomycin|mesh-list
93051120|NCT01067690|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93051121|NCT01067690|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93051122|NCT01067690|Protease Inhibitors|protease inhibitors|mesh-ancestor
93051123|NCT01067690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051124|NCT01067690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051125|NCT01067690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93051126|NCT01067690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93051127|NCT01067690|Antiviral Agents|antiviral agents|mesh-ancestor
93051128|NCT01067690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051129|NCT01067690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93051130|NCT01067690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051131|NCT03982004|Pembrolizumab|pembrolizumab|mesh-list
93051132|NCT03982004|Imiquimod|imiquimod|mesh-list
93051133|NCT03982004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051134|NCT03982004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051135|NCT03982004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93051136|NCT03982004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051137|NCT03982004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93051138|NCT03982004|Immunologic Factors|immunologic factors|mesh-ancestor
93051139|NCT03982004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051140|NCT03982004|Interferon Inducers|interferon inducers|mesh-ancestor
93051141|NCT01026233|Brentuximab Vedotin|brentuximab vedotin|mesh-list
93051142|NCT01026233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051143|NCT01026233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051144|NCT01026233|Immunotoxins|immunotoxins|mesh-ancestor
93051145|NCT01026233|Immunoconjugates|immunoconjugates|mesh-ancestor
93051146|NCT01026233|Immunologic Factors|immunologic factors|mesh-ancestor
93051147|NCT01026233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051148|NCT01062932|Cycloserine|cycloserine|mesh-list
93051149|NCT01062932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93051150|NCT01062932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051151|NCT01062932|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93051152|NCT01062932|Antitubercular Agents|antitubercular agents|mesh-ancestor
93051153|NCT01062932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051154|NCT01062932|Antimetabolites|antimetabolites|mesh-ancestor
93051155|NCT01062932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051156|NCT01026311|Ubiquinone|ubiquinone|mesh-list
93051157|NCT01026311|Coenzyme Q10|coenzyme q10|mesh-list
93051158|NCT01026311|Micronutrients|micronutrients|mesh-ancestor
93051159|NCT01026311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051160|NCT01026311|Vitamins|vitamins|mesh-ancestor
93051161|NCT01063010|Bevacizumab|bevacizumab|mesh-list
93051162|NCT01063010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051163|NCT01063010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051164|NCT01063010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051165|NCT01063010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051166|NCT01063010|Growth Substances|growth substances|mesh-ancestor
93051167|NCT01063010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051168|NCT01063010|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051169|NCT00460577|Bromides|bromides|mesh-list
93051170|NCT00460577|Fenoterol|fenoterol|mesh-list
93051171|NCT00460577|Formoterol Fumarate|formoterol fumarate|mesh-list
93051172|NCT00460577|Ipratropium|ipratropium|mesh-list
93051173|NCT00460577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93051174|NCT00460577|Autonomic Agents|autonomic agents|mesh-ancestor
93051175|NCT00460577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051176|NCT00460577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051177|NCT00460577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93051178|NCT00460577|Respiratory System Agents|respiratory system agents|mesh-ancestor
93051179|NCT00460577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93051180|NCT00460577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93051181|NCT00460577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93051182|NCT00460577|Adrenergic Agents|adrenergic agents|mesh-ancestor
93051183|NCT00460577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051184|NCT00460577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051185|NCT00460577|Anticonvulsants|anticonvulsants|mesh-ancestor
93051186|NCT00460577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93051187|NCT00460577|Cholinergic Agents|cholinergic agents|mesh-ancestor
93051188|NCT00460577|Sympathomimetics|sympathomimetics|mesh-ancestor
93051189|NCT00460577|Tocolytic Agents|tocolytic agents|mesh-ancestor
93051190|NCT00460577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93051191|NCT01581320|Vitamin D|vitamin d|mesh-list
93051192|NCT01581320|Cholecalciferol|cholecalciferol|mesh-list
93051193|NCT01581320|Ibandronic Acid|ibandronic acid|mesh-list
93051194|NCT01581320|Vitamins|vitamins|mesh-ancestor
93051195|NCT01581320|Micronutrients|micronutrients|mesh-ancestor
93051196|NCT01581320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051197|NCT01581320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93051198|NCT01581320|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93051199|NCT00289016|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93051200|NCT00289016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051201|NCT00289016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051202|NCT00288704|Rilonacept|rilonacept|mesh-list
93051203|NCT00288704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051204|NCT00288626|Cytarabine|cytarabine|mesh-list
93051205|NCT00288626|Prednisone|prednisone|mesh-list
93051206|NCT00288626|Etoposide|etoposide|mesh-list
93051207|NCT00288626|Melphalan|melphalan|mesh-list
93051208|NCT00288626|Carmustine|carmustine|mesh-list
93051209|NCT00288626|Lenograstim|lenograstim|mesh-list
93051210|NCT00288626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051211|NCT00288626|Glucocorticoids|glucocorticoids|mesh-ancestor
93051212|NCT00288626|Hormones|hormones|mesh-ancestor
93051213|NCT00288626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051214|NCT00288626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051215|NCT00288626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93051216|NCT00288626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051217|NCT00288626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93051218|NCT00288626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93051219|NCT00288626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051220|NCT00288626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051221|NCT00288626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051222|NCT00288626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051223|NCT00288626|Antimetabolites|antimetabolites|mesh-ancestor
93051224|NCT00288626|Antiviral Agents|antiviral agents|mesh-ancestor
93051225|NCT00288626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051226|NCT00288626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051227|NCT00288626|Immunologic Factors|immunologic factors|mesh-ancestor
93051228|NCT00288626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93051229|NCT00288626|Alkylating Agents|alkylating agents|mesh-ancestor
93051230|NCT00288626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93051231|NCT00288626|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93051232|NCT00087490|Vancomycin|vancomycin|mesh-list
93051233|NCT00087490|Linezolid|linezolid|mesh-list
93051234|NCT00087490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051235|NCT00087490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051236|NCT00087490|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93051237|NCT00087490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051238|NCT00087490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051239|NCT00087178|Cyclophosphamide|cyclophosphamide|mesh-list
93051240|NCT00087178|Doxorubicin|doxorubicin|mesh-list
93051241|NCT00087178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93051242|NCT00087178|Fluorouracil|fluorouracil|mesh-list
93051243|NCT00087178|Epirubicin|epirubicin|mesh-list
93051244|NCT00087178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051245|NCT00087178|Immunologic Factors|immunologic factors|mesh-ancestor
93051246|NCT00087178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051247|NCT00087178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051248|NCT00087178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93051249|NCT00087178|Alkylating Agents|alkylating agents|mesh-ancestor
93051250|NCT00087178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051251|NCT00087178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051252|NCT00087178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93051253|NCT00087178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93051254|NCT00087178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93051255|NCT00087178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051256|NCT00087178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051257|NCT00087178|Antimetabolites|antimetabolites|mesh-ancestor
93051258|NCT00087178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051259|NCT00288080|Dexamethasone|dexamethasone|mesh-list
93051260|NCT00288080|Prednisone|prednisone|mesh-list
93051261|NCT00288080|Docetaxel|docetaxel|mesh-list
93051262|NCT00288080|Androgen Antagonists|androgen antagonists|mesh-list
93051263|NCT00288080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051264|NCT00288080|Antiemetics|antiemetics|mesh-ancestor
93051265|NCT00288080|Autonomic Agents|autonomic agents|mesh-ancestor
93051266|NCT00288080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051267|NCT00288080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051268|NCT00288080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696257|NCT00507962|Cisplatin|cisplatin|mesh-list
93051269|NCT00288080|Glucocorticoids|glucocorticoids|mesh-ancestor
93051270|NCT00288080|Hormones|hormones|mesh-ancestor
93051271|NCT00288080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051272|NCT00288080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93051273|NCT00288080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051274|NCT00288080|Tubulin Modulators|tubulin modulators|mesh-ancestor
93051275|NCT00288080|Antimitotic Agents|antimitotic agents|mesh-ancestor
93051276|NCT00288080|Mitosis Modulators|mitosis modulators|mesh-ancestor
93051277|NCT00288080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051278|NCT00288080|Hormone Antagonists|hormone antagonists|mesh-ancestor
93051279|NCT01068392|Prednisolone|prednisolone|mesh-list
93051280|NCT01068392|Oxaliplatin|oxaliplatin|mesh-list
93051281|NCT01068392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051282|NCT01068392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051283|NCT01068392|Glucocorticoids|glucocorticoids|mesh-ancestor
93051284|NCT01068392|Hormones|hormones|mesh-ancestor
93051285|NCT01068392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051286|NCT01068392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051287|NCT01068392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93051288|NCT01086826|Cisplatin|cisplatin|mesh-list
93051289|NCT01086826|Docetaxel|docetaxel|mesh-list
93051290|NCT01086826|Fluorouracil|fluorouracil|mesh-list
93051291|NCT01086826|Cetuximab|cetuximab|mesh-list
93051292|NCT01086826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051293|NCT01086826|Tubulin Modulators|tubulin modulators|mesh-ancestor
93051294|NCT01086826|Antimitotic Agents|antimitotic agents|mesh-ancestor
93051295|NCT01086826|Mitosis Modulators|mitosis modulators|mesh-ancestor
93051296|NCT01086826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051297|NCT01086826|Antimetabolites|antimetabolites|mesh-ancestor
93051298|NCT01086826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051299|NCT01086826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051300|NCT01086826|Immunologic Factors|immunologic factors|mesh-ancestor
93051301|NCT01086826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051302|NCT01086826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051303|NCT00287690|Genistein|genistein|mesh-list
93051304|NCT00287690|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93051305|NCT00287690|Protective Agents|protective agents|mesh-ancestor
93051306|NCT00287690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051307|NCT00287690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051308|NCT00287690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051309|NCT00287690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051310|NCT00287690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051311|NCT00287690|Phytoestrogens|phytoestrogens|mesh-ancestor
93051312|NCT00287690|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93051313|NCT00287690|Estrogens|estrogens|mesh-ancestor
93051314|NCT00287690|Hormones|hormones|mesh-ancestor
93051315|NCT00287690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051316|NCT01070186|Sunitinib|sunitinib|mesh-list
93051317|NCT01070186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051318|NCT01070186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051319|NCT01070186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051320|NCT01070186|Growth Substances|growth substances|mesh-ancestor
93051321|NCT01070186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051322|NCT01070186|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051323|NCT01070186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051324|NCT01070186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051325|NCT01070186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051326|NCT00066742|Etoposide|etoposide|mesh-list
93051327|NCT00066742|Etoposide phosphate|etoposide phosphate|mesh-list
93051328|NCT00066742|Tirapazamine|tirapazamine|mesh-list
93051329|NCT00066742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051330|NCT00066742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93051331|NCT00066742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93051332|NCT00066742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051333|NCT00066742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051334|NCT00066742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051335|NCT01026467|Carboplatin|carboplatin|mesh-list
93051336|NCT01026467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051337|NCT01094158|Cholic Acids|cholic acids|mesh-list
93051338|NCT01094158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051339|NCT00460109|Rituximab|rituximab|mesh-list
93051340|NCT00460109|Denileukin diftitox|denileukin diftitox|mesh-list
93051341|NCT00460109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051342|NCT00460109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051343|NCT00460109|Immunologic Factors|immunologic factors|mesh-ancestor
93051344|NCT00460109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051345|NCT00460109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051346|NCT03956212|Doxycycline|doxycycline|mesh-list
93051347|NCT03956212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051348|NCT03956212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051349|NCT03956212|Antimalarials|antimalarials|mesh-ancestor
93051350|NCT03956212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93051351|NCT03956212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93051352|NCT01091818|Midazolam|midazolam|mesh-list
93051353|NCT01091818|Dexmedetomidine|dexmedetomidine|mesh-list
93051354|NCT01091818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92529429|NCT03668431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051355|NCT01091818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93051356|NCT01091818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051357|NCT01091818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93051358|NCT01091818|Analgesics|analgesics|mesh-ancestor
93051359|NCT01091818|Sensory System Agents|sensory system agents|mesh-ancestor
93051360|NCT01091818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051361|NCT01091818|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93051362|NCT01091818|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93051363|NCT01091818|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93051364|NCT01091818|Adrenergic Agents|adrenergic agents|mesh-ancestor
93051365|NCT01091818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051366|NCT01091818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051367|NCT01091818|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93051368|NCT01091818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93051369|NCT01091818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93051370|NCT01091818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051371|NCT01091818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93051372|NCT01091818|Anesthetics, General|anesthetics, general|mesh-ancestor
93051373|NCT01091818|Anesthetics|anesthetics|mesh-ancestor
93051374|NCT01091818|GABA Modulators|gaba modulators|mesh-ancestor
93051375|NCT01091818|GABA Agents|gaba agents|mesh-ancestor
93051376|NCT01091896|Bevacizumab|bevacizumab|mesh-list
93051377|NCT01091896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051378|NCT01091896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051379|NCT01091896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051380|NCT01091896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051381|NCT01091896|Growth Substances|growth substances|mesh-ancestor
93051382|NCT01091896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051383|NCT01091896|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051384|NCT00065260|Cyclosporine|cyclosporine|mesh-list
93051385|NCT00065260|Alemtuzumab|alemtuzumab|mesh-list
93051386|NCT00065260|Cyclosporins|cyclosporins|mesh-list
93051387|NCT00065260|Thymoglobulin|thymoglobulin|mesh-list
93051388|NCT00065260|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93051389|NCT00065260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051390|NCT00065260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051391|NCT00065260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051392|NCT00065260|Immunologic Factors|immunologic factors|mesh-ancestor
93051393|NCT00065260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051394|NCT00065260|Antifungal Agents|antifungal agents|mesh-ancestor
93051395|NCT00065260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051396|NCT00065260|Dermatologic Agents|dermatologic agents|mesh-ancestor
93051397|NCT00065260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051398|NCT00065260|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93051399|NCT00065260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051400|NCT00065260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051401|NCT01327066|Moxifloxacin|moxifloxacin|mesh-list
93051402|NCT01327066|Droxidopa|droxidopa|mesh-list
93051403|NCT01327066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051404|NCT01327066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051405|NCT01327066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93051406|NCT01327066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051407|NCT01327066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051408|NCT01327066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051409|NCT01327066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051410|NCT01327066|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93051411|NCT01327066|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93051412|NCT01094626|Secretin|secretin|mesh-list
93051413|NCT01094626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051414|NCT01094626|Hormones|hormones|mesh-ancestor
93051415|NCT01094626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051416|NCT01094626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051417|NCT03956134|Tapentadol|tapentadol|mesh-list
93051418|NCT03956134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92696391|NCT00510419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93051419|NCT03956134|Narcotics|narcotics|mesh-ancestor
93051420|NCT03956134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93051421|NCT03956134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051422|NCT03956134|Analgesics|analgesics|mesh-ancestor
93051423|NCT03956134|Sensory System Agents|sensory system agents|mesh-ancestor
93051424|NCT03956134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051425|NCT03956134|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93051426|NCT03956134|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92397012|NCT05270434|Dipyrone|dipyrone|mesh-list
93051428|NCT03956134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051429|NCT03956134|Adrenergic Agents|adrenergic agents|mesh-ancestor
93051430|NCT03956134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051431|NCT00460031|Ketoconazole|ketoconazole|mesh-list
93051432|NCT00460031|Hydrocortisone|hydrocortisone|mesh-list
93051433|NCT00460031|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93051434|NCT00460031|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93051435|NCT00460031|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93051436|NCT00460031|Lenalidomide|lenalidomide|mesh-list
93051437|NCT00460031|Immunologic Factors|immunologic factors|mesh-ancestor
93051438|NCT00460031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051439|NCT00460031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051440|NCT00460031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051441|NCT00460031|Growth Substances|growth substances|mesh-ancestor
93051442|NCT00460031|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051443|NCT00460031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051444|NCT00460031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051445|NCT00460031|Antifungal Agents|antifungal agents|mesh-ancestor
93051446|NCT00460031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051447|NCT00460031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93051448|NCT00460031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93051449|NCT00460031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051450|NCT00460031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051451|NCT00460031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93051452|NCT00460031|Hormone Antagonists|hormone antagonists|mesh-ancestor
93051453|NCT00460031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051454|NCT00460031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93051455|NCT00451217|Glycopyrrolate|glycopyrrolate|mesh-list
93051456|NCT00451217|Neostigmine|neostigmine|mesh-list
93051457|NCT00451217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93051458|NCT00451217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051459|NCT00451217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051460|NCT00451217|Cholinergic Agents|cholinergic agents|mesh-ancestor
93051461|NCT00451217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051462|NCT00451217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051463|NCT00451217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93051464|NCT00451217|Autonomic Agents|autonomic agents|mesh-ancestor
93051465|NCT00451217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051466|NCT00451217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93051467|NCT00451217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93051468|NCT00451217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93051469|NCT00459953|Nicotine|nicotine|mesh-list
93051470|NCT00459953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93051471|NCT00459953|Autonomic Agents|autonomic agents|mesh-ancestor
93051472|NCT00459953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051473|NCT00459953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051474|NCT00459953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93051475|NCT00459953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93051476|NCT00459953|Cholinergic Agents|cholinergic agents|mesh-ancestor
93051477|NCT00459953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051478|NCT00459953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051479|NCT00459875|Sunitinib|sunitinib|mesh-list
93051480|NCT00459875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051481|NCT00459875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051482|NCT00459875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051483|NCT00459875|Growth Substances|growth substances|mesh-ancestor
93051484|NCT00459875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051485|NCT00459875|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051486|NCT00459875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051487|NCT00459875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051488|NCT00459875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051489|NCT00311402|Aspirin|aspirin|mesh-list
93051490|NCT00311402|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
93051491|NCT00311402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93051492|NCT00311402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93051493|NCT00311402|Analgesics|analgesics|mesh-ancestor
93051494|NCT00311402|Sensory System Agents|sensory system agents|mesh-ancestor
93051495|NCT00311402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051496|NCT00311402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051497|NCT00311402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051498|NCT00311402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051499|NCT00311402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93051500|NCT00311402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93051501|NCT00311402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051502|NCT00311402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93051503|NCT00311402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93051504|NCT00311402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051505|NCT00311402|Antipyretics|antipyretics|mesh-ancestor
93051506|NCT03724175|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93051507|NCT03724175|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93051508|NCT03724175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051509|NCT00450749|Lycopene|lycopene|mesh-list
93051510|NCT00450749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051511|NCT00450749|Antioxidants|antioxidants|mesh-ancestor
93051512|NCT00450749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051513|NCT00450749|Protective Agents|protective agents|mesh-ancestor
91982020|NCT05511441|Aspirin|aspirin|mesh-list
93051514|NCT00450749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051515|NCT00450749|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93051516|NCT00450749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93051517|NCT00450749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051518|NCT00292370|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93051519|NCT00292370|Paroxetine|paroxetine|mesh-list
93051520|NCT00292370|Antidepressive Agents|antidepressive agents|mesh-ancestor
93051521|NCT00292370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051522|NCT00292370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93051523|NCT00292370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93051524|NCT00292370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93051525|NCT00292370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051526|NCT00292370|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93051527|NCT00292370|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93051528|NCT00292370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93051529|NCT00292370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051530|NCT00292370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051531|NCT00292370|Serotonin Agents|serotonin agents|mesh-ancestor
93051532|NCT00292370|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93051533|NCT00292370|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93051534|NCT00292370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93051535|NCT00292370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051536|NCT00065182|Docetaxel|docetaxel|mesh-list
93051537|NCT00065182|Topotecan|topotecan|mesh-list
93051538|NCT00065182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051539|NCT00065182|Tubulin Modulators|tubulin modulators|mesh-ancestor
93051540|NCT00065182|Antimitotic Agents|antimitotic agents|mesh-ancestor
93051541|NCT00065182|Mitosis Modulators|mitosis modulators|mesh-ancestor
93051542|NCT00065182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051543|NCT00065182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93051544|NCT00065182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051545|NCT00065182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051546|NCT01026701|Bortezomib|bortezomib|mesh-list
93051547|NCT01026701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051548|NCT01092130|Vitamin D|vitamin d|mesh-list
93051549|NCT01092130|Vitamins|vitamins|mesh-ancestor
93051550|NCT01092130|Micronutrients|micronutrients|mesh-ancestor
93051551|NCT01092130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051552|NCT01092130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93051553|NCT00064792|Simvastatin|simvastatin|mesh-list
93051554|NCT00064792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93051555|NCT00064792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93051556|NCT00064792|Antimetabolites|antimetabolites|mesh-ancestor
93051557|NCT00064792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051558|NCT00064792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93051559|NCT00064792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93051560|NCT00064792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051561|NCT01095016|Fenoterol|fenoterol|mesh-list
93051562|NCT01095016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93051563|NCT01095016|Autonomic Agents|autonomic agents|mesh-ancestor
93051564|NCT01095016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051565|NCT01095016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051566|NCT01095016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93051567|NCT01095016|Respiratory System Agents|respiratory system agents|mesh-ancestor
93051568|NCT01095016|Sympathomimetics|sympathomimetics|mesh-ancestor
93051569|NCT01095016|Tocolytic Agents|tocolytic agents|mesh-ancestor
93051570|NCT01095016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93051571|NCT01095016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93051572|NCT01095016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93051573|NCT01095016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93051574|NCT01095016|Adrenergic Agents|adrenergic agents|mesh-ancestor
93051575|NCT01095016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051576|NCT01095016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051577|NCT01095172|Prednisolone|prednisolone|mesh-list
93051578|NCT01095172|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93051579|NCT01095172|Methylprednisolone|methylprednisolone|mesh-list
92329414|NCT00002707|Tamoxifen|tamoxifen|mesh-list
93051580|NCT01095172|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93051581|NCT01095172|Prednisolone acetate|prednisolone acetate|mesh-list
93051582|NCT01095172|Hydrocortisone|hydrocortisone|mesh-list
93051583|NCT01095172|Rituximab|rituximab|mesh-list
93051584|NCT01095172|Tacrolimus|tacrolimus|mesh-list
93051585|NCT01095172|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93051586|NCT01095172|Prednisolone phosphate|prednisolone phosphate|mesh-list
93051587|NCT01095172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051588|NCT01095172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051589|NCT01095172|Immunologic Factors|immunologic factors|mesh-ancestor
93051590|NCT01095172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051591|NCT01095172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051592|NCT01095172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051593|NCT01095172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93051594|NCT01095172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051595|NCT01095172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051596|NCT01095172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051597|NCT01095172|Glucocorticoids|glucocorticoids|mesh-ancestor
93051598|NCT01095172|Hormones|hormones|mesh-ancestor
93051599|NCT01095172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051600|NCT01095172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93051601|NCT01095172|Antiemetics|antiemetics|mesh-ancestor
93051602|NCT01095172|Autonomic Agents|autonomic agents|mesh-ancestor
93051603|NCT01095172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051604|NCT01095172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051605|NCT01095172|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93051606|NCT01095172|Protective Agents|protective agents|mesh-ancestor
93051607|NCT00286442|Metformin|metformin|mesh-list
93051608|NCT00286442|Alogliptin|alogliptin|mesh-list
93051609|NCT00286442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93051610|NCT00286442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051611|NCT00286442|Incretins|incretins|mesh-ancestor
93051612|NCT00286442|Hormones|hormones|mesh-ancestor
93051613|NCT00286442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051614|NCT00286442|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93051615|NCT00286442|Protease Inhibitors|protease inhibitors|mesh-ancestor
93051616|NCT00286442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051617|NCT00286442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051618|NCT00063934|Docetaxel|docetaxel|mesh-list
93051619|NCT00063934|Doxorubicin|doxorubicin|mesh-list
93051620|NCT00063934|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93051621|NCT00063934|Oblimersen|oblimersen|mesh-list
93051622|NCT00063934|Lenograstim|lenograstim|mesh-list
93051623|NCT00063934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051624|NCT00063934|Tubulin Modulators|tubulin modulators|mesh-ancestor
93051625|NCT00063934|Antimitotic Agents|antimitotic agents|mesh-ancestor
93051626|NCT00063934|Mitosis Modulators|mitosis modulators|mesh-ancestor
93051627|NCT00063934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051628|NCT00063934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93051629|NCT00063934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93051630|NCT00063934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051631|NCT00063934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051632|NCT00063934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93051633|NCT00063934|Immunologic Factors|immunologic factors|mesh-ancestor
93051634|NCT00063934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051635|NCT00063154|Pertuzumab|pertuzumab|mesh-list
93051636|NCT00063154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051637|NCT00063154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051638|NCT01092520|Gabapentin|gabapentin|mesh-list
93051639|NCT01092520|Analgesics|analgesics|mesh-ancestor
93051640|NCT01092520|Sensory System Agents|sensory system agents|mesh-ancestor
93051641|NCT01092520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051642|NCT01092520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051643|NCT01092520|Anticonvulsants|anticonvulsants|mesh-ancestor
93051644|NCT01092520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93051645|NCT01092520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93051646|NCT01092520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93051647|NCT01092520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051648|NCT01092520|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93051649|NCT01092520|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93051650|NCT01092520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051651|NCT01092520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051653|NCT00458705|Thalidomide|thalidomide|mesh-list
93051654|NCT00458705|Dexamethasone|dexamethasone|mesh-list
93051655|NCT00458705|Doxorubicin|doxorubicin|mesh-list
93051656|NCT00458705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93051657|NCT00458705|Bortezomib|bortezomib|mesh-list
93051658|NCT00458705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051659|NCT00458705|Antiemetics|antiemetics|mesh-ancestor
93051660|NCT00458705|Autonomic Agents|autonomic agents|mesh-ancestor
93051661|NCT00458705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051662|NCT00458705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051663|NCT00458705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051664|NCT00458705|Glucocorticoids|glucocorticoids|mesh-ancestor
93051665|NCT00458705|Hormones|hormones|mesh-ancestor
93051666|NCT00458705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051667|NCT00458705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93051668|NCT00458705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051669|NCT00458705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93051670|NCT00458705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93051671|NCT00458705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051672|NCT00458705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051673|NCT00458705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051674|NCT00458705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051675|NCT00458705|Immunologic Factors|immunologic factors|mesh-ancestor
93051676|NCT00458705|Leprostatic Agents|leprostatic agents|mesh-ancestor
93051677|NCT00458705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051678|NCT00458705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051679|NCT00458705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051680|NCT00458705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051681|NCT00458705|Growth Substances|growth substances|mesh-ancestor
93051682|NCT00458705|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051683|NCT00062374|Deoxyglucose|deoxyglucose|mesh-list
93051684|NCT00062374|Alovudine|alovudine|mesh-list
93051685|NCT00062374|Cisplatin|cisplatin|mesh-list
93051686|NCT00062374|Irinotecan|irinotecan|mesh-list
93051687|NCT00062374|Camptothecin|camptothecin|mesh-list
93051688|NCT00062374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93051689|NCT00062374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051690|NCT00062374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93051691|NCT00062374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051692|NCT00062374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051693|NCT00062374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051694|NCT00062374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93051695|NCT00062374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93051696|NCT00062374|Antimetabolites|antimetabolites|mesh-ancestor
93051697|NCT00062374|Antiviral Agents|antiviral agents|mesh-ancestor
93051698|NCT00062374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051699|NCT00285818|Mifepristone|mifepristone|mesh-list
93051700|NCT00285818|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
93051701|NCT00285818|Abortifacient Agents|abortifacient agents|mesh-ancestor
93051702|NCT00285818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93051703|NCT00285818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051704|NCT00285818|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93051705|NCT00285818|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93051706|NCT00285818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93051707|NCT00285818|Contraceptive Agents|contraceptive agents|mesh-ancestor
93051708|NCT00285818|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
93051709|NCT00285818|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
93051710|NCT00285818|Hormone Antagonists|hormone antagonists|mesh-ancestor
93051711|NCT00285818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051712|NCT00285818|Luteolytic Agents|luteolytic agents|mesh-ancestor
93051713|NCT00285818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93051714|NCT00285818|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
93051715|NCT01023347|Paclitaxel|paclitaxel|mesh-list
92696693|NCT02953184|Razoxane|razoxane|mesh-list
93051716|NCT01023347|genexol-PM|genexol-pm|mesh-list
93051717|NCT01023347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93051718|NCT01023347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93051719|NCT01023347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051720|NCT01023347|Tubulin Modulators|tubulin modulators|mesh-ancestor
93051721|NCT01023347|Antimitotic Agents|antimitotic agents|mesh-ancestor
93051722|NCT01023347|Mitosis Modulators|mitosis modulators|mesh-ancestor
93051723|NCT01023347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051724|NCT01023425|Donepezil|donepezil|mesh-list
93051725|NCT01023425|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93051726|NCT01023425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051727|NCT01023425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051728|NCT01023425|Cholinergic Agents|cholinergic agents|mesh-ancestor
93051729|NCT01023425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051730|NCT01023425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051731|NCT01023425|Nootropic Agents|nootropic agents|mesh-ancestor
93051732|NCT00285584|Bupropion|bupropion|mesh-list
93051733|NCT00285584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93051734|NCT00285584|Antidepressive Agents|antidepressive agents|mesh-ancestor
93051735|NCT00285584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051736|NCT00285584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93051737|NCT00285584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93051738|NCT00285584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93051739|NCT00285584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051740|NCT00285584|Dopamine Agents|dopamine agents|mesh-ancestor
93051741|NCT00285584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051742|NCT00285584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051743|NCT00285584|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93051744|NCT00285584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93051745|NCT00285584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051746|NCT01583842|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93051747|NCT01583842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051748|NCT01583842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051749|NCT01583842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051750|NCT01583842|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93051751|NCT00291668|Certolizumab Pegol|certolizumab pegol|mesh-list
93051752|NCT00291668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93051753|NCT00291668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051754|NCT00291668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051755|NCT00291668|Immunologic Factors|immunologic factors|mesh-ancestor
93051756|NCT00291668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051757|NCT00291668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051758|NCT00458393|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93051759|NCT00458393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93051760|NCT00458393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93051761|NCT00458393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051762|NCT00458393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051763|NCT00458393|Antiviral Agents|antiviral agents|mesh-ancestor
93051764|NCT00458393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051765|NCT00458393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93051766|NCT00458393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93051767|NCT03955354|Apatinib|apatinib|mesh-list
93051768|NCT03955354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051769|NCT03955354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051770|NCT03955354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051771|NCT03955354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051772|NCT01095484|Rotigotine|rotigotine|mesh-list
93051773|NCT01095484|Dopamine Agonists|dopamine agonists|mesh-ancestor
93051774|NCT01095484|Dopamine Agents|dopamine agents|mesh-ancestor
93051775|NCT01095484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051776|NCT01095484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051777|NCT01095484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051778|NCT01063478|Everolimus|everolimus|mesh-list
93051779|NCT01063478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93051780|NCT01063478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051781|NCT01063478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051782|NCT01063478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051783|NCT01063478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051784|NCT01063478|Immunologic Factors|immunologic factors|mesh-ancestor
93051785|NCT01063478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051786|NCT01063478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051787|NCT01327144|Acyclovir|acyclovir|mesh-list
93051788|NCT01327144|Famciclovir|famciclovir|mesh-list
93051789|NCT01327144|Antiviral Agents|antiviral agents|mesh-ancestor
93051790|NCT01327144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051791|NCT01327144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93051792|NCT01327144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051793|NCT01327144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051794|NCT01323101|Doxycycline|doxycycline|mesh-list
93051795|NCT01323101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051796|NCT01323101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051797|NCT01323101|Antimalarials|antimalarials|mesh-ancestor
93051798|NCT01323101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93051799|NCT01323101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93051800|NCT00310856|Vaccines|vaccines|mesh-list
93051801|NCT00310856|Immunologic Factors|immunologic factors|mesh-ancestor
93051802|NCT00310856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051803|NCT03670355|Tenofovir|tenofovir|mesh-list
93051804|NCT03670355|Antiviral Agents|antiviral agents|mesh-ancestor
93051805|NCT03670355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051806|NCT03670355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93051807|NCT03670355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93051808|NCT03670355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051809|NCT03670355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051810|NCT03670355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93051811|NCT03670355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93051812|NCT02532062|Vitamin D|vitamin d|mesh-list
93051813|NCT02532062|Cholecalciferol|cholecalciferol|mesh-list
93051814|NCT02532062|Vitamins|vitamins|mesh-ancestor
93051815|NCT02532062|Micronutrients|micronutrients|mesh-ancestor
93051816|NCT02532062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051817|NCT02532062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93051818|NCT02532062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93051819|NCT00283712|Infliximab|infliximab|mesh-list
93051820|NCT00283712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93051821|NCT00283712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051822|NCT00283712|Dermatologic Agents|dermatologic agents|mesh-ancestor
93051823|NCT00283712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93051824|NCT00283712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051825|NCT00048724|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93051826|NCT00048724|Antiviral Agents|antiviral agents|mesh-ancestor
93051827|NCT00048724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051828|NCT00449033|Gemcitabine|gemcitabine|mesh-list
93051829|NCT00449033|Sorafenib|sorafenib|mesh-list
93051830|NCT00449033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051831|NCT00449033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051832|NCT00449033|Antimetabolites|antimetabolites|mesh-ancestor
93051833|NCT00449033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051834|NCT00449033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051835|NCT00449033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051836|NCT01024205|Sunitinib|sunitinib|mesh-list
93051837|NCT01024205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051838|NCT01024205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051839|NCT01024205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051840|NCT01024205|Growth Substances|growth substances|mesh-ancestor
93051841|NCT01024205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051842|NCT01024205|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051843|NCT01024205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051844|NCT01024205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051845|NCT01024205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051846|NCT00448019|Cyclophosphamide|cyclophosphamide|mesh-list
93051847|NCT00448019|Bevacizumab|bevacizumab|mesh-list
93051848|NCT00448019|Rituximab|rituximab|mesh-list
93051849|NCT00448019|Fludarabine|fludarabine|mesh-list
93051850|NCT00448019|Fludarabine phosphate|fludarabine phosphate|mesh-list
93051851|NCT00448019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051852|NCT00448019|Immunologic Factors|immunologic factors|mesh-ancestor
93051853|NCT00448019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051854|NCT00448019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051855|NCT00448019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93051856|NCT00448019|Alkylating Agents|alkylating agents|mesh-ancestor
93051857|NCT00448019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051858|NCT00448019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051859|NCT00448019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93051860|NCT00448019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051861|NCT00448019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051862|NCT00448019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051863|NCT00448019|Growth Substances|growth substances|mesh-ancestor
93051864|NCT00448019|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051865|NCT00448019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051866|NCT00448019|Antimetabolites|antimetabolites|mesh-ancestor
93051867|NCT00457691|Leucovorin|leucovorin|mesh-list
93051868|NCT00457691|Fluorouracil|fluorouracil|mesh-list
93051869|NCT00457691|Irinotecan|irinotecan|mesh-list
93051870|NCT00457691|Sunitinib|sunitinib|mesh-list
93051871|NCT00457691|Levoleucovorin|levoleucovorin|mesh-list
93051872|NCT00457691|Antimetabolites|antimetabolites|mesh-ancestor
93051873|NCT00457691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051874|NCT00457691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051875|NCT00457691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051876|NCT00457691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93051877|NCT00457691|Immunologic Factors|immunologic factors|mesh-ancestor
93051878|NCT00457691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051879|NCT00457691|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93051880|NCT00457691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93051881|NCT00457691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051882|NCT00457691|Antidotes|antidotes|mesh-ancestor
93051883|NCT00457691|Protective Agents|protective agents|mesh-ancestor
93051884|NCT00457691|Vitamin B Complex|vitamin b complex|mesh-ancestor
93051885|NCT00457691|Vitamins|vitamins|mesh-ancestor
93051886|NCT00457691|Micronutrients|micronutrients|mesh-ancestor
93051887|NCT00457691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93051888|NCT00457691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93051889|NCT00457691|Growth Substances|growth substances|mesh-ancestor
93051890|NCT00457691|Growth Inhibitors|growth inhibitors|mesh-ancestor
93051891|NCT00457691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051892|NCT00447005|Axitinib|axitinib|mesh-list
93051893|NCT00447005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051894|NCT00447005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93051895|NCT00447005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051896|NCT00447005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051897|NCT01565759|Lithium Carbonate|lithium carbonate|mesh-list
93051898|NCT01565759|Antidepressive Agents|antidepressive agents|mesh-ancestor
93051899|NCT01565759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051900|NCT01565759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051901|NCT01565759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051902|NCT01565759|Antimanic Agents|antimanic agents|mesh-ancestor
93051903|NCT01565759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93051904|NCT01565759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93051905|NCT01565759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051906|NCT00446849|Mesalamine|mesalamine|mesh-list
92329456|NCT00002719|Etoposide|etoposide|mesh-list
93051907|NCT00446849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93051908|NCT00446849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93051909|NCT00446849|Analgesics|analgesics|mesh-ancestor
93051910|NCT00446849|Sensory System Agents|sensory system agents|mesh-ancestor
93051911|NCT00446849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051912|NCT00446849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051913|NCT00446849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93051914|NCT00446849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93051915|NCT01565837|Ipilimumab|ipilimumab|mesh-list
93051916|NCT01565837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93051917|NCT01565837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051918|NCT01565837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93051919|NCT01565837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051920|NCT00446459|Mycophenolic Acid|mycophenolic acid|mesh-list
93051921|NCT00446459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93051922|NCT00446459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051923|NCT00446459|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93051924|NCT00446459|Antitubercular Agents|antitubercular agents|mesh-ancestor
93051925|NCT00446459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93051926|NCT00446459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93051927|NCT00446459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051928|NCT00446459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051929|NCT00456599|Gemcitabine|gemcitabine|mesh-list
93051930|NCT00456599|Oxaliplatin|oxaliplatin|mesh-list
93051931|NCT00456599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051932|NCT00456599|Antimetabolites|antimetabolites|mesh-ancestor
93051933|NCT00456599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051934|NCT00456599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051935|NCT00456521|Naltrexone|naltrexone|mesh-list
93051936|NCT00456521|Bupropion|bupropion|mesh-list
93051937|NCT00456521|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93051939|NCT00456521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051940|NCT00456521|Sensory System Agents|sensory system agents|mesh-ancestor
93051941|NCT00456521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051942|NCT00456521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93051943|NCT00456521|Antidepressive Agents|antidepressive agents|mesh-ancestor
92696926|NCT00513188|Hormones|hormones|mesh-ancestor
93051944|NCT00456521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051945|NCT00456521|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93051946|NCT00456521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93051947|NCT00456521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93051948|NCT00456521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051949|NCT00456521|Dopamine Agents|dopamine agents|mesh-ancestor
93051950|NCT00456521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051951|NCT00456521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93051952|NCT00456521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93051953|NCT00456521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051954|NCT00456365|Pravastatin|pravastatin|mesh-list
93051955|NCT00456365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93051956|NCT00456365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93051957|NCT00456365|Antimetabolites|antimetabolites|mesh-ancestor
93051958|NCT00456365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051959|NCT00456365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93051960|NCT00456365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93051961|NCT00456365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051962|NCT03843047|Nicotine|nicotine|mesh-list
93051963|NCT03843047|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92329474|NCT00002719|Analgesics|analgesics|mesh-ancestor
93051964|NCT03843047|Autonomic Agents|autonomic agents|mesh-ancestor
93051965|NCT03843047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93051966|NCT03843047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051967|NCT03843047|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93051968|NCT03843047|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93051969|NCT03843047|Cholinergic Agents|cholinergic agents|mesh-ancestor
93051970|NCT03843047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051971|NCT03843047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051972|NCT00455741|Estradiol|estradiol|mesh-list
93051973|NCT00455741|Progesterone|progesterone|mesh-list
93051974|NCT00455741|Estrogens|estrogens|mesh-ancestor
93051975|NCT00455741|Hormones|hormones|mesh-ancestor
93051976|NCT00455741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93051977|NCT00455741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051978|NCT00455741|Progestins|progestins|mesh-ancestor
93051979|NCT00445679|Paroxetine|paroxetine|mesh-list
93051980|NCT00445679|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93051981|NCT00445679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93051982|NCT00445679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93051983|NCT00445679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051984|NCT00445679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93051985|NCT00445679|Serotonin Agents|serotonin agents|mesh-ancestor
93051986|NCT00445679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93051987|NCT00445679|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93051988|NCT00445679|Antidepressive Agents|antidepressive agents|mesh-ancestor
93051989|NCT00445679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93051990|NCT00445679|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93051991|NCT00445679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93051992|NCT00445679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93051993|NCT00445601|Gemcitabine|gemcitabine|mesh-list
93051994|NCT00445601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93051995|NCT00445601|Antimetabolites|antimetabolites|mesh-ancestor
93051996|NCT00445601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93051997|NCT00445601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93051998|NCT00444587|Trastuzumab|trastuzumab|mesh-list
93051999|NCT00444587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052000|NCT00444587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052001|NCT00235716|Vitamins|vitamins|mesh-list
93052002|NCT00235716|Vitamin E|vitamin e|mesh-list
93052003|NCT00235716|Tocopherols|tocopherols|mesh-list
93052004|NCT00235716|Tocotrienols|tocotrienols|mesh-list
93052005|NCT00235716|alpha-Tocopherol|alpha-tocopherol|mesh-list
93052006|NCT00235716|Memantine|memantine|mesh-list
93052007|NCT00235716|Micronutrients|micronutrients|mesh-ancestor
93052008|NCT00235716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052010|NCT00235716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052011|NCT00235716|Protective Agents|protective agents|mesh-ancestor
93052012|NCT00235716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93052013|NCT00235716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93052014|NCT00235716|Dopamine Agents|dopamine agents|mesh-ancestor
93052015|NCT00235716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052016|NCT00235716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93052017|NCT00235716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93052018|NCT00274742|Blinatumomab|blinatumomab|mesh-list
93052019|NCT00274742|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93052020|NCT00274742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052021|NCT00274742|Immunologic Factors|immunologic factors|mesh-ancestor
93052022|NCT00274742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052023|NCT03970044|Dapagliflozin|dapagliflozin|mesh-list
93052024|NCT03970044|Exenatide|exenatide|mesh-list
93052025|NCT03970044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93052026|NCT03970044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052027|NCT03970044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93052028|NCT03970044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052029|NCT03970044|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93052030|NCT03970044|Incretins|incretins|mesh-ancestor
93052031|NCT03970044|Hormones|hormones|mesh-ancestor
93052032|NCT03970044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052033|NCT00444275|Esomeprazole|esomeprazole|mesh-list
93052034|NCT00444275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93052035|NCT00444275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052036|NCT00444275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93052037|NCT00444275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052038|NCT00444275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052039|NCT00454805|Fulvestrant|fulvestrant|mesh-list
93052040|NCT00454805|Cediranib|cediranib|mesh-list
93052041|NCT00454805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052042|NCT00454805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052043|NCT00454805|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93052044|NCT00454805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93052045|NCT00454805|Hormone Antagonists|hormone antagonists|mesh-ancestor
93052046|NCT00454805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052047|NCT00454805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052048|NCT00454805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052049|NCT00454805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052050|NCT00454805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052051|NCT00283244|Gemcitabine|gemcitabine|mesh-list
93052052|NCT00283244|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93052053|NCT00283244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93052054|NCT00283244|Antimetabolites|antimetabolites|mesh-ancestor
93052055|NCT00283244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052056|NCT00283244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052057|NCT00283244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052058|NCT00283244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052059|NCT00282464|Ziprasidone|ziprasidone|mesh-list
93052060|NCT00282464|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93052061|NCT00282464|Serotonin Agents|serotonin agents|mesh-ancestor
93052062|NCT00282464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052063|NCT00282464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052064|NCT00282464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052065|NCT00282464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93052066|NCT00282464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052067|NCT00282464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052068|NCT00282464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052069|NCT00282464|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93052070|NCT00282464|Dopamine Agents|dopamine agents|mesh-ancestor
93052071|NCT03841331|Serlopitant|serlopitant|mesh-list
93052072|NCT03841331|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93052073|NCT03841331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052074|NCT03841331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052075|NCT03841331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052076|NCT00262080|Ecallantide|ecallantide|mesh-list
93052077|NCT00262080|Analgesics|analgesics|mesh-ancestor
93052078|NCT00262080|Sensory System Agents|sensory system agents|mesh-ancestor
93052079|NCT00262080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052080|NCT00262080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529443|NCT00015951|Bevacizumab|bevacizumab|mesh-list
93052081|NCT00262080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93052082|NCT00262080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052083|NCT00262080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052084|NCT00262080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052085|NCT01073904|Levonorgestrel|levonorgestrel|mesh-list
93052086|NCT01073904|Norgestrel|norgestrel|mesh-list
93052087|NCT01073904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93052088|NCT01073904|Contraceptive Agents|contraceptive agents|mesh-ancestor
93052089|NCT01073904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052090|NCT01073904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697106|NCT00512408|Hormones|hormones|mesh-ancestor
93052091|NCT01073904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93052092|NCT01073904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93052093|NCT01073904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93052094|NCT01073904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93052095|NCT00282308|Rituximab|rituximab|mesh-list
93052096|NCT00282308|Methotrexate|methotrexate|mesh-list
93052097|NCT00282308|Vaccines|vaccines|mesh-list
93052098|NCT00282308|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93052099|NCT00282308|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93052100|NCT00282308|Immunologic Factors|immunologic factors|mesh-ancestor
93052101|NCT00282308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052102|NCT00282308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052103|NCT00282308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052104|NCT00282308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052105|NCT00282308|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93052106|NCT00282308|Abortifacient Agents|abortifacient agents|mesh-ancestor
93052107|NCT00282308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052108|NCT00282308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93052109|NCT00282308|Antimetabolites|antimetabolites|mesh-ancestor
93052110|NCT00282308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052111|NCT00282308|Dermatologic Agents|dermatologic agents|mesh-ancestor
93052112|NCT00282308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052113|NCT00282308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93052114|NCT00282308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052115|NCT00282308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93052116|NCT00282308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93052117|NCT00281840|Bevacizumab|bevacizumab|mesh-list
93052118|NCT00281840|Docetaxel|docetaxel|mesh-list
93052119|NCT00281840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052120|NCT00281840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052121|NCT00281840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052122|NCT00281840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052123|NCT00281840|Growth Substances|growth substances|mesh-ancestor
93052124|NCT00281840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052125|NCT00281840|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052126|NCT00281840|Tubulin Modulators|tubulin modulators|mesh-ancestor
93052127|NCT00281840|Antimitotic Agents|antimitotic agents|mesh-ancestor
93052128|NCT00281840|Mitosis Modulators|mitosis modulators|mesh-ancestor
93052129|NCT00281840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052130|NCT00272792|Verapamil|verapamil|mesh-list
93052131|NCT00272792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93052132|NCT00272792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93052133|NCT00272792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052134|NCT00272792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052135|NCT00272792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93052136|NCT00272792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052137|NCT00272792|Vasodilator Agents|vasodilator agents|mesh-ancestor
93052138|NCT01069094|Leuprolide|leuprolide|mesh-list
93052139|NCT01069094|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93052140|NCT01069094|Fertility Agents|fertility agents|mesh-ancestor
93052141|NCT01069094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329513|NCT04609423|Vitamin D|vitamin d|mesh-list
93052142|NCT01069094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052143|NCT01069094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052144|NCT01069094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052145|NCT00048568|Methotrexate|methotrexate|mesh-list
93052146|NCT00048568|Abatacept|abatacept|mesh-list
93052147|NCT00048568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93052148|NCT00048568|Abortifacient Agents|abortifacient agents|mesh-ancestor
93052149|NCT00048568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052150|NCT00048568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052151|NCT00048568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93052152|NCT00048568|Antimetabolites|antimetabolites|mesh-ancestor
93052153|NCT00048568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052154|NCT00048568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052155|NCT00048568|Dermatologic Agents|dermatologic agents|mesh-ancestor
93052156|NCT00048568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052157|NCT00048568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93052158|NCT00048568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052159|NCT00048568|Immunologic Factors|immunologic factors|mesh-ancestor
93052160|NCT00048568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052161|NCT00048568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93052162|NCT00048568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93052163|NCT00048568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052164|NCT00262002|Vaccines|vaccines|mesh-list
93052165|NCT00262002|Immunologic Factors|immunologic factors|mesh-ancestor
93052166|NCT00262002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052167|NCT01584076|Donepezil|donepezil|mesh-list
93052168|NCT01584076|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93052169|NCT01584076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052170|NCT01584076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052171|NCT01584076|Cholinergic Agents|cholinergic agents|mesh-ancestor
93052172|NCT01584076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052173|NCT01584076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052174|NCT01584076|Nootropic Agents|nootropic agents|mesh-ancestor
93052175|NCT03954964|Analgesics, Opioid|analgesics, opioid|mesh-list
93052176|NCT03954964|Narcotics|narcotics|mesh-ancestor
93052177|NCT03954964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052178|NCT03954964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052179|NCT03954964|Analgesics|analgesics|mesh-ancestor
93052180|NCT03954964|Sensory System Agents|sensory system agents|mesh-ancestor
93052181|NCT03954964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052182|NCT00281528|Paclitaxel|paclitaxel|mesh-list
93052183|NCT00281528|Bevacizumab|bevacizumab|mesh-list
93052184|NCT00281528|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93052185|NCT00281528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93052186|NCT00281528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052187|NCT00281528|Tubulin Modulators|tubulin modulators|mesh-ancestor
93052188|NCT00281528|Antimitotic Agents|antimitotic agents|mesh-ancestor
93052189|NCT00281528|Mitosis Modulators|mitosis modulators|mesh-ancestor
93052190|NCT00281528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052191|NCT00281528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052192|NCT00281528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052193|NCT00281528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052194|NCT00281528|Growth Substances|growth substances|mesh-ancestor
93052195|NCT00281528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052196|NCT00281528|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052197|NCT01095640|Adapalene|adapalene|mesh-list
93052198|NCT01095640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93052199|NCT01095640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052200|NCT01095640|Analgesics|analgesics|mesh-ancestor
93052201|NCT01095640|Sensory System Agents|sensory system agents|mesh-ancestor
93052202|NCT01095640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052203|NCT01095640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052204|NCT01095640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052205|NCT01095640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052206|NCT01095640|Dermatologic Agents|dermatologic agents|mesh-ancestor
93052207|NCT00280748|Pemetrexed|pemetrexed|mesh-list
93052208|NCT00280748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052209|NCT00280748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052210|NCT00280748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052211|NCT00280748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93052212|NCT00280748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93052213|NCT03975374|Tobramycin|tobramycin|mesh-list
93052214|NCT03975374|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93052215|NCT03975374|Dexamethasone|dexamethasone|mesh-list
93052216|NCT03975374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93052217|NCT03975374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052218|NCT03975374|Antiemetics|antiemetics|mesh-ancestor
93052219|NCT03975374|Autonomic Agents|autonomic agents|mesh-ancestor
93052220|NCT03975374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052221|NCT03975374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052222|NCT03975374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052223|NCT03975374|Glucocorticoids|glucocorticoids|mesh-ancestor
93052224|NCT03975374|Hormones|hormones|mesh-ancestor
93052225|NCT03975374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052226|NCT03975374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052227|NCT03975374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052228|NCT03975374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052229|NCT03975374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052230|NCT03975374|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93052231|NCT00061048|Alemtuzumab|alemtuzumab|mesh-list
93052232|NCT00061048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052233|NCT00061048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052234|NCT01581398|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93052235|NCT01581398|Interferon-alpha|interferon-alpha|mesh-list
93052236|NCT01581398|Antiviral Agents|antiviral agents|mesh-ancestor
93052237|NCT01581398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052238|NCT01581398|Immunologic Factors|immunologic factors|mesh-ancestor
93052239|NCT01581398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052240|NCT03976544|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93052241|NCT03976544|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93052243|NCT03976544|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93052244|NCT03976544|Progesterone|progesterone|mesh-list
93052245|NCT03976544|Estrogens|estrogens|mesh-ancestor
93052246|NCT03976544|Hormones|hormones|mesh-ancestor
93052247|NCT03976544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052248|NCT03976544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052249|NCT03976544|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93052250|NCT03976544|Contraceptive Agents|contraceptive agents|mesh-ancestor
93052251|NCT03976544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052252|NCT03976544|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93052253|NCT03976544|Progestins|progestins|mesh-ancestor
93052254|NCT03741686|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93052255|NCT03741686|Cathartics|cathartics|mesh-ancestor
93052256|NCT03741686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052257|NCT00279812|Selenium|selenium|mesh-list
93052258|NCT00279812|Antioxidants|antioxidants|mesh-ancestor
93052259|NCT00279812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052260|NCT00279812|Protective Agents|protective agents|mesh-ancestor
93052261|NCT00279812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052262|NCT00279812|Trace Elements|trace elements|mesh-ancestor
93052263|NCT00279812|Micronutrients|micronutrients|mesh-ancestor
93052264|NCT01070732|Acetaminophen|acetaminophen|mesh-list
93052265|NCT01070732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052266|NCT01070732|Analgesics|analgesics|mesh-ancestor
93052267|NCT01070732|Sensory System Agents|sensory system agents|mesh-ancestor
93052268|NCT01070732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052269|NCT01070732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052270|NCT01070732|Antipyretics|antipyretics|mesh-ancestor
93052271|NCT00207714|Infliximab|infliximab|mesh-list
93052272|NCT00207714|Golimumab|golimumab|mesh-list
93052273|NCT00207714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93052274|NCT00207714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052275|NCT00207714|Dermatologic Agents|dermatologic agents|mesh-ancestor
93052276|NCT00207714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052277|NCT00207714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052278|NCT00207714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052279|NCT00207714|Immunologic Factors|immunologic factors|mesh-ancestor
93052280|NCT00207714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052281|NCT00207090|Rifampin|rifampin|mesh-list
93052282|NCT00207090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93052283|NCT00207090|Antitubercular Agents|antitubercular agents|mesh-ancestor
93052284|NCT00207090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052285|NCT00207090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052286|NCT00207090|Leprostatic Agents|leprostatic agents|mesh-ancestor
93052287|NCT00207090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93052288|NCT00207090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052289|NCT00207090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052290|NCT00207090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93052291|NCT00207090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93052292|NCT00207090|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93052293|NCT00207090|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93052294|NCT00207090|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93052295|NCT00207090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93052296|NCT00059332|Magnesium Sulfate|magnesium sulfate|mesh-list
93052297|NCT00059332|Analgesics|analgesics|mesh-ancestor
93052298|NCT00059332|Sensory System Agents|sensory system agents|mesh-ancestor
93052299|NCT00059332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052300|NCT00059332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052301|NCT00059332|Anesthetics|anesthetics|mesh-ancestor
93052302|NCT00059332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052304|NCT00059332|Anticonvulsants|anticonvulsants|mesh-ancestor
93052305|NCT00059332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93052306|NCT00059332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052307|NCT00059332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052308|NCT00059332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93052309|NCT00059332|Tocolytic Agents|tocolytic agents|mesh-ancestor
93052310|NCT00059332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052311|NCT00233454|Midostaurin|midostaurin|mesh-list
93052312|NCT00233454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052313|NCT00233454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052314|NCT00233454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052315|NCT00233454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052316|NCT00047320|Carboplatin|carboplatin|mesh-list
93052317|NCT00047320|Etoposide|etoposide|mesh-list
93052318|NCT00047320|Ifosfamide|ifosfamide|mesh-list
93052319|NCT00047320|Isophosphamide mustard|isophosphamide mustard|mesh-list
93052320|NCT00047320|Thiotepa|thiotepa|mesh-list
93052321|NCT00047320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052322|NCT00047320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329572|NCT00003344|Irinotecan|irinotecan|mesh-list
93052323|NCT00047320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93052324|NCT00047320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93052325|NCT00047320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052326|NCT00047320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052327|NCT00047320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93052328|NCT00047320|Alkylating Agents|alkylating agents|mesh-ancestor
93052329|NCT00047320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93052330|NCT00047320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052331|NCT00047320|Immunologic Factors|immunologic factors|mesh-ancestor
93052332|NCT00047320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052333|NCT00233064|Palivizumab|palivizumab|mesh-list
93052334|NCT00233064|Antiviral Agents|antiviral agents|mesh-ancestor
93052335|NCT00233064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052336|NCT03973086|Cardiac Glycosides|cardiac glycosides|mesh-list
93052337|NCT03973086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93052338|NCT03973086|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93052339|NCT03973086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052340|NCT03973086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052341|NCT03973086|Protective Agents|protective agents|mesh-ancestor
93052342|NCT03973086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052343|NCT00206076|Mycophenolic Acid|mycophenolic acid|mesh-list
93052344|NCT00206076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93052345|NCT00206076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052346|NCT00206076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93052347|NCT00206076|Antitubercular Agents|antitubercular agents|mesh-ancestor
93052348|NCT00206076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052349|NCT00206076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052350|NCT00206076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052351|NCT00206076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052352|NCT00278954|Immunoglobulins|immunoglobulins|mesh-list
93052353|NCT00278954|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93052354|NCT00278954|Antibodies|antibodies|mesh-list
93052355|NCT00278954|gamma-Globulins|gamma-globulins|mesh-list
93052356|NCT00278954|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93052357|NCT00278954|Immunologic Factors|immunologic factors|mesh-ancestor
93052358|NCT00278954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052359|NCT00278564|Methylprednisolone|methylprednisolone|mesh-list
93052360|NCT00278564|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93052361|NCT00278564|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93052362|NCT00278564|Prednisolone|prednisolone|mesh-list
93052363|NCT00278564|Prednisolone acetate|prednisolone acetate|mesh-list
93052364|NCT00278564|Cyclophosphamide|cyclophosphamide|mesh-list
93052365|NCT00278564|Rituximab|rituximab|mesh-list
93052366|NCT00278564|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93052367|NCT00278564|Prednisolone phosphate|prednisolone phosphate|mesh-list
93052368|NCT00278564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052369|NCT00278564|Immunologic Factors|immunologic factors|mesh-ancestor
93052370|NCT00278564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052371|NCT00278564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052372|NCT00278564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93052373|NCT00278564|Alkylating Agents|alkylating agents|mesh-ancestor
93052374|NCT00278564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052375|NCT00278564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052376|NCT00278564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93052377|NCT00278564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052378|NCT00278564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052379|NCT00278564|Antiemetics|antiemetics|mesh-ancestor
93052380|NCT00278564|Autonomic Agents|autonomic agents|mesh-ancestor
93052381|NCT00278564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052382|NCT00278564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052383|NCT00278564|Glucocorticoids|glucocorticoids|mesh-ancestor
93052384|NCT00278564|Hormones|hormones|mesh-ancestor
93052385|NCT00278564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052386|NCT00278564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93052387|NCT00278564|Protective Agents|protective agents|mesh-ancestor
93052388|NCT00278564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060700|NCT01281514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052389|NCT01071564|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93052390|NCT01071564|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93052391|NCT01071564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052392|NCT01071564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052393|NCT00268346|Gefitinib|gefitinib|mesh-list
93052394|NCT00268346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052395|NCT00268346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052396|NCT00268346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052397|NCT00268346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052398|NCT00250718|Levofloxacin|levofloxacin|mesh-list
93052399|NCT00250718|Ofloxacin|ofloxacin|mesh-list
93052400|NCT00250718|Dexamethasone|dexamethasone|mesh-list
93052401|NCT00250718|Rituximab|rituximab|mesh-list
93052402|NCT00250718|Etoposide|etoposide|mesh-list
93052403|NCT00250718|Vincristine|vincristine|mesh-list
93052404|NCT00250718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052405|NCT00250718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052406|NCT00250718|Immunologic Factors|immunologic factors|mesh-ancestor
93052407|NCT00250718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052408|NCT00250718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052409|NCT00250718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052410|NCT00250718|Antiemetics|antiemetics|mesh-ancestor
93052411|NCT00250718|Autonomic Agents|autonomic agents|mesh-ancestor
93052412|NCT00250718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052413|NCT00250718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052414|NCT00250718|Glucocorticoids|glucocorticoids|mesh-ancestor
93052415|NCT00250718|Hormones|hormones|mesh-ancestor
93052416|NCT00250718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052417|NCT00250718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052418|NCT00250718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93052419|NCT00250718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93052420|NCT00250718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93052421|NCT00250718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052422|NCT00250718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052423|NCT00250718|Tubulin Modulators|tubulin modulators|mesh-ancestor
93052424|NCT00250718|Antimitotic Agents|antimitotic agents|mesh-ancestor
93052425|NCT00250718|Mitosis Modulators|mitosis modulators|mesh-ancestor
93052426|NCT00250718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93052427|NCT00250718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052428|NCT00250718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92494486|NCT01975688|Analgesics|analgesics|mesh-ancestor
93052429|NCT00250718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93052430|NCT00250718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93052431|NCT00276614|Bortezomib|bortezomib|mesh-list
93052432|NCT00276614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052433|NCT00276458|Atorvastatin|atorvastatin|mesh-list
93052434|NCT00276458|Ezetimibe|ezetimibe|mesh-list
93052435|NCT00276458|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93052436|NCT00276458|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93052437|NCT00276458|Antimetabolites|antimetabolites|mesh-ancestor
93052438|NCT00276458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052439|NCT00276458|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93052440|NCT00276458|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93052441|NCT00276458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052442|NCT00276380|Aspirin|aspirin|mesh-list
93052443|NCT00276380|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93052444|NCT00276380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052445|NCT00276380|Analgesics|analgesics|mesh-ancestor
93052446|NCT00276380|Sensory System Agents|sensory system agents|mesh-ancestor
93052447|NCT00276380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052448|NCT00276380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052449|NCT00276380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052450|NCT00276380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052451|NCT00276380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93052452|NCT00276380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93052453|NCT00276380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052454|NCT00276380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93052455|NCT00276380|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93052456|NCT00276380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052457|NCT00276380|Antipyretics|antipyretics|mesh-ancestor
93052458|NCT02531984|Azithromycin|azithromycin|mesh-list
93052459|NCT02531984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052460|NCT02531984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052461|NCT00267956|Ustekinumab|ustekinumab|mesh-list
93052462|NCT00267956|Dermatologic Agents|dermatologic agents|mesh-ancestor
93052464|NCT00267488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93052465|NCT00267488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93052466|NCT00267488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052467|NCT00267488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052468|NCT00267488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052469|NCT01073696|Granisetron|granisetron|mesh-list
93052470|NCT01073696|Antiemetics|antiemetics|mesh-ancestor
93052471|NCT01073696|Autonomic Agents|autonomic agents|mesh-ancestor
93052472|NCT01073696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052473|NCT01073696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052474|NCT01073696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052475|NCT01073696|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93052476|NCT01073696|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93052477|NCT01073696|Serotonin Agents|serotonin agents|mesh-ancestor
93052478|NCT01073696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052479|NCT01073696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052480|NCT00058552|Pertuzumab|pertuzumab|mesh-list
93052481|NCT00058552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052482|NCT00058552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052483|NCT01093768|Vasopressins|vasopressins|mesh-list
93052484|NCT01093768|Arginine Vasopressin|arginine vasopressin|mesh-list
93052485|NCT01093768|Oxytocin|oxytocin|mesh-list
93052486|NCT01093768|Oxytocics|oxytocics|mesh-ancestor
93052487|NCT01093768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052488|NCT01093768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052489|NCT01093768|Hemostatics|hemostatics|mesh-ancestor
93052490|NCT01093768|Coagulants|coagulants|mesh-ancestor
93052491|NCT01093768|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93052492|NCT01093768|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93052493|NCT01093768|Natriuretic Agents|natriuretic agents|mesh-ancestor
93052494|NCT00044512|Sorafenib|sorafenib|mesh-list
93052495|NCT00044512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052496|NCT00044512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052497|NCT00044512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052498|NCT00044512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052499|NCT03805438|Chloroprocaine|chloroprocaine|mesh-list
93052500|NCT03805438|Anesthetics, Local|anesthetics, local|mesh-ancestor
93052501|NCT03805438|Anesthetics|anesthetics|mesh-ancestor
93052502|NCT03805438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052503|NCT03805438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052504|NCT03805438|Sensory System Agents|sensory system agents|mesh-ancestor
93052505|NCT03805438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052506|NCT01096420|Topiramate|topiramate|mesh-list
93052507|NCT01096420|Anticonvulsants|anticonvulsants|mesh-ancestor
93052508|NCT01096420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93052509|NCT01096420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052510|NCT03953716|Desogestrel|desogestrel|mesh-list
93052511|NCT03953716|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93052512|NCT03953716|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93052513|NCT03953716|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93052514|NCT03953716|Contraceptive Agents|contraceptive agents|mesh-ancestor
93052515|NCT03953716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052516|NCT03953716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052517|NCT03953716|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93052518|NCT03953716|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93052519|NCT03953716|Progestins|progestins|mesh-ancestor
93052520|NCT03953716|Hormones|hormones|mesh-ancestor
92529449|NCT00015951|Growth Substances|growth substances|mesh-ancestor
93052521|NCT03953716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052523|NCT01096498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93052524|NCT01096498|Contraceptive Agents|contraceptive agents|mesh-ancestor
93052525|NCT01096498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052526|NCT01096498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052527|NCT01096498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93052528|NCT01096498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93052529|NCT01096498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93052530|NCT00147537|Paclitaxel|paclitaxel|mesh-list
93052531|NCT00147537|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93052532|NCT00147537|Carboplatin|carboplatin|mesh-list
93052533|NCT00147537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93052534|NCT00147537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93052535|NCT00147537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93052536|NCT00147537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052537|NCT00147537|Tubulin Modulators|tubulin modulators|mesh-ancestor
93052538|NCT00147537|Antimitotic Agents|antimitotic agents|mesh-ancestor
93052539|NCT00147537|Mitosis Modulators|mitosis modulators|mesh-ancestor
93052540|NCT00147537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052541|NCT00147537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052542|NCT00147537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052543|NCT00147537|Immunologic Factors|immunologic factors|mesh-ancestor
93052544|NCT00147537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052545|NCT00222729|Bevacizumab|bevacizumab|mesh-list
93052546|NCT00222729|Pemetrexed|pemetrexed|mesh-list
93052547|NCT00222729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052548|NCT00222729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052549|NCT00222729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052550|NCT00222729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052551|NCT00222729|Growth Substances|growth substances|mesh-ancestor
93052552|NCT00222729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052553|NCT00222729|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052554|NCT00222729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052555|NCT00222729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052556|NCT00222729|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93052557|NCT00222729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93052558|NCT00147225|Carboplatin|carboplatin|mesh-list
93052559|NCT00147225|Doxorubicin|doxorubicin|mesh-list
93052560|NCT00147225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93052561|NCT00147225|Ifosfamide|ifosfamide|mesh-list
93052562|NCT00147225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052563|NCT00147225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93052564|NCT00147225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93052565|NCT00147225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93052566|NCT00147225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052567|NCT00147225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052568|NCT00147225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93052569|NCT00147225|Alkylating Agents|alkylating agents|mesh-ancestor
93052570|NCT00222105|Thalidomide|thalidomide|mesh-list
93052571|NCT00222105|Dexamethasone|dexamethasone|mesh-list
93052572|NCT00222105|Doxorubicin|doxorubicin|mesh-list
93052573|NCT00222105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93052574|NCT00222105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052575|NCT00222105|Antiemetics|antiemetics|mesh-ancestor
93052576|NCT00222105|Autonomic Agents|autonomic agents|mesh-ancestor
93052577|NCT00222105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052578|NCT00222105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052579|NCT00222105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052580|NCT00222105|Glucocorticoids|glucocorticoids|mesh-ancestor
93052581|NCT00222105|Hormones|hormones|mesh-ancestor
93052582|NCT00222105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052583|NCT00222105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052584|NCT00222105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052585|NCT00222105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93052586|NCT00222105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93052587|NCT00222105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93052588|NCT00222105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052589|NCT00222105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052590|NCT00222105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052591|NCT00222105|Immunologic Factors|immunologic factors|mesh-ancestor
93052592|NCT00222105|Leprostatic Agents|leprostatic agents|mesh-ancestor
93052593|NCT00222105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052594|NCT00222105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052595|NCT00222105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052596|NCT00222105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052597|NCT00222105|Growth Substances|growth substances|mesh-ancestor
93052598|NCT00222105|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052599|NCT00247676|Sunitinib|sunitinib|mesh-list
93052600|NCT00247676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052601|NCT00247676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052602|NCT00247676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052603|NCT00247676|Growth Substances|growth substances|mesh-ancestor
93052604|NCT00247676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052605|NCT00247676|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052606|NCT00247676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052607|NCT00247676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052608|NCT00247676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052609|NCT00267020|Gemcitabine|gemcitabine|mesh-list
93052610|NCT00267020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93052611|NCT00267020|Antimetabolites|antimetabolites|mesh-ancestor
93052612|NCT00267020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052613|NCT00267020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052614|NCT03975062|Dabigatran|dabigatran|mesh-list
93052615|NCT03975062|Antithrombins|antithrombins|mesh-ancestor
93052616|NCT03975062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93052617|NCT03975062|Protease Inhibitors|protease inhibitors|mesh-ancestor
93052618|NCT03975062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052619|NCT03975062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052620|NCT03975062|Anticoagulants|anticoagulants|mesh-ancestor
93052621|NCT03970772|Glucagon|glucagon|mesh-list
93052622|NCT03970772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052623|NCT03970772|Hormones|hormones|mesh-ancestor
93052624|NCT03970772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052625|NCT03970772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052626|NCT00242216|Ritonavir|ritonavir|mesh-list
93052627|NCT00242216|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93052628|NCT00242216|Fosamprenavir|fosamprenavir|mesh-list
93052629|NCT00242216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93052630|NCT00242216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93052631|NCT00242216|Protease Inhibitors|protease inhibitors|mesh-ancestor
93052632|NCT00242216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052633|NCT00242216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052634|NCT00242216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93052635|NCT00242216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93052636|NCT00242216|Antiviral Agents|antiviral agents|mesh-ancestor
93052637|NCT00242216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052638|NCT00242216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93052639|NCT00242216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93052640|NCT00240110|Valproic Acid|valproic acid|mesh-list
93052641|NCT00240110|Lithium Carbonate|lithium carbonate|mesh-list
93052642|NCT00240110|Antidepressive Agents|antidepressive agents|mesh-ancestor
93052643|NCT00240110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052644|NCT00240110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052645|NCT00240110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052646|NCT00240110|Antimanic Agents|antimanic agents|mesh-ancestor
93052647|NCT00240110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052648|NCT00240110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052649|NCT00240110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052650|NCT00240110|Anticonvulsants|anticonvulsants|mesh-ancestor
93052651|NCT00240110|GABA Agents|gaba agents|mesh-ancestor
93052652|NCT00240110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052653|NCT00239720|Muromonab-CD3|muromonab-cd3|mesh-list
93052654|NCT00239720|Immunologic Factors|immunologic factors|mesh-ancestor
93052655|NCT00239720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052656|NCT00239720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052657|NCT02532140|Cefepime|cefepime|mesh-list
93052658|NCT02532140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052659|NCT02532140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052660|NCT00266864|Methyltestosterone|methyltestosterone|mesh-list
93052661|NCT00266864|Testosterone|testosterone|mesh-list
93052662|NCT00266864|Testosterone undecanoate|testosterone undecanoate|mesh-list
93052663|NCT00266864|Testosterone enanthate|testosterone enanthate|mesh-list
93052664|NCT00266864|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93052665|NCT00266864|Androgens|androgens|mesh-ancestor
93052666|NCT00266864|Hormones|hormones|mesh-ancestor
93052667|NCT00266864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052668|NCT00266864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052669|NCT00266864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052670|NCT00266864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052671|NCT00266864|Anabolic Agents|anabolic agents|mesh-ancestor
93052672|NCT00266708|Risedronic Acid|risedronic acid|mesh-list
93052674|NCT00266708|Diphosphonates|diphosphonates|mesh-list
93052675|NCT00266708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93052676|NCT00266708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052677|NCT00266708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052678|NCT00266708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93052679|NCT00266708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052680|NCT00266708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93052681|NCT00266630|Carbamazepine|carbamazepine|mesh-list
93052682|NCT00266630|Valproic Acid|valproic acid|mesh-list
93052683|NCT00266630|Olanzapine|olanzapine|mesh-list
93052684|NCT00266630|Antiemetics|antiemetics|mesh-ancestor
93052685|NCT00266630|Autonomic Agents|autonomic agents|mesh-ancestor
93052686|NCT00266630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052687|NCT00266630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052688|NCT00266630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052689|NCT00266630|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93052690|NCT00266630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052691|NCT00266630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052692|NCT00266630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052693|NCT00266630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93052694|NCT00266630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93052695|NCT00266630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052696|NCT00266630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052697|NCT00266630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052698|NCT00266630|Serotonin Agents|serotonin agents|mesh-ancestor
93052699|NCT00266630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052700|NCT00266630|Antimanic Agents|antimanic agents|mesh-ancestor
93052701|NCT00266630|Anticonvulsants|anticonvulsants|mesh-ancestor
93052702|NCT00266630|GABA Agents|gaba agents|mesh-ancestor
93052703|NCT00266630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052704|NCT00266630|Analgesics|analgesics|mesh-ancestor
93052705|NCT00266630|Sensory System Agents|sensory system agents|mesh-ancestor
93052706|NCT00266630|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93052707|NCT00266630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93052708|NCT00266630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93052709|NCT02531672|Choline|choline|mesh-list
93052710|NCT02531672|Lipotropic Agents|lipotropic agents|mesh-ancestor
93052711|NCT02531672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93052712|NCT02531672|Antimetabolites|antimetabolites|mesh-ancestor
93052713|NCT02531672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052714|NCT02531672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93052715|NCT02531672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93052716|NCT02531672|Nootropic Agents|nootropic agents|mesh-ancestor
93052717|NCT00129129|Vaccines|vaccines|mesh-list
93052718|NCT00129129|Immunologic Factors|immunologic factors|mesh-ancestor
93052719|NCT00129129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052720|NCT00221403|Valproic Acid|valproic acid|mesh-list
93052721|NCT00221403|Risperidone|risperidone|mesh-list
93052722|NCT00221403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93052723|NCT00221403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93052724|NCT00221403|Serotonin Agents|serotonin agents|mesh-ancestor
93052725|NCT00221403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052726|NCT00221403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052727|NCT00221403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052728|NCT00221403|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93052729|NCT00221403|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052730|NCT00221403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052731|NCT00221403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052732|NCT00221403|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93052733|NCT00221403|Dopamine Agents|dopamine agents|mesh-ancestor
93052734|NCT00221403|Anticonvulsants|anticonvulsants|mesh-ancestor
93052735|NCT00221403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052736|NCT00221403|GABA Agents|gaba agents|mesh-ancestor
93052737|NCT00221403|Antimanic Agents|antimanic agents|mesh-ancestor
93052738|NCT00145977|Vitamin D|vitamin d|mesh-list
93052739|NCT00145977|Alendronate|alendronate|mesh-list
93052740|NCT00145977|Calcium|calcium|mesh-list
93052741|NCT00145977|Vitamins|vitamins|mesh-ancestor
93052742|NCT00145977|Micronutrients|micronutrients|mesh-ancestor
93052743|NCT00145977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529453|NCT00015951|Antimetabolites|antimetabolites|mesh-ancestor
93052744|NCT00145977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93052745|NCT00145977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93052746|NCT00238238|Rituximab|rituximab|mesh-list
93052747|NCT00238238|Lenalidomide|lenalidomide|mesh-list
93052748|NCT00238238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052749|NCT00238238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052750|NCT00238238|Immunologic Factors|immunologic factors|mesh-ancestor
93052751|NCT00238238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052752|NCT00238238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052753|NCT00238238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052754|NCT00238238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052755|NCT00238238|Growth Substances|growth substances|mesh-ancestor
93052756|NCT00238238|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052757|NCT01073852|Hydroxychloroquine|hydroxychloroquine|mesh-list
93052758|NCT01073852|Antimalarials|antimalarials|mesh-ancestor
93052759|NCT01073852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93052760|NCT01073852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93052761|NCT01073852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052762|NCT01073852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052763|NCT01073852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052764|NCT01073852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052765|NCT01071122|Valsartan|valsartan|mesh-list
93052766|NCT01071122|Nifedipine|nifedipine|mesh-list
93052767|NCT01071122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93052768|NCT01071122|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93052769|NCT01071122|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93052770|NCT01071122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052771|NCT01071122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93052772|NCT01071122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052773|NCT01071122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93052774|NCT01071122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052775|NCT01071122|Vasodilator Agents|vasodilator agents|mesh-ancestor
93052776|NCT01071122|Tocolytic Agents|tocolytic agents|mesh-ancestor
93052777|NCT01071122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93052778|NCT01072604|Aspirin|aspirin|mesh-list
93052779|NCT01072604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93052780|NCT01072604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052781|NCT01072604|Analgesics|analgesics|mesh-ancestor
93052782|NCT01072604|Sensory System Agents|sensory system agents|mesh-ancestor
93052783|NCT01072604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052784|NCT01072604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052785|NCT01072604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052786|NCT01072604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93052787|NCT01072604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93052788|NCT01072604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93052789|NCT01072604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052790|NCT01072604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93052791|NCT01072604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93052792|NCT01072604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052793|NCT01072604|Antipyretics|antipyretics|mesh-ancestor
93052794|NCT00128661|Vaccines|vaccines|mesh-list
93052795|NCT00128661|Immunologic Factors|immunologic factors|mesh-ancestor
93052796|NCT00128661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052797|NCT00145509|Asenapine|asenapine|mesh-list
93052798|NCT00145509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93052799|NCT00145509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052800|NCT00145509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052801|NCT00145509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052802|NCT00145509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052803|NCT03965871|Esketamine|esketamine|mesh-list
93052804|NCT03965871|Antidepressive Agents|antidepressive agents|mesh-ancestor
93052805|NCT03965871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052806|NCT03965949|Hormones|hormones|mesh-list
93052807|NCT03965949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052808|NCT03965949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052809|NCT00220779|Immunoglobulins|immunoglobulins|mesh-list
93052810|NCT00220779|Antibodies|antibodies|mesh-list
93052811|NCT00220779|gamma-Globulins|gamma-globulins|mesh-list
93052812|NCT00220779|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93052813|NCT00220779|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93052814|NCT00220779|Immunoglobulin G|immunoglobulin g|mesh-list
93052815|NCT00220779|Immunologic Factors|immunologic factors|mesh-ancestor
93052816|NCT00220779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052817|NCT00207740|Golimumab|golimumab|mesh-list
93052818|NCT00207740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93052819|NCT00207740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329670|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
93052820|NCT00207740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052821|NCT00207740|Immunologic Factors|immunologic factors|mesh-ancestor
93052822|NCT00207740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052823|NCT00265382|Ziprasidone|ziprasidone|mesh-list
93052824|NCT00265382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93052825|NCT00265382|Serotonin Agents|serotonin agents|mesh-ancestor
93052826|NCT00265382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052827|NCT00265382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052828|NCT00265382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052829|NCT00265382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93052830|NCT00265382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052831|NCT00265382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052832|NCT00265382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052833|NCT00265382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93052834|NCT00265382|Dopamine Agents|dopamine agents|mesh-ancestor
93052835|NCT03974984|Anesthetics|anesthetics|mesh-list
93052836|NCT03974984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052837|NCT03974984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052838|NCT00206726|Fludarabine|fludarabine|mesh-list
93052839|NCT00206726|Alemtuzumab|alemtuzumab|mesh-list
93052840|NCT00206726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052841|NCT00206726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052842|NCT00237458|Lacosamide|lacosamide|mesh-list
93052843|NCT00237458|Anticonvulsants|anticonvulsants|mesh-ancestor
93052844|NCT00237458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93052845|NCT00237458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93052846|NCT00237458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052847|NCT00237458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052848|NCT01581788|Valproic Acid|valproic acid|mesh-list
93052849|NCT01581788|Anticonvulsants|anticonvulsants|mesh-ancestor
93052850|NCT01581788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052851|NCT01581788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052852|NCT01581788|GABA Agents|gaba agents|mesh-ancestor
93052853|NCT01581788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052854|NCT01581788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052855|NCT01581788|Antimanic Agents|antimanic agents|mesh-ancestor
93052856|NCT01581788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052857|NCT01581788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052858|NCT01581788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052859|NCT00265148|Rosiglitazone|rosiglitazone|mesh-list
93052860|NCT00265148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93052861|NCT00265148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052862|NCT00043186|Denosumab|denosumab|mesh-list
93052863|NCT00043186|Alendronate|alendronate|mesh-list
93052864|NCT00043186|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93052865|NCT00043186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052866|NCT00041470|Paclitaxel|paclitaxel|mesh-list
93052867|NCT00041470|Vinorelbine|vinorelbine|mesh-list
93052868|NCT00041470|Trastuzumab|trastuzumab|mesh-list
93052869|NCT00041470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93052870|NCT00041470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052871|NCT00041470|Tubulin Modulators|tubulin modulators|mesh-ancestor
93052872|NCT00041470|Antimitotic Agents|antimitotic agents|mesh-ancestor
93052873|NCT00041470|Mitosis Modulators|mitosis modulators|mesh-ancestor
93052874|NCT00041470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052875|NCT00041470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93052876|NCT03953950|Losartan|losartan|mesh-list
93052877|NCT03953950|Spironolactone|spironolactone|mesh-list
93052878|NCT03953950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93052879|NCT03953950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93052880|NCT03953950|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93052881|NCT03953950|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93052882|NCT03953950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052883|NCT03953950|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93052884|NCT03953950|Hormone Antagonists|hormone antagonists|mesh-ancestor
93052885|NCT03953950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052886|NCT03953950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052887|NCT03953950|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93052888|NCT03953950|Diuretics|diuretics|mesh-ancestor
93052889|NCT03953950|Natriuretic Agents|natriuretic agents|mesh-ancestor
93052890|NCT00206102|Risperidone|risperidone|mesh-list
93052891|NCT00206102|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93052892|NCT00206102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93052893|NCT00206102|Serotonin Agents|serotonin agents|mesh-ancestor
93052894|NCT00206102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052895|NCT00206102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052896|NCT00206102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052897|NCT00206102|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93052898|NCT00206102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93052899|NCT00206102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052900|NCT00206102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93052901|NCT00206102|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93052902|NCT00206102|Dopamine Agents|dopamine agents|mesh-ancestor
93052903|NCT00206102|Antidepressive Agents|antidepressive agents|mesh-ancestor
93052904|NCT03954262|Propofol|propofol|mesh-list
93052905|NCT03954262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93052906|NCT03954262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052907|NCT03954262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052908|NCT03954262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93052909|NCT03954262|Anesthetics, General|anesthetics, general|mesh-ancestor
93052910|NCT03954262|Anesthetics|anesthetics|mesh-ancestor
93052911|NCT00041080|Tamoxifen|tamoxifen|mesh-list
93052912|NCT00041080|Thalidomide|thalidomide|mesh-list
93052913|NCT00041080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93052914|NCT00041080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92697902|NCT00517946|Ephedrine|ephedrine|mesh-list
93052915|NCT00041080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060701|NCT01281514|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93052916|NCT00041080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052917|NCT00041080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93052918|NCT00041080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052919|NCT00041080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93052920|NCT00041080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93052921|NCT00041080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93052922|NCT00041080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052923|NCT00041080|Immunologic Factors|immunologic factors|mesh-ancestor
93052924|NCT00041080|Leprostatic Agents|leprostatic agents|mesh-ancestor
93052925|NCT00041080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052926|NCT00041080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052927|NCT00041080|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93052928|NCT00041080|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93052929|NCT00041080|Growth Substances|growth substances|mesh-ancestor
93052930|NCT00041080|Growth Inhibitors|growth inhibitors|mesh-ancestor
93052931|NCT00205712|Dexmedetomidine|dexmedetomidine|mesh-list
93052933|NCT00205712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93052934|NCT00205712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052935|NCT00205712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052936|NCT00205712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93052937|NCT00205712|Analgesics|analgesics|mesh-ancestor
93052938|NCT00205712|Sensory System Agents|sensory system agents|mesh-ancestor
93052939|NCT00205712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052940|NCT00205712|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93052941|NCT00205712|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93052942|NCT00205712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93052943|NCT00205712|Adrenergic Agents|adrenergic agents|mesh-ancestor
93052944|NCT00205712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93052945|NCT00205712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052946|NCT00205712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93052947|NCT00205712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93052948|NCT00205712|Anesthetics, General|anesthetics, general|mesh-ancestor
93052949|NCT00205712|Anesthetics|anesthetics|mesh-ancestor
93052950|NCT00205712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93052951|NCT00205712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93052952|NCT03969758|Metronidazole|metronidazole|mesh-list
93052953|NCT03969758|Ciprofloxacin|ciprofloxacin|mesh-list
93052954|NCT03969758|Cefixime|cefixime|mesh-list
93052955|NCT03969758|Liver Extracts|liver extracts|mesh-list
93052956|NCT03969758|Hematinics|hematinics|mesh-ancestor
93052957|NCT03969758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052958|NCT03969758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93052959|NCT03969758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93052960|NCT03969758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93052961|NCT03969758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93052962|NCT03969758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93052963|NCT03969758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052964|NCT03969758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052965|NCT03969758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052966|NCT03969758|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93052967|NCT03969758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93052968|NCT00203294|Triamcinolone|triamcinolone|mesh-list
93052969|NCT00203294|Lidocaine|lidocaine|mesh-list
93052970|NCT00203294|Bupivacaine|bupivacaine|mesh-list
93052971|NCT00203294|Anesthetics, Local|anesthetics, local|mesh-ancestor
93052972|NCT00203294|Anesthetics|anesthetics|mesh-ancestor
93052973|NCT00203294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93052974|NCT00203294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052975|NCT00203294|Sensory System Agents|sensory system agents|mesh-ancestor
93052976|NCT00203294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93052977|NCT00203294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93052978|NCT00203294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93052979|NCT00203294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93052980|NCT00203294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93052981|NCT00203294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052982|NCT00203294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93052983|NCT00203294|Glucocorticoids|glucocorticoids|mesh-ancestor
93052984|NCT00203294|Hormones|hormones|mesh-ancestor
93052985|NCT00203294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93052986|NCT01074086|Everolimus|everolimus|mesh-list
93052987|NCT01074086|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93052988|NCT01074086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93052989|NCT01074086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93052990|NCT01074086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93052991|NCT01074086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93052992|NCT01074086|Immunologic Factors|immunologic factors|mesh-ancestor
93052993|NCT01074086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93052994|NCT01074086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93052995|NCT00264290|Valganciclovir|valganciclovir|mesh-list
93052996|NCT00264290|Antiviral Agents|antiviral agents|mesh-ancestor
93052997|NCT00264290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93052998|NCT00234494|Bevacizumab|bevacizumab|mesh-list
93052999|NCT00234494|Gemcitabine|gemcitabine|mesh-list
93053000|NCT00234494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053001|NCT00234494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053002|NCT00234494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93053003|NCT00234494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93053004|NCT00234494|Growth Substances|growth substances|mesh-ancestor
93053005|NCT00234494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053006|NCT00234494|Growth Inhibitors|growth inhibitors|mesh-ancestor
93053007|NCT00234494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053008|NCT00234494|Antimetabolites|antimetabolites|mesh-ancestor
93053009|NCT00234494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053010|NCT00234104|Tolvaptan|tolvaptan|mesh-list
93053011|NCT00234104|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93053012|NCT00234104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053013|NCT00234104|Natriuretic Agents|natriuretic agents|mesh-ancestor
93053014|NCT00234104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053015|NCT01582568|Certolizumab Pegol|certolizumab pegol|mesh-list
93053016|NCT01582568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93053017|NCT01582568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053018|NCT01582568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053019|NCT01582568|Immunologic Factors|immunologic factors|mesh-ancestor
93053020|NCT01582568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053021|NCT01582568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053022|NCT00195338|Etanercept|etanercept|mesh-list
93053023|NCT00195338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93053024|NCT00195338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93053025|NCT00195338|Analgesics|analgesics|mesh-ancestor
93053026|NCT00195338|Sensory System Agents|sensory system agents|mesh-ancestor
93053027|NCT00195338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053028|NCT00195338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053029|NCT00195338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053030|NCT00195338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053031|NCT00195338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053032|NCT00195338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053033|NCT00195338|Immunologic Factors|immunologic factors|mesh-ancestor
93053034|NCT00039130|Leucovorin|leucovorin|mesh-list
93053035|NCT00039130|Cytarabine|cytarabine|mesh-list
93053036|NCT00039130|Dexamethasone|dexamethasone|mesh-list
93053037|NCT00039130|Prednisone|prednisone|mesh-list
93053038|NCT00039130|Cyclophosphamide|cyclophosphamide|mesh-list
93053039|NCT00039130|Ifosfamide|ifosfamide|mesh-list
93053040|NCT00039130|Rituximab|rituximab|mesh-list
93053041|NCT00039130|Doxorubicin|doxorubicin|mesh-list
93053042|NCT00039130|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93053043|NCT00039130|Methotrexate|methotrexate|mesh-list
93053044|NCT00039130|Etoposide|etoposide|mesh-list
93053045|NCT00039130|Vincristine|vincristine|mesh-list
93053046|NCT00039130|Allopurinol|allopurinol|mesh-list
93053047|NCT00039130|Levoleucovorin|levoleucovorin|mesh-list
93053048|NCT00039130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053049|NCT00039130|Immunologic Factors|immunologic factors|mesh-ancestor
93053050|NCT00039130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053051|NCT00039130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053052|NCT00039130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053053|NCT00039130|Alkylating Agents|alkylating agents|mesh-ancestor
93053054|NCT00039130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053055|NCT00039130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053056|NCT00039130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053057|NCT00039130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053058|NCT00039130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053059|NCT00039130|Antiemetics|antiemetics|mesh-ancestor
93053060|NCT00039130|Autonomic Agents|autonomic agents|mesh-ancestor
93053061|NCT00039130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053062|NCT00039130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053063|NCT00039130|Glucocorticoids|glucocorticoids|mesh-ancestor
93053064|NCT00039130|Hormones|hormones|mesh-ancestor
93053065|NCT00039130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053066|NCT00039130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053067|NCT00039130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053068|NCT00039130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053069|NCT00039130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053070|NCT00039130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053071|NCT00039130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93053072|NCT00039130|Abortifacient Agents|abortifacient agents|mesh-ancestor
93053073|NCT00039130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93053074|NCT00039130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053075|NCT00039130|Antimetabolites|antimetabolites|mesh-ancestor
93053076|NCT00039130|Dermatologic Agents|dermatologic agents|mesh-ancestor
93053077|NCT00039130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93053078|NCT00039130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053079|NCT00039130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053080|NCT00039130|Antiviral Agents|antiviral agents|mesh-ancestor
93053081|NCT00039130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053082|NCT00039130|Antidotes|antidotes|mesh-ancestor
93053083|NCT00039130|Protective Agents|protective agents|mesh-ancestor
93053084|NCT00039130|Vitamin B Complex|vitamin b complex|mesh-ancestor
93053086|NCT00039130|Micronutrients|micronutrients|mesh-ancestor
93053087|NCT00039130|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053088|NCT00039130|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053089|NCT00039130|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053090|NCT00039130|Gout Suppressants|gout suppressants|mesh-ancestor
93053091|NCT00039130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93053092|NCT00039130|Antioxidants|antioxidants|mesh-ancestor
93053093|NCT01096654|Epinephrine|epinephrine|mesh-list
93053094|NCT01096654|Racepinephrine|racepinephrine|mesh-list
93053095|NCT01096654|Epinephryl borate|epinephryl borate|mesh-list
93053096|NCT01096654|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93053097|NCT01096654|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93053098|NCT01096654|Adrenergic Agents|adrenergic agents|mesh-ancestor
93053099|NCT01096654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053100|NCT01096654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053101|NCT01096654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053102|NCT01096654|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93053103|NCT01096654|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93053104|NCT01096654|Autonomic Agents|autonomic agents|mesh-ancestor
93053105|NCT01096654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053106|NCT01096654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93053107|NCT01096654|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053108|NCT01096654|Mydriatics|mydriatics|mesh-ancestor
93053109|NCT01096654|Sympathomimetics|sympathomimetics|mesh-ancestor
93053110|NCT01096654|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93053111|NCT00035932|Ritonavir|ritonavir|mesh-list
93053112|NCT00035932|Lopinavir|lopinavir|mesh-list
93053113|NCT00035932|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93053114|NCT00035932|Saquinavir|saquinavir|mesh-list
93053115|NCT00035932|Tenofovir|tenofovir|mesh-list
93053116|NCT00035932|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93053117|NCT00035932|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93053118|NCT00035932|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053119|NCT00035932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053120|NCT00035932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053121|NCT00035932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053122|NCT00035932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053123|NCT00035932|Antiviral Agents|antiviral agents|mesh-ancestor
93053124|NCT00035932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053125|NCT00035932|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93053126|NCT00035932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93053127|NCT00035932|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93053128|NCT00035932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053129|NCT03953326|Nitroprusside|nitroprusside|mesh-list
93053130|NCT03953326|Acetylcholine|acetylcholine|mesh-list
93053131|NCT03953326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93053132|NCT03953326|Vasodilator Agents|vasodilator agents|mesh-ancestor
93053133|NCT03953326|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93053134|NCT03953326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053135|NCT03953326|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93053136|NCT03953326|Cholinergic Agents|cholinergic agents|mesh-ancestor
93053137|NCT03953326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053138|NCT03953326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053139|NCT01097278|Cholecalciferol|cholecalciferol|mesh-list
93053140|NCT01097278|Vitamin D|vitamin d|mesh-list
93053141|NCT01097278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93053142|NCT01097278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053143|NCT01097278|Vitamins|vitamins|mesh-ancestor
93053144|NCT01097278|Micronutrients|micronutrients|mesh-ancestor
93053145|NCT01097278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93053146|NCT00022516|Cyclophosphamide|cyclophosphamide|mesh-list
93053147|NCT00022516|Methotrexate|methotrexate|mesh-list
93053148|NCT00022516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053149|NCT00022516|Immunologic Factors|immunologic factors|mesh-ancestor
93053150|NCT00022516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053151|NCT00022516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053152|NCT00022516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053153|NCT00022516|Alkylating Agents|alkylating agents|mesh-ancestor
93053154|NCT00022516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053155|NCT00022516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053156|NCT00022516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053157|NCT00022516|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93053158|NCT00022516|Abortifacient Agents|abortifacient agents|mesh-ancestor
93053159|NCT00022516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93053160|NCT00022516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053161|NCT00022516|Antimetabolites|antimetabolites|mesh-ancestor
93053162|NCT00022516|Dermatologic Agents|dermatologic agents|mesh-ancestor
93053163|NCT00022516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053164|NCT00022516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93053165|NCT00022516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053166|NCT01097512|Gemcitabine|gemcitabine|mesh-list
93053167|NCT01097512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053168|NCT01097512|Antimetabolites|antimetabolites|mesh-ancestor
93053169|NCT01097512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053170|NCT01097512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053171|NCT00033514|Trastuzumab|trastuzumab|mesh-list
93053172|NCT00033514|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93053173|NCT00033514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053174|NCT00033514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053175|NCT00033514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93053176|NCT00033514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053177|NCT00033514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053178|NCT00006916|Bleomycin|bleomycin|mesh-list
93053179|NCT00006916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053180|NCT00006916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053181|NCT02529982|Curcumin|curcumin|mesh-list
93053182|NCT02529982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93053183|NCT02529982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93053184|NCT02529982|Analgesics|analgesics|mesh-ancestor
93053185|NCT02529982|Sensory System Agents|sensory system agents|mesh-ancestor
93053186|NCT02529982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053187|NCT02529982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053188|NCT02529982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053189|NCT02529982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053190|NCT02529982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053191|NCT02529982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053192|NCT02529982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053193|NCT00454649|Paclitaxel|paclitaxel|mesh-list
93053194|NCT00454649|Docetaxel|docetaxel|mesh-list
93053195|NCT00454649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93053196|NCT00454649|Cisplatin|cisplatin|mesh-list
93053197|NCT00454649|Carboplatin|carboplatin|mesh-list
93053198|NCT00454649|Gemcitabine|gemcitabine|mesh-list
93053199|NCT00454649|Capecitabine|capecitabine|mesh-list
93053200|NCT00454649|Pemetrexed|pemetrexed|mesh-list
93053201|NCT00454649|Axitinib|axitinib|mesh-list
93053202|NCT00454649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053203|NCT00454649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053204|NCT00454649|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053205|NCT00454649|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053206|NCT00454649|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053207|NCT00454649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053208|NCT00454649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053209|NCT00454649|Antimetabolites|antimetabolites|mesh-ancestor
93053210|NCT00454649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053211|NCT00454649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93053212|NCT00454649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053213|NCT00454649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93053214|NCT00454571|Leuprolide|leuprolide|mesh-list
93053215|NCT00454571|Goserelin|goserelin|mesh-list
93053216|NCT00454571|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93053217|NCT00454571|Fertility Agents|fertility agents|mesh-ancestor
93053218|NCT00454571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93053219|NCT00454571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053220|NCT00454571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053221|NCT00454571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053223|NCT01323257|Darunavir|darunavir|mesh-list
93053224|NCT01323257|Erythromycin|erythromycin|mesh-list
93053225|NCT01323257|Erythromycin Estolate|erythromycin estolate|mesh-list
93053226|NCT01323257|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93053227|NCT01323257|Erythromycin stearate|erythromycin stearate|mesh-list
93053228|NCT01323257|Simeprevir|simeprevir|mesh-list
93053229|NCT01323257|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93053230|NCT01323257|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93053231|NCT01323257|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053232|NCT01323257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053233|NCT01323257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053234|NCT01323257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053235|NCT01323257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053236|NCT01323257|Antiviral Agents|antiviral agents|mesh-ancestor
93053237|NCT01323257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053238|NCT01323257|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93053239|NCT01323257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93053240|NCT01323257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93053241|NCT01323257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053242|NCT01323257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93053243|NCT03837743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93053244|NCT01323335|Rasburicase|rasburicase|mesh-list
93053245|NCT01323335|Uric Acid|uric acid|mesh-list
93053246|NCT01323335|Gout Suppressants|gout suppressants|mesh-ancestor
93053247|NCT01323335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053248|NCT01323335|Antioxidants|antioxidants|mesh-ancestor
93053249|NCT01323335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053250|NCT01323335|Protective Agents|protective agents|mesh-ancestor
93053251|NCT01323335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053252|NCT03836729|Tenofovir|tenofovir|mesh-list
93053253|NCT03836729|Emtricitabine|emtricitabine|mesh-list
93053254|NCT03836729|Antiviral Agents|antiviral agents|mesh-ancestor
93053255|NCT03836729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053256|NCT03836729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93053257|NCT03836729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053258|NCT03836729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053259|NCT03836729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053260|NCT03836729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053261|NCT03836729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053262|NCT01027481|Ranibizumab|ranibizumab|mesh-list
93053263|NCT01027481|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93053264|NCT01027481|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93053265|NCT01027481|Growth Substances|growth substances|mesh-ancestor
93053266|NCT01027481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053267|NCT01027481|Growth Inhibitors|growth inhibitors|mesh-ancestor
93053268|NCT01027481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053269|NCT00443729|Ritonavir|ritonavir|mesh-list
93053270|NCT00443729|Lopinavir|lopinavir|mesh-list
93053271|NCT00443729|Raltegravir Potassium|raltegravir potassium|mesh-list
93053272|NCT00443729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93053273|NCT00443729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93053274|NCT00443729|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053275|NCT00443729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053276|NCT00443729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053277|NCT00443729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053278|NCT00443729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053279|NCT00443729|Antiviral Agents|antiviral agents|mesh-ancestor
93053280|NCT00443729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053281|NCT00443729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93053282|NCT00443729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93053283|NCT00443729|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93053284|NCT00443729|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93053285|NCT00443651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
93053286|NCT00443651|Rituximab|rituximab|mesh-list
93053287|NCT00443651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053288|NCT00443651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053289|NCT00443651|Immunologic Factors|immunologic factors|mesh-ancestor
93053290|NCT00443651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053291|NCT00443651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053292|NCT01027715|Anticonvulsants|anticonvulsants|mesh-list
93053293|NCT03567473|Dexamethasone|dexamethasone|mesh-list
93053294|NCT03567473|Dexamethasone acetate|dexamethasone acetate|mesh-list
93053295|NCT03567473|Epinephrine|epinephrine|mesh-list
93053296|NCT03567473|Racepinephrine|racepinephrine|mesh-list
93053297|NCT03567473|Epinephryl borate|epinephryl borate|mesh-list
93053298|NCT03567473|BB 1101|bb 1101|mesh-list
93053299|NCT03567473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053300|NCT03567473|Antiemetics|antiemetics|mesh-ancestor
93053301|NCT03567473|Autonomic Agents|autonomic agents|mesh-ancestor
93053302|NCT03567473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053303|NCT03567473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053304|NCT03567473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053305|NCT03567473|Glucocorticoids|glucocorticoids|mesh-ancestor
93053306|NCT03567473|Hormones|hormones|mesh-ancestor
93053307|NCT03567473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053308|NCT03567473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053309|NCT03567473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053310|NCT03567473|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053311|NCT03567473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053312|NCT03567473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053313|NCT03567473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93053314|NCT03567473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93053315|NCT03567473|Adrenergic Agents|adrenergic agents|mesh-ancestor
93053316|NCT03567473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053317|NCT03567473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93053318|NCT03567473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93053319|NCT03567473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93053320|NCT03567473|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053321|NCT03567473|Mydriatics|mydriatics|mesh-ancestor
93053322|NCT03567473|Sympathomimetics|sympathomimetics|mesh-ancestor
93053323|NCT03567473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93053324|NCT00443261|Azacitidine|azacitidine|mesh-list
93053325|NCT00443261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053326|NCT00443261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053327|NCT00443261|Antimetabolites|antimetabolites|mesh-ancestor
93053328|NCT00443261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053329|NCT00443261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053330|NCT00439517|Cetuximab|cetuximab|mesh-list
92529465|NCT00001076|polysaccharide-K|polysaccharide-k|mesh-list
93053331|NCT00439517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053332|NCT00439517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053334|NCT01028261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93053335|NCT01028261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93053336|NCT01028261|Growth Substances|growth substances|mesh-ancestor
93053337|NCT01028261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053338|NCT01028261|Growth Inhibitors|growth inhibitors|mesh-ancestor
93053339|NCT01028261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053341|NCT01028339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93053342|NCT01028339|Diuretics|diuretics|mesh-ancestor
93053343|NCT01028339|Natriuretic Agents|natriuretic agents|mesh-ancestor
93053344|NCT01028339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053345|NCT01031459|Interferons|interferons|mesh-list
93053346|NCT01031459|Interferon-beta|interferon-beta|mesh-list
93053347|NCT01031459|Interferon beta-1b|interferon beta-1b|mesh-list
93053348|NCT01031459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053349|NCT01031459|Antiviral Agents|antiviral agents|mesh-ancestor
93053350|NCT01031459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053351|NCT01031459|Immunologic Factors|immunologic factors|mesh-ancestor
93053352|NCT01031459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053353|NCT01031459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93053354|NCT00438815|Complement C1s|complement c1s|mesh-list
93053355|NCT00438815|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93053356|NCT00438815|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
93053357|NCT00438815|Immunologic Factors|immunologic factors|mesh-ancestor
93053358|NCT00438815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053359|NCT00438815|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93053360|NCT00438815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053361|NCT00438659|Mometasone Furoate|mometasone furoate|mesh-list
93053362|NCT00438659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053363|NCT00438659|Dermatologic Agents|dermatologic agents|mesh-ancestor
93053364|NCT00438659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93053365|NCT01028495|Gemcitabine|gemcitabine|mesh-list
93053366|NCT01028495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053367|NCT01028495|Antimetabolites|antimetabolites|mesh-ancestor
93053368|NCT01028495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053369|NCT01028495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053370|NCT00437645|Amlodipine|amlodipine|mesh-list
93053371|NCT00437645|Valsartan|valsartan|mesh-list
93053372|NCT00437645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92698350|NCT02931357|Viscosupplements|viscosupplements|mesh-ancestor
93053373|NCT00437645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93053374|NCT00437645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93053375|NCT00437645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053376|NCT00437645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93053377|NCT00437645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053378|NCT00437645|Vasodilator Agents|vasodilator agents|mesh-ancestor
93053379|NCT00437645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93053380|NCT00437645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93053381|NCT03995147|Prednisone|prednisone|mesh-list
93053382|NCT03995147|Cyclophosphamide|cyclophosphamide|mesh-list
93053383|NCT03995147|Doxorubicin|doxorubicin|mesh-list
93053384|NCT03995147|Pembrolizumab|pembrolizumab|mesh-list
93053385|NCT03995147|Vincristine|vincristine|mesh-list
93053386|NCT03995147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053387|NCT03995147|Immunologic Factors|immunologic factors|mesh-ancestor
93053388|NCT03995147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053389|NCT03995147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053390|NCT03995147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053391|NCT03995147|Alkylating Agents|alkylating agents|mesh-ancestor
93053392|NCT03995147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053393|NCT03995147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053394|NCT03995147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053395|NCT03995147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053396|NCT03995147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053397|NCT03995147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053398|NCT03995147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053399|NCT03995147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053400|NCT03995147|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93053401|NCT03995147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053402|NCT03995147|Glucocorticoids|glucocorticoids|mesh-ancestor
93053403|NCT03995147|Hormones|hormones|mesh-ancestor
93053404|NCT03995147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053405|NCT03995147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053406|NCT03995147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053407|NCT03995147|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053408|NCT03995147|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053409|NCT03995147|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053411|NCT00437489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93053412|NCT00437489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93053413|NCT00437489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053414|NCT01028573|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
93053415|NCT01028573|Laxatives|laxatives|mesh-ancestor
93053416|NCT01028573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053417|NCT04683575|Selenium|selenium|mesh-list
93053418|NCT04683575|Antioxidants|antioxidants|mesh-ancestor
93053419|NCT04683575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053420|NCT04683575|Protective Agents|protective agents|mesh-ancestor
93053421|NCT04683575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053422|NCT04683575|Trace Elements|trace elements|mesh-ancestor
93053423|NCT04683575|Micronutrients|micronutrients|mesh-ancestor
93053424|NCT00442559|Montelukast|montelukast|mesh-list
93053425|NCT00442559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93053426|NCT00442559|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053427|NCT00442559|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93053428|NCT00442559|Hormone Antagonists|hormone antagonists|mesh-ancestor
93053429|NCT00442559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053430|NCT00442559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053431|NCT00442559|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93053432|NCT00442559|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93053433|NCT00442559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053434|NCT01323491|Nicotine|nicotine|mesh-list
93053435|NCT01323491|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93053436|NCT01323491|Autonomic Agents|autonomic agents|mesh-ancestor
93053437|NCT01323491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053438|NCT01323491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053439|NCT01323491|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93053440|NCT01323491|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93053441|NCT01323491|Cholinergic Agents|cholinergic agents|mesh-ancestor
93053442|NCT01323491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053443|NCT01323491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053444|NCT00441545|Sevelamer|sevelamer|mesh-list
93053445|NCT00441545|Chelating Agents|chelating agents|mesh-ancestor
92698429|NCT00522665|Irinotecan|irinotecan|mesh-list
93053447|NCT00441545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053448|NCT00436553|Ranibizumab|ranibizumab|mesh-list
93053449|NCT00436553|Verteporfin|verteporfin|mesh-list
93053450|NCT00436553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93053451|NCT00436553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93053452|NCT00436553|Growth Substances|growth substances|mesh-ancestor
93053453|NCT00436553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053454|NCT00436553|Growth Inhibitors|growth inhibitors|mesh-ancestor
93053455|NCT00436553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053456|NCT00436553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93053457|NCT00436553|Dermatologic Agents|dermatologic agents|mesh-ancestor
93053458|NCT01028729|Gemcitabine|gemcitabine|mesh-list
93053459|NCT01028729|Endostar protein|endostar protein|mesh-list
93053460|NCT01028729|Endostatins|endostatins|mesh-list
93053461|NCT01028729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053462|NCT01028729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053463|NCT01028729|Antimetabolites|antimetabolites|mesh-ancestor
93053464|NCT01028729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053465|NCT01028729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93053466|NCT01028729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93053467|NCT01028729|Growth Substances|growth substances|mesh-ancestor
93053468|NCT01028729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053469|NCT01028729|Growth Inhibitors|growth inhibitors|mesh-ancestor
93053470|NCT03357419|Clindamycin|clindamycin|mesh-list
93053471|NCT03357419|Clindamycin palmitate|clindamycin palmitate|mesh-list
93053472|NCT03357419|Clindamycin phosphate|clindamycin phosphate|mesh-list
93053473|NCT03357419|Cephalexin|cephalexin|mesh-list
93053474|NCT03357419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93053475|NCT03357419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053476|NCT03357419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92529471|NCT00001076|Antiviral Agents|antiviral agents|mesh-ancestor
93053477|NCT03357419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053478|NCT03357419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053479|NCT01031927|Glycine|glycine|mesh-list
93053480|NCT01031927|Glycine Agents|glycine agents|mesh-ancestor
93053481|NCT01031927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053482|NCT01031927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053483|NCT01031927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053484|NCT01032083|Citalopram|citalopram|mesh-list
93053485|NCT01032083|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93053486|NCT01032083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93053487|NCT01032083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93053488|NCT01032083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053489|NCT01032083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053490|NCT01032083|Serotonin Agents|serotonin agents|mesh-ancestor
93053491|NCT01032083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053492|NCT01032083|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93053493|NCT01032083|Antidepressive Agents|antidepressive agents|mesh-ancestor
93053494|NCT01032083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93053495|NCT00436163|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93053496|NCT00436163|Antiviral Agents|antiviral agents|mesh-ancestor
93053497|NCT00436163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053498|NCT01028963|Pioglitazone|pioglitazone|mesh-list
93053499|NCT01028963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93053500|NCT01028963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053501|NCT00006604|Ritonavir|ritonavir|mesh-list
93053502|NCT00006604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93053503|NCT00006604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93053504|NCT00006604|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053505|NCT00006604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053506|NCT00006604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053507|NCT00006604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053508|NCT00006604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053509|NCT00006604|Antiviral Agents|antiviral agents|mesh-ancestor
93053510|NCT00006604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053511|NCT00006604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93053512|NCT00006604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93053513|NCT00006478|Sargramostim|sargramostim|mesh-list
93053514|NCT00006478|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93053515|NCT00006478|Immunologic Factors|immunologic factors|mesh-ancestor
93053516|NCT00006478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053517|NCT00006478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93053518|NCT01097902|Ibuprofen|ibuprofen|mesh-list
93053519|NCT01097902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93053520|NCT01097902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93053522|NCT01097902|Sensory System Agents|sensory system agents|mesh-ancestor
93053523|NCT01097902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053524|NCT01097902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053525|NCT01097902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053526|NCT01097902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053527|NCT01097902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93053528|NCT01097902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494487|NCT01975688|Sensory System Agents|sensory system agents|mesh-ancestor
93053529|NCT01097902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053530|NCT00436007|Vaccines|vaccines|mesh-list
93053531|NCT00436007|Immunologic Factors|immunologic factors|mesh-ancestor
93053532|NCT00436007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053533|NCT00435461|Fluticasone|fluticasone|mesh-list
93053534|NCT00435461|Xhance|xhance|mesh-list
93053535|NCT00435461|Fexofenadine|fexofenadine|mesh-list
93053536|NCT00435461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053537|NCT00435461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93053538|NCT00435461|Autonomic Agents|autonomic agents|mesh-ancestor
93053539|NCT00435461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053540|NCT00435461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053541|NCT00435461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93053542|NCT00435461|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053543|NCT00435461|Dermatologic Agents|dermatologic agents|mesh-ancestor
93053544|NCT00435461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93053545|NCT00435461|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93053546|NCT00435461|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93053547|NCT00435461|Histamine Antagonists|histamine antagonists|mesh-ancestor
93053548|NCT00435461|Histamine Agents|histamine agents|mesh-ancestor
93053549|NCT00435461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053550|NCT00435461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053551|NCT00006436|Prednisone|prednisone|mesh-list
93053552|NCT00006436|Cyclophosphamide|cyclophosphamide|mesh-list
93053553|NCT00006436|Rituximab|rituximab|mesh-list
93053554|NCT00006436|Doxorubicin|doxorubicin|mesh-list
93053555|NCT00006436|Etoposide|etoposide|mesh-list
93053556|NCT00006436|Vincristine|vincristine|mesh-list
93053557|NCT00006436|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93053558|NCT00006436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053559|NCT00006436|Immunologic Factors|immunologic factors|mesh-ancestor
93053560|NCT00006436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053561|NCT00006436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053562|NCT00006436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053563|NCT00006436|Alkylating Agents|alkylating agents|mesh-ancestor
93053564|NCT00006436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053565|NCT00006436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053566|NCT00006436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053567|NCT00006436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053568|NCT00006436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053569|NCT00006436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053570|NCT00006436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053571|NCT00006436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053572|NCT00006436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053573|NCT00006436|Glucocorticoids|glucocorticoids|mesh-ancestor
93053574|NCT00006436|Hormones|hormones|mesh-ancestor
93053575|NCT00006436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053576|NCT00006436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053577|NCT00006436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053578|NCT00006436|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053579|NCT00006436|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053580|NCT00006436|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053581|NCT01097980|Trazodone|trazodone|mesh-list
93053582|NCT01097980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93053583|NCT01097980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93053584|NCT01097980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93053585|NCT01097980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053586|NCT01097980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93053587|NCT01097980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93053588|NCT01097980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93053589|NCT01097980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93053590|NCT01097980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053591|NCT01097980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053592|NCT01097980|Serotonin Agents|serotonin agents|mesh-ancestor
92329805|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053593|NCT01097980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93053594|NCT01097980|Antidepressive Agents|antidepressive agents|mesh-ancestor
93053595|NCT01029275|Octreotide|octreotide|mesh-list
93053596|NCT01029275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053597|NCT01029275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053598|NCT01029275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053599|NCT04829903|Liraglutide|liraglutide|mesh-list
93053600|NCT04829903|Dulaglutide|dulaglutide|mesh-list
93053601|NCT04829903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93053602|NCT04829903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053603|NCT04829903|Incretins|incretins|mesh-ancestor
93053604|NCT04829903|Hormones|hormones|mesh-ancestor
93053605|NCT04829903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053606|NCT00440999|Artesunate|artesunate|mesh-list
93053607|NCT00440999|Chloroquine|chloroquine|mesh-list
93053608|NCT00440999|Pyronaridine|pyronaridine|mesh-list
93053609|NCT00440999|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
93053610|NCT00440999|Antimalarials|antimalarials|mesh-ancestor
93053611|NCT00440999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93053612|NCT00440999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93053613|NCT00440999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053614|NCT00440999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053615|NCT00440999|Antiviral Agents|antiviral agents|mesh-ancestor
93053616|NCT00440999|Schistosomicides|schistosomicides|mesh-ancestor
93053617|NCT00440999|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93053618|NCT00440999|Anthelmintics|anthelmintics|mesh-ancestor
93053619|NCT00440999|Amebicides|amebicides|mesh-ancestor
93053620|NCT00440999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053621|NCT00434213|Methylphenidate|methylphenidate|mesh-list
93053622|NCT00434213|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93053623|NCT00434213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053624|NCT00434213|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93053625|NCT00434213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93053626|NCT00434213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93053627|NCT00434213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053628|NCT00434213|Dopamine Agents|dopamine agents|mesh-ancestor
93053629|NCT00434213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053630|NCT01029743|Aspirin|aspirin|mesh-list
93053632|NCT01029743|Rivaroxaban|rivaroxaban|mesh-list
93053633|NCT01029743|Fondaparinux|fondaparinux|mesh-list
93053634|NCT01029743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93053635|NCT01029743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93053636|NCT01029743|Analgesics|analgesics|mesh-ancestor
93053637|NCT01029743|Sensory System Agents|sensory system agents|mesh-ancestor
93053638|NCT01029743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053639|NCT01029743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053640|NCT01029743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053641|NCT01029743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053642|NCT01029743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93053643|NCT01029743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93053644|NCT01029743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053645|NCT01029743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93053646|NCT01029743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93053647|NCT01029743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053648|NCT01029743|Antipyretics|antipyretics|mesh-ancestor
93053649|NCT01029743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93053650|NCT01029743|Antithrombins|antithrombins|mesh-ancestor
93053651|NCT01029743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93053652|NCT01029743|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053653|NCT01029743|Anticoagulants|anticoagulants|mesh-ancestor
93053654|NCT01029821|Heparin|heparin|mesh-list
92329815|NCT00382135|Tadalafil|tadalafil|mesh-list
93053655|NCT01029821|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93053656|NCT01029821|Tinzaparin|tinzaparin|mesh-list
93053657|NCT01029821|Dalteparin|dalteparin|mesh-list
93053658|NCT01029821|Anticoagulants|anticoagulants|mesh-ancestor
93053659|NCT01029821|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93053660|NCT01029821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93053661|NCT01029821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053662|NCT00006184|Cyclosporine|cyclosporine|mesh-list
93053663|NCT00006184|Prednisone|prednisone|mesh-list
93053664|NCT00006184|Cyclophosphamide|cyclophosphamide|mesh-list
93053665|NCT00006184|Doxorubicin|doxorubicin|mesh-list
93053666|NCT00006184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92698648|NCT02936427|Glucocorticoids|glucocorticoids|mesh-ancestor
93053667|NCT00006184|Methotrexate|methotrexate|mesh-list
93053668|NCT00006184|Fludarabine|fludarabine|mesh-list
93053669|NCT00006184|Fludarabine phosphate|fludarabine phosphate|mesh-list
93053670|NCT00006184|Etoposide|etoposide|mesh-list
93053671|NCT00006184|Vincristine|vincristine|mesh-list
93053672|NCT00006184|Bortezomib|bortezomib|mesh-list
93053673|NCT00006184|Molgramostim|molgramostim|mesh-list
93053674|NCT00006184|Cyclosporins|cyclosporins|mesh-list
93053675|NCT00006184|Immunoglobulins|immunoglobulins|mesh-list
93053676|NCT00006184|Lenograstim|lenograstim|mesh-list
93053677|NCT00006184|Sargramostim|sargramostim|mesh-list
93053678|NCT00006184|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
93053679|NCT00006184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053680|NCT00006184|Immunologic Factors|immunologic factors|mesh-ancestor
93053681|NCT00006184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053682|NCT00006184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053683|NCT00006184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053684|NCT00006184|Alkylating Agents|alkylating agents|mesh-ancestor
93053685|NCT00006184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053686|NCT00006184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053687|NCT00006184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053688|NCT00006184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053689|NCT00006184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053690|NCT00006184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053691|NCT00006184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053692|NCT00006184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053693|NCT00006184|Glucocorticoids|glucocorticoids|mesh-ancestor
93053694|NCT00006184|Hormones|hormones|mesh-ancestor
93053695|NCT00006184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053696|NCT00006184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053697|NCT00006184|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93053698|NCT00006184|Abortifacient Agents|abortifacient agents|mesh-ancestor
93053699|NCT00006184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93053700|NCT00006184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053701|NCT00006184|Antimetabolites|antimetabolites|mesh-ancestor
93053702|NCT00006184|Dermatologic Agents|dermatologic agents|mesh-ancestor
93053703|NCT00006184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93053704|NCT00006184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053705|NCT00006184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053706|NCT00006184|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053707|NCT00006184|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053708|NCT00006184|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053709|NCT00006184|Antifungal Agents|antifungal agents|mesh-ancestor
93053710|NCT00006184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053711|NCT00006184|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93053712|NCT00006184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93053713|NCT00433199|Testosterone|testosterone|mesh-list
93053714|NCT00433199|Androgens|androgens|mesh-ancestor
93053715|NCT00433199|Hormones|hormones|mesh-ancestor
93053716|NCT00433199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053717|NCT00433199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053718|NCT00006046|Antibodies|antibodies|mesh-list
93053719|NCT00006046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93053720|NCT00006046|Immunologic Factors|immunologic factors|mesh-ancestor
93053721|NCT00006046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053722|NCT01098448|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93053723|NCT01098448|Amoxicillin|amoxicillin|mesh-list
93053724|NCT01098448|Metronidazole|metronidazole|mesh-list
93053725|NCT01098448|Tetracycline|tetracycline|mesh-list
93053726|NCT01098448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053727|NCT01098448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93053728|NCT01098448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93053729|NCT01098448|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93053730|NCT01098448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053731|NCT01098448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053732|NCT01098526|Efavirenz|efavirenz|mesh-list
93053733|NCT01098526|Dolutegravir|dolutegravir|mesh-list
93053734|NCT01098526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93053735|NCT01098526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93053736|NCT01098526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053737|NCT01098526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053738|NCT01098526|Antiviral Agents|antiviral agents|mesh-ancestor
93053739|NCT01098526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053740|NCT01098526|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93053741|NCT01098526|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93053742|NCT01098526|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93053743|NCT01098526|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93053744|NCT01098526|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93053745|NCT01098526|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93053746|NCT01098526|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93053747|NCT01098526|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93053748|NCT01098526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053749|NCT01098526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053750|NCT00005908|Tamoxifen|tamoxifen|mesh-list
93053751|NCT00005908|Cyclophosphamide|cyclophosphamide|mesh-list
93053752|NCT00005908|Docetaxel|docetaxel|mesh-list
93053753|NCT00005908|Doxorubicin|doxorubicin|mesh-list
93053754|NCT00005908|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93053755|NCT00005908|Capecitabine|capecitabine|mesh-list
93053756|NCT00005908|Anastrozole|anastrozole|mesh-list
93053757|NCT00005908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053758|NCT00005908|Immunologic Factors|immunologic factors|mesh-ancestor
93053759|NCT00005908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053760|NCT00005908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053761|NCT00005908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053762|NCT00005908|Alkylating Agents|alkylating agents|mesh-ancestor
93053763|NCT00005908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053764|NCT00005908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053765|NCT00005908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053766|NCT00005908|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053767|NCT00005908|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053768|NCT00005908|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053769|NCT00005908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053770|NCT00005908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053771|NCT00005908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053772|NCT00005908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053773|NCT00005908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053774|NCT00005908|Antimetabolites|antimetabolites|mesh-ancestor
93053775|NCT00005908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93053776|NCT00005908|Hormone Antagonists|hormone antagonists|mesh-ancestor
93053777|NCT00005908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053778|NCT00005908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053779|NCT00005908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93053780|NCT00005908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93053781|NCT00005908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93053782|NCT00005908|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93053783|NCT00005908|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93053784|NCT00431951|Tecovirimat|tecovirimat|mesh-list
93053785|NCT00431951|Antiviral Agents|antiviral agents|mesh-ancestor
93053786|NCT00431951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053787|NCT00004978|Aldesleukin|aldesleukin|mesh-list
93053788|NCT00004978|Interleukin-2|interleukin-2|mesh-list
93053789|NCT00004978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053790|NCT00004978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93053791|NCT00004978|Analgesics|analgesics|mesh-ancestor
93053792|NCT00004978|Sensory System Agents|sensory system agents|mesh-ancestor
93053793|NCT00004978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053794|NCT00004978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053795|NCT00004978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93053796|NCT00004978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93053797|NCT00004978|Antiviral Agents|antiviral agents|mesh-ancestor
93053798|NCT00004978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053799|NCT01030601|Dexamethasone|dexamethasone|mesh-list
93053800|NCT01030601|Dexamethasone acetate|dexamethasone acetate|mesh-list
93053801|NCT01030601|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93053802|NCT01030601|BB 1101|bb 1101|mesh-list
93053803|NCT01030601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053804|NCT01030601|Antiemetics|antiemetics|mesh-ancestor
93053805|NCT01030601|Autonomic Agents|autonomic agents|mesh-ancestor
93053806|NCT01030601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053807|NCT01030601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053808|NCT01030601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93053809|NCT01030601|Glucocorticoids|glucocorticoids|mesh-ancestor
93053810|NCT01030601|Hormones|hormones|mesh-ancestor
93053811|NCT01030601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053812|NCT01030601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93053813|NCT01030601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053814|NCT01030601|Protease Inhibitors|protease inhibitors|mesh-ancestor
93053815|NCT01030601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053816|NCT01030601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053817|NCT00430937|Vancomycin|vancomycin|mesh-list
93053818|NCT00430937|Daptomycin|daptomycin|mesh-list
93053819|NCT00430937|Teicoplanin|teicoplanin|mesh-list
93053820|NCT00430937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93053821|NCT00430937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698798|NCT00524186|Micronutrients|micronutrients|mesh-ancestor
93053822|NCT01101412|Calcium, Dietary|calcium, dietary|mesh-list
93053823|NCT01101412|Ethanol|ethanol|mesh-list
93053824|NCT01101412|Trimethoprim|trimethoprim|mesh-list
93053825|NCT01101412|Sulfamethoxazole|sulfamethoxazole|mesh-list
93053826|NCT01101412|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93053827|NCT01101412|Edetic Acid|edetic acid|mesh-list
93053828|NCT01101412|Calcium|calcium|mesh-list
93053829|NCT01101412|Pentetic Acid|pentetic acid|mesh-list
93053830|NCT01101412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93053831|NCT01101412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053832|NCT01101412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93053833|NCT01101412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93053834|NCT01101412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053835|NCT01101412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93053836|NCT01101412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93053837|NCT01101412|Antimalarials|antimalarials|mesh-ancestor
93053838|NCT01101412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93053839|NCT01101412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93053840|NCT01101412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93053841|NCT01101412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053842|NCT01101412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399450|NCT01403740|Antimetabolites|antimetabolites|mesh-ancestor
93053843|NCT01101412|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93053844|NCT01101412|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93053845|NCT01101412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93053846|NCT01101412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93053847|NCT01101412|Anticoagulants|anticoagulants|mesh-ancestor
93053848|NCT01101412|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93053849|NCT01101412|Chelating Agents|chelating agents|mesh-ancestor
93053850|NCT01101412|Sequestering Agents|sequestering agents|mesh-ancestor
93053851|NCT01101412|Antidotes|antidotes|mesh-ancestor
93053852|NCT01101412|Protective Agents|protective agents|mesh-ancestor
93053853|NCT01101412|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93053854|NCT00004888|Docetaxel|docetaxel|mesh-list
93053855|NCT00004888|Doxorubicin|doxorubicin|mesh-list
93053856|NCT00004888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93053857|NCT00004888|Trastuzumab|trastuzumab|mesh-list
93053858|NCT00004888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053859|NCT00004888|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053860|NCT00004888|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053861|NCT00004888|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053862|NCT00004888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053863|NCT00004888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053864|NCT00004888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053865|NCT00004888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053866|NCT00004888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053867|NCT00004888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053868|NCT01098760|Sorafenib|sorafenib|mesh-list
93053869|NCT01098760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053870|NCT01098760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93053871|NCT01098760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053872|NCT01098760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053873|NCT03950830|Disulfiram|disulfiram|mesh-list
93053874|NCT03950830|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93053875|NCT03950830|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93053876|NCT03950830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053877|NCT03950830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053878|NCT00430781|Lapatinib|lapatinib|mesh-list
93053879|NCT00430781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053880|NCT00430781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93053881|NCT00430781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053882|NCT00430781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053883|NCT01033097|Betamethasone|betamethasone|mesh-list
93053884|NCT01033097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93053885|NCT01033097|Glucocorticoids|glucocorticoids|mesh-ancestor
93053886|NCT01033097|Hormones|hormones|mesh-ancestor
93053887|NCT01033097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93053888|NCT01033097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053889|NCT01033097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93053890|NCT01033097|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053891|NCT00429299|Paclitaxel|paclitaxel|mesh-list
93053892|NCT00429299|Cyclophosphamide|cyclophosphamide|mesh-list
93053893|NCT00429299|Fluorouracil|fluorouracil|mesh-list
93053894|NCT00429299|Trastuzumab|trastuzumab|mesh-list
93053895|NCT00429299|Lapatinib|lapatinib|mesh-list
93053896|NCT00429299|Epirubicin|epirubicin|mesh-list
93053897|NCT00429299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053898|NCT00429299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698880|NCT02929719|Dapsone|dapsone|mesh-list
93053899|NCT00429299|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053900|NCT00429299|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053901|NCT00429299|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053902|NCT00429299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053903|NCT00429299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053904|NCT00429299|Immunologic Factors|immunologic factors|mesh-ancestor
93053905|NCT00429299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053906|NCT00429299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053907|NCT00429299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053908|NCT00429299|Alkylating Agents|alkylating agents|mesh-ancestor
93053909|NCT00429299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053910|NCT00429299|Antimetabolites|antimetabolites|mesh-ancestor
93053911|NCT00429299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93053912|NCT00429299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93053913|NCT00429299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93053914|NCT00429299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053915|NCT00429299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053916|NCT00429299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053917|NCT00429299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053918|NCT01033877|Vaccines|vaccines|mesh-list
93053919|NCT01033877|Immunologic Factors|immunologic factors|mesh-ancestor
93053920|NCT01033877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053921|NCT00428597|Sunitinib|sunitinib|mesh-list
93053922|NCT00428597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053923|NCT00428597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93053924|NCT00428597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93053925|NCT00428597|Growth Substances|growth substances|mesh-ancestor
93053926|NCT00428597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053927|NCT00428597|Growth Inhibitors|growth inhibitors|mesh-ancestor
93053928|NCT00428597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93053929|NCT00428597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053930|NCT00428597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053931|NCT01033955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93053932|NCT01033955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93053933|NCT01033955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93053934|NCT01033955|Antimetabolites|antimetabolites|mesh-ancestor
93053935|NCT01033955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053936|NCT01033955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93053937|NCT01033955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93053938|NCT01033955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053939|NCT00428441|Warfarin|warfarin|mesh-list
93053940|NCT00428441|Anticoagulants|anticoagulants|mesh-ancestor
93053941|NCT02488967|Paclitaxel|paclitaxel|mesh-list
93053942|NCT02488967|Cyclophosphamide|cyclophosphamide|mesh-list
93053943|NCT02488967|Carboplatin|carboplatin|mesh-list
93053944|NCT02488967|Doxorubicin|doxorubicin|mesh-list
93053945|NCT02488967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93053946|NCT02488967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93053947|NCT02488967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93053948|NCT02488967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93053949|NCT02488967|Tubulin Modulators|tubulin modulators|mesh-ancestor
93053950|NCT02488967|Antimitotic Agents|antimitotic agents|mesh-ancestor
93053951|NCT02488967|Mitosis Modulators|mitosis modulators|mesh-ancestor
93053952|NCT02488967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053953|NCT02488967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93053954|NCT02488967|Immunologic Factors|immunologic factors|mesh-ancestor
93053955|NCT02488967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053956|NCT02488967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93053957|NCT02488967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93053958|NCT02488967|Alkylating Agents|alkylating agents|mesh-ancestor
93053959|NCT02488967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93053960|NCT02488967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93053961|NCT02488967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93053962|NCT02488967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93053963|NCT02488967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93053964|NCT00144339|Tiotropium Bromide|tiotropium bromide|mesh-list
93053965|NCT00144339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93053966|NCT00144339|Autonomic Agents|autonomic agents|mesh-ancestor
93053967|NCT00144339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93053968|NCT00144339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053969|NCT00144339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93053970|NCT00144339|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053971|NCT00144339|Parasympatholytics|parasympatholytics|mesh-ancestor
93053972|NCT00144339|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93053973|NCT00144339|Cholinergic Agents|cholinergic agents|mesh-ancestor
93053974|NCT00144339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93053975|NCT00144339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053976|NCT03967665|Acetylcysteine|acetylcysteine|mesh-list
93053977|NCT03967665|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93053978|NCT03967665|Antiviral Agents|antiviral agents|mesh-ancestor
93053979|NCT03967665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93053980|NCT03967665|Expectorants|expectorants|mesh-ancestor
93053981|NCT03967665|Respiratory System Agents|respiratory system agents|mesh-ancestor
93053982|NCT03967665|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93053983|NCT03967665|Antioxidants|antioxidants|mesh-ancestor
93053984|NCT03967665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93053985|NCT03967665|Protective Agents|protective agents|mesh-ancestor
93053986|NCT03967665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053987|NCT03967665|Antidotes|antidotes|mesh-ancestor
93053988|NCT00144027|Antipsychotic Agents|antipsychotic agents|mesh-list
93053989|NCT00144027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93053990|NCT00144027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93053991|NCT00144027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053992|NCT00144027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93053994|NCT00127803|Immunologic Factors|immunologic factors|mesh-ancestor
93053995|NCT00127803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93053996|NCT01077999|Paclitaxel|paclitaxel|mesh-list
93053997|NCT01077999|Carboplatin|carboplatin|mesh-list
93053998|NCT01077999|Panitumumab|panitumumab|mesh-list
93053999|NCT01077999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93054000|NCT01077999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054001|NCT01077999|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054002|NCT01077999|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054003|NCT01077999|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054004|NCT01077999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054005|NCT01077999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054006|NCT01033409|Vaccines|vaccines|mesh-list
93054007|NCT01033409|Immunologic Factors|immunologic factors|mesh-ancestor
93054008|NCT01033409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054009|NCT01037465|Acetylcysteine|acetylcysteine|mesh-list
93054010|NCT01037465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93054011|NCT01037465|Antiviral Agents|antiviral agents|mesh-ancestor
93054012|NCT01037465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054013|NCT01037465|Expectorants|expectorants|mesh-ancestor
93054014|NCT01037465|Respiratory System Agents|respiratory system agents|mesh-ancestor
93054015|NCT01037465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93054016|NCT01037465|Antioxidants|antioxidants|mesh-ancestor
93054017|NCT01037465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054018|NCT01037465|Protective Agents|protective agents|mesh-ancestor
93054019|NCT01037465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054020|NCT01037465|Antidotes|antidotes|mesh-ancestor
93054021|NCT01582425|Isavuconazole|isavuconazole|mesh-list
93054022|NCT01582425|Methadone|methadone|mesh-list
93054023|NCT01582425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93054024|NCT01582425|Narcotics|narcotics|mesh-ancestor
93054025|NCT01582425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93054026|NCT01582425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054027|NCT01582425|Analgesics|analgesics|mesh-ancestor
93054028|NCT01582425|Sensory System Agents|sensory system agents|mesh-ancestor
93054029|NCT01582425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054030|NCT01582425|Antitussive Agents|antitussive agents|mesh-ancestor
93054031|NCT01582425|Respiratory System Agents|respiratory system agents|mesh-ancestor
93054032|NCT01582425|Antifungal Agents|antifungal agents|mesh-ancestor
93054033|NCT01582425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054034|NCT00143403|Leucovorin|leucovorin|mesh-list
93054035|NCT00143403|Folic Acid|folic acid|mesh-list
93054036|NCT00143403|Irinotecan|irinotecan|mesh-list
93054037|NCT00143403|Fluorouracil|fluorouracil|mesh-list
93054038|NCT00143403|Levoleucovorin|levoleucovorin|mesh-list
93054039|NCT00143403|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93054040|NCT00143403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93054041|NCT00143403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054042|NCT00143403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329892|NCT00003368|Irinotecan|irinotecan|mesh-list
93054043|NCT00143403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054044|NCT00143403|Antimetabolites|antimetabolites|mesh-ancestor
93054045|NCT00143403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054046|NCT00143403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054047|NCT00143403|Immunologic Factors|immunologic factors|mesh-ancestor
93054048|NCT00143403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054049|NCT00143403|Antidotes|antidotes|mesh-ancestor
93054050|NCT00143403|Protective Agents|protective agents|mesh-ancestor
93054051|NCT00143403|Vitamin B Complex|vitamin b complex|mesh-ancestor
93054052|NCT00143403|Vitamins|vitamins|mesh-ancestor
93054054|NCT00143403|Hematinics|hematinics|mesh-ancestor
93054055|NCT00220701|Dexetimide|dexetimide|mesh-list
93054056|NCT00220701|Citalopram|citalopram|mesh-list
93054057|NCT00220701|Escitalopram|escitalopram|mesh-list
93054058|NCT00220701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93054059|NCT00220701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93054060|NCT00220701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054061|NCT00220701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054062|NCT00220701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054063|NCT00220701|Serotonin Agents|serotonin agents|mesh-ancestor
93054064|NCT00220701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054065|NCT00220701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93054066|NCT00220701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93054067|NCT00220701|Parasympatholytics|parasympatholytics|mesh-ancestor
93054068|NCT00220701|Autonomic Agents|autonomic agents|mesh-ancestor
93054069|NCT00220701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054070|NCT00220701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93054071|NCT00220701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93054072|NCT00220701|Cholinergic Agents|cholinergic agents|mesh-ancestor
93054073|NCT00220701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93054074|NCT00220701|Antidepressive Agents|antidepressive agents|mesh-ancestor
93054075|NCT00220701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93054077|NCT00127101|Bexarotene|bexarotene|mesh-list
93054078|NCT00127101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054079|NCT00127101|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93054080|NCT00127101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054081|NCT00127101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054082|NCT00126555|Gefitinib|gefitinib|mesh-list
93054083|NCT00126555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054084|NCT00126555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054085|NCT00126555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054086|NCT00126555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054087|NCT00004228|Leucovorin|leucovorin|mesh-list
93054088|NCT00004228|Cytarabine|cytarabine|mesh-list
93054089|NCT00004228|Dexamethasone|dexamethasone|mesh-list
93054090|NCT00004228|Prednisone|prednisone|mesh-list
93054091|NCT00004228|Cyclophosphamide|cyclophosphamide|mesh-list
93054092|NCT00004228|Doxorubicin|doxorubicin|mesh-list
93054093|NCT00004228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93054094|NCT00004228|Methotrexate|methotrexate|mesh-list
93054095|NCT00004228|Vincristine|vincristine|mesh-list
93054096|NCT00004228|Daunorubicin|daunorubicin|mesh-list
93054097|NCT00004228|Asparaginase|asparaginase|mesh-list
93054098|NCT00004228|Mercaptopurine|mercaptopurine|mesh-list
93054099|NCT00004228|Thioguanine|thioguanine|mesh-list
93054100|NCT00004228|Levoleucovorin|levoleucovorin|mesh-list
93054101|NCT00004228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054102|NCT00004228|Immunologic Factors|immunologic factors|mesh-ancestor
93054103|NCT00004228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054104|NCT00004228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054105|NCT00004228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93054106|NCT00004228|Alkylating Agents|alkylating agents|mesh-ancestor
93054107|NCT00004228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054108|NCT00004228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054109|NCT00004228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93054110|NCT00004228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054111|NCT00004228|Antiemetics|antiemetics|mesh-ancestor
93054112|NCT00004228|Autonomic Agents|autonomic agents|mesh-ancestor
93054113|NCT00004228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054114|NCT00004228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93054115|NCT00004228|Glucocorticoids|glucocorticoids|mesh-ancestor
93054116|NCT00004228|Hormones|hormones|mesh-ancestor
93054117|NCT00004228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054118|NCT00004228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93054119|NCT00004228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054120|NCT00004228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93054121|NCT00004228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93054122|NCT00004228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054123|NCT00004228|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93054124|NCT00004228|Abortifacient Agents|abortifacient agents|mesh-ancestor
93054125|NCT00004228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93054126|NCT00004228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054127|NCT00004228|Antimetabolites|antimetabolites|mesh-ancestor
93054128|NCT00004228|Dermatologic Agents|dermatologic agents|mesh-ancestor
93054129|NCT00004228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93054130|NCT00004228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93054131|NCT00004228|Antiviral Agents|antiviral agents|mesh-ancestor
93054132|NCT00004228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054133|NCT00004228|Antidotes|antidotes|mesh-ancestor
93054134|NCT00004228|Protective Agents|protective agents|mesh-ancestor
93054135|NCT00004228|Vitamin B Complex|vitamin b complex|mesh-ancestor
93054136|NCT00004228|Vitamins|vitamins|mesh-ancestor
93054137|NCT00004228|Micronutrients|micronutrients|mesh-ancestor
93054138|NCT00004228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93054139|NCT00004228|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054140|NCT00004228|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054141|NCT00004228|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054142|NCT01101568|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93054143|NCT01101568|Simvastatin|simvastatin|mesh-list
93054144|NCT01101568|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92399748|NCT01404871|Clomipramine|clomipramine|mesh-list
93054145|NCT01101568|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93054146|NCT01101568|Antimetabolites|antimetabolites|mesh-ancestor
93054147|NCT01101568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054148|NCT01101568|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93054149|NCT01101568|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93054150|NCT01101568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054151|NCT01087840|Tenofovir|tenofovir|mesh-list
93054152|NCT01087840|Emtricitabine|emtricitabine|mesh-list
93054153|NCT01087840|Raltegravir Potassium|raltegravir potassium|mesh-list
93054154|NCT01087840|Antiviral Agents|antiviral agents|mesh-ancestor
93054155|NCT01087840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054156|NCT01087840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93054157|NCT01087840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93054158|NCT01087840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054159|NCT01087840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054160|NCT01087840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93054161|NCT01087840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93054162|NCT01087840|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93054163|NCT01087840|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93054164|NCT01098994|Vitamin E|vitamin e|mesh-list
93054165|NCT01098994|Tocopherols|tocopherols|mesh-list
93054166|NCT01098994|alpha-Tocopherol|alpha-tocopherol|mesh-list
93054167|NCT01098994|Vitamins|vitamins|mesh-ancestor
93054168|NCT01098994|Micronutrients|micronutrients|mesh-ancestor
93054169|NCT01098994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054170|NCT01098994|Antioxidants|antioxidants|mesh-ancestor
93054171|NCT01098994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054172|NCT01098994|Protective Agents|protective agents|mesh-ancestor
93054173|NCT01099072|Methylphenidate|methylphenidate|mesh-list
93054174|NCT01099072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93054175|NCT01099072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054176|NCT01099072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92329908|NCT00003380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054177|NCT01099072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93054178|NCT01099072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054179|NCT01099072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054180|NCT01099072|Dopamine Agents|dopamine agents|mesh-ancestor
93054181|NCT01099072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054182|NCT00031486|Valacyclovir|valacyclovir|mesh-list
93054183|NCT00031486|Antiviral Agents|antiviral agents|mesh-ancestor
93054184|NCT00031486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054185|NCT01099150|Proanthocyanidin|proanthocyanidin|mesh-list
93054186|NCT01099150|Procyanidin|procyanidin|mesh-list
93054187|NCT01099150|Antioxidants|antioxidants|mesh-ancestor
93054188|NCT01099150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054189|NCT01099150|Protective Agents|protective agents|mesh-ancestor
93054190|NCT01099150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054191|NCT01099150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93054192|NCT01099150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93054193|NCT01099150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054194|NCT02530060|Tenofovir|tenofovir|mesh-list
93054195|NCT02530060|Emtricitabine|emtricitabine|mesh-list
93054196|NCT02530060|Rilpivirine|rilpivirine|mesh-list
93054197|NCT02530060|Antiviral Agents|antiviral agents|mesh-ancestor
93054198|NCT02530060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054199|NCT02530060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93054200|NCT02530060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93054201|NCT02530060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054202|NCT02530060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699177|NCT00526409|Abortifacient Agents|abortifacient agents|mesh-ancestor
93054203|NCT02530060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93054204|NCT02530060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93054205|NCT01101646|Rabeprazole|rabeprazole|mesh-list
93054207|NCT01101646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93054208|NCT01101646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93054209|NCT01101646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054210|NCT01101646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054211|NCT01101802|Mycophenolic Acid|mycophenolic acid|mesh-list
93054212|NCT01101802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054213|NCT01101802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054214|NCT01101802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93054215|NCT01101802|Antitubercular Agents|antitubercular agents|mesh-ancestor
93054216|NCT01101802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054217|NCT01101802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054218|NCT01101802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054219|NCT01101802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054220|NCT01099228|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93054221|NCT01099228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054222|NCT01099228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054223|NCT01099228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054224|NCT01099228|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93054225|NCT01088230|Botulinum Toxins|botulinum toxins|mesh-list
93054226|NCT01088230|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93054227|NCT01088230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054228|NCT01088230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054229|NCT01088230|Cholinergic Agents|cholinergic agents|mesh-ancestor
93054230|NCT01088230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054231|NCT01088230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054232|NCT01099462|Ibuprofen|ibuprofen|mesh-list
93054233|NCT01099462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93054234|NCT01099462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93054235|NCT01099462|Analgesics|analgesics|mesh-ancestor
93054236|NCT01099462|Sensory System Agents|sensory system agents|mesh-ancestor
93054237|NCT01099462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054238|NCT01099462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054239|NCT01099462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054240|NCT01099462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054241|NCT01099462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93054242|NCT01099462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054243|NCT01099462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054244|NCT00003298|Leucovorin|leucovorin|mesh-list
93054245|NCT00003298|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
93054246|NCT00003298|Tetrahydrofolates|tetrahydrofolates|mesh-list
93054247|NCT00003298|Paclitaxel|paclitaxel|mesh-list
93054248|NCT00003298|Cisplatin|cisplatin|mesh-list
93054249|NCT00003298|Fluorouracil|fluorouracil|mesh-list
93054250|NCT00003298|Calcium|calcium|mesh-list
93054251|NCT00003298|Levoleucovorin|levoleucovorin|mesh-list
93054252|NCT00003298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93054253|NCT00003298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054254|NCT00003298|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054255|NCT00003298|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054256|NCT00003298|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054257|NCT00003298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054258|NCT00003298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93054259|NCT00003298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054260|NCT00003298|Antimetabolites|antimetabolites|mesh-ancestor
93054261|NCT00003298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054262|NCT00003298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054263|NCT00003298|Immunologic Factors|immunologic factors|mesh-ancestor
93054264|NCT00003298|Antidotes|antidotes|mesh-ancestor
93054265|NCT00003298|Protective Agents|protective agents|mesh-ancestor
93054266|NCT00003298|Vitamin B Complex|vitamin b complex|mesh-ancestor
93054267|NCT00003298|Vitamins|vitamins|mesh-ancestor
93054268|NCT00003298|Micronutrients|micronutrients|mesh-ancestor
93054269|NCT03960970|Azithromycin|azithromycin|mesh-list
93054270|NCT03960970|Cefoxitin|cefoxitin|mesh-list
93054271|NCT03960970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054272|NCT03960970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054273|NCT00002842|Leucovorin|leucovorin|mesh-list
93054274|NCT00002842|Fluorouracil|fluorouracil|mesh-list
93054275|NCT00002842|Floxuridine|floxuridine|mesh-list
93054276|NCT00002842|Calcium|calcium|mesh-list
93054277|NCT00002842|Levoleucovorin|levoleucovorin|mesh-list
93054278|NCT00002842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699256|NCT00526760|Dexmedetomidine|dexmedetomidine|mesh-list
93054279|NCT00002842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054280|NCT00002842|Antimetabolites|antimetabolites|mesh-ancestor
93054281|NCT00002842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054282|NCT00002842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054284|NCT00002842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054285|NCT00002842|Immunologic Factors|immunologic factors|mesh-ancestor
93054286|NCT00002842|Antidotes|antidotes|mesh-ancestor
93054287|NCT00002842|Protective Agents|protective agents|mesh-ancestor
93054288|NCT00002842|Vitamin B Complex|vitamin b complex|mesh-ancestor
93054289|NCT00002842|Vitamins|vitamins|mesh-ancestor
93054290|NCT00002842|Micronutrients|micronutrients|mesh-ancestor
93054291|NCT00143247|Insulin|insulin|mesh-list
93054292|NCT00143247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93054293|NCT00143247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054294|NCT00125853|Atenolol|atenolol|mesh-list
93054295|NCT00125853|Nebivolol|nebivolol|mesh-list
93054296|NCT00125853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93054297|NCT00125853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93054298|NCT00125853|Sympatholytics|sympatholytics|mesh-ancestor
93054299|NCT00125853|Autonomic Agents|autonomic agents|mesh-ancestor
93054300|NCT00125853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054301|NCT00125853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054302|NCT00125853|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93054303|NCT00125853|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93054304|NCT00125853|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93054305|NCT00125853|Adrenergic Agents|adrenergic agents|mesh-ancestor
93054306|NCT00125853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92329933|NCT00003680|Immunologic Factors|immunologic factors|mesh-ancestor
93054307|NCT00125853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054308|NCT00125853|Vasodilator Agents|vasodilator agents|mesh-ancestor
93054309|NCT00125853|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93054310|NCT00125853|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93054311|NCT00125853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93054312|NCT00219141|Losartan|losartan|mesh-list
93054313|NCT00219141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93054314|NCT00219141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93054315|NCT00219141|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93054316|NCT00219141|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93054317|NCT00219141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054318|NCT03971487|Ocrelizumab|ocrelizumab|mesh-list
93054319|NCT03971487|Immunologic Factors|immunologic factors|mesh-ancestor
93054320|NCT03971487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054321|NCT00233948|Nelfinavir|nelfinavir|mesh-list
93054322|NCT00233948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93054323|NCT00233948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93054324|NCT00233948|Protease Inhibitors|protease inhibitors|mesh-ancestor
93054325|NCT00233948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054326|NCT00233948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054327|NCT00233948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93054328|NCT00233948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93054329|NCT00233948|Antiviral Agents|antiviral agents|mesh-ancestor
93054330|NCT00233948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054331|NCT00233480|Atorvastatin|atorvastatin|mesh-list
93054332|NCT00233480|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93054333|NCT00233480|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93054334|NCT00233480|Antimetabolites|antimetabolites|mesh-ancestor
93054335|NCT00233480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054336|NCT00233480|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93054337|NCT00233480|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93054338|NCT00233480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054339|NCT03801928|Infliximab|infliximab|mesh-list
93054340|NCT03801928|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93054341|NCT03801928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054342|NCT03801928|Dermatologic Agents|dermatologic agents|mesh-ancestor
93054343|NCT03801928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93054344|NCT03801928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054345|NCT02530918|Ranibizumab|ranibizumab|mesh-list
93054346|NCT02530918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93054347|NCT02530918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93054348|NCT02530918|Growth Substances|growth substances|mesh-ancestor
93054349|NCT02530918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054350|NCT02530918|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054351|NCT02530918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054352|NCT03950518|Levamisole|levamisole|mesh-list
93054353|NCT03950518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93054354|NCT03950518|Immunologic Factors|immunologic factors|mesh-ancestor
92699324|NCT02945072|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93054355|NCT03950518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054356|NCT03950518|Antinematodal Agents|antinematodal agents|mesh-ancestor
93054357|NCT03950518|Anthelmintics|anthelmintics|mesh-ancestor
93054358|NCT03950518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93054359|NCT03950518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054360|NCT03950518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054362|NCT01100164|Zopiclone|zopiclone|mesh-list
93054363|NCT01100164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93054364|NCT01100164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93054365|NCT01100164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054366|NCT01102114|Vaccines|vaccines|mesh-list
93054367|NCT01102114|Immunologic Factors|immunologic factors|mesh-ancestor
93054368|NCT01102114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054370|NCT01327222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054371|NCT01327222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054372|NCT01327222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93054373|NCT01327222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93054374|NCT01327222|Growth Substances|growth substances|mesh-ancestor
93054375|NCT01327222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054376|NCT01327222|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054377|NCT03950362|Avelumab|avelumab|mesh-list
93054378|NCT03950362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054379|NCT03950362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054380|NCT00263588|Lapatinib|lapatinib|mesh-list
93054381|NCT00263588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054382|NCT00263588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054383|NCT00263588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054384|NCT00263588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054385|NCT00213135|Cladribine|cladribine|mesh-list
93054386|NCT00213135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054387|NCT00213135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054388|NCT00213135|Immunologic Factors|immunologic factors|mesh-ancestor
93054389|NCT00213135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054390|NCT00077974|Sunitinib|sunitinib|mesh-list
93054391|NCT00077974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054392|NCT00077974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93054393|NCT00077974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93054394|NCT00077974|Growth Substances|growth substances|mesh-ancestor
93054395|NCT00077974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054396|NCT00077974|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054397|NCT00077974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054398|NCT00077974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054399|NCT00077974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054400|NCT00141921|Etanercept|etanercept|mesh-list
93054401|NCT00141921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93054402|NCT00141921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93054403|NCT00141921|Analgesics|analgesics|mesh-ancestor
93054404|NCT00141921|Sensory System Agents|sensory system agents|mesh-ancestor
93054405|NCT00141921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054406|NCT00141921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054407|NCT00141921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054408|NCT00141921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054409|NCT00141921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93054410|NCT00141921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054411|NCT00141921|Immunologic Factors|immunologic factors|mesh-ancestor
93054412|NCT01088620|Pemetrexed|pemetrexed|mesh-list
93054413|NCT01088620|Panitumumab|panitumumab|mesh-list
93054414|NCT01088620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054415|NCT01088620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054416|NCT01088620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054417|NCT01088620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93054418|NCT01088620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93054419|NCT01088620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054420|NCT00026494|Temozolomide|temozolomide|mesh-list
93054421|NCT00026494|Vinorelbine|vinorelbine|mesh-list
93054422|NCT00026494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93054423|NCT00026494|Alkylating Agents|alkylating agents|mesh-ancestor
93054424|NCT00026494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054425|NCT00026494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054426|NCT00026494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92699403|NCT01580501|Tadalafil|tadalafil|mesh-list
93054427|NCT00026494|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054428|NCT00026494|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054429|NCT00026494|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054430|NCT03950050|Ambroxol|ambroxol|mesh-list
93054431|NCT03950050|Expectorants|expectorants|mesh-ancestor
93054432|NCT03950050|Respiratory System Agents|respiratory system agents|mesh-ancestor
93054433|NCT00023764|Bortezomib|bortezomib|mesh-list
93054434|NCT00023764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054435|NCT03961126|Clobetasol|clobetasol|mesh-list
93054436|NCT03961126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054437|NCT03961126|Glucocorticoids|glucocorticoids|mesh-ancestor
93054438|NCT03961126|Hormones|hormones|mesh-ancestor
93054439|NCT03961126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054440|NCT03961126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054441|NCT01584778|Eosinophil Cationic Protein|eosinophil cationic protein|mesh-list
93054443|NCT01584778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054444|NCT00189488|Methotrexate|methotrexate|mesh-list
93054445|NCT00189488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93054446|NCT00189488|Abortifacient Agents|abortifacient agents|mesh-ancestor
93054447|NCT00189488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93054448|NCT00189488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054449|NCT00189488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054450|NCT00189488|Antimetabolites|antimetabolites|mesh-ancestor
93054451|NCT00189488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054452|NCT00189488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054453|NCT00189488|Dermatologic Agents|dermatologic agents|mesh-ancestor
93054454|NCT00189488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054455|NCT00189488|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93054456|NCT00189488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054457|NCT00189488|Immunologic Factors|immunologic factors|mesh-ancestor
93054458|NCT00189488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054459|NCT00189488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93054460|NCT00233324|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93054461|NCT00233324|Respiratory System Agents|respiratory system agents|mesh-ancestor
93054462|NCT00023452|Isoniazid|isoniazid|mesh-list
93054463|NCT00023452|Rifapentine|rifapentine|mesh-list
93054464|NCT00023452|Antitubercular Agents|antitubercular agents|mesh-ancestor
93054465|NCT00023452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054466|NCT00023452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054467|NCT00023452|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93054468|NCT00023452|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93054469|NCT00023452|Antimetabolites|antimetabolites|mesh-ancestor
93054470|NCT00023452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054471|NCT00023452|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93054472|NCT00023452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93054473|NCT00023452|Leprostatic Agents|leprostatic agents|mesh-ancestor
93054474|NCT01088932|SRX246|srx246|mesh-list
93054475|NCT01088932|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93054476|NCT01088932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054477|NCT01088932|Natriuretic Agents|natriuretic agents|mesh-ancestor
93054478|NCT01088932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054479|NCT03961048|Ropivacaine|ropivacaine|mesh-list
93054480|NCT03961048|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93054481|NCT03961048|Anesthetics, Local|anesthetics, local|mesh-ancestor
93054482|NCT03961048|Anesthetics|anesthetics|mesh-ancestor
93054483|NCT03961048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93054484|NCT03961048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054485|NCT03961048|Sensory System Agents|sensory system agents|mesh-ancestor
93054486|NCT03961048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054487|NCT00022672|Trastuzumab|trastuzumab|mesh-list
93054488|NCT00022672|Anastrozole|anastrozole|mesh-list
93054489|NCT00022672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054490|NCT00022672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054491|NCT00022672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93054492|NCT00022672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93054493|NCT00022672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93054494|NCT00022672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054495|NCT00022672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054496|NCT00022672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93054497|NCT00022672|Hormone Antagonists|hormone antagonists|mesh-ancestor
93054498|NCT00022672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054499|NCT00022672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054500|NCT00141453|Olmesartan|olmesartan|mesh-list
93054501|NCT00141453|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92699478|NCT02924337|Moxifloxacin|moxifloxacin|mesh-list
93054502|NCT00141453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93054503|NCT00141453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93054504|NCT00141453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93054505|NCT00141453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054506|NCT00076570|Sirolimus|sirolimus|mesh-list
93054507|NCT00076570|Tacrolimus|tacrolimus|mesh-list
93054508|NCT00076570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054509|NCT00076570|Immunologic Factors|immunologic factors|mesh-ancestor
93054510|NCT00076570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054511|NCT00076570|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93054512|NCT00076570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054513|NCT00076570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054514|NCT00076570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054515|NCT00076570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054516|NCT00076570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054517|NCT00076570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054518|NCT00076570|Antifungal Agents|antifungal agents|mesh-ancestor
93054520|NCT00124449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93054521|NCT00124449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054522|NCT00124449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054523|NCT00124449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054524|NCT00124449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054525|NCT00124449|Immunologic Factors|immunologic factors|mesh-ancestor
93054526|NCT00124449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054527|NCT00124449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054528|NCT00076336|Lamivudine|lamivudine|mesh-list
93054529|NCT00076336|Telbivudine|telbivudine|mesh-list
93054530|NCT00076336|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93054531|NCT00076336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93054532|NCT00076336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054533|NCT00076336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054534|NCT00076336|Antiviral Agents|antiviral agents|mesh-ancestor
93054535|NCT00076336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054536|NCT00076336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93054537|NCT00076336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93054538|NCT00185588|Gemcitabine|gemcitabine|mesh-list
93054539|NCT00185588|Vatalanib|vatalanib|mesh-list
93054540|NCT00185588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054541|NCT00185588|Antimetabolites|antimetabolites|mesh-ancestor
93054542|NCT00185588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054543|NCT00185588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054544|NCT00185588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054545|NCT00185588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054546|NCT00231842|Ifosfamide|ifosfamide|mesh-list
93054547|NCT00231842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054548|NCT00231842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93054549|NCT00231842|Alkylating Agents|alkylating agents|mesh-ancestor
93054550|NCT00231842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054551|NCT01073150|Tea Tree Oil|tea tree oil|mesh-list
93054552|NCT01073150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93054553|NCT01073150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054554|NCT00076102|Pirfenidone|pirfenidone|mesh-list
93054555|NCT00076102|Analgesics|analgesics|mesh-ancestor
93054556|NCT00076102|Sensory System Agents|sensory system agents|mesh-ancestor
93054557|NCT00076102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054558|NCT00076102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054559|NCT00076102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93054560|NCT00076102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93054561|NCT00076102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054562|NCT00076102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054563|NCT00076102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054564|NCT03968588|Mycophenolic Acid|mycophenolic acid|mesh-list
93054565|NCT03968588|Tacrolimus|tacrolimus|mesh-list
93054566|NCT03968588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054567|NCT03968588|Immunologic Factors|immunologic factors|mesh-ancestor
93054568|NCT03968588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054569|NCT03968588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93054570|NCT03968588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054571|NCT03968588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054572|NCT03968588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054573|NCT03968588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054574|NCT03968588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93054575|NCT03968588|Antitubercular Agents|antitubercular agents|mesh-ancestor
92699569|NCT00527540|Ribavirin|ribavirin|mesh-list
93054576|NCT03968588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054577|NCT03968588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054579|NCT01582646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93054580|NCT01582646|Autonomic Agents|autonomic agents|mesh-ancestor
93054581|NCT01582646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054582|NCT01582646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054583|NCT01582646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93054584|NCT01582646|Respiratory System Agents|respiratory system agents|mesh-ancestor
93054585|NCT01582646|Sympathomimetics|sympathomimetics|mesh-ancestor
93054586|NCT01582646|Tocolytic Agents|tocolytic agents|mesh-ancestor
93054587|NCT01582646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93054588|NCT01582646|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93054589|NCT01582646|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93054590|NCT01582646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93054591|NCT01582646|Adrenergic Agents|adrenergic agents|mesh-ancestor
93054592|NCT01582646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054593|NCT01582646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054594|NCT03974360|Erenumab|erenumab|mesh-list
93054595|NCT03974360|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93054596|NCT03974360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054597|NCT03974360|Analgesics|analgesics|mesh-ancestor
93054598|NCT03974360|Sensory System Agents|sensory system agents|mesh-ancestor
93054599|NCT03974360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054600|NCT03974360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054601|NCT00184028|Oxaliplatin|oxaliplatin|mesh-list
93054602|NCT00184028|Docetaxel|docetaxel|mesh-list
93054603|NCT00184028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054604|NCT00184028|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054605|NCT00184028|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054606|NCT00184028|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054607|NCT00184028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054608|NCT00183872|Docetaxel|docetaxel|mesh-list
93054609|NCT00183872|Irinotecan|irinotecan|mesh-list
93054610|NCT00183872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054611|NCT00183872|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054612|NCT00183872|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054613|NCT00183872|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054614|NCT00183872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054615|NCT00183872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93054616|NCT00183872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93054617|NCT00183872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054618|NCT03815175|Aspirin|aspirin|mesh-list
93054619|NCT03815175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93054620|NCT03815175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93054621|NCT03815175|Analgesics|analgesics|mesh-ancestor
93054622|NCT03815175|Sensory System Agents|sensory system agents|mesh-ancestor
93054623|NCT03815175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054624|NCT03815175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054625|NCT03815175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054626|NCT03815175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054627|NCT03815175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93054628|NCT03815175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93054629|NCT03815175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054630|NCT03815175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93054631|NCT03815175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93054632|NCT03815175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054633|NCT03815175|Antipyretics|antipyretics|mesh-ancestor
93054634|NCT01080027|Interferons|interferons|mesh-list
93054635|NCT01080027|Interferon-beta|interferon-beta|mesh-list
93054636|NCT01080027|Interferon beta-1a|interferon beta-1a|mesh-list
93054637|NCT01080027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054638|NCT01080027|Antiviral Agents|antiviral agents|mesh-ancestor
93054639|NCT01080027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054640|NCT01080027|Immunologic Factors|immunologic factors|mesh-ancestor
93054641|NCT01080027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054642|NCT01080027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93054643|NCT00262028|Vaccines|vaccines|mesh-list
93054644|NCT00262028|Immunologic Factors|immunologic factors|mesh-ancestor
93054645|NCT00262028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054646|NCT00183248|Mycophenolic Acid|mycophenolic acid|mesh-list
93054647|NCT00183248|Sirolimus|sirolimus|mesh-list
93054648|NCT00183248|Alemtuzumab|alemtuzumab|mesh-list
93054649|NCT00183248|Tacrolimus|tacrolimus|mesh-list
93054650|NCT00183248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054651|NCT00183248|Immunologic Factors|immunologic factors|mesh-ancestor
93054652|NCT00183248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054653|NCT00183248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93054654|NCT00183248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054655|NCT00183248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054656|NCT00183248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054657|NCT00183248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054658|NCT00183248|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93054659|NCT00183248|Antitubercular Agents|antitubercular agents|mesh-ancestor
93054660|NCT00183248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054662|NCT00183248|Antifungal Agents|antifungal agents|mesh-ancestor
93054663|NCT00183248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054664|NCT00230282|Cyclophosphamide|cyclophosphamide|mesh-list
93054665|NCT00230282|Fludarabine|fludarabine|mesh-list
93054666|NCT00230282|Alemtuzumab|alemtuzumab|mesh-list
93054667|NCT00230282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054668|NCT00230282|Immunologic Factors|immunologic factors|mesh-ancestor
93054669|NCT00230282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054670|NCT00230282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054671|NCT00230282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93054672|NCT00230282|Alkylating Agents|alkylating agents|mesh-ancestor
93054673|NCT00230282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054674|NCT00230282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054675|NCT00230282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93054676|NCT00230282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054677|NCT00261950|Cinacalcet|cinacalcet|mesh-list
93054678|NCT00261950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93054679|NCT00261950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054680|NCT00261950|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93054681|NCT00261950|Hormone Antagonists|hormone antagonists|mesh-ancestor
93054682|NCT00261950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054683|NCT00229658|Pramlintide|pramlintide|mesh-list
93054684|NCT00229658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93054685|NCT00229658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054686|NCT00182078|Sertraline|sertraline|mesh-list
93054687|NCT00182078|Antidepressive Agents|antidepressive agents|mesh-ancestor
93054688|NCT00182078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93054689|NCT00182078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93054690|NCT00182078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93054691|NCT00182078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054692|NCT00182078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054693|NCT00182078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054694|NCT00182078|Serotonin Agents|serotonin agents|mesh-ancestor
93054695|NCT00182078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054696|NCT00181844|Lamotrigine|lamotrigine|mesh-list
93054697|NCT00181844|Anticonvulsants|anticonvulsants|mesh-ancestor
93054698|NCT00181844|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93054699|NCT00181844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054700|NCT00181844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054701|NCT00181844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93054702|NCT00181844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054703|NCT00181844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93054704|NCT00181844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93054705|NCT00181844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93054706|NCT00181844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93054707|NCT00181844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93054708|NCT00181766|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93054709|NCT00181766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93054710|NCT00181766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93054711|NCT00181766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054712|NCT00181766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054713|NCT00181766|Adrenergic Agents|adrenergic agents|mesh-ancestor
93054714|NCT00181766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054715|NCT00181766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054716|NCT00180674|Warfarin|warfarin|mesh-list
93054717|NCT00180674|Anticoagulants|anticoagulants|mesh-ancestor
93054718|NCT01074632|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93054719|NCT01074632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93054720|NCT01074632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93054721|NCT01074632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93054722|NCT01074632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054723|NCT01074632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93054724|NCT01074632|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93054725|NCT01074632|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93054726|NCT01074632|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93054727|NCT01074632|Adrenergic Agents|adrenergic agents|mesh-ancestor
93054728|NCT01074632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054729|NCT01074632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529496|NCT00001085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054730|NCT01074632|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93054731|NCT01074632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93054732|NCT01074632|Serotonin Agents|serotonin agents|mesh-ancestor
93054733|NCT01074632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93054734|NCT01074632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93054735|NCT01074632|Dopamine Agents|dopamine agents|mesh-ancestor
93054736|NCT00076024|Docetaxel|docetaxel|mesh-list
93054737|NCT00076024|Axitinib|axitinib|mesh-list
93054738|NCT00076024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054739|NCT00076024|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054740|NCT00076024|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054741|NCT00076024|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054742|NCT00076024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054743|NCT00076024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054744|NCT00076024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054745|NCT01103050|Cetirizine|cetirizine|mesh-list
93054746|NCT01103050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93054747|NCT01103050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93054748|NCT01103050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93054749|NCT01103050|Histamine Antagonists|histamine antagonists|mesh-ancestor
93054750|NCT01103050|Histamine Agents|histamine agents|mesh-ancestor
93054751|NCT01103050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330008|NCT00002785|Antiviral Agents|antiviral agents|mesh-ancestor
93054752|NCT01103050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054753|NCT01103050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054754|NCT00075478|Cyclosporine|cyclosporine|mesh-list
93054755|NCT00075478|Mycophenolic Acid|mycophenolic acid|mesh-list
93054756|NCT00075478|Fludarabine|fludarabine|mesh-list
93054757|NCT00075478|Fludarabine phosphate|fludarabine phosphate|mesh-list
93054758|NCT00075478|Cyclosporins|cyclosporins|mesh-list
93054759|NCT00075478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054760|NCT00075478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054761|NCT00075478|Antimetabolites|antimetabolites|mesh-ancestor
93054762|NCT00075478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054763|NCT00075478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054764|NCT00075478|Immunologic Factors|immunologic factors|mesh-ancestor
93054765|NCT00075478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054766|NCT00075478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054767|NCT00075478|Antifungal Agents|antifungal agents|mesh-ancestor
93054768|NCT00075478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054769|NCT00075478|Dermatologic Agents|dermatologic agents|mesh-ancestor
93054770|NCT00075478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054771|NCT00075478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93054772|NCT00075478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054773|NCT00075478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93054774|NCT00075478|Antitubercular Agents|antitubercular agents|mesh-ancestor
93054775|NCT00075478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054776|NCT00175916|Brivaracetam|brivaracetam|mesh-list
93054777|NCT00175916|Anticonvulsants|anticonvulsants|mesh-ancestor
93054778|NCT01089088|Gemcitabine|gemcitabine|mesh-list
93054779|NCT01089088|Sunitinib|sunitinib|mesh-list
93054780|NCT01089088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054781|NCT01089088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054782|NCT01089088|Antimetabolites|antimetabolites|mesh-ancestor
93054783|NCT01089088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054784|NCT01089088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93054785|NCT01089088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93054786|NCT01089088|Growth Substances|growth substances|mesh-ancestor
93054787|NCT01089088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054788|NCT01089088|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054789|NCT01089088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054790|NCT01089088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054791|NCT00075400|Imatinib Mesylate|imatinib mesylate|mesh-list
93054792|NCT00075400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054793|NCT00075400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054794|NCT00075400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054795|NCT00075400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054796|NCT01103206|Cinacalcet|cinacalcet|mesh-list
93054797|NCT01103206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93054798|NCT01103206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054799|NCT01103206|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
93054800|NCT01103206|Hormone Antagonists|hormone antagonists|mesh-ancestor
93054801|NCT01103206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054802|NCT00228566|Modafinil|modafinil|mesh-list
93054803|NCT00228566|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93054804|NCT00228566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054805|NCT00228566|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93054806|NCT00228566|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93054807|NCT00228566|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93054808|NCT00228566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054809|NCT05625724|Aspirin|aspirin|mesh-list
93054810|NCT05625724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93054811|NCT05625724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93054812|NCT05625724|Analgesics|analgesics|mesh-ancestor
93054813|NCT05625724|Sensory System Agents|sensory system agents|mesh-ancestor
93054814|NCT05625724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054815|NCT05625724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054816|NCT05625724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93054817|NCT05625724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054818|NCT05625724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93054819|NCT05625724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93054820|NCT05625724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054821|NCT05625724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93054822|NCT05625724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93054823|NCT05625724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054824|NCT05625724|Antipyretics|antipyretics|mesh-ancestor
93054825|NCT01089166|Metformin|metformin|mesh-list
93054826|NCT01089166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93054827|NCT01089166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054828|NCT00203502|Cyclophosphamide|cyclophosphamide|mesh-list
93054829|NCT00203502|Bevacizumab|bevacizumab|mesh-list
93054830|NCT00203502|Docetaxel|docetaxel|mesh-list
93054831|NCT00203502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054832|NCT00203502|Immunologic Factors|immunologic factors|mesh-ancestor
93054833|NCT00203502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054834|NCT00203502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054835|NCT00203502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93054836|NCT00203502|Alkylating Agents|alkylating agents|mesh-ancestor
93054837|NCT00203502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054838|NCT00203502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054839|NCT00203502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93054840|NCT00203502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054841|NCT00203502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93054842|NCT00203502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93054843|NCT00203502|Growth Substances|growth substances|mesh-ancestor
93054844|NCT00203502|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054845|NCT00203502|Tubulin Modulators|tubulin modulators|mesh-ancestor
93054846|NCT00203502|Antimitotic Agents|antimitotic agents|mesh-ancestor
93054847|NCT00203502|Mitosis Modulators|mitosis modulators|mesh-ancestor
93054848|NCT01103518|Cyproterone Acetate|cyproterone acetate|mesh-list
93054849|NCT01103518|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93054850|NCT01103518|Estradiol|estradiol|mesh-list
93054851|NCT01103518|Cyproterone|cyproterone|mesh-list
93054852|NCT01103518|Estrogens|estrogens|mesh-ancestor
93054853|NCT01103518|Hormones|hormones|mesh-ancestor
93054854|NCT01103518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054855|NCT01103518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054856|NCT01103518|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93054857|NCT01103518|Contraceptive Agents|contraceptive agents|mesh-ancestor
93054858|NCT01103518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93054859|NCT01103518|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93054860|NCT01103518|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93054861|NCT01103518|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93054862|NCT01103518|Androgen Antagonists|androgen antagonists|mesh-ancestor
93054863|NCT01103518|Hormone Antagonists|hormone antagonists|mesh-ancestor
93054864|NCT01103518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054865|NCT01103518|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93054866|NCT01327534|Clopidogrel|clopidogrel|mesh-list
93054867|NCT01327534|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93054868|NCT01327534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93054869|NCT01327534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93054870|NCT01327534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93054871|NCT01327534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93054872|NCT01327534|Purinergic Agents|purinergic agents|mesh-ancestor
93054873|NCT01327534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054874|NCT01327534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054875|NCT01327534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330036|NCT00003386|Carboplatin|carboplatin|mesh-list
93054877|NCT00232596|Anticonvulsants|anticonvulsants|mesh-ancestor
93054878|NCT00232596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93054879|NCT00232596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054880|NCT00073918|Iodine|iodine|mesh-list
93054881|NCT00073918|Cadexomer iodine|cadexomer iodine|mesh-list
93054882|NCT00073918|Cyclophosphamide|cyclophosphamide|mesh-list
93054883|NCT00073918|Etoposide|etoposide|mesh-list
93054884|NCT00073918|Etoposide phosphate|etoposide phosphate|mesh-list
93054885|NCT00073918|Tositumomab I-131|tositumomab i-131|mesh-list
93054886|NCT00073918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93054887|NCT00073918|Antibodies|antibodies|mesh-list
93054888|NCT00073918|Immunoglobulins|immunoglobulins|mesh-list
93054889|NCT00073918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93054890|NCT00073918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054891|NCT00073918|Immunologic Factors|immunologic factors|mesh-ancestor
93054892|NCT00073918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054893|NCT00073918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93054894|NCT00073918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93054895|NCT00073918|Alkylating Agents|alkylating agents|mesh-ancestor
93054896|NCT00073918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054897|NCT00073918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054898|NCT00073918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93054899|NCT00073918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93054900|NCT00073918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93054901|NCT00073918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93054902|NCT00073918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054903|NCT00073918|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93054904|NCT00073918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054905|NCT00073918|Trace Elements|trace elements|mesh-ancestor
93054906|NCT00073918|Micronutrients|micronutrients|mesh-ancestor
93054907|NCT00231894|Pioglitazone|pioglitazone|mesh-list
93054908|NCT00231894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93054909|NCT00231894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054910|NCT00203424|Bevacizumab|bevacizumab|mesh-list
93054911|NCT00203424|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93054912|NCT00203424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054913|NCT00203424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054914|NCT00203424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93054915|NCT00203424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93054916|NCT00203424|Growth Substances|growth substances|mesh-ancestor
93054917|NCT00203424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054918|NCT00203424|Growth Inhibitors|growth inhibitors|mesh-ancestor
93054919|NCT00203424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054920|NCT00203424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054921|NCT00203424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054922|NCT00203268|Dihydroergotamine|dihydroergotamine|mesh-list
93054923|NCT00203268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93054924|NCT00203268|Dopamine Agonists|dopamine agonists|mesh-ancestor
93054925|NCT00203268|Dopamine Agents|dopamine agents|mesh-ancestor
93054926|NCT00203268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93054927|NCT00203268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054928|NCT00203268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054929|NCT00203268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93054930|NCT00203268|Analgesics|analgesics|mesh-ancestor
93054931|NCT00203268|Sensory System Agents|sensory system agents|mesh-ancestor
93054932|NCT00203268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93054933|NCT00168818|Enoxaparin|enoxaparin|mesh-list
93054934|NCT00168818|Dabigatran|dabigatran|mesh-list
93054935|NCT00168818|Anticoagulants|anticoagulants|mesh-ancestor
93054936|NCT00168818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93054937|NCT00168818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93054938|NCT00168818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054939|NCT00168818|Antithrombins|antithrombins|mesh-ancestor
93054940|NCT00168818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93054941|NCT00168818|Protease Inhibitors|protease inhibitors|mesh-ancestor
93054942|NCT00168818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054943|NCT00260832|Cytarabine|cytarabine|mesh-list
93054944|NCT00260832|Decitabine|decitabine|mesh-list
93054945|NCT00260832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93054946|NCT00260832|Antimetabolites|antimetabolites|mesh-ancestor
93054947|NCT00260832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054948|NCT00260832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054949|NCT00260832|Antiviral Agents|antiviral agents|mesh-ancestor
93054950|NCT00260832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054951|NCT00260832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054952|NCT00260832|Immunologic Factors|immunologic factors|mesh-ancestor
93054953|NCT00260832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054954|NCT00260832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054955|NCT00168038|Immunoglobulins|immunoglobulins|mesh-list
93054956|NCT00168038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93054957|NCT00168038|Antibodies|antibodies|mesh-list
93054958|NCT00168038|Immunologic Factors|immunologic factors|mesh-ancestor
93054959|NCT00168038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054960|NCT00166712|Mycophenolic Acid|mycophenolic acid|mesh-list
93054961|NCT00166712|Sirolimus|sirolimus|mesh-list
93054962|NCT00166712|Alemtuzumab|alemtuzumab|mesh-list
93054963|NCT00166712|Tacrolimus|tacrolimus|mesh-list
93054964|NCT00166712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93054965|NCT00166712|Immunologic Factors|immunologic factors|mesh-ancestor
93054966|NCT00166712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054967|NCT00166712|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93054968|NCT00166712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054969|NCT00166712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054970|NCT00166712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93054971|NCT00166712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054972|NCT00166712|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93054973|NCT00166712|Antitubercular Agents|antitubercular agents|mesh-ancestor
93054974|NCT00166712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93054975|NCT00166712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93054976|NCT00166712|Antifungal Agents|antifungal agents|mesh-ancestor
93054977|NCT00166712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93054978|NCT00073528|Letrozole|letrozole|mesh-list
93054979|NCT00073528|Lapatinib|lapatinib|mesh-list
93054980|NCT00073528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93054981|NCT00073528|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93054982|NCT00073528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93054983|NCT00073528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054984|NCT00073528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054985|NCT00073528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93054986|NCT00073528|Hormone Antagonists|hormone antagonists|mesh-ancestor
93054987|NCT00073528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93054988|NCT00073528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93054989|NCT00073528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93054990|NCT03801148|Dexlansoprazole|dexlansoprazole|mesh-list
93054991|NCT03801148|Lansoprazole|lansoprazole|mesh-list
93054992|NCT03801148|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93054993|NCT03801148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93054994|NCT03801148|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93054995|NCT03801148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93054996|NCT03801148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93054997|NCT03960814|Insulin Detemir|insulin detemir|mesh-list
93054998|NCT03960814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93054999|NCT03960814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055000|NCT01103830|Moxifloxacin|moxifloxacin|mesh-list
93055001|NCT01103830|Lumefantrine|lumefantrine|mesh-list
93055002|NCT01103830|Artemether|artemether|mesh-list
93055003|NCT01103830|Piperaquine|piperaquine|mesh-list
93055004|NCT01103830|Artenimol|artenimol|mesh-list
93055005|NCT01103830|Artemisinins|artemisinins|mesh-list
93055006|NCT01103830|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92330067|NCT00384566|Antioxidants|antioxidants|mesh-ancestor
93055007|NCT01103830|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93055008|NCT01103830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93055009|NCT01103830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055010|NCT01103830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93055011|NCT01103830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93055012|NCT01103830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055013|NCT01103830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055014|NCT01103830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055015|NCT01103830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93055016|NCT01103830|Contraceptive Agents|contraceptive agents|mesh-ancestor
93055017|NCT01103830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93055018|NCT01103830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055019|NCT01103830|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93055020|NCT01103830|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93055021|NCT01103830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92700002|NCT02943317|Avelumab|avelumab|mesh-list
93055022|NCT01103830|Antimalarials|antimalarials|mesh-ancestor
93055023|NCT01103830|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93055024|NCT01103830|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93055025|NCT00072280|Dactinomycin|dactinomycin|mesh-list
93055026|NCT00072280|Cyclophosphamide|cyclophosphamide|mesh-list
93055027|NCT00072280|Ifosfamide|ifosfamide|mesh-list
93055028|NCT00072280|Isophosphamide mustard|isophosphamide mustard|mesh-list
93055029|NCT00072280|Etoposide|etoposide|mesh-list
93055030|NCT00072280|Vincristine|vincristine|mesh-list
93055031|NCT00072280|Lenograstim|lenograstim|mesh-list
93055032|NCT00072280|Mesna|mesna|mesh-list
93055033|NCT00072280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055034|NCT00072280|Immunologic Factors|immunologic factors|mesh-ancestor
93055035|NCT00072280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055036|NCT00072280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055037|NCT00072280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93055038|NCT00072280|Alkylating Agents|alkylating agents|mesh-ancestor
93055039|NCT00072280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055040|NCT00072280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055041|NCT00072280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93055042|NCT00072280|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93055043|NCT00072280|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93055044|NCT00072280|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93055045|NCT00072280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055046|NCT00072280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93055047|NCT00072280|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055048|NCT00072280|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055049|NCT00072280|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055050|NCT00072280|Protective Agents|protective agents|mesh-ancestor
93055051|NCT00072280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93055052|NCT00072280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055053|NCT00072280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93055054|NCT00072280|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93055055|NCT00072280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93055056|NCT01106716|Lidocaine|lidocaine|mesh-list
93055057|NCT01106716|Anesthetics, Local|anesthetics, local|mesh-ancestor
93055058|NCT01106716|Anesthetics|anesthetics|mesh-ancestor
93055059|NCT01106716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055060|NCT01106716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055061|NCT01106716|Sensory System Agents|sensory system agents|mesh-ancestor
93055062|NCT01106716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055063|NCT01106716|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93055064|NCT01106716|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93055065|NCT01106716|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93055066|NCT01106716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055067|NCT01106716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055068|NCT00071812|Belimumab|belimumab|mesh-list
93055069|NCT00071812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055070|NCT00071812|Immunologic Factors|immunologic factors|mesh-ancestor
92330068|NCT00384566|Protective Agents|protective agents|mesh-ancestor
93055071|NCT00071812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055072|NCT01104298|Doxorubicin|doxorubicin|mesh-list
93055073|NCT01104298|Trabectedin|trabectedin|mesh-list
93055074|NCT01104298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93055075|NCT01104298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055076|NCT01104298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93055077|NCT01104298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93055078|NCT01104298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055079|NCT01104298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055080|NCT01104298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93055081|NCT01104298|Alkylating Agents|alkylating agents|mesh-ancestor
93055082|NCT01106872|Bevacizumab|bevacizumab|mesh-list
93055083|NCT01106872|Gemcitabine|gemcitabine|mesh-list
93055084|NCT01106872|Docetaxel|docetaxel|mesh-list
93055085|NCT01106872|Valproic Acid|valproic acid|mesh-list
93055086|NCT01106872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055087|NCT01106872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055088|NCT01106872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93055089|NCT01106872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93055090|NCT01106872|Growth Substances|growth substances|mesh-ancestor
93055091|NCT01106872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055092|NCT01106872|Growth Inhibitors|growth inhibitors|mesh-ancestor
93055093|NCT01106872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93055094|NCT01106872|Antimetabolites|antimetabolites|mesh-ancestor
93055095|NCT01106872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055096|NCT01106872|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055097|NCT01106872|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055098|NCT01106872|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055099|NCT01106872|Anticonvulsants|anticonvulsants|mesh-ancestor
93055100|NCT01106872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055101|NCT01106872|GABA Agents|gaba agents|mesh-ancestor
93055102|NCT01106872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055103|NCT01106872|Antimanic Agents|antimanic agents|mesh-ancestor
93055104|NCT01106872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055105|NCT01106872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055106|NCT01106872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055107|NCT03960268|Brodalumab|brodalumab|mesh-list
93055108|NCT03960268|Dermatologic Agents|dermatologic agents|mesh-ancestor
93055109|NCT05485480|Analgesics, Opioid|analgesics, opioid|mesh-list
93055110|NCT05485480|Narcotics|narcotics|mesh-ancestor
93055111|NCT05485480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055112|NCT05485480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055113|NCT05485480|Analgesics|analgesics|mesh-ancestor
93055114|NCT05485480|Sensory System Agents|sensory system agents|mesh-ancestor
93055115|NCT05485480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055116|NCT05470270|Hydroxyurea|hydroxyurea|mesh-list
93055117|NCT05470270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055118|NCT05470270|Antisickling Agents|antisickling agents|mesh-ancestor
93055119|NCT05470270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055120|NCT05470270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055121|NCT05470270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93055122|NCT01107106|Ulipristal acetate|ulipristal acetate|mesh-list
93055123|NCT01107106|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93055124|NCT01107106|Contraceptive Agents|contraceptive agents|mesh-ancestor
93055125|NCT01107106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93055126|NCT01107106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055127|NCT01107106|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93055128|NCT00259610|Hydroxychloroquine|hydroxychloroquine|mesh-list
93055129|NCT00259610|Sulfasalazine|sulfasalazine|mesh-list
93055130|NCT00259610|Etanercept|etanercept|mesh-list
93055131|NCT00259610|Methotrexate|methotrexate|mesh-list
93055132|NCT00259610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93055133|NCT00259610|Abortifacient Agents|abortifacient agents|mesh-ancestor
93055134|NCT00259610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93055135|NCT00259610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055136|NCT00259610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93055137|NCT00259610|Antimetabolites|antimetabolites|mesh-ancestor
93055138|NCT00259610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055139|NCT00259610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055140|NCT00259610|Dermatologic Agents|dermatologic agents|mesh-ancestor
93055141|NCT00259610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055142|NCT00259610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93055143|NCT00259610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055144|NCT00259610|Immunologic Factors|immunologic factors|mesh-ancestor
93055145|NCT00259610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055146|NCT00259610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93055147|NCT00259610|Antimalarials|antimalarials|mesh-ancestor
93055148|NCT00259610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93055149|NCT00259610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93055150|NCT00259610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055151|NCT00259610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93055152|NCT00259610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93055153|NCT00259610|Analgesics|analgesics|mesh-ancestor
93055154|NCT00259610|Sensory System Agents|sensory system agents|mesh-ancestor
93055155|NCT00259610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055156|NCT00259610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055157|NCT00259610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055158|NCT05371132|Deferoxamine|deferoxamine|mesh-list
93055159|NCT05371132|Siderophores|siderophores|mesh-ancestor
93055160|NCT05371132|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93055161|NCT05371132|Chelating Agents|chelating agents|mesh-ancestor
93055162|NCT05371132|Sequestering Agents|sequestering agents|mesh-ancestor
93055163|NCT05371132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055164|NCT00165776|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
93055165|NCT00165776|Botulinum Toxins|botulinum toxins|mesh-list
93055166|NCT00165776|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93055167|NCT00165776|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93055168|NCT00165776|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93055169|NCT00165776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055170|NCT00165776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055171|NCT00165776|Cholinergic Agents|cholinergic agents|mesh-ancestor
93055172|NCT00165776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055173|NCT00165776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055175|NCT00165776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055176|NCT00165776|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93055177|NCT04459468|Ethiodized Oil|ethiodized oil|mesh-list
93055178|NCT04459468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055179|NCT00165698|Alfacalcidol|alfacalcidol|mesh-list
93055180|NCT00165698|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
93055181|NCT00165698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055182|NCT00165698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055183|NCT00165698|Vitamins|vitamins|mesh-ancestor
93055184|NCT00165698|Micronutrients|micronutrients|mesh-ancestor
93055185|NCT01075022|Vitamin D|vitamin d|mesh-list
93055186|NCT01075022|Cholecalciferol|cholecalciferol|mesh-list
93055187|NCT01075022|Vitamins|vitamins|mesh-ancestor
93055188|NCT01075022|Micronutrients|micronutrients|mesh-ancestor
93055189|NCT01075022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055190|NCT01075022|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055191|NCT01075022|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055192|NCT00225758|Lapatinib|lapatinib|mesh-list
93055193|NCT00225758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055194|NCT00225758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93055195|NCT00225758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055196|NCT00225758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055197|NCT01104532|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93055198|NCT01104532|Ipragliflozin|ipragliflozin|mesh-list
93055199|NCT01104532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93055200|NCT01104532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055201|NCT01104532|Incretins|incretins|mesh-ancestor
93055202|NCT01104532|Hormones|hormones|mesh-ancestor
93055203|NCT01104532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93055204|NCT01104532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93055205|NCT01104532|Protease Inhibitors|protease inhibitors|mesh-ancestor
93055206|NCT01104532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055207|NCT01104532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055208|NCT01104532|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93055209|NCT01107574|Gabapentin|gabapentin|mesh-list
93055210|NCT01107574|Analgesics|analgesics|mesh-ancestor
93055211|NCT01107574|Sensory System Agents|sensory system agents|mesh-ancestor
93055212|NCT01107574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055213|NCT01107574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055214|NCT01107574|Anticonvulsants|anticonvulsants|mesh-ancestor
93055215|NCT01107574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93055216|NCT01107574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055217|NCT01107574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055218|NCT01107574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055219|NCT01107574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93055220|NCT01107574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93055221|NCT01107574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055222|NCT01107574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055223|NCT01107574|Antimanic Agents|antimanic agents|mesh-ancestor
93055224|NCT03971500|Ticagrelor|ticagrelor|mesh-list
93055225|NCT03971500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055226|NCT03971500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055227|NCT03971500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93055228|NCT03971500|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93055229|NCT03971500|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93055230|NCT03971500|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93055231|NCT03971500|Purinergic Agents|purinergic agents|mesh-ancestor
93055232|NCT03971500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055233|NCT00259298|Teriparatide|teriparatide|mesh-list
93055234|NCT00259298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055235|NCT00259298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055236|NCT00259298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055237|NCT01108744|Mannitol|mannitol|mesh-list
93055238|NCT01108744|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93055239|NCT01108744|Diuretics|diuretics|mesh-ancestor
93055240|NCT01108744|Natriuretic Agents|natriuretic agents|mesh-ancestor
93055241|NCT01108744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055242|NCT01581866|Ziprasidone|ziprasidone|mesh-list
93055243|NCT01581866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93055244|NCT01581866|Serotonin Agents|serotonin agents|mesh-ancestor
93055245|NCT01581866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055246|NCT01581866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055247|NCT01581866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055248|NCT01581866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93055249|NCT01581866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055250|NCT01581866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055251|NCT01581866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055252|NCT01581866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93055253|NCT01581866|Dopamine Agents|dopamine agents|mesh-ancestor
93055255|NCT03892642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055256|NCT03892642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055257|NCT01107808|Calcium, Dietary|calcium, dietary|mesh-list
93055258|NCT01107808|Vitamin D|vitamin d|mesh-list
93055259|NCT01107808|Ergocalciferols|ergocalciferols|mesh-list
93055260|NCT01107808|Metformin|metformin|mesh-list
93055261|NCT01107808|Calcium|calcium|mesh-list
93055262|NCT01107808|Vitamins|vitamins|mesh-ancestor
93055263|NCT01107808|Micronutrients|micronutrients|mesh-ancestor
93055264|NCT01107808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055265|NCT01107808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93055266|NCT01107808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055267|NCT01107808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055268|NCT01104844|Acetaminophen|acetaminophen|mesh-list
93055269|NCT01104844|Ibuprofen|ibuprofen|mesh-list
93055270|NCT01104844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93055271|NCT01104844|Analgesics|analgesics|mesh-ancestor
93055272|NCT01104844|Sensory System Agents|sensory system agents|mesh-ancestor
93055273|NCT01104844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055274|NCT01104844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055275|NCT01104844|Antipyretics|antipyretics|mesh-ancestor
93055276|NCT01104844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93055277|NCT01104844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055278|NCT01104844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055279|NCT01104844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93055280|NCT01104844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055281|NCT01104844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055282|NCT03750136|Furosemide|furosemide|mesh-list
93055283|NCT03750136|Diuretics|diuretics|mesh-ancestor
93055284|NCT03750136|Natriuretic Agents|natriuretic agents|mesh-ancestor
93055285|NCT03750136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055286|NCT03750136|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93055287|NCT03750136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055288|NCT03750136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055289|NCT01108042|Docetaxel|docetaxel|mesh-list
93055290|NCT01108042|Fluorouracil|fluorouracil|mesh-list
93055291|NCT01108042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055292|NCT01108042|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055293|NCT01108042|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055294|NCT01108042|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055295|NCT01108042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055296|NCT01108042|Antimetabolites|antimetabolites|mesh-ancestor
93055297|NCT01108042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93055298|NCT01108042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055299|NCT01108042|Immunologic Factors|immunologic factors|mesh-ancestor
93055300|NCT01108042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060702|NCT01281514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93060703|NCT01281514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060704|NCT01281514|Immunologic Factors|immunologic factors|mesh-ancestor
93060705|NCT01281514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060706|NCT00223080|Aluminum Hydroxide|aluminum hydroxide|mesh-list
93060707|NCT00223080|Immunologic Factors|immunologic factors|mesh-ancestor
93060708|NCT00223080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060709|NCT00223080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93060710|NCT00223080|Antacids|antacids|mesh-ancestor
93060711|NCT00223080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060712|NCT00223080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060713|NCT03971604|Vitamins|vitamins|mesh-list
93060714|NCT03971604|Vitamin E|vitamin e|mesh-list
93060715|NCT03971604|Vitamin A|vitamin a|mesh-list
93060716|NCT03971604|Micronutrients|micronutrients|mesh-ancestor
93060717|NCT03971604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060718|NCT03971604|Antioxidants|antioxidants|mesh-ancestor
92529509|NCT02970916|Growth Substances|growth substances|mesh-ancestor
93060719|NCT03971604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060721|NCT02531490|Labetalol|labetalol|mesh-list
93060722|NCT02531490|Methyldopa|methyldopa|mesh-list
93060723|NCT02531490|Nifedipine|nifedipine|mesh-list
93060724|NCT02531490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93060725|NCT02531490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93060726|NCT02531490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055301|NCT01105234|Vitamin D|vitamin d|mesh-list
93055302|NCT01105234|Calcipotriene|calcipotriene|mesh-list
93055303|NCT01105234|Vitamins|vitamins|mesh-ancestor
93055304|NCT01105234|Micronutrients|micronutrients|mesh-ancestor
93055305|NCT01105234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055306|NCT01105234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055307|NCT01105234|Dermatologic Agents|dermatologic agents|mesh-ancestor
93055308|NCT01108198|Mometasone Furoate|mometasone furoate|mesh-list
93055309|NCT01108198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055310|NCT01108198|Dermatologic Agents|dermatologic agents|mesh-ancestor
93055311|NCT01108198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93055312|NCT01108900|Sildenafil Citrate|sildenafil citrate|mesh-list
93055313|NCT01108900|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055314|NCT01108900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92330203|NCT00004232|Hormones|hormones|mesh-ancestor
93055315|NCT01108900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93055316|NCT01108900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055317|NCT01108900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055318|NCT01108900|Urological Agents|urological agents|mesh-ancestor
93055319|NCT01105390|Pemetrexed|pemetrexed|mesh-list
93055320|NCT01105390|Rilotumumab|rilotumumab|mesh-list
93055321|NCT01105390|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93055322|NCT01105390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055323|NCT01105390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055324|NCT01105390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055325|NCT01105390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93055326|NCT01105390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93055327|NCT01105390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055328|NCT01105390|Immunologic Factors|immunologic factors|mesh-ancestor
93055329|NCT01105390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055330|NCT03947242|Trastuzumab|trastuzumab|mesh-list
93055331|NCT03947242|Vinorelbine|vinorelbine|mesh-list
93055332|NCT03947242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055333|NCT03947242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055334|NCT03947242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93055335|NCT03947242|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055336|NCT03947242|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055337|NCT03947242|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055338|NCT03947242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055339|NCT03944980|Docetaxel|docetaxel|mesh-list
93055340|NCT03944980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055341|NCT03944980|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055342|NCT03944980|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055343|NCT03944980|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055344|NCT03944980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055345|NCT03576664|Carvedilol|carvedilol|mesh-list
93055346|NCT03576664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93055347|NCT03576664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93055348|NCT03576664|Adrenergic Agents|adrenergic agents|mesh-ancestor
93055349|NCT03576664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330472|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
93055350|NCT03576664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055351|NCT03576664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055352|NCT03576664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93055353|NCT03576664|Antioxidants|antioxidants|mesh-ancestor
93055354|NCT03576664|Protective Agents|protective agents|mesh-ancestor
93055355|NCT03576664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93055356|NCT03576664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055357|NCT03576664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055358|NCT03576664|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055359|NCT03576664|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93055360|NCT03576664|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93055361|NCT01109134|Tirofiban|tirofiban|mesh-list
93055362|NCT01109134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93055363|NCT01109134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93055364|NCT01109134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055365|NCT01109134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93055366|NCT01108588|Aspirin|aspirin|mesh-list
93055367|NCT01108588|Clopidogrel|clopidogrel|mesh-list
93055368|NCT01108588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93055369|NCT01108588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93055370|NCT01108588|Analgesics|analgesics|mesh-ancestor
93055371|NCT01108588|Sensory System Agents|sensory system agents|mesh-ancestor
93055372|NCT01108588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055373|NCT01108588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055374|NCT01108588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700375|NCT03153150|Antithrombins|antithrombins|mesh-ancestor
93055375|NCT01108588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055376|NCT01108588|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93055377|NCT01108588|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93055378|NCT01108588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055379|NCT01108588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93055380|NCT01108588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93055381|NCT01108588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055382|NCT01108588|Antipyretics|antipyretics|mesh-ancestor
93055383|NCT01108588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93055384|NCT01108588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93055385|NCT01108588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93055386|NCT01108588|Purinergic Agents|purinergic agents|mesh-ancestor
93055387|NCT01108588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055388|NCT01208740|Metformin|metformin|mesh-list
93055389|NCT01208740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93055390|NCT01208740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055391|NCT01208818|Dexamethasone|dexamethasone|mesh-list
93055392|NCT01208818|Dexamethasone acetate|dexamethasone acetate|mesh-list
93055393|NCT01208818|Cyclophosphamide|cyclophosphamide|mesh-list
93055394|NCT01208818|Bortezomib|bortezomib|mesh-list
93055395|NCT01208818|BB 1101|bb 1101|mesh-list
93055396|NCT01208818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055397|NCT01208818|Immunologic Factors|immunologic factors|mesh-ancestor
93055398|NCT01208818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055399|NCT01208818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055400|NCT01208818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93055401|NCT01208818|Alkylating Agents|alkylating agents|mesh-ancestor
93055402|NCT01208818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055403|NCT01208818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055404|NCT01208818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93055405|NCT01208818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055406|NCT01208818|Antiemetics|antiemetics|mesh-ancestor
93055407|NCT01208818|Autonomic Agents|autonomic agents|mesh-ancestor
93055408|NCT01208818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055409|NCT01208818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055410|NCT01208818|Glucocorticoids|glucocorticoids|mesh-ancestor
93055411|NCT01208818|Hormones|hormones|mesh-ancestor
93055412|NCT01208818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93055413|NCT01208818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93055414|NCT01208818|Protease Inhibitors|protease inhibitors|mesh-ancestor
93055415|NCT01208818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055416|NCT01111630|Epoetin Alfa|epoetin alfa|mesh-list
93055417|NCT01111630|Hematinics|hematinics|mesh-ancestor
93055418|NCT03942796|Pregabalin|pregabalin|mesh-list
93055419|NCT03942796|Analgesics|analgesics|mesh-ancestor
93055420|NCT03942796|Sensory System Agents|sensory system agents|mesh-ancestor
93055421|NCT03942796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055422|NCT03942796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055423|NCT03942796|Anticonvulsants|anticonvulsants|mesh-ancestor
93055424|NCT03942796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93055425|NCT03942796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055426|NCT03942796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055427|NCT03942796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055428|NCT03942796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93055429|NCT03942796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055430|NCT03942796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055431|NCT03942796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055432|NCT01114282|Bortezomib|bortezomib|mesh-list
93055433|NCT01114282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055434|NCT01109212|Bindarit|bindarit|mesh-list
93055435|NCT01109212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055436|NCT01109212|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93055437|NCT01109212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055438|NCT01109212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055439|NCT01111864|Micronutrients|micronutrients|mesh-list
93055440|NCT01111864|Trace Elements|trace elements|mesh-list
93055441|NCT01111864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055442|NCT01111942|Cisplatin|cisplatin|mesh-list
93055443|NCT01111942|Carboplatin|carboplatin|mesh-list
93055444|NCT01111942|Docetaxel|docetaxel|mesh-list
93055445|NCT01111942|Fluorouracil|fluorouracil|mesh-list
93055446|NCT01111942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055447|NCT01111942|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055448|NCT01111942|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055449|NCT01111942|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055450|NCT01111942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055451|NCT01111942|Antimetabolites|antimetabolites|mesh-ancestor
93055452|NCT01111942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93055453|NCT01111942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055454|NCT01111942|Immunologic Factors|immunologic factors|mesh-ancestor
93055455|NCT01111942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055456|NCT01211860|Diazoxide|diazoxide|mesh-list
93055457|NCT01211860|Choline|choline|mesh-list
93055458|NCT01211860|Lipotropic Agents|lipotropic agents|mesh-ancestor
93055459|NCT01211860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93055460|NCT01211860|Antimetabolites|antimetabolites|mesh-ancestor
93055461|NCT01211860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055462|NCT01211860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055463|NCT01211860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93055464|NCT01211860|Nootropic Agents|nootropic agents|mesh-ancestor
93055465|NCT01211860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93055466|NCT01211860|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055467|NCT01211938|Cetuximab|cetuximab|mesh-list
92330940|NCT00005066|Alkylating Agents|alkylating agents|mesh-ancestor
93055468|NCT01211938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055469|NCT01211938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055470|NCT02947438|Epoetin Alfa|epoetin alfa|mesh-list
93055471|NCT02947438|Hematinics|hematinics|mesh-ancestor
93055472|NCT01209130|Rituximab|rituximab|mesh-list
93055473|NCT01209130|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
93055474|NCT01209130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055475|NCT01209130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055476|NCT01209130|Immunologic Factors|immunologic factors|mesh-ancestor
93055477|NCT01209130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055478|NCT01209130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055479|NCT01209130|Immunoconjugates|immunoconjugates|mesh-ancestor
93055480|NCT01209208|Budesonide|budesonide|mesh-list
93055481|NCT01209208|Mesalamine|mesalamine|mesh-list
93055482|NCT01209208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055483|NCT01209208|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93055484|NCT01209208|Autonomic Agents|autonomic agents|mesh-ancestor
93055485|NCT01209208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055486|NCT01209208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055487|NCT01209208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93055488|NCT01209208|Respiratory System Agents|respiratory system agents|mesh-ancestor
93055489|NCT01209208|Glucocorticoids|glucocorticoids|mesh-ancestor
93055490|NCT01209208|Hormones|hormones|mesh-ancestor
93055491|NCT01209208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93055492|NCT01209208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93055493|NCT01209208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93055494|NCT01209208|Analgesics|analgesics|mesh-ancestor
93055495|NCT01209208|Sensory System Agents|sensory system agents|mesh-ancestor
93055496|NCT01209208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055497|NCT01114750|Dextrans|dextrans|mesh-list
93055498|NCT01114750|Anticoagulants|anticoagulants|mesh-ancestor
93055499|NCT01114750|Plasma Substitutes|plasma substitutes|mesh-ancestor
93055500|NCT01114750|Blood Substitutes|blood substitutes|mesh-ancestor
93055501|NCT01328470|Cilostazol|cilostazol|mesh-list
93055502|NCT01328470|Clopidogrel|clopidogrel|mesh-list
93055503|NCT01328470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93055504|NCT01328470|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93055505|NCT01328470|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93055506|NCT01328470|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93055507|NCT01328470|Purinergic Agents|purinergic agents|mesh-ancestor
93055508|NCT01328470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055509|NCT01328470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055510|NCT01328470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055511|NCT01328470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93055512|NCT01328470|Autonomic Agents|autonomic agents|mesh-ancestor
93055513|NCT01328470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055514|NCT01328470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93055515|NCT01328470|Respiratory System Agents|respiratory system agents|mesh-ancestor
93055516|NCT01328470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93055517|NCT01328470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93055518|NCT01328470|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055519|NCT01328470|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93055520|NCT01328470|Protective Agents|protective agents|mesh-ancestor
93055521|NCT01328470|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93055522|NCT01328470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93055523|NCT01328470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055524|NCT01109446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93055525|NCT03940378|Levamisole|levamisole|mesh-list
93055526|NCT03940378|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93055527|NCT03940378|Immunologic Factors|immunologic factors|mesh-ancestor
93055528|NCT03940378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055529|NCT03940378|Antinematodal Agents|antinematodal agents|mesh-ancestor
93055530|NCT03940378|Anthelmintics|anthelmintics|mesh-ancestor
93055531|NCT03940378|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93055532|NCT03940378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055533|NCT03940378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055534|NCT01115062|Lidocaine|lidocaine|mesh-list
93055535|NCT01115062|Anesthetics, Local|anesthetics, local|mesh-ancestor
93055536|NCT01115062|Anesthetics|anesthetics|mesh-ancestor
93055537|NCT01115062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055538|NCT01115062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055539|NCT01115062|Sensory System Agents|sensory system agents|mesh-ancestor
93055540|NCT01115062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055541|NCT01115062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93055542|NCT01115062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93055543|NCT01115062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93055544|NCT01115062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055545|NCT01115062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055546|NCT01115140|Folic Acid|folic acid|mesh-list
93055547|NCT01115140|Vitamin B Complex|vitamin b complex|mesh-list
93055548|NCT01115140|Metformin|metformin|mesh-list
93055549|NCT01115140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93055550|NCT01115140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055551|NCT01115140|Hematinics|hematinics|mesh-ancestor
93055552|NCT01115140|Vitamins|vitamins|mesh-ancestor
93055553|NCT01115140|Micronutrients|micronutrients|mesh-ancestor
93055554|NCT01112644|Oxycodone|oxycodone|mesh-list
93055555|NCT01112644|Naloxone|naloxone|mesh-list
93055556|NCT01112644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93055557|NCT01112644|Narcotics|narcotics|mesh-ancestor
93055558|NCT01112644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055559|NCT01112644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055560|NCT01112644|Analgesics|analgesics|mesh-ancestor
93055561|NCT01112644|Sensory System Agents|sensory system agents|mesh-ancestor
93055562|NCT01112644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055563|NCT01112644|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93055564|NCT01112722|Histamine|histamine|mesh-list
93055565|NCT01112722|Histamine Agonists|histamine agonists|mesh-ancestor
93055566|NCT01112722|Histamine Agents|histamine agents|mesh-ancestor
93055567|NCT01112722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055568|NCT01112722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055569|NCT01112722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055570|NCT01015222|Paclitaxel|paclitaxel|mesh-list
93055571|NCT01015222|Bevacizumab|bevacizumab|mesh-list
93055572|NCT01015222|Dasatinib|dasatinib|mesh-list
93055573|NCT01015222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93055574|NCT01015222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055575|NCT01015222|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055576|NCT01015222|Antimitotic Agents|antimitotic agents|mesh-ancestor
93055577|NCT01015222|Mitosis Modulators|mitosis modulators|mesh-ancestor
93055578|NCT01015222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055579|NCT01015222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93055580|NCT01015222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93055581|NCT01015222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93055582|NCT01015222|Growth Substances|growth substances|mesh-ancestor
93055583|NCT01015222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055584|NCT01015222|Growth Inhibitors|growth inhibitors|mesh-ancestor
93055585|NCT01015222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93055586|NCT01015222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055587|NCT01212250|Carvedilol|carvedilol|mesh-list
93055588|NCT01212250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93055589|NCT01212250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93055590|NCT01212250|Adrenergic Agents|adrenergic agents|mesh-ancestor
93055591|NCT01212250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055592|NCT01212250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055593|NCT01212250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055594|NCT01212250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93055595|NCT01212250|Antioxidants|antioxidants|mesh-ancestor
93055596|NCT01212250|Protective Agents|protective agents|mesh-ancestor
93055597|NCT01212250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93055598|NCT01212250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055599|NCT01212250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055600|NCT01212250|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055601|NCT01212250|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93055602|NCT01212250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93055603|NCT01209988|Tamsulosin|tamsulosin|mesh-list
93055604|NCT01209988|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93055605|NCT01209988|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93055606|NCT01209988|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93055607|NCT01209988|Adrenergic Agents|adrenergic agents|mesh-ancestor
93055608|NCT01209988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055609|NCT01209988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055610|NCT01209988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055611|NCT01209988|Urological Agents|urological agents|mesh-ancestor
93055612|NCT03943186|Hyaluronic Acid|hyaluronic acid|mesh-list
93055613|NCT03943186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93055614|NCT03943186|Immunologic Factors|immunologic factors|mesh-ancestor
93055615|NCT03943186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055616|NCT03943186|Viscosupplements|viscosupplements|mesh-ancestor
93055617|NCT03943186|Protective Agents|protective agents|mesh-ancestor
93055618|NCT01210066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
93055619|NCT01210066|Fentanyl|fentanyl|mesh-list
93055620|NCT01210066|Analgesics, Opioid|analgesics, opioid|mesh-list
93055621|NCT01210066|Narcotics|narcotics|mesh-ancestor
93055622|NCT01210066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055623|NCT01210066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055624|NCT01210066|Analgesics|analgesics|mesh-ancestor
93055625|NCT01210066|Sensory System Agents|sensory system agents|mesh-ancestor
93055626|NCT01210066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055627|NCT01210066|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93055628|NCT01210066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93055629|NCT01210066|Anesthetics, General|anesthetics, general|mesh-ancestor
93055630|NCT01210066|Anesthetics|anesthetics|mesh-ancestor
93055631|NCT01112878|Clonidine|clonidine|mesh-list
93055632|NCT01112878|Gabapentin|gabapentin|mesh-list
93055633|NCT01112878|Analgesics|analgesics|mesh-ancestor
93055634|NCT01112878|Sensory System Agents|sensory system agents|mesh-ancestor
93055635|NCT01112878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055636|NCT01112878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055637|NCT01112878|Anticonvulsants|anticonvulsants|mesh-ancestor
93055638|NCT01112878|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93055639|NCT01112878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055640|NCT01112878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055641|NCT01112878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055642|NCT01112878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93055643|NCT01112878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93055644|NCT01112878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055645|NCT01112878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055646|NCT01112878|Antimanic Agents|antimanic agents|mesh-ancestor
93055647|NCT01112878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93055648|NCT01112878|Sympatholytics|sympatholytics|mesh-ancestor
93055649|NCT01112878|Autonomic Agents|autonomic agents|mesh-ancestor
93055650|NCT01112878|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93055651|NCT01112878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93055652|NCT01112878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93055653|NCT01112878|Adrenergic Agents|adrenergic agents|mesh-ancestor
93055654|NCT01212406|Vitamin D|vitamin d|mesh-list
93055655|NCT01212406|Vitamins|vitamins|mesh-ancestor
93055656|NCT01212406|Micronutrients|micronutrients|mesh-ancestor
93055657|NCT01212406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055658|NCT01212406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055659|NCT01109758|Fenofibrate|fenofibrate|mesh-list
93055660|NCT01109758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93055661|NCT01109758|Antimetabolites|antimetabolites|mesh-ancestor
93055662|NCT01109758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055663|NCT01109758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93055664|NCT01328236|Dexamethasone|dexamethasone|mesh-list
93055665|NCT01328236|Doxorubicin|doxorubicin|mesh-list
93055667|NCT01328236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055668|NCT01328236|Antiemetics|antiemetics|mesh-ancestor
93055669|NCT01328236|Autonomic Agents|autonomic agents|mesh-ancestor
93055670|NCT01328236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055671|NCT01328236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055672|NCT01328236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055673|NCT01328236|Glucocorticoids|glucocorticoids|mesh-ancestor
93055674|NCT01328236|Hormones|hormones|mesh-ancestor
93055675|NCT01328236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93055676|NCT01328236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93055677|NCT01328236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055678|NCT01328236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93055679|NCT01328236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93055680|NCT01328236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93055681|NCT01328236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055682|NCT01328236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055683|NCT01328392|Dexlansoprazole|dexlansoprazole|mesh-list
93055684|NCT01328392|Lansoprazole|lansoprazole|mesh-list
93055685|NCT01328392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93055686|NCT01328392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055687|NCT01328392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93055688|NCT01328392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055689|NCT01328392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055691|NCT01115842|Vitamins|vitamins|mesh-ancestor
93055692|NCT01115842|Micronutrients|micronutrients|mesh-ancestor
93055693|NCT01115842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055694|NCT01115842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93055695|NCT01210378|Nitroglycerin|nitroglycerin|mesh-list
93055696|NCT01210378|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055697|NCT01116154|Lenalidomide|lenalidomide|mesh-list
93055698|NCT01116154|Vorinostat|vorinostat|mesh-list
93055699|NCT01116154|Immunologic Factors|immunologic factors|mesh-ancestor
93055700|NCT01116154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055701|NCT01116154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93055702|NCT01116154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93055703|NCT01116154|Growth Substances|growth substances|mesh-ancestor
93055704|NCT01116154|Growth Inhibitors|growth inhibitors|mesh-ancestor
93055705|NCT01116154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055706|NCT01116154|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93055707|NCT01116154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055708|NCT01116154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055709|NCT01210456|Acetylcysteine|acetylcysteine|mesh-list
93055710|NCT01210456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93055711|NCT01210456|Antiviral Agents|antiviral agents|mesh-ancestor
93055712|NCT01210456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055713|NCT01210456|Expectorants|expectorants|mesh-ancestor
93055714|NCT01210456|Respiratory System Agents|respiratory system agents|mesh-ancestor
93055715|NCT01210456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93055716|NCT01210456|Antioxidants|antioxidants|mesh-ancestor
93055717|NCT01210456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055718|NCT01210456|Protective Agents|protective agents|mesh-ancestor
93055719|NCT01210456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055720|NCT01210456|Antidotes|antidotes|mesh-ancestor
93055721|NCT01116310|Glycine|glycine|mesh-list
93055722|NCT01116310|Glycine Agents|glycine agents|mesh-ancestor
93055723|NCT01116310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055724|NCT01116310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055725|NCT01116310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055726|NCT01210846|Tivozanib|tivozanib|mesh-list
93055727|NCT01210846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93055728|NCT01210846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055729|NCT01210846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055730|NCT01116388|Caseins|caseins|mesh-list
93055731|NCT01116388|Chelating Agents|chelating agents|mesh-ancestor
93055732|NCT01116388|Sequestering Agents|sequestering agents|mesh-ancestor
93055733|NCT01116388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055734|NCT01116622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93055735|NCT01116622|Bexarotene|bexarotene|mesh-list
93055736|NCT01116622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055737|NCT01116622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93055738|NCT01116622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055739|NCT01116622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055740|NCT03941626|Immunomodulating Agents|immunomodulating agents|mesh-list
93055741|NCT03941626|Immunologic Factors|immunologic factors|mesh-ancestor
93055742|NCT03941626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055743|NCT01211002|Endostatins|endostatins|mesh-list
93055744|NCT01211002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055745|NCT01211002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93055746|NCT01211002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93055747|NCT01211002|Growth Substances|growth substances|mesh-ancestor
93055748|NCT01211002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055749|NCT01211002|Growth Inhibitors|growth inhibitors|mesh-ancestor
93055750|NCT01211080|Propranolol|propranolol|mesh-list
93055751|NCT01211080|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93055752|NCT01211080|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93055753|NCT01211080|Adrenergic Agents|adrenergic agents|mesh-ancestor
93055754|NCT01211080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055755|NCT01211080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055756|NCT01211080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055757|NCT01211080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93055758|NCT01211080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93055759|NCT01211080|Vasodilator Agents|vasodilator agents|mesh-ancestor
93055760|NCT01116700|Dexmedetomidine|dexmedetomidine|mesh-list
93055761|NCT01116700|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93055762|NCT01116700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055763|NCT01116700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055764|NCT01116700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93055765|NCT01116700|Analgesics|analgesics|mesh-ancestor
93055766|NCT01116700|Sensory System Agents|sensory system agents|mesh-ancestor
93055767|NCT01116700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055768|NCT01116700|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93055769|NCT01116700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93055770|NCT01116700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93055771|NCT01116700|Adrenergic Agents|adrenergic agents|mesh-ancestor
93055772|NCT01116700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055773|NCT01116700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055774|NCT01113424|Nicotine|nicotine|mesh-list
93055775|NCT01113424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93055776|NCT01113424|Autonomic Agents|autonomic agents|mesh-ancestor
93055777|NCT01113424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055778|NCT01113424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055779|NCT01113424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93055780|NCT01113424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93055781|NCT01113424|Cholinergic Agents|cholinergic agents|mesh-ancestor
93055782|NCT01113424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055783|NCT01113424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055784|NCT01211158|Ketamine|ketamine|mesh-list
93055785|NCT01211158|Propofol|propofol|mesh-list
93055786|NCT01211158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93055787|NCT01211158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055788|NCT01211158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055789|NCT01211158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93055790|NCT01211158|Anesthetics, General|anesthetics, general|mesh-ancestor
93055791|NCT01211158|Anesthetics|anesthetics|mesh-ancestor
93055792|NCT01211158|Analgesics|analgesics|mesh-ancestor
93055793|NCT01211158|Sensory System Agents|sensory system agents|mesh-ancestor
93055794|NCT01211158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055795|NCT01211158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93055796|NCT01211158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93055797|NCT01211158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93055798|NCT01211158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055799|NCT01211158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055800|NCT01110226|Cisplatin|cisplatin|mesh-list
93055801|NCT01110226|Sodium arsenite|sodium arsenite|mesh-list
93055802|NCT01110226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055803|NCT01110226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055804|NCT01110226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055805|NCT03789292|Adalimumab|adalimumab|mesh-list
93055806|NCT03789292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93055807|NCT03789292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055808|NCT03789292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055809|NCT01211314|Enalapril|enalapril|mesh-list
93055810|NCT01211314|Lercanidipine|lercanidipine|mesh-list
93055811|NCT01211314|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93055812|NCT01211314|Protease Inhibitors|protease inhibitors|mesh-ancestor
93055813|NCT01211314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055814|NCT01211314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055815|NCT01211314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93055816|NCT01211314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93055817|NCT01211314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055818|NCT01211314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055819|NCT01211314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055820|NCT01110304|Analgesics|analgesics|mesh-list
93055821|NCT01110304|Sensory System Agents|sensory system agents|mesh-ancestor
93055822|NCT01110304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055823|NCT01110304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055824|NCT02529514|Baclofen|baclofen|mesh-list
93055825|NCT02529514|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93055826|NCT02529514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055827|NCT02529514|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93055828|NCT02529514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055829|NCT02529514|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93055830|NCT02529514|GABA Agonists|gaba agonists|mesh-ancestor
93055832|NCT02529514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055833|NCT02529514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055834|NCT01211470|Daptomycin|daptomycin|mesh-list
93055835|NCT01211470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93055836|NCT01211470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055837|NCT01114048|Thalidomide|thalidomide|mesh-list
93055838|NCT01114048|Dexamethasone|dexamethasone|mesh-list
93055839|NCT01114048|Cyclophosphamide|cyclophosphamide|mesh-list
93055840|NCT01114048|Bortezomib|bortezomib|mesh-list
93055841|NCT01114048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055842|NCT01114048|Immunologic Factors|immunologic factors|mesh-ancestor
93055843|NCT01114048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055844|NCT01114048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055845|NCT01114048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93055846|NCT01114048|Alkylating Agents|alkylating agents|mesh-ancestor
93055847|NCT01114048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055848|NCT01114048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055849|NCT01114048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93055850|NCT01114048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055851|NCT01114048|Antiemetics|antiemetics|mesh-ancestor
93055852|NCT01114048|Autonomic Agents|autonomic agents|mesh-ancestor
93055853|NCT01114048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055854|NCT01114048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055855|NCT01114048|Glucocorticoids|glucocorticoids|mesh-ancestor
93055856|NCT01114048|Hormones|hormones|mesh-ancestor
93055857|NCT01114048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93055858|NCT01114048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93055859|NCT01114048|Leprostatic Agents|leprostatic agents|mesh-ancestor
93055860|NCT01114048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93055861|NCT01114048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93055862|NCT01114048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93055863|NCT01114048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93055864|NCT01114048|Growth Substances|growth substances|mesh-ancestor
93055865|NCT01114048|Growth Inhibitors|growth inhibitors|mesh-ancestor
92331004|NCT04698031|Aspirin|aspirin|mesh-list
93055866|NCT01208194|Immunologic Factors|immunologic factors|mesh-list
93055867|NCT01208194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055868|NCT01211704|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93055869|NCT01211704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93055870|NCT01211704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055871|NCT01211704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055872|NCT01211704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055873|NCT01211704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055874|NCT01211704|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93055875|NCT01211704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93055876|NCT01211704|Serotonin Agents|serotonin agents|mesh-ancestor
93055877|NCT01211704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055878|NCT01211704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055879|NCT01211704|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93055880|NCT01211704|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93055881|NCT01211704|Dopamine Agents|dopamine agents|mesh-ancestor
93055882|NCT02529670|Lidocaine|lidocaine|mesh-list
93055883|NCT02529670|Anesthetics, Local|anesthetics, local|mesh-ancestor
93055884|NCT02529670|Anesthetics|anesthetics|mesh-ancestor
93055885|NCT02529670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055886|NCT02529670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055887|NCT02529670|Sensory System Agents|sensory system agents|mesh-ancestor
93055888|NCT02529670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055889|NCT02529670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93055890|NCT02529670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93055891|NCT02529670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93055892|NCT02529670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055893|NCT02529670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055894|NCT01117636|Aspirin|aspirin|mesh-list
93055895|NCT01117636|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93055896|NCT01117636|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93055897|NCT01117636|Analgesics|analgesics|mesh-ancestor
93055898|NCT01117636|Sensory System Agents|sensory system agents|mesh-ancestor
93055899|NCT01117636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055900|NCT01117636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055901|NCT01117636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93055902|NCT01117636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93055903|NCT01117636|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92700939|NCT01289821|Leucovorin|leucovorin|mesh-list
93055904|NCT01117636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93055905|NCT01117636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055906|NCT01117636|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93055907|NCT01117636|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93055908|NCT01117636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055909|NCT01117636|Antipyretics|antipyretics|mesh-ancestor
93055910|NCT03938740|Insulin|insulin|mesh-list
93055911|NCT03938740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93055912|NCT03938740|Insulin Lispro|insulin lispro|mesh-list
93055913|NCT03938740|Insulin, Long-Acting|insulin, long-acting|mesh-list
93055914|NCT03938740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93055915|NCT03938740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055916|NCT01110616|Lorazepam|lorazepam|mesh-list
93055917|NCT01110616|Anticonvulsants|anticonvulsants|mesh-ancestor
93055918|NCT01110616|Antiemetics|antiemetics|mesh-ancestor
93055919|NCT01110616|Autonomic Agents|autonomic agents|mesh-ancestor
93055920|NCT01110616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055921|NCT01110616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055922|NCT01110616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055923|NCT01110616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93055924|NCT01110616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055925|NCT01110616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93055926|NCT01110616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055927|NCT01110616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055928|NCT01110616|GABA Modulators|gaba modulators|mesh-ancestor
93055929|NCT01110616|GABA Agents|gaba agents|mesh-ancestor
93055930|NCT01110616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93055931|NCT01110616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055932|NCT03938662|Choline|choline|mesh-list
93055933|NCT03938662|Lipotropic Agents|lipotropic agents|mesh-ancestor
93055934|NCT03938662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93055935|NCT03938662|Antimetabolites|antimetabolites|mesh-ancestor
93055936|NCT03938662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055937|NCT03938662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93055938|NCT03938662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93055939|NCT03938662|Nootropic Agents|nootropic agents|mesh-ancestor
93055940|NCT01213498|Atorvastatin|atorvastatin|mesh-list
93055941|NCT01213498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93055942|NCT01213498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93055943|NCT01213498|Antimetabolites|antimetabolites|mesh-ancestor
93055944|NCT01213498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055945|NCT01213498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93055946|NCT01213498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93055947|NCT01213498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055948|NCT01111084|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93055949|NCT01111084|Hormones|hormones|mesh-ancestor
93055950|NCT01111084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93055951|NCT01111084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055952|NCT01118260|Anesthetics|anesthetics|mesh-list
93055953|NCT01118260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055954|NCT01118260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055955|NCT01121770|PENTA|penta|mesh-list
93055956|NCT01121770|Fondaparinux|fondaparinux|mesh-list
93055957|NCT01121770|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93055958|NCT01121770|Antithrombins|antithrombins|mesh-ancestor
93055959|NCT01121770|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93055960|NCT01121770|Protease Inhibitors|protease inhibitors|mesh-ancestor
93055961|NCT01121770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93055962|NCT01121770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055963|NCT01121770|Anticoagulants|anticoagulants|mesh-ancestor
93055964|NCT01121770|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93055965|NCT01121770|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93055966|NCT01121848|Leucovorin|leucovorin|mesh-list
93055967|NCT01121848|Fluorouracil|fluorouracil|mesh-list
93055968|NCT01121848|Oxaliplatin|oxaliplatin|mesh-list
93055969|NCT01121848|Antimetabolites|antimetabolites|mesh-ancestor
93055970|NCT01121848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055971|NCT01121848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93055972|NCT01121848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055973|NCT01121848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93055974|NCT01121848|Immunologic Factors|immunologic factors|mesh-ancestor
93055975|NCT01121848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055976|NCT01121848|Antidotes|antidotes|mesh-ancestor
93055977|NCT01121848|Protective Agents|protective agents|mesh-ancestor
93055978|NCT01121848|Vitamin B Complex|vitamin b complex|mesh-ancestor
93055979|NCT01121848|Vitamins|vitamins|mesh-ancestor
93055980|NCT01121848|Micronutrients|micronutrients|mesh-ancestor
93055981|NCT01122004|Pregabalin|pregabalin|mesh-list
93055982|NCT01122004|Analgesics|analgesics|mesh-ancestor
93055983|NCT01122004|Sensory System Agents|sensory system agents|mesh-ancestor
93055984|NCT01122004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93055985|NCT01122004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93055986|NCT01122004|Anticonvulsants|anticonvulsants|mesh-ancestor
93055987|NCT01122004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93055988|NCT01122004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93055989|NCT01122004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93055990|NCT01122004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93055991|NCT01122004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93055992|NCT01122004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93055993|NCT01122004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93055994|NCT01122004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93055995|NCT03933982|Vinorelbine|vinorelbine|mesh-list
93055996|NCT03933982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93055997|NCT03933982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93055998|NCT03933982|Tubulin Modulators|tubulin modulators|mesh-ancestor
93055999|NCT03933982|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056000|NCT03933982|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056001|NCT03933982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056002|NCT01118572|Celecoxib|celecoxib|mesh-list
93056003|NCT01118572|Etodolac|etodolac|mesh-list
93056004|NCT01118572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93056005|NCT01118572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93056006|NCT01118572|Analgesics|analgesics|mesh-ancestor
93056007|NCT01118572|Sensory System Agents|sensory system agents|mesh-ancestor
93056008|NCT01118572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056009|NCT01118572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056010|NCT01118572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056011|NCT01118572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056012|NCT01118572|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93056013|NCT01118572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93056014|NCT01118572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056015|NCT01118572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056016|NCT03937648|Lasmiditan|lasmiditan|mesh-list
93056017|NCT03937648|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93056018|NCT03937648|Serotonin Agents|serotonin agents|mesh-ancestor
93056019|NCT03937648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056020|NCT03937648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056021|NCT03937648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056022|NCT01219036|Budesonide|budesonide|mesh-list
93056023|NCT01219036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056024|NCT01219036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93056025|NCT01219036|Autonomic Agents|autonomic agents|mesh-ancestor
93056026|NCT01219036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056027|NCT01219036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056028|NCT01219036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93056029|NCT01219036|Respiratory System Agents|respiratory system agents|mesh-ancestor
93056030|NCT01219036|Glucocorticoids|glucocorticoids|mesh-ancestor
93056032|NCT01219036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056033|NCT01124500|Methylphenidate|methylphenidate|mesh-list
93056034|NCT01124500|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93056035|NCT01124500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056036|NCT01124500|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93056037|NCT01124500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93056038|NCT01124500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056039|NCT01124500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056040|NCT01124500|Dopamine Agents|dopamine agents|mesh-ancestor
93056041|NCT01124500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056042|NCT01118884|Promethazine|promethazine|mesh-list
93056043|NCT01118884|Diphenhydramine|diphenhydramine|mesh-list
93056044|NCT01118884|Antipruritics|antipruritics|mesh-ancestor
93056045|NCT01118884|Dermatologic Agents|dermatologic agents|mesh-ancestor
93056046|NCT01118884|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93056047|NCT01118884|Histamine Antagonists|histamine antagonists|mesh-ancestor
93056048|NCT01118884|Histamine Agents|histamine agents|mesh-ancestor
93056049|NCT01118884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056050|NCT01118884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056051|NCT01118884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056052|NCT01118884|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93056053|NCT01118884|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93056054|NCT01118884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93056055|NCT01118884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056056|NCT01118884|Anesthetics, Local|anesthetics, local|mesh-ancestor
93056057|NCT01118884|Anesthetics|anesthetics|mesh-ancestor
93056058|NCT01118884|Sensory System Agents|sensory system agents|mesh-ancestor
93056059|NCT01118884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056060|NCT01118884|Antiemetics|antiemetics|mesh-ancestor
93056061|NCT01118884|Autonomic Agents|autonomic agents|mesh-ancestor
93056062|NCT01118884|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056063|NCT01119196|Dialysis Solutions|dialysis solutions|mesh-list
93056065|NCT01119196|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93056066|NCT01213888|Trientine|trientine|mesh-list
93056067|NCT01213888|Chelating Agents|chelating agents|mesh-ancestor
93056068|NCT01213888|Sequestering Agents|sequestering agents|mesh-ancestor
93056069|NCT01213888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056070|NCT01119430|Fluoxetine|fluoxetine|mesh-list
93056071|NCT01119430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93056072|NCT01119430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93056073|NCT01119430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056074|NCT01119430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056075|NCT01119430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056076|NCT01119430|Serotonin Agents|serotonin agents|mesh-ancestor
93056077|NCT01119430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056078|NCT01119430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93056079|NCT01119430|Antidepressive Agents|antidepressive agents|mesh-ancestor
93056080|NCT01119430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056081|NCT01119430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93056082|NCT01119430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93056083|NCT01119430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056084|NCT02529124|Caseins|caseins|mesh-list
93056085|NCT02529124|Chelating Agents|chelating agents|mesh-ancestor
93056086|NCT02529124|Sequestering Agents|sequestering agents|mesh-ancestor
93056087|NCT02529124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056088|NCT03780244|Mannitol|mannitol|mesh-list
93056089|NCT03780244|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
93056090|NCT03780244|Diuretics|diuretics|mesh-ancestor
93056091|NCT03780244|Natriuretic Agents|natriuretic agents|mesh-ancestor
93056092|NCT03780244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056093|NCT01119742|Butenafine|butenafine|mesh-list
93056094|NCT01119742|Antifungal Agents|antifungal agents|mesh-ancestor
93056095|NCT01119742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056096|NCT01216696|Ipilimumab|ipilimumab|mesh-list
93056097|NCT01216696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93056098|NCT01216696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056099|NCT01216696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93056100|NCT01216696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056101|NCT03937258|Probenecid|probenecid|mesh-list
93056102|NCT03937258|Abrocitinib|abrocitinib|mesh-list
93056103|NCT03937258|Uricosuric Agents|uricosuric agents|mesh-ancestor
93056104|NCT03937258|Gout Suppressants|gout suppressants|mesh-ancestor
93056105|NCT03937258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056106|NCT03937258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056107|NCT03937258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056108|NCT03937258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056110|NCT01124656|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
93056111|NCT01124656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056112|NCT01124656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056113|NCT01124656|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93056114|NCT01124656|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93056115|NCT01124656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056116|NCT01122472|Lenalidomide|lenalidomide|mesh-list
93056117|NCT01122472|Immunologic Factors|immunologic factors|mesh-ancestor
93056118|NCT01122472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056119|NCT01122472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93056120|NCT01122472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056121|NCT01122472|Growth Substances|growth substances|mesh-ancestor
93056122|NCT01122472|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056123|NCT01122472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056124|NCT01214122|Warfarin|warfarin|mesh-list
93056125|NCT01214122|Anticoagulants|anticoagulants|mesh-ancestor
93056126|NCT03935152|Dydrogesterone|dydrogesterone|mesh-list
93056127|NCT03935152|Progestins|progestins|mesh-ancestor
93056128|NCT03935152|Hormones|hormones|mesh-ancestor
92701159|NCT02935647|Propofol|propofol|mesh-list
93056129|NCT03935152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056130|NCT03935152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056131|NCT01216852|Losartan|losartan|mesh-list
93056132|NCT01216852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93056133|NCT01216852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93056134|NCT01216852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93056135|NCT01216852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93056136|NCT01216852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056137|NCT03933748|Teicoplanin|teicoplanin|mesh-list
93056138|NCT03933748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93056139|NCT03933748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056140|NCT01120366|Methotrexate|methotrexate|mesh-list
93056141|NCT01120366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93056142|NCT01120366|Abortifacient Agents|abortifacient agents|mesh-ancestor
93056143|NCT01120366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93056144|NCT01120366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056145|NCT01120366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93056146|NCT01120366|Antimetabolites|antimetabolites|mesh-ancestor
93056147|NCT01120366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056148|NCT01120366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056149|NCT01120366|Dermatologic Agents|dermatologic agents|mesh-ancestor
93056150|NCT01120366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056151|NCT01120366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93056152|NCT01120366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056153|NCT01120366|Immunologic Factors|immunologic factors|mesh-ancestor
93056154|NCT01120366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056155|NCT01120366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93056156|NCT01217086|Infliximab|infliximab|mesh-list
93056157|NCT01217086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93056158|NCT01217086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056159|NCT01217086|Dermatologic Agents|dermatologic agents|mesh-ancestor
93056160|NCT01217086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056161|NCT01217086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056162|NCT01120444|Insulin|insulin|mesh-list
93056163|NCT01120444|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056164|NCT01120444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056165|NCT01217398|Bevacizumab|bevacizumab|mesh-list
93056166|NCT01217398|Temozolomide|temozolomide|mesh-list
93056167|NCT01217398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93056168|NCT01217398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056169|NCT01217398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93056170|NCT01217398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056171|NCT01217398|Growth Substances|growth substances|mesh-ancestor
93056172|NCT01217398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056173|NCT01217398|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056174|NCT01217398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93056175|NCT01217398|Alkylating Agents|alkylating agents|mesh-ancestor
93056176|NCT01217398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056177|NCT01125124|Silver Nitrate|silver nitrate|mesh-list
93056178|NCT01125124|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93056179|NCT01125124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056180|NCT01214746|Atorvastatin|atorvastatin|mesh-list
93056181|NCT01214746|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93056182|NCT01214746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93056183|NCT01214746|Antimetabolites|antimetabolites|mesh-ancestor
93056184|NCT01214746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056185|NCT01214746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93056186|NCT01214746|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93056187|NCT01214746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056188|NCT03935074|Melphalan|melphalan|mesh-list
93056189|NCT03935074|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93056190|NCT03935074|Alkylating Agents|alkylating agents|mesh-ancestor
93056191|NCT03935074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056192|NCT03935074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056193|NCT03935074|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93056194|NCT03935074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056195|NCT03935074|Immunologic Factors|immunologic factors|mesh-ancestor
93056196|NCT03935074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056197|NCT01217632|Entecavir|entecavir|mesh-list
93056198|NCT01217632|Antiviral Agents|antiviral agents|mesh-ancestor
93056199|NCT01217632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056200|NCT03933280|Dexmedetomidine|dexmedetomidine|mesh-list
93056201|NCT03933280|Nalbuphine|nalbuphine|mesh-list
93056202|NCT03933280|Propofol|propofol|mesh-list
93056203|NCT03933280|Benoxinate|benoxinate|mesh-list
93056204|NCT03933280|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93056205|NCT03933280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93056206|NCT03933280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056207|NCT03933280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056208|NCT03933280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93056209|NCT03933280|Analgesics|analgesics|mesh-ancestor
93056210|NCT03933280|Sensory System Agents|sensory system agents|mesh-ancestor
93056211|NCT03933280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056212|NCT03933280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93056213|NCT03933280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93056214|NCT03933280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93056215|NCT03933280|Adrenergic Agents|adrenergic agents|mesh-ancestor
93056216|NCT03933280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056217|NCT03933280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056218|NCT03933280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93056219|NCT03933280|Anesthetics, General|anesthetics, general|mesh-ancestor
93056220|NCT03933280|Anesthetics|anesthetics|mesh-ancestor
93056221|NCT03933280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93056222|NCT03933280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93056223|NCT03933280|Narcotics|narcotics|mesh-ancestor
93056224|NCT03933280|Anesthetics, Local|anesthetics, local|mesh-ancestor
93056225|NCT01120912|Insulin|insulin|mesh-list
93056226|NCT01120912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056227|NCT01120912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056228|NCT01219582|Metformin|metformin|mesh-list
93056229|NCT01219582|Acarbose|acarbose|mesh-list
93056230|NCT01219582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056231|NCT01219582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056232|NCT01219582|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93056233|NCT01219582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056234|NCT01219582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056235|NCT03933358|Hormones|hormones|mesh-list
93056236|NCT03933358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056237|NCT03933358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056238|NCT01122940|Phenytoin|phenytoin|mesh-list
93056239|NCT01122940|Anticonvulsants|anticonvulsants|mesh-ancestor
93056240|NCT01122940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93056241|NCT01122940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93056242|NCT01122940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056243|NCT01122940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056244|NCT01122940|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93056245|NCT01122940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93056246|NCT01219816|Epratuzumab|epratuzumab|mesh-list
93056247|NCT01219816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93056248|NCT01219816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056249|NCT01215136|Paclitaxel|paclitaxel|mesh-list
93056250|NCT01215136|Everolimus|everolimus|mesh-list
93056251|NCT01215136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056252|NCT01215136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056253|NCT01215136|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056254|NCT01215136|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056255|NCT01215136|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056256|NCT01215136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056257|NCT01215136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93056258|NCT01215136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056259|NCT01215136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056260|NCT01215136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056261|NCT01215136|Immunologic Factors|immunologic factors|mesh-ancestor
93056262|NCT01215136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056263|NCT01218022|Losartan|losartan|mesh-list
93056264|NCT01218022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93056265|NCT01218022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93056266|NCT01218022|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93056267|NCT01218022|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93056268|NCT01218022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056269|NCT01121458|Clevidipine|clevidipine|mesh-list
93056270|NCT01121458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93056271|NCT01121458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056272|NCT01121458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056273|NCT01121458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93056274|NCT01121458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701293|NCT02935101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056276|NCT01215214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93056277|NCT01215214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93056278|NCT01215214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056279|NCT01215214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056280|NCT01215214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93056281|NCT01215214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93056282|NCT01215214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056283|NCT01215214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93056284|NCT01215214|Anesthetics, General|anesthetics, general|mesh-ancestor
93056285|NCT01215214|Anesthetics|anesthetics|mesh-ancestor
93056286|NCT01215214|GABA Modulators|gaba modulators|mesh-ancestor
93056287|NCT01215214|GABA Agents|gaba agents|mesh-ancestor
93056288|NCT01215214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056289|NCT01215214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056290|NCT03936166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93056291|NCT01125670|Darexaban|darexaban|mesh-list
93056292|NCT01125670|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93056293|NCT01125670|Antithrombins|antithrombins|mesh-ancestor
93056294|NCT01125670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93056295|NCT01125670|Protease Inhibitors|protease inhibitors|mesh-ancestor
93056296|NCT01125670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056297|NCT01125670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056298|NCT01125670|Anticoagulants|anticoagulants|mesh-ancestor
93056299|NCT03934450|Primaquine|primaquine|mesh-list
93056300|NCT03934450|Antimalarials|antimalarials|mesh-ancestor
93056301|NCT03934450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93056302|NCT03934450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93056303|NCT03934450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056304|NCT01215682|Vitamin D|vitamin d|mesh-list
93056305|NCT01215682|Vitamins|vitamins|mesh-ancestor
93056306|NCT01215682|Micronutrients|micronutrients|mesh-ancestor
93056307|NCT01215682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056308|NCT01215682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93056309|NCT03932344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93056310|NCT03932344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056311|NCT01123408|Haloperidol|haloperidol|mesh-list
93056312|NCT01123408|Olanzapine|olanzapine|mesh-list
93056313|NCT01123408|Haloperidol decanoate|haloperidol decanoate|mesh-list
93056314|NCT01123408|Clozapine|clozapine|mesh-list
93056315|NCT01123408|Antiemetics|antiemetics|mesh-ancestor
93056316|NCT01123408|Autonomic Agents|autonomic agents|mesh-ancestor
93056317|NCT01123408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056318|NCT01123408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056319|NCT01123408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056320|NCT01123408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93056321|NCT01123408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93056322|NCT01123408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056323|NCT01123408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056324|NCT01123408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93056325|NCT01123408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93056326|NCT01123408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056327|NCT01123408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056328|NCT01123408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056329|NCT01123408|Serotonin Agents|serotonin agents|mesh-ancestor
93056330|NCT01123408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93056331|NCT01123408|Dopamine Agents|dopamine agents|mesh-ancestor
93056332|NCT01123408|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93056333|NCT01123408|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93056334|NCT01123408|GABA Antagonists|gaba antagonists|mesh-ancestor
93056335|NCT01123408|GABA Agents|gaba agents|mesh-ancestor
93056336|NCT00141297|Palbociclib|palbociclib|mesh-list
93056337|NCT00141297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056338|NCT00141297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056339|NCT00141297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056340|NCT00141297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056341|NCT01123486|Hydromorphone|hydromorphone|mesh-list
93056342|NCT01123486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93056343|NCT01123486|Narcotics|narcotics|mesh-ancestor
93056344|NCT01123486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056345|NCT01123486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056346|NCT01123486|Analgesics|analgesics|mesh-ancestor
93056347|NCT01123486|Sensory System Agents|sensory system agents|mesh-ancestor
93056348|NCT01123486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056349|NCT01123564|Ranibizumab|ranibizumab|mesh-list
93056350|NCT01123564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93056351|NCT01123564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056352|NCT01123564|Growth Substances|growth substances|mesh-ancestor
93056353|NCT01123564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056354|NCT01123564|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056355|NCT01123564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056356|NCT01222312|Docetaxel|docetaxel|mesh-list
93056357|NCT01222312|Oxaliplatin|oxaliplatin|mesh-list
93056358|NCT01222312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056359|NCT01222312|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056360|NCT01222312|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056361|NCT01222312|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056362|NCT01222312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056363|NCT03932266|Docetaxel|docetaxel|mesh-list
93056364|NCT03932266|Endostar protein|endostar protein|mesh-list
93056365|NCT03932266|Endostatins|endostatins|mesh-list
93056366|NCT03932266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056367|NCT03932266|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056368|NCT03932266|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056369|NCT03932266|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056370|NCT03932266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056371|NCT03932266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92331409|NCT00005612|Paclitaxel|paclitaxel|mesh-list
93056372|NCT03932266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056373|NCT03932266|Growth Substances|growth substances|mesh-ancestor
93056374|NCT03932266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056375|NCT03932266|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056376|NCT00141219|Pregabalin|pregabalin|mesh-list
93056377|NCT00141219|Analgesics|analgesics|mesh-ancestor
93056378|NCT00141219|Sensory System Agents|sensory system agents|mesh-ancestor
93056379|NCT00141219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056380|NCT00141219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056381|NCT00141219|Anticonvulsants|anticonvulsants|mesh-ancestor
93056382|NCT00141219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93056383|NCT00141219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056384|NCT00141219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056385|NCT00141219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93056386|NCT00141219|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93056387|NCT00141219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93056388|NCT00141219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056389|NCT00141219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056390|NCT01222468|Nabilone|nabilone|mesh-list
93056391|NCT01222468|Antiemetics|antiemetics|mesh-ancestor
93056392|NCT01222468|Autonomic Agents|autonomic agents|mesh-ancestor
93056393|NCT01222468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056394|NCT01222468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056395|NCT01222468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056396|NCT01222468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93056397|NCT01222468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93056398|NCT01222468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056399|NCT01222468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056400|NCT01220284|Vinorelbine|vinorelbine|mesh-list
93056401|NCT01220284|Satraplatin|satraplatin|mesh-list
93056402|NCT01220284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056403|NCT01220284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056404|NCT01220284|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056405|NCT01220284|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056406|NCT01220284|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056407|NCT01220284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056409|NCT01127464|Interferon Inducers|interferon inducers|mesh-ancestor
93056410|NCT01127464|Immunologic Factors|immunologic factors|mesh-ancestor
93056411|NCT01127464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056412|NCT01222780|Vincristine|vincristine|mesh-list
93056413|NCT01222780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056414|NCT01222780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056415|NCT01222780|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056416|NCT01222780|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056417|NCT01222780|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056418|NCT01222780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056419|NCT01222936|Panobinostat|panobinostat|mesh-list
93056420|NCT01222936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056421|NCT01222936|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93056422|NCT01222936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056423|NCT01222936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056424|NCT01125904|Crizotinib|crizotinib|mesh-list
93056425|NCT01125904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056426|NCT01125904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056427|NCT01125904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056428|NCT01125904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056429|NCT01125982|Propofol|propofol|mesh-list
93056430|NCT01125982|Desflurane|desflurane|mesh-list
93056431|NCT01125982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93056432|NCT01125982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056433|NCT01125982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056434|NCT01125982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93056435|NCT01125982|Anesthetics, General|anesthetics, general|mesh-ancestor
93056436|NCT01125982|Anesthetics|anesthetics|mesh-ancestor
93056437|NCT01125982|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93056438|NCT01220362|Fentanyl|fentanyl|mesh-list
93056439|NCT01220362|Bupivacaine|bupivacaine|mesh-list
93056440|NCT01220362|Anesthetics, Local|anesthetics, local|mesh-ancestor
93056441|NCT01220362|Anesthetics|anesthetics|mesh-ancestor
93056442|NCT01220362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056443|NCT01220362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056444|NCT01220362|Sensory System Agents|sensory system agents|mesh-ancestor
93056445|NCT01220362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056446|NCT01220362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93056447|NCT01220362|Narcotics|narcotics|mesh-ancestor
93056448|NCT01220362|Analgesics|analgesics|mesh-ancestor
93056449|NCT01220362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93056450|NCT01220362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93056451|NCT01220362|Anesthetics, General|anesthetics, general|mesh-ancestor
93056452|NCT01220440|Methylphenidate|methylphenidate|mesh-list
93056453|NCT01220440|Dextroamphetamine|dextroamphetamine|mesh-list
93056454|NCT01220440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93056455|NCT01220440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056456|NCT01220440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93056457|NCT01220440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93056458|NCT01220440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056459|NCT01220440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056460|NCT01220440|Dopamine Agents|dopamine agents|mesh-ancestor
93056461|NCT01220440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056462|NCT01123876|Veliparib|veliparib|mesh-list
93056463|NCT01123876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93056464|NCT01123876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056465|NCT01123876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056466|NCT01123876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056467|NCT01124032|Methylphenidate|methylphenidate|mesh-list
93056468|NCT01124032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93056469|NCT01124032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056470|NCT01124032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93056471|NCT01124032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93056472|NCT01124032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056473|NCT01124032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056474|NCT01124032|Dopamine Agents|dopamine agents|mesh-ancestor
93056475|NCT01124032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056476|NCT03934294|Metoclopramide|metoclopramide|mesh-list
93056477|NCT03934294|Antiemetics|antiemetics|mesh-ancestor
93056478|NCT03934294|Autonomic Agents|autonomic agents|mesh-ancestor
93056479|NCT03934294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056480|NCT03934294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056481|NCT03934294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056482|NCT03934294|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93056483|NCT03934294|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93056484|NCT03934294|Dopamine Agents|dopamine agents|mesh-ancestor
93056485|NCT03934294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056486|NCT03934294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056487|NCT01218568|Rifaximin|rifaximin|mesh-list
93056488|NCT01218568|Lactulose|lactulose|mesh-list
93056489|NCT01218568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93056490|NCT01218568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056491|NCT01218568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056492|NCT01127542|Lenalidomide|lenalidomide|mesh-list
93056493|NCT01127542|Immunologic Factors|immunologic factors|mesh-ancestor
93056494|NCT01127542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056495|NCT01127542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93056496|NCT01127542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056497|NCT01127542|Growth Substances|growth substances|mesh-ancestor
93056498|NCT01127542|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056499|NCT01127542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056500|NCT01127620|Cetirizine|cetirizine|mesh-list
93056501|NCT01127620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93056502|NCT01127620|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93056503|NCT01127620|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93056504|NCT01127620|Histamine Antagonists|histamine antagonists|mesh-ancestor
93056505|NCT01127620|Histamine Agents|histamine agents|mesh-ancestor
93056506|NCT01127620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056507|NCT01127620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056508|NCT01127620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056509|NCT01220518|Infliximab|infliximab|mesh-list
93056510|NCT01220518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93056511|NCT01220518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056512|NCT01220518|Dermatologic Agents|dermatologic agents|mesh-ancestor
93056513|NCT01220518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056514|NCT01220518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056515|NCT01220596|Interferons|interferons|mesh-list
93056516|NCT01220596|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93056517|NCT01220596|Interferon-alpha|interferon-alpha|mesh-list
93056518|NCT01220596|Entecavir|entecavir|mesh-list
93056519|NCT01220596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056520|NCT01220596|Antiviral Agents|antiviral agents|mesh-ancestor
93056521|NCT01220596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056522|NCT01220596|Immunologic Factors|immunologic factors|mesh-ancestor
93056523|NCT01220596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056524|NCT01218724|Losartan|losartan|mesh-list
93056525|NCT01218724|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93056526|NCT01218724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93056527|NCT01218724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93056528|NCT01218724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93056529|NCT01218724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93056530|NCT01218724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056531|NCT01218724|Diuretics|diuretics|mesh-ancestor
93056532|NCT01218724|Natriuretic Agents|natriuretic agents|mesh-ancestor
93056533|NCT01218724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056534|NCT01218724|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93056535|NCT01218724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056536|NCT01126216|Paclitaxel|paclitaxel|mesh-list
93056537|NCT01126216|Cisplatin|cisplatin|mesh-list
93056538|NCT01126216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056539|NCT01126216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056540|NCT01126216|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056541|NCT01126216|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056542|NCT01126216|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056543|NCT01126216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056544|NCT01329016|Metformin|metformin|mesh-list
93056545|NCT01329016|Glyburide|glyburide|mesh-list
93056546|NCT01329016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056547|NCT01329016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056548|NCT01223326|Acetylcysteine|acetylcysteine|mesh-list
93056549|NCT01223326|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93056550|NCT01223326|Antiviral Agents|antiviral agents|mesh-ancestor
93056551|NCT01223326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056552|NCT01223326|Expectorants|expectorants|mesh-ancestor
93056553|NCT01223326|Respiratory System Agents|respiratory system agents|mesh-ancestor
93056554|NCT01223326|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93056555|NCT01223326|Antioxidants|antioxidants|mesh-ancestor
93056556|NCT01223326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056557|NCT01223326|Protective Agents|protective agents|mesh-ancestor
93056558|NCT01223326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056559|NCT01223326|Antidotes|antidotes|mesh-ancestor
93056560|NCT01223560|Insulin Aspart|insulin aspart|mesh-list
93056561|NCT01223560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056562|NCT01223560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056563|NCT01126294|Melatonin|melatonin|mesh-list
93056564|NCT01126294|Antioxidants|antioxidants|mesh-ancestor
93056565|NCT01126294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056566|NCT01126294|Protective Agents|protective agents|mesh-ancestor
93056567|NCT01126294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056568|NCT01126294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056569|NCT00162266|Abatacept|abatacept|mesh-list
93056570|NCT00162266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93056571|NCT00162266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056572|NCT00162266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93056573|NCT00162266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056574|NCT00162266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056575|NCT00162266|Immunologic Factors|immunologic factors|mesh-ancestor
93056576|NCT00162266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056577|NCT00162266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056578|NCT01126450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93056579|NCT01126450|Cetuximab|cetuximab|mesh-list
93056580|NCT01126450|Lenalidomide|lenalidomide|mesh-list
93056581|NCT01126450|Antibodies|antibodies|mesh-list
93056582|NCT01126450|Immunoglobulins|immunoglobulins|mesh-list
93056583|NCT01126450|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93056584|NCT01126450|Immunologic Factors|immunologic factors|mesh-ancestor
93056585|NCT01126450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056586|NCT01126450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056587|NCT01126450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93056588|NCT01126450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056589|NCT01126450|Growth Substances|growth substances|mesh-ancestor
93056590|NCT01126450|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056591|NCT01073384|Beclomethasone|beclomethasone|mesh-list
93056592|NCT01073384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056593|NCT01073384|Glucocorticoids|glucocorticoids|mesh-ancestor
93056594|NCT01073384|Hormones|hormones|mesh-ancestor
93056595|NCT01073384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056596|NCT01073384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056597|NCT01073384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93056598|NCT01073384|Respiratory System Agents|respiratory system agents|mesh-ancestor
93056599|NCT01126528|Vitamin D|vitamin d|mesh-list
93056600|NCT01126528|Cholecalciferol|cholecalciferol|mesh-list
93056601|NCT01126528|Vitamins|vitamins|mesh-ancestor
93056602|NCT01126528|Micronutrients|micronutrients|mesh-ancestor
93056603|NCT01126528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056604|NCT01126528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93056605|NCT01126528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93056606|NCT00225212|Rituximab|rituximab|mesh-list
93056607|NCT00225212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93056608|NCT00225212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056609|NCT00225212|Immunologic Factors|immunologic factors|mesh-ancestor
93056610|NCT00225212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056611|NCT00225212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056612|NCT03853330|Bupivacaine|bupivacaine|mesh-list
93056613|NCT03853330|Anesthetics, Local|anesthetics, local|mesh-ancestor
93056614|NCT03853330|Anesthetics|anesthetics|mesh-ancestor
93056615|NCT03853330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056616|NCT03853330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056617|NCT03853330|Sensory System Agents|sensory system agents|mesh-ancestor
93056618|NCT03853330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056619|NCT01581944|Goserelin|goserelin|mesh-list
93056620|NCT01581944|Hormones|hormones|mesh-list
93056621|NCT01581944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056622|NCT01581944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056623|NCT01581944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93056624|NCT01581944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056625|NCT01226056|Everolimus|everolimus|mesh-list
93056626|NCT01226056|Sorafenib|sorafenib|mesh-list
93056627|NCT01226056|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93056628|NCT01226056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056629|NCT01226056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056630|NCT01226056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056631|NCT01226056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056632|NCT01226056|Immunologic Factors|immunologic factors|mesh-ancestor
93056633|NCT01226056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056634|NCT01226056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056635|NCT00162032|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
93056636|NCT00162032|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93056637|NCT00162032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056638|NCT01126606|Glycerol|glycerol|mesh-list
93056639|NCT01126606|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
93056640|NCT01126606|Protective Agents|protective agents|mesh-ancestor
93056641|NCT01126606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056642|NCT01329406|Milnacipran|milnacipran|mesh-list
93056643|NCT01329406|Levomilnacipran|levomilnacipran|mesh-list
93056644|NCT01329406|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93056645|NCT01329406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93056646|NCT01329406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056647|NCT01329406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056648|NCT01329406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056649|NCT01329406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056650|NCT01329406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93056651|NCT01329406|Analgesics|analgesics|mesh-ancestor
93056652|NCT01329406|Sensory System Agents|sensory system agents|mesh-ancestor
93056653|NCT01329406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056654|NCT01329406|Antidepressive Agents|antidepressive agents|mesh-ancestor
93056655|NCT01329406|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056656|NCT01126684|Atorvastatin|atorvastatin|mesh-list
93056657|NCT01126684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93056658|NCT01126684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93056659|NCT01126684|Antimetabolites|antimetabolites|mesh-ancestor
93056660|NCT01126684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056661|NCT01126684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93056662|NCT01126684|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93056663|NCT01126684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056664|NCT01224028|Tacrolimus|tacrolimus|mesh-list
93056665|NCT01224028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056666|NCT01224028|Immunologic Factors|immunologic factors|mesh-ancestor
93056667|NCT01224028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056668|NCT01224028|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93056669|NCT01224028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056670|NCT01224028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056671|NCT01226212|Sulfalene|sulfalene|mesh-list
93056672|NCT01226212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056673|NCT01226212|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93056674|NCT01226212|Antimalarials|antimalarials|mesh-ancestor
93056675|NCT01226212|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93056676|NCT01226212|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93056677|NCT01075490|Clonidine|clonidine|mesh-list
93056678|NCT01075490|Analgesics|analgesics|mesh-ancestor
93056679|NCT01075490|Sensory System Agents|sensory system agents|mesh-ancestor
93056680|NCT01075490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056681|NCT01075490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056682|NCT01075490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93056683|NCT01075490|Sympatholytics|sympatholytics|mesh-ancestor
93056684|NCT01075490|Autonomic Agents|autonomic agents|mesh-ancestor
93056685|NCT01075490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93056686|NCT01075490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93056687|NCT01075490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93056688|NCT01075490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93056689|NCT01075490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056690|NCT01075490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056691|NCT01126138|Docetaxel|docetaxel|mesh-list
93056692|NCT01126138|Capecitabine|capecitabine|mesh-list
93056694|NCT01126138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056695|NCT01126138|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056696|NCT01126138|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056697|NCT01126138|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056698|NCT01126138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056699|NCT01126138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93056700|NCT01126138|Antimetabolites|antimetabolites|mesh-ancestor
93056701|NCT01126138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056702|NCT03930706|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93056703|NCT03930706|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93056704|NCT03930706|Estradiol|estradiol|mesh-list
93056705|NCT03930706|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93056706|NCT03930706|Estrogens|estrogens|mesh-ancestor
93056707|NCT03930706|Hormones|hormones|mesh-ancestor
93056708|NCT03930706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056709|NCT03930706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056710|NCT03930706|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93056711|NCT03930706|Contraceptive Agents|contraceptive agents|mesh-ancestor
93056712|NCT03930706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93056713|NCT03930706|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93056714|NCT03932578|Atropine|atropine|mesh-list
93056715|NCT03932578|Metoclopramide|metoclopramide|mesh-list
93056716|NCT03932578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93056717|NCT03932578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93056718|NCT03932578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93056719|NCT03932578|Autonomic Agents|autonomic agents|mesh-ancestor
93056720|NCT03932578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056721|NCT03932578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056722|NCT03932578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93056723|NCT03932578|Respiratory System Agents|respiratory system agents|mesh-ancestor
93056724|NCT03932578|Mydriatics|mydriatics|mesh-ancestor
93056725|NCT03932578|Parasympatholytics|parasympatholytics|mesh-ancestor
93056726|NCT03932578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93056727|NCT03932578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93056728|NCT03932578|Cholinergic Agents|cholinergic agents|mesh-ancestor
93056729|NCT03932578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056730|NCT03932578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056732|NCT03932578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056733|NCT03932578|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93056734|NCT03932578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93056735|NCT03932578|Dopamine Agents|dopamine agents|mesh-ancestor
93056736|NCT00258440|Epoetin Alfa|epoetin alfa|mesh-list
93056737|NCT00258440|Hematinics|hematinics|mesh-ancestor
93056738|NCT01329250|Moxifloxacin|moxifloxacin|mesh-list
93056739|NCT01329250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93056740|NCT01329250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056741|NCT01329250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93056742|NCT01329250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93056743|NCT01329250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056744|NCT01329250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056745|NCT01329250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056746|NCT00224120|Silodosin|silodosin|mesh-list
93056747|NCT00224120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93056748|NCT00224120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93056749|NCT00224120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93056750|NCT00224120|Adrenergic Agents|adrenergic agents|mesh-ancestor
93056751|NCT00224120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056752|NCT00224120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056753|NCT00224120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056754|NCT00224120|Urological Agents|urological agents|mesh-ancestor
93056755|NCT01226446|Vitamin D|vitamin d|mesh-list
93056756|NCT01226446|Vitamins|vitamins|mesh-ancestor
93056757|NCT01226446|Micronutrients|micronutrients|mesh-ancestor
93056758|NCT01226446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056759|NCT01226446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93056760|NCT01224418|Tacrolimus|tacrolimus|mesh-list
93056761|NCT01224418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056762|NCT01224418|Immunologic Factors|immunologic factors|mesh-ancestor
93056763|NCT01224418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056764|NCT01224418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93056765|NCT01224418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056766|NCT01224418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056767|NCT00257660|Botulinum Toxins|botulinum toxins|mesh-list
92402452|NCT01422733|Hormones|hormones|mesh-ancestor
93056769|NCT00257660|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93056770|NCT00257660|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93056771|NCT00257660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056772|NCT00257660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056773|NCT00257660|Cholinergic Agents|cholinergic agents|mesh-ancestor
93056774|NCT00257660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056775|NCT00257660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056776|NCT00257660|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93056777|NCT00257660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056778|NCT01129180|Azacitidine|azacitidine|mesh-list
93056779|NCT01129180|Bortezomib|bortezomib|mesh-list
93056780|NCT01129180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93056781|NCT01129180|Antimetabolites|antimetabolites|mesh-ancestor
93056782|NCT01129180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056783|NCT01129180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056784|NCT01129180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056785|NCT00224042|Ferric gluconate|ferric gluconate|mesh-list
93056786|NCT00224042|Hematinics|hematinics|mesh-ancestor
93056787|NCT01129258|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
93056788|NCT01129258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056789|NCT01129258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056790|NCT01221376|Imatinib Mesylate|imatinib mesylate|mesh-list
93056791|NCT01221376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056792|NCT01221376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056793|NCT01221376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056794|NCT01221376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056795|NCT01224652|Paclitaxel|paclitaxel|mesh-list
93056796|NCT01224652|Irinotecan|irinotecan|mesh-list
93056797|NCT01224652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056798|NCT01224652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056799|NCT01224652|Tubulin Modulators|tubulin modulators|mesh-ancestor
93056800|NCT01224652|Antimitotic Agents|antimitotic agents|mesh-ancestor
93056801|NCT01224652|Mitosis Modulators|mitosis modulators|mesh-ancestor
92701818|NCT01283971|Adalimumab|adalimumab|mesh-list
93056802|NCT01224652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056803|NCT01224652|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93056804|NCT01224652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93056806|NCT00160706|Certolizumab Pegol|certolizumab pegol|mesh-list
93056807|NCT00160706|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93056808|NCT00160706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056809|NCT00160706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93056810|NCT00160706|Immunologic Factors|immunologic factors|mesh-ancestor
93056811|NCT00160706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056812|NCT00160706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056813|NCT01226602|Ticagrelor|ticagrelor|mesh-list
93056814|NCT01226602|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93056815|NCT01226602|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93056816|NCT01226602|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93056817|NCT01226602|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93056818|NCT01226602|Purinergic Agents|purinergic agents|mesh-ancestor
93056819|NCT01226602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056820|NCT01226602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056821|NCT01226602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056822|NCT01226680|Tofacitinib|tofacitinib|mesh-list
93056823|NCT01226680|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93056824|NCT01226680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93056825|NCT01226680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056826|NCT01226680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056827|NCT00257192|Ziprasidone|ziprasidone|mesh-list
93056828|NCT00257192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93056829|NCT00257192|Serotonin Agents|serotonin agents|mesh-ancestor
93056830|NCT00257192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056831|NCT00257192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056832|NCT00257192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056833|NCT00257192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93056834|NCT00257192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93056835|NCT00257192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056836|NCT00257192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056837|NCT00257192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93056838|NCT00257192|Dopamine Agents|dopamine agents|mesh-ancestor
93056839|NCT01224964|Montelukast|montelukast|mesh-list
93056840|NCT01224964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93056841|NCT01224964|Respiratory System Agents|respiratory system agents|mesh-ancestor
93056842|NCT01224964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93056843|NCT01224964|Hormone Antagonists|hormone antagonists|mesh-ancestor
93056844|NCT01224964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056845|NCT01224964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056846|NCT01224964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93056847|NCT01224964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93056848|NCT01224964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056849|NCT03967964|Methyltestosterone|methyltestosterone|mesh-list
93056850|NCT03967964|Testosterone|testosterone|mesh-list
93056851|NCT03967964|Testosterone undecanoate|testosterone undecanoate|mesh-list
93056852|NCT03967964|Testosterone enanthate|testosterone enanthate|mesh-list
93056853|NCT03967964|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93056854|NCT03967964|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93056855|NCT03967964|Androgens|androgens|mesh-ancestor
93056856|NCT03967964|Hormones|hormones|mesh-ancestor
93056857|NCT03967964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056858|NCT03967964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056859|NCT03967964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93056860|NCT03967964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056861|NCT03967964|Anabolic Agents|anabolic agents|mesh-ancestor
93056862|NCT03967964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93056863|NCT03967964|Immunologic Factors|immunologic factors|mesh-ancestor
93056864|NCT01129414|Omeprazole|omeprazole|mesh-list
93056865|NCT01129414|Clopidogrel|clopidogrel|mesh-list
93056866|NCT01129414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93056867|NCT01129414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93056868|NCT01129414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93056869|NCT01129414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93056870|NCT01129414|Purinergic Agents|purinergic agents|mesh-ancestor
93056871|NCT01129414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056872|NCT01129414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701908|NCT01283386|Rituximab|rituximab|mesh-list
93056873|NCT01129414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056874|NCT01129414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93056875|NCT01129414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056876|NCT01129414|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93056877|NCT01129414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056878|NCT03967886|Esomeprazole|esomeprazole|mesh-list
93056879|NCT03967886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93056880|NCT03967886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056881|NCT03967886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93056882|NCT03967886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056883|NCT03967886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056884|NCT03968042|Thiamine|thiamine|mesh-list
93056885|NCT03968042|Edaravone|edaravone|mesh-list
93056886|NCT03968042|Mitogens|mitogens|mesh-list
93056887|NCT03968042|Vitamins|vitamins|mesh-ancestor
93056888|NCT03968042|Micronutrients|micronutrients|mesh-ancestor
93056889|NCT03968042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056890|NCT03968042|Mitosis Modulators|mitosis modulators|mesh-ancestor
93056891|NCT03968042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056892|NCT03968042|Vitamin B Complex|vitamin b complex|mesh-ancestor
93056893|NCT03968042|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93056894|NCT03968042|Antioxidants|antioxidants|mesh-ancestor
93056895|NCT03968042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93056896|NCT03968042|Protective Agents|protective agents|mesh-ancestor
93056897|NCT01128322|Niacin|niacin|mesh-list
93056898|NCT01128322|Amlodipine|amlodipine|mesh-list
93056899|NCT01128322|Telmisartan|telmisartan|mesh-list
93056900|NCT01128322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93056901|NCT01128322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93056902|NCT01128322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056903|NCT01128322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056904|NCT01128322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93056905|NCT01128322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056906|NCT01128322|Vasodilator Agents|vasodilator agents|mesh-ancestor
93056907|NCT01128322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92331468|NCT00005642|Semaxinib|semaxinib|mesh-list
93056908|NCT01128322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93056909|NCT01128322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93056910|NCT01128322|Antimetabolites|antimetabolites|mesh-ancestor
93056911|NCT01128322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93056912|NCT01128322|Vitamin B Complex|vitamin b complex|mesh-ancestor
93056913|NCT01128322|Vitamins|vitamins|mesh-ancestor
93056914|NCT01128322|Micronutrients|micronutrients|mesh-ancestor
93056915|NCT01129570|Silybin|silybin|mesh-list
93056916|NCT01129570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93056917|NCT01129570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056918|NCT01129570|Protective Agents|protective agents|mesh-ancestor
93056919|NCT01129570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056920|NCT01073540|Cephalexin|cephalexin|mesh-list
93056921|NCT01073540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93056922|NCT01073540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056923|NCT03740386|Phentolamine|phentolamine|mesh-list
93056924|NCT03740386|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93056925|NCT03740386|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93056926|NCT03740386|Adrenergic Agents|adrenergic agents|mesh-ancestor
93056927|NCT03740386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93056928|NCT03740386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056929|NCT03740386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056930|NCT03740386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93056931|NCT03927352|Adalimumab|adalimumab|mesh-list
93056932|NCT03927352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93056933|NCT03927352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056934|NCT03927352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93056935|NCT01225198|Vitamins|vitamins|mesh-list
93056936|NCT01225198|Micronutrients|micronutrients|mesh-ancestor
93056937|NCT01225198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056938|NCT01226992|Vancomycin|vancomycin|mesh-list
93056939|NCT01226992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93056940|NCT01226992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93056941|NCT01128556|Bepotastine besilate|bepotastine besilate|mesh-list
93056942|NCT01128556|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93056943|NCT03740464|Lenograstim|lenograstim|mesh-list
93056944|NCT03740464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93056945|NCT03740464|Immunologic Factors|immunologic factors|mesh-ancestor
93056946|NCT03740464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056947|NCT03927118|Dexamethasone|dexamethasone|mesh-list
93056948|NCT03927118|Dexamethasone acetate|dexamethasone acetate|mesh-list
93056949|NCT03927118|BB 1101|bb 1101|mesh-list
93056950|NCT03927118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93056952|NCT03927118|Autonomic Agents|autonomic agents|mesh-ancestor
93056953|NCT03927118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056954|NCT03927118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056955|NCT03927118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93056956|NCT03927118|Glucocorticoids|glucocorticoids|mesh-ancestor
93056957|NCT03927118|Hormones|hormones|mesh-ancestor
93056958|NCT03927118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93056959|NCT03927118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93056960|NCT03927118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056961|NCT03927118|Protease Inhibitors|protease inhibitors|mesh-ancestor
93056962|NCT03927118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93056963|NCT03927118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056964|NCT01227148|Insulin|insulin|mesh-list
93056965|NCT01227148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056966|NCT01227148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056967|NCT01227226|Lubricant Eye Drops|lubricant eye drops|mesh-list
93056968|NCT01227226|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93056969|NCT01227226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93056970|NCT01127308|Ertugliflozin|ertugliflozin|mesh-list
93056971|NCT01127308|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93056972|NCT01127308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056973|NCT01127308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93056974|NCT01127308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056975|NCT01128712|Pregabalin|pregabalin|mesh-list
93056976|NCT01128712|Analgesics|analgesics|mesh-ancestor
93056977|NCT01128712|Sensory System Agents|sensory system agents|mesh-ancestor
93056978|NCT01128712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93056979|NCT01128712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056980|NCT01128712|Anticonvulsants|anticonvulsants|mesh-ancestor
93056981|NCT01128712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93056982|NCT01128712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93056983|NCT01128712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93056984|NCT01128712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93056985|NCT01128712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93056986|NCT01128712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93056987|NCT01128712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93056988|NCT01128712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93056990|NCT01127386|Immunologic Factors|immunologic factors|mesh-ancestor
93056991|NCT01127386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93056992|NCT01127386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93056993|NCT01127386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93056994|NCT01127386|Growth Substances|growth substances|mesh-ancestor
93056995|NCT01127386|Growth Inhibitors|growth inhibitors|mesh-ancestor
93056996|NCT01127386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056997|NCT01130194|Procarbazine|procarbazine|mesh-list
93056998|NCT01130194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93056999|NCT01225744|Oxaliplatin|oxaliplatin|mesh-list
93057000|NCT01225744|Irinotecan|irinotecan|mesh-list
93057001|NCT01225744|Cetuximab|cetuximab|mesh-list
93057002|NCT01225744|Tegafur|tegafur|mesh-list
93057003|NCT01225744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057004|NCT01225744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93057005|NCT01225744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93057006|NCT01225744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057007|NCT01225744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057008|NCT01225744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057009|NCT01225744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93057010|NCT01225744|Antimetabolites|antimetabolites|mesh-ancestor
93057011|NCT03926806|Vitamins|vitamins|mesh-list
93057012|NCT03926806|Vitamin B Complex|vitamin b complex|mesh-list
93057013|NCT03926806|Micronutrients|micronutrients|mesh-ancestor
93057014|NCT03926806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057015|NCT03926962|Nafithromycin|nafithromycin|mesh-list
93057016|NCT03926962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057017|NCT03926962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057018|NCT03926962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93057019|NCT03926962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057020|NCT03926962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057021|NCT03919786|Anesthetics|anesthetics|mesh-list
93057022|NCT03919786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057023|NCT03919786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057024|NCT03924544|Mitomycins|mitomycins|mesh-list
93057025|NCT03924544|Mitomycin|mitomycin|mesh-list
93057026|NCT03924544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93057027|NCT03924544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057028|NCT03924544|Alkylating Agents|alkylating agents|mesh-ancestor
93057029|NCT03924544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057030|NCT03924544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93057031|NCT03924544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057032|NCT01131364|Doxorubicin|doxorubicin|mesh-list
93057033|NCT01131364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93057034|NCT01131364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057035|NCT01131364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93057036|NCT01131364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93057037|NCT01131364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057038|NCT01131364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057039|NCT02529202|Dexmedetomidine|dexmedetomidine|mesh-list
93057040|NCT02529202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93057041|NCT02529202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057042|NCT02529202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057043|NCT02529202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057044|NCT02529202|Analgesics|analgesics|mesh-ancestor
93057045|NCT02529202|Sensory System Agents|sensory system agents|mesh-ancestor
93057046|NCT02529202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057047|NCT02529202|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93057048|NCT02529202|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93057049|NCT02529202|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92331478|NCT00005648|Gemcitabine|gemcitabine|mesh-list
93057050|NCT02529202|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057051|NCT02529202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057052|NCT02529202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057053|NCT00154310|Cyclosporine|cyclosporine|mesh-list
93057054|NCT00154310|Mycophenolic Acid|mycophenolic acid|mesh-list
93057055|NCT00154310|Everolimus|everolimus|mesh-list
93057056|NCT00154310|Cyclosporins|cyclosporins|mesh-list
93057057|NCT00154310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057058|NCT00154310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057059|NCT00154310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057060|NCT00154310|Immunologic Factors|immunologic factors|mesh-ancestor
93057061|NCT00154310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057062|NCT00154310|Antifungal Agents|antifungal agents|mesh-ancestor
93057063|NCT00154310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057064|NCT00154310|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057065|NCT00154310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057066|NCT00154310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93057067|NCT00154310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93057068|NCT00154310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057069|NCT00154310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057070|NCT00154310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93057071|NCT00154310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93057072|NCT00154310|Antitubercular Agents|antitubercular agents|mesh-ancestor
93057073|NCT00154310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057074|NCT03770728|Metformin|metformin|mesh-list
93057075|NCT03770728|Efpeglenatide|efpeglenatide|mesh-list
93057076|NCT03770728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057077|NCT03770728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057078|NCT01132222|Ibuprofen|ibuprofen|mesh-list
93057079|NCT01132222|Pseudoephedrine|pseudoephedrine|mesh-list
93057080|NCT01132222|Ephedrine|ephedrine|mesh-list
93057081|NCT01132222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93057082|NCT01132222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057083|NCT01132222|Analgesics|analgesics|mesh-ancestor
93057084|NCT01132222|Sensory System Agents|sensory system agents|mesh-ancestor
93057085|NCT01132222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057086|NCT01132222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057087|NCT01132222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057088|NCT01132222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057089|NCT01132222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93057090|NCT01132222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057091|NCT01132222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057092|NCT01132222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93057093|NCT01132222|Autonomic Agents|autonomic agents|mesh-ancestor
93057094|NCT01132222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93057095|NCT01132222|Respiratory System Agents|respiratory system agents|mesh-ancestor
93057096|NCT01132222|Nasal Decongestants|nasal decongestants|mesh-ancestor
93057097|NCT01132222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93057098|NCT01132222|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93057099|NCT01132222|Sympathomimetics|sympathomimetics|mesh-ancestor
93057100|NCT01132222|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057101|NCT01132222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057103|NCT03926182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057104|NCT03926182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057105|NCT03926182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057106|NCT01130506|Cytarabine|cytarabine|mesh-list
93057107|NCT01130506|Decitabine|decitabine|mesh-list
93057108|NCT01130506|Vorinostat|vorinostat|mesh-list
93057109|NCT01130506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93057110|NCT01130506|Antimetabolites|antimetabolites|mesh-ancestor
93057111|NCT01130506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057112|NCT01130506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057113|NCT01130506|Antiviral Agents|antiviral agents|mesh-ancestor
93057114|NCT01130506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057115|NCT01130506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057116|NCT01130506|Immunologic Factors|immunologic factors|mesh-ancestor
93057117|NCT01130506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057118|NCT01130506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057119|NCT01130506|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93057120|NCT01130662|Decitabine|decitabine|mesh-list
93057121|NCT01130662|Midostaurin|midostaurin|mesh-list
93057122|NCT01130662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93057123|NCT01130662|Antimetabolites|antimetabolites|mesh-ancestor
93057124|NCT01130662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057125|NCT01130662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057126|NCT01130662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057127|NCT01130662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057128|NCT03925714|Metformin|metformin|mesh-list
93057129|NCT03925714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057130|NCT03925714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057131|NCT01228552|Ketoprofen|ketoprofen|mesh-list
93057132|NCT01228552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93057133|NCT01228552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057134|NCT01228552|Analgesics|analgesics|mesh-ancestor
93057135|NCT01228552|Sensory System Agents|sensory system agents|mesh-ancestor
93057136|NCT01228552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057137|NCT01228552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057138|NCT01228552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057139|NCT01228552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057140|NCT01228552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93057141|NCT01228552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057142|NCT01228552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057143|NCT03919084|Nicotine|nicotine|mesh-list
93057144|NCT03919084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93057145|NCT03919084|Autonomic Agents|autonomic agents|mesh-ancestor
93057146|NCT03919084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057147|NCT03919084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057148|NCT03919084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93057149|NCT03919084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93057150|NCT03919084|Cholinergic Agents|cholinergic agents|mesh-ancestor
93057151|NCT03919084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057152|NCT03919084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057153|NCT03923842|Denosumab|denosumab|mesh-list
93057154|NCT03923842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93057155|NCT03923842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057156|NCT01132768|Atenolol|atenolol|mesh-list
93057157|NCT01132768|Olmesartan|olmesartan|mesh-list
93057158|NCT01132768|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93057159|NCT01132768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93057160|NCT01132768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93057161|NCT01132768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93057162|NCT01132768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057163|NCT01132768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93057164|NCT01132768|Sympatholytics|sympatholytics|mesh-ancestor
93057165|NCT01132768|Autonomic Agents|autonomic agents|mesh-ancestor
93057166|NCT01132768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057167|NCT01132768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057168|NCT01132768|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93057169|NCT01132768|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93057170|NCT01132768|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93057171|NCT01132768|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057172|NCT01132768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057173|NCT01230034|Ramipril|ramipril|mesh-list
92702194|NCT00532428|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
93057174|NCT01230034|Imidapril|imidapril|mesh-list
93057175|NCT01230034|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93057176|NCT01230034|Protease Inhibitors|protease inhibitors|mesh-ancestor
93057177|NCT01230034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057178|NCT01230034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057179|NCT01230034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93057180|NCT03918616|Dopamine|dopamine|mesh-list
93057181|NCT03918616|Memantine|memantine|mesh-list
93057182|NCT03918616|Dopamine Agonists|dopamine agonists|mesh-list
93057183|NCT03918616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93057184|NCT03918616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93057185|NCT03918616|Dopamine Agents|dopamine agents|mesh-ancestor
93057186|NCT03918616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057187|NCT03918616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057188|NCT03918616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057189|NCT03918616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93057190|NCT03918616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93057191|NCT03918616|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93057192|NCT03918616|Sympathomimetics|sympathomimetics|mesh-ancestor
93057193|NCT03918616|Autonomic Agents|autonomic agents|mesh-ancestor
93057194|NCT03918616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057195|NCT03918616|Protective Agents|protective agents|mesh-ancestor
93057196|NCT01228630|Loratadine|loratadine|mesh-list
93057197|NCT01228630|Fexofenadine|fexofenadine|mesh-list
93057198|NCT01228630|Pseudoephedrine|pseudoephedrine|mesh-list
93057199|NCT01228630|Ephedrine|ephedrine|mesh-list
93057200|NCT01228630|Antipruritics|antipruritics|mesh-ancestor
93057201|NCT01228630|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057202|NCT01228630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93057203|NCT01228630|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93057204|NCT01228630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93057205|NCT01228630|Histamine Antagonists|histamine antagonists|mesh-ancestor
93057206|NCT01228630|Histamine Agents|histamine agents|mesh-ancestor
93057207|NCT01228630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057208|NCT01228630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057210|NCT01228630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93057211|NCT01228630|Autonomic Agents|autonomic agents|mesh-ancestor
93057212|NCT01228630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057213|NCT01228630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93057214|NCT01228630|Respiratory System Agents|respiratory system agents|mesh-ancestor
93057215|NCT01228630|Nasal Decongestants|nasal decongestants|mesh-ancestor
93057216|NCT01228630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93057217|NCT01228630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93057218|NCT01228630|Sympathomimetics|sympathomimetics|mesh-ancestor
93057219|NCT01228630|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057220|NCT01134406|Hylan|hylan|mesh-list
93057221|NCT01134406|Viscosupplements|viscosupplements|mesh-ancestor
93057222|NCT01134406|Protective Agents|protective agents|mesh-ancestor
93057223|NCT01134406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057224|NCT01231828|Lactulose|lactulose|mesh-list
93057225|NCT01231828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057226|NCT03923218|Vitamin D|vitamin d|mesh-list
93057227|NCT03923218|Cholecalciferol|cholecalciferol|mesh-list
93057228|NCT03923218|Vitamins|vitamins|mesh-ancestor
93057229|NCT03923218|Micronutrients|micronutrients|mesh-ancestor
93057230|NCT03923218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057231|NCT03923218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93057232|NCT03923218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93057233|NCT03923140|Tranilast|tranilast|mesh-list
93057234|NCT03923140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93057235|NCT03923140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057236|NCT03923140|Analgesics|analgesics|mesh-ancestor
93057237|NCT03923140|Sensory System Agents|sensory system agents|mesh-ancestor
93057238|NCT03923140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057239|NCT03923140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057240|NCT03923140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057241|NCT03923140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057242|NCT03923140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93057243|NCT03923140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93057244|NCT03923140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057245|NCT03923140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93057246|NCT03923140|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93057247|NCT03923140|Histamine Antagonists|histamine antagonists|mesh-ancestor
93057248|NCT03923140|Histamine Agents|histamine agents|mesh-ancestor
93057249|NCT03923140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057250|NCT03923140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93057251|NCT03923140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93057252|NCT01133080|Minocycline|minocycline|mesh-list
93057253|NCT01133080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057254|NCT01133080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057255|NCT01230580|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93057256|NCT01230580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93057257|NCT01230580|Protease Inhibitors|protease inhibitors|mesh-list
93057258|NCT01230580|Antiviral Agents|antiviral agents|mesh-ancestor
93057259|NCT01230580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057260|NCT01230580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057261|NCT01230580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057262|NCT01230580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93057263|NCT01230580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93057264|NCT01585792|Glimepiride|glimepiride|mesh-list
93057265|NCT01585792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93057266|NCT01585792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057267|NCT01585792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057268|NCT01585792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057269|NCT01585792|Immunologic Factors|immunologic factors|mesh-ancestor
93057270|NCT01134484|Thalidomide|thalidomide|mesh-list
93057271|NCT01134484|Dexamethasone|dexamethasone|mesh-list
93057272|NCT01134484|Bortezomib|bortezomib|mesh-list
93057273|NCT01134484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057274|NCT01134484|Antiemetics|antiemetics|mesh-ancestor
93057275|NCT01134484|Autonomic Agents|autonomic agents|mesh-ancestor
93057276|NCT01134484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057277|NCT01134484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057278|NCT01134484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057279|NCT01134484|Glucocorticoids|glucocorticoids|mesh-ancestor
93057280|NCT01134484|Hormones|hormones|mesh-ancestor
93057281|NCT01134484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057282|NCT01134484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93057283|NCT01134484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057284|NCT01134484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057285|NCT01134484|Immunologic Factors|immunologic factors|mesh-ancestor
93057286|NCT01134484|Leprostatic Agents|leprostatic agents|mesh-ancestor
93057287|NCT01134484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057288|NCT01134484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057289|NCT01134484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93057290|NCT01134484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93057291|NCT01134484|Growth Substances|growth substances|mesh-ancestor
93057292|NCT01134484|Growth Inhibitors|growth inhibitors|mesh-ancestor
93057294|NCT01133470|Pseudoephedrine|pseudoephedrine|mesh-list
93057295|NCT01133470|Ephedrine|ephedrine|mesh-list
93057296|NCT01133470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93057297|NCT01133470|Autonomic Agents|autonomic agents|mesh-ancestor
93057298|NCT01133470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057299|NCT01133470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057300|NCT01133470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93057301|NCT01133470|Respiratory System Agents|respiratory system agents|mesh-ancestor
93057302|NCT01133470|Nasal Decongestants|nasal decongestants|mesh-ancestor
93057303|NCT01133470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93057304|NCT01133470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93057305|NCT01133470|Sympathomimetics|sympathomimetics|mesh-ancestor
93057306|NCT01133470|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057307|NCT01133470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057308|NCT01133470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057309|NCT01133470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93057310|NCT01133470|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93057311|NCT01133470|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93057312|NCT01133470|Histamine Antagonists|histamine antagonists|mesh-ancestor
93057313|NCT01133470|Histamine Agents|histamine agents|mesh-ancestor
93057314|NCT01134718|Simeprevir|simeprevir|mesh-list
93057315|NCT01134718|Antiviral Agents|antiviral agents|mesh-ancestor
93057316|NCT01134718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057317|NCT01134718|Protease Inhibitors|protease inhibitors|mesh-ancestor
93057318|NCT01134718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057319|NCT01134718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057320|NCT03917758|Dapagliflozin|dapagliflozin|mesh-list
93057321|NCT03917758|Empagliflozin|empagliflozin|mesh-list
93057322|NCT03917758|Canagliflozin|canagliflozin|mesh-list
93057323|NCT03917758|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93057324|NCT03917758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702373|NCT03694262|Rucaparib|rucaparib|mesh-list
93057325|NCT03917758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057326|NCT03917758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057327|NCT01230736|Timolol|timolol|mesh-list
93057328|NCT01230736|Travoprost|travoprost|mesh-list
93057329|NCT01230736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93057330|NCT01230736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93057331|NCT01230736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93057332|NCT01230736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93057333|NCT01230736|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057334|NCT01230736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057335|NCT01230736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057336|NCT01230736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057337|NCT01230736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93057338|NCT01230736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93057339|NCT01133548|Methyltestosterone|methyltestosterone|mesh-list
93057340|NCT01133548|Testosterone|testosterone|mesh-list
93057341|NCT01133548|Testosterone undecanoate|testosterone undecanoate|mesh-list
93057342|NCT01133548|Testosterone enanthate|testosterone enanthate|mesh-list
93057343|NCT01133548|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
93057344|NCT01133548|Androgens|androgens|mesh-ancestor
93057345|NCT01133548|Hormones|hormones|mesh-ancestor
93057346|NCT01133548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057347|NCT01133548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057348|NCT01133548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93057349|NCT01133548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057350|NCT01133548|Anabolic Agents|anabolic agents|mesh-ancestor
93057351|NCT03917134|Metronidazole|metronidazole|mesh-list
93057352|NCT03917134|Cephalosporins|cephalosporins|mesh-list
93057353|NCT03917134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057354|NCT03917134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057355|NCT03917134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93057356|NCT03917134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93057357|NCT01232140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93057358|NCT01232140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057359|NCT01231126|Misoprostol|misoprostol|mesh-list
93057360|NCT01231126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93057361|NCT01231126|Abortifacient Agents|abortifacient agents|mesh-ancestor
93057362|NCT01231126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93057363|NCT01231126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057364|NCT01231126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93057365|NCT01231126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057366|NCT01231126|Oxytocics|oxytocics|mesh-ancestor
93057367|NCT03769090|Budesonide|budesonide|mesh-list
93057368|NCT03769090|Albuterol|albuterol|mesh-list
93057369|NCT03769090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057370|NCT03769090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93057371|NCT03769090|Autonomic Agents|autonomic agents|mesh-ancestor
93057372|NCT03769090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057373|NCT03769090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057374|NCT03769090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93057375|NCT03769090|Respiratory System Agents|respiratory system agents|mesh-ancestor
93057376|NCT03769090|Glucocorticoids|glucocorticoids|mesh-ancestor
93057377|NCT03769090|Hormones|hormones|mesh-ancestor
93057378|NCT03769090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057379|NCT03769090|Tocolytic Agents|tocolytic agents|mesh-ancestor
93057380|NCT03769090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93057381|NCT03769090|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93057382|NCT03769090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93057383|NCT03769090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93057384|NCT03769090|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057385|NCT03769090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057386|NCT03769090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057387|NCT03921736|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93057388|NCT03921736|Perindopril|perindopril|mesh-list
93057389|NCT03921736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93057390|NCT03921736|Diuretics|diuretics|mesh-ancestor
93057391|NCT03921736|Natriuretic Agents|natriuretic agents|mesh-ancestor
93057392|NCT03921736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057393|NCT03921736|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93057394|NCT03921736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93057395|NCT03921736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057396|NCT03921736|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93057397|NCT03921736|Protease Inhibitors|protease inhibitors|mesh-ancestor
93057398|NCT03921736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057399|NCT05401006|Acitretin|acitretin|mesh-list
93057400|NCT05401006|Keratolytic Agents|keratolytic agents|mesh-ancestor
93057401|NCT05401006|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057402|NCT01232374|Nimotuzumab|nimotuzumab|mesh-list
93057403|NCT01232374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057404|NCT01232374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057405|NCT01231438|Alfacalcidol|alfacalcidol|mesh-list
93057406|NCT01231438|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93057407|NCT01231438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057408|NCT01131754|Heparin|heparin|mesh-list
93057409|NCT01131754|Anticoagulants|anticoagulants|mesh-ancestor
93057410|NCT01131754|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93057411|NCT01131754|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93057412|NCT01131754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057413|NCT01231594|Trametinib|trametinib|mesh-list
93057414|NCT01231594|Dabrafenib|dabrafenib|mesh-list
93057415|NCT01231594|Antineoplastic Agents|antineoplastic agents|mesh-list
93057416|NCT01231594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057417|NCT01231594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057418|NCT01231594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057419|NCT01136278|Clonidine|clonidine|mesh-list
93057420|NCT01136278|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93057421|NCT01136278|Analgesics|analgesics|mesh-ancestor
93057422|NCT01136278|Sensory System Agents|sensory system agents|mesh-ancestor
93057423|NCT01136278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057424|NCT01136278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057425|NCT01136278|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93057426|NCT01136278|Sympatholytics|sympatholytics|mesh-ancestor
93057427|NCT01136278|Autonomic Agents|autonomic agents|mesh-ancestor
93057428|NCT01136278|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93057429|NCT01136278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93057430|NCT01136278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93057431|NCT01136278|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057432|NCT01136278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057433|NCT01136278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057434|NCT01136278|Hallucinogens|hallucinogens|mesh-ancestor
93057435|NCT01136278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93057436|NCT01136278|Serotonin Agents|serotonin agents|mesh-ancestor
93057437|NCT01136278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93057438|NCT01136278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93057439|NCT01136278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93057440|NCT05402722|Antibodies|antibodies|mesh-list
93057441|NCT05402722|Immunologic Factors|immunologic factors|mesh-ancestor
93057442|NCT05402722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057443|NCT05480488|Midazolam|midazolam|mesh-list
93057444|NCT05480488|Warfarin|warfarin|mesh-list
93057445|NCT05480488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93057446|NCT05480488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93057447|NCT05480488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057448|NCT05480488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057449|NCT05480488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93057450|NCT05480488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93057451|NCT05480488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93057452|NCT05480488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93057453|NCT05480488|Anesthetics, General|anesthetics, general|mesh-ancestor
93057454|NCT05480488|Anesthetics|anesthetics|mesh-ancestor
93057455|NCT05480488|GABA Modulators|gaba modulators|mesh-ancestor
93057456|NCT05480488|GABA Agents|gaba agents|mesh-ancestor
93057457|NCT05480488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057458|NCT05480488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057459|NCT05480488|Anticoagulants|anticoagulants|mesh-ancestor
93057460|NCT01229332|Carbidopa|carbidopa|mesh-list
93057461|NCT01229332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93057462|NCT01229332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93057463|NCT01229332|Dopamine Agents|dopamine agents|mesh-ancestor
93057464|NCT01229332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057465|NCT01229332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057466|NCT01229332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057467|NCT01229332|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93057468|NCT01229332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057469|NCT03921034|Ropivacaine|ropivacaine|mesh-list
93057470|NCT03921034|Anesthetics, Local|anesthetics, local|mesh-ancestor
93057471|NCT03921034|Anesthetics|anesthetics|mesh-ancestor
93057472|NCT03921034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057473|NCT03921034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057474|NCT03921034|Sensory System Agents|sensory system agents|mesh-ancestor
93057475|NCT03921034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057476|NCT01136590|Tranexamic Acid|tranexamic acid|mesh-list
93057477|NCT01136590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93057478|NCT01136590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93057479|NCT01136590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057480|NCT01136590|Hemostatics|hemostatics|mesh-ancestor
93057481|NCT01136590|Coagulants|coagulants|mesh-ancestor
93057482|NCT03920878|Aflibercept|aflibercept|mesh-list
93057483|NCT03920878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93057484|NCT03920878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93057485|NCT03920878|Growth Substances|growth substances|mesh-ancestor
93057486|NCT03920878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057487|NCT03920878|Growth Inhibitors|growth inhibitors|mesh-ancestor
93057488|NCT03920878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057489|NCT03920644|Scopolamine|scopolamine|mesh-list
93057490|NCT03920644|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
93057491|NCT03920644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93057492|NCT03920644|Antiemetics|antiemetics|mesh-ancestor
93057493|NCT03920644|Autonomic Agents|autonomic agents|mesh-ancestor
93057494|NCT03920644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057495|NCT03920644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057496|NCT03920644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057497|NCT03920644|Mydriatics|mydriatics|mesh-ancestor
93057498|NCT03920644|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93057499|NCT03920644|Cholinergic Agents|cholinergic agents|mesh-ancestor
93057500|NCT03920644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057501|NCT03920644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057502|NCT03920644|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93057503|NCT03920644|Parasympatholytics|parasympatholytics|mesh-ancestor
93057504|NCT01137916|Imatinib Mesylate|imatinib mesylate|mesh-list
93057505|NCT01137916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057506|NCT01137916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057507|NCT01137916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057508|NCT01137916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057509|NCT01137994|Paclitaxel|paclitaxel|mesh-list
93057510|NCT01137994|Vinorelbine|vinorelbine|mesh-list
93057511|NCT01137994|Docetaxel|docetaxel|mesh-list
93057512|NCT01137994|Trastuzumab|trastuzumab|mesh-list
93057513|NCT01137994|Lapatinib|lapatinib|mesh-list
93057514|NCT01137994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93057515|NCT01137994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057516|NCT01137994|Tubulin Modulators|tubulin modulators|mesh-ancestor
93057517|NCT01137994|Antimitotic Agents|antimitotic agents|mesh-ancestor
93057518|NCT01137994|Mitosis Modulators|mitosis modulators|mesh-ancestor
93057519|NCT01137994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057520|NCT01137994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057521|NCT01137994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057522|NCT01137994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057523|NCT01138072|Atorvastatin|atorvastatin|mesh-list
93057524|NCT01138072|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93057525|NCT01138072|Simvastatin|simvastatin|mesh-list
93057526|NCT01138072|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93057527|NCT01138072|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93057528|NCT01138072|Antimetabolites|antimetabolites|mesh-ancestor
93057529|NCT01138072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057530|NCT01138072|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93057531|NCT01138072|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93057532|NCT01138072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057533|NCT01131910|Vaccines|vaccines|mesh-list
93057534|NCT01131910|Immunologic Factors|immunologic factors|mesh-ancestor
93057535|NCT01131910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057536|NCT03739606|Antibodies|antibodies|mesh-list
93057537|NCT03739606|Immunoglobulins|immunoglobulins|mesh-list
93057538|NCT03739606|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93057539|NCT03739606|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93057540|NCT03739606|Immunologic Factors|immunologic factors|mesh-ancestor
93057541|NCT03739606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057542|NCT01138384|Lapatinib|lapatinib|mesh-list
93057543|NCT01138384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057544|NCT01138384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057545|NCT01138384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057546|NCT01138384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057547|NCT05533372|Methotrexate|methotrexate|mesh-list
93057548|NCT05533372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93057549|NCT05533372|Abortifacient Agents|abortifacient agents|mesh-ancestor
93057550|NCT05533372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93057551|NCT05533372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057552|NCT05533372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93057553|NCT05533372|Antimetabolites|antimetabolites|mesh-ancestor
93057554|NCT05533372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057555|NCT05533372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057556|NCT05533372|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057557|NCT05533372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057558|NCT05533372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93057559|NCT05533372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057560|NCT05533372|Immunologic Factors|immunologic factors|mesh-ancestor
93057561|NCT05533372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057562|NCT05533372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93057563|NCT01233622|Vildagliptin|vildagliptin|mesh-list
93057564|NCT01233622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057565|NCT01233622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057566|NCT01233622|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93057567|NCT01233622|Protease Inhibitors|protease inhibitors|mesh-ancestor
93057568|NCT01233622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057569|NCT01233622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057570|NCT01138774|Thioctic Acid|thioctic acid|mesh-list
93057571|NCT01138774|Antioxidants|antioxidants|mesh-ancestor
93057572|NCT01138774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057573|NCT01138774|Protective Agents|protective agents|mesh-ancestor
93057574|NCT01138774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057575|NCT01138774|Vitamin B Complex|vitamin b complex|mesh-ancestor
93057576|NCT01138774|Vitamins|vitamins|mesh-ancestor
93057577|NCT01138774|Micronutrients|micronutrients|mesh-ancestor
93057578|NCT01131988|Tacrolimus|tacrolimus|mesh-list
93057579|NCT01131988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057580|NCT01131988|Immunologic Factors|immunologic factors|mesh-ancestor
93057581|NCT01131988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057582|NCT01131988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93057583|NCT01131988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057584|NCT01131988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057585|NCT01138852|Ampicillin|ampicillin|mesh-list
93057586|NCT01138852|Cefuroxime|cefuroxime|mesh-list
93057587|NCT01138852|Cefuroxime axetil|cefuroxime axetil|mesh-list
93057588|NCT01138852|Sulbactam|sulbactam|mesh-list
93057589|NCT01138852|Sultamicillin|sultamicillin|mesh-list
93057590|NCT01138852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057591|NCT01138852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057592|NCT01138852|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93057593|NCT01138852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057594|NCT01138852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057595|NCT05487196|Clonidine|clonidine|mesh-list
93057596|NCT05487196|Fentanyl|fentanyl|mesh-list
93057597|NCT05487196|Dexmedetomidine|dexmedetomidine|mesh-list
93057598|NCT05487196|Ropivacaine|ropivacaine|mesh-list
93057599|NCT05487196|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93057600|NCT05487196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057601|NCT05487196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057602|NCT05487196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057603|NCT05487196|Analgesics|analgesics|mesh-ancestor
93057604|NCT05487196|Sensory System Agents|sensory system agents|mesh-ancestor
93057605|NCT05487196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057606|NCT05487196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93057607|NCT05487196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93057608|NCT05487196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93057609|NCT05487196|Adrenergic Agents|adrenergic agents|mesh-ancestor
93057610|NCT05487196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057611|NCT05487196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057612|NCT05487196|Anesthetics, Local|anesthetics, local|mesh-ancestor
93057613|NCT05487196|Anesthetics|anesthetics|mesh-ancestor
93057614|NCT05487196|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93057615|NCT05487196|Narcotics|narcotics|mesh-ancestor
93057616|NCT05487196|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93057617|NCT05487196|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93057618|NCT05487196|Anesthetics, General|anesthetics, general|mesh-ancestor
93057619|NCT05487196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93057620|NCT05487196|Sympatholytics|sympatholytics|mesh-ancestor
93057621|NCT05487196|Autonomic Agents|autonomic agents|mesh-ancestor
93057622|NCT01585870|Sorafenib|sorafenib|mesh-list
93057623|NCT01585870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057624|NCT01585870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057625|NCT01585870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057626|NCT01585870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057627|NCT05210140|Escitalopram|escitalopram|mesh-list
93057628|NCT05210140|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92702643|NCT00532727|Docetaxel|docetaxel|mesh-list
93057629|NCT05210140|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93057630|NCT05210140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93057631|NCT05210140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057632|NCT05210140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057633|NCT05210140|Serotonin Agents|serotonin agents|mesh-ancestor
93057634|NCT05210140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057635|NCT01233934|Chlorpheniramine|chlorpheniramine|mesh-list
93057636|NCT01233934|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
93057637|NCT01233934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93057638|NCT01233934|Histamine Antagonists|histamine antagonists|mesh-ancestor
93057639|NCT01233934|Histamine Agents|histamine agents|mesh-ancestor
93057640|NCT01233934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057641|NCT01233934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057642|NCT01233934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057643|NCT01233934|Antipruritics|antipruritics|mesh-ancestor
93057644|NCT01233934|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057645|NCT01233934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93057646|NCT01236508|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93057647|NCT01236508|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93057648|NCT01236508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057649|NCT05195944|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93057650|NCT05195944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057651|NCT05195944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057652|NCT05195944|Incretins|incretins|mesh-ancestor
93057653|NCT05195944|Hormones|hormones|mesh-ancestor
93057654|NCT05195944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057655|NCT05195944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93057657|NCT05195944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057658|NCT05195944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057659|NCT01236586|Dexamethasone|dexamethasone|mesh-list
93057660|NCT01236586|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93057661|NCT01236586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057662|NCT01236586|Antiemetics|antiemetics|mesh-ancestor
93057663|NCT01236586|Autonomic Agents|autonomic agents|mesh-ancestor
93057664|NCT01236586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057665|NCT01236586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057666|NCT01236586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057667|NCT01236586|Glucocorticoids|glucocorticoids|mesh-ancestor
93057668|NCT01236586|Hormones|hormones|mesh-ancestor
93057669|NCT01236586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057670|NCT01236586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93057671|NCT01236586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057672|NCT01236586|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93057673|NCT01236586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057674|NCT01236586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057675|NCT01234792|Nicotine|nicotine|mesh-list
93057676|NCT01234792|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93057677|NCT01234792|Autonomic Agents|autonomic agents|mesh-ancestor
93057678|NCT01234792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057679|NCT01234792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057680|NCT01234792|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93057681|NCT01234792|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93057682|NCT01234792|Cholinergic Agents|cholinergic agents|mesh-ancestor
93057683|NCT01234792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057684|NCT01234792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057685|NCT03513328|Thiotepa|thiotepa|mesh-list
93057686|NCT03513328|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93057687|NCT03513328|Alkylating Agents|alkylating agents|mesh-ancestor
93057688|NCT03513328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057689|NCT03513328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057690|NCT03513328|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93057691|NCT03513328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057692|NCT03513328|Immunologic Factors|immunologic factors|mesh-ancestor
93057693|NCT03513328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057694|NCT03467932|Insulin|insulin|mesh-list
93057695|NCT03467932|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93057696|NCT03467932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057697|NCT03467932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057698|NCT03199612|Sildenafil Citrate|sildenafil citrate|mesh-list
93057699|NCT03199612|Vasodilator Agents|vasodilator agents|mesh-ancestor
93057700|NCT03199612|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93057701|NCT03199612|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93057702|NCT03199612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057703|NCT03199612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057704|NCT03199612|Urological Agents|urological agents|mesh-ancestor
93057705|NCT01140100|Thiopental|thiopental|mesh-list
93057706|NCT01140100|Propofol|propofol|mesh-list
93057707|NCT01140100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93057708|NCT01140100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057709|NCT01140100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057710|NCT01140100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93057711|NCT01140100|Anesthetics, General|anesthetics, general|mesh-ancestor
93057712|NCT01140100|Anesthetics|anesthetics|mesh-ancestor
93057713|NCT01140100|Anticonvulsants|anticonvulsants|mesh-ancestor
93057714|NCT01140100|GABA Modulators|gaba modulators|mesh-ancestor
93057715|NCT01140100|GABA Agents|gaba agents|mesh-ancestor
93057716|NCT01140100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057717|NCT01140100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057718|NCT01141036|Midazolam|midazolam|mesh-list
93057719|NCT01141036|Propofol|propofol|mesh-list
93057720|NCT01141036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93057721|NCT01141036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057722|NCT01141036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057723|NCT01141036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93057724|NCT01141036|Anesthetics, General|anesthetics, general|mesh-ancestor
93057725|NCT01141036|Anesthetics|anesthetics|mesh-ancestor
93057726|NCT01141036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93057727|NCT01141036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93057728|NCT01141036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93057729|NCT01141036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93057730|NCT01141036|GABA Modulators|gaba modulators|mesh-ancestor
93057731|NCT01141036|GABA Agents|gaba agents|mesh-ancestor
93057732|NCT01141036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057733|NCT01141036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057734|NCT02685826|Dexamethasone|dexamethasone|mesh-list
93057735|NCT02685826|Lenalidomide|lenalidomide|mesh-list
93057736|NCT02685826|Durvalumab|durvalumab|mesh-list
93057737|NCT02685826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057738|NCT02685826|Antiemetics|antiemetics|mesh-ancestor
93057739|NCT02685826|Autonomic Agents|autonomic agents|mesh-ancestor
93057740|NCT02685826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057741|NCT02685826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057742|NCT02685826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057743|NCT02685826|Glucocorticoids|glucocorticoids|mesh-ancestor
93057744|NCT02685826|Hormones|hormones|mesh-ancestor
93057745|NCT02685826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057746|NCT02685826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93057747|NCT02685826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057748|NCT02685826|Immunologic Factors|immunologic factors|mesh-ancestor
93057749|NCT02685826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93057750|NCT02685826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93057751|NCT02685826|Growth Substances|growth substances|mesh-ancestor
93057752|NCT02685826|Growth Inhibitors|growth inhibitors|mesh-ancestor
93057753|NCT02685826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057754|NCT04906720|Colchicine|colchicine|mesh-list
93057755|NCT04906720|Gout Suppressants|gout suppressants|mesh-ancestor
93057756|NCT04906720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057757|NCT04906720|Tubulin Modulators|tubulin modulators|mesh-ancestor
93057758|NCT04906720|Antimitotic Agents|antimitotic agents|mesh-ancestor
93057759|NCT04906720|Mitosis Modulators|mitosis modulators|mesh-ancestor
93057760|NCT04906720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057761|NCT04906720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057762|NCT01141192|Vitamin D|vitamin d|mesh-list
93057763|NCT01141192|Cholecalciferol|cholecalciferol|mesh-list
93057764|NCT01141192|Vitamins|vitamins|mesh-ancestor
92331587|NCT00005768|Estrogens|estrogens|mesh-list
93057765|NCT01141192|Micronutrients|micronutrients|mesh-ancestor
93057766|NCT01141192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057767|NCT01141192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93057768|NCT01141192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93057769|NCT01144000|Daptomycin|daptomycin|mesh-list
93057770|NCT01144000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057771|NCT01144000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057772|NCT01140412|Ritonavir|ritonavir|mesh-list
93057773|NCT01140412|Fosamprenavir|fosamprenavir|mesh-list
93057774|NCT01140412|Maraviroc|maraviroc|mesh-list
93057775|NCT01140412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93057776|NCT01140412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93057777|NCT01140412|Protease Inhibitors|protease inhibitors|mesh-ancestor
92702797|NCT05104229|Antipyretics|antipyretics|mesh-ancestor
93057778|NCT01140412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057779|NCT01140412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057780|NCT01140412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93057781|NCT01140412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93057782|NCT01140412|Antiviral Agents|antiviral agents|mesh-ancestor
93057783|NCT01140412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057784|NCT01140412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93057785|NCT01140412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93057786|NCT01140412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93057787|NCT01140412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93057788|NCT01140412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93057789|NCT01234324|Cisplatin|cisplatin|mesh-list
93057790|NCT01234324|Capecitabine|capecitabine|mesh-list
93057791|NCT01234324|Epirubicin|epirubicin|mesh-list
93057792|NCT01234324|Panitumumab|panitumumab|mesh-list
93057793|NCT01234324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057794|NCT01234324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93057795|NCT01234324|Antimetabolites|antimetabolites|mesh-ancestor
93057796|NCT01234324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057797|NCT01234324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93057798|NCT01234324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93057799|NCT01234324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93057800|NCT01234324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057801|NCT01234324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057803|NCT02334124|Floxacillin|floxacillin|mesh-list
93057804|NCT02334124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93057805|NCT02334124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057806|NCT01144156|Adalimumab|adalimumab|mesh-list
93057807|NCT01144156|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93057808|NCT01144156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057809|NCT01144156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057810|NCT01235260|Becaplermin|becaplermin|mesh-list
93057811|NCT01235260|Anticoagulants|anticoagulants|mesh-ancestor
93057812|NCT01235260|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
93057813|NCT01235260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93057814|NCT01235260|Growth Substances|growth substances|mesh-ancestor
93057815|NCT01235260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057816|NCT01144312|Fentanyl|fentanyl|mesh-list
93057817|NCT01144312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93057818|NCT01144312|Narcotics|narcotics|mesh-ancestor
93057819|NCT01144312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057820|NCT01144312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057821|NCT01144312|Analgesics|analgesics|mesh-ancestor
93057822|NCT01144312|Sensory System Agents|sensory system agents|mesh-ancestor
93057823|NCT01144312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057824|NCT01144312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93057825|NCT01144312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93057826|NCT01144312|Anesthetics, General|anesthetics, general|mesh-ancestor
93057827|NCT01144312|Anesthetics|anesthetics|mesh-ancestor
93057828|NCT01144390|Methadone|methadone|mesh-list
93057829|NCT01144390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93057830|NCT01144390|Narcotics|narcotics|mesh-ancestor
93057831|NCT01144390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057832|NCT01144390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057833|NCT01144390|Analgesics|analgesics|mesh-ancestor
93057834|NCT01144390|Sensory System Agents|sensory system agents|mesh-ancestor
93057835|NCT01144390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057836|NCT01144390|Antitussive Agents|antitussive agents|mesh-ancestor
93057837|NCT01144390|Respiratory System Agents|respiratory system agents|mesh-ancestor
93057838|NCT01329640|Paclitaxel|paclitaxel|mesh-list
93057839|NCT01329640|Cyclophosphamide|cyclophosphamide|mesh-list
93057840|NCT01329640|Trastuzumab|trastuzumab|mesh-list
93057841|NCT01329640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93057842|NCT01329640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057843|NCT01329640|Tubulin Modulators|tubulin modulators|mesh-ancestor
93057844|NCT01329640|Antimitotic Agents|antimitotic agents|mesh-ancestor
93057845|NCT01329640|Mitosis Modulators|mitosis modulators|mesh-ancestor
93057846|NCT01329640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057847|NCT01329640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057848|NCT01329640|Immunologic Factors|immunologic factors|mesh-ancestor
93057849|NCT01329640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057850|NCT01329640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057851|NCT01329640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93057852|NCT01329640|Alkylating Agents|alkylating agents|mesh-ancestor
93057853|NCT01329640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93057854|NCT01329640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057855|NCT05335018|Lenalidomide|lenalidomide|mesh-list
92702864|NCT04942730|Mycophenolic Acid|mycophenolic acid|mesh-list
93057856|NCT05335018|Immunologic Factors|immunologic factors|mesh-ancestor
93057857|NCT05335018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057858|NCT05335018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93057859|NCT05335018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93057860|NCT05335018|Growth Substances|growth substances|mesh-ancestor
93057861|NCT05335018|Growth Inhibitors|growth inhibitors|mesh-ancestor
93057862|NCT05335018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057863|NCT00114777|Cyclosporine|cyclosporine|mesh-list
93057864|NCT00114777|Abatacept|abatacept|mesh-list
93057865|NCT00114777|Cyclosporins|cyclosporins|mesh-list
93057866|NCT00114777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057867|NCT00114777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057868|NCT00114777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057869|NCT00114777|Immunologic Factors|immunologic factors|mesh-ancestor
93057870|NCT00114777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057871|NCT00114777|Antifungal Agents|antifungal agents|mesh-ancestor
93057872|NCT00114777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057873|NCT00114777|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057874|NCT00114777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057875|NCT00114777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93057876|NCT00114777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93057877|NCT00114777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93057878|NCT00114777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057879|NCT00139737|Ziprasidone|ziprasidone|mesh-list
93057880|NCT00139737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93057881|NCT00139737|Serotonin Agents|serotonin agents|mesh-ancestor
93057882|NCT00139737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057883|NCT00139737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057884|NCT00139737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057885|NCT00139737|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93057886|NCT00139737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93057887|NCT00139737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93057888|NCT00139737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93057889|NCT00139737|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93057890|NCT00139737|Dopamine Agents|dopamine agents|mesh-ancestor
93057891|NCT00139659|Insulin|insulin|mesh-list
93057892|NCT00139659|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93057893|NCT00139659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93057894|NCT00139659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057895|NCT01076439|Fluticasone|fluticasone|mesh-list
93057896|NCT01076439|Xhance|xhance|mesh-list
93057897|NCT01076439|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93057898|NCT01076439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057899|NCT01076439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93057900|NCT01076439|Autonomic Agents|autonomic agents|mesh-ancestor
93057901|NCT01076439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057902|NCT01076439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057903|NCT01076439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93057904|NCT01076439|Respiratory System Agents|respiratory system agents|mesh-ancestor
93057905|NCT01076439|Dermatologic Agents|dermatologic agents|mesh-ancestor
93057906|NCT01076439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93057907|NCT01076439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93057908|NCT01076439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057909|NCT01076439|Analgesics|analgesics|mesh-ancestor
93057910|NCT01076439|Sensory System Agents|sensory system agents|mesh-ancestor
93057911|NCT01076439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057912|NCT01076439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93057913|NCT01076439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93057914|NCT01076439|Histamine Antagonists|histamine antagonists|mesh-ancestor
93057915|NCT01076439|Histamine Agents|histamine agents|mesh-ancestor
93057916|NCT01076439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93057917|NCT01076439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057918|NCT03965637|Ascorbic Acid|ascorbic acid|mesh-list
93057919|NCT03965637|Vitamins|vitamins|mesh-ancestor
93057920|NCT03965637|Micronutrients|micronutrients|mesh-ancestor
93057921|NCT03965637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057922|NCT03965637|Antioxidants|antioxidants|mesh-ancestor
93057923|NCT03965637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057924|NCT03965637|Protective Agents|protective agents|mesh-ancestor
93057925|NCT01078779|Chloroquine|chloroquine|mesh-list
93057926|NCT01078779|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
93057927|NCT01078779|Amebicides|amebicides|mesh-ancestor
93057928|NCT01078779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93057929|NCT01078779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93057930|NCT01078779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93057931|NCT01078779|Antimalarials|antimalarials|mesh-ancestor
93057932|NCT01078779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057933|NCT01078779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93057934|NCT01078779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057936|NCT01078779|Sensory System Agents|sensory system agents|mesh-ancestor
93057937|NCT01078779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057938|NCT01078779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057939|NCT01078779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057940|NCT01078779|Filaricides|filaricides|mesh-ancestor
93057941|NCT01078779|Antinematodal Agents|antinematodal agents|mesh-ancestor
93057942|NCT01078779|Anthelmintics|anthelmintics|mesh-ancestor
93057943|NCT00114231|Capecitabine|capecitabine|mesh-list
93057944|NCT00114231|Oxaliplatin|oxaliplatin|mesh-list
93057945|NCT00114231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93057946|NCT00114231|Antimetabolites|antimetabolites|mesh-ancestor
93057947|NCT00114231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057948|NCT00114231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057949|NCT00113919|Busulfan|busulfan|mesh-list
93057950|NCT00113919|Alkylating Agents|alkylating agents|mesh-ancestor
93057951|NCT00113919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057952|NCT00113919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93057953|NCT00113919|Immunologic Factors|immunologic factors|mesh-ancestor
93057954|NCT00113919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057955|NCT00113919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93057956|NCT00113919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057957|NCT00113919|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93057958|NCT00113841|Curcumin|curcumin|mesh-list
93057959|NCT00113841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93057960|NCT00113841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93057961|NCT00113841|Analgesics|analgesics|mesh-ancestor
93057962|NCT00113841|Sensory System Agents|sensory system agents|mesh-ancestor
93057963|NCT00113841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057964|NCT00113841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057965|NCT00113841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057966|NCT00113841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93057967|NCT00113841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057968|NCT00113841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057969|NCT00113841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057970|NCT00113607|Dexamethasone|dexamethasone|mesh-list
93057971|NCT00113607|Trabectedin|trabectedin|mesh-list
93057972|NCT00113607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93057973|NCT00113607|Antiemetics|antiemetics|mesh-ancestor
93057974|NCT00113607|Autonomic Agents|autonomic agents|mesh-ancestor
93057975|NCT00113607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93057976|NCT00113607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057977|NCT00113607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93057978|NCT00113607|Glucocorticoids|glucocorticoids|mesh-ancestor
93057979|NCT00113607|Hormones|hormones|mesh-ancestor
93057980|NCT00113607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93057981|NCT00113607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93057982|NCT00113607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057983|NCT00113607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93057984|NCT00113607|Alkylating Agents|alkylating agents|mesh-ancestor
93057985|NCT00113607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057986|NCT00113529|Sunitinib|sunitinib|mesh-list
93057987|NCT00113529|Gefitinib|gefitinib|mesh-list
93057988|NCT00113529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93057989|NCT00113529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93057990|NCT00113529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93057991|NCT00113529|Growth Substances|growth substances|mesh-ancestor
93057992|NCT00113529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93057993|NCT00113529|Growth Inhibitors|growth inhibitors|mesh-ancestor
93057994|NCT00113529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93057995|NCT00113529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93057996|NCT00113529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93057997|NCT01079013|Treosulfan|treosulfan|mesh-list
93057998|NCT01079013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93057999|NCT01079013|Alkylating Agents|alkylating agents|mesh-ancestor
93058000|NCT01079013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058001|NCT01079013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058002|NCT00134901|Memantine|memantine|mesh-list
93058003|NCT00134901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93058004|NCT00134901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93058005|NCT00134901|Dopamine Agents|dopamine agents|mesh-ancestor
92703018|NCT05471063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058006|NCT00134901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058007|NCT00134901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058008|NCT00134901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058009|NCT00134901|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93058010|NCT00134901|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93058011|NCT01076595|Interferons|interferons|mesh-list
93058012|NCT01076595|Interferon-beta|interferon-beta|mesh-list
93058013|NCT01076595|Interferon beta-1b|interferon beta-1b|mesh-list
93058014|NCT01076595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058015|NCT01076595|Antiviral Agents|antiviral agents|mesh-ancestor
93058016|NCT01076595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058017|NCT01076595|Immunologic Factors|immunologic factors|mesh-ancestor
93058018|NCT01076595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058019|NCT01076595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058022|NCT00113373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058023|NCT00113373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058024|NCT00113373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058025|NCT00113295|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93058026|NCT00113295|Paroxetine|paroxetine|mesh-list
93058027|NCT00113295|Antidepressive Agents|antidepressive agents|mesh-ancestor
93058028|NCT00113295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058029|NCT00113295|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93058030|NCT00113295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93058031|NCT00113295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058032|NCT00113295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058033|NCT00113295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92331620|NCT00005798|Alkylating Agents|alkylating agents|mesh-ancestor
93058034|NCT00113295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93058035|NCT00113295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058036|NCT00113295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058037|NCT00113295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058038|NCT00113295|Serotonin Agents|serotonin agents|mesh-ancestor
93058039|NCT00113295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93058040|NCT00113295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93058041|NCT00113295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93058042|NCT00113295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058043|NCT00112905|Sorafenib|sorafenib|mesh-list
93058044|NCT00112905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058045|NCT00112905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058046|NCT00112905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058047|NCT00112905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058048|NCT00427895|Vaccines|vaccines|mesh-list
93058049|NCT00427895|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93058050|NCT00427895|Immunologic Factors|immunologic factors|mesh-ancestor
93058051|NCT00427895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058052|NCT01034189|Paclitaxel|paclitaxel|mesh-list
93058053|NCT01034189|Cetuximab|cetuximab|mesh-list
93058054|NCT01034189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93058055|NCT01034189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058056|NCT01034189|Tubulin Modulators|tubulin modulators|mesh-ancestor
93058057|NCT01034189|Antimitotic Agents|antimitotic agents|mesh-ancestor
93058058|NCT01034189|Mitosis Modulators|mitosis modulators|mesh-ancestor
93058059|NCT01034189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058060|NCT01034189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93058061|NCT00425945|Pycnogenols|pycnogenols|mesh-list
93058062|NCT00425945|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058063|NCT00425945|Immunologic Factors|immunologic factors|mesh-ancestor
93058064|NCT00425945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058065|NCT00425945|Antioxidants|antioxidants|mesh-ancestor
93058066|NCT00425945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058067|NCT00425945|Protective Agents|protective agents|mesh-ancestor
93058068|NCT00425945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93058069|NCT00121641|Metformin|metformin|mesh-list
93058070|NCT00121641|Saxagliptin|saxagliptin|mesh-list
93058071|NCT00121641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93058072|NCT00121641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058073|NCT00121641|Incretins|incretins|mesh-ancestor
93058074|NCT00121641|Hormones|hormones|mesh-ancestor
93058075|NCT00121641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058076|NCT00121641|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93058077|NCT00121641|Protease Inhibitors|protease inhibitors|mesh-ancestor
92703095|NCT01606540|Ibuprofen|ibuprofen|mesh-list
93058078|NCT00121641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058079|NCT00121641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058080|NCT00425555|Panobinostat|panobinostat|mesh-list
93058081|NCT00425555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058082|NCT00425555|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93058083|NCT00425555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058084|NCT00425555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058085|NCT00424775|Vorinostat|vorinostat|mesh-list
93058086|NCT00424775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058087|NCT00424775|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93058088|NCT00424775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058089|NCT00424775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058090|NCT01034345|Sirolimus|sirolimus|mesh-list
93058091|NCT01034345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
93058092|NCT01034345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058093|NCT01034345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058094|NCT01034345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93058095|NCT01034345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058096|NCT01034345|Antifungal Agents|antifungal agents|mesh-ancestor
93058097|NCT01034345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058098|NCT01034345|Immunologic Factors|immunologic factors|mesh-ancestor
93058099|NCT01034345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058100|NCT01034345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331633|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
93058101|NCT01034345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058102|NCT01763866|Atorvastatin|atorvastatin|mesh-list
93058103|NCT01763866|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93058104|NCT01763866|Simvastatin|simvastatin|mesh-list
93058105|NCT01763866|Ezetimibe|ezetimibe|mesh-list
93058106|NCT01763866|Evolocumab|evolocumab|mesh-list
93058107|NCT01763866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93058108|NCT01763866|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93058109|NCT01763866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93058110|NCT01763866|Antimetabolites|antimetabolites|mesh-ancestor
93058111|NCT01763866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058112|NCT01763866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93058113|NCT01763866|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93058114|NCT01763866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058115|NCT01763866|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93058116|NCT01763866|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93058117|NCT01763866|Protease Inhibitors|protease inhibitors|mesh-ancestor
93058118|NCT01763866|Immunologic Factors|immunologic factors|mesh-ancestor
93058119|NCT01763866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058120|NCT00132873|Sodium Oxybate|sodium oxybate|mesh-list
93058121|NCT00132873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93058122|NCT00132873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93058123|NCT00132873|Anesthetics, General|anesthetics, general|mesh-ancestor
93058124|NCT00132873|Anesthetics|anesthetics|mesh-ancestor
93058125|NCT00132873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058126|NCT00132873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058127|NCT01588925|Dexamethasone|dexamethasone|mesh-list
93058128|NCT01588925|Dexamethasone acetate|dexamethasone acetate|mesh-list
93058129|NCT01588925|BB 1101|bb 1101|mesh-list
93058130|NCT01588925|Hyaluronic Acid|hyaluronic acid|mesh-list
93058131|NCT01588925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93058132|NCT01588925|Antiemetics|antiemetics|mesh-ancestor
93058133|NCT01588925|Autonomic Agents|autonomic agents|mesh-ancestor
93058134|NCT01588925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058135|NCT01588925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058136|NCT01588925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058137|NCT01588925|Glucocorticoids|glucocorticoids|mesh-ancestor
93058138|NCT01588925|Hormones|hormones|mesh-ancestor
93058139|NCT01588925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058140|NCT01588925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93058141|NCT01588925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058142|NCT01588925|Protease Inhibitors|protease inhibitors|mesh-ancestor
93058143|NCT01588925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058144|NCT01588925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058145|NCT01588925|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058146|NCT01588925|Immunologic Factors|immunologic factors|mesh-ancestor
93058147|NCT01588925|Viscosupplements|viscosupplements|mesh-ancestor
93058148|NCT01588925|Protective Agents|protective agents|mesh-ancestor
93058149|NCT01238146|Rituximab|rituximab|mesh-list
93058150|NCT01238146|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93058151|NCT01238146|Obatoclax|obatoclax|mesh-list
93058152|NCT01238146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93058153|NCT01238146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058155|NCT01238146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058156|NCT01238146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058157|NCT01238146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93058158|NCT01238146|Alkylating Agents|alkylating agents|mesh-ancestor
93058159|NCT01238146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058160|NCT01238146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058161|NCT01141894|Phenylephrine|phenylephrine|mesh-list
93058162|NCT01141894|Dobutamine|dobutamine|mesh-list
93058163|NCT01141894|Oxymetazoline|oxymetazoline|mesh-list
93058164|NCT01141894|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
93058165|NCT01141894|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93058167|NCT01141894|Autonomic Agents|autonomic agents|mesh-ancestor
93058168|NCT01141894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058169|NCT01141894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058170|NCT01141894|Sympathomimetics|sympathomimetics|mesh-ancestor
93058171|NCT01141894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93058172|NCT01141894|Nasal Decongestants|nasal decongestants|mesh-ancestor
93058173|NCT01141894|Respiratory System Agents|respiratory system agents|mesh-ancestor
93058174|NCT01141894|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93058175|NCT01141894|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93058176|NCT01141894|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93058177|NCT01141894|Adrenergic Agents|adrenergic agents|mesh-ancestor
93058178|NCT01141894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058179|NCT01141894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058180|NCT01141894|Protective Agents|protective agents|mesh-ancestor
93058181|NCT01141894|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93058182|NCT01141894|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93058183|NCT01141894|Plasma Substitutes|plasma substitutes|mesh-ancestor
93058184|NCT01141894|Blood Substitutes|blood substitutes|mesh-ancestor
93058185|NCT01238224|Tadalafil|tadalafil|mesh-list
93058186|NCT01238224|Vasodilator Agents|vasodilator agents|mesh-ancestor
93058187|NCT01238224|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93058188|NCT01238224|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93058189|NCT01238224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058190|NCT01238224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058191|NCT01238224|Urological Agents|urological agents|mesh-ancestor
93058192|NCT01237444|Ritonavir|ritonavir|mesh-list
93058193|NCT01237444|Lopinavir|lopinavir|mesh-list
93058194|NCT01237444|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93058195|NCT01237444|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93058196|NCT01237444|Protease Inhibitors|protease inhibitors|mesh-ancestor
93058197|NCT01237444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058198|NCT01237444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058199|NCT01237444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93058200|NCT01237444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93058201|NCT01237444|Antiviral Agents|antiviral agents|mesh-ancestor
93058202|NCT01237444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058203|NCT01237444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93058204|NCT01237444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93058205|NCT01145170|Nimotuzumab|nimotuzumab|mesh-list
93058206|NCT01145170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93058207|NCT01145170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058208|NCT01141972|Vitamin D|vitamin d|mesh-list
93058209|NCT01141972|Vitamins|vitamins|mesh-ancestor
93058210|NCT01141972|Micronutrients|micronutrients|mesh-ancestor
93058211|NCT01141972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058212|NCT01141972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93058213|NCT04316806|Rifaximin|rifaximin|mesh-list
93058214|NCT04316806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058215|NCT04316806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058216|NCT04316806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058217|NCT01145326|Lidocaine|lidocaine|mesh-list
93058218|NCT01145326|Anesthetics, Local|anesthetics, local|mesh-ancestor
93058219|NCT01145326|Anesthetics|anesthetics|mesh-ancestor
93058220|NCT01145326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058221|NCT01145326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058222|NCT01145326|Sensory System Agents|sensory system agents|mesh-ancestor
93058223|NCT01145326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058224|NCT01145326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93058225|NCT01145326|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93058226|NCT01145326|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92703246|NCT01808820|Imiquimod|imiquimod|mesh-list
93058227|NCT01145326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058228|NCT01145326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058229|NCT01144702|Artesunate|artesunate|mesh-list
93058230|NCT01144702|Mefloquine|mefloquine|mesh-list
93058231|NCT01144702|Antimalarials|antimalarials|mesh-ancestor
93058232|NCT01144702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93058233|NCT01144702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93058234|NCT01144702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058235|NCT01144702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058236|NCT01144702|Antiviral Agents|antiviral agents|mesh-ancestor
93058237|NCT01144702|Schistosomicides|schistosomicides|mesh-ancestor
93058238|NCT01144702|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93058239|NCT01144702|Anthelmintics|anthelmintics|mesh-ancestor
93058241|NCT01145404|Lapatinib|lapatinib|mesh-list
93058242|NCT01145404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058243|NCT01145404|Antimetabolites|antimetabolites|mesh-ancestor
93058244|NCT01145404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058245|NCT01145404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058246|NCT01145404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058247|NCT01145404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058248|NCT01237522|Metformin|metformin|mesh-list
93058249|NCT01237522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93058250|NCT01237522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058251|NCT01235416|Motesanib diphosphate|motesanib diphosphate|mesh-list
93058252|NCT01235416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058253|NCT01235416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058254|NCT01235416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058255|NCT04246996|Gentamicins|gentamicins|mesh-list
93058256|NCT04246996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058257|NCT04246996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058258|NCT04246996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93058259|NCT04246996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058260|NCT04246996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058261|NCT00424463|Edaravone|edaravone|mesh-list
93058262|NCT00424463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93058263|NCT00424463|Antioxidants|antioxidants|mesh-ancestor
93058264|NCT00424463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058265|NCT00424463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93058266|NCT00424463|Protective Agents|protective agents|mesh-ancestor
93058267|NCT00424463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058268|NCT01324115|Nitroarginine|nitroarginine|mesh-list
93058269|NCT01324115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058270|NCT01324115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058271|NCT01037621|Valacyclovir|valacyclovir|mesh-list
93058272|NCT01037621|Antiviral Agents|antiviral agents|mesh-ancestor
93058273|NCT01037621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058274|NCT00424385|Sorafenib|sorafenib|mesh-list
93058275|NCT00424385|Imatinib Mesylate|imatinib mesylate|mesh-list
93058276|NCT00424385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058277|NCT00424385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058278|NCT00424385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058279|NCT00424385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058280|NCT03994055|Antioxidants|antioxidants|mesh-list
93058281|NCT03994055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058282|NCT03994055|Protective Agents|protective agents|mesh-ancestor
93058283|NCT03994055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058284|NCT01037699|Hormones|hormones|mesh-list
93058285|NCT01037699|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93058286|NCT01037699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058287|NCT01037699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058288|NCT00423917|Bevacizumab|bevacizumab|mesh-list
93058289|NCT00423917|Fulvestrant|fulvestrant|mesh-list
93058290|NCT00423917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93058291|NCT00423917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058292|NCT00423917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93058293|NCT00423917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93058294|NCT00423917|Growth Substances|growth substances|mesh-ancestor
93058295|NCT00423917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058296|NCT00423917|Growth Inhibitors|growth inhibitors|mesh-ancestor
93058297|NCT00423917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93058298|NCT00423917|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93058299|NCT00423917|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93058300|NCT00423917|Hormone Antagonists|hormone antagonists|mesh-ancestor
93058301|NCT00423917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703322|NCT05471427|Taxane|taxane|mesh-list
93058302|NCT00845026|Olanzapine|olanzapine|mesh-list
93058303|NCT00845026|Risperidone|risperidone|mesh-list
93058304|NCT00845026|Aripiprazole|aripiprazole|mesh-list
93058305|NCT00845026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93058306|NCT00845026|Serotonin Agents|serotonin agents|mesh-ancestor
93058307|NCT00845026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058308|NCT00845026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058309|NCT00845026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058310|NCT00845026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93058311|NCT00845026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93058312|NCT00845026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058313|NCT00845026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058314|NCT00845026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93058315|NCT00845026|Dopamine Agents|dopamine agents|mesh-ancestor
93058316|NCT00845026|Antiemetics|antiemetics|mesh-ancestor
93058317|NCT00845026|Autonomic Agents|autonomic agents|mesh-ancestor
93058318|NCT00845026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058319|NCT00845026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058320|NCT00845026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93058321|NCT00845026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93058322|NCT00845026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058323|NCT00845026|Antidepressive Agents|antidepressive agents|mesh-ancestor
93058324|NCT00845026|Dopamine Agonists|dopamine agonists|mesh-ancestor
93058325|NCT00845026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93058326|NCT00845026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93058327|NCT00845026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93058328|NCT00845026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93058329|NCT02445131|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93058330|NCT02445131|Obinutuzumab|obinutuzumab|mesh-list
93058331|NCT02445131|Idelalisib|idelalisib|mesh-list
93058332|NCT02445131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93058333|NCT02445131|Alkylating Agents|alkylating agents|mesh-ancestor
93058334|NCT02445131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058335|NCT02445131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058336|NCT02445131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93058337|NCT02445131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058338|NCT00003838|Cyclosporine|cyclosporine|mesh-list
93058339|NCT00003838|Methotrexate|methotrexate|mesh-list
93058340|NCT00003838|Cyclosporins|cyclosporins|mesh-list
93058341|NCT00003838|Lenograstim|lenograstim|mesh-list
93058342|NCT00003838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93058343|NCT00003838|Abortifacient Agents|abortifacient agents|mesh-ancestor
93058344|NCT00003838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93058345|NCT00003838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058346|NCT00003838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058347|NCT00003838|Antimetabolites|antimetabolites|mesh-ancestor
93058348|NCT00003838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058349|NCT00003838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058350|NCT00003838|Dermatologic Agents|dermatologic agents|mesh-ancestor
93058351|NCT00003838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058352|NCT00003838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93058353|NCT00003838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058354|NCT00003838|Immunologic Factors|immunologic factors|mesh-ancestor
93058355|NCT00003838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058356|NCT00003838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93058357|NCT00003838|Antifungal Agents|antifungal agents|mesh-ancestor
93058358|NCT00003838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058359|NCT00003838|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93058360|NCT00003838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058361|NCT01238770|Cyclophosphamide|cyclophosphamide|mesh-list
93058362|NCT01238770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058363|NCT01238770|Immunologic Factors|immunologic factors|mesh-ancestor
93058364|NCT01238770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058365|NCT01238770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058366|NCT01238770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93058367|NCT01238770|Alkylating Agents|alkylating agents|mesh-ancestor
93058368|NCT01238770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058369|NCT01238770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058370|NCT01238770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93058371|NCT01145950|Etanercept|etanercept|mesh-list
93058372|NCT01145950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93058373|NCT01145950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93058374|NCT01145950|Analgesics|analgesics|mesh-ancestor
93058375|NCT01145950|Sensory System Agents|sensory system agents|mesh-ancestor
92703399|NCT00596050|Lidocaine|lidocaine|mesh-list
93058376|NCT01145950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058377|NCT01145950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058379|NCT01145950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058380|NCT01145950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058381|NCT01145950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058382|NCT01145950|Immunologic Factors|immunologic factors|mesh-ancestor
93058383|NCT01238926|Vitamins|vitamins|mesh-list
93058384|NCT01238926|Folic Acid|folic acid|mesh-list
93058385|NCT01238926|Hydroxocobalamin|hydroxocobalamin|mesh-list
93058386|NCT01238926|Vitamin B 12|vitamin b 12|mesh-list
93058387|NCT01238926|Vitamin B 6|vitamin b 6|mesh-list
93058388|NCT01238926|Pyridoxal|pyridoxal|mesh-list
93058389|NCT01238926|Pyridoxine|pyridoxine|mesh-list
93058390|NCT01238926|Vitamin B Complex|vitamin b complex|mesh-list
93058391|NCT01238926|Micronutrients|micronutrients|mesh-ancestor
93058392|NCT01238926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058393|NCT01238926|Hematinics|hematinics|mesh-ancestor
93058394|NCT01239004|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93058395|NCT01239004|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93058396|NCT01239004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93058397|NCT01239004|Antimetabolites|antimetabolites|mesh-ancestor
93058398|NCT01239004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058399|NCT01239004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93058400|NCT01142518|Interferons|interferons|mesh-list
93058401|NCT01142518|Interferon-beta|interferon-beta|mesh-list
93058402|NCT01142518|Interferon beta-1a|interferon beta-1a|mesh-list
93058403|NCT01142518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058404|NCT01142518|Antiviral Agents|antiviral agents|mesh-ancestor
93058405|NCT01142518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058406|NCT01142518|Immunologic Factors|immunologic factors|mesh-ancestor
93058407|NCT01142518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058408|NCT01142518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058409|NCT00423449|Gemcitabine|gemcitabine|mesh-list
93058410|NCT00423449|Vorinostat|vorinostat|mesh-list
93058411|NCT00423449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058412|NCT00423449|Antimetabolites|antimetabolites|mesh-ancestor
93058413|NCT00423449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058414|NCT00423449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058415|NCT00423449|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93058416|NCT00423449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058417|NCT00423293|Fluorouracil|fluorouracil|mesh-list
93058418|NCT00423293|Mitomycins|mitomycins|mesh-list
93058419|NCT00423293|Mitomycin|mitomycin|mesh-list
93058420|NCT00423293|Antimetabolites|antimetabolites|mesh-ancestor
93058421|NCT00423293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058422|NCT00423293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058423|NCT00423293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058424|NCT00423293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058425|NCT00423293|Immunologic Factors|immunologic factors|mesh-ancestor
93058426|NCT00423293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058427|NCT00423293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93058428|NCT00423293|Alkylating Agents|alkylating agents|mesh-ancestor
93058429|NCT00423293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93058430|NCT00423293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058431|NCT00422903|Letrozole|letrozole|mesh-list
93058432|NCT00422903|Lapatinib|lapatinib|mesh-list
93058433|NCT00422903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058434|NCT00422903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93058435|NCT00422903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93058436|NCT00422903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058437|NCT00422903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058438|NCT00422903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93058439|NCT00422903|Hormone Antagonists|hormone antagonists|mesh-ancestor
93058440|NCT00422903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058441|NCT00422903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058442|NCT00422903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058443|NCT00422591|Cytarabine|cytarabine|mesh-list
93058444|NCT00422591|Idarubicin|idarubicin|mesh-list
93058445|NCT00422591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058446|NCT00422591|Antimetabolites|antimetabolites|mesh-ancestor
93058447|NCT00422591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058448|NCT00422591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058449|NCT00422591|Antiviral Agents|antiviral agents|mesh-ancestor
93058450|NCT00422591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058451|NCT00422591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058452|NCT00422591|Immunologic Factors|immunologic factors|mesh-ancestor
93058453|NCT00422591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058454|NCT00422591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93058455|NCT00422591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93058456|NCT00422591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93058457|NCT00422591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058459|NCT00422513|Hematinics|hematinics|mesh-ancestor
93058460|NCT00202878|Simvastatin|simvastatin|mesh-list
93058461|NCT00202878|Ezetimibe|ezetimibe|mesh-list
93058462|NCT00202878|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
93058463|NCT00202878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93058464|NCT00202878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93058465|NCT00202878|Antimetabolites|antimetabolites|mesh-ancestor
93058466|NCT00202878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058467|NCT00202878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93058468|NCT00202878|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93058469|NCT00202878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058470|NCT00414011|Moxifloxacin|moxifloxacin|mesh-list
93058471|NCT00414011|Gatifloxacin|gatifloxacin|mesh-list
93058472|NCT00414011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058473|NCT00414011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058474|NCT00414011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93058475|NCT00414011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93058476|NCT00414011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331723|NCT04568876|Palmidrol|palmidrol|mesh-list
93058477|NCT00414011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058478|NCT00414011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058479|NCT00414011|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93058480|NCT00414011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93058481|NCT00260208|Cyclosporine|cyclosporine|mesh-list
93058482|NCT00260208|Tacrolimus|tacrolimus|mesh-list
93058483|NCT00260208|Cyclosporins|cyclosporins|mesh-list
93058484|NCT00260208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058485|NCT00260208|Immunologic Factors|immunologic factors|mesh-ancestor
93058486|NCT00260208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058487|NCT00260208|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93058488|NCT00260208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058489|NCT00260208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058490|NCT00260208|Antifungal Agents|antifungal agents|mesh-ancestor
93058491|NCT00260208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058492|NCT00260208|Dermatologic Agents|dermatologic agents|mesh-ancestor
93058493|NCT00260208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058494|NCT00202644|Hydroxyurea|hydroxyurea|mesh-list
93058495|NCT00202644|Anagrelide|anagrelide|mesh-list
93058496|NCT00202644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058497|NCT00202644|Antisickling Agents|antisickling agents|mesh-ancestor
93058498|NCT00202644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058499|NCT00202644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058500|NCT00202644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93058501|NCT00202644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93058502|NCT00202644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93058503|NCT00202644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93058504|NCT00259740|Denosumab|denosumab|mesh-list
93058505|NCT00259740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93058506|NCT00259740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058507|NCT01073202|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93058508|NCT01073202|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93058509|NCT01073202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058510|NCT01236040|Vaccines|vaccines|mesh-list
93058511|NCT01236040|Immunologic Factors|immunologic factors|mesh-ancestor
93058512|NCT01236040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058513|NCT03812224|Erenumab|erenumab|mesh-list
93058514|NCT03812224|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
93058515|NCT03812224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058516|NCT03812224|Analgesics|analgesics|mesh-ancestor
93058517|NCT03812224|Sensory System Agents|sensory system agents|mesh-ancestor
93058518|NCT03812224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058519|NCT03812224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058520|NCT01146028|Tizanidine|tizanidine|mesh-list
92332216|NCT00003391|Antibodies|antibodies|mesh-list
93058521|NCT01146028|Analgesics|analgesics|mesh-ancestor
93058522|NCT01146028|Sensory System Agents|sensory system agents|mesh-ancestor
93058523|NCT01146028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058524|NCT01146028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058525|NCT01146028|Anticonvulsants|anticonvulsants|mesh-ancestor
93058526|NCT01146028|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93058527|NCT01146028|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93058528|NCT01146028|Parasympatholytics|parasympatholytics|mesh-ancestor
93058530|NCT01146028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93058531|NCT01146028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93058532|NCT01146028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93058533|NCT01146028|Adrenergic Agents|adrenergic agents|mesh-ancestor
93058534|NCT01146028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058535|NCT01146028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058536|NCT03530800|Dronabinol|dronabinol|mesh-list
93058537|NCT03530800|Hallucinogens|hallucinogens|mesh-ancestor
93058538|NCT03530800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058539|NCT03530800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058540|NCT03530800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93058542|NCT03530800|Sensory System Agents|sensory system agents|mesh-ancestor
93058543|NCT03530800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058544|NCT03530800|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93058545|NCT03530800|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93058546|NCT03530800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058547|NCT03530800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058548|NCT03530800|Hormones|hormones|mesh-ancestor
93058549|NCT03530800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058550|NCT04982146|Acetylcysteine|acetylcysteine|mesh-list
93058551|NCT04982146|N-monoacetylcystine|n-monoacetylcystine|mesh-list
93058552|NCT04982146|Antiviral Agents|antiviral agents|mesh-ancestor
93058553|NCT04982146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058554|NCT04982146|Expectorants|expectorants|mesh-ancestor
93058555|NCT04982146|Respiratory System Agents|respiratory system agents|mesh-ancestor
93058556|NCT04982146|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93058557|NCT04982146|Antioxidants|antioxidants|mesh-ancestor
92332413|NCT00003013|Methotrexate|methotrexate|mesh-list
93058558|NCT04982146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058559|NCT04982146|Protective Agents|protective agents|mesh-ancestor
93058560|NCT04982146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058561|NCT04982146|Antidotes|antidotes|mesh-ancestor
93058562|NCT04958746|Propofol|propofol|mesh-list
93058563|NCT04958746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93058564|NCT04958746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058565|NCT04958746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058566|NCT04958746|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93058567|NCT04958746|Anesthetics, General|anesthetics, general|mesh-ancestor
93058568|NCT04958746|Anesthetics|anesthetics|mesh-ancestor
93058569|NCT01146106|Pravastatin|pravastatin|mesh-list
93058570|NCT01146106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93058571|NCT01146106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93058572|NCT01146106|Antimetabolites|antimetabolites|mesh-ancestor
93058573|NCT01146106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058574|NCT01146106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93058575|NCT01146106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93058576|NCT01146106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058577|NCT03431584|Hyaluronic Acid|hyaluronic acid|mesh-list
93058578|NCT03431584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058579|NCT03431584|Immunologic Factors|immunologic factors|mesh-ancestor
93058580|NCT03431584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058581|NCT03431584|Viscosupplements|viscosupplements|mesh-ancestor
93058582|NCT03431584|Protective Agents|protective agents|mesh-ancestor
93058583|NCT00259272|Olanzapine|olanzapine|mesh-list
93058584|NCT00259272|Antiemetics|antiemetics|mesh-ancestor
93058585|NCT00259272|Autonomic Agents|autonomic agents|mesh-ancestor
93058586|NCT00259272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058587|NCT00259272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058588|NCT00259272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058589|NCT00259272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93058590|NCT00259272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93058591|NCT00259272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058592|NCT00259272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058593|NCT00259272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93058594|NCT00259272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93058595|NCT00259272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058596|NCT00259272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058597|NCT00259272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058598|NCT00259272|Serotonin Agents|serotonin agents|mesh-ancestor
93058599|NCT03106324|Lenalidomide|lenalidomide|mesh-list
93058600|NCT03106324|Immunologic Factors|immunologic factors|mesh-ancestor
93058601|NCT03106324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058602|NCT03106324|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93058603|NCT03106324|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93058604|NCT03106324|Growth Substances|growth substances|mesh-ancestor
93058605|NCT03106324|Growth Inhibitors|growth inhibitors|mesh-ancestor
93058606|NCT03106324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058607|NCT01147276|Vildagliptin|vildagliptin|mesh-list
93058608|NCT01147276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93058609|NCT01147276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058610|NCT01147276|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92529565|NCT00001151|Micronutrients|micronutrients|mesh-ancestor
93058611|NCT01147276|Protease Inhibitors|protease inhibitors|mesh-ancestor
93058612|NCT01147276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058613|NCT01147276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058614|NCT01239940|Paclitaxel|paclitaxel|mesh-list
93058615|NCT01239940|Everolimus|everolimus|mesh-list
93058616|NCT01239940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93058617|NCT01239940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058618|NCT01239940|Tubulin Modulators|tubulin modulators|mesh-ancestor
93058619|NCT01239940|Antimitotic Agents|antimitotic agents|mesh-ancestor
93058620|NCT01239940|Mitosis Modulators|mitosis modulators|mesh-ancestor
93058621|NCT01239940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058622|NCT01239940|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93058623|NCT01239940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058624|NCT01239940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058625|NCT01239940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058626|NCT01239940|Immunologic Factors|immunologic factors|mesh-ancestor
93058627|NCT01239940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058628|NCT02526004|Tobramycin|tobramycin|mesh-list
93058629|NCT02526004|Ceftazidime|ceftazidime|mesh-list
93058630|NCT02526004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058631|NCT02526004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058632|NCT00421889|Paclitaxel|paclitaxel|mesh-list
93058633|NCT00421889|Carboplatin|carboplatin|mesh-list
93058634|NCT00421889|Belinostat|belinostat|mesh-list
93058635|NCT00421889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93058636|NCT00421889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058637|NCT00421889|Tubulin Modulators|tubulin modulators|mesh-ancestor
93058638|NCT00421889|Antimitotic Agents|antimitotic agents|mesh-ancestor
93058639|NCT00421889|Mitosis Modulators|mitosis modulators|mesh-ancestor
93058640|NCT00421889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332585|NCT00383929|Candesartan|candesartan|mesh-list
93058641|NCT00421889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93058642|NCT00421889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058643|NCT03913468|Ascorbic Acid|ascorbic acid|mesh-list
93058644|NCT03913468|Antioxidants|antioxidants|mesh-ancestor
93058645|NCT03913468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058646|NCT03913468|Protective Agents|protective agents|mesh-ancestor
93058647|NCT03913468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058648|NCT03913468|Vitamins|vitamins|mesh-ancestor
93058649|NCT03913468|Micronutrients|micronutrients|mesh-ancestor
93058650|NCT01147354|Selenium|selenium|mesh-list
93058651|NCT01147354|Antioxidants|antioxidants|mesh-ancestor
93058652|NCT01147354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058653|NCT01147354|Protective Agents|protective agents|mesh-ancestor
93058654|NCT01147354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058655|NCT01147354|Trace Elements|trace elements|mesh-ancestor
93058656|NCT01147354|Micronutrients|micronutrients|mesh-ancestor
93058657|NCT04744480|Anesthetics|anesthetics|mesh-list
93058658|NCT04744480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92332623|NCT00003541|Tubulin Modulators|tubulin modulators|mesh-ancestor
93058659|NCT04744480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058660|NCT01147432|Capsaicin|capsaicin|mesh-list
93058661|NCT01147432|Antipruritics|antipruritics|mesh-ancestor
93058662|NCT01147432|Dermatologic Agents|dermatologic agents|mesh-ancestor
93058663|NCT01147432|Sensory System Agents|sensory system agents|mesh-ancestor
93058664|NCT01147432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058665|NCT01147432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058666|NCT01147510|Montelukast|montelukast|mesh-list
93058667|NCT01147510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93058668|NCT01147510|Respiratory System Agents|respiratory system agents|mesh-ancestor
93058669|NCT01147510|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93058670|NCT01147510|Hormone Antagonists|hormone antagonists|mesh-ancestor
93058671|NCT01147510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058672|NCT01147510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058673|NCT01147510|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93058674|NCT01147510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92703691|NCT00598624|Treosulfan|treosulfan|mesh-list
93058675|NCT01147510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058676|NCT03916432|Sirolimus|sirolimus|mesh-list
93058677|NCT03916432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058678|NCT03916432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058679|NCT03916432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93058680|NCT03916432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058681|NCT03916432|Antifungal Agents|antifungal agents|mesh-ancestor
93058682|NCT03916432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058683|NCT03916432|Immunologic Factors|immunologic factors|mesh-ancestor
93058684|NCT03916432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058685|NCT00421733|Ergocalciferols|ergocalciferols|mesh-list
93058686|NCT00421733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93058687|NCT00421733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058688|NCT00421733|Vitamins|vitamins|mesh-ancestor
93058689|NCT00421733|Micronutrients|micronutrients|mesh-ancestor
93058690|NCT00421733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93058691|NCT00421343|Cholecalciferol|cholecalciferol|mesh-list
93058692|NCT00421343|Vitamin D|vitamin d|mesh-list
93058693|NCT00421343|Alendronate|alendronate|mesh-list
93058694|NCT00421343|Calcium Carbonate|calcium carbonate|mesh-list
93058695|NCT00421343|Calcium|calcium|mesh-list
93058696|NCT00421343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93058697|NCT00421343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058698|NCT00421343|Vitamins|vitamins|mesh-ancestor
93058699|NCT00421343|Micronutrients|micronutrients|mesh-ancestor
93058700|NCT00421343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93058701|NCT00421343|Antacids|antacids|mesh-ancestor
93058702|NCT00421343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058703|NCT00421343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058704|NCT01147588|Esomeprazole|esomeprazole|mesh-list
93058705|NCT01147588|Omeprazole|omeprazole|mesh-list
93058706|NCT01147588|Lansoprazole|lansoprazole|mesh-list
93058707|NCT01147588|Dexlansoprazole|dexlansoprazole|mesh-list
93058708|NCT01147588|Clopidogrel|clopidogrel|mesh-list
93058709|NCT01147588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93058710|NCT01147588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93058711|NCT01147588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93058712|NCT01147588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93058713|NCT01147588|Purinergic Agents|purinergic agents|mesh-ancestor
93058714|NCT01147588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058715|NCT01147588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058716|NCT01147588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058717|NCT01147588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93058718|NCT01147588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93058719|NCT01147588|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93058720|NCT01147588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058721|NCT03908242|Salvianolic acid A|salvianolic acid a|mesh-list
93058722|NCT03908242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058723|NCT03908242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058724|NCT03908242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058725|NCT03908242|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93058726|NCT00230178|Allopurinol|allopurinol|mesh-list
93058727|NCT00230178|Rasburicase|rasburicase|mesh-list
93058728|NCT00230178|Antimetabolites|antimetabolites|mesh-ancestor
93058729|NCT00230178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058730|NCT00230178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058731|NCT00230178|Gout Suppressants|gout suppressants|mesh-ancestor
93058732|NCT00230178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058733|NCT00230178|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93058734|NCT00230178|Antioxidants|antioxidants|mesh-ancestor
93058735|NCT00230178|Protective Agents|protective agents|mesh-ancestor
93058736|NCT00230178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058737|NCT03908008|Botulinum Toxins|botulinum toxins|mesh-list
93058738|NCT03908008|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93058739|NCT03908008|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93058740|NCT03908008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93058741|NCT03908008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058742|NCT03908008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058743|NCT03908008|Cholinergic Agents|cholinergic agents|mesh-ancestor
93058744|NCT03908008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058745|NCT03908008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058746|NCT03908008|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93058747|NCT03908008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058748|NCT01251172|Melphalan|melphalan|mesh-list
93058749|NCT01251172|Mechlorethamine|mechlorethamine|mesh-list
93058750|NCT01251172|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
93058751|NCT01251172|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93058752|NCT01251172|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
93058753|NCT01251172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93058754|NCT01251172|Alkylating Agents|alkylating agents|mesh-ancestor
93058755|NCT01251172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058756|NCT01251172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058757|NCT01251172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93058758|NCT01251172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058759|NCT01251172|Immunologic Factors|immunologic factors|mesh-ancestor
93058760|NCT01251172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058761|NCT01251172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058762|NCT00413777|Tolvaptan|tolvaptan|mesh-list
93058763|NCT00413777|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93058764|NCT00413777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058765|NCT00413777|Natriuretic Agents|natriuretic agents|mesh-ancestor
93058766|NCT00413777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058767|NCT01250236|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93058768|NCT01250236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93058769|NCT01250236|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93058770|NCT01250236|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93058771|NCT01250236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93058772|NCT01250236|Adrenergic Agents|adrenergic agents|mesh-ancestor
93058773|NCT01250236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058774|NCT01250236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058775|NCT01250236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058776|NCT01074060|Plerixafor|plerixafor|mesh-list
93058777|NCT01074060|Cyclophosphamide|cyclophosphamide|mesh-list
93058778|NCT01074060|Lenograstim|lenograstim|mesh-list
93058779|NCT01074060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058780|NCT01074060|Immunologic Factors|immunologic factors|mesh-ancestor
93058781|NCT01074060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058782|NCT01074060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058783|NCT01074060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93058784|NCT01074060|Alkylating Agents|alkylating agents|mesh-ancestor
93058785|NCT01074060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058786|NCT01074060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058787|NCT01074060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93058788|NCT01074060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058789|NCT01074060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93058790|NCT01074060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93058791|NCT01074060|Antiviral Agents|antiviral agents|mesh-ancestor
93058792|NCT01074060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058793|NCT03915340|Propafenone|propafenone|mesh-list
93058794|NCT03915340|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93058795|NCT03915340|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93058796|NCT03915340|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93058797|NCT03915340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058798|NCT03915340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058799|NCT01581918|Carbamazepine|carbamazepine|mesh-list
93058800|NCT01581918|Anticonvulsants|anticonvulsants|mesh-ancestor
93058801|NCT01581918|Antimanic Agents|antimanic agents|mesh-ancestor
93058802|NCT01581918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93058803|NCT01581918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058804|NCT01581918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058805|NCT01581918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058806|NCT01581918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93058807|NCT01581918|Analgesics|analgesics|mesh-ancestor
93058808|NCT01581918|Sensory System Agents|sensory system agents|mesh-ancestor
93058809|NCT01581918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058810|NCT01581918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93058811|NCT01581918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058812|NCT01581918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058813|NCT01581918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93058814|NCT01581918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93058815|NCT01582542|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93058816|NCT01582542|Hemostatics|hemostatics|mesh-ancestor
93058817|NCT01582542|Coagulants|coagulants|mesh-ancestor
93058818|NCT01582542|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93058819|NCT01582542|Natriuretic Agents|natriuretic agents|mesh-ancestor
93058820|NCT01582542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058821|NCT03912766|Arginine Vasopressin|arginine vasopressin|mesh-list
93058822|NCT03912766|Hemostatics|hemostatics|mesh-ancestor
93058823|NCT03912766|Coagulants|coagulants|mesh-ancestor
93058824|NCT03912766|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93058825|NCT03912766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93058826|NCT03912766|Natriuretic Agents|natriuretic agents|mesh-ancestor
93058827|NCT03912766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058829|NCT01251328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058830|NCT01251328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058831|NCT00420641|Paroxetine|paroxetine|mesh-list
93058832|NCT00420641|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93058834|NCT00420641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93058835|NCT00420641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058836|NCT00420641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058837|NCT00420641|Serotonin Agents|serotonin agents|mesh-ancestor
93058838|NCT00420641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058839|NCT00420641|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93058840|NCT00420641|Antidepressive Agents|antidepressive agents|mesh-ancestor
93058841|NCT00420641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058842|NCT00420641|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92333125|NCT00003103|Docetaxel|docetaxel|mesh-list
93058843|NCT00420641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93058844|NCT00420641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058845|NCT00257556|Menotropins|menotropins|mesh-list
93058846|NCT00257556|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93058847|NCT00257556|Hormones|hormones|mesh-ancestor
93058848|NCT00257556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058849|NCT00257556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058850|NCT00257556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93058851|NCT00257556|Fertility Agents|fertility agents|mesh-ancestor
93058852|NCT00257556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93058853|NCT03906916|Micafungin|micafungin|mesh-list
93058854|NCT03906916|Antifungal Agents|antifungal agents|mesh-ancestor
93058855|NCT03906916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058856|NCT01250470|Sargramostim|sargramostim|mesh-list
93058857|NCT01250470|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93058858|NCT01250470|Immunologic Factors|immunologic factors|mesh-ancestor
93058859|NCT01250470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058860|NCT01250470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93058861|NCT01250548|Apremilast|apremilast|mesh-list
93058862|NCT01250548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93058863|NCT01250548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93058864|NCT01250548|Analgesics|analgesics|mesh-ancestor
93058865|NCT01250548|Sensory System Agents|sensory system agents|mesh-ancestor
93058866|NCT01250548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058867|NCT01250548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058868|NCT01250548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93058869|NCT01250548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058870|NCT01250548|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93058871|NCT01250548|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93058872|NCT01250548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058873|NCT01250548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058874|NCT03906838|Ropivacaine|ropivacaine|mesh-list
93058875|NCT03906838|Anesthetics, Local|anesthetics, local|mesh-ancestor
93058876|NCT03906838|Anesthetics|anesthetics|mesh-ancestor
93058877|NCT03906838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058878|NCT03906838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058879|NCT03906838|Sensory System Agents|sensory system agents|mesh-ancestor
93058880|NCT03906838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058881|NCT01251484|Nintedanib|nintedanib|mesh-list
93058882|NCT01251484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058883|NCT01251484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058884|NCT01251484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058885|NCT01251484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058886|NCT03914638|Albuterol|albuterol|mesh-list
93058887|NCT03914638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93058888|NCT03914638|Autonomic Agents|autonomic agents|mesh-ancestor
93058889|NCT03914638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93058890|NCT03914638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058891|NCT03914638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93058892|NCT03914638|Respiratory System Agents|respiratory system agents|mesh-ancestor
93058893|NCT03914638|Tocolytic Agents|tocolytic agents|mesh-ancestor
93058894|NCT03914638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93058895|NCT03914638|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92333231|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93058896|NCT03914638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92703947|NCT04319926|Lidocaine|lidocaine|mesh-list
93058897|NCT03914638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93058898|NCT03914638|Adrenergic Agents|adrenergic agents|mesh-ancestor
93058899|NCT03914638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058900|NCT03914638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058901|NCT01148446|Prednisone|prednisone|mesh-list
93058902|NCT01148446|Cyclophosphamide|cyclophosphamide|mesh-list
93058903|NCT01148446|Rituximab|rituximab|mesh-list
93058905|NCT01148446|Vincristine|vincristine|mesh-list
93058906|NCT01148446|Epirubicin|epirubicin|mesh-list
93058907|NCT01148446|Vinblastine|vinblastine|mesh-list
93058908|NCT01148446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058909|NCT01148446|Immunologic Factors|immunologic factors|mesh-ancestor
93058910|NCT01148446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058911|NCT01148446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93058912|NCT01148446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93058913|NCT01148446|Alkylating Agents|alkylating agents|mesh-ancestor
93058914|NCT01148446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058915|NCT01148446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058916|NCT01148446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93058917|NCT01148446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93058918|NCT01148446|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93058919|NCT01148446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93058920|NCT01148446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93058921|NCT01148446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058922|NCT01148446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93058923|NCT01148446|Glucocorticoids|glucocorticoids|mesh-ancestor
93058924|NCT01148446|Hormones|hormones|mesh-ancestor
93058925|NCT01148446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058926|NCT01148446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93058927|NCT01148446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93058928|NCT01148446|Tubulin Modulators|tubulin modulators|mesh-ancestor
93058929|NCT01148446|Antimitotic Agents|antimitotic agents|mesh-ancestor
93058930|NCT01148446|Mitosis Modulators|mitosis modulators|mesh-ancestor
93058931|NCT03914404|Thioctic Acid|thioctic acid|mesh-list
93058932|NCT03914404|Antioxidants|antioxidants|mesh-ancestor
93058933|NCT03914404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058934|NCT03914404|Protective Agents|protective agents|mesh-ancestor
93058935|NCT03914404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058936|NCT03914404|Vitamin B Complex|vitamin b complex|mesh-ancestor
93058937|NCT03914404|Vitamins|vitamins|mesh-ancestor
93058938|NCT03914404|Micronutrients|micronutrients|mesh-ancestor
93058939|NCT01251640|Gemcitabine|gemcitabine|mesh-list
93058940|NCT01251640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058941|NCT01251640|Antimetabolites|antimetabolites|mesh-ancestor
93058942|NCT01251640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058943|NCT01251640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058944|NCT00257166|Ziprasidone|ziprasidone|mesh-list
93058945|NCT00257166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93058946|NCT00257166|Serotonin Agents|serotonin agents|mesh-ancestor
93058947|NCT00257166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93058948|NCT00257166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058949|NCT00257166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058950|NCT00257166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93058951|NCT00257166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93058952|NCT00257166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058953|NCT00257166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93058954|NCT00257166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93058955|NCT00257166|Dopamine Agents|dopamine agents|mesh-ancestor
93058956|NCT03914092|Triamcinolone|triamcinolone|mesh-list
92333342|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058957|NCT03914092|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93058958|NCT03914092|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93058959|NCT03914092|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93058960|NCT03914092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93058961|NCT03914092|Glucocorticoids|glucocorticoids|mesh-ancestor
93058962|NCT03914092|Hormones|hormones|mesh-ancestor
93058963|NCT03914092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93058964|NCT03914092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058965|NCT03914092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93058966|NCT03914092|Immunologic Factors|immunologic factors|mesh-ancestor
93058967|NCT03914092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058968|NCT03914092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058969|NCT03913858|Anesthetics|anesthetics|mesh-list
93058970|NCT03913858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93058971|NCT03913858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93058973|NCT00227370|Antiviral Agents|antiviral agents|mesh-ancestor
93058974|NCT00227370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058975|NCT01251796|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93058976|NCT01251796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058977|NCT01251796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93058978|NCT01251796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058979|NCT01251796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058981|NCT01251874|Carboplatin|carboplatin|mesh-list
93058982|NCT01251874|Veliparib|veliparib|mesh-list
93058983|NCT01251874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058984|NCT01251874|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93058985|NCT01251874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93058986|NCT01251874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93058987|NCT01251874|Antiviral Agents|antiviral agents|mesh-ancestor
93058988|NCT01251874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058989|NCT03911440|Azithromycin|azithromycin|mesh-list
93058990|NCT03911440|Doxycycline|doxycycline|mesh-list
93058991|NCT03911440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93058992|NCT03911440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93058993|NCT03911440|Antimalarials|antimalarials|mesh-ancestor
93058994|NCT03911440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93058995|NCT03911440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93058996|NCT00191100|Gemcitabine|gemcitabine|mesh-list
93058997|NCT00191100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93058998|NCT00191100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93058999|NCT00191100|Antimetabolites|antimetabolites|mesh-ancestor
93059000|NCT00191100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059001|NCT01149226|Chloral Hydrate|chloral hydrate|mesh-list
93059002|NCT01149226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93059003|NCT01149226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059004|NCT01149226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059005|NCT01252342|Oxytocin|oxytocin|mesh-list
93059006|NCT01252342|Oxytocics|oxytocics|mesh-ancestor
93059007|NCT01252342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93059008|NCT01252342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059009|NCT01254994|Entecavir|entecavir|mesh-list
93059010|NCT01254994|Antiviral Agents|antiviral agents|mesh-ancestor
93059011|NCT01254994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059012|NCT03904732|Aspirin|aspirin|mesh-list
93059013|NCT03904732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93059014|NCT03904732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93059015|NCT03904732|Analgesics|analgesics|mesh-ancestor
93059016|NCT03904732|Sensory System Agents|sensory system agents|mesh-ancestor
93059017|NCT03904732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059018|NCT03904732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059019|NCT03904732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059020|NCT03904732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059021|NCT03904732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93059022|NCT03904732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93059023|NCT03904732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059024|NCT03904732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93059025|NCT03904732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93059026|NCT03904732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059027|NCT03904732|Antipyretics|antipyretics|mesh-ancestor
93059028|NCT01252420|Enoxaparin|enoxaparin|mesh-list
93059029|NCT01252420|Anticoagulants|anticoagulants|mesh-ancestor
93059030|NCT01252420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93059031|NCT01252420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93059032|NCT01252420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059033|NCT01149304|Enoxaparin|enoxaparin|mesh-list
93059034|NCT01149304|Pentoxifylline|pentoxifylline|mesh-list
93059035|NCT01149304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
93059036|NCT01149304|Anticoagulants|anticoagulants|mesh-ancestor
93059037|NCT01149304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93059038|NCT01149304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93059039|NCT01149304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059040|NCT01149304|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93059041|NCT01149304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059042|NCT01149304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92704066|NCT00551954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059043|NCT01149304|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93059044|NCT01149304|Protective Agents|protective agents|mesh-ancestor
93059045|NCT01149304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059046|NCT01149304|Vasodilator Agents|vasodilator agents|mesh-ancestor
93059047|NCT01149304|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93059049|NCT01149304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
93059050|NCT01149304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059051|NCT01254526|Paclitaxel|paclitaxel|mesh-list
93059052|NCT01254526|Bevacizumab|bevacizumab|mesh-list
93059053|NCT01254526|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92404699|NCT01432080|Azithromycin|azithromycin|mesh-list
93059054|NCT01254526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059055|NCT01254526|Tubulin Modulators|tubulin modulators|mesh-ancestor
93059056|NCT01254526|Antimitotic Agents|antimitotic agents|mesh-ancestor
93059057|NCT01254526|Mitosis Modulators|mitosis modulators|mesh-ancestor
93059058|NCT01254526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059059|NCT01254526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93059060|NCT01254526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93059061|NCT01254526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93059062|NCT01254526|Growth Substances|growth substances|mesh-ancestor
93059063|NCT01254526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059064|NCT01254526|Growth Inhibitors|growth inhibitors|mesh-ancestor
93059065|NCT01148992|Lofexidine|lofexidine|mesh-list
93059066|NCT01148992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93059067|NCT01148992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93059068|NCT01148992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059069|NCT01148992|Sensory System Agents|sensory system agents|mesh-ancestor
93059070|NCT01148992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059071|NCT01148992|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93059072|NCT01148992|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93059073|NCT01148992|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93059074|NCT01148992|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059075|NCT01148992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059076|NCT01148992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059077|NCT03901612|Ropivacaine|ropivacaine|mesh-list
93059078|NCT03901612|Anesthetics, Local|anesthetics, local|mesh-ancestor
93059079|NCT03901612|Anesthetics|anesthetics|mesh-ancestor
93059080|NCT03901612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059081|NCT03901612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059082|NCT03901612|Sensory System Agents|sensory system agents|mesh-ancestor
93059083|NCT03901612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059084|NCT03903952|Vitamin B 12|vitamin b 12|mesh-list
93059085|NCT03903952|Hydroxocobalamin|hydroxocobalamin|mesh-list
93059086|NCT03903952|Vitamins|vitamins|mesh-ancestor
93059087|NCT03903952|Micronutrients|micronutrients|mesh-ancestor
93059088|NCT03903952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059089|NCT03903952|Vitamin B Complex|vitamin b complex|mesh-ancestor
93059090|NCT03903952|Hematinics|hematinics|mesh-ancestor
93059091|NCT00257010|Almotriptan|almotriptan|mesh-list
93059092|NCT00257010|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93059093|NCT00257010|Serotonin Agents|serotonin agents|mesh-ancestor
93059094|NCT00257010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059095|NCT00257010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059096|NCT00257010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059097|NCT03901768|Dexamethasone|dexamethasone|mesh-list
93059098|NCT03901768|Triamcinolone|triamcinolone|mesh-list
93059099|NCT03901768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059100|NCT03901768|Antiemetics|antiemetics|mesh-ancestor
93059101|NCT03901768|Autonomic Agents|autonomic agents|mesh-ancestor
93059102|NCT03901768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059103|NCT03901768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059104|NCT03901768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059105|NCT03901768|Glucocorticoids|glucocorticoids|mesh-ancestor
93059106|NCT03901768|Hormones|hormones|mesh-ancestor
93059107|NCT03901768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059108|NCT03901768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93059109|NCT03901768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059110|NCT03903718|Oseltamivir|oseltamivir|mesh-list
93059111|NCT03903718|MEDI8852|medi8852|mesh-list
93059112|NCT03903718|Antiviral Agents|antiviral agents|mesh-ancestor
93059113|NCT03903718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059114|NCT03903718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059115|NCT03903718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059116|NCT03910504|Rocuronium|rocuronium|mesh-list
93059117|NCT03910504|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
93059118|NCT03910504|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
93059119|NCT03910504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93059120|NCT03910504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704138|NCT01258738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93059121|NCT03910504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059122|NCT03901690|Imiquimod|imiquimod|mesh-list
93059123|NCT03901690|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93059124|NCT03901690|Immunologic Factors|immunologic factors|mesh-ancestor
93059125|NCT03901690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059126|NCT03901690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059127|NCT03901690|Interferon Inducers|interferon inducers|mesh-ancestor
93059128|NCT03901378|Pembrolizumab|pembrolizumab|mesh-list
93059129|NCT03901378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93059130|NCT03901378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059131|NCT03901378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93059132|NCT03901378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059133|NCT00256854|Ropinirole|ropinirole|mesh-list
93059134|NCT00256854|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93059135|NCT00256854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93059136|NCT00256854|Dopamine Agonists|dopamine agonists|mesh-ancestor
93059137|NCT00256854|Dopamine Agents|dopamine agents|mesh-ancestor
93059138|NCT00256854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059139|NCT00256854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059140|NCT00256854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059141|NCT00189462|Montelukast|montelukast|mesh-list
93059142|NCT00189462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059143|NCT00189462|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059144|NCT00189462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93059145|NCT00189462|Hormone Antagonists|hormone antagonists|mesh-ancestor
93059146|NCT00189462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059147|NCT00189462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059148|NCT00189462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93059149|NCT00189462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93059150|NCT00189462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059151|NCT01150318|Iodine|iodine|mesh-list
93059152|NCT01150318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93059153|NCT01150318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059154|NCT01150318|Trace Elements|trace elements|mesh-ancestor
93059155|NCT01150318|Micronutrients|micronutrients|mesh-ancestor
93059156|NCT01150318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059157|NCT05667298|Immunomodulating Agents|immunomodulating agents|mesh-list
93059158|NCT05667298|Immunologic Factors|immunologic factors|mesh-ancestor
93059159|NCT05667298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059160|NCT01256632|Ranibizumab|ranibizumab|mesh-list
93059161|NCT01256632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93059162|NCT01256632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93059163|NCT01256632|Growth Substances|growth substances|mesh-ancestor
93059164|NCT01256632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059165|NCT01256632|Growth Inhibitors|growth inhibitors|mesh-ancestor
92333528|NCT00003733|Paclitaxel|paclitaxel|mesh-list
93059166|NCT01256632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059167|NCT00256698|Fulvestrant|fulvestrant|mesh-list
93059168|NCT00256698|Anastrozole|anastrozole|mesh-list
93059169|NCT00256698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93059170|NCT00256698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059171|NCT00256698|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93059172|NCT00256698|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93059173|NCT00256698|Hormone Antagonists|hormone antagonists|mesh-ancestor
93059174|NCT00256698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059175|NCT00256698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059176|NCT00256698|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93059177|NCT00256698|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93059178|NCT00256698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059179|NCT00256698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059180|NCT01150630|Gemcitabine|gemcitabine|mesh-list
93059181|NCT01150630|Capecitabine|capecitabine|mesh-list
93059182|NCT01150630|Epirubicin|epirubicin|mesh-list
93059183|NCT01150630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059184|NCT01150630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93059185|NCT01150630|Antimetabolites|antimetabolites|mesh-ancestor
93059186|NCT01150630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059187|NCT01150630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93059188|NCT01150630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93059189|NCT01150630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93059190|NCT01150630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059191|NCT00189306|Imiquimod|imiquimod|mesh-list
93059192|NCT00189306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93059193|NCT00189306|Immunologic Factors|immunologic factors|mesh-ancestor
93059194|NCT00189306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059195|NCT00189306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059196|NCT00189306|Interferon Inducers|interferon inducers|mesh-ancestor
93059197|NCT03898336|Micronutrients|micronutrients|mesh-list
93059198|NCT03898336|Trace Elements|trace elements|mesh-list
93059199|NCT03898336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059201|NCT03972462|Temsirolimus|temsirolimus|mesh-list
93059202|NCT03972462|MTOR Inhibitors|mtor inhibitors|mesh-list
93059203|NCT03972462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93059204|NCT03972462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059205|NCT03972462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93059206|NCT03972462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059207|NCT03972462|Antifungal Agents|antifungal agents|mesh-ancestor
93059208|NCT03972462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059209|NCT03972462|Immunologic Factors|immunologic factors|mesh-ancestor
93059210|NCT03972462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059211|NCT03972462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93059212|NCT03972462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059213|NCT03972462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059214|NCT01150786|Selenium|selenium|mesh-list
93059215|NCT01150786|Antioxidants|antioxidants|mesh-ancestor
93059216|NCT01150786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059217|NCT01150786|Protective Agents|protective agents|mesh-ancestor
93059218|NCT01150786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059219|NCT01150786|Trace Elements|trace elements|mesh-ancestor
93059220|NCT01150786|Micronutrients|micronutrients|mesh-ancestor
93059221|NCT03909724|Sunitinib|sunitinib|mesh-list
93059222|NCT03909724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059223|NCT03909724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93059224|NCT03909724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93059225|NCT03909724|Growth Substances|growth substances|mesh-ancestor
93059226|NCT03909724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059227|NCT03909724|Growth Inhibitors|growth inhibitors|mesh-ancestor
93059228|NCT03909724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93059229|NCT03909724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494488|NCT01975688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059230|NCT03909724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059231|NCT03909646|Fluorouracil|fluorouracil|mesh-list
93059232|NCT03909646|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93059233|NCT03909646|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93059234|NCT03909646|Antimetabolites|antimetabolites|mesh-ancestor
93059235|NCT03909646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059236|NCT03909646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93059237|NCT03909646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059238|NCT03909646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059239|NCT03909646|Immunologic Factors|immunologic factors|mesh-ancestor
93059240|NCT03909646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059241|NCT03909646|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93059242|NCT03909646|Dermatologic Agents|dermatologic agents|mesh-ancestor
93059243|NCT01256866|Midazolam|midazolam|mesh-list
93059244|NCT01256866|Dexmedetomidine|dexmedetomidine|mesh-list
93059245|NCT01256866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93059246|NCT01256866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059247|NCT01256866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059248|NCT01256866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93059249|NCT01256866|Analgesics|analgesics|mesh-ancestor
93059250|NCT01256866|Sensory System Agents|sensory system agents|mesh-ancestor
93059251|NCT01256866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059252|NCT01256866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93059253|NCT01256866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93059254|NCT01256866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93059255|NCT01256866|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059256|NCT01256866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059257|NCT01256866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059258|NCT01256866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93059259|NCT01256866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93059260|NCT01256866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93059261|NCT01256866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93059262|NCT01256866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93059263|NCT01256866|Anesthetics, General|anesthetics, general|mesh-ancestor
93059264|NCT01256866|Anesthetics|anesthetics|mesh-ancestor
93059265|NCT01256866|GABA Modulators|gaba modulators|mesh-ancestor
93059266|NCT01256866|GABA Agents|gaba agents|mesh-ancestor
93059267|NCT03902782|Dexamethasone|dexamethasone|mesh-list
93059268|NCT03902782|Dexamethasone acetate|dexamethasone acetate|mesh-list
93059269|NCT03902782|Epinephrine|epinephrine|mesh-list
93059270|NCT03902782|Bupivacaine|bupivacaine|mesh-list
93059271|NCT03902782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059272|NCT03902782|Antiemetics|antiemetics|mesh-ancestor
93059273|NCT03902782|Autonomic Agents|autonomic agents|mesh-ancestor
93059274|NCT03902782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404922|NCT01433705|Purinergic Agonists|purinergic agonists|mesh-ancestor
93059275|NCT03902782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059276|NCT03902782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059277|NCT03902782|Glucocorticoids|glucocorticoids|mesh-ancestor
93059278|NCT03902782|Hormones|hormones|mesh-ancestor
93059279|NCT03902782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059280|NCT03902782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93059281|NCT03902782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059282|NCT03902782|Anesthetics, Local|anesthetics, local|mesh-ancestor
93059283|NCT03902782|Anesthetics|anesthetics|mesh-ancestor
92333556|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059284|NCT03902782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059285|NCT03902782|Sensory System Agents|sensory system agents|mesh-ancestor
93059286|NCT03902782|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93059287|NCT03902782|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93059288|NCT03902782|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059289|NCT03902782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059290|NCT03902782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059291|NCT03902782|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93059292|NCT03902782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93059293|NCT03902782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059294|NCT03902782|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059295|NCT03902782|Mydriatics|mydriatics|mesh-ancestor
93059296|NCT03902782|Sympathomimetics|sympathomimetics|mesh-ancestor
93059297|NCT03902782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93059298|NCT03908944|Methadone|methadone|mesh-list
93059299|NCT03908944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93059300|NCT03908944|Narcotics|narcotics|mesh-ancestor
93059301|NCT03908944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059302|NCT03908944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059303|NCT03908944|Analgesics|analgesics|mesh-ancestor
93059304|NCT03908944|Sensory System Agents|sensory system agents|mesh-ancestor
93059305|NCT03908944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059306|NCT03908944|Antitussive Agents|antitussive agents|mesh-ancestor
93059307|NCT03908944|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059308|NCT03899506|Midazolam|midazolam|mesh-list
93059309|NCT03899506|Olanzapine|olanzapine|mesh-list
93059310|NCT03899506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93059311|NCT03899506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93059312|NCT03899506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059313|NCT03899506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059314|NCT03899506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93059315|NCT03899506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93059316|NCT03899506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93059317|NCT03899506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93059318|NCT03899506|Anesthetics, General|anesthetics, general|mesh-ancestor
93059319|NCT03899506|Anesthetics|anesthetics|mesh-ancestor
93059320|NCT03899506|GABA Modulators|gaba modulators|mesh-ancestor
93059321|NCT03899506|GABA Agents|gaba agents|mesh-ancestor
93059322|NCT03899506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059323|NCT03899506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059324|NCT03899506|Antiemetics|antiemetics|mesh-ancestor
93059325|NCT03899506|Autonomic Agents|autonomic agents|mesh-ancestor
93059326|NCT03899506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059327|NCT03899506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059328|NCT03899506|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93059329|NCT03899506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93059330|NCT03899506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93059331|NCT03899506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059332|NCT03899506|Serotonin Agents|serotonin agents|mesh-ancestor
93059333|NCT03896932|Immunoglobulins|immunoglobulins|mesh-list
93059334|NCT03896932|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93059335|NCT03896932|Antibodies|antibodies|mesh-list
93059336|NCT03896932|gamma-Globulins|gamma-globulins|mesh-list
93059337|NCT03896932|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93059338|NCT03896932|Immunologic Factors|immunologic factors|mesh-ancestor
93059339|NCT03896932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059340|NCT01257334|Empagliflozin|empagliflozin|mesh-list
93059341|NCT01257334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92333577|NCT00004087|Antibodies|antibodies|mesh-list
93059342|NCT01257334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059343|NCT01257334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93059344|NCT01257334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059345|NCT01151176|Insulin|insulin|mesh-list
93059346|NCT01151176|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93059347|NCT01151176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93059348|NCT01151176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059349|NCT01257412|Dapagliflozin|dapagliflozin|mesh-list
93059350|NCT01257412|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93059351|NCT01257412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059352|NCT01257412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93059353|NCT01257412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059354|NCT01257490|Bupropion|bupropion|mesh-list
93059355|NCT01257490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93059356|NCT01257490|Antidepressive Agents|antidepressive agents|mesh-ancestor
93059357|NCT01257490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93059358|NCT01257490|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93059359|NCT01257490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93059360|NCT01257490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059361|NCT01257490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059362|NCT01257490|Dopamine Agents|dopamine agents|mesh-ancestor
93059363|NCT01257490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059364|NCT01257490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059365|NCT01257490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93059366|NCT01257490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93059367|NCT01257490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059368|NCT03894280|Fluticasone|fluticasone|mesh-list
93059369|NCT03894280|Xhance|xhance|mesh-list
93059370|NCT03894280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93059371|NCT03894280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93059372|NCT03894280|Charcoal|charcoal|mesh-list
93059373|NCT03894280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059374|NCT03894280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93059375|NCT03894280|Autonomic Agents|autonomic agents|mesh-ancestor
93059376|NCT03894280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059377|NCT03894280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059378|NCT03894280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059379|NCT03894280|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059380|NCT03894280|Dermatologic Agents|dermatologic agents|mesh-ancestor
93059381|NCT03894280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93059382|NCT03894280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93059383|NCT03894280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93059384|NCT03894280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93059385|NCT03894280|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059386|NCT03894280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059387|NCT03894280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059388|NCT03894280|Glucocorticoids|glucocorticoids|mesh-ancestor
93059389|NCT03894280|Hormones|hormones|mesh-ancestor
93059390|NCT03894280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059391|NCT03894280|Sympathomimetics|sympathomimetics|mesh-ancestor
93059392|NCT03894280|Antidotes|antidotes|mesh-ancestor
93059393|NCT03894280|Protective Agents|protective agents|mesh-ancestor
93059394|NCT03899584|4-Aminopyridine|4-aminopyridine|mesh-list
93059395|NCT03899584|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93059396|NCT03899584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059397|NCT03899584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059398|NCT01150162|Omeprazole|omeprazole|mesh-list
93059399|NCT01150162|Rebamipide|rebamipide|mesh-list
93059400|NCT01150162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93059401|NCT01150162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059402|NCT01150162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93059403|NCT01150162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059404|NCT01150162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059405|NCT01150162|Antioxidants|antioxidants|mesh-ancestor
93059406|NCT01150162|Protective Agents|protective agents|mesh-ancestor
93059407|NCT01150162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059408|NCT03893734|Methadone|methadone|mesh-list
93059409|NCT03893734|Hydromorphone|hydromorphone|mesh-list
93059410|NCT03893734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93059411|NCT03893734|Narcotics|narcotics|mesh-ancestor
93059412|NCT03893734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059413|NCT03893734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059414|NCT03893734|Analgesics|analgesics|mesh-ancestor
93059415|NCT03893734|Sensory System Agents|sensory system agents|mesh-ancestor
93059416|NCT03893734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059417|NCT03893734|Antitussive Agents|antitussive agents|mesh-ancestor
93059418|NCT03893734|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059419|NCT03899194|Escitalopram|escitalopram|mesh-list
93059420|NCT03899194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93059421|NCT03899194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93059422|NCT03899194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059423|NCT03899194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059424|NCT03899194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059425|NCT03899194|Serotonin Agents|serotonin agents|mesh-ancestor
93059426|NCT03899194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059427|NCT01151800|Benzocaine|benzocaine|mesh-list
93059428|NCT01151800|Anesthetics, Local|anesthetics, local|mesh-ancestor
93059429|NCT01151800|Anesthetics|anesthetics|mesh-ancestor
93059430|NCT01151800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059431|NCT01151800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059432|NCT01151800|Sensory System Agents|sensory system agents|mesh-ancestor
93059433|NCT01151800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059434|NCT03896074|Bevacizumab|bevacizumab|mesh-list
93059435|NCT03896074|Atezolizumab|atezolizumab|mesh-list
93059436|NCT03896074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93059437|NCT03896074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059438|NCT03896074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93059439|NCT03896074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93059440|NCT03896074|Growth Substances|growth substances|mesh-ancestor
93059441|NCT03896074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059442|NCT03896074|Growth Inhibitors|growth inhibitors|mesh-ancestor
93059443|NCT03896074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93059444|NCT03896074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059445|NCT03899038|Anesthetics|anesthetics|mesh-list
93059446|NCT03899038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059447|NCT03899038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059448|NCT01151878|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
93059449|NCT01151878|Cathartics|cathartics|mesh-ancestor
93059450|NCT01151878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059451|NCT03898882|Oxytocin|oxytocin|mesh-list
93059452|NCT03898882|Oxytocics|oxytocics|mesh-ancestor
93059453|NCT03898882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93059454|NCT03898882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059455|NCT01151254|Propofol|propofol|mesh-list
93059456|NCT01151254|Sevoflurane|sevoflurane|mesh-list
93059457|NCT01151254|Isoflurane|isoflurane|mesh-list
93059458|NCT01151254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93059459|NCT01151254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059460|NCT01151254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059461|NCT01151254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93059462|NCT01151254|Anesthetics, General|anesthetics, general|mesh-ancestor
93059463|NCT01151254|Anesthetics|anesthetics|mesh-ancestor
93059464|NCT01151254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93059465|NCT01151254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93059466|NCT01255774|Ranibizumab|ranibizumab|mesh-list
93059467|NCT01255774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93059468|NCT01255774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93059469|NCT01255774|Growth Substances|growth substances|mesh-ancestor
93059470|NCT01255774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059471|NCT01255774|Growth Inhibitors|growth inhibitors|mesh-ancestor
93059472|NCT01255774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059473|NCT01255852|Atorvastatin|atorvastatin|mesh-list
93059474|NCT01255852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93059475|NCT01255852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93059476|NCT01255852|Antimetabolites|antimetabolites|mesh-ancestor
93059477|NCT01255852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059478|NCT01255852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93059479|NCT01255852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93059480|NCT01255852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059481|NCT03895528|Lonafarnib|lonafarnib|mesh-list
93059482|NCT03895528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059483|NCT03895528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059484|NCT01257958|Vitamin D|vitamin d|mesh-list
93059485|NCT01257958|Vitamins|vitamins|mesh-ancestor
93059486|NCT01257958|Micronutrients|micronutrients|mesh-ancestor
93059487|NCT01257958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059488|NCT01257958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93059489|NCT03893032|Modafinil|modafinil|mesh-list
93059490|NCT03893032|Amphetamine|amphetamine|mesh-list
93059491|NCT03893032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93059492|NCT03893032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059493|NCT03893032|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93059494|NCT03893032|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93059495|NCT03893032|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93059496|NCT03893032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059498|NCT03893032|Autonomic Agents|autonomic agents|mesh-ancestor
93059499|NCT03893032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059500|NCT03893032|Dopamine Agents|dopamine agents|mesh-ancestor
93059501|NCT03893032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059502|NCT03893032|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059503|NCT03893032|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93059504|NCT03893032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93059505|NCT03893032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059506|NCT03893032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93059507|NCT01258036|Hormones|hormones|mesh-list
93059508|NCT01258036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059509|NCT01258036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059510|NCT03889366|Aprepitant|aprepitant|mesh-list
93059511|NCT03889366|Antiemetics|antiemetics|mesh-ancestor
93059512|NCT03889366|Autonomic Agents|autonomic agents|mesh-ancestor
93059513|NCT03889366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059514|NCT03889366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059515|NCT03889366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059516|NCT03889366|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93059517|NCT03889366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059518|NCT03889366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059519|NCT03894826|Vorinostat|vorinostat|mesh-list
93059520|NCT03894826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059521|NCT03894826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93059522|NCT03894826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059523|NCT03894826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059524|NCT03894748|Botulinum Toxins|botulinum toxins|mesh-list
93059525|NCT03894748|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93059526|NCT03894748|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93059527|NCT03894748|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93059528|NCT03894748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059529|NCT03894748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059530|NCT03894748|Cholinergic Agents|cholinergic agents|mesh-ancestor
93059531|NCT03894748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059532|NCT03894748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059533|NCT03894748|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93059534|NCT03894748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059535|NCT01153750|Imatinib Mesylate|imatinib mesylate|mesh-list
93059536|NCT01153750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059537|NCT01153750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93059538|NCT01153750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059539|NCT01153750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059540|NCT03888664|Interferons|interferons|mesh-list
93059541|NCT03888664|Interferon-gamma|interferon-gamma|mesh-list
93059542|NCT03888664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059543|NCT03888664|Antiviral Agents|antiviral agents|mesh-ancestor
93059544|NCT03888664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059545|NCT00256308|Oxaliplatin|oxaliplatin|mesh-list
93059546|NCT00256308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059547|NCT01153828|Mupirocin|mupirocin|mesh-list
93059548|NCT01153828|Retapamulin|retapamulin|mesh-list
93059549|NCT01153828|Fusidic Acid|fusidic acid|mesh-list
93059550|NCT01153828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93059551|NCT01153828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059552|NCT01153828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93059553|NCT01153828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059554|NCT01153828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059555|NCT01151722|Bevacizumab|bevacizumab|mesh-list
93059556|NCT01151722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93059557|NCT01151722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059558|NCT01151722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93059559|NCT01151722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93059560|NCT01151722|Growth Substances|growth substances|mesh-ancestor
93059561|NCT01151722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059562|NCT01151722|Growth Inhibitors|growth inhibitors|mesh-ancestor
93059563|NCT01258192|Paclitaxel|paclitaxel|mesh-list
93059564|NCT01258192|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93059565|NCT01258192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93059566|NCT01258192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059567|NCT01258192|Tubulin Modulators|tubulin modulators|mesh-ancestor
93059568|NCT01258192|Antimitotic Agents|antimitotic agents|mesh-ancestor
93059569|NCT01258192|Mitosis Modulators|mitosis modulators|mesh-ancestor
93059570|NCT01258192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059572|NCT01326078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93059573|NCT01326078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059574|NCT01326078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059575|NCT01326078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93059576|NCT01326078|Anesthetics, General|anesthetics, general|mesh-ancestor
93059577|NCT01326078|Anesthetics|anesthetics|mesh-ancestor
93059579|NCT01260376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93059580|NCT01260376|Antimetabolites|antimetabolites|mesh-ancestor
93059581|NCT01260376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059582|NCT01260376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93059583|NCT01259050|Copper|copper|mesh-list
93059584|NCT01259050|Trace Elements|trace elements|mesh-ancestor
93059585|NCT01259050|Micronutrients|micronutrients|mesh-ancestor
93059586|NCT01259050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059587|NCT00255840|Ritonavir|ritonavir|mesh-list
93059588|NCT00255840|Lopinavir|lopinavir|mesh-list
93059589|NCT00255840|Lamivudine|lamivudine|mesh-list
93059590|NCT00255840|Nevirapine|nevirapine|mesh-list
93059591|NCT00255840|Stavudine|stavudine|mesh-list
93059592|NCT00255840|Efavirenz|efavirenz|mesh-list
93059593|NCT00255840|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93059594|NCT00255840|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93059595|NCT00255840|Protease Inhibitors|protease inhibitors|mesh-ancestor
93059596|NCT00255840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059597|NCT00255840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059598|NCT00255840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93059599|NCT00255840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93059600|NCT00255840|Antiviral Agents|antiviral agents|mesh-ancestor
93059601|NCT00255840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059602|NCT00255840|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93059603|NCT00255840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93059604|NCT00255840|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93059605|NCT00255840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93059606|NCT00255840|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93059607|NCT00255840|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93059608|NCT00255840|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93059609|NCT00255840|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93059610|NCT00255840|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93059611|NCT00255840|Antimetabolites|antimetabolites|mesh-ancestor
93059612|NCT03972228|Antineoplastic Agents|antineoplastic agents|mesh-list
93059613|NCT00224874|Mycophenolic Acid|mycophenolic acid|mesh-list
93059614|NCT00224874|Etanercept|etanercept|mesh-list
93059615|NCT00224874|Pentostatin|pentostatin|mesh-list
93059616|NCT00224874|Denileukin diftitox|denileukin diftitox|mesh-list
93059617|NCT00224874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93059618|NCT00224874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059619|NCT00224874|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93059620|NCT00224874|Antitubercular Agents|antitubercular agents|mesh-ancestor
93059621|NCT00224874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93059622|NCT00224874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059623|NCT00224874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059624|NCT00224874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059625|NCT00224874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93059626|NCT00224874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93059627|NCT00224874|Analgesics|analgesics|mesh-ancestor
93059628|NCT00224874|Sensory System Agents|sensory system agents|mesh-ancestor
93059629|NCT00224874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059630|NCT00224874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059631|NCT00224874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059632|NCT00224874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059633|NCT00224874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059634|NCT00224874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059635|NCT00224874|Immunologic Factors|immunologic factors|mesh-ancestor
93059636|NCT00224874|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
93059637|NCT03892330|Oxytetracycline|oxytetracycline|mesh-list
93059638|NCT03892330|Cyclophosphamide|cyclophosphamide|mesh-list
93059639|NCT03892330|Doxorubicin|doxorubicin|mesh-list
93059640|NCT03892330|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93059641|NCT03892330|Vincristine|vincristine|mesh-list
93059642|NCT03892330|Pirarubicin|pirarubicin|mesh-list
93059643|NCT03892330|Epirubicin|epirubicin|mesh-list
93059644|NCT03892330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059645|NCT03892330|Immunologic Factors|immunologic factors|mesh-ancestor
93059646|NCT03892330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059647|NCT03892330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059648|NCT03892330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93059649|NCT03892330|Alkylating Agents|alkylating agents|mesh-ancestor
93059650|NCT03892330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059651|NCT03892330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059652|NCT03892330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93059653|NCT03892330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93059654|NCT03892330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93059655|NCT03892330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93059656|NCT03892330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059657|NCT03892330|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93059658|NCT03892330|Tubulin Modulators|tubulin modulators|mesh-ancestor
93059659|NCT03892330|Antimitotic Agents|antimitotic agents|mesh-ancestor
93059660|NCT03892330|Mitosis Modulators|mitosis modulators|mesh-ancestor
93059661|NCT03892330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93059662|NCT03892330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059663|NCT00186186|Valproic Acid|valproic acid|mesh-list
93059664|NCT00186186|Anticonvulsants|anticonvulsants|mesh-ancestor
93059665|NCT00186186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059666|NCT00186186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059667|NCT00186186|GABA Agents|gaba agents|mesh-ancestor
93059668|NCT00186186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059669|NCT00186186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059670|NCT00186186|Antimanic Agents|antimanic agents|mesh-ancestor
93059671|NCT00186186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93059672|NCT00186186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059673|NCT00186186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93059674|NCT00185640|Cyclosporine|cyclosporine|mesh-list
93059675|NCT00185640|Mycophenolic Acid|mycophenolic acid|mesh-list
93059676|NCT00185640|Lenograstim|lenograstim|mesh-list
93059677|NCT00185640|Cyclosporins|cyclosporins|mesh-list
93059678|NCT00185640|Thymoglobulin|thymoglobulin|mesh-list
93059679|NCT00185640|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93059680|NCT00185640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93059681|NCT00185640|Immunologic Factors|immunologic factors|mesh-ancestor
93059682|NCT00185640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059683|NCT00185640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059684|NCT00185640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059685|NCT00185640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059686|NCT00185640|Antifungal Agents|antifungal agents|mesh-ancestor
93059687|NCT00185640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059688|NCT00185640|Dermatologic Agents|dermatologic agents|mesh-ancestor
93059689|NCT00185640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059690|NCT00185640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93059691|NCT00185640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93059692|NCT00185640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059693|NCT00185640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93059694|NCT00185640|Antitubercular Agents|antitubercular agents|mesh-ancestor
93059695|NCT00185640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93059696|NCT03885388|Dactinomycin|dactinomycin|mesh-list
93059697|NCT03885388|Methotrexate|methotrexate|mesh-list
93059698|NCT03885388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93059699|NCT03885388|Abortifacient Agents|abortifacient agents|mesh-ancestor
93059700|NCT03885388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93059701|NCT03885388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059702|NCT03885388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93059703|NCT03885388|Antimetabolites|antimetabolites|mesh-ancestor
93059704|NCT03885388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059705|NCT03885388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059706|NCT03885388|Dermatologic Agents|dermatologic agents|mesh-ancestor
93059707|NCT03885388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059708|NCT03885388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93059709|NCT03885388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059710|NCT03885388|Immunologic Factors|immunologic factors|mesh-ancestor
93059711|NCT03885388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059712|NCT03885388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93059713|NCT03885388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93059714|NCT03885388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059715|NCT03885388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93059716|NCT03885388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93059717|NCT01152346|Azacitidine|azacitidine|mesh-list
93059718|NCT01152346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93059719|NCT01152346|Antimetabolites|antimetabolites|mesh-ancestor
93059720|NCT01152346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059721|NCT01152346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059722|NCT01152346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059724|NCT01260610|Telbivudine|telbivudine|mesh-list
93059725|NCT01260610|Antiviral Agents|antiviral agents|mesh-ancestor
93059726|NCT01260610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059727|NCT01260610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93059728|NCT01260610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93059729|NCT01260610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059730|NCT01260610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059731|NCT01260610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93059732|NCT01260610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93059734|NCT01155700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93059735|NCT01155700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059736|NCT01155700|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059737|NCT03887884|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93059738|NCT03887884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93059739|NCT03887884|Immunologic Factors|immunologic factors|mesh-ancestor
93059740|NCT03887884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059741|NCT03887884|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93059742|NCT03887884|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93059743|NCT03887884|Dopamine Agonists|dopamine agonists|mesh-ancestor
93059744|NCT03887884|Dopamine Agents|dopamine agents|mesh-ancestor
93059745|NCT03887884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059746|NCT03887884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059747|NCT03887650|Dexamethasone|dexamethasone|mesh-list
93059748|NCT03887650|Epinephrine|epinephrine|mesh-list
93059749|NCT03887650|Bupivacaine|bupivacaine|mesh-list
93059750|NCT03887650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059751|NCT03887650|Antiemetics|antiemetics|mesh-ancestor
93059752|NCT03887650|Autonomic Agents|autonomic agents|mesh-ancestor
93059753|NCT03887650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059754|NCT03887650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059755|NCT03887650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059756|NCT03887650|Glucocorticoids|glucocorticoids|mesh-ancestor
93059757|NCT03887650|Hormones|hormones|mesh-ancestor
93059758|NCT03887650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059759|NCT03887650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93059760|NCT03887650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059761|NCT03887650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059762|NCT03887650|Anesthetics, Local|anesthetics, local|mesh-ancestor
93059763|NCT03887650|Anesthetics|anesthetics|mesh-ancestor
93059764|NCT03887650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059765|NCT03887650|Sensory System Agents|sensory system agents|mesh-ancestor
93059766|NCT03887650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93059767|NCT03887650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93059768|NCT03887650|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059769|NCT03887650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059770|NCT03887650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93059771|NCT03887650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93059772|NCT03887650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059773|NCT03887650|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059774|NCT03887650|Mydriatics|mydriatics|mesh-ancestor
93059775|NCT03887650|Sympathomimetics|sympathomimetics|mesh-ancestor
93059776|NCT03887650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93059777|NCT01154530|Chlorhexidine|chlorhexidine|mesh-list
93059778|NCT01154530|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93059779|NCT01154530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059780|NCT01154530|Disinfectants|disinfectants|mesh-ancestor
93059781|NCT03887416|Dapagliflozin|dapagliflozin|mesh-list
93059782|NCT03887416|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93059783|NCT03887416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059784|NCT03887416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93059785|NCT03887416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059786|NCT01260844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93059787|NCT01260844|Immunologic Factors|immunologic factors|mesh-ancestor
93059788|NCT01260844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059789|NCT03891472|Fluorouracil|fluorouracil|mesh-list
93059790|NCT03891472|Oxaliplatin|oxaliplatin|mesh-list
93059791|NCT03891472|Irinotecan|irinotecan|mesh-list
93059792|NCT03891472|Antimetabolites|antimetabolites|mesh-ancestor
93059793|NCT03891472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059794|NCT03891472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93059795|NCT03891472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059796|NCT03891472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93059797|NCT03891472|Immunologic Factors|immunologic factors|mesh-ancestor
93059798|NCT03891472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059799|NCT03891472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93059800|NCT03891472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93059802|NCT01262482|Oxaliplatin|oxaliplatin|mesh-list
93059803|NCT01262482|Sorafenib|sorafenib|mesh-list
93059804|NCT01262482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059805|NCT01262482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93059806|NCT01262482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059807|NCT01262482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059808|NCT01261078|Epinephrine|epinephrine|mesh-list
93059809|NCT01261078|Racepinephrine|racepinephrine|mesh-list
93059810|NCT01261078|Epinephryl borate|epinephryl borate|mesh-list
93059811|NCT01261078|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93059812|NCT01261078|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93059813|NCT01261078|Adrenergic Agents|adrenergic agents|mesh-ancestor
93059814|NCT01261078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059815|NCT01261078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059816|NCT01261078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059817|NCT01261078|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93059818|NCT01261078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93059819|NCT01261078|Autonomic Agents|autonomic agents|mesh-ancestor
93059820|NCT01261078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059821|NCT01261078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059822|NCT01261078|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059823|NCT01261078|Mydriatics|mydriatics|mesh-ancestor
93059824|NCT01261078|Sympathomimetics|sympathomimetics|mesh-ancestor
93059825|NCT01261078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93059826|NCT01155934|Risperidone|risperidone|mesh-list
93059827|NCT01155934|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93059828|NCT01155934|Serotonin Agents|serotonin agents|mesh-ancestor
93059829|NCT01155934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059830|NCT01155934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059831|NCT01155934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059832|NCT01155934|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93059833|NCT01155934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93059834|NCT01155934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059835|NCT01155934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93059836|NCT01155934|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93059837|NCT01155934|Dopamine Agents|dopamine agents|mesh-ancestor
93059838|NCT03891550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93059839|NCT03891550|Antiviral Agents|antiviral agents|mesh-ancestor
93059840|NCT03891550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059841|NCT01261156|Diltiazem|diltiazem|mesh-list
93059842|NCT01261156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93059843|NCT01261156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93059844|NCT01261156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059845|NCT01261156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059846|NCT01261156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93059847|NCT01261156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059848|NCT01261156|Vasodilator Agents|vasodilator agents|mesh-ancestor
93059849|NCT03884530|Aspirin|aspirin|mesh-list
93059850|NCT03884530|Ticagrelor|ticagrelor|mesh-list
93059851|NCT03884530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93059852|NCT03884530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93059853|NCT03884530|Analgesics|analgesics|mesh-ancestor
93059854|NCT03884530|Sensory System Agents|sensory system agents|mesh-ancestor
93059855|NCT03884530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059856|NCT03884530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059857|NCT03884530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059858|NCT03884530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059859|NCT03884530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93059860|NCT03884530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93059861|NCT03884530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059862|NCT03884530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93059864|NCT03884530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059865|NCT03884530|Antipyretics|antipyretics|mesh-ancestor
93059866|NCT03884530|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93059867|NCT03884530|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93059868|NCT03884530|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93059869|NCT03884530|Purinergic Agents|purinergic agents|mesh-ancestor
93059870|NCT03884530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059871|NCT03891316|Sevoflurane|sevoflurane|mesh-list
93059872|NCT03891316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93059873|NCT03891316|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93059874|NCT03891316|Anesthetics, General|anesthetics, general|mesh-ancestor
93059875|NCT03891316|Anesthetics|anesthetics|mesh-ancestor
93059876|NCT03891316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059877|NCT03891316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059878|NCT03887260|Fentanyl|fentanyl|mesh-list
93059879|NCT03887260|Morphine|morphine|mesh-list
93059880|NCT03887260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93059881|NCT03887260|Narcotics|narcotics|mesh-ancestor
93059882|NCT03887260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059883|NCT03887260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059884|NCT03887260|Analgesics|analgesics|mesh-ancestor
93059885|NCT03887260|Sensory System Agents|sensory system agents|mesh-ancestor
93059886|NCT03887260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059887|NCT03887260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93059888|NCT03887260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93059889|NCT03887260|Anesthetics, General|anesthetics, general|mesh-ancestor
93059890|NCT03887260|Anesthetics|anesthetics|mesh-ancestor
93059891|NCT03883984|Cysteamine|cysteamine|mesh-list
93059892|NCT03883984|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
93059893|NCT03883984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059894|NCT01586494|Tramadol|tramadol|mesh-list
93059895|NCT01586494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93059896|NCT01586494|Narcotics|narcotics|mesh-ancestor
93059897|NCT01586494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059898|NCT01586494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059899|NCT01586494|Analgesics|analgesics|mesh-ancestor
93059900|NCT01586494|Sensory System Agents|sensory system agents|mesh-ancestor
93059901|NCT01586494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059902|NCT03886948|Mirikizumab|mirikizumab|mesh-list
93059903|NCT03886948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93059904|NCT03886948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93059905|NCT03886948|Analgesics|analgesics|mesh-ancestor
93059906|NCT03886948|Sensory System Agents|sensory system agents|mesh-ancestor
93059907|NCT03886948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059908|NCT03886948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059909|NCT03886948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059910|NCT03886948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93059911|NCT03886948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93059912|NCT03886948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059913|NCT01259362|Cocaine|cocaine|mesh-list
93059914|NCT01259362|Anesthetics, Local|anesthetics, local|mesh-ancestor
93059915|NCT01259362|Anesthetics|anesthetics|mesh-ancestor
93059916|NCT01259362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059917|NCT01259362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059918|NCT01259362|Sensory System Agents|sensory system agents|mesh-ancestor
93059919|NCT01259362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059920|NCT01259362|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92333765|NCT00003205|Bryostatin 1|bryostatin 1|mesh-list
93059921|NCT01259362|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93059922|NCT01259362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93059923|NCT01259362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059924|NCT01259362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059925|NCT01259362|Dopamine Agents|dopamine agents|mesh-ancestor
93059926|NCT01259362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059927|NCT03891238|Avelumab|avelumab|mesh-list
93059928|NCT03891238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93059929|NCT03891238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059930|NCT01261234|Cilostazol|cilostazol|mesh-list
93059931|NCT01261234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93059932|NCT01261234|Autonomic Agents|autonomic agents|mesh-ancestor
93059933|NCT01261234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059934|NCT01261234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059935|NCT01261234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93059936|NCT01261234|Respiratory System Agents|respiratory system agents|mesh-ancestor
93059938|NCT01261234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93059939|NCT01261234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059940|NCT01261234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93059941|NCT01261234|Vasodilator Agents|vasodilator agents|mesh-ancestor
93059942|NCT01261234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93059943|NCT01261234|Protective Agents|protective agents|mesh-ancestor
93059944|NCT01261234|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93059945|NCT01261234|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93059946|NCT01261234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059947|NCT01152736|Nicotine|nicotine|mesh-list
93059948|NCT01152736|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93059949|NCT01152736|Autonomic Agents|autonomic agents|mesh-ancestor
93059950|NCT01152736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059951|NCT01152736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059952|NCT01152736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93059953|NCT01152736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93059954|NCT01152736|Cholinergic Agents|cholinergic agents|mesh-ancestor
93059955|NCT01152736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93059956|NCT01152736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059957|NCT01154764|Ketoconazole|ketoconazole|mesh-list
93059958|NCT01154764|Antifungal Agents|antifungal agents|mesh-ancestor
93059959|NCT01154764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93059960|NCT01154764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93059961|NCT01154764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93059962|NCT01154764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93059963|NCT01154764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059964|NCT01154764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93059965|NCT01154764|Hormone Antagonists|hormone antagonists|mesh-ancestor
93059966|NCT01154764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059967|NCT01154764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059968|NCT01154764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93059969|NCT01261546|Dexamethasone|dexamethasone|mesh-list
93059970|NCT01261546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93059971|NCT01261546|Antiemetics|antiemetics|mesh-ancestor
93059972|NCT01261546|Autonomic Agents|autonomic agents|mesh-ancestor
93059973|NCT01261546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059974|NCT01261546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059975|NCT01261546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93059976|NCT01261546|Glucocorticoids|glucocorticoids|mesh-ancestor
93059977|NCT01261546|Hormones|hormones|mesh-ancestor
93059978|NCT01261546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93059979|NCT01261546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93059980|NCT01261546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93059981|NCT03883360|Cannabidiol|cannabidiol|mesh-list
93059982|NCT03883360|Anticonvulsants|anticonvulsants|mesh-ancestor
93059983|NCT01261702|Magnesium Sulfate|magnesium sulfate|mesh-list
93059984|NCT01261702|Analgesics|analgesics|mesh-ancestor
93059985|NCT01261702|Sensory System Agents|sensory system agents|mesh-ancestor
93059986|NCT01261702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93059987|NCT01261702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93059988|NCT01261702|Anesthetics|anesthetics|mesh-ancestor
93059989|NCT01261702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93059990|NCT01261702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93059991|NCT01261702|Anticonvulsants|anticonvulsants|mesh-ancestor
93059992|NCT01261702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93059993|NCT01261702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93059994|NCT01261702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93059995|NCT01261702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93059996|NCT01261702|Tocolytic Agents|tocolytic agents|mesh-ancestor
93059997|NCT01261702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93059998|NCT01156246|Metformin|metformin|mesh-list
93059999|NCT01156246|Dapagliflozin|dapagliflozin|mesh-list
93060000|NCT01156246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93060001|NCT01156246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060002|NCT01156246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93060003|NCT01156246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060004|NCT03890770|Deucravacitinib|deucravacitinib|mesh-list
93060005|NCT03890770|Dermatologic Agents|dermatologic agents|mesh-ancestor
93060006|NCT03890770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93060007|NCT03890770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099879|NCT01925547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060008|NCT03890770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060009|NCT03883204|Risperidone|risperidone|mesh-list
93060010|NCT03883204|Aripiprazole|aripiprazole|mesh-list
93060011|NCT03883204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93060012|NCT03883204|Serotonin Agents|serotonin agents|mesh-ancestor
93060013|NCT03883204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060014|NCT03883204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060015|NCT03883204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060016|NCT03883204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93060017|NCT03883204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93060018|NCT03883204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060019|NCT03883204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93060021|NCT03883204|Dopamine Agents|dopamine agents|mesh-ancestor
93060022|NCT03883204|Antidepressive Agents|antidepressive agents|mesh-ancestor
93060023|NCT03883204|Dopamine Agonists|dopamine agonists|mesh-ancestor
93060024|NCT03883204|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93060025|NCT03883204|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93060026|NCT03883204|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93060027|NCT03883204|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93060028|NCT01263418|Ofatumumab|ofatumumab|mesh-list
93060029|NCT01263418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060030|NCT03882814|Meperidine|meperidine|mesh-list
93060031|NCT03882814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93060032|NCT03882814|Narcotics|narcotics|mesh-ancestor
93060033|NCT03882814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060034|NCT03882814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060035|NCT03882814|Analgesics|analgesics|mesh-ancestor
93060036|NCT03882814|Sensory System Agents|sensory system agents|mesh-ancestor
93060037|NCT03882814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060038|NCT03882814|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93060039|NCT03647566|Listerine|listerine|mesh-list
93060040|NCT03647566|Fluorides|fluorides|mesh-list
93060041|NCT03647566|Sodium Fluoride|sodium fluoride|mesh-list
93060042|NCT03647566|Cariostatic Agents|cariostatic agents|mesh-ancestor
93060043|NCT03647566|Protective Agents|protective agents|mesh-ancestor
93060044|NCT03647566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060045|NCT03647566|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93060046|NCT03647566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060047|NCT01156636|Sildenafil Citrate|sildenafil citrate|mesh-list
93060048|NCT01156636|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060049|NCT01156636|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93060050|NCT01156636|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93060051|NCT01156636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060052|NCT01156636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060053|NCT01156636|Urological Agents|urological agents|mesh-ancestor
93060054|NCT03889288|Analgesics|analgesics|mesh-list
93060055|NCT03889288|Sensory System Agents|sensory system agents|mesh-ancestor
93060056|NCT03889288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060057|NCT03889288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060058|NCT01153204|Sildenafil Citrate|sildenafil citrate|mesh-list
93060059|NCT01153204|Citric Acid|citric acid|mesh-list
93060060|NCT01153204|Sodium Citrate|sodium citrate|mesh-list
93060061|NCT01153204|Anticoagulants|anticoagulants|mesh-ancestor
93060062|NCT01153204|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93060063|NCT01153204|Chelating Agents|chelating agents|mesh-ancestor
93060064|NCT01153204|Sequestering Agents|sequestering agents|mesh-ancestor
93060065|NCT01153204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060066|NCT01153204|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060067|NCT01153204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93060068|NCT01153204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93060069|NCT01153204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060070|NCT01153204|Urological Agents|urological agents|mesh-ancestor
93060071|NCT03760666|Ribavirin|ribavirin|mesh-list
93060072|NCT03760666|Brequinar|brequinar|mesh-list
93060073|NCT03760666|Antimetabolites|antimetabolites|mesh-ancestor
93060074|NCT03760666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060075|NCT03760666|Antiviral Agents|antiviral agents|mesh-ancestor
93060076|NCT03760666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060077|NCT03760666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060078|NCT03760666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060079|NCT03760666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060080|NCT03760666|Immunologic Factors|immunologic factors|mesh-ancestor
93060081|NCT03760666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060082|NCT01263574|Ethanol|ethanol|mesh-list
93060083|NCT01263574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93060084|NCT01263574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060085|NCT01263574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060086|NCT01263574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060087|NCT03464734|Paclitaxel|paclitaxel|mesh-list
93060088|NCT03464734|Pembrolizumab|pembrolizumab|mesh-list
93060089|NCT03464734|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93060090|NCT03464734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93060091|NCT03464734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060092|NCT03464734|Tubulin Modulators|tubulin modulators|mesh-ancestor
93060093|NCT03464734|Antimitotic Agents|antimitotic agents|mesh-ancestor
93060094|NCT03464734|Mitosis Modulators|mitosis modulators|mesh-ancestor
93060095|NCT03464734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060096|NCT03464734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93060097|NCT03464734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93060098|NCT01156948|Misoprostol|misoprostol|mesh-list
93060099|NCT01156948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93060100|NCT01156948|Abortifacient Agents|abortifacient agents|mesh-ancestor
93060101|NCT01156948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93060102|NCT01156948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060103|NCT01156948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93060104|NCT01156948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060105|NCT01156948|Oxytocics|oxytocics|mesh-ancestor
93060106|NCT01157026|Tamoxifen|tamoxifen|mesh-list
93060107|NCT01157026|Tocotrienols|tocotrienols|mesh-list
93060108|NCT01157026|Vitamin E|vitamin e|mesh-list
93060109|NCT01157026|Tocopherols|tocopherols|mesh-list
93060110|NCT01157026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93060111|NCT01157026|Hormone Antagonists|hormone antagonists|mesh-ancestor
93060112|NCT01157026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060113|NCT01157026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060114|NCT01157026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060115|NCT01157026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060116|NCT01157026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93060117|NCT01157026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93060118|NCT01157026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93060119|NCT01157026|Antioxidants|antioxidants|mesh-ancestor
93060120|NCT01157026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060121|NCT01157026|Protective Agents|protective agents|mesh-ancestor
93060122|NCT01157026|Vitamins|vitamins|mesh-ancestor
93060123|NCT01157026|Micronutrients|micronutrients|mesh-ancestor
93060124|NCT01263652|Dipyrone|dipyrone|mesh-list
93060125|NCT01263652|Diclofenac|diclofenac|mesh-list
93060126|NCT01263652|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
93060127|NCT01263652|Tramadol|tramadol|mesh-list
93060128|NCT01263652|Orphenadrine|orphenadrine|mesh-list
93060129|NCT01263652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93060130|NCT01263652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93060131|NCT01263652|Analgesics|analgesics|mesh-ancestor
93060132|NCT01263652|Sensory System Agents|sensory system agents|mesh-ancestor
93060133|NCT01263652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060134|NCT01263652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060135|NCT01263652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060136|NCT01263652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060137|NCT01263652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93060138|NCT01263652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060139|NCT01263652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060140|NCT01263652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93060141|NCT01263652|Narcotics|narcotics|mesh-ancestor
93060142|NCT01263652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060143|NCT01263652|Antipyretics|antipyretics|mesh-ancestor
93060144|NCT01263652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93060145|NCT01263652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93060146|NCT01263652|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93060147|NCT01263652|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93060148|NCT01263652|Parasympatholytics|parasympatholytics|mesh-ancestor
93060149|NCT01263652|Autonomic Agents|autonomic agents|mesh-ancestor
93060150|NCT01263652|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93060151|NCT01263652|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93060152|NCT01263652|Cholinergic Agents|cholinergic agents|mesh-ancestor
93060153|NCT01263652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060154|NCT01263652|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
93060155|NCT01263652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93060156|NCT03881644|Sumatriptan|sumatriptan|mesh-list
93060157|NCT03881644|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
93060158|NCT03881644|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93060159|NCT03881644|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93060160|NCT03881644|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93060161|NCT03881644|Serotonin Agents|serotonin agents|mesh-ancestor
93060162|NCT03881644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060163|NCT03881644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060164|NCT03881644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060165|NCT03881644|Growth Substances|growth substances|mesh-ancestor
93060166|NCT03881644|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060167|NCT01259830|Etoricoxib|etoricoxib|mesh-list
93060168|NCT01259830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93060169|NCT01259830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93060170|NCT01259830|Analgesics|analgesics|mesh-ancestor
93060171|NCT01259830|Sensory System Agents|sensory system agents|mesh-ancestor
93060172|NCT01259830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060173|NCT01259830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060174|NCT01259830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060175|NCT01259830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060176|NCT01259830|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93060177|NCT01259830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93060178|NCT01259830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060179|NCT01259830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060181|NCT00224484|Immunologic Factors|immunologic factors|mesh-ancestor
93060182|NCT00224484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060183|NCT01265680|Epoetin Alfa|epoetin alfa|mesh-list
93060184|NCT01265680|Hematinics|hematinics|mesh-ancestor
93060185|NCT01263808|Moxifloxacin|moxifloxacin|mesh-list
93060186|NCT01263808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93060187|NCT01263808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060188|NCT01263808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93060189|NCT01263808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93060190|NCT01263808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060191|NCT01263808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060192|NCT01263808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060193|NCT01157572|Metoprolol|metoprolol|mesh-list
93060194|NCT01157572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93060195|NCT01157572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93060196|NCT01157572|Sympatholytics|sympatholytics|mesh-ancestor
93060197|NCT01157572|Autonomic Agents|autonomic agents|mesh-ancestor
93060198|NCT01157572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060199|NCT01157572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060200|NCT01157572|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93060201|NCT01157572|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93060202|NCT01157572|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93060203|NCT01157572|Adrenergic Agents|adrenergic agents|mesh-ancestor
93060204|NCT01157572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060205|NCT01157572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060206|NCT01074372|Alirocumab|alirocumab|mesh-list
93060207|NCT01074372|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93060208|NCT01074372|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93060209|NCT01074372|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93060210|NCT01074372|Antimetabolites|antimetabolites|mesh-ancestor
93060211|NCT01074372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060212|NCT01074372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93060213|NCT01074372|Protease Inhibitors|protease inhibitors|mesh-ancestor
93060214|NCT01074372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060215|NCT01074372|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93060216|NCT01267942|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
93060217|NCT01267942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93060218|NCT01267942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060219|NCT01267942|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93060220|NCT01267942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060221|NCT01267942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060222|NCT00254982|Infliximab|infliximab|mesh-list
93060223|NCT00254982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93060224|NCT00254982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060225|NCT00254982|Dermatologic Agents|dermatologic agents|mesh-ancestor
93060226|NCT00254982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060227|NCT00254982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060228|NCT01586572|Vaccines|vaccines|mesh-list
93060229|NCT01586572|Immunologic Factors|immunologic factors|mesh-ancestor
93060230|NCT01586572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060231|NCT00224016|Mandelic Acids|mandelic acids|mesh-list
93060233|NCT00224016|Parasympatholytics|parasympatholytics|mesh-ancestor
93060234|NCT00224016|Autonomic Agents|autonomic agents|mesh-ancestor
93060235|NCT00224016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060236|NCT00224016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060237|NCT00224016|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93060238|NCT00224016|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93060239|NCT00224016|Cholinergic Agents|cholinergic agents|mesh-ancestor
93060240|NCT00224016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060241|NCT00224016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060242|NCT00224016|Urological Agents|urological agents|mesh-ancestor
93060243|NCT00224016|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92705360|NCT02236013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060244|NCT00224016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060245|NCT02527174|Cytarabine|cytarabine|mesh-list
93060246|NCT02527174|Idarubicin|idarubicin|mesh-list
93060247|NCT02527174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93060248|NCT02527174|Antimetabolites|antimetabolites|mesh-ancestor
93060249|NCT02527174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060250|NCT02527174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060251|NCT02527174|Antiviral Agents|antiviral agents|mesh-ancestor
93060252|NCT02527174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060253|NCT02527174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060254|NCT02527174|Immunologic Factors|immunologic factors|mesh-ancestor
93060255|NCT02527174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060256|NCT02527174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93060257|NCT02527174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93060258|NCT02527174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93060259|NCT02527174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060260|NCT01161940|Nizatidine|nizatidine|mesh-list
93060261|NCT01161940|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93060262|NCT01161940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060263|NCT01161940|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93060264|NCT01161940|Histamine Antagonists|histamine antagonists|mesh-ancestor
93060265|NCT01161940|Histamine Agents|histamine agents|mesh-ancestor
93060266|NCT01161940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060267|NCT01161940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060268|NCT01161940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060269|NCT01160068|Metformin|metformin|mesh-list
93060270|NCT01160068|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93060271|NCT01160068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060272|NCT01266694|Colchicine|colchicine|mesh-list
93060273|NCT01266694|Gout Suppressants|gout suppressants|mesh-ancestor
93060274|NCT01266694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060275|NCT01266694|Tubulin Modulators|tubulin modulators|mesh-ancestor
93060276|NCT01266694|Antimitotic Agents|antimitotic agents|mesh-ancestor
93060277|NCT01266694|Mitosis Modulators|mitosis modulators|mesh-ancestor
93060278|NCT01266694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060279|NCT01266694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060280|NCT03876886|Paclitaxel|paclitaxel|mesh-list
93060281|NCT03876886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93060282|NCT03876886|Cyclophosphamide|cyclophosphamide|mesh-list
93060283|NCT03876886|Carboplatin|carboplatin|mesh-list
93060284|NCT03876886|Epirubicin|epirubicin|mesh-list
93060285|NCT03876886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93060286|NCT03876886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060287|NCT03876886|Tubulin Modulators|tubulin modulators|mesh-ancestor
93060288|NCT03876886|Antimitotic Agents|antimitotic agents|mesh-ancestor
93060289|NCT03876886|Mitosis Modulators|mitosis modulators|mesh-ancestor
93060290|NCT03876886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060291|NCT03876886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060292|NCT03876886|Immunologic Factors|immunologic factors|mesh-ancestor
93060293|NCT03876886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060294|NCT03876886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060295|NCT03876886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93060296|NCT03876886|Alkylating Agents|alkylating agents|mesh-ancestor
93060297|NCT03876886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93060298|NCT03876886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93060299|NCT03876886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93060300|NCT03876886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93060301|NCT03876886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060302|NCT01266772|Budesonide|budesonide|mesh-list
93060303|NCT01266772|Montelukast|montelukast|mesh-list
93060304|NCT01266772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060305|NCT01266772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93060306|NCT01266772|Autonomic Agents|autonomic agents|mesh-ancestor
93060307|NCT01266772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060308|NCT01266772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060309|NCT01266772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93060310|NCT01266772|Respiratory System Agents|respiratory system agents|mesh-ancestor
93060311|NCT01266772|Glucocorticoids|glucocorticoids|mesh-ancestor
93060312|NCT01266772|Hormones|hormones|mesh-ancestor
93060313|NCT01266772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060314|NCT01266772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93060315|NCT01266772|Hormone Antagonists|hormone antagonists|mesh-ancestor
93060316|NCT01266772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93060317|NCT01266772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93060318|NCT01266772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060319|NCT01264354|Adefovir|adefovir|mesh-list
93060321|NCT01264354|Clevudine|clevudine|mesh-list
93060322|NCT01264354|Antiviral Agents|antiviral agents|mesh-ancestor
93060323|NCT01264354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060324|NCT01264354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93060325|NCT01264354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93060326|NCT01264354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060327|NCT01264354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060328|NCT01264432|Veliparib|veliparib|mesh-list
93060329|NCT01264432|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93060330|NCT01264432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060331|NCT01264432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060332|NCT01264432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060333|NCT02527096|Lamivudine|lamivudine|mesh-list
93060334|NCT02527096|Dolutegravir|dolutegravir|mesh-list
93060335|NCT02527096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93060336|NCT02527096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93060337|NCT02527096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060338|NCT02527096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060339|NCT02527096|Antiviral Agents|antiviral agents|mesh-ancestor
93060340|NCT02527096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060341|NCT02527096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93060342|NCT02527096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93060343|NCT02527096|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93060344|NCT02527096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93060345|NCT01160302|Curcumin|curcumin|mesh-list
93060346|NCT01160302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93060347|NCT01160302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93060348|NCT01160302|Analgesics|analgesics|mesh-ancestor
93060349|NCT01160302|Sensory System Agents|sensory system agents|mesh-ancestor
93060350|NCT01160302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060351|NCT01160302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060352|NCT01160302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060353|NCT01160302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060354|NCT01160302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060355|NCT01160302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060356|NCT01160302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060357|NCT01162720|Oxymetazoline|oxymetazoline|mesh-list
93060358|NCT01162720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93060359|NCT01162720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93060360|NCT01162720|Adrenergic Agents|adrenergic agents|mesh-ancestor
93060361|NCT01162720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060362|NCT01162720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060363|NCT01162720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060364|NCT01162720|Sympathomimetics|sympathomimetics|mesh-ancestor
93060365|NCT01162720|Autonomic Agents|autonomic agents|mesh-ancestor
93060366|NCT01162720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060367|NCT01162720|Nasal Decongestants|nasal decongestants|mesh-ancestor
93060368|NCT01162720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93060369|NCT01162720|Respiratory System Agents|respiratory system agents|mesh-ancestor
93060370|NCT01268176|Vitamin D|vitamin d|mesh-list
93060371|NCT01268176|Cholecalciferol|cholecalciferol|mesh-list
93060372|NCT01268176|Vitamins|vitamins|mesh-ancestor
93060373|NCT01268176|Micronutrients|micronutrients|mesh-ancestor
93060374|NCT01268176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060375|NCT01268176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93060376|NCT01268176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93060377|NCT01264588|Calcium|calcium|mesh-list
93060378|NCT01264588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93060379|NCT01264588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060380|NCT05075200|Tranexamic Acid|tranexamic acid|mesh-list
93060381|NCT05075200|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93060382|NCT05075200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93060383|NCT05075200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060384|NCT05075200|Hemostatics|hemostatics|mesh-ancestor
93060385|NCT05075200|Coagulants|coagulants|mesh-ancestor
93060386|NCT01158274|Capecitabine|capecitabine|mesh-list
93060387|NCT01158274|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
93060388|NCT01158274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93060389|NCT01158274|Antimetabolites|antimetabolites|mesh-ancestor
93060390|NCT01158274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060391|NCT01158274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060392|NCT01158274|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93060393|NCT01158274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060395|NCT01267084|Dexamethasone|dexamethasone|mesh-list
93060396|NCT01267084|Trabectedin|trabectedin|mesh-list
93060397|NCT01267084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060398|NCT01267084|Antiemetics|antiemetics|mesh-ancestor
93060399|NCT01267084|Autonomic Agents|autonomic agents|mesh-ancestor
93060400|NCT01267084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060401|NCT01267084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060402|NCT01267084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060403|NCT01267084|Glucocorticoids|glucocorticoids|mesh-ancestor
93060405|NCT01267084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060406|NCT01267084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060407|NCT01267084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060408|NCT01267084|Antifungal Agents|antifungal agents|mesh-ancestor
93060409|NCT01267084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060410|NCT01267084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93060411|NCT01267084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93060412|NCT01267084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060413|NCT01267084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333873|NCT00003217|Vincristine|vincristine|mesh-list
93060414|NCT01267084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93060415|NCT01267084|Hormone Antagonists|hormone antagonists|mesh-ancestor
93060416|NCT01267084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93060417|NCT01267084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93060418|NCT01267084|Alkylating Agents|alkylating agents|mesh-ancestor
93060419|NCT01264822|Rabeprazole|rabeprazole|mesh-list
93060420|NCT01264822|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93060421|NCT01264822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060422|NCT01264822|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93060423|NCT01264822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060424|NCT01264822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060425|NCT03876574|Dexamethasone|dexamethasone|mesh-list
93060426|NCT03876574|Gemcitabine|gemcitabine|mesh-list
93060427|NCT03876574|Floxuridine|floxuridine|mesh-list
93060428|NCT03876574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060429|NCT03876574|Antiemetics|antiemetics|mesh-ancestor
93060430|NCT03876574|Autonomic Agents|autonomic agents|mesh-ancestor
93060431|NCT03876574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060432|NCT03876574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060433|NCT03876574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060434|NCT03876574|Glucocorticoids|glucocorticoids|mesh-ancestor
93060435|NCT03876574|Hormones|hormones|mesh-ancestor
93060436|NCT03876574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060437|NCT03876574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060438|NCT03876574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060439|NCT03876574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93060440|NCT03876574|Antimetabolites|antimetabolites|mesh-ancestor
93060441|NCT03876574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060442|NCT01161082|Alirocumab|alirocumab|mesh-list
93060443|NCT01161082|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93060444|NCT01161082|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93060445|NCT01161082|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93060446|NCT01161082|Antimetabolites|antimetabolites|mesh-ancestor
93060447|NCT01161082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060448|NCT01161082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93060449|NCT01161082|Protease Inhibitors|protease inhibitors|mesh-ancestor
93060450|NCT01161082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060451|NCT01161082|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93060452|NCT01158586|Levobupivacaine|levobupivacaine|mesh-list
93060453|NCT01158586|Anesthetics, Local|anesthetics, local|mesh-ancestor
93060454|NCT01158586|Anesthetics|anesthetics|mesh-ancestor
93060455|NCT01158586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060456|NCT01158586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060457|NCT01158586|Sensory System Agents|sensory system agents|mesh-ancestor
93060458|NCT01158586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060459|NCT01267396|Sertraline|sertraline|mesh-list
93060460|NCT01267396|Antidepressive Agents|antidepressive agents|mesh-ancestor
93060461|NCT01267396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93060462|NCT01267396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93060463|NCT01267396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93060464|NCT01267396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705589|NCT04681937|Hormones|hormones|mesh-ancestor
93060465|NCT01267396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060466|NCT01267396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060467|NCT01267396|Serotonin Agents|serotonin agents|mesh-ancestor
93060468|NCT01267396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060469|NCT01159132|Raltegravir Potassium|raltegravir potassium|mesh-list
93060470|NCT01159132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93060471|NCT01159132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93060472|NCT01159132|Antiviral Agents|antiviral agents|mesh-ancestor
93060473|NCT01159132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060474|NCT01159132|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93060475|NCT01159132|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93060476|NCT01159132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060477|NCT01159132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060479|NCT01161316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93060480|NCT01161316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060481|NCT01161550|Cytarabine|cytarabine|mesh-list
93060482|NCT01161550|Tretinoin|tretinoin|mesh-list
93060483|NCT01161550|Cladribine|cladribine|mesh-list
93060484|NCT01161550|Midostaurin|midostaurin|mesh-list
93060485|NCT01161550|Lenograstim|lenograstim|mesh-list
93060486|NCT01161550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93060487|NCT01161550|Antimetabolites|antimetabolites|mesh-ancestor
93060488|NCT01161550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060489|NCT01161550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060490|NCT01161550|Antiviral Agents|antiviral agents|mesh-ancestor
93060491|NCT01161550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060492|NCT01161550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060493|NCT01161550|Immunologic Factors|immunologic factors|mesh-ancestor
93060494|NCT01161550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060495|NCT01161550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93060496|NCT01161550|Keratolytic Agents|keratolytic agents|mesh-ancestor
93060497|NCT01161550|Dermatologic Agents|dermatologic agents|mesh-ancestor
93060498|NCT01161550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93060499|NCT01161550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060500|NCT01159210|Thrombin|thrombin|mesh-list
93060501|NCT01159210|Hemostatics|hemostatics|mesh-ancestor
93060502|NCT01159210|Coagulants|coagulants|mesh-ancestor
93060503|NCT03879460|Naltrexone|naltrexone|mesh-list
93060504|NCT03879460|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93060505|NCT03879460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93060506|NCT03879460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060507|NCT03879460|Sensory System Agents|sensory system agents|mesh-ancestor
93060508|NCT03879460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060509|NCT03877120|Diazepam|diazepam|mesh-list
93060510|NCT03877120|Dexmedetomidine|dexmedetomidine|mesh-list
93060511|NCT03877120|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93060512|NCT03877120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060513|NCT03877120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060514|NCT03877120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93060515|NCT03877120|Analgesics|analgesics|mesh-ancestor
93060516|NCT03877120|Sensory System Agents|sensory system agents|mesh-ancestor
93060517|NCT03877120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060518|NCT03877120|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93060519|NCT03877120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93060520|NCT03877120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93060521|NCT03877120|Adrenergic Agents|adrenergic agents|mesh-ancestor
93060522|NCT03877120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060523|NCT03877120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060524|NCT03877120|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93060526|NCT03877120|Antiemetics|antiemetics|mesh-ancestor
93060527|NCT03877120|Autonomic Agents|autonomic agents|mesh-ancestor
93060528|NCT03877120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060529|NCT03877120|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93060530|NCT03877120|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93060531|NCT03877120|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93060532|NCT03877120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93060533|NCT03877120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93060534|NCT03877120|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93060535|NCT03877120|Anesthetics, General|anesthetics, general|mesh-ancestor
93060536|NCT03877120|Anesthetics|anesthetics|mesh-ancestor
93060537|NCT03877120|GABA Modulators|gaba modulators|mesh-ancestor
93060538|NCT03877120|GABA Agents|gaba agents|mesh-ancestor
93060539|NCT03879382|Cyclophosphamide|cyclophosphamide|mesh-list
93060540|NCT03879382|Fludarabine|fludarabine|mesh-list
93060541|NCT03879382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060542|NCT03879382|Immunologic Factors|immunologic factors|mesh-ancestor
93060543|NCT03879382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060544|NCT03879382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060545|NCT03879382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93060546|NCT03879382|Alkylating Agents|alkylating agents|mesh-ancestor
93060547|NCT03879382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060548|NCT03879382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060549|NCT03879382|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93060550|NCT01166932|Amoxicillin|amoxicillin|mesh-list
93060551|NCT01166932|Ceftriaxone|ceftriaxone|mesh-list
93060552|NCT01166932|Clavulanic Acids|clavulanic acids|mesh-list
93060553|NCT01166932|Clavulanic Acid|clavulanic acid|mesh-list
93060554|NCT01166932|Oxacillin|oxacillin|mesh-list
93060555|NCT01166932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93060556|NCT01166932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060557|NCT01166932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060558|NCT01166932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060559|NCT01166932|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93060560|NCT01167010|Budesonide|budesonide|mesh-list
93060561|NCT01167010|Formoterol Fumarate|formoterol fumarate|mesh-list
93060562|NCT01167010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060563|NCT01167010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93060564|NCT01167010|Autonomic Agents|autonomic agents|mesh-ancestor
93060565|NCT01167010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060566|NCT01167010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060567|NCT01167010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93060568|NCT01167010|Respiratory System Agents|respiratory system agents|mesh-ancestor
93060569|NCT01167010|Glucocorticoids|glucocorticoids|mesh-ancestor
93060570|NCT01167010|Hormones|hormones|mesh-ancestor
93060571|NCT01167010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060572|NCT01167010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93060573|NCT01167010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93060574|NCT01167010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93060575|NCT01167010|Adrenergic Agents|adrenergic agents|mesh-ancestor
93060576|NCT01167010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060577|NCT01167010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060578|NCT01280188|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93060579|NCT01280188|Hemostatics|hemostatics|mesh-ancestor
93060580|NCT01280188|Coagulants|coagulants|mesh-ancestor
93060581|NCT01280188|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93060582|NCT01280188|Natriuretic Agents|natriuretic agents|mesh-ancestor
93060583|NCT01280188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060584|NCT03871972|Sirolimus|sirolimus|mesh-list
93060585|NCT03871972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93060586|NCT03871972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060587|NCT03871972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93060588|NCT03871972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060589|NCT03871972|Antifungal Agents|antifungal agents|mesh-ancestor
93060590|NCT03871972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060591|NCT03871972|Immunologic Factors|immunologic factors|mesh-ancestor
93060592|NCT03871972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060593|NCT01165060|Bezafibrate|bezafibrate|mesh-list
93060594|NCT01165060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93060595|NCT01165060|Antimetabolites|antimetabolites|mesh-ancestor
93060596|NCT01165060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060597|NCT01165060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93060598|NCT01165294|Ketamine|ketamine|mesh-list
93060599|NCT01165294|Analgesics|analgesics|mesh-ancestor
93060600|NCT01165294|Sensory System Agents|sensory system agents|mesh-ancestor
93060601|NCT01165294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060602|NCT01165294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060603|NCT01165294|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93060604|NCT01165294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93060605|NCT01165294|Anesthetics, General|anesthetics, general|mesh-ancestor
93060606|NCT01165294|Anesthetics|anesthetics|mesh-ancestor
93060607|NCT01165294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060608|NCT01165294|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93060609|NCT01165294|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93060610|NCT01165294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060611|NCT01165294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060612|NCT01165372|Artesunate|artesunate|mesh-list
93060613|NCT01165372|Piperaquine|piperaquine|mesh-list
93060614|NCT01165372|Artenimol|artenimol|mesh-list
93060615|NCT01165372|Antimalarials|antimalarials|mesh-ancestor
93060616|NCT01165372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93060617|NCT01165372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93060618|NCT01165372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060619|NCT01165372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060620|NCT01165372|Antiviral Agents|antiviral agents|mesh-ancestor
93060621|NCT01165372|Schistosomicides|schistosomicides|mesh-ancestor
93060622|NCT01165372|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93060623|NCT01165372|Anthelmintics|anthelmintics|mesh-ancestor
93060625|NCT01280734|Antioxidants|antioxidants|mesh-ancestor
93060626|NCT01280734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060627|NCT01280734|Protective Agents|protective agents|mesh-ancestor
93060628|NCT01280734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060629|NCT01280734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060630|NCT01269970|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93060631|NCT01269970|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93060632|NCT01269970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060633|NCT01587430|Cytarabine|cytarabine|mesh-list
93060634|NCT01587430|Daunorubicin|daunorubicin|mesh-list
93060635|NCT01587430|Mitoxantrone|mitoxantrone|mesh-list
93060636|NCT01587430|Idarubicin|idarubicin|mesh-list
93060637|NCT01587430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93060638|NCT01587430|Antimetabolites|antimetabolites|mesh-ancestor
93060639|NCT01587430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060640|NCT01587430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060641|NCT01587430|Antiviral Agents|antiviral agents|mesh-ancestor
93060642|NCT01587430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060643|NCT01587430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060644|NCT01587430|Immunologic Factors|immunologic factors|mesh-ancestor
93060645|NCT01587430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060646|NCT01587430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93060647|NCT01587430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93060648|NCT01587430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93060649|NCT01587430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060650|NCT01587430|Analgesics|analgesics|mesh-ancestor
93060651|NCT01587430|Sensory System Agents|sensory system agents|mesh-ancestor
93060652|NCT01587430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060653|NCT03874000|Metformin|metformin|mesh-list
93060654|NCT03874000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93060655|NCT03874000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060656|NCT03757234|Levofloxacin|levofloxacin|mesh-list
93060657|NCT03757234|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93060658|NCT03757234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060659|NCT03757234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93060660|NCT03757234|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93060661|NCT03757234|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93060662|NCT03757234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060663|NCT03757234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060664|NCT03757234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060665|NCT03757234|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93060666|NCT03757234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93060667|NCT03874156|Atorvastatin|atorvastatin|mesh-list
93060668|NCT03874156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93060669|NCT03874156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93060670|NCT03874156|Antimetabolites|antimetabolites|mesh-ancestor
93060671|NCT03874156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060672|NCT03874156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93060673|NCT03874156|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93060675|NCT01167478|Caffeine|caffeine|mesh-list
93060676|NCT01167478|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93060677|NCT01167478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333912|NCT00004183|Capecitabine|capecitabine|mesh-list
93060678|NCT01167478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93060679|NCT01167478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060680|NCT01167478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060681|NCT01167478|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93060682|NCT01167478|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93060683|NCT01167478|Purinergic Agents|purinergic agents|mesh-ancestor
93060684|NCT01167478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060685|NCT01587196|Naltrexone|naltrexone|mesh-list
93060686|NCT01587196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93060687|NCT01587196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93060688|NCT01587196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060689|NCT01587196|Sensory System Agents|sensory system agents|mesh-ancestor
93060690|NCT01587196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060691|NCT01281514|Carboplatin|carboplatin|mesh-list
92705809|NCT02907749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755892|NCT01260467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92755893|NCT01260467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92755894|NCT01260467|Dopamine Agents|dopamine agents|mesh-ancestor
92755895|NCT01260467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755896|NCT01260467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755897|NCT01260467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755898|NCT01260467|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92755899|NCT01260467|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92755900|NCT01260311|Fesoterodine|fesoterodine|mesh-list
92755901|NCT01260311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92755902|NCT01260311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92755903|NCT01260311|Cholinergic Agents|cholinergic agents|mesh-ancestor
92755904|NCT01260311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755905|NCT01260311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755906|NCT01260311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755907|NCT01260311|Urological Agents|urological agents|mesh-ancestor
92755908|NCT00623987|Warfarin|warfarin|mesh-list
92755909|NCT00623987|Anticoagulants|anticoagulants|mesh-ancestor
92755910|NCT01259375|Amrubicin|amrubicin|mesh-list
92755911|NCT01259375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755912|NCT05536037|Metformin|metformin|mesh-list
92755913|NCT05536037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92755914|NCT05536037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755915|NCT00624143|Voriconazole|voriconazole|mesh-list
92755916|NCT00624143|Amphotericin B|amphotericin b|mesh-list
92755917|NCT00624143|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92755918|NCT00624143|Antifungal Agents|antifungal agents|mesh-ancestor
92755919|NCT00624143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755920|NCT00624143|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92755921|NCT00624143|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92755922|NCT00624143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755923|NCT00624143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755924|NCT00624143|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92755925|NCT00624143|Hormone Antagonists|hormone antagonists|mesh-ancestor
92755926|NCT00624143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755927|NCT00624143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755928|NCT00624143|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92755929|NCT00624143|Amebicides|amebicides|mesh-ancestor
92755930|NCT00624143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92755931|NCT00624143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92755932|NCT00624143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92755933|NCT05241275|Xenon|xenon|mesh-list
92755934|NCT05241275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92755935|NCT05241275|Anesthetics, General|anesthetics, general|mesh-ancestor
92755936|NCT05241275|Anesthetics|anesthetics|mesh-ancestor
92755937|NCT05241275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755938|NCT05241275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755939|NCT04005287|Pirenzepine|pirenzepine|mesh-list
92755940|NCT04005287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92755941|NCT04005287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936961|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
92755942|NCT04005287|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92755943|NCT04005287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92755944|NCT04005287|Cholinergic Agents|cholinergic agents|mesh-ancestor
92755945|NCT04005287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755946|NCT04005287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755947|NCT04005287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755948|NCT04320173|Lidocaine|lidocaine|mesh-list
92755949|NCT04320173|Anesthetics, Local|anesthetics, local|mesh-ancestor
92755950|NCT04320173|Anesthetics|anesthetics|mesh-ancestor
92755951|NCT04320173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755952|NCT04320173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755953|NCT04320173|Sensory System Agents|sensory system agents|mesh-ancestor
92755954|NCT04320173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755955|NCT04320173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92755956|NCT04320173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92755957|NCT04320173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92755958|NCT04320173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92755959|NCT04320173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755960|NCT04321733|Amoxicillin|amoxicillin|mesh-list
92755961|NCT04321733|Clavulanic Acid|clavulanic acid|mesh-list
92755962|NCT04321733|Clavulanic Acids|clavulanic acids|mesh-list
92755963|NCT04321733|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92705890|NCT04682132|Antibodies|antibodies|mesh-list
92755964|NCT04321733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92755965|NCT04321733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755966|NCT04321733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92755967|NCT04321733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755968|NCT04321733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755969|NCT02029001|Everolimus|everolimus|mesh-list
92755970|NCT02029001|Sorafenib|sorafenib|mesh-list
92755971|NCT02029001|Durvalumab|durvalumab|mesh-list
92755972|NCT02029001|Olaparib|olaparib|mesh-list
92755973|NCT02029001|Lapatinib|lapatinib|mesh-list
92755974|NCT02029001|Tremelimumab|tremelimumab|mesh-list
92755975|NCT02029001|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92755976|NCT02029001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755977|NCT02029001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755978|NCT02029001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755979|NCT02029001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755980|NCT02029001|Immunologic Factors|immunologic factors|mesh-ancestor
92755981|NCT02029001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755982|NCT02029001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755983|NCT02029001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755984|NCT02029001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92755985|NCT01613495|Octreotide|octreotide|mesh-list
92755986|NCT01613495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92755987|NCT01613495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92755988|NCT01613495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755989|NCT01321073|Treprostinil|treprostinil|mesh-list
92755990|NCT01321073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92755991|NCT00694733|Anastrozole|anastrozole|mesh-list
92755992|NCT00694733|Leuprolide|leuprolide|mesh-list
92755993|NCT00694733|Methyltestosterone|methyltestosterone|mesh-list
92755994|NCT00694733|Estradiol|estradiol|mesh-list
92755995|NCT00694733|Estrogens|estrogens|mesh-list
92755996|NCT00694733|Testosterone|testosterone|mesh-list
92755997|NCT00694733|Testosterone undecanoate|testosterone undecanoate|mesh-list
92755998|NCT00694733|Testosterone enanthate|testosterone enanthate|mesh-list
92755999|NCT00694733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92756000|NCT00694733|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92756001|NCT00694733|Hormones|hormones|mesh-ancestor
92756002|NCT00694733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756003|NCT00694733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756004|NCT00694733|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92756005|NCT00694733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756006|NCT00694733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756007|NCT00694733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92756008|NCT00694733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756009|NCT00694733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756010|NCT00694733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92756011|NCT00694733|Hormone Antagonists|hormone antagonists|mesh-ancestor
92756012|NCT00694733|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92756013|NCT00694733|Fertility Agents|fertility agents|mesh-ancestor
92756014|NCT00694733|Androgens|androgens|mesh-ancestor
92756015|NCT00694733|Anabolic Agents|anabolic agents|mesh-ancestor
92756016|NCT01259297|Amlodipine|amlodipine|mesh-list
92756017|NCT01259297|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92529592|NCT00016302|Cytarabine|cytarabine|mesh-list
92756018|NCT01259297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92756019|NCT01259297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92756020|NCT01259297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756021|NCT01259297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756022|NCT01259297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756023|NCT01259297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756024|NCT01259297|Vasodilator Agents|vasodilator agents|mesh-ancestor
92756025|NCT01259297|Diuretics|diuretics|mesh-ancestor
92756026|NCT01259297|Natriuretic Agents|natriuretic agents|mesh-ancestor
92756027|NCT01259297|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92756028|NCT01126437|Tiotropium Bromide|tiotropium bromide|mesh-list
92756029|NCT01126437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92756030|NCT01126437|Autonomic Agents|autonomic agents|mesh-ancestor
92756031|NCT01126437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756032|NCT01126437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756033|NCT01126437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92756034|NCT01126437|Respiratory System Agents|respiratory system agents|mesh-ancestor
92756035|NCT01126437|Parasympatholytics|parasympatholytics|mesh-ancestor
92756036|NCT01126437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92756037|NCT01126437|Cholinergic Agents|cholinergic agents|mesh-ancestor
92756038|NCT01126437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756039|NCT01126437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756041|NCT01258595|Immunologic Factors|immunologic factors|mesh-ancestor
92756042|NCT01258595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756043|NCT01257737|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92756044|NCT01257737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756045|NCT01126359|Lidocaine|lidocaine|mesh-list
92756046|NCT01126359|Anesthetics, Local|anesthetics, local|mesh-ancestor
92756047|NCT01126359|Anesthetics|anesthetics|mesh-ancestor
92756048|NCT01126359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756049|NCT01126359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756050|NCT01126359|Sensory System Agents|sensory system agents|mesh-ancestor
92756051|NCT01126359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756052|NCT01126359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92756053|NCT01126359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92756054|NCT01126359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92756055|NCT01126359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756056|NCT01126359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756057|NCT00637533|Botulinum Toxins|botulinum toxins|mesh-list
92756058|NCT00637533|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92756059|NCT00637533|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92756060|NCT00637533|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92756061|NCT00637533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756062|NCT00637533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756063|NCT00637533|Cholinergic Agents|cholinergic agents|mesh-ancestor
92756064|NCT00637533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756065|NCT00637533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756066|NCT00637533|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92756067|NCT00637533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756068|NCT01125813|Factor VIII|factor viii|mesh-list
92756069|NCT01125813|Coagulants|coagulants|mesh-ancestor
92756070|NCT04311645|Charcoal|charcoal|mesh-list
92756071|NCT04311645|Antidotes|antidotes|mesh-ancestor
92756072|NCT04311645|Protective Agents|protective agents|mesh-ancestor
92756073|NCT04311645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756074|NCT01257581|Tamoxifen|tamoxifen|mesh-list
92756075|NCT01257581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92756076|NCT01257581|Hormone Antagonists|hormone antagonists|mesh-ancestor
92756077|NCT01257581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756078|NCT01257581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756079|NCT01257581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756080|NCT01257581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756081|NCT01257581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92756082|NCT01257581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92756083|NCT01257581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92756084|NCT00995566|Sitaxsentan|sitaxsentan|mesh-list
92756085|NCT00995566|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92756086|NCT00995566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756087|NCT01257425|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92756088|NCT01257425|Luteolytic Agents|luteolytic agents|mesh-ancestor
92529596|NCT00016302|Doxorubicin|doxorubicin|mesh-list
92756089|NCT01257425|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92756090|NCT01257425|Contraceptive Agents|contraceptive agents|mesh-ancestor
92756091|NCT01257425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92756092|NCT01257425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756093|NCT01257425|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92756094|NCT01257425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756095|NCT01257425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756096|NCT00995488|Paclitaxel|paclitaxel|mesh-list
92756097|NCT00995488|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92756098|NCT00995488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92756099|NCT00995488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756100|NCT00995488|Tubulin Modulators|tubulin modulators|mesh-ancestor
92756101|NCT00995488|Antimitotic Agents|antimitotic agents|mesh-ancestor
92756102|NCT00995488|Mitosis Modulators|mitosis modulators|mesh-ancestor
92756103|NCT00995488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756104|NCT04293172|Ticagrelor|ticagrelor|mesh-list
92756105|NCT04293172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92756106|NCT04293172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92756107|NCT04293172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92756108|NCT04293172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92756109|NCT04293172|Purinergic Agents|purinergic agents|mesh-ancestor
92756110|NCT04293172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756111|NCT04293172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756112|NCT04293172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756113|NCT01256879|Cimetidine|cimetidine|mesh-list
92756114|NCT01256879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92756115|NCT01256879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92756116|NCT01256879|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92756117|NCT01256879|Histamine Antagonists|histamine antagonists|mesh-ancestor
92756118|NCT01256879|Histamine Agents|histamine agents|mesh-ancestor
92756119|NCT01256879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756120|NCT01256879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756121|NCT01256879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756122|NCT01256879|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92756123|NCT01256879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92756124|NCT01256879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756125|NCT02869672|Vaccines|vaccines|mesh-list
92756126|NCT02869672|Immunologic Factors|immunologic factors|mesh-ancestor
92333950|NCT00003835|Vitamins|vitamins|mesh-ancestor
92756127|NCT02869672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756128|NCT01125189|Interferons|interferons|mesh-list
92756129|NCT01125189|Ribavirin|ribavirin|mesh-list
92756130|NCT01125189|Interferon-alpha|interferon-alpha|mesh-list
92756131|NCT01125189|Interferon alpha-2|interferon alpha-2|mesh-list
92756132|NCT01125189|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92756133|NCT01125189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756134|NCT01125189|Antiviral Agents|antiviral agents|mesh-ancestor
92756135|NCT01125189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756136|NCT01125189|Antimetabolites|antimetabolites|mesh-ancestor
92756137|NCT01125189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756138|NCT01125189|Immunologic Factors|immunologic factors|mesh-ancestor
92756139|NCT01125189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756140|NCT01256567|Docetaxel|docetaxel|mesh-list
92756141|NCT01256567|Ramucirumab|ramucirumab|mesh-list
92756142|NCT01256567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756143|NCT01256567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92756144|NCT01256567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92756145|NCT01256567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92756146|NCT01256567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756147|NCT00996736|Voriconazole|voriconazole|mesh-list
92756148|NCT00996736|Natamycin|natamycin|mesh-list
92756149|NCT00996736|Antifungal Agents|antifungal agents|mesh-ancestor
92756150|NCT00996736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756151|NCT00996736|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92756152|NCT00996736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92756153|NCT00996736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756154|NCT00996736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756155|NCT00996736|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92756156|NCT00996736|Hormone Antagonists|hormone antagonists|mesh-ancestor
92756157|NCT00996736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756158|NCT00996736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756159|NCT00996736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92756160|NCT00996736|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92756161|NCT00996736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756162|NCT00996658|Linagliptin|linagliptin|mesh-list
92756163|NCT00996658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92756164|NCT00996658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756165|NCT00996658|Incretins|incretins|mesh-ancestor
92756167|NCT00996658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756168|NCT00996658|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92756169|NCT00996658|Protease Inhibitors|protease inhibitors|mesh-ancestor
92756170|NCT00996658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756171|NCT00996658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756172|NCT04310631|Ranibizumab|ranibizumab|mesh-list
92756173|NCT04310631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92756174|NCT04310631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92756175|NCT04310631|Growth Substances|growth substances|mesh-ancestor
92756176|NCT04310631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756177|NCT04310631|Growth Inhibitors|growth inhibitors|mesh-ancestor
92756178|NCT04310631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756179|NCT01256411|Amlodipine|amlodipine|mesh-list
92756180|NCT01256411|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92756181|NCT01256411|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92756182|NCT01256411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92756183|NCT01256411|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92756184|NCT01256411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93060692|NCT01281514|Doxorubicin|doxorubicin|mesh-list
92756185|NCT01256411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756186|NCT01256411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756187|NCT01256411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756188|NCT01256411|Vasodilator Agents|vasodilator agents|mesh-ancestor
92756189|NCT01256411|Diuretics|diuretics|mesh-ancestor
92756190|NCT01256411|Natriuretic Agents|natriuretic agents|mesh-ancestor
92756191|NCT01256411|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92756192|NCT01256411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92756193|NCT00996580|Levonorgestrel|levonorgestrel|mesh-list
92756194|NCT00996580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92756195|NCT00996580|Estradiol|estradiol|mesh-list
92756196|NCT00996580|Estrogens|estrogens|mesh-ancestor
92756197|NCT00996580|Hormones|hormones|mesh-ancestor
92756198|NCT00996580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756199|NCT00996580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756200|NCT00996580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92756201|NCT00996580|Contraceptive Agents|contraceptive agents|mesh-ancestor
92756202|NCT00996580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92756203|NCT00996580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92756204|NCT00996580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92756205|NCT00996580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92756206|NCT00996580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92756207|NCT01124175|Losartan|losartan|mesh-list
92756208|NCT01124175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92756209|NCT01124175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92756210|NCT01124175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92756211|NCT01124175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92756212|NCT01124175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756213|NCT01256177|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92756214|NCT01256177|Antidepressive Agents|antidepressive agents|mesh-ancestor
92756215|NCT01256177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756216|NCT01256177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92756217|NCT01256177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756218|NCT01256177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756219|NCT01256177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756220|NCT02882451|Pinaverium|pinaverium|mesh-list
92756221|NCT02882451|Bromides|bromides|mesh-list
92756222|NCT02882451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756223|NCT02882451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756224|NCT02882451|Anticonvulsants|anticonvulsants|mesh-ancestor
92756225|NCT02882451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92756226|NCT02882451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756227|NCT02882451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756228|NCT02882451|Parasympatholytics|parasympatholytics|mesh-ancestor
92756229|NCT02882451|Autonomic Agents|autonomic agents|mesh-ancestor
92756230|NCT02882451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756231|NCT00999544|Oxycodone|oxycodone|mesh-list
92756232|NCT00999544|Aprepitant|aprepitant|mesh-list
92756233|NCT00999544|Fosaprepitant|fosaprepitant|mesh-list
92756234|NCT00999544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92756235|NCT00999544|Narcotics|narcotics|mesh-ancestor
92756236|NCT00999544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756237|NCT00999544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756238|NCT00999544|Analgesics|analgesics|mesh-ancestor
92756239|NCT00999544|Sensory System Agents|sensory system agents|mesh-ancestor
92756240|NCT00999544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756241|NCT00999544|Antiemetics|antiemetics|mesh-ancestor
92756242|NCT00999544|Autonomic Agents|autonomic agents|mesh-ancestor
92756243|NCT00999544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92756244|NCT00999544|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92756245|NCT00999544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756246|NCT00999544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756247|NCT02869984|Ramosetron|ramosetron|mesh-list
92756248|NCT02869984|Antiemetics|antiemetics|mesh-ancestor
92756249|NCT02869984|Autonomic Agents|autonomic agents|mesh-ancestor
92756250|NCT02869984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756251|NCT02869984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756252|NCT02869984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92756253|NCT02869984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92756254|NCT02869984|Serotonin Agents|serotonin agents|mesh-ancestor
92756255|NCT02869984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756256|NCT02869984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756257|NCT01124097|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92756258|NCT01124097|Anticonvulsants|anticonvulsants|mesh-ancestor
92756259|NCT01124097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92756260|NCT01124097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92756261|NCT01124097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756262|NCT01124097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756264|NCT01123395|Gout Suppressants|gout suppressants|mesh-ancestor
92756265|NCT01123395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756266|NCT01123395|Tubulin Modulators|tubulin modulators|mesh-ancestor
92756267|NCT01123395|Antimitotic Agents|antimitotic agents|mesh-ancestor
92756268|NCT01123395|Mitosis Modulators|mitosis modulators|mesh-ancestor
92756269|NCT01123395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756270|NCT01123395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756271|NCT01255787|Vortioxetine|vortioxetine|mesh-list
92756272|NCT01255787|Antidepressive Agents|antidepressive agents|mesh-ancestor
92756273|NCT01255787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756274|NCT01255787|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92756275|NCT01255787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756276|NCT01255787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756277|NCT01255787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756278|NCT01255787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92756279|NCT01255787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92756280|NCT01255787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756281|NCT01255787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756282|NCT01255787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756283|NCT01255787|Serotonin Agents|serotonin agents|mesh-ancestor
92756284|NCT01255787|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92756285|NCT01255787|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92756286|NCT01255787|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92756287|NCT01255787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92756288|NCT04540835|Calcium|calcium|mesh-list
92756289|NCT04540835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756290|NCT04540835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756291|NCT01255163|Exenatide|exenatide|mesh-list
92756292|NCT01255163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92756293|NCT01255163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756294|NCT01255163|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92756295|NCT01255163|Incretins|incretins|mesh-ancestor
92756296|NCT01255163|Hormones|hormones|mesh-ancestor
92756297|NCT01255163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756298|NCT01123083|Muromonab-CD3|muromonab-cd3|mesh-list
92756299|NCT01123083|Immunologic Factors|immunologic factors|mesh-ancestor
92756300|NCT01123083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756301|NCT01123083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92756302|NCT02870062|Chlorhexidine|chlorhexidine|mesh-list
92756303|NCT02870062|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92756304|NCT02870062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756305|NCT02870062|Disinfectants|disinfectants|mesh-ancestor
92756306|NCT01254305|Milnacipran|milnacipran|mesh-list
92756307|NCT01254305|Sertraline|sertraline|mesh-list
92756308|NCT01254305|Fluoxetine|fluoxetine|mesh-list
92756309|NCT01254305|Paroxetine|paroxetine|mesh-list
92756310|NCT01254305|Citalopram|citalopram|mesh-list
92756311|NCT01254305|Levomilnacipran|levomilnacipran|mesh-list
92756312|NCT01254305|Antidepressive Agents|antidepressive agents|mesh-ancestor
92756313|NCT01254305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756314|NCT01254305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92756315|NCT01254305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92756316|NCT01254305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756317|NCT01254305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756318|NCT01254305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756319|NCT01254305|Serotonin Agents|serotonin agents|mesh-ancestor
92756320|NCT01254305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756321|NCT01254305|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92756322|NCT01254305|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92756323|NCT01254305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92756324|NCT01254305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756325|NCT01254305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361604|NCT05198232|TEMPO|tempo|mesh-list
92756326|NCT01254305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92756327|NCT01254305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92756328|NCT01254305|Analgesics|analgesics|mesh-ancestor
92756329|NCT01254305|Sensory System Agents|sensory system agents|mesh-ancestor
92756330|NCT01122927|Aripiprazole|aripiprazole|mesh-list
92756331|NCT01122927|Antidepressive Agents|antidepressive agents|mesh-ancestor
92756332|NCT01122927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756333|NCT01122927|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92756334|NCT01122927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756335|NCT01122927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756336|NCT01122927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756337|NCT01122927|Dopamine Agonists|dopamine agonists|mesh-ancestor
92756338|NCT01122927|Dopamine Agents|dopamine agents|mesh-ancestor
92756339|NCT01122927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756340|NCT01122927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756341|NCT01122927|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92756342|NCT01122927|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92756343|NCT01122927|Serotonin Agents|serotonin agents|mesh-ancestor
92756344|NCT01122927|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92756345|NCT01122927|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92756346|NCT01122927|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92756347|NCT01122927|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92756348|NCT01254227|Deferasirox|deferasirox|mesh-list
92756349|NCT01254227|Deferoxamine|deferoxamine|mesh-list
92756350|NCT01254227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92756351|NCT01254227|Chelating Agents|chelating agents|mesh-ancestor
92756352|NCT01254227|Sequestering Agents|sequestering agents|mesh-ancestor
92756353|NCT01254227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756354|NCT01254227|Siderophores|siderophores|mesh-ancestor
92756355|NCT04311255|Anesthetics|anesthetics|mesh-list
92756356|NCT04311255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756357|NCT04311255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756358|NCT01122381|Ethosuximide|ethosuximide|mesh-list
92756359|NCT01122381|Anticonvulsants|anticonvulsants|mesh-ancestor
92756360|NCT00996034|Nicotine|nicotine|mesh-list
92756361|NCT00996034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756362|NCT00996034|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92756363|NCT00996034|Autonomic Agents|autonomic agents|mesh-ancestor
92756364|NCT00996034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756365|NCT00996034|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92756366|NCT00996034|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92756367|NCT00996034|Cholinergic Agents|cholinergic agents|mesh-ancestor
92756368|NCT00996034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756369|NCT00996034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756370|NCT01121991|Hormones|hormones|mesh-list
92756371|NCT01121991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756372|NCT01121991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756373|NCT04292236|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92756374|NCT04292236|Perilla seed oil|perilla seed oil|mesh-list
92756375|NCT04292236|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92756376|NCT04292236|Protective Agents|protective agents|mesh-ancestor
92756377|NCT04292236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756378|NCT04292236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756380|NCT01121913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92756381|NCT01121913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756382|NCT01121913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756383|NCT01121913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756384|NCT01121913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756385|NCT01121913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92756386|NCT01121913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92756387|NCT01121913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756388|NCT01121913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756389|NCT01121913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756390|NCT01121913|Serotonin Agents|serotonin agents|mesh-ancestor
92756391|NCT01121913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92756392|NCT01121913|Antidepressive Agents|antidepressive agents|mesh-ancestor
92756393|NCT04310943|Paclitaxel|paclitaxel|mesh-list
92756394|NCT04310943|Tislelizumab|tislelizumab|mesh-list
92756395|NCT04310943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92756396|NCT04310943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756397|NCT04310943|Tubulin Modulators|tubulin modulators|mesh-ancestor
92756398|NCT04310943|Antimitotic Agents|antimitotic agents|mesh-ancestor
92756399|NCT04310943|Mitosis Modulators|mitosis modulators|mesh-ancestor
92756400|NCT04310943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756401|NCT04310943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92756402|NCT02868814|Pregabalin|pregabalin|mesh-list
92756403|NCT02868814|Analgesics|analgesics|mesh-ancestor
92756404|NCT02868814|Sensory System Agents|sensory system agents|mesh-ancestor
92756405|NCT02868814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756406|NCT02868814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756407|NCT02868814|Anticonvulsants|anticonvulsants|mesh-ancestor
92756408|NCT02868814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92756409|NCT02868814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756410|NCT02868814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756411|NCT02868814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756412|NCT02868814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92756413|NCT02868814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756414|NCT02868814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756415|NCT02868814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756416|NCT04292314|Hydroxyurea|hydroxyurea|mesh-list
92756417|NCT04292314|Deferoxamine|deferoxamine|mesh-list
92756418|NCT04292314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756419|NCT04292314|Antisickling Agents|antisickling agents|mesh-ancestor
92756420|NCT04292314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756421|NCT04292314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756422|NCT04292314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92756423|NCT04292314|Siderophores|siderophores|mesh-ancestor
92756424|NCT04292314|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92756425|NCT04292314|Chelating Agents|chelating agents|mesh-ancestor
92756426|NCT04292314|Sequestering Agents|sequestering agents|mesh-ancestor
92756427|NCT01121757|Lenalidomide|lenalidomide|mesh-list
92756428|NCT01121757|Azacitidine|azacitidine|mesh-list
92756429|NCT01121757|Immunologic Factors|immunologic factors|mesh-ancestor
92756430|NCT01121757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756431|NCT01121757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92756432|NCT01121757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92756433|NCT01121757|Growth Substances|growth substances|mesh-ancestor
92756434|NCT01121757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92756435|NCT01121757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756436|NCT01121757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92756437|NCT01121757|Antimetabolites|antimetabolites|mesh-ancestor
92756438|NCT01121757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756439|NCT01121757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756440|NCT04319471|Capecitabine|capecitabine|mesh-list
92756441|NCT04319471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92756442|NCT04319471|Antimetabolites|antimetabolites|mesh-ancestor
92756443|NCT04319471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756444|NCT04319471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756445|NCT02882217|Histamine|histamine|mesh-list
92756446|NCT02882217|Glutarimide|glutarimide|mesh-list
92756447|NCT02882217|Histamine Agonists|histamine agonists|mesh-ancestor
92756448|NCT02882217|Histamine Agents|histamine agents|mesh-ancestor
92756449|NCT02882217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756450|NCT02882217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756451|NCT02882217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756452|NCT02882217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92756453|NCT02882217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756454|NCT01253135|Petrolatum|petrolatum|mesh-list
92756455|NCT01253135|Emollients|emollients|mesh-ancestor
92756456|NCT01253135|Dermatologic Agents|dermatologic agents|mesh-ancestor
92756457|NCT00993616|Carboplatin|carboplatin|mesh-list
92756458|NCT00993616|Belinostat|belinostat|mesh-list
92756459|NCT00993616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756460|NCT00993616|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92756461|NCT00993616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756462|NCT00993616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756463|NCT01120899|Minocycline|minocycline|mesh-list
92756464|NCT01120899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756465|NCT01120899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756466|NCT01120275|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92756467|NCT01120275|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92756468|NCT01120275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756469|NCT01120275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756470|NCT00991510|Mycophenolic Acid|mycophenolic acid|mesh-list
92756471|NCT00991510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92756472|NCT00991510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756473|NCT00991510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92756474|NCT00991510|Antitubercular Agents|antitubercular agents|mesh-ancestor
92756475|NCT00991510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756476|NCT00991510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756477|NCT00991510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756478|NCT00991510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756479|NCT01119963|Castor Oil|castor oil|mesh-list
92756480|NCT01119963|Progesterone|progesterone|mesh-list
92756481|NCT01119963|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92756482|NCT01119963|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92756483|NCT01119963|Progestins|progestins|mesh-ancestor
92756484|NCT01119963|Hormones|hormones|mesh-ancestor
92756485|NCT01119963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756486|NCT01119963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756487|NCT01119963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92756488|NCT01119963|Hormone Antagonists|hormone antagonists|mesh-ancestor
92756489|NCT01119963|Cathartics|cathartics|mesh-ancestor
92756490|NCT01119963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92756491|NCT01252667|Cyclosporine|cyclosporine|mesh-list
92756492|NCT01252667|Mycophenolic Acid|mycophenolic acid|mesh-list
92756493|NCT01252667|Clofarabine|clofarabine|mesh-list
92756494|NCT01252667|Cyclosporins|cyclosporins|mesh-list
92756495|NCT01252667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756496|NCT01252667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756497|NCT01252667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92756498|NCT01252667|Immunologic Factors|immunologic factors|mesh-ancestor
92756499|NCT01252667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756500|NCT01252667|Antifungal Agents|antifungal agents|mesh-ancestor
92756501|NCT01252667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756502|NCT01252667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92756503|NCT01252667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756504|NCT01252667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92756505|NCT01252667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92756506|NCT01252667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756507|NCT01252667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92756508|NCT01252667|Antitubercular Agents|antitubercular agents|mesh-ancestor
92756509|NCT01252667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756510|NCT01252667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92756511|NCT01252667|Antimetabolites|antimetabolites|mesh-ancestor
92756512|NCT02868580|Lamivudine|lamivudine|mesh-list
92756513|NCT02868580|Abacavir|abacavir|mesh-list
92756514|NCT02868580|Dolutegravir|dolutegravir|mesh-list
92756515|NCT02868580|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
92756516|NCT02868580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92756517|NCT02868580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92756518|NCT02868580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334005|NCT00003859|Etoposide|etoposide|mesh-list
92756519|NCT02868580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756520|NCT02868580|Antiviral Agents|antiviral agents|mesh-ancestor
92756521|NCT02868580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756522|NCT02868580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92756523|NCT02868580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92756524|NCT02868580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92756525|NCT02868580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92756526|NCT02881749|Mechlorethamine|mechlorethamine|mesh-list
92756527|NCT02881749|Alkylating Agents|alkylating agents|mesh-ancestor
92756528|NCT02881749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756529|NCT02881749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92756530|NCT02881749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756532|NCT01119105|Lefamulin|lefamulin|mesh-list
92756533|NCT01119105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756534|NCT01119105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756535|NCT01118949|Lacosamide|lacosamide|mesh-list
92756536|NCT01118949|Anticonvulsants|anticonvulsants|mesh-ancestor
92756537|NCT01118949|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92756538|NCT01118949|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92756539|NCT01118949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756540|NCT01118949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756541|NCT01252355|Interferons|interferons|mesh-list
92756542|NCT01252355|Interferon-beta|interferon-beta|mesh-list
92756543|NCT01252355|Teriflunomide|teriflunomide|mesh-list
92756544|NCT01252355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756545|NCT01252355|Antiviral Agents|antiviral agents|mesh-ancestor
92756546|NCT01252355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756547|NCT01252355|Immunologic Factors|immunologic factors|mesh-ancestor
92756548|NCT01252355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756549|NCT01252355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92756550|NCT01252355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92756551|NCT01252355|Analgesics|analgesics|mesh-ancestor
92756552|NCT01252355|Sensory System Agents|sensory system agents|mesh-ancestor
92756553|NCT01252355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756554|NCT01252355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756555|NCT01252355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756556|NCT01252355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92756557|NCT01118325|Clopidogrel|clopidogrel|mesh-list
92756558|NCT01118325|Ticagrelor|ticagrelor|mesh-list
92756559|NCT01118325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92756560|NCT01118325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92756561|NCT01118325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92756562|NCT01118325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92756563|NCT01118325|Purinergic Agents|purinergic agents|mesh-ancestor
92756564|NCT01118325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756565|NCT01118325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756566|NCT01118325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756567|NCT01117857|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92756568|NCT01117857|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92756569|NCT01117857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92756570|NCT01117857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756571|NCT01117857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756572|NCT01117857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756573|NCT01117857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756574|NCT01117857|Analgesics|analgesics|mesh-ancestor
92756575|NCT01117857|Sensory System Agents|sensory system agents|mesh-ancestor
92756576|NCT01117857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756577|NCT01117857|Antidepressive Agents|antidepressive agents|mesh-ancestor
92756578|NCT01117857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756579|NCT01117857|Dopamine Agents|dopamine agents|mesh-ancestor
92756580|NCT00991276|Pregabalin|pregabalin|mesh-list
92756581|NCT00991276|Pramipexole|pramipexole|mesh-list
92756582|NCT00991276|Analgesics|analgesics|mesh-ancestor
92756583|NCT00991276|Sensory System Agents|sensory system agents|mesh-ancestor
92756584|NCT00991276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756585|NCT00991276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756586|NCT00991276|Anticonvulsants|anticonvulsants|mesh-ancestor
92756587|NCT00991276|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92756588|NCT00991276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756589|NCT00991276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756590|NCT00991276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756591|NCT00991276|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92756592|NCT00991276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756593|NCT00991276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756594|NCT00991276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756595|NCT00991276|Antioxidants|antioxidants|mesh-ancestor
92756596|NCT00991276|Protective Agents|protective agents|mesh-ancestor
92756597|NCT00991276|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92756598|NCT00991276|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92756599|NCT00991276|Dopamine Agonists|dopamine agonists|mesh-ancestor
92756600|NCT00991276|Dopamine Agents|dopamine agents|mesh-ancestor
92756601|NCT00991276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756602|NCT02869126|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92756603|NCT02869126|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92756604|NCT02869126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756605|NCT00990652|Temozolomide|temozolomide|mesh-list
92756606|NCT00990652|Bortezomib|bortezomib|mesh-list
92756607|NCT00990652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92756608|NCT00990652|Alkylating Agents|alkylating agents|mesh-ancestor
92756609|NCT00990652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756610|NCT00990652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756611|NCT02867878|Adenosine|adenosine|mesh-list
92756612|NCT02867878|Analgesics|analgesics|mesh-ancestor
92756613|NCT02867878|Sensory System Agents|sensory system agents|mesh-ancestor
92756614|NCT02867878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756615|NCT02867878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756616|NCT02867878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92756617|NCT02867878|Vasodilator Agents|vasodilator agents|mesh-ancestor
92756618|NCT02867878|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92756619|NCT02867878|Purinergic Agonists|purinergic agonists|mesh-ancestor
92756620|NCT02867878|Purinergic Agents|purinergic agents|mesh-ancestor
92756621|NCT02867878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756622|NCT02867878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756623|NCT01207440|Ponatinib|ponatinib|mesh-list
92756624|NCT01207440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756625|NCT01207440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92756626|NCT01207440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756627|NCT01207440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756628|NCT00990184|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92756629|NCT00990184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92756630|NCT00990184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92756631|NCT00990184|Antimetabolites|antimetabolites|mesh-ancestor
92756632|NCT00990184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756633|NCT00990184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92756634|NCT00990106|Prazosin|prazosin|mesh-list
92756635|NCT00990106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92756636|NCT00990106|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92756637|NCT00990106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92756638|NCT00990106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92756639|NCT00990106|Adrenergic Agents|adrenergic agents|mesh-ancestor
92756640|NCT00990106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756641|NCT00990106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756642|NCT00990106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756643|NCT02867566|Rituximab|rituximab|mesh-list
92756644|NCT02867566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92756645|NCT02867566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756646|NCT02867566|Immunologic Factors|immunologic factors|mesh-ancestor
92756647|NCT02867566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756648|NCT02867566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756649|NCT02867722|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92756650|NCT02867722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92756651|NCT02867722|Dermatologic Agents|dermatologic agents|mesh-ancestor
92756652|NCT02867800|Acetaminophen|acetaminophen|mesh-list
92756653|NCT02867800|Diphenhydramine|diphenhydramine|mesh-list
92756654|NCT02867800|Promethazine|promethazine|mesh-list
92756655|NCT02867800|Cyclosporine|cyclosporine|mesh-list
92756656|NCT02867800|Sirolimus|sirolimus|mesh-list
92756657|NCT02867800|Mycophenolic Acid|mycophenolic acid|mesh-list
92756658|NCT02867800|Methylprednisolone|methylprednisolone|mesh-list
92756659|NCT02867800|Methotrexate|methotrexate|mesh-list
92756660|NCT02867800|Fludarabine|fludarabine|mesh-list
92756661|NCT02867800|Melphalan|melphalan|mesh-list
92756662|NCT02867800|Alemtuzumab|alemtuzumab|mesh-list
92756663|NCT02867800|Abatacept|abatacept|mesh-list
92756664|NCT02867800|Thiotepa|thiotepa|mesh-list
92756665|NCT02867800|Meperidine|meperidine|mesh-list
92756666|NCT02867800|Tacrolimus|tacrolimus|mesh-list
92756667|NCT02867800|Cyclosporins|cyclosporins|mesh-list
92756668|NCT02867800|Thymoglobulin|thymoglobulin|mesh-list
92756669|NCT02867800|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92756670|NCT02867800|Abortifacient Agents|abortifacient agents|mesh-ancestor
92756671|NCT02867800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92756672|NCT02867800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756673|NCT02867800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92756674|NCT02867800|Antimetabolites|antimetabolites|mesh-ancestor
92756675|NCT02867800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756676|NCT02867800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756677|NCT02867800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92756678|NCT02867800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756679|NCT02867800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92756680|NCT02867800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92756681|NCT02867800|Immunologic Factors|immunologic factors|mesh-ancestor
92756682|NCT02867800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756683|NCT02867800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92756684|NCT02867800|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92756685|NCT02867800|Antifungal Agents|antifungal agents|mesh-ancestor
92756686|NCT02867800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756687|NCT02867800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92756688|NCT02867800|Analgesics|analgesics|mesh-ancestor
92756689|NCT02867800|Sensory System Agents|sensory system agents|mesh-ancestor
92334061|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
92756690|NCT02867800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756691|NCT02867800|Antipyretics|antipyretics|mesh-ancestor
92756692|NCT02867800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92756693|NCT02867800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92756694|NCT02867800|Antitubercular Agents|antitubercular agents|mesh-ancestor
92756695|NCT02867800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756696|NCT02867800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756697|NCT02867800|Antiemetics|antiemetics|mesh-ancestor
92756698|NCT02867800|Autonomic Agents|autonomic agents|mesh-ancestor
92756699|NCT02867800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92756700|NCT02867800|Glucocorticoids|glucocorticoids|mesh-ancestor
92756701|NCT02867800|Hormones|hormones|mesh-ancestor
92756702|NCT02867800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756703|NCT02867800|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92756704|NCT02867800|Protective Agents|protective agents|mesh-ancestor
92706633|NCT00550992|Hormones|hormones|mesh-ancestor
93060693|NCT01281514|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92756705|NCT02867800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92756706|NCT02867800|Alkylating Agents|alkylating agents|mesh-ancestor
92756707|NCT02867800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92756708|NCT02867800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92756709|NCT02867800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92756710|NCT02867800|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92756711|NCT02867800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92756712|NCT02867800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756713|NCT02867800|Anesthetics, Local|anesthetics, local|mesh-ancestor
92756714|NCT02867800|Anesthetics|anesthetics|mesh-ancestor
92756715|NCT02867800|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92756716|NCT02867800|Histamine Antagonists|histamine antagonists|mesh-ancestor
92756717|NCT02867800|Histamine Agents|histamine agents|mesh-ancestor
92756718|NCT02867800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756719|NCT02867800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92756720|NCT02867800|Antipruritics|antipruritics|mesh-ancestor
92756721|NCT02867800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92756722|NCT02867800|Narcotics|narcotics|mesh-ancestor
92756723|NCT02867800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92756724|NCT00629200|Interferons|interferons|mesh-list
92756725|NCT00629200|Interferon-alpha|interferon-alpha|mesh-list
92756726|NCT00629200|Interferon alpha-2|interferon alpha-2|mesh-list
92756727|NCT00629200|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92756728|NCT00629200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756729|NCT00629200|Antiviral Agents|antiviral agents|mesh-ancestor
92756730|NCT00629200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756731|NCT00629200|Immunologic Factors|immunologic factors|mesh-ancestor
92756732|NCT00629200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756733|NCT00629200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92756734|NCT00629200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92756735|NCT00629200|Schistosomicides|schistosomicides|mesh-ancestor
92756736|NCT00629200|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92756737|NCT00629200|Anthelmintics|anthelmintics|mesh-ancestor
92756738|NCT02867176|Ketorolac|ketorolac|mesh-list
92756739|NCT02867176|Gabapentin|gabapentin|mesh-list
92756740|NCT02867176|Analgesics|analgesics|mesh-ancestor
92756741|NCT02867176|Sensory System Agents|sensory system agents|mesh-ancestor
92756742|NCT02867176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756743|NCT02867176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756744|NCT02867176|Anticonvulsants|anticonvulsants|mesh-ancestor
92756745|NCT02867176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92756746|NCT02867176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756747|NCT02867176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756748|NCT02867176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92334084|NCT04225819|Vitamins|vitamins|mesh-ancestor
92756749|NCT02867176|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92756750|NCT02867176|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92756751|NCT02867176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756752|NCT02867176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756753|NCT02867176|Antimanic Agents|antimanic agents|mesh-ancestor
92756754|NCT02867176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92756755|NCT02867176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92756756|NCT02867176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756757|NCT02867176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756758|NCT02867176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92756759|NCT02867176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756760|NCT00982228|Insulin|insulin|mesh-list
92756761|NCT00982228|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92756762|NCT00982228|Insulin Glargine|insulin glargine|mesh-list
92756763|NCT00982228|Insulin Aspart|insulin aspart|mesh-list
92756764|NCT00982228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92756765|NCT00982228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756766|NCT02867956|Etoposide|etoposide|mesh-list
92756767|NCT02867956|Apatinib|apatinib|mesh-list
92756768|NCT02867956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92756769|NCT02867956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756770|NCT02867956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92756771|NCT02867956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92756772|NCT02867956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756773|NCT02867956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756774|NCT02867956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92756775|NCT04291066|Acetylcysteine|acetylcysteine|mesh-list
92756776|NCT04291066|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92756777|NCT04291066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756778|NCT04291066|Antiviral Agents|antiviral agents|mesh-ancestor
92756779|NCT04291066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756780|NCT04291066|Expectorants|expectorants|mesh-ancestor
92756781|NCT04291066|Respiratory System Agents|respiratory system agents|mesh-ancestor
92756782|NCT04291066|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92756783|NCT04291066|Antioxidants|antioxidants|mesh-ancestor
92756784|NCT04291066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756785|NCT04291066|Protective Agents|protective agents|mesh-ancestor
92756786|NCT04291066|Antidotes|antidotes|mesh-ancestor
92756787|NCT01260350|Sofosbuvir|sofosbuvir|mesh-list
92756788|NCT01260350|Antiviral Agents|antiviral agents|mesh-ancestor
92756789|NCT01260350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756790|NCT01260194|Trastuzumab|trastuzumab|mesh-list
92756791|NCT01260194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92756792|NCT01260194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756793|NCT00629278|Tamoxifen|tamoxifen|mesh-list
92756794|NCT00629278|Docetaxel|docetaxel|mesh-list
92756795|NCT00629278|Cyclophosphamide|cyclophosphamide|mesh-list
92756796|NCT00629278|Doxorubicin|doxorubicin|mesh-list
92756797|NCT00629278|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92756798|NCT00629278|Fluorouracil|fluorouracil|mesh-list
92756799|NCT00629278|Trastuzumab|trastuzumab|mesh-list
92756800|NCT00629278|Epirubicin|epirubicin|mesh-list
92756801|NCT00629278|Hormones|hormones|mesh-list
92756802|NCT00629278|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92756803|NCT00629278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756804|NCT00629278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92756805|NCT00629278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92756806|NCT00629278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92756807|NCT00629278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756808|NCT00629278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92756809|NCT00629278|Immunologic Factors|immunologic factors|mesh-ancestor
92756810|NCT00629278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756811|NCT00629278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92756812|NCT00629278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92756813|NCT00629278|Alkylating Agents|alkylating agents|mesh-ancestor
92756814|NCT00629278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92756815|NCT00629278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92756816|NCT00629278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92756817|NCT00629278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92756818|NCT00629278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756819|NCT00629278|Antimetabolites|antimetabolites|mesh-ancestor
92756820|NCT00629278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92756821|NCT00629278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92756822|NCT00629278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756823|NCT00629278|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92756824|NCT00629278|Hormone Antagonists|hormone antagonists|mesh-ancestor
92756825|NCT00629278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756826|NCT00629278|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92756827|NCT00629278|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92756828|NCT00629278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92756829|NCT00629278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92756830|NCT04207112|Moxifloxacin|moxifloxacin|mesh-list
92756831|NCT04207112|Linezolid|linezolid|mesh-list
92756832|NCT04207112|Bedaquiline|bedaquiline|mesh-list
92756833|NCT04207112|Clofazimine|clofazimine|mesh-list
92756834|NCT04207112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756835|NCT04207112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756836|NCT04207112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92756837|NCT04207112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92756838|NCT04207112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756839|NCT04207112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756840|NCT04207112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756841|NCT04207112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92756842|NCT04207112|Antitubercular Agents|antitubercular agents|mesh-ancestor
92756843|NCT04207112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756844|NCT04207112|Leprostatic Agents|leprostatic agents|mesh-ancestor
92756845|NCT01259492|Methylphenidate|methylphenidate|mesh-list
92756846|NCT01259492|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92756847|NCT01259492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756848|NCT01259492|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92756849|NCT01259492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92756850|NCT01259492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756851|NCT01259492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756852|NCT01259492|Dopamine Agents|dopamine agents|mesh-ancestor
92756853|NCT01259492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756854|NCT00624026|Memantine|memantine|mesh-list
92756855|NCT00624026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92756856|NCT00624026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92756857|NCT00624026|Dopamine Agents|dopamine agents|mesh-ancestor
92756858|NCT00624026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756859|NCT00624026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756860|NCT00624026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756861|NCT00624026|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92756862|NCT00624026|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92756863|NCT05512910|Minocycline|minocycline|mesh-list
92756864|NCT05512910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756865|NCT05512910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756867|NCT02888990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756868|NCT02888990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92756869|NCT02888990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756870|NCT02888990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756871|NCT05101928|Prednisone|prednisone|mesh-list
92756872|NCT05101928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756873|NCT05101928|Glucocorticoids|glucocorticoids|mesh-ancestor
92756874|NCT05101928|Hormones|hormones|mesh-ancestor
92756875|NCT05101928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756876|NCT05101928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756877|NCT05101928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756878|NCT05101928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756879|NCT04654052|Clopidogrel|clopidogrel|mesh-list
92756880|NCT04654052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92756881|NCT04654052|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92756882|NCT04654052|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92756883|NCT04654052|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92756884|NCT04654052|Purinergic Agents|purinergic agents|mesh-ancestor
92756885|NCT04654052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92756886|NCT04654052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756887|NCT04654052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756888|NCT05625308|Folic Acid|folic acid|mesh-list
92756889|NCT05625308|Vitamin B 12|vitamin b 12|mesh-list
92756890|NCT05625308|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92756891|NCT05625308|Hyaluronic Acid|hyaluronic acid|mesh-list
92756892|NCT05625308|Vitamins|vitamins|mesh-ancestor
92756893|NCT05625308|Micronutrients|micronutrients|mesh-ancestor
92756894|NCT05625308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756895|NCT05625308|Hematinics|hematinics|mesh-ancestor
92756896|NCT05625308|Vitamin B Complex|vitamin b complex|mesh-ancestor
92756897|NCT05625308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92756898|NCT05625308|Immunologic Factors|immunologic factors|mesh-ancestor
92756899|NCT05625308|Viscosupplements|viscosupplements|mesh-ancestor
92756900|NCT05625308|Protective Agents|protective agents|mesh-ancestor
92756901|NCT05625308|Antioxidants|antioxidants|mesh-ancestor
92756902|NCT05625308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756903|NCT05625308|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92756904|NCT05625308|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92756905|NCT05625308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756906|NCT05625308|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92756907|NCT04291664|Prednisone|prednisone|mesh-list
92756908|NCT04291664|Abiraterone Acetate|abiraterone acetate|mesh-list
92756909|NCT04291664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756910|NCT04291664|Glucocorticoids|glucocorticoids|mesh-ancestor
92756911|NCT04291664|Hormones|hormones|mesh-ancestor
92756912|NCT04291664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756913|NCT04291664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756914|NCT04291664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756915|NCT04291664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756916|NCT04291664|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92756917|NCT04291664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756918|NCT04291664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756919|NCT04291664|Hormone Antagonists|hormone antagonists|mesh-ancestor
92756920|NCT04291664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92756921|NCT04187469|Moxifloxacin|moxifloxacin|mesh-list
92756922|NCT04187469|Rifampin|rifampin|mesh-list
92756923|NCT04187469|Isoniazid|isoniazid|mesh-list
92756924|NCT04187469|Pyrazinamide|pyrazinamide|mesh-list
92756925|NCT04187469|Ethambutol|ethambutol|mesh-list
92756926|NCT04187469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92756927|NCT04187469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92756928|NCT04187469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92756929|NCT04187469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92756930|NCT04187469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706856|NCT01212094|Rituximab|rituximab|mesh-list
92706891|NCT01211665|Hormones|hormones|mesh-ancestor
93060694|NCT01281514|Everolimus|everolimus|mesh-list
92756931|NCT04187469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756932|NCT04187469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756933|NCT04187469|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92756934|NCT04187469|Antitubercular Agents|antitubercular agents|mesh-ancestor
92756935|NCT04187469|Leprostatic Agents|leprostatic agents|mesh-ancestor
92756936|NCT04187469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92756937|NCT04187469|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92756938|NCT04187469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92756939|NCT04187469|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92756940|NCT04187469|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92756941|NCT04187469|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92756942|NCT04187469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92756943|NCT04187469|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92756944|NCT04187469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92756945|NCT04187469|Antimetabolites|antimetabolites|mesh-ancestor
92756946|NCT04187469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92756947|NCT01116687|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92756948|NCT01116687|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92756949|NCT01116687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92756950|NCT01116687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756952|NCT02867020|Goserelin|goserelin|mesh-list
92756953|NCT02867020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756954|NCT02867020|Glucocorticoids|glucocorticoids|mesh-ancestor
92756955|NCT02867020|Hormones|hormones|mesh-ancestor
92756956|NCT02867020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756957|NCT02867020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756958|NCT02867020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756959|NCT02867020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756960|NCT03817502|Cariprazine|cariprazine|mesh-list
92756961|NCT03817502|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92756962|NCT03817502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92756963|NCT03817502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92756964|NCT03817502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756965|NCT03817502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92756966|NCT04319978|Dexamethasone|dexamethasone|mesh-list
92756967|NCT04319978|Dexamethasone acetate|dexamethasone acetate|mesh-list
92756968|NCT04319978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92756969|NCT04319978|Antiemetics|antiemetics|mesh-ancestor
92756970|NCT04319978|Autonomic Agents|autonomic agents|mesh-ancestor
92756971|NCT04319978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92756972|NCT04319978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756973|NCT04319978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92756974|NCT04319978|Glucocorticoids|glucocorticoids|mesh-ancestor
92756976|NCT04319978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92756977|NCT04319978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92756978|NCT04319978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756979|NCT01114737|Verapamil|verapamil|mesh-list
92756980|NCT01114737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92756981|NCT01114737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92756982|NCT01114737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92756983|NCT01114737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756984|NCT01114737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92756985|NCT01114737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756986|NCT01114737|Vasodilator Agents|vasodilator agents|mesh-ancestor
92756987|NCT00624182|Gemcitabine|gemcitabine|mesh-list
92756988|NCT00624182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92756989|NCT00624182|Antimetabolites|antimetabolites|mesh-ancestor
92756990|NCT00624182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92756991|NCT00624182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756992|NCT03304418|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92756993|NCT03304418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92756994|NCT00625677|Vaccines|vaccines|mesh-list
92756995|NCT00625677|Immunologic Factors|immunologic factors|mesh-ancestor
92756996|NCT00625677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92756997|NCT00979576|Pemetrexed|pemetrexed|mesh-list
92756998|NCT00979576|Nintedanib|nintedanib|mesh-list
92756999|NCT00979576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757000|NCT00979576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757001|NCT00979576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757002|NCT00979576|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92757003|NCT00979576|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92757004|NCT00979576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92757005|NCT02867332|Cyclophosphamide|cyclophosphamide|mesh-list
92757006|NCT02867332|Interleukin-2|interleukin-2|mesh-list
92757007|NCT02867332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757008|NCT02867332|Immunologic Factors|immunologic factors|mesh-ancestor
92757009|NCT02867332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757010|NCT02867332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757011|NCT02867332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92757012|NCT02867332|Alkylating Agents|alkylating agents|mesh-ancestor
92757013|NCT02867332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757014|NCT02867332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757015|NCT02867332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92757016|NCT02867332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757017|NCT02867332|Analgesics|analgesics|mesh-ancestor
92757018|NCT02867332|Sensory System Agents|sensory system agents|mesh-ancestor
92757019|NCT02867332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757020|NCT02702180|Molgramostim|molgramostim|mesh-list
92757021|NCT02702180|Sargramostim|sargramostim|mesh-list
92757022|NCT02702180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757023|NCT02702180|Immunologic Factors|immunologic factors|mesh-ancestor
92757024|NCT02702180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757025|NCT00980980|Chlorhexidine|chlorhexidine|mesh-list
92757026|NCT00980980|Mupirocin|mupirocin|mesh-list
92757027|NCT00980980|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92757028|NCT00980980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757029|NCT00980980|Disinfectants|disinfectants|mesh-ancestor
92757030|NCT00980980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92757031|NCT00980980|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92757032|NCT00980980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757033|NCT00980980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757034|NCT04128748|Cytarabine|cytarabine|mesh-list
92757035|NCT04128748|Daunorubicin|daunorubicin|mesh-list
92757036|NCT04128748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92757038|NCT04128748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757039|NCT04128748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757040|NCT04128748|Antiviral Agents|antiviral agents|mesh-ancestor
92757041|NCT04128748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757042|NCT04128748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757043|NCT04128748|Immunologic Factors|immunologic factors|mesh-ancestor
92757044|NCT04128748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757045|NCT04128748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92757046|NCT04128748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92757047|NCT04128748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92757048|NCT04128748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757049|NCT04116502|Interferons|interferons|mesh-list
92757050|NCT04116502|Interferon-alpha|interferon-alpha|mesh-list
92757051|NCT04116502|Interferon alpha-2|interferon alpha-2|mesh-list
92757052|NCT04116502|Hydroxyurea|hydroxyurea|mesh-list
92757053|NCT04116502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757054|NCT04116502|Antiviral Agents|antiviral agents|mesh-ancestor
92757055|NCT04116502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757056|NCT04116502|Immunologic Factors|immunologic factors|mesh-ancestor
92757057|NCT04116502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757058|NCT04116502|Antisickling Agents|antisickling agents|mesh-ancestor
92757059|NCT04116502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757060|NCT04116502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757061|NCT04116502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92757062|NCT04290442|Ropivacaine|ropivacaine|mesh-list
92757063|NCT04290442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92757064|NCT04290442|Anesthetics|anesthetics|mesh-ancestor
92757065|NCT04290442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757066|NCT04290442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757067|NCT04290442|Sensory System Agents|sensory system agents|mesh-ancestor
92757068|NCT04290442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757069|NCT02866786|Metformin|metformin|mesh-list
92757070|NCT02866786|Cyproterone Acetate|cyproterone acetate|mesh-list
92757071|NCT02866786|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92757072|NCT02866786|Estradiol|estradiol|mesh-list
92757073|NCT02866786|Cyproterone|cyproterone|mesh-list
92757074|NCT02866786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92757075|NCT02866786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757076|NCT02866786|Estrogens|estrogens|mesh-ancestor
92757077|NCT02866786|Hormones|hormones|mesh-ancestor
93060695|NCT01281514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757078|NCT02866786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757079|NCT02866786|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92757080|NCT02866786|Contraceptive Agents|contraceptive agents|mesh-ancestor
92757081|NCT02866786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757082|NCT02866786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92757083|NCT02866786|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92757084|NCT02866786|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92757085|NCT02866786|Androgen Antagonists|androgen antagonists|mesh-ancestor
92757086|NCT02866786|Hormone Antagonists|hormone antagonists|mesh-ancestor
92757087|NCT02866786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757088|NCT02866786|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92757089|NCT00979654|Sifalimumab|sifalimumab|mesh-list
92757090|NCT00979654|Immunologic Factors|immunologic factors|mesh-ancestor
92757091|NCT00979654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757092|NCT00978562|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92757093|NCT00978562|Hematinics|hematinics|mesh-ancestor
92757094|NCT00978562|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92757095|NCT00978562|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92757096|NCT04289974|Fulvestrant|fulvestrant|mesh-list
92757097|NCT04289974|Palbociclib|palbociclib|mesh-list
92757098|NCT04289974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757099|NCT04289974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757100|NCT04289974|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92757101|NCT04289974|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92757102|NCT04289974|Hormone Antagonists|hormone antagonists|mesh-ancestor
92757103|NCT04289974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757104|NCT04289974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757105|NCT04289974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92757106|NCT04289974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757107|NCT04289974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757108|NCT02865616|Vancomycin|vancomycin|mesh-list
92757109|NCT02865616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92757110|NCT02865616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757111|NCT02865460|Coenzyme Q10|coenzyme q10|mesh-list
92757112|NCT02865460|Micronutrients|micronutrients|mesh-ancestor
92757113|NCT02865460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757115|NCT01206816|Afatinib|afatinib|mesh-list
92757116|NCT01206816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757117|NCT01206816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92757118|NCT01206816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757119|NCT01206816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757120|NCT01259102|Buprenorphine|buprenorphine|mesh-list
92757121|NCT01259102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92757122|NCT01259102|Narcotics|narcotics|mesh-ancestor
92757123|NCT01259102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757124|NCT01259102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757125|NCT01259102|Analgesics|analgesics|mesh-ancestor
92757126|NCT01259102|Sensory System Agents|sensory system agents|mesh-ancestor
92757127|NCT01259102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757128|NCT01259102|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92757129|NCT00978250|Tetrahydrouridine|tetrahydrouridine|mesh-list
92757130|NCT00978250|Antimetabolites|antimetabolites|mesh-ancestor
92757131|NCT00978250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757132|NCT01259024|Chlorotrianisene|chlorotrianisene|mesh-list
92757133|NCT01259024|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92757134|NCT01259024|Estrogens|estrogens|mesh-ancestor
92757135|NCT01259024|Hormones|hormones|mesh-ancestor
92757136|NCT01259024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757137|NCT01259024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757138|NCT01259024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757139|NCT01259024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757140|NCT04319900|Chloroquine|chloroquine|mesh-list
92757141|NCT04319900|Favipiravir|favipiravir|mesh-list
92757142|NCT04319900|Amebicides|amebicides|mesh-ancestor
92757143|NCT04319900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92757144|NCT04319900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92757145|NCT04319900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757146|NCT04319900|Antimalarials|antimalarials|mesh-ancestor
92757147|NCT04319900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757148|NCT04319900|Antiviral Agents|antiviral agents|mesh-ancestor
92757149|NCT01257698|Timolol|timolol|mesh-list
92757150|NCT01257698|Dorzolamide|dorzolamide|mesh-list
92757151|NCT01257698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92757152|NCT01257698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92757153|NCT01257698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92757154|NCT01257698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757155|NCT01257698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757156|NCT01257698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757157|NCT01257698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757158|NCT01257698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92757159|NCT01257698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757160|NCT01257698|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92757161|NCT01257698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757162|NCT01257698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92757163|NCT01257542|Dextromethorphan|dextromethorphan|mesh-list
92757164|NCT01257542|Antitussive Agents|antitussive agents|mesh-ancestor
92757165|NCT01257542|Respiratory System Agents|respiratory system agents|mesh-ancestor
92757166|NCT01257542|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92757167|NCT01257542|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92757168|NCT01257542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757169|NCT01257542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757170|NCT01257542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757171|NCT01257230|Tiotropium Bromide|tiotropium bromide|mesh-list
92757172|NCT01257230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92757173|NCT01257230|Autonomic Agents|autonomic agents|mesh-ancestor
92757174|NCT01257230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757175|NCT01257230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757176|NCT01257230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92757177|NCT01257230|Respiratory System Agents|respiratory system agents|mesh-ancestor
92757178|NCT01257230|Parasympatholytics|parasympatholytics|mesh-ancestor
92757179|NCT01257230|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92757180|NCT01257230|Cholinergic Agents|cholinergic agents|mesh-ancestor
92757181|NCT01257230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757182|NCT01257230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757183|NCT01256684|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92757184|NCT01256684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92757185|NCT01256684|Immunologic Factors|immunologic factors|mesh-ancestor
92757186|NCT01256684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757187|NCT01204710|Prednisone|prednisone|mesh-list
92757188|NCT01204710|Mitoxantrone|mitoxantrone|mesh-list
92757189|NCT01204710|Olaratumab|olaratumab|mesh-list
92757190|NCT01204710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92757191|NCT01204710|Glucocorticoids|glucocorticoids|mesh-ancestor
92757192|NCT01204710|Hormones|hormones|mesh-ancestor
92757193|NCT01204710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757194|NCT01204710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757195|NCT01204710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757196|NCT01204710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757197|NCT01204710|Analgesics|analgesics|mesh-ancestor
92757198|NCT01204710|Sensory System Agents|sensory system agents|mesh-ancestor
92757199|NCT01204710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757200|NCT01204710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92757201|NCT01204710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92757202|NCT01204710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334159|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92757203|NCT01204710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757204|NCT01256450|Buprenorphine|buprenorphine|mesh-list
92757205|NCT01256450|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92757206|NCT01256450|Narcotics|narcotics|mesh-ancestor
92757207|NCT01256450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757208|NCT01256450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757209|NCT01256450|Analgesics|analgesics|mesh-ancestor
92757210|NCT01256450|Sensory System Agents|sensory system agents|mesh-ancestor
92757211|NCT01256450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757212|NCT01256450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92757213|NCT01204398|Amlodipine|amlodipine|mesh-list
92757214|NCT01204398|Telmisartan|telmisartan|mesh-list
92757215|NCT01204398|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92757216|NCT01204398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757217|NCT01204398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92757218|NCT01204398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757219|NCT01204398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757220|NCT01204398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92757221|NCT01204398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757222|NCT01204398|Vasodilator Agents|vasodilator agents|mesh-ancestor
92757223|NCT01204398|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92757224|NCT01204398|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92757225|NCT01111851|Dexamethasone|dexamethasone|mesh-list
92757226|NCT01111851|Dexamethasone acetate|dexamethasone acetate|mesh-list
92757228|NCT01111851|Aprepitant|aprepitant|mesh-list
92757229|NCT01111851|Fosaprepitant|fosaprepitant|mesh-list
92757230|NCT01111851|BB 1101|bb 1101|mesh-list
92757231|NCT01111851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92757232|NCT01111851|Antiemetics|antiemetics|mesh-ancestor
92757233|NCT01111851|Autonomic Agents|autonomic agents|mesh-ancestor
92757234|NCT01111851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757235|NCT01111851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757236|NCT01111851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92757237|NCT01111851|Glucocorticoids|glucocorticoids|mesh-ancestor
92757238|NCT01111851|Hormones|hormones|mesh-ancestor
92757239|NCT01111851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757240|NCT01111851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757241|NCT01111851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757242|NCT01111851|Protease Inhibitors|protease inhibitors|mesh-ancestor
92757243|NCT01111851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757244|NCT01111851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757245|NCT01111851|Antipruritics|antipruritics|mesh-ancestor
92757246|NCT01111851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92757247|NCT01111851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92757248|NCT01111851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92757249|NCT01111851|Serotonin Agents|serotonin agents|mesh-ancestor
92757250|NCT01111851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757251|NCT01111851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92757252|NCT01256294|Tacrolimus|tacrolimus|mesh-list
92757253|NCT01256294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757254|NCT01256294|Immunologic Factors|immunologic factors|mesh-ancestor
92757255|NCT01256294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757256|NCT01256294|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92757257|NCT01256294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757258|NCT01256294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757260|NCT01256060|Oxytocics|oxytocics|mesh-ancestor
92757261|NCT01256060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757262|NCT01256060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757263|NCT01255904|Dexmedetomidine|dexmedetomidine|mesh-list
92757264|NCT01255904|Chloral Hydrate|chloral hydrate|mesh-list
92757265|NCT01255904|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92757266|NCT01255904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757267|NCT01255904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757268|NCT01255904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757269|NCT01255904|Analgesics|analgesics|mesh-ancestor
92757270|NCT01255904|Sensory System Agents|sensory system agents|mesh-ancestor
92334165|NCT00003925|Tegafur|tegafur|mesh-list
92757271|NCT01255904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757272|NCT01255904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92757273|NCT01255904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92757274|NCT01255904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92757275|NCT01255904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757276|NCT01255904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757277|NCT01255904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757278|NCT01255670|Metronidazole|metronidazole|mesh-list
92757279|NCT01255670|Penicillins|penicillins|mesh-list
92757280|NCT01255670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757281|NCT01255670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92757282|NCT01255670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92757283|NCT01255670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92757284|NCT01203930|Rituximab|rituximab|mesh-list
92757285|NCT01203930|Idelalisib|idelalisib|mesh-list
92757286|NCT01203930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92757287|NCT01203930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757288|NCT01203930|Immunologic Factors|immunologic factors|mesh-ancestor
92757289|NCT01203930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757290|NCT01203930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757291|NCT01203930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757292|NCT01203930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757293|NCT01254890|Azacitidine|azacitidine|mesh-list
92757294|NCT01254890|Sorafenib|sorafenib|mesh-list
92757295|NCT01254890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92757296|NCT01254890|Antimetabolites|antimetabolites|mesh-ancestor
92757297|NCT01254890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757298|NCT01254890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757299|NCT01254890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757300|NCT01254890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92757301|NCT01203852|Metoprolol|metoprolol|mesh-list
92757302|NCT01203852|Chlorthalidone|chlorthalidone|mesh-list
92757303|NCT01203852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92757304|NCT01203852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757305|NCT01203852|Sympatholytics|sympatholytics|mesh-ancestor
92757306|NCT01203852|Autonomic Agents|autonomic agents|mesh-ancestor
92757307|NCT01203852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757308|NCT01203852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757309|NCT01203852|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92757310|NCT01203852|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92757311|NCT01203852|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92757312|NCT01203852|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757313|NCT01203852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757314|NCT01203852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757315|NCT01203852|Diuretics|diuretics|mesh-ancestor
92757316|NCT01203852|Natriuretic Agents|natriuretic agents|mesh-ancestor
92757317|NCT01203852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92757318|NCT01203852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757320|NCT01203072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92757321|NCT01203072|Antithrombins|antithrombins|mesh-ancestor
92757322|NCT01203072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92757323|NCT01203072|Protease Inhibitors|protease inhibitors|mesh-ancestor
92757324|NCT01203072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757325|NCT01203072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757326|NCT01203072|Anticoagulants|anticoagulants|mesh-ancestor
92757327|NCT01105377|Azacitidine|azacitidine|mesh-list
92757328|NCT01105377|Entinostat|entinostat|mesh-list
92757329|NCT01105377|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92757330|NCT01105377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334183|NCT00004255|Tacrolimus|tacrolimus|mesh-list
92757331|NCT01105377|Antimetabolites|antimetabolites|mesh-ancestor
92757332|NCT01105377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757333|NCT01105377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757334|NCT01105377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757335|NCT01105065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92757336|NCT01105065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757337|NCT01105065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92757338|NCT01105065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92757339|NCT01105065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92757340|NCT01105065|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757341|NCT01105065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757342|NCT01105065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757343|NCT01105065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757345|NCT01111539|Escitalopram|escitalopram|mesh-list
92757346|NCT01111539|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92757347|NCT01111539|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92757348|NCT01111539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757349|NCT01111539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757350|NCT01111539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757351|NCT01111539|Serotonin Agents|serotonin agents|mesh-ancestor
92757352|NCT01111539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757353|NCT01111539|Antidepressive Agents|antidepressive agents|mesh-ancestor
92757354|NCT01111539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757355|NCT01111539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92757356|NCT01111539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92757357|NCT01111539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757358|NCT01111539|Dopamine Agonists|dopamine agonists|mesh-ancestor
92757359|NCT01111539|Dopamine Agents|dopamine agents|mesh-ancestor
92757360|NCT01111539|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92757361|NCT01111539|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92757362|NCT01111539|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92757363|NCT01111539|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92757364|NCT01111539|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92757365|NCT01111539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92757366|NCT02880345|Pembrolizumab|pembrolizumab|mesh-list
92757367|NCT02880345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92757368|NCT02880345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757369|NCT02880345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92757370|NCT02880345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757371|NCT02879955|Acarbose|acarbose|mesh-list
92757372|NCT02879955|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92757373|NCT02879955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757374|NCT02879955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757375|NCT02879955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92757376|NCT02879955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757378|NCT02880033|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92757379|NCT02880033|Chelating Agents|chelating agents|mesh-ancestor
92757380|NCT02880033|Sequestering Agents|sequestering agents|mesh-ancestor
92757381|NCT02880033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757382|NCT00625911|Ketamine|ketamine|mesh-list
92757383|NCT00625911|Morphine|morphine|mesh-list
92757384|NCT00625911|Analgesics|analgesics|mesh-ancestor
92757385|NCT00625911|Sensory System Agents|sensory system agents|mesh-ancestor
92757386|NCT00625911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757387|NCT00625911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757388|NCT00625911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92757389|NCT00625911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92757390|NCT00625911|Anesthetics, General|anesthetics, general|mesh-ancestor
92757391|NCT00625911|Anesthetics|anesthetics|mesh-ancestor
92757392|NCT00625911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986739|NCT02355197|Ascorbic Acid|ascorbic acid|mesh-list
92757393|NCT00625911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92757394|NCT00625911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92757395|NCT00625911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757396|NCT00625911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757397|NCT00625911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92757398|NCT00625911|Narcotics|narcotics|mesh-ancestor
92757399|NCT01111149|Bupropion|bupropion|mesh-list
92757400|NCT01111149|Varenicline|varenicline|mesh-list
92757401|NCT01111149|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92757402|NCT01111149|Antidepressive Agents|antidepressive agents|mesh-ancestor
92757403|NCT01111149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757404|NCT01111149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92757405|NCT01111149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92757406|NCT01111149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757407|NCT01111149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757408|NCT01111149|Dopamine Agents|dopamine agents|mesh-ancestor
92757409|NCT01111149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757410|NCT01111149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757411|NCT01111149|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92757412|NCT01111149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92757413|NCT01111149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757414|NCT01111149|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92757415|NCT01111149|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92757416|NCT01111149|Cholinergic Agents|cholinergic agents|mesh-ancestor
92757417|NCT01254656|Efavirenz|efavirenz|mesh-list
92757418|NCT01254656|Etravirine|etravirine|mesh-list
92757419|NCT01254656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92757420|NCT01254656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92757421|NCT01254656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757422|NCT01254656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757423|NCT01254656|Antiviral Agents|antiviral agents|mesh-ancestor
92757424|NCT01254656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757425|NCT01254656|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92757426|NCT01254656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92757427|NCT01254656|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92757428|NCT01254656|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92757429|NCT01254656|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92757430|NCT01254656|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92757431|NCT01254344|Metronidazole|metronidazole|mesh-list
92757432|NCT01254344|Ceftriaxone|ceftriaxone|mesh-list
92757433|NCT01254344|Ertapenem|ertapenem|mesh-list
92757434|NCT01254344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757435|NCT01254344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92757436|NCT01254344|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92757437|NCT01254344|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92757438|NCT05051007|Lidocaine|lidocaine|mesh-list
92757439|NCT05051007|Fentanyl|fentanyl|mesh-list
92757440|NCT05051007|Anesthetics, Local|anesthetics, local|mesh-ancestor
92757441|NCT05051007|Anesthetics|anesthetics|mesh-ancestor
92757442|NCT05051007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757443|NCT05051007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757444|NCT05051007|Sensory System Agents|sensory system agents|mesh-ancestor
92757445|NCT05051007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757446|NCT05051007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92757447|NCT05051007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92707380|NCT03147612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92757448|NCT05051007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92757449|NCT05051007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757450|NCT05051007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757451|NCT05051007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92757452|NCT05051007|Narcotics|narcotics|mesh-ancestor
92757453|NCT05051007|Analgesics|analgesics|mesh-ancestor
92757454|NCT05051007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92757455|NCT05051007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92757456|NCT05051007|Anesthetics, General|anesthetics, general|mesh-ancestor
92757457|NCT01102803|Cycloserine|cycloserine|mesh-list
92757458|NCT01102803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92757459|NCT01102803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757460|NCT01102803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92757461|NCT01102803|Antitubercular Agents|antitubercular agents|mesh-ancestor
92757462|NCT01102803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92757463|NCT01102803|Antimetabolites|antimetabolites|mesh-ancestor
92757464|NCT01102803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757465|NCT01109979|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92757466|NCT01109979|Drospirenone|drospirenone|mesh-list
92757467|NCT01109979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92757468|NCT01109979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92757469|NCT01109979|Medroxyprogesterone|medroxyprogesterone|mesh-list
92757470|NCT01109979|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92757471|NCT01109979|Estradiol|estradiol|mesh-list
92757472|NCT01109979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92757473|NCT01109979|Estrogens|estrogens|mesh-ancestor
92757474|NCT01109979|Hormones|hormones|mesh-ancestor
92757475|NCT01109979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757476|NCT01109979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757477|NCT01109979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92757478|NCT01109979|Contraceptive Agents|contraceptive agents|mesh-ancestor
92757479|NCT01109979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757480|NCT01109979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92757481|NCT01109979|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92757482|NCT01109979|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92757483|NCT01109979|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92757484|NCT01109979|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92757485|NCT01109979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757486|NCT01109979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757487|NCT01109979|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92757488|NCT01109979|Hormone Antagonists|hormone antagonists|mesh-ancestor
92757489|NCT01109979|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92757490|NCT01109979|Diuretics|diuretics|mesh-ancestor
92757491|NCT01109979|Natriuretic Agents|natriuretic agents|mesh-ancestor
92757492|NCT01102491|Ramosetron|ramosetron|mesh-list
92757493|NCT01102491|Antiemetics|antiemetics|mesh-ancestor
92757494|NCT01102491|Autonomic Agents|autonomic agents|mesh-ancestor
92757495|NCT01102491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757496|NCT01102491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757497|NCT01102491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92757498|NCT01102491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92757499|NCT01102491|Serotonin Agents|serotonin agents|mesh-ancestor
92757500|NCT01102491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757501|NCT01102491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757502|NCT01108809|Telmisartan|telmisartan|mesh-list
92757503|NCT01108809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757504|NCT01108809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92757505|NCT01108809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92757506|NCT01108809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757507|NCT01253408|Dronabinol|dronabinol|mesh-list
92757508|NCT01253408|Hallucinogens|hallucinogens|mesh-ancestor
92757509|NCT01253408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757510|NCT01253408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757511|NCT01253408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757512|NCT01253408|Analgesics|analgesics|mesh-ancestor
92757513|NCT01253408|Sensory System Agents|sensory system agents|mesh-ancestor
92757514|NCT01253408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757515|NCT01253408|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92757516|NCT01253408|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92757517|NCT01253408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757518|NCT01253408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757519|NCT01253408|Hormones|hormones|mesh-ancestor
92757520|NCT01253408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757522|NCT05506982|Hallucinogens|hallucinogens|mesh-ancestor
92757523|NCT05506982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757524|NCT05506982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757525|NCT02879643|Vincristine|vincristine|mesh-list
92757526|NCT02879643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92757527|NCT02879643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757528|NCT02879643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92757529|NCT02879643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92757530|NCT02879643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92757531|NCT02879643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757532|NCT02879721|Candesartan|candesartan|mesh-list
92757533|NCT02879721|Candesartan cilexetil|candesartan cilexetil|mesh-list
92757534|NCT02879721|Enalapril|enalapril|mesh-list
92757535|NCT02879721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757536|NCT02879721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92757537|NCT02879721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92757538|NCT02879721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757539|NCT02879721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92757540|NCT02879721|Protease Inhibitors|protease inhibitors|mesh-ancestor
92757541|NCT02879721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757542|NCT01253174|Tetrahydrofolates|tetrahydrofolates|mesh-list
92757543|NCT01253174|Drospirenone|drospirenone|mesh-list
92757544|NCT01253174|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92757545|NCT01253174|Hormone Antagonists|hormone antagonists|mesh-ancestor
92757546|NCT01253174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757547|NCT01253174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757548|NCT01253174|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92757549|NCT01253174|Diuretics|diuretics|mesh-ancestor
92757550|NCT01253174|Natriuretic Agents|natriuretic agents|mesh-ancestor
92757551|NCT01253174|Vitamin B Complex|vitamin b complex|mesh-ancestor
92757552|NCT01253174|Vitamins|vitamins|mesh-ancestor
92757553|NCT01253174|Micronutrients|micronutrients|mesh-ancestor
92757554|NCT01108731|Milnacipran|milnacipran|mesh-list
92757555|NCT01108731|Levomilnacipran|levomilnacipran|mesh-list
92757556|NCT01108731|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92757557|NCT01108731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92757558|NCT01108731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757559|NCT01108731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757560|NCT01108731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757561|NCT01108731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757562|NCT01108731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757563|NCT01108731|Analgesics|analgesics|mesh-ancestor
92757564|NCT01108731|Sensory System Agents|sensory system agents|mesh-ancestor
92757565|NCT01108731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757566|NCT01108731|Antidepressive Agents|antidepressive agents|mesh-ancestor
92757567|NCT01108731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757568|NCT04308525|Analgesics, Opioid|analgesics, opioid|mesh-list
92757569|NCT04308525|Narcotics|narcotics|mesh-ancestor
92757570|NCT04308525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757571|NCT04308525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757572|NCT04308525|Analgesics|analgesics|mesh-ancestor
92757573|NCT04308525|Sensory System Agents|sensory system agents|mesh-ancestor
92757574|NCT04308525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757575|NCT01108341|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92757576|NCT01108341|Ofatumumab|ofatumumab|mesh-list
92757577|NCT01108341|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92757578|NCT01108341|Alkylating Agents|alkylating agents|mesh-ancestor
92757579|NCT01108341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757580|NCT01108341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757581|NCT01252940|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
92757582|NCT01252940|Antiviral Agents|antiviral agents|mesh-ancestor
92757583|NCT01252940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757584|NCT01252940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92757585|NCT01252940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92757586|NCT01252940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757587|NCT01252940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757588|NCT01252940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92757589|NCT01252940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92757590|NCT01252238|Amlodipine|amlodipine|mesh-list
92757591|NCT01252238|Valsartan|valsartan|mesh-list
92757592|NCT01252238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757593|NCT01252238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92757594|NCT01252238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757595|NCT01252238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757596|NCT01252238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92757597|NCT01252238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757598|NCT01252238|Vasodilator Agents|vasodilator agents|mesh-ancestor
92757599|NCT01252238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92757600|NCT01252238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92757601|NCT01101321|Oxycodone|oxycodone|mesh-list
92757602|NCT01101321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92757603|NCT01101321|Narcotics|narcotics|mesh-ancestor
92757604|NCT01101321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757605|NCT01101321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757606|NCT01101321|Analgesics|analgesics|mesh-ancestor
92757607|NCT01101321|Sensory System Agents|sensory system agents|mesh-ancestor
92757608|NCT01101321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757609|NCT04309929|Analgesics|analgesics|mesh-list
92757610|NCT04309929|Sensory System Agents|sensory system agents|mesh-ancestor
92757611|NCT04309929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757612|NCT04309929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757613|NCT01101165|Oxycodone|oxycodone|mesh-list
92757614|NCT01101165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92757615|NCT01101165|Narcotics|narcotics|mesh-ancestor
92757616|NCT01101165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757617|NCT01101165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757618|NCT01101165|Analgesics|analgesics|mesh-ancestor
92757619|NCT01101165|Sensory System Agents|sensory system agents|mesh-ancestor
92757620|NCT01101165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757621|NCT01100853|Naltrexone|naltrexone|mesh-list
92757622|NCT01100853|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92757623|NCT01100853|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92757624|NCT01100853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757625|NCT01100853|Sensory System Agents|sensory system agents|mesh-ancestor
92757626|NCT01100853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757628|NCT02879097|Carboplatin|carboplatin|mesh-list
92757629|NCT02879097|Bevacizumab|bevacizumab|mesh-list
92757630|NCT02879097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92757631|NCT02879097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757632|NCT02879097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92757633|NCT02879097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92757634|NCT02879097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92757635|NCT02879097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757636|NCT02879097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92757637|NCT02879097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92757638|NCT02879097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92757639|NCT02879097|Growth Substances|growth substances|mesh-ancestor
92757640|NCT02879097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757641|NCT02879097|Growth Inhibitors|growth inhibitors|mesh-ancestor
92757642|NCT02878863|Peoniflorin|peoniflorin|mesh-list
92757643|NCT02878863|Silymarin|silymarin|mesh-list
92757644|NCT02878863|Antioxidants|antioxidants|mesh-ancestor
92757645|NCT02878863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757646|NCT02878863|Protective Agents|protective agents|mesh-ancestor
92757647|NCT02878863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757648|NCT02878863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92757649|NCT02878863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757650|NCT02878863|Analgesics|analgesics|mesh-ancestor
92757651|NCT02878863|Sensory System Agents|sensory system agents|mesh-ancestor
92757652|NCT02878863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757653|NCT02878863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92757654|NCT02878863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757655|NCT02881125|Paclitaxel|paclitaxel|mesh-list
92757656|NCT02881125|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92757657|NCT02881125|Nortriptyline|nortriptyline|mesh-list
92757658|NCT02881125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92757659|NCT02881125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757660|NCT02881125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92757661|NCT02881125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92757662|NCT02881125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92757663|NCT02881125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757664|NCT02881125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92757665|NCT02881125|Antidepressive Agents|antidepressive agents|mesh-ancestor
92757666|NCT02881125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757667|NCT02881125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92707602|NCT02529852|Hormones|hormones|mesh-ancestor
92757668|NCT02881125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92757669|NCT02881125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757671|NCT02881125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757672|NCT02881125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757673|NCT01107405|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92757674|NCT01107405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92757675|NCT01097577|Pregabalin|pregabalin|mesh-list
92757676|NCT01097577|Analgesics|analgesics|mesh-ancestor
92757677|NCT01097577|Sensory System Agents|sensory system agents|mesh-ancestor
92757678|NCT01097577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757679|NCT01097577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757680|NCT01097577|Anticonvulsants|anticonvulsants|mesh-ancestor
92757681|NCT01097577|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92757682|NCT01097577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757683|NCT01097577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757684|NCT01097577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92757685|NCT01097577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92757686|NCT01097577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92757687|NCT01097577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757688|NCT01097577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92757689|NCT01097421|Pramipexole|pramipexole|mesh-list
92757690|NCT01097421|Antioxidants|antioxidants|mesh-ancestor
92757691|NCT01097421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757692|NCT01097421|Protective Agents|protective agents|mesh-ancestor
92757693|NCT01097421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757694|NCT01097421|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92757695|NCT01097421|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92757696|NCT01097421|Dopamine Agonists|dopamine agonists|mesh-ancestor
92757698|NCT01097421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757699|NCT01251614|Adalimumab|adalimumab|mesh-list
92757700|NCT01251614|Methotrexate|methotrexate|mesh-list
92757701|NCT01251614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92757702|NCT01251614|Abortifacient Agents|abortifacient agents|mesh-ancestor
92757703|NCT01251614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757704|NCT01251614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757705|NCT01251614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92757706|NCT01251614|Antimetabolites|antimetabolites|mesh-ancestor
92757707|NCT01251614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757708|NCT01251614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757709|NCT01251614|Dermatologic Agents|dermatologic agents|mesh-ancestor
92757710|NCT01251614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757711|NCT01251614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92757712|NCT01251614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757713|NCT01251614|Immunologic Factors|immunologic factors|mesh-ancestor
92757714|NCT01251614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757715|NCT01251614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92757716|NCT01251614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92757717|NCT01251614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92757718|NCT01106625|Metformin|metformin|mesh-list
92757719|NCT01106625|Canagliflozin|canagliflozin|mesh-list
92757720|NCT01106625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92757721|NCT01106625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757722|NCT01106625|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92757723|NCT01106625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757724|NCT01251380|Botulinum Toxins|botulinum toxins|mesh-list
92757725|NCT01251380|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92757726|NCT01251380|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92757727|NCT01251380|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92757728|NCT01251380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92757729|NCT01251380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757730|NCT01251380|Cholinergic Agents|cholinergic agents|mesh-ancestor
92757731|NCT01251380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757732|NCT01251380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757733|NCT01251380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92757734|NCT01251380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757735|NCT01251146|Atenolol|atenolol|mesh-list
92757736|NCT01251146|Bisoprolol|bisoprolol|mesh-list
92757737|NCT01251146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92757738|NCT01251146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92757739|NCT01251146|Sympatholytics|sympatholytics|mesh-ancestor
92757740|NCT01251146|Autonomic Agents|autonomic agents|mesh-ancestor
92707679|NCT01209949|Adapalene|adapalene|mesh-list
92757741|NCT01251146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757742|NCT01251146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757743|NCT01251146|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92757745|NCT01251146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92757746|NCT01251146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757747|NCT01251146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757748|NCT01251146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757749|NCT02878707|Dexmedetomidine|dexmedetomidine|mesh-list
92757750|NCT02878707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92757751|NCT02878707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92757752|NCT02878707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757753|NCT02878707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757754|NCT02878707|Analgesics|analgesics|mesh-ancestor
92757755|NCT02878707|Sensory System Agents|sensory system agents|mesh-ancestor
92757756|NCT02878707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757757|NCT02878707|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92757758|NCT02878707|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92757759|NCT02878707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92757760|NCT02878707|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757761|NCT02878707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757762|NCT02878707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757763|NCT01096017|Albuterol|albuterol|mesh-list
92757764|NCT01096017|Terbutaline|terbutaline|mesh-list
92757765|NCT01096017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92757766|NCT01096017|Autonomic Agents|autonomic agents|mesh-ancestor
92757767|NCT01096017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102480|NCT03399474|Lidocaine|lidocaine|mesh-list
92757768|NCT01096017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757769|NCT01096017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92757770|NCT01096017|Respiratory System Agents|respiratory system agents|mesh-ancestor
92757772|NCT01096017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757773|NCT01096017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92757774|NCT01096017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92757775|NCT01096017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92757776|NCT01096017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757777|NCT01096017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757778|NCT01096017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757779|NCT01096017|Sympathomimetics|sympathomimetics|mesh-ancestor
92757780|NCT00626223|Folic Acid|folic acid|mesh-list
92757781|NCT00626223|Hematinics|hematinics|mesh-ancestor
92757782|NCT00626223|Vitamin B Complex|vitamin b complex|mesh-ancestor
92757783|NCT00626223|Vitamins|vitamins|mesh-ancestor
92757784|NCT00626223|Micronutrients|micronutrients|mesh-ancestor
92757785|NCT00626223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757786|NCT01106157|Thymoglobulin|thymoglobulin|mesh-list
92757787|NCT01106157|Immunologic Factors|immunologic factors|mesh-ancestor
92757788|NCT01106157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757789|NCT01106157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757790|NCT04828005|Naloxone|naloxone|mesh-list
92757791|NCT04828005|Nalmefene|nalmefene|mesh-list
92757792|NCT04828005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92757793|NCT04828005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757794|NCT04828005|Sensory System Agents|sensory system agents|mesh-ancestor
92757795|NCT04828005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757796|NCT02878161|Prednisone|prednisone|mesh-list
92757797|NCT02878161|Methylprednisolone|methylprednisolone|mesh-list
92757798|NCT02878161|Adalimumab|adalimumab|mesh-list
92757799|NCT02878161|Infliximab|infliximab|mesh-list
92757800|NCT02878161|Etanercept|etanercept|mesh-list
92757801|NCT02878161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92757802|NCT02878161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92757803|NCT02878161|Methotrexate|methotrexate|mesh-list
92757804|NCT02878161|Glucocorticoids|glucocorticoids|mesh-list
92757805|NCT02878161|Leflunomide|leflunomide|mesh-list
92757806|NCT02878161|Hormones|hormones|mesh-ancestor
92757807|NCT02878161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757808|NCT02878161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757809|NCT02878161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757810|NCT02878161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757811|NCT02878161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92757812|NCT02878161|Abortifacient Agents|abortifacient agents|mesh-ancestor
92757813|NCT02878161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757814|NCT02878161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92757815|NCT02878161|Antimetabolites|antimetabolites|mesh-ancestor
92757816|NCT02878161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757817|NCT02878161|Dermatologic Agents|dermatologic agents|mesh-ancestor
92757818|NCT02878161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757819|NCT02878161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92757820|NCT02878161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757821|NCT02878161|Immunologic Factors|immunologic factors|mesh-ancestor
92757822|NCT02878161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757823|NCT02878161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92757824|NCT02878161|Antiemetics|antiemetics|mesh-ancestor
92757825|NCT02878161|Autonomic Agents|autonomic agents|mesh-ancestor
92757826|NCT02878161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757827|NCT02878161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92757828|NCT02878161|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92757829|NCT02878161|Protective Agents|protective agents|mesh-ancestor
92757830|NCT02878161|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92757831|NCT02878161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757832|NCT02878161|Analgesics|analgesics|mesh-ancestor
92757833|NCT02878161|Sensory System Agents|sensory system agents|mesh-ancestor
92757834|NCT01093755|Omeprazole|omeprazole|mesh-list
92757835|NCT01093755|Dexlansoprazole|dexlansoprazole|mesh-list
92757836|NCT01093755|Lansoprazole|lansoprazole|mesh-list
92757837|NCT01093755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92757838|NCT01093755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92757839|NCT01093755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92757840|NCT01093755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757841|NCT01093755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757842|NCT01092663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92757843|NCT01092663|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92757844|NCT01092663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92757845|NCT01092663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757846|NCT01092663|Incretins|incretins|mesh-ancestor
92757847|NCT01092663|Hormones|hormones|mesh-ancestor
92757848|NCT01092663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757849|NCT01092663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92757850|NCT01092663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92334261|NCT00004861|Gemcitabine|gemcitabine|mesh-list
92757851|NCT01092663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757852|NCT01092663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757853|NCT01092663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92757854|NCT01092663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92757855|NCT01092663|Antimetabolites|antimetabolites|mesh-ancestor
92757856|NCT01092663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92757857|NCT01078623|Formoterol Fumarate|formoterol fumarate|mesh-list
92757858|NCT01078623|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92757859|NCT01078623|Autonomic Agents|autonomic agents|mesh-ancestor
92757860|NCT01078623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757861|NCT01078623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757862|NCT01078623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92757863|NCT01078623|Respiratory System Agents|respiratory system agents|mesh-ancestor
92757864|NCT01078623|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92757865|NCT01078623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92757866|NCT01078623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92757867|NCT01078623|Adrenergic Agents|adrenergic agents|mesh-ancestor
92757868|NCT01078623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757869|NCT01078623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757870|NCT01092507|Vaccines|vaccines|mesh-list
92757871|NCT01092507|Immunologic Factors|immunologic factors|mesh-ancestor
92757872|NCT01092507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757873|NCT01078545|Leuprolide|leuprolide|mesh-list
92757874|NCT01078545|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92757875|NCT01078545|Fertility Agents|fertility agents|mesh-ancestor
92757876|NCT01078545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92757877|NCT01078545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757878|NCT01078545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92757879|NCT01078545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757880|NCT01091259|Bevacizumab|bevacizumab|mesh-list
92757881|NCT01091259|Irinotecan|irinotecan|mesh-list
92757882|NCT01091259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92757883|NCT01091259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757884|NCT01091259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92757885|NCT01091259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92757886|NCT01091259|Growth Substances|growth substances|mesh-ancestor
92757887|NCT01091259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757888|NCT01091259|Growth Inhibitors|growth inhibitors|mesh-ancestor
92757889|NCT01091259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92757890|NCT01091259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92757891|NCT01091259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757892|NCT01091259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757894|NCT01078389|Gout Suppressants|gout suppressants|mesh-ancestor
92757895|NCT01078389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757896|NCT01090323|Deferasirox|deferasirox|mesh-list
92757897|NCT01090323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92757898|NCT01090323|Chelating Agents|chelating agents|mesh-ancestor
92757899|NCT01090323|Sequestering Agents|sequestering agents|mesh-ancestor
92757900|NCT01090323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757901|NCT02876991|Listerine|listerine|mesh-list
92757902|NCT02876991|Fluorides|fluorides|mesh-list
92757903|NCT02876991|Sodium Fluoride|sodium fluoride|mesh-list
92757904|NCT02876991|Cariostatic Agents|cariostatic agents|mesh-ancestor
92757905|NCT02876991|Protective Agents|protective agents|mesh-ancestor
92757906|NCT02876991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757907|NCT02876991|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92757908|NCT02876991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92757909|NCT01201356|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92757910|NCT01201356|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92757911|NCT01201356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757912|NCT01201356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757913|NCT01201356|Immunologic Factors|immunologic factors|mesh-ancestor
92757914|NCT01201356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757915|NCT00637611|Fexofenadine|fexofenadine|mesh-list
92757916|NCT00637611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92757917|NCT00637611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92757918|NCT00637611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92757919|NCT00637611|Histamine Antagonists|histamine antagonists|mesh-ancestor
92757920|NCT00637611|Histamine Agents|histamine agents|mesh-ancestor
92757921|NCT00637611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92757922|NCT00637611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757923|NCT00637611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757924|NCT00626535|Esomeprazole|esomeprazole|mesh-list
92757925|NCT00626535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92757926|NCT00626535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92757927|NCT00626535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92757928|NCT00626535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757929|NCT00626535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757930|NCT01200810|Bicalutamide|bicalutamide|mesh-list
92757931|NCT01200810|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92757932|NCT01200810|Androgen Antagonists|androgen antagonists|mesh-ancestor
92757933|NCT01200810|Hormone Antagonists|hormone antagonists|mesh-ancestor
92757934|NCT01200810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92757935|NCT01200810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757936|NCT01200810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757937|NCT01200810|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92757938|NCT01200810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757939|NCT01200810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757940|NCT01200342|Paclitaxel|paclitaxel|mesh-list
92757941|NCT01200342|Carboplatin|carboplatin|mesh-list
92757942|NCT01200342|Oblimersen|oblimersen|mesh-list
92757943|NCT01200342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92757944|NCT01200342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757945|NCT01200342|Tubulin Modulators|tubulin modulators|mesh-ancestor
92757946|NCT01200342|Antimitotic Agents|antimitotic agents|mesh-ancestor
92757947|NCT01200342|Mitosis Modulators|mitosis modulators|mesh-ancestor
92757948|NCT01200342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757949|NCT01198548|Vitamin D|vitamin d|mesh-list
92757950|NCT01198548|Cholecalciferol|cholecalciferol|mesh-list
92757951|NCT01198548|Leucovorin|leucovorin|mesh-list
92757952|NCT01198548|Bevacizumab|bevacizumab|mesh-list
92757953|NCT01198548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92757954|NCT01198548|Fluorouracil|fluorouracil|mesh-list
92757955|NCT01198548|Oxaliplatin|oxaliplatin|mesh-list
92757956|NCT01198548|Antibodies|antibodies|mesh-list
92757957|NCT01198548|Immunoglobulins|immunoglobulins|mesh-list
92757958|NCT01198548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92757959|NCT01198548|Levoleucovorin|levoleucovorin|mesh-list
92757960|NCT01198548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92757961|NCT01198548|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92757962|NCT01198548|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92757963|NCT01198548|Growth Substances|growth substances|mesh-ancestor
92707905|NCT04665830|Evolocumab|evolocumab|mesh-list
92757964|NCT01198548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757965|NCT01198548|Growth Inhibitors|growth inhibitors|mesh-ancestor
92757966|NCT01198548|Vitamins|vitamins|mesh-ancestor
92757967|NCT01198548|Micronutrients|micronutrients|mesh-ancestor
92757968|NCT01198548|Immunologic Factors|immunologic factors|mesh-ancestor
92757969|NCT01198548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92757970|NCT01198548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92757971|NCT01198548|Antimetabolites|antimetabolites|mesh-ancestor
92757972|NCT01198548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757973|NCT01198548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92757974|NCT01198548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92757975|NCT01198548|Antidotes|antidotes|mesh-ancestor
92757976|NCT01198548|Protective Agents|protective agents|mesh-ancestor
92757977|NCT01198548|Vitamin B Complex|vitamin b complex|mesh-ancestor
92757978|NCT00977938|Aspirin|aspirin|mesh-list
92757979|NCT00977938|Clopidogrel|clopidogrel|mesh-list
92757980|NCT00977938|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92757981|NCT00977938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92757982|NCT00977938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92757983|NCT00977938|Analgesics|analgesics|mesh-ancestor
92757984|NCT00977938|Sensory System Agents|sensory system agents|mesh-ancestor
92757985|NCT00977938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92757986|NCT00977938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92757987|NCT00977938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92757988|NCT00977938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92757989|NCT00977938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92757990|NCT00977938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92757991|NCT00977938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92757992|NCT00977938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92757993|NCT00977938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92757994|NCT00977938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92757995|NCT00977938|Antipyretics|antipyretics|mesh-ancestor
92757996|NCT00977938|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92757997|NCT00977938|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92757998|NCT00977938|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92757999|NCT00977938|Purinergic Agents|purinergic agents|mesh-ancestor
92758000|NCT00977938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758001|NCT00977548|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92758002|NCT00977548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758003|NCT00977548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758004|NCT00977548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758005|NCT00977548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758006|NCT04290208|Acetaminophen|acetaminophen|mesh-list
92758007|NCT04290208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758008|NCT04290208|Analgesics|analgesics|mesh-ancestor
92758009|NCT04290208|Sensory System Agents|sensory system agents|mesh-ancestor
92758010|NCT04290208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758011|NCT04290208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758012|NCT04290208|Antipyretics|antipyretics|mesh-ancestor
92758013|NCT03223597|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92758014|NCT03223597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758016|NCT01090011|Afatinib|afatinib|mesh-list
92758017|NCT01090011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758018|NCT01090011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758019|NCT01090011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758020|NCT01090011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758021|NCT01090011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758022|NCT02877615|S44819|s44819|mesh-list
92758023|NCT02877615|GABA-A Receptor Antagonists|gaba-a receptor antagonists|mesh-ancestor
92758024|NCT02877615|GABA Antagonists|gaba antagonists|mesh-ancestor
92758025|NCT02877615|GABA Agents|gaba agents|mesh-ancestor
92758026|NCT02877615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758027|NCT02877615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758028|NCT02877615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758029|NCT02437279|Nivolumab|nivolumab|mesh-list
92758030|NCT02437279|Ipilimumab|ipilimumab|mesh-list
92758031|NCT02437279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758032|NCT02437279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758033|NCT02437279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92758034|NCT02437279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758035|NCT01251653|Gemcitabine|gemcitabine|mesh-list
92758036|NCT01251653|Docetaxel|docetaxel|mesh-list
92758037|NCT01251653|Afatinib|afatinib|mesh-list
92758038|NCT01251653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92758039|NCT01251653|Antimetabolites|antimetabolites|mesh-ancestor
92758040|NCT01251653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758041|NCT01251653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758042|NCT01251653|Tubulin Modulators|tubulin modulators|mesh-ancestor
92758043|NCT01251653|Antimitotic Agents|antimitotic agents|mesh-ancestor
92758044|NCT01251653|Mitosis Modulators|mitosis modulators|mesh-ancestor
92758045|NCT01251653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758046|NCT01251653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758047|NCT00910663|Mycophenolic Acid|mycophenolic acid|mesh-list
92758048|NCT00910663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92758049|NCT00910663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758050|NCT00910663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92758051|NCT00910663|Antitubercular Agents|antitubercular agents|mesh-ancestor
92758052|NCT00910663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92758053|NCT00910663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758054|NCT00910663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758055|NCT00910663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758056|NCT01077375|Milnacipran|milnacipran|mesh-list
92758057|NCT01077375|Levomilnacipran|levomilnacipran|mesh-list
92529630|NCT00016302|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92758058|NCT01077375|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92758059|NCT01077375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92758060|NCT01077375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758061|NCT01077375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758062|NCT01077375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758063|NCT01077375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758064|NCT01077375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758065|NCT01077375|Analgesics|analgesics|mesh-ancestor
92758066|NCT01077375|Sensory System Agents|sensory system agents|mesh-ancestor
92758067|NCT01077375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758068|NCT01077375|Antidepressive Agents|antidepressive agents|mesh-ancestor
92758069|NCT01077375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758070|NCT02877771|Insulin|insulin|mesh-list
92758071|NCT02877771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92758072|NCT02877771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758073|NCT04306653|Betamethasone|betamethasone|mesh-list
92758074|NCT04306653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758075|NCT04306653|Glucocorticoids|glucocorticoids|mesh-ancestor
92758076|NCT04306653|Hormones|hormones|mesh-ancestor
92758077|NCT04306653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758078|NCT04306653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758079|NCT04306653|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92758080|NCT04306653|Respiratory System Agents|respiratory system agents|mesh-ancestor
92758081|NCT04306731|Trimethoprim|trimethoprim|mesh-list
92758082|NCT04306731|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92758083|NCT04306731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758084|NCT04306731|Antimalarials|antimalarials|mesh-ancestor
92758085|NCT04306731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92758086|NCT04306731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92758087|NCT04306731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92758088|NCT04306731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758089|NCT04306731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758090|NCT04306731|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92758091|NCT04306731|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92758092|NCT04306731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92758093|NCT02877537|Albuterol|albuterol|mesh-list
92758094|NCT02877537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92758095|NCT02877537|Autonomic Agents|autonomic agents|mesh-ancestor
92758096|NCT02877537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758097|NCT02877537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758098|NCT02877537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92758099|NCT02877537|Respiratory System Agents|respiratory system agents|mesh-ancestor
92758100|NCT02877537|Tocolytic Agents|tocolytic agents|mesh-ancestor
92758101|NCT02877537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92758102|NCT02877537|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92758103|NCT02877537|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92758104|NCT02877537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92758105|NCT02877537|Adrenergic Agents|adrenergic agents|mesh-ancestor
92758106|NCT02877537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758107|NCT02877537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758108|NCT01250873|Sertraline|sertraline|mesh-list
92758109|NCT01250873|Antidepressive Agents|antidepressive agents|mesh-ancestor
92758110|NCT01250873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758111|NCT01250873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92758112|NCT01250873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92758113|NCT01250873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758114|NCT01250873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758115|NCT01250873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758116|NCT01250873|Serotonin Agents|serotonin agents|mesh-ancestor
92758117|NCT01250873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758118|NCT02888327|Oseltamivir|oseltamivir|mesh-list
92758119|NCT02888327|Digoxin|digoxin|mesh-list
92758120|NCT02888327|Midazolam|midazolam|mesh-list
92758121|NCT02888327|Pitavastatin|pitavastatin|mesh-list
92758122|NCT02888327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92758123|NCT02888327|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92758124|NCT02888327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758125|NCT02888327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758126|NCT02888327|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92758127|NCT02888327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92758128|NCT02888327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758129|NCT02888327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92758130|NCT02888327|Anesthetics, General|anesthetics, general|mesh-ancestor
92758132|NCT02888327|GABA Modulators|gaba modulators|mesh-ancestor
92758133|NCT02888327|GABA Agents|gaba agents|mesh-ancestor
92758134|NCT02888327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758135|NCT02888327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758136|NCT02888327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92758137|NCT02888327|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92758138|NCT02888327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758139|NCT02888327|Protective Agents|protective agents|mesh-ancestor
92758140|NCT02888327|Antiviral Agents|antiviral agents|mesh-ancestor
92758141|NCT02888327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758142|NCT02888327|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92758143|NCT02888327|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92758144|NCT02888327|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92758145|NCT02888327|Antimetabolites|antimetabolites|mesh-ancestor
92758146|NCT02888327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92758147|NCT01248065|Vitamin D|vitamin d|mesh-list
92758148|NCT01248065|Cholecalciferol|cholecalciferol|mesh-list
92758149|NCT01248065|Ciclesonide|ciclesonide|mesh-list
92758150|NCT01248065|Vitamins|vitamins|mesh-ancestor
92758151|NCT01248065|Micronutrients|micronutrients|mesh-ancestor
92758152|NCT01248065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758153|NCT01248065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92758154|NCT01248065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758155|NCT01248065|Glucocorticoids|glucocorticoids|mesh-ancestor
92758156|NCT01248065|Hormones|hormones|mesh-ancestor
92758157|NCT01248065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758158|NCT01248065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92758159|NCT01250756|Vaccines|vaccines|mesh-list
92758160|NCT01250756|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92758161|NCT01250756|Immunologic Factors|immunologic factors|mesh-ancestor
92758162|NCT01250756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758163|NCT00977470|Hydroxychloroquine|hydroxychloroquine|mesh-list
92758164|NCT00977470|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92758165|NCT00977470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758166|NCT00977470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758167|NCT00977470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758168|NCT00977470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758169|NCT00977470|Antimalarials|antimalarials|mesh-ancestor
92758170|NCT00977470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92758171|NCT00977470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92758172|NCT00977470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758173|NCT00977470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758174|NCT02865304|Endostar protein|endostar protein|mesh-list
92758175|NCT02865304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92758176|NCT02865304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92758177|NCT02865304|Growth Substances|growth substances|mesh-ancestor
92758178|NCT02865304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758179|NCT02865304|Growth Inhibitors|growth inhibitors|mesh-ancestor
92758180|NCT02865304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758181|NCT04075474|Listerine|listerine|mesh-list
92758182|NCT04075474|Fluorides|fluorides|mesh-list
92758183|NCT04075474|Sodium Fluoride|sodium fluoride|mesh-list
92758184|NCT04075474|Cariostatic Agents|cariostatic agents|mesh-ancestor
92758185|NCT04075474|Protective Agents|protective agents|mesh-ancestor
92758186|NCT04075474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758187|NCT04075474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92758188|NCT04075474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758190|NCT02866396|Analgesics|analgesics|mesh-ancestor
92758191|NCT02866396|Sensory System Agents|sensory system agents|mesh-ancestor
92758192|NCT02866396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758193|NCT02866396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758194|NCT02866396|Anticonvulsants|anticonvulsants|mesh-ancestor
92758195|NCT02866396|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92758196|NCT02866396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758197|NCT02866396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758198|NCT02866396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758199|NCT02866396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92758200|NCT02866396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92758201|NCT02866396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758202|NCT02866396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758203|NCT01087203|Tanezumab|tanezumab|mesh-list
92758204|NCT01087203|Analgesics|analgesics|mesh-ancestor
92758205|NCT01087203|Sensory System Agents|sensory system agents|mesh-ancestor
92758206|NCT01087203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758207|NCT01087203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758209|NCT01246583|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92758210|NCT01246583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758211|NCT01246583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758212|NCT01246583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758213|NCT00626613|Risperidone|risperidone|mesh-list
92758214|NCT00626613|Galantamine|galantamine|mesh-list
92758215|NCT00626613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92758216|NCT00626613|Serotonin Agents|serotonin agents|mesh-ancestor
92758217|NCT00626613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758218|NCT00626613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758219|NCT00626613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758220|NCT00626613|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92758221|NCT00626613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92758222|NCT00626613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758223|NCT00626613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758224|NCT00626613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92758225|NCT00626613|Dopamine Agents|dopamine agents|mesh-ancestor
92758226|NCT00626613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92758227|NCT00626613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758228|NCT00626613|Cholinergic Agents|cholinergic agents|mesh-ancestor
92758229|NCT00626613|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92758230|NCT00626613|Autonomic Agents|autonomic agents|mesh-ancestor
92758231|NCT00626613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758232|NCT00626613|Nootropic Agents|nootropic agents|mesh-ancestor
92758233|NCT01080807|Modafinil|modafinil|mesh-list
92758234|NCT01080807|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92758235|NCT01080807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758236|NCT01080807|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92758237|NCT01080807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92758238|NCT01080807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92758239|NCT01080807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758240|NCT01079949|Cetrorelix|cetrorelix|mesh-list
92758241|NCT01079949|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92758242|NCT01079949|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92758243|NCT01079949|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92758244|NCT01079949|Fertility Agents|fertility agents|mesh-ancestor
92758245|NCT01079949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92758246|NCT01079949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758247|NCT01079949|Hormone Antagonists|hormone antagonists|mesh-ancestor
92758248|NCT01079949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758249|NCT01079949|Hormones|hormones|mesh-ancestor
92758250|NCT00910429|Riociguat|riociguat|mesh-list
92758251|NCT00910429|Enzyme Activators|enzyme activators|mesh-ancestor
92758252|NCT00910429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758253|NCT03432949|Dexamethasone|dexamethasone|mesh-list
92758254|NCT03432949|Dexamethasone acetate|dexamethasone acetate|mesh-list
92758255|NCT03432949|BB 1101|bb 1101|mesh-list
92758256|NCT03432949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758257|NCT03432949|Antiemetics|antiemetics|mesh-ancestor
92758258|NCT03432949|Autonomic Agents|autonomic agents|mesh-ancestor
92758259|NCT03432949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758260|NCT03432949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758261|NCT03432949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758262|NCT03432949|Glucocorticoids|glucocorticoids|mesh-ancestor
92758263|NCT03432949|Hormones|hormones|mesh-ancestor
92758264|NCT03432949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758265|NCT03432949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758266|NCT03432949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758267|NCT03432949|Protease Inhibitors|protease inhibitors|mesh-ancestor
92758268|NCT03432949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758269|NCT03432949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758270|NCT00909727|Ivacaftor|ivacaftor|mesh-list
92758271|NCT00909727|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92758272|NCT00909727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758273|NCT00909727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758274|NCT00977080|Cinacalcet|cinacalcet|mesh-list
92758275|NCT00977080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758276|NCT00977080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758277|NCT00977080|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92758279|NCT00977080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758280|NCT04289194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92758281|NCT04289194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92758282|NCT04289194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758283|NCT04083157|Imiquimod|imiquimod|mesh-list
92758284|NCT04083157|Vaccines|vaccines|mesh-list
92758285|NCT04083157|Immunologic Factors|immunologic factors|mesh-ancestor
92758286|NCT04083157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758287|NCT04083157|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92758288|NCT04083157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758289|NCT04083157|Interferon Inducers|interferon inducers|mesh-ancestor
92758290|NCT00975286|Metformin|metformin|mesh-list
92758291|NCT00975286|Insulin Glargine|insulin glargine|mesh-list
92758292|NCT00975286|Lixisenatide|lixisenatide|mesh-list
92758293|NCT00975286|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92758294|NCT00975286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92758295|NCT00975286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758296|NCT00907777|Vaccines|vaccines|mesh-list
92758297|NCT00907777|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92758298|NCT00907777|Immunologic Factors|immunologic factors|mesh-ancestor
92758299|NCT00907777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758300|NCT03741517|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92758301|NCT03741517|Edotreotide|edotreotide|mesh-list
92758302|NCT03741517|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92758303|NCT03741517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758304|NCT02864758|Vitamin K|vitamin k|mesh-list
92758305|NCT02864758|Rivaroxaban|rivaroxaban|mesh-list
92758306|NCT02864758|Dabigatran|dabigatran|mesh-list
92758307|NCT02864758|Vitamins|vitamins|mesh-ancestor
92758308|NCT02864758|Micronutrients|micronutrients|mesh-ancestor
92758309|NCT02864758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758310|NCT02864758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92758311|NCT02864758|Antithrombins|antithrombins|mesh-ancestor
92758312|NCT02864758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92758313|NCT02864758|Protease Inhibitors|protease inhibitors|mesh-ancestor
92758314|NCT02864758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758315|NCT02864758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758316|NCT02864758|Anticoagulants|anticoagulants|mesh-ancestor
92758317|NCT02864758|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92758318|NCT02864758|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92758319|NCT02864758|Hemostatics|hemostatics|mesh-ancestor
92758320|NCT02864758|Coagulants|coagulants|mesh-ancestor
92758321|NCT04204798|Dexmedetomidine|dexmedetomidine|mesh-list
92758322|NCT04204798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92758323|NCT04204798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758324|NCT04204798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758325|NCT04204798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758326|NCT04204798|Analgesics|analgesics|mesh-ancestor
92758327|NCT04204798|Sensory System Agents|sensory system agents|mesh-ancestor
92758328|NCT04204798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758329|NCT04204798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92758330|NCT04204798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92758331|NCT04204798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92758332|NCT04204798|Adrenergic Agents|adrenergic agents|mesh-ancestor
92758333|NCT04204798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758334|NCT04204798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758335|NCT00908011|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92758336|NCT00908011|Ezetimibe|ezetimibe|mesh-list
92758337|NCT00908011|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92758338|NCT00908011|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92758339|NCT00908011|Antimetabolites|antimetabolites|mesh-ancestor
92758340|NCT00908011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758341|NCT00908011|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92758342|NCT00908011|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92758343|NCT00908011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758345|NCT00976456|Carboplatin|carboplatin|mesh-list
92758346|NCT00976456|Pemetrexed|pemetrexed|mesh-list
92758347|NCT00976456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758348|NCT00976456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758349|NCT00976456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92758350|NCT00976456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92758351|NCT00976456|Growth Substances|growth substances|mesh-ancestor
92758352|NCT00976456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758353|NCT00976456|Growth Inhibitors|growth inhibitors|mesh-ancestor
92758354|NCT00976456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758355|NCT00976456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758356|NCT00976456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92758357|NCT00976456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92758358|NCT01243151|Bococizumab|bococizumab|mesh-list
92758359|NCT01243151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92758360|NCT01243151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92758361|NCT01243151|Antimetabolites|antimetabolites|mesh-ancestor
92758362|NCT01243151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758363|NCT01243151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92758364|NCT00629512|Esomeprazole|esomeprazole|mesh-list
92758365|NCT00629512|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92758366|NCT00629512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758367|NCT00629512|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92758368|NCT00629512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758369|NCT00629512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758370|NCT01711021|Amphetamine|amphetamine|mesh-list
92758371|NCT01711021|Dextroamphetamine|dextroamphetamine|mesh-list
92758372|NCT01711021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92758373|NCT01711021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758374|NCT01711021|Sympathomimetics|sympathomimetics|mesh-ancestor
92758375|NCT01711021|Autonomic Agents|autonomic agents|mesh-ancestor
92334332|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758376|NCT01711021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758377|NCT01711021|Dopamine Agents|dopamine agents|mesh-ancestor
92758378|NCT01711021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758379|NCT01711021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758380|NCT01711021|Adrenergic Agents|adrenergic agents|mesh-ancestor
92758381|NCT01711021|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92758382|NCT01711021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92758383|NCT01711021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758384|NCT01711021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92758385|NCT05517265|Acalabrutinib|acalabrutinib|mesh-list
92758386|NCT05517265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758387|NCT02864602|Dexamethasone|dexamethasone|mesh-list
92758388|NCT02864602|Dexamethasone acetate|dexamethasone acetate|mesh-list
92758389|NCT02864602|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92758390|NCT02864602|BB 1101|bb 1101|mesh-list
92758391|NCT02864602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758392|NCT02864602|Antiemetics|antiemetics|mesh-ancestor
92758393|NCT02864602|Autonomic Agents|autonomic agents|mesh-ancestor
92758394|NCT02864602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758395|NCT02864602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758396|NCT02864602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758397|NCT02864602|Glucocorticoids|glucocorticoids|mesh-ancestor
92758398|NCT02864602|Hormones|hormones|mesh-ancestor
92758399|NCT02864602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758400|NCT02864602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758401|NCT02864602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758402|NCT02864602|Protease Inhibitors|protease inhibitors|mesh-ancestor
92758403|NCT02864602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758404|NCT02864602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758405|NCT00993148|Ritonavir|ritonavir|mesh-list
92758406|NCT00993148|Darunavir|darunavir|mesh-list
92758407|NCT00993148|Maraviroc|maraviroc|mesh-list
92758408|NCT00993148|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92758409|NCT00993148|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92758410|NCT00993148|Protease Inhibitors|protease inhibitors|mesh-ancestor
92758411|NCT00993148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758412|NCT00993148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758413|NCT00993148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92758414|NCT00993148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92758415|NCT00993148|Antiviral Agents|antiviral agents|mesh-ancestor
92758416|NCT00993148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758417|NCT00993148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92758418|NCT00993148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92758419|NCT00993148|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92758420|NCT00993148|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92758421|NCT00993148|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92758422|NCT03401047|Estradiol|estradiol|mesh-list
92758423|NCT03401047|Estrogens|estrogens|mesh-ancestor
92758424|NCT03401047|Hormones|hormones|mesh-ancestor
92758425|NCT03401047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758426|NCT03401047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758427|NCT03384589|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92758428|NCT03384589|Immunologic Factors|immunologic factors|mesh-ancestor
92758429|NCT03384589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758430|NCT03531073|Methotrexate|methotrexate|mesh-list
92758431|NCT03531073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92758432|NCT03531073|Abortifacient Agents|abortifacient agents|mesh-ancestor
92758433|NCT03531073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92758434|NCT03531073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758435|NCT03531073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92758436|NCT03531073|Antimetabolites|antimetabolites|mesh-ancestor
92758437|NCT03531073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758438|NCT03531073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758439|NCT03531073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92758440|NCT03531073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758441|NCT03531073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92758442|NCT03531073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758443|NCT03531073|Immunologic Factors|immunologic factors|mesh-ancestor
92758444|NCT03531073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758445|NCT03531073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92758447|NCT00907153|Vitamins|vitamins|mesh-ancestor
92758448|NCT00907153|Micronutrients|micronutrients|mesh-ancestor
92758449|NCT00907153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758450|NCT00907153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92758451|NCT00904033|Calcitriol|calcitriol|mesh-list
92758452|NCT00904033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758453|NCT00904033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758454|NCT00904033|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92758455|NCT00904033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758456|NCT00904033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758457|NCT00904033|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92758458|NCT00904033|Vitamins|vitamins|mesh-ancestor
92758459|NCT00904033|Micronutrients|micronutrients|mesh-ancestor
92758460|NCT00904033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92758461|NCT05175625|Myeloma Proteins|myeloma proteins|mesh-list
92758462|NCT05175625|Paraproteins|paraproteins|mesh-list
92758463|NCT05175625|Immunologic Factors|immunologic factors|mesh-ancestor
92758464|NCT05175625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758465|NCT02555839|Thalidomide|thalidomide|mesh-list
92758466|NCT02555839|Dexamethasone|dexamethasone|mesh-list
92758467|NCT02555839|Dexamethasone acetate|dexamethasone acetate|mesh-list
92758468|NCT02555839|Bortezomib|bortezomib|mesh-list
92758469|NCT02555839|Pomalidomide|pomalidomide|mesh-list
92758470|NCT02555839|BB 1101|bb 1101|mesh-list
92758471|NCT02555839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758472|NCT02555839|Antiemetics|antiemetics|mesh-ancestor
92758473|NCT02555839|Autonomic Agents|autonomic agents|mesh-ancestor
92758474|NCT02555839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758475|NCT02555839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758476|NCT02555839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758477|NCT02555839|Glucocorticoids|glucocorticoids|mesh-ancestor
92758478|NCT02555839|Hormones|hormones|mesh-ancestor
92758479|NCT02555839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758480|NCT02555839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758481|NCT02555839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758482|NCT02555839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92758483|NCT02555839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758484|NCT02555839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758485|NCT02555839|Immunologic Factors|immunologic factors|mesh-ancestor
92758486|NCT02555839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92758487|NCT02555839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92708432|NCT00541047|Leuprolide|leuprolide|mesh-list
92758488|NCT02555839|Growth Substances|growth substances|mesh-ancestor
92758489|NCT02555839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92758490|NCT02555839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758491|NCT02555839|Leprostatic Agents|leprostatic agents|mesh-ancestor
92758492|NCT02555839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92758493|NCT02555839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758494|NCT01241591|Etanercept|etanercept|mesh-list
92758495|NCT01241591|Tofacitinib|tofacitinib|mesh-list
92758496|NCT01241591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92758497|NCT01241591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758498|NCT01241591|Analgesics|analgesics|mesh-ancestor
92758499|NCT01241591|Sensory System Agents|sensory system agents|mesh-ancestor
92758500|NCT01241591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758501|NCT01241591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758502|NCT01241591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758503|NCT01241591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758504|NCT01241591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758505|NCT01241591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758506|NCT01241591|Immunologic Factors|immunologic factors|mesh-ancestor
92758507|NCT01241591|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92758508|NCT01241591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758509|NCT01241591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494489|NCT01975688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758510|NCT01241591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758512|NCT04319705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92758513|NCT04319705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758514|NCT00906373|Sorafenib|sorafenib|mesh-list
92758515|NCT00906373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92758516|NCT00906373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758517|NCT00906373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758518|NCT00906373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758519|NCT00906373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758520|NCT00906373|Immunologic Factors|immunologic factors|mesh-ancestor
92758521|NCT00906373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758522|NCT02850445|Olanzapine|olanzapine|mesh-list
92758523|NCT02850445|Antiemetics|antiemetics|mesh-ancestor
92758524|NCT02850445|Autonomic Agents|autonomic agents|mesh-ancestor
92758525|NCT02850445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758526|NCT02850445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758527|NCT02850445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758528|NCT02850445|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92758529|NCT02850445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92758530|NCT02850445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758531|NCT02850445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758532|NCT02850445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92758533|NCT02850445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92758534|NCT02850445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758535|NCT02850445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758536|NCT02850445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758537|NCT02850445|Serotonin Agents|serotonin agents|mesh-ancestor
92758538|NCT04220203|Capecitabine|capecitabine|mesh-list
92758539|NCT04220203|Trastuzumab|trastuzumab|mesh-list
92758540|NCT04220203|Tucatinib|tucatinib|mesh-list
92758541|NCT04220203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92758542|NCT04220203|Antimetabolites|antimetabolites|mesh-ancestor
92758543|NCT04220203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758544|NCT04220203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758545|NCT04220203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758546|NCT04220203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758547|NCT04220203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758548|NCT02850211|Ibuprofen|ibuprofen|mesh-list
92758549|NCT02850211|Celecoxib|celecoxib|mesh-list
92758550|NCT02850211|Tramadol|tramadol|mesh-list
92758551|NCT02850211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92758552|NCT02850211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758553|NCT02850211|Analgesics|analgesics|mesh-ancestor
92758554|NCT02850211|Sensory System Agents|sensory system agents|mesh-ancestor
92758555|NCT02850211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758556|NCT02850211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758557|NCT02850211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758558|NCT02850211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758559|NCT02850211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92758560|NCT02850211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758561|NCT02850211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708506|NCT00541125|Vitamins|vitamins|mesh-ancestor
92758562|NCT02850211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92758563|NCT02850211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92758564|NCT02850211|Narcotics|narcotics|mesh-ancestor
92758565|NCT02850211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758566|NCT02850289|Interferons|interferons|mesh-list
92758567|NCT02850289|Ribavirin|ribavirin|mesh-list
92758568|NCT02850289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758569|NCT02850289|Antiviral Agents|antiviral agents|mesh-ancestor
92758570|NCT02850289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758571|NCT02850289|Antimetabolites|antimetabolites|mesh-ancestor
92758572|NCT02850289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758573|NCT05331781|Morphine|morphine|mesh-list
92758574|NCT05331781|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92758575|NCT05331781|Narcotics|narcotics|mesh-ancestor
92334361|NCT00004885|Fluorouracil|fluorouracil|mesh-list
92758576|NCT05331781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758577|NCT05331781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758578|NCT05331781|Analgesics|analgesics|mesh-ancestor
92758579|NCT05331781|Sensory System Agents|sensory system agents|mesh-ancestor
92758580|NCT05331781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758581|NCT04202887|Fentanyl|fentanyl|mesh-list
92758582|NCT04202887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92758583|NCT04202887|Narcotics|narcotics|mesh-ancestor
92758584|NCT04202887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758585|NCT04202887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758586|NCT04202887|Analgesics|analgesics|mesh-ancestor
92758587|NCT04202887|Sensory System Agents|sensory system agents|mesh-ancestor
92758588|NCT04202887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758589|NCT04202887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92758590|NCT04202887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92758591|NCT04202887|Anesthetics, General|anesthetics, general|mesh-ancestor
92758592|NCT04202887|Anesthetics|anesthetics|mesh-ancestor
92758593|NCT05324215|Fentanyl|fentanyl|mesh-list
92758594|NCT05324215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92758595|NCT05324215|Narcotics|narcotics|mesh-ancestor
92758596|NCT05324215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758597|NCT05324215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758598|NCT05324215|Analgesics|analgesics|mesh-ancestor
92758599|NCT05324215|Sensory System Agents|sensory system agents|mesh-ancestor
92758600|NCT05324215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758601|NCT05324215|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92758602|NCT05324215|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92758603|NCT05324215|Anesthetics, General|anesthetics, general|mesh-ancestor
92758604|NCT05324215|Anesthetics|anesthetics|mesh-ancestor
92758605|NCT00905437|Pregabalin|pregabalin|mesh-list
92758606|NCT00905437|Analgesics|analgesics|mesh-ancestor
92758607|NCT00905437|Sensory System Agents|sensory system agents|mesh-ancestor
92758608|NCT00905437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758609|NCT00905437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758610|NCT00905437|Anticonvulsants|anticonvulsants|mesh-ancestor
92758611|NCT00905437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92758612|NCT00905437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758613|NCT00905437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758614|NCT00905437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758615|NCT00905437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92758616|NCT00905437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92758617|NCT00905437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758618|NCT00905437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92758619|NCT05007691|Salicylic Acid|salicylic acid|mesh-list
92758620|NCT05007691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758621|NCT05007691|Antifungal Agents|antifungal agents|mesh-ancestor
92758622|NCT05007691|Keratolytic Agents|keratolytic agents|mesh-ancestor
92758623|NCT05007691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92758624|NCT01238861|Benralizumab|benralizumab|mesh-list
92758625|NCT01238861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92758626|NCT01238861|Respiratory System Agents|respiratory system agents|mesh-ancestor
92758627|NCT02888561|Dobutamine|dobutamine|mesh-list
92758628|NCT02888561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92758629|NCT02888561|Sympathomimetics|sympathomimetics|mesh-ancestor
92758630|NCT02888561|Autonomic Agents|autonomic agents|mesh-ancestor
92758631|NCT02888561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758632|NCT02888561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758633|NCT02888561|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92758634|NCT02888561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92758635|NCT02888561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92758636|NCT02888561|Adrenergic Agents|adrenergic agents|mesh-ancestor
92758637|NCT02888561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758638|NCT02888561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758639|NCT02888561|Protective Agents|protective agents|mesh-ancestor
92758640|NCT04319549|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92758642|NCT04319549|Ketorolac|ketorolac|mesh-list
92758643|NCT04319549|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92758644|NCT04319549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92758645|NCT04319549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758646|NCT04319549|Analgesics|analgesics|mesh-ancestor
92758647|NCT04319549|Sensory System Agents|sensory system agents|mesh-ancestor
92758648|NCT04319549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758649|NCT04319549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758650|NCT04319549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758651|NCT04319549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529641|NCT00016302|Vitamins|vitamins|mesh-ancestor
92758652|NCT04319549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92758653|NCT04319549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758654|NCT04319549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758655|NCT04319549|Disinfectants|disinfectants|mesh-ancestor
92758656|NCT04319549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758657|NCT00903409|Simvastatin|simvastatin|mesh-list
92758658|NCT00903409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92758659|NCT00903409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92758660|NCT00903409|Antimetabolites|antimetabolites|mesh-ancestor
92758661|NCT00903409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758662|NCT00903409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92758663|NCT00903409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92758664|NCT00903409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758665|NCT01237223|Amlodipine|amlodipine|mesh-list
92758666|NCT01237223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92758667|NCT01237223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92758668|NCT01237223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758669|NCT01237223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758670|NCT01237223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758671|NCT01237223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758672|NCT01237223|Vasodilator Agents|vasodilator agents|mesh-ancestor
92758673|NCT01236365|Atorvastatin|atorvastatin|mesh-list
92758674|NCT01236365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92758675|NCT01236365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92758676|NCT01236365|Antimetabolites|antimetabolites|mesh-ancestor
92758677|NCT01236365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758678|NCT01236365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92758679|NCT01236365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92758680|NCT01236365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758681|NCT00903331|Macitentan|macitentan|mesh-list
92758682|NCT00903331|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92758683|NCT00903331|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92758684|NCT00903331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758685|NCT00903331|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92758686|NCT01235741|Pramlintide|pramlintide|mesh-list
92758687|NCT01235741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92758688|NCT01235741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758689|NCT02849353|Immunomodulating Agents|immunomodulating agents|mesh-list
92758690|NCT02849353|Immunologic Factors|immunologic factors|mesh-ancestor
92758691|NCT02849353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758692|NCT01235507|Methotrexate|methotrexate|mesh-list
92758693|NCT01235507|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92758694|NCT01235507|Abortifacient Agents|abortifacient agents|mesh-ancestor
92758695|NCT01235507|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92758696|NCT01235507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758697|NCT01235507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92758698|NCT01235507|Antimetabolites|antimetabolites|mesh-ancestor
92758699|NCT01235507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758700|NCT01235507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758701|NCT01235507|Dermatologic Agents|dermatologic agents|mesh-ancestor
92758702|NCT01235507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758703|NCT01235507|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92758704|NCT01235507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758705|NCT01235507|Immunologic Factors|immunologic factors|mesh-ancestor
92758706|NCT01235507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758707|NCT01235507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92758708|NCT01868269|Dexamethasone|dexamethasone|mesh-list
92758709|NCT01868269|Dexamethasone acetate|dexamethasone acetate|mesh-list
92758710|NCT01868269|Cyclophosphamide|cyclophosphamide|mesh-list
92758711|NCT01868269|Rituximab|rituximab|mesh-list
92758712|NCT01868269|BB 1101|bb 1101|mesh-list
92758713|NCT01868269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758714|NCT01868269|Immunologic Factors|immunologic factors|mesh-ancestor
92758715|NCT01868269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758716|NCT01868269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758717|NCT01868269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92758718|NCT01868269|Alkylating Agents|alkylating agents|mesh-ancestor
92758719|NCT01868269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758720|NCT01868269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758721|NCT01868269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92758722|NCT01868269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758723|NCT01868269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758725|NCT01868269|Autonomic Agents|autonomic agents|mesh-ancestor
92758726|NCT01868269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758727|NCT01868269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758728|NCT01868269|Glucocorticoids|glucocorticoids|mesh-ancestor
92758729|NCT01868269|Hormones|hormones|mesh-ancestor
92758730|NCT01868269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758731|NCT01868269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758732|NCT01868269|Protease Inhibitors|protease inhibitors|mesh-ancestor
92758733|NCT01868269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758734|NCT01235351|Clopidogrel|clopidogrel|mesh-list
92758735|NCT01235351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92758736|NCT01235351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92758737|NCT01235351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92758738|NCT01235351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92758739|NCT01235351|Purinergic Agents|purinergic agents|mesh-ancestor
92758740|NCT01235351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758741|NCT01235351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758742|NCT01235351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758743|NCT01234883|Plasma-lyte 148|plasma-lyte 148|mesh-list
92758744|NCT01234883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92758745|NCT01234883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92758746|NCT01234649|Metformin|metformin|mesh-list
92758747|NCT01234649|Liraglutide|liraglutide|mesh-list
92758748|NCT01234649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92758749|NCT01234649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758750|NCT01234649|Incretins|incretins|mesh-ancestor
92758751|NCT01234649|Hormones|hormones|mesh-ancestor
92758752|NCT01234649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758753|NCT02876679|Cyclosporine|cyclosporine|mesh-list
92758754|NCT02876679|Mycophenolic Acid|mycophenolic acid|mesh-list
92758755|NCT02876679|Cyclophosphamide|cyclophosphamide|mesh-list
92758756|NCT02876679|Cyclosporins|cyclosporins|mesh-list
92758757|NCT02876679|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92758758|NCT02876679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758759|NCT02876679|Immunologic Factors|immunologic factors|mesh-ancestor
92758760|NCT02876679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758761|NCT02876679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758762|NCT02876679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92758763|NCT02876679|Alkylating Agents|alkylating agents|mesh-ancestor
92758764|NCT02876679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758765|NCT02876679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758766|NCT02876679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92758767|NCT02876679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758768|NCT02876679|Antifungal Agents|antifungal agents|mesh-ancestor
92758769|NCT02876679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758770|NCT02876679|Dermatologic Agents|dermatologic agents|mesh-ancestor
92758771|NCT02876679|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92758772|NCT02876679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92758773|NCT02876679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92758774|NCT02876679|Antitubercular Agents|antitubercular agents|mesh-ancestor
92758775|NCT02876679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92758776|NCT01075815|Hormones|hormones|mesh-list
92758777|NCT01075815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92758778|NCT01075815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758779|NCT01075815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758780|NCT01072149|Fluticasone|fluticasone|mesh-list
92758781|NCT01072149|Xhance|xhance|mesh-list
92758782|NCT01072149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758783|NCT01072149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92758784|NCT01072149|Autonomic Agents|autonomic agents|mesh-ancestor
92758785|NCT01072149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758786|NCT01072149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758787|NCT01072149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92758788|NCT01072149|Respiratory System Agents|respiratory system agents|mesh-ancestor
92758789|NCT01072149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92758790|NCT01072149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92758791|NCT04413253|Dexamethasone|dexamethasone|mesh-list
92758792|NCT04413253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92758793|NCT04413253|Lifitegrast|lifitegrast|mesh-list
92758794|NCT04413253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92758795|NCT04413253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758796|NCT04413253|Antiemetics|antiemetics|mesh-ancestor
92758797|NCT04413253|Autonomic Agents|autonomic agents|mesh-ancestor
92758798|NCT04413253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758799|NCT04413253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758800|NCT04413253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758801|NCT04413253|Glucocorticoids|glucocorticoids|mesh-ancestor
92758802|NCT04413253|Hormones|hormones|mesh-ancestor
92758803|NCT04413253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758804|NCT04413253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758805|NCT04413253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758806|NCT01679119|Prednisolone|prednisolone|mesh-list
92758807|NCT01679119|Cyclophosphamide|cyclophosphamide|mesh-list
92758808|NCT01679119|Rituximab|rituximab|mesh-list
92758809|NCT01679119|Gemcitabine|gemcitabine|mesh-list
92758810|NCT01679119|Vincristine|vincristine|mesh-list
92758811|NCT01679119|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92758812|NCT01679119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92758813|NCT01679119|Immunologic Factors|immunologic factors|mesh-ancestor
92758814|NCT01679119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758815|NCT01679119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92758816|NCT01679119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92758817|NCT01679119|Alkylating Agents|alkylating agents|mesh-ancestor
92758818|NCT01679119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758819|NCT01679119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758820|NCT01679119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92758821|NCT01679119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758822|NCT01679119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92758823|NCT01679119|Antimetabolites|antimetabolites|mesh-ancestor
92758824|NCT01679119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92758825|NCT01679119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92758826|NCT01679119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92758827|NCT01679119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92758828|NCT01679119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92758829|NCT01679119|Glucocorticoids|glucocorticoids|mesh-ancestor
92758830|NCT01679119|Hormones|hormones|mesh-ancestor
92758831|NCT01679119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758832|NCT01679119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758833|NCT01679119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92758834|NCT01679119|Immunotoxins|immunotoxins|mesh-ancestor
92758835|NCT01679119|Immunoconjugates|immunoconjugates|mesh-ancestor
92758836|NCT04778787|Dapagliflozin|dapagliflozin|mesh-list
92758837|NCT04778787|Digoxin|digoxin|mesh-list
92758838|NCT04778787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92758839|NCT04778787|Vasodilator Agents|vasodilator agents|mesh-list
92758840|NCT04778787|Diuretics|diuretics|mesh-list
92758841|NCT04778787|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92758842|NCT04778787|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92758843|NCT04778787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758844|NCT04778787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92758845|NCT04778787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758846|NCT04778787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92758847|NCT04778787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92758848|NCT04778787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758849|NCT04778787|Protective Agents|protective agents|mesh-ancestor
92758850|NCT04778787|Natriuretic Agents|natriuretic agents|mesh-ancestor
92758851|NCT04778787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758852|NCT04304157|Dexmedetomidine|dexmedetomidine|mesh-list
92758853|NCT04304157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92758854|NCT04304157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758855|NCT04304157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758856|NCT04304157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92758857|NCT04304157|Analgesics|analgesics|mesh-ancestor
92758858|NCT04304157|Sensory System Agents|sensory system agents|mesh-ancestor
92758859|NCT04304157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758860|NCT04304157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92758861|NCT04304157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92758862|NCT04304157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92758864|NCT04304157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758865|NCT04304157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758866|NCT04937413|Evolocumab|evolocumab|mesh-list
92758867|NCT04937413|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92758868|NCT04937413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92758869|NCT04937413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92758870|NCT04937413|Antimetabolites|antimetabolites|mesh-ancestor
92758871|NCT04937413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334443|NCT00004357|Hormones|hormones|mesh-ancestor
92758872|NCT04937413|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92758874|NCT04937413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758875|NCT04937413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92758876|NCT02875587|Cabergoline|cabergoline|mesh-list
92758877|NCT02875587|Calcium|calcium|mesh-list
92758878|NCT02875587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758879|NCT02875587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758880|NCT02875587|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92758881|NCT02875587|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92758882|NCT02875587|Dopamine Agonists|dopamine agonists|mesh-ancestor
92758883|NCT02875587|Dopamine Agents|dopamine agents|mesh-ancestor
92758884|NCT02875587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758885|NCT02875587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758886|NCT01070979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92758887|NCT01070979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92758888|NCT01070979|Estradiol|estradiol|mesh-list
92758889|NCT01070979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92758890|NCT01070979|Estrogens|estrogens|mesh-list
92758891|NCT01070979|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92758892|NCT01070979|Hormones|hormones|mesh-ancestor
92758893|NCT01070979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758894|NCT01070979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758895|NCT01070979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92758896|NCT01070979|Contraceptive Agents|contraceptive agents|mesh-ancestor
92758897|NCT01070979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92758898|NCT01070979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92758899|NCT01234337|Capecitabine|capecitabine|mesh-list
92758900|NCT01234337|Sorafenib|sorafenib|mesh-list
92758901|NCT01234337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92758902|NCT01234337|Antimetabolites|antimetabolites|mesh-ancestor
92758903|NCT01234337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758904|NCT01234337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758905|NCT01234337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92758906|NCT01234337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758907|NCT02848963|Ketamine|ketamine|mesh-list
92758908|NCT02848963|Propofol|propofol|mesh-list
92758909|NCT02848963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92758910|NCT02848963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92758911|NCT02848963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758912|NCT02848963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92758913|NCT02848963|Anesthetics, General|anesthetics, general|mesh-ancestor
92758914|NCT02848963|Anesthetics|anesthetics|mesh-ancestor
92758915|NCT02848963|Analgesics|analgesics|mesh-ancestor
92758916|NCT02848963|Sensory System Agents|sensory system agents|mesh-ancestor
92758917|NCT02848963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758918|NCT02848963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92758919|NCT02848963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92758920|NCT02848963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92758921|NCT02848963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758922|NCT02848963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758923|NCT01070043|Amlodipine|amlodipine|mesh-list
92758924|NCT01070043|Valsartan|valsartan|mesh-list
92758925|NCT01070043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92758926|NCT01070043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92758927|NCT01070043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758928|NCT01070043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758929|NCT01070043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92758930|NCT01070043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758931|NCT01070043|Vasodilator Agents|vasodilator agents|mesh-ancestor
92758932|NCT01070043|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92758933|NCT01070043|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92758934|NCT01074255|Aprepitant|aprepitant|mesh-list
92758935|NCT01074255|Antiemetics|antiemetics|mesh-ancestor
92758936|NCT01074255|Autonomic Agents|autonomic agents|mesh-ancestor
92758937|NCT01074255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92758938|NCT01074255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758939|NCT01074255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758940|NCT01074255|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92758941|NCT01074255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92758942|NCT01074255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758944|NCT02962063|Carboplatin|carboplatin|mesh-list
92758945|NCT02962063|Durvalumab|durvalumab|mesh-list
92758946|NCT02962063|Tremelimumab|tremelimumab|mesh-list
92758947|NCT02962063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92758948|NCT02962063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758949|NCT02962063|Tubulin Modulators|tubulin modulators|mesh-ancestor
92758950|NCT02962063|Antimitotic Agents|antimitotic agents|mesh-ancestor
92758951|NCT02962063|Mitosis Modulators|mitosis modulators|mesh-ancestor
92758952|NCT02962063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758953|NCT02962063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92758954|NCT01073943|Bisacodyl|bisacodyl|mesh-list
92758955|NCT01073943|Picosulfate sodium|picosulfate sodium|mesh-list
92758956|NCT01073943|Cathartics|cathartics|mesh-ancestor
92758957|NCT01073943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92758958|NCT01073943|Laxatives|laxatives|mesh-ancestor
92758959|NCT01073865|Goserelin|goserelin|mesh-list
92758960|NCT01073865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92758961|NCT01073865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758962|NCT04862065|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92758963|NCT04862065|Immunologic Factors|immunologic factors|mesh-ancestor
92758964|NCT04862065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758965|NCT01064635|Letrozole|letrozole|mesh-list
92758966|NCT01064635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92758967|NCT01064635|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92758968|NCT01064635|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92758969|NCT01064635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758970|NCT01064635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758971|NCT01064635|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92758972|NCT01064635|Hormone Antagonists|hormone antagonists|mesh-ancestor
92758973|NCT01064635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758974|NCT01064635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758975|NCT04697485|Eplerenone|eplerenone|mesh-list
92758976|NCT04697485|Bumetanide|bumetanide|mesh-list
92758977|NCT04697485|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92758978|NCT04697485|Hormone Antagonists|hormone antagonists|mesh-ancestor
92758979|NCT04697485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758980|NCT04697485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758981|NCT04697485|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92758982|NCT04697485|Diuretics|diuretics|mesh-ancestor
92758983|NCT04697485|Natriuretic Agents|natriuretic agents|mesh-ancestor
92758984|NCT04697485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92758985|NCT04697485|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92758986|NCT04697485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92758987|NCT04697485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758988|NCT01073631|Voriconazole|voriconazole|mesh-list
92758989|NCT01073631|Antifungal Agents|antifungal agents|mesh-ancestor
92758990|NCT01073631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92758991|NCT01073631|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92758992|NCT01073631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92758993|NCT01073631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92758994|NCT01073631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92758995|NCT01073631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92758996|NCT01073631|Hormone Antagonists|hormone antagonists|mesh-ancestor
92758997|NCT01073631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92758998|NCT01073631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92758999|NCT01073631|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92759000|NCT00626769|Genistein|genistein|mesh-list
92759001|NCT00626769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92759002|NCT00626769|Protective Agents|protective agents|mesh-ancestor
92759003|NCT00626769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759004|NCT00626769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759005|NCT00626769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92759006|NCT00626769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759007|NCT00626769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759008|NCT00626769|Phytoestrogens|phytoestrogens|mesh-ancestor
92759009|NCT00626769|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92759011|NCT00626769|Hormones|hormones|mesh-ancestor
92759012|NCT00626769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759013|NCT02875743|Posaconazole|posaconazole|mesh-list
92759014|NCT02875743|Antifungal Agents|antifungal agents|mesh-ancestor
92759015|NCT02875743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759016|NCT02875743|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92759017|NCT02875743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92759018|NCT02875743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92759019|NCT02875743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92759020|NCT02875743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92759021|NCT02875743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759022|NCT02875743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759023|NCT02875743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92759024|NCT02875743|Hormone Antagonists|hormone antagonists|mesh-ancestor
92759025|NCT02875743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759026|NCT02875743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759027|NCT01073163|Rituximab|rituximab|mesh-list
92759028|NCT01073163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92759029|NCT01073163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759030|NCT01073163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759031|NCT01073163|Immunologic Factors|immunologic factors|mesh-ancestor
92759032|NCT01073163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759033|NCT01073163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759034|NCT01073163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92759035|NCT01073163|Alkylating Agents|alkylating agents|mesh-ancestor
92759036|NCT01073163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759037|NCT02875821|Metformin|metformin|mesh-list
92759038|NCT02875821|Pioglitazone|pioglitazone|mesh-list
92759039|NCT02875821|Ipragliflozin|ipragliflozin|mesh-list
92759040|NCT02875821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759041|NCT02875821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759042|NCT02875821|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92759043|NCT02875821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759044|NCT04304313|Sildenafil Citrate|sildenafil citrate|mesh-list
92759045|NCT04304313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759046|NCT04304313|Vasodilator Agents|vasodilator agents|mesh-ancestor
92759047|NCT04304313|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92759048|NCT04304313|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92334493|NCT00004981|Lamivudine|lamivudine|mesh-list
92759049|NCT04304313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759050|NCT04304313|Urological Agents|urological agents|mesh-ancestor
92759051|NCT01072929|Modafinil|modafinil|mesh-list
92759052|NCT01072929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92759053|NCT01072929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759054|NCT01072929|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92759055|NCT01072929|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92759056|NCT01072929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92759057|NCT01072929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759058|NCT04753749|Aspirin|aspirin|mesh-list
92759059|NCT04753749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759060|NCT04753749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759061|NCT04753749|Analgesics|analgesics|mesh-ancestor
92759062|NCT04753749|Sensory System Agents|sensory system agents|mesh-ancestor
92759063|NCT04753749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759064|NCT04753749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759065|NCT04753749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759066|NCT04753749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759067|NCT04753749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92759068|NCT04753749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92759069|NCT04753749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759070|NCT04753749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92759071|NCT04753749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92759072|NCT04753749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759073|NCT04753749|Antipyretics|antipyretics|mesh-ancestor
92759074|NCT04305015|Analgesics, Opioid|analgesics, opioid|mesh-list
92759075|NCT04305015|Narcotics|narcotics|mesh-ancestor
92759076|NCT04305015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759077|NCT04305015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759078|NCT04305015|Analgesics|analgesics|mesh-ancestor
92759079|NCT04305015|Sensory System Agents|sensory system agents|mesh-ancestor
92709037|NCT00543933|Nitric Oxide|nitric oxide|mesh-list
92759080|NCT04305015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759081|NCT01231607|Finasteride|finasteride|mesh-list
92759082|NCT01231607|Dutasteride|dutasteride|mesh-list
92759083|NCT01231607|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92759084|NCT01231607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92759085|NCT01231607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759086|NCT01231607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759087|NCT01231607|Hormone Antagonists|hormone antagonists|mesh-ancestor
92759088|NCT01231607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759089|NCT01231607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759090|NCT01231607|Urological Agents|urological agents|mesh-ancestor
92759091|NCT01231373|Polidocanol|polidocanol|mesh-list
92759092|NCT01231373|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92759093|NCT01231373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92759095|NCT00975130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92759096|NCT00975130|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92759097|NCT00975130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759098|NCT00975130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759099|NCT00975130|Immunologic Factors|immunologic factors|mesh-ancestor
92759100|NCT00975130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759101|NCT01230827|Golimumab|golimumab|mesh-list
92759102|NCT01230827|Methotrexate|methotrexate|mesh-list
92759103|NCT01230827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92759104|NCT01230827|Abortifacient Agents|abortifacient agents|mesh-ancestor
92759105|NCT01230827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92759106|NCT01230827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759107|NCT01230827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759108|NCT01230827|Antimetabolites|antimetabolites|mesh-ancestor
92759109|NCT01230827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334502|NCT00004981|Antiviral Agents|antiviral agents|mesh-ancestor
92759110|NCT01230827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759111|NCT01230827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759112|NCT01230827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759113|NCT01230827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92759114|NCT01230827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759115|NCT01230827|Immunologic Factors|immunologic factors|mesh-ancestor
92759116|NCT01230827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759117|NCT01230827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92759118|NCT01230827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92759119|NCT01230827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759120|NCT01230749|Pioglitazone|pioglitazone|mesh-list
92759121|NCT01230749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759122|NCT01230749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759123|NCT00903175|Everolimus|everolimus|mesh-list
92759124|NCT00903175|Sunitinib|sunitinib|mesh-list
92759125|NCT00903175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92759126|NCT00903175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92759127|NCT00903175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759128|NCT00903175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759129|NCT00903175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759130|NCT00903175|Immunologic Factors|immunologic factors|mesh-ancestor
92759131|NCT00903175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759132|NCT00903175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759133|NCT00903175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92759134|NCT00903175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92759135|NCT00903175|Growth Substances|growth substances|mesh-ancestor
92759136|NCT00903175|Growth Inhibitors|growth inhibitors|mesh-ancestor
92759137|NCT01229735|Topiramate|topiramate|mesh-list
92759138|NCT01229735|Levetiracetam|levetiracetam|mesh-list
92759139|NCT01229735|Anticonvulsants|anticonvulsants|mesh-ancestor
92759140|NCT01229735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759141|NCT01229735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759142|NCT01229735|Nootropic Agents|nootropic agents|mesh-ancestor
92759143|NCT03866200|Resveratrol|resveratrol|mesh-list
92759144|NCT03866200|Antioxidants|antioxidants|mesh-ancestor
92759145|NCT03866200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759146|NCT03866200|Protective Agents|protective agents|mesh-ancestor
92759147|NCT03866200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759148|NCT03866200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759149|NCT03866200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92759150|NCT02848183|Cytarabine|cytarabine|mesh-list
92759151|NCT02848183|Etoposide|etoposide|mesh-list
92759152|NCT02848183|Mitoxantrone|mitoxantrone|mesh-list
92759153|NCT02848183|Idarubicin|idarubicin|mesh-list
92759154|NCT02848183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92759155|NCT02848183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759156|NCT02848183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92759158|NCT02848183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759159|NCT02848183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759160|NCT02848183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759161|NCT02848183|Antimetabolites|antimetabolites|mesh-ancestor
92759162|NCT02848183|Antiviral Agents|antiviral agents|mesh-ancestor
92759163|NCT02848183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759164|NCT02848183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759165|NCT02848183|Immunologic Factors|immunologic factors|mesh-ancestor
92759166|NCT02848183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759167|NCT02848183|Analgesics|analgesics|mesh-ancestor
92759168|NCT02848183|Sensory System Agents|sensory system agents|mesh-ancestor
92759169|NCT02848183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759170|NCT02848183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92759171|NCT00974974|Levodopa|levodopa|mesh-list
92759172|NCT00974974|Carbidopa|carbidopa|mesh-list
92759173|NCT00974974|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92759174|NCT00974974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92759175|NCT00974974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92759176|NCT00974974|Dopamine Agents|dopamine agents|mesh-ancestor
92759177|NCT00974974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759178|NCT00974974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759179|NCT00974974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759180|NCT00974974|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92759181|NCT00974974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759182|NCT00974974|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92759183|NCT00974974|Immunologic Factors|immunologic factors|mesh-ancestor
92759184|NCT00974974|Dopamine Agonists|dopamine agonists|mesh-ancestor
92759185|NCT02848417|Curcumin|curcumin|mesh-list
92759186|NCT02848417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759187|NCT02848417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759188|NCT02848417|Analgesics|analgesics|mesh-ancestor
92759189|NCT02848417|Sensory System Agents|sensory system agents|mesh-ancestor
92759190|NCT02848417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759191|NCT02848417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759192|NCT02848417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759193|NCT02848417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759194|NCT02848417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759195|NCT02848417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759196|NCT02848417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759197|NCT02847403|Exenatide|exenatide|mesh-list
92759198|NCT02847403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759199|NCT02847403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759200|NCT02847403|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92759201|NCT02847403|Incretins|incretins|mesh-ancestor
92759202|NCT02847403|Hormones|hormones|mesh-ancestor
92759203|NCT02847403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759204|NCT02848339|Aspirin|aspirin|mesh-list
92759205|NCT02848339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759206|NCT02848339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759207|NCT02848339|Analgesics|analgesics|mesh-ancestor
92759208|NCT02848339|Sensory System Agents|sensory system agents|mesh-ancestor
92759209|NCT02848339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759210|NCT02848339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759211|NCT02848339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759212|NCT02848339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759213|NCT02848339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92759214|NCT02848339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92759215|NCT02848339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759216|NCT02848339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92759217|NCT02848339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92759218|NCT02848339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759219|NCT02848339|Antipyretics|antipyretics|mesh-ancestor
92759220|NCT02847481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92759221|NCT02847481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92759222|NCT02847481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759223|NCT02847481|Antitubercular Agents|antitubercular agents|mesh-ancestor
92759224|NCT04216303|Chrysarobin|chrysarobin|mesh-list
92759225|NCT04216303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759226|NCT04216303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759227|NCT04216303|Analgesics|analgesics|mesh-ancestor
92759228|NCT04216303|Sensory System Agents|sensory system agents|mesh-ancestor
92709182|NCT03456531|Aspirin|aspirin|mesh-list
92759229|NCT04216303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759230|NCT04216303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759231|NCT04216303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759232|NCT04216303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759233|NCT02847013|Bupivacaine|bupivacaine|mesh-list
92759234|NCT02847013|Anesthetics, Local|anesthetics, local|mesh-ancestor
92759235|NCT02847013|Anesthetics|anesthetics|mesh-ancestor
92759236|NCT02847013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759237|NCT02847013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759238|NCT02847013|Sensory System Agents|sensory system agents|mesh-ancestor
92759239|NCT02847013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759240|NCT02847091|Ipragliflozin|ipragliflozin|mesh-list
92759241|NCT02847091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759242|NCT02847091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759243|NCT02847091|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92759244|NCT02847091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759245|NCT02846935|Decitabine|decitabine|mesh-list
92759246|NCT02846935|Tetrahydrouridine|tetrahydrouridine|mesh-list
92759247|NCT02846935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759248|NCT02846935|Antimetabolites|antimetabolites|mesh-ancestor
92759249|NCT02846935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759250|NCT02846935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759251|NCT02846935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759252|NCT02844673|Hydroxyurea|hydroxyurea|mesh-list
92759253|NCT02844673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759254|NCT02844673|Antisickling Agents|antisickling agents|mesh-ancestor
92759255|NCT02844673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759256|NCT02844673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759257|NCT02844673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92759258|NCT00992992|Tositumomab I-131|tositumomab i-131|mesh-list
92759259|NCT00992992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759260|NCT04201951|Tranexamic Acid|tranexamic acid|mesh-list
92759261|NCT04201951|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92759262|NCT04201951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92759263|NCT04201951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759264|NCT04201951|Hemostatics|hemostatics|mesh-ancestor
92759265|NCT04201951|Coagulants|coagulants|mesh-ancestor
92759266|NCT04753723|Gentamicins|gentamicins|mesh-list
92759267|NCT04753723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92759268|NCT04753723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759269|NCT04753723|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92759270|NCT04753723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759271|NCT04753723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759272|NCT04751851|Oxymetazoline|oxymetazoline|mesh-list
92759273|NCT04751851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92759274|NCT04751851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92759275|NCT04751851|Adrenergic Agents|adrenergic agents|mesh-ancestor
92759276|NCT04751851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759277|NCT04751851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759278|NCT04751851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759279|NCT04751851|Sympathomimetics|sympathomimetics|mesh-ancestor
92759280|NCT04751851|Autonomic Agents|autonomic agents|mesh-ancestor
92759281|NCT04751851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759282|NCT04751851|Nasal Decongestants|nasal decongestants|mesh-ancestor
92759283|NCT04751851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92759284|NCT04751851|Respiratory System Agents|respiratory system agents|mesh-ancestor
92759285|NCT02844517|Pancrelipase|pancrelipase|mesh-list
92759286|NCT02844517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759287|NCT03901729|Furosemide|furosemide|mesh-list
92759288|NCT03901729|Diuretics|diuretics|mesh-ancestor
92759289|NCT03901729|Natriuretic Agents|natriuretic agents|mesh-ancestor
92759290|NCT03901729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759291|NCT03901729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92759292|NCT03901729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92759293|NCT03901729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759294|NCT02846857|Insulin|insulin|mesh-list
92759295|NCT02846857|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92759296|NCT02846857|Glucagon|glucagon|mesh-list
92759297|NCT02846857|Hormones|hormones|mesh-list
92759298|NCT02846857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759299|NCT02846857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759300|NCT02846857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759301|NCT02846857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759302|NCT04672525|Rifampin|rifampin|mesh-list
92759303|NCT04672525|Rifabutin|rifabutin|mesh-list
92759304|NCT04672525|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92759305|NCT04672525|Antitubercular Agents|antitubercular agents|mesh-ancestor
92759306|NCT04672525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92759307|NCT04672525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759309|NCT04672525|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92759310|NCT04672525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759311|NCT04672525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759312|NCT04672525|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92759313|NCT04672525|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92759314|NCT04672525|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92759315|NCT04672525|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92759316|NCT04672525|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92759317|NCT04672525|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92759318|NCT00992446|Cytarabine|cytarabine|mesh-list
92759319|NCT00992446|Rituximab|rituximab|mesh-list
92759320|NCT00992446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92759321|NCT00992446|Etoposide|etoposide|mesh-list
92759322|NCT00992446|Etoposide phosphate|etoposide phosphate|mesh-list
92759323|NCT00992446|Bortezomib|bortezomib|mesh-list
92759324|NCT00992446|Melphalan|melphalan|mesh-list
92759325|NCT00992446|Mechlorethamine|mechlorethamine|mesh-list
92759326|NCT00992446|Vorinostat|vorinostat|mesh-list
92759327|NCT00992446|Carmustine|carmustine|mesh-list
92759328|NCT00992446|Podophyllotoxin|podophyllotoxin|mesh-list
92759329|NCT00992446|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92759330|NCT00992446|Antibodies|antibodies|mesh-list
92759331|NCT00992446|Immunoglobulins|immunoglobulins|mesh-list
92759332|NCT00992446|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92759333|NCT00992446|Immunologic Factors|immunologic factors|mesh-ancestor
92759334|NCT00992446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759335|NCT00992446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759336|NCT00992446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759337|NCT00992446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92759338|NCT00992446|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92759339|NCT00992446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92759340|NCT00992446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759341|NCT00992446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759342|NCT00992446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759343|NCT00992446|Antimetabolites|antimetabolites|mesh-ancestor
92759344|NCT00992446|Antiviral Agents|antiviral agents|mesh-ancestor
92759345|NCT00992446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759346|NCT00992446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759347|NCT00992446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92759348|NCT00992446|Alkylating Agents|alkylating agents|mesh-ancestor
92759349|NCT00992446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92759350|NCT00992446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92759351|NCT00992446|Keratolytic Agents|keratolytic agents|mesh-ancestor
92759352|NCT00992446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759353|NCT00992446|Tubulin Modulators|tubulin modulators|mesh-ancestor
92759354|NCT00992446|Antimitotic Agents|antimitotic agents|mesh-ancestor
92759355|NCT00992446|Mitosis Modulators|mitosis modulators|mesh-ancestor
92759356|NCT04452565|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92759357|NCT04452565|Dexamethasone|dexamethasone|mesh-list
92759358|NCT04452565|Dexamethasone acetate|dexamethasone acetate|mesh-list
92759359|NCT04452565|BB 1101|bb 1101|mesh-list
92759360|NCT04452565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759361|NCT04452565|Antiemetics|antiemetics|mesh-ancestor
92759362|NCT04452565|Autonomic Agents|autonomic agents|mesh-ancestor
92759363|NCT04452565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759364|NCT04452565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759365|NCT04452565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759366|NCT04452565|Glucocorticoids|glucocorticoids|mesh-ancestor
92759367|NCT04452565|Hormones|hormones|mesh-ancestor
92759368|NCT04452565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759369|NCT04452565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92759370|NCT04452565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759371|NCT04452565|Protease Inhibitors|protease inhibitors|mesh-ancestor
92759372|NCT04452565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759373|NCT04452565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759374|NCT04452565|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92759375|NCT04452565|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92759376|NCT04452565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92759377|NCT04452565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92759378|NCT04452565|Antiviral Agents|antiviral agents|mesh-ancestor
92709334|NCT00544596|Retinol acetate|retinol acetate|mesh-list
92759379|NCT04452565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759380|NCT02863120|Bupivacaine|bupivacaine|mesh-list
92759381|NCT02863120|Ropivacaine|ropivacaine|mesh-list
92759382|NCT02863120|Anesthetics, Local|anesthetics, local|mesh-ancestor
92759383|NCT02863120|Anesthetics|anesthetics|mesh-ancestor
92759384|NCT02863120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759385|NCT02863120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759386|NCT02863120|Sensory System Agents|sensory system agents|mesh-ancestor
92759387|NCT02863120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759388|NCT03823534|Acetaminophen|acetaminophen|mesh-list
92759389|NCT03823534|Ketorolac|ketorolac|mesh-list
92759390|NCT03823534|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92759391|NCT03823534|Morphine|morphine|mesh-list
92759392|NCT03823534|Oxycodone|oxycodone|mesh-list
92759393|NCT03823534|Hydrocodone|hydrocodone|mesh-list
92759394|NCT03823534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92759395|NCT03823534|Narcotics|narcotics|mesh-ancestor
92759396|NCT03823534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759397|NCT03823534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759398|NCT03823534|Analgesics|analgesics|mesh-ancestor
92759399|NCT03823534|Sensory System Agents|sensory system agents|mesh-ancestor
92759400|NCT03823534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759401|NCT03823534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759402|NCT03823534|Antipyretics|antipyretics|mesh-ancestor
92759403|NCT03823534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759404|NCT03823534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759405|NCT03823534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759406|NCT03823534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92759407|NCT03823534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759408|NCT03823534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759409|NCT03823534|Antitussive Agents|antitussive agents|mesh-ancestor
92759410|NCT03823534|Respiratory System Agents|respiratory system agents|mesh-ancestor
92759411|NCT02846701|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92759412|NCT02846701|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92759413|NCT02846701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92759414|NCT02846701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92759415|NCT02846701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759416|NCT02846701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759417|NCT02846701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759418|NCT02846701|Analgesics|analgesics|mesh-ancestor
92759419|NCT02846701|Sensory System Agents|sensory system agents|mesh-ancestor
92759420|NCT02846701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759421|NCT02846701|Antidepressive Agents|antidepressive agents|mesh-ancestor
92759422|NCT02846701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92759423|NCT02846701|Dopamine Agents|dopamine agents|mesh-ancestor
92759424|NCT04327063|Ropivacaine|ropivacaine|mesh-list
92759425|NCT04327063|Anesthetics, Local|anesthetics, local|mesh-ancestor
92759426|NCT04327063|Anesthetics|anesthetics|mesh-ancestor
92759427|NCT04327063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759428|NCT04327063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759429|NCT04327063|Sensory System Agents|sensory system agents|mesh-ancestor
92759430|NCT04327063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759431|NCT04565431|Natalizumab|natalizumab|mesh-list
92759432|NCT04565431|Immunologic Factors|immunologic factors|mesh-ancestor
92759433|NCT04565431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759434|NCT04292704|Clotrimazole|clotrimazole|mesh-list
92759435|NCT04292704|Miconazole|miconazole|mesh-list
92759436|NCT04292704|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92759437|NCT04292704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759438|NCT04292704|Antifungal Agents|antifungal agents|mesh-ancestor
92759439|NCT04292704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92759440|NCT04292704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92759441|NCT04292704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759442|NCT04292704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759443|NCT04292704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92759444|NCT04292704|Hormone Antagonists|hormone antagonists|mesh-ancestor
92759445|NCT04292704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759446|NCT04292704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759447|NCT04292704|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92759448|NCT04292704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92759449|NCT05242783|Terlipressin|terlipressin|mesh-list
92759450|NCT05242783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92759451|NCT05242783|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92759452|NCT03987685|Topotecan|topotecan|mesh-list
92759453|NCT03987685|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92759454|NCT03987685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92759455|NCT03987685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759456|NCT03987685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759457|NCT03987685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759459|NCT00900757|Antiemetics|antiemetics|mesh-ancestor
92759460|NCT00900757|Autonomic Agents|autonomic agents|mesh-ancestor
92759461|NCT00900757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759462|NCT00900757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759463|NCT00900757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759464|NCT00900757|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92759465|NCT00900757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92759466|NCT00900757|Serotonin Agents|serotonin agents|mesh-ancestor
92759467|NCT00900757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759468|NCT00900757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759469|NCT04136743|Dexamethasone|dexamethasone|mesh-list
92759470|NCT04136743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759471|NCT04136743|Antiemetics|antiemetics|mesh-ancestor
92759472|NCT04136743|Autonomic Agents|autonomic agents|mesh-ancestor
92759473|NCT04136743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759474|NCT04136743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759475|NCT04136743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759476|NCT04136743|Glucocorticoids|glucocorticoids|mesh-ancestor
92759477|NCT04136743|Hormones|hormones|mesh-ancestor
92759478|NCT04136743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759479|NCT04136743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92759480|NCT04136743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759481|NCT03931057|Midazolam|midazolam|mesh-list
92759482|NCT03931057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92759483|NCT03931057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92759484|NCT03931057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759485|NCT03931057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759486|NCT03931057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92759487|NCT03931057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92759488|NCT03931057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92759489|NCT03931057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92759490|NCT03931057|Anesthetics, General|anesthetics, general|mesh-ancestor
92759491|NCT03931057|Anesthetics|anesthetics|mesh-ancestor
92759492|NCT03931057|GABA Modulators|gaba modulators|mesh-ancestor
92759493|NCT03931057|GABA Agents|gaba agents|mesh-ancestor
92759494|NCT03931057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759495|NCT03931057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759496|NCT02846155|Simethicone|simethicone|mesh-list
92759497|NCT02846155|Antifoaming Agents|antifoaming agents|mesh-ancestor
92759498|NCT02846155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759499|NCT02846155|Emollients|emollients|mesh-ancestor
92759500|NCT02846155|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759501|NCT02845843|Interferons|interferons|mesh-list
92759502|NCT02845843|Ritonavir|ritonavir|mesh-list
92759503|NCT02845843|Lopinavir|lopinavir|mesh-list
92759504|NCT02845843|Interferon-beta|interferon-beta|mesh-list
92759505|NCT02845843|Interferon beta-1b|interferon beta-1b|mesh-list
92759506|NCT02845843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759507|NCT02845843|Antiviral Agents|antiviral agents|mesh-ancestor
92759508|NCT02845843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759509|NCT02845843|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92759510|NCT02845843|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92759511|NCT02845843|Protease Inhibitors|protease inhibitors|mesh-ancestor
92759512|NCT02845843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759513|NCT02845843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759514|NCT02845843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92759515|NCT02845843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92759516|NCT02845843|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92759517|NCT02845843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92759518|NCT02845843|Immunologic Factors|immunologic factors|mesh-ancestor
92759519|NCT02845843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759520|NCT02845843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92759521|NCT02845999|Cyclophosphamide|cyclophosphamide|mesh-list
92759522|NCT02845999|Fludarabine|fludarabine|mesh-list
92759523|NCT02845999|Cetuximab|cetuximab|mesh-list
92759524|NCT02845999|Interleukin-2|interleukin-2|mesh-list
92759525|NCT02845999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709479|NCT04647344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759526|NCT02845999|Immunologic Factors|immunologic factors|mesh-ancestor
92759527|NCT02845999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759528|NCT02845999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759529|NCT02845999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92759530|NCT02845999|Alkylating Agents|alkylating agents|mesh-ancestor
92759531|NCT02845999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759532|NCT02845999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759533|NCT02845999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92759534|NCT02845999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759535|NCT02845999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759536|NCT02845999|Analgesics|analgesics|mesh-ancestor
92759537|NCT02845999|Sensory System Agents|sensory system agents|mesh-ancestor
92759538|NCT02845999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759539|NCT05337085|Midazolam|midazolam|mesh-list
92759540|NCT05337085|Dexmedetomidine|dexmedetomidine|mesh-list
92759541|NCT05337085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92759542|NCT05337085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759543|NCT05337085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759544|NCT05337085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759545|NCT05337085|Analgesics|analgesics|mesh-ancestor
92759546|NCT05337085|Sensory System Agents|sensory system agents|mesh-ancestor
92759547|NCT05337085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759548|NCT05337085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92759549|NCT05337085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92759550|NCT05337085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92759551|NCT05337085|Adrenergic Agents|adrenergic agents|mesh-ancestor
92759552|NCT05337085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759553|NCT05337085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759554|NCT05337085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92759555|NCT05337085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92759556|NCT05337085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92759557|NCT05337085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92759558|NCT05337085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92759559|NCT05337085|Anesthetics, General|anesthetics, general|mesh-ancestor
92759560|NCT05337085|Anesthetics|anesthetics|mesh-ancestor
92759561|NCT05337085|GABA Modulators|gaba modulators|mesh-ancestor
92759562|NCT05337085|GABA Agents|gaba agents|mesh-ancestor
92759563|NCT02845765|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92759564|NCT02845765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92759565|NCT02845765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759566|NCT02845765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759567|NCT01723579|Estradiol|estradiol|mesh-list
92759568|NCT01723579|Estrogens|estrogens|mesh-ancestor
92759569|NCT01723579|Hormones|hormones|mesh-ancestor
92759570|NCT01723579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759571|NCT01723579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759572|NCT00901927|Rituximab|rituximab|mesh-list
92759573|NCT00901927|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92759574|NCT00901927|Mitoxantrone|mitoxantrone|mesh-list
92759575|NCT00901927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759576|NCT00901927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759577|NCT00901927|Immunologic Factors|immunologic factors|mesh-ancestor
92759578|NCT00901927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759579|NCT00901927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759580|NCT00901927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92759581|NCT00901927|Alkylating Agents|alkylating agents|mesh-ancestor
92759582|NCT00901927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759583|NCT00901927|Analgesics|analgesics|mesh-ancestor
92759584|NCT00901927|Sensory System Agents|sensory system agents|mesh-ancestor
92759585|NCT00901927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759586|NCT00901927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92759587|NCT00901927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92759588|NCT00901927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759589|NCT05335837|Anesthetics|anesthetics|mesh-list
92759590|NCT05335837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759591|NCT05335837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759592|NCT00903721|Mometasone Furoate|mometasone furoate|mesh-list
92759593|NCT00903721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759594|NCT00903721|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759595|NCT00903721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92759596|NCT02845219|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92759597|NCT02845219|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92759598|NCT02845219|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92759599|NCT02845219|Contraceptive Agents|contraceptive agents|mesh-ancestor
92759600|NCT02845219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709555|NCT04682184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92759601|NCT02845219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759602|NCT02845219|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92759603|NCT02845219|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92759604|NCT02845219|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92759605|NCT02845219|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92759606|NCT02845219|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92759607|NCT02845219|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92759608|NCT02845219|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92759609|NCT02845219|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92759610|NCT00968968|Trastuzumab|trastuzumab|mesh-list
92759612|NCT00968968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759613|NCT00968968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759614|NCT00968968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92759615|NCT00968968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759616|NCT00968968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759618|NCT00973102|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92759619|NCT00973102|Hormones|hormones|mesh-ancestor
92759620|NCT00973102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759621|NCT00973102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759622|NCT03691090|Paclitaxel|paclitaxel|mesh-list
92759623|NCT03691090|Cisplatin|cisplatin|mesh-list
92759624|NCT03691090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92759625|NCT03691090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759626|NCT03691090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92759627|NCT03691090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92759628|NCT03691090|Mitosis Modulators|mitosis modulators|mesh-ancestor
92759629|NCT03691090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759630|NCT00783211|Fexofenadine|fexofenadine|mesh-list
92759631|NCT00783211|Desloratadine|desloratadine|mesh-list
92759632|NCT00783211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92759633|NCT00783211|Cholinergic Agents|cholinergic agents|mesh-ancestor
92759634|NCT00783211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759635|NCT00783211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759636|NCT00783211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759637|NCT00783211|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92759638|NCT00783211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92759639|NCT00783211|Histamine Antagonists|histamine antagonists|mesh-ancestor
92759640|NCT00783211|Histamine Agents|histamine agents|mesh-ancestor
92759641|NCT00783211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92759642|NCT03679546|Infliximab|infliximab|mesh-list
92759643|NCT03679546|Vedolizumab|vedolizumab|mesh-list
92759644|NCT03679546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92759645|NCT03679546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759646|NCT03679546|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759647|NCT03679546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759648|NCT03679546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759649|NCT00779545|Mometasone Furoate|mometasone furoate|mesh-list
92759650|NCT00779545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759651|NCT00779545|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759652|NCT00779545|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92759653|NCT03679312|Nitric Oxide|nitric oxide|mesh-list
92759654|NCT03679312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92759655|NCT03679312|Autonomic Agents|autonomic agents|mesh-ancestor
92759656|NCT03679312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759657|NCT03679312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759658|NCT03679312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92759659|NCT03679312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92759660|NCT03679312|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92759661|NCT03679312|Antioxidants|antioxidants|mesh-ancestor
92759662|NCT03679312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759663|NCT03679312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759664|NCT03679312|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92759665|NCT03679312|Vasodilator Agents|vasodilator agents|mesh-ancestor
92759666|NCT03679312|Gasotransmitters|gasotransmitters|mesh-ancestor
92759667|NCT03679312|Protective Agents|protective agents|mesh-ancestor
92759668|NCT02842567|Vitamin E|vitamin e|mesh-list
92759669|NCT02842567|Tocopherols|tocopherols|mesh-list
92759670|NCT02842567|alpha-Tocopherol|alpha-tocopherol|mesh-list
92759671|NCT02842567|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92759672|NCT02842567|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
92759673|NCT02842567|Vitamins|vitamins|mesh-ancestor
92759674|NCT02842567|Micronutrients|micronutrients|mesh-ancestor
92759675|NCT02842567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759677|NCT02842567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759678|NCT02842567|Protective Agents|protective agents|mesh-ancestor
92759679|NCT02842567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759680|NCT02842567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92759681|NCT02842567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92759683|NCT00705211|Ezetimibe|ezetimibe|mesh-list
92759684|NCT00705211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92759685|NCT00705211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92759686|NCT00705211|Antimetabolites|antimetabolites|mesh-ancestor
92759687|NCT00705211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759688|NCT00705211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92759689|NCT02839213|Scopolamine|scopolamine|mesh-list
92759690|NCT02839213|Bromides|bromides|mesh-list
92759691|NCT02839213|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92759692|NCT02839213|Anticonvulsants|anticonvulsants|mesh-ancestor
92759693|NCT02839213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92759694|NCT02839213|Antiemetics|antiemetics|mesh-ancestor
92759695|NCT02839213|Autonomic Agents|autonomic agents|mesh-ancestor
92759696|NCT02839213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759697|NCT02839213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759698|NCT02839213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759699|NCT02839213|Mydriatics|mydriatics|mesh-ancestor
92759700|NCT02839213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92759701|NCT02839213|Cholinergic Agents|cholinergic agents|mesh-ancestor
92759702|NCT02839213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759703|NCT02839213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759704|NCT02839213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92759705|NCT02839213|Parasympatholytics|parasympatholytics|mesh-ancestor
92759706|NCT05334043|Curcumin|curcumin|mesh-list
92759707|NCT05334043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759708|NCT05334043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759709|NCT05334043|Analgesics|analgesics|mesh-ancestor
92759710|NCT05334043|Sensory System Agents|sensory system agents|mesh-ancestor
92759711|NCT05334043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759712|NCT05334043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759713|NCT05334043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759714|NCT05334043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759715|NCT05334043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759716|NCT05334043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759717|NCT05334043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759718|NCT02838823|Antibodies|antibodies|mesh-list
92759719|NCT02838823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92759720|NCT02838823|Immunologic Factors|immunologic factors|mesh-ancestor
92759721|NCT02838823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759722|NCT00156091|Olanzapine|olanzapine|mesh-list
92759723|NCT00156091|Asenapine|asenapine|mesh-list
92759724|NCT00156091|Antiemetics|antiemetics|mesh-ancestor
92759725|NCT00156091|Autonomic Agents|autonomic agents|mesh-ancestor
92759726|NCT00156091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759727|NCT00156091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759728|NCT00156091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759729|NCT00156091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92759730|NCT00156091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92759731|NCT00156091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759732|NCT00156091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92759733|NCT00156091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92759734|NCT00156091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92759735|NCT00156091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92759736|NCT00156091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759737|NCT00156091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759738|NCT00156091|Serotonin Agents|serotonin agents|mesh-ancestor
92759739|NCT00140959|Losartan|losartan|mesh-list
92759740|NCT00140959|Atenolol|atenolol|mesh-list
92759741|NCT00140959|Amlodipine|amlodipine|mesh-list
92759742|NCT00140959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92759743|NCT00140959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92759744|NCT00140959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92759745|NCT00140959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759746|NCT00140959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92759747|NCT00140959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759748|NCT00140959|Vasodilator Agents|vasodilator agents|mesh-ancestor
92759749|NCT00140959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92709707|NCT04643483|Adalimumab|adalimumab|mesh-list
92759750|NCT00140959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92759751|NCT00140959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92759752|NCT00140959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92759753|NCT00140959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759755|NCT00140959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759756|NCT00140959|Sympatholytics|sympatholytics|mesh-ancestor
92759757|NCT00140959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92759758|NCT00140959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92759759|NCT00140959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92759760|NCT00095017|Etoricoxib|etoricoxib|mesh-list
92759761|NCT00095017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759762|NCT00095017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759763|NCT00095017|Analgesics|analgesics|mesh-ancestor
92759764|NCT00095017|Sensory System Agents|sensory system agents|mesh-ancestor
92759765|NCT00095017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759766|NCT00095017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759767|NCT00095017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759768|NCT00095017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759769|NCT00095017|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92759770|NCT00095017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92759771|NCT00095017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759772|NCT00095017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759773|NCT00092755|Ibuprofen|ibuprofen|mesh-list
92759774|NCT00092755|Etoricoxib|etoricoxib|mesh-list
92759775|NCT00092755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759776|NCT00092755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759777|NCT00092755|Analgesics|analgesics|mesh-ancestor
92759778|NCT00092755|Sensory System Agents|sensory system agents|mesh-ancestor
92759779|NCT00092755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759780|NCT00092755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759781|NCT00092755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759782|NCT00092755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759783|NCT00092755|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92759784|NCT00092755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759785|NCT00092755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759786|NCT00092755|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92759787|NCT00899431|Rituximab|rituximab|mesh-list
92759788|NCT00899431|Fludarabine|fludarabine|mesh-list
92759789|NCT00899431|Fludarabine phosphate|fludarabine phosphate|mesh-list
92759790|NCT00899431|Lenalidomide|lenalidomide|mesh-list
92759791|NCT00899431|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92759792|NCT00899431|Allopurinol|allopurinol|mesh-list
92759793|NCT00899431|Thymoglobulin|thymoglobulin|mesh-list
92759794|NCT00899431|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92759795|NCT00899431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759796|NCT00899431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759797|NCT00899431|Immunologic Factors|immunologic factors|mesh-ancestor
92759798|NCT00899431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759799|NCT00899431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759800|NCT00899431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759801|NCT00899431|Antimetabolites|antimetabolites|mesh-ancestor
92759802|NCT00899431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759803|NCT00899431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759804|NCT00899431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92759805|NCT00899431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92759806|NCT00899431|Growth Substances|growth substances|mesh-ancestor
92759807|NCT00899431|Growth Inhibitors|growth inhibitors|mesh-ancestor
92759808|NCT00899431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92759809|NCT00899431|Alkylating Agents|alkylating agents|mesh-ancestor
92759810|NCT00899431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759811|NCT00899431|Gout Suppressants|gout suppressants|mesh-ancestor
92759812|NCT00899431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92759813|NCT00899431|Antioxidants|antioxidants|mesh-ancestor
92759814|NCT00899431|Protective Agents|protective agents|mesh-ancestor
92759815|NCT00898807|Citalopram|citalopram|mesh-list
92759816|NCT00898807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92334632|NCT00005023|Sargramostim|sargramostim|mesh-list
92759817|NCT00898807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92759818|NCT00898807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92759819|NCT00898807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759820|NCT00898807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759821|NCT00898807|Serotonin Agents|serotonin agents|mesh-ancestor
92759822|NCT00898807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759823|NCT00898807|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92759824|NCT00898807|Antidepressive Agents|antidepressive agents|mesh-ancestor
92759825|NCT00898807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92759826|NCT01229267|Vaccines|vaccines|mesh-list
92759827|NCT01229267|Immunologic Factors|immunologic factors|mesh-ancestor
92759828|NCT01229267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759829|NCT00897715|Rilonacept|rilonacept|mesh-list
92759830|NCT00897715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759831|NCT01229111|Leucovorin|leucovorin|mesh-list
92759832|NCT01229111|Fluorouracil|fluorouracil|mesh-list
92759833|NCT01229111|Oxaliplatin|oxaliplatin|mesh-list
92759834|NCT01229111|Cediranib|cediranib|mesh-list
92759835|NCT01229111|Calcium|calcium|mesh-list
92759836|NCT01229111|Levoleucovorin|levoleucovorin|mesh-list
92759837|NCT01229111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92759838|NCT01229111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759839|NCT01229111|Antimetabolites|antimetabolites|mesh-ancestor
92759840|NCT01229111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759841|NCT01229111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759842|NCT01229111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759843|NCT01229111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759844|NCT01229111|Immunologic Factors|immunologic factors|mesh-ancestor
92759845|NCT01229111|Antidotes|antidotes|mesh-ancestor
92759846|NCT01229111|Protective Agents|protective agents|mesh-ancestor
92759847|NCT01229111|Vitamin B Complex|vitamin b complex|mesh-ancestor
92759848|NCT01229111|Vitamins|vitamins|mesh-ancestor
92759849|NCT01229111|Micronutrients|micronutrients|mesh-ancestor
92759850|NCT01229111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759851|NCT01229111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92759852|NCT02843815|Immunomodulating Agents|immunomodulating agents|mesh-list
92759853|NCT02843815|Immunologic Factors|immunologic factors|mesh-ancestor
92759854|NCT02843815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759855|NCT01228175|Riboflavin|riboflavin|mesh-list
92759856|NCT01228175|Varenicline|varenicline|mesh-list
92759857|NCT01228175|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92759858|NCT01228175|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92759859|NCT01228175|Cholinergic Agents|cholinergic agents|mesh-ancestor
92759860|NCT01228175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759861|NCT01228175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759862|NCT01228175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759863|NCT01228175|Vitamin B Complex|vitamin b complex|mesh-ancestor
92759864|NCT01228175|Vitamins|vitamins|mesh-ancestor
92759865|NCT01228175|Micronutrients|micronutrients|mesh-ancestor
92759866|NCT01228175|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92759867|NCT01228175|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759868|NCT01228019|Niacin|niacin|mesh-list
92759869|NCT01228019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92759870|NCT01228019|Antimetabolites|antimetabolites|mesh-ancestor
92759871|NCT01228019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759872|NCT01228019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92759873|NCT01228019|Vasodilator Agents|vasodilator agents|mesh-ancestor
92759874|NCT01228019|Vitamin B Complex|vitamin b complex|mesh-ancestor
92759875|NCT01228019|Vitamins|vitamins|mesh-ancestor
92759876|NCT01228019|Micronutrients|micronutrients|mesh-ancestor
92759877|NCT01228019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759878|NCT01227707|Leucovorin|leucovorin|mesh-list
92759879|NCT01227707|Bevacizumab|bevacizumab|mesh-list
92759880|NCT01227707|Fluorouracil|fluorouracil|mesh-list
92759881|NCT01227707|Capecitabine|capecitabine|mesh-list
92494490|NCT01975714|Bimatoprost|bimatoprost|mesh-list
92759882|NCT01227707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759883|NCT01227707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759884|NCT01227707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92759885|NCT01227707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92759886|NCT01227707|Growth Substances|growth substances|mesh-ancestor
92759887|NCT01227707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759888|NCT01227707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92759889|NCT01227707|Antimetabolites|antimetabolites|mesh-ancestor
92759890|NCT01227707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759891|NCT01227707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92759892|NCT01227707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759893|NCT01227707|Immunologic Factors|immunologic factors|mesh-ancestor
92759894|NCT01227707|Antidotes|antidotes|mesh-ancestor
92759895|NCT01227707|Protective Agents|protective agents|mesh-ancestor
92759896|NCT01227707|Vitamin B Complex|vitamin b complex|mesh-ancestor
92759897|NCT01227707|Vitamins|vitamins|mesh-ancestor
92759898|NCT01227707|Micronutrients|micronutrients|mesh-ancestor
92759899|NCT00633373|Cyclosporine|cyclosporine|mesh-list
92759900|NCT00633373|Cyclosporins|cyclosporins|mesh-list
92759901|NCT00633373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759902|NCT00633373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759903|NCT00633373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92759904|NCT00633373|Immunologic Factors|immunologic factors|mesh-ancestor
92759905|NCT00633373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759906|NCT00633373|Antifungal Agents|antifungal agents|mesh-ancestor
92759907|NCT00633373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759908|NCT00633373|Dermatologic Agents|dermatologic agents|mesh-ancestor
92759909|NCT00633373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759910|NCT00633373|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92759911|NCT05334745|Hyaluronic Acid|hyaluronic acid|mesh-list
92759912|NCT05334745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92759913|NCT05334745|Immunologic Factors|immunologic factors|mesh-ancestor
92759914|NCT05334745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759915|NCT05334745|Viscosupplements|viscosupplements|mesh-ancestor
92759916|NCT05334745|Protective Agents|protective agents|mesh-ancestor
92759917|NCT02838589|Exenatide|exenatide|mesh-list
92759918|NCT02838589|Glucagon|glucagon|mesh-list
92759919|NCT02838589|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92759920|NCT02838589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92759921|NCT02838589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759922|NCT02838589|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92759923|NCT02838589|Incretins|incretins|mesh-ancestor
92759924|NCT02838589|Hormones|hormones|mesh-ancestor
92759925|NCT02838589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759926|NCT02838589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759927|NCT02839135|Scopolamine|scopolamine|mesh-list
92759928|NCT02839135|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92759929|NCT02839135|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92759930|NCT02839135|Antiemetics|antiemetics|mesh-ancestor
92759931|NCT02839135|Autonomic Agents|autonomic agents|mesh-ancestor
92759932|NCT02839135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759933|NCT02839135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759934|NCT02839135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92759935|NCT02839135|Mydriatics|mydriatics|mesh-ancestor
92759936|NCT02839135|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92759937|NCT02839135|Cholinergic Agents|cholinergic agents|mesh-ancestor
92759938|NCT02839135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759939|NCT02839135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759940|NCT02839135|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92759941|NCT02839135|Parasympatholytics|parasympatholytics|mesh-ancestor
92759942|NCT00895843|Ibuprofen|ibuprofen|mesh-list
92759943|NCT00895843|Epinephrine|epinephrine|mesh-list
92759944|NCT00895843|Bupivacaine|bupivacaine|mesh-list
92759945|NCT00895843|Anesthetics, Local|anesthetics, local|mesh-ancestor
92759946|NCT00895843|Anesthetics|anesthetics|mesh-ancestor
92759947|NCT00895843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92759948|NCT00895843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759949|NCT00895843|Sensory System Agents|sensory system agents|mesh-ancestor
92759950|NCT00895843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92759951|NCT00895843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92759952|NCT00895843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92759953|NCT00895843|Analgesics|analgesics|mesh-ancestor
92759954|NCT00895843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92759955|NCT00895843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92759956|NCT00895843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92759957|NCT00895843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759958|NCT00895843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759959|NCT00895843|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92759960|NCT00895843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92759961|NCT00895843|Adrenergic Agents|adrenergic agents|mesh-ancestor
92759962|NCT00895843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92759963|NCT00895843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92759964|NCT00895843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92759965|NCT00895843|Autonomic Agents|autonomic agents|mesh-ancestor
92759966|NCT00895843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92759967|NCT00895843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92759968|NCT00895843|Mydriatics|mydriatics|mesh-ancestor
92759969|NCT00895843|Sympathomimetics|sympathomimetics|mesh-ancestor
92759970|NCT00895843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92759971|NCT05333809|Pembrolizumab|pembrolizumab|mesh-list
92759972|NCT05333809|Disitamab vedotin|disitamab vedotin|mesh-list
92759973|NCT05333809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92759974|NCT05333809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92759975|NCT05333809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92759976|NCT05333809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759977|NCT05333809|Immunoconjugates|immunoconjugates|mesh-ancestor
92759978|NCT05333809|Immunologic Factors|immunologic factors|mesh-ancestor
92759979|NCT05333809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759980|NCT05333731|Oxytocin|oxytocin|mesh-list
92759982|NCT05333731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92759983|NCT05333731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759984|NCT02843581|Immunomodulating Agents|immunomodulating agents|mesh-list
92759985|NCT02843581|Immunologic Factors|immunologic factors|mesh-ancestor
92759986|NCT02843581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759987|NCT00895453|Iron|iron|mesh-list
92759988|NCT00895453|Itraconazole|itraconazole|mesh-list
92759989|NCT00895453|Antifungal Agents|antifungal agents|mesh-ancestor
92759990|NCT00895453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92759991|NCT00895453|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92759992|NCT00895453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92759993|NCT00895453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92759994|NCT00895453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92759995|NCT00895453|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92759996|NCT00895453|Hormone Antagonists|hormone antagonists|mesh-ancestor
92759997|NCT00895453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92759998|NCT00895453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92759999|NCT00895453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92760000|NCT00895453|Trace Elements|trace elements|mesh-ancestor
92760001|NCT00895453|Micronutrients|micronutrients|mesh-ancestor
92760002|NCT00893737|Naproxen|naproxen|mesh-list
92760003|NCT00893737|Sumatriptan|sumatriptan|mesh-list
92760004|NCT00893737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92760005|NCT00893737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92760006|NCT00893737|Analgesics|analgesics|mesh-ancestor
92760007|NCT00893737|Sensory System Agents|sensory system agents|mesh-ancestor
92760008|NCT00893737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760009|NCT00893737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760010|NCT00893737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760011|NCT00893737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760012|NCT00893737|Gout Suppressants|gout suppressants|mesh-ancestor
92760013|NCT00893737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92760014|NCT00893737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760015|NCT00893737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760016|NCT00893737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92494491|NCT01975714|Latanoprost|latanoprost|mesh-list
92760017|NCT00893737|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92760018|NCT00893737|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92760019|NCT00893737|Serotonin Agents|serotonin agents|mesh-ancestor
92760020|NCT00893737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760021|NCT00893113|Alfuzosin|alfuzosin|mesh-list
92760022|NCT00893113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92760023|NCT00893113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92760024|NCT00893113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92760025|NCT00893113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760026|NCT00893113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760027|NCT00893113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760028|NCT00893113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760029|NCT00893113|Urological Agents|urological agents|mesh-ancestor
92760030|NCT02840929|Esomeprazole|esomeprazole|mesh-list
92760031|NCT02840929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92760032|NCT02840929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760033|NCT02840929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92760034|NCT02840929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760035|NCT02840929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760036|NCT02838121|Zoledronic Acid|zoledronic acid|mesh-list
92760037|NCT02838121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92760038|NCT02838121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760039|NCT02837965|Doxycycline|doxycycline|mesh-list
92760040|NCT02837965|Prednisone|prednisone|mesh-list
92760041|NCT02837965|Methotrexate|methotrexate|mesh-list
92760042|NCT02837965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760043|NCT02837965|Glucocorticoids|glucocorticoids|mesh-ancestor
92760044|NCT02837965|Hormones|hormones|mesh-ancestor
92760045|NCT02837965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760046|NCT02837965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760047|NCT02837965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92760048|NCT02837965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760049|NCT02837965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92760050|NCT02837965|Abortifacient Agents|abortifacient agents|mesh-ancestor
92760051|NCT02837965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92760052|NCT02837965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760053|NCT02837965|Antimetabolites|antimetabolites|mesh-ancestor
92760054|NCT02837965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760055|NCT02837965|Dermatologic Agents|dermatologic agents|mesh-ancestor
92760056|NCT02837965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760057|NCT02837965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92760058|NCT02837965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760059|NCT02837965|Immunologic Factors|immunologic factors|mesh-ancestor
92760060|NCT02837965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760061|NCT02837965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92760062|NCT02837965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760063|NCT02837965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760064|NCT02837965|Antimalarials|antimalarials|mesh-ancestor
92760065|NCT02837965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92760066|NCT02837965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92760067|NCT00892957|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92760069|NCT00892957|Aprotinin|aprotinin|mesh-list
92760070|NCT00892957|Hemostatics|hemostatics|mesh-ancestor
92760071|NCT00892957|Coagulants|coagulants|mesh-ancestor
92760072|NCT00892957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92760073|NCT00892957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92760074|NCT00892957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760075|NCT00892957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760076|NCT00892957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760077|NCT05322733|Cyclophosphamide|cyclophosphamide|mesh-list
92760078|NCT05322733|Fludarabine|fludarabine|mesh-list
92760079|NCT05322733|Obinutuzumab|obinutuzumab|mesh-list
92760080|NCT05322733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760081|NCT05322733|Immunologic Factors|immunologic factors|mesh-ancestor
92760082|NCT05322733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760083|NCT05322733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760084|NCT05322733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92365398|NCT04745442|Antithrombins|antithrombins|mesh-list
92760085|NCT05322733|Alkylating Agents|alkylating agents|mesh-ancestor
92760086|NCT05322733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760087|NCT05322733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760088|NCT05322733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92760089|NCT05322733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760090|NCT00968812|Metformin|metformin|mesh-list
92760091|NCT00968812|Glimepiride|glimepiride|mesh-list
92760092|NCT00968812|Canagliflozin|canagliflozin|mesh-list
92760093|NCT00968812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760094|NCT00968812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760095|NCT00968812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92760096|NCT00968812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760097|NCT00968812|Immunologic Factors|immunologic factors|mesh-ancestor
92760098|NCT00968812|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92760099|NCT00968812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760100|NCT02834845|Sevoflurane|sevoflurane|mesh-list
92760101|NCT02834845|Desflurane|desflurane|mesh-list
92760102|NCT02834845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92760103|NCT02834845|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92760104|NCT02834845|Anesthetics, General|anesthetics, general|mesh-ancestor
92760105|NCT02834845|Anesthetics|anesthetics|mesh-ancestor
92760106|NCT02834845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760107|NCT02834845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760108|NCT05197192|Venetoclax|venetoclax|mesh-list
92760109|NCT05197192|Obinutuzumab|obinutuzumab|mesh-list
92760110|NCT05197192|Acalabrutinib|acalabrutinib|mesh-list
92760111|NCT05197192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760112|NCT05197192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760113|NCT00992056|Metoprolol|metoprolol|mesh-list
92760114|NCT00992056|Nebivolol|nebivolol|mesh-list
92760115|NCT00992056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92760116|NCT00992056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92760117|NCT00992056|Sympatholytics|sympatholytics|mesh-ancestor
92760118|NCT00992056|Autonomic Agents|autonomic agents|mesh-ancestor
92760119|NCT00992056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760120|NCT00992056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760121|NCT00992056|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92760122|NCT00992056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92760123|NCT00992056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92760124|NCT00992056|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760125|NCT00992056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760126|NCT00992056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760127|NCT00992056|Vasodilator Agents|vasodilator agents|mesh-ancestor
92760128|NCT00992056|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92760129|NCT00992056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92760130|NCT00992056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92760131|NCT00967798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92760132|NCT00967798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760133|NCT00967798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760135|NCT00967798|Hormones|hormones|mesh-ancestor
92760136|NCT00967798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760137|NCT00967798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92760138|NCT00967798|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760139|NCT00967798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760140|NCT00967798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760141|NCT04248205|Ketamine|ketamine|mesh-list
92760142|NCT04248205|Analgesics|analgesics|mesh-ancestor
92760143|NCT04248205|Sensory System Agents|sensory system agents|mesh-ancestor
92760144|NCT04248205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760145|NCT04248205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760146|NCT04248205|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92760147|NCT04248205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760148|NCT04248205|Anesthetics, General|anesthetics, general|mesh-ancestor
92760149|NCT04248205|Anesthetics|anesthetics|mesh-ancestor
92760150|NCT04248205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760151|NCT04248205|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92760152|NCT04248205|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92760153|NCT04248205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760154|NCT04248205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760155|NCT02833831|Moxifloxacin|moxifloxacin|mesh-list
92760156|NCT02833831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760157|NCT02833831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760158|NCT02833831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92760159|NCT02833831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92760160|NCT02833831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760161|NCT02833831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760162|NCT02833831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760163|NCT02833987|Warfarin|warfarin|mesh-list
92760164|NCT02833987|Rivaroxaban|rivaroxaban|mesh-list
92760165|NCT02833987|Dabigatran|dabigatran|mesh-list
92760166|NCT02833987|Apixaban|apixaban|mesh-list
92760167|NCT02833987|Anticoagulants|anticoagulants|mesh-ancestor
92760168|NCT02833987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92760169|NCT02833987|Antithrombins|antithrombins|mesh-ancestor
92760170|NCT02833987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92760171|NCT02833987|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760172|NCT02833987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760173|NCT02833987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760174|NCT02837185|Botulinum Toxins|botulinum toxins|mesh-list
92760175|NCT02837185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92760176|NCT02837185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760177|NCT02837185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760178|NCT02837185|Cholinergic Agents|cholinergic agents|mesh-ancestor
92760179|NCT02837185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760180|NCT02837185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760181|NCT00965458|Alefacept|alefacept|mesh-list
92760182|NCT00965458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92760183|NCT00965458|Immunologic Factors|immunologic factors|mesh-ancestor
92760184|NCT00965458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760185|NCT04249531|Amikacin|amikacin|mesh-list
92760186|NCT04249531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760187|NCT04249531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760188|NCT02836639|Etoposide|etoposide|mesh-list
92760189|NCT02836639|Busulfan|busulfan|mesh-list
92760190|NCT02836639|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92760191|NCT02836639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92760192|NCT02836639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760193|NCT02836639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92760194|NCT02836639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92760195|NCT02836639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760196|NCT02836639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760197|NCT02836639|Alkylating Agents|alkylating agents|mesh-ancestor
92760198|NCT02836639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760199|NCT02836639|Immunologic Factors|immunologic factors|mesh-ancestor
92760200|NCT02836639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760201|NCT02836639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92760202|NCT02836639|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92760203|NCT00972244|Dapagliflozin|dapagliflozin|mesh-list
92760204|NCT00972244|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92760205|NCT00972244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760206|NCT00972244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760207|NCT00972244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760208|NCT05333419|Latanoprost|latanoprost|mesh-list
92760209|NCT05333419|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92760210|NCT05333419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92760211|NCT02836795|Antibodies|antibodies|mesh-list
92760212|NCT02836795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92760213|NCT02836795|Immunologic Factors|immunologic factors|mesh-ancestor
92760214|NCT02836795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760215|NCT02836483|Linezolid|linezolid|mesh-list
92760216|NCT02836483|Delpazolid|delpazolid|mesh-list
92760217|NCT02836483|Oxazolidinones|oxazolidinones|mesh-list
92760218|NCT02836483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760219|NCT02836483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760220|NCT02836483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92760221|NCT02836483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760222|NCT02836483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760223|NCT02836171|Itraconazole|itraconazole|mesh-list
92760224|NCT02836171|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92760225|NCT02836171|Apatinib|apatinib|mesh-list
92760226|NCT02836171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760227|NCT02836171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92760228|NCT02836171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760229|NCT02836171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760230|NCT02836171|Antifungal Agents|antifungal agents|mesh-ancestor
92760231|NCT02836171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760232|NCT02836171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92760233|NCT02836171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92760234|NCT02836171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92760235|NCT02836171|Hormone Antagonists|hormone antagonists|mesh-ancestor
92760236|NCT02836171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760237|NCT02836171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760238|NCT02836171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92760239|NCT00971932|Carboplatin|carboplatin|mesh-list
92760240|NCT00971932|Fluorouracil|fluorouracil|mesh-list
92760241|NCT00971932|Cetuximab|cetuximab|mesh-list
92760242|NCT00971932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760243|NCT00971932|Antimetabolites|antimetabolites|mesh-ancestor
92760244|NCT00971932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760245|NCT00971932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760246|NCT00971932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760247|NCT00971932|Immunologic Factors|immunologic factors|mesh-ancestor
92760248|NCT00971932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760249|NCT00971932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760250|NCT04400929|Molgramostim|molgramostim|mesh-list
92760251|NCT04400929|Sargramostim|sargramostim|mesh-list
92760252|NCT04400929|Immunologic Factors|immunologic factors|mesh-ancestor
92760253|NCT04400929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760254|NCT04400929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760255|NCT05170672|Abatacept|abatacept|mesh-list
92760256|NCT05170672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92760257|NCT05170672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760258|NCT05170672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760259|NCT05170672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760260|NCT05170672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760261|NCT05170672|Immunologic Factors|immunologic factors|mesh-ancestor
92760262|NCT05170672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760264|NCT00970684|Bevacizumab|bevacizumab|mesh-list
92760265|NCT00970684|Gemcitabine|gemcitabine|mesh-list
92760266|NCT00970684|Docetaxel|docetaxel|mesh-list
92760267|NCT00970684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760268|NCT00970684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760269|NCT00970684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92760270|NCT00970684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92760271|NCT00970684|Growth Substances|growth substances|mesh-ancestor
92760272|NCT00970684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760273|NCT00970684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92760274|NCT00970684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760275|NCT00970684|Antimetabolites|antimetabolites|mesh-ancestor
92760276|NCT00970684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760277|NCT00970684|Tubulin Modulators|tubulin modulators|mesh-ancestor
92760278|NCT00970684|Antimitotic Agents|antimitotic agents|mesh-ancestor
92760279|NCT00970684|Mitosis Modulators|mitosis modulators|mesh-ancestor
92760280|NCT00967330|Bevacizumab|bevacizumab|mesh-list
92760281|NCT00967330|Irinotecan|irinotecan|mesh-list
92760282|NCT00967330|Temozolomide|temozolomide|mesh-list
92760283|NCT00967330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760284|NCT00967330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760285|NCT00967330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92760286|NCT00967330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92760287|NCT00967330|Growth Substances|growth substances|mesh-ancestor
92760288|NCT00967330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760289|NCT00967330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92760290|NCT00967330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92760291|NCT00967330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92760292|NCT00967330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760293|NCT00967330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760294|NCT00967330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92760295|NCT00967330|Alkylating Agents|alkylating agents|mesh-ancestor
92760296|NCT02863276|Insulin|insulin|mesh-list
92760297|NCT02863276|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92760298|NCT02863276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760299|NCT02863276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760300|NCT04286152|Mirabegron|mirabegron|mesh-list
92760301|NCT04286152|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92760302|NCT04286152|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92760303|NCT04286152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92760304|NCT04286152|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760305|NCT04286152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760306|NCT04286152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760307|NCT04286152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760308|NCT04286152|Urological Agents|urological agents|mesh-ancestor
92760309|NCT00966940|Travoprost|travoprost|mesh-list
92760310|NCT00966940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92760311|NCT00966940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92760312|NCT00966940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92760313|NCT00965848|Doripenem|doripenem|mesh-list
92760314|NCT00965848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760315|NCT00965848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760316|NCT03447574|Ethanol|ethanol|mesh-list
92760317|NCT03447574|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92760318|NCT03447574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494492|NCT01975714|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92760319|NCT03447574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760320|NCT03447574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760321|NCT04284826|Mitomycins|mitomycins|mesh-list
92760322|NCT04284826|Mitomycin|mitomycin|mesh-list
92760323|NCT04284826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92760324|NCT04284826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760325|NCT04284826|Alkylating Agents|alkylating agents|mesh-ancestor
92760326|NCT04284826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760327|NCT04284826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92760328|NCT04284826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760329|NCT04285528|Lidocaine|lidocaine|mesh-list
92760330|NCT04285528|Fentanyl|fentanyl|mesh-list
92760331|NCT04285528|Ketamine|ketamine|mesh-list
92760332|NCT04285528|Propofol|propofol|mesh-list
92760333|NCT04285528|Anesthetics, Local|anesthetics, local|mesh-ancestor
92760334|NCT04285528|Anesthetics|anesthetics|mesh-ancestor
92760335|NCT04285528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760336|NCT04285528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760337|NCT04285528|Sensory System Agents|sensory system agents|mesh-ancestor
92760338|NCT04285528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760340|NCT04285528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92760341|NCT04285528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92760342|NCT04285528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760343|NCT04285528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760344|NCT04285528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92760345|NCT04285528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760346|NCT04285528|Anesthetics, General|anesthetics, general|mesh-ancestor
92760347|NCT04285528|Analgesics|analgesics|mesh-ancestor
92760348|NCT04285528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92760349|NCT04285528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92760350|NCT04285528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92760351|NCT04285528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760352|NCT04285528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92760353|NCT04285528|Narcotics|narcotics|mesh-ancestor
92760354|NCT04285528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92710293|NCT00560378|Immunologic Factors|immunologic factors|mesh-ancestor
92760356|NCT00629824|Ribavirin|ribavirin|mesh-list
92760357|NCT00629824|Interferon-alpha|interferon-alpha|mesh-list
92760358|NCT00629824|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92760359|NCT00629824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760360|NCT00629824|Antiviral Agents|antiviral agents|mesh-ancestor
92760361|NCT00629824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760362|NCT00629824|Antimetabolites|antimetabolites|mesh-ancestor
92760363|NCT00629824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760364|NCT00629824|Immunologic Factors|immunologic factors|mesh-ancestor
92760365|NCT00629824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760366|NCT00961636|Niacin|niacin|mesh-list
92760367|NCT00961636|Niacinamide|niacinamide|mesh-list
92760368|NCT00961636|Nicotinic Acids|nicotinic acids|mesh-list
92760369|NCT00961636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92760370|NCT00961636|Antimetabolites|antimetabolites|mesh-ancestor
92760371|NCT00961636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760372|NCT00961636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92760373|NCT00961636|Vasodilator Agents|vasodilator agents|mesh-ancestor
92760374|NCT00961636|Vitamin B Complex|vitamin b complex|mesh-ancestor
92760375|NCT00961636|Vitamins|vitamins|mesh-ancestor
92760376|NCT00961636|Micronutrients|micronutrients|mesh-ancestor
92760377|NCT00961636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760378|NCT00964678|Carvedilol|carvedilol|mesh-list
92760379|NCT00964678|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92760380|NCT00964678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92760381|NCT00964678|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760382|NCT00964678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760383|NCT00964678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760384|NCT00964678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760385|NCT00964678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92760386|NCT00964678|Antioxidants|antioxidants|mesh-ancestor
92760387|NCT00964678|Protective Agents|protective agents|mesh-ancestor
92760388|NCT00964678|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92760389|NCT00964678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760390|NCT00964678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92760391|NCT00964678|Vasodilator Agents|vasodilator agents|mesh-ancestor
92760392|NCT00964678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92760393|NCT00964678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92760394|NCT00964366|Clindamycin|clindamycin|mesh-list
92760395|NCT00964366|Clindamycin palmitate|clindamycin palmitate|mesh-list
92760396|NCT00964366|Clindamycin phosphate|clindamycin phosphate|mesh-list
92760397|NCT00964366|Dapsone|dapsone|mesh-list
92760398|NCT00964366|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92760399|NCT00964366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760400|NCT00964366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760401|NCT00964366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92760402|NCT00964366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760403|NCT00964366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760404|NCT00964366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92760405|NCT00964366|Antimalarials|antimalarials|mesh-ancestor
92760406|NCT00964366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92760407|NCT00964366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92760408|NCT00964366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92760409|NCT00964366|Leprostatic Agents|leprostatic agents|mesh-ancestor
92760410|NCT03545464|Prednisone|prednisone|mesh-list
92760411|NCT03545464|Levocetirizine|levocetirizine|mesh-list
92760412|NCT03545464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760413|NCT03545464|Glucocorticoids|glucocorticoids|mesh-ancestor
92760414|NCT03545464|Hormones|hormones|mesh-ancestor
92760415|NCT03545464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760416|NCT03545464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760417|NCT03545464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92760418|NCT03545464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760419|NCT03545464|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92760420|NCT03545464|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92760421|NCT03545464|Histamine Antagonists|histamine antagonists|mesh-ancestor
92760422|NCT03545464|Histamine Agents|histamine agents|mesh-ancestor
92760423|NCT03545464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760424|NCT03545464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760425|NCT04284514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92760426|NCT04284514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92760427|NCT02860936|Lenvatinib|lenvatinib|mesh-list
92760428|NCT02860936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760429|NCT02860936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92760430|NCT02860936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760431|NCT02860936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760432|NCT00630214|Calcium, Dietary|calcium, dietary|mesh-list
92760433|NCT00630214|Vitamin D|vitamin d|mesh-list
92760434|NCT00630214|Ergocalciferols|ergocalciferols|mesh-list
92760435|NCT00630214|Cholecalciferol|cholecalciferol|mesh-list
92760436|NCT00630214|Vitamins|vitamins|mesh-list
92760437|NCT00630214|Calcium Carbonate|calcium carbonate|mesh-list
92760438|NCT00630214|Calcium|calcium|mesh-list
92760439|NCT00630214|Micronutrients|micronutrients|mesh-ancestor
92760440|NCT00630214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760441|NCT00630214|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92760442|NCT00630214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92760443|NCT00630214|Antacids|antacids|mesh-ancestor
92760444|NCT00630214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760445|NCT00630214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760446|NCT02860858|Aflibercept|aflibercept|mesh-list
92760447|NCT02860858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92760448|NCT02860858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92760449|NCT02860858|Growth Substances|growth substances|mesh-ancestor
92760450|NCT02860858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760451|NCT02860858|Growth Inhibitors|growth inhibitors|mesh-ancestor
92760452|NCT02860858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760453|NCT00960076|Metformin|metformin|mesh-list
92760454|NCT00960076|Saxagliptin|saxagliptin|mesh-list
92760455|NCT00960076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760456|NCT00960076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760457|NCT00960076|Incretins|incretins|mesh-ancestor
92760458|NCT00960076|Hormones|hormones|mesh-ancestor
92760459|NCT00960076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760460|NCT00960076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92760461|NCT00960076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760462|NCT00960076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760463|NCT00960076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760464|NCT04281082|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92760465|NCT04281082|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92760466|NCT04281082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760467|NCT04284202|Dasatinib|dasatinib|mesh-list
92760468|NCT04284202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760469|NCT04284202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92760470|NCT04284202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760471|NCT04284202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760472|NCT01227629|Warfarin|warfarin|mesh-list
92760473|NCT01227629|Dabigatran|dabigatran|mesh-list
92760474|NCT01227629|Anticoagulants|anticoagulants|mesh-ancestor
92760475|NCT01227629|Antithrombins|antithrombins|mesh-ancestor
92760476|NCT01227629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92760477|NCT01227629|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760478|NCT01227629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760479|NCT01227629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760480|NCT00963820|Ixazomib|ixazomib|mesh-list
92760481|NCT00963820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760482|NCT00963820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760483|NCT00963820|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760484|NCT00963820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760485|NCT03241186|Nivolumab|nivolumab|mesh-list
92760486|NCT03241186|Ipilimumab|ipilimumab|mesh-list
92760487|NCT03241186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760488|NCT03241186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760489|NCT03241186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92760490|NCT03241186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760492|NCT01227395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760493|NCT01227395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760494|NCT03237286|Ketamine|ketamine|mesh-list
92760495|NCT03237286|Analgesics|analgesics|mesh-ancestor
92760496|NCT03237286|Sensory System Agents|sensory system agents|mesh-ancestor
92760497|NCT03237286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760498|NCT03237286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760499|NCT03237286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92760500|NCT03237286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760501|NCT03237286|Anesthetics, General|anesthetics, general|mesh-ancestor
92760502|NCT03237286|Anesthetics|anesthetics|mesh-ancestor
92760503|NCT03237286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760504|NCT03237286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92760505|NCT03237286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92760506|NCT03237286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760507|NCT03237286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760508|NCT01226459|Minoxidil|minoxidil|mesh-list
92760509|NCT01226459|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92760510|NCT01226459|Vasodilator Agents|vasodilator agents|mesh-ancestor
92760511|NCT01225991|Milnacipran|milnacipran|mesh-list
92760512|NCT01225991|Levomilnacipran|levomilnacipran|mesh-list
92760513|NCT01225991|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92760514|NCT01225991|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92760515|NCT01225991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760516|NCT01225991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760517|NCT01225991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760518|NCT01225991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334762|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
92760519|NCT01225991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92760520|NCT01225991|Analgesics|analgesics|mesh-ancestor
92760521|NCT01225991|Sensory System Agents|sensory system agents|mesh-ancestor
92760522|NCT01225991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760523|NCT01225991|Antidepressive Agents|antidepressive agents|mesh-ancestor
92760524|NCT01225991|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92760525|NCT04283110|Midazolam|midazolam|mesh-list
92760526|NCT04283110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92760527|NCT04283110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92760528|NCT04283110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760529|NCT04283110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760530|NCT04283110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92760531|NCT04283110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92760532|NCT04283110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92760533|NCT04283110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760534|NCT04283110|Anesthetics, General|anesthetics, general|mesh-ancestor
92760535|NCT04283110|Anesthetics|anesthetics|mesh-ancestor
92760536|NCT04283110|GABA Modulators|gaba modulators|mesh-ancestor
92760537|NCT04283110|GABA Agents|gaba agents|mesh-ancestor
92760538|NCT04283110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760539|NCT04283110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760540|NCT02860780|Prexasertib|prexasertib|mesh-list
92760541|NCT02860780|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92760542|NCT02860780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760543|NCT02860780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760544|NCT01225835|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92760545|NCT01225835|Cetrorelix|cetrorelix|mesh-list
92760546|NCT01225835|Menotropins|menotropins|mesh-list
92760547|NCT01225835|Progesterone|progesterone|mesh-list
92760548|NCT01225835|Progestins|progestins|mesh-ancestor
92760549|NCT01225835|Hormones|hormones|mesh-ancestor
92760550|NCT01225835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760551|NCT01225835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760552|NCT01225835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92760553|NCT01225835|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92760554|NCT01225835|Fertility Agents|fertility agents|mesh-ancestor
92760555|NCT01225835|Hormone Antagonists|hormone antagonists|mesh-ancestor
92760556|NCT04282096|Caseins|caseins|mesh-list
92760557|NCT04282096|Chelating Agents|chelating agents|mesh-ancestor
92760558|NCT04282096|Sequestering Agents|sequestering agents|mesh-ancestor
92760559|NCT04282096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760560|NCT02899000|Doxycycline|doxycycline|mesh-list
92760561|NCT02899000|Adapalene|adapalene|mesh-list
92760562|NCT02899000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92760563|NCT02899000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92760564|NCT02899000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760565|NCT02899000|Antimalarials|antimalarials|mesh-ancestor
92760566|NCT02899000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92760567|NCT02899000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92760568|NCT02899000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92760569|NCT02899000|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92760570|NCT02899000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92760571|NCT02899000|Analgesics|analgesics|mesh-ancestor
92760572|NCT02899000|Sensory System Agents|sensory system agents|mesh-ancestor
92760573|NCT02899000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760574|NCT02899000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760575|NCT02899000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760576|NCT02899000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760577|NCT04281862|Prednisolone|prednisolone|mesh-list
92760578|NCT04281862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760579|NCT04281862|Glucocorticoids|glucocorticoids|mesh-ancestor
92760580|NCT04281862|Hormones|hormones|mesh-ancestor
92760581|NCT04281862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760582|NCT04281862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760583|NCT04281862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92760584|NCT04281862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760585|NCT03122002|Clopidogrel|clopidogrel|mesh-list
92760586|NCT03122002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760587|NCT03122002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760588|NCT03122002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92334769|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760589|NCT03122002|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92760590|NCT03122002|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92760591|NCT03122002|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92760592|NCT03122002|Purinergic Agents|purinergic agents|mesh-ancestor
92760593|NCT03122002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760594|NCT02861482|Oxytocin|oxytocin|mesh-list
92760595|NCT02861482|Carboprost tromethamine|carboprost tromethamine|mesh-list
92760596|NCT02861482|Oxytocics|oxytocics|mesh-ancestor
92760597|NCT02861482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92760598|NCT02861482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760599|NCT02861716|Fentanyl|fentanyl|mesh-list
92760600|NCT02861716|Dexmedetomidine|dexmedetomidine|mesh-list
92760601|NCT02861716|Bupivacaine|bupivacaine|mesh-list
92760602|NCT02861716|Anesthetics, Local|anesthetics, local|mesh-ancestor
92760603|NCT02861716|Anesthetics|anesthetics|mesh-ancestor
92760604|NCT02861716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760605|NCT02861716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760606|NCT02861716|Sensory System Agents|sensory system agents|mesh-ancestor
92760607|NCT02861716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760608|NCT02861716|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92760609|NCT02861716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92760610|NCT02861716|Analgesics|analgesics|mesh-ancestor
92760611|NCT02861716|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92760612|NCT02861716|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92760613|NCT02861716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92760614|NCT02861716|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760615|NCT02861716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760616|NCT02861716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760617|NCT02861716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92760618|NCT02861716|Narcotics|narcotics|mesh-ancestor
92760619|NCT02861716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92760620|NCT02861716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760621|NCT02861716|Anesthetics, General|anesthetics, general|mesh-ancestor
92760622|NCT00960934|Vitamin D|vitamin d|mesh-list
92760623|NCT00960934|Cholecalciferol|cholecalciferol|mesh-list
92760624|NCT00960934|Calcium Carbonate|calcium carbonate|mesh-list
92760625|NCT00960934|Calcium|calcium|mesh-list
92760626|NCT00960934|Vitamins|vitamins|mesh-ancestor
92760627|NCT00960934|Micronutrients|micronutrients|mesh-ancestor
92760628|NCT00960934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760629|NCT00960934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92760630|NCT00960934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92760631|NCT00960934|Antacids|antacids|mesh-ancestor
92760632|NCT00960934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760633|NCT00960934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760634|NCT00892177|Bevacizumab|bevacizumab|mesh-list
92760635|NCT00892177|Dasatinib|dasatinib|mesh-list
92760636|NCT00892177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760637|NCT00892177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760638|NCT00892177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92760639|NCT00892177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92760640|NCT00892177|Growth Substances|growth substances|mesh-ancestor
92760641|NCT00892177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760642|NCT00892177|Growth Inhibitors|growth inhibitors|mesh-ancestor
92760643|NCT00892177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92760644|NCT00892177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760645|NCT00892177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760646|NCT00962104|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92760647|NCT00962104|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92760648|NCT00962104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92760649|NCT00962104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760650|NCT00962104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760651|NCT00962104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760652|NCT00962104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760653|NCT00962104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760654|NCT02821000|Pembrolizumab|pembrolizumab|mesh-list
92760655|NCT02821000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760656|NCT02821000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760657|NCT02821000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92760658|NCT02821000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760659|NCT02860624|Esomeprazole|esomeprazole|mesh-list
92760660|NCT02860624|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92760661|NCT02860624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760662|NCT02860624|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92760663|NCT02860624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760664|NCT02860624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760665|NCT00892099|Vitamin D|vitamin d|mesh-list
92760666|NCT00892099|Ergocalciferols|ergocalciferols|mesh-list
92760667|NCT00892099|Cholecalciferol|cholecalciferol|mesh-list
92760668|NCT00892099|Vitamins|vitamins|mesh-list
92760669|NCT00892099|Micronutrients|micronutrients|mesh-ancestor
92760670|NCT00892099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760671|NCT00892099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92760672|NCT00892099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92760673|NCT00960856|Fenofibric acid|fenofibric acid|mesh-list
92760674|NCT00960856|Fenofibrate|fenofibrate|mesh-list
92760675|NCT00960856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92760676|NCT00960856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92760677|NCT00960856|Antimetabolites|antimetabolites|mesh-ancestor
92760678|NCT00960856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760679|NCT00960856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92760680|NCT00958438|Rilonacept|rilonacept|mesh-list
92760681|NCT00958438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760682|NCT02835469|Menotropins|menotropins|mesh-list
92760683|NCT02835469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92760684|NCT02835469|Fertility Agents|fertility agents|mesh-ancestor
92760685|NCT02835469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92760686|NCT02835469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760687|NCT02832973|Ramipril|ramipril|mesh-list
92760688|NCT02832973|Bisoprolol|bisoprolol|mesh-list
92760689|NCT02832973|Amiloride|amiloride|mesh-list
92760690|NCT02832973|Furosemide|furosemide|mesh-list
92760691|NCT02832973|Spironolactone|spironolactone|mesh-list
92760692|NCT02832973|Diuretics|diuretics|mesh-list
92760693|NCT02832973|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92760694|NCT02832973|Natriuretic Agents|natriuretic agents|mesh-ancestor
92760695|NCT02832973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760696|NCT02832973|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92760697|NCT02832973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760698|NCT02832973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760699|NCT02832973|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92760700|NCT02832973|Hormone Antagonists|hormone antagonists|mesh-ancestor
92760701|NCT02832973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760702|NCT02832973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92760703|NCT02832973|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760704|NCT02832973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760705|NCT02832973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92760706|NCT02832973|Sympatholytics|sympatholytics|mesh-ancestor
92760707|NCT02832973|Autonomic Agents|autonomic agents|mesh-ancestor
92760708|NCT02832973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760709|NCT02832973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92760710|NCT02832973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92760711|NCT02832973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92760712|NCT02832973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92760713|NCT02832973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760714|NCT02832973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92760715|NCT02832973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92760716|NCT02832973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92760717|NCT02831491|Docetaxel|docetaxel|mesh-list
92760718|NCT02831491|Ramucirumab|ramucirumab|mesh-list
92760719|NCT02831491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760720|NCT02831491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92760721|NCT02831491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92760722|NCT02831491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92760723|NCT02831491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760724|NCT02860234|Capecitabine|capecitabine|mesh-list
92760725|NCT02860234|Oxaliplatin|oxaliplatin|mesh-list
92760726|NCT02860234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760727|NCT02860234|Antimetabolites|antimetabolites|mesh-ancestor
92760728|NCT02860234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760729|NCT02860234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760730|NCT00630370|ATI 7505|ati 7505|mesh-list
92760731|NCT00630370|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92760732|NCT00630370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92760733|NCT00630370|Serotonin Agents|serotonin agents|mesh-ancestor
92760734|NCT00630370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760735|NCT00630370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760736|NCT00630370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760737|NCT04281706|Propofol|propofol|mesh-list
92760738|NCT04281706|Etomidate|etomidate|mesh-list
92760739|NCT04281706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92760740|NCT04281706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760741|NCT04281706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760742|NCT04281706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760743|NCT04281706|Anesthetics, General|anesthetics, general|mesh-ancestor
92760744|NCT04281706|Anesthetics|anesthetics|mesh-ancestor
92760745|NCT02835391|Surgiflo|surgiflo|mesh-list
92760746|NCT02835391|Hemostatics|hemostatics|mesh-ancestor
92760747|NCT02835391|Coagulants|coagulants|mesh-ancestor
92760748|NCT02831101|Sufentanil|sufentanil|mesh-list
92760749|NCT02831101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92760750|NCT02831101|Narcotics|narcotics|mesh-ancestor
92760751|NCT02831101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760752|NCT02831101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760753|NCT02831101|Analgesics|analgesics|mesh-ancestor
92760754|NCT02831101|Sensory System Agents|sensory system agents|mesh-ancestor
92760755|NCT02831101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760756|NCT02831101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92760757|NCT02831101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760758|NCT02831101|Anesthetics, General|anesthetics, general|mesh-ancestor
92760759|NCT02831101|Anesthetics|anesthetics|mesh-ancestor
92760760|NCT04245787|Fluorides|fluorides|mesh-list
92760761|NCT04245787|Cariostatic Agents|cariostatic agents|mesh-ancestor
92760762|NCT04245787|Protective Agents|protective agents|mesh-ancestor
92760763|NCT04245787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760764|NCT02831179|Capecitabine|capecitabine|mesh-list
92760765|NCT02831179|Temozolomide|temozolomide|mesh-list
92760766|NCT02831179|Veliparib|veliparib|mesh-list
92760767|NCT02831179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760768|NCT02831179|Antimetabolites|antimetabolites|mesh-ancestor
92760769|NCT02831179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760770|NCT02831179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760771|NCT02831179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92760772|NCT02831179|Alkylating Agents|alkylating agents|mesh-ancestor
92760773|NCT02831179|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92760774|NCT02831179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760775|NCT02830789|Calcium, Dietary|calcium, dietary|mesh-list
92760776|NCT02830789|Calcium Carbonate|calcium carbonate|mesh-list
92760777|NCT02830789|Calcium|calcium|mesh-list
92760778|NCT02830789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92760779|NCT02830789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760780|NCT02830789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92760781|NCT02830789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760782|NCT02830789|Antacids|antacids|mesh-ancestor
92760783|NCT02830789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760784|NCT04243993|Calcium|calcium|mesh-list
92760785|NCT04243993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92760786|NCT04243993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760787|NCT04245319|Acitretin|acitretin|mesh-list
92760788|NCT04245319|Keratolytic Agents|keratolytic agents|mesh-ancestor
92760789|NCT04245319|Dermatologic Agents|dermatologic agents|mesh-ancestor
92760790|NCT02828059|Ropivacaine|ropivacaine|mesh-list
92760791|NCT02828059|Anesthetics, Local|anesthetics, local|mesh-ancestor
92760792|NCT02828059|Anesthetics|anesthetics|mesh-ancestor
92760793|NCT02828059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760794|NCT02828059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760795|NCT02828059|Sensory System Agents|sensory system agents|mesh-ancestor
92760796|NCT02828059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760797|NCT02827903|Metformin|metformin|mesh-list
92760798|NCT02827903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92760799|NCT02827903|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760800|NCT02827903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760801|NCT02827903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92760802|NCT02827903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92760803|NCT02827903|Antimetabolites|antimetabolites|mesh-ancestor
92760804|NCT02827903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760805|NCT02827903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92760806|NCT02827903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92760807|NCT02827903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760808|NCT01243424|Glimepiride|glimepiride|mesh-list
92760810|NCT01243424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92760811|NCT01243424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92760812|NCT01243424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760813|NCT01243424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760814|NCT01243424|Immunologic Factors|immunologic factors|mesh-ancestor
92760815|NCT01243424|Incretins|incretins|mesh-ancestor
92760816|NCT01243424|Hormones|hormones|mesh-ancestor
92760817|NCT01243424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760818|NCT01243424|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92760819|NCT01243424|Protease Inhibitors|protease inhibitors|mesh-ancestor
92760820|NCT01243424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760821|NCT01243424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760822|NCT02831023|Pyrimethamine|pyrimethamine|mesh-list
92760823|NCT02831023|Primaquine|primaquine|mesh-list
92760824|NCT02831023|Piperaquine|piperaquine|mesh-list
92760825|NCT02831023|Sulfadoxine|sulfadoxine|mesh-list
92760826|NCT02831023|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92760827|NCT02831023|Amodiaquine|amodiaquine|mesh-list
92760828|NCT02831023|Artenimol|artenimol|mesh-list
92760829|NCT02831023|Methylene Blue|methylene blue|mesh-list
92760830|NCT02831023|Antimalarials|antimalarials|mesh-ancestor
92760831|NCT02831023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92760832|NCT02831023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92760833|NCT02831023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760834|NCT02831023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92760835|NCT02831023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760836|NCT02831023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760837|NCT02831023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92760838|NCT04244695|Dexamethasone|dexamethasone|mesh-list
92760839|NCT04244695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92760840|NCT04244695|Antiemetics|antiemetics|mesh-ancestor
92760841|NCT04244695|Autonomic Agents|autonomic agents|mesh-ancestor
92760842|NCT04244695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760843|NCT04244695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760844|NCT04244695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92760845|NCT04244695|Glucocorticoids|glucocorticoids|mesh-ancestor
92760846|NCT04244695|Hormones|hormones|mesh-ancestor
92760847|NCT04244695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760848|NCT04244695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92760849|NCT04244695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760850|NCT00887809|Bevacizumab|bevacizumab|mesh-list
92760851|NCT00887809|Gemcitabine|gemcitabine|mesh-list
92760852|NCT00887809|Docetaxel|docetaxel|mesh-list
92760853|NCT00887809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760854|NCT00887809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760855|NCT00887809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92760856|NCT00887809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92760857|NCT00887809|Growth Substances|growth substances|mesh-ancestor
92760858|NCT00887809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760859|NCT00887809|Growth Inhibitors|growth inhibitors|mesh-ancestor
92760860|NCT00887809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760861|NCT00887809|Antimetabolites|antimetabolites|mesh-ancestor
92760862|NCT00887809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760863|NCT00887809|Tubulin Modulators|tubulin modulators|mesh-ancestor
92760864|NCT00887809|Antimitotic Agents|antimitotic agents|mesh-ancestor
92760865|NCT00887809|Mitosis Modulators|mitosis modulators|mesh-ancestor
92760866|NCT02827747|Vitamin A|vitamin a|mesh-list
92760867|NCT02827747|Antioxidants|antioxidants|mesh-list
92760868|NCT02827747|Vitamins|vitamins|mesh-ancestor
92760869|NCT02827747|Micronutrients|micronutrients|mesh-ancestor
92760870|NCT02827747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760871|NCT02827747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760872|NCT02827747|Protective Agents|protective agents|mesh-ancestor
92760873|NCT04281628|Ketamine|ketamine|mesh-list
92760874|NCT04281628|Analgesics|analgesics|mesh-ancestor
92760875|NCT04281628|Sensory System Agents|sensory system agents|mesh-ancestor
92760876|NCT04281628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760877|NCT04281628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760878|NCT04281628|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92760879|NCT04281628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760880|NCT04281628|Anesthetics, General|anesthetics, general|mesh-ancestor
92760881|NCT04281628|Anesthetics|anesthetics|mesh-ancestor
92760882|NCT04281628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760883|NCT04281628|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92760884|NCT04281628|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92760885|NCT04281628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760886|NCT04281628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760887|NCT00886795|Abatacept|abatacept|mesh-list
92760888|NCT00886795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92760889|NCT00886795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760890|NCT00886795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92760891|NCT00886795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760892|NCT00886795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760893|NCT00886795|Immunologic Factors|immunologic factors|mesh-ancestor
92760894|NCT00886795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760895|NCT00886795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760896|NCT02783482|Immunoglobulins|immunoglobulins|mesh-list
92760897|NCT02783482|gamma-Globulins|gamma-globulins|mesh-list
92760898|NCT02783482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92760899|NCT02783482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92760900|NCT02783482|Immunologic Factors|immunologic factors|mesh-ancestor
92760901|NCT02783482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760902|NCT00953680|Losartan|losartan|mesh-list
92760903|NCT00953680|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92760904|NCT00953680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92760905|NCT00953680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92760906|NCT00953680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92760907|NCT00953680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92760908|NCT00953680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760909|NCT00953680|Diuretics|diuretics|mesh-ancestor
92760910|NCT00953680|Natriuretic Agents|natriuretic agents|mesh-ancestor
92760911|NCT00953680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760912|NCT00953680|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92760913|NCT00953680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760914|NCT00890929|Lenalidomide|lenalidomide|mesh-list
92760915|NCT00890929|Azacitidine|azacitidine|mesh-list
92760916|NCT00890929|Immunologic Factors|immunologic factors|mesh-ancestor
92760917|NCT00890929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760918|NCT00890929|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92760919|NCT00890929|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92760920|NCT00890929|Growth Substances|growth substances|mesh-ancestor
92760921|NCT00890929|Growth Inhibitors|growth inhibitors|mesh-ancestor
92760922|NCT00890929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760923|NCT00890929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92760924|NCT00890929|Antimetabolites|antimetabolites|mesh-ancestor
92760925|NCT00890929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760926|NCT00890929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760927|NCT04246567|Fentanyl|fentanyl|mesh-list
92760928|NCT04246567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92760929|NCT04246567|Narcotics|narcotics|mesh-ancestor
92760930|NCT04246567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760931|NCT04246567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760932|NCT04246567|Analgesics|analgesics|mesh-ancestor
92760933|NCT04246567|Sensory System Agents|sensory system agents|mesh-ancestor
92760934|NCT04246567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760935|NCT04246567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92760936|NCT04246567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92760937|NCT04246567|Anesthetics, General|anesthetics, general|mesh-ancestor
92760938|NCT04246567|Anesthetics|anesthetics|mesh-ancestor
92760939|NCT02830243|Sevoflurane|sevoflurane|mesh-list
92760940|NCT02830243|Desflurane|desflurane|mesh-list
92760941|NCT02830243|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92760942|NCT02830243|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92760943|NCT02830243|Anesthetics, General|anesthetics, general|mesh-ancestor
92760944|NCT02830243|Anesthetics|anesthetics|mesh-ancestor
92760945|NCT02830243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760946|NCT02830243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760947|NCT00889603|Donepezil|donepezil|mesh-list
92760948|NCT00889603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92760949|NCT00889603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760950|NCT00889603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760951|NCT00889603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92760952|NCT00889603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92760953|NCT00889603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760954|NCT00889603|Nootropic Agents|nootropic agents|mesh-ancestor
92760955|NCT02829385|Apatinib|apatinib|mesh-list
92760956|NCT02829385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92760957|NCT02829385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92760958|NCT02829385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710899|NCT00447863|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92760959|NCT02829385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760961|NCT02826343|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92760962|NCT02826343|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92760963|NCT02826343|Anesthetics, General|anesthetics, general|mesh-ancestor
92760964|NCT02826343|Anesthetics|anesthetics|mesh-ancestor
92760965|NCT02826343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760966|NCT02826343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760967|NCT02826343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92760968|NCT02826343|Autonomic Agents|autonomic agents|mesh-ancestor
92760969|NCT02826343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760970|NCT02826343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92760971|NCT02826343|Respiratory System Agents|respiratory system agents|mesh-ancestor
92760972|NCT02826343|Glucocorticoids|glucocorticoids|mesh-ancestor
92760973|NCT02826343|Hormones|hormones|mesh-ancestor
92760974|NCT02826343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92760975|NCT02826343|Sympathomimetics|sympathomimetics|mesh-ancestor
92760976|NCT05660785|Cyclosporine|cyclosporine|mesh-list
92760977|NCT05660785|Cyclosporins|cyclosporins|mesh-list
92760978|NCT05660785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92760979|NCT05660785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92760980|NCT05660785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92760981|NCT05660785|Immunologic Factors|immunologic factors|mesh-ancestor
92760982|NCT05660785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760983|NCT05660785|Antifungal Agents|antifungal agents|mesh-ancestor
92760984|NCT05660785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92760985|NCT05660785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92760986|NCT05660785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92760987|NCT05660785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92760988|NCT04246255|Lidocaine|lidocaine|mesh-list
92760989|NCT04246255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92760990|NCT04246255|Anesthetics|anesthetics|mesh-ancestor
92760991|NCT04246255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92760992|NCT04246255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92760993|NCT04246255|Sensory System Agents|sensory system agents|mesh-ancestor
92760994|NCT04246255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92760995|NCT04246255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92760996|NCT04246255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92760997|NCT04246255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92760998|NCT04246255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92760999|NCT04246255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761000|NCT02825953|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92761001|NCT02825953|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761002|NCT05217589|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92529685|NCT00001181|Testolactone|testolactone|mesh-list
92761003|NCT05217589|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92761004|NCT05217589|beta-Endorphin|beta-endorphin|mesh-list
92761005|NCT05217589|Hormones|hormones|mesh-ancestor
92761006|NCT05217589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92761007|NCT05217589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761008|NCT05217589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761009|NCT05217589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761010|NCT05210725|Rivaroxaban|rivaroxaban|mesh-list
92761011|NCT05210725|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92761012|NCT05210725|Antithrombins|antithrombins|mesh-ancestor
92761013|NCT05210725|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92761014|NCT05210725|Protease Inhibitors|protease inhibitors|mesh-ancestor
92761015|NCT05210725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761016|NCT05210725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761017|NCT05210725|Anticoagulants|anticoagulants|mesh-ancestor
92761018|NCT02826031|Hyaluronic Acid|hyaluronic acid|mesh-list
92761019|NCT02826031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92761020|NCT02826031|Immunologic Factors|immunologic factors|mesh-ancestor
92761021|NCT02826031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761022|NCT02826031|Viscosupplements|viscosupplements|mesh-ancestor
92761023|NCT02826031|Protective Agents|protective agents|mesh-ancestor
92761024|NCT02829697|Ropivacaine|ropivacaine|mesh-list
92761025|NCT02829697|Anesthetics, Local|anesthetics, local|mesh-ancestor
92761026|NCT02829697|Anesthetics|anesthetics|mesh-ancestor
92761027|NCT02829697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761028|NCT02829697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761029|NCT02829697|Sensory System Agents|sensory system agents|mesh-ancestor
92761030|NCT02829697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761031|NCT02829151|Aspirin|aspirin|mesh-list
92761032|NCT02829151|Cilostazol|cilostazol|mesh-list
92761033|NCT02829151|Clopidogrel|clopidogrel|mesh-list
92761034|NCT02829151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92761035|NCT02829151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761036|NCT02829151|Analgesics|analgesics|mesh-ancestor
92761037|NCT02829151|Sensory System Agents|sensory system agents|mesh-ancestor
92761038|NCT02829151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761039|NCT02829151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761040|NCT02829151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92761041|NCT02829151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761042|NCT02829151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92761043|NCT02829151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92761044|NCT02829151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761045|NCT02829151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92761046|NCT02829151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92761047|NCT02829151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761048|NCT02829151|Antipyretics|antipyretics|mesh-ancestor
92761049|NCT02829151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92761050|NCT02829151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92761051|NCT02829151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92761052|NCT02829151|Purinergic Agents|purinergic agents|mesh-ancestor
92761053|NCT02829151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761054|NCT02829151|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92761055|NCT02829151|Autonomic Agents|autonomic agents|mesh-ancestor
92761056|NCT02829151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92761057|NCT02829151|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761058|NCT02829151|Vasodilator Agents|vasodilator agents|mesh-ancestor
92761059|NCT02829151|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92761060|NCT02829151|Protective Agents|protective agents|mesh-ancestor
92761061|NCT02829151|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92761062|NCT02829151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92761063|NCT02825719|Tranexamic Acid|tranexamic acid|mesh-list
92761064|NCT02825719|Ulipristal acetate|ulipristal acetate|mesh-list
92761065|NCT02825719|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92761066|NCT02825719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92761067|NCT02825719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761068|NCT02825719|Hemostatics|hemostatics|mesh-ancestor
92761069|NCT02825719|Coagulants|coagulants|mesh-ancestor
92761070|NCT02825719|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92761071|NCT02825719|Contraceptive Agents|contraceptive agents|mesh-ancestor
92761072|NCT02825719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92761073|NCT02825719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761074|NCT02825719|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92761075|NCT04241653|Sevoflurane|sevoflurane|mesh-list
92761076|NCT04241653|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92761077|NCT04241653|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92761079|NCT04241653|Anesthetics|anesthetics|mesh-ancestor
92761080|NCT04241653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761081|NCT04241653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761082|NCT04241731|Cetuximab|cetuximab|mesh-list
92761083|NCT04241731|Raltitrexed|raltitrexed|mesh-list
92761084|NCT04241731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92761085|NCT04241731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761086|NCT04241731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92761087|NCT04241731|Antimetabolites|antimetabolites|mesh-ancestor
92761088|NCT04241731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761089|NCT04241731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92761090|NCT04241731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761091|NCT04241887|Anesthetics|anesthetics|mesh-list
92761092|NCT04241887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761093|NCT04241887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761094|NCT02825797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92761095|NCT02825797|Antibodies|antibodies|mesh-list
92761096|NCT02825797|Immunoglobulins|immunoglobulins|mesh-list
92761097|NCT02825797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92761098|NCT02825797|Immunologic Factors|immunologic factors|mesh-ancestor
92761099|NCT02825797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761100|NCT02825797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761101|NCT02824315|Simeprevir|simeprevir|mesh-list
92761102|NCT02824315|Odalasvir|odalasvir|mesh-list
92761103|NCT02824315|Antiviral Agents|antiviral agents|mesh-ancestor
92761104|NCT02824315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761105|NCT02824315|Protease Inhibitors|protease inhibitors|mesh-ancestor
92761106|NCT02824315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761107|NCT02824315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761108|NCT04242433|Antiviral Agents|antiviral agents|mesh-list
92761109|NCT04242433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761110|NCT02823925|Zoledronic Acid|zoledronic acid|mesh-list
92761111|NCT02823925|Pamidronate|pamidronate|mesh-list
92761112|NCT02823925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92761113|NCT02823925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761114|NCT04201249|Piroxicam|piroxicam|mesh-list
92761115|NCT04201249|Lidocaine|lidocaine|mesh-list
92761116|NCT04201249|Anesthetics, Local|anesthetics, local|mesh-ancestor
92761117|NCT04201249|Anesthetics|anesthetics|mesh-ancestor
92761118|NCT04201249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761119|NCT04201249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761120|NCT04201249|Sensory System Agents|sensory system agents|mesh-ancestor
92761121|NCT04201249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761122|NCT04201249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92761123|NCT04201249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92761124|NCT04201249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92761125|NCT04201249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761126|NCT04201249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761127|NCT04201249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92761128|NCT04201249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761129|NCT04201249|Analgesics|analgesics|mesh-ancestor
92761130|NCT04201249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92761131|NCT04201249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761132|NCT04201249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92761133|NCT04201249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761134|NCT00633685|Fluoxetine|fluoxetine|mesh-list
92761135|NCT00633685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92761136|NCT00633685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92761137|NCT00633685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761138|NCT00633685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761139|NCT00633685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761140|NCT00633685|Serotonin Agents|serotonin agents|mesh-ancestor
92761141|NCT00633685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761142|NCT00633685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92761143|NCT00633685|Antidepressive Agents|antidepressive agents|mesh-ancestor
92761144|NCT00633685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92761145|NCT00633685|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92761146|NCT00633685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92761147|NCT00633685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761148|NCT02823691|Metformin|metformin|mesh-list
92761149|NCT02823691|Lanreotide|lanreotide|mesh-list
92761150|NCT02823691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761151|NCT02823691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761152|NCT02823691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761154|NCT02825095|Anesthetics, Local|anesthetics, local|mesh-ancestor
92761155|NCT02825095|Anesthetics|anesthetics|mesh-ancestor
92761156|NCT02825095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761157|NCT02825095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761158|NCT02825095|Sensory System Agents|sensory system agents|mesh-ancestor
92761159|NCT02825095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761160|NCT02825095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92761161|NCT02825095|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92761162|NCT02825095|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92761163|NCT02825095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761164|NCT02825095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761165|NCT04195009|Anesthetics|anesthetics|mesh-list
92761166|NCT04195009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761167|NCT04195009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761168|NCT05660083|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92761169|NCT05660083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761170|NCT05660083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761171|NCT02822131|Sevelamer|sevelamer|mesh-list
92761172|NCT02822131|Chelating Agents|chelating agents|mesh-ancestor
92761173|NCT02822131|Sequestering Agents|sequestering agents|mesh-ancestor
92761174|NCT02822131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761175|NCT04239625|Vitamin A|vitamin a|mesh-list
92761176|NCT04239625|Retinol acetate|retinol acetate|mesh-list
92761177|NCT04239625|Vitamins|vitamins|mesh-ancestor
92761178|NCT04239625|Micronutrients|micronutrients|mesh-ancestor
92761179|NCT04239625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761180|NCT04239625|Protective Agents|protective agents|mesh-ancestor
92761181|NCT04239625|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92761182|NCT04239625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761183|NCT04239625|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92761184|NCT04239625|Immunologic Factors|immunologic factors|mesh-ancestor
92761186|NCT02821897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761187|NCT02821897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761188|NCT02820493|Vedolizumab|vedolizumab|mesh-list
92761189|NCT02820493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92761190|NCT05659459|Pioglitazone|pioglitazone|mesh-list
92761191|NCT05659459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761192|NCT05659459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761193|NCT02820259|Tacrolimus|tacrolimus|mesh-list
92761194|NCT02820259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761195|NCT02820259|Immunologic Factors|immunologic factors|mesh-ancestor
92761196|NCT02820259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761197|NCT02820259|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92761198|NCT02820259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761199|NCT02820259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761200|NCT00633763|Fallypride|fallypride|mesh-list
92761201|NCT00633763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92761202|NCT00633763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92761203|NCT00633763|Dopamine Agents|dopamine agents|mesh-ancestor
92761204|NCT00633763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761205|NCT00633763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761206|NCT00633763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761207|NCT02820025|Doxapram|doxapram|mesh-list
92761208|NCT02820025|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92761209|NCT02820025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761210|NCT02820025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761211|NCT02819869|Metformin|metformin|mesh-list
92761212|NCT02819869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761213|NCT02819869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761214|NCT02820883|Vaccines|vaccines|mesh-list
92761215|NCT02820883|Immunologic Factors|immunologic factors|mesh-ancestor
92761216|NCT02820883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761217|NCT02819089|Dexmedetomidine|dexmedetomidine|mesh-list
92761218|NCT02819089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92761219|NCT02819089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761220|NCT02819089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761221|NCT02819089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761222|NCT02819089|Analgesics|analgesics|mesh-ancestor
92761223|NCT02819089|Sensory System Agents|sensory system agents|mesh-ancestor
92761224|NCT02819089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761225|NCT02819089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92761226|NCT02819089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92761227|NCT02819089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92761228|NCT02819089|Adrenergic Agents|adrenergic agents|mesh-ancestor
92761229|NCT02819089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761230|NCT02819089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761231|NCT04238923|Vancomycin|vancomycin|mesh-list
92761232|NCT04238923|Gentamicins|gentamicins|mesh-list
92761233|NCT04238923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92761234|NCT04238923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761235|NCT04238923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92761236|NCT04238923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761237|NCT04238923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761238|NCT02815657|Valsartan|valsartan|mesh-list
92761239|NCT02815657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92761240|NCT02815657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92761241|NCT02815657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92334862|NCT00005119|Calcium|calcium|mesh-list
92761242|NCT02815657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761243|NCT04597333|Dinoprostone|dinoprostone|mesh-list
92761244|NCT04597333|Oxytocics|oxytocics|mesh-ancestor
92761245|NCT04597333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92761246|NCT04597333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761247|NCT00957580|Niacinamide|niacinamide|mesh-list
92761248|NCT00957580|Vitamin B Complex|vitamin b complex|mesh-ancestor
92761249|NCT00957580|Vitamins|vitamins|mesh-ancestor
92761250|NCT00957580|Micronutrients|micronutrients|mesh-ancestor
92761251|NCT00957580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761252|NCT00957424|Nicotine|nicotine|mesh-list
92761253|NCT00957424|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92761254|NCT00957424|Autonomic Agents|autonomic agents|mesh-ancestor
92761255|NCT00957424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711198|NCT01188538|Analgesics|analgesics|mesh-ancestor
92761256|NCT00957424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761257|NCT00957424|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92761258|NCT00957424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92761259|NCT00957424|Cholinergic Agents|cholinergic agents|mesh-ancestor
92761260|NCT00957424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761261|NCT00957424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761262|NCT02818621|Dexmedetomidine|dexmedetomidine|mesh-list
92761263|NCT02818621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92761264|NCT02818621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761265|NCT02818621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761266|NCT02818621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761267|NCT02818621|Analgesics|analgesics|mesh-ancestor
92761268|NCT02818621|Sensory System Agents|sensory system agents|mesh-ancestor
92761269|NCT02818621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761270|NCT02818621|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92761271|NCT02818621|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92761272|NCT02818621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92761273|NCT02818621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92761274|NCT02818621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761275|NCT02818621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761276|NCT04642651|Dexmedetomidine|dexmedetomidine|mesh-list
92761277|NCT04642651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92761278|NCT04642651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761279|NCT04642651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761280|NCT04642651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761281|NCT04642651|Analgesics|analgesics|mesh-ancestor
92761282|NCT04642651|Sensory System Agents|sensory system agents|mesh-ancestor
92761283|NCT04642651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761284|NCT04642651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92761285|NCT04642651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92761286|NCT04642651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92761287|NCT04642651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92761288|NCT04642651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761289|NCT04642651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761290|NCT01061151|Ritonavir|ritonavir|mesh-list
92761291|NCT01061151|Lopinavir|lopinavir|mesh-list
92761292|NCT01061151|Tenofovir|tenofovir|mesh-list
92761293|NCT01061151|Lamivudine|lamivudine|mesh-list
92761294|NCT01061151|Emtricitabine|emtricitabine|mesh-list
92761295|NCT01061151|Zidovudine|zidovudine|mesh-list
92761296|NCT01061151|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92761297|NCT01061151|Nevirapine|nevirapine|mesh-list
92761298|NCT01061151|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92761299|NCT01061151|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92761300|NCT01061151|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92761301|NCT01061151|Protease Inhibitors|protease inhibitors|mesh-ancestor
92761302|NCT01061151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761303|NCT01061151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761304|NCT01061151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92761305|NCT01061151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92761306|NCT01061151|Antiviral Agents|antiviral agents|mesh-ancestor
92761307|NCT01061151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987406|NCT03189901|Protective Agents|protective agents|mesh-ancestor
92761308|NCT01061151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92761309|NCT01061151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92761310|NCT01061151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92761311|NCT01061151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92761312|NCT01061151|Antimetabolites|antimetabolites|mesh-ancestor
92761313|NCT01061151|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92761314|NCT01061151|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92761315|NCT04472143|Granisetron|granisetron|mesh-list
92761316|NCT04472143|Antiemetics|antiemetics|mesh-ancestor
92761317|NCT04472143|Autonomic Agents|autonomic agents|mesh-ancestor
92761318|NCT04472143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761319|NCT04472143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761320|NCT04472143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92761321|NCT04472143|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92761322|NCT04472143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92761323|NCT04472143|Serotonin Agents|serotonin agents|mesh-ancestor
92761324|NCT04472143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761325|NCT04472143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761326|NCT01241552|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92761327|NCT01241552|Immunologic Factors|immunologic factors|mesh-ancestor
92761328|NCT01241552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761330|NCT04748523|Antidepressive Agents|antidepressive agents|mesh-ancestor
92761331|NCT04748523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92761332|NCT04748523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92761333|NCT04748523|Histamine Antagonists|histamine antagonists|mesh-ancestor
92761334|NCT04748523|Histamine Agents|histamine agents|mesh-ancestor
92761335|NCT04748523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761336|NCT04748523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761337|NCT04748523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761338|NCT04748523|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92761339|NCT04748523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92761340|NCT04748523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761341|NCT04748523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92761342|NCT04748523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92761343|NCT04748523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92761344|NCT04748523|Adrenergic Agents|adrenergic agents|mesh-ancestor
92761345|NCT04748523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92761346|NCT04748523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92761347|NCT04748523|Serotonin Agents|serotonin agents|mesh-ancestor
92761348|NCT04748523|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92761349|NCT02817217|Valsartan|valsartan|mesh-list
92761350|NCT02817217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92761351|NCT02817217|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92761352|NCT02817217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92761353|NCT02817217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761354|NCT00948922|Fludarabine|fludarabine|mesh-list
92761355|NCT00948922|Bortezomib|bortezomib|mesh-list
92761356|NCT00948922|Melphalan|melphalan|mesh-list
92761357|NCT00948922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761358|NCT00948922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761359|NCT00948922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761360|NCT00948922|Immunologic Factors|immunologic factors|mesh-ancestor
92761361|NCT00948922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761362|NCT00948922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92761363|NCT00948922|Alkylating Agents|alkylating agents|mesh-ancestor
92761364|NCT00948922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92761365|NCT00634309|Candesartan|candesartan|mesh-list
92761366|NCT00634309|Candesartan cilexetil|candesartan cilexetil|mesh-list
92761367|NCT00634309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92761368|NCT00634309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92761369|NCT00634309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92761370|NCT00634309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761371|NCT01239992|Niacin|niacin|mesh-list
92761372|NCT01239992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92761373|NCT01239992|Antimetabolites|antimetabolites|mesh-ancestor
92761374|NCT01239992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761375|NCT01239992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92761376|NCT01239992|Vasodilator Agents|vasodilator agents|mesh-ancestor
92761377|NCT01239992|Vitamin B Complex|vitamin b complex|mesh-ancestor
92761378|NCT01239992|Vitamins|vitamins|mesh-ancestor
92761379|NCT01239992|Micronutrients|micronutrients|mesh-ancestor
92761380|NCT01239992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761381|NCT02816905|Fluorometholone|fluorometholone|mesh-list
92761382|NCT02816905|Dexamethasone|dexamethasone|mesh-list
92761383|NCT02816905|Rimexolone|rimexolone|mesh-list
92761384|NCT02816905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92761385|NCT02816905|Antiemetics|antiemetics|mesh-ancestor
92761386|NCT02816905|Autonomic Agents|autonomic agents|mesh-ancestor
92761387|NCT02816905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761388|NCT02816905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761389|NCT02816905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92761390|NCT02816905|Glucocorticoids|glucocorticoids|mesh-ancestor
92761391|NCT02816905|Hormones|hormones|mesh-ancestor
92761392|NCT02816905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92761393|NCT02816905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92761394|NCT02816905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761395|NCT02816905|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92761396|NCT01072539|Tigecycline|tigecycline|mesh-list
92761397|NCT01072539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92761398|NCT01072539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761399|NCT01072539|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92761400|NCT01072539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761401|NCT01072539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761402|NCT05517590|Tranexamic Acid|tranexamic acid|mesh-list
92761403|NCT05517590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92761404|NCT05517590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92761405|NCT05517590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761406|NCT05517590|Hemostatics|hemostatics|mesh-ancestor
92761407|NCT05517590|Coagulants|coagulants|mesh-ancestor
92761408|NCT05654077|Cyclophosphamide|cyclophosphamide|mesh-list
92761409|NCT05654077|Fludarabine|fludarabine|mesh-list
92761410|NCT05654077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761411|NCT05654077|Immunologic Factors|immunologic factors|mesh-ancestor
92761412|NCT05654077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761413|NCT05654077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761414|NCT05654077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92761415|NCT05654077|Alkylating Agents|alkylating agents|mesh-ancestor
92761416|NCT05654077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761417|NCT05654077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761418|NCT05654077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92761419|NCT04303767|Calcium|calcium|mesh-list
92761420|NCT04303767|Caseins|caseins|mesh-list
92761421|NCT04303767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92761422|NCT04303767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761423|NCT04303767|Chelating Agents|chelating agents|mesh-ancestor
92761424|NCT04303767|Sequestering Agents|sequestering agents|mesh-ancestor
92761425|NCT04303767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761426|NCT02874963|Ethanol|ethanol|mesh-list
92761427|NCT02874963|Listerine|listerine|mesh-list
92761428|NCT02874963|Thymol|thymol|mesh-list
92761429|NCT02874963|Eucalyptol|eucalyptol|mesh-list
92761430|NCT02874963|Salicylates|salicylates|mesh-list
92761431|NCT02874963|Methyl salicylate|methyl salicylate|mesh-list
92761432|NCT02874963|Menthol|menthol|mesh-list
92761433|NCT02874963|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92761434|NCT02874963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761435|NCT02874963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761436|NCT02874963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761437|NCT02874963|Antipruritics|antipruritics|mesh-ancestor
92761438|NCT02874963|Dermatologic Agents|dermatologic agents|mesh-ancestor
92761439|NCT02874963|Protective Agents|protective agents|mesh-ancestor
92761440|NCT02874963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92761441|NCT02874963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761442|NCT02874963|Analgesics|analgesics|mesh-ancestor
92761443|NCT02874963|Sensory System Agents|sensory system agents|mesh-ancestor
92761444|NCT02874963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761445|NCT02874963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92761446|NCT02874963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761447|NCT02874963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92761448|NCT02874963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761449|NCT02874963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761450|NCT02874963|Antifungal Agents|antifungal agents|mesh-ancestor
92761451|NCT02874963|Antitussive Agents|antitussive agents|mesh-ancestor
92761452|NCT02874963|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761453|NCT02874963|Insect Repellents|insect repellents|mesh-ancestor
92761454|NCT02818309|Lesogaberan|lesogaberan|mesh-list
92761455|NCT02818309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92761456|NCT02818309|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92761457|NCT02818309|GABA Agonists|gaba agonists|mesh-ancestor
92761458|NCT02818309|GABA Agents|gaba agents|mesh-ancestor
92761459|NCT02818309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761460|NCT02818309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761461|NCT02818309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761462|NCT01238822|Methylphenidate|methylphenidate|mesh-list
92761463|NCT01238822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92761464|NCT01238822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761465|NCT01238822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92761466|NCT01238822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92761467|NCT01238822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761468|NCT01238822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761469|NCT01238822|Dopamine Agents|dopamine agents|mesh-ancestor
92761470|NCT01238822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761471|NCT02818387|Midazolam|midazolam|mesh-list
92761472|NCT02818387|Remifentanil|remifentanil|mesh-list
92761473|NCT02818387|Propofol|propofol|mesh-list
92761474|NCT02818387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92761475|NCT02818387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761476|NCT02818387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761477|NCT02818387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92761478|NCT02818387|Anesthetics, General|anesthetics, general|mesh-ancestor
92761479|NCT02818387|Anesthetics|anesthetics|mesh-ancestor
92761480|NCT02818387|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92761481|NCT02818387|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92761482|NCT02818387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92761483|NCT02818387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92761484|NCT02818387|GABA Modulators|gaba modulators|mesh-ancestor
92761485|NCT02818387|GABA Agents|gaba agents|mesh-ancestor
92761486|NCT02818387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761487|NCT02818387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761488|NCT02818387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92761489|NCT02818387|Narcotics|narcotics|mesh-ancestor
92761490|NCT02818387|Analgesics|analgesics|mesh-ancestor
92761491|NCT02818387|Sensory System Agents|sensory system agents|mesh-ancestor
92761492|NCT02818387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761493|NCT05296629|Doxycycline|doxycycline|mesh-list
92761494|NCT05296629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92761495|NCT05296629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761496|NCT05296629|Antimalarials|antimalarials|mesh-ancestor
92761497|NCT05296629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92761498|NCT05296629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92761499|NCT01238588|Sevelamer|sevelamer|mesh-list
92761500|NCT01238588|Chelating Agents|chelating agents|mesh-ancestor
92761501|NCT01238588|Sequestering Agents|sequestering agents|mesh-ancestor
92761502|NCT01238588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761503|NCT00627003|Cabergoline|cabergoline|mesh-list
92761504|NCT00627003|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92761505|NCT00627003|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92761506|NCT00627003|Dopamine Agonists|dopamine agonists|mesh-ancestor
92761507|NCT00627003|Dopamine Agents|dopamine agents|mesh-ancestor
92761508|NCT00627003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92334899|NCT00005641|Busulfan|busulfan|mesh-list
92761509|NCT00627003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761510|NCT00627003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761511|NCT04238221|Doxofylline|doxofylline|mesh-list
92761512|NCT04238221|Antitussive Agents|antitussive agents|mesh-ancestor
92761513|NCT04238221|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761514|NCT04238221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92761515|NCT04238221|Autonomic Agents|autonomic agents|mesh-ancestor
92761516|NCT04238221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529696|NCT00016380|Glucocorticoids|glucocorticoids|mesh-ancestor
92761517|NCT04238221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761518|NCT04238221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92761519|NCT04238221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92761520|NCT04238221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761521|NCT04238221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761522|NCT01047501|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92761523|NCT01047501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92761524|NCT01047501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92761525|NCT01238120|Ibuprofen|ibuprofen|mesh-list
92761526|NCT01238120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92761527|NCT01238120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92761528|NCT01238120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761529|NCT01238120|Analgesics|analgesics|mesh-ancestor
92761530|NCT01238120|Sensory System Agents|sensory system agents|mesh-ancestor
92761531|NCT01238120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761532|NCT01238120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761533|NCT01238120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761534|NCT01238120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92761535|NCT01238120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761536|NCT01238120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761537|NCT00634231|Valacyclovir|valacyclovir|mesh-list
92761538|NCT00634231|Antiviral Agents|antiviral agents|mesh-ancestor
92761539|NCT00634231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761540|NCT02816593|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92761541|NCT02816593|Carbamide Peroxide|carbamide peroxide|mesh-list
92761542|NCT02816593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92761543|NCT02816593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761544|NCT04237987|Cyclosporine|cyclosporine|mesh-list
92761545|NCT04237987|Aldesleukin|aldesleukin|mesh-list
92761546|NCT04237987|Interleukin-2|interleukin-2|mesh-list
92761547|NCT04237987|Cyclosporins|cyclosporins|mesh-list
92761548|NCT04237987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761549|NCT04237987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761550|NCT04237987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761551|NCT04237987|Immunologic Factors|immunologic factors|mesh-ancestor
92711497|NCT04689815|Arsenic Trioxide|arsenic trioxide|mesh-list
92761552|NCT04237987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761553|NCT04237987|Antifungal Agents|antifungal agents|mesh-ancestor
92761554|NCT04237987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761555|NCT04237987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92761556|NCT04237987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761557|NCT04237987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92761558|NCT04237987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761559|NCT04237987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761560|NCT04237987|Analgesics|analgesics|mesh-ancestor
92761561|NCT04237987|Sensory System Agents|sensory system agents|mesh-ancestor
92761562|NCT04237987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761563|NCT04237987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92761564|NCT04237987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92761565|NCT04237987|Antiviral Agents|antiviral agents|mesh-ancestor
92761567|NCT04551547|Immunologic Factors|immunologic factors|mesh-ancestor
92761568|NCT04551547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761569|NCT01045707|Insulin|insulin|mesh-list
92761570|NCT01045707|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92761571|NCT01045707|Insulin Glargine|insulin glargine|mesh-list
92761572|NCT01045707|Insulin Aspart|insulin aspart|mesh-list
92761573|NCT01045707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92366891|NCT00787332|Anticoagulants|anticoagulants|mesh-ancestor
92761574|NCT01045707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761575|NCT04533997|Furosemide|furosemide|mesh-list
92761576|NCT04533997|Diuretics|diuretics|mesh-ancestor
92761577|NCT04533997|Natriuretic Agents|natriuretic agents|mesh-ancestor
92761578|NCT04533997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761579|NCT04533997|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92761580|NCT04533997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761581|NCT04533997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761582|NCT02874807|Empagliflozin|empagliflozin|mesh-list
92761583|NCT02874807|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92761584|NCT02874807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761585|NCT02874807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761586|NCT02874807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761587|NCT01054599|Memantine|memantine|mesh-list
92761588|NCT01054599|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92761589|NCT01054599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92761590|NCT01054599|Dopamine Agents|dopamine agents|mesh-ancestor
92761591|NCT01054599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761592|NCT01054599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761593|NCT01054599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761594|NCT01054599|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92761595|NCT01054599|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92761596|NCT05635201|Anesthetics|anesthetics|mesh-list
92761597|NCT05635201|Propofol|propofol|mesh-list
92761598|NCT05635201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761599|NCT05635201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761600|NCT05635201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92761601|NCT05635201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92761602|NCT05635201|Anesthetics, General|anesthetics, general|mesh-ancestor
92761603|NCT02813863|Metformin|metformin|mesh-list
92761604|NCT02813863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761605|NCT02813863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761606|NCT02874729|Dimercaprol|dimercaprol|mesh-list
92761607|NCT02874729|Chelating Agents|chelating agents|mesh-ancestor
92761608|NCT02874729|Sequestering Agents|sequestering agents|mesh-ancestor
92761609|NCT02874729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761610|NCT04275661|Magnesium Sulfate|magnesium sulfate|mesh-list
92761611|NCT04275661|Ketamine|ketamine|mesh-list
92761612|NCT04275661|Levobupivacaine|levobupivacaine|mesh-list
92761613|NCT04275661|Analgesics|analgesics|mesh-ancestor
92761614|NCT04275661|Sensory System Agents|sensory system agents|mesh-ancestor
92761615|NCT04275661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761616|NCT04275661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761617|NCT04275661|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92761618|NCT04275661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92761619|NCT04275661|Anesthetics, General|anesthetics, general|mesh-ancestor
92761620|NCT04275661|Anesthetics|anesthetics|mesh-ancestor
92761621|NCT04275661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761622|NCT04275661|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92761623|NCT04275661|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92761624|NCT04275661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761625|NCT04275661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761626|NCT04275661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92761627|NCT04275661|Anticonvulsants|anticonvulsants|mesh-ancestor
92761628|NCT04275661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92761629|NCT04275661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761630|NCT04275661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92761631|NCT04275661|Tocolytic Agents|tocolytic agents|mesh-ancestor
92761632|NCT04275661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92761633|NCT04275661|Anesthetics, Local|anesthetics, local|mesh-ancestor
92761634|NCT00948766|Rivastigmine|rivastigmine|mesh-list
92761635|NCT00948766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92761636|NCT00948766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761637|NCT00948766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761638|NCT00948766|Cholinergic Agents|cholinergic agents|mesh-ancestor
92761639|NCT00948766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761640|NCT00948766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761641|NCT00948766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92761642|NCT00948766|Protective Agents|protective agents|mesh-ancestor
92761643|NCT01053663|Oseltamivir|oseltamivir|mesh-list
92761644|NCT01053663|Antiviral Agents|antiviral agents|mesh-ancestor
92761645|NCT01053663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761646|NCT01053663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761647|NCT01053663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761648|NCT01235546|Azithromycin|azithromycin|mesh-list
92761649|NCT01235546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92761650|NCT01235546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761651|NCT01053429|Ziprasidone|ziprasidone|mesh-list
92761652|NCT01053429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92761653|NCT01053429|Serotonin Agents|serotonin agents|mesh-ancestor
92761654|NCT01053429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761655|NCT01053429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761656|NCT01053429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761657|NCT01053429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92761658|NCT01053429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92761659|NCT01053429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761660|NCT01053429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92761661|NCT01053429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92761662|NCT01053429|Dopamine Agents|dopamine agents|mesh-ancestor
92761663|NCT01233284|Bromides|bromides|mesh-list
92761664|NCT01233284|Tiotropium Bromide|tiotropium bromide|mesh-list
92761665|NCT01233284|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92761666|NCT01233284|Autonomic Agents|autonomic agents|mesh-ancestor
92761667|NCT01233284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761668|NCT01233284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761669|NCT01233284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92761670|NCT01233284|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761671|NCT01233284|Parasympatholytics|parasympatholytics|mesh-ancestor
92761672|NCT01233284|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92761673|NCT01233284|Cholinergic Agents|cholinergic agents|mesh-ancestor
92761674|NCT01233284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761675|NCT01233284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761676|NCT01233284|Anticonvulsants|anticonvulsants|mesh-ancestor
92761677|NCT00948688|Vorinostat|vorinostat|mesh-list
92761678|NCT00948688|Fluorouracil|fluorouracil|mesh-list
92761679|NCT00948688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761680|NCT00948688|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92761681|NCT00948688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761682|NCT00948688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761683|NCT00948688|Antimetabolites|antimetabolites|mesh-ancestor
92334949|NCT00005647|Growth Substances|growth substances|mesh-ancestor
92761684|NCT00948688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92761685|NCT00948688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761686|NCT00948688|Immunologic Factors|immunologic factors|mesh-ancestor
92761687|NCT00948688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761688|NCT02188264|Cyclosporine|cyclosporine|mesh-list
92761689|NCT02188264|Cyclosporins|cyclosporins|mesh-list
92761690|NCT02188264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761691|NCT02188264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761692|NCT02188264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761693|NCT02188264|Immunologic Factors|immunologic factors|mesh-ancestor
92761694|NCT02188264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761695|NCT02188264|Antifungal Agents|antifungal agents|mesh-ancestor
92761696|NCT02188264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761697|NCT02188264|Dermatologic Agents|dermatologic agents|mesh-ancestor
92761698|NCT02188264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761699|NCT02188264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92761700|NCT01233050|Ethanol|ethanol|mesh-list
92761701|NCT01233050|Chlorhexidine|chlorhexidine|mesh-list
92761702|NCT01233050|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92761703|NCT01233050|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92761704|NCT01233050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711646|NCT02929316|Vedolizumab|vedolizumab|mesh-list
92761705|NCT01233050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761706|NCT01233050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761707|NCT01233050|Disinfectants|disinfectants|mesh-ancestor
92761708|NCT01233050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92761709|NCT01049217|Pregabalin|pregabalin|mesh-list
92761710|NCT01049217|Analgesics|analgesics|mesh-ancestor
92761711|NCT01049217|Sensory System Agents|sensory system agents|mesh-ancestor
92761712|NCT01049217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761713|NCT01049217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761714|NCT01049217|Anticonvulsants|anticonvulsants|mesh-ancestor
92761715|NCT01049217|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92761716|NCT01049217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761717|NCT01049217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761718|NCT01049217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92761719|NCT01049217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92761720|NCT01049217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92761721|NCT01049217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761722|NCT01049217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92761723|NCT01232738|Rasagiline|rasagiline|mesh-list
92761724|NCT01232738|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92761725|NCT01232738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761726|NCT01232738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761727|NCT01232738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92761728|NCT01232738|Protective Agents|protective agents|mesh-ancestor
92761729|NCT01232738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761730|NCT00957268|Alogliptin|alogliptin|mesh-list
92761731|NCT00957268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761732|NCT00957268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761733|NCT00957268|Incretins|incretins|mesh-ancestor
92761734|NCT00957268|Hormones|hormones|mesh-ancestor
92761735|NCT00957268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334956|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761736|NCT00957268|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92761737|NCT00957268|Protease Inhibitors|protease inhibitors|mesh-ancestor
92761738|NCT00957268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761739|NCT00957268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761740|NCT02888444|Varenicline|varenicline|mesh-list
92761741|NCT02888444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92761742|NCT02888444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92761743|NCT02888444|Cholinergic Agents|cholinergic agents|mesh-ancestor
92761744|NCT02888444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761745|NCT02888444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761746|NCT02888444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761747|NCT01230788|Rituximab|rituximab|mesh-list
92761748|NCT01230788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92761749|NCT01230788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761750|NCT01230788|Immunologic Factors|immunologic factors|mesh-ancestor
92761751|NCT01230788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761752|NCT01230788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761753|NCT01230710|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92761754|NCT01230710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761755|NCT01230710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92761756|NCT01230710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761757|NCT01230710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761758|NCT00627081|Remifentanil|remifentanil|mesh-list
92761759|NCT00627081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92761760|NCT00627081|Narcotics|narcotics|mesh-ancestor
92761761|NCT00627081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761762|NCT00627081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761763|NCT00627081|Analgesics|analgesics|mesh-ancestor
92761764|NCT00627081|Sensory System Agents|sensory system agents|mesh-ancestor
92761765|NCT00627081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761766|NCT02888054|Allopurinol|allopurinol|mesh-list
92761767|NCT02888054|Lesinurad|lesinurad|mesh-list
92761768|NCT02888054|Antimetabolites|antimetabolites|mesh-ancestor
92761769|NCT02888054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761770|NCT02888054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761771|NCT02888054|Gout Suppressants|gout suppressants|mesh-ancestor
92761772|NCT02888054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761773|NCT02888054|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92761774|NCT02888054|Antioxidants|antioxidants|mesh-ancestor
92761775|NCT02888054|Protective Agents|protective agents|mesh-ancestor
92761776|NCT02888054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761777|NCT02888054|Uricosuric Agents|uricosuric agents|mesh-ancestor
92761778|NCT01040793|Olodaterol|olodaterol|mesh-list
92761779|NCT01040793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92761780|NCT01040793|Autonomic Agents|autonomic agents|mesh-ancestor
92761781|NCT01040793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761782|NCT01040793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761783|NCT01040793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92761784|NCT01040793|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761785|NCT02811055|Aprepitant|aprepitant|mesh-list
92761786|NCT02811055|Antiemetics|antiemetics|mesh-ancestor
92761787|NCT02811055|Autonomic Agents|autonomic agents|mesh-ancestor
92761788|NCT02811055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761789|NCT02811055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761790|NCT02811055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92761791|NCT02811055|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92761792|NCT02811055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761793|NCT02811055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761794|NCT04192903|Cisplatin|cisplatin|mesh-list
92761795|NCT04192903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761796|NCT02810899|Dexmedetomidine|dexmedetomidine|mesh-list
92761797|NCT02810899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92761798|NCT02810899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761799|NCT02810899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761800|NCT02810899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92367131|NCT00803400|Alprazolam|alprazolam|mesh-list
92761801|NCT02810899|Analgesics|analgesics|mesh-ancestor
92761802|NCT02810899|Sensory System Agents|sensory system agents|mesh-ancestor
92761803|NCT02810899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761804|NCT02810899|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92761805|NCT02810899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92761806|NCT02810899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92761807|NCT02810899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92761808|NCT02810899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761809|NCT02810899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761810|NCT04237129|Insulin Aspart|insulin aspart|mesh-list
92761811|NCT04237129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761812|NCT04237129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761813|NCT02810587|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92761814|NCT02810587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761815|NCT02810275|Leucovorin|leucovorin|mesh-list
92761816|NCT02810275|Folic Acid|folic acid|mesh-list
92761817|NCT02810275|Levoleucovorin|levoleucovorin|mesh-list
92761818|NCT02810275|Antidotes|antidotes|mesh-ancestor
92761819|NCT02810275|Protective Agents|protective agents|mesh-ancestor
92761820|NCT02810275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761821|NCT02810275|Vitamin B Complex|vitamin b complex|mesh-ancestor
92761822|NCT02810275|Vitamins|vitamins|mesh-ancestor
92761823|NCT02810275|Micronutrients|micronutrients|mesh-ancestor
92761824|NCT02810275|Hematinics|hematinics|mesh-ancestor
92761825|NCT00948064|Azacitidine|azacitidine|mesh-list
92761826|NCT00948064|Vorinostat|vorinostat|mesh-list
92761827|NCT00948064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92761828|NCT00948064|Antimetabolites|antimetabolites|mesh-ancestor
92761829|NCT00948064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761830|NCT00948064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761831|NCT00948064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761832|NCT00948064|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92761833|NCT02813239|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92761834|NCT02813239|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92761835|NCT02813239|Luteolytic Agents|luteolytic agents|mesh-ancestor
92761836|NCT02813239|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92761837|NCT02813239|Contraceptive Agents|contraceptive agents|mesh-ancestor
92761838|NCT02813239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92761839|NCT02813239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761840|NCT02813239|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92761841|NCT02813239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92761842|NCT02813239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761843|NCT02858206|Paclitaxel|paclitaxel|mesh-list
92761844|NCT02858206|Nimotuzumab|nimotuzumab|mesh-list
92761845|NCT02858206|Nedaplatin|nedaplatin|mesh-list
92761846|NCT02858206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92761847|NCT02858206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761848|NCT02858206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92761849|NCT02858206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92761850|NCT02858206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92761851|NCT02858206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761852|NCT02858206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92761853|NCT02815189|Acetaminophen|acetaminophen|mesh-list
92761854|NCT02815189|Ibuprofen|ibuprofen|mesh-list
92711792|NCT02926976|GABA Agents|gaba agents|mesh-ancestor
92761855|NCT02815189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761856|NCT02815189|Analgesics|analgesics|mesh-ancestor
92761857|NCT02815189|Sensory System Agents|sensory system agents|mesh-ancestor
92761858|NCT02815189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761859|NCT02815189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761860|NCT02815189|Antipyretics|antipyretics|mesh-ancestor
92761861|NCT02815189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92761862|NCT02815189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92761863|NCT02815189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761864|NCT02815189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92761865|NCT02815189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334987|NCT00004747|Immunoglobulins|immunoglobulins|mesh-list
92761866|NCT02815189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761867|NCT02809963|Eplerenone|eplerenone|mesh-list
92761868|NCT02809963|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92761869|NCT02809963|Hormone Antagonists|hormone antagonists|mesh-ancestor
92761870|NCT02809963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92761871|NCT02809963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761872|NCT02809963|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92761873|NCT02809963|Diuretics|diuretics|mesh-ancestor
92761874|NCT02809963|Natriuretic Agents|natriuretic agents|mesh-ancestor
92761875|NCT02809963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92761876|NCT02815111|Acetaminophen|acetaminophen|mesh-list
92761877|NCT02815111|Lidocaine|lidocaine|mesh-list
92761878|NCT02815111|Ketamine|ketamine|mesh-list
92761879|NCT02815111|Gabapentin|gabapentin|mesh-list
92761880|NCT02815111|Anesthetics, Local|anesthetics, local|mesh-ancestor
92761881|NCT02815111|Anesthetics|anesthetics|mesh-ancestor
92761882|NCT02815111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92761883|NCT02815111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761884|NCT02815111|Sensory System Agents|sensory system agents|mesh-ancestor
92761885|NCT02815111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761886|NCT02815111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92761887|NCT02815111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92761888|NCT02815111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92761889|NCT02815111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92761890|NCT02815111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761891|NCT02815111|Analgesics|analgesics|mesh-ancestor
92761892|NCT02815111|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92761893|NCT02815111|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92761894|NCT02815111|Anesthetics, General|anesthetics, general|mesh-ancestor
92761895|NCT02815111|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92761896|NCT02815111|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92761897|NCT02815111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761898|NCT02815111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92761899|NCT02815111|Antipyretics|antipyretics|mesh-ancestor
92761900|NCT02815111|Anticonvulsants|anticonvulsants|mesh-ancestor
92761901|NCT02815111|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92761902|NCT02815111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92761903|NCT02815111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92761904|NCT02815111|Antimanic Agents|antimanic agents|mesh-ancestor
92761905|NCT04236895|Insulin Glargine|insulin glargine|mesh-list
92761906|NCT04236895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761907|NCT04236895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761908|NCT02809729|Cefazolin|cefazolin|mesh-list
92761909|NCT02809729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92761910|NCT02809729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92761911|NCT04303377|Evolocumab|evolocumab|mesh-list
92761912|NCT04303377|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92761913|NCT04303377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92761914|NCT04303377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92761915|NCT04303377|Antimetabolites|antimetabolites|mesh-ancestor
92761916|NCT04303377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761917|NCT04303377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92761918|NCT04303377|Protease Inhibitors|protease inhibitors|mesh-ancestor
92761919|NCT04303377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761920|NCT04303377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92761921|NCT00953524|Vaccines|vaccines|mesh-list
92761922|NCT00953524|Immunologic Factors|immunologic factors|mesh-ancestor
92761923|NCT00953524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761924|NCT02809573|Prednisone|prednisone|mesh-list
92761925|NCT02809573|Cyclophosphamide|cyclophosphamide|mesh-list
92761926|NCT02809573|Vincristine|vincristine|mesh-list
92761927|NCT02809573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92761928|NCT02809573|Immunologic Factors|immunologic factors|mesh-ancestor
92761929|NCT02809573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761930|NCT02809573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92761931|NCT02809573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92761932|NCT02809573|Alkylating Agents|alkylating agents|mesh-ancestor
92761933|NCT02809573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761934|NCT02809573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92761935|NCT02809573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92761936|NCT02809573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92761937|NCT02809573|Glucocorticoids|glucocorticoids|mesh-ancestor
92761938|NCT02809573|Hormones|hormones|mesh-ancestor
92761939|NCT02809573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92761940|NCT02809573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92761941|NCT02809573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92761942|NCT02809573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92761943|NCT02809573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92761944|NCT02809573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92761945|NCT04388683|Nitric Oxide|nitric oxide|mesh-list
92761946|NCT04388683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92761947|NCT04388683|Autonomic Agents|autonomic agents|mesh-ancestor
92761948|NCT04388683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761949|NCT04388683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761950|NCT04388683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92761951|NCT04388683|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761952|NCT04388683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92761953|NCT04388683|Antioxidants|antioxidants|mesh-ancestor
92761954|NCT04388683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761955|NCT04388683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761956|NCT04388683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92761957|NCT04388683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92761958|NCT04388683|Gasotransmitters|gasotransmitters|mesh-ancestor
92761959|NCT04388683|Protective Agents|protective agents|mesh-ancestor
92761960|NCT01040403|Bromides|bromides|mesh-list
92761961|NCT01040403|Tiotropium Bromide|tiotropium bromide|mesh-list
92761962|NCT01040403|Olodaterol|olodaterol|mesh-list
92761963|NCT01040403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92761964|NCT01040403|Autonomic Agents|autonomic agents|mesh-ancestor
92761965|NCT01040403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92761966|NCT01040403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761967|NCT01040403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92761968|NCT01040403|Respiratory System Agents|respiratory system agents|mesh-ancestor
92761969|NCT01040403|Parasympatholytics|parasympatholytics|mesh-ancestor
92761970|NCT01040403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92761971|NCT01040403|Cholinergic Agents|cholinergic agents|mesh-ancestor
92761972|NCT01040403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92761973|NCT01040403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761974|NCT01040403|Anticonvulsants|anticonvulsants|mesh-ancestor
92761975|NCT00957034|Testosterone|testosterone|mesh-list
92761976|NCT00957034|Androgens|androgens|mesh-ancestor
92761977|NCT00957034|Hormones|hormones|mesh-ancestor
92761978|NCT00957034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92761979|NCT00957034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761980|NCT02812693|Pembrolizumab|pembrolizumab|mesh-list
92761981|NCT02812693|Imatinib Mesylate|imatinib mesylate|mesh-list
92761982|NCT02812693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92761983|NCT02812693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335026|NCT00004771|Fertility Agents|fertility agents|mesh-ancestor
92761984|NCT02812693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92761985|NCT02812693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761986|NCT02812693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92761987|NCT02812693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92761988|NCT04270552|Broncho-Vaxom|broncho-vaxom|mesh-list
92761989|NCT04270552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92761990|NCT04270552|Immunologic Factors|immunologic factors|mesh-ancestor
92761991|NCT04270552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761992|NCT04237597|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
92761993|NCT04237597|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92761994|NCT04237597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92761995|NCT04237597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92761996|NCT04237597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92761997|NCT02689999|Rabeprazole|rabeprazole|mesh-list
92761998|NCT02689999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92761999|NCT02689999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762000|NCT02689999|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92762001|NCT02689999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762002|NCT02689999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762003|NCT02809105|Linaclotide|linaclotide|mesh-list
92762004|NCT02809105|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92762005|NCT02809105|Enzyme Activators|enzyme activators|mesh-ancestor
92762006|NCT02809105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762007|NCT02809105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762008|NCT00953056|Vaccines|vaccines|mesh-list
92762009|NCT00953056|Immunologic Factors|immunologic factors|mesh-ancestor
92762010|NCT00953056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762011|NCT02811289|Mirabegron|mirabegron|mesh-list
92762012|NCT02811289|Glycerol|glycerol|mesh-list
92762013|NCT02811289|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92762014|NCT02811289|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92762015|NCT02811289|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92762016|NCT02811289|Adrenergic Agents|adrenergic agents|mesh-ancestor
92762017|NCT02811289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762018|NCT02811289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762019|NCT02811289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762020|NCT02811289|Urological Agents|urological agents|mesh-ancestor
92762021|NCT02811289|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92762022|NCT02811289|Protective Agents|protective agents|mesh-ancestor
92762023|NCT02808949|Dapivirine|dapivirine|mesh-list
92762024|NCT02808949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92762025|NCT02808949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92762026|NCT02808949|Antiviral Agents|antiviral agents|mesh-ancestor
92762027|NCT02808949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762028|NCT04207177|Mycophenolic Acid|mycophenolic acid|mesh-list
92762029|NCT04207177|Tacrolimus|tacrolimus|mesh-list
92762030|NCT04207177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762031|NCT04207177|Immunologic Factors|immunologic factors|mesh-ancestor
92762032|NCT04207177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762033|NCT04207177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92762034|NCT04207177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762035|NCT04207177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762036|NCT04207177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92762037|NCT04207177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762038|NCT04207177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92762039|NCT04207177|Antitubercular Agents|antitubercular agents|mesh-ancestor
92762040|NCT04207177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92762041|NCT04207177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762042|NCT02812147|Droxidopa|droxidopa|mesh-list
92762043|NCT02812147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92762044|NCT02812147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92762045|NCT04303065|Dexamethasone|dexamethasone|mesh-list
92762046|NCT04303065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762047|NCT04303065|Antiemetics|antiemetics|mesh-ancestor
92762048|NCT04303065|Autonomic Agents|autonomic agents|mesh-ancestor
92762049|NCT04303065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762050|NCT04303065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762051|NCT04303065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762052|NCT04303065|Glucocorticoids|glucocorticoids|mesh-ancestor
92762053|NCT04303065|Hormones|hormones|mesh-ancestor
92762054|NCT04303065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762055|NCT04303065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92762056|NCT04303065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762057|NCT02814877|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92762058|NCT02814877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762059|NCT00952822|Factor VIII|factor viii|mesh-list
92762060|NCT00952822|Coagulants|coagulants|mesh-ancestor
92762061|NCT02854072|Gemcitabine|gemcitabine|mesh-list
92762062|NCT02854072|Capecitabine|capecitabine|mesh-list
92762063|NCT02854072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92762064|NCT02854072|Antimetabolites|antimetabolites|mesh-ancestor
92762065|NCT02854072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762066|NCT02854072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762067|NCT02537314|Benzocaine|benzocaine|mesh-list
92762068|NCT02537314|Anesthetics, Local|anesthetics, local|mesh-ancestor
92762069|NCT02537314|Anesthetics|anesthetics|mesh-ancestor
92762070|NCT02537314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762071|NCT02537314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762072|NCT02537314|Sensory System Agents|sensory system agents|mesh-ancestor
92762073|NCT02537314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762074|NCT00631150|Levetiracetam|levetiracetam|mesh-list
92762075|NCT00631150|Anticonvulsants|anticonvulsants|mesh-ancestor
92762076|NCT00631150|Nootropic Agents|nootropic agents|mesh-ancestor
92762077|NCT04278040|Melphalan|melphalan|mesh-list
92762078|NCT04278040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762079|NCT04278040|Alkylating Agents|alkylating agents|mesh-ancestor
92762080|NCT04278040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762081|NCT04278040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762082|NCT04278040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92762083|NCT04278040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762084|NCT04278040|Immunologic Factors|immunologic factors|mesh-ancestor
92762085|NCT04278040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762086|NCT02856724|Dinoprostone|dinoprostone|mesh-list
92762087|NCT02856724|Oxytocics|oxytocics|mesh-ancestor
92762088|NCT02856724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762089|NCT02856724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762090|NCT02808325|Polygeline|polygeline|mesh-list
92762091|NCT02808325|Plasma Substitutes|plasma substitutes|mesh-ancestor
92762092|NCT02808325|Blood Substitutes|blood substitutes|mesh-ancestor
92762093|NCT00955474|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92762094|NCT00955474|Citalopram|citalopram|mesh-list
92762095|NCT00955474|Sertraline|sertraline|mesh-list
92762096|NCT00955474|Escitalopram|escitalopram|mesh-list
92762097|NCT00955474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92762098|NCT00955474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92762099|NCT00955474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762100|NCT00955474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762101|NCT00955474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762102|NCT00955474|Serotonin Agents|serotonin agents|mesh-ancestor
92762103|NCT00955474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762104|NCT00955474|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92762105|NCT00955474|Antidepressive Agents|antidepressive agents|mesh-ancestor
92762106|NCT00955474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92762107|NCT00955474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92762108|NCT00955474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92762109|NCT00955474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762110|NCT02808247|Ifosfamide|ifosfamide|mesh-list
92762111|NCT02808247|Nintedanib|nintedanib|mesh-list
92762112|NCT02808247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762113|NCT02808247|Alkylating Agents|alkylating agents|mesh-ancestor
92762114|NCT02808247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762115|NCT02808247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762116|NCT02808247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92762117|NCT02808247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762118|NCT02808091|Bortezomib|bortezomib|mesh-list
92762119|NCT02808091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762120|NCT02811991|Acetaminophen|acetaminophen|mesh-list
92762121|NCT02811991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762122|NCT02811991|Analgesics|analgesics|mesh-ancestor
92335037|NCT00004807|Donepezil|donepezil|mesh-list
92762123|NCT02811991|Sensory System Agents|sensory system agents|mesh-ancestor
92762124|NCT02811991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762125|NCT02811991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762126|NCT02811991|Antipyretics|antipyretics|mesh-ancestor
92762127|NCT04237675|Anesthetics|anesthetics|mesh-list
92762128|NCT04237675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762129|NCT04237675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762130|NCT05598853|Nivolumab|nivolumab|mesh-list
92762131|NCT05598853|Ipilimumab|ipilimumab|mesh-list
92762132|NCT05598853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762133|NCT05598853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762134|NCT05598853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92762135|NCT05598853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762136|NCT01229150|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92762137|NCT01229150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762138|NCT01229150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92762139|NCT01229150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762140|NCT01229150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762141|NCT02804815|Aspirin|aspirin|mesh-list
92762142|NCT02804815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92762143|NCT02804815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762144|NCT02804815|Analgesics|analgesics|mesh-ancestor
92762145|NCT02804815|Sensory System Agents|sensory system agents|mesh-ancestor
92762146|NCT02804815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762147|NCT02804815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762148|NCT02804815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762149|NCT02804815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762150|NCT02804815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92762151|NCT02804815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762152|NCT02804815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762153|NCT02804815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92762154|NCT02804815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92712102|NCT04688723|Dabigatran|dabigatran|mesh-list
92762155|NCT02804815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762156|NCT02804815|Antipyretics|antipyretics|mesh-ancestor
92762157|NCT04017247|Oxytocin|oxytocin|mesh-list
92762158|NCT04017247|Oxytocics|oxytocics|mesh-ancestor
92762159|NCT04017247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762160|NCT04017247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762161|NCT02814409|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92762162|NCT02814409|Plasminogen|plasminogen|mesh-list
92762163|NCT02814409|Tenecteplase|tenecteplase|mesh-list
92762164|NCT02814409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92762165|NCT02814409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762166|NCT02814409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762167|NCT01227902|Ezogabine|ezogabine|mesh-list
92762168|NCT01227902|Anticonvulsants|anticonvulsants|mesh-ancestor
92762169|NCT01227902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762170|NCT01227902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762171|NCT00946192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92762172|NCT00946192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92762173|NCT00946192|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92762174|NCT00946192|Desogestrel|desogestrel|mesh-list
92762175|NCT00946192|Estradiol|estradiol|mesh-list
92762176|NCT00946192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92762177|NCT00946192|Progesterone|progesterone|mesh-list
92762178|NCT00946192|Estrogens|estrogens|mesh-ancestor
92762179|NCT00946192|Hormones|hormones|mesh-ancestor
92762180|NCT00946192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762182|NCT00946192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92762183|NCT00946192|Contraceptive Agents|contraceptive agents|mesh-ancestor
92762184|NCT00946192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762185|NCT00946192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92762186|NCT00946192|Progestins|progestins|mesh-ancestor
92762187|NCT00946192|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92762188|NCT00946192|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92762189|NCT00946192|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92762190|NCT01037127|Trametinib|trametinib|mesh-list
92762191|NCT01037127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762192|NCT01037127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92762193|NCT01037127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762194|NCT01037127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762195|NCT02806999|Insulin|insulin|mesh-list
92762196|NCT02806999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92762197|NCT02806999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92762198|NCT02806999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762199|NCT00946114|Sildenafil Citrate|sildenafil citrate|mesh-list
92762200|NCT00946114|Vasodilator Agents|vasodilator agents|mesh-ancestor
92762201|NCT00946114|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92762202|NCT00946114|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92762203|NCT00946114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762204|NCT00946114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762205|NCT00946114|Urological Agents|urological agents|mesh-ancestor
92762206|NCT00627471|Insulin|insulin|mesh-list
92762207|NCT00627471|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92762208|NCT00627471|Insulin Glargine|insulin glargine|mesh-list
92762209|NCT00627471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92762210|NCT00627471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762211|NCT04302441|Capecitabine|capecitabine|mesh-list
92762212|NCT04302441|Vinorelbine|vinorelbine|mesh-list
92762213|NCT04302441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92762214|NCT04302441|Antimetabolites|antimetabolites|mesh-ancestor
92762215|NCT04302441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762216|NCT04302441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762217|NCT04302441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92762218|NCT04302441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92762219|NCT04302441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92762220|NCT04302441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92762221|NCT02800447|Procarbazine|procarbazine|mesh-list
92762222|NCT02800447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762223|NCT05520619|Paclitaxel|paclitaxel|mesh-list
92762224|NCT05520619|Tislelizumab|tislelizumab|mesh-list
92762225|NCT05520619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92762226|NCT05520619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762227|NCT05520619|Tubulin Modulators|tubulin modulators|mesh-ancestor
92762228|NCT05520619|Antimitotic Agents|antimitotic agents|mesh-ancestor
92762229|NCT05520619|Mitosis Modulators|mitosis modulators|mesh-ancestor
92712172|NCT01666977|Growth Substances|growth substances|mesh-ancestor
92762230|NCT05520619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762231|NCT05520619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762232|NCT01038921|Melatonin|melatonin|mesh-list
92762233|NCT01038921|Antioxidants|antioxidants|mesh-ancestor
92762234|NCT01038921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762235|NCT01038921|Protective Agents|protective agents|mesh-ancestor
92762236|NCT01038921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762237|NCT01038921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762238|NCT02856568|Cisplatin|cisplatin|mesh-list
92762239|NCT02856568|Gemcitabine|gemcitabine|mesh-list
92762240|NCT02856568|Ricolinostat|ricolinostat|mesh-list
92762241|NCT02856568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762242|NCT02856568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92762243|NCT02856568|Antimetabolites|antimetabolites|mesh-ancestor
92762244|NCT02856568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762245|NCT02856568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92762246|NCT02856568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762247|NCT04081831|Aspirin|aspirin|mesh-list
92762248|NCT04081831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92762249|NCT04081831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762250|NCT04081831|Analgesics|analgesics|mesh-ancestor
92762251|NCT04081831|Sensory System Agents|sensory system agents|mesh-ancestor
92762252|NCT04081831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762254|NCT04081831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762255|NCT04081831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762256|NCT04081831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92762257|NCT04081831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762258|NCT04081831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762259|NCT04081831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92762260|NCT04081831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92762261|NCT04081831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762262|NCT04081831|Antipyretics|antipyretics|mesh-ancestor
92762263|NCT01081912|Hydrocodone|hydrocodone|mesh-list
92762264|NCT01081912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92762265|NCT01081912|Narcotics|narcotics|mesh-ancestor
92762266|NCT01081912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762267|NCT01081912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762268|NCT01081912|Analgesics|analgesics|mesh-ancestor
92762269|NCT01081912|Sensory System Agents|sensory system agents|mesh-ancestor
92762270|NCT01081912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762271|NCT01081912|Antitussive Agents|antitussive agents|mesh-ancestor
92762272|NCT01081912|Respiratory System Agents|respiratory system agents|mesh-ancestor
92762273|NCT01038609|Acetaminophen|acetaminophen|mesh-list
92762274|NCT01038609|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92762275|NCT01038609|Morphine|morphine|mesh-list
92762276|NCT01038609|Hydrocodone|hydrocodone|mesh-list
92762277|NCT01038609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92762278|NCT01038609|Narcotics|narcotics|mesh-ancestor
92762279|NCT01038609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762280|NCT01038609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762281|NCT01038609|Analgesics|analgesics|mesh-ancestor
92762282|NCT01038609|Sensory System Agents|sensory system agents|mesh-ancestor
92762283|NCT01038609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762284|NCT01038609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762285|NCT01038609|Antipyretics|antipyretics|mesh-ancestor
92762286|NCT01038609|Antitussive Agents|antitussive agents|mesh-ancestor
92762287|NCT01038609|Respiratory System Agents|respiratory system agents|mesh-ancestor
92762288|NCT01038609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92762289|NCT01038609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762290|NCT01038609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762291|NCT02857582|Metronidazole|metronidazole|mesh-list
92762292|NCT02857582|Vancomycin|vancomycin|mesh-list
92762293|NCT02857582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762294|NCT02857582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92762295|NCT02857582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92762296|NCT02857582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92762297|NCT04301895|Remifentanil|remifentanil|mesh-list
92762298|NCT04301895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92762299|NCT04301895|Narcotics|narcotics|mesh-ancestor
92762300|NCT04301895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762301|NCT04301895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762302|NCT04301895|Analgesics|analgesics|mesh-ancestor
92762303|NCT04301895|Sensory System Agents|sensory system agents|mesh-ancestor
92762304|NCT04301895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762305|NCT02853526|Propranolol|propranolol|mesh-list
92762306|NCT02853526|Warfarin|warfarin|mesh-list
92762307|NCT02853526|Anticoagulants|anticoagulants|mesh-ancestor
92762308|NCT02853526|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92762309|NCT02853526|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92762310|NCT02853526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92762311|NCT02853526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762312|NCT02853526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335054|NCT00004825|Mecasermin|mecasermin|mesh-list
92762313|NCT02853526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762314|NCT02853526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92762315|NCT02853526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92762316|NCT02853526|Vasodilator Agents|vasodilator agents|mesh-ancestor
92762317|NCT00630682|Dextroamphetamine|dextroamphetamine|mesh-list
92762318|NCT00630682|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92762319|NCT00630682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762320|NCT00630682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92762321|NCT00630682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92762322|NCT00630682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762323|NCT00630682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762324|NCT00630682|Dopamine Agents|dopamine agents|mesh-ancestor
92762325|NCT00630682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762326|NCT04269460|Bupivacaine|bupivacaine|mesh-list
92762327|NCT04269460|Anesthetics, Local|anesthetics, local|mesh-ancestor
92762328|NCT04269460|Anesthetics|anesthetics|mesh-ancestor
92762329|NCT04269460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762330|NCT04269460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762331|NCT04269460|Sensory System Agents|sensory system agents|mesh-ancestor
92762332|NCT04269460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762333|NCT04236115|Felypressin|felypressin|mesh-list
92762334|NCT04236115|Carticaine|carticaine|mesh-list
92762335|NCT04236115|Anesthetics, Local|anesthetics, local|mesh-ancestor
92762336|NCT04236115|Anesthetics|anesthetics|mesh-ancestor
92762337|NCT04236115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762338|NCT04236115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762339|NCT04236115|Sensory System Agents|sensory system agents|mesh-ancestor
92762340|NCT04236115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762341|NCT04236115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92762342|NCT02853370|Rituximab|rituximab|mesh-list
92762343|NCT02853370|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92762344|NCT02853370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762345|NCT02853370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762346|NCT02853370|Immunologic Factors|immunologic factors|mesh-ancestor
92762347|NCT02853370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762348|NCT02853370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762349|NCT02853370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762350|NCT02853370|Alkylating Agents|alkylating agents|mesh-ancestor
92762351|NCT02853370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762352|NCT02690155|Vitamin K|vitamin k|mesh-list
92762353|NCT02690155|Rivaroxaban|rivaroxaban|mesh-list
92762354|NCT02690155|Vitamins|vitamins|mesh-ancestor
92762355|NCT02690155|Micronutrients|micronutrients|mesh-ancestor
92762356|NCT02690155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762357|NCT02690155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92762358|NCT02690155|Antithrombins|antithrombins|mesh-ancestor
92762359|NCT02690155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92762360|NCT02690155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92762361|NCT02690155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762362|NCT02690155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762363|NCT02690155|Anticoagulants|anticoagulants|mesh-ancestor
92762364|NCT02690155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92762365|NCT02690155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762366|NCT02690155|Hemostatics|hemostatics|mesh-ancestor
92762367|NCT02690155|Coagulants|coagulants|mesh-ancestor
92762368|NCT02806375|Cyclophosphamide|cyclophosphamide|mesh-list
92762369|NCT02806375|Busulfan|busulfan|mesh-list
92762370|NCT02806375|Fludarabine|fludarabine|mesh-list
92762371|NCT02806375|Fludarabine phosphate|fludarabine phosphate|mesh-list
92762372|NCT02806375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762373|NCT02806375|Immunologic Factors|immunologic factors|mesh-ancestor
92762374|NCT02806375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762375|NCT02806375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762376|NCT02806375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762377|NCT02806375|Alkylating Agents|alkylating agents|mesh-ancestor
92762378|NCT02806375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762379|NCT02806375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762380|NCT02806375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92762381|NCT02806375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92762382|NCT02806375|Antimetabolites|antimetabolites|mesh-ancestor
92762383|NCT04273984|Misoprostol|misoprostol|mesh-list
92762384|NCT04273984|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92762385|NCT04273984|Abortifacient Agents|abortifacient agents|mesh-ancestor
92762386|NCT04273984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762387|NCT04273984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762388|NCT04273984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92762389|NCT04273984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762390|NCT04273984|Oxytocics|oxytocics|mesh-ancestor
92762392|NCT00943852|Isosorbide|isosorbide|mesh-list
92762393|NCT00943852|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92762394|NCT00943852|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92762395|NCT00943852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92762396|NCT00943852|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92762397|NCT00943852|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92762398|NCT00943852|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92762399|NCT00943852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762400|NCT00943852|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92762401|NCT00943852|Diuretics|diuretics|mesh-ancestor
92762402|NCT00943852|Natriuretic Agents|natriuretic agents|mesh-ancestor
92762403|NCT00943852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762404|NCT00943852|Vasodilator Agents|vasodilator agents|mesh-ancestor
92762405|NCT00943852|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92762406|NCT02853136|Fluvoxamine|fluvoxamine|mesh-list
92762407|NCT02853136|BI 409306|bi 409306|mesh-list
92762408|NCT02853136|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92762409|NCT02853136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92762410|NCT02853136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762411|NCT02853136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762412|NCT02853136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92762413|NCT02853136|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92762414|NCT02853136|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92762415|NCT02853136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762416|NCT02853136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762417|NCT02853136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762418|NCT02853136|Serotonin Agents|serotonin agents|mesh-ancestor
92762419|NCT02853136|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92762420|NCT02853136|Antidepressive Agents|antidepressive agents|mesh-ancestor
92762421|NCT02853136|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92762422|NCT02853136|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92762423|NCT02853136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762424|NCT02853136|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92762425|NCT02853136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92762426|NCT02806141|Colistin|colistin|mesh-list
92762427|NCT02806141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92762428|NCT02806141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762429|NCT00952276|Vaccines|vaccines|mesh-list
92762430|NCT00952276|Immunologic Factors|immunologic factors|mesh-ancestor
92762431|NCT00952276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762432|NCT02805829|Trastuzumab|trastuzumab|mesh-list
92762433|NCT02805829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762434|NCT02805829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762435|NCT02856178|Caspofungin|caspofungin|mesh-list
92762436|NCT02856178|Olorofim|olorofim|mesh-list
92762437|NCT02856178|Antifungal Agents|antifungal agents|mesh-ancestor
92762438|NCT02856178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762439|NCT02856178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762440|NCT02856178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762441|NCT02800135|Furosemide|furosemide|mesh-list
92762442|NCT02800135|Diuretics|diuretics|mesh-ancestor
92762443|NCT02800135|Natriuretic Agents|natriuretic agents|mesh-ancestor
92762444|NCT02800135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762445|NCT02800135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92762446|NCT02800135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762447|NCT02800135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762448|NCT02799901|Nivolumab|nivolumab|mesh-list
92762449|NCT02799901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762450|NCT02799901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762451|NCT02799901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92762452|NCT02799901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762453|NCT02802163|Dexamethasone|dexamethasone|mesh-list
92762454|NCT02802163|Lenalidomide|lenalidomide|mesh-list
92762455|NCT02802163|Panobinostat|panobinostat|mesh-list
92762456|NCT02802163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762457|NCT02802163|Antiemetics|antiemetics|mesh-ancestor
92762458|NCT02802163|Autonomic Agents|autonomic agents|mesh-ancestor
92762459|NCT02802163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762460|NCT02802163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762461|NCT02802163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762462|NCT02802163|Glucocorticoids|glucocorticoids|mesh-ancestor
92762463|NCT02802163|Hormones|hormones|mesh-ancestor
92762464|NCT02802163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762465|NCT02802163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92762466|NCT02802163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762467|NCT02802163|Immunologic Factors|immunologic factors|mesh-ancestor
92762468|NCT02802163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92762469|NCT02802163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92762470|NCT02802163|Growth Substances|growth substances|mesh-ancestor
92762471|NCT02802163|Growth Inhibitors|growth inhibitors|mesh-ancestor
92762472|NCT02802163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92762473|NCT02802163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762474|NCT02802163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762475|NCT02805049|Caspofungin|caspofungin|mesh-list
92762476|NCT02805049|Micafungin|micafungin|mesh-list
92762477|NCT02805049|Echinocandins|echinocandins|mesh-list
92762478|NCT02805049|Antifungal Agents|antifungal agents|mesh-ancestor
92762479|NCT02805049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762480|NCT02805049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762481|NCT02805049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762482|NCT02799589|Dexmedetomidine|dexmedetomidine|mesh-list
92762483|NCT02799589|Remifentanil|remifentanil|mesh-list
92762484|NCT02799589|Ropivacaine|ropivacaine|mesh-list
92762485|NCT02799589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92762486|NCT02799589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762487|NCT02799589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762488|NCT02799589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762489|NCT02799589|Analgesics|analgesics|mesh-ancestor
92762490|NCT02799589|Sensory System Agents|sensory system agents|mesh-ancestor
92762491|NCT02799589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762492|NCT02799589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92762493|NCT02799589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92762494|NCT02799589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92762495|NCT02799589|Adrenergic Agents|adrenergic agents|mesh-ancestor
92762496|NCT02799589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762497|NCT02799589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762498|NCT02799589|Anesthetics, Local|anesthetics, local|mesh-ancestor
92762499|NCT02799589|Anesthetics|anesthetics|mesh-ancestor
92762500|NCT02799589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92762501|NCT02799589|Narcotics|narcotics|mesh-ancestor
92762502|NCT02856100|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92762503|NCT02856100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762504|NCT02801383|Interferons|interferons|mesh-list
92762505|NCT02801383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762506|NCT02801383|Antiviral Agents|antiviral agents|mesh-ancestor
92762507|NCT02801383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762508|NCT02799355|Interferons|interferons|mesh-list
92762509|NCT02799355|Ribavirin|ribavirin|mesh-list
92762510|NCT02799355|Sofosbuvir|sofosbuvir|mesh-list
92762511|NCT02799355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762512|NCT02799355|Antiviral Agents|antiviral agents|mesh-ancestor
92762513|NCT02799355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762514|NCT02799355|Antimetabolites|antimetabolites|mesh-ancestor
92762515|NCT02799355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762516|NCT02801305|Diltiazem|diltiazem|mesh-list
92762517|NCT02801305|Nitroglycerin|nitroglycerin|mesh-list
92762518|NCT02801305|Petrolatum|petrolatum|mesh-list
92762519|NCT02801305|Vasodilator Agents|vasodilator agents|mesh-ancestor
92762520|NCT02801305|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92762521|NCT02801305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92762522|NCT02801305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762523|NCT02801305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762524|NCT02801305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92762525|NCT02801305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762526|NCT02801305|Emollients|emollients|mesh-ancestor
92762527|NCT02801305|Dermatologic Agents|dermatologic agents|mesh-ancestor
92762528|NCT00637975|Pregabalin|pregabalin|mesh-list
92762529|NCT00637975|Oxycodone|oxycodone|mesh-list
92762530|NCT00637975|Analgesics|analgesics|mesh-ancestor
92762531|NCT00637975|Sensory System Agents|sensory system agents|mesh-ancestor
92762532|NCT00637975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762533|NCT00637975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762534|NCT00637975|Anticonvulsants|anticonvulsants|mesh-ancestor
92762535|NCT00637975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92762536|NCT00637975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762537|NCT00637975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762538|NCT00637975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92762539|NCT00637975|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92762540|NCT00637975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92762541|NCT00637975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762542|NCT00637975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92762543|NCT00637975|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92762544|NCT00637975|Narcotics|narcotics|mesh-ancestor
92762545|NCT02801227|Oxytocin|oxytocin|mesh-list
92762546|NCT02801227|Dinoprostone|dinoprostone|mesh-list
92762547|NCT02801227|Oxytocics|oxytocics|mesh-ancestor
92762548|NCT02801227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762549|NCT02801227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762550|NCT02795299|Folic Acid|folic acid|mesh-list
92762552|NCT02795299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92762553|NCT02795299|Abortifacient Agents|abortifacient agents|mesh-ancestor
92762554|NCT02795299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762555|NCT02795299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762556|NCT02795299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92762557|NCT02795299|Antimetabolites|antimetabolites|mesh-ancestor
92762558|NCT02795299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762559|NCT02795299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762560|NCT02795299|Dermatologic Agents|dermatologic agents|mesh-ancestor
92762561|NCT02795299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762562|NCT02795299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92762563|NCT02795299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762564|NCT02795299|Immunologic Factors|immunologic factors|mesh-ancestor
92762565|NCT02795299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762566|NCT02795299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92762567|NCT02795299|Hematinics|hematinics|mesh-ancestor
92762568|NCT02795299|Vitamin B Complex|vitamin b complex|mesh-ancestor
92762569|NCT02795299|Vitamins|vitamins|mesh-ancestor
92762570|NCT02795299|Micronutrients|micronutrients|mesh-ancestor
92762571|NCT02799277|Testosterone|testosterone|mesh-list
92762572|NCT02799277|Androgens|androgens|mesh-ancestor
92762573|NCT02799277|Hormones|hormones|mesh-ancestor
92762574|NCT02799277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762575|NCT02799277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762576|NCT01198002|Methotrexate|methotrexate|mesh-list
92762577|NCT01198002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92762578|NCT01198002|Abortifacient Agents|abortifacient agents|mesh-ancestor
92762579|NCT01198002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762580|NCT01198002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762581|NCT01198002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92762582|NCT01198002|Antimetabolites|antimetabolites|mesh-ancestor
92762583|NCT01198002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762584|NCT01198002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762585|NCT01198002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92762586|NCT01198002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762587|NCT01198002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92762588|NCT01198002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762589|NCT01198002|Immunologic Factors|immunologic factors|mesh-ancestor
92762590|NCT01198002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335156|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
92762591|NCT01198002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92762592|NCT02795065|Enoxaparin|enoxaparin|mesh-list
92762593|NCT02795065|Bemiparin|bemiparin|mesh-list
92762594|NCT02795065|Anticoagulants|anticoagulants|mesh-ancestor
92762595|NCT02795065|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92762596|NCT02795065|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762597|NCT02795065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762598|NCT04233697|Romidepsin|romidepsin|mesh-list
92762599|NCT04233697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92762600|NCT04233697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762601|NCT04233697|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92762602|NCT04233697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762603|NCT04233697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762604|NCT05470699|Fluorides|fluorides|mesh-list
92762605|NCT05470699|Cariostatic Agents|cariostatic agents|mesh-ancestor
92762606|NCT05470699|Protective Agents|protective agents|mesh-ancestor
92762607|NCT05470699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762608|NCT03826303|Ethanol|ethanol|mesh-list
92762609|NCT03826303|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92762610|NCT03826303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762611|NCT03826303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762612|NCT03826303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762613|NCT02798653|Progesterone|progesterone|mesh-list
92762614|NCT02798653|Progestins|progestins|mesh-ancestor
92762615|NCT02798653|Hormones|hormones|mesh-ancestor
92762616|NCT02798653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762617|NCT02798653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762618|NCT03863587|Ramucirumab|ramucirumab|mesh-list
92762619|NCT03863587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762620|NCT04233463|Budesonide|budesonide|mesh-list
92762621|NCT04233463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762622|NCT04233463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92762623|NCT04233463|Autonomic Agents|autonomic agents|mesh-ancestor
92762624|NCT04233463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762625|NCT04233463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762626|NCT04233463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92762627|NCT04233463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92762629|NCT04233463|Hormones|hormones|mesh-ancestor
92762630|NCT04233463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762631|NCT02793739|Hyaluronic Acid|hyaluronic acid|mesh-list
92762632|NCT02793739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92762633|NCT02793739|Immunologic Factors|immunologic factors|mesh-ancestor
92762634|NCT02793739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762635|NCT02793739|Viscosupplements|viscosupplements|mesh-ancestor
92762636|NCT02793739|Protective Agents|protective agents|mesh-ancestor
92762637|NCT02793505|Metformin|metformin|mesh-list
92762638|NCT02793505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92762639|NCT02793505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762640|NCT02793193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92762641|NCT02793193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92762642|NCT02793193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762643|NCT02793193|Antitubercular Agents|antitubercular agents|mesh-ancestor
92762644|NCT04234321|Mitogens|mitogens|mesh-list
92762645|NCT04234321|Mitosis Modulators|mitosis modulators|mesh-ancestor
92762646|NCT04234321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762647|NCT02797717|Prednisone|prednisone|mesh-list
92762648|NCT02797717|Cyclophosphamide|cyclophosphamide|mesh-list
92762649|NCT02797717|Dacarbazine|dacarbazine|mesh-list
92762650|NCT02797717|Doxorubicin|doxorubicin|mesh-list
92762651|NCT02797717|Etoposide|etoposide|mesh-list
92762652|NCT02797717|Vincristine|vincristine|mesh-list
92762653|NCT02797717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762654|NCT02797717|Immunologic Factors|immunologic factors|mesh-ancestor
92762655|NCT02797717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762656|NCT02797717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762657|NCT02797717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762658|NCT02797717|Alkylating Agents|alkylating agents|mesh-ancestor
92762659|NCT02797717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762660|NCT02797717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762661|NCT02797717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92762662|NCT02797717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92762663|NCT02797717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92762664|NCT02797717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92762665|NCT02797717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762666|NCT02797717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762667|NCT02797717|Glucocorticoids|glucocorticoids|mesh-ancestor
92762668|NCT02797717|Hormones|hormones|mesh-ancestor
92762669|NCT02797717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762670|NCT02797717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92762671|NCT02797717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92762672|NCT02797717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92762673|NCT02797717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92762674|NCT02797717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92762675|NCT04235569|Enoxaparin|enoxaparin|mesh-list
92762676|NCT04235569|Warfarin|warfarin|mesh-list
92762677|NCT04235569|Enoxaparin sodium|enoxaparin sodium|mesh-list
92762678|NCT04235569|Anticoagulants|anticoagulants|mesh-ancestor
92762679|NCT04235569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92762680|NCT04235569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762681|NCT04235569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762682|NCT01197378|Cysteamine|cysteamine|mesh-list
92762683|NCT01197378|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92762684|NCT01197378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762685|NCT02792491|Prednisone|prednisone|mesh-list
92762686|NCT02792491|Cyclophosphamide|cyclophosphamide|mesh-list
92762687|NCT02792491|Rituximab|rituximab|mesh-list
92762688|NCT02792491|Doxorubicin|doxorubicin|mesh-list
92762689|NCT02792491|Vincristine|vincristine|mesh-list
92762690|NCT02792491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762691|NCT02792491|Immunologic Factors|immunologic factors|mesh-ancestor
92762692|NCT02792491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762693|NCT02792491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762694|NCT02792491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762695|NCT02792491|Alkylating Agents|alkylating agents|mesh-ancestor
92762696|NCT02792491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762697|NCT02792491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762698|NCT02792491|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92762699|NCT02792491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762700|NCT02792491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92762701|NCT02792491|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92762702|NCT02792491|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92762703|NCT02792491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762704|NCT02792491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762705|NCT02792491|Glucocorticoids|glucocorticoids|mesh-ancestor
92762706|NCT02792491|Hormones|hormones|mesh-ancestor
92762707|NCT02792491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762708|NCT02792491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92762709|NCT02792491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92762710|NCT02792491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92762711|NCT02792491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92762712|NCT02792491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92762713|NCT02792803|Latanoprost|latanoprost|mesh-list
92762714|NCT02792803|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92762715|NCT02792803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92762716|NCT02797249|Aspirin|aspirin|mesh-list
92762717|NCT02797249|Salicylic Acid|salicylic acid|mesh-list
92762718|NCT02797249|Salicylates|salicylates|mesh-list
92762719|NCT02797249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92762720|NCT02797249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762721|NCT02797249|Analgesics|analgesics|mesh-ancestor
92762722|NCT02797249|Sensory System Agents|sensory system agents|mesh-ancestor
92762723|NCT02797249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762724|NCT02797249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762725|NCT02797249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762726|NCT02797249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762727|NCT02797249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92762728|NCT02797249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92762729|NCT02797249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762730|NCT02797249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92762731|NCT02797249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92762732|NCT02797249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762733|NCT02797249|Antipyretics|antipyretics|mesh-ancestor
92762734|NCT02797249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762735|NCT02797249|Antifungal Agents|antifungal agents|mesh-ancestor
92762736|NCT02797249|Keratolytic Agents|keratolytic agents|mesh-ancestor
92762737|NCT02797249|Dermatologic Agents|dermatologic agents|mesh-ancestor
92762738|NCT02792335|Warfarin|warfarin|mesh-list
92762739|NCT02792335|Rivaroxaban|rivaroxaban|mesh-list
92762740|NCT02792335|Dabigatran|dabigatran|mesh-list
92762741|NCT02792335|Apixaban|apixaban|mesh-list
92762742|NCT02792335|Anticoagulants|anticoagulants|mesh-ancestor
92762743|NCT02792335|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92762744|NCT02792335|Antithrombins|antithrombins|mesh-ancestor
92762745|NCT02792335|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92762746|NCT02792335|Protease Inhibitors|protease inhibitors|mesh-ancestor
92762747|NCT02792335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762748|NCT02792335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762749|NCT01197300|Zoledronic Acid|zoledronic acid|mesh-list
92762750|NCT01197300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92762751|NCT01197300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762752|NCT04200235|Dexmedetomidine|dexmedetomidine|mesh-list
92762753|NCT04200235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92762754|NCT04200235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762755|NCT04200235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762756|NCT04200235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762757|NCT04200235|Analgesics|analgesics|mesh-ancestor
92762758|NCT04200235|Sensory System Agents|sensory system agents|mesh-ancestor
92762759|NCT04200235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762760|NCT04200235|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92762761|NCT04200235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92712729|NCT04676997|Paclitaxel|paclitaxel|mesh-list
92762762|NCT04200235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92762763|NCT04200235|Adrenergic Agents|adrenergic agents|mesh-ancestor
92762764|NCT04200235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762765|NCT04200235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762766|NCT02791243|Finasteride|finasteride|mesh-list
92762767|NCT02791243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92762768|NCT02791243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92762769|NCT02791243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762770|NCT02791243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762771|NCT02791243|Hormone Antagonists|hormone antagonists|mesh-ancestor
92762772|NCT02791243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762773|NCT02791243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762774|NCT02791243|Urological Agents|urological agents|mesh-ancestor
92762775|NCT02797015|Ozanimod|ozanimod|mesh-list
92762776|NCT02797015|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92762777|NCT02797015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762778|NCT02797015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762779|NCT02797015|Immunologic Factors|immunologic factors|mesh-ancestor
92762780|NCT02797015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762781|NCT03803761|Fulvestrant|fulvestrant|mesh-list
92762782|NCT03803761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92762783|NCT03803761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762784|NCT03803761|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92762785|NCT03803761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92762786|NCT03803761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92762787|NCT03803761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762788|NCT03803761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762789|NCT02796547|Levobupivacaine|levobupivacaine|mesh-list
92762790|NCT02796547|Anesthetics, Local|anesthetics, local|mesh-ancestor
92762791|NCT02796547|Anesthetics|anesthetics|mesh-ancestor
92762792|NCT02796547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762793|NCT02796547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762794|NCT02796547|Sensory System Agents|sensory system agents|mesh-ancestor
92762795|NCT02796547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762796|NCT01196988|Vaccines|vaccines|mesh-list
92762797|NCT01196988|Immunologic Factors|immunologic factors|mesh-ancestor
92762798|NCT01196988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762799|NCT02796469|Pentoxifylline|pentoxifylline|mesh-list
92762800|NCT02796469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92762801|NCT02796469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762802|NCT02796469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762803|NCT02796469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92762804|NCT02796469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92762805|NCT02796469|Protective Agents|protective agents|mesh-ancestor
92762806|NCT02796469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762807|NCT02796469|Vasodilator Agents|vasodilator agents|mesh-ancestor
92762808|NCT02796469|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92762809|NCT02796469|Antioxidants|antioxidants|mesh-ancestor
92762810|NCT02796157|Everolimus|everolimus|mesh-list
92762811|NCT02796157|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92762812|NCT02796157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92762813|NCT02796157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762814|NCT02796157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762815|NCT02796157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762816|NCT02796157|Immunologic Factors|immunologic factors|mesh-ancestor
92762817|NCT02796157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762818|NCT02796157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762819|NCT01196052|Trastuzumab|trastuzumab|mesh-list
92762820|NCT01196052|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92762821|NCT01196052|Maytansine|maytansine|mesh-list
92762822|NCT01196052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762823|NCT01196052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762824|NCT01196052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92762825|NCT01196052|Tubulin Modulators|tubulin modulators|mesh-ancestor
92762826|NCT01196052|Antimitotic Agents|antimitotic agents|mesh-ancestor
92762827|NCT01196052|Mitosis Modulators|mitosis modulators|mesh-ancestor
92762828|NCT01196052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762829|NCT01196052|Immunotoxins|immunotoxins|mesh-ancestor
92762830|NCT01196052|Immunoconjugates|immunoconjugates|mesh-ancestor
92762831|NCT01196052|Immunologic Factors|immunologic factors|mesh-ancestor
92762832|NCT01196052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762833|NCT02689921|Trastuzumab|trastuzumab|mesh-list
92712777|NCT02909972|Cytarabine|cytarabine|mesh-list
92762834|NCT02689921|Pertuzumab|pertuzumab|mesh-list
92762835|NCT02689921|Letrozole|letrozole|mesh-list
92762836|NCT02689921|Anastrozole|anastrozole|mesh-list
92762837|NCT02689921|Leuprolide|leuprolide|mesh-list
92762838|NCT02689921|Exemestane|exemestane|mesh-list
92762839|NCT02689921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92762840|NCT02689921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762841|NCT02689921|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92762842|NCT02689921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92762843|NCT02689921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762844|NCT02689921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762845|NCT02689921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92762846|NCT02689921|Hormone Antagonists|hormone antagonists|mesh-ancestor
92762847|NCT02689921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762848|NCT02689921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762849|NCT02689921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92762850|NCT02689921|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92762851|NCT02689921|Fertility Agents|fertility agents|mesh-ancestor
92762852|NCT02689921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92762853|NCT03116425|Pantothenic Acid|pantothenic acid|mesh-list
92762854|NCT03116425|Vitamin B Complex|vitamin b complex|mesh-ancestor
92762856|NCT03116425|Micronutrients|micronutrients|mesh-ancestor
92762857|NCT03116425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762858|NCT01195662|Dapagliflozin|dapagliflozin|mesh-list
92762859|NCT01195662|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92762860|NCT01195662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762861|NCT01195662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92762862|NCT01195662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762863|NCT02786407|Botulinum Toxins|botulinum toxins|mesh-list
92762864|NCT02786407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92762865|NCT02786407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92762866|NCT02786407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92762867|NCT02786407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92762868|NCT02786407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762869|NCT02786407|Cholinergic Agents|cholinergic agents|mesh-ancestor
92762870|NCT02786407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762871|NCT02786407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762872|NCT02786407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92762873|NCT02786407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762874|NCT03028519|Vitamin D|vitamin d|mesh-list
92762875|NCT03028519|Cholecalciferol|cholecalciferol|mesh-list
92762876|NCT03028519|Vitamins|vitamins|mesh-ancestor
92762877|NCT03028519|Micronutrients|micronutrients|mesh-ancestor
92762878|NCT03028519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762879|NCT03028519|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92762880|NCT03028519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92762881|NCT02786641|Cisplatin|cisplatin|mesh-list
92762882|NCT02786641|Docetaxel|docetaxel|mesh-list
92762883|NCT02786641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762884|NCT02786641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92762885|NCT02786641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92762886|NCT02786641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92762887|NCT02786641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762888|NCT02787967|Beclomethasone|beclomethasone|mesh-list
92762889|NCT02787967|Formoterol Fumarate|formoterol fumarate|mesh-list
92762890|NCT02787967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92762891|NCT02787967|Autonomic Agents|autonomic agents|mesh-ancestor
92762892|NCT02787967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762893|NCT02787967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762894|NCT02787967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92762895|NCT02787967|Respiratory System Agents|respiratory system agents|mesh-ancestor
92762896|NCT02787967|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92762897|NCT02787967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92762898|NCT02787967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92762899|NCT02787967|Adrenergic Agents|adrenergic agents|mesh-ancestor
92762900|NCT02787967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762901|NCT02787967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762902|NCT02787967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762903|NCT02787967|Glucocorticoids|glucocorticoids|mesh-ancestor
92762904|NCT02787967|Hormones|hormones|mesh-ancestor
92762905|NCT02787967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762906|NCT02788123|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92762907|NCT02788123|Pantoprazole|pantoprazole|mesh-list
92762908|NCT02788123|Bismuth|bismuth|mesh-list
92762909|NCT02788123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92762910|NCT02788123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762911|NCT02788123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92762912|NCT02788123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762913|NCT02788123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762914|NCT02788123|Antacids|antacids|mesh-ancestor
92762915|NCT02788123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762916|NCT01194804|Eculizumab|eculizumab|mesh-list
92762917|NCT01194804|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92762918|NCT01194804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762919|NCT01194804|Immunologic Factors|immunologic factors|mesh-ancestor
92762920|NCT01194804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762921|NCT02785549|Acetaminophen|acetaminophen|mesh-list
92762922|NCT02785549|Amoxicillin|amoxicillin|mesh-list
92762923|NCT02785549|Clavulanic Acids|clavulanic acids|mesh-list
92762924|NCT02785549|Clavulanic Acid|clavulanic acid|mesh-list
92762925|NCT02785549|Ibuprofen|ibuprofen|mesh-list
92762926|NCT02785549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92762927|NCT02785549|Analgesics|analgesics|mesh-ancestor
92762928|NCT02785549|Sensory System Agents|sensory system agents|mesh-ancestor
92762929|NCT02785549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762930|NCT02785549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762931|NCT02785549|Antipyretics|antipyretics|mesh-ancestor
92762932|NCT02785549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92762933|NCT02785549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92762934|NCT02785549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762935|NCT02785549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92762936|NCT02785549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92762937|NCT02785549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762938|NCT02785549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92762939|NCT02785549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762940|NCT02785549|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92762941|NCT02785705|Vaccines|vaccines|mesh-list
92762942|NCT02785705|Immunologic Factors|immunologic factors|mesh-ancestor
92762943|NCT02785705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762944|NCT02821507|Sirolimus|sirolimus|mesh-list
92762945|NCT02821507|Cyclophosphamide|cyclophosphamide|mesh-list
92762946|NCT02821507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92762947|NCT02821507|Immunologic Factors|immunologic factors|mesh-ancestor
92762948|NCT02821507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762949|NCT02821507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92762950|NCT02821507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92762951|NCT02821507|Alkylating Agents|alkylating agents|mesh-ancestor
92762952|NCT02821507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762953|NCT02821507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762954|NCT02821507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92762955|NCT02821507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92762956|NCT02821507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92762957|NCT02821507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92762958|NCT02821507|Antifungal Agents|antifungal agents|mesh-ancestor
92762959|NCT02785393|Doxazosin|doxazosin|mesh-list
92762960|NCT02785393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92762961|NCT02785393|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92762962|NCT02785393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92762963|NCT02785393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92762964|NCT02785393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92762965|NCT02785393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92762966|NCT02785393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762967|NCT02785393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762968|NCT02787031|Anesthetics|anesthetics|mesh-list
92762969|NCT02787031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762970|NCT02787031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762971|NCT02784223|Choline|choline|mesh-list
92762972|NCT02784223|Lipotropic Agents|lipotropic agents|mesh-ancestor
92762973|NCT02784223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92762974|NCT02784223|Antimetabolites|antimetabolites|mesh-ancestor
92762975|NCT02784223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762976|NCT02784223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762977|NCT02784223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92762978|NCT02784223|Nootropic Agents|nootropic agents|mesh-ancestor
92762979|NCT05262751|Nintedanib|nintedanib|mesh-list
92762980|NCT05262751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92762981|NCT05262751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92762982|NCT05262751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060696|NCT01281514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92712928|NCT04312555|Alprostadil|alprostadil|mesh-list
92762983|NCT05262751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92762984|NCT04231123|Anesthetics|anesthetics|mesh-list
92762985|NCT04231123|Anesthetics, Local|anesthetics, local|mesh-list
92762986|NCT04231123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92762987|NCT04231123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762988|NCT04231123|Sensory System Agents|sensory system agents|mesh-ancestor
92762989|NCT04231123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92762990|NCT04231279|Secretin|secretin|mesh-list
92762991|NCT04231279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92762992|NCT04231279|Hormones|hormones|mesh-ancestor
92762993|NCT04231279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92762994|NCT04231279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92762995|NCT02782273|Ketorolac|ketorolac|mesh-list
92762996|NCT02782273|Morphine|morphine|mesh-list
92762997|NCT02782273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92762998|NCT02782273|Narcotics|narcotics|mesh-ancestor
92762999|NCT02782273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763000|NCT02782273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763001|NCT02782273|Analgesics|analgesics|mesh-ancestor
92763002|NCT02782273|Sensory System Agents|sensory system agents|mesh-ancestor
92763003|NCT02782273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763004|NCT02782273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763005|NCT02782273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763006|NCT02782273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763007|NCT02782273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763008|NCT02782273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92763009|NCT02782273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763010|NCT02782273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763011|NCT05342389|Apatinib|apatinib|mesh-list
92763012|NCT05342389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763013|NCT05342389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92763014|NCT05342389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763015|NCT05342389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763016|NCT02268175|Prednisone|prednisone|mesh-list
92763017|NCT02268175|Leuprolide|leuprolide|mesh-list
92763018|NCT02268175|Abiraterone Acetate|abiraterone acetate|mesh-list
92763019|NCT02268175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763020|NCT02268175|Glucocorticoids|glucocorticoids|mesh-ancestor
92763021|NCT02268175|Hormones|hormones|mesh-ancestor
92763022|NCT02268175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763023|NCT02268175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763024|NCT02268175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92763025|NCT02268175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763026|NCT02268175|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92763027|NCT02268175|Fertility Agents|fertility agents|mesh-ancestor
92763028|NCT02268175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763029|NCT02268175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92763030|NCT02268175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763031|NCT02268175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763032|NCT02268175|Hormone Antagonists|hormone antagonists|mesh-ancestor
92763033|NCT02268175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92763034|NCT02783989|4-hydroxyphenylethanol|4-hydroxyphenylethanol|mesh-list
92763035|NCT02783989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92763036|NCT02783989|Antioxidants|antioxidants|mesh-ancestor
92763037|NCT02783989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763038|NCT02783989|Protective Agents|protective agents|mesh-ancestor
92763039|NCT02783989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763040|NCT02782429|Ketamine|ketamine|mesh-list
92763041|NCT02782429|Analgesics|analgesics|mesh-ancestor
92763042|NCT02782429|Sensory System Agents|sensory system agents|mesh-ancestor
92763043|NCT02782429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763044|NCT02782429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763045|NCT02782429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92763046|NCT02782429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763047|NCT02782429|Anesthetics, General|anesthetics, general|mesh-ancestor
92763048|NCT02782429|Anesthetics|anesthetics|mesh-ancestor
92763049|NCT02782429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763050|NCT02782429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92763051|NCT02782429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92763052|NCT02782429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763053|NCT02782429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763054|NCT04229719|Melatonin|melatonin|mesh-list
92763055|NCT04229719|Antioxidants|antioxidants|mesh-ancestor
92712999|NCT04673955|Cetuximab|cetuximab|mesh-list
92763056|NCT04229719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763057|NCT04229719|Protective Agents|protective agents|mesh-ancestor
92335230|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763058|NCT04229719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763059|NCT04229719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763060|NCT01855867|Tenofovir|tenofovir|mesh-list
92763061|NCT01855867|Emtricitabine|emtricitabine|mesh-list
92763062|NCT01855867|Antiviral Agents|antiviral agents|mesh-ancestor
92763063|NCT01855867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763064|NCT01855867|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92763065|NCT01855867|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92763066|NCT01855867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763067|NCT01855867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763068|NCT01855867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92763069|NCT01855867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92763070|NCT02689843|Metformin|metformin|mesh-list
92763071|NCT02689843|Pioglitazone|pioglitazone|mesh-list
92763072|NCT02689843|Cyproterone Acetate|cyproterone acetate|mesh-list
92763073|NCT02689843|Spironolactone|spironolactone|mesh-list
92763074|NCT02689843|Cyproterone|cyproterone|mesh-list
92763075|NCT02689843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763076|NCT02689843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763077|NCT02689843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92763078|NCT02689843|Hormone Antagonists|hormone antagonists|mesh-ancestor
92763079|NCT02689843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763080|NCT02689843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92763081|NCT02689843|Diuretics|diuretics|mesh-ancestor
92763082|NCT02689843|Natriuretic Agents|natriuretic agents|mesh-ancestor
92763083|NCT02689843|Androgen Antagonists|androgen antagonists|mesh-ancestor
92763084|NCT02689843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763085|NCT02689843|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92763086|NCT02689843|Contraceptive Agents|contraceptive agents|mesh-ancestor
92763087|NCT02689843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763088|NCT05166577|Valganciclovir|valganciclovir|mesh-list
92763089|NCT05166577|Pembrolizumab|pembrolizumab|mesh-list
92763090|NCT05166577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92763091|NCT05166577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763092|NCT05166577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92763093|NCT05166577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763094|NCT05166577|Antiviral Agents|antiviral agents|mesh-ancestor
92763095|NCT05166577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763096|NCT05341999|Ibuprofen|ibuprofen|mesh-list
92763097|NCT05341999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763098|NCT05341999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763099|NCT05341999|Analgesics|analgesics|mesh-ancestor
92763100|NCT05341999|Sensory System Agents|sensory system agents|mesh-ancestor
92763101|NCT05341999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763102|NCT05341999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763103|NCT05341999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763104|NCT05341999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763105|NCT05341999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92763106|NCT05341999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763107|NCT05341999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763108|NCT02781805|Alendronate|alendronate|mesh-list
92763109|NCT02781805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92763110|NCT02781805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763111|NCT02781493|Prucalopride|prucalopride|mesh-list
92763112|NCT02781493|Laxatives|laxatives|mesh-ancestor
92763113|NCT02781493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763114|NCT02781493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92763115|NCT02781493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92763116|NCT02781493|Serotonin Agents|serotonin agents|mesh-ancestor
92763117|NCT02781493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763118|NCT02781493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763119|NCT02781493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763120|NCT02783053|Metformin|metformin|mesh-list
92763121|NCT02783053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763122|NCT02783053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763123|NCT02782819|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92763124|NCT02781415|Morphine|morphine|mesh-list
92763125|NCT02781415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92763126|NCT02781415|Narcotics|narcotics|mesh-ancestor
92763127|NCT02781415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763128|NCT02781415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763129|NCT02781415|Analgesics|analgesics|mesh-ancestor
92713074|NCT00556023|Antimetabolites|antimetabolites|mesh-ancestor
92763130|NCT02781415|Sensory System Agents|sensory system agents|mesh-ancestor
92763131|NCT02781415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763132|NCT02785003|Acetaminophen|acetaminophen|mesh-list
92763133|NCT02785003|Ketamine|ketamine|mesh-list
92763134|NCT02785003|Morphine|morphine|mesh-list
92763135|NCT02785003|Narcotics|narcotics|mesh-list
92763136|NCT02785003|Alvimopan|alvimopan|mesh-list
92763137|NCT02785003|Analgesics|analgesics|mesh-ancestor
92763138|NCT02785003|Sensory System Agents|sensory system agents|mesh-ancestor
92763139|NCT02785003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763140|NCT02785003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763141|NCT02785003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92763142|NCT02785003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763143|NCT02785003|Anesthetics, General|anesthetics, general|mesh-ancestor
92763144|NCT02785003|Anesthetics|anesthetics|mesh-ancestor
92763145|NCT02785003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763146|NCT02785003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92763147|NCT02785003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92763148|NCT02785003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763149|NCT02785003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763150|NCT02785003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92763151|NCT02785003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763152|NCT02785003|Antipyretics|antipyretics|mesh-ancestor
92763153|NCT02785003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763154|NCT05297617|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92763155|NCT05297617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92763156|NCT05297617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763157|NCT05297617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763158|NCT05297617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92763159|NCT05297617|Hormone Antagonists|hormone antagonists|mesh-ancestor
92763160|NCT05297617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763161|NCT05297617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763162|NCT02782897|Immunoglobulins|immunoglobulins|mesh-list
92763163|NCT02782897|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92763164|NCT02782897|Antibodies|antibodies|mesh-list
92763165|NCT02782897|Immunologic Factors|immunologic factors|mesh-ancestor
92763166|NCT02782897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763167|NCT00638131|Bosentan|bosentan|mesh-list
92763168|NCT00638131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92763169|NCT00638131|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92763170|NCT00638131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763171|NCT02780245|Tranexamic Acid|tranexamic acid|mesh-list
92763172|NCT02780245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92763173|NCT02780245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92763174|NCT02780245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763175|NCT02780245|Hemostatics|hemostatics|mesh-ancestor
92763176|NCT02780245|Coagulants|coagulants|mesh-ancestor
92763177|NCT05340985|Vitamin D|vitamin d|mesh-list
92763178|NCT05340985|Ergocalciferols|ergocalciferols|mesh-list
92763179|NCT05340985|Cholecalciferol|cholecalciferol|mesh-list
92763180|NCT05340985|Calcifediol|calcifediol|mesh-list
92763181|NCT05340985|Vitamins|vitamins|mesh-list
92763182|NCT05340985|Dehydrocholesterols|dehydrocholesterols|mesh-list
92763183|NCT05340985|7-dehydrocholesterol|7-dehydrocholesterol|mesh-list
92763184|NCT05340985|Micronutrients|micronutrients|mesh-ancestor
92763185|NCT05340985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763186|NCT05340985|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92763187|NCT05340985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92763188|NCT05340985|Provitamins|provitamins|mesh-ancestor
92763189|NCT02784457|Cetrorelix|cetrorelix|mesh-list
92763190|NCT02784457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92763191|NCT02784457|Fertility Agents|fertility agents|mesh-ancestor
92763192|NCT02784457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763193|NCT02784457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763194|NCT02784457|Hormone Antagonists|hormone antagonists|mesh-ancestor
92763195|NCT02784457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763196|NCT02780323|Celecoxib|celecoxib|mesh-list
92763197|NCT02780323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763198|NCT02780323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763199|NCT02780323|Analgesics|analgesics|mesh-ancestor
92763200|NCT02780323|Sensory System Agents|sensory system agents|mesh-ancestor
92763201|NCT02780323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763202|NCT02780323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763203|NCT02780323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763204|NCT02780323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763205|NCT02780323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92763206|NCT02780323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92763207|NCT02780323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763208|NCT02780323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763210|NCT05331859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763211|NCT05331859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763213|NCT04229407|Vitamin B Complex|vitamin b complex|mesh-list
92763214|NCT04229407|Micronutrients|micronutrients|mesh-ancestor
92763215|NCT04229407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763216|NCT04231435|Metformin|metformin|mesh-list
92763217|NCT04231435|Digoxin|digoxin|mesh-list
92763218|NCT04231435|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92763219|NCT04231435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763220|NCT04231435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763221|NCT04231435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92763222|NCT04231435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92763223|NCT04231435|Antimetabolites|antimetabolites|mesh-ancestor
92763224|NCT04231435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763225|NCT04231435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92763226|NCT04231435|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92763227|NCT04231435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763228|NCT04231435|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92763229|NCT04231435|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92763230|NCT04231435|Protective Agents|protective agents|mesh-ancestor
92763231|NCT05340439|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92763232|NCT05340439|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92763233|NCT05340439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763234|NCT05340439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763235|NCT05340439|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92763236|NCT05340439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92763237|NCT05340439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763238|NCT05340439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92763239|NCT05340439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763240|NCT01194414|Antirheumatic Agents|antirheumatic agents|mesh-list
92763241|NCT02173405|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92763242|NCT02173405|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92763243|NCT02173405|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92763244|NCT02173405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763245|NCT02173405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763246|NCT02173405|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92763247|NCT02173405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92763248|NCT02173405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763249|NCT02173405|Cholinergic Agents|cholinergic agents|mesh-ancestor
92763250|NCT02173405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763251|NCT02120365|Anticonvulsants|anticonvulsants|mesh-list
92763252|NCT05322031|Aripiprazole|aripiprazole|mesh-list
92763253|NCT05322031|Antidepressive Agents|antidepressive agents|mesh-ancestor
92763254|NCT05322031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92763255|NCT05322031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92763256|NCT05322031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92763257|NCT05322031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763258|NCT05322031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763259|NCT05322031|Dopamine Agonists|dopamine agonists|mesh-ancestor
92763260|NCT05322031|Dopamine Agents|dopamine agents|mesh-ancestor
92763261|NCT05322031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763262|NCT05322031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763263|NCT05322031|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92763264|NCT05322031|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92763265|NCT05322031|Serotonin Agents|serotonin agents|mesh-ancestor
92763266|NCT05322031|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92763267|NCT05322031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92763268|NCT05322031|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92763269|NCT05322031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92763270|NCT02780011|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92763271|NCT02780011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92763272|NCT02780011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763273|NCT02780011|Immunotoxins|immunotoxins|mesh-ancestor
92763274|NCT02780011|Immunoconjugates|immunoconjugates|mesh-ancestor
92763275|NCT02780011|Immunologic Factors|immunologic factors|mesh-ancestor
92763276|NCT02780011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763277|NCT02780479|Dexamethasone|dexamethasone|mesh-list
92763278|NCT02780479|Prednisone|prednisone|mesh-list
92763279|NCT02780479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763280|NCT02780479|Antiemetics|antiemetics|mesh-ancestor
92763281|NCT02780479|Autonomic Agents|autonomic agents|mesh-ancestor
92763282|NCT02780479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763283|NCT02780479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763284|NCT02780479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763285|NCT02780479|Glucocorticoids|glucocorticoids|mesh-ancestor
92763286|NCT02780479|Hormones|hormones|mesh-ancestor
92763287|NCT02780479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763288|NCT02780479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92763289|NCT02780479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763290|NCT05252923|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92763291|NCT05252923|Anticoagulants|anticoagulants|mesh-ancestor
92763292|NCT05252923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92763293|NCT05252923|Antimetabolites|antimetabolites|mesh-ancestor
92763294|NCT05252923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763295|NCT05252923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92763296|NCT05252923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92763297|NCT05252923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92763298|NCT05252923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763299|NCT05252923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763300|NCT05097079|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92763301|NCT05097079|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92763302|NCT05097079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92763303|NCT05097079|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92763304|NCT05097079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92763305|NCT05097079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763306|NCT05097079|Cholinergic Agents|cholinergic agents|mesh-ancestor
92763307|NCT05097079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763308|NCT05097079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763309|NCT05097079|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92763310|NCT05097079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763311|NCT02779387|Goserelin|goserelin|mesh-list
92763312|NCT02779387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92763313|NCT02779387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763314|NCT04228315|Primaquine|primaquine|mesh-list
92763315|NCT04228315|Antimalarials|antimalarials|mesh-ancestor
92763316|NCT04228315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92763317|NCT04228315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92763318|NCT04228315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763319|NCT04228393|Mercaptopurine|mercaptopurine|mesh-list
92763320|NCT04228393|Antimetabolites|antimetabolites|mesh-ancestor
92763321|NCT04228393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763322|NCT04228393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335260|NCT04735770|Anesthetics|anesthetics|mesh-ancestor
92763323|NCT04228393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763324|NCT04228393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92763325|NCT04228393|Immunologic Factors|immunologic factors|mesh-ancestor
92763326|NCT04228393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763327|NCT04228393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92763328|NCT04228393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763329|NCT02779777|Tipifarnib|tipifarnib|mesh-list
92763330|NCT02779777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763331|NCT05069545|Insulin|insulin|mesh-list
92763332|NCT05069545|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92763333|NCT05069545|Insulin Aspart|insulin aspart|mesh-list
92763334|NCT05069545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763335|NCT05069545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763336|NCT05279833|Sotalol|sotalol|mesh-list
92763337|NCT05279833|Dronedarone|dronedarone|mesh-list
92763338|NCT05279833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92763339|NCT05279833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92763340|NCT05279833|Adrenergic Agents|adrenergic agents|mesh-ancestor
92763341|NCT05279833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763342|NCT05279833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763343|NCT05279833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763344|NCT05279833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92763345|NCT05279833|Sympatholytics|sympatholytics|mesh-ancestor
92763346|NCT05279833|Autonomic Agents|autonomic agents|mesh-ancestor
92763347|NCT05279833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763348|NCT01880359|Nimorazole|nimorazole|mesh-list
92763349|NCT01880359|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92763350|NCT01880359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92763351|NCT01880359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92763352|NCT01880359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763353|NCT04975555|Siltuximab|siltuximab|mesh-list
92763354|NCT04975555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713308|NCT01774578|Docetaxel|docetaxel|mesh-list
92763355|NCT05338489|Itraconazole|itraconazole|mesh-list
92763356|NCT05338489|Rifampin|rifampin|mesh-list
92763357|NCT05338489|Antifungal Agents|antifungal agents|mesh-ancestor
92763358|NCT05338489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763359|NCT05338489|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92763360|NCT05338489|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92763362|NCT05338489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763363|NCT05338489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92763364|NCT05338489|Hormone Antagonists|hormone antagonists|mesh-ancestor
92763365|NCT05338489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763366|NCT05338489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763367|NCT05338489|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92763368|NCT05338489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92763369|NCT05338489|Antitubercular Agents|antitubercular agents|mesh-ancestor
92763370|NCT05338489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92763371|NCT05338489|Leprostatic Agents|leprostatic agents|mesh-ancestor
92763372|NCT05338489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92763373|NCT05338489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92763374|NCT05338489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92763375|NCT05338489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92763376|NCT05338489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92763377|NCT05338489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92763378|NCT05338489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92763379|NCT05266417|Insulin|insulin|mesh-list
92763380|NCT05266417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763381|NCT05266417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763382|NCT02779465|Vitamin D|vitamin d|mesh-list
92763383|NCT02779465|Cholecalciferol|cholecalciferol|mesh-list
92763384|NCT02779465|Vitamins|vitamins|mesh-ancestor
92763385|NCT02779465|Micronutrients|micronutrients|mesh-ancestor
92763386|NCT02779465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763387|NCT02779465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92763388|NCT02779465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92763389|NCT02776189|Midazolam|midazolam|mesh-list
92763390|NCT02776189|Dexmedetomidine|dexmedetomidine|mesh-list
92763391|NCT02776189|Propofol|propofol|mesh-list
92763392|NCT02776189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92763393|NCT02776189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763394|NCT02776189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763395|NCT02776189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763396|NCT02776189|Analgesics|analgesics|mesh-ancestor
92763397|NCT02776189|Sensory System Agents|sensory system agents|mesh-ancestor
92763398|NCT02776189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763399|NCT02776189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92763400|NCT02776189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92763401|NCT02776189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92763402|NCT02776189|Adrenergic Agents|adrenergic agents|mesh-ancestor
92763403|NCT02776189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763404|NCT02776189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763405|NCT02776189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763406|NCT02776189|Anesthetics, General|anesthetics, general|mesh-ancestor
92763407|NCT02776189|Anesthetics|anesthetics|mesh-ancestor
92763408|NCT02776189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92763409|NCT02776189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92763410|NCT02776189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92763411|NCT02776189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92763412|NCT02776189|GABA Modulators|gaba modulators|mesh-ancestor
92763413|NCT02776189|GABA Agents|gaba agents|mesh-ancestor
92763414|NCT01194258|Insulin|insulin|mesh-list
92763415|NCT01194258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92763416|NCT01194258|Insulin Glargine|insulin glargine|mesh-list
92763417|NCT01194258|Insulin Aspart|insulin aspart|mesh-list
92763418|NCT01194258|Insulin Lispro|insulin lispro|mesh-list
92763419|NCT01194258|Insulin glulisine|insulin glulisine|mesh-list
92763420|NCT01194258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763421|NCT01194258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763422|NCT04883437|Obinutuzumab|obinutuzumab|mesh-list
92763423|NCT04883437|Acalabrutinib|acalabrutinib|mesh-list
92763424|NCT04883437|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92763425|NCT04883437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92763426|NCT04883437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763427|NCT04883437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92763428|NCT04883437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763429|NCT04883437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763431|NCT02775877|Clomiphene|clomiphene|mesh-list
92763432|NCT02775877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763433|NCT02775877|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92763434|NCT02775877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92763436|NCT02775877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763437|NCT02775877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92763438|NCT02775877|Hormone Antagonists|hormone antagonists|mesh-ancestor
92763439|NCT02775877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763440|NCT02775877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763441|NCT02775877|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92763442|NCT02775877|Fertility Agents|fertility agents|mesh-ancestor
92763443|NCT02775877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763444|NCT02775877|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92763445|NCT02775877|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92763446|NCT02777671|Gliclazide|gliclazide|mesh-list
92763447|NCT02777671|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92763448|NCT02777671|Anticonvulsants|anticonvulsants|mesh-ancestor
92763449|NCT02777671|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92763450|NCT02777671|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92763451|NCT02777671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92763452|NCT02777671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763453|NCT02777671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763454|NCT02777671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763455|NCT02778919|Leuprolide|leuprolide|mesh-list
92763456|NCT02778919|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92763457|NCT02778919|Fertility Agents|fertility agents|mesh-ancestor
92763458|NCT02778919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763459|NCT02778919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763460|NCT02778919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92763461|NCT02778919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763462|NCT02779153|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92763463|NCT02779153|Hormones|hormones|mesh-ancestor
92763464|NCT02779153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763465|NCT02779153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763466|NCT04226443|Midazolam|midazolam|mesh-list
92763467|NCT04226443|Remifentanil|remifentanil|mesh-list
92763468|NCT04226443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92763469|NCT04226443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92763470|NCT04226443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763471|NCT04226443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763472|NCT04226443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92763473|NCT04226443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92763474|NCT04226443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92763475|NCT04226443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763476|NCT04226443|Anesthetics, General|anesthetics, general|mesh-ancestor
92763477|NCT04226443|Anesthetics|anesthetics|mesh-ancestor
92763478|NCT04226443|GABA Modulators|gaba modulators|mesh-ancestor
92763479|NCT04226443|GABA Agents|gaba agents|mesh-ancestor
92763480|NCT04226443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763481|NCT04226443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763482|NCT04226443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92763483|NCT04226443|Narcotics|narcotics|mesh-ancestor
92763484|NCT04226443|Analgesics|analgesics|mesh-ancestor
92763485|NCT04226443|Sensory System Agents|sensory system agents|mesh-ancestor
92763486|NCT04226443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763487|NCT02776891|Citric Acid|citric acid|mesh-list
92763488|NCT02776891|Sodium Citrate|sodium citrate|mesh-list
92763489|NCT02776891|Gallium citrate|gallium citrate|mesh-list
92763490|NCT02776891|Anticoagulants|anticoagulants|mesh-ancestor
92763491|NCT02776891|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92763492|NCT02776891|Chelating Agents|chelating agents|mesh-ancestor
92763493|NCT02776891|Sequestering Agents|sequestering agents|mesh-ancestor
92763494|NCT02776891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763495|NCT02776891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92763496|NCT02776813|Rituximab|rituximab|mesh-list
92763497|NCT02776813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92763498|NCT02776813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763499|NCT02776813|Immunologic Factors|immunologic factors|mesh-ancestor
92763500|NCT02776813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763501|NCT02776813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763502|NCT05157997|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92763503|NCT05157997|Antibodies|antibodies|mesh-list
92763504|NCT05157997|Immunologic Factors|immunologic factors|mesh-ancestor
92763505|NCT05157997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763506|NCT05157997|Antiviral Agents|antiviral agents|mesh-ancestor
92763507|NCT05157997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763508|NCT02773147|Pyridoxine|pyridoxine|mesh-list
92763509|NCT02773147|Vitamin B 12|vitamin b 12|mesh-list
92763510|NCT02773147|Hydroxocobalamin|hydroxocobalamin|mesh-list
92763511|NCT02773147|Hematinics|hematinics|mesh-ancestor
92763512|NCT02773147|Vitamin B Complex|vitamin b complex|mesh-ancestor
92763513|NCT02773147|Vitamins|vitamins|mesh-ancestor
92763514|NCT02773147|Micronutrients|micronutrients|mesh-ancestor
92763515|NCT02773147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763516|NCT02773927|Metformin|metformin|mesh-list
92763517|NCT02773927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763518|NCT02773927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763519|NCT02773459|Capecitabine|capecitabine|mesh-list
92763520|NCT02773459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92763521|NCT02773459|Antimetabolites|antimetabolites|mesh-ancestor
92763522|NCT02773459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763523|NCT02773459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763524|NCT04818229|Moxifloxacin|moxifloxacin|mesh-list
92763525|NCT04818229|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92763526|NCT04818229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92763527|NCT04818229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763528|NCT04818229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92763529|NCT04818229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92763530|NCT04818229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763531|NCT04818229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763532|NCT04818229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763533|NCT04818229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92763534|NCT04818229|Contraceptive Agents|contraceptive agents|mesh-ancestor
92763535|NCT04818229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763536|NCT04818229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763537|NCT04818229|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92763538|NCT04818229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92763539|NCT04818229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92763540|NCT04771741|Acetaminophen|acetaminophen|mesh-list
92763541|NCT04771741|Ketorolac|ketorolac|mesh-list
92763542|NCT04771741|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92763543|NCT04771741|Meloxicam|meloxicam|mesh-list
92763544|NCT04771741|Pregabalin|pregabalin|mesh-list
92763545|NCT04771741|Cyclobenzaprine|cyclobenzaprine|mesh-list
92763546|NCT04771741|Analgesics|analgesics|mesh-ancestor
92763547|NCT04771741|Sensory System Agents|sensory system agents|mesh-ancestor
92763548|NCT04771741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763549|NCT04771741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763550|NCT04771741|Anticonvulsants|anticonvulsants|mesh-ancestor
92763551|NCT04771741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92763552|NCT04771741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92763553|NCT04771741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494493|NCT01975714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92763554|NCT04771741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92763555|NCT04771741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92763556|NCT04771741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92763557|NCT04771741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763558|NCT04771741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92763559|NCT04771741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763560|NCT04771741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763561|NCT04771741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763562|NCT04771741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763563|NCT04771741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92763564|NCT04771741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763565|NCT04771741|Antipyretics|antipyretics|mesh-ancestor
92763566|NCT04771741|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92763567|NCT04771741|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92763568|NCT04771741|Antidepressive Agents|antidepressive agents|mesh-ancestor
92763569|NCT04771741|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92763570|NCT04771741|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92763571|NCT02772601|Metoprolol|metoprolol|mesh-list
92763572|NCT02772601|Midazolam|midazolam|mesh-list
92763573|NCT02772601|Caffeine|caffeine|mesh-list
92763574|NCT02772601|Omeprazole|omeprazole|mesh-list
92763575|NCT02772601|Warfarin|warfarin|mesh-list
92763576|NCT02772601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92763577|NCT02772601|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92763578|NCT02772601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713537|NCT00556413|Vitamins|vitamins|mesh-ancestor
92763579|NCT02772601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763580|NCT02772601|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92763581|NCT02772601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92763582|NCT02772601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92763583|NCT02772601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763584|NCT02772601|Anesthetics, General|anesthetics, general|mesh-ancestor
92763585|NCT02772601|Anesthetics|anesthetics|mesh-ancestor
92763586|NCT02772601|GABA Modulators|gaba modulators|mesh-ancestor
92763587|NCT02772601|GABA Agents|gaba agents|mesh-ancestor
92763588|NCT02772601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763589|NCT02772601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763590|NCT02772601|Anticoagulants|anticoagulants|mesh-ancestor
92763591|NCT02772601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92763592|NCT02772601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92763593|NCT02772601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763594|NCT02772601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92763595|NCT02772601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92763596|NCT02772601|Purinergic Agents|purinergic agents|mesh-ancestor
92763597|NCT02772601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92763598|NCT02772601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763599|NCT02772601|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92763600|NCT02772601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92763601|NCT02772601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92763602|NCT02772601|Sympatholytics|sympatholytics|mesh-ancestor
92763603|NCT02772601|Autonomic Agents|autonomic agents|mesh-ancestor
92763604|NCT02772601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763605|NCT02772601|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92763606|NCT02772601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92763607|NCT02772601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92763608|NCT02772601|Adrenergic Agents|adrenergic agents|mesh-ancestor
92763609|NCT02772211|Cycloserine|cycloserine|mesh-list
92763610|NCT02772211|Ketamine|ketamine|mesh-list
92763611|NCT02772211|Analgesics|analgesics|mesh-ancestor
92763612|NCT02772211|Sensory System Agents|sensory system agents|mesh-ancestor
92763613|NCT02772211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763614|NCT02772211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763615|NCT02772211|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92763616|NCT02772211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763617|NCT02772211|Anesthetics, General|anesthetics, general|mesh-ancestor
92763618|NCT02772211|Anesthetics|anesthetics|mesh-ancestor
92763619|NCT02772211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763620|NCT02772211|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92763621|NCT02772211|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92763622|NCT02772211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763623|NCT02772211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763624|NCT02772211|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92763625|NCT02772211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763626|NCT02772211|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92763627|NCT02772211|Antitubercular Agents|antitubercular agents|mesh-ancestor
92763628|NCT02772211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92763629|NCT02772211|Antimetabolites|antimetabolites|mesh-ancestor
92763630|NCT04225195|Amphotericin B|amphotericin b|mesh-list
92763631|NCT04225195|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92763632|NCT04225195|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
92763633|NCT04225195|Amebicides|amebicides|mesh-ancestor
92763634|NCT04225195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92763635|NCT04225195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92763636|NCT04225195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763637|NCT04225195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92763638|NCT04225195|Antifungal Agents|antifungal agents|mesh-ancestor
92763639|NCT04225195|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92763640|NCT04225195|Protease Inhibitors|protease inhibitors|mesh-ancestor
92763641|NCT04225195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763642|NCT04225195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763643|NCT04225195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92763644|NCT04225195|Protective Agents|protective agents|mesh-ancestor
92763645|NCT04225195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763646|NCT04225195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763647|NCT02771509|Mitogens|mitogens|mesh-list
92763648|NCT02771509|Mitosis Modulators|mitosis modulators|mesh-ancestor
92763649|NCT02771509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763650|NCT02696941|Metformin|metformin|mesh-list
92763651|NCT02696941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92763652|NCT02696941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763653|NCT02696941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763654|NCT02696941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763655|NCT02767375|Fluorouracil|fluorouracil|mesh-list
92763656|NCT02767375|Oxaliplatin|oxaliplatin|mesh-list
92763657|NCT02767375|Antimetabolites|antimetabolites|mesh-ancestor
92763658|NCT02767375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763659|NCT02767375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92763660|NCT02767375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763661|NCT02767375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92763662|NCT02767375|Immunologic Factors|immunologic factors|mesh-ancestor
92763663|NCT02767375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763664|NCT02767219|Dexamethasone|dexamethasone|mesh-list
92763665|NCT02767219|Bevacizumab|bevacizumab|mesh-list
92763666|NCT02767219|Fluorouracil|fluorouracil|mesh-list
92763667|NCT02767219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92763668|NCT02767219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763669|NCT02767219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92763670|NCT02767219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92763671|NCT02767219|Growth Substances|growth substances|mesh-ancestor
92763672|NCT02767219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763673|NCT02767219|Growth Inhibitors|growth inhibitors|mesh-ancestor
92763674|NCT02767219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763675|NCT02767219|Antiemetics|antiemetics|mesh-ancestor
92763676|NCT02767219|Autonomic Agents|autonomic agents|mesh-ancestor
92763677|NCT02767219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763678|NCT02767219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763679|NCT02767219|Glucocorticoids|glucocorticoids|mesh-ancestor
92763680|NCT02767219|Hormones|hormones|mesh-ancestor
92763681|NCT02767219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763682|NCT02767219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92763683|NCT02767219|Antimetabolites|antimetabolites|mesh-ancestor
92763684|NCT02767219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763685|NCT02767219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92763686|NCT02767219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92763687|NCT02767219|Immunologic Factors|immunologic factors|mesh-ancestor
92763688|NCT02771587|Ethanol|ethanol|mesh-list
92335358|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763689|NCT02771587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92763690|NCT02771587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763691|NCT02771587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763692|NCT02771587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763693|NCT02771743|Cyclophosphamide|cyclophosphamide|mesh-list
92763694|NCT02771743|Ifosfamide|ifosfamide|mesh-list
92763695|NCT02771743|Carboplatin|carboplatin|mesh-list
92763696|NCT02771743|Doxorubicin|doxorubicin|mesh-list
92763697|NCT02771743|Etoposide|etoposide|mesh-list
92763698|NCT02771743|Interleukin-2|interleukin-2|mesh-list
92763699|NCT02771743|Isotretinoin|isotretinoin|mesh-list
92763700|NCT02771743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92763701|NCT02771743|Immunologic Factors|immunologic factors|mesh-ancestor
92763702|NCT02771743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763703|NCT02771743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763704|NCT02771743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92763705|NCT02771743|Alkylating Agents|alkylating agents|mesh-ancestor
92763706|NCT02771743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763707|NCT02771743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763708|NCT02771743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92763709|NCT02771743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92763710|NCT02771743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92763711|NCT02771743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92763712|NCT02771743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763713|NCT02771743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92763714|NCT02771743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763715|NCT02771743|Analgesics|analgesics|mesh-ancestor
92763716|NCT02771743|Sensory System Agents|sensory system agents|mesh-ancestor
92763717|NCT02771743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763718|NCT02771743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92763719|NCT02762851|Vaccines|vaccines|mesh-list
92763720|NCT02762851|Immunologic Factors|immunologic factors|mesh-ancestor
92763721|NCT02762851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763722|NCT02767063|Pioglitazone|pioglitazone|mesh-list
92763723|NCT02767063|Avelumab|avelumab|mesh-list
92763724|NCT02767063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763725|NCT02767063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763726|NCT02767063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92763727|NCT02767063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763728|NCT04224103|Nitric Oxide|nitric oxide|mesh-list
92763729|NCT04224103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92763730|NCT04224103|Autonomic Agents|autonomic agents|mesh-ancestor
92763731|NCT04224103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763732|NCT04224103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763733|NCT04224103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92763734|NCT04224103|Respiratory System Agents|respiratory system agents|mesh-ancestor
92763735|NCT04224103|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92763736|NCT04224103|Antioxidants|antioxidants|mesh-ancestor
92763737|NCT04224103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763738|NCT04224103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763739|NCT04224103|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92763740|NCT04224103|Vasodilator Agents|vasodilator agents|mesh-ancestor
92763741|NCT04224103|Gasotransmitters|gasotransmitters|mesh-ancestor
92763742|NCT04224103|Protective Agents|protective agents|mesh-ancestor
92763743|NCT02766439|Etanercept|etanercept|mesh-list
92763744|NCT02766439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763745|NCT02766439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763746|NCT02766439|Analgesics|analgesics|mesh-ancestor
92763747|NCT02766439|Sensory System Agents|sensory system agents|mesh-ancestor
92763748|NCT02766439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763749|NCT02766439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763750|NCT02766439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763751|NCT02766439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763752|NCT02766439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763753|NCT02766439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335369|NCT02122380|Incretins|incretins|mesh-ancestor
92763754|NCT02766439|Immunologic Factors|immunologic factors|mesh-ancestor
92763755|NCT04701307|Niraparib|niraparib|mesh-list
92763756|NCT04701307|Dostarlimab|dostarlimab|mesh-list
92763757|NCT04701307|Immunoglobulins|immunoglobulins|mesh-list
92763758|NCT04701307|Immunoglobulin G|immunoglobulin g|mesh-list
92763759|NCT04701307|Immunologic Factors|immunologic factors|mesh-ancestor
92763760|NCT04701307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763761|NCT04701307|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92763762|NCT04701307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763763|NCT04701307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763764|NCT04701307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763765|NCT02765971|Picosulfate sodium|picosulfate sodium|mesh-list
92763766|NCT02765971|Cathartics|cathartics|mesh-ancestor
92763767|NCT02765971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92763768|NCT02765815|Ketorolac|ketorolac|mesh-list
92763769|NCT02765815|Epinephrine|epinephrine|mesh-list
92763770|NCT02765815|Racepinephrine|racepinephrine|mesh-list
92763771|NCT02765815|Morphine|morphine|mesh-list
92763772|NCT02765815|Bupivacaine|bupivacaine|mesh-list
92763773|NCT02765815|Epinephryl borate|epinephryl borate|mesh-list
92763774|NCT02765815|Anesthetics, Local|anesthetics, local|mesh-ancestor
92763775|NCT02765815|Anesthetics|anesthetics|mesh-ancestor
92763776|NCT02765815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763777|NCT02765815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763778|NCT02765815|Sensory System Agents|sensory system agents|mesh-ancestor
92763779|NCT02765815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763780|NCT02765815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92763781|NCT02765815|Narcotics|narcotics|mesh-ancestor
92763782|NCT02765815|Analgesics|analgesics|mesh-ancestor
92763783|NCT02765815|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92763784|NCT02765815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92763785|NCT02765815|Adrenergic Agents|adrenergic agents|mesh-ancestor
92763786|NCT02765815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763787|NCT02765815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763788|NCT02765815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92763789|NCT02765815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92763790|NCT02765815|Autonomic Agents|autonomic agents|mesh-ancestor
92763791|NCT02765815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92763792|NCT02765815|Respiratory System Agents|respiratory system agents|mesh-ancestor
92763793|NCT02765815|Mydriatics|mydriatics|mesh-ancestor
92763794|NCT02765815|Sympathomimetics|sympathomimetics|mesh-ancestor
92763795|NCT02765815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92763796|NCT02765815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763797|NCT02765815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763798|NCT02765815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763799|NCT02765815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763800|NCT02765815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92763801|NCT02765815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763802|NCT02765347|Metformin|metformin|mesh-list
92763803|NCT02765347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763804|NCT02765347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763805|NCT02770885|Dulaglutide|dulaglutide|mesh-list
92763806|NCT02770885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92763807|NCT02770885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763808|NCT02770651|Everolimus|everolimus|mesh-list
92763809|NCT02770651|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92763810|NCT02770651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92763811|NCT02770651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763812|NCT02770651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763813|NCT02770651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92763814|NCT02770651|Immunologic Factors|immunologic factors|mesh-ancestor
92335376|NCT02121756|Dipyridamole|dipyridamole|mesh-list
92763815|NCT02770651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763816|NCT02770651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763817|NCT02770729|Moxifloxacin|moxifloxacin|mesh-list
92763818|NCT02770729|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92763819|NCT02770729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92763820|NCT02770729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763821|NCT02770729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92763822|NCT02770729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92763823|NCT02770729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763824|NCT02770729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763825|NCT02770729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763826|NCT02770729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92763827|NCT02770729|Contraceptive Agents|contraceptive agents|mesh-ancestor
92763828|NCT02770729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92763829|NCT02770729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763830|NCT02770729|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92763831|NCT02770729|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92763832|NCT02770729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92763833|NCT02770105|Caffeine|caffeine|mesh-list
92763834|NCT02770105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92763835|NCT02770105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763836|NCT02770105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92763837|NCT02770105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763838|NCT02770105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763839|NCT02770105|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92763840|NCT02770105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92763841|NCT02770105|Purinergic Agents|purinergic agents|mesh-ancestor
92763842|NCT02770105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763843|NCT02769793|Levodopa|levodopa|mesh-list
92763844|NCT02769793|Benserazide|benserazide|mesh-list
92763845|NCT02769793|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92763846|NCT02769793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92763847|NCT02769793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92763848|NCT02769793|Dopamine Agents|dopamine agents|mesh-ancestor
92763849|NCT02769793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763850|NCT02769793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763851|NCT02769793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763852|NCT02769793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763853|NCT02769325|Ketorolac|ketorolac|mesh-list
92763854|NCT02769325|Atropine|atropine|mesh-list
92763855|NCT02769325|Morphine|morphine|mesh-list
92763856|NCT02769325|Propofol|propofol|mesh-list
92763857|NCT02769325|Sevoflurane|sevoflurane|mesh-list
92763858|NCT02769325|Rocuronium|rocuronium|mesh-list
92763859|NCT02769325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92763860|NCT02769325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763861|NCT02769325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763862|NCT02769325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92763863|NCT02769325|Anesthetics, General|anesthetics, general|mesh-ancestor
92763864|NCT02769325|Anesthetics|anesthetics|mesh-ancestor
92763865|NCT02769325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92763866|NCT02769325|Narcotics|narcotics|mesh-ancestor
92763867|NCT02769325|Analgesics|analgesics|mesh-ancestor
92763868|NCT02769325|Sensory System Agents|sensory system agents|mesh-ancestor
92763869|NCT02769325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763870|NCT02769325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92763871|NCT02769325|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92763872|NCT02769325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92763873|NCT02769325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92763874|NCT02769325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763875|NCT02769325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92763876|NCT02769325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92763877|NCT02769325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763878|NCT02769325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763879|NCT02769325|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92763880|NCT02769325|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92763881|NCT02769325|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92763882|NCT02769325|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92713832|NCT04665141|Omalizumab|omalizumab|mesh-list
92763883|NCT02769325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92763884|NCT02769325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92763885|NCT02769325|Autonomic Agents|autonomic agents|mesh-ancestor
92763886|NCT02769325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92763887|NCT02769325|Respiratory System Agents|respiratory system agents|mesh-ancestor
92763888|NCT02769325|Mydriatics|mydriatics|mesh-ancestor
92763889|NCT02769325|Parasympatholytics|parasympatholytics|mesh-ancestor
92763890|NCT02769325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92763891|NCT02769325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92763892|NCT02769325|Cholinergic Agents|cholinergic agents|mesh-ancestor
92763893|NCT02769325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763894|NCT02770261|Candesartan|candesartan|mesh-list
92763895|NCT02770261|Candesartan cilexetil|candesartan cilexetil|mesh-list
92763896|NCT02770261|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92763897|NCT02770261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92763898|NCT02770261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92763899|NCT02770261|Antimetabolites|antimetabolites|mesh-ancestor
92763900|NCT02770261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763901|NCT02770261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92763902|NCT02770261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92763903|NCT02770261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92763904|NCT02770261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92763905|NCT02770261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92763906|NCT02770261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92763907|NCT04224649|Lidocaine|lidocaine|mesh-list
92763908|NCT04224649|Hyaluronic Acid|hyaluronic acid|mesh-list
92763909|NCT04224649|Anesthetics, Local|anesthetics, local|mesh-ancestor
92763910|NCT04224649|Anesthetics|anesthetics|mesh-ancestor
92763911|NCT04224649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763912|NCT04224649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763913|NCT04224649|Sensory System Agents|sensory system agents|mesh-ancestor
92763914|NCT04224649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763915|NCT04224649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92763916|NCT04224649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92763917|NCT04224649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92763918|NCT04224649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92763919|NCT04224649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763920|NCT04224649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92763921|NCT04224649|Immunologic Factors|immunologic factors|mesh-ancestor
92763922|NCT04224649|Viscosupplements|viscosupplements|mesh-ancestor
92763923|NCT04224649|Protective Agents|protective agents|mesh-ancestor
92763924|NCT02769169|Ranibizumab|ranibizumab|mesh-list
92763925|NCT02769169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92763926|NCT02769169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92763927|NCT02769169|Growth Substances|growth substances|mesh-ancestor
92763928|NCT02769169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763929|NCT02769169|Growth Inhibitors|growth inhibitors|mesh-ancestor
92763930|NCT02769169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763931|NCT02769013|Praziquantel|praziquantel|mesh-list
92763932|NCT02769013|Anthelmintics|anthelmintics|mesh-ancestor
92763933|NCT02769013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92763934|NCT02769013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92763935|NCT02768545|Ezetimibe|ezetimibe|mesh-list
92763936|NCT02768545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92763937|NCT02768545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92763938|NCT02768545|Antimetabolites|antimetabolites|mesh-ancestor
92763939|NCT02768545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763940|NCT02768545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92763941|NCT02764723|Bupivacaine|bupivacaine|mesh-list
92763942|NCT02764723|Ropivacaine|ropivacaine|mesh-list
92763943|NCT02764723|Anesthetics, Local|anesthetics, local|mesh-ancestor
92763944|NCT02764723|Anesthetics|anesthetics|mesh-ancestor
92763945|NCT02764723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763946|NCT02764723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763947|NCT02764723|Sensory System Agents|sensory system agents|mesh-ancestor
92763948|NCT02764723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92763949|NCT04664959|Denosumab|denosumab|mesh-list
92763950|NCT04664959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92763951|NCT04664959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763952|NCT00951496|Paclitaxel|paclitaxel|mesh-list
92763953|NCT00951496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92763954|NCT00951496|Bevacizumab|bevacizumab|mesh-list
92763955|NCT00951496|Cisplatin|cisplatin|mesh-list
92763956|NCT00951496|Carboplatin|carboplatin|mesh-list
92763957|NCT00951496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92763958|NCT00951496|Endothelial Growth Factors|endothelial growth factors|mesh-list
92763959|NCT00951496|Antibodies|antibodies|mesh-list
92763960|NCT00951496|Immunoglobulins|immunoglobulins|mesh-list
92763961|NCT00951496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92763962|NCT00951496|Immunoglobulin G|immunoglobulin g|mesh-list
92763963|NCT00951496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92763964|NCT00951496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763965|NCT00951496|Tubulin Modulators|tubulin modulators|mesh-ancestor
92763966|NCT00951496|Antimitotic Agents|antimitotic agents|mesh-ancestor
92763967|NCT00951496|Mitosis Modulators|mitosis modulators|mesh-ancestor
92763968|NCT00951496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763969|NCT00951496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92763970|NCT00951496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92763971|NCT00951496|Growth Substances|growth substances|mesh-ancestor
92763972|NCT00951496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763973|NCT00951496|Growth Inhibitors|growth inhibitors|mesh-ancestor
92763974|NCT00951496|Immunologic Factors|immunologic factors|mesh-ancestor
92763975|NCT02764411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92763976|NCT02764411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92763977|NCT02764411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92763978|NCT02764411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92763979|NCT02764411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92763980|NCT02764411|Adrenergic Agents|adrenergic agents|mesh-ancestor
92763981|NCT02764411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92763982|NCT02764411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763983|NCT02764411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763984|NCT02768077|Melatonin|melatonin|mesh-list
92763985|NCT02768077|Antioxidants|antioxidants|mesh-ancestor
92763986|NCT02768077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92763987|NCT02768077|Protective Agents|protective agents|mesh-ancestor
92763988|NCT02768077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763989|NCT02768077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92763990|NCT01193244|Prednisone|prednisone|mesh-list
92763991|NCT01193244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92763992|NCT01193244|Glucocorticoids|glucocorticoids|mesh-ancestor
92763993|NCT01193244|Hormones|hormones|mesh-ancestor
92763994|NCT01193244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92763995|NCT01193244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92763996|NCT01193244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92763997|NCT01193244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92763998|NCT04224337|Doxorubicin|doxorubicin|mesh-list
92763999|NCT04224337|Durvalumab|durvalumab|mesh-list
92764000|NCT04224337|Ifosfamide|ifosfamide|mesh-list
92764001|NCT04224337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92764002|NCT04224337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764003|NCT04224337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92764004|NCT04224337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92764005|NCT04224337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764006|NCT04224337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764007|NCT04224337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764008|NCT04224337|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92764009|NCT04224337|Alkylating Agents|alkylating agents|mesh-ancestor
92764010|NCT02767999|Fluoxetine|fluoxetine|mesh-list
92764011|NCT02767999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92764012|NCT02767999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92764013|NCT02767999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764014|NCT02767999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764015|NCT02767999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764016|NCT02767999|Serotonin Agents|serotonin agents|mesh-ancestor
92764017|NCT02767999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764018|NCT02767999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92764019|NCT02767999|Antidepressive Agents|antidepressive agents|mesh-ancestor
92764020|NCT02767999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764021|NCT02767999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92764022|NCT02767999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92764023|NCT02767999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764024|NCT02764021|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92764025|NCT02764021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764027|NCT02762617|Antiviral Agents|antiviral agents|mesh-ancestor
92764028|NCT02762617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764029|NCT02762617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92764030|NCT02762617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92713979|NCT03303339|Decitabine|decitabine|mesh-list
92764031|NCT02762617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764032|NCT02762617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764033|NCT02762617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92764034|NCT02762617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92764035|NCT01192152|Metformin|metformin|mesh-list
92764036|NCT01192152|Saxagliptin|saxagliptin|mesh-list
92764037|NCT01192152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764038|NCT01192152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764039|NCT01192152|Incretins|incretins|mesh-ancestor
92764040|NCT01192152|Hormones|hormones|mesh-ancestor
92764041|NCT01192152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764042|NCT01192152|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92764043|NCT01192152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764044|NCT01192152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764045|NCT01192152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764046|NCT04572451|Nivolumab|nivolumab|mesh-list
92764047|NCT04572451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764048|NCT04572451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764049|NCT04572451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92764050|NCT04572451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764051|NCT02758249|Propofol|propofol|mesh-list
92764052|NCT02758249|Sevoflurane|sevoflurane|mesh-list
92764053|NCT02758249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92764054|NCT02758249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764055|NCT02758249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764056|NCT02758249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92764057|NCT02758249|Anesthetics, General|anesthetics, general|mesh-ancestor
92764058|NCT02758249|Anesthetics|anesthetics|mesh-ancestor
92764059|NCT02758249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92764060|NCT02758249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92764061|NCT02758405|Fentanyl|fentanyl|mesh-list
92764062|NCT02758405|Bupivacaine|bupivacaine|mesh-list
92764063|NCT02758405|Anesthetics, Local|anesthetics, local|mesh-ancestor
92764064|NCT02758405|Anesthetics|anesthetics|mesh-ancestor
92764065|NCT02758405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764066|NCT02758405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764067|NCT02758405|Sensory System Agents|sensory system agents|mesh-ancestor
92764068|NCT02758405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764069|NCT02758405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92764070|NCT02758405|Narcotics|narcotics|mesh-ancestor
92764071|NCT02758405|Analgesics|analgesics|mesh-ancestor
92764072|NCT02758405|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92764073|NCT02758405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92764074|NCT02758405|Anesthetics, General|anesthetics, general|mesh-ancestor
92764075|NCT02758327|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92764076|NCT02758327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92764077|NCT02758327|Lubricant Eye Drops|lubricant eye drops|mesh-list
92764078|NCT02758327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92764079|NCT02758327|Laxatives|laxatives|mesh-ancestor
92764080|NCT02758327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764081|NCT02763475|Cyclophosphamide|cyclophosphamide|mesh-list
92764082|NCT02763475|Fludarabine|fludarabine|mesh-list
92764083|NCT02763475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764084|NCT02763475|Immunologic Factors|immunologic factors|mesh-ancestor
92764085|NCT02763475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764086|NCT02763475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764087|NCT02763475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92764088|NCT02763475|Alkylating Agents|alkylating agents|mesh-ancestor
92764089|NCT02763475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764090|NCT02763475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764091|NCT02763475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92764092|NCT02762383|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92764093|NCT02762383|Antiviral Agents|antiviral agents|mesh-ancestor
92764094|NCT02762383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764095|NCT02758015|Betaine|betaine|mesh-list
92764096|NCT02758015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764097|NCT02758015|Lipotropic Agents|lipotropic agents|mesh-ancestor
92764098|NCT02758015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92764099|NCT02758015|Antimetabolites|antimetabolites|mesh-ancestor
92764100|NCT02758015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764101|NCT02758015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92764102|NCT02757703|Terlipressin|terlipressin|mesh-list
92764103|NCT02757703|Pantoprazole|pantoprazole|mesh-list
92764104|NCT02757703|Somatostatin|somatostatin|mesh-list
92764105|NCT02757703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92764106|NCT02757703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764107|NCT02757703|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92764108|NCT02757703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764109|NCT02757703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764110|NCT02757703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92764111|NCT02757703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92764112|NCT02757703|Hormones|hormones|mesh-ancestor
92764113|NCT02757703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764114|NCT02757703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764115|NCT02763007|Pioglitazone|pioglitazone|mesh-list
92764116|NCT02763007|Alogliptin|alogliptin|mesh-list
92764117|NCT02763007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764118|NCT02763007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764119|NCT02763007|Incretins|incretins|mesh-ancestor
92764120|NCT02763007|Hormones|hormones|mesh-ancestor
92764121|NCT02763007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764122|NCT02763007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92764123|NCT02763007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764124|NCT02763007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764125|NCT02763007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764126|NCT00635323|Capecitabine|capecitabine|mesh-list
92764127|NCT00635323|Irinotecan|irinotecan|mesh-list
92335439|NCT02119416|Caffeine|caffeine|mesh-list
92764128|NCT00635323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764129|NCT00635323|Antimetabolites|antimetabolites|mesh-ancestor
92764130|NCT00635323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764131|NCT00635323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764132|NCT00635323|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92764133|NCT00635323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92764134|NCT00635323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764135|NCT01191840|Vancomycin|vancomycin|mesh-list
92764136|NCT01191840|Cefazolin|cefazolin|mesh-list
92764137|NCT01191840|Daptomycin|daptomycin|mesh-list
92764138|NCT01191840|Cloxacillin|cloxacillin|mesh-list
92764139|NCT01191840|Oxacillin|oxacillin|mesh-list
92764140|NCT01191840|Nafcillin|nafcillin|mesh-list
92764141|NCT01191840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92764142|NCT01191840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764143|NCT02752555|Antioxidants|antioxidants|mesh-list
92764144|NCT02752555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764145|NCT02752555|Protective Agents|protective agents|mesh-ancestor
92764146|NCT02752555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764147|NCT00624546|Lansoprazole|lansoprazole|mesh-list
92764148|NCT00624546|Dexlansoprazole|dexlansoprazole|mesh-list
92764149|NCT00624546|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92764150|NCT00624546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764151|NCT00624546|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92764152|NCT00624546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764153|NCT00624546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764154|NCT02757469|Drospirenone|drospirenone|mesh-list
92764155|NCT02757469|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92764156|NCT02757469|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92764157|NCT02757469|Estradiol|estradiol|mesh-list
92764158|NCT02757469|Estrogens|estrogens|mesh-ancestor
92764159|NCT02757469|Hormones|hormones|mesh-ancestor
92764160|NCT02757469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764161|NCT02757469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764162|NCT02757469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92764163|NCT02757469|Contraceptive Agents|contraceptive agents|mesh-ancestor
92764164|NCT02757469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92764165|NCT02757469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92764166|NCT02757469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92764167|NCT02757469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92764168|NCT02757469|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92764169|NCT02757469|Hormone Antagonists|hormone antagonists|mesh-ancestor
92764170|NCT02757469|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92764172|NCT02757469|Natriuretic Agents|natriuretic agents|mesh-ancestor
92764173|NCT02757391|Aldesleukin|aldesleukin|mesh-list
92764174|NCT02757391|Cyclophosphamide|cyclophosphamide|mesh-list
92764175|NCT02757391|Pembrolizumab|pembrolizumab|mesh-list
92764176|NCT02757391|Interleukin-2|interleukin-2|mesh-list
92764177|NCT02757391|Immunologic Factors|immunologic factors|mesh-list
92764178|NCT02757391|Immunomodulating Agents|immunomodulating agents|mesh-list
92764179|NCT02757391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764180|NCT02757391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764181|NCT02757391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764182|NCT02757391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92764183|NCT02757391|Alkylating Agents|alkylating agents|mesh-ancestor
92764184|NCT02757391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764185|NCT02757391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764186|NCT02757391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92764187|NCT02757391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764188|NCT02757391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92764189|NCT02757391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92764191|NCT02757391|Sensory System Agents|sensory system agents|mesh-ancestor
92764192|NCT02757391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764193|NCT02757391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92764194|NCT02757391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92764195|NCT02757391|Antiviral Agents|antiviral agents|mesh-ancestor
92764196|NCT02757391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764197|NCT04564417|Pembrolizumab|pembrolizumab|mesh-list
92764198|NCT04564417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764199|NCT04564417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764200|NCT04564417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92764201|NCT04564417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764202|NCT02757079|Melatonin|melatonin|mesh-list
92764203|NCT02757079|Antioxidants|antioxidants|mesh-ancestor
92764204|NCT02757079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764205|NCT02757079|Protective Agents|protective agents|mesh-ancestor
92764206|NCT02757079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764207|NCT02757079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764208|NCT02768389|Bevacizumab|bevacizumab|mesh-list
92764209|NCT02768389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764210|NCT02768389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764211|NCT02768389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92764212|NCT02768389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92764213|NCT02768389|Growth Substances|growth substances|mesh-ancestor
92764214|NCT02768389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764215|NCT02768389|Growth Inhibitors|growth inhibitors|mesh-ancestor
92764216|NCT04529005|Angiotensin II|angiotensin ii|mesh-list
92764217|NCT04529005|Giapreza|giapreza|mesh-list
92764218|NCT04529005|Angiotensinogen|angiotensinogen|mesh-list
92764219|NCT04529005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92764220|NCT04529005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92764221|NCT04529005|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764222|NCT04529005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764223|NCT04529005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764224|NCT05357040|Nitrous Oxide|nitrous oxide|mesh-list
92764225|NCT05357040|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92764226|NCT05357040|Anesthetics, General|anesthetics, general|mesh-ancestor
92764227|NCT05357040|Anesthetics|anesthetics|mesh-ancestor
92764228|NCT05357040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764229|NCT05357040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764230|NCT05357040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92764231|NCT05357040|Analgesics|analgesics|mesh-ancestor
92764232|NCT05357040|Sensory System Agents|sensory system agents|mesh-ancestor
92764233|NCT05357040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764234|NCT00943072|Aflibercept|aflibercept|mesh-list
92764235|NCT00943072|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92764236|NCT00943072|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92764237|NCT00943072|Growth Substances|growth substances|mesh-ancestor
92764238|NCT00943072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764239|NCT00943072|Growth Inhibitors|growth inhibitors|mesh-ancestor
92764240|NCT00943072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764241|NCT04222855|Diltiazem|diltiazem|mesh-list
92764242|NCT04222855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92764243|NCT04222855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92764244|NCT04222855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764245|NCT04222855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764246|NCT04222855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92764247|NCT04222855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764248|NCT04222855|Vasodilator Agents|vasodilator agents|mesh-ancestor
92764249|NCT00942994|Amlodipine|amlodipine|mesh-list
92764250|NCT00942994|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92764251|NCT00942994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92764252|NCT00942994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92764253|NCT00942994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764254|NCT00942994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764255|NCT00942994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714206|NCT00538070|Glycine|glycine|mesh-list
92764256|NCT00942994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764257|NCT00942994|Vasodilator Agents|vasodilator agents|mesh-ancestor
92764258|NCT00942994|Diuretics|diuretics|mesh-ancestor
92764259|NCT00942994|Natriuretic Agents|natriuretic agents|mesh-ancestor
92764260|NCT00942994|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92764261|NCT04268602|Anesthetics|anesthetics|mesh-list
92764262|NCT04268602|Anesthetics, Local|anesthetics, local|mesh-list
92764263|NCT04268602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764264|NCT04268602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764265|NCT04268602|Sensory System Agents|sensory system agents|mesh-ancestor
92764266|NCT04268602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764267|NCT04314336|Coal Tar|coal tar|mesh-list
92764268|NCT04314336|Keratolytic Agents|keratolytic agents|mesh-ancestor
92764269|NCT04314336|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764270|NCT00624702|Maleic acid|maleic acid|mesh-list
92764271|NCT00624702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764272|NCT00624702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764273|NCT02756377|Chlorhexidine|chlorhexidine|mesh-list
92764274|NCT02756377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92764275|NCT02756377|Cetylpyridinium|cetylpyridinium|mesh-list
92764276|NCT02756377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92764277|NCT02756377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764278|NCT02756377|Disinfectants|disinfectants|mesh-ancestor
92764279|NCT02756377|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764280|NCT02199184|Prednisone|prednisone|mesh-list
92764281|NCT02199184|Cortisone|cortisone|mesh-list
92764282|NCT02199184|Cyclophosphamide|cyclophosphamide|mesh-list
92764283|NCT02199184|Rituximab|rituximab|mesh-list
92764284|NCT02199184|Doxorubicin|doxorubicin|mesh-list
92764285|NCT02199184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92764286|NCT02199184|Etoposide|etoposide|mesh-list
92764287|NCT02199184|Vincristine|vincristine|mesh-list
92764288|NCT02199184|Etoposide phosphate|etoposide phosphate|mesh-list
92764289|NCT02199184|Ofatumumab|ofatumumab|mesh-list
92764290|NCT02199184|Podophyllotoxin|podophyllotoxin|mesh-list
92764291|NCT02199184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92764292|NCT02199184|Antibodies|antibodies|mesh-list
92764293|NCT02199184|Immunoglobulins|immunoglobulins|mesh-list
92764294|NCT02199184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92764295|NCT02199184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764296|NCT02199184|Immunologic Factors|immunologic factors|mesh-ancestor
92764297|NCT02199184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764298|NCT02199184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764299|NCT02199184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92764300|NCT02199184|Alkylating Agents|alkylating agents|mesh-ancestor
92764301|NCT02199184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764302|NCT02199184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764303|NCT02199184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92764304|NCT02199184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92764305|NCT02199184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92335488|NCT02095158|Mydriatics|mydriatics|mesh-ancestor
92764306|NCT02199184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92764307|NCT02199184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764308|NCT02199184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764310|NCT02199184|Hormones|hormones|mesh-ancestor
92764311|NCT02199184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764312|NCT02199184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92764313|NCT02199184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92764314|NCT02199184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92764315|NCT02199184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92764316|NCT02199184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92764317|NCT02199184|Keratolytic Agents|keratolytic agents|mesh-ancestor
92764318|NCT02199184|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764319|NCT05378100|Midazolam|midazolam|mesh-list
92764320|NCT05378100|Ketamine|ketamine|mesh-list
92764321|NCT05378100|Analgesics|analgesics|mesh-ancestor
92764322|NCT05378100|Sensory System Agents|sensory system agents|mesh-ancestor
92764323|NCT05378100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764324|NCT05378100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764325|NCT05378100|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92764326|NCT05378100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92764327|NCT05378100|Anesthetics, General|anesthetics, general|mesh-ancestor
92764328|NCT05378100|Anesthetics|anesthetics|mesh-ancestor
92764329|NCT05378100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764330|NCT05378100|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92764331|NCT05378100|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92764332|NCT05378100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060697|NCT01281514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92764333|NCT05378100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764334|NCT05378100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92764335|NCT05378100|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92764336|NCT05378100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92764337|NCT05378100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92764338|NCT05378100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764339|NCT05378100|GABA Modulators|gaba modulators|mesh-ancestor
92764340|NCT05378100|GABA Agents|gaba agents|mesh-ancestor
92764341|NCT02752477|Anesthetics|anesthetics|mesh-list
92764342|NCT02752477|Anesthetics, General|anesthetics, general|mesh-list
92764343|NCT02752477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764344|NCT02752477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764345|NCT04204096|Vaccines|vaccines|mesh-list
92764346|NCT04204096|Immunologic Factors|immunologic factors|mesh-ancestor
92764347|NCT04204096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764348|NCT05376852|Decitabine|decitabine|mesh-list
92764349|NCT05376852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764350|NCT05376852|Antimetabolites|antimetabolites|mesh-ancestor
92764351|NCT05376852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764352|NCT05376852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764353|NCT05376852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764354|NCT00061282|Clotrimazole|clotrimazole|mesh-list
92764355|NCT00061282|Miconazole|miconazole|mesh-list
92764356|NCT00061282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92764357|NCT00061282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764358|NCT00061282|Antifungal Agents|antifungal agents|mesh-ancestor
92764359|NCT00061282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92764360|NCT00061282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92764361|NCT00061282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764362|NCT00061282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764363|NCT00061282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92764364|NCT00061282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92764365|NCT00061282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764366|NCT00061282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764367|NCT00061282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92764368|NCT00061282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92764369|NCT05657496|Triamcinolone|triamcinolone|mesh-list
92764370|NCT05657496|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92764371|NCT05657496|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92764372|NCT05657496|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92764373|NCT05657496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764374|NCT05657496|Glucocorticoids|glucocorticoids|mesh-ancestor
92764375|NCT05657496|Hormones|hormones|mesh-ancestor
92764376|NCT05657496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764377|NCT05657496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529749|NCT01156545|Afatinib|afatinib|mesh-list
92764378|NCT05657496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764379|NCT05657496|Immunologic Factors|immunologic factors|mesh-ancestor
92764380|NCT05657496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764381|NCT05657496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764383|NCT04268524|Antifungal Agents|antifungal agents|mesh-ancestor
92764384|NCT04268524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764385|NCT04268524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764386|NCT04268524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92764387|NCT04268524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92764388|NCT02855632|Hormones|hormones|mesh-list
92764389|NCT02855632|Progesterone|progesterone|mesh-list
92764390|NCT02855632|Lenograstim|lenograstim|mesh-list
92764391|NCT02855632|Estrogens|estrogens|mesh-list
92764392|NCT02855632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764393|NCT02855632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764394|NCT02855632|Progestins|progestins|mesh-ancestor
92764395|NCT02855632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92764396|NCT02855632|Immunologic Factors|immunologic factors|mesh-ancestor
92764397|NCT04220281|Nitroglycerin|nitroglycerin|mesh-list
92764398|NCT04220281|Propofol|propofol|mesh-list
92764399|NCT04220281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92764400|NCT04220281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764401|NCT04220281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764402|NCT04220281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92764403|NCT04220281|Anesthetics, General|anesthetics, general|mesh-ancestor
92764404|NCT04220281|Anesthetics|anesthetics|mesh-ancestor
92764405|NCT04220281|Vasodilator Agents|vasodilator agents|mesh-ancestor
92764406|NCT02751619|Lidocaine|lidocaine|mesh-list
92764407|NCT02751619|Anesthetics, Local|anesthetics, local|mesh-ancestor
92764408|NCT02751619|Anesthetics|anesthetics|mesh-ancestor
92764409|NCT02751619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764410|NCT02751619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764411|NCT02751619|Sensory System Agents|sensory system agents|mesh-ancestor
92764412|NCT02751619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764413|NCT02751619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92764414|NCT02751619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92764415|NCT02751619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92764416|NCT02751619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764417|NCT02751619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764418|NCT02751541|Sunscreening Agents|sunscreening agents|mesh-list
92764419|NCT02751541|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92764420|NCT02751541|Protective Agents|protective agents|mesh-ancestor
92764421|NCT02751541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764422|NCT02751541|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764423|NCT02755753|Lansoprazole|lansoprazole|mesh-list
92764424|NCT02755753|Dexlansoprazole|dexlansoprazole|mesh-list
92764425|NCT02755753|Rebamipide|rebamipide|mesh-list
92764426|NCT02755753|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92764427|NCT02755753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764428|NCT02755753|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92764429|NCT02755753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764430|NCT02755753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764431|NCT02755753|Antioxidants|antioxidants|mesh-ancestor
92764432|NCT02755753|Protective Agents|protective agents|mesh-ancestor
92764433|NCT02755753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764434|NCT02755909|Anesthetics|anesthetics|mesh-list
92764435|NCT02755909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764436|NCT02755909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764437|NCT02761291|Valganciclovir|valganciclovir|mesh-list
92764438|NCT02761291|Gemcitabine|gemcitabine|mesh-list
92764439|NCT02761291|Valproic Acid|valproic acid|mesh-list
92764440|NCT02761291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764441|NCT02761291|Antimetabolites|antimetabolites|mesh-ancestor
92764442|NCT02761291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764443|NCT02761291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764444|NCT02761291|Anticonvulsants|anticonvulsants|mesh-ancestor
92764445|NCT02761291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764446|NCT02761291|GABA Agents|gaba agents|mesh-ancestor
92764447|NCT02761291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764448|NCT02761291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764449|NCT02761291|Antimanic Agents|antimanic agents|mesh-ancestor
92764450|NCT02761291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92764451|NCT02761291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764452|NCT02761291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764453|NCT02761291|Antiviral Agents|antiviral agents|mesh-ancestor
92764454|NCT02761291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764455|NCT01187550|Hormones|hormones|mesh-list
92764456|NCT01187550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764457|NCT01187550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764458|NCT02855866|Acetaminophen|acetaminophen|mesh-list
92764459|NCT02855866|Dexamethasone|dexamethasone|mesh-list
92764460|NCT02855866|Cortisone|cortisone|mesh-list
92764461|NCT02855866|Dexamethasone acetate|dexamethasone acetate|mesh-list
92764462|NCT02855866|BB 1101|bb 1101|mesh-list
92764463|NCT02855866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764464|NCT02855866|Antiemetics|antiemetics|mesh-ancestor
92764465|NCT02855866|Autonomic Agents|autonomic agents|mesh-ancestor
92764466|NCT02855866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764467|NCT02855866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764468|NCT02855866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764469|NCT02855866|Glucocorticoids|glucocorticoids|mesh-ancestor
92764470|NCT02855866|Hormones|hormones|mesh-ancestor
92764471|NCT02855866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764472|NCT02855866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92764473|NCT02855866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764474|NCT02855866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92764475|NCT02855866|Analgesics|analgesics|mesh-ancestor
92764476|NCT02855866|Sensory System Agents|sensory system agents|mesh-ancestor
92764477|NCT02855866|Antipyretics|antipyretics|mesh-ancestor
92764478|NCT02855866|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764479|NCT02855866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764480|NCT02855866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764481|NCT02751307|Metformin|metformin|mesh-list
92764482|NCT02751307|Clozapine|clozapine|mesh-list
92764483|NCT02751307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764484|NCT02751307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335531|NCT02091414|Cyclosporine|cyclosporine|mesh-list
92764485|NCT02751307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92764486|NCT02751307|Serotonin Agents|serotonin agents|mesh-ancestor
92764487|NCT02751307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764488|NCT02751307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764489|NCT02751307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92764490|NCT02751307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92764491|NCT02751307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764492|NCT02751307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764493|NCT02751307|GABA Antagonists|gaba antagonists|mesh-ancestor
92764494|NCT02751307|GABA Agents|gaba agents|mesh-ancestor
92764495|NCT00638209|Insulin|insulin|mesh-list
92764496|NCT00638209|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92764497|NCT00638209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764498|NCT00638209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764499|NCT05429671|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92764500|NCT05429671|Gentamicins|gentamicins|mesh-list
92764501|NCT05429671|Tobramycin|tobramycin|mesh-list
92764502|NCT05429671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764503|NCT05429671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92764504|NCT05429671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764505|NCT05429671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764506|NCT01186770|Methylnaltrexone|methylnaltrexone|mesh-list
92764507|NCT01186770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92764508|NCT01186770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764509|NCT01186770|Sensory System Agents|sensory system agents|mesh-ancestor
92764510|NCT01186770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764511|NCT02754817|Liraglutide|liraglutide|mesh-list
92764512|NCT02754817|Xultophy|xultophy|mesh-list
92764513|NCT02754817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764514|NCT02754817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764515|NCT02754817|Incretins|incretins|mesh-ancestor
92764516|NCT02754817|Hormones|hormones|mesh-ancestor
92764517|NCT02754817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764518|NCT04230031|Daratumumab|daratumumab|mesh-list
92764519|NCT04230031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764520|NCT01186458|Rituximab|rituximab|mesh-list
92764521|NCT01186458|Fludarabine|fludarabine|mesh-list
92764522|NCT01186458|Bortezomib|bortezomib|mesh-list
92764523|NCT01186458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764524|NCT01186458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764525|NCT01186458|Immunologic Factors|immunologic factors|mesh-ancestor
92764526|NCT01186458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764527|NCT01186458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764528|NCT01185366|Everolimus|everolimus|mesh-list
92764529|NCT01185366|Sunitinib|sunitinib|mesh-list
92764531|NCT01185366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92764532|NCT01185366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764533|NCT01185366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764534|NCT01185366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764535|NCT01185366|Immunologic Factors|immunologic factors|mesh-ancestor
92764536|NCT01185366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764537|NCT01185366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764538|NCT01185366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92764539|NCT01185366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92764540|NCT01185366|Growth Substances|growth substances|mesh-ancestor
92764541|NCT01185366|Growth Inhibitors|growth inhibitors|mesh-ancestor
92764542|NCT01185288|Adalimumab|adalimumab|mesh-list
92764543|NCT01185288|Methotrexate|methotrexate|mesh-list
92764544|NCT01185288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92764545|NCT01185288|Abortifacient Agents|abortifacient agents|mesh-ancestor
92764546|NCT01185288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92764547|NCT01185288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764548|NCT01185288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764549|NCT01185288|Antimetabolites|antimetabolites|mesh-ancestor
92764550|NCT01185288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764551|NCT01185288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764552|NCT01185288|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764553|NCT01185288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764554|NCT01185288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92764555|NCT01185288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764556|NCT01185288|Immunologic Factors|immunologic factors|mesh-ancestor
92714518|NCT00539669|Docetaxel|docetaxel|mesh-list
92764557|NCT01185288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764558|NCT01185288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92764559|NCT01185288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92764560|NCT01185288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764562|NCT01184118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764563|NCT01184118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92764564|NCT01184118|Autonomic Agents|autonomic agents|mesh-ancestor
92764565|NCT01184118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764566|NCT01184118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764567|NCT01184118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92764568|NCT01184118|Respiratory System Agents|respiratory system agents|mesh-ancestor
92764569|NCT01184118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764570|NCT01184118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92764571|NCT01183884|Tretinoin|tretinoin|mesh-list
92764572|NCT01183884|Isotretinoin|isotretinoin|mesh-list
92764573|NCT01183884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764574|NCT01183884|Keratolytic Agents|keratolytic agents|mesh-ancestor
92764575|NCT01183884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764576|NCT05344248|Antibodies|antibodies|mesh-list
92764577|NCT05344248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92764578|NCT05344248|Immunologic Factors|immunologic factors|mesh-ancestor
92764579|NCT05344248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764580|NCT01191762|Sevelamer|sevelamer|mesh-list
92764581|NCT01191762|Chelating Agents|chelating agents|mesh-ancestor
92764582|NCT01191762|Sequestering Agents|sequestering agents|mesh-ancestor
92764583|NCT01191762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764584|NCT04315974|Rivaroxaban|rivaroxaban|mesh-list
92764585|NCT04315974|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92764586|NCT04315974|Antithrombins|antithrombins|mesh-ancestor
92764587|NCT04315974|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92764588|NCT04315974|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764589|NCT04315974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764590|NCT04315974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764591|NCT04315974|Anticoagulants|anticoagulants|mesh-ancestor
92764592|NCT01723774|Anastrozole|anastrozole|mesh-list
92764593|NCT01723774|Goserelin|goserelin|mesh-list
92764594|NCT01723774|Palbociclib|palbociclib|mesh-list
92764595|NCT01723774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92764596|NCT01723774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764597|NCT01723774|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92764598|NCT01723774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92764599|NCT01723774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764600|NCT01723774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764601|NCT01723774|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92764602|NCT01723774|Hormone Antagonists|hormone antagonists|mesh-ancestor
92529755|NCT01156545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92764603|NCT01723774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764604|NCT01723774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764605|NCT01723774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92764607|NCT02855788|Paclitaxel|paclitaxel|mesh-list
92764608|NCT02855788|Oxaliplatin|oxaliplatin|mesh-list
92764609|NCT02855788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92764610|NCT02855788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764611|NCT02855788|Tubulin Modulators|tubulin modulators|mesh-ancestor
92764612|NCT02855788|Antimitotic Agents|antimitotic agents|mesh-ancestor
92764613|NCT02855788|Mitosis Modulators|mitosis modulators|mesh-ancestor
92764614|NCT02855788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764615|NCT02855788|Antidotes|antidotes|mesh-ancestor
92764616|NCT02855788|Protective Agents|protective agents|mesh-ancestor
92764617|NCT02855788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764618|NCT02855788|Vitamin B Complex|vitamin b complex|mesh-ancestor
92764619|NCT02855788|Vitamins|vitamins|mesh-ancestor
92764620|NCT02855788|Micronutrients|micronutrients|mesh-ancestor
92764621|NCT01190514|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92764622|NCT01190514|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92764623|NCT01190514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92764624|NCT01190514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764625|NCT01190514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764626|NCT01190514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764627|NCT01190514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764628|NCT01190514|Antidepressive Agents|antidepressive agents|mesh-ancestor
92764629|NCT01190514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764630|NCT01190436|Bisoprolol|bisoprolol|mesh-list
92764631|NCT01190436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92764632|NCT01190436|Sympatholytics|sympatholytics|mesh-ancestor
92764633|NCT01190436|Autonomic Agents|autonomic agents|mesh-ancestor
92764634|NCT01190436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764635|NCT01190436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714584|NCT04660110|Piperaquine|piperaquine|mesh-list
92764636|NCT01190436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92764637|NCT01190436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92764638|NCT01190436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92764639|NCT01190436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92764640|NCT01190436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764641|NCT01190436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764642|NCT02852122|Choline|choline|mesh-list
92764643|NCT02852122|Lipotropic Agents|lipotropic agents|mesh-ancestor
92764644|NCT02852122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92764645|NCT02852122|Antimetabolites|antimetabolites|mesh-ancestor
92764646|NCT02852122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764647|NCT02852122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764648|NCT02852122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92764649|NCT02852122|Nootropic Agents|nootropic agents|mesh-ancestor
92764650|NCT01035255|Enalapril|enalapril|mesh-list
92764651|NCT01035255|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92764652|NCT01035255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92764653|NCT01035255|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764654|NCT01035255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764655|NCT01035255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764656|NCT01035255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92764657|NCT01035255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92764658|NCT00602524|Pilocarpine|pilocarpine|mesh-list
92764659|NCT00602524|Miotics|miotics|mesh-ancestor
92764660|NCT00602524|Autonomic Agents|autonomic agents|mesh-ancestor
92764661|NCT00602524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764662|NCT00602524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764663|NCT00602524|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92764664|NCT00602524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92764665|NCT00602524|Cholinergic Agents|cholinergic agents|mesh-ancestor
92764666|NCT00602524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764667|NCT00602524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764668|NCT01189890|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92764669|NCT01189890|Glimepiride|glimepiride|mesh-list
92764670|NCT01189890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764671|NCT01189890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764672|NCT01189890|Incretins|incretins|mesh-ancestor
92764673|NCT01189890|Hormones|hormones|mesh-ancestor
92764674|NCT01189890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764675|NCT01189890|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92764676|NCT01189890|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764677|NCT01189890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764678|NCT01189890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764679|NCT01189890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92764680|NCT01189890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764681|NCT01189890|Immunologic Factors|immunologic factors|mesh-ancestor
92764682|NCT01189812|Lithium Carbonate|lithium carbonate|mesh-list
92764683|NCT01189812|Citalopram|citalopram|mesh-list
92764684|NCT01189812|Antidepressive Agents|antidepressive agents|mesh-ancestor
92764685|NCT01189812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764686|NCT01189812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764687|NCT01189812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764688|NCT01189812|Antimanic Agents|antimanic agents|mesh-ancestor
92335559|NCT02116530|Doxorubicin|doxorubicin|mesh-list
92764689|NCT01189812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92764690|NCT01189812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764691|NCT01189812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764692|NCT01189812|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92764693|NCT01189812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92764694|NCT01189812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764695|NCT01189812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764696|NCT01189812|Serotonin Agents|serotonin agents|mesh-ancestor
92764697|NCT01189812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92764698|NCT01189500|Tamoxifen|tamoxifen|mesh-list
92764699|NCT01189500|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92764700|NCT01189500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92764701|NCT01189500|Hormone Antagonists|hormone antagonists|mesh-ancestor
92764702|NCT01189500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764703|NCT01189500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764704|NCT01189500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92764705|NCT01189500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764706|NCT01189500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92714668|NCT00540956|Cytarabine|cytarabine|mesh-list
92764707|NCT01189500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92764708|NCT01189500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92764709|NCT01189500|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92764710|NCT01189500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92764711|NCT01189500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764712|NCT01189500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764713|NCT01189500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764714|NCT01189500|Antidepressive Agents|antidepressive agents|mesh-ancestor
92764715|NCT01189500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764716|NCT00938860|Cyclosporine|cyclosporine|mesh-list
92764717|NCT00938860|Tacrolimus|tacrolimus|mesh-list
92764718|NCT00938860|Cyclosporins|cyclosporins|mesh-list
92764719|NCT00938860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764720|NCT00938860|Immunologic Factors|immunologic factors|mesh-ancestor
92764721|NCT00938860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764722|NCT00938860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92764723|NCT00938860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764724|NCT00938860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764725|NCT00938860|Antifungal Agents|antifungal agents|mesh-ancestor
92764726|NCT00938860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764727|NCT00938860|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764728|NCT00938860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764729|NCT00604396|Insulin|insulin|mesh-list
92764730|NCT00604396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92764731|NCT00604396|Insulin Detemir|insulin detemir|mesh-list
92764732|NCT00604396|Isophane Insulin, Human|isophane insulin, human|mesh-list
92764733|NCT00604396|Insulin, Isophane|insulin, isophane|mesh-list
92764734|NCT00604396|Isophane insulin, beef|isophane insulin, beef|mesh-list
92764735|NCT00604396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764736|NCT00604396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764737|NCT00938470|Docetaxel|docetaxel|mesh-list
92764738|NCT00938470|Fluorouracil|fluorouracil|mesh-list
92764739|NCT00938470|Capecitabine|capecitabine|mesh-list
92764740|NCT00938470|Oxaliplatin|oxaliplatin|mesh-list
92764741|NCT00938470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764742|NCT00938470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92764743|NCT00938470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92764744|NCT00938470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92764745|NCT00938470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764746|NCT00938470|Antimetabolites|antimetabolites|mesh-ancestor
92764747|NCT00938470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764748|NCT00938470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764749|NCT00938470|Immunologic Factors|immunologic factors|mesh-ancestor
92764750|NCT00938470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764751|NCT00602680|Donepezil|donepezil|mesh-list
92764752|NCT00602680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92764753|NCT00602680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764754|NCT00602680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764755|NCT00602680|Cholinergic Agents|cholinergic agents|mesh-ancestor
92764756|NCT00602680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764757|NCT00602680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764758|NCT00602680|Nootropic Agents|nootropic agents|mesh-ancestor
92764759|NCT00938392|Vaccines|vaccines|mesh-list
92764760|NCT00938392|Immunologic Factors|immunologic factors|mesh-ancestor
92764761|NCT00938392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764762|NCT02851888|Ropivacaine|ropivacaine|mesh-list
92764763|NCT02851888|Anesthetics|anesthetics|mesh-ancestor
92764764|NCT02851888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764765|NCT02851888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764766|NCT02851888|Anesthetics, Local|anesthetics, local|mesh-ancestor
92764767|NCT02851888|Sensory System Agents|sensory system agents|mesh-ancestor
92764768|NCT02851888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764769|NCT05381428|Indomethacin|indomethacin|mesh-list
92764770|NCT05381428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92764771|NCT05381428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92764772|NCT05381428|Analgesics|analgesics|mesh-ancestor
92764773|NCT05381428|Sensory System Agents|sensory system agents|mesh-ancestor
92764774|NCT05381428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764775|NCT05381428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764776|NCT05381428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764777|NCT05381428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764778|NCT05381428|Gout Suppressants|gout suppressants|mesh-ancestor
92764779|NCT05381428|Tocolytic Agents|tocolytic agents|mesh-ancestor
92764780|NCT05381428|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92764781|NCT05381428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92764782|NCT05381428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764783|NCT05381428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764784|NCT01022853|Nintedanib|nintedanib|mesh-list
92764785|NCT01022853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764786|NCT01022853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92764787|NCT01022853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764788|NCT01022853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764789|NCT00937768|Leuprolide|leuprolide|mesh-list
92764790|NCT00937768|Goserelin|goserelin|mesh-list
92764791|NCT00937768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92764792|NCT00937768|Fertility Agents|fertility agents|mesh-ancestor
92764793|NCT00937768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92764794|NCT00937768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764795|NCT00937768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92764796|NCT00937768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764797|NCT00631228|Everolimus|everolimus|mesh-list
92764798|NCT00631228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92764799|NCT00631228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92764800|NCT00631228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764801|NCT00631228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764802|NCT00631228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764803|NCT00631228|Immunologic Factors|immunologic factors|mesh-ancestor
92764804|NCT00631228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764805|NCT00631228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764806|NCT05381038|Paclitaxel|paclitaxel|mesh-list
92764807|NCT05381038|Docetaxel|docetaxel|mesh-list
92764808|NCT05381038|Irinotecan|irinotecan|mesh-list
92764809|NCT05381038|Azacitidine|azacitidine|mesh-list
92764810|NCT05381038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92764811|NCT05381038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764812|NCT05381038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92764813|NCT05381038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92764814|NCT05381038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92764815|NCT05381038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764816|NCT05381038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92764817|NCT05381038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92764818|NCT05381038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764819|NCT05381038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764820|NCT05381038|Antimetabolites|antimetabolites|mesh-ancestor
92764821|NCT05380960|Fibrin fragment D|fibrin fragment d|mesh-list
92764822|NCT05380960|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92764823|NCT05380960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92764824|NCT05380960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764826|NCT05380960|Coagulants|coagulants|mesh-ancestor
92764827|NCT00604630|Epoetin Alfa|epoetin alfa|mesh-list
92764828|NCT00604630|Hematinics|hematinics|mesh-ancestor
92764829|NCT01189266|Vorinostat|vorinostat|mesh-list
92764830|NCT01189266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764831|NCT01189266|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92764832|NCT01189266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764833|NCT01189266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764834|NCT01189032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92764835|NCT01189032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92764836|NCT01188798|Methotrexate|methotrexate|mesh-list
92764837|NCT01188798|Pentostatin|pentostatin|mesh-list
92764838|NCT01188798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92764839|NCT01188798|Abortifacient Agents|abortifacient agents|mesh-ancestor
92764840|NCT01188798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92764841|NCT01188798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764842|NCT01188798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92764843|NCT01188798|Antimetabolites|antimetabolites|mesh-ancestor
92764844|NCT01188798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764845|NCT01188798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764846|NCT01188798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764847|NCT01188798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764848|NCT01188798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92764849|NCT01188798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764850|NCT01188798|Immunologic Factors|immunologic factors|mesh-ancestor
92764851|NCT01188798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764852|NCT01188798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92764853|NCT01188798|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92764854|NCT01183104|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92764855|NCT01183104|Glimepiride|glimepiride|mesh-list
92764856|NCT01183104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764857|NCT01183104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764858|NCT01183104|Incretins|incretins|mesh-ancestor
92764860|NCT01183104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764861|NCT01183104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92764862|NCT01183104|Protease Inhibitors|protease inhibitors|mesh-ancestor
92764863|NCT01183104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764864|NCT01183104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764865|NCT01183104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92764866|NCT01183104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764867|NCT01183104|Immunologic Factors|immunologic factors|mesh-ancestor
92764868|NCT02885688|Insulin|insulin|mesh-list
92764869|NCT02885688|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764870|NCT02885688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764871|NCT00950248|Idebenone|idebenone|mesh-list
92764872|NCT00950248|Antioxidants|antioxidants|mesh-ancestor
92764873|NCT00950248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764874|NCT00950248|Protective Agents|protective agents|mesh-ancestor
92764875|NCT00950248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764876|NCT04269928|Epinephrine|epinephrine|mesh-list
92764877|NCT04269928|Racepinephrine|racepinephrine|mesh-list
92370191|NCT01084278|Colchicine|colchicine|mesh-list
92764878|NCT04269928|Epinephryl borate|epinephryl borate|mesh-list
92764879|NCT04269928|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92764880|NCT04269928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92764881|NCT04269928|Adrenergic Agents|adrenergic agents|mesh-ancestor
92764882|NCT04269928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764883|NCT04269928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764884|NCT04269928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764885|NCT04269928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92764886|NCT04269928|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92764887|NCT04269928|Autonomic Agents|autonomic agents|mesh-ancestor
92764888|NCT04269928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764889|NCT04269928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92764890|NCT04269928|Respiratory System Agents|respiratory system agents|mesh-ancestor
92764891|NCT04269928|Mydriatics|mydriatics|mesh-ancestor
92764892|NCT04269928|Sympathomimetics|sympathomimetics|mesh-ancestor
92764893|NCT04269928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92764894|NCT00950170|Factor VIII|factor viii|mesh-list
92764895|NCT00950170|Coagulants|coagulants|mesh-ancestor
92764896|NCT00604864|Infliximab|infliximab|mesh-list
92764897|NCT00604864|Antibodies|antibodies|mesh-list
92764898|NCT00604864|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92764899|NCT00604864|Immunologic Factors|immunologic factors|mesh-ancestor
92764900|NCT00604864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764901|NCT00604864|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92764902|NCT00604864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92764903|NCT00604864|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764904|NCT00604864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92764905|NCT00604864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92764906|NCT01227824|Raltegravir Potassium|raltegravir potassium|mesh-list
92764907|NCT01227824|Dolutegravir|dolutegravir|mesh-list
92764908|NCT01227824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92764909|NCT01227824|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92764910|NCT01227824|Antiviral Agents|antiviral agents|mesh-ancestor
92764911|NCT01227824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764912|NCT01227824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92764913|NCT01227824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92764914|NCT01227824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764915|NCT01227824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764916|NCT00949702|Vemurafenib|vemurafenib|mesh-list
92764917|NCT00949702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764918|NCT00949702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92764919|NCT00949702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764920|NCT00949702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764921|NCT01034631|Everolimus|everolimus|mesh-list
92764922|NCT01034631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92764923|NCT01034631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92764924|NCT01034631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764925|NCT01034631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764926|NCT01034631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92764927|NCT01034631|Immunologic Factors|immunologic factors|mesh-ancestor
92764928|NCT01034631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764929|NCT01034631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764930|NCT01227668|Aripiprazole|aripiprazole|mesh-list
92764931|NCT01227668|Antidepressive Agents|antidepressive agents|mesh-ancestor
92764932|NCT01227668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92764933|NCT01227668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92764934|NCT01227668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92764935|NCT01227668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92764936|NCT01227668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764937|NCT01227668|Dopamine Agonists|dopamine agonists|mesh-ancestor
92764938|NCT01227668|Dopamine Agents|dopamine agents|mesh-ancestor
92764939|NCT01227668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92764940|NCT01227668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764941|NCT01227668|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92764942|NCT01227668|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92764943|NCT01227668|Serotonin Agents|serotonin agents|mesh-ancestor
92764944|NCT01227668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92764945|NCT01227668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92764946|NCT01227668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92764947|NCT01227668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92764949|NCT01227512|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92764950|NCT01227512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764951|NCT01227512|Natriuretic Agents|natriuretic agents|mesh-ancestor
92764952|NCT01227512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764953|NCT01227278|Benralizumab|benralizumab|mesh-list
92764954|NCT01227278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92764955|NCT01227278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92764956|NCT01227044|Naltrexone|naltrexone|mesh-list
92764957|NCT01227044|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92764958|NCT01227044|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92764959|NCT01227044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764960|NCT01227044|Sensory System Agents|sensory system agents|mesh-ancestor
92764961|NCT01227044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92764962|NCT01034163|Panobinostat|panobinostat|mesh-list
92764963|NCT01034163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529762|NCT01140516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92764964|NCT01034163|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92764965|NCT01034163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92764966|NCT01034163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764968|NCT01162122|Immunologic Factors|immunologic factors|mesh-ancestor
92764969|NCT01162122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764970|NCT01033071|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92764971|NCT01033071|Olmesartan|olmesartan|mesh-list
92764972|NCT01033071|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92764973|NCT01033071|Chlorthalidone|chlorthalidone|mesh-list
92764974|NCT01033071|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92764975|NCT01033071|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92764976|NCT01033071|Diuretics|diuretics|mesh-ancestor
92764977|NCT01033071|Natriuretic Agents|natriuretic agents|mesh-ancestor
92764978|NCT01033071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764979|NCT01033071|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92764980|NCT01033071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92764981|NCT01033071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92764982|NCT01033071|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92764983|NCT01033071|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92764984|NCT01032915|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92764985|NCT01032915|Immunologic Factors|immunologic factors|mesh-ancestor
92764986|NCT01032915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764987|NCT04589325|Ixekizumab|ixekizumab|mesh-list
92764988|NCT04589325|Dermatologic Agents|dermatologic agents|mesh-ancestor
92764989|NCT01161498|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92764990|NCT01161498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92764991|NCT01161498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92764992|NCT02873559|Testosterone|testosterone|mesh-list
92764993|NCT02873559|Androgens|androgens|mesh-ancestor
92764994|NCT02873559|Hormones|hormones|mesh-ancestor
92764995|NCT02873559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92764996|NCT02873559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92764997|NCT01029795|Glyburide|glyburide|mesh-list
92764998|NCT01029795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92764999|NCT01029795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765000|NCT02885454|Simeprevir|simeprevir|mesh-list
92765001|NCT02885454|Odalasvir|odalasvir|mesh-list
92765002|NCT02885454|Drospirenone|drospirenone|mesh-list
92765003|NCT02885454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92765004|NCT02885454|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92335618|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
92765005|NCT02885454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92765006|NCT02885454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92765007|NCT02885454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92765008|NCT02885454|Contraceptive Agents|contraceptive agents|mesh-ancestor
92765009|NCT02885454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92765010|NCT02885454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765011|NCT02885454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92765012|NCT02885454|Estrogens|estrogens|mesh-ancestor
92765013|NCT02885454|Hormones|hormones|mesh-ancestor
92765014|NCT02885454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765015|NCT02885454|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92765016|NCT02885454|Hormone Antagonists|hormone antagonists|mesh-ancestor
92765017|NCT02885454|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92765018|NCT02885454|Diuretics|diuretics|mesh-ancestor
92765019|NCT02885454|Natriuretic Agents|natriuretic agents|mesh-ancestor
92765020|NCT02885454|Antiviral Agents|antiviral agents|mesh-ancestor
92765021|NCT02885454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765022|NCT02885454|Protease Inhibitors|protease inhibitors|mesh-ancestor
92765023|NCT02885454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765024|NCT02885454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765025|NCT01032837|Oseltamivir|oseltamivir|mesh-list
92765026|NCT01032837|Antiviral Agents|antiviral agents|mesh-ancestor
92765027|NCT01032837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765028|NCT01032837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765029|NCT01032837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765030|NCT01180296|Progesterone|progesterone|mesh-list
92765031|NCT01180296|Progestins|progestins|mesh-ancestor
92765032|NCT01180296|Hormones|hormones|mesh-ancestor
92765033|NCT01180296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765034|NCT01180296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765035|NCT01160640|Metronidazole|metronidazole|mesh-list
92765036|NCT01160640|Doxycycline|doxycycline|mesh-list
92765037|NCT01160640|Ceftriaxone|ceftriaxone|mesh-list
92765038|NCT01160640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765039|NCT01160640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92765040|NCT01160640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92765041|NCT01160640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92765042|NCT01160640|Antimalarials|antimalarials|mesh-ancestor
92765044|NCT01160484|Bortezomib|bortezomib|mesh-list
92765045|NCT01160484|Immunologic Factors|immunologic factors|mesh-ancestor
92765046|NCT01160484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765047|NCT01160484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92765048|NCT01160484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92765049|NCT01160484|Growth Substances|growth substances|mesh-ancestor
92765050|NCT01160484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92765051|NCT01160484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765052|NCT01032291|Lenalidomide|lenalidomide|mesh-list
92765053|NCT01032291|Cetuximab|cetuximab|mesh-list
92765054|NCT01032291|Immunologic Factors|immunologic factors|mesh-ancestor
92765055|NCT01032291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765056|NCT01032291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92765057|NCT01032291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92765058|NCT01032291|Growth Substances|growth substances|mesh-ancestor
92765059|NCT01032291|Growth Inhibitors|growth inhibitors|mesh-ancestor
92765060|NCT01032291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765061|NCT01032291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92765062|NCT01159938|Insulin Lispro|insulin lispro|mesh-list
92765063|NCT01159938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765064|NCT01159938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765065|NCT02873871|Hemostatics|hemostatics|mesh-list
92765066|NCT02873871|Coagulants|coagulants|mesh-ancestor
92765067|NCT04301739|Paclitaxel|paclitaxel|mesh-list
92765068|NCT04301739|Cyclophosphamide|cyclophosphamide|mesh-list
92765069|NCT04301739|Carboplatin|carboplatin|mesh-list
92765070|NCT04301739|Doxorubicin|doxorubicin|mesh-list
92765071|NCT04301739|Epirubicin|epirubicin|mesh-list
92765072|NCT04301739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92765073|NCT04301739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765074|NCT04301739|Tubulin Modulators|tubulin modulators|mesh-ancestor
92765075|NCT04301739|Antimitotic Agents|antimitotic agents|mesh-ancestor
92765076|NCT04301739|Mitosis Modulators|mitosis modulators|mesh-ancestor
92765077|NCT04301739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765078|NCT04301739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765079|NCT04301739|Immunologic Factors|immunologic factors|mesh-ancestor
92765080|NCT04301739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765081|NCT04301739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765082|NCT04301739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92715039|NCT00543842|Bevacizumab|bevacizumab|mesh-list
92765083|NCT04301739|Alkylating Agents|alkylating agents|mesh-ancestor
92765084|NCT04301739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92765085|NCT04301739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92765086|NCT04301739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92765087|NCT04301739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92765088|NCT04301739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765089|NCT04301583|Proanthocyanidin|proanthocyanidin|mesh-list
92765090|NCT04301583|Procyanidin|procyanidin|mesh-list
92765091|NCT04301583|Antioxidants|antioxidants|mesh-ancestor
92765092|NCT04301583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765093|NCT04301583|Protective Agents|protective agents|mesh-ancestor
92765094|NCT04301583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765095|NCT04301583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92765096|NCT04301583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92765097|NCT04301583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765098|NCT01021683|Itraconazole|itraconazole|mesh-list
92765099|NCT01021683|Antifungal Agents|antifungal agents|mesh-ancestor
92765100|NCT01021683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765101|NCT01021683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92765102|NCT01021683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92765103|NCT01021683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765104|NCT01021683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765105|NCT01021683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92765106|NCT01021683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92765107|NCT01021683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765108|NCT01021683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765109|NCT01021683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92765110|NCT04625725|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92765111|NCT04625725|Antiviral Agents|antiviral agents|mesh-ancestor
92765112|NCT04625725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765113|NCT01021215|Celecoxib|celecoxib|mesh-list
92765114|NCT01021215|Zileuton|zileuton|mesh-list
92765115|NCT01021215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765116|NCT01021215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765117|NCT01021215|Analgesics|analgesics|mesh-ancestor
92765118|NCT01021215|Sensory System Agents|sensory system agents|mesh-ancestor
92765119|NCT01021215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765120|NCT01021215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765121|NCT01021215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765122|NCT01021215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765123|NCT01021215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92765124|NCT01021215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92765125|NCT01021215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765126|NCT01021215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765127|NCT01021215|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92765128|NCT01021215|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92765129|NCT01021215|Hormone Antagonists|hormone antagonists|mesh-ancestor
92765130|NCT01021215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765131|NCT02760979|Denosumab|denosumab|mesh-list
92765132|NCT02760979|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92765133|NCT02760979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765134|NCT02873325|Antiviral Agents|antiviral agents|mesh-list
92765135|NCT02873325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765136|NCT02760901|Acetylcysteine|acetylcysteine|mesh-list
92765137|NCT02760901|Mannitol|mannitol|mesh-list
92765138|NCT02760901|Acetazolamide|acetazolamide|mesh-list
92765139|NCT02760901|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92765140|NCT02760901|Antiviral Agents|antiviral agents|mesh-ancestor
92765141|NCT02760901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765142|NCT02760901|Expectorants|expectorants|mesh-ancestor
92765143|NCT02760901|Respiratory System Agents|respiratory system agents|mesh-ancestor
92765144|NCT02760901|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92765145|NCT02760901|Antioxidants|antioxidants|mesh-ancestor
92765146|NCT02760901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765147|NCT02760901|Protective Agents|protective agents|mesh-ancestor
92765148|NCT02760901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765149|NCT02760901|Antidotes|antidotes|mesh-ancestor
92765150|NCT02760901|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92765151|NCT02760901|Diuretics|diuretics|mesh-ancestor
92765152|NCT02760901|Natriuretic Agents|natriuretic agents|mesh-ancestor
92765153|NCT02760901|Anticonvulsants|anticonvulsants|mesh-ancestor
92765154|NCT02760901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92765155|NCT02760901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765156|NCT00635713|Fulvestrant|fulvestrant|mesh-list
92765157|NCT00635713|Anastrozole|anastrozole|mesh-list
92765158|NCT00635713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92765159|NCT00635713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715105|NCT00544193|Gemcitabine|gemcitabine|mesh-list
92765160|NCT00635713|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92765161|NCT00635713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92765162|NCT00635713|Hormone Antagonists|hormone antagonists|mesh-ancestor
92765163|NCT00635713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765164|NCT00635713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765165|NCT00635713|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92765166|NCT00635713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92765167|NCT00635713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765168|NCT00635713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765169|NCT02760823|Thioctic Acid|thioctic acid|mesh-list
92765170|NCT02760823|Antioxidants|antioxidants|mesh-ancestor
92765171|NCT02760823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765172|NCT02760823|Protective Agents|protective agents|mesh-ancestor
92765173|NCT02760823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765174|NCT02760823|Vitamin B Complex|vitamin b complex|mesh-ancestor
92765175|NCT02760823|Vitamins|vitamins|mesh-ancestor
92765176|NCT02760823|Micronutrients|micronutrients|mesh-ancestor
92765177|NCT01020747|Bevacizumab|bevacizumab|mesh-list
92335674|NCT02084238|Interleukin-2|interleukin-2|mesh-list
92765178|NCT01020747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92765179|NCT01020747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765180|NCT01020747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92765181|NCT01020747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92765182|NCT01020747|Growth Substances|growth substances|mesh-ancestor
92765183|NCT01020747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765184|NCT01020747|Growth Inhibitors|growth inhibitors|mesh-ancestor
92765185|NCT02754739|Pravastatin|pravastatin|mesh-list
92765186|NCT02754739|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92765187|NCT02754739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92765188|NCT02754739|Antimetabolites|antimetabolites|mesh-ancestor
92765189|NCT02754739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765190|NCT02754739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92765191|NCT02754739|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92765192|NCT02754739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765193|NCT02754583|Azithromycin|azithromycin|mesh-list
92765194|NCT02754583|Tetracycline|tetracycline|mesh-list
92765195|NCT02754583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92765196|NCT02754583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765197|NCT02754583|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92765198|NCT02754583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765199|NCT02754583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765200|NCT01031979|Yohimbine|yohimbine|mesh-list
92765201|NCT01031979|Mydriatics|mydriatics|mesh-ancestor
92765202|NCT01031979|Autonomic Agents|autonomic agents|mesh-ancestor
92765203|NCT01031979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765204|NCT01031979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765205|NCT01031979|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92765206|NCT01031979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92765207|NCT01031979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92765208|NCT01031979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92765209|NCT01031979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765210|NCT01031979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765211|NCT01031979|Urological Agents|urological agents|mesh-ancestor
92765212|NCT04624633|Acalabrutinib|acalabrutinib|mesh-list
92765213|NCT04624633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765214|NCT02753803|Pioglitazone|pioglitazone|mesh-list
92765215|NCT02753803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765216|NCT02753803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765217|NCT04219579|Antithrombins|antithrombins|mesh-list
92765218|NCT04219579|Antithrombin III|antithrombin iii|mesh-list
92765219|NCT04219579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92765220|NCT04219579|Protease Inhibitors|protease inhibitors|mesh-ancestor
92765221|NCT04219579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765222|NCT04219579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765223|NCT04219579|Anticoagulants|anticoagulants|mesh-ancestor
92765224|NCT00635401|Varenicline|varenicline|mesh-list
92765225|NCT00635401|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92765226|NCT00635401|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92765227|NCT00635401|Cholinergic Agents|cholinergic agents|mesh-ancestor
92765228|NCT00635401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765229|NCT00635401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765230|NCT00635401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765231|NCT02753725|Fentanyl|fentanyl|mesh-list
92715181|NCT00544505|Cyclophosphamide|cyclophosphamide|mesh-list
92765232|NCT02753725|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92765233|NCT02753725|Narcotics|narcotics|mesh-ancestor
92765234|NCT02753725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765235|NCT02753725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765236|NCT02753725|Analgesics|analgesics|mesh-ancestor
92765237|NCT02753725|Sensory System Agents|sensory system agents|mesh-ancestor
92765238|NCT02753725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765239|NCT02753725|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92765240|NCT02753725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92765241|NCT02753725|Anesthetics, General|anesthetics, general|mesh-ancestor
92765242|NCT02753725|Anesthetics|anesthetics|mesh-ancestor
92765243|NCT01020123|Glipizide|glipizide|mesh-list
92765244|NCT01020123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765245|NCT01020123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765246|NCT04300959|Cisplatin|cisplatin|mesh-list
92765247|NCT04300959|Gemcitabine|gemcitabine|mesh-list
92765248|NCT04300959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765249|NCT04300959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92765250|NCT04300959|Antimetabolites|antimetabolites|mesh-ancestor
92765251|NCT04300959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765252|NCT02760355|Ribavirin|ribavirin|mesh-list
92765253|NCT02760355|Sofosbuvir|sofosbuvir|mesh-list
92765254|NCT02760355|Ledipasvir|ledipasvir|mesh-list
92765255|NCT02760355|Antimetabolites|antimetabolites|mesh-ancestor
92765256|NCT02760355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765257|NCT02760355|Antiviral Agents|antiviral agents|mesh-ancestor
92765258|NCT02760355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765259|NCT01028391|Metformin|metformin|mesh-list
92765260|NCT01028391|Pioglitazone|pioglitazone|mesh-list
92765261|NCT01028391|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92765262|NCT01028391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765263|NCT01028391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765264|NCT01028391|Incretins|incretins|mesh-ancestor
92765265|NCT01028391|Hormones|hormones|mesh-ancestor
92765266|NCT01028391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765267|NCT01028391|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92765268|NCT01028391|Protease Inhibitors|protease inhibitors|mesh-ancestor
92765269|NCT01028391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765270|NCT01028391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765271|NCT01179672|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92765272|NCT01179672|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92765273|NCT01179672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92765274|NCT01179672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92765275|NCT01179672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765276|NCT01179672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765277|NCT01179672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765278|NCT01179672|Analgesics|analgesics|mesh-ancestor
92765279|NCT01179672|Sensory System Agents|sensory system agents|mesh-ancestor
92765280|NCT01179672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765281|NCT01179672|Antidepressive Agents|antidepressive agents|mesh-ancestor
92765282|NCT01179672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92765283|NCT01179672|Dopamine Agents|dopamine agents|mesh-ancestor
92765284|NCT04301349|Misoprostol|misoprostol|mesh-list
92765285|NCT04301349|Dinoprostone|dinoprostone|mesh-list
92765286|NCT04301349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92765287|NCT04301349|Abortifacient Agents|abortifacient agents|mesh-ancestor
92765288|NCT04301349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92765289|NCT04301349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765290|NCT04301349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92765291|NCT04301349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765292|NCT04301349|Oxytocics|oxytocics|mesh-ancestor
92765293|NCT02753647|Prednisone|prednisone|mesh-list
92765294|NCT02753647|Cyclophosphamide|cyclophosphamide|mesh-list
92765295|NCT02753647|Rituximab|rituximab|mesh-list
92765296|NCT02753647|Doxorubicin|doxorubicin|mesh-list
92765297|NCT02753647|Vincristine|vincristine|mesh-list
92765298|NCT02753647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765299|NCT02753647|Immunologic Factors|immunologic factors|mesh-ancestor
92765300|NCT02753647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765301|NCT02753647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765302|NCT02753647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92765303|NCT02753647|Alkylating Agents|alkylating agents|mesh-ancestor
92765304|NCT02753647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765305|NCT02753647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765306|NCT02753647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92765307|NCT02753647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92765308|NCT02753647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92765309|NCT02753647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92765310|NCT02753647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92765312|NCT02753647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765313|NCT02753647|Glucocorticoids|glucocorticoids|mesh-ancestor
92765314|NCT02753647|Hormones|hormones|mesh-ancestor
92765315|NCT02753647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765316|NCT02753647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92765317|NCT02753647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92765318|NCT02753647|Tubulin Modulators|tubulin modulators|mesh-ancestor
92765319|NCT02753647|Antimitotic Agents|antimitotic agents|mesh-ancestor
92765320|NCT02753647|Mitosis Modulators|mitosis modulators|mesh-ancestor
92765321|NCT02872389|Sevoflurane|sevoflurane|mesh-list
92765322|NCT02872389|Desflurane|desflurane|mesh-list
92765323|NCT02872389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92765324|NCT02872389|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92765325|NCT02872389|Anesthetics, General|anesthetics, general|mesh-ancestor
92765326|NCT02872389|Anesthetics|anesthetics|mesh-ancestor
92765327|NCT02872389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765328|NCT02872389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765329|NCT01179516|Vortioxetine|vortioxetine|mesh-list
92765330|NCT01179516|Antidepressive Agents|antidepressive agents|mesh-ancestor
92765331|NCT01179516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92765332|NCT01179516|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92765333|NCT01179516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92765334|NCT01179516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765335|NCT01179516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765336|NCT01179516|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92765337|NCT01179516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92765338|NCT01179516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92765339|NCT01179516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765340|NCT01179516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765341|NCT01179516|Serotonin Agents|serotonin agents|mesh-ancestor
92765342|NCT01179516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92765343|NCT01179516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92765344|NCT01179516|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92765345|NCT01179516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92765346|NCT00635791|Sorafenib|sorafenib|mesh-list
92765347|NCT00635791|Vorinostat|vorinostat|mesh-list
92765348|NCT00635791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765349|NCT00635791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765350|NCT00635791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765351|NCT00635791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765352|NCT00635791|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92765353|NCT02760121|Acetazolamide|acetazolamide|mesh-list
92765354|NCT02760121|Methazolamide|methazolamide|mesh-list
92765355|NCT02760121|Anticonvulsants|anticonvulsants|mesh-ancestor
92765356|NCT02760121|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92765357|NCT02760121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765358|NCT02760121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765359|NCT02760121|Diuretics|diuretics|mesh-ancestor
92765360|NCT02760121|Natriuretic Agents|natriuretic agents|mesh-ancestor
92765361|NCT02760121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765362|NCT05215873|Misoprostol|misoprostol|mesh-list
92765363|NCT05215873|Oxytocin|oxytocin|mesh-list
92765364|NCT05215873|Oxytocics|oxytocics|mesh-ancestor
92765365|NCT05215873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92765366|NCT05215873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765367|NCT05215873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92765368|NCT05215873|Abortifacient Agents|abortifacient agents|mesh-ancestor
92765369|NCT05215873|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92765370|NCT05215873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765371|NCT02759887|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92765372|NCT02759887|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92765373|NCT02759887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765374|NCT02750917|Etoricoxib|etoricoxib|mesh-list
92765375|NCT02750917|Lornoxicam|lornoxicam|mesh-list
92765376|NCT02750917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765377|NCT02750917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765378|NCT02750917|Analgesics|analgesics|mesh-ancestor
92765379|NCT02750917|Sensory System Agents|sensory system agents|mesh-ancestor
92765380|NCT02750917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765381|NCT02750917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765382|NCT02750917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765383|NCT02750917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765384|NCT02750917|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92765385|NCT02750917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92765386|NCT02750917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765387|NCT02750917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765389|NCT02750995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92765390|NCT02750995|Antimetabolites|antimetabolites|mesh-ancestor
92765391|NCT02750995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765392|NCT02750995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765393|NCT02750995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765394|NCT01027845|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92765395|NCT01027845|Immunologic Factors|immunologic factors|mesh-ancestor
92765396|NCT01027845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765397|NCT04221919|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92765398|NCT04221919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92765399|NCT04221919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92765400|NCT04221919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765401|NCT04221919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765402|NCT04221919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765403|NCT04299633|Calcium|calcium|mesh-list
92765404|NCT04299633|Sevelamer|sevelamer|mesh-list
92765405|NCT04299633|Calcium acetate|calcium acetate|mesh-list
92529772|NCT02734771|Prednisone|prednisone|mesh-list
92765406|NCT04299633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92765407|NCT04299633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765408|NCT04299633|Chelating Agents|chelating agents|mesh-ancestor
92765409|NCT04299633|Sequestering Agents|sequestering agents|mesh-ancestor
92765410|NCT04299633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765411|NCT02695459|Everolimus|everolimus|mesh-list
92765412|NCT02695459|Cisplatin|cisplatin|mesh-list
92765413|NCT02695459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92765414|NCT02695459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765415|NCT02695459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765416|NCT02695459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765417|NCT02695459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765418|NCT02695459|Immunologic Factors|immunologic factors|mesh-ancestor
92765419|NCT02695459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765420|NCT02695459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765421|NCT04288713|Eculizumab|eculizumab|mesh-list
92765422|NCT04288713|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92765423|NCT04288713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765424|NCT04288713|Immunologic Factors|immunologic factors|mesh-ancestor
92765425|NCT04288713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765426|NCT05112991|Lenvatinib|lenvatinib|mesh-list
92765427|NCT05112991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765428|NCT05112991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765429|NCT05112991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335704|NCT02083926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765430|NCT05112991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765431|NCT01030341|Insulin|insulin|mesh-list
92765432|NCT01030341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92765433|NCT01030341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765434|NCT01030341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765435|NCT02750293|Cholecalciferol|cholecalciferol|mesh-list
92765436|NCT02750293|Vitamin D|vitamin d|mesh-list
92765437|NCT02750293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92765438|NCT02750293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765439|NCT02750293|Vitamins|vitamins|mesh-ancestor
92765440|NCT02750293|Micronutrients|micronutrients|mesh-ancestor
92765441|NCT02750293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92765442|NCT04217785|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92765443|NCT04217785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92765444|NCT01026831|Timolol|timolol|mesh-list
92765445|NCT01026831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92765446|NCT01026831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92765447|NCT01026831|Adrenergic Agents|adrenergic agents|mesh-ancestor
92765448|NCT01026831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765449|NCT01026831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765450|NCT01026831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765451|NCT01026831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92765452|NCT01026831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92765453|NCT02750137|Tetracaine|tetracaine|mesh-list
92765454|NCT02750137|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765455|NCT02750137|Anesthetics|anesthetics|mesh-ancestor
92765456|NCT02750137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765457|NCT02750137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765458|NCT02750137|Sensory System Agents|sensory system agents|mesh-ancestor
92765459|NCT02750137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765460|NCT02760043|Dexamethasone|dexamethasone|mesh-list
92765461|NCT02760043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765462|NCT02760043|Antiemetics|antiemetics|mesh-ancestor
92765463|NCT02760043|Autonomic Agents|autonomic agents|mesh-ancestor
92765464|NCT02760043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765465|NCT02760043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765466|NCT02760043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765467|NCT02760043|Glucocorticoids|glucocorticoids|mesh-ancestor
92765468|NCT02760043|Hormones|hormones|mesh-ancestor
92765469|NCT02760043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765470|NCT02760043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92765471|NCT02760043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765472|NCT02750059|Tenofovir|tenofovir|mesh-list
92765473|NCT02750059|Lamivudine|lamivudine|mesh-list
92765474|NCT02750059|Efavirenz|efavirenz|mesh-list
92765475|NCT02750059|Telmisartan|telmisartan|mesh-list
92765476|NCT02750059|Antiviral Agents|antiviral agents|mesh-ancestor
92765477|NCT02750059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765478|NCT02750059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92765479|NCT02750059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92765480|NCT02750059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765481|NCT02750059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765483|NCT02750059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92765484|NCT02750059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92765485|NCT02750059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92765486|NCT02750059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92765487|NCT02750059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92765488|NCT02750059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92765489|NCT02750059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92765490|NCT02750059|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92765491|NCT02750059|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92765492|NCT02750059|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92765493|NCT02749825|Goserelin|goserelin|mesh-list
92765494|NCT02749825|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92765495|NCT02749825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92765496|NCT02749825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765497|NCT02749825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92765498|NCT02749825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765499|NCT02749825|Luteolytic Agents|luteolytic agents|mesh-ancestor
92765500|NCT02749825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92765501|NCT02749825|Contraceptive Agents|contraceptive agents|mesh-ancestor
92765502|NCT02749825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92765503|NCT02759107|Dulaglutide|dulaglutide|mesh-list
92765504|NCT02759107|Tirzepatide|tirzepatide|mesh-list
92765505|NCT02759107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765506|NCT02759107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765507|NCT02759107|Incretins|incretins|mesh-ancestor
92765508|NCT02759107|Hormones|hormones|mesh-ancestor
92765509|NCT02759107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765510|NCT02758873|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92765511|NCT02758873|Montelukast|montelukast|mesh-list
92765512|NCT02758873|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92765513|NCT02758873|Autonomic Agents|autonomic agents|mesh-ancestor
92765514|NCT02758873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765515|NCT02758873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765516|NCT02758873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92765517|NCT02758873|Respiratory System Agents|respiratory system agents|mesh-ancestor
92765518|NCT02758873|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92765519|NCT02758873|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92765520|NCT02758873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92765521|NCT02758873|Adrenergic Agents|adrenergic agents|mesh-ancestor
92765522|NCT02758873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765523|NCT02758873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765524|NCT02758873|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92765525|NCT02758873|Hormone Antagonists|hormone antagonists|mesh-ancestor
92765526|NCT02758873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765527|NCT02758873|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92765528|NCT02758873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92765529|NCT02749747|Sulpiride|sulpiride|mesh-list
92765530|NCT02749747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92765531|NCT02749747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92765532|NCT02749747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765533|NCT02749747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765534|NCT02749747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92765535|NCT02749747|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92765536|NCT02749747|Dopamine Agents|dopamine agents|mesh-ancestor
92765537|NCT02749747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765538|NCT02749747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765539|NCT02749747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92765540|NCT02749747|Antidepressive Agents|antidepressive agents|mesh-ancestor
92765541|NCT02749591|Botulinum Toxins|botulinum toxins|mesh-list
92765542|NCT02749591|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92765543|NCT02749591|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92765544|NCT02749591|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92765545|NCT02749591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92765546|NCT02749591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765547|NCT02749591|Cholinergic Agents|cholinergic agents|mesh-ancestor
92765548|NCT02749591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765549|NCT02749591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765550|NCT02749591|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92529774|NCT02734771|Rituximab|rituximab|mesh-list
92765551|NCT02749591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765552|NCT04359979|Tamsulosin|tamsulosin|mesh-list
92765553|NCT04359979|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92765554|NCT04359979|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92765555|NCT04359979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92765556|NCT04359979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92765557|NCT04359979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765558|NCT04359979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765559|NCT04359979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765560|NCT04359979|Urological Agents|urological agents|mesh-ancestor
92765561|NCT04180813|Linagliptin|linagliptin|mesh-list
92765562|NCT04180813|Acarbose|acarbose|mesh-list
92765563|NCT04180813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765564|NCT04180813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765565|NCT04180813|Incretins|incretins|mesh-ancestor
92765566|NCT04180813|Hormones|hormones|mesh-ancestor
92765567|NCT04180813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765568|NCT04180813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92765569|NCT04180813|Protease Inhibitors|protease inhibitors|mesh-ancestor
92765570|NCT04180813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765571|NCT04180813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765572|NCT04180813|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92765573|NCT04116775|Pembrolizumab|pembrolizumab|mesh-list
92765574|NCT04116775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92765575|NCT04116775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765576|NCT04116775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92765577|NCT04116775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765578|NCT03913741|Tisotumab vedotin|tisotumab vedotin|mesh-list
92765579|NCT03913741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92765580|NCT03913741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765581|NCT02749123|Lidocaine|lidocaine|mesh-list
92765582|NCT02749123|Menthol|menthol|mesh-list
92765583|NCT02749123|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765584|NCT02749123|Anesthetics|anesthetics|mesh-ancestor
92765585|NCT02749123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765586|NCT02749123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765587|NCT02749123|Sensory System Agents|sensory system agents|mesh-ancestor
92765588|NCT02749123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765589|NCT02749123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92765590|NCT02749123|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92765591|NCT02749123|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92765592|NCT02749123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92765593|NCT02749123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765594|NCT02749123|Antipruritics|antipruritics|mesh-ancestor
92765595|NCT02749123|Dermatologic Agents|dermatologic agents|mesh-ancestor
92765596|NCT00635557|Carboplatin|carboplatin|mesh-list
92765597|NCT00635557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765598|NCT02748265|Epoprostenol|epoprostenol|mesh-list
92765599|NCT02748265|Phenylephrine|phenylephrine|mesh-list
92765600|NCT02748265|Oxymetazoline|oxymetazoline|mesh-list
92765601|NCT02748265|Tezosentan|tezosentan|mesh-list
92765602|NCT02748265|Propofol|propofol|mesh-list
92765603|NCT02748265|Sevoflurane|sevoflurane|mesh-list
92765604|NCT02748265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92765605|NCT02748265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765606|NCT02748265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765607|NCT02748265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92765608|NCT02748265|Anesthetics, General|anesthetics, general|mesh-ancestor
92765609|NCT02748265|Anesthetics|anesthetics|mesh-ancestor
92765610|NCT02748265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92765611|NCT02748265|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92765612|NCT02748265|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92765613|NCT02748265|Mydriatics|mydriatics|mesh-ancestor
92765614|NCT02748265|Autonomic Agents|autonomic agents|mesh-ancestor
92765615|NCT02748265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765616|NCT02748265|Sympathomimetics|sympathomimetics|mesh-ancestor
92765617|NCT02748265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92765618|NCT02748265|Nasal Decongestants|nasal decongestants|mesh-ancestor
92765619|NCT02748265|Respiratory System Agents|respiratory system agents|mesh-ancestor
92765620|NCT02748265|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92765621|NCT02748265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92765622|NCT02748265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92765623|NCT02748265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92765624|NCT02748265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765625|NCT02748265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765626|NCT02748265|Protective Agents|protective agents|mesh-ancestor
92765627|NCT02748265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92765628|NCT02748265|Vasodilator Agents|vasodilator agents|mesh-ancestor
92765629|NCT01015833|Doxorubicin|doxorubicin|mesh-list
92765630|NCT01015833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92765631|NCT01015833|Sorafenib|sorafenib|mesh-list
92765632|NCT01015833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92765633|NCT01015833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765634|NCT01015833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92765635|NCT01015833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92765636|NCT01015833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765637|NCT01015833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765638|NCT01015833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765639|NCT03523273|Liraglutide|liraglutide|mesh-list
92765640|NCT03523273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765641|NCT03523273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765642|NCT03523273|Incretins|incretins|mesh-ancestor
92765643|NCT03523273|Hormones|hormones|mesh-ancestor
92765644|NCT03523273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765645|NCT02695381|Etodolac|etodolac|mesh-list
92765646|NCT02695381|Lidocaine|lidocaine|mesh-list
92765647|NCT02695381|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765648|NCT02695381|Anesthetics|anesthetics|mesh-ancestor
92765649|NCT02695381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765650|NCT02695381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765651|NCT02695381|Sensory System Agents|sensory system agents|mesh-ancestor
92765652|NCT02695381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765653|NCT02695381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92765654|NCT02695381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92765655|NCT02695381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92765656|NCT02695381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92765657|NCT02695381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765658|NCT02695381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765659|NCT02695381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765660|NCT02695381|Analgesics|analgesics|mesh-ancestor
92765661|NCT02695381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765662|NCT02695381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765663|NCT02695381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92765664|NCT02695381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92765665|NCT02695381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765666|NCT02746783|Vaccines|vaccines|mesh-list
92765667|NCT02746783|Immunologic Factors|immunologic factors|mesh-ancestor
92765668|NCT02746783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765669|NCT02747953|Afatinib|afatinib|mesh-list
92765670|NCT02747953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765671|NCT02747953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765672|NCT02747953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765673|NCT02747953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765674|NCT02735239|Leucovorin|leucovorin|mesh-list
92765675|NCT02735239|Paclitaxel|paclitaxel|mesh-list
92765676|NCT02735239|Docetaxel|docetaxel|mesh-list
92765677|NCT02735239|Carboplatin|carboplatin|mesh-list
92765678|NCT02735239|Fluorouracil|fluorouracil|mesh-list
92765679|NCT02735239|Capecitabine|capecitabine|mesh-list
92765680|NCT02735239|Oxaliplatin|oxaliplatin|mesh-list
92765681|NCT02735239|Durvalumab|durvalumab|mesh-list
92715626|NCT04823156|Calcium|calcium|mesh-list
92765682|NCT02735239|Tremelimumab|tremelimumab|mesh-list
92765683|NCT02735239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92765684|NCT02735239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765685|NCT02735239|Tubulin Modulators|tubulin modulators|mesh-ancestor
92765686|NCT02735239|Antimitotic Agents|antimitotic agents|mesh-ancestor
92765687|NCT02735239|Mitosis Modulators|mitosis modulators|mesh-ancestor
92765688|NCT02735239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765689|NCT02735239|Antimetabolites|antimetabolites|mesh-ancestor
92765690|NCT02735239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92765691|NCT02735239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765692|NCT02735239|Immunologic Factors|immunologic factors|mesh-ancestor
92335793|NCT02106390|Vaccines|vaccines|mesh-list
92765693|NCT02735239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765694|NCT02735239|Antidotes|antidotes|mesh-ancestor
92765695|NCT02735239|Protective Agents|protective agents|mesh-ancestor
92765696|NCT02735239|Vitamin B Complex|vitamin b complex|mesh-ancestor
92765698|NCT02735239|Micronutrients|micronutrients|mesh-ancestor
92765699|NCT02735239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92765700|NCT02655523|Dexamethasone|dexamethasone|mesh-list
92765701|NCT02655523|Triamcinolone|triamcinolone|mesh-list
92765702|NCT02655523|Bupivacaine|bupivacaine|mesh-list
92765703|NCT02655523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765704|NCT02655523|Antiemetics|antiemetics|mesh-ancestor
92765705|NCT02655523|Autonomic Agents|autonomic agents|mesh-ancestor
92765706|NCT02655523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765707|NCT02655523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765708|NCT02655523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765709|NCT02655523|Glucocorticoids|glucocorticoids|mesh-ancestor
92765710|NCT02655523|Hormones|hormones|mesh-ancestor
92765711|NCT02655523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765712|NCT02655523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92765713|NCT02655523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765714|NCT02655523|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765715|NCT02655523|Anesthetics|anesthetics|mesh-ancestor
92765716|NCT02655523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765717|NCT02655523|Sensory System Agents|sensory system agents|mesh-ancestor
92765718|NCT02644291|Mebendazole|mebendazole|mesh-list
92765719|NCT02644291|Piperazine|piperazine|mesh-list
92765720|NCT02644291|Piperazine citrate|piperazine citrate|mesh-list
92765721|NCT02644291|DMP 777|dmp 777|mesh-list
92765722|NCT02644291|Antinematodal Agents|antinematodal agents|mesh-ancestor
92765723|NCT02644291|Anthelmintics|anthelmintics|mesh-ancestor
92765724|NCT02644291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92765725|NCT02644291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765726|NCT02644291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92765727|NCT02644291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92765728|NCT02644291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92765729|NCT02644291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765730|NCT02644291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765731|NCT02644291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765732|NCT01015677|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92765733|NCT01015677|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92765734|NCT01015677|Estradiol|estradiol|mesh-list
92765735|NCT01015677|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92765736|NCT01015677|Estrogens|estrogens|mesh-ancestor
92765737|NCT01015677|Hormones|hormones|mesh-ancestor
92765738|NCT01015677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765739|NCT01015677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765740|NCT01015677|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92765741|NCT01015677|Contraceptive Agents|contraceptive agents|mesh-ancestor
92765742|NCT01015677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92765743|NCT01015677|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92765744|NCT02281981|Curcumin|curcumin|mesh-list
92765745|NCT02281981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765746|NCT02281981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765747|NCT02281981|Analgesics|analgesics|mesh-ancestor
92765748|NCT02281981|Sensory System Agents|sensory system agents|mesh-ancestor
92335838|NCT02079246|Serotonin Agents|serotonin agents|mesh-ancestor
92765749|NCT02281981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765750|NCT02281981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765751|NCT02281981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765752|NCT02281981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765753|NCT02281981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765754|NCT02281981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765755|NCT02281981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765756|NCT04297839|Heparin|heparin|mesh-list
92765757|NCT04297839|Calcium heparin|calcium heparin|mesh-list
92765758|NCT04297839|Citric Acid|citric acid|mesh-list
92765759|NCT04297839|Sodium Citrate|sodium citrate|mesh-list
92765760|NCT04297839|Anticoagulants|anticoagulants|mesh-ancestor
92765761|NCT04297839|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92765762|NCT04297839|Chelating Agents|chelating agents|mesh-ancestor
92765763|NCT04297839|Sequestering Agents|sequestering agents|mesh-ancestor
92765764|NCT04297839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765765|NCT04297839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92765766|NCT04297839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92765767|NCT02751151|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92765768|NCT02751151|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92765769|NCT02751151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92765770|NCT04216459|Cholecalciferol|cholecalciferol|mesh-list
92765771|NCT04216459|Vitamin D|vitamin d|mesh-list
92765772|NCT04216459|Thiamine|thiamine|mesh-list
92765773|NCT04216459|Vitamins|vitamins|mesh-ancestor
92765774|NCT04216459|Micronutrients|micronutrients|mesh-ancestor
92529780|NCT02734771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765775|NCT04216459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765776|NCT04216459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92765777|NCT04216459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92765778|NCT04216459|Vitamin B Complex|vitamin b complex|mesh-ancestor
92765779|NCT04216771|Cytarabine|cytarabine|mesh-list
92765780|NCT04216771|Idarubicin|idarubicin|mesh-list
92765781|NCT04216771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92765782|NCT04216771|Antimetabolites|antimetabolites|mesh-ancestor
92765783|NCT04216771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765784|NCT04216771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765785|NCT04216771|Antiviral Agents|antiviral agents|mesh-ancestor
92765786|NCT04216771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765787|NCT04216771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765788|NCT04216771|Immunologic Factors|immunologic factors|mesh-ancestor
92765789|NCT04216771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765790|NCT04216771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92765791|NCT04216771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92765792|NCT04216771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92765793|NCT04216771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765794|NCT00636259|Bicalutamide|bicalutamide|mesh-list
92765795|NCT00636259|Androgen Antagonists|androgen antagonists|mesh-ancestor
92765796|NCT00636259|Hormone Antagonists|hormone antagonists|mesh-ancestor
92765797|NCT00636259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765798|NCT00636259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765799|NCT00636259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765800|NCT02736019|Celecoxib|celecoxib|mesh-list
92765801|NCT02736019|Tramadol|tramadol|mesh-list
92765802|NCT02736019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765803|NCT02736019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765804|NCT02736019|Analgesics|analgesics|mesh-ancestor
92765805|NCT02736019|Sensory System Agents|sensory system agents|mesh-ancestor
92765806|NCT02736019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765807|NCT02736019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765808|NCT02736019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765809|NCT02736019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765810|NCT02736019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92765811|NCT02736019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92765812|NCT02736019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765813|NCT02736019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765814|NCT02736019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92765815|NCT02736019|Narcotics|narcotics|mesh-ancestor
92765816|NCT02736019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765817|NCT04284397|Aspirin|aspirin|mesh-list
92765818|NCT04284397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765819|NCT04284397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765820|NCT04284397|Analgesics|analgesics|mesh-ancestor
92765821|NCT04284397|Sensory System Agents|sensory system agents|mesh-ancestor
92765822|NCT04284397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765823|NCT04284397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765824|NCT04284397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765825|NCT04284397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765826|NCT04284397|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92765827|NCT04284397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92765828|NCT04284397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765829|NCT04284397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92765830|NCT04284397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92765831|NCT04284397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765832|NCT04284397|Antipyretics|antipyretics|mesh-ancestor
92765833|NCT05595889|Irinotecan|irinotecan|mesh-list
92765834|NCT05595889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92765835|NCT05595889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92765836|NCT05595889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765837|NCT05595889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765838|NCT05595889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765839|NCT02735395|Amoxicillin|amoxicillin|mesh-list
92765840|NCT02735395|Metronidazole|metronidazole|mesh-list
92765841|NCT02735395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92765842|NCT02735395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765843|NCT02735395|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92765844|NCT02735395|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92765845|NCT02741947|Levodopa|levodopa|mesh-list
92765846|NCT02741947|Benserazide|benserazide|mesh-list
92765847|NCT02741947|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92765848|NCT02741947|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92765849|NCT02741947|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92765851|NCT02741947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765852|NCT02741947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765853|NCT02741947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765854|NCT02741947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765855|NCT02740933|Demeclocycline|demeclocycline|mesh-list
92765856|NCT02740933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92765857|NCT02740933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765858|NCT02739685|Everolimus|everolimus|mesh-list
92765859|NCT02739685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92765860|NCT02739685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765861|NCT02739685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765862|NCT02739685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765863|NCT02739685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92765864|NCT02739685|Immunologic Factors|immunologic factors|mesh-ancestor
92765865|NCT02739685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765866|NCT02739685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765867|NCT02735317|Vitamin B 12|vitamin b 12|mesh-list
92765868|NCT02735317|Hydroxocobalamin|hydroxocobalamin|mesh-list
92765869|NCT02735317|Gentamicins|gentamicins|mesh-list
92765870|NCT02735317|Dexamethasone|dexamethasone|mesh-list
92765871|NCT02735317|Procaine|procaine|mesh-list
92765872|NCT02735317|Vitamins|vitamins|mesh-ancestor
92765873|NCT02735317|Micronutrients|micronutrients|mesh-ancestor
92765874|NCT02735317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765875|NCT02735317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765876|NCT02735317|Antiemetics|antiemetics|mesh-ancestor
92765877|NCT02735317|Autonomic Agents|autonomic agents|mesh-ancestor
92765878|NCT02735317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765879|NCT02735317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765880|NCT02735317|Glucocorticoids|glucocorticoids|mesh-ancestor
92765881|NCT02735317|Hormones|hormones|mesh-ancestor
92765882|NCT02735317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92765883|NCT02735317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92765884|NCT02735317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765885|NCT02735317|Vitamin B Complex|vitamin b complex|mesh-ancestor
92765886|NCT02735317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92765887|NCT02735317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765888|NCT02735317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92765889|NCT02735317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765890|NCT02735317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765891|NCT02735317|Hematinics|hematinics|mesh-ancestor
92765892|NCT02735317|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765893|NCT02735317|Anesthetics|anesthetics|mesh-ancestor
92765894|NCT02735317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765895|NCT02735317|Sensory System Agents|sensory system agents|mesh-ancestor
92765896|NCT02739529|genexol-PM|genexol-pm|mesh-list
92765897|NCT02739529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765898|NCT02739529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92765899|NCT02739529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92765900|NCT02739529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92765901|NCT02739529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765902|NCT05544721|Ropivacaine|ropivacaine|mesh-list
92765903|NCT05544721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765904|NCT05544721|Anesthetics|anesthetics|mesh-ancestor
92765905|NCT05544721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765906|NCT05544721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765907|NCT05544721|Sensory System Agents|sensory system agents|mesh-ancestor
92765908|NCT05544721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765909|NCT02738983|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92765910|NCT02738983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765911|NCT02738983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765912|NCT02738983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765913|NCT02738983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765914|NCT02739061|Fluvoxamine|fluvoxamine|mesh-list
92765915|NCT02739061|Sertraline|sertraline|mesh-list
92765916|NCT02739061|Antidepressive Agents|antidepressive agents|mesh-ancestor
92765917|NCT02739061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92765918|NCT02739061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92765919|NCT02739061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92765920|NCT02739061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92765921|NCT02739061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765922|NCT02739061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92765923|NCT02739061|Serotonin Agents|serotonin agents|mesh-ancestor
92765924|NCT02739061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765925|NCT02739061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92765926|NCT02739061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92765927|NCT02739061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765928|NCT02739061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92765929|NCT02739061|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92765930|NCT02739061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92765931|NCT02739061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765932|NCT02739061|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92765933|NCT02745925|Ibuprofen|ibuprofen|mesh-list
92765934|NCT02745925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92765935|NCT02745925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92765936|NCT02745925|Analgesics|analgesics|mesh-ancestor
92765937|NCT02745925|Sensory System Agents|sensory system agents|mesh-ancestor
92765938|NCT02745925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765939|NCT02745925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765940|NCT02745925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92765941|NCT02745925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92765942|NCT02745925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92765943|NCT02745925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765944|NCT02745925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765945|NCT04374253|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92765946|NCT04374253|Immunologic Factors|immunologic factors|mesh-ancestor
92765947|NCT04374253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765948|NCT02738905|Rifaximin|rifaximin|mesh-list
92765949|NCT02738905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92765950|NCT02738905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92765951|NCT02738905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765952|NCT02745691|Gefitinib|gefitinib|mesh-list
92765953|NCT02745691|Crizotinib|crizotinib|mesh-list
92765954|NCT02745691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765955|NCT02745691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92765956|NCT02745691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92765957|NCT02745691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92765958|NCT02745769|Ramucirumab|ramucirumab|mesh-list
92765959|NCT02745769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765960|NCT02734069|Carboplatin|carboplatin|mesh-list
92765961|NCT02734069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92765962|NCT02737813|Bupivacaine|bupivacaine|mesh-list
92765963|NCT02737813|Anesthetics, Local|anesthetics, local|mesh-ancestor
92765964|NCT02737813|Anesthetics|anesthetics|mesh-ancestor
92765965|NCT02737813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765966|NCT02737813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765967|NCT02737813|Sensory System Agents|sensory system agents|mesh-ancestor
92765968|NCT02737813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765969|NCT00636415|Morphine|morphine|mesh-list
92765970|NCT00636415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92765971|NCT00636415|Narcotics|narcotics|mesh-ancestor
92765972|NCT00636415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765973|NCT00636415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765974|NCT00636415|Analgesics|analgesics|mesh-ancestor
92765975|NCT00636415|Sensory System Agents|sensory system agents|mesh-ancestor
92765976|NCT00636415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765977|NCT02733835|Remifentanil|remifentanil|mesh-list
92765978|NCT02733835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92765979|NCT02733835|Narcotics|narcotics|mesh-ancestor
92765980|NCT02733835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92765981|NCT02733835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765982|NCT02733835|Analgesics|analgesics|mesh-ancestor
92765983|NCT02733835|Sensory System Agents|sensory system agents|mesh-ancestor
92765984|NCT02733835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92765985|NCT02737423|Vitamin D|vitamin d|mesh-list
92715930|NCT04129086|Anesthetics, General|anesthetics, general|mesh-ancestor
92765986|NCT02737423|Cholecalciferol|cholecalciferol|mesh-list
92765987|NCT02737423|Vitamins|vitamins|mesh-ancestor
92765988|NCT02737423|Micronutrients|micronutrients|mesh-ancestor
92765989|NCT02737423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765990|NCT02737423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92765991|NCT02737423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92765992|NCT02733679|Metformin|metformin|mesh-list
92765993|NCT02733679|Pioglitazone|pioglitazone|mesh-list
92765994|NCT02733679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92765995|NCT02733679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92765996|NCT03289741|Octreotide|octreotide|mesh-list
92765997|NCT03289741|Lanreotide|lanreotide|mesh-list
92765998|NCT03289741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92765999|NCT03289741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92766000|NCT03289741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766001|NCT05629429|Olaparib|olaparib|mesh-list
92766002|NCT05629429|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92766003|NCT05629429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766004|NCT05629429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766005|NCT05629429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766006|NCT02744131|Metformin|metformin|mesh-list
92766007|NCT02744131|Cyproterone Acetate|cyproterone acetate|mesh-list
92766008|NCT02744131|Contraceptive Agents|contraceptive agents|mesh-list
92766009|NCT02744131|Contraceptives, Oral|contraceptives, oral|mesh-list
92766010|NCT02744131|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92766011|NCT02744131|Estradiol|estradiol|mesh-list
92766012|NCT02744131|Cyproterone|cyproterone|mesh-list
92766013|NCT02744131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766014|NCT02744131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766015|NCT02744131|Estrogens|estrogens|mesh-ancestor
92766016|NCT02744131|Hormones|hormones|mesh-ancestor
92766017|NCT02744131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766018|NCT02744131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92766019|NCT02744131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92766020|NCT02744131|Androgen Antagonists|androgen antagonists|mesh-ancestor
92766021|NCT02744131|Hormone Antagonists|hormone antagonists|mesh-ancestor
92766022|NCT02744131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766023|NCT02744131|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92766024|NCT03326791|Aspirin|aspirin|mesh-list
92766025|NCT03326791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92766026|NCT03326791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766027|NCT03326791|Analgesics|analgesics|mesh-ancestor
92766028|NCT03326791|Sensory System Agents|sensory system agents|mesh-ancestor
92766029|NCT03326791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766030|NCT03326791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766031|NCT03326791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766032|NCT03326791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766033|NCT03326791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92766034|NCT03326791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92766035|NCT03326791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766036|NCT03326791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92766037|NCT03326791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92766038|NCT03326791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766039|NCT03326791|Antipyretics|antipyretics|mesh-ancestor
92766040|NCT02743975|Bevacizumab|bevacizumab|mesh-list
92766041|NCT02743975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766042|NCT02743975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766043|NCT02743975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92766044|NCT02743975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92766045|NCT02743975|Growth Substances|growth substances|mesh-ancestor
92766046|NCT02743975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766047|NCT02743975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92766048|NCT02743663|Albuterol|albuterol|mesh-list
92766049|NCT02743663|Bronchodilator Agents|bronchodilator agents|mesh-list
92766050|NCT02743663|Autonomic Agents|autonomic agents|mesh-ancestor
92766051|NCT02743663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766052|NCT02743663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766053|NCT02743663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92766054|NCT02743663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92766055|NCT02743663|Tocolytic Agents|tocolytic agents|mesh-ancestor
92766056|NCT02743663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92766057|NCT02743663|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92766058|NCT02743663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92716002|NCT03737643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766059|NCT02743663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92766060|NCT02743663|Adrenergic Agents|adrenergic agents|mesh-ancestor
92766062|NCT02743663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766063|NCT02733445|Dasatinib|dasatinib|mesh-list
92766064|NCT02733445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766065|NCT02733445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92766066|NCT02733445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766067|NCT02733445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766068|NCT02731105|Clindamycin|clindamycin|mesh-list
92766069|NCT02731105|Clindamycin palmitate|clindamycin palmitate|mesh-list
92766070|NCT02731105|Clindamycin phosphate|clindamycin phosphate|mesh-list
92766071|NCT02731105|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92766072|NCT02731105|Tretinoin|tretinoin|mesh-list
92766073|NCT02731105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766074|NCT02731105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766075|NCT02731105|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92766076|NCT02731105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766077|NCT02731105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766078|NCT02731105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766079|NCT02731105|Keratolytic Agents|keratolytic agents|mesh-ancestor
92766080|NCT02731105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92766081|NCT02731105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92766082|NCT02731105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766083|NCT02731105|Analgesics|analgesics|mesh-ancestor
92766084|NCT02731105|Sensory System Agents|sensory system agents|mesh-ancestor
92766085|NCT02731105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766086|NCT02731105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766087|NCT02731105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766088|NCT02731105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766089|NCT02743429|Dinutuximab|dinutuximab|mesh-list
92766090|NCT02743429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766091|NCT02730949|Folic Acid|folic acid|mesh-list
92766092|NCT02730949|Inositol|inositol|mesh-list
92766093|NCT02730949|Hematinics|hematinics|mesh-ancestor
92766094|NCT02730949|Vitamin B Complex|vitamin b complex|mesh-ancestor
92766095|NCT02730949|Vitamins|vitamins|mesh-ancestor
92766096|NCT02730949|Micronutrients|micronutrients|mesh-ancestor
92766097|NCT02730949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766098|NCT04205929|Curcumin|curcumin|mesh-list
92766099|NCT04205929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92766100|NCT04205929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766101|NCT04205929|Analgesics|analgesics|mesh-ancestor
92766102|NCT04205929|Sensory System Agents|sensory system agents|mesh-ancestor
92766103|NCT04205929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766104|NCT04205929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766105|NCT04205929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766106|NCT04205929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766107|NCT04205929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766108|NCT04205929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766109|NCT04205929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766110|NCT03259867|Nivolumab|nivolumab|mesh-list
92766111|NCT03259867|Tirapazamine|tirapazamine|mesh-list
92766112|NCT03259867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371416|NCT01276314|Analgesics|analgesics|mesh-ancestor
92766113|NCT03259867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766114|NCT03259867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92766115|NCT03259867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766116|NCT00636493|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92766117|NCT00636493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766118|NCT00636493|Glucocorticoids|glucocorticoids|mesh-ancestor
92766119|NCT00636493|Hormones|hormones|mesh-ancestor
92766120|NCT00636493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766121|NCT00636493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766122|NCT02730481|Paclitaxel|paclitaxel|mesh-list
92766123|NCT02730481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92766124|NCT02730481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766125|NCT02730481|Tubulin Modulators|tubulin modulators|mesh-ancestor
92766126|NCT02730481|Antimitotic Agents|antimitotic agents|mesh-ancestor
92766127|NCT02730481|Mitosis Modulators|mitosis modulators|mesh-ancestor
92766128|NCT02730481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766129|NCT02730091|Letrozole|letrozole|mesh-list
92766130|NCT02730091|Vinorelbine|vinorelbine|mesh-list
92766131|NCT02730091|Anastrozole|anastrozole|mesh-list
92766132|NCT02730091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766133|NCT02730091|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92766134|NCT02730091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92766135|NCT02730091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766136|NCT02730091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766138|NCT02730091|Hormone Antagonists|hormone antagonists|mesh-ancestor
92766139|NCT02730091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766140|NCT02730091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766141|NCT02730091|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92766142|NCT02730091|Tubulin Modulators|tubulin modulators|mesh-ancestor
92766143|NCT02730091|Antimitotic Agents|antimitotic agents|mesh-ancestor
92766144|NCT02730091|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537652|NCT03555149|Growth Substances|growth substances|mesh-ancestor
92766145|NCT02730091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92766146|NCT02742805|Vitamin D|vitamin d|mesh-list
92766147|NCT02742805|Ergocalciferols|ergocalciferols|mesh-list
92766148|NCT02742805|Cholecalciferol|cholecalciferol|mesh-list
92766149|NCT02742805|Vitamins|vitamins|mesh-list
92766150|NCT02742805|Omalizumab|omalizumab|mesh-list
92766151|NCT02742805|Micronutrients|micronutrients|mesh-ancestor
92766152|NCT02742805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766153|NCT02742805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92766154|NCT02742805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92766155|NCT02742805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92766156|NCT02742805|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92766157|NCT02742805|Respiratory System Agents|respiratory system agents|mesh-ancestor
92766158|NCT02690389|Flumazenil|flumazenil|mesh-list
92766159|NCT02690389|Antidotes|antidotes|mesh-ancestor
92766160|NCT02690389|Protective Agents|protective agents|mesh-ancestor
92766161|NCT02690389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766162|NCT02690389|GABA Modulators|gaba modulators|mesh-ancestor
92766163|NCT02690389|GABA Agents|gaba agents|mesh-ancestor
92766164|NCT02690389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766165|NCT02690389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766166|NCT02732197|Thiopental|thiopental|mesh-list
92766167|NCT02732197|Anticonvulsants|anticonvulsants|mesh-ancestor
92766168|NCT02732197|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92766169|NCT02732197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766170|NCT02732197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766171|NCT02732197|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92766172|NCT02732197|Anesthetics, General|anesthetics, general|mesh-ancestor
92766173|NCT02732197|Anesthetics|anesthetics|mesh-ancestor
92766174|NCT02732197|GABA Modulators|gaba modulators|mesh-ancestor
92766175|NCT02732197|GABA Agents|gaba agents|mesh-ancestor
92766176|NCT02732197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766177|NCT02732197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766178|NCT02729935|Parecoxib|parecoxib|mesh-list
92335949|NCT02043366|Antitussive Agents|antitussive agents|mesh-ancestor
92766179|NCT02729935|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92766180|NCT02729935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92766181|NCT02729935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766182|NCT02729935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766183|NCT02729935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92766184|NCT02729935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766185|NCT02729935|Analgesics|analgesics|mesh-ancestor
92766186|NCT02729935|Sensory System Agents|sensory system agents|mesh-ancestor
92766187|NCT02729935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766188|NCT02729935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766189|NCT02729935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766190|NCT02729935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766191|NCT02729467|Itraconazole|itraconazole|mesh-list
92766192|NCT02729467|Rifampin|rifampin|mesh-list
92766193|NCT02729467|Antifungal Agents|antifungal agents|mesh-ancestor
92766194|NCT02729467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766195|NCT02729467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92766196|NCT02729467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92766197|NCT02729467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766198|NCT02729467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766199|NCT02729467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92766200|NCT02729467|Hormone Antagonists|hormone antagonists|mesh-ancestor
92766201|NCT02729467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766202|NCT02729467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766203|NCT02729467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92766204|NCT02729467|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92766205|NCT02729467|Antitubercular Agents|antitubercular agents|mesh-ancestor
92766206|NCT02729467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766207|NCT02729467|Leprostatic Agents|leprostatic agents|mesh-ancestor
92766208|NCT02729467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92766209|NCT02729467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92766210|NCT02729467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92766211|NCT02729467|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92766212|NCT02729467|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92766213|NCT02729467|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92766214|NCT02729467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92766215|NCT02727205|Rotigotine|rotigotine|mesh-list
92766216|NCT02727205|Dopamine Agonists|dopamine agonists|mesh-ancestor
92766217|NCT02727205|Dopamine Agents|dopamine agents|mesh-ancestor
92766218|NCT02727205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766219|NCT02727205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766220|NCT02727205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766222|NCT02721433|Zoledronic Acid|zoledronic acid|mesh-list
92766223|NCT02721433|Pamidronate|pamidronate|mesh-list
92766224|NCT02721433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92766225|NCT02721433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766226|NCT02721043|Lenalidomide|lenalidomide|mesh-list
92766227|NCT02721043|Vaccines|vaccines|mesh-list
92766228|NCT02721043|Poly ICLC|poly iclc|mesh-list
92766229|NCT02721043|Immunologic Factors|immunologic factors|mesh-ancestor
92766230|NCT02721043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766231|NCT02721043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92766232|NCT02721043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92766233|NCT02721043|Growth Substances|growth substances|mesh-ancestor
92766234|NCT02721043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92766235|NCT02721043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766236|NCT02721043|Interferon Inducers|interferon inducers|mesh-ancestor
92766237|NCT02728843|Deferiprone|deferiprone|mesh-list
92766238|NCT02728843|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92766239|NCT02728843|Chelating Agents|chelating agents|mesh-ancestor
92766240|NCT02728843|Sequestering Agents|sequestering agents|mesh-ancestor
92766241|NCT02728843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766242|NCT02726503|Lenvatinib|lenvatinib|mesh-list
92766243|NCT02726503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766244|NCT02726503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92766245|NCT02726503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766246|NCT02726503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766247|NCT02720965|Anesthetics|anesthetics|mesh-list
92766248|NCT02720965|Anesthetics, Local|anesthetics, local|mesh-list
92766249|NCT02720965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766250|NCT02720965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766251|NCT02720965|Sensory System Agents|sensory system agents|mesh-ancestor
92766252|NCT02720965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766253|NCT02792413|Denosumab|denosumab|mesh-list
92766254|NCT02792413|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92766255|NCT02792413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766256|NCT02726737|Lidocaine|lidocaine|mesh-list
92766257|NCT02726737|Anesthetics, Local|anesthetics, local|mesh-ancestor
92766258|NCT02726737|Anesthetics|anesthetics|mesh-ancestor
92766259|NCT02726737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766260|NCT02726737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766261|NCT02726737|Sensory System Agents|sensory system agents|mesh-ancestor
92766262|NCT02726737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766263|NCT02726737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92766264|NCT02726737|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92766265|NCT02726737|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92766266|NCT02726737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766267|NCT02726737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766268|NCT02720575|Vitamin D|vitamin d|mesh-list
92766269|NCT02720575|Vitamins|vitamins|mesh-ancestor
92766270|NCT02720575|Micronutrients|micronutrients|mesh-ancestor
92766271|NCT02720575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766272|NCT02720575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92766273|NCT02720341|Armin|armin|mesh-list
92766274|NCT02720341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92766275|NCT02720341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766276|NCT02720341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766277|NCT02720341|Cholinergic Agents|cholinergic agents|mesh-ancestor
92766278|NCT02720341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766279|NCT02720341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766280|NCT02728453|Empagliflozin|empagliflozin|mesh-list
92766281|NCT02728453|Glimepiride|glimepiride|mesh-list
92766282|NCT02728453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92716257|NCT00521222|Xhance|xhance|mesh-list
92766283|NCT02728453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766284|NCT02728453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766285|NCT02728453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766286|NCT02728453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92766287|NCT02728453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92766288|NCT02728453|Immunologic Factors|immunologic factors|mesh-ancestor
92766290|NCT02728687|Menthol|menthol|mesh-list
92766291|NCT02728687|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92766292|NCT02728687|Diuretics|diuretics|mesh-ancestor
92766293|NCT02728687|Natriuretic Agents|natriuretic agents|mesh-ancestor
92766294|NCT02728687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766295|NCT02728687|Antipruritics|antipruritics|mesh-ancestor
92766296|NCT02728687|Dermatologic Agents|dermatologic agents|mesh-ancestor
92766297|NCT02726269|Ofloxacin|ofloxacin|mesh-list
92766298|NCT02726269|Levofloxacin|levofloxacin|mesh-list
92766299|NCT02726269|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92766300|NCT02726269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766301|NCT02726269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766302|NCT02726269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92766303|NCT02726269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92766304|NCT02726269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766305|NCT02726269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766306|NCT02726269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766307|NCT02726269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92766308|NCT02726269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92766309|NCT02694289|Metformin|metformin|mesh-list
92766310|NCT02694289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766311|NCT02694289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766312|NCT02719795|Ropivacaine|ropivacaine|mesh-list
92766313|NCT02719795|Anesthetics, Local|anesthetics, local|mesh-ancestor
92766314|NCT02719795|Anesthetics|anesthetics|mesh-ancestor
92766315|NCT02719795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766316|NCT02719795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766317|NCT02719795|Sensory System Agents|sensory system agents|mesh-ancestor
92766318|NCT02719795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766319|NCT02726347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92766320|NCT02726347|Immunologic Factors|immunologic factors|mesh-ancestor
92766321|NCT02726347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766322|NCT02726035|Naltrexone|naltrexone|mesh-list
92766323|NCT02726035|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92766324|NCT02726035|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92766325|NCT02726035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766326|NCT02726035|Sensory System Agents|sensory system agents|mesh-ancestor
92766327|NCT02726035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766328|NCT02719405|Caseins|caseins|mesh-list
92766329|NCT02719405|Chelating Agents|chelating agents|mesh-ancestor
92766330|NCT02719405|Sequestering Agents|sequestering agents|mesh-ancestor
92766331|NCT02719405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766332|NCT02725255|Albendazole|albendazole|mesh-list
92766333|NCT02725255|Anthelmintics|anthelmintics|mesh-ancestor
92766334|NCT02725255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92766335|NCT02725255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766336|NCT02725255|Anticestodal Agents|anticestodal agents|mesh-ancestor
92766337|NCT02725255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92766338|NCT02725255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92766339|NCT02725255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92766340|NCT02725255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92766341|NCT02725255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92766342|NCT02725255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766343|NCT02725255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766344|NCT02719015|Pembrolizumab|pembrolizumab|mesh-list
92766345|NCT02719015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766346|NCT02719015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766347|NCT02719015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92766348|NCT02719015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766349|NCT02725489|Durvalumab|durvalumab|mesh-list
92766350|NCT02725489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766351|NCT02725489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766352|NCT02718547|Timolol|timolol|mesh-list
92766353|NCT02718547|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92766354|NCT02718547|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92766355|NCT02718547|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92716306|NCT03456401|Sorafenib|sorafenib|mesh-list
92766356|NCT02718547|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92766357|NCT02718547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766358|NCT02718547|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92766359|NCT02718547|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92766360|NCT02718547|Adrenergic Agents|adrenergic agents|mesh-ancestor
92766361|NCT02718547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766362|NCT02718547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766363|NCT02718547|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92766364|NCT02718547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92766365|NCT02718547|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92766366|NCT02718547|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92766367|NCT02718547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92766368|NCT02725099|Ticagrelor|ticagrelor|mesh-list
92766369|NCT02725099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92766370|NCT02725099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92766371|NCT02725099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92766372|NCT02725099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92766373|NCT02725099|Purinergic Agents|purinergic agents|mesh-ancestor
92766374|NCT02725099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766375|NCT02725099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766376|NCT02725099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766377|NCT01225211|Ivacaftor|ivacaftor|mesh-list
92766378|NCT01225211|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92766379|NCT01225211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766380|NCT01225211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766381|NCT02685709|Octreotide|octreotide|mesh-list
92766382|NCT02685709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766383|NCT02685709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92766384|NCT02685709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766385|NCT02265367|Milnacipran|milnacipran|mesh-list
92766386|NCT02265367|Levomilnacipran|levomilnacipran|mesh-list
92766387|NCT02265367|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92766388|NCT02265367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92766389|NCT02265367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766390|NCT02265367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766391|NCT02265367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766392|NCT02265367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766393|NCT02265367|Antidepressive Agents|antidepressive agents|mesh-ancestor
92766394|NCT02265367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92766395|NCT02265367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766396|NCT02265367|Analgesics|analgesics|mesh-ancestor
92766397|NCT02265367|Sensory System Agents|sensory system agents|mesh-ancestor
92766398|NCT02265367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766399|NCT02718469|Vaccines|vaccines|mesh-list
92766400|NCT02718469|Immunologic Factors|immunologic factors|mesh-ancestor
92766401|NCT02718469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766402|NCT02716285|Peppermint oil|peppermint oil|mesh-list
92766403|NCT02716285|Antiemetics|antiemetics|mesh-ancestor
92766404|NCT02716285|Autonomic Agents|autonomic agents|mesh-ancestor
92766405|NCT02716285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766406|NCT02716285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766407|NCT02716285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766408|NCT02716285|Parasympatholytics|parasympatholytics|mesh-ancestor
92766409|NCT01224821|Tositumomab I-131|tositumomab i-131|mesh-list
92766410|NCT01224821|Antibodies|antibodies|mesh-list
92766411|NCT01224821|Immunologic Factors|immunologic factors|mesh-ancestor
92766412|NCT01224821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766413|NCT01224821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766414|NCT02684851|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92766415|NCT02684851|Tranexamic Acid|tranexamic acid|mesh-list
92766416|NCT02684851|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
92766417|NCT02684851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92766418|NCT02684851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766419|NCT02684851|Hemostatics|hemostatics|mesh-ancestor
92766420|NCT02684851|Coagulants|coagulants|mesh-ancestor
92766421|NCT01224431|Lidocaine|lidocaine|mesh-list
92766422|NCT01224431|Anesthetics, Local|anesthetics, local|mesh-ancestor
92766423|NCT01224431|Anesthetics|anesthetics|mesh-ancestor
92766424|NCT01224431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766425|NCT01224431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766426|NCT01224431|Sensory System Agents|sensory system agents|mesh-ancestor
92766427|NCT01224431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766428|NCT01224431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92766429|NCT01224431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92716405|NCT04645914|Nicotine|nicotine|mesh-list
92766431|NCT01224431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766432|NCT01224431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766433|NCT02716129|Morphine|morphine|mesh-list
92766434|NCT02716129|Nalbuphine|nalbuphine|mesh-list
92766435|NCT02716129|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92766436|NCT02716129|Narcotics|narcotics|mesh-ancestor
92766437|NCT02716129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766438|NCT02716129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766439|NCT02716129|Analgesics|analgesics|mesh-ancestor
92766440|NCT02716129|Sensory System Agents|sensory system agents|mesh-ancestor
92766441|NCT02716129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766442|NCT02718079|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92766443|NCT02718079|Acetylcysteine|acetylcysteine|mesh-list
92766444|NCT02718079|Mannitol|mannitol|mesh-list
92766445|NCT02718079|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92766446|NCT02718079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766447|NCT02718079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92766448|NCT02718079|Diuretics|diuretics|mesh-ancestor
92766449|NCT02718079|Natriuretic Agents|natriuretic agents|mesh-ancestor
92766450|NCT02718079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766451|NCT02718079|Antiviral Agents|antiviral agents|mesh-ancestor
92766452|NCT02718079|Expectorants|expectorants|mesh-ancestor
92766453|NCT02718079|Respiratory System Agents|respiratory system agents|mesh-ancestor
92766454|NCT02718079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92766455|NCT02718079|Antioxidants|antioxidants|mesh-ancestor
92766456|NCT02718079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766457|NCT02718079|Protective Agents|protective agents|mesh-ancestor
92766458|NCT02718079|Antidotes|antidotes|mesh-ancestor
92766459|NCT02717923|Capecitabine|capecitabine|mesh-list
92766460|NCT02717923|Cetuximab|cetuximab|mesh-list
92766461|NCT02717923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92766462|NCT02717923|Antimetabolites|antimetabolites|mesh-ancestor
92766463|NCT02717923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766464|NCT02717923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766465|NCT02717923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766467|NCT02724163|Cyclophosphamide|cyclophosphamide|mesh-list
92766468|NCT02724163|Busulfan|busulfan|mesh-list
92766469|NCT02724163|Fludarabine|fludarabine|mesh-list
92766470|NCT02724163|Daunorubicin|daunorubicin|mesh-list
92766471|NCT02724163|Mitoxantrone|mitoxantrone|mesh-list
92766472|NCT02724163|Gemtuzumab|gemtuzumab|mesh-list
92766473|NCT02724163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92766474|NCT02724163|Immunologic Factors|immunologic factors|mesh-ancestor
92766475|NCT02724163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766476|NCT02724163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766477|NCT02724163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92766478|NCT02724163|Alkylating Agents|alkylating agents|mesh-ancestor
92766479|NCT02724163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766480|NCT02724163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766481|NCT02724163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92766482|NCT02724163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92766483|NCT02724163|Antimetabolites|antimetabolites|mesh-ancestor
92766484|NCT02724163|Antiviral Agents|antiviral agents|mesh-ancestor
92766485|NCT02724163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766486|NCT02724163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92766487|NCT02724163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92766488|NCT02724163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92766489|NCT02724163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766490|NCT02724163|Analgesics|analgesics|mesh-ancestor
92766491|NCT02724163|Sensory System Agents|sensory system agents|mesh-ancestor
92766492|NCT02724163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766493|NCT02724163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766494|NCT02724163|Immunotoxins|immunotoxins|mesh-ancestor
92766495|NCT02724163|Immunoconjugates|immunoconjugates|mesh-ancestor
92766496|NCT02723461|Oxytocin|oxytocin|mesh-list
92766497|NCT02723461|Oxytocics|oxytocics|mesh-ancestor
92766498|NCT02723461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92766499|NCT02723461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766500|NCT02715193|Volagidemab|volagidemab|mesh-list
92766501|NCT02715193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766502|NCT02715193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766503|NCT01223027|Sorafenib|sorafenib|mesh-list
92716454|NCT00546533|Etanercept|etanercept|mesh-list
92766504|NCT01223027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766505|NCT01223027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92766506|NCT01223027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766507|NCT01223027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766508|NCT02714959|Aldesleukin|aldesleukin|mesh-list
92766509|NCT02714959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766510|NCT02714959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92766511|NCT02714959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92766512|NCT02714959|Antiviral Agents|antiviral agents|mesh-ancestor
92766513|NCT02714959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766514|NCT02714725|Dexmedetomidine|dexmedetomidine|mesh-list
92766515|NCT02714725|Propofol|propofol|mesh-list
92766516|NCT02714725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92766517|NCT02714725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766518|NCT02714725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766519|NCT02714725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766520|NCT02714725|Analgesics|analgesics|mesh-ancestor
92766521|NCT02714725|Sensory System Agents|sensory system agents|mesh-ancestor
92766522|NCT02714725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766523|NCT02714725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92766524|NCT02714725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92766525|NCT02714725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92766526|NCT02714725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92766527|NCT02714725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766528|NCT02714725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766529|NCT02714725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92766530|NCT02714725|Anesthetics, General|anesthetics, general|mesh-ancestor
92766531|NCT02714725|Anesthetics|anesthetics|mesh-ancestor
92766532|NCT01015287|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92766533|NCT01015287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92766534|NCT02714179|Acetaminophen|acetaminophen|mesh-list
92766535|NCT02714179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766536|NCT02714179|Analgesics|analgesics|mesh-ancestor
92766537|NCT02714179|Sensory System Agents|sensory system agents|mesh-ancestor
92766538|NCT02714179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766539|NCT02714179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766540|NCT02714179|Antipyretics|antipyretics|mesh-ancestor
92766541|NCT01015131|Alovudine|alovudine|mesh-list
92766542|NCT01015131|Antiviral Agents|antiviral agents|mesh-ancestor
92766543|NCT01015131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766544|NCT02723383|Baclofen|baclofen|mesh-list
92766545|NCT02723383|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92766546|NCT02723383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766547|NCT02723383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92766548|NCT02723383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766549|NCT02723383|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92766550|NCT02723383|GABA Agonists|gaba agonists|mesh-ancestor
92766551|NCT02723383|GABA Agents|gaba agents|mesh-ancestor
92766552|NCT02723383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766553|NCT02723383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766554|NCT05269537|Ephedrine|ephedrine|mesh-list
92766555|NCT05269537|Fentanyl|fentanyl|mesh-list
92766556|NCT05269537|Bupivacaine|bupivacaine|mesh-list
92766557|NCT05269537|Oxytocin|oxytocin|mesh-list
92766558|NCT05269537|Anesthetics, Local|anesthetics, local|mesh-ancestor
92766559|NCT05269537|Anesthetics|anesthetics|mesh-ancestor
92766560|NCT05269537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766561|NCT05269537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766562|NCT05269537|Sensory System Agents|sensory system agents|mesh-ancestor
92766563|NCT05269537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766564|NCT05269537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92766565|NCT05269537|Narcotics|narcotics|mesh-ancestor
92766566|NCT05269537|Analgesics|analgesics|mesh-ancestor
92766567|NCT05269537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92766568|NCT05269537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92766569|NCT05269537|Anesthetics, General|anesthetics, general|mesh-ancestor
92766570|NCT05269537|Oxytocics|oxytocics|mesh-ancestor
92766571|NCT05269537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92336014|NCT02058966|Entacapone|entacapone|mesh-list
92766572|NCT05269537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92766573|NCT05269537|Sympathomimetics|sympathomimetics|mesh-ancestor
92766574|NCT05269537|Autonomic Agents|autonomic agents|mesh-ancestor
92766575|NCT05269537|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92766576|NCT05269537|Adrenergic Agents|adrenergic agents|mesh-ancestor
92766577|NCT05269537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766578|NCT05269537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766579|NCT01222715|Sirolimus|sirolimus|mesh-list
92766580|NCT01222715|Cyclophosphamide|cyclophosphamide|mesh-list
92766581|NCT01222715|Bevacizumab|bevacizumab|mesh-list
92766582|NCT01222715|Temsirolimus|temsirolimus|mesh-list
92766583|NCT01222715|Vinorelbine|vinorelbine|mesh-list
92766584|NCT01222715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92766585|NCT01222715|MTOR Inhibitors|mtor inhibitors|mesh-list
92766586|NCT01222715|Antibodies|antibodies|mesh-list
92766587|NCT01222715|Immunoglobulins|immunoglobulins|mesh-list
92766588|NCT01222715|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92766589|NCT01222715|Immunoglobulin G|immunoglobulin g|mesh-list
92766590|NCT01222715|Endothelial Growth Factors|endothelial growth factors|mesh-list
92766591|NCT01222715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92766592|NCT01222715|Immunologic Factors|immunologic factors|mesh-ancestor
92766593|NCT01222715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766594|NCT01222715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766595|NCT01222715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92766596|NCT01222715|Alkylating Agents|alkylating agents|mesh-ancestor
92766597|NCT01222715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766598|NCT01222715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766599|NCT01222715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92766600|NCT01222715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92766601|NCT01222715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92766602|NCT01222715|Growth Substances|growth substances|mesh-ancestor
92766603|NCT01222715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92766604|NCT01222715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766605|NCT01222715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766606|NCT01222715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92766607|NCT01222715|Antifungal Agents|antifungal agents|mesh-ancestor
92766608|NCT01222715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92766609|NCT01222715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766610|NCT01222715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92766611|NCT01222715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92766612|NCT01222715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92766613|NCT01222715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92766614|NCT02723071|Ocrelizumab|ocrelizumab|mesh-list
92766615|NCT02723071|Immunologic Factors|immunologic factors|mesh-ancestor
92766616|NCT02723071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766617|NCT02722759|Chrysarobin|chrysarobin|mesh-list
92766618|NCT02722759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92766619|NCT02722759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766620|NCT02722759|Analgesics|analgesics|mesh-ancestor
92766621|NCT02722759|Sensory System Agents|sensory system agents|mesh-ancestor
92766622|NCT02722759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766623|NCT02722759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766624|NCT02722759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766625|NCT02722759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766626|NCT02722447|Rivaroxaban|rivaroxaban|mesh-list
92766627|NCT02722447|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92766628|NCT02722447|Antithrombins|antithrombins|mesh-ancestor
92766629|NCT02722447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92766630|NCT02722447|Protease Inhibitors|protease inhibitors|mesh-ancestor
92766631|NCT02722447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766632|NCT02722447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766633|NCT02722447|Anticoagulants|anticoagulants|mesh-ancestor
92766634|NCT01222403|Vaccines|vaccines|mesh-list
92766635|NCT01222403|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92766636|NCT01222403|Immunologic Factors|immunologic factors|mesh-ancestor
92766637|NCT01222403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766638|NCT01222403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92766639|NCT02722369|Hydroxychloroquine|hydroxychloroquine|mesh-list
92766640|NCT02722369|Carboplatin|carboplatin|mesh-list
92766641|NCT02722369|Gemcitabine|gemcitabine|mesh-list
92766642|NCT02722369|Etoposide|etoposide|mesh-list
92766643|NCT02722369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766644|NCT02722369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92766645|NCT02722369|Antimetabolites|antimetabolites|mesh-ancestor
92766646|NCT02722369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766647|NCT02722369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92766648|NCT02722369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92766649|NCT02722369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92766650|NCT02722369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766651|NCT02722369|Antimalarials|antimalarials|mesh-ancestor
92766652|NCT02722369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92766653|NCT02722369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92766654|NCT02722369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766655|NCT02722369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766656|NCT01222247|Betamethasone|betamethasone|mesh-list
92766657|NCT01222247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766658|NCT01222247|Glucocorticoids|glucocorticoids|mesh-ancestor
92766659|NCT01222247|Hormones|hormones|mesh-ancestor
92766660|NCT01222247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766661|NCT01222247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766662|NCT01222247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92766663|NCT01222247|Respiratory System Agents|respiratory system agents|mesh-ancestor
92766664|NCT01014975|Fibrinolysin|fibrinolysin|mesh-list
92766665|NCT01014975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92766666|NCT01014975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92766667|NCT01014975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766668|NCT03982537|Acetylcysteine|acetylcysteine|mesh-list
92766669|NCT03982537|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92766670|NCT03982537|Antiviral Agents|antiviral agents|mesh-ancestor
92766671|NCT03982537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766672|NCT03982537|Expectorants|expectorants|mesh-ancestor
92766673|NCT03982537|Respiratory System Agents|respiratory system agents|mesh-ancestor
92766674|NCT03982537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92766675|NCT03982537|Antioxidants|antioxidants|mesh-ancestor
92766676|NCT03982537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766677|NCT03982537|Protective Agents|protective agents|mesh-ancestor
92766678|NCT03982537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766679|NCT03982537|Antidotes|antidotes|mesh-ancestor
92766680|NCT05260593|Vitamins|vitamins|mesh-list
92766681|NCT05260593|Hydroxocobalamin|hydroxocobalamin|mesh-list
92766682|NCT05260593|Vitamin B 12|vitamin b 12|mesh-list
92766683|NCT05260593|Vitamin B Complex|vitamin b complex|mesh-list
92766684|NCT05260593|Micronutrients|micronutrients|mesh-ancestor
92766685|NCT05260593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766686|NCT05260593|Hematinics|hematinics|mesh-ancestor
92766687|NCT02713477|Insulin|insulin|mesh-list
92766688|NCT02713477|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92766689|NCT02713477|Insulin Glargine|insulin glargine|mesh-list
92766690|NCT02713477|Lixisenatide|lixisenatide|mesh-list
92766691|NCT02713477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766692|NCT02713477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766693|NCT01014585|Milnacipran|milnacipran|mesh-list
92766694|NCT01014585|Levomilnacipran|levomilnacipran|mesh-list
92766695|NCT01014585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92766696|NCT01014585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92766697|NCT01014585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766698|NCT01014585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766699|NCT01014585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766700|NCT01014585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766701|NCT01014585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92766702|NCT01014585|Analgesics|analgesics|mesh-ancestor
92766703|NCT01014585|Sensory System Agents|sensory system agents|mesh-ancestor
92766704|NCT01014585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766705|NCT01014585|Antidepressive Agents|antidepressive agents|mesh-ancestor
92766706|NCT01014585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92766707|NCT00611143|Atorvastatin|atorvastatin|mesh-list
92766708|NCT00611143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92766709|NCT00611143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92766710|NCT00611143|Antimetabolites|antimetabolites|mesh-ancestor
92766711|NCT00611143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766712|NCT00611143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92766713|NCT00611143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92766714|NCT00611143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766715|NCT02712619|Metformin|metformin|mesh-list
92766716|NCT02712619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766717|NCT02712619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766718|NCT01220609|Epothilones|epothilones|mesh-list
92766719|NCT01220609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92766720|NCT01220609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92766721|NCT01220609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92766722|NCT01220609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766723|NCT01220609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766724|NCT02713087|Phenylephrine|phenylephrine|mesh-list
92766725|NCT02713087|Oxymetazoline|oxymetazoline|mesh-list
92766726|NCT02713087|Ephedrine|ephedrine|mesh-list
92766727|NCT02713087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92766728|NCT02713087|Mydriatics|mydriatics|mesh-ancestor
92766729|NCT02713087|Autonomic Agents|autonomic agents|mesh-ancestor
92766730|NCT02713087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766731|NCT02713087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766732|NCT02713087|Sympathomimetics|sympathomimetics|mesh-ancestor
92766733|NCT02713087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92766734|NCT02713087|Nasal Decongestants|nasal decongestants|mesh-ancestor
92766735|NCT02713087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92766736|NCT02713087|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92766737|NCT02713087|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92766738|NCT02713087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92766739|NCT02713087|Adrenergic Agents|adrenergic agents|mesh-ancestor
92766740|NCT02713087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766741|NCT02713087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766742|NCT02713087|Protective Agents|protective agents|mesh-ancestor
92766743|NCT02713087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92766744|NCT02722603|Gabapentin|gabapentin|mesh-list
92766745|NCT02722603|Tramadol|tramadol|mesh-list
92766746|NCT02722603|Analgesics|analgesics|mesh-ancestor
92766747|NCT02722603|Sensory System Agents|sensory system agents|mesh-ancestor
92766748|NCT02722603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766749|NCT02722603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766750|NCT02722603|Anticonvulsants|anticonvulsants|mesh-ancestor
92766751|NCT02722603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92766752|NCT02722603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92766753|NCT02722603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766754|NCT02722603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92766755|NCT02722603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92766756|NCT02722603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92766757|NCT02722603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766758|NCT02722603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766759|NCT02722603|Antimanic Agents|antimanic agents|mesh-ancestor
92766760|NCT02722603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92766761|NCT02722603|Narcotics|narcotics|mesh-ancestor
92766762|NCT02712697|Prednisone|prednisone|mesh-list
92766763|NCT02712697|Hormones|hormones|mesh-list
92766764|NCT02712697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766765|NCT02712697|Glucocorticoids|glucocorticoids|mesh-ancestor
92766766|NCT02712697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766767|NCT02712697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766768|NCT02712697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92766769|NCT02712697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766770|NCT01220297|Mycophenolic Acid|mycophenolic acid|mesh-list
92766771|NCT01220297|Sirolimus|sirolimus|mesh-list
92766772|NCT01220297|Cyclophosphamide|cyclophosphamide|mesh-list
92766773|NCT01220297|Carmustine|carmustine|mesh-list
92766774|NCT01220297|Etoposide|etoposide|mesh-list
92766775|NCT01220297|Etoposide phosphate|etoposide phosphate|mesh-list
92766776|NCT01220297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92766777|NCT01220297|Immunologic Factors|immunologic factors|mesh-ancestor
92766778|NCT01220297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766779|NCT01220297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766780|NCT01220297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92766781|NCT01220297|Alkylating Agents|alkylating agents|mesh-ancestor
92766782|NCT01220297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766783|NCT01220297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766784|NCT01220297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92766785|NCT01220297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92766786|NCT01220297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92766787|NCT01220297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92766788|NCT01220297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766789|NCT01220297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92766790|NCT01220297|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92766791|NCT01220297|Antitubercular Agents|antitubercular agents|mesh-ancestor
92766792|NCT01220297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766793|NCT01220297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766794|NCT01220297|Antifungal Agents|antifungal agents|mesh-ancestor
92766795|NCT02712775|Minocycline|minocycline|mesh-list
92766796|NCT02712775|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766797|NCT02712775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766798|NCT04318847|Ondansetron|ondansetron|mesh-list
92766799|NCT04318847|Antiemetics|antiemetics|mesh-ancestor
92766800|NCT04318847|Autonomic Agents|autonomic agents|mesh-ancestor
92766801|NCT04318847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766802|NCT04318847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766803|NCT04318847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766804|NCT04318847|Antipruritics|antipruritics|mesh-ancestor
92766805|NCT04318847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92766806|NCT04318847|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92766807|NCT04318847|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92766808|NCT04318847|Serotonin Agents|serotonin agents|mesh-ancestor
92766809|NCT04318847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766810|NCT04318847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766811|NCT02721511|Furosemide|furosemide|mesh-list
92766812|NCT02721511|Diuretics|diuretics|mesh-ancestor
92766813|NCT02721511|Natriuretic Agents|natriuretic agents|mesh-ancestor
92766814|NCT02721511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766815|NCT02721511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92766816|NCT02721511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766817|NCT02721511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766818|NCT02712307|Penicillins|penicillins|mesh-list
92766819|NCT02712307|Penicillin V|penicillin v|mesh-list
92766820|NCT02712307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766821|NCT02712307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766822|NCT02708251|Lidocaine|lidocaine|mesh-list
92766823|NCT02708251|Nitroglycerin|nitroglycerin|mesh-list
92766824|NCT02708251|Anesthetics, Local|anesthetics, local|mesh-ancestor
92766825|NCT02708251|Anesthetics|anesthetics|mesh-ancestor
92766826|NCT02708251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766827|NCT02708251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766828|NCT02708251|Sensory System Agents|sensory system agents|mesh-ancestor
92766829|NCT02708251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766830|NCT02708251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92766831|NCT02708251|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92766832|NCT02708251|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92766833|NCT02708251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92766834|NCT02708251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766835|NCT02708251|Vasodilator Agents|vasodilator agents|mesh-ancestor
92766836|NCT02708173|Vaccines|vaccines|mesh-list
92766837|NCT02708173|Immunologic Factors|immunologic factors|mesh-ancestor
92766838|NCT02708173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766839|NCT00611611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92766840|NCT00611611|Immunologic Factors|immunologic factors|mesh-ancestor
92766841|NCT00611611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766842|NCT00612625|Glucagon|glucagon|mesh-list
92766843|NCT00612625|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92766844|NCT00612625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766845|NCT00612625|Hormones|hormones|mesh-ancestor
92766846|NCT00612625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766847|NCT00612625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766848|NCT00612625|Incretins|incretins|mesh-ancestor
92766849|NCT02711917|Propofol|propofol|mesh-list
92766850|NCT02711917|Etomidate|etomidate|mesh-list
92766851|NCT02711917|Rocuronium|rocuronium|mesh-list
92766852|NCT02711917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92766853|NCT02711917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766854|NCT02711917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766855|NCT02711917|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92766856|NCT02711917|Anesthetics, General|anesthetics, general|mesh-ancestor
92766857|NCT02711917|Anesthetics|anesthetics|mesh-ancestor
92766858|NCT02711917|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92766859|NCT02711917|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92766860|NCT02711917|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92766861|NCT02711917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766862|NCT02711449|Methylprednisolone|methylprednisolone|mesh-list
92766863|NCT02711449|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92766864|NCT02711449|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92766865|NCT02711449|Prednisolone|prednisolone|mesh-list
92766866|NCT02711449|Prednisolone acetate|prednisolone acetate|mesh-list
92766867|NCT02711449|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92766868|NCT02711449|Prednisolone phosphate|prednisolone phosphate|mesh-list
92766869|NCT02711449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92766870|NCT02711449|Antiemetics|antiemetics|mesh-ancestor
92766871|NCT02711449|Autonomic Agents|autonomic agents|mesh-ancestor
92766872|NCT02711449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766873|NCT02711449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766874|NCT02711449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766875|NCT02711449|Glucocorticoids|glucocorticoids|mesh-ancestor
92766876|NCT02711449|Hormones|hormones|mesh-ancestor
92766877|NCT02711449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92766878|NCT02711449|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92766879|NCT02711449|Protective Agents|protective agents|mesh-ancestor
92766880|NCT02711449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92766881|NCT02711449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766882|NCT00612079|Sertindole|sertindole|mesh-list
92766883|NCT00612079|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92766884|NCT00612079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92766885|NCT00612079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766886|NCT00612079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766887|NCT00612079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92766888|NCT00940498|Gedatolisib|gedatolisib|mesh-list
92766889|NCT00940498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92766890|NCT00940498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766891|NCT00940498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766893|NCT03820531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766894|NCT02850718|Sildenafil Citrate|sildenafil citrate|mesh-list
92766895|NCT02850718|Vasodilator Agents|vasodilator agents|mesh-ancestor
92766896|NCT02850718|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92766897|NCT02850718|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92766898|NCT02850718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766899|NCT02850718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766900|NCT02850718|Urological Agents|urological agents|mesh-ancestor
92766901|NCT02707393|Cyclosporine|cyclosporine|mesh-list
92766902|NCT02707393|Mycophenolic Acid|mycophenolic acid|mesh-list
92766903|NCT02707393|Fludarabine|fludarabine|mesh-list
92766904|NCT02707393|Melphalan|melphalan|mesh-list
92766905|NCT02707393|Thiotepa|thiotepa|mesh-list
92766906|NCT02707393|Cyclosporins|cyclosporins|mesh-list
92766907|NCT02707393|Thymoglobulin|thymoglobulin|mesh-list
92766908|NCT02707393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766909|NCT02707393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766910|NCT02707393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92766911|NCT02707393|Immunologic Factors|immunologic factors|mesh-ancestor
92766912|NCT02707393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766913|NCT02707393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766914|NCT02707393|Antifungal Agents|antifungal agents|mesh-ancestor
92766915|NCT02707393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766916|NCT02707393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92766917|NCT02707393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766918|NCT02707393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92766919|NCT02707393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92766920|NCT02707393|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92766921|NCT02707393|Antitubercular Agents|antitubercular agents|mesh-ancestor
92766922|NCT02707393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766923|NCT02707393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92766924|NCT02707393|Alkylating Agents|alkylating agents|mesh-ancestor
92766925|NCT02707393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92766926|NCT00940342|Rituximab|rituximab|mesh-list
92766927|NCT00940342|Molgramostim|molgramostim|mesh-list
92766928|NCT00940342|Sargramostim|sargramostim|mesh-list
92766929|NCT00940342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92766930|NCT00940342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766931|NCT00940342|Immunologic Factors|immunologic factors|mesh-ancestor
92766932|NCT00940342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766933|NCT00940342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92766934|NCT00936910|Amphotericin B|amphotericin b|mesh-list
92766935|NCT00936910|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92766936|NCT00936910|Amebicides|amebicides|mesh-ancestor
92766937|NCT00936910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92766938|NCT00936910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92766939|NCT00936910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92766940|NCT00936910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92766941|NCT00936910|Antifungal Agents|antifungal agents|mesh-ancestor
92766942|NCT02707315|Gemcitabine|gemcitabine|mesh-list
92766943|NCT02707315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92766944|NCT02707315|Antimetabolites|antimetabolites|mesh-ancestor
92766945|NCT02707315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766946|NCT02707315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92766947|NCT00604942|Domperidone|domperidone|mesh-list
92766948|NCT00604942|Esomeprazole|esomeprazole|mesh-list
92766949|NCT00604942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92766950|NCT00604942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766951|NCT00604942|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92766952|NCT00604942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766953|NCT00604942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766954|NCT00604942|Antiemetics|antiemetics|mesh-ancestor
92766955|NCT00604942|Autonomic Agents|autonomic agents|mesh-ancestor
92766956|NCT00604942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766957|NCT00604942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766958|NCT00604942|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92766959|NCT00604942|Dopamine Agents|dopamine agents|mesh-ancestor
92766960|NCT00604942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766961|NCT02711683|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92766962|NCT02711683|Donepezil|donepezil|mesh-list
92766963|NCT02711683|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92766964|NCT02711683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92766965|NCT02711683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92766966|NCT02711683|Cholinergic Agents|cholinergic agents|mesh-ancestor
92766967|NCT02711683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92766968|NCT02711683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766969|NCT02711683|Nootropic Agents|nootropic agents|mesh-ancestor
92766970|NCT02711683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92766971|NCT02711683|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92766972|NCT02711683|Protective Agents|protective agents|mesh-ancestor
92766973|NCT05079061|Misoprostol|misoprostol|mesh-list
92766974|NCT05079061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92766975|NCT05079061|Abortifacient Agents|abortifacient agents|mesh-ancestor
92766976|NCT05079061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92766977|NCT05079061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766978|NCT05079061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92766979|NCT05079061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92766980|NCT05079061|Oxytocics|oxytocics|mesh-ancestor
92766981|NCT00605020|Insulin|insulin|mesh-list
92766982|NCT00605020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92766983|NCT00605020|Insulin Aspart|insulin aspart|mesh-list
92766984|NCT00605020|Insulin, Long-Acting|insulin, long-acting|mesh-list
92766985|NCT00605020|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92766986|NCT00605020|Insulin Detemir|insulin detemir|mesh-list
92766987|NCT00605020|Biphasic Insulins|biphasic insulins|mesh-list
92766988|NCT00605020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92766989|NCT00605020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766990|NCT02707081|Lidocaine|lidocaine|mesh-list
92766991|NCT02707081|Anesthetics, Local|anesthetics, local|mesh-ancestor
92766992|NCT02707081|Anesthetics|anesthetics|mesh-ancestor
92766993|NCT02707081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92766994|NCT02707081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92766995|NCT02707081|Sensory System Agents|sensory system agents|mesh-ancestor
92766996|NCT02707081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92766997|NCT02707081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92766998|NCT02707081|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92766999|NCT02707081|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92767000|NCT02707081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92767001|NCT02707081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767002|NCT00605098|Ritonavir|ritonavir|mesh-list
92767003|NCT00605098|Lopinavir|lopinavir|mesh-list
92767004|NCT00605098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92767005|NCT00605098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92767006|NCT00605098|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767007|NCT00605098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767008|NCT00605098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767009|NCT00605098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92767010|NCT00605098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92767011|NCT00605098|Antiviral Agents|antiviral agents|mesh-ancestor
92767012|NCT00605098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767013|NCT00605098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92767014|NCT00605098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92767015|NCT02711215|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92767016|NCT02711215|Mirtazapine|mirtazapine|mesh-list
92767017|NCT02711215|Citalopram|citalopram|mesh-list
92767018|NCT02711215|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92767019|NCT02711215|Escitalopram|escitalopram|mesh-list
92767020|NCT02711215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92767021|NCT02711215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92767022|NCT02711215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92767023|NCT02711215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767024|NCT02711215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767025|NCT02711215|Serotonin Agents|serotonin agents|mesh-ancestor
92767026|NCT02711215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767027|NCT02711215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767028|NCT02711215|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92767029|NCT02711215|Antidepressive Agents|antidepressive agents|mesh-ancestor
92767030|NCT02711215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92767031|NCT02711215|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92767032|NCT02711215|Analgesics|analgesics|mesh-ancestor
92767033|NCT02711215|Sensory System Agents|sensory system agents|mesh-ancestor
92767034|NCT02711215|Dopamine Agents|dopamine agents|mesh-ancestor
92767035|NCT02711215|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92767036|NCT02711215|Histamine Antagonists|histamine antagonists|mesh-ancestor
92767037|NCT02711215|Histamine Agents|histamine agents|mesh-ancestor
92767038|NCT02711215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92767039|NCT02711215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92767040|NCT02711215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767041|NCT02711215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92767042|NCT02711215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92767043|NCT02711215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92767044|NCT02711215|Adrenergic Agents|adrenergic agents|mesh-ancestor
92767045|NCT02711215|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92767046|NCT02711215|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92767047|NCT02711215|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92767049|NCT00603772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767050|NCT00603772|Keratolytic Agents|keratolytic agents|mesh-ancestor
92767051|NCT00603772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92767052|NCT02706769|Acetaminophen|acetaminophen|mesh-list
92767053|NCT02706769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92767054|NCT02706769|Analgesics|analgesics|mesh-ancestor
92767055|NCT02706769|Sensory System Agents|sensory system agents|mesh-ancestor
92767056|NCT02706769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767057|NCT02706769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767058|NCT02706769|Antipyretics|antipyretics|mesh-ancestor
92767059|NCT05044117|Capecitabine|capecitabine|mesh-list
92767060|NCT05044117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92767061|NCT05044117|Antimetabolites|antimetabolites|mesh-ancestor
92767062|NCT05044117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767063|NCT05044117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767064|NCT03961165|Scopolamine|scopolamine|mesh-list
92767065|NCT03961165|Bromides|bromides|mesh-list
92767066|NCT03961165|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92767067|NCT03961165|Anticonvulsants|anticonvulsants|mesh-ancestor
92767068|NCT03961165|Parasympatholytics|parasympatholytics|mesh-ancestor
92767069|NCT03961165|Autonomic Agents|autonomic agents|mesh-ancestor
92767070|NCT03961165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767071|NCT03961165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767072|NCT03961165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92767073|NCT03961165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92767074|NCT03961165|Cholinergic Agents|cholinergic agents|mesh-ancestor
92767075|NCT03961165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767076|NCT03961165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767077|NCT03961165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92767078|NCT03961165|Antiemetics|antiemetics|mesh-ancestor
92767079|NCT03961165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767080|NCT03961165|Mydriatics|mydriatics|mesh-ancestor
92767081|NCT02706535|Itraconazole|itraconazole|mesh-list
92767082|NCT02706535|Rifampin|rifampin|mesh-list
92767083|NCT02706535|Antifungal Agents|antifungal agents|mesh-ancestor
92767084|NCT02706535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767085|NCT02706535|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92767086|NCT02706535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92767087|NCT02706535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767088|NCT02706535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767089|NCT02706535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92767090|NCT02706535|Hormone Antagonists|hormone antagonists|mesh-ancestor
92767091|NCT02706535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767092|NCT02706535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767093|NCT02706535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92767094|NCT02706535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92336103|NCT01622868|Lapatinib|lapatinib|mesh-list
92767095|NCT02706535|Antitubercular Agents|antitubercular agents|mesh-ancestor
92767096|NCT02706535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767097|NCT02706535|Leprostatic Agents|leprostatic agents|mesh-ancestor
92767098|NCT02706535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92767099|NCT02706535|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92767100|NCT02706535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92767101|NCT02706535|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92767102|NCT02706535|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92767103|NCT02706535|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92767104|NCT02706535|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92767105|NCT02711059|Parathyroid Hormone|parathyroid hormone|mesh-list
92767106|NCT02711059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92767107|NCT02711059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767108|NCT00612157|Eszopiclone|eszopiclone|mesh-list
92767109|NCT00612157|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92767110|NCT00612157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767111|NCT00612157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767112|NCT00936598|Zolpidem|zolpidem|mesh-list
92767113|NCT00936598|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92767114|NCT00936598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92767115|NCT00936598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767116|NCT00936598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767117|NCT00936598|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92767118|NCT00936598|GABA Agonists|gaba agonists|mesh-ancestor
92767119|NCT00936598|GABA Agents|gaba agents|mesh-ancestor
92767120|NCT00936598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767121|NCT00936598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767122|NCT01025817|Mycophenolic Acid|mycophenolic acid|mesh-list
92767123|NCT01025817|Everolimus|everolimus|mesh-list
92767124|NCT01025817|Tacrolimus|tacrolimus|mesh-list
92767125|NCT01025817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767126|NCT01025817|Immunologic Factors|immunologic factors|mesh-ancestor
92767127|NCT01025817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767128|NCT01025817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92767129|NCT01025817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767130|NCT01025817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767131|NCT01025817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92767132|NCT01025817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767133|NCT01025817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767134|NCT01025817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92767135|NCT01025817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92767136|NCT01025817|Antitubercular Agents|antitubercular agents|mesh-ancestor
92767137|NCT01025817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767138|NCT01025817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767139|NCT00636883|Gemcitabine|gemcitabine|mesh-list
92767140|NCT00636883|Oxaliplatin|oxaliplatin|mesh-list
92767141|NCT00636883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92767142|NCT00636883|Antimetabolites|antimetabolites|mesh-ancestor
92767143|NCT00636883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767144|NCT00636883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767145|NCT00605410|Bromides|bromides|mesh-list
92767146|NCT00605410|Ipratropium|ipratropium|mesh-list
92767147|NCT00605410|Anticonvulsants|anticonvulsants|mesh-ancestor
92767148|NCT00605410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92767149|NCT00605410|Autonomic Agents|autonomic agents|mesh-ancestor
92767150|NCT00605410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767151|NCT00605410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767152|NCT00605410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92767153|NCT00605410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92767154|NCT00605410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92767155|NCT00605410|Cholinergic Agents|cholinergic agents|mesh-ancestor
92767156|NCT00605410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767157|NCT00605410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767158|NCT04300881|Eplerenone|eplerenone|mesh-list
92767159|NCT04300881|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92767160|NCT04300881|Hormone Antagonists|hormone antagonists|mesh-ancestor
92767161|NCT04300881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767162|NCT04300881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767163|NCT04300881|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92767164|NCT04300881|Diuretics|diuretics|mesh-ancestor
92767165|NCT04300881|Natriuretic Agents|natriuretic agents|mesh-ancestor
92767166|NCT04300881|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767167|NCT03873493|Venetoclax|venetoclax|mesh-list
92767168|NCT03873493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767169|NCT04300309|Lumefantrine|lumefantrine|mesh-list
92767170|NCT04300309|Artemether|artemether|mesh-list
92767171|NCT04300309|Antimalarials|antimalarials|mesh-ancestor
92767172|NCT04300309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92767173|NCT04300309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92767174|NCT04300309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767175|NCT00611689|Imatinib Mesylate|imatinib mesylate|mesh-list
92767176|NCT00611689|Vatalanib|vatalanib|mesh-list
92767177|NCT00611689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767178|NCT00611689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767179|NCT00611689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767180|NCT00611689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767181|NCT05264077|Midazolam|midazolam|mesh-list
92767182|NCT05264077|Dexmedetomidine|dexmedetomidine|mesh-list
92767183|NCT05264077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92767184|NCT05264077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767185|NCT05264077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767186|NCT05264077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92767187|NCT05264077|Analgesics|analgesics|mesh-ancestor
92767188|NCT05264077|Sensory System Agents|sensory system agents|mesh-ancestor
92767189|NCT05264077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767190|NCT05264077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92767191|NCT05264077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92767192|NCT05264077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92767193|NCT05264077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92767194|NCT05264077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767195|NCT05264077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767196|NCT05264077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92767197|NCT05264077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92767198|NCT05264077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92767199|NCT05264077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92767200|NCT05264077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92767201|NCT05264077|Anesthetics, General|anesthetics, general|mesh-ancestor
92767202|NCT05264077|Anesthetics|anesthetics|mesh-ancestor
92767203|NCT05264077|GABA Modulators|gaba modulators|mesh-ancestor
92767204|NCT05264077|GABA Agents|gaba agents|mesh-ancestor
92767205|NCT00612859|Levetiracetam|levetiracetam|mesh-list
92767206|NCT00612859|Anticonvulsants|anticonvulsants|mesh-ancestor
92767207|NCT00612859|Nootropic Agents|nootropic agents|mesh-ancestor
92767208|NCT03872401|Evolocumab|evolocumab|mesh-list
92767209|NCT03872401|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92767210|NCT03872401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92767211|NCT03872401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92767212|NCT03872401|Antimetabolites|antimetabolites|mesh-ancestor
92767213|NCT03872401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767214|NCT03872401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92767215|NCT03872401|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767216|NCT03872401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767217|NCT03872401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92767218|NCT01010217|Mycophenolic Acid|mycophenolic acid|mesh-list
92767219|NCT01010217|Cyclophosphamide|cyclophosphamide|mesh-list
92767220|NCT01010217|Melphalan|melphalan|mesh-list
92767221|NCT01010217|Thiotepa|thiotepa|mesh-list
92767222|NCT01010217|Rituximab|rituximab|mesh-list
92767223|NCT01010217|Fludarabine|fludarabine|mesh-list
92767224|NCT01010217|Fludarabine phosphate|fludarabine phosphate|mesh-list
92767225|NCT01010217|Tacrolimus|tacrolimus|mesh-list
92767226|NCT01010217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767227|NCT01010217|Immunologic Factors|immunologic factors|mesh-ancestor
92767228|NCT01010217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767229|NCT01010217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767230|NCT01010217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92767231|NCT01010217|Alkylating Agents|alkylating agents|mesh-ancestor
92767232|NCT01010217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767233|NCT01010217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767234|NCT01010217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92767235|NCT01010217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767236|NCT01010217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92767237|NCT01010217|Antimetabolites|antimetabolites|mesh-ancestor
92767238|NCT01010217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767239|NCT01010217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92767240|NCT01010217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767241|NCT01010217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92767242|NCT01010217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92767243|NCT01010217|Antitubercular Agents|antitubercular agents|mesh-ancestor
92767244|NCT01010217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767245|NCT04558359|Angiotensin II|angiotensin ii|mesh-list
92767246|NCT04558359|Giapreza|giapreza|mesh-list
92767247|NCT04558359|Angiotensinogen|angiotensinogen|mesh-list
92767248|NCT04558359|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92767249|NCT04558359|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92767250|NCT04558359|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767251|NCT04558359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767252|NCT04558359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767253|NCT00604006|Spironolactone|spironolactone|mesh-list
92767254|NCT00604006|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92767255|NCT00604006|Hormone Antagonists|hormone antagonists|mesh-ancestor
92767256|NCT00604006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529876|NCT00038506|Tenofovir|tenofovir|mesh-list
92767257|NCT00604006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767258|NCT00604006|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92767259|NCT00604006|Diuretics|diuretics|mesh-ancestor
92767260|NCT00604006|Natriuretic Agents|natriuretic agents|mesh-ancestor
92767261|NCT00604084|Ivermectin|ivermectin|mesh-list
92767262|NCT00604084|Permethrin|permethrin|mesh-list
92767263|NCT00604084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92767264|NCT00604084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717205|NCT01214434|Emollients|emollients|mesh-list
92767265|NCT00604084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767266|NCT00604084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767268|NCT05379478|Immunologic Factors|immunologic factors|mesh-ancestor
92767269|NCT05379478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767270|NCT04267042|Budesonide|budesonide|mesh-list
92767271|NCT04267042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767272|NCT04267042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92767273|NCT04267042|Autonomic Agents|autonomic agents|mesh-ancestor
92767274|NCT04267042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767275|NCT04267042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767276|NCT04267042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92767277|NCT04267042|Respiratory System Agents|respiratory system agents|mesh-ancestor
92767278|NCT04267042|Glucocorticoids|glucocorticoids|mesh-ancestor
92767279|NCT04267042|Hormones|hormones|mesh-ancestor
92767280|NCT04267042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767281|NCT01217957|Dexamethasone|dexamethasone|mesh-list
92767282|NCT01217957|Lenalidomide|lenalidomide|mesh-list
92767283|NCT01217957|Ixazomib|ixazomib|mesh-list
92767284|NCT01217957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767285|NCT01217957|Antiemetics|antiemetics|mesh-ancestor
92767286|NCT01217957|Autonomic Agents|autonomic agents|mesh-ancestor
92767287|NCT01217957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767288|NCT01217957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767289|NCT01217957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767290|NCT01217957|Glucocorticoids|glucocorticoids|mesh-ancestor
92767291|NCT01217957|Hormones|hormones|mesh-ancestor
92767292|NCT01217957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767293|NCT01217957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92767294|NCT01217957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767295|NCT01217957|Immunologic Factors|immunologic factors|mesh-ancestor
92767296|NCT01217957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92767297|NCT01217957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92767298|NCT01217957|Growth Substances|growth substances|mesh-ancestor
92767299|NCT01217957|Growth Inhibitors|growth inhibitors|mesh-ancestor
92767300|NCT01217957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767301|NCT01217957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767302|NCT01217957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767303|NCT01217801|Ondansetron|ondansetron|mesh-list
92767304|NCT01217801|Antiemetics|antiemetics|mesh-ancestor
92767305|NCT01217801|Autonomic Agents|autonomic agents|mesh-ancestor
92767306|NCT01217801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767307|NCT01217801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767308|NCT01217801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767309|NCT01217801|Antipruritics|antipruritics|mesh-ancestor
92767310|NCT01217801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92767311|NCT01217801|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92767312|NCT01217801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92767313|NCT01217801|Serotonin Agents|serotonin agents|mesh-ancestor
92767314|NCT01217801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767315|NCT01217801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767316|NCT00935818|Bupropion|bupropion|mesh-list
92767317|NCT00935818|Varenicline|varenicline|mesh-list
92767318|NCT00935818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92767319|NCT00935818|Antidepressive Agents|antidepressive agents|mesh-ancestor
92767320|NCT00935818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92767321|NCT00935818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92767322|NCT00935818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92767323|NCT00935818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92767324|NCT00935818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767325|NCT00935818|Dopamine Agents|dopamine agents|mesh-ancestor
92767326|NCT00935818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767327|NCT00935818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767328|NCT00935818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92767329|NCT00935818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92767330|NCT00935818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767331|NCT00935818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92767333|NCT00935818|Cholinergic Agents|cholinergic agents|mesh-ancestor
92767334|NCT02709265|Amikacin|amikacin|mesh-list
92767335|NCT02709265|Fosfomycin|fosfomycin|mesh-list
92767336|NCT02709265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767337|NCT02709265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767338|NCT00611845|Aprotinin|aprotinin|mesh-list
92767339|NCT00611845|Hemostatics|hemostatics|mesh-ancestor
92767340|NCT00611845|Coagulants|coagulants|mesh-ancestor
92717280|NCT04657107|Anesthetics|anesthetics|mesh-ancestor
92767341|NCT00611845|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92767342|NCT00611845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92767343|NCT00611845|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767344|NCT00611845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767345|NCT00611845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767346|NCT01216163|Acetaminophen|acetaminophen|mesh-list
92767347|NCT01216163|Ibuprofen|ibuprofen|mesh-list
92767348|NCT01216163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92767349|NCT01216163|Analgesics|analgesics|mesh-ancestor
92767350|NCT01216163|Sensory System Agents|sensory system agents|mesh-ancestor
92767351|NCT01216163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767352|NCT01216163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767353|NCT01216163|Antipyretics|antipyretics|mesh-ancestor
92767354|NCT01216163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92767355|NCT01216163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767356|NCT01216163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767357|NCT01216163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92767358|NCT01216163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767359|NCT01216163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767360|NCT05260255|Vitamin D|vitamin d|mesh-list
92767361|NCT05260255|Ergocalciferols|ergocalciferols|mesh-list
92767362|NCT05260255|Vitamins|vitamins|mesh-ancestor
92767363|NCT05260255|Micronutrients|micronutrients|mesh-ancestor
92767364|NCT05260255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767365|NCT05260255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92767366|NCT05260255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92767367|NCT00612469|Chlorhexidine|chlorhexidine|mesh-list
92767368|NCT00612469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92767369|NCT00612469|Listerine|listerine|mesh-list
92767370|NCT00612469|Vancomycin|vancomycin|mesh-list
92767371|NCT00612469|Fluorides|fluorides|mesh-list
92767372|NCT00612469|Sodium Fluoride|sodium fluoride|mesh-list
92767373|NCT00612469|Cariostatic Agents|cariostatic agents|mesh-ancestor
92767374|NCT00612469|Protective Agents|protective agents|mesh-ancestor
92767375|NCT00612469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767376|NCT00612469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92767377|NCT00612469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767378|NCT00612469|Disinfectants|disinfectants|mesh-ancestor
92767379|NCT00612469|Dermatologic Agents|dermatologic agents|mesh-ancestor
92767380|NCT00612469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767381|NCT00933244|Vitamin D|vitamin d|mesh-list
92767382|NCT00933244|Ergocalciferols|ergocalciferols|mesh-list
92767383|NCT00933244|Cholecalciferol|cholecalciferol|mesh-list
92767384|NCT00933244|Vitamins|vitamins|mesh-list
92767385|NCT00933244|Micronutrients|micronutrients|mesh-ancestor
92767386|NCT00933244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767387|NCT00933244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92767388|NCT00933244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92767389|NCT02709187|Candesartan|candesartan|mesh-list
92767390|NCT02709187|Candesartan cilexetil|candesartan cilexetil|mesh-list
92767391|NCT02709187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92767392|NCT02709187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92767393|NCT02709187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92767394|NCT02709187|Antimetabolites|antimetabolites|mesh-ancestor
92767395|NCT02709187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767396|NCT02709187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92767397|NCT02709187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92767398|NCT02709187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767399|NCT02709187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767400|NCT02709187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92767401|NCT02709187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92767402|NCT00930046|Ropivacaine|ropivacaine|mesh-list
92767403|NCT00930046|Anesthetics, Local|anesthetics, local|mesh-ancestor
92767404|NCT00930046|Anesthetics|anesthetics|mesh-ancestor
92767405|NCT00930046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767406|NCT00930046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767407|NCT00930046|Sensory System Agents|sensory system agents|mesh-ancestor
92529878|NCT00038506|Zidovudine|zidovudine|mesh-list
92767408|NCT00930046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767410|NCT05244031|Narcotics|narcotics|mesh-ancestor
92767411|NCT05244031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767412|NCT05244031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767413|NCT05244031|Analgesics|analgesics|mesh-ancestor
92767414|NCT05244031|Sensory System Agents|sensory system agents|mesh-ancestor
92767415|NCT05244031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767416|NCT04712071|Ketamine|ketamine|mesh-list
92717352|NCT04824911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92767417|NCT04712071|Analgesics|analgesics|mesh-ancestor
92767418|NCT04712071|Sensory System Agents|sensory system agents|mesh-ancestor
92767419|NCT04712071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767420|NCT04712071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767421|NCT04712071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92767422|NCT04712071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92767423|NCT04712071|Anesthetics, General|anesthetics, general|mesh-ancestor
92767424|NCT04712071|Anesthetics|anesthetics|mesh-ancestor
92767425|NCT04712071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767426|NCT04712071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92767427|NCT04712071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92767428|NCT04712071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767429|NCT04712071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767430|NCT05151328|Plecanatide|plecanatide|mesh-list
92767431|NCT05151328|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92767432|NCT05151328|Enzyme Activators|enzyme activators|mesh-ancestor
92767433|NCT05151328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767434|NCT05151328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767435|NCT00609388|Tacrolimus|tacrolimus|mesh-list
92767436|NCT00609388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767437|NCT00609388|Immunologic Factors|immunologic factors|mesh-ancestor
92767438|NCT00609388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767439|NCT00609388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92767440|NCT00609388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767441|NCT00609388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767442|NCT02709031|Cicletanine|cicletanine|mesh-list
92767443|NCT02709031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92767444|NCT02709031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767445|NCT02709031|Diuretics|diuretics|mesh-ancestor
92767446|NCT02709031|Natriuretic Agents|natriuretic agents|mesh-ancestor
92767447|NCT02709031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767448|NCT05225545|Iron|iron|mesh-list
92767449|NCT05225545|Trace Elements|trace elements|mesh-ancestor
92767450|NCT05225545|Micronutrients|micronutrients|mesh-ancestor
92767451|NCT05225545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767452|NCT05378932|Melatonin|melatonin|mesh-list
92767453|NCT05378932|Antioxidants|antioxidants|mesh-ancestor
92767454|NCT05378932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767455|NCT05378932|Protective Agents|protective agents|mesh-ancestor
92767456|NCT05378932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767457|NCT05378932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767458|NCT00612547|Artesunate|artesunate|mesh-list
92767459|NCT00612547|Amodiaquine|amodiaquine|mesh-list
92767460|NCT00612547|Antimalarials|antimalarials|mesh-ancestor
92767461|NCT00612547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92767462|NCT00612547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92767463|NCT00612547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767464|NCT00612547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767465|NCT00612547|Antiviral Agents|antiviral agents|mesh-ancestor
92767466|NCT00612547|Schistosomicides|schistosomicides|mesh-ancestor
92767467|NCT00612547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92767468|NCT00612547|Anthelmintics|anthelmintics|mesh-ancestor
92767469|NCT00606268|Micafungin|micafungin|mesh-list
92767470|NCT00606268|Antifungal Agents|antifungal agents|mesh-ancestor
92767471|NCT00606268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767472|NCT05342857|Aflibercept|aflibercept|mesh-list
92767473|NCT05342857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92767474|NCT05342857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92767475|NCT05342857|Growth Substances|growth substances|mesh-ancestor
92767476|NCT05342857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767477|NCT05342857|Growth Inhibitors|growth inhibitors|mesh-ancestor
92767478|NCT05342857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767479|NCT04264624|Erythritol|erythritol|mesh-list
92767480|NCT04264624|Vasodilator Agents|vasodilator agents|mesh-ancestor
92767481|NCT04188691|Vaccines|vaccines|mesh-list
92767482|NCT04188691|Immunologic Factors|immunologic factors|mesh-ancestor
92529879|NCT00038506|Abacavir|abacavir|mesh-list
92767483|NCT04188691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767484|NCT01215851|Moxifloxacin|moxifloxacin|mesh-list
92767485|NCT01215851|Pyrazinamide|pyrazinamide|mesh-list
92767486|NCT01215851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767487|NCT01215851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767488|NCT01215851|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92767489|NCT01215851|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92767490|NCT01215851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767491|NCT01215851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767492|NCT01215851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717427|NCT04537598|Analgesics|analgesics|mesh-ancestor
92767493|NCT01215851|Antitubercular Agents|antitubercular agents|mesh-ancestor
92767495|NCT00613093|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92767496|NCT00613093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92767497|NCT00613093|Alkylating Agents|alkylating agents|mesh-ancestor
92767498|NCT00613093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767499|NCT00613093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767500|NCT00613093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767501|NCT00607750|Mecamylamine|mecamylamine|mesh-list
92767502|NCT00607750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767503|NCT00607750|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92767504|NCT00607750|Autonomic Agents|autonomic agents|mesh-ancestor
92767505|NCT00607750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767506|NCT00607750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767507|NCT00607750|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92767508|NCT00607750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92767509|NCT00607750|Cholinergic Agents|cholinergic agents|mesh-ancestor
92767510|NCT00607750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767511|NCT00607750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767512|NCT00609544|Rilonacept|rilonacept|mesh-list
92767513|NCT00609544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767514|NCT04908475|Apremilast|apremilast|mesh-list
92767515|NCT04908475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92767516|NCT04908475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92767517|NCT04908475|Analgesics|analgesics|mesh-ancestor
92767518|NCT04908475|Sensory System Agents|sensory system agents|mesh-ancestor
92767519|NCT04908475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767520|NCT04908475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767521|NCT04908475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767522|NCT04908475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767523|NCT04908475|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92767524|NCT04908475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92767525|NCT04908475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767526|NCT04908475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767527|NCT03513211|Hydroxychloroquine|hydroxychloroquine|mesh-list
92767528|NCT03513211|Itraconazole|itraconazole|mesh-list
92767529|NCT03513211|Antimalarials|antimalarials|mesh-ancestor
92767530|NCT03513211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92767531|NCT03513211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92767532|NCT03513211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767533|NCT03513211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767534|NCT03513211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767535|NCT03513211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767536|NCT03513211|Antifungal Agents|antifungal agents|mesh-ancestor
92767537|NCT03513211|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92767538|NCT03513211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92767539|NCT03513211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92767540|NCT03513211|Hormone Antagonists|hormone antagonists|mesh-ancestor
92767541|NCT03513211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767542|NCT03513211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767543|NCT03513211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92767544|NCT04611139|Pembrolizumab|pembrolizumab|mesh-list
92767545|NCT04611139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767546|NCT04611139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767547|NCT04611139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92767548|NCT04611139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767549|NCT04570501|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92767550|NCT04570501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767551|NCT04570501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92767552|NCT05198791|Eplerenone|eplerenone|mesh-list
92767553|NCT05198791|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92767554|NCT05198791|Hormone Antagonists|hormone antagonists|mesh-ancestor
92767555|NCT05198791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767556|NCT05198791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767557|NCT05198791|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92767559|NCT05198791|Natriuretic Agents|natriuretic agents|mesh-ancestor
92767560|NCT05198791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767561|NCT01010061|Rituximab|rituximab|mesh-list
92767562|NCT01010061|Obinutuzumab|obinutuzumab|mesh-list
92767563|NCT01010061|Chlorambucil|chlorambucil|mesh-list
92767564|NCT01010061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767565|NCT01010061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767566|NCT01010061|Immunologic Factors|immunologic factors|mesh-ancestor
92767567|NCT01010061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767568|NCT01010061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767569|NCT01010061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92767570|NCT01010061|Alkylating Agents|alkylating agents|mesh-ancestor
92767571|NCT01010061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767572|NCT00607984|Melphalan|melphalan|mesh-list
92767573|NCT00607984|Thiotepa|thiotepa|mesh-list
92767574|NCT00607984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92767575|NCT00607984|Alkylating Agents|alkylating agents|mesh-ancestor
92767576|NCT00607984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767577|NCT00607984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767578|NCT00607984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92767579|NCT00607984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767580|NCT00607984|Immunologic Factors|immunologic factors|mesh-ancestor
92767581|NCT00607984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767582|NCT00929734|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92767583|NCT00929734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92767584|NCT00929734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92767585|NCT00929734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92767586|NCT00929734|Antimetabolites|antimetabolites|mesh-ancestor
92767587|NCT00929734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767588|NCT00929734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92767589|NCT00929734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767590|NCT00609856|Insulin Glargine|insulin glargine|mesh-list
92767591|NCT00609856|Pioglitazone|pioglitazone|mesh-list
92767592|NCT00609856|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92767593|NCT00609856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767594|NCT04527757|Anesthetics|anesthetics|mesh-list
92767595|NCT04527757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767596|NCT04527757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767597|NCT00613249|Dapivirine|dapivirine|mesh-list
92767598|NCT00613249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92767599|NCT00613249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92767600|NCT00613249|Antiviral Agents|antiviral agents|mesh-ancestor
92767601|NCT00613249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767602|NCT00613561|Fludarabine|fludarabine|mesh-list
92767603|NCT00613561|Busulfan|busulfan|mesh-list
92767604|NCT00613561|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92767605|NCT00613561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767606|NCT00613561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767607|NCT00613561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767608|NCT00613561|Immunologic Factors|immunologic factors|mesh-ancestor
92767609|NCT00613561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767610|NCT00613561|Alkylating Agents|alkylating agents|mesh-ancestor
92767611|NCT00613561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92767612|NCT00613561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92767613|NCT01009983|Paclitaxel|paclitaxel|mesh-list
92767614|NCT01009983|Carboplatin|carboplatin|mesh-list
92767615|NCT01009983|Panitumumab|panitumumab|mesh-list
92767616|NCT01009983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92767617|NCT01009983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767618|NCT01009983|Tubulin Modulators|tubulin modulators|mesh-ancestor
92767619|NCT01009983|Antimitotic Agents|antimitotic agents|mesh-ancestor
92767620|NCT01009983|Mitosis Modulators|mitosis modulators|mesh-ancestor
92767621|NCT01009983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336169|NCT02036502|Hormones|hormones|mesh-ancestor
92767622|NCT01009983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767623|NCT04297215|Anti-Infective Agents|anti-infective agents|mesh-list
92767624|NCT04297215|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92767625|NCT04297215|Chitosan|chitosan|mesh-list
92767626|NCT04297215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92767627|NCT04297215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92767628|NCT04297215|Antimetabolites|antimetabolites|mesh-ancestor
92529881|NCT00038506|Antiviral Agents|antiviral agents|mesh-ancestor
92767629|NCT04297215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767630|NCT04297215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92767631|NCT04297215|Chelating Agents|chelating agents|mesh-ancestor
92767632|NCT04297215|Sequestering Agents|sequestering agents|mesh-ancestor
92767633|NCT04297215|Hemostatics|hemostatics|mesh-ancestor
92767634|NCT04297215|Coagulants|coagulants|mesh-ancestor
92767635|NCT02873091|Sufentanil|sufentanil|mesh-list
92767636|NCT02873091|Ropivacaine|ropivacaine|mesh-list
92767637|NCT02873091|Anesthetics, Local|anesthetics, local|mesh-ancestor
92767638|NCT02873091|Anesthetics|anesthetics|mesh-ancestor
92767639|NCT02873091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767640|NCT02873091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767641|NCT02873091|Sensory System Agents|sensory system agents|mesh-ancestor
92767642|NCT02873091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767643|NCT02873091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92767644|NCT02873091|Narcotics|narcotics|mesh-ancestor
92767645|NCT02873091|Analgesics|analgesics|mesh-ancestor
92767646|NCT02873091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92767647|NCT02873091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92767648|NCT02873091|Anesthetics, General|anesthetics, general|mesh-ancestor
92767649|NCT04298775|Morphine|morphine|mesh-list
92767650|NCT04298775|Anesthetics|anesthetics|mesh-list
92767651|NCT04298775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767652|NCT04298775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767653|NCT04298775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92767654|NCT04298775|Narcotics|narcotics|mesh-ancestor
92767655|NCT04298775|Analgesics|analgesics|mesh-ancestor
92767656|NCT04298775|Sensory System Agents|sensory system agents|mesh-ancestor
92767657|NCT04298775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767658|NCT01215227|Rasagiline|rasagiline|mesh-list
92767659|NCT01215227|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92767660|NCT01215227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767661|NCT01215227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767662|NCT01215227|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92767663|NCT01215227|Protective Agents|protective agents|mesh-ancestor
92767664|NCT01215227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767665|NCT01009515|Paclitaxel|paclitaxel|mesh-list
92767666|NCT01009515|Carboplatin|carboplatin|mesh-list
92767667|NCT01009515|Temozolomide|temozolomide|mesh-list
92767668|NCT01009515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92767669|NCT01009515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767670|NCT01009515|Tubulin Modulators|tubulin modulators|mesh-ancestor
92767671|NCT01009515|Antimitotic Agents|antimitotic agents|mesh-ancestor
92767672|NCT01009515|Mitosis Modulators|mitosis modulators|mesh-ancestor
92767673|NCT01009515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767674|NCT01009515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92767675|NCT01009515|Alkylating Agents|alkylating agents|mesh-ancestor
92767676|NCT04550481|Lisinopril|lisinopril|mesh-list
92767677|NCT04550481|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92767678|NCT04550481|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767679|NCT04550481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767680|NCT04550481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767681|NCT04550481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92767682|NCT04550481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92767683|NCT04550481|Protective Agents|protective agents|mesh-ancestor
92767684|NCT04550481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767685|NCT01214915|Anagrelide|anagrelide|mesh-list
92767686|NCT01214915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92767687|NCT01214915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92767688|NCT01214915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767689|NCT01214915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92767690|NCT01009203|Sirolimus|sirolimus|mesh-list
92767691|NCT01009203|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92767692|NCT01009203|Temsirolimus|temsirolimus|mesh-list
92767693|NCT01009203|MTOR Inhibitors|mtor inhibitors|mesh-list
92767694|NCT01009203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767695|NCT01009203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767696|NCT01009203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767697|NCT01009203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767698|NCT01009203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767699|NCT01009203|Immunologic Factors|immunologic factors|mesh-ancestor
92767700|NCT01009203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767701|NCT01009203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767702|NCT01009203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767703|NCT01009203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92767704|NCT01009203|Antifungal Agents|antifungal agents|mesh-ancestor
92767705|NCT01009047|Aripiprazole|aripiprazole|mesh-list
92767706|NCT01009047|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92767707|NCT01009047|Antidepressive Agents|antidepressive agents|mesh-ancestor
92767708|NCT01009047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92767709|NCT01009047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92767710|NCT01009047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92767711|NCT01009047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92767712|NCT01009047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767713|NCT01009047|Dopamine Agonists|dopamine agonists|mesh-ancestor
92767714|NCT01009047|Dopamine Agents|dopamine agents|mesh-ancestor
92767715|NCT01009047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717651|NCT04653792|Anticonvulsants|anticonvulsants|mesh-ancestor
92767716|NCT01009047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767717|NCT01009047|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92767718|NCT01009047|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92767719|NCT01009047|Serotonin Agents|serotonin agents|mesh-ancestor
92767720|NCT01009047|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92767721|NCT01009047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92767722|NCT01009047|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92767723|NCT01009047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92767724|NCT04205097|Neostigmine|neostigmine|mesh-list
92767725|NCT04205097|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92767726|NCT04205097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767727|NCT04205097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767728|NCT04205097|Cholinergic Agents|cholinergic agents|mesh-ancestor
92767729|NCT04205097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767730|NCT04205097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767731|NCT04205097|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92767732|NCT04205097|Autonomic Agents|autonomic agents|mesh-ancestor
92767733|NCT04205097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767734|NCT04205565|Oxiracetam|oxiracetam|mesh-list
92767735|NCT04205565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92767736|NCT04205565|Nootropic Agents|nootropic agents|mesh-ancestor
92767737|NCT01025193|Belimumab|belimumab|mesh-list
92767738|NCT01025193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767739|NCT01025193|Immunologic Factors|immunologic factors|mesh-ancestor
92767740|NCT01025193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767741|NCT01008423|Budesonide|budesonide|mesh-list
92767742|NCT01008423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767743|NCT01008423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92767744|NCT01008423|Autonomic Agents|autonomic agents|mesh-ancestor
92767745|NCT01008423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767746|NCT01008423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767747|NCT01008423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92767748|NCT01008423|Respiratory System Agents|respiratory system agents|mesh-ancestor
92767749|NCT01008423|Glucocorticoids|glucocorticoids|mesh-ancestor
92767750|NCT01008423|Hormones|hormones|mesh-ancestor
92767751|NCT01008423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767752|NCT04735861|Bevacizumab|bevacizumab|mesh-list
92767753|NCT04735861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767754|NCT04735861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767755|NCT04735861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92767756|NCT04735861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92767757|NCT04735861|Growth Substances|growth substances|mesh-ancestor
92767758|NCT04735861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767759|NCT04735861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92767760|NCT03685747|Vancomycin|vancomycin|mesh-list
92767761|NCT03685747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767762|NCT03685747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767763|NCT03586687|Triamcinolone|triamcinolone|mesh-list
92767764|NCT03586687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767765|NCT03586687|Glucocorticoids|glucocorticoids|mesh-ancestor
92767766|NCT03586687|Hormones|hormones|mesh-ancestor
92767767|NCT03586687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767768|NCT03586687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767769|NCT01212185|Oxytocin|oxytocin|mesh-list
92767770|NCT01212185|Oxytocics|oxytocics|mesh-ancestor
92767771|NCT01212185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92767772|NCT01212185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767773|NCT00613717|Vitamin D|vitamin d|mesh-list
92767774|NCT00613717|Vitamins|vitamins|mesh-list
92767775|NCT00613717|Folic Acid|folic acid|mesh-list
92767776|NCT00613717|Vitamin A|vitamin a|mesh-list
92767778|NCT00613717|Vitamin B Complex|vitamin b complex|mesh-list
92767779|NCT00613717|Retinol palmitate|retinol palmitate|mesh-list
92767780|NCT00613717|Micronutrients|micronutrients|mesh-ancestor
92767781|NCT00613717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767782|NCT00613717|Trace Elements|trace elements|mesh-ancestor
92767783|NCT00613717|Hematinics|hematinics|mesh-ancestor
92767784|NCT00613717|Antioxidants|antioxidants|mesh-ancestor
92767785|NCT00613717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767786|NCT00613717|Protective Agents|protective agents|mesh-ancestor
92767787|NCT00613717|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92767788|NCT00613717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767789|NCT00613717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92767790|NCT04477759|Atezolizumab|atezolizumab|mesh-list
92767791|NCT04477759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92767792|NCT04477759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767793|NCT04477759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767794|NCT04477759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767796|NCT03369301|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92767797|NCT03369301|Antibodies|antibodies|mesh-list
92767798|NCT03369301|Immunologic Factors|immunologic factors|mesh-ancestor
92767799|NCT03369301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767800|NCT04865887|Pembrolizumab|pembrolizumab|mesh-list
92767801|NCT04865887|Lenvatinib|lenvatinib|mesh-list
92767802|NCT04865887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767803|NCT04865887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767804|NCT04865887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92767805|NCT04865887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767806|NCT04865887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767807|NCT04865887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767808|NCT05345119|Sirolimus|sirolimus|mesh-list
92767809|NCT05345119|Methylprednisolone|methylprednisolone|mesh-list
92767810|NCT05345119|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92767811|NCT05345119|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92767812|NCT05345119|Prednisolone|prednisolone|mesh-list
92767813|NCT05345119|Prednisolone acetate|prednisolone acetate|mesh-list
92767814|NCT05345119|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92767815|NCT05345119|Prednisolone phosphate|prednisolone phosphate|mesh-list
92767816|NCT05345119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92767817|NCT05345119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767818|NCT05345119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92767819|NCT05345119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767820|NCT05345119|Antifungal Agents|antifungal agents|mesh-ancestor
92767821|NCT05345119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92767822|NCT05345119|Immunologic Factors|immunologic factors|mesh-ancestor
92767823|NCT05345119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767824|NCT05345119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767825|NCT05345119|Antiemetics|antiemetics|mesh-ancestor
92767826|NCT05345119|Autonomic Agents|autonomic agents|mesh-ancestor
92767827|NCT05345119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767828|NCT05345119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767829|NCT05345119|Glucocorticoids|glucocorticoids|mesh-ancestor
92767830|NCT05345119|Hormones|hormones|mesh-ancestor
92767831|NCT05345119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767832|NCT05345119|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92767833|NCT05345119|Protective Agents|protective agents|mesh-ancestor
92767834|NCT05345119|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92767835|NCT03529123|Insulin|insulin|mesh-list
92767836|NCT03529123|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92767837|NCT03529123|Metformin|metformin|mesh-list
92767838|NCT03529123|Insulin Glargine|insulin glargine|mesh-list
92767839|NCT03529123|Insulin glulisine|insulin glulisine|mesh-list
92767840|NCT03529123|Lixisenatide|lixisenatide|mesh-list
92767841|NCT03529123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92767842|NCT03529123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767843|NCT04074187|Methylprednisolone|methylprednisolone|mesh-list
92767844|NCT04074187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92767845|NCT04074187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92767846|NCT04074187|Prednisolone|prednisolone|mesh-list
92767847|NCT04074187|Prednisolone acetate|prednisolone acetate|mesh-list
92767848|NCT04074187|Rituximab|rituximab|mesh-list
92767849|NCT04074187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92767850|NCT04074187|Prednisolone phosphate|prednisolone phosphate|mesh-list
92767851|NCT04074187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92767852|NCT04074187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767853|NCT04074187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767854|NCT04074187|Immunologic Factors|immunologic factors|mesh-ancestor
92767855|NCT04074187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767857|NCT04074187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767858|NCT04074187|Antiemetics|antiemetics|mesh-ancestor
92767859|NCT04074187|Autonomic Agents|autonomic agents|mesh-ancestor
92767860|NCT04074187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92767861|NCT04074187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92767862|NCT04074187|Glucocorticoids|glucocorticoids|mesh-ancestor
92767863|NCT04074187|Hormones|hormones|mesh-ancestor
92767864|NCT04074187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767865|NCT04074187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92767866|NCT04074187|Protective Agents|protective agents|mesh-ancestor
92767867|NCT04074187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92767868|NCT03128905|Prednisone|prednisone|mesh-list
92767869|NCT03128905|Colchicine|colchicine|mesh-list
92767870|NCT03128905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92767871|NCT03128905|Glucocorticoids|glucocorticoids|mesh-ancestor
92767872|NCT03128905|Hormones|hormones|mesh-ancestor
92767873|NCT03128905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92767874|NCT03128905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767875|NCT03128905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92767876|NCT03128905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767877|NCT03128905|Gout Suppressants|gout suppressants|mesh-ancestor
92767878|NCT03128905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92767879|NCT03128905|Tubulin Modulators|tubulin modulators|mesh-ancestor
92767880|NCT03128905|Antimitotic Agents|antimitotic agents|mesh-ancestor
92767881|NCT03128905|Mitosis Modulators|mitosis modulators|mesh-ancestor
92767882|NCT03128905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767883|NCT02430181|Interferons|interferons|mesh-list
92767884|NCT02430181|Ritonavir|ritonavir|mesh-list
92767885|NCT02430181|Interferon-alpha|interferon-alpha|mesh-list
92767886|NCT02430181|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92767887|NCT02430181|Lonafarnib|lonafarnib|mesh-list
92767888|NCT02430181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767889|NCT02430181|Antiviral Agents|antiviral agents|mesh-ancestor
92767890|NCT02430181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767891|NCT02430181|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92767892|NCT02430181|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92767893|NCT02430181|Protease Inhibitors|protease inhibitors|mesh-ancestor
92767894|NCT02430181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767895|NCT02430181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767896|NCT02430181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92767897|NCT02430181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92336206|NCT02034552|Abiraterone Acetate|abiraterone acetate|mesh-list
92767898|NCT02430181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92767899|NCT02430181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92767900|NCT02430181|Immunologic Factors|immunologic factors|mesh-ancestor
92767901|NCT02430181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767902|NCT00614653|Bevacizumab|bevacizumab|mesh-list
92767903|NCT00614653|Capecitabine|capecitabine|mesh-list
92767904|NCT00614653|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92767905|NCT00614653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767906|NCT00614653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767907|NCT00614653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92767908|NCT00614653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92767909|NCT00614653|Growth Substances|growth substances|mesh-ancestor
92767910|NCT00614653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767911|NCT00614653|Growth Inhibitors|growth inhibitors|mesh-ancestor
92767912|NCT00614653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92767913|NCT00614653|Antimetabolites|antimetabolites|mesh-ancestor
92767914|NCT00614653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767915|NCT00614653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767916|NCT00614653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767917|NCT03909451|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92767918|NCT03909451|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92767919|NCT03909451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767920|NCT03909451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92767921|NCT03909451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767922|NCT03463135|Immunomodulating Agents|immunomodulating agents|mesh-list
92767923|NCT03463135|Immunologic Factors|immunologic factors|mesh-ancestor
92767924|NCT03463135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767925|NCT03596125|Acetylcysteine|acetylcysteine|mesh-list
92767926|NCT03596125|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92767927|NCT03596125|Antiviral Agents|antiviral agents|mesh-ancestor
92767928|NCT03596125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92767929|NCT03596125|Expectorants|expectorants|mesh-ancestor
92767930|NCT03596125|Respiratory System Agents|respiratory system agents|mesh-ancestor
92767931|NCT03596125|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92767932|NCT03596125|Antioxidants|antioxidants|mesh-ancestor
92767933|NCT03596125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767934|NCT03596125|Protective Agents|protective agents|mesh-ancestor
92767935|NCT03596125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767936|NCT03596125|Antidotes|antidotes|mesh-ancestor
92767938|NCT02118727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92767939|NCT02118727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92767940|NCT02118727|Dopamine Agents|dopamine agents|mesh-ancestor
92767941|NCT02118727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767942|NCT02118727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767943|NCT02118727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767944|NCT02118727|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92767945|NCT02118727|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92767946|NCT05343637|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92767947|NCT05343637|Vasodilator Agents|vasodilator agents|mesh-ancestor
92767948|NCT05343637|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92767949|NCT05343637|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92767950|NCT05343637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767951|NCT05343637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767952|NCT05343637|Urological Agents|urological agents|mesh-ancestor
92767953|NCT03776227|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92767954|NCT03776227|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92767955|NCT03776227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767956|NCT03776227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92767957|NCT03776227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767959|NCT00614809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767960|NCT00614809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767961|NCT00614809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767962|NCT00614809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767963|NCT02964013|Carboplatin|carboplatin|mesh-list
92767964|NCT02964013|Pembrolizumab|pembrolizumab|mesh-list
92767965|NCT02964013|Etoposide|etoposide|mesh-list
92767966|NCT02964013|Pemetrexed|pemetrexed|mesh-list
92767967|NCT02964013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767968|NCT02964013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92767969|NCT02964013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92767970|NCT02964013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767971|NCT02964013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92767972|NCT02964013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92767973|NCT02964013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92767974|NCT02964013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767975|NCT02964013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92767976|NCT02964013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92767977|NCT02480803|Levodopa|levodopa|mesh-list
92767978|NCT02480803|Carbidopa|carbidopa|mesh-list
92767979|NCT02480803|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92767980|NCT02480803|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92767981|NCT02480803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92767982|NCT02480803|Dopamine Agents|dopamine agents|mesh-ancestor
92767983|NCT02480803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92767984|NCT02480803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92767985|NCT02480803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767986|NCT02480803|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92767987|NCT02480803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767988|NCT02480803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92767989|NCT02480803|Immunologic Factors|immunologic factors|mesh-ancestor
92767990|NCT02480803|Dopamine Agonists|dopamine agonists|mesh-ancestor
92767991|NCT02699437|Antibodies|antibodies|mesh-list
92767992|NCT02699437|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
92767993|NCT02699437|Immunologic Factors|immunologic factors|mesh-ancestor
92767994|NCT02699437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92767995|NCT01211483|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92767996|NCT01211483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92767997|NCT01211483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92767998|NCT01211483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92767999|NCT01211483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070874|NCT01456546|Proguanil|proguanil|mesh-list
92768000|NCT00615823|Atorvastatin|atorvastatin|mesh-list
92768001|NCT00615823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92768002|NCT00615823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92768003|NCT00615823|Antimetabolites|antimetabolites|mesh-ancestor
92768004|NCT00615823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768005|NCT00615823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92768006|NCT00615823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92768007|NCT00615823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768008|NCT02699281|Palmidrol|palmidrol|mesh-list
92768009|NCT02699281|Analgesics|analgesics|mesh-ancestor
92768010|NCT02699281|Sensory System Agents|sensory system agents|mesh-ancestor
92768011|NCT02699281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768012|NCT02699281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768013|NCT02699281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768014|NCT02699281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92413074|NCT01459445|Estrogens|estrogens|mesh-ancestor
92768015|NCT02699281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768016|NCT02699281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768017|NCT02699281|Antiviral Agents|antiviral agents|mesh-ancestor
92768018|NCT02699281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768019|NCT02699281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92768020|NCT02699281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92768021|NCT02699281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768022|NCT02699281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768023|NCT02699281|Hormones|hormones|mesh-ancestor
92768024|NCT02699281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768025|NCT02704507|Triamcinolone|triamcinolone|mesh-list
92768026|NCT02704507|Tretinoin|tretinoin|mesh-list
92768027|NCT02704507|Emollients|emollients|mesh-list
92768028|NCT02704507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768029|NCT02704507|Glucocorticoids|glucocorticoids|mesh-ancestor
92768030|NCT02704507|Hormones|hormones|mesh-ancestor
92768031|NCT02704507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768032|NCT02704507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768033|NCT02704507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768034|NCT02704507|Keratolytic Agents|keratolytic agents|mesh-ancestor
92768035|NCT02704507|Dermatologic Agents|dermatologic agents|mesh-ancestor
92768036|NCT01210001|Empagliflozin|empagliflozin|mesh-list
92768037|NCT01210001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92768038|NCT01210001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768039|NCT01210001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768040|NCT01210001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768041|NCT00624455|Gabapentin|gabapentin|mesh-list
92768042|NCT00624455|Analgesics|analgesics|mesh-ancestor
92768043|NCT00624455|Sensory System Agents|sensory system agents|mesh-ancestor
92768044|NCT00624455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768045|NCT00624455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768046|NCT00624455|Anticonvulsants|anticonvulsants|mesh-ancestor
92768047|NCT00624455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92768048|NCT00624455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92768049|NCT00624455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768050|NCT00624455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92768051|NCT00624455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92768052|NCT00624455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92768053|NCT00624455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768054|NCT00624455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768055|NCT00624455|Antimanic Agents|antimanic agents|mesh-ancestor
92768056|NCT01127659|Testosterone|testosterone|mesh-list
92768057|NCT01127659|Androgens|androgens|mesh-ancestor
92768058|NCT01127659|Hormones|hormones|mesh-ancestor
92768059|NCT01127659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768060|NCT01127659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768061|NCT02698969|Atropine|atropine|mesh-list
92768062|NCT02698969|Fentanyl|fentanyl|mesh-list
92768063|NCT02698969|Propofol|propofol|mesh-list
92768064|NCT02698969|Sevoflurane|sevoflurane|mesh-list
92768065|NCT02698969|Rocuronium|rocuronium|mesh-list
92768066|NCT02698969|Neostigmine|neostigmine|mesh-list
92768067|NCT02698969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92768068|NCT02698969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768069|NCT02698969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768070|NCT02698969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92768071|NCT02698969|Anesthetics, General|anesthetics, general|mesh-ancestor
92768072|NCT02698969|Anesthetics|anesthetics|mesh-ancestor
92768073|NCT02698969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92768074|NCT02698969|Narcotics|narcotics|mesh-ancestor
92768075|NCT02698969|Analgesics|analgesics|mesh-ancestor
92768076|NCT02698969|Sensory System Agents|sensory system agents|mesh-ancestor
92768077|NCT02698969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768078|NCT02698969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92768079|NCT02698969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92768080|NCT02698969|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92768081|NCT02698969|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92768082|NCT02698969|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92768083|NCT02698969|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92768084|NCT02698969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92768085|NCT02698969|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92768086|NCT02698969|Autonomic Agents|autonomic agents|mesh-ancestor
92336234|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768087|NCT02698969|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92768088|NCT02698969|Respiratory System Agents|respiratory system agents|mesh-ancestor
92768089|NCT02698969|Mydriatics|mydriatics|mesh-ancestor
92768090|NCT02698969|Parasympatholytics|parasympatholytics|mesh-ancestor
92768091|NCT02698969|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92768092|NCT02698969|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92768093|NCT02698969|Cholinergic Agents|cholinergic agents|mesh-ancestor
92768094|NCT02698969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768095|NCT02698969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768096|NCT02698969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92768097|NCT02698969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768098|NCT02698969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92768100|NCT00848731|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92768101|NCT00848731|Autonomic Agents|autonomic agents|mesh-ancestor
92768102|NCT00848731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768103|NCT00848731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768104|NCT00848731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92768105|NCT00848731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92768106|NCT00848731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92768107|NCT00848731|Antioxidants|antioxidants|mesh-ancestor
92768108|NCT00848731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768109|NCT00848731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768110|NCT00848731|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92768111|NCT00848731|Vasodilator Agents|vasodilator agents|mesh-ancestor
92768112|NCT00848731|Gasotransmitters|gasotransmitters|mesh-ancestor
92768113|NCT00848731|Protective Agents|protective agents|mesh-ancestor
92768114|NCT01209143|Rosiglitazone|rosiglitazone|mesh-list
92768115|NCT01209143|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92768116|NCT01209143|Norethindrone|norethindrone|mesh-list
92768117|NCT01209143|Norethindrone Acetate|norethindrone acetate|mesh-list
92768118|NCT01209143|Estradiol|estradiol|mesh-list
92768119|NCT01209143|Estrogens|estrogens|mesh-ancestor
92768120|NCT01209143|Hormones|hormones|mesh-ancestor
92768121|NCT01209143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768122|NCT01209143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768123|NCT01209143|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92768124|NCT01209143|Contraceptive Agents|contraceptive agents|mesh-ancestor
92768125|NCT01209143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92768126|NCT01209143|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92768127|NCT01209143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768128|NCT01209143|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92768129|NCT01209143|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92768130|NCT01209143|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92768131|NCT00454285|Amoxicillin|amoxicillin|mesh-list
92768132|NCT00454285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92768133|NCT00454285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768134|NCT00614965|Irinotecan|irinotecan|mesh-list
92768135|NCT00614965|Pemetrexed|pemetrexed|mesh-list
92768136|NCT00614965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768137|NCT00614965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92768138|NCT00614965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92768139|NCT00614965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768140|NCT00614965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768141|NCT00614965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92768142|NCT00614965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92768143|NCT00390325|Sorafenib|sorafenib|mesh-list
92768144|NCT00390325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768145|NCT00390325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768146|NCT00390325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336243|NCT02034006|Growth Substances|growth substances|mesh-ancestor
92768147|NCT00390325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768149|NCT00405613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768150|NCT00405613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92768151|NCT00405613|Analgesics|analgesics|mesh-ancestor
92768152|NCT00405613|Sensory System Agents|sensory system agents|mesh-ancestor
92768153|NCT00405613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768154|NCT00405613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768155|NCT00405613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768156|NCT00405613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768157|NCT00405613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92768158|NCT00405613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92768159|NCT00405613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768160|NCT00405613|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92768161|NCT00405613|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92768162|NCT00405613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768163|NCT00405613|Antipyretics|antipyretics|mesh-ancestor
92768164|NCT02703961|Cisplatin|cisplatin|mesh-list
92768165|NCT02703961|Docetaxel|docetaxel|mesh-list
92768166|NCT02703961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768167|NCT02703961|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768168|NCT02703961|Antimitotic Agents|antimitotic agents|mesh-ancestor
92768169|NCT02703961|Mitosis Modulators|mitosis modulators|mesh-ancestor
92768170|NCT02703961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768171|NCT02703649|Letrozole|letrozole|mesh-list
92768172|NCT02703649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768173|NCT02703649|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92768174|NCT02703649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92768175|NCT02703649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768176|NCT02703649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768177|NCT02703649|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92768178|NCT02703649|Hormone Antagonists|hormone antagonists|mesh-ancestor
92768179|NCT02703649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768180|NCT02703649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768181|NCT02703571|Trametinib|trametinib|mesh-list
92768182|NCT02703571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768183|NCT02703571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768184|NCT02703571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768185|NCT02703571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768186|NCT02703415|Tramadol|tramadol|mesh-list
92768187|NCT02703415|Bupivacaine|bupivacaine|mesh-list
92768188|NCT02703415|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768189|NCT02703415|Anesthetics|anesthetics|mesh-ancestor
92768190|NCT02703415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768191|NCT02703415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768192|NCT02703415|Sensory System Agents|sensory system agents|mesh-ancestor
92768193|NCT02703415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768194|NCT02703415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92768195|NCT02703415|Narcotics|narcotics|mesh-ancestor
92768196|NCT02703415|Analgesics|analgesics|mesh-ancestor
92768197|NCT02703181|Diketopiperazines|diketopiperazines|mesh-list
92768198|NCT02703181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92768199|NCT02703181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768200|NCT04215835|Letrozole|letrozole|mesh-list
92768201|NCT04215835|Misoprostol|misoprostol|mesh-list
92768202|NCT04215835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768203|NCT04215835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92768204|NCT04215835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92768205|NCT04215835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768206|NCT04215835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768207|NCT04215835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92768208|NCT04215835|Hormone Antagonists|hormone antagonists|mesh-ancestor
92768209|NCT04215835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768210|NCT04215835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768211|NCT04215835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92768212|NCT04215835|Abortifacient Agents|abortifacient agents|mesh-ancestor
92768213|NCT04215835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92768214|NCT04215835|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92768215|NCT04215835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768216|NCT04215835|Oxytocics|oxytocics|mesh-ancestor
92768217|NCT01208207|Naproxen|naproxen|mesh-list
92768218|NCT01208207|Etoricoxib|etoricoxib|mesh-list
92768219|NCT01208207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768220|NCT01208207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92768221|NCT01208207|Analgesics|analgesics|mesh-ancestor
92768222|NCT01208207|Sensory System Agents|sensory system agents|mesh-ancestor
92768223|NCT01208207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768224|NCT01208207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768225|NCT01208207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768226|NCT01208207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768227|NCT01208207|Gout Suppressants|gout suppressants|mesh-ancestor
92768228|NCT01208207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92768229|NCT01208207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768230|NCT01208207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768231|NCT01208207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92768232|NCT05420285|Dapagliflozin|dapagliflozin|mesh-list
92768233|NCT05420285|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92768234|NCT05420285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768235|NCT05420285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768236|NCT05420285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768237|NCT01012713|Calcitriol|calcitriol|mesh-list
92768238|NCT01012713|Clobetasol|clobetasol|mesh-list
92768239|NCT01012713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768240|NCT01012713|Glucocorticoids|glucocorticoids|mesh-ancestor
92768242|NCT01012713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768243|NCT01012713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768244|NCT01012713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92768245|NCT01012713|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92768246|NCT01012713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768247|NCT01012713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768248|NCT01012713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92768249|NCT01012713|Vitamins|vitamins|mesh-ancestor
92768250|NCT01012713|Micronutrients|micronutrients|mesh-ancestor
92768251|NCT01012713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92768252|NCT02698813|Hyaluronic Acid|hyaluronic acid|mesh-list
92768253|NCT02698813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92768254|NCT02698813|Immunologic Factors|immunologic factors|mesh-ancestor
92768255|NCT02698813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768256|NCT02698813|Viscosupplements|viscosupplements|mesh-ancestor
92768257|NCT02698813|Protective Agents|protective agents|mesh-ancestor
92768258|NCT02702323|Apatinib|apatinib|mesh-list
92768259|NCT02702323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768260|NCT02702323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768261|NCT02702323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768262|NCT02702323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768263|NCT01007253|Fluticasone|fluticasone|mesh-list
92768264|NCT01007253|Xhance|xhance|mesh-list
92768265|NCT01007253|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92768266|NCT01007253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92768267|NCT01007253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92768268|NCT01007253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768269|NCT01007253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92768270|NCT01007253|Autonomic Agents|autonomic agents|mesh-ancestor
92768271|NCT01007253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768272|NCT01007253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768273|NCT01007253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92768274|NCT01007253|Respiratory System Agents|respiratory system agents|mesh-ancestor
92768275|NCT01007253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92768276|NCT01007253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92768277|NCT01007253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768278|NCT01007253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92768279|NCT01007253|Analgesics|analgesics|mesh-ancestor
92768280|NCT01007253|Sensory System Agents|sensory system agents|mesh-ancestor
92768281|NCT01007253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768282|NCT01007253|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92768283|NCT01007253|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92768284|NCT01007253|Histamine Antagonists|histamine antagonists|mesh-ancestor
92768285|NCT01007253|Histamine Agents|histamine agents|mesh-ancestor
92768286|NCT01007253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768287|NCT01007253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768288|NCT02691949|Mycophenolic Acid|mycophenolic acid|mesh-list
92768289|NCT02691949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92768290|NCT02691949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768291|NCT02691949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92768292|NCT02691949|Antitubercular Agents|antitubercular agents|mesh-ancestor
92768293|NCT02691949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92768294|NCT02691949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768296|NCT02691949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768297|NCT01006707|Ondansetron|ondansetron|mesh-list
92768298|NCT01006707|Antiemetics|antiemetics|mesh-ancestor
92768299|NCT01006707|Autonomic Agents|autonomic agents|mesh-ancestor
92768300|NCT01006707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768301|NCT01006707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768302|NCT01006707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768303|NCT01006707|Antipruritics|antipruritics|mesh-ancestor
92768304|NCT01006707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92768305|NCT01006707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92768306|NCT01006707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92768307|NCT01006707|Serotonin Agents|serotonin agents|mesh-ancestor
92768308|NCT01006707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768309|NCT01006707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768310|NCT01006629|Palivizumab|palivizumab|mesh-list
92768311|NCT01006629|Antiviral Agents|antiviral agents|mesh-ancestor
92768312|NCT01006629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768313|NCT04214977|Anesthetics|anesthetics|mesh-list
92768314|NCT04214977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768315|NCT04214977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768316|NCT02701933|Ketamine|ketamine|mesh-list
92768317|NCT02701933|Analgesics|analgesics|mesh-ancestor
92768318|NCT02701933|Sensory System Agents|sensory system agents|mesh-ancestor
92768319|NCT02701933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768320|NCT02701933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768321|NCT02701933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92768322|NCT02701933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92768323|NCT02701933|Anesthetics, General|anesthetics, general|mesh-ancestor
92768324|NCT02701933|Anesthetics|anesthetics|mesh-ancestor
92768325|NCT02701933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768326|NCT02701933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92768327|NCT02701933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92768328|NCT02701933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768329|NCT02701933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768330|NCT04295967|Formaldehyde|formaldehyde|mesh-list
92768331|NCT04295967|Disinfectants|disinfectants|mesh-ancestor
92768332|NCT04295967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768333|NCT01012323|Immunoglobulins|immunoglobulins|mesh-list
92768334|NCT01012323|Immunologic Factors|immunologic factors|mesh-ancestor
92768335|NCT01012323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768336|NCT02871765|Warfarin|warfarin|mesh-list
92768337|NCT02871765|Anticoagulants|anticoagulants|mesh-ancestor
92768338|NCT02549209|Paclitaxel|paclitaxel|mesh-list
92768339|NCT02549209|Carboplatin|carboplatin|mesh-list
92768340|NCT02549209|Pembrolizumab|pembrolizumab|mesh-list
92768341|NCT02549209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92768342|NCT02549209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768343|NCT02549209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768344|NCT02549209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92768345|NCT02549209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92768346|NCT02549209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768347|NCT02549209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92768348|NCT02549209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92768349|NCT02698267|Itraconazole|itraconazole|mesh-list
92768350|NCT02698267|Antifungal Agents|antifungal agents|mesh-ancestor
92768351|NCT02698267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768352|NCT02698267|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92768353|NCT02698267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92768354|NCT02698267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768355|NCT02698267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768356|NCT02698267|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92768357|NCT02698267|Hormone Antagonists|hormone antagonists|mesh-ancestor
92768358|NCT02698267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768359|NCT02698267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768360|NCT02698267|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92768361|NCT01011465|Oxytocin|oxytocin|mesh-list
92768362|NCT01011465|Oxytocics|oxytocics|mesh-ancestor
92768363|NCT01011465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92768364|NCT01011465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768365|NCT02494141|Curcumin|curcumin|mesh-list
92768366|NCT02494141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768367|NCT02494141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92768368|NCT02494141|Analgesics|analgesics|mesh-ancestor
92768370|NCT02494141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768371|NCT02494141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768372|NCT02494141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768373|NCT02494141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768374|NCT02494141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768375|NCT02494141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768376|NCT02494141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768377|NCT01011309|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92768378|NCT01011309|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92768379|NCT01011309|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92768380|NCT01011309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768381|NCT01011309|Schistosomicides|schistosomicides|mesh-ancestor
92768382|NCT01011309|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92768383|NCT01011309|Anthelmintics|anthelmintics|mesh-ancestor
92768384|NCT04214821|Moxifloxacin|moxifloxacin|mesh-list
92768385|NCT04214821|Levofloxacin|levofloxacin|mesh-list
92768386|NCT04214821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92768387|NCT04214821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92768388|NCT04214821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413446|NCT01463735|Vitamins|vitamins|mesh-ancestor
92336311|NCT02006706|Antimetabolites|antimetabolites|mesh-ancestor
92768389|NCT04214821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768390|NCT04214821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92768391|NCT04214821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92768392|NCT04214821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768393|NCT04214821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768394|NCT04214821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768395|NCT04214821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92768396|NCT04214821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92768397|NCT04214821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92768398|NCT00616213|Lenograstim|lenograstim|mesh-list
92768399|NCT00616213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92768400|NCT00616213|Immunologic Factors|immunologic factors|mesh-ancestor
92768401|NCT00616213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768402|NCT00615667|Tacrolimus|tacrolimus|mesh-list
92768403|NCT00615667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92768404|NCT00615667|Immunologic Factors|immunologic factors|mesh-ancestor
92768405|NCT00615667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768406|NCT00615667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92768407|NCT00615667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768408|NCT00615667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768409|NCT02697955|Epinephrine|epinephrine|mesh-list
92768410|NCT02697955|Bupivacaine|bupivacaine|mesh-list
92768411|NCT02697955|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768412|NCT02697955|Anesthetics|anesthetics|mesh-ancestor
92768413|NCT02697955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768414|NCT02697955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768415|NCT02697955|Sensory System Agents|sensory system agents|mesh-ancestor
92768416|NCT02697955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768417|NCT02697955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92768418|NCT02697955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92768419|NCT02697955|Adrenergic Agents|adrenergic agents|mesh-ancestor
92768420|NCT02697955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768421|NCT02697955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768422|NCT02697955|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92768423|NCT02697955|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92768424|NCT02697955|Autonomic Agents|autonomic agents|mesh-ancestor
92768425|NCT02697955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92768426|NCT02697955|Respiratory System Agents|respiratory system agents|mesh-ancestor
92768427|NCT02697955|Mydriatics|mydriatics|mesh-ancestor
92768428|NCT02697955|Sympathomimetics|sympathomimetics|mesh-ancestor
92768429|NCT02697955|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92768430|NCT04294329|Bupivacaine|bupivacaine|mesh-list
92768431|NCT04294329|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768432|NCT04294329|Anesthetics|anesthetics|mesh-ancestor
92768433|NCT04294329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768434|NCT04294329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768435|NCT04294329|Sensory System Agents|sensory system agents|mesh-ancestor
92768436|NCT04294329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768437|NCT02701309|Iron|iron|mesh-list
92768438|NCT02701309|Protoporphyrin IX|protoporphyrin ix|mesh-list
92768439|NCT02701309|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
92768440|NCT02701309|Trace Elements|trace elements|mesh-ancestor
92768441|NCT02701309|Micronutrients|micronutrients|mesh-ancestor
92768442|NCT02701309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768443|NCT02701309|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92768444|NCT02701309|Dermatologic Agents|dermatologic agents|mesh-ancestor
92768445|NCT02701309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768446|NCT02701309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768447|NCT03250507|Bupivacaine|bupivacaine|mesh-list
92768448|NCT03250507|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768449|NCT03250507|Anesthetics|anesthetics|mesh-ancestor
92336320|NCT02006706|Autonomic Agents|autonomic agents|mesh-ancestor
92768450|NCT03250507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768451|NCT03250507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768452|NCT03250507|Sensory System Agents|sensory system agents|mesh-ancestor
92768453|NCT03250507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768454|NCT00997893|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92768455|NCT00997893|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92768456|NCT00997893|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92768457|NCT00997893|Medroxyprogesterone|medroxyprogesterone|mesh-list
92768458|NCT00997893|Estradiol|estradiol|mesh-list
92768459|NCT00997893|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92768460|NCT00997893|Estrogens|estrogens|mesh-list
92768461|NCT00997893|Phytoestrogens|phytoestrogens|mesh-list
92768462|NCT00997893|Hormones|hormones|mesh-ancestor
92768463|NCT00997893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413527|NCT01464112|Hormones|hormones|mesh-ancestor
92768464|NCT00997893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768465|NCT00997893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92768466|NCT00997893|Contraceptive Agents|contraceptive agents|mesh-ancestor
92768467|NCT00997893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92768468|NCT00997893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92768469|NCT00997893|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92768470|NCT00997893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92768471|NCT00997893|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92768472|NCT00997893|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92768473|NCT00997893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92768474|NCT00997893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768475|NCT00997893|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92768476|NCT02697877|Regadenoson|regadenoson|mesh-list
92768477|NCT02697877|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92768478|NCT02697877|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92768479|NCT02697877|Purinergic Agonists|purinergic agonists|mesh-ancestor
92768480|NCT02697877|Purinergic Agents|purinergic agents|mesh-ancestor
92768481|NCT02697877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768482|NCT02697877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768483|NCT02697877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768484|NCT04214665|Thioctic Acid|thioctic acid|mesh-list
92768485|NCT04214665|Antioxidants|antioxidants|mesh-ancestor
92768486|NCT04214665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768487|NCT04214665|Protective Agents|protective agents|mesh-ancestor
92768488|NCT04214665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768489|NCT04214665|Vitamin B Complex|vitamin b complex|mesh-ancestor
92768490|NCT04214665|Vitamins|vitamins|mesh-ancestor
92768491|NCT04214665|Micronutrients|micronutrients|mesh-ancestor
92768492|NCT02870673|Triamcinolone|triamcinolone|mesh-list
92768493|NCT02870673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92768494|NCT02870673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92768495|NCT02870673|Lidocaine|lidocaine|mesh-list
92768496|NCT02870673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92768497|NCT02870673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768498|NCT02870673|Glucocorticoids|glucocorticoids|mesh-ancestor
92768499|NCT02870673|Hormones|hormones|mesh-ancestor
92768500|NCT02870673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768501|NCT02870673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768502|NCT02870673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92768503|NCT02870673|Immunologic Factors|immunologic factors|mesh-ancestor
92768504|NCT02870673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768505|NCT02870673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768506|NCT02870673|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768507|NCT02870673|Anesthetics|anesthetics|mesh-ancestor
92768508|NCT02870673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768509|NCT02870673|Sensory System Agents|sensory system agents|mesh-ancestor
92768510|NCT02870673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768511|NCT02870673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92768512|NCT02870673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92768513|NCT02870673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92768514|NCT02870673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494494|NCT01975714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92768515|NCT00615745|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92768516|NCT00615745|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92768517|NCT00615745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92768518|NCT00615745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768519|NCT00615745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768520|NCT00615745|Antiviral Agents|antiviral agents|mesh-ancestor
92768521|NCT00615745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768522|NCT00615745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92768523|NCT00615745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92768524|NCT05324839|Botulinum Toxins|botulinum toxins|mesh-list
92768525|NCT05324839|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92768526|NCT05324839|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92768527|NCT05324839|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92768528|NCT05324839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768529|NCT05324839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768530|NCT05324839|Cholinergic Agents|cholinergic agents|mesh-ancestor
92768531|NCT05324839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768532|NCT05324839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768533|NCT05324839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92768534|NCT05324839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768535|NCT02700685|Methylphenidate|methylphenidate|mesh-list
92768536|NCT02700685|Pycnogenols|pycnogenols|mesh-list
92768537|NCT02700685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92768538|NCT02700685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768539|NCT02700685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92768540|NCT02700685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92768541|NCT02700685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768542|NCT02700685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768543|NCT02700685|Dopamine Agents|dopamine agents|mesh-ancestor
92768544|NCT02700685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768545|NCT02700685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92768546|NCT02700685|Immunologic Factors|immunologic factors|mesh-ancestor
92768547|NCT02700685|Antioxidants|antioxidants|mesh-ancestor
92768548|NCT02700685|Protective Agents|protective agents|mesh-ancestor
92768549|NCT02700685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92768550|NCT02700763|Dabrafenib|dabrafenib|mesh-list
92768551|NCT02700763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768552|NCT02700763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768553|NCT02700763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768554|NCT02700763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768555|NCT03151681|Propranolol|propranolol|mesh-list
92768556|NCT03151681|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92768557|NCT03151681|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92768558|NCT03151681|Adrenergic Agents|adrenergic agents|mesh-ancestor
92768559|NCT03151681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768560|NCT03151681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768561|NCT03151681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768562|NCT03151681|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92768563|NCT03151681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92768564|NCT03151681|Vasodilator Agents|vasodilator agents|mesh-ancestor
92768565|NCT04215445|Empagliflozin|empagliflozin|mesh-list
92768566|NCT04215445|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92768567|NCT04215445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768568|NCT04215445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768569|NCT04215445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768570|NCT00951457|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92768571|NCT00951457|Alemtuzumab|alemtuzumab|mesh-list
92494495|NCT01975727|Dexamethasone|dexamethasone|mesh-list
92768572|NCT00951457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92768573|NCT00951457|Alkylating Agents|alkylating agents|mesh-ancestor
92768574|NCT00951457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768575|NCT00951457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768576|NCT00951457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92768577|NCT02691871|Docetaxel|docetaxel|mesh-list
92768578|NCT02691871|Apatinib|apatinib|mesh-list
92768579|NCT02691871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768580|NCT02691871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768581|NCT02691871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92768582|NCT02691871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92768583|NCT02691871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768584|NCT02691871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768585|NCT02691871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768586|NCT02700217|Remifentanil|remifentanil|mesh-list
92768587|NCT02700217|Heroin|heroin|mesh-list
92768588|NCT02700217|Bupivacaine|bupivacaine|mesh-list
92768589|NCT02700217|Propofol|propofol|mesh-list
92768590|NCT02700217|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768591|NCT02700217|Anesthetics|anesthetics|mesh-ancestor
92768592|NCT02700217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768593|NCT02700217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768594|NCT02700217|Sensory System Agents|sensory system agents|mesh-ancestor
92768595|NCT02700217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768596|NCT02700217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92768597|NCT02700217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92768598|NCT02700217|Anesthetics, General|anesthetics, general|mesh-ancestor
92768599|NCT02700217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92768600|NCT02700217|Narcotics|narcotics|mesh-ancestor
92768601|NCT02700217|Analgesics|analgesics|mesh-ancestor
92768602|NCT02699827|Magnesium Sulfate|magnesium sulfate|mesh-list
92768603|NCT02699827|Levobupivacaine|levobupivacaine|mesh-list
92768604|NCT02699827|Analgesics|analgesics|mesh-ancestor
92768605|NCT02699827|Sensory System Agents|sensory system agents|mesh-ancestor
92768606|NCT02699827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768607|NCT02699827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768608|NCT02699827|Anesthetics|anesthetics|mesh-ancestor
92768609|NCT02699827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768610|NCT02699827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92768611|NCT02699827|Anticonvulsants|anticonvulsants|mesh-ancestor
92768612|NCT02699827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92768613|NCT02699827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768614|NCT02699827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768615|NCT02699827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92768616|NCT02699827|Tocolytic Agents|tocolytic agents|mesh-ancestor
92768617|NCT02699827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92768618|NCT02699827|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768619|NCT02705989|Branebrutinib|branebrutinib|mesh-list
92768620|NCT02705989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768621|NCT02705989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768622|NCT02705989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768623|NCT02706067|Orlistat|orlistat|mesh-list
92768624|NCT02706067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768625|NCT02706067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768626|NCT02706067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92768627|NCT02706067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92768628|NCT02939287|Olanzapine|olanzapine|mesh-list
92768629|NCT02939287|Aprepitant|aprepitant|mesh-list
92768630|NCT02939287|Fosaprepitant|fosaprepitant|mesh-list
92768631|NCT02939287|Antiemetics|antiemetics|mesh-ancestor
92768632|NCT02939287|Autonomic Agents|autonomic agents|mesh-ancestor
92768633|NCT02939287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768634|NCT02939287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768635|NCT02939287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768636|NCT02939287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92768637|NCT02939287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92768638|NCT02939287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768639|NCT02939287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92768640|NCT02939287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92768641|NCT02939287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92768642|NCT02939287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768643|NCT02939287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768644|NCT02939287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768645|NCT02939287|Serotonin Agents|serotonin agents|mesh-ancestor
92768646|NCT02939287|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92768647|NCT05323201|Cyclophosphamide|cyclophosphamide|mesh-list
92768648|NCT05323201|Fludarabine|fludarabine|mesh-list
92768649|NCT05323201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92768650|NCT05323201|Immunologic Factors|immunologic factors|mesh-ancestor
92768651|NCT05323201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768652|NCT05323201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768653|NCT05323201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92768654|NCT05323201|Alkylating Agents|alkylating agents|mesh-ancestor
92768655|NCT05323201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768656|NCT05323201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768658|NCT01208051|Lenalidomide|lenalidomide|mesh-list
92768659|NCT01208051|Cediranib|cediranib|mesh-list
92768660|NCT01208051|Maleic acid|maleic acid|mesh-list
92768661|NCT01208051|Immunologic Factors|immunologic factors|mesh-ancestor
92768662|NCT01208051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768663|NCT01208051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92768664|NCT01208051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92768665|NCT01208051|Growth Substances|growth substances|mesh-ancestor
92768666|NCT01208051|Growth Inhibitors|growth inhibitors|mesh-ancestor
92768667|NCT01208051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768668|NCT01208051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768669|NCT01208051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768670|NCT01208051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768671|NCT05322889|Telmisartan|telmisartan|mesh-list
92768672|NCT05322889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92768673|NCT05322889|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92768674|NCT05322889|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92768675|NCT05322889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768676|NCT00616915|Bupropion|bupropion|mesh-list
92768677|NCT00616915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92768678|NCT00616915|Antidepressive Agents|antidepressive agents|mesh-ancestor
92768679|NCT00616915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92768680|NCT00616915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92768681|NCT00616915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92768682|NCT00616915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768683|NCT00616915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768684|NCT00616915|Dopamine Agents|dopamine agents|mesh-ancestor
92768685|NCT00616915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768686|NCT00616915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768687|NCT00616915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92768688|NCT00616915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92768689|NCT00616915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768690|NCT05410223|Amoxicillin|amoxicillin|mesh-list
92768691|NCT05410223|Clarithromycin|clarithromycin|mesh-list
92768692|NCT05410223|Doxycycline|doxycycline|mesh-list
92768693|NCT05410223|Furazolidone|furazolidone|mesh-list
92768694|NCT05410223|Bismuth|bismuth|mesh-list
92768695|NCT05410223|Antibodies|antibodies|mesh-list
92768696|NCT05410223|Immunoglobulins|immunoglobulins|mesh-list
92768697|NCT05410223|Immunologic Factors|immunologic factors|mesh-ancestor
92336425|NCT02003898|Insulin|insulin|mesh-list
92768698|NCT05410223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768699|NCT05410223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92768700|NCT05410223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768701|NCT05410223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92768702|NCT05410223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768703|NCT05410223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768704|NCT05410223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92768705|NCT05410223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92768706|NCT05410223|Antimalarials|antimalarials|mesh-ancestor
92768707|NCT05410223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92768708|NCT05410223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92768709|NCT05410223|Antacids|antacids|mesh-ancestor
92768710|NCT05410223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768711|NCT05410223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92768712|NCT05410223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92768713|NCT05410223|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92768714|NCT05410223|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92768715|NCT01206101|Liraglutide|liraglutide|mesh-list
92768716|NCT01206101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768717|NCT01206101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768718|NCT01206101|Incretins|incretins|mesh-ancestor
92768719|NCT01206101|Hormones|hormones|mesh-ancestor
92768720|NCT01206101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768721|NCT00997503|Aspirin|aspirin|mesh-list
92768722|NCT00997503|Paclitaxel|paclitaxel|mesh-list
92768723|NCT00997503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92768724|NCT00997503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92768725|NCT00997503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768726|NCT00997503|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768727|NCT00997503|Antimitotic Agents|antimitotic agents|mesh-ancestor
92768728|NCT00997503|Mitosis Modulators|mitosis modulators|mesh-ancestor
92768729|NCT00997503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768730|NCT00997503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768731|NCT00997503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92768732|NCT00997503|Analgesics|analgesics|mesh-ancestor
92768733|NCT00997503|Sensory System Agents|sensory system agents|mesh-ancestor
92768734|NCT00997503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768735|NCT00997503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768736|NCT00997503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768737|NCT00997503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768738|NCT00997503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92768739|NCT00997503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92768740|NCT00997503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92768741|NCT00997503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92768742|NCT00997503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768743|NCT00997503|Antipyretics|antipyretics|mesh-ancestor
92768744|NCT02705053|Insulin|insulin|mesh-list
92768745|NCT02705053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768746|NCT02705053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768747|NCT01204775|Metformin|metformin|mesh-list
92768748|NCT01204775|Saxagliptin|saxagliptin|mesh-list
92768749|NCT01204775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768750|NCT01204775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768751|NCT01204775|Incretins|incretins|mesh-ancestor
92768752|NCT01204775|Hormones|hormones|mesh-ancestor
92768753|NCT01204775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768754|NCT01204775|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92768755|NCT01204775|Protease Inhibitors|protease inhibitors|mesh-ancestor
92768756|NCT01204775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768757|NCT01204775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768758|NCT02844907|Dexamethasone|dexamethasone|mesh-list
92768759|NCT02844907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768760|NCT02844907|Antiemetics|antiemetics|mesh-ancestor
92768761|NCT02844907|Autonomic Agents|autonomic agents|mesh-ancestor
92768762|NCT02844907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768763|NCT02844907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768764|NCT02844907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768765|NCT02844907|Glucocorticoids|glucocorticoids|mesh-ancestor
92768766|NCT02844907|Hormones|hormones|mesh-ancestor
92768767|NCT02844907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768768|NCT02844907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92768769|NCT02844907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768770|NCT00628719|Amphotericin B|amphotericin b|mesh-list
92768771|NCT00628719|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92768772|NCT00628719|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92768773|NCT00628719|Deoxycholic Acid|deoxycholic acid|mesh-list
92768774|NCT00628719|Amebicides|amebicides|mesh-ancestor
92768775|NCT00628719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92768776|NCT00628719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92768777|NCT00628719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768778|NCT00628719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92768779|NCT00628719|Antifungal Agents|antifungal agents|mesh-ancestor
92768780|NCT00628719|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92768781|NCT00628719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768782|NCT00616993|Difluprednate|difluprednate|mesh-list
92768783|NCT00616993|Glucocorticoids|glucocorticoids|mesh-ancestor
92768784|NCT00616993|Hormones|hormones|mesh-ancestor
92768785|NCT00616993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768786|NCT00616993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768787|NCT02870361|Insulin|insulin|mesh-list
92768788|NCT02870361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92768789|NCT02870361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768790|NCT00616681|Oxcarbazepine|oxcarbazepine|mesh-list
92768791|NCT00616681|Anticonvulsants|anticonvulsants|mesh-ancestor
92768792|NCT00616681|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92768793|NCT00616681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92768794|NCT00616681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768795|NCT00616681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768796|NCT00616681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92768797|NCT00616681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92768798|NCT00997035|Voriconazole|voriconazole|mesh-list
92768799|NCT00997035|Antifungal Agents|antifungal agents|mesh-ancestor
92768800|NCT00997035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768801|NCT00997035|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92768802|NCT00997035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92768803|NCT00997035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768804|NCT00997035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768805|NCT00997035|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92768806|NCT00997035|Hormone Antagonists|hormone antagonists|mesh-ancestor
92768807|NCT00997035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768808|NCT00997035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768809|NCT00997035|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92768810|NCT01204697|Docetaxel|docetaxel|mesh-list
92768811|NCT01204697|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92768812|NCT01204697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768813|NCT01204697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768814|NCT01204697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92768815|NCT01204697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92768816|NCT01204697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768817|NCT01204697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768818|NCT01204697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768819|NCT01203917|Gefitinib|gefitinib|mesh-list
92768820|NCT01203917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768821|NCT01203917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768822|NCT01203917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768823|NCT01203917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768824|NCT04213495|Anesthetics|anesthetics|mesh-list
92768825|NCT04213495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768826|NCT04213495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768827|NCT04318223|Palbociclib|palbociclib|mesh-list
92768828|NCT04318223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768829|NCT04318223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768830|NCT04318223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768831|NCT04318223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413903|NCT01468389|Capecitabine|capecitabine|mesh-list
92768832|NCT01202903|Omalizumab|omalizumab|mesh-list
92768833|NCT01202903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92768834|NCT01202903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92768835|NCT01202903|Respiratory System Agents|respiratory system agents|mesh-ancestor
92768836|NCT00618631|Carfentanil|carfentanil|mesh-list
92768837|NCT00618631|Nicotine|nicotine|mesh-list
92768838|NCT00618631|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92768839|NCT00618631|Autonomic Agents|autonomic agents|mesh-ancestor
92768840|NCT00618631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768841|NCT00618631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768842|NCT00618631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92768843|NCT00618631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92768844|NCT00618631|Cholinergic Agents|cholinergic agents|mesh-ancestor
92768845|NCT00618631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768846|NCT00618631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768847|NCT00618631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92768848|NCT00618631|Narcotics|narcotics|mesh-ancestor
92768849|NCT00618631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768850|NCT00618631|Analgesics|analgesics|mesh-ancestor
92768851|NCT00618631|Sensory System Agents|sensory system agents|mesh-ancestor
92768852|NCT04213573|Fluorides|fluorides|mesh-list
92768853|NCT04213573|Cariostatic Agents|cariostatic agents|mesh-ancestor
92768854|NCT04213573|Protective Agents|protective agents|mesh-ancestor
92768855|NCT04213573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768856|NCT00620269|Irinotecan|irinotecan|mesh-list
92768857|NCT00620269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92768858|NCT00620269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768859|NCT00620269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92768860|NCT00620269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92768861|NCT00620269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768862|NCT00620269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768863|NCT00620269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768864|NCT04212403|Levofloxacin|levofloxacin|mesh-list
92768865|NCT04212403|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92768866|NCT04212403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768867|NCT04212403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92768868|NCT04212403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92768869|NCT04212403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92768870|NCT04212403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768871|NCT04212403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768872|NCT04212403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768873|NCT04212403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92768874|NCT04212403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92768875|NCT00637117|Interferons|interferons|mesh-list
92768876|NCT00637117|Interferon-alpha|interferon-alpha|mesh-list
92768877|NCT00637117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768878|NCT00637117|Antiviral Agents|antiviral agents|mesh-ancestor
92768879|NCT00637117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768880|NCT00637117|Immunologic Factors|immunologic factors|mesh-ancestor
92768881|NCT00637117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768882|NCT02052193|Vemurafenib|vemurafenib|mesh-list
92768883|NCT02052193|Dabrafenib|dabrafenib|mesh-list
92768884|NCT02052193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768885|NCT02052193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768886|NCT02052193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768887|NCT02052193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768888|NCT00617695|Zolmitriptan|zolmitriptan|mesh-list
92768889|NCT00617695|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92768890|NCT00617695|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92768891|NCT00617695|Serotonin Agents|serotonin agents|mesh-ancestor
92768892|NCT00617695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768893|NCT00617695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768894|NCT00617695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768895|NCT00619021|Gemcitabine|gemcitabine|mesh-list
92768896|NCT00619021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92768897|NCT00619021|Antimetabolites|antimetabolites|mesh-ancestor
92768898|NCT00619021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768899|NCT00619021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768900|NCT00620347|Sunitinib|sunitinib|mesh-list
92768901|NCT00620347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768902|NCT00620347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92768903|NCT00620347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92768904|NCT00620347|Growth Substances|growth substances|mesh-ancestor
92768905|NCT00620347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768906|NCT00620347|Growth Inhibitors|growth inhibitors|mesh-ancestor
92768907|NCT00620347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92768908|NCT00620347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768909|NCT00620347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768910|NCT04213105|Denosumab|denosumab|mesh-list
92768911|NCT04213105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92768912|NCT04213105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768913|NCT01887301|Nabiximols|nabiximols|mesh-list
92768914|NCT01887301|Analgesics|analgesics|mesh-ancestor
92768915|NCT01887301|Sensory System Agents|sensory system agents|mesh-ancestor
92768916|NCT01887301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768917|NCT01887301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768918|NCT00996801|Vitamin D|vitamin d|mesh-list
92768919|NCT00996801|Cholecalciferol|cholecalciferol|mesh-list
92768920|NCT00996801|Alendronate|alendronate|mesh-list
92768921|NCT00996801|Calcium Carbonate|calcium carbonate|mesh-list
92768922|NCT00996801|Calcium|calcium|mesh-list
92768923|NCT00996801|Vitamins|vitamins|mesh-ancestor
92768924|NCT00996801|Micronutrients|micronutrients|mesh-ancestor
92768925|NCT00996801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768926|NCT00996801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92768927|NCT00996801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92768928|NCT00996801|Antacids|antacids|mesh-ancestor
92768929|NCT00996801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768930|NCT00996801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92768931|NCT00619333|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92768932|NCT00619333|Hormones|hormones|mesh-ancestor
92768933|NCT00619333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92768934|NCT00619333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768935|NCT04924621|Midazolam|midazolam|mesh-list
92768936|NCT04924621|Sufentanil|sufentanil|mesh-list
92768937|NCT04924621|Propofol|propofol|mesh-list
92768938|NCT04924621|Tetracaine|tetracaine|mesh-list
92768939|NCT04924621|Rocuronium|rocuronium|mesh-list
92768940|NCT04924621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92768941|NCT04924621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92768942|NCT04924621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768943|NCT04924621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92768944|NCT04924621|Anesthetics, General|anesthetics, general|mesh-ancestor
92768945|NCT04924621|Anesthetics|anesthetics|mesh-ancestor
92768946|NCT04924621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92768947|NCT04924621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92374246|NCT01759602|Complement C1s|complement c1s|mesh-list
92768948|NCT04924621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92768949|NCT04924621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92768950|NCT04924621|GABA Modulators|gaba modulators|mesh-ancestor
92768951|NCT04924621|GABA Agents|gaba agents|mesh-ancestor
92768952|NCT04924621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92768953|NCT04924621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768954|NCT04924621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92768955|NCT04924621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92768956|NCT04924621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92768957|NCT04924621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768958|NCT04924621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92768959|NCT04924621|Narcotics|narcotics|mesh-ancestor
92768960|NCT04924621|Analgesics|analgesics|mesh-ancestor
92768961|NCT04924621|Sensory System Agents|sensory system agents|mesh-ancestor
92768962|NCT04924621|Anesthetics, Local|anesthetics, local|mesh-ancestor
92768963|NCT02213497|Paclitaxel|paclitaxel|mesh-list
92768964|NCT02213497|Carboplatin|carboplatin|mesh-list
92768965|NCT02213497|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92768966|NCT02213497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92768967|NCT02213497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92768968|NCT02213497|Tubulin Modulators|tubulin modulators|mesh-ancestor
92768969|NCT02213497|Antimitotic Agents|antimitotic agents|mesh-ancestor
92768970|NCT02213497|Mitosis Modulators|mitosis modulators|mesh-ancestor
92768971|NCT02213497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768972|NCT02213497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92768973|NCT00618163|Meloxicam|meloxicam|mesh-list
92768974|NCT00618163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92768975|NCT00618163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92768976|NCT00618163|Analgesics|analgesics|mesh-ancestor
92768977|NCT00618163|Sensory System Agents|sensory system agents|mesh-ancestor
92768978|NCT00618163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92768979|NCT00618163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92768980|NCT00618163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92768981|NCT00618163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92768982|NCT00618163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92768983|NCT00618163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92768984|NCT00618163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768985|NCT00618163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768986|NCT00618241|Raltegravir Potassium|raltegravir potassium|mesh-list
92768987|NCT00618241|Lamotrigine|lamotrigine|mesh-list
92768988|NCT00618241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92768989|NCT00618241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92768990|NCT00618241|Antiviral Agents|antiviral agents|mesh-ancestor
92768991|NCT00618241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92768992|NCT00618241|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92768993|NCT00618241|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92768994|NCT00618241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92768995|NCT00618241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92768996|NCT00618241|Anticonvulsants|anticonvulsants|mesh-ancestor
92768997|NCT00618241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92768998|NCT00618241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92768999|NCT00618241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92769000|NCT00618241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769001|NCT00618241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92769002|NCT00618241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92769003|NCT00618241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769004|NCT00618241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769005|NCT00618241|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92769006|NCT00618397|Ketamine|ketamine|mesh-list
92769007|NCT00618397|Analgesics|analgesics|mesh-ancestor
92769008|NCT00618397|Sensory System Agents|sensory system agents|mesh-ancestor
92769009|NCT00618397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769010|NCT00618397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769011|NCT00618397|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92769012|NCT00618397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92769013|NCT00618397|Anesthetics, General|anesthetics, general|mesh-ancestor
92769014|NCT00618397|Anesthetics|anesthetics|mesh-ancestor
92769015|NCT00618397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769016|NCT00618397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92113834|NCT03698669|Analgesics|analgesics|mesh-ancestor
92769017|NCT00618397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92769018|NCT00618397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769019|NCT00618397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769020|NCT04211545|Rabeprazole|rabeprazole|mesh-list
92769021|NCT04211545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92769022|NCT04211545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769023|NCT04211545|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92769024|NCT04211545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769025|NCT04211545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769026|NCT00620581|Paroxetine|paroxetine|mesh-list
92769027|NCT00620581|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92769028|NCT00620581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92769029|NCT00620581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769030|NCT00620581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336544|NCT01987596|Lenograstim|lenograstim|mesh-list
92769031|NCT00620581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769032|NCT00620581|Serotonin Agents|serotonin agents|mesh-ancestor
92769033|NCT00620581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769034|NCT00620581|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92769035|NCT00620581|Antidepressive Agents|antidepressive agents|mesh-ancestor
92769036|NCT00620581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769037|NCT00620581|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92769038|NCT00620581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92769039|NCT00620581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769040|NCT01000311|Vaccines|vaccines|mesh-list
92769041|NCT01000311|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92769042|NCT01000311|Immunologic Factors|immunologic factors|mesh-ancestor
92769043|NCT01000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769044|NCT04209439|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92769045|NCT04209439|Bupivacaine|bupivacaine|mesh-list
92769046|NCT04209439|Anesthetics, Local|anesthetics, local|mesh-ancestor
92769047|NCT04209439|Anesthetics|anesthetics|mesh-ancestor
92769048|NCT04209439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769049|NCT04209439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769050|NCT04209439|Sensory System Agents|sensory system agents|mesh-ancestor
92769051|NCT04209439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769052|NCT04209439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769053|NCT04209439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769054|NCT04209439|Analgesics|analgesics|mesh-ancestor
92769055|NCT04209439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769056|NCT04209439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769058|NCT05228041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92769059|NCT05228041|Respiratory System Agents|respiratory system agents|mesh-ancestor
92769060|NCT01003899|Afatinib|afatinib|mesh-list
92769061|NCT01003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769062|NCT01003899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92769063|NCT01003899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769064|NCT01003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769065|NCT04160377|Fluvoxamine|fluvoxamine|mesh-list
92769066|NCT04160377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769067|NCT04160377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769068|NCT04160377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92769069|NCT04160377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92769070|NCT04160377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769071|NCT04160377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769072|NCT04160377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769073|NCT04160377|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92769074|NCT04160377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92769075|NCT04160377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769076|NCT04160377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769077|NCT04160377|Serotonin Agents|serotonin agents|mesh-ancestor
92769078|NCT04160377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92769079|NCT04160377|Antidepressive Agents|antidepressive agents|mesh-ancestor
92769080|NCT04160377|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92769081|NCT04160377|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92769082|NCT04160377|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92769083|NCT01000155|Vorinostat|vorinostat|mesh-list
92769084|NCT01000155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769085|NCT01000155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92769086|NCT01000155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769087|NCT01000155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769088|NCT00999921|Tamoxifen|tamoxifen|mesh-list
92769089|NCT00999921|Evening primrose oil|evening primrose oil|mesh-list
92769090|NCT00999921|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92769091|NCT00999921|Hormone Antagonists|hormone antagonists|mesh-ancestor
92769092|NCT00999921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769093|NCT00999921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769094|NCT00999921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92769095|NCT00999921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769096|NCT00999921|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92769097|NCT00999921|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92769098|NCT00999921|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92769099|NCT00999921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769100|NCT00999921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769101|NCT00999921|Analgesics|analgesics|mesh-ancestor
92769102|NCT00999921|Sensory System Agents|sensory system agents|mesh-ancestor
92769103|NCT00999921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769104|NCT00999921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769105|NCT00999921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769106|NCT00999921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92769107|NCT00999921|Antimetabolites|antimetabolites|mesh-ancestor
92769108|NCT00999921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769109|NCT00999921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92769110|NCT00999921|Dermatologic Agents|dermatologic agents|mesh-ancestor
92769111|NCT02869347|Complement C1s|complement c1s|mesh-list
92769112|NCT02869347|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92769113|NCT02869347|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92769114|NCT02869347|Immunologic Factors|immunologic factors|mesh-ancestor
92769115|NCT02869347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769116|NCT02869347|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92769117|NCT02869347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769118|NCT00621673|Factor VIII|factor viii|mesh-list
92769119|NCT00621673|Coagulants|coagulants|mesh-ancestor
92769120|NCT01002573|Acetaminophen|acetaminophen|mesh-list
92769121|NCT01002573|Ibuprofen|ibuprofen|mesh-list
92769122|NCT01002573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769123|NCT01002573|Analgesics|analgesics|mesh-ancestor
92769124|NCT01002573|Sensory System Agents|sensory system agents|mesh-ancestor
92769125|NCT01002573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769126|NCT01002573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769127|NCT01002573|Antipyretics|antipyretics|mesh-ancestor
92769128|NCT01002573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769129|NCT01002573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769130|NCT01002573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769131|NCT01002573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92769132|NCT01002573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769133|NCT01002573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769134|NCT00620893|Lubricant Eye Drops|lubricant eye drops|mesh-list
92769135|NCT00620893|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92769136|NCT00620893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92769137|NCT04293549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92769138|NCT04293549|Mitogens|mitogens|mesh-list
92769139|NCT04293549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92769140|NCT04293549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769141|NCT04293549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92769142|NCT00996333|Gemcitabine|gemcitabine|mesh-list
92769143|NCT00996333|Capecitabine|capecitabine|mesh-list
92769144|NCT00996333|Docetaxel|docetaxel|mesh-list
92769145|NCT00996333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769146|NCT00996333|Antimetabolites|antimetabolites|mesh-ancestor
92769147|NCT00996333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769148|NCT00996333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769149|NCT00996333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92769150|NCT00996333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92769151|NCT00996333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92769152|NCT00621907|Levobupivacaine|levobupivacaine|mesh-list
92769153|NCT00621907|Anesthetics, Local|anesthetics, local|mesh-ancestor
92769154|NCT00621907|Anesthetics|anesthetics|mesh-ancestor
92769155|NCT00621907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769156|NCT00621907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769157|NCT00621907|Sensory System Agents|sensory system agents|mesh-ancestor
92769158|NCT00621907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769159|NCT01349101|Mycophenolic Acid|mycophenolic acid|mesh-list
92769160|NCT01349101|Cyclophosphamide|cyclophosphamide|mesh-list
92769161|NCT01349101|Busulfan|busulfan|mesh-list
92769162|NCT01349101|Fludarabine|fludarabine|mesh-list
92769163|NCT01349101|Fludarabine phosphate|fludarabine phosphate|mesh-list
92769164|NCT01349101|Tacrolimus|tacrolimus|mesh-list
92769165|NCT01349101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769166|NCT01349101|Immunologic Factors|immunologic factors|mesh-ancestor
92769167|NCT01349101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769168|NCT01349101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769169|NCT01349101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92769170|NCT01349101|Alkylating Agents|alkylating agents|mesh-ancestor
92769171|NCT01349101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336614|NCT01945242|Hormones|hormones|mesh-ancestor
92769172|NCT01349101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769173|NCT01349101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92769174|NCT01349101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769175|NCT01349101|Antimetabolites|antimetabolites|mesh-ancestor
92769176|NCT01349101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769177|NCT01349101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92769178|NCT01349101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769179|NCT01349101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92769180|NCT01349101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92769181|NCT01349101|Antitubercular Agents|antitubercular agents|mesh-ancestor
92769182|NCT01349101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92769183|NCT00620971|Bevacizumab|bevacizumab|mesh-list
92769184|NCT00620971|Cisplatin|cisplatin|mesh-list
92769185|NCT00620971|Gemcitabine|gemcitabine|mesh-list
92769186|NCT00620971|Docetaxel|docetaxel|mesh-list
92769187|NCT00620971|Vinorelbine|vinorelbine|mesh-list
92769188|NCT00620971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92769189|NCT00620971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769190|NCT00620971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92769191|NCT00620971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92769192|NCT00620971|Growth Substances|growth substances|mesh-ancestor
92769193|NCT00620971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769194|NCT00620971|Growth Inhibitors|growth inhibitors|mesh-ancestor
92769195|NCT00620971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769196|NCT00620971|Antimetabolites|antimetabolites|mesh-ancestor
92769197|NCT00620971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769198|NCT00620971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92769199|NCT00620971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92769200|NCT00620971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92769201|NCT00620971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92769202|NCT04223661|Dexamethasone|dexamethasone|mesh-list
92769203|NCT04223661|Lenalidomide|lenalidomide|mesh-list
92769204|NCT04223661|Daratumumab|daratumumab|mesh-list
92769205|NCT04223661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769207|NCT04223661|Autonomic Agents|autonomic agents|mesh-ancestor
92769208|NCT04223661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769209|NCT04223661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769210|NCT04223661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769211|NCT04223661|Glucocorticoids|glucocorticoids|mesh-ancestor
92769212|NCT04223661|Hormones|hormones|mesh-ancestor
92769213|NCT04223661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769214|NCT04223661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92769215|NCT04223661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769216|NCT04223661|Immunologic Factors|immunologic factors|mesh-ancestor
92769217|NCT04223661|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92769218|NCT04223661|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92769219|NCT04223661|Growth Substances|growth substances|mesh-ancestor
92769220|NCT04223661|Growth Inhibitors|growth inhibitors|mesh-ancestor
92769221|NCT00622141|Saquinavir|saquinavir|mesh-list
92769222|NCT00622141|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92769223|NCT00622141|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92769224|NCT00622141|Protease Inhibitors|protease inhibitors|mesh-ancestor
92769225|NCT00622141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769226|NCT00622141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769227|NCT00622141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92769228|NCT00622141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92769229|NCT00622141|Antiviral Agents|antiviral agents|mesh-ancestor
92769230|NCT00622141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769231|NCT00622141|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92769232|NCT00622141|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92769234|NCT04210765|Enclomiphene|enclomiphene|mesh-list
92769235|NCT04210765|Zuclomiphene|zuclomiphene|mesh-list
92769236|NCT04210765|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92769237|NCT04210765|Hormone Antagonists|hormone antagonists|mesh-ancestor
92769238|NCT04210765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769239|NCT04210765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769240|NCT04210765|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92769241|NCT04210765|Fertility Agents|fertility agents|mesh-ancestor
92769242|NCT04210765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92769243|NCT04210765|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92769244|NCT04210765|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92769245|NCT03735901|Levodopa|levodopa|mesh-list
92769246|NCT03735901|Carbidopa|carbidopa|mesh-list
92769247|NCT03735901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92769248|NCT03735901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92769249|NCT03735901|Dopamine Agents|dopamine agents|mesh-ancestor
92769250|NCT03735901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769251|NCT03735901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769252|NCT03735901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769253|NCT03735901|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92769254|NCT03735901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769255|NCT00621283|Secretin|secretin|mesh-list
92769256|NCT00621283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769257|NCT00621283|Hormones|hormones|mesh-ancestor
92769258|NCT00621283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769259|NCT00621283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769260|NCT00995709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92769261|NCT00995709|Immunologic Factors|immunologic factors|mesh-ancestor
92769262|NCT00995709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769263|NCT05662189|Exenatide|exenatide|mesh-list
92769264|NCT05662189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92769265|NCT05662189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769266|NCT05662189|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92769267|NCT05662189|Incretins|incretins|mesh-ancestor
92769268|NCT05662189|Hormones|hormones|mesh-ancestor
92769269|NCT05662189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769270|NCT00629031|Paromomycin|paromomycin|mesh-list
92769271|NCT00629031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92769272|NCT00629031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769273|NCT00629031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92769274|NCT00629031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92769275|NCT00621361|Etoposide|etoposide|mesh-list
92769276|NCT00621361|Cediranib|cediranib|mesh-list
92769277|NCT00621361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769278|NCT00621361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92769279|NCT00621361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92769280|NCT00621361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92769281|NCT00621361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769282|NCT00621361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769283|NCT00621361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92769285|NCT04208581|Xhance|xhance|mesh-list
92769286|NCT04208581|Budesonide|budesonide|mesh-list
92769287|NCT04208581|Bromides|bromides|mesh-list
92769288|NCT04208581|Formoterol Fumarate|formoterol fumarate|mesh-list
92769289|NCT04208581|Tiotropium Bromide|tiotropium bromide|mesh-list
92769290|NCT04208581|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92769291|NCT04208581|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92769292|NCT04208581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769293|NCT04208581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92769294|NCT04208581|Autonomic Agents|autonomic agents|mesh-ancestor
92769295|NCT04208581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769296|NCT04208581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769297|NCT04208581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92769298|NCT04208581|Respiratory System Agents|respiratory system agents|mesh-ancestor
92769299|NCT04208581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92769300|NCT04208581|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92769301|NCT04208581|Glucocorticoids|glucocorticoids|mesh-ancestor
92769302|NCT04208581|Hormones|hormones|mesh-ancestor
92769303|NCT04208581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769304|NCT04208581|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92769305|NCT04208581|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92769306|NCT04208581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92769307|NCT04208581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92769308|NCT04208581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769309|NCT04208581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769310|NCT04208581|Parasympatholytics|parasympatholytics|mesh-ancestor
92769311|NCT04208581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92769312|NCT04208581|Cholinergic Agents|cholinergic agents|mesh-ancestor
92769313|NCT04208581|Anticonvulsants|anticonvulsants|mesh-ancestor
92769314|NCT05368675|Buprenorphine|buprenorphine|mesh-list
92769315|NCT05368675|Methadone|methadone|mesh-list
92769316|NCT05368675|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92769317|NCT05368675|Naloxone|naloxone|mesh-list
92769318|NCT05368675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92769319|NCT05368675|Narcotics|narcotics|mesh-ancestor
92769320|NCT05368675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769321|NCT05368675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769322|NCT05368675|Analgesics|analgesics|mesh-ancestor
92769323|NCT05368675|Sensory System Agents|sensory system agents|mesh-ancestor
92769324|NCT05368675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769325|NCT05368675|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92769326|NCT05368675|Antitussive Agents|antitussive agents|mesh-ancestor
92769327|NCT05368675|Respiratory System Agents|respiratory system agents|mesh-ancestor
92769328|NCT05368207|Pembrolizumab|pembrolizumab|mesh-list
92769329|NCT05368207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92769330|NCT05368207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769331|NCT05368207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92769332|NCT05368207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769333|NCT05368051|Capecitabine|capecitabine|mesh-list
92769334|NCT05368051|Antibodies|antibodies|mesh-list
92769335|NCT05368051|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92769336|NCT05368051|Immunologic Factors|immunologic factors|mesh-ancestor
92769337|NCT05368051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769338|NCT05368051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769339|NCT05368051|Antimetabolites|antimetabolites|mesh-ancestor
92769340|NCT05368051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769341|NCT05368051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769342|NCT02641873|Leucovorin|leucovorin|mesh-list
92769343|NCT02641873|Bevacizumab|bevacizumab|mesh-list
92769344|NCT02641873|Irinotecan|irinotecan|mesh-list
92769345|NCT02641873|Levoleucovorin|levoleucovorin|mesh-list
92769346|NCT02641873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92769347|NCT02641873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769348|NCT02641873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92769349|NCT02641873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92769350|NCT02641873|Growth Substances|growth substances|mesh-ancestor
92769351|NCT02641873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769352|NCT02641873|Growth Inhibitors|growth inhibitors|mesh-ancestor
92769353|NCT02641873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92769354|NCT02641873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92414420|NCT01471730|Thrombin|thrombin|mesh-list
92769355|NCT02641873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769356|NCT02641873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769357|NCT02641873|Antidotes|antidotes|mesh-ancestor
92769358|NCT02641873|Protective Agents|protective agents|mesh-ancestor
92769359|NCT02641873|Vitamin B Complex|vitamin b complex|mesh-ancestor
92769360|NCT02641873|Vitamins|vitamins|mesh-ancestor
92769361|NCT02641873|Micronutrients|micronutrients|mesh-ancestor
92769362|NCT00998985|Grazoprevir|grazoprevir|mesh-list
92769363|NCT00998985|Antiviral Agents|antiviral agents|mesh-ancestor
92769364|NCT00998985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769365|NCT05240391|Midodrine|midodrine|mesh-list
92769366|NCT05240391|Sympathomimetics|sympathomimetics|mesh-ancestor
92769367|NCT05240391|Autonomic Agents|autonomic agents|mesh-ancestor
92769368|NCT05240391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769369|NCT05240391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769370|NCT05240391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92769371|NCT05240391|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92769372|NCT05240391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92769373|NCT05240391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92769374|NCT05240391|Adrenergic Agents|adrenergic agents|mesh-ancestor
92769375|NCT05240391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769376|NCT05240391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769377|NCT00628953|Esomeprazole|esomeprazole|mesh-list
92769378|NCT00628953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92769379|NCT00628953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769380|NCT00628953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92769381|NCT00628953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769382|NCT00628953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769383|NCT04294953|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92769384|NCT04294953|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92769385|NCT04294953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92769386|NCT04294953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769387|NCT04294953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769388|NCT04294953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769389|NCT04294953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769390|NCT04294953|Analgesics|analgesics|mesh-ancestor
92769391|NCT04294953|Sensory System Agents|sensory system agents|mesh-ancestor
92769392|NCT04294953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769393|NCT04294953|Antidepressive Agents|antidepressive agents|mesh-ancestor
92769394|NCT04294953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769395|NCT04294953|Dopamine Agents|dopamine agents|mesh-ancestor
92769396|NCT02869815|Methylene Blue|methylene blue|mesh-list
92769397|NCT02869815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769398|NCT02869815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769399|NCT04293081|Maleic acid|maleic acid|mesh-list
92769400|NCT04293081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769401|NCT04293081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769402|NCT04205643|Infliximab|infliximab|mesh-list
92769403|NCT04205643|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92769404|NCT04205643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769405|NCT04205643|Dermatologic Agents|dermatologic agents|mesh-ancestor
92769406|NCT04205643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769407|NCT04205643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769408|NCT02868801|Pregabalin|pregabalin|mesh-list
92769409|NCT02868801|Analgesics|analgesics|mesh-ancestor
92769410|NCT02868801|Sensory System Agents|sensory system agents|mesh-ancestor
92769411|NCT02868801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769412|NCT02868801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769413|NCT02868801|Anticonvulsants|anticonvulsants|mesh-ancestor
92769414|NCT02868801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92769415|NCT02868801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769416|NCT02868801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769417|NCT02868801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92769418|NCT02868801|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92769419|NCT02868801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92769420|NCT02868801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769421|NCT02868801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769422|NCT01002339|Mycophenolic Acid|mycophenolic acid|mesh-list
92769423|NCT01002339|Cyclosporine|cyclosporine|mesh-list
92769424|NCT01002339|Prednisone|prednisone|mesh-list
92769425|NCT01002339|Tacrolimus|tacrolimus|mesh-list
92769426|NCT01002339|Basiliximab|basiliximab|mesh-list
92769427|NCT01002339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769428|NCT01002339|Immunologic Factors|immunologic factors|mesh-ancestor
92769429|NCT01002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769430|NCT01002339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92769431|NCT01002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769432|NCT01002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769433|NCT01002339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92769434|NCT01002339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769435|NCT01002339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92769436|NCT01002339|Antitubercular Agents|antitubercular agents|mesh-ancestor
92769437|NCT01002339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92769438|NCT01002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769439|NCT01002339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769440|NCT01002339|Glucocorticoids|glucocorticoids|mesh-ancestor
92769441|NCT01002339|Hormones|hormones|mesh-ancestor
92769442|NCT01002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769443|NCT01002339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92769444|NCT01002339|Antifungal Agents|antifungal agents|mesh-ancestor
92769445|NCT01002339|Dermatologic Agents|dermatologic agents|mesh-ancestor
92769446|NCT01002339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769447|NCT01002105|Baclofen|baclofen|mesh-list
92769448|NCT01002105|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92769449|NCT01002105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769450|NCT01002105|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92769451|NCT01002105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769452|NCT01002105|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92769453|NCT01002105|GABA Agonists|gaba agonists|mesh-ancestor
92769454|NCT01002105|GABA Agents|gaba agents|mesh-ancestor
92769455|NCT01002105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769456|NCT01002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769457|NCT02605993|Ravulizumab|ravulizumab|mesh-list
92769458|NCT02605993|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92769459|NCT02605993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769460|NCT02605993|Immunologic Factors|immunologic factors|mesh-ancestor
92769461|NCT02605993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769462|NCT00995085|Pyridoxine|pyridoxine|mesh-list
92769463|NCT00995085|Metadoxine|metadoxine|mesh-list
92769464|NCT00995085|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92769465|NCT00995085|Vitamin B Complex|vitamin b complex|mesh-ancestor
92769466|NCT00995085|Vitamins|vitamins|mesh-ancestor
92769467|NCT00995085|Micronutrients|micronutrients|mesh-ancestor
92769468|NCT00995085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769469|NCT00603733|Mesalamine|mesalamine|mesh-list
92769470|NCT00603733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769471|NCT00603733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769472|NCT00603733|Analgesics|analgesics|mesh-ancestor
92769473|NCT00603733|Sensory System Agents|sensory system agents|mesh-ancestor
92769474|NCT00603733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769475|NCT00603733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769476|NCT00603733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769477|NCT00603733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769478|NCT02471911|Dexamethasone|dexamethasone|mesh-list
92769479|NCT02471911|Rituximab|rituximab|mesh-list
92769480|NCT02471911|Carboplatin|carboplatin|mesh-list
92769481|NCT02471911|Etoposide|etoposide|mesh-list
92769482|NCT02471911|Ifosfamide|ifosfamide|mesh-list
92769483|NCT02471911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92769484|NCT02471911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769485|NCT02471911|Immunologic Factors|immunologic factors|mesh-ancestor
92769486|NCT02471911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769487|NCT02471911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769488|NCT02471911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769489|NCT02471911|Antiemetics|antiemetics|mesh-ancestor
92769490|NCT02471911|Autonomic Agents|autonomic agents|mesh-ancestor
92769491|NCT02471911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769492|NCT02471911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769493|NCT02471911|Glucocorticoids|glucocorticoids|mesh-ancestor
92769494|NCT02471911|Hormones|hormones|mesh-ancestor
92769495|NCT02471911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769496|NCT02471911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92769497|NCT02471911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92769498|NCT02471911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92769499|NCT02471911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92769500|NCT02471911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769501|NCT02471911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769502|NCT02471911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92769503|NCT02471911|Alkylating Agents|alkylating agents|mesh-ancestor
92769504|NCT00622375|Mesalamine|mesalamine|mesh-list
92769505|NCT00622375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769506|NCT00622375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769507|NCT00622375|Analgesics|analgesics|mesh-ancestor
92769508|NCT00622375|Sensory System Agents|sensory system agents|mesh-ancestor
92769509|NCT00622375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769510|NCT00622375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769511|NCT00622375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769512|NCT00622375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769513|NCT02691325|Charcoal|charcoal|mesh-list
92769514|NCT02691325|Nemiralisib|nemiralisib|mesh-list
92769515|NCT02691325|Antidotes|antidotes|mesh-ancestor
92769516|NCT02691325|Protective Agents|protective agents|mesh-ancestor
92769517|NCT02691325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769518|NCT02691325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92769519|NCT02691325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769520|NCT02691325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769521|NCT01678027|Clarithromycin|clarithromycin|mesh-list
92769522|NCT01678027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92769523|NCT01678027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769524|NCT01678027|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92769525|NCT01678027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769526|NCT01678027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769527|NCT01678027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92769528|NCT01678027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92769530|NCT02697331|Progestins|progestins|mesh-ancestor
92769531|NCT02697331|Hormones|hormones|mesh-ancestor
92769532|NCT02697331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769533|NCT02697331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769534|NCT04278625|Acetaminophen|acetaminophen|mesh-list
92769535|NCT04278625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769536|NCT04278625|Analgesics|analgesics|mesh-ancestor
92769537|NCT04278625|Sensory System Agents|sensory system agents|mesh-ancestor
92769538|NCT04278625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769539|NCT04278625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769540|NCT04278625|Antipyretics|antipyretics|mesh-ancestor
92769541|NCT02689141|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92769542|NCT02689141|Ofatumumab|ofatumumab|mesh-list
92769543|NCT02689141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92769544|NCT02689141|Alkylating Agents|alkylating agents|mesh-ancestor
92769545|NCT02689141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769546|NCT02689141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769547|NCT00622687|Iloprost|iloprost|mesh-list
92769548|NCT00622687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92769549|NCT00622687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92769550|NCT02691403|Bupivacaine|bupivacaine|mesh-list
92769551|NCT02691403|Levobupivacaine|levobupivacaine|mesh-list
92769552|NCT02691403|Anesthetics, Local|anesthetics, local|mesh-ancestor
92769553|NCT02691403|Anesthetics|anesthetics|mesh-ancestor
92769554|NCT02691403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769555|NCT02691403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769556|NCT02691403|Sensory System Agents|sensory system agents|mesh-ancestor
92769557|NCT02691403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769558|NCT00995007|Carboplatin|carboplatin|mesh-list
92769559|NCT00995007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769560|NCT00909883|Botulinum Toxins|botulinum toxins|mesh-list
92769561|NCT00909883|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92769562|NCT00909883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769563|NCT00909883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769564|NCT00909883|Cholinergic Agents|cholinergic agents|mesh-ancestor
92769565|NCT00909883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769566|NCT00909883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769567|NCT00639925|Gemcitabine|gemcitabine|mesh-list
92769568|NCT00639925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769569|NCT00639925|Antimetabolites|antimetabolites|mesh-ancestor
92769570|NCT00639925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769571|NCT00639925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769572|NCT00994461|Celecoxib|celecoxib|mesh-list
92769573|NCT00994461|Loxoprofen|loxoprofen|mesh-list
92769574|NCT00994461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769575|NCT00994461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769576|NCT00994461|Analgesics|analgesics|mesh-ancestor
92769577|NCT00994461|Sensory System Agents|sensory system agents|mesh-ancestor
92769578|NCT00994461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769579|NCT00994461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769580|NCT00994461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769581|NCT00994461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769582|NCT00994461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92769583|NCT00994461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92769584|NCT00994461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769585|NCT00994461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769586|NCT00993915|Atorvastatin|atorvastatin|mesh-list
92769587|NCT00993915|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92769588|NCT00993915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92769589|NCT00993915|Antimetabolites|antimetabolites|mesh-ancestor
92769590|NCT00993915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769591|NCT00993915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92769592|NCT00993915|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92769593|NCT00993915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769594|NCT01202591|Fulvestrant|fulvestrant|mesh-list
92769595|NCT01202591|Exemestane|exemestane|mesh-list
92769596|NCT01202591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92769597|NCT01202591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769598|NCT01202591|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92769599|NCT01202591|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92769600|NCT01202591|Hormone Antagonists|hormone antagonists|mesh-ancestor
92769601|NCT01202591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769602|NCT01202591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769603|NCT01202591|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92769604|NCT01202591|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92769605|NCT01202591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769606|NCT01202591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769607|NCT01202279|Phenylpropanolamine|phenylpropanolamine|mesh-list
92769608|NCT01202279|Pseudoephedrine|pseudoephedrine|mesh-list
92769609|NCT01202279|Guaifenesin|guaifenesin|mesh-list
92769610|NCT01202279|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92769611|NCT01202279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92769612|NCT01202279|Autonomic Agents|autonomic agents|mesh-ancestor
92769613|NCT01202279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769614|NCT01202279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769615|NCT01202279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92769616|NCT01202279|Respiratory System Agents|respiratory system agents|mesh-ancestor
92769617|NCT01202279|Nasal Decongestants|nasal decongestants|mesh-ancestor
92769618|NCT01202279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92769619|NCT01202279|Sympathomimetics|sympathomimetics|mesh-ancestor
92769620|NCT01202279|Adrenergic Agents|adrenergic agents|mesh-ancestor
92769621|NCT01202279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769622|NCT01202279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769623|NCT01202279|Expectorants|expectorants|mesh-ancestor
92769624|NCT01202279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92769625|NCT01202279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92769626|NCT01202279|Appetite Depressants|appetite depressants|mesh-ancestor
92769627|NCT01202279|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92769628|NCT03877315|Cimetidine|cimetidine|mesh-list
92769629|NCT03877315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92769630|NCT03877315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769631|NCT03877315|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92769632|NCT03877315|Histamine Antagonists|histamine antagonists|mesh-ancestor
92769633|NCT03877315|Histamine Agents|histamine agents|mesh-ancestor
92769634|NCT03877315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769635|NCT03877315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769636|NCT03877315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769637|NCT03877315|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92769638|NCT03877315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92769639|NCT03877315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769640|NCT02687347|Morphine|morphine|mesh-list
92769641|NCT02687347|Methadone|methadone|mesh-list
92769642|NCT02687347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92769643|NCT02687347|Narcotics|narcotics|mesh-ancestor
92769644|NCT02687347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769645|NCT02687347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769646|NCT02687347|Analgesics|analgesics|mesh-ancestor
92769647|NCT02687347|Sensory System Agents|sensory system agents|mesh-ancestor
92769648|NCT02687347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769649|NCT02687347|Antitussive Agents|antitussive agents|mesh-ancestor
92769650|NCT02687347|Respiratory System Agents|respiratory system agents|mesh-ancestor
92769651|NCT02687425|Pioglitazone|pioglitazone|mesh-list
92769652|NCT02687425|Imatinib Mesylate|imatinib mesylate|mesh-list
92769653|NCT02687425|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92769654|NCT02687425|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92769655|NCT02687425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769656|NCT02687425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769657|NCT02687425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92769658|NCT02687425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769659|NCT02687425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769661|NCT02687269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92769662|NCT02687269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769663|NCT02687269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769664|NCT02689297|Chlorine dioxide|chlorine dioxide|mesh-list
92769665|NCT02689297|Dental Disinfectants|dental disinfectants|mesh-ancestor
92769666|NCT02689297|Disinfectants|disinfectants|mesh-ancestor
92769667|NCT02689297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769668|NCT04185805|Fexuprazan|fexuprazan|mesh-list
92769669|NCT04185805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769670|NCT01201811|Azacitidine|azacitidine|mesh-list
92769671|NCT01201811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769672|NCT01201811|Antimetabolites|antimetabolites|mesh-ancestor
92769673|NCT01201811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769674|NCT01201811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769675|NCT01201811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769676|NCT04186897|Salicylic Acid|salicylic acid|mesh-list
92769677|NCT04186897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769678|NCT04186897|Antifungal Agents|antifungal agents|mesh-ancestor
92769679|NCT04186897|Keratolytic Agents|keratolytic agents|mesh-ancestor
92769680|NCT04186897|Dermatologic Agents|dermatologic agents|mesh-ancestor
92769681|NCT05392127|Vitamin K|vitamin k|mesh-list
92769682|NCT05392127|Vitamin K 1|vitamin k 1|mesh-list
92769683|NCT05392127|Repaglinide|repaglinide|mesh-list
92769684|NCT05392127|Midazolam|midazolam|mesh-list
92769685|NCT05392127|Omeprazole|omeprazole|mesh-list
92769686|NCT05392127|Warfarin|warfarin|mesh-list
92769687|NCT05392127|Vitamins|vitamins|mesh-ancestor
92769688|NCT05392127|Micronutrients|micronutrients|mesh-ancestor
92769689|NCT05392127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769690|NCT05392127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92769691|NCT05392127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92769692|NCT05392127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769693|NCT05392127|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92769694|NCT05392127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92769695|NCT05392127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769696|NCT05392127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92769697|NCT05392127|Anesthetics, General|anesthetics, general|mesh-ancestor
92769698|NCT05392127|Anesthetics|anesthetics|mesh-ancestor
92769699|NCT05392127|GABA Modulators|gaba modulators|mesh-ancestor
92769700|NCT05392127|GABA Agents|gaba agents|mesh-ancestor
92769701|NCT05392127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769702|NCT05392127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769703|NCT05392127|Anticoagulants|anticoagulants|mesh-ancestor
92769704|NCT05392127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92769705|NCT05392127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769706|NCT05392127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92769707|NCT05392127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769708|NCT05392127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92769709|NCT05392127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92769710|NCT05392127|Hemostatics|hemostatics|mesh-ancestor
92769711|NCT05392127|Coagulants|coagulants|mesh-ancestor
92769712|NCT05392127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92769713|NCT05378399|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92769714|NCT05378399|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92769715|NCT05378399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92769716|NCT05378399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92769717|NCT05378399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769718|NCT05378399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769719|NCT05378399|Antiviral Agents|antiviral agents|mesh-ancestor
92769720|NCT05378399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769721|NCT05378399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92336794|NCT01938846|Paclitaxel|paclitaxel|mesh-list
92769722|NCT05378399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92769723|NCT04379011|Brivaracetam|brivaracetam|mesh-list
92769724|NCT04379011|Anticonvulsants|anticonvulsants|mesh-ancestor
92769725|NCT02685163|Antioxidants|antioxidants|mesh-list
92769726|NCT02685163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769727|NCT02685163|Protective Agents|protective agents|mesh-ancestor
92769728|NCT02685163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769729|NCT00640003|Baclofen|baclofen|mesh-list
92769730|NCT00640003|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92769731|NCT00640003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769732|NCT00640003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92769733|NCT00640003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769734|NCT00640003|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92769735|NCT00640003|GABA Agonists|gaba agonists|mesh-ancestor
92769736|NCT00640003|GABA Agents|gaba agents|mesh-ancestor
92769737|NCT00640003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529925|NCT00038701|Growth Substances|growth substances|mesh-ancestor
92769738|NCT00640003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769739|NCT01201343|Interferons|interferons|mesh-list
92769740|NCT01201343|Interferon-beta|interferon-beta|mesh-list
92769741|NCT01201343|Interferon beta-1a|interferon beta-1a|mesh-list
92769742|NCT01201343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769743|NCT01201343|Antiviral Agents|antiviral agents|mesh-ancestor
92769744|NCT01201343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769745|NCT01201343|Immunologic Factors|immunologic factors|mesh-ancestor
92769746|NCT01201343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769747|NCT01201343|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92769748|NCT04185649|Capecitabine|capecitabine|mesh-list
92769749|NCT04185649|Lapatinib|lapatinib|mesh-list
92769750|NCT04185649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769751|NCT04185649|Antimetabolites|antimetabolites|mesh-ancestor
92769752|NCT04185649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769753|NCT04185649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769754|NCT04185649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92769755|NCT04185649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769756|NCT01201265|Bevacizumab|bevacizumab|mesh-list
92769757|NCT01201265|Carboplatin|carboplatin|mesh-list
92769758|NCT01201265|Gemcitabine|gemcitabine|mesh-list
92769759|NCT01201265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92769760|NCT01201265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769761|NCT01201265|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92769762|NCT01201265|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92769763|NCT01201265|Growth Substances|growth substances|mesh-ancestor
92769764|NCT01201265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769765|NCT01201265|Growth Inhibitors|growth inhibitors|mesh-ancestor
92769766|NCT01201265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769767|NCT01201265|Antimetabolites|antimetabolites|mesh-ancestor
92769768|NCT01201265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769769|NCT04246801|Clobetasol|clobetasol|mesh-list
92769770|NCT04246801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769771|NCT04246801|Glucocorticoids|glucocorticoids|mesh-ancestor
92769772|NCT04246801|Hormones|hormones|mesh-ancestor
92769773|NCT04246801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769774|NCT04246801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769775|NCT00638677|Sorbitol|sorbitol|mesh-list
92769776|NCT00638677|Cathartics|cathartics|mesh-ancestor
92769777|NCT00638677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769778|NCT01200485|Allopurinol|allopurinol|mesh-list
92769779|NCT01200485|Rasburicase|rasburicase|mesh-list
92769780|NCT01200485|Antimetabolites|antimetabolites|mesh-ancestor
92769781|NCT01200485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375090|NCT04360044|Hormones|hormones|mesh-ancestor
92769782|NCT01200485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769783|NCT01200485|Gout Suppressants|gout suppressants|mesh-ancestor
92769784|NCT01200485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769785|NCT01200485|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92769786|NCT01200485|Antioxidants|antioxidants|mesh-ancestor
92769787|NCT01200485|Protective Agents|protective agents|mesh-ancestor
92769788|NCT01200485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769789|NCT02688907|Adavosertib|adavosertib|mesh-list
92769790|NCT02688907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769791|NCT02688907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769792|NCT02686645|Metronidazole|metronidazole|mesh-list
92769793|NCT02686645|Vancomycin|vancomycin|mesh-list
92769794|NCT02686645|Loperamide|loperamide|mesh-list
92769795|NCT02686645|Antidiarrheals|antidiarrheals|mesh-list
92769796|NCT02686645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769797|NCT02686645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92769798|NCT02686645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92769799|NCT02686645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92769800|NCT02686645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769801|NCT04318067|Melatonin|melatonin|mesh-list
92769802|NCT04318067|Antioxidants|antioxidants|mesh-ancestor
92769803|NCT04318067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769804|NCT04318067|Protective Agents|protective agents|mesh-ancestor
92769805|NCT04318067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769806|NCT04318067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769807|NCT01200407|Amlodipine|amlodipine|mesh-list
92769808|NCT01200407|Olmesartan|olmesartan|mesh-list
92769809|NCT01200407|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92769810|NCT01200407|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92769811|NCT01200407|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92769812|NCT01200407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769813|NCT01200407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769814|NCT01200407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92769815|NCT01200407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769816|NCT01200407|Vasodilator Agents|vasodilator agents|mesh-ancestor
92769817|NCT01200407|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92769818|NCT01200407|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92769819|NCT02685085|Misoprostol|misoprostol|mesh-list
92769820|NCT02685085|Dinoprostone|dinoprostone|mesh-list
92769821|NCT02685085|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92769822|NCT02685085|Abortifacient Agents|abortifacient agents|mesh-ancestor
92769823|NCT02685085|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92769824|NCT02685085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769825|NCT02685085|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92769826|NCT02685085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769827|NCT02685085|Oxytocics|oxytocics|mesh-ancestor
92769828|NCT02688595|Anesthetics|anesthetics|mesh-list
92769829|NCT02688595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92769830|NCT02688595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769831|NCT01200329|Gemcitabine|gemcitabine|mesh-list
92769832|NCT01200329|Melphalan|melphalan|mesh-list
92769833|NCT01200329|Busulfan|busulfan|mesh-list
92769834|NCT01200329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769835|NCT01200329|Antimetabolites|antimetabolites|mesh-ancestor
92769836|NCT01200329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769837|NCT01200329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769838|NCT01200329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92769839|NCT01200329|Alkylating Agents|alkylating agents|mesh-ancestor
92769840|NCT01200329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92769841|NCT01200329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769842|NCT01200329|Immunologic Factors|immunologic factors|mesh-ancestor
92769843|NCT01200329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769844|NCT01199939|Ritonavir|ritonavir|mesh-list
92769845|NCT01199939|Darunavir|darunavir|mesh-list
92769846|NCT01199939|Etravirine|etravirine|mesh-list
92769847|NCT01199939|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92769848|NCT01199939|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92769849|NCT01199939|Protease Inhibitors|protease inhibitors|mesh-ancestor
92769850|NCT01199939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769851|NCT01199939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769852|NCT01199939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92769853|NCT01199939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92769854|NCT01199939|Antiviral Agents|antiviral agents|mesh-ancestor
92769855|NCT01199939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769856|NCT01199939|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92769857|NCT01199939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92769858|NCT01199939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92769859|NCT01199939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92769860|NCT02688361|Acetylcysteine|acetylcysteine|mesh-list
92769861|NCT02688361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92769862|NCT02688361|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92769863|NCT02688361|Antiviral Agents|antiviral agents|mesh-ancestor
92769864|NCT02688361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769865|NCT02688361|Expectorants|expectorants|mesh-ancestor
92769866|NCT02688361|Respiratory System Agents|respiratory system agents|mesh-ancestor
92769867|NCT02688361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92769868|NCT02688361|Antioxidants|antioxidants|mesh-ancestor
92769869|NCT02688361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769870|NCT02688361|Protective Agents|protective agents|mesh-ancestor
92769871|NCT02688361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769872|NCT02688361|Antidotes|antidotes|mesh-ancestor
92769873|NCT01199861|Vaccines|vaccines|mesh-list
92769874|NCT01199861|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92769875|NCT01199861|Immunologic Factors|immunologic factors|mesh-ancestor
92769876|NCT01199861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769877|NCT01199861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92769878|NCT01199861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769879|NCT01199861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769880|NCT03196219|Anti-Infective Agents|anti-infective agents|mesh-list
92769881|NCT03196219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92769882|NCT00640081|Leucovorin|leucovorin|mesh-list
92769883|NCT00640081|Fluorouracil|fluorouracil|mesh-list
92769884|NCT00640081|Capecitabine|capecitabine|mesh-list
92414954|NCT01475760|Hemostatics|hemostatics|mesh-ancestor
92769885|NCT00640081|Oxaliplatin|oxaliplatin|mesh-list
92769886|NCT00640081|Cetuximab|cetuximab|mesh-list
92769887|NCT00640081|Calcium|calcium|mesh-list
92769888|NCT00640081|Levoleucovorin|levoleucovorin|mesh-list
92769889|NCT00640081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92769890|NCT00640081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336839|NCT01959672|Antidotes|antidotes|mesh-ancestor
92769891|NCT00640081|Antimetabolites|antimetabolites|mesh-ancestor
92769892|NCT00640081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769893|NCT00640081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92769894|NCT00640081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769895|NCT00640081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92769896|NCT00640081|Immunologic Factors|immunologic factors|mesh-ancestor
92769897|NCT00640081|Antidotes|antidotes|mesh-ancestor
92769898|NCT00640081|Protective Agents|protective agents|mesh-ancestor
92769899|NCT00640081|Vitamin B Complex|vitamin b complex|mesh-ancestor
92769900|NCT00640081|Vitamins|vitamins|mesh-ancestor
92769901|NCT00640081|Micronutrients|micronutrients|mesh-ancestor
92769902|NCT00640081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92769903|NCT01199705|Immunoglobulins|immunoglobulins|mesh-list
92769904|NCT01199705|Antibodies|antibodies|mesh-list
92769905|NCT01199705|gamma-Globulins|gamma-globulins|mesh-list
92769906|NCT01199705|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92769907|NCT01199705|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92769908|NCT01199705|Immunologic Factors|immunologic factors|mesh-ancestor
92769909|NCT01199705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769910|NCT02688127|Tranexamic Acid|tranexamic acid|mesh-list
92769911|NCT02688127|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92769912|NCT02688127|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92769913|NCT02688127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769914|NCT02688127|Hemostatics|hemostatics|mesh-ancestor
92769915|NCT02688127|Coagulants|coagulants|mesh-ancestor
92769916|NCT04184947|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92769917|NCT04184947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769918|NCT04184947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92769919|NCT04184947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769920|NCT00638833|Memantine|memantine|mesh-list
92769921|NCT00638833|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92769922|NCT00638833|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92769923|NCT00638833|Dopamine Agents|dopamine agents|mesh-ancestor
92769924|NCT00638833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769925|NCT00638833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769926|NCT00638833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769927|NCT00638833|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92769928|NCT00638833|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92769929|NCT01198145|Sulfasalazine|sulfasalazine|mesh-list
92769930|NCT01198145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769931|NCT01198145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769932|NCT01198145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769933|NCT01198145|Analgesics|analgesics|mesh-ancestor
92769934|NCT01198145|Sensory System Agents|sensory system agents|mesh-ancestor
92769935|NCT01198145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769936|NCT01198145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769937|NCT01198145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769938|NCT01198145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769939|NCT01198145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92769940|NCT01179048|Liraglutide|liraglutide|mesh-list
92769941|NCT01179048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92769942|NCT01179048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769943|NCT01179048|Incretins|incretins|mesh-ancestor
92769944|NCT01179048|Hormones|hormones|mesh-ancestor
92769945|NCT01179048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769946|NCT00603265|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92769947|NCT00603265|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92769948|NCT00603265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92769949|NCT00603265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92769950|NCT00603265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769951|NCT00603265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92769952|NCT00603265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769953|NCT00603265|Analgesics|analgesics|mesh-ancestor
92769954|NCT00603265|Sensory System Agents|sensory system agents|mesh-ancestor
92769955|NCT00603265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769956|NCT00603265|Antidepressive Agents|antidepressive agents|mesh-ancestor
92769957|NCT00603265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92769958|NCT00603265|Dopamine Agents|dopamine agents|mesh-ancestor
92769959|NCT02686177|Metformin|metformin|mesh-list
92769960|NCT02686177|Liraglutide|liraglutide|mesh-list
92769961|NCT02686177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92769962|NCT02686177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769963|NCT02686177|Incretins|incretins|mesh-ancestor
92769964|NCT02686177|Hormones|hormones|mesh-ancestor
92769965|NCT02686177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92769966|NCT02686021|Dipyrone|dipyrone|mesh-list
92769967|NCT02686021|Ibuprofen|ibuprofen|mesh-list
92769968|NCT02686021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769969|NCT02686021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769970|NCT02686021|Analgesics|analgesics|mesh-ancestor
92769971|NCT02686021|Sensory System Agents|sensory system agents|mesh-ancestor
92769972|NCT02686021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769973|NCT02686021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769974|NCT02686021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769975|NCT02686021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769976|NCT02686021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92769977|NCT02686021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769978|NCT02686021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92769979|NCT02686021|Antipyretics|antipyretics|mesh-ancestor
92769980|NCT01158534|Interferons|interferons|mesh-list
92769981|NCT01158534|Interferon-alpha|interferon-alpha|mesh-list
92769982|NCT01158534|Interferon alpha-2|interferon alpha-2|mesh-list
92769983|NCT01158534|Celecoxib|celecoxib|mesh-list
92769984|NCT01158534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92769985|NCT01158534|Antiviral Agents|antiviral agents|mesh-ancestor
92769986|NCT01158534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92769987|NCT01158534|Immunologic Factors|immunologic factors|mesh-ancestor
92769988|NCT01158534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92769989|NCT01158534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92769990|NCT01158534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92769991|NCT01158534|Analgesics|analgesics|mesh-ancestor
92769992|NCT01158534|Sensory System Agents|sensory system agents|mesh-ancestor
92769993|NCT01158534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92769994|NCT01158534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92769995|NCT01158534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92769996|NCT01158534|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92769997|NCT01158534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92769998|NCT01158534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92769999|NCT01158534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770000|NCT02687971|Miltefosine|miltefosine|mesh-list
92770001|NCT02687971|Antifungal Agents|antifungal agents|mesh-ancestor
92770002|NCT02687971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770003|NCT02687971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770004|NCT02687971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92770005|NCT02687971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92770006|NCT05272878|Irbesartan|irbesartan|mesh-list
92770007|NCT05272878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92770008|NCT05272878|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92770009|NCT05272878|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92770010|NCT05272878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770011|NCT02683213|Fluoxetine|fluoxetine|mesh-list
92770012|NCT02683213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92770013|NCT02683213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92770014|NCT02683213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92770015|NCT02683213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770016|NCT02683213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770017|NCT02683213|Serotonin Agents|serotonin agents|mesh-ancestor
92770018|NCT02683213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770019|NCT02683213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92770020|NCT02683213|Antidepressive Agents|antidepressive agents|mesh-ancestor
92770021|NCT02683213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770022|NCT02683213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92770023|NCT02683213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92770024|NCT02683213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770025|NCT04185103|Valsartan|valsartan|mesh-list
92770026|NCT04185103|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92770027|NCT04185103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92770028|NCT04185103|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92770029|NCT04185103|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92770030|NCT04185103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770031|NCT04033939|Propofol|propofol|mesh-list
92770032|NCT04033939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92770033|NCT04033939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770034|NCT04033939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770035|NCT04033939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92770036|NCT04033939|Anesthetics, General|anesthetics, general|mesh-ancestor
92770037|NCT04033939|Anesthetics|anesthetics|mesh-ancestor
92770038|NCT00639691|Omalizumab|omalizumab|mesh-list
92770039|NCT00639691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92770040|NCT00639691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92770041|NCT00639691|Respiratory System Agents|respiratory system agents|mesh-ancestor
92770042|NCT02684071|Cyclophosphamide|cyclophosphamide|mesh-list
92770043|NCT02684071|Methotrexate|methotrexate|mesh-list
92770044|NCT02684071|Topotecan|topotecan|mesh-list
92770045|NCT02684071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770046|NCT02684071|Immunologic Factors|immunologic factors|mesh-ancestor
92770047|NCT02684071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770048|NCT02684071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770049|NCT02684071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770050|NCT02684071|Alkylating Agents|alkylating agents|mesh-ancestor
92770051|NCT02684071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770052|NCT02684071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770053|NCT02684071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92770054|NCT02684071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92770055|NCT02684071|Abortifacient Agents|abortifacient agents|mesh-ancestor
92770056|NCT02684071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92770057|NCT02684071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770058|NCT02684071|Antimetabolites|antimetabolites|mesh-ancestor
92770059|NCT02684071|Dermatologic Agents|dermatologic agents|mesh-ancestor
92770060|NCT02684071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770061|NCT02684071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92770062|NCT02684071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92770063|NCT02684071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92770064|NCT02684071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770065|NCT00640159|Selegiline|selegiline|mesh-list
92770066|NCT00640159|Antidepressive Agents|antidepressive agents|mesh-ancestor
92770067|NCT00640159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770068|NCT00640159|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92770069|NCT00640159|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92770070|NCT00640159|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92529964|NCT00039091|Ipilimumab|ipilimumab|mesh-list
92770071|NCT00640159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770072|NCT00640159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770073|NCT00640159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92770074|NCT00640159|Protective Agents|protective agents|mesh-ancestor
92770075|NCT00640159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770076|NCT00640861|Vaccines|vaccines|mesh-list
92770077|NCT00640861|Sargramostim|sargramostim|mesh-list
92770078|NCT00640861|Freund's Adjuvant|freund's adjuvant|mesh-list
92770079|NCT00640861|Immunologic Factors|immunologic factors|mesh-ancestor
92770080|NCT00640861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770081|NCT00640861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92770082|NCT00602797|Paclitaxel|paclitaxel|mesh-list
92770083|NCT00602797|Vinorelbine|vinorelbine|mesh-list
92770084|NCT00602797|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92770085|NCT00602797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92770086|NCT00602797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770087|NCT00602797|Tubulin Modulators|tubulin modulators|mesh-ancestor
92770088|NCT00602797|Antimitotic Agents|antimitotic agents|mesh-ancestor
92770089|NCT00602797|Mitosis Modulators|mitosis modulators|mesh-ancestor
92770090|NCT00602797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770091|NCT01158222|Sunitinib|sunitinib|mesh-list
92770092|NCT01158222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770093|NCT01158222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92770094|NCT01158222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92770095|NCT01158222|Growth Substances|growth substances|mesh-ancestor
92770096|NCT01158222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770097|NCT01158222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92770098|NCT01158222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92770099|NCT01158222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770100|NCT01158222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770101|NCT02684305|Oxytocin|oxytocin|mesh-list
92770102|NCT02684305|Oxytocics|oxytocics|mesh-ancestor
92770103|NCT02684305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92770104|NCT02684305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415176|NCT01477203|Serotonin Agents|serotonin agents|mesh-ancestor
92770105|NCT02940769|Methamphetamine|methamphetamine|mesh-list
92770106|NCT02940769|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92770107|NCT02940769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770108|NCT02940769|Sympathomimetics|sympathomimetics|mesh-ancestor
92770109|NCT02940769|Autonomic Agents|autonomic agents|mesh-ancestor
92770110|NCT02940769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770111|NCT02940769|Dopamine Agents|dopamine agents|mesh-ancestor
92770112|NCT02940769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770113|NCT02940769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770114|NCT02940769|Adrenergic Agents|adrenergic agents|mesh-ancestor
92770115|NCT02940769|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92770116|NCT02940769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92770117|NCT02940769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92770118|NCT02940769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92770119|NCT04315584|Deoxyglucose|deoxyglucose|mesh-list
92770120|NCT04315584|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92770121|NCT04315584|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92770122|NCT04315584|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92770123|NCT04315584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770124|NCT04315584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770125|NCT04315584|Antimetabolites|antimetabolites|mesh-ancestor
92770126|NCT04315584|Antiviral Agents|antiviral agents|mesh-ancestor
92770127|NCT04315584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770128|NCT04315584|Dopamine Agents|dopamine agents|mesh-ancestor
92770129|NCT04315584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770130|NCT02683291|Mycophenolic Acid|mycophenolic acid|mesh-list
92770131|NCT02683291|Sirolimus|sirolimus|mesh-list
92770132|NCT02683291|Prednisone|prednisone|mesh-list
92770133|NCT02683291|Tacrolimus|tacrolimus|mesh-list
92770134|NCT02683291|Thymoglobulin|thymoglobulin|mesh-list
92770135|NCT02683291|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92770136|NCT02683291|Basiliximab|basiliximab|mesh-list
92770137|NCT02683291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770138|NCT02683291|Glucocorticoids|glucocorticoids|mesh-ancestor
92770139|NCT02683291|Hormones|hormones|mesh-ancestor
92770140|NCT02683291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92770141|NCT02683291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770142|NCT02683291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92770143|NCT02683291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770144|NCT02683291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770145|NCT02683291|Immunologic Factors|immunologic factors|mesh-ancestor
92770146|NCT02683291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92770147|NCT02683291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770148|NCT02683291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770149|NCT02683291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92770150|NCT02683291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92770151|NCT02683291|Antitubercular Agents|antitubercular agents|mesh-ancestor
92770152|NCT02683291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336884|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
92770153|NCT02683291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770154|NCT02683291|Antifungal Agents|antifungal agents|mesh-ancestor
92770155|NCT02685397|Leuprolide|leuprolide|mesh-list
92770156|NCT02685397|Goserelin|goserelin|mesh-list
92770157|NCT02685397|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92770158|NCT02685397|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92770159|NCT02685397|Fertility Agents|fertility agents|mesh-ancestor
92770160|NCT02685397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92770161|NCT02685397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770162|NCT02685397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92770163|NCT02685397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770164|NCT02685397|Luteolytic Agents|luteolytic agents|mesh-ancestor
92770165|NCT02685397|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92770166|NCT02685397|Contraceptive Agents|contraceptive agents|mesh-ancestor
92770167|NCT02685397|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92770168|NCT02683837|Remifentanil|remifentanil|mesh-list
92770169|NCT02683837|Sevoflurane|sevoflurane|mesh-list
92770170|NCT02683837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92770171|NCT02683837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92770172|NCT02683837|Anesthetics, General|anesthetics, general|mesh-ancestor
92770173|NCT02683837|Anesthetics|anesthetics|mesh-ancestor
92770174|NCT02683837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770175|NCT02683837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770176|NCT02683837|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92770177|NCT02683837|Narcotics|narcotics|mesh-ancestor
92770178|NCT02683837|Analgesics|analgesics|mesh-ancestor
92770179|NCT02683837|Sensory System Agents|sensory system agents|mesh-ancestor
92770180|NCT02683837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415257|NCT01477632|Norethindrone|norethindrone|mesh-list
92770181|NCT02680951|Cytarabine|cytarabine|mesh-list
92770182|NCT02680951|Fludarabine|fludarabine|mesh-list
92770183|NCT02680951|Dasatinib|dasatinib|mesh-list
92770184|NCT02680951|Idarubicin|idarubicin|mesh-list
92770185|NCT02680951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770186|NCT02680951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770187|NCT02680951|Antimetabolites|antimetabolites|mesh-ancestor
92770188|NCT02680951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770189|NCT02680951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770190|NCT02680951|Immunologic Factors|immunologic factors|mesh-ancestor
92770191|NCT02680951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770192|NCT02680951|Antiviral Agents|antiviral agents|mesh-ancestor
92770193|NCT02680951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770194|NCT02680951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92770195|NCT02680951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770196|NCT02680951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92770197|NCT02680951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92770198|NCT02680951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770199|NCT02680717|Clobetasol|clobetasol|mesh-list
92770200|NCT02680717|Calcipotriene|calcipotriene|mesh-list
92770201|NCT02680717|Tacrolimus|tacrolimus|mesh-list
92770202|NCT02680717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770203|NCT02680717|Immunologic Factors|immunologic factors|mesh-ancestor
92770204|NCT02680717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770205|NCT02680717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92770206|NCT02680717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770207|NCT02680717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770208|NCT02680717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770209|NCT02680717|Glucocorticoids|glucocorticoids|mesh-ancestor
92770210|NCT02680717|Hormones|hormones|mesh-ancestor
92770211|NCT02680717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92770212|NCT02680717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92770213|NCT02680795|Belinostat|belinostat|mesh-list
92770214|NCT02680795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770215|NCT02680795|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92770216|NCT02680795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770217|NCT02680795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770218|NCT00640237|Calcifediol|calcifediol|mesh-list
92770219|NCT00640237|Vitamins|vitamins|mesh-ancestor
92770220|NCT00640237|Micronutrients|micronutrients|mesh-ancestor
92770221|NCT00640237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770222|NCT00640237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92770223|NCT02683759|Curcumin|curcumin|mesh-list
92770224|NCT02683759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92770225|NCT02683759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770226|NCT02683759|Analgesics|analgesics|mesh-ancestor
92770227|NCT02683759|Sensory System Agents|sensory system agents|mesh-ancestor
92770228|NCT02683759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770229|NCT02683759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770230|NCT02683759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770231|NCT02683759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770232|NCT02683759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770233|NCT02683759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770234|NCT02683759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770235|NCT04292691|Ropivacaine|ropivacaine|mesh-list
92770236|NCT04292691|Anesthetics, Local|anesthetics, local|mesh-ancestor
92770237|NCT04292691|Anesthetics|anesthetics|mesh-ancestor
92770238|NCT04292691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770239|NCT04292691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770240|NCT04292691|Sensory System Agents|sensory system agents|mesh-ancestor
92770241|NCT04292691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770242|NCT00990249|Busulfan|busulfan|mesh-list
92770243|NCT00990249|Clofarabine|clofarabine|mesh-list
92770244|NCT00990249|Thymoglobulin|thymoglobulin|mesh-list
92770245|NCT00990249|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92770246|NCT00990249|Alkylating Agents|alkylating agents|mesh-ancestor
92770247|NCT00990249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770248|NCT00990249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770249|NCT00990249|Immunologic Factors|immunologic factors|mesh-ancestor
92770250|NCT00990249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770251|NCT00990249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770252|NCT00990249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770253|NCT00990249|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92770254|NCT00990249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770255|NCT00990249|Antimetabolites|antimetabolites|mesh-ancestor
92770256|NCT02846545|Golimumab|golimumab|mesh-list
92770257|NCT02846545|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92770258|NCT02846545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770259|NCT02846545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770260|NCT02846545|Immunologic Factors|immunologic factors|mesh-ancestor
92770261|NCT02846545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770262|NCT04291755|Pembrolizumab|pembrolizumab|mesh-list
92770263|NCT04291755|Nivolumab|nivolumab|mesh-list
92770264|NCT04291755|Ipilimumab|ipilimumab|mesh-list
92770265|NCT04291755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770266|NCT04291755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770267|NCT04291755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92770268|NCT04291755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770269|NCT04292769|Decitabine|decitabine|mesh-list
92770270|NCT04292769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770271|NCT04292769|Antimetabolites|antimetabolites|mesh-ancestor
92770272|NCT04292769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770273|NCT04292769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770274|NCT04292769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770275|NCT00640939|Diclofenac|diclofenac|mesh-list
92770276|NCT00640939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92770277|NCT00640939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770278|NCT00640939|Analgesics|analgesics|mesh-ancestor
92770279|NCT00640939|Sensory System Agents|sensory system agents|mesh-ancestor
92770280|NCT00640939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494496|NCT01975727|Dexamethasone acetate|dexamethasone acetate|mesh-list
92770281|NCT00640939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770282|NCT00640939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770283|NCT00640939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770284|NCT00640939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92770285|NCT00640939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770286|NCT00640939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770287|NCT05663749|Metformin|metformin|mesh-list
92770288|NCT05663749|Topiramate|topiramate|mesh-list
92770289|NCT05663749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92770290|NCT05663749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770291|NCT05663749|Anticonvulsants|anticonvulsants|mesh-ancestor
92770292|NCT02867553|Rituximab|rituximab|mesh-list
92770293|NCT02867553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770294|NCT02867553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770295|NCT02867553|Immunologic Factors|immunologic factors|mesh-ancestor
92770296|NCT02867553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770297|NCT02867553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770298|NCT00909961|Zoledronic Acid|zoledronic acid|mesh-list
92770299|NCT00909961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92770300|NCT00909961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770301|NCT00642577|Leucovorin|leucovorin|mesh-list
92770302|NCT00642577|Bevacizumab|bevacizumab|mesh-list
92770303|NCT00642577|Fluorouracil|fluorouracil|mesh-list
92770304|NCT00642577|Irinotecan|irinotecan|mesh-list
92770305|NCT00642577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770306|NCT00642577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770307|NCT00642577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92770308|NCT00642577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92770309|NCT00642577|Growth Substances|growth substances|mesh-ancestor
92770310|NCT00642577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770311|NCT00642577|Growth Inhibitors|growth inhibitors|mesh-ancestor
92770312|NCT00642577|Antimetabolites|antimetabolites|mesh-ancestor
92770313|NCT00642577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770314|NCT00642577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770315|NCT00642577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770316|NCT00642577|Immunologic Factors|immunologic factors|mesh-ancestor
92770317|NCT00642577|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92770318|NCT00642577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770319|NCT00642577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770320|NCT00642577|Antidotes|antidotes|mesh-ancestor
92770321|NCT00642577|Protective Agents|protective agents|mesh-ancestor
92770322|NCT00642577|Vitamin B Complex|vitamin b complex|mesh-ancestor
92770323|NCT00642577|Vitamins|vitamins|mesh-ancestor
92770324|NCT00642577|Micronutrients|micronutrients|mesh-ancestor
92770325|NCT02682121|Metformin|metformin|mesh-list
92770326|NCT02682121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92770327|NCT02682121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770328|NCT02683603|Imipenem|imipenem|mesh-list
92770329|NCT02683603|Colistin|colistin|mesh-list
92770330|NCT02683603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92770331|NCT02683603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770332|NCT00641095|Cyclophosphamide|cyclophosphamide|mesh-list
92770333|NCT00641095|Rituximab|rituximab|mesh-list
92770334|NCT00641095|Fludarabine|fludarabine|mesh-list
92770335|NCT00641095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770336|NCT00641095|Immunologic Factors|immunologic factors|mesh-ancestor
92770337|NCT00641095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770339|NCT00641095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770340|NCT00641095|Alkylating Agents|alkylating agents|mesh-ancestor
92770341|NCT00641095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770342|NCT00641095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770343|NCT00641095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92770344|NCT00641095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770345|NCT01196975|Vaccines|vaccines|mesh-list
92770346|NCT01196975|Immunologic Factors|immunologic factors|mesh-ancestor
92770347|NCT01196975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770348|NCT00992589|Rabeprazole|rabeprazole|mesh-list
92770349|NCT00992589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92770350|NCT00992589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770351|NCT00992589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92770352|NCT00992589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770353|NCT00992589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770354|NCT01196741|Paclitaxel|paclitaxel|mesh-list
92770355|NCT01196741|Saracatinib|saracatinib|mesh-list
92770356|NCT01196741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92770357|NCT01196741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770358|NCT01196741|Tubulin Modulators|tubulin modulators|mesh-ancestor
92770359|NCT01196741|Antimitotic Agents|antimitotic agents|mesh-ancestor
92770360|NCT01196741|Mitosis Modulators|mitosis modulators|mesh-ancestor
92770361|NCT01196741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770362|NCT01196741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770363|NCT00629187|Temozolomide|temozolomide|mesh-list
92770364|NCT00629187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770366|NCT00629187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770367|NCT00629187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770368|NCT04291287|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92770369|NCT04291287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92770370|NCT04291287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770371|NCT00983385|Tapentadol|tapentadol|mesh-list
92770372|NCT00983385|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92770373|NCT00983385|Narcotics|narcotics|mesh-ancestor
92770374|NCT00983385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770375|NCT00983385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770376|NCT00983385|Analgesics|analgesics|mesh-ancestor
92770377|NCT00983385|Sensory System Agents|sensory system agents|mesh-ancestor
92770378|NCT00983385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770379|NCT00983385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92770380|NCT00983385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92770381|NCT00983385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92770382|NCT00983385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770383|NCT00983385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92770384|NCT00983385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770385|NCT00992511|Vaccines|vaccines|mesh-list
92770386|NCT00992511|Immunologic Factors|immunologic factors|mesh-ancestor
92770387|NCT00992511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770388|NCT02869035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92770389|NCT02869035|Escitalopram|escitalopram|mesh-list
92770390|NCT02869035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92770391|NCT02869035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92770392|NCT02869035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92770393|NCT02869035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770394|NCT02869035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770395|NCT02869035|Serotonin Agents|serotonin agents|mesh-ancestor
92770396|NCT02869035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770397|NCT02869035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770398|NCT02869035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92770399|NCT02869035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770400|NCT02869035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92770401|NCT02869035|Analgesics|analgesics|mesh-ancestor
92770402|NCT02869035|Sensory System Agents|sensory system agents|mesh-ancestor
92770403|NCT02869035|Dopamine Agents|dopamine agents|mesh-ancestor
92770404|NCT04290819|Caffeine|caffeine|mesh-list
92770405|NCT04290819|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92770406|NCT04290819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770407|NCT04290819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92770408|NCT04290819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415467|NCT01478633|Galantamine|galantamine|mesh-list
92770409|NCT04290819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770410|NCT04290819|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92770411|NCT04290819|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92770412|NCT04290819|Purinergic Agents|purinergic agents|mesh-ancestor
92770413|NCT04290819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770414|NCT04157517|Pembrolizumab|pembrolizumab|mesh-list
92770415|NCT04157517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770416|NCT04157517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770417|NCT04157517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92770418|NCT04157517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770419|NCT01196429|Sirolimus|sirolimus|mesh-list
92770420|NCT01196429|Paclitaxel|paclitaxel|mesh-list
92770421|NCT01196429|Docetaxel|docetaxel|mesh-list
92770422|NCT01196429|Carboplatin|carboplatin|mesh-list
92770423|NCT01196429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92770424|NCT01196429|Temsirolimus|temsirolimus|mesh-list
92770425|NCT01196429|MTOR Inhibitors|mtor inhibitors|mesh-list
92770426|NCT01196429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92770427|NCT01196429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770428|NCT01196429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92770429|NCT01196429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92770430|NCT01196429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92770431|NCT01196429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770432|NCT01196429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92770433|NCT01196429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770434|NCT01196429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92770435|NCT01196429|Antifungal Agents|antifungal agents|mesh-ancestor
92770437|NCT01196429|Immunologic Factors|immunologic factors|mesh-ancestor
92770438|NCT01196429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770439|NCT01196429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92770440|NCT01196429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770441|NCT01157364|Bimatoprost|bimatoprost|mesh-list
92770442|NCT01157364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92770443|NCT01195415|Gemcitabine|gemcitabine|mesh-list
92770444|NCT01195415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770445|NCT01195415|Antimetabolites|antimetabolites|mesh-ancestor
92770446|NCT01195415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770447|NCT01195415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770448|NCT01195103|Fentanyl|fentanyl|mesh-list
92770449|NCT01195103|Midazolam|midazolam|mesh-list
92770450|NCT01195103|Propofol|propofol|mesh-list
92770451|NCT01195103|Fospropofol|fospropofol|mesh-list
92770452|NCT01195103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92770453|NCT01195103|Narcotics|narcotics|mesh-ancestor
92770454|NCT01195103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770455|NCT01195103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770456|NCT01195103|Analgesics|analgesics|mesh-ancestor
92770457|NCT01195103|Sensory System Agents|sensory system agents|mesh-ancestor
92770458|NCT01195103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770459|NCT01195103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92770460|NCT01195103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92770461|NCT01195103|Anesthetics, General|anesthetics, general|mesh-ancestor
92770462|NCT01195103|Anesthetics|anesthetics|mesh-ancestor
92770463|NCT01195103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92770464|NCT01195103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92770465|NCT01195103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92770466|NCT01195103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770467|NCT01195103|GABA Modulators|gaba modulators|mesh-ancestor
92770468|NCT01195103|GABA Agents|gaba agents|mesh-ancestor
92770469|NCT01195103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770470|NCT01195103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770471|NCT01194869|Paclitaxel|paclitaxel|mesh-list
92770472|NCT01194869|Cisplatin|cisplatin|mesh-list
92770473|NCT01194869|Sorafenib|sorafenib|mesh-list
92770474|NCT01194869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92770475|NCT01194869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770476|NCT01194869|Tubulin Modulators|tubulin modulators|mesh-ancestor
92770477|NCT01194869|Antimitotic Agents|antimitotic agents|mesh-ancestor
92770478|NCT01194869|Mitosis Modulators|mitosis modulators|mesh-ancestor
92770479|NCT01194869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770480|NCT01194869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92770481|NCT01194869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770482|NCT01177800|Infliximab|infliximab|mesh-list
92770483|NCT01177800|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92415571|NCT01479283|Cefazolin|cefazolin|mesh-list
92770484|NCT01177800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770485|NCT01177800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92770486|NCT01177800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770487|NCT01177800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770488|NCT01177722|Vaccines|vaccines|mesh-list
92770489|NCT01177722|Immunologic Factors|immunologic factors|mesh-ancestor
92770490|NCT01177722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770491|NCT02884986|Etoricoxib|etoricoxib|mesh-list
92770492|NCT02884986|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92770493|NCT02884986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770494|NCT02884986|Analgesics|analgesics|mesh-ancestor
92770495|NCT02884986|Sensory System Agents|sensory system agents|mesh-ancestor
92770496|NCT02884986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770497|NCT02884986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770498|NCT02884986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770499|NCT02884986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770500|NCT02884986|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92770501|NCT02884986|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92770502|NCT02884986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770503|NCT02884986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770504|NCT04124562|Nitrous Oxide|nitrous oxide|mesh-list
92770505|NCT04124562|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92770506|NCT04124562|Anesthetics, General|anesthetics, general|mesh-ancestor
92770507|NCT04124562|Anesthetics|anesthetics|mesh-ancestor
92770508|NCT04124562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770509|NCT04124562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770510|NCT04124562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770511|NCT04124562|Analgesics|analgesics|mesh-ancestor
92770513|NCT04124562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770514|NCT01177410|Mesalamine|mesalamine|mesh-list
92770515|NCT01177410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92770516|NCT01177410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770517|NCT01177410|Analgesics|analgesics|mesh-ancestor
92770518|NCT01177410|Sensory System Agents|sensory system agents|mesh-ancestor
92770519|NCT01177410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770520|NCT01177410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770521|NCT01177410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770522|NCT01177410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770523|NCT02884596|Serotonin|serotonin|mesh-list
92770524|NCT02884596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92770525|NCT02884596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92770526|NCT02884596|Serotonin Agents|serotonin agents|mesh-ancestor
92770527|NCT02884596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770528|NCT02884596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770529|NCT02884596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770530|NCT02884596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92770531|NCT02884596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92770532|NCT04205916|Moxifloxacin|moxifloxacin|mesh-list
92770533|NCT04205916|Dexamethasone|dexamethasone|mesh-list
92770534|NCT04205916|Ketorolac|ketorolac|mesh-list
92770535|NCT04205916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770536|NCT04205916|Antiemetics|antiemetics|mesh-ancestor
92770537|NCT04205916|Autonomic Agents|autonomic agents|mesh-ancestor
92770538|NCT04205916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770539|NCT04205916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770540|NCT04205916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770541|NCT04205916|Glucocorticoids|glucocorticoids|mesh-ancestor
92770542|NCT04205916|Hormones|hormones|mesh-ancestor
92770543|NCT04205916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92770544|NCT04205916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92770545|NCT04205916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770546|NCT04205916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92770547|NCT04205916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770548|NCT04205916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92770549|NCT04205916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770550|NCT04205916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770551|NCT04205916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770552|NCT04205916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92770553|NCT04205916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770554|NCT04205916|Analgesics|analgesics|mesh-ancestor
92770555|NCT04205916|Sensory System Agents|sensory system agents|mesh-ancestor
92770556|NCT04205916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770557|NCT04205916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92770558|NCT01176240|Mannitol|mannitol|mesh-list
92415621|NCT01479751|Ketamine|ketamine|mesh-list
92770559|NCT01176240|Droxidopa|droxidopa|mesh-list
92770560|NCT01176240|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92770561|NCT01176240|Diuretics|diuretics|mesh-ancestor
92770562|NCT01176240|Natriuretic Agents|natriuretic agents|mesh-ancestor
92770563|NCT01176240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770564|NCT01176240|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92770565|NCT01176240|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92770566|NCT01149096|Lenograstim|lenograstim|mesh-list
92770567|NCT01149096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92770568|NCT01149096|Immunologic Factors|immunologic factors|mesh-ancestor
92770569|NCT01149096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770570|NCT02867397|Oxaliplatin|oxaliplatin|mesh-list
92770571|NCT02867397|Epirubicin|epirubicin|mesh-list
92770572|NCT02867397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770573|NCT02867397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92770574|NCT02867397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92770575|NCT02867397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770576|NCT02867397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770577|NCT02867397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770578|NCT01175382|Tamsulosin|tamsulosin|mesh-list
92770579|NCT01175382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92770580|NCT01175382|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92770581|NCT01175382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92770582|NCT01175382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92770583|NCT01175382|Adrenergic Agents|adrenergic agents|mesh-ancestor
92770584|NCT01175382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770585|NCT01175382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770586|NCT01175382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770587|NCT01175382|Urological Agents|urological agents|mesh-ancestor
92770588|NCT01175382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92770589|NCT01175382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92770590|NCT01175382|Cholinergic Agents|cholinergic agents|mesh-ancestor
92770591|NCT01194245|Insulin|insulin|mesh-list
92770592|NCT01194245|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92770593|NCT01194245|Insulin Glargine|insulin glargine|mesh-list
92770594|NCT01194245|Insulin Aspart|insulin aspart|mesh-list
92770595|NCT01194245|Insulin Lispro|insulin lispro|mesh-list
92770596|NCT01194245|Insulin glulisine|insulin glulisine|mesh-list
92770597|NCT01194245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92770598|NCT01194245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770599|NCT00979407|Vaccines|vaccines|mesh-list
92770600|NCT00979407|Immunologic Factors|immunologic factors|mesh-ancestor
92770601|NCT00979407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770602|NCT04290429|Teduglutide|teduglutide|mesh-list
92770603|NCT04290429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770604|NCT04290429|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92770605|NCT04290429|Protective Agents|protective agents|mesh-ancestor
92770606|NCT04290429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770607|NCT00975975|Basiliximab|basiliximab|mesh-list
92770608|NCT00975975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770609|NCT00975975|Immunologic Factors|immunologic factors|mesh-ancestor
92770610|NCT00975975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770611|NCT01193153|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92770612|NCT01193153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92770613|NCT01193153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92770614|NCT01193153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337020|NCT01930188|Incretins|incretins|mesh-ancestor
92770615|NCT01193153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770616|NCT01193153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770617|NCT01193153|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92770618|NCT01193153|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92770619|NCT01193153|Serotonin Agents|serotonin agents|mesh-ancestor
92770620|NCT01193153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770621|NCT01193153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770622|NCT01193153|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92770623|NCT01193153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92770624|NCT01193153|Dopamine Agents|dopamine agents|mesh-ancestor
92770625|NCT02867007|Mogamulizumab|mogamulizumab|mesh-list
92770626|NCT02867007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770627|NCT04289883|Calcium|calcium|mesh-list
92770628|NCT04289883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92770629|NCT04289883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770630|NCT02865369|Asunaprevir|asunaprevir|mesh-list
92770631|NCT02865369|Protease Inhibitors|protease inhibitors|mesh-ancestor
92770632|NCT02865369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770633|NCT02865369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770634|NCT01192295|Oxycodone|oxycodone|mesh-list
92770635|NCT01192295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92770636|NCT01192295|Narcotics|narcotics|mesh-ancestor
92770637|NCT01192295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770638|NCT01192295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770640|NCT01192295|Sensory System Agents|sensory system agents|mesh-ancestor
92770641|NCT01192295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770642|NCT04289103|Inolimomab|inolimomab|mesh-list
92770643|NCT04289103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770644|NCT04289103|Immunologic Factors|immunologic factors|mesh-ancestor
92770645|NCT04289103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770646|NCT01154166|Ropinirole|ropinirole|mesh-list
92770647|NCT01154166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92770648|NCT01154166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92770649|NCT01154166|Dopamine Agonists|dopamine agonists|mesh-ancestor
92770650|NCT01154166|Dopamine Agents|dopamine agents|mesh-ancestor
92770651|NCT01154166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770652|NCT01154166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770653|NCT01154166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770654|NCT04290195|Aflibercept|aflibercept|mesh-list
92770655|NCT04290195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92770656|NCT04290195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92770657|NCT04290195|Growth Substances|growth substances|mesh-ancestor
92770658|NCT04290195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770659|NCT04290195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92770660|NCT04290195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770661|NCT05656703|Anesthetics|anesthetics|mesh-list
92770662|NCT05656703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770663|NCT05656703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770664|NCT05656079|Cyclophosphamide|cyclophosphamide|mesh-list
92770665|NCT05656079|Docetaxel|docetaxel|mesh-list
92770666|NCT05656079|Doxorubicin|doxorubicin|mesh-list
92770667|NCT05656079|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92770668|NCT05656079|Trastuzumab|trastuzumab|mesh-list
92770669|NCT05656079|Epirubicin|epirubicin|mesh-list
92770670|NCT05656079|Pertuzumab|pertuzumab|mesh-list
92770671|NCT05656079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770672|NCT05656079|Immunologic Factors|immunologic factors|mesh-ancestor
92770673|NCT05656079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770674|NCT05656079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770675|NCT05656079|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770676|NCT05656079|Alkylating Agents|alkylating agents|mesh-ancestor
92770677|NCT05656079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770678|NCT05656079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770679|NCT05656079|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92770680|NCT05656079|Tubulin Modulators|tubulin modulators|mesh-ancestor
92770681|NCT05656079|Antimitotic Agents|antimitotic agents|mesh-ancestor
92770682|NCT05656079|Mitosis Modulators|mitosis modulators|mesh-ancestor
92770683|NCT05656079|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92770684|NCT05656079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92770685|NCT05656079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770686|NCT05656079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770687|NCT05656079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770688|NCT01181921|Galantamine|galantamine|mesh-list
92770689|NCT01181921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92770690|NCT01181921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770691|NCT01181921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770692|NCT01181921|Cholinergic Agents|cholinergic agents|mesh-ancestor
92770693|NCT01181921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770694|NCT01181921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770695|NCT01181921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92770696|NCT01181921|Autonomic Agents|autonomic agents|mesh-ancestor
92770697|NCT01181921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770698|NCT01181921|Nootropic Agents|nootropic agents|mesh-ancestor
92770699|NCT00932698|Ixazomib|ixazomib|mesh-list
92770700|NCT00932698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770701|NCT00932698|Protease Inhibitors|protease inhibitors|mesh-ancestor
92770702|NCT00932698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770703|NCT00932698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770704|NCT00978627|Insulin|insulin|mesh-list
92770705|NCT00978627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92770706|NCT00978627|Insulin Aspart|insulin aspart|mesh-list
92770707|NCT00978627|Insulin, Long-Acting|insulin, long-acting|mesh-list
92770708|NCT00978627|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92770709|NCT00978627|Insulin Detemir|insulin detemir|mesh-list
92770710|NCT00978627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92770711|NCT00978627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770712|NCT01181609|Bevacizumab|bevacizumab|mesh-list
92770713|NCT01181609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770715|NCT01181609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92770716|NCT01181609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92115555|NCT02715726|Atorvastatin|atorvastatin|mesh-list
92770717|NCT01181609|Growth Substances|growth substances|mesh-ancestor
92770718|NCT01181609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770719|NCT01181609|Growth Inhibitors|growth inhibitors|mesh-ancestor
92770720|NCT04261426|Immunoglobulins|immunoglobulins|mesh-list
92770721|NCT04261426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92770722|NCT04261426|Antibodies|antibodies|mesh-list
92770723|NCT04261426|gamma-Globulins|gamma-globulins|mesh-list
92770724|NCT04261426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92770725|NCT04261426|Immunologic Factors|immunologic factors|mesh-ancestor
92770726|NCT04261426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770727|NCT04264078|Fludarabine|fludarabine|mesh-list
92770728|NCT04264078|Cyclophosphamide|cyclophosphamide|mesh-list
92770729|NCT04264078|Melphalan|melphalan|mesh-list
92770730|NCT04264078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770731|NCT04264078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770732|NCT04264078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770733|NCT04264078|Immunologic Factors|immunologic factors|mesh-ancestor
92770734|NCT04264078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770735|NCT04264078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770736|NCT04264078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770737|NCT04264078|Alkylating Agents|alkylating agents|mesh-ancestor
92770738|NCT04264078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92770739|NCT01153698|Dabigatran|dabigatran|mesh-list
92770740|NCT01153698|Antithrombins|antithrombins|mesh-ancestor
92770741|NCT01153698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92770742|NCT01153698|Protease Inhibitors|protease inhibitors|mesh-ancestor
92770743|NCT01153698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770744|NCT01153698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770745|NCT01153698|Anticoagulants|anticoagulants|mesh-ancestor
92770746|NCT00608218|Ciclesonide|ciclesonide|mesh-list
92770747|NCT00608218|Glucocorticoids|glucocorticoids|mesh-ancestor
92770748|NCT00608218|Hormones|hormones|mesh-ancestor
92770749|NCT00608218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92770750|NCT00608218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770751|NCT00608218|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92770752|NCT02884050|Topiramate|topiramate|mesh-list
92770753|NCT02884050|Anticonvulsants|anticonvulsants|mesh-ancestor
92770754|NCT02884050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92770755|NCT02884050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770756|NCT00609934|Sorafenib|sorafenib|mesh-list
92770757|NCT00609934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770758|NCT00609934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92770759|NCT00609934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770760|NCT00609934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770761|NCT01147926|Prucalopride|prucalopride|mesh-list
92770762|NCT01147926|Laxatives|laxatives|mesh-ancestor
92770763|NCT01147926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770764|NCT01147926|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92770765|NCT01147926|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92770766|NCT01147926|Serotonin Agents|serotonin agents|mesh-ancestor
92770767|NCT01147926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770768|NCT01147926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770769|NCT01147926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770770|NCT05115136|Diphenhydramine|diphenhydramine|mesh-list
92770771|NCT05115136|Promethazine|promethazine|mesh-list
92770772|NCT05115136|Doxepin|doxepin|mesh-list
92770773|NCT05115136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92770774|NCT05115136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92770775|NCT05115136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770776|NCT05115136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770777|NCT05115136|Anesthetics, Local|anesthetics, local|mesh-ancestor
92770778|NCT05115136|Anesthetics|anesthetics|mesh-ancestor
92770779|NCT05115136|Sensory System Agents|sensory system agents|mesh-ancestor
92770780|NCT05115136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770781|NCT05115136|Antiemetics|antiemetics|mesh-ancestor
92770782|NCT05115136|Autonomic Agents|autonomic agents|mesh-ancestor
92770783|NCT05115136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770784|NCT05115136|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92770785|NCT05115136|Histamine Antagonists|histamine antagonists|mesh-ancestor
92770786|NCT05115136|Histamine Agents|histamine agents|mesh-ancestor
92770787|NCT05115136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415834|NCT01480986|Irinotecan|irinotecan|mesh-list
92770788|NCT05115136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770789|NCT05115136|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92770790|NCT05115136|Antipruritics|antipruritics|mesh-ancestor
92770791|NCT05115136|Dermatologic Agents|dermatologic agents|mesh-ancestor
92770792|NCT05115136|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92770793|NCT05115136|Antidepressive Agents|antidepressive agents|mesh-ancestor
92770794|NCT05115136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770795|NCT00608374|Fludarabine|fludarabine|mesh-list
92770796|NCT00608374|Fludarabine phosphate|fludarabine phosphate|mesh-list
92770797|NCT00608374|Chlorambucil|chlorambucil|mesh-list
92770798|NCT00608374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770799|NCT00608374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770800|NCT00608374|Antimetabolites|antimetabolites|mesh-ancestor
92770801|NCT00608374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770802|NCT00608374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770803|NCT00608374|Immunologic Factors|immunologic factors|mesh-ancestor
92770804|NCT00608374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770805|NCT00608374|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92770806|NCT00608374|Alkylating Agents|alkylating agents|mesh-ancestor
92770807|NCT00625014|Haloperidol|haloperidol|mesh-list
92770808|NCT00625014|Haloperidol decanoate|haloperidol decanoate|mesh-list
92770809|NCT00625014|Antiemetics|antiemetics|mesh-ancestor
92770810|NCT00625014|Autonomic Agents|autonomic agents|mesh-ancestor
92770811|NCT00625014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770812|NCT00625014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770813|NCT00625014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92770814|NCT00625014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92770815|NCT00625014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92770816|NCT00625014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770817|NCT00625014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770818|NCT00625014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92770819|NCT00625014|Dopamine Agents|dopamine agents|mesh-ancestor
92770820|NCT00625014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770821|NCT00625014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770822|NCT00625014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92770823|NCT01147848|Fluticasone|fluticasone|mesh-list
92770824|NCT01147848|Xhance|xhance|mesh-list
92770825|NCT01147848|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92770826|NCT01147848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92770827|NCT01147848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92770828|NCT01147848|Autonomic Agents|autonomic agents|mesh-ancestor
92770829|NCT01147848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770830|NCT01147848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770831|NCT01147848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92770832|NCT01147848|Respiratory System Agents|respiratory system agents|mesh-ancestor
92770833|NCT01147848|Dermatologic Agents|dermatologic agents|mesh-ancestor
92770834|NCT01147848|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92770835|NCT01147848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92770836|NCT01147848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92770837|NCT01147848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92770838|NCT01147848|Adrenergic Agents|adrenergic agents|mesh-ancestor
92770839|NCT01147848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770840|NCT01147848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770841|NCT04261270|Ritonavir|ritonavir|mesh-list
92770842|NCT04261270|Oseltamivir|oseltamivir|mesh-list
92770843|NCT04261270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92770844|NCT04261270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92770845|NCT04261270|Protease Inhibitors|protease inhibitors|mesh-ancestor
92770846|NCT04261270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770847|NCT04261270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770848|NCT04261270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92770849|NCT04261270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92770850|NCT04261270|Antiviral Agents|antiviral agents|mesh-ancestor
92770851|NCT04261270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770852|NCT04261270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92770853|NCT04261270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92770854|NCT01152996|Vortioxetine|vortioxetine|mesh-list
92770855|NCT01152996|Antidepressive Agents|antidepressive agents|mesh-ancestor
92770856|NCT01152996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770857|NCT01152996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92770858|NCT01152996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92770859|NCT01152996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770860|NCT01152996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770861|NCT01152996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92770862|NCT01152996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92770863|NCT01152996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92770864|NCT01152996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770866|NCT01152996|Serotonin Agents|serotonin agents|mesh-ancestor
92770867|NCT01152996|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92770868|NCT01152996|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92770869|NCT01152996|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92770870|NCT01152996|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92770871|NCT00624936|Azacitidine|azacitidine|mesh-list
92770872|NCT00624936|Bortezomib|bortezomib|mesh-list
92770873|NCT00624936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770874|NCT00624936|Antimetabolites|antimetabolites|mesh-ancestor
92770875|NCT00624936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770876|NCT00624936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770877|NCT00624936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770878|NCT00979953|Oxycodone|oxycodone|mesh-list
92770879|NCT00979953|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92770880|NCT00979953|Narcotics|narcotics|mesh-ancestor
92770881|NCT00979953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770882|NCT00979953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770883|NCT00979953|Analgesics|analgesics|mesh-ancestor
92770884|NCT00979953|Sensory System Agents|sensory system agents|mesh-ancestor
92770885|NCT00979953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770886|NCT01181531|Vitamin D|vitamin d|mesh-list
92770887|NCT01181531|Cinacalcet|cinacalcet|mesh-list
92770888|NCT01181531|Vitamins|vitamins|mesh-ancestor
92770889|NCT01181531|Micronutrients|micronutrients|mesh-ancestor
92337124|NCT00378833|Vitamins|vitamins|mesh-ancestor
92770890|NCT01181531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770891|NCT01181531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92770892|NCT01181531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92770893|NCT01181531|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92770894|NCT01181531|Hormone Antagonists|hormone antagonists|mesh-ancestor
92770895|NCT01181531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92770896|NCT01152450|Tiotropium Bromide|tiotropium bromide|mesh-list
92770897|NCT01152450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92770898|NCT01152450|Autonomic Agents|autonomic agents|mesh-ancestor
92770899|NCT01152450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770900|NCT01152450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770901|NCT01152450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92770902|NCT01152450|Respiratory System Agents|respiratory system agents|mesh-ancestor
92770903|NCT01152450|Parasympatholytics|parasympatholytics|mesh-ancestor
92770904|NCT01152450|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92770905|NCT01152450|Cholinergic Agents|cholinergic agents|mesh-ancestor
92770906|NCT01152450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770907|NCT01152450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770908|NCT00610246|Sorafenib|sorafenib|mesh-list
92770909|NCT00610246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770910|NCT00610246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92770911|NCT00610246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770912|NCT00610246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770913|NCT01181141|Enoxaparin|enoxaparin|mesh-list
92770914|NCT01181141|Enoxaparin sodium|enoxaparin sodium|mesh-list
92770915|NCT01181141|Edoxaban|edoxaban|mesh-list
92770916|NCT01181141|Anticoagulants|anticoagulants|mesh-ancestor
92770917|NCT01181141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92770918|NCT01181141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92770919|NCT01181141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770920|NCT01181141|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92770921|NCT01181141|Antithrombins|antithrombins|mesh-ancestor
92770922|NCT01181141|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92770923|NCT01181141|Protease Inhibitors|protease inhibitors|mesh-ancestor
92770924|NCT01181141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770925|NCT00606814|Docetaxel|docetaxel|mesh-list
92770926|NCT00606814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770927|NCT00606814|Tubulin Modulators|tubulin modulators|mesh-ancestor
92770928|NCT00606814|Antimitotic Agents|antimitotic agents|mesh-ancestor
92770929|NCT00606814|Mitosis Modulators|mitosis modulators|mesh-ancestor
92770930|NCT00606814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770932|NCT01173120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92770933|NCT01173120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770934|NCT01173120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92770935|NCT01173120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770936|NCT01173120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770937|NCT01173120|Immunologic Factors|immunologic factors|mesh-ancestor
92770938|NCT01173120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770939|NCT01173120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92770940|NCT00977379|Capecitabine|capecitabine|mesh-list
92770941|NCT00977379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770942|NCT00977379|Antimetabolites|antimetabolites|mesh-ancestor
92770943|NCT00977379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770944|NCT00977379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770945|NCT04263844|Midazolam|midazolam|mesh-list
92770946|NCT04263844|Dexmedetomidine|dexmedetomidine|mesh-list
92770947|NCT04263844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92770948|NCT04263844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92770949|NCT04263844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770950|NCT04263844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92770951|NCT04263844|Analgesics|analgesics|mesh-ancestor
92770952|NCT04263844|Sensory System Agents|sensory system agents|mesh-ancestor
92770953|NCT04263844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92770954|NCT04263844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92770955|NCT04263844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92770956|NCT04263844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92770957|NCT04263844|Adrenergic Agents|adrenergic agents|mesh-ancestor
92770958|NCT04263844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92770959|NCT04263844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770960|NCT04263844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92770961|NCT04263844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92770962|NCT04263844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92770963|NCT04263844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92770964|NCT04263844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92770965|NCT04263844|Anesthetics, General|anesthetics, general|mesh-ancestor
92770966|NCT04263844|Anesthetics|anesthetics|mesh-ancestor
92770967|NCT04263844|GABA Modulators|gaba modulators|mesh-ancestor
92770968|NCT04263844|GABA Agents|gaba agents|mesh-ancestor
92770969|NCT00610324|Chlorhexidine|chlorhexidine|mesh-list
92770970|NCT00610324|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92770971|NCT00610324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92770972|NCT00610324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92770973|NCT00610324|Disinfectants|disinfectants|mesh-ancestor
92770974|NCT00610324|Dermatologic Agents|dermatologic agents|mesh-ancestor
92770975|NCT02884128|Leucovorin|leucovorin|mesh-list
92770976|NCT02884128|Fluorouracil|fluorouracil|mesh-list
92770977|NCT02884128|Irinotecan|irinotecan|mesh-list
92770978|NCT02884128|Antimetabolites|antimetabolites|mesh-ancestor
92770979|NCT02884128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770980|NCT02884128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770981|NCT02884128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770982|NCT02884128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92770983|NCT02884128|Immunologic Factors|immunologic factors|mesh-ancestor
92770984|NCT02884128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92770985|NCT02884128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92770986|NCT02884128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92770987|NCT02884128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92770988|NCT02884128|Antidotes|antidotes|mesh-ancestor
92770989|NCT02884128|Protective Agents|protective agents|mesh-ancestor
92770990|NCT02884128|Vitamin B Complex|vitamin b complex|mesh-ancestor
92770991|NCT02884128|Vitamins|vitamins|mesh-ancestor
92770992|NCT02884128|Micronutrients|micronutrients|mesh-ancestor
92770993|NCT00629343|Azacitidine|azacitidine|mesh-list
92770994|NCT00629343|Temozolomide|temozolomide|mesh-list
92770995|NCT00629343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92770996|NCT00629343|Antimetabolites|antimetabolites|mesh-ancestor
92770997|NCT00629343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92770998|NCT00629343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92770999|NCT00629343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771000|NCT00629343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92771001|NCT00629343|Alkylating Agents|alkylating agents|mesh-ancestor
92771002|NCT01180049|Sirolimus|sirolimus|mesh-list
92771003|NCT01180049|Temsirolimus|temsirolimus|mesh-list
92771004|NCT01180049|MTOR Inhibitors|mtor inhibitors|mesh-list
92771005|NCT01180049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92771006|NCT01180049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771007|NCT01180049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771008|NCT01180049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771009|NCT01180049|Immunologic Factors|immunologic factors|mesh-ancestor
92771010|NCT01180049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771011|NCT01180049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771012|NCT01180049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771013|NCT01180049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771014|NCT01180049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92771015|NCT01180049|Antifungal Agents|antifungal agents|mesh-ancestor
92771016|NCT01147458|Naproxen|naproxen|mesh-list
92771017|NCT01147458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771018|NCT01147458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771019|NCT01147458|Analgesics|analgesics|mesh-ancestor
92771020|NCT01147458|Sensory System Agents|sensory system agents|mesh-ancestor
92771021|NCT01147458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771022|NCT01147458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771023|NCT01147458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771024|NCT01147458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771025|NCT01147458|Gout Suppressants|gout suppressants|mesh-ancestor
92771026|NCT01147458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771027|NCT01147458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771028|NCT01147458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771029|NCT01172808|Tiotropium Bromide|tiotropium bromide|mesh-list
92771030|NCT01172808|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92771031|NCT01172808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771032|NCT01172808|Autonomic Agents|autonomic agents|mesh-ancestor
92771033|NCT01172808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771034|NCT01172808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771035|NCT01172808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771036|NCT01172808|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771037|NCT01172808|Parasympatholytics|parasympatholytics|mesh-ancestor
92771038|NCT01172808|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92771039|NCT01172808|Cholinergic Agents|cholinergic agents|mesh-ancestor
92771040|NCT01172808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771041|NCT01172808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771042|NCT01172808|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92771043|NCT01172808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92771044|NCT01172808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92771045|NCT01172808|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771046|NCT04315194|Clarithromycin|clarithromycin|mesh-list
92771047|NCT04315194|Oseltamivir|oseltamivir|mesh-list
92771048|NCT04315194|Naproxen|naproxen|mesh-list
92771049|NCT04315194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771050|NCT04315194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771051|NCT04315194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92771052|NCT04315194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771053|NCT04315194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771054|NCT04315194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92771055|NCT04315194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92771056|NCT04315194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771057|NCT04315194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771058|NCT04315194|Analgesics|analgesics|mesh-ancestor
92771059|NCT04315194|Sensory System Agents|sensory system agents|mesh-ancestor
92771060|NCT04315194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771061|NCT04315194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771062|NCT04315194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771063|NCT04315194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771064|NCT04315194|Gout Suppressants|gout suppressants|mesh-ancestor
92771065|NCT04315194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771066|NCT04315194|Antiviral Agents|antiviral agents|mesh-ancestor
92771067|NCT04066491|Gemcitabine|gemcitabine|mesh-list
92771068|NCT04066491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771069|NCT04066491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771070|NCT04066491|Antimetabolites|antimetabolites|mesh-ancestor
92771071|NCT04066491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771072|NCT01149486|Losartan|losartan|mesh-list
92771073|NCT01149486|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92771074|NCT01149486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92771075|NCT01149486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92771076|NCT01149486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92771077|NCT01149486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92771078|NCT01149486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771079|NCT01149486|Diuretics|diuretics|mesh-ancestor
92771080|NCT01149486|Natriuretic Agents|natriuretic agents|mesh-ancestor
92771081|NCT01149486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771082|NCT01149486|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92771083|NCT01149486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92771084|NCT00640471|Cetuximab|cetuximab|mesh-list
92771085|NCT00640471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771086|NCT00640471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771087|NCT00601705|Fluorouracil|fluorouracil|mesh-list
92771088|NCT00601705|Oxaliplatin|oxaliplatin|mesh-list
92771089|NCT00601705|Epirubicin|epirubicin|mesh-list
92771090|NCT00601705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771091|NCT00601705|Antimetabolites|antimetabolites|mesh-ancestor
92494497|NCT01975727|BB 1101|bb 1101|mesh-list
92337161|NCT02994251|Mitomycin|mitomycin|mesh-list
92771092|NCT00601705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771093|NCT00601705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771094|NCT00601705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771095|NCT00601705|Immunologic Factors|immunologic factors|mesh-ancestor
92771096|NCT00601705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771097|NCT00601705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92771098|NCT00601705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92771099|NCT00601705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92771100|NCT00601705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771101|NCT00641173|Paroxetine|paroxetine|mesh-list
92771102|NCT00641173|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92771103|NCT00641173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92771104|NCT00641173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92771105|NCT00641173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771106|NCT00641173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771107|NCT00641173|Serotonin Agents|serotonin agents|mesh-ancestor
92771108|NCT00641173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771109|NCT00641173|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92771110|NCT00641173|Antidepressive Agents|antidepressive agents|mesh-ancestor
92771111|NCT00641173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92771112|NCT00641173|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92771113|NCT00641173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92771114|NCT00641173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771115|NCT00929110|Glycopyrrolate|glycopyrrolate|mesh-list
92771116|NCT00929110|Bromides|bromides|mesh-list
92771117|NCT00929110|Tiotropium Bromide|tiotropium bromide|mesh-list
92771118|NCT00929110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771119|NCT00929110|Autonomic Agents|autonomic agents|mesh-ancestor
92771120|NCT00929110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771121|NCT00929110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771122|NCT00929110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771123|NCT00929110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771124|NCT00929110|Parasympatholytics|parasympatholytics|mesh-ancestor
92771125|NCT00929110|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92771126|NCT00929110|Cholinergic Agents|cholinergic agents|mesh-ancestor
92771127|NCT00929110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771128|NCT00929110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771129|NCT00929110|Anticonvulsants|anticonvulsants|mesh-ancestor
92771130|NCT00929110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92771131|NCT00929110|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92771132|NCT00922519|Listerine|listerine|mesh-list
92771133|NCT00922519|Fluorides|fluorides|mesh-list
92771134|NCT00922519|Sodium Fluoride|sodium fluoride|mesh-list
92771135|NCT00922519|Cariostatic Agents|cariostatic agents|mesh-ancestor
92771136|NCT00922519|Protective Agents|protective agents|mesh-ancestor
92771137|NCT00922519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771138|NCT00922519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92771139|NCT00922519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771140|NCT00640549|Atorvastatin|atorvastatin|mesh-list
92771141|NCT00640549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92771142|NCT00640549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92771143|NCT00640549|Antimetabolites|antimetabolites|mesh-ancestor
92771144|NCT00640549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771145|NCT00640549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92771146|NCT00640549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92771147|NCT00640549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771148|NCT02683369|Iron|iron|mesh-list
92771149|NCT02683369|Trace Elements|trace elements|mesh-ancestor
92771150|NCT02683369|Micronutrients|micronutrients|mesh-ancestor
92771151|NCT02683369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771153|NCT01147068|Agglutinins|agglutinins|mesh-ancestor
92771154|NCT01147068|Immunologic Factors|immunologic factors|mesh-ancestor
92771155|NCT01147068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771156|NCT01147068|Coagulants|coagulants|mesh-ancestor
92771157|NCT00640627|Celecoxib|celecoxib|mesh-list
92771158|NCT00640627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771159|NCT00640627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771160|NCT00640627|Analgesics|analgesics|mesh-ancestor
92771161|NCT00640627|Sensory System Agents|sensory system agents|mesh-ancestor
92771162|NCT00640627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771163|NCT00640627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771164|NCT00640627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771165|NCT00640627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771166|NCT00640627|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92771167|NCT00640627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771168|NCT00640627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771169|NCT00640627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771170|NCT02681887|Melatonin|melatonin|mesh-list
92771171|NCT02681887|Antioxidants|antioxidants|mesh-ancestor
92771172|NCT02681887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771173|NCT02681887|Protective Agents|protective agents|mesh-ancestor
92771174|NCT02681887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771175|NCT02681887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92771176|NCT01134042|Fluticasone|fluticasone|mesh-list
92771177|NCT01134042|Xhance|xhance|mesh-list
92771178|NCT01134042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771179|NCT01134042|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771180|NCT01134042|Autonomic Agents|autonomic agents|mesh-ancestor
92771181|NCT01134042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771182|NCT01134042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771183|NCT01134042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771184|NCT01134042|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771185|NCT01134042|Dermatologic Agents|dermatologic agents|mesh-ancestor
92771186|NCT01134042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92771187|NCT01179347|Tiotropium Bromide|tiotropium bromide|mesh-list
92771188|NCT01179347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771189|NCT01179347|Autonomic Agents|autonomic agents|mesh-ancestor
92771190|NCT01179347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771191|NCT01179347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771192|NCT01179347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771193|NCT01179347|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771194|NCT01179347|Parasympatholytics|parasympatholytics|mesh-ancestor
92771195|NCT01179347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92771196|NCT01179347|Cholinergic Agents|cholinergic agents|mesh-ancestor
92771197|NCT01179347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771198|NCT01179347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771199|NCT01146288|Furosemide|furosemide|mesh-list
92771200|NCT01146288|Acetazolamide|acetazolamide|mesh-list
92771201|NCT01146288|Diuretics|diuretics|mesh-ancestor
92771202|NCT01146288|Natriuretic Agents|natriuretic agents|mesh-ancestor
92771203|NCT01146288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771204|NCT01146288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92771205|NCT01146288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92771206|NCT01146288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771207|NCT01146288|Anticonvulsants|anticonvulsants|mesh-ancestor
92771208|NCT01146288|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92771209|NCT01146288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771210|NCT01146054|Gemcitabine|gemcitabine|mesh-list
92771211|NCT01146054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92771212|NCT01146054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771213|NCT01146054|Antimetabolites|antimetabolites|mesh-ancestor
92771214|NCT01146054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771215|NCT01146054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771216|NCT01146054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92771217|NCT00640705|Diclofenac|diclofenac|mesh-list
92771218|NCT00640705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771219|NCT00640705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771220|NCT00640705|Analgesics|analgesics|mesh-ancestor
92771221|NCT00640705|Sensory System Agents|sensory system agents|mesh-ancestor
92771222|NCT00640705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771223|NCT00640705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771224|NCT00640705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771226|NCT00640705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771227|NCT00640705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771228|NCT00640705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771229|NCT01145898|Timolol|timolol|mesh-list
92771230|NCT01145898|Dorzolamide|dorzolamide|mesh-list
92771231|NCT01145898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92771232|NCT01145898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92771233|NCT01145898|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771234|NCT01145898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771235|NCT01145898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771236|NCT01145898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771237|NCT01145898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92771238|NCT01145898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92771239|NCT01145898|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92771240|NCT01145898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771241|NCT02681653|Atorvastatin|atorvastatin|mesh-list
92771242|NCT02681653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92771243|NCT02681653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92771244|NCT02681653|Antimetabolites|antimetabolites|mesh-ancestor
92771245|NCT02681653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771246|NCT02681653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92771247|NCT02681653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92771248|NCT02681653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771249|NCT04315116|Loperamide|loperamide|mesh-list
92771250|NCT04315116|Antidiarrheals|antidiarrheals|mesh-list
92771251|NCT04315116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771252|NCT02883114|Itraconazole|itraconazole|mesh-list
92771253|NCT02883114|Antifungal Agents|antifungal agents|mesh-ancestor
92771254|NCT02883114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771255|NCT02883114|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92771256|NCT02883114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92771257|NCT02883114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771258|NCT02883114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771259|NCT02883114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92771260|NCT02883114|Hormone Antagonists|hormone antagonists|mesh-ancestor
92771261|NCT02883114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771262|NCT02883114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771263|NCT02883114|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92771264|NCT04183387|Simvastatin|simvastatin|mesh-list
92771265|NCT04183387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92771266|NCT04183387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92771267|NCT04183387|Antimetabolites|antimetabolites|mesh-ancestor
92771268|NCT04183387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771269|NCT04183387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92771270|NCT04183387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92771271|NCT04183387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771272|NCT00625092|Leucovorin|leucovorin|mesh-list
92771273|NCT00625092|Fluorouracil|fluorouracil|mesh-list
92771274|NCT00625092|Oxaliplatin|oxaliplatin|mesh-list
92771275|NCT00625092|Calcium|calcium|mesh-list
92771276|NCT00625092|Levoleucovorin|levoleucovorin|mesh-list
92771277|NCT00625092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92771278|NCT00625092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771279|NCT00625092|Antimetabolites|antimetabolites|mesh-ancestor
92771280|NCT00625092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771281|NCT00625092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771282|NCT00625092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771283|NCT00625092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771284|NCT00625092|Immunologic Factors|immunologic factors|mesh-ancestor
92771285|NCT00625092|Antidotes|antidotes|mesh-ancestor
92771286|NCT00625092|Protective Agents|protective agents|mesh-ancestor
92771287|NCT00625092|Vitamin B Complex|vitamin b complex|mesh-ancestor
92771288|NCT00625092|Vitamins|vitamins|mesh-ancestor
92771289|NCT00625092|Micronutrients|micronutrients|mesh-ancestor
92771290|NCT00931918|Prednisone|prednisone|mesh-list
92771291|NCT00931918|Cyclophosphamide|cyclophosphamide|mesh-list
92771292|NCT00931918|Rituximab|rituximab|mesh-list
92771293|NCT00931918|Doxorubicin|doxorubicin|mesh-list
92771294|NCT00931918|Vincristine|vincristine|mesh-list
92771295|NCT00931918|Bortezomib|bortezomib|mesh-list
92771296|NCT00931918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771297|NCT00931918|Immunologic Factors|immunologic factors|mesh-ancestor
92771298|NCT00931918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771299|NCT00931918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771300|NCT00931918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92771302|NCT00931918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771303|NCT00931918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771304|NCT00931918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92771305|NCT00931918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771306|NCT00931918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92771307|NCT00931918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92771308|NCT00931918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92771309|NCT00931918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771310|NCT00931918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771311|NCT00931918|Glucocorticoids|glucocorticoids|mesh-ancestor
92771312|NCT00931918|Hormones|hormones|mesh-ancestor
93060698|NCT01281514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92771313|NCT00931918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771314|NCT00931918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92771315|NCT00931918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92771316|NCT00931918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92771317|NCT00931918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92771318|NCT00931918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92771319|NCT04183075|Vitamins|vitamins|mesh-list
92771320|NCT04183075|Ascorbic Acid|ascorbic acid|mesh-list
92771321|NCT04183075|Micronutrients|micronutrients|mesh-ancestor
92771322|NCT04183075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771323|NCT04183075|Antioxidants|antioxidants|mesh-ancestor
92771324|NCT04183075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771325|NCT04183075|Protective Agents|protective agents|mesh-ancestor
92771326|NCT02679001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92771327|NCT02679001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771328|NCT02678221|Aspirin|aspirin|mesh-list
92771329|NCT02678221|Sildenafil Citrate|sildenafil citrate|mesh-list
92771330|NCT02678221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771331|NCT02678221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771332|NCT02678221|Analgesics|analgesics|mesh-ancestor
92771333|NCT02678221|Sensory System Agents|sensory system agents|mesh-ancestor
92771334|NCT02678221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771335|NCT02678221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771336|NCT02678221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771337|NCT02678221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771338|NCT02678221|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92771339|NCT02678221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92771340|NCT02678221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771341|NCT02678221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92771342|NCT02678221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771343|NCT02678221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771344|NCT02678221|Antipyretics|antipyretics|mesh-ancestor
92771345|NCT02678221|Vasodilator Agents|vasodilator agents|mesh-ancestor
92771346|NCT02678221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92771347|NCT02678221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92771348|NCT02678221|Urological Agents|urological agents|mesh-ancestor
92771349|NCT00641329|Clonidine|clonidine|mesh-list
92771350|NCT00641329|Analgesics|analgesics|mesh-ancestor
92771351|NCT00641329|Sensory System Agents|sensory system agents|mesh-ancestor
92771352|NCT00641329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771353|NCT00641329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771354|NCT00641329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92771355|NCT00641329|Sympatholytics|sympatholytics|mesh-ancestor
92771356|NCT00641329|Autonomic Agents|autonomic agents|mesh-ancestor
92771357|NCT00641329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92771358|NCT00641329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92771359|NCT00641329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92771360|NCT00641329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771361|NCT00641329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771362|NCT00641329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771363|NCT01179191|Naltrexone|naltrexone|mesh-list
92771364|NCT01179191|Morphine|morphine|mesh-list
92771365|NCT01179191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92771366|NCT01179191|Narcotics|narcotics|mesh-ancestor
92771367|NCT01179191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92771368|NCT01179191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771369|NCT01179191|Analgesics|analgesics|mesh-ancestor
92771370|NCT01179191|Sensory System Agents|sensory system agents|mesh-ancestor
92771371|NCT01179191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771372|NCT01179191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92771373|NCT01179191|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92771374|NCT00642421|Octreotide|octreotide|mesh-list
92771375|NCT00642421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771376|NCT00642421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92771377|NCT00642421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771378|NCT00642187|Budesonide|budesonide|mesh-list
92771379|NCT00642187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771380|NCT00642187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771381|NCT00642187|Autonomic Agents|autonomic agents|mesh-ancestor
92771382|NCT00642187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771383|NCT00642187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771384|NCT00642187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771385|NCT00642187|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771386|NCT00642187|Glucocorticoids|glucocorticoids|mesh-ancestor
92771387|NCT00642187|Hormones|hormones|mesh-ancestor
93060699|NCT01281514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771388|NCT00642187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771390|NCT05663125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92771391|NCT05663125|Alkylating Agents|alkylating agents|mesh-ancestor
92771392|NCT05663125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771393|NCT05663125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771394|NCT01132482|Sildenafil Citrate|sildenafil citrate|mesh-list
92771395|NCT01132482|Vasodilator Agents|vasodilator agents|mesh-ancestor
92771396|NCT01132482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92771397|NCT01132482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92771398|NCT01132482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771399|NCT01132482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771400|NCT01132482|Urological Agents|urological agents|mesh-ancestor
92771401|NCT02678767|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92771402|NCT02678767|Hematinics|hematinics|mesh-ancestor
92771403|NCT02678767|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92771404|NCT02678767|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92771405|NCT00931762|Panobinostat|panobinostat|mesh-list
92771406|NCT00931762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771407|NCT00931762|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92771408|NCT00931762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771409|NCT00931762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771410|NCT00641407|Insulin|insulin|mesh-list
92771411|NCT00641407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92771412|NCT00641407|Insulin Glargine|insulin glargine|mesh-list
92771413|NCT00641407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92771414|NCT00641407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771415|NCT02677597|Paclitaxel|paclitaxel|mesh-list
92771416|NCT02677597|Cisplatin|cisplatin|mesh-list
92771417|NCT02677597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92771418|NCT02677597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771419|NCT02677597|Tubulin Modulators|tubulin modulators|mesh-ancestor
92771420|NCT02677597|Antimitotic Agents|antimitotic agents|mesh-ancestor
92771421|NCT02677597|Mitosis Modulators|mitosis modulators|mesh-ancestor
92771422|NCT02677597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771423|NCT01132326|Droxidopa|droxidopa|mesh-list
92771424|NCT01132326|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92771425|NCT01132326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92771426|NCT02681263|Temocillin|temocillin|mesh-list
92771427|NCT02681263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771428|NCT02681263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771429|NCT02677519|Methylphenidate|methylphenidate|mesh-list
92771430|NCT02677519|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92771431|NCT02677519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771432|NCT02677519|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92771433|NCT02677519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92771434|NCT02677519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92771435|NCT02677519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771436|NCT02677519|Dopamine Agents|dopamine agents|mesh-ancestor
92771437|NCT02677519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771438|NCT01145508|Metronidazole|metronidazole|mesh-list
92771439|NCT01145508|Prednisone|prednisone|mesh-list
92771440|NCT01145508|Cortisone|cortisone|mesh-list
92771441|NCT01145508|Docetaxel|docetaxel|mesh-list
92771442|NCT01145508|Vaccines|vaccines|mesh-list
92771443|NCT01145508|Immunologic Factors|immunologic factors|mesh-ancestor
92771444|NCT01145508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771445|NCT01145508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771446|NCT01145508|Tubulin Modulators|tubulin modulators|mesh-ancestor
92771447|NCT01145508|Antimitotic Agents|antimitotic agents|mesh-ancestor
92771448|NCT01145508|Mitosis Modulators|mitosis modulators|mesh-ancestor
92771449|NCT01145508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771450|NCT01145508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771451|NCT01145508|Glucocorticoids|glucocorticoids|mesh-ancestor
92771452|NCT01145508|Hormones|hormones|mesh-ancestor
92771453|NCT01145508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771454|NCT01145508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92771455|NCT01145508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771456|NCT01145508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771457|NCT01145508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92771458|NCT01145508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92771459|NCT00931528|Tadalafil|tadalafil|mesh-list
92771460|NCT00931528|Vasodilator Agents|vasodilator agents|mesh-ancestor
92771461|NCT00931528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92416524|NCT01485744|Leucovorin|leucovorin|mesh-list
92771462|NCT00931528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92771464|NCT00931528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771465|NCT00931528|Urological Agents|urological agents|mesh-ancestor
92771466|NCT04181749|Aspirin|aspirin|mesh-list
92771467|NCT04181749|Atorvastatin|atorvastatin|mesh-list
92771468|NCT04181749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771469|NCT04181749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771470|NCT04181749|Analgesics|analgesics|mesh-ancestor
92771471|NCT04181749|Sensory System Agents|sensory system agents|mesh-ancestor
92771472|NCT04181749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771473|NCT04181749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771474|NCT04181749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771475|NCT04181749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771476|NCT04181749|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92771477|NCT04181749|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92771478|NCT04181749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771479|NCT04181749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92771480|NCT04181749|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771481|NCT04181749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771482|NCT04181749|Antipyretics|antipyretics|mesh-ancestor
92337222|NCT01340885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771483|NCT04181749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92771484|NCT04181749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92771485|NCT04181749|Antimetabolites|antimetabolites|mesh-ancestor
92771486|NCT04181749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92771487|NCT04181749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92771488|NCT04312152|Vitamins|vitamins|mesh-list
92771489|NCT04312152|Vitamin E|vitamin e|mesh-list
92771490|NCT04312152|Tocopherols|tocopherols|mesh-list
92771491|NCT04312152|Folic Acid|folic acid|mesh-list
92771492|NCT04312152|Vitamin B Complex|vitamin b complex|mesh-list
92771493|NCT04312152|Micronutrients|micronutrients|mesh-ancestor
92771494|NCT04312152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771495|NCT04312152|Antioxidants|antioxidants|mesh-ancestor
92771496|NCT04312152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771497|NCT04312152|Protective Agents|protective agents|mesh-ancestor
92771498|NCT04312152|Hematinics|hematinics|mesh-ancestor
92771499|NCT00975195|Fluticasone|fluticasone|mesh-list
92771501|NCT00975195|Tiotropium Bromide|tiotropium bromide|mesh-list
92771502|NCT00975195|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92771503|NCT00975195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771504|NCT00975195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771505|NCT00975195|Autonomic Agents|autonomic agents|mesh-ancestor
92771506|NCT00975195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771507|NCT00975195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771508|NCT00975195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771509|NCT00975195|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771510|NCT00975195|Dermatologic Agents|dermatologic agents|mesh-ancestor
92771511|NCT00975195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92771512|NCT00975195|Parasympatholytics|parasympatholytics|mesh-ancestor
92771513|NCT00975195|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92771514|NCT00975195|Cholinergic Agents|cholinergic agents|mesh-ancestor
92771515|NCT00975195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771516|NCT00975195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771517|NCT00975195|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92771518|NCT00975195|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92771519|NCT00975195|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92771520|NCT00975195|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771521|NCT00642499|Dronabinol|dronabinol|mesh-list
92771522|NCT00642499|Hallucinogens|hallucinogens|mesh-ancestor
92771523|NCT00642499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771524|NCT00642499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92771525|NCT00642499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771526|NCT00642499|Analgesics|analgesics|mesh-ancestor
92771527|NCT00642499|Sensory System Agents|sensory system agents|mesh-ancestor
92771528|NCT00642499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771529|NCT00642499|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92771530|NCT00642499|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92771531|NCT00642499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771532|NCT00642499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771533|NCT00642499|Hormones|hormones|mesh-ancestor
92771534|NCT00642499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416598|NCT01486004|Simeprevir|simeprevir|mesh-list
92771535|NCT00644215|Mitomycins|mitomycins|mesh-list
92771536|NCT00644215|Mitomycin|mitomycin|mesh-list
92771537|NCT00644215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92771538|NCT00644215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771539|NCT00644215|Alkylating Agents|alkylating agents|mesh-ancestor
92771540|NCT00644215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771541|NCT00644215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92771542|NCT00644215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771543|NCT01145352|Etanercept|etanercept|mesh-list
92771544|NCT01145352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771545|NCT01145352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771546|NCT01145352|Analgesics|analgesics|mesh-ancestor
92771547|NCT01145352|Sensory System Agents|sensory system agents|mesh-ancestor
92771548|NCT01145352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771549|NCT01145352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771550|NCT01145352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771551|NCT01145352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337232|NCT03855059|BB 1101|bb 1101|mesh-list
92771552|NCT01145352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771553|NCT01145352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771554|NCT01145352|Immunologic Factors|immunologic factors|mesh-ancestor
92771555|NCT01178099|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92771556|NCT01178099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92771557|NCT02673463|Spironolactone|spironolactone|mesh-list
92771558|NCT02673463|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92771559|NCT02673463|Hormone Antagonists|hormone antagonists|mesh-ancestor
92771560|NCT02673463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771561|NCT02673463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771562|NCT02673463|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92771563|NCT02673463|Diuretics|diuretics|mesh-ancestor
92771564|NCT02673463|Natriuretic Agents|natriuretic agents|mesh-ancestor
92771565|NCT01169532|Vorinostat|vorinostat|mesh-list
92771566|NCT01169532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771567|NCT01169532|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92771568|NCT01169532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771569|NCT01169532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771570|NCT02537353|Epinephrine|epinephrine|mesh-list
92771571|NCT02537353|Racepinephrine|racepinephrine|mesh-list
92771572|NCT02537353|Epinephryl borate|epinephryl borate|mesh-list
92771573|NCT02537353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92771574|NCT02537353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92771575|NCT02537353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771576|NCT02537353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771577|NCT02537353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771578|NCT02537353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771579|NCT02537353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92771580|NCT02537353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771581|NCT02537353|Autonomic Agents|autonomic agents|mesh-ancestor
92771582|NCT02537353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771583|NCT02537353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771584|NCT02537353|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771585|NCT02537353|Mydriatics|mydriatics|mesh-ancestor
92771586|NCT02537353|Sympathomimetics|sympathomimetics|mesh-ancestor
92771587|NCT02537353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92771588|NCT00643357|Nitrous Oxide|nitrous oxide|mesh-list
92771589|NCT00643357|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92771590|NCT00643357|Anesthetics, General|anesthetics, general|mesh-ancestor
92771591|NCT00643357|Anesthetics|anesthetics|mesh-ancestor
92771592|NCT00643357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254791|NCT01750073|Doxorubicin|doxorubicin|mesh-list
92771593|NCT00643357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771594|NCT00643357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771595|NCT00643357|Analgesics|analgesics|mesh-ancestor
92771596|NCT00643357|Sensory System Agents|sensory system agents|mesh-ancestor
92771597|NCT00643357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771598|NCT01177943|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92771599|NCT01177943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92771600|NCT01177943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92771601|NCT01177943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92771602|NCT01177943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771603|NCT01177943|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771604|NCT01177943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771605|NCT01177943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771606|NCT04178785|Remifentanil|remifentanil|mesh-list
92771607|NCT04178785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92771608|NCT04178785|Narcotics|narcotics|mesh-ancestor
92771609|NCT04178785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92771610|NCT04178785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771611|NCT04178785|Analgesics|analgesics|mesh-ancestor
92771612|NCT04178785|Sensory System Agents|sensory system agents|mesh-ancestor
92771613|NCT04178785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771614|NCT00928486|Dexamethasone|dexamethasone|mesh-list
92771615|NCT00928486|Lenalidomide|lenalidomide|mesh-list
92771616|NCT00928486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771617|NCT00928486|Antiemetics|antiemetics|mesh-ancestor
92771618|NCT00928486|Autonomic Agents|autonomic agents|mesh-ancestor
92771619|NCT00928486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771620|NCT00928486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771621|NCT00928486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771622|NCT00928486|Glucocorticoids|glucocorticoids|mesh-ancestor
92771623|NCT00928486|Hormones|hormones|mesh-ancestor
92771624|NCT00928486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771625|NCT00928486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92771626|NCT00928486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771627|NCT00928486|Immunologic Factors|immunologic factors|mesh-ancestor
92771628|NCT00928486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92771629|NCT00928486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92771630|NCT00928486|Growth Substances|growth substances|mesh-ancestor
92771631|NCT00928486|Growth Inhibitors|growth inhibitors|mesh-ancestor
92771632|NCT03867357|Goserelin|goserelin|mesh-list
92771633|NCT03867357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92771634|NCT03867357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771635|NCT05655221|Mitogens|mitogens|mesh-list
92771636|NCT05655221|Mitosis Modulators|mitosis modulators|mesh-ancestor
92771637|NCT05655221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771638|NCT00610792|Doxorubicin|doxorubicin|mesh-list
92771639|NCT00610792|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92771640|NCT00610792|Bortezomib|bortezomib|mesh-list
92771641|NCT00610792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92771642|NCT00610792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771643|NCT00610792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92771644|NCT00610792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92771645|NCT00610792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771646|NCT00610792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771647|NCT00610870|Atorvastatin|atorvastatin|mesh-list
92771648|NCT00610870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92771649|NCT00610870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92771650|NCT00610870|Antimetabolites|antimetabolites|mesh-ancestor
92771651|NCT00610870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771652|NCT00610870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92771653|NCT00610870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92771654|NCT00610870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771655|NCT01168596|Rasagiline|rasagiline|mesh-list
92771656|NCT01168596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92771657|NCT01168596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771658|NCT01168596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771659|NCT01168596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92771660|NCT01168596|Protective Agents|protective agents|mesh-ancestor
92771661|NCT01168596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771662|NCT02675647|Heparin|heparin|mesh-list
92771663|NCT02675647|Protamines|protamines|mesh-list
92771664|NCT02675647|Anticoagulants|anticoagulants|mesh-ancestor
92771665|NCT02675647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92771666|NCT02675647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92771667|NCT02675647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771668|NCT02675647|Heparin Antagonists|heparin antagonists|mesh-ancestor
92771669|NCT02675647|Coagulants|coagulants|mesh-ancestor
92771670|NCT05370898|Calcium Carbonate|calcium carbonate|mesh-list
92771671|NCT05370898|Antacids|antacids|mesh-ancestor
92771672|NCT05370898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771673|NCT05370898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771674|NCT00610948|Leucovorin|leucovorin|mesh-list
92771675|NCT00610948|Fluorouracil|fluorouracil|mesh-list
92771676|NCT00610948|Oxaliplatin|oxaliplatin|mesh-list
92771677|NCT00610948|Everolimus|everolimus|mesh-list
92771678|NCT00610948|Panitumumab|panitumumab|mesh-list
92771679|NCT00610948|Calcium|calcium|mesh-list
92771680|NCT00610948|Levoleucovorin|levoleucovorin|mesh-list
92771681|NCT00610948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92771682|NCT00610948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771683|NCT00610948|Antimetabolites|antimetabolites|mesh-ancestor
92771684|NCT00610948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771685|NCT00610948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771686|NCT00610948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771687|NCT00610948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771688|NCT00610948|Immunologic Factors|immunologic factors|mesh-ancestor
92771689|NCT00610948|Antidotes|antidotes|mesh-ancestor
92771690|NCT00610948|Protective Agents|protective agents|mesh-ancestor
92771691|NCT00610948|Vitamin B Complex|vitamin b complex|mesh-ancestor
92771692|NCT00610948|Vitamins|vitamins|mesh-ancestor
92771693|NCT00610948|Micronutrients|micronutrients|mesh-ancestor
92771694|NCT00610948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92771695|NCT00610948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92771696|NCT00610948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771697|NCT00610948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771698|NCT02675413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92771699|NCT02675413|Dermatologic Agents|dermatologic agents|mesh-ancestor
92771700|NCT02675413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771701|NCT02675413|Immunologic Factors|immunologic factors|mesh-ancestor
92771702|NCT02675413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771703|NCT00928408|Cinacalcet|cinacalcet|mesh-list
92771704|NCT00928408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92771705|NCT00928408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771706|NCT00928408|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92771707|NCT00928408|Hormone Antagonists|hormone antagonists|mesh-ancestor
92771708|NCT00928408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771709|NCT00928252|Fluorides|fluorides|mesh-list
92771710|NCT00928252|Cariostatic Agents|cariostatic agents|mesh-ancestor
92771711|NCT00928252|Protective Agents|protective agents|mesh-ancestor
92771712|NCT00928252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771713|NCT02673229|Bacitracin|bacitracin|mesh-list
92771714|NCT02673229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92771715|NCT02673229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771716|NCT02673229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771717|NCT00644293|Azithromycin|azithromycin|mesh-list
92771718|NCT00644293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771719|NCT00644293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771720|NCT00930982|Ciprofloxacin|ciprofloxacin|mesh-list
92771721|NCT00930982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771722|NCT00930982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771723|NCT00930982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92771724|NCT00930982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92771725|NCT00930982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494498|NCT01975727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771726|NCT00930982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771727|NCT00930982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771728|NCT00930982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92771729|NCT00930982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92771730|NCT01176773|Hyaluronic Acid|hyaluronic acid|mesh-list
92771731|NCT01176773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92771732|NCT01176773|Immunologic Factors|immunologic factors|mesh-ancestor
92771733|NCT01176773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771734|NCT01176773|Viscosupplements|viscosupplements|mesh-ancestor
92771735|NCT01176773|Protective Agents|protective agents|mesh-ancestor
92771736|NCT02887625|Insulin|insulin|mesh-list
92771737|NCT02887625|Insulin Glargine|insulin glargine|mesh-list
92771738|NCT02887625|Pioglitazone|pioglitazone|mesh-list
92771739|NCT02887625|Insulin Aspart|insulin aspart|mesh-list
92771740|NCT02887625|Exenatide|exenatide|mesh-list
92771741|NCT02887625|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92771742|NCT02887625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771743|NCT02887625|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92771744|NCT02887625|Incretins|incretins|mesh-ancestor
92771745|NCT02887625|Hormones|hormones|mesh-ancestor
92771746|NCT02887625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771747|NCT02886377|Antibodies|antibodies|mesh-list
92771748|NCT02886377|Immunologic Factors|immunologic factors|mesh-ancestor
92771749|NCT02886377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771750|NCT02675335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92771751|NCT02675335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92771752|NCT02675335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771753|NCT02675335|Incretins|incretins|mesh-ancestor
92771754|NCT02675335|Hormones|hormones|mesh-ancestor
92771755|NCT02675335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771756|NCT02675335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92771757|NCT02675335|Protease Inhibitors|protease inhibitors|mesh-ancestor
92771758|NCT02675335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771759|NCT02675335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771760|NCT02675101|Sucrose polyester|sucrose polyester|mesh-list
92771761|NCT02675101|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92771762|NCT02675101|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92771763|NCT02675101|Antimetabolites|antimetabolites|mesh-ancestor
92771764|NCT02675101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771765|NCT02675101|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92771766|NCT00928018|Cyclosporine|cyclosporine|mesh-list
92771767|NCT00928018|Sirolimus|sirolimus|mesh-list
92771768|NCT00928018|Mycophenolic Acid|mycophenolic acid|mesh-list
92771769|NCT00928018|Methotrexate|methotrexate|mesh-list
92771770|NCT00928018|Tacrolimus|tacrolimus|mesh-list
92771771|NCT00928018|Cyclosporins|cyclosporins|mesh-list
92771772|NCT00928018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92771773|NCT00928018|Abortifacient Agents|abortifacient agents|mesh-ancestor
92771774|NCT00928018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92771775|NCT00928018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771776|NCT00928018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771777|NCT00928018|Antimetabolites|antimetabolites|mesh-ancestor
92771778|NCT00928018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771779|NCT00928018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771780|NCT00928018|Dermatologic Agents|dermatologic agents|mesh-ancestor
92771781|NCT00928018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771782|NCT00928018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92771783|NCT00928018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771784|NCT00928018|Immunologic Factors|immunologic factors|mesh-ancestor
92771785|NCT00928018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771786|NCT00928018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92771787|NCT00928018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92771788|NCT00928018|Antifungal Agents|antifungal agents|mesh-ancestor
92771789|NCT00928018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771790|NCT00928018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92771791|NCT00928018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92771792|NCT00928018|Antitubercular Agents|antitubercular agents|mesh-ancestor
92771793|NCT00928018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92771794|NCT02672839|Betadex|betadex|mesh-list
92771795|NCT02672839|Sequestering Agents|sequestering agents|mesh-ancestor
92771796|NCT02672839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771797|NCT00609154|Glucagon|glucagon|mesh-list
92771798|NCT00609154|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92771799|NCT00609154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771800|NCT00609154|Hormones|hormones|mesh-ancestor
92771801|NCT00609154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771802|NCT00609154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771803|NCT00609154|Incretins|incretins|mesh-ancestor
92771804|NCT00910117|Nimotuzumab|nimotuzumab|mesh-list
92771805|NCT00910117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771806|NCT00910117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771807|NCT00927862|Warfarin|warfarin|mesh-list
92771808|NCT00927862|Anticoagulants|anticoagulants|mesh-ancestor
92771809|NCT02672527|Dexamethasone|dexamethasone|mesh-list
92771810|NCT02672527|Trabectedin|trabectedin|mesh-list
92771811|NCT02672527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771812|NCT02672527|Antiemetics|antiemetics|mesh-ancestor
92771813|NCT02672527|Autonomic Agents|autonomic agents|mesh-ancestor
92771814|NCT02672527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771815|NCT02672527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771816|NCT02672527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771817|NCT02672527|Glucocorticoids|glucocorticoids|mesh-ancestor
92771818|NCT02672527|Hormones|hormones|mesh-ancestor
92771819|NCT02672527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92771821|NCT02672527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771822|NCT02672527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92771823|NCT02672527|Alkylating Agents|alkylating agents|mesh-ancestor
92771824|NCT02672527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771825|NCT00976989|Docetaxel|docetaxel|mesh-list
92771826|NCT00976989|Trastuzumab|trastuzumab|mesh-list
92771827|NCT00976989|Pertuzumab|pertuzumab|mesh-list
92771828|NCT00976989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771829|NCT00976989|Tubulin Modulators|tubulin modulators|mesh-ancestor
92771830|NCT00976989|Antimitotic Agents|antimitotic agents|mesh-ancestor
92337328|NCT01216631|Hormones|hormones|mesh-ancestor
92771831|NCT00976989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92771832|NCT00976989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771833|NCT00976989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771834|NCT05449171|Vitamin D|vitamin d|mesh-list
92771835|NCT05449171|Vitamins|vitamins|mesh-list
92771836|NCT05449171|Thioctic Acid|thioctic acid|mesh-list
92771837|NCT05449171|Vitamin B 6|vitamin b 6|mesh-list
92771838|NCT05449171|Pyridoxal|pyridoxal|mesh-list
92771839|NCT05449171|Pyridoxine|pyridoxine|mesh-list
92771840|NCT05449171|Hyaluronic Acid|hyaluronic acid|mesh-list
92771841|NCT05449171|Micronutrients|micronutrients|mesh-ancestor
92771842|NCT05449171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771844|NCT05449171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92771845|NCT05449171|Immunologic Factors|immunologic factors|mesh-ancestor
92771846|NCT05449171|Viscosupplements|viscosupplements|mesh-ancestor
92771847|NCT05449171|Protective Agents|protective agents|mesh-ancestor
92771848|NCT05449171|Vitamin B Complex|vitamin b complex|mesh-ancestor
92771849|NCT05449171|Antioxidants|antioxidants|mesh-ancestor
92771850|NCT05449171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771851|NCT02675023|Adalimumab|adalimumab|mesh-list
92771852|NCT02675023|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92771853|NCT02675023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771854|NCT02675023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771855|NCT00644371|Rituximab|rituximab|mesh-list
92771856|NCT00644371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771857|NCT00644371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771858|NCT00644371|Immunologic Factors|immunologic factors|mesh-ancestor
92771859|NCT00644371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771860|NCT00644371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771861|NCT02864199|Ribavirin|ribavirin|mesh-list
92771862|NCT02864199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92771863|NCT02864199|Antimetabolites|antimetabolites|mesh-ancestor
92771864|NCT02864199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771865|NCT02864199|Antiviral Agents|antiviral agents|mesh-ancestor
92771866|NCT02864199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771867|NCT05911126|Celecoxib|celecoxib|mesh-list
92771868|NCT05911126|Scopolamine|scopolamine|mesh-list
92771869|NCT05911126|Bromides|bromides|mesh-list
92771870|NCT05911126|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92771871|NCT05911126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771872|NCT05911126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771873|NCT05911126|Analgesics|analgesics|mesh-ancestor
92771874|NCT05911126|Sensory System Agents|sensory system agents|mesh-ancestor
92771875|NCT05911126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771876|NCT05911126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771877|NCT05911126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771878|NCT05911126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771879|NCT05911126|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92771880|NCT05911126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771881|NCT05911126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771882|NCT05911126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771883|NCT05911126|Anticonvulsants|anticonvulsants|mesh-ancestor
92771884|NCT05911126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92771885|NCT05911126|Antiemetics|antiemetics|mesh-ancestor
92771886|NCT05911126|Autonomic Agents|autonomic agents|mesh-ancestor
92771887|NCT05911126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92771888|NCT05911126|Mydriatics|mydriatics|mesh-ancestor
92771889|NCT05911126|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92771890|NCT05911126|Cholinergic Agents|cholinergic agents|mesh-ancestor
92771891|NCT05911126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771892|NCT05911126|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92771893|NCT05911126|Parasympatholytics|parasympatholytics|mesh-ancestor
92771894|NCT05908526|Suvorexant|suvorexant|mesh-list
92771895|NCT05908526|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92771896|NCT05908526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92771897|NCT05908526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92771898|NCT05908526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771899|NCT05908526|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92771900|NCT05908526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771901|NCT05908526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771902|NCT05908513|Acetylcysteine|acetylcysteine|mesh-list
92771903|NCT05908513|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92771904|NCT05908513|Antiviral Agents|antiviral agents|mesh-ancestor
92771905|NCT05908513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92771906|NCT05908513|Expectorants|expectorants|mesh-ancestor
92771907|NCT05908513|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771908|NCT05908513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92771909|NCT05908513|Antioxidants|antioxidants|mesh-ancestor
92771910|NCT05908513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771911|NCT05908513|Protective Agents|protective agents|mesh-ancestor
92771912|NCT05908513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771913|NCT05908513|Antidotes|antidotes|mesh-ancestor
92771914|NCT05908305|Epinephrine|epinephrine|mesh-list
92771915|NCT05908305|Racepinephrine|racepinephrine|mesh-list
92771916|NCT05908305|Anesthetics|anesthetics|mesh-list
92771917|NCT05908305|Carticaine|carticaine|mesh-list
92771918|NCT05908305|Mepivacaine|mepivacaine|mesh-list
92771919|NCT05908305|Epinephryl borate|epinephryl borate|mesh-list
92771920|NCT05908305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92771921|NCT05908305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771922|NCT05908305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92771923|NCT05908305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92771924|NCT05908305|Adrenergic Agents|adrenergic agents|mesh-ancestor
92771925|NCT05908305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92771926|NCT05908305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771927|NCT05908305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92771928|NCT05908305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92771929|NCT05908305|Autonomic Agents|autonomic agents|mesh-ancestor
92771930|NCT05908305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771931|NCT05908305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92771932|NCT05908305|Respiratory System Agents|respiratory system agents|mesh-ancestor
92771933|NCT05908305|Mydriatics|mydriatics|mesh-ancestor
92771934|NCT05908305|Sympathomimetics|sympathomimetics|mesh-ancestor
92771935|NCT05908305|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92771936|NCT05908305|Anesthetics, Local|anesthetics, local|mesh-ancestor
92771937|NCT05908305|Sensory System Agents|sensory system agents|mesh-ancestor
92771938|NCT02672995|Bevacizumab|bevacizumab|mesh-list
92771939|NCT02672995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771940|NCT02672995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771941|NCT02672995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92771942|NCT02672995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92771943|NCT02672995|Growth Substances|growth substances|mesh-ancestor
92771944|NCT02672995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771945|NCT02672995|Growth Inhibitors|growth inhibitors|mesh-ancestor
92771946|NCT05907980|Atezolizumab|atezolizumab|mesh-list
92771947|NCT05907980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92771948|NCT05907980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771949|NCT05907980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92771950|NCT05907980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771951|NCT05907902|Aspirin|aspirin|mesh-list
92771952|NCT05907902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92771953|NCT05907902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92771954|NCT05907902|Analgesics|analgesics|mesh-ancestor
92771955|NCT05907902|Sensory System Agents|sensory system agents|mesh-ancestor
92771956|NCT05907902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92771957|NCT05907902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771958|NCT05907902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92771959|NCT05907902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771960|NCT05907902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92771961|NCT05907902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92771962|NCT05907902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771963|NCT05907902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92771964|NCT05907902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92771965|NCT05907902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771966|NCT05907902|Antipyretics|antipyretics|mesh-ancestor
92771967|NCT05907733|Mitogens|mitogens|mesh-list
92771968|NCT05907733|Mitosis Modulators|mitosis modulators|mesh-ancestor
92771969|NCT05907733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771970|NCT05907499|Decitabine|decitabine|mesh-list
92771971|NCT05907499|Epoetin Alfa|epoetin alfa|mesh-list
92771972|NCT05907499|Lenograstim|lenograstim|mesh-list
92771973|NCT05907499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771974|NCT05907499|Antimetabolites|antimetabolites|mesh-ancestor
92771975|NCT05907499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771976|NCT05907499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771977|NCT05907499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92771978|NCT05907499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92771979|NCT05907499|Immunologic Factors|immunologic factors|mesh-ancestor
92771980|NCT05907499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771981|NCT05907499|Hematinics|hematinics|mesh-ancestor
92771982|NCT05907486|Cytarabine|cytarabine|mesh-list
92771983|NCT05907486|Acetylcysteine|acetylcysteine|mesh-list
92771984|NCT05907486|Cyclophosphamide|cyclophosphamide|mesh-list
92771985|NCT05907486|Busulfan|busulfan|mesh-list
92771986|NCT05907486|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92771987|NCT05907486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92771988|NCT05907486|Immunologic Factors|immunologic factors|mesh-ancestor
92494499|NCT01975727|Antiemetics|antiemetics|mesh-ancestor
92771989|NCT05907486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92771990|NCT05907486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92771991|NCT05907486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92771992|NCT05907486|Alkylating Agents|alkylating agents|mesh-ancestor
92771993|NCT05907486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92771994|NCT05907486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92771995|NCT05907486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92771996|NCT05907486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92771997|NCT05907486|Antimetabolites|antimetabolites|mesh-ancestor
92771998|NCT05907486|Antiviral Agents|antiviral agents|mesh-ancestor
92771999|NCT05907486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772000|NCT05907486|Expectorants|expectorants|mesh-ancestor
92772001|NCT05907486|Respiratory System Agents|respiratory system agents|mesh-ancestor
92772002|NCT05907486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92772003|NCT05907486|Antioxidants|antioxidants|mesh-ancestor
92772004|NCT05907486|Protective Agents|protective agents|mesh-ancestor
92772005|NCT05907486|Antidotes|antidotes|mesh-ancestor
92772006|NCT05907122|Nivolumab|nivolumab|mesh-list
92772007|NCT05907122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772008|NCT05907122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772009|NCT05907122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772010|NCT05907122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772011|NCT05906992|Ocrelizumab|ocrelizumab|mesh-list
92772012|NCT05906992|Immunologic Factors|immunologic factors|mesh-ancestor
92772013|NCT05906992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772014|NCT05906914|Cytarabine|cytarabine|mesh-list
92772015|NCT05906914|Cladribine|cladribine|mesh-list
92772016|NCT05906914|Homoharringtonine|homoharringtonine|mesh-list
92772017|NCT05906914|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772018|NCT05906914|Antimetabolites|antimetabolites|mesh-ancestor
92772019|NCT05906914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772020|NCT05906914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772021|NCT05906914|Antiviral Agents|antiviral agents|mesh-ancestor
92772022|NCT05906914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772023|NCT05906914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772024|NCT05906914|Immunologic Factors|immunologic factors|mesh-ancestor
92772025|NCT05906914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772026|NCT05906914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772027|NCT05906914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92772028|NCT05906914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772029|NCT05906615|Lidocaine|lidocaine|mesh-list
92772030|NCT05906615|Anesthetics, Local|anesthetics, local|mesh-ancestor
92772031|NCT05906615|Anesthetics|anesthetics|mesh-ancestor
92772032|NCT05906615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772033|NCT05906615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772034|NCT05906615|Sensory System Agents|sensory system agents|mesh-ancestor
92772035|NCT05906615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772036|NCT05906615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92772037|NCT05906615|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92772038|NCT05906615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92772039|NCT05906615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92772040|NCT05906615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772041|NCT05906589|Psyllium|psyllium|mesh-list
92772042|NCT05906589|Cathartics|cathartics|mesh-ancestor
92772043|NCT05906589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92772044|NCT05906576|Infliximab|infliximab|mesh-list
92772045|NCT05906576|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92772046|NCT05906576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772047|NCT05906576|Dermatologic Agents|dermatologic agents|mesh-ancestor
92772048|NCT05906576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92772049|NCT05906576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772050|NCT05906563|Metformin|metformin|mesh-list
92772051|NCT05906563|Melatonin|melatonin|mesh-list
92772052|NCT05906563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772053|NCT05906563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772054|NCT05906563|Antioxidants|antioxidants|mesh-ancestor
92772055|NCT05906563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772056|NCT05906563|Protective Agents|protective agents|mesh-ancestor
92772057|NCT05906563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772058|NCT05906524|Bevacizumab|bevacizumab|mesh-list
92772059|NCT05906524|Tislelizumab|tislelizumab|mesh-list
92772060|NCT05906524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772061|NCT05906524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772062|NCT05906524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772063|NCT05906524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772064|NCT05906524|Growth Substances|growth substances|mesh-ancestor
92772065|NCT05906524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772066|NCT05906524|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772067|NCT05906498|Vitamin E|vitamin e|mesh-list
92772068|NCT05906498|Acetylcysteine|acetylcysteine|mesh-list
92417122|NCT01489228|Benzonidazole|benzonidazole|mesh-list
92772069|NCT05906498|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92772070|NCT05906498|Vitamins|vitamins|mesh-ancestor
92772072|NCT05906498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772073|NCT05906498|Antioxidants|antioxidants|mesh-ancestor
92772074|NCT05906498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772075|NCT05906498|Protective Agents|protective agents|mesh-ancestor
92772076|NCT05906498|Antiviral Agents|antiviral agents|mesh-ancestor
92772077|NCT05906498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772078|NCT05906498|Expectorants|expectorants|mesh-ancestor
92772079|NCT05906498|Respiratory System Agents|respiratory system agents|mesh-ancestor
92772080|NCT05906498|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92772081|NCT05906498|Antidotes|antidotes|mesh-ancestor
92772082|NCT05901961|Zinc|zinc|mesh-list
92772083|NCT05901961|Zinc Oxide|zinc oxide|mesh-list
92772084|NCT05901961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92772085|NCT05901961|Trace Elements|trace elements|mesh-ancestor
92772086|NCT05901961|Micronutrients|micronutrients|mesh-ancestor
92772087|NCT05901961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772088|NCT05901961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92772089|NCT05901961|Sunscreening Agents|sunscreening agents|mesh-ancestor
92772090|NCT05901961|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92772091|NCT05901961|Protective Agents|protective agents|mesh-ancestor
92772092|NCT05892510|Tenecteplase|tenecteplase|mesh-list
92772093|NCT05892510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92772094|NCT05892510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92772095|NCT05892510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772096|NCT05886972|Propofol|propofol|mesh-list
92772097|NCT05886972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92772098|NCT05886972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772099|NCT05886972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772100|NCT05886972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92772101|NCT05886972|Anesthetics, General|anesthetics, general|mesh-ancestor
92772102|NCT05886972|Anesthetics|anesthetics|mesh-ancestor
92772103|NCT05879835|Heparin|heparin|mesh-list
92772104|NCT05879835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92772105|NCT05879835|Anticoagulants|anticoagulants|mesh-ancestor
92772106|NCT05879835|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92772107|NCT05879835|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92772108|NCT05879835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772109|NCT05874401|Topotecan|topotecan|mesh-list
92772110|NCT05874401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92772111|NCT05874401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92772112|NCT05874401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772113|NCT05874401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772114|NCT05874401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772115|NCT05858957|Magnesium Sulfate|magnesium sulfate|mesh-list
92772116|NCT05858957|Analgesics|analgesics|mesh-ancestor
92772117|NCT05858957|Sensory System Agents|sensory system agents|mesh-ancestor
92772118|NCT05858957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772119|NCT05858957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772120|NCT05858957|Anesthetics|anesthetics|mesh-ancestor
92530030|NCT00039403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772121|NCT05858957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772122|NCT05858957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92772123|NCT05858957|Anticonvulsants|anticonvulsants|mesh-ancestor
92772124|NCT05858957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92772125|NCT05858957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92772126|NCT05858957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772127|NCT05858957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92772128|NCT05858957|Tocolytic Agents|tocolytic agents|mesh-ancestor
92772129|NCT05858957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92772130|NCT05826964|Tamoxifen|tamoxifen|mesh-list
92772131|NCT05826964|Sirolimus|sirolimus|mesh-list
92772132|NCT05826964|Capecitabine|capecitabine|mesh-list
92772133|NCT05826964|Everolimus|everolimus|mesh-list
92772134|NCT05826964|Letrozole|letrozole|mesh-list
92772135|NCT05826964|Vinorelbine|vinorelbine|mesh-list
92772136|NCT05826964|Fulvestrant|fulvestrant|mesh-list
92772137|NCT05826964|Palbociclib|palbociclib|mesh-list
92772138|NCT05826964|Anastrozole|anastrozole|mesh-list
92772139|NCT05826964|Exemestane|exemestane|mesh-list
92772140|NCT05826964|Temsirolimus|temsirolimus|mesh-list
92772141|NCT05826964|MTOR Inhibitors|mtor inhibitors|mesh-list
92772143|NCT05826964|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92417190|NCT01489592|Turmeric extract|turmeric extract|mesh-list
92772144|NCT05826964|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-list
92772145|NCT05826964|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
92772146|NCT05826964|Estrogens|estrogens|mesh-list
92772147|NCT05826964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772148|NCT05826964|Antimetabolites|antimetabolites|mesh-ancestor
92772149|NCT05826964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772150|NCT05826964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772151|NCT05826964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772152|NCT05826964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772153|NCT05826964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772154|NCT05826964|Immunologic Factors|immunologic factors|mesh-ancestor
92772155|NCT05826964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772156|NCT05826964|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92772157|NCT05826964|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92772158|NCT05826964|Hormone Antagonists|hormone antagonists|mesh-ancestor
92772159|NCT05826964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772160|NCT05826964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92772161|NCT05826964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772162|NCT05826964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92772163|NCT05826964|Antifungal Agents|antifungal agents|mesh-ancestor
92772164|NCT05826964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772165|NCT05826964|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772166|NCT05826964|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772167|NCT05826964|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772168|NCT05826964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92772169|NCT05826964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92772170|NCT05826964|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92772171|NCT05826964|Hormones|hormones|mesh-ancestor
92772172|NCT05826964|Protease Inhibitors|protease inhibitors|mesh-ancestor
92772173|NCT05806164|Mirabegron|mirabegron|mesh-list
92772174|NCT05806164|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92772175|NCT05806164|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92772176|NCT05806164|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
92772177|NCT05806164|Adrenergic Agents|adrenergic agents|mesh-list
92772178|NCT05806164|Adrenergic Agonists|adrenergic agonists|mesh-list
92772179|NCT05806164|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92772180|NCT05806164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772181|NCT05806164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772182|NCT05806164|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92772183|NCT05806164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92772184|NCT05806164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772185|NCT05806164|Cholinergic Agents|cholinergic agents|mesh-ancestor
92772186|NCT05806164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92772187|NCT05806164|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92772188|NCT05806164|Urological Agents|urological agents|mesh-ancestor
92772189|NCT05760807|Oxytocin|oxytocin|mesh-list
92772190|NCT05760807|Oxytocics|oxytocics|mesh-ancestor
92772191|NCT05760807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92772192|NCT05760807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772193|NCT05754996|Nifuroxazide|nifuroxazide|mesh-list
92772194|NCT05754996|Lactulose|lactulose|mesh-list
92772195|NCT05754996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92772196|NCT05754996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772198|NCT05746442|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92772199|NCT05746442|Autonomic Agents|autonomic agents|mesh-ancestor
92772200|NCT05746442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772201|NCT05746442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772202|NCT05746442|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92772203|NCT05746442|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92772204|NCT05746442|Cholinergic Agents|cholinergic agents|mesh-ancestor
92772205|NCT05746442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92772206|NCT05746442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772207|NCT05736874|Fluticasone|fluticasone|mesh-list
92772208|NCT05736874|Xhance|xhance|mesh-list
92772209|NCT05736874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772210|NCT05736874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92772211|NCT05736874|Autonomic Agents|autonomic agents|mesh-ancestor
92772212|NCT05736874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772213|NCT05736874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772214|NCT05736874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92772215|NCT05736874|Respiratory System Agents|respiratory system agents|mesh-ancestor
92772216|NCT05736874|Dermatologic Agents|dermatologic agents|mesh-ancestor
92772217|NCT05736874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92772218|NCT05730036|Dexamethasone|dexamethasone|mesh-list
92772219|NCT05730036|Pomalidomide|pomalidomide|mesh-list
92772220|NCT05730036|Elotuzumab|elotuzumab|mesh-list
92772221|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772222|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
92772223|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
92772224|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772225|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772226|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92772227|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
92772228|NCT05730036|Hormones|hormones|mesh-ancestor
92772229|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772230|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92772231|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772232|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
92772233|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772234|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772235|NCT05730036|Growth Substances|growth substances|mesh-ancestor
92772236|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772237|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
92772238|NCT05699655|Apatinib|apatinib|mesh-list
92772239|NCT05699655|Tislelizumab|tislelizumab|mesh-list
92772240|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772241|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772242|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772243|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772244|NCT05699655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772245|NCT05687500|Glyburide|glyburide|mesh-list
92772246|NCT05687500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772247|NCT05687500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772248|NCT05681611|Rocuronium|rocuronium|mesh-list
92772249|NCT05681611|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92772250|NCT05681611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92772251|NCT05681611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92772252|NCT05681611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772253|NCT05681611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772254|NCT05675163|Vitamin K|vitamin k|mesh-list
92772255|NCT05675163|Vitamin K 2|vitamin k 2|mesh-list
92772256|NCT05675163|Vitamins|vitamins|mesh-ancestor
92772257|NCT05675163|Micronutrients|micronutrients|mesh-ancestor
92772258|NCT05675163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772259|NCT05675163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92772260|NCT05675163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92772261|NCT05675163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772262|NCT05675163|Hemostatics|hemostatics|mesh-ancestor
92772263|NCT05675163|Coagulants|coagulants|mesh-ancestor
92772264|NCT05660538|Pregabalin|pregabalin|mesh-list
92772265|NCT05660538|Analgesics|analgesics|mesh-ancestor
92772266|NCT05660538|Sensory System Agents|sensory system agents|mesh-ancestor
92772267|NCT05660538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772268|NCT05660538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772269|NCT05660538|Anticonvulsants|anticonvulsants|mesh-ancestor
92772270|NCT05660538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92772271|NCT05660538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92772272|NCT05660538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772273|NCT05660538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92772274|NCT05660538|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92772275|NCT05660538|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92772276|NCT05660538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772277|NCT05660538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92772278|NCT05659381|Cisplatin|cisplatin|mesh-list
92772279|NCT05659381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772280|NCT05656170|Bupivacaine|bupivacaine|mesh-list
92772281|NCT05656170|Anesthetics, Local|anesthetics, local|mesh-ancestor
92772282|NCT05656170|Anesthetics|anesthetics|mesh-ancestor
92772283|NCT05656170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772284|NCT05656170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772285|NCT05656170|Sensory System Agents|sensory system agents|mesh-ancestor
92772286|NCT05656170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772287|NCT05650879|Trastuzumab|trastuzumab|mesh-list
92772288|NCT05650879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92772289|NCT05650879|Maytansine|maytansine|mesh-list
92772290|NCT05650879|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92772291|NCT05650879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772292|NCT05650879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772293|NCT05650879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92337455|NCT02499887|Tocolytic Agents|tocolytic agents|mesh-ancestor
92772294|NCT05650879|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772295|NCT05650879|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772296|NCT05650879|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772297|NCT05650879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772298|NCT05650879|Immunotoxins|immunotoxins|mesh-ancestor
92772299|NCT05650879|Immunoconjugates|immunoconjugates|mesh-ancestor
92772300|NCT05650879|Immunologic Factors|immunologic factors|mesh-ancestor
92772301|NCT05650879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772303|NCT05596786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772304|NCT05596786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772305|NCT05596786|Immunologic Factors|immunologic factors|mesh-ancestor
92772306|NCT05596786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772307|NCT05596786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772308|NCT05584657|Amoxicillin|amoxicillin|mesh-list
92772309|NCT05584657|Clavulanic Acid|clavulanic acid|mesh-list
92772310|NCT05584657|Clavulanic Acids|clavulanic acids|mesh-list
92772311|NCT05584657|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92772312|NCT05584657|Lactams|lactams|mesh-list
92772313|NCT05584657|Probenecid|probenecid|mesh-list
92772314|NCT05584657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92772315|NCT05584657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772316|NCT05584657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92772317|NCT05584657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772318|NCT05584657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772319|NCT05584657|Uricosuric Agents|uricosuric agents|mesh-ancestor
92772320|NCT05584657|Gout Suppressants|gout suppressants|mesh-ancestor
92772321|NCT05584657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772322|NCT05582707|Pioglitazone|pioglitazone|mesh-list
92772323|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772324|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772325|NCT05564611|Omalizumab|omalizumab|mesh-list
92772326|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92772327|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92772328|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
92772329|NCT05559164|Atorvastatin|atorvastatin|mesh-list
92772330|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92772331|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92772332|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
92772333|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772334|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92772335|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92772336|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772337|NCT05558098|Dapagliflozin|dapagliflozin|mesh-list
92772338|NCT05558098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92772339|NCT05558098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772340|NCT05558098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772341|NCT05558098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772342|NCT05558007|Tadalafil|tadalafil|mesh-list
92772343|NCT05558007|Vasodilator Agents|vasodilator agents|mesh-ancestor
92772344|NCT05558007|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92772345|NCT05558007|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92772346|NCT05558007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772347|NCT05558007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772348|NCT05558007|Urological Agents|urological agents|mesh-ancestor
92772349|NCT05553704|Metformin|metformin|mesh-list
92772350|NCT05553704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772351|NCT05553704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772352|NCT05553405|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92772353|NCT05553405|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92772354|NCT05553405|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92337488|NCT01074437|Propranolol|propranolol|mesh-list
92772355|NCT05553405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92772356|NCT05536349|Valacyclovir|valacyclovir|mesh-list
92772357|NCT05536349|Venetoclax|venetoclax|mesh-list
92772358|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
92772359|NCT05536349|Allopurinol|allopurinol|mesh-list
92772360|NCT05536349|Pirtobrutinib|pirtobrutinib|mesh-list
92772361|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772362|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772363|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
92772364|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772365|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772366|NCT05536349|Gout Suppressants|gout suppressants|mesh-ancestor
92772367|NCT05536349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772368|NCT05536349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92772369|NCT05536349|Antioxidants|antioxidants|mesh-ancestor
92772370|NCT05536349|Protective Agents|protective agents|mesh-ancestor
92772371|NCT05536349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772372|NCT05536349|Antiviral Agents|antiviral agents|mesh-ancestor
92772373|NCT05536349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772374|NCT05536349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772375|NCT05518903|FAPI-46|fapi-46|mesh-list
92772376|NCT05518903|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92772377|NCT05518903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772378|NCT05517642|Vaccines|vaccines|mesh-list
92772379|NCT05517642|Immunologic Factors|immunologic factors|mesh-ancestor
92772380|NCT05517642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772381|NCT05514132|Durvalumab|durvalumab|mesh-list
92772382|NCT05514132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92772383|NCT05514132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772384|NCT05514132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772385|NCT05514132|Immunologic Factors|immunologic factors|mesh-ancestor
92772386|NCT05514132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772387|NCT05487261|Valsartan|valsartan|mesh-list
92772388|NCT05487261|Enalapril|enalapril|mesh-list
92772389|NCT05487261|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92772390|NCT05487261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92772391|NCT05487261|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92772392|NCT05487261|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92772393|NCT05487261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772394|NCT05487261|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92772395|NCT05487261|Protease Inhibitors|protease inhibitors|mesh-ancestor
92772396|NCT05487261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772397|NCT05479240|Capecitabine|capecitabine|mesh-list
92772398|NCT05479240|Oxaliplatin|oxaliplatin|mesh-list
92772399|NCT05479240|Tislelizumab|tislelizumab|mesh-list
92772400|NCT05479240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772401|NCT05479240|Antimetabolites|antimetabolites|mesh-ancestor
92772402|NCT05479240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772403|NCT05479240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772404|NCT05479240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772405|NCT05465941|Irinotecan|irinotecan|mesh-list
92772406|NCT05465941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92772407|NCT05465941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92772408|NCT05465941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772409|NCT05465941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772410|NCT05465941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772411|NCT05461573|Drospirenone|drospirenone|mesh-list
92772412|NCT05461573|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92772413|NCT05461573|Hormone Antagonists|hormone antagonists|mesh-ancestor
92772414|NCT05461573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772415|NCT05461573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772416|NCT05461573|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92772417|NCT05461573|Diuretics|diuretics|mesh-ancestor
92530036|NCT00039481|Cyclophosphamide|cyclophosphamide|mesh-list
92772418|NCT05461573|Natriuretic Agents|natriuretic agents|mesh-ancestor
92772419|NCT05457972|Estradiol|estradiol|mesh-list
92772420|NCT05457972|Estrogens|estrogens|mesh-ancestor
92772421|NCT05457972|Hormones|hormones|mesh-ancestor
92772422|NCT05457972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772423|NCT05457972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772425|NCT05452772|Psilocybin|psilocybin|mesh-list
92772426|NCT05452772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92772427|NCT05452772|Antimetabolites|antimetabolites|mesh-ancestor
92772428|NCT05452772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772429|NCT05452772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92772430|NCT05452772|Vasodilator Agents|vasodilator agents|mesh-ancestor
92772431|NCT05452772|Vitamin B Complex|vitamin b complex|mesh-ancestor
92772432|NCT05452772|Vitamins|vitamins|mesh-ancestor
92772433|NCT05452772|Micronutrients|micronutrients|mesh-ancestor
92772434|NCT05452772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772435|NCT05452772|Hallucinogens|hallucinogens|mesh-ancestor
92772436|NCT05452772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92772437|NCT05442684|Vaccines|vaccines|mesh-list
92772438|NCT05442684|Immunologic Factors|immunologic factors|mesh-ancestor
92772439|NCT05442684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772440|NCT05380388|Vaccines|vaccines|mesh-list
92772441|NCT05380388|Immunologic Factors|immunologic factors|mesh-ancestor
92772442|NCT05380388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772443|NCT05369819|Midazolam|midazolam|mesh-list
92772444|NCT05369819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92772445|NCT05369819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92772446|NCT05369819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92772447|NCT05369819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772448|NCT05369819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92772449|NCT05369819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92772450|NCT05369819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92417489|NCT01490749|Capecitabine|capecitabine|mesh-list
92772451|NCT05369819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92772452|NCT05369819|Anesthetics, General|anesthetics, general|mesh-ancestor
92772453|NCT05369819|Anesthetics|anesthetics|mesh-ancestor
92772454|NCT05369819|GABA Modulators|gaba modulators|mesh-ancestor
92772455|NCT05369819|GABA Agents|gaba agents|mesh-ancestor
92772456|NCT05369819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92772457|NCT05369819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772458|NCT05332444|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92772459|NCT05332444|Amoxicillin|amoxicillin|mesh-list
92772460|NCT05332444|Metronidazole|metronidazole|mesh-list
92772461|NCT05332444|Clarithromycin|clarithromycin|mesh-list
92772462|NCT05332444|Levofloxacin|levofloxacin|mesh-list
92772463|NCT05332444|Tetracycline|tetracycline|mesh-list
92772464|NCT05332444|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92772465|NCT05332444|Rabeprazole|rabeprazole|mesh-list
92772466|NCT05332444|Bismuth|bismuth|mesh-list
92772467|NCT05332444|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92494500|NCT01975727|Autonomic Agents|autonomic agents|mesh-ancestor
92772468|NCT05332444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772469|NCT05332444|Antitubercular Agents|antitubercular agents|mesh-ancestor
92772470|NCT05332444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92772471|NCT05332444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92772472|NCT05332444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92772473|NCT05332444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772474|NCT05332444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772475|NCT05332444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92772476|NCT05332444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92772477|NCT05332444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92772478|NCT05332444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92772479|NCT05332444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92772480|NCT05332444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772481|NCT05332444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92772482|NCT05332444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92772483|NCT05332444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92772484|NCT05332444|Antacids|antacids|mesh-ancestor
92772485|NCT05290740|Norepinephrine|norepinephrine|mesh-list
92772486|NCT05290740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92772487|NCT05290740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92772488|NCT05290740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92772489|NCT05290740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92772490|NCT05290740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772491|NCT05290740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772492|NCT05290740|Sympathomimetics|sympathomimetics|mesh-ancestor
92772493|NCT05290740|Autonomic Agents|autonomic agents|mesh-ancestor
92772494|NCT05290740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772495|NCT05290740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92772496|NCT05260684|Trametinib|trametinib|mesh-list
92772497|NCT05260684|Vemurafenib|vemurafenib|mesh-list
92772498|NCT05260684|Dabrafenib|dabrafenib|mesh-list
92772499|NCT05260684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772500|NCT05260684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772501|NCT05260684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772502|NCT05260684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772503|NCT05234554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92772504|NCT05234554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92772505|NCT05212311|Chitosan|chitosan|mesh-list
92772506|NCT05212311|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92772507|NCT05212311|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92772508|NCT05212311|Antimetabolites|antimetabolites|mesh-ancestor
92772509|NCT05212311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772510|NCT05212311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92772511|NCT05212311|Chelating Agents|chelating agents|mesh-ancestor
92772512|NCT05212311|Sequestering Agents|sequestering agents|mesh-ancestor
92772513|NCT05212311|Hemostatics|hemostatics|mesh-ancestor
92772514|NCT05212311|Coagulants|coagulants|mesh-ancestor
92772515|NCT05208242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92772516|NCT05194293|Durvalumab|durvalumab|mesh-list
92772517|NCT05194293|Immunoglobulins|immunoglobulins|mesh-list
92772518|NCT05194293|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92772519|NCT05194293|Immunoglobulin G|immunoglobulin g|mesh-list
92772520|NCT05194293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772521|NCT05194293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772522|NCT05194293|Immunologic Factors|immunologic factors|mesh-ancestor
92772523|NCT05194293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772524|NCT05159752|Afamelanotide|afamelanotide|mesh-list
92772525|NCT05159752|Dermatologic Agents|dermatologic agents|mesh-ancestor
92772526|NCT05141721|Leucovorin|leucovorin|mesh-list
92772527|NCT05141721|Bevacizumab|bevacizumab|mesh-list
92772528|NCT05141721|Ipilimumab|ipilimumab|mesh-list
92772529|NCT05141721|Atezolizumab|atezolizumab|mesh-list
92772530|NCT05141721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772531|NCT05141721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772532|NCT05141721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772533|NCT05141721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772534|NCT05141721|Growth Substances|growth substances|mesh-ancestor
92772535|NCT05141721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772536|NCT05141721|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772537|NCT05141721|Antidotes|antidotes|mesh-ancestor
92772538|NCT05141721|Protective Agents|protective agents|mesh-ancestor
92772539|NCT05141721|Vitamin B Complex|vitamin b complex|mesh-ancestor
92772540|NCT05141721|Vitamins|vitamins|mesh-ancestor
92772541|NCT05141721|Micronutrients|micronutrients|mesh-ancestor
92772542|NCT05141721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772543|NCT05141721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772544|NCT05095116|Fluticasone|fluticasone|mesh-list
92772545|NCT05095116|Xhance|xhance|mesh-list
92772546|NCT05095116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772547|NCT05095116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92772548|NCT05095116|Autonomic Agents|autonomic agents|mesh-ancestor
92772549|NCT05095116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772550|NCT05095116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772551|NCT05095116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92772552|NCT05095116|Respiratory System Agents|respiratory system agents|mesh-ancestor
92772553|NCT05095116|Dermatologic Agents|dermatologic agents|mesh-ancestor
92772554|NCT05095116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92772555|NCT05093322|Gemcitabine|gemcitabine|mesh-list
92772556|NCT05093322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772557|NCT05093322|Antimetabolites|antimetabolites|mesh-ancestor
92772558|NCT05093322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772559|NCT05093322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772560|NCT05074355|Azacitidine|azacitidine|mesh-list
92772561|NCT05074355|Venetoclax|venetoclax|mesh-list
92772562|NCT05074355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772563|NCT05074355|Antimetabolites|antimetabolites|mesh-ancestor
92772564|NCT05074355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772565|NCT05074355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772566|NCT05074355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772567|NCT05039801|Paclitaxel|paclitaxel|mesh-list
92772568|NCT05039801|Bevacizumab|bevacizumab|mesh-list
92772569|NCT05039801|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92772570|NCT05039801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92772571|NCT05039801|Endothelial Growth Factors|endothelial growth factors|mesh-list
92772572|NCT05039801|Antibodies|antibodies|mesh-list
92772573|NCT05039801|Immunoglobulins|immunoglobulins|mesh-list
92772574|NCT05039801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92772575|NCT05039801|Immunoglobulin G|immunoglobulin g|mesh-list
92772576|NCT05039801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772577|NCT05039801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772578|NCT05039801|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772579|NCT05039801|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772580|NCT05039801|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772581|NCT05039801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772582|NCT05039801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772583|NCT05039801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772584|NCT05039801|Growth Substances|growth substances|mesh-ancestor
92772585|NCT05039801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772586|NCT05039801|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772587|NCT05039801|Immunologic Factors|immunologic factors|mesh-ancestor
92772589|NCT05020860|Cyclophosphamide|cyclophosphamide|mesh-list
92772590|NCT05020860|Carboplatin|carboplatin|mesh-list
92772591|NCT05020860|Doxorubicin|doxorubicin|mesh-list
92772592|NCT05020860|Pembrolizumab|pembrolizumab|mesh-list
92772593|NCT05020860|Trastuzumab|trastuzumab|mesh-list
92772594|NCT05020860|Pertuzumab|pertuzumab|mesh-list
92772595|NCT05020860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772596|NCT05020860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337558|NCT01009931|Hormones|hormones|mesh-ancestor
92772597|NCT05020860|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772598|NCT05020860|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772599|NCT05020860|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772600|NCT05020860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772601|NCT05020860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772602|NCT05020860|Immunologic Factors|immunologic factors|mesh-ancestor
92772603|NCT05020860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772604|NCT05020860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772605|NCT05020860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92772606|NCT05020860|Alkylating Agents|alkylating agents|mesh-ancestor
92772607|NCT05020860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92772608|NCT05020860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92772609|NCT05020860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92772610|NCT05020860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92772611|NCT05020860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772612|NCT05020860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772613|NCT05020860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772614|NCT05006417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92772615|NCT05006417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92772616|NCT05006417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772617|NCT05006417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772618|NCT05006417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92772619|NCT05006417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92772620|NCT05006417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772621|NCT05006417|Cholinergic Agents|cholinergic agents|mesh-ancestor
92772622|NCT05006417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92772623|NCT05001152|Ozanimod|ozanimod|mesh-list
92772624|NCT05001152|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92772625|NCT05001152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772626|NCT05001152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772627|NCT05001152|Immunologic Factors|immunologic factors|mesh-ancestor
92772628|NCT05001152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772629|NCT04930653|Mogamulizumab|mogamulizumab|mesh-list
92772630|NCT04930653|Immunoglobulins|immunoglobulins|mesh-list
92772631|NCT04930653|Immunoglobulin G|immunoglobulin g|mesh-list
92772632|NCT04930653|Immunologic Factors|immunologic factors|mesh-ancestor
92772633|NCT04930653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772634|NCT04930653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772635|NCT04929392|Paclitaxel|paclitaxel|mesh-list
92772636|NCT04929392|Carboplatin|carboplatin|mesh-list
92772637|NCT04929392|Pembrolizumab|pembrolizumab|mesh-list
92772638|NCT04929392|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92772639|NCT04929392|Lenvatinib|lenvatinib|mesh-list
92772640|NCT04929392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772641|NCT04929392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772642|NCT04929392|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772643|NCT04929392|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772644|NCT04929392|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772645|NCT04929392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530039|NCT00039481|Dexrazoxane|dexrazoxane|mesh-list
92772646|NCT04929392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772647|NCT04929392|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772648|NCT04929392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772649|NCT04929392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772650|NCT04919629|Bevacizumab|bevacizumab|mesh-list
92772651|NCT04919629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92772652|NCT04919629|Pembrolizumab|pembrolizumab|mesh-list
92772653|NCT04919629|Endothelial Growth Factors|endothelial growth factors|mesh-list
92772654|NCT04919629|Antibodies|antibodies|mesh-list
92772655|NCT04919629|Immunoglobulins|immunoglobulins|mesh-list
92772656|NCT04919629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92772657|NCT04919629|Immunoglobulin G|immunoglobulin g|mesh-list
92772658|NCT04919629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772659|NCT04919629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772660|NCT04919629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772661|NCT04919629|Growth Substances|growth substances|mesh-ancestor
92772662|NCT04919629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772663|NCT04919629|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772664|NCT04919629|Immunologic Factors|immunologic factors|mesh-ancestor
92772665|NCT04919629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772666|NCT04919629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772667|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
92772668|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
92772669|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92772670|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
92772671|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772672|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772673|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
92772674|NCT04889079|Contraceptive Agents|contraceptive agents|mesh-list
92772675|NCT04889079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92772676|NCT04889079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772677|NCT04880434|Cyclophosphamide|cyclophosphamide|mesh-list
92772678|NCT04880434|Fludarabine|fludarabine|mesh-list
92772679|NCT04880434|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92772680|NCT04880434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772681|NCT04880434|Immunologic Factors|immunologic factors|mesh-ancestor
92772682|NCT04880434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772683|NCT04880434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772684|NCT04880434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92772685|NCT04880434|Alkylating Agents|alkylating agents|mesh-ancestor
92772686|NCT04880434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772687|NCT04880434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772688|NCT04880434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92772689|NCT04880434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772690|NCT04840394|Pembrolizumab|pembrolizumab|mesh-list
92772691|NCT04840394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772692|NCT04840394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772693|NCT04840394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772694|NCT04840394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772695|NCT04839549|Fluorometholone|fluorometholone|mesh-list
92772696|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772697|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772698|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
92772699|NCT04839549|Hormones|hormones|mesh-ancestor
92772700|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772701|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92772702|NCT04802161|Cytarabine|cytarabine|mesh-list
92772703|NCT04802161|Daunorubicin|daunorubicin|mesh-list
92772704|NCT04802161|Pomalidomide|pomalidomide|mesh-list
92772705|NCT04802161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772706|NCT04802161|Antimetabolites|antimetabolites|mesh-ancestor
92772707|NCT04802161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772708|NCT04802161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772709|NCT04802161|Antiviral Agents|antiviral agents|mesh-ancestor
92772710|NCT04802161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772711|NCT04802161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772712|NCT04802161|Immunologic Factors|immunologic factors|mesh-ancestor
92772713|NCT04802161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772714|NCT04802161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92772715|NCT04802161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92772716|NCT04802161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92772717|NCT04802161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772718|NCT04802161|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92117566|NCT04777227|Lidocaine|lidocaine|mesh-list
92772719|NCT04802161|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772720|NCT04802161|Growth Substances|growth substances|mesh-ancestor
92772721|NCT04802161|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772722|NCT04794569|Tinzaparin|tinzaparin|mesh-list
92772723|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92772724|NCT04794569|Dalteparin|dalteparin|mesh-list
92772725|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
92772726|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92772727|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
92772728|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92772729|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92772730|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772731|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772732|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
92772733|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92772734|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92772735|NCT04787042|Pembrolizumab|pembrolizumab|mesh-list
92772736|NCT04787042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772737|NCT04787042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772738|NCT04787042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772739|NCT04787042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772740|NCT04781322|Alirocumab|alirocumab|mesh-list
92772741|NCT04781322|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92772742|NCT04781322|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92772743|NCT04781322|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92772744|NCT04781322|Antimetabolites|antimetabolites|mesh-ancestor
92772745|NCT04781322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772746|NCT04781322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92772747|NCT04781322|Protease Inhibitors|protease inhibitors|mesh-ancestor
92772748|NCT04781322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772749|NCT04781322|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92772750|NCT04661358|Fenofibrate|fenofibrate|mesh-list
92772751|NCT04661358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92772752|NCT04661358|Antimetabolites|antimetabolites|mesh-ancestor
92772753|NCT04661358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772754|NCT04661358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92772755|NCT04652700|Tenofovir|tenofovir|mesh-list
92772756|NCT04652700|Emtricitabine|emtricitabine|mesh-list
92772757|NCT04652700|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92772758|NCT04652700|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92772760|NCT04652700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772761|NCT04652700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92772762|NCT04652700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92772763|NCT04652700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772764|NCT04652700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772765|NCT04652700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92772766|NCT04652700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92772767|NCT04630808|Latanoprost|latanoprost|mesh-list
92772768|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92772769|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92772770|NCT04624230|Tofacitinib|tofacitinib|mesh-list
92772771|NCT04624230|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92772772|NCT04624230|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772773|NCT04624230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772774|NCT04624230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772775|NCT04624178|Nivolumab|nivolumab|mesh-list
92772776|NCT04624178|Rucaparib|rucaparib|mesh-list
92772777|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772778|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772779|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772780|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772781|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92772782|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772783|NCT04619004|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92772784|NCT04619004|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92772785|NCT04619004|Immunologic Factors|immunologic factors|mesh-ancestor
92772786|NCT04619004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772787|NCT04619004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772788|NCT04619004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772789|NCT04563338|Bevacizumab|bevacizumab|mesh-list
92772790|NCT04563338|Atezolizumab|atezolizumab|mesh-list
92772791|NCT04563338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92117637|NCT03260166|Niacin|niacin|mesh-list
92772792|NCT04563338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772793|NCT04563338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772794|NCT04563338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772795|NCT04563338|Growth Substances|growth substances|mesh-ancestor
92772796|NCT04563338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772797|NCT04563338|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772798|NCT04563338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772799|NCT04563338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772800|NCT04524910|Aflibercept|aflibercept|mesh-list
92772801|NCT04524910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92772802|NCT04524910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92772803|NCT04524910|Growth Substances|growth substances|mesh-ancestor
92772804|NCT04524910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772805|NCT04524910|Growth Inhibitors|growth inhibitors|mesh-ancestor
92772806|NCT04524910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772807|NCT04513522|Nivolumab|nivolumab|mesh-list
92772808|NCT04513522|Ipilimumab|ipilimumab|mesh-list
92772809|NCT04513522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772810|NCT04513522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772811|NCT04513522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772812|NCT04513522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772813|NCT04410653|Afatinib|afatinib|mesh-list
92772814|NCT04410653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772815|NCT04410653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772816|NCT04410653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772817|NCT04410653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772818|NCT04377087|Olaparib|olaparib|mesh-list
92772819|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92772820|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772821|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772822|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772823|NCT04341779|Tenofovir|tenofovir|mesh-list
92772824|NCT04341779|Antiviral Agents|antiviral agents|mesh-ancestor
92772825|NCT04341779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772826|NCT04341779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92772827|NCT04341779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92337618|NCT00957827|Cephalexin|cephalexin|mesh-list
92772828|NCT04341779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772829|NCT04341779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772830|NCT04341779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92772831|NCT04341779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92772832|NCT04205838|Vidarabine|vidarabine|mesh-list
92772833|NCT04205838|Cyclophosphamide|cyclophosphamide|mesh-list
92772834|NCT04205838|Fludarabine|fludarabine|mesh-list
92772835|NCT04205838|Fludarabine phosphate|fludarabine phosphate|mesh-list
92772836|NCT04205838|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92772837|NCT04205838|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92772838|NCT04205838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772839|NCT04205838|Immunologic Factors|immunologic factors|mesh-ancestor
92772840|NCT04205838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772841|NCT04205838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772842|NCT04205838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92772843|NCT04205838|Alkylating Agents|alkylating agents|mesh-ancestor
92772844|NCT04205838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772845|NCT04205838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772846|NCT04205838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92772847|NCT04205838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772848|NCT04205838|Antimetabolites|antimetabolites|mesh-ancestor
92772849|NCT04205838|Antiviral Agents|antiviral agents|mesh-ancestor
92772850|NCT04205838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92772851|NCT04205838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772852|NCT04196530|Atezolizumab|atezolizumab|mesh-list
92772853|NCT04196530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772854|NCT04196530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772855|NCT04196530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772856|NCT04196530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772857|NCT04190056|Tamoxifen|tamoxifen|mesh-list
92772858|NCT04190056|Pembrolizumab|pembrolizumab|mesh-list
92772859|NCT04190056|Vorinostat|vorinostat|mesh-list
92772860|NCT04190056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772861|NCT04190056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772862|NCT04190056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772863|NCT04190056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772864|NCT04190056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92772865|NCT04190056|Hormone Antagonists|hormone antagonists|mesh-ancestor
92772866|NCT04190056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772867|NCT04190056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772868|NCT04190056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92772869|NCT04190056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92772870|NCT04190056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92772871|NCT04190056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92772872|NCT04190056|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92772873|NCT04190056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772874|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
92772875|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92772876|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772877|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772878|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772879|NCT04163016|Certolizumab Pegol|certolizumab pegol|mesh-list
92772880|NCT04163016|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92772881|NCT04163016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772882|NCT04163016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92772883|NCT04163016|Immunologic Factors|immunologic factors|mesh-ancestor
92772884|NCT04163016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772885|NCT04163016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92772886|NCT04147013|Celecoxib|celecoxib|mesh-list
92772887|NCT04147013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92772888|NCT04147013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92772889|NCT04147013|Analgesics|analgesics|mesh-ancestor
92772890|NCT04147013|Sensory System Agents|sensory system agents|mesh-ancestor
92772891|NCT04147013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772892|NCT04147013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772893|NCT04147013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92772894|NCT04147013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337636|NCT00920309|Antifungal Agents|antifungal agents|mesh-ancestor
92772895|NCT04147013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92772896|NCT04147013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92772897|NCT04147013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772898|NCT04147013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772899|NCT04086485|Olaparib|olaparib|mesh-list
92772900|NCT04086485|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92772901|NCT04086485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772902|NCT04086485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772903|NCT04086485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772904|NCT04084717|Crizotinib|crizotinib|mesh-list
92772905|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772906|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772907|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772908|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772909|NCT04042701|Pembrolizumab|pembrolizumab|mesh-list
92772910|NCT04042701|Trastuzumab|trastuzumab|mesh-list
92772911|NCT04042701|Camptothecin|camptothecin|mesh-list
92772912|NCT04042701|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92772913|NCT04042701|Immunoconjugates|immunoconjugates|mesh-list
92772914|NCT04042701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772915|NCT04042701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772916|NCT04042701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772917|NCT04042701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772918|NCT04042701|Immunologic Factors|immunologic factors|mesh-ancestor
92772919|NCT04042701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772920|NCT04042701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772921|NCT04042701|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92772922|NCT04042701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92772923|NCT04042701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772924|NCT04016389|Paclitaxel|paclitaxel|mesh-list
92772925|NCT04016389|Carboplatin|carboplatin|mesh-list
92772926|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772927|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772928|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772929|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772930|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772931|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772932|NCT03991819|Pembrolizumab|pembrolizumab|mesh-list
92772933|NCT03991819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772934|NCT03991819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772935|NCT03991819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772936|NCT03991819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772937|NCT03954041|Glyburide|glyburide|mesh-list
92772938|NCT03954041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92772939|NCT03954041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772940|NCT03945513|Dienogest|dienogest|mesh-list
92772941|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92772942|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92772943|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92772944|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92772945|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
92772946|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92772947|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772948|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92772949|NCT03945513|Estrogens|estrogens|mesh-ancestor
92772950|NCT03945513|Hormones|hormones|mesh-ancestor
92772951|NCT03945513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92772952|NCT03945513|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92772953|NCT03945513|Hormone Antagonists|hormone antagonists|mesh-ancestor
92772954|NCT03945513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92772955|NCT03945513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772956|NCT03919552|Cisplatin|cisplatin|mesh-list
92772957|NCT03919552|Carboplatin|carboplatin|mesh-list
92772958|NCT03919552|Docetaxel|docetaxel|mesh-list
92772959|NCT03919552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772960|NCT03919552|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772961|NCT03919552|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772962|NCT03919552|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772963|NCT03919552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772964|NCT03901469|Talazoparib|talazoparib|mesh-list
92772965|NCT03901469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92772966|NCT03901469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772967|NCT03901469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772968|NCT03901469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772969|NCT03897998|Naloxone|naloxone|mesh-list
92772970|NCT03897998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92772971|NCT03897998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772972|NCT03897998|Sensory System Agents|sensory system agents|mesh-ancestor
92772973|NCT03897998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92772974|NCT03853707|Paclitaxel|paclitaxel|mesh-list
92772975|NCT03853707|Carboplatin|carboplatin|mesh-list
92772976|NCT03853707|Capecitabine|capecitabine|mesh-list
92772977|NCT03853707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92772978|NCT03853707|Atezolizumab|atezolizumab|mesh-list
92772979|NCT03853707|Ipatasertib|ipatasertib|mesh-list
92772980|NCT03853707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92772981|NCT03853707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92772982|NCT03853707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92772983|NCT03853707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92772984|NCT03853707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92772985|NCT03853707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92772986|NCT03853707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92772987|NCT03853707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772988|NCT03853707|Antimetabolites|antimetabolites|mesh-ancestor
92772989|NCT03853707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92772990|NCT03853707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92772991|NCT03853707|Immunologic Factors|immunologic factors|mesh-ancestor
92772992|NCT03853707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92772993|NCT03853707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92772994|NCT03853707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92772995|NCT03836209|Cytarabine|cytarabine|mesh-list
92772996|NCT03836209|Daunorubicin|daunorubicin|mesh-list
92772997|NCT03836209|Midostaurin|midostaurin|mesh-list
92772998|NCT03836209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92772999|NCT03836209|Antimetabolites|antimetabolites|mesh-ancestor
92773000|NCT03836209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773001|NCT03836209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773002|NCT03836209|Antiviral Agents|antiviral agents|mesh-ancestor
92773003|NCT03836209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773004|NCT03836209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773005|NCT03836209|Immunologic Factors|immunologic factors|mesh-ancestor
92773006|NCT03836209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773007|NCT03836209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773008|NCT03836209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773009|NCT03836209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773010|NCT03836209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773011|NCT03836209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773012|NCT03834506|Dexamethasone|dexamethasone|mesh-list
92773013|NCT03834506|Prednisone|prednisone|mesh-list
92773014|NCT03834506|Docetaxel|docetaxel|mesh-list
92773015|NCT03834506|Pembrolizumab|pembrolizumab|mesh-list
92773016|NCT03834506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773017|NCT03834506|Antiemetics|antiemetics|mesh-ancestor
92773018|NCT03834506|Autonomic Agents|autonomic agents|mesh-ancestor
92773019|NCT03834506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773020|NCT03834506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773021|NCT03834506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92773022|NCT03834506|Glucocorticoids|glucocorticoids|mesh-ancestor
92773023|NCT03834506|Hormones|hormones|mesh-ancestor
92773024|NCT03834506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773025|NCT03834506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773026|NCT03834506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773027|NCT03834506|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773028|NCT03834506|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773029|NCT03834506|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773030|NCT03834506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773031|NCT03834506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773032|NCT03834506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92773033|NCT03824808|Lidocaine|lidocaine|mesh-list
92773034|NCT03824808|Anesthetics, Local|anesthetics, local|mesh-ancestor
92773035|NCT03824808|Anesthetics|anesthetics|mesh-ancestor
92773036|NCT03824808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773037|NCT03824808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773038|NCT03824808|Sensory System Agents|sensory system agents|mesh-ancestor
92773039|NCT03824808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773040|NCT03824808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92773041|NCT03824808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92773042|NCT03824808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92773043|NCT03824808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92773044|NCT03824808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773045|NCT03822962|Acetaminophen|acetaminophen|mesh-list
92773046|NCT03822962|Ibuprofen|ibuprofen|mesh-list
92773047|NCT03822962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418089|NCT01494636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92773048|NCT03822962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92773049|NCT03822962|Analgesics|analgesics|mesh-ancestor
92773050|NCT03822962|Sensory System Agents|sensory system agents|mesh-ancestor
92773051|NCT03822962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773052|NCT03822962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773053|NCT03822962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773054|NCT03822962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773055|NCT03822962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92773056|NCT03822962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773057|NCT03822962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773058|NCT03822962|Antipyretics|antipyretics|mesh-ancestor
92773059|NCT03785405|Valsartan|valsartan|mesh-list
92773060|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92773061|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92773062|NCT03785405|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92773063|NCT03785405|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92773064|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773065|NCT03758950|Mometasone Furoate|mometasone furoate|mesh-list
92773066|NCT03758950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773067|NCT03758950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773068|NCT03758950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92773069|NCT03749460|Nivolumab|nivolumab|mesh-list
92773070|NCT03749460|Ipilimumab|ipilimumab|mesh-list
92773071|NCT03749460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773072|NCT03749460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773073|NCT03749460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92773074|NCT03749460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773075|NCT03725007|Upadacitinib|upadacitinib|mesh-list
92773076|NCT03725007|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92773077|NCT03725007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773078|NCT03725007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773079|NCT03725007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773080|NCT03725007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773081|NCT03712098|Liraglutide|liraglutide|mesh-list
92773082|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92773083|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773084|NCT03712098|Incretins|incretins|mesh-ancestor
92773085|NCT03712098|Hormones|hormones|mesh-ancestor
92773086|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773087|NCT03711279|Apatinib|apatinib|mesh-list
92773088|NCT03711279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773089|NCT03711279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773090|NCT03711279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773091|NCT03711279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773092|NCT03703297|Durvalumab|durvalumab|mesh-list
92773093|NCT03703297|Tremelimumab|tremelimumab|mesh-list
92773094|NCT03703297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773095|NCT03703297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773096|NCT03641456|Dexamethasone|dexamethasone|mesh-list
92773097|NCT03641456|Dexamethasone acetate|dexamethasone acetate|mesh-list
92773098|NCT03641456|Lenalidomide|lenalidomide|mesh-list
92773099|NCT03641456|Bortezomib|bortezomib|mesh-list
92773100|NCT03641456|BB 1101|bb 1101|mesh-list
92773101|NCT03641456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773102|NCT03641456|Antiemetics|antiemetics|mesh-ancestor
92773103|NCT03641456|Autonomic Agents|autonomic agents|mesh-ancestor
92773104|NCT03641456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773105|NCT03641456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773106|NCT03641456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92773107|NCT03641456|Glucocorticoids|glucocorticoids|mesh-ancestor
92773108|NCT03641456|Hormones|hormones|mesh-ancestor
92773109|NCT03641456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773110|NCT03641456|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773111|NCT03641456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773112|NCT03641456|Protease Inhibitors|protease inhibitors|mesh-ancestor
92773113|NCT03641456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773114|NCT03641456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773115|NCT03641456|Immunologic Factors|immunologic factors|mesh-ancestor
92773116|NCT03641456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92773117|NCT03641456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92773118|NCT03641456|Growth Substances|growth substances|mesh-ancestor
92773119|NCT03641456|Growth Inhibitors|growth inhibitors|mesh-ancestor
92773120|NCT03582176|Ketotifen|ketotifen|mesh-list
92773121|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
92773122|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773123|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92773124|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
92773125|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
92773126|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773127|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773128|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773129|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92773130|NCT03512197|Midostaurin|midostaurin|mesh-list
92773131|NCT03512197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773132|NCT03512197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773133|NCT03512197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773134|NCT03512197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773135|NCT03493152|Everolimus|everolimus|mesh-list
92773136|NCT03493152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92773137|NCT03493152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773138|NCT03493152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773139|NCT03493152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773140|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773141|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
92773142|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773143|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773144|NCT03492671|Paclitaxel|paclitaxel|mesh-list
92773145|NCT03492671|Gemcitabine|gemcitabine|mesh-list
92773146|NCT03492671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773147|NCT03492671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773148|NCT03492671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773149|NCT03492671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773150|NCT03492671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773151|NCT03492671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773152|NCT03492671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773153|NCT03492671|Antimetabolites|antimetabolites|mesh-ancestor
92773154|NCT03486301|Pembrolizumab|pembrolizumab|mesh-list
92773155|NCT03486301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773156|NCT03486301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773157|NCT03486301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92773158|NCT03486301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773159|NCT03391479|Avelumab|avelumab|mesh-list
92773160|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773161|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773162|NCT04218851|Posaconazole|posaconazole|mesh-list
92773163|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
92773164|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773165|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92773166|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92773167|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92773168|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92773169|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92773170|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773171|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773172|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92773173|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773174|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773175|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773176|NCT03355300|Cannabidiol|cannabidiol|mesh-list
92773177|NCT03355300|Anticonvulsants|anticonvulsants|mesh-ancestor
92773178|NCT03255434|Oxaliplatin|oxaliplatin|mesh-list
92773179|NCT03255434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773180|NCT03199040|Durvalumab|durvalumab|mesh-list
92773181|NCT03199040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773182|NCT03199040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773183|NCT03190954|Raclopride|raclopride|mesh-list
92773184|NCT03190954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92773185|NCT03190954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92773186|NCT03190954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773187|NCT03190954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773188|NCT03190954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92773189|NCT03190954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92773190|NCT03190954|Dopamine Agents|dopamine agents|mesh-ancestor
92773191|NCT03190954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773192|NCT03190954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773193|NCT03173924|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92773194|NCT03173924|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92773195|NCT03173924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773196|NCT03121586|Pimavanserin|pimavanserin|mesh-list
92773197|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92773198|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92773199|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92773200|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92773201|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773202|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773203|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92773204|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92773205|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92773207|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773208|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773209|NCT03087903|Grape Seed Extract|grape seed extract|mesh-list
92773210|NCT03087903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773211|NCT03087903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773212|NCT03087903|Antioxidants|antioxidants|mesh-ancestor
92773213|NCT03087903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773214|NCT03087903|Protective Agents|protective agents|mesh-ancestor
92773215|NCT03087903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773216|NCT03074045|Drospirenone|drospirenone|mesh-list
92773217|NCT03074045|Levonorgestrel|levonorgestrel|mesh-list
92773218|NCT03074045|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92773219|NCT03074045|Estradiol|estradiol|mesh-list
92773220|NCT03074045|Estrogens|estrogens|mesh-ancestor
92773221|NCT03074045|Hormones|hormones|mesh-ancestor
92773222|NCT03074045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773223|NCT03074045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773224|NCT03074045|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92773225|NCT03074045|Contraceptive Agents|contraceptive agents|mesh-ancestor
92773226|NCT03074045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773227|NCT03074045|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92773228|NCT03074045|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92773229|NCT03074045|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92773230|NCT03074045|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92773231|NCT03074045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92773232|NCT03074045|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773233|NCT03074045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92773234|NCT03074045|Diuretics|diuretics|mesh-ancestor
92773235|NCT03074045|Natriuretic Agents|natriuretic agents|mesh-ancestor
92773236|NCT02948543|Mitomycins|mitomycins|mesh-list
92773237|NCT02948543|Mitomycin|mitomycin|mesh-list
92773238|NCT02948543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773239|NCT02948543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773240|NCT02948543|Alkylating Agents|alkylating agents|mesh-ancestor
92773241|NCT02948543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773242|NCT02948543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92773243|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773244|NCT02901184|Spironolactone|spironolactone|mesh-list
92773245|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92773246|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773247|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773248|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773249|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92773250|NCT02901184|Diuretics|diuretics|mesh-ancestor
92773251|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
92773252|NCT02901041|Zonisamide|zonisamide|mesh-list
92773253|NCT02901041|Anticonvulsants|anticonvulsants|mesh-ancestor
92773254|NCT02901041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92773255|NCT02901041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92773256|NCT02901041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773257|NCT02901041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92773258|NCT02901041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773259|NCT02840227|Anesthetics|anesthetics|mesh-list
92773260|NCT02840227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773261|NCT02840227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773262|NCT02830594|Pembrolizumab|pembrolizumab|mesh-list
92773263|NCT02830594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773264|NCT02830594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773265|NCT02830594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92773266|NCT02830594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773267|NCT02705508|Gemcitabine|gemcitabine|mesh-list
92773268|NCT02705508|Etoposide|etoposide|mesh-list
92773269|NCT02705508|Etoposide phosphate|etoposide phosphate|mesh-list
92773270|NCT02705508|Pegaspargase|pegaspargase|mesh-list
92773271|NCT02705508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773272|NCT02705508|Antimetabolites|antimetabolites|mesh-ancestor
92773273|NCT02705508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773274|NCT02705508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773275|NCT02705508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773276|NCT02705508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92337693|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
92773277|NCT02705508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773278|NCT02705508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773279|NCT02700841|Melphalan|melphalan|mesh-list
92773280|NCT02700841|Mechlorethamine|mechlorethamine|mesh-list
92773281|NCT02700841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773282|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
92773283|NCT02700841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773284|NCT02700841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773285|NCT02700841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773286|NCT02700841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773287|NCT02700841|Immunologic Factors|immunologic factors|mesh-ancestor
92773288|NCT02700841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773289|NCT02672917|Paclitaxel|paclitaxel|mesh-list
92773290|NCT02672917|Gemcitabine|gemcitabine|mesh-list
92773291|NCT02672917|Folfirinox|folfirinox|mesh-list
92773292|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773293|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773294|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773295|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773296|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773297|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773298|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773299|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
92773300|NCT02636322|Prednisone|prednisone|mesh-list
92773301|NCT02636322|Cortisone|cortisone|mesh-list
92773302|NCT02636322|Cyclophosphamide|cyclophosphamide|mesh-list
92773303|NCT02636322|Rituximab|rituximab|mesh-list
92773304|NCT02636322|Doxorubicin|doxorubicin|mesh-list
92773305|NCT02636322|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92773306|NCT02636322|Etoposide|etoposide|mesh-list
92773307|NCT02636322|Vincristine|vincristine|mesh-list
92773308|NCT02636322|Lenalidomide|lenalidomide|mesh-list
92773309|NCT02636322|Etoposide phosphate|etoposide phosphate|mesh-list
92773310|NCT02636322|Podophyllotoxin|podophyllotoxin|mesh-list
92773311|NCT02636322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92773312|NCT02636322|Antibodies|antibodies|mesh-list
92773313|NCT02636322|Immunoglobulins|immunoglobulins|mesh-list
92773314|NCT02636322|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92773315|NCT02636322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773316|NCT02636322|Immunologic Factors|immunologic factors|mesh-ancestor
92773317|NCT02636322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773318|NCT02636322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773319|NCT02636322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773320|NCT02636322|Alkylating Agents|alkylating agents|mesh-ancestor
92773321|NCT02636322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773322|NCT02636322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773323|NCT02636322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773324|NCT02636322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773325|NCT02636322|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773326|NCT02636322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773327|NCT02636322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773328|NCT02636322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773329|NCT02636322|Glucocorticoids|glucocorticoids|mesh-ancestor
92773330|NCT02636322|Hormones|hormones|mesh-ancestor
92773331|NCT02636322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773332|NCT02636322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773333|NCT02636322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773334|NCT02636322|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773335|NCT02636322|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773336|NCT02636322|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773337|NCT02636322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92773338|NCT02636322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92773339|NCT02636322|Growth Substances|growth substances|mesh-ancestor
92773340|NCT02636322|Growth Inhibitors|growth inhibitors|mesh-ancestor
92773341|NCT02636322|Keratolytic Agents|keratolytic agents|mesh-ancestor
92773342|NCT02636322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773343|NCT02547987|Carboplatin|carboplatin|mesh-list
92773344|NCT02547987|Docetaxel|docetaxel|mesh-list
92773345|NCT02547987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773346|NCT02547987|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773347|NCT02547987|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773348|NCT02547987|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773349|NCT02547987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773351|NCT02530489|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92773352|NCT02530489|Atezolizumab|atezolizumab|mesh-list
92773353|NCT02530489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92773354|NCT02530489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773355|NCT02530489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773356|NCT02530489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773357|NCT02530489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773358|NCT02530489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773359|NCT02530489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773360|NCT02530489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92773361|NCT02530489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773362|NCT02530489|Immunologic Factors|immunologic factors|mesh-ancestor
92773363|NCT02530489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773364|NCT02523040|Lenalidomide|lenalidomide|mesh-list
92773365|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
92773366|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773367|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92773368|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92773369|NCT02523040|Growth Substances|growth substances|mesh-ancestor
92773370|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
92773371|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773372|NCT02396043|Cytarabine|cytarabine|mesh-list
92773373|NCT02396043|Dexamethasone|dexamethasone|mesh-list
92773374|NCT02396043|Prednisone|prednisone|mesh-list
92773375|NCT02396043|Cyclophosphamide|cyclophosphamide|mesh-list
92773376|NCT02396043|Methotrexate|methotrexate|mesh-list
92773377|NCT02396043|Vincristine|vincristine|mesh-list
92773378|NCT02396043|Mercaptopurine|mercaptopurine|mesh-list
92773379|NCT02396043|Pegaspargase|pegaspargase|mesh-list
92773380|NCT02396043|Asparaginase|asparaginase|mesh-list
92773381|NCT02396043|Pirarubicin|pirarubicin|mesh-list
92773382|NCT02396043|Doxorubicin|doxorubicin|mesh-list
92773383|NCT02396043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773384|NCT02396043|Immunologic Factors|immunologic factors|mesh-ancestor
92773385|NCT02396043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773386|NCT02396043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773387|NCT02396043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773388|NCT02396043|Alkylating Agents|alkylating agents|mesh-ancestor
92773389|NCT02396043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773390|NCT02396043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773391|NCT02396043|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773392|NCT02396043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773393|NCT02396043|Antiemetics|antiemetics|mesh-ancestor
92773394|NCT02396043|Autonomic Agents|autonomic agents|mesh-ancestor
92773395|NCT02396043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773396|NCT02396043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92773397|NCT02396043|Glucocorticoids|glucocorticoids|mesh-ancestor
92773398|NCT02396043|Hormones|hormones|mesh-ancestor
92773399|NCT02396043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773400|NCT02396043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773401|NCT02396043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773402|NCT02396043|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92773403|NCT02396043|Abortifacient Agents|abortifacient agents|mesh-ancestor
92773404|NCT02396043|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773405|NCT02396043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773406|NCT02396043|Antimetabolites|antimetabolites|mesh-ancestor
92773407|NCT02396043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773408|NCT02396043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92773409|NCT02396043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92773410|NCT02396043|Antiviral Agents|antiviral agents|mesh-ancestor
92773411|NCT02396043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773412|NCT02396043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773413|NCT02396043|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773414|NCT02396043|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773415|NCT02396043|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773416|NCT02396043|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773417|NCT02396043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773418|NCT02396043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773419|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92773420|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
92773421|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773422|NCT02181413|Ixazomib|ixazomib|mesh-list
92418472|NCT01496911|Hydroxyzine|hydroxyzine|mesh-list
92773423|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773424|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773425|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
92773426|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773427|NCT02151981|Osimertinib|osimertinib|mesh-list
92773428|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773429|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773430|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773431|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773432|NCT02097134|Melphalan|melphalan|mesh-list
92773433|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
92773434|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92773435|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773436|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
92773437|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773438|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773439|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773440|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773441|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
92773442|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773443|NCT01525966|Paclitaxel|paclitaxel|mesh-list
92773444|NCT01525966|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92773445|NCT01525966|Carboplatin|carboplatin|mesh-list
92773446|NCT01525966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773447|NCT01525966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773448|NCT01525966|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773449|NCT01525966|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773450|NCT01525966|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773451|NCT01525966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773452|NCT01273610|Trastuzumab|trastuzumab|mesh-list
92773453|NCT01273610|Lapatinib|lapatinib|mesh-list
92773454|NCT01273610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773455|NCT01273610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773456|NCT01273610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773457|NCT01273610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773458|NCT01273610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773459|NCT01231906|Cyclophosphamide|cyclophosphamide|mesh-list
92773460|NCT01231906|Ifosfamide|ifosfamide|mesh-list
92773461|NCT01231906|Isophosphamide mustard|isophosphamide mustard|mesh-list
92773462|NCT01231906|Doxorubicin|doxorubicin|mesh-list
92773463|NCT01231906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92773464|NCT01231906|Etoposide|etoposide|mesh-list
92773465|NCT01231906|Vincristine|vincristine|mesh-list
92773466|NCT01231906|Etoposide phosphate|etoposide phosphate|mesh-list
92773467|NCT01231906|Topotecan|topotecan|mesh-list
92773468|NCT01231906|Podophyllotoxin|podophyllotoxin|mesh-list
92773469|NCT01231906|Dexrazoxane|dexrazoxane|mesh-list
92773470|NCT01231906|Razoxane|razoxane|mesh-list
92773471|NCT01231906|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
92773472|NCT01231906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773473|NCT01231906|Immunologic Factors|immunologic factors|mesh-ancestor
92773474|NCT01231906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773475|NCT01231906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773476|NCT01231906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773477|NCT01231906|Alkylating Agents|alkylating agents|mesh-ancestor
92773478|NCT01231906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773479|NCT01231906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773480|NCT01231906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773481|NCT01231906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773482|NCT01231906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773483|NCT01231906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773484|NCT01231906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773485|NCT01231906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773486|NCT01231906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773487|NCT01231906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773488|NCT01231906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773489|NCT01231906|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92773490|NCT01231906|Keratolytic Agents|keratolytic agents|mesh-ancestor
92773491|NCT01231906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773492|NCT01231906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92773493|NCT01231906|Protective Agents|protective agents|mesh-ancestor
92773494|NCT00999804|Trastuzumab|trastuzumab|mesh-list
92773495|NCT00999804|Letrozole|letrozole|mesh-list
92773496|NCT00999804|Lapatinib|lapatinib|mesh-list
92773497|NCT00999804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773498|NCT00999804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418540|NCT01497145|Darbepoetin alfa|darbepoetin alfa|mesh-list
92773499|NCT00999804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92773500|NCT00999804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92773501|NCT00999804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773502|NCT00999804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773503|NCT00999804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92773504|NCT00999804|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773505|NCT00999804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773506|NCT00999804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773507|NCT00999804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773508|NCT00544830|Leuprolide|leuprolide|mesh-list
92773509|NCT00544830|Goserelin|goserelin|mesh-list
92773510|NCT00544830|Bicalutamide|bicalutamide|mesh-list
92773511|NCT00544830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92773512|NCT00544830|Fertility Agents|fertility agents|mesh-ancestor
92773513|NCT00544830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773514|NCT00544830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773515|NCT00544830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773516|NCT00544830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773517|NCT00544830|Androgen Antagonists|androgen antagonists|mesh-ancestor
92773518|NCT00544830|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773519|NCT00544830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773520|NCT00130221|Chlorhexidine|chlorhexidine|mesh-list
92773521|NCT00130221|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92773522|NCT00130221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92773523|NCT00130221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773524|NCT00130221|Disinfectants|disinfectants|mesh-ancestor
92773525|NCT00130221|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773527|NCT00077129|Carboplatin|carboplatin|mesh-list
92773528|NCT00077129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773529|NCT00077129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773530|NCT00077129|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773531|NCT00077129|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773532|NCT00077129|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773533|NCT00077129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773534|NCT00052884|Melphalan|melphalan|mesh-list
92773535|NCT00052884|Amifostine|amifostine|mesh-list
92773536|NCT00052884|Immunologic Factors|immunologic factors|mesh-ancestor
92773537|NCT00052884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773538|NCT00052884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773539|NCT00052884|Alkylating Agents|alkylating agents|mesh-ancestor
92773540|NCT00052884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773541|NCT00052884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773542|NCT00052884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773543|NCT00052884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773544|NCT00052884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92773545|NCT00052884|Protective Agents|protective agents|mesh-ancestor
92773546|NCT00040807|Docetaxel|docetaxel|mesh-list
92773547|NCT00040807|Irinotecan|irinotecan|mesh-list
92773548|NCT00040807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773549|NCT00040807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773550|NCT00040807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773551|NCT00040807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773552|NCT00040807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773553|NCT00040807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92773554|NCT00040807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773555|NCT00040807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773556|NCT00028678|Dalteparin|dalteparin|mesh-list
92773557|NCT00028678|Tinzaparin|tinzaparin|mesh-list
92773558|NCT00028678|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92773559|NCT00028678|Anticoagulants|anticoagulants|mesh-ancestor
92773560|NCT00028678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92773561|NCT00028678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92773562|NCT00028678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773563|NCT00004223|Gemcitabine|gemcitabine|mesh-list
92773564|NCT00004223|Docetaxel|docetaxel|mesh-list
92773565|NCT00004223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773566|NCT00004223|Antimetabolites|antimetabolites|mesh-ancestor
92773567|NCT00004223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773568|NCT00004223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773569|NCT00004223|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773570|NCT00004223|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773571|NCT00004223|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773572|NCT00003764|Cyclophosphamide|cyclophosphamide|mesh-list
92773573|NCT00003764|Fludarabine|fludarabine|mesh-list
92773574|NCT00003764|Fludarabine phosphate|fludarabine phosphate|mesh-list
92773575|NCT00003764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773576|NCT00003764|Immunologic Factors|immunologic factors|mesh-ancestor
92773577|NCT00003764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773578|NCT00003764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773579|NCT00003764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773580|NCT00003764|Alkylating Agents|alkylating agents|mesh-ancestor
92773581|NCT00003764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773582|NCT00003764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773583|NCT00003764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773584|NCT00003764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773585|NCT00003764|Antimetabolites|antimetabolites|mesh-ancestor
92773586|NCT00003601|Tretinoin|tretinoin|mesh-list
92773587|NCT00003601|Fenretinide|fenretinide|mesh-list
92773588|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773589|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
92773590|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773591|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92773592|NCT00003601|Protective Agents|protective agents|mesh-ancestor
92773593|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773594|NCT00003266|Methylphenidate|methylphenidate|mesh-list
92773595|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92773596|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773597|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92773598|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92773599|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92773600|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773601|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
92773602|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773603|NCT00003236|ISIS 5132|isis 5132|mesh-list
92773604|NCT00003236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773605|NCT00003236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773606|NCT00003236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773607|NCT00003057|Octreotide|octreotide|mesh-list
92773608|NCT00003057|Loperamide|loperamide|mesh-list
92773609|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
92773610|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92773611|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773612|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773613|NCT00002922|Paclitaxel|paclitaxel|mesh-list
92773614|NCT00002922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773615|NCT00002922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773616|NCT00002922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773617|NCT00002922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773618|NCT00002922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773619|NCT00002922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773620|NCT00002514|Leucovorin|leucovorin|mesh-list
92773621|NCT00002514|Cytarabine|cytarabine|mesh-list
92773622|NCT00002514|Dexamethasone|dexamethasone|mesh-list
92773623|NCT00002514|Prednisone|prednisone|mesh-list
92773624|NCT00002514|Cyclophosphamide|cyclophosphamide|mesh-list
92773625|NCT00002514|Methotrexate|methotrexate|mesh-list
92773626|NCT00002514|Etoposide|etoposide|mesh-list
92773627|NCT00002514|Vincristine|vincristine|mesh-list
92773628|NCT00002514|Imatinib Mesylate|imatinib mesylate|mesh-list
92773629|NCT00002514|Daunorubicin|daunorubicin|mesh-list
92773630|NCT00002514|Asparaginase|asparaginase|mesh-list
92773631|NCT00002514|Mercaptopurine|mercaptopurine|mesh-list
92773632|NCT00002514|Thioguanine|thioguanine|mesh-list
92773633|NCT00002514|Sargramostim|sargramostim|mesh-list
92773634|NCT00002514|Levoleucovorin|levoleucovorin|mesh-list
92773635|NCT00002514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773636|NCT00002514|Immunologic Factors|immunologic factors|mesh-ancestor
92773637|NCT00002514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773638|NCT00002514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773639|NCT00002514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773640|NCT00002514|Alkylating Agents|alkylating agents|mesh-ancestor
92773641|NCT00002514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773642|NCT00002514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773643|NCT00002514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92773644|NCT00002514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773645|NCT00002514|Antiemetics|antiemetics|mesh-ancestor
92773646|NCT00002514|Autonomic Agents|autonomic agents|mesh-ancestor
92773647|NCT00002514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418691|NCT01498016|Busulfan|busulfan|mesh-list
92773648|NCT00002514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92773649|NCT00002514|Glucocorticoids|glucocorticoids|mesh-ancestor
92773650|NCT00002514|Hormones|hormones|mesh-ancestor
92773651|NCT00002514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773652|NCT00002514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773653|NCT00002514|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92773654|NCT00002514|Abortifacient Agents|abortifacient agents|mesh-ancestor
92773655|NCT00002514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773656|NCT00002514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773658|NCT00002514|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773659|NCT00002514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773660|NCT00002514|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92773661|NCT00002514|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92773662|NCT00002514|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773663|NCT00002514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773664|NCT00002514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773665|NCT00002514|Antiviral Agents|antiviral agents|mesh-ancestor
92773666|NCT00002514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773667|NCT00002514|Antidotes|antidotes|mesh-ancestor
92773668|NCT00002514|Protective Agents|protective agents|mesh-ancestor
92773669|NCT00002514|Vitamin B Complex|vitamin b complex|mesh-ancestor
92773670|NCT00002514|Vitamins|vitamins|mesh-ancestor
92773671|NCT00002514|Micronutrients|micronutrients|mesh-ancestor
92773672|NCT00002514|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773673|NCT00002514|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773674|NCT00002514|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773675|NCT00002514|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773676|NCT00002514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773677|NCT00607282|Udenafil|udenafil|mesh-list
92337753|NCT01938833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773678|NCT00607282|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92773679|NCT00607282|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92773680|NCT00607282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773681|NCT00607282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773682|NCT00927472|Permethrin|permethrin|mesh-list
92773683|NCT00927472|Malathion|malathion|mesh-list
92773684|NCT00927472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773685|NCT00927472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773686|NCT00927472|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92773687|NCT00927472|Cholinergic Agents|cholinergic agents|mesh-ancestor
92773688|NCT00927472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773689|NCT00927472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773690|NCT00642655|Rituximab|rituximab|mesh-list
92773691|NCT00642655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773692|NCT00642655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773693|NCT00642655|Immunologic Factors|immunologic factors|mesh-ancestor
92773694|NCT00642655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773695|NCT00642655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773696|NCT00642733|Gemcitabine|gemcitabine|mesh-list
92773697|NCT00642733|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92773698|NCT00642733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773699|NCT00642733|Antimetabolites|antimetabolites|mesh-ancestor
92773700|NCT00642733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773701|NCT00642733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773702|NCT00642733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773703|NCT00642733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773704|NCT00927394|Valsartan|valsartan|mesh-list
92773705|NCT00927394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92773706|NCT00927394|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92773707|NCT00927394|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92773708|NCT00927394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773709|NCT00643825|Temozolomide|temozolomide|mesh-list
92773710|NCT00643825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92773711|NCT00643825|Alkylating Agents|alkylating agents|mesh-ancestor
92773712|NCT00643825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773713|NCT00643825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773714|NCT04178863|Timolol|timolol|mesh-list
92773715|NCT04178863|Latanoprost|latanoprost|mesh-list
92773716|NCT04178863|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92773717|NCT04178863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92773718|NCT04178863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92773719|NCT04178863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773720|NCT04178863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773721|NCT04178863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773722|NCT04178863|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92773723|NCT04178863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92773724|NCT04178863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92418765|NCT01498809|Midodrine|midodrine|mesh-list
92773725|NCT04178863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92773726|NCT04264858|Immunoglobulins|immunoglobulins|mesh-list
92773727|NCT04264858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92773728|NCT04264858|Antibodies|antibodies|mesh-list
92773729|NCT04264858|gamma-Globulins|gamma-globulins|mesh-list
92773730|NCT04264858|Immunologic Factors|immunologic factors|mesh-ancestor
92773731|NCT04264858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773732|NCT00976911|Paclitaxel|paclitaxel|mesh-list
92773733|NCT00976911|Bevacizumab|bevacizumab|mesh-list
92773734|NCT00976911|Doxorubicin|doxorubicin|mesh-list
92773735|NCT00976911|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92773736|NCT00976911|Topotecan|topotecan|mesh-list
92773737|NCT00976911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773738|NCT00976911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773739|NCT00976911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773740|NCT00976911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773741|NCT00976911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92494501|NCT01975727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773742|NCT00976911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773743|NCT00976911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773744|NCT00976911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92773745|NCT00976911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92773746|NCT00976911|Growth Substances|growth substances|mesh-ancestor
92773747|NCT00976911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773748|NCT00976911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92773749|NCT00976911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92773750|NCT00976911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773751|NCT00976911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773752|NCT00976911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773753|NCT00976911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92773754|NCT05336968|Triamcinolone|triamcinolone|mesh-list
92773755|NCT05336968|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92773756|NCT05336968|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92773757|NCT05336968|Ketorolac|ketorolac|mesh-list
92773758|NCT05336968|Ropivacaine|ropivacaine|mesh-list
92773759|NCT05336968|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92773760|NCT05336968|Anesthetics, Local|anesthetics, local|mesh-ancestor
92773761|NCT05336968|Anesthetics|anesthetics|mesh-ancestor
92773762|NCT05336968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773763|NCT05336968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773764|NCT05336968|Sensory System Agents|sensory system agents|mesh-ancestor
92773765|NCT05336968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773766|NCT05336968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92773767|NCT05336968|Glucocorticoids|glucocorticoids|mesh-ancestor
92773768|NCT05336968|Hormones|hormones|mesh-ancestor
92773769|NCT05336968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773770|NCT05336968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773771|NCT05336968|Immunologic Factors|immunologic factors|mesh-ancestor
92773772|NCT05336968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773773|NCT05336968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773774|NCT05336968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92773775|NCT05336968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92773776|NCT05336968|Analgesics|analgesics|mesh-ancestor
92773777|NCT05336968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773778|NCT05336968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92773779|NCT02674555|Naquotinib|naquotinib|mesh-list
92773780|NCT02674555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773781|NCT02674555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773782|NCT02674555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773783|NCT02674555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773784|NCT00934648|Rituximab|rituximab|mesh-list
92773785|NCT00934648|Methotrexate|methotrexate|mesh-list
92773786|NCT00934648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773787|NCT00934648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773788|NCT00934648|Immunologic Factors|immunologic factors|mesh-ancestor
92773789|NCT00934648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773790|NCT00934648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92773791|NCT00934648|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92773792|NCT00934648|Abortifacient Agents|abortifacient agents|mesh-ancestor
92773793|NCT00934648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773794|NCT00934648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92773795|NCT00934648|Antimetabolites|antimetabolites|mesh-ancestor
92773796|NCT00934648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773797|NCT00934648|Dermatologic Agents|dermatologic agents|mesh-ancestor
92773798|NCT00934648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773799|NCT00934648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92418845|NCT01499108|Hormones|hormones|mesh-ancestor
92773801|NCT00934648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92773802|NCT01175213|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92773803|NCT01175213|gamma-Globulins|gamma-globulins|mesh-list
92773804|NCT01175213|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92773805|NCT01175213|Immunologic Factors|immunologic factors|mesh-ancestor
92773806|NCT01175213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773807|NCT00644449|Azithromycin|azithromycin|mesh-list
92773808|NCT00644449|Levofloxacin|levofloxacin|mesh-list
92773809|NCT00644449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92773810|NCT00644449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773811|NCT00644449|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92773812|NCT00644449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92773813|NCT00644449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92773814|NCT00644449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773815|NCT00644449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773816|NCT00644449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773817|NCT00644449|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92773818|NCT00644449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92773819|NCT04287777|Mupirocin|mupirocin|mesh-list
92773820|NCT04287777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92773821|NCT04287777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773822|NCT04287777|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92773823|NCT04287777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773824|NCT04287777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773825|NCT04180657|Protein C|protein c|mesh-list
92773826|NCT04180657|Anticoagulants|anticoagulants|mesh-ancestor
92773827|NCT04180657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92773828|NCT04180657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92773829|NCT04180657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773830|NCT00927082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92773831|NCT00927082|Antiviral Agents|antiviral agents|mesh-ancestor
92773832|NCT00927082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773833|NCT02674243|Povidone-Iodine|povidone-iodine|mesh-list
92773834|NCT02674243|Povidone|povidone|mesh-list
92773835|NCT02674243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92773836|NCT02674243|Plasma Substitutes|plasma substitutes|mesh-ancestor
92773837|NCT02674243|Blood Substitutes|blood substitutes|mesh-ancestor
92773838|NCT02674243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92773839|NCT02674243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773840|NCT04256200|Dienogest|dienogest|mesh-list
92773841|NCT04256200|Contraceptive Agents|contraceptive agents|mesh-list
92773842|NCT04256200|Contraceptives, Oral|contraceptives, oral|mesh-list
92773843|NCT04256200|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92773844|NCT04256200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773845|NCT04256200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773846|NCT04256200|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92773847|NCT04256200|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92773848|NCT04256200|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92773849|NCT04256200|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92773850|NCT04256200|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773851|NCT04256200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773852|NCT04256200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92773853|NCT04256200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773854|NCT02676739|Adderall|adderall|mesh-list
92773855|NCT02676739|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92773856|NCT02676739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773857|NCT00976677|Paclitaxel|paclitaxel|mesh-list
92773858|NCT00976677|Bevacizumab|bevacizumab|mesh-list
92773859|NCT00976677|Carboplatin|carboplatin|mesh-list
92773860|NCT00976677|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92773861|NCT00976677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92773862|NCT00976677|Antibodies|antibodies|mesh-list
92773863|NCT00976677|Immunoglobulins|immunoglobulins|mesh-list
92773864|NCT00976677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92773865|NCT00976677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92773866|NCT00976677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773867|NCT00976677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92773868|NCT00976677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92773869|NCT00976677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92773870|NCT00976677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337779|NCT00791843|Hormones|hormones|mesh-list
92773871|NCT00976677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92773872|NCT00976677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92773873|NCT00976677|Growth Substances|growth substances|mesh-ancestor
92773874|NCT00976677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773875|NCT00976677|Growth Inhibitors|growth inhibitors|mesh-ancestor
92773876|NCT00976677|Immunologic Factors|immunologic factors|mesh-ancestor
92773877|NCT00976677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92773878|NCT00976677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773879|NCT00642967|Epoetin Alfa|epoetin alfa|mesh-list
92773880|NCT00642967|Hematinics|hematinics|mesh-ancestor
92773881|NCT02865993|Povidone-Iodine|povidone-iodine|mesh-list
92773882|NCT02865993|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92773883|NCT02865993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92773884|NCT04287543|Melatonin|melatonin|mesh-list
92773885|NCT04287543|Antioxidants|antioxidants|mesh-ancestor
92773886|NCT04287543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773887|NCT04287543|Protective Agents|protective agents|mesh-ancestor
92773888|NCT04287543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773889|NCT04287543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773890|NCT04287387|Pioglitazone|pioglitazone|mesh-list
92773891|NCT04287387|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92773892|NCT04287387|Dapagliflozin|dapagliflozin|mesh-list
92773893|NCT04287387|Metformin|metformin|mesh-list
92773894|NCT04287387|Glimepiride|glimepiride|mesh-list
92773895|NCT04287387|Acarbose|acarbose|mesh-list
92773896|NCT04287387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92773897|NCT04287387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773899|NCT04287387|Hormones|hormones|mesh-ancestor
92773900|NCT04287387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773901|NCT04287387|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92773902|NCT04287387|Protease Inhibitors|protease inhibitors|mesh-ancestor
92773903|NCT04287387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773904|NCT04287387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773905|NCT04287387|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92773906|NCT04287387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92773907|NCT04287387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92773908|NCT04287387|Immunologic Factors|immunologic factors|mesh-ancestor
92773909|NCT04287387|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92773910|NCT00644605|Sildenafil Citrate|sildenafil citrate|mesh-list
92773911|NCT00644605|Vasodilator Agents|vasodilator agents|mesh-ancestor
92773912|NCT00644605|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92773913|NCT00644605|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92773914|NCT00644605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773915|NCT00644605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773916|NCT00644605|Urological Agents|urological agents|mesh-ancestor
92773917|NCT02865681|Letrozole|letrozole|mesh-list
92773918|NCT02865681|Clomiphene|clomiphene|mesh-list
92773919|NCT02865681|Enclomiphene|enclomiphene|mesh-list
92773920|NCT02865681|Zuclomiphene|zuclomiphene|mesh-list
92773921|NCT02865681|Menotropins|menotropins|mesh-list
92773922|NCT02865681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773923|NCT02865681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773924|NCT02865681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92773925|NCT02865681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92773926|NCT02865681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92773927|NCT02865681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92773928|NCT02865681|Hormone Antagonists|hormone antagonists|mesh-ancestor
92773929|NCT02865681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92773930|NCT02865681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773931|NCT02865681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92773932|NCT02865681|Fertility Agents|fertility agents|mesh-ancestor
92773933|NCT02865681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92773934|NCT02865681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92773935|NCT02865681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92773936|NCT00644137|Pregabalin|pregabalin|mesh-list
92773937|NCT00644137|Analgesics|analgesics|mesh-ancestor
92773938|NCT00644137|Sensory System Agents|sensory system agents|mesh-ancestor
92773939|NCT00644137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773940|NCT00644137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773941|NCT00644137|Anticonvulsants|anticonvulsants|mesh-ancestor
92773942|NCT00644137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92773943|NCT00644137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92773944|NCT00644137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773945|NCT00644137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92773946|NCT00644137|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92773947|NCT00644137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92773948|NCT00644137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773949|NCT00644137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92773950|NCT00910195|Acetaminophen|acetaminophen|mesh-list
92773951|NCT00910195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92773952|NCT00910195|Analgesics|analgesics|mesh-ancestor
92773953|NCT00910195|Sensory System Agents|sensory system agents|mesh-ancestor
92773954|NCT00910195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773955|NCT00910195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773956|NCT00910195|Antipyretics|antipyretics|mesh-ancestor
92773957|NCT04176367|Nicergoline|nicergoline|mesh-list
92773958|NCT04176367|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92773959|NCT04176367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92773960|NCT04176367|Adrenergic Agents|adrenergic agents|mesh-ancestor
92773961|NCT04176367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773962|NCT04176367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773963|NCT04176367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773964|NCT04176367|Vasodilator Agents|vasodilator agents|mesh-ancestor
92773965|NCT04176367|Nootropic Agents|nootropic agents|mesh-ancestor
92773966|NCT04259476|Ketamine|ketamine|mesh-list
92773967|NCT04259476|Analgesics|analgesics|mesh-ancestor
92773968|NCT04259476|Sensory System Agents|sensory system agents|mesh-ancestor
92530059|NCT00001322|Leuprolide|leuprolide|mesh-list
92773969|NCT04259476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773970|NCT04259476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773971|NCT04259476|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92773972|NCT04259476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92773973|NCT04259476|Anesthetics, General|anesthetics, general|mesh-ancestor
92773974|NCT04259476|Anesthetics|anesthetics|mesh-ancestor
92773975|NCT04259476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773976|NCT04259476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92773977|NCT04259476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92773978|NCT04259476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773979|NCT04259476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773980|NCT05319574|Tislelizumab|tislelizumab|mesh-list
92773981|NCT05319574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92773982|NCT05319574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92773983|NCT00970281|Olanzapine|olanzapine|mesh-list
92773984|NCT00970281|Antiemetics|antiemetics|mesh-ancestor
92773985|NCT00970281|Autonomic Agents|autonomic agents|mesh-ancestor
92773986|NCT00970281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92773987|NCT00970281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92773988|NCT00970281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92773989|NCT00970281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92773990|NCT00970281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92773991|NCT00970281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92773992|NCT00970281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92773993|NCT00970281|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92773994|NCT00970281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92773995|NCT00970281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92773996|NCT00970281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92773997|NCT00970281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92773998|NCT00970281|Serotonin Agents|serotonin agents|mesh-ancestor
92773999|NCT00607438|Paclitaxel|paclitaxel|mesh-list
92774000|NCT00607438|Sorafenib|sorafenib|mesh-list
92774001|NCT00607438|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92774002|NCT00607438|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92774003|NCT00607438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774004|NCT00607438|Tubulin Modulators|tubulin modulators|mesh-ancestor
92774005|NCT00607438|Antimitotic Agents|antimitotic agents|mesh-ancestor
92774006|NCT00607438|Mitosis Modulators|mitosis modulators|mesh-ancestor
92774007|NCT00607438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774008|NCT00607438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774009|NCT00607438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774010|NCT00976209|Phenylephrine|phenylephrine|mesh-list
92774011|NCT00976209|Oxymetazoline|oxymetazoline|mesh-list
92774012|NCT00976209|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92774013|NCT00976209|Mydriatics|mydriatics|mesh-ancestor
92774014|NCT00976209|Autonomic Agents|autonomic agents|mesh-ancestor
92774015|NCT00976209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774016|NCT00976209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774017|NCT00976209|Sympathomimetics|sympathomimetics|mesh-ancestor
92774018|NCT00976209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92774019|NCT00976209|Nasal Decongestants|nasal decongestants|mesh-ancestor
92774020|NCT00976209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92774021|NCT00976209|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92774022|NCT00976209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92774023|NCT00976209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92774024|NCT00976209|Adrenergic Agents|adrenergic agents|mesh-ancestor
92774025|NCT00976209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774026|NCT00976209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774027|NCT00976209|Protective Agents|protective agents|mesh-ancestor
92774028|NCT03746301|Rivaroxaban|rivaroxaban|mesh-list
92774029|NCT03746301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92774030|NCT03746301|Antithrombins|antithrombins|mesh-ancestor
92774031|NCT03746301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92774032|NCT03746301|Protease Inhibitors|protease inhibitors|mesh-ancestor
92774033|NCT03746301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774034|NCT03746301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774035|NCT03746301|Anticoagulants|anticoagulants|mesh-ancestor
92774036|NCT00925990|Ribavirin|ribavirin|mesh-list
92774037|NCT00925990|Antimetabolites|antimetabolites|mesh-ancestor
92774038|NCT00925990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774039|NCT00925990|Antiviral Agents|antiviral agents|mesh-ancestor
92774040|NCT00925990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774041|NCT02670655|Lidocaine|lidocaine|mesh-list
92774042|NCT02670655|Prilocaine|prilocaine|mesh-list
92774043|NCT02670655|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92774044|NCT02670655|Anesthetics, Local|anesthetics, local|mesh-ancestor
92774046|NCT02670655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774047|NCT02670655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774048|NCT02670655|Sensory System Agents|sensory system agents|mesh-ancestor
92774049|NCT02670655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774050|NCT02670655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92774051|NCT02670655|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92774052|NCT02670655|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92774053|NCT02670655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92774054|NCT02670655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774055|NCT02670655|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92774056|NCT01131078|Bevacizumab|bevacizumab|mesh-list
92774057|NCT01131078|Capecitabine|capecitabine|mesh-list
92774058|NCT01131078|Irinotecan|irinotecan|mesh-list
92774059|NCT01131078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92774060|NCT01131078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774061|NCT01131078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92774062|NCT01131078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92774063|NCT01131078|Growth Substances|growth substances|mesh-ancestor
92774064|NCT01131078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774065|NCT01131078|Growth Inhibitors|growth inhibitors|mesh-ancestor
92774066|NCT01131078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774067|NCT01131078|Antimetabolites|antimetabolites|mesh-ancestor
92774068|NCT01131078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774069|NCT01131078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92774070|NCT01131078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92774071|NCT01131078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774072|NCT03709017|Ponatinib|ponatinib|mesh-list
92774073|NCT03709017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774074|NCT03709017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774075|NCT03709017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774076|NCT03709017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774077|NCT03695445|Norepinephrine|norepinephrine|mesh-list
92774078|NCT03695445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92774079|NCT03695445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92774080|NCT03695445|Adrenergic Agents|adrenergic agents|mesh-ancestor
92774081|NCT03695445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774082|NCT03695445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774083|NCT03695445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774084|NCT03695445|Sympathomimetics|sympathomimetics|mesh-ancestor
92774085|NCT03695445|Autonomic Agents|autonomic agents|mesh-ancestor
92774086|NCT03695445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774087|NCT03695445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92774088|NCT04177303|Metformin|metformin|mesh-list
92774089|NCT04177303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92774090|NCT04177303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774091|NCT01167426|Glatiramer Acetate|glatiramer acetate|mesh-list
92774092|NCT01167426|(T,G)-A-L|(t,g)-a-l|mesh-list
92774093|NCT01167426|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92774094|NCT01167426|Immunologic Factors|immunologic factors|mesh-ancestor
92774095|NCT01167426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774096|NCT01167426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774097|NCT01167426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774098|NCT02862873|Ondansetron|ondansetron|mesh-list
92774099|NCT02862873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774100|NCT02862873|Antiemetics|antiemetics|mesh-ancestor
92774101|NCT02862873|Autonomic Agents|autonomic agents|mesh-ancestor
92774102|NCT02862873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774103|NCT02862873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774104|NCT02862873|Antipruritics|antipruritics|mesh-ancestor
92774105|NCT02862873|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774106|NCT02862873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92774107|NCT02862873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92774108|NCT02862873|Serotonin Agents|serotonin agents|mesh-ancestor
92774109|NCT02862873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774110|NCT02862873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774111|NCT03814005|Paclitaxel|paclitaxel|mesh-list
92774112|NCT03814005|Docetaxel|docetaxel|mesh-list
92774113|NCT03814005|Carboplatin|carboplatin|mesh-list
92774114|NCT03814005|Azacitidine|azacitidine|mesh-list
92774115|NCT03814005|Pevonedistat|pevonedistat|mesh-list
92774116|NCT03814005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92774117|NCT03814005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774118|NCT03814005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92774119|NCT03814005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92774120|NCT03814005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92774121|NCT03814005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774122|NCT03814005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774123|NCT03814005|Antimetabolites|antimetabolites|mesh-ancestor
92774124|NCT03814005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774125|NCT03683433|Azacitidine|azacitidine|mesh-list
92774126|NCT03683433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774127|NCT03683433|Antimetabolites|antimetabolites|mesh-ancestor
92774128|NCT03683433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774129|NCT03683433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774130|NCT03683433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774131|NCT03449901|Gemcitabine|gemcitabine|mesh-list
92774132|NCT03449901|Docetaxel|docetaxel|mesh-list
92774133|NCT03449901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774134|NCT03449901|Antimetabolites|antimetabolites|mesh-ancestor
92774135|NCT03449901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774136|NCT03449901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774137|NCT03449901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92774138|NCT03449901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92774139|NCT03449901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92774140|NCT00968799|Cisplatin|cisplatin|mesh-list
92774141|NCT00968799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774142|NCT04016233|Tenofovir|tenofovir|mesh-list
92774143|NCT04016233|Antiviral Agents|antiviral agents|mesh-ancestor
92774144|NCT04016233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774145|NCT04016233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92774146|NCT04016233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774147|NCT04016233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774148|NCT04016233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774149|NCT04016233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92774150|NCT04016233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92774151|NCT04033471|Midazolam|midazolam|mesh-list
92774152|NCT04033471|Morphine|morphine|mesh-list
92774153|NCT04033471|Bupivacaine|bupivacaine|mesh-list
92774154|NCT04033471|Anesthetics, Local|anesthetics, local|mesh-ancestor
92774155|NCT04033471|Anesthetics|anesthetics|mesh-ancestor
92774156|NCT04033471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774157|NCT04033471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774158|NCT04033471|Sensory System Agents|sensory system agents|mesh-ancestor
92774159|NCT04033471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774160|NCT04033471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92774161|NCT04033471|Narcotics|narcotics|mesh-ancestor
92774162|NCT04033471|Analgesics|analgesics|mesh-ancestor
92774163|NCT04033471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92774164|NCT04033471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92774165|NCT04033471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92774166|NCT04033471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774167|NCT04033471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774168|NCT04033471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92774169|NCT04033471|Anesthetics, General|anesthetics, general|mesh-ancestor
92774170|NCT04033471|GABA Modulators|gaba modulators|mesh-ancestor
92774171|NCT04033471|GABA Agents|gaba agents|mesh-ancestor
92774172|NCT04033471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774173|NCT04033471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774174|NCT00910351|Ciprofloxacin|ciprofloxacin|mesh-list
92774175|NCT00910351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774176|NCT00910351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774177|NCT00910351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92774178|NCT00910351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92774179|NCT00910351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774180|NCT00910351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774181|NCT00910351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774182|NCT00910351|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92774183|NCT00910351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92774184|NCT04175587|Tretinoin|tretinoin|mesh-list
92774185|NCT04175587|Arsenic Trioxide|arsenic trioxide|mesh-list
92774186|NCT04175587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774187|NCT04175587|Keratolytic Agents|keratolytic agents|mesh-ancestor
92774188|NCT04175587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774189|NCT02668159|Vitamin D|vitamin d|mesh-list
92774190|NCT02668159|Ergocalciferols|ergocalciferols|mesh-list
92774191|NCT02668159|Cholecalciferol|cholecalciferol|mesh-list
92774192|NCT02668159|Vitamins|vitamins|mesh-list
92774194|NCT02668159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774195|NCT02668159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92774196|NCT02668159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92774197|NCT02670109|Cyclophosphamide|cyclophosphamide|mesh-list
92774198|NCT02670109|Busulfan|busulfan|mesh-list
92774199|NCT02670109|Carmustine|carmustine|mesh-list
92774200|NCT02670109|Carboplatin|carboplatin|mesh-list
92774201|NCT02670109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774202|NCT02670109|Immunologic Factors|immunologic factors|mesh-ancestor
92774203|NCT02670109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774204|NCT02670109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774205|NCT02670109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92774206|NCT02670109|Alkylating Agents|alkylating agents|mesh-ancestor
92774207|NCT02670109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774208|NCT02670109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774209|NCT02670109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92774210|NCT00922636|Methylphenidate|methylphenidate|mesh-list
92774211|NCT00922636|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92774212|NCT00922636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774213|NCT00922636|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92774214|NCT00922636|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92774215|NCT00922636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92774216|NCT00922636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774217|NCT00922636|Dopamine Agents|dopamine agents|mesh-ancestor
92774218|NCT00922636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774219|NCT02667925|Cisplatin|cisplatin|mesh-list
92774220|NCT02667925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774221|NCT02669719|Carboplatin|carboplatin|mesh-list
92774222|NCT02669719|Pemetrexed|pemetrexed|mesh-list
92774223|NCT02669719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774224|NCT02669719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774225|NCT02669719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774226|NCT02669719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92774227|NCT02669719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774228|NCT00644761|Adefovir|adefovir|mesh-list
92774229|NCT00644761|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92774230|NCT00644761|Antiviral Agents|antiviral agents|mesh-ancestor
92774231|NCT00644761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774232|NCT00644761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92774233|NCT00644761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774234|NCT00644761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774235|NCT00644761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774236|NCT00645073|Levofloxacin|levofloxacin|mesh-list
92774237|NCT00645073|Cefdinir|cefdinir|mesh-list
92774238|NCT00645073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92774239|NCT00645073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774240|NCT00645073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774241|NCT00645073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92774242|NCT00645073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92774243|NCT00645073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774244|NCT00645073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774245|NCT00645073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774246|NCT00645073|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92774247|NCT00645073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92774248|NCT04259008|Manganese|manganese|mesh-list
92774249|NCT04259008|Trace Elements|trace elements|mesh-ancestor
92774250|NCT04259008|Micronutrients|micronutrients|mesh-ancestor
92774251|NCT04259008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774252|NCT04258930|Calcium|calcium|mesh-list
92774253|NCT04258930|Calcium acetate|calcium acetate|mesh-list
92774254|NCT04258930|Aluminum sulfate|aluminum sulfate|mesh-list
92774255|NCT04258930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92774256|NCT04258930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774257|NCT04258930|Chelating Agents|chelating agents|mesh-ancestor
92774258|NCT04258930|Sequestering Agents|sequestering agents|mesh-ancestor
92774259|NCT04258930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774260|NCT04258930|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92774261|NCT04258930|Immunologic Factors|immunologic factors|mesh-ancestor
92774262|NCT01175135|Risperidone|risperidone|mesh-list
92774263|NCT01175135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92774264|NCT01175135|Serotonin Agents|serotonin agents|mesh-ancestor
92774265|NCT01175135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119109|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
92774266|NCT01175135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774267|NCT01175135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774268|NCT01175135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92774269|NCT01175135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774270|NCT01175135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774271|NCT01175135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774272|NCT01175135|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92774273|NCT01175135|Dopamine Agents|dopamine agents|mesh-ancestor
92774274|NCT02669641|Choline|choline|mesh-list
92774275|NCT02669641|Lipotropic Agents|lipotropic agents|mesh-ancestor
92774276|NCT02669641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92774277|NCT02669641|Antimetabolites|antimetabolites|mesh-ancestor
92774278|NCT02669641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774279|NCT02669641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774280|NCT02669641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92774281|NCT02669641|Nootropic Agents|nootropic agents|mesh-ancestor
92774282|NCT00922480|Losartan|losartan|mesh-list
92774283|NCT00922480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92774284|NCT00922480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92774285|NCT00922480|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92774286|NCT00922480|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92774287|NCT00922480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774288|NCT04963036|Anesthetics|anesthetics|mesh-list
92774289|NCT04963036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774290|NCT04963036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774291|NCT00973479|Golimumab|golimumab|mesh-list
92774292|NCT00973479|Methotrexate|methotrexate|mesh-list
92774293|NCT00973479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92774294|NCT00973479|Abortifacient Agents|abortifacient agents|mesh-ancestor
92774295|NCT00973479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92774296|NCT00973479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774297|NCT00973479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774298|NCT00973479|Antimetabolites|antimetabolites|mesh-ancestor
92774299|NCT00973479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774300|NCT00973479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774301|NCT00973479|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774302|NCT00973479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774303|NCT00973479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92774304|NCT00973479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774305|NCT00973479|Immunologic Factors|immunologic factors|mesh-ancestor
92774306|NCT00973479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774307|NCT00973479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774308|NCT00973479|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92774309|NCT00973479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774310|NCT01174043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92774311|NCT01174043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774312|NCT01174043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774313|NCT01174043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774314|NCT01174043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774315|NCT04315493|Maleic acid|maleic acid|mesh-list
92774316|NCT04315493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774317|NCT04315493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774318|NCT04173871|Snake venom protein C activator|snake venom protein c activator|mesh-list
92774319|NCT04173871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92774320|NCT04173871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92774321|NCT04173871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774322|NCT02862483|Tadalafil|tadalafil|mesh-list
92774323|NCT02862483|Tamsulosin|tamsulosin|mesh-list
92774324|NCT02862483|Vasodilator Agents|vasodilator agents|mesh-ancestor
92774325|NCT02862483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92774327|NCT02862483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774328|NCT02862483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774329|NCT02862483|Urological Agents|urological agents|mesh-ancestor
92774330|NCT02862483|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92774331|NCT02862483|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92774332|NCT02862483|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92774333|NCT02862483|Adrenergic Agents|adrenergic agents|mesh-ancestor
92774334|NCT02862483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774335|NCT02862483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774336|NCT02667535|Isosorbide|isosorbide|mesh-list
92774337|NCT02667535|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92774338|NCT02667535|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92774339|NCT02667535|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92774341|NCT02667535|Natriuretic Agents|natriuretic agents|mesh-ancestor
92774342|NCT02667535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774343|NCT02667535|Vasodilator Agents|vasodilator agents|mesh-ancestor
92774344|NCT02667535|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92774345|NCT02667535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774346|NCT04286841|Immunomodulating Agents|immunomodulating agents|mesh-list
92774347|NCT04286841|Immunologic Factors|immunologic factors|mesh-ancestor
92774348|NCT04286841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774349|NCT00645151|Atorvastatin|atorvastatin|mesh-list
92774350|NCT00645151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92774351|NCT00645151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92774352|NCT00645151|Antimetabolites|antimetabolites|mesh-ancestor
92774353|NCT00645151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774354|NCT00645151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92774355|NCT00645151|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92774356|NCT00645151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774357|NCT00645229|Ziprasidone|ziprasidone|mesh-list
92774358|NCT00645229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92774359|NCT00645229|Serotonin Agents|serotonin agents|mesh-ancestor
92774360|NCT00645229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774361|NCT00645229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774362|NCT00645229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774363|NCT00645229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92774364|NCT00645229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774365|NCT00645229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774366|NCT00645229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774367|NCT00645229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92774368|NCT00645229|Dopamine Agents|dopamine agents|mesh-ancestor
92774369|NCT01172873|Cycloserine|cycloserine|mesh-list
92774370|NCT01172873|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92774371|NCT01172873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774372|NCT01172873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92774373|NCT01172873|Antitubercular Agents|antitubercular agents|mesh-ancestor
92774374|NCT01172873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774375|NCT01172873|Antimetabolites|antimetabolites|mesh-ancestor
92774376|NCT01172873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774377|NCT02886299|Simvastatin|simvastatin|mesh-list
92774378|NCT02886299|Fenofibrate|fenofibrate|mesh-list
92774379|NCT02886299|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92774380|NCT02886299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92774381|NCT02886299|Antimetabolites|antimetabolites|mesh-ancestor
92774382|NCT02886299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774383|NCT02886299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92774384|NCT02886299|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92774385|NCT02886299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774386|NCT00925600|Denosumab|denosumab|mesh-list
92774387|NCT00925600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92774388|NCT00925600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774389|NCT00645307|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92774390|NCT00645307|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92774391|NCT00645307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774392|NCT00645307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774393|NCT00645307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774394|NCT00645307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774395|NCT00645307|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92774396|NCT00645307|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92774397|NCT00645307|Serotonin Agents|serotonin agents|mesh-ancestor
92774398|NCT00645307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774399|NCT00645307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774400|NCT00645307|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92774401|NCT00645307|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92774402|NCT00645307|Dopamine Agents|dopamine agents|mesh-ancestor
92774403|NCT02668861|Vitamin D|vitamin d|mesh-list
92774404|NCT02668861|Budesonide|budesonide|mesh-list
92774405|NCT02668861|Vitamins|vitamins|mesh-ancestor
92774406|NCT02668861|Micronutrients|micronutrients|mesh-ancestor
92774407|NCT02668861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774408|NCT02668861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92774409|NCT02668861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774410|NCT02668861|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92774411|NCT02668861|Autonomic Agents|autonomic agents|mesh-ancestor
92774412|NCT02668861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774413|NCT02668861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92774414|NCT02668861|Respiratory System Agents|respiratory system agents|mesh-ancestor
92774415|NCT02668861|Glucocorticoids|glucocorticoids|mesh-ancestor
92774416|NCT02668861|Hormones|hormones|mesh-ancestor
92774417|NCT02668861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774418|NCT00968253|Cytarabine|cytarabine|mesh-list
92774419|NCT00968253|Dexamethasone|dexamethasone|mesh-list
92774420|NCT00968253|Methylprednisolone|methylprednisolone|mesh-list
92774421|NCT00968253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92774422|NCT00968253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92774423|NCT00968253|Prednisolone|prednisolone|mesh-list
92774424|NCT00968253|Prednisolone acetate|prednisolone acetate|mesh-list
92774425|NCT00968253|Cyclophosphamide|cyclophosphamide|mesh-list
92774426|NCT00968253|Doxorubicin|doxorubicin|mesh-list
92774427|NCT00968253|Methotrexate|methotrexate|mesh-list
92774428|NCT00968253|Vincristine|vincristine|mesh-list
92774429|NCT00968253|Everolimus|everolimus|mesh-list
92774430|NCT00968253|Lenograstim|lenograstim|mesh-list
92774431|NCT00968253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92774432|NCT00968253|Prednisolone phosphate|prednisolone phosphate|mesh-list
92774433|NCT00968253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774434|NCT00968253|Immunologic Factors|immunologic factors|mesh-ancestor
92774435|NCT00968253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774436|NCT00968253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774437|NCT00968253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92774438|NCT00968253|Alkylating Agents|alkylating agents|mesh-ancestor
92774439|NCT00968253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774440|NCT00968253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774441|NCT00968253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92774442|NCT00968253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774443|NCT00968253|Antiemetics|antiemetics|mesh-ancestor
92774444|NCT00968253|Autonomic Agents|autonomic agents|mesh-ancestor
92774445|NCT00968253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774446|NCT00968253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774447|NCT00968253|Glucocorticoids|glucocorticoids|mesh-ancestor
92774448|NCT00968253|Hormones|hormones|mesh-ancestor
92774449|NCT00968253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774450|NCT00968253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92774451|NCT00968253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92774452|NCT00968253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92774453|NCT00968253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92774454|NCT00968253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774455|NCT00968253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92774456|NCT00968253|Abortifacient Agents|abortifacient agents|mesh-ancestor
92774457|NCT00968253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92774458|NCT00968253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774459|NCT00968253|Antimetabolites|antimetabolites|mesh-ancestor
92774460|NCT00968253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774461|NCT00968253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92774462|NCT00968253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774463|NCT00968253|Antiviral Agents|antiviral agents|mesh-ancestor
92774464|NCT00968253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774465|NCT00968253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92774466|NCT00968253|Tubulin Modulators|tubulin modulators|mesh-ancestor
92774467|NCT00968253|Antimitotic Agents|antimitotic agents|mesh-ancestor
92774468|NCT00968253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92774469|NCT00968253|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92774470|NCT00968253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774471|NCT00968253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92774472|NCT00968253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92774473|NCT00968253|Protective Agents|protective agents|mesh-ancestor
92774474|NCT00646009|Fluticasone|fluticasone|mesh-list
92774475|NCT00646009|Budesonide|budesonide|mesh-list
92774476|NCT00646009|Albuterol|albuterol|mesh-list
92774477|NCT00646009|Formoterol Fumarate|formoterol fumarate|mesh-list
92774478|NCT00646009|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92774479|NCT00646009|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92774480|NCT00646009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774481|NCT00646009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92774482|NCT00646009|Autonomic Agents|autonomic agents|mesh-ancestor
92774483|NCT00646009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774484|NCT00646009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774485|NCT00646009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92774486|NCT00646009|Respiratory System Agents|respiratory system agents|mesh-ancestor
92774487|NCT00646009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774488|NCT00646009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92774490|NCT00646009|Hormones|hormones|mesh-ancestor
92774491|NCT00646009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774492|NCT00646009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92774493|NCT00646009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92774494|NCT00646009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92774495|NCT00646009|Adrenergic Agents|adrenergic agents|mesh-ancestor
92774496|NCT00646009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774497|NCT00646009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774498|NCT00646009|Tocolytic Agents|tocolytic agents|mesh-ancestor
92774499|NCT00646009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92774500|NCT00646009|Sympathomimetics|sympathomimetics|mesh-ancestor
92774501|NCT00646087|Ketamine|ketamine|mesh-list
92774502|NCT00646087|Analgesics|analgesics|mesh-ancestor
92774503|NCT00646087|Sensory System Agents|sensory system agents|mesh-ancestor
92774504|NCT00646087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774505|NCT00646087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774506|NCT00646087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92774507|NCT00646087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92774508|NCT00646087|Anesthetics, General|anesthetics, general|mesh-ancestor
92774509|NCT00646087|Anesthetics|anesthetics|mesh-ancestor
92774510|NCT00646087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774511|NCT00646087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92774512|NCT00646087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92774513|NCT00646087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774514|NCT00646087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774515|NCT04255576|Vitamin D|vitamin d|mesh-list
92774516|NCT04255576|Calcium|calcium|mesh-list
92774517|NCT04255576|Vitamins|vitamins|mesh-ancestor
92774518|NCT04255576|Micronutrients|micronutrients|mesh-ancestor
92774519|NCT04255576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774520|NCT04255576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92774521|NCT04255576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92774522|NCT04255498|Etanercept|etanercept|mesh-list
92774523|NCT04255498|Mifepristone|mifepristone|mesh-list
92774524|NCT04255498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92774525|NCT04255498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92774526|NCT04255498|Analgesics|analgesics|mesh-ancestor
92774527|NCT04255498|Sensory System Agents|sensory system agents|mesh-ancestor
92774528|NCT04255498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774529|NCT04255498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774530|NCT04255498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774531|NCT04255498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774532|NCT04255498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774533|NCT04255498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774534|NCT04255498|Immunologic Factors|immunologic factors|mesh-ancestor
92774535|NCT04255498|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92774536|NCT04255498|Abortifacient Agents|abortifacient agents|mesh-ancestor
92774537|NCT04255498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92774538|NCT04255498|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92774539|NCT04255498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92774540|NCT04255498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92774541|NCT04255498|Contraceptive Agents|contraceptive agents|mesh-ancestor
92774542|NCT04255498|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92774543|NCT04255498|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92774544|NCT04255498|Hormone Antagonists|hormone antagonists|mesh-ancestor
92774545|NCT04255498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774546|NCT04255498|Luteolytic Agents|luteolytic agents|mesh-ancestor
92774547|NCT04255498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92774548|NCT04255498|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92774549|NCT02666209|Dexamethasone|dexamethasone|mesh-list
92774550|NCT02666209|Lenalidomide|lenalidomide|mesh-list
92774551|NCT02666209|Bortezomib|bortezomib|mesh-list
92774552|NCT02666209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774553|NCT02666209|Antiemetics|antiemetics|mesh-ancestor
92774554|NCT02666209|Autonomic Agents|autonomic agents|mesh-ancestor
92774555|NCT02666209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774556|NCT02666209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774557|NCT02666209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774558|NCT02666209|Glucocorticoids|glucocorticoids|mesh-ancestor
92774559|NCT02666209|Hormones|hormones|mesh-ancestor
92774560|NCT02666209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774561|NCT02666209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92774562|NCT02666209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774563|NCT02666209|Immunologic Factors|immunologic factors|mesh-ancestor
92774564|NCT02666209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92774565|NCT02666209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92774566|NCT02666209|Growth Substances|growth substances|mesh-ancestor
92774567|NCT02666209|Growth Inhibitors|growth inhibitors|mesh-ancestor
92774568|NCT00964743|Cytarabine|cytarabine|mesh-list
92774569|NCT00964743|Sorafenib|sorafenib|mesh-list
92774570|NCT00964743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774571|NCT00964743|Antimetabolites|antimetabolites|mesh-ancestor
92774572|NCT00964743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774573|NCT00964743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774574|NCT00964743|Antiviral Agents|antiviral agents|mesh-ancestor
92774575|NCT00964743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774576|NCT00964743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774577|NCT00964743|Immunologic Factors|immunologic factors|mesh-ancestor
92774578|NCT00964743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774579|NCT00964743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774580|NCT00964743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774581|NCT02862327|Dexamethasone|dexamethasone|mesh-list
92774582|NCT02862327|Dexamethasone acetate|dexamethasone acetate|mesh-list
92774583|NCT02862327|Ropivacaine|ropivacaine|mesh-list
92774584|NCT02862327|BB 1101|bb 1101|mesh-list
92774585|NCT02862327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774586|NCT02862327|Antiemetics|antiemetics|mesh-ancestor
92774587|NCT02862327|Autonomic Agents|autonomic agents|mesh-ancestor
92774588|NCT02862327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774589|NCT02862327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774590|NCT02862327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774591|NCT02862327|Glucocorticoids|glucocorticoids|mesh-ancestor
92774592|NCT02862327|Hormones|hormones|mesh-ancestor
92774593|NCT02862327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774594|NCT02862327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92774595|NCT02862327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774596|NCT02862327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92774597|NCT02862327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774598|NCT02862327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774599|NCT02862327|Anesthetics, Local|anesthetics, local|mesh-ancestor
92774600|NCT02862327|Anesthetics|anesthetics|mesh-ancestor
92774601|NCT02862327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774602|NCT02862327|Sensory System Agents|sensory system agents|mesh-ancestor
92774603|NCT04945720|Durvalumab|durvalumab|mesh-list
92774604|NCT04945720|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92774605|NCT04945720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92774606|NCT04945720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774607|NCT04945720|Immunologic Factors|immunologic factors|mesh-ancestor
92774608|NCT04945720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774609|NCT02666365|Cefazolin|cefazolin|mesh-list
92774610|NCT02666365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774611|NCT02666365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774612|NCT02666443|Dexamethasone|dexamethasone|mesh-list
92774613|NCT02666443|Dexamethasone acetate|dexamethasone acetate|mesh-list
92774614|NCT02666443|BB 1101|bb 1101|mesh-list
92774615|NCT02666443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774616|NCT02666443|Antiemetics|antiemetics|mesh-ancestor
92774617|NCT02666443|Autonomic Agents|autonomic agents|mesh-ancestor
92774618|NCT02666443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774619|NCT02666443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774620|NCT02666443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774621|NCT02666443|Glucocorticoids|glucocorticoids|mesh-ancestor
92774622|NCT02666443|Hormones|hormones|mesh-ancestor
92774623|NCT02666443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774624|NCT02666443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92774625|NCT02666443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774626|NCT02666443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92774627|NCT02666443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774628|NCT02666443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774629|NCT01130532|Tadalafil|tadalafil|mesh-list
92774630|NCT01130532|Vasodilator Agents|vasodilator agents|mesh-ancestor
92774631|NCT01130532|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92774632|NCT01130532|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92774633|NCT01130532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774634|NCT01130532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774635|NCT01130532|Urological Agents|urological agents|mesh-ancestor
92774636|NCT04258306|Resveratrol|resveratrol|mesh-list
92774637|NCT04258306|Antioxidants|antioxidants|mesh-ancestor
92774638|NCT04258306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774639|NCT04258306|Protective Agents|protective agents|mesh-ancestor
92774640|NCT04258306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774641|NCT04258306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774642|NCT04258306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92774643|NCT00646711|Valproic Acid|valproic acid|mesh-list
92774644|NCT00646711|Anticonvulsants|anticonvulsants|mesh-ancestor
92774645|NCT00646711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494502|NCT01975727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774646|NCT00646711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774647|NCT00646711|GABA Agents|gaba agents|mesh-ancestor
92774648|NCT00646711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774649|NCT00646711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774650|NCT00646711|Antimanic Agents|antimanic agents|mesh-ancestor
92774651|NCT00646711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774652|NCT00646711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774653|NCT00646711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774654|NCT00972777|Besifloxacin|besifloxacin|mesh-list
92774655|NCT00972777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774656|NCT00972777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774657|NCT00972777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92774658|NCT00972777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92774659|NCT00972777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774660|NCT00972777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774661|NCT00972777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774662|NCT04254874|Interferons|interferons|mesh-list
92774663|NCT04254874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774664|NCT04254874|Antiviral Agents|antiviral agents|mesh-ancestor
92774665|NCT04254874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774666|NCT02667223|Bococizumab|bococizumab|mesh-list
92774667|NCT02667223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92774668|NCT02667223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92774669|NCT02667223|Antimetabolites|antimetabolites|mesh-ancestor
92774670|NCT02667223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774671|NCT02667223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92774672|NCT00918736|Hyaluronic Acid|hyaluronic acid|mesh-list
92774673|NCT00918736|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92774674|NCT00918736|Immunologic Factors|immunologic factors|mesh-ancestor
92774675|NCT00918736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774676|NCT00918736|Viscosupplements|viscosupplements|mesh-ancestor
92774677|NCT00918736|Protective Agents|protective agents|mesh-ancestor
92774678|NCT02666053|Fostemsavir|fostemsavir|mesh-list
92774679|NCT02666053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92774680|NCT02666053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92774681|NCT02666053|Antiviral Agents|antiviral agents|mesh-ancestor
92774682|NCT02666053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774683|NCT02666053|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92774684|NCT02666053|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92774685|NCT02666053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774686|NCT04257838|Meropenem|meropenem|mesh-list
92774687|NCT04257838|Tazobactam|tazobactam|mesh-list
92774688|NCT04257838|Piperacillin|piperacillin|mesh-list
92774689|NCT04257838|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92774690|NCT04257838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774691|NCT04257838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774692|NCT04257838|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92774693|NCT04257838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774694|NCT04257838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774695|NCT01172639|Sulfasalazine|sulfasalazine|mesh-list
92774696|NCT01172639|Prednisone|prednisone|mesh-list
92774697|NCT01172639|Methotrexate|methotrexate|mesh-list
92774698|NCT01172639|Leflunomide|leflunomide|mesh-list
92774699|NCT01172639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774700|NCT01172639|Glucocorticoids|glucocorticoids|mesh-ancestor
92774701|NCT01172639|Hormones|hormones|mesh-ancestor
92774702|NCT01172639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774703|NCT01172639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774704|NCT01172639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92774705|NCT01172639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774706|NCT01172639|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92774707|NCT01172639|Abortifacient Agents|abortifacient agents|mesh-ancestor
92774708|NCT01172639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92774709|NCT01172639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774710|NCT01172639|Antimetabolites|antimetabolites|mesh-ancestor
92774711|NCT01172639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774712|NCT01172639|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774713|NCT01172639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774714|NCT01172639|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92774715|NCT01172639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774716|NCT01172639|Immunologic Factors|immunologic factors|mesh-ancestor
92774717|NCT01172639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774718|NCT01172639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774719|NCT01172639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774720|NCT01172639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92774721|NCT01172639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92774722|NCT01172639|Analgesics|analgesics|mesh-ancestor
92774723|NCT01172639|Sensory System Agents|sensory system agents|mesh-ancestor
92774724|NCT01172639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774725|NCT01172639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774726|NCT01225562|Ticagrelor|ticagrelor|mesh-list
92774727|NCT01225562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92774728|NCT01225562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92774729|NCT01225562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92774730|NCT01225562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92774731|NCT01225562|Purinergic Agents|purinergic agents|mesh-ancestor
92774732|NCT01225562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774733|NCT01225562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774734|NCT01225562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774735|NCT00925288|Vaccines|vaccines|mesh-list
92774736|NCT00925288|Immunologic Factors|immunologic factors|mesh-ancestor
92774737|NCT00925288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774738|NCT01143714|Petrolatum|petrolatum|mesh-list
92774739|NCT01143714|Emollients|emollients|mesh-ancestor
92774740|NCT01143714|Dermatologic Agents|dermatologic agents|mesh-ancestor
92774741|NCT04920682|Iodine|iodine|mesh-list
92774742|NCT04920682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92774743|NCT04920682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774744|NCT04920682|Trace Elements|trace elements|mesh-ancestor
92774745|NCT04920682|Micronutrients|micronutrients|mesh-ancestor
92774746|NCT04920682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774747|NCT04174339|Apatinib|apatinib|mesh-list
92774748|NCT04174339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774749|NCT04174339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92774750|NCT04174339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774751|NCT04174339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774752|NCT00972543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92774753|NCT00972543|Immunologic Factors|immunologic factors|mesh-ancestor
92774754|NCT00972543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774755|NCT00925132|Temozolomide|temozolomide|mesh-list
92774756|NCT00925132|Decitabine|decitabine|mesh-list
92774757|NCT00925132|Panobinostat|panobinostat|mesh-list
92774758|NCT00925132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92774759|NCT00925132|Alkylating Agents|alkylating agents|mesh-ancestor
92774760|NCT00925132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774761|NCT00925132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774762|NCT00925132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774763|NCT00925132|Antimetabolites|antimetabolites|mesh-ancestor
92774764|NCT00925132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774765|NCT00925132|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92774766|NCT02862015|Gemcitabine|gemcitabine|mesh-list
92774767|NCT02862015|Folfirinox|folfirinox|mesh-list
92774768|NCT02862015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774769|NCT02862015|Antimetabolites|antimetabolites|mesh-ancestor
92774770|NCT02862015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774771|NCT02862015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774772|NCT01143402|Temozolomide|temozolomide|mesh-list
92774773|NCT01143402|Dacarbazine|dacarbazine|mesh-list
92774774|NCT01143402|Imidazole|imidazole|mesh-list
92774775|NCT01143402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92774776|NCT01143402|Alkylating Agents|alkylating agents|mesh-ancestor
92774777|NCT01143402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774778|NCT01143402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774780|NCT00646945|Nitrous Oxide|nitrous oxide|mesh-list
92337933|NCT01645709|Verapamil|verapamil|mesh-list
92774781|NCT00646945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92774782|NCT00646945|Anesthetics, General|anesthetics, general|mesh-ancestor
92774783|NCT00646945|Anesthetics|anesthetics|mesh-ancestor
92774784|NCT00646945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774785|NCT00646945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774786|NCT00646945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92774787|NCT00646945|Analgesics|analgesics|mesh-ancestor
92774788|NCT00646945|Sensory System Agents|sensory system agents|mesh-ancestor
92774789|NCT00646945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774790|NCT00629889|Pregabalin|pregabalin|mesh-list
92774791|NCT00629889|Levetiracetam|levetiracetam|mesh-list
92774792|NCT00629889|Analgesics|analgesics|mesh-ancestor
92774793|NCT00629889|Sensory System Agents|sensory system agents|mesh-ancestor
92774794|NCT00629889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774795|NCT00629889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774796|NCT00629889|Anticonvulsants|anticonvulsants|mesh-ancestor
92774797|NCT00629889|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92774798|NCT00629889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92774799|NCT00629889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774800|NCT00629889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92774801|NCT00629889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92774802|NCT00629889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774803|NCT00629889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774804|NCT00629889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774805|NCT00629889|Nootropic Agents|nootropic agents|mesh-ancestor
92774806|NCT03381261|Botulinum Toxins|botulinum toxins|mesh-list
92774807|NCT03381261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92774808|NCT03381261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92774809|NCT03381261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92774810|NCT03381261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92774811|NCT03381261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774812|NCT03381261|Cholinergic Agents|cholinergic agents|mesh-ancestor
92774813|NCT03381261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774814|NCT03381261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774815|NCT03381261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92774816|NCT03381261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774817|NCT00630045|Capecitabine|capecitabine|mesh-list
92774818|NCT00630045|Oxaliplatin|oxaliplatin|mesh-list
92774819|NCT00630045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774820|NCT00630045|Antimetabolites|antimetabolites|mesh-ancestor
92774821|NCT00630045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774822|NCT00630045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774823|NCT02861859|Olanzapine|olanzapine|mesh-list
92774824|NCT02861859|Antiemetics|antiemetics|mesh-ancestor
92774825|NCT02861859|Autonomic Agents|autonomic agents|mesh-ancestor
92774826|NCT02861859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774827|NCT02861859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774828|NCT02861859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92774829|NCT02861859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92774830|NCT02861859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92774831|NCT02861859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92774832|NCT02861859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92774833|NCT02861859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92774834|NCT02861859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92774835|NCT02861859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92774836|NCT02861859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774837|NCT02861859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774838|NCT02861859|Serotonin Agents|serotonin agents|mesh-ancestor
92774839|NCT00647023|Metformin|metformin|mesh-list
92774840|NCT00647023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92774841|NCT00647023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774842|NCT00924898|Tenofovir|tenofovir|mesh-list
92774843|NCT00924898|Emtricitabine|emtricitabine|mesh-list
92774844|NCT00924898|Efavirenz|efavirenz|mesh-list
92774845|NCT00924898|Antiviral Agents|antiviral agents|mesh-ancestor
92774846|NCT00924898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337941|NCT00608465|Ramipril|ramipril|mesh-list
92774847|NCT00924898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92774848|NCT00924898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92774849|NCT00924898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774850|NCT00924898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774851|NCT00924898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92774852|NCT00924898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92774853|NCT00924898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92774854|NCT00924898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92774855|NCT00924898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92774856|NCT00924898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92119703|NCT02046772|Bupivacaine|bupivacaine|mesh-list
92774857|NCT00924898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92774858|NCT00924898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92774860|NCT01167192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774861|NCT00646321|Budesonide|budesonide|mesh-list
92774862|NCT00646321|Formoterol Fumarate|formoterol fumarate|mesh-list
92774863|NCT00646321|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92774864|NCT00646321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774865|NCT00646321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92774866|NCT00646321|Autonomic Agents|autonomic agents|mesh-ancestor
92774867|NCT00646321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92774868|NCT00646321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774869|NCT00646321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92774870|NCT00646321|Respiratory System Agents|respiratory system agents|mesh-ancestor
92774871|NCT00646321|Glucocorticoids|glucocorticoids|mesh-ancestor
92774872|NCT00646321|Hormones|hormones|mesh-ancestor
92774873|NCT00646321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774874|NCT00646321|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92774875|NCT00646321|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92774876|NCT00646321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92774877|NCT00646321|Adrenergic Agents|adrenergic agents|mesh-ancestor
92774878|NCT00646321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92774879|NCT00646321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774880|NCT00647101|Latanoprost|latanoprost|mesh-list
92774881|NCT00647101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92774882|NCT00647101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92774883|NCT01166958|Teriparatide|teriparatide|mesh-list
92774884|NCT01166958|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92774885|NCT01166958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92774886|NCT01166958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774887|NCT01166958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92774888|NCT01166958|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92774889|NCT01166958|Hormone Antagonists|hormone antagonists|mesh-ancestor
92774890|NCT01166958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774891|NCT01166958|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92774892|NCT01166958|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92774893|NCT01170221|Linezolid|linezolid|mesh-list
92774894|NCT01170221|Tedizolid phosphate|tedizolid phosphate|mesh-list
92774895|NCT01170221|Tedizolid|tedizolid|mesh-list
92774896|NCT01170221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92774897|NCT01170221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774898|NCT01170221|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92774899|NCT01170221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774900|NCT01170221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774901|NCT04254640|Cytarabine|cytarabine|mesh-list
92774902|NCT04254640|Cladribine|cladribine|mesh-list
92774903|NCT04254640|Aclarubicin|aclarubicin|mesh-list
92774904|NCT04254640|Lenograstim|lenograstim|mesh-list
92774905|NCT04254640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774906|NCT04254640|Antimetabolites|antimetabolites|mesh-ancestor
92774907|NCT04254640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774908|NCT04254640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774909|NCT04254640|Antiviral Agents|antiviral agents|mesh-ancestor
92774910|NCT04254640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92774911|NCT04254640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774912|NCT04254640|Immunologic Factors|immunologic factors|mesh-ancestor
92337947|NCT00608465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92774913|NCT04254640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774914|NCT04254640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92774915|NCT04254640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92774916|NCT04254640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92774917|NCT04254640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92774918|NCT04254640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774919|NCT01166646|Clobetasol|clobetasol|mesh-list
92774920|NCT01166646|Halobetasol|halobetasol|mesh-list
92774921|NCT01166646|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92774922|NCT01166646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774923|NCT01166646|Glucocorticoids|glucocorticoids|mesh-ancestor
92774924|NCT01166646|Hormones|hormones|mesh-ancestor
92774925|NCT01166646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774926|NCT01166646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774927|NCT01129284|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92774929|NCT01129284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774930|NCT01129284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774931|NCT00647257|Losartan|losartan|mesh-list
92774932|NCT00647257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92774933|NCT00647257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92774934|NCT00647257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92774935|NCT00647257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92774936|NCT00647257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774937|NCT04895761|Cyclophosphamide|cyclophosphamide|mesh-list
92774939|NCT04895761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92774940|NCT04895761|Immunologic Factors|immunologic factors|mesh-ancestor
92774941|NCT04895761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774942|NCT04895761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774943|NCT04895761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92774944|NCT04895761|Alkylating Agents|alkylating agents|mesh-ancestor
92774945|NCT04895761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774946|NCT04895761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774947|NCT04895761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92774948|NCT04895761|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92774949|NCT04895761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92774950|NCT04895761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774951|NCT04895761|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92774952|NCT04895761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92774953|NCT04895761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774954|NCT01166178|Vitamin D|vitamin d|mesh-list
92774955|NCT01166178|Zoledronic Acid|zoledronic acid|mesh-list
92774956|NCT01166178|Calcium|calcium|mesh-list
92774957|NCT01166178|Vitamins|vitamins|mesh-ancestor
92774958|NCT01166178|Micronutrients|micronutrients|mesh-ancestor
92774959|NCT01166178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774960|NCT01166178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92774961|NCT01166178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92774962|NCT00924820|Bevacizumab|bevacizumab|mesh-list
92774963|NCT00924820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92774964|NCT00924820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774965|NCT00924820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92774966|NCT00924820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92774967|NCT00924820|Growth Substances|growth substances|mesh-ancestor
92774968|NCT00924820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774969|NCT00924820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92774970|NCT01225172|Letrozole|letrozole|mesh-list
92774971|NCT01225172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774972|NCT01225172|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92774973|NCT01225172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92774974|NCT01225172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92774975|NCT01225172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774976|NCT01225172|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92774977|NCT01225172|Hormone Antagonists|hormone antagonists|mesh-ancestor
92774978|NCT01225172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92774979|NCT01225172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92774980|NCT02665039|Carboplatin|carboplatin|mesh-list
92774981|NCT02665039|Gemcitabine|gemcitabine|mesh-list
92774982|NCT02665039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92774983|NCT02665039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774984|NCT02665039|Antimetabolites|antimetabolites|mesh-ancestor
92774985|NCT02665039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774986|NCT00647491|Adalimumab|adalimumab|mesh-list
92774987|NCT00647491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92774988|NCT00647491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92774989|NCT00647491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92774990|NCT04252456|Leucovorin|leucovorin|mesh-list
92774991|NCT04252456|Folic Acid|folic acid|mesh-list
92774992|NCT04252456|Fluorouracil|fluorouracil|mesh-list
92774993|NCT04252456|Aflibercept|aflibercept|mesh-list
92774994|NCT04252456|Levoleucovorin|levoleucovorin|mesh-list
92774995|NCT04252456|Antimetabolites|antimetabolites|mesh-ancestor
92774996|NCT04252456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92774997|NCT04252456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92774998|NCT04252456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420043|NCT01504503|Cholinergic Agents|cholinergic agents|mesh-ancestor
92774999|NCT04252456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775000|NCT04252456|Immunologic Factors|immunologic factors|mesh-ancestor
92775001|NCT04252456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775002|NCT04252456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92775003|NCT04252456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92775004|NCT04252456|Growth Substances|growth substances|mesh-ancestor
92775005|NCT04252456|Growth Inhibitors|growth inhibitors|mesh-ancestor
92775006|NCT04252456|Antidotes|antidotes|mesh-ancestor
92775007|NCT04252456|Protective Agents|protective agents|mesh-ancestor
92775008|NCT04252456|Vitamin B Complex|vitamin b complex|mesh-ancestor
92775009|NCT04252456|Vitamins|vitamins|mesh-ancestor
92775010|NCT04252456|Micronutrients|micronutrients|mesh-ancestor
92775011|NCT04252456|Hematinics|hematinics|mesh-ancestor
92775012|NCT02665351|Peramivir|peramivir|mesh-list
92775013|NCT02665351|Antiviral Agents|antiviral agents|mesh-ancestor
92775014|NCT02665351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775015|NCT02665351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775016|NCT02665351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775017|NCT01222520|Amlodipine|amlodipine|mesh-list
92775018|NCT01222520|Telmisartan|telmisartan|mesh-list
92775019|NCT01222520|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92775020|NCT01222520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92775021|NCT01222520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92775022|NCT01222520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775023|NCT01222520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775024|NCT01222520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92775025|NCT01222520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775026|NCT01222520|Vasodilator Agents|vasodilator agents|mesh-ancestor
92775027|NCT01222520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92775028|NCT01222520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92775029|NCT01221350|Thioctic Acid|thioctic acid|mesh-list
92775030|NCT01221350|Antioxidants|antioxidants|mesh-ancestor
92775031|NCT01221350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775032|NCT01221350|Protective Agents|protective agents|mesh-ancestor
92775033|NCT01221350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775034|NCT01221350|Vitamin B Complex|vitamin b complex|mesh-ancestor
92775035|NCT01221350|Vitamins|vitamins|mesh-ancestor
92775036|NCT01221350|Micronutrients|micronutrients|mesh-ancestor
92775037|NCT00647647|Terbinafine|terbinafine|mesh-list
92775038|NCT00647647|Antifungal Agents|antifungal agents|mesh-ancestor
92775039|NCT00647647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775040|NCT00647647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775041|NCT00647647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775042|NCT01221272|Ranolazine|ranolazine|mesh-list
92775043|NCT01221272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92775044|NCT01221272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775045|NCT01221272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775046|NCT01220414|Naltrexone|naltrexone|mesh-list
92775047|NCT01220414|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92775048|NCT01220414|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92775049|NCT01220414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775050|NCT01220414|Sensory System Agents|sensory system agents|mesh-ancestor
92775051|NCT01220414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775052|NCT01128894|Liraglutide|liraglutide|mesh-list
92775053|NCT01128894|rGLP-1 protein|rglp-1 protein|mesh-list
92775054|NCT01128894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775055|NCT01128894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775056|NCT01128894|Incretins|incretins|mesh-ancestor
92775057|NCT01128894|Hormones|hormones|mesh-ancestor
92775058|NCT01128894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775059|NCT01220180|Pregabalin|pregabalin|mesh-list
92775060|NCT01220180|Analgesics|analgesics|mesh-ancestor
92775061|NCT01220180|Sensory System Agents|sensory system agents|mesh-ancestor
92775062|NCT01220180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775063|NCT01220180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775064|NCT01220180|Anticonvulsants|anticonvulsants|mesh-ancestor
92775065|NCT01220180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92775066|NCT01220180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775067|NCT01220180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775068|NCT01220180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92775069|NCT01220180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92775070|NCT01220180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775071|NCT01220180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775072|NCT01220180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775073|NCT01220024|Bupivacaine|bupivacaine|mesh-list
92420127|NCT01505049|Vaccines|vaccines|mesh-list
92775074|NCT01220024|Anesthetics, Local|anesthetics, local|mesh-ancestor
92775075|NCT01220024|Anesthetics|anesthetics|mesh-ancestor
92775076|NCT01220024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775077|NCT01220024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775078|NCT01220024|Sensory System Agents|sensory system agents|mesh-ancestor
92775079|NCT01220024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775081|NCT00625248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92775082|NCT01143090|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92775083|NCT01143090|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92775084|NCT01143090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775085|NCT01143090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775086|NCT01143090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775087|NCT01143090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775088|NCT01143090|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92775089|NCT01143090|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92775090|NCT01143090|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92775091|NCT01143090|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775092|NCT01143090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775093|NCT01143090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775094|NCT01143090|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92775095|NCT01143090|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92775096|NCT01143090|Serotonin Agents|serotonin agents|mesh-ancestor
92775097|NCT01143090|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92775098|NCT01143090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92775099|NCT01143090|Dopamine Agents|dopamine agents|mesh-ancestor
92775100|NCT05125146|Trazodone|trazodone|mesh-list
92775101|NCT05125146|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92775102|NCT05125146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775103|NCT05125146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775104|NCT05125146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775105|NCT05125146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775106|NCT05125146|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92775107|NCT05125146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775108|NCT05125146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775109|NCT05125146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775110|NCT05125146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775111|NCT05125146|Serotonin Agents|serotonin agents|mesh-ancestor
92775112|NCT05125146|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92775113|NCT05125146|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775114|NCT01165554|Flutemetamol|flutemetamol|mesh-list
92775115|NCT01165554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92775116|NCT01165554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775117|NCT01218308|Vaccines|vaccines|mesh-list
92775118|NCT01218308|Immunologic Factors|immunologic factors|mesh-ancestor
92775119|NCT01218308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775120|NCT02887976|Methylprednisolone|methylprednisolone|mesh-list
92775121|NCT02887976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92775122|NCT02887976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92775123|NCT02887976|Prednisolone|prednisolone|mesh-list
92775124|NCT02887976|Prednisolone acetate|prednisolone acetate|mesh-list
92775125|NCT02887976|Abiraterone Acetate|abiraterone acetate|mesh-list
92775126|NCT02887976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92775127|NCT02887976|Prednisolone phosphate|prednisolone phosphate|mesh-list
92775128|NCT02887976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92775129|NCT02887976|Antiemetics|antiemetics|mesh-ancestor
92775130|NCT02887976|Autonomic Agents|autonomic agents|mesh-ancestor
92775131|NCT02887976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775132|NCT02887976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775133|NCT02887976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775134|NCT02887976|Glucocorticoids|glucocorticoids|mesh-ancestor
92775135|NCT02887976|Hormones|hormones|mesh-ancestor
92775136|NCT02887976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775137|NCT02887976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92775138|NCT02887976|Protective Agents|protective agents|mesh-ancestor
92775139|NCT02887976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92775140|NCT02887976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775141|NCT02887976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92775142|NCT02887976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775143|NCT02887976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775144|NCT02887976|Hormone Antagonists|hormone antagonists|mesh-ancestor
92775145|NCT02887976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92420202|NCT01505283|Lidocaine|lidocaine|mesh-list
92775146|NCT01165320|Caspofungin|caspofungin|mesh-list
92775147|NCT01165320|Antifungal Agents|antifungal agents|mesh-ancestor
92775148|NCT01165320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775149|NCT01165320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775150|NCT01165320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775151|NCT01217606|Timolol|timolol|mesh-list
92775152|NCT01217606|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92775153|NCT01217606|Bimatoprost|bimatoprost|mesh-list
92775154|NCT01217606|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92775155|NCT01217606|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92775156|NCT01217606|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92775157|NCT01217606|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92775158|NCT01217606|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775159|NCT01217606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775160|NCT01217606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775161|NCT01217606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775162|NCT01217606|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92775163|NCT01217606|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92775164|NCT01217606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92775165|NCT01217606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92775166|NCT01217606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92775167|NCT01128114|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92775168|NCT01128114|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775169|NCT01128114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775170|NCT01128114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92775171|NCT01128114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775172|NCT01128114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775173|NCT01128114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775174|NCT01217060|Dexamethasone|dexamethasone|mesh-list
92775175|NCT01217060|Docetaxel|docetaxel|mesh-list
92775176|NCT01217060|Fluorouracil|fluorouracil|mesh-list
92775177|NCT01217060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92775178|NCT01217060|Antiemetics|antiemetics|mesh-ancestor
92775179|NCT01217060|Autonomic Agents|autonomic agents|mesh-ancestor
92775180|NCT01217060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775181|NCT01217060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775182|NCT01217060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775183|NCT01217060|Glucocorticoids|glucocorticoids|mesh-ancestor
92775184|NCT01217060|Hormones|hormones|mesh-ancestor
92775185|NCT01217060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775186|NCT01217060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92775187|NCT01217060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775188|NCT01217060|Tubulin Modulators|tubulin modulators|mesh-ancestor
92775189|NCT01217060|Antimitotic Agents|antimitotic agents|mesh-ancestor
92775190|NCT01217060|Mitosis Modulators|mitosis modulators|mesh-ancestor
92775191|NCT01217060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775192|NCT01217060|Antimetabolites|antimetabolites|mesh-ancestor
92775193|NCT01217060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92775194|NCT01217060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775195|NCT01217060|Immunologic Factors|immunologic factors|mesh-ancestor
92775196|NCT01170065|Nintedanib|nintedanib|mesh-list
92775197|NCT01170065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775198|NCT01170065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92775199|NCT01170065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775200|NCT01170065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775201|NCT02885922|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92775202|NCT02885922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775203|NCT00966693|Thalidomide|thalidomide|mesh-list
92775204|NCT00966693|Dexamethasone|dexamethasone|mesh-list
92775205|NCT00966693|Dexamethasone acetate|dexamethasone acetate|mesh-list
92775206|NCT00966693|Lenalidomide|lenalidomide|mesh-list
92775207|NCT00966693|Ichthammol|ichthammol|mesh-list
92775208|NCT00966693|BB 1101|bb 1101|mesh-list
92775209|NCT00966693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92775210|NCT00966693|Antiemetics|antiemetics|mesh-ancestor
92775211|NCT00966693|Autonomic Agents|autonomic agents|mesh-ancestor
92775212|NCT00966693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775213|NCT00966693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775214|NCT00966693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775215|NCT00966693|Glucocorticoids|glucocorticoids|mesh-ancestor
92775216|NCT00966693|Hormones|hormones|mesh-ancestor
92775217|NCT00966693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775218|NCT00966693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92775219|NCT00966693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775220|NCT00966693|Immunologic Factors|immunologic factors|mesh-ancestor
92775221|NCT00966693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92775222|NCT00966693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92775223|NCT00966693|Growth Substances|growth substances|mesh-ancestor
92775224|NCT00966693|Growth Inhibitors|growth inhibitors|mesh-ancestor
92775225|NCT00966693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775226|NCT00966693|Leprostatic Agents|leprostatic agents|mesh-ancestor
92775227|NCT00966693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92775228|NCT00966693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775229|NCT00966693|Protease Inhibitors|protease inhibitors|mesh-ancestor
92775230|NCT00966693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775231|NCT00966693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775232|NCT00966693|Dermatologic Agents|dermatologic agents|mesh-ancestor
92775233|NCT01215968|Dulaglutide|dulaglutide|mesh-list
92775234|NCT01215968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775235|NCT01215968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775236|NCT02663713|Clopidogrel|clopidogrel|mesh-list
92775237|NCT02663713|Ticagrelor|ticagrelor|mesh-list
92775238|NCT02663713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92775239|NCT02663713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92775240|NCT02663713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92775241|NCT02663713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92775242|NCT02663713|Purinergic Agents|purinergic agents|mesh-ancestor
92775243|NCT02663713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775244|NCT02663713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775245|NCT02663713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775246|NCT02664649|Apixaban|apixaban|mesh-list
92775247|NCT02664649|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
92775248|NCT02664649|Anticoagulants|anticoagulants|mesh-list
92775249|NCT02664649|Antithrombins|antithrombins|mesh-ancestor
92775250|NCT02664649|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92775251|NCT02664649|Protease Inhibitors|protease inhibitors|mesh-ancestor
92775252|NCT02664649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775253|NCT02664649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775254|NCT02664493|Methylprednisolone|methylprednisolone|mesh-list
92775255|NCT02664493|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92775256|NCT02664493|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92775257|NCT02664493|Prednisolone|prednisolone|mesh-list
92775258|NCT02664493|Prednisolone acetate|prednisolone acetate|mesh-list
92775259|NCT02664493|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92775260|NCT02664493|Prednisolone phosphate|prednisolone phosphate|mesh-list
92775261|NCT02664493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92775262|NCT02664493|Antiemetics|antiemetics|mesh-ancestor
92775263|NCT02664493|Autonomic Agents|autonomic agents|mesh-ancestor
92775264|NCT02664493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775265|NCT02664493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775266|NCT02664493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775267|NCT02664493|Glucocorticoids|glucocorticoids|mesh-ancestor
92775268|NCT02664493|Hormones|hormones|mesh-ancestor
92775269|NCT02664493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775270|NCT02664493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92775271|NCT02664493|Protective Agents|protective agents|mesh-ancestor
92775272|NCT02664493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92775273|NCT02664493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775274|NCT00963807|Deoxyglucose|deoxyglucose|mesh-list
92775275|NCT00963807|Alovudine|alovudine|mesh-list
92775276|NCT00963807|Dideoxynucleosides|dideoxynucleosides|mesh-list
92775277|NCT00963807|Cisplatin|cisplatin|mesh-list
92775278|NCT00963807|Docetaxel|docetaxel|mesh-list
92775279|NCT00963807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92775280|NCT00963807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775281|NCT00963807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92775282|NCT00963807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92775283|NCT00963807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92775284|NCT00963807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775285|NCT00963807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92775286|NCT00963807|Antimetabolites|antimetabolites|mesh-ancestor
92775287|NCT00963807|Antiviral Agents|antiviral agents|mesh-ancestor
92775288|NCT00963807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775289|NCT00963807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92775290|NCT00963807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92775291|NCT00963807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775292|NCT01142466|Interferons|interferons|mesh-list
92775293|NCT01142466|Interferon-beta|interferon-beta|mesh-list
92775294|NCT01142466|Interferon beta-1a|interferon beta-1a|mesh-list
92775295|NCT01142466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775296|NCT01142466|Antiviral Agents|antiviral agents|mesh-ancestor
92775297|NCT01142466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775298|NCT01142466|Immunologic Factors|immunologic factors|mesh-ancestor
92775299|NCT01142466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775300|NCT01142466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92775302|NCT00648505|Glipizide|glipizide|mesh-list
92775303|NCT00648505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775304|NCT00648505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775305|NCT01215734|Vaccines|vaccines|mesh-list
92775306|NCT01215734|Immunologic Factors|immunologic factors|mesh-ancestor
92775307|NCT01215734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775308|NCT04172311|Levetiracetam|levetiracetam|mesh-list
92775309|NCT04172311|Anticonvulsants|anticonvulsants|mesh-ancestor
92775310|NCT04172311|Nootropic Agents|nootropic agents|mesh-ancestor
92775311|NCT02863185|Atorvastatin|atorvastatin|mesh-list
92775312|NCT02863185|Pitavastatin|pitavastatin|mesh-list
92775313|NCT02863185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92775314|NCT02863185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92775315|NCT02863185|Antimetabolites|antimetabolites|mesh-ancestor
92775316|NCT02863185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775317|NCT02863185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92775318|NCT02863185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92775319|NCT02863185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775320|NCT00647881|Paroxetine|paroxetine|mesh-list
92775321|NCT00647881|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92775322|NCT00647881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775323|NCT00647881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775324|NCT00647881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775325|NCT00647881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775326|NCT00647881|Serotonin Agents|serotonin agents|mesh-ancestor
92775327|NCT00647881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775328|NCT00647881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92775329|NCT00647881|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775330|NCT00647881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775331|NCT00647881|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92775332|NCT00647881|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92775333|NCT00647881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775334|NCT04174261|Clopidogrel|clopidogrel|mesh-list
92775335|NCT04174261|Ticagrelor|ticagrelor|mesh-list
92775336|NCT04174261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92775337|NCT04174261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92775338|NCT04174261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92775339|NCT04174261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92775340|NCT04174261|Purinergic Agents|purinergic agents|mesh-ancestor
92775341|NCT04174261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775342|NCT04174261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775343|NCT04174261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775344|NCT00971997|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
92775345|NCT00971997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775346|NCT00971997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775347|NCT01142388|Paclitaxel|paclitaxel|mesh-list
92775348|NCT01142388|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92775349|NCT01142388|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92775350|NCT01142388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92775351|NCT01142388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775352|NCT01142388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92775353|NCT01142388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92775354|NCT01142388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92775355|NCT01142388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775356|NCT01142388|Immunologic Factors|immunologic factors|mesh-ancestor
92775357|NCT01142388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775358|NCT00910741|Gemcitabine|gemcitabine|mesh-list
92775359|NCT00910741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92775360|NCT00910741|Antimetabolites|antimetabolites|mesh-ancestor
92775361|NCT00910741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775362|NCT00910741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775363|NCT00647959|Doxycycline|doxycycline|mesh-list
92775364|NCT00647959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92775365|NCT00647959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775366|NCT00647959|Antimalarials|antimalarials|mesh-ancestor
92775367|NCT00647959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92775368|NCT00647959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92775369|NCT03602235|Ascorbic Acid|ascorbic acid|mesh-list
92775370|NCT03602235|Melphalan|melphalan|mesh-list
92775371|NCT03602235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92420420|NCT01506388|Misoprostol|misoprostol|mesh-list
92775372|NCT03602235|Alkylating Agents|alkylating agents|mesh-ancestor
92775373|NCT03602235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775374|NCT03602235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775375|NCT03602235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92775376|NCT03602235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775377|NCT03602235|Immunologic Factors|immunologic factors|mesh-ancestor
92775378|NCT03602235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775379|NCT03602235|Antioxidants|antioxidants|mesh-ancestor
92775380|NCT03602235|Protective Agents|protective agents|mesh-ancestor
92775381|NCT03602235|Vitamins|vitamins|mesh-ancestor
92775382|NCT03602235|Micronutrients|micronutrients|mesh-ancestor
92775383|NCT00648583|Ondansetron|ondansetron|mesh-list
92775384|NCT00648583|Antiemetics|antiemetics|mesh-ancestor
92775385|NCT00648583|Autonomic Agents|autonomic agents|mesh-ancestor
92775386|NCT00648583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775387|NCT00648583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775388|NCT00648583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775389|NCT00648583|Antipruritics|antipruritics|mesh-ancestor
92775390|NCT00648583|Dermatologic Agents|dermatologic agents|mesh-ancestor
92775391|NCT00648583|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92775392|NCT00648583|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92775393|NCT00648583|Serotonin Agents|serotonin agents|mesh-ancestor
92775394|NCT00648583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775395|NCT00648583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775396|NCT03809481|Danaparoid|danaparoid|mesh-list
92775397|NCT03809481|Argatroban|argatroban|mesh-list
92775398|NCT03809481|Antithrombins|antithrombins|mesh-ancestor
92775399|NCT03809481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92775400|NCT03809481|Protease Inhibitors|protease inhibitors|mesh-ancestor
92775401|NCT03809481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775402|NCT03809481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775403|NCT03809481|Anticoagulants|anticoagulants|mesh-ancestor
92775404|NCT03809481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92775405|NCT03809481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92775406|NCT03809481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92775407|NCT00649129|Oxybutynin|oxybutynin|mesh-list
92775408|NCT00649129|Parasympatholytics|parasympatholytics|mesh-ancestor
92775409|NCT00649129|Autonomic Agents|autonomic agents|mesh-ancestor
92775410|NCT00649129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775411|NCT00649129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775412|NCT00649129|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92775413|NCT00649129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92775414|NCT00649129|Cholinergic Agents|cholinergic agents|mesh-ancestor
92775415|NCT00649129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775416|NCT00649129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775417|NCT00649129|Urological Agents|urological agents|mesh-ancestor
92775418|NCT01127646|Methylphenidate|methylphenidate|mesh-list
92775419|NCT01127646|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92775420|NCT01127646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92775421|NCT01127646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775422|NCT01127646|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92775423|NCT01127646|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775424|NCT01127646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775425|NCT01127646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775426|NCT01127646|Dopamine Agents|dopamine agents|mesh-ancestor
92775427|NCT01127646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775428|NCT01127646|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92775429|NCT01127646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775430|NCT02660047|Liraglutide|liraglutide|mesh-list
92775431|NCT02660047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775432|NCT02660047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775433|NCT02660047|Incretins|incretins|mesh-ancestor
92775434|NCT02660047|Hormones|hormones|mesh-ancestor
92775435|NCT02660047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775436|NCT00648661|Dexetimide|dexetimide|mesh-list
92775437|NCT00648661|Citalopram|citalopram|mesh-list
92775438|NCT00648661|Escitalopram|escitalopram|mesh-list
92775439|NCT00648661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92775440|NCT00648661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775441|NCT00648661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775442|NCT00648661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775443|NCT00648661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775444|NCT00648661|Serotonin Agents|serotonin agents|mesh-ancestor
92775445|NCT00648661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775446|NCT00648661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92775447|NCT00648661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92775448|NCT00648661|Parasympatholytics|parasympatholytics|mesh-ancestor
92775449|NCT00648661|Autonomic Agents|autonomic agents|mesh-ancestor
92775450|NCT00648661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775451|NCT00648661|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92775452|NCT00648661|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92775453|NCT00648661|Cholinergic Agents|cholinergic agents|mesh-ancestor
92775454|NCT00648661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92775455|NCT00648661|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775456|NCT00648661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775457|NCT05367414|Tea Tree Oil|tea tree oil|mesh-list
92775458|NCT05367414|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92775459|NCT05367414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775460|NCT04171687|Clopidogrel|clopidogrel|mesh-list
92775461|NCT04171687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92775462|NCT04171687|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92775463|NCT04171687|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92775464|NCT04171687|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92775465|NCT04171687|Purinergic Agents|purinergic agents|mesh-ancestor
92775466|NCT04171687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775467|NCT04171687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775468|NCT04171687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775469|NCT00648817|Tenofovir|tenofovir|mesh-list
92775470|NCT00648817|Antiviral Agents|antiviral agents|mesh-ancestor
92775471|NCT00648817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775472|NCT00648817|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92775473|NCT00648817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92775474|NCT00648817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775475|NCT00648817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775476|NCT00648817|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92775477|NCT00648817|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92775478|NCT03391869|Nivolumab|nivolumab|mesh-list
92775479|NCT03391869|Ipilimumab|ipilimumab|mesh-list
92775480|NCT03391869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92775481|NCT03391869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775482|NCT03391869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92775483|NCT03391869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775484|NCT02663323|Sirolimus|sirolimus|mesh-list
92775485|NCT02663323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92775486|NCT02663323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775487|NCT02663323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92775488|NCT02663323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775489|NCT02663323|Antifungal Agents|antifungal agents|mesh-ancestor
92775490|NCT02663323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775491|NCT02663323|Immunologic Factors|immunologic factors|mesh-ancestor
92775492|NCT02663323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775493|NCT01215188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92775494|NCT01215188|Immunologic Factors|immunologic factors|mesh-ancestor
92775495|NCT01215188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775496|NCT04285281|Gabapentin|gabapentin|mesh-list
92775497|NCT04285281|Analgesics|analgesics|mesh-ancestor
92775498|NCT04285281|Sensory System Agents|sensory system agents|mesh-ancestor
92775499|NCT04285281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775500|NCT04285281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775501|NCT04285281|Anticonvulsants|anticonvulsants|mesh-ancestor
92775502|NCT04285281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92775503|NCT04285281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775504|NCT04285281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775505|NCT04285281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775506|NCT04285281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92775507|NCT04285281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92775508|NCT04285281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775509|NCT04285281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775510|NCT04285281|Antimanic Agents|antimanic agents|mesh-ancestor
92775511|NCT02659657|Interleukin-2|interleukin-2|mesh-list
92775512|NCT02659657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775513|NCT02659657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92775514|NCT02659657|Analgesics|analgesics|mesh-ancestor
92775515|NCT02659657|Sensory System Agents|sensory system agents|mesh-ancestor
92775516|NCT02659657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775517|NCT02659657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775518|NCT02659891|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92775519|NCT02659891|Immunologic Factors|immunologic factors|mesh-ancestor
92775520|NCT02659891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775521|NCT05438498|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92775523|NCT05438498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775524|NCT00648193|Paroxetine|paroxetine|mesh-list
92775525|NCT00648193|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92775526|NCT00648193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775527|NCT00648193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775528|NCT00648193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775529|NCT00648193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775530|NCT00648193|Serotonin Agents|serotonin agents|mesh-ancestor
92775531|NCT00648193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775532|NCT00648193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92775533|NCT00648193|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775534|NCT00648193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775535|NCT00648193|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92775536|NCT00648193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92775537|NCT00648193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775538|NCT01215032|Metformin|metformin|mesh-list
92775539|NCT01215032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775540|NCT01215032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775541|NCT02663089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92775542|NCT02664103|Cyclophosphamide|cyclophosphamide|mesh-list
92775543|NCT02664103|Capecitabine|capecitabine|mesh-list
92775544|NCT02664103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775545|NCT02664103|Immunologic Factors|immunologic factors|mesh-ancestor
92775546|NCT02664103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775547|NCT02664103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92775548|NCT02664103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92775549|NCT02664103|Alkylating Agents|alkylating agents|mesh-ancestor
92775550|NCT02664103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775551|NCT02664103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775552|NCT02664103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92775553|NCT02664103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92775554|NCT02664103|Antimetabolites|antimetabolites|mesh-ancestor
92775555|NCT02662855|Favipiravir|favipiravir|mesh-list
92775556|NCT02662855|Antiviral Agents|antiviral agents|mesh-ancestor
92775557|NCT02662855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775558|NCT00648271|Metoprolol|metoprolol|mesh-list
92775559|NCT00648271|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92775560|NCT00648271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92775561|NCT00648271|Sympatholytics|sympatholytics|mesh-ancestor
92775562|NCT00648271|Autonomic Agents|autonomic agents|mesh-ancestor
92775563|NCT00648271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775564|NCT00648271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775565|NCT00648271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92775566|NCT00648271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92775567|NCT00648271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92775568|NCT00648271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775569|NCT00648271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775570|NCT00648271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775571|NCT00648349|Rabeprazole|rabeprazole|mesh-list
92775572|NCT00648349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92775573|NCT00648349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775574|NCT00648349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92775575|NCT00648349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775576|NCT00648349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775577|NCT00649207|Veliparib|veliparib|mesh-list
92775578|NCT00649207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92775579|NCT00649207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775580|NCT00649207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775581|NCT00649207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775582|NCT00920686|Sumatriptan|sumatriptan|mesh-list
92775583|NCT00920686|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92775584|NCT00920686|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92775585|NCT00920686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92775586|NCT00920686|Serotonin Agents|serotonin agents|mesh-ancestor
92775587|NCT00920686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775588|NCT00920686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775589|NCT00920686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775590|NCT00648427|Paroxetine|paroxetine|mesh-list
92775591|NCT00648427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92420643|NCT01507285|Hormones|hormones|mesh-ancestor
92338017|NCT01629329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92775592|NCT00648427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775593|NCT00648427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775594|NCT00648427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775595|NCT00648427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775597|NCT00648427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775598|NCT00648427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92775599|NCT00648427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775600|NCT00648427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775601|NCT00648427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92775602|NCT00648427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92775603|NCT00648427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775604|NCT04170751|Vasopressins|vasopressins|mesh-list
92775605|NCT04170751|Arginine Vasopressin|arginine vasopressin|mesh-list
92775606|NCT04170751|Norepinephrine|norepinephrine|mesh-list
92775607|NCT04170751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92775608|NCT04170751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92775609|NCT04170751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775610|NCT04170751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775611|NCT04170751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775612|NCT04170751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775613|NCT04170751|Sympathomimetics|sympathomimetics|mesh-ancestor
92775614|NCT04170751|Autonomic Agents|autonomic agents|mesh-ancestor
92775615|NCT04170751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775616|NCT04170751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92775617|NCT04170751|Hemostatics|hemostatics|mesh-ancestor
92775618|NCT04170751|Coagulants|coagulants|mesh-ancestor
92775619|NCT04170751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92775620|NCT04170751|Natriuretic Agents|natriuretic agents|mesh-ancestor
92775621|NCT02659033|Ceftriaxone|ceftriaxone|mesh-list
92775622|NCT02659033|Cephalosporins|cephalosporins|mesh-list
92775623|NCT02659033|Cefotaxime|cefotaxime|mesh-list
92775624|NCT02659033|Cefoxitin|cefoxitin|mesh-list
92775625|NCT02659033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92775626|NCT02659033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775627|NCT04170595|Trastuzumab|trastuzumab|mesh-list
92775628|NCT04170595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92775629|NCT04170595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775630|NCT00648973|Diphenhydramine|diphenhydramine|mesh-list
92775631|NCT00648973|Promethazine|promethazine|mesh-list
92775632|NCT00648973|Pseudoephedrine|pseudoephedrine|mesh-list
92775633|NCT00648973|Ephedrine|ephedrine|mesh-list
92775634|NCT00648973|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92775635|NCT00648973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92775636|NCT00648973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775637|NCT00648973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775638|NCT00648973|Anesthetics, Local|anesthetics, local|mesh-ancestor
92775639|NCT00648973|Anesthetics|anesthetics|mesh-ancestor
92775640|NCT00648973|Sensory System Agents|sensory system agents|mesh-ancestor
92775641|NCT00648973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775642|NCT00648973|Antiemetics|antiemetics|mesh-ancestor
92775643|NCT00648973|Autonomic Agents|autonomic agents|mesh-ancestor
92775644|NCT00648973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775645|NCT00648973|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92775646|NCT00648973|Histamine Antagonists|histamine antagonists|mesh-ancestor
92775647|NCT00648973|Histamine Agents|histamine agents|mesh-ancestor
92775648|NCT00648973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775649|NCT00648973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775650|NCT00648973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92775651|NCT00648973|Antipruritics|antipruritics|mesh-ancestor
92775652|NCT00648973|Dermatologic Agents|dermatologic agents|mesh-ancestor
92775653|NCT00648973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92775654|NCT00648973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92775655|NCT00648973|Respiratory System Agents|respiratory system agents|mesh-ancestor
92775656|NCT00648973|Nasal Decongestants|nasal decongestants|mesh-ancestor
92775657|NCT00648973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92775658|NCT00648973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92775659|NCT00648973|Sympathomimetics|sympathomimetics|mesh-ancestor
92775660|NCT00648973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775661|NCT02662309|Atezolizumab|atezolizumab|mesh-list
92775662|NCT02662309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92775663|NCT02662309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338022|NCT01629329|Antiemetics|antiemetics|mesh-ancestor
92775664|NCT02662309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92775666|NCT04032691|Clonidine|clonidine|mesh-list
92775667|NCT04032691|Analgesics|analgesics|mesh-ancestor
92775668|NCT04032691|Sensory System Agents|sensory system agents|mesh-ancestor
92775669|NCT04032691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775670|NCT04032691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775671|NCT04032691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92775673|NCT04032691|Autonomic Agents|autonomic agents|mesh-ancestor
92775674|NCT04032691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92775675|NCT04032691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92775676|NCT04032691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92775677|NCT04032691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775678|NCT04032691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775679|NCT04032691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775680|NCT02658799|Diclofenac|diclofenac|mesh-list
92775681|NCT02658799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92775682|NCT02658799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92775683|NCT02658799|Analgesics|analgesics|mesh-ancestor
92775684|NCT02658799|Sensory System Agents|sensory system agents|mesh-ancestor
92775685|NCT02658799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775686|NCT02658799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775687|NCT02658799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92775688|NCT02658799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92775689|NCT02658799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92775690|NCT02658799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775691|NCT02658799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775692|NCT02655757|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92775693|NCT02655757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775694|NCT02655757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775695|NCT02655757|Incretins|incretins|mesh-ancestor
92775696|NCT02655757|Hormones|hormones|mesh-ancestor
92775697|NCT02655757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775698|NCT02655757|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92775699|NCT02655757|Protease Inhibitors|protease inhibitors|mesh-ancestor
92775700|NCT02655757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775701|NCT02655757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775702|NCT01214720|Bevacizumab|bevacizumab|mesh-list
92775703|NCT01214720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92775704|NCT01214720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775705|NCT01214720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92775706|NCT01214720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92775707|NCT01214720|Growth Substances|growth substances|mesh-ancestor
92775708|NCT01214720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775709|NCT01214720|Growth Inhibitors|growth inhibitors|mesh-ancestor
92775710|NCT02655913|Ascorbic Acid|ascorbic acid|mesh-list
92775711|NCT02655913|Vitamins|vitamins|mesh-ancestor
92775712|NCT02655913|Micronutrients|micronutrients|mesh-ancestor
92775713|NCT02655913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775714|NCT02655913|Antioxidants|antioxidants|mesh-ancestor
92775715|NCT02655913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775716|NCT02655913|Protective Agents|protective agents|mesh-ancestor
92775717|NCT00649285|Nitrofurantoin|nitrofurantoin|mesh-list
92775718|NCT00649285|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92775719|NCT00649285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775720|NCT00649285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92775721|NCT04169269|Enoxaparin|enoxaparin|mesh-list
92775722|NCT04169269|Rivaroxaban|rivaroxaban|mesh-list
92775723|NCT04169269|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92775724|NCT04169269|Antithrombins|antithrombins|mesh-ancestor
92775725|NCT04169269|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92775726|NCT04169269|Protease Inhibitors|protease inhibitors|mesh-ancestor
92775727|NCT04169269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775728|NCT04169269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775729|NCT04169269|Anticoagulants|anticoagulants|mesh-ancestor
92775730|NCT04169269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92775731|NCT04169269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92775732|NCT02661373|Cobicistat|cobicistat|mesh-list
92775733|NCT02661373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338025|NCT01629329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92775734|NCT02661373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92775735|NCT02661373|Antiviral Agents|antiviral agents|mesh-ancestor
92775736|NCT02661373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775737|NCT02661373|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92775738|NCT02661373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92775739|NCT02661373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775740|NCT02661373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775742|NCT00649051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92775743|NCT00649051|Diuretics|diuretics|mesh-ancestor
92775744|NCT00649051|Natriuretic Agents|natriuretic agents|mesh-ancestor
92775745|NCT00649051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775746|NCT00649051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92775747|NCT00649051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775748|NCT00649051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775749|NCT04168879|Bupivacaine|bupivacaine|mesh-list
92775750|NCT04168879|Anesthetics, Local|anesthetics, local|mesh-ancestor
92775751|NCT04168879|Anesthetics|anesthetics|mesh-ancestor
92775752|NCT04168879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775753|NCT04168879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775754|NCT04168879|Sensory System Agents|sensory system agents|mesh-ancestor
92775755|NCT04168879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775756|NCT00649987|Albuterol|albuterol|mesh-list
92775757|NCT00649987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92775758|NCT00649987|Autonomic Agents|autonomic agents|mesh-ancestor
92775759|NCT00649987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775760|NCT00649987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775761|NCT00649987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92775762|NCT00649987|Respiratory System Agents|respiratory system agents|mesh-ancestor
92775763|NCT00649987|Tocolytic Agents|tocolytic agents|mesh-ancestor
92775764|NCT00649987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92775765|NCT00649987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92775766|NCT00649987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92775767|NCT00649987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92775768|NCT00649987|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775769|NCT00649987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775770|NCT00649987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775771|NCT01142232|Lenalidomide|lenalidomide|mesh-list
92775772|NCT01142232|Melphalan|melphalan|mesh-list
92775773|NCT01142232|Immunologic Factors|immunologic factors|mesh-ancestor
92775774|NCT01142232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775775|NCT01142232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92775776|NCT01142232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92775777|NCT01142232|Growth Substances|growth substances|mesh-ancestor
92775778|NCT01142232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92775779|NCT01142232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775780|NCT01142232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92775781|NCT01142232|Alkylating Agents|alkylating agents|mesh-ancestor
92775782|NCT01142232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775783|NCT01142232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92775784|NCT01142232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92775785|NCT02536807|Hyaluronic Acid|hyaluronic acid|mesh-list
92775786|NCT02536807|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92775787|NCT02536807|Immunologic Factors|immunologic factors|mesh-ancestor
92775788|NCT02536807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775789|NCT02536807|Viscosupplements|viscosupplements|mesh-ancestor
92775790|NCT02536807|Protective Agents|protective agents|mesh-ancestor
92775791|NCT02536495|Docetaxel|docetaxel|mesh-list
92775792|NCT02536495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775793|NCT02536495|Tubulin Modulators|tubulin modulators|mesh-ancestor
92775794|NCT02536495|Antimitotic Agents|antimitotic agents|mesh-ancestor
92775795|NCT02536495|Mitosis Modulators|mitosis modulators|mesh-ancestor
92775796|NCT02536495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775797|NCT02536417|Melatonin|melatonin|mesh-list
92775798|NCT02536417|Antioxidants|antioxidants|mesh-ancestor
92775799|NCT02536417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775800|NCT02536417|Protective Agents|protective agents|mesh-ancestor
92775801|NCT02536417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775802|NCT02536417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775803|NCT01140906|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92775804|NCT01140906|Vortioxetine|vortioxetine|mesh-list
92775805|NCT01140906|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92775806|NCT01140906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92775807|NCT01140906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775808|NCT01140906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775809|NCT01140906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775810|NCT01140906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775811|NCT01140906|Analgesics|analgesics|mesh-ancestor
92775812|NCT01140906|Sensory System Agents|sensory system agents|mesh-ancestor
92775813|NCT01140906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420870|NCT01508143|Oxytocics|oxytocics|mesh-ancestor
92775814|NCT01140906|Antidepressive Agents|antidepressive agents|mesh-ancestor
92775815|NCT01140906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775816|NCT01140906|Dopamine Agents|dopamine agents|mesh-ancestor
92775817|NCT01140906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92775818|NCT01140906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775819|NCT01140906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775820|NCT01140906|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92775821|NCT01140906|Serotonin Agents|serotonin agents|mesh-ancestor
92775822|NCT01140906|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92775823|NCT01140906|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92775824|NCT01140906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92775825|NCT01140906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92775826|NCT00650065|Cetirizine|cetirizine|mesh-list
92775827|NCT00650065|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92775828|NCT00650065|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92775829|NCT00650065|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92775830|NCT00650065|Histamine Antagonists|histamine antagonists|mesh-ancestor
92775831|NCT00650065|Histamine Agents|histamine agents|mesh-ancestor
92775832|NCT00650065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775833|NCT00650065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775834|NCT00650065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775835|NCT04170439|Chromium|chromium|mesh-list
92775836|NCT04170439|Metformin|metformin|mesh-list
92775837|NCT04170439|Citric Acid|citric acid|mesh-list
92775838|NCT04170439|Sodium Citrate|sodium citrate|mesh-list
92775839|NCT04170439|Clomiphene|clomiphene|mesh-list
92775840|NCT04170439|Enclomiphene|enclomiphene|mesh-list
92775841|NCT04170439|Zuclomiphene|zuclomiphene|mesh-list
92775842|NCT04170439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775843|NCT04170439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775844|NCT04170439|Anticoagulants|anticoagulants|mesh-ancestor
92775845|NCT04170439|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92775846|NCT04170439|Chelating Agents|chelating agents|mesh-ancestor
92775847|NCT04170439|Sequestering Agents|sequestering agents|mesh-ancestor
92775848|NCT04170439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775849|NCT04170439|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92775850|NCT04170439|Hormone Antagonists|hormone antagonists|mesh-ancestor
92775851|NCT04170439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775852|NCT04170439|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92775853|NCT04170439|Fertility Agents|fertility agents|mesh-ancestor
92775854|NCT04170439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92775855|NCT04170439|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92775856|NCT04170439|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92775857|NCT04170439|Trace Elements|trace elements|mesh-ancestor
92775858|NCT04170439|Micronutrients|micronutrients|mesh-ancestor
92775859|NCT00649363|Ondansetron|ondansetron|mesh-list
92775860|NCT00649363|Antiemetics|antiemetics|mesh-ancestor
92775861|NCT00649363|Autonomic Agents|autonomic agents|mesh-ancestor
92775862|NCT00649363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775863|NCT00649363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775864|NCT00649363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775865|NCT00649363|Antipruritics|antipruritics|mesh-ancestor
92775866|NCT00649363|Dermatologic Agents|dermatologic agents|mesh-ancestor
92775867|NCT00649363|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92775868|NCT00649363|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92775869|NCT00649363|Serotonin Agents|serotonin agents|mesh-ancestor
92775870|NCT00649363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775871|NCT00649363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775872|NCT02654743|Sulforaphane|sulforaphane|mesh-list
92775873|NCT02654743|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92775874|NCT02654743|Protective Agents|protective agents|mesh-ancestor
92775875|NCT02654743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775876|NCT02654743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775877|NCT04168723|Moxifloxacin|moxifloxacin|mesh-list
92775878|NCT04168723|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92775879|NCT04168723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92775880|NCT04168723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775881|NCT04168723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92775882|NCT04168723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92775883|NCT04168723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775884|NCT04168723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775885|NCT04168723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775886|NCT04168723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92775887|NCT04168723|Contraceptive Agents|contraceptive agents|mesh-ancestor
92775888|NCT04168723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92775889|NCT04168723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775890|NCT04168723|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92775891|NCT04168723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92775892|NCT04168723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92775893|NCT00649441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92775895|NCT00649441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92775896|NCT00649441|Diuretics|diuretics|mesh-ancestor
92775897|NCT00649441|Natriuretic Agents|natriuretic agents|mesh-ancestor
92775898|NCT00649441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775899|NCT00649441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92775900|NCT00649441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775901|NCT00649441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775902|NCT00649441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92775903|NCT00649441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92775904|NCT00649441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775905|NCT02654665|Liraglutide|liraglutide|mesh-list
92775906|NCT02654665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92775907|NCT02654665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775908|NCT02654665|Incretins|incretins|mesh-ancestor
92775909|NCT02654665|Hormones|hormones|mesh-ancestor
92775910|NCT02654665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92775911|NCT02658721|Diclofenac|diclofenac|mesh-list
92775912|NCT02658721|Lidocaine|lidocaine|mesh-list
92775913|NCT02658721|Atropine|atropine|mesh-list
92775914|NCT02658721|Ephedrine|ephedrine|mesh-list
92775915|NCT02658721|Fentanyl|fentanyl|mesh-list
92775916|NCT02658721|Midazolam|midazolam|mesh-list
92775917|NCT02658721|Tramadol|tramadol|mesh-list
92775918|NCT02658721|Ondansetron|ondansetron|mesh-list
92775919|NCT02658721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92775920|NCT02658721|Anesthetics|anesthetics|mesh-ancestor
92775921|NCT02658721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92775922|NCT02658721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775923|NCT02658721|Sensory System Agents|sensory system agents|mesh-ancestor
92775924|NCT02658721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92775925|NCT02658721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92775926|NCT02658721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92775927|NCT02658721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92775928|NCT02658721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92775929|NCT02658721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775930|NCT02658721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92775931|NCT02658721|Narcotics|narcotics|mesh-ancestor
92775932|NCT02658721|Analgesics|analgesics|mesh-ancestor
92775933|NCT02658721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92775934|NCT02658721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92775935|NCT02658721|Anesthetics, General|anesthetics, general|mesh-ancestor
92775936|NCT02658721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92775937|NCT02658721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92775938|NCT02658721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92775939|NCT02658721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92775940|NCT02658721|GABA Modulators|gaba modulators|mesh-ancestor
92775941|NCT02658721|GABA Agents|gaba agents|mesh-ancestor
92775942|NCT02658721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92775943|NCT02658721|Antiemetics|antiemetics|mesh-ancestor
92775944|NCT02658721|Autonomic Agents|autonomic agents|mesh-ancestor
92775945|NCT02658721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92775946|NCT02658721|Antipruritics|antipruritics|mesh-ancestor
92775947|NCT02658721|Dermatologic Agents|dermatologic agents|mesh-ancestor
92775948|NCT02658721|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92775949|NCT02658721|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92775950|NCT02658721|Serotonin Agents|serotonin agents|mesh-ancestor
92775951|NCT02658721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92775952|NCT02658721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92775953|NCT02658721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92775954|NCT02658721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92775955|NCT02658721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92775956|NCT02658721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775957|NCT02658721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92775958|NCT02658721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92775959|NCT02658721|Respiratory System Agents|respiratory system agents|mesh-ancestor
92775960|NCT02658721|Mydriatics|mydriatics|mesh-ancestor
92775961|NCT02658721|Parasympatholytics|parasympatholytics|mesh-ancestor
92775962|NCT02658721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92775963|NCT02658721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92775964|NCT02658721|Cholinergic Agents|cholinergic agents|mesh-ancestor
92775965|NCT02658721|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92775966|NCT02658721|Sympathomimetics|sympathomimetics|mesh-ancestor
92775967|NCT02658721|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92775968|NCT02658721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92775969|NCT00629967|Interferons|interferons|mesh-list
92775970|NCT00629967|Ribavirin|ribavirin|mesh-list
92775971|NCT00629967|Interferon-alpha|interferon-alpha|mesh-list
92775972|NCT00629967|Interferon alpha-2|interferon alpha-2|mesh-list
92775973|NCT00629967|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92775974|NCT00629967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775975|NCT00629967|Antiviral Agents|antiviral agents|mesh-ancestor
92775976|NCT00629967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92775977|NCT00629967|Antimetabolites|antimetabolites|mesh-ancestor
92775978|NCT00629967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775979|NCT00629967|Immunologic Factors|immunologic factors|mesh-ancestor
92775980|NCT00629967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92775981|NCT02654587|Docetaxel|docetaxel|mesh-list
92775982|NCT02654587|Pemetrexed|pemetrexed|mesh-list
92775983|NCT02654587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92775984|NCT02654587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92775985|NCT02654587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92775986|NCT02654587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92775987|NCT02654587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775988|NCT02654587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775989|NCT02654587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92775990|NCT02654587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92775991|NCT01122264|Sildenafil Citrate|sildenafil citrate|mesh-list
92775992|NCT01122264|Tadalafil|tadalafil|mesh-list
92775993|NCT01122264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92775994|NCT01122264|Vasodilator Agents|vasodilator agents|mesh-ancestor
92775995|NCT01122264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92775996|NCT01122264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92775997|NCT01122264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92775998|NCT01122264|Urological Agents|urological agents|mesh-ancestor
92775999|NCT03288675|Serotonin|serotonin|mesh-list
92776000|NCT03288675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92776001|NCT03288675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92776002|NCT03288675|Serotonin Agents|serotonin agents|mesh-ancestor
92776003|NCT03288675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776004|NCT03288675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776005|NCT03288675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776006|NCT03288675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92776007|NCT03288675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776008|NCT00920218|Vaccines|vaccines|mesh-list
92776009|NCT00920218|Immunologic Factors|immunologic factors|mesh-ancestor
92776010|NCT00920218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776011|NCT00649519|Amlodipine|amlodipine|mesh-list
92776012|NCT00649519|Benazepril|benazepril|mesh-list
92776013|NCT00649519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92776014|NCT00649519|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92776015|NCT00649519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776016|NCT00649519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776017|NCT00649519|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92776018|NCT00649519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776019|NCT00649519|Vasodilator Agents|vasodilator agents|mesh-ancestor
92776020|NCT00649519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92776021|NCT00649519|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776022|NCT00649519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776023|NCT00629811|Mitogens|mitogens|mesh-list
92776024|NCT00629811|Mitosis Modulators|mitosis modulators|mesh-ancestor
92776025|NCT00629811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776026|NCT02652091|Interferons|interferons|mesh-list
92776027|NCT02652091|Interferon-beta|interferon-beta|mesh-list
92776028|NCT02652091|Interferon beta-1b|interferon beta-1b|mesh-list
92776029|NCT02652091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776030|NCT02652091|Antiviral Agents|antiviral agents|mesh-ancestor
92776031|NCT02652091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776032|NCT02652091|Immunologic Factors|immunologic factors|mesh-ancestor
92776033|NCT02652091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776034|NCT02652091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92776035|NCT00625560|Lamivudine|lamivudine|mesh-list
92776036|NCT00625560|Entecavir|entecavir|mesh-list
92776037|NCT00625560|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92776038|NCT00625560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92776039|NCT00625560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776040|NCT00625560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776041|NCT00625560|Antiviral Agents|antiviral agents|mesh-ancestor
92776042|NCT00625560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776043|NCT00625560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92776044|NCT00625560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92776046|NCT00650455|Valdecoxib|valdecoxib|mesh-list
92776047|NCT00650455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92776048|NCT00650455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92776049|NCT00650455|Analgesics|analgesics|mesh-ancestor
92776050|NCT00650455|Sensory System Agents|sensory system agents|mesh-ancestor
92776051|NCT00650455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776052|NCT00650455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776053|NCT00650455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776054|NCT00650455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92776055|NCT00650455|Gout Suppressants|gout suppressants|mesh-ancestor
92776056|NCT00650455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92776057|NCT00650455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776058|NCT00650455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776059|NCT00650455|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92776060|NCT02654041|Methimazole|methimazole|mesh-list
92776061|NCT02654041|Antithyroid Agents|antithyroid agents|mesh-ancestor
92776062|NCT02654041|Hormone Antagonists|hormone antagonists|mesh-ancestor
92776063|NCT02654041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776064|NCT02654041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776065|NCT02658409|Vaccines|vaccines|mesh-list
92776066|NCT02658409|Immunologic Factors|immunologic factors|mesh-ancestor
92776067|NCT02658409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776068|NCT01121562|Sunitinib|sunitinib|mesh-list
92776069|NCT01121562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776070|NCT01121562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92776071|NCT01121562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92776072|NCT01121562|Growth Substances|growth substances|mesh-ancestor
92776073|NCT01121562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776074|NCT01121562|Growth Inhibitors|growth inhibitors|mesh-ancestor
92776075|NCT01121562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92776076|NCT01121562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776077|NCT01121562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776078|NCT02658253|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92776079|NCT02658253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92776080|NCT02658253|Immunologic Factors|immunologic factors|mesh-ancestor
92776081|NCT02658253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776082|NCT02658253|Antacids|antacids|mesh-ancestor
92776083|NCT02658253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776084|NCT02658253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776085|NCT02651623|Moxifloxacin|moxifloxacin|mesh-list
92776086|NCT02651623|Sertraline|sertraline|mesh-list
92776087|NCT02651623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776088|NCT02651623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776089|NCT02651623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92776090|NCT02651623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92776091|NCT02651623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776092|NCT02651623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776093|NCT02651623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776094|NCT02651623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776095|NCT02651623|Antidepressive Agents|antidepressive agents|mesh-ancestor
92776096|NCT02651623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92776097|NCT02651623|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92776098|NCT02651623|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92776099|NCT02651623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776100|NCT02651623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776101|NCT02651623|Serotonin Agents|serotonin agents|mesh-ancestor
92776102|NCT01121484|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92776103|NCT01121484|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92776104|NCT01121484|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92776105|NCT01121484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776106|NCT01121484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776107|NCT01121484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776108|NCT01121484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776109|NCT01121484|Antidepressive Agents|antidepressive agents|mesh-ancestor
92776110|NCT01121484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92776111|NCT00650221|Pravastatin|pravastatin|mesh-list
92776112|NCT00650221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92776113|NCT00650221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92776114|NCT00650221|Antimetabolites|antimetabolites|mesh-ancestor
92776115|NCT00650221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776117|NCT00650221|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92776118|NCT00650221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776119|NCT01169675|Pemetrexed|pemetrexed|mesh-list
92776120|NCT01169675|Afatinib|afatinib|mesh-list
92776121|NCT01169675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776122|NCT01169675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776123|NCT01169675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776124|NCT01169675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92776125|NCT01169675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92776126|NCT01169675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92776127|NCT00650533|Glimepiride|glimepiride|mesh-list
92776128|NCT00650533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92776129|NCT00650533|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776130|NCT00650533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776131|NCT00650533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92776132|NCT00650533|Immunologic Factors|immunologic factors|mesh-ancestor
92776133|NCT02881866|Furosemide|furosemide|mesh-list
92776134|NCT02881866|Diuretics|diuretics|mesh-ancestor
92776135|NCT02881866|Natriuretic Agents|natriuretic agents|mesh-ancestor
92776136|NCT02881866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776137|NCT02881866|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92776138|NCT02881866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776139|NCT02881866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776140|NCT00924664|Tanezumab|tanezumab|mesh-list
92776141|NCT00924664|Analgesics|analgesics|mesh-ancestor
92776142|NCT00924664|Sensory System Agents|sensory system agents|mesh-ancestor
92776143|NCT00924664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776144|NCT00924664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776145|NCT02653651|Lidocaine|lidocaine|mesh-list
92776146|NCT02653651|Ketamine|ketamine|mesh-list
92776147|NCT02653651|Anesthetics, Local|anesthetics, local|mesh-ancestor
92776148|NCT02653651|Anesthetics|anesthetics|mesh-ancestor
92776149|NCT02653651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776150|NCT02653651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776151|NCT02653651|Sensory System Agents|sensory system agents|mesh-ancestor
92776152|NCT02653651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776153|NCT02653651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92776154|NCT02653651|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92776155|NCT02653651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92776156|NCT02653651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776157|NCT02653651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776158|NCT02653651|Analgesics|analgesics|mesh-ancestor
92776159|NCT02653651|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92776160|NCT02653651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92776161|NCT02653651|Anesthetics, General|anesthetics, general|mesh-ancestor
92776162|NCT02653651|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92776163|NCT02653651|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92776164|NCT02653651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776165|NCT02651311|Ibuprofen|ibuprofen|mesh-list
92776166|NCT02651311|Fentanyl|fentanyl|mesh-list
92776167|NCT02651311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92776168|NCT02651311|Narcotics|narcotics|mesh-ancestor
92776169|NCT02651311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776170|NCT02651311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776171|NCT02651311|Analgesics|analgesics|mesh-ancestor
92776172|NCT02651311|Sensory System Agents|sensory system agents|mesh-ancestor
92776173|NCT02651311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776175|NCT02651311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92776176|NCT02651311|Anesthetics, General|anesthetics, general|mesh-ancestor
92776177|NCT02651311|Anesthetics|anesthetics|mesh-ancestor
92776178|NCT02651311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92776179|NCT02651311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92776180|NCT02651311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776181|NCT02651311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92776182|NCT02651311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92776183|NCT02651311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776184|NCT02651311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776185|NCT02653261|Tranexamic Acid|tranexamic acid|mesh-list
92776186|NCT02653261|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92776187|NCT02653261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92776188|NCT02653261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776189|NCT02653261|Hemostatics|hemostatics|mesh-ancestor
92776190|NCT02653261|Coagulants|coagulants|mesh-ancestor
92776191|NCT02653339|Loratadine|loratadine|mesh-list
92776192|NCT02653339|Antipruritics|antipruritics|mesh-ancestor
92776193|NCT02653339|Dermatologic Agents|dermatologic agents|mesh-ancestor
92776194|NCT02653339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92776195|NCT02653339|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92776196|NCT02653339|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92776197|NCT02653339|Histamine Antagonists|histamine antagonists|mesh-ancestor
92776198|NCT02653339|Histamine Agents|histamine agents|mesh-ancestor
92776199|NCT02653339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776200|NCT02653339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776201|NCT02653339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776202|NCT00649597|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92776203|NCT00649597|Benazepril|benazepril|mesh-list
92776204|NCT00649597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92776205|NCT00649597|Diuretics|diuretics|mesh-ancestor
92776206|NCT00649597|Natriuretic Agents|natriuretic agents|mesh-ancestor
92776207|NCT00649597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776208|NCT00649597|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92776209|NCT00649597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776210|NCT00649597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776211|NCT00649597|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92776212|NCT00649597|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776213|NCT00649597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776214|NCT02653027|Ivacaftor|ivacaftor|mesh-list
92776215|NCT02653027|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92776216|NCT02653027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776217|NCT02653027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776218|NCT02652793|Lamivudine|lamivudine|mesh-list
92776219|NCT02652793|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92776220|NCT02652793|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92776221|NCT02652793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92776222|NCT02652793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776223|NCT02652793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776224|NCT02652793|Antiviral Agents|antiviral agents|mesh-ancestor
92776225|NCT02652793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776226|NCT02652793|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92776227|NCT02652793|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92776228|NCT02652793|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92776229|NCT02652793|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92776230|NCT02652793|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776231|NCT00650611|Ziprasidone|ziprasidone|mesh-list
92776232|NCT00650611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92776233|NCT00650611|Serotonin Agents|serotonin agents|mesh-ancestor
92776234|NCT00650611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776235|NCT00650611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776236|NCT00650611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776237|NCT00650611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92776238|NCT00650611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92776239|NCT00650611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776240|NCT00650611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92776241|NCT00650611|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92776242|NCT00650611|Dopamine Agents|dopamine agents|mesh-ancestor
92776243|NCT00600067|Topiramate|topiramate|mesh-list
92776244|NCT00600067|Phentermine|phentermine|mesh-list
92776245|NCT00600067|Anticonvulsants|anticonvulsants|mesh-ancestor
92776246|NCT00600067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776247|NCT00600067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776248|NCT00600067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92776249|NCT00600067|Appetite Depressants|appetite depressants|mesh-ancestor
92776250|NCT00600067|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92776251|NCT00600067|Sympathomimetics|sympathomimetics|mesh-ancestor
92776252|NCT00600067|Autonomic Agents|autonomic agents|mesh-ancestor
92776253|NCT00600067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776254|NCT00600067|Adrenergic Agents|adrenergic agents|mesh-ancestor
92776255|NCT00600067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776256|NCT00600067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776257|NCT02650609|Methylprednisolone|methylprednisolone|mesh-list
92776258|NCT02650609|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92776259|NCT02650609|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92776260|NCT02650609|Prednisolone|prednisolone|mesh-list
92776261|NCT02650609|Prednisolone acetate|prednisolone acetate|mesh-list
92776262|NCT02650609|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92776263|NCT02650609|Prednisolone phosphate|prednisolone phosphate|mesh-list
92776264|NCT02650609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776266|NCT02650609|Autonomic Agents|autonomic agents|mesh-ancestor
92776267|NCT02650609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776268|NCT02650609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776269|NCT02650609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776270|NCT02650609|Glucocorticoids|glucocorticoids|mesh-ancestor
92776271|NCT02650609|Hormones|hormones|mesh-ancestor
92776272|NCT02650609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776273|NCT02650609|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92776274|NCT02650609|Protective Agents|protective agents|mesh-ancestor
92776275|NCT02650609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92776276|NCT02650609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776277|NCT02652871|Cytarabine|cytarabine|mesh-list
92776278|NCT02652871|Idarubicin|idarubicin|mesh-list
92776279|NCT02652871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92776280|NCT02652871|Antimetabolites|antimetabolites|mesh-ancestor
92776281|NCT02652871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776282|NCT02652871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776283|NCT02652871|Antiviral Agents|antiviral agents|mesh-ancestor
92776284|NCT02652871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776285|NCT02652871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92776286|NCT02652871|Immunologic Factors|immunologic factors|mesh-ancestor
92776287|NCT02652871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776288|NCT02652871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92776289|NCT02652871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92776290|NCT02652871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92776291|NCT02652871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776292|NCT00650299|Alprazolam|alprazolam|mesh-list
92776293|NCT00650299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92776294|NCT00650299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776295|NCT00650299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776296|NCT00650299|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92776297|NCT00650299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92776298|NCT00650299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92776299|NCT00650299|GABA Modulators|gaba modulators|mesh-ancestor
92776300|NCT00650299|GABA Agents|gaba agents|mesh-ancestor
92776301|NCT00650299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776302|NCT00650299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776303|NCT04168099|Cefotaxime|cefotaxime|mesh-list
92776304|NCT04168099|Cefoxitin|cefoxitin|mesh-list
92776305|NCT04168099|Gemifloxacin|gemifloxacin|mesh-list
92776306|NCT04168099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776307|NCT04168099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776308|NCT04168099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92776309|NCT04168099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92776310|NCT04168099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776311|NCT04168099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776312|NCT04168099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776313|NCT04283877|Methylphenidate|methylphenidate|mesh-list
92776314|NCT04283877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92776315|NCT04283877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776316|NCT04283877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92776317|NCT04283877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92776318|NCT04283877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537659|NCT00141895|Abortifacient Agents|abortifacient agents|mesh-ancestor
92776319|NCT04283877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776320|NCT04283877|Dopamine Agents|dopamine agents|mesh-ancestor
92776321|NCT04283877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776322|NCT04283487|Levan|levan|mesh-list
92776323|NCT04283487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776324|NCT04283331|Proxymetacaine|proxymetacaine|mesh-list
92776325|NCT04283331|Propoxycaine|propoxycaine|mesh-list
92776326|NCT04283331|Anesthetics, Local|anesthetics, local|mesh-ancestor
92776327|NCT04283331|Anesthetics|anesthetics|mesh-ancestor
92776328|NCT04283331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776329|NCT04283331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776330|NCT04283331|Sensory System Agents|sensory system agents|mesh-ancestor
92776331|NCT04283331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776332|NCT02657473|Tobramycin|tobramycin|mesh-list
92776333|NCT02657473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92776334|NCT02657473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776335|NCT02657473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421397|NCT01511211|Antiemetics|antiemetics|mesh-ancestor
92776336|NCT02652637|Metronidazole|metronidazole|mesh-list
92776337|NCT02652637|Neomycin|neomycin|mesh-list
92776338|NCT02652637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776339|NCT02652637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776340|NCT02652637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92776341|NCT02652637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92776342|NCT02652637|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92776343|NCT02652637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776344|NCT02652637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776346|NCT00649675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92776347|NCT00649675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92776348|NCT00649675|Analgesics|analgesics|mesh-ancestor
92776349|NCT00649675|Sensory System Agents|sensory system agents|mesh-ancestor
92776350|NCT00649675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776351|NCT00649675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776352|NCT00649675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776353|NCT00649675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92776354|NCT00649675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92776355|NCT00649675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92776356|NCT00649675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776357|NCT00649675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776358|NCT02860923|Exenatide|exenatide|mesh-list
92776359|NCT02860923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776360|NCT02860923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776361|NCT02860923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92776362|NCT02860923|Incretins|incretins|mesh-ancestor
92776363|NCT02860923|Hormones|hormones|mesh-ancestor
92776364|NCT02860923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776365|NCT01121406|Paclitaxel|paclitaxel|mesh-list
92776366|NCT01121406|Gemcitabine|gemcitabine|mesh-list
92776367|NCT01121406|Doxorubicin|doxorubicin|mesh-list
92776368|NCT01121406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92776369|NCT01121406|Topotecan|topotecan|mesh-list
92776370|NCT01121406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92776371|NCT01121406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776372|NCT01121406|Tubulin Modulators|tubulin modulators|mesh-ancestor
92776373|NCT01121406|Antimitotic Agents|antimitotic agents|mesh-ancestor
92776374|NCT01121406|Mitosis Modulators|mitosis modulators|mesh-ancestor
92776375|NCT01121406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776376|NCT01121406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92776377|NCT01121406|Antimetabolites|antimetabolites|mesh-ancestor
92776378|NCT01121406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92776379|NCT01121406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92776380|NCT01121406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92776381|NCT01121406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776382|NCT01121406|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92776383|NCT02652325|Iodine|iodine|mesh-list
92776384|NCT02652325|Cadexomer iodine|cadexomer iodine|mesh-list
92776385|NCT02652325|Povidone-Iodine|povidone-iodine|mesh-list
92776386|NCT02652325|Povidone|povidone|mesh-list
92776387|NCT02652325|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92776388|NCT02652325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776389|NCT02652325|Trace Elements|trace elements|mesh-ancestor
92776390|NCT02652325|Micronutrients|micronutrients|mesh-ancestor
92776391|NCT02652325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776392|NCT02652325|Plasma Substitutes|plasma substitutes|mesh-ancestor
92776393|NCT02652325|Blood Substitutes|blood substitutes|mesh-ancestor
92776394|NCT00960687|Fenofibrate|fenofibrate|mesh-list
92776395|NCT00960687|Fenofibric acid|fenofibric acid|mesh-list
92776396|NCT00960687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92776397|NCT00960687|Antimetabolites|antimetabolites|mesh-ancestor
92776398|NCT00960687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776399|NCT00960687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92776400|NCT00960687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92776401|NCT00920140|Trametinib|trametinib|mesh-list
92776402|NCT00920140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776403|NCT00920140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92776404|NCT00920140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776405|NCT00920140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776406|NCT04032847|Pembrolizumab|pembrolizumab|mesh-list
92776407|NCT04032847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92776408|NCT04032847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776409|NCT04032847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92776410|NCT04032847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776411|NCT01120626|Donepezil|donepezil|mesh-list
92776412|NCT01120626|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92421473|NCT01511367|Hormones|hormones|mesh-ancestor
92776413|NCT01120626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776414|NCT01120626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776415|NCT01120626|Cholinergic Agents|cholinergic agents|mesh-ancestor
92776416|NCT01120626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776417|NCT01120626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776418|NCT01120626|Nootropic Agents|nootropic agents|mesh-ancestor
92776419|NCT00650377|Finasteride|finasteride|mesh-list
92776420|NCT00650377|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92776421|NCT00650377|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92776422|NCT00650377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776423|NCT00650377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776424|NCT00650377|Hormone Antagonists|hormone antagonists|mesh-ancestor
92776425|NCT00650377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776426|NCT00650377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776427|NCT00650377|Urological Agents|urological agents|mesh-ancestor
92776428|NCT02649751|Roscovitine|roscovitine|mesh-list
92776429|NCT02649751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776430|NCT02649751|Antiviral Agents|antiviral agents|mesh-ancestor
92776431|NCT02649751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776432|NCT02649751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92338161|NCT00000773|Atovaquone|atovaquone|mesh-list
92776433|NCT02649751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776434|NCT02649751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776435|NCT04252300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92776436|NCT04252300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92776437|NCT04252300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92776438|NCT04252300|Antimetabolites|antimetabolites|mesh-ancestor
92776439|NCT04252300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776440|NCT04252300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92776441|NCT04252300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92776442|NCT04252300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776443|NCT00924508|Triamcinolone|triamcinolone|mesh-list
92776444|NCT00924508|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92776445|NCT00924508|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92776446|NCT00924508|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92776447|NCT00924508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776448|NCT00924508|Glucocorticoids|glucocorticoids|mesh-ancestor
92776449|NCT00924508|Hormones|hormones|mesh-ancestor
92776450|NCT00924508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776451|NCT00924508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776452|NCT00924508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92776453|NCT00924508|Immunologic Factors|immunologic factors|mesh-ancestor
92776454|NCT00924508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776455|NCT00924508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776456|NCT00650923|Temozolomide|temozolomide|mesh-list
92776457|NCT00650923|Aflibercept|aflibercept|mesh-list
92776458|NCT00650923|Endothelial Growth Factors|endothelial growth factors|mesh-list
92776459|NCT00650923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92776460|NCT00650923|Alkylating Agents|alkylating agents|mesh-ancestor
92776461|NCT00650923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776462|NCT00650923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776463|NCT00650923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92776464|NCT00650923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92776465|NCT00650923|Growth Substances|growth substances|mesh-ancestor
92776466|NCT00650923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776467|NCT00650923|Growth Inhibitors|growth inhibitors|mesh-ancestor
92776468|NCT00637858|Lycopene|lycopene|mesh-list
92776469|NCT00637858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776470|NCT00637858|Antioxidants|antioxidants|mesh-ancestor
92776471|NCT00637858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776472|NCT00637858|Protective Agents|protective agents|mesh-ancestor
92776473|NCT00637858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776474|NCT00637858|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92776475|NCT00637858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92776476|NCT00637858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776477|NCT02657161|Vaccines|vaccines|mesh-list
92776478|NCT02657161|Immunologic Factors|immunologic factors|mesh-ancestor
92776479|NCT02657161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776480|NCT01139580|Calcipotriene|calcipotriene|mesh-list
92776481|NCT01139580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92776482|NCT04686760|Nitroglycerin|nitroglycerin|mesh-list
92776483|NCT04686760|Vasodilator Agents|vasodilator agents|mesh-ancestor
92776484|NCT04312698|Antihypertensive Agents|antihypertensive agents|mesh-list
92776485|NCT04312698|Hypolipidemic Agents|hypolipidemic agents|mesh-list
92776486|NCT04312698|Antimetabolites|antimetabolites|mesh-ancestor
92776487|NCT04312698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776488|NCT04312698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92776489|NCT04251832|Sodium thiosulfate|sodium thiosulfate|mesh-list
92776490|NCT04251832|Antidotes|antidotes|mesh-ancestor
92776491|NCT04251832|Protective Agents|protective agents|mesh-ancestor
92776492|NCT04251832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776493|NCT04251832|Antioxidants|antioxidants|mesh-ancestor
92776494|NCT04251832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776495|NCT04251832|Antitubercular Agents|antitubercular agents|mesh-ancestor
92776496|NCT04251832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776497|NCT04251832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776498|NCT04251832|Chelating Agents|chelating agents|mesh-ancestor
92776499|NCT04251832|Sequestering Agents|sequestering agents|mesh-ancestor
92776500|NCT02656771|Metronidazole|metronidazole|mesh-list
92776501|NCT02656771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776502|NCT02656771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776503|NCT02656771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92776504|NCT02656771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92776505|NCT00917644|Atorvastatin|atorvastatin|mesh-list
92776506|NCT00917644|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92776507|NCT00917644|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92776508|NCT00917644|Antimetabolites|antimetabolites|mesh-ancestor
92776509|NCT00917644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776510|NCT00917644|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92776511|NCT00917644|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92776512|NCT00917644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776513|NCT00625170|Haloperidol|haloperidol|mesh-list
92776514|NCT00625170|Olanzapine|olanzapine|mesh-list
92776515|NCT00625170|Haloperidol decanoate|haloperidol decanoate|mesh-list
92776516|NCT00625170|Antiemetics|antiemetics|mesh-ancestor
92776517|NCT00625170|Autonomic Agents|autonomic agents|mesh-ancestor
92776518|NCT00625170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776519|NCT00625170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776520|NCT00625170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776521|NCT00625170|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92776522|NCT00625170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92776523|NCT00625170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776524|NCT00625170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92776525|NCT00625170|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92776526|NCT00625170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92776527|NCT00625170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776528|NCT00625170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776529|NCT00625170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776530|NCT00625170|Serotonin Agents|serotonin agents|mesh-ancestor
92776531|NCT00625170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92776532|NCT00625170|Dopamine Agents|dopamine agents|mesh-ancestor
92776533|NCT00625170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92776534|NCT00599755|Carboplatin|carboplatin|mesh-list
92776535|NCT00599755|Gemcitabine|gemcitabine|mesh-list
92776536|NCT00599755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776537|NCT00599755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92776538|NCT00599755|Antimetabolites|antimetabolites|mesh-ancestor
92776539|NCT00599755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776540|NCT04251364|Acetazolamide|acetazolamide|mesh-list
92776541|NCT04251364|Atorvastatin|atorvastatin|mesh-list
92776542|NCT04251364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92776543|NCT04251364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92776544|NCT04251364|Antimetabolites|antimetabolites|mesh-ancestor
92776545|NCT04251364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776546|NCT04251364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92776547|NCT04251364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92776548|NCT04251364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776549|NCT04251364|Anticonvulsants|anticonvulsants|mesh-ancestor
92776550|NCT04251364|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92776551|NCT04251364|Diuretics|diuretics|mesh-ancestor
92776552|NCT04251364|Natriuretic Agents|natriuretic agents|mesh-ancestor
92776553|NCT04251364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776554|NCT04811014|Buprenorphine|buprenorphine|mesh-list
92776555|NCT04811014|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92776556|NCT04811014|Naloxone|naloxone|mesh-list
92776557|NCT04811014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92776558|NCT04811014|Narcotics|narcotics|mesh-ancestor
92776559|NCT04811014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776560|NCT04811014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776561|NCT04811014|Analgesics|analgesics|mesh-ancestor
92421621|NCT01511874|Leuprolide|leuprolide|mesh-list
92776562|NCT04811014|Sensory System Agents|sensory system agents|mesh-ancestor
92776563|NCT04811014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776564|NCT04811014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92776565|NCT02648425|Leucovorin|leucovorin|mesh-list
92776566|NCT02648425|Cisplatin|cisplatin|mesh-list
92776567|NCT02648425|Fluorouracil|fluorouracil|mesh-list
92776568|NCT02648425|Capecitabine|capecitabine|mesh-list
92776569|NCT02648425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776570|NCT02648425|Antimetabolites|antimetabolites|mesh-ancestor
92776571|NCT02648425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776572|NCT02648425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92776573|NCT02648425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92776574|NCT02648425|Immunologic Factors|immunologic factors|mesh-ancestor
92776575|NCT02648425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776576|NCT02648425|Antidotes|antidotes|mesh-ancestor
92776577|NCT02648425|Protective Agents|protective agents|mesh-ancestor
92776578|NCT02648425|Vitamin B Complex|vitamin b complex|mesh-ancestor
92776579|NCT02648425|Vitamins|vitamins|mesh-ancestor
92776580|NCT02648425|Micronutrients|micronutrients|mesh-ancestor
92776581|NCT02648503|Atropine|atropine|mesh-list
92776582|NCT02648503|Rocuronium|rocuronium|mesh-list
92776583|NCT02648503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92776584|NCT02648503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92776585|NCT02648503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92776586|NCT02648503|Autonomic Agents|autonomic agents|mesh-ancestor
92776587|NCT02648503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776588|NCT02648503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776589|NCT02648503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92776590|NCT02648503|Respiratory System Agents|respiratory system agents|mesh-ancestor
92776591|NCT02648503|Mydriatics|mydriatics|mesh-ancestor
92776592|NCT02648503|Parasympatholytics|parasympatholytics|mesh-ancestor
92776593|NCT02648503|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92776594|NCT02648503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92776595|NCT02648503|Cholinergic Agents|cholinergic agents|mesh-ancestor
92776596|NCT02648503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776597|NCT02648503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776598|NCT02648503|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92776599|NCT02648503|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92776600|NCT02648503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92776601|NCT05253508|Lidocaine|lidocaine|mesh-list
92776602|NCT05253508|Anesthetics, Local|anesthetics, local|mesh-ancestor
92776603|NCT05253508|Anesthetics|anesthetics|mesh-ancestor
92776604|NCT05253508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776605|NCT05253508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776606|NCT05253508|Sensory System Agents|sensory system agents|mesh-ancestor
92776607|NCT05253508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776608|NCT05253508|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92776609|NCT05253508|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92776610|NCT05253508|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92776611|NCT05253508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776612|NCT05253508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776613|NCT04524130|Lidocaine|lidocaine|mesh-list
92776614|NCT04524130|Ketamine|ketamine|mesh-list
92776615|NCT04524130|Anesthetics, Local|anesthetics, local|mesh-ancestor
92776616|NCT04524130|Anesthetics|anesthetics|mesh-ancestor
92776617|NCT04524130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776618|NCT04524130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776619|NCT04524130|Sensory System Agents|sensory system agents|mesh-ancestor
92776620|NCT04524130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776621|NCT04524130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92776622|NCT04524130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92776623|NCT04524130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92776624|NCT04524130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776625|NCT04524130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776626|NCT04524130|Analgesics|analgesics|mesh-ancestor
92776627|NCT04524130|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92776628|NCT04524130|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92776629|NCT04524130|Anesthetics, General|anesthetics, general|mesh-ancestor
92776630|NCT04524130|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92776631|NCT04524130|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92776632|NCT04524130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776633|NCT00649831|Amoxicillin|amoxicillin|mesh-list
92776634|NCT00649831|Azithromycin|azithromycin|mesh-list
92776635|NCT00649831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776636|NCT00649831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776637|NCT02648659|Amoxicillin|amoxicillin|mesh-list
92776638|NCT02648659|Metronidazole|metronidazole|mesh-list
92776639|NCT02648659|Clarithromycin|clarithromycin|mesh-list
92776640|NCT02648659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776641|NCT02648659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776642|NCT02648659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92776643|NCT02648659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92776644|NCT02648659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92776645|NCT02648659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776646|NCT02648659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776647|NCT02648659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92776648|NCT02648659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92776649|NCT01125930|Tretinoin|tretinoin|mesh-list
92776650|NCT01125930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776651|NCT01125930|Keratolytic Agents|keratolytic agents|mesh-ancestor
92776652|NCT01125930|Dermatologic Agents|dermatologic agents|mesh-ancestor
92776653|NCT02656615|Abiraterone Acetate|abiraterone acetate|mesh-list
92776654|NCT02656615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776655|NCT02656615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92776656|NCT02656615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776657|NCT02656615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776658|NCT02656615|Hormone Antagonists|hormone antagonists|mesh-ancestor
92776659|NCT02656615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776660|NCT02656615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776661|NCT02656615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92776662|NCT00651235|Losartan|losartan|mesh-list
92776663|NCT00651235|Propranolol|propranolol|mesh-list
92776664|NCT00651235|Atenolol|atenolol|mesh-list
92776665|NCT00651235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92776666|NCT00651235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92776667|NCT00651235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92776668|NCT00651235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92776669|NCT00651235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776670|NCT00651235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92776671|NCT00651235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92338203|NCT00000803|Zidovudine|zidovudine|mesh-list
92776672|NCT00651235|Adrenergic Agents|adrenergic agents|mesh-ancestor
92776673|NCT00651235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776674|NCT00651235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776675|NCT00651235|Vasodilator Agents|vasodilator agents|mesh-ancestor
92776676|NCT00651235|Sympatholytics|sympatholytics|mesh-ancestor
92776677|NCT00651235|Autonomic Agents|autonomic agents|mesh-ancestor
92776678|NCT00651235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776679|NCT00651235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92776680|NCT04806178|BCG Vaccine|bcg vaccine|mesh-list
92776681|NCT04806178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92776682|NCT04806178|Immunologic Factors|immunologic factors|mesh-ancestor
92776683|NCT04806178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776684|NCT04015219|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92776685|NCT04015219|Lifitegrast|lifitegrast|mesh-list
92776686|NCT04015219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92776687|NCT01137474|Dapagliflozin|dapagliflozin|mesh-list
92776688|NCT01137474|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92776689|NCT01137474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776690|NCT01137474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776691|NCT01137474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776692|NCT04790188|Nootropic Agents|nootropic agents|mesh-list
92776693|NCT01168973|Docetaxel|docetaxel|mesh-list
92776694|NCT01168973|Ramucirumab|ramucirumab|mesh-list
92776695|NCT01168973|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92776696|NCT01168973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776697|NCT01168973|Tubulin Modulators|tubulin modulators|mesh-ancestor
92776698|NCT01168973|Antimitotic Agents|antimitotic agents|mesh-ancestor
92776699|NCT01168973|Mitosis Modulators|mitosis modulators|mesh-ancestor
92776700|NCT01168973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776701|NCT01168973|Immunologic Factors|immunologic factors|mesh-ancestor
92776702|NCT01168973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776703|NCT04747912|Dexamethasone|dexamethasone|mesh-list
92776704|NCT04747912|Dexamethasone acetate|dexamethasone acetate|mesh-list
92776705|NCT04747912|Methotrexate|methotrexate|mesh-list
92776706|NCT04747912|Vincristine|vincristine|mesh-list
92776707|NCT04747912|Dasatinib|dasatinib|mesh-list
92776708|NCT04747912|Ponatinib|ponatinib|mesh-list
92776709|NCT04747912|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92776710|NCT04747912|BB 1101|bb 1101|mesh-list
92776711|NCT04747912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776712|NCT04747912|Antiemetics|antiemetics|mesh-ancestor
92776713|NCT04747912|Autonomic Agents|autonomic agents|mesh-ancestor
92776714|NCT04747912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776715|NCT04747912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776716|NCT04747912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776717|NCT04747912|Glucocorticoids|glucocorticoids|mesh-ancestor
92776718|NCT04747912|Hormones|hormones|mesh-ancestor
92776719|NCT04747912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92338229|NCT01351415|Docetaxel|docetaxel|mesh-list
92776720|NCT04747912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92776721|NCT04747912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776722|NCT04747912|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776723|NCT04747912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776724|NCT04747912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776725|NCT04747912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92776726|NCT04747912|Abortifacient Agents|abortifacient agents|mesh-ancestor
92776727|NCT04747912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92776728|NCT04747912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92776729|NCT04747912|Antimetabolites|antimetabolites|mesh-ancestor
92776730|NCT04747912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92776731|NCT04747912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92776732|NCT04747912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92776733|NCT04747912|Immunologic Factors|immunologic factors|mesh-ancestor
92776734|NCT04747912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92776735|NCT04747912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92776736|NCT04747912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92776737|NCT04747912|Tubulin Modulators|tubulin modulators|mesh-ancestor
92776738|NCT04747912|Antimitotic Agents|antimitotic agents|mesh-ancestor
92776739|NCT04747912|Mitosis Modulators|mitosis modulators|mesh-ancestor
92776740|NCT04747912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92776741|NCT04747912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92776742|NCT04747912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92776743|NCT04747912|Immunotoxins|immunotoxins|mesh-ancestor
92776744|NCT04747912|Immunoconjugates|immunoconjugates|mesh-ancestor
92776745|NCT00631618|Sunitinib|sunitinib|mesh-list
92776746|NCT00631618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776747|NCT00631618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92776748|NCT00631618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92776749|NCT00631618|Growth Substances|growth substances|mesh-ancestor
92776750|NCT00631618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776751|NCT00631618|Growth Inhibitors|growth inhibitors|mesh-ancestor
92776752|NCT00631618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92776753|NCT00631618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776754|NCT00631618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776755|NCT04431778|Ethosuximide|ethosuximide|mesh-list
92776756|NCT04431778|Anticonvulsants|anticonvulsants|mesh-ancestor
92776757|NCT04669132|Olanzapine|olanzapine|mesh-list
92776758|NCT04669132|Antiemetics|antiemetics|mesh-ancestor
92776759|NCT04669132|Autonomic Agents|autonomic agents|mesh-ancestor
92776760|NCT04669132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776761|NCT04669132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776762|NCT04669132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776763|NCT04669132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92776764|NCT04669132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92776765|NCT04669132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776766|NCT04669132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92776767|NCT04669132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92776768|NCT04669132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92776769|NCT04669132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92776770|NCT04669132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776771|NCT04669132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776772|NCT04669132|Serotonin Agents|serotonin agents|mesh-ancestor
92776773|NCT01168349|Epoetin Alfa|epoetin alfa|mesh-list
92776774|NCT01168349|Hematinics|hematinics|mesh-ancestor
92776775|NCT00915772|Metformin|metformin|mesh-list
92776776|NCT00915772|Linagliptin|linagliptin|mesh-list
92776777|NCT00915772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776778|NCT00915772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776779|NCT00915772|Incretins|incretins|mesh-ancestor
92776780|NCT00915772|Hormones|hormones|mesh-ancestor
92776781|NCT00915772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776782|NCT00915772|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92776783|NCT00915772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776784|NCT00915772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494503|NCT01975727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776785|NCT00915772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776786|NCT00632086|Aspirin|aspirin|mesh-list
92776787|NCT00632086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92776788|NCT00632086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92776790|NCT00632086|Sensory System Agents|sensory system agents|mesh-ancestor
92776791|NCT00632086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776792|NCT00632086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776793|NCT00632086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776794|NCT00632086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92776795|NCT00632086|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92776796|NCT00632086|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92776797|NCT00632086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776798|NCT00632086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92776799|NCT00632086|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92776800|NCT00632086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776801|NCT00632086|Antipyretics|antipyretics|mesh-ancestor
92776802|NCT00912964|Mirabegron|mirabegron|mesh-list
92776803|NCT00912964|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92776804|NCT00912964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92776805|NCT00912964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92776806|NCT00912964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92776807|NCT00912964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776808|NCT00912964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776809|NCT00912964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776810|NCT00912964|Urological Agents|urological agents|mesh-ancestor
92776811|NCT02641639|Fosbretabulin|fosbretabulin|mesh-list
92776812|NCT02641639|Combretastatin|combretastatin|mesh-list
92776813|NCT02641639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92776814|NCT02641639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776815|NCT02641639|Tubulin Modulators|tubulin modulators|mesh-ancestor
92776816|NCT02641639|Antimitotic Agents|antimitotic agents|mesh-ancestor
92776817|NCT02641639|Mitosis Modulators|mitosis modulators|mesh-ancestor
92776818|NCT02641639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776819|NCT02647567|Caffeine|caffeine|mesh-list
92776820|NCT02647567|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92776821|NCT02647567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776822|NCT02647567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92776823|NCT02647567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776824|NCT02647567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776825|NCT02647567|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92776826|NCT02647567|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92776827|NCT02647567|Purinergic Agents|purinergic agents|mesh-ancestor
92776828|NCT02647567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776829|NCT02647489|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92776830|NCT02647489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92776831|NCT02647489|Immunologic Factors|immunologic factors|mesh-ancestor
92776832|NCT02647489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776833|NCT02647489|Antacids|antacids|mesh-ancestor
92776834|NCT02647489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776835|NCT02647489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776836|NCT00910897|Thalidomide|thalidomide|mesh-list
92776837|NCT00910897|Dexamethasone|dexamethasone|mesh-list
92776838|NCT00910897|Dexamethasone acetate|dexamethasone acetate|mesh-list
92776839|NCT00910897|Bortezomib|bortezomib|mesh-list
92776840|NCT00910897|BB 1101|bb 1101|mesh-list
92776841|NCT00910897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776842|NCT00910897|Antiemetics|antiemetics|mesh-ancestor
92776843|NCT00910897|Autonomic Agents|autonomic agents|mesh-ancestor
92776844|NCT00910897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776845|NCT00910897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776846|NCT00910897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776847|NCT00910897|Glucocorticoids|glucocorticoids|mesh-ancestor
92776848|NCT00910897|Hormones|hormones|mesh-ancestor
92776849|NCT00910897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776850|NCT00910897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92776851|NCT00910897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776852|NCT00910897|Protease Inhibitors|protease inhibitors|mesh-ancestor
92776853|NCT00910897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776854|NCT00910897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776855|NCT00910897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92776856|NCT00910897|Immunologic Factors|immunologic factors|mesh-ancestor
92776857|NCT00910897|Leprostatic Agents|leprostatic agents|mesh-ancestor
92776858|NCT00910897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92776859|NCT00910897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776860|NCT00910897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92776861|NCT00910897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92776862|NCT00910897|Growth Substances|growth substances|mesh-ancestor
92776863|NCT00910897|Growth Inhibitors|growth inhibitors|mesh-ancestor
92776864|NCT00651547|Budesonide|budesonide|mesh-list
92776865|NCT00651547|Formoterol Fumarate|formoterol fumarate|mesh-list
92776866|NCT00651547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776867|NCT00651547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92776868|NCT00651547|Autonomic Agents|autonomic agents|mesh-ancestor
92776869|NCT00651547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776870|NCT00651547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776871|NCT00651547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92776872|NCT00651547|Respiratory System Agents|respiratory system agents|mesh-ancestor
92776873|NCT00651547|Glucocorticoids|glucocorticoids|mesh-ancestor
92776874|NCT00651547|Hormones|hormones|mesh-ancestor
92776875|NCT00651547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776876|NCT00651547|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92776877|NCT00651547|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92776878|NCT00651547|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92776879|NCT00651547|Adrenergic Agents|adrenergic agents|mesh-ancestor
92776880|NCT00651547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776881|NCT00651547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776882|NCT00912808|Donepezil|donepezil|mesh-list
92776883|NCT00912808|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92776884|NCT00912808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776885|NCT00912808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776886|NCT00912808|Cholinergic Agents|cholinergic agents|mesh-ancestor
92776887|NCT00912808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776888|NCT00912808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776889|NCT00912808|Nootropic Agents|nootropic agents|mesh-ancestor
92776890|NCT02647255|Methylprednisolone|methylprednisolone|mesh-list
92776891|NCT02647255|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92776892|NCT02647255|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92776893|NCT02647255|Prednisolone|prednisolone|mesh-list
92776894|NCT02647255|Prednisolone acetate|prednisolone acetate|mesh-list
92776895|NCT02647255|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92776896|NCT02647255|Prednisolone phosphate|prednisolone phosphate|mesh-list
92776897|NCT02647255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776898|NCT02647255|Antiemetics|antiemetics|mesh-ancestor
92776899|NCT02647255|Autonomic Agents|autonomic agents|mesh-ancestor
92776900|NCT02647255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776901|NCT02647255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776902|NCT02647255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776903|NCT02647255|Glucocorticoids|glucocorticoids|mesh-ancestor
92776904|NCT02647255|Hormones|hormones|mesh-ancestor
92776905|NCT02647255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776906|NCT02647255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92776907|NCT02647255|Protective Agents|protective agents|mesh-ancestor
92776908|NCT02647255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530101|NCT00001328|Antiviral Agents|antiviral agents|mesh-ancestor
92776909|NCT02647255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776911|NCT04329442|Emtricitabine|emtricitabine|mesh-list
92776912|NCT04329442|Antiviral Agents|antiviral agents|mesh-ancestor
92776913|NCT04329442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776914|NCT04329442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92776915|NCT04329442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92776916|NCT04329442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92776917|NCT04329442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776918|NCT04329442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92776919|NCT04329442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92776920|NCT04414228|Anesthetics|anesthetics|mesh-list
92776921|NCT04414228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92776922|NCT04414228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776923|NCT00960531|Saponin QA-21V1|saponin qa-21v1|mesh-list
92776924|NCT00960531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92776925|NCT00960531|Immunologic Factors|immunologic factors|mesh-ancestor
92776926|NCT00960531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776927|NCT03017833|Metformin|metformin|mesh-list
92776928|NCT03017833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776929|NCT03017833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776930|NCT02859909|Immunoglobulins|immunoglobulins|mesh-list
92776931|NCT02859909|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92776932|NCT02859909|Immunologic Factors|immunologic factors|mesh-ancestor
92776933|NCT02859909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776934|NCT00652639|Clonazepam|clonazepam|mesh-list
92776935|NCT00652639|Anticonvulsants|anticonvulsants|mesh-ancestor
92776936|NCT00652639|GABA Modulators|gaba modulators|mesh-ancestor
92776937|NCT00652639|GABA Agents|gaba agents|mesh-ancestor
92776938|NCT00652639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92776939|NCT00652639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776940|NCT00652639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776942|NCT02644915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92776943|NCT02644915|Antioxidants|antioxidants|mesh-ancestor
92776944|NCT02644915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776945|NCT02644915|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92776946|NCT02644915|Protective Agents|protective agents|mesh-ancestor
92776947|NCT02644915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776948|NCT00651703|Imiquimod|imiquimod|mesh-list
92776949|NCT00651703|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92776950|NCT00651703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92776951|NCT00651703|Immunologic Factors|immunologic factors|mesh-ancestor
92776952|NCT00651703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776953|NCT00651703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776954|NCT00651703|Interferon Inducers|interferon inducers|mesh-ancestor
92776955|NCT02964585|Canagliflozin|canagliflozin|mesh-list
92776956|NCT02964585|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92776957|NCT02964585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92776958|NCT02964585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92776959|NCT02964585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776960|NCT02640703|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92776961|NCT02640703|Immunologic Factors|immunologic factors|mesh-ancestor
92776962|NCT02640703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776963|NCT00651781|Bortezomib|bortezomib|mesh-list
92776964|NCT00651781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776965|NCT00957801|Methylprednisolone|methylprednisolone|mesh-list
92776966|NCT00957801|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92776967|NCT00957801|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92776968|NCT00957801|Prednisolone|prednisolone|mesh-list
92776969|NCT00957801|Prednisolone acetate|prednisolone acetate|mesh-list
92776970|NCT00957801|Methyltestosterone|methyltestosterone|mesh-list
92776971|NCT00957801|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92776972|NCT00957801|Prednisolone phosphate|prednisolone phosphate|mesh-list
92776973|NCT00957801|Testosterone|testosterone|mesh-list
92776974|NCT00957801|Testosterone undecanoate|testosterone undecanoate|mesh-list
92776975|NCT00957801|Testosterone enanthate|testosterone enanthate|mesh-list
92776976|NCT00957801|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92776977|NCT00957801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92776978|NCT00957801|Antiemetics|antiemetics|mesh-ancestor
92776979|NCT00957801|Autonomic Agents|autonomic agents|mesh-ancestor
92776980|NCT00957801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92776981|NCT00957801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92776982|NCT00957801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92776983|NCT00957801|Glucocorticoids|glucocorticoids|mesh-ancestor
92776984|NCT00957801|Hormones|hormones|mesh-ancestor
92121841|NCT03187548|Calcium|calcium|mesh-list
92776985|NCT00957801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92776987|NCT00957801|Protective Agents|protective agents|mesh-ancestor
92776988|NCT00957801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92776989|NCT00957801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92776990|NCT00957801|Androgens|androgens|mesh-ancestor
92776991|NCT00957801|Anabolic Agents|anabolic agents|mesh-ancestor
92776992|NCT02640469|Chlorhexidine|chlorhexidine|mesh-list
92776993|NCT02640469|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92776994|NCT02640469|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92776995|NCT02640469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92776996|NCT02640469|Disinfectants|disinfectants|mesh-ancestor
92776997|NCT02640469|Dermatologic Agents|dermatologic agents|mesh-ancestor
92776998|NCT02646709|Ketamine|ketamine|mesh-list
92776999|NCT02646709|Rocuronium|rocuronium|mesh-list
92777000|NCT02646709|Analgesics|analgesics|mesh-ancestor
92777001|NCT02646709|Sensory System Agents|sensory system agents|mesh-ancestor
92777002|NCT02646709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777003|NCT02646709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777004|NCT02646709|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92777005|NCT02646709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92777006|NCT02646709|Anesthetics, General|anesthetics, general|mesh-ancestor
92777007|NCT02646709|Anesthetics|anesthetics|mesh-ancestor
92777008|NCT02646709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777009|NCT02646709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92777010|NCT02646709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92777011|NCT02646709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777012|NCT02646709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777013|NCT02646709|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92777014|NCT02646709|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92777015|NCT02646709|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92777016|NCT00651859|Bimatoprost|bimatoprost|mesh-list
92777017|NCT00651859|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92777018|NCT00651859|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92777019|NCT00651859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92777020|NCT02640313|Choline|choline|mesh-list
92777021|NCT02640313|Lipotropic Agents|lipotropic agents|mesh-ancestor
92777022|NCT02640313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92777023|NCT02640313|Antimetabolites|antimetabolites|mesh-ancestor
92777024|NCT02640313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777025|NCT02640313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777026|NCT02640313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92777027|NCT02640313|Nootropic Agents|nootropic agents|mesh-ancestor
92777028|NCT02955823|Dexamethasone|dexamethasone|mesh-list
92777029|NCT02955823|Rituximab|rituximab|mesh-list
92777030|NCT02955823|Lenalidomide|lenalidomide|mesh-list
92777031|NCT02955823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777032|NCT02955823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777033|NCT02955823|Immunologic Factors|immunologic factors|mesh-ancestor
92777034|NCT02955823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777035|NCT02955823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777036|NCT02955823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777037|NCT02955823|Antiemetics|antiemetics|mesh-ancestor
92777038|NCT02955823|Autonomic Agents|autonomic agents|mesh-ancestor
92777039|NCT02955823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777040|NCT02955823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777041|NCT02955823|Glucocorticoids|glucocorticoids|mesh-ancestor
92777042|NCT02955823|Hormones|hormones|mesh-ancestor
92777043|NCT02955823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777044|NCT02955823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92777045|NCT02955823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777046|NCT02955823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777047|NCT02955823|Growth Substances|growth substances|mesh-ancestor
92777048|NCT02955823|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777049|NCT02646397|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92777050|NCT02646397|Fosinopril|fosinopril|mesh-list
92777051|NCT02646397|Benidipine|benidipine|mesh-list
92777052|NCT02646397|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92777053|NCT02646397|Diuretics|diuretics|mesh-ancestor
92777054|NCT02646397|Natriuretic Agents|natriuretic agents|mesh-ancestor
92777055|NCT02646397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777056|NCT02646397|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92777057|NCT02646397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777058|NCT02646397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777059|NCT02646397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92777060|NCT02646397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92777061|NCT02646397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777062|NCT02646397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92777063|NCT02646397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92777064|NCT02646397|Vasodilator Agents|vasodilator agents|mesh-ancestor
92777065|NCT00652795|Doxycycline|doxycycline|mesh-list
92777066|NCT00652795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92777067|NCT00652795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777068|NCT00652795|Antimalarials|antimalarials|mesh-ancestor
92777069|NCT00652795|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92777070|NCT00652795|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92777071|NCT00911170|Bevacizumab|bevacizumab|mesh-list
92777072|NCT00911170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777073|NCT00911170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777074|NCT00911170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777075|NCT00911170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777076|NCT00911170|Growth Substances|growth substances|mesh-ancestor
92777077|NCT00911170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777078|NCT00911170|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777079|NCT00910975|Interferons|interferons|mesh-list
92777080|NCT00910975|Ribavirin|ribavirin|mesh-list
92777081|NCT00910975|Interferon-alpha|interferon-alpha|mesh-list
92777082|NCT00910975|Interferon alpha-2|interferon alpha-2|mesh-list
92777083|NCT00910975|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92777084|NCT00910975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777085|NCT00910975|Antiviral Agents|antiviral agents|mesh-ancestor
92777086|NCT00910975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777087|NCT00910975|Antimetabolites|antimetabolites|mesh-ancestor
92777088|NCT00910975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777089|NCT00910975|Immunologic Factors|immunologic factors|mesh-ancestor
92777090|NCT00910975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777092|NCT01167881|Empagliflozin|empagliflozin|mesh-list
92777093|NCT01167881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92777094|NCT01167881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92777095|NCT01167881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777096|NCT01167881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777097|NCT01167881|Immunologic Factors|immunologic factors|mesh-ancestor
92777098|NCT01167881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92777099|NCT01167881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777100|NCT02646085|Carbon-11 methionine|carbon-11 methionine|mesh-list
92777101|NCT02646085|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92777102|NCT02646085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777103|NCT02639767|Pemetrexed|pemetrexed|mesh-list
92777104|NCT02639767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777105|NCT02639767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777106|NCT02639767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777107|NCT02639767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92777108|NCT02639767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92777109|NCT04829344|Carticaine|carticaine|mesh-list
92777110|NCT04829344|Anesthetics, Local|anesthetics, local|mesh-ancestor
92777111|NCT04829344|Anesthetics|anesthetics|mesh-ancestor
92777112|NCT04829344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777113|NCT04829344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777114|NCT04829344|Sensory System Agents|sensory system agents|mesh-ancestor
92777115|NCT04829344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777116|NCT00960063|Cyclophosphamide|cyclophosphamide|mesh-list
92777117|NCT00960063|Temozolomide|temozolomide|mesh-list
92777118|NCT00960063|Ifosfamide|ifosfamide|mesh-list
92777119|NCT00960063|Doxorubicin|doxorubicin|mesh-list
92777120|NCT00960063|Irinotecan|irinotecan|mesh-list
92777121|NCT00960063|Etoposide|etoposide|mesh-list
92777122|NCT00960063|Vincristine|vincristine|mesh-list
92777123|NCT00960063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777124|NCT00960063|Immunologic Factors|immunologic factors|mesh-ancestor
92777125|NCT00960063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777126|NCT00960063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777127|NCT00960063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92777128|NCT00960063|Alkylating Agents|alkylating agents|mesh-ancestor
92777129|NCT00960063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777130|NCT00960063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777131|NCT00960063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92777132|NCT00960063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92777133|NCT00960063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92777134|NCT00960063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92777135|NCT00960063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777136|NCT00960063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92777137|NCT00960063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92777138|NCT00960063|Tubulin Modulators|tubulin modulators|mesh-ancestor
92777139|NCT00960063|Antimitotic Agents|antimitotic agents|mesh-ancestor
92777140|NCT00960063|Mitosis Modulators|mitosis modulators|mesh-ancestor
92777141|NCT02646319|Sirolimus|sirolimus|mesh-list
92777142|NCT02646319|Temsirolimus|temsirolimus|mesh-list
92777143|NCT02646319|MTOR Inhibitors|mtor inhibitors|mesh-list
92777144|NCT02646319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92777145|NCT02646319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777146|NCT02646319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92777147|NCT02646319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777148|NCT02646319|Antifungal Agents|antifungal agents|mesh-ancestor
92777149|NCT02646319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777150|NCT02646319|Immunologic Factors|immunologic factors|mesh-ancestor
92777151|NCT02646319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777152|NCT02646319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92777153|NCT02646319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777154|NCT02646319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777155|NCT00653965|Atorvastatin|atorvastatin|mesh-list
92777156|NCT00653965|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92777157|NCT00653965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92777158|NCT00653965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92777159|NCT00653965|Antimetabolites|antimetabolites|mesh-ancestor
92777160|NCT00653965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777161|NCT00653965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92777162|NCT00653965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92422229|NCT01515397|Polygeline|polygeline|mesh-list
92777163|NCT00653965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777164|NCT00959907|Botulinum Toxins|botulinum toxins|mesh-list
92777165|NCT00959907|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92777166|NCT00959907|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92777167|NCT00959907|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92777168|NCT00959907|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92777169|NCT00959907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777170|NCT00959907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777171|NCT00959907|Cholinergic Agents|cholinergic agents|mesh-ancestor
92777172|NCT00959907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777173|NCT00959907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777174|NCT00959907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92777175|NCT00959907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777176|NCT00912340|Trastuzumab|trastuzumab|mesh-list
92777177|NCT00912340|Everolimus|everolimus|mesh-list
92777178|NCT00912340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777179|NCT00912340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777180|NCT00912340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92777181|NCT00912340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92777182|NCT00912340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777183|NCT00912340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777184|NCT00912340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777185|NCT00912340|Immunologic Factors|immunologic factors|mesh-ancestor
92777186|NCT00912340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777187|NCT01167257|Botulinum Toxins|botulinum toxins|mesh-list
92777188|NCT01167257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92777189|NCT01167257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92777190|NCT01167257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92777191|NCT01167257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777192|NCT01167257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777193|NCT01167257|Cholinergic Agents|cholinergic agents|mesh-ancestor
92777194|NCT01167257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777195|NCT01167257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777196|NCT01167257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92777197|NCT01167257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777198|NCT01119846|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92777199|NCT01119846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92777200|NCT01119846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777201|NCT01119846|Incretins|incretins|mesh-ancestor
92777202|NCT01119846|Hormones|hormones|mesh-ancestor
92777203|NCT01119846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777204|NCT01119846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92777205|NCT01119846|Protease Inhibitors|protease inhibitors|mesh-ancestor
92777206|NCT01119846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777207|NCT01119846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777208|NCT03775525|Capecitabine|capecitabine|mesh-list
92777209|NCT03775525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777210|NCT03775525|Antimetabolites|antimetabolites|mesh-ancestor
92777211|NCT03775525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777212|NCT03775525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777213|NCT00654043|Torsemide|torsemide|mesh-list
92777214|NCT00654043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92777215|NCT00654043|Diuretics|diuretics|mesh-ancestor
92777216|NCT00654043|Natriuretic Agents|natriuretic agents|mesh-ancestor
92777217|NCT00654043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777218|NCT00654043|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92777219|NCT00654043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777220|NCT00654043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777221|NCT04167007|Gemcitabine|gemcitabine|mesh-list
92777222|NCT04167007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777223|NCT04167007|Antimetabolites|antimetabolites|mesh-ancestor
92777224|NCT04167007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777225|NCT04167007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777226|NCT01167023|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92777227|NCT01167023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92777228|NCT00654121|Insulin|insulin|mesh-list
92777229|NCT00654121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92777230|NCT00654121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92777231|NCT00654121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777232|NCT03421288|Leucovorin|leucovorin|mesh-list
92777233|NCT03421288|Docetaxel|docetaxel|mesh-list
92777234|NCT03421288|Fluorouracil|fluorouracil|mesh-list
92777235|NCT03421288|Oxaliplatin|oxaliplatin|mesh-list
92777236|NCT03421288|Atezolizumab|atezolizumab|mesh-list
92777237|NCT03421288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777238|NCT03421288|Tubulin Modulators|tubulin modulators|mesh-ancestor
92777239|NCT03421288|Antimitotic Agents|antimitotic agents|mesh-ancestor
92777240|NCT03421288|Mitosis Modulators|mitosis modulators|mesh-ancestor
92777241|NCT03421288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777242|NCT03421288|Antimetabolites|antimetabolites|mesh-ancestor
92777243|NCT03421288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777244|NCT03421288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777245|NCT03421288|Immunologic Factors|immunologic factors|mesh-ancestor
92777246|NCT03421288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777247|NCT03421288|Antidotes|antidotes|mesh-ancestor
92777248|NCT03421288|Protective Agents|protective agents|mesh-ancestor
92777249|NCT03421288|Vitamin B Complex|vitamin b complex|mesh-ancestor
92777250|NCT03421288|Vitamins|vitamins|mesh-ancestor
92777251|NCT03421288|Micronutrients|micronutrients|mesh-ancestor
92777252|NCT03421288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92777253|NCT03421288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777254|NCT01166945|Amoxicillin|amoxicillin|mesh-list
92777255|NCT01166945|Clavulanic Acid|clavulanic acid|mesh-list
92777256|NCT01166945|Clavulanic Acids|clavulanic acids|mesh-list
92777257|NCT01166945|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92777258|NCT01166945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92777259|NCT01166945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777260|NCT01166945|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92777261|NCT01166945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777262|NCT01166945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777263|NCT02639533|Pregabalin|pregabalin|mesh-list
92777264|NCT02639533|Analgesics|analgesics|mesh-ancestor
92777265|NCT02639533|Sensory System Agents|sensory system agents|mesh-ancestor
92777266|NCT02639533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777267|NCT02639533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777268|NCT02639533|Anticonvulsants|anticonvulsants|mesh-ancestor
92777269|NCT02639533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92777270|NCT02639533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777271|NCT02639533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777272|NCT02639533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92777273|NCT02639533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92777274|NCT02639533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92777275|NCT02639533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777276|NCT02639533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92777277|NCT02639377|Chlorhexidine|chlorhexidine|mesh-list
92777278|NCT02639377|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92777279|NCT02639377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92777280|NCT02639377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777281|NCT02639377|Disinfectants|disinfectants|mesh-ancestor
92777282|NCT02639377|Dermatologic Agents|dermatologic agents|mesh-ancestor
92777283|NCT00910000|Carboplatin|carboplatin|mesh-list
92777284|NCT00910000|Gemcitabine|gemcitabine|mesh-list
92777285|NCT00910000|Vorinostat|vorinostat|mesh-list
92777286|NCT00910000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777287|NCT00910000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777288|NCT00910000|Antimetabolites|antimetabolites|mesh-ancestor
92777289|NCT00910000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777290|NCT00910000|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92777291|NCT00910000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777292|NCT02885909|Insulin|insulin|mesh-list
92777293|NCT02885909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92777294|NCT02885909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777295|NCT05657171|Cyproterone Acetate|cyproterone acetate|mesh-list
92777296|NCT05657171|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92777297|NCT05657171|Estradiol|estradiol|mesh-list
92777298|NCT05657171|Cyproterone|cyproterone|mesh-list
92777299|NCT05657171|Estrogens|estrogens|mesh-ancestor
92777300|NCT05657171|Hormones|hormones|mesh-ancestor
92777301|NCT05657171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777302|NCT05657171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777303|NCT05657171|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92777304|NCT05657171|Contraceptive Agents|contraceptive agents|mesh-ancestor
92777305|NCT05657171|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92777306|NCT05657171|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92777307|NCT05657171|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92777308|NCT05657171|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92777309|NCT05657171|Androgen Antagonists|androgen antagonists|mesh-ancestor
92777310|NCT05657171|Hormone Antagonists|hormone antagonists|mesh-ancestor
92777311|NCT05657171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777312|NCT05657171|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92777313|NCT00652873|Cabergoline|cabergoline|mesh-list
92777315|NCT00652873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92777316|NCT00652873|Dopamine Agonists|dopamine agonists|mesh-ancestor
92777317|NCT00652873|Dopamine Agents|dopamine agents|mesh-ancestor
92777318|NCT00652873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777319|NCT00652873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777320|NCT00652873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777321|NCT00652171|Lamotrigine|lamotrigine|mesh-list
92777322|NCT00652171|Anticonvulsants|anticonvulsants|mesh-ancestor
92777323|NCT00652171|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92777324|NCT00652171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777325|NCT00652171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777326|NCT00652171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92777327|NCT00652171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777328|NCT00652171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92777329|NCT00652171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92777330|NCT00652171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777331|NCT00652171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92777332|NCT00652171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92777333|NCT01119768|Esomeprazole|esomeprazole|mesh-list
92777334|NCT01119768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92777335|NCT01119768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777336|NCT01119768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92777337|NCT01119768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777338|NCT01119768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777339|NCT01165307|Naproxen|naproxen|mesh-list
92777340|NCT01165307|Levonorgestrel|levonorgestrel|mesh-list
92777341|NCT01165307|Contraceptive Agents|contraceptive agents|mesh-list
92777342|NCT01165307|Contraceptives, Oral|contraceptives, oral|mesh-list
92777343|NCT01165307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92777344|NCT01165307|Estradiol|estradiol|mesh-list
92777345|NCT01165307|Estrogens|estrogens|mesh-ancestor
92777346|NCT01165307|Hormones|hormones|mesh-ancestor
92777347|NCT01165307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777348|NCT01165307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777349|NCT01165307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92777350|NCT01165307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92777351|NCT01165307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92777352|NCT01165307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92777353|NCT01165307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92777354|NCT01165307|Analgesics|analgesics|mesh-ancestor
92777355|NCT01165307|Sensory System Agents|sensory system agents|mesh-ancestor
92777356|NCT01165307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777357|NCT01165307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777359|NCT01165307|Gout Suppressants|gout suppressants|mesh-ancestor
92777360|NCT01165307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92777361|NCT01165307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777362|NCT01165307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777363|NCT01165307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92777364|NCT02639143|Clopidogrel|clopidogrel|mesh-list
92777365|NCT02639143|Ticagrelor|ticagrelor|mesh-list
92777366|NCT02639143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92777367|NCT02639143|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92777368|NCT02639143|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92777369|NCT02639143|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92777370|NCT02639143|Purinergic Agents|purinergic agents|mesh-ancestor
92777371|NCT02639143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777372|NCT02639143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777373|NCT02639143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777374|NCT02644057|Dobutamine|dobutamine|mesh-list
92777375|NCT02644057|Milrinone|milrinone|mesh-list
92777376|NCT02644057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92777377|NCT02644057|Sympathomimetics|sympathomimetics|mesh-ancestor
92777378|NCT02644057|Autonomic Agents|autonomic agents|mesh-ancestor
92777379|NCT02644057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777380|NCT02644057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777381|NCT02644057|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92777382|NCT02644057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92777383|NCT02644057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92777384|NCT02644057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92777385|NCT02644057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422451|NCT01516580|Cytarabine|cytarabine|mesh-list
92777386|NCT02644057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777387|NCT02644057|Protective Agents|protective agents|mesh-ancestor
92777388|NCT02644057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92777389|NCT02644057|Vasodilator Agents|vasodilator agents|mesh-ancestor
92777390|NCT02644057|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92777391|NCT02644057|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92777392|NCT02644057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777393|NCT00654277|Ondansetron|ondansetron|mesh-list
92777394|NCT00654277|Antiemetics|antiemetics|mesh-ancestor
92777395|NCT00654277|Autonomic Agents|autonomic agents|mesh-ancestor
92777396|NCT00654277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777397|NCT00654277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777398|NCT00654277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777399|NCT00654277|Antipruritics|antipruritics|mesh-ancestor
92777400|NCT00654277|Dermatologic Agents|dermatologic agents|mesh-ancestor
92777401|NCT00654277|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92777402|NCT00654277|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92777403|NCT00654277|Serotonin Agents|serotonin agents|mesh-ancestor
92777404|NCT00654277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777405|NCT00654277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777406|NCT01124838|Prednisone|prednisone|mesh-list
92777407|NCT01124838|Adalimumab|adalimumab|mesh-list
92777408|NCT01124838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777409|NCT01124838|Glucocorticoids|glucocorticoids|mesh-ancestor
92777410|NCT01124838|Hormones|hormones|mesh-ancestor
92777411|NCT01124838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777412|NCT01124838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777413|NCT01124838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92777414|NCT01124838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777415|NCT01124838|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92777416|NCT01124838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777417|NCT00630435|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92777418|NCT00630435|Estrogens|estrogens|mesh-ancestor
92777419|NCT00630435|Hormones|hormones|mesh-ancestor
92777420|NCT00630435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777421|NCT00630435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777422|NCT02858193|Carbocysteine|carbocysteine|mesh-list
92777423|NCT02858193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92777424|NCT02858193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777425|NCT02858193|Expectorants|expectorants|mesh-ancestor
92777426|NCT02858193|Respiratory System Agents|respiratory system agents|mesh-ancestor
92777427|NCT02581215|Ramucirumab|ramucirumab|mesh-list
92777428|NCT02581215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777429|NCT04282941|Ibuprofen|ibuprofen|mesh-list
92777430|NCT04282941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92777431|NCT04282941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92777433|NCT04282941|Sensory System Agents|sensory system agents|mesh-ancestor
92777434|NCT04282941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777435|NCT04282941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777436|NCT04282941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777437|NCT04282941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777438|NCT04282941|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92777439|NCT04282941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777440|NCT04282941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777441|NCT00910858|Lenalidomide|lenalidomide|mesh-list
92777442|NCT00910858|Epoetin Alfa|epoetin alfa|mesh-list
92777443|NCT00910858|Immunologic Factors|immunologic factors|mesh-ancestor
92777444|NCT00910858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777445|NCT00910858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777446|NCT00910858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777447|NCT00910858|Growth Substances|growth substances|mesh-ancestor
92777448|NCT00910858|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777449|NCT00910858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777450|NCT00910858|Hematinics|hematinics|mesh-ancestor
92777451|NCT02567253|Cisplatin|cisplatin|mesh-list
92777452|NCT02567253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777453|NCT02859285|Estradiol|estradiol|mesh-list
92777454|NCT02859285|Estrogens|estrogens|mesh-ancestor
92777455|NCT02859285|Hormones|hormones|mesh-ancestor
92777456|NCT02859285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777457|NCT02859285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777458|NCT04260412|Psyllium|psyllium|mesh-list
92777459|NCT04260412|Cathartics|cathartics|mesh-ancestor
92777460|NCT04260412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777461|NCT03223155|Nivolumab|nivolumab|mesh-list
92777462|NCT03223155|Ipilimumab|ipilimumab|mesh-list
92777463|NCT03223155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777464|NCT03223155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777465|NCT03223155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92777466|NCT03223155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777467|NCT04476550|Lenograstim|lenograstim|mesh-list
92777468|NCT04476550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92777469|NCT04476550|Immunologic Factors|immunologic factors|mesh-ancestor
92777470|NCT04476550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777471|NCT00598975|Irinotecan|irinotecan|mesh-list
92777472|NCT00598975|Cetuximab|cetuximab|mesh-list
92777473|NCT00598975|Etirinotecan pegol|etirinotecan pegol|mesh-list
92777474|NCT00598975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92777475|NCT00598975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92777476|NCT00598975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777477|NCT00598975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777478|NCT00598975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777479|NCT00598975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777480|NCT00598975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92777481|NCT01124604|Tapentadol|tapentadol|mesh-list
92777482|NCT01124604|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92777483|NCT01124604|Narcotics|narcotics|mesh-ancestor
92777484|NCT01124604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777485|NCT01124604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777486|NCT01124604|Analgesics|analgesics|mesh-ancestor
92777487|NCT01124604|Sensory System Agents|sensory system agents|mesh-ancestor
92777488|NCT01124604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777489|NCT01124604|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92777490|NCT01124604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92777491|NCT01124604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777492|NCT01124604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777493|NCT01124604|Adrenergic Agents|adrenergic agents|mesh-ancestor
92777494|NCT01124604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777495|NCT00909844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92777496|NCT00909844|Luteolytic Agents|luteolytic agents|mesh-ancestor
92777497|NCT00909844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92777498|NCT00909844|Contraceptive Agents|contraceptive agents|mesh-ancestor
92777499|NCT00909844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92777500|NCT00909844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777501|NCT00909844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92777502|NCT00909844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92777503|NCT00909844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777504|NCT01124448|TFF1 protein, human|tff1 protein, human|mesh-list
92777505|NCT01124448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777506|NCT01124448|Growth Substances|growth substances|mesh-ancestor
92777507|NCT01124448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777508|NCT02638909|Ceritinib|ceritinib|mesh-list
92777509|NCT02638909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777510|NCT02638909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92777511|NCT02638909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777512|NCT02638909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777513|NCT02643823|Methotrexate|methotrexate|mesh-list
92777514|NCT02643823|Antirheumatic Agents|antirheumatic agents|mesh-list
92777515|NCT02643823|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92777516|NCT02643823|Abortifacient Agents|abortifacient agents|mesh-ancestor
92777517|NCT02643823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92777518|NCT02643823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777519|NCT02643823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777520|NCT02643823|Antimetabolites|antimetabolites|mesh-ancestor
92777521|NCT02643823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777522|NCT02643823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777523|NCT02643823|Dermatologic Agents|dermatologic agents|mesh-ancestor
92777524|NCT02643823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777525|NCT02643823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92777526|NCT02643823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777527|NCT02643823|Immunologic Factors|immunologic factors|mesh-ancestor
92777528|NCT02643823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92777529|NCT02638831|Ketorolac|ketorolac|mesh-list
92777530|NCT02638831|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92777531|NCT02638831|Ketoprofen|ketoprofen|mesh-list
92777532|NCT02638831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92777533|NCT02638831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92777534|NCT02638831|Analgesics|analgesics|mesh-ancestor
92777535|NCT02638831|Sensory System Agents|sensory system agents|mesh-ancestor
92777536|NCT02638831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777537|NCT02638831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777538|NCT02638831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777539|NCT02638831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777540|NCT02638831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92777541|NCT02638831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777542|NCT02638831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777543|NCT01136772|Haloperidol|haloperidol|mesh-list
92777544|NCT01136772|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92777545|NCT01136772|Haloperidol decanoate|haloperidol decanoate|mesh-list
92777546|NCT01136772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92777547|NCT01136772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92777548|NCT01136772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777549|NCT01136772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777550|NCT01136772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92777551|NCT01136772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92777552|NCT01136772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92777553|NCT01136772|Serotonin Agents|serotonin agents|mesh-ancestor
92777554|NCT01136772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777555|NCT01136772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777556|NCT01136772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92777557|NCT01136772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92777558|NCT01136772|Dopamine Agents|dopamine agents|mesh-ancestor
92777559|NCT01136772|Antiemetics|antiemetics|mesh-ancestor
92777560|NCT01136772|Autonomic Agents|autonomic agents|mesh-ancestor
92777561|NCT01136772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777562|NCT01136772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777563|NCT01136772|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92777564|NCT00909532|Ivacaftor|ivacaftor|mesh-list
92777565|NCT00909532|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92777566|NCT00909532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777567|NCT00909532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777568|NCT02756845|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92777569|NCT02756845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777570|NCT02756845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777571|NCT01136382|Budesonide|budesonide|mesh-list
92777572|NCT01136382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777573|NCT01136382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92777574|NCT01136382|Autonomic Agents|autonomic agents|mesh-ancestor
92777575|NCT01136382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777576|NCT01136382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777577|NCT01136382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92777578|NCT01136382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92777579|NCT01136382|Glucocorticoids|glucocorticoids|mesh-ancestor
92777580|NCT01136382|Hormones|hormones|mesh-ancestor
92777581|NCT01136382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777582|NCT03513562|Venetoclax|venetoclax|mesh-list
92777583|NCT03513562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777584|NCT02731729|Nivolumab|nivolumab|mesh-list
92777585|NCT02731729|Ipilimumab|ipilimumab|mesh-list
92777586|NCT02731729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777587|NCT02731729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777588|NCT02731729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92777589|NCT02731729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777590|NCT02645461|Palmidrol|palmidrol|mesh-list
92777591|NCT02645461|Riluzole|riluzole|mesh-list
92777592|NCT02645461|Anticonvulsants|anticonvulsants|mesh-ancestor
92494504|NCT01975727|Glucocorticoids|glucocorticoids|mesh-ancestor
92777593|NCT02645461|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92777594|NCT02645461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92777595|NCT02645461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777596|NCT02645461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777597|NCT02645461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777598|NCT02645461|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92777599|NCT02645461|Protective Agents|protective agents|mesh-ancestor
92777600|NCT02645461|Analgesics|analgesics|mesh-ancestor
92777601|NCT02645461|Sensory System Agents|sensory system agents|mesh-ancestor
92777602|NCT02645461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777603|NCT02645461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92777604|NCT02645461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92777605|NCT02645461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777606|NCT02645461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777607|NCT02645461|Antiviral Agents|antiviral agents|mesh-ancestor
92777608|NCT02645461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422672|NCT01517607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777609|NCT02645461|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92777610|NCT02645461|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92777611|NCT02645461|Hormones|hormones|mesh-ancestor
92777612|NCT02645461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777613|NCT00654589|Deferasirox|deferasirox|mesh-list
92777614|NCT00654589|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92777615|NCT00654589|Chelating Agents|chelating agents|mesh-ancestor
92777616|NCT00654589|Sequestering Agents|sequestering agents|mesh-ancestor
92777617|NCT00654589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777618|NCT02645227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92777619|NCT02645227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92777620|NCT02645227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92777621|NCT02645227|Antimetabolites|antimetabolites|mesh-ancestor
92777622|NCT02645227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777623|NCT02645227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92777624|NCT02645227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92777625|NCT02645227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777626|NCT00652483|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92777627|NCT00652483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92777628|NCT00652483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92777629|NCT00652483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92777630|NCT00652483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92777631|NCT00652483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92777632|NCT00652483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92777633|NCT00652483|Adrenergic Agents|adrenergic agents|mesh-ancestor
92777634|NCT00652483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777635|NCT00652483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777636|NCT00652483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777637|NCT01119066|Cyclophosphamide|cyclophosphamide|mesh-list
92777638|NCT01119066|Melphalan|melphalan|mesh-list
92777639|NCT01119066|Busulfan|busulfan|mesh-list
92777640|NCT01119066|Thiotepa|thiotepa|mesh-list
92777641|NCT01119066|Fludarabine|fludarabine|mesh-list
92777642|NCT01119066|Clofarabine|clofarabine|mesh-list
92777643|NCT01119066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777644|NCT01119066|Immunologic Factors|immunologic factors|mesh-ancestor
92777645|NCT01119066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777646|NCT01119066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777647|NCT01119066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92777648|NCT01119066|Alkylating Agents|alkylating agents|mesh-ancestor
92777649|NCT01119066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777650|NCT01119066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777651|NCT01119066|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92777652|NCT01119066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777653|NCT01119066|Antimetabolites|antimetabolites|mesh-ancestor
92777654|NCT00910624|Ribavirin|ribavirin|mesh-list
92777655|NCT00910624|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92777656|NCT00910624|Antimetabolites|antimetabolites|mesh-ancestor
92777657|NCT00910624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777658|NCT00910624|Antiviral Agents|antiviral agents|mesh-ancestor
92777659|NCT00910624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777660|NCT00654667|Resveratrol|resveratrol|mesh-list
92777661|NCT00654667|Antioxidants|antioxidants|mesh-ancestor
92777662|NCT00654667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777663|NCT00654667|Protective Agents|protective agents|mesh-ancestor
92777664|NCT00654667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777665|NCT00654667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777666|NCT00654667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92777667|NCT01123980|Insulin|insulin|mesh-list
92777668|NCT01123980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92777669|NCT01123980|Metformin|metformin|mesh-list
92777670|NCT01123980|Insulin Glargine|insulin glargine|mesh-list
92777671|NCT01123980|Insulin Aspart|insulin aspart|mesh-list
92777672|NCT01123980|Glimepiride|glimepiride|mesh-list
92777673|NCT01123980|Biphasic Insulins|biphasic insulins|mesh-list
92777674|NCT01123980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92777675|NCT01123980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92777676|NCT01123980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777677|NCT01123980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92777678|NCT01123980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777679|NCT01123980|Immunologic Factors|immunologic factors|mesh-ancestor
92777680|NCT02859129|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92777681|NCT02859129|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92777682|NCT02859129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92777683|NCT02859129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92777684|NCT02859129|Antimetabolites|antimetabolites|mesh-ancestor
92777685|NCT02859129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777686|NCT02859129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92777687|NCT02859129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92777688|NCT02859129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777689|NCT02859129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92777690|NCT04164823|Analgesics|analgesics|mesh-list
92777691|NCT04164823|Sensory System Agents|sensory system agents|mesh-ancestor
92777692|NCT04164823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777693|NCT04164823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777694|NCT02857959|Penicillins|penicillins|mesh-list
92777695|NCT02857959|Penicillin G|penicillin g|mesh-list
92777696|NCT02857959|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92777697|NCT02857959|Penicillin G Procaine|penicillin g procaine|mesh-list
92777698|NCT02857959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92777699|NCT02857959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777700|NCT02643433|Vaccines|vaccines|mesh-list
92777701|NCT02643433|Immunologic Factors|immunologic factors|mesh-ancestor
92777702|NCT02643433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777703|NCT00632476|Ascorbic Acid|ascorbic acid|mesh-list
92777704|NCT00632476|Vitamins|vitamins|mesh-ancestor
92777705|NCT00632476|Micronutrients|micronutrients|mesh-ancestor
92777706|NCT00632476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777707|NCT00632476|Antioxidants|antioxidants|mesh-ancestor
92777708|NCT00632476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777709|NCT00632476|Protective Agents|protective agents|mesh-ancestor
92777710|NCT04164745|Pembrolizumab|pembrolizumab|mesh-list
92777711|NCT04164745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777712|NCT04164745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777713|NCT04164745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92777714|NCT04164745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777715|NCT01198522|Gemcitabine|gemcitabine|mesh-list
92777716|NCT01198522|Antibodies|antibodies|mesh-list
92777717|NCT01198522|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92777718|NCT01198522|Immunologic Factors|immunologic factors|mesh-ancestor
92777719|NCT01198522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777720|NCT01198522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92777721|NCT01198522|Antimetabolites|antimetabolites|mesh-ancestor
92777722|NCT01198522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777723|NCT01198522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777724|NCT02638285|Clomiphene|clomiphene|mesh-list
92777725|NCT02638285|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92777726|NCT02638285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92777727|NCT02638285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777728|NCT02638285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777729|NCT02638285|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92777730|NCT02638285|Fertility Agents|fertility agents|mesh-ancestor
92777731|NCT02638285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92777732|NCT02638285|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92777733|NCT02638285|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92777734|NCT01134250|Paclitaxel|paclitaxel|mesh-list
92777735|NCT01134250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92777736|NCT01134250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777737|NCT01134250|Tubulin Modulators|tubulin modulators|mesh-ancestor
92777738|NCT01134250|Antimitotic Agents|antimitotic agents|mesh-ancestor
92777739|NCT01134250|Mitosis Modulators|mitosis modulators|mesh-ancestor
92777740|NCT01134250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777741|NCT01118520|Amlodipine|amlodipine|mesh-list
92777742|NCT01118520|Perindopril|perindopril|mesh-list
92777743|NCT01118520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92777744|NCT01118520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92777745|NCT01118520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777746|NCT01118520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777747|NCT01118520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92777748|NCT01118520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777749|NCT01118520|Vasodilator Agents|vasodilator agents|mesh-ancestor
92777750|NCT01118520|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92777751|NCT01118520|Protease Inhibitors|protease inhibitors|mesh-ancestor
92777752|NCT01118520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777753|NCT01135992|Insulin|insulin|mesh-list
92777754|NCT01135992|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92777755|NCT01135992|Insulin Glargine|insulin glargine|mesh-list
92777756|NCT01135992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92777757|NCT01135992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777759|NCT03734770|Progestins|progestins|mesh-ancestor
92777760|NCT03734770|Hormones|hormones|mesh-ancestor
92777761|NCT03734770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777762|NCT03734770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777763|NCT00959049|Vaccines|vaccines|mesh-list
92777764|NCT00959049|Immunologic Factors|immunologic factors|mesh-ancestor
92777765|NCT00959049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777766|NCT00956943|Nicotine|nicotine|mesh-list
92777767|NCT00956943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92777768|NCT00956943|Autonomic Agents|autonomic agents|mesh-ancestor
92777769|NCT00956943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777770|NCT00956943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777771|NCT00956943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92777772|NCT00956943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92777773|NCT00956943|Cholinergic Agents|cholinergic agents|mesh-ancestor
92777774|NCT00956943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777775|NCT00956943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777776|NCT01135914|Ranibizumab|ranibizumab|mesh-list
92777777|NCT01135914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777778|NCT01135914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777779|NCT01135914|Growth Substances|growth substances|mesh-ancestor
92777780|NCT01135914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777781|NCT01135914|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777782|NCT01135914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777783|NCT00907738|Vorinostat|vorinostat|mesh-list
92777784|NCT00907738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777785|NCT00907738|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92777786|NCT00907738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777787|NCT00907738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777788|NCT02829723|Spartalizumab|spartalizumab|mesh-list
92777789|NCT02829723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92777790|NCT02829723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777791|NCT02829723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777792|NCT02829723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777793|NCT01123356|Lenalidomide|lenalidomide|mesh-list
92777794|NCT01123356|Ofatumumab|ofatumumab|mesh-list
92777795|NCT01123356|Immunologic Factors|immunologic factors|mesh-ancestor
92777796|NCT01123356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122671|NCT04718116|Tramadol|tramadol|mesh-list
92777797|NCT01123356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777798|NCT01123356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777799|NCT01123356|Growth Substances|growth substances|mesh-ancestor
92777800|NCT01123356|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777801|NCT01123356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777802|NCT00630357|Levetiracetam|levetiracetam|mesh-list
92777803|NCT00630357|Anticonvulsants|anticonvulsants|mesh-ancestor
92777804|NCT00630357|Nootropic Agents|nootropic agents|mesh-ancestor
92777805|NCT02858817|Atovaquone|atovaquone|mesh-list
92777806|NCT02858817|Proguanil|proguanil|mesh-list
92777807|NCT02858817|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92777808|NCT02858817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777809|NCT02858817|Antimalarials|antimalarials|mesh-ancestor
92777810|NCT02858817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92777811|NCT02858817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92777812|NCT02858817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777813|NCT02858817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777814|NCT02858817|Antimetabolites|antimetabolites|mesh-ancestor
92777815|NCT02883192|Ondansetron|ondansetron|mesh-list
92777816|NCT02883192|Antiemetics|antiemetics|mesh-ancestor
92777817|NCT02883192|Autonomic Agents|autonomic agents|mesh-ancestor
92777818|NCT02883192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777819|NCT02883192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777820|NCT02883192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777821|NCT02883192|Antipruritics|antipruritics|mesh-ancestor
92777822|NCT02883192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92777823|NCT02883192|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92777824|NCT02883192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92777825|NCT02883192|Serotonin Agents|serotonin agents|mesh-ancestor
92777826|NCT02883192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777827|NCT02883192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777828|NCT03116529|Immunomodulating Agents|immunomodulating agents|mesh-list
92777829|NCT03116529|Immunologic Factors|immunologic factors|mesh-ancestor
92777830|NCT03116529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777831|NCT00632554|Prednisolone|prednisolone|mesh-list
92777832|NCT00632554|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92777833|NCT00632554|Methylprednisolone|methylprednisolone|mesh-list
92777834|NCT00632554|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92777835|NCT00632554|Prednisolone acetate|prednisolone acetate|mesh-list
92777836|NCT00632554|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92777837|NCT00632554|Prednisolone phosphate|prednisolone phosphate|mesh-list
92777838|NCT00632554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92777839|NCT00632554|Glucocorticoids|glucocorticoids|mesh-ancestor
92777840|NCT00632554|Hormones|hormones|mesh-ancestor
92777841|NCT00632554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777842|NCT00632554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777843|NCT00632554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92777844|NCT00632554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777845|NCT00632554|Antiemetics|antiemetics|mesh-ancestor
92777846|NCT00632554|Autonomic Agents|autonomic agents|mesh-ancestor
92777847|NCT00632554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777848|NCT00632554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777849|NCT00632554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92777850|NCT00632554|Protective Agents|protective agents|mesh-ancestor
92777851|NCT03082209|Bevacizumab|bevacizumab|mesh-list
92777852|NCT03082209|Venetoclax|venetoclax|mesh-list
92777853|NCT03082209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777854|NCT03082209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777855|NCT03082209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777856|NCT03082209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777857|NCT03082209|Growth Substances|growth substances|mesh-ancestor
92777858|NCT03082209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777859|NCT03082209|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777860|NCT02224144|Vitamin D|vitamin d|mesh-list
92777861|NCT02224144|Cholecalciferol|cholecalciferol|mesh-list
92777862|NCT02224144|Calcitriol|calcitriol|mesh-list
92777863|NCT02224144|Vitamins|vitamins|mesh-ancestor
92777864|NCT02224144|Micronutrients|micronutrients|mesh-ancestor
92777865|NCT02224144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777866|NCT02224144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92777867|NCT02224144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92777868|NCT02224144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92777869|NCT02224144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92777870|NCT02224144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777871|NCT02224144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92777872|NCT05419180|Stiripentol|stiripentol|mesh-list
92777873|NCT05419180|Anticonvulsants|anticonvulsants|mesh-ancestor
92777874|NCT04280289|Cannabidiol|cannabidiol|mesh-list
92777875|NCT04280289|Anticonvulsants|anticonvulsants|mesh-ancestor
92777876|NCT03302728|Lenalidomide|lenalidomide|mesh-list
92777877|NCT03302728|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92777878|NCT03302728|Immunologic Factors|immunologic factors|mesh-ancestor
92777879|NCT03302728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777880|NCT03302728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777881|NCT03302728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777882|NCT03302728|Growth Substances|growth substances|mesh-ancestor
92777883|NCT03302728|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777884|NCT03302728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777885|NCT03302728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777886|NCT03302728|Immunotoxins|immunotoxins|mesh-ancestor
92777887|NCT03302728|Immunoconjugates|immunoconjugates|mesh-ancestor
92777888|NCT03832972|Estrogens|estrogens|mesh-list
92777889|NCT03832972|Hormones|hormones|mesh-ancestor
92777890|NCT03832972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92777891|NCT03832972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777892|NCT02860299|Heparin|heparin|mesh-list
92777893|NCT02860299|Calcium heparin|calcium heparin|mesh-list
92777894|NCT02860299|Anticoagulants|anticoagulants|mesh-ancestor
92777895|NCT02860299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777896|NCT02860299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92777897|NCT02860299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92777898|NCT05374564|Flutemetamol|flutemetamol|mesh-list
92777899|NCT05374564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92777900|NCT05374564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777901|NCT02858505|Iron|iron|mesh-list
92777902|NCT02858505|Trace Elements|trace elements|mesh-ancestor
92777903|NCT02858505|Micronutrients|micronutrients|mesh-ancestor
92777904|NCT02858505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777905|NCT01518556|Idarubicin|idarubicin|mesh-list
92422972|NCT01519154|Anesthetics|anesthetics|mesh-ancestor
92777906|NCT01518556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92777907|NCT01518556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777908|NCT01518556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92777909|NCT01518556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92777911|NCT01518556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777912|NCT02994069|Cisplatin|cisplatin|mesh-list
92777913|NCT02994069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777914|NCT02860221|Epinephrine|epinephrine|mesh-list
92777915|NCT02860221|Tranexamic Acid|tranexamic acid|mesh-list
92777916|NCT02860221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92777917|NCT02860221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92777918|NCT02860221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777919|NCT02860221|Hemostatics|hemostatics|mesh-ancestor
92777920|NCT02860221|Coagulants|coagulants|mesh-ancestor
92777921|NCT02860221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92777922|NCT02860221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92777923|NCT02860221|Adrenergic Agents|adrenergic agents|mesh-ancestor
92777924|NCT02860221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92777925|NCT02860221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777926|NCT02860221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92777927|NCT02860221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92777928|NCT02860221|Autonomic Agents|autonomic agents|mesh-ancestor
92777929|NCT02860221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92777930|NCT02860221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92777931|NCT02860221|Respiratory System Agents|respiratory system agents|mesh-ancestor
92777932|NCT02860221|Mydriatics|mydriatics|mesh-ancestor
92777933|NCT02860221|Sympathomimetics|sympathomimetics|mesh-ancestor
92777934|NCT02860221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92777935|NCT02857569|Nivolumab|nivolumab|mesh-list
92777936|NCT02857569|Ipilimumab|ipilimumab|mesh-list
92777937|NCT02857569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777938|NCT02857569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777939|NCT02857569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92777940|NCT02857569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777941|NCT04164355|Tadalafil|tadalafil|mesh-list
92777942|NCT04164355|Vasodilator Agents|vasodilator agents|mesh-ancestor
92777943|NCT04164355|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92777944|NCT04164355|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92777945|NCT04164355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777946|NCT04164355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777947|NCT04164355|Urological Agents|urological agents|mesh-ancestor
92777949|NCT01605253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92777950|NCT01605253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92777951|NCT01605253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777952|NCT00655135|Vedolizumab|vedolizumab|mesh-list
92777953|NCT00655135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92777954|NCT02635867|Calcium, Dietary|calcium, dietary|mesh-list
92777955|NCT02635867|Calcium|calcium|mesh-list
92777956|NCT02635867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92777957|NCT02635867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777958|NCT02635867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92777959|NCT00955305|Paclitaxel|paclitaxel|mesh-list
92777960|NCT00955305|Bevacizumab|bevacizumab|mesh-list
92777961|NCT00955305|Carboplatin|carboplatin|mesh-list
92777962|NCT00955305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92777963|NCT00955305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92777964|NCT00955305|Tubulin Modulators|tubulin modulators|mesh-ancestor
92777965|NCT00955305|Antimitotic Agents|antimitotic agents|mesh-ancestor
92777966|NCT00955305|Mitosis Modulators|mitosis modulators|mesh-ancestor
92777967|NCT00955305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777968|NCT00955305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92777969|NCT00955305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92777970|NCT00955305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92777971|NCT00955305|Growth Substances|growth substances|mesh-ancestor
92777972|NCT00955305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777973|NCT00955305|Growth Inhibitors|growth inhibitors|mesh-ancestor
92777974|NCT00656695|Cyclosporine|cyclosporine|mesh-list
92777975|NCT00656695|Cyclosporins|cyclosporins|mesh-list
92777976|NCT00656695|Antifungal Agents|antifungal agents|mesh-ancestor
92777977|NCT00656695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92777978|NCT00656695|Dermatologic Agents|dermatologic agents|mesh-ancestor
92777979|NCT00656695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777980|NCT00656695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777981|NCT00656695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92777982|NCT00656695|Immunologic Factors|immunologic factors|mesh-ancestor
92777983|NCT00656695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777984|NCT00656695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92777985|NCT00656695|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92777986|NCT04204083|Hyaluronic Acid|hyaluronic acid|mesh-list
92777987|NCT04204083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92777988|NCT04204083|Immunologic Factors|immunologic factors|mesh-ancestor
92777989|NCT04204083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92777990|NCT04204083|Viscosupplements|viscosupplements|mesh-ancestor
92777991|NCT04204083|Protective Agents|protective agents|mesh-ancestor
92777992|NCT00598585|Sildenafil Citrate|sildenafil citrate|mesh-list
92777993|NCT00598585|Vasodilator Agents|vasodilator agents|mesh-ancestor
92777994|NCT00598585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92777995|NCT00598585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92777996|NCT00598585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92777997|NCT00598585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92777998|NCT00598585|Urological Agents|urological agents|mesh-ancestor
92777999|NCT02635243|Glucagon|glucagon|mesh-list
92778000|NCT02635243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778001|NCT02635243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92778002|NCT02635243|Hormones|hormones|mesh-ancestor
92778003|NCT02635243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778004|NCT00953667|Niacin|niacin|mesh-list
92778005|NCT00953667|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92778006|NCT00953667|Antimetabolites|antimetabolites|mesh-ancestor
92778007|NCT00953667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778008|NCT00953667|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92778009|NCT00953667|Vasodilator Agents|vasodilator agents|mesh-ancestor
92778010|NCT00953667|Vitamin B Complex|vitamin b complex|mesh-ancestor
92778011|NCT00953667|Vitamins|vitamins|mesh-ancestor
92778012|NCT00953667|Micronutrients|micronutrients|mesh-ancestor
92778013|NCT00953667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778014|NCT02857491|Ranibizumab|ranibizumab|mesh-list
92778015|NCT02857491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92778016|NCT02857491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92778017|NCT02857491|Growth Substances|growth substances|mesh-ancestor
92778018|NCT02857491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778019|NCT02857491|Growth Inhibitors|growth inhibitors|mesh-ancestor
92778020|NCT02857491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778021|NCT00883129|Mycophenolic Acid|mycophenolic acid|mesh-list
92778022|NCT00883129|Cyclophosphamide|cyclophosphamide|mesh-list
92778024|NCT00883129|Immunologic Factors|immunologic factors|mesh-ancestor
92778025|NCT00883129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778026|NCT00883129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778027|NCT00883129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92778028|NCT00883129|Alkylating Agents|alkylating agents|mesh-ancestor
92778029|NCT00883129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778030|NCT00883129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778031|NCT00883129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92778032|NCT00883129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92778033|NCT00883129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92778034|NCT00883129|Antitubercular Agents|antitubercular agents|mesh-ancestor
92778035|NCT00883129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778036|NCT00883129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778037|NCT00883129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778038|NCT02856867|Leucovorin|leucovorin|mesh-list
92778039|NCT02856867|Fluorouracil|fluorouracil|mesh-list
92778040|NCT02856867|Oxaliplatin|oxaliplatin|mesh-list
92778041|NCT02856867|Nintedanib|nintedanib|mesh-list
92778042|NCT02856867|Antimetabolites|antimetabolites|mesh-ancestor
92778043|NCT02856867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778044|NCT02856867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92778045|NCT02856867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778046|NCT02856867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778047|NCT02856867|Immunologic Factors|immunologic factors|mesh-ancestor
92778048|NCT02856867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778049|NCT02856867|Antidotes|antidotes|mesh-ancestor
92778050|NCT02856867|Protective Agents|protective agents|mesh-ancestor
92778051|NCT02856867|Vitamin B Complex|vitamin b complex|mesh-ancestor
92778052|NCT02856867|Vitamins|vitamins|mesh-ancestor
92778053|NCT02856867|Micronutrients|micronutrients|mesh-ancestor
92778054|NCT02856867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778055|NCT02856867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778056|NCT00630513|Ampicillin|ampicillin|mesh-list
92778057|NCT00630513|Ertapenem|ertapenem|mesh-list
92778058|NCT00630513|Sulbactam|sulbactam|mesh-list
92778059|NCT00630513|Sultamicillin|sultamicillin|mesh-list
92778060|NCT00630513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778061|NCT00630513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778062|NCT00630513|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92778063|NCT00630513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778064|NCT00630513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778066|NCT05287360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778067|NCT05287360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778068|NCT05287360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778069|NCT05287360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778070|NCT00954447|Linagliptin|linagliptin|mesh-list
92778071|NCT00954447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92778072|NCT00954447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778073|NCT00954447|Incretins|incretins|mesh-ancestor
92778074|NCT00954447|Hormones|hormones|mesh-ancestor
92778075|NCT00954447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778076|NCT00954447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92778077|NCT00954447|Protease Inhibitors|protease inhibitors|mesh-ancestor
92778078|NCT00954447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778079|NCT00954447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778080|NCT00903760|Decitabine|decitabine|mesh-list
92778081|NCT00903760|Clofarabine|clofarabine|mesh-list
92778082|NCT00903760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92778083|NCT00903760|Antimetabolites|antimetabolites|mesh-ancestor
92778084|NCT00903760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778085|NCT00903760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778086|NCT00903760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778087|NCT05273554|Pembrolizumab|pembrolizumab|mesh-list
92778088|NCT05273554|Lenvatinib|lenvatinib|mesh-list
92778089|NCT05273554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92778090|NCT05273554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778091|NCT05273554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92778092|NCT05273554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778093|NCT05273554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778094|NCT05273554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778095|NCT05177614|Micronutrients|micronutrients|mesh-list
92778096|NCT05177614|Trace Elements|trace elements|mesh-list
92778097|NCT05177614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778099|NCT04202536|Antiviral Agents|antiviral agents|mesh-ancestor
92778100|NCT04202536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778101|NCT04202536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92778102|NCT04202536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92778103|NCT04202536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778104|NCT04202536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778105|NCT04202536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92778106|NCT04202536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92778107|NCT02794402|Exenatide|exenatide|mesh-list
92778108|NCT02794402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92778109|NCT02794402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778110|NCT02794402|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92778111|NCT02794402|Incretins|incretins|mesh-ancestor
92778112|NCT02794402|Hormones|hormones|mesh-ancestor
92778113|NCT02794402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778114|NCT00883051|Lasmiditan|lasmiditan|mesh-list
92778115|NCT00883051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92778116|NCT00883051|Serotonin Agents|serotonin agents|mesh-ancestor
92778117|NCT00883051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778118|NCT00883051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778119|NCT00883051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778120|NCT03395587|Temozolomide|temozolomide|mesh-list
92778121|NCT03395587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92778122|NCT03395587|Alkylating Agents|alkylating agents|mesh-ancestor
92778123|NCT03395587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778124|NCT03395587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778125|NCT00903682|Efavirenz|efavirenz|mesh-list
92778126|NCT00903682|Etravirine|etravirine|mesh-list
92338438|NCT00000881|Antiviral Agents|antiviral agents|mesh-ancestor
92778127|NCT00903682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92778128|NCT00903682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92778129|NCT00903682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778130|NCT00903682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778131|NCT00903682|Antiviral Agents|antiviral agents|mesh-ancestor
92778132|NCT00903682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778133|NCT00903682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92778134|NCT00903682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92778135|NCT00903682|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92778136|NCT00903682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92778137|NCT00903682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92778138|NCT00903682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92778139|NCT00655603|Pancrelipase|pancrelipase|mesh-list
92778140|NCT00655603|Hormones|hormones|mesh-list
92778141|NCT00655603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778142|NCT00655603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778143|NCT00655603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92778144|NCT02715466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92778145|NCT00655681|Pamidronate|pamidronate|mesh-list
92778146|NCT00655681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92778147|NCT00655681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778148|NCT04221568|Fentanyl|fentanyl|mesh-list
92778149|NCT04221568|Bupivacaine|bupivacaine|mesh-list
92778150|NCT04221568|Levobupivacaine|levobupivacaine|mesh-list
92778151|NCT04221568|Anesthetics, Local|anesthetics, local|mesh-ancestor
92778152|NCT04221568|Anesthetics|anesthetics|mesh-ancestor
92778153|NCT04221568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778154|NCT04221568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778155|NCT04221568|Sensory System Agents|sensory system agents|mesh-ancestor
92778156|NCT04221568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778157|NCT04221568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92778158|NCT04221568|Narcotics|narcotics|mesh-ancestor
92778159|NCT04221568|Analgesics|analgesics|mesh-ancestor
92778160|NCT04221568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92778161|NCT04221568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92778162|NCT04221568|Anesthetics, General|anesthetics, general|mesh-ancestor
92778163|NCT01135524|Buprenorphine|buprenorphine|mesh-list
92778164|NCT01135524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92778165|NCT01135524|Narcotics|narcotics|mesh-ancestor
92778166|NCT01135524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778167|NCT01135524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778168|NCT01135524|Analgesics|analgesics|mesh-ancestor
92778169|NCT01135524|Sensory System Agents|sensory system agents|mesh-ancestor
92778170|NCT01135524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778171|NCT01135524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92778172|NCT00948675|Paclitaxel|paclitaxel|mesh-list
92778173|NCT00948675|Bevacizumab|bevacizumab|mesh-list
92778174|NCT00948675|Carboplatin|carboplatin|mesh-list
92778175|NCT00948675|Pemetrexed|pemetrexed|mesh-list
92778176|NCT00948675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92778177|NCT00948675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778178|NCT00948675|Tubulin Modulators|tubulin modulators|mesh-ancestor
92778179|NCT00948675|Antimitotic Agents|antimitotic agents|mesh-ancestor
92778180|NCT00948675|Mitosis Modulators|mitosis modulators|mesh-ancestor
92778181|NCT00948675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778182|NCT00948675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92778183|NCT00948675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92778184|NCT00948675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92778185|NCT00948675|Growth Substances|growth substances|mesh-ancestor
92778186|NCT00948675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778187|NCT00948675|Growth Inhibitors|growth inhibitors|mesh-ancestor
92778188|NCT00948675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778189|NCT00948675|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92778190|NCT00948675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92778191|NCT02642497|Ketamine|ketamine|mesh-list
92778192|NCT02642497|Analgesics|analgesics|mesh-ancestor
92778193|NCT02642497|Sensory System Agents|sensory system agents|mesh-ancestor
92778194|NCT02642497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778195|NCT02642497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778196|NCT02642497|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92778197|NCT02642497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92778198|NCT02642497|Anesthetics, General|anesthetics, general|mesh-ancestor
92778199|NCT02642497|Anesthetics|anesthetics|mesh-ancestor
92778200|NCT02642497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778201|NCT02642497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92778202|NCT02642497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92778203|NCT02642497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778204|NCT02642497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778205|NCT04273581|Thalidomide|thalidomide|mesh-list
92778206|NCT04273581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778207|NCT04273581|Immunologic Factors|immunologic factors|mesh-ancestor
92778208|NCT04273581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778209|NCT04273581|Leprostatic Agents|leprostatic agents|mesh-ancestor
92778210|NCT04273581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778211|NCT04273581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778212|NCT04273581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92778213|NCT04273581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92778214|NCT04273581|Growth Substances|growth substances|mesh-ancestor
92778215|NCT04273581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92778216|NCT04273581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778217|NCT01110408|Amoxicillin|amoxicillin|mesh-list
92778218|NCT01110408|Clavulanic Acid|clavulanic acid|mesh-list
92778219|NCT01110408|Clavulanic Acids|clavulanic acids|mesh-list
92778220|NCT01110408|Cefepime|cefepime|mesh-list
92778221|NCT01110408|Doripenem|doripenem|mesh-list
92778222|NCT01110408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92778223|NCT01110408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778224|NCT01110408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778225|NCT01110408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92778226|NCT01110408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778227|NCT01110408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778228|NCT00953043|Lubiprostone|lubiprostone|mesh-list
92778229|NCT00953043|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92778230|NCT00953043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778231|NCT00953043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778232|NCT02850484|Budesonide|budesonide|mesh-list
92778233|NCT02850484|Formoterol Fumarate|formoterol fumarate|mesh-list
92778234|NCT02850484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778235|NCT02850484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92778236|NCT02850484|Autonomic Agents|autonomic agents|mesh-ancestor
92778237|NCT02850484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778238|NCT02850484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778239|NCT02850484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92778240|NCT02850484|Respiratory System Agents|respiratory system agents|mesh-ancestor
92778241|NCT02850484|Glucocorticoids|glucocorticoids|mesh-ancestor
92778242|NCT02850484|Hormones|hormones|mesh-ancestor
92530115|NCT00017160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778243|NCT02850484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778244|NCT02850484|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92778245|NCT02850484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92778246|NCT02850484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92778247|NCT02850484|Adrenergic Agents|adrenergic agents|mesh-ancestor
92778248|NCT02850484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778249|NCT02850484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778250|NCT01135134|Mometasone Furoate|mometasone furoate|mesh-list
92778251|NCT01135134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778252|NCT01135134|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778253|NCT01135134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92778254|NCT00948441|Ethanol|ethanol|mesh-list
92778255|NCT00948441|Heparin|heparin|mesh-list
92778256|NCT00948441|Anticoagulants|anticoagulants|mesh-ancestor
92778257|NCT00948441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92778258|NCT00948441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92778259|NCT00948441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778260|NCT00948441|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92778261|NCT00948441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778262|NCT00948441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778263|NCT00948441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778264|NCT02849782|4-Aminopyridine|4-aminopyridine|mesh-list
92778265|NCT02849782|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92778266|NCT02849782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778267|NCT02849782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778268|NCT00630903|Methoxsalen|methoxsalen|mesh-list
92778269|NCT00630903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92778270|NCT00630903|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778271|NCT02883426|Vaccines|vaccines|mesh-list
92778272|NCT02883426|Immunologic Factors|immunologic factors|mesh-ancestor
92778273|NCT02883426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778274|NCT02849314|Immunomodulating Agents|immunomodulating agents|mesh-list
92778275|NCT02849314|Immunologic Factors|immunologic factors|mesh-ancestor
92778276|NCT02849314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778277|NCT02849236|Ropivacaine|ropivacaine|mesh-list
92778278|NCT02849236|Anesthetics, Local|anesthetics, local|mesh-ancestor
92778279|NCT02849236|Anesthetics|anesthetics|mesh-ancestor
92778280|NCT02849236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778281|NCT02849236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778282|NCT02849236|Sensory System Agents|sensory system agents|mesh-ancestor
92778283|NCT02849236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778284|NCT02856789|Hemostatics|hemostatics|mesh-list
92778285|NCT02856789|Coagulants|coagulants|mesh-ancestor
92778286|NCT01117350|Metformin|metformin|mesh-list
92778287|NCT01117350|Insulin Glargine|insulin glargine|mesh-list
92778288|NCT01117350|Liraglutide|liraglutide|mesh-list
92778289|NCT01117350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92778290|NCT01117350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778291|NCT01117350|Incretins|incretins|mesh-ancestor
92778293|NCT01117350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778294|NCT00952731|Tamoxifen|tamoxifen|mesh-list
92778295|NCT00952731|Afimoxifene|afimoxifene|mesh-list
92778296|NCT00952731|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92778297|NCT00952731|Hormone Antagonists|hormone antagonists|mesh-ancestor
92778298|NCT00952731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778299|NCT00952731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778300|NCT00952731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92778301|NCT00952731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778302|NCT00952731|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92778303|NCT00952731|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92778304|NCT00952731|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92778305|NCT04202224|Acetaminophen|acetaminophen|mesh-list
92778306|NCT04202224|Ibuprofen|ibuprofen|mesh-list
92778307|NCT04202224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92778308|NCT04202224|Analgesics|analgesics|mesh-ancestor
92778309|NCT04202224|Sensory System Agents|sensory system agents|mesh-ancestor
92778310|NCT04202224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778311|NCT04202224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778312|NCT04202224|Antipyretics|antipyretics|mesh-ancestor
92778313|NCT04202224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92778314|NCT04202224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778315|NCT04202224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778316|NCT04202224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92778317|NCT04202224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338467|NCT00000923|Indinavir|indinavir|mesh-list
92778318|NCT04202224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778319|NCT00947427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92778320|NCT00947427|Immunologic Factors|immunologic factors|mesh-ancestor
92778321|NCT00947427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778323|NCT02848612|Calcium heparin|calcium heparin|mesh-list
92778324|NCT02848612|Anticoagulants|anticoagulants|mesh-ancestor
92778325|NCT02848612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92778326|NCT02848612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92778327|NCT02848612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778328|NCT04811404|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92778329|NCT04811404|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92778330|NCT04811404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92778331|NCT04235062|Furosemide|furosemide|mesh-list
92778332|NCT04235062|Calcium|calcium|mesh-list
92778333|NCT04235062|Diuretics|diuretics|mesh-list
92778334|NCT04235062|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92778335|NCT04235062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92778336|NCT04235062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778337|NCT04235062|Natriuretic Agents|natriuretic agents|mesh-ancestor
92778338|NCT04235062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778339|NCT04235062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778340|NCT02848768|Sunitinib|sunitinib|mesh-list
92778341|NCT02848768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778342|NCT02848768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92778343|NCT02848768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92778344|NCT02848768|Growth Substances|growth substances|mesh-ancestor
92778345|NCT02848768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778346|NCT02848768|Growth Inhibitors|growth inhibitors|mesh-ancestor
92778347|NCT02848768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778348|NCT02848768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778349|NCT02848768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778350|NCT02848300|Bimatoprost|bimatoprost|mesh-list
92778351|NCT02848300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92778352|NCT00953745|Aripiprazole|aripiprazole|mesh-list
92778353|NCT00953745|Escitalopram|escitalopram|mesh-list
92778354|NCT00953745|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92778355|NCT00953745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92778356|NCT00953745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778357|NCT00953745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778358|NCT00953745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778359|NCT00953745|Serotonin Agents|serotonin agents|mesh-ancestor
92778360|NCT00953745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778361|NCT00953745|Antidepressive Agents|antidepressive agents|mesh-ancestor
92778362|NCT00953745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92778363|NCT00953745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92778364|NCT00953745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92778365|NCT00953745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778366|NCT00953745|Dopamine Agonists|dopamine agonists|mesh-ancestor
92778367|NCT00953745|Dopamine Agents|dopamine agents|mesh-ancestor
92778368|NCT00953745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92778369|NCT00953745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92778370|NCT00953745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92778371|NCT00953745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92778372|NCT00953745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92778373|NCT00953745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92778374|NCT04202380|Azithromycin|azithromycin|mesh-list
92778375|NCT04202380|Ampicillin|ampicillin|mesh-list
92778376|NCT04202380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778377|NCT04202380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778378|NCT02847442|Levodopa|levodopa|mesh-list
92778379|NCT02847442|Opicapone|opicapone|mesh-list
92778380|NCT02847442|Dopa Decarboxylase|dopa decarboxylase|mesh-list
92778381|NCT02847442|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
92778382|NCT02847442|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92778383|NCT02847442|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92778384|NCT02847442|Dopamine Agents|dopamine agents|mesh-ancestor
92778385|NCT02847442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494505|NCT01975727|Hormones|hormones|mesh-ancestor
92778386|NCT02847442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778387|NCT02847442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778388|NCT02847442|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92778389|NCT02847442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778390|NCT04736602|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92778391|NCT04736602|Luteolytic Agents|luteolytic agents|mesh-ancestor
92778392|NCT04736602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92778393|NCT04736602|Contraceptive Agents|contraceptive agents|mesh-ancestor
92778394|NCT04736602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92778395|NCT04736602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778396|NCT04736602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92778397|NCT04736602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92778398|NCT04736602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778399|NCT01478698|Plasminogen|plasminogen|mesh-list
92778400|NCT01478698|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92778401|NCT01478698|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92778402|NCT01478698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92778403|NCT01478698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778404|NCT01199380|Nicotine|nicotine|mesh-list
92778405|NCT01199380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92778406|NCT01199380|Autonomic Agents|autonomic agents|mesh-ancestor
92778407|NCT01199380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778408|NCT01199380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778409|NCT01199380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92778410|NCT01199380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92778411|NCT01199380|Cholinergic Agents|cholinergic agents|mesh-ancestor
92778412|NCT01199380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778413|NCT01199380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778414|NCT02847286|Dapivirine|dapivirine|mesh-list
92778415|NCT02847286|Clotrimazole|clotrimazole|mesh-list
92778416|NCT02847286|Miconazole|miconazole|mesh-list
92778417|NCT02847286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92778418|NCT02847286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92778419|NCT02847286|Antiviral Agents|antiviral agents|mesh-ancestor
92778420|NCT02847286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778421|NCT02847286|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92778422|NCT02847286|Antifungal Agents|antifungal agents|mesh-ancestor
92778423|NCT02847286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92778424|NCT02847286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92778425|NCT02847286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778426|NCT02847286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778427|NCT02847286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92778428|NCT02847286|Hormone Antagonists|hormone antagonists|mesh-ancestor
92778429|NCT02847286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778430|NCT02847286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778431|NCT02847286|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92778432|NCT02847286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92778433|NCT00902668|Lovastatin|lovastatin|mesh-list
92423481|NCT01522612|Vitamins|vitamins|mesh-ancestor
92778435|NCT00902668|Dihydromevinolin|dihydromevinolin|mesh-list
92778436|NCT00902668|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92778437|NCT00902668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92778438|NCT00902668|Antimetabolites|antimetabolites|mesh-ancestor
92778439|NCT00902668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778440|NCT00902668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92778441|NCT00902668|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92778442|NCT00902668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778443|NCT00433420|Paclitaxel|paclitaxel|mesh-list
92778444|NCT00433420|Cyclophosphamide|cyclophosphamide|mesh-list
92778445|NCT00433420|Fluorouracil|fluorouracil|mesh-list
92778446|NCT00433420|Epirubicin|epirubicin|mesh-list
92778447|NCT00433420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92778448|NCT00433420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778449|NCT00433420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92778450|NCT00433420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92778451|NCT00433420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92778452|NCT00433420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778453|NCT00433420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778454|NCT00433420|Immunologic Factors|immunologic factors|mesh-ancestor
92778455|NCT00433420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778456|NCT00433420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778457|NCT00433420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92778458|NCT00433420|Alkylating Agents|alkylating agents|mesh-ancestor
92778459|NCT00433420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92778460|NCT00433420|Antimetabolites|antimetabolites|mesh-ancestor
92778461|NCT00433420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92778462|NCT00433420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92778463|NCT00433420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92778464|NCT00433420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92778465|NCT00433420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778466|NCT04202068|Ceftriaxone|ceftriaxone|mesh-list
92778467|NCT04202068|Sulbactam|sulbactam|mesh-list
92778468|NCT04202068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778469|NCT04202068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778470|NCT04202068|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92778471|NCT04202068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778472|NCT04202068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778473|NCT02850250|Cefuroxime|cefuroxime|mesh-list
92778474|NCT02850250|Cefuroxime axetil|cefuroxime axetil|mesh-list
92778475|NCT02850250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778476|NCT02850250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778477|NCT05012644|Palbociclib|palbociclib|mesh-list
92778478|NCT05012644|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92778479|NCT05012644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778480|NCT05012644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778481|NCT05012644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778482|NCT05012644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778483|NCT05012644|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92778484|NCT05012644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92778485|NCT05012644|Hormone Antagonists|hormone antagonists|mesh-ancestor
92778486|NCT05012644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778487|NCT05012644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778488|NCT02846506|Metformin|metformin|mesh-list
92778489|NCT02846506|Canagliflozin|canagliflozin|mesh-list
92778490|NCT02846506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92778491|NCT02846506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778492|NCT02846506|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92778493|NCT02846506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778494|NCT02846428|Cyclophosphamide|cyclophosphamide|mesh-list
92778495|NCT02846428|Docetaxel|docetaxel|mesh-list
92778496|NCT02846428|Fluorouracil|fluorouracil|mesh-list
92778497|NCT02846428|Capecitabine|capecitabine|mesh-list
92778498|NCT02846428|Epirubicin|epirubicin|mesh-list
92778499|NCT02846428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778500|NCT02846428|Immunologic Factors|immunologic factors|mesh-ancestor
92778501|NCT02846428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778502|NCT02846428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778503|NCT02846428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92778504|NCT02846428|Alkylating Agents|alkylating agents|mesh-ancestor
92778505|NCT02846428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778506|NCT02846428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778507|NCT02846428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92778508|NCT02846428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92338505|NCT00000929|Nonoxynol|nonoxynol|mesh-list
92778509|NCT02846428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92778510|NCT02846428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92778511|NCT02846428|Antimetabolites|antimetabolites|mesh-ancestor
92778512|NCT02846428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92778513|NCT02846428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92778514|NCT02846428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92778515|NCT02846428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92778516|NCT02846428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778517|NCT03561376|Petrolatum|petrolatum|mesh-list
92778518|NCT03561376|Zinc Oxide|zinc oxide|mesh-list
92778519|NCT03561376|Emollients|emollients|mesh-ancestor
92778520|NCT03561376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778521|NCT03561376|Sunscreening Agents|sunscreening agents|mesh-ancestor
92778522|NCT03561376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92778523|NCT03561376|Protective Agents|protective agents|mesh-ancestor
92778524|NCT03561376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778525|NCT02844712|beta-Lactams|beta-lactams|mesh-list
92778526|NCT02844712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778527|NCT02844712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778528|NCT00947349|Interferons|interferons|mesh-list
92778529|NCT00947349|Ribavirin|ribavirin|mesh-list
92778530|NCT00947349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778531|NCT00947349|Antiviral Agents|antiviral agents|mesh-ancestor
92778532|NCT00947349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778533|NCT00947349|Antimetabolites|antimetabolites|mesh-ancestor
92778534|NCT00947349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778535|NCT03425812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92778536|NCT03425812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92778537|NCT03425812|Analgesics|analgesics|mesh-ancestor
92778538|NCT03425812|Sensory System Agents|sensory system agents|mesh-ancestor
92778539|NCT03425812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778540|NCT03425812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778541|NCT03425812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778542|NCT03425812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778543|NCT02845804|Everolimus|everolimus|mesh-list
92778544|NCT02845804|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92778545|NCT02845804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778546|NCT02845804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778547|NCT02845804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778548|NCT02845804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778549|NCT02845804|Immunologic Factors|immunologic factors|mesh-ancestor
92778550|NCT02845804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778551|NCT02845804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778552|NCT02844634|Tenofovir|tenofovir|mesh-list
92778553|NCT02844634|Emtricitabine|emtricitabine|mesh-list
92778554|NCT02844634|Doxycycline|doxycycline|mesh-list
92778555|NCT02844634|Antiviral Agents|antiviral agents|mesh-ancestor
92778556|NCT02844634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778557|NCT02844634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92778558|NCT02844634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92778559|NCT02844634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778560|NCT02844634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778561|NCT02844634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92778562|NCT02844634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92778563|NCT02844634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778564|NCT02844634|Antimalarials|antimalarials|mesh-ancestor
92778565|NCT02844634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92778566|NCT02844634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92778567|NCT02845648|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92778568|NCT02845648|Cholinergic Agents|cholinergic agents|mesh-ancestor
92778569|NCT02845648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778570|NCT02845648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778571|NCT02845648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778572|NCT00952419|Vaccines|vaccines|mesh-list
92778573|NCT00952419|Immunologic Factors|immunologic factors|mesh-ancestor
92778574|NCT00952419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778575|NCT02844322|Rituximab|rituximab|mesh-list
92778576|NCT02844322|Bortezomib|bortezomib|mesh-list
92778577|NCT02844322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92778578|NCT02844322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778579|NCT02844322|Immunologic Factors|immunologic factors|mesh-ancestor
92778580|NCT02844322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778581|NCT02844322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778582|NCT02845570|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92778583|NCT02845570|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92778584|NCT02845570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778585|NCT01996605|Oxytocin|oxytocin|mesh-list
92778586|NCT01996605|Oxytocics|oxytocics|mesh-ancestor
92778587|NCT01996605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92778588|NCT01996605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778589|NCT00630981|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92778590|NCT00630981|Escitalopram|escitalopram|mesh-list
92778591|NCT00630981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92778592|NCT00630981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92778593|NCT00630981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778594|NCT00630981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778595|NCT00630981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778596|NCT00630981|Serotonin Agents|serotonin agents|mesh-ancestor
92778597|NCT00630981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778598|NCT00630981|Antidepressive Agents|antidepressive agents|mesh-ancestor
92778599|NCT00630981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92778600|NCT00630981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92778601|NCT00630981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92778602|NCT00630981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778603|NCT00952341|Dexamethasone|dexamethasone|mesh-list
92778604|NCT00952341|Dexamethasone acetate|dexamethasone acetate|mesh-list
92778605|NCT00952341|Aprepitant|aprepitant|mesh-list
92778606|NCT00952341|Fosaprepitant|fosaprepitant|mesh-list
92778607|NCT00952341|Granisetron|granisetron|mesh-list
92778608|NCT00952341|BB 1101|bb 1101|mesh-list
92778609|NCT00952341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778610|NCT00952341|Antiemetics|antiemetics|mesh-ancestor
92778611|NCT00952341|Autonomic Agents|autonomic agents|mesh-ancestor
92778612|NCT00952341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778613|NCT00952341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778614|NCT00952341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92778616|NCT00952341|Hormones|hormones|mesh-ancestor
92778617|NCT00952341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778618|NCT00952341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92778619|NCT00952341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778620|NCT00952341|Protease Inhibitors|protease inhibitors|mesh-ancestor
92778621|NCT00952341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778622|NCT00952341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778623|NCT00952341|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92778624|NCT00952341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778625|NCT00952341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92778626|NCT00952341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92778627|NCT00952341|Serotonin Agents|serotonin agents|mesh-ancestor
92778628|NCT02845024|Doxycycline|doxycycline|mesh-list
92778629|NCT02845024|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778630|NCT02845024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778631|NCT02845024|Antimalarials|antimalarials|mesh-ancestor
92778632|NCT02845024|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92778633|NCT02845024|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92778634|NCT02853903|Immunomodulating Agents|immunomodulating agents|mesh-list
92778635|NCT02853903|Immunologic Factors|immunologic factors|mesh-ancestor
92778636|NCT02853903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778637|NCT05242120|Anesthetics|anesthetics|mesh-list
92778638|NCT05242120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778639|NCT05242120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778640|NCT01909089|Chloroprocaine|chloroprocaine|mesh-list
92778641|NCT01909089|Anesthetics, Local|anesthetics, local|mesh-ancestor
92778642|NCT01909089|Anesthetics|anesthetics|mesh-ancestor
92778643|NCT01909089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778644|NCT01909089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778645|NCT01909089|Sensory System Agents|sensory system agents|mesh-ancestor
92778646|NCT01909089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778647|NCT02844790|Insulin|insulin|mesh-list
92778648|NCT02844790|Insulin Aspart|insulin aspart|mesh-list
92778649|NCT02844790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92778650|NCT02844790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778651|NCT02856243|Antiviral Agents|antiviral agents|mesh-list
92778652|NCT02856243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778653|NCT04410328|Aspirin|aspirin|mesh-list
92778654|NCT04410328|Dipyridamole|dipyridamole|mesh-list
92778655|NCT04410328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92778656|NCT04410328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92778657|NCT04410328|Analgesics|analgesics|mesh-ancestor
92778658|NCT04410328|Sensory System Agents|sensory system agents|mesh-ancestor
92778659|NCT04410328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778660|NCT04410328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423717|NCT01523431|Antidotes|antidotes|mesh-ancestor
92778661|NCT04410328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778662|NCT04410328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778663|NCT04410328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92778664|NCT04410328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92778665|NCT04410328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778666|NCT04410328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92778667|NCT04410328|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92778668|NCT04410328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778669|NCT04410328|Antipyretics|antipyretics|mesh-ancestor
92778670|NCT04410328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92778671|NCT04410328|Vasodilator Agents|vasodilator agents|mesh-ancestor
92778672|NCT02852577|Clonazepam|clonazepam|mesh-list
92778673|NCT02852577|Paroxetine|paroxetine|mesh-list
92778674|NCT02852577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92778675|NCT02852577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92778676|NCT02852577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778677|NCT02852577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778678|NCT02852577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778679|NCT02852577|Serotonin Agents|serotonin agents|mesh-ancestor
92778680|NCT02852577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778681|NCT02852577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92778682|NCT02852577|Antidepressive Agents|antidepressive agents|mesh-ancestor
92778683|NCT02852577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92778684|NCT02852577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92778685|NCT02852577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92778686|NCT02852577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778688|NCT02852577|GABA Modulators|gaba modulators|mesh-ancestor
92778689|NCT02852577|GABA Agents|gaba agents|mesh-ancestor
92778690|NCT00902044|Cyclophosphamide|cyclophosphamide|mesh-list
92778691|NCT00902044|Fludarabine|fludarabine|mesh-list
92778692|NCT00902044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92778693|NCT00902044|Immunologic Factors|immunologic factors|mesh-ancestor
92778694|NCT00902044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778695|NCT00902044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778696|NCT00902044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92778697|NCT00902044|Alkylating Agents|alkylating agents|mesh-ancestor
92778698|NCT00902044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778699|NCT00902044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778700|NCT00902044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92778701|NCT04201990|Apatinib|apatinib|mesh-list
92778702|NCT04201990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778703|NCT04201990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778704|NCT04201990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778705|NCT04201990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778706|NCT00632866|Hydroxychloroquine|hydroxychloroquine|mesh-list
92778707|NCT00632866|Antimalarials|antimalarials|mesh-ancestor
92778708|NCT00632866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92778709|NCT00632866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92778710|NCT00632866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778711|NCT00632866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778712|NCT00632866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778713|NCT00632866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778714|NCT00901186|Ranibizumab|ranibizumab|mesh-list
92778715|NCT00901186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92778716|NCT00901186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92778717|NCT00901186|Growth Substances|growth substances|mesh-ancestor
92778718|NCT00901186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778719|NCT00901186|Growth Inhibitors|growth inhibitors|mesh-ancestor
92778720|NCT00901186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778721|NCT05040880|Telmisartan|telmisartan|mesh-list
92778722|NCT05040880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92778723|NCT05040880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92778724|NCT05040880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92778725|NCT05040880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778726|NCT04073290|Rifaximin|rifaximin|mesh-list
92778727|NCT04073290|Lactulose|lactulose|mesh-list
92778728|NCT04073290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778729|NCT04073290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778730|NCT04073290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92778731|NCT03763162|Dexamethasone|dexamethasone|mesh-list
92778732|NCT03763162|Dexamethasone acetate|dexamethasone acetate|mesh-list
92778733|NCT03763162|Bortezomib|bortezomib|mesh-list
92778734|NCT03763162|Daratumumab|daratumumab|mesh-list
92778735|NCT03763162|Ixazomib|ixazomib|mesh-list
92778736|NCT03763162|Ichthammol|ichthammol|mesh-list
92778737|NCT03763162|BB 1101|bb 1101|mesh-list
92778738|NCT03763162|Glycine|glycine|mesh-list
92778739|NCT03763162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778740|NCT03763162|Antiemetics|antiemetics|mesh-ancestor
92778741|NCT03763162|Autonomic Agents|autonomic agents|mesh-ancestor
92778742|NCT03763162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778743|NCT03763162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778744|NCT03763162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92778745|NCT03763162|Glucocorticoids|glucocorticoids|mesh-ancestor
92778746|NCT03763162|Hormones|hormones|mesh-ancestor
92778747|NCT03763162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778748|NCT03763162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92778749|NCT03763162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778750|NCT03763162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92778751|NCT03763162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778752|NCT03763162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778753|NCT03763162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778754|NCT03763162|Glycine Agents|glycine agents|mesh-ancestor
92778755|NCT03763162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778756|NCT03936790|Fentanyl|fentanyl|mesh-list
92778757|NCT03936790|Ropivacaine|ropivacaine|mesh-list
92778759|NCT03936790|Anesthetics|anesthetics|mesh-ancestor
92778760|NCT03936790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778761|NCT03936790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778762|NCT03936790|Sensory System Agents|sensory system agents|mesh-ancestor
92778763|NCT03936790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778764|NCT03936790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92778765|NCT03936790|Narcotics|narcotics|mesh-ancestor
92778766|NCT03936790|Analgesics|analgesics|mesh-ancestor
92778767|NCT03936790|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92778768|NCT03936790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92778769|NCT03936790|Anesthetics, General|anesthetics, general|mesh-ancestor
92778770|NCT04782700|Prednisone|prednisone|mesh-list
92778771|NCT04782700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778772|NCT04782700|Glucocorticoids|glucocorticoids|mesh-ancestor
92778773|NCT04782700|Hormones|hormones|mesh-ancestor
92778774|NCT04782700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778775|NCT04782700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778776|NCT04782700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92778777|NCT04782700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778778|NCT03711448|Prednisone|prednisone|mesh-list
92778779|NCT03711448|Ustekinumab|ustekinumab|mesh-list
92778780|NCT03711448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778781|NCT03711448|Glucocorticoids|glucocorticoids|mesh-ancestor
92778782|NCT03711448|Hormones|hormones|mesh-ancestor
92778783|NCT03711448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778784|NCT03711448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778785|NCT03711448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92778786|NCT03711448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778787|NCT03711448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778788|NCT00885703|Fluconazole|fluconazole|mesh-list
92778789|NCT00885703|Amphotericin B|amphotericin b|mesh-list
92778790|NCT00885703|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92778791|NCT00885703|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92778792|NCT00885703|Deoxycholic Acid|deoxycholic acid|mesh-list
92778793|NCT00885703|Antifungal Agents|antifungal agents|mesh-ancestor
92778794|NCT00885703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778795|NCT00885703|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92778796|NCT00885703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92778797|NCT00885703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778798|NCT00885703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778799|NCT00885703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92778800|NCT00885703|Hormone Antagonists|hormone antagonists|mesh-ancestor
92778801|NCT00885703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778802|NCT00885703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778803|NCT00885703|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92778804|NCT00885703|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92778805|NCT00885703|Amebicides|amebicides|mesh-ancestor
92778806|NCT00885703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92778807|NCT00885703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92778808|NCT00885703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778809|NCT00885703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92778810|NCT00885703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92778811|NCT02642419|Aspirin|aspirin|mesh-list
92778812|NCT02642419|Rivaroxaban|rivaroxaban|mesh-list
92778814|NCT02642419|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92778815|NCT02642419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92778816|NCT02642419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92778817|NCT02642419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92778818|NCT02642419|Analgesics|analgesics|mesh-ancestor
92778819|NCT02642419|Sensory System Agents|sensory system agents|mesh-ancestor
92778820|NCT02642419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778821|NCT02642419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778822|NCT02642419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778823|NCT02642419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778824|NCT02642419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92778825|NCT02642419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92778826|NCT02642419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778827|NCT02642419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92778828|NCT02642419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778829|NCT02642419|Antipyretics|antipyretics|mesh-ancestor
92778830|NCT02642419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92778831|NCT02642419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92778832|NCT02642419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92778834|NCT02642419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778835|NCT02642419|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92778836|NCT02642419|Antithrombins|antithrombins|mesh-ancestor
92778837|NCT02642419|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92778838|NCT02642419|Protease Inhibitors|protease inhibitors|mesh-ancestor
92778839|NCT02642419|Anticoagulants|anticoagulants|mesh-ancestor
92778840|NCT00901576|Methylphenidate|methylphenidate|mesh-list
92778841|NCT00901576|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92778842|NCT00901576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778843|NCT00901576|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92778844|NCT00901576|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92778845|NCT00901576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778846|NCT00901576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778847|NCT00901576|Dopamine Agents|dopamine agents|mesh-ancestor
92778848|NCT00901576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778849|NCT00655837|Rituximab|rituximab|mesh-list
92778850|NCT00655837|Dacetuzumab|dacetuzumab|mesh-list
92778851|NCT00655837|Gemcitabine|gemcitabine|mesh-list
92778852|NCT00655837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92778853|NCT00655837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778854|NCT00655837|Immunologic Factors|immunologic factors|mesh-ancestor
92778855|NCT00655837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778856|NCT00655837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778857|NCT00655837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92778858|NCT00655837|Antimetabolites|antimetabolites|mesh-ancestor
92778859|NCT00655837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778860|NCT00655915|Betamethasone|betamethasone|mesh-list
92778861|NCT00655915|Lidocaine|lidocaine|mesh-list
92778862|NCT00655915|Anesthetics, Local|anesthetics, local|mesh-ancestor
92778863|NCT00655915|Anesthetics|anesthetics|mesh-ancestor
92778864|NCT00655915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778865|NCT00655915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778866|NCT00655915|Sensory System Agents|sensory system agents|mesh-ancestor
92778867|NCT00655915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778868|NCT00655915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92778869|NCT00655915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92778870|NCT00655915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92778871|NCT00655915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778872|NCT00655915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778873|NCT00655915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778874|NCT00655915|Glucocorticoids|glucocorticoids|mesh-ancestor
92778875|NCT00655915|Hormones|hormones|mesh-ancestor
92778876|NCT00655915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92778877|NCT00655915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92778878|NCT00655915|Respiratory System Agents|respiratory system agents|mesh-ancestor
92778879|NCT02637193|Moxifloxacin|moxifloxacin|mesh-list
92778880|NCT02637193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92778881|NCT02637193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92778882|NCT02637193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778883|NCT02637193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92778884|NCT02637193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92423932|NCT01524705|Exenatide|exenatide|mesh-list
92778886|NCT02637193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778887|NCT02637193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778888|NCT02637193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778889|NCT02637193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92778890|NCT02637193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92778891|NCT02637193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92778892|NCT02637193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778893|NCT02637193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92778894|NCT02637193|Antidepressive Agents|antidepressive agents|mesh-ancestor
92778895|NCT02637193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92778896|NCT00656773|Sufentanil|sufentanil|mesh-list
92778897|NCT00656773|Morphine|morphine|mesh-list
92778898|NCT00656773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92778899|NCT00656773|Narcotics|narcotics|mesh-ancestor
92778900|NCT00656773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778901|NCT00656773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778903|NCT00656773|Sensory System Agents|sensory system agents|mesh-ancestor
92778904|NCT00656773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778905|NCT00656773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92778906|NCT00656773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92778907|NCT00656773|Anesthetics, General|anesthetics, general|mesh-ancestor
92778908|NCT00656773|Anesthetics|anesthetics|mesh-ancestor
92778909|NCT00882583|Cisplatin|cisplatin|mesh-list
92778910|NCT00882583|Cetuximab|cetuximab|mesh-list
92778911|NCT00882583|Dasatinib|dasatinib|mesh-list
92778912|NCT00882583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778913|NCT00882583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92778914|NCT00882583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92778915|NCT00882583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92778916|NCT00882583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778917|NCT04481308|Fentanyl|fentanyl|mesh-list
92778918|NCT04481308|Propofol|propofol|mesh-list
92778919|NCT04481308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92778920|NCT04481308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778921|NCT04481308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778922|NCT04481308|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92778923|NCT04481308|Anesthetics, General|anesthetics, general|mesh-ancestor
92778924|NCT04481308|Anesthetics|anesthetics|mesh-ancestor
92778925|NCT04481308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92778926|NCT04481308|Narcotics|narcotics|mesh-ancestor
92778927|NCT04481308|Analgesics|analgesics|mesh-ancestor
92778928|NCT04481308|Sensory System Agents|sensory system agents|mesh-ancestor
92778929|NCT04481308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778930|NCT04481308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92778931|NCT02634541|Adalimumab|adalimumab|mesh-list
92778932|NCT02634541|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92778933|NCT02634541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778934|NCT02634541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778935|NCT04475848|Midazolam|midazolam|mesh-list
92778936|NCT04475848|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92778937|NCT04475848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92778938|NCT04475848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778939|NCT04475848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778940|NCT04475848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92778941|NCT04475848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92778942|NCT04475848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92778943|NCT04475848|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92778944|NCT04475848|Anesthetics, General|anesthetics, general|mesh-ancestor
92778945|NCT04475848|Anesthetics|anesthetics|mesh-ancestor
92778946|NCT04475848|GABA Modulators|gaba modulators|mesh-ancestor
92778947|NCT04475848|GABA Agents|gaba agents|mesh-ancestor
92778948|NCT04475848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92778949|NCT04475848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778950|NCT00599521|Adapalene|adapalene|mesh-list
92778951|NCT00599521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92778952|NCT00599521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92778953|NCT00599521|Analgesics|analgesics|mesh-ancestor
92778954|NCT00599521|Sensory System Agents|sensory system agents|mesh-ancestor
92778955|NCT00599521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92778956|NCT00599521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778957|NCT00599521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778958|NCT00599521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92778959|NCT00599521|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778960|NCT04201678|Anesthetics|anesthetics|mesh-list
92778961|NCT04201678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92778962|NCT04201678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778964|NCT00653341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92778965|NCT00653341|Insulin Glargine|insulin glargine|mesh-list
92778966|NCT00653341|Isophane Insulin, Human|isophane insulin, human|mesh-list
92778967|NCT00653341|Insulin, Isophane|insulin, isophane|mesh-list
92778968|NCT00653341|Isophane insulin, beef|isophane insulin, beef|mesh-list
92778969|NCT00653341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92778970|NCT00653341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778971|NCT02642263|Carbetocin|carbetocin|mesh-list
92778972|NCT02642263|Oxytocics|oxytocics|mesh-ancestor
92778973|NCT02642263|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92778974|NCT02642263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92778975|NCT00779740|Mometasone Furoate|mometasone furoate|mesh-list
92778976|NCT00779740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92778977|NCT00779740|Dermatologic Agents|dermatologic agents|mesh-ancestor
92778978|NCT00779740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92778979|NCT02636803|Albendazole|albendazole|mesh-list
92778980|NCT02636803|Oxfendazole|oxfendazole|mesh-list
92778981|NCT02636803|Anthelmintics|anthelmintics|mesh-ancestor
92778982|NCT02636803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92778983|NCT02636803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92778984|NCT02636803|Anticestodal Agents|anticestodal agents|mesh-ancestor
92778985|NCT02636803|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92778986|NCT02636803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92778987|NCT02636803|Tubulin Modulators|tubulin modulators|mesh-ancestor
92778988|NCT02636803|Antimitotic Agents|antimitotic agents|mesh-ancestor
92778989|NCT02636803|Mitosis Modulators|mitosis modulators|mesh-ancestor
92778990|NCT02636803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92778991|NCT02636803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92778992|NCT02636803|Antinematodal Agents|antinematodal agents|mesh-ancestor
92778993|NCT02634463|Olanzapine|olanzapine|mesh-list
92778994|NCT02634463|Risperidone|risperidone|mesh-list
92778995|NCT02634463|Aripiprazole|aripiprazole|mesh-list
92778996|NCT02634463|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92778997|NCT02634463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92778998|NCT02634463|Serotonin Agents|serotonin agents|mesh-ancestor
92778999|NCT02634463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779000|NCT02634463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779001|NCT02634463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779002|NCT02634463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92779003|NCT02634463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779004|NCT02634463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779005|NCT02634463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779006|NCT02634463|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92779007|NCT02634463|Dopamine Agents|dopamine agents|mesh-ancestor
92779008|NCT02634463|Antiemetics|antiemetics|mesh-ancestor
92779009|NCT02634463|Autonomic Agents|autonomic agents|mesh-ancestor
92779010|NCT02634463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779011|NCT02634463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779012|NCT02634463|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92779013|NCT02634463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92779014|NCT02634463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92779015|NCT02634463|Antidepressive Agents|antidepressive agents|mesh-ancestor
92779016|NCT02634463|Dopamine Agonists|dopamine agonists|mesh-ancestor
92779017|NCT02634463|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92779018|NCT02634463|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92779019|NCT02634463|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92779020|NCT02634463|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92779021|NCT00882115|Sulforaphane|sulforaphane|mesh-list
92779022|NCT00882115|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92779023|NCT00882115|Protective Agents|protective agents|mesh-ancestor
92779024|NCT00882115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779025|NCT00882115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779026|NCT00653419|Buspirone|buspirone|mesh-list
92779027|NCT00653419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92779028|NCT00653419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779029|NCT00653419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779030|NCT00653419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779031|NCT00653419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779032|NCT00653419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92779033|NCT00653419|Serotonin Agents|serotonin agents|mesh-ancestor
92424083|NCT01525823|Metformin|metformin|mesh-list
92779034|NCT00653419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779035|NCT00653419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779036|NCT00884377|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92779037|NCT00884377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92779038|NCT00884377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92779039|NCT00884377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779040|NCT00884377|Schistosomicides|schistosomicides|mesh-ancestor
92779041|NCT00884377|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92779042|NCT00884377|Anthelmintics|anthelmintics|mesh-ancestor
92779043|NCT00656929|Vitamin D|vitamin d|mesh-list
92779044|NCT00656929|Cholecalciferol|cholecalciferol|mesh-list
92779045|NCT00656929|Vitamins|vitamins|mesh-ancestor
92779046|NCT00656929|Micronutrients|micronutrients|mesh-ancestor
92779047|NCT00656929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779048|NCT00656929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92779049|NCT00656929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92779051|NCT00884221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92779052|NCT00884221|Fertility Agents|fertility agents|mesh-ancestor
92779053|NCT00884221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779054|NCT00884221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779055|NCT02153632|Amantadine|amantadine|mesh-list
92779056|NCT02153632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92779057|NCT02153632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92779058|NCT02153632|Antiviral Agents|antiviral agents|mesh-ancestor
92779059|NCT02153632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779060|NCT02153632|Dopamine Agents|dopamine agents|mesh-ancestor
92779061|NCT02153632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779062|NCT02153632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779063|NCT02153632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779064|NCT02153632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779065|NCT02153632|Analgesics|analgesics|mesh-ancestor
92779066|NCT02153632|Sensory System Agents|sensory system agents|mesh-ancestor
92779067|NCT02153632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779068|NCT01934452|Sunitinib|sunitinib|mesh-list
92779069|NCT01934452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779070|NCT01934452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92779071|NCT01934452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92779072|NCT01934452|Growth Substances|growth substances|mesh-ancestor
92779073|NCT01934452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779074|NCT01934452|Growth Inhibitors|growth inhibitors|mesh-ancestor
92779075|NCT01934452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92779076|NCT01934452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779077|NCT01934452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779078|NCT03524326|Cetuximab|cetuximab|mesh-list
92779079|NCT03524326|Lenvatinib|lenvatinib|mesh-list
92779080|NCT03524326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92779081|NCT03524326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779082|NCT03524326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92779083|NCT03524326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779084|NCT03524326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779085|NCT01236430|Atorvastatin|atorvastatin|mesh-list
92779086|NCT01236430|Ezetimibe|ezetimibe|mesh-list
92779087|NCT01236430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92779088|NCT01236430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92779089|NCT01236430|Antimetabolites|antimetabolites|mesh-ancestor
92779090|NCT01236430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779091|NCT01236430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92779092|NCT01236430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92779093|NCT01236430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779094|NCT00726856|Ezetimibe|ezetimibe|mesh-list
92779095|NCT00726856|Fenofibrate|fenofibrate|mesh-list
92779096|NCT00726856|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92779097|NCT00726856|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92779098|NCT00726856|Antimetabolites|antimetabolites|mesh-ancestor
92779099|NCT00726856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779100|NCT00726856|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92779101|NCT00651274|Ezetimibe|ezetimibe|mesh-list
92779102|NCT00651274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92779103|NCT00651274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92779104|NCT00651274|Antimetabolites|antimetabolites|mesh-ancestor
92779105|NCT00651274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779106|NCT00651274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92779107|NCT00212836|Olanzapine|olanzapine|mesh-list
92779108|NCT00212836|Asenapine|asenapine|mesh-list
92779109|NCT00212836|Antiemetics|antiemetics|mesh-ancestor
92779110|NCT00212836|Autonomic Agents|autonomic agents|mesh-ancestor
92779111|NCT00212836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779112|NCT00212836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779114|NCT00212836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92779115|NCT00212836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779116|NCT00212836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779117|NCT00212836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779118|NCT00212836|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92779119|NCT00212836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92779120|NCT00212836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92779121|NCT00212836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779122|NCT00212836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779123|NCT00212836|Serotonin Agents|serotonin agents|mesh-ancestor
92779124|NCT00805324|Desloratadine|desloratadine|mesh-list
92779125|NCT00805324|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92779126|NCT00805324|Cholinergic Agents|cholinergic agents|mesh-ancestor
92779127|NCT00805324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779128|NCT00805324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779129|NCT00805324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779130|NCT00805324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92779131|NCT00805324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92779132|NCT00805324|Histamine Antagonists|histamine antagonists|mesh-ancestor
92779133|NCT00805324|Histamine Agents|histamine agents|mesh-ancestor
92779134|NCT00157924|Atorvastatin|atorvastatin|mesh-list
92779135|NCT00157924|Simvastatin|simvastatin|mesh-list
92779137|NCT00157924|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92779138|NCT00157924|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92779139|NCT00157924|Antimetabolites|antimetabolites|mesh-ancestor
92779140|NCT00157924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779141|NCT00157924|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92779142|NCT00157924|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92779143|NCT00157924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779144|NCT00794794|Cetirizine|cetirizine|mesh-list
92779145|NCT00794794|Desloratadine|desloratadine|mesh-list
92779146|NCT00794794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92779147|NCT00794794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92779148|NCT00794794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92779149|NCT00794794|Histamine Antagonists|histamine antagonists|mesh-ancestor
92779150|NCT00794794|Histamine Agents|histamine agents|mesh-ancestor
92779151|NCT00794794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779152|NCT00794794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779153|NCT00794794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779154|NCT00794794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92779155|NCT00794794|Cholinergic Agents|cholinergic agents|mesh-ancestor
92779156|NCT03612466|Plerixafor|plerixafor|mesh-list
92779157|NCT03612466|Calcium Carbonate|calcium carbonate|mesh-list
92779158|NCT03612466|Calcium|calcium|mesh-list
92779159|NCT03612466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92779160|NCT03612466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779161|NCT03612466|Antacids|antacids|mesh-ancestor
92779162|NCT03612466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779163|NCT03612466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779164|NCT03612466|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92779165|NCT03612466|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92779166|NCT03612466|Antiviral Agents|antiviral agents|mesh-ancestor
92779167|NCT03612466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779168|NCT00142558|Indomethacin|indomethacin|mesh-list
92779169|NCT00142558|Etoricoxib|etoricoxib|mesh-list
92779170|NCT00142558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779171|NCT00142558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779172|NCT00142558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779173|NCT00142558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92779174|NCT00142558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779175|NCT00142558|Analgesics|analgesics|mesh-ancestor
92779176|NCT00142558|Sensory System Agents|sensory system agents|mesh-ancestor
92779177|NCT00142558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779178|NCT00142558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779179|NCT00142558|Gout Suppressants|gout suppressants|mesh-ancestor
92779180|NCT00142558|Tocolytic Agents|tocolytic agents|mesh-ancestor
92779181|NCT00142558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779182|NCT00142558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92779183|NCT00142558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779184|NCT00142558|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92779185|NCT02842294|Bevacizumab|bevacizumab|mesh-list
92424234|NCT01526499|Docetaxel|docetaxel|mesh-list
92779186|NCT02842294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92779187|NCT02842294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779188|NCT02842294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92779189|NCT02842294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92779190|NCT02842294|Growth Substances|growth substances|mesh-ancestor
92779191|NCT02842294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779192|NCT02842294|Growth Inhibitors|growth inhibitors|mesh-ancestor
92779193|NCT02841982|Morphine|morphine|mesh-list
92779194|NCT02841982|Ropivacaine|ropivacaine|mesh-list
92779195|NCT02841982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124063|NCT02416102|Losartan|losartan|mesh-list
92779197|NCT02841982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779198|NCT02841982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779199|NCT02841982|Analgesics|analgesics|mesh-ancestor
92779200|NCT02841982|Sensory System Agents|sensory system agents|mesh-ancestor
92779201|NCT02841982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779202|NCT02841982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92779203|NCT02841982|Anesthetics|anesthetics|mesh-ancestor
92779204|NCT02843698|Dexmedetomidine|dexmedetomidine|mesh-list
92779205|NCT02843698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92779206|NCT02843698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779207|NCT02843698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779208|NCT02843698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779209|NCT02843698|Analgesics|analgesics|mesh-ancestor
92779210|NCT02843698|Sensory System Agents|sensory system agents|mesh-ancestor
92779211|NCT02843698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779212|NCT02843698|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92779213|NCT02843698|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92779214|NCT02843698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92779215|NCT02843698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92779216|NCT02843698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779217|NCT02843698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779218|NCT00690898|Lanreotide|lanreotide|mesh-list
92779219|NCT00690898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779220|NCT02841202|Contraceptive Agents|contraceptive agents|mesh-list
92779221|NCT02841202|Contraceptives, Oral|contraceptives, oral|mesh-list
92779222|NCT02841202|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92779223|NCT02841202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779224|NCT02841202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779225|NCT02841202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92779226|NCT00895414|Doxorubicin|doxorubicin|mesh-list
92779227|NCT00895414|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92779228|NCT00895414|Enalapril|enalapril|mesh-list
92779229|NCT00895414|Enalaprilat|enalaprilat|mesh-list
92779230|NCT00895414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92779231|NCT00895414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779232|NCT00895414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92779233|NCT00895414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92779234|NCT00895414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779235|NCT00895414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779236|NCT00895414|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92779237|NCT00895414|Protease Inhibitors|protease inhibitors|mesh-ancestor
92779238|NCT00895414|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92779239|NCT01822288|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92779240|NCT01822288|Tibolone|tibolone|mesh-list
92779241|NCT01822288|Medroxyprogesterone|medroxyprogesterone|mesh-list
92779242|NCT01822288|Estradiol|estradiol|mesh-list
92779243|NCT01822288|Estrogens|estrogens|mesh-ancestor
92779244|NCT01822288|Hormones|hormones|mesh-ancestor
92779245|NCT01822288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779246|NCT01822288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779247|NCT01822288|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92779248|NCT01822288|Contraceptive Agents|contraceptive agents|mesh-ancestor
92779249|NCT01822288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779250|NCT01822288|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92779251|NCT01822288|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92779252|NCT01822288|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92779253|NCT01822288|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92779254|NCT01822288|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92779255|NCT01822288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92779256|NCT01822288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779257|NCT01822288|Androgen Antagonists|androgen antagonists|mesh-ancestor
92779258|NCT01822288|Hormone Antagonists|hormone antagonists|mesh-ancestor
92779259|NCT01822288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92779260|NCT01822288|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92779261|NCT01822288|Anabolic Agents|anabolic agents|mesh-ancestor
92779262|NCT01328626|Venetoclax|venetoclax|mesh-list
92779263|NCT01328626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779264|NCT02840812|Nemonoxacin|nemonoxacin|mesh-list
92779265|NCT02840812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779266|NCT02840812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779267|NCT01212770|Thalidomide|thalidomide|mesh-list
92779268|NCT01212770|Apremilast|apremilast|mesh-list
92779269|NCT01212770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92779270|NCT01212770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779272|NCT01212770|Sensory System Agents|sensory system agents|mesh-ancestor
92779273|NCT01212770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779274|NCT01212770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779275|NCT01212770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779276|NCT01212770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779277|NCT01212770|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92779278|NCT01212770|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92779279|NCT01212770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779280|NCT01212770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779281|NCT01212770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92779282|NCT01212770|Immunologic Factors|immunologic factors|mesh-ancestor
92779283|NCT01212770|Leprostatic Agents|leprostatic agents|mesh-ancestor
92779284|NCT01212770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779285|NCT01212770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779286|NCT01212770|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92779287|NCT01212770|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92779288|NCT01212770|Growth Substances|growth substances|mesh-ancestor
92779289|NCT01212770|Growth Inhibitors|growth inhibitors|mesh-ancestor
92779290|NCT01212770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779291|NCT05334316|Dexamethasone|dexamethasone|mesh-list
92779292|NCT05334316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779293|NCT05334316|Antiemetics|antiemetics|mesh-ancestor
92779294|NCT05334316|Autonomic Agents|autonomic agents|mesh-ancestor
92779295|NCT05334316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779296|NCT05334316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779297|NCT05334316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779298|NCT05334316|Glucocorticoids|glucocorticoids|mesh-ancestor
92779299|NCT05334316|Hormones|hormones|mesh-ancestor
92779300|NCT05334316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779301|NCT05334316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92779302|NCT05334316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779303|NCT00598273|Darbepoetin alfa|darbepoetin alfa|mesh-list
92779304|NCT00598273|Hematinics|hematinics|mesh-ancestor
92779305|NCT02636491|Insulin|insulin|mesh-list
92779306|NCT02636491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92779307|NCT02636491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92779308|NCT02636491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779309|NCT00657007|Belimumab|belimumab|mesh-list
92779310|NCT00657007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92779311|NCT00657007|Immunologic Factors|immunologic factors|mesh-ancestor
92779312|NCT00657007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779313|NCT04318652|Methylprednisolone|methylprednisolone|mesh-list
92779314|NCT04318652|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92779315|NCT04318652|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92779316|NCT04318652|Prednisolone|prednisolone|mesh-list
92779317|NCT04318652|Prednisolone acetate|prednisolone acetate|mesh-list
92779318|NCT04318652|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92779319|NCT04318652|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92779320|NCT04318652|Prednisolone phosphate|prednisolone phosphate|mesh-list
92779321|NCT04318652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779322|NCT04318652|Antiemetics|antiemetics|mesh-ancestor
92779323|NCT04318652|Autonomic Agents|autonomic agents|mesh-ancestor
92779324|NCT04318652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779325|NCT04318652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779326|NCT04318652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779327|NCT04318652|Glucocorticoids|glucocorticoids|mesh-ancestor
92779328|NCT04318652|Hormones|hormones|mesh-ancestor
92779329|NCT04318652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779330|NCT04318652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92779331|NCT04318652|Protective Agents|protective agents|mesh-ancestor
92779332|NCT04318652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92779333|NCT04318652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779334|NCT04318652|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92779335|NCT02633995|Anesthetics|anesthetics|mesh-list
92779336|NCT02633995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779337|NCT02633995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779338|NCT02633683|Gabapentin|gabapentin|mesh-list
92779339|NCT02633683|Analgesics|analgesics|mesh-ancestor
92779340|NCT02633683|Sensory System Agents|sensory system agents|mesh-ancestor
92779341|NCT02633683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779342|NCT02633683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779343|NCT02633683|Anticonvulsants|anticonvulsants|mesh-ancestor
92779344|NCT02633683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92779345|NCT02633683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779346|NCT02633683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779347|NCT02633683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779348|NCT02633683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92779349|NCT02633683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92779350|NCT02633683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779351|NCT02633683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779353|NCT01211522|Haloperidol|haloperidol|mesh-list
92779354|NCT01211522|Haloperidol decanoate|haloperidol decanoate|mesh-list
92779355|NCT01211522|Ziprasidone|ziprasidone|mesh-list
92779356|NCT01211522|Antiemetics|antiemetics|mesh-ancestor
92779357|NCT01211522|Autonomic Agents|autonomic agents|mesh-ancestor
92779358|NCT01211522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779359|NCT01211522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779360|NCT01211522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779361|NCT01211522|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92779362|NCT01211522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779363|NCT01211522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779364|NCT01211522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779365|NCT01211522|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92779366|NCT01211522|Dopamine Agents|dopamine agents|mesh-ancestor
92779367|NCT01211522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779368|NCT01211522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779369|NCT01211522|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92779370|NCT01211522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92779371|NCT01211522|Serotonin Agents|serotonin agents|mesh-ancestor
92779372|NCT05404724|Itraconazole|itraconazole|mesh-list
92779373|NCT05404724|Antifungal Agents|antifungal agents|mesh-ancestor
92779374|NCT05404724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779375|NCT05404724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92779376|NCT05404724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92779377|NCT05404724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779378|NCT05404724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779379|NCT05404724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92779380|NCT05404724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92779381|NCT05404724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779382|NCT05404724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779383|NCT05404724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92779384|NCT03314935|Leucovorin|leucovorin|mesh-list
92779385|NCT03314935|Paclitaxel|paclitaxel|mesh-list
92779386|NCT03314935|Gemcitabine|gemcitabine|mesh-list
92779387|NCT03314935|Fluorouracil|fluorouracil|mesh-list
92779388|NCT03314935|Oxaliplatin|oxaliplatin|mesh-list
92779389|NCT03314935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92779390|NCT03314935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779391|NCT03314935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92779392|NCT03314935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92779393|NCT03314935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92779394|NCT03314935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779395|NCT03314935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92779396|NCT03314935|Antimetabolites|antimetabolites|mesh-ancestor
92779397|NCT03314935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92779398|NCT03314935|Immunologic Factors|immunologic factors|mesh-ancestor
92779399|NCT03314935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779400|NCT03314935|Antidotes|antidotes|mesh-ancestor
92779401|NCT03314935|Protective Agents|protective agents|mesh-ancestor
92779402|NCT03314935|Vitamin B Complex|vitamin b complex|mesh-ancestor
92779403|NCT03314935|Vitamins|vitamins|mesh-ancestor
92779404|NCT03314935|Micronutrients|micronutrients|mesh-ancestor
92779405|NCT02633761|Misoprostol|misoprostol|mesh-list
92779406|NCT02633761|Mifepristone|mifepristone|mesh-list
92779407|NCT02633761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92779408|NCT02633761|Abortifacient Agents|abortifacient agents|mesh-ancestor
92779409|NCT02633761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779410|NCT02633761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779411|NCT02633761|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92424458|NCT01527422|Glucocorticoids|glucocorticoids|mesh-ancestor
92779412|NCT02633761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779413|NCT02633761|Oxytocics|oxytocics|mesh-ancestor
92779414|NCT02633761|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92779415|NCT02633761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92779416|NCT02633761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92779417|NCT02633761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92779418|NCT02633761|Contraceptive Agents|contraceptive agents|mesh-ancestor
92779419|NCT02633761|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92779420|NCT02633761|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92779421|NCT02633761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92779422|NCT02633761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779423|NCT02633761|Luteolytic Agents|luteolytic agents|mesh-ancestor
92779424|NCT02633761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92779425|NCT02633761|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92779426|NCT02633839|Carbidopa|carbidopa|mesh-list
92779427|NCT02633839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92779428|NCT02633839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92779429|NCT02633839|Dopamine Agents|dopamine agents|mesh-ancestor
92779430|NCT02633839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779431|NCT02633839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779432|NCT02633839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779433|NCT02633839|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92779434|NCT02633839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779435|NCT02632903|Zoledronic Acid|zoledronic acid|mesh-list
92779436|NCT02632903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92779437|NCT02632903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779438|NCT00657397|Methadone|methadone|mesh-list
92779439|NCT00657397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92779440|NCT00657397|Narcotics|narcotics|mesh-ancestor
92779441|NCT00657397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779442|NCT00657397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779443|NCT00657397|Analgesics|analgesics|mesh-ancestor
92779444|NCT00657397|Sensory System Agents|sensory system agents|mesh-ancestor
92779445|NCT00657397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779446|NCT00657397|Antitussive Agents|antitussive agents|mesh-ancestor
92779447|NCT00657397|Respiratory System Agents|respiratory system agents|mesh-ancestor
92779448|NCT04160611|Midazolam|midazolam|mesh-list
92779449|NCT04160611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92779450|NCT04160611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92779451|NCT04160611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779452|NCT04160611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779453|NCT04160611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92779454|NCT04160611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779455|NCT04160611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779456|NCT04160611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92779457|NCT04160611|Anesthetics, General|anesthetics, general|mesh-ancestor
92779458|NCT04160611|Anesthetics|anesthetics|mesh-ancestor
92779459|NCT04160611|GABA Modulators|gaba modulators|mesh-ancestor
92779460|NCT04160611|GABA Agents|gaba agents|mesh-ancestor
92779461|NCT04160611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779462|NCT04160611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779463|NCT04161001|Amlodipine|amlodipine|mesh-list
92779464|NCT04161001|Olmesartan|olmesartan|mesh-list
92779465|NCT04161001|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92779466|NCT04161001|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
92779467|NCT04161001|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92779468|NCT04161001|Ezetimibe|ezetimibe|mesh-list
92779469|NCT04161001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92779470|NCT04161001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92779471|NCT04161001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92779472|NCT04161001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779473|NCT04161001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92779474|NCT04161001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779475|NCT04161001|Vasodilator Agents|vasodilator agents|mesh-ancestor
92779476|NCT04161001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92779477|NCT04161001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92779478|NCT04161001|Antimetabolites|antimetabolites|mesh-ancestor
92779479|NCT04161001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92779480|NCT04161001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92779481|NCT04161001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779482|NCT04161001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92779483|NCT04161001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92779484|NCT00881569|Efatutazone|efatutazone|mesh-list
92779485|NCT00881569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779486|NCT00657163|Fluoxetine|fluoxetine|mesh-list
92779487|NCT00657163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92779488|NCT00657163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92779489|NCT00657163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92779490|NCT00657163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779491|NCT00657163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779492|NCT00657163|Serotonin Agents|serotonin agents|mesh-ancestor
92779493|NCT00657163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779494|NCT00657163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92779495|NCT00657163|Antidepressive Agents|antidepressive agents|mesh-ancestor
92779496|NCT00657163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779497|NCT00657163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92779498|NCT00657163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92779499|NCT00657163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779501|NCT02636101|Betamethasone Valerate|betamethasone valerate|mesh-list
92779502|NCT02636101|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92779503|NCT02636101|Betamethasone benzoate|betamethasone benzoate|mesh-list
92779504|NCT02636101|Calcipotriene|calcipotriene|mesh-list
92779505|NCT02636101|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92779506|NCT02636101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779507|NCT02636101|Glucocorticoids|glucocorticoids|mesh-ancestor
92779508|NCT02636101|Hormones|hormones|mesh-ancestor
92779509|NCT02636101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779510|NCT02636101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779511|NCT02636101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92779512|NCT02636101|Respiratory System Agents|respiratory system agents|mesh-ancestor
92779513|NCT02636101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92779514|NCT00657475|Heparin|heparin|mesh-list
92779515|NCT00657475|Calcium heparin|calcium heparin|mesh-list
92779516|NCT00657475|Anticoagulants|anticoagulants|mesh-ancestor
92779517|NCT00657475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92779518|NCT00657475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92779519|NCT00657475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779520|NCT00657319|Insulin Aspart|insulin aspart|mesh-list
92779521|NCT00657319|Biphasic Insulins|biphasic insulins|mesh-list
92779522|NCT00657319|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92779523|NCT00657319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92779524|NCT00657319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779525|NCT04159597|Upadacitinib|upadacitinib|mesh-list
92779526|NCT04159597|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92779527|NCT04159597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92779528|NCT04159597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779529|NCT04159597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779530|NCT04159597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779531|NCT00661219|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92779532|NCT00661219|Vasodilator Agents|vasodilator agents|mesh-ancestor
92779533|NCT00661219|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92779534|NCT00661219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92779535|NCT00661219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779536|NCT00661219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779537|NCT00661219|Urological Agents|urological agents|mesh-ancestor
92779538|NCT00665743|Naproxen|naproxen|mesh-list
92779539|NCT00665743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92779540|NCT00665743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779541|NCT00665743|Analgesics|analgesics|mesh-ancestor
92779542|NCT00665743|Sensory System Agents|sensory system agents|mesh-ancestor
92779543|NCT00665743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779544|NCT00665743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779545|NCT00665743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779546|NCT00665743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779547|NCT00665743|Gout Suppressants|gout suppressants|mesh-ancestor
92779548|NCT00665743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92779549|NCT00665743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779550|NCT00665743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779551|NCT00661297|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92779552|NCT00661297|Vasodilator Agents|vasodilator agents|mesh-ancestor
92779553|NCT00661297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92779554|NCT00661297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92779555|NCT00661297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779556|NCT00661297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779557|NCT00661297|Urological Agents|urological agents|mesh-ancestor
92779558|NCT00879775|Sodium Benzoate|sodium benzoate|mesh-list
92779559|NCT00879775|Caffeine|caffeine|mesh-list
92779560|NCT00879775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92779561|NCT00879775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779562|NCT00879775|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92779563|NCT00879775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338657|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779564|NCT00879775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779565|NCT00879775|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92779566|NCT00879775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92779567|NCT00879775|Purinergic Agents|purinergic agents|mesh-ancestor
92779568|NCT00879775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779569|NCT00879775|Antifungal Agents|antifungal agents|mesh-ancestor
92779570|NCT00879775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779571|NCT00894790|Celecoxib|celecoxib|mesh-list
92779572|NCT00894790|Diclofenac|diclofenac|mesh-list
92779573|NCT00894790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92779574|NCT00894790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779575|NCT00894790|Analgesics|analgesics|mesh-ancestor
92779576|NCT00894790|Sensory System Agents|sensory system agents|mesh-ancestor
92779577|NCT00894790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779578|NCT00894790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779579|NCT00894790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779580|NCT00894790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779581|NCT00894790|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92779582|NCT00894790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92779583|NCT00894790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779584|NCT00894790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779585|NCT00665977|Triamcinolone|triamcinolone|mesh-list
92779586|NCT00665977|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92779587|NCT00665977|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92779588|NCT00665977|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92779589|NCT00665977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779590|NCT00665977|Glucocorticoids|glucocorticoids|mesh-ancestor
92779591|NCT00665977|Hormones|hormones|mesh-ancestor
92779592|NCT00665977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779593|NCT00665977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779594|NCT00665977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92779595|NCT00665977|Immunologic Factors|immunologic factors|mesh-ancestor
92779596|NCT00665977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779597|NCT00665977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779598|NCT00666055|Ritonavir|ritonavir|mesh-list
92779599|NCT00666055|Lopinavir|lopinavir|mesh-list
92779600|NCT00666055|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92779601|NCT00666055|Tenofovir|tenofovir|mesh-list
92779602|NCT00666055|Lamivudine|lamivudine|mesh-list
92779603|NCT00666055|Emtricitabine|emtricitabine|mesh-list
92779604|NCT00666055|Zidovudine|zidovudine|mesh-list
92779605|NCT00666055|Raltegravir Potassium|raltegravir potassium|mesh-list
92779606|NCT00666055|Maraviroc|maraviroc|mesh-list
92779607|NCT00666055|Efavirenz|efavirenz|mesh-list
92779608|NCT00666055|Etravirine|etravirine|mesh-list
92779609|NCT00666055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92779610|NCT00666055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92779611|NCT00666055|Protease Inhibitors|protease inhibitors|mesh-ancestor
92779612|NCT00666055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779613|NCT00666055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779614|NCT00666055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92779615|NCT00666055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92779616|NCT00666055|Antiviral Agents|antiviral agents|mesh-ancestor
92779617|NCT00666055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779618|NCT00666055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92779619|NCT00666055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92779620|NCT00666055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92779621|NCT00666055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92779622|NCT00666055|Antimetabolites|antimetabolites|mesh-ancestor
92779623|NCT00666055|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92779624|NCT00666055|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92779625|NCT00666055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92779626|NCT00666055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92779627|NCT00666055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92779628|NCT00666055|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92779629|NCT00666055|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92779630|NCT00666055|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92779631|NCT00666055|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92779632|NCT00666055|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92424682|NCT01528644|Hematinics|hematinics|mesh-ancestor
92779634|NCT00661375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779635|NCT00661375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92779636|NCT00661375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779637|NCT00661375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779638|NCT00911287|Oxymorphone|oxymorphone|mesh-list
92779639|NCT00911287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92779640|NCT00911287|Narcotics|narcotics|mesh-ancestor
92779641|NCT00911287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779642|NCT00911287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779643|NCT00911287|Analgesics|analgesics|mesh-ancestor
92779644|NCT00911287|Sensory System Agents|sensory system agents|mesh-ancestor
92779645|NCT00911287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779646|NCT00911287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92779647|NCT04494880|Bupivacaine|bupivacaine|mesh-list
92779648|NCT04494880|Anesthetics, Local|anesthetics, local|mesh-ancestor
92779649|NCT04494880|Anesthetics|anesthetics|mesh-ancestor
92779650|NCT04494880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779651|NCT04494880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779652|NCT04494880|Sensory System Agents|sensory system agents|mesh-ancestor
92779653|NCT04494880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779654|NCT02631031|Valsartan|valsartan|mesh-list
92779655|NCT02631031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92779656|NCT02631031|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92779657|NCT02631031|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92779658|NCT02631031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779659|NCT02839408|Azithromycin|azithromycin|mesh-list
92779660|NCT02839408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779661|NCT02839408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779662|NCT02837614|Acetaminophen|acetaminophen|mesh-list
92779663|NCT02837614|Amoxicillin|amoxicillin|mesh-list
92779664|NCT02837614|Dexamethasone|dexamethasone|mesh-list
92779665|NCT02837614|Dexamethasone acetate|dexamethasone acetate|mesh-list
92779666|NCT02837614|BB 1101|bb 1101|mesh-list
92779667|NCT02837614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779668|NCT02837614|Antiemetics|antiemetics|mesh-ancestor
92779669|NCT02837614|Autonomic Agents|autonomic agents|mesh-ancestor
92779670|NCT02837614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779671|NCT02837614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779672|NCT02837614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779673|NCT02837614|Glucocorticoids|glucocorticoids|mesh-ancestor
92779674|NCT02837614|Hormones|hormones|mesh-ancestor
92779675|NCT02837614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779676|NCT02837614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92779677|NCT02837614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779678|NCT02837614|Protease Inhibitors|protease inhibitors|mesh-ancestor
92779679|NCT02837614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779680|NCT02837614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779681|NCT02837614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779682|NCT02837614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779683|NCT02837614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779684|NCT02837614|Analgesics|analgesics|mesh-ancestor
92779685|NCT02837614|Sensory System Agents|sensory system agents|mesh-ancestor
92779686|NCT02837614|Antipyretics|antipyretics|mesh-ancestor
92779687|NCT02839486|Vancomycin|vancomycin|mesh-list
92779688|NCT02839486|Cefoxitin|cefoxitin|mesh-list
92779689|NCT02839486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779690|NCT02839486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779691|NCT00879229|Ambrisentan|ambrisentan|mesh-list
92779692|NCT00879229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92779693|NCT04249570|Povidone-Iodine|povidone-iodine|mesh-list
92779694|NCT04249570|Povidone|povidone|mesh-list
92779695|NCT04249570|Plasma Substitutes|plasma substitutes|mesh-ancestor
92779696|NCT04249570|Blood Substitutes|blood substitutes|mesh-ancestor
92779697|NCT04249570|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92779698|NCT04249570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779699|NCT02837770|Diclofenac|diclofenac|mesh-list
92779700|NCT02837770|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92779701|NCT02837770|Lubricant Eye Drops|lubricant eye drops|mesh-list
92779702|NCT02837770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92779703|NCT02837770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92779704|NCT02837770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92779705|NCT02837770|Analgesics|analgesics|mesh-ancestor
92779706|NCT02837770|Sensory System Agents|sensory system agents|mesh-ancestor
92779707|NCT02837770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424757|NCT01529138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338674|NCT00001025|Zidovudine|zidovudine|mesh-list
92779708|NCT02837770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779709|NCT02837770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779710|NCT02837770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779711|NCT02837770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92779712|NCT02837770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779713|NCT02837770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779714|NCT00878995|Methyltestosterone|methyltestosterone|mesh-list
92779716|NCT00878995|Testosterone undecanoate|testosterone undecanoate|mesh-list
92779717|NCT00878995|Testosterone enanthate|testosterone enanthate|mesh-list
92779718|NCT00878995|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92779719|NCT00878995|Androgens|androgens|mesh-ancestor
92779720|NCT00878995|Hormones|hormones|mesh-ancestor
92779721|NCT00878995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779722|NCT00878995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779723|NCT00878995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92779724|NCT00878995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779725|NCT00878995|Anabolic Agents|anabolic agents|mesh-ancestor
92779726|NCT02837146|Methotrexate|methotrexate|mesh-list
92779727|NCT02837146|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92779728|NCT02837146|Abortifacient Agents|abortifacient agents|mesh-ancestor
92779729|NCT02837146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779730|NCT02837146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779731|NCT02837146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92779732|NCT02837146|Antimetabolites|antimetabolites|mesh-ancestor
92779733|NCT02837146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779734|NCT02837146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779735|NCT02837146|Dermatologic Agents|dermatologic agents|mesh-ancestor
92779736|NCT02837146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779737|NCT02837146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92779738|NCT02837146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92779739|NCT02837146|Immunologic Factors|immunologic factors|mesh-ancestor
92779740|NCT02837146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92779741|NCT02837146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92779742|NCT00657865|Ramipril|ramipril|mesh-list
92779743|NCT00657865|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92779744|NCT00657865|Protease Inhibitors|protease inhibitors|mesh-ancestor
92779745|NCT00657865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779746|NCT00657865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779747|NCT00657865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92779748|NCT00661765|Varenicline|varenicline|mesh-list
92779749|NCT00661765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92779750|NCT00661765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92779751|NCT00661765|Cholinergic Agents|cholinergic agents|mesh-ancestor
92779752|NCT00661765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779753|NCT00661765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779754|NCT00661765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779755|NCT00657943|Insulin|insulin|mesh-list
92779756|NCT00657943|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92779757|NCT00657943|Metformin|metformin|mesh-list
92779758|NCT00657943|Insulin Aspart|insulin aspart|mesh-list
92779759|NCT00657943|Insulin, Long-Acting|insulin, long-acting|mesh-list
92338675|NCT00001025|Didanosine|didanosine|mesh-list
92779760|NCT00657943|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92779761|NCT00657943|Insulin Detemir|insulin detemir|mesh-list
92779762|NCT00657943|Protamines|protamines|mesh-list
92779763|NCT00657943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92779764|NCT00657943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779765|NCT00657943|Heparin Antagonists|heparin antagonists|mesh-ancestor
92779766|NCT00657943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779767|NCT00657943|Coagulants|coagulants|mesh-ancestor
92779768|NCT04249804|Magnesium Sulfate|magnesium sulfate|mesh-list
92779769|NCT04249804|Analgesics|analgesics|mesh-ancestor
92779770|NCT04249804|Sensory System Agents|sensory system agents|mesh-ancestor
92779771|NCT04249804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779772|NCT04249804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779773|NCT04249804|Anesthetics|anesthetics|mesh-ancestor
92779774|NCT04249804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779775|NCT04249804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92779776|NCT04249804|Anticonvulsants|anticonvulsants|mesh-ancestor
92779777|NCT04249804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92779778|NCT04249804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92779779|NCT04249804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779780|NCT04249804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92779781|NCT04249804|Tocolytic Agents|tocolytic agents|mesh-ancestor
92424843|NCT01529229|Histamine Agents|histamine agents|mesh-ancestor
92779782|NCT04249804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92779783|NCT02631109|Methylprednisolone|methylprednisolone|mesh-list
92779784|NCT02631109|Doxorubicin|doxorubicin|mesh-list
92779785|NCT02631109|Etoposide|etoposide|mesh-list
92779786|NCT02631109|Pegaspargase|pegaspargase|mesh-list
92779787|NCT02631109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92779788|NCT02631109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779789|NCT02631109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92779790|NCT02631109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92779791|NCT02631109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779792|NCT02631109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779793|NCT02631109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92779794|NCT02631109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779795|NCT02631109|Antiemetics|antiemetics|mesh-ancestor
92779796|NCT02631109|Autonomic Agents|autonomic agents|mesh-ancestor
92779797|NCT02631109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779798|NCT02631109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779799|NCT02631109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779800|NCT02631109|Glucocorticoids|glucocorticoids|mesh-ancestor
92779801|NCT02631109|Hormones|hormones|mesh-ancestor
92779802|NCT02631109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779803|NCT02631109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92779804|NCT02631109|Protective Agents|protective agents|mesh-ancestor
92779805|NCT02630485|Inositol|inositol|mesh-list
92779806|NCT02630485|Letrozole|letrozole|mesh-list
92779807|NCT02630485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779808|NCT02630485|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92779809|NCT02630485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92779810|NCT02630485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779811|NCT02630485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779812|NCT02630485|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92779813|NCT02630485|Hormone Antagonists|hormone antagonists|mesh-ancestor
92779814|NCT02630485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779815|NCT02630485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779816|NCT02630485|Vitamin B Complex|vitamin b complex|mesh-ancestor
92779817|NCT02630485|Vitamins|vitamins|mesh-ancestor
92338709|NCT03055247|Analgesics|analgesics|mesh-ancestor
92779818|NCT02630485|Micronutrients|micronutrients|mesh-ancestor
92779819|NCT00894556|Sumatriptan|sumatriptan|mesh-list
92779820|NCT00894556|Rizatriptan|rizatriptan|mesh-list
92779821|NCT00894556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92779822|NCT00894556|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92779823|NCT00894556|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92779824|NCT00894556|Serotonin Agents|serotonin agents|mesh-ancestor
92779825|NCT00894556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779826|NCT00894556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779827|NCT00894556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779828|NCT01210352|Oxymorphone|oxymorphone|mesh-list
92779829|NCT01210352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92779830|NCT01210352|Narcotics|narcotics|mesh-ancestor
92779831|NCT01210352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779832|NCT01210352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779833|NCT01210352|Analgesics|analgesics|mesh-ancestor
92779834|NCT01210352|Sensory System Agents|sensory system agents|mesh-ancestor
92779835|NCT01210352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779836|NCT01210352|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92779837|NCT04250506|Moxifloxacin|moxifloxacin|mesh-list
92779838|NCT04250506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779839|NCT04250506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779840|NCT04250506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92779841|NCT04250506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92779842|NCT04250506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779843|NCT04250506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779844|NCT04250506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779845|NCT00662077|Ibandronic Acid|ibandronic acid|mesh-list
92779846|NCT00662077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92779847|NCT00662077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779848|NCT00658099|Insulin|insulin|mesh-list
92779849|NCT00658099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92779850|NCT00658099|Insulin Detemir|insulin detemir|mesh-list
92779851|NCT00658099|Isophane Insulin, Human|isophane insulin, human|mesh-list
92779852|NCT00658099|Insulin, Isophane|insulin, isophane|mesh-list
92779853|NCT00658099|Isophane insulin, beef|isophane insulin, beef|mesh-list
92779854|NCT00658099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92779855|NCT00658099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779856|NCT00658177|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92779857|NCT00658177|Vasodilator Agents|vasodilator agents|mesh-ancestor
92779858|NCT00658177|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92779859|NCT00658177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92779860|NCT00658177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779861|NCT00658177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779862|NCT00658177|Urological Agents|urological agents|mesh-ancestor
92779864|NCT00658255|Formoterol Fumarate|formoterol fumarate|mesh-list
92779865|NCT00658255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92779866|NCT00658255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92779867|NCT00658255|Autonomic Agents|autonomic agents|mesh-ancestor
92779868|NCT00658255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779869|NCT00658255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779870|NCT00658255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92779871|NCT00658255|Respiratory System Agents|respiratory system agents|mesh-ancestor
92779872|NCT00658255|Glucocorticoids|glucocorticoids|mesh-ancestor
92779873|NCT00658255|Hormones|hormones|mesh-ancestor
92779874|NCT00658255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779875|NCT00658255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92779876|NCT00658255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92779877|NCT00658255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92779878|NCT00658255|Adrenergic Agents|adrenergic agents|mesh-ancestor
92779879|NCT00658255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779880|NCT00658255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779881|NCT02836288|Ketamine|ketamine|mesh-list
92779882|NCT02836288|Analgesics|analgesics|mesh-ancestor
92779883|NCT02836288|Sensory System Agents|sensory system agents|mesh-ancestor
92779884|NCT02836288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779885|NCT02836288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338718|NCT00001049|Zidovudine|zidovudine|mesh-list
92779886|NCT02836288|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92779887|NCT02836288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92779888|NCT02836288|Anesthetics, General|anesthetics, general|mesh-ancestor
92779889|NCT02836288|Anesthetics|anesthetics|mesh-ancestor
92779890|NCT02836288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779891|NCT02836288|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92779892|NCT02836288|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92779893|NCT02836288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779894|NCT02836288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779895|NCT00658645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92779896|NCT00658645|Antidepressive Agents|antidepressive agents|mesh-ancestor
92779897|NCT00658645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92779898|NCT00658645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92779899|NCT00658645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92779900|NCT00658645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92779901|NCT00658645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779902|NCT01208402|Esmolol|esmolol|mesh-list
92779903|NCT01208402|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92779904|NCT01208402|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92779905|NCT01208402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92779906|NCT01208402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92779907|NCT01208402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779908|NCT01208402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779909|NCT01208402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779910|NCT01208324|Estrogens|estrogens|mesh-list
92779911|NCT01208324|Hormones|hormones|mesh-ancestor
92779912|NCT01208324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92779913|NCT01208324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779914|NCT02838940|Cefazolin|cefazolin|mesh-list
92779915|NCT02838940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92779916|NCT02838940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779917|NCT02835742|Sargramostim|sargramostim|mesh-list
92779918|NCT02835742|Immunologic Factors|immunologic factors|mesh-ancestor
92779919|NCT02835742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779920|NCT05326360|Ramosetron|ramosetron|mesh-list
92779921|NCT05326360|Antiemetics|antiemetics|mesh-ancestor
92779922|NCT05326360|Autonomic Agents|autonomic agents|mesh-ancestor
92779923|NCT05326360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779924|NCT05326360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779925|NCT05326360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92779926|NCT05326360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92779927|NCT05326360|Serotonin Agents|serotonin agents|mesh-ancestor
92779928|NCT05326360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92779929|NCT05326360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779930|NCT00666601|Tedizolid phosphate|tedizolid phosphate|mesh-list
92779932|NCT00666601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92779933|NCT01207388|Blinatumomab|blinatumomab|mesh-list
92779934|NCT01207388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779935|NCT02835664|Niacinamide|niacinamide|mesh-list
92779936|NCT02835664|Niacin|niacin|mesh-list
92779937|NCT02835664|Nicotinic Acids|nicotinic acids|mesh-list
92779938|NCT02835664|Vitamin B Complex|vitamin b complex|mesh-ancestor
92779939|NCT02835664|Vitamins|vitamins|mesh-ancestor
92779940|NCT02835664|Micronutrients|micronutrients|mesh-ancestor
92779941|NCT02835664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779942|NCT02835664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92779943|NCT02835664|Antimetabolites|antimetabolites|mesh-ancestor
92779944|NCT02835664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779945|NCT02835664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92779946|NCT02835664|Vasodilator Agents|vasodilator agents|mesh-ancestor
92779947|NCT02838472|Ascorbic Acid|ascorbic acid|mesh-list
92779948|NCT02838472|Vitamins|vitamins|mesh-ancestor
92779949|NCT02838472|Micronutrients|micronutrients|mesh-ancestor
92779950|NCT02838472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779951|NCT02838472|Antioxidants|antioxidants|mesh-ancestor
92779952|NCT02838472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779953|NCT02838472|Protective Agents|protective agents|mesh-ancestor
92779954|NCT00666991|Paclitaxel|paclitaxel|mesh-list
92779955|NCT00666991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92779956|NCT00666991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779957|NCT00666991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92779958|NCT00666991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92779959|NCT00666991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92779960|NCT00666991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779961|NCT00667147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92779962|NCT00667147|Paclitaxel|paclitaxel|mesh-list
92779963|NCT00667147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779964|NCT00667147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92779965|NCT00667147|Tubulin Modulators|tubulin modulators|mesh-ancestor
92779966|NCT00667147|Antimitotic Agents|antimitotic agents|mesh-ancestor
92779967|NCT00667147|Mitosis Modulators|mitosis modulators|mesh-ancestor
92779968|NCT00667147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779969|NCT02835586|Paclitaxel|paclitaxel|mesh-list
92779970|NCT02835586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92779971|NCT02835586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779972|NCT02835586|Tubulin Modulators|tubulin modulators|mesh-ancestor
92779973|NCT02835586|Antimitotic Agents|antimitotic agents|mesh-ancestor
92779974|NCT02835586|Mitosis Modulators|mitosis modulators|mesh-ancestor
92779975|NCT02835586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779976|NCT00667303|Antibodies|antibodies|mesh-list
92779977|NCT00667303|Immunologic Factors|immunologic factors|mesh-ancestor
92779978|NCT00667303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779979|NCT02838238|Capecitabine|capecitabine|mesh-list
92779980|NCT02838238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92779981|NCT02838238|Antimetabolites|antimetabolites|mesh-ancestor
92779982|NCT02838238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779983|NCT02838238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779984|NCT00667537|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92779985|NCT00667537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92779986|NCT00667771|Naltrexone|naltrexone|mesh-list
92779987|NCT00667771|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92779988|NCT00667771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92779989|NCT00667771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92779990|NCT00667771|Sensory System Agents|sensory system agents|mesh-ancestor
92779991|NCT00667771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92779992|NCT01206764|Everolimus|everolimus|mesh-list
92779993|NCT01206764|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92779994|NCT01206764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92779995|NCT01206764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92779996|NCT01206764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92779997|NCT01206764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92779998|NCT01206764|Immunologic Factors|immunologic factors|mesh-ancestor
92779999|NCT01206764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780000|NCT01206764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780001|NCT00667927|Cyclophosphamide|cyclophosphamide|mesh-list
92780002|NCT00667927|Busulfan|busulfan|mesh-list
92780003|NCT00667927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780004|NCT00667927|Immunologic Factors|immunologic factors|mesh-ancestor
92780005|NCT00667927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780006|NCT00667927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780007|NCT00667927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92780008|NCT00667927|Alkylating Agents|alkylating agents|mesh-ancestor
92780009|NCT00667927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780010|NCT00667927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780011|NCT00667927|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92780012|NCT00668005|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92780013|NCT00668005|Vasodilator Agents|vasodilator agents|mesh-ancestor
92780014|NCT00668005|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92780015|NCT00668005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92780016|NCT00668005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780017|NCT00668005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780018|NCT00668005|Urological Agents|urological agents|mesh-ancestor
92780020|NCT00668239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780021|NCT00668239|Glucocorticoids|glucocorticoids|mesh-ancestor
92780022|NCT00668239|Hormones|hormones|mesh-ancestor
92780023|NCT00668239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780024|NCT00668239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780025|NCT02631499|Epirubicin|epirubicin|mesh-list
92780026|NCT02631499|Ethiodized Oil|ethiodized oil|mesh-list
92780027|NCT02631499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92780028|NCT02631499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780029|NCT02631499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92780030|NCT02631499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92780031|NCT02631499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780032|NCT02631499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780033|NCT00662233|Cyclophosphamide|cyclophosphamide|mesh-list
92780034|NCT00662233|Ifosfamide|ifosfamide|mesh-list
92780035|NCT00662233|Doxorubicin|doxorubicin|mesh-list
92780036|NCT00662233|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92780037|NCT00662233|Etoposide|etoposide|mesh-list
92780038|NCT00662233|Vincristine|vincristine|mesh-list
92780039|NCT00662233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780040|NCT00662233|Immunologic Factors|immunologic factors|mesh-ancestor
92780041|NCT00662233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780042|NCT00662233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780043|NCT00662233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92780044|NCT00662233|Alkylating Agents|alkylating agents|mesh-ancestor
92780045|NCT00662233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780046|NCT00662233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780047|NCT00662233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92780048|NCT00662233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92780049|NCT00662233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92780050|NCT00662233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92780051|NCT00662233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780052|NCT00662233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92780053|NCT00662233|Tubulin Modulators|tubulin modulators|mesh-ancestor
92780054|NCT00662233|Antimitotic Agents|antimitotic agents|mesh-ancestor
92780055|NCT00662233|Mitosis Modulators|mitosis modulators|mesh-ancestor
92780056|NCT00658957|Gentamicins|gentamicins|mesh-list
92780057|NCT00658957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780058|NCT00658957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780059|NCT00658957|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92780060|NCT00658957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780061|NCT00658957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780062|NCT00662467|Aspirin|aspirin|mesh-list
92780063|NCT00662467|Warfarin|warfarin|mesh-list
92780064|NCT00662467|Clopidogrel|clopidogrel|mesh-list
92780065|NCT00662467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780066|NCT00662467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780067|NCT00662467|Analgesics|analgesics|mesh-ancestor
92780068|NCT00662467|Sensory System Agents|sensory system agents|mesh-ancestor
92780069|NCT00662467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780070|NCT00662467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338761|NCT00000281|Amantadine|amantadine|mesh-list
92780071|NCT00662467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780072|NCT00662467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780073|NCT00662467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92780074|NCT00662467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780075|NCT00662467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780076|NCT00662467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92780077|NCT00662467|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92780078|NCT00662467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780079|NCT00662467|Antipyretics|antipyretics|mesh-ancestor
92780080|NCT00662467|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92780081|NCT00662467|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92780083|NCT00662467|Purinergic Agents|purinergic agents|mesh-ancestor
92780084|NCT00662467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780085|NCT00662467|Anticoagulants|anticoagulants|mesh-ancestor
92780086|NCT00668941|Vitamin D|vitamin d|mesh-list
92780087|NCT00668941|Cholecalciferol|cholecalciferol|mesh-list
92780088|NCT00668941|Alendronate|alendronate|mesh-list
92780089|NCT00668941|Teriparatide|teriparatide|mesh-list
92780090|NCT00668941|Calcium|calcium|mesh-list
92780091|NCT00668941|Vitamins|vitamins|mesh-ancestor
92780092|NCT00668941|Micronutrients|micronutrients|mesh-ancestor
92780093|NCT00668941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780094|NCT00668941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92780095|NCT00668941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92780096|NCT00894322|Exenatide|exenatide|mesh-list
92780097|NCT00894322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92780098|NCT00894322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780099|NCT00894322|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92780100|NCT00894322|Incretins|incretins|mesh-ancestor
92780101|NCT00894322|Hormones|hormones|mesh-ancestor
92780102|NCT00894322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780103|NCT00633412|Esomeprazole|esomeprazole|mesh-list
92780104|NCT00633412|Ranitidine|ranitidine|mesh-list
92780105|NCT00633412|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92780106|NCT00633412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92780107|NCT00633412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780108|NCT00633412|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92780109|NCT00633412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780110|NCT00633412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780111|NCT00633412|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92780112|NCT00633412|Histamine Antagonists|histamine antagonists|mesh-ancestor
92780113|NCT00633412|Histamine Agents|histamine agents|mesh-ancestor
92780114|NCT00633412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780115|NCT00633412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780116|NCT04250116|Apixaban|apixaban|mesh-list
92780117|NCT04250116|Clopidogrel|clopidogrel|mesh-list
92780118|NCT04250116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92780119|NCT04250116|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92780120|NCT04250116|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92780121|NCT04250116|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92780122|NCT04250116|Purinergic Agents|purinergic agents|mesh-ancestor
92780123|NCT04250116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780124|NCT04250116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780125|NCT04250116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780126|NCT04250116|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92780127|NCT04250116|Antithrombins|antithrombins|mesh-ancestor
92780128|NCT04250116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92780129|NCT04250116|Protease Inhibitors|protease inhibitors|mesh-ancestor
92780130|NCT04250116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780131|NCT04250116|Anticoagulants|anticoagulants|mesh-ancestor
92780132|NCT00659113|Tegafur|tegafur|mesh-list
92780133|NCT00659113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780134|NCT00659113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92780135|NCT00659113|Antimetabolites|antimetabolites|mesh-ancestor
92780136|NCT00659113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780137|NCT00662779|Formoterol Fumarate|formoterol fumarate|mesh-list
92780138|NCT00662779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92780139|NCT00662779|Autonomic Agents|autonomic agents|mesh-ancestor
92780140|NCT00662779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780141|NCT00662779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780142|NCT00662779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92780143|NCT00662779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92780144|NCT00662779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92780145|NCT00662779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92530149|NCT00040027|Thymalfasin|thymalfasin|mesh-list
92780146|NCT00662779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92780147|NCT00662779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92780148|NCT00662779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780149|NCT00662779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780150|NCT02630095|Nadroparin|nadroparin|mesh-list
92780151|NCT02630095|Warfarin|warfarin|mesh-list
92780152|NCT02630095|Calcium|calcium|mesh-list
92780153|NCT02630095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92780154|NCT02630095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780155|NCT02630095|Anticoagulants|anticoagulants|mesh-ancestor
92780156|NCT02630095|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92780157|NCT02630095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780158|NCT02630095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780159|NCT00669487|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92780160|NCT00669487|Lamivudine|lamivudine|mesh-list
92780161|NCT00669487|Stavudine|stavudine|mesh-list
92780162|NCT00669487|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92780163|NCT00669487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780164|NCT00669487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780165|NCT00669487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780166|NCT00669487|Antiviral Agents|antiviral agents|mesh-ancestor
92780167|NCT00669487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780168|NCT00669487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92780169|NCT00669487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92780170|NCT00669487|Antimetabolites|antimetabolites|mesh-ancestor
92780171|NCT00669565|Bavituximab|bavituximab|mesh-list
92780172|NCT00669565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92780173|NCT00669565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780174|NCT00669643|Rifampin|rifampin|mesh-list
92780175|NCT00669643|Dapsone|dapsone|mesh-list
92780176|NCT00669643|Clofazimine|clofazimine|mesh-list
92780177|NCT00669643|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92780178|NCT00669643|Antitubercular Agents|antitubercular agents|mesh-ancestor
92780179|NCT00669643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780180|NCT00669643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780181|NCT00669643|Leprostatic Agents|leprostatic agents|mesh-ancestor
92780182|NCT00669643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780183|NCT00669643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780184|NCT00669643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780185|NCT00669643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92780186|NCT00669643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92780187|NCT00669643|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92780188|NCT00669643|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92780189|NCT00669643|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92780190|NCT00669643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92780191|NCT00669643|Antimalarials|antimalarials|mesh-ancestor
92780192|NCT00669643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92780193|NCT00669643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92780194|NCT00669643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92780195|NCT00669643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780196|NCT00669721|Heparin|heparin|mesh-list
92780197|NCT00669721|Calcium heparin|calcium heparin|mesh-list
92780198|NCT00669721|Nadroparin|nadroparin|mesh-list
92780199|NCT00669721|Anticoagulants|anticoagulants|mesh-ancestor
92780200|NCT00669721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92780201|NCT00669721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780202|NCT00669721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780203|NCT00894166|Bupropion|bupropion|mesh-list
92780204|NCT00894166|Nicotine|nicotine|mesh-list
92780205|NCT00894166|Varenicline|varenicline|mesh-list
92780206|NCT00894166|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92780207|NCT00894166|Autonomic Agents|autonomic agents|mesh-ancestor
92780208|NCT00894166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780209|NCT00894166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780210|NCT00894166|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92780211|NCT00894166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92780212|NCT00894166|Cholinergic Agents|cholinergic agents|mesh-ancestor
92780213|NCT00894166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780214|NCT00894166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780215|NCT00894166|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92780216|NCT00894166|Antidepressive Agents|antidepressive agents|mesh-ancestor
92780217|NCT00894166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92780218|NCT00894166|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92780219|NCT00894166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92780220|NCT00894166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92780221|NCT00894166|Dopamine Agents|dopamine agents|mesh-ancestor
92780222|NCT00894166|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92780223|NCT00894166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92780224|NCT00894166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780225|NCT00659503|Ciclesonide|ciclesonide|mesh-list
92780226|NCT00659503|Glucocorticoids|glucocorticoids|mesh-ancestor
92780227|NCT00659503|Hormones|hormones|mesh-ancestor
92780228|NCT00659503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780229|NCT00659503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780230|NCT00659503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92425290|NCT01531647|Ritonavir|ritonavir|mesh-list
92780231|NCT00670345|Tranexamic Acid|tranexamic acid|mesh-list
92780232|NCT00670345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92780233|NCT00670345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780234|NCT00670345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780236|NCT00670345|Coagulants|coagulants|mesh-ancestor
92780237|NCT04153981|Insulin Glargine|insulin glargine|mesh-list
92780238|NCT04153981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92780239|NCT04153981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780240|NCT00670423|Sirolimus|sirolimus|mesh-list
92780241|NCT00670423|Bortezomib|bortezomib|mesh-list
92780242|NCT00670423|Tacrolimus|tacrolimus|mesh-list
92780243|NCT00670423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780244|NCT00670423|Immunologic Factors|immunologic factors|mesh-ancestor
92780245|NCT00670423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780246|NCT00670423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92780247|NCT00670423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780248|NCT00670423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780249|NCT00670423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780250|NCT00670423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780251|NCT00670423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780252|NCT00670423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92780253|NCT00670423|Antifungal Agents|antifungal agents|mesh-ancestor
92780254|NCT00659659|Benralizumab|benralizumab|mesh-list
92780255|NCT00659659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92780256|NCT00659659|Respiratory System Agents|respiratory system agents|mesh-ancestor
92780257|NCT00670501|Vitamin D|vitamin d|mesh-list
92780258|NCT00670501|Teriparatide|teriparatide|mesh-list
92780259|NCT00670501|Calcium|calcium|mesh-list
92780260|NCT00670501|Vitamins|vitamins|mesh-ancestor
92780261|NCT00670501|Micronutrients|micronutrients|mesh-ancestor
92780262|NCT00670501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780263|NCT00670501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92780264|NCT00670501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92780265|NCT00663247|Mesalamine|mesalamine|mesh-list
92780266|NCT00663247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780267|NCT00663247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780268|NCT00663247|Analgesics|analgesics|mesh-ancestor
92780269|NCT00663247|Sensory System Agents|sensory system agents|mesh-ancestor
92780270|NCT00663247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780271|NCT00663247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780272|NCT00663247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780273|NCT00663247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780274|NCT01163747|Methotrexate|methotrexate|mesh-list
92780275|NCT01163747|Vaccines|vaccines|mesh-list
92780276|NCT01163747|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92780277|NCT01163747|Immunologic Factors|immunologic factors|mesh-ancestor
92780278|NCT01163747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338776|NCT00001067|Stavudine|stavudine|mesh-list
92780279|NCT01163747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92780280|NCT01163747|Abortifacient Agents|abortifacient agents|mesh-ancestor
92780281|NCT01163747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92780282|NCT01163747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92780283|NCT01163747|Antimetabolites|antimetabolites|mesh-ancestor
92780284|NCT01163747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780285|NCT01163747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780286|NCT01163747|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780287|NCT01163747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780288|NCT01163747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92780289|NCT01163747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780290|NCT01163747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780291|NCT01163747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780292|NCT00670657|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92780293|NCT00670657|Antifungal Agents|antifungal agents|mesh-ancestor
92780294|NCT00670657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780295|NCT00670657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92780296|NCT00670657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92780297|NCT05657015|Simvastatin|simvastatin|mesh-list
92780298|NCT05657015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92780299|NCT05657015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92780300|NCT05657015|Antimetabolites|antimetabolites|mesh-ancestor
92780301|NCT05657015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780302|NCT05657015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92780303|NCT05657015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92780304|NCT05657015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780305|NCT02887313|Leucovorin|leucovorin|mesh-list
92780306|NCT02887313|Fluorouracil|fluorouracil|mesh-list
92780307|NCT02887313|Oxaliplatin|oxaliplatin|mesh-list
92780308|NCT02887313|Antimetabolites|antimetabolites|mesh-ancestor
92780309|NCT02887313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780310|NCT02887313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92780311|NCT02887313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780312|NCT02887313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780313|NCT02887313|Immunologic Factors|immunologic factors|mesh-ancestor
92780314|NCT02887313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780315|NCT02887313|Antidotes|antidotes|mesh-ancestor
92780316|NCT02887313|Protective Agents|protective agents|mesh-ancestor
92780317|NCT02887313|Vitamin B Complex|vitamin b complex|mesh-ancestor
92780318|NCT02887313|Vitamins|vitamins|mesh-ancestor
92780319|NCT02887313|Micronutrients|micronutrients|mesh-ancestor
92780320|NCT01206140|Sirolimus|sirolimus|mesh-list
92780321|NCT01206140|Temsirolimus|temsirolimus|mesh-list
92780322|NCT01206140|MTOR Inhibitors|mtor inhibitors|mesh-list
92780323|NCT01206140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780324|NCT01206140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780325|NCT01206140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92780326|NCT01206140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780327|NCT01206140|Antifungal Agents|antifungal agents|mesh-ancestor
92780328|NCT01206140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780329|NCT01206140|Immunologic Factors|immunologic factors|mesh-ancestor
92780330|NCT01206140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780331|NCT01206140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92780332|NCT01206140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780333|NCT01206140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780334|NCT01162421|Adalimumab|adalimumab|mesh-list
92780335|NCT01162421|Methotrexate|methotrexate|mesh-list
92780336|NCT01162421|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92780337|NCT01162421|Abortifacient Agents|abortifacient agents|mesh-ancestor
92780338|NCT01162421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92780339|NCT01162421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780340|NCT01162421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92780341|NCT01162421|Antimetabolites|antimetabolites|mesh-ancestor
92780342|NCT01162421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780343|NCT01162421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780344|NCT01162421|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780345|NCT01162421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780346|NCT01162421|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92780347|NCT01162421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780348|NCT01162421|Immunologic Factors|immunologic factors|mesh-ancestor
92780349|NCT01162421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780350|NCT01162421|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780351|NCT01162421|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92780352|NCT01162421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780353|NCT02885441|Ketorolac|ketorolac|mesh-list
92780354|NCT02885441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780355|NCT02885441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780356|NCT02885441|Analgesics|analgesics|mesh-ancestor
92780357|NCT02885441|Sensory System Agents|sensory system agents|mesh-ancestor
92780358|NCT02885441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780359|NCT02885441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780360|NCT02885441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780361|NCT02885441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780362|NCT02885441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92780363|NCT02885441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780364|NCT02885441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780365|NCT02885597|Methotrexate|methotrexate|mesh-list
92780366|NCT02885597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92780367|NCT02885597|Abortifacient Agents|abortifacient agents|mesh-ancestor
92780368|NCT02885597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92780369|NCT02885597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780370|NCT02885597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92780371|NCT02885597|Antimetabolites|antimetabolites|mesh-ancestor
92780372|NCT02885597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780373|NCT02885597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780374|NCT02885597|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780375|NCT02885597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780376|NCT02885597|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92780377|NCT02885597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780378|NCT02885597|Immunologic Factors|immunologic factors|mesh-ancestor
92780379|NCT02885597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780380|NCT02885597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780381|NCT01188551|Fentanyl|fentanyl|mesh-list
92780382|NCT01188551|Midazolam|midazolam|mesh-list
92780383|NCT01188551|Dexmedetomidine|dexmedetomidine|mesh-list
92780384|NCT01188551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92780385|NCT01188551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780386|NCT01188551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780387|NCT01188551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780388|NCT01188551|Analgesics|analgesics|mesh-ancestor
92780389|NCT01188551|Sensory System Agents|sensory system agents|mesh-ancestor
92780390|NCT01188551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780391|NCT01188551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92780392|NCT01188551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92780393|NCT01188551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92780394|NCT01188551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92780395|NCT01188551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780396|NCT01188551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780397|NCT01188551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92780398|NCT01188551|Narcotics|narcotics|mesh-ancestor
92780399|NCT01188551|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92780400|NCT01188551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92780401|NCT01188551|Anesthetics, General|anesthetics, general|mesh-ancestor
92780402|NCT01188551|Anesthetics|anesthetics|mesh-ancestor
92780403|NCT01188551|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92780404|NCT01188551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92780405|NCT01188551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92780406|NCT01188551|GABA Modulators|gaba modulators|mesh-ancestor
92780407|NCT01188551|GABA Agents|gaba agents|mesh-ancestor
92780408|NCT01161407|Calcium Carbonate|calcium carbonate|mesh-list
92780409|NCT01161407|Calcium|calcium|mesh-list
92780410|NCT01161407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92780411|NCT01161407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780412|NCT01161407|Antacids|antacids|mesh-ancestor
92780413|NCT01161407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780414|NCT01161407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780415|NCT01161173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92780416|NCT01161173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780417|NCT01161173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92780418|NCT01161173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780419|NCT01161173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780420|NCT01159769|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92780421|NCT01159769|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92780422|NCT01159769|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92780423|NCT01159769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780424|NCT01159769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780425|NCT01159769|Analgesics|analgesics|mesh-ancestor
92780426|NCT01159769|Sensory System Agents|sensory system agents|mesh-ancestor
92780427|NCT01159769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780428|NCT01159769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780429|NCT01159769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780430|NCT01159769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780431|NCT01159769|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92780432|NCT01159769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92780433|NCT01159769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92780434|NCT01159769|Histamine Antagonists|histamine antagonists|mesh-ancestor
92780435|NCT01159769|Histamine Agents|histamine agents|mesh-ancestor
92780436|NCT01159769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780437|NCT01159769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780439|NCT01185821|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92780440|NCT01185821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780441|NCT01185821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780442|NCT01185821|Immunologic Factors|immunologic factors|mesh-ancestor
92780443|NCT01185821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780444|NCT00893464|Ixazomib|ixazomib|mesh-list
92780445|NCT00893464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780446|NCT00893464|Protease Inhibitors|protease inhibitors|mesh-ancestor
92780447|NCT00893464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780448|NCT00893464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780449|NCT00891904|Cetuximab|cetuximab|mesh-list
92780450|NCT00891904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92780451|NCT00891904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780452|NCT02834260|Dexamethasone|dexamethasone|mesh-list
92780453|NCT02834260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780454|NCT02834260|Antiemetics|antiemetics|mesh-ancestor
92425505|NCT01533155|Analgesics|analgesics|mesh-ancestor
92780455|NCT02834260|Autonomic Agents|autonomic agents|mesh-ancestor
92780456|NCT02834260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780457|NCT02834260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780458|NCT02834260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780459|NCT02834260|Glucocorticoids|glucocorticoids|mesh-ancestor
92780460|NCT02834260|Hormones|hormones|mesh-ancestor
92780461|NCT02834260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780462|NCT02834260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92780463|NCT02834260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780464|NCT01157351|Olanzapine|olanzapine|mesh-list
92780465|NCT01157351|Risperidone|risperidone|mesh-list
92780466|NCT01157351|Aripiprazole|aripiprazole|mesh-list
92780467|NCT01157351|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92780468|NCT01157351|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92780469|NCT01157351|Perphenazine|perphenazine|mesh-list
92780470|NCT01157351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92780471|NCT01157351|Serotonin Agents|serotonin agents|mesh-ancestor
92780472|NCT01157351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780473|NCT01157351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780474|NCT01157351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780475|NCT01157351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92780476|NCT01157351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92780477|NCT01157351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780478|NCT01157351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92780479|NCT01157351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92780480|NCT01157351|Dopamine Agents|dopamine agents|mesh-ancestor
92780481|NCT01157351|Antiemetics|antiemetics|mesh-ancestor
92780482|NCT01157351|Autonomic Agents|autonomic agents|mesh-ancestor
92780483|NCT01157351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780484|NCT01157351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780485|NCT01157351|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92780486|NCT01157351|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92780487|NCT01157351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92780488|NCT01157351|Antidepressive Agents|antidepressive agents|mesh-ancestor
92780489|NCT01157351|Dopamine Agonists|dopamine agonists|mesh-ancestor
92780490|NCT01157351|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92780491|NCT01157351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92780492|NCT01157351|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92780493|NCT01157351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92780494|NCT02831686|Dexamethasone|dexamethasone|mesh-list
92780495|NCT02831686|Ixazomib|ixazomib|mesh-list
92780496|NCT02831686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780497|NCT02831686|Antiemetics|antiemetics|mesh-ancestor
92780498|NCT02831686|Autonomic Agents|autonomic agents|mesh-ancestor
92780499|NCT02831686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780500|NCT02831686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780501|NCT02831686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780502|NCT02831686|Glucocorticoids|glucocorticoids|mesh-ancestor
92780503|NCT02831686|Hormones|hormones|mesh-ancestor
92780504|NCT02831686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780505|NCT02831686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92780506|NCT02831686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780507|NCT02831686|Protease Inhibitors|protease inhibitors|mesh-ancestor
92780508|NCT02831686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780509|NCT02831686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780511|NCT00633490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780512|NCT00633490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92780513|NCT00633490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780514|NCT00633490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780515|NCT02831374|Anesthetics|anesthetics|mesh-list
92780516|NCT02831374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780517|NCT02831374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780518|NCT02831218|Aspirin|aspirin|mesh-list
92780519|NCT02831218|Clopidogrel|clopidogrel|mesh-list
92780520|NCT02831218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780521|NCT02831218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780522|NCT02831218|Analgesics|analgesics|mesh-ancestor
92780523|NCT02831218|Sensory System Agents|sensory system agents|mesh-ancestor
92780524|NCT02831218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780525|NCT02831218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780526|NCT02831218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780527|NCT02831218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780528|NCT02831218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92780529|NCT02831218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780530|NCT02831218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780531|NCT02831218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92780532|NCT02831218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92780533|NCT02831218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780534|NCT02831218|Antipyretics|antipyretics|mesh-ancestor
92780535|NCT02831218|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92780536|NCT02831218|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92780537|NCT02831218|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92780538|NCT02831218|Purinergic Agents|purinergic agents|mesh-ancestor
92780539|NCT02831218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780540|NCT02833480|Fluticasone|fluticasone|mesh-list
92780541|NCT02833480|Budesonide|budesonide|mesh-list
92780542|NCT02833480|Formoterol Fumarate|formoterol fumarate|mesh-list
92780543|NCT02833480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780544|NCT02833480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92780545|NCT02833480|Autonomic Agents|autonomic agents|mesh-ancestor
92780546|NCT02833480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780547|NCT02833480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780548|NCT02833480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92780549|NCT02833480|Respiratory System Agents|respiratory system agents|mesh-ancestor
92780550|NCT02833480|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780551|NCT02833480|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92780552|NCT02833480|Glucocorticoids|glucocorticoids|mesh-ancestor
92780553|NCT02833480|Hormones|hormones|mesh-ancestor
92780554|NCT02833480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780555|NCT02833480|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92780556|NCT02833480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92780557|NCT02833480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92780558|NCT02833480|Adrenergic Agents|adrenergic agents|mesh-ancestor
92780559|NCT02833480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780560|NCT02833480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780561|NCT04201054|Fluconazole|fluconazole|mesh-list
92780562|NCT04201054|Antifungal Agents|antifungal agents|mesh-ancestor
92780563|NCT04201054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780564|NCT04201054|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92780565|NCT04201054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92780566|NCT04201054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780567|NCT04201054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780568|NCT04201054|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92780569|NCT04201054|Hormone Antagonists|hormone antagonists|mesh-ancestor
92780570|NCT04201054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780571|NCT04201054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780572|NCT04201054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92780573|NCT04201054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92780574|NCT01157117|Omalizumab|omalizumab|mesh-list
92780575|NCT01157117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92780576|NCT01157117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92780577|NCT01157117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92780578|NCT01157117|Respiratory System Agents|respiratory system agents|mesh-ancestor
92780579|NCT01157117|Immunologic Factors|immunologic factors|mesh-ancestor
92780580|NCT01157117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780581|NCT00891202|Eliglustat|eliglustat|mesh-list
92780582|NCT00891202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780583|NCT00891202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780584|NCT02830906|Ondansetron|ondansetron|mesh-list
92780585|NCT02830906|Ramosetron|ramosetron|mesh-list
92780586|NCT02830906|Antiemetics|antiemetics|mesh-ancestor
92780587|NCT02830906|Autonomic Agents|autonomic agents|mesh-ancestor
92780588|NCT02830906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780589|NCT02830906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780590|NCT02830906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780591|NCT02830906|Antipruritics|antipruritics|mesh-ancestor
92780592|NCT02830906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780593|NCT02830906|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92780594|NCT02830906|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92780595|NCT02830906|Serotonin Agents|serotonin agents|mesh-ancestor
92780596|NCT02830906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780597|NCT02830906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780598|NCT02832778|Tenofovir|tenofovir|mesh-list
92780599|NCT02832778|Lamivudine|lamivudine|mesh-list
92780600|NCT02832778|Emtricitabine|emtricitabine|mesh-list
92780601|NCT02832778|Zidovudine|zidovudine|mesh-list
92780602|NCT02832778|Efavirenz|efavirenz|mesh-list
92780603|NCT02832778|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92780604|NCT02832778|Isoniazid|isoniazid|mesh-list
92780605|NCT02832778|Antiviral Agents|antiviral agents|mesh-ancestor
92780606|NCT02832778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780607|NCT02832778|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92780608|NCT02832778|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780609|NCT02832778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780610|NCT02832778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780611|NCT02832778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92780612|NCT02832778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92780613|NCT02832778|Antimetabolites|antimetabolites|mesh-ancestor
92780614|NCT02832778|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92780615|NCT02832778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92780616|NCT02832778|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92780617|NCT02832778|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92780618|NCT02832778|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92780619|NCT02832778|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92780620|NCT02832778|Antitubercular Agents|antitubercular agents|mesh-ancestor
92780621|NCT02832778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780622|NCT02832778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92780623|NCT02832778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92780624|NCT02832778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92780625|NCT01185509|Trastuzumab|trastuzumab|mesh-list
92780626|NCT01185509|Vinorelbine|vinorelbine|mesh-list
92780627|NCT01185509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92780628|NCT01185509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780629|NCT01185509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92780630|NCT01185509|Tubulin Modulators|tubulin modulators|mesh-ancestor
92780631|NCT01185509|Antimitotic Agents|antimitotic agents|mesh-ancestor
92780632|NCT01185509|Mitosis Modulators|mitosis modulators|mesh-ancestor
92780633|NCT01185509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780634|NCT04247230|Tetracaine|tetracaine|mesh-list
92780635|NCT04247230|Anesthetics, Local|anesthetics, local|mesh-ancestor
92780636|NCT04247230|Anesthetics|anesthetics|mesh-ancestor
92780637|NCT04247230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780638|NCT04247230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780639|NCT04247230|Sensory System Agents|sensory system agents|mesh-ancestor
92780640|NCT04247230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780641|NCT02832700|Caseins|caseins|mesh-list
92780642|NCT02832700|Chelating Agents|chelating agents|mesh-ancestor
92780643|NCT02832700|Sequestering Agents|sequestering agents|mesh-ancestor
92780644|NCT02832700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780645|NCT02831842|Bevacizumab|bevacizumab|mesh-list
92780646|NCT02831842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92780647|NCT02831842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780648|NCT02831842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92780649|NCT02831842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92780650|NCT02831842|Growth Substances|growth substances|mesh-ancestor
92338851|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92780651|NCT02831842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780652|NCT02831842|Growth Inhibitors|growth inhibitors|mesh-ancestor
92780653|NCT02830048|Glyburide|glyburide|mesh-list
92780654|NCT02830048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92780655|NCT02830048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780656|NCT02830126|Anesthetics|anesthetics|mesh-list
92780657|NCT02830126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780658|NCT02830126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780659|NCT02828566|Ketamine|ketamine|mesh-list
92780660|NCT02828566|Analgesics|analgesics|mesh-ancestor
92780661|NCT02828566|Sensory System Agents|sensory system agents|mesh-ancestor
92780662|NCT02828566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780663|NCT02828566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780664|NCT02828566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92780665|NCT02828566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92780666|NCT02828566|Anesthetics, General|anesthetics, general|mesh-ancestor
92780667|NCT02828566|Anesthetics|anesthetics|mesh-ancestor
92780668|NCT02828566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780669|NCT02828566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92780670|NCT02828566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92780671|NCT02828566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530293|NCT00017238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92780672|NCT02828566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780673|NCT04245046|Amlodipine|amlodipine|mesh-list
92780674|NCT04245046|Candesartan|candesartan|mesh-list
92780675|NCT04245046|Candesartan cilexetil|candesartan cilexetil|mesh-list
92780676|NCT04245046|Atorvastatin|atorvastatin|mesh-list
92780677|NCT04245046|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92780678|NCT04245046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92780679|NCT04245046|Antimetabolites|antimetabolites|mesh-ancestor
92780680|NCT04245046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780681|NCT04245046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92780682|NCT04245046|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92780683|NCT04245046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780684|NCT04245046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92780685|NCT04245046|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92780686|NCT04245046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92780687|NCT04245046|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92780688|NCT04245046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780689|NCT04245046|Vasodilator Agents|vasodilator agents|mesh-ancestor
92780690|NCT04245046|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92780691|NCT04245046|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92780692|NCT02828176|Anesthetics|anesthetics|mesh-list
92780693|NCT02828176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780694|NCT02828176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780695|NCT00633568|Cisplatin|cisplatin|mesh-list
92780696|NCT00633568|Docetaxel|docetaxel|mesh-list
92780697|NCT00633568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780698|NCT00633568|Tubulin Modulators|tubulin modulators|mesh-ancestor
92780699|NCT00633568|Antimitotic Agents|antimitotic agents|mesh-ancestor
92780700|NCT00633568|Mitosis Modulators|mitosis modulators|mesh-ancestor
92780701|NCT00633568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780702|NCT02829424|Methotrexate|methotrexate|mesh-list
92780703|NCT02829424|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92780704|NCT02829424|Abortifacient Agents|abortifacient agents|mesh-ancestor
92780705|NCT02829424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92780706|NCT02829424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780707|NCT02829424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92780708|NCT02829424|Antimetabolites|antimetabolites|mesh-ancestor
92780709|NCT02829424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780710|NCT02829424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780711|NCT02829424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780712|NCT02829424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780713|NCT02829424|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92780714|NCT02829424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780715|NCT02829424|Immunologic Factors|immunologic factors|mesh-ancestor
92780716|NCT02829424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780717|NCT02829424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780718|NCT02829346|Tranexamic Acid|tranexamic acid|mesh-list
92780719|NCT02829346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92780720|NCT02829346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780721|NCT02829346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780722|NCT02829346|Hemostatics|hemostatics|mesh-ancestor
92780723|NCT02829346|Coagulants|coagulants|mesh-ancestor
92780724|NCT05210764|Ketamine|ketamine|mesh-list
92780725|NCT05210764|Anesthetics|anesthetics|mesh-list
92780726|NCT05210764|Propofol|propofol|mesh-list
92780727|NCT05210764|Sevoflurane|sevoflurane|mesh-list
92780728|NCT05210764|Esketamine|esketamine|mesh-list
92780729|NCT05210764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780730|NCT05210764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780731|NCT05210764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92780732|NCT05210764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92780733|NCT05210764|Anesthetics, General|anesthetics, general|mesh-ancestor
92780734|NCT05210764|Analgesics|analgesics|mesh-ancestor
92780735|NCT05210764|Sensory System Agents|sensory system agents|mesh-ancestor
92780736|NCT05210764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780737|NCT05210764|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92780738|NCT05210764|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92780739|NCT05210764|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92780740|NCT05210764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780741|NCT05210764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780742|NCT05210764|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92780743|NCT05210764|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92780744|NCT05210764|Antidepressive Agents|antidepressive agents|mesh-ancestor
92780745|NCT05210764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92780746|NCT00889720|Varenicline|varenicline|mesh-list
92780747|NCT00889720|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92780748|NCT00889720|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92780749|NCT00889720|Cholinergic Agents|cholinergic agents|mesh-ancestor
92780750|NCT00889720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780751|NCT00889720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425808|NCT01534754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780752|NCT00889720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780753|NCT01116648|Olaparib|olaparib|mesh-list
92780754|NCT01116648|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92780755|NCT01116648|Cediranib|cediranib|mesh-list
92780756|NCT01116648|Maleic acid|maleic acid|mesh-list
92780757|NCT01116648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780758|NCT01116648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780759|NCT01116648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780760|NCT01116648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92780761|NCT04243954|Morphine|morphine|mesh-list
92780762|NCT04243954|Hydromorphone|hydromorphone|mesh-list
92780763|NCT04243954|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92780764|NCT04243954|Narcotics|narcotics|mesh-ancestor
92780765|NCT04243954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780766|NCT04243954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780767|NCT04243954|Analgesics|analgesics|mesh-ancestor
92780768|NCT04243954|Sensory System Agents|sensory system agents|mesh-ancestor
92780769|NCT04243954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780770|NCT02827942|Amoxicillin|amoxicillin|mesh-list
92780771|NCT02827942|Metronidazole|metronidazole|mesh-list
92780772|NCT02827942|Clarithromycin|clarithromycin|mesh-list
92780773|NCT02827942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780774|NCT02827942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780775|NCT02827942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92780776|NCT02827942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92780777|NCT02827942|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92780778|NCT02827942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338875|NCT00000317|Serotonin Agents|serotonin agents|mesh-ancestor
92780779|NCT02827942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780780|NCT02827942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92780781|NCT02827942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92780782|NCT00889252|Ketotifen|ketotifen|mesh-list
92780783|NCT00889252|Antipruritics|antipruritics|mesh-ancestor
92780784|NCT00889252|Dermatologic Agents|dermatologic agents|mesh-ancestor
92780785|NCT00889252|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92780786|NCT00889252|Histamine Antagonists|histamine antagonists|mesh-ancestor
92780787|NCT00889252|Histamine Agents|histamine agents|mesh-ancestor
92780788|NCT00889252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780789|NCT00889252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780790|NCT00889252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780791|NCT00889252|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92780792|NCT00670813|Modafinil|modafinil|mesh-list
92780793|NCT00670813|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92780794|NCT00670813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780795|NCT00670813|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92780796|NCT00670813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92780797|NCT00670813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92780798|NCT00670813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780799|NCT01110330|Ketoconazole|ketoconazole|mesh-list
92780800|NCT01110330|Antifungal Agents|antifungal agents|mesh-ancestor
92780801|NCT01110330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780802|NCT01110330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92780803|NCT01110330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92780804|NCT01110330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780805|NCT01110330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780806|NCT01110330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92780807|NCT01110330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92780808|NCT01110330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780809|NCT01110330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780810|NCT01110330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92780811|NCT00663481|Leucovorin|leucovorin|mesh-list
92780812|NCT00663481|Antidotes|antidotes|mesh-ancestor
92780813|NCT00663481|Protective Agents|protective agents|mesh-ancestor
92780814|NCT00663481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780815|NCT00663481|Vitamin B Complex|vitamin b complex|mesh-ancestor
92780816|NCT00663481|Vitamins|vitamins|mesh-ancestor
92780817|NCT00663481|Micronutrients|micronutrients|mesh-ancestor
92780818|NCT04308954|Flumazenil|flumazenil|mesh-list
92780819|NCT04308954|Antidotes|antidotes|mesh-ancestor
92780820|NCT04308954|Protective Agents|protective agents|mesh-ancestor
92780821|NCT04308954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780822|NCT04308954|GABA Modulators|gaba modulators|mesh-ancestor
92780823|NCT04308954|GABA Agents|gaba agents|mesh-ancestor
92780824|NCT04308954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92780825|NCT04308954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780826|NCT00596947|Mycophenolic Acid|mycophenolic acid|mesh-list
92780828|NCT00596947|Methylprednisolone|methylprednisolone|mesh-list
92780829|NCT00596947|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92780830|NCT00596947|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92780831|NCT00596947|Prednisolone|prednisolone|mesh-list
92780832|NCT00596947|Prednisolone acetate|prednisolone acetate|mesh-list
92780833|NCT00596947|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92780834|NCT00596947|Prednisolone phosphate|prednisolone phosphate|mesh-list
92780835|NCT00596947|Tacrolimus|tacrolimus|mesh-list
92780836|NCT00596947|Thymoglobulin|thymoglobulin|mesh-list
92780837|NCT00596947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92780838|NCT00596947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780839|NCT00596947|Glucocorticoids|glucocorticoids|mesh-ancestor
92780840|NCT00596947|Hormones|hormones|mesh-ancestor
92780841|NCT00596947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780842|NCT00596947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780843|NCT00596947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92780844|NCT00596947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780845|NCT00596947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92780846|NCT00596947|Immunologic Factors|immunologic factors|mesh-ancestor
92780847|NCT00596947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92780848|NCT00596947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780849|NCT00596947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780850|NCT00596947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92780851|NCT00596947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92780852|NCT00596947|Antitubercular Agents|antitubercular agents|mesh-ancestor
92780853|NCT00596947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780854|NCT00596947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780855|NCT00596947|Antiemetics|antiemetics|mesh-ancestor
92780856|NCT00596947|Autonomic Agents|autonomic agents|mesh-ancestor
92780857|NCT00596947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780858|NCT00596947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780859|NCT00596947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92780860|NCT00596947|Protective Agents|protective agents|mesh-ancestor
92780861|NCT04155697|Hand Sanitizers|hand sanitizers|mesh-list
92780862|NCT04155697|Ethanol|ethanol|mesh-list
92780863|NCT04155697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92780864|NCT04155697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780865|NCT04155697|Disinfectants|disinfectants|mesh-ancestor
92780866|NCT04155697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780867|NCT04155697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780868|NCT00663559|Sunitinib|sunitinib|mesh-list
92780869|NCT00663559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780870|NCT00663559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92780871|NCT00663559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92780872|NCT00663559|Growth Substances|growth substances|mesh-ancestor
92780873|NCT00663559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780874|NCT00663559|Growth Inhibitors|growth inhibitors|mesh-ancestor
92780875|NCT00663559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92780876|NCT00663559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780877|NCT00663559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780878|NCT04158349|Oxaliplatin|oxaliplatin|mesh-list
92780879|NCT04158349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780881|NCT00888940|Tranexamic Acid|tranexamic acid|mesh-list
92780882|NCT00888940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92780883|NCT00888940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780884|NCT00888940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780885|NCT00888940|Hemostatics|hemostatics|mesh-ancestor
92780886|NCT00888940|Coagulants|coagulants|mesh-ancestor
92780887|NCT00888940|Analgesics|analgesics|mesh-ancestor
92780888|NCT00888940|Sensory System Agents|sensory system agents|mesh-ancestor
92780889|NCT00888940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780890|NCT00888940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780891|NCT00888940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780892|NCT00888940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780893|NCT00888940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780894|NCT00888940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780895|NCT02826070|Adefovir|adefovir|mesh-list
92780896|NCT02826070|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92780897|NCT02826070|Telbivudine|telbivudine|mesh-list
92780898|NCT02826070|Antiviral Agents|antiviral agents|mesh-ancestor
92780899|NCT02826070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780900|NCT02826070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92780901|NCT02826070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92780902|NCT02826070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780903|NCT02826070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780904|NCT02826226|Bronchodilator Agents|bronchodilator agents|mesh-list
92780905|NCT02826226|Autonomic Agents|autonomic agents|mesh-ancestor
92780906|NCT02826226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780907|NCT02826226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780908|NCT02826226|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92780909|NCT02826226|Respiratory System Agents|respiratory system agents|mesh-ancestor
92780910|NCT00671203|Erythromycin|erythromycin|mesh-list
92780911|NCT00671203|Erythromycin Estolate|erythromycin estolate|mesh-list
92780912|NCT00671203|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92780913|NCT00671203|Erythromycin stearate|erythromycin stearate|mesh-list
92780914|NCT00671203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780915|NCT00671203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780916|NCT00671203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92780917|NCT00671203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92780918|NCT00671203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780919|NCT00671203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780920|NCT04157803|Acetic Acid|acetic acid|mesh-list
92780921|NCT04157803|Retinol acetate|retinol acetate|mesh-list
92780922|NCT04157803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780923|NCT04157803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780924|NCT04157803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92780925|NCT04157803|Immunologic Factors|immunologic factors|mesh-ancestor
92780926|NCT04157803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780927|NCT04157803|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92780928|NCT04157803|Protective Agents|protective agents|mesh-ancestor
92780929|NCT04157803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780930|NCT04157959|Febuxostat|febuxostat|mesh-list
92780931|NCT04157959|Gout Suppressants|gout suppressants|mesh-ancestor
92780932|NCT04157959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780933|NCT00660283|Temozolomide|temozolomide|mesh-list
92780934|NCT00660283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92780935|NCT00660283|Alkylating Agents|alkylating agents|mesh-ancestor
92780936|NCT00660283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780937|NCT00660283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92780938|NCT00663949|Captopril|captopril|mesh-list
92780939|NCT00663949|Pentoxifylline|pentoxifylline|mesh-list
92780940|NCT00663949|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92780941|NCT00663949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780942|NCT00663949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780943|NCT00663949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92780944|NCT00663949|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92780945|NCT00663949|Protective Agents|protective agents|mesh-ancestor
92780946|NCT00663949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780947|NCT00663949|Vasodilator Agents|vasodilator agents|mesh-ancestor
92780948|NCT00663949|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92780949|NCT00663949|Antioxidants|antioxidants|mesh-ancestor
92780950|NCT00663949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92780951|NCT00663949|Protease Inhibitors|protease inhibitors|mesh-ancestor
92780952|NCT00663949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92780953|NCT00888238|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92780954|NCT00888238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92780955|NCT00888238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780956|NCT00888238|Incretins|incretins|mesh-ancestor
92780957|NCT00888238|Hormones|hormones|mesh-ancestor
92780958|NCT00888238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780959|NCT00888238|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92780960|NCT00888238|Protease Inhibitors|protease inhibitors|mesh-ancestor
92780961|NCT00888238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92780962|NCT00888238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780963|NCT05660356|Hormones|hormones|mesh-list
92780964|NCT05660356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92780965|NCT05660356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780966|NCT02825914|Caseins|caseins|mesh-list
92780967|NCT02825914|Chelating Agents|chelating agents|mesh-ancestor
92780968|NCT02825914|Sequestering Agents|sequestering agents|mesh-ancestor
92780969|NCT02825914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780970|NCT00671281|Tranexamic Acid|tranexamic acid|mesh-list
92780971|NCT00671281|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92780972|NCT00671281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92780973|NCT00671281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92780974|NCT00671281|Hemostatics|hemostatics|mesh-ancestor
92780975|NCT00671281|Coagulants|coagulants|mesh-ancestor
92780976|NCT04155229|Acetaminophen|acetaminophen|mesh-list
92780977|NCT04155229|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92780978|NCT04155229|Oxycodone|oxycodone|mesh-list
92780979|NCT04155229|Hydrocodone|hydrocodone|mesh-list
92780980|NCT04155229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92780981|NCT04155229|Analgesics|analgesics|mesh-ancestor
92780982|NCT04155229|Sensory System Agents|sensory system agents|mesh-ancestor
92780983|NCT04155229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92780984|NCT04155229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92780985|NCT04155229|Antipyretics|antipyretics|mesh-ancestor
92780986|NCT04155229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92780987|NCT04155229|Narcotics|narcotics|mesh-ancestor
92780988|NCT04155229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92780989|NCT04155229|Antitussive Agents|antitussive agents|mesh-ancestor
92780990|NCT04155229|Respiratory System Agents|respiratory system agents|mesh-ancestor
92780991|NCT04155229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92780992|NCT04155229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92780993|NCT04155229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92780994|NCT00671359|Tedizolid phosphate|tedizolid phosphate|mesh-list
92780995|NCT00671359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92780996|NCT00671359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92780997|NCT04153201|Hydroxychloroquine|hydroxychloroquine|mesh-list
92780998|NCT04153201|Antimalarials|antimalarials|mesh-list
92780999|NCT04153201|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92781000|NCT04153201|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92781001|NCT04153201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781002|NCT04153201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781003|NCT04153201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781004|NCT04153201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781005|NCT05660278|Caseins|caseins|mesh-list
92781006|NCT05660278|Chelating Agents|chelating agents|mesh-ancestor
92781007|NCT05660278|Sequestering Agents|sequestering agents|mesh-ancestor
92781008|NCT05660278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781009|NCT04153123|Epinephrine|epinephrine|mesh-list
92781010|NCT04153123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92781011|NCT04153123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92781012|NCT04153123|Adrenergic Agents|adrenergic agents|mesh-ancestor
92781013|NCT04153123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781014|NCT04153123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781015|NCT04153123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781016|NCT04153123|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92781017|NCT04153123|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92781018|NCT04153123|Autonomic Agents|autonomic agents|mesh-ancestor
92781019|NCT04153123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781020|NCT04153123|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92781021|NCT04153123|Respiratory System Agents|respiratory system agents|mesh-ancestor
92781022|NCT04153123|Mydriatics|mydriatics|mesh-ancestor
92781023|NCT04153123|Sympathomimetics|sympathomimetics|mesh-ancestor
92781024|NCT04153123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92781025|NCT00671593|Phenol|phenol|mesh-list
92781026|NCT00671593|Glycerol|glycerol|mesh-list
92781027|NCT00671593|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92781028|NCT00671593|Protective Agents|protective agents|mesh-ancestor
92781029|NCT00671593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781030|NCT00671593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92781031|NCT00671593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781032|NCT00671593|Disinfectants|disinfectants|mesh-ancestor
92781033|NCT00671593|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92781034|NCT00671593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92781035|NCT01104870|Treprostinil|treprostinil|mesh-list
92781036|NCT01104870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92781037|NCT02632279|Tryptophan|tryptophan|mesh-list
92781038|NCT02632279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92781039|NCT02632279|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781040|NCT02632279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781041|NCT00664417|Vaccines|vaccines|mesh-list
92781042|NCT00664417|Immunologic Factors|immunologic factors|mesh-ancestor
92781043|NCT00664417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781044|NCT04031755|Minocycline|minocycline|mesh-list
92781045|NCT04031755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92781046|NCT04031755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781047|NCT01104792|Cariprazine|cariprazine|mesh-list
92781048|NCT01104792|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92781049|NCT01104792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781050|NCT01104792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781051|NCT01104792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781052|NCT01104792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781053|NCT01205126|Oxycodone|oxycodone|mesh-list
92781054|NCT01205126|Hydromorphone|hydromorphone|mesh-list
92781055|NCT01205126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92781056|NCT01205126|Narcotics|narcotics|mesh-ancestor
92781057|NCT01205126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781058|NCT01205126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781059|NCT01205126|Analgesics|analgesics|mesh-ancestor
92781060|NCT01205126|Sensory System Agents|sensory system agents|mesh-ancestor
92781061|NCT01205126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781063|NCT02629627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781064|NCT02629627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781065|NCT00946647|Azacitidine|azacitidine|mesh-list
92781066|NCT00946647|Panobinostat|panobinostat|mesh-list
92781067|NCT00946647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92781068|NCT00946647|Antimetabolites|antimetabolites|mesh-ancestor
92781069|NCT00946647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781070|NCT00946647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781071|NCT00946647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781072|NCT00946647|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92781073|NCT05117736|Valsartan|valsartan|mesh-list
92781074|NCT05117736|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92781075|NCT05117736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92781076|NCT05117736|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92781077|NCT05117736|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92781078|NCT05117736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781080|NCT04157491|Immunologic Factors|immunologic factors|mesh-ancestor
92781081|NCT04157491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781082|NCT00660751|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92781083|NCT00660751|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92781084|NCT00660751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92781085|NCT00660751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92781086|NCT00660751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781087|NCT00660751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781088|NCT00660751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781089|NCT00660751|Analgesics|analgesics|mesh-ancestor
92781090|NCT00660751|Sensory System Agents|sensory system agents|mesh-ancestor
92781091|NCT00660751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781092|NCT00660751|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781093|NCT00660751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781094|NCT00660751|Dopamine Agents|dopamine agents|mesh-ancestor
92781095|NCT00664963|Sirolimus|sirolimus|mesh-list
92781096|NCT00664963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92781097|NCT00664963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781098|NCT00664963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92781099|NCT00664963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781100|NCT00664963|Antifungal Agents|antifungal agents|mesh-ancestor
92781101|NCT00664963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781102|NCT00664963|Immunologic Factors|immunologic factors|mesh-ancestor
92781103|NCT00664963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781104|NCT00672295|Paclitaxel|paclitaxel|mesh-list
92781105|NCT00672295|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92781106|NCT00672295|Carboplatin|carboplatin|mesh-list
92781107|NCT00672295|Dasatinib|dasatinib|mesh-list
92781108|NCT00672295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92781109|NCT00672295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781110|NCT00672295|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781111|NCT00672295|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781112|NCT00672295|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781113|NCT00672295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781114|NCT00672295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92781115|NCT00672295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781116|NCT00665041|Quinagolide|quinagolide|mesh-list
92781117|NCT00665041|Dopamine Agonists|dopamine agonists|mesh-ancestor
92781118|NCT00665041|Dopamine Agents|dopamine agents|mesh-ancestor
92781119|NCT00665041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781120|NCT00665041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781121|NCT00665041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781122|NCT04152655|Coenzyme Q10|coenzyme q10|mesh-list
92781123|NCT04152655|Idebenone|idebenone|mesh-list
92781124|NCT04152655|Micronutrients|micronutrients|mesh-ancestor
92781125|NCT04152655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781126|NCT04152655|Vitamins|vitamins|mesh-ancestor
92781127|NCT04152655|Antioxidants|antioxidants|mesh-ancestor
92781128|NCT04152655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781129|NCT04152655|Protective Agents|protective agents|mesh-ancestor
92781130|NCT00665119|Remifentanil|remifentanil|mesh-list
92781131|NCT00665119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92781132|NCT00665119|Narcotics|narcotics|mesh-ancestor
92781133|NCT00665119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781134|NCT00665119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781135|NCT00665119|Analgesics|analgesics|mesh-ancestor
92781136|NCT00665119|Sensory System Agents|sensory system agents|mesh-ancestor
92781137|NCT00665119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781138|NCT00887224|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92781139|NCT00887224|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92781140|NCT00887224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92781141|NCT00887224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92781142|NCT00887224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781143|NCT00887224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781144|NCT00887224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781145|NCT00887224|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781146|NCT00887224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781147|NCT00672763|Calcium, Dietary|calcium, dietary|mesh-list
92781148|NCT00672763|Vitamin D|vitamin d|mesh-list
92781149|NCT00672763|Ergocalciferols|ergocalciferols|mesh-list
92781150|NCT00672763|Cholecalciferol|cholecalciferol|mesh-list
92781151|NCT00672763|Vitamins|vitamins|mesh-list
92781152|NCT00672763|Calcium|calcium|mesh-list
92781153|NCT00672763|Micronutrients|micronutrients|mesh-ancestor
92781154|NCT00672763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781155|NCT00672763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92781156|NCT00672763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92781157|NCT04154449|Insulin|insulin|mesh-list
92781158|NCT04154449|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781159|NCT04154449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781160|NCT00661063|Clonidine|clonidine|mesh-list
92781161|NCT00661063|Ketamine|ketamine|mesh-list
92781162|NCT00661063|Analgesics|analgesics|mesh-ancestor
92781163|NCT00661063|Sensory System Agents|sensory system agents|mesh-ancestor
92781164|NCT00661063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781165|NCT00661063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781166|NCT00661063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92781167|NCT00661063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92781168|NCT00661063|Anesthetics, General|anesthetics, general|mesh-ancestor
92781169|NCT00661063|Anesthetics|anesthetics|mesh-ancestor
92781170|NCT00661063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781171|NCT00661063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92781172|NCT00661063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92781173|NCT00661063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781174|NCT00661063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781175|NCT00661063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92781176|NCT00661063|Sympatholytics|sympatholytics|mesh-ancestor
92781177|NCT00661063|Autonomic Agents|autonomic agents|mesh-ancestor
92781178|NCT00661063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92781179|NCT00661063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92781180|NCT00661063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92781181|NCT00661063|Adrenergic Agents|adrenergic agents|mesh-ancestor
92781182|NCT00672919|Pioglitazone|pioglitazone|mesh-list
92781183|NCT00672919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781184|NCT00672919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781185|NCT01109316|Insulin|insulin|mesh-list
92781186|NCT01109316|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92781187|NCT01109316|Insulin Aspart|insulin aspart|mesh-list
92781188|NCT01109316|Insulin Lispro|insulin lispro|mesh-list
92781189|NCT01109316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781190|NCT01109316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781191|NCT02825290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92781192|NCT02825290|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92781193|NCT02825290|Luteolytic Agents|luteolytic agents|mesh-ancestor
92781194|NCT02825290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92781195|NCT02825290|Contraceptive Agents|contraceptive agents|mesh-ancestor
92781196|NCT02825290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92781197|NCT02825290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781198|NCT02825290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92781199|NCT02825290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92781200|NCT02825290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781201|NCT00675961|Naltrexone|naltrexone|mesh-list
92781202|NCT00675961|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92781203|NCT00675961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92781204|NCT00675961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781205|NCT00675961|Sensory System Agents|sensory system agents|mesh-ancestor
92781206|NCT00675961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781207|NCT00887068|Azacitidine|azacitidine|mesh-list
92781208|NCT00887068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92781209|NCT00887068|Antimetabolites|antimetabolites|mesh-ancestor
92781210|NCT00887068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781211|NCT00887068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781212|NCT00887068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781213|NCT00941031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92781214|NCT00941031|Immunologic Factors|immunologic factors|mesh-ancestor
92781215|NCT00941031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781216|NCT00886834|Misoprostol|misoprostol|mesh-list
92781217|NCT00886834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92781218|NCT00886834|Abortifacient Agents|abortifacient agents|mesh-ancestor
92781219|NCT00886834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92781220|NCT00886834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781221|NCT00886834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92781222|NCT00886834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781223|NCT00886834|Oxytocics|oxytocics|mesh-ancestor
92781224|NCT00880009|Letrozole|letrozole|mesh-list
92781225|NCT00880009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781226|NCT00880009|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92781227|NCT00880009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92781228|NCT00880009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781229|NCT00880009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781230|NCT00880009|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92781231|NCT00880009|Hormone Antagonists|hormone antagonists|mesh-ancestor
92781232|NCT00880009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781233|NCT00880009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781234|NCT00676039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92781235|NCT00676039|Citalopram|citalopram|mesh-list
92781236|NCT00676039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92781237|NCT00676039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92781238|NCT00676039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92781239|NCT00676039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781240|NCT00676039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781241|NCT00676039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781242|NCT00676039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92781243|NCT00676039|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781244|NCT00676039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781245|NCT00676039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92781246|NCT00676039|Serotonin Agents|serotonin agents|mesh-ancestor
92781247|NCT01104636|Varenicline|varenicline|mesh-list
92781248|NCT01104636|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92781249|NCT01104636|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92781250|NCT01104636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92781251|NCT01104636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781252|NCT01104636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781253|NCT01104636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781254|NCT04931602|Vitamin D|vitamin d|mesh-list
92781255|NCT04931602|Vitamins|vitamins|mesh-ancestor
92781256|NCT04931602|Micronutrients|micronutrients|mesh-ancestor
92781257|NCT04931602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781258|NCT04931602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92781259|NCT04157257|Tenofovir|tenofovir|mesh-list
92781260|NCT04157257|Entecavir|entecavir|mesh-list
92781261|NCT04157257|Antiviral Agents|antiviral agents|mesh-ancestor
92781262|NCT04157257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781263|NCT04157257|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92781264|NCT04157257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92781265|NCT04157257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781266|NCT04157257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781267|NCT04157257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92781268|NCT04157257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92781269|NCT04152889|Docetaxel|docetaxel|mesh-list
92781270|NCT04152889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781271|NCT04152889|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781272|NCT04152889|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781273|NCT04152889|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781274|NCT04152889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781275|NCT00602511|Thalidomide|thalidomide|mesh-list
92781276|NCT00602511|Bortezomib|bortezomib|mesh-list
92781277|NCT00602511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426337|NCT01537861|Hormones|hormones|mesh-ancestor
92781278|NCT00602511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781279|NCT00602511|Immunologic Factors|immunologic factors|mesh-ancestor
92781280|NCT00602511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781281|NCT00602511|Leprostatic Agents|leprostatic agents|mesh-ancestor
92781282|NCT00602511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92781283|NCT00602511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781284|NCT00602511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92781285|NCT00602511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92781286|NCT00602511|Growth Substances|growth substances|mesh-ancestor
92781287|NCT00602511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92781288|NCT02826616|Trimetazidine|trimetazidine|mesh-list
92781289|NCT02826616|Vasodilator Agents|vasodilator agents|mesh-ancestor
92781290|NCT00676117|Loxoprofen|loxoprofen|mesh-list
92781291|NCT00676117|Esomeprazole|esomeprazole|mesh-list
92781292|NCT00676117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92781293|NCT00676117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781294|NCT00676117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92781295|NCT00676117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781296|NCT00676117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781297|NCT00676117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92781298|NCT00676117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92781299|NCT00676117|Analgesics|analgesics|mesh-ancestor
92781300|NCT00676117|Sensory System Agents|sensory system agents|mesh-ancestor
92781301|NCT00676117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781302|NCT00676117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781303|NCT00676117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781304|NCT00676117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781305|NCT01104558|Bisoprolol|bisoprolol|mesh-list
92781306|NCT01104558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92781307|NCT01104558|Sympatholytics|sympatholytics|mesh-ancestor
92781308|NCT01104558|Autonomic Agents|autonomic agents|mesh-ancestor
92781309|NCT01104558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781310|NCT01104558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781311|NCT01104558|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92781312|NCT01104558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92781313|NCT01104558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92781314|NCT01104558|Adrenergic Agents|adrenergic agents|mesh-ancestor
92781315|NCT01104558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781316|NCT01104558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781317|NCT00602589|Levofloxacin|levofloxacin|mesh-list
92781318|NCT00602589|Ofloxacin|ofloxacin|mesh-list
92781319|NCT00602589|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92781320|NCT00602589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781321|NCT00602589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92781322|NCT00602589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92781323|NCT00602589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92781324|NCT00602589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781325|NCT00602589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781326|NCT00602589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781327|NCT00602589|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92781328|NCT00602589|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92781329|NCT04270071|Nitroglycerin|nitroglycerin|mesh-list
92781330|NCT04270071|Vasodilator Agents|vasodilator agents|mesh-ancestor
92781331|NCT02856087|Remifentanil|remifentanil|mesh-list
92781332|NCT02856087|Naloxone|naloxone|mesh-list
92781333|NCT02856087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92781334|NCT02856087|Narcotics|narcotics|mesh-ancestor
92781335|NCT02856087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781336|NCT02856087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781337|NCT02856087|Analgesics|analgesics|mesh-ancestor
92781338|NCT02856087|Sensory System Agents|sensory system agents|mesh-ancestor
92781339|NCT02856087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781340|NCT02856087|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92781341|NCT00676429|Ziprasidone|ziprasidone|mesh-list
92781342|NCT00676429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92781343|NCT00676429|Serotonin Agents|serotonin agents|mesh-ancestor
92781344|NCT00676429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781345|NCT00676429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781346|NCT00676429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781347|NCT00676429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92781348|NCT00676429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781349|NCT00676429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781350|NCT00676429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781351|NCT00676429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92781352|NCT00676429|Dopamine Agents|dopamine agents|mesh-ancestor
92781353|NCT02629315|Formaldehyde|formaldehyde|mesh-list
92781354|NCT02629315|Disinfectants|disinfectants|mesh-ancestor
92781355|NCT02629315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781356|NCT01204658|Vaccines|vaccines|mesh-list
92781357|NCT01204658|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92781358|NCT01204658|Immunologic Factors|immunologic factors|mesh-ancestor
92781359|NCT01204658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781360|NCT00951483|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92781361|NCT00951483|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781362|NCT00951483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781363|NCT00951483|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92781364|NCT00951483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781365|NCT00951483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781366|NCT00951483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781368|NCT01104246|Androgens|androgens|mesh-ancestor
92781369|NCT01104246|Hormones|hormones|mesh-ancestor
92781370|NCT01104246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781371|NCT01104246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781372|NCT00676741|Insulin|insulin|mesh-list
92781373|NCT00676741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92781374|NCT00676741|Insulin Aspart|insulin aspart|mesh-list
92781375|NCT00676741|Insulin, Long-Acting|insulin, long-acting|mesh-list
92781376|NCT00676741|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92781377|NCT00676741|Insulin Detemir|insulin detemir|mesh-list
92781378|NCT00676741|Biphasic Insulins|biphasic insulins|mesh-list
92781379|NCT00676741|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92781380|NCT00676741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781381|NCT00676741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781382|NCT01103778|Bortezomib|bortezomib|mesh-list
92781383|NCT01103778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781384|NCT00673621|Albuterol|albuterol|mesh-list
92781385|NCT00673621|Methacholine Chloride|methacholine chloride|mesh-list
92781386|NCT00673621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781387|NCT00673621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92781388|NCT00673621|Autonomic Agents|autonomic agents|mesh-ancestor
92781389|NCT00673621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781390|NCT00673621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92781391|NCT00673621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92781392|NCT00673621|Tocolytic Agents|tocolytic agents|mesh-ancestor
92781393|NCT00673621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92781394|NCT00673621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92781395|NCT00673621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92781396|NCT00673621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92781397|NCT00673621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92781398|NCT00673621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781399|NCT00673621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781400|NCT00673621|Miotics|miotics|mesh-ancestor
92781401|NCT00673621|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92781402|NCT00673621|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92781403|NCT00673621|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92781404|NCT00673621|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92781405|NCT00673621|Cholinergic Agents|cholinergic agents|mesh-ancestor
92781406|NCT02627053|Rivaroxaban|rivaroxaban|mesh-list
92781407|NCT02627053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92781408|NCT02627053|Antithrombins|antithrombins|mesh-ancestor
92781409|NCT02627053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92781410|NCT02627053|Protease Inhibitors|protease inhibitors|mesh-ancestor
92781411|NCT02627053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781412|NCT02627053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781413|NCT02627053|Anticoagulants|anticoagulants|mesh-ancestor
92781414|NCT00945945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92781415|NCT00945945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92781416|NCT00945945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92781417|NCT00945945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92781418|NCT00945945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781419|NCT00945945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781420|NCT00945945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781421|NCT00945945|Analgesics|analgesics|mesh-ancestor
92781422|NCT00945945|Sensory System Agents|sensory system agents|mesh-ancestor
92781423|NCT00945945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781424|NCT00945945|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781425|NCT00945945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781426|NCT00945945|Dopamine Agents|dopamine agents|mesh-ancestor
92781427|NCT01112982|Colchicine|colchicine|mesh-list
92781428|NCT01112982|Febuxostat|febuxostat|mesh-list
92781429|NCT01112982|Gout Suppressants|gout suppressants|mesh-ancestor
92781430|NCT01112982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781431|NCT01112982|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781432|NCT01112982|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781433|NCT01112982|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530361|NCT00017355|Immunologic Factors|immunologic factors|mesh-ancestor
92781434|NCT01112982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781435|NCT01112982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781436|NCT01203878|Imiquimod|imiquimod|mesh-list
92781437|NCT01203878|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92781438|NCT01203878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92781439|NCT01203878|Immunologic Factors|immunologic factors|mesh-ancestor
92781440|NCT01203878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781441|NCT01203878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781442|NCT01203878|Interferon Inducers|interferon inducers|mesh-ancestor
92781443|NCT01203878|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92781444|NCT01203878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92781445|NCT00676819|Insulin|insulin|mesh-list
92781446|NCT00676819|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92781447|NCT00676819|Insulin Aspart|insulin aspart|mesh-list
92781448|NCT00676819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781449|NCT00676819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781450|NCT00625794|Nicotine|nicotine|mesh-list
92781451|NCT00625794|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92781452|NCT00625794|Autonomic Agents|autonomic agents|mesh-ancestor
92781453|NCT00625794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781454|NCT00625794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781455|NCT00625794|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92781456|NCT00625794|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92781457|NCT00625794|Cholinergic Agents|cholinergic agents|mesh-ancestor
92781458|NCT00625794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781459|NCT00625794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781460|NCT01203098|Enoxaparin|enoxaparin|mesh-list
92781461|NCT01203098|Enoxaparin sodium|enoxaparin sodium|mesh-list
92781462|NCT01203098|Edoxaban|edoxaban|mesh-list
92781463|NCT01203098|Anticoagulants|anticoagulants|mesh-ancestor
92781464|NCT01203098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92781465|NCT01203098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92781466|NCT01203098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781467|NCT01203098|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92781468|NCT01203098|Antithrombins|antithrombins|mesh-ancestor
92781469|NCT01203098|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92781470|NCT01203098|Protease Inhibitors|protease inhibitors|mesh-ancestor
92781471|NCT01203098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781472|NCT05032794|Bisacodyl|bisacodyl|mesh-list
92781473|NCT05032794|Cathartics|cathartics|mesh-ancestor
92781474|NCT05032794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781475|NCT05032794|Laxatives|laxatives|mesh-ancestor
92781476|NCT00945555|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92781477|NCT00945555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781478|NCT01108458|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92781479|NCT01108458|Pertuzumab|pertuzumab|mesh-list
92781480|NCT01108458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781481|NCT01108458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92781482|NCT01108458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781483|NCT01108458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781484|NCT01108458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92781485|NCT04318262|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92781486|NCT04318262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781487|NCT00680485|Ketoconazole|ketoconazole|mesh-list
92781488|NCT00680485|Antifungal Agents|antifungal agents|mesh-ancestor
92781489|NCT00680485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781490|NCT00680485|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92781491|NCT00680485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92781492|NCT00680485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781493|NCT00680485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781494|NCT00680485|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92781495|NCT00680485|Hormone Antagonists|hormone antagonists|mesh-ancestor
92781496|NCT00680485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781497|NCT00680485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781498|NCT00680485|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92781499|NCT00680563|Epoetin Alfa|epoetin alfa|mesh-list
92781500|NCT00680563|Hematinics|hematinics|mesh-ancestor
92781501|NCT01108068|Lithium Carbonate|lithium carbonate|mesh-list
92781502|NCT01108068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781503|NCT01108068|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781505|NCT01108068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781506|NCT01108068|Antimanic Agents|antimanic agents|mesh-ancestor
92781507|NCT01108068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781508|NCT01108068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781509|NCT01108068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781510|NCT00680641|Simvastatin|simvastatin|mesh-list
92781511|NCT00680641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92781512|NCT00680641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92781513|NCT00680641|Antimetabolites|antimetabolites|mesh-ancestor
92781514|NCT00680641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781515|NCT00680641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92781516|NCT00680641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92781517|NCT00680641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781518|NCT01201850|Bevacizumab|bevacizumab|mesh-list
92781519|NCT01201850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92781520|NCT01201850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781521|NCT01201850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92781522|NCT01201850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92781523|NCT01201850|Growth Substances|growth substances|mesh-ancestor
92781524|NCT01201850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781525|NCT01201850|Growth Inhibitors|growth inhibitors|mesh-ancestor
92781526|NCT05660122|Fexuprazan|fexuprazan|mesh-list
92781527|NCT05660122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781528|NCT04980144|Lubricant Eye Drops|lubricant eye drops|mesh-list
92781529|NCT04980144|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92781530|NCT04980144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92781531|NCT02825056|Morphine|morphine|mesh-list
92781532|NCT02825056|Bupivacaine|bupivacaine|mesh-list
92781533|NCT02825056|Anesthetics, Local|anesthetics, local|mesh-ancestor
92781534|NCT02825056|Anesthetics|anesthetics|mesh-ancestor
92781535|NCT02825056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781536|NCT02825056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781537|NCT02825056|Sensory System Agents|sensory system agents|mesh-ancestor
92781538|NCT02825056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781539|NCT02825056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92781540|NCT02825056|Narcotics|narcotics|mesh-ancestor
92781541|NCT02825056|Analgesics|analgesics|mesh-ancestor
92781542|NCT02826772|Androgens|androgens|mesh-list
92781543|NCT02826772|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92781544|NCT02826772|Hormones|hormones|mesh-ancestor
92781545|NCT02826772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781546|NCT02826772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781547|NCT02826772|Androgen Antagonists|androgen antagonists|mesh-ancestor
92781548|NCT02826772|Hormone Antagonists|hormone antagonists|mesh-ancestor
92781549|NCT00674011|Bevacizumab|bevacizumab|mesh-list
92781550|NCT00674011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92781551|NCT00674011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781552|NCT00674011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92781553|NCT00674011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92781554|NCT00674011|Growth Substances|growth substances|mesh-ancestor
92781555|NCT00674011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781556|NCT00674011|Growth Inhibitors|growth inhibitors|mesh-ancestor
92781557|NCT00674089|Vitamin A|vitamin a|mesh-list
92781558|NCT00674089|Vitamins|vitamins|mesh-ancestor
92781559|NCT00674089|Micronutrients|micronutrients|mesh-ancestor
92781560|NCT00674089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781561|NCT01200992|Mitomycins|mitomycins|mesh-list
92781562|NCT01200992|Mitomycin|mitomycin|mesh-list
92781563|NCT01200992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92781564|NCT01200992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781565|NCT01200992|Alkylating Agents|alkylating agents|mesh-ancestor
92781566|NCT01200992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781567|NCT01200992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92781568|NCT01200992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781569|NCT02824666|Fallypride|fallypride|mesh-list
92781570|NCT02824666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92781571|NCT02824666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92781572|NCT02824666|Dopamine Agents|dopamine agents|mesh-ancestor
92781573|NCT02824666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781574|NCT02824666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781575|NCT02824666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781576|NCT00674167|Docetaxel|docetaxel|mesh-list
92781577|NCT00674167|Capecitabine|capecitabine|mesh-list
92781578|NCT00674167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781579|NCT00674167|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781580|NCT00674167|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781581|NCT00674167|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781582|NCT00674167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781583|NCT00674167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92781584|NCT00674167|Antimetabolites|antimetabolites|mesh-ancestor
92781586|NCT00912145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92781587|NCT00912145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781588|NCT00912145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781589|NCT00912145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92781590|NCT00912145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781591|NCT00912145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781592|NCT00912145|GABA Modulators|gaba modulators|mesh-ancestor
92781593|NCT00912145|GABA Agents|gaba agents|mesh-ancestor
92781594|NCT00912145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781595|NCT00912145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781596|NCT02824510|Insulin|insulin|mesh-list
92781597|NCT02824510|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92781598|NCT02824510|Insulin Aspart|insulin aspart|mesh-list
92781599|NCT02824510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781600|NCT02824510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781601|NCT00674245|Pantoprazole|pantoprazole|mesh-list
92781602|NCT00674245|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92781603|NCT00674245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781604|NCT00674245|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92781605|NCT00674245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781606|NCT00674245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781607|NCT00878215|Liver Extracts|liver extracts|mesh-list
92781608|NCT00878215|Hematinics|hematinics|mesh-ancestor
92781609|NCT02628847|Sildenafil Citrate|sildenafil citrate|mesh-list
92781610|NCT02628847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781611|NCT02628847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92781612|NCT02628847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92781613|NCT02628847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92781614|NCT02628847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781615|NCT02628847|Urological Agents|urological agents|mesh-ancestor
92781616|NCT00677443|Capecitabine|capecitabine|mesh-list
92781617|NCT00677443|Oxaliplatin|oxaliplatin|mesh-list
92781618|NCT00677443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92781619|NCT00677443|Antimetabolites|antimetabolites|mesh-ancestor
92781620|NCT00677443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781621|NCT00677443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781622|NCT00674557|Exemestane|exemestane|mesh-list
92781623|NCT00674557|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92781624|NCT00674557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781625|NCT00674557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92781626|NCT00674557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92781627|NCT00674557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781628|NCT00674557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781629|NCT00674557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92781630|NCT00674557|Hormone Antagonists|hormone antagonists|mesh-ancestor
92781631|NCT00674557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781632|NCT00674557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781633|NCT00674557|Chelating Agents|chelating agents|mesh-ancestor
92781634|NCT00674557|Sequestering Agents|sequestering agents|mesh-ancestor
92781635|NCT00674557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92781636|NCT00674557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92781637|NCT00674557|Growth Substances|growth substances|mesh-ancestor
92781638|NCT00674557|Growth Inhibitors|growth inhibitors|mesh-ancestor
92781639|NCT00677521|Acarbose|acarbose|mesh-list
92781640|NCT00677521|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92781641|NCT00677521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781642|NCT00677521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781643|NCT00677521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781644|NCT00677521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781645|NCT00674713|Ondansetron|ondansetron|mesh-list
92781646|NCT00674713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92781647|NCT00674713|Antiemetics|antiemetics|mesh-ancestor
92781648|NCT00674713|Autonomic Agents|autonomic agents|mesh-ancestor
92781649|NCT00674713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781650|NCT00674713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781651|NCT00674713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781652|NCT00674713|Antipruritics|antipruritics|mesh-ancestor
92781653|NCT00674713|Dermatologic Agents|dermatologic agents|mesh-ancestor
92781654|NCT00674713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92781655|NCT00674713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92781656|NCT00674713|Serotonin Agents|serotonin agents|mesh-ancestor
92781657|NCT00674713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781658|NCT00674713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781660|NCT04241380|Anticoagulants|anticoagulants|mesh-list
92781661|NCT04241380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92781662|NCT04241380|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92781663|NCT04241380|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92781664|NCT04241380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781665|NCT02824354|Nalmefene|nalmefene|mesh-list
92781666|NCT02824354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92781667|NCT02824354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781668|NCT02824354|Sensory System Agents|sensory system agents|mesh-ancestor
92781669|NCT02824354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781670|NCT02823496|Sunscreening Agents|sunscreening agents|mesh-list
92781671|NCT02823496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92781672|NCT02823496|Protective Agents|protective agents|mesh-ancestor
92781673|NCT02823496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781674|NCT02823496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92781675|NCT00677755|Misoprostol|misoprostol|mesh-list
92781676|NCT00677755|Mifepristone|mifepristone|mesh-list
92781677|NCT00677755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92781678|NCT00677755|Abortifacient Agents|abortifacient agents|mesh-ancestor
92781679|NCT00677755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92781680|NCT00677755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781681|NCT00677755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92781682|NCT00677755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781683|NCT00677755|Oxytocics|oxytocics|mesh-ancestor
92781684|NCT00677755|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92781685|NCT00677755|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92781686|NCT00677755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92781687|NCT00677755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92781688|NCT00677755|Contraceptive Agents|contraceptive agents|mesh-ancestor
92781689|NCT00677755|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92781690|NCT00677755|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92781691|NCT00677755|Hormone Antagonists|hormone antagonists|mesh-ancestor
92781692|NCT00677755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781693|NCT00677755|Luteolytic Agents|luteolytic agents|mesh-ancestor
92781694|NCT00677755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92781695|NCT00677755|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92781696|NCT00674947|huB3F6-SPDB-DM4 immunoconjugate|hub3f6-spdb-dm4 immunoconjugate|mesh-list
92781697|NCT00674947|Immunoconjugates|immunoconjugates|mesh-ancestor
92781698|NCT00674947|Immunologic Factors|immunologic factors|mesh-ancestor
92781699|NCT00674947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781700|NCT02824042|Itraconazole|itraconazole|mesh-list
92781701|NCT02824042|Maytansine|maytansine|mesh-list
92781702|NCT02824042|Anetumab ravtansine|anetumab ravtansine|mesh-list
92781703|NCT02824042|Antifungal Agents|antifungal agents|mesh-ancestor
92781704|NCT02824042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781705|NCT02824042|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92781706|NCT02824042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92781707|NCT02824042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781708|NCT02824042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781709|NCT02824042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92781710|NCT02824042|Hormone Antagonists|hormone antagonists|mesh-ancestor
92781711|NCT02824042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781712|NCT02824042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781713|NCT02824042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92781714|NCT02824042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92781715|NCT02824042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781716|NCT02824042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781717|NCT02824042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781718|NCT02824042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781719|NCT02824042|Immunoconjugates|immunoconjugates|mesh-ancestor
92781720|NCT02824042|Immunologic Factors|immunologic factors|mesh-ancestor
92781721|NCT00675181|Melatonin|melatonin|mesh-list
92781722|NCT00675181|Antioxidants|antioxidants|mesh-ancestor
92781723|NCT00675181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781724|NCT00675181|Protective Agents|protective agents|mesh-ancestor
92781725|NCT00675181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781726|NCT00675181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781727|NCT04241458|Midazolam|midazolam|mesh-list
92781728|NCT04241458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92781729|NCT04241458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92781731|NCT04241458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781732|NCT04241458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92781733|NCT04241458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781734|NCT04241458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781735|NCT04241458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92781736|NCT04241458|Anesthetics, General|anesthetics, general|mesh-ancestor
92781737|NCT04241458|Anesthetics|anesthetics|mesh-ancestor
92781738|NCT04241458|GABA Modulators|gaba modulators|mesh-ancestor
92781739|NCT04241458|GABA Agents|gaba agents|mesh-ancestor
92781740|NCT04241458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781741|NCT04241458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781742|NCT00681343|Alemtuzumab|alemtuzumab|mesh-list
92781743|NCT00681343|Thymoglobulin|thymoglobulin|mesh-list
92781744|NCT00681343|Daclizumab|daclizumab|mesh-list
92781745|NCT00681343|Immunologic Factors|immunologic factors|mesh-ancestor
92781746|NCT00681343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781747|NCT00681343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781748|NCT00681343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92781749|NCT00681343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781750|NCT02823808|Glimepiride|glimepiride|mesh-list
92781751|NCT02823808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92781752|NCT02823808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781753|NCT02823808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781754|NCT02823808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781755|NCT02823808|Immunologic Factors|immunologic factors|mesh-ancestor
92781756|NCT04151719|Bromides|bromides|mesh-list
92781757|NCT04151719|Methylnaltrexone|methylnaltrexone|mesh-list
92781758|NCT04151719|Anticonvulsants|anticonvulsants|mesh-ancestor
92781759|NCT04151719|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92781760|NCT04151719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781761|NCT04151719|Sensory System Agents|sensory system agents|mesh-ancestor
92781762|NCT04151719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781763|NCT02822482|Cetuximab|cetuximab|mesh-list
92781764|NCT02822482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92781765|NCT02822482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781766|NCT00675493|Insulin Aspart|insulin aspart|mesh-list
92781767|NCT00675493|Biphasic Insulins|biphasic insulins|mesh-list
92781768|NCT00675493|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92781769|NCT00675493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781770|NCT00675493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781771|NCT04240834|Aspirin|aspirin|mesh-list
92781772|NCT04240834|Ticagrelor|ticagrelor|mesh-list
92781773|NCT04240834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92781774|NCT04240834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92530386|NCT00001436|Tamoxifen|tamoxifen|mesh-list
92781775|NCT04240834|Analgesics|analgesics|mesh-ancestor
92781776|NCT04240834|Sensory System Agents|sensory system agents|mesh-ancestor
92781777|NCT04240834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781778|NCT04240834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781779|NCT04240834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781780|NCT04240834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781781|NCT04240834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92781782|NCT04240834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92781783|NCT04240834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781784|NCT04240834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92781785|NCT04240834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92781786|NCT04240834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781787|NCT04240834|Antipyretics|antipyretics|mesh-ancestor
92339120|NCT00001955|Celecoxib|celecoxib|mesh-list
92781788|NCT04240834|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92781789|NCT04240834|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92781790|NCT04240834|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92781791|NCT04240834|Purinergic Agents|purinergic agents|mesh-ancestor
92781792|NCT04240834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781793|NCT01200758|Prednisone|prednisone|mesh-list
92781794|NCT01200758|Prednisolone|prednisolone|mesh-list
92781795|NCT01200758|Cyclophosphamide|cyclophosphamide|mesh-list
92781796|NCT01200758|Rituximab|rituximab|mesh-list
92781797|NCT01200758|Doxorubicin|doxorubicin|mesh-list
92781798|NCT01200758|Vincristine|vincristine|mesh-list
92781799|NCT01200758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781800|NCT01200758|Immunologic Factors|immunologic factors|mesh-ancestor
92781801|NCT01200758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781802|NCT01200758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781803|NCT01200758|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92781804|NCT01200758|Alkylating Agents|alkylating agents|mesh-ancestor
92426852|NCT01540682|Cetuximab|cetuximab|mesh-list
92781805|NCT01200758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781806|NCT01200758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781807|NCT01200758|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92781808|NCT01200758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92781809|NCT01200758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92781810|NCT01200758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92781811|NCT01200758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92781812|NCT01200758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781813|NCT01200758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781814|NCT01200758|Glucocorticoids|glucocorticoids|mesh-ancestor
92781815|NCT01200758|Hormones|hormones|mesh-ancestor
92781816|NCT01200758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781817|NCT01200758|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92781818|NCT01200758|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92781819|NCT01200758|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781820|NCT01200758|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781821|NCT01200758|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781822|NCT02823106|Verapamil|verapamil|mesh-list
92781823|NCT02823106|Choline|choline|mesh-list
92781824|NCT02823106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92781825|NCT02823106|Lipotropic Agents|lipotropic agents|mesh-ancestor
92781826|NCT02823106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92781827|NCT02823106|Antimetabolites|antimetabolites|mesh-ancestor
92781828|NCT02823106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781829|NCT02823106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781830|NCT02823106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92781831|NCT02823106|Nootropic Agents|nootropic agents|mesh-ancestor
92781832|NCT02823106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92781833|NCT02823106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92781834|NCT02823106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92781835|NCT02823106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92781836|NCT02823106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781837|NCT02823106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92781838|NCT02821858|Odalasvir|odalasvir|mesh-list
92781839|NCT02821858|Antiviral Agents|antiviral agents|mesh-ancestor
92781840|NCT02821858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92781841|NCT00876343|Aripiprazole|aripiprazole|mesh-list
92781842|NCT00876343|Antidepressive Agents|antidepressive agents|mesh-ancestor
92781843|NCT00876343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781844|NCT00876343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92781845|NCT00876343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781846|NCT00876343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781847|NCT00876343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781848|NCT00876343|Dopamine Agonists|dopamine agonists|mesh-ancestor
92781849|NCT00876343|Dopamine Agents|dopamine agents|mesh-ancestor
92781850|NCT00876343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781851|NCT00876343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781852|NCT00876343|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92781853|NCT00876343|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92781854|NCT00876343|Serotonin Agents|serotonin agents|mesh-ancestor
92781855|NCT00876343|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92781856|NCT00876343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92781857|NCT00876343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92781858|NCT00876343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92781859|NCT02627989|Diflucortolone|diflucortolone|mesh-list
92781860|NCT02627989|Diflucortolone valerate|diflucortolone valerate|mesh-list
92781861|NCT02627989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781862|NCT02627989|Glucocorticoids|glucocorticoids|mesh-ancestor
92781863|NCT02627989|Hormones|hormones|mesh-ancestor
92781864|NCT02627989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92781865|NCT02627989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781866|NCT00675649|Golimumab|golimumab|mesh-list
92781867|NCT00675649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92781868|NCT00675649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781869|NCT00675649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781870|NCT00675649|Immunologic Factors|immunologic factors|mesh-ancestor
92781871|NCT00675649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781872|NCT01107912|Clopidogrel|clopidogrel|mesh-list
92781873|NCT01107912|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92781874|NCT01107912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92781875|NCT01107912|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92781876|NCT01107912|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92426931|NCT01540812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92781877|NCT01107912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92781878|NCT01107912|Purinergic Agents|purinergic agents|mesh-ancestor
92781879|NCT01107912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781880|NCT01107912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781881|NCT01107912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781882|NCT00678145|Epinephrine|epinephrine|mesh-list
92781883|NCT00678145|Morphine|morphine|mesh-list
92781884|NCT00678145|Naloxone|naloxone|mesh-list
92781885|NCT00678145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781886|NCT00678145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92781887|NCT00678145|Narcotics|narcotics|mesh-ancestor
92781888|NCT00678145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781889|NCT00678145|Analgesics|analgesics|mesh-ancestor
92781890|NCT00678145|Sensory System Agents|sensory system agents|mesh-ancestor
92781891|NCT00678145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781892|NCT00678145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92781893|NCT00678145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92781894|NCT00678145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92781895|NCT00678145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92781896|NCT00678145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781897|NCT00678145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92530415|NCT00041665|Mitogens|mitogens|mesh-list
92781898|NCT00678145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92781899|NCT00678145|Autonomic Agents|autonomic agents|mesh-ancestor
92781900|NCT00678145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92781901|NCT00678145|Respiratory System Agents|respiratory system agents|mesh-ancestor
92781902|NCT00678145|Mydriatics|mydriatics|mesh-ancestor
92781903|NCT00678145|Sympathomimetics|sympathomimetics|mesh-ancestor
92781904|NCT00678145|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92781905|NCT00678145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92781906|NCT02879916|Levobupivacaine|levobupivacaine|mesh-list
92781907|NCT02879916|Anesthetics, Local|anesthetics, local|mesh-ancestor
92781908|NCT02879916|Anesthetics|anesthetics|mesh-ancestor
92781909|NCT02879916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781910|NCT02879916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781911|NCT02879916|Sensory System Agents|sensory system agents|mesh-ancestor
92781912|NCT02879916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781914|NCT02690506|Analgesics|analgesics|mesh-ancestor
92781915|NCT02690506|Sensory System Agents|sensory system agents|mesh-ancestor
92781916|NCT02690506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781917|NCT02690506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781918|NCT02690506|Anticonvulsants|anticonvulsants|mesh-ancestor
92781919|NCT02690506|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92781920|NCT02690506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92781921|NCT02690506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781922|NCT02690506|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92781923|NCT02690506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92781924|NCT02690506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92781925|NCT02690506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92781926|NCT02690506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92781927|NCT04310280|Insulin Glargine|insulin glargine|mesh-list
92781928|NCT04310280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781929|NCT04310280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781930|NCT04239586|Glyburide|glyburide|mesh-list
92781931|NCT04239586|Glipizide|glipizide|mesh-list
92781932|NCT04239586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92781933|NCT04239586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781934|NCT02628613|Paclitaxel|paclitaxel|mesh-list
92781935|NCT02628613|Vinorelbine|vinorelbine|mesh-list
92781936|NCT02628613|Epirubicin|epirubicin|mesh-list
92781937|NCT02628613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92781938|NCT02628613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781939|NCT02628613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781940|NCT02628613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781941|NCT02628613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781942|NCT02628613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781943|NCT02628613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92781944|NCT02628613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92781945|NCT02628613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92781946|NCT02628613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781947|NCT01100034|Etanercept|etanercept|mesh-list
92781948|NCT01100034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92781949|NCT01100034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92781950|NCT01100034|Analgesics|analgesics|mesh-ancestor
92781951|NCT01100034|Sensory System Agents|sensory system agents|mesh-ancestor
92781952|NCT01100034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781953|NCT01100034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781954|NCT01100034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781955|NCT01100034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781956|NCT01100034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92781957|NCT01100034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92781958|NCT01100034|Immunologic Factors|immunologic factors|mesh-ancestor
92781959|NCT04148833|Paclitaxel|paclitaxel|mesh-list
92781960|NCT04148833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92781961|NCT04148833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781962|NCT04148833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781963|NCT04148833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92781964|NCT04148833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92781965|NCT04148833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781966|NCT02821546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92781967|NCT02821468|Acetaminophen|acetaminophen|mesh-list
92781968|NCT02821468|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92781969|NCT02821468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92781970|NCT02821468|Analgesics|analgesics|mesh-ancestor
92781971|NCT02821468|Sensory System Agents|sensory system agents|mesh-ancestor
92781972|NCT02821468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781973|NCT02821468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781974|NCT02821468|Antipyretics|antipyretics|mesh-ancestor
92781975|NCT02821468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92781976|NCT02821468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781977|NCT02821468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781978|NCT02821468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92781979|NCT02821468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781980|NCT02821468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781981|NCT04964622|Ibuprofen|ibuprofen|mesh-list
92781982|NCT04964622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92781983|NCT04964622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92781984|NCT04964622|Analgesics|analgesics|mesh-ancestor
92781985|NCT04964622|Sensory System Agents|sensory system agents|mesh-ancestor
92781986|NCT04964622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92781987|NCT04964622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92781988|NCT04964622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92781989|NCT04964622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92781990|NCT04964622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92781991|NCT04964622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92781992|NCT04964622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92781993|NCT04769050|Docetaxel|docetaxel|mesh-list
92781994|NCT04769050|Capecitabine|capecitabine|mesh-list
92781995|NCT04769050|Trastuzumab|trastuzumab|mesh-list
92781996|NCT04769050|Pertuzumab|pertuzumab|mesh-list
92781997|NCT04769050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92781998|NCT04769050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92781999|NCT04769050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92782000|NCT04769050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92782001|NCT04769050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782002|NCT04769050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92782003|NCT04769050|Antimetabolites|antimetabolites|mesh-ancestor
92782004|NCT04769050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782005|NCT02821390|Nepafenac|nepafenac|mesh-list
92782006|NCT02821390|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92782007|NCT02821390|Lubricant Eye Drops|lubricant eye drops|mesh-list
92782008|NCT02821390|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92782009|NCT02821390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92782010|NCT02821390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782011|NCT02821390|Analgesics|analgesics|mesh-ancestor
92782012|NCT02821390|Sensory System Agents|sensory system agents|mesh-ancestor
92782013|NCT02821390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782014|NCT02821390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782015|NCT02821390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782016|NCT02821390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782017|NCT02821312|DA-8010|da-8010|mesh-list
92782018|NCT02821312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92782019|NCT02821312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92782020|NCT02821312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92782022|NCT02821312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782023|NCT02821312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782024|NCT02821156|Nitric Oxide|nitric oxide|mesh-list
92782025|NCT02821156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92782026|NCT02821156|Autonomic Agents|autonomic agents|mesh-ancestor
92782027|NCT02821156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782028|NCT02821156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782029|NCT02821156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92782030|NCT02821156|Respiratory System Agents|respiratory system agents|mesh-ancestor
92782031|NCT02821156|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92782032|NCT02821156|Antioxidants|antioxidants|mesh-ancestor
92782033|NCT02821156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782034|NCT02821156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782035|NCT02821156|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92782036|NCT02821156|Vasodilator Agents|vasodilator agents|mesh-ancestor
92782037|NCT02821156|Gasotransmitters|gasotransmitters|mesh-ancestor
92782038|NCT02821156|Protective Agents|protective agents|mesh-ancestor
92782039|NCT02820922|Anesthetics|anesthetics|mesh-list
92782040|NCT02820922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782041|NCT02820922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782042|NCT00633958|Alovudine|alovudine|mesh-list
92782043|NCT00633958|Antiviral Agents|antiviral agents|mesh-ancestor
92782044|NCT00633958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782045|NCT02820688|Bupivacaine|bupivacaine|mesh-list
92782046|NCT02820688|Prilocaine|prilocaine|mesh-list
92782047|NCT02820688|Anesthetics, Local|anesthetics, local|mesh-ancestor
92782048|NCT02820688|Anesthetics|anesthetics|mesh-ancestor
92782049|NCT02820688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782050|NCT02820688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782051|NCT02820688|Sensory System Agents|sensory system agents|mesh-ancestor
92782052|NCT02820688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782053|NCT02818816|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92782054|NCT02818816|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92782055|NCT02818816|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92782056|NCT02818816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92782057|NCT02818816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92782058|NCT02818816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92782059|NCT02818816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92782060|NCT02818816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92782061|NCT02818816|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782062|NCT02818816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782063|NCT02818816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782064|NCT02818816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782065|NCT02818816|Laxatives|laxatives|mesh-ancestor
92782066|NCT02818816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782067|NCT02820610|Magnesium Sulfate|magnesium sulfate|mesh-list
92782068|NCT02820610|Dexmedetomidine|dexmedetomidine|mesh-list
92782069|NCT02820610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92782070|NCT02820610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782071|NCT02820610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782072|NCT02820610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782073|NCT02820610|Analgesics|analgesics|mesh-ancestor
92782074|NCT02820610|Sensory System Agents|sensory system agents|mesh-ancestor
92339240|NCT00000647|Interferons|interferons|mesh-list
92782075|NCT02820610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782076|NCT02820610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92782077|NCT02820610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92782078|NCT02820610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92782079|NCT02820610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782080|NCT02820610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782081|NCT02820610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782082|NCT02820610|Anesthetics|anesthetics|mesh-ancestor
92782083|NCT02820610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92782084|NCT02820610|Anticonvulsants|anticonvulsants|mesh-ancestor
92782085|NCT02820610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92782086|NCT02820610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92782087|NCT02820610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92782088|NCT02820610|Tocolytic Agents|tocolytic agents|mesh-ancestor
92782089|NCT02820610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782090|NCT04745728|Prednisone|prednisone|mesh-list
92782091|NCT04745728|Cyclophosphamide|cyclophosphamide|mesh-list
92782092|NCT04745728|Rituximab|rituximab|mesh-list
92782093|NCT04745728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782094|NCT04745728|Immunologic Factors|immunologic factors|mesh-ancestor
92782095|NCT04745728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782096|NCT04745728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782097|NCT04745728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92782098|NCT04745728|Alkylating Agents|alkylating agents|mesh-ancestor
92782099|NCT04745728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782100|NCT04745728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782101|NCT04745728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92782102|NCT04745728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782104|NCT04745728|Glucocorticoids|glucocorticoids|mesh-ancestor
92782105|NCT04745728|Hormones|hormones|mesh-ancestor
92782106|NCT04745728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782107|NCT04745728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92782108|NCT02818660|Cosyntropin|cosyntropin|mesh-list
92782109|NCT02818660|Hormones|hormones|mesh-ancestor
92782110|NCT02818660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782111|NCT02818660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782112|NCT05659186|Tislelizumab|tislelizumab|mesh-list
92782113|NCT05659186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782114|NCT05659186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782115|NCT01107444|Docetaxel|docetaxel|mesh-list
92782116|NCT01107444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782117|NCT01107444|Tubulin Modulators|tubulin modulators|mesh-ancestor
92782118|NCT01107444|Antimitotic Agents|antimitotic agents|mesh-ancestor
92782119|NCT01107444|Mitosis Modulators|mitosis modulators|mesh-ancestor
92782120|NCT01107444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782121|NCT04238806|Desflurane|desflurane|mesh-list
92782122|NCT04238806|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92782123|NCT04238806|Anesthetics, General|anesthetics, general|mesh-ancestor
92782124|NCT04238806|Anesthetics|anesthetics|mesh-ancestor
92782125|NCT04238806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782126|NCT04238806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782127|NCT00876187|Naproxen|naproxen|mesh-list
92782128|NCT00876187|Tanezumab|tanezumab|mesh-list
92782129|NCT00876187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92782130|NCT00876187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782131|NCT00876187|Analgesics|analgesics|mesh-ancestor
92782132|NCT00876187|Sensory System Agents|sensory system agents|mesh-ancestor
92782133|NCT00876187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782134|NCT00876187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782135|NCT00876187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782136|NCT00876187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782137|NCT00876187|Gout Suppressants|gout suppressants|mesh-ancestor
92782138|NCT00876187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92782139|NCT00876187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782140|NCT00876187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782141|NCT04238884|Voriconazole|voriconazole|mesh-list
92782142|NCT04238884|Antifungal Agents|antifungal agents|mesh-ancestor
92782143|NCT04238884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782144|NCT04238884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92782145|NCT04238884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92782146|NCT04238884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782147|NCT04238884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782148|NCT04238884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92782149|NCT04238884|Hormone Antagonists|hormone antagonists|mesh-ancestor
92782150|NCT04238884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782151|NCT04238884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782152|NCT04238884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92782153|NCT01102374|Vitamin D|vitamin d|mesh-list
92782154|NCT01102374|Ergocalciferols|ergocalciferols|mesh-list
92782155|NCT01102374|Cholecalciferol|cholecalciferol|mesh-list
92782156|NCT01102374|Vitamins|vitamins|mesh-list
92782157|NCT01102374|Micronutrients|micronutrients|mesh-ancestor
92782158|NCT01102374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782159|NCT01102374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92782160|NCT01102374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92782161|NCT05658640|Cytarabine|cytarabine|mesh-list
92782162|NCT05658640|Dexamethasone|dexamethasone|mesh-list
92782163|NCT05658640|Cyclophosphamide|cyclophosphamide|mesh-list
92782164|NCT05658640|Trametinib|trametinib|mesh-list
92782165|NCT05658640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782166|NCT05658640|Immunologic Factors|immunologic factors|mesh-ancestor
92782167|NCT05658640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782169|NCT05658640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92782170|NCT05658640|Alkylating Agents|alkylating agents|mesh-ancestor
92782171|NCT05658640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782172|NCT05658640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782173|NCT05658640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92782174|NCT05658640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782175|NCT05658640|Antiemetics|antiemetics|mesh-ancestor
92782176|NCT05658640|Autonomic Agents|autonomic agents|mesh-ancestor
92782177|NCT05658640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782178|NCT05658640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782179|NCT05658640|Glucocorticoids|glucocorticoids|mesh-ancestor
92782180|NCT05658640|Hormones|hormones|mesh-ancestor
92782181|NCT05658640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782182|NCT05658640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92782183|NCT05658640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92782184|NCT05658640|Antimetabolites|antimetabolites|mesh-ancestor
92782185|NCT05658640|Antiviral Agents|antiviral agents|mesh-ancestor
92782186|NCT05658640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782187|NCT05658640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92782188|NCT05658640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782189|NCT02818270|Acetylcysteine|acetylcysteine|mesh-list
92782190|NCT02818270|Albuterol|albuterol|mesh-list
92782191|NCT02818270|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92782192|NCT02818270|Antiviral Agents|antiviral agents|mesh-ancestor
92782193|NCT02818270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782194|NCT02818270|Expectorants|expectorants|mesh-ancestor
92782195|NCT02818270|Respiratory System Agents|respiratory system agents|mesh-ancestor
92782196|NCT02818270|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92782197|NCT02818270|Antioxidants|antioxidants|mesh-ancestor
92782198|NCT02818270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782199|NCT02818270|Protective Agents|protective agents|mesh-ancestor
92782200|NCT02818270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782201|NCT02818270|Antidotes|antidotes|mesh-ancestor
92782202|NCT02818270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92782203|NCT02818270|Autonomic Agents|autonomic agents|mesh-ancestor
92782204|NCT02818270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782205|NCT02818270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92782206|NCT02818270|Tocolytic Agents|tocolytic agents|mesh-ancestor
92782207|NCT02818270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782208|NCT02818270|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92782209|NCT02818270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92782210|NCT02818270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92782211|NCT02818270|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782212|NCT02818270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782213|NCT02879760|Pembrolizumab|pembrolizumab|mesh-list
92782214|NCT02879760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782215|NCT02879760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782216|NCT02879760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92782217|NCT02879760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782218|NCT02818348|Darunavir|darunavir|mesh-list
92782219|NCT02818348|Cobicistat|cobicistat|mesh-list
92782220|NCT02818348|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92782221|NCT02818348|Etravirine|etravirine|mesh-list
92782222|NCT02818348|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92782223|NCT02818348|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92782224|NCT02818348|Protease Inhibitors|protease inhibitors|mesh-ancestor
92782225|NCT02818348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782226|NCT02818348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782227|NCT02818348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92782228|NCT02818348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92782229|NCT02818348|Antiviral Agents|antiviral agents|mesh-ancestor
92782230|NCT02818348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782231|NCT02818348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92782232|NCT02818348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92782233|NCT02818348|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92782234|NCT02818348|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92782235|NCT00634192|Tobramycin|tobramycin|mesh-list
92782236|NCT00634192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782237|NCT00634192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782238|NCT00684463|Palonosetron|palonosetron|mesh-list
92782239|NCT00684463|Antiemetics|antiemetics|mesh-ancestor
92782240|NCT00684463|Autonomic Agents|autonomic agents|mesh-ancestor
92782241|NCT00684463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782242|NCT00684463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782243|NCT00684463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782244|NCT00684463|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92782245|NCT00684463|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92782246|NCT00684463|Serotonin Agents|serotonin agents|mesh-ancestor
92782247|NCT00684463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782248|NCT00684463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782249|NCT00678457|Ondansetron|ondansetron|mesh-list
92782250|NCT00678457|Olanzapine|olanzapine|mesh-list
92782251|NCT00678457|Antiemetics|antiemetics|mesh-ancestor
92782252|NCT00678457|Autonomic Agents|autonomic agents|mesh-ancestor
92782253|NCT00678457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782254|NCT00678457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782255|NCT00678457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782256|NCT00678457|Antipruritics|antipruritics|mesh-ancestor
92782257|NCT00678457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92782258|NCT00678457|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92782259|NCT00678457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92782260|NCT00678457|Serotonin Agents|serotonin agents|mesh-ancestor
92782261|NCT00678457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782262|NCT00678457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782263|NCT00678457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92782264|NCT00678457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92782265|NCT00678457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782266|NCT00678457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92782267|NCT00678457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92782268|NCT00678457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92782269|NCT00678457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92782270|NCT00678613|Norfloxacin|norfloxacin|mesh-list
92782271|NCT00678613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782272|NCT00678613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782273|NCT00678613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92782274|NCT00678613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92782275|NCT00678613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782276|NCT00678613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782277|NCT00678613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782278|NCT00678613|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92782279|NCT00678613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92782280|NCT00678769|Sirolimus|sirolimus|mesh-list
92782281|NCT00678769|Temsirolimus|temsirolimus|mesh-list
92782282|NCT00678769|MTOR Inhibitors|mtor inhibitors|mesh-list
92782283|NCT00678769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92782284|NCT00678769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782285|NCT00678769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782286|NCT00678769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92782287|NCT00678769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782288|NCT00678769|Antifungal Agents|antifungal agents|mesh-ancestor
92782289|NCT00678769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782290|NCT00678769|Immunologic Factors|immunologic factors|mesh-ancestor
92782291|NCT00678769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782292|NCT00678769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92782293|NCT00678769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782294|NCT00678769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782295|NCT04146883|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92782296|NCT04146883|Cephalexin|cephalexin|mesh-list
92782297|NCT04146883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782298|NCT02817256|Vitamins|vitamins|mesh-list
92782299|NCT02817256|Micronutrients|micronutrients|mesh-ancestor
92782300|NCT02817256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782301|NCT02817100|Itraconazole|itraconazole|mesh-list
92782302|NCT02817100|Antifungal Agents|antifungal agents|mesh-ancestor
92782303|NCT02817100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782304|NCT02817100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92782305|NCT02817100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92782306|NCT02817100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782307|NCT02817100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782308|NCT02817100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92782309|NCT02817100|Hormone Antagonists|hormone antagonists|mesh-ancestor
92782310|NCT02817100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530451|NCT00041977|Doxycycline|doxycycline|mesh-list
92782311|NCT02817100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782312|NCT02817100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92782314|NCT00684853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782315|NCT00684853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782316|NCT00684853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92782317|NCT00684853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92782318|NCT00684853|Growth Substances|growth substances|mesh-ancestor
92782319|NCT00684853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782320|NCT00684853|Growth Inhibitors|growth inhibitors|mesh-ancestor
92782321|NCT02816476|Daratumumab|daratumumab|mesh-list
92782322|NCT02816476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782323|NCT04547140|Protease Inhibitors|protease inhibitors|mesh-list
92782324|NCT04547140|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92427377|NCT01543724|Lithium Carbonate|lithium carbonate|mesh-list
92782325|NCT04547140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782326|NCT04547140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782327|NCT04547140|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92782328|NCT04547140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92782329|NCT00679159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92782330|NCT00679159|Immunologic Factors|immunologic factors|mesh-ancestor
92782331|NCT00679159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782332|NCT00685009|Hormones|hormones|mesh-list
92782333|NCT00685009|Progesterone|progesterone|mesh-list
92782334|NCT00685009|Estrogens|estrogens|mesh-list
92782335|NCT00685009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782336|NCT00685009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782337|NCT00685009|Progestins|progestins|mesh-ancestor
92782338|NCT00679237|Metformin|metformin|mesh-list
92782339|NCT00679237|Glimepiride|glimepiride|mesh-list
92782340|NCT00679237|Ezetimibe|ezetimibe|mesh-list
92782341|NCT00679237|Diuretics|diuretics|mesh-list
92782342|NCT00679237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92782343|NCT00679237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782344|NCT00679237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92782345|NCT00679237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92782346|NCT00679237|Antimetabolites|antimetabolites|mesh-ancestor
92782347|NCT00679237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782348|NCT00679237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92782349|NCT00679237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92782350|NCT00679237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782351|NCT00679237|Immunologic Factors|immunologic factors|mesh-ancestor
92782352|NCT00679237|Natriuretic Agents|natriuretic agents|mesh-ancestor
92782353|NCT00681733|Pioglitazone|pioglitazone|mesh-list
92782354|NCT00681733|Pentoxifylline|pentoxifylline|mesh-list
92782355|NCT00681733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92782356|NCT00681733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782357|NCT00681733|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92782358|NCT00681733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782359|NCT00681733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782360|NCT00681733|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92782361|NCT00681733|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92782362|NCT00681733|Protective Agents|protective agents|mesh-ancestor
92782363|NCT00681733|Vasodilator Agents|vasodilator agents|mesh-ancestor
92782364|NCT00681733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92782365|NCT00681733|Antioxidants|antioxidants|mesh-ancestor
92782366|NCT00679315|Alfuzosin|alfuzosin|mesh-list
92782367|NCT00679315|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92782368|NCT00679315|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92782369|NCT00679315|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92782370|NCT00679315|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782371|NCT00679315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782372|NCT00679315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782373|NCT00679315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782374|NCT00679315|Urological Agents|urological agents|mesh-ancestor
92782375|NCT05652400|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92782376|NCT05652400|Antiviral Agents|antiviral agents|mesh-ancestor
92782377|NCT05652400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782378|NCT01098474|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92782379|NCT01098474|Immunologic Factors|immunologic factors|mesh-ancestor
92782380|NCT01098474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782381|NCT00633802|Risperidone|risperidone|mesh-list
92782382|NCT00633802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92782383|NCT00633802|Serotonin Agents|serotonin agents|mesh-ancestor
92782384|NCT00633802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782385|NCT00633802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782386|NCT00633802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782387|NCT00633802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92782388|NCT00633802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92782389|NCT00633802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782390|NCT00633802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92782391|NCT00633802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92782392|NCT00633802|Dopamine Agents|dopamine agents|mesh-ancestor
92782393|NCT04460248|Rituximab|rituximab|mesh-list
92782394|NCT04460248|Lenalidomide|lenalidomide|mesh-list
92782395|NCT04460248|Zanubrutinib|zanubrutinib|mesh-list
92782396|NCT04460248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782397|NCT04460248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782398|NCT04460248|Immunologic Factors|immunologic factors|mesh-ancestor
92782399|NCT04460248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782400|NCT04460248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782401|NCT04460248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92782402|NCT04460248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92782403|NCT04460248|Growth Substances|growth substances|mesh-ancestor
92782404|NCT04460248|Growth Inhibitors|growth inhibitors|mesh-ancestor
92782405|NCT04460248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92782406|NCT04460248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782407|NCT04460248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782408|NCT05658874|Methenamine|methenamine|mesh-list
92782409|NCT05658874|Methenamine hippurate|methenamine hippurate|mesh-list
92782410|NCT05658874|Methenamine mandelate|methenamine mandelate|mesh-list
92782411|NCT05658874|Gabapentin|gabapentin|mesh-list
92782412|NCT05658874|Amitriptyline|amitriptyline|mesh-list
92782413|NCT05658874|Mirabegron|mirabegron|mesh-list
92782414|NCT05658874|Oxybutynin|oxybutynin|mesh-list
92782415|NCT05658874|Estrogens|estrogens|mesh-list
92782416|NCT05658874|Analgesics|analgesics|mesh-ancestor
92782417|NCT05658874|Sensory System Agents|sensory system agents|mesh-ancestor
92782418|NCT05658874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782419|NCT05658874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782420|NCT05658874|Anticonvulsants|anticonvulsants|mesh-ancestor
92782421|NCT05658874|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92782422|NCT05658874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92782423|NCT05658874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782424|NCT05658874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92782425|NCT05658874|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92782426|NCT05658874|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92782427|NCT05658874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782428|NCT05658874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782429|NCT05658874|Antimanic Agents|antimanic agents|mesh-ancestor
92782430|NCT05658874|Hormones|hormones|mesh-ancestor
92782431|NCT05658874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782432|NCT05658874|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92782433|NCT05658874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92782434|NCT05658874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92782435|NCT05658874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782436|NCT05658874|Urological Agents|urological agents|mesh-ancestor
92782437|NCT05658874|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92782438|NCT05658874|Antidepressive Agents|antidepressive agents|mesh-ancestor
92782439|NCT05658874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782440|NCT05658874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92782441|NCT05658874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92782442|NCT05658874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92782443|NCT05658874|Parasympatholytics|parasympatholytics|mesh-ancestor
92782444|NCT05658874|Autonomic Agents|autonomic agents|mesh-ancestor
92782445|NCT05658874|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92782446|NCT05658874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92782447|NCT05658874|Cholinergic Agents|cholinergic agents|mesh-ancestor
92782448|NCT05658874|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92782449|NCT05658874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782450|NCT05658874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782451|NCT01106898|Paclitaxel|paclitaxel|mesh-list
92782452|NCT01106898|Cyclophosphamide|cyclophosphamide|mesh-list
92782453|NCT01106898|Trastuzumab|trastuzumab|mesh-list
92782454|NCT01106898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92782455|NCT01106898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782456|NCT01106898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92782457|NCT01106898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92782458|NCT01106898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92782459|NCT01106898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782460|NCT01106898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782461|NCT01106898|Immunologic Factors|immunologic factors|mesh-ancestor
92782462|NCT01106898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782463|NCT01106898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782464|NCT01106898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92782465|NCT01106898|Alkylating Agents|alkylating agents|mesh-ancestor
92782466|NCT01106898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92782467|NCT01106898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782469|NCT04425538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92782470|NCT04425538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782471|NCT04425538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92782472|NCT04425538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782473|NCT04425538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782474|NCT02627521|Ticagrelor|ticagrelor|mesh-list
92427531|NCT01544517|Alkylating Agents|alkylating agents|mesh-ancestor
92782475|NCT02627521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92782476|NCT02627521|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92782477|NCT02627521|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92782478|NCT02627521|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92782479|NCT02627521|Purinergic Agents|purinergic agents|mesh-ancestor
92782480|NCT02627521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782481|NCT02627521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782482|NCT02627521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782483|NCT00681967|Gefitinib|gefitinib|mesh-list
92782484|NCT00681967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782485|NCT00681967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92782486|NCT00681967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782487|NCT00681967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782488|NCT04239118|Hemostatics|hemostatics|mesh-list
92782489|NCT04239118|Coagulants|coagulants|mesh-ancestor
92782490|NCT04139941|Antibodies|antibodies|mesh-list
92782491|NCT04139941|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92782492|NCT04139941|Immunologic Factors|immunologic factors|mesh-ancestor
92782493|NCT04139941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782494|NCT02814994|Respiratory System Agents|respiratory system agents|mesh-list
92782495|NCT00875017|Sevelamer|sevelamer|mesh-list
92782496|NCT00875017|Chelating Agents|chelating agents|mesh-ancestor
92782497|NCT00875017|Sequestering Agents|sequestering agents|mesh-ancestor
92782498|NCT00875017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782499|NCT00679705|Atosiban|atosiban|mesh-list
92782500|NCT00679705|Ritodrine|ritodrine|mesh-list
92782501|NCT00679705|Hormone Antagonists|hormone antagonists|mesh-ancestor
92782502|NCT00679705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782503|NCT00679705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782504|NCT00679705|Tocolytic Agents|tocolytic agents|mesh-ancestor
92782505|NCT00679705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782506|NCT00679705|Sympathomimetics|sympathomimetics|mesh-ancestor
92782507|NCT00679705|Autonomic Agents|autonomic agents|mesh-ancestor
92782508|NCT00679705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782509|NCT00679705|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92782510|NCT00679705|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92782511|NCT00679705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92782512|NCT00679705|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782513|NCT00679705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782514|NCT00679705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782515|NCT00685633|Bicalutamide|bicalutamide|mesh-list
92782516|NCT00685633|Androgen Antagonists|androgen antagonists|mesh-ancestor
92782517|NCT00685633|Hormone Antagonists|hormone antagonists|mesh-ancestor
92339308|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
92782518|NCT00685633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782519|NCT00685633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782520|NCT00685633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782521|NCT04371952|Doxycycline|doxycycline|mesh-list
92782522|NCT04371952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782523|NCT04371952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782524|NCT04371952|Antimalarials|antimalarials|mesh-ancestor
92782525|NCT04371952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92782526|NCT04371952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92782527|NCT04329832|Azithromycin|azithromycin|mesh-list
92782528|NCT04329832|Hydroxychloroquine|hydroxychloroquine|mesh-list
92782529|NCT04329832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782530|NCT04329832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782531|NCT04329832|Antimalarials|antimalarials|mesh-ancestor
92782532|NCT04329832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92782533|NCT04329832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92782534|NCT04329832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782535|NCT04329832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782536|NCT04329832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782537|NCT04237246|Tacrolimus|tacrolimus|mesh-list
92782538|NCT04237246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782539|NCT04237246|Immunologic Factors|immunologic factors|mesh-ancestor
92782540|NCT04237246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782541|NCT04237246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92782542|NCT04237246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782543|NCT04237246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782544|NCT00680095|Tavaborole|tavaborole|mesh-list
92782545|NCT00680095|Antifungal Agents|antifungal agents|mesh-ancestor
92782546|NCT00680095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782547|NCT02814058|Zolpidem|zolpidem|mesh-list
92782548|NCT02814058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92782549|NCT02814058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92427606|NCT01544842|Hormones|hormones|mesh-ancestor
92782550|NCT02814058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782551|NCT02814058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782552|NCT02814058|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92782553|NCT02814058|GABA Agonists|gaba agonists|mesh-ancestor
92782554|NCT02814058|GABA Agents|gaba agents|mesh-ancestor
92782555|NCT02814058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782556|NCT02814058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782557|NCT00680173|Interferons|interferons|mesh-list
92782558|NCT00680173|Ribavirin|ribavirin|mesh-list
92782559|NCT00680173|Interferon-alpha|interferon-alpha|mesh-list
92782560|NCT00680173|Interferon alpha-2|interferon alpha-2|mesh-list
92782561|NCT00680173|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92782562|NCT00680173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782563|NCT00680173|Antiviral Agents|antiviral agents|mesh-ancestor
92782564|NCT00680173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782565|NCT00680173|Antimetabolites|antimetabolites|mesh-ancestor
92782566|NCT00680173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782567|NCT00680173|Immunologic Factors|immunologic factors|mesh-ancestor
92782568|NCT00680173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782569|NCT00682279|Topotecan|topotecan|mesh-list
92782570|NCT00682279|Lapatinib|lapatinib|mesh-list
92782571|NCT00682279|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92782572|NCT00682279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92782573|NCT00682279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782574|NCT00682279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782575|NCT00682279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782576|NCT00682279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92782577|NCT02811484|Dapagliflozin|dapagliflozin|mesh-list
92782578|NCT02811484|Exenatide|exenatide|mesh-list
92782579|NCT02811484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92782580|NCT02811484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782581|NCT02811484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92782582|NCT02811484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782583|NCT02811484|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92782584|NCT02811484|Incretins|incretins|mesh-ancestor
92782585|NCT02811484|Hormones|hormones|mesh-ancestor
92782586|NCT02811484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782587|NCT00686179|Moxifloxacin|moxifloxacin|mesh-list
92782588|NCT00686179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782589|NCT00686179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782590|NCT00686179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92782591|NCT00686179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92782592|NCT00686179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782593|NCT00686179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782594|NCT00686179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782595|NCT00922597|Factor VIII|factor viii|mesh-list
92782596|NCT00922597|Coagulants|coagulants|mesh-ancestor
92782597|NCT00874939|Donepezil|donepezil|mesh-list
92782598|NCT00874939|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92782599|NCT00874939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782600|NCT00874939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782601|NCT00874939|Cholinergic Agents|cholinergic agents|mesh-ancestor
92782602|NCT00874939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782603|NCT00874939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782604|NCT00874939|Nootropic Agents|nootropic agents|mesh-ancestor
92782605|NCT00634348|Aripiprazole|aripiprazole|mesh-list
92782606|NCT00634348|Ziprasidone|ziprasidone|mesh-list
92782607|NCT00634348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92782608|NCT00634348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92782609|NCT00634348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92782610|NCT00634348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92782611|NCT00634348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782612|NCT00634348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782613|NCT00634348|Dopamine Agonists|dopamine agonists|mesh-ancestor
92782614|NCT00634348|Dopamine Agents|dopamine agents|mesh-ancestor
92782615|NCT00634348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782616|NCT00634348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782617|NCT00634348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92782618|NCT00634348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92782619|NCT00634348|Serotonin Agents|serotonin agents|mesh-ancestor
92782620|NCT00634348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92782621|NCT00634348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92782622|NCT00634348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92782623|NCT00634348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92782624|NCT00680329|Timolol|timolol|mesh-list
92782625|NCT00680329|Travoprost|travoprost|mesh-list
92427680|NCT01545297|Analgesics|analgesics|mesh-ancestor
92782626|NCT00680329|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92782627|NCT00680329|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92782628|NCT00680329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92782629|NCT00680329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92782630|NCT00680329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782631|NCT00680329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782632|NCT00680329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782633|NCT00680329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339358|NCT00002033|Zidovudine|zidovudine|mesh-list
92782634|NCT00680329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92782635|NCT00680329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92782636|NCT02811016|Budesonide|budesonide|mesh-list
92782637|NCT02811016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782638|NCT02811016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92782639|NCT02811016|Autonomic Agents|autonomic agents|mesh-ancestor
92782640|NCT02811016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782641|NCT02811016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782642|NCT02811016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92782643|NCT02811016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92782644|NCT02811016|Glucocorticoids|glucocorticoids|mesh-ancestor
92782645|NCT02811016|Hormones|hormones|mesh-ancestor
92782646|NCT02811016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782647|NCT00690313|Moxifloxacin|moxifloxacin|mesh-list
92782648|NCT00690313|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92782649|NCT00690313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782650|NCT00690313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782651|NCT00690313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92782652|NCT00690313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92782653|NCT00690313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782654|NCT00690313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782655|NCT00690313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782656|NCT00690313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92782657|NCT00690313|Contraceptive Agents|contraceptive agents|mesh-ancestor
92782658|NCT00690313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782659|NCT00690313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782660|NCT00690313|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92782661|NCT00690313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92782662|NCT00690313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92782663|NCT04237480|Vitamin D|vitamin d|mesh-list
92782664|NCT04237480|Ergocalciferols|ergocalciferols|mesh-list
92782665|NCT04237480|Cholecalciferol|cholecalciferol|mesh-list
92782666|NCT04237480|Vitamins|vitamins|mesh-list
92782667|NCT04237480|Micronutrients|micronutrients|mesh-ancestor
92782668|NCT04237480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782669|NCT04237480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92782670|NCT04237480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92782671|NCT02810782|Morphine|morphine|mesh-list
92782672|NCT02810782|Phenobarbital|phenobarbital|mesh-list
92782674|NCT02810782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92782675|NCT02810782|Narcotics|narcotics|mesh-ancestor
92782676|NCT02810782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782677|NCT02810782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782678|NCT02810782|Analgesics|analgesics|mesh-ancestor
92782679|NCT02810782|Sensory System Agents|sensory system agents|mesh-ancestor
92782680|NCT02810782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782681|NCT02810782|Anticonvulsants|anticonvulsants|mesh-ancestor
92782682|NCT02810782|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92782683|NCT02810782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92782684|NCT02810782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92782685|NCT02810782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782686|NCT02810782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782687|NCT02810782|GABA Modulators|gaba modulators|mesh-ancestor
92782688|NCT02810782|GABA Agents|gaba agents|mesh-ancestor
92782689|NCT02810782|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92782690|NCT02810782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92782691|NCT02810782|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92782692|NCT02810782|Antiemetics|antiemetics|mesh-ancestor
92782693|NCT02810782|Autonomic Agents|autonomic agents|mesh-ancestor
92782694|NCT02810782|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782695|NCT02810782|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92782696|NCT02810782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92782697|NCT02810782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92782698|NCT02810782|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92782699|NCT02810782|Dopamine Agents|dopamine agents|mesh-ancestor
92782700|NCT02810548|Mitogens|mitogens|mesh-list
92782702|NCT02810548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782703|NCT01155869|Naltrexone|naltrexone|mesh-list
92782704|NCT01155869|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92782705|NCT01155869|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92782706|NCT01155869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782707|NCT01155869|Sensory System Agents|sensory system agents|mesh-ancestor
92782708|NCT01155869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782709|NCT00687037|Cetylpyridinium|cetylpyridinium|mesh-list
92782710|NCT00687037|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92782711|NCT00687037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782712|NCT02625415|Vitamins|vitamins|mesh-list
92782713|NCT02625415|Vitamin B 6|vitamin b 6|mesh-list
92782714|NCT02625415|Pyridoxal|pyridoxal|mesh-list
92782715|NCT02625415|Pyridoxine|pyridoxine|mesh-list
92782716|NCT02625415|Vitamin B Complex|vitamin b complex|mesh-list
92782717|NCT02625415|Micronutrients|micronutrients|mesh-ancestor
92782718|NCT02625415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782719|NCT02809768|Itraconazole|itraconazole|mesh-list
92782720|NCT02809768|Fluconazole|fluconazole|mesh-list
92782721|NCT02809768|Rifampin|rifampin|mesh-list
92782722|NCT02809768|Antifungal Agents|antifungal agents|mesh-ancestor
92782723|NCT02809768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782724|NCT02809768|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92782725|NCT02809768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92782726|NCT02809768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782727|NCT02809768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782728|NCT02809768|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92782729|NCT02809768|Hormone Antagonists|hormone antagonists|mesh-ancestor
92782730|NCT02809768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782731|NCT02809768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782732|NCT02809768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92782733|NCT02809768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92782734|NCT02809768|Antitubercular Agents|antitubercular agents|mesh-ancestor
92782735|NCT02809768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782736|NCT02809768|Leprostatic Agents|leprostatic agents|mesh-ancestor
92782737|NCT02809768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92782738|NCT02809768|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92782739|NCT02809768|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92782740|NCT02809768|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92782741|NCT02809768|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92782742|NCT02809768|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92782743|NCT02809768|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92782744|NCT02809768|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92782745|NCT02809768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92782746|NCT04237090|Diphenhydramine|diphenhydramine|mesh-list
92782747|NCT04237090|Promethazine|promethazine|mesh-list
92782749|NCT04237090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92782750|NCT04237090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92782751|NCT04237090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782752|NCT04237090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782753|NCT04237090|Anesthetics, Local|anesthetics, local|mesh-ancestor
92782754|NCT04237090|Anesthetics|anesthetics|mesh-ancestor
92782755|NCT04237090|Sensory System Agents|sensory system agents|mesh-ancestor
92782756|NCT04237090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782757|NCT04237090|Antiemetics|antiemetics|mesh-ancestor
92782758|NCT04237090|Autonomic Agents|autonomic agents|mesh-ancestor
92782759|NCT04237090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782760|NCT04237090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92782761|NCT04237090|Histamine Antagonists|histamine antagonists|mesh-ancestor
92782762|NCT04237090|Histamine Agents|histamine agents|mesh-ancestor
92782763|NCT04237090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782764|NCT04237090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782765|NCT04237090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92782766|NCT04237090|Antipruritics|antipruritics|mesh-ancestor
92782767|NCT04237090|Dermatologic Agents|dermatologic agents|mesh-ancestor
92782768|NCT04237090|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92782769|NCT00690781|Caseins|caseins|mesh-list
92782770|NCT00690781|Chelating Agents|chelating agents|mesh-ancestor
92782771|NCT00690781|Sequestering Agents|sequestering agents|mesh-ancestor
92782772|NCT00690781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782773|NCT00682825|Anesthetics|anesthetics|mesh-list
92782774|NCT00682825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
92782775|NCT00682825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782776|NCT00682825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782777|NCT00682825|Anesthetics, General|anesthetics, general|mesh-ancestor
92782778|NCT04187248|Asparaginase|asparaginase|mesh-list
92782779|NCT04187248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782780|NCT00912379|Chrysarobin|chrysarobin|mesh-list
92782781|NCT00912379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92782782|NCT00912379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782783|NCT00912379|Analgesics|analgesics|mesh-ancestor
92782784|NCT00912379|Sensory System Agents|sensory system agents|mesh-ancestor
92782785|NCT00912379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782786|NCT00912379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782787|NCT00912379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782788|NCT00912379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782789|NCT02809378|Remifentanil|remifentanil|mesh-list
92782790|NCT02809378|Thiopental|thiopental|mesh-list
92782791|NCT02809378|Palonosetron|palonosetron|mesh-list
92782792|NCT02809378|Propofol|propofol|mesh-list
92782793|NCT02809378|Sevoflurane|sevoflurane|mesh-list
92782794|NCT02809378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92782795|NCT02809378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782796|NCT02809378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782797|NCT02809378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92782798|NCT02809378|Anesthetics, General|anesthetics, general|mesh-ancestor
92782799|NCT02809378|Anesthetics|anesthetics|mesh-ancestor
92782800|NCT02809378|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92782801|NCT02809378|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92782802|NCT02809378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92782803|NCT02809378|Narcotics|narcotics|mesh-ancestor
92782804|NCT02809378|Analgesics|analgesics|mesh-ancestor
92782805|NCT02809378|Sensory System Agents|sensory system agents|mesh-ancestor
92782806|NCT02809378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782807|NCT02809378|Antiemetics|antiemetics|mesh-ancestor
92782808|NCT02809378|Autonomic Agents|autonomic agents|mesh-ancestor
92782809|NCT02809378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92782810|NCT02809378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92782811|NCT02809378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92782812|NCT02809378|Serotonin Agents|serotonin agents|mesh-ancestor
92782813|NCT02809378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782814|NCT02809378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782815|NCT02809378|Anticonvulsants|anticonvulsants|mesh-ancestor
92782816|NCT02809378|GABA Modulators|gaba modulators|mesh-ancestor
92782817|NCT02809378|GABA Agents|gaba agents|mesh-ancestor
92782818|NCT00683059|Paclitaxel|paclitaxel|mesh-list
92782819|NCT00683059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92782820|NCT00683059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782821|NCT00683059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92782822|NCT00683059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92782823|NCT00683059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92127725|NCT01529645|Vaccines|vaccines|mesh-list
92782824|NCT00683059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782826|NCT01185353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92782827|NCT01185353|Abortifacient Agents|abortifacient agents|mesh-ancestor
92782828|NCT01185353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782829|NCT01185353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782830|NCT01185353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92782831|NCT01185353|Antimetabolites|antimetabolites|mesh-ancestor
92782832|NCT01185353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782833|NCT01185353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782834|NCT01185353|Dermatologic Agents|dermatologic agents|mesh-ancestor
92782835|NCT01185353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782836|NCT01185353|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92782837|NCT01185353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92782838|NCT01185353|Immunologic Factors|immunologic factors|mesh-ancestor
92782839|NCT01185353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782840|NCT01185353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92782841|NCT00683137|Valdecoxib|valdecoxib|mesh-list
92782842|NCT00683137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92782843|NCT00683137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92782844|NCT00683137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782845|NCT00683137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782846|NCT00683137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92782847|NCT00683137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782848|NCT00683137|Analgesics|analgesics|mesh-ancestor
92782849|NCT00683137|Sensory System Agents|sensory system agents|mesh-ancestor
92782850|NCT00683137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782851|NCT00683137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782852|NCT00683137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782853|NCT00683137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782854|NCT02809456|Nicorandil|nicorandil|mesh-list
92782855|NCT02809456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92782856|NCT02809456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92782857|NCT02809456|Vasodilator Agents|vasodilator agents|mesh-ancestor
92782858|NCT02809456|Vitamin B Complex|vitamin b complex|mesh-ancestor
92782859|NCT02809456|Vitamins|vitamins|mesh-ancestor
92782860|NCT02809456|Micronutrients|micronutrients|mesh-ancestor
92782861|NCT02809456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782862|NCT05576740|Contraceptive Agents|contraceptive agents|mesh-list
92782863|NCT05576740|Hormones|hormones|mesh-list
92782864|NCT05576740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782865|NCT05576740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782866|NCT05576740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92782867|NCT04139629|Antibodies|antibodies|mesh-list
92782868|NCT04139629|Immunologic Factors|immunologic factors|mesh-ancestor
92782869|NCT04139629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782870|NCT02813044|Anesthetics|anesthetics|mesh-list
92782871|NCT02813044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782872|NCT02813044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782873|NCT04236778|Vancomycin|vancomycin|mesh-list
92782874|NCT04236778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92782875|NCT04236778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92782876|NCT02812888|Propranolol|propranolol|mesh-list
92782877|NCT02812888|Methimazole|methimazole|mesh-list
92782878|NCT02812888|Propylthiouracil|propylthiouracil|mesh-list
92782879|NCT02812888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92782880|NCT02812888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92782881|NCT02812888|Adrenergic Agents|adrenergic agents|mesh-ancestor
92782882|NCT02812888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782883|NCT02812888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782884|NCT02812888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782885|NCT02812888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92782886|NCT02812888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92782887|NCT02812888|Vasodilator Agents|vasodilator agents|mesh-ancestor
92782888|NCT02812888|Antithyroid Agents|antithyroid agents|mesh-ancestor
92782889|NCT02812888|Hormone Antagonists|hormone antagonists|mesh-ancestor
92782890|NCT02812888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92782891|NCT02812888|Antimetabolites|antimetabolites|mesh-ancestor
92782892|NCT00687661|Diphosphonates|diphosphonates|mesh-list
92782893|NCT00687661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92782894|NCT00687661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782895|NCT00687817|Paclitaxel|paclitaxel|mesh-list
92782896|NCT00687817|Carboplatin|carboplatin|mesh-list
92782897|NCT00687817|Bavituximab|bavituximab|mesh-list
92782898|NCT00687817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92782899|NCT00687817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782900|NCT00687817|Tubulin Modulators|tubulin modulators|mesh-ancestor
92782901|NCT00687817|Antimitotic Agents|antimitotic agents|mesh-ancestor
92782902|NCT00687817|Mitosis Modulators|mitosis modulators|mesh-ancestor
92782903|NCT00687817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782904|NCT00687817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92782905|NCT02808988|Zoledronic Acid|zoledronic acid|mesh-list
92782906|NCT02808988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92782907|NCT02808988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782908|NCT02625805|Methylphenidate|methylphenidate|mesh-list
92782909|NCT02625805|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92782910|NCT02625805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782911|NCT02625805|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92782912|NCT02625805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92782913|NCT02625805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92782914|NCT02625805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782915|NCT02625805|Dopamine Agents|dopamine agents|mesh-ancestor
92782916|NCT02625805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782917|NCT00688207|Rosiglitazone|rosiglitazone|mesh-list
92782918|NCT00688207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92782919|NCT00688207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782920|NCT02880462|Sulforaphane|sulforaphane|mesh-list
92782921|NCT02880462|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92782922|NCT02880462|Protective Agents|protective agents|mesh-ancestor
92782923|NCT02880462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427983|NCT01547559|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
92782924|NCT02880462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782925|NCT00688363|Chrysarobin|chrysarobin|mesh-list
92782926|NCT00688363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92782927|NCT00688363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92782928|NCT00688363|Analgesics|analgesics|mesh-ancestor
92782929|NCT00688363|Sensory System Agents|sensory system agents|mesh-ancestor
92782930|NCT00688363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92782931|NCT00688363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782932|NCT00688363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782933|NCT00688363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92782934|NCT02812654|Doxorubicin|doxorubicin|mesh-list
92782935|NCT02812654|Ifosfamide|ifosfamide|mesh-list
92782936|NCT02812654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92782937|NCT02812654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782938|NCT02812654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92782939|NCT02812654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92782940|NCT02812654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782941|NCT02812654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782942|NCT02812654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92782943|NCT02812654|Alkylating Agents|alkylating agents|mesh-ancestor
92782944|NCT02809066|Calcium, Dietary|calcium, dietary|mesh-list
92782945|NCT02809066|Calcium|calcium|mesh-list
92782946|NCT02809066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92782947|NCT02809066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782948|NCT02809066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92782949|NCT01097694|Imatinib Mesylate|imatinib mesylate|mesh-list
92782950|NCT01097694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92782951|NCT01097694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92782952|NCT01097694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782953|NCT01097694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782954|NCT00688987|Hydrocortisone|hydrocortisone|mesh-list
92782955|NCT00688987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92782956|NCT02808676|Vitamin D|vitamin d|mesh-list
92782957|NCT02808676|Cholecalciferol|cholecalciferol|mesh-list
92782958|NCT02808676|Vitamins|vitamins|mesh-ancestor
92782959|NCT02808676|Micronutrients|micronutrients|mesh-ancestor
92782960|NCT02808676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782961|NCT02808676|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92530472|NCT00001457|Antiviral Agents|antiviral agents|mesh-ancestor
92782962|NCT02808676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92782963|NCT00690937|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92782964|NCT00690937|Sevelamer|sevelamer|mesh-list
92782965|NCT00690937|Chelating Agents|chelating agents|mesh-ancestor
92782966|NCT00690937|Sequestering Agents|sequestering agents|mesh-ancestor
92782967|NCT00690937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782968|NCT00690937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92782969|NCT00690937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92782970|NCT00690937|Antimetabolites|antimetabolites|mesh-ancestor
92782971|NCT00690937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92782972|NCT00689143|Sargramostim|sargramostim|mesh-list
92782973|NCT00689143|Immunologic Factors|immunologic factors|mesh-ancestor
92782974|NCT00689143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782975|NCT00912457|Donepezil|donepezil|mesh-list
92782976|NCT00912457|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92782977|NCT00912457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92782978|NCT00912457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782979|NCT00912457|Cholinergic Agents|cholinergic agents|mesh-ancestor
92782980|NCT00912457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782981|NCT00912457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782982|NCT00912457|Nootropic Agents|nootropic agents|mesh-ancestor
92782983|NCT04200586|Dapagliflozin|dapagliflozin|mesh-list
92782984|NCT04200586|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92782985|NCT04200586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782986|NCT04200586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92782987|NCT04200586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782988|NCT02625103|Clozapine|clozapine|mesh-list
92782989|NCT02625103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92782990|NCT02625103|Serotonin Agents|serotonin agents|mesh-ancestor
92782991|NCT02625103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92782992|NCT02625103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92782993|NCT02625103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92782994|NCT02625103|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92782995|NCT02625103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92782996|NCT02625103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92782997|NCT02625103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92782998|NCT02625103|GABA Antagonists|gaba antagonists|mesh-ancestor
92428080|NCT01548248|Insulin|insulin|mesh-list
92783000|NCT01155479|Rasagiline|rasagiline|mesh-list
92783001|NCT01155479|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92783002|NCT01155479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783003|NCT01155479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783004|NCT01155479|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92783005|NCT01155479|Protective Agents|protective agents|mesh-ancestor
92783006|NCT01155479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783007|NCT02807272|Tipifarnib|tipifarnib|mesh-list
92783008|NCT02807272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783009|NCT02807194|Anesthetics|anesthetics|mesh-list
92783010|NCT02807194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783011|NCT02807194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783012|NCT00912535|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92783013|NCT00912535|Antidepressive Agents|antidepressive agents|mesh-ancestor
92783014|NCT00912535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92783015|NCT00912535|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92783016|NCT00912535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92783017|NCT00912535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783018|NCT00912535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783019|NCT02625727|Hyaluronic Acid|hyaluronic acid|mesh-list
92783020|NCT02625727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92783021|NCT02625727|Immunologic Factors|immunologic factors|mesh-ancestor
92783022|NCT02625727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783023|NCT02625727|Viscosupplements|viscosupplements|mesh-ancestor
92783024|NCT02625727|Protective Agents|protective agents|mesh-ancestor
92783025|NCT02807116|Rifampin|rifampin|mesh-list
92783026|NCT02807116|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92783027|NCT02807116|Antitubercular Agents|antitubercular agents|mesh-ancestor
92530476|NCT00042172|Donepezil|donepezil|mesh-list
92783028|NCT02807116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783029|NCT02807116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783030|NCT02807116|Leprostatic Agents|leprostatic agents|mesh-ancestor
92783031|NCT02807116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92783032|NCT02807116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783033|NCT02807116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783034|NCT02807116|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92783035|NCT02807116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92783036|NCT02807116|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92783037|NCT02807116|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92783038|NCT02807116|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92783039|NCT02807116|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92783040|NCT04313699|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92783041|NCT04313699|Antiviral Agents|antiviral agents|mesh-ancestor
92783042|NCT04313699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783043|NCT01155167|Lidocaine|lidocaine|mesh-list
92783044|NCT01155167|Nitroglycerin|nitroglycerin|mesh-list
92783045|NCT01155167|Anesthetics, Local|anesthetics, local|mesh-ancestor
92783046|NCT01155167|Anesthetics|anesthetics|mesh-ancestor
92783047|NCT01155167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783048|NCT01155167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783049|NCT01155167|Sensory System Agents|sensory system agents|mesh-ancestor
92783050|NCT01155167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783051|NCT01155167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92339446|NCT00002063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92783052|NCT01155167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92783053|NCT01155167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92783054|NCT01155167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783055|NCT01155167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783056|NCT01155167|Vasodilator Agents|vasodilator agents|mesh-ancestor
92783057|NCT05238155|Antimetabolites|antimetabolites|mesh-list
92783058|NCT05238155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783059|NCT01106586|Ritonavir|ritonavir|mesh-list
92783060|NCT01106586|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92783061|NCT01106586|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92783062|NCT01106586|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92783063|NCT01106586|Protease Inhibitors|protease inhibitors|mesh-ancestor
92783064|NCT01106586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783065|NCT01106586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783066|NCT01106586|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92783067|NCT01106586|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92783068|NCT01106586|Antiviral Agents|antiviral agents|mesh-ancestor
92783069|NCT01106586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783070|NCT01106586|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92783071|NCT01106586|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92783072|NCT00683995|Fentanyl|fentanyl|mesh-list
92783073|NCT00683995|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92783074|NCT00683995|Narcotics|narcotics|mesh-ancestor
92783075|NCT00683995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783076|NCT00683995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783077|NCT00683995|Analgesics|analgesics|mesh-ancestor
92783078|NCT00683995|Sensory System Agents|sensory system agents|mesh-ancestor
92783079|NCT00683995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783080|NCT00683995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92783081|NCT00683995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92783082|NCT00683995|Anesthetics, General|anesthetics, general|mesh-ancestor
92783083|NCT00683995|Anesthetics|anesthetics|mesh-ancestor
92783084|NCT02806882|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92783085|NCT02806882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783086|NCT02806882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783087|NCT02884817|Listerine|listerine|mesh-list
92783088|NCT02884817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92783089|NCT02884817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783090|NCT02806804|Vaccines|vaccines|mesh-list
92783091|NCT02806804|Immunologic Factors|immunologic factors|mesh-ancestor
92783092|NCT02806804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783093|NCT02879292|Anesthetics|anesthetics|mesh-list
92783094|NCT02879292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783095|NCT02879292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783096|NCT02806648|Palbociclib|palbociclib|mesh-list
92783097|NCT02806648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783098|NCT02806648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783099|NCT02806648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783100|NCT02806648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783101|NCT00689845|Cytarabine|cytarabine|mesh-list
92783102|NCT00689845|Prednisone|prednisone|mesh-list
92783103|NCT00689845|Prednisolone|prednisolone|mesh-list
92783104|NCT00689845|Cyclophosphamide|cyclophosphamide|mesh-list
92783105|NCT00689845|Ifosfamide|ifosfamide|mesh-list
92783106|NCT00689845|Rituximab|rituximab|mesh-list
92783107|NCT00689845|Doxorubicin|doxorubicin|mesh-list
92783108|NCT00689845|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92783109|NCT00689845|Methotrexate|methotrexate|mesh-list
92783110|NCT00689845|Etoposide|etoposide|mesh-list
92783111|NCT00689845|Vincristine|vincristine|mesh-list
92783112|NCT00689845|Bleomycin|bleomycin|mesh-list
92783113|NCT00689845|Etoposide phosphate|etoposide phosphate|mesh-list
92783114|NCT00689845|Vindesine|vindesine|mesh-list
92783115|NCT00689845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783116|NCT00689845|Immunologic Factors|immunologic factors|mesh-ancestor
92783117|NCT00689845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783118|NCT00689845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92783119|NCT00689845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92783120|NCT00689845|Alkylating Agents|alkylating agents|mesh-ancestor
92783121|NCT00689845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783122|NCT00689845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783123|NCT00689845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92783124|NCT00689845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783125|NCT00689845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92783126|NCT00689845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92783127|NCT00689845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92783128|NCT00689845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783129|NCT00689845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783130|NCT00689845|Glucocorticoids|glucocorticoids|mesh-ancestor
92783131|NCT00689845|Hormones|hormones|mesh-ancestor
92783132|NCT00689845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783133|NCT00689845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92783134|NCT00689845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92783135|NCT00689845|Abortifacient Agents|abortifacient agents|mesh-ancestor
92783136|NCT00689845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92783137|NCT00689845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530519|NCT02970643|Olanzapine|olanzapine|mesh-list
92783139|NCT00689845|Dermatologic Agents|dermatologic agents|mesh-ancestor
92783140|NCT00689845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92783141|NCT00689845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92783142|NCT00689845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92783143|NCT00689845|Antiviral Agents|antiviral agents|mesh-ancestor
92783144|NCT00689845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783145|NCT00689845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92783146|NCT00689845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92783147|NCT00689845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783148|NCT00624767|Insulin|insulin|mesh-list
92783149|NCT00624767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92783150|NCT00624767|Insulin Aspart|insulin aspart|mesh-list
92783151|NCT00624767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92783152|NCT00624767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783153|NCT02806492|Phenylephrine|phenylephrine|mesh-list
92783154|NCT02806492|Oxymetazoline|oxymetazoline|mesh-list
92783155|NCT02806492|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92783156|NCT02806492|Mydriatics|mydriatics|mesh-ancestor
92783157|NCT02806492|Autonomic Agents|autonomic agents|mesh-ancestor
92783158|NCT02806492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783159|NCT02806492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783160|NCT02806492|Sympathomimetics|sympathomimetics|mesh-ancestor
92783161|NCT02806492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92783162|NCT02806492|Nasal Decongestants|nasal decongestants|mesh-ancestor
92783163|NCT02806492|Respiratory System Agents|respiratory system agents|mesh-ancestor
92783164|NCT02806492|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92783165|NCT02806492|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92783166|NCT02806492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783167|NCT02806492|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783168|NCT02806492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783169|NCT02806492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783170|NCT02806492|Protective Agents|protective agents|mesh-ancestor
92783171|NCT00691405|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92783172|NCT00691405|Formoterol Fumarate|formoterol fumarate|mesh-list
92783173|NCT00691405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92783174|NCT00691405|Autonomic Agents|autonomic agents|mesh-ancestor
92783175|NCT00691405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783176|NCT00691405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783177|NCT00691405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92783178|NCT00691405|Respiratory System Agents|respiratory system agents|mesh-ancestor
92783179|NCT00691405|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92783180|NCT00691405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92783181|NCT00691405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783182|NCT00691405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783183|NCT00691405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783184|NCT00691405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783185|NCT01106430|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92783186|NCT01106430|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92783187|NCT01106430|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92783188|NCT01106430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92783189|NCT01106430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783190|NCT01106430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783191|NCT01106430|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783192|NCT01106430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783193|NCT01106430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783194|NCT01106430|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92783195|NCT01106430|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92783196|NCT01106430|Dopamine Agents|dopamine agents|mesh-ancestor
92783197|NCT02804776|Gefitinib|gefitinib|mesh-list
92783198|NCT02804776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783199|NCT02804776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783200|NCT02804776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783201|NCT02804776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783202|NCT01154153|Loratadine|loratadine|mesh-list
92783203|NCT01154153|Triamcinolone|triamcinolone|mesh-list
92783204|NCT01154153|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92783205|NCT01154153|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92783206|NCT01154153|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92783207|NCT01154153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783208|NCT01154153|Glucocorticoids|glucocorticoids|mesh-ancestor
92783209|NCT01154153|Hormones|hormones|mesh-ancestor
92783210|NCT01154153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128112|NCT01560949|Fluorouracil|fluorouracil|mesh-list
92783211|NCT01154153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783212|NCT01154153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783213|NCT01154153|Immunologic Factors|immunologic factors|mesh-ancestor
92783214|NCT01154153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783215|NCT01154153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783217|NCT01154153|Dermatologic Agents|dermatologic agents|mesh-ancestor
92783218|NCT01154153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92783219|NCT01154153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92783220|NCT01154153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92783221|NCT01154153|Histamine Antagonists|histamine antagonists|mesh-ancestor
92783222|NCT01154153|Histamine Agents|histamine agents|mesh-ancestor
92783223|NCT01154153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783225|NCT00684229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783226|NCT00684229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783227|NCT00874237|Moxifloxacin|moxifloxacin|mesh-list
92783228|NCT00874237|Loxapine|loxapine|mesh-list
92783229|NCT00874237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783230|NCT00874237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783231|NCT00874237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92783232|NCT00874237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92783233|NCT00874237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783234|NCT00874237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783235|NCT00874237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783236|NCT00874237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783237|NCT00874237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92783238|NCT00874237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92783239|NCT00874237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783240|NCT00874237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92783241|NCT00874237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92783242|NCT00874237|Dopamine Agents|dopamine agents|mesh-ancestor
92783243|NCT00874237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783244|NCT02805946|Posaconazole|posaconazole|mesh-list
92783245|NCT02805946|Antifungal Agents|antifungal agents|mesh-ancestor
92783246|NCT02805946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783247|NCT02805946|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92783248|NCT02805946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92783249|NCT02805946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92783250|NCT02805946|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92783251|NCT02805946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92783252|NCT02805946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783253|NCT02805946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783254|NCT02805946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92783255|NCT02805946|Hormone Antagonists|hormone antagonists|mesh-ancestor
92783256|NCT02805946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783257|NCT02805946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783258|NCT02804386|Sofosbuvir|sofosbuvir|mesh-list
92783259|NCT02804386|Antiviral Agents|antiviral agents|mesh-ancestor
92783260|NCT02804386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783261|NCT02805868|Siltuximab|siltuximab|mesh-list
92783262|NCT02805868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92783263|NCT02805868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783264|NCT02805868|Immunologic Factors|immunologic factors|mesh-ancestor
92783265|NCT02805868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783266|NCT00684385|Gefitinib|gefitinib|mesh-list
92783267|NCT00684385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783268|NCT00684385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783269|NCT00684385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783270|NCT00684385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783271|NCT02690038|Immunoglobulins|immunoglobulins|mesh-list
92783272|NCT02690038|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92783273|NCT02690038|Antibodies|antibodies|mesh-list
92783274|NCT02690038|gamma-Globulins|gamma-globulins|mesh-list
92783275|NCT02690038|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92783276|NCT02690038|Immunologic Factors|immunologic factors|mesh-ancestor
92783277|NCT02690038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783278|NCT00691795|Clonidine|clonidine|mesh-list
92783279|NCT00691795|Fentanyl|fentanyl|mesh-list
92783280|NCT00691795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92783281|NCT00691795|Narcotics|narcotics|mesh-ancestor
92783282|NCT00691795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783283|NCT00691795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783284|NCT00691795|Analgesics|analgesics|mesh-ancestor
92783285|NCT00691795|Sensory System Agents|sensory system agents|mesh-ancestor
92783286|NCT00691795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783287|NCT00691795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92783288|NCT00691795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92783289|NCT00691795|Anesthetics, General|anesthetics, general|mesh-ancestor
92783290|NCT00691795|Anesthetics|anesthetics|mesh-ancestor
92783291|NCT00691795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92783292|NCT00691795|Sympatholytics|sympatholytics|mesh-ancestor
92783293|NCT00691795|Autonomic Agents|autonomic agents|mesh-ancestor
92783294|NCT00691795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92783295|NCT00691795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92783296|NCT00691795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783297|NCT00691795|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783298|NCT00691795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783299|NCT00691795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783300|NCT02805556|Fostemsavir|fostemsavir|mesh-list
92783301|NCT02805556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92783302|NCT02805556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92783303|NCT02805556|Antiviral Agents|antiviral agents|mesh-ancestor
92783304|NCT02805556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783305|NCT02805556|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92783306|NCT02805556|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92783307|NCT02805556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783308|NCT04032964|Doxorubicin|doxorubicin|mesh-list
92783309|NCT04032964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92783310|NCT04032964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783311|NCT04032964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92783312|NCT04032964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92783313|NCT04032964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783314|NCT04032964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783315|NCT00694291|Sorafenib|sorafenib|mesh-list
92783316|NCT00694291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783317|NCT00694291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783318|NCT00694291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783319|NCT00694291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783320|NCT01153763|Dabrafenib|dabrafenib|mesh-list
92783321|NCT01153763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783322|NCT01153763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783323|NCT01153763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783324|NCT01153763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783325|NCT00691873|Omalizumab|omalizumab|mesh-list
92783326|NCT00691873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92783327|NCT00691873|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92783328|NCT00691873|Respiratory System Agents|respiratory system agents|mesh-ancestor
92783329|NCT05538052|Lidocaine|lidocaine|mesh-list
92783330|NCT05538052|Tramadol|tramadol|mesh-list
92783331|NCT05538052|Anesthetics, Local|anesthetics, local|mesh-ancestor
92783332|NCT05538052|Anesthetics|anesthetics|mesh-ancestor
92783333|NCT05538052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783334|NCT05538052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783335|NCT05538052|Sensory System Agents|sensory system agents|mesh-ancestor
92783336|NCT05538052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783337|NCT05538052|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92783338|NCT05538052|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92783339|NCT05538052|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92783340|NCT05538052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783341|NCT05538052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783342|NCT05538052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92783343|NCT05538052|Narcotics|narcotics|mesh-ancestor
92783344|NCT05538052|Analgesics|analgesics|mesh-ancestor
92783345|NCT05298475|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92339545|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783346|NCT05298475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92783347|NCT05298475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92783348|NCT05298475|Antimetabolites|antimetabolites|mesh-ancestor
92783349|NCT05298475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783350|NCT05298475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92783351|NCT05298475|Protease Inhibitors|protease inhibitors|mesh-ancestor
92783352|NCT05298475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783353|NCT05298475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92783354|NCT00691951|Budesonide|budesonide|mesh-list
92783355|NCT00691951|Formoterol Fumarate|formoterol fumarate|mesh-list
92783356|NCT00691951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783357|NCT00691951|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92783358|NCT00691951|Autonomic Agents|autonomic agents|mesh-ancestor
92783359|NCT00691951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783360|NCT00691951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783361|NCT00691951|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92783362|NCT00691951|Respiratory System Agents|respiratory system agents|mesh-ancestor
92783363|NCT00691951|Glucocorticoids|glucocorticoids|mesh-ancestor
92783365|NCT00691951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783366|NCT00691951|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92783367|NCT00691951|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92783368|NCT00691951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783369|NCT00691951|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783370|NCT00691951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428431|NCT01550419|Antimetabolites|antimetabolites|mesh-ancestor
92783371|NCT00691951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783372|NCT04316351|Pemetrexed|pemetrexed|mesh-list
92783373|NCT04316351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783374|NCT04316351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783375|NCT04316351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783376|NCT04316351|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92783377|NCT04316351|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92783378|NCT02625337|Pembrolizumab|pembrolizumab|mesh-list
92783379|NCT02625337|Trametinib|trametinib|mesh-list
92783380|NCT02625337|Dabrafenib|dabrafenib|mesh-list
92783381|NCT02625337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783382|NCT02625337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783383|NCT02625337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92783384|NCT02625337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783385|NCT02625337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783386|NCT02625337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783387|NCT04236310|Trastuzumab|trastuzumab|mesh-list
92783388|NCT04236310|Anastrozole|anastrozole|mesh-list
92783389|NCT04236310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783390|NCT04236310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783391|NCT04236310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92783392|NCT04236310|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92783393|NCT04236310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92783394|NCT04236310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783395|NCT04236310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783396|NCT04236310|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92783397|NCT04236310|Hormone Antagonists|hormone antagonists|mesh-ancestor
92783398|NCT04236310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783399|NCT04236310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783400|NCT02621515|Nivolumab|nivolumab|mesh-list
92783401|NCT02621515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783402|NCT02621515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783403|NCT02621515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92783404|NCT02621515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783405|NCT02803918|Metformin|metformin|mesh-list
92783406|NCT02803918|Lixisenatide|lixisenatide|mesh-list
92783407|NCT02803918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92783408|NCT02803918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783409|NCT02805010|Abatacept|abatacept|mesh-list
92783410|NCT02805010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92783411|NCT02805010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783412|NCT02805010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783413|NCT02805010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783414|NCT02805010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783415|NCT02805010|Immunologic Factors|immunologic factors|mesh-ancestor
92783416|NCT02805010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783417|NCT02805010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92783418|NCT02800408|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
92783419|NCT02800408|Provitamins|provitamins|mesh-ancestor
92783420|NCT02800408|Vitamins|vitamins|mesh-ancestor
92783421|NCT02800408|Micronutrients|micronutrients|mesh-ancestor
92783422|NCT02800408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783423|NCT00692263|Tramadol|tramadol|mesh-list
92783424|NCT00692263|Escitalopram|escitalopram|mesh-list
92783425|NCT00692263|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92530526|NCT02970643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92783426|NCT00692263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92783427|NCT00692263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783428|NCT00692263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783429|NCT00692263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783430|NCT00692263|Serotonin Agents|serotonin agents|mesh-ancestor
92783431|NCT00692263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783432|NCT00692263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783433|NCT00692263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92783434|NCT00692263|Narcotics|narcotics|mesh-ancestor
92783435|NCT00692263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783436|NCT00692263|Analgesics|analgesics|mesh-ancestor
92783437|NCT00692263|Sensory System Agents|sensory system agents|mesh-ancestor
92783438|NCT02800486|Cetuximab|cetuximab|mesh-list
92783439|NCT02800486|Mannitol|mannitol|mesh-list
92783440|NCT02800486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783441|NCT02800486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783442|NCT02800486|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92783443|NCT02800486|Diuretics|diuretics|mesh-ancestor
92783444|NCT02800486|Natriuretic Agents|natriuretic agents|mesh-ancestor
92783445|NCT02800486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783446|NCT00694759|Metformin|metformin|mesh-list
92783447|NCT00694759|Pioglitazone|pioglitazone|mesh-list
92783448|NCT00694759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92783449|NCT00694759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783450|NCT00694837|Nelfinavir|nelfinavir|mesh-list
92783451|NCT00694837|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92783452|NCT00694837|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92783453|NCT00694837|Protease Inhibitors|protease inhibitors|mesh-ancestor
92783454|NCT00694837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783455|NCT00694837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783456|NCT00694837|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92783457|NCT00694837|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92783458|NCT00694837|Antiviral Agents|antiviral agents|mesh-ancestor
92783459|NCT00694837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783460|NCT02800252|Aspirin|aspirin|mesh-list
92783461|NCT02800252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92783462|NCT02800252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92783463|NCT02800252|Analgesics|analgesics|mesh-ancestor
92783464|NCT02800252|Sensory System Agents|sensory system agents|mesh-ancestor
92783465|NCT02800252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783466|NCT02800252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783467|NCT02800252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783468|NCT02800252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92783469|NCT02800252|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92783470|NCT02800252|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92783471|NCT02800252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783472|NCT02800252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92783473|NCT02800252|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92783474|NCT02800252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783475|NCT02800252|Antipyretics|antipyretics|mesh-ancestor
92783476|NCT02621359|Doxycycline|doxycycline|mesh-list
92783477|NCT02621359|Levofloxacin|levofloxacin|mesh-list
92783478|NCT02621359|Nitazoxanide|nitazoxanide|mesh-list
92783479|NCT02621359|Omeprazole|omeprazole|mesh-list
92783480|NCT02621359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92783481|NCT02621359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92783482|NCT02621359|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92783483|NCT02621359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783484|NCT02621359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783485|NCT02621359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783486|NCT02621359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783487|NCT02621359|Antimalarials|antimalarials|mesh-ancestor
92783488|NCT02621359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92783489|NCT02621359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92783490|NCT02621359|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92783491|NCT02621359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92783492|NCT02621359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92783493|NCT02621359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783494|NCT02621359|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92783495|NCT02621359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92783496|NCT01152437|Cetuximab|cetuximab|mesh-list
92783497|NCT01152437|Afatinib|afatinib|mesh-list
92783498|NCT01152437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783499|NCT01152437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783500|NCT01152437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783501|NCT01152437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783502|NCT01152437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783503|NCT02800174|Clopidogrel|clopidogrel|mesh-list
92783504|NCT02800174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92783505|NCT02800174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783506|NCT02800174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783507|NCT02800174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92783508|NCT02800174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92783509|NCT02800174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92783510|NCT02800174|Purinergic Agents|purinergic agents|mesh-ancestor
92339602|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
92783511|NCT02800174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783512|NCT02800330|Esomeprazole|esomeprazole|mesh-list
92783513|NCT02800330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92783514|NCT02800330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92783515|NCT02800330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92783516|NCT02800330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783517|NCT02800330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783518|NCT02799862|Paclitaxel|paclitaxel|mesh-list
92783519|NCT02799862|Carboplatin|carboplatin|mesh-list
92783520|NCT02799862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92783521|NCT02799862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783522|NCT02799862|Tubulin Modulators|tubulin modulators|mesh-ancestor
92783523|NCT02799862|Antimitotic Agents|antimitotic agents|mesh-ancestor
92783524|NCT02799862|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783525|NCT02799862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783526|NCT01151579|Albuterol|albuterol|mesh-list
92783527|NCT01151579|Ipratropium|ipratropium|mesh-list
92783528|NCT01151579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92783529|NCT01151579|Autonomic Agents|autonomic agents|mesh-ancestor
92783530|NCT01151579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783531|NCT01151579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783532|NCT01151579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92783533|NCT01151579|Respiratory System Agents|respiratory system agents|mesh-ancestor
92783534|NCT01151579|Tocolytic Agents|tocolytic agents|mesh-ancestor
92783535|NCT01151579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92783536|NCT01151579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92783537|NCT01151579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92783538|NCT01151579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783539|NCT01151579|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783540|NCT01151579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783541|NCT01151579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783542|NCT01151579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92783543|NCT01151579|Cholinergic Agents|cholinergic agents|mesh-ancestor
92783544|NCT00694915|BCG Vaccine|bcg vaccine|mesh-list
92783545|NCT00694915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92783546|NCT00694915|Immunologic Factors|immunologic factors|mesh-ancestor
92783547|NCT00694915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783548|NCT01097616|Suvorexant|suvorexant|mesh-list
92783549|NCT01097616|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92783550|NCT01097616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92783551|NCT01097616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783552|NCT01097616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783553|NCT01097616|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92783554|NCT01097616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783555|NCT01097616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783556|NCT00695071|Itraconazole|itraconazole|mesh-list
92783557|NCT00695071|Antifungal Agents|antifungal agents|mesh-ancestor
92783558|NCT00695071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783559|NCT00695071|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92783560|NCT00695071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92783561|NCT00695071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783562|NCT00695071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783563|NCT00695071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92783564|NCT00695071|Hormone Antagonists|hormone antagonists|mesh-ancestor
92783565|NCT00695071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783566|NCT00695071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783567|NCT00695071|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92783568|NCT04939428|Molnupiravir|molnupiravir|mesh-list
92783569|NCT04939428|Antiviral Agents|antiviral agents|mesh-ancestor
92783570|NCT04939428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783571|NCT02803216|Amoxicillin|amoxicillin|mesh-list
92783572|NCT02803216|Clarithromycin|clarithromycin|mesh-list
92783573|NCT02803216|Omeprazole|omeprazole|mesh-list
92783574|NCT02803216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783575|NCT02803216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783576|NCT02803216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92783577|NCT02803216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92783578|NCT02803216|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92783579|NCT02803216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783580|NCT02803216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783581|NCT02803216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92783582|NCT02803216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92783583|NCT02803216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92783584|NCT02799316|Antibodies|antibodies|mesh-list
92783585|NCT02799316|Immunologic Factors|immunologic factors|mesh-ancestor
92783586|NCT02799316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783587|NCT02620969|Dialysis Solutions|dialysis solutions|mesh-list
92783588|NCT02620969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92783589|NCT02799238|Temozolomide|temozolomide|mesh-list
92783590|NCT02799238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92783591|NCT02799238|Alkylating Agents|alkylating agents|mesh-ancestor
92783592|NCT02799238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783593|NCT02799238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783594|NCT02620813|Tretinoin|tretinoin|mesh-list
92783595|NCT02620813|Isotretinoin|isotretinoin|mesh-list
92783596|NCT02620813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92783597|NCT02620813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783598|NCT02620813|Keratolytic Agents|keratolytic agents|mesh-ancestor
92783599|NCT00692731|Caffeine|caffeine|mesh-list
92783600|NCT00692731|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92783601|NCT00692731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783602|NCT00692731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92783603|NCT00692731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783604|NCT00692731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783605|NCT00692731|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92783606|NCT00692731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92783607|NCT00692731|Purinergic Agents|purinergic agents|mesh-ancestor
92783608|NCT00692731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783609|NCT02624401|Dexmedetomidine|dexmedetomidine|mesh-list
92783610|NCT02624401|Ketamine|ketamine|mesh-list
92783611|NCT02624401|Propofol|propofol|mesh-list
92783612|NCT02624401|Sevoflurane|sevoflurane|mesh-list
92783613|NCT02624401|Esketamine|esketamine|mesh-list
92783614|NCT02624401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92783615|NCT02624401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783616|NCT02624401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783617|NCT02624401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92783618|NCT02624401|Analgesics|analgesics|mesh-ancestor
92783619|NCT02624401|Sensory System Agents|sensory system agents|mesh-ancestor
92783620|NCT02624401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783621|NCT02624401|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92783622|NCT02624401|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92783623|NCT02624401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783624|NCT02624401|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783625|NCT02624401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783626|NCT02624401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783627|NCT02624401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92783628|NCT02624401|Anesthetics, General|anesthetics, general|mesh-ancestor
92783629|NCT02624401|Anesthetics|anesthetics|mesh-ancestor
92783630|NCT02624401|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92783631|NCT02624401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92783632|NCT02624401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92783633|NCT02624401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92783634|NCT02624401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92783635|NCT02624401|Antidepressive Agents|antidepressive agents|mesh-ancestor
92783636|NCT02624401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92783637|NCT02802748|Letrozole|letrozole|mesh-list
92783638|NCT02802748|Vinorelbine|vinorelbine|mesh-list
92783639|NCT02802748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783640|NCT02802748|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92783641|NCT02802748|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92783642|NCT02802748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783643|NCT02802748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783644|NCT02802748|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92783645|NCT02802748|Hormone Antagonists|hormone antagonists|mesh-ancestor
92783646|NCT02802748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783647|NCT02802748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783648|NCT02802748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92783649|NCT02802748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92783650|NCT02802748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92783651|NCT02802748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783652|NCT02798068|Methylprednisolone|methylprednisolone|mesh-list
92783653|NCT02798068|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92783654|NCT02798068|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92783655|NCT02798068|Prednisolone|prednisolone|mesh-list
92783656|NCT02798068|Prednisolone acetate|prednisolone acetate|mesh-list
92783657|NCT02798068|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92783658|NCT02798068|Prednisolone phosphate|prednisolone phosphate|mesh-list
92783659|NCT02798068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783660|NCT02798068|Antiemetics|antiemetics|mesh-ancestor
92783661|NCT02798068|Autonomic Agents|autonomic agents|mesh-ancestor
92783662|NCT02798068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783663|NCT02798068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783664|NCT02798068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92783665|NCT02798068|Glucocorticoids|glucocorticoids|mesh-ancestor
92783666|NCT02798068|Hormones|hormones|mesh-ancestor
92783667|NCT02798068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783668|NCT02798068|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92783669|NCT02798068|Protective Agents|protective agents|mesh-ancestor
92783670|NCT02798068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92783671|NCT02798068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783672|NCT00593827|Epothilones|epothilones|mesh-list
92783673|NCT00593827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92783674|NCT00593827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92783675|NCT00593827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783676|NCT00593827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783677|NCT00593827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783678|NCT04135885|Folic Acid|folic acid|mesh-list
92783679|NCT04135885|Hematinics|hematinics|mesh-ancestor
92783680|NCT04135885|Vitamin B Complex|vitamin b complex|mesh-ancestor
92783681|NCT04135885|Vitamins|vitamins|mesh-ancestor
92783682|NCT04135885|Micronutrients|micronutrients|mesh-ancestor
92783683|NCT04135885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783684|NCT00693043|Lidocaine|lidocaine|mesh-list
92783685|NCT00693043|Anesthetics, Local|anesthetics, local|mesh-ancestor
92783686|NCT00693043|Anesthetics|anesthetics|mesh-ancestor
92783687|NCT00693043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783688|NCT00693043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783689|NCT00693043|Sensory System Agents|sensory system agents|mesh-ancestor
92339631|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783690|NCT00693043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783691|NCT00693043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92783692|NCT00693043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92783693|NCT00693043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92783694|NCT00693043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783695|NCT00693043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783696|NCT00695929|Simendan|simendan|mesh-list
92783697|NCT00695929|Milrinone|milrinone|mesh-list
92783698|NCT00695929|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92783699|NCT00695929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92783700|NCT00695929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92783701|NCT00695929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92783702|NCT00695929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783703|NCT00695929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783704|NCT00695929|Protective Agents|protective agents|mesh-ancestor
92783705|NCT00695929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783706|NCT00695929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92783707|NCT04235296|Mitogens|mitogens|mesh-list
92783708|NCT04235296|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783709|NCT04235296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783710|NCT02620501|Lidocaine|lidocaine|mesh-list
92783711|NCT02620501|Anesthetics, Local|anesthetics, local|mesh-ancestor
92783712|NCT02620501|Anesthetics|anesthetics|mesh-ancestor
92783713|NCT02620501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783714|NCT02620501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783715|NCT02620501|Sensory System Agents|sensory system agents|mesh-ancestor
92783716|NCT02620501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783717|NCT02620501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92783718|NCT02620501|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92783719|NCT02620501|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92783720|NCT02620501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783721|NCT02620501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783722|NCT00693121|Amantadine|amantadine|mesh-list
92783723|NCT00693121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92783724|NCT00693121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92783725|NCT00693121|Antiviral Agents|antiviral agents|mesh-ancestor
92783726|NCT00693121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783727|NCT00693121|Dopamine Agents|dopamine agents|mesh-ancestor
92783728|NCT00693121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783729|NCT00693121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783730|NCT00693121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783731|NCT00693121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92783732|NCT00693121|Analgesics|analgesics|mesh-ancestor
92783733|NCT00693121|Sensory System Agents|sensory system agents|mesh-ancestor
92783734|NCT00693121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783735|NCT02620423|Leucovorin|leucovorin|mesh-list
92783736|NCT02620423|Gemcitabine|gemcitabine|mesh-list
92783737|NCT02620423|Fluorouracil|fluorouracil|mesh-list
92783738|NCT02620423|Pembrolizumab|pembrolizumab|mesh-list
92783739|NCT02620423|Irinotecan|irinotecan|mesh-list
92783740|NCT02620423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92783741|NCT02620423|Antimetabolites|antimetabolites|mesh-ancestor
92783742|NCT02620423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783743|NCT02620423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783744|NCT02620423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783745|NCT02620423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92783746|NCT02620423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783747|NCT02620423|Immunologic Factors|immunologic factors|mesh-ancestor
92783748|NCT02620423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783749|NCT02620423|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92783750|NCT02620423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92783751|NCT02620423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783752|NCT02620423|Antidotes|antidotes|mesh-ancestor
92783753|NCT02620423|Protective Agents|protective agents|mesh-ancestor
92783754|NCT02620423|Vitamin B Complex|vitamin b complex|mesh-ancestor
92783755|NCT02620423|Vitamins|vitamins|mesh-ancestor
92783756|NCT02620423|Micronutrients|micronutrients|mesh-ancestor
92783757|NCT00696007|Gemcitabine|gemcitabine|mesh-list
92783758|NCT00696007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783759|NCT00696007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92783760|NCT00696007|Antimetabolites|antimetabolites|mesh-ancestor
92783761|NCT00696007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783762|NCT02624089|Ropivacaine|ropivacaine|mesh-list
92783763|NCT02624089|Anesthetics, Local|anesthetics, local|mesh-ancestor
92783764|NCT02624089|Anesthetics|anesthetics|mesh-ancestor
92783765|NCT02624089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783766|NCT02624089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783767|NCT02624089|Sensory System Agents|sensory system agents|mesh-ancestor
92783768|NCT02624089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783769|NCT02796196|Coal Tar|coal tar|mesh-list
92783770|NCT02796196|Keratolytic Agents|keratolytic agents|mesh-ancestor
92783771|NCT02796196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92783772|NCT00693199|Amlodipine|amlodipine|mesh-list
92783773|NCT00693199|Prazosin|prazosin|mesh-list
92783774|NCT00693199|Terazosin|terazosin|mesh-list
92783775|NCT00693199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92783776|NCT00693199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92783777|NCT00693199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783778|NCT00693199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783779|NCT00693199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92783780|NCT00693199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783781|NCT00693199|Vasodilator Agents|vasodilator agents|mesh-ancestor
92783782|NCT00693199|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92783783|NCT00693199|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92783784|NCT00693199|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92783785|NCT00693199|Adrenergic Agents|adrenergic agents|mesh-ancestor
92530538|NCT00017628|Methylprednisolone|methylprednisolone|mesh-list
92783786|NCT00693199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783787|NCT00693199|Urological Agents|urological agents|mesh-ancestor
92783788|NCT02795884|Cisplatin|cisplatin|mesh-list
92783789|NCT02795884|Pemetrexed|pemetrexed|mesh-list
92783790|NCT02795884|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92783791|NCT02795884|Vinorelbine|vinorelbine|mesh-list
92783792|NCT02795884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783793|NCT02795884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783794|NCT02795884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783795|NCT02795884|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92783796|NCT02795884|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92783797|NCT02795884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783798|NCT02795884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92783799|NCT02795884|Tubulin Modulators|tubulin modulators|mesh-ancestor
92783800|NCT02795884|Antimitotic Agents|antimitotic agents|mesh-ancestor
92783801|NCT02795884|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783802|NCT02795572|Vitamin D|vitamin d|mesh-list
92783803|NCT02795572|Vitamins|vitamins|mesh-list
92783804|NCT02795572|Vitamin B 12|vitamin b 12|mesh-list
92783805|NCT02795572|Vitamin B 6|vitamin b 6|mesh-list
92783806|NCT02795572|Pyridoxal|pyridoxal|mesh-list
92783807|NCT02795572|Pyridoxine|pyridoxine|mesh-list
92783808|NCT02795572|Vitamin B Complex|vitamin b complex|mesh-list
92783809|NCT02795572|Micronutrients|micronutrients|mesh-ancestor
92783810|NCT02795572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783811|NCT02795572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92783812|NCT02801188|Dexmedetomidine|dexmedetomidine|mesh-list
92783813|NCT02801188|Bupivacaine|bupivacaine|mesh-list
92783814|NCT02801188|Anesthetics, Local|anesthetics, local|mesh-ancestor
92783815|NCT02801188|Anesthetics|anesthetics|mesh-ancestor
92783816|NCT02801188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783817|NCT02801188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783818|NCT02801188|Sensory System Agents|sensory system agents|mesh-ancestor
92783819|NCT02801188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783820|NCT02801188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92783821|NCT02801188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92783822|NCT02801188|Analgesics|analgesics|mesh-ancestor
92783823|NCT02801188|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92783825|NCT02801188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92783826|NCT02801188|Adrenergic Agents|adrenergic agents|mesh-ancestor
92783827|NCT02801188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783828|NCT02801188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783829|NCT02801032|Tadalafil|tadalafil|mesh-list
92783830|NCT02801032|Vasodilator Agents|vasodilator agents|mesh-ancestor
92783831|NCT02801032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92783832|NCT02801032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92783833|NCT02801032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783834|NCT02801032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783835|NCT02801032|Urological Agents|urological agents|mesh-ancestor
92783836|NCT05442190|Hypericin|hypericin|mesh-list
92783837|NCT05442190|Antidepressive Agents|antidepressive agents|mesh-ancestor
92783838|NCT05442190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92783839|NCT05442190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783840|NCT05442190|Antiviral Agents|antiviral agents|mesh-ancestor
92783841|NCT05442190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783842|NCT05442190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783843|NCT05442190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783844|NCT05442190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783845|NCT05442190|Immunologic Factors|immunologic factors|mesh-ancestor
92783846|NCT05442190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783847|NCT02689960|Prednisone|prednisone|mesh-list
92783848|NCT02689960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783849|NCT02689960|Glucocorticoids|glucocorticoids|mesh-ancestor
92783850|NCT02689960|Hormones|hormones|mesh-ancestor
92783851|NCT02689960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783852|NCT02689960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783853|NCT02689960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92783854|NCT02689960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783855|NCT01150097|Everolimus|everolimus|mesh-list
92783856|NCT01150097|Tacrolimus|tacrolimus|mesh-list
92783857|NCT01150097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783858|NCT01150097|Immunologic Factors|immunologic factors|mesh-ancestor
92783859|NCT01150097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783860|NCT01150097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92783861|NCT01150097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783862|NCT01150097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783863|NCT01150097|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92783864|NCT01150097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783865|NCT01150097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783866|NCT02794948|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92783867|NCT02794948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92783868|NCT02794948|Immunologic Factors|immunologic factors|mesh-ancestor
92783869|NCT02794948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783870|NCT01149863|Plerixafor|plerixafor|mesh-list
92783871|NCT01149863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92783872|NCT01149863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92783873|NCT01149863|Antiviral Agents|antiviral agents|mesh-ancestor
92783874|NCT01149863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783875|NCT02794792|Metformin|metformin|mesh-list
92783876|NCT02794792|Ipragliflozin|ipragliflozin|mesh-list
92783877|NCT02794792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92783878|NCT02794792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783879|NCT02794792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92783880|NCT02794792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783881|NCT01149473|Losartan|losartan|mesh-list
92783882|NCT01149473|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92783883|NCT01149473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92783884|NCT01149473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92783885|NCT01149473|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92783886|NCT01149473|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92783887|NCT01149473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783888|NCT01149473|Diuretics|diuretics|mesh-ancestor
92783889|NCT01149473|Natriuretic Agents|natriuretic agents|mesh-ancestor
92783890|NCT01149473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783891|NCT01149473|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92783892|NCT01149473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92783893|NCT00872989|Docetaxel|docetaxel|mesh-list
92783894|NCT00872989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783895|NCT00872989|Tubulin Modulators|tubulin modulators|mesh-ancestor
92783896|NCT00872989|Antimitotic Agents|antimitotic agents|mesh-ancestor
92783897|NCT00872989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92783898|NCT00872989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783899|NCT02794714|Rocuronium|rocuronium|mesh-list
92783900|NCT02794714|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92783901|NCT02794714|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92783902|NCT02794714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92783903|NCT02794714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783904|NCT02794714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783905|NCT01148771|Ertapenem|ertapenem|mesh-list
92783906|NCT01148771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783907|NCT01148771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783908|NCT01148693|Gentamicins|gentamicins|mesh-list
92783909|NCT01148693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783910|NCT01148693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783911|NCT01148693|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92783912|NCT01148693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783913|NCT01148693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783914|NCT00693355|Butyric Acid|butyric acid|mesh-list
92783915|NCT00693355|Histamine Antagonists|histamine antagonists|mesh-ancestor
92783916|NCT00693355|Histamine Agents|histamine agents|mesh-ancestor
92783917|NCT00693355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783918|NCT00693355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783919|NCT00693355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783920|NCT00693433|Sirolimus|sirolimus|mesh-list
92783921|NCT00693433|Dexamethasone|dexamethasone|mesh-list
92783922|NCT00693433|Temsirolimus|temsirolimus|mesh-list
92783923|NCT00693433|MTOR Inhibitors|mtor inhibitors|mesh-list
92783924|NCT00693433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92783925|NCT00693433|Antiemetics|antiemetics|mesh-ancestor
92783926|NCT00693433|Autonomic Agents|autonomic agents|mesh-ancestor
92783927|NCT00693433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783928|NCT00693433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783929|NCT00693433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92783930|NCT00693433|Glucocorticoids|glucocorticoids|mesh-ancestor
92783931|NCT00693433|Hormones|hormones|mesh-ancestor
92783932|NCT00693433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92783933|NCT00693433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92783934|NCT00693433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783935|NCT00693433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92783936|NCT00693433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783937|NCT00693433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783938|NCT00693433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92783939|NCT00693433|Immunologic Factors|immunologic factors|mesh-ancestor
92783940|NCT00693433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783941|NCT00693433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783942|NCT00693433|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92783943|NCT00693433|Antifungal Agents|antifungal agents|mesh-ancestor
92783944|NCT05414422|Ketamine|ketamine|mesh-list
92783945|NCT05414422|Analgesics|analgesics|mesh-ancestor
92783946|NCT05414422|Sensory System Agents|sensory system agents|mesh-ancestor
92783947|NCT05414422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92783948|NCT05414422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783949|NCT05414422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92783950|NCT05414422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92783951|NCT05414422|Anesthetics, General|anesthetics, general|mesh-ancestor
92783952|NCT05414422|Anesthetics|anesthetics|mesh-ancestor
92783953|NCT05414422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92783954|NCT05414422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92783955|NCT05414422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92783956|NCT05414422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92783957|NCT05414422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783958|NCT00872599|Fenofibrate|fenofibrate|mesh-list
92783959|NCT00872599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92783960|NCT00872599|Antimetabolites|antimetabolites|mesh-ancestor
92783961|NCT00872599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783962|NCT00872599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92783963|NCT02623621|Bevacizumab|bevacizumab|mesh-list
92783964|NCT02623621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92783965|NCT02623621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783966|NCT02623621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92783967|NCT02623621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92783968|NCT02623621|Growth Substances|growth substances|mesh-ancestor
92783969|NCT02623621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783970|NCT02623621|Growth Inhibitors|growth inhibitors|mesh-ancestor
92783971|NCT00693589|Folic Acid|folic acid|mesh-list
92783973|NCT00693589|Hydroxocobalamin|hydroxocobalamin|mesh-list
92783974|NCT00693589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92783975|NCT00693589|Vitamins|vitamins|mesh-ancestor
92783976|NCT00693589|Micronutrients|micronutrients|mesh-ancestor
92783977|NCT00693589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92783978|NCT00693589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92783979|NCT00693589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92783980|NCT00693589|Antimetabolites|antimetabolites|mesh-ancestor
92783981|NCT00693589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783982|NCT00693589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92783983|NCT00693589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92783984|NCT00693589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783985|NCT00693589|Hematinics|hematinics|mesh-ancestor
92783986|NCT00693589|Vitamin B Complex|vitamin b complex|mesh-ancestor
92783987|NCT01148537|Moxifloxacin|moxifloxacin|mesh-list
92783988|NCT01148537|Buprenorphine|buprenorphine|mesh-list
92783989|NCT01148537|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92783990|NCT01148537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92783991|NCT01148537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92783992|NCT01148537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92783993|NCT01148537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92783994|NCT01148537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92783995|NCT01148537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92783996|NCT01148537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92783997|NCT01148537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92783998|NCT01148537|Contraceptive Agents|contraceptive agents|mesh-ancestor
92783999|NCT01148537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92784000|NCT01148537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784001|NCT01148537|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92784002|NCT01148537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92784003|NCT01148537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92784004|NCT01148537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92784005|NCT01148537|Narcotics|narcotics|mesh-ancestor
92784006|NCT01148537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784007|NCT01148537|Analgesics|analgesics|mesh-ancestor
92530543|NCT00017628|Cyclophosphamide|cyclophosphamide|mesh-list
92784008|NCT01148537|Sensory System Agents|sensory system agents|mesh-ancestor
92784009|NCT01148537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784010|NCT01148537|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92784011|NCT02793544|Mycophenolic Acid|mycophenolic acid|mesh-list
92784012|NCT02793544|Sirolimus|sirolimus|mesh-list
92784013|NCT02793544|Cyclophosphamide|cyclophosphamide|mesh-list
92784014|NCT02793544|Busulfan|busulfan|mesh-list
92784015|NCT02793544|Fludarabine|fludarabine|mesh-list
92784016|NCT02793544|Mesna|mesna|mesh-list
92784017|NCT02793544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784018|NCT02793544|Immunologic Factors|immunologic factors|mesh-ancestor
92784019|NCT02793544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784020|NCT02793544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784021|NCT02793544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784022|NCT02793544|Alkylating Agents|alkylating agents|mesh-ancestor
92784023|NCT02793544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784024|NCT02793544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784025|NCT02793544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92784026|NCT02793544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92784027|NCT02793544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92784028|NCT02793544|Antitubercular Agents|antitubercular agents|mesh-ancestor
92784029|NCT02793544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784030|NCT02793544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784031|NCT02793544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784032|NCT02793544|Antifungal Agents|antifungal agents|mesh-ancestor
92784033|NCT02793544|Protective Agents|protective agents|mesh-ancestor
92784034|NCT02793388|Primaquine|primaquine|mesh-list
92784035|NCT02793388|Antimalarials|antimalarials|mesh-ancestor
92784036|NCT02793388|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92784037|NCT02793388|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92784038|NCT02793388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784039|NCT02689882|Niacinamide|niacinamide|mesh-list
92784040|NCT02689882|Niacin|niacin|mesh-list
92784041|NCT02689882|Nicotinic Acids|nicotinic acids|mesh-list
92784042|NCT02689882|Vitamin B Complex|vitamin b complex|mesh-ancestor
92784043|NCT02689882|Vitamins|vitamins|mesh-ancestor
92784044|NCT02689882|Micronutrients|micronutrients|mesh-ancestor
92784045|NCT02689882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784046|NCT02689882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92784047|NCT02689882|Antimetabolites|antimetabolites|mesh-ancestor
92784048|NCT02689882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784049|NCT02689882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92784050|NCT02689882|Vasodilator Agents|vasodilator agents|mesh-ancestor
92784051|NCT02789644|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92784052|NCT02789644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92784053|NCT02789644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92784054|NCT04234594|Panitumumab|panitumumab|mesh-list
92784055|NCT04234594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784056|NCT04234594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784057|NCT02789488|Fenugreek seed meal|fenugreek seed meal|mesh-list
92784058|NCT02789488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92784059|NCT02789488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784060|NCT04233346|Ponatinib|ponatinib|mesh-list
92784061|NCT04233346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784062|NCT04233346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784063|NCT04233346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784064|NCT04233346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784065|NCT01148459|Vaccines|vaccines|mesh-list
92784066|NCT01148459|Immunologic Factors|immunologic factors|mesh-ancestor
92784067|NCT01148459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784068|NCT03913234|Trastuzumab|trastuzumab|mesh-list
92784069|NCT03913234|Letrozole|letrozole|mesh-list
92784070|NCT03913234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784071|NCT03913234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784072|NCT03913234|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92530544|NCT00017628|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92784073|NCT03913234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92784074|NCT03913234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784075|NCT03913234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784076|NCT03913234|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92784077|NCT03913234|Hormone Antagonists|hormone antagonists|mesh-ancestor
92784078|NCT03913234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784079|NCT03913234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784080|NCT03854500|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92784081|NCT03854500|Tenecteplase|tenecteplase|mesh-list
92784082|NCT03854500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92784083|NCT03854500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92784084|NCT03854500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784086|NCT02789332|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92784087|NCT02789332|Cyclophosphamide|cyclophosphamide|mesh-list
92784088|NCT02789332|Carboplatin|carboplatin|mesh-list
92784089|NCT02789332|Epirubicin|epirubicin|mesh-list
92784090|NCT02789332|Olaparib|olaparib|mesh-list
92784091|NCT02789332|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92784092|NCT02789332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784093|NCT02789332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92784094|NCT02789332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92784095|NCT02789332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784096|NCT02789332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784097|NCT02789332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784098|NCT02789332|Immunologic Factors|immunologic factors|mesh-ancestor
92784099|NCT02789332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784100|NCT02789332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784101|NCT02789332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784102|NCT02789332|Alkylating Agents|alkylating agents|mesh-ancestor
92784103|NCT02789332|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92784104|NCT02789332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92784105|NCT02789332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784106|NCT02789332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784107|NCT02789332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784108|NCT02789332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92784109|NCT02792140|Naltrexone|naltrexone|mesh-list
92784110|NCT02792140|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92784111|NCT02792140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92784112|NCT02792140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784113|NCT02792140|Sensory System Agents|sensory system agents|mesh-ancestor
92784114|NCT02792140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784115|NCT02791594|Pembrolizumab|pembrolizumab|mesh-list
92784116|NCT02791594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92784117|NCT02791594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784118|NCT02791594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92784119|NCT02791594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784120|NCT04234516|Morphine|morphine|mesh-list
92784121|NCT04234516|Buprenorphine|buprenorphine|mesh-list
92784122|NCT04234516|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92784123|NCT04234516|Naloxone|naloxone|mesh-list
92784124|NCT04234516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92784125|NCT04234516|Narcotics|narcotics|mesh-ancestor
92784126|NCT04234516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784127|NCT04234516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784128|NCT04234516|Analgesics|analgesics|mesh-ancestor
92784129|NCT04234516|Sensory System Agents|sensory system agents|mesh-ancestor
92784130|NCT04234516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784131|NCT04234516|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92784132|NCT02789566|Primaquine|primaquine|mesh-list
92784133|NCT02789566|Antimalarials|antimalarials|mesh-ancestor
92784134|NCT02789566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92784135|NCT02789566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92784136|NCT02789566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784137|NCT00697021|Aspirin|aspirin|mesh-list
92784138|NCT00697021|Clopidogrel|clopidogrel|mesh-list
92784139|NCT00697021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92784140|NCT00697021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92784141|NCT00697021|Analgesics|analgesics|mesh-ancestor
92530556|NCT00017628|Antiemetics|antiemetics|mesh-ancestor
92784142|NCT00697021|Sensory System Agents|sensory system agents|mesh-ancestor
92784143|NCT00697021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92784144|NCT00697021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784145|NCT00697021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784146|NCT00697021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784147|NCT00697021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92784148|NCT00697021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92784149|NCT00697021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784150|NCT00697021|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92784151|NCT00697021|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92784152|NCT00697021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784153|NCT00697021|Antipyretics|antipyretics|mesh-ancestor
92784154|NCT00697021|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92784155|NCT00697021|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92784156|NCT00697021|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92784157|NCT00697021|Purinergic Agents|purinergic agents|mesh-ancestor
92784158|NCT00697021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784159|NCT02620345|Dydrogesterone|dydrogesterone|mesh-list
92784160|NCT02620345|Progestins|progestins|mesh-ancestor
92784161|NCT02620345|Hormones|hormones|mesh-ancestor
92784162|NCT02620345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92784163|NCT02620345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784164|NCT00696163|Insulin Aspart|insulin aspart|mesh-list
92784165|NCT00696163|Biphasic Insulins|biphasic insulins|mesh-list
92784166|NCT00696163|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92784167|NCT00696163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92784168|NCT00696163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784169|NCT02790580|Cyclophosphamide|cyclophosphamide|mesh-list
92784170|NCT02790580|Doxorubicin|doxorubicin|mesh-list
92784171|NCT02790580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92784172|NCT02790580|Sunitinib|sunitinib|mesh-list
92784173|NCT02790580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92784174|NCT02790580|Immunologic Factors|immunologic factors|mesh-ancestor
92784175|NCT02790580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784176|NCT02790580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784177|NCT02790580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92784178|NCT02790580|Alkylating Agents|alkylating agents|mesh-ancestor
92784179|NCT02790580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784180|NCT02790580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784181|NCT02790580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92784182|NCT02790580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92784183|NCT02790580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92784184|NCT02790580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92784185|NCT02790580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784186|NCT02790580|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92784187|NCT02790580|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92784188|NCT02790580|Growth Substances|growth substances|mesh-ancestor
92784189|NCT02790580|Growth Inhibitors|growth inhibitors|mesh-ancestor
92784190|NCT02790580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784191|NCT02788864|Piperaquine|piperaquine|mesh-list
92339827|NCT00002417|Amprenavir|amprenavir|mesh-list
92784192|NCT02788864|Antimalarials|antimalarials|mesh-ancestor
92784193|NCT02788864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92784194|NCT02788864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92784195|NCT02788864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784196|NCT02788786|Chlorhexidine|chlorhexidine|mesh-list
92784197|NCT02788786|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92784198|NCT02788786|Cetylpyridinium|cetylpyridinium|mesh-list
92784199|NCT02788786|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92784200|NCT02788786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784201|NCT02788786|Disinfectants|disinfectants|mesh-ancestor
92784202|NCT02788786|Dermatologic Agents|dermatologic agents|mesh-ancestor
92784204|NCT02623465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92784205|NCT02623465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784206|NCT00693979|Paclitaxel|paclitaxel|mesh-list
92784207|NCT00693979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92784208|NCT00693979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784209|NCT00693979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92784210|NCT00693979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92784211|NCT00693979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92784212|NCT00693979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784213|NCT04232800|Riboflavin|riboflavin|mesh-list
92784214|NCT04232800|Vitamins|vitamins|mesh-ancestor
92784216|NCT04232800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784217|NCT04232800|Vitamin B Complex|vitamin b complex|mesh-ancestor
92784218|NCT04232800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92784219|NCT04232800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92784220|NCT01148225|Adalimumab|adalimumab|mesh-list
92784221|NCT01148225|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92784222|NCT01148225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92784223|NCT01148225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92784224|NCT02788240|Meropenem|meropenem|mesh-list
92784225|NCT02788240|Terlipressin|terlipressin|mesh-list
92784226|NCT02788240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784227|NCT02788240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784228|NCT02788240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92784229|NCT02788240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92784230|NCT04134715|Contraceptive Agents|contraceptive agents|mesh-list
92784231|NCT04134715|Contraceptives, Oral|contraceptives, oral|mesh-list
92784232|NCT04134715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92784233|NCT04134715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784234|NCT04134715|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92784235|NCT02884115|Penicillins|penicillins|mesh-list
92784236|NCT02884115|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92784237|NCT02884115|Penicillin G|penicillin g|mesh-list
92784238|NCT02884115|Penicillin G Procaine|penicillin g procaine|mesh-list
92784239|NCT02884115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92784240|NCT02884115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92784241|NCT01190813|Levodopa|levodopa|mesh-list
92784242|NCT01190813|Carbidopa|carbidopa|mesh-list
92784243|NCT01190813|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92784244|NCT01190813|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92784245|NCT01190813|Dopamine Agents|dopamine agents|mesh-ancestor
92784246|NCT01190813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784247|NCT01190813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784248|NCT01190813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784249|NCT01190813|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92784250|NCT01190813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784251|NCT03641326|Sunitinib|sunitinib|mesh-list
92784252|NCT03641326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92784253|NCT03641326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92784254|NCT03641326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92784255|NCT03641326|Growth Substances|growth substances|mesh-ancestor
92784256|NCT03641326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784257|NCT03641326|Growth Inhibitors|growth inhibitors|mesh-ancestor
92784258|NCT03641326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92784259|NCT03641326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92784260|NCT03641326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784261|NCT00870727|Aripiprazole|aripiprazole|mesh-list
92784262|NCT00870727|Antidepressive Agents|antidepressive agents|mesh-ancestor
92784263|NCT00870727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92784264|NCT00870727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92784265|NCT00870727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92784266|NCT00870727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92784267|NCT00870727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92784268|NCT00870727|Dopamine Agonists|dopamine agonists|mesh-ancestor
92784269|NCT00870727|Dopamine Agents|dopamine agents|mesh-ancestor
92784270|NCT00870727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92784271|NCT00870727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92784272|NCT00870727|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92784273|NCT00870727|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92784274|NCT00870727|Serotonin Agents|serotonin agents|mesh-ancestor
92784275|NCT00870727|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93060727|NCT02531490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93060728|NCT02531490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060729|NCT02531490|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060730|NCT02531490|Tocolytic Agents|tocolytic agents|mesh-ancestor
93060731|NCT02531490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93060732|NCT02531490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93060733|NCT02531490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93060734|NCT02531490|Adrenergic Agents|adrenergic agents|mesh-ancestor
93060735|NCT02531490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060736|NCT02531490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93060737|NCT02531490|Sympathomimetics|sympathomimetics|mesh-ancestor
93060738|NCT02531490|Autonomic Agents|autonomic agents|mesh-ancestor
93060739|NCT02531490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060740|NCT02531490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93060741|NCT02531490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93060742|NCT02531490|Sympatholytics|sympatholytics|mesh-ancestor
93060743|NCT02531490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93060744|NCT02531490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93060745|NCT02531490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93060747|NCT03871114|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93060748|NCT03871114|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93060749|NCT03871114|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93060750|NCT03871114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060751|NCT03871114|Glucocorticoids|glucocorticoids|mesh-ancestor
93060752|NCT03871114|Hormones|hormones|mesh-ancestor
93060753|NCT03871114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060754|NCT03871114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060755|NCT03871114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060756|NCT03871114|Immunologic Factors|immunologic factors|mesh-ancestor
93060757|NCT03871114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060758|NCT03871114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060759|NCT01281748|Methylprednisolone|methylprednisolone|mesh-list
93060760|NCT01281748|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93060761|NCT01281748|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93060762|NCT01281748|Prednisolone|prednisolone|mesh-list
93060763|NCT01281748|Prednisolone acetate|prednisolone acetate|mesh-list
93060764|NCT01281748|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93060765|NCT01281748|Prednisolone phosphate|prednisolone phosphate|mesh-list
93060766|NCT01281748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060767|NCT01281748|Antiemetics|antiemetics|mesh-ancestor
93060768|NCT01281748|Autonomic Agents|autonomic agents|mesh-ancestor
93060769|NCT01281748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060770|NCT01281748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060771|NCT01281748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060772|NCT01281748|Glucocorticoids|glucocorticoids|mesh-ancestor
93060773|NCT01281748|Hormones|hormones|mesh-ancestor
93060774|NCT01281748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060775|NCT01281748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93060776|NCT01281748|Protective Agents|protective agents|mesh-ancestor
93060777|NCT01281748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060778|NCT01281748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060779|NCT00220740|Immunoglobulins|immunoglobulins|mesh-list
93060780|NCT00220740|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93060781|NCT00220740|Antibodies|antibodies|mesh-list
93060782|NCT00220740|gamma-Globulins|gamma-globulins|mesh-list
93060783|NCT00220740|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93060784|NCT00220740|Immunoglobulin G|immunoglobulin g|mesh-list
93060785|NCT00220740|Immunologic Factors|immunologic factors|mesh-ancestor
93060786|NCT00220740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060787|NCT01273402|Antibodies|antibodies|mesh-list
93060788|NCT01273402|Immunoglobulins|immunoglobulins|mesh-list
93060789|NCT01273402|Antibodies, Bispecific|antibodies, bispecific|mesh-list
93060790|NCT01273402|Immunologic Factors|immunologic factors|mesh-ancestor
93060791|NCT01273402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060792|NCT03873298|Nitric Oxide|nitric oxide|mesh-list
93060793|NCT03873298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93060794|NCT03873298|Autonomic Agents|autonomic agents|mesh-ancestor
93060795|NCT03873298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060796|NCT03873298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060797|NCT03873298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93060798|NCT03873298|Respiratory System Agents|respiratory system agents|mesh-ancestor
93060799|NCT03873298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93060800|NCT03873298|Antioxidants|antioxidants|mesh-ancestor
93060801|NCT03873298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060802|NCT03873298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060803|NCT03873298|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93060804|NCT03873298|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060805|NCT03873298|Gasotransmitters|gasotransmitters|mesh-ancestor
93060806|NCT03873298|Protective Agents|protective agents|mesh-ancestor
93060807|NCT00184002|Prednisone|prednisone|mesh-list
93060808|NCT00184002|Cyclophosphamide|cyclophosphamide|mesh-list
93060809|NCT00184002|Doxorubicin|doxorubicin|mesh-list
93060810|NCT00184002|Vincristine|vincristine|mesh-list
93060811|NCT00184002|Rituximab|rituximab|mesh-list
93060812|NCT00184002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93060813|NCT00184002|Immunologic Factors|immunologic factors|mesh-ancestor
93060814|NCT00184002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060815|NCT00184002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060816|NCT00184002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93060817|NCT00184002|Alkylating Agents|alkylating agents|mesh-ancestor
93060818|NCT00184002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060819|NCT00184002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060820|NCT00184002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93060821|NCT00184002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93060822|NCT00184002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93060823|NCT00184002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93060824|NCT00184002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060825|NCT00184002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060826|NCT00184002|Glucocorticoids|glucocorticoids|mesh-ancestor
93060827|NCT00184002|Hormones|hormones|mesh-ancestor
93060828|NCT00184002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060829|NCT00184002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060830|NCT00184002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93060831|NCT00184002|Tubulin Modulators|tubulin modulators|mesh-ancestor
93060832|NCT00184002|Antimitotic Agents|antimitotic agents|mesh-ancestor
93060833|NCT00184002|Mitosis Modulators|mitosis modulators|mesh-ancestor
93060834|NCT00184002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93060835|NCT01167946|Methylprednisolone|methylprednisolone|mesh-list
93060836|NCT01167946|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93060837|NCT01167946|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93060838|NCT01167946|Prednisolone|prednisolone|mesh-list
93060839|NCT01167946|Prednisolone acetate|prednisolone acetate|mesh-list
93060840|NCT01167946|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93060841|NCT01167946|Prednisolone phosphate|prednisolone phosphate|mesh-list
93060842|NCT01167946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060843|NCT01167946|Antiemetics|antiemetics|mesh-ancestor
93060844|NCT01167946|Autonomic Agents|autonomic agents|mesh-ancestor
93060845|NCT01167946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060846|NCT01167946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060847|NCT01167946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060848|NCT01167946|Glucocorticoids|glucocorticoids|mesh-ancestor
93060849|NCT01167946|Hormones|hormones|mesh-ancestor
93060850|NCT01167946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060851|NCT01167946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93060852|NCT01167946|Protective Agents|protective agents|mesh-ancestor
93060853|NCT01167946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060854|NCT01167946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060855|NCT01275508|Adalimumab|adalimumab|mesh-list
93060856|NCT01275508|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93060857|NCT01275508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060858|NCT01275508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060859|NCT01073670|Acetaminophen|acetaminophen|mesh-list
93060860|NCT01073670|Indomethacin|indomethacin|mesh-list
93060861|NCT01073670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93060862|NCT01073670|Analgesics|analgesics|mesh-ancestor
93060863|NCT01073670|Sensory System Agents|sensory system agents|mesh-ancestor
93060864|NCT01073670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060865|NCT01073670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060866|NCT01073670|Antipyretics|antipyretics|mesh-ancestor
93060867|NCT01073670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93060868|NCT01073670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060869|NCT01073670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060870|NCT01073670|Gout Suppressants|gout suppressants|mesh-ancestor
93060871|NCT01073670|Tocolytic Agents|tocolytic agents|mesh-ancestor
93060872|NCT01073670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93060873|NCT01073670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93060874|NCT01073670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060875|NCT01073670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060876|NCT03971370|Vaccines|vaccines|mesh-list
93060877|NCT03971370|Immunologic Factors|immunologic factors|mesh-ancestor
93060878|NCT03971370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060879|NCT01168336|Betahistine|betahistine|mesh-list
93060880|NCT01168336|Vasodilator Agents|vasodilator agents|mesh-ancestor
93060881|NCT01168336|Histamine Agonists|histamine agonists|mesh-ancestor
93060882|NCT01168336|Histamine Agents|histamine agents|mesh-ancestor
93060883|NCT01168336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060884|NCT01168336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060885|NCT01168336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060886|NCT00165672|Rabeprazole|rabeprazole|mesh-list
93060887|NCT00165672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93060888|NCT00165672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060889|NCT00165672|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93060890|NCT00165672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93060891|NCT00165672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060892|NCT03870646|Hyaluronic Acid|hyaluronic acid|mesh-list
93060893|NCT03870646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93060894|NCT03870646|Immunologic Factors|immunologic factors|mesh-ancestor
93060895|NCT03870646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060896|NCT03870646|Viscosupplements|viscosupplements|mesh-ancestor
93060897|NCT03870646|Protective Agents|protective agents|mesh-ancestor
93060898|NCT01168492|Ketamine|ketamine|mesh-list
93060899|NCT01168492|Analgesics|analgesics|mesh-ancestor
93060900|NCT01168492|Sensory System Agents|sensory system agents|mesh-ancestor
93060901|NCT01168492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060902|NCT01168492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060903|NCT01168492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93060904|NCT01168492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93060905|NCT01168492|Anesthetics, General|anesthetics, general|mesh-ancestor
93060906|NCT01168492|Anesthetics|anesthetics|mesh-ancestor
93060907|NCT01168492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060908|NCT01168492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93060909|NCT01168492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93060910|NCT01168492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93060911|NCT01168492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060912|NCT03870490|Cefepime|cefepime|mesh-list
93060913|NCT03870490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93060914|NCT03870490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93060915|NCT01278082|Budesonide|budesonide|mesh-list
93060916|NCT01278082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060917|NCT01278082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93060918|NCT01278082|Autonomic Agents|autonomic agents|mesh-ancestor
93060919|NCT01278082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060920|NCT01278082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060921|NCT01278082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93060922|NCT01278082|Respiratory System Agents|respiratory system agents|mesh-ancestor
93060923|NCT01278082|Glucocorticoids|glucocorticoids|mesh-ancestor
93060924|NCT01278082|Hormones|hormones|mesh-ancestor
93060925|NCT01278082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060926|NCT03870256|Misoprostol|misoprostol|mesh-list
93060927|NCT03870256|Carbetocin|carbetocin|mesh-list
93060928|NCT03870256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93060929|NCT03870256|Abortifacient Agents|abortifacient agents|mesh-ancestor
93060930|NCT03870256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93060931|NCT03870256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060932|NCT03870256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93060933|NCT03870256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060934|NCT03870256|Oxytocics|oxytocics|mesh-ancestor
93060935|NCT01166542|Paclitaxel|paclitaxel|mesh-list
93060936|NCT01166542|Carboplatin|carboplatin|mesh-list
93060937|NCT01166542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93060938|NCT01166542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060939|NCT01166542|Tubulin Modulators|tubulin modulators|mesh-ancestor
93060940|NCT01166542|Antimitotic Agents|antimitotic agents|mesh-ancestor
93060941|NCT01166542|Mitosis Modulators|mitosis modulators|mesh-ancestor
93060942|NCT01166542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060943|NCT00169104|Trastuzumab|trastuzumab|mesh-list
93060944|NCT00169104|Vinorelbine|vinorelbine|mesh-list
93060945|NCT00169104|Lenograstim|lenograstim|mesh-list
93060946|NCT00169104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93060947|NCT00169104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060948|NCT00169104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93060949|NCT00169104|Immunologic Factors|immunologic factors|mesh-ancestor
93060950|NCT00169104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060951|NCT00169104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93060952|NCT00169104|Tubulin Modulators|tubulin modulators|mesh-ancestor
93060953|NCT00169104|Antimitotic Agents|antimitotic agents|mesh-ancestor
93060954|NCT00169104|Mitosis Modulators|mitosis modulators|mesh-ancestor
93060955|NCT00169104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93060956|NCT03872830|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
93060957|NCT03872830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93060958|NCT03872830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93060959|NCT03872830|Analgesics|analgesics|mesh-ancestor
93060960|NCT03872830|Sensory System Agents|sensory system agents|mesh-ancestor
93060961|NCT03872830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060962|NCT03872830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060963|NCT03872830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060964|NCT03872830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93060965|NCT02526316|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93060966|NCT02526316|Freund's Adjuvant|freund's adjuvant|mesh-list
93060967|NCT02526316|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93060968|NCT02526316|Immunologic Factors|immunologic factors|mesh-ancestor
93060969|NCT02526316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060970|NCT03872596|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93060971|NCT03872596|Antidepressive Agents|antidepressive agents|mesh-ancestor
93060972|NCT03872596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93060973|NCT03872596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93060974|NCT03872596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93060975|NCT03872596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93060976|NCT03872596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060977|NCT00163020|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93060978|NCT00163020|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93060979|NCT00163020|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93060980|NCT00163020|Hormone Antagonists|hormone antagonists|mesh-ancestor
93060981|NCT00163020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060982|NCT00163020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060983|NCT00163020|Progestins|progestins|mesh-ancestor
93060985|NCT01168804|Dexamethasone|dexamethasone|mesh-list
93060986|NCT01168804|Bortezomib|bortezomib|mesh-list
93060987|NCT01168804|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93060988|NCT01168804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93060989|NCT01168804|Antiemetics|antiemetics|mesh-ancestor
93060990|NCT01168804|Autonomic Agents|autonomic agents|mesh-ancestor
93060991|NCT01168804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93060992|NCT01168804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93060993|NCT01168804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93060994|NCT01168804|Glucocorticoids|glucocorticoids|mesh-ancestor
93060995|NCT01168804|Hormones|hormones|mesh-ancestor
93060996|NCT01168804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93060997|NCT01168804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93060998|NCT01168804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93060999|NCT01168804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93061000|NCT01168804|Alkylating Agents|alkylating agents|mesh-ancestor
93061001|NCT01168804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061002|NCT03873532|Capecitabine|capecitabine|mesh-list
93061003|NCT03873532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93061004|NCT03873532|Antimetabolites|antimetabolites|mesh-ancestor
93061005|NCT03873532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061006|NCT03873532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061007|NCT01282528|Infliximab|infliximab|mesh-list
93061008|NCT01282528|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93061009|NCT01282528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061010|NCT01282528|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061011|NCT01282528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061012|NCT01282528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061013|NCT01169506|Silicon|silicon|mesh-list
93061014|NCT01169506|Trace Elements|trace elements|mesh-ancestor
93061015|NCT01169506|Micronutrients|micronutrients|mesh-ancestor
93061016|NCT01169506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061017|NCT01169740|Bilirubin|bilirubin|mesh-list
93061018|NCT01169740|Antioxidants|antioxidants|mesh-ancestor
93061019|NCT01169740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061020|NCT01169740|Protective Agents|protective agents|mesh-ancestor
93061021|NCT01169740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061022|NCT01169584|Molgramostim|molgramostim|mesh-list
93061023|NCT01169584|Sargramostim|sargramostim|mesh-list
93061024|NCT01169584|Immunologic Factors|immunologic factors|mesh-ancestor
93061025|NCT01169584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061026|NCT01169584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061027|NCT01169818|Insulin Glargine|insulin glargine|mesh-list
92527978|NCT00034801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93061028|NCT01169818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93061029|NCT01169818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061030|NCT01282762|Vaccines|vaccines|mesh-list
93061031|NCT01282762|Immunologic Factors|immunologic factors|mesh-ancestor
93061032|NCT01282762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061033|NCT01282840|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92129485|NCT02364804|Aprepitant|aprepitant|mesh-list
93061034|NCT01282840|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93061035|NCT01282840|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93061036|NCT01282840|Cholinergic Agents|cholinergic agents|mesh-ancestor
93061037|NCT01282840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061038|NCT01282840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061039|NCT01282840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061040|NCT01282840|Urological Agents|urological agents|mesh-ancestor
93061041|NCT01172548|Imatinib Mesylate|imatinib mesylate|mesh-list
93061042|NCT01172548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061043|NCT01172548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061044|NCT01172548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061045|NCT01172548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061046|NCT01172626|Valproic Acid|valproic acid|mesh-list
93061047|NCT01172626|Anticonvulsants|anticonvulsants|mesh-ancestor
93061048|NCT01172626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061049|NCT01172626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061050|NCT01172626|GABA Agents|gaba agents|mesh-ancestor
93061051|NCT01172626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061052|NCT01172626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061053|NCT01172626|Antimanic Agents|antimanic agents|mesh-ancestor
93061054|NCT01172626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93061055|NCT01172626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061056|NCT01172626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93061057|NCT01172782|Hydromorphone|hydromorphone|mesh-list
93061058|NCT01172782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93061059|NCT01172782|Narcotics|narcotics|mesh-ancestor
93061060|NCT01172782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061061|NCT01172782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061062|NCT01172782|Analgesics|analgesics|mesh-ancestor
93061063|NCT01172782|Sensory System Agents|sensory system agents|mesh-ancestor
93061064|NCT01172782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061065|NCT03866746|Aflibercept|aflibercept|mesh-list
93061066|NCT03866746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93061067|NCT03866746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93061068|NCT03866746|Growth Substances|growth substances|mesh-ancestor
93061069|NCT03866746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061070|NCT03866746|Growth Inhibitors|growth inhibitors|mesh-ancestor
93061071|NCT03866746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061072|NCT03869398|Calcitriol|calcitriol|mesh-list
93061073|NCT03869398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93061074|NCT03869398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061075|NCT03869398|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93061076|NCT03869398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061077|NCT03869398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061078|NCT03869398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93061079|NCT03869398|Vitamins|vitamins|mesh-ancestor
93061080|NCT03869398|Micronutrients|micronutrients|mesh-ancestor
93061081|NCT03869398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93061082|NCT01170052|Sirolimus|sirolimus|mesh-list
93061083|NCT01170052|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93061084|NCT01170052|Temsirolimus|temsirolimus|mesh-list
93061085|NCT01170052|MTOR Inhibitors|mtor inhibitors|mesh-list
93061086|NCT01170052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93061087|NCT01170052|Alkylating Agents|alkylating agents|mesh-ancestor
93061088|NCT01170052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061089|NCT01170052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061090|NCT01170052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061091|NCT01170052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061092|NCT01170052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061093|NCT01170052|Immunologic Factors|immunologic factors|mesh-ancestor
93061094|NCT01170052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061095|NCT01170052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93061096|NCT01170052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061097|NCT01170052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93061098|NCT01170052|Antifungal Agents|antifungal agents|mesh-ancestor
93061099|NCT01284478|Dexamethasone|dexamethasone|mesh-list
93061100|NCT01284478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061101|NCT01284478|Antiemetics|antiemetics|mesh-ancestor
92527979|NCT00034801|Dopamine Agents|dopamine agents|mesh-ancestor
93061102|NCT01284478|Autonomic Agents|autonomic agents|mesh-ancestor
93061103|NCT01284478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061104|NCT01284478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061105|NCT01284478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061106|NCT01284478|Glucocorticoids|glucocorticoids|mesh-ancestor
93061107|NCT01284478|Hormones|hormones|mesh-ancestor
93061108|NCT01284478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061109|NCT01284478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93061110|NCT01284478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061111|NCT00252720|Candesartan|candesartan|mesh-list
93061112|NCT00252720|Candesartan cilexetil|candesartan cilexetil|mesh-list
93061113|NCT00252720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061114|NCT00252720|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93061115|NCT00252720|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93061116|NCT00252720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061117|NCT01284556|Phenobarbital|phenobarbital|mesh-list
93061118|NCT01284556|Anticonvulsants|anticonvulsants|mesh-ancestor
93061119|NCT01284556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93061120|NCT01284556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061121|NCT01284556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061122|NCT01284556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93061123|NCT01284556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93061124|NCT01284556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061125|NCT01284556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061126|NCT01284556|GABA Modulators|gaba modulators|mesh-ancestor
93061127|NCT01284556|GABA Agents|gaba agents|mesh-ancestor
93061128|NCT01284556|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93061129|NCT01284556|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93061130|NCT01284556|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93061131|NCT01170130|Lidocaine|lidocaine|mesh-list
93061132|NCT01170130|Anesthetics, Local|anesthetics, local|mesh-ancestor
93061133|NCT01170130|Anesthetics|anesthetics|mesh-ancestor
93061134|NCT01170130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061135|NCT01170130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061136|NCT01170130|Sensory System Agents|sensory system agents|mesh-ancestor
93061137|NCT01170130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061138|NCT01170130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93061139|NCT01170130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93061140|NCT01170130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93061141|NCT01170130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061142|NCT01170130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061143|NCT03868852|Apatinib|apatinib|mesh-list
93061144|NCT03868852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061145|NCT03868852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061146|NCT03868852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061147|NCT03868852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061148|NCT01283776|Cyclophosphamide|cyclophosphamide|mesh-list
93061149|NCT01283776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061150|NCT01283776|Immunologic Factors|immunologic factors|mesh-ancestor
93061151|NCT01283776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061152|NCT01283776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061153|NCT01283776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93061154|NCT01283776|Alkylating Agents|alkylating agents|mesh-ancestor
93061155|NCT01283776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061156|NCT01283776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061157|NCT01283776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93061158|NCT01163500|Ubiquinone|ubiquinone|mesh-list
93061159|NCT01163500|Coenzyme Q10|coenzyme q10|mesh-list
93061160|NCT01163500|Micronutrients|micronutrients|mesh-ancestor
93061161|NCT01163500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061162|NCT01163500|Vitamins|vitamins|mesh-ancestor
93061163|NCT01163734|Ranolazine|ranolazine|mesh-list
93061164|NCT01163734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93061165|NCT01163734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061166|NCT01163734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061167|NCT01284868|Propranolol|propranolol|mesh-list
93061168|NCT01284868|Bisoprolol|bisoprolol|mesh-list
93061169|NCT01284868|Mirabegron|mirabegron|mesh-list
93061170|NCT01284868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93061171|NCT01284868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93061172|NCT01284868|Adrenergic Agents|adrenergic agents|mesh-ancestor
93061173|NCT01284868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061174|NCT01284868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061175|NCT01284868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061176|NCT01284868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93061177|NCT01284868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061178|NCT01284868|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061179|NCT01284868|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93061180|NCT01284868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93061181|NCT01284868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93061182|NCT01284868|Urological Agents|urological agents|mesh-ancestor
93061184|NCT01284868|Autonomic Agents|autonomic agents|mesh-ancestor
93061185|NCT01284868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061186|NCT01284868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93061187|NCT01170442|Vitamin D|vitamin d|mesh-list
93061188|NCT01170442|Ergocalciferols|ergocalciferols|mesh-list
93061189|NCT01170442|Cholecalciferol|cholecalciferol|mesh-list
93061190|NCT01170442|Vitamins|vitamins|mesh-list
93061191|NCT01170442|Micronutrients|micronutrients|mesh-ancestor
93061192|NCT01170442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061193|NCT01170442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93061194|NCT01170442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93061195|NCT00252564|Leucovorin|leucovorin|mesh-list
93061196|NCT00252564|Bevacizumab|bevacizumab|mesh-list
93061197|NCT00252564|Cetuximab|cetuximab|mesh-list
93061198|NCT00252564|Fluorouracil|fluorouracil|mesh-list
93061199|NCT00252564|Oxaliplatin|oxaliplatin|mesh-list
93061200|NCT00252564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93061201|NCT00252564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061202|NCT00252564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93061203|NCT00252564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93061204|NCT00252564|Growth Substances|growth substances|mesh-ancestor
93061205|NCT00252564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061206|NCT00252564|Growth Inhibitors|growth inhibitors|mesh-ancestor
93061207|NCT00252564|Antimetabolites|antimetabolites|mesh-ancestor
93061208|NCT00252564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061209|NCT00252564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93061210|NCT00252564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061211|NCT00252564|Immunologic Factors|immunologic factors|mesh-ancestor
93061212|NCT00252564|Antidotes|antidotes|mesh-ancestor
93061213|NCT00252564|Protective Agents|protective agents|mesh-ancestor
93061214|NCT00252564|Vitamin B Complex|vitamin b complex|mesh-ancestor
93061215|NCT00252564|Vitamins|vitamins|mesh-ancestor
93061216|NCT00252564|Micronutrients|micronutrients|mesh-ancestor
93061217|NCT01284946|Deferasirox|deferasirox|mesh-list
93061218|NCT01284946|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93061219|NCT01284946|Chelating Agents|chelating agents|mesh-ancestor
93061220|NCT01284946|Sequestering Agents|sequestering agents|mesh-ancestor
93061221|NCT01284946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061222|NCT01173562|Mebendazole|mebendazole|mesh-list
93061223|NCT01173562|Piperazine|piperazine|mesh-list
93061224|NCT01173562|Piperazine citrate|piperazine citrate|mesh-list
93061225|NCT01173562|DMP 777|dmp 777|mesh-list
93061226|NCT01173562|Antinematodal Agents|antinematodal agents|mesh-ancestor
93061227|NCT01173562|Anthelmintics|anthelmintics|mesh-ancestor
93061228|NCT01173562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93061229|NCT01173562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061230|NCT01173562|Tubulin Modulators|tubulin modulators|mesh-ancestor
93061231|NCT01173562|Antimitotic Agents|antimitotic agents|mesh-ancestor
93061232|NCT01173562|Mitosis Modulators|mitosis modulators|mesh-ancestor
93061233|NCT01173562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061234|NCT01173562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061235|NCT01173562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061236|NCT00166296|Escitalopram|escitalopram|mesh-list
93061237|NCT00166296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93061238|NCT00166296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93061239|NCT00166296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061240|NCT00166296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061241|NCT00166296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061242|NCT00166296|Serotonin Agents|serotonin agents|mesh-ancestor
93061243|NCT00166296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061244|NCT01173640|Midazolam|midazolam|mesh-list
93061245|NCT01173640|Resveratrol|resveratrol|mesh-list
93061246|NCT01173640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93061247|NCT01173640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93061248|NCT01173640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061249|NCT01173640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061250|NCT01173640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92718337|NCT04618497|Ketorolac|ketorolac|mesh-list
93061251|NCT01173640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93061252|NCT01173640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93061253|NCT01173640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93061254|NCT01173640|Anesthetics, General|anesthetics, general|mesh-ancestor
93061256|NCT01173640|GABA Modulators|gaba modulators|mesh-ancestor
93061257|NCT01173640|GABA Agents|gaba agents|mesh-ancestor
93061258|NCT01173640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061259|NCT01173640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061260|NCT01173640|Antioxidants|antioxidants|mesh-ancestor
93061261|NCT01173640|Protective Agents|protective agents|mesh-ancestor
93061262|NCT01173640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061263|NCT01173640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93061264|NCT00252174|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93061265|NCT00252174|Hallucinogens|hallucinogens|mesh-ancestor
93061266|NCT00252174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061267|NCT00252174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93061268|NCT00252174|Serotonin Agents|serotonin agents|mesh-ancestor
93061269|NCT00252174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061270|NCT00252174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061271|NCT00252174|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93061272|NCT00252174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93061273|NCT00252174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061274|NCT00252174|Adrenergic Agents|adrenergic agents|mesh-ancestor
93061275|NCT03868306|Chrysarobin|chrysarobin|mesh-list
93061276|NCT03868306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93061277|NCT03868306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93061278|NCT03868306|Analgesics|analgesics|mesh-ancestor
93061279|NCT03868306|Sensory System Agents|sensory system agents|mesh-ancestor
93061280|NCT03868306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061281|NCT03868306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061282|NCT03868306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061283|NCT03868306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061285|NCT01164046|Heparin|heparin|mesh-list
93061286|NCT01164046|Enoxaparin|enoxaparin|mesh-list
93061287|NCT01164046|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
93061288|NCT01164046|Tinzaparin|tinzaparin|mesh-list
93061289|NCT01164046|Dalteparin|dalteparin|mesh-list
93061290|NCT01164046|Nadroparin|nadroparin|mesh-list
93061291|NCT01164046|Reviparin|reviparin|mesh-list
93061292|NCT01164046|Warfarin|warfarin|mesh-list
93061293|NCT01164046|Acenocoumarol|acenocoumarol|mesh-list
93061294|NCT01164046|Phenprocoumon|phenprocoumon|mesh-list
93061295|NCT01164046|Bemiparin|bemiparin|mesh-list
93061296|NCT01164046|Certoparin|certoparin|mesh-list
93061297|NCT01164046|Vitamins|vitamins|mesh-ancestor
93061298|NCT01164046|Micronutrients|micronutrients|mesh-ancestor
93061299|NCT01164046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061300|NCT01164046|Anticoagulants|anticoagulants|mesh-ancestor
93061301|NCT01164046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93061302|NCT01164046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93061303|NCT01164046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061304|NCT01164046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93061305|NCT01164046|Hemostatics|hemostatics|mesh-ancestor
93061306|NCT01164046|Coagulants|coagulants|mesh-ancestor
93061307|NCT01075464|Paclitaxel|paclitaxel|mesh-list
93061308|NCT01075464|Bevacizumab|bevacizumab|mesh-list
93061309|NCT01075464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93061310|NCT01075464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061311|NCT01075464|Tubulin Modulators|tubulin modulators|mesh-ancestor
93061312|NCT01075464|Antimitotic Agents|antimitotic agents|mesh-ancestor
93061313|NCT01075464|Mitosis Modulators|mitosis modulators|mesh-ancestor
93061314|NCT01075464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061315|NCT01075464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93061316|NCT01075464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93061317|NCT01075464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93061318|NCT01075464|Growth Substances|growth substances|mesh-ancestor
92339974|NCT00002471|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061319|NCT01075464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061320|NCT01075464|Growth Inhibitors|growth inhibitors|mesh-ancestor
93061321|NCT01074996|Leucovorin|leucovorin|mesh-list
93061322|NCT01074996|Antidotes|antidotes|mesh-ancestor
93061323|NCT01074996|Protective Agents|protective agents|mesh-ancestor
93061324|NCT01074996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061325|NCT01074996|Vitamin B Complex|vitamin b complex|mesh-ancestor
93061326|NCT01074996|Vitamins|vitamins|mesh-ancestor
93061327|NCT01074996|Micronutrients|micronutrients|mesh-ancestor
93061328|NCT00160680|Levocetirizine|levocetirizine|mesh-list
93061329|NCT00160680|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93061330|NCT00160680|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93061331|NCT00160680|Histamine Antagonists|histamine antagonists|mesh-ancestor
93061332|NCT00160680|Histamine Agents|histamine agents|mesh-ancestor
92129801|NCT05795491|Clotrimazole|clotrimazole|mesh-list
93061333|NCT00160680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061334|NCT00160680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061335|NCT00160680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061336|NCT00160524|Certolizumab Pegol|certolizumab pegol|mesh-list
93061337|NCT00160524|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93061338|NCT00160524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061339|NCT00160524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061340|NCT00160524|Immunologic Factors|immunologic factors|mesh-ancestor
93061341|NCT00160524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061342|NCT00160524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061343|NCT01077570|Repaglinide|repaglinide|mesh-list
93061344|NCT01077570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93061345|NCT01077570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061346|NCT01075698|Telmisartan|telmisartan|mesh-list
93061347|NCT01075698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061348|NCT01075698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93061349|NCT01075698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93061350|NCT01075698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061351|NCT00159822|Voriconazole|voriconazole|mesh-list
93061352|NCT00159822|Antifungal Agents|antifungal agents|mesh-ancestor
93061353|NCT00159822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061354|NCT00159822|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93061355|NCT00159822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93061356|NCT00159822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061357|NCT00159822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061358|NCT00159822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93061359|NCT00159822|Hormone Antagonists|hormone antagonists|mesh-ancestor
93061360|NCT00159822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061361|NCT00159822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061362|NCT00159822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93061363|NCT00158262|Propranolol|propranolol|mesh-list
93061364|NCT00158262|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93061365|NCT00158262|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93061366|NCT00158262|Adrenergic Agents|adrenergic agents|mesh-ancestor
93061367|NCT00158262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061368|NCT00158262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061369|NCT00158262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061370|NCT00158262|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93061371|NCT00158262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061372|NCT00158262|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061373|NCT03868072|Tofacitinib|tofacitinib|mesh-list
93061374|NCT03868072|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93061375|NCT03868072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061376|NCT03868072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061377|NCT03868072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061378|NCT02526394|Vaccines|vaccines|mesh-list
93061379|NCT02526394|Immunologic Factors|immunologic factors|mesh-ancestor
93061380|NCT02526394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061381|NCT01283932|Pantoprazole|pantoprazole|mesh-list
93061382|NCT01283932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93061383|NCT01283932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061384|NCT01283932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93061385|NCT01283932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061386|NCT01283932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061387|NCT01075308|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
93061388|NCT01075308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061389|NCT01075308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061390|NCT01171300|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93061391|NCT01171300|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93061392|NCT01171300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061393|NCT01171378|Ofatumumab|ofatumumab|mesh-list
93061394|NCT01171378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061395|NCT01171456|Metformin|metformin|mesh-list
93061396|NCT01171456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93061397|NCT01171456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061398|NCT03865888|Cyclosporine|cyclosporine|mesh-list
93061399|NCT03865888|Tacrolimus|tacrolimus|mesh-list
93061400|NCT03865888|Cyclosporins|cyclosporins|mesh-list
93061401|NCT03865888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061402|NCT03865888|Immunologic Factors|immunologic factors|mesh-ancestor
93061403|NCT03865888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061404|NCT03865888|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93061405|NCT03865888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061406|NCT03865888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061407|NCT03865888|Antifungal Agents|antifungal agents|mesh-ancestor
93061408|NCT03865888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061409|NCT03865888|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061410|NCT03865888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061412|NCT01284166|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93061413|NCT01284166|Dorzolamide|dorzolamide|mesh-list
93061414|NCT01284166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93061415|NCT01284166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93061416|NCT01284166|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93061417|NCT01284166|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93061418|NCT01284166|Adrenergic Agents|adrenergic agents|mesh-ancestor
93061419|NCT01284166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061420|NCT01284166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061421|NCT01284166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061422|NCT01284166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93061423|NCT01284166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061424|NCT01284166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93061425|NCT01284166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93061426|NCT01284166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93061427|NCT01284166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93061428|NCT01284166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061429|NCT01285414|Temozolomide|temozolomide|mesh-list
93061430|NCT01285414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93061431|NCT01285414|Alkylating Agents|alkylating agents|mesh-ancestor
93061432|NCT01285414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061433|NCT01285414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061434|NCT01172002|Azathioprine|azathioprine|mesh-list
93061435|NCT01172002|Leflunomide|leflunomide|mesh-list
93061436|NCT01172002|Antimetabolites|antimetabolites|mesh-ancestor
93061437|NCT01172002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061438|NCT01172002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93061439|NCT01172002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061440|NCT01172002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061441|NCT01172002|Immunologic Factors|immunologic factors|mesh-ancestor
93061442|NCT01172002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061443|NCT01172002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061444|NCT01172002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061445|NCT03867994|Carvedilol|carvedilol|mesh-list
93061446|NCT03867994|Atorvastatin|atorvastatin|mesh-list
93061447|NCT03867994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93061448|NCT03867994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93061449|NCT03867994|Antimetabolites|antimetabolites|mesh-ancestor
93061450|NCT03867994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061451|NCT03867994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93061452|NCT03867994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93061453|NCT03867994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061454|NCT03867994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93061455|NCT03867994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93061456|NCT03867994|Adrenergic Agents|adrenergic agents|mesh-ancestor
93061457|NCT03867994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061458|NCT03867994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061459|NCT03867994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061460|NCT03867994|Antioxidants|antioxidants|mesh-ancestor
93061461|NCT03867994|Protective Agents|protective agents|mesh-ancestor
93061462|NCT03867994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93061463|NCT03867994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061464|NCT03867994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93061465|NCT03867994|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061466|NCT03867994|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93061467|NCT03867994|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93061468|NCT01172236|Lactoferrin|lactoferrin|mesh-list
93061469|NCT01172236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061470|NCT02525848|Dexamethasone|dexamethasone|mesh-list
93061471|NCT02525848|Gabapentin|gabapentin|mesh-list
93061472|NCT02525848|Aprepitant|aprepitant|mesh-list
93061473|NCT02525848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061474|NCT02525848|Antiemetics|antiemetics|mesh-ancestor
93061475|NCT02525848|Autonomic Agents|autonomic agents|mesh-ancestor
93061476|NCT02525848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061477|NCT02525848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061478|NCT02525848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061479|NCT02525848|Glucocorticoids|glucocorticoids|mesh-ancestor
93061480|NCT02525848|Hormones|hormones|mesh-ancestor
93061481|NCT02525848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061482|NCT02525848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93061483|NCT02525848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061484|NCT02525848|Analgesics|analgesics|mesh-ancestor
93061485|NCT02525848|Sensory System Agents|sensory system agents|mesh-ancestor
93061486|NCT02525848|Anticonvulsants|anticonvulsants|mesh-ancestor
93061487|NCT02525848|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93061488|NCT02525848|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93061489|NCT02525848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061490|NCT02525848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93061491|NCT02525848|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93061492|NCT02525848|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93061493|NCT02525848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061494|NCT02525848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061495|NCT02525848|Antimanic Agents|antimanic agents|mesh-ancestor
93061496|NCT02525848|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93061497|NCT01269112|Citric Acid|citric acid|mesh-list
93061498|NCT01269112|Sodium Citrate|sodium citrate|mesh-list
93061499|NCT01269112|Anticoagulants|anticoagulants|mesh-ancestor
93061500|NCT01269112|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93061501|NCT01269112|Chelating Agents|chelating agents|mesh-ancestor
93061502|NCT01269112|Sequestering Agents|sequestering agents|mesh-ancestor
93061503|NCT01269112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061504|NCT01174420|Mitomycins|mitomycins|mesh-list
93061505|NCT01174420|Mitomycin|mitomycin|mesh-list
93061506|NCT01174420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93061507|NCT01174420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061508|NCT01174420|Alkylating Agents|alkylating agents|mesh-ancestor
93061509|NCT01174420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061510|NCT01174420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93061511|NCT01174420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061512|NCT01164826|Nabumetone|nabumetone|mesh-list
93061513|NCT01164826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93061514|NCT01164826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93061515|NCT01164826|Analgesics|analgesics|mesh-ancestor
93061516|NCT01164826|Sensory System Agents|sensory system agents|mesh-ancestor
93061517|NCT01164826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061518|NCT01164826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061519|NCT01164826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061520|NCT01164826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061521|NCT01164826|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93061522|NCT01164826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93061523|NCT01164826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061524|NCT01164826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061525|NCT03867370|Lenvatinib|lenvatinib|mesh-list
93061526|NCT03867370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061527|NCT03867370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061528|NCT03867370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061529|NCT03867370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061530|NCT01172392|Interferons|interferons|mesh-list
93061531|NCT01172392|Interferon-alpha|interferon-alpha|mesh-list
93061532|NCT01172392|Interferon alpha-2|interferon alpha-2|mesh-list
93061533|NCT01172392|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93061534|NCT01172392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061535|NCT01172392|Antiviral Agents|antiviral agents|mesh-ancestor
93061536|NCT01172392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061537|NCT01172392|Immunologic Factors|immunologic factors|mesh-ancestor
93061538|NCT01172392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061539|NCT01172470|Carboplatin|carboplatin|mesh-list
93061540|NCT01172470|Gemcitabine|gemcitabine|mesh-list
93061541|NCT01172470|Pemetrexed|pemetrexed|mesh-list
93061542|NCT01172470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061543|NCT01172470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93061544|NCT01172470|Antimetabolites|antimetabolites|mesh-ancestor
93061545|NCT01172470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061546|NCT01172470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061547|NCT01172470|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93061548|NCT01172470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93061550|NCT01175044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92718645|NCT00563238|Metoprolol|metoprolol|mesh-list
93061551|NCT01175044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061553|NCT03864016|Dsuvia|dsuvia|mesh-list
93061554|NCT03864016|Anesthetics|anesthetics|mesh-ancestor
93061555|NCT03864016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061556|NCT03864016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061557|NCT03864016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93061558|NCT03864016|Narcotics|narcotics|mesh-ancestor
93061559|NCT03864016|Analgesics|analgesics|mesh-ancestor
93061560|NCT03864016|Sensory System Agents|sensory system agents|mesh-ancestor
93061561|NCT03864016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061562|NCT03864016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93061563|NCT03864016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93061564|NCT03864016|Anesthetics, General|anesthetics, general|mesh-ancestor
93061565|NCT03860662|Baclofen|baclofen|mesh-list
93061566|NCT03860662|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93061567|NCT03860662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061568|NCT03860662|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93061569|NCT03860662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92340037|NCT00002489|Antimetabolites|antimetabolites|mesh-ancestor
93061570|NCT03860662|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93061571|NCT03860662|GABA Agonists|gaba agonists|mesh-ancestor
93061572|NCT03860662|GABA Agents|gaba agents|mesh-ancestor
93061573|NCT03860662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061574|NCT03860662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061575|NCT01177696|Psychotropic Drugs|psychotropic drugs|mesh-list
93061576|NCT01177852|Diphenhydramine|diphenhydramine|mesh-list
93061577|NCT01177852|Promethazine|promethazine|mesh-list
93061578|NCT01177852|Brompheniramine|brompheniramine|mesh-list
93061579|NCT01177852|Pseudoephedrine|pseudoephedrine|mesh-list
93061580|NCT01177852|Brompheniramine, pseudoephedrine drug combination|brompheniramine, pseudoephedrine drug combination|mesh-list
93061581|NCT01177852|Ephedrine|ephedrine|mesh-list
93061582|NCT01177852|Dipropizine|dipropizine|mesh-list
93061583|NCT01177852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061584|NCT01177852|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93061585|NCT01177852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93061586|NCT01177852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061587|NCT01177852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061588|NCT01177852|Anesthetics, Local|anesthetics, local|mesh-ancestor
93061589|NCT01177852|Anesthetics|anesthetics|mesh-ancestor
93061590|NCT01177852|Sensory System Agents|sensory system agents|mesh-ancestor
93061591|NCT01177852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061592|NCT01177852|Antiemetics|antiemetics|mesh-ancestor
93061593|NCT01177852|Autonomic Agents|autonomic agents|mesh-ancestor
93061594|NCT01177852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061595|NCT01177852|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93061596|NCT01177852|Histamine Antagonists|histamine antagonists|mesh-ancestor
93061597|NCT01177852|Histamine Agents|histamine agents|mesh-ancestor
93061598|NCT01177852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061599|NCT01177852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93061600|NCT01177852|Antipruritics|antipruritics|mesh-ancestor
93061601|NCT01177852|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061602|NCT01177852|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93061603|NCT01177852|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93061604|NCT01177852|Respiratory System Agents|respiratory system agents|mesh-ancestor
93061605|NCT01177852|Nasal Decongestants|nasal decongestants|mesh-ancestor
93061606|NCT01177852|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93061607|NCT01177852|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93061608|NCT01177852|Sympathomimetics|sympathomimetics|mesh-ancestor
93061609|NCT01177852|Adrenergic Agents|adrenergic agents|mesh-ancestor
93061610|NCT01177852|Antitussive Agents|antitussive agents|mesh-ancestor
93061611|NCT03863392|Misoprostol|misoprostol|mesh-list
93061612|NCT03863392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93061613|NCT03863392|Abortifacient Agents|abortifacient agents|mesh-ancestor
93061614|NCT03863392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93061615|NCT03863392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061616|NCT03863392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93061617|NCT03863392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061618|NCT03863392|Oxytocics|oxytocics|mesh-ancestor
93061619|NCT01175200|Lansoprazole|lansoprazole|mesh-list
93061620|NCT01175200|Dexlansoprazole|dexlansoprazole|mesh-list
93061621|NCT01175200|Clopidogrel|clopidogrel|mesh-list
93061622|NCT01175200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
93061623|NCT01175200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93061624|NCT01175200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92130092|NCT04908202|Deucravacitinib|deucravacitinib|mesh-list
93061625|NCT01175200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93061626|NCT01175200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93061627|NCT01175200|Purinergic Agents|purinergic agents|mesh-ancestor
93061628|NCT01175200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061629|NCT01175200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061630|NCT01175200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061631|NCT01175200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93061632|NCT01175200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061633|NCT01175200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93061634|NCT01175200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061636|NCT03863626|Diuretics|diuretics|mesh-ancestor
93061637|NCT03863626|Natriuretic Agents|natriuretic agents|mesh-ancestor
93061638|NCT03863626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340045|NCT00002489|Vitamins|vitamins|mesh-ancestor
93061639|NCT03863626|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
93061640|NCT03863626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061641|NCT03863626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061642|NCT01288378|Caspofungin|caspofungin|mesh-list
93061643|NCT01288378|Antifungal Agents|antifungal agents|mesh-ancestor
93061644|NCT01288378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061645|NCT01288378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061646|NCT01288378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061647|NCT01178320|Niacin|niacin|mesh-list
93061648|NCT01178320|Niacinamide|niacinamide|mesh-list
93061649|NCT01178320|Nicotinic Acids|nicotinic acids|mesh-list
93061650|NCT01178320|Simvastatin|simvastatin|mesh-list
93061651|NCT01178320|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93061652|NCT01178320|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93061653|NCT01178320|Antimetabolites|antimetabolites|mesh-ancestor
93061654|NCT01178320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061655|NCT01178320|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93061656|NCT01178320|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93061657|NCT01178320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061658|NCT01178320|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061659|NCT01178320|Vitamin B Complex|vitamin b complex|mesh-ancestor
93061660|NCT01178320|Vitamins|vitamins|mesh-ancestor
93061661|NCT01178320|Micronutrients|micronutrients|mesh-ancestor
93061662|NCT01178320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061663|NCT01175512|Naltrexone|naltrexone|mesh-list
93061664|NCT01175512|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93061665|NCT01175512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93061666|NCT01175512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061667|NCT01175512|Sensory System Agents|sensory system agents|mesh-ancestor
93061668|NCT01175512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061669|NCT03859570|Pentoxifylline|pentoxifylline|mesh-list
93061670|NCT03859570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93061671|NCT03859570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061672|NCT03859570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061673|NCT03859570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93061674|NCT03859570|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93061675|NCT03859570|Protective Agents|protective agents|mesh-ancestor
93061676|NCT03859570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061677|NCT03859570|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061678|NCT03859570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93061679|NCT03859570|Antioxidants|antioxidants|mesh-ancestor
93061680|NCT03745222|Tislelizumab|tislelizumab|mesh-list
93061681|NCT03745222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93061682|NCT03745222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061683|NCT01286584|Varenicline|varenicline|mesh-list
93061684|NCT01286584|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93061685|NCT01286584|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93061686|NCT01286584|Cholinergic Agents|cholinergic agents|mesh-ancestor
93061687|NCT01286584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92340053|NCT00002495|Doxorubicin|doxorubicin|mesh-list
93061688|NCT01286584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061689|NCT01286584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061690|NCT03743038|Minocycline|minocycline|mesh-list
93061691|NCT03743038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93061692|NCT03743038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061693|NCT03864250|Prednisone|prednisone|mesh-list
93061694|NCT03864250|Tacrolimus|tacrolimus|mesh-list
93061695|NCT03864250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061696|NCT03864250|Glucocorticoids|glucocorticoids|mesh-ancestor
93061697|NCT03864250|Hormones|hormones|mesh-ancestor
93061698|NCT03864250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061699|NCT03864250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061700|NCT03864250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92527980|NCT00014196|Docetaxel|docetaxel|mesh-list
93061701|NCT03864250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061702|NCT03864250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061703|NCT03864250|Immunologic Factors|immunologic factors|mesh-ancestor
93061704|NCT03864250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93061705|NCT03864250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061706|NCT03864250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061708|NCT01175746|Remifentanil|remifentanil|mesh-list
93061709|NCT01175746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93061710|NCT01175746|Narcotics|narcotics|mesh-ancestor
93061711|NCT01175746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061712|NCT01175746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061713|NCT01175746|Analgesics|analgesics|mesh-ancestor
93061714|NCT01175746|Sensory System Agents|sensory system agents|mesh-ancestor
93061715|NCT01175746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061716|NCT01175746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93061717|NCT01175746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93061718|NCT01175746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061719|NCT01175746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061720|NCT01175746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93061721|NCT01175746|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061722|NCT01174810|Exenatide|exenatide|mesh-list
93061723|NCT01174810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93061724|NCT01174810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061725|NCT01174810|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93061726|NCT01174810|Incretins|incretins|mesh-ancestor
93061727|NCT01174810|Hormones|hormones|mesh-ancestor
93061728|NCT01174810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061729|NCT01178710|Simvastatin|simvastatin|mesh-list
93061730|NCT01178710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93061731|NCT01178710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93061732|NCT01178710|Antimetabolites|antimetabolites|mesh-ancestor
93061733|NCT01178710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061734|NCT01178710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93061735|NCT01178710|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93061736|NCT01178710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061737|NCT01174888|Cytarabine|cytarabine|mesh-list
93061738|NCT01174888|Etoposide|etoposide|mesh-list
93061739|NCT01174888|Podophyllotoxin|podophyllotoxin|mesh-list
93061740|NCT01174888|Mitoxantrone|mitoxantrone|mesh-list
93061741|NCT01174888|Etoposide phosphate|etoposide phosphate|mesh-list
93061742|NCT01174888|Bortezomib|bortezomib|mesh-list
93061743|NCT01174888|Midostaurin|midostaurin|mesh-list
93061744|NCT01174888|Staurosporine|staurosporine|mesh-list
93061745|NCT01174888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93061746|NCT01174888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061747|NCT01174888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93061748|NCT01174888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93061749|NCT01174888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061750|NCT01174888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061751|NCT01174888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93061752|NCT01174888|Antimetabolites|antimetabolites|mesh-ancestor
93061753|NCT01174888|Antiviral Agents|antiviral agents|mesh-ancestor
93061754|NCT01174888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061755|NCT01174888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061756|NCT01174888|Immunologic Factors|immunologic factors|mesh-ancestor
93061757|NCT01174888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061758|NCT01174888|Analgesics|analgesics|mesh-ancestor
93061759|NCT01174888|Sensory System Agents|sensory system agents|mesh-ancestor
93061760|NCT01174888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530586|NCT00042679|Carboplatin|carboplatin|mesh-list
93061761|NCT01174888|Keratolytic Agents|keratolytic agents|mesh-ancestor
93061762|NCT01174888|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061763|NCT01174888|Tubulin Modulators|tubulin modulators|mesh-ancestor
93061764|NCT01174888|Antimitotic Agents|antimitotic agents|mesh-ancestor
93061765|NCT01174888|Mitosis Modulators|mitosis modulators|mesh-ancestor
93061766|NCT01174888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061767|NCT01178788|Progesterone|progesterone|mesh-list
93061768|NCT01178788|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
93061769|NCT01178788|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
93061770|NCT01178788|Progestins|progestins|mesh-ancestor
93061771|NCT01178788|Hormones|hormones|mesh-ancestor
93061772|NCT01178788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061773|NCT01178788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061774|NCT01178788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93061775|NCT01178788|Hormone Antagonists|hormone antagonists|mesh-ancestor
93061776|NCT00153816|Vitamin D|vitamin d|mesh-list
93061777|NCT00153816|Cholecalciferol|cholecalciferol|mesh-list
93061778|NCT00153816|Calcium Carbonate|calcium carbonate|mesh-list
93061779|NCT00153816|Calcium|calcium|mesh-list
93061780|NCT00153816|Vitamins|vitamins|mesh-ancestor
93061781|NCT00153816|Micronutrients|micronutrients|mesh-ancestor
93061782|NCT00153816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061783|NCT00153816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93061784|NCT00153816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93061785|NCT00153816|Antacids|antacids|mesh-ancestor
93061786|NCT00153816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061787|NCT00153816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061788|NCT02525146|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
93061789|NCT02525146|Antiviral Agents|antiviral agents|mesh-ancestor
93061790|NCT02525146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061791|NCT01077648|Trastuzumab|trastuzumab|mesh-list
93061792|NCT01077648|Lapatinib|lapatinib|mesh-list
93061793|NCT01077648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93061794|NCT01077648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061795|NCT01077648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061796|NCT01077648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061797|NCT01077648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061798|NCT00151476|Celecoxib|celecoxib|mesh-list
93061799|NCT00151476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93061800|NCT00151476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93061801|NCT00151476|Analgesics|analgesics|mesh-ancestor
93061802|NCT00151476|Sensory System Agents|sensory system agents|mesh-ancestor
93061803|NCT00151476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061804|NCT00151476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061805|NCT00151476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061806|NCT00151476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061807|NCT00151476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93061808|NCT00151476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93061809|NCT00151476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061810|NCT00151476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061811|NCT01077726|Capecitabine|capecitabine|mesh-list
93061812|NCT01077726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93061813|NCT01077726|Antimetabolites|antimetabolites|mesh-ancestor
93061814|NCT01077726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061815|NCT01077726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061816|NCT01179100|Lidocaine|lidocaine|mesh-list
93061817|NCT01179100|Anesthetics, Local|anesthetics, local|mesh-ancestor
93061818|NCT01179100|Anesthetics|anesthetics|mesh-ancestor
93061819|NCT01179100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061820|NCT01179100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061821|NCT01179100|Sensory System Agents|sensory system agents|mesh-ancestor
93061822|NCT01179100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061823|NCT01179100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93061824|NCT01179100|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93061825|NCT01179100|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93061826|NCT01179100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93061827|NCT01179100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061828|NCT03864172|Calcium, Dietary|calcium, dietary|mesh-list
93061829|NCT03864172|Calcium|calcium|mesh-list
93061830|NCT03864172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93061831|NCT03864172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061832|NCT03864172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93061833|NCT02525302|Halofuginone|halofuginone|mesh-list
93061834|NCT02525302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061835|NCT02525302|Coccidiostats|coccidiostats|mesh-ancestor
93061836|NCT02525302|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93061837|NCT02525302|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93061838|NCT02525302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061839|NCT02525302|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93061840|NCT02525302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061841|NCT02525302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061842|NCT02525302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93061843|NCT02525302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93061844|NCT02525302|Growth Substances|growth substances|mesh-ancestor
93061845|NCT02525302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061846|NCT02525302|Growth Inhibitors|growth inhibitors|mesh-ancestor
93061847|NCT01286194|Rabeprazole|rabeprazole|mesh-list
93061848|NCT01286194|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93061849|NCT01286194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061850|NCT01286194|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93061851|NCT01286194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061852|NCT01286194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061853|NCT01179256|Curcumin|curcumin|mesh-list
93061854|NCT01179256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93061855|NCT01179256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93061856|NCT01179256|Analgesics|analgesics|mesh-ancestor
93061857|NCT01179256|Sensory System Agents|sensory system agents|mesh-ancestor
93061858|NCT01179256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061859|NCT01179256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061860|NCT01179256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061861|NCT01179256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061862|NCT01179256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061863|NCT01179256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061864|NCT01179256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061865|NCT01179412|Iodine|iodine|mesh-list
93061866|NCT01179412|Cadexomer iodine|cadexomer iodine|mesh-list
93061867|NCT01179412|Povidone-Iodine|povidone-iodine|mesh-list
93061868|NCT01179412|Povidone|povidone|mesh-list
93061869|NCT01179412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93061870|NCT01179412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061871|NCT01179412|Trace Elements|trace elements|mesh-ancestor
93061872|NCT01179412|Micronutrients|micronutrients|mesh-ancestor
93061873|NCT01179412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061874|NCT01179412|Plasma Substitutes|plasma substitutes|mesh-ancestor
93061875|NCT01179412|Blood Substitutes|blood substitutes|mesh-ancestor
93061876|NCT03862690|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93061877|NCT03862690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93061878|NCT03862690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061879|NCT03862768|Sunitinib|sunitinib|mesh-list
93061880|NCT03862768|Imatinib Mesylate|imatinib mesylate|mesh-list
93061881|NCT03862768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061882|NCT03862768|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93061883|NCT03862768|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93061884|NCT03862768|Growth Substances|growth substances|mesh-ancestor
93061885|NCT03862768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061886|NCT03862768|Growth Inhibitors|growth inhibitors|mesh-ancestor
93061887|NCT03862768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061888|NCT03862768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061889|NCT03862768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061890|NCT03862456|Azithromycin|azithromycin|mesh-list
93061892|NCT03862456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93061893|NCT03862456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061894|NCT03862456|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93061895|NCT03862456|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93061896|NCT03859102|Acetaminophen|acetaminophen|mesh-list
93061897|NCT03859102|Dexamethasone|dexamethasone|mesh-list
93061898|NCT03859102|Gabapentin|gabapentin|mesh-list
93061899|NCT03859102|Ondansetron|ondansetron|mesh-list
93061900|NCT03859102|Anesthetics|anesthetics|mesh-list
93061901|NCT03859102|Anesthetics, Local|anesthetics, local|mesh-list
93061902|NCT03859102|Lansoprazole|lansoprazole|mesh-list
93061903|NCT03859102|Dexlansoprazole|dexlansoprazole|mesh-list
93061904|NCT03859102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061905|NCT03859102|Antiemetics|antiemetics|mesh-ancestor
93061906|NCT03859102|Autonomic Agents|autonomic agents|mesh-ancestor
93061907|NCT03859102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061908|NCT03859102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061909|NCT03859102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061910|NCT03859102|Glucocorticoids|glucocorticoids|mesh-ancestor
93061911|NCT03859102|Hormones|hormones|mesh-ancestor
93061912|NCT03859102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061913|NCT03859102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93061914|NCT03859102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061915|NCT03859102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93061916|NCT03859102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93061917|NCT03859102|Analgesics|analgesics|mesh-ancestor
93061918|NCT03859102|Sensory System Agents|sensory system agents|mesh-ancestor
93061919|NCT03859102|Antipyretics|antipyretics|mesh-ancestor
93061920|NCT03859102|Anticonvulsants|anticonvulsants|mesh-ancestor
93061921|NCT03859102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93061922|NCT03859102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93061923|NCT03859102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93061924|NCT03859102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93061925|NCT03859102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93061926|NCT03859102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061927|NCT03859102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061928|NCT03859102|Antimanic Agents|antimanic agents|mesh-ancestor
93061929|NCT03859102|Antipruritics|antipruritics|mesh-ancestor
93061930|NCT03859102|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061931|NCT03859102|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93061932|NCT03859102|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93061933|NCT03859102|Serotonin Agents|serotonin agents|mesh-ancestor
93061934|NCT03859102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93061935|NCT03859102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93061936|NCT03859102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061937|NCT00149994|Cyclosporine|cyclosporine|mesh-list
93061938|NCT00149994|Prednisone|prednisone|mesh-list
93061939|NCT00149994|Methylprednisolone|methylprednisolone|mesh-list
93061940|NCT00149994|Tacrolimus|tacrolimus|mesh-list
93061941|NCT00149994|Cyclosporins|cyclosporins|mesh-list
93061942|NCT00149994|Basiliximab|basiliximab|mesh-list
93061943|NCT00149994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93061944|NCT00149994|Glucocorticoids|glucocorticoids|mesh-ancestor
93061945|NCT00149994|Hormones|hormones|mesh-ancestor
93061946|NCT00149994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93061947|NCT00149994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061948|NCT00149994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93061949|NCT00149994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061950|NCT00149994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93061951|NCT00149994|Immunologic Factors|immunologic factors|mesh-ancestor
93061952|NCT00149994|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93061953|NCT00149994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340105|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
93061954|NCT00149994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061955|NCT00149994|Antifungal Agents|antifungal agents|mesh-ancestor
93061956|NCT00149994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93061957|NCT00149994|Dermatologic Agents|dermatologic agents|mesh-ancestor
93061958|NCT00149994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93061959|NCT00149994|Antiemetics|antiemetics|mesh-ancestor
93061960|NCT00149994|Autonomic Agents|autonomic agents|mesh-ancestor
93061961|NCT00149994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061962|NCT00149994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061963|NCT00149994|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93061964|NCT00149994|Protective Agents|protective agents|mesh-ancestor
93061965|NCT01179646|Pantoprazole|pantoprazole|mesh-list
93061966|NCT01179646|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93061967|NCT01179646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93061968|NCT01179646|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93061969|NCT01179646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061970|NCT01179646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061971|NCT01075776|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
93061972|NCT01075776|Acetylcholine|acetylcholine|mesh-list
93061973|NCT01075776|Vasodilator Agents|vasodilator agents|mesh-ancestor
93061974|NCT01075776|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93061975|NCT01075776|Cholinergic Agents|cholinergic agents|mesh-ancestor
93061976|NCT01075776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93061977|NCT01075776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061978|NCT01075776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061979|NCT01075776|Natriuretic Agents|natriuretic agents|mesh-ancestor
93061980|NCT01079910|Fluorides|fluorides|mesh-list
93061981|NCT01079910|Cariostatic Agents|cariostatic agents|mesh-ancestor
93061982|NCT01079910|Protective Agents|protective agents|mesh-ancestor
93061983|NCT01079910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061984|NCT01286896|Sunitinib|sunitinib|mesh-list
93061985|NCT01286896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93061986|NCT01286896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93061987|NCT01286896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93061988|NCT01286896|Growth Substances|growth substances|mesh-ancestor
93061989|NCT01286896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061990|NCT01286896|Growth Inhibitors|growth inhibitors|mesh-ancestor
93061991|NCT01286896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93061992|NCT01286896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93061993|NCT01286896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93061994|NCT03857854|Pirfenidone|pirfenidone|mesh-list
93061995|NCT03857854|Analgesics|analgesics|mesh-ancestor
93061996|NCT03857854|Sensory System Agents|sensory system agents|mesh-ancestor
93061997|NCT03857854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93061998|NCT03857854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93061999|NCT03857854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062000|NCT03857854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062001|NCT03857854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062002|NCT03857854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062003|NCT03857854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062004|NCT01287052|Nitrous Oxide|nitrous oxide|mesh-list
93062005|NCT01287052|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93062006|NCT01287052|Anesthetics, General|anesthetics, general|mesh-ancestor
93062007|NCT01287052|Anesthetics|anesthetics|mesh-ancestor
93062008|NCT01287052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062009|NCT01287052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062010|NCT01287052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062011|NCT01287052|Analgesics|analgesics|mesh-ancestor
93062012|NCT01287052|Sensory System Agents|sensory system agents|mesh-ancestor
93062013|NCT01287052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062014|NCT01288924|Parecoxib|parecoxib|mesh-list
93062015|NCT01288924|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93062016|NCT01288924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93062017|NCT01288924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062018|NCT01288924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062019|NCT01288924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062020|NCT01288924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062021|NCT01288924|Analgesics|analgesics|mesh-ancestor
93062022|NCT01288924|Sensory System Agents|sensory system agents|mesh-ancestor
93062023|NCT01288924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062024|NCT01288924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062025|NCT01288924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062026|NCT01288924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062027|NCT01179724|Pantoprazole|pantoprazole|mesh-list
93062028|NCT01179724|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93062029|NCT01179724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93062030|NCT01179724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062031|NCT01179724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062032|NCT01179724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062033|NCT03862612|Anesthetics|anesthetics|mesh-list
93062034|NCT03862612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062035|NCT03862612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062036|NCT01287130|Cetuximab|cetuximab|mesh-list
93062037|NCT01287130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062038|NCT01287130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062039|NCT00149214|Cyclophosphamide|cyclophosphamide|mesh-list
93062040|NCT00149214|Docetaxel|docetaxel|mesh-list
93062041|NCT00149214|Doxorubicin|doxorubicin|mesh-list
93062042|NCT00149214|Pemetrexed|pemetrexed|mesh-list
93062043|NCT00149214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93062044|NCT00149214|Immunologic Factors|immunologic factors|mesh-ancestor
93062045|NCT00149214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062046|NCT00149214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062047|NCT00149214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93062048|NCT00149214|Alkylating Agents|alkylating agents|mesh-ancestor
93062049|NCT00149214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062050|NCT00149214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062051|NCT00149214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93062052|NCT00149214|Tubulin Modulators|tubulin modulators|mesh-ancestor
93062053|NCT00149214|Antimitotic Agents|antimitotic agents|mesh-ancestor
93062054|NCT00149214|Mitosis Modulators|mitosis modulators|mesh-ancestor
93062055|NCT00149214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93062056|NCT00149214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93062057|NCT00149214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93062058|NCT00149214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062059|NCT00149214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93062060|NCT00149214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93062061|NCT03034018|Suvorexant|suvorexant|mesh-list
93062062|NCT03034018|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93062063|NCT03034018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062064|NCT03034018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062065|NCT03034018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062066|NCT03034018|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
93062067|NCT03034018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062068|NCT03034018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062069|NCT02525458|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
93062070|NCT02525458|Vasodilator Agents|vasodilator agents|mesh-ancestor
93062071|NCT02525458|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
93062072|NCT02525458|Protective Agents|protective agents|mesh-ancestor
93062073|NCT02525458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062074|NCT02555254|Methamphetamine|methamphetamine|mesh-list
93062075|NCT02555254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93062076|NCT02555254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062077|NCT02555254|Sympathomimetics|sympathomimetics|mesh-ancestor
93062078|NCT02555254|Autonomic Agents|autonomic agents|mesh-ancestor
93062079|NCT02555254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062080|NCT02555254|Dopamine Agents|dopamine agents|mesh-ancestor
93062081|NCT02555254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062082|NCT02555254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062083|NCT02555254|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062084|NCT02555254|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93062085|NCT02555254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93062086|NCT02555254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062087|NCT02555254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93062088|NCT00114972|Paclitaxel|paclitaxel|mesh-list
93062089|NCT00114972|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93062090|NCT00114972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93062091|NCT00114972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062092|NCT00114972|Tubulin Modulators|tubulin modulators|mesh-ancestor
93062093|NCT00114972|Antimitotic Agents|antimitotic agents|mesh-ancestor
93062094|NCT00114972|Mitosis Modulators|mitosis modulators|mesh-ancestor
93062095|NCT00114972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062096|NCT02444728|Hydroxychloroquine|hydroxychloroquine|mesh-list
93062097|NCT02444728|Methylprednisolone|methylprednisolone|mesh-list
93062098|NCT02444728|Cyclophosphamide|cyclophosphamide|mesh-list
93062099|NCT02444728|Azathioprine|azathioprine|mesh-list
93062100|NCT02444728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93062101|NCT02444728|Immunologic Factors|immunologic factors|mesh-ancestor
93062102|NCT02444728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062103|NCT02444728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062104|NCT02444728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93062105|NCT02444728|Alkylating Agents|alkylating agents|mesh-ancestor
93062106|NCT02444728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062107|NCT02444728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062108|NCT02444728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93062109|NCT02444728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062110|NCT02444728|Antiemetics|antiemetics|mesh-ancestor
93062111|NCT02444728|Autonomic Agents|autonomic agents|mesh-ancestor
93062112|NCT02444728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062113|NCT02444728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062114|NCT02444728|Glucocorticoids|glucocorticoids|mesh-ancestor
93062115|NCT02444728|Hormones|hormones|mesh-ancestor
93062116|NCT02444728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062117|NCT02444728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93062118|NCT02444728|Protective Agents|protective agents|mesh-ancestor
93062119|NCT02444728|Antimalarials|antimalarials|mesh-ancestor
93062120|NCT02444728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93062121|NCT02444728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93062122|NCT02444728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062123|NCT02444728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062124|NCT02444728|Antimetabolites|antimetabolites|mesh-ancestor
93062125|NCT02444728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93062126|NCT00129402|Simvastatin|simvastatin|mesh-list
93062127|NCT00129402|Ezetimibe|ezetimibe|mesh-list
93062128|NCT00129402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93062129|NCT00129402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93062130|NCT00129402|Antimetabolites|antimetabolites|mesh-ancestor
93062131|NCT00129402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062132|NCT00129402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93062133|NCT00129402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93062134|NCT00129402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062135|NCT03739528|Levofloxacin|levofloxacin|mesh-list
93062136|NCT03739528|Ofloxacin|ofloxacin|mesh-list
93062137|NCT03739528|Tobramycin|tobramycin|mesh-list
93062138|NCT03739528|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
93062139|NCT03739528|Dexamethasone|dexamethasone|mesh-list
93062140|NCT03739528|Dexamethasone acetate|dexamethasone acetate|mesh-list
93062141|NCT03739528|BB 1101|bb 1101|mesh-list
93062142|NCT03739528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062143|NCT03739528|Antiemetics|antiemetics|mesh-ancestor
93062144|NCT03739528|Autonomic Agents|autonomic agents|mesh-ancestor
93062145|NCT03739528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062146|NCT03739528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062147|NCT03739528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062148|NCT03739528|Glucocorticoids|glucocorticoids|mesh-ancestor
93062149|NCT03739528|Hormones|hormones|mesh-ancestor
93062150|NCT03739528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062151|NCT03739528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93062152|NCT03739528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340134|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93062153|NCT03739528|Protease Inhibitors|protease inhibitors|mesh-ancestor
93062154|NCT03739528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719237|NCT01165138|Fluticasone|fluticasone|mesh-list
93062155|NCT03739528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062156|NCT03739528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93062157|NCT03739528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062158|NCT03739528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93062159|NCT03739528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93062160|NCT03739528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93062161|NCT03739528|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93062162|NCT03739528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93062163|NCT03739528|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93062164|NCT03739528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93062165|NCT03857386|Anesthetics|anesthetics|mesh-list
93062166|NCT03857386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062167|NCT03857386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062168|NCT01587586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93062169|NCT01587586|Antiviral Agents|antiviral agents|mesh-ancestor
93062170|NCT01587586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062171|NCT01289236|Milnacipran|milnacipran|mesh-list
93062172|NCT01289236|Levomilnacipran|levomilnacipran|mesh-list
93062173|NCT01289236|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93062174|NCT01289236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93062175|NCT01289236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062176|NCT01289236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062177|NCT01289236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062178|NCT01289236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062179|NCT01289236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062180|NCT01289236|Analgesics|analgesics|mesh-ancestor
93062181|NCT01289236|Sensory System Agents|sensory system agents|mesh-ancestor
93062182|NCT01289236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062183|NCT01289236|Antidepressive Agents|antidepressive agents|mesh-ancestor
93062184|NCT01289236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062185|NCT01289938|Diphenhydramine|diphenhydramine|mesh-list
93062186|NCT01289938|Promethazine|promethazine|mesh-list
93062187|NCT01289938|Metoclopramide|metoclopramide|mesh-list
93062188|NCT01289938|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93062189|NCT01289938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062190|NCT01289938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062191|NCT01289938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062192|NCT01289938|Anesthetics, Local|anesthetics, local|mesh-ancestor
93062193|NCT01289938|Anesthetics|anesthetics|mesh-ancestor
93062194|NCT01289938|Sensory System Agents|sensory system agents|mesh-ancestor
93062195|NCT01289938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062196|NCT01289938|Antiemetics|antiemetics|mesh-ancestor
93062197|NCT01289938|Autonomic Agents|autonomic agents|mesh-ancestor
93062198|NCT01289938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062199|NCT01289938|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93062200|NCT01289938|Histamine Antagonists|histamine antagonists|mesh-ancestor
93062201|NCT01289938|Histamine Agents|histamine agents|mesh-ancestor
93062202|NCT01289938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062203|NCT01289938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062204|NCT01289938|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93062205|NCT01289938|Antipruritics|antipruritics|mesh-ancestor
93062206|NCT01289938|Dermatologic Agents|dermatologic agents|mesh-ancestor
93062207|NCT01289938|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93062208|NCT01289938|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93062209|NCT01289938|Dopamine Agents|dopamine agents|mesh-ancestor
93062210|NCT00114738|Rituximab|rituximab|mesh-list
93062211|NCT00114738|Bortezomib|bortezomib|mesh-list
93062212|NCT00114738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062213|NCT00114738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062214|NCT00114738|Immunologic Factors|immunologic factors|mesh-ancestor
93062215|NCT00114738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062216|NCT00114738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062217|NCT01180348|Botulinum Toxins|botulinum toxins|mesh-list
93062218|NCT01180348|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93062219|NCT01180348|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93062220|NCT01180348|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93062221|NCT01180348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062222|NCT01180348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062223|NCT01180348|Cholinergic Agents|cholinergic agents|mesh-ancestor
93062224|NCT01180348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062225|NCT01180348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062226|NCT01180348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93062227|NCT01180348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062228|NCT01180426|Tosedostat|tosedostat|mesh-list
93062229|NCT01180426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062230|NCT01180426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062231|NCT00148122|Docetaxel|docetaxel|mesh-list
93062232|NCT00148122|Capecitabine|capecitabine|mesh-list
93062233|NCT00148122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062234|NCT00148122|Tubulin Modulators|tubulin modulators|mesh-ancestor
93062235|NCT00148122|Antimitotic Agents|antimitotic agents|mesh-ancestor
93062236|NCT00148122|Mitosis Modulators|mitosis modulators|mesh-ancestor
93062237|NCT00148122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062238|NCT00148122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93062239|NCT00148122|Antimetabolites|antimetabolites|mesh-ancestor
93062240|NCT01182142|Capecitabine|capecitabine|mesh-list
93062241|NCT01182142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93062242|NCT01182142|Antimetabolites|antimetabolites|mesh-ancestor
93062243|NCT01182142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062244|NCT01182142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062245|NCT01180816|Temozolomide|temozolomide|mesh-list
93062246|NCT01180816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93062247|NCT01180816|Alkylating Agents|alkylating agents|mesh-ancestor
93062248|NCT01180816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062249|NCT01180816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062250|NCT01287598|Rosiglitazone|rosiglitazone|mesh-list
93062251|NCT01287598|Midazolam|midazolam|mesh-list
93062252|NCT01287598|Omeprazole|omeprazole|mesh-list
93062253|NCT01287598|Warfarin|warfarin|mesh-list
93062254|NCT01287598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93062255|NCT01287598|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062256|NCT01287598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062257|NCT01287598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062258|NCT01287598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93062259|NCT01287598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93062260|NCT01287598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062261|NCT01287598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93062262|NCT01287598|Anesthetics, General|anesthetics, general|mesh-ancestor
93062263|NCT01287598|Anesthetics|anesthetics|mesh-ancestor
93062264|NCT01287598|GABA Modulators|gaba modulators|mesh-ancestor
93062265|NCT01287598|GABA Agents|gaba agents|mesh-ancestor
93062266|NCT01287598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062267|NCT01287598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062268|NCT01287598|Anticoagulants|anticoagulants|mesh-ancestor
93062269|NCT01287598|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93062270|NCT01287598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062271|NCT01287598|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93062272|NCT01287598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062273|NCT01287598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93062274|NCT03862144|Palonosetron|palonosetron|mesh-list
93062275|NCT03862144|Antiemetics|antiemetics|mesh-ancestor
93062276|NCT03862144|Autonomic Agents|autonomic agents|mesh-ancestor
93062277|NCT03862144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062278|NCT03862144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062279|NCT03862144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062280|NCT03862144|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93062281|NCT03862144|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93062282|NCT03862144|Serotonin Agents|serotonin agents|mesh-ancestor
93062283|NCT03862144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062284|NCT03862144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062285|NCT01290172|Somatostatin|somatostatin|mesh-list
93062286|NCT01290172|Hormones|hormones|mesh-ancestor
93062287|NCT01290172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062288|NCT01290172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062289|NCT03861598|Carvedilol|carvedilol|mesh-list
93062290|NCT03861598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93062291|NCT03861598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93062292|NCT03861598|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062293|NCT03861598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062294|NCT03861598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062295|NCT03861598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062296|NCT03861598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93062297|NCT03861598|Antioxidants|antioxidants|mesh-ancestor
93062298|NCT03861598|Protective Agents|protective agents|mesh-ancestor
93062299|NCT03861598|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93062300|NCT03861598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062301|NCT03861598|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93062302|NCT03861598|Vasodilator Agents|vasodilator agents|mesh-ancestor
93062303|NCT03861598|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93062304|NCT03861598|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93062306|NCT01184482|Lapatinib|lapatinib|mesh-list
93062307|NCT01184482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062308|NCT01184482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062309|NCT01184482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93062310|NCT01184482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062311|NCT01184482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062312|NCT01184560|Orlistat|orlistat|mesh-list
93062313|NCT01184560|Sibutramine|sibutramine|mesh-list
93062314|NCT01184560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062315|NCT01184560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062316|NCT01184560|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93062317|NCT01184560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93062318|NCT01184560|Antidepressive Agents|antidepressive agents|mesh-ancestor
93062319|NCT01184560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062320|NCT01184560|Appetite Depressants|appetite depressants|mesh-ancestor
93062321|NCT01184638|Propofol|propofol|mesh-list
93062322|NCT01184638|Sevoflurane|sevoflurane|mesh-list
93062323|NCT01184638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062324|NCT01184638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062325|NCT01184638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062326|NCT01184638|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93062327|NCT01184638|Anesthetics, General|anesthetics, general|mesh-ancestor
93062328|NCT01184638|Anesthetics|anesthetics|mesh-ancestor
93062329|NCT01184638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93062330|NCT01184638|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93062331|NCT01290328|Epoetin Alfa|epoetin alfa|mesh-list
93062332|NCT01290328|Hematinics|hematinics|mesh-ancestor
93062333|NCT01184716|Vitamin D|vitamin d|mesh-list
93062335|NCT01184716|Micronutrients|micronutrients|mesh-ancestor
93062336|NCT01184716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062337|NCT01184716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93062338|NCT01184794|Levobupivacaine|levobupivacaine|mesh-list
93062339|NCT01184794|Anesthetics, Local|anesthetics, local|mesh-ancestor
93062340|NCT01184794|Anesthetics|anesthetics|mesh-ancestor
93062341|NCT01184794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062342|NCT01184794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062343|NCT01184794|Sensory System Agents|sensory system agents|mesh-ancestor
93062344|NCT01184794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062345|NCT01587508|Meloxicam|meloxicam|mesh-list
93062346|NCT01587508|Amitriptyline|amitriptyline|mesh-list
93062347|NCT01587508|Cyclobenzaprine|cyclobenzaprine|mesh-list
93062348|NCT01587508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062349|NCT01587508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062350|NCT01587508|Analgesics|analgesics|mesh-ancestor
93062351|NCT01587508|Sensory System Agents|sensory system agents|mesh-ancestor
93062352|NCT01587508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062353|NCT01587508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062354|NCT01587508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062355|NCT01587508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062356|NCT01587508|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93062357|NCT01587508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93062358|NCT01587508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062359|NCT01587508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062360|NCT01587508|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93062361|NCT01587508|Antidepressive Agents|antidepressive agents|mesh-ancestor
93062362|NCT01587508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062363|NCT01587508|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93062364|NCT01587508|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93062365|NCT01587508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93062366|NCT01587508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062367|NCT01587508|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93062368|NCT01587508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93062369|NCT01587508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062370|NCT01587508|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062371|NCT01587508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062372|NCT00147498|Tofacitinib|tofacitinib|mesh-list
93062373|NCT00147498|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92719458|NCT01163266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062374|NCT00147498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93062375|NCT00147498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062376|NCT00147498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062377|NCT01176760|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93062378|NCT01176760|Protease Inhibitors|protease inhibitors|mesh-ancestor
93062379|NCT01176760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062380|NCT01176760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062381|NCT01176760|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93062382|NCT01176760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062383|NCT01080066|Cetuximab|cetuximab|mesh-list
93062384|NCT01080066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062385|NCT01080066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062386|NCT01185184|Tofacitinib|tofacitinib|mesh-list
93062387|NCT01185184|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93062388|NCT01185184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93062389|NCT01185184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062390|NCT01185184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062391|NCT00113568|Tranexamic Acid|tranexamic acid|mesh-list
93062392|NCT00113568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93062393|NCT00113568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93062394|NCT00113568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062395|NCT00113568|Hemostatics|hemostatics|mesh-ancestor
93062396|NCT00113568|Coagulants|coagulants|mesh-ancestor
93062397|NCT01185262|Rituximab|rituximab|mesh-list
93062398|NCT01185262|Lenalidomide|lenalidomide|mesh-list
93062399|NCT01185262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062400|NCT01185262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062401|NCT01185262|Immunologic Factors|immunologic factors|mesh-ancestor
93062402|NCT01185262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062403|NCT01185262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062404|NCT01185262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93062405|NCT01185262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93062406|NCT01185262|Growth Substances|growth substances|mesh-ancestor
93062407|NCT01185262|Growth Inhibitors|growth inhibitors|mesh-ancestor
93062409|NCT00113490|Antiviral Agents|antiviral agents|mesh-ancestor
93062410|NCT00113490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062411|NCT00146640|Prednisone|prednisone|mesh-list
93062412|NCT00146640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062413|NCT00146640|Glucocorticoids|glucocorticoids|mesh-ancestor
93062414|NCT00146640|Hormones|hormones|mesh-ancestor
93062415|NCT00146640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062416|NCT00146640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062417|NCT00146640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93062418|NCT00146640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062419|NCT01185418|Haloperidol|haloperidol|mesh-list
93062420|NCT01185418|Risperidone|risperidone|mesh-list
93062421|NCT01185418|Aripiprazole|aripiprazole|mesh-list
93062422|NCT01185418|Haloperidol decanoate|haloperidol decanoate|mesh-list
93062423|NCT01185418|Amisulpride|amisulpride|mesh-list
93062424|NCT01185418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93062425|NCT01185418|Serotonin Agents|serotonin agents|mesh-ancestor
93062426|NCT01185418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062427|NCT01185418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062428|NCT01185418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062429|NCT01185418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93062430|NCT01185418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93062431|NCT01185418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062432|NCT01185418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062433|NCT01185418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93062434|NCT01185418|Dopamine Agents|dopamine agents|mesh-ancestor
93062435|NCT01185418|Antidepressive Agents|antidepressive agents|mesh-ancestor
93062436|NCT01185418|Dopamine Agonists|dopamine agonists|mesh-ancestor
93062437|NCT01185418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93062438|NCT01185418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93062439|NCT01185418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93062440|NCT01185418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93062441|NCT01185418|Antiemetics|antiemetics|mesh-ancestor
93062442|NCT01185418|Autonomic Agents|autonomic agents|mesh-ancestor
93062443|NCT01185418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062444|NCT01185418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062445|NCT01185418|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93062446|NCT01185418|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93062447|NCT01185574|Vitamin D|vitamin d|mesh-list
93062448|NCT01185574|Vitamins|vitamins|mesh-ancestor
93062449|NCT01185574|Micronutrients|micronutrients|mesh-ancestor
93062450|NCT01185574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062451|NCT01185574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93062452|NCT03861364|Propofol|propofol|mesh-list
93062453|NCT03861364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062454|NCT03861364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062455|NCT03861364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062456|NCT03861364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93062457|NCT03861364|Anesthetics, General|anesthetics, general|mesh-ancestor
93062458|NCT03861364|Anesthetics|anesthetics|mesh-ancestor
93062459|NCT01185808|Vitamin D|vitamin d|mesh-list
93062460|NCT01185808|Ergocalciferols|ergocalciferols|mesh-list
93062461|NCT01185808|Cholecalciferol|cholecalciferol|mesh-list
93062462|NCT01185808|Vitamins|vitamins|mesh-list
93062463|NCT01185808|Micronutrients|micronutrients|mesh-ancestor
93062464|NCT01185808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062465|NCT01185808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93062466|NCT01185808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93062467|NCT01183624|Analgesics|analgesics|mesh-list
93062468|NCT01183624|Sensory System Agents|sensory system agents|mesh-ancestor
93062469|NCT01183624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062470|NCT01183624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062471|NCT01291186|Epinephrine|epinephrine|mesh-list
93062472|NCT01291186|Racepinephrine|racepinephrine|mesh-list
93062473|NCT01291186|Bupivacaine|bupivacaine|mesh-list
93062474|NCT01291186|Epinephryl borate|epinephryl borate|mesh-list
93062475|NCT01291186|Anesthetics, Local|anesthetics, local|mesh-ancestor
93062476|NCT01291186|Anesthetics|anesthetics|mesh-ancestor
93062477|NCT01291186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062478|NCT01291186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062479|NCT01291186|Sensory System Agents|sensory system agents|mesh-ancestor
93062480|NCT01291186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130964|NCT00310401|Albuterol|albuterol|mesh-list
93062481|NCT01291186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93062482|NCT01291186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93062483|NCT01291186|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062484|NCT01291186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062485|NCT01291186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062486|NCT01291186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93062487|NCT01291186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93062489|NCT01291186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93062490|NCT01291186|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062491|NCT01291186|Mydriatics|mydriatics|mesh-ancestor
93062492|NCT01291186|Sympathomimetics|sympathomimetics|mesh-ancestor
93062493|NCT01291186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93062494|NCT04979338|Bupivacaine|bupivacaine|mesh-list
93062495|NCT04979338|Anesthetics, Local|anesthetics, local|mesh-list
93062496|NCT04979338|Anesthetics|anesthetics|mesh-list
93062497|NCT04979338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062498|NCT04979338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062499|NCT04979338|Sensory System Agents|sensory system agents|mesh-ancestor
93062500|NCT04979338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062501|NCT01177306|Guanfacine|guanfacine|mesh-list
93062502|NCT01177306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93062503|NCT01177306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93062504|NCT01177306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93062505|NCT01177306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93062506|NCT01177306|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062507|NCT01177306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062508|NCT01177306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062509|NCT01177306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062510|NCT01290406|Dactolisib|dactolisib|mesh-list
93062511|NCT01290406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062512|NCT03854812|Magnesium Sulfate|magnesium sulfate|mesh-list
93062513|NCT03854812|Fentanyl|fentanyl|mesh-list
93062514|NCT03854812|Propofol|propofol|mesh-list
93062515|NCT03854812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062516|NCT03854812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062517|NCT03854812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062518|NCT03854812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93062519|NCT03854812|Anesthetics, General|anesthetics, general|mesh-ancestor
93062520|NCT03854812|Anesthetics|anesthetics|mesh-ancestor
93062521|NCT03854812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93062522|NCT03854812|Narcotics|narcotics|mesh-ancestor
93062523|NCT03854812|Analgesics|analgesics|mesh-ancestor
93062524|NCT03854812|Sensory System Agents|sensory system agents|mesh-ancestor
93062525|NCT03854812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062526|NCT03854812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93062527|NCT03854812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93062528|NCT03854812|Anticonvulsants|anticonvulsants|mesh-ancestor
93062529|NCT03854812|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93062530|NCT03854812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062531|NCT03854812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062532|NCT03854812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93062534|NCT03854812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93062535|NCT01186120|Umirolimus|umirolimus|mesh-list
93062536|NCT01186120|Everolimus|everolimus|mesh-list
93062537|NCT01186120|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93062538|NCT01186120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93062539|NCT01186120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340183|NCT00002195|Protease Inhibitors|protease inhibitors|mesh-ancestor
93062540|NCT01186120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062541|NCT01186120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93062542|NCT01186120|Immunologic Factors|immunologic factors|mesh-ancestor
93062543|NCT01186120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062544|NCT01186120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062545|NCT01186120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062546|NCT03855826|Amiodarone|amiodarone|mesh-list
93062547|NCT03855826|Nifekalant|nifekalant|mesh-list
93062548|NCT03855826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93062549|NCT03855826|Vasodilator Agents|vasodilator agents|mesh-ancestor
93062550|NCT03855826|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93062551|NCT03855826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062552|NCT03855826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062553|NCT03855826|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93062554|NCT03855826|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93062555|NCT03855826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089267|NCT00856024|Ribavirin|ribavirin|mesh-list
93062556|NCT03855826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062557|NCT03855826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93062558|NCT03855826|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93062559|NCT03855826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93062560|NCT01184404|Bosentan|bosentan|mesh-list
93062561|NCT01184404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93062562|NCT01184404|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
93062563|NCT01184404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062564|NCT01186588|Canagliflozin|canagliflozin|mesh-list
93062565|NCT01186588|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93062566|NCT01186588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062567|NCT01186588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93062568|NCT01186588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062569|NCT03854266|Heparin|heparin|mesh-list
93062570|NCT03854266|Calcium heparin|calcium heparin|mesh-list
93062571|NCT03854266|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
93062572|NCT03854266|Anticoagulants|anticoagulants|mesh-ancestor
93062573|NCT03854266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93062574|NCT03854266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93062575|NCT03854266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062576|NCT01187992|Atorvastatin|atorvastatin|mesh-list
93062577|NCT01187992|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93062578|NCT01187992|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93062579|NCT01187992|Antimetabolites|antimetabolites|mesh-ancestor
93062580|NCT01187992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062581|NCT01187992|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93062582|NCT01187992|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93062583|NCT01187992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062584|NCT01191034|Imiquimod|imiquimod|mesh-list
93062585|NCT01191034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93062586|NCT01191034|Immunologic Factors|immunologic factors|mesh-ancestor
93062587|NCT01191034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062588|NCT01191034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062589|NCT01191034|Interferon Inducers|interferon inducers|mesh-ancestor
93062590|NCT01188148|Memantine|memantine|mesh-list
93062591|NCT01188148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93062592|NCT01188148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93062593|NCT01188148|Dopamine Agents|dopamine agents|mesh-ancestor
93062594|NCT01188148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062595|NCT01188148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062596|NCT01188148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062597|NCT01188148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93062598|NCT01188148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93062599|NCT01187212|Cisplatin|cisplatin|mesh-list
93062600|NCT01187212|Capecitabine|capecitabine|mesh-list
93062601|NCT01187212|Sorafenib|sorafenib|mesh-list
93062602|NCT01187212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719685|NCT04608981|Prednisolone|prednisolone|mesh-list
93062603|NCT01187212|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93062604|NCT01187212|Antimetabolites|antimetabolites|mesh-ancestor
93062605|NCT01187212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062606|NCT01187212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93062607|NCT01187212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062608|NCT03849508|Phenylephrine|phenylephrine|mesh-list
93062609|NCT03849508|Oxymetazoline|oxymetazoline|mesh-list
93062610|NCT03849508|Norepinephrine|norepinephrine|mesh-list
93062611|NCT03849508|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93062612|NCT03849508|Mydriatics|mydriatics|mesh-ancestor
93062613|NCT03849508|Autonomic Agents|autonomic agents|mesh-ancestor
93062614|NCT03849508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062615|NCT03849508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062616|NCT03849508|Sympathomimetics|sympathomimetics|mesh-ancestor
93062617|NCT03849508|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93062618|NCT03849508|Nasal Decongestants|nasal decongestants|mesh-ancestor
93062619|NCT03849508|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062620|NCT03849508|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93062621|NCT03849508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93062622|NCT03849508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93062623|NCT03849508|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062624|NCT03849508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062625|NCT03849508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062626|NCT03849508|Protective Agents|protective agents|mesh-ancestor
93062627|NCT03849664|Riboflavin|riboflavin|mesh-list
93062628|NCT03849664|Niacinamide|niacinamide|mesh-list
93062629|NCT03849664|Niacin|niacin|mesh-list
93062630|NCT03849664|Nicotinic Acids|nicotinic acids|mesh-list
93062631|NCT03849664|Flavin Mononucleotide|flavin mononucleotide|mesh-list
93062632|NCT03849664|Povidone|povidone|mesh-list
93062633|NCT03849664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93062634|NCT03849664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062635|NCT03849664|Plasma Substitutes|plasma substitutes|mesh-ancestor
93062636|NCT03849664|Blood Substitutes|blood substitutes|mesh-ancestor
93062637|NCT03849664|Vitamin B Complex|vitamin b complex|mesh-ancestor
93062638|NCT03849664|Vitamins|vitamins|mesh-ancestor
93062639|NCT03849664|Micronutrients|micronutrients|mesh-ancestor
93062640|NCT03849664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93062641|NCT03849664|Dermatologic Agents|dermatologic agents|mesh-ancestor
93062642|NCT03849664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93062643|NCT03849664|Antimetabolites|antimetabolites|mesh-ancestor
93062644|NCT03849664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062645|NCT03849664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93062646|NCT03849664|Vasodilator Agents|vasodilator agents|mesh-ancestor
93062647|NCT01293838|Escitalopram|escitalopram|mesh-list
93062648|NCT01293838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93062649|NCT01293838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93062650|NCT01293838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062651|NCT01293838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062652|NCT01293838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062653|NCT01293838|Serotonin Agents|serotonin agents|mesh-ancestor
93062654|NCT01293838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062655|NCT01188304|Aspirin|aspirin|mesh-list
93062656|NCT01188304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062657|NCT01188304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062658|NCT01188304|Analgesics|analgesics|mesh-ancestor
93062659|NCT01188304|Sensory System Agents|sensory system agents|mesh-ancestor
93062660|NCT01188304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062661|NCT01188304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062662|NCT01188304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062663|NCT01188304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062664|NCT01188304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93062665|NCT01188304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93062666|NCT01188304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062667|NCT01188304|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93062668|NCT01188304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93062669|NCT01188304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062670|NCT01188304|Antipyretics|antipyretics|mesh-ancestor
93062671|NCT02524444|Pyrimethamine|pyrimethamine|mesh-list
93062672|NCT02524444|Sulfadoxine|sulfadoxine|mesh-list
93062673|NCT02524444|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93062674|NCT02524444|Mefloquine|mefloquine|mesh-list
93062675|NCT02524444|Antimalarials|antimalarials|mesh-ancestor
93062676|NCT02524444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93062677|NCT02524444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93062678|NCT02524444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062679|NCT02524444|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93062680|NCT02524444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062681|NCT02524444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062682|NCT02524444|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93062684|NCT03853642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93062685|NCT03853642|Autonomic Agents|autonomic agents|mesh-ancestor
93062686|NCT03853642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062687|NCT03853642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062688|NCT03853642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93062689|NCT03853642|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062690|NCT03853642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93062691|NCT03853642|Antioxidants|antioxidants|mesh-ancestor
93062692|NCT03853642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062693|NCT03853642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062694|NCT03853642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93062695|NCT03853642|Vasodilator Agents|vasodilator agents|mesh-ancestor
93062696|NCT03853642|Gasotransmitters|gasotransmitters|mesh-ancestor
93062697|NCT03853642|Protective Agents|protective agents|mesh-ancestor
93062698|NCT02296918|Rituximab|rituximab|mesh-list
93062699|NCT02296918|Obinutuzumab|obinutuzumab|mesh-list
93062700|NCT02296918|Venetoclax|venetoclax|mesh-list
93062701|NCT02296918|Acalabrutinib|acalabrutinib|mesh-list
92530631|NCT00042835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93062702|NCT02296918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062703|NCT02296918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062704|NCT02296918|Immunologic Factors|immunologic factors|mesh-ancestor
93062705|NCT02296918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062706|NCT02296918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062708|NCT01294072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062709|NCT01294072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062710|NCT01294072|Analgesics|analgesics|mesh-ancestor
93062711|NCT01294072|Sensory System Agents|sensory system agents|mesh-ancestor
93062712|NCT01294072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062713|NCT01294072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062714|NCT01294072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062715|NCT01294072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062716|NCT01294072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062717|NCT01294072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062718|NCT01294072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062719|NCT01191424|Formoterol Fumarate|formoterol fumarate|mesh-list
93062720|NCT01191424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93062721|NCT01191424|Autonomic Agents|autonomic agents|mesh-ancestor
93062722|NCT01191424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062723|NCT01191424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062724|NCT01191424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93062725|NCT01191424|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062726|NCT01191424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93062727|NCT01191424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93062728|NCT01191424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93062729|NCT01191424|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062730|NCT01191424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062731|NCT01191424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062732|NCT01291654|Acetaminophen|acetaminophen|mesh-list
93062733|NCT01291654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062734|NCT01291654|Analgesics|analgesics|mesh-ancestor
93062735|NCT01291654|Sensory System Agents|sensory system agents|mesh-ancestor
93062736|NCT01291654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062737|NCT01291654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062738|NCT01291654|Antipyretics|antipyretics|mesh-ancestor
93062739|NCT03853096|Cefazolin|cefazolin|mesh-list
93062740|NCT03853096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93062741|NCT03853096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062742|NCT05671276|Aspirin|aspirin|mesh-list
93062743|NCT05671276|Rivaroxaban|rivaroxaban|mesh-list
93062744|NCT05671276|Clopidogrel|clopidogrel|mesh-list
93062745|NCT05671276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062746|NCT05671276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062747|NCT05671276|Analgesics|analgesics|mesh-ancestor
93062748|NCT05671276|Sensory System Agents|sensory system agents|mesh-ancestor
93062749|NCT05671276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062750|NCT05671276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062751|NCT05671276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062752|NCT05671276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062753|NCT05671276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93062754|NCT05671276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93062755|NCT05671276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062756|NCT05671276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93062757|NCT05671276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93062758|NCT05671276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062759|NCT05671276|Antipyretics|antipyretics|mesh-ancestor
93062760|NCT05671276|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93062761|NCT05671276|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93062762|NCT05671276|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93062763|NCT05671276|Purinergic Agents|purinergic agents|mesh-ancestor
93062764|NCT05671276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062765|NCT05671276|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93062766|NCT05671276|Antithrombins|antithrombins|mesh-ancestor
93062767|NCT05671276|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93062768|NCT05671276|Protease Inhibitors|protease inhibitors|mesh-ancestor
93062769|NCT05671276|Anticoagulants|anticoagulants|mesh-ancestor
93062770|NCT03852160|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
93062771|NCT03852160|Mirtazapine|mirtazapine|mesh-list
93062772|NCT03852160|Trazodone|trazodone|mesh-list
93062773|NCT03852160|Agomelatine|agomelatine|mesh-list
93062774|NCT03852160|Bupropion|bupropion|mesh-list
93062775|NCT03852160|Sertraline|sertraline|mesh-list
93062776|NCT03852160|Esketamine|esketamine|mesh-list
93062777|NCT03852160|Escitalopram|escitalopram|mesh-list
93062778|NCT03852160|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93062779|NCT03852160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93062780|NCT03852160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062781|NCT03852160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062782|NCT03852160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062783|NCT03852160|Serotonin Agents|serotonin agents|mesh-ancestor
93062784|NCT03852160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062785|NCT03852160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062786|NCT03852160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93062787|NCT03852160|Antidepressive Agents|antidepressive agents|mesh-ancestor
93062788|NCT03852160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062789|NCT03852160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93062790|NCT03852160|Dopamine Agents|dopamine agents|mesh-ancestor
93062791|NCT03852160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92340244|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062792|NCT03852160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93062793|NCT03852160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062794|NCT03852160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93062795|NCT03852160|Analgesics|analgesics|mesh-ancestor
93062796|NCT03852160|Sensory System Agents|sensory system agents|mesh-ancestor
93062797|NCT03852160|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93062798|NCT03852160|Histamine Antagonists|histamine antagonists|mesh-ancestor
93062799|NCT03852160|Histamine Agents|histamine agents|mesh-ancestor
93062800|NCT03852160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93062801|NCT03852160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93062802|NCT03852160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062803|NCT03852160|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93062804|NCT03852160|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93062805|NCT03852160|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93062806|NCT03852160|Adrenergic Agents|adrenergic agents|mesh-ancestor
93062807|NCT03852160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93062808|NCT03852160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93062809|NCT03852160|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93062810|NCT03852160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93062811|NCT02524210|Omeprazole|omeprazole|mesh-list
93062812|NCT02524210|Rabeprazole|rabeprazole|mesh-list
93062813|NCT02524210|Dabigatran|dabigatran|mesh-list
93062814|NCT02524210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93062815|NCT02524210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062816|NCT02524210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93062817|NCT02524210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062818|NCT02524210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062819|NCT02524210|Antithrombins|antithrombins|mesh-ancestor
93062820|NCT02524210|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93062821|NCT02524210|Protease Inhibitors|protease inhibitors|mesh-ancestor
93062822|NCT02524210|Anticoagulants|anticoagulants|mesh-ancestor
93062823|NCT03847792|Dexamethasone|dexamethasone|mesh-list
93062824|NCT03847792|Fentanyl|fentanyl|mesh-list
93062825|NCT03847792|Bupivacaine|bupivacaine|mesh-list
93062826|NCT03847792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062827|NCT03847792|Antiemetics|antiemetics|mesh-ancestor
92719903|NCT01563731|Atorvastatin|atorvastatin|mesh-list
93062828|NCT03847792|Autonomic Agents|autonomic agents|mesh-ancestor
93062829|NCT03847792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062830|NCT03847792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062831|NCT03847792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062832|NCT03847792|Glucocorticoids|glucocorticoids|mesh-ancestor
93062833|NCT03847792|Hormones|hormones|mesh-ancestor
93062834|NCT03847792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062835|NCT03847792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93062836|NCT03847792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062837|NCT03847792|Anesthetics, Local|anesthetics, local|mesh-ancestor
93062838|NCT03847792|Anesthetics|anesthetics|mesh-ancestor
92131324|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
93062839|NCT03847792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062840|NCT03847792|Sensory System Agents|sensory system agents|mesh-ancestor
93062842|NCT03847792|Narcotics|narcotics|mesh-ancestor
93062843|NCT03847792|Analgesics|analgesics|mesh-ancestor
93062844|NCT03847792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93062845|NCT03847792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93062846|NCT03847792|Anesthetics, General|anesthetics, general|mesh-ancestor
93062847|NCT01294618|Interferons|interferons|mesh-list
93062848|NCT01294618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062849|NCT01294618|Antiviral Agents|antiviral agents|mesh-ancestor
93062850|NCT01294618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062851|NCT01194232|Sildenafil Citrate|sildenafil citrate|mesh-list
93062852|NCT01194232|Vasodilator Agents|vasodilator agents|mesh-ancestor
93062853|NCT01194232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93062854|NCT01194232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93062855|NCT01194232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062856|NCT01194232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062857|NCT01194232|Urological Agents|urological agents|mesh-ancestor
93062858|NCT01296334|Morphine|morphine|mesh-list
93062859|NCT01296334|Buprenorphine|buprenorphine|mesh-list
93062860|NCT01296334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93062861|NCT01296334|Narcotics|narcotics|mesh-ancestor
93062862|NCT01296334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062863|NCT01296334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062864|NCT01296334|Analgesics|analgesics|mesh-ancestor
93062865|NCT01296334|Sensory System Agents|sensory system agents|mesh-ancestor
93062866|NCT01296334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062867|NCT01296334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93062868|NCT03847558|Hormones|hormones|mesh-list
93062869|NCT03847558|Testosterone|testosterone|mesh-list
93062870|NCT03847558|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93062871|NCT03847558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062872|NCT03847558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062873|NCT03847558|Androgens|androgens|mesh-ancestor
93062874|NCT01189006|Dextromethorphan|dextromethorphan|mesh-list
93062875|NCT01189006|Antitussive Agents|antitussive agents|mesh-ancestor
93062876|NCT01189006|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062877|NCT01189006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93062878|NCT01189006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93062879|NCT01189006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062880|NCT01189006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062881|NCT01189006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062882|NCT01292356|Cetuximab|cetuximab|mesh-list
93062883|NCT01292356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062884|NCT01292356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062885|NCT01294852|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93062886|NCT01294852|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062887|NCT03847246|Entecavir|entecavir|mesh-list
93062888|NCT03847246|Antiviral Agents|antiviral agents|mesh-ancestor
93062889|NCT03847246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062890|NCT03849196|Bisacodyl|bisacodyl|mesh-list
93062891|NCT03849196|Cathartics|cathartics|mesh-ancestor
93062892|NCT03849196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93062893|NCT03849196|Laxatives|laxatives|mesh-ancestor
93062894|NCT01292668|Aminolevulinic Acid|aminolevulinic acid|mesh-list
93062895|NCT01292668|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
93062896|NCT01292668|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93062897|NCT01292668|Dermatologic Agents|dermatologic agents|mesh-ancestor
93062898|NCT01296802|Fenfluramine|fenfluramine|mesh-list
93062899|NCT01296802|Dexfenfluramine|dexfenfluramine|mesh-list
93062900|NCT01296802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93062901|NCT01296802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93062902|NCT01296802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062903|NCT01296802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062904|NCT01296802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062905|NCT01296802|Serotonin Agents|serotonin agents|mesh-ancestor
93062906|NCT01296802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062907|NCT01296802|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93062908|NCT01296958|Niclosamide|niclosamide|mesh-list
93062909|NCT01296958|Anticestodal Agents|anticestodal agents|mesh-ancestor
93062910|NCT01296958|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93062911|NCT01296958|Anthelmintics|anthelmintics|mesh-ancestor
93062912|NCT01296958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93062913|NCT01296958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93062914|NCT01296958|Antinematodal Agents|antinematodal agents|mesh-ancestor
93062915|NCT01295086|Docetaxel|docetaxel|mesh-list
93062916|NCT01295086|Capecitabine|capecitabine|mesh-list
93062917|NCT01295086|Oxaliplatin|oxaliplatin|mesh-list
93062918|NCT01295086|Trastuzumab|trastuzumab|mesh-list
93062919|NCT01295086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93062920|NCT01295086|Tubulin Modulators|tubulin modulators|mesh-ancestor
93062921|NCT01295086|Antimitotic Agents|antimitotic agents|mesh-ancestor
93062922|NCT01295086|Mitosis Modulators|mitosis modulators|mesh-ancestor
93062923|NCT01295086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062924|NCT01295086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93062925|NCT01295086|Antimetabolites|antimetabolites|mesh-ancestor
93062926|NCT01295086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93062927|NCT01194700|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
93062928|NCT01194700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93062929|NCT01194700|Autonomic Agents|autonomic agents|mesh-ancestor
93062930|NCT01194700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062931|NCT01194700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062932|NCT01194700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93062933|NCT01194700|Respiratory System Agents|respiratory system agents|mesh-ancestor
93062934|NCT01194700|Glucocorticoids|glucocorticoids|mesh-ancestor
93062935|NCT01194700|Hormones|hormones|mesh-ancestor
93062936|NCT01194700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93062937|NCT01194700|Sympathomimetics|sympathomimetics|mesh-ancestor
93062938|NCT01189318|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93062939|NCT01189318|Antidepressive Agents|antidepressive agents|mesh-ancestor
93062940|NCT01189318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93062941|NCT01189318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93062942|NCT01189318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93062943|NCT01189318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93062944|NCT01189318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062945|NCT01194778|Vitamins|vitamins|mesh-list
93062946|NCT01194778|Vitamin K|vitamin k|mesh-list
93062947|NCT01194778|Vitamin K 2|vitamin k 2|mesh-list
93062948|NCT01194778|Vitamin K 1|vitamin k 1|mesh-list
93062949|NCT01194778|Micronutrients|micronutrients|mesh-ancestor
93062950|NCT01194778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062951|NCT01194778|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93062952|NCT01194778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93062953|NCT01194778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062954|NCT01194778|Hemostatics|hemostatics|mesh-ancestor
93062955|NCT01194778|Coagulants|coagulants|mesh-ancestor
93062956|NCT01194934|Lenograstim|lenograstim|mesh-list
93062957|NCT01194934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93062958|NCT01194934|Immunologic Factors|immunologic factors|mesh-ancestor
93062959|NCT01194934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062960|NCT01297036|Donepezil|donepezil|mesh-list
93062961|NCT01297036|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93062962|NCT01297036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93062963|NCT01297036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062964|NCT01297036|Cholinergic Agents|cholinergic agents|mesh-ancestor
93062965|NCT01297036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93062966|NCT01297036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062967|NCT01297036|Nootropic Agents|nootropic agents|mesh-ancestor
93062968|NCT03848806|Calcitriol|calcitriol|mesh-list
93062969|NCT03848806|Calcipotriene|calcipotriene|mesh-list
93062970|NCT03848806|Dermatologic Agents|dermatologic agents|mesh-ancestor
93062971|NCT03848806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93062972|NCT03848806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062973|NCT03848806|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93062974|NCT03848806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93062975|NCT03848806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93062976|NCT03848806|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93062977|NCT03848806|Vitamins|vitamins|mesh-ancestor
93062978|NCT03848806|Micronutrients|micronutrients|mesh-ancestor
93062979|NCT03848806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93062980|NCT03737110|Rilonacept|rilonacept|mesh-list
93062981|NCT03737110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062982|NCT01189864|Diclofenac|diclofenac|mesh-list
93062983|NCT01189864|Prednisolone acetate|prednisolone acetate|mesh-list
93062984|NCT01189864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93062985|NCT01189864|Methylprednisolone|methylprednisolone|mesh-list
93062986|NCT01189864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93062987|NCT01189864|Prednisolone|prednisolone|mesh-list
93062988|NCT01189864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92340273|NCT00002255|Zidovudine|zidovudine|mesh-list
93062989|NCT01189864|Prednisolone phosphate|prednisolone phosphate|mesh-list
93062990|NCT01189864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93062991|NCT01189864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93062992|NCT01189864|Analgesics|analgesics|mesh-ancestor
93062993|NCT01189864|Sensory System Agents|sensory system agents|mesh-ancestor
93062994|NCT01189864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93062995|NCT01189864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93062996|NCT01189864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93062997|NCT01189864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93062998|NCT01189864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93062999|NCT01189864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063000|NCT01189864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063001|NCT01189864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063002|NCT01189864|Antiemetics|antiemetics|mesh-ancestor
93063003|NCT01189864|Autonomic Agents|autonomic agents|mesh-ancestor
93063004|NCT01189864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93063005|NCT01189864|Glucocorticoids|glucocorticoids|mesh-ancestor
93063006|NCT01189864|Hormones|hormones|mesh-ancestor
93063007|NCT01189864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063008|NCT01189864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93063009|NCT01189864|Protective Agents|protective agents|mesh-ancestor
93063010|NCT01189864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063011|NCT01195246|Vaccines|vaccines|mesh-list
93063012|NCT01195246|Immunologic Factors|immunologic factors|mesh-ancestor
93063013|NCT01195246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063014|NCT01191892|Carboplatin|carboplatin|mesh-list
93063015|NCT01191892|Gemcitabine|gemcitabine|mesh-list
93063016|NCT01191892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063017|NCT01191892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063018|NCT01191892|Antimetabolites|antimetabolites|mesh-ancestor
93063019|NCT01191892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063020|NCT01293058|Naloxone|naloxone|mesh-list
93063021|NCT01293058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93063022|NCT01293058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063023|NCT01293058|Sensory System Agents|sensory system agents|mesh-ancestor
93063024|NCT01293058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063025|NCT01195324|Canagliflozin|canagliflozin|mesh-list
93063026|NCT01195324|Warfarin|warfarin|mesh-list
93063027|NCT01195324|Anticoagulants|anticoagulants|mesh-ancestor
93063028|NCT01195324|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93063029|NCT01195324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063030|NCT01195324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93063031|NCT01195324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063032|NCT01293136|Analgesics, Opioid|analgesics, opioid|mesh-list
93063033|NCT01293136|Narcotics|narcotics|mesh-ancestor
93063034|NCT01293136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063035|NCT01293136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063036|NCT01293136|Analgesics|analgesics|mesh-ancestor
93063037|NCT01293136|Sensory System Agents|sensory system agents|mesh-ancestor
93063038|NCT01293136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063039|NCT01293292|Teriparatide|teriparatide|mesh-list
93063040|NCT01293292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063041|NCT01293292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063042|NCT01293292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93063043|NCT01195714|Ofatumumab|ofatumumab|mesh-list
93063044|NCT01195714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063045|NCT01190722|Diclofenac|diclofenac|mesh-list
93063046|NCT01190722|Etoricoxib|etoricoxib|mesh-list
93063047|NCT01190722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063048|NCT01190722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063049|NCT01190722|Analgesics|analgesics|mesh-ancestor
93063050|NCT01190722|Sensory System Agents|sensory system agents|mesh-ancestor
93063051|NCT01190722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063052|NCT01190722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340280|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
93063053|NCT01190722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063054|NCT01190722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063055|NCT01190722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93063056|NCT01190722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063057|NCT01190722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063058|NCT01190722|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93063059|NCT01196260|Capecitabine|capecitabine|mesh-list
93063061|NCT01196260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063062|NCT01196260|Antimetabolites|antimetabolites|mesh-ancestor
93063063|NCT01196260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063064|NCT01196260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063065|NCT01192984|Mogamulizumab|mogamulizumab|mesh-list
93063066|NCT01192984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063068|NCT05412082|Fluorouracil|fluorouracil|mesh-list
93063069|NCT05412082|Capecitabine|capecitabine|mesh-list
93063070|NCT05412082|Oxaliplatin|oxaliplatin|mesh-list
93063071|NCT05412082|Antimetabolites|antimetabolites|mesh-ancestor
93063072|NCT05412082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063073|NCT05412082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063074|NCT05412082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063075|NCT05412082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93063076|NCT05412082|Immunologic Factors|immunologic factors|mesh-ancestor
93063077|NCT05412082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063078|NCT05412082|Antidotes|antidotes|mesh-ancestor
93063079|NCT05412082|Protective Agents|protective agents|mesh-ancestor
93063080|NCT05412082|Vitamin B Complex|vitamin b complex|mesh-ancestor
93063081|NCT05412082|Vitamins|vitamins|mesh-ancestor
93063082|NCT05412082|Micronutrients|micronutrients|mesh-ancestor
93063083|NCT01193296|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93063084|NCT01193296|Vildagliptin|vildagliptin|mesh-list
93063085|NCT01193296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93063086|NCT01193296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063087|NCT01193296|Incretins|incretins|mesh-ancestor
93063088|NCT01193296|Hormones|hormones|mesh-ancestor
93063089|NCT01193296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063090|NCT01193296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93063091|NCT01193296|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063092|NCT01193296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063093|NCT01193296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063094|NCT01197040|Mycophenolic Acid|mycophenolic acid|mesh-list
93063095|NCT01197040|Prednisone|prednisone|mesh-list
93063096|NCT01197040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063097|NCT01197040|Glucocorticoids|glucocorticoids|mesh-ancestor
93063098|NCT01197040|Hormones|hormones|mesh-ancestor
93063099|NCT01197040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063100|NCT01197040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063101|NCT01197040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063102|NCT01197040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063103|NCT01197040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93063104|NCT01197040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93063105|NCT01197040|Antitubercular Agents|antitubercular agents|mesh-ancestor
93063106|NCT01197040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063107|NCT01197040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063108|NCT01197040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063109|NCT01197040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063110|NCT01193452|Leucovorin|leucovorin|mesh-list
93063111|NCT01193452|Fluorouracil|fluorouracil|mesh-list
93063112|NCT01193452|Levoleucovorin|levoleucovorin|mesh-list
93063113|NCT01193452|Antimetabolites|antimetabolites|mesh-ancestor
93063114|NCT01193452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063115|NCT01193452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063116|NCT01193452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063117|NCT01193452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93063118|NCT01193452|Immunologic Factors|immunologic factors|mesh-ancestor
93063119|NCT01193452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063120|NCT01193452|Antidotes|antidotes|mesh-ancestor
93063121|NCT01193452|Protective Agents|protective agents|mesh-ancestor
93063122|NCT01193452|Vitamin B Complex|vitamin b complex|mesh-ancestor
93063123|NCT01193452|Vitamins|vitamins|mesh-ancestor
93063124|NCT01193452|Micronutrients|micronutrients|mesh-ancestor
93063125|NCT05670886|Carbetocin|carbetocin|mesh-list
93063126|NCT05670886|Oxytocics|oxytocics|mesh-ancestor
93063127|NCT05670886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93063128|NCT05670886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063129|NCT01295632|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
93063130|NCT01295632|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
93063131|NCT01295632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063132|NCT01295632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063133|NCT03844594|Eptifibatide|eptifibatide|mesh-list
93063135|NCT03848182|Gemcitabine|gemcitabine|mesh-list
93063136|NCT03848182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063137|NCT03848182|Antimetabolites|antimetabolites|mesh-ancestor
93063138|NCT03848182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063139|NCT03848182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063140|NCT00146328|Tipranavir|tipranavir|mesh-list
93063141|NCT00146328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93063142|NCT00146328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93063143|NCT00146328|Antiviral Agents|antiviral agents|mesh-ancestor
93063144|NCT00146328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063145|NCT04916938|Psychotropic Drugs|psychotropic drugs|mesh-list
93063146|NCT01295866|Nitric Oxide|nitric oxide|mesh-list
93063147|NCT01295866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93063148|NCT01295866|Autonomic Agents|autonomic agents|mesh-ancestor
93063149|NCT01295866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063150|NCT01295866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063151|NCT01295866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93063152|NCT01295866|Respiratory System Agents|respiratory system agents|mesh-ancestor
93063153|NCT01295866|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93063154|NCT01295866|Antioxidants|antioxidants|mesh-ancestor
93063155|NCT01295866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063156|NCT01295866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063157|NCT01295866|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93063158|NCT01295866|Vasodilator Agents|vasodilator agents|mesh-ancestor
93063159|NCT01295866|Gasotransmitters|gasotransmitters|mesh-ancestor
93063160|NCT01295866|Protective Agents|protective agents|mesh-ancestor
93063161|NCT03848104|Cefoxitin|cefoxitin|mesh-list
93063162|NCT03848104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063163|NCT03848104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063164|NCT05670808|Epinephrine|epinephrine|mesh-list
93063165|NCT05670808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93063166|NCT05670808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93063167|NCT05670808|Adrenergic Agents|adrenergic agents|mesh-ancestor
93063168|NCT05670808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063169|NCT05670808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063170|NCT05670808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063171|NCT05670808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93063172|NCT05670808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93063173|NCT05670808|Autonomic Agents|autonomic agents|mesh-ancestor
93063174|NCT05670808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063175|NCT05670808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93063176|NCT05670808|Respiratory System Agents|respiratory system agents|mesh-ancestor
93063177|NCT05670808|Mydriatics|mydriatics|mesh-ancestor
93063178|NCT05670808|Sympathomimetics|sympathomimetics|mesh-ancestor
93063179|NCT05670808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93063180|NCT01197664|Fluorouracil|fluorouracil|mesh-list
93063181|NCT01197664|Antimetabolites|antimetabolites|mesh-ancestor
93063182|NCT01197664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063183|NCT01197664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063184|NCT01197664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063185|NCT01197664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93063186|NCT01197664|Immunologic Factors|immunologic factors|mesh-ancestor
93063187|NCT01197664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063188|NCT01199458|Alfentanil|alfentanil|mesh-list
93063189|NCT01199458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93063190|NCT01199458|Narcotics|narcotics|mesh-ancestor
93063191|NCT01199458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063192|NCT01199458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063193|NCT01199458|Analgesics|analgesics|mesh-ancestor
93063194|NCT01199458|Sensory System Agents|sensory system agents|mesh-ancestor
93063195|NCT01199458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063196|NCT01199458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93063197|NCT01199458|Anesthetics, General|anesthetics, general|mesh-ancestor
93063198|NCT01199458|Anesthetics|anesthetics|mesh-ancestor
93063199|NCT01199614|Parathyroid Hormone|parathyroid hormone|mesh-list
93063200|NCT01199614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063201|NCT01199614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063202|NCT01588522|Calcitriol|calcitriol|mesh-list
93063203|NCT01588522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063204|NCT01588522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063205|NCT01588522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93063206|NCT01588522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063207|NCT01588522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063208|NCT01588522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93063209|NCT01588522|Vitamins|vitamins|mesh-ancestor
93063210|NCT01588522|Micronutrients|micronutrients|mesh-ancestor
93063211|NCT01588522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93063212|NCT01296178|Idarubicin|idarubicin|mesh-list
93063213|NCT01296178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93063214|NCT01296178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063215|NCT01296178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93063216|NCT01296178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93063217|NCT01296178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063218|NCT01296178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063219|NCT01296256|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93063220|NCT01296256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93063221|NCT01296256|Alkylating Agents|alkylating agents|mesh-ancestor
93063222|NCT01296256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063223|NCT01296256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063224|NCT03731182|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93063225|NCT03731182|Immunologic Factors|immunologic factors|mesh-ancestor
93063226|NCT03731182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063227|NCT03730012|Atezolizumab|atezolizumab|mesh-list
93063228|NCT03730012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93063229|NCT03730012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063230|NCT03730012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93063231|NCT03730012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063232|NCT03844360|Anti-Infective Agents|anti-infective agents|mesh-list
93063233|NCT03844360|Bortezomib|bortezomib|mesh-list
93063234|NCT03844360|Imatinib Mesylate|imatinib mesylate|mesh-list
93063235|NCT03844360|Dasatinib|dasatinib|mesh-list
93063236|NCT03844360|Pegaspargase|pegaspargase|mesh-list
93063237|NCT03844360|Lenograstim|lenograstim|mesh-list
93063238|NCT03844360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063239|NCT03844360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93063240|NCT03844360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063241|NCT03844360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063242|NCT03844360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93063243|NCT03844360|Immunologic Factors|immunologic factors|mesh-ancestor
92340316|NCT00002279|Zalcitabine|zalcitabine|mesh-list
93063244|NCT03844360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063245|NCT01198054|Lenalidomide|lenalidomide|mesh-list
93063246|NCT01198054|Immunologic Factors|immunologic factors|mesh-ancestor
93063247|NCT01198054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063248|NCT01198054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93063249|NCT01198054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93063250|NCT01198054|Growth Substances|growth substances|mesh-ancestor
93063251|NCT01198054|Growth Inhibitors|growth inhibitors|mesh-ancestor
93063252|NCT01198054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063253|NCT01202032|Bevacizumab|bevacizumab|mesh-list
93063254|NCT01202032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93063255|NCT01202032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063256|NCT01202032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93063257|NCT01202032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93063258|NCT01202032|Growth Substances|growth substances|mesh-ancestor
93063259|NCT01202032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063260|NCT01202032|Growth Inhibitors|growth inhibitors|mesh-ancestor
93063261|NCT03844984|Lidocaine|lidocaine|mesh-list
93063262|NCT03844984|Midazolam|midazolam|mesh-list
93063263|NCT03844984|Ketamine|ketamine|mesh-list
93063264|NCT03844984|Anesthetics, Local|anesthetics, local|mesh-ancestor
93063265|NCT03844984|Anesthetics|anesthetics|mesh-ancestor
93063266|NCT03844984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063267|NCT03844984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063268|NCT03844984|Sensory System Agents|sensory system agents|mesh-ancestor
93063269|NCT03844984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063270|NCT03844984|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93063271|NCT03844984|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93063272|NCT03844984|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93063273|NCT03844984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063274|NCT03844984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063275|NCT03844984|Analgesics|analgesics|mesh-ancestor
93063276|NCT03844984|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93063277|NCT03844984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93063278|NCT03844984|Anesthetics, General|anesthetics, general|mesh-ancestor
93063279|NCT03844984|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93063280|NCT03844984|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93063281|NCT03844984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063282|NCT03844984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93063283|NCT03844984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93063284|NCT03844984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93063285|NCT03844984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93063286|NCT03844984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063287|NCT03844984|GABA Modulators|gaba modulators|mesh-ancestor
93063288|NCT03844984|GABA Agents|gaba agents|mesh-ancestor
93063289|NCT03842020|Amiodarone|amiodarone|mesh-list
93063290|NCT03842020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93063291|NCT03842020|Vasodilator Agents|vasodilator agents|mesh-ancestor
93063292|NCT03842020|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93063293|NCT03842020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063294|NCT03842020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063295|NCT03842020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93063296|NCT03842020|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93063297|NCT03842020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93063298|NCT03842020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063299|NCT03842020|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93063300|NCT03842020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93063301|NCT03842020|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93063302|NCT01200004|Lenalidomide|lenalidomide|mesh-list
93063303|NCT01200004|Azacitidine|azacitidine|mesh-list
93063304|NCT01200004|Immunologic Factors|immunologic factors|mesh-ancestor
93063305|NCT01200004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063306|NCT01200004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93063307|NCT01200004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93063308|NCT01200004|Growth Substances|growth substances|mesh-ancestor
93063309|NCT01200004|Growth Inhibitors|growth inhibitors|mesh-ancestor
93063310|NCT01200004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063311|NCT01200004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063312|NCT01200004|Antimetabolites|antimetabolites|mesh-ancestor
93063313|NCT01200004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063314|NCT01200004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063315|NCT01198210|Dexamethasone|dexamethasone|mesh-list
93063316|NCT01198210|Dexamethasone acetate|dexamethasone acetate|mesh-list
93063317|NCT01198210|Ketamine|ketamine|mesh-list
93063318|NCT01198210|BB 1101|bb 1101|mesh-list
93063319|NCT01198210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063320|NCT01198210|Antiemetics|antiemetics|mesh-ancestor
93063321|NCT01198210|Autonomic Agents|autonomic agents|mesh-ancestor
93063322|NCT01198210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063323|NCT01198210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063324|NCT01198210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93063325|NCT01198210|Glucocorticoids|glucocorticoids|mesh-ancestor
93063326|NCT01198210|Hormones|hormones|mesh-ancestor
93063327|NCT01198210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063328|NCT01198210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063329|NCT01198210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063330|NCT01198210|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063331|NCT01198210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063332|NCT01198210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063333|NCT01198210|Analgesics|analgesics|mesh-ancestor
93063334|NCT01198210|Sensory System Agents|sensory system agents|mesh-ancestor
93063335|NCT01198210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93063336|NCT01198210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93063337|NCT01198210|Anesthetics, General|anesthetics, general|mesh-ancestor
93063338|NCT01198210|Anesthetics|anesthetics|mesh-ancestor
93063339|NCT01198210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063340|NCT01198210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93063341|NCT01198210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93063342|NCT01198210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063343|NCT03843736|Drospirenone|drospirenone|mesh-list
93063344|NCT03843736|Contraceptive Agents|contraceptive agents|mesh-list
93063345|NCT03843736|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93063346|NCT03843736|Contraceptives, Oral|contraceptives, oral|mesh-list
93063347|NCT03843736|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93063348|NCT03843736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93063349|NCT03843736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063350|NCT03843736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93063351|NCT03843736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93063352|NCT03843736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93063353|NCT03843736|Estrogens|estrogens|mesh-ancestor
93063354|NCT03843736|Hormones|hormones|mesh-ancestor
92720426|NCT02885311|Naltrexone|naltrexone|mesh-list
93063355|NCT03843736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063356|NCT03843736|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93063357|NCT03843736|Hormone Antagonists|hormone antagonists|mesh-ancestor
93063358|NCT03843736|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93063359|NCT03843736|Diuretics|diuretics|mesh-ancestor
93063360|NCT03843736|Natriuretic Agents|natriuretic agents|mesh-ancestor
93063361|NCT01200472|Apremilast|apremilast|mesh-list
93063362|NCT01200472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063363|NCT01200472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063364|NCT01200472|Analgesics|analgesics|mesh-ancestor
93063365|NCT01200472|Sensory System Agents|sensory system agents|mesh-ancestor
93063366|NCT01200472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063367|NCT01200472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063368|NCT01200472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063369|NCT01200472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063370|NCT01200472|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93063371|NCT01200472|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93063372|NCT01200472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063373|NCT01200472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063374|NCT04638790|Dexamethasone|dexamethasone|mesh-list
93063375|NCT04638790|Cyclophosphamide|cyclophosphamide|mesh-list
93063376|NCT04638790|Dacarbazine|dacarbazine|mesh-list
93063377|NCT04638790|Doxorubicin|doxorubicin|mesh-list
93063378|NCT04638790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93063379|NCT04638790|Etoposide|etoposide|mesh-list
93063380|NCT04638790|Vincristine|vincristine|mesh-list
93063381|NCT04638790|Bleomycin|bleomycin|mesh-list
93063382|NCT04638790|Vinblastine|vinblastine|mesh-list
93063383|NCT04638790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93063384|NCT04638790|Immunologic Factors|immunologic factors|mesh-ancestor
93063385|NCT04638790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063386|NCT04638790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063387|NCT04638790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93063388|NCT04638790|Alkylating Agents|alkylating agents|mesh-ancestor
93063389|NCT04638790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063390|NCT04638790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063391|NCT04638790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93063392|NCT04638790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063393|NCT04638790|Antiemetics|antiemetics|mesh-ancestor
93063394|NCT04638790|Autonomic Agents|autonomic agents|mesh-ancestor
93063395|NCT04638790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063396|NCT04638790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93063397|NCT04638790|Glucocorticoids|glucocorticoids|mesh-ancestor
93063398|NCT04638790|Hormones|hormones|mesh-ancestor
93063399|NCT04638790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063400|NCT04638790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063401|NCT04638790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93063402|NCT04638790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93063403|NCT04638790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93063404|NCT04638790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063405|NCT04638790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93063406|NCT04638790|Tubulin Modulators|tubulin modulators|mesh-ancestor
93063407|NCT04638790|Antimitotic Agents|antimitotic agents|mesh-ancestor
93063408|NCT04638790|Mitosis Modulators|mitosis modulators|mesh-ancestor
93063409|NCT03249142|Durvalumab|durvalumab|mesh-list
93063410|NCT03249142|Tremelimumab|tremelimumab|mesh-list
93063411|NCT03249142|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93063412|NCT03249142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93063413|NCT03249142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063414|NCT03249142|Immunologic Factors|immunologic factors|mesh-ancestor
93063415|NCT03249142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063416|NCT01200706|Amoxicillin|amoxicillin|mesh-list
93063417|NCT01200706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063418|NCT01200706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063419|NCT01200784|Niacinamide|niacinamide|mesh-list
93063420|NCT01200784|Niacin|niacin|mesh-list
93063421|NCT01200784|Nicotinic Acids|nicotinic acids|mesh-list
93063422|NCT01200784|Vitamin B Complex|vitamin b complex|mesh-ancestor
93063423|NCT01200784|Vitamins|vitamins|mesh-ancestor
93063424|NCT01200784|Micronutrients|micronutrients|mesh-ancestor
93063425|NCT01200784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063426|NCT01200784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93063427|NCT01200784|Antimetabolites|antimetabolites|mesh-ancestor
93063428|NCT01200784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720502|NCT03454646|Rivastigmine|rivastigmine|mesh-list
93063429|NCT01200784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93063430|NCT01200784|Vasodilator Agents|vasodilator agents|mesh-ancestor
93063432|NCT03841474|Escitalopram|escitalopram|mesh-list
93063433|NCT03841474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93063434|NCT03841474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93063435|NCT03841474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063436|NCT03841474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063437|NCT03841474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063438|NCT03841474|Serotonin Agents|serotonin agents|mesh-ancestor
93063439|NCT03841474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063440|NCT03841474|Antidepressive Agents|antidepressive agents|mesh-ancestor
93063441|NCT03841474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063442|NCT01198444|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
93063443|NCT01198444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93063444|NCT01198444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063445|NCT05670184|Ethanol|ethanol|mesh-list
93063446|NCT05670184|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
93063447|NCT05670184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93063448|NCT05670184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063449|NCT05670184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063450|NCT05670184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063451|NCT05670184|Hallucinogens|hallucinogens|mesh-ancestor
93063452|NCT05670184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063453|NCT05670184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93063454|NCT05670184|Serotonin Agents|serotonin agents|mesh-ancestor
93063455|NCT05670184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063456|NCT05670184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063457|NCT05670184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93063458|NCT05084248|Vitamin D|vitamin d|mesh-list
93063459|NCT05084248|Ergocalciferols|ergocalciferols|mesh-list
93063460|NCT05084248|Vitamins|vitamins|mesh-ancestor
93063461|NCT05084248|Micronutrients|micronutrients|mesh-ancestor
93063462|NCT05084248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063463|NCT05084248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93063464|NCT05084248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063465|NCT03842800|Ketamine|ketamine|mesh-list
93063466|NCT03842800|Analgesics|analgesics|mesh-ancestor
93063467|NCT03842800|Sensory System Agents|sensory system agents|mesh-ancestor
93063468|NCT03842800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063469|NCT03842800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063470|NCT03842800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93063471|NCT03842800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93063472|NCT03842800|Anesthetics, General|anesthetics, general|mesh-ancestor
93063473|NCT03842800|Anesthetics|anesthetics|mesh-ancestor
93063474|NCT03842800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063475|NCT03842800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93063476|NCT03842800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93063477|NCT03842800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063478|NCT03842800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063479|NCT01202422|Pregabalin|pregabalin|mesh-list
93063480|NCT01202422|Analgesics|analgesics|mesh-ancestor
93063481|NCT01202422|Sensory System Agents|sensory system agents|mesh-ancestor
93063482|NCT01202422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063483|NCT01202422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063484|NCT01202422|Anticonvulsants|anticonvulsants|mesh-ancestor
93063485|NCT01202422|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93063486|NCT01202422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063487|NCT01202422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063488|NCT01202422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063489|NCT01202422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93063490|NCT01202422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93063491|NCT01202422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063492|NCT01202422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063493|NCT03892018|Paclitaxel|paclitaxel|mesh-list
93063494|NCT03892018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93063495|NCT03892018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063496|NCT03892018|Tubulin Modulators|tubulin modulators|mesh-ancestor
93063497|NCT03892018|Antimitotic Agents|antimitotic agents|mesh-ancestor
93063498|NCT03892018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530660|NCT00042913|Epratuzumab|epratuzumab|mesh-list
93063499|NCT03892018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063500|NCT01198912|Doxycycline|doxycycline|mesh-list
93063501|NCT01198912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063502|NCT01198912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063503|NCT01198912|Antimalarials|antimalarials|mesh-ancestor
93063504|NCT01198912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93063505|NCT01198912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93063506|NCT03842488|Raltegravir Potassium|raltegravir potassium|mesh-list
93063508|NCT03842488|Cobicistat|cobicistat|mesh-list
93063509|NCT03842488|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
93063510|NCT03842488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340356|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
93063511|NCT03842488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93063512|NCT03842488|Antiviral Agents|antiviral agents|mesh-ancestor
93063513|NCT03842488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063514|NCT03842488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
93063515|NCT03842488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
93063516|NCT03842488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063517|NCT03842488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063518|NCT03842488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93063519|NCT03842488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93063520|NCT03842488|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063521|NCT03842488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93063522|NCT03842488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93063523|NCT04256824|Triclosan|triclosan|mesh-list
93063524|NCT04256824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93063525|NCT04256824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063526|NCT04256824|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93063527|NCT04256824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93063528|NCT04256824|Antimetabolites|antimetabolites|mesh-ancestor
93063529|NCT04256824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063530|NCT04256824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93063531|NCT03842254|Epoetin Alfa|epoetin alfa|mesh-list
93063532|NCT03842254|Hematinics|hematinics|mesh-ancestor
93063533|NCT01201642|Prednisolone|prednisolone|mesh-list
93063534|NCT01201642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063535|NCT01201642|Glucocorticoids|glucocorticoids|mesh-ancestor
93063536|NCT01201642|Hormones|hormones|mesh-ancestor
93063537|NCT01201642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063538|NCT01201642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063539|NCT01201642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063540|NCT01201642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063541|NCT05004064|Rituximab|rituximab|mesh-list
93063542|NCT05004064|Acalabrutinib|acalabrutinib|mesh-list
93063543|NCT05004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93063544|NCT05004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063545|NCT05004064|Immunologic Factors|immunologic factors|mesh-ancestor
93063546|NCT05004064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063547|NCT05004064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063548|NCT04982692|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
93063549|NCT04982692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93063550|NCT04982692|Immunologic Factors|immunologic factors|mesh-ancestor
93063551|NCT04982692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063552|NCT01202734|Methylphenidate|methylphenidate|mesh-list
93063553|NCT01202734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93063554|NCT01202734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063555|NCT01202734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93063556|NCT01202734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93063557|NCT01202734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063558|NCT01202734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063559|NCT01202734|Dopamine Agents|dopamine agents|mesh-ancestor
93063560|NCT01202734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063561|NCT03173092|Dexamethasone|dexamethasone|mesh-list
93063562|NCT03173092|Lenalidomide|lenalidomide|mesh-list
93063563|NCT03173092|Ixazomib|ixazomib|mesh-list
93063564|NCT03173092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063565|NCT03173092|Antiemetics|antiemetics|mesh-ancestor
93063566|NCT03173092|Autonomic Agents|autonomic agents|mesh-ancestor
93063567|NCT03173092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063568|NCT03173092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063569|NCT03173092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93063570|NCT03173092|Glucocorticoids|glucocorticoids|mesh-ancestor
93063571|NCT03173092|Hormones|hormones|mesh-ancestor
93063572|NCT03173092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063573|NCT03173092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063574|NCT03173092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063575|NCT03173092|Immunologic Factors|immunologic factors|mesh-ancestor
93063576|NCT03173092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93063577|NCT03173092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93063578|NCT03173092|Growth Substances|growth substances|mesh-ancestor
93063579|NCT03173092|Growth Inhibitors|growth inhibitors|mesh-ancestor
93063580|NCT03173092|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063581|NCT03173092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340363|NCT00002531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93063582|NCT03173092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063584|NCT02966314|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93063585|NCT02966314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93063586|NCT02966314|Respiratory System Agents|respiratory system agents|mesh-ancestor
93063587|NCT01203982|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93063588|NCT01203982|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93063589|NCT01203982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93063590|NCT01203982|Antimetabolites|antimetabolites|mesh-ancestor
93063591|NCT01203982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063592|NCT01203982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93063593|NCT01203982|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93063594|NCT01203982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063596|NCT01202890|Lenalidomide|lenalidomide|mesh-list
93063597|NCT01202890|Doxorubicin|doxorubicin|mesh-list
93063598|NCT01202890|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93063599|NCT01202890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93063600|NCT01202890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063601|NCT01202890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93063602|NCT01202890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93063603|NCT01202890|Growth Substances|growth substances|mesh-ancestor
93063604|NCT01202890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063605|NCT01202890|Growth Inhibitors|growth inhibitors|mesh-ancestor
93063606|NCT01202890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93063607|NCT01202890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93063608|NCT01202890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93063609|NCT01202890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063610|NCT01202890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063611|NCT01202890|Immunologic Factors|immunologic factors|mesh-ancestor
93063612|NCT01199224|Veliparib|veliparib|mesh-list
93063613|NCT01199224|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93063614|NCT01199224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063615|NCT01199224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063616|NCT01199224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063617|NCT01204138|Apremilast|apremilast|mesh-list
93063618|NCT01204138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063619|NCT01204138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063620|NCT01204138|Analgesics|analgesics|mesh-ancestor
93063621|NCT01204138|Sensory System Agents|sensory system agents|mesh-ancestor
93063622|NCT01204138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063623|NCT01204138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063624|NCT01204138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063625|NCT01204138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063626|NCT01204138|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93063627|NCT01204138|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93063628|NCT01204138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063629|NCT01204138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063630|NCT02927392|Leuprolide|leuprolide|mesh-list
93063631|NCT02927392|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93063632|NCT02927392|Fertility Agents|fertility agents|mesh-ancestor
93063633|NCT02927392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93063634|NCT02927392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063635|NCT02927392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93063636|NCT02927392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063637|NCT01204372|Gemcitabine|gemcitabine|mesh-list
93063638|NCT01204372|Trastuzumab|trastuzumab|mesh-list
93063639|NCT01204372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93063640|NCT01204372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063641|NCT01204372|Antimetabolites|antimetabolites|mesh-ancestor
93063642|NCT01204372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063643|NCT01204372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063644|NCT01204372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93063645|NCT01204372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93063647|NCT01204450|Sirolimus|sirolimus|mesh-list
93063648|NCT01204450|Temsirolimus|temsirolimus|mesh-list
93063649|NCT01204450|MTOR Inhibitors|mtor inhibitors|mesh-list
93063650|NCT01204450|Valproic Acid|valproic acid|mesh-list
93063651|NCT01204450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92340366|NCT00002531|Autonomic Agents|autonomic agents|mesh-ancestor
93063652|NCT01204450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063653|NCT01204450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063654|NCT01204450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93063655|NCT01204450|Immunologic Factors|immunologic factors|mesh-ancestor
93063656|NCT01204450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063657|NCT01204450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063658|NCT01204450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063659|NCT01204450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063660|NCT01204450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93063661|NCT01204450|Antifungal Agents|antifungal agents|mesh-ancestor
93063662|NCT01204450|Anticonvulsants|anticonvulsants|mesh-ancestor
93063663|NCT01204450|GABA Agents|gaba agents|mesh-ancestor
93063664|NCT01204450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063665|NCT01204450|Antimanic Agents|antimanic agents|mesh-ancestor
93063666|NCT01204450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93063667|NCT01204450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063668|NCT01204450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063669|NCT03834454|Bupivacaine|bupivacaine|mesh-list
93063670|NCT03834454|Anesthetics, Local|anesthetics, local|mesh-ancestor
93063671|NCT03834454|Anesthetics|anesthetics|mesh-ancestor
93063672|NCT03834454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063673|NCT03834454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063674|NCT03834454|Sensory System Agents|sensory system agents|mesh-ancestor
93063675|NCT03834454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063676|NCT02428270|Trametinib|trametinib|mesh-list
93063677|NCT02428270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063678|NCT02428270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93063679|NCT02428270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063680|NCT02428270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063681|NCT03829930|Entinostat|entinostat|mesh-list
93063682|NCT03829930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063683|NCT03829930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93063684|NCT03829930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063685|NCT03829930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063686|NCT01203202|Clomipramine|clomipramine|mesh-list
93063687|NCT01203202|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93063688|NCT01203202|Antidepressive Agents|antidepressive agents|mesh-ancestor
93063689|NCT01203202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063690|NCT01203202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93063691|NCT01203202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93063692|NCT01203202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063693|NCT01203202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063694|NCT01203202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063695|NCT01203202|Serotonin Agents|serotonin agents|mesh-ancestor
93063696|NCT01203202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063697|NCT02047474|Leucovorin|leucovorin|mesh-list
93063698|NCT02047474|Fluorouracil|fluorouracil|mesh-list
93063699|NCT02047474|Oxaliplatin|oxaliplatin|mesh-list
93063700|NCT02047474|Irinotecan|irinotecan|mesh-list
93063701|NCT02047474|Calcium|calcium|mesh-list
93063702|NCT02047474|Levoleucovorin|levoleucovorin|mesh-list
93063703|NCT02047474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063704|NCT02047474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063705|NCT02047474|Antimetabolites|antimetabolites|mesh-ancestor
93063706|NCT02047474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063707|NCT02047474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063708|NCT02047474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063709|NCT02047474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93063710|NCT02047474|Immunologic Factors|immunologic factors|mesh-ancestor
93063711|NCT02047474|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93063712|NCT02047474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93063713|NCT02047474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063714|NCT02047474|Antidotes|antidotes|mesh-ancestor
93063715|NCT02047474|Protective Agents|protective agents|mesh-ancestor
93063716|NCT02047474|Vitamin B Complex|vitamin b complex|mesh-ancestor
93063717|NCT02047474|Vitamins|vitamins|mesh-ancestor
93063718|NCT02047474|Micronutrients|micronutrients|mesh-ancestor
93063719|NCT01298284|Propranolol|propranolol|mesh-list
93063720|NCT01298284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93063721|NCT01298284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93063722|NCT01298284|Adrenergic Agents|adrenergic agents|mesh-ancestor
93063723|NCT01298284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063724|NCT01298284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063725|NCT01298284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063726|NCT01298284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93063727|NCT01298284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93063728|NCT01298284|Vasodilator Agents|vasodilator agents|mesh-ancestor
93063729|NCT01204840|Hormones|hormones|mesh-list
93063730|NCT01204840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063731|NCT01204840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063732|NCT01203358|Beractant|beractant|mesh-list
93063733|NCT01203358|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
93063734|NCT01203358|Respiratory System Agents|respiratory system agents|mesh-ancestor
93063735|NCT05669560|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93063736|NCT05669560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93063737|NCT05669560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063738|NCT03832426|Ritonavir|ritonavir|mesh-list
93063739|NCT03832426|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93063740|NCT03832426|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93063741|NCT03832426|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063742|NCT03832426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063743|NCT03832426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063744|NCT03832426|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93063745|NCT03832426|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93063746|NCT03832426|Antiviral Agents|antiviral agents|mesh-ancestor
93063747|NCT03832426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063748|NCT03832426|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93063749|NCT03832426|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93063750|NCT03840070|Hyaluronic Acid|hyaluronic acid|mesh-list
93063751|NCT03840070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93063752|NCT03840070|Immunologic Factors|immunologic factors|mesh-ancestor
93063753|NCT03840070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063754|NCT03840070|Viscosupplements|viscosupplements|mesh-ancestor
93063755|NCT03840070|Protective Agents|protective agents|mesh-ancestor
93063756|NCT03272698|Ketamine|ketamine|mesh-list
93063757|NCT03272698|Analgesics|analgesics|mesh-ancestor
93063758|NCT03272698|Sensory System Agents|sensory system agents|mesh-ancestor
93063759|NCT03272698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063760|NCT03272698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063761|NCT03272698|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93063762|NCT03272698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93063763|NCT03272698|Anesthetics, General|anesthetics, general|mesh-ancestor
93063764|NCT03272698|Anesthetics|anesthetics|mesh-ancestor
93063765|NCT03272698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063766|NCT03272698|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93063767|NCT03272698|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93063768|NCT03272698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063769|NCT03272698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063770|NCT01203514|Epoetin Alfa|epoetin alfa|mesh-list
93063771|NCT01203514|Hematinics|hematinics|mesh-ancestor
93063772|NCT01204996|Paclitaxel|paclitaxel|mesh-list
93063773|NCT01204996|Docetaxel|docetaxel|mesh-list
93063774|NCT01204996|Carboplatin|carboplatin|mesh-list
93063775|NCT01204996|Gemcitabine|gemcitabine|mesh-list
93063776|NCT01204996|Doxorubicin|doxorubicin|mesh-list
93063777|NCT01204996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93063778|NCT01204996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93063779|NCT01204996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063780|NCT01204996|Tubulin Modulators|tubulin modulators|mesh-ancestor
93063781|NCT01204996|Antimitotic Agents|antimitotic agents|mesh-ancestor
93063782|NCT01204996|Mitosis Modulators|mitosis modulators|mesh-ancestor
93063783|NCT01204996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063784|NCT01204996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93063785|NCT01204996|Antimetabolites|antimetabolites|mesh-ancestor
93063786|NCT01204996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93063787|NCT01204996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93063788|NCT01204996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93063789|NCT01204996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063790|NCT01297192|Solifenacin Succinate|solifenacin succinate|mesh-list
93063791|NCT01297192|Mirabegron|mirabegron|mesh-list
93063792|NCT01297192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93063793|NCT01297192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93063794|NCT01297192|Cholinergic Agents|cholinergic agents|mesh-ancestor
93063795|NCT01297192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063796|NCT01297192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063797|NCT01297192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063798|NCT01297192|Urological Agents|urological agents|mesh-ancestor
93063799|NCT01297192|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
93063800|NCT01297192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93063801|NCT01297192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93063802|NCT01297192|Adrenergic Agents|adrenergic agents|mesh-ancestor
93063804|NCT01205074|Propranolol|propranolol|mesh-list
93063805|NCT01205074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93063806|NCT01205074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93063807|NCT01205074|Adrenergic Agents|adrenergic agents|mesh-ancestor
93063808|NCT01205074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063809|NCT01205074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063810|NCT01205074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063811|NCT01205074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93063812|NCT01205074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93063813|NCT01205074|Vasodilator Agents|vasodilator agents|mesh-ancestor
93063814|NCT01205074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93063815|NCT01205074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063816|NCT01205074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063817|NCT05667376|Curcumin|curcumin|mesh-list
93063818|NCT05667376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063819|NCT05667376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063820|NCT05667376|Analgesics|analgesics|mesh-ancestor
93063821|NCT05667376|Sensory System Agents|sensory system agents|mesh-ancestor
93063822|NCT05667376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063823|NCT05667376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063824|NCT05667376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063825|NCT05667376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063826|NCT05667376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063827|NCT05667376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063828|NCT05667376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063829|NCT03722524|Amlodipine|amlodipine|mesh-list
93063830|NCT03722524|Perindopril|perindopril|mesh-list
93063831|NCT03722524|Indapamide|indapamide|mesh-list
93063832|NCT03722524|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
93063833|NCT03722524|Diuretics|diuretics|mesh-list
93063834|NCT03722524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
93063835|NCT03722524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93063836|NCT03722524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93063837|NCT03722524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93063838|NCT03722524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063839|NCT03722524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93063840|NCT03722524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063841|NCT03722524|Vasodilator Agents|vasodilator agents|mesh-ancestor
93063842|NCT03722524|Natriuretic Agents|natriuretic agents|mesh-ancestor
93063843|NCT03722524|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063844|NCT03722524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063845|NCT03722524|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93063846|NCT05667220|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93063847|NCT05667220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93063848|NCT05667220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063849|NCT05667220|Incretins|incretins|mesh-ancestor
93063850|NCT05667220|Hormones|hormones|mesh-ancestor
93063851|NCT05667220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063852|NCT05667220|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93063853|NCT05667220|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063854|NCT05667220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063855|NCT05667220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063856|NCT01203592|Albuterol|albuterol|mesh-list
93063857|NCT01203592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93063858|NCT01203592|Autonomic Agents|autonomic agents|mesh-ancestor
93063859|NCT01203592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063860|NCT01203592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063861|NCT01203592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93063862|NCT01203592|Respiratory System Agents|respiratory system agents|mesh-ancestor
93063863|NCT01203592|Tocolytic Agents|tocolytic agents|mesh-ancestor
92132366|NCT02339844|Aripiprazole|aripiprazole|mesh-list
93063864|NCT01203592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93063865|NCT01203592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93063866|NCT01203592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93063867|NCT01203592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93063868|NCT01203592|Adrenergic Agents|adrenergic agents|mesh-ancestor
93063869|NCT01203592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063870|NCT01203592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063871|NCT05281276|Celecoxib|celecoxib|mesh-list
93063872|NCT05281276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063873|NCT05281276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063874|NCT05281276|Analgesics|analgesics|mesh-ancestor
93063875|NCT05281276|Sensory System Agents|sensory system agents|mesh-ancestor
92720955|NCT00562172|Metformin|metformin|mesh-list
93063876|NCT05281276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063877|NCT05281276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063878|NCT05281276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063879|NCT05281276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063880|NCT05281276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93063881|NCT05281276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93063882|NCT05281276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063883|NCT05281276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063884|NCT03829150|Amoxicillin|amoxicillin|mesh-list
93063885|NCT03829150|Metronidazole|metronidazole|mesh-list
93063886|NCT03829150|Clarithromycin|clarithromycin|mesh-list
93063887|NCT03829150|Dexlansoprazole|dexlansoprazole|mesh-list
93063888|NCT03829150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063889|NCT03829150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063890|NCT03829150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93063891|NCT03829150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93063892|NCT03829150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93063893|NCT03829150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063894|NCT03829150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063895|NCT03829150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93063896|NCT03829150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93063897|NCT03829150|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93063898|NCT03829150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93063899|NCT03829150|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93063900|NCT01205464|Doxycycline|doxycycline|mesh-list
93063901|NCT01205464|Tetracycline|tetracycline|mesh-list
93063902|NCT01205464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063903|NCT01205464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063904|NCT01205464|Antimalarials|antimalarials|mesh-ancestor
93063905|NCT01205464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93063906|NCT01205464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93063907|NCT01205464|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93063908|NCT01205464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063909|NCT01205464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063910|NCT03828838|177Lu-PSMA-617|177lu-psma-617|mesh-list
93063911|NCT03828838|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93063912|NCT03828838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063913|NCT03819010|Letrozole|letrozole|mesh-list
93063914|NCT03819010|Palbociclib|palbociclib|mesh-list
93063915|NCT03819010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93063916|NCT03819010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93063917|NCT03819010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93063918|NCT03819010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063919|NCT03819010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063920|NCT03819010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93063921|NCT03819010|Hormone Antagonists|hormone antagonists|mesh-ancestor
93063922|NCT03819010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93063923|NCT03819010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063924|NCT03819010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93063925|NCT03818932|Acetaminophen|acetaminophen|mesh-list
93063926|NCT03818932|Celecoxib|celecoxib|mesh-list
93063927|NCT03818932|Ketorolac|ketorolac|mesh-list
93063928|NCT03818932|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
93063929|NCT03818932|Diazepam|diazepam|mesh-list
93063930|NCT03818932|Gabapentin|gabapentin|mesh-list
93063931|NCT03818932|Hydrocodone|hydrocodone|mesh-list
93063932|NCT03818932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063933|NCT03818932|Analgesics|analgesics|mesh-ancestor
93063934|NCT03818932|Sensory System Agents|sensory system agents|mesh-ancestor
93063935|NCT03818932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063936|NCT03818932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063937|NCT03818932|Antipyretics|antipyretics|mesh-ancestor
93063938|NCT03818932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063939|NCT03818932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063940|NCT03818932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063941|NCT03818932|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93063942|NCT03818932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93063943|NCT03818932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063944|NCT03818932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063945|NCT03818932|Anticonvulsants|anticonvulsants|mesh-ancestor
93063946|NCT03818932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93063947|NCT03818932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93063948|NCT03818932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93063949|NCT03818932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93063950|NCT03818932|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93063951|NCT03818932|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93063952|NCT03818932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93063953|NCT03818932|Antimanic Agents|antimanic agents|mesh-ancestor
93063954|NCT03818932|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93063956|NCT03818932|Antitussive Agents|antitussive agents|mesh-ancestor
93063957|NCT03818932|Respiratory System Agents|respiratory system agents|mesh-ancestor
93063958|NCT03818932|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93063959|NCT03818932|Antiemetics|antiemetics|mesh-ancestor
93063960|NCT03818932|Autonomic Agents|autonomic agents|mesh-ancestor
93063961|NCT03818932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93063962|NCT03818932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93063963|NCT03818932|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93063964|NCT03818932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93063965|NCT03818932|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93063966|NCT03818932|Anesthetics, General|anesthetics, general|mesh-ancestor
93063967|NCT03818932|Anesthetics|anesthetics|mesh-ancestor
93063968|NCT03818932|GABA Modulators|gaba modulators|mesh-ancestor
93063969|NCT03818932|GABA Agents|gaba agents|mesh-ancestor
93063970|NCT01205932|Enoxaparin|enoxaparin|mesh-list
93063971|NCT01205932|Rivaroxaban|rivaroxaban|mesh-list
93063972|NCT01205932|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93063973|NCT01205932|Antithrombins|antithrombins|mesh-ancestor
93063974|NCT01205932|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93063975|NCT01205932|Protease Inhibitors|protease inhibitors|mesh-ancestor
93063976|NCT01205932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063977|NCT01205932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063978|NCT01205932|Anticoagulants|anticoagulants|mesh-ancestor
93063979|NCT01205932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93063980|NCT01205932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93063981|NCT01300780|Etoricoxib|etoricoxib|mesh-list
93063982|NCT01300780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93063983|NCT01300780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93063984|NCT01300780|Analgesics|analgesics|mesh-ancestor
93063985|NCT01300780|Sensory System Agents|sensory system agents|mesh-ancestor
93063986|NCT01300780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93063987|NCT01300780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93063988|NCT01300780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93063989|NCT01300780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93063990|NCT01300780|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93063991|NCT01300780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93063992|NCT01300780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93063993|NCT01300780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93063994|NCT01297816|Minocycline|minocycline|mesh-list
93063995|NCT01297816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93063996|NCT01297816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93063997|NCT01297894|Colistin|colistin|mesh-list
93063998|NCT01297894|Fosfomycin|fosfomycin|mesh-list
93063999|NCT01297894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93064000|NCT01297894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064001|NCT05666362|Benoxinate|benoxinate|mesh-list
93064002|NCT05666362|Anesthetics, Local|anesthetics, local|mesh-ancestor
93064003|NCT05666362|Anesthetics|anesthetics|mesh-ancestor
93064004|NCT05666362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064005|NCT05666362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064006|NCT05666362|Sensory System Agents|sensory system agents|mesh-ancestor
93064007|NCT05666362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064008|NCT01206010|Varenicline|varenicline|mesh-list
93064009|NCT01206010|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93064010|NCT01206010|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93064011|NCT01206010|Cholinergic Agents|cholinergic agents|mesh-ancestor
93064012|NCT01206010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064013|NCT01206010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064014|NCT01206010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064015|NCT05665114|Cytarabine|cytarabine|mesh-list
93064016|NCT05665114|Cyclophosphamide|cyclophosphamide|mesh-list
93064017|NCT05665114|Fludarabine|fludarabine|mesh-list
93064018|NCT05665114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064019|NCT05665114|Immunologic Factors|immunologic factors|mesh-ancestor
93064020|NCT05665114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064021|NCT05665114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064022|NCT05665114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93064023|NCT05665114|Alkylating Agents|alkylating agents|mesh-ancestor
93064024|NCT05665114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064025|NCT05665114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064026|NCT05665114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93064027|NCT05665114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93064028|NCT05665114|Antimetabolites|antimetabolites|mesh-ancestor
93064029|NCT05665114|Antiviral Agents|antiviral agents|mesh-ancestor
93064030|NCT05665114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064032|NCT05345002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064033|NCT05345002|Keratolytic Agents|keratolytic agents|mesh-ancestor
93064034|NCT05345002|Dermatologic Agents|dermatologic agents|mesh-ancestor
93064035|NCT03814642|Esomeprazole|esomeprazole|mesh-list
93064036|NCT03814642|Clopidogrel|clopidogrel|mesh-list
93064037|NCT03814642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93064038|NCT03814642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93064039|NCT03814642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93064040|NCT03814642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93064041|NCT03814642|Purinergic Agents|purinergic agents|mesh-ancestor
93064042|NCT03814642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064043|NCT03814642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064044|NCT03814642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064045|NCT03814642|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064046|NCT03814642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064047|NCT03814642|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93064048|NCT03814642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064049|NCT01299220|Acitretin|acitretin|mesh-list
93064050|NCT01299220|Keratolytic Agents|keratolytic agents|mesh-ancestor
93064051|NCT01299220|Dermatologic Agents|dermatologic agents|mesh-ancestor
93064052|NCT03813784|Capecitabine|capecitabine|mesh-list
93064053|NCT03813784|Oxaliplatin|oxaliplatin|mesh-list
93064054|NCT03813784|Apatinib|apatinib|mesh-list
93064055|NCT03813784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93064056|NCT03813784|Antimetabolites|antimetabolites|mesh-ancestor
93064057|NCT03813784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064058|NCT03813784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064059|NCT03813784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93064060|NCT03813784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064061|NCT03818308|Sofosbuvir|sofosbuvir|mesh-list
93064062|NCT03818308|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
93064063|NCT03818308|Velpatasvir|velpatasvir|mesh-list
93064064|NCT03818308|Antiviral Agents|antiviral agents|mesh-ancestor
92340408|NCT00002291|Pentamidine|pentamidine|mesh-list
93064065|NCT03818308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064066|NCT03827044|Avelumab|avelumab|mesh-list
93064067|NCT03827044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064068|NCT03827044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064069|NCT00145626|Cyclophosphamide|cyclophosphamide|mesh-list
93064070|NCT00145626|Melphalan|melphalan|mesh-list
93064071|NCT00145626|Thiotepa|thiotepa|mesh-list
93064072|NCT00145626|Fludarabine|fludarabine|mesh-list
93064073|NCT00145626|Antibodies|antibodies|mesh-list
93064074|NCT00145626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064075|NCT00145626|Immunologic Factors|immunologic factors|mesh-ancestor
93064076|NCT00145626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064077|NCT00145626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064078|NCT00145626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93064079|NCT00145626|Alkylating Agents|alkylating agents|mesh-ancestor
93064080|NCT00145626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064081|NCT00145626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064082|NCT00145626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93064083|NCT01206946|Betamethasone|betamethasone|mesh-list
93064084|NCT01206946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064085|NCT01206946|Glucocorticoids|glucocorticoids|mesh-ancestor
93064086|NCT01206946|Hormones|hormones|mesh-ancestor
93064087|NCT01206946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064088|NCT01206946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064089|NCT01206946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93064090|NCT01206946|Respiratory System Agents|respiratory system agents|mesh-ancestor
93064091|NCT03813940|Vaccines|vaccines|mesh-list
93064092|NCT03813940|Immunologic Factors|immunologic factors|mesh-ancestor
93064093|NCT03813940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064094|NCT03967938|Olaparib|olaparib|mesh-list
93064095|NCT03967938|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93064096|NCT03967938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064097|NCT03967938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064098|NCT03967938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064099|NCT01299298|Mipomersen|mipomersen|mesh-list
93064100|NCT01299298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93064101|NCT01299298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92721172|NCT04622111|Metformin|metformin|mesh-list
93064102|NCT01299298|Antimetabolites|antimetabolites|mesh-ancestor
93064103|NCT01299298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064104|NCT01299298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93064105|NCT00153062|Telmisartan|telmisartan|mesh-list
93064106|NCT00153062|Clopidogrel|clopidogrel|mesh-list
93064107|NCT00153062|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
93064108|NCT00153062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93064109|NCT00153062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93064110|NCT00153062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93064111|NCT00153062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93064112|NCT00153062|Purinergic Agents|purinergic agents|mesh-ancestor
93064113|NCT00153062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064114|NCT00153062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064115|NCT00153062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064116|NCT00153062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93064117|NCT00153062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93064118|NCT00153062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93064119|NCT00145470|Asenapine|asenapine|mesh-list
93064120|NCT00145470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93064121|NCT00145470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93064122|NCT00145470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064123|NCT00145470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064124|NCT00145470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93064125|NCT03813394|Bevacizumab|bevacizumab|mesh-list
93064126|NCT03813394|Pembrolizumab|pembrolizumab|mesh-list
93064127|NCT03813394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064128|NCT03813394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064129|NCT03813394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93064130|NCT03813394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93064131|NCT03813394|Growth Substances|growth substances|mesh-ancestor
92340412|NCT00002291|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93064132|NCT03813394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064133|NCT03813394|Growth Inhibitors|growth inhibitors|mesh-ancestor
93064134|NCT03813394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93064135|NCT03813394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064136|NCT03813316|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93064137|NCT03813316|Ertugliflozin|ertugliflozin|mesh-list
93064138|NCT03813316|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
93064139|NCT03813316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93064140|NCT03813316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93064141|NCT03813316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064142|NCT03813316|Incretins|incretins|mesh-ancestor
93064143|NCT03813316|Hormones|hormones|mesh-ancestor
93064144|NCT03813316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064145|NCT03813316|Protease Inhibitors|protease inhibitors|mesh-ancestor
93064146|NCT03813316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064147|NCT03813316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064148|NCT01301248|Cisplatin|cisplatin|mesh-list
93064149|NCT01301248|Cetuximab|cetuximab|mesh-list
93064150|NCT01301248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064151|NCT01301248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064152|NCT03817684|BPN14770|bpn14770|mesh-list
93064153|NCT03817684|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
93064154|NCT03817684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93064155|NCT03817684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132653|NCT03664830|Plerixafor|plerixafor|mesh-list
93064156|NCT03817684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064157|NCT01302028|Ipragliflozin|ipragliflozin|mesh-list
93064158|NCT01302028|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93064159|NCT01302028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064160|NCT01302028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93064161|NCT01302028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064162|NCT01302106|Clofarabine|clofarabine|mesh-list
93064163|NCT01302106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93064164|NCT01302106|Antimetabolites|antimetabolites|mesh-ancestor
93064165|NCT01302106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064166|NCT01302106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064167|NCT00152516|Levetiracetam|levetiracetam|mesh-list
93064168|NCT00152516|Anticonvulsants|anticonvulsants|mesh-ancestor
93064169|NCT00152516|Nootropic Agents|nootropic agents|mesh-ancestor
93064170|NCT00145158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
93064171|NCT00145158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93064172|NCT00145158|Immunologic Factors|immunologic factors|mesh-ancestor
93064173|NCT00145158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064174|NCT05624008|Methamphetamine|methamphetamine|mesh-list
93064175|NCT05624008|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92721257|NCT04588935|Bisoprolol|bisoprolol|mesh-list
93064176|NCT05624008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064177|NCT05624008|Sympathomimetics|sympathomimetics|mesh-ancestor
93064178|NCT05624008|Autonomic Agents|autonomic agents|mesh-ancestor
93064179|NCT05624008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064180|NCT05624008|Dopamine Agents|dopamine agents|mesh-ancestor
93064181|NCT05624008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064182|NCT05624008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064183|NCT05624008|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064184|NCT05624008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93064185|NCT05624008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93064186|NCT05624008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064187|NCT05624008|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93064188|NCT05623852|Fucoidan|fucoidan|mesh-list
93064189|NCT05623852|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064190|NCT05623852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064191|NCT05623852|Anticoagulants|anticoagulants|mesh-ancestor
93064192|NCT05623852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064193|NCT01302340|Dronabinol|dronabinol|mesh-list
93064194|NCT01302340|Hallucinogens|hallucinogens|mesh-ancestor
93064195|NCT01302340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064196|NCT01302340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93064197|NCT01302340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064198|NCT01302340|Analgesics|analgesics|mesh-ancestor
93064199|NCT01302340|Sensory System Agents|sensory system agents|mesh-ancestor
93064200|NCT01302340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064201|NCT01302340|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93064202|NCT01302340|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92340420|NCT00002549|Idarubicin|idarubicin|mesh-list
93064203|NCT01302340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064204|NCT01302340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064205|NCT01302340|Hormones|hormones|mesh-ancestor
93064206|NCT01302340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064207|NCT00150800|Brivaracetam|brivaracetam|mesh-list
93064208|NCT00150800|Anticonvulsants|anticonvulsants|mesh-ancestor
93064209|NCT03812770|Leucovorin|leucovorin|mesh-list
93064210|NCT03812770|Fluorouracil|fluorouracil|mesh-list
93064211|NCT03812770|Oxaliplatin|oxaliplatin|mesh-list
93064212|NCT03812770|Sorafenib|sorafenib|mesh-list
93064213|NCT03812770|Antimetabolites|antimetabolites|mesh-ancestor
93064214|NCT03812770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064215|NCT03812770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93064216|NCT03812770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064217|NCT03812770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064218|NCT03812770|Immunologic Factors|immunologic factors|mesh-ancestor
93064219|NCT03812770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064220|NCT03812770|Antidotes|antidotes|mesh-ancestor
93064221|NCT03812770|Protective Agents|protective agents|mesh-ancestor
93064222|NCT03812770|Vitamin B Complex|vitamin b complex|mesh-ancestor
93064223|NCT03812770|Vitamins|vitamins|mesh-ancestor
93064224|NCT03812770|Micronutrients|micronutrients|mesh-ancestor
93064225|NCT03812770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93064226|NCT03812770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064227|NCT00144300|Pramipexole|pramipexole|mesh-list
93064228|NCT00144300|Antioxidants|antioxidants|mesh-ancestor
93064229|NCT00144300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064230|NCT00144300|Protective Agents|protective agents|mesh-ancestor
93064231|NCT00144300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064232|NCT00144300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93064233|NCT00144300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93064234|NCT00144300|Dopamine Agonists|dopamine agonists|mesh-ancestor
93064235|NCT00144300|Dopamine Agents|dopamine agents|mesh-ancestor
93064236|NCT00144300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064237|NCT00149630|Disulfiram|disulfiram|mesh-list
93064238|NCT00149630|Methadone|methadone|mesh-list
93064239|NCT00149630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93064240|NCT00149630|Narcotics|narcotics|mesh-ancestor
93064241|NCT00149630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064242|NCT00149630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064243|NCT00149630|Analgesics|analgesics|mesh-ancestor
93064244|NCT00149630|Sensory System Agents|sensory system agents|mesh-ancestor
93064245|NCT00149630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064246|NCT00149630|Antitussive Agents|antitussive agents|mesh-ancestor
93064247|NCT00149630|Respiratory System Agents|respiratory system agents|mesh-ancestor
93064248|NCT00149630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
93064249|NCT00149630|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
93064250|NCT00149630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064251|NCT00149630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064252|NCT01302496|Ipilimumab|ipilimumab|mesh-list
93064253|NCT01302496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064254|NCT01302496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064255|NCT01302496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93064256|NCT01302496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064257|NCT00127842|Etanercept|etanercept|mesh-list
93064258|NCT00127842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93064259|NCT00127842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064260|NCT00127842|Analgesics|analgesics|mesh-ancestor
93064261|NCT00127842|Sensory System Agents|sensory system agents|mesh-ancestor
93064262|NCT00127842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064263|NCT00127842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064264|NCT00127842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064265|NCT00127842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064266|NCT00127842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064267|NCT00127842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064268|NCT00127842|Immunologic Factors|immunologic factors|mesh-ancestor
93064269|NCT01075802|Tamoxifen|tamoxifen|mesh-list
93064270|NCT01075802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93064271|NCT01075802|Hormone Antagonists|hormone antagonists|mesh-ancestor
93064272|NCT01075802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064273|NCT01075802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064274|NCT01075802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93064275|NCT01075802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064276|NCT01075802|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93064277|NCT01075802|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93064278|NCT01075802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93064279|NCT03816592|Analgesics, Opioid|analgesics, opioid|mesh-list
93064280|NCT03816592|Anesthetics|anesthetics|mesh-list
93064281|NCT03816592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064282|NCT03816592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064283|NCT03816592|Narcotics|narcotics|mesh-ancestor
93064284|NCT03816592|Analgesics|analgesics|mesh-ancestor
93064285|NCT03816592|Sensory System Agents|sensory system agents|mesh-ancestor
93064286|NCT03816592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064287|NCT01078038|Sirolimus|sirolimus|mesh-list
93064288|NCT01078038|Everolimus|everolimus|mesh-list
93064289|NCT01078038|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93064290|NCT01078038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93064291|NCT01078038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064292|NCT01078038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064293|NCT01078038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064294|NCT01078038|Immunologic Factors|immunologic factors|mesh-ancestor
93064295|NCT01078038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064296|NCT01078038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064297|NCT01078038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93064298|NCT01078038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064299|NCT01078038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93064300|NCT01078038|Antifungal Agents|antifungal agents|mesh-ancestor
93064301|NCT00223496|Aripiprazole|aripiprazole|mesh-list
93064302|NCT00223496|Antidepressive Agents|antidepressive agents|mesh-ancestor
93064303|NCT00223496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93064304|NCT00223496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93064305|NCT00223496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93064306|NCT00223496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064307|NCT00223496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064308|NCT00223496|Dopamine Agonists|dopamine agonists|mesh-ancestor
93064309|NCT00223496|Dopamine Agents|dopamine agents|mesh-ancestor
93064310|NCT00223496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064311|NCT00223496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064312|NCT00223496|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93064313|NCT00223496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93064314|NCT00223496|Serotonin Agents|serotonin agents|mesh-ancestor
93064315|NCT00223496|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93064316|NCT00223496|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93064317|NCT00223496|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93064318|NCT00223496|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93064319|NCT02531412|Spironolactone|spironolactone|mesh-list
93064320|NCT02531412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93064321|NCT02531412|Hormone Antagonists|hormone antagonists|mesh-ancestor
93064322|NCT02531412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064323|NCT02531412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064324|NCT02531412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93064325|NCT02531412|Diuretics|diuretics|mesh-ancestor
93064326|NCT02531412|Natriuretic Agents|natriuretic agents|mesh-ancestor
93064328|NCT00126672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93064329|NCT00126672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064330|NCT00126672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93064331|NCT00126672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064332|NCT00126672|Antifungal Agents|antifungal agents|mesh-ancestor
93064333|NCT00126672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064334|NCT00126672|Immunologic Factors|immunologic factors|mesh-ancestor
93064335|NCT00126672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064336|NCT00145574|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
93064337|NCT00145574|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93064338|NCT00145574|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93064339|NCT00145574|Antimetabolites|antimetabolites|mesh-ancestor
93064340|NCT00145574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993030|NCT02674399|Hylan|hylan|mesh-list
93064341|NCT00145574|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93064342|NCT05034562|Edetic Acid|edetic acid|mesh-list
93064343|NCT05034562|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
93064344|NCT05034562|Chelating Agents|chelating agents|mesh-ancestor
93064345|NCT05034562|Sequestering Agents|sequestering agents|mesh-ancestor
93064346|NCT05034562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064347|NCT05034562|Anticoagulants|anticoagulants|mesh-ancestor
93064348|NCT05034562|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93064349|NCT05034562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93064350|NCT00145496|Olanzapine|olanzapine|mesh-list
93064351|NCT00145496|Asenapine|asenapine|mesh-list
93064352|NCT00145496|Antiemetics|antiemetics|mesh-ancestor
93064353|NCT00145496|Autonomic Agents|autonomic agents|mesh-ancestor
93064354|NCT00145496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064355|NCT00145496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064356|NCT00145496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064357|NCT00145496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93064358|NCT00145496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93064359|NCT00145496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064360|NCT00145496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93064361|NCT00145496|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93064362|NCT00145496|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93064363|NCT00145496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064364|NCT00145496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064365|NCT00145496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064366|NCT00145496|Serotonin Agents|serotonin agents|mesh-ancestor
93064367|NCT01299922|Cyclosporine|cyclosporine|mesh-list
93064368|NCT01299922|Mycophenolic Acid|mycophenolic acid|mesh-list
93064369|NCT01299922|Cyclosporins|cyclosporins|mesh-list
93064370|NCT01299922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064371|NCT01299922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064372|NCT01299922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530679|NCT00043069|Hormones|hormones|mesh-ancestor
93064374|NCT01299922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064375|NCT01299922|Antifungal Agents|antifungal agents|mesh-ancestor
93064376|NCT01299922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064377|NCT01299922|Dermatologic Agents|dermatologic agents|mesh-ancestor
93064378|NCT01299922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064379|NCT01299922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93064380|NCT01299922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93064381|NCT01299922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064382|NCT01299922|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93064383|NCT01299922|Antitubercular Agents|antitubercular agents|mesh-ancestor
93064384|NCT01299922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93064385|NCT05030818|Aspirin|aspirin|mesh-list
93064386|NCT05030818|Ramipril|ramipril|mesh-list
93064387|NCT05030818|Atorvastatin|atorvastatin|mesh-list
93064388|NCT05030818|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93064389|NCT05030818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93064390|NCT05030818|Antimetabolites|antimetabolites|mesh-ancestor
93064391|NCT05030818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064392|NCT05030818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93064393|NCT05030818|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93064394|NCT05030818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064395|NCT05030818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93064396|NCT05030818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064397|NCT05030818|Analgesics|analgesics|mesh-ancestor
93064398|NCT05030818|Sensory System Agents|sensory system agents|mesh-ancestor
93064399|NCT05030818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064400|NCT05030818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064401|NCT05030818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064402|NCT05030818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064403|NCT05030818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92340433|NCT00002549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064404|NCT05030818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93064405|NCT05030818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93064406|NCT05030818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93064407|NCT05030818|Antipyretics|antipyretics|mesh-ancestor
93064408|NCT05030818|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93064409|NCT05030818|Protease Inhibitors|protease inhibitors|mesh-ancestor
93064410|NCT05030818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93064411|NCT01582022|Bupivacaine|bupivacaine|mesh-list
93064412|NCT01582022|Anesthetics, Local|anesthetics, local|mesh-ancestor
93064413|NCT01582022|Anesthetics|anesthetics|mesh-ancestor
93064414|NCT01582022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064415|NCT01582022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064416|NCT01582022|Sensory System Agents|sensory system agents|mesh-ancestor
93064417|NCT01582022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064418|NCT01582412|Isavuconazole|isavuconazole|mesh-list
93064420|NCT01582412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93064421|NCT01582412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93064422|NCT01582412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064423|NCT01582412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064424|NCT01582412|Protective Agents|protective agents|mesh-ancestor
93064425|NCT01582412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064426|NCT01582412|Antifungal Agents|antifungal agents|mesh-ancestor
93064427|NCT01582412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064428|NCT00255164|Dexlansoprazole|dexlansoprazole|mesh-list
93064429|NCT00255164|Lansoprazole|lansoprazole|mesh-list
93064430|NCT00255164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064431|NCT00255164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064432|NCT00255164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93064433|NCT00255164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064434|NCT00255164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064435|NCT01300156|Oxaliplatin|oxaliplatin|mesh-list
93064436|NCT01300156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064437|NCT00126594|Interferons|interferons|mesh-list
93064438|NCT00126594|Interferon-alpha|interferon-alpha|mesh-list
93064439|NCT00126594|Interferon alpha-2|interferon alpha-2|mesh-list
93064440|NCT00126594|Sorafenib|sorafenib|mesh-list
93064441|NCT00126594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064442|NCT00126594|Antiviral Agents|antiviral agents|mesh-ancestor
93064443|NCT00126594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064444|NCT00126594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93064445|NCT00126594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530681|NCT00043069|Antacids|antacids|mesh-ancestor
93064446|NCT00126594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064447|NCT00126594|Immunologic Factors|immunologic factors|mesh-ancestor
93064448|NCT00126594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064449|NCT01080456|Tacrolimus|tacrolimus|mesh-list
93064450|NCT01080456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064451|NCT01080456|Immunologic Factors|immunologic factors|mesh-ancestor
93064452|NCT01080456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064453|NCT01080456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93064454|NCT01080456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064455|NCT01080456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064456|NCT03811054|Apatinib|apatinib|mesh-list
93064457|NCT03811054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064458|NCT03811054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93064459|NCT03811054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064460|NCT03811054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064461|NCT00126438|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
93064462|NCT00126438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064463|NCT00126438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064464|NCT00126438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064465|NCT00126438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93064466|NCT01075854|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93064467|NCT01075854|Hormones|hormones|mesh-ancestor
93064468|NCT01075854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064469|NCT01075854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064470|NCT03967392|Lidocaine|lidocaine|mesh-list
93064471|NCT03967392|Anesthetics, Local|anesthetics, local|mesh-ancestor
93064472|NCT03967392|Anesthetics|anesthetics|mesh-ancestor
93064473|NCT03967392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064474|NCT03967392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064475|NCT03967392|Sensory System Agents|sensory system agents|mesh-ancestor
93064476|NCT03967392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064477|NCT03967392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93064478|NCT03967392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93064479|NCT03967392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93064480|NCT03967392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064481|NCT03967392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064482|NCT04898764|Mometasone Furoate|mometasone furoate|mesh-list
93064483|NCT04898764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064484|NCT04898764|Dermatologic Agents|dermatologic agents|mesh-ancestor
93064485|NCT04898764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93064486|NCT00142584|Metoprolol|metoprolol|mesh-list
93064487|NCT00142584|Nebivolol|nebivolol|mesh-list
93064488|NCT00142584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93064489|NCT00142584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93064490|NCT00142584|Sympatholytics|sympatholytics|mesh-ancestor
93064491|NCT00142584|Autonomic Agents|autonomic agents|mesh-ancestor
93064492|NCT00142584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064493|NCT00142584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064494|NCT00142584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93064495|NCT00142584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93064496|NCT00142584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93064497|NCT00142584|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064498|NCT00142584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064499|NCT00142584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064500|NCT00142584|Vasodilator Agents|vasodilator agents|mesh-ancestor
93064501|NCT00142584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93064502|NCT00142584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93064503|NCT00142584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93064504|NCT04848064|Cyclophosphamide|cyclophosphamide|mesh-list
93064505|NCT04848064|Fludarabine|fludarabine|mesh-list
93064506|NCT04848064|Mogamulizumab|mogamulizumab|mesh-list
93064507|NCT04848064|Immunoglobulins|immunoglobulins|mesh-list
93064508|NCT04848064|Immunoglobulin G|immunoglobulin g|mesh-list
93064509|NCT04848064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064510|NCT04848064|Immunologic Factors|immunologic factors|mesh-ancestor
93064511|NCT04848064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064512|NCT04848064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064513|NCT04848064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93064514|NCT04848064|Alkylating Agents|alkylating agents|mesh-ancestor
93064515|NCT04848064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064516|NCT04848064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064517|NCT04848064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93064518|NCT03816046|Botulinum Toxins|botulinum toxins|mesh-list
93064519|NCT03816046|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93064520|NCT03816046|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93064521|NCT03816046|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93064522|NCT03816046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064523|NCT03816046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064524|NCT03816046|Cholinergic Agents|cholinergic agents|mesh-ancestor
93064525|NCT03816046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064526|NCT03816046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064527|NCT03816046|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93064528|NCT03816046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064529|NCT01080534|Tacrolimus|tacrolimus|mesh-list
93064530|NCT01080534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064531|NCT01080534|Immunologic Factors|immunologic factors|mesh-ancestor
93064532|NCT01080534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064533|NCT01080534|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93064534|NCT01080534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064535|NCT01080534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064536|NCT00125190|Mecasermin|mecasermin|mesh-list
93064537|NCT00125190|Growth Substances|growth substances|mesh-ancestor
93064538|NCT00125190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064539|NCT00141726|Etanercept|etanercept|mesh-list
93064540|NCT00141726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93064541|NCT00141726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064542|NCT00141726|Analgesics|analgesics|mesh-ancestor
93064543|NCT00141726|Sensory System Agents|sensory system agents|mesh-ancestor
93064544|NCT00141726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064545|NCT00141726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064546|NCT00141726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064547|NCT00141726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064548|NCT00141726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064549|NCT00141726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93064550|NCT00141726|Immunologic Factors|immunologic factors|mesh-ancestor
93064551|NCT03967548|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93064552|NCT03967548|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93064553|NCT01301716|Paclitaxel|paclitaxel|mesh-list
93064554|NCT01301716|Bevacizumab|bevacizumab|mesh-list
93064555|NCT01301716|Carboplatin|carboplatin|mesh-list
93064556|NCT01301716|Pemetrexed|pemetrexed|mesh-list
93064557|NCT01301716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93064558|NCT01301716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064559|NCT01301716|Tubulin Modulators|tubulin modulators|mesh-ancestor
93064560|NCT01301716|Antimitotic Agents|antimitotic agents|mesh-ancestor
93064561|NCT01301716|Mitosis Modulators|mitosis modulators|mesh-ancestor
93064562|NCT01301716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064563|NCT01301716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064564|NCT01301716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93064565|NCT01301716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93064566|NCT01301716|Growth Substances|growth substances|mesh-ancestor
93064567|NCT01301716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064568|NCT01301716|Growth Inhibitors|growth inhibitors|mesh-ancestor
93064569|NCT01301716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064570|NCT01301716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93064571|NCT01301716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93064572|NCT01303042|Insulin Lispro|insulin lispro|mesh-list
93064573|NCT01303042|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
93064574|NCT01303042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93064575|NCT01303042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064576|NCT01300312|Diclofenac|diclofenac|mesh-list
93064577|NCT01300312|Eperisone|eperisone|mesh-list
93064578|NCT01300312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93064579|NCT01300312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064580|NCT01300312|Analgesics|analgesics|mesh-ancestor
93064581|NCT01300312|Sensory System Agents|sensory system agents|mesh-ancestor
93064582|NCT01300312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064583|NCT01300312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064584|NCT01300312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064585|NCT01300312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064586|NCT01300312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93064587|NCT01300312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064588|NCT01300312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064589|NCT01300312|Anticonvulsants|anticonvulsants|mesh-ancestor
93064590|NCT01300312|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93064591|NCT01300312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064592|NCT01300312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93064593|NCT01300312|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93064594|NCT01300312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93064595|NCT01300312|Parasympatholytics|parasympatholytics|mesh-ancestor
93064596|NCT01300312|Autonomic Agents|autonomic agents|mesh-ancestor
93064597|NCT01300312|Vasodilator Agents|vasodilator agents|mesh-ancestor
93064598|NCT01567384|Pemetrexed|pemetrexed|mesh-list
93064599|NCT01567384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064600|NCT01567384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340459|NCT00002561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93064601|NCT01567384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064602|NCT01567384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93064603|NCT01567384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93064604|NCT01080612|Pregabalin|pregabalin|mesh-list
93064605|NCT01080612|Analgesics|analgesics|mesh-ancestor
93064606|NCT01080612|Sensory System Agents|sensory system agents|mesh-ancestor
93064607|NCT01080612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064608|NCT01080612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064609|NCT01080612|Anticonvulsants|anticonvulsants|mesh-ancestor
93064610|NCT01080612|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93064611|NCT01080612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064612|NCT01080612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064613|NCT01080612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93064614|NCT01080612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93064615|NCT01080612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93064616|NCT01080612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064617|NCT01080612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93064618|NCT03815344|Misoprostol|misoprostol|mesh-list
93064619|NCT03815344|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93064620|NCT03815344|Abortifacient Agents|abortifacient agents|mesh-ancestor
93064621|NCT03815344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93064622|NCT03815344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721691|NCT04617782|Donepezil|donepezil|mesh-list
93064623|NCT03815344|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064624|NCT03815344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064625|NCT03815344|Oxytocics|oxytocics|mesh-ancestor
93064626|NCT03819790|Insulin|insulin|mesh-list
93064627|NCT03819790|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93064628|NCT03819790|Metformin|metformin|mesh-list
93064629|NCT03819790|Insulin Glargine|insulin glargine|mesh-list
93064630|NCT03819790|Lixisenatide|lixisenatide|mesh-list
93064631|NCT03819790|Gliclazide|gliclazide|mesh-list
93064632|NCT03819790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93064633|NCT03819790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064634|NCT01560442|Buprenorphine|buprenorphine|mesh-list
93064635|NCT01560442|Methadone|methadone|mesh-list
93064636|NCT01560442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93064637|NCT01560442|Narcotics|narcotics|mesh-ancestor
93064638|NCT01560442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064639|NCT01560442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064640|NCT01560442|Analgesics|analgesics|mesh-ancestor
93064641|NCT01560442|Sensory System Agents|sensory system agents|mesh-ancestor
93064642|NCT01560442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064643|NCT01560442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93064644|NCT01560442|Antitussive Agents|antitussive agents|mesh-ancestor
93064645|NCT01560442|Respiratory System Agents|respiratory system agents|mesh-ancestor
93064646|NCT00110994|Sorafenib|sorafenib|mesh-list
93064647|NCT00110994|Dacarbazine|dacarbazine|mesh-list
93064648|NCT00110994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064649|NCT00110994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93064650|NCT00110994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064651|NCT00110994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064652|NCT00110994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93064653|NCT00110994|Alkylating Agents|alkylating agents|mesh-ancestor
93064654|NCT01560052|Methylprednisolone|methylprednisolone|mesh-list
93064655|NCT01560052|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93064656|NCT01560052|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93064658|NCT01560052|Prednisolone acetate|prednisolone acetate|mesh-list
93064659|NCT01560052|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93064660|NCT01560052|Prednisolone phosphate|prednisolone phosphate|mesh-list
93064661|NCT01560052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064662|NCT01560052|Antiemetics|antiemetics|mesh-ancestor
93064663|NCT01560052|Autonomic Agents|autonomic agents|mesh-ancestor
93064664|NCT01560052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064665|NCT01560052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064666|NCT01560052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064667|NCT01560052|Glucocorticoids|glucocorticoids|mesh-ancestor
93064668|NCT01560052|Hormones|hormones|mesh-ancestor
93064669|NCT01560052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064670|NCT01560052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93064671|NCT01560052|Protective Agents|protective agents|mesh-ancestor
93064672|NCT01560052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93064673|NCT01560052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064674|NCT05098132|Pembrolizumab|pembrolizumab|mesh-list
93064675|NCT05098132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064676|NCT05098132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064677|NCT05098132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93064678|NCT05098132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064679|NCT04356352|Lidocaine|lidocaine|mesh-list
93064680|NCT04356352|Esmolol|esmolol|mesh-list
93064681|NCT04356352|Anesthetics, Local|anesthetics, local|mesh-ancestor
93064682|NCT04356352|Anesthetics|anesthetics|mesh-ancestor
93064683|NCT04356352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064684|NCT04356352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064685|NCT04356352|Sensory System Agents|sensory system agents|mesh-ancestor
93064686|NCT04356352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064687|NCT04356352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93064688|NCT04356352|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93064689|NCT04356352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93064690|NCT04356352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064691|NCT04356352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064692|NCT04356352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93064693|NCT04356352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93064694|NCT04356352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93064695|NCT04356352|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064696|NCT04356352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064697|NCT05622994|Rimonabant|rimonabant|mesh-list
93064698|NCT05622994|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93064699|NCT05622994|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
93064700|NCT05622994|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93064701|NCT05622994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064702|NCT05622994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064703|NCT05622994|Hormones|hormones|mesh-ancestor
93064704|NCT05622994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064705|NCT05622994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064706|NCT05622916|Ethanol|ethanol|mesh-list
93064707|NCT05622916|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93064708|NCT05622916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064709|NCT05622916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064710|NCT05622916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064711|NCT03819556|Caseins|caseins|mesh-list
93064712|NCT03819556|Chelating Agents|chelating agents|mesh-ancestor
93064713|NCT03819556|Sequestering Agents|sequestering agents|mesh-ancestor
93064714|NCT03819556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064715|NCT03804034|Molybdenum|molybdenum|mesh-list
93064716|NCT03804034|Trace Elements|trace elements|mesh-ancestor
93064717|NCT03804034|Micronutrients|micronutrients|mesh-ancestor
93064718|NCT03804034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064719|NCT04246762|Vitamin K|vitamin k|mesh-list
93064720|NCT04246762|Midazolam|midazolam|mesh-list
93064721|NCT04246762|Caffeine|caffeine|mesh-list
93064722|NCT04246762|Omeprazole|omeprazole|mesh-list
93064723|NCT04246762|Warfarin|warfarin|mesh-list
93064724|NCT04246762|Vitamins|vitamins|mesh-ancestor
93064725|NCT04246762|Micronutrients|micronutrients|mesh-ancestor
93064726|NCT04246762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064727|NCT04246762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93064728|NCT04246762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93064729|NCT04246762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064731|NCT04246762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93064732|NCT04246762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93064733|NCT04246762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93064734|NCT04246762|Anesthetics, General|anesthetics, general|mesh-ancestor
93064735|NCT04246762|Anesthetics|anesthetics|mesh-ancestor
93064736|NCT04246762|GABA Modulators|gaba modulators|mesh-ancestor
93064737|NCT04246762|GABA Agents|gaba agents|mesh-ancestor
93064738|NCT04246762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064739|NCT04246762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064740|NCT04246762|Anticoagulants|anticoagulants|mesh-ancestor
93064741|NCT04246762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93064742|NCT04246762|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93064743|NCT04246762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064744|NCT04246762|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93064745|NCT04246762|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93064746|NCT04246762|Purinergic Agents|purinergic agents|mesh-ancestor
93064747|NCT04246762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064748|NCT04246762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064749|NCT04246762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93064750|NCT04246762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93064751|NCT04246762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93064752|NCT04246762|Hemostatics|hemostatics|mesh-ancestor
93064753|NCT04246762|Coagulants|coagulants|mesh-ancestor
93064754|NCT03799120|Tamsulosin|tamsulosin|mesh-list
93064755|NCT03799120|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
93064756|NCT03799120|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93064757|NCT03799120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93064758|NCT03799120|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064759|NCT03799120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064760|NCT03799120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064761|NCT03799120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064762|NCT03799120|Urological Agents|urological agents|mesh-ancestor
93064763|NCT03792724|Nivolumab|nivolumab|mesh-list
93064764|NCT03792724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93064765|NCT03792724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064766|NCT03792724|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93064767|NCT03792724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064768|NCT00144170|Ritonavir|ritonavir|mesh-list
93064769|NCT00144170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93064770|NCT00144170|Tipranavir|tipranavir|mesh-list
93064771|NCT00144170|Protease Inhibitors|protease inhibitors|mesh-list
93064772|NCT00144170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93064773|NCT00144170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064774|NCT00144170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064775|NCT00144170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93064776|NCT00144170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93064777|NCT00144170|Antiviral Agents|antiviral agents|mesh-ancestor
93064778|NCT00144170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064779|NCT00144170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93064780|NCT00144170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93064781|NCT00255086|Memantine|memantine|mesh-list
93064782|NCT00255086|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93064783|NCT00255086|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93064784|NCT00255086|Dopamine Agents|dopamine agents|mesh-ancestor
93064785|NCT00255086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064786|NCT00255086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064787|NCT00255086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064788|NCT00255086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93064789|NCT00255086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93064790|NCT00110214|Prednisone|prednisone|mesh-list
93064791|NCT00110214|Bevacizumab|bevacizumab|mesh-list
93064792|NCT00110214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93064793|NCT00110214|Docetaxel|docetaxel|mesh-list
93064794|NCT00110214|Antibodies|antibodies|mesh-list
93064795|NCT00110214|Immunoglobulins|immunoglobulins|mesh-list
93064796|NCT00110214|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93064797|NCT00110214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064798|NCT00110214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93064799|NCT00110214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93064800|NCT00110214|Growth Substances|growth substances|mesh-ancestor
93064801|NCT00110214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064802|NCT00110214|Growth Inhibitors|growth inhibitors|mesh-ancestor
93064803|NCT00110214|Immunologic Factors|immunologic factors|mesh-ancestor
93064804|NCT00110214|Tubulin Modulators|tubulin modulators|mesh-ancestor
93064805|NCT00110214|Antimitotic Agents|antimitotic agents|mesh-ancestor
93064806|NCT00110214|Mitosis Modulators|mitosis modulators|mesh-ancestor
93064807|NCT00110214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064808|NCT00110214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064809|NCT00110214|Glucocorticoids|glucocorticoids|mesh-ancestor
93064810|NCT00110214|Hormones|hormones|mesh-ancestor
93064811|NCT00110214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064812|NCT00110214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93064813|NCT04176172|Nicotine|nicotine|mesh-list
93064814|NCT04176172|Varenicline|varenicline|mesh-list
93064815|NCT04176172|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93064816|NCT04176172|Autonomic Agents|autonomic agents|mesh-ancestor
93064817|NCT04176172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064818|NCT04176172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064819|NCT04176172|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93064820|NCT04176172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93064821|NCT04176172|Cholinergic Agents|cholinergic agents|mesh-ancestor
93064822|NCT04176172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064823|NCT04176172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064824|NCT03795844|Liver Extracts|liver extracts|mesh-list
93064825|NCT03795844|Hematinics|hematinics|mesh-ancestor
93064826|NCT05669170|Methylphenidate|methylphenidate|mesh-list
93064827|NCT05669170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93064828|NCT05669170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064829|NCT05669170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93064830|NCT05669170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93064831|NCT05669170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93064832|NCT05669170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064833|NCT05669170|Dopamine Agents|dopamine agents|mesh-ancestor
93064834|NCT05669170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064835|NCT03799822|Vitamin K|vitamin k|mesh-list
93064836|NCT03799822|Rivaroxaban|rivaroxaban|mesh-list
93064837|NCT03799822|Vitamins|vitamins|mesh-ancestor
93064838|NCT03799822|Micronutrients|micronutrients|mesh-ancestor
93064839|NCT03799822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064840|NCT03799822|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93064841|NCT03799822|Antithrombins|antithrombins|mesh-ancestor
93064842|NCT03799822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93064843|NCT03799822|Protease Inhibitors|protease inhibitors|mesh-ancestor
93064844|NCT03799822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064845|NCT03799822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064846|NCT03799822|Anticoagulants|anticoagulants|mesh-ancestor
93064847|NCT03799822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93064848|NCT03799822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93064849|NCT03799822|Hemostatics|hemostatics|mesh-ancestor
93064850|NCT03799822|Coagulants|coagulants|mesh-ancestor
93064851|NCT03799900|Ketamine|ketamine|mesh-list
93064852|NCT03799900|Analgesics|analgesics|mesh-ancestor
93064853|NCT03799900|Sensory System Agents|sensory system agents|mesh-ancestor
93064854|NCT03799900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064855|NCT03799900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064856|NCT03799900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93064857|NCT03799900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93064858|NCT03799900|Anesthetics, General|anesthetics, general|mesh-ancestor
93064859|NCT03799900|Anesthetics|anesthetics|mesh-ancestor
93064860|NCT03799900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064861|NCT03799900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93064862|NCT03799900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93064863|NCT03799900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064864|NCT03799900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064865|NCT05624866|Triamcinolone|triamcinolone|mesh-list
93064866|NCT05624866|Dexmedetomidine|dexmedetomidine|mesh-list
93064867|NCT05624866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93064868|NCT05624866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064869|NCT05624866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064870|NCT05624866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064871|NCT05624866|Analgesics|analgesics|mesh-ancestor
93064872|NCT05624866|Sensory System Agents|sensory system agents|mesh-ancestor
93064873|NCT05624866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064874|NCT05624866|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93064875|NCT05624866|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93064876|NCT05624866|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93064877|NCT05624866|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064878|NCT05624866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064879|NCT05624866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064880|NCT05624866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064881|NCT05624866|Glucocorticoids|glucocorticoids|mesh-ancestor
93064882|NCT05624866|Hormones|hormones|mesh-ancestor
93064883|NCT05624866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064884|NCT01304602|Irinotecan|irinotecan|mesh-list
93064885|NCT01304602|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93064886|NCT01304602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93064887|NCT01304602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064888|NCT01304602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064889|NCT01304602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064890|NCT01304134|Morphine|morphine|mesh-list
93064891|NCT01304134|Oxycodone|oxycodone|mesh-list
93064892|NCT01304134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93064893|NCT01304134|Narcotics|narcotics|mesh-ancestor
93064894|NCT01304134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064895|NCT01304134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064896|NCT01304134|Analgesics|analgesics|mesh-ancestor
93064897|NCT01304134|Sensory System Agents|sensory system agents|mesh-ancestor
93064898|NCT01304134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064899|NCT00124020|Vancomycin|vancomycin|mesh-list
93064900|NCT00124020|Telavancin|telavancin|mesh-list
93064901|NCT00124020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93064902|NCT00124020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064903|NCT05630794|TIC10 compound|tic10 compound|mesh-list
93064904|NCT05630794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064905|NCT01080846|Misoprostol|misoprostol|mesh-list
93064906|NCT01080846|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93064907|NCT01080846|Abortifacient Agents|abortifacient agents|mesh-ancestor
93064908|NCT01080846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93064909|NCT01080846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064910|NCT01080846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064911|NCT01080846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064912|NCT01080846|Oxytocics|oxytocics|mesh-ancestor
93064913|NCT01076322|Albuterol|albuterol|mesh-list
93064914|NCT01076322|Procaterol|procaterol|mesh-list
93064915|NCT01076322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93064916|NCT01076322|Autonomic Agents|autonomic agents|mesh-ancestor
93064917|NCT01076322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064918|NCT01076322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064919|NCT01076322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93064920|NCT01076322|Respiratory System Agents|respiratory system agents|mesh-ancestor
93064921|NCT01076322|Tocolytic Agents|tocolytic agents|mesh-ancestor
93064922|NCT01076322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93064923|NCT01076322|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93064924|NCT01076322|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93064925|NCT01076322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93064926|NCT01076322|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064927|NCT01076322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064928|NCT01076322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064929|NCT01076322|Sympathomimetics|sympathomimetics|mesh-ancestor
93064930|NCT03966066|Erythromycin|erythromycin|mesh-list
93064931|NCT03966066|Erythromycin Estolate|erythromycin estolate|mesh-list
93064932|NCT03966066|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93064933|NCT03966066|Erythromycin stearate|erythromycin stearate|mesh-list
93064934|NCT03966066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93064935|NCT03966066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93064936|NCT03966066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064937|NCT03966066|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93064938|NCT03966066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064939|NCT03966066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064940|NCT00215540|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93064941|NCT00215540|Respiratory System Agents|respiratory system agents|mesh-ancestor
93064942|NCT01304212|Ketorolac|ketorolac|mesh-list
93064943|NCT01304212|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93064944|NCT01304212|Epinephrine|epinephrine|mesh-list
93064945|NCT01304212|Racepinephrine|racepinephrine|mesh-list
93064946|NCT01304212|Morphine|morphine|mesh-list
93064947|NCT01304212|Ropivacaine|ropivacaine|mesh-list
93064948|NCT01304212|Epinephryl borate|epinephryl borate|mesh-list
93064949|NCT01304212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93064950|NCT01304212|Narcotics|narcotics|mesh-ancestor
93064951|NCT01304212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93064952|NCT01304212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064953|NCT01304212|Analgesics|analgesics|mesh-ancestor
93064954|NCT01304212|Sensory System Agents|sensory system agents|mesh-ancestor
93064955|NCT01304212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93064956|NCT01304212|Anesthetics, Local|anesthetics, local|mesh-ancestor
93064957|NCT01304212|Anesthetics|anesthetics|mesh-ancestor
93064958|NCT01304212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93064959|NCT01304212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93064960|NCT01304212|Adrenergic Agents|adrenergic agents|mesh-ancestor
93064961|NCT01304212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93064962|NCT01304212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064963|NCT01304212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93064964|NCT01304212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93064965|NCT01304212|Autonomic Agents|autonomic agents|mesh-ancestor
93064966|NCT01304212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93064967|NCT01304212|Respiratory System Agents|respiratory system agents|mesh-ancestor
93064968|NCT01304212|Mydriatics|mydriatics|mesh-ancestor
93064969|NCT01304212|Sympathomimetics|sympathomimetics|mesh-ancestor
93064970|NCT01304212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93064971|NCT01304212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93064972|NCT01304212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93064973|NCT01304212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93064974|NCT01304212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93064975|NCT01304212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93064976|NCT01304212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064977|NCT00143390|Anastrozole|anastrozole|mesh-list
93064978|NCT00143390|Exemestane|exemestane|mesh-list
93064979|NCT00143390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93064980|NCT00143390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93064981|NCT00143390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93064982|NCT00143390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93064983|NCT00143390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064984|NCT00143390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064985|NCT00143390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93064986|NCT00143390|Hormone Antagonists|hormone antagonists|mesh-ancestor
93064987|NCT00143390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93064988|NCT00143390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93064989|NCT03238534|Omeprazole|omeprazole|mesh-list
93064990|NCT03238534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93064991|NCT03238534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93064992|NCT03238534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93064993|NCT03238534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93064994|NCT03238534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93064995|NCT00141102|Celecoxib|celecoxib|mesh-list
93064996|NCT00141102|Diclofenac|diclofenac|mesh-list
93064997|NCT00141102|Omeprazole|omeprazole|mesh-list
93064998|NCT00141102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92722067|NCT00568347|Xhance|xhance|mesh-list
93064999|NCT00141102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065000|NCT00141102|Analgesics|analgesics|mesh-ancestor
93065001|NCT00141102|Sensory System Agents|sensory system agents|mesh-ancestor
93065002|NCT00141102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065003|NCT00141102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065004|NCT00141102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065005|NCT00141102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065006|NCT00141102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93065007|NCT00141102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93065008|NCT00141102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065009|NCT00141102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065010|NCT00141102|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93065011|NCT00141102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065012|NCT00141102|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92340508|NCT00002609|Antiviral Agents|antiviral agents|mesh-ancestor
93065013|NCT03663712|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
93065014|NCT03663712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065015|NCT03663712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065017|NCT01078428|Emollients|emollients|mesh-ancestor
93065018|NCT01078428|Dermatologic Agents|dermatologic agents|mesh-ancestor
93065019|NCT01081002|Lidocaine|lidocaine|mesh-list
93065020|NCT01081002|Anesthetics, Local|anesthetics, local|mesh-ancestor
93065021|NCT01081002|Anesthetics|anesthetics|mesh-ancestor
93065022|NCT01081002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065023|NCT01081002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065024|NCT01081002|Sensory System Agents|sensory system agents|mesh-ancestor
93065025|NCT01081002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065026|NCT01081002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93065027|NCT01081002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93065028|NCT01081002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93065029|NCT01081002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065030|NCT01081002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065031|NCT03789058|Ibuprofen|ibuprofen|mesh-list
93065032|NCT03789058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065033|NCT03789058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065034|NCT03789058|Analgesics|analgesics|mesh-ancestor
93065035|NCT03789058|Sensory System Agents|sensory system agents|mesh-ancestor
93065036|NCT03789058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065037|NCT03789058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065038|NCT03789058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065039|NCT03789058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065040|NCT03789058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93065041|NCT03789058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065042|NCT03789058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065043|NCT03788902|Methylphenidate|methylphenidate|mesh-list
93065044|NCT03788902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93065045|NCT03788902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065046|NCT03788902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93065047|NCT03788902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93065048|NCT03788902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065049|NCT03788902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065050|NCT03788902|Dopamine Agents|dopamine agents|mesh-ancestor
93065051|NCT03788902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065052|NCT05669092|Capecitabine|capecitabine|mesh-list
93065053|NCT05669092|Oxaliplatin|oxaliplatin|mesh-list
93065054|NCT05669092|Irinotecan|irinotecan|mesh-list
93065055|NCT05669092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93065056|NCT05669092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93065057|NCT05669092|Antimetabolites|antimetabolites|mesh-ancestor
93065058|NCT05669092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065059|NCT05669092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065060|NCT05669092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93065061|NCT05669092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93065062|NCT05669092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065063|NCT05669092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065064|NCT00255008|Ribavirin|ribavirin|mesh-list
93065065|NCT00255008|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93065066|NCT00255008|Interferon-alpha|interferon-alpha|mesh-list
93065067|NCT00255008|Antimetabolites|antimetabolites|mesh-ancestor
93065068|NCT00255008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065069|NCT00255008|Antiviral Agents|antiviral agents|mesh-ancestor
93065070|NCT00255008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065071|NCT00255008|Immunologic Factors|immunologic factors|mesh-ancestor
93065072|NCT00255008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065073|NCT01306240|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93065074|NCT01306240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722141|NCT04581876|Antimetabolites|antimetabolites|mesh-ancestor
93065076|NCT03714022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93065077|NCT03714022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065078|NCT03714022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065079|NCT03714022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065080|NCT03714022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065081|NCT03714022|Immunologic Factors|immunologic factors|mesh-ancestor
93065082|NCT03714022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065083|NCT03714022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065084|NCT00143312|Voriconazole|voriconazole|mesh-list
93065085|NCT00143312|Antifungal Agents|antifungal agents|mesh-ancestor
93065086|NCT00143312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065087|NCT00143312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93065088|NCT00143312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93065089|NCT00143312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065090|NCT00143312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065091|NCT00143312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93065092|NCT00143312|Hormone Antagonists|hormone antagonists|mesh-ancestor
93065093|NCT00143312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065094|NCT00143312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065095|NCT00143312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93065096|NCT04833946|Andrographolide|andrographolide|mesh-list
93065097|NCT04833946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065098|NCT04833946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065099|NCT04833946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065100|NCT04833946|Analgesics|analgesics|mesh-ancestor
93065101|NCT04833946|Sensory System Agents|sensory system agents|mesh-ancestor
93065102|NCT04833946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065103|NCT04833946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065104|NCT04833946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065105|NCT04833946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93065106|NCT04833946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93065107|NCT04833946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065108|NCT04833946|Antiviral Agents|antiviral agents|mesh-ancestor
93065109|NCT04833946|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065110|NCT01077206|Simvastatin|simvastatin|mesh-list
93065111|NCT01077206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93065112|NCT01077206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93065113|NCT01077206|Antimetabolites|antimetabolites|mesh-ancestor
93065114|NCT01077206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065115|NCT01077206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93065116|NCT01077206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93065117|NCT01077206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065118|NCT05623540|Diphosphonates|diphosphonates|mesh-list
93065119|NCT05623540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93065120|NCT05623540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065121|NCT05622838|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
93065122|NCT05622838|Protein C Inhibitor|protein c inhibitor|mesh-list
93065123|NCT05622838|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93065124|NCT05622838|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93065125|NCT05622838|Protease Inhibitors|protease inhibitors|mesh-ancestor
93065126|NCT05622838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065127|NCT05622838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065128|NCT01306318|Diclofenac|diclofenac|mesh-list
93065129|NCT01306318|Eperisone|eperisone|mesh-list
93065130|NCT01306318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065131|NCT01306318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065132|NCT01306318|Analgesics|analgesics|mesh-ancestor
93065133|NCT01306318|Sensory System Agents|sensory system agents|mesh-ancestor
93065134|NCT01306318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065135|NCT01306318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065136|NCT01306318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065137|NCT01306318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065138|NCT01306318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93065139|NCT01306318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065140|NCT01306318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065141|NCT01306318|Anticonvulsants|anticonvulsants|mesh-ancestor
93065142|NCT01306318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93065143|NCT01306318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065144|NCT01306318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93065145|NCT01306318|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93065146|NCT01306318|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93065147|NCT01306318|Parasympatholytics|parasympatholytics|mesh-ancestor
93065148|NCT01306318|Autonomic Agents|autonomic agents|mesh-ancestor
93065149|NCT01306318|Vasodilator Agents|vasodilator agents|mesh-ancestor
93065150|NCT00254540|Sunitinib|sunitinib|mesh-list
93065151|NCT00254540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065152|NCT00254540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93065153|NCT00254540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93065154|NCT00254540|Growth Substances|growth substances|mesh-ancestor
93065155|NCT00254540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065156|NCT00254540|Growth Inhibitors|growth inhibitors|mesh-ancestor
93065157|NCT00254540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065158|NCT00254540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065159|NCT00254540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065160|NCT01326494|Prednisone|prednisone|mesh-list
93065161|NCT01326494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065162|NCT01326494|Glucocorticoids|glucocorticoids|mesh-ancestor
93065163|NCT01326494|Hormones|hormones|mesh-ancestor
93065164|NCT01326494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065165|NCT01326494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065166|NCT01326494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93065167|NCT01326494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065168|NCT05316220|Mesalamine|mesalamine|mesh-list
93065169|NCT05316220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065170|NCT05316220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065171|NCT05316220|Analgesics|analgesics|mesh-ancestor
93065172|NCT05316220|Sensory System Agents|sensory system agents|mesh-ancestor
93065173|NCT05316220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065174|NCT05316220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065175|NCT05316220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065176|NCT05316220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065177|NCT01305850|Losartan|losartan|mesh-list
93065178|NCT01305850|Enalapril|enalapril|mesh-list
93065179|NCT01305850|Enalaprilat|enalaprilat|mesh-list
93065180|NCT01305850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93065181|NCT01305850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93065182|NCT01305850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93065183|NCT01305850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93065184|NCT01305850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065185|NCT01305850|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93065186|NCT01305850|Protease Inhibitors|protease inhibitors|mesh-ancestor
93065187|NCT01305850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065188|NCT01306630|Capecitabine|capecitabine|mesh-list
93065189|NCT01306630|Tivozanib|tivozanib|mesh-list
93065190|NCT01306630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93065191|NCT01306630|Antimetabolites|antimetabolites|mesh-ancestor
93065192|NCT01306630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065193|NCT01306630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065194|NCT01306630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065195|NCT01306630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065196|NCT01306708|Amitriptyline|amitriptyline|mesh-list
93065197|NCT01306708|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
93065198|NCT01306708|Antidepressive Agents|antidepressive agents|mesh-ancestor
93065199|NCT01306708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93065200|NCT01306708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065201|NCT01306708|Analgesics|analgesics|mesh-ancestor
93065202|NCT01306708|Sensory System Agents|sensory system agents|mesh-ancestor
93065203|NCT01306708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065204|NCT01306708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065205|NCT01306708|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93065206|NCT01306708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92340532|NCT00002621|Interferon-alpha|interferon-alpha|mesh-list
93065207|NCT01306708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065208|NCT01306708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065209|NCT01306708|Adrenergic Agents|adrenergic agents|mesh-ancestor
93065210|NCT01306708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065211|NCT03794518|Pioglitazone|pioglitazone|mesh-list
93065212|NCT03794518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93065213|NCT03794518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065214|NCT05566288|Moxifloxacin|moxifloxacin|mesh-list
93065215|NCT05566288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93065216|NCT05566288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065217|NCT05566288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93065218|NCT05566288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93065219|NCT05566288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065220|NCT05566288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065221|NCT05566288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065222|NCT03790540|Benzocaine|benzocaine|mesh-list
93065223|NCT03790540|Anesthetics, Local|anesthetics, local|mesh-ancestor
93065224|NCT03790540|Anesthetics|anesthetics|mesh-ancestor
93065225|NCT03790540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065226|NCT03790540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065227|NCT03790540|Sensory System Agents|sensory system agents|mesh-ancestor
93065228|NCT03790540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065229|NCT03794596|Aspirin|aspirin|mesh-list
93065230|NCT03794596|Avelumab|avelumab|mesh-list
93065232|NCT03794596|Dexlansoprazole|dexlansoprazole|mesh-list
93065233|NCT03794596|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
93065234|NCT03794596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065235|NCT03794596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065236|NCT03794596|Analgesics|analgesics|mesh-ancestor
93065237|NCT03794596|Sensory System Agents|sensory system agents|mesh-ancestor
93065238|NCT03794596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065239|NCT03794596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065240|NCT03794596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065241|NCT03794596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065242|NCT03794596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93065243|NCT03794596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93065244|NCT03794596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065245|NCT03794596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065246|NCT03794596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93065247|NCT03794596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065248|NCT03794596|Antipyretics|antipyretics|mesh-ancestor
93065249|NCT03794596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065250|NCT03794596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065251|NCT03794596|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93065252|NCT03794596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065253|NCT05571748|Thioctic Acid|thioctic acid|mesh-list
93065254|NCT05571748|Antioxidants|antioxidants|mesh-ancestor
93065255|NCT05571748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065256|NCT05571748|Protective Agents|protective agents|mesh-ancestor
93065257|NCT05571748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065258|NCT05571748|Vitamin B Complex|vitamin b complex|mesh-ancestor
93065259|NCT05571748|Vitamins|vitamins|mesh-ancestor
93065260|NCT05571748|Micronutrients|micronutrients|mesh-ancestor
93065261|NCT03790618|Methamphetamine|methamphetamine|mesh-list
93065262|NCT03790618|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
93065263|NCT03790618|Hallucinogens|hallucinogens|mesh-ancestor
93065264|NCT03790618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065265|NCT03790618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93065266|NCT03790618|Serotonin Agents|serotonin agents|mesh-ancestor
93065267|NCT03790618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065268|NCT03790618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065269|NCT03790618|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93065270|NCT03790618|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93065271|NCT03790618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065272|NCT03790618|Adrenergic Agents|adrenergic agents|mesh-ancestor
93065273|NCT03790618|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93065274|NCT03790618|Sympathomimetics|sympathomimetics|mesh-ancestor
93065275|NCT03790618|Autonomic Agents|autonomic agents|mesh-ancestor
93065276|NCT03790618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065277|NCT03790618|Dopamine Agents|dopamine agents|mesh-ancestor
93065278|NCT03790618|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93065279|NCT03790228|Carboplatin|carboplatin|mesh-list
93065280|NCT03790228|Pemetrexed|pemetrexed|mesh-list
93065281|NCT03790228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065282|NCT03790228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065283|NCT03790228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065284|NCT03790228|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93065285|NCT03790228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93065286|NCT01304836|Mycophenolic Acid|mycophenolic acid|mesh-list
93065287|NCT01304836|Methylprednisolone|methylprednisolone|mesh-list
93065288|NCT01304836|Prednisolone|prednisolone|mesh-list
93065289|NCT01304836|Tacrolimus|tacrolimus|mesh-list
93065290|NCT01304836|Basiliximab|basiliximab|mesh-list
93065291|NCT01304836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065292|NCT01304836|Immunologic Factors|immunologic factors|mesh-ancestor
93065293|NCT01304836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065294|NCT01304836|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93065295|NCT01304836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065296|NCT01304836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065297|NCT01304836|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93065298|NCT01304836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065299|NCT01304836|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93065300|NCT01304836|Antitubercular Agents|antitubercular agents|mesh-ancestor
93065301|NCT01304836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93065302|NCT01304836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065303|NCT01304836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065305|NCT01304836|Autonomic Agents|autonomic agents|mesh-ancestor
93065306|NCT01304836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065307|NCT01304836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065308|NCT01304836|Glucocorticoids|glucocorticoids|mesh-ancestor
93065309|NCT01304836|Hormones|hormones|mesh-ancestor
93065310|NCT01304836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065311|NCT01304836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93065312|NCT01304836|Protective Agents|protective agents|mesh-ancestor
93065313|NCT01304836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93065314|NCT01306864|Hemostatics|hemostatics|mesh-list
93065315|NCT01306864|Coagulants|coagulants|mesh-ancestor
93065316|NCT01307332|Alemtuzumab|alemtuzumab|mesh-list
93065317|NCT01307332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065318|NCT01307332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065319|NCT03790384|Mitomycins|mitomycins|mesh-list
93065320|NCT03790384|Mitomycin|mitomycin|mesh-list
93065321|NCT03790384|BCG Vaccine|bcg vaccine|mesh-list
93065322|NCT03790384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93065323|NCT03790384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065324|NCT03790384|Alkylating Agents|alkylating agents|mesh-ancestor
93065325|NCT03790384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065326|NCT03790384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93065327|NCT03790384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065328|NCT03790384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93065329|NCT03790384|Immunologic Factors|immunologic factors|mesh-ancestor
93065330|NCT03790384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065331|NCT01307488|Ritonavir|ritonavir|mesh-list
93065332|NCT01307488|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93065333|NCT01307488|Lamivudine|lamivudine|mesh-list
93065334|NCT01307488|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93065335|NCT01307488|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93065336|NCT01307488|Protease Inhibitors|protease inhibitors|mesh-ancestor
93065337|NCT01307488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065338|NCT01307488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065339|NCT01307488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93065340|NCT01307488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93065341|NCT01307488|Antiviral Agents|antiviral agents|mesh-ancestor
93065342|NCT01307488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065343|NCT01307488|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93065344|NCT01307488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93065345|NCT01307488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93065346|NCT01307488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93065347|NCT03790072|Cyclophosphamide|cyclophosphamide|mesh-list
93065348|NCT03790072|Fludarabine|fludarabine|mesh-list
93065349|NCT03790072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065350|NCT03790072|Immunologic Factors|immunologic factors|mesh-ancestor
93065351|NCT03790072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065352|NCT03790072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065353|NCT03790072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93065354|NCT03790072|Alkylating Agents|alkylating agents|mesh-ancestor
93065355|NCT03790072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065356|NCT03790072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065357|NCT03790072|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93065358|NCT01306006|Vaccines|vaccines|mesh-list
93065359|NCT01306006|Immunologic Factors|immunologic factors|mesh-ancestor
93065360|NCT01306006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065361|NCT03794440|Sorafenib|sorafenib|mesh-list
93065362|NCT03794440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065363|NCT03794440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065364|NCT03794440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065365|NCT03794440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065366|NCT00139776|Celecoxib|celecoxib|mesh-list
93065367|NCT00139776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065368|NCT00139776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065369|NCT00139776|Analgesics|analgesics|mesh-ancestor
93065370|NCT00139776|Sensory System Agents|sensory system agents|mesh-ancestor
93065371|NCT00139776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065372|NCT00139776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065373|NCT00139776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065374|NCT00139776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065375|NCT00139776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93065376|NCT00139776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93065377|NCT00139776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065378|NCT00139776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065379|NCT00413699|Tofacitinib|tofacitinib|mesh-list
93065380|NCT00413699|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93065381|NCT00413699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065382|NCT00413699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065383|NCT00413699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065384|NCT03713320|Vorinostat|vorinostat|mesh-list
93065385|NCT03713320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065386|NCT03713320|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93065387|NCT03713320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065388|NCT03713320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065389|NCT03712930|Pamiparib|pamiparib|mesh-list
93065390|NCT03712930|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93065391|NCT03712930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065392|NCT03712930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065393|NCT03712930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065394|NCT00420407|Vasopressins|vasopressins|mesh-list
93065395|NCT00420407|Arginine Vasopressin|arginine vasopressin|mesh-list
93065396|NCT00420407|Hemostatics|hemostatics|mesh-ancestor
93065397|NCT00420407|Coagulants|coagulants|mesh-ancestor
93065398|NCT00420407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93065399|NCT00420407|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93065400|NCT00420407|Natriuretic Agents|natriuretic agents|mesh-ancestor
93065401|NCT00420407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065402|NCT03789370|Propofol|propofol|mesh-list
93065403|NCT03789370|Sevoflurane|sevoflurane|mesh-list
93065404|NCT03789370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93065405|NCT03789370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065406|NCT03789370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065407|NCT03789370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93065408|NCT03789370|Anesthetics, General|anesthetics, general|mesh-ancestor
93065409|NCT03789370|Anesthetics|anesthetics|mesh-ancestor
93065410|NCT03789370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065411|NCT03789370|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93065412|NCT00420095|Insulin|insulin|mesh-list
93065413|NCT00420095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93065414|NCT00420095|Insulin Lispro|insulin lispro|mesh-list
93065415|NCT00420095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93065416|NCT00420095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065417|NCT04904692|Dimercaprol|dimercaprol|mesh-list
93065418|NCT04904692|Chelating Agents|chelating agents|mesh-ancestor
93065419|NCT04904692|Sequestering Agents|sequestering agents|mesh-ancestor
93065420|NCT04904692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065421|NCT01038089|Resveratrol|resveratrol|mesh-list
93065422|NCT01038089|Antioxidants|antioxidants|mesh-ancestor
93065423|NCT01038089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065424|NCT01038089|Protective Agents|protective agents|mesh-ancestor
93065425|NCT01038089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065426|NCT01038089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065427|NCT01038089|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065428|NCT05495464|Cyclophosphamide|cyclophosphamide|mesh-list
93065429|NCT05495464|Rituximab|rituximab|mesh-list
93065430|NCT05495464|Fludarabine|fludarabine|mesh-list
93065431|NCT05495464|Fludarabine phosphate|fludarabine phosphate|mesh-list
93065432|NCT05495464|Acalabrutinib|acalabrutinib|mesh-list
93065433|NCT05495464|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
93065434|NCT05495464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065435|NCT05495464|Immunologic Factors|immunologic factors|mesh-ancestor
93065436|NCT05495464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065437|NCT05495464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065438|NCT05495464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93065439|NCT05495464|Alkylating Agents|alkylating agents|mesh-ancestor
93065440|NCT05495464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065441|NCT05495464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065442|NCT05495464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93065443|NCT05495464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065444|NCT05495464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93065445|NCT05495464|Antimetabolites|antimetabolites|mesh-ancestor
93065446|NCT00419393|Levetiracetam|levetiracetam|mesh-list
92722514|NCT00573885|Antioxidants|antioxidants|mesh-ancestor
93065448|NCT00419393|Nootropic Agents|nootropic agents|mesh-ancestor
93065449|NCT01038167|Cyclosporine|cyclosporine|mesh-list
93065450|NCT01038167|Tacrolimus|tacrolimus|mesh-list
93065451|NCT01038167|Cyclosporins|cyclosporins|mesh-list
93065452|NCT01038167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065453|NCT01038167|Immunologic Factors|immunologic factors|mesh-ancestor
93065454|NCT01038167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065455|NCT01038167|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93065456|NCT01038167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065457|NCT01038167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065458|NCT01038167|Antifungal Agents|antifungal agents|mesh-ancestor
93065459|NCT01038167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065460|NCT01038167|Dermatologic Agents|dermatologic agents|mesh-ancestor
93065461|NCT01038167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065463|NCT03787030|Tocopherols|tocopherols|mesh-list
93065464|NCT03787030|alpha-Tocopherol|alpha-tocopherol|mesh-list
93065465|NCT03787030|Nitroglycerin|nitroglycerin|mesh-list
93065466|NCT03787030|Vitamins|vitamins|mesh-ancestor
93065467|NCT03787030|Micronutrients|micronutrients|mesh-ancestor
93065468|NCT03787030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065469|NCT03787030|Antioxidants|antioxidants|mesh-ancestor
93065470|NCT03787030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065471|NCT03787030|Protective Agents|protective agents|mesh-ancestor
93065472|NCT03787030|Vasodilator Agents|vasodilator agents|mesh-ancestor
93065473|NCT02174549|Tirapazamine|tirapazamine|mesh-list
93065474|NCT02174549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065475|NCT03786562|Morphine|morphine|mesh-list
93065476|NCT03786562|Nalbuphine|nalbuphine|mesh-list
93065477|NCT03786562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93065478|NCT03786562|Narcotics|narcotics|mesh-ancestor
93065479|NCT03786562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065480|NCT03786562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065481|NCT03786562|Analgesics|analgesics|mesh-ancestor
93065482|NCT03786562|Sensory System Agents|sensory system agents|mesh-ancestor
93065483|NCT03786562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065484|NCT01305148|Warfarin|warfarin|mesh-list
93065485|NCT01305148|Anticoagulants|anticoagulants|mesh-ancestor
93065486|NCT01305226|Streptokinase|streptokinase|mesh-list
93065487|NCT01305226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93065488|NCT01305226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93065489|NCT01305226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065490|NCT01308268|Ivermectin|ivermectin|mesh-list
93065491|NCT01308268|Albendazole|albendazole|mesh-list
93065492|NCT01308268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93065493|NCT01308268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065494|NCT01308268|Anthelmintics|anthelmintics|mesh-ancestor
93065495|NCT01308268|Anticestodal Agents|anticestodal agents|mesh-ancestor
93065496|NCT01308268|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93065497|NCT01308268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93065498|NCT01308268|Tubulin Modulators|tubulin modulators|mesh-ancestor
93065499|NCT01308268|Antimitotic Agents|antimitotic agents|mesh-ancestor
93065500|NCT01308268|Mitosis Modulators|mitosis modulators|mesh-ancestor
93065501|NCT01308268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065502|NCT01308268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065503|NCT01308346|Everolimus|everolimus|mesh-list
93065504|NCT01308346|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93065505|NCT01308346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065506|NCT01308346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065507|NCT01308346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065508|NCT01308346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065509|NCT01308346|Immunologic Factors|immunologic factors|mesh-ancestor
93065510|NCT01308346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065511|NCT01308346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065512|NCT05694130|Prednisolone|prednisolone|mesh-list
93065513|NCT05694130|Tacrolimus|tacrolimus|mesh-list
93065514|NCT05694130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065515|NCT05694130|Immunologic Factors|immunologic factors|mesh-ancestor
93065516|NCT05694130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065517|NCT05694130|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93065518|NCT05694130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065519|NCT05694130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065520|NCT05694130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065521|NCT05694130|Glucocorticoids|glucocorticoids|mesh-ancestor
93065522|NCT05694130|Hormones|hormones|mesh-ancestor
93065523|NCT05694130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065524|NCT05694130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93065525|NCT05694130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065527|NCT00419159|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93065528|NCT00419159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065529|NCT00419159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065530|NCT00419159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065531|NCT00419159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065532|NCT00419159|Immunologic Factors|immunologic factors|mesh-ancestor
93065533|NCT00419159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134028|NCT01478971|Epoetin Alfa|epoetin alfa|mesh-list
93065535|NCT03717064|Pitavastatin|pitavastatin|mesh-list
93065536|NCT03717064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93065537|NCT03717064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93065538|NCT03717064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93065539|NCT03717064|Antimetabolites|antimetabolites|mesh-ancestor
93065540|NCT03717064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065541|NCT03717064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065542|NCT03717064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93065543|NCT03716050|Nitroglycerin|nitroglycerin|mesh-list
93065544|NCT03716050|Vasodilator Agents|vasodilator agents|mesh-ancestor
93065545|NCT02113163|Metformin|metformin|mesh-list
93065546|NCT02113163|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
93065547|NCT02113163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93065548|NCT02113163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065549|NCT02113163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065550|NCT02113163|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93065551|NCT00413153|Ritonavir|ritonavir|mesh-list
93065552|NCT00413153|Lopinavir|lopinavir|mesh-list
93065553|NCT00413153|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93065554|NCT00413153|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93065555|NCT00413153|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93065556|NCT00413153|Protease Inhibitors|protease inhibitors|mesh-ancestor
93065557|NCT00413153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065558|NCT00413153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065559|NCT00413153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93065560|NCT00413153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93065561|NCT00413153|Antiviral Agents|antiviral agents|mesh-ancestor
93065562|NCT00413153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065563|NCT00413153|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93065564|NCT00413153|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93065565|NCT02107937|Paclitaxel|paclitaxel|mesh-list
93065566|NCT02107937|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93065567|NCT02107937|Carboplatin|carboplatin|mesh-list
93065568|NCT02107937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93065569|NCT02107937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065570|NCT02107937|Tubulin Modulators|tubulin modulators|mesh-ancestor
93065571|NCT02107937|Antimitotic Agents|antimitotic agents|mesh-ancestor
93065572|NCT02107937|Mitosis Modulators|mitosis modulators|mesh-ancestor
93065573|NCT02107937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065574|NCT01312402|Brinzolamide|brinzolamide|mesh-list
93065575|NCT01312402|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93065576|NCT01312402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065577|NCT01312402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065578|NCT05693428|Propofol|propofol|mesh-list
93065579|NCT05693428|Sevoflurane|sevoflurane|mesh-list
93065580|NCT05693428|Isoflurane|isoflurane|mesh-list
93065581|NCT05693428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93065582|NCT05693428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065583|NCT05693428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065584|NCT05693428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93065585|NCT05693428|Anesthetics, General|anesthetics, general|mesh-ancestor
93065586|NCT05693428|Anesthetics|anesthetics|mesh-ancestor
93065587|NCT05693428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065588|NCT05693428|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93065589|NCT01035281|Nabilone|nabilone|mesh-list
93065590|NCT01035281|Antiemetics|antiemetics|mesh-ancestor
93065591|NCT01035281|Autonomic Agents|autonomic agents|mesh-ancestor
93065592|NCT01035281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065593|NCT01035281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065594|NCT01035281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065595|NCT01035281|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93065596|NCT01035281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93065597|NCT01035281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065598|NCT01035281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93065599|NCT01561066|Octreotide|octreotide|mesh-list
93065600|NCT01561066|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93065601|NCT01561066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065602|NCT01561066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93065603|NCT01561066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065604|NCT01561066|Hemostatics|hemostatics|mesh-ancestor
93065605|NCT01561066|Coagulants|coagulants|mesh-ancestor
93065606|NCT00419003|Lamotrigine|lamotrigine|mesh-list
93065607|NCT00419003|Ketamine|ketamine|mesh-list
93065608|NCT00419003|Riluzole|riluzole|mesh-list
93065609|NCT00419003|Analgesics|analgesics|mesh-ancestor
93065610|NCT00419003|Sensory System Agents|sensory system agents|mesh-ancestor
93065611|NCT00419003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065612|NCT00419003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065613|NCT00419003|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93065614|NCT00419003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93065616|NCT00419003|Anesthetics|anesthetics|mesh-ancestor
93065617|NCT00419003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065618|NCT00419003|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93065619|NCT00419003|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93065620|NCT00419003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065621|NCT00419003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065622|NCT00419003|Anticonvulsants|anticonvulsants|mesh-ancestor
93065623|NCT00419003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93065624|NCT00419003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065625|NCT00419003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93065626|NCT00419003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93065627|NCT00419003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93065628|NCT00419003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93065629|NCT00419003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93065630|NCT00419003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93065631|NCT00419003|Protective Agents|protective agents|mesh-ancestor
93065632|NCT00418691|Methylphenidate|methylphenidate|mesh-list
93065633|NCT00418691|Modafinil|modafinil|mesh-list
93065634|NCT00418691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93065635|NCT00418691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065636|NCT00418691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93065637|NCT00418691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93065638|NCT00418691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065639|NCT00418691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065640|NCT00418691|Dopamine Agents|dopamine agents|mesh-ancestor
93065641|NCT00418691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065642|NCT00418691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93065643|NCT00418691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93065644|NCT00418691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93065645|NCT03781258|Warfarin|warfarin|mesh-list
93065646|NCT03781258|Anticoagulants|anticoagulants|mesh-ancestor
93065647|NCT00412373|Paliperidone Palmitate|paliperidone palmitate|mesh-list
93065648|NCT00412373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93065649|NCT00412373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93065650|NCT00412373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065651|NCT00412373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065652|NCT00412373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93065653|NCT00412373|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93065654|NCT00412373|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93065655|NCT00412373|Serotonin Agents|serotonin agents|mesh-ancestor
93065656|NCT00412373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065657|NCT00412373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065658|NCT00412373|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93065659|NCT00412373|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93065660|NCT00412373|Dopamine Agents|dopamine agents|mesh-ancestor
93065661|NCT01308658|Ritonavir|ritonavir|mesh-list
93065662|NCT01308658|Darunavir|darunavir|mesh-list
93065663|NCT01308658|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93065664|NCT01308658|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93065665|NCT01308658|Protease Inhibitors|protease inhibitors|mesh-ancestor
93065666|NCT01308658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065667|NCT01308658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065668|NCT01308658|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93065669|NCT01308658|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93065670|NCT01308658|Antiviral Agents|antiviral agents|mesh-ancestor
93065671|NCT01308658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065672|NCT01308658|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93065673|NCT01308658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93065674|NCT03777514|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
93065675|NCT03777514|Hematinics|hematinics|mesh-ancestor
93065676|NCT03777514|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
93065677|NCT03777514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93065679|NCT03777124|Pemetrexed|pemetrexed|mesh-list
93065680|NCT03777124|Apatinib|apatinib|mesh-list
93065681|NCT03777124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065682|NCT03777124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065683|NCT03777124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065684|NCT03777124|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93065685|NCT03777124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93065686|NCT03777124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065687|NCT00418379|Immunomodulating Agents|immunomodulating agents|mesh-list
93065688|NCT00418379|Immunologic Factors|immunologic factors|mesh-list
93065689|NCT00418379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065690|NCT03780556|Lornoxicam|lornoxicam|mesh-list
93065691|NCT03780556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065692|NCT03780556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065693|NCT03780556|Analgesics|analgesics|mesh-ancestor
93065694|NCT03780556|Sensory System Agents|sensory system agents|mesh-ancestor
93065695|NCT03780556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065696|NCT03780556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065697|NCT03780556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065698|NCT03780556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065699|NCT00418145|Methylprednisolone|methylprednisolone|mesh-list
93065700|NCT00418145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93065701|NCT00418145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93065702|NCT00418145|Prednisolone|prednisolone|mesh-list
93065703|NCT00418145|Prednisolone acetate|prednisolone acetate|mesh-list
93065704|NCT00418145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93065705|NCT00418145|Prednisolone phosphate|prednisolone phosphate|mesh-list
93065706|NCT00418145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065707|NCT00418145|Antiemetics|antiemetics|mesh-ancestor
93065708|NCT00418145|Autonomic Agents|autonomic agents|mesh-ancestor
93065709|NCT00418145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065710|NCT00418145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065711|NCT00418145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065712|NCT00418145|Glucocorticoids|glucocorticoids|mesh-ancestor
93065713|NCT00418145|Hormones|hormones|mesh-ancestor
93065714|NCT00418145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065715|NCT00418145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93065716|NCT00418145|Protective Agents|protective agents|mesh-ancestor
93065717|NCT00418145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93065718|NCT00418145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065719|NCT03780634|Sorafenib|sorafenib|mesh-list
93065720|NCT03780634|Antibodies|antibodies|mesh-list
93065721|NCT03780634|Immunoglobulins|immunoglobulins|mesh-list
93065722|NCT03780634|Immunologic Factors|immunologic factors|mesh-ancestor
93065723|NCT03780634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065724|NCT03780634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065725|NCT03780634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065726|NCT03780634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065727|NCT03780634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065728|NCT03777280|Cobalt|cobalt|mesh-list
93065729|NCT03777280|Chromium|chromium|mesh-list
93065730|NCT03777280|Trace Elements|trace elements|mesh-ancestor
93065731|NCT03777280|Micronutrients|micronutrients|mesh-ancestor
93065732|NCT03777280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065733|NCT02043587|Leucovorin|leucovorin|mesh-list
93065734|NCT02043587|Cytarabine|cytarabine|mesh-list
93065735|NCT02043587|Prednisone|prednisone|mesh-list
93065736|NCT02043587|Hydrocortisone|hydrocortisone|mesh-list
93065737|NCT02043587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93065738|NCT02043587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93065739|NCT02043587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93065740|NCT02043587|Cyclophosphamide|cyclophosphamide|mesh-list
93065741|NCT02043587|Rituximab|rituximab|mesh-list
93065742|NCT02043587|Methotrexate|methotrexate|mesh-list
93065743|NCT02043587|Etoposide|etoposide|mesh-list
93065744|NCT02043587|Vincristine|vincristine|mesh-list
93065745|NCT02043587|Daunorubicin|daunorubicin|mesh-list
93065746|NCT02043587|Asparaginase|asparaginase|mesh-list
93065747|NCT02043587|Dasatinib|dasatinib|mesh-list
93065748|NCT02043587|Pegaspargase|pegaspargase|mesh-list
93065749|NCT02043587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065750|NCT02043587|Immunologic Factors|immunologic factors|mesh-ancestor
92722808|NCT00566891|Tirofiban|tirofiban|mesh-list
93065751|NCT02043587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065752|NCT02043587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065753|NCT02043587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93065754|NCT02043587|Alkylating Agents|alkylating agents|mesh-ancestor
93065755|NCT02043587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065756|NCT02043587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065757|NCT02043587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93065758|NCT02043587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065759|NCT02043587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065760|NCT02043587|Glucocorticoids|glucocorticoids|mesh-ancestor
93065762|NCT02043587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065763|NCT02043587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93065764|NCT02043587|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93065765|NCT02043587|Abortifacient Agents|abortifacient agents|mesh-ancestor
93065766|NCT02043587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93065767|NCT02043587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93065768|NCT02043587|Antimetabolites|antimetabolites|mesh-ancestor
93065769|NCT02043587|Dermatologic Agents|dermatologic agents|mesh-ancestor
93065770|NCT02043587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065771|NCT02043587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93065772|NCT02043587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93065773|NCT02043587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93065774|NCT02043587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93065775|NCT02043587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93065776|NCT02043587|Antiviral Agents|antiviral agents|mesh-ancestor
93065777|NCT02043587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065778|NCT02043587|Antidotes|antidotes|mesh-ancestor
93065779|NCT02043587|Protective Agents|protective agents|mesh-ancestor
93065780|NCT02043587|Vitamin B Complex|vitamin b complex|mesh-ancestor
93065781|NCT02043587|Vitamins|vitamins|mesh-ancestor
93065782|NCT02043587|Micronutrients|micronutrients|mesh-ancestor
93065783|NCT02043587|Tubulin Modulators|tubulin modulators|mesh-ancestor
93065784|NCT02043587|Antimitotic Agents|antimitotic agents|mesh-ancestor
93065785|NCT02043587|Mitosis Modulators|mitosis modulators|mesh-ancestor
93065786|NCT02043587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93065787|NCT02043587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065788|NCT01561222|Calcitriol|calcitriol|mesh-list
93065789|NCT01561222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93065790|NCT01561222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065791|NCT01561222|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93065792|NCT01561222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065793|NCT01561222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065794|NCT01561222|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93065795|NCT01561222|Vitamins|vitamins|mesh-ancestor
93065796|NCT01561222|Micronutrients|micronutrients|mesh-ancestor
93065797|NCT01561222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93065798|NCT01035515|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
93065799|NCT01035515|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
93065800|NCT01035515|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93065801|NCT01035515|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93065802|NCT01035515|Purinergic Agents|purinergic agents|mesh-ancestor
93065803|NCT01035515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065804|NCT01035515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065805|NCT01035515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065806|NCT01039025|Cyclophosphamide|cyclophosphamide|mesh-list
93065807|NCT01039025|Melphalan|melphalan|mesh-list
93065808|NCT01039025|Topotecan|topotecan|mesh-list
93065809|NCT01039025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065810|NCT01039025|Immunologic Factors|immunologic factors|mesh-ancestor
93065811|NCT01039025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065812|NCT01039025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065813|NCT01039025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93065814|NCT01039025|Alkylating Agents|alkylating agents|mesh-ancestor
93065815|NCT01039025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065816|NCT01039025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065817|NCT01039025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93065818|NCT01039025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93065819|NCT01039025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93065820|NCT01039025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065821|NCT03779776|Vitamins|vitamins|mesh-list
93065822|NCT03779776|Micronutrients|micronutrients|mesh-ancestor
93065823|NCT03779776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065824|NCT00412217|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92722882|NCT04592081|Autonomic Agents|autonomic agents|mesh-ancestor
93065825|NCT00412217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065826|NCT00412217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065827|NCT00412217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065828|NCT00412217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065829|NCT01035593|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
93065830|NCT01035593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93065831|NCT01035593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93065833|NCT01035593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065835|NCT01317784|Immunoglobulins|immunoglobulins|mesh-list
93065836|NCT01317784|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
93065837|NCT01317784|Immunologic Factors|immunologic factors|mesh-ancestor
93065838|NCT01317784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065839|NCT03779464|Gemcitabine|gemcitabine|mesh-list
93065840|NCT03779464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93065841|NCT03779464|Antimetabolites|antimetabolites|mesh-ancestor
93065842|NCT03779464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065843|NCT03779464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065844|NCT01309126|Cetuximab|cetuximab|mesh-list
93065845|NCT01309126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93065846|NCT01309126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065847|NCT03784378|Agerafenib|agerafenib|mesh-list
93065848|NCT03784378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065849|NCT03784378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065850|NCT03784378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065851|NCT01314898|Spironolactone|spironolactone|mesh-list
93065852|NCT01314898|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93065853|NCT01314898|Hormone Antagonists|hormone antagonists|mesh-ancestor
93065854|NCT01314898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065855|NCT01314898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065856|NCT01314898|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93065857|NCT01314898|Diuretics|diuretics|mesh-ancestor
93065858|NCT01314898|Natriuretic Agents|natriuretic agents|mesh-ancestor
93065859|NCT01315912|Letrozole|letrozole|mesh-list
93065860|NCT01315912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065861|NCT01315912|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93065862|NCT01315912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93065863|NCT01315912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065864|NCT01315912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065865|NCT01315912|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93065866|NCT01315912|Hormone Antagonists|hormone antagonists|mesh-ancestor
93065867|NCT01315912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93065868|NCT01315912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065869|NCT03778450|Analgesics, Opioid|analgesics, opioid|mesh-list
93065870|NCT03778450|Analgesics|analgesics|mesh-list
93065871|NCT03778450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
93065872|NCT03778450|Narcotics|narcotics|mesh-ancestor
93065873|NCT03778450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065874|NCT03778450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065875|NCT03778450|Sensory System Agents|sensory system agents|mesh-ancestor
93065876|NCT03778450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065877|NCT03776500|Macozinone|macozinone|mesh-list
93065878|NCT03776500|Antitubercular Agents|antitubercular agents|mesh-ancestor
93065879|NCT03776500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93065880|NCT03776500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065881|NCT03778138|Pemetrexed|pemetrexed|mesh-list
93065882|NCT03778138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065883|NCT03778138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065884|NCT03778138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065885|NCT03778138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93065886|NCT03778138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93065887|NCT03783754|Amlodipine|amlodipine|mesh-list
93065888|NCT03783754|Telmisartan|telmisartan|mesh-list
93065889|NCT03783754|Indapamide|indapamide|mesh-list
93065890|NCT03783754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93065891|NCT03783754|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93065892|NCT03783754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93065893|NCT03783754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065894|NCT03783754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93065895|NCT03783754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065896|NCT03783754|Vasodilator Agents|vasodilator agents|mesh-ancestor
92722953|NCT00580827|Disulfiram|disulfiram|mesh-list
93065897|NCT03783754|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93065898|NCT03783754|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93065900|NCT03783754|Natriuretic Agents|natriuretic agents|mesh-ancestor
93065901|NCT03783754|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93065902|NCT01309438|Erythromycin|erythromycin|mesh-list
93065903|NCT01309438|Erythromycin Estolate|erythromycin estolate|mesh-list
93065904|NCT01309438|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
93065905|NCT01309438|Erythromycin stearate|erythromycin stearate|mesh-list
93065906|NCT01309438|Rivaroxaban|rivaroxaban|mesh-list
93065907|NCT01309438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93065908|NCT01309438|Antithrombins|antithrombins|mesh-ancestor
93065909|NCT01309438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93065910|NCT01309438|Protease Inhibitors|protease inhibitors|mesh-ancestor
93065911|NCT01309438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065912|NCT01309438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065913|NCT01309438|Anticoagulants|anticoagulants|mesh-ancestor
93065914|NCT01309438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93065915|NCT01309438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065916|NCT01309438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93065917|NCT01309438|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93065918|NCT03776032|Darbepoetin alfa|darbepoetin alfa|mesh-list
93065919|NCT03776032|Hematinics|hematinics|mesh-ancestor
93065920|NCT03775798|Antiviral Agents|antiviral agents|mesh-list
93065921|NCT03775798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065922|NCT03775876|Dexmedetomidine|dexmedetomidine|mesh-list
93065923|NCT03775876|Propofol|propofol|mesh-list
93065924|NCT03775876|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93065925|NCT03775876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065926|NCT03775876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065927|NCT03775876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065928|NCT03775876|Analgesics|analgesics|mesh-ancestor
93065929|NCT03775876|Sensory System Agents|sensory system agents|mesh-ancestor
93065930|NCT03775876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065931|NCT03775876|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93065932|NCT03775876|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93065933|NCT03775876|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93065934|NCT03775876|Adrenergic Agents|adrenergic agents|mesh-ancestor
93065935|NCT03775876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93065936|NCT03775876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065937|NCT03775876|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93065938|NCT03775876|Anesthetics, General|anesthetics, general|mesh-ancestor
93065939|NCT03775876|Anesthetics|anesthetics|mesh-ancestor
93065940|NCT01320514|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
93065941|NCT01320514|Hemostatics|hemostatics|mesh-ancestor
93065942|NCT01320514|Coagulants|coagulants|mesh-ancestor
93065943|NCT03773536|Artesunate|artesunate|mesh-list
93065944|NCT03773536|Primaquine|primaquine|mesh-list
93065945|NCT03773536|Amodiaquine|amodiaquine|mesh-list
93065946|NCT03773536|Antimalarials|antimalarials|mesh-ancestor
93065947|NCT03773536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93065948|NCT03773536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93065949|NCT03773536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065950|NCT03773536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065951|NCT03773536|Antiviral Agents|antiviral agents|mesh-ancestor
93065952|NCT03773536|Schistosomicides|schistosomicides|mesh-ancestor
93065953|NCT03773536|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93065954|NCT03773536|Anthelmintics|anthelmintics|mesh-ancestor
93065955|NCT01320592|Paclitaxel|paclitaxel|mesh-list
93065956|NCT01320592|Palbociclib|palbociclib|mesh-list
93065957|NCT01320592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93065958|NCT01320592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93065959|NCT01320592|Tubulin Modulators|tubulin modulators|mesh-ancestor
93065960|NCT01320592|Antimitotic Agents|antimitotic agents|mesh-ancestor
93065961|NCT01320592|Mitosis Modulators|mitosis modulators|mesh-ancestor
93065962|NCT01320592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065963|NCT01320592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93065964|NCT01320592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065965|NCT03783676|Remifentanil|remifentanil|mesh-list
93065966|NCT03783676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93065967|NCT03783676|Narcotics|narcotics|mesh-ancestor
93065968|NCT03783676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93065969|NCT03783676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065970|NCT03783676|Analgesics|analgesics|mesh-ancestor
93065971|NCT03783676|Sensory System Agents|sensory system agents|mesh-ancestor
93065972|NCT03783676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065973|NCT03783520|Sodium Hypochlorite|sodium hypochlorite|mesh-list
93065974|NCT03783520|Eusol|eusol|mesh-list
93065975|NCT03783520|Disinfectants|disinfectants|mesh-ancestor
93065976|NCT03783520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065977|NCT01320982|Aspirin|aspirin|mesh-list
93065978|NCT01320982|Minocycline|minocycline|mesh-list
93065979|NCT01320982|Pramipexole|pramipexole|mesh-list
93065980|NCT01320982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93065981|NCT01320982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93065982|NCT01320982|Analgesics|analgesics|mesh-ancestor
93065983|NCT01320982|Sensory System Agents|sensory system agents|mesh-ancestor
93065984|NCT01320982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93065985|NCT01320982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93065986|NCT01320982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93065987|NCT01320982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93065988|NCT01320982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93065989|NCT01320982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93065990|NCT01320982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93065991|NCT01320982|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93065992|NCT01320982|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93065993|NCT01320982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93065994|NCT01320982|Antipyretics|antipyretics|mesh-ancestor
93065995|NCT01320982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93065996|NCT01320982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93065997|NCT01320982|Antioxidants|antioxidants|mesh-ancestor
93065998|NCT01320982|Protective Agents|protective agents|mesh-ancestor
93065999|NCT01320982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93066000|NCT01320982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93066001|NCT01320982|Dopamine Agonists|dopamine agonists|mesh-ancestor
93066002|NCT01320982|Dopamine Agents|dopamine agents|mesh-ancestor
93066003|NCT01320982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066004|NCT04893382|Plasma-lyte 148|plasma-lyte 148|mesh-list
93066005|NCT04893382|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93066006|NCT04893382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93066007|NCT01321138|Morphine|morphine|mesh-list
93066008|NCT01321138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93066009|NCT01321138|Narcotics|narcotics|mesh-ancestor
93066010|NCT01321138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066011|NCT01321138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066012|NCT01321138|Analgesics|analgesics|mesh-ancestor
93066013|NCT01321138|Sensory System Agents|sensory system agents|mesh-ancestor
93066014|NCT01321138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066015|NCT04628572|Ceftazidime|ceftazidime|mesh-list
93066016|NCT04628572|Avibactam|avibactam|mesh-list
93066017|NCT04628572|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
93066018|NCT04628572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93066019|NCT04628572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066020|NCT04628572|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
93066021|NCT04628572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066022|NCT04628572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066023|NCT03772990|Calcium|calcium|mesh-list
93066024|NCT03772990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93066025|NCT03772990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066026|NCT03782662|Itraconazole|itraconazole|mesh-list
93066027|NCT03782662|Rifampin|rifampin|mesh-list
93066028|NCT03782662|Verapamil|verapamil|mesh-list
93066029|NCT03782662|Midazolam|midazolam|mesh-list
93066030|NCT03782662|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93066031|NCT03782662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93066032|NCT03782662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066033|NCT03782662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066034|NCT03782662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93066035|NCT03782662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93066036|NCT03782662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93066037|NCT03782662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93066038|NCT03782662|Anesthetics, General|anesthetics, general|mesh-ancestor
93066039|NCT03782662|Anesthetics|anesthetics|mesh-ancestor
93066040|NCT03782662|GABA Modulators|gaba modulators|mesh-ancestor
93066041|NCT03782662|GABA Agents|gaba agents|mesh-ancestor
93066042|NCT03782662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066043|NCT03782662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066044|NCT03782662|Antifungal Agents|antifungal agents|mesh-ancestor
93066045|NCT03782662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066046|NCT03782662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93066047|NCT03782662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93066048|NCT03782662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066049|NCT03782662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93066050|NCT03782662|Hormone Antagonists|hormone antagonists|mesh-ancestor
93066051|NCT03782662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066052|NCT03782662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93066053|NCT03782662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93066054|NCT03782662|Antitubercular Agents|antitubercular agents|mesh-ancestor
93066055|NCT03782662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93066056|NCT03782662|Leprostatic Agents|leprostatic agents|mesh-ancestor
93066057|NCT03782662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93066058|NCT03782662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93066059|NCT03782662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93066060|NCT03782662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93066061|NCT03782662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93066062|NCT03782662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93066063|NCT03782662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93066064|NCT03782662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93066065|NCT03782662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93066066|NCT03782662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93066067|NCT03782662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93066068|NCT03782662|Vasodilator Agents|vasodilator agents|mesh-ancestor
93066070|NCT01309984|Fospropofol|fospropofol|mesh-list
93066071|NCT01309984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93066072|NCT01309984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066073|NCT01309984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066074|NCT01309984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93066075|NCT01309984|Anesthetics, General|anesthetics, general|mesh-ancestor
93066076|NCT01309984|Anesthetics|anesthetics|mesh-ancestor
93066077|NCT03772054|Propofol|propofol|mesh-list
93066078|NCT03772054|Sevoflurane|sevoflurane|mesh-list
93066079|NCT03772054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93066080|NCT03772054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066081|NCT03772054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066082|NCT03772054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93066083|NCT03772054|Anesthetics, General|anesthetics, general|mesh-ancestor
93066084|NCT03772054|Anesthetics|anesthetics|mesh-ancestor
93066085|NCT03772054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93066086|NCT03772054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93066087|NCT03771820|Pembrolizumab|pembrolizumab|mesh-list
93066088|NCT03771820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066089|NCT03771820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066090|NCT03771820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93066091|NCT03771820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066092|NCT05531890|Betamethasone|betamethasone|mesh-list
93066093|NCT05531890|Betamethasone Valerate|betamethasone valerate|mesh-list
93066094|NCT05531890|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
93066095|NCT05531890|Betamethasone benzoate|betamethasone benzoate|mesh-list
93066096|NCT05531890|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93066097|NCT05531890|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
93066098|NCT05531890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066099|NCT05531890|Glucocorticoids|glucocorticoids|mesh-ancestor
93066100|NCT05531890|Hormones|hormones|mesh-ancestor
93066101|NCT05531890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066102|NCT05531890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066103|NCT05531890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93066104|NCT05531890|Respiratory System Agents|respiratory system agents|mesh-ancestor
93066105|NCT00123474|Dasatinib|dasatinib|mesh-list
93066106|NCT00123474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066107|NCT00123474|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066108|NCT00123474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066109|NCT00123474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066110|NCT00142298|Telbivudine|telbivudine|mesh-list
93066111|NCT00142298|Antiviral Agents|antiviral agents|mesh-ancestor
93066112|NCT00142298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066113|NCT00142298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93066114|NCT00142298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066115|NCT00142298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066116|NCT03774706|Misoprostol|misoprostol|mesh-list
93066117|NCT03774706|Tranexamic Acid|tranexamic acid|mesh-list
93066118|NCT03774706|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93066119|NCT03774706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93066120|NCT03774706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066121|NCT03774706|Hemostatics|hemostatics|mesh-ancestor
93066122|NCT03774706|Coagulants|coagulants|mesh-ancestor
93066123|NCT03774706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93066124|NCT03774706|Abortifacient Agents|abortifacient agents|mesh-ancestor
93066125|NCT03774706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93066126|NCT03774706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066127|NCT03774706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93066128|NCT03774706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066130|NCT03967496|Metformin|metformin|mesh-list
93066131|NCT03967496|Amlodipine|amlodipine|mesh-list
93066132|NCT03967496|Lisinopril|lisinopril|mesh-list
93066133|NCT03967496|Bisoprolol|bisoprolol|mesh-list
93066134|NCT03967496|Hydralazine|hydralazine|mesh-list
93066135|NCT03967496|Anesthetics|anesthetics|mesh-list
93066136|NCT03967496|Atorvastatin|atorvastatin|mesh-list
93066137|NCT03967496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066138|NCT03967496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066139|NCT03967496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066140|NCT03967496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93066141|NCT03967496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93066142|NCT03967496|Antimetabolites|antimetabolites|mesh-ancestor
93066143|NCT03967496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066144|NCT03967496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93066145|NCT03967496|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93066146|NCT03967496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066147|NCT03967496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93066148|NCT03967496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93066149|NCT03967496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93066150|NCT03967496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93066151|NCT03967496|Vasodilator Agents|vasodilator agents|mesh-ancestor
93066152|NCT03967496|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93066153|NCT03967496|Protease Inhibitors|protease inhibitors|mesh-ancestor
93066154|NCT03967496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93066155|NCT03967496|Protective Agents|protective agents|mesh-ancestor
93066156|NCT03967496|Sympatholytics|sympatholytics|mesh-ancestor
93066157|NCT03967496|Autonomic Agents|autonomic agents|mesh-ancestor
93066158|NCT03967496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066159|NCT03967496|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93066160|NCT03967496|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93066161|NCT03967496|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93066162|NCT03967496|Adrenergic Agents|adrenergic agents|mesh-ancestor
93066163|NCT03967496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066164|NCT00412061|Everolimus|everolimus|mesh-list
93066165|NCT00412061|Octreotide|octreotide|mesh-list
93066166|NCT00412061|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93066167|NCT00412061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066168|NCT00412061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066169|NCT00412061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066170|NCT00412061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066171|NCT00412061|Immunologic Factors|immunologic factors|mesh-ancestor
93066172|NCT00412061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066173|NCT00412061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066174|NCT00412061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066175|NCT00412061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93066176|NCT03964350|Ethanol|ethanol|mesh-list
93066177|NCT03964350|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93066178|NCT03964350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066179|NCT03964350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066180|NCT03964350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066181|NCT01310452|Insulin|insulin|mesh-list
93066182|NCT01310452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93066183|NCT01310452|Insulin Detemir|insulin detemir|mesh-list
93066184|NCT01310452|Protamines|protamines|mesh-list
93066185|NCT01310452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066186|NCT01310452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066187|NCT01310452|Heparin Antagonists|heparin antagonists|mesh-ancestor
93066188|NCT01310452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066189|NCT01310452|Coagulants|coagulants|mesh-ancestor
93066190|NCT01035671|Vitamin E|vitamin e|mesh-list
93066191|NCT01035671|Tocopherylquinone|tocopherylquinone|mesh-list
93066192|NCT01035671|Anticoagulants|anticoagulants|mesh-ancestor
93066193|NCT01035671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93066194|NCT01035671|Antioxidants|antioxidants|mesh-ancestor
93066195|NCT01035671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066196|NCT01035671|Protective Agents|protective agents|mesh-ancestor
93066197|NCT01035671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066198|NCT01035671|Vitamins|vitamins|mesh-ancestor
93066199|NCT01035671|Micronutrients|micronutrients|mesh-ancestor
93066200|NCT04560868|Nicotine|nicotine|mesh-list
93066201|NCT04560868|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93066202|NCT04560868|Autonomic Agents|autonomic agents|mesh-ancestor
93066203|NCT04560868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066204|NCT04560868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066205|NCT04560868|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93066206|NCT04560868|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93066207|NCT04560868|Cholinergic Agents|cholinergic agents|mesh-ancestor
93066208|NCT04560868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066209|NCT04560868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066210|NCT03769714|Bupivacaine|bupivacaine|mesh-list
93066211|NCT03769714|Anesthetics, Local|anesthetics, local|mesh-ancestor
93066212|NCT03769714|Anesthetics|anesthetics|mesh-ancestor
93066213|NCT03769714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066214|NCT03769714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066215|NCT03769714|Sensory System Agents|sensory system agents|mesh-ancestor
93066216|NCT03769714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066217|NCT03769402|Citric Acid|citric acid|mesh-list
93066218|NCT03769402|Sodium Citrate|sodium citrate|mesh-list
93066219|NCT03769402|Anticoagulants|anticoagulants|mesh-ancestor
93066220|NCT03769402|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
93066221|NCT03769402|Chelating Agents|chelating agents|mesh-ancestor
93066222|NCT03769402|Sequestering Agents|sequestering agents|mesh-ancestor
93066223|NCT03769402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066225|NCT00411671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066226|NCT00411671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066227|NCT00411671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066228|NCT00411671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066229|NCT01035983|Frovatriptan|frovatriptan|mesh-list
93066230|NCT01035983|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93066231|NCT01035983|Serotonin Agents|serotonin agents|mesh-ancestor
93066232|NCT01035983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066233|NCT01035983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066234|NCT01035983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066235|NCT03770806|Acetaminophen|acetaminophen|mesh-list
93066236|NCT03770806|Celecoxib|celecoxib|mesh-list
93066237|NCT03770806|Oxycodone|oxycodone|mesh-list
93066238|NCT03770806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93066239|NCT03770806|Analgesics|analgesics|mesh-ancestor
93066240|NCT03770806|Sensory System Agents|sensory system agents|mesh-ancestor
93066241|NCT03770806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066242|NCT03770806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066243|NCT03770806|Antipyretics|antipyretics|mesh-ancestor
93066244|NCT03770806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93066245|NCT03770806|Narcotics|narcotics|mesh-ancestor
93066246|NCT03770806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066247|NCT03770806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93066248|NCT03770806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066249|NCT03770806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066250|NCT03770806|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93066251|NCT03770806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93066252|NCT03770806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066253|NCT03770806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066254|NCT01039103|Methylprednisolone|methylprednisolone|mesh-list
93066255|NCT01039103|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93066256|NCT01039103|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93066257|NCT01039103|Prednisolone|prednisolone|mesh-list
93066258|NCT01039103|Prednisolone acetate|prednisolone acetate|mesh-list
93066259|NCT01039103|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93066260|NCT01039103|Prednisolone phosphate|prednisolone phosphate|mesh-list
93066261|NCT01039103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066262|NCT01039103|Antiemetics|antiemetics|mesh-ancestor
93066263|NCT01039103|Autonomic Agents|autonomic agents|mesh-ancestor
93066264|NCT01039103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066265|NCT01039103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066266|NCT01039103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066267|NCT01039103|Glucocorticoids|glucocorticoids|mesh-ancestor
93066268|NCT01039103|Hormones|hormones|mesh-ancestor
93066269|NCT01039103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066270|NCT01039103|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93066271|NCT01039103|Protective Agents|protective agents|mesh-ancestor
93066272|NCT01039103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93066273|NCT01039103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066274|NCT01039181|Vitamin D|vitamin d|mesh-list
93066275|NCT01039181|Calcitriol|calcitriol|mesh-list
93066276|NCT01039181|Vitamins|vitamins|mesh-ancestor
93066278|NCT01039181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066279|NCT01039181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93066280|NCT01039181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93066281|NCT01039181|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
93066282|NCT01039181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93066283|NCT01039181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066284|NCT01039181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93066285|NCT03770026|Clomiphene|clomiphene|mesh-list
93066286|NCT03770026|Enclomiphene|enclomiphene|mesh-list
93066287|NCT03770026|Zuclomiphene|zuclomiphene|mesh-list
93066288|NCT03770026|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93066289|NCT03770026|Hormone Antagonists|hormone antagonists|mesh-ancestor
93066290|NCT03770026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066291|NCT03770026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066292|NCT03770026|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93066293|NCT03770026|Fertility Agents|fertility agents|mesh-ancestor
93066294|NCT03770026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93066295|NCT03770026|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93066296|NCT03770026|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93066297|NCT03769870|Atorvastatin|atorvastatin|mesh-list
93066298|NCT03769870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93066299|NCT03769870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93066300|NCT03769870|Antimetabolites|antimetabolites|mesh-ancestor
93066301|NCT03769870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066302|NCT03769870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93066303|NCT03769870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93066304|NCT03769870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066305|NCT01589081|Nicotine|nicotine|mesh-list
93066306|NCT01589081|Progesterone|progesterone|mesh-list
93066307|NCT01589081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93066308|NCT01589081|Autonomic Agents|autonomic agents|mesh-ancestor
93066309|NCT01589081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066310|NCT01589081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066311|NCT01589081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93066312|NCT01589081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93066313|NCT01589081|Cholinergic Agents|cholinergic agents|mesh-ancestor
93066314|NCT01589081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066315|NCT01589081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066316|NCT01589081|Progestins|progestins|mesh-ancestor
93066317|NCT01589081|Hormones|hormones|mesh-ancestor
93066318|NCT01589081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066319|NCT01567540|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93066320|NCT01567540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066321|NCT01567540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066322|NCT01567540|Incretins|incretins|mesh-ancestor
93066323|NCT01567540|Hormones|hormones|mesh-ancestor
93066324|NCT01567540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066325|NCT01567540|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93066326|NCT01567540|Protease Inhibitors|protease inhibitors|mesh-ancestor
93066327|NCT01567540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066328|NCT01567540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066329|NCT01036841|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
93066330|NCT01036841|Hemostatics|hemostatics|mesh-ancestor
93066331|NCT01036841|Coagulants|coagulants|mesh-ancestor
93066332|NCT01036841|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
93066333|NCT01036841|Natriuretic Agents|natriuretic agents|mesh-ancestor
93066334|NCT01036841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066335|NCT03709576|Azacitidine|azacitidine|mesh-list
93066336|NCT03709576|Pevonedistat|pevonedistat|mesh-list
93066337|NCT03709576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066338|NCT03709576|Antimetabolites|antimetabolites|mesh-ancestor
93066339|NCT03709576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066340|NCT03709576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066341|NCT03709576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066342|NCT00122460|Cisplatin|cisplatin|mesh-list
93066343|NCT00122460|Carboplatin|carboplatin|mesh-list
93066344|NCT00122460|Fluorouracil|fluorouracil|mesh-list
93066345|NCT00122460|Cetuximab|cetuximab|mesh-list
93066346|NCT00122460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066347|NCT00122460|Antimetabolites|antimetabolites|mesh-ancestor
93066348|NCT00122460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066350|NCT00122460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066351|NCT00122460|Immunologic Factors|immunologic factors|mesh-ancestor
93066352|NCT00122460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066353|NCT00122460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066354|NCT03763396|Ketoconazole|ketoconazole|mesh-list
93066355|NCT03763396|Posaconazole|posaconazole|mesh-list
93066356|NCT03763396|Antifungal Agents|antifungal agents|mesh-ancestor
93066357|NCT03763396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066358|NCT03763396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93066359|NCT03763396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93066360|NCT03763396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066361|NCT03763396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066362|NCT03763396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93066363|NCT03763396|Hormone Antagonists|hormone antagonists|mesh-ancestor
93066364|NCT03763396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066365|NCT03763396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066366|NCT03763396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93066367|NCT03763396|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93066368|NCT03763396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93066369|NCT03763396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93066370|NCT01320436|Aminosalicylic Acid|aminosalicylic acid|mesh-list
93066371|NCT01320436|Curcumin|curcumin|mesh-list
93066372|NCT01320436|Mesalamine|mesalamine|mesh-list
93066373|NCT01320436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93066374|NCT01320436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93066375|NCT01320436|Analgesics|analgesics|mesh-ancestor
93066376|NCT01320436|Sensory System Agents|sensory system agents|mesh-ancestor
93066377|NCT01320436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066378|NCT01320436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066379|NCT01320436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066380|NCT01320436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066381|NCT01320436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066382|NCT01320436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066383|NCT01320436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066384|NCT01320436|Antitubercular Agents|antitubercular agents|mesh-ancestor
93066385|NCT01320436|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93066386|NCT01320436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066387|NCT04794088|Imatinib Mesylate|imatinib mesylate|mesh-list
93066388|NCT04794088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066389|NCT04794088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066390|NCT04794088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066391|NCT04794088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066392|NCT03763084|Acetaminophen|acetaminophen|mesh-list
93066393|NCT03763084|Sufentanil|sufentanil|mesh-list
93066394|NCT03763084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93066395|NCT03763084|Analgesics|analgesics|mesh-ancestor
93066396|NCT03763084|Sensory System Agents|sensory system agents|mesh-ancestor
93066397|NCT03763084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066398|NCT03763084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066399|NCT03763084|Antipyretics|antipyretics|mesh-ancestor
93066400|NCT03763084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93066401|NCT03763084|Narcotics|narcotics|mesh-ancestor
93066402|NCT03763084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066403|NCT03763084|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93066404|NCT03763084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93066405|NCT03763084|Anesthetics, General|anesthetics, general|mesh-ancestor
93066406|NCT03763084|Anesthetics|anesthetics|mesh-ancestor
93066407|NCT01567618|Docetaxel|docetaxel|mesh-list
93066408|NCT01567618|Fluorouracil|fluorouracil|mesh-list
93066409|NCT01567618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066410|NCT01567618|Tubulin Modulators|tubulin modulators|mesh-ancestor
93066411|NCT01567618|Antimitotic Agents|antimitotic agents|mesh-ancestor
93066412|NCT01567618|Mitosis Modulators|mitosis modulators|mesh-ancestor
93066413|NCT01567618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066414|NCT01567618|Antimetabolites|antimetabolites|mesh-ancestor
93066415|NCT01567618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066416|NCT01567618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066417|NCT01567618|Immunologic Factors|immunologic factors|mesh-ancestor
93066418|NCT01567618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066419|NCT04771078|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
93066420|NCT04771078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066421|NCT04771078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066422|NCT03762928|Efavirenz|efavirenz|mesh-list
93066423|NCT03762928|Midazolam|midazolam|mesh-list
93066424|NCT03762928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93066425|NCT03762928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92723455|NCT00568217|Antipyretics|antipyretics|mesh-ancestor
93066426|NCT03762928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066427|NCT03762928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066428|NCT03762928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93066429|NCT03762928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93066430|NCT03762928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93066431|NCT03762928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93066432|NCT03762928|Anesthetics, General|anesthetics, general|mesh-ancestor
93066434|NCT03762928|GABA Modulators|gaba modulators|mesh-ancestor
93066435|NCT03762928|GABA Agents|gaba agents|mesh-ancestor
93066436|NCT03762928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066437|NCT03762928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066438|NCT03762928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93066439|NCT03762928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93066440|NCT03762928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066441|NCT03762928|Antiviral Agents|antiviral agents|mesh-ancestor
93066442|NCT03762928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066443|NCT03762928|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93066444|NCT03762928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93066445|NCT03762928|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93066446|NCT03762928|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93066447|NCT03762928|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93066448|NCT03762928|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93066449|NCT01561456|Docetaxel|docetaxel|mesh-list
93066450|NCT01561456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066451|NCT01561456|Tubulin Modulators|tubulin modulators|mesh-ancestor
93066452|NCT01561456|Antimitotic Agents|antimitotic agents|mesh-ancestor
93066453|NCT01561456|Mitosis Modulators|mitosis modulators|mesh-ancestor
93066454|NCT01561456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066455|NCT00137436|Prednisone|prednisone|mesh-list
93066456|NCT00137436|Docetaxel|docetaxel|mesh-list
93066457|NCT00137436|Sunitinib|sunitinib|mesh-list
93066458|NCT00137436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066459|NCT00137436|Tubulin Modulators|tubulin modulators|mesh-ancestor
93066460|NCT00137436|Antimitotic Agents|antimitotic agents|mesh-ancestor
93066461|NCT00137436|Mitosis Modulators|mitosis modulators|mesh-ancestor
93066462|NCT00137436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066463|NCT00137436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066464|NCT00137436|Glucocorticoids|glucocorticoids|mesh-ancestor
93066465|NCT00137436|Hormones|hormones|mesh-ancestor
93066466|NCT00137436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066467|NCT00137436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066468|NCT00137436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93066469|NCT00137436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93066470|NCT00137436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93066471|NCT00137436|Growth Substances|growth substances|mesh-ancestor
93066472|NCT00137436|Growth Inhibitors|growth inhibitors|mesh-ancestor
93066473|NCT00137436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066474|NCT00137436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066475|NCT03762538|Propofol|propofol|mesh-list
93066476|NCT03762538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93066477|NCT03762538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066478|NCT03762538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066479|NCT03762538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93066480|NCT03762538|Anesthetics, General|anesthetics, general|mesh-ancestor
93066481|NCT03762538|Anesthetics|anesthetics|mesh-ancestor
93066482|NCT03762382|Tenofovir|tenofovir|mesh-list
93066483|NCT03762382|Levonorgestrel|levonorgestrel|mesh-list
93066484|NCT03762382|Antiviral Agents|antiviral agents|mesh-ancestor
93066485|NCT03762382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066486|NCT03762382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93066487|NCT03762382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93066488|NCT03762382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066489|NCT03762382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066490|NCT03762382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93066491|NCT03762382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93066492|NCT03762382|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93066493|NCT03762382|Contraceptive Agents|contraceptive agents|mesh-ancestor
93066494|NCT03762382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93066495|NCT03762382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066496|NCT03762382|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93066497|NCT03762382|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93066498|NCT03762382|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93066499|NCT03767920|Dexamethasone|dexamethasone|mesh-list
93066500|NCT03767920|Dexamethasone acetate|dexamethasone acetate|mesh-list
93066501|NCT03767920|Bupivacaine|bupivacaine|mesh-list
93066502|NCT03767920|BB 1101|bb 1101|mesh-list
93066503|NCT03767920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066504|NCT03767920|Antiemetics|antiemetics|mesh-ancestor
93066505|NCT03767920|Autonomic Agents|autonomic agents|mesh-ancestor
93066506|NCT03767920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066507|NCT03767920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066508|NCT03767920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066509|NCT03767920|Glucocorticoids|glucocorticoids|mesh-ancestor
93066510|NCT03767920|Hormones|hormones|mesh-ancestor
93066511|NCT03767920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066512|NCT03767920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93066513|NCT03767920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066514|NCT03767920|Protease Inhibitors|protease inhibitors|mesh-ancestor
93066515|NCT03767920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066516|NCT03767920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066517|NCT03767920|Anesthetics, Local|anesthetics, local|mesh-ancestor
93066518|NCT03767920|Anesthetics|anesthetics|mesh-ancestor
93066519|NCT03767920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066520|NCT03767920|Sensory System Agents|sensory system agents|mesh-ancestor
93066521|NCT03834623|Nivolumab|nivolumab|mesh-list
93066522|NCT03834623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066523|NCT03834623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066524|NCT03834623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93066525|NCT03834623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066526|NCT03762148|Vitamins|vitamins|mesh-list
93066527|NCT03762148|Ascorbic Acid|ascorbic acid|mesh-list
93066528|NCT03762148|Ferrous fumarate|ferrous fumarate|mesh-list
93066529|NCT03762148|Iron|iron|mesh-list
93066530|NCT03762148|Micronutrients|micronutrients|mesh-ancestor
93066531|NCT03762148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066532|NCT03762148|Antioxidants|antioxidants|mesh-ancestor
93066533|NCT03762148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066534|NCT03762148|Protective Agents|protective agents|mesh-ancestor
93066535|NCT03762148|Trace Elements|trace elements|mesh-ancestor
93066536|NCT01589159|Capecitabine|capecitabine|mesh-list
93066537|NCT01589159|Etoposide|etoposide|mesh-list
93066538|NCT01589159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066539|NCT01589159|Antimetabolites|antimetabolites|mesh-ancestor
93066540|NCT01589159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066541|NCT01589159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066542|NCT01589159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93066543|NCT01589159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93066544|NCT01589159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93066545|NCT01589159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066546|NCT03711292|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93066547|NCT03711292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066548|NCT03937895|Pembrolizumab|pembrolizumab|mesh-list
93066549|NCT03937895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066550|NCT03937895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066551|NCT03937895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93066552|NCT03937895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066553|NCT03625648|Pentoxifylline|pentoxifylline|mesh-list
93066554|NCT03625648|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93066555|NCT03625648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066556|NCT03625648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066557|NCT03625648|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93066558|NCT03625648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93066559|NCT03625648|Protective Agents|protective agents|mesh-ancestor
93066560|NCT03625648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066561|NCT03625648|Vasodilator Agents|vasodilator agents|mesh-ancestor
93066562|NCT03625648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93066563|NCT03625648|Antioxidants|antioxidants|mesh-ancestor
93066564|NCT03767296|Phenylephrine|phenylephrine|mesh-list
93066565|NCT03767296|Oxymetazoline|oxymetazoline|mesh-list
93066566|NCT03767296|Ephedrine|ephedrine|mesh-list
93066567|NCT03767296|Pseudoephedrine|pseudoephedrine|mesh-list
93066568|NCT03767296|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93066569|NCT03767296|Mydriatics|mydriatics|mesh-ancestor
93066570|NCT03767296|Autonomic Agents|autonomic agents|mesh-ancestor
93066572|NCT03767296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066573|NCT03767296|Sympathomimetics|sympathomimetics|mesh-ancestor
93066574|NCT03767296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92723596|NCT00568763|Sargramostim|sargramostim|mesh-list
93066575|NCT03767296|Nasal Decongestants|nasal decongestants|mesh-ancestor
93066577|NCT03767296|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93066578|NCT03767296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93066579|NCT03767296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93066580|NCT03767296|Adrenergic Agents|adrenergic agents|mesh-ancestor
93066581|NCT03767296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066582|NCT03767296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066583|NCT03767296|Protective Agents|protective agents|mesh-ancestor
93066584|NCT03767296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93066585|NCT03767296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93066586|NCT03767296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93066587|NCT00410813|Dasatinib|dasatinib|mesh-list
93066588|NCT00410813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066589|NCT00410813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066590|NCT00410813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066591|NCT00410813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066592|NCT03760978|Dexmedetomidine|dexmedetomidine|mesh-list
93066593|NCT03760978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93066594|NCT03760978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066595|NCT03760978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066596|NCT03760978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93066597|NCT03760978|Analgesics|analgesics|mesh-ancestor
93066598|NCT03760978|Sensory System Agents|sensory system agents|mesh-ancestor
93066599|NCT03760978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066600|NCT03760978|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93066601|NCT03760978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93066602|NCT03760978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93066603|NCT03760978|Adrenergic Agents|adrenergic agents|mesh-ancestor
93066604|NCT03760978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066605|NCT03760978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066606|NCT03766984|Diclofenac|diclofenac|mesh-list
93066607|NCT03766984|Tramadol|tramadol|mesh-list
93066608|NCT03766984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93066609|NCT03766984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93066610|NCT03766984|Analgesics|analgesics|mesh-ancestor
93066611|NCT03766984|Sensory System Agents|sensory system agents|mesh-ancestor
93066612|NCT03766984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066613|NCT03766984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066614|NCT03766984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066615|NCT03766984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066616|NCT03766984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93066617|NCT03766984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066618|NCT03766984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066619|NCT03766984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93066620|NCT03766984|Narcotics|narcotics|mesh-ancestor
93066621|NCT03766984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066622|NCT00405821|Acyclovir|acyclovir|mesh-list
93066623|NCT00405821|Antiviral Agents|antiviral agents|mesh-ancestor
93066624|NCT00405821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066625|NCT03928600|Misoprostol|misoprostol|mesh-list
93066626|NCT03928600|Dinoprostone|dinoprostone|mesh-list
93066627|NCT03928600|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93066628|NCT03928600|Abortifacient Agents|abortifacient agents|mesh-ancestor
93066629|NCT03928600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93066630|NCT03928600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066631|NCT03928600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93066632|NCT03928600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066633|NCT03928600|Oxytocics|oxytocics|mesh-ancestor
93066634|NCT03924856|Gemcitabine|gemcitabine|mesh-list
93066635|NCT03924856|Pembrolizumab|pembrolizumab|mesh-list
93066636|NCT03924856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066637|NCT03924856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066638|NCT03924856|Antimetabolites|antimetabolites|mesh-ancestor
93066639|NCT03924856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066640|NCT03924856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066641|NCT03924856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93066642|NCT03760822|Paclitaxel|paclitaxel|mesh-list
93066643|NCT03760822|Ramucirumab|ramucirumab|mesh-list
92530736|NCT00017940|Mitosis Modulators|mitosis modulators|mesh-ancestor
93066644|NCT03760822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93066645|NCT03760822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066646|NCT03760822|Tubulin Modulators|tubulin modulators|mesh-ancestor
93066647|NCT03760822|Antimitotic Agents|antimitotic agents|mesh-ancestor
93066648|NCT03760822|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723676|NCT00569816|Sevoflurane|sevoflurane|mesh-list
93066649|NCT03760822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066650|NCT01322152|Capecitabine|capecitabine|mesh-list
93066651|NCT01322152|Irinotecan|irinotecan|mesh-list
93066652|NCT01322152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066653|NCT01322152|Antimetabolites|antimetabolites|mesh-ancestor
93066654|NCT01322152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066655|NCT01322152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066656|NCT01322152|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93066657|NCT01322152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93066658|NCT01322152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066659|NCT01446016|Paclitaxel|paclitaxel|mesh-list
93066660|NCT01446016|Docetaxel|docetaxel|mesh-list
93066661|NCT01446016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93066662|NCT01446016|Taxane|taxane|mesh-list
93066663|NCT01446016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93066664|NCT01446016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066665|NCT01446016|Tubulin Modulators|tubulin modulators|mesh-ancestor
93066666|NCT01446016|Antimitotic Agents|antimitotic agents|mesh-ancestor
93066667|NCT01446016|Mitosis Modulators|mitosis modulators|mesh-ancestor
93066668|NCT01446016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066669|NCT00137046|Insulin|insulin|mesh-list
93066670|NCT00137046|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93066671|NCT00137046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066672|NCT00137046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066673|NCT03383458|Nivolumab|nivolumab|mesh-list
93066674|NCT03383458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066675|NCT03383458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066676|NCT03383458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93066677|NCT03383458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066678|NCT03760354|Methylprednisolone|methylprednisolone|mesh-list
93066679|NCT03760354|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
93066680|NCT03760354|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
93066681|NCT03760354|Prednisolone|prednisolone|mesh-list
93066682|NCT03760354|Prednisolone acetate|prednisolone acetate|mesh-list
93066683|NCT03760354|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
93066684|NCT03760354|Prednisolone phosphate|prednisolone phosphate|mesh-list
93066685|NCT03760354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93066686|NCT03760354|Antiemetics|antiemetics|mesh-ancestor
93066687|NCT03760354|Autonomic Agents|autonomic agents|mesh-ancestor
93066688|NCT03760354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066689|NCT03760354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066690|NCT03760354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066691|NCT03760354|Glucocorticoids|glucocorticoids|mesh-ancestor
93066692|NCT03760354|Hormones|hormones|mesh-ancestor
93066693|NCT03760354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066694|NCT03760354|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93066695|NCT03760354|Protective Agents|protective agents|mesh-ancestor
93066696|NCT03760354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93066697|NCT03760354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066698|NCT03760276|Voriconazole|voriconazole|mesh-list
93066699|NCT03760276|Antifungal Agents|antifungal agents|mesh-ancestor
93066700|NCT03760276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066701|NCT03760276|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93066702|NCT03760276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93066703|NCT03760276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066704|NCT03760276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066705|NCT03760276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93066706|NCT03760276|Hormone Antagonists|hormone antagonists|mesh-ancestor
93066707|NCT03760276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066708|NCT03760276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066709|NCT03760276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93066710|NCT03766594|Folic Acid|folic acid|mesh-list
93066711|NCT03766594|Sildenafil Citrate|sildenafil citrate|mesh-list
93066712|NCT03766594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066713|NCT03766594|Vasodilator Agents|vasodilator agents|mesh-ancestor
93066714|NCT03766594|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93066715|NCT03766594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93066716|NCT03766594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066717|NCT03766594|Urological Agents|urological agents|mesh-ancestor
93066718|NCT03766594|Hematinics|hematinics|mesh-ancestor
93066719|NCT03766594|Vitamin B Complex|vitamin b complex|mesh-ancestor
93066720|NCT03766594|Vitamins|vitamins|mesh-ancestor
93066721|NCT03766594|Micronutrients|micronutrients|mesh-ancestor
93066722|NCT03766594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066723|NCT00122382|Methotrexate|methotrexate|mesh-list
93066724|NCT00122382|Abatacept|abatacept|mesh-list
93066725|NCT00122382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93066726|NCT00122382|Abortifacient Agents|abortifacient agents|mesh-ancestor
93066727|NCT00122382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93066728|NCT00122382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066729|NCT00122382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066730|NCT00122382|Antimetabolites|antimetabolites|mesh-ancestor
93066731|NCT00122382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066732|NCT00122382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066733|NCT00122382|Dermatologic Agents|dermatologic agents|mesh-ancestor
93066734|NCT00122382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066735|NCT00122382|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93066736|NCT00122382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066737|NCT00122382|Immunologic Factors|immunologic factors|mesh-ancestor
93066738|NCT00122382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066739|NCT00122382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93066740|NCT00122382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93066741|NCT00122382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066742|NCT01028716|Mycophenolic Acid|mycophenolic acid|mesh-list
93066743|NCT01028716|Cyclophosphamide|cyclophosphamide|mesh-list
93066744|NCT01028716|Fludarabine|fludarabine|mesh-list
93066745|NCT01028716|Fludarabine phosphate|fludarabine phosphate|mesh-list
93066746|NCT01028716|Tacrolimus|tacrolimus|mesh-list
93066747|NCT01028716|Lenograstim|lenograstim|mesh-list
93066748|NCT01028716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066749|NCT01028716|Immunologic Factors|immunologic factors|mesh-ancestor
93066750|NCT01028716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066751|NCT01028716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066752|NCT01028716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93066753|NCT01028716|Alkylating Agents|alkylating agents|mesh-ancestor
93066754|NCT01028716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066755|NCT01028716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066756|NCT01028716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93066757|NCT01028716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93066758|NCT01028716|Antimetabolites|antimetabolites|mesh-ancestor
93066759|NCT01028716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93066760|NCT01028716|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93066761|NCT01028716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066762|NCT01028716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93066763|NCT01028716|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93066764|NCT01028716|Antitubercular Agents|antitubercular agents|mesh-ancestor
93066765|NCT01028716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93066766|NCT01028716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066767|NCT02531724|Simendan|simendan|mesh-list
93066768|NCT02531724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93066769|NCT02531724|Vasodilator Agents|vasodilator agents|mesh-ancestor
93066770|NCT02531724|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93066771|NCT02531724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93066772|NCT02531724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066773|NCT02531724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066774|NCT02531724|Protective Agents|protective agents|mesh-ancestor
93066775|NCT02531724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066776|NCT03760198|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93066777|NCT03760198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93066778|NCT03760198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066779|NCT03760198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066780|NCT03760198|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93066781|NCT03760198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93066782|NCT03760198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066783|NCT03760198|Cholinergic Agents|cholinergic agents|mesh-ancestor
93066784|NCT03760198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066785|NCT00106704|Pioglitazone|pioglitazone|mesh-list
93066786|NCT00106704|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93066787|NCT00106704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066788|NCT00106704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066789|NCT00106704|Incretins|incretins|mesh-ancestor
93066791|NCT00106704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066792|NCT00106704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93066793|NCT00106704|Protease Inhibitors|protease inhibitors|mesh-ancestor
93066794|NCT00106704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066795|NCT00106704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066796|NCT03759886|Metronidazole|metronidazole|mesh-list
93066797|NCT03759886|Paromomycin|paromomycin|mesh-list
93066798|NCT03759886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066799|NCT03759886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93066800|NCT03759886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93066801|NCT03759886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93066802|NCT01081158|Ritonavir|ritonavir|mesh-list
93066803|NCT01081158|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
93066804|NCT01081158|Interferon-alpha|interferon-alpha|mesh-list
93066805|NCT01081158|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93066806|NCT01081158|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93066807|NCT01081158|Protease Inhibitors|protease inhibitors|mesh-ancestor
93066808|NCT01081158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066809|NCT01081158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066810|NCT01081158|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93066811|NCT01081158|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93066812|NCT01081158|Antiviral Agents|antiviral agents|mesh-ancestor
93066813|NCT01081158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066814|NCT01081158|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93066815|NCT01081158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93066816|NCT01081158|Immunologic Factors|immunologic factors|mesh-ancestor
93066817|NCT01081158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066818|NCT00105066|Metformin|metformin|mesh-list
93066819|NCT00105066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066820|NCT00105066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066821|NCT01322308|Pioglitazone|pioglitazone|mesh-list
93066822|NCT01322308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066823|NCT01322308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066824|NCT05208268|Rabeprazole|rabeprazole|mesh-list
93066825|NCT05208268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93066826|NCT05208268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066827|NCT05208268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93066828|NCT05208268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066829|NCT05208268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066830|NCT03165292|Topotecan|topotecan|mesh-list
93066831|NCT03165292|Thiotepa|thiotepa|mesh-list
93066832|NCT03165292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93066833|NCT03165292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93066834|NCT03165292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066835|NCT03165292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066836|NCT03165292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066837|NCT03165292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93066838|NCT03165292|Alkylating Agents|alkylating agents|mesh-ancestor
93066839|NCT03165292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93066840|NCT03165292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066841|NCT03165292|Immunologic Factors|immunologic factors|mesh-ancestor
93066842|NCT03165292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066843|NCT03759262|Vitamin D|vitamin d|mesh-list
93066844|NCT03759262|Cholecalciferol|cholecalciferol|mesh-list
93066845|NCT03759262|Vitamins|vitamins|mesh-ancestor
93066846|NCT03759262|Micronutrients|micronutrients|mesh-ancestor
93066847|NCT03759262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066848|NCT03759262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93066849|NCT03759262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93066850|NCT00135330|Exenatide|exenatide|mesh-list
93066851|NCT00135330|Rosiglitazone|rosiglitazone|mesh-list
93066852|NCT00135330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066853|NCT00135330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066854|NCT00135330|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93066855|NCT00135330|Incretins|incretins|mesh-ancestor
93066856|NCT00135330|Hormones|hormones|mesh-ancestor
93066857|NCT00135330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93066858|NCT01076478|Cilostazol|cilostazol|mesh-list
93066859|NCT01076478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93066860|NCT01076478|Autonomic Agents|autonomic agents|mesh-ancestor
93066861|NCT01076478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530741|NCT02970604|Analgesics|analgesics|mesh-ancestor
93066862|NCT01076478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066864|NCT01076478|Respiratory System Agents|respiratory system agents|mesh-ancestor
93066865|NCT01076478|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93066866|NCT01076478|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93066867|NCT01076478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066868|NCT01076478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93066869|NCT01076478|Vasodilator Agents|vasodilator agents|mesh-ancestor
93066870|NCT01076478|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93066871|NCT01076478|Protective Agents|protective agents|mesh-ancestor
93066872|NCT01076478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93066873|NCT01076478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93066874|NCT01076478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066875|NCT01076556|Cyclophosphamide|cyclophosphamide|mesh-list
93066876|NCT01076556|Rituximab|rituximab|mesh-list
93066877|NCT01076556|Alvocidib|alvocidib|mesh-list
93066878|NCT01076556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93066879|NCT01076556|Antibodies|antibodies|mesh-list
93066880|NCT01076556|Immunoglobulins|immunoglobulins|mesh-list
93066881|NCT01076556|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93066882|NCT01076556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066883|NCT01076556|Immunologic Factors|immunologic factors|mesh-ancestor
93066884|NCT01076556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066885|NCT01076556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066886|NCT01076556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93066887|NCT01076556|Alkylating Agents|alkylating agents|mesh-ancestor
93066888|NCT01076556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066889|NCT01076556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066890|NCT01076556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93066891|NCT01076556|Growth Inhibitors|growth inhibitors|mesh-ancestor
93066892|NCT01076556|Growth Substances|growth substances|mesh-ancestor
93066893|NCT01076556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066894|NCT01076556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066895|NCT03965442|Esmolol|esmolol|mesh-list
93066896|NCT03965442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
93066897|NCT03965442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93066898|NCT03965442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93066899|NCT03965442|Adrenergic Agents|adrenergic agents|mesh-ancestor
93066900|NCT03965442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066901|NCT03965442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066902|NCT03965442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066903|NCT00134082|Cyclophosphamide|cyclophosphamide|mesh-list
93066904|NCT00134082|Rituximab|rituximab|mesh-list
93066905|NCT00134082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066906|NCT00134082|Immunologic Factors|immunologic factors|mesh-ancestor
93066907|NCT00134082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066908|NCT00134082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93066909|NCT00134082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93066910|NCT00134082|Alkylating Agents|alkylating agents|mesh-ancestor
93066911|NCT00134082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066912|NCT00134082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066913|NCT00134082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93066914|NCT00134082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066915|NCT03765346|Oxycodone|oxycodone|mesh-list
93066916|NCT03765346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93066917|NCT03765346|Narcotics|narcotics|mesh-ancestor
93066918|NCT03765346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066919|NCT03765346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066920|NCT03765346|Analgesics|analgesics|mesh-ancestor
93066921|NCT03765346|Sensory System Agents|sensory system agents|mesh-ancestor
93066922|NCT03765346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066923|NCT01078818|Ferrous fumarate|ferrous fumarate|mesh-list
93066924|NCT01078818|Trace Elements|trace elements|mesh-ancestor
93066925|NCT01078818|Micronutrients|micronutrients|mesh-ancestor
93066926|NCT01078818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066927|NCT01079052|Famotidine|famotidine|mesh-list
93066928|NCT01079052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93066929|NCT01079052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93066930|NCT01079052|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
93066931|NCT01079052|Histamine Antagonists|histamine antagonists|mesh-ancestor
93066932|NCT01079052|Histamine Agents|histamine agents|mesh-ancestor
93066933|NCT01079052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066934|NCT01079052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066935|NCT01079052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066936|NCT01326468|Sirolimus|sirolimus|mesh-list
93066937|NCT01326468|Cisplatin|cisplatin|mesh-list
93066938|NCT01326468|Cetuximab|cetuximab|mesh-list
93066939|NCT01326468|Temsirolimus|temsirolimus|mesh-list
93066940|NCT01326468|MTOR Inhibitors|mtor inhibitors|mesh-list
93066941|NCT01326468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066942|NCT01326468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93066943|NCT01326468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066944|NCT01326468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066945|NCT01326468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066946|NCT01326468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93066947|NCT01326468|Immunologic Factors|immunologic factors|mesh-ancestor
93066948|NCT01326468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066949|NCT01326468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93066950|NCT01326468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93066951|NCT01326468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93066952|NCT01326468|Antifungal Agents|antifungal agents|mesh-ancestor
93066953|NCT01076634|Insulin|insulin|mesh-list
93066954|NCT01076634|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93066955|NCT01076634|Insulin, Long-Acting|insulin, long-acting|mesh-list
93066956|NCT01076634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93066957|NCT01076634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066958|NCT00132678|Risperidone|risperidone|mesh-list
93066959|NCT00132678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93066960|NCT00132678|Serotonin Agents|serotonin agents|mesh-ancestor
93066961|NCT00132678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066962|NCT00132678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066963|NCT00132678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066964|NCT00132678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93066965|NCT00132678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93066966|NCT00132678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066967|NCT00132678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93066968|NCT00132678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93066969|NCT00132678|Dopamine Agents|dopamine agents|mesh-ancestor
93066970|NCT01081548|Atorvastatin|atorvastatin|mesh-list
93066971|NCT01081548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93066972|NCT01081548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93066973|NCT01081548|Antimetabolites|antimetabolites|mesh-ancestor
93066974|NCT01081548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066975|NCT01081548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93066976|NCT01081548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93066977|NCT01081548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066978|NCT00101400|Sorafenib|sorafenib|mesh-list
93066979|NCT00101400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93066980|NCT00101400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93066981|NCT00101400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93066982|NCT00101400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066983|NCT01076790|Dexmedetomidine|dexmedetomidine|mesh-list
93066984|NCT01076790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93066985|NCT01076790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93066986|NCT01076790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93066987|NCT01076790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93066988|NCT01076790|Analgesics|analgesics|mesh-ancestor
93066989|NCT01076790|Sensory System Agents|sensory system agents|mesh-ancestor
93066990|NCT01076790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93066991|NCT01076790|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93066992|NCT01076790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93066993|NCT01076790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93066994|NCT01076790|Adrenergic Agents|adrenergic agents|mesh-ancestor
93066995|NCT01076790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93066996|NCT01076790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93066997|NCT01582932|Calcipotriene|calcipotriene|mesh-list
93066998|NCT01582932|Dermatologic Agents|dermatologic agents|mesh-ancestor
93066999|NCT03965286|Sofosbuvir|sofosbuvir|mesh-list
93067000|NCT03965286|Ledipasvir|ledipasvir|mesh-list
93067001|NCT03965286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
93067002|NCT03965286|Antiviral Agents|antiviral agents|mesh-ancestor
93067003|NCT03965286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067004|NCT01079286|Sirolimus|sirolimus|mesh-list
93067005|NCT01079286|Nelfinavir|nelfinavir|mesh-list
93067006|NCT01079286|Temsirolimus|temsirolimus|mesh-list
93067007|NCT01079286|MTOR Inhibitors|mtor inhibitors|mesh-list
93067008|NCT01079286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93067009|NCT01079286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135509|NCT01452529|Analgesics|analgesics|mesh-ancestor
93067010|NCT01079286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067011|NCT01079286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067012|NCT01079286|Immunologic Factors|immunologic factors|mesh-ancestor
93067013|NCT01079286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067014|NCT01079286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067015|NCT01079286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93067016|NCT01079286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067017|NCT01079286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93067018|NCT01079286|Antifungal Agents|antifungal agents|mesh-ancestor
93067019|NCT01079286|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93067020|NCT01079286|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93067021|NCT01079286|Protease Inhibitors|protease inhibitors|mesh-ancestor
93067022|NCT01079286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93067023|NCT01079286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93067024|NCT01079286|Antiviral Agents|antiviral agents|mesh-ancestor
93067027|NCT00141518|Levodopa|levodopa|mesh-list
93067028|NCT00141518|Carbidopa|carbidopa|mesh-list
93067029|NCT00141518|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93067030|NCT00141518|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93067031|NCT00141518|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93067032|NCT00141518|Dopamine Agents|dopamine agents|mesh-ancestor
93067033|NCT00141518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067034|NCT00141518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067035|NCT00141518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067036|NCT00141518|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93067037|NCT00141518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067038|NCT00141518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93067039|NCT00141518|Immunologic Factors|immunologic factors|mesh-ancestor
93067040|NCT00141518|Dopamine Agonists|dopamine agonists|mesh-ancestor
93067041|NCT01075880|Interferons|interferons|mesh-list
93067042|NCT01075880|Interferon-beta|interferon-beta|mesh-list
93067043|NCT01075880|Interferon beta-1a|interferon beta-1a|mesh-list
93067044|NCT01075880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067045|NCT01075880|Antiviral Agents|antiviral agents|mesh-ancestor
93067046|NCT01075880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067047|NCT01075880|Immunologic Factors|immunologic factors|mesh-ancestor
93067048|NCT01075880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067049|NCT01075880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93067050|NCT00098748|Maraviroc|maraviroc|mesh-list
93067051|NCT00098748|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93067052|NCT00098748|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93067053|NCT00098748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067054|NCT00098748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93067055|NCT00098748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93067056|NCT00098748|Antiviral Agents|antiviral agents|mesh-ancestor
93067057|NCT00098748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067058|NCT00098748|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93067059|NCT00130520|Bevacizumab|bevacizumab|mesh-list
93067060|NCT00130520|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93067061|NCT00130520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067062|NCT00130520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067063|NCT00130520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067064|NCT00130520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93067065|NCT00130520|Growth Substances|growth substances|mesh-ancestor
93067066|NCT00130520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067067|NCT00130520|Growth Inhibitors|growth inhibitors|mesh-ancestor
93067068|NCT00130520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93067069|NCT00130520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067070|NCT00130520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067071|NCT00130442|Dacarbazine|dacarbazine|mesh-list
93067072|NCT00130442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93067073|NCT00130442|Alkylating Agents|alkylating agents|mesh-ancestor
93067074|NCT00130442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067075|NCT00130442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067076|NCT00130208|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
93067077|NCT00130208|Anticoagulants|anticoagulants|mesh-ancestor
93067078|NCT00130208|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93067079|NCT00130208|Antimetabolites|antimetabolites|mesh-ancestor
93067080|NCT00130208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067081|NCT00130208|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93067082|NCT00130208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93067083|NCT00130208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93067084|NCT00130208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067085|NCT00130208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067086|NCT00253370|Cisplatin|cisplatin|mesh-list
93067087|NCT00253370|Docetaxel|docetaxel|mesh-list
93067088|NCT00253370|Sorafenib|sorafenib|mesh-list
93067089|NCT00253370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067090|NCT00253370|Tubulin Modulators|tubulin modulators|mesh-ancestor
93067091|NCT00253370|Antimitotic Agents|antimitotic agents|mesh-ancestor
93067092|NCT00253370|Mitosis Modulators|mitosis modulators|mesh-ancestor
93067093|NCT00253370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067094|NCT00253370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93067095|NCT00253370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067096|NCT03966170|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
93067097|NCT03966170|Nootropic Agents|nootropic agents|mesh-ancestor
93067098|NCT00140426|Risperidone|risperidone|mesh-list
93067099|NCT00140426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93067100|NCT00140426|Serotonin Agents|serotonin agents|mesh-ancestor
93067101|NCT00140426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067102|NCT00140426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067103|NCT00140426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067104|NCT00140426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93067105|NCT00140426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93067106|NCT00140426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067107|NCT00140426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067108|NCT00140426|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93067109|NCT00140426|Dopamine Agents|dopamine agents|mesh-ancestor
93067110|NCT03966560|Timolol|timolol|mesh-list
93067111|NCT03966560|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93067112|NCT03966560|Bimatoprost|bimatoprost|mesh-list
93067113|NCT03966560|Travoprost|travoprost|mesh-list
93067114|NCT03966560|Dorzolamide|dorzolamide|mesh-list
93067115|NCT03966560|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93067116|NCT03966560|Latanoprost|latanoprost|mesh-list
93067117|NCT03966560|Brinzolamide|brinzolamide|mesh-list
93067118|NCT03966560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93067119|NCT03966560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340754|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
93067120|NCT03966560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067121|NCT03966560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93067122|NCT03966560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93067123|NCT03966560|Adrenergic Agents|adrenergic agents|mesh-ancestor
93067124|NCT03966560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067125|NCT03966560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067126|NCT03966560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93067127|NCT03966560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93067128|NCT03966560|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93067129|NCT03966560|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93067130|NCT03966560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93067131|NCT03966560|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93067132|NCT01072058|Adalimumab|adalimumab|mesh-list
93067133|NCT01072058|Infliximab|infliximab|mesh-list
93067134|NCT01072058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
93067135|NCT01072058|Etanercept|etanercept|mesh-list
93067136|NCT01072058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067137|NCT01072058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067138|NCT01072058|Dermatologic Agents|dermatologic agents|mesh-ancestor
93067139|NCT01072058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93067140|NCT01072058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93067141|NCT01072058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93067142|NCT01072058|Analgesics|analgesics|mesh-ancestor
93067143|NCT01072058|Sensory System Agents|sensory system agents|mesh-ancestor
93067144|NCT01072058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067145|NCT01072058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067146|NCT01072058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067147|NCT01072058|Immunologic Factors|immunologic factors|mesh-ancestor
93067148|NCT00121134|Cyclophosphamide|cyclophosphamide|mesh-list
93067149|NCT00121134|Bevacizumab|bevacizumab|mesh-list
93067150|NCT00121134|Capecitabine|capecitabine|mesh-list
93067151|NCT00121134|Methotrexate|methotrexate|mesh-list
93067152|NCT00121134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067153|NCT00121134|Immunologic Factors|immunologic factors|mesh-ancestor
93067154|NCT00121134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067155|NCT00121134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067156|NCT00121134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93067157|NCT00121134|Alkylating Agents|alkylating agents|mesh-ancestor
93067158|NCT00121134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067159|NCT00121134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067160|NCT00121134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92135667|NCT01467505|Interferons|interferons|mesh-list
93067161|NCT00121134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067162|NCT00121134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067163|NCT00121134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93067164|NCT00121134|Growth Substances|growth substances|mesh-ancestor
93067165|NCT00121134|Growth Inhibitors|growth inhibitors|mesh-ancestor
93067166|NCT00121134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93067167|NCT00121134|Antimetabolites|antimetabolites|mesh-ancestor
93067168|NCT00121134|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93067169|NCT00121134|Abortifacient Agents|abortifacient agents|mesh-ancestor
93067170|NCT00121134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93067171|NCT00121134|Dermatologic Agents|dermatologic agents|mesh-ancestor
93067172|NCT00121134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067173|NCT00121134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93067174|NCT00121134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067175|NCT03966378|Grape Seed Extract|grape seed extract|mesh-list
92724190|NCT00586092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067176|NCT03966378|Calcium|calcium|mesh-list
93067177|NCT03966378|Caseins|caseins|mesh-list
93067178|NCT03966378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93067179|NCT03966378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067180|NCT03966378|Chelating Agents|chelating agents|mesh-ancestor
93067181|NCT03966378|Sequestering Agents|sequestering agents|mesh-ancestor
93067182|NCT03966378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067183|NCT03966378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93067184|NCT03966378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067185|NCT03966378|Antioxidants|antioxidants|mesh-ancestor
93067186|NCT03966378|Protective Agents|protective agents|mesh-ancestor
93067187|NCT02657434|Carboplatin|carboplatin|mesh-list
93067188|NCT02657434|Pemetrexed|pemetrexed|mesh-list
93067189|NCT02657434|Atezolizumab|atezolizumab|mesh-list
93067190|NCT02657434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067191|NCT02657434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067192|NCT02657434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067193|NCT02657434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93067194|NCT02657434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067195|NCT02657434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93067196|NCT02657434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067197|NCT02652052|Dasatinib|dasatinib|mesh-list
93067198|NCT02652052|Quercetin|quercetin|mesh-list
93067199|NCT02652052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067200|NCT02652052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93067201|NCT02652052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067202|NCT02652052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067203|NCT02652052|Antioxidants|antioxidants|mesh-ancestor
93067204|NCT02652052|Protective Agents|protective agents|mesh-ancestor
93067205|NCT02652052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067206|NCT00119262|Tamoxifen|tamoxifen|mesh-list
93067207|NCT00119262|Cyclophosphamide|cyclophosphamide|mesh-list
93067208|NCT00119262|Bevacizumab|bevacizumab|mesh-list
93067209|NCT00119262|Doxorubicin|doxorubicin|mesh-list
93067210|NCT00119262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93067211|NCT00119262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93067212|NCT00119262|Antibodies|antibodies|mesh-list
93067213|NCT00119262|Immunoglobulins|immunoglobulins|mesh-list
93067214|NCT00119262|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93067215|NCT00119262|Lenograstim|lenograstim|mesh-list
93067216|NCT00119262|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93067217|NCT00119262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067218|NCT00119262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067219|NCT00119262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067220|NCT00119262|Immunologic Factors|immunologic factors|mesh-ancestor
93067221|NCT00119262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067222|NCT00119262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067223|NCT00119262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93067224|NCT00119262|Alkylating Agents|alkylating agents|mesh-ancestor
93067225|NCT00119262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93067226|NCT00119262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067227|NCT00119262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93067228|NCT00119262|Growth Substances|growth substances|mesh-ancestor
93067229|NCT00119262|Growth Inhibitors|growth inhibitors|mesh-ancestor
93067230|NCT00119262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93067231|NCT00119262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93067232|NCT00119262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93067233|NCT00119262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067234|NCT00119262|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93067235|NCT00119262|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93067236|NCT00119262|Hormone Antagonists|hormone antagonists|mesh-ancestor
93067237|NCT00119262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067238|NCT00119262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93067239|NCT00119262|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93067240|NCT00119262|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93067241|NCT00119262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93067242|NCT00119262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93067243|NCT00131664|Metformin|metformin|mesh-list
93067244|NCT00131664|Glimepiride|glimepiride|mesh-list
93067245|NCT00131664|Rosiglitazone|rosiglitazone|mesh-list
93067246|NCT00131664|Maleic acid|maleic acid|mesh-list
93067247|NCT00131664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067248|NCT00131664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067249|NCT00131664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067250|NCT00131664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067251|NCT00131664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93067252|NCT00131664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067253|NCT00131664|Immunologic Factors|immunologic factors|mesh-ancestor
93067254|NCT05050318|Vaccines|vaccines|mesh-list
93067255|NCT05050318|Immunologic Factors|immunologic factors|mesh-ancestor
93067256|NCT05050318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067257|NCT03778996|Sirolimus|sirolimus|mesh-list
93067258|NCT03778996|Phenytoin|phenytoin|mesh-list
93067259|NCT03778996|Methoxsalen|methoxsalen|mesh-list
93067260|NCT03778996|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
93067261|NCT03778996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93067262|NCT03778996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067263|NCT03778996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93067264|NCT03778996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067265|NCT03778996|Antifungal Agents|antifungal agents|mesh-ancestor
93067266|NCT03778996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067267|NCT03778996|Immunologic Factors|immunologic factors|mesh-ancestor
93067268|NCT03778996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067269|NCT03778996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067270|NCT03778996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067271|NCT03778996|Anticonvulsants|anticonvulsants|mesh-ancestor
93067272|NCT03778996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93067273|NCT03778996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93067274|NCT03778996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93067275|NCT03778996|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93067276|NCT03778996|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93067277|NCT03778996|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
93067278|NCT03778996|Dermatologic Agents|dermatologic agents|mesh-ancestor
93067279|NCT03764722|Simendan|simendan|mesh-list
93067280|NCT03764722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93067281|NCT03764722|Vasodilator Agents|vasodilator agents|mesh-ancestor
93067282|NCT03764722|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
93067283|NCT03764722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93067284|NCT03764722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067285|NCT03764722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067286|NCT03764722|Protective Agents|protective agents|mesh-ancestor
93067287|NCT03764722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067288|NCT05024734|Gemcitabine|gemcitabine|mesh-list
93067289|NCT05024734|Docetaxel|docetaxel|mesh-list
93067290|NCT05024734|Epirubicin|epirubicin|mesh-list
93067291|NCT05024734|Mitomycins|mitomycins|mesh-list
93067292|NCT05024734|Mitomycin|mitomycin|mesh-list
93067293|NCT05024734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93067294|NCT05024734|Antimetabolites|antimetabolites|mesh-ancestor
93067295|NCT05024734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067296|NCT05024734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067297|NCT05024734|Tubulin Modulators|tubulin modulators|mesh-ancestor
93067298|NCT05024734|Antimitotic Agents|antimitotic agents|mesh-ancestor
93067299|NCT05024734|Mitosis Modulators|mitosis modulators|mesh-ancestor
93067300|NCT05024734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93067301|NCT05024734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93067302|NCT05024734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93067303|NCT05024734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067304|NCT05024734|Alkylating Agents|alkylating agents|mesh-ancestor
93067305|NCT05024734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067306|NCT03699124|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
93067307|NCT03699124|Antiviral Agents|antiviral agents|mesh-ancestor
93067308|NCT03699124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067309|NCT03756298|Capecitabine|capecitabine|mesh-list
93067310|NCT03756298|Atezolizumab|atezolizumab|mesh-list
93067311|NCT03756298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93067312|NCT03756298|Antimetabolites|antimetabolites|mesh-ancestor
93067313|NCT03756298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067314|NCT03756298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067315|NCT03756298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93067316|NCT03756298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067317|NCT03756220|Ascorbic Acid|ascorbic acid|mesh-list
93067318|NCT03756220|Thiamine|thiamine|mesh-list
93067319|NCT03756220|Vitamins|vitamins|mesh-ancestor
93067320|NCT03756220|Micronutrients|micronutrients|mesh-ancestor
93067321|NCT03756220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067322|NCT03756220|Antioxidants|antioxidants|mesh-ancestor
93067323|NCT03756220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067324|NCT03756220|Protective Agents|protective agents|mesh-ancestor
93067325|NCT03756220|Vitamin B Complex|vitamin b complex|mesh-ancestor
93067326|NCT04980040|Alogliptin|alogliptin|mesh-list
93067327|NCT04980040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067328|NCT04980040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067329|NCT04980040|Incretins|incretins|mesh-ancestor
93067330|NCT04980040|Hormones|hormones|mesh-ancestor
93067331|NCT04980040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067332|NCT04980040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93067333|NCT04980040|Protease Inhibitors|protease inhibitors|mesh-ancestor
93067334|NCT04980040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067335|NCT04980040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067336|NCT04647916|Camptothecin|camptothecin|mesh-list
93067337|NCT04647916|Irinotecan|irinotecan|mesh-list
93067338|NCT04647916|Immunoconjugates|immunoconjugates|mesh-list
93067339|NCT04647916|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
93067340|NCT04647916|Immunologic Factors|immunologic factors|mesh-ancestor
93067341|NCT04647916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067342|NCT04647916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93067343|NCT04647916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067344|NCT04647916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93067345|NCT04647916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93067346|NCT04647916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067347|NCT04647916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067348|NCT00131352|Hylan|hylan|mesh-list
93067349|NCT00131352|Viscosupplements|viscosupplements|mesh-ancestor
93067350|NCT00131352|Protective Agents|protective agents|mesh-ancestor
93067351|NCT00131352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067352|NCT00136916|Insulin|insulin|mesh-list
93067353|NCT00136916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93067354|NCT00136916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067355|NCT00136916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067356|NCT04633564|Bevacizumab|bevacizumab|mesh-list
93067357|NCT04633564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067358|NCT04633564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067359|NCT04633564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067360|NCT04633564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93067361|NCT04633564|Growth Substances|growth substances|mesh-ancestor
93067362|NCT04633564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067363|NCT04633564|Growth Inhibitors|growth inhibitors|mesh-ancestor
93067364|NCT03756064|Carboplatin|carboplatin|mesh-list
93067365|NCT03756064|Docetaxel|docetaxel|mesh-list
93067366|NCT03756064|Trastuzumab|trastuzumab|mesh-list
93067367|NCT03756064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067368|NCT03756064|Tubulin Modulators|tubulin modulators|mesh-ancestor
93067369|NCT03756064|Antimitotic Agents|antimitotic agents|mesh-ancestor
93067370|NCT03756064|Mitosis Modulators|mitosis modulators|mesh-ancestor
93067371|NCT03756064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067372|NCT03756064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067373|NCT04607980|Ustekinumab|ustekinumab|mesh-list
93067374|NCT04607980|Dermatologic Agents|dermatologic agents|mesh-ancestor
93067375|NCT03764020|Melatonin|melatonin|mesh-list
93067376|NCT03764020|Antioxidants|antioxidants|mesh-ancestor
93067377|NCT03764020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067378|NCT03764020|Protective Agents|protective agents|mesh-ancestor
93067379|NCT03764020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067380|NCT03764020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067381|NCT00135512|Bupropion|bupropion|mesh-list
92530746|NCT02970604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067382|NCT00135512|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93067383|NCT00135512|Antidepressive Agents|antidepressive agents|mesh-ancestor
93067384|NCT00135512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067385|NCT00135512|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93067386|NCT00135512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93067387|NCT00135512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93067388|NCT00135512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067389|NCT00135512|Dopamine Agents|dopamine agents|mesh-ancestor
93067390|NCT00135512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067391|NCT00135512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067392|NCT00135512|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93067393|NCT00135512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93067394|NCT00135512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067396|NCT00130728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93067397|NCT00130728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067398|NCT00130728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067399|NCT00130728|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067400|NCT00130728|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93067401|NCT00130728|Growth Substances|growth substances|mesh-ancestor
93067402|NCT00130728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067403|NCT00130728|Growth Inhibitors|growth inhibitors|mesh-ancestor
93067404|NCT00130728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93067405|NCT00130728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067406|NCT00130728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067407|NCT00129974|Gemcitabine|gemcitabine|mesh-list
93067408|NCT00129974|Pemetrexed|pemetrexed|mesh-list
93067409|NCT00129974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93067410|NCT00129974|Antimetabolites|antimetabolites|mesh-ancestor
93067411|NCT00129974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067412|NCT00129974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067413|NCT00129974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067414|NCT00129974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93067415|NCT00129974|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067416|NCT03966326|Fentanyl|fentanyl|mesh-list
93067417|NCT03966326|Anesthetics|anesthetics|mesh-list
93067418|NCT03966326|Sevoflurane|sevoflurane|mesh-list
93067419|NCT03966326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067420|NCT03966326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067421|NCT03966326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93067422|NCT03966326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93067423|NCT03966326|Anesthetics, General|anesthetics, general|mesh-ancestor
93067424|NCT03966326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93067425|NCT03966326|Narcotics|narcotics|mesh-ancestor
93067426|NCT03966326|Analgesics|analgesics|mesh-ancestor
93067427|NCT03966326|Sensory System Agents|sensory system agents|mesh-ancestor
93067428|NCT03966326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067429|NCT03966326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93067430|NCT03966326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93067431|NCT00119106|Tenofovir|tenofovir|mesh-list
93067432|NCT00119106|Antiviral Agents|antiviral agents|mesh-ancestor
93067433|NCT00119106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067434|NCT00119106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93067435|NCT00119106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067436|NCT00119106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067437|NCT00119106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067438|NCT00119106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93067439|NCT00119106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93067440|NCT03758014|Lomustine|lomustine|mesh-list
93067441|NCT03758014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93067442|NCT03758014|Alkylating Agents|alkylating agents|mesh-ancestor
93067443|NCT03758014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067444|NCT03758014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067445|NCT00135356|Ritonavir|ritonavir|mesh-list
93067446|NCT00135356|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93067447|NCT00135356|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
93067448|NCT00135356|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
93067449|NCT00135356|Protease Inhibitors|protease inhibitors|mesh-list
93067450|NCT00135356|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93067451|NCT00135356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067452|NCT00135356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067453|NCT00135356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93067454|NCT00135356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93067455|NCT00135356|Antiviral Agents|antiviral agents|mesh-ancestor
93067456|NCT00135356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067457|NCT00135356|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93067458|NCT00135356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93067459|NCT00135356|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93067460|NCT00118716|Fluticasone|fluticasone|mesh-list
93067461|NCT00118716|Xhance|xhance|mesh-list
93067462|NCT00118716|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93067463|NCT00118716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067464|NCT00118716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93067465|NCT00118716|Autonomic Agents|autonomic agents|mesh-ancestor
92340781|NCT00002759|Cyclosporine|cyclosporine|mesh-list
93067466|NCT00118716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067467|NCT00118716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067468|NCT00118716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93067469|NCT00118716|Respiratory System Agents|respiratory system agents|mesh-ancestor
93067470|NCT00118716|Dermatologic Agents|dermatologic agents|mesh-ancestor
93067471|NCT00118716|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93067472|NCT00118716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93067473|NCT00118716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93067474|NCT00118716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93067475|NCT00118716|Adrenergic Agents|adrenergic agents|mesh-ancestor
93067476|NCT00118716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067477|NCT00118716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067478|NCT00118482|Fludrocortisone|fludrocortisone|mesh-list
93067479|NCT00118482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067480|NCT03966950|Melatonin|melatonin|mesh-list
93067481|NCT03966950|Antioxidants|antioxidants|mesh-ancestor
93067482|NCT03966950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067483|NCT03966950|Protective Agents|protective agents|mesh-ancestor
93067484|NCT03966950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067485|NCT03966950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067486|NCT03755752|Diminazene aceturate|diminazene aceturate|mesh-list
93067487|NCT03755752|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93067488|NCT03755752|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93067489|NCT03755752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067490|NCT03755752|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
93067491|NCT01076582|Ethinyl Estradiol|ethinyl estradiol|mesh-list
93067492|NCT01076582|Desogestrel|desogestrel|mesh-list
93067493|NCT01076582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93067494|NCT01076582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93067495|NCT01076582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93067496|NCT01076582|Contraceptive Agents|contraceptive agents|mesh-ancestor
93067497|NCT01076582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93067498|NCT01076582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067499|NCT01076582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93067500|NCT01076582|Estrogens|estrogens|mesh-ancestor
93067501|NCT01076582|Hormones|hormones|mesh-ancestor
93067502|NCT01076582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067503|NCT01076582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93067504|NCT01076582|Progestins|progestins|mesh-ancestor
93067505|NCT01081938|Insulin|insulin|mesh-list
93067506|NCT01081938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93067507|NCT01081938|Insulin Glargine|insulin glargine|mesh-list
93067508|NCT01081938|Insulin glulisine|insulin glulisine|mesh-list
93067509|NCT01081938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067510|NCT01081938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067511|NCT01082796|Glipizide|glipizide|mesh-list
93067512|NCT01082796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067513|NCT01082796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067514|NCT03763786|Cetrorelix|cetrorelix|mesh-list
93067515|NCT03763786|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93067516|NCT03763786|Fertility Agents|fertility agents|mesh-ancestor
93067517|NCT03763786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93067518|NCT03763786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067519|NCT03763786|Hormone Antagonists|hormone antagonists|mesh-ancestor
93067520|NCT03763786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067521|NCT01079364|Insulin|insulin|mesh-list
93067522|NCT01079364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93067523|NCT01079364|Insulin Glargine|insulin glargine|mesh-list
93067524|NCT01079364|Insulin Aspart|insulin aspart|mesh-list
93067525|NCT01079364|Insulin glulisine|insulin glulisine|mesh-list
93067526|NCT01079364|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
93067527|NCT01079364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067528|NCT01079364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067529|NCT01077752|Acetaminophen|acetaminophen|mesh-list
93067530|NCT01077752|Lidocaine|lidocaine|mesh-list
93067532|NCT01077752|Ropivacaine|ropivacaine|mesh-list
93067533|NCT01077752|Anesthetics, Local|anesthetics, local|mesh-ancestor
93067534|NCT01077752|Anesthetics|anesthetics|mesh-ancestor
93067535|NCT01077752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067536|NCT01077752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067537|NCT01077752|Sensory System Agents|sensory system agents|mesh-ancestor
93067538|NCT01077752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067539|NCT01077752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93067540|NCT01077752|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93067541|NCT01077752|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93067542|NCT01077752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93067543|NCT01077752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067544|NCT01077752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93067545|NCT01077752|Narcotics|narcotics|mesh-ancestor
93067546|NCT01077752|Analgesics|analgesics|mesh-ancestor
93067547|NCT01077752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93067548|NCT01077752|Antipyretics|antipyretics|mesh-ancestor
93067549|NCT00129272|Bupropion|bupropion|mesh-list
93067550|NCT00129272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93067551|NCT00129272|Antidepressive Agents|antidepressive agents|mesh-ancestor
93067552|NCT00129272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067553|NCT00129272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93067554|NCT00129272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93067555|NCT00129272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93067556|NCT00129272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067557|NCT00129272|Dopamine Agents|dopamine agents|mesh-ancestor
93067558|NCT00129272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067559|NCT00129272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067560|NCT00129272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93067561|NCT00129272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93067562|NCT00129272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067563|NCT01326338|Nitazoxanide|nitazoxanide|mesh-list
93067564|NCT01326338|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93067565|NCT01326338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067566|NCT03963648|Nitric Oxide|nitric oxide|mesh-list
93067567|NCT03963648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93067568|NCT03963648|Autonomic Agents|autonomic agents|mesh-ancestor
93067569|NCT03963648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067570|NCT03963648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067571|NCT03963648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93067572|NCT03963648|Respiratory System Agents|respiratory system agents|mesh-ancestor
93067573|NCT03963648|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93067574|NCT03963648|Antioxidants|antioxidants|mesh-ancestor
93067575|NCT03963648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067576|NCT03963648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067577|NCT03963648|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93067578|NCT03963648|Vasodilator Agents|vasodilator agents|mesh-ancestor
93067579|NCT03963648|Gasotransmitters|gasotransmitters|mesh-ancestor
93067580|NCT03963648|Protective Agents|protective agents|mesh-ancestor
93067581|NCT04899232|Antithrombins|antithrombins|mesh-list
93067582|NCT04899232|Antithrombin III|antithrombin iii|mesh-list
93067583|NCT04899232|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93067584|NCT04899232|Protease Inhibitors|protease inhibitors|mesh-ancestor
93067585|NCT04899232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067586|NCT04899232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067587|NCT04899232|Anticoagulants|anticoagulants|mesh-ancestor
93067588|NCT03757858|Antibodies|antibodies|mesh-list
93067589|NCT03757858|Immunologic Factors|immunologic factors|mesh-ancestor
93067590|NCT03757858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067591|NCT01079676|Lenograstim|lenograstim|mesh-list
93067592|NCT01079676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93067593|NCT01079676|Immunologic Factors|immunologic factors|mesh-ancestor
93067594|NCT01079676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067595|NCT01082250|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93067596|NCT01082250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93067597|NCT01082250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93067598|NCT01082250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067599|NCT01082250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067600|NCT01082250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067601|NCT01082250|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93067602|NCT01082250|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93067603|NCT01082250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93067604|NCT01082250|Adrenergic Agents|adrenergic agents|mesh-ancestor
93067605|NCT01082250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067606|NCT01082250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340789|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067607|NCT01082250|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93067608|NCT01082250|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93067609|NCT01082250|Serotonin Agents|serotonin agents|mesh-ancestor
93067610|NCT01082250|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93067611|NCT01082250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93067612|NCT01082250|Dopamine Agents|dopamine agents|mesh-ancestor
93067614|NCT00133952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067615|NCT00133952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067616|NCT04555096|Avasopasem manganese|avasopasem manganese|mesh-list
93067617|NCT04555096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93067618|NCT04555096|Antioxidants|antioxidants|mesh-ancestor
93067619|NCT04555096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067620|NCT04555096|Protective Agents|protective agents|mesh-ancestor
93067621|NCT04555096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067622|NCT00097500|Metformin|metformin|mesh-list
93067623|NCT00097500|Insulin Glargine|insulin glargine|mesh-list
93067624|NCT00097500|Exenatide|exenatide|mesh-list
93067625|NCT00097500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93067626|NCT00097500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067627|NCT00097500|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93067628|NCT00097500|Incretins|incretins|mesh-ancestor
93067629|NCT00097500|Hormones|hormones|mesh-ancestor
93067630|NCT00097500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067631|NCT01082484|Treprostinil|treprostinil|mesh-list
93067632|NCT01082484|Iloprost|iloprost|mesh-list
93067633|NCT01082484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93067634|NCT01082484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93067635|NCT01082484|Vasodilator Agents|vasodilator agents|mesh-ancestor
93067636|NCT05459974|Colchicine|colchicine|mesh-list
93067637|NCT05459974|Gout Suppressants|gout suppressants|mesh-ancestor
93067638|NCT05459974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067639|NCT05459974|Tubulin Modulators|tubulin modulators|mesh-ancestor
93067640|NCT05459974|Antimitotic Agents|antimitotic agents|mesh-ancestor
93067641|NCT05459974|Mitosis Modulators|mitosis modulators|mesh-ancestor
93067642|NCT05459974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067643|NCT05459974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067644|NCT03754816|Anesthetics|anesthetics|mesh-list
93067645|NCT03754816|Levobupivacaine|levobupivacaine|mesh-list
93067646|NCT03754816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067647|NCT03754816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067648|NCT03754816|Anesthetics, Local|anesthetics, local|mesh-ancestor
93067649|NCT03754816|Sensory System Agents|sensory system agents|mesh-ancestor
93067650|NCT03754816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067651|NCT04542694|Favipiravir|favipiravir|mesh-list
93067652|NCT04542694|Antiviral Agents|antiviral agents|mesh-ancestor
93067653|NCT04542694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067654|NCT03965208|Heparin|heparin|mesh-list
93067655|NCT03965208|Calcium heparin|calcium heparin|mesh-list
93067656|NCT03965208|Bivalirudin|bivalirudin|mesh-list
93067657|NCT03965208|Anticoagulants|anticoagulants|mesh-ancestor
93067658|NCT03965208|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93067659|NCT03965208|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93067660|NCT03965208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067661|NCT03965208|Antithrombins|antithrombins|mesh-ancestor
93067662|NCT03965208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93067663|NCT03965208|Protease Inhibitors|protease inhibitors|mesh-ancestor
93067664|NCT03965208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067665|NCT01083264|Gestodene|gestodene|mesh-list
93067666|NCT01083264|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93067667|NCT01083264|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93067668|NCT01083264|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93067669|NCT01083264|Contraceptive Agents|contraceptive agents|mesh-ancestor
93067670|NCT01083264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93067671|NCT01083264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067672|NCT01083264|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93067673|NCT01083264|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93067674|NCT01083264|Progestins|progestins|mesh-ancestor
93067675|NCT01083264|Hormones|hormones|mesh-ancestor
92530751|NCT02970604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93067676|NCT01083264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067677|NCT00129116|Vaccines|vaccines|mesh-list
93067678|NCT00129116|Immunologic Factors|immunologic factors|mesh-ancestor
93067679|NCT00129116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067680|NCT00117156|Rituximab|rituximab|mesh-list
92396596|NCT05268627|Hormones|hormones|mesh-ancestor
93067681|NCT00117156|Fludarabine|fludarabine|mesh-list
93067682|NCT00117156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93067683|NCT00117156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067684|NCT00117156|Immunologic Factors|immunologic factors|mesh-ancestor
93067685|NCT00117156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067686|NCT00117156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067687|NCT01083420|Minocycline|minocycline|mesh-list
93067688|NCT01083420|Dexamethasone|dexamethasone|mesh-list
93067689|NCT01083420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067690|NCT01083420|Antiemetics|antiemetics|mesh-ancestor
93067691|NCT01083420|Autonomic Agents|autonomic agents|mesh-ancestor
93067692|NCT01083420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067693|NCT01083420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067694|NCT01083420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93067695|NCT01083420|Glucocorticoids|glucocorticoids|mesh-ancestor
93067696|NCT01083420|Hormones|hormones|mesh-ancestor
93067697|NCT01083420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067698|NCT01083420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93067699|NCT01083420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067700|NCT01083420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93067701|NCT01083420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067702|NCT00096954|Omalizumab|omalizumab|mesh-list
93067703|NCT00096954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93067704|NCT00096954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93067705|NCT00096954|Respiratory System Agents|respiratory system agents|mesh-ancestor
93067707|NCT00096486|Gefitinib|gefitinib|mesh-list
93067708|NCT00096486|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93067709|NCT00096486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93067710|NCT00096486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067711|NCT00096486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067712|NCT00096486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067713|NCT00096486|Immunologic Factors|immunologic factors|mesh-ancestor
93067714|NCT00096486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067715|NCT00096486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067716|NCT00116844|Valacyclovir|valacyclovir|mesh-list
93067717|NCT00116844|Antiviral Agents|antiviral agents|mesh-ancestor
93067718|NCT00116844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067719|NCT03963336|Acetazolamide|acetazolamide|mesh-list
93067720|NCT03963336|Anticonvulsants|anticonvulsants|mesh-ancestor
93067721|NCT03963336|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93067722|NCT03963336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067723|NCT03963336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067724|NCT03963336|Diuretics|diuretics|mesh-ancestor
93067725|NCT03963336|Natriuretic Agents|natriuretic agents|mesh-ancestor
93067726|NCT03963336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067727|NCT00132314|Risperidone|risperidone|mesh-list
93067728|NCT00132314|Antipsychotic Agents|antipsychotic agents|mesh-list
93067729|NCT00132314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93067730|NCT00132314|Serotonin Agents|serotonin agents|mesh-ancestor
93067731|NCT00132314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067732|NCT00132314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067733|NCT00132314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067734|NCT00132314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93067735|NCT00132314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067736|NCT00132314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067737|NCT00132314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93067738|NCT00132314|Dopamine Agents|dopamine agents|mesh-ancestor
93067739|NCT04539262|Remdesivir|remdesivir|mesh-list
93067740|NCT04539262|Antimetabolites|antimetabolites|mesh-ancestor
93067741|NCT04539262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067742|NCT04539262|Antiviral Agents|antiviral agents|mesh-ancestor
93067743|NCT04539262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067744|NCT04537234|Vaccines|vaccines|mesh-list
93067745|NCT04537234|Immunologic Factors|immunologic factors|mesh-ancestor
93067746|NCT04537234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067747|NCT04537078|Triptorelin Pamoate|triptorelin pamoate|mesh-list
93067748|NCT04537078|Contraceptive Agents|contraceptive agents|mesh-list
93067749|NCT04537078|Contraceptives, Oral|contraceptives, oral|mesh-list
93067750|NCT04537078|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
93067751|NCT04537078|Cetrorelix|cetrorelix|mesh-list
93067752|NCT04537078|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
93067753|NCT04537078|Progesterone|progesterone|mesh-list
93067754|NCT04537078|Dydrogesterone|dydrogesterone|mesh-list
93067755|NCT04537078|Estradiol|estradiol|mesh-list
93067756|NCT04537078|Progestins|progestins|mesh-ancestor
93067757|NCT04537078|Hormones|hormones|mesh-ancestor
93067758|NCT04537078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067759|NCT04537078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067760|NCT04537078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93067761|NCT04537078|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93067762|NCT04537078|Luteolytic Agents|luteolytic agents|mesh-ancestor
93067763|NCT04537078|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93067764|NCT04537078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93067765|NCT04537078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067766|NCT04537078|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93067767|NCT04537078|Fertility Agents|fertility agents|mesh-ancestor
93067768|NCT04537078|Hormone Antagonists|hormone antagonists|mesh-ancestor
93067769|NCT04537078|Estrogens|estrogens|mesh-ancestor
93067770|NCT04532164|Antifungal Agents|antifungal agents|mesh-list
93067771|NCT04532164|Clotrimazole|clotrimazole|mesh-list
93067772|NCT04532164|Miconazole|miconazole|mesh-list
93067773|NCT04532164|Butenafine|butenafine|mesh-list
93067774|NCT04532164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067775|NCT04532164|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93067776|NCT04532164|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93067777|NCT04532164|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93067778|NCT04532164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067779|NCT04532164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067780|NCT04532164|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93067781|NCT04532164|Hormone Antagonists|hormone antagonists|mesh-ancestor
93067782|NCT04532164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93067783|NCT04532164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067784|NCT04532164|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93067785|NCT04532164|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93067786|NCT04531540|Butenafine|butenafine|mesh-list
93067787|NCT04531540|Antifungal Agents|antifungal agents|mesh-ancestor
93067788|NCT04531540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067789|NCT04799782|Mirtazapine|mirtazapine|mesh-list
93067790|NCT04799782|Antidepressive Agents|antidepressive agents|mesh-ancestor
93067791|NCT04799782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067792|NCT04799782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93067793|NCT04799782|Histamine Antagonists|histamine antagonists|mesh-ancestor
93067794|NCT04799782|Histamine Agents|histamine agents|mesh-ancestor
93067795|NCT04799782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067796|NCT04799782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067797|NCT04799782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067798|NCT04799782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93067799|NCT04799782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93067800|NCT04799782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067801|NCT04799782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93067802|NCT04799782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93067803|NCT04799782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93067804|NCT04799782|Adrenergic Agents|adrenergic agents|mesh-ancestor
93067805|NCT04799782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93067806|NCT04799782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93067807|NCT04799782|Serotonin Agents|serotonin agents|mesh-ancestor
93067808|NCT04799782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93067809|NCT04790812|Acetaminophen|acetaminophen|mesh-list
93067810|NCT04790812|Celecoxib|celecoxib|mesh-list
93067811|NCT04790812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93067812|NCT04790812|Analgesics|analgesics|mesh-ancestor
93067813|NCT04790812|Sensory System Agents|sensory system agents|mesh-ancestor
93067814|NCT04790812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067815|NCT04790812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067816|NCT04790812|Antipyretics|antipyretics|mesh-ancestor
93067817|NCT04790812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93067818|NCT04790812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067819|NCT04790812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067820|NCT04790812|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93067821|NCT04790812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93067822|NCT04790812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067823|NCT04790812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067824|NCT03697252|Xanomeline|xanomeline|mesh-list
93067826|NCT03697252|Parasympatholytics|parasympatholytics|mesh-ancestor
93067827|NCT03697252|Autonomic Agents|autonomic agents|mesh-ancestor
93067828|NCT03697252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067829|NCT03697252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067830|NCT03697252|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93067831|NCT03697252|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93067832|NCT03697252|Cholinergic Agents|cholinergic agents|mesh-ancestor
93067833|NCT03697252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93067834|NCT03697252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067835|NCT03697252|Urological Agents|urological agents|mesh-ancestor
93067836|NCT03697252|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93067837|NCT03697252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067838|NCT03697252|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93067839|NCT03697252|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93067840|NCT03701074|Acetaminophen|acetaminophen|mesh-list
93067841|NCT03701074|Ibuprofen|ibuprofen|mesh-list
93067842|NCT03701074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93067843|NCT03701074|Analgesics|analgesics|mesh-ancestor
93067844|NCT03701074|Sensory System Agents|sensory system agents|mesh-ancestor
93067845|NCT03701074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067846|NCT03701074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067847|NCT03701074|Antipyretics|antipyretics|mesh-ancestor
93067848|NCT03701074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93067849|NCT03701074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067850|NCT03701074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067851|NCT03701074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93067852|NCT03701074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067853|NCT03701074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067854|NCT03757390|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
93067855|NCT03757390|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
93067857|NCT03757390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93067858|NCT03757390|Antimetabolites|antimetabolites|mesh-ancestor
93067859|NCT03757390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067860|NCT03757390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93067861|NCT03757390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93067862|NCT03757390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067863|NCT03757390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93067864|NCT03757156|Aspirin|aspirin|mesh-list
93067865|NCT03757156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93067866|NCT03757156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93067867|NCT03757156|Analgesics|analgesics|mesh-ancestor
93067868|NCT03757156|Sensory System Agents|sensory system agents|mesh-ancestor
93067869|NCT03757156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067870|NCT03757156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067871|NCT03757156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93067872|NCT03757156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067873|NCT03757156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93067874|NCT03757156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93067875|NCT03757156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067876|NCT03757156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93067877|NCT03757156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93067878|NCT03757156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067879|NCT03757156|Antipyretics|antipyretics|mesh-ancestor
93067880|NCT03750916|Docetaxel|docetaxel|mesh-list
93067881|NCT03750916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067882|NCT03750916|Tubulin Modulators|tubulin modulators|mesh-ancestor
93067883|NCT03750916|Antimitotic Agents|antimitotic agents|mesh-ancestor
93067884|NCT03750916|Mitosis Modulators|mitosis modulators|mesh-ancestor
93067885|NCT03750916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067886|NCT05322148|Loteprednol Etabonate|loteprednol etabonate|mesh-list
93067887|NCT05322148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93067888|NCT03750760|Atorvastatin|atorvastatin|mesh-list
93067889|NCT03750760|Ezetimibe|ezetimibe|mesh-list
93067890|NCT03750760|Alirocumab|alirocumab|mesh-list
93067891|NCT03750760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93067892|NCT03750760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93067893|NCT03750760|Antimetabolites|antimetabolites|mesh-ancestor
93067894|NCT03750760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067895|NCT03750760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93067896|NCT03750760|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92340804|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
93067897|NCT03750760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067898|NCT03750760|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
93067899|NCT03750760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93067901|NCT01076894|Anesthetics|anesthetics|mesh-list
93067902|NCT01076894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067903|NCT01076894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067904|NCT00130832|Vaccines|vaccines|mesh-list
93067905|NCT00130832|Immunologic Factors|immunologic factors|mesh-ancestor
93067906|NCT00130832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067907|NCT00096018|Thalidomide|thalidomide|mesh-list
93067908|NCT00096018|Fludarabine|fludarabine|mesh-list
93067909|NCT00096018|Fludarabine phosphate|fludarabine phosphate|mesh-list
93067910|NCT00096018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067911|NCT00096018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93067912|NCT00096018|Antimetabolites|antimetabolites|mesh-ancestor
93067913|NCT00096018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067914|NCT00096018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067915|NCT00096018|Immunologic Factors|immunologic factors|mesh-ancestor
93067916|NCT00096018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067917|NCT00096018|Leprostatic Agents|leprostatic agents|mesh-ancestor
93067918|NCT00096018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93067919|NCT00096018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067920|NCT00096018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93067921|NCT00096018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93067922|NCT00096018|Growth Substances|growth substances|mesh-ancestor
93067923|NCT00096018|Growth Inhibitors|growth inhibitors|mesh-ancestor
93067924|NCT01079754|Morphine|morphine|mesh-list
93067925|NCT01079754|Analgesics, Opioid|analgesics, opioid|mesh-list
93067926|NCT01079754|Narcotics|narcotics|mesh-ancestor
93067927|NCT01079754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93067928|NCT01079754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067929|NCT01079754|Analgesics|analgesics|mesh-ancestor
93067930|NCT01079754|Sensory System Agents|sensory system agents|mesh-ancestor
93067931|NCT01079754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067932|NCT04701658|Bamlanivimab|bamlanivimab|mesh-list
93067933|NCT04701658|Antiviral Agents|antiviral agents|mesh-ancestor
93067934|NCT04701658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067935|NCT01322776|Cyclophosphamide|cyclophosphamide|mesh-list
93067936|NCT01322776|Fludarabine|fludarabine|mesh-list
93067937|NCT01322776|Bortezomib|bortezomib|mesh-list
93067938|NCT01322776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93067939|NCT01322776|Immunologic Factors|immunologic factors|mesh-ancestor
93067940|NCT01322776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067941|NCT01322776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93067942|NCT01322776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93067943|NCT01322776|Alkylating Agents|alkylating agents|mesh-ancestor
93067944|NCT01322776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067945|NCT01322776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067946|NCT01322776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93067947|NCT00128102|Vorinostat|vorinostat|mesh-list
93067948|NCT00128102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93067949|NCT00128102|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93067950|NCT00128102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067951|NCT00128102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067952|NCT03965858|Esketamine|esketamine|mesh-list
93067953|NCT03965858|Antidepressive Agents|antidepressive agents|mesh-ancestor
93067954|NCT03965858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93067955|NCT04668274|Resveratrol|resveratrol|mesh-list
93067956|NCT04668274|Antioxidants|antioxidants|mesh-ancestor
93067957|NCT04668274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067958|NCT04668274|Protective Agents|protective agents|mesh-ancestor
93067959|NCT04668274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067960|NCT04668274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067961|NCT04668274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93067962|NCT01077908|Antiviral Agents|antiviral agents|mesh-list
93067963|NCT01077908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067964|NCT04406194|Favipiravir|favipiravir|mesh-list
93067965|NCT04406194|Antiviral Agents|antiviral agents|mesh-ancestor
93067966|NCT04406194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067967|NCT03822884|Epoetin Alfa|epoetin alfa|mesh-list
93067968|NCT03822884|Hematinics|hematinics|mesh-ancestor
93067969|NCT03822416|Nicotine|nicotine|mesh-list
93067970|NCT03822416|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93067971|NCT03822416|Autonomic Agents|autonomic agents|mesh-ancestor
93067972|NCT03822416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93067973|NCT03822416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93067974|NCT03822416|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93067975|NCT03822416|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93067976|NCT03822416|Cholinergic Agents|cholinergic agents|mesh-ancestor
93067978|NCT03822416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067979|NCT04405570|Molnupiravir|molnupiravir|mesh-list
93067980|NCT04405570|Antiviral Agents|antiviral agents|mesh-ancestor
93067981|NCT04405570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93067982|NCT00127712|Amiodarone|amiodarone|mesh-list
93067983|NCT00127712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93067984|NCT00127712|Vasodilator Agents|vasodilator agents|mesh-ancestor
93067985|NCT00127712|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93067986|NCT00127712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93067987|NCT00127712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93067988|NCT00127712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93067989|NCT00127712|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93067990|NCT00127712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93067991|NCT00127712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93067992|NCT00127712|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93067993|NCT00127712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93067994|NCT00127712|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93067995|NCT01082744|Sufentanil|sufentanil|mesh-list
93067996|NCT01082744|Ropivacaine|ropivacaine|mesh-list
93067997|NCT01082744|Anesthetics, Local|anesthetics, local|mesh-ancestor
93067998|NCT01082744|Anesthetics|anesthetics|mesh-ancestor
93067999|NCT01082744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068000|NCT01082744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068001|NCT01082744|Sensory System Agents|sensory system agents|mesh-ancestor
93068002|NCT01082744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068003|NCT01082744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93068004|NCT01082744|Narcotics|narcotics|mesh-ancestor
93068005|NCT01082744|Analgesics|analgesics|mesh-ancestor
93068006|NCT01082744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93068008|NCT01082744|Anesthetics, General|anesthetics, general|mesh-ancestor
93068009|NCT00096356|Vitamins|vitamins|mesh-list
93068010|NCT00096356|Vitamin E|vitamin e|mesh-list
93068011|NCT00096356|Tocopherols|tocopherols|mesh-list
93068012|NCT00096356|Tocotrienols|tocotrienols|mesh-list
93068013|NCT00096356|alpha-Tocopherol|alpha-tocopherol|mesh-list
93068014|NCT00096356|Micronutrients|micronutrients|mesh-ancestor
93068015|NCT00096356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068016|NCT00096356|Antioxidants|antioxidants|mesh-ancestor
93068017|NCT00096356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068018|NCT00096356|Protective Agents|protective agents|mesh-ancestor
93068019|NCT03749590|Magnesium Sulfate|magnesium sulfate|mesh-list
93068020|NCT03749590|Analgesics|analgesics|mesh-ancestor
93068021|NCT03749590|Sensory System Agents|sensory system agents|mesh-ancestor
93068022|NCT03749590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068023|NCT03749590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068024|NCT03749590|Anesthetics|anesthetics|mesh-ancestor
93068025|NCT03749590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068026|NCT03749590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93068027|NCT03749590|Anticonvulsants|anticonvulsants|mesh-ancestor
93068028|NCT03749590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93068029|NCT03749590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93068030|NCT03749590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068031|NCT03749590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93068032|NCT03749590|Tocolytic Agents|tocolytic agents|mesh-ancestor
93068033|NCT03749590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93068034|NCT01076816|Dexmedetomidine|dexmedetomidine|mesh-list
93068035|NCT01076816|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93068036|NCT01076816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068037|NCT01076816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068038|NCT01076816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068039|NCT01076816|Analgesics|analgesics|mesh-ancestor
93068040|NCT01076816|Sensory System Agents|sensory system agents|mesh-ancestor
93068041|NCT01076816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068042|NCT01076816|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93068043|NCT01076816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93068044|NCT01076816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93068045|NCT01076816|Adrenergic Agents|adrenergic agents|mesh-ancestor
93068046|NCT01076816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068047|NCT01076816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068048|NCT03749356|Tacrolimus|tacrolimus|mesh-list
93068049|NCT03749356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068050|NCT03749356|Immunologic Factors|immunologic factors|mesh-ancestor
93068051|NCT03749356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068052|NCT03749356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93068053|NCT03749356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068054|NCT03749356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068055|NCT04358068|Azithromycin|azithromycin|mesh-list
93068056|NCT04358068|Hydroxychloroquine|hydroxychloroquine|mesh-list
93068057|NCT04358068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068058|NCT04358068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068059|NCT04358068|Antimalarials|antimalarials|mesh-ancestor
93068060|NCT04358068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93068061|NCT04358068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93068062|NCT04358068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068063|NCT04358068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068064|NCT04358068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068065|NCT00096278|Calcium, Dietary|calcium, dietary|mesh-list
93068066|NCT00096278|Leucovorin|leucovorin|mesh-list
93068067|NCT00096278|Folic Acid|folic acid|mesh-list
93068068|NCT00096278|Bevacizumab|bevacizumab|mesh-list
93068069|NCT00096278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93068070|NCT00096278|Fluorouracil|fluorouracil|mesh-list
93068071|NCT00096278|Oxaliplatin|oxaliplatin|mesh-list
93068072|NCT00096278|Endothelial Growth Factors|endothelial growth factors|mesh-list
93068073|NCT00096278|Antibodies|antibodies|mesh-list
93068074|NCT00096278|Immunoglobulins|immunoglobulins|mesh-list
93068075|NCT00096278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93068076|NCT00096278|Immunoglobulin G|immunoglobulin g|mesh-list
93068077|NCT00096278|Calcium|calcium|mesh-list
93068078|NCT00096278|Levoleucovorin|levoleucovorin|mesh-list
93068079|NCT00096278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725098|NCT00590070|Nitroprusside|nitroprusside|mesh-list
93068080|NCT00096278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93068081|NCT00096278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93068082|NCT00096278|Growth Substances|growth substances|mesh-ancestor
93068083|NCT00096278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068085|NCT00096278|Immunologic Factors|immunologic factors|mesh-ancestor
93068086|NCT00096278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93068087|NCT00096278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93068088|NCT00096278|Antimetabolites|antimetabolites|mesh-ancestor
93068089|NCT00096278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068090|NCT00096278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068091|NCT00096278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068092|NCT00096278|Antidotes|antidotes|mesh-ancestor
93068093|NCT00096278|Protective Agents|protective agents|mesh-ancestor
93068094|NCT00096278|Vitamin B Complex|vitamin b complex|mesh-ancestor
93068095|NCT00096278|Vitamins|vitamins|mesh-ancestor
93068096|NCT00096278|Micronutrients|micronutrients|mesh-ancestor
93068097|NCT00096278|Hematinics|hematinics|mesh-ancestor
93068098|NCT00095940|Lapatinib|lapatinib|mesh-list
93068099|NCT00095940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068100|NCT00095940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068101|NCT00095940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068102|NCT00095940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068103|NCT00114218|Gemcitabine|gemcitabine|mesh-list
93068104|NCT00114218|Docetaxel|docetaxel|mesh-list
93068105|NCT00114218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068106|NCT00114218|Antimetabolites|antimetabolites|mesh-ancestor
93068107|NCT00114218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068108|NCT00114218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068109|NCT00114218|Tubulin Modulators|tubulin modulators|mesh-ancestor
93068110|NCT00114218|Antimitotic Agents|antimitotic agents|mesh-ancestor
93068111|NCT00114218|Mitosis Modulators|mitosis modulators|mesh-ancestor
93068112|NCT01077986|Capecitabine|capecitabine|mesh-list
93068113|NCT01077986|Cetuximab|cetuximab|mesh-list
93068114|NCT01077986|Everolimus|everolimus|mesh-list
93068115|NCT01077986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068116|NCT01077986|Antimetabolites|antimetabolites|mesh-ancestor
93068117|NCT01077986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068118|NCT01077986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068119|NCT01077986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068120|NCT01077986|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93068121|NCT01077986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068122|NCT01077986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068123|NCT01077986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068124|NCT01077986|Immunologic Factors|immunologic factors|mesh-ancestor
93068125|NCT01077986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068126|NCT03963024|Treosulfan|treosulfan|mesh-list
92530759|NCT00043381|Decitabine|decitabine|mesh-list
93068128|NCT03963024|Alkylating Agents|alkylating agents|mesh-ancestor
93068129|NCT03963024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068130|NCT03963024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068131|NCT01082718|Artesunate|artesunate|mesh-list
93068132|NCT01082718|Mefloquine|mefloquine|mesh-list
93068133|NCT01082718|Antimalarials|antimalarials|mesh-ancestor
93068134|NCT01082718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93068135|NCT01082718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93068136|NCT01082718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068137|NCT01082718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068138|NCT01082718|Antiviral Agents|antiviral agents|mesh-ancestor
93068139|NCT01082718|Schistosomicides|schistosomicides|mesh-ancestor
93068140|NCT01082718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93068141|NCT01082718|Anthelmintics|anthelmintics|mesh-ancestor
93068142|NCT04380142|Levodopa|levodopa|mesh-list
93068143|NCT04380142|Carbidopa|carbidopa|mesh-list
93068144|NCT04380142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93068145|NCT04380142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93068146|NCT04380142|Dopamine Agents|dopamine agents|mesh-ancestor
93068147|NCT04380142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068148|NCT04380142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068149|NCT04380142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068150|NCT04380142|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93068151|NCT04380142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068152|NCT04336228|Dexetimide|dexetimide|mesh-list
93068153|NCT04336228|Citalopram|citalopram|mesh-list
93068154|NCT04336228|Escitalopram|escitalopram|mesh-list
93068155|NCT04336228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068156|NCT04336228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93068157|NCT04336228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93068158|NCT04336228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93068159|NCT04336228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068160|NCT04336228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068161|NCT04336228|Serotonin Agents|serotonin agents|mesh-ancestor
93068162|NCT04336228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93068163|NCT04336228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93068164|NCT04336228|Parasympatholytics|parasympatholytics|mesh-ancestor
93068165|NCT04336228|Autonomic Agents|autonomic agents|mesh-ancestor
93068166|NCT04336228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068167|NCT04336228|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93068168|NCT04336228|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93068169|NCT04336228|Cholinergic Agents|cholinergic agents|mesh-ancestor
93068170|NCT04336228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93068171|NCT04336228|Antidepressive Agents|antidepressive agents|mesh-ancestor
93068172|NCT04336228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93068173|NCT03917446|Propofol|propofol|mesh-list
93068174|NCT03917446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93068175|NCT03917446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068176|NCT03917446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068177|NCT03917446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93068178|NCT03917446|Anesthetics, General|anesthetics, general|mesh-ancestor
93068179|NCT03917446|Anesthetics|anesthetics|mesh-ancestor
93068180|NCT04332874|Dactinomycin|dactinomycin|mesh-list
93068181|NCT04332874|Pembrolizumab|pembrolizumab|mesh-list
93068182|NCT04332874|Melphalan|melphalan|mesh-list
93068183|NCT04332874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068184|NCT04332874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068185|NCT04332874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93068186|NCT04332874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068187|NCT04332874|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93068188|NCT04332874|Alkylating Agents|alkylating agents|mesh-ancestor
93068189|NCT04332874|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93068190|NCT04332874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068191|NCT04332874|Immunologic Factors|immunologic factors|mesh-ancestor
93068192|NCT04332874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068193|NCT04332874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068194|NCT04332874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068195|NCT04332874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93068196|NCT04332874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93068197|NCT04332874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068198|NCT04332874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93068199|NCT03748108|Lidocaine|lidocaine|mesh-list
92136708|NCT01446809|Ifosfamide|ifosfamide|mesh-list
93068200|NCT03748108|Anesthetics, Local|anesthetics, local|mesh-ancestor
93068201|NCT03748108|Anesthetics|anesthetics|mesh-ancestor
93068202|NCT03748108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068203|NCT03748108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068204|NCT03748108|Sensory System Agents|sensory system agents|mesh-ancestor
93068205|NCT03748108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068206|NCT03748108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93068207|NCT03748108|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93068208|NCT03748108|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93068209|NCT03748108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93068210|NCT03748108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068211|NCT04171414|Adalimumab|adalimumab|mesh-list
93068212|NCT04171414|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93068213|NCT04171414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068214|NCT04171414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068215|NCT04167670|Amoxicillin|amoxicillin|mesh-list
93068216|NCT04167670|Clarithromycin|clarithromycin|mesh-list
93068217|NCT04167670|Lansoprazole|lansoprazole|mesh-list
93068218|NCT04167670|Dexlansoprazole|dexlansoprazole|mesh-list
93068219|NCT04167670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068220|NCT04167670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068221|NCT04167670|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93068222|NCT04167670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068223|NCT04167670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068224|NCT04167670|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93068225|NCT04167670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93068226|NCT04167670|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93068227|NCT04167670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068228|NCT04167670|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93068229|NCT00113516|Paclitaxel|paclitaxel|mesh-list
93068230|NCT00113516|Carboplatin|carboplatin|mesh-list
93068231|NCT00113516|Sunitinib|sunitinib|mesh-list
93068232|NCT00113516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92725268|NCT00473889|Paclitaxel|paclitaxel|mesh-list
93068233|NCT00113516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068234|NCT00113516|Tubulin Modulators|tubulin modulators|mesh-ancestor
93068235|NCT00113516|Antimitotic Agents|antimitotic agents|mesh-ancestor
93068236|NCT00113516|Mitosis Modulators|mitosis modulators|mesh-ancestor
93068237|NCT00113516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068238|NCT00113516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93068239|NCT00113516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93068240|NCT00113516|Growth Substances|growth substances|mesh-ancestor
93068241|NCT00113516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068242|NCT00113516|Growth Inhibitors|growth inhibitors|mesh-ancestor
93068243|NCT00113516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068244|NCT00113516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068246|NCT04142242|Immunologic Factors|immunologic factors|mesh-ancestor
93068247|NCT04142242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068248|NCT03251326|Propranolol|propranolol|mesh-list
93068249|NCT03251326|Nabilone|nabilone|mesh-list
93068250|NCT03251326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93068251|NCT03251326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93068252|NCT03251326|Adrenergic Agents|adrenergic agents|mesh-ancestor
93068253|NCT03251326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068254|NCT03251326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068255|NCT03251326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068256|NCT03251326|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93068257|NCT03251326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93068258|NCT03251326|Vasodilator Agents|vasodilator agents|mesh-ancestor
93068259|NCT03251326|Antiemetics|antiemetics|mesh-ancestor
93068260|NCT03251326|Autonomic Agents|autonomic agents|mesh-ancestor
93068261|NCT03251326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068262|NCT03251326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068263|NCT03251326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93068264|NCT03251326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93068265|NCT03251326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068266|NCT03251326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93068267|NCT04140292|Vitamin D|vitamin d|mesh-list
93068268|NCT04140292|Cholecalciferol|cholecalciferol|mesh-list
93068269|NCT04140292|Vitamins|vitamins|mesh-ancestor
93068270|NCT04140292|Micronutrients|micronutrients|mesh-ancestor
93068271|NCT04140292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068272|NCT04140292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93068273|NCT04140292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93068275|NCT00127166|Xhance|xhance|mesh-list
93068276|NCT00127166|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
93068277|NCT00127166|Montelukast|montelukast|mesh-list
93068278|NCT00127166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068279|NCT00127166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93068280|NCT00127166|Autonomic Agents|autonomic agents|mesh-ancestor
93068281|NCT00127166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068282|NCT00127166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068283|NCT00127166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93068284|NCT00127166|Respiratory System Agents|respiratory system agents|mesh-ancestor
93068285|NCT00127166|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068286|NCT00127166|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93068287|NCT00127166|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93068288|NCT00127166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93068289|NCT00127166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93068290|NCT00127166|Adrenergic Agents|adrenergic agents|mesh-ancestor
93068291|NCT00127166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068292|NCT00127166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068293|NCT00127166|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93068294|NCT00127166|Hormone Antagonists|hormone antagonists|mesh-ancestor
93068295|NCT00127166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93068296|NCT00127166|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93068297|NCT00127166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93068298|NCT00125138|Metylperon|metylperon|mesh-list
93068299|NCT00125138|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93068300|NCT00125138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93068301|NCT00125138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068302|NCT00125138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068303|NCT00125138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93068304|NCT04132336|Naproxen|naproxen|mesh-list
93068305|NCT04132336|Caffeine|caffeine|mesh-list
93068306|NCT04132336|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93068307|NCT04132336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068308|NCT04132336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93068309|NCT04132336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068310|NCT04132336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068311|NCT04132336|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93068312|NCT04132336|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93068313|NCT04132336|Purinergic Agents|purinergic agents|mesh-ancestor
93068314|NCT04132336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068315|NCT04132336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068316|NCT04132336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068318|NCT04132336|Sensory System Agents|sensory system agents|mesh-ancestor
93068319|NCT04132336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068320|NCT04132336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068321|NCT04132336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068322|NCT04132336|Gout Suppressants|gout suppressants|mesh-ancestor
93068323|NCT04132336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93068324|NCT04131556|Maribavir|maribavir|mesh-list
93068325|NCT04131556|Antiviral Agents|antiviral agents|mesh-ancestor
93068326|NCT04131556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068327|NCT04315636|Pulmonary Surfactants|pulmonary surfactants|mesh-list
93068328|NCT04315636|Respiratory System Agents|respiratory system agents|mesh-ancestor
93068329|NCT03691948|Analgesics, Opioid|analgesics, opioid|mesh-list
93068330|NCT03691948|Narcotics|narcotics|mesh-ancestor
93068331|NCT03691948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068332|NCT03691948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068333|NCT03691948|Analgesics|analgesics|mesh-ancestor
93068334|NCT03691948|Sensory System Agents|sensory system agents|mesh-ancestor
93068335|NCT03691948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068336|NCT04124926|Lansoprazole|lansoprazole|mesh-list
93068337|NCT04124926|Dexlansoprazole|dexlansoprazole|mesh-list
93068338|NCT04124926|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93068339|NCT04124926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068340|NCT04124926|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93068341|NCT04124926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340822|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068342|NCT04124926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068343|NCT03746158|Curcumin|curcumin|mesh-list
93068344|NCT03746158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068345|NCT03746158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068346|NCT03746158|Analgesics|analgesics|mesh-ancestor
93068347|NCT03746158|Sensory System Agents|sensory system agents|mesh-ancestor
93068348|NCT03746158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068349|NCT03746158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068350|NCT03746158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068351|NCT03746158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068352|NCT03746158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068353|NCT03746158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068354|NCT03746158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068356|NCT03747094|Ketamine|ketamine|mesh-list
93068357|NCT03747094|Analgesics|analgesics|mesh-ancestor
93068358|NCT03747094|Sensory System Agents|sensory system agents|mesh-ancestor
93068359|NCT03747094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068360|NCT03747094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068361|NCT03747094|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93068362|NCT03747094|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93068363|NCT03747094|Anesthetics, General|anesthetics, general|mesh-ancestor
93068364|NCT03747094|Anesthetics|anesthetics|mesh-ancestor
93068365|NCT03747094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068366|NCT03747094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93068367|NCT03747094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93068368|NCT03747094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068369|NCT03747094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068370|NCT03747094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93068371|NCT03747094|Narcotics|narcotics|mesh-ancestor
93068372|NCT03747094|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93068373|NCT04105972|Ivacaftor|ivacaftor|mesh-list
93068374|NCT04105972|Elexacaftor|elexacaftor|mesh-list
93068375|NCT04105972|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
93068376|NCT04105972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93068377|NCT04105972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068378|NCT00124982|Abatacept|abatacept|mesh-list
93068379|NCT00124982|Antirheumatic Agents|antirheumatic agents|mesh-list
93068380|NCT00124982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93068381|NCT00124982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068382|NCT00124982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068383|NCT00124982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068384|NCT00124982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068385|NCT00124982|Immunologic Factors|immunologic factors|mesh-ancestor
93068386|NCT00124982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068387|NCT04090528|Pembrolizumab|pembrolizumab|mesh-list
93068388|NCT04090528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068389|NCT04090528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068390|NCT04090528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93068391|NCT04090528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068392|NCT04249336|Listerine|listerine|mesh-list
93068393|NCT04249336|Calcium|calcium|mesh-list
93068394|NCT04249336|Fluorides|fluorides|mesh-list
93068395|NCT04249336|Sodium Fluoride|sodium fluoride|mesh-list
93068396|NCT04249336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93068397|NCT04249336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068398|NCT04249336|Cariostatic Agents|cariostatic agents|mesh-ancestor
93068399|NCT04249336|Protective Agents|protective agents|mesh-ancestor
93068400|NCT04249336|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93068401|NCT04249336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068402|NCT03752476|Lactams|lactams|mesh-list
93068403|NCT03752476|beta-Lactams|beta-lactams|mesh-list
93068404|NCT03752476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068405|NCT03752476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068406|NCT04078126|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
93068407|NCT04078126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93068408|NCT04078126|Respiratory System Agents|respiratory system agents|mesh-ancestor
93068409|NCT04380688|Acalabrutinib|acalabrutinib|mesh-list
93068410|NCT04380688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068411|NCT00124748|Imatinib Mesylate|imatinib mesylate|mesh-list
93068412|NCT00124748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068413|NCT00124748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068414|NCT00124748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068415|NCT00124748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068416|NCT01078142|Sirolimus|sirolimus|mesh-list
93068417|NCT01078142|Rituximab|rituximab|mesh-list
93068418|NCT01078142|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93068419|NCT01078142|Temsirolimus|temsirolimus|mesh-list
93068420|NCT01078142|MTOR Inhibitors|mtor inhibitors|mesh-list
92530764|NCT00043381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068421|NCT01078142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068422|NCT01078142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068423|NCT01078142|Immunologic Factors|immunologic factors|mesh-ancestor
93068424|NCT01078142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068425|NCT01078142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068426|NCT01078142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93068427|NCT01078142|Alkylating Agents|alkylating agents|mesh-ancestor
93068428|NCT01078142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068429|NCT01078142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068430|NCT01078142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068431|NCT01078142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068432|NCT01078142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068433|NCT01078142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068434|NCT01078142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93068435|NCT01078142|Antifungal Agents|antifungal agents|mesh-ancestor
93068437|NCT04060654|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93068438|NCT04060654|Narcotics|narcotics|mesh-ancestor
93068439|NCT04060654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068440|NCT04060654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068441|NCT04060654|Analgesics|analgesics|mesh-ancestor
93068442|NCT04060654|Sensory System Agents|sensory system agents|mesh-ancestor
93068443|NCT04060654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068444|NCT04060654|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93068445|NCT00096200|Paclitaxel|paclitaxel|mesh-list
93068446|NCT00096200|Carboplatin|carboplatin|mesh-list
93068447|NCT00096200|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93068448|NCT00096200|Sorafenib|sorafenib|mesh-list
93068449|NCT00096200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93068450|NCT00096200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068451|NCT00096200|Tubulin Modulators|tubulin modulators|mesh-ancestor
93068452|NCT00096200|Antimitotic Agents|antimitotic agents|mesh-ancestor
93068453|NCT00096200|Mitosis Modulators|mitosis modulators|mesh-ancestor
93068454|NCT00096200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068455|NCT00096200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527981|NCT00014196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068456|NCT00096200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068457|NCT00096044|Rituximab|rituximab|mesh-list
93068458|NCT00096044|Lenalidomide|lenalidomide|mesh-list
93068459|NCT00096044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068460|NCT00096044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068461|NCT00096044|Immunologic Factors|immunologic factors|mesh-ancestor
93068462|NCT00096044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068463|NCT00096044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068464|NCT00096044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93068465|NCT00096044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93068466|NCT00096044|Growth Substances|growth substances|mesh-ancestor
93068467|NCT00096044|Growth Inhibitors|growth inhibitors|mesh-ancestor
93068468|NCT03963128|Vitamin D|vitamin d|mesh-list
93068469|NCT03963128|Cholecalciferol|cholecalciferol|mesh-list
93068470|NCT03963128|Vitamins|vitamins|mesh-ancestor
93068471|NCT03963128|Micronutrients|micronutrients|mesh-ancestor
93068472|NCT03963128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068473|NCT03963128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93068474|NCT03963128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93068475|NCT01083212|Gemfibrozil|gemfibrozil|mesh-list
93068476|NCT01083212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93068477|NCT01083212|Antimetabolites|antimetabolites|mesh-ancestor
93068478|NCT01083212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068479|NCT01083212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93068480|NCT01083212|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93068481|NCT01083212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93068482|NCT01083212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068483|NCT01083290|Spironolactone|spironolactone|mesh-list
92340828|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
93068484|NCT01083290|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
93068485|NCT01083290|Hormone Antagonists|hormone antagonists|mesh-ancestor
93068486|NCT01083290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93068487|NCT01083290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068488|NCT01083290|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93068489|NCT01083290|Diuretics|diuretics|mesh-ancestor
93068490|NCT01083290|Natriuretic Agents|natriuretic agents|mesh-ancestor
93068491|NCT01326650|Vitamin D|vitamin d|mesh-list
93068492|NCT01326650|Ergocalciferols|ergocalciferols|mesh-list
93068493|NCT01326650|Cholecalciferol|cholecalciferol|mesh-list
93068495|NCT01326650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93068496|NCT01326650|Micronutrients|micronutrients|mesh-ancestor
93068497|NCT01326650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068498|NCT01326650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93068499|NCT01326650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93068500|NCT03689374|Insulin|insulin|mesh-list
93068501|NCT03689374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
93068502|NCT03689374|Insulin Glargine|insulin glargine|mesh-list
93068503|NCT03689374|Insulin Aspart|insulin aspart|mesh-list
93068504|NCT03689374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93068505|NCT03689374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068506|NCT00113360|Everolimus|everolimus|mesh-list
93068507|NCT00113360|Octreotide|octreotide|mesh-list
93068508|NCT00113360|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93068509|NCT00113360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068510|NCT00113360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068511|NCT00113360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068512|NCT00113360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068513|NCT00113360|Immunologic Factors|immunologic factors|mesh-ancestor
93068514|NCT00113360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068515|NCT00113360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068516|NCT00113360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068517|NCT00113360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93068518|NCT03745300|Atorvastatin|atorvastatin|mesh-list
93068519|NCT03745300|Simvastatin|simvastatin|mesh-list
93068520|NCT03745300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93068521|NCT03745300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93068522|NCT03745300|Antimetabolites|antimetabolites|mesh-ancestor
93068523|NCT03745300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068524|NCT03745300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93068525|NCT03745300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93068526|NCT03745300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068527|NCT00112736|Sirolimus|sirolimus|mesh-list
93068528|NCT00112736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93068529|NCT00112736|Temsirolimus|temsirolimus|mesh-list
93068530|NCT00112736|MTOR Inhibitors|mtor inhibitors|mesh-list
93068531|NCT00112736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068532|NCT00112736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068533|NCT00112736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068534|NCT00112736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068536|NCT00112736|Immunologic Factors|immunologic factors|mesh-ancestor
93068537|NCT00112736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068538|NCT00112736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068539|NCT00112736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068540|NCT00112736|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93068541|NCT00112736|Antifungal Agents|antifungal agents|mesh-ancestor
93068542|NCT04052620|Diclofenac|diclofenac|mesh-list
93068543|NCT04052620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068544|NCT04052620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068545|NCT04052620|Analgesics|analgesics|mesh-ancestor
93068546|NCT04052620|Sensory System Agents|sensory system agents|mesh-ancestor
93068547|NCT04052620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068548|NCT04052620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068549|NCT04052620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068550|NCT04052620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068551|NCT04052620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93068552|NCT04052620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068553|NCT04052620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068554|NCT00112580|Ipilimumab|ipilimumab|mesh-list
93068555|NCT00112580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068556|NCT00112580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068557|NCT00112580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92340831|NCT00002771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93068558|NCT00112580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068559|NCT04238650|Bevacizumab|bevacizumab|mesh-list
93068560|NCT04238650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068561|NCT04238650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068562|NCT04238650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93068563|NCT04238650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93068564|NCT04238650|Growth Substances|growth substances|mesh-ancestor
93068565|NCT04238650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068566|NCT04238650|Growth Inhibitors|growth inhibitors|mesh-ancestor
93068567|NCT04049578|Balovaptan|balovaptan|mesh-list
93068568|NCT04049578|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93068569|NCT04049578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068570|NCT04049578|Natriuretic Agents|natriuretic agents|mesh-ancestor
93068571|NCT04049578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068572|NCT00095498|Denosumab|denosumab|mesh-list
93068573|NCT00095498|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93068574|NCT00095498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068575|NCT04237792|Dexmedetomidine|dexmedetomidine|mesh-list
93068576|NCT04237792|Propofol|propofol|mesh-list
93068577|NCT04237792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93068578|NCT04237792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068579|NCT04237792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068580|NCT04237792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068581|NCT04237792|Analgesics|analgesics|mesh-ancestor
93068582|NCT04237792|Sensory System Agents|sensory system agents|mesh-ancestor
93068583|NCT04237792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068584|NCT04237792|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93068585|NCT04237792|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93068586|NCT04237792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93068587|NCT04237792|Adrenergic Agents|adrenergic agents|mesh-ancestor
93068588|NCT04237792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068589|NCT04237792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068590|NCT04237792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93068591|NCT04237792|Anesthetics, General|anesthetics, general|mesh-ancestor
93068592|NCT04237792|Anesthetics|anesthetics|mesh-ancestor
93068593|NCT03744988|Androgens|androgens|mesh-list
93068594|NCT03744988|Hormones|hormones|mesh-ancestor
93068595|NCT03744988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93068596|NCT03744988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068597|NCT03746782|Thrombin|thrombin|mesh-list
93068598|NCT03746782|Hemostatics|hemostatics|mesh-ancestor
93068599|NCT03746782|Coagulants|coagulants|mesh-ancestor
93068600|NCT04026568|4-Aminopyridine|4-aminopyridine|mesh-list
93068601|NCT04026568|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
93068602|NCT04026568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93068603|NCT04026568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068604|NCT04024228|Hemagglutinins|hemagglutinins|mesh-list
93068605|NCT04024228|Vaccines|vaccines|mesh-list
93068606|NCT04024228|Immunologic Factors|immunologic factors|mesh-ancestor
93068607|NCT04024228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068608|NCT04024228|Agglutinins|agglutinins|mesh-ancestor
93068609|NCT04024228|Coagulants|coagulants|mesh-ancestor
93068610|NCT04023682|Hand Sanitizers|hand sanitizers|mesh-list
93068611|NCT04023682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93068612|NCT04023682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068613|NCT04023682|Disinfectants|disinfectants|mesh-ancestor
93068614|NCT04018612|Acetaminophen|acetaminophen|mesh-list
93068615|NCT04018612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068616|NCT04018612|Analgesics|analgesics|mesh-ancestor
93068617|NCT04018612|Sensory System Agents|sensory system agents|mesh-ancestor
93068618|NCT04018612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068619|NCT04018612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068620|NCT04018612|Antipyretics|antipyretics|mesh-ancestor
93068621|NCT04207840|Epinephrine|epinephrine|mesh-list
93068622|NCT04207840|Racepinephrine|racepinephrine|mesh-list
93068623|NCT04207840|Albuterol|albuterol|mesh-list
93068624|NCT04207840|Epinephryl borate|epinephryl borate|mesh-list
93068625|NCT04207840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93068626|NCT04207840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93068627|NCT04207840|Adrenergic Agents|adrenergic agents|mesh-ancestor
93068628|NCT04207840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068629|NCT04207840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068630|NCT04207840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068631|NCT04207840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93068632|NCT04207840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93068633|NCT04207840|Autonomic Agents|autonomic agents|mesh-ancestor
93068634|NCT04207840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068635|NCT04207840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93068636|NCT04207840|Respiratory System Agents|respiratory system agents|mesh-ancestor
93068637|NCT04207840|Mydriatics|mydriatics|mesh-ancestor
93068638|NCT04207840|Sympathomimetics|sympathomimetics|mesh-ancestor
93068639|NCT04207840|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93068640|NCT04207840|Tocolytic Agents|tocolytic agents|mesh-ancestor
93068641|NCT04207840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93068642|NCT04207840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
93068643|NCT04195828|Paclitaxel|paclitaxel|mesh-list
93068645|NCT04195828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93068646|NCT04195828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068647|NCT04195828|Tubulin Modulators|tubulin modulators|mesh-ancestor
93068648|NCT04195828|Antimitotic Agents|antimitotic agents|mesh-ancestor
93068649|NCT04195828|Mitosis Modulators|mitosis modulators|mesh-ancestor
93068650|NCT04195828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068651|NCT04195828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068652|NCT04195828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068653|NCT03744364|Misoprostol|misoprostol|mesh-list
93068654|NCT03744364|Dinoprostone|dinoprostone|mesh-list
93068655|NCT03744364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93068656|NCT03744364|Abortifacient Agents|abortifacient agents|mesh-ancestor
93068657|NCT03744364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93068658|NCT03744364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068659|NCT03744364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93068660|NCT03744364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068661|NCT03744364|Oxytocics|oxytocics|mesh-ancestor
93068662|NCT03744208|Antibodies|antibodies|mesh-list
93068663|NCT03744208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93068664|NCT03744208|Immunologic Factors|immunologic factors|mesh-ancestor
93068665|NCT03744208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068666|NCT05069896|Mirikizumab|mirikizumab|mesh-list
93068667|NCT05069896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068668|NCT05069896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068669|NCT05069896|Analgesics|analgesics|mesh-ancestor
93068670|NCT05069896|Sensory System Agents|sensory system agents|mesh-ancestor
93068671|NCT05069896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068672|NCT05069896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068673|NCT05069896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068674|NCT05069896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068675|NCT05069896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93068676|NCT05069896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068677|NCT01562626|Flucytosine|flucytosine|mesh-list
93068678|NCT01562626|Antifungal Agents|antifungal agents|mesh-ancestor
93068679|NCT01562626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068680|NCT01562626|Antimetabolites|antimetabolites|mesh-ancestor
93068681|NCT01562626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068682|NCT04470622|Aprepitant|aprepitant|mesh-list
93068683|NCT04470622|Antiemetics|antiemetics|mesh-ancestor
92725672|NCT04570254|Vitamins|vitamins|mesh-list
93068684|NCT04470622|Autonomic Agents|autonomic agents|mesh-ancestor
93068685|NCT04470622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068686|NCT04470622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068687|NCT04470622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068688|NCT04470622|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
93068689|NCT04470622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068690|NCT04470622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068691|NCT04465396|Teduglutide|teduglutide|mesh-list
93068692|NCT04465396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068693|NCT04465396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93068694|NCT04465396|Protective Agents|protective agents|mesh-ancestor
93068695|NCT04465396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068696|NCT03996694|Oxycodone|oxycodone|mesh-list
93068697|NCT03996694|Buprenorphine|buprenorphine|mesh-list
93068698|NCT03996694|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93068699|NCT03996694|Narcotics|narcotics|mesh-ancestor
93068700|NCT03996694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92340837|NCT00002777|Tamoxifen|tamoxifen|mesh-list
93068701|NCT03996694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068702|NCT03996694|Analgesics|analgesics|mesh-ancestor
93068703|NCT03996694|Sensory System Agents|sensory system agents|mesh-ancestor
93068704|NCT03996694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068705|NCT03996694|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93068706|NCT03743896|Capsaicin|capsaicin|mesh-list
93068707|NCT03743896|Antipruritics|antipruritics|mesh-ancestor
93068708|NCT03743896|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068709|NCT03743896|Sensory System Agents|sensory system agents|mesh-ancestor
93068710|NCT03743896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068711|NCT03743896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068712|NCT03737344|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
93068713|NCT03737344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068714|NCT03751228|Deucravacitinib|deucravacitinib|mesh-list
93068715|NCT03751228|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068716|NCT03751228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068717|NCT03751228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530769|NCT00001568|Antiviral Agents|antiviral agents|mesh-ancestor
93068718|NCT03751228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068719|NCT03656692|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
93068721|NCT03656692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93068722|NCT03656692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068723|NCT04439266|Crizotinib|crizotinib|mesh-list
93068724|NCT04439266|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
93068725|NCT04439266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068726|NCT04439266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068727|NCT04439266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068728|NCT04439266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068729|NCT01329796|Lidocaine|lidocaine|mesh-list
93068730|NCT01329796|Anesthetics, Local|anesthetics, local|mesh-ancestor
93068731|NCT01329796|Anesthetics|anesthetics|mesh-ancestor
93068732|NCT01329796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068733|NCT01329796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068734|NCT01329796|Sensory System Agents|sensory system agents|mesh-ancestor
93068735|NCT01329796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068736|NCT01329796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93068737|NCT01329796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93068738|NCT01329796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93068739|NCT01329796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93068740|NCT01329796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068741|NCT04428502|Etanercept|etanercept|mesh-list
93068742|NCT04428502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068743|NCT04428502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068744|NCT04428502|Analgesics|analgesics|mesh-ancestor
93068745|NCT04428502|Sensory System Agents|sensory system agents|mesh-ancestor
93068746|NCT04428502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068747|NCT04428502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068748|NCT04428502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068749|NCT04428502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068750|NCT04428502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068751|NCT04428502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068752|NCT04428502|Immunologic Factors|immunologic factors|mesh-ancestor
93068753|NCT03736330|Pembrolizumab|pembrolizumab|mesh-list
93068754|NCT03736330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93068755|NCT03736330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068756|NCT03736330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93068757|NCT03736330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068758|NCT04428424|Etanercept|etanercept|mesh-list
93068759|NCT04428424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068760|NCT04428424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068761|NCT04428424|Analgesics|analgesics|mesh-ancestor
93068762|NCT04428424|Sensory System Agents|sensory system agents|mesh-ancestor
93068763|NCT04428424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068764|NCT04428424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068765|NCT04428424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068766|NCT04428424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068767|NCT04428424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068768|NCT04428424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068769|NCT04428424|Immunologic Factors|immunologic factors|mesh-ancestor
93068770|NCT00095238|Irbesartan|irbesartan|mesh-list
93068771|NCT00095238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93068772|NCT00095238|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93068773|NCT00095238|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93068774|NCT00095238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068775|NCT01087008|Zoledronic Acid|zoledronic acid|mesh-list
93068776|NCT01087008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93068777|NCT01087008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068778|NCT01084044|Urinastatin|urinastatin|mesh-list
93068779|NCT01084044|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
93068780|NCT01084044|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93068781|NCT01084044|Protease Inhibitors|protease inhibitors|mesh-ancestor
93068782|NCT01084044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068783|NCT01084044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068784|NCT01090518|Hydrocortisone|hydrocortisone|mesh-list
93068785|NCT01090518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068786|NCT01090596|Naproxen|naproxen|mesh-list
93068787|NCT01090596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068788|NCT01090596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068789|NCT01090596|Analgesics|analgesics|mesh-ancestor
93068790|NCT01090596|Sensory System Agents|sensory system agents|mesh-ancestor
93068791|NCT01090596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068792|NCT01090596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068793|NCT01090596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068794|NCT01090596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068795|NCT01090596|Gout Suppressants|gout suppressants|mesh-ancestor
93068796|NCT01090596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93068797|NCT01090596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068798|NCT01090596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068799|NCT01084122|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93068800|NCT01084122|Hematinics|hematinics|mesh-ancestor
93068801|NCT01084200|Propofol|propofol|mesh-list
93068802|NCT01084200|Sevoflurane|sevoflurane|mesh-list
93068803|NCT01084200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93068804|NCT01084200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068805|NCT01084200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068806|NCT01084200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93068807|NCT01084200|Anesthetics, General|anesthetics, general|mesh-ancestor
93068808|NCT01084200|Anesthetics|anesthetics|mesh-ancestor
93068809|NCT01084200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93068810|NCT01084200|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93068811|NCT00094770|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93068812|NCT00094770|Glipizide|glipizide|mesh-list
93068813|NCT00094770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93068814|NCT00094770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068815|NCT00094770|Incretins|incretins|mesh-ancestor
93068816|NCT00094770|Hormones|hormones|mesh-ancestor
93068817|NCT00094770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93068818|NCT00094770|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93068819|NCT00094770|Protease Inhibitors|protease inhibitors|mesh-ancestor
93068820|NCT00094770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068821|NCT00094770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068822|NCT01087398|Cyclosporine|cyclosporine|mesh-list
93068823|NCT01087398|Cyclophosphamide|cyclophosphamide|mesh-list
93068824|NCT01087398|Busulfan|busulfan|mesh-list
93068825|NCT01087398|Methotrexate|methotrexate|mesh-list
93068826|NCT01087398|Fludarabine|fludarabine|mesh-list
93068827|NCT01087398|Cyclosporins|cyclosporins|mesh-list
93068828|NCT01087398|Thymoglobulin|thymoglobulin|mesh-list
93068829|NCT01087398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725807|NCT01132807|Dacarbazine|dacarbazine|mesh-list
93068830|NCT01087398|Immunologic Factors|immunologic factors|mesh-ancestor
93068831|NCT01087398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068832|NCT01087398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068833|NCT01087398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93068834|NCT01087398|Alkylating Agents|alkylating agents|mesh-ancestor
93068835|NCT01087398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068836|NCT01087398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068837|NCT01087398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93068838|NCT01087398|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93068839|NCT01087398|Abortifacient Agents|abortifacient agents|mesh-ancestor
93068840|NCT01087398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93068841|NCT01087398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068842|NCT01087398|Antimetabolites|antimetabolites|mesh-ancestor
93068843|NCT01087398|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068844|NCT01087398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068845|NCT01087398|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93068846|NCT01087398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93068847|NCT01087398|Antifungal Agents|antifungal agents|mesh-ancestor
93068848|NCT01087398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068849|NCT01087398|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93068850|NCT01087476|Doxycycline|doxycycline|mesh-list
93068851|NCT01087476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068852|NCT01087476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068853|NCT01087476|Antimalarials|antimalarials|mesh-ancestor
93068854|NCT01087476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93068855|NCT01087476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93068856|NCT00069108|Leucovorin|leucovorin|mesh-list
93068857|NCT00069108|Capecitabine|capecitabine|mesh-list
93068858|NCT00069108|Oxaliplatin|oxaliplatin|mesh-list
92137355|NCT01575899|Rabeprazole|rabeprazole|mesh-list
93068859|NCT00069108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068860|NCT00069108|Antimetabolites|antimetabolites|mesh-ancestor
93068861|NCT00069108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068862|NCT00069108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068863|NCT00069108|Antidotes|antidotes|mesh-ancestor
93068864|NCT00069108|Protective Agents|protective agents|mesh-ancestor
93068865|NCT00069108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068866|NCT00069108|Vitamin B Complex|vitamin b complex|mesh-ancestor
93068867|NCT00069108|Vitamins|vitamins|mesh-ancestor
93068868|NCT00069108|Micronutrients|micronutrients|mesh-ancestor
93068869|NCT00405587|Vemurafenib|vemurafenib|mesh-list
93068870|NCT00405587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068871|NCT00405587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93068872|NCT00405587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068873|NCT00405587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068874|NCT01040429|Clonidine|clonidine|mesh-list
93068875|NCT01040429|Analgesics|analgesics|mesh-ancestor
93068876|NCT01040429|Sensory System Agents|sensory system agents|mesh-ancestor
93068877|NCT01040429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068878|NCT01040429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068879|NCT01040429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93068880|NCT01040429|Sympatholytics|sympatholytics|mesh-ancestor
93068881|NCT01040429|Autonomic Agents|autonomic agents|mesh-ancestor
93068882|NCT01040429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93068883|NCT01040429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93068884|NCT01040429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93068885|NCT01040429|Adrenergic Agents|adrenergic agents|mesh-ancestor
93068886|NCT01040429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93068887|NCT01040429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068888|NCT01039883|Albaconazole|albaconazole|mesh-list
93068889|NCT01039883|Antifungal Agents|antifungal agents|mesh-ancestor
93068890|NCT01039883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068891|NCT00405275|Hydroxychloroquine|hydroxychloroquine|mesh-list
93068892|NCT00405275|Sulfasalazine|sulfasalazine|mesh-list
93068893|NCT00405275|Etanercept|etanercept|mesh-list
93068894|NCT00405275|Methotrexate|methotrexate|mesh-list
93068895|NCT00405275|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93068896|NCT00405275|Abortifacient Agents|abortifacient agents|mesh-ancestor
93068897|NCT00405275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93068898|NCT00405275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068899|NCT00405275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068900|NCT00405275|Antimetabolites|antimetabolites|mesh-ancestor
93068901|NCT00405275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068902|NCT00405275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068903|NCT00405275|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068904|NCT00405275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068905|NCT00405275|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93068906|NCT00405275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068907|NCT00405275|Immunologic Factors|immunologic factors|mesh-ancestor
93068908|NCT00405275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068909|NCT00405275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93068910|NCT00405275|Antimalarials|antimalarials|mesh-ancestor
93068911|NCT00405275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93068912|NCT00405275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93068913|NCT00405275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068914|NCT00405275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068915|NCT00405275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068916|NCT00405275|Analgesics|analgesics|mesh-ancestor
93068917|NCT00405275|Sensory System Agents|sensory system agents|mesh-ancestor
92397834|NCT03071601|Anesthetics|anesthetics|mesh-ancestor
93068918|NCT00405275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068919|NCT00405275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068920|NCT00405275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068921|NCT00404651|Vaccines|vaccines|mesh-list
93068922|NCT00404651|Immunologic Factors|immunologic factors|mesh-ancestor
93068923|NCT00404651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068924|NCT00404495|Irinotecan|irinotecan|mesh-list
93068925|NCT00404495|Temozolomide|temozolomide|mesh-list
93068926|NCT00404495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93068927|NCT00404495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93068928|NCT00404495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068929|NCT00404495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068930|NCT00404495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068931|NCT00404495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93068932|NCT00404495|Alkylating Agents|alkylating agents|mesh-ancestor
93068933|NCT00409409|Immunomodulating Agents|immunomodulating agents|mesh-list
93068934|NCT00409409|Immunologic Factors|immunologic factors|mesh-ancestor
93068935|NCT00409409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068936|NCT00409331|Amifostine|amifostine|mesh-list
93068937|NCT00409331|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93068938|NCT00409331|Protective Agents|protective agents|mesh-ancestor
93068939|NCT00409331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068940|NCT00362219|Morphine|morphine|mesh-list
93068941|NCT00362219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93068942|NCT00362219|Narcotics|narcotics|mesh-ancestor
93068943|NCT00362219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068944|NCT00362219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068945|NCT00362219|Analgesics|analgesics|mesh-ancestor
93068946|NCT00362219|Sensory System Agents|sensory system agents|mesh-ancestor
93068947|NCT00362219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068948|NCT01040585|Linezolid|linezolid|mesh-list
93068949|NCT01040585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93068950|NCT01040585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068951|NCT01040585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93068952|NCT01040585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068953|NCT01040585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068954|NCT01040195|Hydroxychloroquine|hydroxychloroquine|mesh-list
93068955|NCT01040195|Methotrexate|methotrexate|mesh-list
93068956|NCT01040195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93068957|NCT01040195|Abortifacient Agents|abortifacient agents|mesh-ancestor
93068958|NCT01040195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93068959|NCT01040195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068960|NCT01040195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93068961|NCT01040195|Antimetabolites|antimetabolites|mesh-ancestor
93068962|NCT01040195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068963|NCT01040195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068964|NCT01040195|Dermatologic Agents|dermatologic agents|mesh-ancestor
93068965|NCT01040195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93068966|NCT01040195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93068967|NCT01040195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93068968|NCT01040195|Immunologic Factors|immunologic factors|mesh-ancestor
93068969|NCT01040195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068970|NCT01040195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93068971|NCT01040195|Antimalarials|antimalarials|mesh-ancestor
93068972|NCT01040195|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93068973|NCT01040195|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93068974|NCT01040195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93068975|NCT01040273|Bupivacaine|bupivacaine|mesh-list
93068976|NCT01040273|Anesthetics, Local|anesthetics, local|mesh-ancestor
93068977|NCT01040273|Anesthetics|anesthetics|mesh-ancestor
93068978|NCT01040273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93068979|NCT01040273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93068980|NCT01040273|Sensory System Agents|sensory system agents|mesh-ancestor
93068981|NCT01040273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93068982|NCT00408629|Adalimumab|adalimumab|mesh-list
93068983|NCT00408629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93068984|NCT00408629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93068985|NCT00408629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93068986|NCT00408317|Pancrelipase|pancrelipase|mesh-list
93068987|NCT00408317|Pancreatin|pancreatin|mesh-list
93068988|NCT00408317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93068989|NCT00112502|Thalidomide|thalidomide|mesh-list
93068990|NCT00112502|Celecoxib|celecoxib|mesh-list
93068991|NCT00112502|Temozolomide|temozolomide|mesh-list
93068992|NCT00112502|Isotretinoin|isotretinoin|mesh-list
93068993|NCT00112502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93068994|NCT00112502|Alkylating Agents|alkylating agents|mesh-ancestor
93068995|NCT00112502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93068996|NCT00112502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93068997|NCT00112502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93068998|NCT00112502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93068999|NCT00112502|Analgesics|analgesics|mesh-ancestor
93069000|NCT00112502|Sensory System Agents|sensory system agents|mesh-ancestor
93069001|NCT00112502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069002|NCT00112502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069003|NCT00112502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069004|NCT00112502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069005|NCT00112502|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93069006|NCT00112502|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93069007|NCT00112502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069008|NCT00112502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069009|NCT00112502|Immunologic Factors|immunologic factors|mesh-ancestor
93069010|NCT00112502|Leprostatic Agents|leprostatic agents|mesh-ancestor
93069011|NCT00112502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069012|NCT00112502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069013|NCT00112502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069014|NCT00112502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069015|NCT00112502|Growth Substances|growth substances|mesh-ancestor
93069016|NCT00112502|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069017|NCT00112502|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069018|NCT03965546|Sorafenib|sorafenib|mesh-list
93069019|NCT03965546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069020|NCT03965546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069021|NCT03965546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069022|NCT03965546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069023|NCT01083992|Vitamin D|vitamin d|mesh-list
93069024|NCT01083992|Vildagliptin|vildagliptin|mesh-list
93069025|NCT01083992|Vitamins|vitamins|mesh-ancestor
93069026|NCT01083992|Micronutrients|micronutrients|mesh-ancestor
93069027|NCT01083992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069028|NCT01083992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93069029|NCT01083992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93069030|NCT01083992|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93069031|NCT01083992|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069032|NCT01083992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069033|NCT01083992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069034|NCT03822182|Dexamethasone|dexamethasone|mesh-list
93069035|NCT03822182|Bupivacaine|bupivacaine|mesh-list
93069036|NCT03822182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069037|NCT03822182|Antiemetics|antiemetics|mesh-ancestor
93069038|NCT03822182|Autonomic Agents|autonomic agents|mesh-ancestor
93069039|NCT03822182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069040|NCT03822182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069041|NCT03822182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93069042|NCT03822182|Glucocorticoids|glucocorticoids|mesh-ancestor
93069043|NCT03822182|Hormones|hormones|mesh-ancestor
93069044|NCT03822182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069045|NCT03822182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93069046|NCT03822182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069047|NCT03822182|Anesthetics, Local|anesthetics, local|mesh-ancestor
93069048|NCT03822182|Anesthetics|anesthetics|mesh-ancestor
93069049|NCT03822182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93069050|NCT03822182|Sensory System Agents|sensory system agents|mesh-ancestor
93069051|NCT01078610|Adalimumab|adalimumab|mesh-list
93069052|NCT01078610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93069053|NCT01078610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069054|NCT01078610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069055|NCT01080482|Tacrolimus|tacrolimus|mesh-list
93069056|NCT01080482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726033|NCT00587327|Atosiban|atosiban|mesh-list
93069057|NCT01080482|Immunologic Factors|immunologic factors|mesh-ancestor
93069058|NCT01080482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069059|NCT01080482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93069060|NCT01080482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069061|NCT01080482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069063|NCT03965624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069064|NCT03965624|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069065|NCT03965624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069066|NCT03965624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069067|NCT01080560|Cyclosporine|cyclosporine|mesh-list
93069068|NCT01080560|Cyclosporins|cyclosporins|mesh-list
93069069|NCT01080560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069070|NCT01080560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069071|NCT01080560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069072|NCT01080560|Immunologic Factors|immunologic factors|mesh-ancestor
93069073|NCT01080560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069074|NCT01080560|Antifungal Agents|antifungal agents|mesh-ancestor
93069075|NCT01080560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069076|NCT01080560|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069077|NCT01080560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069078|NCT01080560|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93069079|NCT00094328|Anastrozole|anastrozole|mesh-list
93069080|NCT00094328|Bicalutamide|bicalutamide|mesh-list
93069081|NCT00094328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93069082|NCT00094328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069083|NCT00094328|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93069084|NCT00094328|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93069085|NCT00094328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069086|NCT00094328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069087|NCT00094328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93069088|NCT00094328|Hormone Antagonists|hormone antagonists|mesh-ancestor
93069089|NCT00094328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069090|NCT00094328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069091|NCT00094328|Androgen Antagonists|androgen antagonists|mesh-ancestor
93069092|NCT00094172|Atorvastatin|atorvastatin|mesh-list
93069093|NCT00094172|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93069094|NCT00094172|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93069095|NCT00094172|Antimetabolites|antimetabolites|mesh-ancestor
93069096|NCT00094172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069097|NCT00094172|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93069098|NCT00094172|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93069099|NCT00094172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069101|NCT00094094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069102|NCT00094094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069103|NCT00094094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069104|NCT00094094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069105|NCT03962816|Vaccines|vaccines|mesh-list
93069106|NCT03962816|Immunologic Factors|immunologic factors|mesh-ancestor
93069107|NCT03962816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069108|NCT01080638|polysaccharide-K|polysaccharide-k|mesh-list
93069109|NCT01080638|Abciximab|abciximab|mesh-list
93069110|NCT01080638|Anticoagulants|anticoagulants|mesh-ancestor
93069111|NCT01080638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93069112|NCT01080638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93069113|NCT01080638|Immunologic Factors|immunologic factors|mesh-ancestor
93069114|NCT01080638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069115|NCT01080638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93069116|NCT01080638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069117|NCT01080638|Antiviral Agents|antiviral agents|mesh-ancestor
93069118|NCT01080638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069119|NCT01080638|Interferon Inducers|interferon inducers|mesh-ancestor
93069120|NCT01080638|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93069121|NCT01080638|Protective Agents|protective agents|mesh-ancestor
93069122|NCT00110396|Interferons|interferons|mesh-list
93069123|NCT00110396|Interferon-beta|interferon-beta|mesh-list
93069124|NCT00110396|Interferon beta-1a|interferon beta-1a|mesh-list
93069125|NCT00110396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069126|NCT00110396|Antiviral Agents|antiviral agents|mesh-ancestor
93069127|NCT00110396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069128|NCT00110396|Immunologic Factors|immunologic factors|mesh-ancestor
93069129|NCT00110396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069130|NCT00110396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93069131|NCT00093470|Tipifarnib|tipifarnib|mesh-list
93069132|NCT00093470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069133|NCT00407537|Amlodipine|amlodipine|mesh-list
93069134|NCT00407537|Atorvastatin|atorvastatin|mesh-list
93069135|NCT00407537|Calcium|calcium|mesh-list
93069136|NCT00407537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93069137|NCT00407537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069138|NCT00407537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93069140|NCT00407537|Antimetabolites|antimetabolites|mesh-ancestor
93069141|NCT00407537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069142|NCT00407537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93069143|NCT00407537|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93069144|NCT00407537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069145|NCT00407537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93069146|NCT00407537|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93069147|NCT00407537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93069148|NCT00407537|Vasodilator Agents|vasodilator agents|mesh-ancestor
93069149|NCT00094458|Infliximab|infliximab|mesh-list
93069150|NCT00094458|Azathioprine|azathioprine|mesh-list
93069151|NCT00094458|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93069152|NCT00094458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069153|NCT00094458|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069154|NCT00094458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93069155|NCT00094458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069157|NCT00094458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069158|NCT00094458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069159|NCT00094458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069160|NCT00094458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069161|NCT00094458|Immunologic Factors|immunologic factors|mesh-ancestor
93069162|NCT00094458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069163|NCT00406367|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
93069164|NCT00406367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93069165|NCT00406367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069166|NCT00406367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069167|NCT00406367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93069168|NCT00406367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93069169|NCT00406367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069170|NCT00406367|Cholinergic Agents|cholinergic agents|mesh-ancestor
93069171|NCT00406367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069172|NCT01041443|Tetrahydrouridine|tetrahydrouridine|mesh-list
93069173|NCT01041443|Antimetabolites|antimetabolites|mesh-ancestor
93069174|NCT01041443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069175|NCT03961464|Cycloserine|cycloserine|mesh-list
93069176|NCT03961464|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93069177|NCT03961464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069178|NCT03961464|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93069179|NCT03961464|Antitubercular Agents|antitubercular agents|mesh-ancestor
93069180|NCT03961464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069181|NCT03961464|Antimetabolites|antimetabolites|mesh-ancestor
93069182|NCT03961464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069183|NCT01087554|Sirolimus|sirolimus|mesh-list
93069184|NCT01087554|Everolimus|everolimus|mesh-list
93069185|NCT01087554|MTOR Inhibitors|mtor inhibitors|mesh-list
93069186|NCT01087554|Temsirolimus|temsirolimus|mesh-list
93069187|NCT01087554|Vorinostat|vorinostat|mesh-list
93069188|NCT01087554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069189|NCT01087554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069190|NCT01087554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069191|NCT01087554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069192|NCT01087554|Immunologic Factors|immunologic factors|mesh-ancestor
93069193|NCT01087554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069194|NCT01087554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069195|NCT01087554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069196|NCT01087554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069197|NCT01087554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93069198|NCT01087554|Antifungal Agents|antifungal agents|mesh-ancestor
93069199|NCT01087554|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93069200|NCT01087632|Folic Acid|folic acid|mesh-list
93069201|NCT01087632|Coenzyme Q10|coenzyme q10|mesh-list
93069202|NCT01087632|Policosanol|policosanol|mesh-list
93069203|NCT01087632|Red yeast rice|red yeast rice|mesh-list
93069204|NCT01087632|Hematinics|hematinics|mesh-ancestor
92340860|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
93069205|NCT01087632|Vitamin B Complex|vitamin b complex|mesh-ancestor
93069206|NCT01087632|Vitamins|vitamins|mesh-ancestor
93069207|NCT01087632|Micronutrients|micronutrients|mesh-ancestor
93069208|NCT01087632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069209|NCT01087632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93069210|NCT01087632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93069211|NCT01087632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93069212|NCT01087632|Antimetabolites|antimetabolites|mesh-ancestor
93069213|NCT01087632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069214|NCT01087632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069215|NCT01087632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93069216|NCT01087632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93069217|NCT00394589|Infliximab|infliximab|mesh-list
93069218|NCT00394589|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93069219|NCT00394589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069220|NCT00394589|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069221|NCT00394589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93069222|NCT00394589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069223|NCT00068406|Cisplatin|cisplatin|mesh-list
93069224|NCT00068406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069225|NCT00403559|Ketoconazole|ketoconazole|mesh-list
93069226|NCT00403559|Pimecrolimus|pimecrolimus|mesh-list
93069227|NCT00403559|Antifungal Agents|antifungal agents|mesh-ancestor
93069228|NCT00403559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069229|NCT00403559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93069230|NCT00403559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93069231|NCT00403559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069232|NCT00403559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069233|NCT00403559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93069234|NCT00403559|Hormone Antagonists|hormone antagonists|mesh-ancestor
93069235|NCT00403559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069236|NCT00403559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069237|NCT00403559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93069238|NCT00403559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93069239|NCT00403559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93069240|NCT00403559|Analgesics|analgesics|mesh-ancestor
93069241|NCT00403559|Sensory System Agents|sensory system agents|mesh-ancestor
93069242|NCT00403559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069243|NCT00403559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069244|NCT00403559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069245|NCT00403559|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069246|NCT00403559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069247|NCT00403559|Immunologic Factors|immunologic factors|mesh-ancestor
93069248|NCT00403559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93069249|NCT01087710|Vitamins|vitamins|mesh-list
93069250|NCT01087710|Antioxidants|antioxidants|mesh-list
93069251|NCT01087710|Micronutrients|micronutrients|mesh-ancestor
93069252|NCT01087710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069253|NCT01087710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069254|NCT01087710|Protective Agents|protective agents|mesh-ancestor
93069255|NCT00403481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93069256|NCT00403481|Olmesartan|olmesartan|mesh-list
93069257|NCT00403481|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
93069258|NCT00403481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93069259|NCT00403481|Diuretics|diuretics|mesh-ancestor
93069260|NCT00403481|Natriuretic Agents|natriuretic agents|mesh-ancestor
93069261|NCT00403481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069262|NCT00403481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
93069263|NCT00403481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93069264|NCT00403481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069265|NCT00403481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93069266|NCT00403481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93069267|NCT00402779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93069268|NCT00402779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069269|NCT00402779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069270|NCT00402779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069271|NCT00402779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069272|NCT00394433|Bevacizumab|bevacizumab|mesh-list
93069273|NCT00394433|Cisplatin|cisplatin|mesh-list
93069274|NCT00394433|Docetaxel|docetaxel|mesh-list
93069275|NCT00394433|Irinotecan|irinotecan|mesh-list
93069276|NCT00394433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069277|NCT00394433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069278|NCT00394433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069279|NCT00394433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069280|NCT00394433|Growth Substances|growth substances|mesh-ancestor
93069281|NCT00394433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069282|NCT00394433|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069283|NCT00394433|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069285|NCT00394433|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069286|NCT00394433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069287|NCT00394433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93069288|NCT00394433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93069289|NCT00394433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069290|NCT00092534|Vaccines|vaccines|mesh-list
93069291|NCT00092534|Immunologic Factors|immunologic factors|mesh-ancestor
93069292|NCT00092534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069293|NCT00068250|Rituximab|rituximab|mesh-list
93069294|NCT00068250|Methotrexate|methotrexate|mesh-list
93069295|NCT00068250|Temozolomide|temozolomide|mesh-list
93069296|NCT00068250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069297|NCT00068250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069298|NCT00068250|Immunologic Factors|immunologic factors|mesh-ancestor
93069299|NCT00068250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069300|NCT00068250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137789|NCT00674115|Omeprazole|omeprazole|mesh-list
93069301|NCT00068250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93069302|NCT00068250|Abortifacient Agents|abortifacient agents|mesh-ancestor
93069303|NCT00068250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93069304|NCT00068250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069305|NCT00068250|Antimetabolites|antimetabolites|mesh-ancestor
93069306|NCT00068250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069307|NCT00068250|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069308|NCT00068250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069309|NCT00068250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93069310|NCT00068250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069311|NCT00068250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93069312|NCT00068250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93069313|NCT00068250|Alkylating Agents|alkylating agents|mesh-ancestor
93069314|NCT03957720|Penicillamine|penicillamine|mesh-list
93069315|NCT03957720|Succimer|succimer|mesh-list
93069316|NCT03957720|Antidotes|antidotes|mesh-ancestor
93069317|NCT03957720|Protective Agents|protective agents|mesh-ancestor
93069318|NCT03957720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069319|NCT03957720|Chelating Agents|chelating agents|mesh-ancestor
93069320|NCT03957720|Sequestering Agents|sequestering agents|mesh-ancestor
93069321|NCT03957720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069322|NCT03957720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069323|NCT00393029|Aldesleukin|aldesleukin|mesh-list
93069324|NCT00393029|Cyclophosphamide|cyclophosphamide|mesh-list
93069325|NCT00393029|Fludarabine|fludarabine|mesh-list
93069326|NCT00393029|Fludarabine phosphate|fludarabine phosphate|mesh-list
93069327|NCT00393029|Interleukin-2|interleukin-2|mesh-list
93069328|NCT00393029|Lenograstim|lenograstim|mesh-list
93069329|NCT00393029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069330|NCT00393029|Immunologic Factors|immunologic factors|mesh-ancestor
93069331|NCT00393029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069332|NCT00393029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069333|NCT00393029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93069334|NCT00393029|Alkylating Agents|alkylating agents|mesh-ancestor
93069335|NCT00393029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069336|NCT00393029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069337|NCT00393029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93069338|NCT00393029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069339|NCT00393029|Antimetabolites|antimetabolites|mesh-ancestor
93069340|NCT00393029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93069341|NCT00393029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93069342|NCT00393029|Analgesics|analgesics|mesh-ancestor
93069343|NCT00393029|Sensory System Agents|sensory system agents|mesh-ancestor
93069344|NCT00393029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069345|NCT00393029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340868|NCT00002783|Vitamins|vitamins|mesh-ancestor
93069346|NCT00393029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93069347|NCT00393029|Antiviral Agents|antiviral agents|mesh-ancestor
93069348|NCT00393029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069349|NCT00402233|Pramipexole|pramipexole|mesh-list
93069350|NCT00402233|Antioxidants|antioxidants|mesh-ancestor
93069351|NCT00402233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069352|NCT00402233|Protective Agents|protective agents|mesh-ancestor
93069353|NCT00402233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069354|NCT00402233|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93069355|NCT00402233|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93069356|NCT00402233|Dopamine Agonists|dopamine agonists|mesh-ancestor
93069357|NCT00402233|Dopamine Agents|dopamine agents|mesh-ancestor
93069358|NCT00402233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069359|NCT03993431|Methamphetamine|methamphetamine|mesh-list
93069360|NCT03993431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93069361|NCT03993431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069363|NCT03993431|Autonomic Agents|autonomic agents|mesh-ancestor
93069364|NCT03993431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069365|NCT03993431|Dopamine Agents|dopamine agents|mesh-ancestor
93069366|NCT03993431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069367|NCT03993431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069368|NCT03993431|Adrenergic Agents|adrenergic agents|mesh-ancestor
93069369|NCT03993431|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93069370|NCT03993431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93069371|NCT03993431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93069372|NCT03993431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93069373|NCT00401843|Dexamethasone|dexamethasone|mesh-list
93069374|NCT00401843|Bortezomib|bortezomib|mesh-list
93069375|NCT00401843|Siltuximab|siltuximab|mesh-list
93069376|NCT00401843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069377|NCT00401843|Antiemetics|antiemetics|mesh-ancestor
93069378|NCT00401843|Autonomic Agents|autonomic agents|mesh-ancestor
93069379|NCT00401843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069380|NCT00401843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069381|NCT00401843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93069382|NCT00401843|Glucocorticoids|glucocorticoids|mesh-ancestor
93069383|NCT00401843|Hormones|hormones|mesh-ancestor
93069384|NCT00401843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069385|NCT00401843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93069386|NCT00401843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069387|NCT00401531|Vaccines|vaccines|mesh-list
93069388|NCT00401531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93069389|NCT00401531|Immunologic Factors|immunologic factors|mesh-ancestor
93069390|NCT00401531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069391|NCT00401375|Methylnaltrexone|methylnaltrexone|mesh-list
93069392|NCT00401375|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93069393|NCT00401375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069394|NCT00401375|Sensory System Agents|sensory system agents|mesh-ancestor
93069395|NCT00401375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069396|NCT00400517|Thalidomide|thalidomide|mesh-list
93069397|NCT00400517|Sargramostim|sargramostim|mesh-list
93069398|NCT00400517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069399|NCT00400517|Immunologic Factors|immunologic factors|mesh-ancestor
93069400|NCT00400517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069401|NCT00400517|Leprostatic Agents|leprostatic agents|mesh-ancestor
93069402|NCT00400517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069403|NCT00400517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069404|NCT00400517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069405|NCT00400517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069406|NCT00400517|Growth Substances|growth substances|mesh-ancestor
93069407|NCT00400517|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069408|NCT00400517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069409|NCT01044095|Vaccines|vaccines|mesh-list
93069410|NCT01044095|Immunologic Factors|immunologic factors|mesh-ancestor
93069411|NCT01044095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069412|NCT00392171|Temozolomide|temozolomide|mesh-list
93069413|NCT00392171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93069414|NCT00392171|Alkylating Agents|alkylating agents|mesh-ancestor
93069415|NCT00392171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069416|NCT00392171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069417|NCT00091832|Denosumab|denosumab|mesh-list
93069418|NCT00091832|Diphosphonates|diphosphonates|mesh-list
93069419|NCT00091832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93069420|NCT00091832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069421|NCT00391391|Vaccines|vaccines|mesh-list
93069422|NCT00391391|Immunologic Factors|immunologic factors|mesh-ancestor
93069423|NCT00391391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069424|NCT01044251|Frovatriptan|frovatriptan|mesh-list
93069425|NCT01044251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93069426|NCT01044251|Serotonin Agents|serotonin agents|mesh-ancestor
93069427|NCT01044251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069428|NCT01044251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069429|NCT01044251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069430|NCT01044329|Triamcinolone|triamcinolone|mesh-list
93069431|NCT01044329|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
93069432|NCT01044329|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
93069433|NCT01044329|Bevacizumab|bevacizumab|mesh-list
93069434|NCT01044329|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
93069435|NCT01044329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069436|NCT01044329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069437|NCT01044329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069438|NCT01044329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069439|NCT01044329|Growth Substances|growth substances|mesh-ancestor
93069440|NCT01044329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069441|NCT01044329|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069442|NCT01044329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069443|NCT01044329|Glucocorticoids|glucocorticoids|mesh-ancestor
93069444|NCT01044329|Hormones|hormones|mesh-ancestor
93069445|NCT01044329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069446|NCT01044329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069447|NCT01044329|Immunologic Factors|immunologic factors|mesh-ancestor
93069448|NCT01044329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530786|NCT00043576|Calcitriol|calcitriol|mesh-list
93069449|NCT01044329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069451|NCT00091442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93069452|NCT00091442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069453|NCT00091442|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069454|NCT00091442|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069455|NCT00091442|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069456|NCT00091442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069457|NCT00091442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93069458|NCT00390689|Pramipexole|pramipexole|mesh-list
93069459|NCT00390689|Antioxidants|antioxidants|mesh-ancestor
93069460|NCT00390689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069461|NCT00390689|Protective Agents|protective agents|mesh-ancestor
93069462|NCT00390689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069463|NCT00390689|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93069464|NCT00390689|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93069465|NCT00390689|Dopamine Agonists|dopamine agonists|mesh-ancestor
93069466|NCT00390689|Dopamine Agents|dopamine agents|mesh-ancestor
93069467|NCT00390689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069468|NCT01079078|Acetaminophen|acetaminophen|mesh-list
93069469|NCT01079078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93069470|NCT01079078|Analgesics|analgesics|mesh-ancestor
93069471|NCT01079078|Sensory System Agents|sensory system agents|mesh-ancestor
93069472|NCT01079078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069473|NCT01079078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069474|NCT01079078|Antipyretics|antipyretics|mesh-ancestor
93069475|NCT00390455|Fulvestrant|fulvestrant|mesh-list
93069476|NCT00390455|Lapatinib|lapatinib|mesh-list
93069477|NCT00390455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93069478|NCT00390455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069479|NCT00390455|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93069480|NCT00390455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93069481|NCT00390455|Hormone Antagonists|hormone antagonists|mesh-ancestor
93069482|NCT00390455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069483|NCT00390455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069484|NCT00390455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069485|NCT00390455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069486|NCT00390455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069487|NCT03812510|Hydrogen Peroxide|hydrogen peroxide|mesh-list
93069488|NCT03812510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93069489|NCT03812510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069490|NCT01583114|Perindopril|perindopril|mesh-list
93069491|NCT01583114|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93069492|NCT01583114|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069493|NCT01583114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069494|NCT01583114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069495|NCT01583114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93069496|NCT01079312|Fentanyl|fentanyl|mesh-list
93069497|NCT01079312|Remifentanil|remifentanil|mesh-list
93069498|NCT01079312|Propofol|propofol|mesh-list
93069499|NCT01079312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
93069500|NCT01079312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93069501|NCT01079312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069502|NCT01079312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93069503|NCT01079312|Anesthetics, General|anesthetics, general|mesh-ancestor
93069504|NCT01079312|Anesthetics|anesthetics|mesh-ancestor
93069505|NCT01079312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93069506|NCT01079312|Narcotics|narcotics|mesh-ancestor
93069507|NCT01079312|Analgesics|analgesics|mesh-ancestor
93069508|NCT01079312|Sensory System Agents|sensory system agents|mesh-ancestor
92527982|NCT00014196|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069509|NCT01079312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069510|NCT01079312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93069511|NCT01044485|Docetaxel|docetaxel|mesh-list
93069512|NCT01044485|Lapatinib|lapatinib|mesh-list
93069513|NCT01044485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069514|NCT01044485|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069515|NCT01044485|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069516|NCT01044485|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069517|NCT01044485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069518|NCT01044485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069519|NCT01044485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069520|NCT00119678|Prednisone|prednisone|mesh-list
93069521|NCT00119678|Abatacept|abatacept|mesh-list
93069523|NCT00119678|Glucocorticoids|glucocorticoids|mesh-ancestor
93069524|NCT00119678|Hormones|hormones|mesh-ancestor
93069525|NCT00119678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069526|NCT00119678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069527|NCT00119678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93069528|NCT00119678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069529|NCT00119678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93069530|NCT00119678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069531|NCT00119678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069532|NCT00119678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069533|NCT00119678|Immunologic Factors|immunologic factors|mesh-ancestor
93069534|NCT00119678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069535|NCT00110084|Paclitaxel|paclitaxel|mesh-list
93069536|NCT00110084|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93069537|NCT00110084|Gemcitabine|gemcitabine|mesh-list
93069538|NCT00110084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93069539|NCT00110084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069540|NCT00110084|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069541|NCT00110084|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069542|NCT00110084|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069543|NCT00110084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069544|NCT00110084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069545|NCT00110084|Antimetabolites|antimetabolites|mesh-ancestor
93069546|NCT00390221|Daclizumab|daclizumab|mesh-list
93069547|NCT00390221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069548|NCT00390221|Immunologic Factors|immunologic factors|mesh-ancestor
93069549|NCT00390221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069550|NCT00389831|Rotigotine|rotigotine|mesh-list
93069551|NCT00389831|Dopamine Agonists|dopamine agonists|mesh-ancestor
93069552|NCT00389831|Dopamine Agents|dopamine agents|mesh-ancestor
93069553|NCT00389831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069554|NCT00389831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069555|NCT00389831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069556|NCT00389519|Ramipril|ramipril|mesh-list
93069557|NCT00389519|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
93069558|NCT00389519|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069559|NCT00389519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069560|NCT00389519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069561|NCT00389519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93069562|NCT00389441|Axitinib|axitinib|mesh-list
93069563|NCT00389441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069564|NCT00389441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069565|NCT00389441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069566|NCT00389441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069567|NCT00118898|Ritonavir|ritonavir|mesh-list
93069568|NCT00118898|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93069569|NCT00118898|Tenofovir|tenofovir|mesh-list
93069570|NCT00118898|Lamivudine|lamivudine|mesh-list
93069571|NCT00118898|Emtricitabine|emtricitabine|mesh-list
93069572|NCT00118898|Abacavir|abacavir|mesh-list
93069573|NCT00118898|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93069574|NCT00118898|Efavirenz|efavirenz|mesh-list
93069575|NCT00118898|Dideoxynucleosides|dideoxynucleosides|mesh-list
93069576|NCT00118898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93069577|NCT00118898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93069578|NCT00118898|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069579|NCT00118898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069580|NCT00118898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069581|NCT00118898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93069582|NCT00118898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93069583|NCT00118898|Antiviral Agents|antiviral agents|mesh-ancestor
93069584|NCT00118898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069585|NCT00118898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93069586|NCT00118898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93069587|NCT00118898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93069588|NCT00118898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93069589|NCT00118898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93069590|NCT00118898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93069591|NCT00118898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93069592|NCT00118898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93069593|NCT00118898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93069594|NCT00118898|Antimetabolites|antimetabolites|mesh-ancestor
93069596|NCT00118430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93069598|NCT01085552|Hematinics|hematinics|mesh-ancestor
93069599|NCT01085708|Rabeprazole|rabeprazole|mesh-list
93069600|NCT01085708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
93069601|NCT01085708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93069602|NCT01085708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
93069603|NCT01085708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069604|NCT01085708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069605|NCT00090584|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93069606|NCT00090584|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93069607|NCT00090584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93069608|NCT00090584|Cholinergic Agents|cholinergic agents|mesh-ancestor
93069609|NCT00090584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069610|NCT00090584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069611|NCT00090584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069612|NCT00090584|Urological Agents|urological agents|mesh-ancestor
93069613|NCT01079624|Glucagon|glucagon|mesh-list
93069614|NCT01079624|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
93069615|NCT01079624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93069616|NCT01079624|Hormones|hormones|mesh-ancestor
93069617|NCT01079624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069618|NCT01079624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069619|NCT01079624|Incretins|incretins|mesh-ancestor
93069620|NCT01086020|Atorvastatin|atorvastatin|mesh-list
93069621|NCT01086020|Ezetimibe|ezetimibe|mesh-list
93069622|NCT01086020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
93069623|NCT01086020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93069624|NCT01086020|Antimetabolites|antimetabolites|mesh-ancestor
93069625|NCT01086020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069626|NCT01086020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93069627|NCT01086020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
93069628|NCT01086020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069629|NCT03670810|Lasmiditan|lasmiditan|mesh-list
93069630|NCT03670810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93069631|NCT03670810|Serotonin Agents|serotonin agents|mesh-ancestor
93069632|NCT03670810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069633|NCT03670810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069634|NCT03670810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069635|NCT01086254|Gemcitabine|gemcitabine|mesh-list
93069636|NCT01086254|Iniparib|iniparib|mesh-list
93069637|NCT01086254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069638|NCT01086254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069639|NCT01086254|Antimetabolites|antimetabolites|mesh-ancestor
93069640|NCT01086254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069641|NCT01086254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93069642|NCT01086254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069643|NCT01086332|Nelfinavir|nelfinavir|mesh-list
93069644|NCT01086332|Gemcitabine|gemcitabine|mesh-list
93069645|NCT01086332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069646|NCT01086332|Antimetabolites|antimetabolites|mesh-ancestor
93069647|NCT01086332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069648|NCT01086332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069649|NCT01086332|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93069650|NCT01086332|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93069651|NCT01086332|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069652|NCT01086332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069653|NCT01086332|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93069654|NCT01086332|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93069655|NCT01086332|Antiviral Agents|antiviral agents|mesh-ancestor
93069656|NCT01086332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069657|NCT01811368|Cyclosporine|cyclosporine|mesh-list
92726641|NCT04564326|Fentanyl|fentanyl|mesh-list
93069658|NCT01811368|Mycophenolic Acid|mycophenolic acid|mesh-list
93069659|NCT01811368|Rituximab|rituximab|mesh-list
93069660|NCT01811368|Cyclosporins|cyclosporins|mesh-list
93069661|NCT01811368|Thymoglobulin|thymoglobulin|mesh-list
93069662|NCT01811368|Antilymphocyte Serum|antilymphocyte serum|mesh-list
93069663|NCT01811368|Immunoglobulins|immunoglobulins|mesh-list
93069664|NCT01811368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069665|NCT01811368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069666|NCT01811368|Immunologic Factors|immunologic factors|mesh-ancestor
93069667|NCT01811368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069668|NCT01811368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069669|NCT01811368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069670|NCT01811368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069671|NCT01811368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069672|NCT01811368|Antifungal Agents|antifungal agents|mesh-ancestor
93069673|NCT01811368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069674|NCT01811368|Dermatologic Agents|dermatologic agents|mesh-ancestor
93069675|NCT01811368|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93069676|NCT01811368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93069677|NCT01811368|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93069678|NCT01811368|Antitubercular Agents|antitubercular agents|mesh-ancestor
93069679|NCT01811368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069681|NCT00089648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069682|NCT00089648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069683|NCT00089648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069684|NCT00089648|Growth Substances|growth substances|mesh-ancestor
93069685|NCT00089648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069686|NCT00089648|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069687|NCT00089648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069688|NCT00089648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069689|NCT00089648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069690|NCT01079702|Capecitabine|capecitabine|mesh-list
93069691|NCT01079702|Everolimus|everolimus|mesh-list
93069692|NCT01079702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069693|NCT01079702|Antimetabolites|antimetabolites|mesh-ancestor
93069694|NCT01079702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069695|NCT01079702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069696|NCT01079702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93069697|NCT01079702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069698|NCT01079702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069699|NCT01079702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069700|NCT01079702|Immunologic Factors|immunologic factors|mesh-ancestor
93069701|NCT01079702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069702|NCT00118040|Genistein|genistein|mesh-list
93069703|NCT00118040|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93069704|NCT00118040|Protective Agents|protective agents|mesh-ancestor
93069705|NCT00118040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069706|NCT00118040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069707|NCT00118040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069708|NCT00118040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340885|NCT00002789|Abortifacient Agents|abortifacient agents|mesh-ancestor
93069709|NCT00118040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069710|NCT00118040|Phytoestrogens|phytoestrogens|mesh-ancestor
93069711|NCT00118040|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93069712|NCT00118040|Estrogens|estrogens|mesh-ancestor
93069713|NCT00118040|Hormones|hormones|mesh-ancestor
93069714|NCT00118040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069715|NCT03961958|Propofol|propofol|mesh-list
93069716|NCT03961958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93069717|NCT03961958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93069718|NCT03961958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069719|NCT03961958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93069720|NCT03961958|Anesthetics, General|anesthetics, general|mesh-ancestor
93069721|NCT03961958|Anesthetics|anesthetics|mesh-ancestor
93069722|NCT00389207|Atazanavir Sulfate|atazanavir sulfate|mesh-list
93069723|NCT00389207|Nevirapine|nevirapine|mesh-list
93069724|NCT00389207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93069725|NCT00389207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93069726|NCT00389207|Protease Inhibitors|protease inhibitors|mesh-ancestor
93069727|NCT00389207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069728|NCT00389207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069729|NCT00389207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93069730|NCT00389207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93069731|NCT00389207|Antiviral Agents|antiviral agents|mesh-ancestor
93069732|NCT00389207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069733|NCT00389207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93069734|NCT00389207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93069735|NCT00389207|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93069736|NCT00389207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93069737|NCT00388973|Quetiapine Fumarate|quetiapine fumarate|mesh-list
93069738|NCT00388973|Antidepressive Agents|antidepressive agents|mesh-ancestor
93069739|NCT00388973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93069740|NCT00388973|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93069741|NCT00388973|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93069742|NCT00388973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93069743|NCT00388973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069744|NCT00085202|Cyclophosphamide|cyclophosphamide|mesh-list
93069745|NCT00085202|Vincristine|vincristine|mesh-list
93069746|NCT00085202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069747|NCT00085202|Immunologic Factors|immunologic factors|mesh-ancestor
93069748|NCT00085202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069749|NCT00085202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069750|NCT00085202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93069751|NCT00085202|Alkylating Agents|alkylating agents|mesh-ancestor
93069752|NCT00085202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069753|NCT00085202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069754|NCT00085202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93069755|NCT00085202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93069756|NCT00085202|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069757|NCT00085202|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069758|NCT00085202|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069759|NCT00388583|Vaccines|vaccines|mesh-list
93069760|NCT00388583|Immunologic Factors|immunologic factors|mesh-ancestor
93069761|NCT00388583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069762|NCT00117572|Docetaxel|docetaxel|mesh-list
93069763|NCT00117572|Fluorouracil|fluorouracil|mesh-list
93069764|NCT00117572|Hydroxyurea|hydroxyurea|mesh-list
93069765|NCT00117572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069766|NCT00117572|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069767|NCT00117572|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069768|NCT00117572|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069769|NCT00117572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069770|NCT00117572|Antimetabolites|antimetabolites|mesh-ancestor
93069771|NCT00117572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069772|NCT00117572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069773|NCT00117572|Immunologic Factors|immunologic factors|mesh-ancestor
93069774|NCT00117572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069775|NCT00117572|Antisickling Agents|antisickling agents|mesh-ancestor
93069776|NCT00117572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069777|NCT00117572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93069778|NCT00388505|Tobramycin|tobramycin|mesh-list
93069779|NCT00388505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069780|NCT00388505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069781|NCT00388349|Cyclophosphamide|cyclophosphamide|mesh-list
93069782|NCT00388349|Carmustine|carmustine|mesh-list
93069783|NCT00388349|Gemcitabine|gemcitabine|mesh-list
93069784|NCT00388349|Etoposide|etoposide|mesh-list
93069785|NCT00388349|Vinorelbine|vinorelbine|mesh-list
93069786|NCT00388349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069787|NCT00388349|Immunologic Factors|immunologic factors|mesh-ancestor
93069788|NCT00388349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069789|NCT00388349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069790|NCT00388349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93069791|NCT00388349|Alkylating Agents|alkylating agents|mesh-ancestor
93069792|NCT00388349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069793|NCT00388349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069794|NCT00388349|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93069795|NCT00388349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069796|NCT00388349|Antimetabolites|antimetabolites|mesh-ancestor
93069797|NCT00388349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93069798|NCT00388349|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93069799|NCT00388349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93069800|NCT00388349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069801|NCT00388349|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069802|NCT00388349|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069803|NCT00388349|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069804|NCT00117338|Montelukast|montelukast|mesh-list
93069805|NCT00117338|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93069806|NCT00117338|Respiratory System Agents|respiratory system agents|mesh-ancestor
93069807|NCT00117338|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
93069808|NCT00117338|Hormone Antagonists|hormone antagonists|mesh-ancestor
93069809|NCT00117338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069810|NCT00117338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069811|NCT00117338|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
93069812|NCT00117338|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93069813|NCT00117338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069814|NCT00388037|Sunitinib|sunitinib|mesh-list
93069815|NCT00388037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069816|NCT00388037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069817|NCT00388037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069818|NCT00388037|Growth Substances|growth substances|mesh-ancestor
93069819|NCT00388037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069820|NCT00388037|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069821|NCT00388037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069822|NCT00388037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069823|NCT00388037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069824|NCT00387881|Naproxen|naproxen|mesh-list
93069825|NCT00387881|Sumatriptan|sumatriptan|mesh-list
93069826|NCT00387881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93069827|NCT00387881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93069828|NCT00387881|Analgesics|analgesics|mesh-ancestor
93069829|NCT00387881|Sensory System Agents|sensory system agents|mesh-ancestor
93069830|NCT00387881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069831|NCT00387881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069832|NCT00387881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069833|NCT00387881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069834|NCT00387881|Gout Suppressants|gout suppressants|mesh-ancestor
93069835|NCT00387881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93069836|NCT00387881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069837|NCT00387881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069838|NCT00387881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93069839|NCT00387881|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93069840|NCT00387881|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93069841|NCT00387881|Serotonin Agents|serotonin agents|mesh-ancestor
93069842|NCT00387881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069843|NCT00084656|Ipilimumab|ipilimumab|mesh-list
93069844|NCT00084656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069845|NCT00084656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069846|NCT00084656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93069847|NCT00084656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069848|NCT00387647|Azacitidine|azacitidine|mesh-list
93069849|NCT00387647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069850|NCT00387647|Antimetabolites|antimetabolites|mesh-ancestor
93069851|NCT00387647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069852|NCT00387647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069853|NCT00387647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069854|NCT00386009|Tadalafil|tadalafil|mesh-list
93069855|NCT00386009|Vasodilator Agents|vasodilator agents|mesh-ancestor
93069856|NCT00386009|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93069857|NCT00386009|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93069858|NCT00386009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069859|NCT00386009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069860|NCT00386009|Urological Agents|urological agents|mesh-ancestor
93069861|NCT01045889|Prednisone|prednisone|mesh-list
93069862|NCT01045889|Cyclophosphamide|cyclophosphamide|mesh-list
93069863|NCT01045889|Melphalan|melphalan|mesh-list
93069864|NCT01045889|Rituximab|rituximab|mesh-list
93069865|NCT01045889|Etoposide|etoposide|mesh-list
93069866|NCT01045889|Vincristine|vincristine|mesh-list
93069867|NCT01045889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069868|NCT01045889|Immunologic Factors|immunologic factors|mesh-ancestor
93069869|NCT01045889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069870|NCT01045889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069871|NCT01045889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93069872|NCT01045889|Alkylating Agents|alkylating agents|mesh-ancestor
93069873|NCT01045889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069874|NCT01045889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069875|NCT01045889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93069876|NCT01045889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069877|NCT01045889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069878|NCT01045889|Glucocorticoids|glucocorticoids|mesh-ancestor
93069880|NCT01045889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069881|NCT01045889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93069882|NCT01045889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93069883|NCT01045889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93069884|NCT01045889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93069885|NCT01045889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069886|NCT01045889|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069887|NCT01045889|Antimitotic Agents|antimitotic agents|mesh-ancestor
93069888|NCT01045889|Mitosis Modulators|mitosis modulators|mesh-ancestor
93069889|NCT00373685|Celecoxib|celecoxib|mesh-list
93069890|NCT00373685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93069891|NCT00373685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93069892|NCT00373685|Analgesics|analgesics|mesh-ancestor
93069893|NCT00373685|Sensory System Agents|sensory system agents|mesh-ancestor
93069894|NCT00373685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069895|NCT00373685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069896|NCT00373685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93069897|NCT00373685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069898|NCT00373685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93069899|NCT00373685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93069900|NCT00373685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069901|NCT00373685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069902|NCT00373529|Clofarabine|clofarabine|mesh-list
93069903|NCT00373529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069904|NCT00373529|Antimetabolites|antimetabolites|mesh-ancestor
93069905|NCT00373529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069906|NCT00373529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069907|NCT00373295|Baclofen|baclofen|mesh-list
93069908|NCT00373295|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93069909|NCT00373295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069910|NCT00373295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93069911|NCT00373295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069912|NCT00373295|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
93069913|NCT00373295|GABA Agonists|gaba agonists|mesh-ancestor
93069914|NCT00373295|GABA Agents|gaba agents|mesh-ancestor
93069915|NCT00373295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93069916|NCT00373295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069917|NCT00385541|Morphine|morphine|mesh-list
93069918|NCT00385541|Hydromorphone|hydromorphone|mesh-list
93069919|NCT00385541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93069920|NCT00385541|Narcotics|narcotics|mesh-ancestor
93069921|NCT00385541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93069922|NCT00385541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069923|NCT00385541|Analgesics|analgesics|mesh-ancestor
93069924|NCT00385541|Sensory System Agents|sensory system agents|mesh-ancestor
93069925|NCT00385541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93069926|NCT01046045|Everolimus|everolimus|mesh-list
93069927|NCT01046045|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93069928|NCT01046045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93069929|NCT01046045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069930|NCT01046045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069931|NCT01046045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93069932|NCT01046045|Immunologic Factors|immunologic factors|mesh-ancestor
93069933|NCT01046045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069934|NCT01046045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069935|NCT01044719|Meropenem|meropenem|mesh-list
93069936|NCT01044719|Tobramycin|tobramycin|mesh-list
93069937|NCT01044719|Ceftazidime|ceftazidime|mesh-list
93069938|NCT01044719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93069939|NCT01044719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93069940|NCT01045109|Vitamin D|vitamin d|mesh-list
93069941|NCT01045109|Ergocalciferols|ergocalciferols|mesh-list
93069942|NCT01045109|Cholecalciferol|cholecalciferol|mesh-list
93069943|NCT01045109|Vitamins|vitamins|mesh-list
93069944|NCT01045109|Micronutrients|micronutrients|mesh-ancestor
93069945|NCT01045109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069946|NCT01045109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93069947|NCT01045109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93069948|NCT00094302|Spironolactone|spironolactone|mesh-list
93069949|NCT00094302|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
93069950|NCT00094302|Hormone Antagonists|hormone antagonists|mesh-ancestor
93069951|NCT00094302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93069952|NCT00094302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069953|NCT00094302|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
93069954|NCT00094302|Diuretics|diuretics|mesh-ancestor
93069955|NCT00094302|Natriuretic Agents|natriuretic agents|mesh-ancestor
93069957|NCT00372905|Bortezomib|bortezomib|mesh-list
93069958|NCT00372905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93069959|NCT00372905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069960|NCT00372905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069961|NCT00372905|Immunologic Factors|immunologic factors|mesh-ancestor
93069962|NCT00372905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069963|NCT00372905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93069964|NCT00384839|Azacitidine|azacitidine|mesh-list
93069965|NCT00384839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93069966|NCT00384839|Antimetabolites|antimetabolites|mesh-ancestor
93069967|NCT00384839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069968|NCT00384839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069969|NCT00384839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93069970|NCT01046279|Bevacizumab|bevacizumab|mesh-list
93069971|NCT01046279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93069972|NCT01046279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069973|NCT01046279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93069974|NCT01046279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93069975|NCT01046279|Growth Substances|growth substances|mesh-ancestor
93069976|NCT01046279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069977|NCT01046279|Growth Inhibitors|growth inhibitors|mesh-ancestor
93069979|NCT00384293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93069980|NCT00384293|Antimetabolites|antimetabolites|mesh-ancestor
93069981|NCT00384293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93069982|NCT00384293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93069983|NCT00384293|Vasodilator Agents|vasodilator agents|mesh-ancestor
93069984|NCT00384293|Vitamin B Complex|vitamin b complex|mesh-ancestor
93069985|NCT00384293|Vitamins|vitamins|mesh-ancestor
93069986|NCT00384293|Micronutrients|micronutrients|mesh-ancestor
93069987|NCT00384293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069988|NCT01087866|Metformin|metformin|mesh-list
93069989|NCT01087866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93069990|NCT01087866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93069991|NCT01090830|Paclitaxel|paclitaxel|mesh-list
93069992|NCT01090830|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93069993|NCT01090830|Bevacizumab|bevacizumab|mesh-list
93069994|NCT01090830|Carboplatin|carboplatin|mesh-list
93069995|NCT01090830|Belinostat|belinostat|mesh-list
93069996|NCT01090830|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93069997|NCT01090830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93069998|NCT01090830|Tubulin Modulators|tubulin modulators|mesh-ancestor
93069999|NCT01090830|Antimitotic Agents|antimitotic agents|mesh-ancestor
93070000|NCT01090830|Mitosis Modulators|mitosis modulators|mesh-ancestor
93070001|NCT01090830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070002|NCT01090830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93070003|NCT01090830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93070004|NCT01090830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93070005|NCT01090830|Growth Substances|growth substances|mesh-ancestor
93070006|NCT01090830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070007|NCT01090830|Growth Inhibitors|growth inhibitors|mesh-ancestor
93070008|NCT01090830|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93070009|NCT01090830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070010|NCT01084824|Cantharidin|cantharidin|mesh-list
93070011|NCT01084824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070012|NCT01084824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070013|NCT01088022|Dexamethasone|dexamethasone|mesh-list
93070014|NCT01088022|Dexamethasone acetate|dexamethasone acetate|mesh-list
93070015|NCT01088022|Aprepitant|aprepitant|mesh-list
93070016|NCT01088022|Palonosetron|palonosetron|mesh-list
93070017|NCT01088022|BB 1101|bb 1101|mesh-list
93070018|NCT01088022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070019|NCT01088022|Antiemetics|antiemetics|mesh-ancestor
93070020|NCT01088022|Autonomic Agents|autonomic agents|mesh-ancestor
93070021|NCT01088022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070022|NCT01088022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070023|NCT01088022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93070024|NCT01088022|Glucocorticoids|glucocorticoids|mesh-ancestor
93070025|NCT01088022|Hormones|hormones|mesh-ancestor
93070026|NCT01088022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070027|NCT01088022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070028|NCT01088022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070029|NCT01088022|Protease Inhibitors|protease inhibitors|mesh-ancestor
93070030|NCT01088022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070031|NCT01088022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070032|NCT01088022|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92726988|NCT02211222|Lenvatinib|lenvatinib|mesh-list
93070033|NCT01088022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070034|NCT01088022|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
93070035|NCT01088022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93070036|NCT01088022|Serotonin Agents|serotonin agents|mesh-ancestor
93070037|NCT00067002|Cyclophosphamide|cyclophosphamide|mesh-list
93070039|NCT00067002|Thiotepa|thiotepa|mesh-list
93070040|NCT00067002|Rituximab|rituximab|mesh-list
93070041|NCT00067002|Fludarabine|fludarabine|mesh-list
93070042|NCT00067002|Fludarabine phosphate|fludarabine phosphate|mesh-list
93070043|NCT00067002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070044|NCT00067002|Immunologic Factors|immunologic factors|mesh-ancestor
93070045|NCT00067002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070046|NCT00067002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070047|NCT00067002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93070048|NCT00067002|Alkylating Agents|alkylating agents|mesh-ancestor
93070049|NCT00067002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070050|NCT00067002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070051|NCT00067002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93070052|NCT00067002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93070053|NCT00067002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070054|NCT00067002|Antimetabolites|antimetabolites|mesh-ancestor
93070055|NCT03961698|Paclitaxel|paclitaxel|mesh-list
93070056|NCT03961698|Bevacizumab|bevacizumab|mesh-list
93070057|NCT03961698|Atezolizumab|atezolizumab|mesh-list
93070058|NCT03961698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93070059|NCT03961698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070060|NCT03961698|Tubulin Modulators|tubulin modulators|mesh-ancestor
93070061|NCT03961698|Antimitotic Agents|antimitotic agents|mesh-ancestor
93070062|NCT03961698|Mitosis Modulators|mitosis modulators|mesh-ancestor
93070063|NCT03961698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070064|NCT03961698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93070065|NCT03961698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93070066|NCT03961698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93070067|NCT03961698|Growth Substances|growth substances|mesh-ancestor
93070068|NCT03961698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070069|NCT03961698|Growth Inhibitors|growth inhibitors|mesh-ancestor
93070070|NCT03961698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93070071|NCT01090908|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93070072|NCT01090908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070073|NCT01084902|Latanoprost|latanoprost|mesh-list
93070074|NCT01084902|Brinzolamide|brinzolamide|mesh-list
93070075|NCT01084902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
93070076|NCT01084902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93070077|NCT01084902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93070078|NCT01084902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070079|NCT01084902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070080|NCT01084980|Tacrolimus|tacrolimus|mesh-list
93070081|NCT01084980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070082|NCT01084980|Immunologic Factors|immunologic factors|mesh-ancestor
93070083|NCT01084980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070084|NCT01084980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93070085|NCT01084980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070086|NCT01084980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070087|NCT01085058|Lenograstim|lenograstim|mesh-list
93070088|NCT01085058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93070089|NCT01085058|Immunologic Factors|immunologic factors|mesh-ancestor
93070090|NCT01085058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070091|NCT01088178|Levonorgestrel|levonorgestrel|mesh-list
93070092|NCT01088178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93070093|NCT01088178|Contraceptive Agents|contraceptive agents|mesh-ancestor
93070094|NCT01088178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93070095|NCT01088178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070096|NCT01088178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93070097|NCT01088178|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93070098|NCT01088178|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93070099|NCT01088256|Etoricoxib|etoricoxib|mesh-list
93070100|NCT01088256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93070101|NCT01088256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93070102|NCT01088256|Analgesics|analgesics|mesh-ancestor
93070103|NCT01088256|Sensory System Agents|sensory system agents|mesh-ancestor
93070104|NCT01088256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070105|NCT01088256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070106|NCT01088256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070107|NCT01088256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070108|NCT01088256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93070109|NCT01088256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93070110|NCT01088256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070111|NCT01088256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070112|NCT01326858|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
93070113|NCT01326858|Ketotifen|ketotifen|mesh-list
93070114|NCT01326858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
93070115|NCT01326858|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93070116|NCT01326858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93070117|NCT01326858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93070118|NCT01326858|Analgesics|analgesics|mesh-ancestor
93070119|NCT01326858|Sensory System Agents|sensory system agents|mesh-ancestor
93070120|NCT01326858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070121|NCT01326858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070122|NCT01326858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070123|NCT01326858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070124|NCT01326858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93070125|NCT01326858|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93070126|NCT01326858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93070127|NCT01326858|Histamine Antagonists|histamine antagonists|mesh-ancestor
93070128|NCT01326858|Histamine Agents|histamine agents|mesh-ancestor
93070129|NCT01326858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070130|NCT01326858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070131|NCT01326858|Antipruritics|antipruritics|mesh-ancestor
93070132|NCT01326858|Dermatologic Agents|dermatologic agents|mesh-ancestor
93070133|NCT00091572|Temozolomide|temozolomide|mesh-list
93070134|NCT00091572|Dacarbazine|dacarbazine|mesh-list
93070135|NCT00091572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93070136|NCT00091572|Alkylating Agents|alkylating agents|mesh-ancestor
93070137|NCT00091572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070138|NCT00091572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070139|NCT01091220|Certolizumab Pegol|certolizumab pegol|mesh-list
93070140|NCT01091220|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93070141|NCT01091220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070142|NCT01091220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070143|NCT01091220|Immunologic Factors|immunologic factors|mesh-ancestor
93070144|NCT01091220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070145|NCT01091220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070146|NCT00084266|Vancomycin|vancomycin|mesh-list
93070147|NCT00084266|Linezolid|linezolid|mesh-list
93070148|NCT00084266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070149|NCT00084266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070150|NCT00084266|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93070151|NCT00084266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070152|NCT00084266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070153|NCT01086878|Trimethoprim|trimethoprim|mesh-list
93070154|NCT01086878|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
93070155|NCT01086878|Sulfamethoxazole|sulfamethoxazole|mesh-list
93070156|NCT01086878|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93070157|NCT01086878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070158|NCT01086878|Antimalarials|antimalarials|mesh-ancestor
93070159|NCT01086878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93070160|NCT01086878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93070161|NCT01086878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070162|NCT01086878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070163|NCT01086878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070164|NCT01086878|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93070165|NCT01086878|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
93070166|NCT01086878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93070167|NCT01086878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070168|NCT01086956|Sufentanil|sufentanil|mesh-list
93070169|NCT01086956|Ropivacaine|ropivacaine|mesh-list
93070170|NCT01086956|Anesthetics, Local|anesthetics, local|mesh-ancestor
93070171|NCT01086956|Anesthetics|anesthetics|mesh-ancestor
93070172|NCT01086956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93070173|NCT01086956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070174|NCT01086956|Sensory System Agents|sensory system agents|mesh-ancestor
93070175|NCT01086956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070176|NCT01086956|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93070178|NCT01086956|Analgesics|analgesics|mesh-ancestor
93070179|NCT01086956|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93070180|NCT01086956|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93070181|NCT01086956|Anesthetics, General|anesthetics, general|mesh-ancestor
93070182|NCT00091026|Bevacizumab|bevacizumab|mesh-list
93070183|NCT00091026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93070185|NCT00091026|Gemcitabine|gemcitabine|mesh-list
93070186|NCT00091026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93070187|NCT00091026|Antibodies|antibodies|mesh-list
93070188|NCT00091026|Immunoglobulins|immunoglobulins|mesh-list
93070189|NCT00091026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93070190|NCT00091026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070191|NCT00091026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93070192|NCT00091026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93070193|NCT00091026|Growth Substances|growth substances|mesh-ancestor
93070194|NCT00091026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070195|NCT00091026|Growth Inhibitors|growth inhibitors|mesh-ancestor
93070196|NCT00091026|Immunologic Factors|immunologic factors|mesh-ancestor
93070197|NCT00091026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070198|NCT00091026|Antimetabolites|antimetabolites|mesh-ancestor
93070199|NCT00091026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070200|NCT00091026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070201|NCT00091026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070202|NCT01091376|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
93070203|NCT01091376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070204|NCT01091376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070205|NCT01091376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070206|NCT01091376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070207|NCT00115778|Immunoglobulins|immunoglobulins|mesh-list
93070208|NCT00115778|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93070209|NCT00115778|gamma-Globulins|gamma-globulins|mesh-list
93070210|NCT00115778|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93070211|NCT00115778|Immunologic Factors|immunologic factors|mesh-ancestor
93070212|NCT00115778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070213|NCT00100178|Mycophenolic Acid|mycophenolic acid|mesh-list
93070214|NCT00100178|Daclizumab|daclizumab|mesh-list
93070215|NCT00100178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070216|NCT00100178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070217|NCT00100178|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93070218|NCT00100178|Antitubercular Agents|antitubercular agents|mesh-ancestor
93070219|NCT00100178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070220|NCT00100178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070221|NCT00100178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070222|NCT00100178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070223|NCT00100178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070224|NCT00100178|Immunologic Factors|immunologic factors|mesh-ancestor
93070225|NCT00100178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070226|NCT00099632|Ritonavir|ritonavir|mesh-list
93070227|NCT00099632|Lopinavir|lopinavir|mesh-list
93070228|NCT00099632|Tenofovir|tenofovir|mesh-list
93070229|NCT00099632|Lamivudine|lamivudine|mesh-list
93070230|NCT00099632|Emtricitabine|emtricitabine|mesh-list
93070231|NCT00099632|Zidovudine|zidovudine|mesh-list
93070232|NCT00099632|Nevirapine|nevirapine|mesh-list
93070233|NCT00099632|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93070234|NCT00099632|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93070235|NCT00099632|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93070236|NCT00099632|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93070237|NCT00099632|Protease Inhibitors|protease inhibitors|mesh-ancestor
93070238|NCT00099632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070239|NCT00099632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070240|NCT00099632|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93070241|NCT00099632|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93070242|NCT00099632|Antiviral Agents|antiviral agents|mesh-ancestor
93070243|NCT00099632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070244|NCT00099632|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93070245|NCT00099632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93070246|NCT00099632|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93070247|NCT00099632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070248|NCT00099632|Antimetabolites|antimetabolites|mesh-ancestor
93070249|NCT00099632|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93070250|NCT00099632|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93070252|NCT01087190|Antitubercular Agents|antitubercular agents|mesh-ancestor
93070253|NCT01087190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070254|NCT01087190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070255|NCT01087190|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
93070256|NCT01087190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93070257|NCT01087190|Antimetabolites|antimetabolites|mesh-ancestor
93070258|NCT01087190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070259|NCT01087190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93070260|NCT01090466|Sirolimus|sirolimus|mesh-list
93070261|NCT01090466|Gemcitabine|gemcitabine|mesh-list
93070262|NCT01090466|Temsirolimus|temsirolimus|mesh-list
93070263|NCT01090466|MTOR Inhibitors|mtor inhibitors|mesh-list
93070264|NCT01090466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070265|NCT01090466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070266|NCT01090466|Antimetabolites|antimetabolites|mesh-ancestor
93070267|NCT01090466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070268|NCT01090466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070269|NCT01090466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070270|NCT01090466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070271|NCT01090466|Immunologic Factors|immunologic factors|mesh-ancestor
93070272|NCT01090466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070273|NCT01090466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070274|NCT01090466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070275|NCT01090466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070276|NCT01090466|Antifungal Agents|antifungal agents|mesh-ancestor
93070277|NCT04116398|Dexamethasone|dexamethasone|mesh-list
93070278|NCT04116398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070279|NCT04116398|Antiemetics|antiemetics|mesh-ancestor
93070280|NCT04116398|Autonomic Agents|autonomic agents|mesh-ancestor
93070281|NCT04116398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070282|NCT04116398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070283|NCT04116398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93070284|NCT04116398|Glucocorticoids|glucocorticoids|mesh-ancestor
93070285|NCT04116398|Hormones|hormones|mesh-ancestor
92340916|NCT00382343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070286|NCT04116398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070287|NCT04116398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070288|NCT04116398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070289|NCT00098774|Leucovorin|leucovorin|mesh-list
93070290|NCT00098774|Cytarabine|cytarabine|mesh-list
93070291|NCT00098774|Rituximab|rituximab|mesh-list
93070292|NCT00098774|Methotrexate|methotrexate|mesh-list
93070293|NCT00098774|Etoposide|etoposide|mesh-list
93070294|NCT00098774|Temozolomide|temozolomide|mesh-list
93070295|NCT00098774|Calcium|calcium|mesh-list
93070296|NCT00098774|Levoleucovorin|levoleucovorin|mesh-list
93070297|NCT00098774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93070298|NCT00098774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070299|NCT00098774|Immunologic Factors|immunologic factors|mesh-ancestor
93070300|NCT00098774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070301|NCT00098774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070302|NCT00098774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93070303|NCT00098774|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93070304|NCT00098774|Abortifacient Agents|abortifacient agents|mesh-ancestor
93070305|NCT00098774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93070306|NCT00098774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070307|NCT00098774|Antimetabolites|antimetabolites|mesh-ancestor
93070308|NCT00098774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070309|NCT00098774|Dermatologic Agents|dermatologic agents|mesh-ancestor
93070310|NCT00098774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070311|NCT00098774|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070312|NCT00098774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070313|NCT00098774|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070314|NCT00098774|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93070315|NCT00098774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93070316|NCT00098774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070317|NCT00098774|Antiviral Agents|antiviral agents|mesh-ancestor
93070318|NCT00098774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070319|NCT00098774|Antidotes|antidotes|mesh-ancestor
93070320|NCT00098774|Protective Agents|protective agents|mesh-ancestor
93070321|NCT00098774|Vitamin B Complex|vitamin b complex|mesh-ancestor
93070322|NCT00098774|Vitamins|vitamins|mesh-ancestor
93070323|NCT00098774|Micronutrients|micronutrients|mesh-ancestor
92530808|NCT00043654|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93070324|NCT00098774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93070325|NCT00098774|Alkylating Agents|alkylating agents|mesh-ancestor
93070326|NCT01081652|Progesterone|progesterone|mesh-list
93070327|NCT01081652|Progestins|progestins|mesh-ancestor
93070328|NCT01081652|Hormones|hormones|mesh-ancestor
93070329|NCT01081652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070330|NCT01081652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070331|NCT01087580|Prednisone|prednisone|mesh-list
93070332|NCT01087580|Docetaxel|docetaxel|mesh-list
93070333|NCT01087580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070334|NCT01087580|Tubulin Modulators|tubulin modulators|mesh-ancestor
93070336|NCT01087580|Mitosis Modulators|mitosis modulators|mesh-ancestor
93070337|NCT01087580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070338|NCT01087580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070339|NCT01087580|Glucocorticoids|glucocorticoids|mesh-ancestor
93070340|NCT01087580|Hormones|hormones|mesh-ancestor
93070341|NCT01087580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070342|NCT01087580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070343|NCT01087580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070344|NCT01087658|Calcium|calcium|mesh-list
93070345|NCT01087658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93070346|NCT01087658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070347|NCT03958058|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93070348|NCT03958058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
93070349|NCT03958058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070350|NCT03958058|Antitubercular Agents|antitubercular agents|mesh-ancestor
93070351|NCT01081730|Ustekinumab|ustekinumab|mesh-list
93070352|NCT01081730|Dermatologic Agents|dermatologic agents|mesh-ancestor
93070353|NCT01090700|Simeprevir|simeprevir|mesh-list
93070354|NCT01090700|Dexetimide|dexetimide|mesh-list
93070355|NCT01090700|Citalopram|citalopram|mesh-list
93070356|NCT01090700|Escitalopram|escitalopram|mesh-list
93070357|NCT01090700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93070358|NCT01090700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93070359|NCT01090700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93070360|NCT01090700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070361|NCT01090700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070362|NCT01090700|Serotonin Agents|serotonin agents|mesh-ancestor
93070363|NCT01090700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070364|NCT01090700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93070365|NCT01090700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93070366|NCT01090700|Parasympatholytics|parasympatholytics|mesh-ancestor
93070367|NCT01090700|Autonomic Agents|autonomic agents|mesh-ancestor
93070368|NCT01090700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070369|NCT01090700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93070370|NCT01090700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93070371|NCT01090700|Cholinergic Agents|cholinergic agents|mesh-ancestor
93070372|NCT01090700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93070373|NCT01090700|Antidepressive Agents|antidepressive agents|mesh-ancestor
93070374|NCT01090700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93070375|NCT01090700|Antiviral Agents|antiviral agents|mesh-ancestor
93070376|NCT01090700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070377|NCT01090700|Protease Inhibitors|protease inhibitors|mesh-ancestor
93070378|NCT01090700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070379|NCT03957902|Aspirin|aspirin|mesh-list
93070380|NCT03957902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93070381|NCT03957902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93070382|NCT03957902|Analgesics|analgesics|mesh-ancestor
93070383|NCT03957902|Sensory System Agents|sensory system agents|mesh-ancestor
93070384|NCT03957902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070385|NCT03957902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070386|NCT03957902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070387|NCT03957902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070388|NCT03957902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93070389|NCT03957902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93070390|NCT03957902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070391|NCT03957902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93070392|NCT03957902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93070393|NCT03957902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070394|NCT03957902|Antipyretics|antipyretics|mesh-ancestor
93070395|NCT00384059|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93070396|NCT00384059|Immunologic Factors|immunologic factors|mesh-ancestor
93070397|NCT00384059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070398|NCT01046435|Amoxicillin|amoxicillin|mesh-list
93070399|NCT01046435|Metronidazole|metronidazole|mesh-list
93070400|NCT01046435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070401|NCT01046435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070402|NCT01046435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93070403|NCT01046435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93070404|NCT00858364|Darbepoetin alfa|darbepoetin alfa|mesh-list
93070405|NCT00858364|Hematinics|hematinics|mesh-ancestor
93070406|NCT00382733|Topotecan|topotecan|mesh-list
93070407|NCT00382733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93070408|NCT00382733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070409|NCT00382733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070410|NCT00382733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070411|NCT00382733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070412|NCT03992885|Pemetrexed|pemetrexed|mesh-list
93070413|NCT03992885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070414|NCT03992885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070415|NCT03992885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070416|NCT03992885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070417|NCT03992885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070418|NCT03739294|Fluticasone|fluticasone|mesh-list
93070419|NCT03739294|Xhance|xhance|mesh-list
93070420|NCT03739294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070421|NCT03739294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93070422|NCT03739294|Autonomic Agents|autonomic agents|mesh-ancestor
93070423|NCT03739294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070424|NCT03739294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070425|NCT03739294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93070426|NCT03739294|Respiratory System Agents|respiratory system agents|mesh-ancestor
93070427|NCT03739294|Dermatologic Agents|dermatologic agents|mesh-ancestor
93070428|NCT03739294|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93070429|NCT03732508|Fluorouracil|fluorouracil|mesh-list
93070430|NCT03732508|Irinotecan|irinotecan|mesh-list
93070431|NCT03732508|Antimetabolites|antimetabolites|mesh-ancestor
93070432|NCT03732508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070433|NCT03732508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070434|NCT03732508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070435|NCT03732508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070436|NCT03732508|Immunologic Factors|immunologic factors|mesh-ancestor
93070437|NCT03732508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070438|NCT03732508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93070439|NCT03732508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070440|NCT03732508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070441|NCT03628924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93070442|NCT03628924|Immunologic Factors|immunologic factors|mesh-ancestor
93070443|NCT03628924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070444|NCT00112437|Vitamin D|vitamin d|mesh-list
93070445|NCT00112437|Cholecalciferol|cholecalciferol|mesh-list
93070446|NCT00112437|Calcium Carbonate|calcium carbonate|mesh-list
93070447|NCT00112437|Calcium|calcium|mesh-list
93070448|NCT00112437|Vitamins|vitamins|mesh-ancestor
93070449|NCT00112437|Micronutrients|micronutrients|mesh-ancestor
93070450|NCT00112437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070451|NCT00112437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93070452|NCT00112437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93070453|NCT00112437|Antacids|antacids|mesh-ancestor
93070454|NCT00112437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070455|NCT00112437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93070456|NCT03653416|Bupivacaine|bupivacaine|mesh-list
93070457|NCT03653416|Anesthetics, Local|anesthetics, local|mesh-ancestor
93070458|NCT03653416|Anesthetics|anesthetics|mesh-ancestor
93070459|NCT03653416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93070460|NCT03653416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070461|NCT03653416|Sensory System Agents|sensory system agents|mesh-ancestor
93070462|NCT03653416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070463|NCT01076673|Hyaluronic Acid|hyaluronic acid|mesh-list
93070464|NCT01076673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93070465|NCT01076673|Immunologic Factors|immunologic factors|mesh-ancestor
93070466|NCT01076673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070467|NCT01076673|Viscosupplements|viscosupplements|mesh-ancestor
93070468|NCT01076673|Protective Agents|protective agents|mesh-ancestor
93070469|NCT00119379|Tenofovir|tenofovir|mesh-list
93070470|NCT00119379|Antiviral Agents|antiviral agents|mesh-ancestor
93070471|NCT00119379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070472|NCT00119379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92530812|NCT00043654|Hormone Antagonists|hormone antagonists|mesh-ancestor
93070473|NCT00119379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070475|NCT00119379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070476|NCT00119379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93070477|NCT00119379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93070478|NCT01080417|Mycophenolic Acid|mycophenolic acid|mesh-list
93070479|NCT01080417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070480|NCT01080417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070481|NCT01080417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93070482|NCT01080417|Antitubercular Agents|antitubercular agents|mesh-ancestor
93070483|NCT01080417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070484|NCT01080417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070485|NCT01080417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070486|NCT01080417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070488|NCT01079481|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93070489|NCT01079481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070490|NCT01079481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070491|NCT01079481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070492|NCT01079481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070493|NCT01079481|Immunologic Factors|immunologic factors|mesh-ancestor
93070494|NCT01079481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070495|NCT01079481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070496|NCT03964779|Antibodies|antibodies|mesh-list
93070497|NCT03964779|Immunoglobulins|immunoglobulins|mesh-list
93070498|NCT03964779|Immunologic Factors|immunologic factors|mesh-ancestor
93070499|NCT03964779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070500|NCT00131937|Sorafenib|sorafenib|mesh-list
93070501|NCT00131937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070502|NCT00131937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070503|NCT00131937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070504|NCT00131937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070505|NCT01079559|Tobramycin|tobramycin|mesh-list
93070506|NCT01079559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070507|NCT01079559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070508|NCT00131469|Teriparatide|teriparatide|mesh-list
93070509|NCT00131469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93070510|NCT00131469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070511|NCT00131469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93070512|NCT00372593|Cytarabine|cytarabine|mesh-list
93070513|NCT00372593|Etoposide|etoposide|mesh-list
93070514|NCT00372593|Daunorubicin|daunorubicin|mesh-list
93070515|NCT00372593|Mitoxantrone|mitoxantrone|mesh-list
93070516|NCT00372593|Asparaginase|asparaginase|mesh-list
93070517|NCT00372593|Gemtuzumab|gemtuzumab|mesh-list
93070518|NCT00372593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93070519|NCT00372593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070520|NCT00372593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93070521|NCT00372593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070522|NCT00372593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070523|NCT00372593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070524|NCT00372593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070525|NCT00372593|Antimetabolites|antimetabolites|mesh-ancestor
93070526|NCT00372593|Antiviral Agents|antiviral agents|mesh-ancestor
93070527|NCT00372593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070528|NCT00372593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070529|NCT00372593|Immunologic Factors|immunologic factors|mesh-ancestor
93070530|NCT00372593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070531|NCT00372593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070532|NCT00372593|Analgesics|analgesics|mesh-ancestor
93070533|NCT00372593|Sensory System Agents|sensory system agents|mesh-ancestor
93070534|NCT00372593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070535|NCT00372593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93070536|NCT00372593|Immunotoxins|immunotoxins|mesh-ancestor
93070537|NCT00372593|Immunoconjugates|immunoconjugates|mesh-ancestor
93070538|NCT01324583|Prednisolone|prednisolone|mesh-list
93070539|NCT01324583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92530817|NCT00043771|Tolvaptan|tolvaptan|mesh-list
93070540|NCT01324583|Glucocorticoids|glucocorticoids|mesh-ancestor
93070541|NCT01324583|Hormones|hormones|mesh-ancestor
93070542|NCT01324583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070543|NCT01324583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070544|NCT01324583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070545|NCT01324583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070546|NCT00382109|Sirolimus|sirolimus|mesh-list
93070547|NCT00382109|Cyclophosphamide|cyclophosphamide|mesh-list
93070548|NCT00382109|Thiotepa|thiotepa|mesh-list
93070549|NCT00382109|Methotrexate|methotrexate|mesh-list
93070550|NCT00382109|Tacrolimus|tacrolimus|mesh-list
93070551|NCT00382109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070552|NCT00382109|Immunologic Factors|immunologic factors|mesh-ancestor
93070553|NCT00382109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070554|NCT00382109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070555|NCT00382109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93070556|NCT00382109|Alkylating Agents|alkylating agents|mesh-ancestor
93070557|NCT00382109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070558|NCT00382109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727509|NCT01089647|Hormones|hormones|mesh-ancestor
93070559|NCT00382109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93070560|NCT00382109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93070561|NCT00382109|Abortifacient Agents|abortifacient agents|mesh-ancestor
93070562|NCT00382109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93070563|NCT00382109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070564|NCT00382109|Antimetabolites|antimetabolites|mesh-ancestor
93070565|NCT00382109|Dermatologic Agents|dermatologic agents|mesh-ancestor
93070566|NCT00382109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070567|NCT00382109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070568|NCT00382109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070569|NCT00382109|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93070570|NCT00382109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070571|NCT00382109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070572|NCT00382109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070573|NCT00382109|Antifungal Agents|antifungal agents|mesh-ancestor
93070574|NCT00381797|Deoxyglucose|deoxyglucose|mesh-list
93070575|NCT00381797|Bevacizumab|bevacizumab|mesh-list
93070576|NCT00381797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93070577|NCT00381797|Irinotecan|irinotecan|mesh-list
93070578|NCT00381797|Camptothecin|camptothecin|mesh-list
93070579|NCT00381797|Endothelial Growth Factors|endothelial growth factors|mesh-list
93070580|NCT00381797|Antibodies|antibodies|mesh-list
93070581|NCT00381797|Immunoglobulins|immunoglobulins|mesh-list
93070582|NCT00381797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93070583|NCT00381797|Immunoglobulin G|immunoglobulin g|mesh-list
93070584|NCT00381797|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93070585|NCT00381797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070586|NCT00381797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93070587|NCT00381797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93070588|NCT00381797|Growth Substances|growth substances|mesh-ancestor
93070589|NCT00381797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070590|NCT00381797|Growth Inhibitors|growth inhibitors|mesh-ancestor
93070591|NCT00381797|Immunologic Factors|immunologic factors|mesh-ancestor
93070592|NCT00381797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93070593|NCT00381797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070594|NCT00381797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070595|NCT00381797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070596|NCT00381797|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93070597|NCT00381797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93070598|NCT00381797|Antimetabolites|antimetabolites|mesh-ancestor
93070599|NCT00381797|Antiviral Agents|antiviral agents|mesh-ancestor
93070600|NCT00381797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070601|NCT03665038|Brexanolone|brexanolone|mesh-list
93070602|NCT03665038|Neurosteroids|neurosteroids|mesh-ancestor
93070603|NCT03665038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070604|NCT03665038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070605|NCT03665038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070606|NCT03665038|GABA Modulators|gaba modulators|mesh-ancestor
93070607|NCT03665038|GABA Agents|gaba agents|mesh-ancestor
93070608|NCT03664024|Carboplatin|carboplatin|mesh-list
93070609|NCT03664024|Pembrolizumab|pembrolizumab|mesh-list
93070610|NCT03664024|Pemetrexed|pemetrexed|mesh-list
93070611|NCT03664024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070612|NCT03664024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92530822|NCT00043810|Fludarabine|fludarabine|mesh-list
93070614|NCT03664024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070615|NCT03664024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070616|NCT03664024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070617|NCT03664024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070618|NCT00381641|Sunitinib|sunitinib|mesh-list
93070619|NCT00381641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070620|NCT00381641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93070621|NCT00381641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93070622|NCT00381641|Growth Substances|growth substances|mesh-ancestor
93070623|NCT00381641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070624|NCT00381641|Growth Inhibitors|growth inhibitors|mesh-ancestor
93070625|NCT00381641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070626|NCT00381641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070627|NCT00381641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070628|NCT03624946|Immunoglobulins|immunoglobulins|mesh-list
93070629|NCT03624946|Antibodies|antibodies|mesh-list
93070630|NCT03624946|gamma-Globulins|gamma-globulins|mesh-list
93070631|NCT03624946|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93070632|NCT03624946|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
93070633|NCT03624946|Immunoglobulin G|immunoglobulin g|mesh-list
93070634|NCT03624946|Immunologic Factors|immunologic factors|mesh-ancestor
93070635|NCT03624946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070636|NCT03735082|Paclitaxel|paclitaxel|mesh-list
92727583|NCT04672499|Cortisone|cortisone|mesh-list
93070637|NCT03735082|Carboplatin|carboplatin|mesh-list
93070638|NCT03735082|Apatinib|apatinib|mesh-list
93070639|NCT03735082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93070640|NCT03735082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070641|NCT03735082|Tubulin Modulators|tubulin modulators|mesh-ancestor
93070642|NCT03735082|Antimitotic Agents|antimitotic agents|mesh-ancestor
93070643|NCT03735082|Mitosis Modulators|mitosis modulators|mesh-ancestor
93070644|NCT03735082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070645|NCT03735082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070646|NCT03735082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070647|NCT00381095|Pregabalin|pregabalin|mesh-list
93070648|NCT00381095|Analgesics|analgesics|mesh-ancestor
93070649|NCT00381095|Sensory System Agents|sensory system agents|mesh-ancestor
93070650|NCT00381095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070651|NCT00381095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070652|NCT00381095|Anticonvulsants|anticonvulsants|mesh-ancestor
93070653|NCT00381095|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93070654|NCT00381095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93070655|NCT00381095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070656|NCT00381095|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93070657|NCT00381095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93070658|NCT00381095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93070659|NCT00381095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93070660|NCT00381095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93070661|NCT03737656|Progesterone|progesterone|mesh-list
93070662|NCT03737656|Progestins|progestins|mesh-ancestor
93070663|NCT03737656|Hormones|hormones|mesh-ancestor
93070664|NCT03737656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070665|NCT03737656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070666|NCT00112047|Tenofovir|tenofovir|mesh-list
93070667|NCT00112047|Lamivudine|lamivudine|mesh-list
93070668|NCT00112047|Emtricitabine|emtricitabine|mesh-list
93070669|NCT00112047|Zidovudine|zidovudine|mesh-list
93070670|NCT00112047|Efavirenz|efavirenz|mesh-list
93070671|NCT00112047|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
93070672|NCT00112047|Antiviral Agents|antiviral agents|mesh-ancestor
93070673|NCT00112047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070674|NCT00112047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93070675|NCT00112047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070676|NCT00112047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070677|NCT00112047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070678|NCT00112047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93070679|NCT00112047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93070680|NCT00112047|Antimetabolites|antimetabolites|mesh-ancestor
93070681|NCT00112047|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
93070682|NCT00112047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93070683|NCT00112047|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92530824|NCT00043810|Busulfan|busulfan|mesh-list
93070684|NCT00112047|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93070685|NCT00112047|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93070686|NCT00112047|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93070687|NCT03658876|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93070688|NCT03658876|Hematinics|hematinics|mesh-ancestor
93070689|NCT03618628|Carbon Fiber|carbon fiber|mesh-list
93070690|NCT03618628|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93070691|NCT03618628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070692|NCT03639922|Imatinib Mesylate|imatinib mesylate|mesh-list
93070693|NCT03639922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070694|NCT03639922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93070695|NCT03639922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070696|NCT03639922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070698|NCT03734614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93070699|NCT03734614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93070700|NCT03734614|Analgesics|analgesics|mesh-ancestor
93070701|NCT03734614|Sensory System Agents|sensory system agents|mesh-ancestor
93070702|NCT03734614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070703|NCT03734614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070704|NCT03734614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070705|NCT03734614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070706|NCT03734614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93070707|NCT03734614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93070708|NCT03734614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070709|NCT03734614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93070710|NCT03734614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93070711|NCT03734614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070712|NCT03734614|Antipyretics|antipyretics|mesh-ancestor
93070713|NCT00380393|Vaccines|vaccines|mesh-list
93070714|NCT00380393|Immunologic Factors|immunologic factors|mesh-ancestor
93070715|NCT00380393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070716|NCT00380081|Zolpidem|zolpidem|mesh-list
93070717|NCT00380081|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93070718|NCT00380081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93070719|NCT00380081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93070720|NCT00380081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070721|NCT00380081|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93070722|NCT00380081|GABA Agonists|gaba agonists|mesh-ancestor
93070723|NCT00380081|GABA Agents|gaba agents|mesh-ancestor
93070724|NCT00380081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070725|NCT00380081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070726|NCT03579940|Lasmiditan|lasmiditan|mesh-list
93070727|NCT03579940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93070728|NCT03579940|Serotonin Agents|serotonin agents|mesh-ancestor
93070729|NCT03579940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070730|NCT03579940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070731|NCT03579940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070732|NCT03732040|Fluorides|fluorides|mesh-list
93070733|NCT03732040|Cariostatic Agents|cariostatic agents|mesh-ancestor
93070734|NCT03732040|Protective Agents|protective agents|mesh-ancestor
93070735|NCT03732040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070736|NCT00098306|Maraviroc|maraviroc|mesh-list
93070737|NCT00098306|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
93070738|NCT00098306|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
93070739|NCT00098306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070740|NCT00098306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93070741|NCT00098306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93070742|NCT00098306|Antiviral Agents|antiviral agents|mesh-ancestor
93070743|NCT00098306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070744|NCT00098306|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
93070745|NCT03615040|Astegolimab|astegolimab|mesh-list
93070746|NCT03615040|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
93070747|NCT03615040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070748|NCT03615040|Antiviral Agents|antiviral agents|mesh-ancestor
93070749|NCT03615040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070750|NCT01090778|Hormones|hormones|mesh-list
93070751|NCT01090778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070752|NCT01090778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070753|NCT00068588|Capecitabine|capecitabine|mesh-list
93070754|NCT00068588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070755|NCT00068588|Antimetabolites|antimetabolites|mesh-ancestor
93070756|NCT00068588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139233|NCT04476966|Mirabegron|mirabegron|mesh-list
93070757|NCT00068588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070759|NCT01088282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93070760|NCT01088282|Adrenergic Agents|adrenergic agents|mesh-ancestor
93070761|NCT01088282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070762|NCT01088282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070763|NCT01088282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070764|NCT03963752|Megestrol|megestrol|mesh-list
93070765|NCT03963752|Megestrol Acetate|megestrol acetate|mesh-list
93070766|NCT03963752|Leuprolide|leuprolide|mesh-list
93070767|NCT03963752|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93070768|NCT03963752|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93070769|NCT03963752|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93070770|NCT03963752|Contraceptive Agents|contraceptive agents|mesh-ancestor
93070771|NCT03963752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93070772|NCT03963752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070773|NCT03963752|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93070774|NCT03963752|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93070775|NCT03963752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070776|NCT03963752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070777|NCT03963752|Appetite Stimulants|appetite stimulants|mesh-ancestor
93070778|NCT03963752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93070779|NCT03963752|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93070780|NCT03963752|Fertility Agents|fertility agents|mesh-ancestor
93070781|NCT03734302|Brexpiprazole|brexpiprazole|mesh-list
93070782|NCT03734302|Serotonin Agents|serotonin agents|mesh-ancestor
93070783|NCT03734302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070784|NCT03734302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727743|NCT01085045|Anticonvulsants|anticonvulsants|mesh-ancestor
93070785|NCT03734302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070786|NCT03734302|Dopamine Agonists|dopamine agonists|mesh-ancestor
93070787|NCT03734302|Dopamine Agents|dopamine agents|mesh-ancestor
93070788|NCT01310296|Lofexidine|lofexidine|mesh-list
93070789|NCT01310296|Clonidine|clonidine|mesh-list
93070790|NCT01310296|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93070791|NCT01310296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
93070792|NCT01310296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070793|NCT01310296|Sensory System Agents|sensory system agents|mesh-ancestor
93070794|NCT01310296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070795|NCT01310296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93070796|NCT01310296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93070797|NCT01310296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93070798|NCT01310296|Adrenergic Agents|adrenergic agents|mesh-ancestor
93070799|NCT01310296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070800|NCT01310296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070801|NCT01310296|Analgesics|analgesics|mesh-ancestor
93070802|NCT01310296|Sympatholytics|sympatholytics|mesh-ancestor
93070803|NCT01310296|Autonomic Agents|autonomic agents|mesh-ancestor
93070804|NCT03734068|Doxorubicin|doxorubicin|mesh-list
93070805|NCT03734068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070806|NCT03734068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070807|NCT03734068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93070808|NCT03734068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070809|NCT03734068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070810|NCT03734068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070811|NCT03575806|Chlorotrianisene|chlorotrianisene|mesh-list
93070812|NCT03575806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070813|NCT03575806|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
93070814|NCT03575806|Estrogens|estrogens|mesh-ancestor
93070815|NCT03575806|Hormones|hormones|mesh-ancestor
93070816|NCT03575806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070817|NCT03575806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070818|NCT03575806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070819|NCT03606460|Ocrelizumab|ocrelizumab|mesh-list
93070820|NCT03606460|Immunologic Factors|immunologic factors|mesh-ancestor
93070821|NCT03606460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070822|NCT03729310|Triamcinolone|triamcinolone|mesh-list
93070823|NCT03729310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070824|NCT03729310|Glucocorticoids|glucocorticoids|mesh-ancestor
93070825|NCT03729310|Hormones|hormones|mesh-ancestor
93070826|NCT03729310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070827|NCT03729310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070828|NCT03731494|Nickel|nickel|mesh-list
93070829|NCT03731494|Trace Elements|trace elements|mesh-ancestor
93070830|NCT03731494|Micronutrients|micronutrients|mesh-ancestor
93070831|NCT03731494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070832|NCT00111813|Bortezomib|bortezomib|mesh-list
93070833|NCT00111813|Vorinostat|vorinostat|mesh-list
93070834|NCT00111813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070835|NCT00111813|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93070836|NCT00111813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070837|NCT00111813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070838|NCT00118287|Etanercept|etanercept|mesh-list
93070839|NCT00118287|Azacitidine|azacitidine|mesh-list
93070840|NCT00118287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070841|NCT00118287|Antimetabolites|antimetabolites|mesh-ancestor
93070842|NCT00118287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070843|NCT00118287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070844|NCT00118287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070845|NCT00118287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93070846|NCT00118287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93070847|NCT00118287|Analgesics|analgesics|mesh-ancestor
93070848|NCT00118287|Sensory System Agents|sensory system agents|mesh-ancestor
93070849|NCT00118287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070850|NCT00118287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070851|NCT00118287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070852|NCT00118287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070853|NCT00118287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93070854|NCT00118287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070855|NCT00118287|Immunologic Factors|immunologic factors|mesh-ancestor
93070856|NCT03965247|Lithium Carbonate|lithium carbonate|mesh-list
93070857|NCT03965247|Antidepressive Agents|antidepressive agents|mesh-ancestor
93070858|NCT03965247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93070859|NCT03965247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527983|NCT00014196|Antimitotic Agents|antimitotic agents|mesh-ancestor
93070860|NCT03965247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070861|NCT03965247|Antimanic Agents|antimanic agents|mesh-ancestor
93070862|NCT03965247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93070863|NCT03965247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93070864|NCT03965247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070865|NCT01079715|Propranolol|propranolol|mesh-list
93070866|NCT01079715|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93070867|NCT01079715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93070868|NCT01079715|Adrenergic Agents|adrenergic agents|mesh-ancestor
93070869|NCT01079715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070870|NCT01079715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070871|NCT01079715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070872|NCT01079715|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93070873|NCT01079715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93070874|NCT01079715|Vasodilator Agents|vasodilator agents|mesh-ancestor
93070875|NCT00130689|Cetuximab|cetuximab|mesh-list
93070876|NCT00130689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93070877|NCT00130689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070878|NCT01326585|Dexamethasone|dexamethasone|mesh-list
93070879|NCT01326585|Dexamethasone acetate|dexamethasone acetate|mesh-list
93070880|NCT01326585|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
93070881|NCT01326585|BB 1101|bb 1101|mesh-list
93070882|NCT01326585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070883|NCT01326585|Antiemetics|antiemetics|mesh-ancestor
93070884|NCT01326585|Autonomic Agents|autonomic agents|mesh-ancestor
93070885|NCT01326585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070886|NCT01326585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070887|NCT01326585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93070888|NCT01326585|Glucocorticoids|glucocorticoids|mesh-ancestor
93070889|NCT01326585|Hormones|hormones|mesh-ancestor
93070890|NCT01326585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070891|NCT01326585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070892|NCT01326585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070893|NCT01326585|Protease Inhibitors|protease inhibitors|mesh-ancestor
93070894|NCT01326585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070895|NCT01326585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070896|NCT03964935|Minocycline|minocycline|mesh-list
93070897|NCT03964935|Lycopene|lycopene|mesh-list
93070898|NCT03964935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93070899|NCT03964935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070900|NCT03964935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070901|NCT03964935|Antioxidants|antioxidants|mesh-ancestor
93070902|NCT03964935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070903|NCT03964935|Protective Agents|protective agents|mesh-ancestor
93070904|NCT03964935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070905|NCT03964935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93070906|NCT03964935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93070907|NCT03964935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070909|NCT03605212|Gout Suppressants|gout suppressants|mesh-ancestor
93070910|NCT03605212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070911|NCT00117507|Deferasirox|deferasirox|mesh-list
93070912|NCT00117507|Chelating Agents|chelating agents|mesh-list
93070913|NCT00117507|Iron Chelating Agents|iron chelating agents|mesh-ancestor
93070914|NCT00117507|Sequestering Agents|sequestering agents|mesh-ancestor
93070915|NCT00117507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070916|NCT03621046|Zolpidem|zolpidem|mesh-list
93070917|NCT03621046|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
93070918|NCT03621046|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93070919|NCT03621046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93070920|NCT03621046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070921|NCT03621046|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
93070922|NCT03621046|GABA Agonists|gaba agonists|mesh-ancestor
93070923|NCT03621046|GABA Agents|gaba agents|mesh-ancestor
93070924|NCT03621046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070925|NCT03621046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070926|NCT03965013|Insulin Glargine|insulin glargine|mesh-list
93070927|NCT03965013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93070928|NCT03965013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070929|NCT03603496|Nicotine|nicotine|mesh-list
93070930|NCT03603496|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
93070931|NCT03603496|Autonomic Agents|autonomic agents|mesh-ancestor
93070932|NCT03603496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070933|NCT03603496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070934|NCT03603496|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
93070935|NCT03603496|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93070936|NCT03603496|Cholinergic Agents|cholinergic agents|mesh-ancestor
93070937|NCT03603496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93070938|NCT03603496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070939|NCT00096135|Leucovorin|leucovorin|mesh-list
93070940|NCT00096135|Cytarabine|cytarabine|mesh-list
93070941|NCT00096135|Dexamethasone|dexamethasone|mesh-list
93070942|NCT00096135|Hydrocortisone|hydrocortisone|mesh-list
93070943|NCT00096135|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
93070944|NCT00096135|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
93070945|NCT00096135|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
93070946|NCT00096135|Cyclophosphamide|cyclophosphamide|mesh-list
93070947|NCT00096135|Methotrexate|methotrexate|mesh-list
93070948|NCT00096135|Etoposide|etoposide|mesh-list
93070949|NCT00096135|Vincristine|vincristine|mesh-list
93070950|NCT00096135|Daunorubicin|daunorubicin|mesh-list
93070951|NCT00096135|Asparaginase|asparaginase|mesh-list
93070952|NCT00096135|Mercaptopurine|mercaptopurine|mesh-list
93070953|NCT00096135|Pegaspargase|pegaspargase|mesh-list
93070954|NCT00096135|Lenograstim|lenograstim|mesh-list
93070955|NCT00096135|Levoleucovorin|levoleucovorin|mesh-list
93070956|NCT00096135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93070957|NCT00096135|Immunologic Factors|immunologic factors|mesh-ancestor
93070958|NCT00096135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93070959|NCT00096135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93070960|NCT00096135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93070961|NCT00096135|Alkylating Agents|alkylating agents|mesh-ancestor
93070962|NCT00096135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93070963|NCT00096135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93070964|NCT00096135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93070965|NCT00096135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93070966|NCT00096135|Antiemetics|antiemetics|mesh-ancestor
93070967|NCT00096135|Autonomic Agents|autonomic agents|mesh-ancestor
93070968|NCT00096135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93070969|NCT00096135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93070970|NCT00096135|Glucocorticoids|glucocorticoids|mesh-ancestor
93070971|NCT00096135|Hormones|hormones|mesh-ancestor
93070972|NCT00096135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93070973|NCT00096135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93070974|NCT00096135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
93070975|NCT00096135|Abortifacient Agents|abortifacient agents|mesh-ancestor
93070976|NCT00096135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93070977|NCT00096135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93070978|NCT00096135|Antimetabolites|antimetabolites|mesh-ancestor
93070979|NCT00096135|Dermatologic Agents|dermatologic agents|mesh-ancestor
93070980|NCT00096135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93070981|NCT00096135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93070982|NCT00096135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93070983|NCT00096135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93070984|NCT00096135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93070985|NCT00096135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93070986|NCT00096135|Antiviral Agents|antiviral agents|mesh-ancestor
93070987|NCT00096135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93070988|NCT00096135|Antidotes|antidotes|mesh-ancestor
93070989|NCT00096135|Protective Agents|protective agents|mesh-ancestor
93070990|NCT00096135|Vitamin B Complex|vitamin b complex|mesh-ancestor
93070991|NCT00096135|Vitamins|vitamins|mesh-ancestor
93070992|NCT00096135|Micronutrients|micronutrients|mesh-ancestor
93070993|NCT00096135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93070994|NCT00096135|Tubulin Modulators|tubulin modulators|mesh-ancestor
93070995|NCT00096135|Antimitotic Agents|antimitotic agents|mesh-ancestor
93070996|NCT00096135|Mitosis Modulators|mitosis modulators|mesh-ancestor
93070997|NCT00096135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93070998|NCT00116805|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
93070999|NCT00116805|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93071000|NCT00116805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93071001|NCT00116805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071002|NCT00116805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071003|NCT00116805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071004|NCT00116805|Antiviral Agents|antiviral agents|mesh-ancestor
93071005|NCT00116805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071006|NCT00116805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93071007|NCT00116805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92727955|NCT04551768|Antimetabolites|antimetabolites|mesh-ancestor
93071008|NCT00116649|Imiquimod|imiquimod|mesh-list
93071009|NCT00116649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93071010|NCT00116649|Immunologic Factors|immunologic factors|mesh-ancestor
93071011|NCT00116649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071012|NCT00116649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071013|NCT00116649|Interferon Inducers|interferon inducers|mesh-ancestor
93071014|NCT01080651|Voriconazole|voriconazole|mesh-list
93071015|NCT01080651|Antifungal Agents|antifungal agents|mesh-ancestor
93071016|NCT01080651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071017|NCT01080651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
93071018|NCT01080651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93071019|NCT01080651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071020|NCT01080651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071021|NCT01080651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93071022|NCT01080651|Hormone Antagonists|hormone antagonists|mesh-ancestor
93071023|NCT01080651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071024|NCT01080651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071025|NCT01080651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93071026|NCT01080729|Hormones|hormones|mesh-list
93071027|NCT01080729|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
93071028|NCT01080729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071029|NCT01080729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071030|NCT03962907|Chlorhexidine|chlorhexidine|mesh-list
93071031|NCT03962907|Mupirocin|mupirocin|mesh-list
93071032|NCT03962907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93071033|NCT03962907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071034|NCT03962907|Disinfectants|disinfectants|mesh-ancestor
93071035|NCT03962907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071036|NCT03962907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
93071037|NCT03962907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071038|NCT03962907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071039|NCT00083889|Interferons|interferons|mesh-list
93071040|NCT00083889|Interferon-alpha|interferon-alpha|mesh-list
93071041|NCT00083889|Sunitinib|sunitinib|mesh-list
93071042|NCT00083889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071043|NCT00083889|Antiviral Agents|antiviral agents|mesh-ancestor
93071044|NCT00083889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071045|NCT00083889|Immunologic Factors|immunologic factors|mesh-ancestor
93071046|NCT00083889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530833|NCT00043810|Alkylating Agents|alkylating agents|mesh-ancestor
93071047|NCT00083889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071048|NCT00083889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071049|NCT00083889|Growth Substances|growth substances|mesh-ancestor
93071050|NCT00083889|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071051|NCT00083889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93071052|NCT00083889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071053|NCT00083889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071055|NCT03639532|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93071056|NCT03639532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071057|NCT03639532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071058|NCT03639532|Cholinergic Agents|cholinergic agents|mesh-ancestor
93071059|NCT03639532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071060|NCT03639532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071061|NCT03639532|Parasympathomimetics|parasympathomimetics|mesh-ancestor
93071062|NCT03639532|Autonomic Agents|autonomic agents|mesh-ancestor
93071063|NCT03639532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071064|NCT03639532|Nootropic Agents|nootropic agents|mesh-ancestor
93071065|NCT03571516|Teduglutide|teduglutide|mesh-list
93071066|NCT03571516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93071067|NCT03571516|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93071068|NCT03571516|Protective Agents|protective agents|mesh-ancestor
93071069|NCT03571516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071070|NCT03600376|Dantrolene|dantrolene|mesh-list
93071071|NCT03600376|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
93071072|NCT03600376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071073|NCT03600376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93071074|NCT03600376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071075|NCT03961659|Metformin|metformin|mesh-list
93071076|NCT03961659|Dapagliflozin|dapagliflozin|mesh-list
93071077|NCT03961659|Acarbose|acarbose|mesh-list
93071078|NCT03961659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071079|NCT03961659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071080|NCT03961659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93071081|NCT03961659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071082|NCT03961659|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
93071083|NCT03961659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527984|NCT00014196|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071085|NCT03599362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93071086|NCT03599362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071087|NCT03599362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93071088|NCT03599362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071089|NCT03741309|Calcium|calcium|mesh-list
93071090|NCT03741309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93071091|NCT03741309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071092|NCT00082407|Insulin Aspart|insulin aspart|mesh-list
93071093|NCT00082407|Exenatide|exenatide|mesh-list
93071094|NCT00082407|Biphasic Insulins|biphasic insulins|mesh-list
93071095|NCT00082407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071096|NCT00082407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071097|NCT00082407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93071098|NCT00082407|Incretins|incretins|mesh-ancestor
93071099|NCT00082407|Hormones|hormones|mesh-ancestor
93071100|NCT00082407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071101|NCT01080963|Daptomycin|daptomycin|mesh-list
93071102|NCT01080963|Cefuroxime|cefuroxime|mesh-list
93071103|NCT01080963|Cefuroxime axetil|cefuroxime axetil|mesh-list
93071104|NCT01080963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071105|NCT01080963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071106|NCT01083381|Risperidone|risperidone|mesh-list
93071107|NCT01083381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93071108|NCT01083381|Serotonin Agents|serotonin agents|mesh-ancestor
93071109|NCT01083381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92340989|NCT05215691|Analgesics|analgesics|mesh-ancestor
93071110|NCT01083381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071111|NCT01083381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071112|NCT01083381|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93071113|NCT01083381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93071114|NCT01083381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071115|NCT01083381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93071116|NCT01083381|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93071117|NCT01083381|Dopamine Agents|dopamine agents|mesh-ancestor
93071118|NCT01087359|Melatonin|melatonin|mesh-list
93071119|NCT01087359|Antioxidants|antioxidants|mesh-ancestor
93071120|NCT01087359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071121|NCT01087359|Protective Agents|protective agents|mesh-ancestor
93071122|NCT01087359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071123|NCT01087359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071124|NCT01087437|Calcium|calcium|mesh-list
93071125|NCT01087437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93071126|NCT01087437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071127|NCT01083537|Paclitaxel|paclitaxel|mesh-list
93071128|NCT01083537|Cisplatin|cisplatin|mesh-list
93071129|NCT01083537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93071130|NCT01083537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071131|NCT01083537|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071132|NCT01083537|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071133|NCT01083537|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071134|NCT01083537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071135|NCT03597022|Lipoprotein-associated coagulation inhibitor|lipoprotein-associated coagulation inhibitor|mesh-list
93071136|NCT03597022|Immunoglobulins|immunoglobulins|mesh-list
93071137|NCT03597022|Immunoglobulin G|immunoglobulin g|mesh-list
93071138|NCT03597022|Immunologic Factors|immunologic factors|mesh-ancestor
93071139|NCT03597022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071140|NCT03597022|Anticoagulants|anticoagulants|mesh-ancestor
93071141|NCT03597022|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93071142|NCT03597022|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93071143|NCT03597022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071144|NCT03597022|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93071145|NCT03597022|Protease Inhibitors|protease inhibitors|mesh-ancestor
93071146|NCT03597022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071147|NCT03597022|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93071148|NCT03597022|Antithrombins|antithrombins|mesh-ancestor
93071149|NCT03569098|Hemagglutinins|hemagglutinins|mesh-list
93071150|NCT03569098|Botulinum Toxins|botulinum toxins|mesh-list
93071151|NCT03569098|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93071152|NCT03569098|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93071153|NCT03569098|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92341000|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
93071154|NCT03569098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93071155|NCT03569098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071156|NCT03569098|Cholinergic Agents|cholinergic agents|mesh-ancestor
93071157|NCT03569098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071158|NCT03569098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071159|NCT03569098|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93071160|NCT03569098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071161|NCT03569098|Agglutinins|agglutinins|mesh-ancestor
93071162|NCT03569098|Immunologic Factors|immunologic factors|mesh-ancestor
93071163|NCT03569098|Coagulants|coagulants|mesh-ancestor
93071164|NCT03727282|Dobutamine|dobutamine|mesh-list
93071165|NCT03727282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93071166|NCT03727282|Sympathomimetics|sympathomimetics|mesh-ancestor
93071167|NCT03727282|Autonomic Agents|autonomic agents|mesh-ancestor
93071168|NCT03727282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071169|NCT03727282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071170|NCT03727282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
93071171|NCT03727282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93071172|NCT03727282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93071173|NCT03727282|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071174|NCT03727282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071175|NCT03727282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071176|NCT03727282|Protective Agents|protective agents|mesh-ancestor
93071177|NCT03568942|Gepotidacin|gepotidacin|mesh-list
93071178|NCT03568942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93071179|NCT03568942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071180|NCT03568942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071181|NCT03568942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071182|NCT00110019|Paclitaxel|paclitaxel|mesh-list
93071183|NCT00110019|Carboplatin|carboplatin|mesh-list
93071184|NCT00110019|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93071185|NCT00110019|Sorafenib|sorafenib|mesh-list
93071186|NCT00110019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93071187|NCT00110019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071188|NCT00110019|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071189|NCT00110019|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071190|NCT00110019|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071191|NCT00110019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071192|NCT00110019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93071193|NCT00110019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071194|NCT03642262|Guaifenesin|guaifenesin|mesh-list
93071195|NCT03642262|Expectorants|expectorants|mesh-ancestor
93071196|NCT03642262|Respiratory System Agents|respiratory system agents|mesh-ancestor
93071197|NCT03727048|Ketorolac|ketorolac|mesh-list
93071198|NCT03727048|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93071199|NCT03727048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93071200|NCT03727048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93071201|NCT03727048|Analgesics|analgesics|mesh-ancestor
93071202|NCT03727048|Sensory System Agents|sensory system agents|mesh-ancestor
93071203|NCT03727048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071204|NCT03727048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071205|NCT03727048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071206|NCT03727048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071207|NCT03727048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93071208|NCT03727048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071209|NCT03727048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071210|NCT00095979|Epothilones|epothilones|mesh-list
93071211|NCT00095979|Epothilone B|epothilone b|mesh-list
93071212|NCT00095979|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071213|NCT00095979|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071214|NCT00095979|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071215|NCT00095979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071216|NCT00095979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071217|NCT01087593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93071218|NCT01087593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93071219|NCT01087593|Estradiol|estradiol|mesh-list
93071220|NCT01087593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93071221|NCT01087593|Estrogens|estrogens|mesh-ancestor
93071222|NCT01087593|Hormones|hormones|mesh-ancestor
93071223|NCT01087593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071224|NCT01087593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071225|NCT01087593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93071226|NCT01087593|Contraceptive Agents|contraceptive agents|mesh-ancestor
93071227|NCT01087593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93071228|NCT01087593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93071229|NCT00082173|Moxifloxacin|moxifloxacin|mesh-list
93071230|NCT00082173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071231|NCT00082173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071232|NCT00082173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93071233|NCT00082173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93071234|NCT00082173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071235|NCT00082173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071236|NCT00082173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071237|NCT01087749|Losartan|losartan|mesh-list
93071238|NCT01087749|Propranolol|propranolol|mesh-list
93071239|NCT01087749|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
93071240|NCT01087749|Eprosartan|eprosartan|mesh-list
93071241|NCT01087749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93071242|NCT01087749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93071243|NCT01087749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93071244|NCT01087749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93071245|NCT01087749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071246|NCT01087749|Diuretics|diuretics|mesh-ancestor
93071247|NCT01087749|Natriuretic Agents|natriuretic agents|mesh-ancestor
93071248|NCT01087749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071249|NCT01087749|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92341061|NCT00382421|Sympatholytics|sympatholytics|mesh-ancestor
93071250|NCT01087749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93071251|NCT01087749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93071252|NCT01087749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93071253|NCT01087749|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071254|NCT01087749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071255|NCT01087749|Vasodilator Agents|vasodilator agents|mesh-ancestor
93071256|NCT01087749|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
93071257|NCT00108069|Tamoxifen|tamoxifen|mesh-list
93071258|NCT00108069|Bortezomib|bortezomib|mesh-list
93071259|NCT00108069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071260|NCT00108069|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93071261|NCT00108069|Hormone Antagonists|hormone antagonists|mesh-ancestor
93071262|NCT00108069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071263|NCT00108069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071264|NCT00108069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93071265|NCT00108069|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93071266|NCT00108069|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93071267|NCT00108069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93071268|NCT00079274|Leucovorin|leucovorin|mesh-list
93071269|NCT00079274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93071270|NCT00079274|Cetuximab|cetuximab|mesh-list
93071271|NCT00079274|Fluorouracil|fluorouracil|mesh-list
93071272|NCT00079274|Oxaliplatin|oxaliplatin|mesh-list
93071273|NCT00079274|Irinotecan|irinotecan|mesh-list
93071274|NCT00079274|Antibodies|antibodies|mesh-list
93071275|NCT00079274|Immunoglobulins|immunoglobulins|mesh-list
93071276|NCT00079274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93071277|NCT00079274|Levoleucovorin|levoleucovorin|mesh-list
93071278|NCT00079274|Immunologic Factors|immunologic factors|mesh-ancestor
93071279|NCT00079274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071280|NCT00079274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071281|NCT00079274|Antimetabolites|antimetabolites|mesh-ancestor
93071282|NCT00079274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071283|NCT00079274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93071284|NCT00079274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071285|NCT00079274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93071286|NCT00079274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93071287|NCT00079274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071288|NCT00079274|Antidotes|antidotes|mesh-ancestor
93071289|NCT00079274|Protective Agents|protective agents|mesh-ancestor
93071290|NCT00079274|Vitamin B Complex|vitamin b complex|mesh-ancestor
93071291|NCT00079274|Vitamins|vitamins|mesh-ancestor
93071292|NCT00079274|Micronutrients|micronutrients|mesh-ancestor
93071293|NCT01081964|Levofloxacin|levofloxacin|mesh-list
93071294|NCT01081964|Fluoroquinolones|fluoroquinolones|mesh-list
93071295|NCT01081964|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93071296|NCT01081964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071297|NCT01081964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071298|NCT01081964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93071299|NCT01081964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93071300|NCT01081964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071301|NCT01081964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071302|NCT01081964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071303|NCT01081964|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93071304|NCT01081964|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93071305|NCT01081964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071306|NCT00079040|Bevacizumab|bevacizumab|mesh-list
93071307|NCT00079040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93071308|NCT00079040|Etoposide|etoposide|mesh-list
92728261|NCT00478023|Morphine|morphine|mesh-list
93071309|NCT00079040|Etoposide phosphate|etoposide phosphate|mesh-list
93071311|NCT00079040|Immunoglobulins|immunoglobulins|mesh-list
93071312|NCT00079040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93071313|NCT00079040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071314|NCT00079040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071315|NCT00079040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071316|NCT00079040|Growth Substances|growth substances|mesh-ancestor
93071317|NCT00079040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071318|NCT00079040|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071319|NCT00079040|Immunologic Factors|immunologic factors|mesh-ancestor
93071320|NCT00079040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93071321|NCT00079040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93071322|NCT00079040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93071323|NCT00079040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071324|NCT00079040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071325|NCT01088516|Ritonavir|ritonavir|mesh-list
93071326|NCT01088516|Lopinavir|lopinavir|mesh-list
93071327|NCT01088516|Zidovudine|zidovudine|mesh-list
93071328|NCT01088516|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
93071329|NCT01088516|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
93071330|NCT01088516|Protease Inhibitors|protease inhibitors|mesh-ancestor
93071331|NCT01088516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071332|NCT01088516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071333|NCT01088516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93071334|NCT01088516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93071335|NCT01088516|Antiviral Agents|antiviral agents|mesh-ancestor
93071336|NCT01088516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071337|NCT01088516|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
93071338|NCT01088516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93071339|NCT01088516|Antimetabolites|antimetabolites|mesh-ancestor
93071340|NCT01088516|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93071341|NCT01088516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071342|NCT00078806|Etanercept|etanercept|mesh-list
93071343|NCT00078806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93071344|NCT00078806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93071345|NCT00078806|Analgesics|analgesics|mesh-ancestor
93071346|NCT00078806|Sensory System Agents|sensory system agents|mesh-ancestor
93071347|NCT00078806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071348|NCT00078806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071349|NCT00078806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071350|NCT00078806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071351|NCT00078806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93071352|NCT00078806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071353|NCT00078806|Immunologic Factors|immunologic factors|mesh-ancestor
93071354|NCT00078338|Interferons|interferons|mesh-list
93071355|NCT00078338|Interferon-beta|interferon-beta|mesh-list
93071356|NCT00078338|Interferon beta-1a|interferon beta-1a|mesh-list
93071357|NCT00078338|Glatiramer Acetate|glatiramer acetate|mesh-list
93071359|NCT00078338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071360|NCT00078338|Antiviral Agents|antiviral agents|mesh-ancestor
93071361|NCT00078338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071362|NCT00078338|Immunologic Factors|immunologic factors|mesh-ancestor
93071363|NCT00078338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071364|NCT00078338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93071365|NCT00078338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071366|NCT00078338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071367|NCT01088594|Pioglitazone|pioglitazone|mesh-list
93071368|NCT01088594|Rosiglitazone|rosiglitazone|mesh-list
93071369|NCT01088594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071370|NCT01088594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071371|NCT01082120|Pioglitazone|pioglitazone|mesh-list
93071372|NCT01082120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071373|NCT01082120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071374|NCT03808688|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93071375|NCT03808688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93071376|NCT03808298|Moxifloxacin|moxifloxacin|mesh-list
93071377|NCT03808298|Balovaptan|balovaptan|mesh-list
93071378|NCT03808298|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
93071379|NCT03808298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071380|NCT03808298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071381|NCT03808298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93071382|NCT03808298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93071383|NCT03808298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071384|NCT03808298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071385|NCT03808298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071386|NCT03808298|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93071387|NCT03808298|Contraceptive Agents|contraceptive agents|mesh-ancestor
93071388|NCT03808298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93071389|NCT03808298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071390|NCT03808298|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
93071391|NCT03808298|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93071392|NCT03808298|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93071393|NCT03808298|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93071394|NCT03808298|Natriuretic Agents|natriuretic agents|mesh-ancestor
93071395|NCT00077636|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
93071397|NCT00077636|Ribavirin|ribavirin|mesh-list
93071398|NCT00077636|Antiviral Agents|antiviral agents|mesh-ancestor
93071399|NCT00077636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071400|NCT00077636|Immunologic Factors|immunologic factors|mesh-ancestor
93071401|NCT00077636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071402|NCT00077636|Antimetabolites|antimetabolites|mesh-ancestor
93071403|NCT00077636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071404|NCT01082198|Vaccines|vaccines|mesh-list
93071405|NCT01082198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
93071406|NCT01082198|Immunologic Factors|immunologic factors|mesh-ancestor
93071407|NCT01082198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071408|NCT01082198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93071409|NCT01088750|Prednisolone|prednisolone|mesh-list
93071410|NCT01088750|Cyclophosphamide|cyclophosphamide|mesh-list
93071411|NCT01088750|Vinblastine|vinblastine|mesh-list
93071412|NCT01088750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071413|NCT01088750|Immunologic Factors|immunologic factors|mesh-ancestor
93071414|NCT01088750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071415|NCT01088750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071416|NCT01088750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93071417|NCT01088750|Alkylating Agents|alkylating agents|mesh-ancestor
93071418|NCT01088750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071419|NCT01088750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071420|NCT01088750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93071421|NCT01088750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071422|NCT01088750|Glucocorticoids|glucocorticoids|mesh-ancestor
93071423|NCT01088750|Hormones|hormones|mesh-ancestor
93071424|NCT01088750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071425|NCT01088750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93071426|NCT01088750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93071427|NCT01088750|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071428|NCT01088750|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071429|NCT01088750|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071430|NCT01091012|Sildenafil Citrate|sildenafil citrate|mesh-list
93071431|NCT01091012|Vasodilator Agents|vasodilator agents|mesh-ancestor
93071432|NCT01091012|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
93071433|NCT01091012|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93071434|NCT01091012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071435|NCT01091012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071436|NCT01091012|Urological Agents|urological agents|mesh-ancestor
93071437|NCT01082276|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
93071438|NCT01082276|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93071439|NCT01082276|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93071440|NCT01082276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071441|NCT01082276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071442|NCT01082276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93071443|NCT01082276|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
93071444|NCT01082276|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93071445|NCT01082276|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93071446|NCT01082276|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071447|NCT01082276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071448|NCT01082276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071449|NCT01082276|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93071450|NCT01082276|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93071451|NCT01082276|Serotonin Agents|serotonin agents|mesh-ancestor
93071452|NCT01082276|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93071453|NCT01082276|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93071454|NCT01082276|Dopamine Agents|dopamine agents|mesh-ancestor
93071455|NCT01088906|Pemetrexed|pemetrexed|mesh-list
93071456|NCT01088906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071457|NCT01088906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071458|NCT01088906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071459|NCT01088906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93071460|NCT01088906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071461|NCT00095199|Docetaxel|docetaxel|mesh-list
93071462|NCT00095199|Pemetrexed|pemetrexed|mesh-list
93071463|NCT00095199|Cetuximab|cetuximab|mesh-list
93071464|NCT00095199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071465|NCT00095199|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071466|NCT00095199|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071467|NCT00095199|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071468|NCT00095199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071469|NCT00095199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071470|NCT00095199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93071471|NCT00095199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071472|NCT00095199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93071473|NCT00075764|Fulvestrant|fulvestrant|mesh-list
93071474|NCT00075764|Anastrozole|anastrozole|mesh-list
93071475|NCT00075764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93071476|NCT00075764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071477|NCT00075764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93071478|NCT00075764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93071479|NCT00075764|Hormone Antagonists|hormone antagonists|mesh-ancestor
93071480|NCT00075764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071481|NCT00075764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071482|NCT00075764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93071483|NCT00075764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93071484|NCT00075764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071485|NCT00075764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071486|NCT03567616|Dexamethasone|dexamethasone|mesh-list
93071487|NCT03567616|Venetoclax|venetoclax|mesh-list
93071488|NCT03567616|Pomalidomide|pomalidomide|mesh-list
93071489|NCT03567616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071490|NCT03567616|Antiemetics|antiemetics|mesh-ancestor
93071491|NCT03567616|Autonomic Agents|autonomic agents|mesh-ancestor
93071492|NCT03567616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071493|NCT03567616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071495|NCT03567616|Glucocorticoids|glucocorticoids|mesh-ancestor
93071496|NCT03567616|Hormones|hormones|mesh-ancestor
93071497|NCT03567616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071498|NCT03567616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93071499|NCT03567616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071500|NCT03567616|Immunologic Factors|immunologic factors|mesh-ancestor
93071501|NCT03567616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071502|NCT03567616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071503|NCT03567616|Growth Substances|growth substances|mesh-ancestor
93071504|NCT03567616|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071505|NCT03567382|Tenofovir|tenofovir|mesh-list
93071506|NCT03567382|Antiviral Agents|antiviral agents|mesh-ancestor
93071507|NCT03567382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071508|NCT03567382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93071509|NCT03567382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071510|NCT03567382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071511|NCT03567382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071512|NCT03567382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93071513|NCT03567382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93071514|NCT03591874|Brimonidine Tartrate|brimonidine tartrate|mesh-list
93071515|NCT03591874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93071516|NCT03591874|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93071517|NCT03591874|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93071518|NCT03591874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93071519|NCT03591874|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071520|NCT03591874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071521|NCT03591874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071522|NCT03591874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071523|NCT03730714|Epinephrine|epinephrine|mesh-list
93071524|NCT03730714|Racepinephrine|racepinephrine|mesh-list
93071525|NCT03730714|Morphine|morphine|mesh-list
93071526|NCT03730714|Anesthetics|anesthetics|mesh-list
93071527|NCT03730714|Anesthetics, Local|anesthetics, local|mesh-list
93071528|NCT03730714|Epinephryl borate|epinephryl borate|mesh-list
93071529|NCT03730714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93071530|NCT03730714|Narcotics|narcotics|mesh-ancestor
93071531|NCT03730714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071532|NCT03730714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071533|NCT03730714|Analgesics|analgesics|mesh-ancestor
93071534|NCT03730714|Sensory System Agents|sensory system agents|mesh-ancestor
93071535|NCT03730714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071536|NCT03730714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93071537|NCT03730714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93071538|NCT03730714|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071539|NCT03730714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071540|NCT03730714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071541|NCT03730714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93071542|NCT03730714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93071543|NCT03730714|Autonomic Agents|autonomic agents|mesh-ancestor
93071544|NCT03730714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93071545|NCT03730714|Respiratory System Agents|respiratory system agents|mesh-ancestor
93071546|NCT03730714|Mydriatics|mydriatics|mesh-ancestor
93071547|NCT03730714|Sympathomimetics|sympathomimetics|mesh-ancestor
93071548|NCT03730714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93071549|NCT00106353|Temsirolimus|temsirolimus|mesh-list
93071550|NCT00106353|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93071551|NCT00106353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93071552|NCT00106353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071553|NCT00106353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071554|NCT00106353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071555|NCT00106353|Immunologic Factors|immunologic factors|mesh-ancestor
93071556|NCT00106353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071557|NCT00106353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071558|NCT01087983|Metformin|metformin|mesh-list
93071559|NCT01087983|Sirolimus|sirolimus|mesh-list
93071560|NCT01087983|Lapatinib|lapatinib|mesh-list
93071561|NCT01087983|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071562|NCT01087983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071563|NCT01087983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071564|NCT01087983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071565|NCT01087983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93071566|NCT01087983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071567|NCT01087983|Antifungal Agents|antifungal agents|mesh-ancestor
93071568|NCT01087983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071569|NCT01087983|Immunologic Factors|immunologic factors|mesh-ancestor
93071570|NCT01087983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93071571|NCT01087983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071572|NCT01087983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071573|NCT00080301|Capecitabine|capecitabine|mesh-list
93071574|NCT00080301|Epothilones|epothilones|mesh-list
93071575|NCT00080301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93071576|NCT00080301|Antimetabolites|antimetabolites|mesh-ancestor
93071577|NCT00080301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071578|NCT00080301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071579|NCT00080301|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071580|NCT00080301|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071581|NCT00080301|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071582|NCT03961503|Vancomycin|vancomycin|mesh-list
93071583|NCT03961503|Daptomycin|daptomycin|mesh-list
93071584|NCT03961503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071585|NCT03961503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071586|NCT00079677|Modafinil|modafinil|mesh-list
93071587|NCT00079677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93071588|NCT00079677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071589|NCT00079677|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
93071590|NCT00079677|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93071591|NCT00079677|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92341111|NCT05015621|Irinotecan|irinotecan|mesh-list
93071592|NCT00079677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071593|NCT01081353|Aspirin|aspirin|mesh-list
93071594|NCT01081353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93071595|NCT01081353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93071596|NCT01081353|Analgesics|analgesics|mesh-ancestor
93071597|NCT01081353|Sensory System Agents|sensory system agents|mesh-ancestor
93071598|NCT01081353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071599|NCT01081353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071600|NCT01081353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071601|NCT01081353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071602|NCT01081353|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93071603|NCT01081353|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93071604|NCT01081353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071605|NCT01081353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93071606|NCT01081353|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93071607|NCT01081353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071608|NCT01081353|Antipyretics|antipyretics|mesh-ancestor
93071609|NCT00095121|Lamivudine|lamivudine|mesh-list
93071610|NCT00095121|Adefovir|adefovir|mesh-list
93071611|NCT00095121|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
93071612|NCT00095121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
93071613|NCT00095121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071614|NCT00095121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071615|NCT00095121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071616|NCT00095121|Antiviral Agents|antiviral agents|mesh-ancestor
93071617|NCT00095121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071618|NCT00095121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
93071619|NCT00095121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
93071620|NCT01081431|Lenalidomide|lenalidomide|mesh-list
93071621|NCT01081431|Immunologic Factors|immunologic factors|mesh-ancestor
93071622|NCT01081431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071623|NCT01081431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071624|NCT01081431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071625|NCT01081431|Growth Substances|growth substances|mesh-ancestor
93071626|NCT01081431|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071627|NCT01081431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071628|NCT03962829|1-(3-chlorophenyl)piperazine|1-(3-chlorophenyl)piperazine|mesh-list
93071629|NCT03962829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93071630|NCT03962829|Serotonin Agents|serotonin agents|mesh-ancestor
93071631|NCT03962829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071632|NCT03962829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071633|NCT03962829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071634|NCT01084473|Dexmedetomidine|dexmedetomidine|mesh-list
93071636|NCT01084473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93071637|NCT01084473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071638|NCT01084473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071640|NCT01084473|Analgesics|analgesics|mesh-ancestor
93071641|NCT01084473|Sensory System Agents|sensory system agents|mesh-ancestor
93071642|NCT01084473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071643|NCT01084473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93071644|NCT01084473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93071645|NCT01084473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93071646|NCT01084473|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071647|NCT01084473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071648|NCT01084473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071649|NCT01084473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93071650|NCT01084473|Narcotics|narcotics|mesh-ancestor
93071651|NCT01088373|Lenalidomide|lenalidomide|mesh-list
93071652|NCT01088373|Azacitidine|azacitidine|mesh-list
93071653|NCT01088373|Immunologic Factors|immunologic factors|mesh-ancestor
93071654|NCT01088373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071655|NCT01088373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071656|NCT01088373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071657|NCT01088373|Growth Substances|growth substances|mesh-ancestor
93071658|NCT01088373|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071659|NCT01088373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071660|NCT01088373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93071661|NCT01088373|Antimetabolites|antimetabolites|mesh-ancestor
93071662|NCT01088373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071663|NCT01088373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071664|NCT01088451|Insulin|insulin|mesh-list
93071665|NCT01088451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071666|NCT01088451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071667|NCT00075218|Sunitinib|sunitinib|mesh-list
93071668|NCT00075218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071669|NCT00075218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071670|NCT00075218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071671|NCT00075218|Growth Substances|growth substances|mesh-ancestor
93071672|NCT00075218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071673|NCT00075218|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071674|NCT00075218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93071675|NCT00075218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071676|NCT00075218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071677|NCT01089140|Tranexamic Acid|tranexamic acid|mesh-list
93071678|NCT01089140|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93071679|NCT01089140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93071680|NCT01089140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071681|NCT01089140|Hemostatics|hemostatics|mesh-ancestor
93071682|NCT01089140|Coagulants|coagulants|mesh-ancestor
93071683|NCT00094653|Ipilimumab|ipilimumab|mesh-list
93071684|NCT00094653|Vaccines|vaccines|mesh-list
93071685|NCT00094653|Antibodies|antibodies|mesh-list
93071686|NCT00094653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93071687|NCT00094653|Immunologic Factors|immunologic factors|mesh-ancestor
93071688|NCT00094653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071689|NCT00094653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93071690|NCT00094653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071691|NCT00094653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93071692|NCT00094653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071693|NCT00104247|Verapamil|verapamil|mesh-list
93071694|NCT00104247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93071695|NCT00104247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
93071696|NCT00104247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93071697|NCT00104247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071698|NCT00104247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93071699|NCT00104247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071700|NCT00104247|Vasodilator Agents|vasodilator agents|mesh-ancestor
93071701|NCT03565900|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
93071702|NCT03565900|Immunologic Factors|immunologic factors|mesh-ancestor
93071703|NCT03565900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071704|NCT05665348|Bevacizumab|bevacizumab|mesh-list
93071705|NCT05665348|Ipilimumab|ipilimumab|mesh-list
93071706|NCT05665348|Atezolizumab|atezolizumab|mesh-list
93071707|NCT05665348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93071708|NCT05665348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93071709|NCT05665348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071710|NCT05665348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071711|NCT05665348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071712|NCT05665348|Growth Substances|growth substances|mesh-ancestor
93071713|NCT05665348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071714|NCT05665348|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071715|NCT05665348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93071716|NCT05665348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071717|NCT05665348|Immunologic Factors|immunologic factors|mesh-ancestor
93071718|NCT03726736|Docetaxel|docetaxel|mesh-list
93071719|NCT03726736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071720|NCT03726736|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071721|NCT03726736|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071722|NCT03726736|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071723|NCT03726736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071724|NCT03591406|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
93071725|NCT03591406|Hematinics|hematinics|mesh-ancestor
93071726|NCT03726580|Propofol|propofol|mesh-list
93071727|NCT03726580|Sevoflurane|sevoflurane|mesh-list
93071728|NCT03726580|Isoflurane|isoflurane|mesh-list
93071729|NCT03726580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93071730|NCT03726580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071731|NCT03726580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071732|NCT03726580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93071733|NCT03726580|Anesthetics, General|anesthetics, general|mesh-ancestor
93071734|NCT03726580|Anesthetics|anesthetics|mesh-ancestor
93071735|NCT03726580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93071736|NCT03726580|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93071737|NCT03730558|Aflibercept|aflibercept|mesh-list
93071738|NCT03730558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071739|NCT03730558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071740|NCT03730558|Growth Substances|growth substances|mesh-ancestor
93071741|NCT03730558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071742|NCT03730558|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071743|NCT03730558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071744|NCT03588910|Acetaminophen|acetaminophen|mesh-list
93071745|NCT03588910|Ibuprofen|ibuprofen|mesh-list
93071746|NCT03588910|Oxycodone|oxycodone|mesh-list
93071747|NCT03588910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93071748|NCT03588910|Analgesics|analgesics|mesh-ancestor
93071749|NCT03588910|Sensory System Agents|sensory system agents|mesh-ancestor
93071750|NCT03588910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071751|NCT03588910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071752|NCT03588910|Antipyretics|antipyretics|mesh-ancestor
93071753|NCT03588910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93071754|NCT03588910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071755|NCT03588910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071756|NCT03588910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93071757|NCT03588910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071758|NCT03588910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071759|NCT03588910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92728708|NCT04558580|Rufinamide|rufinamide|mesh-list
93071760|NCT03588910|Narcotics|narcotics|mesh-ancestor
93071761|NCT03588910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071762|NCT03730402|Bupivacaine|bupivacaine|mesh-list
93071763|NCT03730402|Anesthetics, Local|anesthetics, local|mesh-ancestor
93071764|NCT03730402|Anesthetics|anesthetics|mesh-ancestor
93071765|NCT03730402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071766|NCT03730402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071767|NCT03730402|Sensory System Agents|sensory system agents|mesh-ancestor
93071768|NCT03730402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071769|NCT00103857|Metformin|metformin|mesh-list
93071770|NCT00103857|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
93071771|NCT00103857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071772|NCT00103857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071773|NCT00103857|Incretins|incretins|mesh-ancestor
93071774|NCT00103857|Hormones|hormones|mesh-ancestor
93071775|NCT00103857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071776|NCT00103857|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93071777|NCT00103857|Protease Inhibitors|protease inhibitors|mesh-ancestor
93071778|NCT00103857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071779|NCT00103857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071780|NCT03587584|Bupivacaine|bupivacaine|mesh-list
93071781|NCT03587584|Anesthetics, Local|anesthetics, local|mesh-ancestor
93071782|NCT03587584|Anesthetics|anesthetics|mesh-ancestor
93071783|NCT03587584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071784|NCT03587584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071785|NCT03587584|Sensory System Agents|sensory system agents|mesh-ancestor
93071786|NCT03587584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071787|NCT03586726|Rifampin|rifampin|mesh-list
93071788|NCT03586726|Balovaptan|balovaptan|mesh-list
93071789|NCT03586726|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
93071791|NCT03586726|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93071792|NCT03586726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341135|NCT05289167|Abatacept|abatacept|mesh-list
93071793|NCT03586726|Leprostatic Agents|leprostatic agents|mesh-ancestor
93071794|NCT03586726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93071795|NCT03586726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071796|NCT03586726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071797|NCT03586726|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
93071798|NCT03586726|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
93071799|NCT03586726|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
93071800|NCT03586726|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
93071801|NCT03586726|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
93071802|NCT03586726|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
93071803|NCT03586726|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
93071804|NCT03586726|Natriuretic Agents|natriuretic agents|mesh-ancestor
93071805|NCT03586726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071806|NCT03725878|Folic Acid|folic acid|mesh-list
93071807|NCT03725878|Hematinics|hematinics|mesh-ancestor
93071808|NCT03725878|Vitamin B Complex|vitamin b complex|mesh-ancestor
93071809|NCT03725878|Vitamins|vitamins|mesh-ancestor
93071810|NCT03725878|Micronutrients|micronutrients|mesh-ancestor
93071811|NCT03725878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071812|NCT03721900|Ketamine|ketamine|mesh-list
93071813|NCT03721900|Analgesics|analgesics|mesh-ancestor
93071814|NCT03721900|Sensory System Agents|sensory system agents|mesh-ancestor
93071815|NCT03721900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071816|NCT03721900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071817|NCT03721900|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93071818|NCT03721900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93071819|NCT03721900|Anesthetics, General|anesthetics, general|mesh-ancestor
93071820|NCT03721900|Anesthetics|anesthetics|mesh-ancestor
93071821|NCT03721900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071822|NCT03721900|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93071823|NCT03721900|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93071824|NCT03721900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071825|NCT03721900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071826|NCT03585712|Norgestrel|norgestrel|mesh-list
93071827|NCT03585712|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93071828|NCT03585712|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93071829|NCT03585712|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93071830|NCT03585712|Contraceptive Agents|contraceptive agents|mesh-ancestor
93071831|NCT03585712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93071832|NCT03585712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071833|NCT03585712|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93071834|NCT03585712|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93071836|NCT01082510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93071837|NCT01082510|Antimetabolites|antimetabolites|mesh-ancestor
93071838|NCT01082510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071839|NCT01082510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071840|NCT03583372|Tolterodine Tartrate|tolterodine tartrate|mesh-list
93071841|NCT03583372|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93071842|NCT03583372|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93071843|NCT03583372|Cholinergic Agents|cholinergic agents|mesh-ancestor
93071844|NCT03583372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071845|NCT03583372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071846|NCT03583372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071847|NCT03583372|Urological Agents|urological agents|mesh-ancestor
93071848|NCT01091324|Dextromethorphan|dextromethorphan|mesh-list
93071849|NCT01091324|Silymarin|silymarin|mesh-list
93071850|NCT01091324|Antitussive Agents|antitussive agents|mesh-ancestor
93071851|NCT01091324|Respiratory System Agents|respiratory system agents|mesh-ancestor
93071852|NCT01091324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92341147|NCT00382499|Lidocaine|lidocaine|mesh-list
93071853|NCT01091324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93071854|NCT01091324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071855|NCT01091324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071856|NCT01091324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071857|NCT01091324|Antioxidants|antioxidants|mesh-ancestor
93071858|NCT01091324|Protective Agents|protective agents|mesh-ancestor
93071859|NCT05782608|Ibuprofen|ibuprofen|mesh-list
93071860|NCT05782608|Ketorolac|ketorolac|mesh-list
93071861|NCT05782608|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93071862|NCT05782608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93071863|NCT05782608|Analgesics|analgesics|mesh-ancestor
93071864|NCT05782608|Sensory System Agents|sensory system agents|mesh-ancestor
93071865|NCT05782608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071866|NCT05782608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071867|NCT05782608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93071868|NCT05782608|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071869|NCT05782608|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93071870|NCT05782608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071871|NCT05782608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071872|NCT05782426|Paclitaxel|paclitaxel|mesh-list
93071873|NCT05782426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93071874|NCT05782426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071875|NCT05782426|Tubulin Modulators|tubulin modulators|mesh-ancestor
93071876|NCT05782426|Antimitotic Agents|antimitotic agents|mesh-ancestor
93071877|NCT05782426|Mitosis Modulators|mitosis modulators|mesh-ancestor
93071878|NCT05782426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071879|NCT05782348|Listerine|listerine|mesh-list
93071880|NCT05782348|Sodium Fluoride|sodium fluoride|mesh-list
93071881|NCT05782348|Cariostatic Agents|cariostatic agents|mesh-ancestor
93071882|NCT05782348|Protective Agents|protective agents|mesh-ancestor
93071883|NCT05782348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071884|NCT05782348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93071885|NCT05782348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93071886|NCT05782192|Alogliptin|alogliptin|mesh-list
93071887|NCT05782192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93071888|NCT05782192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071889|NCT05782192|Incretins|incretins|mesh-ancestor
93071890|NCT05782192|Hormones|hormones|mesh-ancestor
93071891|NCT05782192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071892|NCT05782192|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
93071893|NCT05782192|Protease Inhibitors|protease inhibitors|mesh-ancestor
93071894|NCT05782192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071895|NCT05782192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071896|NCT05781997|Mydriatics|mydriatics|mesh-list
93071897|NCT05781997|Autonomic Agents|autonomic agents|mesh-ancestor
93071898|NCT05781997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071899|NCT05781997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071900|NCT05781854|Dexmedetomidine|dexmedetomidine|mesh-list
93071901|NCT05781854|Bupivacaine|bupivacaine|mesh-list
93071902|NCT05781854|Anesthetics, Local|anesthetics, local|mesh-ancestor
93071903|NCT05781854|Anesthetics|anesthetics|mesh-ancestor
93071904|NCT05781854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071905|NCT05781854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071906|NCT05781854|Sensory System Agents|sensory system agents|mesh-ancestor
92728857|NCT00637468|Antipyretics|antipyretics|mesh-ancestor
93071907|NCT05781854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93071908|NCT05781854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93071909|NCT05781854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93071910|NCT05781854|Analgesics|analgesics|mesh-ancestor
93071911|NCT05781854|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93071912|NCT05781854|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93071913|NCT05781854|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93071914|NCT05781854|Adrenergic Agents|adrenergic agents|mesh-ancestor
93071915|NCT05781854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93071916|NCT05781854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071917|NCT05781685|Testosterone|testosterone|mesh-list
93071918|NCT05781685|Androgens|androgens|mesh-ancestor
93071919|NCT05781685|Hormones|hormones|mesh-ancestor
93071920|NCT05781685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93071921|NCT05781685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071922|NCT05781633|Bevacizumab|bevacizumab|mesh-list
93071923|NCT05781633|Etoposide|etoposide|mesh-list
93071924|NCT05781633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93071925|NCT05781633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071926|NCT05781633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071927|NCT05781633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071928|NCT05781633|Growth Substances|growth substances|mesh-ancestor
93071929|NCT05781633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071930|NCT05781633|Growth Inhibitors|growth inhibitors|mesh-ancestor
93071931|NCT05781633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93071932|NCT05781633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93071934|NCT05781633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071935|NCT05781633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071936|NCT05781620|Vitamin D|vitamin d|mesh-list
93071937|NCT05781620|Vitamins|vitamins|mesh-ancestor
93071938|NCT05781620|Micronutrients|micronutrients|mesh-ancestor
93071939|NCT05781620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071940|NCT05781620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93071941|NCT05781529|Hyaluronic Acid|hyaluronic acid|mesh-list
93071942|NCT05781529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93071943|NCT05781529|Immunologic Factors|immunologic factors|mesh-ancestor
93071944|NCT05781529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071945|NCT05781529|Viscosupplements|viscosupplements|mesh-ancestor
93071946|NCT05781529|Protective Agents|protective agents|mesh-ancestor
93071947|NCT05780554|Cyclophosphamide|cyclophosphamide|mesh-list
93071948|NCT05780554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93071949|NCT05780554|Immunologic Factors|immunologic factors|mesh-ancestor
93071950|NCT05780554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071951|NCT05780554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93071952|NCT05780554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93071953|NCT05780554|Alkylating Agents|alkylating agents|mesh-ancestor
93071954|NCT05780554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071955|NCT05780554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071956|NCT05780554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93071957|NCT05869812|Calcium, Dietary|calcium, dietary|mesh-list
93071958|NCT05869812|Calcium|calcium|mesh-list
93071959|NCT05869812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93071960|NCT05869812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071961|NCT05869812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93071962|NCT05869760|Carotenoids|carotenoids|mesh-list
93071963|NCT05869760|Antioxidants|antioxidants|mesh-ancestor
93071964|NCT05869760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071965|NCT05869760|Protective Agents|protective agents|mesh-ancestor
93071966|NCT05869760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071967|NCT05869591|Apixaban|apixaban|mesh-list
93071968|NCT05869591|Edoxaban|edoxaban|mesh-list
93071969|NCT05869591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93071970|NCT05869591|Antithrombins|antithrombins|mesh-ancestor
93071971|NCT05869591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93071972|NCT05869591|Protease Inhibitors|protease inhibitors|mesh-ancestor
93071973|NCT05869591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93071974|NCT05869591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071975|NCT05869591|Anticoagulants|anticoagulants|mesh-ancestor
93071976|NCT05869578|Anesthetics|anesthetics|mesh-list
93071977|NCT05869578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93071978|NCT05869578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071979|NCT05869227|Capecitabine|capecitabine|mesh-list
93071980|NCT05869227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93071981|NCT05869227|Antimetabolites|antimetabolites|mesh-ancestor
93071982|NCT05869227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93071983|NCT05869227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071984|NCT05869201|Vaccines|vaccines|mesh-list
93071985|NCT05869201|Immunologic Factors|immunologic factors|mesh-ancestor
93071986|NCT05869201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071987|NCT05869136|Hyaluronic Acid|hyaluronic acid|mesh-list
93071988|NCT05869136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93071989|NCT05869136|Immunologic Factors|immunologic factors|mesh-ancestor
93071990|NCT05869136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93071991|NCT05869136|Viscosupplements|viscosupplements|mesh-ancestor
93071992|NCT05869136|Protective Agents|protective agents|mesh-ancestor
93071993|NCT05869097|Trifluridine|trifluridine|mesh-list
93071994|NCT05869097|Bevacizumab|bevacizumab|mesh-list
93071995|NCT05869097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93071996|NCT05869097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93071997|NCT05869097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93071998|NCT05869097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93071999|NCT05869097|Growth Substances|growth substances|mesh-ancestor
93072000|NCT05869097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072001|NCT05869097|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072002|NCT05869097|Antimetabolites|antimetabolites|mesh-ancestor
93072003|NCT05869097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072004|NCT05869097|Antiviral Agents|antiviral agents|mesh-ancestor
92140522|NCT01396057|Dexamethasone|dexamethasone|mesh-list
93072005|NCT05869097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072006|NCT05868993|Ropivacaine|ropivacaine|mesh-list
93072007|NCT05868993|Anesthetics, Local|anesthetics, local|mesh-ancestor
93072008|NCT05868993|Anesthetics|anesthetics|mesh-ancestor
93072009|NCT05868993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072010|NCT05868993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072011|NCT05868993|Sensory System Agents|sensory system agents|mesh-ancestor
93072012|NCT05868993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072014|NCT05868967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93072015|NCT05868720|Risperidone|risperidone|mesh-list
93072016|NCT05868720|Aripiprazole|aripiprazole|mesh-list
93072017|NCT05868720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
93072018|NCT05868720|Serotonin Agents|serotonin agents|mesh-ancestor
93072019|NCT05868720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072020|NCT05868720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072021|NCT05868720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072022|NCT05868720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
93072023|NCT05868720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93072024|NCT05868720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072025|NCT05868720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93072026|NCT05868720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
93072027|NCT05868720|Dopamine Agents|dopamine agents|mesh-ancestor
93072028|NCT05868720|Antidepressive Agents|antidepressive agents|mesh-ancestor
93072029|NCT05868720|Dopamine Agonists|dopamine agonists|mesh-ancestor
93072030|NCT05868720|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
93072031|NCT05868720|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93072032|NCT05868720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
93072033|NCT05868720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
93072034|NCT05868525|Aspirin|aspirin|mesh-list
93072035|NCT05868525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93072036|NCT05868525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93072037|NCT05868525|Analgesics|analgesics|mesh-ancestor
93072038|NCT05868525|Sensory System Agents|sensory system agents|mesh-ancestor
93072039|NCT05868525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072040|NCT05868525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072041|NCT05868525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93072042|NCT05868525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072043|NCT05868525|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93072044|NCT05868525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93072045|NCT05868525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072046|NCT05868525|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93072047|NCT05868525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93072048|NCT05868525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072049|NCT05868525|Antipyretics|antipyretics|mesh-ancestor
93072050|NCT05868395|Rituximab|rituximab|mesh-list
93072051|NCT05868395|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93072052|NCT05868395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072053|NCT05868395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072054|NCT05868395|Immunologic Factors|immunologic factors|mesh-ancestor
93072055|NCT05868395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729007|NCT04538976|Urological Agents|urological agents|mesh-ancestor
93072056|NCT05868395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072057|NCT05868395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93072058|NCT05868395|Alkylating Agents|alkylating agents|mesh-ancestor
93072059|NCT05868395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072060|NCT05868317|Fluorouracil|fluorouracil|mesh-list
93072061|NCT05868317|Irinotecan|irinotecan|mesh-list
93072062|NCT05868317|Folfirinox|folfirinox|mesh-list
93072063|NCT05868317|Oxaliplatin|oxaliplatin|mesh-list
93072064|NCT05868317|Antimetabolites|antimetabolites|mesh-ancestor
93072065|NCT05868317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072066|NCT05868317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93072067|NCT05868317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072068|NCT05868317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072069|NCT05868317|Immunologic Factors|immunologic factors|mesh-ancestor
93072070|NCT05868317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072071|NCT05868317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
93072072|NCT05868317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93072073|NCT05868317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072074|NCT05868200|Listerine|listerine|mesh-list
93072075|NCT05868200|Sodium Fluoride|sodium fluoride|mesh-list
93072076|NCT05868200|Cariostatic Agents|cariostatic agents|mesh-ancestor
93072077|NCT05868200|Protective Agents|protective agents|mesh-ancestor
93072078|NCT05868200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072079|NCT05868200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93072080|NCT05868200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072081|NCT05868109|Nitric Oxide|nitric oxide|mesh-list
93072082|NCT05868109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93072083|NCT05868109|Autonomic Agents|autonomic agents|mesh-ancestor
93072084|NCT05868109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072085|NCT05868109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072086|NCT05868109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93072087|NCT05868109|Respiratory System Agents|respiratory system agents|mesh-ancestor
93072088|NCT05868109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93072089|NCT05868109|Antioxidants|antioxidants|mesh-ancestor
93072090|NCT05868109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072091|NCT05868109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072092|NCT05868109|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93072093|NCT05868109|Vasodilator Agents|vasodilator agents|mesh-ancestor
93072094|NCT05868109|Gasotransmitters|gasotransmitters|mesh-ancestor
93072095|NCT05868109|Protective Agents|protective agents|mesh-ancestor
93072096|NCT05867472|Sevoflurane|sevoflurane|mesh-list
93072097|NCT05867472|Isoflurane|isoflurane|mesh-list
93072098|NCT05867472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93072099|NCT05867472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93072100|NCT05867472|Anesthetics, General|anesthetics, general|mesh-ancestor
93072101|NCT05867472|Anesthetics|anesthetics|mesh-ancestor
93072102|NCT05867472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072103|NCT05867472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072104|NCT05865080|Ketamine|ketamine|mesh-list
93072105|NCT05865080|Analgesics|analgesics|mesh-ancestor
93072106|NCT05865080|Sensory System Agents|sensory system agents|mesh-ancestor
93072107|NCT05865080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072108|NCT05865080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072109|NCT05865080|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93072110|NCT05865080|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93072111|NCT05865080|Anesthetics, General|anesthetics, general|mesh-ancestor
93072112|NCT05865080|Anesthetics|anesthetics|mesh-ancestor
93072113|NCT05865080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072114|NCT05865080|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93072115|NCT05865080|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93072116|NCT05865080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072117|NCT05865080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072118|NCT05863286|Botulinum Toxins|botulinum toxins|mesh-list
93072119|NCT05863286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
93072120|NCT05863286|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
93072121|NCT05863286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
93072122|NCT05863286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93072123|NCT05863286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072124|NCT05863286|Cholinergic Agents|cholinergic agents|mesh-ancestor
93072125|NCT05863286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072126|NCT05863286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072127|NCT05863286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93072128|NCT05863286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072129|NCT05851768|Dexmedetomidine|dexmedetomidine|mesh-list
92729104|NCT01124422|Xhance|xhance|mesh-list
93072130|NCT05851768|Bupivacaine|bupivacaine|mesh-list
93072131|NCT05851768|Anesthetics, Local|anesthetics, local|mesh-ancestor
93072132|NCT05851768|Anesthetics|anesthetics|mesh-ancestor
93072133|NCT05851768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072134|NCT05851768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072135|NCT05851768|Sensory System Agents|sensory system agents|mesh-ancestor
93072136|NCT05851768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072137|NCT05851768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93072138|NCT05851768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93072139|NCT05851768|Analgesics|analgesics|mesh-ancestor
93072140|NCT05851768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
93072141|NCT05851768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93072142|NCT05851768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93072143|NCT05851768|Adrenergic Agents|adrenergic agents|mesh-ancestor
93072144|NCT05851768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072145|NCT05851768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072146|NCT05768373|Fluorides|fluorides|mesh-list
93072147|NCT05768373|Cariostatic Agents|cariostatic agents|mesh-ancestor
93072148|NCT05768373|Protective Agents|protective agents|mesh-ancestor
92530847|NCT00001586|Fludarabine|fludarabine|mesh-list
93072149|NCT05768373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072150|NCT05734690|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
93072151|NCT05734690|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93072152|NCT05734690|Adrenergic Agents|adrenergic agents|mesh-ancestor
93072153|NCT05734690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072154|NCT05734690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072155|NCT05734690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072156|NCT05733624|Cyclosporine|cyclosporine|mesh-list
93072157|NCT05733624|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93072158|NCT05733624|Cyclosporins|cyclosporins|mesh-list
93072159|NCT05733624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072160|NCT05733624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072161|NCT05733624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072162|NCT05733624|Immunologic Factors|immunologic factors|mesh-ancestor
93072163|NCT05733624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072164|NCT05733624|Antifungal Agents|antifungal agents|mesh-ancestor
93072165|NCT05733624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072166|NCT05733624|Dermatologic Agents|dermatologic agents|mesh-ancestor
93072167|NCT05733624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072168|NCT05733624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
93072169|NCT05733624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93072170|NCT05717049|Theophylline|theophylline|mesh-list
93072171|NCT05717049|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93072172|NCT05717049|Autonomic Agents|autonomic agents|mesh-ancestor
93072173|NCT05717049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072174|NCT05717049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072175|NCT05717049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93072176|NCT05717049|Respiratory System Agents|respiratory system agents|mesh-ancestor
93072177|NCT05717049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93072178|NCT05717049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072179|NCT05717049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072180|NCT05717049|Vasodilator Agents|vasodilator agents|mesh-ancestor
93072181|NCT05717049|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93072182|NCT05717049|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93072183|NCT05717049|Purinergic Agents|purinergic agents|mesh-ancestor
93072184|NCT05717049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072185|NCT05645900|Vaccines|vaccines|mesh-list
93072186|NCT05645900|Immunologic Factors|immunologic factors|mesh-ancestor
93072187|NCT05645900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072188|NCT05642572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93072189|NCT05642572|Osimertinib|osimertinib|mesh-list
93072190|NCT05642572|Ramucirumab|ramucirumab|mesh-list
93072191|NCT05642572|Antibodies|antibodies|mesh-list
93072192|NCT05642572|Immunoglobulins|immunoglobulins|mesh-list
93072193|NCT05642572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93072194|NCT05642572|Lexatumumab|lexatumumab|mesh-list
93072195|NCT05642572|Immunologic Factors|immunologic factors|mesh-ancestor
93072196|NCT05642572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072197|NCT05642572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072198|NCT05642572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93072199|NCT05642572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072200|NCT05642572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072201|NCT05539365|Pembrolizumab|pembrolizumab|mesh-list
93072202|NCT05539365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072203|NCT05539365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072204|NCT05539365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072205|NCT05539365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072206|NCT05518799|Midazolam|midazolam|mesh-list
93072207|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93072208|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93072209|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072210|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072211|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93072212|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93072213|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93072214|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93072215|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
93072216|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
93072217|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
93072218|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
93072219|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072220|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072221|NCT05447702|Paclitaxel|paclitaxel|mesh-list
93072222|NCT05447702|Cyclophosphamide|cyclophosphamide|mesh-list
93072223|NCT05447702|Apatinib|apatinib|mesh-list
93072224|NCT05447702|Epirubicin|epirubicin|mesh-list
93072225|NCT05447702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93072226|NCT05447702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072227|NCT05447702|Tubulin Modulators|tubulin modulators|mesh-ancestor
93072228|NCT05447702|Antimitotic Agents|antimitotic agents|mesh-ancestor
93072229|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
93072230|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072231|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072232|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
93072233|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072234|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072235|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93072236|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
93072237|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93072238|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93072239|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072240|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93072241|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93072242|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93072243|NCT05418010|Natalizumab|natalizumab|mesh-list
93072244|NCT05418010|Immunologic Factors|immunologic factors|mesh-ancestor
93072245|NCT05418010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072246|NCT05413369|Metformin|metformin|mesh-list
93072247|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
93072248|NCT05413369|Lixisenatide|lixisenatide|mesh-list
93072249|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
93072250|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93072251|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072252|NCT05413369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072253|NCT05391971|Bupivacaine|bupivacaine|mesh-list
93072254|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
93072255|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
93072256|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072257|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072258|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
93072259|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072260|NCT05361720|Nivolumab|nivolumab|mesh-list
93072261|NCT05361720|Ipilimumab|ipilimumab|mesh-list
93072262|NCT05361720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072263|NCT05361720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072264|NCT05361720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072265|NCT05361720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072266|NCT05323396|Metronidazole|metronidazole|mesh-list
93072267|NCT05323396|Albendazole|albendazole|mesh-list
93072268|NCT05323396|Praziquantel|praziquantel|mesh-list
93072269|NCT05323396|Antiparasitic Agents|antiparasitic agents|mesh-list
93072270|NCT05323396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072271|NCT05323396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93072272|NCT05323396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93072273|NCT05323396|Anthelmintics|anthelmintics|mesh-ancestor
93072274|NCT05323396|Anticestodal Agents|anticestodal agents|mesh-ancestor
93072275|NCT05323396|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
93072276|NCT05323396|Tubulin Modulators|tubulin modulators|mesh-ancestor
93072277|NCT05323396|Antimitotic Agents|antimitotic agents|mesh-ancestor
93072278|NCT05323396|Mitosis Modulators|mitosis modulators|mesh-ancestor
93072279|NCT05323396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072280|NCT05323396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072281|NCT05285917|Hydroxyurea|hydroxyurea|mesh-list
93072282|NCT05285917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072283|NCT05285917|Antisickling Agents|antisickling agents|mesh-ancestor
93072284|NCT05285917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072285|NCT05285917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072286|NCT05285917|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93072288|NCT05266469|Ocrelizumab|ocrelizumab|mesh-list
93072289|NCT05266469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072290|NCT05266469|Immunologic Factors|immunologic factors|mesh-ancestor
93072291|NCT05266469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072292|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
93072293|NCT05222529|Bromides|bromides|mesh-list
93072294|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
93072295|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93072296|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93072297|NCT05222529|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93072298|NCT05222529|Cholinergic Agents|cholinergic agents|mesh-ancestor
93072299|NCT05222529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072300|NCT05222529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072301|NCT05222529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072302|NCT05186779|Progestins|progestins|mesh-list
93072303|NCT05186779|Hormones|hormones|mesh-ancestor
93072304|NCT05186779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072305|NCT05186779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072306|NCT05178550|Heparin|heparin|mesh-list
93072307|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
93072308|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93072309|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93072310|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072311|NCT05168566|Maleic acid|maleic acid|mesh-list
93072312|NCT05168566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072313|NCT05168566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072314|NCT05085782|Propranolol|propranolol|mesh-list
93072315|NCT05085782|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93072316|NCT05085782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93072317|NCT05085782|Adrenergic Agents|adrenergic agents|mesh-ancestor
93072318|NCT05085782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072319|NCT05085782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072320|NCT05085782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072321|NCT05085782|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93072322|NCT05085782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93072323|NCT05085782|Vasodilator Agents|vasodilator agents|mesh-ancestor
93072324|NCT05011123|Vaccines|vaccines|mesh-list
93072325|NCT05011123|Immunologic Factors|immunologic factors|mesh-ancestor
93072326|NCT05011123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072327|NCT04908449|Bupivacaine|bupivacaine|mesh-list
93072328|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
93072329|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
93072330|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072331|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072332|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
93072333|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072334|NCT04829383|Bevacizumab|bevacizumab|mesh-list
93072335|NCT04829383|Atezolizumab|atezolizumab|mesh-list
93072336|NCT04829383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072337|NCT04829383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072338|NCT04829383|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072339|NCT04829383|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072340|NCT04829383|Growth Substances|growth substances|mesh-ancestor
93072341|NCT04829383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072342|NCT04829383|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072343|NCT04829383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072344|NCT04829383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072345|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
93072346|NCT04821375|Estrogens|estrogens|mesh-list
93072347|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93072348|NCT04821375|Hormones|hormones|mesh-ancestor
93072349|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072350|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072351|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
93072352|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
93072353|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
93072354|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93072355|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93072356|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
93072357|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072358|NCT04781387|REP 3123|rep 3123|mesh-list
93072359|NCT04781387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93072360|NCT04781387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072361|NCT04732195|Pilocarpine|pilocarpine|mesh-list
93072362|NCT04732195|Miotics|miotics|mesh-ancestor
93072363|NCT04732195|Autonomic Agents|autonomic agents|mesh-ancestor
93072364|NCT04732195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072365|NCT04732195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072366|NCT04732195|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
93072367|NCT04732195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
93072368|NCT04732195|Cholinergic Agents|cholinergic agents|mesh-ancestor
93072369|NCT04732195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072370|NCT04732195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072371|NCT04704921|Ranibizumab|ranibizumab|mesh-list
93072372|NCT04704921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072373|NCT04704921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072374|NCT04704921|Growth Substances|growth substances|mesh-ancestor
93072375|NCT04704921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072376|NCT04704921|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072377|NCT04704921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072378|NCT04703426|Pembrolizumab|pembrolizumab|mesh-list
93072379|NCT04703426|Sargramostim|sargramostim|mesh-list
93072380|NCT04703426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072381|NCT04703426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072382|NCT04703426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072383|NCT04703426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072384|NCT04703426|Immunologic Factors|immunologic factors|mesh-ancestor
93072385|NCT04703426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072386|NCT04681482|Apixaban|apixaban|mesh-list
93072387|NCT04681482|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93072388|NCT04681482|Antithrombins|antithrombins|mesh-ancestor
93072389|NCT04681482|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93072390|NCT04681482|Protease Inhibitors|protease inhibitors|mesh-ancestor
93072391|NCT04681482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072392|NCT04681482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072393|NCT04681482|Anticoagulants|anticoagulants|mesh-ancestor
93072394|NCT04676477|Osimertinib|osimertinib|mesh-list
93072395|NCT04676477|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
93072396|NCT04676477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93072397|NCT04676477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072398|NCT04676477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93072399|NCT04676477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072400|NCT04676477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072401|NCT04676477|Immunologic Factors|immunologic factors|mesh-ancestor
93072402|NCT04676477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072403|NCT04676477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072404|NCT04635644|Morphine|morphine|mesh-list
93072405|NCT04635644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93072406|NCT04635644|Narcotics|narcotics|mesh-ancestor
93072407|NCT04635644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072408|NCT04635644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072409|NCT04635644|Analgesics|analgesics|mesh-ancestor
93072410|NCT04635644|Sensory System Agents|sensory system agents|mesh-ancestor
93072411|NCT04635644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072412|NCT04631601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93072413|NCT04631601|Androgens|androgens|mesh-list
93072414|NCT04631601|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
93072415|NCT04631601|Hormones|hormones|mesh-ancestor
93072416|NCT04631601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072417|NCT04631601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072418|NCT04631601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072419|NCT04631601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072420|NCT04631601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072421|NCT04631601|Androgen Antagonists|androgen antagonists|mesh-ancestor
93072422|NCT04631601|Hormone Antagonists|hormone antagonists|mesh-ancestor
93072423|NCT04580277|Tofacitinib|tofacitinib|mesh-list
93072424|NCT04580277|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
93072425|NCT04580277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93072426|NCT04580277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072427|NCT04580277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072428|NCT04571229|Mifamurtide|mifamurtide|mesh-list
93072429|NCT04571229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93072430|NCT04571229|Immunologic Factors|immunologic factors|mesh-ancestor
93072431|NCT04571229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072432|NCT04535713|Gemcitabine|gemcitabine|mesh-list
93072434|NCT04535713|Doxorubicin|doxorubicin|mesh-list
93072435|NCT04535713|Nivolumab|nivolumab|mesh-list
93072436|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93072437|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
93072438|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072439|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072440|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
93072441|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
93072442|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
93072443|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93072444|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93072445|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93072446|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072447|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072448|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072449|NCT04526132|Biphenylylacetic acid|biphenylylacetic acid|mesh-list
93072450|NCT04526132|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93072451|NCT04526132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93072452|NCT04526132|Analgesics|analgesics|mesh-ancestor
93072453|NCT04526132|Sensory System Agents|sensory system agents|mesh-ancestor
93072454|NCT04526132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072455|NCT04526132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072456|NCT04526132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93072457|NCT04526132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072458|NCT04514653|Ranibizumab|ranibizumab|mesh-list
93072459|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072460|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072461|NCT04514653|Growth Substances|growth substances|mesh-ancestor
93072462|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072463|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072464|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072465|NCT04513925|Atezolizumab|atezolizumab|mesh-list
93072466|NCT04513925|Durvalumab|durvalumab|mesh-list
93072467|NCT04513925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072468|NCT04513925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072469|NCT04513925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072470|NCT04513925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072471|NCT04507438|Donepezil|donepezil|mesh-list
93072472|NCT04507438|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93072473|NCT04507438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072474|NCT04507438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341356|NCT04009967|Pembrolizumab|pembrolizumab|mesh-list
93072475|NCT04507438|Cholinergic Agents|cholinergic agents|mesh-ancestor
93072476|NCT04507438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072477|NCT04507438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072478|NCT04507438|Nootropic Agents|nootropic agents|mesh-ancestor
93072479|NCT04505670|Donepezil|donepezil|mesh-list
93072480|NCT04505670|Zinc Oxide|zinc oxide|mesh-list
93072481|NCT04505670|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
93072482|NCT04505670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072483|NCT04505670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072484|NCT04505670|Cholinergic Agents|cholinergic agents|mesh-ancestor
93072485|NCT04505670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072486|NCT04505670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072487|NCT04505670|Nootropic Agents|nootropic agents|mesh-ancestor
93072488|NCT04505670|Dermatologic Agents|dermatologic agents|mesh-ancestor
93072489|NCT04505670|Sunscreening Agents|sunscreening agents|mesh-ancestor
93072490|NCT04505670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
93072491|NCT04505670|Protective Agents|protective agents|mesh-ancestor
93072492|NCT04493320|Levodopa|levodopa|mesh-list
93072493|NCT04493320|Carbidopa|carbidopa|mesh-list
93072494|NCT04493320|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93072495|NCT04493320|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93072496|NCT04493320|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93072497|NCT04493320|Dopamine Agents|dopamine agents|mesh-ancestor
93072498|NCT04493320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072499|NCT04493320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072500|NCT04493320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072501|NCT04493320|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93072502|NCT04493320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072503|NCT04493320|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93072504|NCT04493320|Immunologic Factors|immunologic factors|mesh-ancestor
93072506|NCT04417166|Pembrolizumab|pembrolizumab|mesh-list
93072507|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072508|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072509|NCT04417166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072510|NCT04417166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072511|NCT04270747|Aflibercept|aflibercept|mesh-list
93072512|NCT04270747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072513|NCT04270747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072514|NCT04270747|Growth Substances|growth substances|mesh-ancestor
93072515|NCT04270747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072516|NCT04270747|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072517|NCT04270747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072518|NCT04218123|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93072519|NCT04218123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93072520|NCT04218123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93072521|NCT04218123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93072522|NCT04218123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072523|NCT04218123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072524|NCT04218123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072525|NCT04218123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93072526|NCT04218123|Antidepressive Agents|antidepressive agents|mesh-ancestor
93072527|NCT04218123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93072528|NCT04189744|Metronidazole|metronidazole|mesh-list
93072529|NCT04189744|Pyrimethamine|pyrimethamine|mesh-list
93072530|NCT04189744|Piperaquine|piperaquine|mesh-list
93072531|NCT04189744|Sulfadoxine|sulfadoxine|mesh-list
93072532|NCT04189744|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
93072533|NCT04189744|Artenimol|artenimol|mesh-list
93072534|NCT04189744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072535|NCT04189744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93072536|NCT04189744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93072537|NCT04189744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93072538|NCT04189744|Antimalarials|antimalarials|mesh-ancestor
93072539|NCT04189744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93072540|NCT04189744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072541|NCT04189744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072542|NCT04189744|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
93072543|NCT04175470|Tocotrienols|tocotrienols|mesh-list
93072544|NCT04175470|Vitamin E|vitamin e|mesh-list
93072545|NCT04175470|Tocopherols|tocopherols|mesh-list
93072546|NCT04175470|Bevacizumab|bevacizumab|mesh-list
93072547|NCT04175470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072548|NCT04175470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072549|NCT04175470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072550|NCT04175470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072551|NCT04175470|Growth Substances|growth substances|mesh-ancestor
93072552|NCT04175470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072553|NCT04175470|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072554|NCT04175470|Antioxidants|antioxidants|mesh-ancestor
93072555|NCT04175470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072556|NCT04175470|Protective Agents|protective agents|mesh-ancestor
93072557|NCT04175470|Vitamins|vitamins|mesh-ancestor
93072558|NCT04175470|Micronutrients|micronutrients|mesh-ancestor
93072559|NCT04165330|Nivolumab|nivolumab|mesh-list
93072560|NCT04165330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072561|NCT04165330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072562|NCT04165330|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072563|NCT04165330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072564|NCT04149574|Nivolumab|nivolumab|mesh-list
93072565|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
93072566|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072567|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072568|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072569|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072570|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93072571|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
93072572|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072573|NCT04115878|Oxybutynin|oxybutynin|mesh-list
93072574|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
93072575|NCT04115878|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
93072576|NCT04115878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93072577|NCT04115878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93072578|NCT04115878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072579|NCT04115878|Adrenergic Agents|adrenergic agents|mesh-ancestor
93072580|NCT04115878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072581|NCT04115878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072582|NCT04115878|Parasympatholytics|parasympatholytics|mesh-ancestor
93072583|NCT04115878|Autonomic Agents|autonomic agents|mesh-ancestor
93072584|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072585|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
93072586|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
93072587|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
93072588|NCT04115878|Urological Agents|urological agents|mesh-ancestor
93072589|NCT03965130|Glucagon|glucagon|mesh-list
93072590|NCT03965130|Hormones|hormones|mesh-ancestor
93072591|NCT03965130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072592|NCT03965130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072593|NCT03965130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93072595|NCT03900884|Venetoclax|venetoclax|mesh-list
93072596|NCT03900884|Palbociclib|palbociclib|mesh-list
93072597|NCT03900884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072598|NCT03900884|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93072599|NCT03900884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93072600|NCT03900884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072601|NCT03900884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072602|NCT03900884|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93072603|NCT03900884|Hormone Antagonists|hormone antagonists|mesh-ancestor
93072604|NCT03900884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072605|NCT03900884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072606|NCT03900884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93072607|NCT03878524|Vitamins|vitamins|mesh-list
93072608|NCT03878524|Leucovorin|leucovorin|mesh-list
93072609|NCT03878524|Vitamin A|vitamin a|mesh-list
93072610|NCT03878524|Sirolimus|sirolimus|mesh-list
93072611|NCT03878524|Celecoxib|celecoxib|mesh-list
93072612|NCT03878524|Paclitaxel|paclitaxel|mesh-list
93072613|NCT03878524|Maytansine|maytansine|mesh-list
93072614|NCT03878524|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
93072615|NCT03878524|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93072616|NCT03878524|Bevacizumab|bevacizumab|mesh-list
93072617|NCT03878524|Carboplatin|carboplatin|mesh-list
93072618|NCT03878524|Doxorubicin|doxorubicin|mesh-list
93072619|NCT03878524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93072620|NCT03878524|Pembrolizumab|pembrolizumab|mesh-list
93072621|NCT03878524|Fluorouracil|fluorouracil|mesh-list
93072622|NCT03878524|Capecitabine|capecitabine|mesh-list
93072623|NCT03878524|Oxaliplatin|oxaliplatin|mesh-list
93072624|NCT03878524|Nivolumab|nivolumab|mesh-list
93072625|NCT03878524|Trastuzumab|trastuzumab|mesh-list
93072626|NCT03878524|Everolimus|everolimus|mesh-list
93072627|NCT03878524|Bortezomib|bortezomib|mesh-list
93072628|NCT03878524|Ipilimumab|ipilimumab|mesh-list
93072629|NCT03878524|Sorafenib|sorafenib|mesh-list
93072630|NCT03878524|Temsirolimus|temsirolimus|mesh-list
93072631|NCT03878524|Durvalumab|durvalumab|mesh-list
93072632|NCT03878524|Sunitinib|sunitinib|mesh-list
93072633|NCT03878524|Daunorubicin|daunorubicin|mesh-list
93072634|NCT03878524|Venetoclax|venetoclax|mesh-list
93072635|NCT03878524|Dasatinib|dasatinib|mesh-list
93072636|NCT03878524|Lenvatinib|lenvatinib|mesh-list
93072637|NCT03878524|Olaparib|olaparib|mesh-list
93072638|NCT03878524|Palbociclib|palbociclib|mesh-list
93072639|NCT03878524|Pertuzumab|pertuzumab|mesh-list
93072640|NCT03878524|Vorinostat|vorinostat|mesh-list
93072641|NCT03878524|Trametinib|trametinib|mesh-list
93072642|NCT03878524|Tretinoin|tretinoin|mesh-list
93072643|NCT03878524|Retinol palmitate|retinol palmitate|mesh-list
93072644|NCT03878524|Bicalutamide|bicalutamide|mesh-list
93072645|NCT03878524|Afatinib|afatinib|mesh-list
93072646|NCT03878524|Vemurafenib|vemurafenib|mesh-list
93072647|NCT03878524|Dabrafenib|dabrafenib|mesh-list
93072648|NCT03878524|Panobinostat|panobinostat|mesh-list
93072649|NCT03878524|Ponatinib|ponatinib|mesh-list
93072650|NCT03878524|Idelalisib|idelalisib|mesh-list
93072651|NCT03878524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
93072652|NCT03878524|MTOR Inhibitors|mtor inhibitors|mesh-list
92729611|NCT02217189|Zinc Sulfate|zinc sulfate|mesh-list
93072653|NCT03878524|Losartan|losartan|mesh-list
93072654|NCT03878524|Endothelial Growth Factors|endothelial growth factors|mesh-list
93072655|NCT03878524|Antibodies|antibodies|mesh-list
93072656|NCT03878524|Immunoglobulins|immunoglobulins|mesh-list
93072657|NCT03878524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93072658|NCT03878524|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93072659|NCT03878524|Immunoglobulin G|immunoglobulin g|mesh-list
93072660|NCT03878524|Entrectinib|entrectinib|mesh-list
93072661|NCT03878524|Immunoconjugates|immunoconjugates|mesh-list
93072662|NCT03878524|Benzenesulfonamide|benzenesulfonamide|mesh-list
93072663|NCT03878524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93072664|NCT03878524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072665|NCT03878524|Tubulin Modulators|tubulin modulators|mesh-ancestor
93072666|NCT03878524|Antimitotic Agents|antimitotic agents|mesh-ancestor
93072667|NCT03878524|Mitosis Modulators|mitosis modulators|mesh-ancestor
93072668|NCT03878524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072669|NCT03878524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072670|NCT03878524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072671|NCT03878524|Growth Substances|growth substances|mesh-ancestor
93072672|NCT03878524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072673|NCT03878524|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072674|NCT03878524|Micronutrients|micronutrients|mesh-ancestor
93072675|NCT03878524|Immunologic Factors|immunologic factors|mesh-ancestor
93072676|NCT03878524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93072677|NCT03878524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93072678|NCT03878524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93072679|NCT03878524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072680|NCT03878524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072681|NCT03878524|Antimetabolites|antimetabolites|mesh-ancestor
93072682|NCT03878524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93072683|NCT03878524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072684|NCT03878524|Antidotes|antidotes|mesh-ancestor
93072685|NCT03878524|Protective Agents|protective agents|mesh-ancestor
93072686|NCT03878524|Vitamin B Complex|vitamin b complex|mesh-ancestor
93072687|NCT03878524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93072688|NCT03878524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93072689|NCT03878524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93072690|NCT03878524|Antifungal Agents|antifungal agents|mesh-ancestor
93072691|NCT03878524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93072692|NCT03878524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93072693|NCT03878524|Analgesics|analgesics|mesh-ancestor
93072694|NCT03878524|Sensory System Agents|sensory system agents|mesh-ancestor
93072695|NCT03878524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072696|NCT03878524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93072697|NCT03878524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072698|NCT03878524|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
93072699|NCT03878524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93072700|NCT03878524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93072701|NCT03878524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93072702|NCT03878524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
93072703|NCT03878524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
93072704|NCT03878524|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93072705|NCT03878524|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
93072706|NCT03878524|Keratolytic Agents|keratolytic agents|mesh-ancestor
93072707|NCT03878524|Dermatologic Agents|dermatologic agents|mesh-ancestor
93072708|NCT03878524|Antioxidants|antioxidants|mesh-ancestor
93072709|NCT03878524|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
93072710|NCT03878524|Androgen Antagonists|androgen antagonists|mesh-ancestor
93072711|NCT03878524|Hormone Antagonists|hormone antagonists|mesh-ancestor
93072712|NCT03878524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072713|NCT03878524|Immunotoxins|immunotoxins|mesh-ancestor
93072714|NCT03878524|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
93072715|NCT03761030|Levodopa|levodopa|mesh-list
93072716|NCT03761030|Carbidopa|carbidopa|mesh-list
93072717|NCT03761030|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
93072718|NCT03761030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93072719|NCT03761030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93072720|NCT03761030|Dopamine Agents|dopamine agents|mesh-ancestor
93072721|NCT03761030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072722|NCT03761030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072723|NCT03761030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072724|NCT03761030|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
93072725|NCT03761030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072726|NCT03761030|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93072727|NCT03761030|Immunologic Factors|immunologic factors|mesh-ancestor
93072728|NCT03761030|Dopamine Agonists|dopamine agonists|mesh-ancestor
93072729|NCT03742505|Cholecalciferol|cholecalciferol|mesh-list
93072730|NCT03742505|Vitamin D|vitamin d|mesh-list
93072731|NCT03742505|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93072732|NCT03742505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072733|NCT03742505|Vitamins|vitamins|mesh-ancestor
93072734|NCT03742505|Micronutrients|micronutrients|mesh-ancestor
93072735|NCT03742505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93072736|NCT03663205|Cisplatin|cisplatin|mesh-list
93072737|NCT03663205|Carboplatin|carboplatin|mesh-list
93072738|NCT03663205|Pemetrexed|pemetrexed|mesh-list
93072740|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072741|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072742|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072743|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
93072744|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93072745|NCT03663205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072746|NCT03638999|Ketorolac|ketorolac|mesh-list
93072747|NCT03638999|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
93072748|NCT03638999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93072749|NCT03638999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93072750|NCT03638999|Analgesics|analgesics|mesh-ancestor
93072751|NCT03638999|Sensory System Agents|sensory system agents|mesh-ancestor
93072752|NCT03638999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072753|NCT03638999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072754|NCT03638999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93072755|NCT03638999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072756|NCT03638999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
93072757|NCT03638999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072758|NCT03638999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072759|NCT03600883|Sotorasib|sotorasib|mesh-list
93072760|NCT03600883|Midazolam|midazolam|mesh-list
93072761|NCT03600883|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93072762|NCT03600883|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93072763|NCT03600883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072764|NCT03600883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072765|NCT03600883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93072766|NCT03600883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93072767|NCT03600883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93072768|NCT03600883|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93072769|NCT03600883|Anesthetics, General|anesthetics, general|mesh-ancestor
93072770|NCT03600883|Anesthetics|anesthetics|mesh-ancestor
93072771|NCT03600883|GABA Modulators|gaba modulators|mesh-ancestor
93072772|NCT03600883|GABA Agents|gaba agents|mesh-ancestor
93072773|NCT03600883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072774|NCT03600883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072775|NCT03600883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072776|NCT03600883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072777|NCT03600883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072778|NCT03575793|Nivolumab|nivolumab|mesh-list
93072779|NCT03575793|Ipilimumab|ipilimumab|mesh-list
93072780|NCT03575793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072781|NCT03575793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072782|NCT03575793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072783|NCT03575793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072784|NCT03572088|Terlipressin|terlipressin|mesh-list
93072785|NCT03572088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93072786|NCT03572088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93072787|NCT03560934|Dronabinol|dronabinol|mesh-list
93072788|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
93072789|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072790|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93072791|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93072792|NCT03560934|Analgesics|analgesics|mesh-ancestor
93072793|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
93072794|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072795|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
93072796|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
93072797|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072798|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072799|NCT03560934|Hormones|hormones|mesh-ancestor
93072800|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072801|NCT03527472|Memantine|memantine|mesh-list
93072802|NCT03527472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
93072803|NCT03527472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
93072804|NCT03527472|Dopamine Agents|dopamine agents|mesh-ancestor
93072805|NCT03527472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072806|NCT03527472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072807|NCT03527472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072808|NCT03527472|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93072809|NCT03527472|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93072810|NCT03483012|Atezolizumab|atezolizumab|mesh-list
93072811|NCT03483012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072812|NCT03483012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072813|NCT03483012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072815|NCT03477396|Estrogens|estrogens|mesh-list
93072816|NCT03477396|Aromatase Inhibitors|aromatase inhibitors|mesh-list
93072817|NCT03477396|Hormones|hormones|mesh-ancestor
93072818|NCT03477396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072819|NCT03477396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072820|NCT03477396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93072821|NCT03477396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072822|NCT03477396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072823|NCT03477396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93072824|NCT03477396|Hormone Antagonists|hormone antagonists|mesh-ancestor
93072825|NCT03388788|CGP 12177|cgp 12177|mesh-list
93072826|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
93072827|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93072828|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
93072829|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072830|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072831|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072832|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93072833|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93072834|NCT03289962|Atezolizumab|atezolizumab|mesh-list
93072835|NCT03289962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072836|NCT03289962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072837|NCT03289962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072838|NCT03289962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072839|NCT03283761|Leucovorin|leucovorin|mesh-list
93072840|NCT03283761|Paclitaxel|paclitaxel|mesh-list
93072841|NCT03283761|Fluorouracil|fluorouracil|mesh-list
93072842|NCT03283761|Oxaliplatin|oxaliplatin|mesh-list
93072843|NCT03283761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93072844|NCT03283761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072845|NCT03283761|Tubulin Modulators|tubulin modulators|mesh-ancestor
93072846|NCT03283761|Antimitotic Agents|antimitotic agents|mesh-ancestor
93072847|NCT03283761|Mitosis Modulators|mitosis modulators|mesh-ancestor
93072848|NCT03283761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072849|NCT03283761|Antimetabolites|antimetabolites|mesh-ancestor
93072850|NCT03283761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93072851|NCT03283761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072852|NCT03283761|Immunologic Factors|immunologic factors|mesh-ancestor
93072853|NCT03283761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072854|NCT03283761|Antidotes|antidotes|mesh-ancestor
93072855|NCT03283761|Protective Agents|protective agents|mesh-ancestor
93072856|NCT03283761|Vitamin B Complex|vitamin b complex|mesh-ancestor
93072857|NCT03283761|Vitamins|vitamins|mesh-ancestor
93072858|NCT03283761|Micronutrients|micronutrients|mesh-ancestor
93072859|NCT03240081|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
93072860|NCT03240081|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
93072861|NCT03240081|Estradiol|estradiol|mesh-list
93072862|NCT03240081|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
93072863|NCT03240081|Estrogens|estrogens|mesh-ancestor
93072864|NCT03240081|Hormones|hormones|mesh-ancestor
93072865|NCT03240081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072866|NCT03240081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072867|NCT03240081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93072868|NCT03240081|Contraceptive Agents|contraceptive agents|mesh-ancestor
93072869|NCT03240081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93072870|NCT03240081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93072871|NCT03236857|Venetoclax|venetoclax|mesh-list
93072872|NCT03236857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072873|NCT03097120|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
93072874|NCT03097120|Medroxyprogesterone|medroxyprogesterone|mesh-list
93072875|NCT03097120|Estrogens|estrogens|mesh-list
93072876|NCT03097120|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
93072877|NCT03097120|Hormones|hormones|mesh-ancestor
93072878|NCT03097120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072879|NCT03097120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072880|NCT03097120|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
93072881|NCT03097120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
93072882|NCT03097120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
93072883|NCT03097120|Contraceptive Agents|contraceptive agents|mesh-ancestor
93072884|NCT03097120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729833|NCT02217930|Moxifloxacin|moxifloxacin|mesh-list
93072885|NCT03097120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
93072886|NCT03097120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
93072887|NCT03097120|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
93072888|NCT03097120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93072889|NCT03097120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072890|NCT03056755|Letrozole|letrozole|mesh-list
93072891|NCT03056755|Fulvestrant|fulvestrant|mesh-list
93072892|NCT03056755|Leuprolide|leuprolide|mesh-list
93072893|NCT03056755|Goserelin|goserelin|mesh-list
93072894|NCT03056755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072895|NCT03056755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93072896|NCT03056755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93072897|NCT03056755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072898|NCT03056755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072899|NCT03056755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93072900|NCT03056755|Hormone Antagonists|hormone antagonists|mesh-ancestor
93072901|NCT03056755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072902|NCT03056755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072903|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93072904|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93072905|NCT03056755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93072906|NCT03056755|Fertility Agents|fertility agents|mesh-ancestor
93072907|NCT03056755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93072908|NCT03003520|Prednisone|prednisone|mesh-list
93072909|NCT03003520|Prednisolone|prednisolone|mesh-list
93072910|NCT03003520|Cyclophosphamide|cyclophosphamide|mesh-list
93072911|NCT03003520|Rituximab|rituximab|mesh-list
93072912|NCT03003520|Doxorubicin|doxorubicin|mesh-list
93072913|NCT03003520|Vincristine|vincristine|mesh-list
93072914|NCT03003520|Lenalidomide|lenalidomide|mesh-list
93072915|NCT03003520|Durvalumab|durvalumab|mesh-list
93072916|NCT03003520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072917|NCT03003520|Immunologic Factors|immunologic factors|mesh-ancestor
93072918|NCT03003520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072919|NCT03003520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072920|NCT03003520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93072921|NCT03003520|Alkylating Agents|alkylating agents|mesh-ancestor
93072922|NCT03003520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072923|NCT03003520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072924|NCT03003520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93072925|NCT03003520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072926|NCT03003520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93072927|NCT03003520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93072928|NCT03003520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93072929|NCT03003520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93072930|NCT03003520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93072931|NCT03003520|Glucocorticoids|glucocorticoids|mesh-ancestor
93072932|NCT03003520|Hormones|hormones|mesh-ancestor
93072933|NCT03003520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072934|NCT03003520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93072935|NCT03003520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93072936|NCT03003520|Tubulin Modulators|tubulin modulators|mesh-ancestor
93072937|NCT03003520|Antimitotic Agents|antimitotic agents|mesh-ancestor
93072938|NCT03003520|Mitosis Modulators|mitosis modulators|mesh-ancestor
93072939|NCT03003520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93072940|NCT03003520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93072941|NCT03003520|Growth Substances|growth substances|mesh-ancestor
93072942|NCT03003520|Growth Inhibitors|growth inhibitors|mesh-ancestor
93072943|NCT02989597|Dexamethasone|dexamethasone|mesh-list
93072944|NCT02989597|Sufentanil|sufentanil|mesh-list
93072945|NCT02989597|Ketamine|ketamine|mesh-list
93072946|NCT02989597|Remifentanil|remifentanil|mesh-list
93072947|NCT02989597|Methadone|methadone|mesh-list
93072948|NCT02989597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93072949|NCT02989597|Antiemetics|antiemetics|mesh-ancestor
93072950|NCT02989597|Autonomic Agents|autonomic agents|mesh-ancestor
93072951|NCT02989597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93072952|NCT02989597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072953|NCT02989597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93072954|NCT02989597|Glucocorticoids|glucocorticoids|mesh-ancestor
93072955|NCT02989597|Hormones|hormones|mesh-ancestor
93072956|NCT02989597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93072957|NCT02989597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93072958|NCT02989597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072959|NCT02989597|Analgesics|analgesics|mesh-ancestor
93072960|NCT02989597|Sensory System Agents|sensory system agents|mesh-ancestor
93072961|NCT02989597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
93072962|NCT02989597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93072963|NCT02989597|Anesthetics, General|anesthetics, general|mesh-ancestor
93072964|NCT02989597|Anesthetics|anesthetics|mesh-ancestor
93072965|NCT02989597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93072966|NCT02989597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
93072967|NCT02989597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
93072968|NCT02989597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072969|NCT02989597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072970|NCT02989597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93072971|NCT02989597|Narcotics|narcotics|mesh-ancestor
93072972|NCT02989597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93072973|NCT02989597|Antitussive Agents|antitussive agents|mesh-ancestor
93072974|NCT02989597|Respiratory System Agents|respiratory system agents|mesh-ancestor
93072975|NCT02958527|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
93072976|NCT02958527|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93072977|NCT02958527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93072978|NCT02958527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93072979|NCT02958527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072980|NCT02958527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93072981|NCT02958527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072982|NCT02958527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93072983|NCT02958527|Antidepressive Agents|antidepressive agents|mesh-ancestor
93072984|NCT02958527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93072985|NCT02768701|Cyclophosphamide|cyclophosphamide|mesh-list
93072986|NCT02768701|Pembrolizumab|pembrolizumab|mesh-list
93072987|NCT02768701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93072988|NCT02768701|Immunologic Factors|immunologic factors|mesh-ancestor
93072989|NCT02768701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93072990|NCT02768701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93072991|NCT02768701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93072992|NCT02768701|Alkylating Agents|alkylating agents|mesh-ancestor
93072993|NCT02768701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93072994|NCT02768701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93072995|NCT02768701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93072996|NCT02768701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93072997|NCT02768701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93072998|NCT02621944|Melatonin|melatonin|mesh-list
93072999|NCT02621944|Antioxidants|antioxidants|mesh-ancestor
93073000|NCT02621944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073001|NCT02621944|Protective Agents|protective agents|mesh-ancestor
93073002|NCT02621944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073003|NCT02621944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073004|NCT02620046|Vedolizumab|vedolizumab|mesh-list
93073005|NCT02620046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93073006|NCT02586025|Docetaxel|docetaxel|mesh-list
93073007|NCT02586025|Trastuzumab|trastuzumab|mesh-list
93073008|NCT02586025|Pertuzumab|pertuzumab|mesh-list
93073009|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073010|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
93073011|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
93073012|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
93073013|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073014|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073015|NCT02465164|Oxytocin|oxytocin|mesh-list
93073016|NCT02465164|Oxytocics|oxytocics|mesh-ancestor
93073017|NCT02465164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93073018|NCT02465164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073019|NCT02446600|Paclitaxel|paclitaxel|mesh-list
93073020|NCT02446600|Carboplatin|carboplatin|mesh-list
93073021|NCT02446600|Gemcitabine|gemcitabine|mesh-list
93073022|NCT02446600|Doxorubicin|doxorubicin|mesh-list
93073023|NCT02446600|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
93073024|NCT02446600|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
93073025|NCT02446600|Olaparib|olaparib|mesh-list
93073026|NCT02446600|Cediranib|cediranib|mesh-list
93073027|NCT02446600|Maleic acid|maleic acid|mesh-list
93073028|NCT02446600|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93073029|NCT02446600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073030|NCT02446600|Tubulin Modulators|tubulin modulators|mesh-ancestor
93073031|NCT02446600|Antimitotic Agents|antimitotic agents|mesh-ancestor
93073032|NCT02446600|Mitosis Modulators|mitosis modulators|mesh-ancestor
93073033|NCT02446600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073034|NCT02446600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073035|NCT02446600|Antimetabolites|antimetabolites|mesh-ancestor
93073036|NCT02446600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93073037|NCT02446600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93073038|NCT02446600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93073039|NCT02446600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073040|NCT02446600|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93073041|NCT02446600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93073042|NCT02094261|Osimertinib|osimertinib|mesh-list
93073043|NCT02094261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073044|NCT02094261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93073045|NCT02094261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073046|NCT02094261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073047|NCT01955512|Clopidogrel|clopidogrel|mesh-list
93073048|NCT01955512|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
93073049|NCT01955512|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
93073050|NCT01955512|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
93073051|NCT01955512|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93073052|NCT01955512|Purinergic Agents|purinergic agents|mesh-ancestor
93073053|NCT01955512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073054|NCT01955512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073055|NCT01955512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073056|NCT01194570|Ocrelizumab|ocrelizumab|mesh-list
93073057|NCT01194570|Immunologic Factors|immunologic factors|mesh-ancestor
93073058|NCT01194570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073059|NCT00227617|Leucovorin|leucovorin|mesh-list
93073060|NCT00227617|Bevacizumab|bevacizumab|mesh-list
93073061|NCT00227617|Fluorouracil|fluorouracil|mesh-list
93073062|NCT00227617|Oxaliplatin|oxaliplatin|mesh-list
93073063|NCT00227617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073064|NCT00227617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073065|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93073066|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93073067|NCT00227617|Growth Substances|growth substances|mesh-ancestor
93073068|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073069|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
93073070|NCT00227617|Antimetabolites|antimetabolites|mesh-ancestor
93073071|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073072|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073073|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073074|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
93073075|NCT00227617|Antidotes|antidotes|mesh-ancestor
93073076|NCT00227617|Protective Agents|protective agents|mesh-ancestor
93073077|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
93073078|NCT00227617|Vitamins|vitamins|mesh-ancestor
93073079|NCT00227617|Micronutrients|micronutrients|mesh-ancestor
93073080|NCT05710081|Broncho-Vaxom|broncho-vaxom|mesh-list
93073081|NCT05710081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93073082|NCT05710081|Immunologic Factors|immunologic factors|mesh-ancestor
93073083|NCT05710081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073084|NCT05703191|Nitric Oxide|nitric oxide|mesh-list
93073085|NCT05703191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93073086|NCT05703191|Autonomic Agents|autonomic agents|mesh-ancestor
93073087|NCT05703191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073088|NCT05703191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073089|NCT05703191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93073090|NCT05703191|Respiratory System Agents|respiratory system agents|mesh-ancestor
93073091|NCT05703191|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93073092|NCT05703191|Antioxidants|antioxidants|mesh-ancestor
93073093|NCT05703191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073094|NCT05703191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073095|NCT05703191|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
93073096|NCT05703191|Vasodilator Agents|vasodilator agents|mesh-ancestor
93073097|NCT05703191|Gasotransmitters|gasotransmitters|mesh-ancestor
93073098|NCT05703191|Protective Agents|protective agents|mesh-ancestor
93073099|NCT05687071|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
93073100|NCT05687071|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
93073101|NCT05687071|Antimetabolites|antimetabolites|mesh-ancestor
93073102|NCT05687071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073103|NCT05687071|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93073104|NCT05687071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073105|NCT05687071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93073106|NCT05687071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073107|NCT05657470|Tenecteplase|tenecteplase|mesh-list
93073108|NCT05657470|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93073109|NCT05657470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93073110|NCT05657470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073111|NCT05649059|Cannabidiol|cannabidiol|mesh-list
93073112|NCT05649059|Anticonvulsants|anticonvulsants|mesh-ancestor
93073113|NCT05639686|Remifentanil|remifentanil|mesh-list
93073114|NCT05639686|Anesthetics|anesthetics|mesh-list
93073115|NCT05639686|Propofol|propofol|mesh-list
93073116|NCT05639686|Isoflurane|isoflurane|mesh-list
93073117|NCT05639686|Tranexamic Acid|tranexamic acid|mesh-list
93073118|NCT05639686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073119|NCT05639686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073121|NCT05639686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93073122|NCT05639686|Anesthetics, General|anesthetics, general|mesh-ancestor
93073123|NCT05639686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
93073124|NCT05639686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93073125|NCT05639686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073126|NCT05639686|Hemostatics|hemostatics|mesh-ancestor
93073127|NCT05639686|Coagulants|coagulants|mesh-ancestor
93073128|NCT05639686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93073129|NCT05639686|Narcotics|narcotics|mesh-ancestor
93073130|NCT05639686|Analgesics|analgesics|mesh-ancestor
93073131|NCT05639686|Sensory System Agents|sensory system agents|mesh-ancestor
93073132|NCT05639686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073133|NCT05639686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93073134|NCT05633576|Ophthalmic Solutions|ophthalmic solutions|mesh-list
93073135|NCT05633576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
93073136|NCT05586074|Cytarabine|cytarabine|mesh-list
93073137|NCT05586074|Fludarabine|fludarabine|mesh-list
93073138|NCT05586074|Azacitidine|azacitidine|mesh-list
93073139|NCT05586074|Decitabine|decitabine|mesh-list
93073140|NCT05586074|Idarubicin|idarubicin|mesh-list
93073141|NCT05586074|Lenograstim|lenograstim|mesh-list
93073142|NCT05586074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073143|NCT05586074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073144|NCT05586074|Antimetabolites|antimetabolites|mesh-ancestor
93073145|NCT05586074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073146|NCT05586074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073147|NCT05586074|Immunologic Factors|immunologic factors|mesh-ancestor
93073148|NCT05586074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073149|NCT05586074|Antiviral Agents|antiviral agents|mesh-ancestor
93073150|NCT05586074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073151|NCT05586074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073152|NCT05586074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93073153|NCT05586074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93073154|NCT05586074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93073155|NCT05586074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93073156|NCT05568615|Edaravone|edaravone|mesh-list
93073157|NCT05568615|Free Radical Scavengers|free radical scavengers|mesh-ancestor
93073158|NCT05568615|Antioxidants|antioxidants|mesh-ancestor
93073159|NCT05568615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073160|NCT05568615|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
93073161|NCT05568615|Protective Agents|protective agents|mesh-ancestor
93073162|NCT05568615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073163|NCT05541146|Paclitaxel|paclitaxel|mesh-list
93073164|NCT05541146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93073165|NCT05541146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073166|NCT05541146|Tubulin Modulators|tubulin modulators|mesh-ancestor
93073167|NCT05541146|Antimitotic Agents|antimitotic agents|mesh-ancestor
93073168|NCT05541146|Mitosis Modulators|mitosis modulators|mesh-ancestor
93073169|NCT05541146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073170|NCT05532358|Midazolam|midazolam|mesh-list
93073171|NCT05532358|Fluvoxamine|fluvoxamine|mesh-list
93073172|NCT05532358|Caffeine|caffeine|mesh-list
93073173|NCT05532358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93073174|NCT05532358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
93073175|NCT05532358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073176|NCT05532358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073177|NCT05532358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
93073178|NCT05532358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
93073179|NCT05532358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073180|NCT05532358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93073181|NCT05532358|Anesthetics, General|anesthetics, general|mesh-ancestor
93073182|NCT05532358|Anesthetics|anesthetics|mesh-ancestor
93073183|NCT05532358|GABA Modulators|gaba modulators|mesh-ancestor
93073184|NCT05532358|GABA Agents|gaba agents|mesh-ancestor
92730137|NCT04577378|Itraconazole|itraconazole|mesh-list
93073185|NCT05532358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073186|NCT05532358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073187|NCT05532358|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
93073188|NCT05532358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
93073190|NCT05532358|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
93073191|NCT05532358|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
93073192|NCT05532358|Purinergic Agents|purinergic agents|mesh-ancestor
93073193|NCT05532358|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93073194|NCT05532358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93073195|NCT05532358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073196|NCT05532358|Serotonin Agents|serotonin agents|mesh-ancestor
93073197|NCT05532358|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93073198|NCT05532358|Antidepressive Agents|antidepressive agents|mesh-ancestor
93073199|NCT05532358|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93073200|NCT05532358|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93073201|NCT05532358|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
93073202|NCT05525416|Propranolol|propranolol|mesh-list
93073203|NCT05525416|Nitroprusside|nitroprusside|mesh-list
93073204|NCT05525416|Phentolamine|phentolamine|mesh-list
93073205|NCT05525416|Phenylephrine|phenylephrine|mesh-list
93073206|NCT05525416|Oxymetazoline|oxymetazoline|mesh-list
93073207|NCT05525416|Norepinephrine|norepinephrine|mesh-list
93073208|NCT05525416|Synephrine|synephrine|mesh-list
93073209|NCT05525416|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
93073210|NCT05525416|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
93073211|NCT05525416|Adrenergic Agents|adrenergic agents|mesh-ancestor
93073212|NCT05525416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073213|NCT05525416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073214|NCT05525416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073215|NCT05525416|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93073216|NCT05525416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
93073217|NCT05525416|Vasodilator Agents|vasodilator agents|mesh-ancestor
93073218|NCT05525416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
93073219|NCT05525416|Mydriatics|mydriatics|mesh-ancestor
93073220|NCT05525416|Autonomic Agents|autonomic agents|mesh-ancestor
93073221|NCT05525416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073222|NCT05525416|Sympathomimetics|sympathomimetics|mesh-ancestor
93073223|NCT05525416|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
93073224|NCT05525416|Nasal Decongestants|nasal decongestants|mesh-ancestor
93073225|NCT05525416|Respiratory System Agents|respiratory system agents|mesh-ancestor
93073226|NCT05525416|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
93073227|NCT05525416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
93073228|NCT05525416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
93073229|NCT05525416|Protective Agents|protective agents|mesh-ancestor
93073230|NCT05525416|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
93073231|NCT05525416|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
93073232|NCT05491512|Carboplatin|carboplatin|mesh-list
93073233|NCT05491512|Fluorouracil|fluorouracil|mesh-list
93073234|NCT05491512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073235|NCT05491512|Antimetabolites|antimetabolites|mesh-ancestor
93073236|NCT05491512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073237|NCT05491512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073238|NCT05491512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073239|NCT05491512|Immunologic Factors|immunologic factors|mesh-ancestor
93073240|NCT05491512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073241|NCT05449405|Chlorpheniramine|chlorpheniramine|mesh-list
93073242|NCT05449405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073243|NCT05449405|Antipruritics|antipruritics|mesh-ancestor
93073244|NCT05449405|Dermatologic Agents|dermatologic agents|mesh-ancestor
93073245|NCT05449405|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93073246|NCT05449405|Histamine Antagonists|histamine antagonists|mesh-ancestor
93073247|NCT05449405|Histamine Agents|histamine agents|mesh-ancestor
93073248|NCT05449405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073249|NCT05449405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073250|NCT05449405|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93073251|NCT05412706|Niraparib|niraparib|mesh-list
93073252|NCT05412706|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
93073253|NCT05412706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073254|NCT05412706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073255|NCT05412706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073256|NCT05394740|Leucovorin|leucovorin|mesh-list
93073257|NCT05394740|Fluorouracil|fluorouracil|mesh-list
93073258|NCT05394740|Capecitabine|capecitabine|mesh-list
93073259|NCT05394740|Oxaliplatin|oxaliplatin|mesh-list
93073260|NCT05394740|Nivolumab|nivolumab|mesh-list
93073261|NCT05394740|Antimetabolites|antimetabolites|mesh-ancestor
93073262|NCT05394740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730205|NCT02211846|Urological Agents|urological agents|mesh-ancestor
93073263|NCT05394740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073264|NCT05394740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073265|NCT05394740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073266|NCT05394740|Immunologic Factors|immunologic factors|mesh-ancestor
93073267|NCT05394740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073268|NCT05394740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073269|NCT05394740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93073271|NCT05394740|Protective Agents|protective agents|mesh-ancestor
93073272|NCT05394740|Vitamin B Complex|vitamin b complex|mesh-ancestor
93073274|NCT05394740|Micronutrients|micronutrients|mesh-ancestor
93073275|NCT05390021|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
93073276|NCT05390021|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
93073277|NCT05390021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073278|NCT05273996|Bupropion|bupropion|mesh-list
93073279|NCT05273996|Sertraline|sertraline|mesh-list
93073280|NCT05273996|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
93073281|NCT05273996|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
93073282|NCT05273996|Antidepressive Agents|antidepressive agents|mesh-ancestor
93073283|NCT05273996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
93073284|NCT05273996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
93073285|NCT05273996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
93073286|NCT05273996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073287|NCT05273996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073288|NCT05273996|Dopamine Agents|dopamine agents|mesh-ancestor
93073289|NCT05273996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073290|NCT05273996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073291|NCT05273996|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
93073292|NCT05273996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93073293|NCT05273996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073294|NCT05273996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
93073295|NCT05273996|Serotonin Agents|serotonin agents|mesh-ancestor
93073296|NCT05273996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
93073297|NCT05264025|Fexofenadine|fexofenadine|mesh-list
93073298|NCT05264025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93073299|NCT05264025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93073300|NCT05264025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93073301|NCT05264025|Histamine Antagonists|histamine antagonists|mesh-ancestor
93073302|NCT05264025|Histamine Agents|histamine agents|mesh-ancestor
93073303|NCT05264025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073304|NCT05264025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073305|NCT05264025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073306|NCT05262244|Bevacizumab|bevacizumab|mesh-list
93073307|NCT05262244|Vedolizumab|vedolizumab|mesh-list
93073308|NCT05262244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073309|NCT05262244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073310|NCT05262244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93073311|NCT05262244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93073312|NCT05262244|Growth Substances|growth substances|mesh-ancestor
93073313|NCT05262244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073314|NCT05262244|Growth Inhibitors|growth inhibitors|mesh-ancestor
93073315|NCT05262244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93073316|NCT05244213|Paclitaxel|paclitaxel|mesh-list
93073317|NCT05244213|Carboplatin|carboplatin|mesh-list
93073318|NCT05244213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93073319|NCT05244213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073320|NCT05244213|Tubulin Modulators|tubulin modulators|mesh-ancestor
93073321|NCT05244213|Antimitotic Agents|antimitotic agents|mesh-ancestor
93073322|NCT05244213|Mitosis Modulators|mitosis modulators|mesh-ancestor
93073323|NCT05244213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073324|NCT05233956|Chrysarobin|chrysarobin|mesh-list
93073325|NCT05233956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
93073326|NCT05233956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
93073327|NCT05233956|Analgesics|analgesics|mesh-ancestor
93073328|NCT05233956|Sensory System Agents|sensory system agents|mesh-ancestor
93073329|NCT05233956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073330|NCT05233956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073331|NCT05233956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073332|NCT05233956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93073333|NCT05231148|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
93073334|NCT05231148|Calcium|calcium|mesh-list
93073335|NCT05231148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93073336|NCT05231148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073337|NCT05231148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073338|NCT05219487|Risdiplam|risdiplam|mesh-list
93073339|NCT05219487|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
93073340|NCT05219487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073341|NCT05219487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073342|NCT05169112|Leuprolide|leuprolide|mesh-list
93073343|NCT05169112|Fertility Agents, Female|fertility agents, female|mesh-ancestor
93073345|NCT05169112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
93073346|NCT05169112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073347|NCT05169112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073348|NCT05169112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073349|NCT05137184|Fentanyl|fentanyl|mesh-list
93073350|NCT05137184|Morphine|morphine|mesh-list
93073351|NCT05137184|Methoxyflurane|methoxyflurane|mesh-list
93073352|NCT05137184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93073353|NCT05137184|Narcotics|narcotics|mesh-ancestor
93073354|NCT05137184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073355|NCT05137184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073356|NCT05137184|Analgesics|analgesics|mesh-ancestor
93073357|NCT05137184|Sensory System Agents|sensory system agents|mesh-ancestor
93073358|NCT05137184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073359|NCT05137184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
93073360|NCT05137184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
93073361|NCT05137184|Anesthetics, General|anesthetics, general|mesh-ancestor
93073362|NCT05137184|Anesthetics|anesthetics|mesh-ancestor
93073363|NCT05137184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
93073364|NCT05097209|Cisplatin|cisplatin|mesh-list
93073365|NCT05097209|Gemcitabine|gemcitabine|mesh-list
93073366|NCT05097209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073367|NCT05097209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073368|NCT05097209|Antimetabolites|antimetabolites|mesh-ancestor
93073369|NCT05097209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073370|NCT05067998|Vitamins|vitamins|mesh-list
93073371|NCT05067998|Micronutrients|micronutrients|mesh-ancestor
93073372|NCT05067998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073373|NCT05065411|Everolimus|everolimus|mesh-list
93073374|NCT05065411|Fulvestrant|fulvestrant|mesh-list
93073375|NCT05065411|Exemestane|exemestane|mesh-list
93073376|NCT05065411|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
93073377|NCT05065411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93073378|NCT05065411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073379|NCT05065411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073380|NCT05065411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073381|NCT05065411|Immunologic Factors|immunologic factors|mesh-ancestor
93073382|NCT05065411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073383|NCT05065411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073384|NCT05065411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073385|NCT05065411|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93073386|NCT05065411|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
93073387|NCT05065411|Hormone Antagonists|hormone antagonists|mesh-ancestor
93073388|NCT05065411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073389|NCT05065411|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
93073390|NCT05065411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
93073391|NCT05025293|Zoledronic Acid|zoledronic acid|mesh-list
93073392|NCT05025293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93073393|NCT05025293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073394|NCT05021991|Pramoxine|pramoxine|mesh-list
93073395|NCT05021991|Anesthetics, Local|anesthetics, local|mesh-ancestor
93073396|NCT05021991|Anesthetics|anesthetics|mesh-ancestor
93073397|NCT05021991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073398|NCT05021991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073399|NCT05021991|Sensory System Agents|sensory system agents|mesh-ancestor
93073400|NCT05021991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073402|NCT05001776|Fondaparinux|fondaparinux|mesh-list
93073403|NCT05001776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
93073404|NCT05001776|Antithrombins|antithrombins|mesh-ancestor
93073405|NCT05001776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
93073406|NCT05001776|Protease Inhibitors|protease inhibitors|mesh-ancestor
93073407|NCT05001776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073408|NCT05001776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073409|NCT05001776|Anticoagulants|anticoagulants|mesh-ancestor
93073410|NCT05001776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
93073411|NCT05001776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
93073412|NCT04991974|Buprenorphine|buprenorphine|mesh-list
93073413|NCT04991974|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
93073414|NCT04991974|Naloxone|naloxone|mesh-list
93073415|NCT04991974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
93073416|NCT04991974|Narcotics|narcotics|mesh-ancestor
93073417|NCT04991974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073418|NCT04991974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073419|NCT04991974|Analgesics|analgesics|mesh-ancestor
93073420|NCT04991974|Sensory System Agents|sensory system agents|mesh-ancestor
93073421|NCT04991974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073423|NCT04977479|Vaccines|vaccines|mesh-list
93073424|NCT04977479|Immunologic Factors|immunologic factors|mesh-ancestor
93073425|NCT04977479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073426|NCT04971473|Hormones|hormones|mesh-list
93073427|NCT04971473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073428|NCT04971473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073429|NCT04943588|Antibodies|antibodies|mesh-list
93073430|NCT04943588|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
93073431|NCT04943588|Immunologic Factors|immunologic factors|mesh-ancestor
93073432|NCT04943588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073433|NCT04917692|Empagliflozin|empagliflozin|mesh-list
93073434|NCT04917692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
93073435|NCT04917692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073436|NCT04917692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
93073437|NCT04917692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073438|NCT04915248|Dexamethasone|dexamethasone|mesh-list
93073439|NCT04915248|Dexamethasone acetate|dexamethasone acetate|mesh-list
93073440|NCT04915248|Bortezomib|bortezomib|mesh-list
93073441|NCT04915248|Daratumumab|daratumumab|mesh-list
93073442|NCT04915248|BB 1101|bb 1101|mesh-list
93073443|NCT04915248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
93073444|NCT04915248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073445|NCT04915248|Antiemetics|antiemetics|mesh-ancestor
93073446|NCT04915248|Autonomic Agents|autonomic agents|mesh-ancestor
93073447|NCT04915248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073448|NCT04915248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073449|NCT04915248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
93073450|NCT04915248|Glucocorticoids|glucocorticoids|mesh-ancestor
93073451|NCT04915248|Hormones|hormones|mesh-ancestor
93073452|NCT04915248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073453|NCT04915248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073454|NCT04915248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073455|NCT04915248|Protease Inhibitors|protease inhibitors|mesh-ancestor
93073456|NCT04915248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073457|NCT04915248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073458|NCT04915248|Immunologic Factors|immunologic factors|mesh-ancestor
93073459|NCT04893785|Temozolomide|temozolomide|mesh-list
93073460|NCT04893785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93073461|NCT04893785|Alkylating Agents|alkylating agents|mesh-ancestor
93073462|NCT04893785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073463|NCT04893785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073464|NCT04881747|Lasmiditan|lasmiditan|mesh-list
93073465|NCT04881747|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
93073466|NCT04881747|Serotonin Agents|serotonin agents|mesh-ancestor
93073467|NCT04881747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073468|NCT04881747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073469|NCT04881747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073470|NCT04862949|Bevacizumab|bevacizumab|mesh-list
93073471|NCT04862949|Atezolizumab|atezolizumab|mesh-list
93073472|NCT04862949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073473|NCT04862949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073474|NCT04862949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
93073475|NCT04862949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
93073476|NCT04862949|Growth Substances|growth substances|mesh-ancestor
93073477|NCT04862949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073478|NCT04862949|Growth Inhibitors|growth inhibitors|mesh-ancestor
93073479|NCT04862949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93073480|NCT04862949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073481|NCT04862663|Fulvestrant|fulvestrant|mesh-list
93073482|NCT04862663|Palbociclib|palbociclib|mesh-list
93073483|NCT04862663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
93073484|NCT04862663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073485|NCT04862663|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
93073486|NCT04862663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92730428|NCT01640535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93073487|NCT04862663|Hormone Antagonists|hormone antagonists|mesh-ancestor
93073488|NCT04862663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073489|NCT04862663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073490|NCT04862663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
93073491|NCT04862663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073492|NCT04862663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073494|NCT04848974|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
93073495|NCT04848974|Cladribine|cladribine|mesh-list
93073496|NCT04848974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073497|NCT04848974|Antimetabolites|antimetabolites|mesh-ancestor
93073498|NCT04848974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073499|NCT04848974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073500|NCT04848974|Antiviral Agents|antiviral agents|mesh-ancestor
93073501|NCT04848974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073502|NCT04848974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073503|NCT04848974|Immunologic Factors|immunologic factors|mesh-ancestor
93073504|NCT04848974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073505|NCT04840823|Enoxacin|enoxacin|mesh-list
93073506|NCT04840823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93073507|NCT04840823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073508|NCT04840823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93073509|NCT04840823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93073510|NCT04840823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073511|NCT04840823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073512|NCT04840823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073513|NCT04840823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
93073514|NCT04840823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
93073515|NCT04825704|Bupivacaine|bupivacaine|mesh-list
93073516|NCT04825704|Anesthetics, Local|anesthetics, local|mesh-ancestor
93073517|NCT04825704|Anesthetics|anesthetics|mesh-ancestor
93073518|NCT04825704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341533|NCT03850067|Nivolumab|nivolumab|mesh-list
93073519|NCT04825704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073520|NCT04825704|Sensory System Agents|sensory system agents|mesh-ancestor
93073521|NCT04825704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073522|NCT04781959|Lenograstim|lenograstim|mesh-list
93073523|NCT04781959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
93073524|NCT04781959|Immunologic Factors|immunologic factors|mesh-ancestor
93073525|NCT04781959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073526|NCT04729608|Paclitaxel|paclitaxel|mesh-list
93073527|NCT04729608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93073528|NCT04729608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073529|NCT04729608|Tubulin Modulators|tubulin modulators|mesh-ancestor
93073530|NCT04729608|Antimitotic Agents|antimitotic agents|mesh-ancestor
93073531|NCT04729608|Mitosis Modulators|mitosis modulators|mesh-ancestor
93073532|NCT04729608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073533|NCT04652245|Fluticasone|fluticasone|mesh-list
93073534|NCT04652245|Xhance|xhance|mesh-list
93073535|NCT04652245|Azelastine|azelastine|mesh-list
93073536|NCT04652245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073537|NCT04652245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
93073538|NCT04652245|Autonomic Agents|autonomic agents|mesh-ancestor
93073539|NCT04652245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073540|NCT04652245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073541|NCT04652245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
93073542|NCT04652245|Respiratory System Agents|respiratory system agents|mesh-ancestor
93073543|NCT04652245|Dermatologic Agents|dermatologic agents|mesh-ancestor
93073544|NCT04652245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
93073545|NCT04652245|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
93073546|NCT04652245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073547|NCT04652245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073548|NCT04652245|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
93073549|NCT04652245|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
93073550|NCT04652245|Histamine Antagonists|histamine antagonists|mesh-ancestor
93073551|NCT04652245|Histamine Agents|histamine agents|mesh-ancestor
93073552|NCT04652245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
93073553|NCT04642287|Fluorouracil|fluorouracil|mesh-list
93073554|NCT04642287|Calcipotriene|calcipotriene|mesh-list
93073555|NCT04642287|Petrolatum|petrolatum|mesh-list
93073556|NCT04642287|Antimetabolites|antimetabolites|mesh-ancestor
93073557|NCT04642287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073558|NCT04642287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073559|NCT04642287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073560|NCT04642287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073561|NCT04642287|Immunologic Factors|immunologic factors|mesh-ancestor
93073562|NCT04642287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073563|NCT04642287|Dermatologic Agents|dermatologic agents|mesh-ancestor
93073564|NCT04642287|Emollients|emollients|mesh-ancestor
93073565|NCT04635735|Ipilimumab|ipilimumab|mesh-list
93073566|NCT04635735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073567|NCT04635735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073568|NCT04635735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93073569|NCT04635735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073570|NCT04595513|Sirolimus|sirolimus|mesh-list
93073571|NCT04595513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93073572|NCT04595513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073573|NCT04595513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93073574|NCT04595513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073575|NCT04595513|Antifungal Agents|antifungal agents|mesh-ancestor
93073576|NCT04595513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073577|NCT04595513|Immunologic Factors|immunologic factors|mesh-ancestor
93073578|NCT04595513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073579|NCT04564339|Ravulizumab|ravulizumab|mesh-list
93073580|NCT04564339|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
93073581|NCT04564339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073582|NCT04564339|Immunologic Factors|immunologic factors|mesh-ancestor
93073583|NCT04564339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073584|NCT04543110|Durvalumab|durvalumab|mesh-list
93073585|NCT04543110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073586|NCT04543110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073587|NCT04487652|Coenzyme Q10|coenzyme q10|mesh-list
93073588|NCT04487652|Vitamins|vitamins|mesh-ancestor
93073589|NCT04487652|Micronutrients|micronutrients|mesh-ancestor
93073590|NCT04487652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073591|NCT04454489|Pembrolizumab|pembrolizumab|mesh-list
93073592|NCT04454489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073593|NCT04454489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073594|NCT04454489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93073595|NCT04454489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073597|NCT04447183|Hormones|hormones|mesh-list
93073598|NCT04447183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073599|NCT04447183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073600|NCT04447183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
93073601|NCT04447183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073602|NCT04447183|Trace Elements|trace elements|mesh-ancestor
93073603|NCT04447183|Micronutrients|micronutrients|mesh-ancestor
93073604|NCT04429334|Nangibotide|nangibotide|mesh-list
93073605|NCT04429334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073606|NCT04421820|Leucovorin|leucovorin|mesh-list
93073607|NCT04421820|Fluorouracil|fluorouracil|mesh-list
93073608|NCT04421820|Oxaliplatin|oxaliplatin|mesh-list
93073609|NCT04421820|Antimetabolites|antimetabolites|mesh-ancestor
93073610|NCT04421820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073611|NCT04421820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
93073612|NCT04421820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073613|NCT04421820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073614|NCT04421820|Immunologic Factors|immunologic factors|mesh-ancestor
93073615|NCT04421820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073616|NCT04421820|Antidotes|antidotes|mesh-ancestor
93073617|NCT04421820|Protective Agents|protective agents|mesh-ancestor
93073618|NCT04421820|Vitamin B Complex|vitamin b complex|mesh-ancestor
93073619|NCT04421820|Vitamins|vitamins|mesh-ancestor
93073620|NCT04421820|Micronutrients|micronutrients|mesh-ancestor
93073621|NCT04408443|Vitamin D|vitamin d|mesh-list
93073622|NCT04408443|Cholecalciferol|cholecalciferol|mesh-list
93073623|NCT04408443|Vitamins|vitamins|mesh-ancestor
93073624|NCT04408443|Micronutrients|micronutrients|mesh-ancestor
93073625|NCT04408443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073626|NCT04408443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
93073627|NCT04408443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
93073628|NCT04405739|Molnupiravir|molnupiravir|mesh-list
93073629|NCT04405739|Antiviral Agents|antiviral agents|mesh-ancestor
93073630|NCT04405739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073631|NCT04396457|Pembrolizumab|pembrolizumab|mesh-list
93073632|NCT04396457|Pemetrexed|pemetrexed|mesh-list
93073633|NCT04396457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073634|NCT04396457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073635|NCT04396457|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93073636|NCT04396457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073637|NCT04396457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073639|NCT04396457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
93073640|NCT04377204|Lidocaine|lidocaine|mesh-list
93073641|NCT04377204|Bupivacaine|bupivacaine|mesh-list
93073642|NCT04377204|Anesthetics, Local|anesthetics, local|mesh-ancestor
93073644|NCT04377204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073645|NCT04377204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073646|NCT04377204|Sensory System Agents|sensory system agents|mesh-ancestor
93073647|NCT04377204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073648|NCT04377204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
93073649|NCT04377204|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
93073650|NCT04377204|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
93073651|NCT04377204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
93073652|NCT04377204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073653|NCT04349267|Nivolumab|nivolumab|mesh-list
93073654|NCT04349267|Cetuximab|cetuximab|mesh-list
93073655|NCT04349267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073656|NCT04349267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073657|NCT04349267|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
93073658|NCT04349267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073659|NCT04346589|Antibodies|antibodies|mesh-list
93073660|NCT04346589|Immunoglobulins|immunoglobulins|mesh-list
93073661|NCT04346589|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
93073662|NCT04346589|Immunologic Factors|immunologic factors|mesh-ancestor
93073663|NCT04346589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073664|NCT05934253|Chloroprocaine|chloroprocaine|mesh-list
93073665|NCT05934253|Anesthetics, Local|anesthetics, local|mesh-ancestor
93073666|NCT05934253|Anesthetics|anesthetics|mesh-ancestor
93073667|NCT05934253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
93073668|NCT05934253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073669|NCT05934253|Sensory System Agents|sensory system agents|mesh-ancestor
93073670|NCT05934253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
93073671|NCT05934227|Amoxicillin|amoxicillin|mesh-list
93073672|NCT05934227|Metronidazole|metronidazole|mesh-list
93073673|NCT05934227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
93073674|NCT05934227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
93073675|NCT05934227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
93073676|NCT05934227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
93073677|NCT05934214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
93073678|NCT05934214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073679|NCT05934214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073680|NCT05934214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073681|NCT05934110|Orlistat|orlistat|mesh-list
93073682|NCT05934110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073683|NCT05934110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073684|NCT05934110|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
93073685|NCT05934110|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
93073686|NCT05934097|Prednisone|prednisone|mesh-list
93073687|NCT05934097|Cyclophosphamide|cyclophosphamide|mesh-list
93073688|NCT05934097|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
93073689|NCT05934097|Rituximab|rituximab|mesh-list
93073690|NCT05934097|Doxorubicin|doxorubicin|mesh-list
93073691|NCT05934097|Vincristine|vincristine|mesh-list
93073692|NCT05934097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
93073693|NCT05934097|Immunologic Factors|immunologic factors|mesh-ancestor
93073694|NCT05934097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
93073695|NCT05934097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
93073696|NCT05934097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
93073697|NCT05934097|Alkylating Agents|alkylating agents|mesh-ancestor
93073698|NCT05934097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
93073699|NCT05934097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
93073700|NCT05934097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
93073701|NCT05934097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
93073702|NCT05934097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
93073703|NCT05934097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
93073704|NCT05934097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
93073705|NCT05934097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
93073706|NCT05934097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
93073707|NCT05934097|Glucocorticoids|glucocorticoids|mesh-ancestor
93073708|NCT05934097|Hormones|hormones|mesh-ancestor
93073709|NCT05934097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
93073710|NCT05934097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92730668|NCT01181986|Exenatide|exenatide|mesh-list
93073711|NCT05934097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
93073712|NCT05934097|Tubulin Modulators|tubulin modulators|mesh-ancestor
93073713|NCT05934097|Antimitotic Agents|antimitotic agents|mesh-ancestor
93073714|NCT05934097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92731177|NCT04543565|Pradefovir|pradefovir|mesh-list
92731843|NCT01684995|Autonomic Agents|autonomic agents|mesh-ancestor
92731921|NCT04530422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732069|NCT02217956|Growth Substances|growth substances|mesh-ancestor
92732219|NCT01198795|Escitalopram|escitalopram|mesh-list
92732975|NCT01644071|Dexetimide|dexetimide|mesh-list
92733056|NCT01681667|Ibuprofen|ibuprofen|mesh-list
92733866|NCT01606098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733938|NCT01602393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734083|NCT02271282|Toremifene|toremifene|mesh-list
92734158|NCT01687127|Folic Acid|folic acid|mesh-list
92734455|NCT03558854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734753|NCT01342341|Chlorzoxazone|chlorzoxazone|mesh-list
92735203|NCT01113541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735349|NCT01601327|Hormones|hormones|mesh-ancestor
92735500|NCT01111552|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92735578|NCT01608464|Immunologic Factors|immunologic factors|mesh-ancestor
92735653|NCT01604057|Teriparatide|teriparatide|mesh-list
92736005|NCT02270606|Fluorouracil|fluorouracil|mesh-list
92736802|NCT04328870|Oxytocin|oxytocin|mesh-list
92736943|NCT01340768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737601|NCT00623168|Ribavirin|ribavirin|mesh-list
92737749|NCT01324232|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92737821|NCT00598533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92737897|NCT00600639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92737970|NCT01325493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92738118|NCT01100437|Analgesics|analgesics|mesh-ancestor
92738195|NCT01320722|Gout Suppressants|gout suppressants|mesh-ancestor
92738417|NCT01075321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739238|NCT00627133|Levetiracetam|levetiracetam|mesh-list
92739898|NCT01320683|Fluorouracil|fluorouracil|mesh-list
92740049|NCT01312961|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92740154|NCT01057693|Pregabalin|pregabalin|mesh-list
92740191|NCT01034137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92740621|NCT01019317|Antiviral Agents|antiviral agents|mesh-ancestor
92740703|NCT01283139|Sifalimumab|sifalimumab|mesh-list
92740924|NCT01075984|Posaconazole|posaconazole|mesh-list
92741364|NCT01003639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92741440|NCT04322175|Meloxicam|meloxicam|mesh-list
92741598|NCT04439799|Hormones|hormones|mesh-ancestor
92741888|NCT01296672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92742186|NCT04305028|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743378|NCT01054222|Urological Agents|urological agents|mesh-ancestor
92743602|NCT01007149|Omalizumab|omalizumab|mesh-list
92743761|NCT01224171|Vedolizumab|vedolizumab|mesh-list
92744131|NCT00985621|Tanezumab|tanezumab|mesh-list
92744430|NCT01002820|GABA Agents|gaba agents|mesh-ancestor
92744803|NCT01202409|Panitumumab|panitumumab|mesh-list
92744955|NCT04288219|Tocolytic Agents|tocolytic agents|mesh-ancestor
92745483|NCT05926570|Cinacalcet|cinacalcet|mesh-list
92745916|NCT05394337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746520|NCT04063267|Nicotine|nicotine|mesh-list
92746916|NCT02861417|Vidarabine|vidarabine|mesh-list
92747651|NCT01289678|Interleukin-2|interleukin-2|mesh-list
92747735|NCT01182207|Diuretics|diuretics|mesh-ancestor
92748175|NCT02862145|Dexamethasone|dexamethasone|mesh-list
92748323|NCT01294787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92748549|NCT01292603|Rituximab|rituximab|mesh-list
92749220|NCT00946309|Sulforaphane|sulforaphane|mesh-list
92749373|NCT01231620|Oseltamivir|oseltamivir|mesh-list
92749446|NCT01154673|Ritonavir|ritonavir|mesh-list
92749882|NCT01146561|Tanezumab|tanezumab|mesh-list
92749970|NCT01143051|Epinephrine|epinephrine|mesh-list
92750104|NCT00602719|Zolpidem|zolpidem|mesh-list
92750175|NCT04312347|Tamoxifen|tamoxifen|mesh-list
92750697|NCT05937711|Analgesics|analgesics|mesh-ancestor
92750844|NCT05881291|Sensory System Agents|sensory system agents|mesh-ancestor
92751007|NCT05624281|Nintedanib|nintedanib|mesh-list
92751216|NCT05138822|Nitrofurantoin|nitrofurantoin|mesh-list
92752558|NCT05937282|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92752844|NCT05760261|Anesthetics, General|anesthetics, general|mesh-ancestor
92752916|NCT05683691|Sensory System Agents|sensory system agents|mesh-ancestor
92752991|NCT05625594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92753144|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
92753595|NCT04900623|Paclitaxel|paclitaxel|mesh-list
92753894|NCT04002115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92754519|NCT05025397|Propofol|propofol|mesh-list
92754577|NCT00929695|Prednisone|prednisone|mesh-list
92755093|NCT04254601|Erythromycin|erythromycin|mesh-list
92755245|NCT01128387|Panitumumab|panitumumab|mesh-list
92755694|NCT05566223|Immunologic Factors|immunologic factors|mesh-ancestor
92527985|NCT00014196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527987|NCT00034840|Telmisartan|telmisartan|mesh-list
92527988|NCT00034840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92527989|NCT00034840|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92527990|NCT00034840|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92527991|NCT00034840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527993|NCT00000689|Cytarabine|cytarabine|mesh-list
92527994|NCT00000689|Dexamethasone|dexamethasone|mesh-list
92527995|NCT00000689|Cyclophosphamide|cyclophosphamide|mesh-list
92527996|NCT00000689|Doxorubicin|doxorubicin|mesh-list
92527997|NCT00000689|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92527998|NCT00000689|Methotrexate|methotrexate|mesh-list
92527999|NCT00000689|Vincristine|vincristine|mesh-list
92528000|NCT00000689|Bleomycin|bleomycin|mesh-list
92528001|NCT00000689|Sargramostim|sargramostim|mesh-list
92528002|NCT00000689|Levoleucovorin|levoleucovorin|mesh-list
92528003|NCT00000689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528004|NCT00000689|Immunologic Factors|immunologic factors|mesh-ancestor
92528005|NCT00000689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528006|NCT00000689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528007|NCT00000689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92528008|NCT00000689|Alkylating Agents|alkylating agents|mesh-ancestor
92528009|NCT00000689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528010|NCT00000689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528011|NCT00000689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92528012|NCT00000689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528013|NCT00000689|Antiemetics|antiemetics|mesh-ancestor
92528014|NCT00000689|Autonomic Agents|autonomic agents|mesh-ancestor
92528015|NCT00000689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429401|NCT05840406|Antipyretics|antipyretics|mesh-ancestor
92429402|NCT05840406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92429403|NCT05840406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429404|NCT05840406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429405|NCT05840406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92429406|NCT05840406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429407|NCT05840406|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92429408|NCT05840406|Narcotics|narcotics|mesh-ancestor
92429409|NCT05840406|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429410|NCT05840406|Anesthetics|anesthetics|mesh-ancestor
92429411|NCT05840328|Dexmedetomidine|dexmedetomidine|mesh-list
92429412|NCT05840328|Bupivacaine|bupivacaine|mesh-list
92429413|NCT05840328|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429414|NCT05840328|Anesthetics|anesthetics|mesh-ancestor
92429415|NCT05840328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429416|NCT05840328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429417|NCT05840328|Sensory System Agents|sensory system agents|mesh-ancestor
92429418|NCT05840328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429419|NCT05840328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92429420|NCT05840328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92429421|NCT05840328|Analgesics|analgesics|mesh-ancestor
92429422|NCT05840328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92429423|NCT05840328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92429424|NCT05840328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429425|NCT05840328|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429426|NCT05840328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429427|NCT05840328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429428|NCT05840172|Benzocaine|benzocaine|mesh-list
92429429|NCT05840172|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429430|NCT05840172|Anesthetics|anesthetics|mesh-ancestor
92429431|NCT05840172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429432|NCT05840172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429433|NCT05840172|Sensory System Agents|sensory system agents|mesh-ancestor
92429434|NCT05840172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429435|NCT05840159|Doxycycline|doxycycline|mesh-list
92429436|NCT05840159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92429437|NCT05840159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429438|NCT05840159|Antimalarials|antimalarials|mesh-ancestor
92429439|NCT05840159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92429440|NCT05840159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92429441|NCT05840094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92429442|NCT05840094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92429443|NCT05840094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429444|NCT05840016|Carboplatin|carboplatin|mesh-list
92429445|NCT05840016|Tislelizumab|tislelizumab|mesh-list
92429446|NCT05840016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429447|NCT05840016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429448|NCT05839899|Misoprostol|misoprostol|mesh-list
92429449|NCT05839899|Mifepristone|mifepristone|mesh-list
92429450|NCT05839899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92429451|NCT05839899|Abortifacient Agents|abortifacient agents|mesh-ancestor
92429452|NCT05839899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92429453|NCT05839899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429454|NCT05839899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92429455|NCT05839899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429456|NCT05839899|Oxytocics|oxytocics|mesh-ancestor
92429457|NCT05839899|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92429458|NCT05839899|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92429459|NCT05839899|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92429460|NCT05839899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92429461|NCT05839899|Contraceptive Agents|contraceptive agents|mesh-ancestor
92429462|NCT05839899|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92429463|NCT05839899|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92429464|NCT05839899|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429465|NCT05839899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429466|NCT05839899|Luteolytic Agents|luteolytic agents|mesh-ancestor
92429467|NCT05839899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92429468|NCT05839899|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92429469|NCT05839652|Midodrine|midodrine|mesh-list
92429470|NCT05839652|Droxidopa|droxidopa|mesh-list
92429471|NCT05839652|Sympathomimetics|sympathomimetics|mesh-ancestor
92429472|NCT05839652|Autonomic Agents|autonomic agents|mesh-ancestor
92429473|NCT05839652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429474|NCT05839652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154174|NCT04148963|Loxapine|loxapine|mesh-list
92429475|NCT05839652|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92429476|NCT05839652|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92429478|NCT05839652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429479|NCT05839652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429480|NCT05839652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429481|NCT05839652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429482|NCT05839652|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92429483|NCT05839652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92429484|NCT05839574|Letrozole|letrozole|mesh-list
92429485|NCT05839574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429486|NCT05839574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92429487|NCT05839574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92429488|NCT05839574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429489|NCT05839574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429490|NCT05839574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92429491|NCT05839574|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429492|NCT05839574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429493|NCT05839574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429494|NCT05839561|Letrozole|letrozole|mesh-list
92429495|NCT05839561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429496|NCT05839561|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92429497|NCT05839561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92429498|NCT05839561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429499|NCT05839561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429500|NCT05839561|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92429501|NCT05839561|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429502|NCT05839561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429503|NCT05839561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429504|NCT05839548|Epinephrine|epinephrine|mesh-list
92429505|NCT05839548|Racepinephrine|racepinephrine|mesh-list
92429506|NCT05839548|Carticaine|carticaine|mesh-list
92429507|NCT05839548|Mepivacaine|mepivacaine|mesh-list
92429508|NCT05839548|Epinephryl borate|epinephryl borate|mesh-list
92429509|NCT05839548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92429510|NCT05839548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429511|NCT05839548|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429512|NCT05839548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429513|NCT05839548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429514|NCT05839548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429515|NCT05839548|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92429516|NCT05839548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92429517|NCT05839548|Autonomic Agents|autonomic agents|mesh-ancestor
92429518|NCT05839548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429519|NCT05839548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92429520|NCT05839548|Respiratory System Agents|respiratory system agents|mesh-ancestor
92429521|NCT05839548|Mydriatics|mydriatics|mesh-ancestor
92429522|NCT05839548|Sympathomimetics|sympathomimetics|mesh-ancestor
92429523|NCT05839548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92429524|NCT05839548|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429525|NCT05839548|Anesthetics|anesthetics|mesh-ancestor
92429526|NCT05839548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429527|NCT05839548|Sensory System Agents|sensory system agents|mesh-ancestor
92429529|NCT05839522|Immunoglobulins|immunoglobulins|mesh-list
92429530|NCT05839522|HIV Antibodies|hiv antibodies|mesh-list
92429531|NCT05839522|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92429532|NCT05839522|Immunologic Factors|immunologic factors|mesh-ancestor
92429533|NCT05839522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429534|NCT05839509|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92429535|NCT05839509|Hallucinogens|hallucinogens|mesh-ancestor
92429536|NCT05839509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429537|NCT05839509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92429538|NCT05839509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92429539|NCT05839509|Serotonin Agents|serotonin agents|mesh-ancestor
92429540|NCT05839509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429541|NCT05839509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429542|NCT05839509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92429543|NCT05839470|Leucovorin|leucovorin|mesh-list
92429544|NCT05839470|Oxaliplatin|oxaliplatin|mesh-list
92429545|NCT05839470|Irinotecan|irinotecan|mesh-list
92429546|NCT05839470|Levoleucovorin|levoleucovorin|mesh-list
92429547|NCT05839470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429548|NCT05839470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92429549|NCT05839470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92429550|NCT05839470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704576|NCT04397692|Nitric Oxide|nitric oxide|mesh-list
92429551|NCT05839470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429552|NCT05839470|Antidotes|antidotes|mesh-ancestor
92429553|NCT05839470|Protective Agents|protective agents|mesh-ancestor
92429554|NCT05839470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429555|NCT05839470|Vitamin B Complex|vitamin b complex|mesh-ancestor
92429557|NCT05839470|Micronutrients|micronutrients|mesh-ancestor
92429558|NCT05839236|Atorvastatin|atorvastatin|mesh-list
92429559|NCT05839236|Calcium|calcium|mesh-list
92429560|NCT05839236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429561|NCT05839236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429562|NCT05839236|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92429563|NCT05839236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92429564|NCT05839236|Antimetabolites|antimetabolites|mesh-ancestor
92429565|NCT05839236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429566|NCT05839236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92429567|NCT05839236|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92429568|NCT05839236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429569|NCT05839197|Apatinib|apatinib|mesh-list
92429570|NCT05839197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429571|NCT05839197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92429572|NCT05839197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429573|NCT05839197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429574|NCT05839119|Gemcitabine|gemcitabine|mesh-list
92429575|NCT05839119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429576|NCT05839119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429577|NCT05839119|Antimetabolites|antimetabolites|mesh-ancestor
92429578|NCT05839119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429579|NCT05839054|Methamphetamine|methamphetamine|mesh-list
92429580|NCT05839054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92429581|NCT05839054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429582|NCT05839054|Sympathomimetics|sympathomimetics|mesh-ancestor
92429583|NCT05839054|Autonomic Agents|autonomic agents|mesh-ancestor
92429584|NCT05839054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429585|NCT05839054|Dopamine Agents|dopamine agents|mesh-ancestor
92429586|NCT05839054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429587|NCT05839054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429588|NCT05839054|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429589|NCT05839054|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92429590|NCT05839054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92429591|NCT05839054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429592|NCT05839054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92429593|NCT05838846|Milrinone|milrinone|mesh-list
92429594|NCT05838846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92429595|NCT05838846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92429596|NCT05838846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92429597|NCT05838846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92429598|NCT05838846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92429599|NCT05838846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429600|NCT05838846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429601|NCT05838846|Protective Agents|protective agents|mesh-ancestor
92429602|NCT05838846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429603|NCT05837403|Nitroglycerin|nitroglycerin|mesh-list
92429604|NCT05837403|Vasodilator Agents|vasodilator agents|mesh-ancestor
92429605|NCT05836610|Hydrocortisone|hydrocortisone|mesh-list
92429606|NCT05836610|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92429607|NCT05836610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429608|NCT05833529|Cocaine|cocaine|mesh-list
92429609|NCT05833529|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429610|NCT05833529|Anesthetics|anesthetics|mesh-ancestor
92429611|NCT05833529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429612|NCT05833529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429613|NCT05833529|Sensory System Agents|sensory system agents|mesh-ancestor
92429614|NCT05833529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429615|NCT05833529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92429616|NCT05833529|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92429617|NCT05833529|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92429618|NCT05833529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429619|NCT05833529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429620|NCT05833529|Dopamine Agents|dopamine agents|mesh-ancestor
92429621|NCT05833529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429622|NCT05830630|Bupivacaine|bupivacaine|mesh-list
92429623|NCT05830630|Methylene Blue|methylene blue|mesh-list
92429624|NCT05830630|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429625|NCT05830630|Anesthetics|anesthetics|mesh-ancestor
92429626|NCT05830630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429627|NCT05830630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429628|NCT05830630|Sensory System Agents|sensory system agents|mesh-ancestor
92429629|NCT05830630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429630|NCT05830630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429631|NCT05830630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429632|NCT05823753|Cannabidiol|cannabidiol|mesh-list
92429633|NCT05823753|Anticonvulsants|anticonvulsants|mesh-ancestor
92429634|NCT05823311|Cisplatin|cisplatin|mesh-list
92429635|NCT05823311|Gemcitabine|gemcitabine|mesh-list
92429636|NCT05823311|Lenvatinib|lenvatinib|mesh-list
92429637|NCT05823311|Tislelizumab|tislelizumab|mesh-list
92429638|NCT05823311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429639|NCT05823311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429640|NCT05823311|Antimetabolites|antimetabolites|mesh-ancestor
92429641|NCT05823311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429642|NCT05823311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92429643|NCT05823311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429644|NCT05823311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429645|NCT05813158|Bupivacaine|bupivacaine|mesh-list
92429646|NCT05813158|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429647|NCT05813158|Anesthetics|anesthetics|mesh-ancestor
92429648|NCT05813158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429649|NCT05813158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429650|NCT05813158|Sensory System Agents|sensory system agents|mesh-ancestor
92429651|NCT05813158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429652|NCT05805683|Calcitonin|calcitonin|mesh-list
92429653|NCT05805683|Salmon calcitonin|salmon calcitonin|mesh-list
92429654|NCT05805683|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92429655|NCT05805683|Katacalcin|katacalcin|mesh-list
92429656|NCT05805683|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429657|NCT05805683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429658|NCT05805683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92429659|NCT05805683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92429660|NCT05782361|Pembrolizumab|pembrolizumab|mesh-list
92429661|NCT05782361|Tepotinib|tepotinib|mesh-list
92429662|NCT05782361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429663|NCT05782361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429664|NCT05782361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92429665|NCT05782361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429666|NCT05780801|Glycerol|glycerol|mesh-list
92429667|NCT05780801|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92429668|NCT05780801|Protective Agents|protective agents|mesh-ancestor
92429669|NCT05780801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429670|NCT05753670|Tamsulosin|tamsulosin|mesh-list
92530871|NCT00043888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92429671|NCT05753670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92429672|NCT05753670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92429673|NCT05753670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92429674|NCT05753670|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429675|NCT05753670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429676|NCT05753670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429677|NCT05753670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429678|NCT05753670|Urological Agents|urological agents|mesh-ancestor
92429679|NCT05753059|Bendroflumethiazide|bendroflumethiazide|mesh-list
92429680|NCT05753059|Amiloride|amiloride|mesh-list
92429681|NCT05753059|Diuretics|diuretics|mesh-ancestor
92429682|NCT05753059|Natriuretic Agents|natriuretic agents|mesh-ancestor
92429683|NCT05753059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429684|NCT05753059|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92429685|NCT05753059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92429686|NCT05753059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429687|NCT05753059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429688|NCT05753059|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92429689|NCT05753059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92429690|NCT05753059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92429691|NCT05753059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92429692|NCT05726032|Empagliflozin|empagliflozin|mesh-list
92429693|NCT05726032|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92429694|NCT05726032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429695|NCT05726032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92429696|NCT05726032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429697|NCT05686005|Tranexamic Acid|tranexamic acid|mesh-list
92429698|NCT05686005|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92429699|NCT05686005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92429700|NCT05686005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429701|NCT05686005|Hemostatics|hemostatics|mesh-ancestor
92429702|NCT05686005|Coagulants|coagulants|mesh-ancestor
92429703|NCT05671991|Empagliflozin|empagliflozin|mesh-list
92429704|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92429705|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429706|NCT05671991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92429707|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429708|NCT05660681|Glycerol|glycerol|mesh-list
92429709|NCT05660681|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92429710|NCT05660681|Protective Agents|protective agents|mesh-ancestor
92429711|NCT05660681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429712|NCT05624268|Psilocybin|psilocybin|mesh-list
92429713|NCT05624268|Hallucinogens|hallucinogens|mesh-ancestor
92429714|NCT05624268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429715|NCT05624268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92429716|NCT05600114|Cannabidiol|cannabidiol|mesh-list
92429717|NCT05600114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92429718|NCT05600114|Anticonvulsants|anticonvulsants|mesh-ancestor
92429719|NCT05585151|Evolocumab|evolocumab|mesh-list
92429720|NCT05585151|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92429721|NCT05585151|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92429722|NCT05585151|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92429723|NCT05585151|Antimetabolites|antimetabolites|mesh-ancestor
92429724|NCT05585151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429725|NCT05585151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92429726|NCT05585151|Protease Inhibitors|protease inhibitors|mesh-ancestor
92429727|NCT05585151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429728|NCT05585151|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92429729|NCT05585112|Lidocaine|lidocaine|mesh-list
92429730|NCT05585112|Carticaine|carticaine|mesh-list
92429731|NCT05585112|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429732|NCT05585112|Anesthetics|anesthetics|mesh-ancestor
92429733|NCT05585112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429734|NCT05585112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429735|NCT05585112|Sensory System Agents|sensory system agents|mesh-ancestor
92429736|NCT05585112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429737|NCT05585112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92429738|NCT05585112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92429739|NCT05585112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92429740|NCT05585112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429741|NCT05585112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429742|NCT05552443|Hydromorphone|hydromorphone|mesh-list
92429743|NCT05552443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92429744|NCT05552443|Narcotics|narcotics|mesh-ancestor
92429745|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429746|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429747|NCT05552443|Analgesics|analgesics|mesh-ancestor
92429748|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
92429749|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429750|NCT05550337|Trifarotene|trifarotene|mesh-list
92429751|NCT05550337|Dermatologic Agents|dermatologic agents|mesh-ancestor
92429752|NCT05527483|Listerine|listerine|mesh-list
92429753|NCT05527483|Fluorides|fluorides|mesh-list
92429754|NCT05527483|Sodium Fluoride|sodium fluoride|mesh-list
92429755|NCT05527483|Cariostatic Agents|cariostatic agents|mesh-ancestor
92429756|NCT05527483|Protective Agents|protective agents|mesh-ancestor
92429757|NCT05527483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429758|NCT05527483|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92429759|NCT05527483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429760|NCT05527470|Cisplatin|cisplatin|mesh-list
92429761|NCT05527470|Gemcitabine|gemcitabine|mesh-list
92429762|NCT05527470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429763|NCT05527470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429764|NCT05527470|Antimetabolites|antimetabolites|mesh-ancestor
92341621|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92429765|NCT05527470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429766|NCT05477485|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92429767|NCT05477485|Antiviral Agents|antiviral agents|mesh-ancestor
92429768|NCT05477485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429769|NCT05458102|Voriconazole|voriconazole|mesh-list
92429770|NCT05458102|Cobicistat|cobicistat|mesh-list
92429771|NCT05458102|Rifabutin|rifabutin|mesh-list
92429772|NCT05458102|Vesatolimod|vesatolimod|mesh-list
92429773|NCT05458102|Antifungal Agents|antifungal agents|mesh-ancestor
92429774|NCT05458102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429775|NCT05458102|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92154473|NCT04145921|Tacrine|tacrine|mesh-list
92429776|NCT05458102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92429777|NCT05458102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429778|NCT05458102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429779|NCT05458102|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92429780|NCT05458102|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429781|NCT05458102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429782|NCT05458102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429783|NCT05458102|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92429784|NCT05458102|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92429785|NCT05458102|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92429786|NCT05458102|Antiviral Agents|antiviral agents|mesh-ancestor
92429787|NCT05458102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92429788|NCT05458102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92429789|NCT05458102|Antitubercular Agents|antitubercular agents|mesh-ancestor
92429791|NCT05439356|Gout Suppressants|gout suppressants|mesh-ancestor
92429792|NCT05439356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429793|NCT05439356|Tubulin Modulators|tubulin modulators|mesh-ancestor
92429794|NCT05439356|Antimitotic Agents|antimitotic agents|mesh-ancestor
92429795|NCT05439356|Mitosis Modulators|mitosis modulators|mesh-ancestor
92429796|NCT05439356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429797|NCT05439356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429798|NCT05335356|Ustekinumab|ustekinumab|mesh-list
92429799|NCT05335356|Dermatologic Agents|dermatologic agents|mesh-ancestor
92429800|NCT05323487|Bumetanide|bumetanide|mesh-list
92429801|NCT05323487|Diuretics|diuretics|mesh-ancestor
92429802|NCT05323487|Natriuretic Agents|natriuretic agents|mesh-ancestor
92429803|NCT05323487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429804|NCT05323487|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92429805|NCT05323487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429806|NCT05323487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429807|NCT05301842|Durvalumab|durvalumab|mesh-list
92429808|NCT05301842|Lenvatinib|lenvatinib|mesh-list
92429809|NCT05301842|Tremelimumab|tremelimumab|mesh-list
92429810|NCT05301842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429811|NCT05301842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429812|NCT05301842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92429813|NCT05301842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429814|NCT05301842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429815|NCT05301322|Vaccines|vaccines|mesh-list
92429816|NCT05301322|Immunologic Factors|immunologic factors|mesh-ancestor
92429817|NCT05301322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429818|NCT05281601|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92429819|NCT05281601|Antiviral Agents|antiviral agents|mesh-ancestor
92429820|NCT05281601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429821|NCT05266807|Vancomycin|vancomycin|mesh-list
92429822|NCT05266807|Fidaxomicin|fidaxomicin|mesh-list
92429823|NCT05266807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92429824|NCT05266807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429825|NCT05254418|Dulaglutide|dulaglutide|mesh-list
92429826|NCT05254418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92429827|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429828|NCT05224050|Nicotine|nicotine|mesh-list
92429829|NCT05224050|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92429830|NCT05224050|Autonomic Agents|autonomic agents|mesh-ancestor
92429831|NCT05224050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429832|NCT05224050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429833|NCT05224050|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92429834|NCT05224050|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92429835|NCT05224050|Cholinergic Agents|cholinergic agents|mesh-ancestor
92429836|NCT05224050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429837|NCT05224050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429838|NCT05174065|Apremilast|apremilast|mesh-list
92429839|NCT05174065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92429840|NCT05174065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92429841|NCT05174065|Analgesics|analgesics|mesh-ancestor
92429842|NCT05174065|Sensory System Agents|sensory system agents|mesh-ancestor
92429843|NCT05174065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429844|NCT05174065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429845|NCT05174065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429846|NCT05174065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429847|NCT05174065|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92429848|NCT05174065|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92429849|NCT05174065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429850|NCT05174065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429851|NCT05150704|Methylprednisolone|methylprednisolone|mesh-list
92429852|NCT05150704|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92429853|NCT05150704|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92429854|NCT05150704|Prednisolone|prednisolone|mesh-list
92429855|NCT05150704|Prednisolone acetate|prednisolone acetate|mesh-list
92429856|NCT05150704|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92429857|NCT05150704|Prednisolone phosphate|prednisolone phosphate|mesh-list
92429858|NCT05150704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429859|NCT05150704|Antiemetics|antiemetics|mesh-ancestor
92429860|NCT05150704|Autonomic Agents|autonomic agents|mesh-ancestor
92429861|NCT05150704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429862|NCT05150704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429863|NCT05150704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429864|NCT05150704|Glucocorticoids|glucocorticoids|mesh-ancestor
92429865|NCT05150704|Hormones|hormones|mesh-ancestor
92429866|NCT05150704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429867|NCT05150704|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92429868|NCT05150704|Protective Agents|protective agents|mesh-ancestor
92429869|NCT05150704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92429870|NCT05150704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429871|NCT05117866|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92429872|NCT05117866|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92429873|NCT05116241|Vaccines|vaccines|mesh-list
92429874|NCT05116241|Immunologic Factors|immunologic factors|mesh-ancestor
92429875|NCT05116241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429876|NCT05095259|Insulin|insulin|mesh-list
92429877|NCT05095259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92429878|NCT05095259|Epinephrine|epinephrine|mesh-list
92429879|NCT05095259|Glucagon|glucagon|mesh-list
92429880|NCT05095259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92429881|NCT05095259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429882|NCT05095259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92429883|NCT05095259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429884|NCT05095259|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429885|NCT05095259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429886|NCT05095259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429887|NCT05095259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92429888|NCT05095259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92429889|NCT05095259|Autonomic Agents|autonomic agents|mesh-ancestor
92429890|NCT05095259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429891|NCT05095259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92429892|NCT05095259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92429893|NCT05095259|Mydriatics|mydriatics|mesh-ancestor
92429894|NCT05095259|Sympathomimetics|sympathomimetics|mesh-ancestor
92429895|NCT05095259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92429896|NCT05095259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429897|NCT05095259|Hormones|hormones|mesh-ancestor
92429898|NCT05095259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429899|NCT05064280|Pembrolizumab|pembrolizumab|mesh-list
92429900|NCT05064280|Lenvatinib|lenvatinib|mesh-list
92429901|NCT05064280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429902|NCT05064280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429903|NCT05064280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92429904|NCT05064280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429905|NCT05064280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92429906|NCT05064280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429907|NCT05049278|Phenylephrine|phenylephrine|mesh-list
92429908|NCT05049278|Oxymetazoline|oxymetazoline|mesh-list
92429909|NCT05049278|Norepinephrine|norepinephrine|mesh-list
92429910|NCT05049278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92429911|NCT05049278|Mydriatics|mydriatics|mesh-ancestor
92429912|NCT05049278|Autonomic Agents|autonomic agents|mesh-ancestor
92429913|NCT05049278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429914|NCT05049278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429915|NCT05049278|Sympathomimetics|sympathomimetics|mesh-ancestor
92429916|NCT05049278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92429917|NCT05049278|Nasal Decongestants|nasal decongestants|mesh-ancestor
92429918|NCT05049278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92429919|NCT05049278|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92429920|NCT05049278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92429921|NCT05049278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429922|NCT05049278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429923|NCT05049278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429924|NCT05049278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429925|NCT05049278|Protective Agents|protective agents|mesh-ancestor
92429926|NCT05040282|Etonogestrel|etonogestrel|mesh-list
92429927|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92429928|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
92429929|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92429930|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429931|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92429932|NCT04982614|Vaccines|vaccines|mesh-list
92429933|NCT04982614|Immunologic Factors|immunologic factors|mesh-ancestor
92429934|NCT04982614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429935|NCT04982354|Fludarabine|fludarabine|mesh-list
92429936|NCT04982354|Melphalan|melphalan|mesh-list
92429937|NCT04982354|Busulfan|busulfan|mesh-list
92429938|NCT04982354|Midostaurin|midostaurin|mesh-list
92429939|NCT04982354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429940|NCT04982354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429941|NCT04982354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92429942|NCT04982354|Immunologic Factors|immunologic factors|mesh-ancestor
92429943|NCT04982354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429944|NCT04982354|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92429945|NCT04982354|Alkylating Agents|alkylating agents|mesh-ancestor
92429946|NCT04982354|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92429947|NCT04982354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92429948|NCT04982354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429949|NCT04953754|Melatonin|melatonin|mesh-list
92429950|NCT04953754|Antioxidants|antioxidants|mesh-ancestor
92429951|NCT04953754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429952|NCT04953754|Protective Agents|protective agents|mesh-ancestor
92429953|NCT04953754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429954|NCT04953754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429955|NCT04932382|Misoprostol|misoprostol|mesh-list
92429956|NCT04932382|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92429957|NCT04932382|Abortifacient Agents|abortifacient agents|mesh-ancestor
92429958|NCT04932382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92429959|NCT04932382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429960|NCT04932382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92429961|NCT04932382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429962|NCT04932382|Oxytocics|oxytocics|mesh-ancestor
92429963|NCT04909801|Adalimumab|adalimumab|mesh-list
92429964|NCT04909801|Methotrexate|methotrexate|mesh-list
92429965|NCT04909801|Abatacept|abatacept|mesh-list
92429966|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92429967|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
92429968|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92429969|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429970|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429971|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
92429972|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429973|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429974|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92429975|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429976|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92429977|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92429978|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
92429979|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429980|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92429981|NCT04909801|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92429982|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429983|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92429984|NCT04909801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429985|NCT04901715|Albuterol|albuterol|mesh-list
92429986|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92429987|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
92429988|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429989|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429990|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92429991|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92429992|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
92429993|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92429994|NCT04901715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92429995|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92429996|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429997|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429998|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429999|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430000|NCT04895592|Dexamethasone|dexamethasone|mesh-list
92430001|NCT04895592|Dexamethasone acetate|dexamethasone acetate|mesh-list
92430002|NCT04895592|Ichthammol|ichthammol|mesh-list
92430003|NCT04895592|BB 1101|bb 1101|mesh-list
92430004|NCT04895592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430005|NCT04895592|Antiemetics|antiemetics|mesh-ancestor
92430006|NCT04895592|Autonomic Agents|autonomic agents|mesh-ancestor
92430007|NCT04895592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430008|NCT04895592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430009|NCT04895592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430010|NCT04895592|Glucocorticoids|glucocorticoids|mesh-ancestor
92430011|NCT04895592|Hormones|hormones|mesh-ancestor
92430012|NCT04895592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430013|NCT04895592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430014|NCT04895592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430015|NCT04895592|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430016|NCT04895592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430017|NCT04895592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430018|NCT04895592|Dermatologic Agents|dermatologic agents|mesh-ancestor
92430019|NCT04861103|Enoxaparin|enoxaparin|mesh-list
92430020|NCT04861103|Anticoagulants|anticoagulants|mesh-ancestor
92430021|NCT04861103|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92430022|NCT04861103|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92430023|NCT04861103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430024|NCT04843761|Remdesivir|remdesivir|mesh-list
92430025|NCT04843761|Phentolamine|phentolamine|mesh-list
92430026|NCT04843761|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92430027|NCT04843761|Antimetabolites|antimetabolites|mesh-ancestor
92430028|NCT04843761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430029|NCT04843761|Antiviral Agents|antiviral agents|mesh-ancestor
92430030|NCT04843761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430031|NCT04843761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92430032|NCT04843761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92430033|NCT04843761|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430034|NCT04843761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430035|NCT04843761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430036|NCT04843761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430037|NCT04843761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430038|NCT04843761|Vasodilator Agents|vasodilator agents|mesh-ancestor
92430039|NCT04843761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92430040|NCT04843761|Protective Agents|protective agents|mesh-ancestor
92430041|NCT04835129|Dexamethasone|dexamethasone|mesh-list
92430042|NCT04835129|Pomalidomide|pomalidomide|mesh-list
92430044|NCT04835129|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92430045|NCT04835129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430046|NCT04835129|Antiemetics|antiemetics|mesh-ancestor
92430047|NCT04835129|Autonomic Agents|autonomic agents|mesh-ancestor
92430048|NCT04835129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430049|NCT04835129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430050|NCT04835129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430051|NCT04835129|Glucocorticoids|glucocorticoids|mesh-ancestor
92430052|NCT04835129|Hormones|hormones|mesh-ancestor
92430053|NCT04835129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430054|NCT04835129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430055|NCT04835129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430056|NCT04835129|Immunologic Factors|immunologic factors|mesh-ancestor
92430057|NCT04835129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92430058|NCT04835129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92430059|NCT04835129|Growth Substances|growth substances|mesh-ancestor
92430060|NCT04835129|Growth Inhibitors|growth inhibitors|mesh-ancestor
92430061|NCT04799249|Carboplatin|carboplatin|mesh-list
92430062|NCT04799249|Gemcitabine|gemcitabine|mesh-list
92430063|NCT04799249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430064|NCT04799249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430065|NCT04799249|Antimetabolites|antimetabolites|mesh-ancestor
92430066|NCT04799249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430067|NCT04722172|Obinutuzumab|obinutuzumab|mesh-list
92430068|NCT04722172|Acalabrutinib|acalabrutinib|mesh-list
92430069|NCT04722172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430070|NCT04722172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430071|NCT04710368|Evolocumab|evolocumab|mesh-list
92430072|NCT04710368|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92430073|NCT04710368|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92430074|NCT04710368|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92430076|NCT04710368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430077|NCT04710368|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92430078|NCT04710368|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430079|NCT04710368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430080|NCT04710368|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92430081|NCT04699604|Levocetirizine|levocetirizine|mesh-list
92430082|NCT04699604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92430083|NCT04699604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92430084|NCT04699604|Histamine Antagonists|histamine antagonists|mesh-ancestor
92430085|NCT04699604|Histamine Agents|histamine agents|mesh-ancestor
92430086|NCT04699604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430087|NCT04699604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430088|NCT04699604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430089|NCT04614974|Famotidine|famotidine|mesh-list
92430090|NCT04614974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92430091|NCT04614974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430092|NCT04614974|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92430093|NCT04614974|Histamine Antagonists|histamine antagonists|mesh-ancestor
92430094|NCT04614974|Histamine Agents|histamine agents|mesh-ancestor
92430095|NCT04614974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430096|NCT04614974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430097|NCT04614974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430098|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
92430099|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430100|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430101|NCT04609579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430102|NCT04609579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430103|NCT04603066|Ondansetron|ondansetron|mesh-list
92430104|NCT04603066|Antiemetics|antiemetics|mesh-ancestor
92430105|NCT04603066|Autonomic Agents|autonomic agents|mesh-ancestor
92430106|NCT04603066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430107|NCT04603066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430108|NCT04603066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430109|NCT04603066|Antipruritics|antipruritics|mesh-ancestor
92430110|NCT04603066|Dermatologic Agents|dermatologic agents|mesh-ancestor
92430111|NCT04603066|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92430112|NCT04603066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92430113|NCT04603066|Serotonin Agents|serotonin agents|mesh-ancestor
92430114|NCT04603066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430115|NCT04603066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430116|NCT04591431|Nivolumab|nivolumab|mesh-list
92430118|NCT04591431|Ipilimumab|ipilimumab|mesh-list
92430119|NCT04591431|Atezolizumab|atezolizumab|mesh-list
92430120|NCT04591431|Pertuzumab|pertuzumab|mesh-list
92430121|NCT04591431|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92430122|NCT04591431|Everolimus|everolimus|mesh-list
92430123|NCT04591431|Palbociclib|palbociclib|mesh-list
92430124|NCT04591431|Lapatinib|lapatinib|mesh-list
92430125|NCT04591431|Vemurafenib|vemurafenib|mesh-list
92430126|NCT04591431|Maytansine|maytansine|mesh-list
92430127|NCT04591431|Talazoparib|talazoparib|mesh-list
92430128|NCT04591431|Ponatinib|ponatinib|mesh-list
92430129|NCT04591431|Ipatasertib|ipatasertib|mesh-list
92430130|NCT04591431|Tepotinib|tepotinib|mesh-list
92430131|NCT04591431|Pralsetinib|pralsetinib|mesh-list
92430132|NCT04591431|Entrectinib|entrectinib|mesh-list
92430133|NCT04591431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430134|NCT04591431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430135|NCT04591431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430136|NCT04591431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430137|NCT04591431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92430138|NCT04591431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92430139|NCT04591431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430140|NCT04591431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430141|NCT04591431|Immunologic Factors|immunologic factors|mesh-ancestor
92430142|NCT04591431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430143|NCT04591431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430144|NCT04591431|Tubulin Modulators|tubulin modulators|mesh-ancestor
92430145|NCT04591431|Antimitotic Agents|antimitotic agents|mesh-ancestor
92430146|NCT04591431|Mitosis Modulators|mitosis modulators|mesh-ancestor
92430147|NCT04591431|Immunotoxins|immunotoxins|mesh-ancestor
92430148|NCT04591431|Immunoconjugates|immunoconjugates|mesh-ancestor
92430149|NCT04591431|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92430150|NCT04571164|Rotigotine|rotigotine|mesh-list
92154847|NCT03070704|Liraglutide|liraglutide|mesh-list
92430151|NCT04571164|Dopamine Agonists|dopamine agonists|mesh-ancestor
92430152|NCT04571164|Dopamine Agents|dopamine agents|mesh-ancestor
92430153|NCT04571164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430154|NCT04571164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430155|NCT04571164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430156|NCT04559880|Tranexamic Acid|tranexamic acid|mesh-list
92430157|NCT04559880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92430158|NCT04559880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92430159|NCT04559880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430160|NCT04559880|Hemostatics|hemostatics|mesh-ancestor
92430161|NCT04559880|Coagulants|coagulants|mesh-ancestor
92430162|NCT04542369|Carboplatin|carboplatin|mesh-list
92430163|NCT04542369|Etoposide|etoposide|mesh-list
92430164|NCT04542369|Tislelizumab|tislelizumab|mesh-list
92430165|NCT04542369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430166|NCT04542369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430167|NCT04542369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92430168|NCT04542369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92430169|NCT04542369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430170|NCT04542369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430171|NCT04542369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430172|NCT04496596|Suramin|suramin|mesh-list
92430173|NCT04496596|Antinematodal Agents|antinematodal agents|mesh-ancestor
92430174|NCT04496596|Anthelmintics|anthelmintics|mesh-ancestor
92430175|NCT04496596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92430176|NCT04496596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430177|NCT04496596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430178|NCT04496596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92430179|NCT04496596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92430180|NCT04477850|Luspatercept|luspatercept|mesh-list
92430181|NCT04477850|Hematinics|hematinics|mesh-ancestor
92430182|NCT04346654|Dexamethasone|dexamethasone|mesh-list
92430183|NCT04346654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430184|NCT04346654|Antiemetics|antiemetics|mesh-ancestor
92430185|NCT04346654|Autonomic Agents|autonomic agents|mesh-ancestor
92430186|NCT04346654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430187|NCT04346654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430188|NCT04346654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430189|NCT04346654|Glucocorticoids|glucocorticoids|mesh-ancestor
92430190|NCT04346654|Hormones|hormones|mesh-ancestor
92430191|NCT04346654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430192|NCT04346654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430193|NCT04346654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430194|NCT04312503|Olanzapine|olanzapine|mesh-list
92430195|NCT04312503|Risperidone|risperidone|mesh-list
92430196|NCT04312503|Aripiprazole|aripiprazole|mesh-list
92430197|NCT04312503|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92430198|NCT04312503|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92430199|NCT04312503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92430200|NCT04312503|Serotonin Agents|serotonin agents|mesh-ancestor
92430201|NCT04312503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430202|NCT04312503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430203|NCT04312503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430204|NCT04312503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92430205|NCT04312503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92430206|NCT04312503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430207|NCT04312503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92430208|NCT04312503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92430209|NCT04312503|Dopamine Agents|dopamine agents|mesh-ancestor
92430210|NCT04312503|Antiemetics|antiemetics|mesh-ancestor
92430211|NCT04312503|Autonomic Agents|autonomic agents|mesh-ancestor
92430212|NCT04312503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430213|NCT04312503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430214|NCT04312503|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92430215|NCT04312503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92430216|NCT04312503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92430217|NCT04312503|Antidepressive Agents|antidepressive agents|mesh-ancestor
92430218|NCT04312503|Dopamine Agonists|dopamine agonists|mesh-ancestor
92430219|NCT04312503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92430220|NCT04312503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92430221|NCT04312503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92430222|NCT04312503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92430223|NCT04312503|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92430224|NCT04312503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92430225|NCT04312503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92430226|NCT04312503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430227|NCT04310540|Edetic Acid|edetic acid|mesh-list
92430228|NCT04310540|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92430229|NCT04310540|Chelating Agents|chelating agents|mesh-ancestor
92430230|NCT04310540|Sequestering Agents|sequestering agents|mesh-ancestor
92430231|NCT04310540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430232|NCT04310540|Anticoagulants|anticoagulants|mesh-ancestor
92430233|NCT04310540|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92430234|NCT04310540|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92430236|NCT04305444|Pomalidomide|pomalidomide|mesh-list
92430237|NCT04305444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92341685|NCT01545557|Viscosupplements|viscosupplements|mesh-ancestor
92430238|NCT04305444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92430239|NCT04305444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430240|NCT04305444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430241|NCT04305444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430242|NCT04305444|Immunologic Factors|immunologic factors|mesh-ancestor
92430243|NCT04305444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430244|NCT04305444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430245|NCT04305444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92430246|NCT04305444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92430247|NCT04305444|Growth Substances|growth substances|mesh-ancestor
92430248|NCT04305444|Growth Inhibitors|growth inhibitors|mesh-ancestor
92430249|NCT04297332|Nicotine|nicotine|mesh-list
92430250|NCT04297332|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92430251|NCT04297332|Autonomic Agents|autonomic agents|mesh-ancestor
92430252|NCT04297332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430253|NCT04297332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430254|NCT04297332|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92430255|NCT04297332|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92430256|NCT04297332|Cholinergic Agents|cholinergic agents|mesh-ancestor
92430257|NCT04297332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430258|NCT04297332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430259|NCT04273776|Zolpidem|zolpidem|mesh-list
92430260|NCT04273776|Suvorexant|suvorexant|mesh-list
92430261|NCT04273776|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92430262|NCT04273776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92430263|NCT04273776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430264|NCT04273776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430265|NCT04273776|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92430266|NCT04273776|GABA Agonists|gaba agonists|mesh-ancestor
92430267|NCT04273776|GABA Agents|gaba agents|mesh-ancestor
92430268|NCT04273776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430269|NCT04273776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430270|NCT04273776|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92430272|NCT04249063|Anesthetics|anesthetics|mesh-list
92430273|NCT04249063|Anesthetics, Local|anesthetics, local|mesh-list
92430274|NCT04249063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430275|NCT04249063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430276|NCT04249063|Sensory System Agents|sensory system agents|mesh-ancestor
92430277|NCT04249063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430278|NCT04249063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92430279|NCT04249063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92430280|NCT04249063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92430281|NCT04249063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92430282|NCT04249063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430283|NCT04245722|Cyclophosphamide|cyclophosphamide|mesh-list
92430284|NCT04245722|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92430285|NCT04245722|Rituximab|rituximab|mesh-list
92430286|NCT04245722|Fludarabine|fludarabine|mesh-list
92430287|NCT04245722|Obinutuzumab|obinutuzumab|mesh-list
92430288|NCT04245722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430289|NCT04245722|Immunologic Factors|immunologic factors|mesh-ancestor
92430290|NCT04245722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430291|NCT04245722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430292|NCT04245722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92430293|NCT04245722|Alkylating Agents|alkylating agents|mesh-ancestor
92430294|NCT04245722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430295|NCT04245722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430296|NCT04245722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92430297|NCT04245722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430298|NCT04239040|Nivolumab|nivolumab|mesh-list
92430299|NCT04239040|Ipilimumab|ipilimumab|mesh-list
92430300|NCT04239040|Vaccines|vaccines|mesh-list
92430301|NCT04239040|Immunologic Factors|immunologic factors|mesh-ancestor
92430302|NCT04239040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430303|NCT04239040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430304|NCT04239040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430305|NCT04239040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430306|NCT04239040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430307|NCT04205409|Nivolumab|nivolumab|mesh-list
92430308|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430309|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430310|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430311|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430312|NCT04204252|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92430313|NCT04204252|Protein C Inhibitor|protein c inhibitor|mesh-list
92430314|NCT04204252|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92430315|NCT04204252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92430316|NCT04204252|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430317|NCT04204252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430318|NCT04204252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430319|NCT04198116|Guanfacine|guanfacine|mesh-list
92430320|NCT04198116|Varenicline|varenicline|mesh-list
92430321|NCT04198116|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92430322|NCT04198116|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92430323|NCT04198116|Cholinergic Agents|cholinergic agents|mesh-ancestor
92430324|NCT04198116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430325|NCT04198116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430326|NCT04198116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430327|NCT04198116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430328|NCT04198116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92430329|NCT04198116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92430330|NCT04198116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92430331|NCT04198116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430332|NCT04192955|Salicylates|salicylates|mesh-list
92430333|NCT04192955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92430334|NCT04192955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92430335|NCT04192955|Analgesics|analgesics|mesh-ancestor
92430336|NCT04192955|Sensory System Agents|sensory system agents|mesh-ancestor
92430337|NCT04192955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430338|NCT04192955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430339|NCT04192955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430340|NCT04192955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430341|NCT04192955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92430342|NCT04192955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430343|NCT04192955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430344|NCT04184869|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92430345|NCT04184869|Belinostat|belinostat|mesh-list
92430346|NCT04184869|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92430347|NCT04184869|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92430348|NCT04184869|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430349|NCT04184869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430350|NCT04184869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430351|NCT04184869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92430352|NCT04184869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92430353|NCT04184869|Antiviral Agents|antiviral agents|mesh-ancestor
92430354|NCT04184869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430355|NCT04184869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430356|NCT04184869|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92430357|NCT04175262|Sunitinib|sunitinib|mesh-list
92430358|NCT04175262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430359|NCT04175262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92430360|NCT04175262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92430361|NCT04175262|Growth Substances|growth substances|mesh-ancestor
92430362|NCT04175262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430363|NCT04175262|Growth Inhibitors|growth inhibitors|mesh-ancestor
92430364|NCT04175262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92430365|NCT04175262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430366|NCT04175262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430367|NCT04149899|Timolol|timolol|mesh-list
92430368|NCT04149899|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92430369|NCT04149899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92430370|NCT04149899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430371|NCT04149899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430372|NCT04149899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430373|NCT04149899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430374|NCT04149899|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92430375|NCT04149899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430376|NCT04137536|Antibodies|antibodies|mesh-list
92430377|NCT04137536|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92430378|NCT04137536|Immunologic Factors|immunologic factors|mesh-ancestor
92430379|NCT04137536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430380|NCT04102098|Bevacizumab|bevacizumab|mesh-list
92430381|NCT04102098|Atezolizumab|atezolizumab|mesh-list
92430382|NCT04102098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430383|NCT04102098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430384|NCT04102098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92430385|NCT04102098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92430386|NCT04102098|Growth Substances|growth substances|mesh-ancestor
92430387|NCT04102098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430388|NCT04102098|Growth Inhibitors|growth inhibitors|mesh-ancestor
92430389|NCT04102098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430390|NCT04102098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430391|NCT04087421|Glycerol|glycerol|mesh-list
92430392|NCT04087421|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92430393|NCT04087421|Protective Agents|protective agents|mesh-ancestor
92430394|NCT04087421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430395|NCT04080531|Vaccines|vaccines|mesh-list
92430396|NCT04080531|Immunologic Factors|immunologic factors|mesh-ancestor
92430397|NCT04080531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430398|NCT04070378|Daratumumab|daratumumab|mesh-list
92430399|NCT04070378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430400|NCT04023071|Cyclophosphamide|cyclophosphamide|mesh-list
92430401|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92430402|NCT04023071|Rituximab|rituximab|mesh-list
92430403|NCT04023071|Fludarabine|fludarabine|mesh-list
92430404|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
92430405|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430406|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
92430407|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430408|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430409|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92430410|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
92430411|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430412|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430413|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530885|NCT00043927|Etoposide|etoposide|mesh-list
92430415|NCT04014075|Trastuzumab|trastuzumab|mesh-list
92430416|NCT04014075|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92430417|NCT04014075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430418|NCT04014075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430419|NCT04014075|Immunoconjugates|immunoconjugates|mesh-ancestor
92430420|NCT04014075|Immunologic Factors|immunologic factors|mesh-ancestor
92430421|NCT04014075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430422|NCT04009109|Dexamethasone|dexamethasone|mesh-list
92430423|NCT04009109|Lenalidomide|lenalidomide|mesh-list
92430424|NCT04009109|Daratumumab|daratumumab|mesh-list
92430425|NCT04009109|Ixazomib|ixazomib|mesh-list
92430426|NCT04009109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430427|NCT04009109|Antiemetics|antiemetics|mesh-ancestor
92430428|NCT04009109|Autonomic Agents|autonomic agents|mesh-ancestor
92430429|NCT04009109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430430|NCT04009109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430431|NCT04009109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430432|NCT04009109|Glucocorticoids|glucocorticoids|mesh-ancestor
92430433|NCT04009109|Hormones|hormones|mesh-ancestor
92430434|NCT04009109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430435|NCT04009109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430436|NCT04009109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430437|NCT04009109|Immunologic Factors|immunologic factors|mesh-ancestor
92430438|NCT04009109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92430439|NCT04009109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92430440|NCT04009109|Growth Substances|growth substances|mesh-ancestor
92430441|NCT04009109|Growth Inhibitors|growth inhibitors|mesh-ancestor
92430442|NCT04009109|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430443|NCT04009109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430444|NCT04009109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430445|NCT03983993|Panitumumab|panitumumab|mesh-list
92430446|NCT03983993|Niraparib|niraparib|mesh-list
92403763|NCT01426971|Ibuprofen|ibuprofen|mesh-list
92430447|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430448|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430449|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92430450|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430451|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430452|NCT03964090|Cytarabine|cytarabine|mesh-list
92155148|NCT04939662|Growth Substances|growth substances|mesh-ancestor
92430453|NCT03964090|Isavuconazole|isavuconazole|mesh-list
92430455|NCT03964090|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92430456|NCT03964090|Abortifacient Agents|abortifacient agents|mesh-ancestor
92430457|NCT03964090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92430458|NCT03964090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430459|NCT03964090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430460|NCT03964090|Antimetabolites|antimetabolites|mesh-ancestor
92430461|NCT03964090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430462|NCT03964090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430463|NCT03964090|Dermatologic Agents|dermatologic agents|mesh-ancestor
92430464|NCT03964090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430465|NCT03964090|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92430466|NCT03964090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430467|NCT03964090|Immunologic Factors|immunologic factors|mesh-ancestor
92430468|NCT03964090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430469|NCT03964090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92430470|NCT03964090|Antiviral Agents|antiviral agents|mesh-ancestor
92430471|NCT03964090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430472|NCT03964090|Antifungal Agents|antifungal agents|mesh-ancestor
92430473|NCT03944577|Evolocumab|evolocumab|mesh-list
92430474|NCT03944577|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92430475|NCT03944577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92430476|NCT03944577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92430477|NCT03944577|Antimetabolites|antimetabolites|mesh-ancestor
92430478|NCT03944577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430479|NCT03944577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92430480|NCT03944577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430481|NCT03944577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430482|NCT03944577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92430483|NCT03909152|Anastrozole|anastrozole|mesh-list
92430484|NCT03909152|Onapristone|onapristone|mesh-list
92430485|NCT03909152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430486|NCT03909152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430487|NCT03909152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92430488|NCT03909152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92430490|NCT03909152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430491|NCT03909152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92430492|NCT03909152|Hormone Antagonists|hormone antagonists|mesh-ancestor
92430493|NCT03909152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430494|NCT03909152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430495|NCT03909152|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92430496|NCT03909152|Fertility Agents|fertility agents|mesh-ancestor
92430497|NCT03909152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92430498|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92430499|NCT03797001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430500|NCT03778424|Rufinamide|rufinamide|mesh-list
92430501|NCT03778424|Anticonvulsants|anticonvulsants|mesh-ancestor
92430502|NCT03778424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92430503|NCT03778424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92430504|NCT03778424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92430505|NCT03778424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430506|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92430507|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430508|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
92430509|NCT03776864|Pembrolizumab|pembrolizumab|mesh-list
92430510|NCT03776864|Immunoglobulins|immunoglobulins|mesh-list
92430511|NCT03776864|Immunoglobulin G|immunoglobulin g|mesh-list
92430512|NCT03776864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430513|NCT03776864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430514|NCT03776864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430515|NCT03776864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430516|NCT03776864|Immunologic Factors|immunologic factors|mesh-ancestor
92430517|NCT03776864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430518|NCT03762759|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92430519|NCT03762759|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92430520|NCT03762759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430521|NCT03754933|Fludarabine|fludarabine|mesh-list
92430522|NCT03754933|Fludarabine phosphate|fludarabine phosphate|mesh-list
92430523|NCT03754933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430524|NCT03754933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430525|NCT03754933|Antimetabolites|antimetabolites|mesh-ancestor
92430526|NCT03754933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430527|NCT03754933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430528|NCT03754933|Immunologic Factors|immunologic factors|mesh-ancestor
92430529|NCT03754933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430530|NCT03675412|Caffeine|caffeine|mesh-list
92430531|NCT03675412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92430532|NCT03675412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430533|NCT03675412|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92430534|NCT03675412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430535|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430536|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92430537|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92430538|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
92430539|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430540|NCT03664180|Heparin|heparin|mesh-list
92430541|NCT03664180|Calcium heparin|calcium heparin|mesh-list
92430542|NCT03664180|Enoxaparin|enoxaparin|mesh-list
92430543|NCT03664180|Hirudins|hirudins|mesh-list
92430544|NCT03664180|Enoxaparin sodium|enoxaparin sodium|mesh-list
92430545|NCT03664180|Bivalirudin|bivalirudin|mesh-list
92430546|NCT03664180|Anticoagulants|anticoagulants|mesh-ancestor
92430547|NCT03664180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92430548|NCT03664180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92430549|NCT03664180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430550|NCT03664180|Antithrombins|antithrombins|mesh-ancestor
92430551|NCT03664180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92430552|NCT03664180|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430553|NCT03664180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430554|NCT03652870|Dexetimide|dexetimide|mesh-list
92430555|NCT03652870|Citalopram|citalopram|mesh-list
92430556|NCT03652870|Nortriptyline|nortriptyline|mesh-list
92430557|NCT03652870|Escitalopram|escitalopram|mesh-list
92430558|NCT03652870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92430559|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92430560|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92430561|NCT03652870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430562|NCT03652870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430563|NCT03652870|Serotonin Agents|serotonin agents|mesh-ancestor
92430564|NCT03652870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430565|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92430566|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92430567|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
92430568|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
92430569|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430570|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92430571|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92430572|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
92430573|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92430574|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
92430575|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92430576|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92430577|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92430578|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430579|NCT03648905|Dopamine|dopamine|mesh-list
92430580|NCT03648905|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92430581|NCT03648905|Sympathomimetics|sympathomimetics|mesh-ancestor
92430582|NCT03648905|Autonomic Agents|autonomic agents|mesh-ancestor
92430583|NCT03648905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430584|NCT03648905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430585|NCT03648905|Dopamine Agents|dopamine agents|mesh-ancestor
92430586|NCT03648905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430587|NCT03648905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430588|NCT03648905|Protective Agents|protective agents|mesh-ancestor
92430589|NCT03634852|Moxifloxacin|moxifloxacin|mesh-list
92430590|NCT03634852|Dexamethasone|dexamethasone|mesh-list
92430591|NCT03634852|Triamcinolone|triamcinolone|mesh-list
92430592|NCT03634852|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92430593|NCT03634852|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92430594|NCT03634852|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92430595|NCT03634852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92430596|NCT03634852|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92430597|NCT03634852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430598|NCT03634852|Antiemetics|antiemetics|mesh-ancestor
92430599|NCT03634852|Autonomic Agents|autonomic agents|mesh-ancestor
92430600|NCT03634852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430601|NCT03634852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430602|NCT03634852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430604|NCT03634852|Hormones|hormones|mesh-ancestor
92430605|NCT03634852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430606|NCT03634852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430607|NCT03634852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430608|NCT03634852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92430609|NCT03634852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430610|NCT03634852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92430611|NCT03634852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92430612|NCT03634852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430613|NCT03634852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430614|NCT03634852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92430615|NCT03634852|Contraceptive Agents|contraceptive agents|mesh-ancestor
92430616|NCT03634852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92430617|NCT03634852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92430618|NCT03634852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92430619|NCT03634852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92430620|NCT03634852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92430621|NCT03634852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430622|NCT03634852|Immunologic Factors|immunologic factors|mesh-ancestor
92430623|NCT03625986|Nicotine|nicotine|mesh-list
92430624|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92430625|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
92430626|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430627|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430628|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92430629|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92430630|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
92430631|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430632|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430633|NCT03604289|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92430634|NCT03604289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430635|NCT03604289|Vasodilator Agents|vasodilator agents|mesh-ancestor
92430636|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
92430637|NCT03593811|Ondansetron|ondansetron|mesh-list
92430638|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
92430639|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
92430640|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430641|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430642|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430643|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
92430644|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92430645|NCT03593811|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92341730|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
92430646|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92430647|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
92430648|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430649|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430650|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92430651|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
92430652|NCT03593811|Histamine Agents|histamine agents|mesh-ancestor
92430653|NCT03593811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92430654|NCT03588754|Propranolol|propranolol|mesh-list
92430655|NCT03588754|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92430656|NCT03588754|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92430657|NCT03588754|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430658|NCT03588754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430659|NCT03588754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430660|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430661|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92430662|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430663|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
92430664|NCT03569085|Sevoflurane|sevoflurane|mesh-list
92430665|NCT03569085|Isoflurane|isoflurane|mesh-list
92430666|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92430667|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92430668|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
92430669|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
92430670|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430671|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430672|NCT03564340|Cemiplimab|cemiplimab|mesh-list
92430673|NCT03564340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430674|NCT03564340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430675|NCT03552575|Valsartan|valsartan|mesh-list
92430676|NCT03552575|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92430677|NCT03552575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430678|NCT03552575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92430679|NCT03552575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92430680|NCT03552575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430681|NCT03528902|Tamoxifen|tamoxifen|mesh-list
92430682|NCT03528902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92430683|NCT03528902|Hormone Antagonists|hormone antagonists|mesh-ancestor
92430684|NCT03528902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430685|NCT03528902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430686|NCT03528902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430687|NCT03528902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430688|NCT03528902|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92430689|NCT03528902|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92430690|NCT03528902|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92430691|NCT03523156|Azithromycin|azithromycin|mesh-list
92430692|NCT03523156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92430693|NCT03523156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430694|NCT03495388|Oxycodone|oxycodone|mesh-list
92430695|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92430696|NCT03495388|Narcotics|narcotics|mesh-ancestor
92430697|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430698|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430699|NCT03495388|Analgesics|analgesics|mesh-ancestor
92430700|NCT03495388|Sensory System Agents|sensory system agents|mesh-ancestor
92430701|NCT03495388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430702|NCT03463408|Nivolumab|nivolumab|mesh-list
92430703|NCT03463408|Ipilimumab|ipilimumab|mesh-list
92430704|NCT03463408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430705|NCT03463408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430706|NCT03463408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430707|NCT03463408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430708|NCT03456063|Paclitaxel|paclitaxel|mesh-list
92430709|NCT03456063|Carboplatin|carboplatin|mesh-list
92430710|NCT03456063|Gemcitabine|gemcitabine|mesh-list
92430711|NCT03456063|Pemetrexed|pemetrexed|mesh-list
92430712|NCT03456063|Atezolizumab|atezolizumab|mesh-list
92430713|NCT03456063|Antibodies|antibodies|mesh-list
92430714|NCT03456063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430715|NCT03456063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430716|NCT03456063|Tubulin Modulators|tubulin modulators|mesh-ancestor
92430717|NCT03456063|Antimitotic Agents|antimitotic agents|mesh-ancestor
92430718|NCT03456063|Mitosis Modulators|mitosis modulators|mesh-ancestor
92430719|NCT03456063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430720|NCT03456063|Immunologic Factors|immunologic factors|mesh-ancestor
92430721|NCT03456063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430722|NCT03456063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430723|NCT03456063|Antimetabolites|antimetabolites|mesh-ancestor
92430724|NCT03456063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430725|NCT03456063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92430726|NCT03456063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92430727|NCT03456063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430728|NCT03456063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430729|NCT03420144|Hormones|hormones|mesh-list
92430730|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430731|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430732|NCT03418038|Vitamins|vitamins|mesh-list
92430733|NCT03418038|Ascorbic Acid|ascorbic acid|mesh-list
92430734|NCT03418038|Cytarabine|cytarabine|mesh-list
92430735|NCT03418038|Dexamethasone|dexamethasone|mesh-list
92430736|NCT03418038|Dexamethasone acetate|dexamethasone acetate|mesh-list
92430737|NCT03418038|Rituximab|rituximab|mesh-list
92430738|NCT03418038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92430739|NCT03418038|Cisplatin|cisplatin|mesh-list
92430740|NCT03418038|Carboplatin|carboplatin|mesh-list
92430741|NCT03418038|Gemcitabine|gemcitabine|mesh-list
92430742|NCT03418038|Oxaliplatin|oxaliplatin|mesh-list
92430743|NCT03418038|Etoposide|etoposide|mesh-list
92430744|NCT03418038|Etoposide phosphate|etoposide phosphate|mesh-list
92430745|NCT03418038|Ifosfamide|ifosfamide|mesh-list
92430746|NCT03418038|Isophosphamide mustard|isophosphamide mustard|mesh-list
92430747|NCT03418038|Podophyllotoxin|podophyllotoxin|mesh-list
92430748|NCT03418038|Antibodies|antibodies|mesh-list
92430749|NCT03418038|Immunoglobulins|immunoglobulins|mesh-list
92430750|NCT03418038|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92430751|NCT03418038|BB 1101|bb 1101|mesh-list
92430752|NCT03418038|Micronutrients|micronutrients|mesh-ancestor
92430753|NCT03418038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430754|NCT03418038|Immunologic Factors|immunologic factors|mesh-ancestor
92430755|NCT03418038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430756|NCT03418038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430757|NCT03418038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430758|NCT03418038|Antiemetics|antiemetics|mesh-ancestor
92430759|NCT03418038|Autonomic Agents|autonomic agents|mesh-ancestor
92430760|NCT03418038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430761|NCT03418038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430762|NCT03418038|Glucocorticoids|glucocorticoids|mesh-ancestor
92430763|NCT03418038|Hormones|hormones|mesh-ancestor
92430764|NCT03418038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430765|NCT03418038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430766|NCT03418038|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430767|NCT03418038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430768|NCT03418038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430769|NCT03418038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430770|NCT03418038|Antimetabolites|antimetabolites|mesh-ancestor
92341753|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
92430771|NCT03418038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430772|NCT03418038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92430773|NCT03418038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92430774|NCT03418038|Antiviral Agents|antiviral agents|mesh-ancestor
92430775|NCT03418038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430776|NCT03418038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430777|NCT03418038|Antioxidants|antioxidants|mesh-ancestor
92430778|NCT03418038|Protective Agents|protective agents|mesh-ancestor
92430779|NCT03418038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92430780|NCT03418038|Alkylating Agents|alkylating agents|mesh-ancestor
92430781|NCT03418038|Keratolytic Agents|keratolytic agents|mesh-ancestor
92430782|NCT03418038|Dermatologic Agents|dermatologic agents|mesh-ancestor
92430783|NCT03418038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92430784|NCT03418038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92430785|NCT03418038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92430786|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
92430787|NCT03386539|Everolimus|everolimus|mesh-list
92430788|NCT03386539|Tacrolimus|tacrolimus|mesh-list
92430789|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430790|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
92430791|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430792|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92430793|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430794|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430795|NCT03386539|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92430796|NCT03386539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92430797|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430798|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92430799|NCT03386539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92430800|NCT03386539|Antitubercular Agents|antitubercular agents|mesh-ancestor
92430801|NCT03386539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92430802|NCT03386539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430803|NCT03384784|Galantamine|galantamine|mesh-list
92430804|NCT03384784|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92430805|NCT03384784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430806|NCT03384784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430807|NCT03384784|Cholinergic Agents|cholinergic agents|mesh-ancestor
92430808|NCT03384784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430809|NCT03384784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430810|NCT03384784|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92430811|NCT03384784|Autonomic Agents|autonomic agents|mesh-ancestor
92430812|NCT03384784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430813|NCT03384784|Nootropic Agents|nootropic agents|mesh-ancestor
92430814|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
92430815|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430816|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430817|NCT03383094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430818|NCT03383094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430819|NCT03366103|Navitoclax|navitoclax|mesh-list
92430820|NCT03366103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430821|NCT03344419|Ketamine|ketamine|mesh-list
92430822|NCT03344419|Analgesics|analgesics|mesh-ancestor
92430823|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
92430824|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430825|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430826|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92430827|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92155530|NCT00952653|Midazolam|midazolam|mesh-list
92430828|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
92430829|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
92430830|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430831|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92430832|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92430834|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430835|NCT03321526|Norepinephrine|norepinephrine|mesh-list
92430836|NCT03321526|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92430837|NCT03321526|Serotonin|serotonin|mesh-list
92430838|NCT03321526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92430839|NCT03321526|Antidepressive Agents|antidepressive agents|mesh-ancestor
92430840|NCT03321526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92430841|NCT03321526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92430842|NCT03321526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92430843|NCT03321526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92430844|NCT03321526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430845|NCT03321526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92430846|NCT03321526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92430847|NCT03321526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92430848|NCT03321526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430849|NCT03321526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430850|NCT03321526|Sympathomimetics|sympathomimetics|mesh-ancestor
92430851|NCT03321526|Autonomic Agents|autonomic agents|mesh-ancestor
92430852|NCT03321526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430853|NCT03321526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92430854|NCT03321526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92430855|NCT03321526|Serotonin Agents|serotonin agents|mesh-ancestor
92430856|NCT03321526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92430857|NCT03321526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92430859|NCT03297593|Ipilimumab|ipilimumab|mesh-list
92430860|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430861|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430862|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430863|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430864|NCT03263650|Prednisone|prednisone|mesh-list
92430865|NCT03263650|Carboplatin|carboplatin|mesh-list
92430866|NCT03263650|Olaparib|olaparib|mesh-list
92430867|NCT03263650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430868|NCT03263650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92430869|NCT03263650|Glucocorticoids|glucocorticoids|mesh-ancestor
92430870|NCT03263650|Hormones|hormones|mesh-ancestor
92430871|NCT03263650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92430872|NCT03263650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430873|NCT03263650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92430874|NCT03263650|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92430875|NCT03263650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430876|NCT03263650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430877|NCT03240068|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92430878|NCT03240068|Angiotensin II|angiotensin ii|mesh-list
92430879|NCT03240068|Angiotensinogen|angiotensinogen|mesh-list
92430880|NCT03240068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92430881|NCT03240068|Vasodilator Agents|vasodilator agents|mesh-ancestor
92430882|NCT03240068|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92430883|NCT03240068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92430884|NCT03240068|Protease Inhibitors|protease inhibitors|mesh-ancestor
92430885|NCT03240068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430886|NCT03240068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430887|NCT03217669|Sirolimus|sirolimus|mesh-list
92430888|NCT03217669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92430889|NCT03217669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92430890|NCT03217669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92430891|NCT03217669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430892|NCT03217669|Antifungal Agents|antifungal agents|mesh-ancestor
92430893|NCT03217669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430894|NCT03217669|Immunologic Factors|immunologic factors|mesh-ancestor
92430895|NCT03217669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430896|NCT03196427|Vedolizumab|vedolizumab|mesh-list
92430897|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430898|NCT03185819|Midazolam|midazolam|mesh-list
92430899|NCT03185819|Esketamine|esketamine|mesh-list
92430900|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92430901|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92430902|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155595|NCT01674257|Hematinics|hematinics|mesh-ancestor
92430903|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430905|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92430906|NCT03185819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92430907|NCT03185819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92430908|NCT03185819|Anesthetics, General|anesthetics, general|mesh-ancestor
92430909|NCT03185819|Anesthetics|anesthetics|mesh-ancestor
92430910|NCT03185819|GABA Modulators|gaba modulators|mesh-ancestor
92430911|NCT03185819|GABA Agents|gaba agents|mesh-ancestor
92430912|NCT03185819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92430913|NCT03185819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430914|NCT03185819|Antidepressive Agents|antidepressive agents|mesh-ancestor
92430915|NCT03153111|Macitentan|macitentan|mesh-list
92430916|NCT03153111|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92430917|NCT03153111|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92430918|NCT03153111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430919|NCT03153111|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92430920|NCT03126435|Gemcitabine|gemcitabine|mesh-list
92430921|NCT03126435|Paclitaxel|paclitaxel|mesh-list
92430922|NCT03126435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430923|NCT03126435|Antimetabolites|antimetabolites|mesh-ancestor
92430924|NCT03126435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430925|NCT03126435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430926|NCT03126435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430927|NCT03126435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92430928|NCT03126435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92430929|NCT03126435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92430930|NCT03119584|Linaclotide|linaclotide|mesh-list
92430931|NCT03119584|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92430932|NCT03119584|Enzyme Activators|enzyme activators|mesh-ancestor
92430933|NCT03119584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430934|NCT03119584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92430935|NCT03095781|Pembrolizumab|pembrolizumab|mesh-list
92430936|NCT03095781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430937|NCT03095781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430938|NCT03095781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92430939|NCT03095781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430940|NCT03084939|Capecitabine|capecitabine|mesh-list
92430941|NCT03084939|Trastuzumab|trastuzumab|mesh-list
92430942|NCT03084939|Lapatinib|lapatinib|mesh-list
92430943|NCT03084939|Maytansine|maytansine|mesh-list
92430944|NCT03084939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92430945|NCT03084939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92430946|NCT03084939|Antimetabolites|antimetabolites|mesh-ancestor
92430947|NCT03084939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92430948|NCT03084939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92430949|NCT03084939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92430950|NCT03084939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92430951|NCT03084939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92430952|NCT03084939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92430953|NCT03084939|Tubulin Modulators|tubulin modulators|mesh-ancestor
92430954|NCT03084939|Antimitotic Agents|antimitotic agents|mesh-ancestor
92430955|NCT03084939|Mitosis Modulators|mitosis modulators|mesh-ancestor
92430956|NCT03084939|Immunotoxins|immunotoxins|mesh-ancestor
92430957|NCT03084939|Immunoconjugates|immunoconjugates|mesh-ancestor
92430958|NCT03084939|Immunologic Factors|immunologic factors|mesh-ancestor
92430959|NCT03084939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430960|NCT03047005|Naltrexone|naltrexone|mesh-list
92430961|NCT03047005|Bupropion|bupropion|mesh-list
92430962|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92430963|NCT03047005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92430964|NCT03047005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430965|NCT03047005|Sensory System Agents|sensory system agents|mesh-ancestor
92430966|NCT03047005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92430967|NCT03047005|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92430968|NCT03047005|Antidepressive Agents|antidepressive agents|mesh-ancestor
92430969|NCT03047005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92430970|NCT03047005|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92430971|NCT03047005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92430972|NCT03047005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92430973|NCT03047005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410827|NCT04951115|Etoposide|etoposide|mesh-list
92430974|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
92430975|NCT03047005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155672|NCT01675973|Ranolazine|ranolazine|mesh-list
92430976|NCT03047005|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92430977|NCT03047005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92430979|NCT03020030|Leucovorin|leucovorin|mesh-list
92430980|NCT03020030|Cytarabine|cytarabine|mesh-list
92430981|NCT03020030|Dexamethasone|dexamethasone|mesh-list
92430982|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
92430983|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
92430984|NCT03020030|Doxorubicin|doxorubicin|mesh-list
92430985|NCT03020030|Methotrexate|methotrexate|mesh-list
92430986|NCT03020030|Etoposide|etoposide|mesh-list
92430987|NCT03020030|Vincristine|vincristine|mesh-list
92430988|NCT03020030|Asparaginase|asparaginase|mesh-list
92430989|NCT03020030|Dasatinib|dasatinib|mesh-list
92430990|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
92430991|NCT03020030|Pegaspargase|pegaspargase|mesh-list
92430992|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
92430993|NCT03020030|Razoxane|razoxane|mesh-list
92430994|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
92430995|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92430996|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
92430997|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92430998|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92430999|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92431000|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
92431001|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431002|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431003|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92431004|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431005|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
92431006|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
92431007|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431008|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431009|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
92431011|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431012|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92431013|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92431014|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92431015|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431016|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431017|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92431018|NCT03020030|Abortifacient Agents|abortifacient agents|mesh-ancestor
92431019|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92431020|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92431021|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
92431022|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431023|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92431024|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92431025|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92431026|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
92431027|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431028|NCT03020030|Antidotes|antidotes|mesh-ancestor
92431029|NCT03020030|Protective Agents|protective agents|mesh-ancestor
92431030|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
92431031|NCT03020030|Vitamins|vitamins|mesh-ancestor
92431032|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
92431033|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92431034|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341798|NCT00003425|Melphalan|melphalan|mesh-list
92431035|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92431036|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431037|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92431038|NCT03011684|Tamoxifen|tamoxifen|mesh-list
92431039|NCT03011684|Letrozole|letrozole|mesh-list
92431040|NCT03011684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431041|NCT03011684|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92431042|NCT03011684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92431043|NCT03011684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431044|NCT03011684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431045|NCT03011684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92431046|NCT03011684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92431047|NCT03011684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431048|NCT03011684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431049|NCT03011684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92431050|NCT03011684|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92431051|NCT03011684|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92431052|NCT03011684|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92431053|NCT03007030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92431054|NCT03007030|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92431055|NCT03007030|Antibodies|antibodies|mesh-list
92431056|NCT03007030|Immunoglobulins|immunoglobulins|mesh-list
92431057|NCT03007030|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431058|NCT03007030|Immunoconjugates|immunoconjugates|mesh-list
92431059|NCT03007030|Immunologic Factors|immunologic factors|mesh-ancestor
92431060|NCT03007030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431061|NCT03007030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431062|NCT03007030|Immunotoxins|immunotoxins|mesh-ancestor
92431063|NCT02968108|Ustekinumab|ustekinumab|mesh-list
92431064|NCT02968108|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431065|NCT02947347|Rituximab|rituximab|mesh-list
92431066|NCT02947347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431067|NCT02947347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431068|NCT02947347|Immunologic Factors|immunologic factors|mesh-ancestor
92431069|NCT02947347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431070|NCT02947347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431071|NCT02946996|Metformin|metformin|mesh-list
92431072|NCT02946996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92431073|NCT02946996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431074|NCT02870907|Cyclophosphamide|cyclophosphamide|mesh-list
92431075|NCT02870907|Thiotepa|thiotepa|mesh-list
92431076|NCT02870907|Carboplatin|carboplatin|mesh-list
92431077|NCT02870907|Etoposide|etoposide|mesh-list
92431078|NCT02870907|Etoposide phosphate|etoposide phosphate|mesh-list
92431079|NCT02870907|Vincristine|vincristine|mesh-list
92431080|NCT02870907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431081|NCT02870907|Immunologic Factors|immunologic factors|mesh-ancestor
92431082|NCT02870907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431083|NCT02870907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431084|NCT02870907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92431085|NCT02870907|Alkylating Agents|alkylating agents|mesh-ancestor
92431086|NCT02870907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431087|NCT02870907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431088|NCT02870907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92431089|NCT02870907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92431090|NCT02870907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92431091|NCT02870907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431092|NCT02870907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431093|NCT02870907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92431094|NCT02870907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92431095|NCT02870907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92431096|NCT02823574|Nivolumab|nivolumab|mesh-list
92431097|NCT02823574|Ipilimumab|ipilimumab|mesh-list
92431098|NCT02823574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431099|NCT02823574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431100|NCT02823574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341811|NCT00330551|Risperidone|risperidone|mesh-list
92431101|NCT02823574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431102|NCT02641028|Aticaprant|aticaprant|mesh-list
92431103|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92431104|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431105|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
92431106|NCT02641028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431107|NCT02525796|Eplerenone|eplerenone|mesh-list
92431108|NCT02525796|Amiloride|amiloride|mesh-list
92431109|NCT02525796|Cinacalcet|cinacalcet|mesh-list
92431110|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92431111|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
92431112|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431113|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431114|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92431115|NCT02525796|Diuretics|diuretics|mesh-ancestor
92431116|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
92431117|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431118|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92431119|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92431120|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92431121|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92431122|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431123|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431124|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92431125|NCT02360280|Midazolam|midazolam|mesh-list
92431126|NCT02360280|Ketamine|ketamine|mesh-list
92431127|NCT02360280|Analgesics|analgesics|mesh-ancestor
92155817|NCT03016611|Ticagrelor|ticagrelor|mesh-list
92431128|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
92431129|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431130|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431131|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92431132|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92431133|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
92431134|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
92431135|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431136|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92431137|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92431138|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431139|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431140|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92431141|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92431142|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92431143|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92431144|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92431145|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
92431146|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
92431147|NCT02201251|Topiramate|topiramate|mesh-list
92431148|NCT02201251|Levetiracetam|levetiracetam|mesh-list
92431149|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
92431150|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92431151|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431152|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
92431154|NCT02192021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92431155|NCT02192021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92431156|NCT02192021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431157|NCT02192021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92431158|NCT02192021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431159|NCT02192021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431160|NCT02192021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431161|NCT02174575|Sevoflurane|sevoflurane|mesh-list
92431162|NCT02174575|Desflurane|desflurane|mesh-list
92431163|NCT02174575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92431164|NCT02174575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92431165|NCT02174575|Anesthetics, General|anesthetics, general|mesh-ancestor
92431166|NCT02174575|Anesthetics|anesthetics|mesh-ancestor
92431167|NCT02174575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341817|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92431168|NCT02174575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431169|NCT01889810|Vitamin D|vitamin d|mesh-list
92431170|NCT01889810|Cholecalciferol|cholecalciferol|mesh-list
92431171|NCT01889810|Vitamins|vitamins|mesh-ancestor
92431172|NCT01889810|Micronutrients|micronutrients|mesh-ancestor
92431173|NCT01889810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431174|NCT01889810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92431175|NCT01889810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92431176|NCT01840592|Doxorubicin|doxorubicin|mesh-list
92431177|NCT01840592|Sorafenib|sorafenib|mesh-list
92431178|NCT01840592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92431179|NCT01840592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431180|NCT01840592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92431181|NCT01840592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431182|NCT01840592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431183|NCT01840592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431184|NCT01840592|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431185|NCT01734694|Vancomycin|vancomycin|mesh-list
92431186|NCT01734694|Linezolid|linezolid|mesh-list
92431187|NCT01734694|Daptomycin|daptomycin|mesh-list
92431188|NCT01734694|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92431189|NCT01734694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92431190|NCT01734694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431191|NCT01734694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92431192|NCT01734694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431193|NCT01734694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431194|NCT01703949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92431195|NCT01703949|Nivolumab|nivolumab|mesh-list
92431196|NCT01703949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92431197|NCT01703949|Antibodies|antibodies|mesh-list
92431198|NCT01703949|Immunoglobulins|immunoglobulins|mesh-list
92431199|NCT01703949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431200|NCT01703949|Immunoconjugates|immunoconjugates|mesh-list
92431201|NCT01703949|Immunologic Factors|immunologic factors|mesh-ancestor
92431202|NCT01703949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431203|NCT01703949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431204|NCT01703949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92704577|NCT04397692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92431205|NCT01703949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431207|NCT01599234|Nabiximols|nabiximols|mesh-list
92431208|NCT01599234|Analgesics|analgesics|mesh-ancestor
92431209|NCT01599234|Sensory System Agents|sensory system agents|mesh-ancestor
92431210|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431211|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431212|NCT01468896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92431213|NCT01468896|Cetuximab|cetuximab|mesh-list
92431214|NCT01468896|Interleukin-12|interleukin-12|mesh-list
92431215|NCT01468896|Antibodies|antibodies|mesh-list
92431216|NCT01468896|Immunoglobulins|immunoglobulins|mesh-list
92431217|NCT01468896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431218|NCT01468896|Immunologic Factors|immunologic factors|mesh-ancestor
92431219|NCT01468896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431220|NCT01468896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431221|NCT01468896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92431222|NCT01468896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92431223|NCT01468896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92431224|NCT01468896|Growth Substances|growth substances|mesh-ancestor
92431226|NCT01251861|Bicalutamide|bicalutamide|mesh-list
92431227|NCT01251861|Androgen Antagonists|androgen antagonists|mesh-ancestor
92431228|NCT01251861|Hormone Antagonists|hormone antagonists|mesh-ancestor
92431229|NCT01251861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431230|NCT01251861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431231|NCT01251861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431232|NCT01236560|Bevacizumab|bevacizumab|mesh-list
92431233|NCT01236560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92431234|NCT01236560|Temozolomide|temozolomide|mesh-list
92431235|NCT01236560|Vorinostat|vorinostat|mesh-list
92431236|NCT01236560|Endothelial Growth Factors|endothelial growth factors|mesh-list
92431237|NCT01236560|Antibodies|antibodies|mesh-list
92431238|NCT01236560|Immunoglobulins|immunoglobulins|mesh-list
92431239|NCT01236560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431240|NCT01236560|Immunoglobulin G|immunoglobulin g|mesh-list
92431241|NCT01236560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431242|NCT01236560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92431243|NCT01236560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92431244|NCT01236560|Growth Substances|growth substances|mesh-ancestor
92431245|NCT01236560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431246|NCT01236560|Growth Inhibitors|growth inhibitors|mesh-ancestor
92431247|NCT01236560|Immunologic Factors|immunologic factors|mesh-ancestor
92431248|NCT01236560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92431249|NCT01236560|Alkylating Agents|alkylating agents|mesh-ancestor
92431250|NCT01236560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431251|NCT01236560|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92431252|NCT01236560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431253|NCT00843882|Lenalidomide|lenalidomide|mesh-list
92431254|NCT00843882|Epoetin Alfa|epoetin alfa|mesh-list
92431255|NCT00843882|Immunologic Factors|immunologic factors|mesh-ancestor
92431256|NCT00843882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431257|NCT00843882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92431258|NCT00843882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92431259|NCT00843882|Growth Substances|growth substances|mesh-ancestor
92431260|NCT00843882|Growth Inhibitors|growth inhibitors|mesh-ancestor
92431261|NCT00843882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431262|NCT00843882|Hematinics|hematinics|mesh-ancestor
92431263|NCT00716625|Sunitinib|sunitinib|mesh-list
92431264|NCT00716625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431265|NCT00716625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92431266|NCT00716625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92431267|NCT00716625|Growth Substances|growth substances|mesh-ancestor
92431268|NCT00716625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431269|NCT00716625|Growth Inhibitors|growth inhibitors|mesh-ancestor
92431270|NCT00716625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431271|NCT00716625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431272|NCT00716625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431273|NCT00713817|Nabiximols|nabiximols|mesh-list
92431274|NCT00713817|Analgesics|analgesics|mesh-ancestor
92431275|NCT00713817|Sensory System Agents|sensory system agents|mesh-ancestor
92431276|NCT00713817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431277|NCT00713817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431278|NCT00713323|Nabiximols|nabiximols|mesh-list
92431279|NCT00713323|Analgesics|analgesics|mesh-ancestor
92431280|NCT00713323|Sensory System Agents|sensory system agents|mesh-ancestor
92155977|NCT04364802|Iodine|iodine|mesh-list
92431281|NCT00713323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431282|NCT00713323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431283|NCT00713193|Cyclosporine|cyclosporine|mesh-list
92431284|NCT00713193|Prednisone|prednisone|mesh-list
92431285|NCT00713193|Cyclosporins|cyclosporins|mesh-list
92431286|NCT00713193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431287|NCT00713193|Glucocorticoids|glucocorticoids|mesh-ancestor
92431288|NCT00713193|Hormones|hormones|mesh-ancestor
92431289|NCT00713193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431290|NCT00713193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431291|NCT00713193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92431292|NCT00713193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431293|NCT00713193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431294|NCT00713193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431295|NCT00713193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431296|NCT00713193|Immunologic Factors|immunologic factors|mesh-ancestor
92431297|NCT00713193|Antifungal Agents|antifungal agents|mesh-ancestor
92431298|NCT00713193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431299|NCT00713193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431300|NCT00713193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431301|NCT00713193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92431302|NCT00710554|Nabiximols|nabiximols|mesh-list
92431303|NCT00710554|Analgesics|analgesics|mesh-ancestor
92431304|NCT00710554|Sensory System Agents|sensory system agents|mesh-ancestor
92431305|NCT00710554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431306|NCT00710554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431307|NCT00710424|Nabiximols|nabiximols|mesh-list
92431308|NCT00710424|Analgesics|analgesics|mesh-ancestor
92431309|NCT00710424|Sensory System Agents|sensory system agents|mesh-ancestor
92431310|NCT00710424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431311|NCT00710424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431312|NCT00674609|Nabiximols|nabiximols|mesh-list
92431313|NCT00674609|Analgesics|analgesics|mesh-ancestor
92431314|NCT00674609|Sensory System Agents|sensory system agents|mesh-ancestor
92431315|NCT00674609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431316|NCT00674609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431317|NCT00026312|Vitamin A|vitamin a|mesh-list
92431318|NCT00026312|Aldesleukin|aldesleukin|mesh-list
92431319|NCT00026312|Interleukin-2|interleukin-2|mesh-list
92431320|NCT00026312|Tretinoin|tretinoin|mesh-list
92431321|NCT00026312|Dinutuximab|dinutuximab|mesh-list
92431322|NCT00026312|Isotretinoin|isotretinoin|mesh-list
92431323|NCT00026312|Sargramostim|sargramostim|mesh-list
92431324|NCT00026312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431325|NCT00026312|Vitamins|vitamins|mesh-ancestor
92431326|NCT00026312|Micronutrients|micronutrients|mesh-ancestor
92431327|NCT00026312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431328|NCT00026312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431329|NCT00026312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431330|NCT00026312|Analgesics|analgesics|mesh-ancestor
92431331|NCT00026312|Sensory System Agents|sensory system agents|mesh-ancestor
92431332|NCT00026312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431333|NCT00026312|Immunologic Factors|immunologic factors|mesh-ancestor
92431334|NCT00026312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92431335|NCT00026312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92431336|NCT00026312|Antiviral Agents|antiviral agents|mesh-ancestor
92431337|NCT00026312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431338|NCT00026312|Keratolytic Agents|keratolytic agents|mesh-ancestor
92431339|NCT00026312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431340|NCT01556646|Tolvaptan|tolvaptan|mesh-list
92431341|NCT01556646|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92431342|NCT01556646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431343|NCT01556646|Natriuretic Agents|natriuretic agents|mesh-ancestor
92431344|NCT01556646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431345|NCT01556659|Acenocoumarol|acenocoumarol|mesh-list
92431346|NCT01556659|Anticoagulants|anticoagulants|mesh-ancestor
92431347|NCT01556672|Adalimumab|adalimumab|mesh-list
92431348|NCT01556672|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92431349|NCT01556672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431350|NCT01556672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431351|NCT01556698|Nitric Oxide|nitric oxide|mesh-list
92431352|NCT01556698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92431353|NCT01556698|Autonomic Agents|autonomic agents|mesh-ancestor
92431354|NCT01556698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431355|NCT01556698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431356|NCT01556698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92431357|NCT01556698|Respiratory System Agents|respiratory system agents|mesh-ancestor
92431358|NCT01556698|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92431359|NCT01556698|Antioxidants|antioxidants|mesh-ancestor
92431360|NCT01556698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431361|NCT01556698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431362|NCT01556698|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92431363|NCT01556698|Vasodilator Agents|vasodilator agents|mesh-ancestor
92431365|NCT01556698|Protective Agents|protective agents|mesh-ancestor
92431366|NCT01556737|Genistein|genistein|mesh-list
92431367|NCT01556737|Daidzein|daidzein|mesh-list
92431368|NCT01556737|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92431369|NCT01556737|Protective Agents|protective agents|mesh-ancestor
92431370|NCT01556737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431371|NCT01556737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431372|NCT01556737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431373|NCT01556737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431374|NCT01556737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431375|NCT01556737|Phytoestrogens|phytoestrogens|mesh-ancestor
92431376|NCT01556737|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92431377|NCT01556737|Estrogens|estrogens|mesh-ancestor
92431378|NCT01556737|Hormones|hormones|mesh-ancestor
92341836|NCT00003143|Amifostine|amifostine|mesh-list
92431379|NCT01556737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431380|NCT01556815|Sorafenib|sorafenib|mesh-list
92431381|NCT01556815|Chlorotrianisene|chlorotrianisene|mesh-list
92431382|NCT01556815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431383|NCT01556815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431384|NCT01556815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431385|NCT01556815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431386|NCT01556815|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92431387|NCT01556815|Estrogens|estrogens|mesh-ancestor
92431388|NCT01556815|Hormones|hormones|mesh-ancestor
92431389|NCT01556815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431390|NCT01556815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431391|NCT01556815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92431392|NCT01556867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92431393|NCT01556867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431394|NCT01557075|Atorvastatin|atorvastatin|mesh-list
92431395|NCT01557075|Pravastatin|pravastatin|mesh-list
92431396|NCT01557075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92431397|NCT01557075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92431398|NCT01557075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92431399|NCT01557075|Antimetabolites|antimetabolites|mesh-ancestor
92431400|NCT01557075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431401|NCT01557075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92431402|NCT01557075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431403|NCT01557114|Ipilimumab|ipilimumab|mesh-list
92431404|NCT01557114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431405|NCT01557114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431406|NCT01557114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92431407|NCT01557114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431408|NCT01557127|Sorafenib|sorafenib|mesh-list
92431409|NCT01557127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431410|NCT01557127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431411|NCT01557127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431412|NCT01557127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431413|NCT01557140|Carvedilol|carvedilol|mesh-list
92431414|NCT01557140|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92431415|NCT01557140|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92431416|NCT01557140|Adrenergic Agents|adrenergic agents|mesh-ancestor
92431417|NCT01557140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431418|NCT01557140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431419|NCT01557140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431420|NCT01557140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431421|NCT01557140|Antioxidants|antioxidants|mesh-ancestor
92431422|NCT01557140|Protective Agents|protective agents|mesh-ancestor
92431423|NCT01557140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92431424|NCT01557140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431425|NCT01557140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92431426|NCT01557140|Vasodilator Agents|vasodilator agents|mesh-ancestor
92431427|NCT01557140|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92431428|NCT01557140|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92431429|NCT01557153|Amlodipine|amlodipine|mesh-list
92431430|NCT01557153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431431|NCT01557153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92156124|NCT03830723|Hormones|hormones|mesh-ancestor
92431432|NCT01557153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431433|NCT01557153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431434|NCT01557153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92431435|NCT01557153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431436|NCT01557153|Vasodilator Agents|vasodilator agents|mesh-ancestor
92431438|NCT01557257|Oxycodone|oxycodone|mesh-list
92431439|NCT01557257|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92431440|NCT01557257|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92431441|NCT01557257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431442|NCT01557257|Sensory System Agents|sensory system agents|mesh-ancestor
92431443|NCT01557257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431444|NCT01557257|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92431445|NCT01557257|Narcotics|narcotics|mesh-ancestor
92431446|NCT01557257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431447|NCT01557257|Analgesics|analgesics|mesh-ancestor
92431448|NCT01557270|Dexmedetomidine|dexmedetomidine|mesh-list
92431449|NCT01557270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92431450|NCT01557270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431451|NCT01557270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431452|NCT01557270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431453|NCT01557270|Analgesics|analgesics|mesh-ancestor
92431454|NCT01557270|Sensory System Agents|sensory system agents|mesh-ancestor
92431455|NCT01557270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431456|NCT01557270|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92431457|NCT01557270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92431458|NCT01557270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92431459|NCT01557270|Adrenergic Agents|adrenergic agents|mesh-ancestor
92431460|NCT01557270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431461|NCT01557270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431462|NCT01557335|Aspirin|aspirin|mesh-list
92431463|NCT01557335|Omeprazole|omeprazole|mesh-list
92431464|NCT01557335|Clopidogrel|clopidogrel|mesh-list
92431465|NCT01557335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92431466|NCT01557335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431467|NCT01557335|Analgesics|analgesics|mesh-ancestor
92431468|NCT01557335|Sensory System Agents|sensory system agents|mesh-ancestor
92431469|NCT01557335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431470|NCT01557335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431471|NCT01557335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431472|NCT01557335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431473|NCT01557335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92431474|NCT01557335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92431475|NCT01557335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431476|NCT01557335|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92431477|NCT01557335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92431478|NCT01557335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431479|NCT01557335|Antipyretics|antipyretics|mesh-ancestor
92431480|NCT01557335|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92431481|NCT01557335|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92431482|NCT01557335|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92431483|NCT01557335|Purinergic Agents|purinergic agents|mesh-ancestor
92431484|NCT01557335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431485|NCT01557335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92431486|NCT01557335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431487|NCT01557335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92431488|NCT01557374|Abatacept|abatacept|mesh-list
92431489|NCT01557374|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92431490|NCT01557374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431491|NCT01557374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431492|NCT01557374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431493|NCT01557374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431494|NCT01557374|Immunologic Factors|immunologic factors|mesh-ancestor
92431495|NCT01557374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431496|NCT01557374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431497|NCT01557439|Levocetirizine|levocetirizine|mesh-list
92431498|NCT01557439|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92431499|NCT01557439|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92431500|NCT01557439|Histamine Antagonists|histamine antagonists|mesh-ancestor
92431501|NCT01557439|Histamine Agents|histamine agents|mesh-ancestor
92431502|NCT01557439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431503|NCT01557439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156206|NCT01017003|Colchicine|colchicine|mesh-list
92431504|NCT01557439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431505|NCT01557478|Melatonin|melatonin|mesh-list
92431506|NCT01557478|Antioxidants|antioxidants|mesh-ancestor
92431507|NCT01557478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431508|NCT01557478|Protective Agents|protective agents|mesh-ancestor
92431509|NCT01557478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530915|NCT04731727|Riboflavin|riboflavin|mesh-list
92341849|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431510|NCT01557478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431512|NCT01557634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92431513|NCT01557634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431514|NCT01557647|Treprostinil|treprostinil|mesh-list
92431515|NCT01557647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431516|NCT01557660|Treprostinil|treprostinil|mesh-list
92431517|NCT01557660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431518|NCT01557712|Ketamine|ketamine|mesh-list
92431519|NCT01557712|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92431520|NCT01557712|Analgesics|analgesics|mesh-ancestor
92431521|NCT01557712|Sensory System Agents|sensory system agents|mesh-ancestor
92431522|NCT01557712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431523|NCT01557712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431524|NCT01557712|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92431525|NCT01557712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92431526|NCT01557712|Anesthetics, General|anesthetics, general|mesh-ancestor
92431527|NCT01557712|Anesthetics|anesthetics|mesh-ancestor
92431528|NCT01557712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431529|NCT01557712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92431530|NCT01557712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92431531|NCT01557712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431532|NCT01557712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431533|NCT01557712|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92431534|NCT01557712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92431535|NCT01557712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431536|NCT01557712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92431537|NCT01557712|Antidepressive Agents|antidepressive agents|mesh-ancestor
92431538|NCT01557712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92431539|NCT01557764|Trastuzumab|trastuzumab|mesh-list
92431540|NCT01557764|Lapatinib|lapatinib|mesh-list
92431541|NCT01557764|Antibodies|antibodies|mesh-list
92431542|NCT01557764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431543|NCT01557764|Immunologic Factors|immunologic factors|mesh-ancestor
92431544|NCT01557764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431545|NCT01557764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431546|NCT01557764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431547|NCT01557764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92431548|NCT01557764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431549|NCT01557764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431550|NCT01557816|Naproxen|naproxen|mesh-list
92431551|NCT01557816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92431552|NCT01557816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431553|NCT01557816|Analgesics|analgesics|mesh-ancestor
92431554|NCT01557816|Sensory System Agents|sensory system agents|mesh-ancestor
92431555|NCT01557816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431556|NCT01557816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431557|NCT01557816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431558|NCT01557816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431559|NCT01557816|Gout Suppressants|gout suppressants|mesh-ancestor
92431560|NCT01557816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92431561|NCT01557816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431562|NCT01557816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431563|NCT01557829|Silicon|silicon|mesh-list
92431564|NCT01557829|Trace Elements|trace elements|mesh-ancestor
92431565|NCT01557829|Micronutrients|micronutrients|mesh-ancestor
92431566|NCT01557829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431567|NCT01557907|Insulin|insulin|mesh-list
92431568|NCT01557907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92431569|NCT01557907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92431570|NCT01557907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431571|NCT01557985|Bupivacaine|bupivacaine|mesh-list
92431572|NCT01557985|Anesthetics, Local|anesthetics, local|mesh-ancestor
92431573|NCT01557985|Anesthetics|anesthetics|mesh-ancestor
92431574|NCT01557985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431575|NCT01557985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431576|NCT01557985|Sensory System Agents|sensory system agents|mesh-ancestor
92431577|NCT01557985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431578|NCT01558011|Docetaxel|docetaxel|mesh-list
92431579|NCT01558011|Capecitabine|capecitabine|mesh-list
92431580|NCT01558011|Oxaliplatin|oxaliplatin|mesh-list
92431581|NCT01558011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431582|NCT01558011|Tubulin Modulators|tubulin modulators|mesh-ancestor
92431583|NCT01558011|Antimitotic Agents|antimitotic agents|mesh-ancestor
92431584|NCT01558011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92431585|NCT01558011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431586|NCT01558011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92431587|NCT01558011|Antimetabolites|antimetabolites|mesh-ancestor
92431588|NCT01558167|Rituximab|rituximab|mesh-list
92431589|NCT01558167|Lenalidomide|lenalidomide|mesh-list
92431590|NCT01558167|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92431591|NCT01558167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431592|NCT01558167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431593|NCT01558167|Immunologic Factors|immunologic factors|mesh-ancestor
92431594|NCT01558167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431595|NCT01558167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431596|NCT01558167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92431597|NCT01558167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92431598|NCT01558167|Growth Substances|growth substances|mesh-ancestor
92431599|NCT01558167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92431600|NCT01558167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92431601|NCT01558167|Alkylating Agents|alkylating agents|mesh-ancestor
92431602|NCT01558167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431603|NCT01558193|Vitamins|vitamins|mesh-list
92431604|NCT01558193|Evening primrose oil|evening primrose oil|mesh-list
92431605|NCT01558193|Micronutrients|micronutrients|mesh-ancestor
92431606|NCT01558193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431607|NCT01558193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92431608|NCT01558193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431609|NCT01558193|Analgesics|analgesics|mesh-ancestor
92431610|NCT01558193|Sensory System Agents|sensory system agents|mesh-ancestor
92431611|NCT01558193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431612|NCT01558193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431613|NCT01558193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431614|NCT01558193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92431615|NCT01558193|Antimetabolites|antimetabolites|mesh-ancestor
92431616|NCT01558193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431617|NCT01558193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92431618|NCT01558193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431619|NCT01558245|Kallikreins|kallikreins|mesh-list
92431620|NCT01558245|Coagulants|coagulants|mesh-ancestor
92431621|NCT01558245|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92431622|NCT01558245|Fertility Agents|fertility agents|mesh-ancestor
92431623|NCT01558245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92431624|NCT01558245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431625|NCT01558310|Ustekinumab|ustekinumab|mesh-list
92431626|NCT01558310|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431627|NCT01558336|Praziquantel|praziquantel|mesh-list
92431628|NCT01558336|Anthelmintics|anthelmintics|mesh-ancestor
92431629|NCT01558336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92431630|NCT01558336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431631|NCT01558375|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92431632|NCT01558375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431633|NCT01558453|Oxaliplatin|oxaliplatin|mesh-list
92431634|NCT01558453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431635|NCT01558466|Sildenafil Citrate|sildenafil citrate|mesh-list
92431636|NCT01558466|Vasodilator Agents|vasodilator agents|mesh-ancestor
92431637|NCT01558466|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92431638|NCT01558466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92431639|NCT01558466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431640|NCT01558466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431641|NCT01558466|Urological Agents|urological agents|mesh-ancestor
92431642|NCT01558622|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92431643|NCT01558622|Ketoprofen|ketoprofen|mesh-list
92431644|NCT01558622|Meperidine|meperidine|mesh-list
92431645|NCT01558622|Tramadol|tramadol|mesh-list
92156350|NCT05394909|Hormones|hormones|mesh-ancestor
92156351|NCT05394909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156352|NCT05394909|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92156353|NCT05394909|Protective Agents|protective agents|mesh-ancestor
92156354|NCT05694858|Lidocaine|lidocaine|mesh-list
92156355|NCT05694858|Anesthetics, Local|anesthetics, local|mesh-ancestor
92156356|NCT05694858|Anesthetics|anesthetics|mesh-ancestor
92156357|NCT05694858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156358|NCT05694858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704578|NCT04397692|Autonomic Agents|autonomic agents|mesh-ancestor
92431646|NCT01558622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431647|NCT01558622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431648|NCT01558622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92431649|NCT01558622|Narcotics|narcotics|mesh-ancestor
92431650|NCT01558622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431651|NCT01558622|Analgesics|analgesics|mesh-ancestor
92431652|NCT01558622|Sensory System Agents|sensory system agents|mesh-ancestor
92431653|NCT01558622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431654|NCT01558622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92431655|NCT01558622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431656|NCT01558622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431657|NCT01558622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431658|NCT01558622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92431659|NCT01558622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92431660|NCT01558622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431662|NCT01558648|Sensory System Agents|sensory system agents|mesh-ancestor
92431663|NCT01558648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431664|NCT01558648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431665|NCT01558713|Fentanyl|fentanyl|mesh-list
92431666|NCT01558713|Bupivacaine|bupivacaine|mesh-list
92431667|NCT01558713|Ropivacaine|ropivacaine|mesh-list
92431668|NCT01558713|Levobupivacaine|levobupivacaine|mesh-list
92431669|NCT01558713|Anesthetics, Local|anesthetics, local|mesh-ancestor
92431670|NCT01558713|Anesthetics|anesthetics|mesh-ancestor
92431671|NCT01558713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431672|NCT01558713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431673|NCT01558713|Sensory System Agents|sensory system agents|mesh-ancestor
92431674|NCT01558713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431675|NCT01558713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92431676|NCT01558713|Narcotics|narcotics|mesh-ancestor
92431677|NCT01558713|Analgesics|analgesics|mesh-ancestor
92431678|NCT01558713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92431679|NCT01558713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92431680|NCT01558713|Anesthetics, General|anesthetics, general|mesh-ancestor
92431681|NCT01558830|Ranolazine|ranolazine|mesh-list
92431682|NCT01558830|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92431683|NCT01558830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431684|NCT01558830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431685|NCT01558869|Capecitabine|capecitabine|mesh-list
92431686|NCT01558869|Oxaliplatin|oxaliplatin|mesh-list
92431687|NCT01558869|Irinotecan|irinotecan|mesh-list
92431688|NCT01558869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92431689|NCT01558869|Antimetabolites|antimetabolites|mesh-ancestor
92431690|NCT01558869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431691|NCT01558869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431692|NCT01558869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92431693|NCT01558869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431694|NCT01558869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431695|NCT01558934|Lofexidine|lofexidine|mesh-list
92341889|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431696|NCT01558934|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431697|NCT01558934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92431698|NCT01558934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431699|NCT01558934|Sensory System Agents|sensory system agents|mesh-ancestor
92431700|NCT01558934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431701|NCT01558934|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92431702|NCT01558934|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92431703|NCT01558934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92431704|NCT01558934|Adrenergic Agents|adrenergic agents|mesh-ancestor
92431705|NCT01558934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431706|NCT01558934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431707|NCT01558960|Melphalan|melphalan|mesh-list
92431708|NCT01558960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92431709|NCT01558960|Alkylating Agents|alkylating agents|mesh-ancestor
92431710|NCT01558960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431711|NCT01558960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431712|NCT01558960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92431713|NCT01558960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431714|NCT01558960|Immunologic Factors|immunologic factors|mesh-ancestor
92431715|NCT01558960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431716|NCT01558986|Cefazolin|cefazolin|mesh-list
92431717|NCT01558986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92431718|NCT01558986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431719|NCT01559025|Vildagliptin|vildagliptin|mesh-list
92431720|NCT01559025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92431722|NCT01559025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431724|NCT01559025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431725|NCT01559025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431726|NCT01559051|Anesthetics|anesthetics|mesh-list
92431727|NCT01559051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431728|NCT01559051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431729|NCT01559142|Infliximab|infliximab|mesh-list
92431730|NCT01559142|Azathioprine|azathioprine|mesh-list
92431731|NCT01559142|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92431732|NCT01559142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431733|NCT01559142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431734|NCT01559142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431735|NCT01559142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431736|NCT01559142|Antimetabolites|antimetabolites|mesh-ancestor
92431737|NCT01559142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431738|NCT01559142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92431739|NCT01559142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431740|NCT01559142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431741|NCT01559142|Immunologic Factors|immunologic factors|mesh-ancestor
92431742|NCT01559142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431743|NCT01559272|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92431744|NCT01559272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92431745|NCT01559272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92431746|NCT01559272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431747|NCT01559272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431748|NCT01559272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92431749|NCT01559272|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92431750|NCT01559272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92431751|NCT01559272|Serotonin Agents|serotonin agents|mesh-ancestor
92431752|NCT01559272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431753|NCT01559272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431754|NCT01559272|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92431755|NCT01559272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92431756|NCT01559272|Dopamine Agents|dopamine agents|mesh-ancestor
92431757|NCT01559285|Ropivacaine|ropivacaine|mesh-list
92431758|NCT01559285|Anesthetics, Local|anesthetics, local|mesh-ancestor
92431759|NCT01559285|Anesthetics|anesthetics|mesh-ancestor
92431760|NCT01559285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431761|NCT01559285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431762|NCT01559285|Sensory System Agents|sensory system agents|mesh-ancestor
92341894|NCT00003437|Antimetabolites|antimetabolites|mesh-ancestor
92431763|NCT01559285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431764|NCT01559298|Aspirin|aspirin|mesh-list
92431765|NCT01559298|Clopidogrel|clopidogrel|mesh-list
92431766|NCT01559298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92431767|NCT01559298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92431768|NCT01559298|Analgesics|analgesics|mesh-ancestor
92431769|NCT01559298|Sensory System Agents|sensory system agents|mesh-ancestor
92431770|NCT01559298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431771|NCT01559298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431772|NCT01559298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431773|NCT01559298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431774|NCT01559298|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92431775|NCT01559298|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92431776|NCT01559298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431777|NCT01559298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92431778|NCT01559298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92530937|NCT00044434|Bupropion|bupropion|mesh-list
92431779|NCT01559298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431780|NCT01559298|Antipyretics|antipyretics|mesh-ancestor
92431781|NCT01559298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92431782|NCT01559298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92431783|NCT01559298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92431784|NCT01559298|Purinergic Agents|purinergic agents|mesh-ancestor
92431785|NCT01559298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431786|NCT01559480|Desogestrel|desogestrel|mesh-list
92431787|NCT01559480|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92431788|NCT01559480|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92431789|NCT01559480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92431790|NCT01559480|Contraceptive Agents|contraceptive agents|mesh-ancestor
92431791|NCT01559480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92431792|NCT01559480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431793|NCT01559480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92431794|NCT01559480|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92431795|NCT01559480|Progestins|progestins|mesh-ancestor
92431796|NCT01559480|Hormones|hormones|mesh-ancestor
92528016|NCT00000689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431797|NCT01559480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431798|NCT01559545|Metronidazole|metronidazole|mesh-list
92431799|NCT01559545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431800|NCT01559545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92431801|NCT01559545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92431802|NCT01559545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92431803|NCT01559584|Triamcinolone|triamcinolone|mesh-list
92431804|NCT01559584|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92431805|NCT01559584|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92431806|NCT01559584|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92431807|NCT01559584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431808|NCT01559584|Glucocorticoids|glucocorticoids|mesh-ancestor
92431809|NCT01559584|Hormones|hormones|mesh-ancestor
92431810|NCT01559584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431811|NCT01559584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431812|NCT01559584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431813|NCT01559584|Immunologic Factors|immunologic factors|mesh-ancestor
92431814|NCT01559584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431815|NCT01559584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431816|NCT01559727|Prednisone|prednisone|mesh-list
92431817|NCT01559727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431818|NCT01559727|Glucocorticoids|glucocorticoids|mesh-ancestor
92431819|NCT01559727|Hormones|hormones|mesh-ancestor
92431820|NCT01559727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431821|NCT01559727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431822|NCT01559727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92431823|NCT01559727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431824|NCT01559740|Bupivacaine|bupivacaine|mesh-list
92431825|NCT01559740|Anesthetics, Local|anesthetics, local|mesh-ancestor
92431826|NCT01559740|Anesthetics|anesthetics|mesh-ancestor
92431827|NCT01559740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92431828|NCT01559740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431829|NCT01559740|Sensory System Agents|sensory system agents|mesh-ancestor
92431830|NCT01559740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431831|NCT01559753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92431832|NCT01559753|Amoxicillin|amoxicillin|mesh-list
92431833|NCT01559753|Ceftriaxone|ceftriaxone|mesh-list
92431834|NCT01559753|Tobramycin|tobramycin|mesh-list
92431835|NCT01559753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92431836|NCT01559753|Clavulanic Acids|clavulanic acids|mesh-list
92431837|NCT01559753|Clavulanic Acid|clavulanic acid|mesh-list
92431838|NCT01559753|Cefotaxime|cefotaxime|mesh-list
92431839|NCT01559753|Cefoxitin|cefoxitin|mesh-list
92431840|NCT01559753|Netilmicin|netilmicin|mesh-list
92431841|NCT01559753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431842|NCT01559753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92431843|NCT01559753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431844|NCT01559753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431845|NCT01559753|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92431846|NCT01559974|Cholecalciferol|cholecalciferol|mesh-list
92431847|NCT01559974|Vitamin D|vitamin d|mesh-list
92431848|NCT01559974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92431849|NCT01559974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431850|NCT01559974|Vitamins|vitamins|mesh-ancestor
92431851|NCT01559974|Micronutrients|micronutrients|mesh-ancestor
92431852|NCT01559974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92431853|NCT01560117|Rituximab|rituximab|mesh-list
92431854|NCT01560117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431855|NCT01560117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431856|NCT01560117|Immunologic Factors|immunologic factors|mesh-ancestor
92431857|NCT01560117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431858|NCT01560117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431859|NCT05570669|Simethicone|simethicone|mesh-list
92431860|NCT05570669|Sodium sulfate|sodium sulfate|mesh-list
92431861|NCT05570669|Antifoaming Agents|antifoaming agents|mesh-ancestor
92431862|NCT05570669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431863|NCT05570669|Emollients|emollients|mesh-ancestor
92431864|NCT05570669|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431865|NCT05570669|Cathartics|cathartics|mesh-ancestor
92431866|NCT05570669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431867|NCT05570383|Antacids|antacids|mesh-list
92431868|NCT05570383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431869|NCT05570383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431870|NCT05570110|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
92431871|NCT05570110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431873|NCT05570084|Silodosin|silodosin|mesh-list
92528017|NCT00000689|Glucocorticoids|glucocorticoids|mesh-ancestor
92431874|NCT05570084|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92431875|NCT05570084|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92431876|NCT05570084|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92431877|NCT05570084|Adrenergic Agents|adrenergic agents|mesh-ancestor
92431878|NCT05570084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431879|NCT05570084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431880|NCT05570084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431881|NCT05570084|Urological Agents|urological agents|mesh-ancestor
92431882|NCT05569668|Paclitaxel|paclitaxel|mesh-list
92431883|NCT05569668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92431884|NCT05569668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431885|NCT05569668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92431886|NCT05569668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92431887|NCT05569668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92431888|NCT05569668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431889|NCT05569655|Furosemide|furosemide|mesh-list
92431890|NCT05569655|Tolvaptan|tolvaptan|mesh-list
92431891|NCT05569655|Diuretics|diuretics|mesh-ancestor
92431892|NCT05569655|Natriuretic Agents|natriuretic agents|mesh-ancestor
92431893|NCT05569655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431894|NCT05569655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92431895|NCT05569655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431896|NCT05569655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431897|NCT05569655|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92431898|NCT05569590|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92431899|NCT05569590|Propolis|propolis|mesh-list
92431900|NCT05569590|Fluorides|fluorides|mesh-list
92431901|NCT05569590|Fluorides, Topical|fluorides, topical|mesh-list
92431902|NCT05569590|Cariostatic Agents|cariostatic agents|mesh-ancestor
92431903|NCT05569590|Protective Agents|protective agents|mesh-ancestor
92431904|NCT05569590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431905|NCT05569590|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92431906|NCT05569590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431907|NCT05569577|Estrogens|estrogens|mesh-list
92431908|NCT05569577|Dydrogesterone|dydrogesterone|mesh-list
92431909|NCT05569577|Hormones|hormones|mesh-ancestor
92431910|NCT05569577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431911|NCT05569577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431912|NCT05569577|Progestins|progestins|mesh-ancestor
92431913|NCT05569408|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92431914|NCT05569408|Antiviral Agents|antiviral agents|mesh-ancestor
92431915|NCT05569408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92431916|NCT05569031|Lofexidine|lofexidine|mesh-list
92431917|NCT05569031|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92431918|NCT05569031|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92431919|NCT05569031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92431920|NCT05569031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92431921|NCT05569031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431922|NCT05569031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431923|NCT05569031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431924|NCT05569031|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92431925|NCT05569031|Antidepressive Agents|antidepressive agents|mesh-ancestor
92431926|NCT05569031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92431927|NCT05569031|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92431928|NCT05569031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92431929|NCT05569031|Sensory System Agents|sensory system agents|mesh-ancestor
92431930|NCT05569031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431931|NCT05569031|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92431932|NCT05569031|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92431933|NCT05569031|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92431934|NCT05569031|Adrenergic Agents|adrenergic agents|mesh-ancestor
92431935|NCT05564741|Norepinephrine|norepinephrine|mesh-list
92431936|NCT05564741|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92431937|NCT05564741|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92431938|NCT05564741|Adrenergic Agents|adrenergic agents|mesh-ancestor
92431939|NCT05564741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431940|NCT05564741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431941|NCT05564741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431942|NCT05564741|Sympathomimetics|sympathomimetics|mesh-ancestor
92431943|NCT05564741|Autonomic Agents|autonomic agents|mesh-ancestor
92431944|NCT05564741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431945|NCT05564741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92431947|NCT05522582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92431949|NCT05522582|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92431950|NCT05522582|Immunologic Factors|immunologic factors|mesh-ancestor
92431951|NCT05522582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431952|NCT05522582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92431953|NCT05522582|Abortifacient Agents|abortifacient agents|mesh-ancestor
92431954|NCT05522582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92431955|NCT05522582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92431956|NCT05522582|Antimetabolites|antimetabolites|mesh-ancestor
92431957|NCT05522582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431958|NCT05522582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431959|NCT05522582|Dermatologic Agents|dermatologic agents|mesh-ancestor
92431960|NCT05522582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431961|NCT05522582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92431962|NCT05522582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92431963|NCT05522582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92431964|NCT05522582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92431965|NCT05522582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431966|NCT05491304|Dexamethasone|dexamethasone|mesh-list
92431967|NCT05491304|Etoposide|etoposide|mesh-list
92431968|NCT05491304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92431969|NCT05491304|Antiemetics|antiemetics|mesh-ancestor
92431970|NCT05491304|Autonomic Agents|autonomic agents|mesh-ancestor
92431971|NCT05491304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92431972|NCT05491304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92431973|NCT05491304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92431974|NCT05491304|Glucocorticoids|glucocorticoids|mesh-ancestor
92431975|NCT05491304|Hormones|hormones|mesh-ancestor
92431976|NCT05491304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92431977|NCT05491304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92431978|NCT05491304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431979|NCT05491304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92431980|NCT05491304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92431981|NCT05491304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431982|NCT05491304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431983|NCT05491304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431984|NCT05461794|Docetaxel|docetaxel|mesh-list
92431985|NCT05461794|Irinotecan|irinotecan|mesh-list
92431986|NCT05461794|Tislelizumab|tislelizumab|mesh-list
92431987|NCT05461794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92431988|NCT05461794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92431989|NCT05461794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92431990|NCT05461794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530946|NCT00044434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92431991|NCT05461794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92431992|NCT05461794|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92431993|NCT05461794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92431994|NCT05461794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92431995|NCT05461794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92431996|NCT05391555|Remifentanil|remifentanil|mesh-list
92431997|NCT05391555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92431998|NCT05391555|Narcotics|narcotics|mesh-ancestor
92431999|NCT05391555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432000|NCT05391555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432001|NCT05391555|Analgesics|analgesics|mesh-ancestor
92432002|NCT05391555|Sensory System Agents|sensory system agents|mesh-ancestor
92432003|NCT05391555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432004|NCT05388656|Estradiol|estradiol|mesh-list
92432005|NCT05388656|Progesterone|progesterone|mesh-list
92432006|NCT05388656|Estrogens|estrogens|mesh-ancestor
92432007|NCT05388656|Hormones|hormones|mesh-ancestor
92432008|NCT05388656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432009|NCT05388656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432010|NCT05388656|Progestins|progestins|mesh-ancestor
92432011|NCT05372393|Anesthetics|anesthetics|mesh-list
92432012|NCT05372393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432013|NCT05372393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432014|NCT05219604|Diphenhydramine|diphenhydramine|mesh-list
92432015|NCT05219604|Promethazine|promethazine|mesh-list
92432016|NCT05219604|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92156733|NCT01677143|Sensory System Agents|sensory system agents|mesh-ancestor
92432017|NCT05219604|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92432018|NCT05219604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432019|NCT05219604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432020|NCT05219604|Anesthetics, Local|anesthetics, local|mesh-ancestor
92432021|NCT05219604|Anesthetics|anesthetics|mesh-ancestor
92432022|NCT05219604|Sensory System Agents|sensory system agents|mesh-ancestor
92432023|NCT05219604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432024|NCT05219604|Antiemetics|antiemetics|mesh-ancestor
92432025|NCT05219604|Autonomic Agents|autonomic agents|mesh-ancestor
92432026|NCT05219604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432027|NCT05219604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92432028|NCT05219604|Histamine Antagonists|histamine antagonists|mesh-ancestor
92432029|NCT05219604|Histamine Agents|histamine agents|mesh-ancestor
92432030|NCT05219604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432031|NCT05219604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432032|NCT05219604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92432033|NCT05219604|Antipruritics|antipruritics|mesh-ancestor
92432034|NCT05219604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432035|NCT05137080|Dexamethasone|dexamethasone|mesh-list
92432036|NCT05137080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432037|NCT05137080|Antiemetics|antiemetics|mesh-ancestor
92432038|NCT05137080|Autonomic Agents|autonomic agents|mesh-ancestor
92432039|NCT05137080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432040|NCT05137080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432041|NCT05137080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432042|NCT05137080|Glucocorticoids|glucocorticoids|mesh-ancestor
92432043|NCT05137080|Hormones|hormones|mesh-ancestor
92432044|NCT05137080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432045|NCT05137080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92432046|NCT05137080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432047|NCT04873323|Moxifloxacin|moxifloxacin|mesh-list
92432048|NCT04873323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432049|NCT04873323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432050|NCT04873323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92432051|NCT04873323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92432052|NCT04873323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432053|NCT04873323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432054|NCT04873323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432055|NCT04818034|Dapagliflozin|dapagliflozin|mesh-list
92432056|NCT04818034|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92432057|NCT04818034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432058|NCT04818034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92432059|NCT04818034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432060|NCT04787731|Lidocaine|lidocaine|mesh-list
92432061|NCT04787731|Bupivacaine|bupivacaine|mesh-list
92432062|NCT04787731|Anesthetics, Local|anesthetics, local|mesh-list
92432063|NCT04787731|Anesthetics|anesthetics|mesh-list
92432064|NCT04787731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432065|NCT04787731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432066|NCT04787731|Sensory System Agents|sensory system agents|mesh-ancestor
92432067|NCT04787731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432068|NCT04787731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92432069|NCT04787731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92432070|NCT04787731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92432071|NCT04787731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432072|NCT04787731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432073|NCT04713358|Nalmefene|nalmefene|mesh-list
92432074|NCT04713358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92432075|NCT04713358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432076|NCT04713358|Sensory System Agents|sensory system agents|mesh-ancestor
92432077|NCT04713358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432078|NCT04705051|Venglustat|venglustat|mesh-list
92432079|NCT04705051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432080|NCT04705051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432081|NCT04696952|Zopiclone|zopiclone|mesh-list
92432082|NCT04696952|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92432083|NCT04696952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432084|NCT04696952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432085|NCT04496999|Midostaurin|midostaurin|mesh-list
92432086|NCT04496999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432087|NCT04496999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432088|NCT04496999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432089|NCT04496999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432090|NCT04492722|Dapagliflozin|dapagliflozin|mesh-list
92432091|NCT04492722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92432092|NCT04492722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432093|NCT04492722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92432094|NCT04492722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432096|NCT04464265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92432097|NCT04464265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432098|NCT04464265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432099|NCT04464265|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92341975|NCT00002825|Docetaxel|docetaxel|mesh-list
92432100|NCT04464265|Anesthetics, General|anesthetics, general|mesh-ancestor
92432101|NCT04464265|Anesthetics|anesthetics|mesh-ancestor
92432102|NCT04424511|Azithromycin|azithromycin|mesh-list
92432103|NCT04424511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432104|NCT04424511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432105|NCT04421079|Resveratrol|resveratrol|mesh-list
92432106|NCT04421079|Antioxidants|antioxidants|mesh-ancestor
92432107|NCT04421079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432108|NCT04421079|Protective Agents|protective agents|mesh-ancestor
92432109|NCT04421079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432110|NCT04421079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432111|NCT04421079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92432112|NCT04410406|Ivermectin|ivermectin|mesh-list
92432113|NCT04410406|Albendazole|albendazole|mesh-list
92432114|NCT04410406|Moxidectin|moxidectin|mesh-list
92432115|NCT04410406|Diethylcarbamazine|diethylcarbamazine|mesh-list
92432116|NCT04410406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432117|NCT04410406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92432118|NCT04410406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432119|NCT04410406|Anthelmintics|anthelmintics|mesh-ancestor
92432120|NCT04410406|Anticestodal Agents|anticestodal agents|mesh-ancestor
92432121|NCT04410406|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92432122|NCT04410406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92432123|NCT04410406|Tubulin Modulators|tubulin modulators|mesh-ancestor
92432124|NCT04410406|Antimitotic Agents|antimitotic agents|mesh-ancestor
92432125|NCT04410406|Mitosis Modulators|mitosis modulators|mesh-ancestor
92432126|NCT04410406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432127|NCT04410406|Antinematodal Agents|antinematodal agents|mesh-ancestor
92432128|NCT04410406|Filaricides|filaricides|mesh-ancestor
92432129|NCT04410406|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92432130|NCT04410406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432131|NCT04393506|Apatinib|apatinib|mesh-list
92432132|NCT04393506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92432133|NCT04393506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432134|NCT04393506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432135|NCT04393506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432136|NCT04393506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432137|NCT04393506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92432138|NCT04349826|Azithromycin|azithromycin|mesh-list
92432139|NCT04349826|Cefixime|cefixime|mesh-list
92432140|NCT04349826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432141|NCT04349826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432142|NCT04298853|Morphine|morphine|mesh-list
92432143|NCT04298853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92432144|NCT04298853|Narcotics|narcotics|mesh-ancestor
92432145|NCT04298853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432146|NCT04298853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432147|NCT04298853|Analgesics|analgesics|mesh-ancestor
92432148|NCT04298853|Sensory System Agents|sensory system agents|mesh-ancestor
92432149|NCT04298853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432150|NCT04232683|Tamsulosin|tamsulosin|mesh-list
92432151|NCT04232683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92432152|NCT04232683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92432153|NCT04232683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92432154|NCT04232683|Adrenergic Agents|adrenergic agents|mesh-ancestor
92432155|NCT04232683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432156|NCT04232683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432157|NCT04232683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432158|NCT04232683|Urological Agents|urological agents|mesh-ancestor
92432159|NCT04227483|Prednisolone|prednisolone|mesh-list
92432160|NCT04227483|Deflazacort|deflazacort|mesh-list
92432161|NCT04227483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432162|NCT04227483|Glucocorticoids|glucocorticoids|mesh-ancestor
92432163|NCT04227483|Hormones|hormones|mesh-ancestor
92432164|NCT04227483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432165|NCT04227483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432166|NCT04227483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92156882|NCT05074056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432167|NCT04227483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432168|NCT04227483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432169|NCT04227483|Immunologic Factors|immunologic factors|mesh-ancestor
92432171|NCT04182672|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92432172|NCT04182672|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92432173|NCT04182672|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92432174|NCT04182672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432175|NCT04182672|Glucocorticoids|glucocorticoids|mesh-ancestor
92432177|NCT04182672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432178|NCT04182672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432179|NCT04182672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432180|NCT04182672|Immunologic Factors|immunologic factors|mesh-ancestor
92432181|NCT04182672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432182|NCT04182672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432183|NCT04101227|Ondansetron|ondansetron|mesh-list
92432184|NCT04101227|Antiemetics|antiemetics|mesh-ancestor
92432185|NCT04101227|Autonomic Agents|autonomic agents|mesh-ancestor
92432186|NCT04101227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432187|NCT04101227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432188|NCT04101227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432189|NCT04101227|Antipruritics|antipruritics|mesh-ancestor
92432190|NCT04101227|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432191|NCT04101227|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92432192|NCT04101227|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92432193|NCT04101227|Serotonin Agents|serotonin agents|mesh-ancestor
92432194|NCT04101227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432195|NCT04101227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432196|NCT04066894|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92432197|NCT04066894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432198|NCT04066894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432199|NCT04047004|Doxorubicin|doxorubicin|mesh-list
92432200|NCT04047004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432201|NCT04047004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92432202|NCT04047004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92432203|NCT04047004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92432204|NCT04047004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432205|NCT04047004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432206|NCT03893435|Valsartan|valsartan|mesh-list
92432207|NCT03893435|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92432208|NCT03893435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92432209|NCT03893435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92432210|NCT03893435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92432211|NCT03893435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432212|NCT03813121|Midazolam|midazolam|mesh-list
92432213|NCT03813121|Ketamine|ketamine|mesh-list
92432214|NCT03813121|Analgesics|analgesics|mesh-ancestor
92432215|NCT03813121|Sensory System Agents|sensory system agents|mesh-ancestor
92432216|NCT03813121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432217|NCT03813121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432218|NCT03813121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92432219|NCT03813121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92432220|NCT03813121|Anesthetics, General|anesthetics, general|mesh-ancestor
92432221|NCT03813121|Anesthetics|anesthetics|mesh-ancestor
92432222|NCT03813121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432223|NCT03813121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92432224|NCT03813121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92432225|NCT03813121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432226|NCT03813121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432227|NCT03813121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92432228|NCT03813121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92432229|NCT03813121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92432230|NCT03813121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432231|NCT03813121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432232|NCT03813121|GABA Modulators|gaba modulators|mesh-ancestor
92432233|NCT03813121|GABA Agents|gaba agents|mesh-ancestor
92432234|NCT03710590|Nicotine|nicotine|mesh-list
92432235|NCT03710590|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92432236|NCT03710590|Autonomic Agents|autonomic agents|mesh-ancestor
92432237|NCT03710590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432238|NCT03710590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432239|NCT03710590|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92432241|NCT03710590|Cholinergic Agents|cholinergic agents|mesh-ancestor
92432242|NCT03710590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432243|NCT03710590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432244|NCT03676725|Lidocaine|lidocaine|mesh-list
92432245|NCT03676725|Anesthetics, Local|anesthetics, local|mesh-ancestor
92432246|NCT03676725|Anesthetics|anesthetics|mesh-ancestor
92432247|NCT03676725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432248|NCT03676725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432249|NCT03676725|Sensory System Agents|sensory system agents|mesh-ancestor
92432250|NCT03676725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432251|NCT03676725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92432252|NCT03676725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92432253|NCT03676725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92432254|NCT03676725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432255|NCT03676725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432256|NCT03471507|Diclofenac|diclofenac|mesh-list
92432257|NCT03471507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92432258|NCT03471507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92432259|NCT03471507|Analgesics|analgesics|mesh-ancestor
92432260|NCT03471507|Sensory System Agents|sensory system agents|mesh-ancestor
92432261|NCT03471507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432262|NCT03471507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432263|NCT03471507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432264|NCT03471507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432265|NCT03471507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92432267|NCT03471507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432268|NCT03470922|Nivolumab|nivolumab|mesh-list
92432269|NCT03470922|Relatlimab|relatlimab|mesh-list
92432270|NCT03470922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92432271|NCT03470922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432272|NCT03470922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92432273|NCT03470922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432274|NCT03468335|Irinotecan|irinotecan|mesh-list
92432275|NCT03468335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92432276|NCT03468335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92432277|NCT03468335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432278|NCT03468335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432279|NCT03468335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432280|NCT03280511|Oxaliplatin|oxaliplatin|mesh-list
92432281|NCT03280511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432282|NCT03205423|Gabapentin|gabapentin|mesh-list
92432283|NCT03205423|Analgesics|analgesics|mesh-ancestor
92432284|NCT03205423|Sensory System Agents|sensory system agents|mesh-ancestor
92432285|NCT03205423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432286|NCT03205423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432287|NCT03205423|Anticonvulsants|anticonvulsants|mesh-ancestor
92432288|NCT03205423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92432289|NCT03205423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432290|NCT03205423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432291|NCT03205423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432292|NCT03205423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92432293|NCT03205423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92432294|NCT03205423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432295|NCT03205423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432296|NCT03205423|Antimanic Agents|antimanic agents|mesh-ancestor
92432297|NCT03104400|Adalimumab|adalimumab|mesh-list
92432298|NCT03104400|Upadacitinib|upadacitinib|mesh-list
92432299|NCT03104400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92432300|NCT03104400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432301|NCT03104400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432302|NCT03104400|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92432303|NCT03104400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432304|NCT03104400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432305|NCT03104400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432306|NCT03104374|Upadacitinib|upadacitinib|mesh-list
92432307|NCT03104374|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92432308|NCT03104374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432309|NCT03104374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432310|NCT03104374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432311|NCT03104374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432312|NCT03008369|Lenvatinib|lenvatinib|mesh-list
92432313|NCT03008369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432314|NCT03008369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432315|NCT03008369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432316|NCT03008369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432317|NCT02965716|Pembrolizumab|pembrolizumab|mesh-list
92432318|NCT02965716|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92432319|NCT02965716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92432320|NCT02965716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432321|NCT02965716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92432322|NCT02965716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432323|NCT02918006|Vaccines|vaccines|mesh-list
92432324|NCT02918006|Immunologic Factors|immunologic factors|mesh-ancestor
92432325|NCT02918006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432326|NCT02917772|Nivolumab|nivolumab|mesh-list
92432327|NCT02917772|Ipilimumab|ipilimumab|mesh-list
92432328|NCT02917772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92432329|NCT02917772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432330|NCT02917772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92432331|NCT02917772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432332|NCT02909686|Curcumin|curcumin|mesh-list
92432333|NCT02909686|Resveratrol|resveratrol|mesh-list
92432334|NCT02909686|Pycnogenols|pycnogenols|mesh-list
92432335|NCT02909686|Turmeric extract|turmeric extract|mesh-list
92432336|NCT02909686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92432337|NCT02909686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92432338|NCT02909686|Analgesics|analgesics|mesh-ancestor
92432339|NCT02909686|Sensory System Agents|sensory system agents|mesh-ancestor
92432340|NCT02909686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432341|NCT02909686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432342|NCT02909686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432343|NCT02909686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432344|NCT02909686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432345|NCT02909686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432346|NCT02909686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432348|NCT02909686|Protective Agents|protective agents|mesh-ancestor
92432349|NCT02909686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92432350|NCT02909686|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92432351|NCT02909686|Immunologic Factors|immunologic factors|mesh-ancestor
92432352|NCT02713373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92432353|NCT02713373|Pembrolizumab|pembrolizumab|mesh-list
92432354|NCT02713373|Cetuximab|cetuximab|mesh-list
92432355|NCT02713373|Antibodies|antibodies|mesh-list
92432356|NCT02713373|Immunoglobulins|immunoglobulins|mesh-list
92432357|NCT02713373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92432358|NCT02713373|Immunologic Factors|immunologic factors|mesh-ancestor
92432359|NCT02713373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432360|NCT02713373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432361|NCT02713373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92432362|NCT02713373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432363|NCT02686593|Mitoxantrone|mitoxantrone|mesh-list
92432364|NCT02686593|Clofarabine|clofarabine|mesh-list
92432365|NCT02686593|Analgesics|analgesics|mesh-ancestor
92432366|NCT02686593|Sensory System Agents|sensory system agents|mesh-ancestor
92432367|NCT02686593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432368|NCT02686593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432369|NCT02686593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432370|NCT02686593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92432371|NCT02686593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92432372|NCT02686593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432373|NCT02686593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432374|NCT02686593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432375|NCT02686593|Antimetabolites|antimetabolites|mesh-ancestor
92432376|NCT02658487|Cytarabine|cytarabine|mesh-list
92432377|NCT02658487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432378|NCT02658487|Antimetabolites|antimetabolites|mesh-ancestor
92432379|NCT02658487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432380|NCT02658487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432381|NCT02658487|Antiviral Agents|antiviral agents|mesh-ancestor
92432382|NCT02658487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432383|NCT02658487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432384|NCT02658487|Immunologic Factors|immunologic factors|mesh-ancestor
92432385|NCT02658487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432386|NCT02583282|Doxycycline|doxycycline|mesh-list
92432387|NCT02583282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432388|NCT02583282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432389|NCT02583282|Antimalarials|antimalarials|mesh-ancestor
92432390|NCT02583282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92432391|NCT02583282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92432392|NCT02553941|Azacitidine|azacitidine|mesh-list
92432393|NCT02553941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432394|NCT02553941|Antimetabolites|antimetabolites|mesh-ancestor
92432395|NCT02553941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432397|NCT02553941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432398|NCT02546492|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92432399|NCT02546492|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92432400|NCT02546492|beta-Endorphin|beta-endorphin|mesh-list
92432401|NCT02546492|Hormones|hormones|mesh-ancestor
92432402|NCT02546492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432403|NCT02546492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432404|NCT02546492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432405|NCT02546492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432406|NCT02527564|Suvorexant|suvorexant|mesh-list
92432407|NCT02527564|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92432408|NCT02527564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92432409|NCT02527564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432410|NCT02527564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432411|NCT02527564|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92530976|NCT00018135|Antacids|antacids|mesh-ancestor
92432412|NCT02527564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432413|NCT02527564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432414|NCT02339168|Metformin|metformin|mesh-list
92432415|NCT02339168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92432416|NCT02339168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432417|NCT02179749|Mifepristone|mifepristone|mesh-list
92432418|NCT02179749|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92432419|NCT02179749|Abortifacient Agents|abortifacient agents|mesh-ancestor
92432420|NCT02179749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92432421|NCT02179749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432422|NCT02179749|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92432423|NCT02179749|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92432424|NCT02179749|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92432425|NCT02179749|Contraceptive Agents|contraceptive agents|mesh-ancestor
92432426|NCT02179749|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92432427|NCT02179749|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92432428|NCT02179749|Hormone Antagonists|hormone antagonists|mesh-ancestor
92432429|NCT02179749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432430|NCT02179749|Luteolytic Agents|luteolytic agents|mesh-ancestor
92432431|NCT02179749|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92432432|NCT02179749|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92432433|NCT02065609|Trastuzumab|trastuzumab|mesh-list
92432434|NCT02065609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92432435|NCT02065609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432436|NCT00641186|Sodium Oxybate|sodium oxybate|mesh-list
92432437|NCT00641186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92432438|NCT00641186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92432439|NCT00641186|Anesthetics, General|anesthetics, general|mesh-ancestor
92432440|NCT00641186|Anesthetics|anesthetics|mesh-ancestor
92432441|NCT00641186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432442|NCT00641186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432443|NCT01561482|Metformin|metformin|mesh-list
92432444|NCT01561482|Simvastatin|simvastatin|mesh-list
92432445|NCT01561482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92432446|NCT01561482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432447|NCT01561482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92432448|NCT01561482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92432449|NCT01561482|Antimetabolites|antimetabolites|mesh-ancestor
92432450|NCT01561482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432451|NCT01561482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92432452|NCT01561482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92432453|NCT01561482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432454|NCT01561586|Cisplatin|cisplatin|mesh-list
92432455|NCT01561586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432456|NCT01562704|Acetaminophen|acetaminophen|mesh-list
92432457|NCT01562704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92432458|NCT01562704|Analgesics|analgesics|mesh-ancestor
92432459|NCT01562704|Sensory System Agents|sensory system agents|mesh-ancestor
92432460|NCT01562704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157179|NCT04374903|Sirolimus|sirolimus|mesh-list
92432461|NCT01562704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432462|NCT01562704|Antipyretics|antipyretics|mesh-ancestor
92432463|NCT01564095|Tryptophan|tryptophan|mesh-list
92432464|NCT01564095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92432465|NCT01564095|Tacrolimus|tacrolimus|mesh-list
92432466|NCT01564095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432467|NCT01564095|Immunologic Factors|immunologic factors|mesh-ancestor
92528018|NCT00000689|Hormones|hormones|mesh-ancestor
92432469|NCT01564095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92432470|NCT01564095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432471|NCT01564095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432472|NCT01564095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92432473|NCT01564095|Antidepressive Agents|antidepressive agents|mesh-ancestor
92432475|NCT01564238|Calcium, Dietary|calcium, dietary|mesh-list
92432476|NCT01564238|Calcium|calcium|mesh-list
92432477|NCT01564238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92432478|NCT01564238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432479|NCT01564238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92432480|NCT01564576|Bromides|bromides|mesh-list
92432481|NCT01564576|Rocuronium|rocuronium|mesh-list
92432482|NCT01564576|Anticonvulsants|anticonvulsants|mesh-ancestor
92432483|NCT01564576|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92432484|NCT01564576|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92432485|NCT01564576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92432486|NCT01564576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432487|NCT01564576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432488|NCT01564823|Metronidazole|metronidazole|mesh-list
92432489|NCT01564823|Adalimumab|adalimumab|mesh-list
92432490|NCT01564823|Azathioprine|azathioprine|mesh-list
92432491|NCT01564823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92432492|NCT01564823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432493|NCT01564823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432494|NCT01564823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432495|NCT01564823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432496|NCT01564823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92432497|NCT01564823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92432498|NCT01564823|Antimetabolites|antimetabolites|mesh-ancestor
92432499|NCT01564823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432500|NCT01564823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432501|NCT01564823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432502|NCT01564823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432503|NCT01564823|Immunologic Factors|immunologic factors|mesh-ancestor
92432504|NCT01564823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432505|NCT01565239|Thrombin|thrombin|mesh-list
92432506|NCT01565239|Hemostatics|hemostatics|mesh-ancestor
92432507|NCT01565239|Coagulants|coagulants|mesh-ancestor
92432508|NCT01565265|Cetrorelix|cetrorelix|mesh-list
92432509|NCT01565265|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92432510|NCT01565265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92432511|NCT01565265|Hormones|hormones|mesh-ancestor
92432512|NCT01565265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432513|NCT01565265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432514|NCT01565265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92432515|NCT01565265|Fertility Agents|fertility agents|mesh-ancestor
92432516|NCT01565265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92432517|NCT01565265|Hormone Antagonists|hormone antagonists|mesh-ancestor
92432518|NCT01566292|Botulinum Toxins|botulinum toxins|mesh-list
92432519|NCT01566292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92432520|NCT01566292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92432521|NCT01566292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92432522|NCT01566292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432523|NCT01566292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432524|NCT01566292|Cholinergic Agents|cholinergic agents|mesh-ancestor
92432525|NCT01566292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432526|NCT01566292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432527|NCT01566292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92432528|NCT01566292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432529|NCT01566422|Vancomycin|vancomycin|mesh-list
92432530|NCT01566422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432531|NCT01566422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432532|NCT01566760|Fesoterodine|fesoterodine|mesh-list
92432533|NCT01566760|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92432534|NCT01566760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92432535|NCT01566760|Cholinergic Agents|cholinergic agents|mesh-ancestor
92432536|NCT01566760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432537|NCT01566760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432539|NCT01566760|Urological Agents|urological agents|mesh-ancestor
92432540|NCT01566890|Regadenoson|regadenoson|mesh-list
92432541|NCT01566890|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92432542|NCT01566890|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92432543|NCT01566890|Purinergic Agonists|purinergic agonists|mesh-ancestor
92432544|NCT01566890|Purinergic Agents|purinergic agents|mesh-ancestor
92432545|NCT01566890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432546|NCT01566890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432547|NCT01566890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432548|NCT01567072|Ibuprofen|ibuprofen|mesh-list
92432549|NCT01567072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92432550|NCT01567072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92432551|NCT01567072|Analgesics|analgesics|mesh-ancestor
92432552|NCT01567072|Sensory System Agents|sensory system agents|mesh-ancestor
92432553|NCT01567072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432554|NCT01567072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432555|NCT01567072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432556|NCT01567072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432557|NCT01567072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92432558|NCT01567072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432559|NCT01567072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432560|NCT01567423|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92432561|NCT01567423|Antimalarials|antimalarials|mesh-ancestor
92432562|NCT01567423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92432563|NCT01567423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92432564|NCT01567423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432565|NCT01568632|Imetelstat|imetelstat|mesh-list
92432566|NCT01568632|Motesanib diphosphate|motesanib diphosphate|mesh-list
92432567|NCT01568632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432568|NCT01568632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432569|NCT01568632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432570|NCT01568645|Imatinib Mesylate|imatinib mesylate|mesh-list
92432571|NCT01568645|Carvedilol|carvedilol|mesh-list
92432572|NCT01568645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432573|NCT01568645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92432574|NCT01568645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432575|NCT01568645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432576|NCT01568645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92432577|NCT01568645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92432578|NCT01568645|Adrenergic Agents|adrenergic agents|mesh-ancestor
92432579|NCT01568645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432580|NCT01568645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432581|NCT01568645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92432582|NCT01568645|Antioxidants|antioxidants|mesh-ancestor
92432583|NCT01568645|Protective Agents|protective agents|mesh-ancestor
92432584|NCT01568645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92432585|NCT01568645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432586|NCT01568645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92432587|NCT01568645|Vasodilator Agents|vasodilator agents|mesh-ancestor
92432588|NCT01568645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92432589|NCT01568645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92432590|NCT01568684|Citalopram|citalopram|mesh-list
92432591|NCT01568684|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92432592|NCT01568684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92432593|NCT01568684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432594|NCT01568684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432595|NCT01568684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432596|NCT01568684|Serotonin Agents|serotonin agents|mesh-ancestor
92432597|NCT01568684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432598|NCT01568684|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92432599|NCT01568684|Antidepressive Agents|antidepressive agents|mesh-ancestor
92432600|NCT01568684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432601|NCT01569685|Sertraline|sertraline|mesh-list
92432602|NCT01569685|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92432603|NCT01569685|Antidepressive Agents|antidepressive agents|mesh-ancestor
92432604|NCT01569685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432605|NCT01569685|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92432606|NCT01569685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92432607|NCT01569685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432608|NCT01569685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432609|NCT01569685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432610|NCT01569685|Serotonin Agents|serotonin agents|mesh-ancestor
92432611|NCT01569685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432612|NCT01569685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92432613|NCT01569685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92432614|NCT01570049|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92432615|NCT01570049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92432616|NCT01570049|Alkylating Agents|alkylating agents|mesh-ancestor
92432617|NCT01570049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432618|NCT01570049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432620|NCT01570088|Hematinics|hematinics|mesh-ancestor
92432621|NCT01570088|Vitamin B Complex|vitamin b complex|mesh-ancestor
92432622|NCT01570088|Vitamins|vitamins|mesh-ancestor
92432623|NCT01570088|Micronutrients|micronutrients|mesh-ancestor
92432624|NCT01570088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432625|NCT01570478|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92432626|NCT01570478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92432627|NCT01570478|Autonomic Agents|autonomic agents|mesh-ancestor
92432628|NCT01570478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432629|NCT01570478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432630|NCT01570478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92432631|NCT01570478|Respiratory System Agents|respiratory system agents|mesh-ancestor
92432632|NCT01570478|Glucocorticoids|glucocorticoids|mesh-ancestor
92432633|NCT01570478|Hormones|hormones|mesh-ancestor
92432634|NCT01570478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432635|NCT01570478|Sympathomimetics|sympathomimetics|mesh-ancestor
92432636|NCT01570504|Ivermectin|ivermectin|mesh-list
92432637|NCT01570504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92432638|NCT01570504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432639|NCT01570556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92432640|NCT01570556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432641|NCT01570569|Losartan|losartan|mesh-list
92432642|NCT01570569|Midazolam|midazolam|mesh-list
92432643|NCT01570569|Dextromethorphan|dextromethorphan|mesh-list
92432644|NCT01570569|Caffeine|caffeine|mesh-list
92432645|NCT01570569|Omeprazole|omeprazole|mesh-list
92432646|NCT01570569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92432647|NCT01570569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92432648|NCT01570569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432649|NCT01570569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432650|NCT01570569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92432651|NCT01570569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432652|NCT01570569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432653|NCT01570569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92432654|NCT01570569|Anesthetics, General|anesthetics, general|mesh-ancestor
92432655|NCT01570569|Anesthetics|anesthetics|mesh-ancestor
92432656|NCT01570569|GABA Modulators|gaba modulators|mesh-ancestor
92432657|NCT01570569|GABA Agents|gaba agents|mesh-ancestor
92432658|NCT01570569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432659|NCT01570569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432660|NCT01570569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92432661|NCT01570569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92432662|NCT01570569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92432663|NCT01570569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92432664|NCT01570569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92432665|NCT01570569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92432666|NCT01570569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432667|NCT01570569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92432668|NCT01570569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92432669|NCT01570569|Purinergic Agents|purinergic agents|mesh-ancestor
92432670|NCT01570569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92432671|NCT01570569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432672|NCT01570569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92432673|NCT01570569|Antitussive Agents|antitussive agents|mesh-ancestor
92432674|NCT01570569|Respiratory System Agents|respiratory system agents|mesh-ancestor
92432675|NCT01570569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92432676|NCT01570569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92432677|NCT01570582|Paclitaxel|paclitaxel|mesh-list
92432678|NCT01570582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92432679|NCT01570582|Carboplatin|carboplatin|mesh-list
92432680|NCT01570582|Gemcitabine|gemcitabine|mesh-list
92432681|NCT01570582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92432682|NCT01570582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432683|NCT01570582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92432684|NCT01570582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92432685|NCT01570582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92432686|NCT01570582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342221|NCT00003953|Abortifacient Agents|abortifacient agents|mesh-ancestor
92432687|NCT01570582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432688|NCT01570582|Antimetabolites|antimetabolites|mesh-ancestor
92432690|NCT01570608|Verteporfin|verteporfin|mesh-list
92432692|NCT01570608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92432693|NCT01570608|Growth Substances|growth substances|mesh-ancestor
92432694|NCT01570608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432695|NCT01570608|Growth Inhibitors|growth inhibitors|mesh-ancestor
92432696|NCT01570608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432697|NCT01570608|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92432698|NCT01570608|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432699|NCT01570660|Pioglitazone|pioglitazone|mesh-list
92432700|NCT01570660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92432701|NCT01570660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432702|NCT01570764|Cyclophosphamide|cyclophosphamide|mesh-list
92432703|NCT01570764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432704|NCT01570764|Immunologic Factors|immunologic factors|mesh-ancestor
92432705|NCT01570764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342335|NCT00003215|Melphalan|melphalan|mesh-list
92432706|NCT01570764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432707|NCT01570764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92432708|NCT01570764|Alkylating Agents|alkylating agents|mesh-ancestor
92432709|NCT01570764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432710|NCT01570764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432711|NCT01570764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92432712|NCT01570790|Fosbretabulin|fosbretabulin|mesh-list
92432713|NCT01570790|Combretastatin|combretastatin|mesh-list
92342494|NCT00004013|Paclitaxel|paclitaxel|mesh-list
92432714|NCT01570790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92432715|NCT01570790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432716|NCT01570790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92432717|NCT01570790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92432718|NCT01570790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342559|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
92432719|NCT01570790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432720|NCT01570894|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92432721|NCT01570894|Antidepressive Agents|antidepressive agents|mesh-ancestor
92432722|NCT01570894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432723|NCT01570894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92432724|NCT01570894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432725|NCT01570894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432726|NCT01570894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432727|NCT01570907|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92432728|NCT01570907|Antidepressive Agents|antidepressive agents|mesh-ancestor
92432729|NCT01570907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92342638|NCT00004115|Antibodies|antibodies|mesh-list
92432730|NCT01570907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92432731|NCT01570907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432732|NCT01570907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432733|NCT01570907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432734|NCT01570959|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92432735|NCT01570959|Antidepressive Agents|antidepressive agents|mesh-ancestor
92432736|NCT01570959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432737|NCT01570959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92432738|NCT01570959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432739|NCT01570959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432740|NCT01570959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432741|NCT01570985|Triamcinolone|triamcinolone|mesh-list
92432742|NCT01570985|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92432743|NCT01570985|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92432744|NCT01570985|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92432745|NCT01570985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432746|NCT01570985|Glucocorticoids|glucocorticoids|mesh-ancestor
92432747|NCT01570985|Hormones|hormones|mesh-ancestor
92432748|NCT01570985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92432749|NCT01570985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432750|NCT01570985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432751|NCT01570985|Immunologic Factors|immunologic factors|mesh-ancestor
92432752|NCT01570985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342926|NCT00004235|Irinotecan|irinotecan|mesh-list
92432753|NCT01570985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432754|NCT01571024|Leucovorin|leucovorin|mesh-list
92432755|NCT01571024|Fluorouracil|fluorouracil|mesh-list
92432756|NCT01571024|Oxaliplatin|oxaliplatin|mesh-list
92432757|NCT01571024|Antimetabolites|antimetabolites|mesh-ancestor
92432758|NCT01571024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432759|NCT01571024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432761|NCT01571024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92432762|NCT01571024|Immunologic Factors|immunologic factors|mesh-ancestor
92432763|NCT01571024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432764|NCT01571024|Antidotes|antidotes|mesh-ancestor
92432765|NCT01571024|Protective Agents|protective agents|mesh-ancestor
92432766|NCT01571024|Vitamin B Complex|vitamin b complex|mesh-ancestor
92432767|NCT01571024|Vitamins|vitamins|mesh-ancestor
92432768|NCT01571024|Micronutrients|micronutrients|mesh-ancestor
92432769|NCT01571037|Milrinone|milrinone|mesh-list
92432770|NCT01571037|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92432771|NCT01571037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92432772|NCT01571037|Vasodilator Agents|vasodilator agents|mesh-ancestor
92432774|NCT01571037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92432775|NCT01571037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432776|NCT01571037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432777|NCT01571037|Protective Agents|protective agents|mesh-ancestor
92432778|NCT01571037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432779|NCT01571050|Calcium Carbonate|calcium carbonate|mesh-list
92432780|NCT01571050|Antacids|antacids|mesh-ancestor
92432781|NCT01571050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432782|NCT01571050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432783|NCT01571063|Vitamin D|vitamin d|mesh-list
92432784|NCT01571063|Cholecalciferol|cholecalciferol|mesh-list
92432785|NCT01571063|Vitamins|vitamins|mesh-ancestor
92432786|NCT01571063|Micronutrients|micronutrients|mesh-ancestor
92432787|NCT01571063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432788|NCT01571063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92432789|NCT01571063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92432790|NCT01571167|Varenicline|varenicline|mesh-list
92432791|NCT01571167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92432792|NCT01571167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92432793|NCT01571167|Cholinergic Agents|cholinergic agents|mesh-ancestor
92432794|NCT01571167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432795|NCT01571167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432796|NCT01571167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432797|NCT01571206|Infliximab|infliximab|mesh-list
92432798|NCT01571206|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92432799|NCT01571206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432800|NCT01571206|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432801|NCT01571206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432802|NCT01571206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432803|NCT01571219|Infliximab|infliximab|mesh-list
92432804|NCT01571219|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92432805|NCT01571219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432806|NCT01571219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432807|NCT01571219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432808|NCT01571219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432809|NCT01571323|Misoprostol|misoprostol|mesh-list
92432810|NCT01571323|Oxytocin|oxytocin|mesh-list
92432811|NCT01571323|Oxytocics|oxytocics|mesh-ancestor
92432812|NCT01571323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92432813|NCT01571323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432814|NCT01571323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92432815|NCT01571323|Abortifacient Agents|abortifacient agents|mesh-ancestor
92432816|NCT01571323|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92432817|NCT01571323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432818|NCT01571414|Ritonavir|ritonavir|mesh-list
92432819|NCT01571414|Lopinavir|lopinavir|mesh-list
92432820|NCT01571414|Efavirenz|efavirenz|mesh-list
92432821|NCT01571414|Rifampin|rifampin|mesh-list
92432822|NCT01571414|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92432823|NCT01571414|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92432824|NCT01571414|Protease Inhibitors|protease inhibitors|mesh-ancestor
92432825|NCT01571414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343230|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92432826|NCT01571414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432827|NCT01571414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92432828|NCT01571414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92432829|NCT01571414|Antiviral Agents|antiviral agents|mesh-ancestor
92432830|NCT01571414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432831|NCT01571414|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92432832|NCT01571414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92432833|NCT01571414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92432834|NCT01571414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92432835|NCT01571414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92432836|NCT01571414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92432837|NCT01571414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92432838|NCT01571414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92432839|NCT01571414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92432840|NCT01571414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92432841|NCT01571414|Antitubercular Agents|antitubercular agents|mesh-ancestor
92432842|NCT01571414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92432843|NCT01571414|Leprostatic Agents|leprostatic agents|mesh-ancestor
92432844|NCT01571414|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92432845|NCT01571414|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92432846|NCT01571414|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92432849|NCT01571570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432850|NCT01571570|Protease Inhibitors|protease inhibitors|mesh-ancestor
92432851|NCT01571570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432852|NCT01571570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432854|NCT01571583|Ribavirin|ribavirin|mesh-list
92432855|NCT01571583|Interferon-alpha|interferon-alpha|mesh-list
92432856|NCT01571583|Interferon alpha-2|interferon alpha-2|mesh-list
92432857|NCT01571583|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92432858|NCT01571583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432859|NCT01571583|Antiviral Agents|antiviral agents|mesh-ancestor
92432860|NCT01571583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92432861|NCT01571583|Antimetabolites|antimetabolites|mesh-ancestor
92432862|NCT01571583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432863|NCT01571583|Immunologic Factors|immunologic factors|mesh-ancestor
92432864|NCT01571583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432865|NCT01571609|Insulin|insulin|mesh-list
92432866|NCT01571609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92432867|NCT01571609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432868|NCT01571648|Azacitidine|azacitidine|mesh-list
92432869|NCT01571648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92432870|NCT01571648|Antimetabolites|antimetabolites|mesh-ancestor
92432871|NCT01571648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432872|NCT01571648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92432873|NCT01571648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432874|NCT01571687|Antioxidants|antioxidants|mesh-list
92432875|NCT01571687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432876|NCT01571687|Protective Agents|protective agents|mesh-ancestor
92432877|NCT01571687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432878|NCT01571791|Ketorolac|ketorolac|mesh-list
92432879|NCT01571791|Lidocaine|lidocaine|mesh-list
92432880|NCT01571791|Anesthetics, Local|anesthetics, local|mesh-ancestor
92432881|NCT01571791|Anesthetics|anesthetics|mesh-ancestor
92432882|NCT01571791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432883|NCT01571791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432884|NCT01571791|Sensory System Agents|sensory system agents|mesh-ancestor
92432885|NCT01571791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432886|NCT01571791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92432887|NCT01571791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92432888|NCT01571791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92432889|NCT01571791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343255|NCT00004637|Protective Agents|protective agents|mesh-ancestor
92432890|NCT01571791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432891|NCT01571791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92432892|NCT01571791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92432893|NCT01571791|Analgesics|analgesics|mesh-ancestor
92432894|NCT01571791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92432895|NCT01571791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92432896|NCT01571791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92432897|NCT01571791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92432898|NCT01571804|Pregabalin|pregabalin|mesh-list
92432899|NCT01571804|Analgesics|analgesics|mesh-ancestor
92432900|NCT01571804|Sensory System Agents|sensory system agents|mesh-ancestor
92432901|NCT01571804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432902|NCT01571804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432903|NCT01571804|Anticonvulsants|anticonvulsants|mesh-ancestor
92432904|NCT01571804|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92432905|NCT01571804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432906|NCT01571804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432907|NCT01571804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92432908|NCT01571804|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92432909|NCT01571804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92432910|NCT01571804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432911|NCT01571804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92432912|NCT01571856|Zinc Sulfate|zinc sulfate|mesh-list
92432913|NCT01571856|Astringents|astringents|mesh-ancestor
92432914|NCT01571856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432915|NCT01571856|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432916|NCT01571882|Policosanol|policosanol|mesh-list
92432917|NCT01571882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92432918|NCT01571882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92432919|NCT01571882|Antimetabolites|antimetabolites|mesh-ancestor
92432920|NCT01571882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432921|NCT01571882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92432922|NCT01571882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92432923|NCT01571921|Tocotrienols|tocotrienols|mesh-list
92432924|NCT01571921|Vitamin E|vitamin e|mesh-list
92432925|NCT01571921|Tocopherols|tocopherols|mesh-list
92432926|NCT01571921|Antioxidants|antioxidants|mesh-ancestor
92432927|NCT01571921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432928|NCT01571921|Protective Agents|protective agents|mesh-ancestor
92432929|NCT01571921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432930|NCT01571921|Vitamins|vitamins|mesh-ancestor
92432931|NCT01571921|Micronutrients|micronutrients|mesh-ancestor
92432932|NCT01571960|Vaccines|vaccines|mesh-list
92432933|NCT01571960|Immunologic Factors|immunologic factors|mesh-ancestor
92432934|NCT01571960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432935|NCT01572012|Ondansetron|ondansetron|mesh-list
92432936|NCT01572012|Antiemetics|antiemetics|mesh-ancestor
92432937|NCT01572012|Autonomic Agents|autonomic agents|mesh-ancestor
92432938|NCT01572012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432939|NCT01572012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432940|NCT01572012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92432941|NCT01572012|Antipruritics|antipruritics|mesh-ancestor
92432942|NCT01572012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92432943|NCT01572012|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92432944|NCT01572012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92432945|NCT01572012|Serotonin Agents|serotonin agents|mesh-ancestor
92432946|NCT01572012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432947|NCT01572012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432948|NCT01572025|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92432949|NCT01572025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92432950|NCT01572025|Immunologic Factors|immunologic factors|mesh-ancestor
92432951|NCT01572025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432952|NCT01572090|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92432953|NCT01572090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432954|NCT01571908|Rocuronium|rocuronium|mesh-list
92432955|NCT01571908|Succinylcholine|succinylcholine|mesh-list
92432956|NCT01571908|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92432957|NCT01571908|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92432958|NCT01571908|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92432959|NCT01571908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432960|NCT01571908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432961|NCT01571908|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92432962|NCT01572116|Lidocaine|lidocaine|mesh-list
92432963|NCT01572116|Epinephrine|epinephrine|mesh-list
92432964|NCT01572116|Racepinephrine|racepinephrine|mesh-list
92432965|NCT01572116|Sufentanil|sufentanil|mesh-list
92432966|NCT01572116|Epinephryl borate|epinephryl borate|mesh-list
92432967|NCT01572116|Anesthetics, Local|anesthetics, local|mesh-ancestor
92432968|NCT01572116|Anesthetics|anesthetics|mesh-ancestor
92432969|NCT01572116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92432970|NCT01572116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92432971|NCT01572116|Sensory System Agents|sensory system agents|mesh-ancestor
92432972|NCT01572116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92432973|NCT01572116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92432974|NCT01572116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92432975|NCT01572116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92432976|NCT01572116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92432977|NCT01572116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92432978|NCT01572116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92432979|NCT01572116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92157705|NCT04152564|Anesthetics|anesthetics|mesh-ancestor
92432980|NCT01572116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92432981|NCT01572116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92432982|NCT01572116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92432983|NCT01572116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92432985|NCT01572116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92432986|NCT01572116|Respiratory System Agents|respiratory system agents|mesh-ancestor
92432987|NCT01572116|Mydriatics|mydriatics|mesh-ancestor
92432989|NCT01572116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92432990|NCT01572116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92432991|NCT01572116|Narcotics|narcotics|mesh-ancestor
92432992|NCT01572116|Analgesics|analgesics|mesh-ancestor
92432993|NCT01572116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92432994|NCT01572116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92432995|NCT01572116|Anesthetics, General|anesthetics, general|mesh-ancestor
92432996|NCT01572129|Clopidogrel|clopidogrel|mesh-list
92432997|NCT01572129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92432998|NCT01572129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92432999|NCT01572129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92433000|NCT01572129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92433001|NCT01572129|Purinergic Agents|purinergic agents|mesh-ancestor
92433002|NCT01572129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433003|NCT01572129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433004|NCT01572129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433005|NCT01572181|Fludarabine|fludarabine|mesh-list
92433006|NCT01572181|Busulfan|busulfan|mesh-list
92433007|NCT01572181|Thymoglobulin|thymoglobulin|mesh-list
92433008|NCT01572181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433009|NCT01572181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433010|NCT01572181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92433011|NCT01572181|Immunologic Factors|immunologic factors|mesh-ancestor
92433012|NCT01572181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433013|NCT01572181|Alkylating Agents|alkylating agents|mesh-ancestor
92433014|NCT01572181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92433015|NCT01572181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92433016|NCT01572259|Hormones|hormones|mesh-list
92433017|NCT01572259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433018|NCT01572259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433019|NCT01572285|Dexamethasone|dexamethasone|mesh-list
92433020|NCT01572285|Dexamethasone acetate|dexamethasone acetate|mesh-list
92433021|NCT01572285|BB 1101|bb 1101|mesh-list
92433022|NCT01572285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433023|NCT01572285|Antiemetics|antiemetics|mesh-ancestor
92433024|NCT01572285|Autonomic Agents|autonomic agents|mesh-ancestor
92433025|NCT01572285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433026|NCT01572285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433027|NCT01572285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433028|NCT01572285|Glucocorticoids|glucocorticoids|mesh-ancestor
92433029|NCT01572285|Hormones|hormones|mesh-ancestor
92433030|NCT01572285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433031|NCT01572285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92433032|NCT01572285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433033|NCT01572285|Protease Inhibitors|protease inhibitors|mesh-ancestor
92433034|NCT01572285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433035|NCT01572285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433036|NCT01572324|Leucovorin|leucovorin|mesh-list
92433037|NCT01572324|Fluorouracil|fluorouracil|mesh-list
92433038|NCT01572324|Capecitabine|capecitabine|mesh-list
92433039|NCT01572324|Oxaliplatin|oxaliplatin|mesh-list
92433040|NCT01572324|Antimetabolites|antimetabolites|mesh-ancestor
92433041|NCT01572324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433042|NCT01572324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92433043|NCT01572324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433044|NCT01572324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92433045|NCT01572324|Immunologic Factors|immunologic factors|mesh-ancestor
92433046|NCT01572324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433047|NCT01572324|Antidotes|antidotes|mesh-ancestor
92433048|NCT01572324|Protective Agents|protective agents|mesh-ancestor
92433049|NCT01572324|Vitamin B Complex|vitamin b complex|mesh-ancestor
92433050|NCT01572324|Vitamins|vitamins|mesh-ancestor
92433051|NCT01572324|Micronutrients|micronutrients|mesh-ancestor
92433052|NCT01572350|Triamcinolone|triamcinolone|mesh-list
92433053|NCT01572350|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92433054|NCT01572350|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92433055|NCT01572350|Bevacizumab|bevacizumab|mesh-list
92433056|NCT01572350|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92433057|NCT01572350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92433058|NCT01572350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433059|NCT01572350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92433060|NCT01572350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92433061|NCT01572350|Growth Substances|growth substances|mesh-ancestor
92154781|NCT04989348|Hormones|hormones|mesh-list
92433062|NCT01572350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154927|NCT02634606|Vitamin E|vitamin e|mesh-list
92433063|NCT01572350|Growth Inhibitors|growth inhibitors|mesh-ancestor
92155070|NCT03584087|Terlipressin|terlipressin|mesh-list
92433064|NCT01572350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433065|NCT01572350|Glucocorticoids|glucocorticoids|mesh-ancestor
92433066|NCT01572350|Hormones|hormones|mesh-ancestor
92155291|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92155300|NCT04405271|Tenofovir|tenofovir|mesh-list
92155516|NCT05629494|Ibuprofen|ibuprofen|mesh-list
92155589|NCT02235701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155811|NCT04764383|Histamine|histamine|mesh-list
92155962|NCT01676597|Protective Agents|protective agents|mesh-ancestor
92433067|NCT01572350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156274|NCT00970203|Vaccines|vaccines|mesh-list
92433068|NCT01572350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156402|NCT01672710|Niacin|niacin|mesh-list
92156441|NCT05319756|Oxycodone|oxycodone|mesh-list
92433069|NCT01572350|Immunologic Factors|immunologic factors|mesh-ancestor
92433070|NCT01572350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156663|NCT00979875|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92156746|NCT02084069|Atorvastatin|atorvastatin|mesh-list
92156814|NCT00981825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156974|NCT03638375|Nivolumab|nivolumab|mesh-list
92157110|NCT00991809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157261|NCT04981704|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92157337|NCT02626182|Vasodilator Agents|vasodilator agents|mesh-ancestor
92157488|NCT03115047|Analgesics|analgesics|mesh-ancestor
92433071|NCT01572350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433072|NCT01572363|Sildenafil Citrate|sildenafil citrate|mesh-list
92433073|NCT01572363|Vasodilator Agents|vasodilator agents|mesh-ancestor
92158002|NCT04730531|Epinephrine|epinephrine|mesh-list
92158153|NCT05852002|Viscosupplements|viscosupplements|mesh-ancestor
92158228|NCT05809297|Antifungal Agents|antifungal agents|mesh-ancestor
92158376|NCT05658887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158450|NCT05477108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158601|NCT05219409|Incretins|incretins|mesh-ancestor
92158674|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158751|NCT05067387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433074|NCT01572363|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92159223|NCT03972592|Sirolimus|sirolimus|mesh-list
92159294|NCT03797196|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92159368|NCT03683069|Hormone Antagonists|hormone antagonists|mesh-ancestor
92433075|NCT01572363|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92159746|NCT02289079|Bupivacaine|bupivacaine|mesh-list
92433076|NCT01572363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160279|NCT04999449|Mydriatics|mydriatics|mesh-ancestor
92160503|NCT01044693|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92160579|NCT01045551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92433077|NCT01572363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433079|NCT01572454|Dexmedetomidine|dexmedetomidine|mesh-list
92433080|NCT01572454|Remifentanil|remifentanil|mesh-list
92433081|NCT01572454|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92161019|NCT01677611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161171|NCT00089843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92161246|NCT01197495|Hyaluronic Acid|hyaluronic acid|mesh-list
92433082|NCT01572454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433083|NCT01572454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161469|NCT03087149|Vitamin D|vitamin d|mesh-list
92161545|NCT01144143|Glucocorticoids|glucocorticoids|mesh-ancestor
92161628|NCT00083915|Antiemetics|antiemetics|mesh-ancestor
92433084|NCT01572454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92161995|NCT05277623|Diuretics|diuretics|mesh-ancestor
92162142|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
92162219|NCT04746365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92162297|NCT03367013|Lactoferrin|lactoferrin|mesh-list
92433087|NCT01572454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433088|NCT01572454|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92433089|NCT01572454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92433090|NCT01572454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92433091|NCT01572454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92433092|NCT01572454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163117|NCT01920919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163430|NCT02984293|Atorvastatin|atorvastatin|mesh-list
92163494|NCT03015259|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92163569|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92433093|NCT01572454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163873|NCT01920113|Propofol|propofol|mesh-list
92433094|NCT01572454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92433095|NCT01572454|Narcotics|narcotics|mesh-ancestor
92433096|NCT01572545|Zoledronic Acid|zoledronic acid|mesh-list
92433097|NCT01572545|Denosumab|denosumab|mesh-list
92164406|NCT01307007|Dextrans|dextrans|mesh-list
92433098|NCT01572545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92164630|NCT01307397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164783|NCT05603975|Esketamine|esketamine|mesh-list
92433099|NCT01572545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433101|NCT01572558|Meropenem|meropenem|mesh-list
92165009|NCT05700669|Olaparib|olaparib|mesh-list
92433102|NCT01572558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433104|NCT01572558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92433105|NCT01572558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92165610|NCT02275780|Ritonavir|ritonavir|mesh-list
92433106|NCT01572558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165832|NCT02654119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165906|NCT03829111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165982|NCT02905591|Antioxidants|antioxidants|mesh-ancestor
92166062|NCT01455883|Incretins|incretins|mesh-ancestor
92166136|NCT04954014|Bevacizumab|bevacizumab|mesh-list
92166508|NCT04942002|Prednisolone|prednisolone|mesh-list
92166582|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166658|NCT04948164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92433107|NCT01572558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433108|NCT01572558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167041|NCT02635555|Phenylephrine|phenylephrine|mesh-list
92167265|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
92433109|NCT01572558|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92167494|NCT02389309|Temsirolimus|temsirolimus|mesh-list
92167574|NCT02461537|Mitoxantrone|mitoxantrone|mesh-list
92167639|NCT05023837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92433110|NCT01572558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92433111|NCT01572597|Metronidazole|metronidazole|mesh-list
92433112|NCT01572597|Clarithromycin|clarithromycin|mesh-list
92433113|NCT01572597|Acetylcysteine|acetylcysteine|mesh-list
92168176|NCT05711082|Dopamine Agents|dopamine agents|mesh-ancestor
92433114|NCT01572597|Rabeprazole|rabeprazole|mesh-list
92433115|NCT01572597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168407|NCT04944654|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92433116|NCT01572597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433117|NCT01572597|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92433118|NCT01572597|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92433119|NCT01572597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92433120|NCT01572597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433121|NCT01572597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92433122|NCT01572597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169628|NCT05767359|Fludarabine phosphate|fludarabine phosphate|mesh-list
92169808|NCT05554627|Serotonin Agents|serotonin agents|mesh-ancestor
92169885|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
92169959|NCT05377242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170032|NCT05329090|Rituximab|rituximab|mesh-list
92433123|NCT01572597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170135|NCT05195918|Pirfenidone|pirfenidone|mesh-list
92170209|NCT05100628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433124|NCT01572597|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92170441|NCT04786210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433125|NCT01572597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92170599|NCT04494425|Paclitaxel|paclitaxel|mesh-list
92170821|NCT04094675|Sirolimus|sirolimus|mesh-list
92170897|NCT04002947|Rituximab|rituximab|mesh-list
92170978|NCT03917082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433126|NCT01572597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92171208|NCT03710772|Cytarabine|cytarabine|mesh-list
92433128|NCT01572597|Expectorants|expectorants|mesh-ancestor
92171444|NCT03323385|Meloxicam|meloxicam|mesh-list
92433129|NCT01572597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92171650|NCT03079999|Analgesics|analgesics|mesh-ancestor
92433130|NCT01572597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92433131|NCT01572597|Antioxidants|antioxidants|mesh-ancestor
92433132|NCT01572597|Protective Agents|protective agents|mesh-ancestor
92172100|NCT01991873|Antidotes|antidotes|mesh-ancestor
92172179|NCT01787487|Azacitidine|azacitidine|mesh-list
92433133|NCT01572597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433135|NCT01572623|Atorvastatin|atorvastatin|mesh-list
92172303|NCT00908050|Botulinum Toxins|botulinum toxins|mesh-list
92172387|NCT00792948|Vitamins|vitamins|mesh-ancestor
92172531|NCT00217737|Bevacizumab|bevacizumab|mesh-list
92172682|NCT03449108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433136|NCT01572623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92433137|NCT01572623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92433138|NCT01572623|Antimetabolites|antimetabolites|mesh-ancestor
92173051|NCT01383759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433139|NCT01572623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173275|NCT03051906|Cetuximab|cetuximab|mesh-list
92173348|NCT04899570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92433140|NCT01572623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92173423|NCT04891458|Analgesics|analgesics|mesh-ancestor
92173498|NCT05585281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173572|NCT02249065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92173647|NCT01406223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92173720|NCT04898712|Coagulants|coagulants|mesh-ancestor
92173868|NCT04889196|Cariostatic Agents|cariostatic agents|mesh-ancestor
92173955|NCT01421797|Hormones|hormones|mesh-ancestor
92174240|NCT04123379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433141|NCT01572623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92174692|NCT04876716|Posaconazole|posaconazole|mesh-list
92433142|NCT01572623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433143|NCT01572623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92433144|NCT01572623|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92433145|NCT01572623|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92433146|NCT01572623|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92175214|NCT01896349|Sertraline|sertraline|mesh-list
92433147|NCT01572623|Purinergic Agents|purinergic agents|mesh-ancestor
92433148|NCT01572623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433149|NCT01572623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433150|NCT01572649|Lixisenatide|lixisenatide|mesh-list
92433151|NCT01572649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433152|NCT01572649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176120|NCT04856124|Anesthetics, General|anesthetics, general|mesh-ancestor
92176351|NCT01890629|Metformin|metformin|mesh-list
92176424|NCT02983097|Immunologic Factors|immunologic factors|mesh-ancestor
92176876|NCT01488279|Incretins|incretins|mesh-ancestor
92433154|NCT01572688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92433155|NCT01572688|Alkylating Agents|alkylating agents|mesh-ancestor
92177324|NCT01498419|Pyrazinamide|pyrazinamide|mesh-list
92177400|NCT04824612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177474|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
92177625|NCT04836156|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92177696|NCT04304040|Antibodies|antibodies|mesh-list
92177771|NCT01456143|Proflavine|proflavine|mesh-list
92177923|NCT00066937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177997|NCT02247141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433156|NCT01572688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178152|NCT04428684|Goserelin|goserelin|mesh-list
92433157|NCT01572688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178678|NCT04427826|Sensory System Agents|sensory system agents|mesh-ancestor
92178832|NCT04816968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433158|NCT01572688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179058|NCT04753619|Niclosamide|niclosamide|mesh-list
92179360|NCT00078559|Antiviral Agents|antiviral agents|mesh-ancestor
92179511|NCT03000777|Melatonin|melatonin|mesh-list
92433159|NCT01572688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92433160|NCT01572688|Immunologic Factors|immunologic factors|mesh-ancestor
92433161|NCT01572688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433162|NCT01572805|Melatonin|melatonin|mesh-list
92433163|NCT01572805|Antioxidants|antioxidants|mesh-ancestor
92433164|NCT01572805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433165|NCT01572805|Protective Agents|protective agents|mesh-ancestor
92433166|NCT01572805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433167|NCT01572805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433168|NCT01572831|Tin Fluorides|tin fluorides|mesh-list
92433169|NCT01572831|Cariostatic Agents|cariostatic agents|mesh-ancestor
92433170|NCT01572831|Protective Agents|protective agents|mesh-ancestor
92433171|NCT01572831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433172|NCT01572857|Immunoglobulins|immunoglobulins|mesh-list
92146210|NCT01502072|Ribavirin|ribavirin|mesh-list
92433173|NCT01572857|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92433174|NCT01572857|Antibodies|antibodies|mesh-list
92433175|NCT01572857|Immunologic Factors|immunologic factors|mesh-ancestor
92433176|NCT01572857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433177|NCT01572961|Aspirin|aspirin|mesh-list
92433178|NCT01572961|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92433179|NCT01572961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433180|NCT01572961|Analgesics|analgesics|mesh-ancestor
92433181|NCT01572961|Sensory System Agents|sensory system agents|mesh-ancestor
92433182|NCT01572961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433183|NCT01572961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433184|NCT01572961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433185|NCT01572961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92433186|NCT01572961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92433187|NCT01572961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92433188|NCT01572961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433189|NCT01572961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92433190|NCT01572961|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92433191|NCT01572961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433192|NCT01572961|Antipyretics|antipyretics|mesh-ancestor
92433193|NCT01573013|Iron|iron|mesh-list
92433194|NCT01573013|Trace Elements|trace elements|mesh-ancestor
92433195|NCT01573013|Micronutrients|micronutrients|mesh-ancestor
92433196|NCT01573013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433197|NCT01573143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92433198|NCT01573143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92433199|NCT01573143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92433200|NCT01573143|Antimetabolites|antimetabolites|mesh-ancestor
92433201|NCT01573143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433202|NCT01573143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92433203|NCT01573143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92433204|NCT01573143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433205|NCT01573286|Glucagon|glucagon|mesh-list
92433206|NCT01573286|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92433207|NCT01573286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179924|NCT05571345|Oxycodone|oxycodone|mesh-list
92179984|NCT05562297|Antimetabolites|antimetabolites|mesh-ancestor
92180060|NCT03002493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180132|NCT04785768|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92180436|NCT00081263|Sensory System Agents|sensory system agents|mesh-ancestor
92180509|NCT05248620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180511|NCT01639599|Dexamethasone|dexamethasone|mesh-list
92180732|NCT02412228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180808|NCT00089011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180956|NCT00194779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92181338|NCT01452152|Purinergic Agents|purinergic agents|mesh-ancestor
92181487|NCT01660893|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92181709|NCT00048815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92181870|NCT00105001|Sirolimus|sirolimus|mesh-list
92181936|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
92182091|NCT00054665|Glucocorticoids|glucocorticoids|mesh-ancestor
92182161|NCT00218491|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92182234|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182313|NCT00116857|Sertraline|sertraline|mesh-list
92182377|NCT01439204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92433209|NCT01573286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433210|NCT01573286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433211|NCT01573286|Incretins|incretins|mesh-ancestor
92182760|NCT00125515|Naltrexone|naltrexone|mesh-list
92182839|NCT00079001|Vitamin D|vitamin d|mesh-list
92433212|NCT01573338|Carboplatin|carboplatin|mesh-list
92433213|NCT01573338|Etoposide|etoposide|mesh-list
92433214|NCT01573338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433215|NCT01573338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92184100|NCT04769271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433216|NCT01573338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92433217|NCT01573338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92433218|NCT01573338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184777|NCT00186875|Antiemetics|antiemetics|mesh-ancestor
92184854|NCT05535036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184999|NCT00189137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185145|NCT01465802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433219|NCT01573338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433221|NCT01573377|Cyproterone Acetate|cyproterone acetate|mesh-list
92433224|NCT01573377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92185894|NCT02097641|Plasma-lyte 148|plasma-lyte 148|mesh-list
92433225|NCT01573377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433226|NCT01573377|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92433227|NCT01573377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92186263|NCT00287989|Tubulin Modulators|tubulin modulators|mesh-ancestor
92186337|NCT01650701|Rituximab|rituximab|mesh-list
92433228|NCT01573377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92186492|NCT01619111|Lapatinib|lapatinib|mesh-list
92186564|NCT01853085|Bimatoprost|bimatoprost|mesh-list
92433229|NCT01573377|Contraceptive Agents|contraceptive agents|mesh-ancestor
92186715|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186789|NCT00330421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186861|NCT05950971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92433230|NCT01573377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92433231|NCT01573377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92187408|NCT05488678|Ceftibuten|ceftibuten|mesh-list
92433233|NCT01573377|Hormones|hormones|mesh-ancestor
92187481|NCT05398757|Dexmedetomidine|dexmedetomidine|mesh-list
92187554|NCT05263388|Hormones|hormones|mesh-ancestor
92187586|NCT05224089|Hormones|hormones|mesh-ancestor
92187890|NCT04644068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92187965|NCT04508023|Rivaroxaban|rivaroxaban|mesh-list
92188043|NCT04363801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188197|NCT03944954|Hormones|hormones|mesh-ancestor
92188346|NCT03573960|Lenvatinib|lenvatinib|mesh-list
92188416|NCT03414658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188493|NCT03211416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433234|NCT01573377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433235|NCT01573377|Androgen Antagonists|androgen antagonists|mesh-ancestor
92188782|NCT01393964|Immunologic Factors|immunologic factors|mesh-ancestor
92188915|NCT02989311|Iron|iron|mesh-list
92189008|NCT00342355|Antimetabolites|antimetabolites|mesh-ancestor
92189161|NCT01891643|Dexamethasone|dexamethasone|mesh-list
92189382|NCT00320749|Gemcitabine|gemcitabine|mesh-list
92189458|NCT00551031|Vaccines|vaccines|mesh-list
92433238|NCT01573377|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92433240|NCT01573468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92433241|NCT01573468|Antimetabolites|antimetabolites|mesh-ancestor
92190215|NCT04524351|Phenserine|phenserine|mesh-list
92190297|NCT00409825|Hormones|hormones|mesh-ancestor
92433242|NCT01573468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433243|NCT01573468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190655|NCT03855371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433244|NCT01573598|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92190881|NCT00384865|Analgesics|analgesics|mesh-ancestor
92433245|NCT01573598|Antidepressive Agents|antidepressive agents|mesh-ancestor
92190951|NCT02078726|Hormones|hormones|mesh-ancestor
92433246|NCT01573598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191100|NCT01423916|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92191177|NCT01423604|Capecitabine|capecitabine|mesh-list
92191252|NCT00374231|Mycophenolic Acid|mycophenolic acid|mesh-list
92191398|NCT00467077|Interferon-alpha|interferon-alpha|mesh-list
92433247|NCT01573598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92433248|NCT01573598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92192149|NCT01396148|Sunitinib|sunitinib|mesh-list
92433249|NCT01573598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192366|NCT00429143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433250|NCT01573598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192517|NCT00535925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192669|NCT03595046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433251|NCT01573598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433252|NCT01573598|Serotonin Agents|serotonin agents|mesh-ancestor
92192901|NCT04406870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92433253|NCT01573598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193047|NCT03590912|Prednisolone|prednisolone|mesh-list
92433254|NCT01573598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92433255|NCT01573598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92193723|NCT04023110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92193883|NCT04193930|Fertility Agents|fertility agents|mesh-ancestor
92433256|NCT01573637|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92194028|NCT04026464|Acetaminophen|acetaminophen|mesh-list
92194183|NCT04025918|Ephedrine|ephedrine|mesh-list
92433258|NCT01573637|Hormone Antagonists|hormone antagonists|mesh-ancestor
92194396|NCT02984930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92194547|NCT04148846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433259|NCT01573637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433260|NCT01573637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433261|NCT01573637|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92433262|NCT01573637|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92433263|NCT01573637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433264|NCT01573663|Dipropizine|dipropizine|mesh-list
92195227|NCT04157985|Pembrolizumab|pembrolizumab|mesh-list
92433265|NCT01573663|Ambroxol|ambroxol|mesh-list
92433266|NCT01573663|Expectorants|expectorants|mesh-ancestor
92433267|NCT01573663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92433268|NCT01573663|Antitussive Agents|antitussive agents|mesh-ancestor
92195820|NCT00578617|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92433271|NCT01573715|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92433272|NCT01573715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92433273|NCT01573715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433274|NCT01573715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433275|NCT01573715|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92196712|NCT01676246|Sensory System Agents|sensory system agents|mesh-ancestor
92433276|NCT01573715|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92433277|NCT01573715|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92433278|NCT01573715|Cholinergic Agents|cholinergic agents|mesh-ancestor
92197251|NCT02510300|Sofosbuvir|sofosbuvir|mesh-list
92433279|NCT01573715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197484|NCT03749018|Glucocorticoids|glucocorticoids|mesh-ancestor
92433280|NCT01573715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433283|NCT01573741|Sensory System Agents|sensory system agents|mesh-ancestor
92433284|NCT01573741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433285|NCT01573741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433286|NCT01573741|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92433287|NCT01573741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92433288|NCT01573741|Anesthetics, General|anesthetics, general|mesh-ancestor
92433289|NCT01573741|Anesthetics|anesthetics|mesh-ancestor
92433291|NCT01573741|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92433292|NCT01573741|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92199121|NCT05220917|Incretins|incretins|mesh-ancestor
92433293|NCT01573741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199569|NCT00571493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433294|NCT01573741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433295|NCT01573806|Exenatide|exenatide|mesh-list
92433296|NCT01573806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199794|NCT00751777|Vaccines|vaccines|mesh-list
92199869|NCT05734911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199943|NCT00574067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433297|NCT01573806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433298|NCT01573806|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92433300|NCT01573806|Hormones|hormones|mesh-ancestor
92433301|NCT01573806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433302|NCT01573975|Clarithromycin|clarithromycin|mesh-list
92433303|NCT01573975|Rabeprazole|rabeprazole|mesh-list
92433304|NCT01573975|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92433305|NCT01573975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433306|NCT01573975|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92433307|NCT01573975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433308|NCT01573975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433309|NCT01573975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433310|NCT01573975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433311|NCT01573975|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92433312|NCT01573975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92433313|NCT01573975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92433314|NCT01574014|Hydrocortisone|hydrocortisone|mesh-list
92433315|NCT01574014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433316|NCT01574027|Vitamin D|vitamin d|mesh-list
92433317|NCT01574027|Cholecalciferol|cholecalciferol|mesh-list
92433318|NCT01574027|Vitamins|vitamins|mesh-ancestor
92433319|NCT01574027|Micronutrients|micronutrients|mesh-ancestor
92433320|NCT01574027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433321|NCT01574027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433322|NCT01574027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433323|NCT01574092|Irinotecan|irinotecan|mesh-list
92433324|NCT01574092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433325|NCT01574092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92433326|NCT01574092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92433327|NCT01574092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433328|NCT01574092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433329|NCT01574131|Fenofibrate|fenofibrate|mesh-list
92433330|NCT01574131|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92433331|NCT01574131|Antimetabolites|antimetabolites|mesh-ancestor
92433332|NCT01574131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433333|NCT01574131|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92433334|NCT01574261|Inositol|inositol|mesh-list
92433335|NCT01574261|Vitamin B Complex|vitamin b complex|mesh-ancestor
92433336|NCT01574261|Vitamins|vitamins|mesh-ancestor
92433337|NCT01574261|Micronutrients|micronutrients|mesh-ancestor
92433338|NCT01574261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433339|NCT01574313|Tocopherols|tocopherols|mesh-list
92433340|NCT01574313|Vitamin E|vitamin e|mesh-list
92433341|NCT01574313|Tocotrienols|tocotrienols|mesh-list
92433342|NCT01574313|alpha-Tocopherol|alpha-tocopherol|mesh-list
92433343|NCT01574313|Niacin|niacin|mesh-list
92433344|NCT01574313|Diphenidol|diphenidol|mesh-list
92433345|NCT01574313|Antioxidants|antioxidants|mesh-ancestor
92433346|NCT01574313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433347|NCT01574313|Protective Agents|protective agents|mesh-ancestor
92433348|NCT01574313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433349|NCT01574313|Vitamins|vitamins|mesh-ancestor
92433350|NCT01574313|Micronutrients|micronutrients|mesh-ancestor
92433351|NCT01574313|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92433352|NCT01574313|Antimetabolites|antimetabolites|mesh-ancestor
92433353|NCT01574313|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92158075|NCT05853263|Analgesics|analgesics|mesh-ancestor
92433354|NCT01574313|Vasodilator Agents|vasodilator agents|mesh-ancestor
92433355|NCT01574313|Vitamin B Complex|vitamin b complex|mesh-ancestor
92433356|NCT01574313|Antiemetics|antiemetics|mesh-ancestor
92433357|NCT01574313|Autonomic Agents|autonomic agents|mesh-ancestor
92433358|NCT01574313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433359|NCT01574313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433361|NCT01574508|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92433362|NCT01574508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433363|NCT01574508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433364|NCT01574638|Rifapentine|rifapentine|mesh-list
92433365|NCT01574638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92433366|NCT01574638|Antitubercular Agents|antitubercular agents|mesh-ancestor
92433367|NCT01574638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433368|NCT01574638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433369|NCT01574638|Leprostatic Agents|leprostatic agents|mesh-ancestor
92433370|NCT01574742|Minocycline|minocycline|mesh-list
92433371|NCT01574742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433372|NCT01574742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433373|NCT01574820|Rosiglitazone|rosiglitazone|mesh-list
92433374|NCT01574820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433375|NCT01574820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433376|NCT01575158|Citalopram|citalopram|mesh-list
92433377|NCT01575158|Clomipramine|clomipramine|mesh-list
92433378|NCT01575158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92433379|NCT01575158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92433380|NCT01575158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433381|NCT01575158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433382|NCT01575158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433383|NCT01575158|Serotonin Agents|serotonin agents|mesh-ancestor
92433384|NCT01575158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433385|NCT01575158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92433386|NCT01575158|Antidepressive Agents|antidepressive agents|mesh-ancestor
92433387|NCT01575158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92433388|NCT01575158|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92433389|NCT01575236|Chlorhexidine|chlorhexidine|mesh-list
92433390|NCT01575236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92433391|NCT01575236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433392|NCT01575236|Disinfectants|disinfectants|mesh-ancestor
92433393|NCT01575301|Liraglutide|liraglutide|mesh-list
92433394|NCT01575301|Exenatide|exenatide|mesh-list
92433395|NCT01575301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433396|NCT01575301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433397|NCT01575301|Incretins|incretins|mesh-ancestor
92433398|NCT01575301|Hormones|hormones|mesh-ancestor
92433399|NCT01575301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433400|NCT01575301|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92433401|NCT01575405|Tenofovir|tenofovir|mesh-list
92433402|NCT01575405|Glycerol|glycerol|mesh-list
92433403|NCT01575405|Antiviral Agents|antiviral agents|mesh-ancestor
92433404|NCT01575405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433405|NCT01575405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92433406|NCT01575405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92433407|NCT01575405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433408|NCT01575405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433409|NCT01575405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92433410|NCT01575405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92433411|NCT01575405|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92433412|NCT01575405|Protective Agents|protective agents|mesh-ancestor
92433413|NCT01575405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433414|NCT01575418|Tenofovir|tenofovir|mesh-list
92433415|NCT01575418|Glycerol|glycerol|mesh-list
92433416|NCT01575418|Antiviral Agents|antiviral agents|mesh-ancestor
92433417|NCT01575418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433418|NCT01575418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92433419|NCT01575418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92433420|NCT01575418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433421|NCT01575418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433422|NCT01575418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92433423|NCT01575418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92433424|NCT01575418|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92433425|NCT01575418|Protective Agents|protective agents|mesh-ancestor
92433426|NCT01575418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433427|NCT01575483|Saxagliptin|saxagliptin|mesh-list
92433429|NCT01575483|Hormones|hormones|mesh-ancestor
92433430|NCT01575483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433431|NCT01575483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158155|NCT05851976|Naproxen|naproxen|mesh-list
92433432|NCT01575483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92433433|NCT01575483|Protease Inhibitors|protease inhibitors|mesh-ancestor
92433434|NCT01575483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433435|NCT01575483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433436|NCT01575483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433437|NCT01575509|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92433438|NCT01575613|Lumefantrine|lumefantrine|mesh-list
92433439|NCT01575613|Artemether|artemether|mesh-list
92433440|NCT01575613|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92433441|NCT01575613|Antimalarials|antimalarials|mesh-ancestor
92433442|NCT01575613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92433443|NCT01575613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92433444|NCT01575613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433445|NCT01575626|Sevoflurane|sevoflurane|mesh-list
92433446|NCT01575626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92433447|NCT01575626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92433448|NCT01575626|Anesthetics, General|anesthetics, general|mesh-ancestor
92433449|NCT01575626|Anesthetics|anesthetics|mesh-ancestor
92433450|NCT01575626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433451|NCT01575626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433452|NCT01575639|Prednisolone|prednisolone|mesh-list
92433453|NCT01575639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433454|NCT01575639|Glucocorticoids|glucocorticoids|mesh-ancestor
92433455|NCT01575639|Hormones|hormones|mesh-ancestor
92433456|NCT01575639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433457|NCT01575639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433458|NCT01575639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92433459|NCT01575639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433460|NCT01575652|Lisinopril|lisinopril|mesh-list
92433461|NCT01575652|Perindopril|perindopril|mesh-list
92433462|NCT01575652|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92433463|NCT01575652|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92433464|NCT01575652|Protease Inhibitors|protease inhibitors|mesh-ancestor
92433465|NCT01575652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433466|NCT01575652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92433467|NCT01575652|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92433468|NCT01575652|Protective Agents|protective agents|mesh-ancestor
92433469|NCT01575652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433470|NCT01575678|Melatonin|melatonin|mesh-list
92433471|NCT01575678|Antioxidants|antioxidants|mesh-ancestor
92433472|NCT01575678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433473|NCT01575678|Protective Agents|protective agents|mesh-ancestor
92433474|NCT01575678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433475|NCT01575678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433476|NCT01575717|Vitamin D|vitamin d|mesh-list
92433477|NCT01575717|Ergocalciferols|ergocalciferols|mesh-list
92433478|NCT01575717|Cholecalciferol|cholecalciferol|mesh-list
92433479|NCT01575717|Vitamins|vitamins|mesh-list
92433480|NCT01575717|Micronutrients|micronutrients|mesh-ancestor
92433481|NCT01575717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433482|NCT01575717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433483|NCT01575717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433484|NCT01575782|Chloroquine|chloroquine|mesh-list
92433485|NCT01575782|Amebicides|amebicides|mesh-ancestor
92433486|NCT01575782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92433487|NCT01575782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92433488|NCT01575782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433489|NCT01575782|Antimalarials|antimalarials|mesh-ancestor
92433490|NCT01575782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92433491|NCT01575795|Ticagrelor|ticagrelor|mesh-list
92433492|NCT01575795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92433493|NCT01575795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92433494|NCT01575795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92433495|NCT01575795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92433496|NCT01575795|Purinergic Agents|purinergic agents|mesh-ancestor
92433497|NCT01575795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343394|NCT00004787|Lenograstim|lenograstim|mesh-list
92433498|NCT01575795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433499|NCT01575795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433500|NCT01576029|Docetaxel|docetaxel|mesh-list
92433501|NCT01576029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433502|NCT01576029|Tubulin Modulators|tubulin modulators|mesh-ancestor
92433503|NCT01576029|Antimitotic Agents|antimitotic agents|mesh-ancestor
92433504|NCT01576029|Mitosis Modulators|mitosis modulators|mesh-ancestor
92433505|NCT01576029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433506|NCT01576094|Simendan|simendan|mesh-list
92433507|NCT01576094|Milrinone|milrinone|mesh-list
92433508|NCT01576094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92433509|NCT01576094|Vasodilator Agents|vasodilator agents|mesh-ancestor
92433510|NCT01576094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92433511|NCT01576094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92433512|NCT01576094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433513|NCT01576094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433514|NCT01576094|Protective Agents|protective agents|mesh-ancestor
92433515|NCT01576094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433516|NCT01576094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92433518|NCT01576185|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92433519|NCT01576185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433520|NCT01576185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92433521|NCT01576185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433522|NCT01576185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433523|NCT01576263|Ropivacaine|ropivacaine|mesh-list
92433524|NCT01576263|Anesthetics, Local|anesthetics, local|mesh-ancestor
92433525|NCT01576263|Anesthetics|anesthetics|mesh-ancestor
92433526|NCT01576263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433527|NCT01576263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433528|NCT01576263|Sensory System Agents|sensory system agents|mesh-ancestor
92433529|NCT01576263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433530|NCT01576354|4-Aminopyridine|4-aminopyridine|mesh-list
92433531|NCT01576354|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92433532|NCT01576354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433533|NCT01576354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433534|NCT01576419|Celecoxib|celecoxib|mesh-list
92433535|NCT01576419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92433536|NCT01576419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433537|NCT01576419|Analgesics|analgesics|mesh-ancestor
92433538|NCT01576419|Sensory System Agents|sensory system agents|mesh-ancestor
92433539|NCT01576419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433540|NCT01576419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433541|NCT01576419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433542|NCT01576419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92433543|NCT01576419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92433544|NCT01576419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92433545|NCT01576419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433546|NCT01576419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433547|NCT01576458|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92433548|NCT01576458|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92433549|NCT01576458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433550|NCT01576627|Zinc|zinc|mesh-list
92433551|NCT01576627|Zinc Oxide|zinc oxide|mesh-list
92433552|NCT01576627|Trace Elements|trace elements|mesh-ancestor
92433553|NCT01576627|Micronutrients|micronutrients|mesh-ancestor
92433554|NCT01576627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433555|NCT01576627|Dermatologic Agents|dermatologic agents|mesh-ancestor
92433556|NCT01576627|Sunscreening Agents|sunscreening agents|mesh-ancestor
92433557|NCT01576627|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92433558|NCT01576627|Protective Agents|protective agents|mesh-ancestor
92433559|NCT01576640|Bupropion|bupropion|mesh-list
92433560|NCT01576640|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92433561|NCT01576640|Antidepressive Agents|antidepressive agents|mesh-ancestor
92433562|NCT01576640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92433563|NCT01576640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92433564|NCT01576640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92433565|NCT01576640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433566|NCT01576640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433567|NCT01576640|Dopamine Agents|dopamine agents|mesh-ancestor
92433568|NCT01576640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433569|NCT01576640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433570|NCT01576640|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92433571|NCT01576640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92433572|NCT01576640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433573|NCT01576679|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92200040|NCT00580073|Cetuximab|cetuximab|mesh-list
92433574|NCT01576679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92433575|NCT01576679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92433576|NCT01576679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433577|NCT01576692|Aldesleukin|aldesleukin|mesh-list
92433578|NCT01576692|Antibodies|antibodies|mesh-list
92433579|NCT01576692|Immunoglobulins|immunoglobulins|mesh-list
92433580|NCT01576692|Sargramostim|sargramostim|mesh-list
92433582|NCT01576692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433583|NCT01576692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433584|NCT01576692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92433585|NCT01576692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92433586|NCT01576692|Antiviral Agents|antiviral agents|mesh-ancestor
92433587|NCT01576692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433588|NCT01576731|Tenofovir|tenofovir|mesh-list
92433589|NCT01576731|Emtricitabine|emtricitabine|mesh-list
92433590|NCT01576731|Lopinavir|lopinavir|mesh-list
92433591|NCT01576731|Raltegravir Potassium|raltegravir potassium|mesh-list
92433592|NCT01576731|Antiviral Agents|antiviral agents|mesh-ancestor
92433593|NCT01576731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433594|NCT01576731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92433595|NCT01576731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92433596|NCT01576731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433597|NCT01576731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433598|NCT01576731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92433599|NCT01576731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92433600|NCT01576731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92433601|NCT01576731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92433602|NCT01576731|Protease Inhibitors|protease inhibitors|mesh-ancestor
92433603|NCT01576731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92433604|NCT01576731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92433605|NCT01576731|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92433606|NCT01576731|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92433607|NCT01576770|Lidocaine|lidocaine|mesh-list
92433608|NCT01576770|Tetracaine|tetracaine|mesh-list
92433609|NCT01576770|Ethyl Chloride|ethyl chloride|mesh-list
92433610|NCT01576770|Anesthetics, Local|anesthetics, local|mesh-ancestor
92433611|NCT01576770|Anesthetics|anesthetics|mesh-ancestor
92433612|NCT01576770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433613|NCT01576770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433614|NCT01576770|Sensory System Agents|sensory system agents|mesh-ancestor
92433615|NCT01576770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433616|NCT01576770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92433617|NCT01576770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92433618|NCT01576770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92433619|NCT01576770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433620|NCT01576770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433621|NCT01576848|Caseins|caseins|mesh-list
92433622|NCT01576848|Chelating Agents|chelating agents|mesh-ancestor
92433623|NCT01576848|Sequestering Agents|sequestering agents|mesh-ancestor
92433624|NCT01576848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433625|NCT01577017|Letrozole|letrozole|mesh-list
92433626|NCT01577017|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92433627|NCT01577017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433628|NCT01577017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92433630|NCT01577017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433631|NCT01577017|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92433632|NCT01577017|Hormone Antagonists|hormone antagonists|mesh-ancestor
92433633|NCT01577017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433634|NCT01577017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433635|NCT01577043|Racecadotril|racecadotril|mesh-list
92433636|NCT01577043|Antidiarrheals|antidiarrheals|mesh-ancestor
92433637|NCT01577043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433638|NCT01577043|Protease Inhibitors|protease inhibitors|mesh-ancestor
92433639|NCT01577043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433640|NCT01577043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433641|NCT01577121|Indomethacin|indomethacin|mesh-list
92433642|NCT01577121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92433643|NCT01577121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433644|NCT01577121|Analgesics|analgesics|mesh-ancestor
92433645|NCT01577121|Sensory System Agents|sensory system agents|mesh-ancestor
92433646|NCT01577121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433647|NCT01577121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433648|NCT01577121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433649|NCT01577121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92433650|NCT01577121|Gout Suppressants|gout suppressants|mesh-ancestor
92433651|NCT01577121|Tocolytic Agents|tocolytic agents|mesh-ancestor
92433652|NCT01577121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92433653|NCT01577121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92433654|NCT01577121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433655|NCT01577121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433657|NCT01577095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92433658|NCT01577095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433659|NCT01577199|Clomiphene|clomiphene|mesh-list
92433660|NCT01577199|Enclomiphene|enclomiphene|mesh-list
92433661|NCT01577199|Zuclomiphene|zuclomiphene|mesh-list
92433662|NCT01577199|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92433663|NCT01577199|Hormone Antagonists|hormone antagonists|mesh-ancestor
92433664|NCT01577199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433665|NCT01577199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433666|NCT01577199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92433667|NCT01577199|Fertility Agents|fertility agents|mesh-ancestor
92433668|NCT01577199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92433669|NCT01577199|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92433670|NCT01577199|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92433671|NCT01577342|Moxifloxacin|moxifloxacin|mesh-list
92433672|NCT01577342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433673|NCT01577342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433674|NCT01577342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92433675|NCT01577342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92433676|NCT01577342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433677|NCT01577342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433678|NCT01577342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433679|NCT01577368|Tazobactam|tazobactam|mesh-list
92433680|NCT01577368|Piperacillin|piperacillin|mesh-list
92433681|NCT01577368|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92433682|NCT01577368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433683|NCT01577368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433684|NCT01577368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92433685|NCT01577368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433686|NCT01577368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433687|NCT01577407|Nefopam|nefopam|mesh-list
92433688|NCT01577407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433689|NCT01577407|Analgesics|analgesics|mesh-ancestor
92433690|NCT01577407|Sensory System Agents|sensory system agents|mesh-ancestor
92433691|NCT01577407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433692|NCT01577407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433693|NCT01577459|Tedizolid phosphate|tedizolid phosphate|mesh-list
92433694|NCT01577459|Tedizolid|tedizolid|mesh-list
92433695|NCT01577459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433696|NCT01577459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433697|NCT01577524|Povidone-Iodine|povidone-iodine|mesh-list
92433698|NCT01577524|Povidone|povidone|mesh-list
92433699|NCT01577524|Plasma Substitutes|plasma substitutes|mesh-ancestor
92531028|NCT00018174|Serotonin Agents|serotonin agents|mesh-ancestor
92433700|NCT01577524|Blood Substitutes|blood substitutes|mesh-ancestor
92433701|NCT01577524|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92433702|NCT01577524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433703|NCT01577550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92433704|NCT01577550|Immunologic Factors|immunologic factors|mesh-ancestor
92433705|NCT01577550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433706|NCT01577589|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92433708|NCT01577589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433709|NCT01577589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433710|NCT01577693|Dutasteride|dutasteride|mesh-list
92433711|NCT01577693|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92433712|NCT01577693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92433713|NCT01577693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433714|NCT01577693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433715|NCT01577693|Hormone Antagonists|hormone antagonists|mesh-ancestor
92433716|NCT01577693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433717|NCT01577693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433718|NCT01577771|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92433719|NCT01577771|Immunologic Factors|immunologic factors|mesh-ancestor
92433720|NCT01577771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433721|NCT01577849|Vitamin D|vitamin d|mesh-list
92433722|NCT01577849|Cholecalciferol|cholecalciferol|mesh-list
92433723|NCT01577849|Vitamins|vitamins|mesh-ancestor
92433724|NCT01577849|Micronutrients|micronutrients|mesh-ancestor
92433725|NCT01577849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433726|NCT01577849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433727|NCT01577849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433728|NCT01577862|Rifampin|rifampin|mesh-list
92158447|NCT05477108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433729|NCT01577862|Colistin|colistin|mesh-list
92433730|NCT01577862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92433731|NCT01577862|Antitubercular Agents|antitubercular agents|mesh-ancestor
92433732|NCT01577862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92433733|NCT01577862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433734|NCT01577862|Leprostatic Agents|leprostatic agents|mesh-ancestor
92433735|NCT01577862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92433736|NCT01577862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433737|NCT01577862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433738|NCT01577862|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92433739|NCT01577862|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92433740|NCT01577862|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92433741|NCT01577862|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92433742|NCT01577862|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92433743|NCT01577862|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92433744|NCT01577914|Carvedilol|carvedilol|mesh-list
92433745|NCT01577914|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92433746|NCT01577914|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92433747|NCT01577914|Adrenergic Agents|adrenergic agents|mesh-ancestor
92433748|NCT01577914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433749|NCT01577914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433750|NCT01577914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433751|NCT01577914|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92433752|NCT01577914|Antioxidants|antioxidants|mesh-ancestor
92433753|NCT01577914|Protective Agents|protective agents|mesh-ancestor
92433754|NCT01577914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92433755|NCT01577914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433756|NCT01577914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433757|NCT01577914|Vasodilator Agents|vasodilator agents|mesh-ancestor
92433758|NCT01577914|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92433759|NCT01577914|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92433760|NCT01577940|Ropivacaine|ropivacaine|mesh-list
92433761|NCT01577940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92433762|NCT01577940|Anesthetics|anesthetics|mesh-ancestor
92433763|NCT01577940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433764|NCT01577940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433765|NCT01577940|Sensory System Agents|sensory system agents|mesh-ancestor
92433766|NCT01577940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433767|NCT01577992|Levodopa|levodopa|mesh-list
92433768|NCT01577992|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92433769|NCT01577992|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92433770|NCT01577992|Dopamine Agents|dopamine agents|mesh-ancestor
92146891|NCT00084253|Ritonavir|ritonavir|mesh-list
92433771|NCT01577992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433772|NCT01577992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433773|NCT01577992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433774|NCT01578057|Ethanol|ethanol|mesh-list
92433775|NCT01578057|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92433776|NCT01578057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433777|NCT01578057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433778|NCT01578057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433779|NCT01578070|Salicylic Acid|salicylic acid|mesh-list
92433780|NCT01578070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92433781|NCT01578070|Antifungal Agents|antifungal agents|mesh-ancestor
92433782|NCT01578070|Keratolytic Agents|keratolytic agents|mesh-ancestor
92433783|NCT01578070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92433784|NCT01578109|Sorafenib|sorafenib|mesh-list
92433785|NCT01578109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433786|NCT01578109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92433787|NCT01578109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433788|NCT01578109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433789|NCT01578161|Dexmedetomidine|dexmedetomidine|mesh-list
92433790|NCT01578161|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92433791|NCT01578161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433792|NCT01578161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433793|NCT01578161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433794|NCT01578161|Analgesics|analgesics|mesh-ancestor
92433795|NCT01578161|Sensory System Agents|sensory system agents|mesh-ancestor
92433796|NCT01578161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433797|NCT01578161|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92433798|NCT01578161|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92433799|NCT01578161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92433800|NCT01578161|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158523|NCT05368753|Lidocaine|lidocaine|mesh-list
92433801|NCT01578161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433802|NCT01578161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433803|NCT01578174|Dexmedetomidine|dexmedetomidine|mesh-list
92433804|NCT01578174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92433805|NCT01578174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92433806|NCT01578174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433807|NCT01578174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433808|NCT01578174|Analgesics|analgesics|mesh-ancestor
92433809|NCT01578174|Sensory System Agents|sensory system agents|mesh-ancestor
92433810|NCT01578174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343461|NCT00385385|KRM 1648|krm 1648|mesh-list
92433811|NCT01578174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92433812|NCT01578174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92433813|NCT01578174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92433814|NCT01578174|Adrenergic Agents|adrenergic agents|mesh-ancestor
92433815|NCT01578174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433816|NCT01578174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433817|NCT01578200|Calcium Carbonate|calcium carbonate|mesh-list
92433818|NCT01578200|Calcium|calcium|mesh-list
92433819|NCT01578200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433820|NCT01578200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433821|NCT01578200|Antacids|antacids|mesh-ancestor
92433822|NCT01578200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433823|NCT01578200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433824|NCT01578213|Imatinib Mesylate|imatinib mesylate|mesh-list
92433825|NCT01578213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433826|NCT01578213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92433827|NCT01578213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433828|NCT01578213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433829|NCT01578252|Ondansetron|ondansetron|mesh-list
92433830|NCT01578252|Antiemetics|antiemetics|mesh-ancestor
92433831|NCT01578252|Autonomic Agents|autonomic agents|mesh-ancestor
92433832|NCT01578252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433833|NCT01578252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433834|NCT01578252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433835|NCT01578252|Antipruritics|antipruritics|mesh-ancestor
92433836|NCT01578252|Dermatologic Agents|dermatologic agents|mesh-ancestor
92433837|NCT01578252|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92433838|NCT01578252|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92433839|NCT01578252|Serotonin Agents|serotonin agents|mesh-ancestor
92433840|NCT01578252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433841|NCT01578252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433843|NCT01578265|Antiemetics|antiemetics|mesh-ancestor
92433844|NCT01578265|Autonomic Agents|autonomic agents|mesh-ancestor
92433845|NCT01578265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433846|NCT01578265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433847|NCT01578265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433848|NCT01578265|Antipruritics|antipruritics|mesh-ancestor
92433849|NCT01578265|Dermatologic Agents|dermatologic agents|mesh-ancestor
92433850|NCT01578265|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92433851|NCT01578265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92433852|NCT01578265|Serotonin Agents|serotonin agents|mesh-ancestor
92433853|NCT01578265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433854|NCT01578265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433855|NCT01578304|Fesoterodine|fesoterodine|mesh-list
92433856|NCT01578304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92433857|NCT01578304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92433858|NCT01578304|Cholinergic Agents|cholinergic agents|mesh-ancestor
92433859|NCT01578304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92433860|NCT01578304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433861|NCT01578304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433862|NCT01578304|Urological Agents|urological agents|mesh-ancestor
92433863|NCT01578343|Dexamethasone|dexamethasone|mesh-list
92433864|NCT01578343|Dexamethasone acetate|dexamethasone acetate|mesh-list
92433865|NCT01578343|Fludarabine|fludarabine|mesh-list
92433866|NCT01578343|Fludarabine phosphate|fludarabine phosphate|mesh-list
92433867|NCT01578343|Mitoxantrone|mitoxantrone|mesh-list
92433868|NCT01578343|Vorinostat|vorinostat|mesh-list
92433869|NCT01578343|BB 1101|bb 1101|mesh-list
92433870|NCT01578343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433871|NCT01578343|Antiemetics|antiemetics|mesh-ancestor
92433872|NCT01578343|Autonomic Agents|autonomic agents|mesh-ancestor
92433873|NCT01578343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433874|NCT01578343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433875|NCT01578343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433876|NCT01578343|Glucocorticoids|glucocorticoids|mesh-ancestor
92433878|NCT01578343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433879|NCT01578343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92433880|NCT01578343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433881|NCT01578343|Protease Inhibitors|protease inhibitors|mesh-ancestor
92433882|NCT01578343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433883|NCT01578343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433884|NCT01578343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92433885|NCT01578343|Antimetabolites|antimetabolites|mesh-ancestor
92433886|NCT01578343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92433887|NCT01578343|Immunologic Factors|immunologic factors|mesh-ancestor
92433888|NCT01578343|Analgesics|analgesics|mesh-ancestor
92433889|NCT01578343|Sensory System Agents|sensory system agents|mesh-ancestor
92433890|NCT01578343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92433891|NCT01578343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92433892|NCT01578343|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92433893|NCT01578434|Calcium, Dietary|calcium, dietary|mesh-list
92433894|NCT01578434|Vitamin D|vitamin d|mesh-list
92433895|NCT01578434|Ergocalciferols|ergocalciferols|mesh-list
92433896|NCT01578434|Cholecalciferol|cholecalciferol|mesh-list
92433897|NCT01578434|Vitamins|vitamins|mesh-list
92433898|NCT01578434|Calcium Carbonate|calcium carbonate|mesh-list
92433899|NCT01578434|Calcium|calcium|mesh-list
92433900|NCT01578434|Micronutrients|micronutrients|mesh-ancestor
92433901|NCT01578434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433902|NCT01578434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433903|NCT01578434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433904|NCT01578434|Antacids|antacids|mesh-ancestor
92433905|NCT01578434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433906|NCT01578434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92433907|NCT01578447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92433908|NCT01578447|Medroxyprogesterone|medroxyprogesterone|mesh-list
92433909|NCT01578447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92433910|NCT01578447|Contraceptive Agents|contraceptive agents|mesh-ancestor
92433911|NCT01578447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92531032|NCT00018174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92433912|NCT01578447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433913|NCT01578447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92433914|NCT01578447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92433915|NCT01578447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92433917|NCT01578447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92433918|NCT01578447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92433919|NCT01578447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92433920|NCT01578473|Vitamin D|vitamin d|mesh-list
92433921|NCT01578473|Ergocalciferols|ergocalciferols|mesh-list
92433922|NCT01578473|Vitamins|vitamins|mesh-list
92433923|NCT01578473|Vitamin E|vitamin e|mesh-list
92433924|NCT01578473|Methyltestosterone|methyltestosterone|mesh-list
92433925|NCT01578473|Testosterone|testosterone|mesh-list
92433926|NCT01578473|Testosterone undecanoate|testosterone undecanoate|mesh-list
92433927|NCT01578473|Testosterone enanthate|testosterone enanthate|mesh-list
92433928|NCT01578473|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92433929|NCT01578473|Micronutrients|micronutrients|mesh-ancestor
92433930|NCT01578473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433931|NCT01578473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92433932|NCT01578473|Androgens|androgens|mesh-ancestor
92433933|NCT01578473|Hormones|hormones|mesh-ancestor
92433934|NCT01578473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92433935|NCT01578473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92433936|NCT01578473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433937|NCT01578473|Anabolic Agents|anabolic agents|mesh-ancestor
92433938|NCT01578473|Antioxidants|antioxidants|mesh-ancestor
92433939|NCT01578473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433940|NCT01578473|Protective Agents|protective agents|mesh-ancestor
92433941|NCT01578473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433942|NCT01578564|SOR-C13|sor-c13|mesh-list
92433943|NCT01578564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433944|NCT01578564|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92433945|NCT01578564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92433946|NCT01578564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433947|NCT01578564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433949|NCT01578603|Calcium|calcium|mesh-list
92433950|NCT01578603|Caseins|caseins|mesh-list
92433951|NCT01578603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92433952|NCT01578603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433953|NCT01578603|Chelating Agents|chelating agents|mesh-ancestor
92433954|NCT01578603|Sequestering Agents|sequestering agents|mesh-ancestor
92433955|NCT01578603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433956|NCT01578629|Aspirin|aspirin|mesh-list
92433957|NCT01578629|Vitamin E|vitamin e|mesh-list
92433958|NCT01578629|Tocopherols|tocopherols|mesh-list
92433959|NCT01578629|Tocotrienols|tocotrienols|mesh-list
92433960|NCT01578629|Vitamins|vitamins|mesh-ancestor
92433961|NCT01578629|Micronutrients|micronutrients|mesh-ancestor
92433962|NCT01578629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433963|NCT01578629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92433964|NCT01578629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92433965|NCT01578629|Analgesics|analgesics|mesh-ancestor
92433966|NCT01578629|Sensory System Agents|sensory system agents|mesh-ancestor
92433967|NCT01578629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433968|NCT01578629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92433969|NCT01578629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92433970|NCT01578629|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92433971|NCT01578629|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92433972|NCT01578629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433973|NCT01578629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92433974|NCT01578629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92433975|NCT01578629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433976|NCT01578629|Antipyretics|antipyretics|mesh-ancestor
92433977|NCT01578629|Antioxidants|antioxidants|mesh-ancestor
92433978|NCT01578629|Protective Agents|protective agents|mesh-ancestor
92433979|NCT01578668|Pemetrexed|pemetrexed|mesh-list
92433980|NCT01578668|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92433981|NCT01578668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433982|NCT01578668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92433983|NCT01578668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92433984|NCT01578668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92433985|NCT01578668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92433986|NCT01578668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92433987|NCT01578720|Aflibercept|aflibercept|mesh-list
92433988|NCT01578720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92433989|NCT01578720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92433990|NCT01578720|Growth Substances|growth substances|mesh-ancestor
92433991|NCT01578720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433992|NCT01578720|Growth Inhibitors|growth inhibitors|mesh-ancestor
92433993|NCT01578720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92433994|NCT01578824|Methacholine Chloride|methacholine chloride|mesh-list
92433995|NCT01578824|Miotics|miotics|mesh-ancestor
92433996|NCT01578824|Autonomic Agents|autonomic agents|mesh-ancestor
92433997|NCT01578824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92433998|NCT01578824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92433999|NCT01578824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92434000|NCT01578824|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92434001|NCT01578824|Respiratory System Agents|respiratory system agents|mesh-ancestor
92434002|NCT01578824|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92434003|NCT01578824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92434004|NCT01578824|Cholinergic Agents|cholinergic agents|mesh-ancestor
92434005|NCT01578824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434006|NCT01578824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434007|NCT01578889|Vaccines|vaccines|mesh-list
92434008|NCT01578889|Immunologic Factors|immunologic factors|mesh-ancestor
92434009|NCT01578889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434010|NCT01578928|Pasireotide|pasireotide|mesh-list
92434011|NCT01578928|Hormones|hormones|mesh-ancestor
92434012|NCT01578928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434013|NCT01578928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434014|NCT01579019|Ritonavir|ritonavir|mesh-list
92434015|NCT01579019|Ribavirin|ribavirin|mesh-list
92434016|NCT01579019|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92434017|NCT01579019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92434018|NCT01579019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92434019|NCT01579019|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434020|NCT01579019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434021|NCT01579019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434022|NCT01579019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92434023|NCT01579019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92434024|NCT01579019|Antiviral Agents|antiviral agents|mesh-ancestor
92434025|NCT01579019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434026|NCT01579019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92434027|NCT01579019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92434028|NCT01579019|Antimetabolites|antimetabolites|mesh-ancestor
92434029|NCT01579058|Bisoprolol|bisoprolol|mesh-list
92434030|NCT01579058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92434031|NCT01579058|Sympatholytics|sympatholytics|mesh-ancestor
92434032|NCT01579058|Autonomic Agents|autonomic agents|mesh-ancestor
92434033|NCT01579058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434034|NCT01579058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434035|NCT01579058|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92434036|NCT01579058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92434037|NCT01579058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92434038|NCT01579058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92434039|NCT01579058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434040|NCT01579058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434041|NCT01579110|Levamisole|levamisole|mesh-list
92434042|NCT01579110|Prednisone|prednisone|mesh-list
92434043|NCT01579110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434044|NCT01579110|Glucocorticoids|glucocorticoids|mesh-ancestor
92434045|NCT01579110|Hormones|hormones|mesh-ancestor
92434046|NCT01579110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434047|NCT01579110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434048|NCT01579110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92434049|NCT01579110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434050|NCT01579110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92434051|NCT01579110|Immunologic Factors|immunologic factors|mesh-ancestor
92434052|NCT01579110|Antinematodal Agents|antinematodal agents|mesh-ancestor
92434053|NCT01579110|Anthelmintics|anthelmintics|mesh-ancestor
92434054|NCT01579110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92434055|NCT01579110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434056|NCT01579110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434057|NCT01579149|Plerixafor|plerixafor|mesh-list
92434058|NCT01579149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92434059|NCT01579149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92434060|NCT01579149|Antiviral Agents|antiviral agents|mesh-ancestor
92434061|NCT01579149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434063|NCT01579201|Oxytocics|oxytocics|mesh-ancestor
92434064|NCT01579201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434065|NCT01579201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434066|NCT01579227|Tamoxifen|tamoxifen|mesh-list
92434067|NCT01579227|Tocotrienols|tocotrienols|mesh-list
92434068|NCT01579227|Vitamin E|vitamin e|mesh-list
92434069|NCT01579227|Tocopherols|tocopherols|mesh-list
92434070|NCT01579227|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92434071|NCT01579227|Hormone Antagonists|hormone antagonists|mesh-ancestor
92434072|NCT01579227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434073|NCT01579227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434074|NCT01579227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343496|NCT00005585|Leucovorin|leucovorin|mesh-list
92434075|NCT01579227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434076|NCT01579227|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92434077|NCT01579227|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92434078|NCT01579227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92434079|NCT01579227|Antioxidants|antioxidants|mesh-ancestor
92434080|NCT01579227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434081|NCT01579227|Protective Agents|protective agents|mesh-ancestor
92434082|NCT01579227|Vitamins|vitamins|mesh-ancestor
92434083|NCT01579227|Micronutrients|micronutrients|mesh-ancestor
92434084|NCT01579279|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92434085|NCT01579279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92434086|NCT01579279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92434087|NCT01579279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92434088|NCT01579279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434089|NCT01579279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434090|NCT01579279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434091|NCT01579279|Analgesics|analgesics|mesh-ancestor
92434092|NCT01579279|Sensory System Agents|sensory system agents|mesh-ancestor
92158820|NCT04977453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158821|NCT04977453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158822|NCT04977453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92158823|NCT04977453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158824|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92158826|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92158827|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434093|NCT01579279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434095|NCT01579279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92434096|NCT01579279|Dopamine Agents|dopamine agents|mesh-ancestor
92434097|NCT01579383|Sumatriptan|sumatriptan|mesh-list
92434098|NCT01579383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92434099|NCT01579383|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92434100|NCT01579383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92434101|NCT01579383|Serotonin Agents|serotonin agents|mesh-ancestor
92434102|NCT01579383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434103|NCT01579383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434104|NCT01579383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434105|NCT01579448|Vaccines|vaccines|mesh-list
92434106|NCT01579448|Immunologic Factors|immunologic factors|mesh-ancestor
92434107|NCT01579448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434108|NCT01579461|Mirabegron|mirabegron|mesh-list
92434109|NCT01579461|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92434110|NCT01579461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92434111|NCT01579461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92434112|NCT01579461|Adrenergic Agents|adrenergic agents|mesh-ancestor
92434113|NCT01579461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434114|NCT01579461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434115|NCT01579461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434116|NCT01579461|Urological Agents|urological agents|mesh-ancestor
92434117|NCT01579500|Botulinum Toxins|botulinum toxins|mesh-list
92434118|NCT01579500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92434119|NCT01579500|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92434120|NCT01579500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92434121|NCT01579500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92434122|NCT01579500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434123|NCT01579500|Cholinergic Agents|cholinergic agents|mesh-ancestor
92434124|NCT01579500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434125|NCT01579500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434126|NCT01579500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92434127|NCT01579500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434128|NCT01579539|Methylprednisolone|methylprednisolone|mesh-list
92434129|NCT01579539|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92434130|NCT01579539|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92434131|NCT01579539|Prednisolone|prednisolone|mesh-list
92434132|NCT01579539|Prednisolone acetate|prednisolone acetate|mesh-list
92434133|NCT01579539|Esomeprazole|esomeprazole|mesh-list
92434134|NCT01579539|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92434135|NCT01579539|Prednisolone phosphate|prednisolone phosphate|mesh-list
92434136|NCT01579539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434137|NCT01579539|Antiemetics|antiemetics|mesh-ancestor
92434138|NCT01579539|Autonomic Agents|autonomic agents|mesh-ancestor
92434139|NCT01579539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434140|NCT01579539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434141|NCT01579539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92434142|NCT01579539|Glucocorticoids|glucocorticoids|mesh-ancestor
92434143|NCT01579539|Hormones|hormones|mesh-ancestor
92434144|NCT01579539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434145|NCT01579539|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92434146|NCT01579539|Protective Agents|protective agents|mesh-ancestor
92434147|NCT01579539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92434148|NCT01579539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434149|NCT01579539|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92434150|NCT01579539|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92434151|NCT01579539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434152|NCT01579539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434153|NCT01579630|Pemetrexed|pemetrexed|mesh-list
92434154|NCT01579630|Gefitinib|gefitinib|mesh-list
92434155|NCT01579630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434156|NCT01579630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434157|NCT01579630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434158|NCT01579630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92434159|NCT01579630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92434160|NCT01579630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92434161|NCT01579695|Tesamorelin|tesamorelin|mesh-list
92434162|NCT01579695|Growth Substances|growth substances|mesh-ancestor
92434163|NCT01579695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434165|NCT01579760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92158896|NCT04801966|Pembrolizumab|pembrolizumab|mesh-list
92434166|NCT01579760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92434167|NCT01579760|Growth Substances|growth substances|mesh-ancestor
92434168|NCT01579760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434169|NCT01579760|Growth Inhibitors|growth inhibitors|mesh-ancestor
92434170|NCT01579760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434172|NCT01579786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434173|NCT01579786|Analgesics|analgesics|mesh-ancestor
92434174|NCT01579786|Sensory System Agents|sensory system agents|mesh-ancestor
92434175|NCT01579786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434176|NCT01579786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434177|NCT01579786|Antipyretics|antipyretics|mesh-ancestor
92434178|NCT01579838|Eculizumab|eculizumab|mesh-list
92434179|NCT01579838|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92434180|NCT01579838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434181|NCT01579838|Immunologic Factors|immunologic factors|mesh-ancestor
92434182|NCT01579838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434183|NCT01579864|Rocuronium|rocuronium|mesh-list
92434184|NCT01579864|Succinylcholine|succinylcholine|mesh-list
92434185|NCT01579864|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92434186|NCT01579864|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92434187|NCT01579864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92434188|NCT01579864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434189|NCT01579864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434190|NCT01579864|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92434191|NCT01579890|Diclofenac|diclofenac|mesh-list
92434192|NCT01579890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92434193|NCT01579890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434194|NCT01579890|Analgesics|analgesics|mesh-ancestor
92434195|NCT01579890|Sensory System Agents|sensory system agents|mesh-ancestor
92434196|NCT01579890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434197|NCT01579890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434198|NCT01579890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434199|NCT01579890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434200|NCT01579890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92434201|NCT01579890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434202|NCT01579890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434203|NCT01579903|Factor VIII|factor viii|mesh-list
92434204|NCT01579903|Coagulants|coagulants|mesh-ancestor
92434205|NCT01579929|Etoposide|etoposide|mesh-list
92434206|NCT01579929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434207|NCT01579929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92434208|NCT01579929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92434209|NCT01579929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92434210|NCT01579929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434211|NCT01579929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434212|NCT01579994|Crizotinib|crizotinib|mesh-list
92434213|NCT01579994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434214|NCT01579994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92434215|NCT01579994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434216|NCT01579994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434217|NCT01580228|Ofatumumab|ofatumumab|mesh-list
92434218|NCT01580228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434219|NCT01581333|Anti-Infective Agents|anti-infective agents|mesh-list
92434220|NCT01581333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92434221|NCT01581359|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92434222|NCT01581359|Luteolytic Agents|luteolytic agents|mesh-ancestor
92434223|NCT01581359|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92434224|NCT01581359|Contraceptive Agents|contraceptive agents|mesh-ancestor
92434225|NCT01581359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434226|NCT01581359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434227|NCT01581359|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92434228|NCT01581359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92434229|NCT01581359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434230|NCT01581476|Quinapril|quinapril|mesh-list
92434231|NCT01581476|Atorvastatin|atorvastatin|mesh-list
92434232|NCT01581476|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92434233|NCT01581476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92434234|NCT01581476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92434235|NCT01581476|Antimetabolites|antimetabolites|mesh-ancestor
92434236|NCT01581476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434237|NCT01581476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92434238|NCT01581476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92158975|NCT04635176|Hormones|hormones|mesh-ancestor
92434239|NCT01581476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434240|NCT01581476|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434241|NCT01581476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92434242|NCT01582321|Cantharidin|cantharidin|mesh-list
92434243|NCT01582321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434244|NCT01582321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434245|NCT01582438|Sildenafil Citrate|sildenafil citrate|mesh-list
92434246|NCT01582438|Citric Acid|citric acid|mesh-list
92434247|NCT01582438|Sodium Citrate|sodium citrate|mesh-list
92434248|NCT01582438|Anticoagulants|anticoagulants|mesh-ancestor
92434249|NCT01582438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92434250|NCT01582438|Chelating Agents|chelating agents|mesh-ancestor
92434251|NCT01582438|Sequestering Agents|sequestering agents|mesh-ancestor
92434252|NCT01582438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434253|NCT01582438|Vasodilator Agents|vasodilator agents|mesh-ancestor
92434254|NCT01582438|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92434255|NCT01582438|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92434256|NCT01582438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434257|NCT01582438|Urological Agents|urological agents|mesh-ancestor
92434258|NCT01582711|Isoniazid|isoniazid|mesh-list
92434259|NCT01582711|Rifapentine|rifapentine|mesh-list
92434260|NCT01582711|Antitubercular Agents|antitubercular agents|mesh-ancestor
92434261|NCT01582711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434262|NCT01582711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434263|NCT01582711|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92434264|NCT01582711|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92434265|NCT01582711|Antimetabolites|antimetabolites|mesh-ancestor
92434266|NCT01582711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434267|NCT01582711|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92434268|NCT01582711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92434269|NCT01582711|Leprostatic Agents|leprostatic agents|mesh-ancestor
92434270|NCT01583062|Amoxicillin|amoxicillin|mesh-list
92434271|NCT01583062|Clavulanic Acids|clavulanic acids|mesh-list
92147387|NCT04499196|Hormones|hormones|mesh-ancestor
92434272|NCT01583062|Clavulanic Acid|clavulanic acid|mesh-list
92434273|NCT01583062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434274|NCT01583062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434275|NCT01583062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434276|NCT01583062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434277|NCT01583062|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92434279|NCT01583426|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92434280|NCT01583426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92434281|NCT01583426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434282|NCT01583426|Tubulin Modulators|tubulin modulators|mesh-ancestor
92434283|NCT01583426|Antimitotic Agents|antimitotic agents|mesh-ancestor
92434284|NCT01583426|Mitosis Modulators|mitosis modulators|mesh-ancestor
92434285|NCT01583426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434286|NCT01583972|Vitamin A|vitamin a|mesh-list
92434287|NCT01583972|Retinol palmitate|retinol palmitate|mesh-list
92434288|NCT01583972|Vitamins|vitamins|mesh-ancestor
92434289|NCT01583972|Micronutrients|micronutrients|mesh-ancestor
92434290|NCT01583972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434291|NCT01583972|Antioxidants|antioxidants|mesh-ancestor
92434292|NCT01583972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434293|NCT01583972|Protective Agents|protective agents|mesh-ancestor
92434294|NCT01583972|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92434295|NCT01583972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434296|NCT01584362|Oxfendazole|oxfendazole|mesh-list
92434297|NCT01584362|Anthelmintics|anthelmintics|mesh-ancestor
92434298|NCT01584362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92434299|NCT01584362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434300|NCT01584362|Antinematodal Agents|antinematodal agents|mesh-ancestor
92434301|NCT01584921|Epoetin Alfa|epoetin alfa|mesh-list
92434302|NCT01584921|Hematinics|hematinics|mesh-ancestor
92434303|NCT01586013|Propofol|propofol|mesh-list
92434304|NCT01586013|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92434305|NCT01586013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434306|NCT01586013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434307|NCT01586013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92434308|NCT01586013|Anesthetics, General|anesthetics, general|mesh-ancestor
92434309|NCT01586013|Anesthetics|anesthetics|mesh-ancestor
92434310|NCT01586845|Cyclosporine|cyclosporine|mesh-list
92434311|NCT01586845|Tacrolimus|tacrolimus|mesh-list
92434312|NCT01586845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434313|NCT01586845|Immunologic Factors|immunologic factors|mesh-ancestor
92434314|NCT01586845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434315|NCT01586845|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92434316|NCT01586845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434317|NCT01586845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434318|NCT01586845|Antifungal Agents|antifungal agents|mesh-ancestor
92434319|NCT01586845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434320|NCT01586845|Dermatologic Agents|dermatologic agents|mesh-ancestor
92434321|NCT01586845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434322|NCT01587339|Pregabalin|pregabalin|mesh-list
92434323|NCT01587339|Zonisamide|zonisamide|mesh-list
92434324|NCT01587339|Lacosamide|lacosamide|mesh-list
92434325|NCT01587339|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92434326|NCT01587339|Ezogabine|ezogabine|mesh-list
92434327|NCT01587339|Analgesics|analgesics|mesh-ancestor
92434328|NCT01587339|Sensory System Agents|sensory system agents|mesh-ancestor
92434329|NCT01587339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434330|NCT01587339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434331|NCT01587339|Anticonvulsants|anticonvulsants|mesh-ancestor
92434332|NCT01587339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92434333|NCT01587339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343537|NCT00005585|Antidotes|antidotes|mesh-ancestor
92434334|NCT01587339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434335|NCT01587339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92434336|NCT01587339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92434337|NCT01587339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92434338|NCT01587339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434339|NCT01587339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92434340|NCT01587339|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92434341|NCT01587339|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92434342|NCT01587378|Metformin|metformin|mesh-list
92434343|NCT01587378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92434344|NCT01587378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434345|NCT01587482|Paclitaxel|paclitaxel|mesh-list
92434346|NCT01587482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92434347|NCT01587482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147462|NCT05303688|Analgesics|analgesics|mesh-ancestor
92434348|NCT01587482|Tubulin Modulators|tubulin modulators|mesh-ancestor
92434349|NCT01587482|Antimitotic Agents|antimitotic agents|mesh-ancestor
92434350|NCT01587482|Mitosis Modulators|mitosis modulators|mesh-ancestor
92434351|NCT01587482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434353|NCT01587625|Oxytocics|oxytocics|mesh-ancestor
92434354|NCT01587625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434355|NCT01587625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434356|NCT01587820|Cisplatin|cisplatin|mesh-list
92434357|NCT01587820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434358|NCT01587937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92434359|NCT01587937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92434360|NCT01587937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434361|NCT01587937|Antitubercular Agents|antitubercular agents|mesh-ancestor
92434362|NCT01588171|Enoxaparin|enoxaparin|mesh-list
92434363|NCT01588171|Bemiparin|bemiparin|mesh-list
92434364|NCT01588171|Anticoagulants|anticoagulants|mesh-ancestor
92434365|NCT01588171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92434366|NCT01588171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92434367|NCT01588171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434368|NCT01588873|Desogestrel|desogestrel|mesh-list
92434369|NCT01588873|NuvaRing|nuvaring|mesh-list
92434370|NCT01588873|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92434371|NCT01588873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92434372|NCT01588873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92434373|NCT01588873|Contraceptive Agents|contraceptive agents|mesh-ancestor
92434374|NCT01588873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434375|NCT01588873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434376|NCT01588873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92434377|NCT01588873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92434378|NCT01588873|Progestins|progestins|mesh-ancestor
92434379|NCT01588873|Hormones|hormones|mesh-ancestor
92434380|NCT01588873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434381|NCT01589367|Metformin|metformin|mesh-list
92434382|NCT01589367|Letrozole|letrozole|mesh-list
92434383|NCT01589367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92434384|NCT01589367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434385|NCT01589367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434386|NCT01589367|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92434387|NCT01589367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92434388|NCT01589367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434389|NCT01589367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434390|NCT01589367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92434391|NCT01589367|Hormone Antagonists|hormone antagonists|mesh-ancestor
92434392|NCT01589367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434393|NCT01589432|Lidocaine|lidocaine|mesh-list
92434394|NCT01589432|Anesthetics, Local|anesthetics, local|mesh-ancestor
92434395|NCT01589432|Anesthetics|anesthetics|mesh-ancestor
92434396|NCT01589432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434397|NCT01589432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434398|NCT01589432|Sensory System Agents|sensory system agents|mesh-ancestor
92434399|NCT01589432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434400|NCT01589432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92434401|NCT01589432|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92434402|NCT01589432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92434403|NCT01589432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92434404|NCT01589432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434405|NCT01589614|Erythromycin|erythromycin|mesh-list
92434406|NCT01589614|Erythromycin Estolate|erythromycin estolate|mesh-list
92434407|NCT01589614|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92434408|NCT01589614|Erythromycin stearate|erythromycin stearate|mesh-list
92434409|NCT01589614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434410|NCT01589614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434411|NCT01589614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92434412|NCT01589614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92434413|NCT01589614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434414|NCT01589614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434415|NCT01589861|Lapatinib|lapatinib|mesh-list
92434416|NCT01589861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434417|NCT01589861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92434418|NCT01589861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531044|NCT00044629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434419|NCT01589861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434420|NCT01590173|Prednisolone|prednisolone|mesh-list
92434421|NCT01590173|Heparin|heparin|mesh-list
92434422|NCT01590173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434423|NCT01590173|Glucocorticoids|glucocorticoids|mesh-ancestor
92434424|NCT01590173|Hormones|hormones|mesh-ancestor
92434425|NCT01590173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434426|NCT01590173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434427|NCT01590173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92434428|NCT01590173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434429|NCT01590173|Anticoagulants|anticoagulants|mesh-ancestor
92434430|NCT01590173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92434431|NCT01590173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92434432|NCT01590173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434433|NCT01590199|Everolimus|everolimus|mesh-list
92434434|NCT01590199|Pasireotide|pasireotide|mesh-list
92434435|NCT01590199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92434436|NCT01590199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92434437|NCT01590199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434438|NCT01590199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434439|NCT01590199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434440|NCT01590199|Immunologic Factors|immunologic factors|mesh-ancestor
92434441|NCT01590199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434442|NCT01590199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434443|NCT01590199|Hormones|hormones|mesh-ancestor
92434444|NCT01590199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434445|NCT01590225|Ribavirin|ribavirin|mesh-list
92434446|NCT01590225|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92434447|NCT01590225|Interferon-alpha|interferon-alpha|mesh-list
92434448|NCT01590225|Antimetabolites|antimetabolites|mesh-ancestor
92434449|NCT01590225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434450|NCT01590225|Antiviral Agents|antiviral agents|mesh-ancestor
92434451|NCT01590225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434452|NCT01590225|Immunologic Factors|immunologic factors|mesh-ancestor
92434453|NCT01590225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434454|NCT01590342|Diclofenac|diclofenac|mesh-list
92434455|NCT01590342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92434456|NCT01590342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434457|NCT01590342|Analgesics|analgesics|mesh-ancestor
92434458|NCT01590342|Sensory System Agents|sensory system agents|mesh-ancestor
92434459|NCT01590342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434460|NCT01590342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434461|NCT01590342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434462|NCT01590342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434463|NCT01590342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92434464|NCT01590342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434465|NCT01590342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434467|NCT01590537|Levonorgestrel|levonorgestrel|mesh-list
92434468|NCT01590537|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92434469|NCT01590537|Contraceptive Agents|contraceptive agents|mesh-ancestor
92434470|NCT01590537|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434471|NCT01590537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434472|NCT01590537|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92434473|NCT01590537|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92434474|NCT01590537|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92434475|NCT01590537|Trace Elements|trace elements|mesh-ancestor
92434476|NCT01590537|Micronutrients|micronutrients|mesh-ancestor
92434477|NCT01590641|Vesatolimod|vesatolimod|mesh-list
92434478|NCT01590641|Antiviral Agents|antiviral agents|mesh-ancestor
92434479|NCT01590641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434480|NCT01590654|Vesatolimod|vesatolimod|mesh-list
92434481|NCT01590654|Antiviral Agents|antiviral agents|mesh-ancestor
92434482|NCT01590654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434483|NCT01590693|Botulinum Toxins|botulinum toxins|mesh-list
92434484|NCT01590693|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92434485|NCT01590693|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92434486|NCT01590693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92434487|NCT01590693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92434488|NCT01590693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434489|NCT01590693|Cholinergic Agents|cholinergic agents|mesh-ancestor
92434490|NCT01590693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434491|NCT01590693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531046|NCT00044668|Exenatide|exenatide|mesh-list
92434492|NCT01590693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92434493|NCT01590693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434494|NCT01590732|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92434495|NCT01590732|Carboplatin|carboplatin|mesh-list
92434496|NCT01590732|Etoposide|etoposide|mesh-list
92434497|NCT01590732|Etoposide phosphate|etoposide phosphate|mesh-list
92434498|NCT01590732|Ifosfamide|ifosfamide|mesh-list
92434499|NCT01590732|Isophosphamide mustard|isophosphamide mustard|mesh-list
92434500|NCT01590732|Podophyllotoxin|podophyllotoxin|mesh-list
92434501|NCT01590732|Romidepsin|romidepsin|mesh-list
92434502|NCT01590732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434503|NCT01590732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92434504|NCT01590732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92434505|NCT01590732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92434506|NCT01590732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434507|NCT01590732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434508|NCT01590732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434509|NCT01590732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92434510|NCT01590732|Alkylating Agents|alkylating agents|mesh-ancestor
92434511|NCT01590732|Keratolytic Agents|keratolytic agents|mesh-ancestor
92434512|NCT01590732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92434513|NCT01590732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92434514|NCT01590732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92434515|NCT01590732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92434516|NCT01590732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92434517|NCT01590732|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92434518|NCT01590823|Dabigatran|dabigatran|mesh-list
92434519|NCT01590823|Antithrombins|antithrombins|mesh-ancestor
92434520|NCT01590823|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92434521|NCT01590823|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434522|NCT01590823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434523|NCT01590823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434524|NCT01590823|Anticoagulants|anticoagulants|mesh-ancestor
92434525|NCT01590836|Insulin|insulin|mesh-list
92434526|NCT01590836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92434527|NCT01590836|Insulin Aspart|insulin aspart|mesh-list
92434528|NCT01590836|Insulin, Long-Acting|insulin, long-acting|mesh-list
92434529|NCT01590836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92434530|NCT01590836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434531|NCT01590849|Contraceptive Agents|contraceptive agents|mesh-list
92434532|NCT01590849|Contraceptives, Oral|contraceptives, oral|mesh-list
92434533|NCT01590849|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92434534|NCT01590849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434535|NCT01590849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434536|NCT01590849|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92434537|NCT01590901|Probucol|probucol|mesh-list
92434538|NCT01590901|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92434539|NCT01590901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92434540|NCT01590901|Antimetabolites|antimetabolites|mesh-ancestor
92434541|NCT01590901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434542|NCT01590901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92434544|NCT01590901|Protective Agents|protective agents|mesh-ancestor
92434545|NCT01590901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434546|NCT01590966|Certolizumab Pegol|certolizumab pegol|mesh-list
92434547|NCT01590966|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92434548|NCT01590966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434549|NCT01590966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434550|NCT01590966|Immunologic Factors|immunologic factors|mesh-ancestor
92434551|NCT01590966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434552|NCT01590966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434553|NCT01591031|Sevoflurane|sevoflurane|mesh-list
92434554|NCT01591031|Rocuronium|rocuronium|mesh-list
92434555|NCT01591031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92434556|NCT01591031|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92434557|NCT01591031|Anesthetics, General|anesthetics, general|mesh-ancestor
92434558|NCT01591031|Anesthetics|anesthetics|mesh-ancestor
92434559|NCT01591031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434560|NCT01591031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434561|NCT01591031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92434562|NCT01591031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92434563|NCT01591031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92434564|NCT01591031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434565|NCT01591070|Tacrolimus|tacrolimus|mesh-list
92434566|NCT01591070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434567|NCT01591070|Immunologic Factors|immunologic factors|mesh-ancestor
92434568|NCT01591070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434569|NCT01591070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92434570|NCT01591070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434571|NCT01591070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434573|NCT01591083|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92434574|NCT01591083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92434575|NCT01591083|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92434576|NCT01591083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434577|NCT01591083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434578|NCT01591122|Prednisone|prednisone|mesh-list
92434579|NCT01591122|Abiraterone Acetate|abiraterone acetate|mesh-list
92434580|NCT01591122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434581|NCT01591122|Glucocorticoids|glucocorticoids|mesh-ancestor
92434582|NCT01591122|Hormones|hormones|mesh-ancestor
92434583|NCT01591122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434584|NCT01591122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434585|NCT01591122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92434586|NCT01591122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434587|NCT01591122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92434588|NCT01591122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434589|NCT01591122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434590|NCT01591122|Hormone Antagonists|hormone antagonists|mesh-ancestor
92434591|NCT01591122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92434592|NCT01591135|Paclitaxel|paclitaxel|mesh-list
92434593|NCT01591135|Fluorouracil|fluorouracil|mesh-list
92434594|NCT01591135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92434595|NCT01591135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434596|NCT01591135|Tubulin Modulators|tubulin modulators|mesh-ancestor
92434597|NCT01591135|Antimitotic Agents|antimitotic agents|mesh-ancestor
92434598|NCT01591135|Mitosis Modulators|mitosis modulators|mesh-ancestor
92434599|NCT01591135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434600|NCT01591135|Antimetabolites|antimetabolites|mesh-ancestor
92434601|NCT01591135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92434602|NCT01591135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434603|NCT01591135|Immunologic Factors|immunologic factors|mesh-ancestor
92434604|NCT01591135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434605|NCT01591148|Propofol|propofol|mesh-list
92434606|NCT01591148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92434607|NCT01591148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434608|NCT01591148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434609|NCT01591148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92434610|NCT01591148|Anesthetics, General|anesthetics, general|mesh-ancestor
92434611|NCT01591148|Anesthetics|anesthetics|mesh-ancestor
92434612|NCT01591226|Mannitol|mannitol|mesh-list
92434613|NCT01591226|Caffeine|caffeine|mesh-list
92434614|NCT01591226|Citric Acid|citric acid|mesh-list
92434615|NCT01591226|Sodium Citrate|sodium citrate|mesh-list
92434616|NCT01591226|Anticoagulants|anticoagulants|mesh-ancestor
92434617|NCT01591226|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92434618|NCT01591226|Chelating Agents|chelating agents|mesh-ancestor
92434619|NCT01591226|Sequestering Agents|sequestering agents|mesh-ancestor
92434620|NCT01591226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434621|NCT01591226|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92434622|NCT01591226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434623|NCT01591226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92434624|NCT01591226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434625|NCT01591226|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92434626|NCT01591226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92434627|NCT01591226|Purinergic Agents|purinergic agents|mesh-ancestor
92434628|NCT01591226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434629|NCT01591226|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92434630|NCT01591226|Diuretics|diuretics|mesh-ancestor
92434631|NCT01591226|Natriuretic Agents|natriuretic agents|mesh-ancestor
92434632|NCT01591421|Panitumumab|panitumumab|mesh-list
92434633|NCT01591421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92434634|NCT01591421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434635|NCT01591434|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92434636|NCT01591434|Laxatives|laxatives|mesh-ancestor
92434637|NCT01591434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92434638|NCT01591551|Natalizumab|natalizumab|mesh-list
92434639|NCT01591551|Immunologic Factors|immunologic factors|mesh-ancestor
92434640|NCT01591551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434641|NCT01591668|Vesatolimod|vesatolimod|mesh-list
92434642|NCT01591668|Antiviral Agents|antiviral agents|mesh-ancestor
92434643|NCT01591668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434644|NCT01591759|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92434645|NCT01591759|Nootropic Agents|nootropic agents|mesh-ancestor
92434646|NCT01591850|Ritonavir|ritonavir|mesh-list
92434647|NCT01591850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92434648|NCT01591850|Rifampin|rifampin|mesh-list
92434649|NCT01591850|Ketoconazole|ketoconazole|mesh-list
92434650|NCT01591850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92434651|NCT01591850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92434652|NCT01591850|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434653|NCT01591850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434654|NCT01591850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434655|NCT01591850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92434656|NCT01591850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92434657|NCT01591850|Antiviral Agents|antiviral agents|mesh-ancestor
92434658|NCT01591850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434659|NCT01591850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92434660|NCT01591850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92434661|NCT01591850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92434662|NCT01591850|Antitubercular Agents|antitubercular agents|mesh-ancestor
92434663|NCT01591850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434664|NCT01591850|Leprostatic Agents|leprostatic agents|mesh-ancestor
92434665|NCT01591850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92434666|NCT01591850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92434667|NCT01591850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92434668|NCT01591850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92434669|NCT01591850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92434670|NCT01591850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92434671|NCT01591850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92434672|NCT01591850|Antifungal Agents|antifungal agents|mesh-ancestor
92434673|NCT01591850|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92434674|NCT01591850|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92434675|NCT01591850|Hormone Antagonists|hormone antagonists|mesh-ancestor
92434676|NCT01591850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434677|NCT01591850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434678|NCT01591889|Tinidazole|tinidazole|mesh-list
92434679|NCT01591889|Alkylating Agents|alkylating agents|mesh-ancestor
92434680|NCT01591889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434681|NCT01591889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434682|NCT01591889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434683|NCT01591889|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92434684|NCT01591889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92434686|NCT01591902|Tesamorelin|tesamorelin|mesh-list
92434687|NCT01591902|Growth Substances|growth substances|mesh-ancestor
92434688|NCT01591902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434689|NCT01591980|Pregabalin|pregabalin|mesh-list
92434690|NCT01591980|Analgesics|analgesics|mesh-ancestor
92434691|NCT01591980|Sensory System Agents|sensory system agents|mesh-ancestor
92434692|NCT01591980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159423|NCT03377543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92434693|NCT01591980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434695|NCT01591980|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92434696|NCT01591980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92434697|NCT01591980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434698|NCT01591980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92434699|NCT01591980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92434700|NCT01591980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92434701|NCT01591980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434702|NCT01591980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92434703|NCT01592019|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92434704|NCT01592019|Diclofenac|diclofenac|mesh-list
92434705|NCT01592019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92434706|NCT01592019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434707|NCT01592019|Analgesics|analgesics|mesh-ancestor
92434708|NCT01592019|Sensory System Agents|sensory system agents|mesh-ancestor
92434709|NCT01592019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434710|NCT01592019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434711|NCT01592019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434712|NCT01592019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343617|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
92434713|NCT01592019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92434714|NCT01592019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434715|NCT01592019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434716|NCT01592032|Vancomycin|vancomycin|mesh-list
92434717|NCT01592032|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92434718|NCT01592032|Linezolid|linezolid|mesh-list
92434719|NCT01592032|Daptomycin|daptomycin|mesh-list
92434720|NCT01592032|Tigecycline|tigecycline|mesh-list
92434721|NCT01592032|Teicoplanin|teicoplanin|mesh-list
92434722|NCT01592032|Anti-Infective Agents|anti-infective agents|mesh-list
92434723|NCT01592032|Heparin|heparin|mesh-list
92434724|NCT01592032|Calcium heparin|calcium heparin|mesh-list
92434725|NCT01592032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92434726|NCT01592032|Anticoagulants|anticoagulants|mesh-ancestor
92434727|NCT01592032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92434728|NCT01592032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92434729|NCT01592032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434730|NCT01592032|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92434731|NCT01592032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434732|NCT01592136|Ponatinib|ponatinib|mesh-list
92434733|NCT01592136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434734|NCT01592136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92434735|NCT01592136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434736|NCT01592136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434737|NCT01592162|Remifentanil|remifentanil|mesh-list
92434738|NCT01592162|Propofol|propofol|mesh-list
92434739|NCT01592162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92434740|NCT01592162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434741|NCT01592162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434742|NCT01592162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92434743|NCT01592162|Anesthetics, General|anesthetics, general|mesh-ancestor
92434744|NCT01592162|Anesthetics|anesthetics|mesh-ancestor
92434745|NCT01592162|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92434746|NCT01592162|Narcotics|narcotics|mesh-ancestor
92434747|NCT01592162|Analgesics|analgesics|mesh-ancestor
92434748|NCT01592162|Sensory System Agents|sensory system agents|mesh-ancestor
92434749|NCT01592162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434750|NCT01592201|Olanzapine|olanzapine|mesh-list
92434751|NCT01592201|Risperidone|risperidone|mesh-list
92434752|NCT01592201|Aripiprazole|aripiprazole|mesh-list
92434753|NCT01592201|Antipsychotic Agents|antipsychotic agents|mesh-list
92434754|NCT01592201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92434755|NCT01592201|Serotonin Agents|serotonin agents|mesh-ancestor
92434756|NCT01592201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434757|NCT01592201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434758|NCT01592201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434759|NCT01592201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92434760|NCT01592201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434762|NCT01592201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92434763|NCT01592201|Dopamine Agents|dopamine agents|mesh-ancestor
92434764|NCT01592201|Antiemetics|antiemetics|mesh-ancestor
92434765|NCT01592201|Autonomic Agents|autonomic agents|mesh-ancestor
92434766|NCT01592201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434767|NCT01592201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92434768|NCT01592201|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92434769|NCT01592201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92434770|NCT01592201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92434771|NCT01592201|Antidepressive Agents|antidepressive agents|mesh-ancestor
92434772|NCT01592201|Dopamine Agonists|dopamine agonists|mesh-ancestor
92434773|NCT01592201|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92434774|NCT01592201|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92434775|NCT01592201|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92434776|NCT01592201|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92434778|NCT01592214|Anesthetics, Local|anesthetics, local|mesh-ancestor
92434779|NCT01592214|Anesthetics|anesthetics|mesh-ancestor
92434780|NCT01592214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434781|NCT01592214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434782|NCT01592214|Sensory System Agents|sensory system agents|mesh-ancestor
92434783|NCT01592214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434784|NCT01592227|Acetaminophen|acetaminophen|mesh-list
92434785|NCT01592227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434786|NCT01592227|Analgesics|analgesics|mesh-ancestor
92434787|NCT01592227|Sensory System Agents|sensory system agents|mesh-ancestor
92434788|NCT01592227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434789|NCT01592227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531051|NCT00044668|Hormones|hormones|mesh-ancestor
92434790|NCT01592227|Antipyretics|antipyretics|mesh-ancestor
92434791|NCT01592253|Sirolimus|sirolimus|mesh-list
92434792|NCT01592253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434793|NCT01592253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434794|NCT01592253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92434795|NCT01592253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434796|NCT01592253|Antifungal Agents|antifungal agents|mesh-ancestor
92434797|NCT01592253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434798|NCT01592253|Immunologic Factors|immunologic factors|mesh-ancestor
92434799|NCT01592253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434800|NCT01592279|Liraglutide|liraglutide|mesh-list
92434801|NCT01592279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92434802|NCT01592279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434803|NCT01592279|Incretins|incretins|mesh-ancestor
92434804|NCT01592279|Hormones|hormones|mesh-ancestor
92434805|NCT01592279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434806|NCT01592305|Ritonavir|ritonavir|mesh-list
92434807|NCT01592305|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92434808|NCT01592305|Tenofovir|tenofovir|mesh-list
92434809|NCT01592305|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92434810|NCT01592305|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92434811|NCT01592305|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434812|NCT01592305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434813|NCT01592305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434814|NCT01592305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92434815|NCT01592305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92434816|NCT01592305|Antiviral Agents|antiviral agents|mesh-ancestor
92434817|NCT01592305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434818|NCT01592305|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92434819|NCT01592305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92434820|NCT01592305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92434821|NCT01592305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92434822|NCT01592318|Ritonavir|ritonavir|mesh-list
92434823|NCT01592318|Lactams|lactams|mesh-list
92434824|NCT01592318|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92434825|NCT01592318|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92434826|NCT01592318|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434827|NCT01592318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434828|NCT01592318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434829|NCT01592318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92434830|NCT01592318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92434831|NCT01592318|Antiviral Agents|antiviral agents|mesh-ancestor
92434832|NCT01592318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434833|NCT01592318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92434834|NCT01592318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92434835|NCT01592318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92434837|NCT01592526|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92434838|NCT01592526|Autonomic Agents|autonomic agents|mesh-ancestor
92434839|NCT01592526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434840|NCT01592526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434841|NCT01592526|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92434842|NCT01592526|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92434843|NCT01592526|Cholinergic Agents|cholinergic agents|mesh-ancestor
92434844|NCT01592526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92434845|NCT01592526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434846|NCT01592630|Ropivacaine|ropivacaine|mesh-list
92434847|NCT01592630|Anesthetics, Local|anesthetics, local|mesh-ancestor
92434848|NCT01592630|Anesthetics|anesthetics|mesh-ancestor
92434849|NCT01592630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434850|NCT01592630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434851|NCT01592630|Sensory System Agents|sensory system agents|mesh-ancestor
92434852|NCT01592630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434853|NCT01592981|Cyclophosphamide|cyclophosphamide|mesh-list
92434854|NCT01592981|Rituximab|rituximab|mesh-list
92434855|NCT01592981|Fludarabine|fludarabine|mesh-list
92434856|NCT01592981|Bortezomib|bortezomib|mesh-list
92434857|NCT01592981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434858|NCT01592981|Immunologic Factors|immunologic factors|mesh-ancestor
92434859|NCT01592981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434860|NCT01592981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434861|NCT01592981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92434862|NCT01592981|Alkylating Agents|alkylating agents|mesh-ancestor
92531053|NCT00044707|Pramlintide|pramlintide|mesh-list
92434863|NCT01592981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434864|NCT01592981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434865|NCT01592981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92434866|NCT01592981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92434868|NCT01593033|Trace Elements|trace elements|mesh-list
92434869|NCT01593033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434870|NCT01593046|Cabotegravir|cabotegravir|mesh-list
92434871|NCT01593046|Rilpivirine|rilpivirine|mesh-list
92434872|NCT01593046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92434873|NCT01593046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92434874|NCT01593046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434875|NCT01593046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434876|NCT01593046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92434877|NCT01593046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92434878|NCT01593046|Antiviral Agents|antiviral agents|mesh-ancestor
92434879|NCT01593046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92434880|NCT01593046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92434881|NCT01593046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92434882|NCT01593124|Imiquimod|imiquimod|mesh-list
92434883|NCT01593124|Nonoxynol|nonoxynol|mesh-list
92434884|NCT01593124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92434885|NCT01593124|Immunologic Factors|immunologic factors|mesh-ancestor
92434886|NCT01593124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434887|NCT01593124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434888|NCT01593124|Interferon Inducers|interferon inducers|mesh-ancestor
92434889|NCT01593124|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92434890|NCT01593124|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92434891|NCT01593124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92434892|NCT01593124|Contraceptive Agents|contraceptive agents|mesh-ancestor
92434893|NCT01593124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92434894|NCT01593124|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92434895|NCT01593137|Metformin|metformin|mesh-list
92434896|NCT01593137|Liraglutide|liraglutide|mesh-list
92434897|NCT01593137|Glimepiride|glimepiride|mesh-list
92434898|NCT01593137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92434899|NCT01593137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434900|NCT01593137|Incretins|incretins|mesh-ancestor
92434901|NCT01593137|Hormones|hormones|mesh-ancestor
92434902|NCT01593137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434903|NCT01593137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92434904|NCT01593137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92434905|NCT01593137|Immunologic Factors|immunologic factors|mesh-ancestor
92434906|NCT01593150|Dabigatran|dabigatran|mesh-list
92434907|NCT01593150|Antithrombins|antithrombins|mesh-ancestor
92434908|NCT01593150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92434909|NCT01593150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92434910|NCT01593150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434911|NCT01593150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434912|NCT01593150|Anticoagulants|anticoagulants|mesh-ancestor
92434913|NCT01593163|Ibuprofen|ibuprofen|mesh-list
92434914|NCT01593163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92434915|NCT01593163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92434916|NCT01593163|Analgesics|analgesics|mesh-ancestor
92434917|NCT01593163|Sensory System Agents|sensory system agents|mesh-ancestor
92434918|NCT01593163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159648|NCT02768363|Valacyclovir|valacyclovir|mesh-list
92434919|NCT01593163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434920|NCT01593163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434921|NCT01593163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434922|NCT01593163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92434923|NCT01593163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434924|NCT01593163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434925|NCT01593280|Morphine|morphine|mesh-list
92434926|NCT01593280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92434927|NCT01593280|Narcotics|narcotics|mesh-ancestor
92434928|NCT01593280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434929|NCT01593280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434930|NCT01593280|Analgesics|analgesics|mesh-ancestor
92434931|NCT01593280|Sensory System Agents|sensory system agents|mesh-ancestor
92434932|NCT01593280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434933|NCT01593293|Pemetrexed|pemetrexed|mesh-list
92434934|NCT01593293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434935|NCT01593293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92434936|NCT01593293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531057|NCT00044746|Piperacillin|piperacillin|mesh-list
92434937|NCT01593293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92434938|NCT01593293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92434939|NCT01593306|Paclitaxel|paclitaxel|mesh-list
92434940|NCT01593306|Cisplatin|cisplatin|mesh-list
92434941|NCT01593306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92434942|NCT01593306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434943|NCT01593306|Tubulin Modulators|tubulin modulators|mesh-ancestor
92434944|NCT01593306|Antimitotic Agents|antimitotic agents|mesh-ancestor
92434945|NCT01593306|Mitosis Modulators|mitosis modulators|mesh-ancestor
92434946|NCT01593306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92434947|NCT01593319|Ropivacaine|ropivacaine|mesh-list
92434948|NCT01593319|Anesthetics, Local|anesthetics, local|mesh-ancestor
92434949|NCT01593319|Anesthetics|anesthetics|mesh-ancestor
92434950|NCT01593319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434951|NCT01593319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434952|NCT01593319|Sensory System Agents|sensory system agents|mesh-ancestor
92434953|NCT01593319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434954|NCT01593332|Rituximab|rituximab|mesh-list
92434955|NCT01593332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92434956|NCT01593332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434957|NCT01593332|Immunologic Factors|immunologic factors|mesh-ancestor
92434958|NCT01593332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434959|NCT01593332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92434960|NCT01593371|Metformin|metformin|mesh-list
92434961|NCT01593371|Pioglitazone|pioglitazone|mesh-list
92434962|NCT01593371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92434963|NCT01593371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434964|NCT01593397|Fentanyl|fentanyl|mesh-list
92434965|NCT01593397|Propofol|propofol|mesh-list
92434966|NCT01593397|Anesthetics|anesthetics|mesh-list
92434967|NCT01593397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92434968|NCT01593397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92434969|NCT01593397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434970|NCT01593397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92434971|NCT01593397|Anesthetics, General|anesthetics, general|mesh-ancestor
92434972|NCT01593397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92434973|NCT01593397|Narcotics|narcotics|mesh-ancestor
92434974|NCT01593397|Analgesics|analgesics|mesh-ancestor
92434975|NCT01593397|Sensory System Agents|sensory system agents|mesh-ancestor
92434976|NCT01593397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434977|NCT01593397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92434978|NCT01593410|Dexamethasone|dexamethasone|mesh-list
92434979|NCT01593410|Lenalidomide|lenalidomide|mesh-list
92434980|NCT01593410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92434981|NCT01593410|Antiemetics|antiemetics|mesh-ancestor
92434982|NCT01593410|Autonomic Agents|autonomic agents|mesh-ancestor
92434983|NCT01593410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92434984|NCT01593410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92434985|NCT01593410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92434986|NCT01593410|Glucocorticoids|glucocorticoids|mesh-ancestor
92434987|NCT01593410|Hormones|hormones|mesh-ancestor
92434988|NCT01593410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92434989|NCT01593410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92434990|NCT01593410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92434991|NCT01593410|Immunologic Factors|immunologic factors|mesh-ancestor
92434992|NCT01593410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92434993|NCT01593410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92434994|NCT01593410|Growth Substances|growth substances|mesh-ancestor
92159741|NCT02308072|Olaparib|olaparib|mesh-list
92434995|NCT01593410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92434996|NCT01593501|Vitamin D|vitamin d|mesh-list
92434997|NCT01593501|Cholecalciferol|cholecalciferol|mesh-list
92434998|NCT01593501|Vitamins|vitamins|mesh-ancestor
92434999|NCT01593501|Micronutrients|micronutrients|mesh-ancestor
92435000|NCT01593501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435001|NCT01593501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92435002|NCT01593501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92435003|NCT01593514|Lactitol|lactitol|mesh-list
92435004|NCT01593514|Vaccines|vaccines|mesh-list
92435005|NCT01593514|Immunologic Factors|immunologic factors|mesh-ancestor
92435006|NCT01593514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435007|NCT01593514|Cathartics|cathartics|mesh-ancestor
92435008|NCT01593514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435009|NCT01593566|Bupivacaine|bupivacaine|mesh-list
92435010|NCT01593566|Anesthetics, Local|anesthetics, local|mesh-ancestor
92435011|NCT01593566|Anesthetics|anesthetics|mesh-ancestor
92435012|NCT01593566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435013|NCT01593566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435014|NCT01593566|Sensory System Agents|sensory system agents|mesh-ancestor
92435015|NCT01593566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435016|NCT01593605|Resveratrol|resveratrol|mesh-list
92435017|NCT01593605|Antioxidants|antioxidants|mesh-ancestor
92435018|NCT01593605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435019|NCT01593605|Protective Agents|protective agents|mesh-ancestor
92435020|NCT01593605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435021|NCT01593605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435022|NCT01593605|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92435023|NCT01593644|Adenosine|adenosine|mesh-list
92435024|NCT01593644|Dipyridamole|dipyridamole|mesh-list
92435025|NCT01593644|Analgesics|analgesics|mesh-ancestor
92435026|NCT01593644|Sensory System Agents|sensory system agents|mesh-ancestor
92435027|NCT01593644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435028|NCT01593644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435029|NCT01593644|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92435030|NCT01593644|Vasodilator Agents|vasodilator agents|mesh-ancestor
92435031|NCT01593644|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92343675|NCT00005777|Dexamethasone|dexamethasone|mesh-list
92435032|NCT01593644|Purinergic Agonists|purinergic agonists|mesh-ancestor
92435033|NCT01593644|Purinergic Agents|purinergic agents|mesh-ancestor
92435034|NCT01593644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435035|NCT01593644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435036|NCT01593644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92435037|NCT01593644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435038|NCT01593644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92435039|NCT01593774|Melatonin|melatonin|mesh-list
92435040|NCT01593774|Antioxidants|antioxidants|mesh-ancestor
92435041|NCT01593774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435042|NCT01593774|Protective Agents|protective agents|mesh-ancestor
92435043|NCT01593774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435044|NCT01593774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435045|NCT01593826|Budesonide|budesonide|mesh-list
92435046|NCT01593826|Formoterol Fumarate|formoterol fumarate|mesh-list
92435047|NCT01593826|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92435048|NCT01593826|Charcoal|charcoal|mesh-list
92435049|NCT01593826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435050|NCT01593826|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92435051|NCT01593826|Autonomic Agents|autonomic agents|mesh-ancestor
92435052|NCT01593826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435053|NCT01593826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435054|NCT01593826|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92435055|NCT01593826|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435056|NCT01593826|Glucocorticoids|glucocorticoids|mesh-ancestor
92435057|NCT01593826|Hormones|hormones|mesh-ancestor
92435058|NCT01593826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435059|NCT01593826|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92435060|NCT01593826|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92435061|NCT01593826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92435062|NCT01593826|Adrenergic Agents|adrenergic agents|mesh-ancestor
92435063|NCT01593826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435064|NCT01593826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435066|NCT01593826|Protective Agents|protective agents|mesh-ancestor
92435067|NCT01593930|Lidocaine|lidocaine|mesh-list
92435068|NCT01593930|Carticaine|carticaine|mesh-list
92435069|NCT01593930|Anesthetics, Local|anesthetics, local|mesh-ancestor
92435070|NCT01593930|Anesthetics|anesthetics|mesh-ancestor
92435071|NCT01593930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435072|NCT01593930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435073|NCT01593930|Sensory System Agents|sensory system agents|mesh-ancestor
92435074|NCT01593930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435075|NCT01593930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92435076|NCT01593930|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92435077|NCT01593930|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92435078|NCT01593930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435079|NCT01593930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435081|NCT01593995|Mitosis Modulators|mitosis modulators|mesh-ancestor
92435082|NCT01593995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435084|NCT01594047|Methadone|methadone|mesh-list
92435085|NCT01594047|Analgesics|analgesics|mesh-ancestor
92435086|NCT01594047|Sensory System Agents|sensory system agents|mesh-ancestor
92435087|NCT01594047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435088|NCT01594047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435089|NCT01594047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92435090|NCT01594047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92435091|NCT01594047|Anesthetics, General|anesthetics, general|mesh-ancestor
92435092|NCT01594047|Anesthetics|anesthetics|mesh-ancestor
92435093|NCT01594047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435094|NCT01594047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92435095|NCT01594047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92435096|NCT01594047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435097|NCT01594047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435098|NCT01594047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92435099|NCT01594047|Narcotics|narcotics|mesh-ancestor
92435100|NCT01594047|Antitussive Agents|antitussive agents|mesh-ancestor
92435101|NCT01594047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435102|NCT01594060|Insulin|insulin|mesh-list
92435103|NCT01594060|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92435104|NCT01594060|Insulin Glargine|insulin glargine|mesh-list
92435105|NCT01594060|Insulin glulisine|insulin glulisine|mesh-list
92435106|NCT01594060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435107|NCT01594060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435108|NCT01594099|Paclitaxel|paclitaxel|mesh-list
92435109|NCT01594099|Cisplatin|cisplatin|mesh-list
92435110|NCT01594099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92435111|NCT01594099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435112|NCT01594099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92435113|NCT01594099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92435114|NCT01594099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92435115|NCT01594099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435116|NCT01594177|Paclitaxel|paclitaxel|mesh-list
92435117|NCT01594177|Cyclophosphamide|cyclophosphamide|mesh-list
92435118|NCT01594177|Trastuzumab|trastuzumab|mesh-list
92435119|NCT01594177|Epirubicin|epirubicin|mesh-list
92435120|NCT01594177|Afatinib|afatinib|mesh-list
92435121|NCT01594177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92435122|NCT01594177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435123|NCT01594177|Tubulin Modulators|tubulin modulators|mesh-ancestor
92435124|NCT01594177|Antimitotic Agents|antimitotic agents|mesh-ancestor
92435125|NCT01594177|Mitosis Modulators|mitosis modulators|mesh-ancestor
92435126|NCT01594177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435127|NCT01594177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92435128|NCT01594177|Immunologic Factors|immunologic factors|mesh-ancestor
92435129|NCT01594177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435130|NCT01594177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435131|NCT01594177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92435132|NCT01594177|Alkylating Agents|alkylating agents|mesh-ancestor
92435133|NCT01594177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92435134|NCT01594177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92435135|NCT01594177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92435136|NCT01594177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92435137|NCT01594177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92435138|NCT01594177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435139|NCT01594177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92435141|NCT01594229|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92435142|NCT01594229|Venetoclax|venetoclax|mesh-list
92435143|NCT01594229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92435144|NCT01594229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435145|NCT01594229|Immunologic Factors|immunologic factors|mesh-ancestor
92435146|NCT01594229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435147|NCT01594229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435148|NCT01594229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92435149|NCT01594229|Alkylating Agents|alkylating agents|mesh-ancestor
92435150|NCT01594229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435151|NCT01594242|Bortezomib|bortezomib|mesh-list
92435152|NCT01594242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435153|NCT01594255|Moxifloxacin|moxifloxacin|mesh-list
92435154|NCT01594255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92435155|NCT01594255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435156|NCT01594255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92435157|NCT01594255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92435158|NCT01594255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435159|NCT01594255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435160|NCT01594255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435161|NCT01594268|Everolimus|everolimus|mesh-list
92435162|NCT01594268|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92435163|NCT01594268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92435164|NCT01594268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435165|NCT01594268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435166|NCT01594268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92435167|NCT01594268|Immunologic Factors|immunologic factors|mesh-ancestor
92435168|NCT01594268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435169|NCT01594268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435170|NCT01594346|Vitamin E|vitamin e|mesh-list
92435171|NCT01594346|Tocopherols|tocopherols|mesh-list
92435172|NCT01594346|Tocotrienols|tocotrienols|mesh-list
92435173|NCT01594346|alpha-Tocopherol|alpha-tocopherol|mesh-list
92435174|NCT01594346|Vitamins|vitamins|mesh-ancestor
92435175|NCT01594346|Micronutrients|micronutrients|mesh-ancestor
92435176|NCT01594346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435177|NCT01594346|Antioxidants|antioxidants|mesh-ancestor
92435178|NCT01594346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435179|NCT01594346|Protective Agents|protective agents|mesh-ancestor
92435180|NCT01594489|Aminophylline|aminophylline|mesh-list
92435181|NCT01594489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92435182|NCT01594489|Autonomic Agents|autonomic agents|mesh-ancestor
92435183|NCT01594489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435184|NCT01594489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435185|NCT01594489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92435186|NCT01594489|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435187|NCT01594489|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92435188|NCT01594489|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92435189|NCT01594489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435190|NCT01594489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159953|NCT00602667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92159954|NCT00602667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92159955|NCT00602667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159956|NCT00602667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92159957|NCT00602667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92159958|NCT00602667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159959|NCT00602667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159960|NCT00602667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159961|NCT00602667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92159962|NCT00602667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92159963|NCT00569127|Interferons|interferons|mesh-list
92159964|NCT00569127|Interferon-alpha|interferon-alpha|mesh-list
92159965|NCT00569127|Interferon alpha-2|interferon alpha-2|mesh-list
92159966|NCT00569127|Bevacizumab|bevacizumab|mesh-list
92159967|NCT00569127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92159968|NCT00569127|Octreotide|octreotide|mesh-list
92159969|NCT00569127|Endothelial Growth Factors|endothelial growth factors|mesh-list
92159970|NCT00569127|Antibodies|antibodies|mesh-list
92159971|NCT00569127|Immunoglobulins|immunoglobulins|mesh-list
92159972|NCT00569127|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92159973|NCT00569127|Immunoglobulin G|immunoglobulin g|mesh-list
92159974|NCT00569127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159975|NCT00569127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92159976|NCT00569127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92159977|NCT00569127|Growth Substances|growth substances|mesh-ancestor
92159978|NCT00569127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159979|NCT00569127|Growth Inhibitors|growth inhibitors|mesh-ancestor
92159980|NCT00569127|Immunologic Factors|immunologic factors|mesh-ancestor
92159981|NCT00569127|Antiviral Agents|antiviral agents|mesh-ancestor
92159982|NCT00569127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159983|NCT00569127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435191|NCT01594489|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92435192|NCT01594489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92435193|NCT01594489|Purinergic Agents|purinergic agents|mesh-ancestor
92435194|NCT01594489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435195|NCT01594489|Protective Agents|protective agents|mesh-ancestor
92435197|NCT01594502|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92435198|NCT01594502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92435199|NCT01594502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435200|NCT01594502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435201|NCT01594502|Hormone Antagonists|hormone antagonists|mesh-ancestor
92435202|NCT01594502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435203|NCT01594502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435205|NCT01594619|Naloxegol|naloxegol|mesh-list
92435206|NCT01594619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92435207|NCT01594619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92435208|NCT01594619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435209|NCT01594619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435210|NCT01594619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92435211|NCT01594619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435212|NCT01594619|Vasodilator Agents|vasodilator agents|mesh-ancestor
92435213|NCT01594619|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92435214|NCT01594619|Sensory System Agents|sensory system agents|mesh-ancestor
92435215|NCT01594619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435216|NCT01594671|Tranexamic Acid|tranexamic acid|mesh-list
92435217|NCT01594671|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92435218|NCT01594671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92435219|NCT01594671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435220|NCT01594671|Hemostatics|hemostatics|mesh-ancestor
92435221|NCT01594671|Coagulants|coagulants|mesh-ancestor
92435222|NCT01594697|Metformin|metformin|mesh-list
92435223|NCT01594697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435224|NCT01594697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435225|NCT01594775|Oxytocin|oxytocin|mesh-list
92435226|NCT01594775|Oxytocics|oxytocics|mesh-ancestor
92435227|NCT01594775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435228|NCT01594775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435229|NCT01594866|Dexetimide|dexetimide|mesh-list
92435230|NCT01594866|Citalopram|citalopram|mesh-list
92435231|NCT01594866|Escitalopram|escitalopram|mesh-list
92435232|NCT01594866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92435233|NCT01594866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92435234|NCT01594866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435235|NCT01594866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435236|NCT01594866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435237|NCT01594866|Serotonin Agents|serotonin agents|mesh-ancestor
92435238|NCT01594866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435239|NCT01594866|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92435240|NCT01594866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92435241|NCT01594866|Parasympatholytics|parasympatholytics|mesh-ancestor
92435242|NCT01594866|Autonomic Agents|autonomic agents|mesh-ancestor
92435243|NCT01594866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435244|NCT01594866|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92435245|NCT01594866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92435246|NCT01594866|Cholinergic Agents|cholinergic agents|mesh-ancestor
92435247|NCT01594866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92435248|NCT01594866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92435249|NCT01594866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92435250|NCT01594879|Levonorgestrel|levonorgestrel|mesh-list
92435251|NCT01594879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92435252|NCT01594879|Contraceptive Agents|contraceptive agents|mesh-ancestor
92435253|NCT01594879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435254|NCT01594879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435255|NCT01594879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92435256|NCT01594879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92160038|NCT00519675|Alitretinoin|alitretinoin|mesh-list
92160039|NCT00519675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160040|NCT00519675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160041|NCT00492999|Leucovorin|leucovorin|mesh-list
92160042|NCT00492999|Dexamethasone|dexamethasone|mesh-list
92160043|NCT00492999|Fluorouracil|fluorouracil|mesh-list
92160044|NCT00492999|Oxaliplatin|oxaliplatin|mesh-list
92160045|NCT00492999|Irinotecan|irinotecan|mesh-list
92160046|NCT00492999|Floxuridine|floxuridine|mesh-list
92435257|NCT01594879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92435258|NCT01594905|Tenofovir|tenofovir|mesh-list
92435259|NCT01594905|Entecavir|entecavir|mesh-list
92435260|NCT01594905|Antiviral Agents|antiviral agents|mesh-ancestor
92435261|NCT01594905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435262|NCT01594905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92435263|NCT01594905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92435264|NCT01594905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435265|NCT01594905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435266|NCT01594905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92435267|NCT01594905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92435268|NCT01594918|Prednisone|prednisone|mesh-list
92435269|NCT01594918|Mitoxantrone|mitoxantrone|mesh-list
92531065|NCT00044785|Fluorouracil|fluorouracil|mesh-list
92435270|NCT01594918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435271|NCT01594918|Glucocorticoids|glucocorticoids|mesh-ancestor
92435272|NCT01594918|Hormones|hormones|mesh-ancestor
92435273|NCT01594918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435274|NCT01594918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435275|NCT01594918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92435276|NCT01594918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435277|NCT01594918|Analgesics|analgesics|mesh-ancestor
92435278|NCT01594918|Sensory System Agents|sensory system agents|mesh-ancestor
92435279|NCT01594918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435280|NCT01594918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92435281|NCT01594918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92435282|NCT01594918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435283|NCT01594918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435284|NCT01595009|Everolimus|everolimus|mesh-list
92435285|NCT01595009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92435286|NCT01595009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92435287|NCT01595009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435288|NCT01595009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435289|NCT01595009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92435290|NCT01595009|Immunologic Factors|immunologic factors|mesh-ancestor
92435291|NCT01595009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435292|NCT01595009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435293|NCT01595022|Levonorgestrel|levonorgestrel|mesh-list
92435294|NCT01595022|Contraceptive Agents|contraceptive agents|mesh-list
92435295|NCT01595022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92435296|NCT01595022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435297|NCT01595022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435298|NCT01595022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92435299|NCT01595022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92435300|NCT01595022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92435301|NCT01595152|Solifenacin Succinate|solifenacin succinate|mesh-list
92435302|NCT01595152|Fesoterodine|fesoterodine|mesh-list
92435303|NCT01595152|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92435304|NCT01595152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92435305|NCT01595152|Cholinergic Agents|cholinergic agents|mesh-ancestor
92435306|NCT01595152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435307|NCT01595152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435308|NCT01595152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435309|NCT01595152|Urological Agents|urological agents|mesh-ancestor
92435310|NCT01595334|Cetrorelix|cetrorelix|mesh-list
92435311|NCT01595334|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92435312|NCT01595334|Fertility Agents|fertility agents|mesh-ancestor
92435313|NCT01595334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435314|NCT01595334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435315|NCT01595334|Hormone Antagonists|hormone antagonists|mesh-ancestor
92435316|NCT01595334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435317|NCT01595399|Atropine|atropine|mesh-list
92435318|NCT01595399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92435319|NCT01595399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92435320|NCT01595399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92435321|NCT01595399|Autonomic Agents|autonomic agents|mesh-ancestor
92435322|NCT01595399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435323|NCT01595399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435324|NCT01595399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92435325|NCT01595399|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435326|NCT01595399|Mydriatics|mydriatics|mesh-ancestor
92435327|NCT01595399|Parasympatholytics|parasympatholytics|mesh-ancestor
92435328|NCT01595399|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92435329|NCT01595399|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92435330|NCT01595399|Cholinergic Agents|cholinergic agents|mesh-ancestor
92435331|NCT01595399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435332|NCT01595399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435333|NCT01595425|Esomeprazole|esomeprazole|mesh-list
92435334|NCT01595425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92435335|NCT01595425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435336|NCT01595425|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92435337|NCT01595425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435338|NCT01595425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435339|NCT01595594|Doxycycline|doxycycline|mesh-list
92435340|NCT01595594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92435341|NCT01595594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435342|NCT01595594|Antimalarials|antimalarials|mesh-ancestor
92435343|NCT01595594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92435344|NCT01595594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92435346|NCT01595633|Adefovir|adefovir|mesh-list
92435347|NCT01595633|Antiviral Agents|antiviral agents|mesh-ancestor
92435348|NCT01595633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435349|NCT01595633|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92435350|NCT01595633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92435351|NCT01595633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435352|NCT01595633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435353|NCT01595633|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92435354|NCT01595633|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92435355|NCT01595685|Entecavir|entecavir|mesh-list
92435356|NCT01595685|Telbivudine|telbivudine|mesh-list
92435357|NCT01595685|Antiviral Agents|antiviral agents|mesh-ancestor
92435358|NCT01595685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435359|NCT01595685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92435360|NCT01595685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435361|NCT01595685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435362|NCT01595724|Dienogest|dienogest|mesh-list
92435363|NCT01595724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92435364|NCT01595724|Contraceptive Agents|contraceptive agents|mesh-ancestor
92435365|NCT01595724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435366|NCT01595724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435367|NCT01595724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92435368|NCT01595724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92435369|NCT01595724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92435370|NCT01595724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92435371|NCT01595724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92435372|NCT01595724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435373|NCT01595724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92435374|NCT01595724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435375|NCT01595737|Simendan|simendan|mesh-list
92435376|NCT01595737|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92435377|NCT01595737|Vasodilator Agents|vasodilator agents|mesh-ancestor
92435378|NCT01595737|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92435379|NCT01595737|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92435380|NCT01595737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435381|NCT01595737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435382|NCT01595737|Protective Agents|protective agents|mesh-ancestor
92435383|NCT01595737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435384|NCT01595763|Fibrin fragment D|fibrin fragment d|mesh-list
92435385|NCT01595763|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92435386|NCT01595763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92435387|NCT01595763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435388|NCT01595763|Hemostatics|hemostatics|mesh-ancestor
92435389|NCT01595763|Coagulants|coagulants|mesh-ancestor
92435390|NCT01595789|Liraglutide|liraglutide|mesh-list
92435391|NCT01595789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435392|NCT01595789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435393|NCT01595789|Incretins|incretins|mesh-ancestor
92435394|NCT01595789|Hormones|hormones|mesh-ancestor
92435395|NCT01595789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435396|NCT01595815|Calcium|calcium|mesh-list
92435397|NCT01595815|Ionophores|ionophores|mesh-list
92435398|NCT01595815|Calcium Ionophores|calcium ionophores|mesh-list
92435399|NCT01595815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92435400|NCT01595815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435401|NCT01595815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435402|NCT01595815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435403|NCT01595828|Pitavastatin|pitavastatin|mesh-list
92435404|NCT01595828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92435405|NCT01595828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92435406|NCT01595828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92435407|NCT01595828|Antimetabolites|antimetabolites|mesh-ancestor
92435408|NCT01595828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435409|NCT01595828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435410|NCT01595828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92435411|NCT01595867|Naltrexone|naltrexone|mesh-list
92435412|NCT01595867|Morphine|morphine|mesh-list
92435413|NCT01595867|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92435414|NCT01595867|Narcotics|narcotics|mesh-ancestor
92435415|NCT01595867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435416|NCT01595867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435417|NCT01595867|Analgesics|analgesics|mesh-ancestor
92435418|NCT01595867|Sensory System Agents|sensory system agents|mesh-ancestor
92435419|NCT01595867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435420|NCT01595867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92435421|NCT01595867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92435422|NCT01595880|Metformin|metformin|mesh-list
92435423|NCT01595880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435424|NCT01595880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435425|NCT01595893|Vitamin D|vitamin d|mesh-list
92435426|NCT01595893|Cholecalciferol|cholecalciferol|mesh-list
92435427|NCT01595893|Vitamins|vitamins|mesh-ancestor
92435428|NCT01595893|Micronutrients|micronutrients|mesh-ancestor
92435429|NCT01595893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435430|NCT01595893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92435431|NCT01595893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92435432|NCT01595958|Cyclosporine|cyclosporine|mesh-list
92435433|NCT01595958|Cyclosporins|cyclosporins|mesh-list
92435434|NCT01595958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435435|NCT01595958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435436|NCT01595958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92435437|NCT01595958|Immunologic Factors|immunologic factors|mesh-ancestor
92435438|NCT01595958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435439|NCT01595958|Antifungal Agents|antifungal agents|mesh-ancestor
92435440|NCT01595958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435441|NCT01595958|Dermatologic Agents|dermatologic agents|mesh-ancestor
92435442|NCT01595958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435443|NCT01595958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92435444|NCT01595984|Cyclosporine|cyclosporine|mesh-list
92435445|NCT01595984|Mycophenolic Acid|mycophenolic acid|mesh-list
92435446|NCT01595984|Everolimus|everolimus|mesh-list
92435447|NCT01595984|Cyclosporins|cyclosporins|mesh-list
92435448|NCT01595984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435449|NCT01595984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435450|NCT01595984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343760|NCT05895240|Urinastatin|urinastatin|mesh-list
92435451|NCT01595984|Immunologic Factors|immunologic factors|mesh-ancestor
92435452|NCT01595984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435453|NCT01595984|Antifungal Agents|antifungal agents|mesh-ancestor
92435454|NCT01595984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435455|NCT01595984|Dermatologic Agents|dermatologic agents|mesh-ancestor
92435456|NCT01595984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435457|NCT01595984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92435458|NCT01595984|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92435459|NCT01595984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92435460|NCT01595984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435461|NCT01595984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92435462|NCT01595984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92435463|NCT01595984|Antitubercular Agents|antitubercular agents|mesh-ancestor
92435464|NCT01595984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92435465|NCT01596010|Norethindrone|norethindrone|mesh-list
92435466|NCT01596010|Norethindrone Acetate|norethindrone acetate|mesh-list
92435467|NCT01596010|Estradiol|estradiol|mesh-list
92435468|NCT01596010|Estrogens|estrogens|mesh-ancestor
92435469|NCT01596010|Hormones|hormones|mesh-ancestor
92435470|NCT01596010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435471|NCT01596010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435472|NCT01596010|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92435473|NCT01596010|Contraceptive Agents|contraceptive agents|mesh-ancestor
92435474|NCT01596010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435475|NCT01596010|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92435476|NCT01596010|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92435477|NCT01596010|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92435478|NCT01596010|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92435479|NCT01596075|Cannabidiol|cannabidiol|mesh-list
92435480|NCT01596075|Anticonvulsants|anticonvulsants|mesh-ancestor
92435481|NCT01596114|Tin Fluorides|tin fluorides|mesh-list
92435482|NCT01596114|Cariostatic Agents|cariostatic agents|mesh-ancestor
92435483|NCT01596114|Protective Agents|protective agents|mesh-ancestor
92435484|NCT01596114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435485|NCT01596140|Sirolimus|sirolimus|mesh-list
92435486|NCT01596140|Everolimus|everolimus|mesh-list
92435487|NCT01596140|Temsirolimus|temsirolimus|mesh-list
92435488|NCT01596140|MTOR Inhibitors|mtor inhibitors|mesh-list
92435489|NCT01596140|Vemurafenib|vemurafenib|mesh-list
92435490|NCT01596140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92435491|NCT01596140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435492|NCT01596140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435493|NCT01596140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92435494|NCT01596140|Immunologic Factors|immunologic factors|mesh-ancestor
92435495|NCT01596140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435496|NCT01596140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435497|NCT01596140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92435498|NCT01596140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435499|NCT01596140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92435500|NCT01596140|Antifungal Agents|antifungal agents|mesh-ancestor
92435501|NCT01596166|Ketorolac|ketorolac|mesh-list
92435502|NCT01596166|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92435503|NCT01596166|Metoclopramide|metoclopramide|mesh-list
92435504|NCT01596166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435505|NCT01596166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92435506|NCT01596166|Analgesics|analgesics|mesh-ancestor
92435507|NCT01596166|Sensory System Agents|sensory system agents|mesh-ancestor
92435508|NCT01596166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435509|NCT01596166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435510|NCT01596166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435511|NCT01596166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435512|NCT01596166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92435513|NCT01596166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435514|NCT01596166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435515|NCT01596166|Antiemetics|antiemetics|mesh-ancestor
92435516|NCT01596166|Autonomic Agents|autonomic agents|mesh-ancestor
92435517|NCT01596166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435518|NCT01596166|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92435519|NCT01596166|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92435520|NCT01596166|Dopamine Agents|dopamine agents|mesh-ancestor
92435521|NCT01596166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435522|NCT01596218|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92343772|NCT05895123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92435523|NCT01596218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92435524|NCT01596218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435525|NCT01596218|Immunotoxins|immunotoxins|mesh-ancestor
92435526|NCT01596218|Immunoconjugates|immunoconjugates|mesh-ancestor
92435527|NCT01596218|Immunologic Factors|immunologic factors|mesh-ancestor
92435528|NCT01596218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435529|NCT01596296|Dinoprostone|dinoprostone|mesh-list
92435530|NCT01596296|Oxytocics|oxytocics|mesh-ancestor
92435531|NCT01596296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435532|NCT01596296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435533|NCT01596387|Propofol|propofol|mesh-list
92435534|NCT01596387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92435535|NCT01596387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435536|NCT01596387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435537|NCT01596387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92435538|NCT01596387|Anesthetics, General|anesthetics, general|mesh-ancestor
92435539|NCT01596387|Anesthetics|anesthetics|mesh-ancestor
92435540|NCT01596400|Granisetron|granisetron|mesh-list
92435541|NCT01596400|Antiemetics|antiemetics|mesh-ancestor
92435542|NCT01596400|Autonomic Agents|autonomic agents|mesh-ancestor
92435543|NCT01596400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435544|NCT01596400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200046|NCT00580073|Immunologic Factors|immunologic factors|mesh-ancestor
92435546|NCT01596400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92435547|NCT01596400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92435548|NCT01596400|Serotonin Agents|serotonin agents|mesh-ancestor
92435549|NCT01596400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435550|NCT01596400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435551|NCT01596413|Granisetron|granisetron|mesh-list
92435552|NCT01596413|Antiemetics|antiemetics|mesh-ancestor
92435553|NCT01596413|Autonomic Agents|autonomic agents|mesh-ancestor
92435554|NCT01596413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435555|NCT01596413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435556|NCT01596413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435557|NCT01596413|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92435558|NCT01596413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92435559|NCT01596413|Serotonin Agents|serotonin agents|mesh-ancestor
92435560|NCT01596413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435561|NCT01596413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435562|NCT01596426|Granisetron|granisetron|mesh-list
92435563|NCT01596426|Antiemetics|antiemetics|mesh-ancestor
92435564|NCT01596426|Autonomic Agents|autonomic agents|mesh-ancestor
92435565|NCT01596426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435566|NCT01596426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435567|NCT01596426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435568|NCT01596426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92435569|NCT01596426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92435570|NCT01596426|Serotonin Agents|serotonin agents|mesh-ancestor
92435571|NCT01596426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435572|NCT01596426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435573|NCT01596517|Ribavirin|ribavirin|mesh-list
92435574|NCT01596517|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92435575|NCT01596517|Interferon-alpha|interferon-alpha|mesh-list
92435576|NCT01596517|Antimetabolites|antimetabolites|mesh-ancestor
92435577|NCT01596517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435578|NCT01596517|Antiviral Agents|antiviral agents|mesh-ancestor
92435579|NCT01596517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435580|NCT01596517|Immunologic Factors|immunologic factors|mesh-ancestor
92435581|NCT01596517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435582|NCT01596556|Nicotine|nicotine|mesh-list
92435583|NCT01596556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92435584|NCT01596556|Autonomic Agents|autonomic agents|mesh-ancestor
92435585|NCT01596556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435586|NCT01596556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435587|NCT01596556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92435588|NCT01596556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92435589|NCT01596556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92435590|NCT01596556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435591|NCT01596556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435592|NCT01596634|Lactoferrin|lactoferrin|mesh-list
92435593|NCT01596634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435594|NCT01596647|Diclofenac|diclofenac|mesh-list
92435595|NCT01596647|Midazolam|midazolam|mesh-list
92435596|NCT01596647|Caffeine|caffeine|mesh-list
92435597|NCT01596647|Omeprazole|omeprazole|mesh-list
92435598|NCT01596647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92435599|NCT01596647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92435600|NCT01596647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435601|NCT01596647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435602|NCT01596647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92435603|NCT01596647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92435604|NCT01596647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92435605|NCT01596647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92435606|NCT01596647|Anesthetics, General|anesthetics, general|mesh-ancestor
92435607|NCT01596647|Anesthetics|anesthetics|mesh-ancestor
92435608|NCT01596647|GABA Modulators|gaba modulators|mesh-ancestor
92435609|NCT01596647|GABA Agents|gaba agents|mesh-ancestor
92435610|NCT01596647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435611|NCT01596647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435612|NCT01596647|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92435613|NCT01596647|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92435614|NCT01596647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435615|NCT01596647|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92435616|NCT01596647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92435617|NCT01596647|Purinergic Agents|purinergic agents|mesh-ancestor
92435618|NCT01596647|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92435619|NCT01596647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435621|NCT01596647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435622|NCT01596647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92435623|NCT01596647|Analgesics|analgesics|mesh-ancestor
92435624|NCT01596647|Sensory System Agents|sensory system agents|mesh-ancestor
92435625|NCT01596647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435626|NCT01596647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435627|NCT01596647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435628|NCT01596647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92435629|NCT01596660|Bupivacaine|bupivacaine|mesh-list
92435630|NCT01596660|Anesthetics, Local|anesthetics, local|mesh-ancestor
92435631|NCT01596660|Anesthetics|anesthetics|mesh-ancestor
92435632|NCT01596660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435633|NCT01596660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435634|NCT01596660|Sensory System Agents|sensory system agents|mesh-ancestor
92148797|NCT05239884|Nicotine|nicotine|mesh-list
92435635|NCT01596660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435637|NCT01596673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92435638|NCT01596673|Narcotics|narcotics|mesh-ancestor
92435639|NCT01596673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435640|NCT01596673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435641|NCT01596673|Analgesics|analgesics|mesh-ancestor
92435642|NCT01596673|Sensory System Agents|sensory system agents|mesh-ancestor
92435643|NCT01596673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435644|NCT01596673|Antitussive Agents|antitussive agents|mesh-ancestor
92435645|NCT01596673|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435646|NCT01596686|Picosulfate sodium|picosulfate sodium|mesh-list
92435647|NCT01596686|Cathartics|cathartics|mesh-ancestor
92435648|NCT01596686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435649|NCT01596738|Tranexamic Acid|tranexamic acid|mesh-list
92435650|NCT01596738|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92435651|NCT01596738|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92435652|NCT01596738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435653|NCT01596738|Hemostatics|hemostatics|mesh-ancestor
92435654|NCT01596738|Coagulants|coagulants|mesh-ancestor
92435655|NCT01596764|Sulfasalazine|sulfasalazine|mesh-list
92435656|NCT01596764|Naloxone|naloxone|mesh-list
92435657|NCT01596764|Methylnaltrexone|methylnaltrexone|mesh-list
92435658|NCT01596764|Loperamide|loperamide|mesh-list
92435659|NCT01596764|Antidiarrheals|antidiarrheals|mesh-list
92435660|NCT01596764|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92435661|NCT01596764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435662|NCT01596764|Sensory System Agents|sensory system agents|mesh-ancestor
92435663|NCT01596764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435664|NCT01596764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435665|NCT01596764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435666|NCT01596764|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435667|NCT01596764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92435668|NCT01596764|Analgesics|analgesics|mesh-ancestor
92435669|NCT01596764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435670|NCT01596764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435671|NCT01596777|Sulfasalazine|sulfasalazine|mesh-list
92435672|NCT01596777|Naltrexone|naltrexone|mesh-list
92435673|NCT01596777|Methylnaltrexone|methylnaltrexone|mesh-list
92435674|NCT01596777|Loperamide|loperamide|mesh-list
92435675|NCT01596777|Antidiarrheals|antidiarrheals|mesh-list
92435676|NCT01596777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435677|NCT01596777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435678|NCT01596777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435679|NCT01596777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92435680|NCT01596777|Analgesics|analgesics|mesh-ancestor
92435681|NCT01596777|Sensory System Agents|sensory system agents|mesh-ancestor
92435682|NCT01596777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435683|NCT01596777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435684|NCT01596777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435685|NCT01596777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435686|NCT01596777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92435687|NCT01596777|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92435688|NCT01596803|Ascorbic Acid|ascorbic acid|mesh-list
92435689|NCT01596803|Vitamin E|vitamin e|mesh-list
92435690|NCT01596803|alpha-Tocopherol|alpha-tocopherol|mesh-list
92435691|NCT01596803|Tocopherols|tocopherols|mesh-list
92435692|NCT01596803|Antioxidants|antioxidants|mesh-list
92435693|NCT01596803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435694|NCT01596803|Protective Agents|protective agents|mesh-ancestor
92435695|NCT01596803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435696|NCT01596803|Vitamins|vitamins|mesh-ancestor
92435697|NCT01596803|Micronutrients|micronutrients|mesh-ancestor
92435699|NCT01596855|Hematinics|hematinics|mesh-ancestor
92435700|NCT01596868|Cisplatin|cisplatin|mesh-list
92435701|NCT01596868|Gemcitabine|gemcitabine|mesh-list
92435702|NCT01596868|Docetaxel|docetaxel|mesh-list
92435703|NCT01596868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92435704|NCT01596868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92435705|NCT01596868|Antimetabolites|antimetabolites|mesh-ancestor
92435706|NCT01596868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435707|NCT01596868|Tubulin Modulators|tubulin modulators|mesh-ancestor
92435708|NCT01596868|Antimitotic Agents|antimitotic agents|mesh-ancestor
92435709|NCT01596868|Mitosis Modulators|mitosis modulators|mesh-ancestor
92435710|NCT01596894|Azithromycin|azithromycin|mesh-list
92435711|NCT01596894|Metronidazole|metronidazole|mesh-list
92435712|NCT01596894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92435713|NCT01596894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435714|NCT01596894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92148879|NCT00864123|Cycloserine|cycloserine|mesh-list
92435715|NCT01596894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92435716|NCT01596907|Ephedrine|ephedrine|mesh-list
92435717|NCT01596907|Pseudoephedrine|pseudoephedrine|mesh-list
92435718|NCT01596907|Caffeine|caffeine|mesh-list
92435719|NCT01596907|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92435720|NCT01596907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435721|NCT01596907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92435722|NCT01596907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435723|NCT01596907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435724|NCT01596907|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92435725|NCT01596907|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92435726|NCT01596907|Purinergic Agents|purinergic agents|mesh-ancestor
92435727|NCT01596907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435728|NCT01596907|Sympathomimetics|sympathomimetics|mesh-ancestor
92435729|NCT01596907|Autonomic Agents|autonomic agents|mesh-ancestor
92435730|NCT01596907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435731|NCT01596907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92435732|NCT01596907|Adrenergic Agents|adrenergic agents|mesh-ancestor
92435733|NCT01596907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92435734|NCT01596907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92435735|NCT01596907|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435736|NCT01596907|Nasal Decongestants|nasal decongestants|mesh-ancestor
92435737|NCT01596998|Epinephrine|epinephrine|mesh-list
92435738|NCT01596998|Racepinephrine|racepinephrine|mesh-list
92435739|NCT01596998|Levobupivacaine|levobupivacaine|mesh-list
92435740|NCT01596998|Epinephryl borate|epinephryl borate|mesh-list
92435741|NCT01596998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92435742|NCT01596998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92435743|NCT01596998|Adrenergic Agents|adrenergic agents|mesh-ancestor
92435744|NCT01596998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435745|NCT01596998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435746|NCT01596998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435747|NCT01596998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92435748|NCT01596998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92435749|NCT01596998|Autonomic Agents|autonomic agents|mesh-ancestor
92435750|NCT01596998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435751|NCT01596998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92435752|NCT01596998|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435753|NCT01596998|Mydriatics|mydriatics|mesh-ancestor
92435754|NCT01596998|Sympathomimetics|sympathomimetics|mesh-ancestor
92435755|NCT01596998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92435756|NCT01596998|Anesthetics, Local|anesthetics, local|mesh-ancestor
92435757|NCT01596998|Anesthetics|anesthetics|mesh-ancestor
92435758|NCT01596998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435759|NCT01596998|Sensory System Agents|sensory system agents|mesh-ancestor
92435760|NCT01597011|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92435761|NCT01597011|Hemostatics|hemostatics|mesh-ancestor
92435762|NCT01597011|Coagulants|coagulants|mesh-ancestor
92435763|NCT01597167|Magnesium Sulfate|magnesium sulfate|mesh-list
92435764|NCT01597167|Analgesics|analgesics|mesh-ancestor
92435765|NCT01597167|Sensory System Agents|sensory system agents|mesh-ancestor
92435766|NCT01597167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435767|NCT01597167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435768|NCT01597167|Anesthetics|anesthetics|mesh-ancestor
92435769|NCT01597167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92435770|NCT01597167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92435771|NCT01597167|Anticonvulsants|anticonvulsants|mesh-ancestor
92435772|NCT01597167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92435773|NCT01597167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435774|NCT01597167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435775|NCT01597167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92435776|NCT01597167|Tocolytic Agents|tocolytic agents|mesh-ancestor
92435777|NCT01597167|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435778|NCT01597206|Cobalt|cobalt|mesh-list
92435779|NCT01597206|Trace Elements|trace elements|mesh-ancestor
92435780|NCT01597206|Micronutrients|micronutrients|mesh-ancestor
92435781|NCT01597206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435782|NCT01597232|Chrysarobin|chrysarobin|mesh-list
92435783|NCT01597232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435784|NCT01597232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92435785|NCT01597232|Analgesics|analgesics|mesh-ancestor
92343819|NCT05894200|Fluorides|fluorides|mesh-list
92435786|NCT01597232|Sensory System Agents|sensory system agents|mesh-ancestor
92435787|NCT01597232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435788|NCT01597232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435789|NCT01597232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435790|NCT01597232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435791|NCT01597297|4-Aminopyridine|4-aminopyridine|mesh-list
92435792|NCT01597297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92160563|NCT01118091|Aldesleukin|aldesleukin|mesh-list
92435793|NCT01597297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435794|NCT01597297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435795|NCT01597310|Pramipexole|pramipexole|mesh-list
92435796|NCT01597310|Warfarin|warfarin|mesh-list
92435797|NCT01597310|Anticoagulants|anticoagulants|mesh-ancestor
92435798|NCT01597310|Antioxidants|antioxidants|mesh-ancestor
92435799|NCT01597310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435800|NCT01597310|Protective Agents|protective agents|mesh-ancestor
92435801|NCT01597310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435802|NCT01597310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92435803|NCT01597310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92435804|NCT01597310|Dopamine Agonists|dopamine agonists|mesh-ancestor
92435805|NCT01597310|Dopamine Agents|dopamine agents|mesh-ancestor
92435806|NCT01597310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435807|NCT01597336|Plasminogen|plasminogen|mesh-list
92435808|NCT01597336|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92435809|NCT01597336|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92435810|NCT01597336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92435811|NCT01597336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435812|NCT01597427|Clonidine|clonidine|mesh-list
92435813|NCT01597427|Analgesics|analgesics|mesh-ancestor
92435814|NCT01597427|Sensory System Agents|sensory system agents|mesh-ancestor
92435815|NCT01597427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435816|NCT01597427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435817|NCT01597427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92435818|NCT01597427|Sympatholytics|sympatholytics|mesh-ancestor
92435819|NCT01597427|Autonomic Agents|autonomic agents|mesh-ancestor
92435820|NCT01597427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92435821|NCT01597427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92435822|NCT01597427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92435823|NCT01597427|Adrenergic Agents|adrenergic agents|mesh-ancestor
92435824|NCT01597427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435825|NCT01597427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435826|NCT01597518|Riluzole|riluzole|mesh-list
92435827|NCT01597518|Anticonvulsants|anticonvulsants|mesh-ancestor
92435828|NCT01597518|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92435829|NCT01597518|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92435830|NCT01597518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435831|NCT01597518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435832|NCT01597518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435833|NCT01597518|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92435834|NCT01597518|Protective Agents|protective agents|mesh-ancestor
92435835|NCT01597531|Liraglutide|liraglutide|mesh-list
92435836|NCT01597531|Orlistat|orlistat|mesh-list
92435837|NCT01597531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435838|NCT01597531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435839|NCT01597531|Incretins|incretins|mesh-ancestor
92435840|NCT01597531|Hormones|hormones|mesh-ancestor
92435841|NCT01597531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435842|NCT01597531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435843|NCT01597531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435845|NCT01597531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92435846|NCT01597609|Sibutramine|sibutramine|mesh-list
92435847|NCT01597609|Antidepressive Agents|antidepressive agents|mesh-ancestor
92435848|NCT01597609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92435849|NCT01597609|Appetite Depressants|appetite depressants|mesh-ancestor
92435850|NCT01597609|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92435851|NCT01597648|Maraviroc|maraviroc|mesh-list
92435852|NCT01597648|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92435853|NCT01597648|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92435854|NCT01597648|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92435855|NCT01597648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435856|NCT01597648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92435857|NCT01597648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92435858|NCT01597648|Antiviral Agents|antiviral agents|mesh-ancestor
92435859|NCT01597648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435860|NCT01597648|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92531081|NCT00044785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435861|NCT01597648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92435862|NCT01597648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92435863|NCT01597648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160638|NCT03013101|Antibodies|antibodies|mesh-list
92435864|NCT01597661|Bupropion|bupropion|mesh-list
92435865|NCT01597661|Antidepressive Agents|antidepressive agents|mesh-list
92435866|NCT01597661|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92435867|NCT01597661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92435868|NCT01597661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92435869|NCT01597661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92435870|NCT01597661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92435871|NCT01597661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435872|NCT01597661|Dopamine Agents|dopamine agents|mesh-ancestor
92435873|NCT01597661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92435874|NCT01597661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435875|NCT01597661|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92435876|NCT01597661|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92435877|NCT01597661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435878|NCT01597700|Ezetimibe|ezetimibe|mesh-list
92435879|NCT01597700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92435880|NCT01597700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92435881|NCT01597700|Antimetabolites|antimetabolites|mesh-ancestor
92435882|NCT01597700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435883|NCT01597700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92435884|NCT01597713|Insulin Glargine|insulin glargine|mesh-list
92435885|NCT01597713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92435886|NCT01597713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435887|NCT01597726|Misoprostol|misoprostol|mesh-list
92435888|NCT01597726|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92435889|NCT01597726|Abortifacient Agents|abortifacient agents|mesh-ancestor
92435890|NCT01597726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435891|NCT01597726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435892|NCT01597726|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92435893|NCT01597726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92435894|NCT01597726|Oxytocics|oxytocics|mesh-ancestor
92435895|NCT01597765|Vitamins|vitamins|mesh-list
92435896|NCT01597765|Vitamin E|vitamin e|mesh-list
92435897|NCT01597765|Tocopherols|tocopherols|mesh-list
92435898|NCT01597765|Tocotrienols|tocotrienols|mesh-list
92435899|NCT01597765|alpha-Tocopherol|alpha-tocopherol|mesh-list
92435900|NCT01597765|Acetylcysteine|acetylcysteine|mesh-list
92435901|NCT01597765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92435902|NCT01597765|Deferiprone|deferiprone|mesh-list
92435903|NCT01597765|Micronutrients|micronutrients|mesh-ancestor
92435904|NCT01597765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435905|NCT01597765|Antiviral Agents|antiviral agents|mesh-ancestor
92435906|NCT01597765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435907|NCT01597765|Expectorants|expectorants|mesh-ancestor
92435908|NCT01597765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92435909|NCT01597765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92435910|NCT01597765|Antioxidants|antioxidants|mesh-ancestor
92435911|NCT01597765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435912|NCT01597765|Protective Agents|protective agents|mesh-ancestor
92435913|NCT01597765|Antidotes|antidotes|mesh-ancestor
92435914|NCT01597765|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92435915|NCT01597765|Chelating Agents|chelating agents|mesh-ancestor
92435916|NCT01597765|Sequestering Agents|sequestering agents|mesh-ancestor
92435917|NCT01597817|Chitosan|chitosan|mesh-list
92435918|NCT01597817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92435919|NCT01597817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92435920|NCT01597817|Antimetabolites|antimetabolites|mesh-ancestor
92435921|NCT01597817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435922|NCT01597817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92435923|NCT01597817|Chelating Agents|chelating agents|mesh-ancestor
92435924|NCT01597817|Sequestering Agents|sequestering agents|mesh-ancestor
92435926|NCT01597817|Coagulants|coagulants|mesh-ancestor
92435927|NCT01597895|Maraviroc|maraviroc|mesh-list
92435928|NCT01597895|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92435929|NCT01597895|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92435930|NCT01597895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435931|NCT01597895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92435932|NCT01597895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92435933|NCT01597895|Antiviral Agents|antiviral agents|mesh-ancestor
92435934|NCT01597895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435935|NCT01597895|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92435936|NCT01597934|Tenofovir|tenofovir|mesh-list
92435937|NCT01597934|Entecavir|entecavir|mesh-list
92435938|NCT01597934|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92435939|NCT01597934|Adefovir|adefovir|mesh-list
92435940|NCT01597934|Lamivudine|lamivudine|mesh-list
92435941|NCT01597934|Telbivudine|telbivudine|mesh-list
92435942|NCT01597934|Antiviral Agents|antiviral agents|mesh-ancestor
92435943|NCT01597934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435944|NCT01597934|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92435945|NCT01597934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92435946|NCT01597934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435947|NCT01597934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435948|NCT01597934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92435949|NCT01597934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92435950|NCT01597986|Isavuconazole|isavuconazole|mesh-list
92435951|NCT01597986|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92435952|NCT01597986|Norethindrone|norethindrone|mesh-list
92435953|NCT01597986|Norethindrone Acetate|norethindrone acetate|mesh-list
92435954|NCT01597986|Norinyl|norinyl|mesh-list
92435955|NCT01597986|Contraceptive Agents|contraceptive agents|mesh-list
92435956|NCT01597986|Contraceptives, Oral|contraceptives, oral|mesh-list
92435957|NCT01597986|Estradiol|estradiol|mesh-list
92435958|NCT01597986|Estrogens|estrogens|mesh-ancestor
92435959|NCT01597986|Hormones|hormones|mesh-ancestor
92435960|NCT01597986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92435961|NCT01597986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435962|NCT01597986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92435963|NCT01597986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92435964|NCT01597986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92435965|NCT01597986|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92435966|NCT01597986|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92435967|NCT01597986|Antifungal Agents|antifungal agents|mesh-ancestor
92435968|NCT01597986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92435969|NCT01597986|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92435970|NCT01598012|Mefenamic Acid|mefenamic acid|mesh-list
92435971|NCT01598012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92435972|NCT01598012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92435973|NCT01598012|Analgesics|analgesics|mesh-ancestor
92435974|NCT01598012|Sensory System Agents|sensory system agents|mesh-ancestor
92435975|NCT01598012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92435976|NCT01598012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92435977|NCT01598012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92435978|NCT01598012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92435979|NCT01598012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92435980|NCT01598012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435981|NCT01598012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435982|NCT01598051|Rivaroxaban|rivaroxaban|mesh-list
92435983|NCT01598051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92435984|NCT01598051|Antithrombins|antithrombins|mesh-ancestor
92435985|NCT01598051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92435986|NCT01598051|Protease Inhibitors|protease inhibitors|mesh-ancestor
92435987|NCT01598051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435988|NCT01598051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435989|NCT01598051|Anticoagulants|anticoagulants|mesh-ancestor
92435990|NCT01598168|Rivaroxaban|rivaroxaban|mesh-list
92435991|NCT01598168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92435992|NCT01598168|Antithrombins|antithrombins|mesh-ancestor
92435993|NCT01598168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92435994|NCT01598168|Protease Inhibitors|protease inhibitors|mesh-ancestor
92435995|NCT01598168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92435996|NCT01598168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92435997|NCT01598168|Anticoagulants|anticoagulants|mesh-ancestor
92435999|NCT01598259|Antioxidants|antioxidants|mesh-ancestor
92436000|NCT01598259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436001|NCT01598259|Protective Agents|protective agents|mesh-ancestor
92436002|NCT01598259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436003|NCT01598259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436004|NCT01598337|Aspirin|aspirin|mesh-list
92436005|NCT01598337|Tirofiban|tirofiban|mesh-list
92436006|NCT01598337|Clopidogrel|clopidogrel|mesh-list
92436007|NCT01598337|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92436008|NCT01598337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92436009|NCT01598337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92436010|NCT01598337|Analgesics|analgesics|mesh-ancestor
92436011|NCT01598337|Sensory System Agents|sensory system agents|mesh-ancestor
92436012|NCT01598337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436013|NCT01598337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436014|NCT01598337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92436015|NCT01598337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436016|NCT01598337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92436017|NCT01598337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92436018|NCT01598337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436019|NCT01598337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92436020|NCT01598337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92436021|NCT01598337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436022|NCT01598337|Antipyretics|antipyretics|mesh-ancestor
92436023|NCT01598337|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92436024|NCT01598337|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92436025|NCT01598337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92436026|NCT01598337|Purinergic Agents|purinergic agents|mesh-ancestor
92436027|NCT01598337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436028|NCT01598363|Digoxin|digoxin|mesh-list
92436029|NCT01598363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92436030|NCT01598363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92436031|NCT01598363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92436032|NCT01598363|Antimetabolites|antimetabolites|mesh-ancestor
92436033|NCT01598363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436034|NCT01598363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92436035|NCT01598363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92436036|NCT01598363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436037|NCT01598363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92436038|NCT01598363|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92436039|NCT01598363|Protective Agents|protective agents|mesh-ancestor
92436040|NCT01598363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436041|NCT01598402|Amoxicillin|amoxicillin|mesh-list
92436042|NCT01598402|Clavulanic Acids|clavulanic acids|mesh-list
92436043|NCT01598402|Clavulanic Acid|clavulanic acid|mesh-list
92436044|NCT01598402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92436045|NCT01598402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436046|NCT01598402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436047|NCT01598402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436048|NCT01598402|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92436049|NCT01598441|Iloprost|iloprost|mesh-list
92436050|NCT01598441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92343857|NCT05893472|Venetoclax|venetoclax|mesh-list
92436051|NCT01598441|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436052|NCT01598480|Anti-Infective Agents|anti-infective agents|mesh-list
92436053|NCT01598480|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92436054|NCT01598480|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92436055|NCT01598480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92436056|NCT01598493|Anti-Infective Agents|anti-infective agents|mesh-list
92436057|NCT01598493|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92436058|NCT01598493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92436059|NCT01598493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92436060|NCT01598558|Rituximab|rituximab|mesh-list
92436061|NCT01598558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436062|NCT01598558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436063|NCT01598558|Immunologic Factors|immunologic factors|mesh-ancestor
92436064|NCT01598558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436065|NCT01598558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436066|NCT01598584|Gemcitabine|gemcitabine|mesh-list
92436067|NCT01598584|Mirtazapine|mirtazapine|mesh-list
92436068|NCT01598584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436069|NCT01598584|Antimetabolites|antimetabolites|mesh-ancestor
92436070|NCT01598584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436071|NCT01598584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436072|NCT01598584|Antidepressive Agents|antidepressive agents|mesh-ancestor
92436073|NCT01598584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92436074|NCT01598584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92436075|NCT01598584|Histamine Antagonists|histamine antagonists|mesh-ancestor
92436076|NCT01598584|Histamine Agents|histamine agents|mesh-ancestor
92436077|NCT01598584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436078|NCT01598584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436079|NCT01598584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92436080|NCT01598584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92436081|NCT01598584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436082|NCT01598584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92436083|NCT01598584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92436084|NCT01598584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92436085|NCT01598584|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436086|NCT01598584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92436087|NCT01598584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92436088|NCT01598584|Serotonin Agents|serotonin agents|mesh-ancestor
92436089|NCT01598584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92436091|NCT01598623|Oxytocics|oxytocics|mesh-ancestor
92436092|NCT01598623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92436093|NCT01598623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436094|NCT01598649|Mannitol|mannitol|mesh-list
92436095|NCT01598649|Caseins|caseins|mesh-list
92436096|NCT01598649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92436097|NCT01598649|Diuretics|diuretics|mesh-ancestor
92436098|NCT01598649|Natriuretic Agents|natriuretic agents|mesh-ancestor
92436099|NCT01598649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436100|NCT01598649|Chelating Agents|chelating agents|mesh-ancestor
92436101|NCT01598649|Sequestering Agents|sequestering agents|mesh-ancestor
92436102|NCT01598649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436103|NCT01598675|Methamphetamine|methamphetamine|mesh-list
92436104|NCT01598675|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92436105|NCT01598675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436106|NCT01598675|Sympathomimetics|sympathomimetics|mesh-ancestor
92436107|NCT01598675|Autonomic Agents|autonomic agents|mesh-ancestor
92436108|NCT01598675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436109|NCT01598675|Dopamine Agents|dopamine agents|mesh-ancestor
92436110|NCT01598675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436111|NCT01598675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436112|NCT01598675|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436113|NCT01598675|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92436114|NCT01598675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92436115|NCT01598675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436116|NCT01598675|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92436117|NCT01598883|Heparin|heparin|mesh-list
92436118|NCT01598883|Calcium heparin|calcium heparin|mesh-list
92436119|NCT01598883|Antithrombins|antithrombins|mesh-list
92436120|NCT01598883|Anticoagulants|anticoagulants|mesh-ancestor
92436121|NCT01598883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92436122|NCT01598883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92436123|NCT01598883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436124|NCT01598883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92436125|NCT01598883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92436126|NCT01598883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436127|NCT01598948|Mipomersen|mipomersen|mesh-list
92436128|NCT01598948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92436129|NCT01598948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92436130|NCT01598948|Antimetabolites|antimetabolites|mesh-ancestor
92436131|NCT01598948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436132|NCT01598948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92436133|NCT01599000|Lumefantrine|lumefantrine|mesh-list
92436134|NCT01599000|Artemether|artemether|mesh-list
92436135|NCT01599000|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92436136|NCT01599000|Antimalarials|antimalarials|mesh-ancestor
92436137|NCT01599000|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92436138|NCT01599000|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92436139|NCT01599000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436140|NCT01599013|Carboplatin|carboplatin|mesh-list
92436141|NCT01599013|Gemcitabine|gemcitabine|mesh-list
92436142|NCT01599013|Vinblastine|vinblastine|mesh-list
92200050|NCT00580073|Vitamin B Complex|vitamin b complex|mesh-ancestor
92436143|NCT01599013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436144|NCT01599013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436145|NCT01599013|Antimetabolites|antimetabolites|mesh-ancestor
92436146|NCT01599013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436147|NCT01599013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436148|NCT01599013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436149|NCT01599013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436150|NCT01599013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436151|NCT01599078|Paclitaxel|paclitaxel|mesh-list
92436152|NCT01599078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436153|NCT01599078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436154|NCT01599078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436155|NCT01599078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436156|NCT01599078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436157|NCT01599078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436158|NCT01599117|Udenafil|udenafil|mesh-list
92531086|NCT00044824|Histamine Antagonists|histamine antagonists|mesh-ancestor
92436159|NCT01599117|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92436160|NCT01599117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92436161|NCT01599117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436162|NCT01599117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436163|NCT01599130|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92436164|NCT01599130|Entecavir|entecavir|mesh-list
92436165|NCT01599130|Antiviral Agents|antiviral agents|mesh-ancestor
92436166|NCT01599130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436167|NCT01599273|Triamcinolone|triamcinolone|mesh-list
92436168|NCT01599273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92436169|NCT01599273|Glucocorticoids|glucocorticoids|mesh-ancestor
92436170|NCT01599273|Hormones|hormones|mesh-ancestor
92436171|NCT01599273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436172|NCT01599273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436173|NCT01599312|Cobalt|cobalt|mesh-list
92436174|NCT01599312|Trace Elements|trace elements|mesh-ancestor
92436175|NCT01599312|Micronutrients|micronutrients|mesh-ancestor
92436176|NCT01599312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436177|NCT01599338|Liraglutide|liraglutide|mesh-list
92436178|NCT01599338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92436179|NCT01599338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436180|NCT01599338|Incretins|incretins|mesh-ancestor
92436181|NCT01599338|Hormones|hormones|mesh-ancestor
92436182|NCT01599338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436183|NCT01599364|Ritonavir|ritonavir|mesh-list
92436184|NCT01599364|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92436185|NCT01599364|Lamivudine|lamivudine|mesh-list
92436186|NCT01599364|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92436187|NCT01599364|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92436188|NCT01599364|Protease Inhibitors|protease inhibitors|mesh-ancestor
92436189|NCT01599364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343873|NCT05892913|Cholinergic Agents|cholinergic agents|mesh-ancestor
92436190|NCT01599364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436191|NCT01599364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92436192|NCT01599364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92436193|NCT01599364|Antiviral Agents|antiviral agents|mesh-ancestor
92436194|NCT01599364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436195|NCT01599364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92436196|NCT01599364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92436197|NCT01599364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92436198|NCT01599364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92436199|NCT01599377|Tofacitinib|tofacitinib|mesh-list
92436200|NCT01599377|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92436201|NCT01599377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92436202|NCT01599377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436203|NCT01599377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436204|NCT05691088|Acetaminophen|acetaminophen|mesh-list
92436205|NCT05691088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92436206|NCT05691088|Analgesics|analgesics|mesh-ancestor
92436207|NCT05691088|Sensory System Agents|sensory system agents|mesh-ancestor
92436208|NCT05691088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436209|NCT05691088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436210|NCT05691088|Antipyretics|antipyretics|mesh-ancestor
92436211|NCT05690802|Palonosetron|palonosetron|mesh-list
92436212|NCT05690802|Antiemetics|antiemetics|mesh-ancestor
92436213|NCT05690802|Autonomic Agents|autonomic agents|mesh-ancestor
92436214|NCT05690802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436215|NCT05690802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436216|NCT05690802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92436217|NCT05690802|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92436218|NCT05690802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92436219|NCT05690802|Serotonin Agents|serotonin agents|mesh-ancestor
92436220|NCT05690802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436221|NCT05690802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436222|NCT05690321|Opium|opium|mesh-list
92436223|NCT05690321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436224|NCT05690321|Narcotics|narcotics|mesh-ancestor
92436225|NCT05690321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436226|NCT05690321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436227|NCT05690321|Analgesics|analgesics|mesh-ancestor
92436228|NCT05690321|Sensory System Agents|sensory system agents|mesh-ancestor
92436229|NCT05690321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436230|NCT05690321|Antidiarrheals|antidiarrheals|mesh-ancestor
92436231|NCT05690321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92436232|NCT05690321|Antitussive Agents|antitussive agents|mesh-ancestor
92436233|NCT05690321|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436234|NCT05690191|Rituximab|rituximab|mesh-list
92436235|NCT05690191|Lenalidomide|lenalidomide|mesh-list
92436236|NCT05690191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436237|NCT05690191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436238|NCT05690191|Immunologic Factors|immunologic factors|mesh-ancestor
92436239|NCT05690191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436240|NCT05690191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436241|NCT05690191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92436242|NCT05690191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92436243|NCT05690191|Growth Substances|growth substances|mesh-ancestor
92436244|NCT05690191|Growth Inhibitors|growth inhibitors|mesh-ancestor
92436245|NCT05689996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92436246|NCT05689996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92436247|NCT05689983|Budesonide|budesonide|mesh-list
92436248|NCT05689983|Formoterol Fumarate|formoterol fumarate|mesh-list
92436249|NCT05689983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92436250|NCT05689983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92436251|NCT05689983|Autonomic Agents|autonomic agents|mesh-ancestor
92436252|NCT05689983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436253|NCT05689983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436254|NCT05689983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92436255|NCT05689983|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436256|NCT05689983|Glucocorticoids|glucocorticoids|mesh-ancestor
92436257|NCT05689983|Hormones|hormones|mesh-ancestor
92436258|NCT05689983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436259|NCT05689983|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92436260|NCT05689983|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92436261|NCT05689983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92436262|NCT05689983|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436263|NCT05689983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436264|NCT05689983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436265|NCT05689957|Rocuronium|rocuronium|mesh-list
92436266|NCT05689957|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92436267|NCT05689957|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92436268|NCT05689957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92436269|NCT05689957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436270|NCT05689957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436271|NCT05689671|Paclitaxel|paclitaxel|mesh-list
92436272|NCT05689671|Carboplatin|carboplatin|mesh-list
92436273|NCT05689671|Pembrolizumab|pembrolizumab|mesh-list
92436274|NCT05689671|Pemetrexed|pemetrexed|mesh-list
92436275|NCT05689671|Atezolizumab|atezolizumab|mesh-list
92436276|NCT05689671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436277|NCT05689671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436278|NCT05689671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436279|NCT05689671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436280|NCT05689671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436281|NCT05689671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436282|NCT05689671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436283|NCT05689671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436284|NCT05689671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436285|NCT05689671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92436286|NCT05689671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92436287|NCT05689632|Vitamin D|vitamin d|mesh-list
92436288|NCT05689632|Ergocalciferols|ergocalciferols|mesh-list
92436289|NCT05689632|Cholecalciferol|cholecalciferol|mesh-list
92436290|NCT05689632|Vitamins|vitamins|mesh-list
92436291|NCT05689632|Micronutrients|micronutrients|mesh-ancestor
92436292|NCT05689632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436293|NCT05689632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92436294|NCT05689632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92436296|NCT05689619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436297|NCT05689619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436298|NCT05689619|Protective Agents|protective agents|mesh-ancestor
92436299|NCT05689619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436300|NCT05689242|Dexmedetomidine|dexmedetomidine|mesh-list
92436301|NCT05689242|Nalbuphine|nalbuphine|mesh-list
92436302|NCT05689242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92436303|NCT05689242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436304|NCT05689242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436305|NCT05689242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92436306|NCT05689242|Analgesics|analgesics|mesh-ancestor
92436307|NCT05689242|Sensory System Agents|sensory system agents|mesh-ancestor
92436308|NCT05689242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436309|NCT05689242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92436310|NCT05689242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92436311|NCT05689242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92436312|NCT05689242|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436313|NCT05689242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436314|NCT05689242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436315|NCT05689242|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436317|NCT05689229|Colistin|colistin|mesh-list
92436318|NCT05689229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92436319|NCT05689229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436320|NCT05688046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92436321|NCT05688046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92436322|NCT05688046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436323|NCT05688046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436324|NCT05688046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436325|NCT05688046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92436326|NCT05688046|Growth Substances|growth substances|mesh-ancestor
92436327|NCT05688046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436328|NCT05688046|Growth Inhibitors|growth inhibitors|mesh-ancestor
92436329|NCT05646563|Eculizumab|eculizumab|mesh-list
92436330|NCT05646563|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92436331|NCT05646563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92436332|NCT05646563|Immunologic Factors|immunologic factors|mesh-ancestor
92436333|NCT05646563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436334|NCT05618132|Acetylcholine|acetylcholine|mesh-list
92436335|NCT05618132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436336|NCT05618132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92436337|NCT05618132|Cholinergic Agents|cholinergic agents|mesh-ancestor
92436338|NCT05618132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436339|NCT05618132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436340|NCT05618132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436341|NCT05553808|Docetaxel|docetaxel|mesh-list
92436342|NCT05553808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436343|NCT05553808|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436344|NCT05553808|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436345|NCT05553808|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436346|NCT05553808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436347|NCT05540184|Allopurinol|allopurinol|mesh-list
92436348|NCT05540184|Trimetazidine|trimetazidine|mesh-list
92436349|NCT05540184|Antimetabolites|antimetabolites|mesh-ancestor
92436350|NCT05540184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436351|NCT05540184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436352|NCT05540184|Gout Suppressants|gout suppressants|mesh-ancestor
92436353|NCT05540184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436354|NCT05540184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92436355|NCT05540184|Antioxidants|antioxidants|mesh-ancestor
92436356|NCT05540184|Protective Agents|protective agents|mesh-ancestor
92436357|NCT05540184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436358|NCT05540184|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436359|NCT05493761|Denosumab|denosumab|mesh-list
92436360|NCT05493761|Alendronate|alendronate|mesh-list
92436361|NCT05493761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92436362|NCT05493761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436363|NCT05473195|Isoniazid|isoniazid|mesh-list
92436364|NCT05473195|Ethionamide|ethionamide|mesh-list
92436365|NCT05473195|Antitubercular Agents|antitubercular agents|mesh-ancestor
92200054|NCT00580151|Clonidine|clonidine|mesh-list
92436366|NCT05473195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92436367|NCT05473195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436368|NCT05473195|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92436369|NCT05473195|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92436370|NCT05473195|Antimetabolites|antimetabolites|mesh-ancestor
92436371|NCT05473195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436372|NCT05473195|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92436373|NCT05442216|Azacitidine|azacitidine|mesh-list
92436374|NCT05442216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436375|NCT05442216|Antimetabolites|antimetabolites|mesh-ancestor
92436376|NCT05442216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436377|NCT05442216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436378|NCT05442216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436379|NCT05422053|Insulin|insulin|mesh-list
92436380|NCT05422053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92436381|NCT05422053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436382|NCT05414240|Ibudilast|ibudilast|mesh-list
92436383|NCT05414240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92436384|NCT05414240|Autonomic Agents|autonomic agents|mesh-ancestor
92436385|NCT05414240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436386|NCT05414240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436387|NCT05414240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92436388|NCT05414240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436389|NCT05414240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92436390|NCT05414240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436391|NCT05414240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436392|NCT05414240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92436393|NCT05414240|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436394|NCT05344911|Remifentanil|remifentanil|mesh-list
92436395|NCT05344911|Alfentanil|alfentanil|mesh-list
92436396|NCT05344911|Propofol|propofol|mesh-list
92436397|NCT05344911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92436398|NCT05344911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436399|NCT05344911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436400|NCT05344911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92436401|NCT05344911|Anesthetics, General|anesthetics, general|mesh-ancestor
92436402|NCT05344911|Anesthetics|anesthetics|mesh-ancestor
92436403|NCT05344911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436404|NCT05344911|Narcotics|narcotics|mesh-ancestor
92436405|NCT05344911|Analgesics|analgesics|mesh-ancestor
92436406|NCT05344911|Sensory System Agents|sensory system agents|mesh-ancestor
92436407|NCT05344911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436408|NCT05344417|Iodine|iodine|mesh-list
92436409|NCT05344417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92436410|NCT05344417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436411|NCT05344417|Trace Elements|trace elements|mesh-ancestor
92436412|NCT05344417|Micronutrients|micronutrients|mesh-ancestor
92436413|NCT05344417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436414|NCT05338021|Vancomycin|vancomycin|mesh-list
92436415|NCT05338021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92436416|NCT05338021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436417|NCT05338008|Vancomycin|vancomycin|mesh-list
92436418|NCT05338008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92436419|NCT05338008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436420|NCT05281328|Octreotide|octreotide|mesh-list
92436421|NCT05281328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92436422|NCT05281328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92436423|NCT05281328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436424|NCT05265208|Capecitabine|capecitabine|mesh-list
92436425|NCT05265208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436426|NCT05265208|Antimetabolites|antimetabolites|mesh-ancestor
92436427|NCT05265208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436428|NCT05265208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436429|NCT05251376|Morphine|morphine|mesh-list
92436430|NCT05251376|Methadone|methadone|mesh-list
92436431|NCT05251376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436432|NCT05251376|Narcotics|narcotics|mesh-ancestor
92436433|NCT05251376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436434|NCT05251376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436435|NCT05251376|Analgesics|analgesics|mesh-ancestor
92436436|NCT05251376|Sensory System Agents|sensory system agents|mesh-ancestor
92436437|NCT05251376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436438|NCT05251376|Antitussive Agents|antitussive agents|mesh-ancestor
92436439|NCT05251376|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436440|NCT05191797|Atezolizumab|atezolizumab|mesh-list
92436441|NCT05191797|Immunoglobulins|immunoglobulins|mesh-list
92436442|NCT05191797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92436444|NCT05191797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436445|NCT05191797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436446|NCT05191797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436447|NCT05191797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436448|NCT05191797|Immunologic Factors|immunologic factors|mesh-ancestor
92436449|NCT05191797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436450|NCT05191446|Ethanol|ethanol|mesh-list
92436451|NCT05191446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92436452|NCT05191446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436453|NCT05191446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436454|NCT05191446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436455|NCT05189483|Paclitaxel|paclitaxel|mesh-list
92436456|NCT05189483|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92436457|NCT05189483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436459|NCT05189483|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436460|NCT05189483|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436461|NCT05189483|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436462|NCT05189483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436463|NCT05188820|Cortisone|cortisone|mesh-list
92436464|NCT05188820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92436465|NCT05177055|Methamphetamine|methamphetamine|mesh-list
92436466|NCT05177055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92436467|NCT05177055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436468|NCT05177055|Sympathomimetics|sympathomimetics|mesh-ancestor
92436469|NCT05177055|Autonomic Agents|autonomic agents|mesh-ancestor
92436470|NCT05177055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436471|NCT05177055|Dopamine Agents|dopamine agents|mesh-ancestor
92436472|NCT05177055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436473|NCT05177055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436474|NCT05177055|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436475|NCT05177055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92436476|NCT05177055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92436477|NCT05177055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436478|NCT05177055|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92436479|NCT05149313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92436480|NCT05149313|Immunologic Factors|immunologic factors|mesh-ancestor
92436481|NCT05149313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436482|NCT05121974|Azithromycin|azithromycin|mesh-list
92436483|NCT05121974|Ceftriaxone|ceftriaxone|mesh-list
92436484|NCT05121974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92436485|NCT05121974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436486|NCT05070247|Pembrolizumab|pembrolizumab|mesh-list
92436487|NCT05070247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436488|NCT05070247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436489|NCT05070247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436490|NCT05070247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436491|NCT05064878|Fenfluramine|fenfluramine|mesh-list
92436492|NCT05064878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92436493|NCT05064878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92436494|NCT05064878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436495|NCT05064878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436496|NCT05064878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436497|NCT05064878|Serotonin Agents|serotonin agents|mesh-ancestor
92436498|NCT05064878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436500|NCT04969250|Immunologic Factors|immunologic factors|mesh-ancestor
92436501|NCT04969250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436502|NCT04965077|Antibodies|antibodies|mesh-list
92436503|NCT04965077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92436504|NCT04965077|Immunologic Factors|immunologic factors|mesh-ancestor
92436505|NCT04965077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436506|NCT04950426|Propranolol|propranolol|mesh-list
92436507|NCT04950426|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92436508|NCT04950426|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92436509|NCT04950426|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436510|NCT04950426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436511|NCT04950426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436512|NCT04950426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436513|NCT04950426|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92436514|NCT04950426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92436515|NCT04950426|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436516|NCT04938609|Pembrolizumab|pembrolizumab|mesh-list
92436517|NCT04938609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436518|NCT04938609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436519|NCT04938609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436520|NCT04938609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436522|NCT04873557|Trace Elements|trace elements|mesh-ancestor
92436523|NCT04873557|Micronutrients|micronutrients|mesh-ancestor
92436524|NCT04873557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436525|NCT04812457|Povidone-Iodine|povidone-iodine|mesh-list
92436526|NCT04812457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92436527|NCT04812457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436528|NCT04789616|Maraviroc|maraviroc|mesh-list
92436529|NCT04789616|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92436530|NCT04789616|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92436531|NCT04789616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436532|NCT04789616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92436533|NCT04789616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92436534|NCT04789616|Antiviral Agents|antiviral agents|mesh-ancestor
92436535|NCT04789616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436536|NCT04789616|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92436537|NCT04785300|Dasatinib|dasatinib|mesh-list
92436538|NCT04785300|Quercetin|quercetin|mesh-list
92436539|NCT04785300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436540|NCT04785300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92436541|NCT04785300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436542|NCT04785300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436543|NCT04785300|Antioxidants|antioxidants|mesh-ancestor
92436544|NCT04785300|Protective Agents|protective agents|mesh-ancestor
92436545|NCT04785300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436546|NCT04753216|Bevacizumab|bevacizumab|mesh-list
92436547|NCT04753216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92436548|NCT04753216|Irinotecan|irinotecan|mesh-list
92436549|NCT04753216|Endothelial Growth Factors|endothelial growth factors|mesh-list
92436550|NCT04753216|Antibodies|antibodies|mesh-list
92436551|NCT04753216|Immunoglobulins|immunoglobulins|mesh-list
92436552|NCT04753216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92436553|NCT04753216|Immunoglobulin G|immunoglobulin g|mesh-list
92436554|NCT04753216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436555|NCT04753216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92436556|NCT04753216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92436557|NCT04753216|Growth Substances|growth substances|mesh-ancestor
92436558|NCT04753216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436559|NCT04753216|Growth Inhibitors|growth inhibitors|mesh-ancestor
92436560|NCT04753216|Immunologic Factors|immunologic factors|mesh-ancestor
92436561|NCT04753216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92436562|NCT04753216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92436563|NCT04753216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436564|NCT04753216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436566|NCT04742634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436567|NCT04742634|Antimetabolites|antimetabolites|mesh-ancestor
92436568|NCT04742634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436569|NCT04742634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436570|NCT04742634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436571|NCT04734990|Azacitidine|azacitidine|mesh-list
92436572|NCT04734990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436573|NCT04734990|Antimetabolites|antimetabolites|mesh-ancestor
92436574|NCT04734990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436575|NCT04734990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436576|NCT04734990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436577|NCT04714619|Letrozole|letrozole|mesh-list
92436578|NCT04714619|Anastrozole|anastrozole|mesh-list
92436579|NCT04714619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436580|NCT04714619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92436581|NCT04714619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92436582|NCT04714619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436583|NCT04714619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436584|NCT04714619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92436585|NCT04714619|Hormone Antagonists|hormone antagonists|mesh-ancestor
92436586|NCT04714619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436587|NCT04714619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436588|NCT04714619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92436589|NCT04690855|Atezolizumab|atezolizumab|mesh-list
92436590|NCT04690855|Talazoparib|talazoparib|mesh-list
92436591|NCT04690855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436592|NCT04690855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436593|NCT04690855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436595|NCT04690855|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92436596|NCT04690855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436597|NCT04689945|Morphine|morphine|mesh-list
92436598|NCT04689945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436599|NCT04689945|Narcotics|narcotics|mesh-ancestor
92436600|NCT04689945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436601|NCT04689945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436602|NCT04689945|Analgesics|analgesics|mesh-ancestor
92436603|NCT04689945|Sensory System Agents|sensory system agents|mesh-ancestor
92531098|NCT00018213|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92436604|NCT04689945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436605|NCT04682483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92436606|NCT04643574|Cyclophosphamide|cyclophosphamide|mesh-list
92436607|NCT04643574|Fludarabine|fludarabine|mesh-list
92436608|NCT04643574|Interleukin-2|interleukin-2|mesh-list
92436609|NCT04643574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92436610|NCT04643574|Immunologic Factors|immunologic factors|mesh-ancestor
92436611|NCT04643574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436612|NCT04643574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436613|NCT04643574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92436614|NCT04643574|Alkylating Agents|alkylating agents|mesh-ancestor
92436615|NCT04643574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436616|NCT04643574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436617|NCT04643574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92436618|NCT04643574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92436619|NCT04643574|Analgesics|analgesics|mesh-ancestor
92436620|NCT04643574|Sensory System Agents|sensory system agents|mesh-ancestor
92436621|NCT04643574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436622|NCT04583501|Omalizumab|omalizumab|mesh-list
92436623|NCT04583501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92436624|NCT04583501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92436625|NCT04583501|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436626|NCT04563494|Dexamethasone|dexamethasone|mesh-list
92436627|NCT04563494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92436628|NCT04563494|Antiemetics|antiemetics|mesh-ancestor
92436629|NCT04563494|Autonomic Agents|autonomic agents|mesh-ancestor
92436630|NCT04563494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436631|NCT04563494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436632|NCT04563494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92436633|NCT04563494|Glucocorticoids|glucocorticoids|mesh-ancestor
92436634|NCT04563494|Hormones|hormones|mesh-ancestor
92436635|NCT04563494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436636|NCT04563494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92436637|NCT04563494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436638|NCT04552288|Benralizumab|benralizumab|mesh-list
92436639|NCT04552288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92436640|NCT04552288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436641|NCT04541173|Bevacizumab|bevacizumab|mesh-list
92436642|NCT04541173|Atezolizumab|atezolizumab|mesh-list
92436643|NCT04541173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436644|NCT04541173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436645|NCT04541173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92436646|NCT04541173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92436647|NCT04541173|Growth Substances|growth substances|mesh-ancestor
92436648|NCT04541173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436649|NCT04541173|Growth Inhibitors|growth inhibitors|mesh-ancestor
92436650|NCT04541173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436651|NCT04541173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436652|NCT04530747|Metformin|metformin|mesh-list
92436653|NCT04530747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92436654|NCT04530747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436655|NCT04464174|Carboplatin|carboplatin|mesh-list
92436656|NCT04464174|Gemcitabine|gemcitabine|mesh-list
92436657|NCT04464174|Capecitabine|capecitabine|mesh-list
92436658|NCT04464174|Ipatasertib|ipatasertib|mesh-list
92436659|NCT04464174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436660|NCT04464174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436661|NCT04464174|Antimetabolites|antimetabolites|mesh-ancestor
92436662|NCT04464174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436663|NCT04464174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92436664|NCT04464174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436665|NCT04463498|Methamphetamine|methamphetamine|mesh-list
92436666|NCT04463498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92436667|NCT04463498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436669|NCT04463498|Autonomic Agents|autonomic agents|mesh-ancestor
92436670|NCT04463498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436671|NCT04463498|Dopamine Agents|dopamine agents|mesh-ancestor
92436672|NCT04463498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436673|NCT04463498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436674|NCT04463498|Adrenergic Agents|adrenergic agents|mesh-ancestor
92436675|NCT04463498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92436676|NCT04463498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92436677|NCT04463498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436678|NCT04463498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92436679|NCT04456296|Methyltestosterone|methyltestosterone|mesh-list
92436680|NCT04456296|Testosterone|testosterone|mesh-list
92436681|NCT04456296|Testosterone undecanoate|testosterone undecanoate|mesh-list
92436682|NCT04456296|Testosterone enanthate|testosterone enanthate|mesh-list
92436683|NCT04456296|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92436684|NCT04456296|Androgens|androgens|mesh-ancestor
92436685|NCT04456296|Hormones|hormones|mesh-ancestor
92436686|NCT04456296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436687|NCT04456296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436688|NCT04456296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92436689|NCT04456296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436690|NCT04456296|Anabolic Agents|anabolic agents|mesh-ancestor
92436691|NCT04408118|Paclitaxel|paclitaxel|mesh-list
92436692|NCT04408118|Atezolizumab|atezolizumab|mesh-list
92436693|NCT04408118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436694|NCT04408118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436695|NCT04408118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436696|NCT04408118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436697|NCT04408118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161455|NCT01207401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161456|NCT04761731|Tacrolimus|tacrolimus|mesh-list
92161457|NCT04761731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92436698|NCT04408118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436699|NCT04408118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436700|NCT04408118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436701|NCT04403321|Tacrolimus|tacrolimus|mesh-list
92436702|NCT04403321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92436703|NCT04403321|Immunologic Factors|immunologic factors|mesh-ancestor
92436704|NCT04403321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436705|NCT04403321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92436706|NCT04403321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436707|NCT04403321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436708|NCT04265755|Erenumab|erenumab|mesh-list
92436709|NCT04265755|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92436710|NCT04265755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436711|NCT04265755|Analgesics|analgesics|mesh-ancestor
92436712|NCT04265755|Sensory System Agents|sensory system agents|mesh-ancestor
92436713|NCT04265755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436714|NCT04265755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436715|NCT04246372|Tofacitinib|tofacitinib|mesh-list
92436716|NCT04246372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92436717|NCT04246372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92436718|NCT04246372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436719|NCT04246372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436720|NCT04229771|Proxymetacaine|proxymetacaine|mesh-list
92436721|NCT04229771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92436722|NCT04229771|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92436723|NCT04229771|Anesthetics, Local|anesthetics, local|mesh-ancestor
92436724|NCT04229771|Anesthetics|anesthetics|mesh-ancestor
92436725|NCT04229771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436726|NCT04229771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436727|NCT04229771|Sensory System Agents|sensory system agents|mesh-ancestor
92436728|NCT04229771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436729|NCT04182334|TEMPO|tempo|mesh-list
92436730|NCT04182334|Antioxidants|antioxidants|mesh-ancestor
92436731|NCT04182334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436732|NCT04182334|Protective Agents|protective agents|mesh-ancestor
92436733|NCT04182334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436734|NCT04123444|Iloprost|iloprost|mesh-list
92436735|NCT04123444|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92436736|NCT04123444|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436737|NCT03987503|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92436738|NCT03987503|Antiviral Agents|antiviral agents|mesh-ancestor
92436739|NCT03987503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436740|NCT03967197|Lidocaine|lidocaine|mesh-list
92436741|NCT03967197|Anesthetics, Local|anesthetics, local|mesh-ancestor
92436742|NCT03967197|Anesthetics|anesthetics|mesh-ancestor
92436743|NCT03967197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436744|NCT03967197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436745|NCT03967197|Sensory System Agents|sensory system agents|mesh-ancestor
92436746|NCT03967197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436747|NCT03967197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92436748|NCT03967197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92436749|NCT03967197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92436750|NCT03967197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436751|NCT03967197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436753|NCT03935646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92436754|NCT03935646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436755|NCT03871153|Paclitaxel|paclitaxel|mesh-list
92436756|NCT03871153|Carboplatin|carboplatin|mesh-list
92436757|NCT03871153|Durvalumab|durvalumab|mesh-list
92436758|NCT03871153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436759|NCT03871153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436760|NCT03871153|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436761|NCT03871153|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436762|NCT03871153|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436763|NCT03871153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436764|NCT03871153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436765|NCT03547999|Nivolumab|nivolumab|mesh-list
92436766|NCT03547999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436767|NCT03547999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436768|NCT03547999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92704579|NCT04397692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161531|NCT01144143|Methylprednisolone|methylprednisolone|mesh-list
92436769|NCT03547999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436770|NCT03536728|Eflornithine|eflornithine|mesh-list
92436771|NCT03536728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436772|NCT03536728|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92436773|NCT03536728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92436774|NCT03536728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92436775|NCT03536728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436776|NCT03536728|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92436777|NCT03536728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436778|NCT03536728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436779|NCT03517423|Brivaracetam|brivaracetam|mesh-list
92436780|NCT03517423|Anticonvulsants|anticonvulsants|mesh-ancestor
92436781|NCT03470675|Ketamine|ketamine|mesh-list
92436782|NCT03470675|Morphine|morphine|mesh-list
92436783|NCT03470675|Analgesics|analgesics|mesh-ancestor
92436784|NCT03470675|Sensory System Agents|sensory system agents|mesh-ancestor
92436785|NCT03470675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436786|NCT03470675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436787|NCT03470675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92436788|NCT03470675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92436789|NCT03470675|Anesthetics, General|anesthetics, general|mesh-ancestor
92436790|NCT03470675|Anesthetics|anesthetics|mesh-ancestor
92436791|NCT03470675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436792|NCT03470675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92436793|NCT03470675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92436794|NCT03470675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436795|NCT03470675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436796|NCT03470675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436797|NCT03470675|Narcotics|narcotics|mesh-ancestor
92436798|NCT03462251|Paclitaxel|paclitaxel|mesh-list
92436799|NCT03462251|Bevacizumab|bevacizumab|mesh-list
92436800|NCT03462251|Capecitabine|capecitabine|mesh-list
92436801|NCT03462251|Fulvestrant|fulvestrant|mesh-list
92436802|NCT03462251|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92436803|NCT03462251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436804|NCT03462251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436805|NCT03462251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436806|NCT03462251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436807|NCT03462251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92436808|NCT03462251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436809|NCT03462251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436810|NCT03462251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92436811|NCT03462251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92436812|NCT03462251|Growth Substances|growth substances|mesh-ancestor
92436813|NCT03462251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436814|NCT03462251|Growth Inhibitors|growth inhibitors|mesh-ancestor
92436815|NCT03462251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92436816|NCT03462251|Antimetabolites|antimetabolites|mesh-ancestor
92436817|NCT03462251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92436818|NCT03462251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92436819|NCT03462251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92436820|NCT03462251|Hormone Antagonists|hormone antagonists|mesh-ancestor
92436821|NCT03462251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436822|NCT03462251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92436823|NCT03462251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436825|NCT03340766|Blinatumomab|blinatumomab|mesh-list
92436826|NCT03340766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436827|NCT03340766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436828|NCT03340766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436829|NCT03340766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436830|NCT03294954|Cyclophosphamide|cyclophosphamide|mesh-list
92436831|NCT03294954|Fludarabine|fludarabine|mesh-list
92436832|NCT03294954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92436833|NCT03294954|Immunologic Factors|immunologic factors|mesh-ancestor
92436834|NCT03294954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436835|NCT03294954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436836|NCT03294954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92436837|NCT03294954|Alkylating Agents|alkylating agents|mesh-ancestor
92436838|NCT03294954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436839|NCT03294954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436840|NCT03294954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92436841|NCT03274414|Cisplatin|cisplatin|mesh-list
92436842|NCT03274414|Etoposide|etoposide|mesh-list
92436843|NCT03274414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436844|NCT03274414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436845|NCT03274414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92436846|NCT03274414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92436847|NCT03274414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436848|NCT03274414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436850|NCT03272685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92436851|NCT03272685|Autonomic Agents|autonomic agents|mesh-ancestor
92436852|NCT03272685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436853|NCT03272685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436854|NCT03272685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92436855|NCT03272685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92436856|NCT03272685|Cholinergic Agents|cholinergic agents|mesh-ancestor
92436857|NCT03272685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436858|NCT03272685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436859|NCT03272334|Pembrolizumab|pembrolizumab|mesh-list
92436860|NCT03272334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436861|NCT03272334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436862|NCT03272334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436863|NCT03272334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436864|NCT03258281|Evolocumab|evolocumab|mesh-list
92436865|NCT03258281|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92436866|NCT03258281|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92436867|NCT03258281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92436868|NCT03258281|Antimetabolites|antimetabolites|mesh-ancestor
92436869|NCT03258281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436870|NCT03258281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92436871|NCT03258281|Protease Inhibitors|protease inhibitors|mesh-ancestor
92436872|NCT03258281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92436873|NCT03258281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92436874|NCT05705492|Olanzapine|olanzapine|mesh-list
92436875|NCT05705492|Antiemetics|antiemetics|mesh-ancestor
92436876|NCT05705492|Autonomic Agents|autonomic agents|mesh-ancestor
92436877|NCT05705492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436878|NCT05705492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436879|NCT05705492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92436880|NCT05705492|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92436881|NCT05705492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92436882|NCT05705492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436883|NCT05705492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92436884|NCT05705492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92436885|NCT05705492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531108|NCT00044902|Epratuzumab|epratuzumab|mesh-list
92436886|NCT05705492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436887|NCT05705492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436888|NCT05705492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436889|NCT05705492|Serotonin Agents|serotonin agents|mesh-ancestor
92436890|NCT05705466|Pembrolizumab|pembrolizumab|mesh-list
92436891|NCT05705466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436892|NCT05705466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343988|NCT05727098|Ketamine|ketamine|mesh-list
92436893|NCT05705466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436894|NCT05705466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436895|NCT05705388|Liraglutide|liraglutide|mesh-list
92436896|NCT05705388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92436897|NCT05705388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436898|NCT05705388|Incretins|incretins|mesh-ancestor
92436899|NCT05705388|Hormones|hormones|mesh-ancestor
92436900|NCT05705388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92436901|NCT05705336|Tranexamic Acid|tranexamic acid|mesh-list
92436902|NCT05705336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92436903|NCT05705336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92436904|NCT05705336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436905|NCT05705336|Hemostatics|hemostatics|mesh-ancestor
92436906|NCT05705336|Coagulants|coagulants|mesh-ancestor
92436907|NCT05705037|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
92436908|NCT05705037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92436909|NCT05705037|Serotonin Agents|serotonin agents|mesh-ancestor
92436910|NCT05705037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92436911|NCT05705037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436912|NCT05705037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436913|NCT05704959|Povidone-Iodine|povidone-iodine|mesh-list
92436914|NCT05704959|Povidone|povidone|mesh-list
92436915|NCT05704959|Plasma Substitutes|plasma substitutes|mesh-ancestor
92436916|NCT05704959|Blood Substitutes|blood substitutes|mesh-ancestor
92436918|NCT05704959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92436919|NCT05704894|Epoetin Alfa|epoetin alfa|mesh-list
92436920|NCT05704894|Hematinics|hematinics|mesh-ancestor
92436921|NCT05704816|Anesthetics|anesthetics|mesh-list
92436922|NCT05704816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436923|NCT05704816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436924|NCT05704634|Cemiplimab|cemiplimab|mesh-list
92436925|NCT05704634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436926|NCT05704634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436927|NCT05704595|Diuretics|diuretics|mesh-list
92436928|NCT05704595|Natriuretic Agents|natriuretic agents|mesh-ancestor
92436929|NCT05704595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436930|NCT05704400|Rituximab|rituximab|mesh-list
92436931|NCT05704400|Daratumumab|daratumumab|mesh-list
92436932|NCT05704400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436933|NCT05704400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436934|NCT05704400|Immunologic Factors|immunologic factors|mesh-ancestor
92436935|NCT05704400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436936|NCT05704400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92436937|NCT05704114|Tazarotene|tazarotene|mesh-list
92436938|NCT05704114|Dermatologic Agents|dermatologic agents|mesh-ancestor
92436939|NCT05704114|Keratolytic Agents|keratolytic agents|mesh-ancestor
92436940|NCT05704088|Dapagliflozin|dapagliflozin|mesh-list
92436941|NCT05704088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92436942|NCT05704088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436943|NCT05704088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92436944|NCT05704088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436945|NCT05703997|Atezolizumab|atezolizumab|mesh-list
92436946|NCT05703997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92436947|NCT05703997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436948|NCT05703997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436949|NCT05703997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436950|NCT05703984|Metformin|metformin|mesh-list
92436951|NCT05703984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92436952|NCT05703984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436953|NCT05703555|Maytansine|maytansine|mesh-list
92436954|NCT05703555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92436955|NCT05703555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436956|NCT05703555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92436957|NCT05703555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92436958|NCT05703555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344006|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531109|NCT00044902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92436959|NCT05703555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436962|NCT05703373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436963|NCT05702190|Opium|opium|mesh-list
92436964|NCT05702190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92436965|NCT05702190|Narcotics|narcotics|mesh-ancestor
92436966|NCT05702190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92436967|NCT05702190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436968|NCT05702190|Analgesics|analgesics|mesh-ancestor
92436969|NCT05702190|Sensory System Agents|sensory system agents|mesh-ancestor
92436970|NCT05702190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92436971|NCT05702190|Antidiarrheals|antidiarrheals|mesh-ancestor
92436972|NCT05702190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92436973|NCT05702190|Antitussive Agents|antitussive agents|mesh-ancestor
92436974|NCT05702190|Respiratory System Agents|respiratory system agents|mesh-ancestor
92436975|NCT05701124|Ranibizumab|ranibizumab|mesh-list
92436976|NCT05701124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92436977|NCT05701124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92436978|NCT05701124|Growth Substances|growth substances|mesh-ancestor
92436979|NCT05701124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436980|NCT05701124|Growth Inhibitors|growth inhibitors|mesh-ancestor
92436981|NCT05701124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92436982|NCT05688085|Amlodipine|amlodipine|mesh-list
92436983|NCT05688085|Irbesartan|irbesartan|mesh-list
92436984|NCT05688085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92436985|NCT05688085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92436986|NCT05688085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92436987|NCT05688085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92436988|NCT05688085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92436989|NCT05688085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92436990|NCT05688085|Vasodilator Agents|vasodilator agents|mesh-ancestor
92436991|NCT05688085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92436992|NCT05688085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92436993|NCT05645380|Cyclophosphamide|cyclophosphamide|mesh-list
92436994|NCT05645380|Carboplatin|carboplatin|mesh-list
92436995|NCT05645380|Docetaxel|docetaxel|mesh-list
92436996|NCT05645380|Doxorubicin|doxorubicin|mesh-list
92436997|NCT05645380|Pembrolizumab|pembrolizumab|mesh-list
92436998|NCT05645380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92436999|NCT05645380|Immunologic Factors|immunologic factors|mesh-ancestor
92437000|NCT05645380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437001|NCT05645380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437002|NCT05645380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437003|NCT05645380|Alkylating Agents|alkylating agents|mesh-ancestor
92437004|NCT05645380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437005|NCT05645380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437006|NCT05645380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437007|NCT05645380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437008|NCT05645380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437009|NCT05645380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437010|NCT05645380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92437011|NCT05645380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92437012|NCT05645380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92437013|NCT05645380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437014|NCT05645380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437015|NCT05645380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437016|NCT05584709|Immunoconjugates|immunoconjugates|mesh-list
92437017|NCT05584709|Immunologic Factors|immunologic factors|mesh-ancestor
92437018|NCT05584709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437019|NCT05504486|Brexpiprazole|brexpiprazole|mesh-list
92437020|NCT05504486|Serotonin Agents|serotonin agents|mesh-ancestor
92437021|NCT05504486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437022|NCT05504486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437023|NCT05504486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437024|NCT05504486|Dopamine Agonists|dopamine agonists|mesh-ancestor
92437025|NCT05504486|Dopamine Agents|dopamine agents|mesh-ancestor
92437026|NCT05476939|Everolimus|everolimus|mesh-list
92437027|NCT05476939|TIC10 compound|tic10 compound|mesh-list
92437028|NCT05476939|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92437029|NCT05476939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437030|NCT05476939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437031|NCT05476939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437032|NCT05476939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437034|NCT05476939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437035|NCT05476939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437036|NCT05458232|Tadalafil|tadalafil|mesh-list
92437037|NCT05458232|Vasodilator Agents|vasodilator agents|mesh-ancestor
92437038|NCT05458232|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92437039|NCT05458232|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92437040|NCT05458232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437041|NCT05458232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437042|NCT05458232|Urological Agents|urological agents|mesh-ancestor
92437043|NCT05274243|Phenol|phenol|mesh-list
92437044|NCT05274243|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92437045|NCT05274243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437046|NCT05274243|Disinfectants|disinfectants|mesh-ancestor
92437047|NCT05274243|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92437048|NCT05274243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92437049|NCT05271799|Gepotidacin|gepotidacin|mesh-list
92437050|NCT05271799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92437051|NCT05271799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437052|NCT05271799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437053|NCT05271799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437054|NCT05270733|Ustekinumab|ustekinumab|mesh-list
92437055|NCT05270733|Dermatologic Agents|dermatologic agents|mesh-ancestor
92437056|NCT05253417|Cannabidiol|cannabidiol|mesh-list
92437057|NCT05253417|Anticonvulsants|anticonvulsants|mesh-ancestor
92437058|NCT05184803|Docetaxel|docetaxel|mesh-list
92437059|NCT05184803|Oxaliplatin|oxaliplatin|mesh-list
92437060|NCT05184803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437061|NCT05184803|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437062|NCT05184803|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437063|NCT05184803|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161836|NCT01216761|Povidone|povidone|mesh-list
92437064|NCT05184803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437065|NCT05030506|Pembrolizumab|pembrolizumab|mesh-list
92437066|NCT05030506|Lenvatinib|lenvatinib|mesh-list
92437067|NCT05030506|Belzutifan|belzutifan|mesh-list
92437068|NCT05030506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437069|NCT05030506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437070|NCT05030506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437071|NCT05030506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437072|NCT05030506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437073|NCT05030506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437075|NCT04911621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437076|NCT04911621|Alkylating Agents|alkylating agents|mesh-ancestor
92437077|NCT04911621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437078|NCT04911621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437079|NCT04877522|Niacinamide|niacinamide|mesh-list
92437080|NCT04877522|Imatinib Mesylate|imatinib mesylate|mesh-list
92437081|NCT04877522|Dasatinib|dasatinib|mesh-list
92437082|NCT04877522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437083|NCT04877522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437084|NCT04877522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437085|NCT04877522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437086|NCT04877522|Vitamin B Complex|vitamin b complex|mesh-ancestor
92437087|NCT04877522|Vitamins|vitamins|mesh-ancestor
92437088|NCT04877522|Micronutrients|micronutrients|mesh-ancestor
92437089|NCT04877522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437090|NCT04764643|Acetylcysteine|acetylcysteine|mesh-list
92437091|NCT04764643|Sodium thiosulfate|sodium thiosulfate|mesh-list
92437092|NCT04764643|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92437093|NCT04764643|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92437094|NCT04764643|Antiviral Agents|antiviral agents|mesh-ancestor
92437095|NCT04764643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437096|NCT04764643|Expectorants|expectorants|mesh-ancestor
92437097|NCT04764643|Respiratory System Agents|respiratory system agents|mesh-ancestor
92437098|NCT04764643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92437099|NCT04764643|Antioxidants|antioxidants|mesh-ancestor
92437100|NCT04764643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437101|NCT04764643|Protective Agents|protective agents|mesh-ancestor
92437102|NCT04764643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437103|NCT04764643|Antidotes|antidotes|mesh-ancestor
92437104|NCT04764643|Antitubercular Agents|antitubercular agents|mesh-ancestor
92437105|NCT04764643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92437106|NCT04764643|Chelating Agents|chelating agents|mesh-ancestor
92437107|NCT04764643|Sequestering Agents|sequestering agents|mesh-ancestor
92437109|NCT04706429|Chelating Agents|chelating agents|mesh-ancestor
92437110|NCT04706429|Sequestering Agents|sequestering agents|mesh-ancestor
92437111|NCT04706429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437112|NCT04558892|Enoxaparin|enoxaparin|mesh-list
92437113|NCT04558892|Anticoagulants|anticoagulants|mesh-ancestor
92437114|NCT04558892|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92437115|NCT04558892|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92437116|NCT04558892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437117|NCT04551885|Aldesleukin|aldesleukin|mesh-list
92437118|NCT04551885|Cyclophosphamide|cyclophosphamide|mesh-list
92437119|NCT04551885|Fludarabine|fludarabine|mesh-list
92437120|NCT04551885|Avelumab|avelumab|mesh-list
92437121|NCT04551885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437122|NCT04551885|Immunologic Factors|immunologic factors|mesh-ancestor
92437123|NCT04551885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437124|NCT04551885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437125|NCT04551885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437126|NCT04551885|Alkylating Agents|alkylating agents|mesh-ancestor
92437127|NCT04551885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437128|NCT04551885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437129|NCT04551885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437130|NCT04551885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92437131|NCT04551885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92437132|NCT04551885|Antiviral Agents|antiviral agents|mesh-ancestor
92437133|NCT04551885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437134|NCT04551885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437135|NCT04304820|Cyclosporine|cyclosporine|mesh-list
92437136|NCT04304820|Cyclosporins|cyclosporins|mesh-list
92437137|NCT04304820|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92437138|NCT04304820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437139|NCT04304820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437140|NCT04304820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437141|NCT04304820|Immunologic Factors|immunologic factors|mesh-ancestor
92437142|NCT04304820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437143|NCT04304820|Antifungal Agents|antifungal agents|mesh-ancestor
92437144|NCT04304820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437145|NCT04304820|Dermatologic Agents|dermatologic agents|mesh-ancestor
92437146|NCT04304820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437147|NCT04304820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92437148|NCT04199728|Liraglutide|liraglutide|mesh-list
92437149|NCT04199728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92437150|NCT04199728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437151|NCT04199728|Incretins|incretins|mesh-ancestor
92437152|NCT04199728|Hormones|hormones|mesh-ancestor
92437153|NCT04199728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437154|NCT04166435|Temozolomide|temozolomide|mesh-list
92437155|NCT04166435|Olaparib|olaparib|mesh-list
92437156|NCT04166435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437157|NCT04166435|Alkylating Agents|alkylating agents|mesh-ancestor
92437158|NCT04166435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437159|NCT04166435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437160|NCT04166435|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92437161|NCT04166435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437162|NCT04162015|Carboplatin|carboplatin|mesh-list
92437163|NCT04162015|Nivolumab|nivolumab|mesh-list
92437164|NCT04162015|Pemetrexed|pemetrexed|mesh-list
92437165|NCT04162015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437166|NCT04162015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437167|NCT04162015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437168|NCT04162015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437169|NCT04162015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437170|NCT04162015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92437171|NCT04162015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92437172|NCT04077515|Sirolimus|sirolimus|mesh-list
92437173|NCT04077515|Temsirolimus|temsirolimus|mesh-list
92437174|NCT04077515|MTOR Inhibitors|mtor inhibitors|mesh-list
92437175|NCT04077515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92437176|NCT04077515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437177|NCT04077515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92437178|NCT04077515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437179|NCT04077515|Antifungal Agents|antifungal agents|mesh-ancestor
92437180|NCT04077515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437181|NCT04077515|Immunologic Factors|immunologic factors|mesh-ancestor
92437182|NCT04077515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437183|NCT04077515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437184|NCT04077515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531113|NCT00045136|Alkylating Agents|alkylating agents|mesh-ancestor
92437185|NCT04077515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437186|NCT03999515|Abiraterone Acetate|abiraterone acetate|mesh-list
92437187|NCT03999515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437188|NCT03999515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92437189|NCT03999515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437190|NCT03999515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437191|NCT03999515|Hormone Antagonists|hormone antagonists|mesh-ancestor
92437192|NCT03999515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437193|NCT03999515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437194|NCT03999515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92437195|NCT03970200|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92437196|NCT03970200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437197|NCT03958461|Anti-Infective Agents|anti-infective agents|mesh-list
92437198|NCT03919773|Immunoglobulins|immunoglobulins|mesh-list
92437199|NCT03919773|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92437200|NCT03919773|gamma-Globulins|gamma-globulins|mesh-list
92437201|NCT03919773|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92437202|NCT03919773|Immunologic Factors|immunologic factors|mesh-ancestor
92437203|NCT03919773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437204|NCT03841110|Aldesleukin|aldesleukin|mesh-list
92437205|NCT03841110|Cyclophosphamide|cyclophosphamide|mesh-list
92437206|NCT03841110|Pembrolizumab|pembrolizumab|mesh-list
92437208|NCT03841110|Fludarabine|fludarabine|mesh-list
92437209|NCT03841110|Atezolizumab|atezolizumab|mesh-list
92437210|NCT03841110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437211|NCT03841110|Immunologic Factors|immunologic factors|mesh-ancestor
92437212|NCT03841110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437213|NCT03841110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437214|NCT03841110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437215|NCT03841110|Alkylating Agents|alkylating agents|mesh-ancestor
92437216|NCT03841110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437217|NCT03841110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437218|NCT03841110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437219|NCT03841110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437220|NCT03841110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437222|NCT03841110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92437223|NCT03841110|Antiviral Agents|antiviral agents|mesh-ancestor
92437224|NCT03841110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437225|NCT03810313|Aflibercept|aflibercept|mesh-list
92437226|NCT03810313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437227|NCT03810313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437228|NCT03810313|Growth Substances|growth substances|mesh-ancestor
92437229|NCT03810313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437230|NCT03810313|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437231|NCT03810313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437232|NCT03802630|Aflibercept|aflibercept|mesh-list
92437233|NCT03802630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437234|NCT03802630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437235|NCT03802630|Growth Substances|growth substances|mesh-ancestor
92437236|NCT03802630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437237|NCT03802630|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437238|NCT03802630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437239|NCT03785691|Ondansetron|ondansetron|mesh-list
92437240|NCT03785691|Mirtazapine|mirtazapine|mesh-list
92437241|NCT03785691|Antiemetics|antiemetics|mesh-ancestor
92437242|NCT03785691|Autonomic Agents|autonomic agents|mesh-ancestor
92437243|NCT03785691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437244|NCT03785691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437245|NCT03785691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92437246|NCT03785691|Antipruritics|antipruritics|mesh-ancestor
92437247|NCT03785691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92437248|NCT03785691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92437249|NCT03785691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92437250|NCT03785691|Serotonin Agents|serotonin agents|mesh-ancestor
92437251|NCT03785691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437252|NCT03785691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437253|NCT03785691|Antidepressive Agents|antidepressive agents|mesh-ancestor
92437254|NCT03785691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92437255|NCT03785691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92437256|NCT03785691|Histamine Antagonists|histamine antagonists|mesh-ancestor
92437257|NCT03785691|Histamine Agents|histamine agents|mesh-ancestor
92437258|NCT03785691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92437259|NCT03785691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92437260|NCT03785691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92437261|NCT03785691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92437262|NCT03785691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92437263|NCT03785691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92437264|NCT03785691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92437265|NCT03785691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92437266|NCT03780829|Cycloserine|cycloserine|mesh-list
92437267|NCT03780829|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92437268|NCT03780829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437269|NCT03780829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92437270|NCT03780829|Antitubercular Agents|antitubercular agents|mesh-ancestor
92437271|NCT03780829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92437272|NCT03780829|Antimetabolites|antimetabolites|mesh-ancestor
92437273|NCT03780829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437274|NCT03736863|Apatinib|apatinib|mesh-list
92437275|NCT03736863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437276|NCT03736863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437277|NCT03736863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437278|NCT03736863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437279|NCT03710564|Aflibercept|aflibercept|mesh-list
92437280|NCT03710564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437281|NCT03710564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437282|NCT03710564|Growth Substances|growth substances|mesh-ancestor
92437283|NCT03710564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437284|NCT03710564|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437285|NCT03710564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437286|NCT03703492|Estradiol|estradiol|mesh-list
92437287|NCT03703492|Estrogens|estrogens|mesh-ancestor
92437288|NCT03703492|Hormones|hormones|mesh-ancestor
92437289|NCT03703492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437290|NCT03703492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437291|NCT03624127|Apremilast|apremilast|mesh-list
92437292|NCT03624127|Deucravacitinib|deucravacitinib|mesh-list
92437293|NCT03624127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162059|NCT03275597|Durvalumab|durvalumab|mesh-list
92437294|NCT03624127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92437295|NCT03624127|Analgesics|analgesics|mesh-ancestor
92437296|NCT03624127|Sensory System Agents|sensory system agents|mesh-ancestor
92437297|NCT03624127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437298|NCT03624127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437299|NCT03624127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92437300|NCT03624127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437301|NCT03624127|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92437302|NCT03624127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92437303|NCT03624127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437304|NCT03624127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437305|NCT03624127|Dermatologic Agents|dermatologic agents|mesh-ancestor
92437306|NCT03624127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437307|NCT03499899|Carboplatin|carboplatin|mesh-list
92437308|NCT03499899|Spartalizumab|spartalizumab|mesh-list
92437309|NCT03499899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437310|NCT03499899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437311|NCT03499899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437312|NCT03499899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437313|NCT03481634|Aflibercept|aflibercept|mesh-list
92437314|NCT03481634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437315|NCT03481634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437316|NCT03481634|Growth Substances|growth substances|mesh-ancestor
92437317|NCT03481634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437318|NCT03481634|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437319|NCT03481634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437320|NCT03476642|Epinephrine|epinephrine|mesh-list
92437321|NCT03476642|Ropivacaine|ropivacaine|mesh-list
92437322|NCT03476642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92437323|NCT03476642|Anesthetics|anesthetics|mesh-ancestor
92437324|NCT03476642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92437325|NCT03476642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437326|NCT03476642|Sensory System Agents|sensory system agents|mesh-ancestor
92437327|NCT03476642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437328|NCT03476642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92437329|NCT03476642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92437330|NCT03476642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92437331|NCT03476642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437332|NCT03476642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437333|NCT03476642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92437334|NCT03476642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92437335|NCT03476642|Autonomic Agents|autonomic agents|mesh-ancestor
92437336|NCT03476642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92437337|NCT03476642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92437339|NCT03476642|Sympathomimetics|sympathomimetics|mesh-ancestor
92437340|NCT03476642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92437341|NCT03460756|Ganaxolone|ganaxolone|mesh-list
92437342|NCT03460756|Neurosteroids|neurosteroids|mesh-ancestor
92437343|NCT03460756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437344|NCT03460756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437345|NCT03460756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437346|NCT03460756|GABA Modulators|gaba modulators|mesh-ancestor
92437347|NCT03460756|GABA Agents|gaba agents|mesh-ancestor
92437348|NCT03430700|Pembrolizumab|pembrolizumab|mesh-list
92437349|NCT03430700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437350|NCT03430700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437351|NCT03430700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437352|NCT03430700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437353|NCT03245151|Everolimus|everolimus|mesh-list
92437354|NCT03245151|Lenvatinib|lenvatinib|mesh-list
92437355|NCT03245151|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92437356|NCT03245151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437357|NCT03245151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437358|NCT03245151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437359|NCT03245151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437360|NCT03245151|Immunologic Factors|immunologic factors|mesh-ancestor
92437361|NCT03245151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437362|NCT03245151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437363|NCT03171025|Nivolumab|nivolumab|mesh-list
92437364|NCT03171025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437365|NCT03171025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437366|NCT03171025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437367|NCT03171025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437368|NCT03149003|Bevacizumab|bevacizumab|mesh-list
92437369|NCT03149003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437370|NCT03149003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437371|NCT03149003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437372|NCT03149003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437373|NCT03149003|Growth Substances|growth substances|mesh-ancestor
92437374|NCT03149003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437375|NCT03149003|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437376|NCT03148275|Trametinib|trametinib|mesh-list
92437377|NCT03148275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437378|NCT03148275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437379|NCT03148275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437380|NCT03148275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437381|NCT03106454|Ferrous fumarate|ferrous fumarate|mesh-list
92437382|NCT03106454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92437383|NCT03106454|Norethindrone|norethindrone|mesh-list
92437384|NCT03106454|Norethindrone Acetate|norethindrone acetate|mesh-list
92437385|NCT03106454|Estradiol|estradiol|mesh-list
92437386|NCT03106454|Estrogens|estrogens|mesh-ancestor
92437387|NCT03106454|Hormones|hormones|mesh-ancestor
92437388|NCT03106454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437389|NCT03106454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437390|NCT03106454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92437391|NCT03106454|Contraceptive Agents|contraceptive agents|mesh-ancestor
92437392|NCT03106454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92437393|NCT03106454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92437394|NCT03106454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92437395|NCT03106454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92437396|NCT03106454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92437397|NCT03106454|Trace Elements|trace elements|mesh-ancestor
92437398|NCT03106454|Micronutrients|micronutrients|mesh-ancestor
92437399|NCT02990806|Infliximab|infliximab|mesh-list
92437400|NCT02990806|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92437401|NCT02990806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92437402|NCT02990806|Dermatologic Agents|dermatologic agents|mesh-ancestor
92437403|NCT02990806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92437404|NCT02990806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437405|NCT02965703|Aspirin|aspirin|mesh-list
92437406|NCT02965703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92437407|NCT02965703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92437408|NCT02965703|Analgesics|analgesics|mesh-ancestor
92437409|NCT02965703|Sensory System Agents|sensory system agents|mesh-ancestor
92437410|NCT02965703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437411|NCT02965703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437412|NCT02965703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92437413|NCT02965703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437414|NCT02965703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92437415|NCT02965703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92437416|NCT02965703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437417|NCT02965703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92437418|NCT02965703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92437419|NCT02965703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437420|NCT02965703|Antipyretics|antipyretics|mesh-ancestor
92437421|NCT02938442|Paclitaxel|paclitaxel|mesh-list
92437422|NCT02938442|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92437423|NCT02938442|Cyclophosphamide|cyclophosphamide|mesh-list
92437424|NCT02938442|Doxorubicin|doxorubicin|mesh-list
92437425|NCT02938442|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92437426|NCT02938442|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92437427|NCT02938442|Freund's Adjuvant|freund's adjuvant|mesh-list
92437428|NCT02938442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92437429|NCT02938442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437430|NCT02938442|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437431|NCT02938442|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437432|NCT02938442|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437433|NCT02938442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437434|NCT02938442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437435|NCT02938442|Immunologic Factors|immunologic factors|mesh-ancestor
92437436|NCT02938442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437437|NCT02938442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437438|NCT02938442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437439|NCT02938442|Alkylating Agents|alkylating agents|mesh-ancestor
92437440|NCT02938442|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437441|NCT02938442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92437442|NCT02938442|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92437443|NCT02938442|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92437444|NCT02938442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437445|NCT02938442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92437446|NCT02650271|Tenofovir|tenofovir|mesh-list
92437447|NCT02650271|Entecavir|entecavir|mesh-list
92437448|NCT02650271|Antiviral Agents|antiviral agents|mesh-ancestor
92437449|NCT02650271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437450|NCT02650271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92437451|NCT02650271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92437452|NCT02650271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437453|NCT02650271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437454|NCT02650271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92437455|NCT02650271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92437456|NCT02420821|Bevacizumab|bevacizumab|mesh-list
92437457|NCT02420821|Atezolizumab|atezolizumab|mesh-list
92437458|NCT02420821|Sunitinib|sunitinib|mesh-list
92437459|NCT02420821|Antibodies|antibodies|mesh-list
92437460|NCT02420821|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92437461|NCT02420821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437462|NCT02420821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437463|NCT02420821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437464|NCT02420821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437465|NCT02420821|Growth Substances|growth substances|mesh-ancestor
92437466|NCT02420821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437467|NCT02420821|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437468|NCT02420821|Immunologic Factors|immunologic factors|mesh-ancestor
92437469|NCT02420821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437470|NCT02420821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437471|NCT02420821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437472|NCT02420821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437473|NCT02811263|Epoetin Alfa|epoetin alfa|mesh-list
92437474|NCT02811263|Hematinics|hematinics|mesh-ancestor
92437475|NCT02398773|Estradiol|estradiol|mesh-list
92437476|NCT02398773|Estrogens|estrogens|mesh-ancestor
92437477|NCT02398773|Hormones|hormones|mesh-ancestor
92437478|NCT02398773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437479|NCT02398773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437482|NCT02229084|Cyclophosphamide|cyclophosphamide|mesh-list
92437483|NCT02229084|Doxorubicin|doxorubicin|mesh-list
92437484|NCT02229084|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92437485|NCT02229084|Freund's Adjuvant|freund's adjuvant|mesh-list
92437486|NCT02229084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92437487|NCT02229084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437488|NCT02229084|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437489|NCT02229084|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437490|NCT02229084|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437491|NCT02229084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437492|NCT02229084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437493|NCT02229084|Immunologic Factors|immunologic factors|mesh-ancestor
92437494|NCT02229084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437495|NCT02229084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437496|NCT02229084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437497|NCT02229084|Alkylating Agents|alkylating agents|mesh-ancestor
92437498|NCT02229084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437499|NCT02229084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92437500|NCT02229084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92437501|NCT02229084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92437502|NCT02229084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437503|NCT02229084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92437504|NCT02188121|Losartan|losartan|mesh-list
92437505|NCT02188121|Simvastatin|simvastatin|mesh-list
92437506|NCT02188121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92437507|NCT02188121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92437508|NCT02188121|Antimetabolites|antimetabolites|mesh-ancestor
92437509|NCT02188121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437510|NCT02188121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92437511|NCT02188121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92437512|NCT02188121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437513|NCT02188121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92437514|NCT02188121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92437515|NCT02188121|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92437516|NCT02188121|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92437517|NCT02039063|Quetmolimab|quetmolimab|mesh-list
92437518|NCT02039063|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92162294|NCT01233921|Mitogens|mitogens|mesh-list
92437519|NCT02039063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437521|NCT02039063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437522|NCT01970410|Teriflunomide|teriflunomide|mesh-list
92437523|NCT01970410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92437524|NCT01970410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92437525|NCT01970410|Analgesics|analgesics|mesh-ancestor
92437526|NCT01970410|Sensory System Agents|sensory system agents|mesh-ancestor
92437527|NCT01970410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437528|NCT01970410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437529|NCT01970410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92437530|NCT01970410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437531|NCT01970410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437532|NCT01970410|Immunologic Factors|immunologic factors|mesh-ancestor
92437533|NCT01861314|Bortezomib|bortezomib|mesh-list
92437534|NCT01861314|Sorafenib|sorafenib|mesh-list
92437535|NCT01861314|Decitabine|decitabine|mesh-list
92437536|NCT01861314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437537|NCT01861314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437538|NCT01861314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437539|NCT01861314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437540|NCT01861314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92437541|NCT01861314|Antimetabolites|antimetabolites|mesh-ancestor
92437542|NCT01746173|Plerixafor|plerixafor|mesh-list
92437543|NCT01746173|Prednisone|prednisone|mesh-list
92437544|NCT01746173|Cyclophosphamide|cyclophosphamide|mesh-list
92437545|NCT01746173|Melphalan|melphalan|mesh-list
92437546|NCT01746173|Busulfan|busulfan|mesh-list
92437547|NCT01746173|Gemcitabine|gemcitabine|mesh-list
92437548|NCT01746173|Doxorubicin|doxorubicin|mesh-list
92437549|NCT01746173|Etoposide|etoposide|mesh-list
92437550|NCT01746173|Etoposide phosphate|etoposide phosphate|mesh-list
92437551|NCT01746173|Vincristine|vincristine|mesh-list
92437552|NCT01746173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437553|NCT01746173|Immunologic Factors|immunologic factors|mesh-ancestor
92437554|NCT01746173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437555|NCT01746173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437556|NCT01746173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437557|NCT01746173|Alkylating Agents|alkylating agents|mesh-ancestor
92437558|NCT01746173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437559|NCT01746173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437560|NCT01746173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437561|NCT01746173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92437562|NCT01746173|Antimetabolites|antimetabolites|mesh-ancestor
92437563|NCT01746173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92437564|NCT01746173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92437565|NCT01746173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92437566|NCT01746173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437567|NCT01746173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92437568|NCT01746173|Glucocorticoids|glucocorticoids|mesh-ancestor
92437569|NCT01746173|Hormones|hormones|mesh-ancestor
92437570|NCT01746173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437571|NCT01746173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92437572|NCT01746173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92437573|NCT01746173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437574|NCT01746173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437575|NCT01746173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437576|NCT01746173|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92437577|NCT01746173|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92437578|NCT01746173|Antiviral Agents|antiviral agents|mesh-ancestor
92437579|NCT01746173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437580|NCT01694004|Benzocaine|benzocaine|mesh-list
92437581|NCT01694004|Anesthetics, Local|anesthetics, local|mesh-ancestor
92437582|NCT01694004|Anesthetics|anesthetics|mesh-ancestor
92437583|NCT01694004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92437584|NCT01694004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437585|NCT01694004|Sensory System Agents|sensory system agents|mesh-ancestor
92437586|NCT01694004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437587|NCT01545843|Fluoxetine|fluoxetine|mesh-list
92437588|NCT01545843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92437589|NCT01545843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92437590|NCT01545843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92437591|NCT01545843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437592|NCT01545843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437593|NCT01545843|Serotonin Agents|serotonin agents|mesh-ancestor
92437594|NCT01545843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162366|NCT03010761|Moclobemide|moclobemide|mesh-list
92437595|NCT01545843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92437596|NCT01545843|Antidepressive Agents|antidepressive agents|mesh-ancestor
92437597|NCT01545843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92437598|NCT01545843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92437599|NCT01545843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92437600|NCT01545843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437601|NCT00843791|Pioglitazone|pioglitazone|mesh-list
92437602|NCT00843791|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92437603|NCT00843791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92437604|NCT00843791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437605|NCT03187769|Olanzapine|olanzapine|mesh-list
92437606|NCT03187769|Antiemetics|antiemetics|mesh-ancestor
92437607|NCT03187769|Autonomic Agents|autonomic agents|mesh-ancestor
92437608|NCT03187769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437609|NCT03187769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437610|NCT03187769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92437611|NCT03187769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92437612|NCT03187769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92437613|NCT03187769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92437614|NCT03187769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92437615|NCT03187769|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92437616|NCT03187769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92437617|NCT03187769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92437618|NCT03187769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437619|NCT03187769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437620|NCT03187769|Serotonin Agents|serotonin agents|mesh-ancestor
92437621|NCT03161353|Tamoxifen|tamoxifen|mesh-list
92437622|NCT03161353|Carboplatin|carboplatin|mesh-list
92437623|NCT03161353|Docetaxel|docetaxel|mesh-list
92437624|NCT03161353|Trastuzumab|trastuzumab|mesh-list
92437625|NCT03161353|Letrozole|letrozole|mesh-list
92437626|NCT03161353|Pertuzumab|pertuzumab|mesh-list
92437627|NCT03161353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437628|NCT03161353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437629|NCT03161353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437630|NCT03161353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437631|NCT03161353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437632|NCT03161353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437633|NCT03161353|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92437634|NCT03161353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92437635|NCT03161353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437636|NCT03161353|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92437637|NCT03161353|Hormone Antagonists|hormone antagonists|mesh-ancestor
92437638|NCT03161353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437639|NCT03161353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437640|NCT03161353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92437641|NCT03161353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92437642|NCT03161353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92437643|NCT03161353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92437644|NCT03136731|Antibodies|antibodies|mesh-list
92437645|NCT03136731|Immunologic Factors|immunologic factors|mesh-ancestor
92437646|NCT03136731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437647|NCT03134196|Valacyclovir|valacyclovir|mesh-list
92437648|NCT03134196|Antiviral Agents|antiviral agents|mesh-ancestor
92437649|NCT03134196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437650|NCT02956382|Venetoclax|venetoclax|mesh-list
92437651|NCT02956382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437652|NCT02939573|Dapsone|dapsone|mesh-list
92437653|NCT02939573|Colchicine|colchicine|mesh-list
92437654|NCT02939573|Azathioprine|azathioprine|mesh-list
92437655|NCT02939573|Gout Suppressants|gout suppressants|mesh-ancestor
92437656|NCT02939573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437657|NCT02939573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437658|NCT02939573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437659|NCT02939573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437660|NCT02939573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437661|NCT02939573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437662|NCT02939573|Antimetabolites|antimetabolites|mesh-ancestor
92437663|NCT02939573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92437664|NCT02939573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437665|NCT02939573|Immunologic Factors|immunologic factors|mesh-ancestor
92437666|NCT02939573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437667|NCT02939573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437668|NCT02939573|Antimalarials|antimalarials|mesh-ancestor
92437669|NCT02939573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92162437|NCT01281501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437670|NCT02939573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92437671|NCT02939573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92437672|NCT02939573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437673|NCT02939573|Leprostatic Agents|leprostatic agents|mesh-ancestor
92437674|NCT02939573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92437675|NCT02876107|Paclitaxel|paclitaxel|mesh-list
92437676|NCT02876107|Carboplatin|carboplatin|mesh-list
92437677|NCT02876107|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92437678|NCT02876107|Panitumumab|panitumumab|mesh-list
92437679|NCT02876107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92437680|NCT02876107|Antibodies|antibodies|mesh-list
92437681|NCT02876107|Immunoglobulins|immunoglobulins|mesh-list
92437682|NCT02876107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92437683|NCT02876107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92437684|NCT02876107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437685|NCT02876107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92437686|NCT02876107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92437687|NCT02876107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437688|NCT02876107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437689|NCT02876107|Immunologic Factors|immunologic factors|mesh-ancestor
92437690|NCT02876107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437691|NCT02855229|Methylphenidate|methylphenidate|mesh-list
92437692|NCT02855229|Modafinil|modafinil|mesh-list
92437693|NCT02855229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92437694|NCT02855229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437695|NCT02855229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92437696|NCT02855229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92437697|NCT02855229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92437698|NCT02855229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437699|NCT02855229|Dopamine Agents|dopamine agents|mesh-ancestor
92437700|NCT02855229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437701|NCT02855229|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92437702|NCT02855229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92437703|NCT02855229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92437705|NCT02829931|Nivolumab|nivolumab|mesh-list
92437706|NCT02829931|Ipilimumab|ipilimumab|mesh-list
92437707|NCT02829931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437708|NCT02829931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437709|NCT02829931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92437710|NCT02829931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92437711|NCT02829931|Growth Substances|growth substances|mesh-ancestor
92437712|NCT02829931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437713|NCT02829931|Growth Inhibitors|growth inhibitors|mesh-ancestor
92437714|NCT02829931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437715|NCT02829931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437716|NCT02815566|Tenofovir|tenofovir|mesh-list
92437717|NCT02815566|Emtricitabine|emtricitabine|mesh-list
92437718|NCT02815566|Antiviral Agents|antiviral agents|mesh-ancestor
92437719|NCT02815566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437720|NCT02815566|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92437721|NCT02815566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92437722|NCT02815566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437723|NCT02815566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437724|NCT02815566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92437725|NCT02815566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92437726|NCT02769845|Hydroxyurea|hydroxyurea|mesh-list
92437727|NCT02769845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437728|NCT02769845|Antisickling Agents|antisickling agents|mesh-ancestor
92437729|NCT02769845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437730|NCT02769845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437731|NCT02769845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92437732|NCT02727803|Cyclophosphamide|cyclophosphamide|mesh-list
92437733|NCT02727803|Melphalan|melphalan|mesh-list
92437734|NCT02727803|Busulfan|busulfan|mesh-list
92437735|NCT02727803|Mechlorethamine|mechlorethamine|mesh-list
92437736|NCT02727803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92437737|NCT02727803|Rituximab|rituximab|mesh-list
92437738|NCT02727803|Fludarabine|fludarabine|mesh-list
92437739|NCT02727803|Fludarabine phosphate|fludarabine phosphate|mesh-list
92437740|NCT02727803|Clofarabine|clofarabine|mesh-list
92437741|NCT02727803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92437742|NCT02727803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92437743|NCT02727803|Antibodies|antibodies|mesh-list
92437744|NCT02727803|Immunoglobulins|immunoglobulins|mesh-list
92437745|NCT02727803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92437746|NCT02727803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437747|NCT02727803|Immunologic Factors|immunologic factors|mesh-ancestor
92437748|NCT02727803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437749|NCT02727803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437750|NCT02727803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437751|NCT02727803|Alkylating Agents|alkylating agents|mesh-ancestor
92437752|NCT02727803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437753|NCT02727803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437754|NCT02727803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437755|NCT02727803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92437757|NCT02702492|Niacin|niacin|mesh-list
92437758|NCT02702492|Nivolumab|nivolumab|mesh-list
92437759|NCT02702492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437760|NCT02702492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437761|NCT02702492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437762|NCT02702492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437763|NCT02702492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92437764|NCT02702492|Antimetabolites|antimetabolites|mesh-ancestor
92437765|NCT02702492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92437766|NCT02702492|Vasodilator Agents|vasodilator agents|mesh-ancestor
92437767|NCT02702492|Vitamin B Complex|vitamin b complex|mesh-ancestor
92437768|NCT02702492|Vitamins|vitamins|mesh-ancestor
92437769|NCT02702492|Micronutrients|micronutrients|mesh-ancestor
92437770|NCT02702492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437771|NCT02652455|Aldesleukin|aldesleukin|mesh-list
92437772|NCT02652455|Cyclophosphamide|cyclophosphamide|mesh-list
92437773|NCT02652455|Nivolumab|nivolumab|mesh-list
92437774|NCT02652455|Fludarabine|fludarabine|mesh-list
92437775|NCT02652455|Interleukin-2|interleukin-2|mesh-list
92437776|NCT02652455|Antibodies|antibodies|mesh-list
92437777|NCT02652455|Immunoglobulins|immunoglobulins|mesh-list
92437778|NCT02652455|Antibodies, Blocking|antibodies, blocking|mesh-list
92437779|NCT02652455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92437780|NCT02652455|Immunologic Factors|immunologic factors|mesh-ancestor
92531121|NCT00001649|Antiviral Agents|antiviral agents|mesh-ancestor
92437781|NCT02652455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437782|NCT02652455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437783|NCT02652455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92437784|NCT02652455|Alkylating Agents|alkylating agents|mesh-ancestor
92437785|NCT02652455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437786|NCT02652455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437787|NCT02652455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92437788|NCT02652455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437789|NCT02652455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92437790|NCT02652455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92437792|NCT02652455|Sensory System Agents|sensory system agents|mesh-ancestor
92437793|NCT02652455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437794|NCT02652455|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92437795|NCT02652455|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92437796|NCT02652455|Antiviral Agents|antiviral agents|mesh-ancestor
92437797|NCT02652455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437798|NCT02491983|Letrozole|letrozole|mesh-list
92437799|NCT02491983|Fulvestrant|fulvestrant|mesh-list
92437800|NCT02491983|Palbociclib|palbociclib|mesh-list
92437801|NCT02491983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437802|NCT02491983|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92437803|NCT02491983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92437804|NCT02491983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437805|NCT02491983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437806|NCT02491983|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92437807|NCT02491983|Hormone Antagonists|hormone antagonists|mesh-ancestor
92437808|NCT02491983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437809|NCT02491983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437810|NCT02491983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92437811|NCT02491983|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92437812|NCT02491983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437813|NCT02467478|Linagliptin|linagliptin|mesh-list
92437814|NCT02467478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92437815|NCT02467478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437816|NCT02467478|Incretins|incretins|mesh-ancestor
92437817|NCT02467478|Hormones|hormones|mesh-ancestor
92437818|NCT02467478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162588|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437819|NCT02467478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92437820|NCT02467478|Protease Inhibitors|protease inhibitors|mesh-ancestor
92437821|NCT02467478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437822|NCT02467478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437823|NCT02466243|Lenabasum|lenabasum|mesh-list
92437824|NCT02466243|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92437825|NCT02466243|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92437826|NCT02466243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437827|NCT02466243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437828|NCT02466243|Hormones|hormones|mesh-ancestor
92437829|NCT02466243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437830|NCT02466243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437831|NCT02321098|Amorolfine|amorolfine|mesh-list
92437832|NCT02321098|Antifungal Agents|antifungal agents|mesh-ancestor
92437833|NCT02321098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437834|NCT02185417|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92437835|NCT02185417|Chlorthalidone|chlorthalidone|mesh-list
92437836|NCT02185417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92437837|NCT02185417|Diuretics|diuretics|mesh-ancestor
92437838|NCT02185417|Natriuretic Agents|natriuretic agents|mesh-ancestor
92437839|NCT02185417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437840|NCT02185417|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92437841|NCT02185417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92437842|NCT02185417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437843|NCT02158234|Cisplatin|cisplatin|mesh-list
92437844|NCT02158234|Alkylating Agents|alkylating agents|mesh-list
92437845|NCT02158234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437846|NCT02158234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437847|NCT01966731|Hydroxyurea|hydroxyurea|mesh-list
92437848|NCT01966731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437849|NCT01966731|Antisickling Agents|antisickling agents|mesh-ancestor
92437850|NCT01966731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437851|NCT01966731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437852|NCT01966731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92437854|NCT01953926|Fulvestrant|fulvestrant|mesh-list
92437855|NCT01953926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92437856|NCT01953926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437857|NCT01953926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92437858|NCT01953926|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92437859|NCT01953926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92437860|NCT01953926|Hormone Antagonists|hormone antagonists|mesh-ancestor
92437861|NCT01953926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437862|NCT01953926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437863|NCT01859026|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92437865|NCT01859026|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92437866|NCT01859026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437867|NCT01859026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437868|NCT01859026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437869|NCT01859026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437870|NCT01859026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92437871|NCT01843374|Tremelimumab|tremelimumab|mesh-list
92437872|NCT01843374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437873|NCT01657591|Vemurafenib|vemurafenib|mesh-list
92437874|NCT01657591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92437875|NCT01657591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92437876|NCT01657591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437877|NCT01657591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437878|NCT01599468|Tranexamic Acid|tranexamic acid|mesh-list
92437879|NCT01599468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92437880|NCT01599468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92437881|NCT01599468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437882|NCT01599468|Hemostatics|hemostatics|mesh-ancestor
92437883|NCT01599468|Coagulants|coagulants|mesh-ancestor
92437885|NCT01599572|Trace Elements|trace elements|mesh-ancestor
92437886|NCT01599572|Micronutrients|micronutrients|mesh-ancestor
92437887|NCT01599572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437888|NCT01599598|Imidacloprid|imidacloprid|mesh-list
92437889|NCT01599598|Cholinergic Agents|cholinergic agents|mesh-ancestor
92437890|NCT01599598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437891|NCT01599598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437892|NCT01599598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437893|NCT01599702|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92437894|NCT01599702|Hematinics|hematinics|mesh-ancestor
92437895|NCT01599728|Substance P|substance p|mesh-list
92437896|NCT01599728|Neurokinin A|neurokinin a|mesh-list
92437897|NCT01599728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437898|NCT01599728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437899|NCT01599728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437900|NCT01599819|Factor VIII|factor viii|mesh-list
92437901|NCT01599819|BAX 855|bax 855|mesh-list
92437902|NCT01599819|Coagulants|coagulants|mesh-ancestor
92437903|NCT01599858|Omeprazole|omeprazole|mesh-list
92437904|NCT01599858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92437905|NCT01599858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92437906|NCT01599858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92437907|NCT01599858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437908|NCT01599858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437909|NCT01599871|Theophylline|theophylline|mesh-list
92437910|NCT01599871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92437911|NCT01599871|Autonomic Agents|autonomic agents|mesh-ancestor
92437912|NCT01599871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437913|NCT01599871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437914|NCT01599871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92437915|NCT01599871|Respiratory System Agents|respiratory system agents|mesh-ancestor
92437916|NCT01599871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92437917|NCT01599871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437918|NCT01599871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437919|NCT01599871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92437920|NCT01599871|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92437921|NCT01599871|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92437922|NCT01599871|Purinergic Agents|purinergic agents|mesh-ancestor
92437923|NCT01599871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437924|NCT01599884|Acetylcysteine|acetylcysteine|mesh-list
92437925|NCT01599884|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92437926|NCT01599884|Antiviral Agents|antiviral agents|mesh-ancestor
92437927|NCT01599884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437928|NCT01599884|Expectorants|expectorants|mesh-ancestor
92437929|NCT01599884|Respiratory System Agents|respiratory system agents|mesh-ancestor
92437930|NCT01599884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92437931|NCT01599884|Antioxidants|antioxidants|mesh-ancestor
92437932|NCT01599884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437933|NCT01599884|Protective Agents|protective agents|mesh-ancestor
92437934|NCT01599884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437935|NCT01599884|Antidotes|antidotes|mesh-ancestor
92437936|NCT01599923|Antivenins|antivenins|mesh-list
92437937|NCT01599923|Immunologic Factors|immunologic factors|mesh-ancestor
92437938|NCT01599923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437939|NCT01599936|Antivenins|antivenins|mesh-list
92437940|NCT01599936|Immunologic Factors|immunologic factors|mesh-ancestor
92437941|NCT01599936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437942|NCT01599962|Cinacalcet|cinacalcet|mesh-list
92437943|NCT01599962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92437944|NCT01599962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437945|NCT01599962|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92437946|NCT01599962|Hormone Antagonists|hormone antagonists|mesh-ancestor
92437947|NCT01599962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92437948|NCT01599975|Methylphenidate|methylphenidate|mesh-list
92437949|NCT01599975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92437950|NCT01599975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437951|NCT01599975|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92437952|NCT01599975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92437953|NCT01599975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92437954|NCT01599975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437955|NCT01599975|Dopamine Agents|dopamine agents|mesh-ancestor
92437956|NCT01599975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92437957|NCT01599988|Caseins|caseins|mesh-list
92437958|NCT01599988|Chelating Agents|chelating agents|mesh-ancestor
92437959|NCT01599988|Sequestering Agents|sequestering agents|mesh-ancestor
92437960|NCT01599988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437961|NCT01600430|Vitamin D|vitamin d|mesh-list
92437962|NCT01600430|Ergocalciferols|ergocalciferols|mesh-list
92437963|NCT01600430|Cholecalciferol|cholecalciferol|mesh-list
92437964|NCT01600430|Vitamins|vitamins|mesh-list
92437965|NCT01600430|Micronutrients|micronutrients|mesh-ancestor
92437966|NCT01600430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437967|NCT01600430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92437968|NCT01600430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92437969|NCT01600599|Tranexamic Acid|tranexamic acid|mesh-list
92437970|NCT01600599|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92437971|NCT01600599|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92437972|NCT01600599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437973|NCT01600599|Hemostatics|hemostatics|mesh-ancestor
92437974|NCT01600599|Coagulants|coagulants|mesh-ancestor
92437975|NCT01601028|Hydroxychloroquine|hydroxychloroquine|mesh-list
92437976|NCT01601028|Antimalarials|antimalarials|mesh-ancestor
92437977|NCT01601028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92437978|NCT01601028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92437979|NCT01601028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92437980|NCT01601028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437981|NCT01601028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437982|NCT01601028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92437983|NCT01602029|Ondansetron|ondansetron|mesh-list
92437984|NCT01602029|Simvastatin|simvastatin|mesh-list
92437985|NCT01602029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92437986|NCT01602029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92437987|NCT01602029|Antimetabolites|antimetabolites|mesh-ancestor
92437988|NCT01602029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92437989|NCT01602029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92437990|NCT01602029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92437991|NCT01602029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92437992|NCT01602029|Antiemetics|antiemetics|mesh-ancestor
92437993|NCT01602029|Autonomic Agents|autonomic agents|mesh-ancestor
92437994|NCT01602029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92437995|NCT01602029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92437996|NCT01602029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92437997|NCT01602029|Antipruritics|antipruritics|mesh-ancestor
92437998|NCT01602029|Dermatologic Agents|dermatologic agents|mesh-ancestor
92437999|NCT01602029|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92438000|NCT01602029|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92438001|NCT01602029|Serotonin Agents|serotonin agents|mesh-ancestor
92438002|NCT01602029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438004|NCT01602874|Clarithromycin|clarithromycin|mesh-list
92438005|NCT01602874|Ceftriaxone|ceftriaxone|mesh-list
92438006|NCT01602874|Tigecycline|tigecycline|mesh-list
92438007|NCT01602874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438008|NCT01602874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438009|NCT01602874|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92438010|NCT01602874|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92438011|NCT01602874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92438012|NCT01602874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438013|NCT01602874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438014|NCT01602874|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92438015|NCT01602874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92438016|NCT01602887|Palbociclib|palbociclib|mesh-list
92438017|NCT01602887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438018|NCT01602887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438019|NCT01602887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438020|NCT01602887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438021|NCT01603264|Trastuzumab|trastuzumab|mesh-list
92438022|NCT01603264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92438023|NCT01603264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438024|NCT01603680|Anesthetics|anesthetics|mesh-list
92438025|NCT01603680|Mepivacaine|mepivacaine|mesh-list
92438026|NCT01603680|Anesthetics, Local|anesthetics, local|mesh-list
92438027|NCT01603680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438028|NCT01603680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438029|NCT01603680|Sensory System Agents|sensory system agents|mesh-ancestor
92438030|NCT01603680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438031|NCT01604213|Metformin|metformin|mesh-list
92438032|NCT01604213|Vildagliptin|vildagliptin|mesh-list
92438033|NCT01604213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438034|NCT01604213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438035|NCT01604213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92438036|NCT01604213|Protease Inhibitors|protease inhibitors|mesh-ancestor
92438037|NCT01604213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438038|NCT01604213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438039|NCT01605240|Acetaminophen|acetaminophen|mesh-list
92438040|NCT01605240|Ibuprofen|ibuprofen|mesh-list
92438041|NCT01605240|Codeine|codeine|mesh-list
92438042|NCT01605240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438043|NCT01605240|Analgesics|analgesics|mesh-ancestor
92438044|NCT01605240|Sensory System Agents|sensory system agents|mesh-ancestor
92438045|NCT01605240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438046|NCT01605240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438047|NCT01605240|Antipyretics|antipyretics|mesh-ancestor
92438048|NCT01605240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438049|NCT01605240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438050|NCT01605240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438051|NCT01605240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92438052|NCT01605240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438053|NCT01605240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438054|NCT01605240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92438055|NCT01605240|Narcotics|narcotics|mesh-ancestor
92438056|NCT01605240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438057|NCT01605240|Antitussive Agents|antitussive agents|mesh-ancestor
92438058|NCT01605240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438059|NCT01605279|Dobutamine|dobutamine|mesh-list
92438060|NCT01605279|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92438061|NCT01605279|Sympathomimetics|sympathomimetics|mesh-ancestor
92438062|NCT01605279|Autonomic Agents|autonomic agents|mesh-ancestor
92438063|NCT01605279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438064|NCT01605279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438065|NCT01605279|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92438066|NCT01605279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92438067|NCT01605279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92438068|NCT01605279|Adrenergic Agents|adrenergic agents|mesh-ancestor
92438069|NCT01605279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438070|NCT01605279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438071|NCT01605279|Protective Agents|protective agents|mesh-ancestor
92438072|NCT01606072|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92438073|NCT01606072|Hemostatics|hemostatics|mesh-ancestor
92438074|NCT01606072|Coagulants|coagulants|mesh-ancestor
92438075|NCT01606072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92438076|NCT01606072|Natriuretic Agents|natriuretic agents|mesh-ancestor
92438077|NCT01606072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438078|NCT01606722|Ritonavir|ritonavir|mesh-list
92438080|NCT01606722|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92438081|NCT01606722|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92438082|NCT01606722|Protease Inhibitors|protease inhibitors|mesh-ancestor
92438083|NCT01606722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438084|NCT01606722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438085|NCT01606722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92438086|NCT01606722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92438087|NCT01606722|Antiviral Agents|antiviral agents|mesh-ancestor
92438088|NCT01606722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438089|NCT01606722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92438090|NCT01606722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92438091|NCT01607983|Nitric Oxide|nitric oxide|mesh-list
92438092|NCT01607983|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92438093|NCT01607983|Autonomic Agents|autonomic agents|mesh-ancestor
92438094|NCT01607983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438095|NCT01607983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438096|NCT01607983|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92438097|NCT01607983|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438098|NCT01607983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92438099|NCT01607983|Antioxidants|antioxidants|mesh-ancestor
92438100|NCT01607983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438101|NCT01607983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438102|NCT01607983|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92438103|NCT01607983|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438104|NCT01607983|Gasotransmitters|gasotransmitters|mesh-ancestor
92438105|NCT01607983|Protective Agents|protective agents|mesh-ancestor
92438106|NCT01608217|Acetaminophen|acetaminophen|mesh-list
92438107|NCT01608217|Dronabinol|dronabinol|mesh-list
92438108|NCT01608217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438109|NCT01608217|Analgesics|analgesics|mesh-ancestor
92438110|NCT01608217|Sensory System Agents|sensory system agents|mesh-ancestor
92438111|NCT01608217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438112|NCT01608217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438113|NCT01608217|Antipyretics|antipyretics|mesh-ancestor
92438114|NCT01608217|Hallucinogens|hallucinogens|mesh-ancestor
92438115|NCT01608217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438116|NCT01608217|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92438117|NCT01608217|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92438118|NCT01608217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438119|NCT01608217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162889|NCT02307149|Ipilimumab|ipilimumab|mesh-list
92438121|NCT01608217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438122|NCT01608594|Ipilimumab|ipilimumab|mesh-list
92438123|NCT01608594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92438124|NCT01608594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438125|NCT01608594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92438126|NCT01608594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438127|NCT01608854|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92438128|NCT01608854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438129|NCT01608880|Nitroglycerin|nitroglycerin|mesh-list
92438130|NCT01608880|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438131|NCT01608958|Oxytocin|oxytocin|mesh-list
92438132|NCT01608958|Oxytocics|oxytocics|mesh-ancestor
92438133|NCT01608958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438134|NCT01608958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438135|NCT01609153|Olanzapine|olanzapine|mesh-list
92438136|NCT01609153|Amisulpride|amisulpride|mesh-list
92438137|NCT01609153|Antiemetics|antiemetics|mesh-ancestor
92438138|NCT01609153|Autonomic Agents|autonomic agents|mesh-ancestor
92438139|NCT01609153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438140|NCT01609153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438141|NCT01609153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438142|NCT01609153|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92438143|NCT01609153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92438144|NCT01609153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438145|NCT01609153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438146|NCT01609153|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92438147|NCT01609153|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92438148|NCT01609153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438149|NCT01609153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438150|NCT01609153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438151|NCT01609153|Serotonin Agents|serotonin agents|mesh-ancestor
92438152|NCT01609153|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92438153|NCT01609153|Dopamine Agents|dopamine agents|mesh-ancestor
92438154|NCT01609153|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92438155|NCT01609153|Antidepressive Agents|antidepressive agents|mesh-ancestor
92438157|NCT01610141|Anticoagulants|anticoagulants|mesh-ancestor
92438158|NCT01610310|Interferon-beta|interferon-beta|mesh-list
92438159|NCT01610310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438160|NCT01610310|Antiviral Agents|antiviral agents|mesh-ancestor
92438161|NCT01610310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438162|NCT01610310|Immunologic Factors|immunologic factors|mesh-ancestor
92438163|NCT01610310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438164|NCT01610362|Immunoglobulins|immunoglobulins|mesh-list
92438165|NCT01610362|Antibodies|antibodies|mesh-list
92438166|NCT01610362|gamma-Globulins|gamma-globulins|mesh-list
92438167|NCT01610362|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92438168|NCT01610362|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92438169|NCT01610362|Immunoglobulin G|immunoglobulin g|mesh-list
92438170|NCT01610362|Immunologic Factors|immunologic factors|mesh-ancestor
92438171|NCT01610362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438172|NCT01610401|Metformin|metformin|mesh-list
92438173|NCT01610401|Caffeine|caffeine|mesh-list
92438174|NCT01610401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438175|NCT01610401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438176|NCT01610401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92438177|NCT01610401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92438178|NCT01610401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438179|NCT01610401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438180|NCT01610401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92438181|NCT01610401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92438182|NCT01610401|Purinergic Agents|purinergic agents|mesh-ancestor
92438183|NCT01610401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438184|NCT01610765|Antiviral Agents|antiviral agents|mesh-list
92438185|NCT01610765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438186|NCT01610778|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92438187|NCT01610778|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92438188|NCT01610778|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438189|NCT01610869|Nintedanib|nintedanib|mesh-list
92438190|NCT01610869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438191|NCT01610869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438192|NCT01610869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438193|NCT01610869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438194|NCT01610921|Adenosine|adenosine|mesh-list
92438195|NCT01610921|Analgesics|analgesics|mesh-ancestor
92438196|NCT01610921|Sensory System Agents|sensory system agents|mesh-ancestor
92438197|NCT01610921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438198|NCT01610921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438199|NCT01610921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92438200|NCT01610921|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438201|NCT01610921|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92438202|NCT01610921|Purinergic Agonists|purinergic agonists|mesh-ancestor
92438203|NCT01610921|Purinergic Agents|purinergic agents|mesh-ancestor
92438204|NCT01610921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438205|NCT01610921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438206|NCT01610934|Liraglutide|liraglutide|mesh-list
92438207|NCT01610934|Glimepiride|glimepiride|mesh-list
92438208|NCT01610934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438209|NCT01610934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438210|NCT01610934|Incretins|incretins|mesh-ancestor
92438211|NCT01610934|Hormones|hormones|mesh-ancestor
92438212|NCT01610934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438213|NCT01610934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92438214|NCT01610934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438215|NCT01610934|Immunologic Factors|immunologic factors|mesh-ancestor
92438216|NCT01610947|Adalimumab|adalimumab|mesh-list
92438217|NCT01610947|Infliximab|infliximab|mesh-list
92438218|NCT01610947|Golimumab|golimumab|mesh-list
92438219|NCT01610947|Etanercept|etanercept|mesh-list
92438220|NCT01610947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92438221|NCT01610947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92438222|NCT01610947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438223|NCT01610947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438224|NCT01610947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438225|NCT01610947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438226|NCT01610947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438227|NCT01610947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438228|NCT01610947|Analgesics|analgesics|mesh-ancestor
92438230|NCT01610947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438231|NCT01610947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438232|NCT01610947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438233|NCT01610947|Immunologic Factors|immunologic factors|mesh-ancestor
92438234|NCT01610999|Plerixafor|plerixafor|mesh-list
92438235|NCT01610999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92438236|NCT01610999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92438237|NCT01610999|Antiviral Agents|antiviral agents|mesh-ancestor
92438238|NCT01610999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438239|NCT01611038|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
92438240|NCT01611038|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92438241|NCT01611038|Protective Agents|protective agents|mesh-ancestor
92438242|NCT01611038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438243|NCT01611038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438244|NCT01611077|Amlodipine|amlodipine|mesh-list
92438245|NCT01611077|Candesartan|candesartan|mesh-list
92438246|NCT01611077|Candesartan cilexetil|candesartan cilexetil|mesh-list
92438247|NCT01611077|Olmesartan|olmesartan|mesh-list
92438248|NCT01611077|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92438249|NCT01611077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92438250|NCT01611077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92438251|NCT01611077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438252|NCT01611077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438253|NCT01611077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92438254|NCT01611077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438255|NCT01611077|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438256|NCT01611077|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92438257|NCT01611077|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92438258|NCT01611142|Mogamulizumab|mogamulizumab|mesh-list
92438259|NCT01611142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438260|NCT01611311|BI 409306|bi 409306|mesh-list
92438261|NCT01611311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92438262|NCT01611311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438263|NCT01611311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438264|NCT01611324|Epinephrine|epinephrine|mesh-list
92438265|NCT01611324|Mepivacaine|mepivacaine|mesh-list
92438266|NCT01611324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92438267|NCT01611324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92438268|NCT01611324|Adrenergic Agents|adrenergic agents|mesh-ancestor
92438269|NCT01611324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438270|NCT01611324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438271|NCT01611324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438272|NCT01611324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92438273|NCT01611324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92438275|NCT01611324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438276|NCT01611324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92438277|NCT01611324|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438278|NCT01611324|Mydriatics|mydriatics|mesh-ancestor
92438279|NCT01611324|Sympathomimetics|sympathomimetics|mesh-ancestor
92438280|NCT01611324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92438281|NCT01611324|Anesthetics, Local|anesthetics, local|mesh-ancestor
92438282|NCT01611324|Anesthetics|anesthetics|mesh-ancestor
92438283|NCT01611324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438284|NCT01611324|Sensory System Agents|sensory system agents|mesh-ancestor
92438285|NCT01611363|Ipragliflozin|ipragliflozin|mesh-list
92438286|NCT01611363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92438287|NCT01611363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438288|NCT01611363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438289|NCT01611363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438290|NCT01611415|Ipragliflozin|ipragliflozin|mesh-list
92438291|NCT01611415|Furosemide|furosemide|mesh-list
92438292|NCT01611415|Diuretics|diuretics|mesh-ancestor
92438293|NCT01611415|Natriuretic Agents|natriuretic agents|mesh-ancestor
92200066|NCT00580151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438294|NCT01611415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438295|NCT01611415|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92438296|NCT01611415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438297|NCT01611415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438298|NCT01611415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92438299|NCT01611415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438300|NCT01611428|Ipragliflozin|ipragliflozin|mesh-list
92438301|NCT01611428|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92438302|NCT01611428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438303|NCT01611428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438304|NCT01611428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438306|NCT01611480|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92438307|NCT01611480|Immunologic Factors|immunologic factors|mesh-ancestor
92438308|NCT01611480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438309|NCT01611480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438310|NCT01611480|Interferon Inducers|interferon inducers|mesh-ancestor
92438311|NCT01611506|Capecitabine|capecitabine|mesh-list
92438312|NCT01611506|Cetuximab|cetuximab|mesh-list
92438313|NCT01611506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438314|NCT01611506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92438315|NCT01611506|Antimetabolites|antimetabolites|mesh-ancestor
92438316|NCT01611506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438317|NCT01611506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92438318|NCT01611675|Vemurafenib|vemurafenib|mesh-list
92438319|NCT01611675|Leflunomide|leflunomide|mesh-list
92438320|NCT01611675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438321|NCT01611675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438322|NCT01611675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438323|NCT01611675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438324|NCT01611675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438325|NCT01611675|Immunologic Factors|immunologic factors|mesh-ancestor
92438326|NCT01611675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438327|NCT01611688|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92438328|NCT01611688|Immunologic Factors|immunologic factors|mesh-ancestor
92438329|NCT01611688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438330|NCT01611727|Cisplatin|cisplatin|mesh-list
92438331|NCT01611727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438332|NCT01611896|Selenium|selenium|mesh-list
92438333|NCT01611896|Antioxidants|antioxidants|mesh-ancestor
92438334|NCT01611896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438335|NCT01611896|Protective Agents|protective agents|mesh-ancestor
92438336|NCT01611896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438337|NCT01611896|Trace Elements|trace elements|mesh-ancestor
92438338|NCT01611896|Micronutrients|micronutrients|mesh-ancestor
92438340|NCT01611909|Expectorants|expectorants|mesh-ancestor
92438341|NCT01611909|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438342|NCT01611961|Docetaxel|docetaxel|mesh-list
92438343|NCT01611961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438344|NCT01611961|Tubulin Modulators|tubulin modulators|mesh-ancestor
92438345|NCT01611961|Antimitotic Agents|antimitotic agents|mesh-ancestor
92438346|NCT01611961|Mitosis Modulators|mitosis modulators|mesh-ancestor
92438347|NCT01611961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438348|NCT01612052|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92438349|NCT01612052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438350|NCT01612065|Misoprostol|misoprostol|mesh-list
92438351|NCT01612065|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92438352|NCT01612065|Abortifacient Agents|abortifacient agents|mesh-ancestor
92438353|NCT01612065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438354|NCT01612065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438355|NCT01612065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92438356|NCT01612065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438357|NCT01612065|Oxytocics|oxytocics|mesh-ancestor
92438358|NCT01612078|Droxidopa|droxidopa|mesh-list
92438359|NCT01612078|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92438360|NCT01612078|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92438361|NCT01612247|Aspirin|aspirin|mesh-list
92438362|NCT01612247|Cyclophosphamide|cyclophosphamide|mesh-list
92438363|NCT01612247|Methotrexate|methotrexate|mesh-list
92438364|NCT01612247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438365|NCT01612247|Immunologic Factors|immunologic factors|mesh-ancestor
92438366|NCT01612247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438367|NCT01612247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438368|NCT01612247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92438369|NCT01612247|Alkylating Agents|alkylating agents|mesh-ancestor
92438370|NCT01612247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438371|NCT01612247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438372|NCT01612247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92438373|NCT01612247|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92438374|NCT01612247|Abortifacient Agents|abortifacient agents|mesh-ancestor
92438375|NCT01612247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438376|NCT01612247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92438377|NCT01612247|Antimetabolites|antimetabolites|mesh-ancestor
92438378|NCT01612247|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438379|NCT01612247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438380|NCT01612247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92438381|NCT01612247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92438382|NCT01612247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438383|NCT01612247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438384|NCT01612247|Analgesics|analgesics|mesh-ancestor
92438385|NCT01612247|Sensory System Agents|sensory system agents|mesh-ancestor
92438386|NCT01612247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438387|NCT01612247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438388|NCT01612247|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92438389|NCT01612247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92438390|NCT01612247|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92438391|NCT01612247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92438392|NCT01612247|Antipyretics|antipyretics|mesh-ancestor
92438393|NCT01612273|Aspirin|aspirin|mesh-list
92438394|NCT01612273|Triflusal|triflusal|mesh-list
92438395|NCT01612273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438396|NCT01612273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438397|NCT01612273|Analgesics|analgesics|mesh-ancestor
92438398|NCT01612273|Sensory System Agents|sensory system agents|mesh-ancestor
92438399|NCT01612273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438400|NCT01612273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438401|NCT01612273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438402|NCT01612273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438403|NCT01612273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92438404|NCT01612273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92438405|NCT01612273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438406|NCT01612273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92438407|NCT01612273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92438408|NCT01612273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438409|NCT01612273|Antipyretics|antipyretics|mesh-ancestor
92438410|NCT01612286|Endostatins|endostatins|mesh-list
92438411|NCT01612286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92438412|NCT01612286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92438413|NCT01612286|Growth Substances|growth substances|mesh-ancestor
92438414|NCT01612286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438415|NCT01612286|Growth Inhibitors|growth inhibitors|mesh-ancestor
92438416|NCT01612286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438417|NCT01612299|Everolimus|everolimus|mesh-list
92438418|NCT01612299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92438419|NCT01612299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438420|NCT01612299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438421|NCT01612299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438422|NCT01612299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438423|NCT01612299|Immunologic Factors|immunologic factors|mesh-ancestor
92438424|NCT01612299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438425|NCT01612299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438427|NCT01612377|Prednisolone|prednisolone|mesh-list
92438428|NCT01612377|Dipyridamole|dipyridamole|mesh-list
92438429|NCT01612377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438430|NCT01612377|Glucocorticoids|glucocorticoids|mesh-ancestor
92438431|NCT01612377|Hormones|hormones|mesh-ancestor
92438432|NCT01612377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438433|NCT01612377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438434|NCT01612377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92438435|NCT01612377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438436|NCT01612377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92438437|NCT01612377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438438|NCT01612377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438439|NCT01612377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92438440|NCT01612377|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438441|NCT01612403|Zinc Sulfate|zinc sulfate|mesh-list
92438442|NCT01612403|Astringents|astringents|mesh-ancestor
92438443|NCT01612403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438444|NCT01612403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438445|NCT01612468|Liraglutide|liraglutide|mesh-list
92438446|NCT01612468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438447|NCT01612468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438448|NCT01612468|Incretins|incretins|mesh-ancestor
92438449|NCT01612468|Hormones|hormones|mesh-ancestor
92438450|NCT01612468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438451|NCT01612507|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92438452|NCT01612507|Cephalosporins|cephalosporins|mesh-list
92438453|NCT01612507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438454|NCT01612507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438455|NCT01612728|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92438456|NCT01612728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92438457|NCT01612728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438458|NCT01612728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438459|NCT01612728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92438460|NCT01612728|Hormone Antagonists|hormone antagonists|mesh-ancestor
92438461|NCT01612728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438462|NCT01612728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438463|NCT01612741|Acarbose|acarbose|mesh-list
92438464|NCT01612741|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92438465|NCT01612741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438466|NCT01612741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438467|NCT01612741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438468|NCT01612741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438469|NCT01612832|Pregabalin|pregabalin|mesh-list
92438470|NCT01612832|Analgesics|analgesics|mesh-ancestor
92438471|NCT01612832|Sensory System Agents|sensory system agents|mesh-ancestor
92438472|NCT01612832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438473|NCT01612832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438474|NCT01612832|Anticonvulsants|anticonvulsants|mesh-ancestor
92438475|NCT01612832|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92438476|NCT01612832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438477|NCT01612832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438478|NCT01612832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92438479|NCT01612832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92438480|NCT01612832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92438481|NCT01612832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438482|NCT01612832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438483|NCT01612871|Tamoxifen|tamoxifen|mesh-list
92438484|NCT01612871|Letrozole|letrozole|mesh-list
92438485|NCT01612871|Anastrozole|anastrozole|mesh-list
92438486|NCT01612871|Exemestane|exemestane|mesh-list
92438487|NCT01612871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438488|NCT01612871|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92438489|NCT01612871|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92438490|NCT01612871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438491|NCT01612871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438492|NCT01612871|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92438493|NCT01612871|Hormone Antagonists|hormone antagonists|mesh-ancestor
92163263|NCT05607901|Tacrolimus|tacrolimus|mesh-list
92438494|NCT01612871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438495|NCT01612871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438496|NCT01612871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92438497|NCT01612871|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92438498|NCT01612871|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92438499|NCT01612871|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92438500|NCT01612910|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92438501|NCT01612910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92438502|NCT01612910|Protective Agents|protective agents|mesh-ancestor
92438503|NCT01612910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438504|NCT01612910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438505|NCT01612936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92438506|NCT01612936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92438507|NCT01612936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438508|NCT01612975|Naproxen|naproxen|mesh-list
92438509|NCT01612975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438510|NCT01612975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438511|NCT01612975|Analgesics|analgesics|mesh-ancestor
92438512|NCT01612975|Sensory System Agents|sensory system agents|mesh-ancestor
92438513|NCT01612975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438514|NCT01612975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438515|NCT01612975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438517|NCT01612975|Gout Suppressants|gout suppressants|mesh-ancestor
92438518|NCT01612975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92438519|NCT01612975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438520|NCT01612975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438521|NCT01613040|Moxifloxacin|moxifloxacin|mesh-list
92438522|NCT01613040|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92438523|NCT01613040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438524|NCT01613040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438525|NCT01613040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92438526|NCT01613040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92438527|NCT01613040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438528|NCT01613040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438529|NCT01613040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438530|NCT01613040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92438531|NCT01613040|Contraceptive Agents|contraceptive agents|mesh-ancestor
92438532|NCT01613040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438533|NCT01613040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438534|NCT01613040|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92438535|NCT01613040|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92438536|NCT01613040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92438537|NCT01613053|Imatinib Mesylate|imatinib mesylate|mesh-list
92438538|NCT01613053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438539|NCT01613053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438540|NCT01613053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438541|NCT01613053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438542|NCT01613079|Methotrexate|methotrexate|mesh-list
92438543|NCT01613079|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92438544|NCT01613079|Abortifacient Agents|abortifacient agents|mesh-ancestor
92438545|NCT01613079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438546|NCT01613079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438547|NCT01613079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92438548|NCT01613079|Antimetabolites|antimetabolites|mesh-ancestor
92438549|NCT01613079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438550|NCT01613079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438551|NCT01613079|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438552|NCT01613079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438553|NCT01613079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92438554|NCT01613079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438555|NCT01613079|Immunologic Factors|immunologic factors|mesh-ancestor
92438556|NCT01613079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438557|NCT01613079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92438558|NCT01613092|Vancomycin|vancomycin|mesh-list
92438559|NCT01613092|Clindamycin|clindamycin|mesh-list
92438560|NCT01613092|Cefazolin|cefazolin|mesh-list
92438561|NCT01613092|Cephalexin|cephalexin|mesh-list
92438562|NCT01613092|Bacitracin|bacitracin|mesh-list
92438563|NCT01613092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438564|NCT01613092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438565|NCT01613092|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92438566|NCT01613092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438567|NCT01613092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438568|NCT01613092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92438569|NCT01613105|Acarbose|acarbose|mesh-list
92438570|NCT01613105|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92438571|NCT01613105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438572|NCT01613105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438573|NCT01613105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438574|NCT01613105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438575|NCT01613170|Estrogens|estrogens|mesh-list
92438576|NCT01613170|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92438577|NCT01613170|Hormones|hormones|mesh-ancestor
92438578|NCT01613170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438579|NCT01613170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438580|NCT01613196|Deoxyglucose|deoxyglucose|mesh-list
92438581|NCT01613196|Antimetabolites|antimetabolites|mesh-ancestor
92438582|NCT01613196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438583|NCT01613196|Antiviral Agents|antiviral agents|mesh-ancestor
92438584|NCT01613196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92344273|NCT05160896|Cetuximab|cetuximab|mesh-list
92438585|NCT01613209|Candesartan|candesartan|mesh-list
92438586|NCT01613209|Candesartan cilexetil|candesartan cilexetil|mesh-list
92438588|NCT01613209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92438589|NCT01613209|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92438590|NCT01613209|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92438591|NCT01613209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438592|NCT01613300|Ofatumumab|ofatumumab|mesh-list
92438593|NCT01613300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438594|NCT01613365|Chlorhexidine|chlorhexidine|mesh-list
92438595|NCT01613365|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92438596|NCT01613365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92438597|NCT01613365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438598|NCT01613365|Disinfectants|disinfectants|mesh-ancestor
92438599|NCT01613365|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438600|NCT01613469|Leucovorin|leucovorin|mesh-list
92438601|NCT01613469|Antidotes|antidotes|mesh-ancestor
92438602|NCT01613469|Protective Agents|protective agents|mesh-ancestor
92438603|NCT01613469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438604|NCT01613469|Vitamin B Complex|vitamin b complex|mesh-ancestor
92438605|NCT01613469|Vitamins|vitamins|mesh-ancestor
92438606|NCT01613469|Micronutrients|micronutrients|mesh-ancestor
92438607|NCT01613482|Trastuzumab|trastuzumab|mesh-list
92438608|NCT01613482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92438609|NCT01613482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438610|NCT01613534|Sucralfate|sucralfate|mesh-list
92438611|NCT01613534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92438612|NCT01613534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438613|NCT01613547|Amoxicillin|amoxicillin|mesh-list
92438614|NCT01613547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438615|NCT01613547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438616|NCT01613573|Hormones|hormones|mesh-list
92438617|NCT01613573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438618|NCT01613573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438619|NCT01613664|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92438620|NCT01613664|Hemostatics|hemostatics|mesh-ancestor
92438621|NCT01613664|Coagulants|coagulants|mesh-ancestor
92438622|NCT01613690|Glycopyrrolate|glycopyrrolate|mesh-list
92438623|NCT01613690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92438624|NCT01613690|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92438625|NCT01613690|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92438626|NCT01613690|Cholinergic Agents|cholinergic agents|mesh-ancestor
92438627|NCT01613690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438628|NCT01613690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438629|NCT01613690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438630|NCT01613755|Metformin|metformin|mesh-list
92438631|NCT01613755|Dipyridamole|dipyridamole|mesh-list
92438632|NCT01613755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438633|NCT01613755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438634|NCT01613755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92438635|NCT01613755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438636|NCT01613755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438637|NCT01613755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92438638|NCT01613755|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438639|NCT01613794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92438640|NCT01613794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92438641|NCT01613794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92438642|NCT01613794|Antimetabolites|antimetabolites|mesh-ancestor
92438643|NCT01613794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438644|NCT01613794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92438645|NCT01613794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92438646|NCT01613794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438647|NCT01613807|Insulin|insulin|mesh-list
92438648|NCT01613807|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92438649|NCT01613807|Insulin Lispro|insulin lispro|mesh-list
92438650|NCT01613807|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
92438651|NCT01613807|Insulin, Long-Acting|insulin, long-acting|mesh-list
92438652|NCT01613807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438653|NCT01613807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438654|NCT01613820|Scopolamine|scopolamine|mesh-list
92438655|NCT01613820|Ketamine|ketamine|mesh-list
92438656|NCT01613820|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92438657|NCT01613820|Analgesics|analgesics|mesh-ancestor
92438658|NCT01613820|Sensory System Agents|sensory system agents|mesh-ancestor
92438659|NCT01613820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438660|NCT01613820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438661|NCT01613820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92438662|NCT01613820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92438663|NCT01613820|Anesthetics, General|anesthetics, general|mesh-ancestor
92438664|NCT01613820|Anesthetics|anesthetics|mesh-ancestor
92438665|NCT01613820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438666|NCT01613820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92438667|NCT01613820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92438668|NCT01613820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438669|NCT01613820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438670|NCT01613820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92438671|NCT01613820|Antiemetics|antiemetics|mesh-ancestor
92438672|NCT01613820|Autonomic Agents|autonomic agents|mesh-ancestor
92438673|NCT01613820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438674|NCT01613820|Mydriatics|mydriatics|mesh-ancestor
92438675|NCT01613820|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92438676|NCT01613820|Cholinergic Agents|cholinergic agents|mesh-ancestor
92438677|NCT01613820|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92438678|NCT01613820|Parasympatholytics|parasympatholytics|mesh-ancestor
92438679|NCT01613846|Sorafenib|sorafenib|mesh-list
92438680|NCT01613846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438681|NCT01613846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438682|NCT01613846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438683|NCT01613846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438684|NCT01613924|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92438685|NCT01613924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438686|NCT01613963|Cyclosporine|cyclosporine|mesh-list
92438687|NCT01613963|Mycophenolic Acid|mycophenolic acid|mesh-list
92438688|NCT01613963|Prednisolone|prednisolone|mesh-list
92438689|NCT01613963|Adalimumab|adalimumab|mesh-list
92438690|NCT01613963|Infliximab|infliximab|mesh-list
92438691|NCT01613963|Etanercept|etanercept|mesh-list
92438692|NCT01613963|Methotrexate|methotrexate|mesh-list
92438693|NCT01613963|Azathioprine|azathioprine|mesh-list
92438694|NCT01613963|Cyclosporins|cyclosporins|mesh-list
92438695|NCT01613963|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92438696|NCT01613963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438697|NCT01613963|Immunologic Factors|immunologic factors|mesh-ancestor
92438698|NCT01613963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438699|NCT01613963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438700|NCT01613963|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92438701|NCT01613963|Abortifacient Agents|abortifacient agents|mesh-ancestor
92438702|NCT01613963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438703|NCT01613963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92438704|NCT01613963|Antimetabolites|antimetabolites|mesh-ancestor
92438705|NCT01613963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438706|NCT01613963|Dermatologic Agents|dermatologic agents|mesh-ancestor
92438707|NCT01613963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438708|NCT01613963|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92438709|NCT01613963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92438710|NCT01613963|Antifungal Agents|antifungal agents|mesh-ancestor
92438711|NCT01613963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438712|NCT01613963|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92438713|NCT01613963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92438714|NCT01613963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92438715|NCT01613963|Antitubercular Agents|antitubercular agents|mesh-ancestor
92438716|NCT01613963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438717|NCT01613963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438718|NCT01613963|Glucocorticoids|glucocorticoids|mesh-ancestor
92438719|NCT01613963|Hormones|hormones|mesh-ancestor
92704580|NCT04397692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438720|NCT01613963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344311|NCT05128617|Paclitaxel|paclitaxel|mesh-list
92438721|NCT01613963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92438722|NCT01613963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438723|NCT01613963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438724|NCT01613963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92438725|NCT01613963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438726|NCT01613963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438727|NCT01613963|Analgesics|analgesics|mesh-ancestor
92438728|NCT01613963|Sensory System Agents|sensory system agents|mesh-ancestor
92438729|NCT01613976|Panobinostat|panobinostat|mesh-list
92438730|NCT01613976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438731|NCT01613976|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92438732|NCT01613976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438733|NCT01613976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438734|NCT01614041|Tandospirone|tandospirone|mesh-list
92438735|NCT01614041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92438736|NCT01614041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92438737|NCT01614041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438738|NCT01614041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438739|NCT01614041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438740|NCT01614041|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92438742|NCT01614041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438743|NCT01614041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438744|NCT01614132|Cisplatin|cisplatin|mesh-list
92438745|NCT01614132|Vincristine|vincristine|mesh-list
92438746|NCT01614132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438747|NCT01614132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438748|NCT01614132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92438749|NCT01614132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92438750|NCT01614132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92438751|NCT01614132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92438752|NCT01614223|Betamethasone|betamethasone|mesh-list
92438753|NCT01614223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438754|NCT01614223|Glucocorticoids|glucocorticoids|mesh-ancestor
92438755|NCT01614223|Hormones|hormones|mesh-ancestor
92438756|NCT01614223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438757|NCT01614223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438758|NCT01614223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92438759|NCT01614223|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438760|NCT01614236|Pregabalin|pregabalin|mesh-list
92438761|NCT01614236|Analgesics|analgesics|mesh-ancestor
92438762|NCT01614236|Sensory System Agents|sensory system agents|mesh-ancestor
92438763|NCT01614236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438764|NCT01614236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438765|NCT01614236|Anticonvulsants|anticonvulsants|mesh-ancestor
92438766|NCT01614236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92438767|NCT01614236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438768|NCT01614236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438769|NCT01614236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92438770|NCT01614236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92438771|NCT01614236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92438772|NCT01614236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438773|NCT01614236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438774|NCT01614301|Pioglitazone|pioglitazone|mesh-list
92438775|NCT01614301|Sirolimus|sirolimus|mesh-list
92438776|NCT01614301|Etoricoxib|etoricoxib|mesh-list
92438777|NCT01614301|Temsirolimus|temsirolimus|mesh-list
92438778|NCT01614301|MTOR Inhibitors|mtor inhibitors|mesh-list
92438779|NCT01614301|Dacarbazine|dacarbazine|mesh-list
92438780|NCT01614301|Trofosfamide|trofosfamide|mesh-list
92438781|NCT01614301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438782|NCT01614301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438783|NCT01614301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92438784|NCT01614301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438785|NCT01614301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438786|NCT01614301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92438787|NCT01614301|Immunologic Factors|immunologic factors|mesh-ancestor
92438788|NCT01614301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438789|NCT01614301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438790|NCT01614301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438791|NCT01614301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92438792|NCT01614301|Antifungal Agents|antifungal agents|mesh-ancestor
92438793|NCT01614301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92438794|NCT01614301|Alkylating Agents|alkylating agents|mesh-ancestor
92438795|NCT01614301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92438796|NCT01614301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92438797|NCT01614301|Analgesics|analgesics|mesh-ancestor
92438798|NCT01614301|Sensory System Agents|sensory system agents|mesh-ancestor
92438799|NCT01614301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438800|NCT01614301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92438801|NCT01614301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92438802|NCT01614301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92438803|NCT01614301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92438804|NCT01614366|Amlodipine|amlodipine|mesh-list
92438805|NCT01614366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92438806|NCT01614366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92438807|NCT01614366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438808|NCT01614366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438809|NCT01614366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92438811|NCT01614366|Vasodilator Agents|vasodilator agents|mesh-ancestor
92438812|NCT01614405|Ritonavir|ritonavir|mesh-list
92438813|NCT01614405|Lopinavir|lopinavir|mesh-list
92438814|NCT01614405|Tenofovir|tenofovir|mesh-list
92438815|NCT01614405|Emtricitabine|emtricitabine|mesh-list
92438816|NCT01614405|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92438817|NCT01614405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92438818|NCT01614405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92438819|NCT01614405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92438820|NCT01614405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438821|NCT01614405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438822|NCT01614405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92438823|NCT01614405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92438824|NCT01614405|Antiviral Agents|antiviral agents|mesh-ancestor
92438825|NCT01614405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438826|NCT01614405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92438827|NCT01614405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92438828|NCT01614405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92438829|NCT01614405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92438830|NCT01614431|Acetylcysteine|acetylcysteine|mesh-list
92438831|NCT01614431|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92438832|NCT01614431|Antiviral Agents|antiviral agents|mesh-ancestor
92438833|NCT01614431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438834|NCT01614431|Expectorants|expectorants|mesh-ancestor
92438835|NCT01614431|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438836|NCT01614431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92438837|NCT01614431|Antioxidants|antioxidants|mesh-ancestor
92438838|NCT01614431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438839|NCT01614431|Protective Agents|protective agents|mesh-ancestor
92438840|NCT01614431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438841|NCT01614431|Antidotes|antidotes|mesh-ancestor
92438842|NCT01614496|Insulin|insulin|mesh-list
92438843|NCT01614496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438844|NCT01614496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438845|NCT01614535|Remifentanil|remifentanil|mesh-list
92438846|NCT01614535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92438847|NCT01614535|Narcotics|narcotics|mesh-ancestor
92438848|NCT01614535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438849|NCT01614535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438850|NCT01614535|Analgesics|analgesics|mesh-ancestor
92438851|NCT01614535|Sensory System Agents|sensory system agents|mesh-ancestor
92438852|NCT01614535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92438853|NCT01614938|Cisplatin|cisplatin|mesh-list
92438854|NCT01614938|Docetaxel|docetaxel|mesh-list
92438855|NCT01614938|Cetuximab|cetuximab|mesh-list
92438856|NCT01614938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438857|NCT01614938|Tubulin Modulators|tubulin modulators|mesh-ancestor
92438858|NCT01614938|Antimitotic Agents|antimitotic agents|mesh-ancestor
92438859|NCT01614938|Mitosis Modulators|mitosis modulators|mesh-ancestor
92438860|NCT01614938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438861|NCT01614938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92438862|NCT01614964|Lumefantrine|lumefantrine|mesh-list
92438863|NCT01614964|Artemether|artemether|mesh-list
92438864|NCT01614964|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92438865|NCT01614964|Antimalarials|antimalarials|mesh-ancestor
92438866|NCT01614964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92438867|NCT01614964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92438868|NCT01614964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438869|NCT01613729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92438870|NCT01613729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92438871|NCT01613729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92438872|NCT01613729|Antimetabolites|antimetabolites|mesh-ancestor
92438873|NCT01613729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438874|NCT01613729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92438875|NCT01613729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92438876|NCT01613729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438877|NCT01615016|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92438878|NCT01615016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92438879|NCT01615042|Lenalidomide|lenalidomide|mesh-list
92438880|NCT01615042|Immunologic Factors|immunologic factors|mesh-ancestor
92438881|NCT01615042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438882|NCT01615042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92438883|NCT01615042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92438884|NCT01615042|Growth Substances|growth substances|mesh-ancestor
92438885|NCT01615042|Growth Inhibitors|growth inhibitors|mesh-ancestor
92438886|NCT01615042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438887|NCT01615055|Fluoxetine|fluoxetine|mesh-list
92438888|NCT01615055|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92438889|NCT01615055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92438890|NCT01615055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92438891|NCT01615055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438892|NCT01615055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438894|NCT01615055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438895|NCT01615055|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92438896|NCT01615055|Antidepressive Agents|antidepressive agents|mesh-ancestor
92438897|NCT01615055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438898|NCT01615055|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92438899|NCT01615055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92438900|NCT01615055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438901|NCT01615081|Insulin|insulin|mesh-list
92438902|NCT01615081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92438903|NCT01615081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438904|NCT01615107|Oxytocin|oxytocin|mesh-list
92438905|NCT01615107|Oxytocics|oxytocics|mesh-ancestor
92438906|NCT01615107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438907|NCT01615107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438908|NCT01615185|Amisulpride|amisulpride|mesh-list
92438909|NCT01615185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92438910|NCT01615185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92438911|NCT01615185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92438912|NCT01615185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438913|NCT01615185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92438914|NCT01615185|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92438915|NCT01615185|Dopamine Agents|dopamine agents|mesh-ancestor
92438916|NCT01615185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92438917|NCT01615185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438918|NCT01615185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92438919|NCT01615185|Antidepressive Agents|antidepressive agents|mesh-ancestor
92438920|NCT01615211|Letrozole|letrozole|mesh-list
92438921|NCT01615211|Trilostane|trilostane|mesh-list
92438922|NCT01615211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92438923|NCT01615211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92438924|NCT01615211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92438925|NCT01615211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438926|NCT01615211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438927|NCT01615211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92438928|NCT01615211|Hormone Antagonists|hormone antagonists|mesh-ancestor
92438929|NCT01615211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92438930|NCT01615211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438931|NCT01615211|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92438932|NCT01615211|Abortifacient Agents|abortifacient agents|mesh-ancestor
92438933|NCT01615211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438934|NCT01615224|Misoprostol|misoprostol|mesh-list
92438935|NCT01615224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92438936|NCT01615224|Abortifacient Agents|abortifacient agents|mesh-ancestor
92438937|NCT01615224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438938|NCT01615224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163716|NCT03822169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92163717|NCT03822169|Nootropic Agents|nootropic agents|mesh-ancestor
92163718|NCT03825601|Flumazenil|flumazenil|mesh-list
92163719|NCT03825601|Antidotes|antidotes|mesh-ancestor
92438939|NCT01615224|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92438940|NCT01615224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92438941|NCT01615224|Oxytocics|oxytocics|mesh-ancestor
92438942|NCT01615289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92438943|NCT01615354|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92438944|NCT01615354|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92438945|NCT01615354|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92438946|NCT01615354|Contraceptive Agents|contraceptive agents|mesh-ancestor
92438947|NCT01615354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92438948|NCT01615354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438949|NCT01615354|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92438950|NCT01615354|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92438951|NCT01615354|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92438952|NCT01615354|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92438953|NCT01615354|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92438954|NCT01615354|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92438955|NCT01615354|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92531140|NCT00018291|Serotonin Agents|serotonin agents|mesh-ancestor
92438956|NCT01615354|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92438959|NCT01615393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438960|NCT01615393|Antiviral Agents|antiviral agents|mesh-ancestor
92438961|NCT01615393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438962|NCT01615445|Resveratrol|resveratrol|mesh-list
92438963|NCT01615445|Antioxidants|antioxidants|mesh-ancestor
92344360|NCT05018585|Cholecalciferol|cholecalciferol|mesh-list
92438964|NCT01615445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438965|NCT01615445|Protective Agents|protective agents|mesh-ancestor
92438966|NCT01615445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92438967|NCT01615445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438968|NCT01615445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92438969|NCT01615601|Ritonavir|ritonavir|mesh-list
92438970|NCT01615601|Darunavir|darunavir|mesh-list
92438971|NCT01615601|Etravirine|etravirine|mesh-list
92438972|NCT01615601|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92438973|NCT01615601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92438974|NCT01615601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92438975|NCT01615601|Protease Inhibitors|protease inhibitors|mesh-ancestor
92438976|NCT01615601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438977|NCT01615601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438978|NCT01615601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92438979|NCT01615601|Antiviral Agents|antiviral agents|mesh-ancestor
92438980|NCT01615601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438981|NCT01615601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92438982|NCT01615601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92438983|NCT01615601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92438984|NCT01615601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92438985|NCT01615614|Rilpivirine|rilpivirine|mesh-list
92438986|NCT01615614|Rifabutin|rifabutin|mesh-list
92438987|NCT01615614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92438988|NCT01615614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92438989|NCT01615614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92438990|NCT01615614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92438991|NCT01615614|Antiviral Agents|antiviral agents|mesh-ancestor
92438992|NCT01615614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92438993|NCT01615614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92438994|NCT01615614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92438995|NCT01615614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92438996|NCT01615614|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92438997|NCT01615614|Antitubercular Agents|antitubercular agents|mesh-ancestor
92438998|NCT01615627|Treprostinil|treprostinil|mesh-list
92438999|NCT01615627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92439000|NCT01615627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439001|NCT01615757|Cytarabine|cytarabine|mesh-list
92439002|NCT01615757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439003|NCT01615757|Antimetabolites|antimetabolites|mesh-ancestor
92439004|NCT01615757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439005|NCT01615757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439006|NCT01615757|Antiviral Agents|antiviral agents|mesh-ancestor
92439007|NCT01615757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439008|NCT01615757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439009|NCT01615757|Immunologic Factors|immunologic factors|mesh-ancestor
92439010|NCT01615757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439011|NCT01615796|Gepotidacin|gepotidacin|mesh-list
92439012|NCT01615796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92439013|NCT01615796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439014|NCT01615796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439015|NCT01615796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439016|NCT01615913|Ketoconazole|ketoconazole|mesh-list
92439017|NCT01615913|Terbinafine|terbinafine|mesh-list
92439018|NCT01615913|Antifungal Agents|antifungal agents|mesh-ancestor
92439019|NCT01615913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439020|NCT01615913|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92439021|NCT01615913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92439022|NCT01615913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439023|NCT01615913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439024|NCT01615913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92322342|NCT00000512|Niacin|niacin|mesh-list
92439026|NCT01615913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439027|NCT01615913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439028|NCT01615913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92439029|NCT01615978|Liraglutide|liraglutide|mesh-list
92439030|NCT01615978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439031|NCT01615978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439032|NCT01615978|Incretins|incretins|mesh-ancestor
92439033|NCT01615978|Hormones|hormones|mesh-ancestor
92344373|NCT04989829|Omeprazole|omeprazole|mesh-list
92439034|NCT01615978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439035|NCT01616004|Nitrous Oxide|nitrous oxide|mesh-list
92439036|NCT01616004|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92439037|NCT01616004|Anesthetics, General|anesthetics, general|mesh-ancestor
92439038|NCT01616004|Anesthetics|anesthetics|mesh-ancestor
92439039|NCT01616004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439040|NCT01616004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439041|NCT01616004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439042|NCT01616004|Analgesics|analgesics|mesh-ancestor
92439043|NCT01616004|Sensory System Agents|sensory system agents|mesh-ancestor
92439044|NCT01616004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439045|NCT01616069|Simendan|simendan|mesh-list
92439046|NCT01616069|Epinephrine|epinephrine|mesh-list
92439047|NCT01616069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92439048|NCT01616069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92439049|NCT01616069|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439050|NCT01616069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439051|NCT01616069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439052|NCT01616069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439053|NCT01616069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92439054|NCT01616069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92439055|NCT01616069|Autonomic Agents|autonomic agents|mesh-ancestor
92439056|NCT01616069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439057|NCT01616069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92439058|NCT01616069|Respiratory System Agents|respiratory system agents|mesh-ancestor
92439059|NCT01616069|Mydriatics|mydriatics|mesh-ancestor
92439060|NCT01616069|Sympathomimetics|sympathomimetics|mesh-ancestor
92439061|NCT01616069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92439062|NCT01616069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92439063|NCT01616069|Vasodilator Agents|vasodilator agents|mesh-ancestor
92439064|NCT01616069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92439065|NCT01616069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92439066|NCT01616069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439067|NCT01616069|Protective Agents|protective agents|mesh-ancestor
92439068|NCT01616108|Bupivacaine|bupivacaine|mesh-list
92439069|NCT01616108|Anesthetics, Local|anesthetics, local|mesh-ancestor
92439070|NCT01616108|Anesthetics|anesthetics|mesh-ancestor
92439071|NCT01616108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439072|NCT01616108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439073|NCT01616108|Sensory System Agents|sensory system agents|mesh-ancestor
92439074|NCT01616108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439075|NCT01616186|Everolimus|everolimus|mesh-list
92439076|NCT01616186|Sorafenib|sorafenib|mesh-list
92439077|NCT01616186|Sunitinib|sunitinib|mesh-list
92439078|NCT01616186|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92439079|NCT01616186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92439080|NCT01616186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439081|NCT01616186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439082|NCT01616186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439083|NCT01616186|Immunologic Factors|immunologic factors|mesh-ancestor
92439084|NCT01616186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439085|NCT01616186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439086|NCT01616186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92439087|NCT01616186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92439088|NCT01616186|Growth Substances|growth substances|mesh-ancestor
92439089|NCT01616186|Growth Inhibitors|growth inhibitors|mesh-ancestor
92439090|NCT01616225|Hormones|hormones|mesh-list
92439091|NCT01616225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439092|NCT01616225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439093|NCT01616355|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92439095|NCT01616355|Disinfectants|disinfectants|mesh-ancestor
92439096|NCT01616355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439097|NCT01616381|Sildenafil Citrate|sildenafil citrate|mesh-list
92439098|NCT01616381|Vasodilator Agents|vasodilator agents|mesh-ancestor
92439099|NCT01616381|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92439100|NCT01616381|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92439101|NCT01616381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439102|NCT01616381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439103|NCT01616381|Urological Agents|urological agents|mesh-ancestor
92439104|NCT01616407|Methylphenidate|methylphenidate|mesh-list
92439105|NCT01616407|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92439106|NCT01616407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92439107|NCT01616407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439108|NCT01616407|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92439109|NCT01616407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92439110|NCT01616407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439111|NCT01616407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439112|NCT01616407|Dopamine Agents|dopamine agents|mesh-ancestor
92439113|NCT01616407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439114|NCT01616407|Hallucinogens|hallucinogens|mesh-ancestor
92439115|NCT01616407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439116|NCT01616407|Serotonin Agents|serotonin agents|mesh-ancestor
92439117|NCT01616407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92439118|NCT01616407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439119|NCT01616485|Sildenafil Citrate|sildenafil citrate|mesh-list
92439120|NCT01616485|Nitroglycerin|nitroglycerin|mesh-list
92439121|NCT01616485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439122|NCT01616485|Vasodilator Agents|vasodilator agents|mesh-ancestor
92439123|NCT01616485|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92439124|NCT01616485|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92439125|NCT01616485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439126|NCT01616485|Urological Agents|urological agents|mesh-ancestor
92439127|NCT01616615|Aspirin|aspirin|mesh-list
92439128|NCT01616615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92439129|NCT01616615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439130|NCT01616615|Analgesics|analgesics|mesh-ancestor
92439131|NCT01616615|Sensory System Agents|sensory system agents|mesh-ancestor
92439132|NCT01616615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439133|NCT01616615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439134|NCT01616615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439135|NCT01616615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439136|NCT01616615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92439137|NCT01616615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92439138|NCT01616615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439139|NCT01616615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92439140|NCT01616615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92439141|NCT01616615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439142|NCT01616615|Antipyretics|antipyretics|mesh-ancestor
92439143|NCT01616680|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92439144|NCT01616680|Antibodies|antibodies|mesh-list
92439145|NCT01616680|Immunoglobulins|immunoglobulins|mesh-list
92439146|NCT01616680|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92439147|NCT01616680|Immunoconjugates|immunoconjugates|mesh-list
92439148|NCT01616680|Immunologic Factors|immunologic factors|mesh-ancestor
92439149|NCT01616680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439150|NCT01616680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92439151|NCT01616680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439152|NCT01616680|Immunotoxins|immunotoxins|mesh-ancestor
92439153|NCT01616732|Testosterone|testosterone|mesh-list
92439154|NCT01616732|Androgens|androgens|mesh-ancestor
92439155|NCT01616732|Hormones|hormones|mesh-ancestor
92439156|NCT01616732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439157|NCT01616732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439158|NCT01616784|Insulin|insulin|mesh-list
92439159|NCT01616784|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92439160|NCT01616784|Insulin Detemir|insulin detemir|mesh-list
92439161|NCT01616784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439162|NCT01616784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439163|NCT01616849|Nimotuzumab|nimotuzumab|mesh-list
92439164|NCT01616849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439165|NCT01616849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92439166|NCT01616875|Cisplatin|cisplatin|mesh-list
92439167|NCT01616875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439168|NCT01616888|Paclitaxel|paclitaxel|mesh-list
92439169|NCT01616888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92439170|NCT01616888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439171|NCT01616888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92439172|NCT01616888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92439173|NCT01616888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92439174|NCT01616888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439176|NCT01616927|Somatostatin|somatostatin|mesh-list
92439177|NCT01616927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439178|NCT01616927|Hormones|hormones|mesh-ancestor
92439179|NCT01616927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439180|NCT01616927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439181|NCT01616966|Remifentanil|remifentanil|mesh-list
92439182|NCT01616966|Propofol|propofol|mesh-list
92439183|NCT01616966|Sevoflurane|sevoflurane|mesh-list
92439184|NCT01616966|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92439185|NCT01616966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439186|NCT01616966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439187|NCT01616966|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92439188|NCT01616966|Anesthetics, General|anesthetics, general|mesh-ancestor
92439189|NCT01616966|Anesthetics|anesthetics|mesh-ancestor
92439190|NCT01616966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92439191|NCT01616966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92439192|NCT01616966|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92439193|NCT01616966|Narcotics|narcotics|mesh-ancestor
92439194|NCT01616966|Analgesics|analgesics|mesh-ancestor
92439195|NCT01616966|Sensory System Agents|sensory system agents|mesh-ancestor
92439196|NCT01616966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439197|NCT01616992|Bupivacaine|bupivacaine|mesh-list
92439198|NCT01616992|Anesthetics, Local|anesthetics, local|mesh-ancestor
92439199|NCT01616992|Anesthetics|anesthetics|mesh-ancestor
92439200|NCT01616992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439201|NCT01616992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439202|NCT01616992|Sensory System Agents|sensory system agents|mesh-ancestor
92439203|NCT01616992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439204|NCT01617057|Tiludronic acid|tiludronic acid|mesh-list
92439205|NCT01617057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92439206|NCT01617057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439207|NCT01617135|Levodopa|levodopa|mesh-list
92439208|NCT01617135|Carbidopa|carbidopa|mesh-list
92439209|NCT01617135|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92439210|NCT01617135|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92439211|NCT01617135|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92439212|NCT01617135|Dopamine Agents|dopamine agents|mesh-ancestor
92439213|NCT01617135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439214|NCT01617135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439215|NCT01617135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344396|NCT04850495|Doxorubicin|doxorubicin|mesh-list
92439216|NCT01617135|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92439217|NCT01617135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439218|NCT01617135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92439219|NCT01617135|Immunologic Factors|immunologic factors|mesh-ancestor
92439220|NCT01617135|Dopamine Agonists|dopamine agonists|mesh-ancestor
92439221|NCT01617200|Olanzapine|olanzapine|mesh-list
92439222|NCT01617200|Asenapine|asenapine|mesh-list
92439223|NCT01617200|Antiemetics|antiemetics|mesh-ancestor
92439224|NCT01617200|Autonomic Agents|autonomic agents|mesh-ancestor
92439225|NCT01617200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439226|NCT01617200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439227|NCT01617200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92439228|NCT01617200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92439229|NCT01617200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92439230|NCT01617200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439231|NCT01617200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439232|NCT01617200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92439233|NCT01617200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92439234|NCT01617200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439235|NCT01617200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439236|NCT01617200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439237|NCT01617200|Serotonin Agents|serotonin agents|mesh-ancestor
92439238|NCT01617213|Lenalidomide|lenalidomide|mesh-list
92439239|NCT01617213|Melphalan|melphalan|mesh-list
92439240|NCT01617213|Immunologic Factors|immunologic factors|mesh-ancestor
92439241|NCT01617213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439242|NCT01617213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92439243|NCT01617213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92439244|NCT01617213|Growth Substances|growth substances|mesh-ancestor
92439245|NCT01617213|Growth Inhibitors|growth inhibitors|mesh-ancestor
92439246|NCT01617213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439247|NCT01617213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92439248|NCT01617213|Alkylating Agents|alkylating agents|mesh-ancestor
92439249|NCT01617213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439250|NCT01617213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92439251|NCT01617213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439254|NCT01617226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439255|NCT01617226|Antimetabolites|antimetabolites|mesh-ancestor
92439256|NCT01617226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439257|NCT01617226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439258|NCT01617226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439259|NCT01617226|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92439260|NCT01617317|Immunoglobulins|immunoglobulins|mesh-list
92439261|NCT01617317|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92439262|NCT01617317|Antibodies|antibodies|mesh-list
92439263|NCT01617317|gamma-Globulins|gamma-globulins|mesh-list
92439264|NCT01617317|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92439265|NCT01617317|Immunologic Factors|immunologic factors|mesh-ancestor
92439266|NCT01617317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439267|NCT01617356|Lidocaine|lidocaine|mesh-list
92439268|NCT01617356|Anesthetics, Local|anesthetics, local|mesh-ancestor
92439269|NCT01617356|Anesthetics|anesthetics|mesh-ancestor
92439270|NCT01617356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439271|NCT01617356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439272|NCT01617356|Sensory System Agents|sensory system agents|mesh-ancestor
92439273|NCT01617356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439274|NCT01617356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92439275|NCT01617356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92439276|NCT01617356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92439277|NCT01617356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439278|NCT01617356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439279|NCT01617538|Atorvastatin|atorvastatin|mesh-list
92439280|NCT01617538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92344427|NCT04804735|Anesthetics|anesthetics|mesh-list
92439281|NCT01617538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92439282|NCT01617538|Antimetabolites|antimetabolites|mesh-ancestor
92439283|NCT01617538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439284|NCT01617538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92439285|NCT01617538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92439286|NCT01617538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439287|NCT01617551|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92439288|NCT01617551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439289|NCT01617551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439290|NCT01617564|Bupivacaine|bupivacaine|mesh-list
92439291|NCT01617564|Anesthetics, Local|anesthetics, local|mesh-ancestor
92439292|NCT01617564|Anesthetics|anesthetics|mesh-ancestor
92439293|NCT01617564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439294|NCT01617564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439295|NCT01617564|Sensory System Agents|sensory system agents|mesh-ancestor
92439296|NCT01617564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439297|NCT01617590|Methotrexate|methotrexate|mesh-list
92439298|NCT01617590|Leflunomide|leflunomide|mesh-list
92439299|NCT01617590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92439300|NCT01617590|Abortifacient Agents|abortifacient agents|mesh-ancestor
92439301|NCT01617590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92439302|NCT01617590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439303|NCT01617590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439304|NCT01617590|Antimetabolites|antimetabolites|mesh-ancestor
92439305|NCT01617590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439306|NCT01617590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439307|NCT01617590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92439308|NCT01617590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439309|NCT01617590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92439310|NCT01617590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439311|NCT01617590|Immunologic Factors|immunologic factors|mesh-ancestor
92439312|NCT01617590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439313|NCT01617590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92439314|NCT01617694|Dexmedetomidine|dexmedetomidine|mesh-list
92439315|NCT01617694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92439316|NCT01617694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439317|NCT01617694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439318|NCT01617694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439319|NCT01617694|Analgesics|analgesics|mesh-ancestor
92439320|NCT01617694|Sensory System Agents|sensory system agents|mesh-ancestor
92439321|NCT01617694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439322|NCT01617694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92439323|NCT01617694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92439324|NCT01617694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92439325|NCT01617694|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439326|NCT01617694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439327|NCT01617694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439329|NCT01617707|Propofol|propofol|mesh-list
92439330|NCT01617707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92439331|NCT01617707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439332|NCT01617707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439333|NCT01617707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92439334|NCT01617707|Anesthetics, General|anesthetics, general|mesh-ancestor
92439335|NCT01617707|Anesthetics|anesthetics|mesh-ancestor
92439336|NCT01617707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92439337|NCT01617707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92439338|NCT01617707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92439339|NCT01617707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439340|NCT01617707|GABA Modulators|gaba modulators|mesh-ancestor
92439341|NCT01617707|GABA Agents|gaba agents|mesh-ancestor
92439342|NCT01617707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439343|NCT01617707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439344|NCT01617733|Pasireotide|pasireotide|mesh-list
92439345|NCT01617733|Hormones|hormones|mesh-ancestor
92439346|NCT01617733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439347|NCT01617733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439348|NCT01617746|Bosentan|bosentan|mesh-list
92439349|NCT01617746|Ambrisentan|ambrisentan|mesh-list
92439350|NCT01617746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439351|NCT01617746|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92439352|NCT01617746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439353|NCT01617772|Atorvastatin|atorvastatin|mesh-list
92439354|NCT01617772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92439355|NCT01617772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92439356|NCT01617772|Antimetabolites|antimetabolites|mesh-ancestor
92439357|NCT01617772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439358|NCT01617772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92439359|NCT01617772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92439360|NCT01617772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439361|NCT01617798|Metolazone|metolazone|mesh-list
92439362|NCT01617798|Furosemide|furosemide|mesh-list
92439363|NCT01617798|Diuretics|diuretics|mesh-ancestor
92439364|NCT01617798|Natriuretic Agents|natriuretic agents|mesh-ancestor
92439365|NCT01617798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439366|NCT01617798|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92439367|NCT01617798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439368|NCT01617798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439369|NCT01617798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439370|NCT01617798|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92439371|NCT01617811|Anesthetics|anesthetics|mesh-list
92439372|NCT01617811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439373|NCT01617811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439374|NCT01617824|Linagliptin|linagliptin|mesh-list
92439375|NCT01617824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439376|NCT01617824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439377|NCT01617824|Incretins|incretins|mesh-ancestor
92439378|NCT01617824|Hormones|hormones|mesh-ancestor
92439379|NCT01617824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439380|NCT01617824|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92439381|NCT01617824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92439382|NCT01617824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439383|NCT01617824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439384|NCT01617928|Paclitaxel|paclitaxel|mesh-list
92439385|NCT01617928|Carboplatin|carboplatin|mesh-list
92439386|NCT01617928|Veliparib|veliparib|mesh-list
92439387|NCT01617928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92439388|NCT01617928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439389|NCT01617928|Tubulin Modulators|tubulin modulators|mesh-ancestor
92439390|NCT01617928|Antimitotic Agents|antimitotic agents|mesh-ancestor
92439391|NCT01617928|Mitosis Modulators|mitosis modulators|mesh-ancestor
92439392|NCT01617928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439394|NCT01617928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439395|NCT01618006|Aspirin|aspirin|mesh-list
92439396|NCT01618006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92439397|NCT01618006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439398|NCT01618006|Analgesics|analgesics|mesh-ancestor
92439399|NCT01618006|Sensory System Agents|sensory system agents|mesh-ancestor
92439400|NCT01618006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439401|NCT01618006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439402|NCT01618006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439403|NCT01618006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439404|NCT01618006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92439405|NCT01618006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92439406|NCT01618006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439407|NCT01618006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92439408|NCT01618006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92439409|NCT01618006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439410|NCT01618006|Antipyretics|antipyretics|mesh-ancestor
92439412|NCT01618253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439413|NCT01618253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92439414|NCT01618253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439415|NCT01618253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439416|NCT01618370|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92439417|NCT01618370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439418|NCT01618396|Midazolam|midazolam|mesh-list
92439419|NCT01618396|Propofol|propofol|mesh-list
92439420|NCT01618396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92439421|NCT01618396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439422|NCT01618396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439423|NCT01618396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92439424|NCT01618396|Anesthetics, General|anesthetics, general|mesh-ancestor
92439425|NCT01618396|Anesthetics|anesthetics|mesh-ancestor
92439426|NCT01618396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92439427|NCT01618396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92439428|NCT01618396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92439429|NCT01618396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439430|NCT01618396|GABA Modulators|gaba modulators|mesh-ancestor
92439431|NCT01618396|GABA Agents|gaba agents|mesh-ancestor
92439432|NCT01618396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439433|NCT01618396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439434|NCT01618188|Insulin|insulin|mesh-list
92439435|NCT01618188|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92439436|NCT01618188|Insulin Aspart|insulin aspart|mesh-list
92439437|NCT01618188|Insulin, Long-Acting|insulin, long-acting|mesh-list
92439438|NCT01618188|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92439439|NCT01618188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439440|NCT01618188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439441|NCT01618448|Tolvaptan|tolvaptan|mesh-list
92439442|NCT01618448|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92439443|NCT01618448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439444|NCT01618448|Natriuretic Agents|natriuretic agents|mesh-ancestor
92439445|NCT01618448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439446|NCT01618474|Docetaxel|docetaxel|mesh-list
92439447|NCT01618474|Capecitabine|capecitabine|mesh-list
92439448|NCT01618474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439449|NCT01618474|Tubulin Modulators|tubulin modulators|mesh-ancestor
92439450|NCT01618474|Antimitotic Agents|antimitotic agents|mesh-ancestor
92439451|NCT01618474|Mitosis Modulators|mitosis modulators|mesh-ancestor
92439452|NCT01618474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439453|NCT01618474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439454|NCT01618474|Antimetabolites|antimetabolites|mesh-ancestor
92439455|NCT01618513|Octreotide|octreotide|mesh-list
92439456|NCT01618513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92439457|NCT01618513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92439458|NCT01618513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439459|NCT01618539|Propofol|propofol|mesh-list
92439460|NCT01618539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92439461|NCT01618539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439462|NCT01618539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439463|NCT01618539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92439464|NCT01618539|Anesthetics, General|anesthetics, general|mesh-ancestor
92439465|NCT01618539|Anesthetics|anesthetics|mesh-ancestor
92439466|NCT01618591|Azithromycin|azithromycin|mesh-list
92439467|NCT01618591|Levofloxacin|levofloxacin|mesh-list
92439469|NCT01618591|Loperamide|loperamide|mesh-list
92439470|NCT01618591|Antidiarrheals|antidiarrheals|mesh-list
92439471|NCT01618591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92439472|NCT01618591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439473|NCT01618591|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92439474|NCT01618591|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92152651|NCT05037240|Antioxidants|antioxidants|mesh-ancestor
92439475|NCT01618591|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92439476|NCT01618591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439477|NCT01618591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439478|NCT01618591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439479|NCT01618591|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92439480|NCT01618591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92344454|NCT04762979|Fulvestrant|fulvestrant|mesh-list
92439481|NCT01618591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92439482|NCT01618643|Acetic Acid|acetic acid|mesh-list
92439483|NCT01618643|Retinol acetate|retinol acetate|mesh-list
92439484|NCT01618643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92439485|NCT01618643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439486|NCT01618643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92439487|NCT01618643|Immunologic Factors|immunologic factors|mesh-ancestor
92439488|NCT01618643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439489|NCT01618643|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92439490|NCT01618643|Protective Agents|protective agents|mesh-ancestor
92439491|NCT01618643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439492|NCT01618760|Risperidone|risperidone|mesh-list
92439493|NCT01618760|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92439494|NCT01618760|Serotonin Agents|serotonin agents|mesh-ancestor
92439495|NCT01618760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439496|NCT01618760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439497|NCT01618760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439498|NCT01618760|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92439499|NCT01618760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92439500|NCT01618760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439501|NCT01618760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439502|NCT01618760|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92439503|NCT01618760|Dopamine Agents|dopamine agents|mesh-ancestor
92439504|NCT01618773|Adapalene|adapalene|mesh-list
92439505|NCT01618773|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92439506|NCT01618773|Dermatologic Agents|dermatologic agents|mesh-ancestor
92439507|NCT01618773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92439508|NCT01618773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439509|NCT01618773|Analgesics|analgesics|mesh-ancestor
92439510|NCT01618773|Sensory System Agents|sensory system agents|mesh-ancestor
92439511|NCT01618773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439512|NCT01618773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439513|NCT01618773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439514|NCT01618773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439515|NCT01618799|Lamotrigine|lamotrigine|mesh-list
92439516|NCT01618799|Anticonvulsants|anticonvulsants|mesh-list
92439517|NCT01618799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92439518|NCT01618799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439519|NCT01618799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439520|NCT01618799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92439521|NCT01618799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439522|NCT01618799|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92439523|NCT01618799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92439524|NCT01618799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439525|NCT01618799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439526|NCT01618799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92439527|NCT01618825|Lamotrigine|lamotrigine|mesh-list
92439528|NCT01618825|Anticonvulsants|anticonvulsants|mesh-list
92439529|NCT01618825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92439530|NCT01618825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439531|NCT01618825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439532|NCT01618825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92439533|NCT01618825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439534|NCT01618825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92439535|NCT01618825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92164320|NCT01302483|Mydriatics|mydriatics|mesh-ancestor
92439536|NCT01618825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439537|NCT01618825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439538|NCT01618825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92439539|NCT01618877|Levetiracetam|levetiracetam|mesh-list
92439540|NCT01618877|Anticonvulsants|anticonvulsants|mesh-ancestor
92439541|NCT01618877|Nootropic Agents|nootropic agents|mesh-ancestor
92439542|NCT01618890|Propranolol|propranolol|mesh-list
92439543|NCT01618890|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92439544|NCT01618890|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92439545|NCT01618890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439546|NCT01618890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439547|NCT01618890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439548|NCT01618890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439549|NCT01618890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92439550|NCT01618890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439551|NCT01618890|Vasodilator Agents|vasodilator agents|mesh-ancestor
92439552|NCT01618903|Levetiracetam|levetiracetam|mesh-list
92439553|NCT01618903|Anticonvulsants|anticonvulsants|mesh-ancestor
92439554|NCT01618903|Nootropic Agents|nootropic agents|mesh-ancestor
92439555|NCT01618929|Montelukast|montelukast|mesh-list
92439556|NCT01618929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92439557|NCT01618929|Respiratory System Agents|respiratory system agents|mesh-ancestor
92439558|NCT01618929|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92439559|NCT01618929|Hormone Antagonists|hormone antagonists|mesh-ancestor
92439560|NCT01618929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439561|NCT01618929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439562|NCT01618929|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92439563|NCT01618929|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92439564|NCT01618929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439565|NCT01619007|Rivaroxaban|rivaroxaban|mesh-list
92439566|NCT01619007|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92439567|NCT01619007|Antithrombins|antithrombins|mesh-ancestor
92439568|NCT01619007|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92439569|NCT01619007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92439570|NCT01619007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439571|NCT01619007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439572|NCT01619007|Anticoagulants|anticoagulants|mesh-ancestor
92439573|NCT01619046|Factor VIII|factor viii|mesh-list
92439574|NCT01619046|Coagulants|coagulants|mesh-ancestor
92439575|NCT01619072|Misoprostol|misoprostol|mesh-list
92439576|NCT01619072|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92439577|NCT01619072|Abortifacient Agents|abortifacient agents|mesh-ancestor
92439578|NCT01619072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92439579|NCT01619072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439580|NCT01619072|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92439581|NCT01619072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92439582|NCT01619072|Oxytocics|oxytocics|mesh-ancestor
92439583|NCT01619137|Povidone-Iodine|povidone-iodine|mesh-list
92439584|NCT01619137|Povidone|povidone|mesh-list
92439585|NCT01619137|Plasma Substitutes|plasma substitutes|mesh-ancestor
92439586|NCT01619137|Blood Substitutes|blood substitutes|mesh-ancestor
92439587|NCT01619137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92439588|NCT01619137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439589|NCT01619150|Etoricoxib|etoricoxib|mesh-list
92439590|NCT01619150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92439591|NCT01619150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439592|NCT01619150|Analgesics|analgesics|mesh-ancestor
92439593|NCT01619150|Sensory System Agents|sensory system agents|mesh-ancestor
92439594|NCT01619150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439595|NCT01619150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439596|NCT01619150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439597|NCT01619150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439598|NCT01619150|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92439599|NCT01619150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92439600|NCT01619150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439601|NCT01619150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439602|NCT01619163|Prednisolone|prednisolone|mesh-list
92439603|NCT01619163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439604|NCT01619163|Glucocorticoids|glucocorticoids|mesh-ancestor
92439605|NCT01619163|Hormones|hormones|mesh-ancestor
92439606|NCT01619163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439607|NCT01619163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439608|NCT01619163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92439609|NCT01619163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439610|NCT01619176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92439611|NCT01619176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92439612|NCT01619176|Methotrexate|methotrexate|mesh-list
92439613|NCT01619176|Leflunomide|leflunomide|mesh-list
92439614|NCT01619176|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92439615|NCT01619176|Abortifacient Agents|abortifacient agents|mesh-ancestor
92439616|NCT01619176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92439617|NCT01619176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439618|NCT01619176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439620|NCT01619176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439621|NCT01619176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439622|NCT01619176|Dermatologic Agents|dermatologic agents|mesh-ancestor
92439623|NCT01619176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439624|NCT01619176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92439625|NCT01619176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439626|NCT01619176|Immunologic Factors|immunologic factors|mesh-ancestor
92439627|NCT01619176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439628|NCT01619176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92439629|NCT01619176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92439630|NCT01619176|Analgesics|analgesics|mesh-ancestor
92439631|NCT01619176|Sensory System Agents|sensory system agents|mesh-ancestor
92439632|NCT01619176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439633|NCT01619280|Nitroprusside|nitroprusside|mesh-list
92439634|NCT01619280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439635|NCT01619280|Vasodilator Agents|vasodilator agents|mesh-ancestor
92439636|NCT01619280|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92439637|NCT01619280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439638|NCT01619436|Clonidine|clonidine|mesh-list
92439639|NCT01619436|Analgesics|analgesics|mesh-ancestor
92439640|NCT01619436|Sensory System Agents|sensory system agents|mesh-ancestor
92439641|NCT01619436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439642|NCT01619436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439643|NCT01619436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439644|NCT01619436|Sympatholytics|sympatholytics|mesh-ancestor
92439645|NCT01619436|Autonomic Agents|autonomic agents|mesh-ancestor
92439646|NCT01619436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92439647|NCT01619436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92439648|NCT01619436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92439649|NCT01619436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439650|NCT01619436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439651|NCT01619436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439652|NCT01619462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92439653|NCT01619462|Immunologic Factors|immunologic factors|mesh-ancestor
92439654|NCT01619462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439655|NCT01619527|Darunavir|darunavir|mesh-list
92439656|NCT01619527|Cobicistat|cobicistat|mesh-list
92439657|NCT01619527|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92439658|NCT01619527|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92439659|NCT01619527|Protease Inhibitors|protease inhibitors|mesh-ancestor
92439660|NCT01619527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439661|NCT01619527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439662|NCT01619527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92439663|NCT01619527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92439664|NCT01619527|Antiviral Agents|antiviral agents|mesh-ancestor
92439665|NCT01619527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439666|NCT01619527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92439667|NCT01619527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92439668|NCT01619566|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92439669|NCT01619566|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92439670|NCT01619566|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92439671|NCT01619566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439672|NCT01619566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439673|NCT01619566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439674|NCT01619566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439675|NCT01619566|Analgesics|analgesics|mesh-ancestor
92439676|NCT01619566|Sensory System Agents|sensory system agents|mesh-ancestor
92439677|NCT01619566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439678|NCT01619566|Antidepressive Agents|antidepressive agents|mesh-ancestor
92439679|NCT01619566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439680|NCT01619566|Dopamine Agents|dopamine agents|mesh-ancestor
92439681|NCT01619644|Valproic Acid|valproic acid|mesh-list
92439682|NCT01619644|Anticonvulsants|anticonvulsants|mesh-ancestor
92439683|NCT01619644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704581|NCT04397692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92439684|NCT01619644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439685|NCT01619644|GABA Agents|gaba agents|mesh-ancestor
92439686|NCT01619644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439687|NCT01619644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439688|NCT01619644|Antimanic Agents|antimanic agents|mesh-ancestor
92439689|NCT01619644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92531150|NCT00045175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439690|NCT01619644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439691|NCT01619644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92439694|NCT01619683|Zuclomiphene|zuclomiphene|mesh-list
92439695|NCT01619683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92439696|NCT01619683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92439697|NCT01619683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439698|NCT01619683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439699|NCT01619683|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92439700|NCT01619683|Fertility Agents|fertility agents|mesh-ancestor
92439701|NCT01619683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92439702|NCT01619683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92439703|NCT01619683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92439704|NCT01619761|Mycophenolic Acid|mycophenolic acid|mesh-list
92439705|NCT01619761|Cyclophosphamide|cyclophosphamide|mesh-list
92439706|NCT01619761|Melphalan|melphalan|mesh-list
92439707|NCT01619761|Mechlorethamine|mechlorethamine|mesh-list
92439708|NCT01619761|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92439709|NCT01619761|Rituximab|rituximab|mesh-list
92439710|NCT01619761|Fludarabine|fludarabine|mesh-list
92439711|NCT01619761|Fludarabine phosphate|fludarabine phosphate|mesh-list
92439712|NCT01619761|Lenalidomide|lenalidomide|mesh-list
92439713|NCT01619761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92439714|NCT01619761|Tacrolimus|tacrolimus|mesh-list
92439715|NCT01619761|Antibodies|antibodies|mesh-list
92439716|NCT01619761|Immunoglobulins|immunoglobulins|mesh-list
92439717|NCT01619761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92439718|NCT01619761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439719|NCT01619761|Immunologic Factors|immunologic factors|mesh-ancestor
92439720|NCT01619761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439721|NCT01619761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92439722|NCT01619761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92439723|NCT01619761|Alkylating Agents|alkylating agents|mesh-ancestor
92439724|NCT01619761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439725|NCT01619761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439726|NCT01619761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92439727|NCT01619761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439728|NCT01619761|Antimetabolites|antimetabolites|mesh-ancestor
92439729|NCT01619761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92439730|NCT01619761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439731|NCT01619761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92439732|NCT01619761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92439733|NCT01619761|Growth Substances|growth substances|mesh-ancestor
92439734|NCT01619761|Growth Inhibitors|growth inhibitors|mesh-ancestor
92439735|NCT01619761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92439736|NCT01619761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92439737|NCT01619761|Antitubercular Agents|antitubercular agents|mesh-ancestor
92439738|NCT01619761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92439739|NCT01619761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439740|NCT01619813|Prednisone|prednisone|mesh-list
92439741|NCT01619813|Docetaxel|docetaxel|mesh-list
92439742|NCT01619813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439743|NCT01619813|Tubulin Modulators|tubulin modulators|mesh-ancestor
92439744|NCT01619813|Antimitotic Agents|antimitotic agents|mesh-ancestor
92439745|NCT01619813|Mitosis Modulators|mitosis modulators|mesh-ancestor
92439746|NCT01619813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439747|NCT01619813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439748|NCT01619813|Glucocorticoids|glucocorticoids|mesh-ancestor
92439749|NCT01619813|Hormones|hormones|mesh-ancestor
92439750|NCT01619813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439751|NCT01619813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439752|NCT01619813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92439753|NCT01619891|Vitamin D|vitamin d|mesh-list
92439754|NCT01619891|Vitamins|vitamins|mesh-ancestor
92439755|NCT01619891|Micronutrients|micronutrients|mesh-ancestor
92439756|NCT01619891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439757|NCT01619891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92439758|NCT01620112|Lidocaine|lidocaine|mesh-list
92439759|NCT01620112|Clonidine|clonidine|mesh-list
92439760|NCT01620112|Anesthetics, Local|anesthetics, local|mesh-ancestor
92439761|NCT01620112|Anesthetics|anesthetics|mesh-ancestor
92439762|NCT01620112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439763|NCT01620112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439764|NCT01620112|Sensory System Agents|sensory system agents|mesh-ancestor
92439765|NCT01620112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439766|NCT01620112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92439767|NCT01620112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92439768|NCT01620112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92439769|NCT01620112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439770|NCT01620112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439771|NCT01620112|Analgesics|analgesics|mesh-ancestor
92439772|NCT01620112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439773|NCT01620112|Sympatholytics|sympatholytics|mesh-ancestor
92439774|NCT01620112|Autonomic Agents|autonomic agents|mesh-ancestor
92439775|NCT01620112|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92439776|NCT01620112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92439777|NCT01620112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92439778|NCT01620112|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439779|NCT01620112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439780|NCT01620229|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92439781|NCT01620229|Antibodies|antibodies|mesh-list
92439782|NCT01620229|Immunoglobulins|immunoglobulins|mesh-list
92439783|NCT01620229|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92439784|NCT01620229|Immunoconjugates|immunoconjugates|mesh-list
92439785|NCT01620229|Immunologic Factors|immunologic factors|mesh-ancestor
92439786|NCT01620229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439787|NCT01620229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92439788|NCT01620229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439789|NCT01620229|Immunotoxins|immunotoxins|mesh-ancestor
92439790|NCT01620268|Leflunomide|leflunomide|mesh-list
92439791|NCT01620268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439792|NCT01620268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439793|NCT01620268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439794|NCT01620268|Immunologic Factors|immunologic factors|mesh-ancestor
92439795|NCT01620268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439796|NCT01620307|Sirolimus|sirolimus|mesh-list
92439797|NCT01620307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92439798|NCT01620307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439799|NCT01620307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92439800|NCT01620307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439801|NCT01620307|Antifungal Agents|antifungal agents|mesh-ancestor
92439802|NCT01620307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439803|NCT01620307|Immunologic Factors|immunologic factors|mesh-ancestor
92439804|NCT01620307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439805|NCT01620320|Dobutamine|dobutamine|mesh-list
92439806|NCT01620320|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92439807|NCT01620320|Sympathomimetics|sympathomimetics|mesh-ancestor
92439808|NCT01620320|Autonomic Agents|autonomic agents|mesh-ancestor
92439809|NCT01620320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439810|NCT01620320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439811|NCT01620320|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92439812|NCT01620320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92439813|NCT01620320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92439814|NCT01620320|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439815|NCT01620320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439816|NCT01620320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344495|NCT04666272|Dabrafenib|dabrafenib|mesh-list
92439817|NCT01620320|Protective Agents|protective agents|mesh-ancestor
92439818|NCT01620333|Insulin|insulin|mesh-list
92439819|NCT01620333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92439820|NCT01620333|Insulin Aspart|insulin aspart|mesh-list
92439821|NCT01620333|Insulin, Long-Acting|insulin, long-acting|mesh-list
92439822|NCT01620333|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92439823|NCT01620333|Biphasic Insulins|biphasic insulins|mesh-list
92439824|NCT01620333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439825|NCT01620333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439826|NCT01620424|Insulin|insulin|mesh-list
92439827|NCT01620424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92439828|NCT01620424|Insulin Aspart|insulin aspart|mesh-list
92439829|NCT01620424|Insulin, Long-Acting|insulin, long-acting|mesh-list
92439830|NCT01620424|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92439831|NCT01620424|Biphasic Insulins|biphasic insulins|mesh-list
92439832|NCT01620424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92439833|NCT01620424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92164625|NCT01928537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439834|NCT01620424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439836|NCT01620437|Biphasic Insulins|biphasic insulins|mesh-list
92439837|NCT01620437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439838|NCT01620437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439839|NCT01620450|Insulin|insulin|mesh-list
92439840|NCT01620450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92439841|NCT01620450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439842|NCT01620450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439843|NCT01620463|Liraglutide|liraglutide|mesh-list
92439844|NCT01620463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439845|NCT01620463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439846|NCT01620463|Incretins|incretins|mesh-ancestor
92439848|NCT01620463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439849|NCT01620476|Liraglutide|liraglutide|mesh-list
92439850|NCT01620476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439851|NCT01620476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439852|NCT01620476|Incretins|incretins|mesh-ancestor
92439853|NCT01620476|Hormones|hormones|mesh-ancestor
92439854|NCT01620476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439855|NCT01620684|Metyrapone|metyrapone|mesh-list
92439856|NCT01620684|Antimetabolites|antimetabolites|mesh-ancestor
92439857|NCT01620684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439858|NCT01620684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439859|NCT01620736|Raltegravir Potassium|raltegravir potassium|mesh-list
92439860|NCT01620736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92439861|NCT01620736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92439862|NCT01620736|Antiviral Agents|antiviral agents|mesh-ancestor
92439863|NCT01620736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439864|NCT01620736|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92439865|NCT01620736|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92439866|NCT01620736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439867|NCT01620736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439868|NCT01620814|Misoprostol|misoprostol|mesh-list
92439869|NCT01620814|Dinoprostone|dinoprostone|mesh-list
92439870|NCT01620814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92439871|NCT01620814|Abortifacient Agents|abortifacient agents|mesh-ancestor
92439872|NCT01620814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92439873|NCT01620814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439874|NCT01620814|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92439875|NCT01620814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92439876|NCT01620814|Oxytocics|oxytocics|mesh-ancestor
92439877|NCT01620840|Lacosamide|lacosamide|mesh-list
92439878|NCT01620840|Anticonvulsants|anticonvulsants|mesh-ancestor
92439879|NCT01620840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92439880|NCT01620840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92439881|NCT01620840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439882|NCT01620840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439883|NCT01620944|Ritonavir|ritonavir|mesh-list
92439884|NCT01620944|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92439885|NCT01620944|Tenofovir|tenofovir|mesh-list
92439886|NCT01620944|Lamivudine|lamivudine|mesh-list
92439887|NCT01620944|Emtricitabine|emtricitabine|mesh-list
92439888|NCT01620944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92439889|NCT01620944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92439890|NCT01620944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92439891|NCT01620944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439892|NCT01620944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439893|NCT01620944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92439894|NCT01620944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92439895|NCT01620944|Antiviral Agents|antiviral agents|mesh-ancestor
92439896|NCT01620944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439897|NCT01620944|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92439898|NCT01620944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92439899|NCT01620944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92439900|NCT01620944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92439901|NCT01621022|Bupropion|bupropion|mesh-list
92439902|NCT01621022|Nicotine|nicotine|mesh-list
92439903|NCT01621022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92439904|NCT01621022|Autonomic Agents|autonomic agents|mesh-ancestor
92439905|NCT01621022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439906|NCT01621022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439907|NCT01621022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92439908|NCT01621022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92439909|NCT01621022|Cholinergic Agents|cholinergic agents|mesh-ancestor
92439910|NCT01621022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164708|NCT05609903|Paclitaxel|paclitaxel|mesh-list
92439911|NCT01621022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439912|NCT01621022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92439913|NCT01621022|Antidepressive Agents|antidepressive agents|mesh-ancestor
92439914|NCT01621022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531152|NCT00045292|Valacyclovir|valacyclovir|mesh-list
92439915|NCT01621022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92439916|NCT01621022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92439917|NCT01621022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439918|NCT01621022|Dopamine Agents|dopamine agents|mesh-ancestor
92439919|NCT01621022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92439920|NCT01621022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92439921|NCT01621022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439922|NCT01621100|Hydromorphone|hydromorphone|mesh-list
92439923|NCT01621100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92439924|NCT01621100|Narcotics|narcotics|mesh-ancestor
92439925|NCT01621100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92439926|NCT01621100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439927|NCT01621100|Analgesics|analgesics|mesh-ancestor
92439928|NCT01621100|Sensory System Agents|sensory system agents|mesh-ancestor
92439929|NCT01621100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92439930|NCT01621113|4-Aminopyridine|4-aminopyridine|mesh-list
92439931|NCT01621113|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92439932|NCT01621113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92439933|NCT01621113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439934|NCT01621165|Prazosin|prazosin|mesh-list
92439935|NCT01621165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92439936|NCT01621165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92439937|NCT01621165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92439938|NCT01621165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92439939|NCT01621165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92439940|NCT01621165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92439941|NCT01621165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439942|NCT01621165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439943|NCT01621204|Immunoglobulins|immunoglobulins|mesh-list
92439944|NCT01621204|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92439945|NCT01621204|gamma-Globulins|gamma-globulins|mesh-list
92439946|NCT01621204|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92439947|NCT01621204|Immunologic Factors|immunologic factors|mesh-ancestor
92439948|NCT01621204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439949|NCT01621217|Cetuximab|cetuximab|mesh-list
92439950|NCT01621217|Mitomycins|mitomycins|mesh-list
92439951|NCT01621217|Mitomycin|mitomycin|mesh-list
92439952|NCT01621217|Fluorouracil|fluorouracil|mesh-list
92439953|NCT01621217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92439954|NCT01621217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439955|NCT01621217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92439956|NCT01621217|Alkylating Agents|alkylating agents|mesh-ancestor
92439957|NCT01621217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439958|NCT01621217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92439959|NCT01621217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439960|NCT01621217|Antimetabolites|antimetabolites|mesh-ancestor
92439961|NCT01621217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92439962|NCT01621217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439963|NCT01621217|Immunologic Factors|immunologic factors|mesh-ancestor
92439964|NCT01621217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439966|NCT01621256|Anticoagulants|anticoagulants|mesh-ancestor
92439967|NCT01621256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92439968|NCT01621256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92439969|NCT01621256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439970|NCT01621269|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92439971|NCT01621269|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92439972|NCT01621269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439973|NCT01621269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92439974|NCT01621269|Immunologic Factors|immunologic factors|mesh-ancestor
92439975|NCT01621269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439976|NCT01621308|Insulin|insulin|mesh-list
92439977|NCT01621308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92439978|NCT01621308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439979|NCT01621321|Voriconazole|voriconazole|mesh-list
92439980|NCT01621321|Prednisolone|prednisolone|mesh-list
92439981|NCT01621321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92439982|NCT01621321|Glucocorticoids|glucocorticoids|mesh-ancestor
92439983|NCT01621321|Hormones|hormones|mesh-ancestor
92704582|NCT04397692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92439984|NCT01621321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92439985|NCT01621321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92439986|NCT01621321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92439987|NCT01621321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92439988|NCT01621321|Antifungal Agents|antifungal agents|mesh-ancestor
92439989|NCT01621321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92439990|NCT01621321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92439991|NCT01621321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92439992|NCT01621321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92439993|NCT01621321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92439994|NCT01621321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92439995|NCT01621321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92439996|NCT01621321|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92439998|NCT01621373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92439999|NCT01621373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440000|NCT01621373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440001|NCT01621373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92440002|NCT01621373|Anesthetics, General|anesthetics, general|mesh-ancestor
92440003|NCT01621373|Anesthetics|anesthetics|mesh-ancestor
92440004|NCT01621386|Prednisone|prednisone|mesh-list
92440005|NCT01621386|Montelukast|montelukast|mesh-list
92440006|NCT01621386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440007|NCT01621386|Glucocorticoids|glucocorticoids|mesh-ancestor
92440008|NCT01621386|Hormones|hormones|mesh-ancestor
92440009|NCT01621386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440010|NCT01621386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440011|NCT01621386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92440012|NCT01621386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440013|NCT01621386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92440014|NCT01621386|Respiratory System Agents|respiratory system agents|mesh-ancestor
92440015|NCT01621386|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92440016|NCT01621386|Hormone Antagonists|hormone antagonists|mesh-ancestor
92440017|NCT01621386|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92440018|NCT01621386|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92440019|NCT01621386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440020|NCT01621451|Aspirin|aspirin|mesh-list
92440021|NCT01621451|Clopidogrel|clopidogrel|mesh-list
92440022|NCT01621451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92440023|NCT01621451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92440024|NCT01621451|Analgesics|analgesics|mesh-ancestor
92440025|NCT01621451|Sensory System Agents|sensory system agents|mesh-ancestor
92440026|NCT01621451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440027|NCT01621451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440028|NCT01621451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440029|NCT01621451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440030|NCT01621451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92440031|NCT01621451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92440032|NCT01621451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440033|NCT01621451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92440034|NCT01621451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92440035|NCT01621451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440036|NCT01621451|Antipyretics|antipyretics|mesh-ancestor
92440037|NCT01621451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92440038|NCT01621451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92440039|NCT01621451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92440040|NCT01621451|Purinergic Agents|purinergic agents|mesh-ancestor
92440041|NCT01621451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440042|NCT01621620|Yohimbine|yohimbine|mesh-list
92440043|NCT01621620|Mydriatics|mydriatics|mesh-ancestor
92440044|NCT01621620|Autonomic Agents|autonomic agents|mesh-ancestor
92440045|NCT01621620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440046|NCT01621620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440047|NCT01621620|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92440048|NCT01621620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92440049|NCT01621620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92440050|NCT01621620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92440051|NCT01621620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440052|NCT01621620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440053|NCT01621620|Urological Agents|urological agents|mesh-ancestor
92440054|NCT01621698|Fentanyl|fentanyl|mesh-list
92440055|NCT01621698|Bupivacaine|bupivacaine|mesh-list
92440056|NCT01621698|Propofol|propofol|mesh-list
92440058|NCT01621698|Anesthetics, Local|anesthetics, local|mesh-ancestor
92440059|NCT01621698|Anesthetics|anesthetics|mesh-ancestor
92440060|NCT01621698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440061|NCT01621698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440062|NCT01621698|Sensory System Agents|sensory system agents|mesh-ancestor
92440063|NCT01621698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440064|NCT01621698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92440065|NCT01621698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92440066|NCT01621698|Anesthetics, General|anesthetics, general|mesh-ancestor
92440067|NCT01621698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92440068|NCT01621698|Narcotics|narcotics|mesh-ancestor
92440069|NCT01621698|Analgesics|analgesics|mesh-ancestor
92440070|NCT01621698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92440071|NCT01621698|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92440072|NCT01621698|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92440073|NCT01621698|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92440074|NCT01621698|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92440075|NCT01621698|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92440076|NCT01621698|Cholinergic Agents|cholinergic agents|mesh-ancestor
92440077|NCT01621698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440078|NCT01621698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440079|NCT01621750|Clopidogrel|clopidogrel|mesh-list
92440080|NCT01621750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92440081|NCT01621750|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92440082|NCT01621750|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92440083|NCT01621750|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92440084|NCT01621750|Purinergic Agents|purinergic agents|mesh-ancestor
92440085|NCT01621750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440086|NCT01621750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440087|NCT01621750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440088|NCT01621763|Clopidogrel|clopidogrel|mesh-list
92440089|NCT01621763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92440090|NCT01621763|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92440091|NCT01621763|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92440092|NCT01621763|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92440093|NCT01621763|Purinergic Agents|purinergic agents|mesh-ancestor
92440094|NCT01621763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440095|NCT01621763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440096|NCT01621763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440097|NCT01621789|Diminazene aceturate|diminazene aceturate|mesh-list
92440098|NCT01621789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92440099|NCT01621789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92440100|NCT01621789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440101|NCT01621789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92440102|NCT01621893|Calcium|calcium|mesh-list
92440103|NCT01621893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92440104|NCT01621893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440105|NCT01621971|Milrinone|milrinone|mesh-list
92440106|NCT01621971|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92440107|NCT01621971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92440108|NCT01621971|Vasodilator Agents|vasodilator agents|mesh-ancestor
92440109|NCT01621971|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92440110|NCT01621971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92440111|NCT01621971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440112|NCT01621971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440113|NCT01621971|Protective Agents|protective agents|mesh-ancestor
92440114|NCT01621971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440115|NCT01622075|Paclitaxel|paclitaxel|mesh-list
92440116|NCT01622075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92440117|NCT01622075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92440118|NCT01622075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440119|NCT01622075|Tubulin Modulators|tubulin modulators|mesh-ancestor
92440120|NCT01622075|Antimitotic Agents|antimitotic agents|mesh-ancestor
92440121|NCT01622075|Mitosis Modulators|mitosis modulators|mesh-ancestor
92440122|NCT01622075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440123|NCT01622283|Cetirizine|cetirizine|mesh-list
92440124|NCT01622283|Levocetirizine|levocetirizine|mesh-list
92440125|NCT01622283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92440126|NCT01622283|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92440127|NCT01622283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92440128|NCT01622283|Histamine Antagonists|histamine antagonists|mesh-ancestor
92440130|NCT01622283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440131|NCT01622283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440132|NCT01622283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440133|NCT01622361|Tamoxifen|tamoxifen|mesh-list
92440134|NCT01622361|Cyclophosphamide|cyclophosphamide|mesh-list
92440135|NCT01622361|Docetaxel|docetaxel|mesh-list
92440136|NCT01622361|Doxorubicin|doxorubicin|mesh-list
92440137|NCT01622361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92440138|NCT01622361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440139|NCT01622361|Immunologic Factors|immunologic factors|mesh-ancestor
92440140|NCT01622361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440141|NCT01622361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440142|NCT01622361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92440143|NCT01622361|Alkylating Agents|alkylating agents|mesh-ancestor
92440144|NCT01622361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440145|NCT01622361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440146|NCT01622361|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92440147|NCT01622361|Tubulin Modulators|tubulin modulators|mesh-ancestor
92440148|NCT01622361|Antimitotic Agents|antimitotic agents|mesh-ancestor
92440149|NCT01622361|Mitosis Modulators|mitosis modulators|mesh-ancestor
92440150|NCT01622361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440151|NCT01622361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92440152|NCT01622361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92440153|NCT01622361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440154|NCT01622361|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92440155|NCT01622361|Hormone Antagonists|hormone antagonists|mesh-ancestor
92440156|NCT01622361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440157|NCT01622361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92440158|NCT01622361|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92440159|NCT01622361|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92440160|NCT01622361|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92440161|NCT01622439|Prednisone|prednisone|mesh-list
92440162|NCT01622439|Cyclophosphamide|cyclophosphamide|mesh-list
92440163|NCT01622439|Rituximab|rituximab|mesh-list
92440164|NCT01622439|Doxorubicin|doxorubicin|mesh-list
92440165|NCT01622439|Vincristine|vincristine|mesh-list
92440166|NCT01622439|Valproic Acid|valproic acid|mesh-list
92440167|NCT01622439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440168|NCT01622439|Immunologic Factors|immunologic factors|mesh-ancestor
92440169|NCT01622439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440170|NCT01622439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440171|NCT01622439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92440172|NCT01622439|Alkylating Agents|alkylating agents|mesh-ancestor
92440173|NCT01622439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440174|NCT01622439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440175|NCT01622439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92440176|NCT01622439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440177|NCT01622439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440178|NCT01622439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92440179|NCT01622439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92440180|NCT01622439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440181|NCT01622439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440182|NCT01622439|Glucocorticoids|glucocorticoids|mesh-ancestor
92440183|NCT01622439|Hormones|hormones|mesh-ancestor
92440184|NCT01622439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440185|NCT01622439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92440186|NCT01622439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92440187|NCT01622439|Tubulin Modulators|tubulin modulators|mesh-ancestor
92440188|NCT01622439|Antimitotic Agents|antimitotic agents|mesh-ancestor
92440189|NCT01622439|Mitosis Modulators|mitosis modulators|mesh-ancestor
92440190|NCT01622439|Anticonvulsants|anticonvulsants|mesh-ancestor
92440191|NCT01622439|GABA Agents|gaba agents|mesh-ancestor
92440192|NCT01622439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440193|NCT01622439|Antimanic Agents|antimanic agents|mesh-ancestor
92440194|NCT01622439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92440195|NCT01622439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440196|NCT01622439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92440197|NCT01622504|Naloxone|naloxone|mesh-list
92440198|NCT01622504|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92440199|NCT01622504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440200|NCT01622504|Sensory System Agents|sensory system agents|mesh-ancestor
92440201|NCT01622504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440202|NCT01622556|Fludarabine|fludarabine|mesh-list
92440203|NCT01622556|Busulfan|busulfan|mesh-list
92440204|NCT01622556|Thymoglobulin|thymoglobulin|mesh-list
92440205|NCT01622556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440206|NCT01622556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440207|NCT01622556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440209|NCT01622556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440210|NCT01622556|Alkylating Agents|alkylating agents|mesh-ancestor
92440211|NCT01622556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92440212|NCT01622556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92440213|NCT01622777|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92440214|NCT01622777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92440215|NCT01622777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92440216|NCT01622777|Antimetabolites|antimetabolites|mesh-ancestor
92440217|NCT01622777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440218|NCT01622777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92440219|NCT01622777|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92440220|NCT01622777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440221|NCT01622790|Lamivudine|lamivudine|mesh-list
92440222|NCT01622790|Abacavir|abacavir|mesh-list
92440223|NCT01622790|Dideoxynucleosides|dideoxynucleosides|mesh-list
92440224|NCT01622790|Dolutegravir|dolutegravir|mesh-list
92440225|NCT01622790|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92440226|NCT01622790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92440227|NCT01622790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440228|NCT01622790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440229|NCT01622790|Antiviral Agents|antiviral agents|mesh-ancestor
92440230|NCT01622790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440231|NCT01622790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92440232|NCT01622790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92440233|NCT01622790|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92440234|NCT01622790|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92440235|NCT01622790|Antimetabolites|antimetabolites|mesh-ancestor
92440236|NCT01622881|Nefopam|nefopam|mesh-list
92440237|NCT01622881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92440238|NCT01622881|Analgesics|analgesics|mesh-ancestor
92440239|NCT01622881|Sensory System Agents|sensory system agents|mesh-ancestor
92440240|NCT01622881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440241|NCT01622881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440242|NCT01622933|Interferons|interferons|mesh-list
92440243|NCT01622933|Interferon-alpha|interferon-alpha|mesh-list
92440244|NCT01622933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440245|NCT01622933|Antiviral Agents|antiviral agents|mesh-ancestor
92440246|NCT01622933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440247|NCT01622933|Immunologic Factors|immunologic factors|mesh-ancestor
92440248|NCT01622933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440249|NCT01622946|Tranexamic Acid|tranexamic acid|mesh-list
92440250|NCT01622946|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92440251|NCT01622946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92440252|NCT01622946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440253|NCT01622946|Hemostatics|hemostatics|mesh-ancestor
92440254|NCT01622946|Coagulants|coagulants|mesh-ancestor
92440255|NCT01622972|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92440256|NCT01622972|Laxatives|laxatives|mesh-ancestor
92440257|NCT01622972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92440258|NCT01623024|Vitamin D|vitamin d|mesh-list
92440259|NCT01623024|Vitamins|vitamins|mesh-ancestor
92440260|NCT01623024|Micronutrients|micronutrients|mesh-ancestor
92440261|NCT01623024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440262|NCT01623024|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92440263|NCT01623102|Bevacizumab|bevacizumab|mesh-list
92440264|NCT01623102|Cisplatin|cisplatin|mesh-list
92440265|NCT01623102|Gemcitabine|gemcitabine|mesh-list
92440266|NCT01623102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440267|NCT01623102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440268|NCT01623102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92440269|NCT01623102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92440270|NCT01623102|Growth Substances|growth substances|mesh-ancestor
92440271|NCT01623102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440272|NCT01623102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92440273|NCT01623102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92440274|NCT01623102|Antimetabolites|antimetabolites|mesh-ancestor
92440275|NCT01623102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440276|NCT01623206|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92440277|NCT01623206|Hemostatics|hemostatics|mesh-ancestor
92440278|NCT01623206|Coagulants|coagulants|mesh-ancestor
92440279|NCT01623206|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92440280|NCT01623206|Natriuretic Agents|natriuretic agents|mesh-ancestor
92440281|NCT01623206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440282|NCT01623284|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92440283|NCT01623284|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92440284|NCT01623284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440285|NCT01623336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92440286|NCT01623336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92440288|NCT01623336|Antiviral Agents|antiviral agents|mesh-ancestor
92440289|NCT01623336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440290|NCT01623336|Immunologic Factors|immunologic factors|mesh-ancestor
92440291|NCT01623336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440292|NCT01623349|Olaparib|olaparib|mesh-list
92440293|NCT01623349|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92440294|NCT01623349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440295|NCT01623349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440296|NCT01623349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440297|NCT01623362|Fluorides|fluorides|mesh-list
92440298|NCT01623362|Cariostatic Agents|cariostatic agents|mesh-ancestor
92440299|NCT01623362|Protective Agents|protective agents|mesh-ancestor
92440300|NCT01623362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440301|NCT01623375|Insulin|insulin|mesh-list
92440302|NCT01623375|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92440303|NCT01623375|Insulin, Long-Acting|insulin, long-acting|mesh-list
92440304|NCT01623375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92440305|NCT01623375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440306|NCT01623401|Tedizolid phosphate|tedizolid phosphate|mesh-list
92440307|NCT01623401|Tedizolid|tedizolid|mesh-list
92440308|NCT01623401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92440309|NCT01623401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440310|NCT01623440|Naltrexone|naltrexone|mesh-list
92440311|NCT01623440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92440312|NCT01623440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92440313|NCT01623440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440314|NCT01623440|Sensory System Agents|sensory system agents|mesh-ancestor
92440315|NCT01623440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440316|NCT01623505|Varenicline|varenicline|mesh-list
92440317|NCT01623505|Nicotine|nicotine|mesh-list
92440318|NCT01623505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92440319|NCT01623505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92440320|NCT01623505|Cholinergic Agents|cholinergic agents|mesh-ancestor
92440321|NCT01623505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440322|NCT01623505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440323|NCT01623505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440324|NCT01623505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92440325|NCT01623505|Autonomic Agents|autonomic agents|mesh-ancestor
92440326|NCT01623505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440327|NCT01623570|Menotropins|menotropins|mesh-list
92440328|NCT01623570|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92440329|NCT01623570|Fertility Agents|fertility agents|mesh-ancestor
92440330|NCT01623570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92440331|NCT01623570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440332|NCT01623609|Naloxegol|naloxegol|mesh-list
92440333|NCT01623609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92440334|NCT01623609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440335|NCT01623609|Sensory System Agents|sensory system agents|mesh-ancestor
92440336|NCT01623609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440337|NCT01623635|Ropivacaine|ropivacaine|mesh-list
92440338|NCT01623635|Anesthetics, Local|anesthetics, local|mesh-ancestor
92440339|NCT01623635|Anesthetics|anesthetics|mesh-ancestor
92440340|NCT01623635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440341|NCT01623635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440342|NCT01623635|Sensory System Agents|sensory system agents|mesh-ancestor
92440343|NCT01623635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440344|NCT01623713|Risperidone|risperidone|mesh-list
92440345|NCT01623713|Iloperidone|iloperidone|mesh-list
92440346|NCT01623713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92440347|NCT01623713|Serotonin Agents|serotonin agents|mesh-ancestor
92440348|NCT01623713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440349|NCT01623713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440350|NCT01623713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440351|NCT01623713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92440352|NCT01623713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92440353|NCT01623713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440354|NCT01623713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92440355|NCT01623713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92440356|NCT01623713|Dopamine Agents|dopamine agents|mesh-ancestor
92440357|NCT01623778|Interferons|interferons|mesh-list
92440358|NCT01623778|Interferon-alpha|interferon-alpha|mesh-list
92440359|NCT01623778|Interferon alpha-2|interferon alpha-2|mesh-list
92440360|NCT01623778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440361|NCT01623778|Antiviral Agents|antiviral agents|mesh-ancestor
92440362|NCT01623778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440363|NCT01623778|Immunologic Factors|immunologic factors|mesh-ancestor
92440364|NCT01623778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440366|NCT01623817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92440367|NCT01623817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440368|NCT01623908|Zoledronic Acid|zoledronic acid|mesh-list
92440369|NCT01623908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92440370|NCT01623908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440371|NCT01623921|Celecoxib|celecoxib|mesh-list
92440372|NCT01623921|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92440373|NCT01623921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92440374|NCT01623921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92440375|NCT01623921|Antimetabolites|antimetabolites|mesh-ancestor
92440376|NCT01623921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440377|NCT01623921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92440378|NCT01623921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92440379|NCT01623921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440380|NCT01623921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92440381|NCT01623921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92440382|NCT01623921|Analgesics|analgesics|mesh-ancestor
92440383|NCT01623921|Sensory System Agents|sensory system agents|mesh-ancestor
92440384|NCT01623921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440385|NCT01623921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440386|NCT01623921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440387|NCT01623921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440388|NCT01623921|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92440389|NCT01623921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92440390|NCT01624025|Docetaxel|docetaxel|mesh-list
92440391|NCT01624025|Epirubicin|epirubicin|mesh-list
92440392|NCT01624025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440393|NCT01624025|Tubulin Modulators|tubulin modulators|mesh-ancestor
92440394|NCT01624025|Antimitotic Agents|antimitotic agents|mesh-ancestor
92440395|NCT01624025|Mitosis Modulators|mitosis modulators|mesh-ancestor
92440396|NCT01624025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440397|NCT01624025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440398|NCT01624025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92440399|NCT01624025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92440400|NCT01624025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440401|NCT01624038|Hydroxyurea|hydroxyurea|mesh-list
92440402|NCT01624038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440403|NCT01624038|Antisickling Agents|antisickling agents|mesh-ancestor
92440404|NCT01624038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440405|NCT01624038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440406|NCT01624038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92440407|NCT01624051|Cisplatin|cisplatin|mesh-list
92440408|NCT01624051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440409|NCT01624064|Calcium, Dietary|calcium, dietary|mesh-list
92440410|NCT01624064|Enalapril|enalapril|mesh-list
92440411|NCT01624064|Calcium|calcium|mesh-list
92440412|NCT01624064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92440413|NCT01624064|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92440414|NCT01624064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92440415|NCT01624064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440416|NCT01624064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92440417|NCT01624064|Protease Inhibitors|protease inhibitors|mesh-ancestor
92440418|NCT01624064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440419|NCT01624064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92440420|NCT01624103|Lidocaine|lidocaine|mesh-list
92440421|NCT01624103|Levobupivacaine|levobupivacaine|mesh-list
92440422|NCT01624103|Anesthetics, Local|anesthetics, local|mesh-ancestor
92440423|NCT01624103|Anesthetics|anesthetics|mesh-ancestor
92440424|NCT01624103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440425|NCT01624103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440426|NCT01624103|Sensory System Agents|sensory system agents|mesh-ancestor
92440427|NCT01624103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440428|NCT01624103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92440429|NCT01624103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92440430|NCT01624103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92440431|NCT01624103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92440432|NCT01624103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440433|NCT01624116|Metformin|metformin|mesh-list
92440434|NCT01624116|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92440435|NCT01624116|Acarbose|acarbose|mesh-list
92440436|NCT01624116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92440437|NCT01624116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440438|NCT01624116|Incretins|incretins|mesh-ancestor
92440439|NCT01624116|Hormones|hormones|mesh-ancestor
92440440|NCT01624116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440441|NCT01624116|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92440442|NCT01624116|Protease Inhibitors|protease inhibitors|mesh-ancestor
92440443|NCT01624116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440444|NCT01624116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440445|NCT01624116|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92440446|NCT01624129|Fluticasone|fluticasone|mesh-list
92440447|NCT01624129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440448|NCT01624129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92440449|NCT01624129|Autonomic Agents|autonomic agents|mesh-ancestor
92440450|NCT01624129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440451|NCT01624129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440452|NCT01624129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92440453|NCT01624129|Respiratory System Agents|respiratory system agents|mesh-ancestor
92440454|NCT01624129|Dermatologic Agents|dermatologic agents|mesh-ancestor
92440455|NCT01624129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92440456|NCT01624207|Atorvastatin|atorvastatin|mesh-list
92440457|NCT01624207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92440458|NCT01624207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92440459|NCT01624207|Antimetabolites|antimetabolites|mesh-ancestor
92440460|NCT01624207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440461|NCT01624207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92440462|NCT01624207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92440463|NCT01624207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440464|NCT01624246|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92440465|NCT01624246|Avibactam|avibactam|mesh-list
92440466|NCT01624246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92440467|NCT01624246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440468|NCT01624246|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92440469|NCT01624246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440470|NCT01624246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440471|NCT01624337|Piperaquine|piperaquine|mesh-list
92440472|NCT01624337|Antimalarials|antimalarials|mesh-ancestor
92440473|NCT01624337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92440474|NCT01624337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92440475|NCT01624337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440476|NCT01624428|Varenicline|varenicline|mesh-list
92440477|NCT01624428|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92440478|NCT01624428|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92440479|NCT01624428|Cholinergic Agents|cholinergic agents|mesh-ancestor
92440480|NCT01624428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440481|NCT01624428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440482|NCT01624428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440483|NCT01624441|Epirubicin|epirubicin|mesh-list
92440484|NCT01624441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440485|NCT01624441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440486|NCT01624441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92440487|NCT01624441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92440488|NCT01624441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440489|NCT01624441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440490|NCT01624493|Carboplatin|carboplatin|mesh-list
92440491|NCT01624493|Gemcitabine|gemcitabine|mesh-list
92440492|NCT01624493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440493|NCT01624493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92440494|NCT01624493|Antimetabolites|antimetabolites|mesh-ancestor
92440495|NCT01624493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440496|NCT01624649|Methylphenidate|methylphenidate|mesh-list
92440497|NCT01624649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92440498|NCT01624649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92440499|NCT01624649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440500|NCT01624649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92440501|NCT01624649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92440502|NCT01624649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92440503|NCT01624649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440504|NCT01624649|Dopamine Agents|dopamine agents|mesh-ancestor
92440505|NCT01624649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165305|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440506|NCT01624649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92440507|NCT01624649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92440508|NCT01624675|Risperidone|risperidone|mesh-list
92440509|NCT01624675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92440510|NCT01624675|Serotonin Agents|serotonin agents|mesh-ancestor
92440511|NCT01624675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440512|NCT01624675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440513|NCT01624675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440514|NCT01624675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92440515|NCT01624675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92440516|NCT01624675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440517|NCT01624675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92440518|NCT01624675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92440519|NCT01624675|Dopamine Agents|dopamine agents|mesh-ancestor
92440520|NCT01624714|Alemtuzumab|alemtuzumab|mesh-list
92440521|NCT01624714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440522|NCT01624714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440523|NCT01624766|Denosumab|denosumab|mesh-list
92440524|NCT01624766|Everolimus|everolimus|mesh-list
92440525|NCT01624766|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92440526|NCT01624766|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92440527|NCT01624766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92440528|NCT01624766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440529|NCT01624766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440530|NCT01624766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440531|NCT01624766|Immunologic Factors|immunologic factors|mesh-ancestor
92440532|NCT01624766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440533|NCT01624766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440534|NCT01624766|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92440535|NCT01624766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440536|NCT01624857|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92440537|NCT01624857|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92440538|NCT01624857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92440539|NCT01624857|Antimetabolites|antimetabolites|mesh-ancestor
92440540|NCT01624857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440541|NCT01624857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92440542|NCT01624857|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92440543|NCT01624857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440544|NCT01625026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92440545|NCT01625026|Cathartics|cathartics|mesh-ancestor
92440546|NCT01625026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92440547|NCT01625260|Gemcitabine|gemcitabine|mesh-list
92440548|NCT01625260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92440549|NCT01625260|Antimetabolites|antimetabolites|mesh-ancestor
92440550|NCT01625260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440551|NCT01625260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440552|NCT01625351|Sirolimus|sirolimus|mesh-list
92440553|NCT01625351|Fludarabine|fludarabine|mesh-list
92440554|NCT01625351|Melphalan|melphalan|mesh-list
92440555|NCT01625351|Busulfan|busulfan|mesh-list
92440556|NCT01625351|Mechlorethamine|mechlorethamine|mesh-list
92440557|NCT01625351|Alemtuzumab|alemtuzumab|mesh-list
92440558|NCT01625351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440559|NCT01625351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440560|NCT01625351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440561|NCT01625351|Immunologic Factors|immunologic factors|mesh-ancestor
92440562|NCT01625351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440563|NCT01625351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92440564|NCT01625351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440565|NCT01625351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440566|NCT01625351|Antifungal Agents|antifungal agents|mesh-ancestor
92440567|NCT01625351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92440568|NCT01625351|Alkylating Agents|alkylating agents|mesh-ancestor
92440569|NCT01625351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92440570|NCT01625351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440571|NCT01625429|Paclitaxel|paclitaxel|mesh-list
92440572|NCT01625429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92440573|NCT01625429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440574|NCT01625429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92440575|NCT01625429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92440576|NCT01625429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92440577|NCT01625429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440578|NCT01625494|Amlodipine|amlodipine|mesh-list
92440579|NCT01625494|Irbesartan|irbesartan|mesh-list
92440580|NCT01625494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92440581|NCT01625494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92440582|NCT01625494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92440583|NCT01625494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440584|NCT01625494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92440585|NCT01625494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440586|NCT01625494|Vasodilator Agents|vasodilator agents|mesh-ancestor
92440587|NCT01625494|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92440588|NCT01625494|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92440589|NCT01625520|Everolimus|everolimus|mesh-list
92440590|NCT01625520|Pasireotide|pasireotide|mesh-list
92440591|NCT01625520|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92440592|NCT01625520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92440593|NCT01625520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440594|NCT01625520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440595|NCT01625520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440596|NCT01625520|Immunologic Factors|immunologic factors|mesh-ancestor
92440597|NCT01625520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440598|NCT01625520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440599|NCT01625520|Hormones|hormones|mesh-ancestor
92440600|NCT01625520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440601|NCT01625572|Morphine|morphine|mesh-list
92440602|NCT01625572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92440603|NCT01625572|Narcotics|narcotics|mesh-ancestor
92440604|NCT01625572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440605|NCT01625572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440606|NCT01625572|Analgesics|analgesics|mesh-ancestor
92440607|NCT01625572|Sensory System Agents|sensory system agents|mesh-ancestor
92440608|NCT01625572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440609|NCT01625715|Ketotifen|ketotifen|mesh-list
92440610|NCT01625715|Antipruritics|antipruritics|mesh-ancestor
92440611|NCT01625715|Dermatologic Agents|dermatologic agents|mesh-ancestor
92440612|NCT01625715|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92440613|NCT01625715|Histamine Antagonists|histamine antagonists|mesh-ancestor
92440614|NCT01625715|Histamine Agents|histamine agents|mesh-ancestor
92440615|NCT01625715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440616|NCT01625715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440617|NCT01625715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440618|NCT01625715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92440619|NCT01625741|Rituximab|rituximab|mesh-list
92440620|NCT01625741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440621|NCT01625741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440622|NCT01625741|Immunologic Factors|immunologic factors|mesh-ancestor
92440623|NCT01625741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440624|NCT01625741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440625|NCT01625793|Interferons|interferons|mesh-list
92440626|NCT01625793|Interferon-alpha|interferon-alpha|mesh-list
92440627|NCT01625793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440628|NCT01625793|Antiviral Agents|antiviral agents|mesh-ancestor
92440629|NCT01625793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440630|NCT01625793|Immunologic Factors|immunologic factors|mesh-ancestor
92440631|NCT01625793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440632|NCT01625806|Ketoconazole|ketoconazole|mesh-list
92440633|NCT01625806|Antifungal Agents|antifungal agents|mesh-ancestor
92440634|NCT01625806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440635|NCT01625806|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92440636|NCT01625806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92440637|NCT01625806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440638|NCT01625806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440639|NCT01625806|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92440640|NCT01625806|Hormone Antagonists|hormone antagonists|mesh-ancestor
92440641|NCT01625806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440642|NCT01625806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440643|NCT01625806|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92440644|NCT01625871|Lumefantrine|lumefantrine|mesh-list
92440645|NCT01625871|Artemether|artemether|mesh-list
92440646|NCT01625871|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92440647|NCT01625871|Antimalarials|antimalarials|mesh-ancestor
92440648|NCT01625871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92440649|NCT01625871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92440650|NCT01625871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440651|NCT01625936|Bevacizumab|bevacizumab|mesh-list
92440652|NCT01625936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440653|NCT01625936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440654|NCT01625936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92165457|NCT04246229|Bilirubin|bilirubin|mesh-list
92440655|NCT01625936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92440656|NCT01625936|Growth Substances|growth substances|mesh-ancestor
92440657|NCT01625936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440658|NCT01625936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92440659|NCT01625156|Sirolimus|sirolimus|mesh-list
92440660|NCT01625156|Temsirolimus|temsirolimus|mesh-list
92440661|NCT01625156|MTOR Inhibitors|mtor inhibitors|mesh-list
92440662|NCT01625156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92440663|NCT01625156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440664|NCT01625156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440665|NCT01625156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440666|NCT01625156|Antifungal Agents|antifungal agents|mesh-ancestor
92440667|NCT01625156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440668|NCT01625156|Immunologic Factors|immunologic factors|mesh-ancestor
92440669|NCT01625156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440670|NCT01625156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92440671|NCT01625156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440672|NCT01625156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440673|NCT01626222|Everolimus|everolimus|mesh-list
92440674|NCT01626222|Exemestane|exemestane|mesh-list
92440675|NCT01626222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92440676|NCT01626222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92440677|NCT01626222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440678|NCT01626222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440679|NCT01626222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440680|NCT01626222|Immunologic Factors|immunologic factors|mesh-ancestor
92440681|NCT01626222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440682|NCT01626222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440683|NCT01626222|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92440684|NCT01626222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92440685|NCT01626222|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92440686|NCT01626222|Hormone Antagonists|hormone antagonists|mesh-ancestor
92440687|NCT01626222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440688|NCT01626339|Bevacizumab|bevacizumab|mesh-list
92440689|NCT01626339|Ranibizumab|ranibizumab|mesh-list
92440690|NCT01626339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440691|NCT01626339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440692|NCT01626339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92440693|NCT01626339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92440694|NCT01626339|Growth Substances|growth substances|mesh-ancestor
92440695|NCT01626339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440696|NCT01626339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92440697|NCT01626443|Folic Acid|folic acid|mesh-list
92440698|NCT01626443|Vitamin B Complex|vitamin b complex|mesh-list
92440699|NCT01626443|Inositol|inositol|mesh-list
92440700|NCT01626443|Hematinics|hematinics|mesh-ancestor
92440701|NCT01626443|Vitamins|vitamins|mesh-ancestor
92440702|NCT01626443|Micronutrients|micronutrients|mesh-ancestor
92440703|NCT01626443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440704|NCT01626469|Captopril|captopril|mesh-list
92440705|NCT01626469|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92440706|NCT01626469|Protease Inhibitors|protease inhibitors|mesh-ancestor
92440707|NCT01626469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440708|NCT01626469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440709|NCT01626469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92440710|NCT01626534|Clopidogrel|clopidogrel|mesh-list
92440711|NCT01626534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92440712|NCT01626534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92440713|NCT01626534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92440714|NCT01626534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92440715|NCT01626534|Purinergic Agents|purinergic agents|mesh-ancestor
92440716|NCT01626534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440717|NCT01626534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440718|NCT01626534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440719|NCT01626560|Vancomycin|vancomycin|mesh-list
92440720|NCT01626560|Daptomycin|daptomycin|mesh-list
92440721|NCT01626560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92440722|NCT01626560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440723|NCT01626612|Anti-Infective Agents|anti-infective agents|mesh-list
92440724|NCT01626612|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92440725|NCT01626651|Ketoconazole|ketoconazole|mesh-list
92440726|NCT01626651|Antifungal Agents|antifungal agents|mesh-ancestor
92440727|NCT01626651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440728|NCT01626651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92440729|NCT01626651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92440730|NCT01626651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440731|NCT01626651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440732|NCT01626651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92440733|NCT01626651|Hormone Antagonists|hormone antagonists|mesh-ancestor
92440734|NCT01626651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440735|NCT01626651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440736|NCT01626651|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92440737|NCT01626911|Heparin|heparin|mesh-list
92440738|NCT01626911|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92440739|NCT01626911|Tinzaparin|tinzaparin|mesh-list
92440740|NCT01626911|Dalteparin|dalteparin|mesh-list
92440741|NCT01626911|Anticoagulants|anticoagulants|mesh-ancestor
92440742|NCT01626911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92440743|NCT01626911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92440744|NCT01626911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440745|NCT01627041|Cytarabine|cytarabine|mesh-list
92440746|NCT01627041|Decitabine|decitabine|mesh-list
92440747|NCT01627041|Daunorubicin|daunorubicin|mesh-list
92440748|NCT01627041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92440749|NCT01627041|Antimetabolites|antimetabolites|mesh-ancestor
92440750|NCT01627041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440751|NCT01627041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440752|NCT01627041|Antiviral Agents|antiviral agents|mesh-ancestor
92440753|NCT01627041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440754|NCT01627041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92440755|NCT01627041|Immunologic Factors|immunologic factors|mesh-ancestor
92440756|NCT01627041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440757|NCT01627041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92440758|NCT01627041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92440759|NCT01627041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92440760|NCT01627041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440761|NCT01627106|Amiodarone|amiodarone|mesh-list
92440762|NCT01627106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92440763|NCT01627106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92440764|NCT01627106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92440765|NCT01627106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92440766|NCT01627106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440767|NCT01627106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92440768|NCT01627106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92440769|NCT01627106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92440770|NCT01627106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440771|NCT01627106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92440772|NCT01627106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92440773|NCT01627106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92440774|NCT01627132|Dasatinib|dasatinib|mesh-list
92440775|NCT01627132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440776|NCT01627132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92440777|NCT01627132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440778|NCT01627132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440779|NCT01627145|Solifenacin Succinate|solifenacin succinate|mesh-list
92440780|NCT01627145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92440781|NCT01627145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92440782|NCT01627145|Cholinergic Agents|cholinergic agents|mesh-ancestor
92440783|NCT01627145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440784|NCT01627145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440785|NCT01627145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440786|NCT01627145|Urological Agents|urological agents|mesh-ancestor
92440787|NCT01627158|Budesonide|budesonide|mesh-list
92440788|NCT01627158|Formoterol Fumarate|formoterol fumarate|mesh-list
92440789|NCT01627158|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92440790|NCT01627158|Charcoal|charcoal|mesh-list
92440791|NCT01627158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440792|NCT01627158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92440793|NCT01627158|Autonomic Agents|autonomic agents|mesh-ancestor
92440794|NCT01627158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440795|NCT01627158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440796|NCT01627158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92440797|NCT01627158|Respiratory System Agents|respiratory system agents|mesh-ancestor
92440798|NCT01627158|Glucocorticoids|glucocorticoids|mesh-ancestor
92440799|NCT01627158|Hormones|hormones|mesh-ancestor
92344681|NCT04299113|Mitosis Modulators|mitosis modulators|mesh-ancestor
92440800|NCT01627158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440801|NCT01627158|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92440802|NCT01627158|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92440803|NCT01627158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92440804|NCT01627158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92440805|NCT01627158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440806|NCT01627158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440807|NCT01627158|Antidotes|antidotes|mesh-ancestor
92440808|NCT01627158|Protective Agents|protective agents|mesh-ancestor
92440809|NCT01627171|Bisacodyl|bisacodyl|mesh-list
92440810|NCT01627171|Picosulfate sodium|picosulfate sodium|mesh-list
92440811|NCT01627171|Cathartics|cathartics|mesh-ancestor
92440812|NCT01627171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92440813|NCT01627171|Laxatives|laxatives|mesh-ancestor
92440814|NCT01627223|Lamivudine|lamivudine|mesh-list
92440815|NCT01627223|Entecavir|entecavir|mesh-list
92440816|NCT01627223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92440817|NCT01627223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92440818|NCT01627223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440819|NCT01627223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440820|NCT01627223|Antiviral Agents|antiviral agents|mesh-ancestor
92440821|NCT01627223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440822|NCT01627223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92440823|NCT01627223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92440824|NCT01627236|Methylprednisolone|methylprednisolone|mesh-list
92440825|NCT01627236|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92440826|NCT01627236|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92440827|NCT01627236|Prednisolone|prednisolone|mesh-list
92440828|NCT01627236|Prednisolone acetate|prednisolone acetate|mesh-list
92440829|NCT01627236|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92440830|NCT01627236|Prednisolone phosphate|prednisolone phosphate|mesh-list
92440831|NCT01627236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440832|NCT01627236|Antiemetics|antiemetics|mesh-ancestor
92440833|NCT01627236|Autonomic Agents|autonomic agents|mesh-ancestor
92440834|NCT01627236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440835|NCT01627236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440836|NCT01627236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92440837|NCT01627236|Glucocorticoids|glucocorticoids|mesh-ancestor
92440838|NCT01627236|Hormones|hormones|mesh-ancestor
92440839|NCT01627236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440840|NCT01627236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92440841|NCT01627236|Protective Agents|protective agents|mesh-ancestor
92440842|NCT01627236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92440843|NCT01627236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440844|NCT01627262|Mesalamine|mesalamine|mesh-list
92440845|NCT01627262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92440846|NCT01627262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92440847|NCT01627262|Analgesics|analgesics|mesh-ancestor
92440848|NCT01627262|Sensory System Agents|sensory system agents|mesh-ancestor
92440849|NCT01627262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440850|NCT01627262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440851|NCT01627262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440852|NCT01627262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440853|NCT01627353|Dexamethasone|dexamethasone|mesh-list
92440854|NCT01627353|Lidocaine|lidocaine|mesh-list
92440855|NCT01627353|Magnesium Sulfate|magnesium sulfate|mesh-list
92440856|NCT01627353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440857|NCT01627353|Antiemetics|antiemetics|mesh-ancestor
92440858|NCT01627353|Autonomic Agents|autonomic agents|mesh-ancestor
92440859|NCT01627353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531174|NCT02970682|Fulvestrant|fulvestrant|mesh-list
92440860|NCT01627353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440862|NCT01627353|Glucocorticoids|glucocorticoids|mesh-ancestor
92440863|NCT01627353|Hormones|hormones|mesh-ancestor
92440864|NCT01627353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440865|NCT01627353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92440866|NCT01627353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440867|NCT01627353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440868|NCT01627353|Anesthetics, Local|anesthetics, local|mesh-ancestor
92440869|NCT01627353|Anesthetics|anesthetics|mesh-ancestor
92440870|NCT01627353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440871|NCT01627353|Sensory System Agents|sensory system agents|mesh-ancestor
92440872|NCT01627353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92440873|NCT01627353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92440874|NCT01627353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92440875|NCT01627353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92440876|NCT01627353|Analgesics|analgesics|mesh-ancestor
92440877|NCT01627353|Anticonvulsants|anticonvulsants|mesh-ancestor
92440878|NCT01627353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92440879|NCT01627353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92440880|NCT01627353|Tocolytic Agents|tocolytic agents|mesh-ancestor
92440881|NCT01627353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92440882|NCT01627379|Panitumumab|panitumumab|mesh-list
92440883|NCT01627379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440884|NCT01627379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92440885|NCT01627431|Aspirin|aspirin|mesh-list
92440886|NCT01627431|Clopidogrel|clopidogrel|mesh-list
92440887|NCT01627431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92440888|NCT01627431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92440889|NCT01627431|Analgesics|analgesics|mesh-ancestor
92440890|NCT01627431|Sensory System Agents|sensory system agents|mesh-ancestor
92440891|NCT01627431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440892|NCT01627431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440893|NCT01627431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92440894|NCT01627431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92440895|NCT01627431|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92440896|NCT01627431|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92440897|NCT01627431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440898|NCT01627431|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92440899|NCT01627431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92440900|NCT01627431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440901|NCT01627431|Antipyretics|antipyretics|mesh-ancestor
92440902|NCT01627431|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92440903|NCT01627431|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92440904|NCT01627431|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92440905|NCT01627431|Purinergic Agents|purinergic agents|mesh-ancestor
92440906|NCT01627431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440907|NCT01627587|Ketoconazole|ketoconazole|mesh-list
92440908|NCT01627587|Antifungal Agents|antifungal agents|mesh-ancestor
92440909|NCT01627587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440910|NCT01627587|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92440911|NCT01627587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92440912|NCT01627587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440913|NCT01627587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440914|NCT01627587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92440915|NCT01627587|Hormone Antagonists|hormone antagonists|mesh-ancestor
92440916|NCT01627587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92440917|NCT01627587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440918|NCT01627587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92440919|NCT01627626|Pilocarpine|pilocarpine|mesh-list
92440920|NCT01627626|Miotics|miotics|mesh-ancestor
92440921|NCT01627626|Autonomic Agents|autonomic agents|mesh-ancestor
92440922|NCT01627626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440923|NCT01627626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440924|NCT01627626|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92440925|NCT01627626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92440926|NCT01627626|Cholinergic Agents|cholinergic agents|mesh-ancestor
92440927|NCT01627626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440928|NCT01627626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440929|NCT01627639|Acetazolamide|acetazolamide|mesh-list
92440930|NCT01627639|Anticonvulsants|anticonvulsants|mesh-ancestor
92440931|NCT01627639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92440932|NCT01627639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440933|NCT01627639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440934|NCT01627639|Diuretics|diuretics|mesh-ancestor
92440935|NCT01627639|Natriuretic Agents|natriuretic agents|mesh-ancestor
92440936|NCT01627639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440937|NCT01627678|Molgramostim|molgramostim|mesh-list
92440938|NCT01627678|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92440939|NCT01627678|Sargramostim|sargramostim|mesh-list
92440940|NCT01627678|Immunologic Factors|immunologic factors|mesh-ancestor
92440941|NCT01627678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440942|NCT01627678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440943|NCT01627678|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92440944|NCT01627678|Antacids|antacids|mesh-ancestor
92440945|NCT01627678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440946|NCT01627678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92440947|NCT01627717|Maraviroc|maraviroc|mesh-list
92440948|NCT01627717|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92440949|NCT01627717|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92440950|NCT01627717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440951|NCT01627717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92440952|NCT01627717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92440953|NCT01627717|Antiviral Agents|antiviral agents|mesh-ancestor
92440954|NCT01627717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92440955|NCT01627717|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92440956|NCT01627834|Ropinirole|ropinirole|mesh-list
92440957|NCT01627834|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92440958|NCT01627834|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92440959|NCT01627834|Dopamine Agonists|dopamine agonists|mesh-ancestor
92440960|NCT01627834|Dopamine Agents|dopamine agents|mesh-ancestor
92440961|NCT01627834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440962|NCT01627834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440963|NCT01627834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440964|NCT01627847|Ropinirole|ropinirole|mesh-list
92440965|NCT01627847|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92440966|NCT01627847|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92440967|NCT01627847|Dopamine Agonists|dopamine agonists|mesh-ancestor
92440968|NCT01627847|Dopamine Agents|dopamine agents|mesh-ancestor
92440969|NCT01627847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92440970|NCT01627847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92440971|NCT01627847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440972|NCT01627873|Fentanyl|fentanyl|mesh-list
92440973|NCT01627873|Remifentanil|remifentanil|mesh-list
92440974|NCT01627873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92440975|NCT01627873|Narcotics|narcotics|mesh-ancestor
92440976|NCT01627873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92440977|NCT01627873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440978|NCT01627873|Analgesics|analgesics|mesh-ancestor
92440979|NCT01627873|Sensory System Agents|sensory system agents|mesh-ancestor
92440980|NCT01627873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440981|NCT01627873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92440982|NCT01627873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92440983|NCT01627873|Anesthetics, General|anesthetics, general|mesh-ancestor
92440984|NCT01627873|Anesthetics|anesthetics|mesh-ancestor
92440985|NCT01627886|Ibandronic Acid|ibandronic acid|mesh-list
92440986|NCT01627886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92440987|NCT01627886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440988|NCT01627938|Mitoxantrone|mitoxantrone|mesh-list
92440989|NCT01627938|Dexrazoxane|dexrazoxane|mesh-list
92440990|NCT01627938|Razoxane|razoxane|mesh-list
92440991|NCT01627938|Analgesics|analgesics|mesh-ancestor
92440992|NCT01627938|Sensory System Agents|sensory system agents|mesh-ancestor
92440993|NCT01627938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92440994|NCT01627938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92440995|NCT01627938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92440996|NCT01627938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92440997|NCT01627938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92440998|NCT01627938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92440999|NCT01627938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441000|NCT01627938|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92441001|NCT01627938|Protective Agents|protective agents|mesh-ancestor
92441003|NCT01627938|Mitosis Modulators|mitosis modulators|mesh-ancestor
92441004|NCT01628055|Immunoglobulins|immunoglobulins|mesh-list
92441005|NCT01628055|Antibodies|antibodies|mesh-list
92441006|NCT01628055|gamma-Globulins|gamma-globulins|mesh-list
92441007|NCT01628055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92441008|NCT01628055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92441009|NCT01628055|Immunoglobulin G|immunoglobulin g|mesh-list
92441010|NCT01628055|Immunologic Factors|immunologic factors|mesh-ancestor
92441011|NCT01628055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441012|NCT01628341|Insulin|insulin|mesh-list
92441013|NCT01628341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441014|NCT01628341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441015|NCT01628354|Ranibizumab|ranibizumab|mesh-list
92441016|NCT01628354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92441017|NCT01628354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92441018|NCT01628354|Growth Substances|growth substances|mesh-ancestor
92441019|NCT01628354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441020|NCT01628354|Growth Inhibitors|growth inhibitors|mesh-ancestor
92441021|NCT01628354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441022|NCT01628445|Liraglutide|liraglutide|mesh-list
92441023|NCT01628445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441024|NCT01628445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441025|NCT01628445|Incretins|incretins|mesh-ancestor
92441026|NCT01628445|Hormones|hormones|mesh-ancestor
92441027|NCT01628445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92441028|NCT01628471|Decitabine|decitabine|mesh-list
92441029|NCT01628471|Genistein|genistein|mesh-list
92441030|NCT01628471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441031|NCT01628471|Antimetabolites|antimetabolites|mesh-ancestor
92441032|NCT01628471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441033|NCT01628471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441034|NCT01628471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441035|NCT01628471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92441036|NCT01628471|Protective Agents|protective agents|mesh-ancestor
92441037|NCT01628471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441038|NCT01628471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92441039|NCT01628471|Phytoestrogens|phytoestrogens|mesh-ancestor
92441040|NCT01628471|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92441041|NCT01628471|Estrogens|estrogens|mesh-ancestor
92441043|NCT01628471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92441044|NCT01628562|Remifentanil|remifentanil|mesh-list
92441045|NCT01628562|Esmolol|esmolol|mesh-list
92441046|NCT01628562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92441047|NCT01628562|Narcotics|narcotics|mesh-ancestor
92441048|NCT01628562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441049|NCT01628562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441050|NCT01628562|Analgesics|analgesics|mesh-ancestor
92441051|NCT01628562|Sensory System Agents|sensory system agents|mesh-ancestor
92441052|NCT01628562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441053|NCT01628562|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92441054|NCT01628562|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92441055|NCT01628562|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92441056|NCT01628562|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441057|NCT01628562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441058|NCT01628562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441059|NCT01628666|Vancomycin|vancomycin|mesh-list
92441060|NCT01628666|Cefazolin|cefazolin|mesh-list
92441061|NCT01628666|Cephalexin|cephalexin|mesh-list
92441062|NCT01628666|Bacitracin|bacitracin|mesh-list
92441063|NCT01628666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92441064|NCT01628666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441065|NCT01628666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92441066|NCT01628731|Furosemide|furosemide|mesh-list
92441067|NCT01628731|Ethacrynic Acid|ethacrynic acid|mesh-list
92441068|NCT01628731|Diuretics|diuretics|mesh-ancestor
92441069|NCT01628731|Natriuretic Agents|natriuretic agents|mesh-ancestor
92441070|NCT01628731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441071|NCT01628731|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92441072|NCT01628731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441073|NCT01628731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441074|NCT01628731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441075|NCT01628770|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92441076|NCT01628770|Hematinics|hematinics|mesh-ancestor
92441077|NCT01628783|Escitalopram|escitalopram|mesh-list
92405275|NCT01435707|Triamcinolone|triamcinolone|mesh-list
92441078|NCT01628783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92441079|NCT01628783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92441080|NCT01628783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441081|NCT01628783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441082|NCT01628783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441083|NCT01628783|Serotonin Agents|serotonin agents|mesh-ancestor
92441084|NCT01628783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441086|NCT01628952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92441087|NCT01628952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92441088|NCT01628952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92441089|NCT01628952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441090|NCT01628952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441091|NCT01628952|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92441092|NCT01628952|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92441093|NCT01628952|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441094|NCT01628952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441095|NCT01628952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441096|NCT01629082|Lenalidomide|lenalidomide|mesh-list
92441097|NCT01629082|Clofarabine|clofarabine|mesh-list
92441098|NCT01629082|Immunologic Factors|immunologic factors|mesh-ancestor
92441099|NCT01629082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441100|NCT01629082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92441101|NCT01629082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92441102|NCT01629082|Growth Substances|growth substances|mesh-ancestor
92441103|NCT01629082|Growth Inhibitors|growth inhibitors|mesh-ancestor
92441104|NCT01629082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441105|NCT01629082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441106|NCT01629082|Antimetabolites|antimetabolites|mesh-ancestor
92441107|NCT01629082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441108|NCT01629173|Ethylene|ethylene|mesh-list
92441109|NCT01629173|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92441110|NCT01629173|Growth Substances|growth substances|mesh-ancestor
92441111|NCT01629173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441112|NCT01629199|Mitogens|mitogens|mesh-list
92441113|NCT01629199|Mitosis Modulators|mitosis modulators|mesh-ancestor
92441114|NCT01629199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441115|NCT01629212|Octylonium|octylonium|mesh-list
92441116|NCT01629212|Bromides|bromides|mesh-list
92441117|NCT01629212|Tiropramide|tiropramide|mesh-list
92441118|NCT01629212|Anticonvulsants|anticonvulsants|mesh-ancestor
92441119|NCT01629212|Parasympatholytics|parasympatholytics|mesh-ancestor
92441120|NCT01629212|Autonomic Agents|autonomic agents|mesh-ancestor
92441121|NCT01629212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441122|NCT01629212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441123|NCT01629212|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441124|NCT01629212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441125|NCT01629212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441126|NCT01629212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441127|NCT01629212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92441128|NCT01629212|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92441129|NCT01629212|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92441130|NCT01629212|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441131|NCT01629212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441132|NCT01629225|Candesartan|candesartan|mesh-list
92441133|NCT01629225|Candesartan cilexetil|candesartan cilexetil|mesh-list
92441134|NCT01629225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441135|NCT01629225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92441136|NCT01629225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92441137|NCT01629225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441138|NCT01629251|Insulin|insulin|mesh-list
92441139|NCT01629251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441140|NCT01629251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441141|NCT01629277|Insulin|insulin|mesh-list
92441142|NCT01629277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441143|NCT01629277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441144|NCT01629368|Carbamazepine|carbamazepine|mesh-list
92441145|NCT01629368|Anticonvulsants|anticonvulsants|mesh-ancestor
92441146|NCT01629368|Antimanic Agents|antimanic agents|mesh-ancestor
92441147|NCT01629368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92441148|NCT01629368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441149|NCT01629368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441150|NCT01629368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92441151|NCT01629368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441152|NCT01629368|Analgesics|analgesics|mesh-ancestor
92441153|NCT01629368|Sensory System Agents|sensory system agents|mesh-ancestor
92441154|NCT01629368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441155|NCT01629368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92441156|NCT01629368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441157|NCT01629368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441158|NCT01629368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92441159|NCT01629368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92441160|NCT01629394|Neostigmine|neostigmine|mesh-list
92441161|NCT01629394|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92441162|NCT01629394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441163|NCT01629394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441164|NCT01629394|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441165|NCT01629394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441166|NCT01629394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441167|NCT01629394|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92441168|NCT01629394|Autonomic Agents|autonomic agents|mesh-ancestor
92441169|NCT01629394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441170|NCT01629446|Lofexidine|lofexidine|mesh-list
92441171|NCT01629446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441172|NCT01629446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92441173|NCT01629446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441174|NCT01629446|Sensory System Agents|sensory system agents|mesh-ancestor
92441175|NCT01629446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441176|NCT01629446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92441177|NCT01629446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92441178|NCT01629446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92441179|NCT01629446|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441180|NCT01629446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441181|NCT01629446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441182|NCT01629511|Gemcitabine|gemcitabine|mesh-list
92441183|NCT01629511|Methotrexate|methotrexate|mesh-list
92441184|NCT01629511|Clofarabine|clofarabine|mesh-list
92441185|NCT01629511|Busulfan|busulfan|mesh-list
92441186|NCT01629511|Tacrolimus|tacrolimus|mesh-list
92441187|NCT01629511|Thymoglobulin|thymoglobulin|mesh-list
92441188|NCT01629511|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92441189|NCT01629511|Lenograstim|lenograstim|mesh-list
92441190|NCT01629511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441191|NCT01629511|Antimetabolites|antimetabolites|mesh-ancestor
92441192|NCT01629511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441193|NCT01629511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441194|NCT01629511|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92441195|NCT01629511|Abortifacient Agents|abortifacient agents|mesh-ancestor
92441196|NCT01629511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92441197|NCT01629511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441198|NCT01629511|Dermatologic Agents|dermatologic agents|mesh-ancestor
92441199|NCT01629511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441200|NCT01629511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92441201|NCT01629511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92441202|NCT01629511|Immunologic Factors|immunologic factors|mesh-ancestor
92441203|NCT01629511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441204|NCT01629511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92441205|NCT01629511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92441206|NCT01629511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92441207|NCT01629511|Alkylating Agents|alkylating agents|mesh-ancestor
92441208|NCT01629511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92441209|NCT01629511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92441210|NCT01629628|Adalimumab|adalimumab|mesh-list
92441211|NCT01629628|Mercaptopurine|mercaptopurine|mesh-list
92441212|NCT01629628|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92441213|NCT01629628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92441214|NCT01629628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441215|NCT01629628|Antimetabolites|antimetabolites|mesh-ancestor
92441216|NCT01629628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441217|NCT01629628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441218|NCT01629628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441219|NCT01629628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92441220|NCT01629628|Immunologic Factors|immunologic factors|mesh-ancestor
92441221|NCT01629628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441222|NCT01629628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92441223|NCT01629628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441224|NCT01629680|Moxaverine|moxaverine|mesh-list
92441225|NCT01629680|Parasympatholytics|parasympatholytics|mesh-ancestor
92441226|NCT01629680|Autonomic Agents|autonomic agents|mesh-ancestor
92441227|NCT01629680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441228|NCT01629680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441229|NCT01629732|Ribavirin|ribavirin|mesh-list
92441230|NCT01629732|Antimetabolites|antimetabolites|mesh-ancestor
92441231|NCT01629732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441232|NCT01629732|Antiviral Agents|antiviral agents|mesh-ancestor
92441233|NCT01629732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441234|NCT01629758|Nivolumab|nivolumab|mesh-list
92441235|NCT01629758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92441236|NCT01629758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441237|NCT01629758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92441238|NCT01629758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441239|NCT01629875|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92441240|NCT01629875|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92441241|NCT01629875|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92441242|NCT01629875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441243|NCT01629875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441244|NCT01629875|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92441245|NCT01629875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441246|NCT01629875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441247|NCT01629875|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441248|NCT01629875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441249|NCT01630018|Topotecan|topotecan|mesh-list
92441250|NCT01630018|Belotecan|belotecan|mesh-list
92441251|NCT01630018|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92441252|NCT01630018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92441253|NCT01630018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441254|NCT01630018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441255|NCT01630018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441256|NCT01630057|Zonisamide|zonisamide|mesh-list
92441257|NCT01630057|Anticonvulsants|anticonvulsants|mesh-ancestor
92441258|NCT01630057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441259|NCT01630057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441260|NCT01630057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441261|NCT01630057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441262|NCT01630057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441263|NCT01630070|Paclitaxel|paclitaxel|mesh-list
92441264|NCT01630070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92441265|NCT01630070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441266|NCT01630070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92441267|NCT01630070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92441268|NCT01630070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92441269|NCT01630070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441270|NCT01630083|Capecitabine|capecitabine|mesh-list
92441271|NCT01630083|Oxaliplatin|oxaliplatin|mesh-list
92441272|NCT01630083|Epirubicin|epirubicin|mesh-list
92441273|NCT01630083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441274|NCT01630083|Antimetabolites|antimetabolites|mesh-ancestor
92441275|NCT01630083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441276|NCT01630083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441277|NCT01630083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92441278|NCT01630083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92441279|NCT01630083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92441280|NCT01630083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344896|NCT03695380|Atezolizumab|atezolizumab|mesh-list
92441281|NCT01630096|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92441282|NCT01630096|Laxatives|laxatives|mesh-ancestor
92441283|NCT01630096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92441284|NCT01630148|Bemiparin|bemiparin|mesh-list
92441285|NCT01630148|Anticoagulants|anticoagulants|mesh-ancestor
92441286|NCT01630187|Carbetocin|carbetocin|mesh-list
92441287|NCT01630187|Oxytocin|oxytocin|mesh-list
92441288|NCT01630187|Oxytocics|oxytocics|mesh-ancestor
92441289|NCT01630187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92441290|NCT01630187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441291|NCT01630226|Cisplatin|cisplatin|mesh-list
92441292|NCT01630226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441293|NCT01630278|Ibuprofen|ibuprofen|mesh-list
92441294|NCT01630278|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92441295|NCT01630278|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441296|NCT01630278|Analgesics|analgesics|mesh-ancestor
92441297|NCT01630278|Sensory System Agents|sensory system agents|mesh-ancestor
92441298|NCT01630278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441299|NCT01630278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441300|NCT01630278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92441301|NCT01630278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441302|NCT01630278|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92441303|NCT01630278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441304|NCT01630278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441305|NCT01630343|Acetaminophen|acetaminophen|mesh-list
92441306|NCT01630343|Tramadol|tramadol|mesh-list
92441307|NCT01630343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441308|NCT01630343|Analgesics|analgesics|mesh-ancestor
92441309|NCT01630343|Sensory System Agents|sensory system agents|mesh-ancestor
92441310|NCT01630343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441311|NCT01630343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441312|NCT01630343|Antipyretics|antipyretics|mesh-ancestor
92441313|NCT01630343|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92441314|NCT01630343|Narcotics|narcotics|mesh-ancestor
92441315|NCT01630343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441316|NCT01630369|Insulin|insulin|mesh-list
92441317|NCT01630369|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92441318|NCT01630369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441319|NCT01630369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441320|NCT01630538|Cyclophosphamide|cyclophosphamide|mesh-list
92441321|NCT01630538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92441322|NCT01630538|Immunologic Factors|immunologic factors|mesh-ancestor
92441323|NCT01630538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441324|NCT01630538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441325|NCT01630538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92441326|NCT01630538|Alkylating Agents|alkylating agents|mesh-ancestor
92441327|NCT01630538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441328|NCT01630538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344921|NCT03597594|Fludarabine|fludarabine|mesh-list
92441329|NCT01630538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92441330|NCT01630564|Aldesleukin|aldesleukin|mesh-list
92441331|NCT01630564|Interleukin-2|interleukin-2|mesh-list
92441332|NCT01630564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441333|NCT01630564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441335|NCT01630564|Sensory System Agents|sensory system agents|mesh-ancestor
92441336|NCT01630564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441337|NCT01630564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441338|NCT01630564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92441339|NCT01630564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92441340|NCT01630564|Antiviral Agents|antiviral agents|mesh-ancestor
92441341|NCT01630564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441342|NCT01630642|Clopidogrel|clopidogrel|mesh-list
92441343|NCT01630642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92441344|NCT01630642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92441345|NCT01630642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92441346|NCT01630642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92441347|NCT01630642|Purinergic Agents|purinergic agents|mesh-ancestor
92441348|NCT01630642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441349|NCT01630642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441350|NCT01630642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441351|NCT01630655|Felodipine|felodipine|mesh-list
92441352|NCT01630655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92441353|NCT01630655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441354|NCT01630655|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441355|NCT01630655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441356|NCT01630655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441357|NCT01630655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441358|NCT01630655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441359|NCT01630655|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441360|NCT01630720|Vitamin D|vitamin d|mesh-list
92441361|NCT01630720|Vitamins|vitamins|mesh-list
92441362|NCT01630720|Micronutrients|micronutrients|mesh-ancestor
92441363|NCT01630720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441364|NCT01630720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441365|NCT01630733|Docetaxel|docetaxel|mesh-list
92441366|NCT01630733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441367|NCT01630733|Tubulin Modulators|tubulin modulators|mesh-ancestor
92441368|NCT01630733|Antimitotic Agents|antimitotic agents|mesh-ancestor
92441369|NCT01630733|Mitosis Modulators|mitosis modulators|mesh-ancestor
92441370|NCT01630733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441371|NCT01630902|Felodipine|felodipine|mesh-list
92441372|NCT01630902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92441373|NCT01630902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441374|NCT01630902|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441375|NCT01630902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441376|NCT01630902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441377|NCT01630902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441378|NCT01630902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441379|NCT01630902|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441380|NCT01630915|Clopidogrel|clopidogrel|mesh-list
92441381|NCT01630915|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92441382|NCT01630915|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92441383|NCT01630915|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92441384|NCT01630915|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92441385|NCT01630915|Purinergic Agents|purinergic agents|mesh-ancestor
92441386|NCT01630915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344945|NCT03563690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441387|NCT01630915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441388|NCT01630915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441389|NCT01630941|Denosumab|denosumab|mesh-list
92441390|NCT01630941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441391|NCT01630941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441392|NCT01631058|Prednisone|prednisone|mesh-list
92441393|NCT01631058|Everolimus|everolimus|mesh-list
92441394|NCT01631058|Lactitol|lactitol|mesh-list
92441395|NCT01631058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92441396|NCT01631058|Glucocorticoids|glucocorticoids|mesh-ancestor
92441397|NCT01631058|Hormones|hormones|mesh-ancestor
92441398|NCT01631058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92441399|NCT01631058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441400|NCT01631058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92441401|NCT01631058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441402|NCT01631058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92441403|NCT01631058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92441404|NCT01631058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441405|NCT01631058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441406|NCT01631058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92441408|NCT01631058|Cathartics|cathartics|mesh-ancestor
92441409|NCT01631058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92441410|NCT01631097|Tivozanib|tivozanib|mesh-list
92441411|NCT01631097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92441412|NCT01631097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441413|NCT01631097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441414|NCT01631136|Cisplatin|cisplatin|mesh-list
92441415|NCT01631136|Gemcitabine|gemcitabine|mesh-list
92441416|NCT01631136|Pemetrexed|pemetrexed|mesh-list
92441417|NCT01631136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441418|NCT01631136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441419|NCT01631136|Antimetabolites|antimetabolites|mesh-ancestor
92441420|NCT01631136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441421|NCT01631136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441422|NCT01631136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92441423|NCT01631136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92441424|NCT01631201|Azithromycin|azithromycin|mesh-list
92441425|NCT01631201|KRM 1648|krm 1648|mesh-list
92441426|NCT01631201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92441427|NCT01631201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441428|NCT01631201|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92441429|NCT01631201|Antitubercular Agents|antitubercular agents|mesh-ancestor
92441430|NCT01631201|Leprostatic Agents|leprostatic agents|mesh-ancestor
92441431|NCT01631305|Magnesium Oxide|magnesium oxide|mesh-list
92441432|NCT01631305|Calcium|calcium|mesh-list
92441433|NCT01631305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441434|NCT01631305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441435|NCT01631305|Antacids|antacids|mesh-ancestor
92441436|NCT01631305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441437|NCT01631305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92441438|NCT01631357|Cisplatin|cisplatin|mesh-list
92441439|NCT01631357|Gemcitabine|gemcitabine|mesh-list
92441440|NCT01631357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344962|NCT03509012|Pemetrexed|pemetrexed|mesh-list
92441441|NCT01631357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441442|NCT01631357|Antimetabolites|antimetabolites|mesh-ancestor
92441443|NCT01631357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441444|NCT01631383|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
92441445|NCT01631383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92441446|NCT01631383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441447|NCT01631383|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441448|NCT01631383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441449|NCT01631383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441450|NCT01631383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441451|NCT01631383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441452|NCT01631383|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92441453|NCT01631383|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92441454|NCT01631383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441455|NCT01631383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92441456|NCT01631383|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92441457|NCT01631383|Dopamine Agents|dopamine agents|mesh-ancestor
92441458|NCT01631383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441459|NCT01631383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441460|NCT01631383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441461|NCT01631383|Analgesics|analgesics|mesh-ancestor
92441462|NCT01631383|Sensory System Agents|sensory system agents|mesh-ancestor
92441463|NCT01631383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441464|NCT01631396|Neostigmine|neostigmine|mesh-list
92441465|NCT01631396|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92441466|NCT01631396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441467|NCT01631396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441468|NCT01631396|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441469|NCT01631396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441470|NCT01631396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441471|NCT01631396|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92441472|NCT01631396|Autonomic Agents|autonomic agents|mesh-ancestor
92441473|NCT01631396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441475|NCT01631409|Atenolol|atenolol|mesh-list
92441476|NCT01631409|Enalapril|enalapril|mesh-list
92441477|NCT01631409|Enalaprilat|enalaprilat|mesh-list
92441478|NCT01631409|Amlodipine|amlodipine|mesh-list
92441479|NCT01631409|Isosorbide|isosorbide|mesh-list
92441480|NCT01631409|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92441481|NCT01631409|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92441482|NCT01631409|Nitroglycerin|nitroglycerin|mesh-list
92441483|NCT01631409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92441484|NCT01631409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441485|NCT01631409|Analgesics|analgesics|mesh-ancestor
92441486|NCT01631409|Sensory System Agents|sensory system agents|mesh-ancestor
92441487|NCT01631409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441488|NCT01631409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441489|NCT01631409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92441490|NCT01631409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441491|NCT01631409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92441492|NCT01631409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92441493|NCT01631409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441494|NCT01631409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92441495|NCT01631409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92441496|NCT01631409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441497|NCT01631409|Antipyretics|antipyretics|mesh-ancestor
92441498|NCT01631409|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92441499|NCT01631409|Protease Inhibitors|protease inhibitors|mesh-ancestor
92441500|NCT01631409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441501|NCT01631409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92441502|NCT01631409|Sympatholytics|sympatholytics|mesh-ancestor
92441503|NCT01631409|Autonomic Agents|autonomic agents|mesh-ancestor
92441504|NCT01631409|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92441505|NCT01631409|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92441506|NCT01631409|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92441507|NCT01631409|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441508|NCT01631409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441509|NCT01631409|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441510|NCT01631409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441511|NCT01631409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441512|NCT01631409|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441513|NCT01631409|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92441514|NCT01631409|Diuretics|diuretics|mesh-ancestor
92441515|NCT01631409|Natriuretic Agents|natriuretic agents|mesh-ancestor
92441516|NCT01631409|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92441517|NCT01631448|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92441518|NCT01631448|Hemostatics|hemostatics|mesh-ancestor
92441519|NCT01631448|Coagulants|coagulants|mesh-ancestor
92441520|NCT01631513|Tapentadol|tapentadol|mesh-list
92441521|NCT01631513|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92441522|NCT01631513|Narcotics|narcotics|mesh-ancestor
92441523|NCT01631513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441524|NCT01631513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441525|NCT01631513|Analgesics|analgesics|mesh-ancestor
92441526|NCT01631513|Sensory System Agents|sensory system agents|mesh-ancestor
92441527|NCT01631513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441528|NCT01631513|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92441529|NCT01631513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92441530|NCT01631513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441531|NCT01631513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441532|NCT01631513|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441533|NCT01631513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441535|NCT01631526|Vitamins|vitamins|mesh-ancestor
92441536|NCT01631526|Micronutrients|micronutrients|mesh-ancestor
92441537|NCT01631526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441538|NCT01631526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441539|NCT01631539|Irinotecan|irinotecan|mesh-list
92441540|NCT01631539|Cetuximab|cetuximab|mesh-list
92441541|NCT01631539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92441542|NCT01631539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92441543|NCT01631539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441544|NCT01631539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441545|NCT01631539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441546|NCT01631539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92441547|NCT01631604|Botulinum Toxins|botulinum toxins|mesh-list
92441548|NCT01631604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92441549|NCT01631604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441550|NCT01631604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441551|NCT01631604|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441552|NCT01631604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441553|NCT01631604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441554|NCT01631669|Celecoxib|celecoxib|mesh-list
92166370|NCT01457911|Metformin|metformin|mesh-list
92441555|NCT01631669|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92441556|NCT01631669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441557|NCT01631669|Analgesics|analgesics|mesh-ancestor
92441558|NCT01631669|Sensory System Agents|sensory system agents|mesh-ancestor
92441559|NCT01631669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441560|NCT01631669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441561|NCT01631669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92441562|NCT01631669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441563|NCT01631669|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92441564|NCT01631669|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92441565|NCT01631669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441566|NCT01631669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441567|NCT01631838|Tocotrienols|tocotrienols|mesh-list
92441568|NCT01631838|Vitamin E|vitamin e|mesh-list
92441569|NCT01631838|Tocopherols|tocopherols|mesh-list
92441570|NCT01631838|Tocovid|tocovid|mesh-list
92441571|NCT01631838|Antioxidants|antioxidants|mesh-ancestor
92441572|NCT01631838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441573|NCT01631838|Protective Agents|protective agents|mesh-ancestor
92441574|NCT01631838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441575|NCT01631838|Vitamins|vitamins|mesh-ancestor
92441576|NCT01631838|Micronutrients|micronutrients|mesh-ancestor
92441577|NCT01631877|Enoxaparin|enoxaparin|mesh-list
92441578|NCT01631877|Acenocoumarol|acenocoumarol|mesh-list
92441579|NCT01631877|Anticoagulants|anticoagulants|mesh-ancestor
92441580|NCT01631877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92441581|NCT01631877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92441582|NCT01631877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441583|NCT01631968|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92441584|NCT01631968|Colistin|colistin|mesh-list
92441585|NCT01631968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441586|NCT01631994|Metoclopramide|metoclopramide|mesh-list
92441587|NCT01631994|Antiemetics|antiemetics|mesh-ancestor
92441588|NCT01631994|Autonomic Agents|autonomic agents|mesh-ancestor
92441589|NCT01631994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441590|NCT01631994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441591|NCT01631994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92441592|NCT01631994|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92441593|NCT01631994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92441594|NCT01631994|Dopamine Agents|dopamine agents|mesh-ancestor
92441595|NCT01631994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441596|NCT01631994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441598|NCT01632007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441599|NCT01632007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441600|NCT01632007|Incretins|incretins|mesh-ancestor
92441601|NCT01632007|Hormones|hormones|mesh-ancestor
92441602|NCT01632007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92441603|NCT01632007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92441604|NCT01632007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92441605|NCT01632007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441606|NCT01632007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441607|NCT01632046|Dialysis Solutions|dialysis solutions|mesh-list
92441608|NCT01632046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92441609|NCT01632163|Lixisenatide|lixisenatide|mesh-list
92441610|NCT01632163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92441611|NCT01632163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441612|NCT01632189|Varenicline|varenicline|mesh-list
92441613|NCT01632189|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92441614|NCT01632189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92441615|NCT01632189|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441616|NCT01632189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441617|NCT01632189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441618|NCT01632189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441619|NCT01632371|Paclitaxel|paclitaxel|mesh-list
92441620|NCT01632371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92441621|NCT01632371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92441622|NCT01632371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441623|NCT01632371|Tubulin Modulators|tubulin modulators|mesh-ancestor
92441624|NCT01632371|Antimitotic Agents|antimitotic agents|mesh-ancestor
92441625|NCT01632371|Mitosis Modulators|mitosis modulators|mesh-ancestor
92441626|NCT01632371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441627|NCT01632436|Pixantrone|pixantrone|mesh-list
92441628|NCT01632436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92441629|NCT01632436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92441630|NCT01632436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441631|NCT01632436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441632|NCT01632436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441633|NCT01632514|Cholecalciferol|cholecalciferol|mesh-list
92441634|NCT01632514|Vitamin D|vitamin d|mesh-list
92441635|NCT01632514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441636|NCT01632514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441637|NCT01632514|Vitamins|vitamins|mesh-ancestor
92441638|NCT01632514|Micronutrients|micronutrients|mesh-ancestor
92441639|NCT01632514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441640|NCT01632540|Beclomethasone|beclomethasone|mesh-list
92441641|NCT01632540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92441642|NCT01632540|Glucocorticoids|glucocorticoids|mesh-ancestor
92441643|NCT01632540|Hormones|hormones|mesh-ancestor
92441644|NCT01632540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92441645|NCT01632540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441646|NCT01632540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92441647|NCT01632540|Respiratory System Agents|respiratory system agents|mesh-ancestor
92441648|NCT01632592|Tesamorelin|tesamorelin|mesh-list
92441649|NCT01632592|Growth Substances|growth substances|mesh-ancestor
92441650|NCT01632592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441651|NCT01632605|Sirolimus|sirolimus|mesh-list
92441652|NCT01632605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92441653|NCT01632605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441654|NCT01632605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92441655|NCT01632605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441656|NCT01632605|Antifungal Agents|antifungal agents|mesh-ancestor
92441657|NCT01632605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92441658|NCT01632605|Immunologic Factors|immunologic factors|mesh-ancestor
92441659|NCT01632605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441660|NCT01632722|Bevacizumab|bevacizumab|mesh-list
92441661|NCT01632722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92441662|NCT01632722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441663|NCT01632722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92441664|NCT01632722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92441665|NCT01632722|Growth Substances|growth substances|mesh-ancestor
92441666|NCT01632722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441667|NCT01632722|Growth Inhibitors|growth inhibitors|mesh-ancestor
92441668|NCT01632761|Vitamin D|vitamin d|mesh-list
92441669|NCT01632761|Ergocalciferols|ergocalciferols|mesh-list
92441670|NCT01632761|Cholecalciferol|cholecalciferol|mesh-list
92441671|NCT01632761|Vitamins|vitamins|mesh-list
92441672|NCT01632761|Micronutrients|micronutrients|mesh-ancestor
92441673|NCT01632761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441674|NCT01632761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441675|NCT01632761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441676|NCT01632826|Pomalidomide|pomalidomide|mesh-list
92441677|NCT01632826|Immunologic Factors|immunologic factors|mesh-ancestor
92441678|NCT01632826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441679|NCT01632826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92441680|NCT01632826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92441681|NCT01632826|Growth Substances|growth substances|mesh-ancestor
92441682|NCT01632826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92441683|NCT01632826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441685|NCT01633086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92441686|NCT01633086|Autonomic Agents|autonomic agents|mesh-ancestor
92441687|NCT01633086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441688|NCT01633086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441689|NCT01633086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92441690|NCT01633086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92441691|NCT01633086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92441692|NCT01633086|Antioxidants|antioxidants|mesh-ancestor
92441693|NCT01633086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441694|NCT01633086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441695|NCT01633086|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92441696|NCT01633086|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441697|NCT01633086|Gasotransmitters|gasotransmitters|mesh-ancestor
92441698|NCT01633086|Protective Agents|protective agents|mesh-ancestor
92441699|NCT01633099|Decitabine|decitabine|mesh-list
92441700|NCT01633099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441701|NCT01633099|Antimetabolites|antimetabolites|mesh-ancestor
92441702|NCT01633099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441703|NCT01633099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166519|NCT04942002|Hormones|hormones|mesh-ancestor
92441704|NCT01633099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441705|NCT01633203|Capecitabine|capecitabine|mesh-list
92441706|NCT01633203|Epirubicin|epirubicin|mesh-list
92441707|NCT01633203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441708|NCT01633203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441709|NCT01633203|Antimetabolites|antimetabolites|mesh-ancestor
92441710|NCT01633203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441711|NCT01633203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92441712|NCT01633203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92441713|NCT01633203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92441714|NCT01633203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441715|NCT01633294|Gentamicins|gentamicins|mesh-list
92441716|NCT01633294|Ampicillin|ampicillin|mesh-list
92441717|NCT01633294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92441718|NCT01633294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441719|NCT01633294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92441720|NCT01633294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441721|NCT01633294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441722|NCT01633359|Atorvastatin|atorvastatin|mesh-list
92441723|NCT01633359|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92441724|NCT01633359|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92441725|NCT01633359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92441726|NCT01633359|Antimetabolites|antimetabolites|mesh-ancestor
92441727|NCT01633359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441728|NCT01633359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92441729|NCT01633359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441730|NCT01633450|Zinc|zinc|mesh-list
92441731|NCT01633450|Trace Elements|trace elements|mesh-ancestor
92441732|NCT01633450|Micronutrients|micronutrients|mesh-ancestor
92441733|NCT01633450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441734|NCT01633476|Valacyclovir|valacyclovir|mesh-list
92441735|NCT01633476|Antiviral Agents|antiviral agents|mesh-ancestor
92441736|NCT01633476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441737|NCT01633593|Donepezil|donepezil|mesh-list
92441738|NCT01633593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92441739|NCT01633593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531192|NCT00045448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92441740|NCT01633593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441741|NCT01633593|Cholinergic Agents|cholinergic agents|mesh-ancestor
92441742|NCT01633593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441743|NCT01633593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441744|NCT01633593|Nootropic Agents|nootropic agents|mesh-ancestor
92441745|NCT01633645|Gemcitabine|gemcitabine|mesh-list
92441746|NCT01633645|Bortezomib|bortezomib|mesh-list
92441747|NCT01633645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441748|NCT01633645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441749|NCT01633645|Antimetabolites|antimetabolites|mesh-ancestor
92441750|NCT01633645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441751|NCT01633658|Cholecalciferol|cholecalciferol|mesh-list
92441752|NCT01633658|Vitamin D|vitamin d|mesh-list
92441753|NCT01633658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441754|NCT01633658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441755|NCT01633658|Vitamins|vitamins|mesh-ancestor
92441756|NCT01633658|Micronutrients|micronutrients|mesh-ancestor
92441757|NCT01633658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441759|NCT01633749|Immunologic Factors|immunologic factors|mesh-ancestor
92441760|NCT01633749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441761|NCT01633762|Vancomycin|vancomycin|mesh-list
92441762|NCT01633762|Gentamicins|gentamicins|mesh-list
92441763|NCT01633762|Meropenem|meropenem|mesh-list
92441764|NCT01633762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92441765|NCT01633762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441766|NCT01633762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92441767|NCT01633762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441768|NCT01633762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441769|NCT01633957|Warfarin|warfarin|mesh-list
92441770|NCT01633957|Anticoagulants|anticoagulants|mesh-ancestor
92441771|NCT01633970|Leucovorin|leucovorin|mesh-list
92441772|NCT01633970|Paclitaxel|paclitaxel|mesh-list
92441773|NCT01633970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92441774|NCT01633970|Bevacizumab|bevacizumab|mesh-list
92441775|NCT01633970|Carboplatin|carboplatin|mesh-list
92441776|NCT01633970|Oxaliplatin|oxaliplatin|mesh-list
92441777|NCT01633970|Pemetrexed|pemetrexed|mesh-list
92441778|NCT01633970|Atezolizumab|atezolizumab|mesh-list
92441779|NCT01633970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92441780|NCT01633970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166592|NCT01459315|Dolutegravir|dolutegravir|mesh-list
92441781|NCT01633970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92441782|NCT01633970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92441783|NCT01633970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92441784|NCT01633970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345081|NCT02246920|Fluticasone|fluticasone|mesh-list
92441785|NCT01633970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92441786|NCT01633970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92441787|NCT01633970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92441788|NCT01633970|Growth Substances|growth substances|mesh-ancestor
92441789|NCT01633970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441790|NCT01633970|Growth Inhibitors|growth inhibitors|mesh-ancestor
92441791|NCT01633970|Antidotes|antidotes|mesh-ancestor
92441792|NCT01633970|Protective Agents|protective agents|mesh-ancestor
92441793|NCT01633970|Vitamin B Complex|vitamin b complex|mesh-ancestor
92441794|NCT01633970|Vitamins|vitamins|mesh-ancestor
92441795|NCT01633970|Micronutrients|micronutrients|mesh-ancestor
92441796|NCT01633970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441797|NCT01633970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92441798|NCT01633970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92441799|NCT01633970|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92441800|NCT01633983|Methotrexate|methotrexate|mesh-list
92441801|NCT01633983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92441802|NCT01633983|Abortifacient Agents|abortifacient agents|mesh-ancestor
92441803|NCT01633983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92441804|NCT01633983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441805|NCT01633983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441806|NCT01633983|Antimetabolites|antimetabolites|mesh-ancestor
92441807|NCT01633983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441808|NCT01633983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441809|NCT01633983|Dermatologic Agents|dermatologic agents|mesh-ancestor
92441810|NCT01633983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441811|NCT01633983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92441812|NCT01633983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92441813|NCT01633983|Immunologic Factors|immunologic factors|mesh-ancestor
92441814|NCT01633983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531193|NCT00045448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92441815|NCT01633983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92441817|NCT01634061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441818|NCT01634230|Phenylacetic acid|phenylacetic acid|mesh-list
92441819|NCT01634230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441820|NCT01634230|Antimetabolites|antimetabolites|mesh-ancestor
92441821|NCT01634230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441822|NCT01634230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441823|NCT01634295|Niacin|niacin|mesh-list
92441824|NCT01634295|Amlodipine|amlodipine|mesh-list
92441825|NCT01634295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441826|NCT01634295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441827|NCT01634295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441828|NCT01634295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441829|NCT01634295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441830|NCT01634295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441831|NCT01634295|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441832|NCT01634295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92441833|NCT01634295|Antimetabolites|antimetabolites|mesh-ancestor
92441834|NCT01634295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92441835|NCT01634295|Vitamin B Complex|vitamin b complex|mesh-ancestor
92441836|NCT01634295|Vitamins|vitamins|mesh-ancestor
92441837|NCT01634295|Micronutrients|micronutrients|mesh-ancestor
92441838|NCT01634321|Leuprolide|leuprolide|mesh-list
92441839|NCT01634321|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92441840|NCT01634321|Fertility Agents|fertility agents|mesh-ancestor
92441841|NCT01634321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92441842|NCT01634321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441843|NCT01634321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92441844|NCT01634321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441845|NCT01634347|Propranolol|propranolol|mesh-list
92441846|NCT01634347|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92441847|NCT01634347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92441848|NCT01634347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441849|NCT01634347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441850|NCT01634347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441851|NCT01634347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441852|NCT01634347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92441853|NCT01634347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441854|NCT01634347|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441855|NCT01634373|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92441856|NCT01634373|Antidepressive Agents|antidepressive agents|mesh-ancestor
92166662|NCT04948164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441857|NCT01634373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92441858|NCT01634373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92441859|NCT01634373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92441860|NCT01634373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441861|NCT01634373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441862|NCT01634386|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92441863|NCT01634386|Antidepressive Agents|antidepressive agents|mesh-ancestor
92441864|NCT01634386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92441865|NCT01634386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92441866|NCT01634386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92441867|NCT01634386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441868|NCT01634386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441869|NCT01634399|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92441870|NCT01634399|Antidepressive Agents|antidepressive agents|mesh-ancestor
92441871|NCT01634399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92441872|NCT01634399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92441873|NCT01634399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92441874|NCT01634399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441875|NCT01634399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441876|NCT01634412|Amitriptyline|amitriptyline|mesh-list
92441877|NCT01634412|Cyclobenzaprine|cyclobenzaprine|mesh-list
92441878|NCT01634412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92441879|NCT01634412|Antidepressive Agents|antidepressive agents|mesh-ancestor
92441880|NCT01634412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92441881|NCT01634412|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92441882|NCT01634412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441883|NCT01634412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92441884|NCT01634412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441885|NCT01634412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92441886|NCT01634412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441887|NCT01634412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441888|NCT01634412|Analgesics|analgesics|mesh-ancestor
92441889|NCT01634412|Sensory System Agents|sensory system agents|mesh-ancestor
92441890|NCT01634412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92441891|NCT01634412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92441892|NCT01634412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441893|NCT01634412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441894|NCT01634412|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441895|NCT01634412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441896|NCT01634438|Heparin|heparin|mesh-list
92441897|NCT01634438|Calcium heparin|calcium heparin|mesh-list
92441898|NCT01634438|Anticoagulants|anticoagulants|mesh-ancestor
92441899|NCT01634438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92441900|NCT01634438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92441901|NCT01634438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441902|NCT01634594|Nicardipine|nicardipine|mesh-list
92441903|NCT01634594|Dexmedetomidine|dexmedetomidine|mesh-list
92441904|NCT01634594|Remifentanil|remifentanil|mesh-list
92441905|NCT01634594|Sevoflurane|sevoflurane|mesh-list
92441906|NCT01634594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92441907|NCT01634594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92441908|NCT01634594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441909|NCT01634594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92441910|NCT01634594|Analgesics|analgesics|mesh-ancestor
92441911|NCT01634594|Sensory System Agents|sensory system agents|mesh-ancestor
92441912|NCT01634594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92441913|NCT01634594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92441914|NCT01634594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92441915|NCT01634594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92441916|NCT01634594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92441917|NCT01634594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92441918|NCT01634594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441919|NCT01634594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92441920|NCT01634594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92441921|NCT01634594|Anesthetics, General|anesthetics, general|mesh-ancestor
92441922|NCT01634594|Anesthetics|anesthetics|mesh-ancestor
92441923|NCT01634594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92441924|NCT01634594|Narcotics|narcotics|mesh-ancestor
92441925|NCT01634594|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92441926|NCT01634594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92441927|NCT01634594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92441928|NCT01634594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92441929|NCT01634594|Vasodilator Agents|vasodilator agents|mesh-ancestor
92441930|NCT01634685|Capecitabine|capecitabine|mesh-list
92441931|NCT01634685|Bavituximab|bavituximab|mesh-list
92441932|NCT01634685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92441933|NCT01634685|Antimetabolites|antimetabolites|mesh-ancestor
92441934|NCT01634685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441935|NCT01634685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441936|NCT01634685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92441937|NCT01634698|Vitamin A|vitamin a|mesh-list
92441938|NCT01634698|Retinol palmitate|retinol palmitate|mesh-list
92441939|NCT01634698|Vitamins|vitamins|mesh-ancestor
92441940|NCT01634698|Micronutrients|micronutrients|mesh-ancestor
92441941|NCT01634698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441942|NCT01634698|Antioxidants|antioxidants|mesh-ancestor
92441943|NCT01634698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441944|NCT01634698|Protective Agents|protective agents|mesh-ancestor
92441945|NCT01634698|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92345148|NCT00003653|Leuprolide|leuprolide|mesh-list
92441946|NCT01634698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441947|NCT01634763|Ceritinib|ceritinib|mesh-list
92441948|NCT01634763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441949|NCT01634763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92441950|NCT01634763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441951|NCT01634763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441952|NCT01634789|Bazedoxifene|bazedoxifene|mesh-list
92441953|NCT01634789|Estrogens|estrogens|mesh-list
92441954|NCT01634789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92441955|NCT01634789|Hormones|hormones|mesh-ancestor
92441956|NCT01634789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92441957|NCT01634789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441958|NCT01634789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92441959|NCT01634789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92441960|NCT01634789|Hormone Antagonists|hormone antagonists|mesh-ancestor
92441961|NCT01634789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92441962|NCT01634880|Panitumumab|panitumumab|mesh-list
92441963|NCT01634880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92441964|NCT01634880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441965|NCT01634893|Hydroxychloroquine|hydroxychloroquine|mesh-list
92441967|NCT01634893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92441968|NCT01634893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92441969|NCT01634893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441970|NCT01634893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441971|NCT01634893|Antimalarials|antimalarials|mesh-ancestor
92441972|NCT01634893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92441973|NCT01634893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92441974|NCT01634893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441975|NCT01634893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92441976|NCT01634906|Atorvastatin|atorvastatin|mesh-list
92441977|NCT01634906|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92441978|NCT01634906|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92441979|NCT01634906|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92441980|NCT01634906|Antimetabolites|antimetabolites|mesh-ancestor
92441981|NCT01634906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92441982|NCT01634906|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92441983|NCT01634906|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92441984|NCT01634906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92441985|NCT01634932|Iron|iron|mesh-list
92441986|NCT01634932|Trace Elements|trace elements|mesh-ancestor
92441987|NCT01634932|Micronutrients|micronutrients|mesh-ancestor
92441988|NCT01634932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441989|NCT01634945|Amodiaquine|amodiaquine|mesh-list
92441990|NCT01634945|Antimalarials|antimalarials|mesh-ancestor
92441991|NCT01634945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92441992|NCT01634945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92441993|NCT01634945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92441994|NCT01634958|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92441995|NCT01634958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92441996|NCT01634958|Immunologic Factors|immunologic factors|mesh-ancestor
92441997|NCT01634958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92441998|NCT01634958|Antacids|antacids|mesh-ancestor
92441999|NCT01634958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442000|NCT01634958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442001|NCT01635088|Mometasone Furoate|mometasone furoate|mesh-list
92442002|NCT01635088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442003|NCT01635088|Dermatologic Agents|dermatologic agents|mesh-ancestor
92442004|NCT01635088|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92442005|NCT01635114|Resveratrol|resveratrol|mesh-list
92442006|NCT01635114|Antioxidants|antioxidants|mesh-ancestor
92442007|NCT01635114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442008|NCT01635114|Protective Agents|protective agents|mesh-ancestor
92442009|NCT01635114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442010|NCT01635114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442011|NCT01635114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92442012|NCT01635205|Anesthetics|anesthetics|mesh-list
92442013|NCT01635205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442014|NCT01635205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442015|NCT01635296|Cytarabine|cytarabine|mesh-list
92442016|NCT01635296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92442017|NCT01635296|Antimetabolites|antimetabolites|mesh-ancestor
92442018|NCT01635296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442019|NCT01635296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442020|NCT01635296|Antiviral Agents|antiviral agents|mesh-ancestor
92442021|NCT01635296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442022|NCT01635296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442023|NCT01635296|Immunologic Factors|immunologic factors|mesh-ancestor
92442024|NCT01635296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442025|NCT01635400|Irinotecan|irinotecan|mesh-list
92442026|NCT01635400|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92442027|NCT01635400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92442028|NCT01635400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442029|NCT01635400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442030|NCT01635400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442031|NCT01635530|Doxycycline|doxycycline|mesh-list
92442032|NCT01635530|Ceftriaxone|ceftriaxone|mesh-list
92442033|NCT01635530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92442034|NCT01635530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442035|NCT01635530|Antimalarials|antimalarials|mesh-ancestor
92442036|NCT01635530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92442037|NCT01635530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92442038|NCT01635608|Acetaminophen|acetaminophen|mesh-list
92442039|NCT01635608|Amoxicillin|amoxicillin|mesh-list
92442040|NCT01635608|Talinolol|talinolol|mesh-list
92442041|NCT01635608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442042|NCT01635608|Analgesics|analgesics|mesh-ancestor
92442043|NCT01635608|Sensory System Agents|sensory system agents|mesh-ancestor
92442044|NCT01635608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442045|NCT01635608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442046|NCT01635608|Antipyretics|antipyretics|mesh-ancestor
92442047|NCT01635608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92442048|NCT01635608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442049|NCT01635608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92442050|NCT01635608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92442051|NCT01635608|Adrenergic Agents|adrenergic agents|mesh-ancestor
92442052|NCT01635608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442053|NCT01635608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442054|NCT01635608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92442055|NCT01635608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92442057|NCT01635686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92442058|NCT01635686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442059|NCT01635686|Analgesics|analgesics|mesh-ancestor
92442060|NCT01635686|Sensory System Agents|sensory system agents|mesh-ancestor
92442061|NCT01635686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442062|NCT01635686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442063|NCT01635686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442064|NCT01635686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442065|NCT01635686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442066|NCT01635686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442067|NCT01635686|Immunologic Factors|immunologic factors|mesh-ancestor
92442068|NCT01635751|Pregabalin|pregabalin|mesh-list
92442069|NCT01635751|Analgesics|analgesics|mesh-ancestor
92442070|NCT01635751|Sensory System Agents|sensory system agents|mesh-ancestor
92442071|NCT01635751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442072|NCT01635751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442073|NCT01635751|Anticonvulsants|anticonvulsants|mesh-ancestor
92442074|NCT01635751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92442075|NCT01635751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92442076|NCT01635751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442077|NCT01635751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92442078|NCT01635751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92442079|NCT01635751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92442080|NCT01635751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442081|NCT01635751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92442082|NCT01635777|Miltefosine|miltefosine|mesh-list
92442083|NCT01635777|Antifungal Agents|antifungal agents|mesh-ancestor
92442084|NCT01635777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442085|NCT01635777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442086|NCT01635777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92442087|NCT01635777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92442088|NCT01635790|Bevacizumab|bevacizumab|mesh-list
92442089|NCT01635790|Ranibizumab|ranibizumab|mesh-list
92442090|NCT01635790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92442091|NCT01635790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442092|NCT01635790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92442093|NCT01635790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92442094|NCT01635790|Growth Substances|growth substances|mesh-ancestor
92442095|NCT01635790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442096|NCT01635790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92442097|NCT01635803|Bevacizumab|bevacizumab|mesh-list
92442098|NCT01635803|Ranibizumab|ranibizumab|mesh-list
92442099|NCT01635803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92442100|NCT01635803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442101|NCT01635803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92442102|NCT01635803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92442103|NCT01635803|Growth Substances|growth substances|mesh-ancestor
92442104|NCT01635803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442105|NCT01635803|Growth Inhibitors|growth inhibitors|mesh-ancestor
92442106|NCT01635816|Vaccines|vaccines|mesh-list
92442107|NCT01635816|Immunologic Factors|immunologic factors|mesh-ancestor
92442108|NCT01635816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442110|NCT01635829|Phenytoin|phenytoin|mesh-list
92442111|NCT01635829|Anticonvulsants|anticonvulsants|mesh-ancestor
92442112|NCT01635829|Antimanic Agents|antimanic agents|mesh-ancestor
92442113|NCT01635829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92442114|NCT01635829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442115|NCT01635829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442116|NCT01635829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92442117|NCT01635829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442118|NCT01635829|Analgesics|analgesics|mesh-ancestor
92442119|NCT01635829|Sensory System Agents|sensory system agents|mesh-ancestor
92442120|NCT01635829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442121|NCT01635829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92442122|NCT01635829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92442123|NCT01635829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442124|NCT01635829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92442125|NCT01635829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92442126|NCT01635829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92442127|NCT01635829|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92442128|NCT01635946|Isavuconazole|isavuconazole|mesh-list
92442129|NCT01635946|Atorvastatin|atorvastatin|mesh-list
92442130|NCT01635946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92442131|NCT01635946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92442132|NCT01635946|Antimetabolites|antimetabolites|mesh-ancestor
92442133|NCT01635946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442134|NCT01635946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92442135|NCT01635946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92442136|NCT01635946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442137|NCT01635946|Antifungal Agents|antifungal agents|mesh-ancestor
92442138|NCT01635946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442139|NCT01635972|Isavuconazole|isavuconazole|mesh-list
92442140|NCT01635972|Bupropion|bupropion|mesh-list
92442141|NCT01635972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92442142|NCT01635972|Antidepressive Agents|antidepressive agents|mesh-ancestor
92442143|NCT01635972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92442144|NCT01635972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92442145|NCT01635972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92442146|NCT01635972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92442147|NCT01635972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442148|NCT01635972|Dopamine Agents|dopamine agents|mesh-ancestor
92442149|NCT01635972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442150|NCT01635972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442151|NCT01635972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92442152|NCT01635972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92166959|NCT01365585|Urological Agents|urological agents|mesh-ancestor
92166960|NCT02664181|Nivolumab|nivolumab|mesh-list
92166961|NCT02664181|Decitabine|decitabine|mesh-list
92166962|NCT02664181|Tetrahydrouridine|tetrahydrouridine|mesh-list
92166963|NCT02664181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166964|NCT02664181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442153|NCT01635972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442154|NCT01635972|Antifungal Agents|antifungal agents|mesh-ancestor
92442155|NCT01635972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442156|NCT01636037|Levodopa|levodopa|mesh-list
92442157|NCT01636037|Carbidopa|carbidopa|mesh-list
92442158|NCT01636037|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92442159|NCT01636037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92442160|NCT01636037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92442161|NCT01636037|Dopamine Agents|dopamine agents|mesh-ancestor
92442162|NCT01636037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442163|NCT01636037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442164|NCT01636037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442165|NCT01636037|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92442166|NCT01636037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442167|NCT01636037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92442168|NCT01636037|Immunologic Factors|immunologic factors|mesh-ancestor
92442169|NCT01636037|Dopamine Agonists|dopamine agonists|mesh-ancestor
92442170|NCT01636128|Eflornithine|eflornithine|mesh-list
92442171|NCT01636128|Sulindac|sulindac|mesh-list
92442172|NCT01636128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442173|NCT01636128|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92442174|NCT01636128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92442175|NCT01636128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92442176|NCT01636128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442177|NCT01636128|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92442178|NCT01636128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442179|NCT01636128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442180|NCT01636128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92442181|NCT01636128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442183|NCT01636128|Sensory System Agents|sensory system agents|mesh-ancestor
92442184|NCT01636128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442185|NCT01636128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442186|NCT01636128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442187|NCT01636128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442188|NCT01636128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92442189|NCT01636141|Dapansutrile|dapansutrile|mesh-list
92442190|NCT01636141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442191|NCT01636180|Clopidogrel|clopidogrel|mesh-list
92442192|NCT01636180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92442193|NCT01636180|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92442194|NCT01636180|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92442195|NCT01636180|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92442196|NCT01636180|Purinergic Agents|purinergic agents|mesh-ancestor
92442197|NCT01636180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442198|NCT01636180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442199|NCT01636180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442200|NCT01636245|Vaccines|vaccines|mesh-list
92442201|NCT01636245|Immunologic Factors|immunologic factors|mesh-ancestor
92442202|NCT01636245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442203|NCT01636271|Darapladib|darapladib|mesh-list
92442204|NCT01636271|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92442205|NCT01636271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442206|NCT01636271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442207|NCT01636310|Nicotine|nicotine|mesh-list
92442208|NCT01636310|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92442209|NCT01636310|Autonomic Agents|autonomic agents|mesh-ancestor
92442210|NCT01636310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442211|NCT01636310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442212|NCT01636310|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92442213|NCT01636310|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92442214|NCT01636310|Cholinergic Agents|cholinergic agents|mesh-ancestor
92442215|NCT01636310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442216|NCT01636310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442217|NCT01636323|Nicotine|nicotine|mesh-list
92442218|NCT01636323|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92442219|NCT01636323|Autonomic Agents|autonomic agents|mesh-ancestor
92442220|NCT01636323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442221|NCT01636323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442222|NCT01636323|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92442223|NCT01636323|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92442224|NCT01636323|Cholinergic Agents|cholinergic agents|mesh-ancestor
92442225|NCT01636323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704583|NCT04397692|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92167043|NCT02635555|Ephedrine|ephedrine|mesh-list
92442226|NCT01636323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442227|NCT01636336|Nicotine|nicotine|mesh-list
92442228|NCT01636336|Progesterone|progesterone|mesh-list
92442229|NCT01636336|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92442230|NCT01636336|Autonomic Agents|autonomic agents|mesh-ancestor
92442231|NCT01636336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442232|NCT01636336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442233|NCT01636336|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92442234|NCT01636336|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92442235|NCT01636336|Cholinergic Agents|cholinergic agents|mesh-ancestor
92442236|NCT01636336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442237|NCT01636336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442238|NCT01636336|Progestins|progestins|mesh-ancestor
92442239|NCT01636336|Hormones|hormones|mesh-ancestor
92442240|NCT01636336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92442241|NCT01636401|Bromides|bromides|mesh-list
92442242|NCT01636401|Anticonvulsants|anticonvulsants|mesh-ancestor
92442243|NCT01636505|Cetrorelix|cetrorelix|mesh-list
92442244|NCT01636505|Buserelin|buserelin|mesh-list
92442245|NCT01636505|Ganirelix|ganirelix|mesh-list
92442246|NCT01636505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92442247|NCT01636505|Fertility Agents|fertility agents|mesh-ancestor
92442248|NCT01636505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92442249|NCT01636505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442250|NCT01636505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92442251|NCT01636505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92442252|NCT01636531|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92442253|NCT01636531|Immunologic Factors|immunologic factors|mesh-ancestor
92442254|NCT01636531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442255|NCT01636557|Vitamin K|vitamin k|mesh-list
92442256|NCT01636557|Midazolam|midazolam|mesh-list
92442257|NCT01636557|Caffeine|caffeine|mesh-list
92442258|NCT01636557|Omeprazole|omeprazole|mesh-list
92442259|NCT01636557|Warfarin|warfarin|mesh-list
92442260|NCT01636557|Vitamins|vitamins|mesh-ancestor
92442261|NCT01636557|Micronutrients|micronutrients|mesh-ancestor
92442262|NCT01636557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442263|NCT01636557|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92442264|NCT01636557|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92442265|NCT01636557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442266|NCT01636557|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92442267|NCT01636557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92442268|NCT01636557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92442269|NCT01636557|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92442270|NCT01636557|Anesthetics, General|anesthetics, general|mesh-ancestor
92442271|NCT01636557|Anesthetics|anesthetics|mesh-ancestor
92442272|NCT01636557|GABA Modulators|gaba modulators|mesh-ancestor
92442273|NCT01636557|GABA Agents|gaba agents|mesh-ancestor
92442274|NCT01636557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442275|NCT01636557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442276|NCT01636557|Anticoagulants|anticoagulants|mesh-ancestor
92442277|NCT01636557|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92442278|NCT01636557|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92442279|NCT01636557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442280|NCT01636557|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92442281|NCT01636557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92442282|NCT01636557|Purinergic Agents|purinergic agents|mesh-ancestor
92442283|NCT01636557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92442284|NCT01636557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442285|NCT01636557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92442286|NCT01636557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92442287|NCT01636557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92442288|NCT01636557|Hemostatics|hemostatics|mesh-ancestor
92442289|NCT01636557|Coagulants|coagulants|mesh-ancestor
92442290|NCT01636570|Vitamin D|vitamin d|mesh-list
92442291|NCT01636570|Cholecalciferol|cholecalciferol|mesh-list
92442292|NCT01636570|Vitamins|vitamins|mesh-ancestor
92442293|NCT01636570|Micronutrients|micronutrients|mesh-ancestor
92442294|NCT01636570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442295|NCT01636570|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92442296|NCT01636570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92442297|NCT01636596|Insulin Lispro|insulin lispro|mesh-list
92442298|NCT01636596|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92442299|NCT01636596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442300|NCT01636609|Cytarabine|cytarabine|mesh-list
92442301|NCT01636609|Azacitidine|azacitidine|mesh-list
92167122|NCT02763319|Rituximab|rituximab|mesh-list
92442302|NCT01636609|Tosedostat|tosedostat|mesh-list
92442303|NCT01636609|Glycine|glycine|mesh-list
92442304|NCT01636609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92442305|NCT01636609|Antimetabolites|antimetabolites|mesh-ancestor
92442306|NCT01636609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442307|NCT01636609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442308|NCT01636609|Antiviral Agents|antiviral agents|mesh-ancestor
92442309|NCT01636609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442310|NCT01636609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442311|NCT01636609|Immunologic Factors|immunologic factors|mesh-ancestor
92442312|NCT01636609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442313|NCT01636609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442314|NCT01636609|Glycine Agents|glycine agents|mesh-ancestor
92442315|NCT01636609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442316|NCT01636622|Paclitaxel|paclitaxel|mesh-list
92442317|NCT01636622|Carboplatin|carboplatin|mesh-list
92442318|NCT01636622|Vemurafenib|vemurafenib|mesh-list
92442319|NCT01636622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92442320|NCT01636622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442321|NCT01636622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92442322|NCT01636622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92442323|NCT01636622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406522|NCT01439230|Nootropic Agents|nootropic agents|mesh-ancestor
92442324|NCT01636622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442325|NCT01636622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92442326|NCT01636622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442327|NCT01636700|Tramadol|tramadol|mesh-list
92442328|NCT01636700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92442329|NCT01636700|Narcotics|narcotics|mesh-ancestor
92442330|NCT01636700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442331|NCT01636700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442332|NCT01636700|Analgesics|analgesics|mesh-ancestor
92442333|NCT01636700|Sensory System Agents|sensory system agents|mesh-ancestor
92442334|NCT01636700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442335|NCT01635426|Aspirin|aspirin|mesh-list
92442336|NCT01635426|Clopidogrel|clopidogrel|mesh-list
92442337|NCT01635426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92442338|NCT01635426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442339|NCT01635426|Analgesics|analgesics|mesh-ancestor
92442340|NCT01635426|Sensory System Agents|sensory system agents|mesh-ancestor
92442341|NCT01635426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442342|NCT01635426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442343|NCT01635426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442344|NCT01635426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442345|NCT01635426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92442346|NCT01635426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92200086|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92442347|NCT01635426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442348|NCT01635426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92442349|NCT01635426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92442351|NCT01635426|Antipyretics|antipyretics|mesh-ancestor
92442352|NCT01635426|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92442353|NCT01635426|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92442354|NCT01635426|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92442355|NCT01635426|Purinergic Agents|purinergic agents|mesh-ancestor
92442356|NCT01635426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442357|NCT01636869|Bupivacaine|bupivacaine|mesh-list
92442358|NCT01636869|Anesthetics, Local|anesthetics, local|mesh-ancestor
92442359|NCT01636869|Anesthetics|anesthetics|mesh-ancestor
92442360|NCT01636869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442361|NCT01636869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442362|NCT01636869|Sensory System Agents|sensory system agents|mesh-ancestor
92442363|NCT01636869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442364|NCT01636895|Pyrimethamine|pyrimethamine|mesh-list
92442365|NCT01636895|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92442366|NCT01636895|Sulfadoxine|sulfadoxine|mesh-list
92442367|NCT01636895|Antimalarials|antimalarials|mesh-ancestor
92442368|NCT01636895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92442369|NCT01636895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92442370|NCT01636895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442371|NCT01636895|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92442372|NCT01636895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442373|NCT01636895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442374|NCT01636895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92442375|NCT01636908|Everolimus|everolimus|mesh-list
92442376|NCT01636908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92442377|NCT01636908|Sorafenib|sorafenib|mesh-list
92442378|NCT01636908|Sunitinib|sunitinib|mesh-list
92442379|NCT01636908|Dasatinib|dasatinib|mesh-list
92442380|NCT01636908|Lapatinib|lapatinib|mesh-list
92442381|NCT01636908|Vemurafenib|vemurafenib|mesh-list
92442382|NCT01636908|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92442383|NCT01636908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92442384|NCT01636908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442385|NCT01636908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442386|NCT01636908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442387|NCT01636908|Immunologic Factors|immunologic factors|mesh-ancestor
92442388|NCT01636908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442389|NCT01636908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442390|NCT01636908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92345369|NCT00003881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92442391|NCT01636908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92442392|NCT01636908|Growth Substances|growth substances|mesh-ancestor
92442393|NCT01636908|Growth Inhibitors|growth inhibitors|mesh-ancestor
92442394|NCT01636999|Nitrous Oxide|nitrous oxide|mesh-list
92442395|NCT01636999|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92442396|NCT01636999|Anesthetics, General|anesthetics, general|mesh-ancestor
92442397|NCT01636999|Anesthetics|anesthetics|mesh-ancestor
92442398|NCT01636999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442399|NCT01636999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442400|NCT01636999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442401|NCT01636999|Analgesics|analgesics|mesh-ancestor
92442402|NCT01636999|Sensory System Agents|sensory system agents|mesh-ancestor
92442403|NCT01636999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442404|NCT01637025|Cellulose, Oxidized|cellulose, oxidized|mesh-list
92442405|NCT01637025|Hemostatics|hemostatics|mesh-ancestor
92442406|NCT01637025|Coagulants|coagulants|mesh-ancestor
92442407|NCT01637155|Vitamin D|vitamin d|mesh-list
92442408|NCT01637155|Cholecalciferol|cholecalciferol|mesh-list
92442409|NCT01637155|Vitamins|vitamins|mesh-ancestor
92442410|NCT01637155|Micronutrients|micronutrients|mesh-ancestor
92442411|NCT01637155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442412|NCT01637155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92442413|NCT01637155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92442414|NCT01637194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92442415|NCT01637194|Cetuximab|cetuximab|mesh-list
92442416|NCT01637194|Everolimus|everolimus|mesh-list
92442417|NCT01637194|Antibodies|antibodies|mesh-list
92442418|NCT01637194|Immunoglobulins|immunoglobulins|mesh-list
92442419|NCT01637194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92442420|NCT01637194|Immunologic Factors|immunologic factors|mesh-ancestor
92442421|NCT01637194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442422|NCT01637194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442423|NCT01637194|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92442424|NCT01637194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92442425|NCT01637194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442426|NCT01637194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442427|NCT01637194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442428|NCT01637233|Ritonavir|ritonavir|mesh-list
92442429|NCT01637233|Lopinavir|lopinavir|mesh-list
92442430|NCT01637233|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92442431|NCT01637233|Darunavir|darunavir|mesh-list
92442432|NCT01637233|Fosamprenavir|fosamprenavir|mesh-list
92442433|NCT01637233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92442434|NCT01637233|Tenofovir|tenofovir|mesh-list
92442435|NCT01637233|Lamivudine|lamivudine|mesh-list
92442436|NCT01637233|Emtricitabine|emtricitabine|mesh-list
92442437|NCT01637233|Zidovudine|zidovudine|mesh-list
92442438|NCT01637233|Maraviroc|maraviroc|mesh-list
92442439|NCT01637233|Abacavir|abacavir|mesh-list
92442440|NCT01637233|Dideoxynucleosides|dideoxynucleosides|mesh-list
92442441|NCT01637233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92442442|NCT01637233|Protease Inhibitors|protease inhibitors|mesh-list
92442443|NCT01637233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92442444|NCT01637233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442445|NCT01637233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442446|NCT01637233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442447|NCT01637233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442448|NCT01637233|Antiviral Agents|antiviral agents|mesh-ancestor
92442449|NCT01637233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442450|NCT01637233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92442451|NCT01637233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92442452|NCT01637233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442453|NCT01637233|Antimetabolites|antimetabolites|mesh-ancestor
92442454|NCT01637233|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92442455|NCT01637233|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92442456|NCT01637233|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92442457|NCT01637259|Ritonavir|ritonavir|mesh-list
92442458|NCT01637259|Lopinavir|lopinavir|mesh-list
92442459|NCT01637259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92442460|NCT01637259|Darunavir|darunavir|mesh-list
92442461|NCT01637259|Fosamprenavir|fosamprenavir|mesh-list
92442462|NCT01637259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92442463|NCT01637259|Tenofovir|tenofovir|mesh-list
92442464|NCT01637259|Lamivudine|lamivudine|mesh-list
92442465|NCT01637259|Emtricitabine|emtricitabine|mesh-list
92442466|NCT01637259|Zidovudine|zidovudine|mesh-list
92442467|NCT01637259|Maraviroc|maraviroc|mesh-list
92442468|NCT01637259|Abacavir|abacavir|mesh-list
92442469|NCT01637259|Dideoxynucleosides|dideoxynucleosides|mesh-list
92442470|NCT01637259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92442471|NCT01637259|Protease Inhibitors|protease inhibitors|mesh-list
92442472|NCT01637259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92442473|NCT01637259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442474|NCT01637259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442475|NCT01637259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442476|NCT01637259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442477|NCT01637259|Antiviral Agents|antiviral agents|mesh-ancestor
92442478|NCT01637259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442479|NCT01637259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92442480|NCT01637259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92442481|NCT01637259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442482|NCT01637259|Antimetabolites|antimetabolites|mesh-ancestor
92442483|NCT01637259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92442484|NCT01637259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92442485|NCT01637259|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92442487|NCT01637376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442488|NCT01637376|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92442489|NCT01637376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92442490|NCT01637454|Terlipressin|terlipressin|mesh-list
92442491|NCT01637454|Norepinephrine|norepinephrine|mesh-list
92442492|NCT01637454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92442493|NCT01637454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92442494|NCT01637454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92442495|NCT01637454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92442496|NCT01637454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92442497|NCT01637454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442498|NCT01637454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442499|NCT01637454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442500|NCT01637454|Sympathomimetics|sympathomimetics|mesh-ancestor
92442501|NCT01637454|Autonomic Agents|autonomic agents|mesh-ancestor
92442502|NCT01637454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442503|NCT01637532|Interferons|interferons|mesh-list
92442504|NCT01637532|Interferon-alpha|interferon-alpha|mesh-list
92442505|NCT01637532|Interferon alpha-2|interferon alpha-2|mesh-list
92442506|NCT01637532|Carboplatin|carboplatin|mesh-list
92442507|NCT01637532|Doxorubicin|doxorubicin|mesh-list
92442508|NCT01637532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442509|NCT01637532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92442510|NCT01637532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92442511|NCT01637532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92442512|NCT01637532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442513|NCT01637532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442514|NCT01637532|Antiviral Agents|antiviral agents|mesh-ancestor
92442515|NCT01637532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442516|NCT01637532|Immunologic Factors|immunologic factors|mesh-ancestor
92442517|NCT01637532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442518|NCT01637545|Ramosetron|ramosetron|mesh-list
92442519|NCT01637545|Antiemetics|antiemetics|mesh-ancestor
92442520|NCT01637545|Autonomic Agents|autonomic agents|mesh-ancestor
92442521|NCT01637545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442522|NCT01637545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442523|NCT01637545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442524|NCT01637545|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92442525|NCT01637545|Serotonin Agents|serotonin agents|mesh-ancestor
92442526|NCT01637545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442527|NCT01637545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442528|NCT01637558|Ritonavir|ritonavir|mesh-list
92442529|NCT01637558|Lopinavir|lopinavir|mesh-list
92442530|NCT01637558|Nevirapine|nevirapine|mesh-list
92442531|NCT01637558|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92442532|NCT01637558|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92442533|NCT01637558|Protease Inhibitors|protease inhibitors|mesh-ancestor
92442534|NCT01637558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442535|NCT01637558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442536|NCT01637558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442537|NCT01637558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442538|NCT01637558|Antiviral Agents|antiviral agents|mesh-ancestor
92442539|NCT01637558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442540|NCT01637558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92442541|NCT01637558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92442542|NCT01637558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92442543|NCT01637558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442544|NCT01637558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92442545|NCT01637558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92442546|NCT01637571|Dexlansoprazole|dexlansoprazole|mesh-list
92442547|NCT01637571|Lansoprazole|lansoprazole|mesh-list
92442548|NCT01637571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92442549|NCT01637571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442550|NCT01637571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92442551|NCT01637571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442552|NCT01637571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442553|NCT01637636|Rifampin|rifampin|mesh-list
92442554|NCT01637636|Ketoconazole|ketoconazole|mesh-list
92442555|NCT01637636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92442556|NCT01637636|Antitubercular Agents|antitubercular agents|mesh-ancestor
92442557|NCT01637636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92442558|NCT01637636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442559|NCT01637636|Leprostatic Agents|leprostatic agents|mesh-ancestor
92442560|NCT01637636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442561|NCT01637636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442562|NCT01637636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442563|NCT01637636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92442564|NCT01637636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92442565|NCT01637636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92442566|NCT01637636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92442567|NCT01637636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92442568|NCT01637636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92442569|NCT01637636|Antifungal Agents|antifungal agents|mesh-ancestor
92442570|NCT01637636|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92442571|NCT01637636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92442572|NCT01637636|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92442573|NCT01637636|Hormone Antagonists|hormone antagonists|mesh-ancestor
92442574|NCT01637636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92442575|NCT01637636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442576|NCT01637636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92442577|NCT01637675|Tanshinone|tanshinone|mesh-list
92442578|NCT01637675|Sildenafil Citrate|sildenafil citrate|mesh-list
92442579|NCT01637675|Citric Acid|citric acid|mesh-list
92442580|NCT01637675|Sodium Citrate|sodium citrate|mesh-list
92442581|NCT01637675|Anticoagulants|anticoagulants|mesh-ancestor
92442582|NCT01637675|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92442583|NCT01637675|Chelating Agents|chelating agents|mesh-ancestor
92442584|NCT01637675|Sequestering Agents|sequestering agents|mesh-ancestor
92442585|NCT01637675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442586|NCT01637675|Vasodilator Agents|vasodilator agents|mesh-ancestor
92442587|NCT01637675|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92442588|NCT01637675|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92442589|NCT01637675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442590|NCT01637675|Urological Agents|urological agents|mesh-ancestor
92442591|NCT01637675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442592|NCT01637675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92442593|NCT01637675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442594|NCT01637675|Analgesics|analgesics|mesh-ancestor
92442595|NCT01637675|Sensory System Agents|sensory system agents|mesh-ancestor
92442596|NCT01637675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442597|NCT01637675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442598|NCT01637675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442599|NCT01637675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442600|NCT01637675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92442601|NCT01637675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442602|NCT01637675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442603|NCT01637675|Immunologic Factors|immunologic factors|mesh-ancestor
92442604|NCT01637753|Carmustine|carmustine|mesh-list
92442605|NCT01637753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92442606|NCT01637753|Alkylating Agents|alkylating agents|mesh-ancestor
92442607|NCT01637753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442608|NCT01637753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442609|NCT01637766|Melphalan|melphalan|mesh-list
92442610|NCT01637766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92442611|NCT01637766|Alkylating Agents|alkylating agents|mesh-ancestor
92442612|NCT01637766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442613|NCT01637766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442614|NCT01637766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92442615|NCT01637766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442616|NCT01637766|Immunologic Factors|immunologic factors|mesh-ancestor
92442617|NCT01637766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442618|NCT01637818|Acetaminophen|acetaminophen|mesh-list
92442619|NCT01637818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92531213|NCT00045604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442620|NCT01637818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92442621|NCT01637818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442622|NCT01637818|Analgesics|analgesics|mesh-ancestor
92442623|NCT01637818|Sensory System Agents|sensory system agents|mesh-ancestor
92345509|NCT04563299|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92442624|NCT01637818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442625|NCT01637818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442626|NCT01637818|Antipyretics|antipyretics|mesh-ancestor
92442627|NCT01637818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442628|NCT01637844|Telbivudine|telbivudine|mesh-list
92442629|NCT01637844|Antiviral Agents|antiviral agents|mesh-ancestor
92442630|NCT01637844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442631|NCT01637844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442632|NCT01637844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442633|NCT01637844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442634|NCT01637883|Benzydamine|benzydamine|mesh-list
92442635|NCT01637883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442636|NCT01637948|Listerine|listerine|mesh-list
92442637|NCT01637948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92442638|NCT01637948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442639|NCT01638026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92442640|NCT01638026|Luteolytic Agents|luteolytic agents|mesh-ancestor
92442641|NCT01638026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92442642|NCT01638026|Contraceptive Agents|contraceptive agents|mesh-ancestor
92442643|NCT01638026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92442644|NCT01638026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442645|NCT01638026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92442646|NCT01638026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92442647|NCT01638026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442649|NCT01638078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442650|NCT01638078|Immunologic Factors|immunologic factors|mesh-ancestor
92442651|NCT01638078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442652|NCT01638078|Leprostatic Agents|leprostatic agents|mesh-ancestor
92442653|NCT01638078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92442654|NCT01638078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442655|NCT01638078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92442656|NCT01638078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92442657|NCT01638078|Growth Substances|growth substances|mesh-ancestor
92442658|NCT01638078|Growth Inhibitors|growth inhibitors|mesh-ancestor
92442659|NCT01638078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442660|NCT01638182|Vitamins|vitamins|mesh-list
92442661|NCT01638182|Vitamin K|vitamin k|mesh-list
92442662|NCT01638182|Vitamin K 2|vitamin k 2|mesh-list
92442663|NCT01638182|Vitamin K 1|vitamin k 1|mesh-list
92442664|NCT01638182|Micronutrients|micronutrients|mesh-ancestor
92442665|NCT01638182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442666|NCT01638182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92442667|NCT01638182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92442668|NCT01638182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442669|NCT01638182|Hemostatics|hemostatics|mesh-ancestor
92442670|NCT01638182|Coagulants|coagulants|mesh-ancestor
92442671|NCT01638234|Melatonin|melatonin|mesh-list
92442672|NCT01638234|Antioxidants|antioxidants|mesh-ancestor
92442673|NCT01638234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442674|NCT01638234|Protective Agents|protective agents|mesh-ancestor
92442675|NCT01638234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442676|NCT01638234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442677|NCT01638247|Tamoxifen|tamoxifen|mesh-list
92442678|NCT01638247|Goserelin|goserelin|mesh-list
92442679|NCT01638247|Exemestane|exemestane|mesh-list
92442680|NCT01638247|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92442681|NCT01638247|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92442682|NCT01638247|Hormone Antagonists|hormone antagonists|mesh-ancestor
92442683|NCT01638247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92442684|NCT01638247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442685|NCT01638247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92442686|NCT01638247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167492|NCT02389309|Sirolimus|sirolimus|mesh-list
92442687|NCT01638247|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92442688|NCT01638247|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92442689|NCT01638247|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92442690|NCT01638247|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92442691|NCT01638247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92442692|NCT01638247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442693|NCT01638247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442694|NCT01638247|Hormones|hormones|mesh-ancestor
92442695|NCT01638260|Liraglutide|liraglutide|mesh-list
92442696|NCT01638260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92442697|NCT01638260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442698|NCT01638260|Incretins|incretins|mesh-ancestor
92442699|NCT01638260|Hormones|hormones|mesh-ancestor
92442700|NCT01638260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92442701|NCT01638273|Pregabalin|pregabalin|mesh-list
92442702|NCT01638273|Analgesics|analgesics|mesh-ancestor
92442703|NCT01638273|Sensory System Agents|sensory system agents|mesh-ancestor
92442704|NCT01638273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442705|NCT01638273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442706|NCT01638273|Anticonvulsants|anticonvulsants|mesh-ancestor
92442707|NCT01638273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92442708|NCT01638273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92442709|NCT01638273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442710|NCT01638273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92442711|NCT01638273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92442712|NCT01638273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92442713|NCT01638273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442714|NCT01638273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92442715|NCT01638299|Insulin|insulin|mesh-list
92442716|NCT01638299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92442717|NCT01638299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442718|NCT01638325|Insulin|insulin|mesh-list
92442719|NCT01638325|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92442720|NCT01638325|Insulin Lispro|insulin lispro|mesh-list
92442721|NCT01638325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92442722|NCT01638325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442723|NCT01638364|Ethanol|ethanol|mesh-list
92442724|NCT01638364|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92442725|NCT01638364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442726|NCT01638364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442727|NCT01638364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442728|NCT01638377|Naltrexone|naltrexone|mesh-list
92442729|NCT01638377|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92442730|NCT01638377|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92442731|NCT01638377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442732|NCT01638377|Sensory System Agents|sensory system agents|mesh-ancestor
92442733|NCT01638377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442734|NCT01638403|Modafinil|modafinil|mesh-list
92442735|NCT01638403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92442736|NCT01638403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442737|NCT01638403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92442738|NCT01638403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92442739|NCT01638403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92442740|NCT01638403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442741|NCT01638442|Tosedostat|tosedostat|mesh-list
92442742|NCT01638442|Glycine|glycine|mesh-list
92442743|NCT01638442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442744|NCT01638442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442745|NCT01638442|Glycine Agents|glycine agents|mesh-ancestor
92442746|NCT01638442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442747|NCT01638442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442748|NCT01638624|Propofol|propofol|mesh-list
92442749|NCT01638624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92442750|NCT01638624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92442751|NCT01638624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442752|NCT01638624|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92442753|NCT01638624|Anesthetics, General|anesthetics, general|mesh-ancestor
92442754|NCT01638624|Anesthetics|anesthetics|mesh-ancestor
92442755|NCT01638650|Ritonavir|ritonavir|mesh-list
92442756|NCT01638650|Saquinavir|saquinavir|mesh-list
92442757|NCT01638650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92442758|NCT01638650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92442759|NCT01638650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92442760|NCT01638650|Protease Inhibitors|protease inhibitors|mesh-ancestor
92167571|NCT02380573|Methylene Blue|methylene blue|mesh-list
92442761|NCT01638650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442762|NCT01638650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442763|NCT01638650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442764|NCT01638650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442765|NCT01638650|Antiviral Agents|antiviral agents|mesh-ancestor
92442766|NCT01638650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442767|NCT01638650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92442768|NCT01638650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92442769|NCT01638650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442771|NCT01638663|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92442772|NCT01638663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442773|NCT01638663|Natriuretic Agents|natriuretic agents|mesh-ancestor
92442774|NCT01638663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442775|NCT01638676|Metformin|metformin|mesh-list
92442776|NCT01638676|Vemurafenib|vemurafenib|mesh-list
92442777|NCT01638676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92442778|NCT01638676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442779|NCT01638676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442780|NCT01638676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92442781|NCT01638676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442782|NCT01638676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442783|NCT01638689|Escitalopram|escitalopram|mesh-list
92442784|NCT01638689|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92442785|NCT01638689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92442786|NCT01638689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200092|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442787|NCT01638689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442788|NCT01638689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442789|NCT01638689|Serotonin Agents|serotonin agents|mesh-ancestor
92442790|NCT01638689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442791|NCT01638715|Infliximab|infliximab|mesh-list
92442792|NCT01638715|Rituximab|rituximab|mesh-list
92442793|NCT01638715|Abatacept|abatacept|mesh-list
92442794|NCT01638715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92442795|NCT01638715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442796|NCT01638715|Immunologic Factors|immunologic factors|mesh-ancestor
92442797|NCT01638715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442798|NCT01638715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442799|NCT01638715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92442800|NCT01638715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442801|NCT01638715|Dermatologic Agents|dermatologic agents|mesh-ancestor
92442802|NCT01638715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442803|NCT01638715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92442804|NCT01638715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442805|NCT01638715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442806|NCT01638767|Contraceptive Agents|contraceptive agents|mesh-list
92442807|NCT01638767|NuvaRing|nuvaring|mesh-list
92442808|NCT01638767|Contraceptives, Oral|contraceptives, oral|mesh-list
92442809|NCT01638767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92442810|NCT01638767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442811|NCT01638767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92442812|NCT01638767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92442813|NCT01638780|Resveratrol|resveratrol|mesh-list
92442814|NCT01638780|Antioxidants|antioxidants|mesh-ancestor
92442815|NCT01638780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442816|NCT01638780|Protective Agents|protective agents|mesh-ancestor
92442817|NCT01638780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442818|NCT01638780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442819|NCT01638780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92442820|NCT01638858|Ranibizumab|ranibizumab|mesh-list
92442821|NCT01638858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92442822|NCT01638858|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92345628|NCT01946880|Analgesics|analgesics|mesh-ancestor
92442823|NCT01638858|Growth Substances|growth substances|mesh-ancestor
92442824|NCT01638858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442825|NCT01638858|Growth Inhibitors|growth inhibitors|mesh-ancestor
92442826|NCT01638858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442827|NCT01638936|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
92442828|NCT01638936|Immunoconjugates|immunoconjugates|mesh-ancestor
92442829|NCT01638936|Immunologic Factors|immunologic factors|mesh-ancestor
92442830|NCT01638936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442831|NCT01638962|Acetaminophen|acetaminophen|mesh-list
92442832|NCT01638962|Aspirin|aspirin|mesh-list
92442833|NCT01638962|Ibuprofen|ibuprofen|mesh-list
92442834|NCT01638962|Celecoxib|celecoxib|mesh-list
92442836|NCT01638962|Naproxen|naproxen|mesh-list
92442837|NCT01638962|Indomethacin|indomethacin|mesh-list
92442838|NCT01638962|Etoricoxib|etoricoxib|mesh-list
92442839|NCT01638962|Meloxicam|meloxicam|mesh-list
92442840|NCT01638962|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92442841|NCT01638962|Etodolac|etodolac|mesh-list
92442842|NCT01638962|Lornoxicam|lornoxicam|mesh-list
92442843|NCT01638962|Nabumetone|nabumetone|mesh-list
92442844|NCT01638962|Tenoxicam|tenoxicam|mesh-list
92442845|NCT01638962|Tiaprofenic acid|tiaprofenic acid|mesh-list
92442846|NCT01638962|Analgesics|analgesics|mesh-list
92442847|NCT01638962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92442848|NCT01638962|Sensory System Agents|sensory system agents|mesh-ancestor
92442849|NCT01638962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442850|NCT01638962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442851|NCT01638962|Antipyretics|antipyretics|mesh-ancestor
92442852|NCT01638962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92442853|NCT01638962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442854|NCT01638962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442855|NCT01638962|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92442856|NCT01638962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442857|NCT01638962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442858|NCT01638962|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92442859|NCT01638962|Gout Suppressants|gout suppressants|mesh-ancestor
92442860|NCT01638962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92442861|NCT01638962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92442862|NCT01638962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92442863|NCT01638962|Tocolytic Agents|tocolytic agents|mesh-ancestor
92442864|NCT01638962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92442865|NCT01638988|Metformin|metformin|mesh-list
92442866|NCT01638988|Clomiphene|clomiphene|mesh-list
92442867|NCT01638988|Enclomiphene|enclomiphene|mesh-list
92442868|NCT01638988|Zuclomiphene|zuclomiphene|mesh-list
92442869|NCT01638988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92442870|NCT01638988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442871|NCT01638988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92442872|NCT01638988|Hormone Antagonists|hormone antagonists|mesh-ancestor
92442873|NCT01638988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92442874|NCT01638988|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92442875|NCT01638988|Fertility Agents|fertility agents|mesh-ancestor
92442876|NCT01638988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92442877|NCT01638988|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92442878|NCT01638988|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92442879|NCT01639027|Drotaverin|drotaverin|mesh-list
92442880|NCT01639027|Analgesics|analgesics|mesh-ancestor
92442881|NCT01639027|Sensory System Agents|sensory system agents|mesh-ancestor
92442882|NCT01639027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442883|NCT01639027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442884|NCT01639027|Parasympatholytics|parasympatholytics|mesh-ancestor
92442885|NCT01639027|Autonomic Agents|autonomic agents|mesh-ancestor
92442886|NCT01639027|Vasodilator Agents|vasodilator agents|mesh-ancestor
92442887|NCT01639066|Tenofovir|tenofovir|mesh-list
92442888|NCT01639066|Entecavir|entecavir|mesh-list
92442889|NCT01639066|Antiviral Agents|antiviral agents|mesh-ancestor
92442890|NCT01639066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442891|NCT01639066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92442892|NCT01639066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442893|NCT01639066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442894|NCT01639066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442895|NCT01639066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442896|NCT01639066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442897|NCT01639092|Tenofovir|tenofovir|mesh-list
92442898|NCT01639092|Entecavir|entecavir|mesh-list
92442899|NCT01639092|Antiviral Agents|antiviral agents|mesh-ancestor
92442900|NCT01639092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442901|NCT01639092|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92442902|NCT01639092|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442903|NCT01639092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442904|NCT01639092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442905|NCT01639092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442906|NCT01639092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442907|NCT01639261|Interferons|interferons|mesh-list
92442908|NCT01639261|Interferon-gamma|interferon-gamma|mesh-list
92442909|NCT01639261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442910|NCT01639261|Antiviral Agents|antiviral agents|mesh-ancestor
92442911|NCT01639261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442912|NCT01639326|Irinotecan|irinotecan|mesh-list
92442913|NCT01639326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92442914|NCT01639326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92442915|NCT01639326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407107|NCT01442935|Growth Inhibitors|growth inhibitors|mesh-ancestor
92442916|NCT01639326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442917|NCT01639326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442918|NCT01639456|Aldesleukin|aldesleukin|mesh-list
92442919|NCT01639456|Cyclophosphamide|cyclophosphamide|mesh-list
92442920|NCT01639456|Fludarabine|fludarabine|mesh-list
92442921|NCT01639456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442922|NCT01639456|Immunologic Factors|immunologic factors|mesh-ancestor
92442923|NCT01639456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442924|NCT01639456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442925|NCT01639456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92442926|NCT01639456|Alkylating Agents|alkylating agents|mesh-ancestor
92442927|NCT01639456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442928|NCT01639456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442929|NCT01639456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92442930|NCT01639456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92442931|NCT01639456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92442932|NCT01639456|Antiviral Agents|antiviral agents|mesh-ancestor
92442933|NCT01639456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442934|NCT01639521|Gemcitabine|gemcitabine|mesh-list
92442935|NCT01639521|Doxorubicin|doxorubicin|mesh-list
92442936|NCT01639521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92442937|NCT01639521|Methotrexate|methotrexate|mesh-list
92442938|NCT01639521|Vinblastine|vinblastine|mesh-list
92442939|NCT01639521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442940|NCT01639521|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92442941|NCT01639521|Antimetabolites|antimetabolites|mesh-ancestor
92442942|NCT01639521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442943|NCT01639521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92442944|NCT01639521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92442945|NCT01639521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92442946|NCT01639521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442947|NCT01639521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92442948|NCT01639521|Abortifacient Agents|abortifacient agents|mesh-ancestor
92442949|NCT01639521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92442950|NCT01639521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442951|NCT01639521|Dermatologic Agents|dermatologic agents|mesh-ancestor
92442952|NCT01639521|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92442953|NCT01639521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92442954|NCT01639521|Immunologic Factors|immunologic factors|mesh-ancestor
92442955|NCT01639521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92442956|NCT01639521|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92442957|NCT01639521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92442958|NCT01639521|Tubulin Modulators|tubulin modulators|mesh-ancestor
92442959|NCT01639521|Antimitotic Agents|antimitotic agents|mesh-ancestor
92442960|NCT01639521|Mitosis Modulators|mitosis modulators|mesh-ancestor
92442961|NCT01639547|Ribavirin|ribavirin|mesh-list
92442962|NCT01639547|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92442963|NCT01639547|Antimetabolites|antimetabolites|mesh-ancestor
92442964|NCT01639547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442965|NCT01639547|Antiviral Agents|antiviral agents|mesh-ancestor
92442966|NCT01639547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92442967|NCT01639573|Alemtuzumab|alemtuzumab|mesh-list
92442968|NCT01639573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92442969|NCT01639573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442970|NCT01639794|Solifenacin Succinate|solifenacin succinate|mesh-list
92442971|NCT01639794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92442972|NCT01639794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92442973|NCT01639794|Cholinergic Agents|cholinergic agents|mesh-ancestor
92442974|NCT01639794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92442975|NCT01639794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92442976|NCT01639794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442977|NCT01639794|Urological Agents|urological agents|mesh-ancestor
92442978|NCT01639807|Latanoprost|latanoprost|mesh-list
92442979|NCT01639807|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92442980|NCT01639807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92442981|NCT01639885|Interferons|interferons|mesh-list
92442982|NCT01639885|Interferon-alpha|interferon-alpha|mesh-list
92442983|NCT01639885|Interferon alpha-2|interferon alpha-2|mesh-list
92442984|NCT01639885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92442985|NCT01639885|Antiviral Agents|antiviral agents|mesh-ancestor
92442986|NCT01639885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167791|NCT00987935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92442987|NCT01639885|Immunologic Factors|immunologic factors|mesh-ancestor
92442988|NCT01639885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442989|NCT01639898|Dexamethasone|dexamethasone|mesh-list
92442990|NCT01639898|Dexamethasone acetate|dexamethasone acetate|mesh-list
92442991|NCT01639898|Lenalidomide|lenalidomide|mesh-list
92442992|NCT01639898|BB 1101|bb 1101|mesh-list
92345697|NCT01917006|Cholinergic Agents|cholinergic agents|mesh-ancestor
92442993|NCT01639898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92442994|NCT01639898|Antiemetics|antiemetics|mesh-ancestor
92442995|NCT01639898|Autonomic Agents|autonomic agents|mesh-ancestor
92442996|NCT01639898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92442997|NCT01639898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92442998|NCT01639898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92442999|NCT01639898|Glucocorticoids|glucocorticoids|mesh-ancestor
92443000|NCT01639898|Hormones|hormones|mesh-ancestor
92443001|NCT01639898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443002|NCT01639898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92443003|NCT01639898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443004|NCT01639898|Protease Inhibitors|protease inhibitors|mesh-ancestor
92443005|NCT01639898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443006|NCT01639898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443007|NCT01639898|Immunologic Factors|immunologic factors|mesh-ancestor
92443008|NCT01639898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92443009|NCT01639898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92443010|NCT01639898|Growth Substances|growth substances|mesh-ancestor
92443011|NCT01639898|Growth Inhibitors|growth inhibitors|mesh-ancestor
92443012|NCT01640743|Methylprednisolone|methylprednisolone|mesh-list
92443013|NCT01640743|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92443014|NCT01640743|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92443015|NCT01640743|Prednisolone|prednisolone|mesh-list
92443016|NCT01640743|Prednisolone acetate|prednisolone acetate|mesh-list
92443017|NCT01640743|Everolimus|everolimus|mesh-list
92443018|NCT01640743|Tacrolimus|tacrolimus|mesh-list
92443019|NCT01640743|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92443020|NCT01640743|Prednisolone phosphate|prednisolone phosphate|mesh-list
92443021|NCT01640743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443022|NCT01640743|Immunologic Factors|immunologic factors|mesh-ancestor
92443023|NCT01640743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443024|NCT01640743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92443025|NCT01640743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443026|NCT01640743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443027|NCT01640743|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92443028|NCT01640743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443029|NCT01640743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443030|NCT01640743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443031|NCT01640743|Antiemetics|antiemetics|mesh-ancestor
92443032|NCT01640743|Autonomic Agents|autonomic agents|mesh-ancestor
92443033|NCT01640743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443034|NCT01640743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443035|NCT01640743|Glucocorticoids|glucocorticoids|mesh-ancestor
92443036|NCT01640743|Hormones|hormones|mesh-ancestor
92443037|NCT01640743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443038|NCT01640743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92443039|NCT01640743|Protective Agents|protective agents|mesh-ancestor
92443040|NCT01640743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92443041|NCT01641016|Efavirenz|efavirenz|mesh-list
92443042|NCT01641016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92443043|NCT01641016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92443044|NCT01641016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345703|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92443045|NCT01641016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443046|NCT01641016|Antiviral Agents|antiviral agents|mesh-ancestor
92443047|NCT01641016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443048|NCT01641016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92443049|NCT01641016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92443050|NCT01641016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92443051|NCT01641016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92443052|NCT01641016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92443053|NCT01641016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92443054|NCT01641718|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92443055|NCT01641718|Hemostatics|hemostatics|mesh-ancestor
92443056|NCT01641718|Coagulants|coagulants|mesh-ancestor
92443057|NCT01642771|Docetaxel|docetaxel|mesh-list
92443058|NCT01642771|Fluorouracil|fluorouracil|mesh-list
92443059|NCT01642771|Capecitabine|capecitabine|mesh-list
92443060|NCT01642771|Epirubicin|epirubicin|mesh-list
92443061|NCT01642771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443062|NCT01642771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92443063|NCT01642771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92443064|NCT01642771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92443065|NCT01642771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443066|NCT01642771|Antimetabolites|antimetabolites|mesh-ancestor
92443067|NCT01642771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443068|NCT01642771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443069|NCT01642771|Immunologic Factors|immunologic factors|mesh-ancestor
92443070|NCT01642771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443071|NCT01642771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92443072|NCT01642771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92443073|NCT01642771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92443074|NCT01642771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443075|NCT01642979|Cyclosporine|cyclosporine|mesh-list
92443076|NCT01642979|Levamisole|levamisole|mesh-list
92443077|NCT01642979|Cyclosporins|cyclosporins|mesh-list
92443078|NCT01642979|Glucocorticoids|glucocorticoids|mesh-list
92443079|NCT01642979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443080|NCT01642979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443081|NCT01642979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443082|NCT01642979|Immunologic Factors|immunologic factors|mesh-ancestor
92443083|NCT01642979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443084|NCT01642979|Antifungal Agents|antifungal agents|mesh-ancestor
92443085|NCT01642979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443086|NCT01642979|Dermatologic Agents|dermatologic agents|mesh-ancestor
92443087|NCT01642979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443088|NCT01642979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92443089|NCT01642979|Hormones|hormones|mesh-ancestor
92443090|NCT01642979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443091|NCT01642979|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92443092|NCT01642979|Antinematodal Agents|antinematodal agents|mesh-ancestor
92443093|NCT01642979|Anthelmintics|anthelmintics|mesh-ancestor
92443094|NCT01642979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92443095|NCT01643031|Clopidogrel|clopidogrel|mesh-list
92443096|NCT01643031|Ticagrelor|ticagrelor|mesh-list
92443097|NCT01643031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92443098|NCT01643031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92443099|NCT01643031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92443100|NCT01643031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92443101|NCT01643031|Purinergic Agents|purinergic agents|mesh-ancestor
92443102|NCT01643031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443103|NCT01643031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443104|NCT01643031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443105|NCT01643434|Clonidine|clonidine|mesh-list
92443106|NCT01643434|Spironolactone|spironolactone|mesh-list
92443107|NCT01643434|Analgesics|analgesics|mesh-ancestor
92443108|NCT01643434|Sensory System Agents|sensory system agents|mesh-ancestor
92443109|NCT01643434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443110|NCT01643434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443111|NCT01643434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92443112|NCT01643434|Sympatholytics|sympatholytics|mesh-ancestor
92443113|NCT01643434|Autonomic Agents|autonomic agents|mesh-ancestor
92443114|NCT01643434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92443115|NCT01643434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92443116|NCT01643434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92443117|NCT01643434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443118|NCT01643434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443119|NCT01643434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443120|NCT01643434|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92443121|NCT01643434|Hormone Antagonists|hormone antagonists|mesh-ancestor
92443122|NCT01643434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443123|NCT01643434|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92443124|NCT01643434|Diuretics|diuretics|mesh-ancestor
92443125|NCT01643434|Natriuretic Agents|natriuretic agents|mesh-ancestor
92443126|NCT01643941|Vaccines|vaccines|mesh-list
92443127|NCT01643941|Immunologic Factors|immunologic factors|mesh-ancestor
92443128|NCT01643941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443129|NCT01643980|Progesterone|progesterone|mesh-list
92443130|NCT01643980|Progestins|progestins|mesh-ancestor
92443131|NCT01643980|Hormones|hormones|mesh-ancestor
92443132|NCT01643980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443133|NCT01643980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443134|NCT01645228|Calcium|calcium|mesh-list
92443135|NCT01645228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92443136|NCT01645228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443138|NCT01645839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443139|NCT01645839|Antimetabolites|antimetabolites|mesh-ancestor
92443140|NCT01645839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443141|NCT01645839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443142|NCT01645839|Antiviral Agents|antiviral agents|mesh-ancestor
92443143|NCT01645839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443144|NCT01645839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443145|NCT01645839|Immunologic Factors|immunologic factors|mesh-ancestor
92443146|NCT01645839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443147|NCT01646437|Aspirin|aspirin|mesh-list
92443148|NCT01646437|Vitamin D|vitamin d|mesh-list
92443149|NCT01646437|Cholecalciferol|cholecalciferol|mesh-list
92443150|NCT01646437|Vitamins|vitamins|mesh-ancestor
92443151|NCT01646437|Micronutrients|micronutrients|mesh-ancestor
92443152|NCT01646437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443153|NCT01646437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92443154|NCT01646437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92443155|NCT01646437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92443156|NCT01646437|Analgesics|analgesics|mesh-ancestor
92443157|NCT01646437|Sensory System Agents|sensory system agents|mesh-ancestor
92443158|NCT01646437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443159|NCT01646437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443160|NCT01646437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443161|NCT01646437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92443162|NCT01646437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92443163|NCT01646437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443164|NCT01646437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92443165|NCT01646437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92443166|NCT01646437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443167|NCT01646437|Antipyretics|antipyretics|mesh-ancestor
92443168|NCT01646437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92443169|NCT01646619|Magnesium Sulfate|magnesium sulfate|mesh-list
92443170|NCT01646619|Analgesics|analgesics|mesh-ancestor
92443171|NCT01646619|Sensory System Agents|sensory system agents|mesh-ancestor
92443172|NCT01646619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443173|NCT01646619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443174|NCT01646619|Anesthetics|anesthetics|mesh-ancestor
92443175|NCT01646619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443176|NCT01646619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92443177|NCT01646619|Anticonvulsants|anticonvulsants|mesh-ancestor
92443178|NCT01646619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92443179|NCT01646619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92443180|NCT01646619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443181|NCT01646619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92443182|NCT01646619|Tocolytic Agents|tocolytic agents|mesh-ancestor
92443183|NCT01646619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92443184|NCT01647880|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92443185|NCT01647880|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92443186|NCT01647880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443187|NCT01647880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443188|NCT01647880|Immunologic Factors|immunologic factors|mesh-ancestor
92443189|NCT01647880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443190|NCT01648218|Insulin|insulin|mesh-list
92443191|NCT01648218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92443192|NCT01648218|Insulin Glargine|insulin glargine|mesh-list
92443193|NCT01648218|Insulin Aspart|insulin aspart|mesh-list
92443194|NCT01648218|Insulin, Isophane|insulin, isophane|mesh-list
92443195|NCT01648218|Isophane Insulin, Human|isophane insulin, human|mesh-list
92443196|NCT01648218|Protamines|protamines|mesh-list
92443197|NCT01648218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92443198|NCT01648218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443199|NCT01648218|Heparin Antagonists|heparin antagonists|mesh-ancestor
92443200|NCT01648218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443201|NCT01648218|Coagulants|coagulants|mesh-ancestor
92443202|NCT01648465|Everolimus|everolimus|mesh-list
92443203|NCT01648465|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92443204|NCT01648465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443205|NCT01648465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443206|NCT01648465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443207|NCT01648465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443208|NCT01648465|Immunologic Factors|immunologic factors|mesh-ancestor
92443209|NCT01648465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443210|NCT01648465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443212|NCT01648777|Anesthetics, Local|anesthetics, local|mesh-ancestor
92443213|NCT01648777|Anesthetics|anesthetics|mesh-ancestor
92443214|NCT01648777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443215|NCT01648777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443216|NCT01648777|Sensory System Agents|sensory system agents|mesh-ancestor
92443217|NCT01648777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443218|NCT01648998|Fludrocortisone|fludrocortisone|mesh-list
92443219|NCT01648998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443220|NCT01649024|Tremelimumab|tremelimumab|mesh-list
92443221|NCT01649024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443222|NCT01649960|Sirolimus|sirolimus|mesh-list
92443223|NCT01649960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443224|NCT01649960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443225|NCT01649960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92443226|NCT01649960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443227|NCT01649960|Antifungal Agents|antifungal agents|mesh-ancestor
92443228|NCT01649960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443229|NCT01649960|Immunologic Factors|immunologic factors|mesh-ancestor
92443230|NCT01649960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443231|NCT01650012|Eplerenone|eplerenone|mesh-list
92443232|NCT01650012|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92443233|NCT01650012|Hormone Antagonists|hormone antagonists|mesh-ancestor
92443234|NCT01650012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443235|NCT01650012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443236|NCT01650012|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92443237|NCT01650012|Diuretics|diuretics|mesh-ancestor
92443238|NCT01650012|Natriuretic Agents|natriuretic agents|mesh-ancestor
92443239|NCT01650012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92443240|NCT01650090|Cisplatin|cisplatin|mesh-list
92443241|NCT01650090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443242|NCT01650129|Insulin|insulin|mesh-list
92443243|NCT01650129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92443244|NCT01650129|Insulin Aspart|insulin aspart|mesh-list
92443245|NCT01650129|Biphasic Insulins|biphasic insulins|mesh-list
92443246|NCT01650129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92443247|NCT01650129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443248|NCT01650181|Selenium|selenium|mesh-list
92443249|NCT01650181|Thioctic Acid|thioctic acid|mesh-list
92443250|NCT01650181|Metformin|metformin|mesh-list
92443251|NCT01650181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92443252|NCT01650181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443253|NCT01650181|Antioxidants|antioxidants|mesh-ancestor
92443254|NCT01650181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443255|NCT01650181|Protective Agents|protective agents|mesh-ancestor
92443256|NCT01650181|Trace Elements|trace elements|mesh-ancestor
92443257|NCT01650181|Micronutrients|micronutrients|mesh-ancestor
92443258|NCT01650181|Vitamin B Complex|vitamin b complex|mesh-ancestor
92443259|NCT01650181|Vitamins|vitamins|mesh-ancestor
92443260|NCT01650272|Minoxidil|minoxidil|mesh-list
92443261|NCT01650272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92443262|NCT01650272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92443263|NCT01650272|Vasodilator Agents|vasodilator agents|mesh-ancestor
92443264|NCT01650376|Paclitaxel|paclitaxel|mesh-list
92443265|NCT01650376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92443266|NCT01650376|Carboplatin|carboplatin|mesh-list
92443267|NCT01650376|Olaparib|olaparib|mesh-list
92443268|NCT01650376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92443269|NCT01650376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443270|NCT01650376|Tubulin Modulators|tubulin modulators|mesh-ancestor
92443271|NCT01650376|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345788|NCT01911780|Amlodipine|amlodipine|mesh-list
92443272|NCT01650376|Mitosis Modulators|mitosis modulators|mesh-ancestor
92443273|NCT01650376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443274|NCT01650376|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92443275|NCT01650376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443276|NCT01650389|BCG Vaccine|bcg vaccine|mesh-list
92443277|NCT01650389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92443278|NCT01650389|Immunologic Factors|immunologic factors|mesh-ancestor
92443279|NCT01650389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443280|NCT01650415|Epoetin Alfa|epoetin alfa|mesh-list
92443281|NCT01650415|Hematinics|hematinics|mesh-ancestor
92443282|NCT01650428|Bevacizumab|bevacizumab|mesh-list
92443283|NCT01650428|Fluorouracil|fluorouracil|mesh-list
92443284|NCT01650428|Oxaliplatin|oxaliplatin|mesh-list
92443285|NCT01650428|Irinotecan|irinotecan|mesh-list
92168095|NCT05799326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168096|NCT05799326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168097|NCT05799326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168101|NCT05797467|Bevacizumab|bevacizumab|mesh-list
92443286|NCT01650428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92443287|NCT01650428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443288|NCT01650428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92443289|NCT01650428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92443290|NCT01650428|Growth Substances|growth substances|mesh-ancestor
92443291|NCT01650428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443292|NCT01650428|Growth Inhibitors|growth inhibitors|mesh-ancestor
92443293|NCT01650428|Antimetabolites|antimetabolites|mesh-ancestor
92443294|NCT01650428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443295|NCT01650428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443296|NCT01650428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443297|NCT01650428|Immunologic Factors|immunologic factors|mesh-ancestor
92443298|NCT01650428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92443299|NCT01650428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92443300|NCT01650428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443301|NCT01650441|Beclomethasone|beclomethasone|mesh-list
92443302|NCT01650441|Formoterol Fumarate|formoterol fumarate|mesh-list
92443303|NCT01650441|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92443304|NCT01650441|Autonomic Agents|autonomic agents|mesh-ancestor
92443305|NCT01650441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443306|NCT01650441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443307|NCT01650441|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92443308|NCT01650441|Respiratory System Agents|respiratory system agents|mesh-ancestor
92443309|NCT01650441|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92443310|NCT01650441|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92443311|NCT01650441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92443312|NCT01650441|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443313|NCT01650441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443314|NCT01650441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443315|NCT01650441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443316|NCT01650441|Glucocorticoids|glucocorticoids|mesh-ancestor
92443317|NCT01650441|Hormones|hormones|mesh-ancestor
92443318|NCT01650441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443319|NCT01650493|Listerine|listerine|mesh-list
92443320|NCT01650493|Sodium Fluoride|sodium fluoride|mesh-list
92443321|NCT01650493|Cariostatic Agents|cariostatic agents|mesh-ancestor
92443322|NCT01650493|Protective Agents|protective agents|mesh-ancestor
92443323|NCT01650493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443324|NCT01650493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92443325|NCT01650493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443326|NCT01650506|Metformin|metformin|mesh-list
92443327|NCT01650506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92443328|NCT01650506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92443329|NCT01650506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443330|NCT01650506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443331|NCT01650506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443332|NCT01650506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345801|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
92443333|NCT01650506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443334|NCT01650597|JNJ-42165279|jnj-42165279|mesh-list
92443335|NCT01650597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443336|NCT01650597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443337|NCT01650649|Lofexidine|lofexidine|mesh-list
92443338|NCT01650649|Clonidine|clonidine|mesh-list
92443339|NCT01650649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92443340|NCT01650649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92443341|NCT01650649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443342|NCT01650649|Sensory System Agents|sensory system agents|mesh-ancestor
92443343|NCT01650649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443344|NCT01650649|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92443345|NCT01650649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92443346|NCT01650649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92443347|NCT01650649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443348|NCT01650649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443349|NCT01650649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443350|NCT01650649|Analgesics|analgesics|mesh-ancestor
92443351|NCT01650649|Sympatholytics|sympatholytics|mesh-ancestor
92443352|NCT01650649|Autonomic Agents|autonomic agents|mesh-ancestor
92443353|NCT01650662|Cyclosporine|cyclosporine|mesh-list
92443354|NCT01650662|Cyclosporins|cyclosporins|mesh-list
92443355|NCT01650662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443356|NCT01650662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443357|NCT01650662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443358|NCT01650662|Immunologic Factors|immunologic factors|mesh-ancestor
92443359|NCT01650662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443360|NCT01650662|Antifungal Agents|antifungal agents|mesh-ancestor
92443361|NCT01650662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443362|NCT01650662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92443363|NCT01650662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443364|NCT01650662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92443366|NCT01650727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92443367|NCT01650727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443368|NCT01650727|Immunologic Factors|immunologic factors|mesh-ancestor
92443369|NCT01650727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443370|NCT01650727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443371|NCT01650740|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92443372|NCT01650740|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92443373|NCT01650740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92443374|NCT01650740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92443375|NCT01650740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443376|NCT01650740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443377|NCT01650740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443379|NCT01650740|Sensory System Agents|sensory system agents|mesh-ancestor
92443380|NCT01650740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443381|NCT01650740|Antidepressive Agents|antidepressive agents|mesh-ancestor
92443382|NCT01650740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92443383|NCT01650740|Dopamine Agents|dopamine agents|mesh-ancestor
92443384|NCT01650870|Lactulose|lactulose|mesh-list
92443385|NCT01650870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443386|NCT01650883|Vitamin D|vitamin d|mesh-list
92443387|NCT01650883|Ergocalciferols|ergocalciferols|mesh-list
92443388|NCT01650883|Cholecalciferol|cholecalciferol|mesh-list
92443390|NCT01650883|Micronutrients|micronutrients|mesh-ancestor
92443391|NCT01650883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443392|NCT01650883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92443393|NCT01650883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92443394|NCT01650961|Palonosetron|palonosetron|mesh-list
92443395|NCT01650961|Antiemetics|antiemetics|mesh-ancestor
92443396|NCT01650961|Autonomic Agents|autonomic agents|mesh-ancestor
92443397|NCT01650961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443398|NCT01650961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443399|NCT01650961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443400|NCT01650961|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92443401|NCT01650961|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92443402|NCT01650961|Serotonin Agents|serotonin agents|mesh-ancestor
92443403|NCT01650961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443404|NCT01650961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443405|NCT01651130|Carbetocin|carbetocin|mesh-list
92443406|NCT01651130|Oxytocics|oxytocics|mesh-ancestor
92443407|NCT01651130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92443408|NCT01651130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443409|NCT01651156|Tolvaptan|tolvaptan|mesh-list
92443410|NCT01651156|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92443411|NCT01651156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443412|NCT01651156|Natriuretic Agents|natriuretic agents|mesh-ancestor
92443413|NCT01651156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443414|NCT01651169|Methylphenidate|methylphenidate|mesh-list
92443415|NCT01651169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92443416|NCT01651169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443417|NCT01651169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92443418|NCT01651169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92443419|NCT01651169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92443420|NCT01651169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443421|NCT01651169|Dopamine Agents|dopamine agents|mesh-ancestor
92443422|NCT01651169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443423|NCT01651182|Tranexamic Acid|tranexamic acid|mesh-list
92443424|NCT01651182|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92443425|NCT01651182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92443426|NCT01651182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443427|NCT01651182|Hemostatics|hemostatics|mesh-ancestor
92443428|NCT01651182|Coagulants|coagulants|mesh-ancestor
92443429|NCT01651312|Mirabegron|mirabegron|mesh-list
92531222|NCT00045682|Antimitotic Agents|antimitotic agents|mesh-ancestor
92443430|NCT01651312|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92443431|NCT01651312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92443432|NCT01651312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92443433|NCT01651312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443434|NCT01651312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443435|NCT01651312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168245|NCT05579730|Histamine Antagonists|histamine antagonists|mesh-ancestor
92168246|NCT05579730|Histamine Agents|histamine agents|mesh-ancestor
92443437|NCT01651312|Urological Agents|urological agents|mesh-ancestor
92443438|NCT01651325|Isavuconazole|isavuconazole|mesh-list
92443439|NCT01651325|Dextromethorphan|dextromethorphan|mesh-list
92443440|NCT01651325|Antitussive Agents|antitussive agents|mesh-ancestor
92443441|NCT01651325|Respiratory System Agents|respiratory system agents|mesh-ancestor
92443442|NCT01651325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92443443|NCT01651325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92443444|NCT01651325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443445|NCT01651325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443446|NCT01651325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443447|NCT01651325|Antifungal Agents|antifungal agents|mesh-ancestor
92443448|NCT01651325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443449|NCT01651364|Cabergoline|cabergoline|mesh-list
92443450|NCT01651364|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92443451|NCT01651364|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92443452|NCT01651364|Dopamine Agonists|dopamine agonists|mesh-ancestor
92443453|NCT01651364|Dopamine Agents|dopamine agents|mesh-ancestor
92443454|NCT01651364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443455|NCT01651364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443456|NCT01651364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443457|NCT01651377|Pramipexole|pramipexole|mesh-list
92443458|NCT01651377|Antioxidants|antioxidants|mesh-ancestor
92443459|NCT01651377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443460|NCT01651377|Protective Agents|protective agents|mesh-ancestor
92443461|NCT01651377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443462|NCT01651377|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92443463|NCT01651377|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92443464|NCT01651377|Dopamine Agonists|dopamine agonists|mesh-ancestor
92443465|NCT01651377|Dopamine Agents|dopamine agents|mesh-ancestor
92443466|NCT01651377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443468|NCT01651390|Paclitaxel|paclitaxel|mesh-list
92443469|NCT01651390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92443470|NCT01651390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443471|NCT01651390|Tubulin Modulators|tubulin modulators|mesh-ancestor
92443472|NCT01651390|Antimitotic Agents|antimitotic agents|mesh-ancestor
92443473|NCT01651390|Mitosis Modulators|mitosis modulators|mesh-ancestor
92443474|NCT01651390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443475|NCT01651390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443476|NCT01651390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443477|NCT01651390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92443478|NCT01651390|Antifungal Agents|antifungal agents|mesh-ancestor
92443479|NCT01651390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443480|NCT01651390|Immunologic Factors|immunologic factors|mesh-ancestor
92443481|NCT01651390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443482|NCT01651416|Lumefantrine|lumefantrine|mesh-list
92443483|NCT01651416|Artemether|artemether|mesh-list
92443484|NCT01651416|Pyrimethamine|pyrimethamine|mesh-list
92443485|NCT01651416|Piperaquine|piperaquine|mesh-list
92443486|NCT01651416|Sulfadoxine|sulfadoxine|mesh-list
92443487|NCT01651416|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92443488|NCT01651416|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92443489|NCT01651416|Amodiaquine|amodiaquine|mesh-list
92443490|NCT01651416|Artenimol|artenimol|mesh-list
92443492|NCT01651416|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92443493|NCT01651416|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92443494|NCT01651416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443495|NCT01651416|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92443496|NCT01651416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443497|NCT01651416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443498|NCT01651416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92443499|NCT01651481|Montelukast|montelukast|mesh-list
92443500|NCT01651481|Levocetirizine|levocetirizine|mesh-list
92443501|NCT01651481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92443502|NCT01651481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92443503|NCT01651481|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92531225|NCT00045721|Carmustine|carmustine|mesh-list
92443504|NCT01651481|Hormone Antagonists|hormone antagonists|mesh-ancestor
92443505|NCT01651481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443506|NCT01651481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443507|NCT01651481|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92443508|NCT01651481|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92443509|NCT01651481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443510|NCT01651481|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92443511|NCT01651481|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92443512|NCT01651481|Histamine Antagonists|histamine antagonists|mesh-ancestor
92443513|NCT01651481|Histamine Agents|histamine agents|mesh-ancestor
92443514|NCT01651481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443515|NCT01651520|Flumazenil|flumazenil|mesh-list
92443516|NCT01651520|Antidotes|antidotes|mesh-ancestor
92443517|NCT01651520|Protective Agents|protective agents|mesh-ancestor
92443518|NCT01651520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443519|NCT01651520|GABA Modulators|gaba modulators|mesh-ancestor
92443520|NCT01651520|GABA Agents|gaba agents|mesh-ancestor
92443521|NCT01651520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443522|NCT01651520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443523|NCT01651572|Rocuronium|rocuronium|mesh-list
92443524|NCT01651572|Cisatracurium|cisatracurium|mesh-list
92443525|NCT01651572|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92443526|NCT01651572|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92443527|NCT01651572|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92443528|NCT01651572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443529|NCT01651572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443530|NCT01651585|Valacyclovir|valacyclovir|mesh-list
92443531|NCT01651585|Antiviral Agents|antiviral agents|mesh-ancestor
92443532|NCT01651585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443533|NCT01651637|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92443534|NCT01651637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92443535|NCT01651715|Antibodies|antibodies|mesh-list
92443536|NCT01651715|Immunologic Factors|immunologic factors|mesh-ancestor
92443537|NCT01651715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443538|NCT01651728|Simvastatin|simvastatin|mesh-list
92443539|NCT01651728|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92443540|NCT01651728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92443541|NCT01651728|Antimetabolites|antimetabolites|mesh-ancestor
92443542|NCT01651728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443543|NCT01651728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92443544|NCT01651728|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92443545|NCT01651728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443546|NCT01651923|Heparin|heparin|mesh-list
92443547|NCT01651923|Calcium heparin|calcium heparin|mesh-list
92443548|NCT01651923|Anticoagulants|anticoagulants|mesh-ancestor
92443549|NCT01651923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92443550|NCT01651923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92443551|NCT01651923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443552|NCT01651962|Fentanyl|fentanyl|mesh-list
92443553|NCT01651962|Terbutaline|terbutaline|mesh-list
92443554|NCT01651962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92443555|NCT01651962|Narcotics|narcotics|mesh-ancestor
92443556|NCT01651962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443557|NCT01651962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443558|NCT01651962|Analgesics|analgesics|mesh-ancestor
92443559|NCT01651962|Sensory System Agents|sensory system agents|mesh-ancestor
92443560|NCT01651962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443561|NCT01651962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92443562|NCT01651962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92443563|NCT01651962|Anesthetics, General|anesthetics, general|mesh-ancestor
92443564|NCT01651962|Anesthetics|anesthetics|mesh-ancestor
92443565|NCT01651962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92443566|NCT01651962|Autonomic Agents|autonomic agents|mesh-ancestor
92443567|NCT01651962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92443568|NCT01651962|Respiratory System Agents|respiratory system agents|mesh-ancestor
92443569|NCT01651962|Sympathomimetics|sympathomimetics|mesh-ancestor
92443570|NCT01651962|Tocolytic Agents|tocolytic agents|mesh-ancestor
92443571|NCT01651962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92443572|NCT01651962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92443573|NCT01651962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92443574|NCT01651962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92443575|NCT01651962|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443576|NCT01651962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531226|NCT00045721|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92443577|NCT01651962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443579|NCT01651988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92443580|NCT01651988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443581|NCT01651988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443582|NCT01651988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92443583|NCT01651988|Anesthetics, General|anesthetics, general|mesh-ancestor
92443584|NCT01651988|Anesthetics|anesthetics|mesh-ancestor
92443585|NCT01652014|Mycophenolic Acid|mycophenolic acid|mesh-list
92443586|NCT01652014|Cyclophosphamide|cyclophosphamide|mesh-list
92443588|NCT01652014|Fludarabine phosphate|fludarabine phosphate|mesh-list
92443589|NCT01652014|Tacrolimus|tacrolimus|mesh-list
92443590|NCT01652014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443591|NCT01652014|Immunologic Factors|immunologic factors|mesh-ancestor
92443592|NCT01652014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443593|NCT01652014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443594|NCT01652014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92443595|NCT01652014|Alkylating Agents|alkylating agents|mesh-ancestor
92443596|NCT01652014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443597|NCT01652014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443598|NCT01652014|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92443599|NCT01652014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443600|NCT01652014|Antimetabolites|antimetabolites|mesh-ancestor
92443601|NCT01652014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92443602|NCT01652014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443603|NCT01652014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92443604|NCT01652014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92443605|NCT01652014|Antitubercular Agents|antitubercular agents|mesh-ancestor
92443606|NCT01652014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443607|NCT01652014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443608|NCT01652118|Clarithromycin|clarithromycin|mesh-list
92443609|NCT01652118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443610|NCT01652118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443611|NCT01652118|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92443612|NCT01652118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443613|NCT01652118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443614|NCT01652118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92443615|NCT01652118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92443616|NCT01652157|Pancrelipase|pancrelipase|mesh-list
92443617|NCT01652157|Pancreatin|pancreatin|mesh-list
92443618|NCT01652157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443619|NCT01652183|Acetaminophen|acetaminophen|mesh-list
92443620|NCT01652183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92443621|NCT01652183|Analgesics|analgesics|mesh-ancestor
92443622|NCT01652183|Sensory System Agents|sensory system agents|mesh-ancestor
92443623|NCT01652183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443624|NCT01652183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443625|NCT01652183|Antipyretics|antipyretics|mesh-ancestor
92443626|NCT01652196|Leucovorin|leucovorin|mesh-list
92443627|NCT01652196|Fluorouracil|fluorouracil|mesh-list
92443628|NCT01652196|Oxaliplatin|oxaliplatin|mesh-list
92443629|NCT01652196|Aflibercept|aflibercept|mesh-list
92443630|NCT01652196|Endothelial Growth Factors|endothelial growth factors|mesh-list
92443631|NCT01652196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92443632|NCT01652196|Antimetabolites|antimetabolites|mesh-ancestor
92443633|NCT01652196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443634|NCT01652196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443635|NCT01652196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443636|NCT01652196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443637|NCT01652196|Immunologic Factors|immunologic factors|mesh-ancestor
92443638|NCT01652196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443639|NCT01652196|Antidotes|antidotes|mesh-ancestor
92443640|NCT01652196|Protective Agents|protective agents|mesh-ancestor
92443641|NCT01652196|Vitamin B Complex|vitamin b complex|mesh-ancestor
92443642|NCT01652196|Vitamins|vitamins|mesh-ancestor
92443643|NCT01652196|Micronutrients|micronutrients|mesh-ancestor
92443644|NCT01652196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92443645|NCT01652196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92443646|NCT01652196|Growth Substances|growth substances|mesh-ancestor
92443647|NCT01652196|Growth Inhibitors|growth inhibitors|mesh-ancestor
92443648|NCT01652196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92443649|NCT01652313|Rasagiline|rasagiline|mesh-list
92443650|NCT01652313|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92443651|NCT01652313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443652|NCT01652313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443653|NCT01652313|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92443654|NCT01652313|Protective Agents|protective agents|mesh-ancestor
92443655|NCT01652313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443656|NCT01652326|Diazepam|diazepam|mesh-list
92168471|NCT04774380|Carboplatin|carboplatin|mesh-list
92168472|NCT04774380|Etoposide|etoposide|mesh-list
92168473|NCT04774380|Durvalumab|durvalumab|mesh-list
92168474|NCT04774380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168475|NCT04774380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92168476|NCT04774380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92168481|NCT04706130|Artesunate|artesunate|mesh-list
92443657|NCT01652326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92443658|NCT01652326|Anticonvulsants|anticonvulsants|mesh-ancestor
92443659|NCT01652326|Antiemetics|antiemetics|mesh-ancestor
92443660|NCT01652326|Autonomic Agents|autonomic agents|mesh-ancestor
92443661|NCT01652326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443662|NCT01652326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443663|NCT01652326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443664|NCT01652326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92443665|NCT01652326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443666|NCT01652326|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92443667|NCT01652326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92443668|NCT01652326|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92443669|NCT01652326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92443670|NCT01652326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92443671|NCT01652326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92443672|NCT01652326|Anesthetics, General|anesthetics, general|mesh-ancestor
92443673|NCT01652326|Anesthetics|anesthetics|mesh-ancestor
92443674|NCT01652326|GABA Modulators|gaba modulators|mesh-ancestor
92443675|NCT01652326|GABA Agents|gaba agents|mesh-ancestor
92443676|NCT01652326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443677|NCT01652326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443678|NCT01652339|Amlodipine|amlodipine|mesh-list
92443679|NCT01652339|Valsartan|valsartan|mesh-list
92443680|NCT01652339|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92443681|NCT01652339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92443682|NCT01652339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92443683|NCT01652339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92443684|NCT01652339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443685|NCT01652339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92443686|NCT01652339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443687|NCT01652339|Vasodilator Agents|vasodilator agents|mesh-ancestor
92443688|NCT01652339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92443689|NCT01652339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92443690|NCT01652378|Lidocaine|lidocaine|mesh-list
92443691|NCT01652378|Ondansetron|ondansetron|mesh-list
92443692|NCT01652378|Anesthetics, Local|anesthetics, local|mesh-ancestor
92443693|NCT01652378|Anesthetics|anesthetics|mesh-ancestor
92443694|NCT01652378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443695|NCT01652378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443696|NCT01652378|Sensory System Agents|sensory system agents|mesh-ancestor
92443697|NCT01652378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443698|NCT01652378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92443699|NCT01652378|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92443700|NCT01652378|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92443701|NCT01652378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92443702|NCT01652378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443703|NCT01652378|Antiemetics|antiemetics|mesh-ancestor
92443704|NCT01652378|Autonomic Agents|autonomic agents|mesh-ancestor
92443705|NCT01652378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443706|NCT01652378|Antipruritics|antipruritics|mesh-ancestor
92443707|NCT01652378|Dermatologic Agents|dermatologic agents|mesh-ancestor
92443708|NCT01652378|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92443709|NCT01652378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92443710|NCT01652378|Serotonin Agents|serotonin agents|mesh-ancestor
92443711|NCT01652378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443712|NCT01652417|Methylprednisolone|methylprednisolone|mesh-list
92443713|NCT01652417|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92443714|NCT01652417|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92443715|NCT01652417|Prednisolone|prednisolone|mesh-list
92443716|NCT01652417|Prednisolone acetate|prednisolone acetate|mesh-list
92443717|NCT01652417|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92443718|NCT01652417|Prednisolone phosphate|prednisolone phosphate|mesh-list
92443719|NCT01652417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443720|NCT01652417|Antiemetics|antiemetics|mesh-ancestor
92443721|NCT01652417|Autonomic Agents|autonomic agents|mesh-ancestor
92443722|NCT01652417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443723|NCT01652417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443724|NCT01652417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443725|NCT01652417|Glucocorticoids|glucocorticoids|mesh-ancestor
92443726|NCT01652417|Hormones|hormones|mesh-ancestor
92443727|NCT01652417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443728|NCT01652417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92443729|NCT01652417|Protective Agents|protective agents|mesh-ancestor
92443730|NCT01652417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92443731|NCT01652417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443732|NCT01652534|Amantadine|amantadine|mesh-list
92443733|NCT01652534|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92443734|NCT01652534|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92443735|NCT01652534|Antiviral Agents|antiviral agents|mesh-ancestor
92443736|NCT01652534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443737|NCT01652534|Dopamine Agents|dopamine agents|mesh-ancestor
92443738|NCT01652534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443739|NCT01652534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443740|NCT01652534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443741|NCT01652534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92443742|NCT01652534|Analgesics|analgesics|mesh-ancestor
92443743|NCT01652534|Sensory System Agents|sensory system agents|mesh-ancestor
92443744|NCT01652534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443745|NCT01652547|Pasireotide|pasireotide|mesh-list
92443746|NCT01652547|Somatostatin|somatostatin|mesh-list
92443747|NCT01652547|Hormones|hormones|mesh-ancestor
92443748|NCT01652547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443749|NCT01652547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443750|NCT01652560|Bevacizumab|bevacizumab|mesh-list
92443751|NCT01652560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92443752|NCT01652560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443753|NCT01652560|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92443754|NCT01652560|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92443755|NCT01652560|Growth Substances|growth substances|mesh-ancestor
92443756|NCT01652560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443757|NCT01652560|Growth Inhibitors|growth inhibitors|mesh-ancestor
92443758|NCT01652586|Midazolam|midazolam|mesh-list
92443759|NCT01652586|Dexmedetomidine|dexmedetomidine|mesh-list
92443760|NCT01652586|Remifentanil|remifentanil|mesh-list
92443761|NCT01652586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92443762|NCT01652586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443763|NCT01652586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443764|NCT01652586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92443765|NCT01652586|Analgesics|analgesics|mesh-ancestor
92443766|NCT01652586|Sensory System Agents|sensory system agents|mesh-ancestor
92443767|NCT01652586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443768|NCT01652586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92443769|NCT01652586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92443770|NCT01652586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92443771|NCT01652586|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443772|NCT01652586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443773|NCT01652586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443774|NCT01652586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92443775|NCT01652586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92443776|NCT01652586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92443777|NCT01652586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92443778|NCT01652586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92443779|NCT01652586|Anesthetics, General|anesthetics, general|mesh-ancestor
92443780|NCT01652586|Anesthetics|anesthetics|mesh-ancestor
92443781|NCT01652586|GABA Modulators|gaba modulators|mesh-ancestor
92443782|NCT01652586|GABA Agents|gaba agents|mesh-ancestor
92443783|NCT01652586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92443784|NCT01652586|Narcotics|narcotics|mesh-ancestor
92443785|NCT01652599|Dexamethasone|dexamethasone|mesh-list
92443786|NCT01652599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443787|NCT01652599|Antiemetics|antiemetics|mesh-ancestor
92443788|NCT01652599|Autonomic Agents|autonomic agents|mesh-ancestor
92443789|NCT01652599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443790|NCT01652599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443791|NCT01652599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443792|NCT01652599|Glucocorticoids|glucocorticoids|mesh-ancestor
92443794|NCT01652599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92443795|NCT01652599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92443796|NCT01652599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443797|NCT01652638|Heparin|heparin|mesh-list
92443798|NCT01652638|Calcium heparin|calcium heparin|mesh-list
92443799|NCT01652638|Anticoagulants|anticoagulants|mesh-ancestor
92443801|NCT01652638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92443802|NCT01652638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443803|NCT01652781|Azacitidine|azacitidine|mesh-list
92443804|NCT01652781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443805|NCT01652781|Antimetabolites|antimetabolites|mesh-ancestor
92443806|NCT01652781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443807|NCT01652781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443808|NCT01652781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443809|NCT01652794|Carboplatin|carboplatin|mesh-list
92443810|NCT01652794|Gemcitabine|gemcitabine|mesh-list
92443811|NCT01652794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443812|NCT01652794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443813|NCT01652794|Antimetabolites|antimetabolites|mesh-ancestor
92443814|NCT01652794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443815|NCT01652820|Carboplatin|carboplatin|mesh-list
92443816|NCT01652820|Gemcitabine|gemcitabine|mesh-list
92443817|NCT01652820|Docetaxel|docetaxel|mesh-list
92443818|NCT01652820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443819|NCT01652820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443820|NCT01652820|Antimetabolites|antimetabolites|mesh-ancestor
92443821|NCT01652820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443822|NCT01652820|Tubulin Modulators|tubulin modulators|mesh-ancestor
92443823|NCT01652820|Antimitotic Agents|antimitotic agents|mesh-ancestor
92443824|NCT01652820|Mitosis Modulators|mitosis modulators|mesh-ancestor
92443825|NCT01652859|Amphotericin B|amphotericin b|mesh-list
92443826|NCT01652859|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92443827|NCT01652859|Amebicides|amebicides|mesh-ancestor
92443828|NCT01652859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92443829|NCT01652859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92443830|NCT01652859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443831|NCT01652859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443832|NCT01652859|Antifungal Agents|antifungal agents|mesh-ancestor
92443833|NCT01652898|Esmolol|esmolol|mesh-list
92443834|NCT01652898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92443835|NCT01652898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92443836|NCT01652898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92443837|NCT01652898|Adrenergic Agents|adrenergic agents|mesh-ancestor
92443838|NCT01652898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443839|NCT01652898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443840|NCT01652898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443841|NCT01652924|Anesthetics|anesthetics|mesh-list
92443842|NCT01652924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92443843|NCT01652924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443844|NCT01653015|Vaccines|vaccines|mesh-list
92443845|NCT01653015|Immunologic Factors|immunologic factors|mesh-ancestor
92443846|NCT01653015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443847|NCT01653041|Everolimus|everolimus|mesh-list
92443848|NCT01653041|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92443849|NCT01653041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443850|NCT01653041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443851|NCT01653041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443852|NCT01653041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443853|NCT01653041|Immunologic Factors|immunologic factors|mesh-ancestor
92443854|NCT01653041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443855|NCT01653041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443856|NCT01653067|Cytarabine|cytarabine|mesh-list
92443857|NCT01653067|Sirolimus|sirolimus|mesh-list
92443858|NCT01653067|Dexamethasone|dexamethasone|mesh-list
92443859|NCT01653067|Dexamethasone acetate|dexamethasone acetate|mesh-list
92443860|NCT01653067|Rituximab|rituximab|mesh-list
92443861|NCT01653067|Temsirolimus|temsirolimus|mesh-list
92200099|NCT05739045|Nivolumab|nivolumab|mesh-list
92443862|NCT01653067|MTOR Inhibitors|mtor inhibitors|mesh-list
92443863|NCT01653067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92443864|NCT01653067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443865|NCT01653067|Immunologic Factors|immunologic factors|mesh-ancestor
92443866|NCT01653067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443867|NCT01653067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443868|NCT01653067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92443870|NCT01653067|Autonomic Agents|autonomic agents|mesh-ancestor
92443871|NCT01653067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92443872|NCT01653067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92443873|NCT01653067|Glucocorticoids|glucocorticoids|mesh-ancestor
92443874|NCT01653067|Hormones|hormones|mesh-ancestor
92443875|NCT01653067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168698|NCT04163900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92168699|NCT04163900|Antimetabolites|antimetabolites|mesh-ancestor
92168700|NCT04163900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168701|NCT04146038|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92168702|NCT04146038|Sodium Salicylate|sodium salicylate|mesh-list
92168703|NCT04146038|Azacitidine|azacitidine|mesh-list
92168704|NCT04146038|Decitabine|decitabine|mesh-list
92443876|NCT01653067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92443877|NCT01653067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443878|NCT01653067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443879|NCT01653067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443880|NCT01653067|Antimetabolites|antimetabolites|mesh-ancestor
92443881|NCT01653067|Antiviral Agents|antiviral agents|mesh-ancestor
92443882|NCT01653067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443883|NCT01653067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443884|NCT01653067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443885|NCT01653067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443886|NCT01653067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92443887|NCT01653067|Antifungal Agents|antifungal agents|mesh-ancestor
92443888|NCT01653119|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92443889|NCT01653119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92443890|NCT01653119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92443891|NCT01653119|Antimetabolites|antimetabolites|mesh-ancestor
92443892|NCT01653119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443893|NCT01653119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92443894|NCT01653119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92443895|NCT01653119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443896|NCT01653171|Acetylcysteine|acetylcysteine|mesh-list
92443897|NCT01653171|Simethicone|simethicone|mesh-list
92443898|NCT01653171|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92443899|NCT01653171|Antiviral Agents|antiviral agents|mesh-ancestor
92443900|NCT01653171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443901|NCT01653171|Expectorants|expectorants|mesh-ancestor
92443902|NCT01653171|Respiratory System Agents|respiratory system agents|mesh-ancestor
92443903|NCT01653171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92443904|NCT01653171|Antioxidants|antioxidants|mesh-ancestor
92443905|NCT01653171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443906|NCT01653171|Protective Agents|protective agents|mesh-ancestor
92443907|NCT01653171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443908|NCT01653171|Antidotes|antidotes|mesh-ancestor
92443909|NCT01653171|Antifoaming Agents|antifoaming agents|mesh-ancestor
92443910|NCT01653171|Emollients|emollients|mesh-ancestor
92443911|NCT01653171|Dermatologic Agents|dermatologic agents|mesh-ancestor
92443912|NCT01653236|Ribavirin|ribavirin|mesh-list
92443913|NCT01653236|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92443914|NCT01653236|Antimetabolites|antimetabolites|mesh-ancestor
92443915|NCT01653236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443916|NCT01653236|Antiviral Agents|antiviral agents|mesh-ancestor
92443917|NCT01653236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443918|NCT01653314|Imatinib Mesylate|imatinib mesylate|mesh-list
92443919|NCT01653314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443920|NCT01653314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443921|NCT01653314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443922|NCT01653314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443923|NCT01653457|Memantine|memantine|mesh-list
92443924|NCT01653457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92443925|NCT01653457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92443926|NCT01653457|Dopamine Agents|dopamine agents|mesh-ancestor
92443927|NCT01653457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92443928|NCT01653457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443929|NCT01653457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443930|NCT01653457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92443931|NCT01653457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92443932|NCT01653470|Leucovorin|leucovorin|mesh-list
92443933|NCT01653470|Paclitaxel|paclitaxel|mesh-list
92443934|NCT01653470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92443935|NCT01653470|Carboplatin|carboplatin|mesh-list
92443936|NCT01653470|Fluorouracil|fluorouracil|mesh-list
92443937|NCT01653470|Irinotecan|irinotecan|mesh-list
92443938|NCT01653470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92443939|NCT01653470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346024|NCT01898130|Antibodies|antibodies|mesh-list
92443940|NCT01653470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92443941|NCT01653470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92443942|NCT01653470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92443943|NCT01653470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443944|NCT01653470|Antimetabolites|antimetabolites|mesh-ancestor
92443945|NCT01653470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443946|NCT01653470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443947|NCT01653470|Immunologic Factors|immunologic factors|mesh-ancestor
92443948|NCT01653470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443949|NCT01653470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92443950|NCT01653470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92443951|NCT01653470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443952|NCT01653470|Antidotes|antidotes|mesh-ancestor
92443953|NCT01653470|Protective Agents|protective agents|mesh-ancestor
92443954|NCT01653470|Vitamin B Complex|vitamin b complex|mesh-ancestor
92443955|NCT01653470|Vitamins|vitamins|mesh-ancestor
92443956|NCT01653470|Micronutrients|micronutrients|mesh-ancestor
92443957|NCT01653522|Doxycycline|doxycycline|mesh-list
92443958|NCT01653522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443959|NCT01653522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443960|NCT01653522|Antimalarials|antimalarials|mesh-ancestor
92443961|NCT01653522|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92443962|NCT01653522|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92443963|NCT01653561|Apatinib|apatinib|mesh-list
92443964|NCT01653561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443965|NCT01653561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92443966|NCT01653561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443967|NCT01653561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443968|NCT01653639|Factor VIII|factor viii|mesh-list
92443969|NCT01653639|Coagulants|coagulants|mesh-ancestor
92443970|NCT01653665|Sargramostim|sargramostim|mesh-list
92443971|NCT01653665|Immunologic Factors|immunologic factors|mesh-ancestor
92443972|NCT01653665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443973|NCT01653717|Cyclophosphamide|cyclophosphamide|mesh-list
92443974|NCT01653717|Fludarabine|fludarabine|mesh-list
92443975|NCT01653717|Fludarabine phosphate|fludarabine phosphate|mesh-list
92443976|NCT01653717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92443977|NCT01653717|Immunologic Factors|immunologic factors|mesh-ancestor
92443978|NCT01653717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92443979|NCT01653717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92443980|NCT01653717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92443981|NCT01653717|Alkylating Agents|alkylating agents|mesh-ancestor
92443982|NCT01653717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443983|NCT01653717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443984|NCT01653717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92443985|NCT01653717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92443986|NCT01653717|Antimetabolites|antimetabolites|mesh-ancestor
92443987|NCT01653977|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92443988|NCT01653990|Moxifloxacin|moxifloxacin|mesh-list
92443989|NCT01653990|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92443990|NCT01653990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92443991|NCT01653990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92443992|NCT01653990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92443993|NCT01653990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92443994|NCT01653990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92443995|NCT01653990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92443996|NCT01653990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92443997|NCT01653990|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92443998|NCT01653990|Contraceptive Agents|contraceptive agents|mesh-ancestor
92443999|NCT01653990|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92444000|NCT01653990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444001|NCT01653990|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92444002|NCT01653990|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92444003|NCT01653990|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92444004|NCT01654003|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92444005|NCT01654081|Irinotecan|irinotecan|mesh-list
92444006|NCT01654081|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92444007|NCT01654081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92444008|NCT01654081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444009|NCT01654081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444010|NCT01654081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444011|NCT01654120|Liraglutide|liraglutide|mesh-list
92444012|NCT01654120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92444013|NCT01654120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444014|NCT01654120|Incretins|incretins|mesh-ancestor
92444015|NCT01654120|Hormones|hormones|mesh-ancestor
92531231|NCT00045721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444016|NCT01654120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444017|NCT01654146|Paclitaxel|paclitaxel|mesh-list
92444018|NCT01654146|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92444019|NCT01654146|Carboplatin|carboplatin|mesh-list
92444020|NCT01654146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92444021|NCT01654146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444022|NCT01654146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92444023|NCT01654146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92444024|NCT01654146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92444025|NCT01654146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444026|NCT01654185|Letrozole|letrozole|mesh-list
92168848|NCT03692052|Mitapivat|mitapivat|mesh-list
92168849|NCT03692052|Enzyme Activators|enzyme activators|mesh-ancestor
92168850|NCT03692052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444027|NCT01654185|Exemestane|exemestane|mesh-list
92444028|NCT01654185|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92444029|NCT01654185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444030|NCT01654185|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444031|NCT01654185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444032|NCT01654185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444033|NCT01654185|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92444034|NCT01654185|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444035|NCT01654185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444036|NCT01654185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444037|NCT01654211|Ritonavir|ritonavir|mesh-list
92444038|NCT01654211|Lactams|lactams|mesh-list
92444039|NCT01654211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92444040|NCT01654211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92444041|NCT01654211|Protease Inhibitors|protease inhibitors|mesh-ancestor
92444042|NCT01654211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444043|NCT01654211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444044|NCT01654211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92444045|NCT01654211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92444046|NCT01654211|Antiviral Agents|antiviral agents|mesh-ancestor
92444047|NCT01654211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444048|NCT01654211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92444049|NCT01654211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92444050|NCT01654211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92444051|NCT01654367|Zoledronic Acid|zoledronic acid|mesh-list
92444052|NCT01654367|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92444053|NCT01654367|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92444054|NCT01654367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444055|NCT01654367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444056|NCT01654367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444057|NCT01654367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444058|NCT01654367|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92444059|NCT01654367|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444060|NCT01654367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444061|NCT01654497|HU 211|hu 211|mesh-list
92444062|NCT01654497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92444063|NCT01654497|Antiemetics|antiemetics|mesh-ancestor
92444064|NCT01654497|Autonomic Agents|autonomic agents|mesh-ancestor
92444065|NCT01654497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444066|NCT01654497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444067|NCT01654497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444068|NCT01654497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92444069|NCT01654497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92444070|NCT01654497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444071|NCT01654497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444072|NCT01654497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92444073|NCT01654497|Protective Agents|protective agents|mesh-ancestor
92444074|NCT01654562|Simvastatin|simvastatin|mesh-list
92444075|NCT01654562|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92444076|NCT01654562|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92444077|NCT01654562|Antimetabolites|antimetabolites|mesh-ancestor
92444078|NCT01654562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444079|NCT01654562|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92444080|NCT01654562|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92444081|NCT01654562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444082|NCT01654575|Methotrexate|methotrexate|mesh-list
92444083|NCT01654575|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92444085|NCT01654575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92444086|NCT01654575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444087|NCT01654575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92444088|NCT01654575|Antimetabolites|antimetabolites|mesh-ancestor
92444089|NCT01654575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444090|NCT01654575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444091|NCT01654575|Dermatologic Agents|dermatologic agents|mesh-ancestor
92444092|NCT01654575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444093|NCT01654575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92444094|NCT01654575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92444095|NCT01654575|Immunologic Factors|immunologic factors|mesh-ancestor
92444096|NCT01654575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92444097|NCT01654575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92444098|NCT01654640|Metformin|metformin|mesh-list
92168926|NCT05909852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92444099|NCT01654640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92444100|NCT01654640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444101|NCT01654692|Ipilimumab|ipilimumab|mesh-list
92444102|NCT01654692|Fotemustine|fotemustine|mesh-list
92444103|NCT01654692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92444104|NCT01654692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444105|NCT01654692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92444106|NCT01654692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444107|NCT01654705|Pantoprazole|pantoprazole|mesh-list
92444108|NCT01654705|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92444109|NCT01654705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444110|NCT01654705|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92444111|NCT01654705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444112|NCT01654705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444113|NCT01654718|Pantoprazole|pantoprazole|mesh-list
92444114|NCT01654718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92444115|NCT01654718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444116|NCT01654718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92444117|NCT01654718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444118|NCT01654718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444119|NCT01654809|Vaccines|vaccines|mesh-list
92444120|NCT01654809|Immunologic Factors|immunologic factors|mesh-ancestor
92444121|NCT01654809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444122|NCT01654913|Chrysarobin|chrysarobin|mesh-list
92444123|NCT01654913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92444124|NCT01654913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92444125|NCT01654913|Analgesics|analgesics|mesh-ancestor
92444126|NCT01654913|Sensory System Agents|sensory system agents|mesh-ancestor
92444127|NCT01654913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444128|NCT01654913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444129|NCT01654913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444130|NCT01654913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92444131|NCT01654939|Rifaximin|rifaximin|mesh-list
92444132|NCT01654939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92444133|NCT01654939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444134|NCT01654939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444135|NCT01654965|Topotecan|topotecan|mesh-list
92444136|NCT01654965|Lenograstim|lenograstim|mesh-list
92444137|NCT01654965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92444138|NCT01654965|Immunologic Factors|immunologic factors|mesh-ancestor
92444139|NCT01654965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444140|NCT01654965|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92444141|NCT01654965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92444142|NCT01654965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444143|NCT01654965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444144|NCT01654965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444145|NCT01655004|Exemestane|exemestane|mesh-list
92444146|NCT01655004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444147|NCT01655004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92444148|NCT01655004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444149|NCT01655004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444150|NCT01655004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444151|NCT01655004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92444152|NCT01655004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444153|NCT01655004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444154|NCT01655004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444155|NCT01655056|Darexaban|darexaban|mesh-list
92444156|NCT01655056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92444157|NCT01655056|Antithrombins|antithrombins|mesh-ancestor
92444158|NCT01655056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92444159|NCT01655056|Protease Inhibitors|protease inhibitors|mesh-ancestor
92444160|NCT01655056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444161|NCT01655056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444162|NCT01655056|Anticoagulants|anticoagulants|mesh-ancestor
92444163|NCT01655082|Nicotine|nicotine|mesh-list
92444164|NCT01655082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92444165|NCT01655082|Autonomic Agents|autonomic agents|mesh-ancestor
92444166|NCT01655082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444167|NCT01655082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444168|NCT01655082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92444169|NCT01655082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92444170|NCT01655082|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444171|NCT01655082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444172|NCT01655082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444173|NCT01655095|Prucalopride|prucalopride|mesh-list
92444174|NCT01655095|Bisacodyl|bisacodyl|mesh-list
92444175|NCT01655095|Laxatives|laxatives|mesh-ancestor
92444176|NCT01655095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444177|NCT01655095|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92444178|NCT01655095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92444179|NCT01655095|Serotonin Agents|serotonin agents|mesh-ancestor
92444180|NCT01655095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444181|NCT01655095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444182|NCT01655095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444183|NCT01655095|Cathartics|cathartics|mesh-ancestor
92444184|NCT01655108|Minoxidil|minoxidil|mesh-list
92444185|NCT01655108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92444186|NCT01655108|Vasodilator Agents|vasodilator agents|mesh-ancestor
92444187|NCT01655147|Rifampin|rifampin|mesh-list
92444188|NCT01655147|Abiraterone Acetate|abiraterone acetate|mesh-list
92444189|NCT01655147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92444190|NCT01655147|Antitubercular Agents|antitubercular agents|mesh-ancestor
92444191|NCT01655147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92444192|NCT01655147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444193|NCT01655147|Leprostatic Agents|leprostatic agents|mesh-ancestor
92444194|NCT01655147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92444195|NCT01655147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444196|NCT01655147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444197|NCT01655147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92444198|NCT01655147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92444199|NCT01655147|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92444200|NCT01655147|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92444201|NCT01655147|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92444202|NCT01655147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92444203|NCT01655147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444204|NCT01655147|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444205|NCT01655147|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444206|NCT01655147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444207|NCT01655147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444208|NCT01655147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92444209|NCT01655199|Albuterol|albuterol|mesh-list
92444210|NCT01655199|Ipratropium|ipratropium|mesh-list
92444211|NCT01655199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444212|NCT01655199|Autonomic Agents|autonomic agents|mesh-ancestor
92444213|NCT01655199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444214|NCT01655199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444215|NCT01655199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444216|NCT01655199|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444217|NCT01655199|Tocolytic Agents|tocolytic agents|mesh-ancestor
92444218|NCT01655199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92444219|NCT01655199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92444220|NCT01655199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92444221|NCT01655199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444222|NCT01655199|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444223|NCT01655199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444224|NCT01655199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444225|NCT01655199|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92444226|NCT01655199|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444227|NCT01655212|Valganciclovir|valganciclovir|mesh-list
92444228|NCT01655212|Antiviral Agents|antiviral agents|mesh-ancestor
92444229|NCT01655212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444231|NCT01655303|Metoprolol|metoprolol|mesh-list
92444232|NCT01655303|Verapamil|verapamil|mesh-list
92444233|NCT01655303|Diltiazem|diltiazem|mesh-list
92444234|NCT01655303|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92444235|NCT01655303|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92444236|NCT01655303|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444237|NCT01655303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444238|NCT01655303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444239|NCT01655303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444240|NCT01655303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92444241|NCT01655303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92444242|NCT01655303|Vasodilator Agents|vasodilator agents|mesh-ancestor
92444243|NCT01655303|Sympatholytics|sympatholytics|mesh-ancestor
92444244|NCT01655303|Autonomic Agents|autonomic agents|mesh-ancestor
92444245|NCT01655303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444246|NCT01655303|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92444247|NCT01655303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92444248|NCT01655303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444249|NCT01655303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444250|NCT01655316|Verapamil|verapamil|mesh-list
92444251|NCT01655316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92444252|NCT01655316|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92444253|NCT01655316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444254|NCT01655316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444255|NCT01655316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444256|NCT01655316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444257|NCT01655316|Vasodilator Agents|vasodilator agents|mesh-ancestor
92444258|NCT01655368|Psychotropic Drugs|psychotropic drugs|mesh-list
92444259|NCT01655524|Aminophylline|aminophylline|mesh-list
92444260|NCT01655524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444261|NCT01655524|Autonomic Agents|autonomic agents|mesh-ancestor
92444262|NCT01655524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444263|NCT01655524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444264|NCT01655524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444265|NCT01655524|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444266|NCT01655524|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92444267|NCT01655524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92444268|NCT01655524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444269|NCT01655524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444270|NCT01655524|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92444271|NCT01655524|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92444272|NCT01655524|Purinergic Agents|purinergic agents|mesh-ancestor
92444273|NCT01655524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444274|NCT01655524|Protective Agents|protective agents|mesh-ancestor
92444275|NCT01655628|Cisplatin|cisplatin|mesh-list
92444276|NCT01655628|Gemcitabine|gemcitabine|mesh-list
92444277|NCT01655628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444278|NCT01655628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92444279|NCT01655628|Antimetabolites|antimetabolites|mesh-ancestor
92444280|NCT01655628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444281|NCT01655641|Tranexamic Acid|tranexamic acid|mesh-list
92444282|NCT01655641|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92444283|NCT01655641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92444284|NCT01655641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444285|NCT01655641|Hemostatics|hemostatics|mesh-ancestor
92444286|NCT01655641|Coagulants|coagulants|mesh-ancestor
92444287|NCT01655706|Aripiprazole|aripiprazole|mesh-list
92444288|NCT01655706|Escitalopram|escitalopram|mesh-list
92444289|NCT01655706|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92444290|NCT01655706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92444291|NCT01655706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444292|NCT01655706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444293|NCT01655706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444294|NCT01655706|Serotonin Agents|serotonin agents|mesh-ancestor
92444295|NCT01655706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444296|NCT01655706|Antidepressive Agents|antidepressive agents|mesh-ancestor
92444297|NCT01655706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92444298|NCT01655706|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92444299|NCT01655706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92444300|NCT01655706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92444301|NCT01655706|Dopamine Agonists|dopamine agonists|mesh-ancestor
92444302|NCT01655706|Dopamine Agents|dopamine agents|mesh-ancestor
92444303|NCT01655706|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92444304|NCT01655706|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92444305|NCT01655706|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92444306|NCT01655706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92444307|NCT01655706|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92444308|NCT01655706|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92444309|NCT01655745|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92444310|NCT01655745|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92444311|NCT01655745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444312|NCT01655758|Timolol|timolol|mesh-list
92444313|NCT01655758|Bimatoprost|bimatoprost|mesh-list
92444314|NCT01655758|Travoprost|travoprost|mesh-list
92444315|NCT01655758|Dorzolamide|dorzolamide|mesh-list
92444316|NCT01655758|Latanoprost|latanoprost|mesh-list
92444317|NCT01655758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92444318|NCT01655758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92444319|NCT01655758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444320|NCT01655758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717878|NCT02902055|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92444321|NCT01655758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444322|NCT01655758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444323|NCT01655758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92444324|NCT01655758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92444325|NCT01655758|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92444326|NCT01655758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92444327|NCT01655758|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92444328|NCT01655758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444329|NCT01655810|Vitamin D|vitamin d|mesh-list
92444330|NCT01655810|Ergocalciferols|ergocalciferols|mesh-list
92444331|NCT01655810|Cholecalciferol|cholecalciferol|mesh-list
92444332|NCT01655810|Vitamins|vitamins|mesh-list
92444333|NCT01655810|Calcium Carbonate|calcium carbonate|mesh-list
92444334|NCT01655810|Micronutrients|micronutrients|mesh-ancestor
92444335|NCT01655810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444336|NCT01655810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444337|NCT01655810|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92444338|NCT01655810|Antacids|antacids|mesh-ancestor
92444339|NCT01655810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444340|NCT01655810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444341|NCT01655862|Botulinum Toxins|botulinum toxins|mesh-list
92444342|NCT01655862|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92444343|NCT01655862|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92444344|NCT01655862|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92444345|NCT01655862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444346|NCT01655862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444347|NCT01655862|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444348|NCT01655862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444349|NCT01655862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444350|NCT01655862|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92444351|NCT01655862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444353|NCT01655875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92444354|NCT01655875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92444355|NCT01655875|Antiviral Agents|antiviral agents|mesh-ancestor
92444356|NCT01655875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444357|NCT01655888|Tremelimumab|tremelimumab|mesh-list
92444358|NCT01655888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444359|NCT01655914|Flumazenil|flumazenil|mesh-list
92444360|NCT01655914|Antidotes|antidotes|mesh-ancestor
92444361|NCT01655914|Protective Agents|protective agents|mesh-ancestor
92444362|NCT01655914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444363|NCT01655914|GABA Modulators|gaba modulators|mesh-ancestor
92444364|NCT01655914|GABA Agents|gaba agents|mesh-ancestor
92444365|NCT01655914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444366|NCT01655914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444367|NCT01655927|Tranexamic Acid|tranexamic acid|mesh-list
92444368|NCT01655927|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92444369|NCT01655927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92444370|NCT01655927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444371|NCT01655927|Hemostatics|hemostatics|mesh-ancestor
92444372|NCT01655927|Coagulants|coagulants|mesh-ancestor
92444373|NCT01655966|Vitamin D|vitamin d|mesh-list
92444374|NCT01655966|Interferons|interferons|mesh-list
92444375|NCT01655966|Ribavirin|ribavirin|mesh-list
92444376|NCT01655966|Vitamins|vitamins|mesh-ancestor
92444377|NCT01655966|Micronutrients|micronutrients|mesh-ancestor
92444378|NCT01655966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444379|NCT01655966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92444380|NCT01655966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444381|NCT01655966|Antiviral Agents|antiviral agents|mesh-ancestor
92444382|NCT01655966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444383|NCT01655966|Antimetabolites|antimetabolites|mesh-ancestor
92444384|NCT01655966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444385|NCT01655992|Capecitabine|capecitabine|mesh-list
92444386|NCT01655992|Tegafur|tegafur|mesh-list
92444387|NCT01655992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92444388|NCT01655992|Antimetabolites|antimetabolites|mesh-ancestor
92444389|NCT01655992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444390|NCT01655992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444391|NCT01656005|Beclomethasone|beclomethasone|mesh-list
92444392|NCT01656005|Carvedilol|carvedilol|mesh-list
92444393|NCT01656005|Bisoprolol|bisoprolol|mesh-list
92444394|NCT01656005|Formoterol Fumarate|formoterol fumarate|mesh-list
92444395|NCT01656005|Tiotropium Bromide|tiotropium bromide|mesh-list
92444396|NCT01656005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444397|NCT01656005|Autonomic Agents|autonomic agents|mesh-ancestor
92444398|NCT01656005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444399|NCT01656005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444400|NCT01656005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444401|NCT01656005|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444402|NCT01656005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92444403|NCT01656005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92444404|NCT01656005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444405|NCT01656005|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444406|NCT01656005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444407|NCT01656005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444408|NCT01656005|Parasympatholytics|parasympatholytics|mesh-ancestor
92444409|NCT01656005|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92444410|NCT01656005|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444411|NCT01656005|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92444412|NCT01656005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92444413|NCT01656005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92444414|NCT01656005|Antioxidants|antioxidants|mesh-ancestor
92444415|NCT01656005|Protective Agents|protective agents|mesh-ancestor
92444416|NCT01656005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92444417|NCT01656005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444418|NCT01656005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444419|NCT01656005|Vasodilator Agents|vasodilator agents|mesh-ancestor
92444420|NCT01656005|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92444421|NCT01656005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92444422|NCT01656005|Sympatholytics|sympatholytics|mesh-ancestor
92444423|NCT01656005|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92444424|NCT01656005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444425|NCT01656005|Glucocorticoids|glucocorticoids|mesh-ancestor
92444426|NCT01656005|Hormones|hormones|mesh-ancestor
92444427|NCT01656005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444428|NCT01656018|Rilpivirine|rilpivirine|mesh-list
92444429|NCT01656018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92444430|NCT01656018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92444431|NCT01656018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444432|NCT01656018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444433|NCT01656018|Antiviral Agents|antiviral agents|mesh-ancestor
92444434|NCT01656018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444435|NCT01656018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92444436|NCT01656018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92444437|NCT01656057|Acetaminophen|acetaminophen|mesh-list
92444438|NCT01656057|Metformin|metformin|mesh-list
92444439|NCT01656057|Cholecystokinin|cholecystokinin|mesh-list
92444440|NCT01656057|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92444441|NCT01656057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92444442|NCT01656057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444443|NCT01656057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92444444|NCT01656057|Analgesics|analgesics|mesh-ancestor
92444445|NCT01656057|Sensory System Agents|sensory system agents|mesh-ancestor
92444446|NCT01656057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444447|NCT01656057|Antipyretics|antipyretics|mesh-ancestor
92444448|NCT01656057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92444449|NCT01656057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92444450|NCT01656057|Antimetabolites|antimetabolites|mesh-ancestor
92444451|NCT01656057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444452|NCT01656057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92444453|NCT01656057|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92444454|NCT01656057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444455|NCT01656070|Vitamin D|vitamin d|mesh-list
92444456|NCT01656070|Cholecalciferol|cholecalciferol|mesh-list
92444457|NCT01656070|Vitamins|vitamins|mesh-ancestor
92444458|NCT01656070|Micronutrients|micronutrients|mesh-ancestor
92444459|NCT01656070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444460|NCT01656070|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92444461|NCT01656070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444462|NCT01656109|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92444463|NCT01656109|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92444464|NCT01656109|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92444465|NCT01656109|Protease Inhibitors|protease inhibitors|mesh-ancestor
92444466|NCT01656109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444467|NCT01656109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444468|NCT01656109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92444469|NCT01656109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92169297|NCT05903456|Lenvatinib|lenvatinib|mesh-list
92444470|NCT01656109|Antiviral Agents|antiviral agents|mesh-ancestor
92444471|NCT01656109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444472|NCT01656122|Abacavir|abacavir|mesh-list
92444473|NCT01656122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92444474|NCT01656122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92444475|NCT01656122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444476|NCT01656122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444477|NCT01656122|Antiviral Agents|antiviral agents|mesh-ancestor
92444478|NCT01656122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444479|NCT01656122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92444480|NCT01656122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92444481|NCT01656148|4-Aminopyridine|4-aminopyridine|mesh-list
92444482|NCT01656148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92444483|NCT01656148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444484|NCT01656148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444485|NCT01656226|Sunscreening Agents|sunscreening agents|mesh-list
92444486|NCT01656226|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92444487|NCT01656226|Protective Agents|protective agents|mesh-ancestor
92444488|NCT01656226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444489|NCT01656226|Dermatologic Agents|dermatologic agents|mesh-ancestor
92444490|NCT01656330|Rivaroxaban|rivaroxaban|mesh-list
92444491|NCT01656330|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92444492|NCT01656330|Antithrombins|antithrombins|mesh-ancestor
92444493|NCT01656330|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92444494|NCT01656330|Protease Inhibitors|protease inhibitors|mesh-ancestor
92444495|NCT01656330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444496|NCT01656330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444497|NCT01656330|Anticoagulants|anticoagulants|mesh-ancestor
92444498|NCT01656512|Vitamin D|vitamin d|mesh-list
92444499|NCT01656512|Diphosphonates|diphosphonates|mesh-list
92444500|NCT01656512|Calcium|calcium|mesh-list
92444501|NCT01656512|Vitamins|vitamins|mesh-ancestor
92444502|NCT01656512|Micronutrients|micronutrients|mesh-ancestor
92444503|NCT01656512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444504|NCT01656512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444506|NCT01656525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92444507|NCT01656525|Immunologic Factors|immunologic factors|mesh-ancestor
92444508|NCT01656525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444509|NCT01656538|Paclitaxel|paclitaxel|mesh-list
92444510|NCT01656538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92444511|NCT01656538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444512|NCT01656538|Tubulin Modulators|tubulin modulators|mesh-ancestor
92444513|NCT01656538|Antimitotic Agents|antimitotic agents|mesh-ancestor
92444514|NCT01656538|Mitosis Modulators|mitosis modulators|mesh-ancestor
92444515|NCT01656538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444516|NCT01656616|Antidotes|antidotes|mesh-list
92444517|NCT01656616|Protective Agents|protective agents|mesh-ancestor
92444518|NCT01656616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444519|NCT01656642|Atezolizumab|atezolizumab|mesh-list
92444520|NCT01656642|Vemurafenib|vemurafenib|mesh-list
92444521|NCT01656642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92444522|NCT01656642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444523|NCT01656642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92444524|NCT01656642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444525|NCT01656642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92444526|NCT01656642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444527|NCT01656668|Theobromine|theobromine|mesh-list
92444528|NCT01656668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444529|NCT01656668|Autonomic Agents|autonomic agents|mesh-ancestor
92444530|NCT01656668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444531|NCT01656668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444532|NCT01656668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444533|NCT01656668|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444534|NCT01656668|Vasodilator Agents|vasodilator agents|mesh-ancestor
92444535|NCT01656720|Methoxamine|methoxamine|mesh-list
92444536|NCT01656720|Sympathomimetics|sympathomimetics|mesh-ancestor
92444537|NCT01656720|Autonomic Agents|autonomic agents|mesh-ancestor
92444538|NCT01656720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444539|NCT01656720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444540|NCT01656720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92444541|NCT01656720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92444542|NCT01656720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92444543|NCT01656720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444544|NCT01656720|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444545|NCT01656720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444546|NCT01656720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444547|NCT01656798|Sildenafil Citrate|sildenafil citrate|mesh-list
92444548|NCT01656798|Citric Acid|citric acid|mesh-list
92444549|NCT01656798|Sodium Citrate|sodium citrate|mesh-list
92444550|NCT01656798|Anticoagulants|anticoagulants|mesh-ancestor
92444551|NCT01656798|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92444552|NCT01656798|Chelating Agents|chelating agents|mesh-ancestor
92444553|NCT01656798|Sequestering Agents|sequestering agents|mesh-ancestor
92444554|NCT01656798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444555|NCT01656798|Vasodilator Agents|vasodilator agents|mesh-ancestor
92444556|NCT01656798|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92444557|NCT01656798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92444558|NCT01656798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444559|NCT01656798|Urological Agents|urological agents|mesh-ancestor
92444560|NCT01656811|Albuterol|albuterol|mesh-list
92444561|NCT01656811|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444562|NCT01656811|Autonomic Agents|autonomic agents|mesh-ancestor
92444563|NCT01656811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444564|NCT01656811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444565|NCT01656811|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444566|NCT01656811|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444567|NCT01656811|Tocolytic Agents|tocolytic agents|mesh-ancestor
92444568|NCT01656811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92444569|NCT01656811|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92444570|NCT01656811|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92444571|NCT01656811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444572|NCT01656811|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444573|NCT01656811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444574|NCT01656811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444575|NCT01656980|Carmustine|carmustine|mesh-list
92444576|NCT01656980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92444577|NCT01656980|Alkylating Agents|alkylating agents|mesh-ancestor
92444578|NCT01656980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444579|NCT01656980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444580|NCT01657058|Dimenhydrinate|dimenhydrinate|mesh-list
92444581|NCT01657058|Antiemetics|antiemetics|mesh-ancestor
92444582|NCT01657058|Autonomic Agents|autonomic agents|mesh-ancestor
92444583|NCT01657058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444584|NCT01657058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444585|NCT01657058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444586|NCT01657058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92444587|NCT01657058|Histamine Antagonists|histamine antagonists|mesh-ancestor
92444588|NCT01657058|Histamine Agents|histamine agents|mesh-ancestor
92444589|NCT01657058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444590|NCT01657058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444591|NCT01657071|Aspirin|aspirin|mesh-list
92444592|NCT01657071|Clopidogrel|clopidogrel|mesh-list
92444593|NCT01657071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92444594|NCT01657071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92444595|NCT01657071|Analgesics|analgesics|mesh-ancestor
92444596|NCT01657071|Sensory System Agents|sensory system agents|mesh-ancestor
92444597|NCT01657071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444598|NCT01657071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444599|NCT01657071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444600|NCT01657071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92444601|NCT01657071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92444602|NCT01657071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92444603|NCT01657071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444604|NCT01657071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92444605|NCT01657071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92444606|NCT01657071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444607|NCT01657071|Antipyretics|antipyretics|mesh-ancestor
92444608|NCT01657071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92444609|NCT01657071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92444610|NCT01657071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92444611|NCT01657071|Purinergic Agents|purinergic agents|mesh-ancestor
92444612|NCT01657071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444613|NCT01657110|Tea Tree Oil|tea tree oil|mesh-list
92444614|NCT01657110|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92444615|NCT01657110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444616|NCT01657136|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92444617|NCT01657136|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92444618|NCT01657136|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444619|NCT01657136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444620|NCT01657136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444621|NCT01657136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346233|NCT01851720|Fentanyl|fentanyl|mesh-list
92444623|NCT01657201|Antifungal Agents|antifungal agents|mesh-ancestor
92444624|NCT01657201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444625|NCT01657201|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92444626|NCT01657201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92444627|NCT01657201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444628|NCT01657201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444629|NCT01657201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444630|NCT01657201|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444631|NCT01657201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444632|NCT01657201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444633|NCT01657201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92444634|NCT01657240|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92444635|NCT01657240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92444636|NCT01657240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92444637|NCT01657240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92444638|NCT01657240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92444639|NCT01657240|Analgesics|analgesics|mesh-ancestor
92444640|NCT01657240|Sensory System Agents|sensory system agents|mesh-ancestor
92444641|NCT01657240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444642|NCT01657240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444643|NCT01657240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444644|NCT01657240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92444645|NCT01657240|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92444646|NCT01657240|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92444647|NCT01657240|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92444648|NCT01657240|Histamine Antagonists|histamine antagonists|mesh-ancestor
92444649|NCT01657240|Histamine Agents|histamine agents|mesh-ancestor
92444650|NCT01657240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444651|NCT01657240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444652|NCT01657318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92444653|NCT01657318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444654|NCT01657331|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92444655|NCT01657331|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92444656|NCT01657331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92444657|NCT01657331|Alkylating Agents|alkylating agents|mesh-ancestor
92444658|NCT01657331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444659|NCT01657331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444660|NCT01657331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92444661|NCT01657331|Immunotoxins|immunotoxins|mesh-ancestor
92444662|NCT01657331|Immunoconjugates|immunoconjugates|mesh-ancestor
92444663|NCT01657331|Immunologic Factors|immunologic factors|mesh-ancestor
92444664|NCT01657331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444665|NCT01657409|Botulinum Toxins|botulinum toxins|mesh-list
92444666|NCT01657409|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92444667|NCT01657409|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92444668|NCT01657409|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92444669|NCT01657409|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92444670|NCT01657409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444671|NCT01657409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444673|NCT01657409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444674|NCT01657409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444675|NCT01657409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92444676|NCT01657409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444677|NCT01657448|Methenamine|methenamine|mesh-list
92444678|NCT01657448|Methenamine hippurate|methenamine hippurate|mesh-list
92444679|NCT01657448|Methenamine mandelate|methenamine mandelate|mesh-list
92444680|NCT01657448|Methylene Blue|methylene blue|mesh-list
92444681|NCT01657448|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92444682|NCT01657448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444683|NCT01657448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92444684|NCT01657448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444685|NCT01657448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444686|NCT01657487|Fluticasone|fluticasone|mesh-list
92444687|NCT01657487|Xhance|xhance|mesh-list
92444688|NCT01657487|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92444689|NCT01657487|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92444690|NCT01657487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444691|NCT01657487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444692|NCT01657487|Autonomic Agents|autonomic agents|mesh-ancestor
92444693|NCT01657487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444694|NCT01657487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444695|NCT01657487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444696|NCT01657487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444697|NCT01657487|Dermatologic Agents|dermatologic agents|mesh-ancestor
92444698|NCT01657487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92444699|NCT01657487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92444700|NCT01657487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92444701|NCT01657487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444702|NCT01657487|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444703|NCT01657487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444704|NCT01657487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444705|NCT01657487|Glucocorticoids|glucocorticoids|mesh-ancestor
92444706|NCT01657487|Hormones|hormones|mesh-ancestor
92444707|NCT01657487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444708|NCT01657487|Sympathomimetics|sympathomimetics|mesh-ancestor
92444709|NCT01657578|Omeprazole|omeprazole|mesh-list
92444710|NCT01657578|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92444711|NCT01657578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444712|NCT01657578|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92444713|NCT01657578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444714|NCT01657578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444715|NCT01657656|Vitamin D|vitamin d|mesh-list
92444716|NCT01657656|Vitamins|vitamins|mesh-ancestor
92444717|NCT01657656|Micronutrients|micronutrients|mesh-ancestor
92444718|NCT01657656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444719|NCT01657656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92444720|NCT01657669|Aflibercept|aflibercept|mesh-list
92444721|NCT01657669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92444722|NCT01657669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92444723|NCT01657669|Growth Substances|growth substances|mesh-ancestor
92444724|NCT01657669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444725|NCT01657669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92444726|NCT01657669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444727|NCT01657682|Crenolanib|crenolanib|mesh-list
92444728|NCT01657682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444729|NCT01657747|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92444730|NCT01657747|Parasympatholytics|parasympatholytics|mesh-ancestor
92444731|NCT01657747|Autonomic Agents|autonomic agents|mesh-ancestor
92444732|NCT01657747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444733|NCT01657747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444734|NCT01657747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92444735|NCT01657747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92444736|NCT01657747|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444737|NCT01657747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444738|NCT01657747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444739|NCT01657812|Dexmedetomidine|dexmedetomidine|mesh-list
92444740|NCT01657812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92444741|NCT01657812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92444742|NCT01657812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444743|NCT01657812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92444744|NCT01657812|Analgesics|analgesics|mesh-ancestor
92444745|NCT01657812|Sensory System Agents|sensory system agents|mesh-ancestor
92444746|NCT01657812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444747|NCT01657812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92444748|NCT01657812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92444749|NCT01657812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444750|NCT01657812|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444751|NCT01657812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444752|NCT01657812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444753|NCT01657825|Isavuconazole|isavuconazole|mesh-list
92444754|NCT01657825|Warfarin|warfarin|mesh-list
92444755|NCT01657825|Anticoagulants|anticoagulants|mesh-ancestor
92444756|NCT01657825|Antifungal Agents|antifungal agents|mesh-ancestor
92444757|NCT01657825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444758|NCT01657838|Ketoconazole|ketoconazole|mesh-list
92444759|NCT01657838|Isavuconazole|isavuconazole|mesh-list
92444760|NCT01657838|Antifungal Agents|antifungal agents|mesh-ancestor
92444761|NCT01657838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444762|NCT01657838|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92444763|NCT01657838|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92444764|NCT01657838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444765|NCT01657838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444766|NCT01657838|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444767|NCT01657838|Hormone Antagonists|hormone antagonists|mesh-ancestor
92717879|NCT02902055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92444768|NCT01657838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444769|NCT01657838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444770|NCT01657838|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92444771|NCT01657851|Tamsulosin|tamsulosin|mesh-list
92444772|NCT01657851|Dutasteride|dutasteride|mesh-list
92444773|NCT01657851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92444774|NCT01657851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92444775|NCT01657851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92444776|NCT01657851|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444777|NCT01657851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444778|NCT01657851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444779|NCT01657851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444780|NCT01657851|Urological Agents|urological agents|mesh-ancestor
92444781|NCT01657851|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92444782|NCT01657851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444783|NCT01657851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444784|NCT01657851|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444785|NCT01657851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444786|NCT01657864|Lamotrigine|lamotrigine|mesh-list
92444787|NCT01657864|Anticonvulsants|anticonvulsants|mesh-ancestor
92444788|NCT01657864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92444789|NCT01657864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92444790|NCT01657864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444791|NCT01657864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92444792|NCT01657864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444793|NCT01657864|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92444794|NCT01657864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92444795|NCT01657864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92444796|NCT01657864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92346278|NCT01867710|Hormones|hormones|mesh-ancestor
92444797|NCT01657864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92444798|NCT01657890|Isavuconazole|isavuconazole|mesh-list
92444799|NCT01657890|Antifungal Agents|antifungal agents|mesh-ancestor
92444800|NCT01657890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444801|NCT01657929|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92444802|NCT01657929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92444803|NCT01657929|Immunologic Factors|immunologic factors|mesh-ancestor
92444804|NCT01657929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444805|NCT01657929|Antacids|antacids|mesh-ancestor
92444806|NCT01657929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444807|NCT01657929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444808|NCT01657955|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92444809|NCT01657955|Chlorambucil|chlorambucil|mesh-list
92444810|NCT01657955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92444811|NCT01657955|Alkylating Agents|alkylating agents|mesh-ancestor
92444812|NCT01657955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444813|NCT01657955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444814|NCT01657513|Adalimumab|adalimumab|mesh-list
92444815|NCT01657513|Infliximab|infliximab|mesh-list
92444816|NCT01657513|Etanercept|etanercept|mesh-list
92444817|NCT01657513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92444818|NCT01657513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444819|NCT01657513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92444820|NCT01657513|Dermatologic Agents|dermatologic agents|mesh-ancestor
92444821|NCT01657513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92444822|NCT01657513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92444823|NCT01657513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92444824|NCT01657513|Analgesics|analgesics|mesh-ancestor
92444825|NCT01657513|Sensory System Agents|sensory system agents|mesh-ancestor
92169671|NCT05683171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169672|NCT05683171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169673|NCT05683171|Immunologic Factors|immunologic factors|mesh-ancestor
92169674|NCT05683171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169675|NCT05683171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169676|NCT05683171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92169677|NCT05683171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92169678|NCT05683171|Growth Substances|growth substances|mesh-ancestor
92169679|NCT05683171|Growth Inhibitors|growth inhibitors|mesh-ancestor
92169680|NCT05678257|Leucovorin|leucovorin|mesh-list
92169681|NCT05678257|Bevacizumab|bevacizumab|mesh-list
92169682|NCT05678257|Fluorouracil|fluorouracil|mesh-list
92169683|NCT05678257|Irinotecan|irinotecan|mesh-list
92169684|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
92169685|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169703|NCT05678257|Vitamins|vitamins|mesh-ancestor
92444826|NCT01657513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444827|NCT01657513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444828|NCT01657513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92444829|NCT01657513|Immunologic Factors|immunologic factors|mesh-ancestor
92444831|NCT01657981|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92444832|NCT01657981|Antithrombins|antithrombins|mesh-ancestor
92444833|NCT01657981|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92444834|NCT01657981|Protease Inhibitors|protease inhibitors|mesh-ancestor
92444835|NCT01657981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444836|NCT01657981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444837|NCT01657981|Anticoagulants|anticoagulants|mesh-ancestor
92444838|NCT01658007|Sirolimus|sirolimus|mesh-list
92444839|NCT01658007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92444840|NCT01658007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444841|NCT01658007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92444842|NCT01658007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444843|NCT01658007|Antifungal Agents|antifungal agents|mesh-ancestor
92444844|NCT01658007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92444845|NCT01658007|Immunologic Factors|immunologic factors|mesh-ancestor
92444846|NCT01658007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444848|NCT01658033|Oxaliplatin|oxaliplatin|mesh-list
92444849|NCT01658033|Bevacizumab|bevacizumab|mesh-list
92444850|NCT01658033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444851|NCT01658033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92444852|NCT01658033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92444853|NCT01658033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92444854|NCT01658033|Growth Substances|growth substances|mesh-ancestor
92444855|NCT01658033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444856|NCT01658033|Growth Inhibitors|growth inhibitors|mesh-ancestor
92444857|NCT01658033|Antidotes|antidotes|mesh-ancestor
92444858|NCT01658033|Protective Agents|protective agents|mesh-ancestor
92444859|NCT01658033|Vitamin B Complex|vitamin b complex|mesh-ancestor
92444860|NCT01658033|Vitamins|vitamins|mesh-ancestor
92444861|NCT01658033|Micronutrients|micronutrients|mesh-ancestor
92444862|NCT01658124|Tranexamic Acid|tranexamic acid|mesh-list
92444863|NCT01658124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92444864|NCT01658124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92444865|NCT01658124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444866|NCT01658124|Hemostatics|hemostatics|mesh-ancestor
92444867|NCT01658124|Coagulants|coagulants|mesh-ancestor
92444868|NCT01658176|Exemestane|exemestane|mesh-list
92444869|NCT01658176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444870|NCT01658176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92444871|NCT01658176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92444872|NCT01658176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444873|NCT01658176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444874|NCT01658176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92444875|NCT01658176|Hormone Antagonists|hormone antagonists|mesh-ancestor
92531246|NCT00001688|Ritonavir|ritonavir|mesh-list
92444876|NCT01658176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444877|NCT01658176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444878|NCT01658202|Nicotine|nicotine|mesh-list
92444879|NCT01658202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92444880|NCT01658202|Autonomic Agents|autonomic agents|mesh-ancestor
92444881|NCT01658202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444882|NCT01658202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444883|NCT01658202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92444884|NCT01658202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92444885|NCT01658202|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444886|NCT01658202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444887|NCT01658202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444888|NCT01658215|Nicotine|nicotine|mesh-list
92444889|NCT01658215|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92444890|NCT01658215|Autonomic Agents|autonomic agents|mesh-ancestor
92444891|NCT01658215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444892|NCT01658215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444893|NCT01658215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92444894|NCT01658215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92444895|NCT01658215|Cholinergic Agents|cholinergic agents|mesh-ancestor
92444896|NCT01658215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444897|NCT01658215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444898|NCT01657396|Chlorhexidine|chlorhexidine|mesh-list
92444899|NCT01657396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92444900|NCT01657396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444901|NCT01657396|Disinfectants|disinfectants|mesh-ancestor
92444902|NCT01658319|Fludarabine|fludarabine|mesh-list
92444903|NCT01658319|Fludarabine phosphate|fludarabine phosphate|mesh-list
92444904|NCT01658319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444905|NCT01658319|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92444906|NCT01658319|Antimetabolites|antimetabolites|mesh-ancestor
92444907|NCT01658319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444908|NCT01658319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92444909|NCT01658319|Immunologic Factors|immunologic factors|mesh-ancestor
92444910|NCT01658319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444911|NCT01658358|Doxorubicin|doxorubicin|mesh-list
92444912|NCT01658358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92444913|NCT01658358|Lapatinib|lapatinib|mesh-list
92444914|NCT01658358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92444915|NCT01658358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444916|NCT01658358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92444917|NCT01658358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92444918|NCT01658358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444919|NCT01658358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444920|NCT01658358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92444921|NCT01658410|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92444922|NCT01658410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92444923|NCT01658410|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92444924|NCT01658410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444926|NCT01658449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92444927|NCT01658449|Immunologic Factors|immunologic factors|mesh-ancestor
92444928|NCT01658449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444929|NCT01658449|Viscosupplements|viscosupplements|mesh-ancestor
92444930|NCT01658449|Protective Agents|protective agents|mesh-ancestor
92444931|NCT01658462|Docetaxel|docetaxel|mesh-list
92444932|NCT01658462|Nintedanib|nintedanib|mesh-list
92444933|NCT01658462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444934|NCT01658462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92444935|NCT01658462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92444936|NCT01658462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92444937|NCT01658462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444938|NCT01658462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92444939|NCT01658462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444940|NCT01658527|Bicalutamide|bicalutamide|mesh-list
92444941|NCT01658527|Androgen Antagonists|androgen antagonists|mesh-ancestor
92444942|NCT01658527|Hormone Antagonists|hormone antagonists|mesh-ancestor
92444943|NCT01658527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444944|NCT01658527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444945|NCT01658527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444946|NCT01658553|Trametinib|trametinib|mesh-list
92444947|NCT01658553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444948|NCT01658553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92444949|NCT01658553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444950|NCT01658553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444952|NCT01658774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444953|NCT01658774|Anthelmintics|anthelmintics|mesh-ancestor
92444954|NCT01658774|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92444955|NCT01658774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444956|NCT01658774|Anticestodal Agents|anticestodal agents|mesh-ancestor
92444957|NCT01658774|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92444958|NCT01658774|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92444959|NCT01658774|Tubulin Modulators|tubulin modulators|mesh-ancestor
92444960|NCT01658774|Antimitotic Agents|antimitotic agents|mesh-ancestor
92444961|NCT01658774|Mitosis Modulators|mitosis modulators|mesh-ancestor
92444962|NCT01658774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444963|NCT01658852|Metronidazole|metronidazole|mesh-list
92444964|NCT01658852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92444965|NCT01658852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92444966|NCT01658852|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92444967|NCT01658852|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92444968|NCT01658878|Nivolumab|nivolumab|mesh-list
92444969|NCT01658878|Ipilimumab|ipilimumab|mesh-list
92444970|NCT01658878|Sorafenib|sorafenib|mesh-list
92444971|NCT01658878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92444972|NCT01658878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92444973|NCT01658878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92444974|NCT01658878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444975|NCT01658878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92444976|NCT01658878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92444977|NCT01658891|Beclomethasone|beclomethasone|mesh-list
92444978|NCT01658891|Formoterol Fumarate|formoterol fumarate|mesh-list
92444979|NCT01658891|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92444980|NCT01658891|Autonomic Agents|autonomic agents|mesh-ancestor
92444981|NCT01658891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92444982|NCT01658891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92444983|NCT01658891|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92444984|NCT01658891|Respiratory System Agents|respiratory system agents|mesh-ancestor
92444985|NCT01658891|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92444986|NCT01658891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92444987|NCT01658891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92444988|NCT01658891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92444989|NCT01658891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92444990|NCT01658891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92444991|NCT01658891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92444992|NCT01658891|Glucocorticoids|glucocorticoids|mesh-ancestor
92444993|NCT01658891|Hormones|hormones|mesh-ancestor
92444994|NCT01658891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444995|NCT01659008|Estradiol|estradiol|mesh-list
92444996|NCT01659008|Estrogens|estrogens|mesh-ancestor
92444997|NCT01659008|Hormones|hormones|mesh-ancestor
92444998|NCT01659008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92444999|NCT01659008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445000|NCT01659047|Idelalisib|idelalisib|mesh-list
92445001|NCT01659047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445002|NCT01659047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445003|NCT01659047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445004|NCT01659086|Vaccines|vaccines|mesh-list
92445005|NCT01659086|Immunologic Factors|immunologic factors|mesh-ancestor
92445006|NCT01659086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445007|NCT01659099|Prednisone|prednisone|mesh-list
92445008|NCT01659099|Cyclophosphamide|cyclophosphamide|mesh-list
92445009|NCT01659099|Rituximab|rituximab|mesh-list
92445010|NCT01659099|Doxorubicin|doxorubicin|mesh-list
92445011|NCT01659099|Vincristine|vincristine|mesh-list
92445012|NCT01659099|Obinutuzumab|obinutuzumab|mesh-list
92445013|NCT01659099|Bleomycin|bleomycin|mesh-list
92445014|NCT01659099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92445015|NCT01659099|Immunologic Factors|immunologic factors|mesh-ancestor
92445016|NCT01659099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445017|NCT01659099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445018|NCT01659099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92445019|NCT01659099|Alkylating Agents|alkylating agents|mesh-ancestor
92445020|NCT01659099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445021|NCT01659099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445022|NCT01659099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92445023|NCT01659099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92445024|NCT01659099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92445025|NCT01659099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92445026|NCT01659099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92445027|NCT01659099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445028|NCT01659099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445029|NCT01659099|Glucocorticoids|glucocorticoids|mesh-ancestor
92445031|NCT01659099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445032|NCT01659099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445033|NCT01659099|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92445034|NCT01659099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92445035|NCT01659099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92445036|NCT01659099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92445037|NCT01659190|Calcium Carbonate|calcium carbonate|mesh-list
92445038|NCT01659190|Antacids|antacids|mesh-ancestor
92445039|NCT01659190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445040|NCT01659190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445041|NCT01659242|Sulfasalazine|sulfasalazine|mesh-list
92445042|NCT01659242|Methotrexate|methotrexate|mesh-list
92445043|NCT01659242|Leflunomide|leflunomide|mesh-list
92445044|NCT01659242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92445045|NCT01659242|Abortifacient Agents|abortifacient agents|mesh-ancestor
92445046|NCT01659242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92445047|NCT01659242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445048|NCT01659242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92445049|NCT01659242|Antimetabolites|antimetabolites|mesh-ancestor
92445050|NCT01659242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169900|NCT05436535|Hormones|hormones|mesh-ancestor
92445051|NCT01659242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445052|NCT01659242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92445053|NCT01659242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445054|NCT01659242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92445055|NCT01659242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92445056|NCT01659242|Immunologic Factors|immunologic factors|mesh-ancestor
92445057|NCT01659242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445058|NCT01659242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92445059|NCT01659242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445060|NCT01659242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92445061|NCT01659242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445063|NCT01659242|Sensory System Agents|sensory system agents|mesh-ancestor
92445064|NCT01659242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445065|NCT01659242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445066|NCT01659242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445067|NCT01659281|Artesunate|artesunate|mesh-list
92445068|NCT01659281|Mefloquine|mefloquine|mesh-list
92445069|NCT01659281|Antimalarials|antimalarials|mesh-ancestor
92445070|NCT01659281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92445071|NCT01659281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92445072|NCT01659281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445073|NCT01659281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445074|NCT01659281|Antiviral Agents|antiviral agents|mesh-ancestor
92445075|NCT01659281|Schistosomicides|schistosomicides|mesh-ancestor
92445076|NCT01659281|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92445077|NCT01659281|Anthelmintics|anthelmintics|mesh-ancestor
92445078|NCT01659346|Carvedilol|carvedilol|mesh-list
92445079|NCT01659346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92445080|NCT01659346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92445081|NCT01659346|Adrenergic Agents|adrenergic agents|mesh-ancestor
92445082|NCT01659346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445083|NCT01659346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445084|NCT01659346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445085|NCT01659346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92445086|NCT01659346|Antioxidants|antioxidants|mesh-ancestor
92445087|NCT01659346|Protective Agents|protective agents|mesh-ancestor
92445088|NCT01659346|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92445089|NCT01659346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92445090|NCT01659346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92445091|NCT01659346|Vasodilator Agents|vasodilator agents|mesh-ancestor
92445092|NCT01659346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92445093|NCT01659346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92445094|NCT01659359|Lidocaine|lidocaine|mesh-list
92445095|NCT01659359|Anesthetics, Local|anesthetics, local|mesh-ancestor
92445096|NCT01659359|Anesthetics|anesthetics|mesh-ancestor
92445097|NCT01659359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531249|NCT00001688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92445098|NCT01659359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445099|NCT01659359|Sensory System Agents|sensory system agents|mesh-ancestor
92445100|NCT01659359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445101|NCT01659359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92445102|NCT01659359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92445103|NCT01659359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92445104|NCT01659359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92445105|NCT01659359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445106|NCT01659372|Naproxen|naproxen|mesh-list
92445107|NCT01659372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92445108|NCT01659372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445109|NCT01659372|Analgesics|analgesics|mesh-ancestor
92445110|NCT01659372|Sensory System Agents|sensory system agents|mesh-ancestor
92445111|NCT01659372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445112|NCT01659372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445113|NCT01659372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445114|NCT01659372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445115|NCT01659372|Gout Suppressants|gout suppressants|mesh-ancestor
92445116|NCT01659372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92445117|NCT01659372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445118|NCT01659372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445119|NCT01659437|Clarithromycin|clarithromycin|mesh-list
92445120|NCT01659437|Streptomycin|streptomycin|mesh-list
92445121|NCT01659437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92445122|NCT01659437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445123|NCT01659437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92445124|NCT01659437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445125|NCT01659437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445126|NCT01659437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92445127|NCT01659437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92445129|NCT01659476|Miotics|miotics|mesh-ancestor
92445130|NCT01659476|Autonomic Agents|autonomic agents|mesh-ancestor
92445131|NCT01659476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998964|NCT05915871|Antacids|antacids|mesh-ancestor
92445132|NCT01659476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445133|NCT01659476|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92445134|NCT01659476|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92445135|NCT01659476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92445136|NCT01659476|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92445137|NCT01659476|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92445138|NCT01659476|Cholinergic Agents|cholinergic agents|mesh-ancestor
92445139|NCT01659476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445140|NCT01659476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445141|NCT01659515|Arbekacin|arbekacin|mesh-list
92445142|NCT01659515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92445143|NCT01659515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445144|NCT01659619|Erythromycin|erythromycin|mesh-list
92445145|NCT01659619|Erythromycin Estolate|erythromycin estolate|mesh-list
92445146|NCT01659619|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92445147|NCT01659619|Erythromycin stearate|erythromycin stearate|mesh-list
92445148|NCT01659619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92445149|NCT01659619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445150|NCT01659619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445151|NCT01659619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92445152|NCT01659619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445153|NCT01659619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445154|NCT01659684|Immunoglobulins|immunoglobulins|mesh-list
92445155|NCT01659684|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92445156|NCT01659684|Antibodies|antibodies|mesh-list
92445157|NCT01659684|gamma-Globulins|gamma-globulins|mesh-list
92445158|NCT01659684|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92445159|NCT01659684|Immunologic Factors|immunologic factors|mesh-ancestor
92445160|NCT01659684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445161|NCT01659788|Ubiquinone|ubiquinone|mesh-list
92445162|NCT01659788|Coenzyme Q10|coenzyme q10|mesh-list
92445163|NCT01659788|Micronutrients|micronutrients|mesh-ancestor
92445164|NCT01659788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445165|NCT01659788|Vitamins|vitamins|mesh-ancestor
92445166|NCT01659827|Bupivacaine|bupivacaine|mesh-list
92445167|NCT01659827|Anesthetics, Local|anesthetics, local|mesh-ancestor
92445168|NCT01659827|Anesthetics|anesthetics|mesh-ancestor
92445169|NCT01659827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531252|NCT00001688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445170|NCT01659827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445171|NCT01659827|Sensory System Agents|sensory system agents|mesh-ancestor
92445172|NCT01659827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445173|NCT01659892|Montelukast|montelukast|mesh-list
92445174|NCT01659892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92445175|NCT01659892|Respiratory System Agents|respiratory system agents|mesh-ancestor
92445176|NCT01659892|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92445177|NCT01659892|Hormone Antagonists|hormone antagonists|mesh-ancestor
92445178|NCT01659892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445179|NCT01659892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346476|NCT01826370|Hormones|hormones|mesh-ancestor
92445180|NCT01659892|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92445181|NCT01659892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92445182|NCT01659892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445183|NCT01659905|Montelukast|montelukast|mesh-list
92445184|NCT01659905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92445185|NCT01659905|Respiratory System Agents|respiratory system agents|mesh-ancestor
92170047|NCT05324059|Anticonvulsants|anticonvulsants|mesh-ancestor
92170048|NCT05324059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92170049|NCT05324059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170050|NCT05324059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170051|NCT05324059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92170052|NCT05324059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92170053|NCT05324059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92170054|NCT05324059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170055|NCT05324059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92170056|NCT05324059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92170057|NCT05324059|Narcotics|narcotics|mesh-ancestor
92170058|NCT05319353|Maribavir|maribavir|mesh-list
92170059|NCT05319353|Antiviral Agents|antiviral agents|mesh-ancestor
92170060|NCT05319353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445187|NCT01659905|Hormone Antagonists|hormone antagonists|mesh-ancestor
92445188|NCT01659905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445189|NCT01659905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445190|NCT01659905|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92445191|NCT01659905|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92445192|NCT01659905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445193|NCT01659918|Montelukast|montelukast|mesh-list
92445194|NCT01659918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92445195|NCT01659918|Respiratory System Agents|respiratory system agents|mesh-ancestor
92445196|NCT01659918|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92445197|NCT01659918|Hormone Antagonists|hormone antagonists|mesh-ancestor
92445198|NCT01659918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445199|NCT01659918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445200|NCT01659918|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92445201|NCT01659918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92445202|NCT01659918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445203|NCT01659931|Montelukast|montelukast|mesh-list
92445204|NCT01659931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92445205|NCT01659931|Respiratory System Agents|respiratory system agents|mesh-ancestor
92445206|NCT01659931|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92445207|NCT01659931|Hormone Antagonists|hormone antagonists|mesh-ancestor
92445208|NCT01659931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445209|NCT01659931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445210|NCT01659931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92346503|NCT01798992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445211|NCT01659931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92445212|NCT01659931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445213|NCT01659944|Metoprolol|metoprolol|mesh-list
92445214|NCT01659944|Eliglustat|eliglustat|mesh-list
92445215|NCT01659944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92445216|NCT01659944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92445217|NCT01659944|Sympatholytics|sympatholytics|mesh-ancestor
92445218|NCT01659944|Autonomic Agents|autonomic agents|mesh-ancestor
92445219|NCT01659944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445220|NCT01659944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445221|NCT01659944|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92445222|NCT01659944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92445223|NCT01659944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92445224|NCT01659944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92445225|NCT01659944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445226|NCT01659944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445227|NCT01659944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445228|NCT01659775|Ondansetron|ondansetron|mesh-list
92445229|NCT01659775|Antiemetics|antiemetics|mesh-ancestor
92445230|NCT01659775|Autonomic Agents|autonomic agents|mesh-ancestor
92445231|NCT01659775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445232|NCT01659775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445233|NCT01659775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445234|NCT01659775|Antipruritics|antipruritics|mesh-ancestor
92445235|NCT01659775|Dermatologic Agents|dermatologic agents|mesh-ancestor
92445236|NCT01659775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92445237|NCT01659775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92445238|NCT01659775|Serotonin Agents|serotonin agents|mesh-ancestor
92445239|NCT01659775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445240|NCT01659775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445241|NCT01660295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92445242|NCT01660295|Dihydroergotamine|dihydroergotamine|mesh-list
92445244|NCT01660295|Anticoagulants|anticoagulants|mesh-ancestor
92445245|NCT01660295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92445246|NCT01660295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92445247|NCT01660295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445248|NCT01660295|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92445249|NCT01660295|Dopamine Agonists|dopamine agonists|mesh-ancestor
92445250|NCT01660295|Dopamine Agents|dopamine agents|mesh-ancestor
92445251|NCT01660295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445252|NCT01660295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445253|NCT01660295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445254|NCT01660295|Analgesics|analgesics|mesh-ancestor
92445255|NCT01660295|Sensory System Agents|sensory system agents|mesh-ancestor
92170121|NCT05197439|Dexmedetomidine|dexmedetomidine|mesh-list
92445256|NCT01660295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445257|NCT01660373|Tirofiban|tirofiban|mesh-list
92445258|NCT01660373|Ticagrelor|ticagrelor|mesh-list
92445259|NCT01660373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92445260|NCT01660373|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92445261|NCT01660373|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92445262|NCT01660373|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92445263|NCT01660373|Purinergic Agents|purinergic agents|mesh-ancestor
92445264|NCT01660373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445265|NCT01660373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445266|NCT01660373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445267|NCT01660373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92445268|NCT01660373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92445269|NCT01660386|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92445270|NCT01660386|Glimepiride|glimepiride|mesh-list
92445271|NCT01660386|Saxagliptin|saxagliptin|mesh-list
92445272|NCT01660386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92445273|NCT01660386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445274|NCT01660386|Incretins|incretins|mesh-ancestor
92445275|NCT01660386|Hormones|hormones|mesh-ancestor
92445276|NCT01660386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445277|NCT01660386|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92445278|NCT01660386|Protease Inhibitors|protease inhibitors|mesh-ancestor
92445279|NCT01660386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445280|NCT01660386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445281|NCT01660386|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92445282|NCT01660386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92445283|NCT01660386|Immunologic Factors|immunologic factors|mesh-ancestor
92445284|NCT01660399|Docetaxel|docetaxel|mesh-list
92445285|NCT01660399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445286|NCT01660399|Tubulin Modulators|tubulin modulators|mesh-ancestor
92445287|NCT01660399|Antimitotic Agents|antimitotic agents|mesh-ancestor
92445288|NCT01660399|Mitosis Modulators|mitosis modulators|mesh-ancestor
92445289|NCT01660399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445290|NCT01660477|Ritonavir|ritonavir|mesh-list
92445291|NCT01660477|Lopinavir|lopinavir|mesh-list
92445292|NCT01660477|Isavuconazole|isavuconazole|mesh-list
92445293|NCT01660477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92445294|NCT01660477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92445295|NCT01660477|Protease Inhibitors|protease inhibitors|mesh-ancestor
92445296|NCT01660477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531255|NCT00001688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92445297|NCT01660477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445299|NCT01660477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92445300|NCT01660477|Antiviral Agents|antiviral agents|mesh-ancestor
92445301|NCT01660477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445302|NCT01660477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92445303|NCT01660477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92445304|NCT01660477|Antifungal Agents|antifungal agents|mesh-ancestor
92445305|NCT01660542|Docetaxel|docetaxel|mesh-list
92445306|NCT01660542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445307|NCT01660542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92445308|NCT01660542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92445309|NCT01660542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92445310|NCT01660542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445311|NCT01660594|Calcium|calcium|mesh-list
92445312|NCT01660594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92445313|NCT01660594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445314|NCT01660620|Betaxolol|betaxolol|mesh-list
92445315|NCT01660620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92445316|NCT01660620|Sympatholytics|sympatholytics|mesh-ancestor
92445317|NCT01660620|Autonomic Agents|autonomic agents|mesh-ancestor
92445318|NCT01660620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445319|NCT01660620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445320|NCT01660620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92346555|NCT01797120|Everolimus|everolimus|mesh-list
92445321|NCT01660620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92445322|NCT01660620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92445323|NCT01660620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92445324|NCT01660620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445325|NCT01660620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445326|NCT01660750|Dexamethasone|dexamethasone|mesh-list
92445327|NCT01660750|Cyclophosphamide|cyclophosphamide|mesh-list
92445328|NCT01660750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92445329|NCT01660750|Immunologic Factors|immunologic factors|mesh-ancestor
92445330|NCT01660750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445331|NCT01660750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445332|NCT01660750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92445333|NCT01660750|Alkylating Agents|alkylating agents|mesh-ancestor
92445334|NCT01660750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445335|NCT01660750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445336|NCT01660750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92445337|NCT01660750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445338|NCT01660750|Antiemetics|antiemetics|mesh-ancestor
92445339|NCT01660750|Autonomic Agents|autonomic agents|mesh-ancestor
92445340|NCT01660750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445341|NCT01660750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445342|NCT01660750|Glucocorticoids|glucocorticoids|mesh-ancestor
92445343|NCT01660750|Hormones|hormones|mesh-ancestor
92445344|NCT01660750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445345|NCT01660750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445346|NCT01660854|Proguanil|proguanil|mesh-list
92445347|NCT01660854|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92445348|NCT01660854|Antimalarials|antimalarials|mesh-ancestor
92445349|NCT01660854|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92445350|NCT01660854|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92445351|NCT01660854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445352|NCT01660854|Antimetabolites|antimetabolites|mesh-ancestor
92445353|NCT01660854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445354|NCT01660867|Dexamethasone|dexamethasone|mesh-list
92445355|NCT01660867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445356|NCT01660867|Antiemetics|antiemetics|mesh-ancestor
92445357|NCT01660867|Autonomic Agents|autonomic agents|mesh-ancestor
92445358|NCT01660867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445359|NCT01660867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445360|NCT01660867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445361|NCT01660867|Glucocorticoids|glucocorticoids|mesh-ancestor
92445362|NCT01660867|Hormones|hormones|mesh-ancestor
92445363|NCT01660867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445364|NCT01660867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445365|NCT01660867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445366|NCT01660919|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92445367|NCT01660919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92445368|NCT01660919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92445369|NCT01660919|Antimetabolites|antimetabolites|mesh-ancestor
92445370|NCT01660919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445371|NCT01660919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92445372|NCT01660919|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92445373|NCT01660919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445374|NCT01660945|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92445375|NCT01660945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92445376|NCT01660945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92445377|NCT01660945|Antimetabolites|antimetabolites|mesh-ancestor
92445378|NCT01660945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445379|NCT01660945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92445380|NCT01660997|Dexamethasone|dexamethasone|mesh-list
92445381|NCT01660997|Ixazomib|ixazomib|mesh-list
92445382|NCT01660997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445383|NCT01660997|Antiemetics|antiemetics|mesh-ancestor
92445384|NCT01660997|Autonomic Agents|autonomic agents|mesh-ancestor
92445385|NCT01660997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445386|NCT01660997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445387|NCT01660997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445388|NCT01660997|Glucocorticoids|glucocorticoids|mesh-ancestor
92445389|NCT01660997|Hormones|hormones|mesh-ancestor
92445390|NCT01660997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445391|NCT01660997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445392|NCT01660997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445393|NCT01660997|Protease Inhibitors|protease inhibitors|mesh-ancestor
92445394|NCT01660997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445395|NCT01660997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445396|NCT01661101|Omeprazole|omeprazole|mesh-list
92445397|NCT01661101|Dabigatran|dabigatran|mesh-list
92445398|NCT01661101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92445399|NCT01661101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445400|NCT01661101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92445401|NCT01661101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445402|NCT01661101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445403|NCT01661101|Antithrombins|antithrombins|mesh-ancestor
92445404|NCT01661101|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92445405|NCT01661101|Protease Inhibitors|protease inhibitors|mesh-ancestor
92445406|NCT01661101|Anticoagulants|anticoagulants|mesh-ancestor
92445407|NCT01661192|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92445408|NCT01661192|Protein C Inhibitor|protein c inhibitor|mesh-list
92445409|NCT01661192|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92445410|NCT01661192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92445411|NCT01661192|Protease Inhibitors|protease inhibitors|mesh-ancestor
92445412|NCT01661192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445413|NCT01661192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445414|NCT01661257|Infliximab|infliximab|mesh-list
92445415|NCT01661257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92445416|NCT01661257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445417|NCT01661257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92445418|NCT01661257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445419|NCT01661257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445420|NCT01661296|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92445421|NCT01661296|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92445422|NCT01661296|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92445423|NCT01661296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445424|NCT01661296|Schistosomicides|schistosomicides|mesh-ancestor
92445425|NCT01661296|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92445426|NCT01661296|Anthelmintics|anthelmintics|mesh-ancestor
92445427|NCT01661309|Vitamin B 12|vitamin b 12|mesh-list
92445428|NCT01661309|Vitamins|vitamins|mesh-ancestor
92445429|NCT01661309|Micronutrients|micronutrients|mesh-ancestor
92445430|NCT01661309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445431|NCT01661309|Vitamin B Complex|vitamin b complex|mesh-ancestor
92445432|NCT01661322|Aspirin|aspirin|mesh-list
92445433|NCT01661322|Clopidogrel|clopidogrel|mesh-list
92445434|NCT01661322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92445435|NCT01661322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445436|NCT01661322|Analgesics|analgesics|mesh-ancestor
92445437|NCT01661322|Sensory System Agents|sensory system agents|mesh-ancestor
92445438|NCT01661322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445439|NCT01661322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445440|NCT01661322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445441|NCT01661322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445442|NCT01661322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92445443|NCT01661322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92445444|NCT01661322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445445|NCT01661322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92445446|NCT01661322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92445447|NCT01661322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445448|NCT01661322|Antipyretics|antipyretics|mesh-ancestor
92445449|NCT01661322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92445450|NCT01661322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92445451|NCT01661322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92445452|NCT01661322|Purinergic Agents|purinergic agents|mesh-ancestor
92445453|NCT01661322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445454|NCT01661335|Dexamethasone|dexamethasone|mesh-list
92445455|NCT01661335|Dexamethasone acetate|dexamethasone acetate|mesh-list
92445456|NCT01661335|Ondansetron|ondansetron|mesh-list
92445457|NCT01661335|Aprepitant|aprepitant|mesh-list
92445458|NCT01661335|Fosaprepitant|fosaprepitant|mesh-list
92445459|NCT01661335|BB 1101|bb 1101|mesh-list
92445460|NCT01661335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445461|NCT01661335|Antiemetics|antiemetics|mesh-ancestor
92445462|NCT01661335|Autonomic Agents|autonomic agents|mesh-ancestor
92445463|NCT01661335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445464|NCT01661335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445465|NCT01661335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445466|NCT01661335|Glucocorticoids|glucocorticoids|mesh-ancestor
92445467|NCT01661335|Hormones|hormones|mesh-ancestor
92445468|NCT01661335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445469|NCT01661335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445470|NCT01661335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445471|NCT01661335|Protease Inhibitors|protease inhibitors|mesh-ancestor
92445472|NCT01661335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445473|NCT01661335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445474|NCT01661335|Antipruritics|antipruritics|mesh-ancestor
92445475|NCT01661335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92445476|NCT01661335|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92445477|NCT01661335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92445478|NCT01661335|Serotonin Agents|serotonin agents|mesh-ancestor
92445479|NCT01661335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445480|NCT01661335|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92445481|NCT01661439|Heparin|heparin|mesh-list
92445482|NCT01661439|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92445483|NCT01661439|Tinzaparin|tinzaparin|mesh-list
92445484|NCT01661439|Dalteparin|dalteparin|mesh-list
92445485|NCT01661439|Anticoagulants|anticoagulants|mesh-ancestor
92445486|NCT01661439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92445487|NCT01661439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92445488|NCT01661439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445489|NCT01661530|Vitamin E|vitamin e|mesh-list
92445490|NCT01661530|Vitamins|vitamins|mesh-ancestor
92445491|NCT01661530|Micronutrients|micronutrients|mesh-ancestor
92445492|NCT01661530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445493|NCT01661530|Antioxidants|antioxidants|mesh-ancestor
92346605|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445494|NCT01661530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445495|NCT01661530|Protective Agents|protective agents|mesh-ancestor
92445496|NCT01661556|Miconazole|miconazole|mesh-list
92445497|NCT01661556|Hydroquinone|hydroquinone|mesh-list
92445498|NCT01661556|Antifungal Agents|antifungal agents|mesh-ancestor
92445499|NCT01661556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445500|NCT01661556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92445501|NCT01661556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92445502|NCT01661556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445503|NCT01661556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445504|NCT01661556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92445505|NCT01661556|Hormone Antagonists|hormone antagonists|mesh-ancestor
92445506|NCT01661556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445507|NCT01661556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445508|NCT01661556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92445509|NCT01661556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92445510|NCT01661556|Antioxidants|antioxidants|mesh-ancestor
92445511|NCT01661556|Protective Agents|protective agents|mesh-ancestor
92445512|NCT01661556|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92445513|NCT01661751|Vaccines|vaccines|mesh-list
92445514|NCT01661751|Immunologic Factors|immunologic factors|mesh-ancestor
92445515|NCT01661751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445516|NCT01661777|Diuretics|diuretics|mesh-list
92445517|NCT01661777|Histamine Antagonists|histamine antagonists|mesh-list
92445518|NCT01661777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92445519|NCT01661777|Natriuretic Agents|natriuretic agents|mesh-ancestor
92445520|NCT01661777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445521|NCT01661777|Histamine Agents|histamine agents|mesh-ancestor
92445522|NCT01661777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445523|NCT01661777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445524|NCT01661855|Riluzole|riluzole|mesh-list
92445525|NCT01661855|Anticonvulsants|anticonvulsants|mesh-ancestor
92445526|NCT01661855|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92445527|NCT01661855|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92445528|NCT01661855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445529|NCT01661855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445530|NCT01661855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445531|NCT01661855|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92445532|NCT01661855|Protective Agents|protective agents|mesh-ancestor
92445533|NCT01661868|Olaparib|olaparib|mesh-list
92445534|NCT01661868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92445535|NCT01661868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445536|NCT01661868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445537|NCT01661868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445538|NCT01662037|Bosentan|bosentan|mesh-list
92445539|NCT01662037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92445540|NCT01662037|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92445541|NCT01662037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445542|NCT01662089|Zinc|zinc|mesh-list
92445543|NCT01662089|Trace Elements|trace elements|mesh-ancestor
92445544|NCT01662089|Micronutrients|micronutrients|mesh-ancestor
92445545|NCT01662089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445546|NCT01662128|Capecitabine|capecitabine|mesh-list
92170420|NCT04868838|Daratumumab|daratumumab|mesh-list
92170421|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170422|NCT04863638|Vaccines|vaccines|mesh-list
92170423|NCT04863638|Immunologic Factors|immunologic factors|mesh-ancestor
92170424|NCT04863638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170425|NCT04855617|Ocrelizumab|ocrelizumab|mesh-list
92170426|NCT04855617|Immunologic Factors|immunologic factors|mesh-ancestor
92170427|NCT04855617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170428|NCT04790786|Sotrovimab|sotrovimab|mesh-list
92170429|NCT04790786|Bamlanivimab|bamlanivimab|mesh-list
92170433|NCT04786210|Triamcinolone|triamcinolone|mesh-list
92445547|NCT01662128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92445548|NCT01662128|Antimetabolites|antimetabolites|mesh-ancestor
92445549|NCT01662128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445550|NCT01662128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445551|NCT01662180|Hormones|hormones|mesh-list
92445552|NCT01662180|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92445553|NCT01662180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445554|NCT01662180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445555|NCT01662193|Calcium, Dietary|calcium, dietary|mesh-list
92445556|NCT01662193|Vitamin D|vitamin d|mesh-list
92445557|NCT01662193|Ergocalciferols|ergocalciferols|mesh-list
92445558|NCT01662193|Cholecalciferol|cholecalciferol|mesh-list
92445559|NCT01662193|Vitamins|vitamins|mesh-list
92445560|NCT01662193|Calcium Carbonate|calcium carbonate|mesh-list
92445561|NCT01662193|Calcium|calcium|mesh-list
92445562|NCT01662193|Micronutrients|micronutrients|mesh-ancestor
92445563|NCT01662193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445564|NCT01662193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92346676|NCT01817790|Xhance|xhance|mesh-list
92445565|NCT01662193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92445566|NCT01662193|Antacids|antacids|mesh-ancestor
92445567|NCT01662193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445568|NCT01662193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445569|NCT01662349|Anti-Infective Agents|anti-infective agents|mesh-list
92445570|NCT01662349|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92445571|NCT01662401|Bupivacaine|bupivacaine|mesh-list
92445572|NCT01662401|Anesthetics, Local|anesthetics, local|mesh-ancestor
92445573|NCT01662401|Anesthetics|anesthetics|mesh-ancestor
92445574|NCT01662401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445575|NCT01662401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445576|NCT01662401|Sensory System Agents|sensory system agents|mesh-ancestor
92445577|NCT01662401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445578|NCT01662466|Methyltestosterone|methyltestosterone|mesh-list
92445579|NCT01662466|Testosterone|testosterone|mesh-list
92445580|NCT01662466|Testosterone undecanoate|testosterone undecanoate|mesh-list
92445581|NCT01662466|Testosterone enanthate|testosterone enanthate|mesh-list
92445582|NCT01662466|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92445583|NCT01662466|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92445584|NCT01662466|Androgens|androgens|mesh-ancestor
92445585|NCT01662466|Hormones|hormones|mesh-ancestor
92445586|NCT01662466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445587|NCT01662466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445588|NCT01662466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445589|NCT01662466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445590|NCT01662466|Anabolic Agents|anabolic agents|mesh-ancestor
92445591|NCT01662466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92445592|NCT01662466|Immunologic Factors|immunologic factors|mesh-ancestor
92445593|NCT01662518|Dexamethasone|dexamethasone|mesh-list
92445594|NCT01662518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445595|NCT01662518|Antiemetics|antiemetics|mesh-ancestor
92445596|NCT01662518|Autonomic Agents|autonomic agents|mesh-ancestor
92445597|NCT01662518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445598|NCT01662518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445599|NCT01662518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445600|NCT01662518|Glucocorticoids|glucocorticoids|mesh-ancestor
92445601|NCT01662518|Hormones|hormones|mesh-ancestor
92445602|NCT01662518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445603|NCT01662518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92445604|NCT01662518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445605|NCT01662622|Sevoflurane|sevoflurane|mesh-list
92445606|NCT01662622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92445607|NCT01662622|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92445608|NCT01662622|Anesthetics, General|anesthetics, general|mesh-ancestor
92445609|NCT01662622|Anesthetics|anesthetics|mesh-ancestor
92445610|NCT01662622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445611|NCT01662622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445612|NCT01662674|Metformin|metformin|mesh-list
92445613|NCT01662674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92445614|NCT01662674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445615|NCT01662687|Granisetron|granisetron|mesh-list
92445616|NCT01662687|Antiemetics|antiemetics|mesh-ancestor
92445617|NCT01662687|Autonomic Agents|autonomic agents|mesh-ancestor
92445618|NCT01662687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445619|NCT01662687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445620|NCT01662687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92445621|NCT01662687|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92445622|NCT01662687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92445623|NCT01662687|Serotonin Agents|serotonin agents|mesh-ancestor
92445624|NCT01662687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445625|NCT01662687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445626|NCT01662700|Artesunate|artesunate|mesh-list
92445627|NCT01662700|Chloroquine|chloroquine|mesh-list
92445628|NCT01662700|Antimalarials|antimalarials|mesh-ancestor
92445629|NCT01662700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92445630|NCT01662700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92445631|NCT01662700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445632|NCT01662700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445633|NCT01662700|Antiviral Agents|antiviral agents|mesh-ancestor
92445634|NCT01662700|Schistosomicides|schistosomicides|mesh-ancestor
92445635|NCT01662700|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92445636|NCT01662700|Anthelmintics|anthelmintics|mesh-ancestor
92445637|NCT01662700|Amebicides|amebicides|mesh-ancestor
92445638|NCT01662700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445639|NCT01662804|Interleukin-2|interleukin-2|mesh-list
92445640|NCT01662804|Antibodies|antibodies|mesh-list
92445641|NCT01662804|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92445642|NCT01662804|Immunologic Factors|immunologic factors|mesh-ancestor
92445643|NCT01662804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445644|NCT01662804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445645|NCT01662804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445646|NCT01662804|Analgesics|analgesics|mesh-ancestor
92445647|NCT01662804|Sensory System Agents|sensory system agents|mesh-ancestor
92445648|NCT01662804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445649|NCT01662869|Leucovorin|leucovorin|mesh-list
92445650|NCT01662869|Folic Acid|folic acid|mesh-list
92445651|NCT01662869|Oxaliplatin|oxaliplatin|mesh-list
92445652|NCT01662869|Fluorouracil|fluorouracil|mesh-list
92445653|NCT01662869|Levoleucovorin|levoleucovorin|mesh-list
92445654|NCT01662869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445655|NCT01662869|Antidotes|antidotes|mesh-ancestor
92531265|NCT00389402|Ritonavir|ritonavir|mesh-list
92445656|NCT01662869|Protective Agents|protective agents|mesh-ancestor
92445657|NCT01662869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445658|NCT01662869|Vitamin B Complex|vitamin b complex|mesh-ancestor
92445659|NCT01662869|Vitamins|vitamins|mesh-ancestor
92445660|NCT01662869|Micronutrients|micronutrients|mesh-ancestor
92445661|NCT01662869|Hematinics|hematinics|mesh-ancestor
92445662|NCT01662869|Antimetabolites|antimetabolites|mesh-ancestor
92445663|NCT01662869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445664|NCT01662869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92445665|NCT01662869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92445666|NCT01662869|Immunologic Factors|immunologic factors|mesh-ancestor
92445667|NCT01662921|Insulin|insulin|mesh-list
92445668|NCT01662921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92445669|NCT01662921|Insulin Lispro|insulin lispro|mesh-list
92445670|NCT01662921|Insulin glulisine|insulin glulisine|mesh-list
92445671|NCT01662921|Isophane Insulin, Human|isophane insulin, human|mesh-list
92445672|NCT01662921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92445673|NCT01662921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445674|NCT01663038|Aspirin|aspirin|mesh-list
92445675|NCT01663038|Clopidogrel|clopidogrel|mesh-list
92445676|NCT01663038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92445677|NCT01663038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445678|NCT01663038|Analgesics|analgesics|mesh-ancestor
92445679|NCT01663038|Sensory System Agents|sensory system agents|mesh-ancestor
92445680|NCT01663038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445681|NCT01663038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445682|NCT01663038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445683|NCT01663038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445684|NCT01663038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92445685|NCT01663038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92445686|NCT01663038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445687|NCT01663038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92445688|NCT01663038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92445689|NCT01663038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445690|NCT01663038|Antipyretics|antipyretics|mesh-ancestor
92445691|NCT01663038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92445692|NCT01663038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92445693|NCT01663038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92445694|NCT01663038|Purinergic Agents|purinergic agents|mesh-ancestor
92445695|NCT01663038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445696|NCT01663077|Clozapine|clozapine|mesh-list
92445697|NCT01663077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92445698|NCT01663077|Serotonin Agents|serotonin agents|mesh-ancestor
92445699|NCT01663077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445700|NCT01663077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445701|NCT01663077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445702|NCT01663077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92445703|NCT01663077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92445704|NCT01663077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445705|NCT01663077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92445707|NCT01663077|GABA Agents|gaba agents|mesh-ancestor
92445708|NCT01663090|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92445709|NCT01663090|Hematinics|hematinics|mesh-ancestor
92445710|NCT01663090|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92445711|NCT01663090|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92445712|NCT01663168|Rifabutin|rifabutin|mesh-list
92445713|NCT01663168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92445714|NCT01663168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445715|NCT01663168|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92445716|NCT01663168|Antitubercular Agents|antitubercular agents|mesh-ancestor
92445717|NCT01663441|Oprelvekin|oprelvekin|mesh-list
92445718|NCT01663441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445719|NCT01661985|Azithromycin|azithromycin|mesh-list
92445720|NCT01661985|Doxycycline|doxycycline|mesh-list
92445721|NCT01661985|Lymecycline|lymecycline|mesh-list
92445722|NCT01661985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92445723|NCT01661985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445724|NCT01661985|Antimalarials|antimalarials|mesh-ancestor
92445725|NCT01661985|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92445726|NCT01661985|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92445727|NCT01663558|Imiquimod|imiquimod|mesh-list
92445728|NCT01663558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92445729|NCT01663558|Immunologic Factors|immunologic factors|mesh-ancestor
92445730|NCT01663558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445731|NCT01663558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445732|NCT01663558|Interferon Inducers|interferon inducers|mesh-ancestor
92445733|NCT01663662|Tolvaptan|tolvaptan|mesh-list
92445734|NCT01663662|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92445735|NCT01663662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445736|NCT01663662|Natriuretic Agents|natriuretic agents|mesh-ancestor
92445737|NCT01663662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445738|NCT01663753|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92445739|NCT01663753|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92445740|NCT01663753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445741|NCT01663805|Everolimus|everolimus|mesh-list
92445742|NCT01663805|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92445743|NCT01663805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92445744|NCT01663805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445745|NCT01663805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445746|NCT01663805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92445747|NCT01663805|Immunologic Factors|immunologic factors|mesh-ancestor
92445748|NCT01663805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445749|NCT01663805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445750|NCT01663961|Digoxin|digoxin|mesh-list
92445751|NCT01663961|Mirabegron|mirabegron|mesh-list
92445752|NCT01663961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92445753|NCT01663961|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92445754|NCT01663961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445755|NCT01663961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445756|NCT01663961|Protective Agents|protective agents|mesh-ancestor
92445757|NCT01663961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445758|NCT01663961|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92445759|NCT01663961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92445760|NCT01663961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92445761|NCT01663961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92445762|NCT01663961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445763|NCT01663961|Urological Agents|urological agents|mesh-ancestor
92445764|NCT01664013|Botulinum Toxins|botulinum toxins|mesh-list
92445765|NCT01664013|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92445766|NCT01664013|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92445767|NCT01664013|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92445768|NCT01664013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92445769|NCT01664013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445770|NCT01664013|Cholinergic Agents|cholinergic agents|mesh-ancestor
92445771|NCT01664013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445772|NCT01664013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445773|NCT01664013|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92445774|NCT01664013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445775|NCT01664065|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92445776|NCT01664065|Cephalosporins|cephalosporins|mesh-list
92445777|NCT01664065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92445778|NCT01664065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445779|NCT01664195|Epoetin Alfa|epoetin alfa|mesh-list
92445780|NCT01664195|Hematinics|hematinics|mesh-ancestor
92445781|NCT01664221|Epoetin Alfa|epoetin alfa|mesh-list
92445782|NCT01664221|Hematinics|hematinics|mesh-ancestor
92445783|NCT01664260|Acetylcysteine|acetylcysteine|mesh-list
92445784|NCT01664260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92445785|NCT01664260|Antiviral Agents|antiviral agents|mesh-ancestor
92445786|NCT01664260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445787|NCT01664260|Expectorants|expectorants|mesh-ancestor
92445788|NCT01664260|Respiratory System Agents|respiratory system agents|mesh-ancestor
92445789|NCT01664260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92445790|NCT01664260|Antioxidants|antioxidants|mesh-ancestor
92445791|NCT01664260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445792|NCT01664260|Protective Agents|protective agents|mesh-ancestor
92445793|NCT01664260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445794|NCT01664260|Antidotes|antidotes|mesh-ancestor
92445795|NCT01664520|Dexmedetomidine|dexmedetomidine|mesh-list
92445796|NCT01664520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92445797|NCT01664520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445798|NCT01664520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445799|NCT01664520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445800|NCT01664520|Analgesics|analgesics|mesh-ancestor
92445801|NCT01664520|Sensory System Agents|sensory system agents|mesh-ancestor
92445802|NCT01664520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445803|NCT01664520|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92445804|NCT01664520|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92445805|NCT01664520|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92445806|NCT01664520|Adrenergic Agents|adrenergic agents|mesh-ancestor
92445807|NCT01664520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445808|NCT01664520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445810|NCT01664650|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92445811|NCT01664650|Protective Agents|protective agents|mesh-ancestor
92445812|NCT01664650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445813|NCT01664650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445814|NCT01664650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92445815|NCT01664650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445816|NCT01664650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445817|NCT01664650|Phytoestrogens|phytoestrogens|mesh-ancestor
92445818|NCT01664650|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92445819|NCT01664650|Estrogens|estrogens|mesh-ancestor
92445820|NCT01664650|Hormones|hormones|mesh-ancestor
92445821|NCT01664650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445822|NCT01664676|Liraglutide|liraglutide|mesh-list
92445823|NCT01664676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92445824|NCT01664676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445825|NCT01664676|Incretins|incretins|mesh-ancestor
92445826|NCT01664676|Hormones|hormones|mesh-ancestor
92445827|NCT01664676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445828|NCT01664728|Abiraterone Acetate|abiraterone acetate|mesh-list
92445829|NCT01664728|Glucocorticoids|glucocorticoids|mesh-list
92445830|NCT01664728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445831|NCT01664728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92445832|NCT01664728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445833|NCT01664728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445834|NCT01664728|Hormone Antagonists|hormone antagonists|mesh-ancestor
92445835|NCT01664728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445836|NCT01664728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445837|NCT01664728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92445838|NCT01664728|Hormones|hormones|mesh-ancestor
92445839|NCT01664754|Carboplatin|carboplatin|mesh-list
92445840|NCT01664754|Pemetrexed|pemetrexed|mesh-list
92445841|NCT01664754|Exemestane|exemestane|mesh-list
92445842|NCT01664754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445843|NCT01664754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445844|NCT01664754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445845|NCT01664754|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92445846|NCT01664754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92445847|NCT01664754|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92445848|NCT01664754|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92445849|NCT01664754|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92445850|NCT01664754|Hormone Antagonists|hormone antagonists|mesh-ancestor
92170724|NCT04239092|Cyclophosphamide|cyclophosphamide|mesh-list
92445851|NCT01664754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92445852|NCT01664754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445853|NCT01664819|Antioxidants|antioxidants|mesh-list
92445854|NCT01664819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445855|NCT01664819|Protective Agents|protective agents|mesh-ancestor
92445856|NCT01664819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445858|NCT01664845|Ribavirin|ribavirin|mesh-list
92445859|NCT01664845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92445860|NCT01664845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445861|NCT01664845|Antimetabolites|antimetabolites|mesh-ancestor
92445862|NCT01664845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445863|NCT01664845|Antiviral Agents|antiviral agents|mesh-ancestor
92445864|NCT01664845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445865|NCT01664871|Fluorides|fluorides|mesh-list
92445866|NCT01664871|Cariostatic Agents|cariostatic agents|mesh-ancestor
92445867|NCT01664871|Protective Agents|protective agents|mesh-ancestor
92445868|NCT01664871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445869|NCT01664936|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92445870|NCT01664936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92445871|NCT01664936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445872|NCT01665066|Nicotine|nicotine|mesh-list
92445873|NCT01665066|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92445874|NCT01665066|Autonomic Agents|autonomic agents|mesh-ancestor
92445875|NCT01665066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445876|NCT01665066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445877|NCT01665066|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92445878|NCT01665066|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92445879|NCT01665066|Cholinergic Agents|cholinergic agents|mesh-ancestor
92445880|NCT01665066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346751|NCT01836276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445881|NCT01665066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445882|NCT01665079|Propofol|propofol|mesh-list
92445883|NCT01665079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92445884|NCT01665079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445885|NCT01665079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445886|NCT01665079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92445887|NCT01665079|Anesthetics, General|anesthetics, general|mesh-ancestor
92445888|NCT01665079|Anesthetics|anesthetics|mesh-ancestor
92445889|NCT01665196|Deoxyglucose|deoxyglucose|mesh-list
92445890|NCT01665196|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92445891|NCT01665196|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92445892|NCT01665196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445893|NCT01665196|Antimetabolites|antimetabolites|mesh-ancestor
92445894|NCT01665196|Antiviral Agents|antiviral agents|mesh-ancestor
92445895|NCT01665196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445896|NCT01665209|Morphine|morphine|mesh-list
92445897|NCT01665209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92445898|NCT01665209|Narcotics|narcotics|mesh-ancestor
92445899|NCT01665209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445900|NCT01665209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445901|NCT01665209|Analgesics|analgesics|mesh-ancestor
92445902|NCT01665209|Sensory System Agents|sensory system agents|mesh-ancestor
92445903|NCT01665209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445904|NCT01665222|Morphine|morphine|mesh-list
92445905|NCT01665222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92445906|NCT01665222|Narcotics|narcotics|mesh-ancestor
92445907|NCT01665222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445908|NCT01665222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445909|NCT01665222|Analgesics|analgesics|mesh-ancestor
92445910|NCT01665222|Sensory System Agents|sensory system agents|mesh-ancestor
92445911|NCT01665222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445912|NCT01665235|Aspirin|aspirin|mesh-list
92445913|NCT01665235|Amlodipine|amlodipine|mesh-list
92445914|NCT01665235|Clopidogrel|clopidogrel|mesh-list
92445915|NCT01665235|Atorvastatin|atorvastatin|mesh-list
92445916|NCT01665235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92445917|NCT01665235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92445918|NCT01665235|Analgesics|analgesics|mesh-ancestor
92445919|NCT01665235|Sensory System Agents|sensory system agents|mesh-ancestor
92445920|NCT01665235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92445921|NCT01665235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445922|NCT01665235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445923|NCT01665235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92445924|NCT01665235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92445925|NCT01665235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92445926|NCT01665235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445927|NCT01665235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92445928|NCT01665235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92445929|NCT01665235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445930|NCT01665235|Antipyretics|antipyretics|mesh-ancestor
92445931|NCT01665235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92445932|NCT01665235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92445933|NCT01665235|Antimetabolites|antimetabolites|mesh-ancestor
92445934|NCT01665235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92445935|NCT01665235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92445936|NCT01665235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92445937|NCT01665235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92445938|NCT01665235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92445939|NCT01665235|Purinergic Agents|purinergic agents|mesh-ancestor
92445940|NCT01665235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445941|NCT01665235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92445942|NCT01665235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92445943|NCT01665235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92445944|NCT01665235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92445945|NCT01665235|Vasodilator Agents|vasodilator agents|mesh-ancestor
92445946|NCT01665248|Listerine|listerine|mesh-list
92445947|NCT01665248|Fluorides|fluorides|mesh-list
92445948|NCT01665248|Sodium Fluoride|sodium fluoride|mesh-list
92445949|NCT01665248|Cariostatic Agents|cariostatic agents|mesh-ancestor
92445950|NCT01665248|Protective Agents|protective agents|mesh-ancestor
92445951|NCT01665248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445952|NCT01665248|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92445953|NCT01665248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92445954|NCT01665378|Folic Acid|folic acid|mesh-list
92445955|NCT01665378|Vitamin B Complex|vitamin b complex|mesh-list
92445956|NCT01665378|Micronutrients|micronutrients|mesh-list
92445957|NCT01665378|Trace Elements|trace elements|mesh-list
92445958|NCT01665378|Hematinics|hematinics|mesh-ancestor
92445959|NCT01665378|Vitamins|vitamins|mesh-ancestor
92445960|NCT01665378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445961|NCT01665404|Fluvoxamine|fluvoxamine|mesh-list
92445962|NCT01665404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92445963|NCT01665404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92445964|NCT01665404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92445965|NCT01665404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445966|NCT01665404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92445967|NCT01665404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92445968|NCT01665404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92445969|NCT01665404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92445970|NCT01665404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445971|NCT01665404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92445972|NCT01665404|Serotonin Agents|serotonin agents|mesh-ancestor
92445973|NCT01665404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92445974|NCT01665404|Antidepressive Agents|antidepressive agents|mesh-ancestor
92445975|NCT01665404|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92445976|NCT01665404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92445977|NCT01665404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92445978|NCT01665404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92445979|NCT01665417|Docetaxel|docetaxel|mesh-list
92445980|NCT01665417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445981|NCT01665417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92445982|NCT01665417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92445983|NCT01665417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92445984|NCT01665417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445985|NCT01665469|Lycopene|lycopene|mesh-list
92445986|NCT01665469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92445987|NCT01665469|Antioxidants|antioxidants|mesh-ancestor
92445988|NCT01665469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92445989|NCT01665469|Protective Agents|protective agents|mesh-ancestor
92445990|NCT01665469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92445991|NCT01665469|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92445992|NCT01665469|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92445993|NCT01665469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92445994|NCT01664507|Epinephrine|epinephrine|mesh-list
92445995|NCT01664507|Racepinephrine|racepinephrine|mesh-list
92445996|NCT01664507|Epinephryl borate|epinephryl borate|mesh-list
92445997|NCT01664507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92445998|NCT01664507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92445999|NCT01664507|Adrenergic Agents|adrenergic agents|mesh-ancestor
92446000|NCT01664507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446001|NCT01664507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446002|NCT01664507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446003|NCT01664507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92446004|NCT01664507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92446005|NCT01664507|Autonomic Agents|autonomic agents|mesh-ancestor
92446006|NCT01664507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446007|NCT01664507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92446008|NCT01664507|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446009|NCT01664507|Mydriatics|mydriatics|mesh-ancestor
92446010|NCT01664507|Sympathomimetics|sympathomimetics|mesh-ancestor
92446011|NCT01664507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92446012|NCT01665586|Dexmedetomidine|dexmedetomidine|mesh-list
92446013|NCT01665586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92446014|NCT01665586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446015|NCT01665586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446016|NCT01665586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446017|NCT01665586|Analgesics|analgesics|mesh-ancestor
92446018|NCT01665586|Sensory System Agents|sensory system agents|mesh-ancestor
92446019|NCT01665586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446020|NCT01665586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92446021|NCT01665586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92446022|NCT01665586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92446023|NCT01665586|Adrenergic Agents|adrenergic agents|mesh-ancestor
92446024|NCT01665586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446025|NCT01665586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446026|NCT01665638|Canagliflozin|canagliflozin|mesh-list
92446027|NCT01665638|Somatostatin|somatostatin|mesh-list
92446028|NCT01665638|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92446029|NCT01665638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446031|NCT01665638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446032|NCT01665638|Hormones|hormones|mesh-ancestor
92446033|NCT01665638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446034|NCT01665703|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92446035|NCT01665703|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92446036|NCT01665703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446037|NCT01665742|Tocopherols|tocopherols|mesh-list
92446038|NCT01665742|Vitamin E|vitamin e|mesh-list
92446039|NCT01665742|alpha-Tocopherol|alpha-tocopherol|mesh-list
92446040|NCT01665742|Lycopene|lycopene|mesh-list
92446041|NCT01665742|Vitamins|vitamins|mesh-ancestor
92446042|NCT01665742|Micronutrients|micronutrients|mesh-ancestor
92446043|NCT01665742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446044|NCT01665742|Antioxidants|antioxidants|mesh-ancestor
92446045|NCT01665742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446046|NCT01665742|Protective Agents|protective agents|mesh-ancestor
92446047|NCT01665742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446048|NCT01665742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92446049|NCT01665742|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92446050|NCT01665742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446051|NCT01665781|Epoetin Alfa|epoetin alfa|mesh-list
92446052|NCT01665781|Hematinics|hematinics|mesh-ancestor
92446053|NCT01665846|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92446054|NCT01665846|Hematinics|hematinics|mesh-ancestor
92446055|NCT01665846|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92446056|NCT01665846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92446057|NCT01666041|Fenofibrate|fenofibrate|mesh-list
92446058|NCT01666041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92446059|NCT01666041|Antimetabolites|antimetabolites|mesh-ancestor
92446060|NCT01666041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446061|NCT01666041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92446062|NCT01666067|Simvastatin|simvastatin|mesh-list
92446063|NCT01666067|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92446064|NCT01666067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92446065|NCT01666067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92446066|NCT01666067|Antimetabolites|antimetabolites|mesh-ancestor
92446067|NCT01666067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446068|NCT01666067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92446069|NCT01666067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92446070|NCT01666067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446071|NCT01666171|Metformin|metformin|mesh-list
92446072|NCT01666171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92446073|NCT01666171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446074|NCT01666223|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92446075|NCT01666223|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92446076|NCT01666223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92446077|NCT01666223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92446078|NCT01666223|Antimetabolites|antimetabolites|mesh-ancestor
92446079|NCT01666223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446080|NCT01666223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92446081|NCT01666223|Cathartics|cathartics|mesh-ancestor
92446082|NCT01666223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446083|NCT01666236|Triamcinolone|triamcinolone|mesh-list
92446084|NCT01666236|Ranibizumab|ranibizumab|mesh-list
92446085|NCT01666236|Verteporfin|verteporfin|mesh-list
92446086|NCT01666236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92446087|NCT01666236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92446088|NCT01666236|Growth Substances|growth substances|mesh-ancestor
92446089|NCT01666236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446090|NCT01666236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92446091|NCT01666236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446092|NCT01666236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446093|NCT01666236|Glucocorticoids|glucocorticoids|mesh-ancestor
92446094|NCT01666236|Hormones|hormones|mesh-ancestor
92446095|NCT01666236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446096|NCT01666236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92446097|NCT01666236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446098|NCT01666249|Immunoglobulins|immunoglobulins|mesh-list
92446099|NCT01666249|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92446101|NCT01666249|Immunologic Factors|immunologic factors|mesh-ancestor
92446102|NCT01666249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446103|NCT01666262|Vaccines|vaccines|mesh-list
92446104|NCT01666262|Immunologic Factors|immunologic factors|mesh-ancestor
92446105|NCT01666262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446106|NCT01666301|Darbepoetin alfa|darbepoetin alfa|mesh-list
92446107|NCT01666301|Hematinics|hematinics|mesh-ancestor
92446108|NCT01666353|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92446109|NCT01666353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92446110|NCT01666353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446111|NCT01666379|Fentanyl|fentanyl|mesh-list
92446112|NCT01666379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92446113|NCT01666379|Narcotics|narcotics|mesh-ancestor
92446114|NCT01666379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446115|NCT01666379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446116|NCT01666379|Analgesics|analgesics|mesh-ancestor
92446117|NCT01666379|Sensory System Agents|sensory system agents|mesh-ancestor
92446118|NCT01666379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446119|NCT01666379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92446120|NCT01666379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92446121|NCT01666379|Anesthetics, General|anesthetics, general|mesh-ancestor
92446122|NCT01666379|Anesthetics|anesthetics|mesh-ancestor
92446123|NCT01666418|Paclitaxel|paclitaxel|mesh-list
92446124|NCT01666418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92446125|NCT01666418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446126|NCT01666418|Tubulin Modulators|tubulin modulators|mesh-ancestor
92446127|NCT01666418|Antimitotic Agents|antimitotic agents|mesh-ancestor
92446128|NCT01666418|Mitosis Modulators|mitosis modulators|mesh-ancestor
92346803|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
92446129|NCT01666418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446130|NCT01666431|Lapatinib|lapatinib|mesh-list
92446131|NCT01666431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446132|NCT01666431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446133|NCT01666431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446134|NCT01666431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446135|NCT01666522|Vitamin D|vitamin d|mesh-list
92446136|NCT01666522|Cholecalciferol|cholecalciferol|mesh-list
92446137|NCT01666522|Vitamins|vitamins|mesh-ancestor
92446138|NCT01666522|Micronutrients|micronutrients|mesh-ancestor
92446139|NCT01666522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446140|NCT01666522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92446141|NCT01666522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92446142|NCT01666587|Ibuprofen|ibuprofen|mesh-list
92446143|NCT01666587|Antioxidants|antioxidants|mesh-list
92446144|NCT01666587|Prostaglandin Antagonists|prostaglandin antagonists|mesh-list
92446145|NCT01666587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446146|NCT01666587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446147|NCT01666587|Analgesics|analgesics|mesh-ancestor
92446148|NCT01666587|Sensory System Agents|sensory system agents|mesh-ancestor
92446149|NCT01666587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446150|NCT01666587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446151|NCT01666587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446152|NCT01666587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446153|NCT01666587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446154|NCT01666587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446155|NCT01666587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446156|NCT01666587|Protective Agents|protective agents|mesh-ancestor
92446157|NCT01666587|Hormone Antagonists|hormone antagonists|mesh-ancestor
92446158|NCT01666587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446160|NCT01666600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446161|NCT01666600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446162|NCT01666600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446163|NCT01666600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446164|NCT01666665|Metformin|metformin|mesh-list
92446165|NCT01666665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92446166|NCT01666665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446167|NCT01666678|Diphenhydramine|diphenhydramine|mesh-list
92446168|NCT01666678|Promethazine|promethazine|mesh-list
92446169|NCT01666678|Naproxen|naproxen|mesh-list
92446170|NCT01666678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446171|NCT01666678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446173|NCT01666678|Sensory System Agents|sensory system agents|mesh-ancestor
92446174|NCT01666678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446175|NCT01666678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446176|NCT01666678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446177|NCT01666678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446178|NCT01666678|Gout Suppressants|gout suppressants|mesh-ancestor
92446179|NCT01666678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446180|NCT01666678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446181|NCT01666678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446182|NCT01666678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92446183|NCT01666678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92446184|NCT01666678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446185|NCT01666678|Anesthetics, Local|anesthetics, local|mesh-ancestor
92446186|NCT01666678|Anesthetics|anesthetics|mesh-ancestor
92446187|NCT01666678|Antiemetics|antiemetics|mesh-ancestor
92446188|NCT01666678|Autonomic Agents|autonomic agents|mesh-ancestor
92446189|NCT01666678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446190|NCT01666678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92446191|NCT01666678|Histamine Antagonists|histamine antagonists|mesh-ancestor
92446192|NCT01666678|Histamine Agents|histamine agents|mesh-ancestor
92446193|NCT01666678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446194|NCT01666678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92446195|NCT01666678|Antipruritics|antipruritics|mesh-ancestor
92446196|NCT01666678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446197|NCT01666691|CKD732|ckd732|mesh-list
92446198|NCT01666691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92446199|NCT01666691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92446200|NCT01666691|Growth Substances|growth substances|mesh-ancestor
92446201|NCT01666691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446202|NCT01666691|Growth Inhibitors|growth inhibitors|mesh-ancestor
92446203|NCT01666691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446204|NCT01666743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92446205|NCT01666743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446206|NCT01666743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446207|NCT01666756|Sorafenib|sorafenib|mesh-list
92446208|NCT01666756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446209|NCT01666756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446210|NCT01666756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446211|NCT01666756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446212|NCT01666769|Micafungin|micafungin|mesh-list
92446213|NCT01666769|Antifungal Agents|antifungal agents|mesh-ancestor
92446214|NCT01666769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446215|NCT01667094|Meropenem|meropenem|mesh-list
92446216|NCT01667094|Tazobactam|tazobactam|mesh-list
92446217|NCT01667094|Piperacillin|piperacillin|mesh-list
92446218|NCT01667094|Clavulanic Acid|clavulanic acid|mesh-list
92446219|NCT01667094|Clavulanic Acids|clavulanic acids|mesh-list
92446220|NCT01667094|Ceftazidime|ceftazidime|mesh-list
92446221|NCT01667094|Cefepime|cefepime|mesh-list
92446222|NCT01667094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92446223|NCT01667094|Ticarcillin|ticarcillin|mesh-list
92171097|NCT03808610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171098|NCT03808610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171099|NCT03808610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171100|NCT03808610|Alkylating Agents|alkylating agents|mesh-ancestor
92171101|NCT03808610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446224|NCT01667094|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
92446225|NCT01667094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446226|NCT01667094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446227|NCT01667094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92446228|NCT01667094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446229|NCT01667094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446230|NCT01667211|Paclitaxel|paclitaxel|mesh-list
92446231|NCT01667211|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92446232|NCT01667211|Nedaplatin|nedaplatin|mesh-list
92446233|NCT01667211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92446234|NCT01667211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446235|NCT01667211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92446236|NCT01667211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92446237|NCT01667211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92446238|NCT01667211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446239|NCT01667263|Tretinoin|tretinoin|mesh-list
92446240|NCT01667263|Danazol|danazol|mesh-list
92446241|NCT01667263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446242|NCT01667263|Keratolytic Agents|keratolytic agents|mesh-ancestor
92446243|NCT01667263|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446244|NCT01667263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92446245|NCT01667263|Hormone Antagonists|hormone antagonists|mesh-ancestor
92446246|NCT01667263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446247|NCT01667263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446248|NCT01667315|Bupivacaine|bupivacaine|mesh-list
92446249|NCT01667315|Anesthetics, Local|anesthetics, local|mesh-ancestor
92446251|NCT01667315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446252|NCT01667315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446253|NCT01667315|Sensory System Agents|sensory system agents|mesh-ancestor
92446254|NCT01667315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446255|NCT01667445|Morphine|morphine|mesh-list
92446256|NCT01667445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92446257|NCT01667445|Narcotics|narcotics|mesh-ancestor
92446258|NCT01667445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446259|NCT01667445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446260|NCT01667445|Analgesics|analgesics|mesh-ancestor
92446261|NCT01667445|Sensory System Agents|sensory system agents|mesh-ancestor
92446262|NCT01667445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446263|NCT01667484|Adderall|adderall|mesh-list
92446264|NCT01667484|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92446265|NCT01667484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446266|NCT01667497|4-Aminopyridine|4-aminopyridine|mesh-list
92446267|NCT01667497|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92446268|NCT01667497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92446269|NCT01667497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446270|NCT01667523|Cinnamaldehyde|cinnamaldehyde|mesh-list
92446271|NCT01667523|Capsaicin|capsaicin|mesh-list
92446272|NCT01667523|Antipruritics|antipruritics|mesh-ancestor
92446273|NCT01667523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446274|NCT01667523|Sensory System Agents|sensory system agents|mesh-ancestor
92446275|NCT01667523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446276|NCT01667523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446277|NCT01667523|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92446278|NCT01667523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446279|NCT01667523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92446280|NCT01667523|Protective Agents|protective agents|mesh-ancestor
92446281|NCT01667575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92446282|NCT01667575|Amoxicillin|amoxicillin|mesh-list
92446283|NCT01667575|Clarithromycin|clarithromycin|mesh-list
92446284|NCT01667575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92446285|NCT01667575|Potassium Citrate|potassium citrate|mesh-list
92446286|NCT01667575|Esomeprazole|esomeprazole|mesh-list
92446287|NCT01667575|Bismuth|bismuth|mesh-list
92446288|NCT01667575|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92446289|NCT01667575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446290|NCT01667575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446291|NCT01667575|Antitubercular Agents|antitubercular agents|mesh-ancestor
92446292|NCT01667575|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92446293|NCT01667575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446294|NCT01667575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446295|NCT01667575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92446296|NCT01667575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92446297|NCT01667575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92446298|NCT01667575|Antacids|antacids|mesh-ancestor
92446299|NCT01667575|Diuretics|diuretics|mesh-ancestor
92446300|NCT01667575|Natriuretic Agents|natriuretic agents|mesh-ancestor
92446301|NCT01667575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446302|NCT01667575|Expectorants|expectorants|mesh-ancestor
92446303|NCT01667575|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446304|NCT01667614|Losartan|losartan|mesh-list
92446305|NCT01667614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92446306|NCT01667614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92446307|NCT01667614|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92446308|NCT01667614|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92446309|NCT01667614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446310|NCT01667692|Azithromycin|azithromycin|mesh-list
92446311|NCT01667692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446312|NCT01667692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446313|NCT01667718|Amoxicillin|amoxicillin|mesh-list
92446314|NCT01667718|Levofloxacin|levofloxacin|mesh-list
92446315|NCT01667718|Potassium Citrate|potassium citrate|mesh-list
92446316|NCT01667718|Lansoprazole|lansoprazole|mesh-list
92446317|NCT01667718|Dexlansoprazole|dexlansoprazole|mesh-list
92446318|NCT01667718|Bismuth|bismuth|mesh-list
92446319|NCT01667718|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92446320|NCT01667718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446321|NCT01667718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446322|NCT01667718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446323|NCT01667718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92446324|NCT01667718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92446325|NCT01667718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92446326|NCT01667718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446327|NCT01667718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446328|NCT01667718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92446329|NCT01667718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92446330|NCT01667718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92446331|NCT01667718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446333|NCT01667718|Diuretics|diuretics|mesh-ancestor
92446334|NCT01667718|Natriuretic Agents|natriuretic agents|mesh-ancestor
92446335|NCT01667718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446336|NCT01667718|Expectorants|expectorants|mesh-ancestor
92446337|NCT01667718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446338|NCT01667874|Gentamicins|gentamicins|mesh-list
92446339|NCT01667874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446340|NCT01667874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446341|NCT01667874|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92446342|NCT01667874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446343|NCT01667874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446344|NCT01668043|UB-421|ub-421|mesh-list
92446345|NCT01668043|Antibodies|antibodies|mesh-list
92446346|NCT01668043|Immunologic Factors|immunologic factors|mesh-ancestor
92446347|NCT01668043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446348|NCT01668043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92446349|NCT01668043|Antiviral Agents|antiviral agents|mesh-ancestor
92446350|NCT01668043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446351|NCT01668056|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92446352|NCT01668056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92446353|NCT01668056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446354|NCT01668069|Ondansetron|ondansetron|mesh-list
92446355|NCT01668069|Antiemetics|antiemetics|mesh-ancestor
92446356|NCT01668069|Autonomic Agents|autonomic agents|mesh-ancestor
92446357|NCT01668069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446358|NCT01668069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446359|NCT01668069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446360|NCT01668069|Antipruritics|antipruritics|mesh-ancestor
92446361|NCT01668069|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446362|NCT01668069|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92446363|NCT01668069|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92446364|NCT01668069|Serotonin Agents|serotonin agents|mesh-ancestor
92446365|NCT01668069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446366|NCT01668069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446367|NCT01668121|Budesonide|budesonide|mesh-list
92446368|NCT01668121|Formoterol Fumarate|formoterol fumarate|mesh-list
92446369|NCT01668121|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92446370|NCT01668121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446371|NCT01668121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92446372|NCT01668121|Autonomic Agents|autonomic agents|mesh-ancestor
92446373|NCT01668121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446374|NCT01668121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446375|NCT01668121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92446376|NCT01668121|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446377|NCT01668121|Glucocorticoids|glucocorticoids|mesh-ancestor
92446378|NCT01668121|Hormones|hormones|mesh-ancestor
92446379|NCT01668121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446380|NCT01668121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92446381|NCT01668121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92446382|NCT01668121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92446383|NCT01668121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92446384|NCT01668121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446385|NCT01668121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446386|NCT01668433|Primaquine|primaquine|mesh-list
92446387|NCT01668433|Methylene Blue|methylene blue|mesh-list
92446388|NCT01668433|Antimalarials|antimalarials|mesh-ancestor
92446389|NCT01668433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92446390|NCT01668433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92446391|NCT01668433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446392|NCT01668433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446393|NCT01668433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446394|NCT01668446|Sildenafil Citrate|sildenafil citrate|mesh-list
92446396|NCT01668446|Estrogens|estrogens|mesh-ancestor
92446397|NCT01668446|Hormones|hormones|mesh-ancestor
92446398|NCT01668446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92531273|NCT00389402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92446399|NCT01668446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446400|NCT01668446|Vasodilator Agents|vasodilator agents|mesh-ancestor
92446401|NCT01668446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92446402|NCT01668446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92446403|NCT01668446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446404|NCT01668446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446405|NCT01668446|Urological Agents|urological agents|mesh-ancestor
92446406|NCT01668485|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92346828|NCT01606800|Ribavirin|ribavirin|mesh-list
92446407|NCT01668485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446408|NCT01668498|Doxycycline|doxycycline|mesh-list
92446409|NCT01668498|Erythromycin|erythromycin|mesh-list
92446410|NCT01668498|Erythromycin Estolate|erythromycin estolate|mesh-list
92446411|NCT01668498|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92446412|NCT01668498|Erythromycin stearate|erythromycin stearate|mesh-list
92446413|NCT01668498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446414|NCT01668498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446415|NCT01668498|Antimalarials|antimalarials|mesh-ancestor
92446416|NCT01668498|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92446417|NCT01668498|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92446418|NCT01668498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446419|NCT01668498|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92446420|NCT01668498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446421|NCT01668498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446422|NCT01668550|AZD-0424|azd-0424|mesh-list
92446423|NCT01668550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446424|NCT01668550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446425|NCT01668550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446426|NCT01668615|Tretinoin|tretinoin|mesh-list
92446427|NCT01668615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446428|NCT01668615|Keratolytic Agents|keratolytic agents|mesh-ancestor
92446429|NCT01668615|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446430|NCT01668680|Celecoxib|celecoxib|mesh-list
92446431|NCT01668680|Capecitabine|capecitabine|mesh-list
92446432|NCT01668680|Methotrexate|methotrexate|mesh-list
92446433|NCT01668680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92446434|NCT01668680|Antimetabolites|antimetabolites|mesh-ancestor
92446435|NCT01668680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446436|NCT01668680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446437|NCT01668680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92446438|NCT01668680|Abortifacient Agents|abortifacient agents|mesh-ancestor
92446439|NCT01668680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92446440|NCT01668680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446441|NCT01668680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446442|NCT01668680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446443|NCT01668680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92446444|NCT01668680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92446445|NCT01668680|Immunologic Factors|immunologic factors|mesh-ancestor
92171322|NCT03616886|Carboplatin|carboplatin|mesh-list
92171323|NCT03616886|Durvalumab|durvalumab|mesh-list
92171324|NCT03616886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171325|NCT03616886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171326|NCT03616886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171327|NCT03616886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171331|NCT03610711|Nivolumab|nivolumab|mesh-list
92446446|NCT01668680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446447|NCT01668680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92446448|NCT01668680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446450|NCT01668680|Analgesics|analgesics|mesh-ancestor
92446451|NCT01668680|Sensory System Agents|sensory system agents|mesh-ancestor
92446452|NCT01668680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446453|NCT01668680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446454|NCT01668680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92446455|NCT01668680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446456|NCT01668901|Aspirin|aspirin|mesh-list
92446457|NCT01668901|Warfarin|warfarin|mesh-list
92446458|NCT01668901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446459|NCT01668901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446460|NCT01668901|Analgesics|analgesics|mesh-ancestor
92446461|NCT01668901|Sensory System Agents|sensory system agents|mesh-ancestor
92200130|NCT00081770|Ribavirin|ribavirin|mesh-list
92446462|NCT01668901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446463|NCT01668901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446464|NCT01668901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446465|NCT01668901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446466|NCT01668901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92446467|NCT01668901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92446468|NCT01668901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446469|NCT01668901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92446470|NCT01668901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446471|NCT01668901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446472|NCT01668901|Antipyretics|antipyretics|mesh-ancestor
92446473|NCT01668901|Anticoagulants|anticoagulants|mesh-ancestor
92446474|NCT01668927|Amoxicillin|amoxicillin|mesh-list
92446475|NCT01668927|Metronidazole|metronidazole|mesh-list
92446476|NCT01668927|Tetracycline|tetracycline|mesh-list
92446477|NCT01668927|Furazolidone|furazolidone|mesh-list
92446478|NCT01668927|Potassium Citrate|potassium citrate|mesh-list
92446479|NCT01668927|Lansoprazole|lansoprazole|mesh-list
92446481|NCT01668927|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92446482|NCT01668927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446483|NCT01668927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446484|NCT01668927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446485|NCT01668927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92446486|NCT01668927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92446487|NCT01668927|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92446488|NCT01668927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446489|NCT01668927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446491|NCT01668927|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92446492|NCT01668927|Diuretics|diuretics|mesh-ancestor
92446493|NCT01668927|Natriuretic Agents|natriuretic agents|mesh-ancestor
92446494|NCT01668927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446495|NCT01668927|Expectorants|expectorants|mesh-ancestor
92446496|NCT01668927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446497|NCT01668927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92446498|NCT01668927|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92446499|NCT01668927|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92446500|NCT01668927|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92446501|NCT01669044|Dexmedetomidine|dexmedetomidine|mesh-list
92446502|NCT01669044|Propofol|propofol|mesh-list
92446503|NCT01669044|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92446504|NCT01669044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446505|NCT01669044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446506|NCT01669044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446507|NCT01669044|Analgesics|analgesics|mesh-ancestor
92446508|NCT01669044|Sensory System Agents|sensory system agents|mesh-ancestor
92446509|NCT01669044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446510|NCT01669044|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92446511|NCT01669044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92446512|NCT01669044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92446513|NCT01669044|Adrenergic Agents|adrenergic agents|mesh-ancestor
92446514|NCT01669044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446515|NCT01669044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446516|NCT01669044|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92446517|NCT01669044|Anesthetics, General|anesthetics, general|mesh-ancestor
92446518|NCT01669044|Anesthetics|anesthetics|mesh-ancestor
92446519|NCT01669083|Diketopiperazines|diketopiperazines|mesh-list
92446520|NCT01669083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446521|NCT01669083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446522|NCT01669135|Anesthetics|anesthetics|mesh-list
92446523|NCT01669135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446524|NCT01669135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446525|NCT01669213|Ondansetron|ondansetron|mesh-list
92446526|NCT01669213|Ramosetron|ramosetron|mesh-list
92446527|NCT01669213|Antiemetics|antiemetics|mesh-ancestor
92446528|NCT01669213|Autonomic Agents|autonomic agents|mesh-ancestor
92446529|NCT01669213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446530|NCT01669213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446531|NCT01669213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446532|NCT01669213|Antipruritics|antipruritics|mesh-ancestor
92446533|NCT01669213|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446534|NCT01669213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92446535|NCT01669213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92446536|NCT01669213|Serotonin Agents|serotonin agents|mesh-ancestor
92446537|NCT01669213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446538|NCT01669213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446540|NCT01669226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446541|NCT01669239|Doxorubicin|doxorubicin|mesh-list
92446542|NCT01669239|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92446543|NCT01669239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92446544|NCT01669239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446545|NCT01669239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92446546|NCT01669239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92446547|NCT01669239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446548|NCT01669239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446549|NCT01669291|Leuprolide|leuprolide|mesh-list
92446550|NCT01669291|Cetrorelix|cetrorelix|mesh-list
92446551|NCT01669291|Menotropins|menotropins|mesh-list
92446552|NCT01669291|Ganirelix|ganirelix|mesh-list
92446553|NCT01669291|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92446554|NCT01669291|Fertility Agents|fertility agents|mesh-ancestor
92446555|NCT01669291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92446556|NCT01669291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446557|NCT01669291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92446558|NCT01669291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446559|NCT01669291|Hormone Antagonists|hormone antagonists|mesh-ancestor
92446560|NCT01669291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446561|NCT01669304|Verapamil|verapamil|mesh-list
92446562|NCT01669304|Sertraline|sertraline|mesh-list
92446563|NCT01669304|Antidepressive Agents|antidepressive agents|mesh-ancestor
92446564|NCT01669304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92446565|NCT01669304|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92446566|NCT01669304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92446567|NCT01669304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92446568|NCT01669304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446569|NCT01669304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446570|NCT01669304|Serotonin Agents|serotonin agents|mesh-ancestor
92171471|NCT03278782|Pembrolizumab|pembrolizumab|mesh-list
92171472|NCT03278782|Romidepsin|romidepsin|mesh-list
92171473|NCT03278782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171474|NCT03278782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171475|NCT03278782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171476|NCT03278782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171477|NCT03278782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171478|NCT03278782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92171479|NCT03278782|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92171480|NCT03278782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171509|NCT03248479|Azacitidine|azacitidine|mesh-list
92171510|NCT03248479|Magrolimab|magrolimab|mesh-list
92171511|NCT03248479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171512|NCT03248479|Antimetabolites|antimetabolites|mesh-ancestor
92171513|NCT03248479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171514|NCT03248479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171515|NCT03248479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171516|NCT03248479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171517|NCT03233711|Nivolumab|nivolumab|mesh-list
92171518|NCT03233711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171519|NCT03233711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171520|NCT03233711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171521|NCT03233711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171522|NCT03223610|Prednisone|prednisone|mesh-list
92171523|NCT03223610|Lenalidomide|lenalidomide|mesh-list
92171524|NCT03223610|Venetoclax|venetoclax|mesh-list
92446571|NCT01669304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446572|NCT01669304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92446573|NCT01669304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92446574|NCT01669304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92446575|NCT01669304|Vasodilator Agents|vasodilator agents|mesh-ancestor
92446576|NCT01669369|Lithium Carbonate|lithium carbonate|mesh-list
92446577|NCT01669369|Antidepressive Agents|antidepressive agents|mesh-ancestor
92446578|NCT01669369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92446579|NCT01669369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446580|NCT01669369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446581|NCT01669369|Antimanic Agents|antimanic agents|mesh-ancestor
92446582|NCT01669369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92446583|NCT01669369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446584|NCT01669369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446585|NCT01669447|Ranibizumab|ranibizumab|mesh-list
92446586|NCT01669447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92446587|NCT01669447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92446588|NCT01669447|Growth Substances|growth substances|mesh-ancestor
92446589|NCT01669447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446590|NCT01669447|Growth Inhibitors|growth inhibitors|mesh-ancestor
92446591|NCT01669447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446592|NCT01669499|Dexamethasone|dexamethasone|mesh-list
92446593|NCT01669499|Dexamethasone acetate|dexamethasone acetate|mesh-list
92446594|NCT01669499|BB 1101|bb 1101|mesh-list
92446595|NCT01669499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446596|NCT01669499|Antiemetics|antiemetics|mesh-ancestor
92446597|NCT01669499|Autonomic Agents|autonomic agents|mesh-ancestor
92446598|NCT01669499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446599|NCT01669499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446600|NCT01669499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446601|NCT01669499|Glucocorticoids|glucocorticoids|mesh-ancestor
92446602|NCT01669499|Hormones|hormones|mesh-ancestor
92446603|NCT01669499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446604|NCT01669499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92446605|NCT01669499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446606|NCT01669499|Protease Inhibitors|protease inhibitors|mesh-ancestor
92446607|NCT01669499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446608|NCT01669499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446609|NCT01669707|Endostar protein|endostar protein|mesh-list
92446610|NCT01669707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92446611|NCT01669707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92446612|NCT01669707|Growth Substances|growth substances|mesh-ancestor
92446613|NCT01669707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446614|NCT01669707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92446615|NCT01669707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446616|NCT01669824|Aspirin|aspirin|mesh-list
92446617|NCT01669824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446618|NCT01669824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446619|NCT01669824|Analgesics|analgesics|mesh-ancestor
92446620|NCT01669824|Sensory System Agents|sensory system agents|mesh-ancestor
92446621|NCT01669824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446622|NCT01669824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446623|NCT01669824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446624|NCT01669824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446625|NCT01669824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92446626|NCT01669824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92446627|NCT01669824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446628|NCT01669824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92446629|NCT01669824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446630|NCT01669824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446631|NCT01669824|Antipyretics|antipyretics|mesh-ancestor
92446632|NCT01669941|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92446633|NCT01669941|Antimalarials|antimalarials|mesh-ancestor
92446634|NCT01669941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92446635|NCT01669941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92446636|NCT01669941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446637|NCT01669967|Diphenhydramine|diphenhydramine|mesh-list
92446638|NCT01669967|Promethazine|promethazine|mesh-list
92446639|NCT01669967|Lidocaine|lidocaine|mesh-list
92446640|NCT01669967|Anesthetics, Local|anesthetics, local|mesh-ancestor
92446641|NCT01669967|Anesthetics|anesthetics|mesh-ancestor
92446642|NCT01669967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446643|NCT01669967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446644|NCT01669967|Sensory System Agents|sensory system agents|mesh-ancestor
92446645|NCT01669967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446647|NCT01669967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92446648|NCT01669967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92446649|NCT01669967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92446650|NCT01669967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446651|NCT01669967|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92446652|NCT01669967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92446653|NCT01669967|Antiemetics|antiemetics|mesh-ancestor
92446654|NCT01669967|Autonomic Agents|autonomic agents|mesh-ancestor
92446655|NCT01669967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446656|NCT01669967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92446657|NCT01669967|Histamine Antagonists|histamine antagonists|mesh-ancestor
92446658|NCT01669967|Histamine Agents|histamine agents|mesh-ancestor
92446659|NCT01669967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446660|NCT01669967|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92446661|NCT01669967|Antipruritics|antipruritics|mesh-ancestor
92446662|NCT01669967|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446663|NCT01670149|Rifaximin|rifaximin|mesh-list
92446664|NCT01670149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446665|NCT01670149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446666|NCT01670149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446667|NCT01670370|Gemcitabine|gemcitabine|mesh-list
92446668|NCT01670370|Oxaliplatin|oxaliplatin|mesh-list
92446669|NCT01670370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446670|NCT01670370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92446671|NCT01670370|Antimetabolites|antimetabolites|mesh-ancestor
92446672|NCT01670370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446673|NCT01670552|Naproxen|naproxen|mesh-list
92446674|NCT01670552|Nimesulide|nimesulide|mesh-list
92446675|NCT01670552|Esomeprazole|esomeprazole|mesh-list
92446676|NCT01670552|Pantoprazole|pantoprazole|mesh-list
92446677|NCT01670552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92446678|NCT01670552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446679|NCT01670552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92446680|NCT01670552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446681|NCT01670552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446682|NCT01670552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446683|NCT01670552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446684|NCT01670552|Analgesics|analgesics|mesh-ancestor
92446685|NCT01670552|Sensory System Agents|sensory system agents|mesh-ancestor
92446686|NCT01670552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446687|NCT01670552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446688|NCT01670552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446689|NCT01670552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446690|NCT01670552|Gout Suppressants|gout suppressants|mesh-ancestor
92446691|NCT01670552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446692|NCT01670578|Hyaluronic Acid|hyaluronic acid|mesh-list
92446693|NCT01670578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92446694|NCT01670578|Immunologic Factors|immunologic factors|mesh-ancestor
92446695|NCT01670578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446696|NCT01670578|Viscosupplements|viscosupplements|mesh-ancestor
92446697|NCT01670578|Protective Agents|protective agents|mesh-ancestor
92446698|NCT01670812|Methylprednisolone|methylprednisolone|mesh-list
92446699|NCT01670812|Rituximab|rituximab|mesh-list
92446700|NCT01670812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92446701|NCT01670812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446702|NCT01670812|Immunologic Factors|immunologic factors|mesh-ancestor
92446703|NCT01670812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446704|NCT01670812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446705|NCT01670812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446706|NCT01670812|Antiemetics|antiemetics|mesh-ancestor
92446707|NCT01670812|Autonomic Agents|autonomic agents|mesh-ancestor
92446708|NCT01670812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446709|NCT01670812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446710|NCT01670812|Glucocorticoids|glucocorticoids|mesh-ancestor
92446711|NCT01670812|Hormones|hormones|mesh-ancestor
92446712|NCT01670812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446713|NCT01670812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92446714|NCT01670812|Protective Agents|protective agents|mesh-ancestor
92446715|NCT01671449|Oxaliplatin|oxaliplatin|mesh-list
92446716|NCT01671449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446717|NCT01671800|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92446718|NCT01671800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92446719|NCT01671800|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92171624|NCT03089983|Methadone|methadone|mesh-list
92446720|NCT01671800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92446721|NCT01671800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446722|NCT01671800|Cholinergic Agents|cholinergic agents|mesh-ancestor
92446723|NCT01671800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446724|NCT01671800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446726|NCT01672359|Lipotropic Agents|lipotropic agents|mesh-ancestor
92446727|NCT01672359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92446728|NCT01672359|Antimetabolites|antimetabolites|mesh-ancestor
92446729|NCT01672359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446730|NCT01672359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446731|NCT01672359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92446732|NCT01672359|Nootropic Agents|nootropic agents|mesh-ancestor
92446733|NCT01673308|Lenalidomide|lenalidomide|mesh-list
92446734|NCT01673308|Immunologic Factors|immunologic factors|mesh-ancestor
92446735|NCT01673308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446736|NCT01673308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92446737|NCT01673308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92446738|NCT01673308|Growth Substances|growth substances|mesh-ancestor
92446739|NCT01673308|Growth Inhibitors|growth inhibitors|mesh-ancestor
92446740|NCT01673308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446741|NCT01673737|Vemurafenib|vemurafenib|mesh-list
92446742|NCT01673737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446743|NCT01673737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446744|NCT01673737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446745|NCT01673737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446746|NCT01674556|Gemcitabine|gemcitabine|mesh-list
92446747|NCT01674556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92446748|NCT01674556|Antimetabolites|antimetabolites|mesh-ancestor
92446749|NCT01674556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446750|NCT01674556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446751|NCT01675115|Aspirin|aspirin|mesh-list
92446752|NCT01675115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92446753|NCT01675115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446754|NCT01675115|Analgesics|analgesics|mesh-ancestor
92446755|NCT01675115|Sensory System Agents|sensory system agents|mesh-ancestor
92446756|NCT01675115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446757|NCT01675115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446758|NCT01675115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446759|NCT01675115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446760|NCT01675115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92446761|NCT01675115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92446762|NCT01675115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446763|NCT01675115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92446764|NCT01675115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92446765|NCT01675115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446766|NCT01675115|Antipyretics|antipyretics|mesh-ancestor
92446767|NCT01675310|Metformin|metformin|mesh-list
92446768|NCT01675310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92446769|NCT01675310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446770|NCT01676649|Paclitaxel|paclitaxel|mesh-list
92446771|NCT01676649|Carboplatin|carboplatin|mesh-list
92446772|NCT01676649|Ipilimumab|ipilimumab|mesh-list
92446773|NCT01676649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92446774|NCT01676649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446775|NCT01676649|Tubulin Modulators|tubulin modulators|mesh-ancestor
92446776|NCT01676649|Antimitotic Agents|antimitotic agents|mesh-ancestor
92446777|NCT01676649|Mitosis Modulators|mitosis modulators|mesh-ancestor
92446778|NCT01676649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446779|NCT01676649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92446780|NCT01676649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92446781|NCT01676987|Budesonide|budesonide|mesh-list
92446782|NCT01676987|Formoterol Fumarate|formoterol fumarate|mesh-list
92446783|NCT01676987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446784|NCT01676987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92446785|NCT01676987|Autonomic Agents|autonomic agents|mesh-ancestor
92446786|NCT01676987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446787|NCT01676987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446788|NCT01676987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92446789|NCT01676987|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446790|NCT01676987|Glucocorticoids|glucocorticoids|mesh-ancestor
92446791|NCT01676987|Hormones|hormones|mesh-ancestor
92446792|NCT01676987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446793|NCT01676987|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92171716|NCT03016377|Fludarabine|fludarabine|mesh-list
92446794|NCT01676987|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92446795|NCT01676987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92446796|NCT01676987|Adrenergic Agents|adrenergic agents|mesh-ancestor
92446797|NCT01676987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446798|NCT01676987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446799|NCT01677039|Ethanol|ethanol|mesh-list
92446800|NCT01677039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92446801|NCT01677039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446802|NCT01677039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446803|NCT01677039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446804|NCT01677065|Oxycodone|oxycodone|mesh-list
92446805|NCT01677065|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92446806|NCT01677065|Narcotics|narcotics|mesh-ancestor
92446807|NCT01677065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446808|NCT01677065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446809|NCT01677065|Analgesics|analgesics|mesh-ancestor
92446810|NCT01677065|Sensory System Agents|sensory system agents|mesh-ancestor
92446811|NCT01677065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446812|NCT01677247|Glimepiride|glimepiride|mesh-list
92446813|NCT01677247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92446814|NCT01677247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92446815|NCT01677247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446816|NCT01677247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92446817|NCT01677247|Immunologic Factors|immunologic factors|mesh-ancestor
92446818|NCT01677260|Metformin|metformin|mesh-list
92446819|NCT01677260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92446820|NCT01677260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446821|NCT01677572|Immunoglobulin G|immunoglobulin g|mesh-list
92446822|NCT01677572|Immunologic Factors|immunologic factors|mesh-ancestor
92446823|NCT01677572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446824|NCT01677650|Methadone|methadone|mesh-list
92446825|NCT01677650|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92446826|NCT01677650|Narcotics|narcotics|mesh-ancestor
92446827|NCT01677650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446828|NCT01677650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446829|NCT01677650|Analgesics|analgesics|mesh-ancestor
92446830|NCT01677650|Sensory System Agents|sensory system agents|mesh-ancestor
92446831|NCT01677650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446832|NCT01677650|Antitussive Agents|antitussive agents|mesh-ancestor
92446833|NCT01677650|Respiratory System Agents|respiratory system agents|mesh-ancestor
92446834|NCT01678053|Omeprazole|omeprazole|mesh-list
92446835|NCT01678053|Botulinum Toxins|botulinum toxins|mesh-list
92446836|NCT01678053|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92446837|NCT01678053|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92446838|NCT01678053|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92446839|NCT01678053|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92446840|NCT01678053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92446841|NCT01678053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446842|NCT01678053|Cholinergic Agents|cholinergic agents|mesh-ancestor
92446843|NCT01678053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446844|NCT01678053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446845|NCT01678053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92446846|NCT01678053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446847|NCT01678053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446848|NCT01678053|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92446849|NCT01678053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446850|NCT01678937|Cyclosporine|cyclosporine|mesh-list
92446851|NCT01678937|Sirolimus|sirolimus|mesh-list
92446852|NCT01678937|Mycophenolic Acid|mycophenolic acid|mesh-list
92446853|NCT01678937|Temsirolimus|temsirolimus|mesh-list
92446854|NCT01678937|MTOR Inhibitors|mtor inhibitors|mesh-list
92446855|NCT01678937|Tacrolimus|tacrolimus|mesh-list
92446856|NCT01678937|Cyclosporins|cyclosporins|mesh-list
92446857|NCT01678937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92446858|NCT01678937|Immunologic Factors|immunologic factors|mesh-ancestor
92446859|NCT01678937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446860|NCT01678937|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92446861|NCT01678937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446862|NCT01678937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446863|NCT01678937|Antifungal Agents|antifungal agents|mesh-ancestor
92446864|NCT01678937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92446865|NCT01678937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446866|NCT01678937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446867|NCT01678937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92446868|NCT01678937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446869|NCT01678937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92446870|NCT01678937|Antitubercular Agents|antitubercular agents|mesh-ancestor
92446871|NCT01678937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92446872|NCT01678937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446873|NCT01679041|Cyclophosphamide|cyclophosphamide|mesh-list
92446874|NCT01679041|Fludarabine|fludarabine|mesh-list
92446875|NCT01679041|Alemtuzumab|alemtuzumab|mesh-list
92446876|NCT01679041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92446877|NCT01679041|Immunologic Factors|immunologic factors|mesh-ancestor
92446878|NCT01679041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446879|NCT01679041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92446880|NCT01679041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92446881|NCT01679041|Alkylating Agents|alkylating agents|mesh-ancestor
92446882|NCT01679041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446883|NCT01679041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446884|NCT01679041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92446885|NCT01679041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92446887|NCT01679093|Droperidol|droperidol|mesh-list
92446888|NCT01679093|Ondansetron|ondansetron|mesh-list
92446889|NCT01679093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92446890|NCT01679093|Antiemetics|antiemetics|mesh-ancestor
92446891|NCT01679093|Autonomic Agents|autonomic agents|mesh-ancestor
92446892|NCT01679093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446893|NCT01679093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446894|NCT01679093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92446895|NCT01679093|Glucocorticoids|glucocorticoids|mesh-ancestor
92446896|NCT01679093|Hormones|hormones|mesh-ancestor
92446897|NCT01679093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92446898|NCT01679093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92446899|NCT01679093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446900|NCT01679093|Antipruritics|antipruritics|mesh-ancestor
92446901|NCT01679093|Dermatologic Agents|dermatologic agents|mesh-ancestor
92446902|NCT01679093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92446903|NCT01679093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92446904|NCT01679093|Serotonin Agents|serotonin agents|mesh-ancestor
92446905|NCT01679093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446906|NCT01679093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446907|NCT01679093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92446908|NCT01679093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92446909|NCT01679093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92446910|NCT01679093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446911|NCT01679093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92446912|NCT01679093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92446913|NCT01679093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92446914|NCT01679093|Dopamine Agents|dopamine agents|mesh-ancestor
92446915|NCT01679743|Trastuzumab|trastuzumab|mesh-list
92446916|NCT01679743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92446917|NCT01679743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446918|NCT01680094|Panobinostat|panobinostat|mesh-list
92446919|NCT01680094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446920|NCT01680094|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92446921|NCT01680094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446922|NCT01680094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446923|NCT01680120|Anesthetics|anesthetics|mesh-list
92446924|NCT01680120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446925|NCT01680120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446926|NCT01680198|Vitamin D|vitamin d|mesh-list
92446927|NCT01680198|Vitamins|vitamins|mesh-ancestor
92446928|NCT01680198|Micronutrients|micronutrients|mesh-ancestor
92446929|NCT01680198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446930|NCT01680198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92446931|NCT05597215|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92446932|NCT05597215|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92446933|NCT05597215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446934|NCT05596981|Sorafenib|sorafenib|mesh-list
92446935|NCT05596981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446936|NCT05596981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446937|NCT05596981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446938|NCT05596981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446939|NCT05596968|Sorafenib|sorafenib|mesh-list
92446940|NCT05596968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446941|NCT05596968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92446942|NCT05596968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446943|NCT05596968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446944|NCT05596890|Paclitaxel|paclitaxel|mesh-list
92446945|NCT05596890|Carboplatin|carboplatin|mesh-list
92446947|NCT05596890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92446948|NCT05596890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92446949|NCT05596890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92446950|NCT05596890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92446951|NCT05596890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92446952|NCT05596890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446953|NCT05596890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92446955|NCT05596669|Morphine|morphine|mesh-list
92446956|NCT05596669|Analgesics|analgesics|mesh-ancestor
92446957|NCT05596669|Sensory System Agents|sensory system agents|mesh-ancestor
92446958|NCT05596669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446959|NCT05596669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446960|NCT05596669|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92446962|NCT05596669|Anesthetics, General|anesthetics, general|mesh-ancestor
92446963|NCT05596669|Anesthetics|anesthetics|mesh-ancestor
92446964|NCT05596669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446965|NCT05596669|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92446966|NCT05596669|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92446967|NCT05596669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92446968|NCT05596669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446969|NCT05596669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92446970|NCT05596669|Narcotics|narcotics|mesh-ancestor
92446971|NCT05596617|Melatonin|melatonin|mesh-list
92446972|NCT05596617|Antioxidants|antioxidants|mesh-ancestor
92446973|NCT05596617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446974|NCT05596617|Protective Agents|protective agents|mesh-ancestor
92446975|NCT05596617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446976|NCT05596617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446977|NCT05596552|Fentanyl|fentanyl|mesh-list
92446978|NCT05596552|Dexmedetomidine|dexmedetomidine|mesh-list
92446979|NCT05596552|Bupivacaine|bupivacaine|mesh-list
92446980|NCT05596552|Anesthetics, Local|anesthetics, local|mesh-ancestor
92446981|NCT05596552|Anesthetics|anesthetics|mesh-ancestor
92446982|NCT05596552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92446983|NCT05596552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92446984|NCT05596552|Sensory System Agents|sensory system agents|mesh-ancestor
92446985|NCT05596552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92446986|NCT05596552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92446987|NCT05596552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92446988|NCT05596552|Analgesics|analgesics|mesh-ancestor
92446989|NCT05596552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92446990|NCT05596552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92446991|NCT05596552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92446992|NCT05596552|Adrenergic Agents|adrenergic agents|mesh-ancestor
92446993|NCT05596552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346898|NCT01786668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92446994|NCT05596552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92446995|NCT05596552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92446996|NCT05596552|Narcotics|narcotics|mesh-ancestor
92446997|NCT05596552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92446998|NCT05596552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92446999|NCT05596552|Anesthetics, General|anesthetics, general|mesh-ancestor
92447000|NCT05596227|Fentanyl|fentanyl|mesh-list
92447001|NCT05596227|Narcotics|narcotics|mesh-list
92447002|NCT05596227|Propofol|propofol|mesh-list
92447003|NCT05596227|Anesthetics|anesthetics|mesh-list
92447004|NCT05596227|Sevoflurane|sevoflurane|mesh-list
92447005|NCT05596227|Rocuronium|rocuronium|mesh-list
92447006|NCT05596227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447007|NCT05596227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447008|NCT05596227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447009|NCT05596227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447010|NCT05596227|Anesthetics, General|anesthetics, general|mesh-ancestor
92447011|NCT05596227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92447012|NCT05596227|Analgesics|analgesics|mesh-ancestor
92447013|NCT05596227|Sensory System Agents|sensory system agents|mesh-ancestor
92447014|NCT05596227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447015|NCT05596227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447016|NCT05596227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92447017|NCT05596227|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92447018|NCT05596227|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92447019|NCT05596227|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92447020|NCT05596227|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92447021|NCT05596214|Curcumin|curcumin|mesh-list
92447022|NCT05596214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92447023|NCT05596214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447024|NCT05596214|Analgesics|analgesics|mesh-ancestor
92447025|NCT05596214|Sensory System Agents|sensory system agents|mesh-ancestor
92447026|NCT05596214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447027|NCT05596214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447028|NCT05596214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447029|NCT05596214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447030|NCT05596214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447031|NCT05596214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447032|NCT05596214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447033|NCT05596149|Listerine|listerine|mesh-list
92447034|NCT05596149|Fluorides|fluorides|mesh-list
92447035|NCT05596149|Sodium Fluoride|sodium fluoride|mesh-list
92447036|NCT05596149|Fluorophosphate|fluorophosphate|mesh-list
92447037|NCT05596149|Cariostatic Agents|cariostatic agents|mesh-ancestor
92447038|NCT05596149|Protective Agents|protective agents|mesh-ancestor
92447039|NCT05596149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447040|NCT05596149|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92447041|NCT05596149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447042|NCT05596097|Zanubrutinib|zanubrutinib|mesh-list
92447043|NCT05596097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447044|NCT05596097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92447045|NCT05596097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447046|NCT05596097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447047|NCT05596071|Sufentanil|sufentanil|mesh-list
92447048|NCT05596071|Dsuvia|dsuvia|mesh-list
92447049|NCT05596071|Ropivacaine|ropivacaine|mesh-list
92447050|NCT05596071|Anesthetics, Local|anesthetics, local|mesh-ancestor
92447051|NCT05596071|Anesthetics|anesthetics|mesh-ancestor
92447052|NCT05596071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447053|NCT05596071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447054|NCT05596071|Sensory System Agents|sensory system agents|mesh-ancestor
92447055|NCT05596071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447056|NCT05596071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92447057|NCT05596071|Narcotics|narcotics|mesh-ancestor
92447058|NCT05596071|Analgesics|analgesics|mesh-ancestor
92447059|NCT05596071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447060|NCT05596071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447061|NCT05596071|Anesthetics, General|anesthetics, general|mesh-ancestor
92447062|NCT05595824|Molnupiravir|molnupiravir|mesh-list
92447063|NCT05595824|Antiviral Agents|antiviral agents|mesh-ancestor
92447064|NCT05595824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447065|NCT05595590|Tislelizumab|tislelizumab|mesh-list
92447066|NCT05595590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447067|NCT05595590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447068|NCT05595447|Pembrolizumab|pembrolizumab|mesh-list
92447069|NCT05595447|Nivolumab|nivolumab|mesh-list
92447070|NCT05595447|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92447071|NCT05595447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447072|NCT05595447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447073|NCT05595447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92447074|NCT05595447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447075|NCT05595447|Immunotoxins|immunotoxins|mesh-ancestor
92447076|NCT05595447|Immunoconjugates|immunoconjugates|mesh-ancestor
92447077|NCT05595447|Immunologic Factors|immunologic factors|mesh-ancestor
92447078|NCT05595447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447079|NCT05595408|Immunomodulating Agents|immunomodulating agents|mesh-list
92447080|NCT05595408|Immunologic Factors|immunologic factors|mesh-ancestor
92447081|NCT05595408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447082|NCT05595369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92447083|NCT05595369|Antiviral Agents|antiviral agents|mesh-ancestor
92447084|NCT05595369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447085|NCT05567822|Esmolol|esmolol|mesh-list
92447086|NCT05567822|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92447087|NCT05567822|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92447088|NCT05567822|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92447089|NCT05567822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92447090|NCT05567822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447091|NCT05567822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447092|NCT05567822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447093|NCT05557253|Anesthetics|anesthetics|mesh-list
92447094|NCT05557253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447095|NCT05557253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447096|NCT05539924|Vitamin B 12|vitamin b 12|mesh-list
92447097|NCT05539924|Pregabalin|pregabalin|mesh-list
92447098|NCT05539924|Gabapentin|gabapentin|mesh-list
92447099|NCT05539924|Vitamins|vitamins|mesh-ancestor
92447100|NCT05539924|Micronutrients|micronutrients|mesh-ancestor
92447101|NCT05539924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447102|NCT05539924|Analgesics|analgesics|mesh-ancestor
92447103|NCT05539924|Sensory System Agents|sensory system agents|mesh-ancestor
92447104|NCT05539924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447105|NCT05539924|Anticonvulsants|anticonvulsants|mesh-ancestor
92447106|NCT05539924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92447107|NCT05539924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92447108|NCT05539924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447109|NCT05539924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92447110|NCT05539924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92447111|NCT05539924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447112|NCT05539924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447113|NCT05539924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447114|NCT05539924|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92447115|NCT05539924|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92447116|NCT05539924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447117|NCT05539924|Antimanic Agents|antimanic agents|mesh-ancestor
92447118|NCT05539924|Vitamin B Complex|vitamin b complex|mesh-ancestor
92447119|NCT05514782|Sunscreening Agents|sunscreening agents|mesh-list
92447120|NCT05514782|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92447121|NCT05514782|Protective Agents|protective agents|mesh-ancestor
92447122|NCT05514782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447123|NCT05514782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92447124|NCT05479370|Vaccines|vaccines|mesh-list
92447125|NCT05479370|Immunologic Factors|immunologic factors|mesh-ancestor
92447126|NCT05479370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447127|NCT05468242|Bevacizumab|bevacizumab|mesh-list
92447128|NCT05468242|Tislelizumab|tislelizumab|mesh-list
92447129|NCT05468242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447130|NCT05468242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447131|NCT05468242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92447132|NCT05468242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92447133|NCT05468242|Growth Substances|growth substances|mesh-ancestor
92447134|NCT05468242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447135|NCT05468242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92447136|NCT05433402|Chlorpromazine|chlorpromazine|mesh-list
92447137|NCT05433402|Antiemetics|antiemetics|mesh-ancestor
92447138|NCT05433402|Autonomic Agents|autonomic agents|mesh-ancestor
92447139|NCT05433402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447140|NCT05433402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447141|NCT05433402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92447142|NCT05433402|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92447143|NCT05433402|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447144|NCT05433402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447145|NCT05433402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447146|NCT05433402|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92447147|NCT05433402|Dopamine Agents|dopamine agents|mesh-ancestor
92447148|NCT05433402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447149|NCT05433402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447150|NCT05423951|Sufentanil|sufentanil|mesh-list
92447151|NCT05423951|Propofol|propofol|mesh-list
92447152|NCT05423951|Rocuronium|rocuronium|mesh-list
92447153|NCT05423951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447154|NCT05423951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447155|NCT05423951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447156|NCT05423951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447157|NCT05423951|Anesthetics, General|anesthetics, general|mesh-ancestor
92447158|NCT05423951|Anesthetics|anesthetics|mesh-ancestor
92447159|NCT05423951|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92447160|NCT05423951|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92447161|NCT05423951|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92447162|NCT05423951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447163|NCT05423951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92447164|NCT05423951|Narcotics|narcotics|mesh-ancestor
92447165|NCT05423951|Analgesics|analgesics|mesh-ancestor
92447166|NCT05423951|Sensory System Agents|sensory system agents|mesh-ancestor
92447167|NCT05423951|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447168|NCT05405621|Exatecan|exatecan|mesh-list
92447169|NCT05405621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92447170|NCT05405621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92447171|NCT05405621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447172|NCT05405621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447173|NCT05405621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172078|NCT02007044|Rituximab|rituximab|mesh-list
92447174|NCT05350696|Morphine|morphine|mesh-list
92447175|NCT05350696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92447176|NCT05350696|Narcotics|narcotics|mesh-ancestor
92447177|NCT05350696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447178|NCT05350696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447179|NCT05350696|Analgesics|analgesics|mesh-ancestor
92447180|NCT05350696|Sensory System Agents|sensory system agents|mesh-ancestor
92447181|NCT05350696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447182|NCT05291156|Cetuximab|cetuximab|mesh-list
92447183|NCT05291156|Avelumab|avelumab|mesh-list
92447184|NCT05291156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447185|NCT05291156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447186|NCT05253118|Pemetrexed|pemetrexed|mesh-list
92447187|NCT05253118|Tislelizumab|tislelizumab|mesh-list
92447188|NCT05253118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447189|NCT05253118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447190|NCT05253118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447191|NCT05253118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92447192|NCT05253118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92447193|NCT05253118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447194|NCT05226923|Meropenem|meropenem|mesh-list
92447195|NCT05226923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92447196|NCT05226923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447197|NCT05098327|Pioglitazone|pioglitazone|mesh-list
92447198|NCT05098327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447199|NCT05098327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447200|NCT05076838|Diazepam|diazepam|mesh-list
92447201|NCT05076838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447202|NCT05076838|Anticonvulsants|anticonvulsants|mesh-ancestor
92447203|NCT05076838|Antiemetics|antiemetics|mesh-ancestor
92447204|NCT05076838|Autonomic Agents|autonomic agents|mesh-ancestor
92447205|NCT05076838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346920|NCT01811238|Oxycodone|oxycodone|mesh-list
92447206|NCT05076838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447207|NCT05076838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92447208|NCT05076838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447209|NCT05076838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447210|NCT05076838|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92447211|NCT05076838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92447212|NCT05076838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92447213|NCT05076838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447214|NCT05076838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447215|NCT05076838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447216|NCT05076838|Anesthetics, General|anesthetics, general|mesh-ancestor
92447217|NCT05076838|Anesthetics|anesthetics|mesh-ancestor
92447218|NCT05076838|GABA Modulators|gaba modulators|mesh-ancestor
92447219|NCT05076838|GABA Agents|gaba agents|mesh-ancestor
92447220|NCT05076838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447221|NCT05076838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447222|NCT05057949|Itraconazole|itraconazole|mesh-list
92447223|NCT05057949|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92447224|NCT05057949|Rifampin|rifampin|mesh-list
92447225|NCT05057949|Antifungal Agents|antifungal agents|mesh-ancestor
92447226|NCT05057949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447227|NCT05057949|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92447228|NCT05057949|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92447229|NCT05057949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447230|NCT05057949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447231|NCT05057949|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92447232|NCT05057949|Hormone Antagonists|hormone antagonists|mesh-ancestor
92447233|NCT05057949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447234|NCT05057949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447235|NCT05057949|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92447236|NCT05057949|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92447237|NCT05057949|Antitubercular Agents|antitubercular agents|mesh-ancestor
92447238|NCT05057949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92447239|NCT05057949|Leprostatic Agents|leprostatic agents|mesh-ancestor
92447240|NCT05057949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92447241|NCT05057949|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92447242|NCT05057949|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92447243|NCT05057949|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92447244|NCT05057949|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92172153|NCT01878617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447245|NCT05057949|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92447246|NCT05057949|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92447247|NCT04925960|Epalrestat|epalrestat|mesh-list
92447249|NCT04925960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447250|NCT04901312|Analgesics, Opioid|analgesics, opioid|mesh-list
92447251|NCT04901312|Narcotics|narcotics|mesh-ancestor
92447252|NCT04901312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447253|NCT04901312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447254|NCT04901312|Analgesics|analgesics|mesh-ancestor
92447255|NCT04901312|Sensory System Agents|sensory system agents|mesh-ancestor
92447256|NCT04901312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447257|NCT04886297|Resveratrol|resveratrol|mesh-list
92447258|NCT04886297|Antioxidants|antioxidants|mesh-ancestor
92447259|NCT04886297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447260|NCT04886297|Protective Agents|protective agents|mesh-ancestor
92447261|NCT04886297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447262|NCT04886297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447263|NCT04886297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92447264|NCT04830410|Levan|levan|mesh-list
92447265|NCT04830410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447266|NCT04810793|Amoxicillin|amoxicillin|mesh-list
92447267|NCT04810793|Levofloxacin|levofloxacin|mesh-list
92447268|NCT04810793|Ofloxacin|ofloxacin|mesh-list
92447269|NCT04810793|Tetracycline|tetracycline|mesh-list
92447270|NCT04810793|Furazolidone|furazolidone|mesh-list
92447271|NCT04810793|Esomeprazole|esomeprazole|mesh-list
92447272|NCT04810793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92447273|NCT04810793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447274|NCT04810793|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92447275|NCT04810793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92447276|NCT04810793|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92447277|NCT04810793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447278|NCT04810793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447279|NCT04810793|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92447280|NCT04810793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92447281|NCT04810793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92447282|NCT04810793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447283|NCT04810793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92447284|NCT04810793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92447285|NCT04810793|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92447286|NCT04810793|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92447287|NCT04810793|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92447288|NCT04810793|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92447289|NCT04810793|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92447290|NCT04810793|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92447291|NCT04797832|Ferric gluconate|ferric gluconate|mesh-list
92447292|NCT04797832|Hematinics|hematinics|mesh-ancestor
92447293|NCT04684511|Rofecoxib|rofecoxib|mesh-list
92447294|NCT04684511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92447295|NCT04684511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92447296|NCT04684511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447297|NCT04684511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447298|NCT04684511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92447299|NCT04684511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447300|NCT04684511|Analgesics|analgesics|mesh-ancestor
92447301|NCT04684511|Sensory System Agents|sensory system agents|mesh-ancestor
92447302|NCT04684511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447303|NCT04684511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447304|NCT04684511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447305|NCT04684511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447306|NCT04650841|Naloxone|naloxone|mesh-list
92447307|NCT04650841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92447308|NCT04650841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447309|NCT04650841|Sensory System Agents|sensory system agents|mesh-ancestor
92447310|NCT04650841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447311|NCT04624854|Aspirin|aspirin|mesh-list
92447312|NCT04624854|Clopidogrel|clopidogrel|mesh-list
92447313|NCT04624854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92447314|NCT04624854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447315|NCT04624854|Analgesics|analgesics|mesh-ancestor
92447316|NCT04624854|Sensory System Agents|sensory system agents|mesh-ancestor
92447317|NCT04624854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447318|NCT04624854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447319|NCT04624854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447320|NCT04624854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447321|NCT04624854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92447322|NCT04624854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92447323|NCT04624854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447324|NCT04624854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92447325|NCT04624854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92447326|NCT04624854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447327|NCT04624854|Antipyretics|antipyretics|mesh-ancestor
92447328|NCT04624854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92447329|NCT04624854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92447330|NCT04624854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92447331|NCT04624854|Purinergic Agents|purinergic agents|mesh-ancestor
92447332|NCT04624854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447333|NCT04602598|Zanubrutinib|zanubrutinib|mesh-list
92447334|NCT04602598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447335|NCT04602598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92447336|NCT04602598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447337|NCT04602598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447338|NCT04565171|Yimitasvir|yimitasvir|mesh-list
92447339|NCT04565171|Antiviral Agents|antiviral agents|mesh-ancestor
92447340|NCT04565171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447341|NCT04463368|Nivolumab|nivolumab|mesh-list
92447342|NCT04463368|Ipilimumab|ipilimumab|mesh-list
92447343|NCT04463368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447344|NCT04463368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447345|NCT04463368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92447346|NCT04463368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447347|NCT04452344|Analgesics|analgesics|mesh-list
92447348|NCT04452344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447349|NCT04452344|Sensory System Agents|sensory system agents|mesh-ancestor
92447350|NCT04452344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447351|NCT04450407|Insulin|insulin|mesh-list
92447352|NCT04450407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447353|NCT04450407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447354|NCT04432506|Cyclophosphamide|cyclophosphamide|mesh-list
92447355|NCT04432506|Fludarabine|fludarabine|mesh-list
92447356|NCT04432506|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92447357|NCT04432506|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92447358|NCT04432506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447359|NCT04432506|Immunologic Factors|immunologic factors|mesh-ancestor
92447360|NCT04432506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447361|NCT04432506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447362|NCT04432506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92447363|NCT04432506|Alkylating Agents|alkylating agents|mesh-ancestor
92447364|NCT04432506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447365|NCT04432506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447366|NCT04432506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92447367|NCT04432506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447369|NCT04231838|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92447370|NCT04231838|Autonomic Agents|autonomic agents|mesh-ancestor
92447371|NCT04231838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447372|NCT04231838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447373|NCT04231838|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92447374|NCT04231838|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92447375|NCT04231838|Cholinergic Agents|cholinergic agents|mesh-ancestor
92447376|NCT04231838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447377|NCT04231838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447379|NCT04218266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92447380|NCT04218266|Antithrombins|antithrombins|mesh-ancestor
92447381|NCT04218266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92447382|NCT04218266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92447383|NCT04218266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447384|NCT04218266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447385|NCT04218266|Anticoagulants|anticoagulants|mesh-ancestor
92447386|NCT04172363|Octenidine|octenidine|mesh-list
92447387|NCT04172363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447388|NCT04172363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92447389|NCT04074603|Insulin|insulin|mesh-list
92447390|NCT04074603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447391|NCT04074603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447392|NCT04068246|Metformin|metformin|mesh-list
92447393|NCT04068246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447394|NCT04068246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447395|NCT04063033|Ferric gluconate|ferric gluconate|mesh-list
92447396|NCT04063033|Hematinics|hematinics|mesh-ancestor
92447397|NCT04037605|Ketoconazole|ketoconazole|mesh-list
92447398|NCT04037605|Dexamethasone|dexamethasone|mesh-list
92447399|NCT04037605|Dexamethasone acetate|dexamethasone acetate|mesh-list
92447400|NCT04037605|Hydrocortisone|hydrocortisone|mesh-list
92447401|NCT04037605|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92447402|NCT04037605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92447403|NCT04037605|Hormones|hormones|mesh-list
92447404|NCT04037605|Cosyntropin|cosyntropin|mesh-list
92447405|NCT04037605|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92447406|NCT04037605|BB 1101|bb 1101|mesh-list
92447407|NCT04037605|Ganirelix|ganirelix|mesh-list
92447408|NCT04037605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447409|NCT04037605|Antiemetics|antiemetics|mesh-ancestor
92447410|NCT04037605|Autonomic Agents|autonomic agents|mesh-ancestor
92447411|NCT04037605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447412|NCT04037605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447413|NCT04037605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92447414|NCT04037605|Glucocorticoids|glucocorticoids|mesh-ancestor
92447415|NCT04037605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447416|NCT04037605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92447417|NCT04037605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447418|NCT04037605|Protease Inhibitors|protease inhibitors|mesh-ancestor
92447419|NCT04037605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447420|NCT04037605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447421|NCT04037605|Antifungal Agents|antifungal agents|mesh-ancestor
92447422|NCT04037605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447423|NCT04037605|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92447424|NCT04037605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92447425|NCT04037605|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92447426|NCT04037605|Hormone Antagonists|hormone antagonists|mesh-ancestor
92447427|NCT04037605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92447428|NCT04002258|Antipsychotic Agents|antipsychotic agents|mesh-list
92447429|NCT04002258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447430|NCT04002258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447431|NCT04002258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447432|NCT04002258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447433|NCT03928093|Pregabalin|pregabalin|mesh-list
92447434|NCT03928093|Analgesics|analgesics|mesh-ancestor
92447435|NCT03928093|Sensory System Agents|sensory system agents|mesh-ancestor
92447436|NCT03928093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447437|NCT03928093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447438|NCT03928093|Anticonvulsants|anticonvulsants|mesh-ancestor
92447439|NCT03928093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92447440|NCT03928093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92447441|NCT03928093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447442|NCT03928093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92447444|NCT03928093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447445|NCT03928093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447446|NCT03928093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447447|NCT03907800|Paclitaxel|paclitaxel|mesh-list
92447448|NCT03907800|Carboplatin|carboplatin|mesh-list
92447449|NCT03907800|Trastuzumab|trastuzumab|mesh-list
92447450|NCT03907800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92447451|NCT03907800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447452|NCT03907800|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447453|NCT03907800|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447454|NCT03907800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447455|NCT03907800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447456|NCT03907800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447457|NCT03894904|Heparin|heparin|mesh-list
92447458|NCT03894904|Papaverine|papaverine|mesh-list
92447459|NCT03894904|Anticoagulants|anticoagulants|mesh-ancestor
92447460|NCT03894904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92447461|NCT03894904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92447462|NCT03894904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447463|NCT03894904|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92447464|NCT03894904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447465|NCT03894904|Vasodilator Agents|vasodilator agents|mesh-ancestor
92447466|NCT03894904|Urological Agents|urological agents|mesh-ancestor
92447467|NCT03797833|Anesthetics|anesthetics|mesh-list
92447468|NCT03797833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447469|NCT03797833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447470|NCT03749174|Anesthetics|anesthetics|mesh-list
92447471|NCT03749174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447472|NCT03749174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447473|NCT03722927|Bupivacaine|bupivacaine|mesh-list
92447474|NCT03722927|Anesthetics, Local|anesthetics, local|mesh-ancestor
92447476|NCT03722927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447477|NCT03722927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447478|NCT03722927|Sensory System Agents|sensory system agents|mesh-ancestor
92447479|NCT03722927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447480|NCT03681652|Azathioprine|azathioprine|mesh-list
92447481|NCT03681652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447482|NCT03681652|Antimetabolites|antimetabolites|mesh-ancestor
92447483|NCT03681652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447484|NCT03681652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92447485|NCT03681652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447486|NCT03681652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447487|NCT03681652|Immunologic Factors|immunologic factors|mesh-ancestor
92447488|NCT03681652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447489|NCT03578198|Rituximab|rituximab|mesh-list
92447490|NCT03578198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447491|NCT03578198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447492|NCT03578198|Immunologic Factors|immunologic factors|mesh-ancestor
92447493|NCT03578198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447494|NCT03578198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447495|NCT03571308|Prednisolone|prednisolone|mesh-list
92447496|NCT03571308|Cyclophosphamide|cyclophosphamide|mesh-list
92447497|NCT03571308|Doxorubicin|doxorubicin|mesh-list
92447498|NCT03571308|Vincristine|vincristine|mesh-list
92447499|NCT03571308|Acalabrutinib|acalabrutinib|mesh-list
92447500|NCT03571308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447501|NCT03571308|Immunologic Factors|immunologic factors|mesh-ancestor
92447502|NCT03571308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447503|NCT03571308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447504|NCT03571308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92447505|NCT03571308|Alkylating Agents|alkylating agents|mesh-ancestor
92447506|NCT03571308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447507|NCT03571308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447508|NCT03571308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92447509|NCT03571308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92447510|NCT03571308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92447511|NCT03571308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92447512|NCT03571308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447513|NCT03571308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92447514|NCT03571308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447515|NCT03571308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447516|NCT03571308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447517|NCT03571308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447519|NCT03571308|Hormones|hormones|mesh-ancestor
92447520|NCT03571308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447521|NCT03571308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92447522|NCT03554200|Empagliflozin|empagliflozin|mesh-list
92447523|NCT03554200|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92447524|NCT03554200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447525|NCT03554200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447526|NCT03554200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447527|NCT03518086|Mirikizumab|mirikizumab|mesh-list
92447528|NCT03518086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92447529|NCT03518086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447530|NCT03518086|Analgesics|analgesics|mesh-ancestor
92447531|NCT03518086|Sensory System Agents|sensory system agents|mesh-ancestor
92447532|NCT03518086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447533|NCT03518086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447534|NCT03518086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447535|NCT03518086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447536|NCT03518086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92447537|NCT03518086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92447538|NCT03517176|Paclitaxel|paclitaxel|mesh-list
92447539|NCT03517176|Gemcitabine|gemcitabine|mesh-list
92447540|NCT03517176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92447541|NCT03517176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447542|NCT03517176|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447543|NCT03517176|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447544|NCT03517176|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447545|NCT03517176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447546|NCT03517176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92447547|NCT03517176|Antimetabolites|antimetabolites|mesh-ancestor
92447548|NCT03512964|Tenofovir|tenofovir|mesh-list
92447549|NCT03512964|Emtricitabine|emtricitabine|mesh-list
92447550|NCT03512964|Dolutegravir|dolutegravir|mesh-list
92447551|NCT03512964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92447552|NCT03512964|Antiviral Agents|antiviral agents|mesh-ancestor
92447553|NCT03512964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447554|NCT03512964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92447555|NCT03512964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92447556|NCT03512964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447557|NCT03512964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447558|NCT03512964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92447559|NCT03512964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92447560|NCT03512964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92447561|NCT03512964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92447562|NCT03476109|Omalizumab|omalizumab|mesh-list
92447563|NCT03476109|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92447564|NCT03476109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92447565|NCT03476109|Respiratory System Agents|respiratory system agents|mesh-ancestor
92447566|NCT03463499|Hyaluronic Acid|hyaluronic acid|mesh-list
92447567|NCT03463499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92447568|NCT03463499|Immunologic Factors|immunologic factors|mesh-ancestor
92447569|NCT03463499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447570|NCT03463499|Viscosupplements|viscosupplements|mesh-ancestor
92447571|NCT03463499|Protective Agents|protective agents|mesh-ancestor
92447572|NCT03366974|Clarithromycin|clarithromycin|mesh-list
92447573|NCT03366974|Midazolam|midazolam|mesh-list
92447574|NCT03366974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447575|NCT03366974|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447576|NCT03366974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447577|NCT03366974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447578|NCT03366974|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92447579|NCT03366974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447580|NCT03366974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447581|NCT03366974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447582|NCT03366974|Anesthetics, General|anesthetics, general|mesh-ancestor
92447583|NCT03366974|Anesthetics|anesthetics|mesh-ancestor
92447584|NCT03366974|GABA Modulators|gaba modulators|mesh-ancestor
92447585|NCT03366974|GABA Agents|gaba agents|mesh-ancestor
92447586|NCT03366974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447587|NCT03366974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447588|NCT03366974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92447589|NCT03366974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447590|NCT03366974|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92447591|NCT03366974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447592|NCT03366974|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92447593|NCT03366974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92447594|NCT03362515|Furosemide|furosemide|mesh-list
92447595|NCT03362515|Diuretics|diuretics|mesh-ancestor
92447596|NCT03362515|Natriuretic Agents|natriuretic agents|mesh-ancestor
92447597|NCT03362515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447598|NCT03362515|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92447599|NCT03362515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92447600|NCT03362515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447601|NCT03340129|Nivolumab|nivolumab|mesh-list
92447602|NCT03340129|Ipilimumab|ipilimumab|mesh-list
92447603|NCT03340129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447604|NCT03340129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447605|NCT03340129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92447606|NCT03340129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447607|NCT03307746|Rituximab|rituximab|mesh-list
92447608|NCT03307746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447609|NCT03307746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447610|NCT03307746|Immunologic Factors|immunologic factors|mesh-ancestor
92447611|NCT03307746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447612|NCT03307746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447613|NCT03294083|Cemiplimab|cemiplimab|mesh-list
92447614|NCT03294083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447615|NCT03294083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447616|NCT03128398|Domperidone|domperidone|mesh-list
92447617|NCT03128398|Antiemetics|antiemetics|mesh-ancestor
92447618|NCT03128398|Autonomic Agents|autonomic agents|mesh-ancestor
92447619|NCT03128398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447620|NCT03128398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447621|NCT03128398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92447622|NCT03128398|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92447623|NCT03128398|Dopamine Agents|dopamine agents|mesh-ancestor
92447624|NCT03128398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447625|NCT03128398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447627|NCT03119038|Clonidine|clonidine|mesh-list
92447628|NCT03119038|Epinephrine|epinephrine|mesh-list
92447629|NCT03119038|Bupivacaine|bupivacaine|mesh-list
92447630|NCT03119038|Ropivacaine|ropivacaine|mesh-list
92447631|NCT03119038|Anesthetics, Local|anesthetics, local|mesh-ancestor
92447632|NCT03119038|Anesthetics|anesthetics|mesh-ancestor
92447633|NCT03119038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447634|NCT03119038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447635|NCT03119038|Sensory System Agents|sensory system agents|mesh-ancestor
92447636|NCT03119038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447637|NCT03119038|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92447638|NCT03119038|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92447639|NCT03119038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92447640|NCT03119038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447641|NCT03119038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447642|NCT03119038|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92447643|NCT03119038|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92447644|NCT03119038|Autonomic Agents|autonomic agents|mesh-ancestor
92447645|NCT03119038|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92447646|NCT03119038|Respiratory System Agents|respiratory system agents|mesh-ancestor
92447647|NCT03119038|Mydriatics|mydriatics|mesh-ancestor
92447648|NCT03119038|Sympathomimetics|sympathomimetics|mesh-ancestor
92447649|NCT03119038|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92447650|NCT03119038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92447651|NCT03119038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447652|NCT03119038|Analgesics|analgesics|mesh-ancestor
92447653|NCT03119038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447654|NCT03119038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447655|NCT03119038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92447656|NCT03119038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447657|NCT03119038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92447658|NCT03119038|Sympatholytics|sympatholytics|mesh-ancestor
92447659|NCT03119038|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92447660|NCT03099265|Leucovorin|leucovorin|mesh-list
92447661|NCT03099265|Fluorouracil|fluorouracil|mesh-list
92447662|NCT03099265|Oxaliplatin|oxaliplatin|mesh-list
92447663|NCT03099265|Irinotecan|irinotecan|mesh-list
92447664|NCT03099265|Antimetabolites|antimetabolites|mesh-ancestor
92447665|NCT03099265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447666|NCT03099265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92447667|NCT03099265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447668|NCT03099265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447669|NCT03099265|Immunologic Factors|immunologic factors|mesh-ancestor
92447670|NCT03099265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447671|NCT03099265|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92447672|NCT03099265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92447673|NCT03099265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447674|NCT03099265|Antidotes|antidotes|mesh-ancestor
92447675|NCT03099265|Protective Agents|protective agents|mesh-ancestor
92447676|NCT03099265|Vitamin B Complex|vitamin b complex|mesh-ancestor
92447677|NCT03099265|Vitamins|vitamins|mesh-ancestor
92447678|NCT03099265|Micronutrients|micronutrients|mesh-ancestor
92447679|NCT03063749|Sirolimus|sirolimus|mesh-list
92447680|NCT03063749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92447681|NCT03063749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447682|NCT03063749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92447683|NCT03063749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447684|NCT03063749|Antifungal Agents|antifungal agents|mesh-ancestor
92447685|NCT03063749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447686|NCT03063749|Immunologic Factors|immunologic factors|mesh-ancestor
92447687|NCT03063749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447688|NCT03007589|Sunscreening Agents|sunscreening agents|mesh-list
92447689|NCT03007589|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92447690|NCT03007589|Protective Agents|protective agents|mesh-ancestor
92447691|NCT03007589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447692|NCT03007589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92447693|NCT02975037|Clarithromycin|clarithromycin|mesh-list
92447694|NCT02975037|Itraconazole|itraconazole|mesh-list
92447695|NCT02975037|Sildenafil Citrate|sildenafil citrate|mesh-list
92447696|NCT02975037|Vasodilator Agents|vasodilator agents|mesh-ancestor
92447697|NCT02975037|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92447698|NCT02975037|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92447699|NCT02975037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447700|NCT02975037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447701|NCT02975037|Urological Agents|urological agents|mesh-ancestor
92447702|NCT02975037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92447703|NCT02975037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447704|NCT02975037|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92447705|NCT02975037|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92447706|NCT02975037|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92447707|NCT02975037|Antifungal Agents|antifungal agents|mesh-ancestor
92447708|NCT02975037|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92447709|NCT02975037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92447710|NCT02975037|Hormone Antagonists|hormone antagonists|mesh-ancestor
92447711|NCT02975037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447712|NCT02975037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447713|NCT02931890|Paclitaxel|paclitaxel|mesh-list
92447714|NCT02931890|Docetaxel|docetaxel|mesh-list
92447715|NCT02931890|Carboplatin|carboplatin|mesh-list
92447716|NCT02931890|Capecitabine|capecitabine|mesh-list
92447717|NCT02931890|Oxaliplatin|oxaliplatin|mesh-list
92447718|NCT02931890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92447719|NCT02931890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447720|NCT02931890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447721|NCT02931890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447722|NCT02931890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447723|NCT02931890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447724|NCT02931890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92447725|NCT02931890|Antimetabolites|antimetabolites|mesh-ancestor
92447726|NCT02914405|Nivolumab|nivolumab|mesh-list
92447727|NCT02914405|Dinutuximab|dinutuximab|mesh-list
92447728|NCT02914405|Immunoglobulins|immunoglobulins|mesh-list
92447729|NCT02914405|Immunoglobulin G|immunoglobulin g|mesh-list
92447730|NCT02914405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447731|NCT02914405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447732|NCT02914405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92447733|NCT02914405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447734|NCT02914405|Immunologic Factors|immunologic factors|mesh-ancestor
92447735|NCT02914405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447736|NCT02812862|Tiotropium Bromide|tiotropium bromide|mesh-list
92447737|NCT02812862|Olodaterol|olodaterol|mesh-list
92447738|NCT02812862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92447739|NCT02812862|Autonomic Agents|autonomic agents|mesh-ancestor
92447740|NCT02812862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447741|NCT02812862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346978|NCT01768572|Antimetabolites|antimetabolites|mesh-ancestor
92447742|NCT02812862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92447743|NCT02812862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92447744|NCT02812862|Parasympatholytics|parasympatholytics|mesh-ancestor
92447745|NCT02812862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92447747|NCT02812862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447748|NCT02812862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447749|NCT02587312|Nicotine|nicotine|mesh-list
92447750|NCT02587312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92447751|NCT02587312|Autonomic Agents|autonomic agents|mesh-ancestor
92447752|NCT02587312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447753|NCT02587312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447754|NCT02587312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92447755|NCT02587312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92447756|NCT02587312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92447757|NCT02587312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447758|NCT02587312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447759|NCT02549677|Cyclophosphamide|cyclophosphamide|mesh-list
92447760|NCT02549677|Docetaxel|docetaxel|mesh-list
92447761|NCT02549677|Epirubicin|epirubicin|mesh-list
92447762|NCT02549677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447763|NCT02549677|Immunologic Factors|immunologic factors|mesh-ancestor
92447764|NCT02549677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447765|NCT02549677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447766|NCT02549677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92447767|NCT02549677|Alkylating Agents|alkylating agents|mesh-ancestor
92447768|NCT02549677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447769|NCT02549677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447770|NCT02549677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92447771|NCT02549677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447772|NCT02549677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447773|NCT02549677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447774|NCT02549677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92447775|NCT02549677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92447776|NCT02549677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92447777|NCT02549677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447778|NCT02536300|Idelalisib|idelalisib|mesh-list
92447779|NCT02536300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447780|NCT02536300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447781|NCT02536300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447782|NCT02450253|Tadalafil|tadalafil|mesh-list
92447783|NCT02450253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92447784|NCT02450253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92447785|NCT02450253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92447786|NCT02450253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447787|NCT02450253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447788|NCT02450253|Urological Agents|urological agents|mesh-ancestor
92447789|NCT02257970|Ketoprofen|ketoprofen|mesh-list
92447790|NCT02257970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92447791|NCT02257970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447792|NCT02257970|Analgesics|analgesics|mesh-ancestor
92447793|NCT02257970|Sensory System Agents|sensory system agents|mesh-ancestor
92447794|NCT02257970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447795|NCT02257970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447796|NCT02257970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447797|NCT02257970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92447798|NCT02257970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92447799|NCT02257970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447800|NCT02257970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447801|NCT05838729|Pembrolizumab|pembrolizumab|mesh-list
92447802|NCT05838729|Nivolumab|nivolumab|mesh-list
92447803|NCT05838729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92447804|NCT05838729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447805|NCT05838729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447806|NCT05838729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447807|NCT05838716|Vitamin D|vitamin d|mesh-list
92447808|NCT05838716|Ergocalciferols|ergocalciferols|mesh-list
92447809|NCT05838716|Cholecalciferol|cholecalciferol|mesh-list
92447810|NCT05838716|Vitamins|vitamins|mesh-list
92447811|NCT05838716|Micronutrients|micronutrients|mesh-ancestor
92447812|NCT05838716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447813|NCT05838716|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92447814|NCT05838716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92447815|NCT05838599|Imiquimod|imiquimod|mesh-list
92447816|NCT05838599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92447817|NCT05838599|Immunologic Factors|immunologic factors|mesh-ancestor
92447818|NCT05838599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447819|NCT05838599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447820|NCT05838599|Interferon Inducers|interferon inducers|mesh-ancestor
92447821|NCT05838248|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92447822|NCT05838248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92447824|NCT05838105|Progestins|progestins|mesh-ancestor
92447825|NCT05838105|Hormones|hormones|mesh-ancestor
92447826|NCT05838105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447827|NCT05838105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447828|NCT05838066|Docetaxel|docetaxel|mesh-list
92447829|NCT05838066|Trastuzumab|trastuzumab|mesh-list
92447830|NCT05838066|Pertuzumab|pertuzumab|mesh-list
92447831|NCT05838066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447832|NCT05838066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447833|NCT05838066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447834|NCT05838066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447835|NCT05838066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447836|NCT05838066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447837|NCT05838001|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92447838|NCT05838001|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92447839|NCT05838001|beta-Endorphin|beta-endorphin|mesh-list
92447840|NCT05838001|Hormones|hormones|mesh-ancestor
92447841|NCT05838001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447842|NCT05838001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447843|NCT05838001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447844|NCT05838001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447845|NCT05837936|Anesthetics|anesthetics|mesh-list
92447846|NCT05837936|Sevoflurane|sevoflurane|mesh-list
92447847|NCT05837936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447848|NCT05837936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447849|NCT05837936|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92447850|NCT05837936|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92447851|NCT05837936|Anesthetics, General|anesthetics, general|mesh-ancestor
92447852|NCT05837845|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92447854|NCT05837845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447855|NCT05837845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447856|NCT05837845|Serotonin Agents|serotonin agents|mesh-ancestor
92447857|NCT05837845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447858|NCT05837845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447859|NCT05837845|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92447860|NCT05837845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92447861|NCT05837845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92447862|NCT05837845|Adrenergic Agents|adrenergic agents|mesh-ancestor
92447863|NCT05837806|Tislelizumab|tislelizumab|mesh-list
92447864|NCT05837806|Disitamab vedotin|disitamab vedotin|mesh-list
92447865|NCT05837806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447866|NCT05837806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447867|NCT05837806|Immunoconjugates|immunoconjugates|mesh-ancestor
92447868|NCT05837806|Immunologic Factors|immunologic factors|mesh-ancestor
92447869|NCT05837806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447870|NCT05837689|Blinatumomab|blinatumomab|mesh-list
92447871|NCT05837689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447873|NCT05837286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92447874|NCT05837091|Sodium Oxybate|sodium oxybate|mesh-list
92447875|NCT05837091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447876|NCT05837091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447877|NCT05837091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447878|NCT05837091|Anesthetics, General|anesthetics, general|mesh-ancestor
92447879|NCT05837091|Anesthetics|anesthetics|mesh-ancestor
92447880|NCT05837091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447881|NCT05836857|Cannabidiol|cannabidiol|mesh-list
92447882|NCT05836857|Anticonvulsants|anticonvulsants|mesh-ancestor
92447883|NCT05836831|Tranexamic Acid|tranexamic acid|mesh-list
92447884|NCT05836831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92447885|NCT05836831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92447886|NCT05836831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447887|NCT05836831|Hemostatics|hemostatics|mesh-ancestor
92447888|NCT05836831|Coagulants|coagulants|mesh-ancestor
92447889|NCT05836545|Midazolam|midazolam|mesh-list
92447890|NCT05836545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447891|NCT05836545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447892|NCT05836545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447893|NCT05836545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447894|NCT05836545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92447895|NCT05836545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447896|NCT05836545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447897|NCT05836545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447898|NCT05836545|Anesthetics, General|anesthetics, general|mesh-ancestor
92447900|NCT05836545|GABA Modulators|gaba modulators|mesh-ancestor
92447901|NCT05836545|GABA Agents|gaba agents|mesh-ancestor
92447902|NCT05836545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447903|NCT05836545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447904|NCT05836441|Tacrolimus|tacrolimus|mesh-list
92447905|NCT05836441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447906|NCT05836441|Immunologic Factors|immunologic factors|mesh-ancestor
92447907|NCT05836441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447908|NCT05836441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92447909|NCT05836441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447910|NCT05836441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447911|NCT05836233|Vasodilator Agents|vasodilator agents|mesh-list
92447912|NCT05835999|Everolimus|everolimus|mesh-list
92447913|NCT05835999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92447914|NCT05835999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92447915|NCT05835999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92447916|NCT05835999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447917|NCT05835999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92447918|NCT05835999|Immunologic Factors|immunologic factors|mesh-ancestor
92447919|NCT05835999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447920|NCT05835999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447921|NCT05835726|Daratumumab|daratumumab|mesh-list
92447922|NCT05835726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447923|NCT05834049|Midazolam|midazolam|mesh-list
92447924|NCT05834049|Anesthetics|anesthetics|mesh-ancestor
92447925|NCT05834049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447926|NCT05834049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447927|NCT05834049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92447928|NCT05834049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447929|NCT05834049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92447930|NCT05834049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92447931|NCT05834049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92447932|NCT05834049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92447933|NCT05834049|Anesthetics, General|anesthetics, general|mesh-ancestor
92447934|NCT05834049|GABA Modulators|gaba modulators|mesh-ancestor
92447936|NCT05834049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447937|NCT05834049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447938|NCT05833217|Insulin|insulin|mesh-list
92447939|NCT05833217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92447940|NCT05833217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447941|NCT05814744|Dexmedetomidine|dexmedetomidine|mesh-list
92447942|NCT05814744|Bupivacaine|bupivacaine|mesh-list
92447943|NCT05814744|Anesthetics, Local|anesthetics, local|mesh-ancestor
92447944|NCT05814744|Anesthetics|anesthetics|mesh-ancestor
92447945|NCT05814744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92447946|NCT05814744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447947|NCT05814744|Sensory System Agents|sensory system agents|mesh-ancestor
92447948|NCT05814744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92447949|NCT05814744|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92447950|NCT05814744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92447951|NCT05814744|Analgesics|analgesics|mesh-ancestor
92447952|NCT05814744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92447953|NCT05814744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92447954|NCT05814744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92447955|NCT05814744|Adrenergic Agents|adrenergic agents|mesh-ancestor
92447956|NCT05814744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92447957|NCT05814744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447958|NCT05797558|Eplerenone|eplerenone|mesh-list
92447959|NCT05797558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92447960|NCT05797558|Mineralocorticoids|mineralocorticoids|mesh-list
92447961|NCT05797558|Hormone Antagonists|hormone antagonists|mesh-ancestor
92447962|NCT05797558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92447963|NCT05797558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447964|NCT05797558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92447965|NCT05797558|Diuretics|diuretics|mesh-ancestor
92447966|NCT05797558|Natriuretic Agents|natriuretic agents|mesh-ancestor
92447967|NCT05797558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92447968|NCT05797558|Hormones|hormones|mesh-ancestor
92447969|NCT05786820|Pycnogenols|pycnogenols|mesh-list
92447970|NCT05786820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92447971|NCT05786820|Immunologic Factors|immunologic factors|mesh-ancestor
92447972|NCT05786820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447973|NCT05786820|Antioxidants|antioxidants|mesh-ancestor
92447974|NCT05786820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447975|NCT05786820|Protective Agents|protective agents|mesh-ancestor
92447976|NCT05786820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92447977|NCT05781308|Paclitaxel|paclitaxel|mesh-list
92447978|NCT05781308|Bevacizumab|bevacizumab|mesh-list
92447979|NCT05781308|Atezolizumab|atezolizumab|mesh-list
92447980|NCT05781308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92447981|NCT05781308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92447982|NCT05781308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92447983|NCT05781308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92447984|NCT05781308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92447985|NCT05781308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92447986|NCT05781308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92447987|NCT05781308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92447988|NCT05781308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92447989|NCT05781308|Growth Substances|growth substances|mesh-ancestor
92447990|NCT05781308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447991|NCT05781308|Growth Inhibitors|growth inhibitors|mesh-ancestor
92447992|NCT05781308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92447993|NCT05772156|Methylergonovine|methylergonovine|mesh-list
92447994|NCT05772156|Oxytocics|oxytocics|mesh-ancestor
92447995|NCT05772156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92447996|NCT05772156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92447997|NCT05769868|Esmolol|esmolol|mesh-list
92447998|NCT05769868|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92447999|NCT05769868|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92448000|NCT05769868|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92172958|NCT01332357|Xhance|xhance|mesh-list
92448002|NCT05769868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448003|NCT05769868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448004|NCT05769868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448006|NCT05727579|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92448007|NCT05727579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448008|NCT05727579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448009|NCT05727579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448010|NCT05685615|Polymyxins|polymyxins|mesh-list
92448011|NCT05685615|Polymyxin B|polymyxin b|mesh-list
92448012|NCT05685615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448013|NCT05685615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448014|NCT05652764|Immunomodulating Agents|immunomodulating agents|mesh-list
92448015|NCT05652764|Immunologic Factors|immunologic factors|mesh-ancestor
92448016|NCT05652764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448017|NCT05650996|Calpastatin|calpastatin|mesh-list
92448018|NCT05650996|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92448019|NCT05650996|Protease Inhibitors|protease inhibitors|mesh-ancestor
92448020|NCT05650996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448021|NCT05650996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448022|NCT05633147|Clarithromycin|clarithromycin|mesh-list
92448023|NCT05633147|Midazolam|midazolam|mesh-list
92448024|NCT05633147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92448025|NCT05633147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92448026|NCT05633147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448027|NCT05633147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448028|NCT05633147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92448029|NCT05633147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92448030|NCT05633147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92448031|NCT05633147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92448032|NCT05633147|Anesthetics, General|anesthetics, general|mesh-ancestor
92448033|NCT05633147|Anesthetics|anesthetics|mesh-ancestor
92448034|NCT05633147|GABA Modulators|gaba modulators|mesh-ancestor
92448035|NCT05633147|GABA Agents|gaba agents|mesh-ancestor
92448036|NCT05633147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448037|NCT05633147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448038|NCT05633147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448039|NCT05633147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448040|NCT05633147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92448041|NCT05633147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448042|NCT05633147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92448043|NCT05633147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92448044|NCT05597254|Niacin|niacin|mesh-list
92448045|NCT05597254|Niacinamide|niacinamide|mesh-list
92448046|NCT05597254|Nicotinic Acids|nicotinic acids|mesh-list
92448048|NCT05597254|Antimetabolites|antimetabolites|mesh-ancestor
92448049|NCT05597254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448050|NCT05597254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92448051|NCT05597254|Vasodilator Agents|vasodilator agents|mesh-ancestor
92448052|NCT05597254|Vitamin B Complex|vitamin b complex|mesh-ancestor
92448053|NCT05597254|Vitamins|vitamins|mesh-ancestor
92448054|NCT05597254|Micronutrients|micronutrients|mesh-ancestor
92448055|NCT05597254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448056|NCT05576415|Varenicline|varenicline|mesh-list
92448057|NCT05576415|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92448058|NCT05576415|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92448059|NCT05576415|Cholinergic Agents|cholinergic agents|mesh-ancestor
92448060|NCT05576415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448061|NCT05576415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448062|NCT05576415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448063|NCT05395052|Cyclophosphamide|cyclophosphamide|mesh-list
92448064|NCT05395052|Pembrolizumab|pembrolizumab|mesh-list
92448065|NCT05395052|Nivolumab|nivolumab|mesh-list
92448066|NCT05395052|Trastuzumab|trastuzumab|mesh-list
92448067|NCT05395052|Fludarabine|fludarabine|mesh-list
92448068|NCT05395052|Cetuximab|cetuximab|mesh-list
92448069|NCT05395052|Atezolizumab|atezolizumab|mesh-list
92448070|NCT05395052|Interleukin-2|interleukin-2|mesh-list
92448071|NCT05395052|Avelumab|avelumab|mesh-list
92448072|NCT05395052|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92448073|NCT05395052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448074|NCT05395052|Immunologic Factors|immunologic factors|mesh-ancestor
92448075|NCT05395052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448076|NCT05395052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448077|NCT05395052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92448078|NCT05395052|Alkylating Agents|alkylating agents|mesh-ancestor
92448079|NCT05395052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448080|NCT05395052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448081|NCT05395052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92448082|NCT05395052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448083|NCT05395052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448084|NCT05395052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92448085|NCT05395052|Analgesics|analgesics|mesh-ancestor
92448086|NCT05395052|Sensory System Agents|sensory system agents|mesh-ancestor
92448087|NCT05395052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448088|NCT05324761|Pregabalin|pregabalin|mesh-list
92448089|NCT05324761|Gabapentin|gabapentin|mesh-list
92448090|NCT05324761|Analgesics|analgesics|mesh-ancestor
92448091|NCT05324761|Sensory System Agents|sensory system agents|mesh-ancestor
92448092|NCT05324761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448093|NCT05324761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448094|NCT05324761|Anticonvulsants|anticonvulsants|mesh-ancestor
92448095|NCT05324761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92448096|NCT05324761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448097|NCT05324761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448098|NCT05324761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92448099|NCT05324761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92448100|NCT05324761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92448101|NCT05324761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448102|NCT05324761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92448103|NCT05324761|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92448104|NCT05324761|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92448105|NCT05324761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448106|NCT05324761|Antimanic Agents|antimanic agents|mesh-ancestor
92448107|NCT05317403|Cytarabine|cytarabine|mesh-list
92448108|NCT05317403|Fludarabine|fludarabine|mesh-list
92448109|NCT05317403|Venetoclax|venetoclax|mesh-list
92448110|NCT05317403|Vorinostat|vorinostat|mesh-list
92448111|NCT05317403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448112|NCT05317403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92448113|NCT05317403|Antimetabolites|antimetabolites|mesh-ancestor
92448114|NCT05317403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448115|NCT05317403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448116|NCT05317403|Immunologic Factors|immunologic factors|mesh-ancestor
92448117|NCT05317403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448118|NCT05317403|Antiviral Agents|antiviral agents|mesh-ancestor
92448119|NCT05317403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448120|NCT05317403|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92448121|NCT05317403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448122|NCT05312242|Folic Acid|folic acid|mesh-list
92448123|NCT05312242|Micronutrients|micronutrients|mesh-list
92448124|NCT05312242|Trace Elements|trace elements|mesh-list
92448125|NCT05312242|Hematinics|hematinics|mesh-ancestor
92448126|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
92448128|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448129|NCT05288829|Ravulizumab|ravulizumab|mesh-list
92448130|NCT05288829|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92448131|NCT05288829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448132|NCT05288829|Immunologic Factors|immunologic factors|mesh-ancestor
92448133|NCT05288829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448134|NCT05233566|Ketamine|ketamine|mesh-list
92448135|NCT05233566|Analgesics|analgesics|mesh-ancestor
92448136|NCT05233566|Sensory System Agents|sensory system agents|mesh-ancestor
92448137|NCT05233566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448138|NCT05233566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448139|NCT05233566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92448140|NCT05233566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92448141|NCT05233566|Anesthetics, General|anesthetics, general|mesh-ancestor
92448142|NCT05233566|Anesthetics|anesthetics|mesh-ancestor
92448143|NCT05233566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448144|NCT05233566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92448145|NCT05233566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92448146|NCT05233566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448147|NCT05233566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448148|NCT05232344|Estradiol|estradiol|mesh-list
92448149|NCT05232344|Progesterone|progesterone|mesh-list
92448150|NCT05232344|Estrogens|estrogens|mesh-ancestor
92448151|NCT05232344|Hormones|hormones|mesh-ancestor
92448152|NCT05232344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448153|NCT05232344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448154|NCT05232344|Progestins|progestins|mesh-ancestor
92448155|NCT05210517|Empagliflozin|empagliflozin|mesh-list
92448156|NCT05210517|Benzbromarone|benzbromarone|mesh-list
92448157|NCT05210517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92448158|NCT05210517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448159|NCT05210517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448160|NCT05210517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448161|NCT05210517|Uricosuric Agents|uricosuric agents|mesh-ancestor
92448162|NCT05210517|Gout Suppressants|gout suppressants|mesh-ancestor
92448163|NCT05210517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448164|NCT05180994|Infliximab|infliximab|mesh-list
92448165|NCT05180994|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92448166|NCT05180994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448167|NCT05180994|Dermatologic Agents|dermatologic agents|mesh-ancestor
92448168|NCT05180994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92448169|NCT05180994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448170|NCT05132699|Cannabidiol|cannabidiol|mesh-list
92448171|NCT05132699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92448172|NCT05132699|Anticonvulsants|anticonvulsants|mesh-ancestor
92448173|NCT05118685|Estrogens|estrogens|mesh-list
92448174|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92448175|NCT05118685|Hormones|hormones|mesh-ancestor
92347016|NCT01809210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92448176|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448177|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448178|NCT05109650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92448179|NCT05109650|Antibodies|antibodies|mesh-list
92448180|NCT05109650|Immunoglobulins|immunoglobulins|mesh-list
92448181|NCT05109650|Immunologic Factors|immunologic factors|mesh-ancestor
92448182|NCT05109650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448183|NCT05108259|Adalimumab|adalimumab|mesh-list
92448184|NCT05108259|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92448185|NCT05108259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448186|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448187|NCT05082610|Pembrolizumab|pembrolizumab|mesh-list
92448188|NCT05082610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448189|NCT05082610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448190|NCT05082610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448191|NCT05082610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448192|NCT05069935|Cyclophosphamide|cyclophosphamide|mesh-list
92448193|NCT05069935|Fludarabine|fludarabine|mesh-list
92448194|NCT05069935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92448195|NCT05069935|Antibodies|antibodies|mesh-list
92448196|NCT05069935|Immunoglobulins|immunoglobulins|mesh-list
92448197|NCT05069935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92448198|NCT05069935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448200|NCT05069935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448201|NCT05069935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448202|NCT05069935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92448203|NCT05069935|Alkylating Agents|alkylating agents|mesh-ancestor
92448204|NCT05069935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448205|NCT05069935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448206|NCT05069935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92448207|NCT05040217|Mitogens|mitogens|mesh-list
92448208|NCT05040217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448209|NCT05040217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448210|NCT05032118|Ketamine|ketamine|mesh-list
92448211|NCT05032118|Propofol|propofol|mesh-list
92448212|NCT05032118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92448213|NCT05032118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448214|NCT05032118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448215|NCT05032118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92448216|NCT05032118|Anesthetics, General|anesthetics, general|mesh-ancestor
92448217|NCT05032118|Anesthetics|anesthetics|mesh-ancestor
92448218|NCT05032118|Analgesics|analgesics|mesh-ancestor
92448219|NCT05032118|Sensory System Agents|sensory system agents|mesh-ancestor
92448220|NCT05032118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448221|NCT05032118|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92531306|NCT00045877|Rituximab|rituximab|mesh-list
92448222|NCT05032118|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92448223|NCT05032118|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92448224|NCT05032118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448225|NCT05032118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448226|NCT04977908|Insulin|insulin|mesh-list
92448227|NCT04977908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448228|NCT04977908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448229|NCT04954599|Carboplatin|carboplatin|mesh-list
92448230|NCT04954599|Pembrolizumab|pembrolizumab|mesh-list
92448231|NCT04954599|Nivolumab|nivolumab|mesh-list
92448232|NCT04954599|Ipilimumab|ipilimumab|mesh-list
92448233|NCT04954599|Atezolizumab|atezolizumab|mesh-list
92448234|NCT04954599|Durvalumab|durvalumab|mesh-list
92448235|NCT04954599|Avelumab|avelumab|mesh-list
92448236|NCT04954599|Cemiplimab|cemiplimab|mesh-list
92448237|NCT04954599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92448238|NCT04954599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448239|NCT04954599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448240|NCT04954599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448241|NCT04896697|Pembrolizumab|pembrolizumab|mesh-list
92448242|NCT04896697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448243|NCT04896697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448244|NCT04896697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92347021|NCT01809132|Prednisolone|prednisolone|mesh-list
92448245|NCT04896697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448246|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
92448247|NCT04874597|Immunologic Factors|immunologic factors|mesh-ancestor
92448248|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448249|NCT04862234|Dulaglutide|dulaglutide|mesh-list
92448250|NCT04862234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448251|NCT04862234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448252|NCT04842643|Immunoglobulins|immunoglobulins|mesh-list
92448253|NCT04842643|Immunologic Factors|immunologic factors|mesh-ancestor
92448254|NCT04842643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448255|NCT04745234|Mogamulizumab|mogamulizumab|mesh-list
92448256|NCT04745234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448257|NCT04701151|BCG Vaccine|bcg vaccine|mesh-list
92448258|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92448259|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
92448260|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448261|NCT04614636|Cyclophosphamide|cyclophosphamide|mesh-list
92448262|NCT04614636|Fludarabine|fludarabine|mesh-list
92448263|NCT04614636|Daratumumab|daratumumab|mesh-list
92448264|NCT04614636|Elotuzumab|elotuzumab|mesh-list
92448265|NCT04614636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448266|NCT04614636|Immunologic Factors|immunologic factors|mesh-ancestor
92448267|NCT04614636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448268|NCT04614636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448269|NCT04614636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92448270|NCT04614636|Alkylating Agents|alkylating agents|mesh-ancestor
92448271|NCT04614636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448272|NCT04614636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448273|NCT04614636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92448274|NCT04573920|Atrasentan|atrasentan|mesh-list
92448275|NCT04573920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448276|NCT04573920|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92448277|NCT04573920|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92448278|NCT04573920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448279|NCT04505878|Ascorbic Acid|ascorbic acid|mesh-list
92448280|NCT04505878|Vitamins|vitamins|mesh-ancestor
92448281|NCT04505878|Micronutrients|micronutrients|mesh-ancestor
92448282|NCT04505878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448283|NCT04505878|Antioxidants|antioxidants|mesh-ancestor
92448284|NCT04505878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448285|NCT04505878|Protective Agents|protective agents|mesh-ancestor
92448286|NCT04505189|Psilocybin|psilocybin|mesh-list
92448287|NCT04505189|Hallucinogens|hallucinogens|mesh-ancestor
92448288|NCT04505189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448289|NCT04505189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92448290|NCT04404881|Bevacizumab|bevacizumab|mesh-list
92448291|NCT04404881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448292|NCT04404881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448293|NCT04404881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92448294|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92448295|NCT04404881|Growth Substances|growth substances|mesh-ancestor
92448296|NCT04404881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448297|NCT04404881|Growth Inhibitors|growth inhibitors|mesh-ancestor
92448298|NCT04370509|Pembrolizumab|pembrolizumab|mesh-list
92448299|NCT04370509|Axitinib|axitinib|mesh-list
92448300|NCT04370509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448301|NCT04370509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448302|NCT04370509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448303|NCT04370509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173186|NCT01596504|Incretins|incretins|mesh-ancestor
92448304|NCT04370509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448305|NCT04370509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448306|NCT04335058|Iron|iron|mesh-list
92448307|NCT04335058|Lactoferrin|lactoferrin|mesh-list
92448308|NCT04335058|Trace Elements|trace elements|mesh-ancestor
92448309|NCT04335058|Micronutrients|micronutrients|mesh-ancestor
92448310|NCT04335058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448311|NCT04335058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448313|NCT04319224|Ipilimumab|ipilimumab|mesh-list
92448314|NCT04319224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448315|NCT04319224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448316|NCT04319224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92347028|NCT01809132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448317|NCT04319224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448318|NCT04280562|Acetaminophen|acetaminophen|mesh-list
92448319|NCT04280562|Analgesics|analgesics|mesh-list
92448320|NCT04280562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92448321|NCT04280562|Sensory System Agents|sensory system agents|mesh-ancestor
92448322|NCT04280562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448323|NCT04280562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448324|NCT04280562|Antipyretics|antipyretics|mesh-ancestor
92448325|NCT04257448|Paclitaxel|paclitaxel|mesh-list
92448326|NCT04257448|Gemcitabine|gemcitabine|mesh-list
92448327|NCT04257448|Lenalidomide|lenalidomide|mesh-list
92448328|NCT04257448|Azacitidine|azacitidine|mesh-list
92448329|NCT04257448|Durvalumab|durvalumab|mesh-list
92448330|NCT04257448|Romidepsin|romidepsin|mesh-list
92448331|NCT04257448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92448332|NCT04257448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448333|NCT04257448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92448334|NCT04257448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92448335|NCT04257448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448336|NCT04257448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448337|NCT04257448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92448338|NCT04257448|Antimetabolites|antimetabolites|mesh-ancestor
92448339|NCT04257448|Immunologic Factors|immunologic factors|mesh-ancestor
92448340|NCT04257448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448341|NCT04257448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92448342|NCT04257448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92448343|NCT04257448|Growth Substances|growth substances|mesh-ancestor
92448344|NCT04257448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92448345|NCT04257448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448346|NCT04257448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448347|NCT04257448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92448348|NCT04257448|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92448349|NCT04256317|Azacitidine|azacitidine|mesh-list
92448350|NCT04256317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92448351|NCT04256317|Antimetabolites|antimetabolites|mesh-ancestor
92448352|NCT04256317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448354|NCT04256317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448355|NCT04075136|Triamcinolone|triamcinolone|mesh-list
92448356|NCT04075136|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92448357|NCT04075136|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92448358|NCT04075136|Ranibizumab|ranibizumab|mesh-list
92448359|NCT04075136|Verteporfin|verteporfin|mesh-list
92448360|NCT04075136|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92448361|NCT04075136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92448362|NCT04075136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92448363|NCT04075136|Growth Substances|growth substances|mesh-ancestor
92448364|NCT04075136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448365|NCT04075136|Growth Inhibitors|growth inhibitors|mesh-ancestor
92448366|NCT04075136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448367|NCT04075136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448368|NCT04075136|Glucocorticoids|glucocorticoids|mesh-ancestor
92448369|NCT04075136|Hormones|hormones|mesh-ancestor
92448370|NCT04075136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448371|NCT04075136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448372|NCT04075136|Immunologic Factors|immunologic factors|mesh-ancestor
92448373|NCT04075136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448374|NCT04075136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448375|NCT04075136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92448376|NCT04075136|Dermatologic Agents|dermatologic agents|mesh-ancestor
92448377|NCT03959566|Moxifloxacin|moxifloxacin|mesh-list
92448378|NCT03959566|Bedaquiline|bedaquiline|mesh-list
92448379|NCT03959566|Midazolam|midazolam|mesh-list
92448380|NCT03959566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92448381|NCT03959566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92173259|NCT01404429|Methotrexate|methotrexate|mesh-list
92448382|NCT03959566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448383|NCT03959566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448384|NCT03959566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92448385|NCT03959566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92448386|NCT03959566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92448387|NCT03959566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92448388|NCT03959566|Anesthetics, General|anesthetics, general|mesh-ancestor
92448389|NCT03959566|Anesthetics|anesthetics|mesh-ancestor
92448390|NCT03959566|GABA Modulators|gaba modulators|mesh-ancestor
92448391|NCT03959566|GABA Agents|gaba agents|mesh-ancestor
92448392|NCT03959566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448393|NCT03959566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448394|NCT03959566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448395|NCT03959566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448396|NCT03959566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92448397|NCT03959566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448398|NCT03959566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448399|NCT03959566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448400|NCT03959566|Antitubercular Agents|antitubercular agents|mesh-ancestor
92448401|NCT03909529|Digoxin|digoxin|mesh-list
92448402|NCT03909529|Spironolactone|spironolactone|mesh-list
92448403|NCT03909529|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92448404|NCT03909529|Hormone Antagonists|hormone antagonists|mesh-ancestor
92448405|NCT03909529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448406|NCT03909529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448407|NCT03909529|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92448408|NCT03909529|Diuretics|diuretics|mesh-ancestor
92448409|NCT03909529|Natriuretic Agents|natriuretic agents|mesh-ancestor
92448410|NCT03909529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92448411|NCT03909529|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92448412|NCT03909529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448413|NCT03909529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448414|NCT03909529|Protective Agents|protective agents|mesh-ancestor
92448415|NCT03875755|Inositol|inositol|mesh-list
92448416|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
92448417|NCT03875755|Vitamins|vitamins|mesh-ancestor
92448418|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
92448419|NCT03875755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448420|NCT03677154|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92448421|NCT03677154|Immunoconjugates|immunoconjugates|mesh-ancestor
92448422|NCT03677154|Immunologic Factors|immunologic factors|mesh-ancestor
92448423|NCT03677154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448424|NCT03519997|Pembrolizumab|pembrolizumab|mesh-list
92448425|NCT03519997|Bavituximab|bavituximab|mesh-list
92448426|NCT03519997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448427|NCT03519997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448428|NCT03519997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448429|NCT03519997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448430|NCT03380546|Insulin|insulin|mesh-list
92448431|NCT03380546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92448432|NCT03380546|Acarbose|acarbose|mesh-list
92448433|NCT03380546|Insulin, Short-Acting|insulin, short-acting|mesh-list
92448434|NCT03380546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448435|NCT03380546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448436|NCT03380546|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92448437|NCT03380546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448438|NCT03380546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448439|NCT03318094|Nitroprusside|nitroprusside|mesh-list
92448440|NCT03318094|Phentolamine|phentolamine|mesh-list
92448441|NCT03318094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92448442|NCT03318094|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92448443|NCT03318094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92448444|NCT03318094|Vasodilator Agents|vasodilator agents|mesh-ancestor
92448445|NCT03318094|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92531312|NCT00045877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448446|NCT03318094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448447|NCT03318094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92448448|NCT03318094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448449|NCT03318094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448450|NCT03268499|Cisplatin|cisplatin|mesh-list
92448451|NCT03268499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448452|NCT03250624|Ivermectin|ivermectin|mesh-list
92448453|NCT03250624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92448454|NCT03250624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448455|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
92448456|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92448457|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92448458|NCT03190915|Trametinib|trametinib|mesh-list
92448459|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448460|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448461|NCT03190915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448462|NCT03190915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448463|NCT03187353|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92448464|NCT03187353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92448465|NCT03187353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448466|NCT03187353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92448467|NCT03187353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92448468|NCT03187353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448469|NCT03187353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448470|NCT03187353|Dopamine Agents|dopamine agents|mesh-ancestor
92448471|NCT03187353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448472|NCT03122717|Gefitinib|gefitinib|mesh-list
92448473|NCT03122717|Osimertinib|osimertinib|mesh-list
92448474|NCT03122717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448475|NCT03122717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448476|NCT03122717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448477|NCT03122717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448478|NCT03069326|Thalidomide|thalidomide|mesh-list
92448479|NCT03069326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448480|NCT03069326|Immunologic Factors|immunologic factors|mesh-ancestor
92448481|NCT03069326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448482|NCT03069326|Leprostatic Agents|leprostatic agents|mesh-ancestor
92448483|NCT03069326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448484|NCT03069326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448485|NCT03069326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92448486|NCT03069326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92448487|NCT03069326|Growth Substances|growth substances|mesh-ancestor
92448488|NCT03069326|Growth Inhibitors|growth inhibitors|mesh-ancestor
92448489|NCT03069326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448490|NCT03015740|Nivolumab|nivolumab|mesh-list
92448491|NCT03015740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448492|NCT03015740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448493|NCT03015740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448494|NCT03015740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448495|NCT02881242|Trametinib|trametinib|mesh-list
92448496|NCT02881242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448497|NCT02881242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448498|NCT02881242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448499|NCT02881242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448500|NCT02720068|Leucovorin|leucovorin|mesh-list
92448501|NCT02720068|Pembrolizumab|pembrolizumab|mesh-list
92448503|NCT02720068|Oxaliplatin|oxaliplatin|mesh-list
92448504|NCT02720068|Irinotecan|irinotecan|mesh-list
92448505|NCT02720068|Lenvatinib|lenvatinib|mesh-list
92448506|NCT02720068|Calcium|calcium|mesh-list
92448507|NCT02720068|Levoleucovorin|levoleucovorin|mesh-list
92448508|NCT02720068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448509|NCT02720068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448510|NCT02720068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448511|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448512|NCT02720068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92448513|NCT02720068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448514|NCT02720068|Antimetabolites|antimetabolites|mesh-ancestor
92448515|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92448516|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448517|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
92448518|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92448519|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448520|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448521|NCT02720068|Antidotes|antidotes|mesh-ancestor
92448522|NCT02720068|Protective Agents|protective agents|mesh-ancestor
92448523|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
92448524|NCT02720068|Vitamins|vitamins|mesh-ancestor
92448525|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
92448526|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448527|NCT02638519|Xenon|xenon|mesh-list
92448528|NCT02638519|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92448529|NCT02638519|Anesthetics, General|anesthetics, general|mesh-ancestor
92448530|NCT02638519|Anesthetics|anesthetics|mesh-ancestor
92448531|NCT02638519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448532|NCT02638519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448533|NCT02615184|Dexlansoprazole|dexlansoprazole|mesh-list
92448534|NCT02615184|Lansoprazole|lansoprazole|mesh-list
92173418|NCT04891458|Propofol|propofol|mesh-list
92448535|NCT02615184|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92448536|NCT02615184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92448537|NCT02615184|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92448538|NCT02615184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448539|NCT02615184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448540|NCT02408549|Lacosamide|lacosamide|mesh-list
92448541|NCT02408549|Anticonvulsants|anticonvulsants|mesh-ancestor
92448542|NCT02408549|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92448543|NCT02408549|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92448544|NCT02408549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448545|NCT02408549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448546|NCT02376699|Paclitaxel|paclitaxel|mesh-list
92448547|NCT02376699|Gemcitabine|gemcitabine|mesh-list
92448548|NCT02376699|Pembrolizumab|pembrolizumab|mesh-list
92448549|NCT02376699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92448550|NCT02376699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448551|NCT02376699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92448552|NCT02376699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92448553|NCT02376699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448554|NCT02376699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448555|NCT02376699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92448556|NCT02376699|Antimetabolites|antimetabolites|mesh-ancestor
92448557|NCT02376699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448558|NCT02376699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448559|NCT02141542|Tremelimumab|tremelimumab|mesh-list
92448560|NCT02141542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448561|NCT01930955|Amoxicillin|amoxicillin|mesh-list
92448562|NCT01930955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448563|NCT01930955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448564|NCT01333514|Insulin Aspart|insulin aspart|mesh-list
92448565|NCT01333514|Insulin, Long-Acting|insulin, long-acting|mesh-list
92448566|NCT01333514|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92448567|NCT01333514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448568|NCT01333514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448569|NCT01241708|Bortezomib|bortezomib|mesh-list
92448570|NCT01241708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448571|NCT02098512|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92448572|NCT02098512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448573|NCT02098512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448574|NCT02098512|Immunotoxins|immunotoxins|mesh-ancestor
92448575|NCT02098512|Immunoconjugates|immunoconjugates|mesh-ancestor
92448576|NCT02098512|Immunologic Factors|immunologic factors|mesh-ancestor
92448577|NCT02098512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448579|NCT02066636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448580|NCT02066636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448581|NCT02066636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92448582|NCT02066636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448583|NCT02036086|Vemurafenib|vemurafenib|mesh-list
92448584|NCT02036086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448585|NCT02036086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448586|NCT02036086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448587|NCT02036086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448588|NCT01486264|Botulinum Toxins|botulinum toxins|mesh-list
92531317|NCT00045877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92448589|NCT01486264|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92448590|NCT01486264|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92448591|NCT01486264|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92448592|NCT01486264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448593|NCT01486264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448594|NCT01486264|Cholinergic Agents|cholinergic agents|mesh-ancestor
92448595|NCT01486264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448596|NCT01486264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448597|NCT01486264|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92448598|NCT01486264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448599|NCT01299480|Vaccines|vaccines|mesh-list
92448600|NCT01299480|Immunologic Factors|immunologic factors|mesh-ancestor
92448601|NCT01299480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448602|NCT01681446|Interferons|interferons|mesh-list
92448603|NCT01681446|Interferon-alpha|interferon-alpha|mesh-list
92448604|NCT01681446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448605|NCT01681446|Antiviral Agents|antiviral agents|mesh-ancestor
92448606|NCT01681446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448607|NCT01681446|Immunologic Factors|immunologic factors|mesh-ancestor
92448608|NCT01681446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448609|NCT01681875|Nicotine|nicotine|mesh-list
92448610|NCT01681875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92448611|NCT01681875|Autonomic Agents|autonomic agents|mesh-ancestor
92448612|NCT01681875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448613|NCT01681875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448614|NCT01681875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92448615|NCT01681875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92448616|NCT01681875|Cholinergic Agents|cholinergic agents|mesh-ancestor
92448617|NCT01681875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448618|NCT01681875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448619|NCT01682577|Perindopril|perindopril|mesh-list
92448620|NCT01682577|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92448621|NCT01682577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92448622|NCT01682577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448623|NCT01682577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448624|NCT01682577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92448625|NCT01683760|Fluconazole|fluconazole|mesh-list
92448626|NCT01683760|Antifungal Agents|antifungal agents|mesh-ancestor
92448627|NCT01683760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448628|NCT01683760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92448629|NCT01683760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92448630|NCT01683760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448631|NCT01683760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448632|NCT01683760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92448633|NCT01683760|Hormone Antagonists|hormone antagonists|mesh-ancestor
92448634|NCT01683760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448635|NCT01683760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448636|NCT01683760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92448637|NCT01683760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92448638|NCT01684813|Clopidogrel|clopidogrel|mesh-list
92448639|NCT01684813|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92448640|NCT01684813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92448641|NCT01684813|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92448642|NCT01684813|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92448643|NCT01684813|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92448644|NCT01684813|Purinergic Agents|purinergic agents|mesh-ancestor
92448645|NCT01684813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448646|NCT01684813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448647|NCT01684813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448649|NCT01684982|Everolimus|everolimus|mesh-list
92448650|NCT01684982|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92448651|NCT01684982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92448652|NCT01684982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448653|NCT01684982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448654|NCT01684982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448655|NCT01684982|Immunologic Factors|immunologic factors|mesh-ancestor
92448656|NCT01684982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448657|NCT01684982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448658|NCT01684982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448659|NCT01684982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448660|NCT01684982|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92448661|NCT01684982|Antifungal Agents|antifungal agents|mesh-ancestor
92448662|NCT01685034|Immunomodulating Agents|immunomodulating agents|mesh-list
92448663|NCT01685034|Immunologic Factors|immunologic factors|mesh-ancestor
92347051|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
92448664|NCT01685034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448665|NCT01685489|polysaccharide-K|polysaccharide-k|mesh-list
92448666|NCT01685489|Docetaxel|docetaxel|mesh-list
92448667|NCT01685489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448668|NCT01685489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92448669|NCT01685489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92448670|NCT01685489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448671|NCT01685489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448672|NCT01685489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92448673|NCT01685489|Immunologic Factors|immunologic factors|mesh-ancestor
92448674|NCT01685489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448675|NCT01685489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92448676|NCT01685489|Antiviral Agents|antiviral agents|mesh-ancestor
92448677|NCT01685489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448678|NCT01685489|Interferon Inducers|interferon inducers|mesh-ancestor
92448679|NCT01685489|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92448680|NCT01685489|Protective Agents|protective agents|mesh-ancestor
92448681|NCT01686386|Dexamethasone|dexamethasone|mesh-list
92173565|NCT04898946|Vaccines|vaccines|mesh-list
92448682|NCT01686386|Lenalidomide|lenalidomide|mesh-list
92448683|NCT01686386|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92448684|NCT01686386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448685|NCT01686386|Antiemetics|antiemetics|mesh-ancestor
92448686|NCT01686386|Autonomic Agents|autonomic agents|mesh-ancestor
92448687|NCT01686386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448688|NCT01686386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448689|NCT01686386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92448690|NCT01686386|Glucocorticoids|glucocorticoids|mesh-ancestor
92448691|NCT01686386|Hormones|hormones|mesh-ancestor
92448692|NCT01686386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448693|NCT01686386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92448694|NCT01686386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448695|NCT01686386|Immunologic Factors|immunologic factors|mesh-ancestor
92448696|NCT01686386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92448697|NCT01686386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92448698|NCT01686386|Growth Substances|growth substances|mesh-ancestor
92448699|NCT01686386|Growth Inhibitors|growth inhibitors|mesh-ancestor
92448700|NCT01686386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92448701|NCT01686386|Alkylating Agents|alkylating agents|mesh-ancestor
92448702|NCT01686386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448703|NCT01686594|Methoxsalen|methoxsalen|mesh-list
92448704|NCT01686594|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92448705|NCT01686594|Dermatologic Agents|dermatologic agents|mesh-ancestor
92448706|NCT01687517|Vaccines|vaccines|mesh-list
92448707|NCT01687517|Immunologic Factors|immunologic factors|mesh-ancestor
92448708|NCT01687517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448709|NCT01687751|Midazolam|midazolam|mesh-list
92448710|NCT01687751|Dexmedetomidine|dexmedetomidine|mesh-list
92448711|NCT01687751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92448712|NCT01687751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448713|NCT01687751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448714|NCT01687751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92448715|NCT01687751|Analgesics|analgesics|mesh-ancestor
92448716|NCT01687751|Sensory System Agents|sensory system agents|mesh-ancestor
92448717|NCT01687751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448718|NCT01687751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92448719|NCT01687751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92448720|NCT01687751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92448721|NCT01687751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92448722|NCT01687751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448723|NCT01687751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448724|NCT01687751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92448725|NCT01687751|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92448726|NCT01687751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92448727|NCT01687751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92448728|NCT01687751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92448729|NCT01687751|Anesthetics, General|anesthetics, general|mesh-ancestor
92448730|NCT01687751|Anesthetics|anesthetics|mesh-ancestor
92448731|NCT01687751|GABA Modulators|gaba modulators|mesh-ancestor
92448732|NCT01687751|GABA Agents|gaba agents|mesh-ancestor
92448733|NCT01688362|Dexamethasone|dexamethasone|mesh-list
92448734|NCT01688362|Bupivacaine|bupivacaine|mesh-list
92448735|NCT01688362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448736|NCT01688362|Antiemetics|antiemetics|mesh-ancestor
92448737|NCT01688362|Autonomic Agents|autonomic agents|mesh-ancestor
92448738|NCT01688362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448739|NCT01688362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448740|NCT01688362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92448741|NCT01688362|Glucocorticoids|glucocorticoids|mesh-ancestor
92448743|NCT01688362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448744|NCT01688362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92448745|NCT01688362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448746|NCT01688362|Anesthetics, Local|anesthetics, local|mesh-ancestor
92448747|NCT01688362|Anesthetics|anesthetics|mesh-ancestor
92448748|NCT01688362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448749|NCT01688362|Sensory System Agents|sensory system agents|mesh-ancestor
92448750|NCT01688375|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92448751|NCT01688375|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92448752|NCT01688375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92448753|NCT01689753|Citric Acid|citric acid|mesh-list
92173635|NCT01406223|Autonomic Agents|autonomic agents|mesh-ancestor
92448754|NCT01689753|Sodium Citrate|sodium citrate|mesh-list
92448755|NCT01689753|Anticoagulants|anticoagulants|mesh-ancestor
92448756|NCT01689753|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92448757|NCT01689753|Chelating Agents|chelating agents|mesh-ancestor
92448758|NCT01689753|Sequestering Agents|sequestering agents|mesh-ancestor
92448759|NCT01689753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448760|NCT01690039|Fludrocortisone|fludrocortisone|mesh-list
92448761|NCT01690039|Furosemide|furosemide|mesh-list
92448762|NCT01690039|Diuretics|diuretics|mesh-ancestor
92448763|NCT01690039|Natriuretic Agents|natriuretic agents|mesh-ancestor
92448764|NCT01690039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448765|NCT01690039|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92448766|NCT01690039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448767|NCT01690039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448768|NCT01690039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448769|NCT01690091|Metformin|metformin|mesh-list
92448770|NCT01690091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92448771|NCT01690091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448772|NCT01690104|Rifampin|rifampin|mesh-list
92448773|NCT01690104|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92448774|NCT01690104|Antitubercular Agents|antitubercular agents|mesh-ancestor
92448775|NCT01690104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448776|NCT01690104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448777|NCT01690104|Leprostatic Agents|leprostatic agents|mesh-ancestor
92448778|NCT01690104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92448779|NCT01690104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448780|NCT01690104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448781|NCT01690104|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92448782|NCT01690104|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92448783|NCT01690104|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92448784|NCT01690104|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92448785|NCT01690104|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92448786|NCT01690104|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92448787|NCT01690221|Diltiazem|diltiazem|mesh-list
92448788|NCT01690221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92448789|NCT01690221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92448790|NCT01690221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448791|NCT01690221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448792|NCT01690221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92448793|NCT01690221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448794|NCT01690221|Vasodilator Agents|vasodilator agents|mesh-ancestor
92448796|NCT01690247|Immunologic Factors|immunologic factors|mesh-ancestor
92448797|NCT01690247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448798|NCT01690286|Ketoconazole|ketoconazole|mesh-list
92448799|NCT01690286|Antifungal Agents|antifungal agents|mesh-ancestor
92448800|NCT01690286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448801|NCT01690286|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92448802|NCT01690286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92448803|NCT01690286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448804|NCT01690286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448805|NCT01690286|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92448806|NCT01690286|Hormone Antagonists|hormone antagonists|mesh-ancestor
92448807|NCT01690286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92448808|NCT01690286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448809|NCT01690286|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92448810|NCT01690325|Cyclophosphamide|cyclophosphamide|mesh-list
92448811|NCT01690325|Bevacizumab|bevacizumab|mesh-list
92448812|NCT01690325|Docetaxel|docetaxel|mesh-list
92448813|NCT01690325|Trastuzumab|trastuzumab|mesh-list
92448814|NCT01690325|Epirubicin|epirubicin|mesh-list
92448815|NCT01690325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448816|NCT01690325|Immunologic Factors|immunologic factors|mesh-ancestor
92448817|NCT01690325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448818|NCT01690325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448819|NCT01690325|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92448820|NCT01690325|Alkylating Agents|alkylating agents|mesh-ancestor
92448821|NCT01690325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448822|NCT01690325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448823|NCT01690325|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92448824|NCT01690325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92448825|NCT01690325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92448826|NCT01690325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92448827|NCT01690325|Growth Substances|growth substances|mesh-ancestor
92448828|NCT01690325|Growth Inhibitors|growth inhibitors|mesh-ancestor
92448829|NCT01690325|Tubulin Modulators|tubulin modulators|mesh-ancestor
92448830|NCT01690325|Antimitotic Agents|antimitotic agents|mesh-ancestor
92448831|NCT01690325|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448832|NCT01690325|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92448833|NCT01690325|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92448834|NCT01690325|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448835|NCT01690325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448836|NCT01690338|Bromides|bromides|mesh-list
92448837|NCT01690338|Rocuronium|rocuronium|mesh-list
92448838|NCT01690338|Vecuronium Bromide|vecuronium bromide|mesh-list
92448839|NCT01690338|Cisatracurium|cisatracurium|mesh-list
92448840|NCT01690338|Anticonvulsants|anticonvulsants|mesh-ancestor
92448841|NCT01690338|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92448842|NCT01690338|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92448843|NCT01690338|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92448844|NCT01690338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448845|NCT01690338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448846|NCT01690338|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92448847|NCT01690338|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92448848|NCT01690338|Cholinergic Agents|cholinergic agents|mesh-ancestor
92448849|NCT01690338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448850|NCT01690338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448851|NCT01690364|Anesthetics|anesthetics|mesh-list
92448852|NCT01690364|Cisatracurium|cisatracurium|mesh-list
92448853|NCT01690364|Vecuronium Bromide|vecuronium bromide|mesh-list
92448854|NCT01690364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448855|NCT01690364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448856|NCT01690364|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92448857|NCT01690364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92448858|NCT01690364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448859|NCT01690364|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92448860|NCT01690364|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92448861|NCT01690364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92448862|NCT01690364|Cholinergic Agents|cholinergic agents|mesh-ancestor
92448863|NCT01690364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448864|NCT01690364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448865|NCT01690403|Rifapentine|rifapentine|mesh-list
92448866|NCT01690403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92448867|NCT01690403|Antitubercular Agents|antitubercular agents|mesh-ancestor
92448869|NCT01690403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448870|NCT01690403|Leprostatic Agents|leprostatic agents|mesh-ancestor
92448871|NCT01690468|Carboplatin|carboplatin|mesh-list
92448872|NCT01690468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448873|NCT01690507|Cytarabine|cytarabine|mesh-list
92448874|NCT01690507|Decitabine|decitabine|mesh-list
92448875|NCT01690507|Aclacinomycins|aclacinomycins|mesh-list
92448876|NCT01690507|Lenograstim|lenograstim|mesh-list
92448877|NCT01690507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92448878|NCT01690507|Antimetabolites|antimetabolites|mesh-ancestor
92448879|NCT01690507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448880|NCT01690507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448881|NCT01690507|Antiviral Agents|antiviral agents|mesh-ancestor
92448882|NCT01690507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448883|NCT01690507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448884|NCT01690507|Immunologic Factors|immunologic factors|mesh-ancestor
92448885|NCT01690507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448886|NCT01690507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448887|NCT01690507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92448888|NCT01690507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92448890|NCT01690533|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92448891|NCT01690533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448892|NCT01690533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448893|NCT01690533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92448894|NCT01690533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448895|NCT01690533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448896|NCT01690533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448897|NCT01690533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448898|NCT01690533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92448899|NCT01690533|Contraceptive Agents|contraceptive agents|mesh-ancestor
92448900|NCT01690533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92448901|NCT01690533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448902|NCT01690533|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92448903|NCT01690533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92448904|NCT01690533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92448905|NCT01690559|Ciprofloxacin|ciprofloxacin|mesh-list
92448906|NCT01690559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92448907|NCT01690559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448908|NCT01690559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92448909|NCT01690559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448910|NCT01690559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448911|NCT01690559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448912|NCT01690559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448913|NCT01690559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92448914|NCT01690559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92448915|NCT01690572|Paclitaxel|paclitaxel|mesh-list
92448916|NCT01690572|Hyaluronic Acid|hyaluronic acid|mesh-list
92448917|NCT01690572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92448918|NCT01690572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448919|NCT01690572|Tubulin Modulators|tubulin modulators|mesh-ancestor
92448920|NCT01690572|Antimitotic Agents|antimitotic agents|mesh-ancestor
92448921|NCT01690572|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448922|NCT01690572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448923|NCT01690572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92448924|NCT01690572|Immunologic Factors|immunologic factors|mesh-ancestor
92448925|NCT01690572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448926|NCT01690572|Viscosupplements|viscosupplements|mesh-ancestor
92448927|NCT01690572|Protective Agents|protective agents|mesh-ancestor
92448928|NCT01690598|Topotecan|topotecan|mesh-list
92448929|NCT01690598|Veliparib|veliparib|mesh-list
92448930|NCT01690598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92448931|NCT01690598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448932|NCT01690598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448933|NCT01690598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448934|NCT01690598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448935|NCT01690598|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92448936|NCT01690637|Oseltamivir|oseltamivir|mesh-list
92448937|NCT01690637|Antiviral Agents|antiviral agents|mesh-ancestor
92448938|NCT01690637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92448939|NCT01690637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448940|NCT01690637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448941|NCT01690702|Paclitaxel|paclitaxel|mesh-list
92448943|NCT01690702|Cyclophosphamide|cyclophosphamide|mesh-list
92448944|NCT01690702|Epirubicin|epirubicin|mesh-list
92448945|NCT01690702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92448946|NCT01690702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92448947|NCT01690702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92448948|NCT01690702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92448949|NCT01690702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92448950|NCT01690702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448951|NCT01690702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92448952|NCT01690702|Immunologic Factors|immunologic factors|mesh-ancestor
92448953|NCT01690702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448954|NCT01690702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448955|NCT01690702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92448956|NCT01690702|Alkylating Agents|alkylating agents|mesh-ancestor
92448957|NCT01690702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92448958|NCT01690702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92448959|NCT01690702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92448960|NCT01690702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92448961|NCT01690702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448962|NCT01690767|Lidocaine|lidocaine|mesh-list
92448963|NCT01690767|Anesthetics, Local|anesthetics, local|mesh-ancestor
92448964|NCT01690767|Anesthetics|anesthetics|mesh-ancestor
92448965|NCT01690767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448966|NCT01690767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448967|NCT01690767|Sensory System Agents|sensory system agents|mesh-ancestor
92448968|NCT01690767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448969|NCT01690767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92448970|NCT01690767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92448971|NCT01690767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92448972|NCT01690767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92448973|NCT01690767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448974|NCT01690780|Ibuprofen|ibuprofen|mesh-list
92448975|NCT01690780|Morphine|morphine|mesh-list
92448976|NCT01690780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92448977|NCT01690780|Narcotics|narcotics|mesh-ancestor
92448978|NCT01690780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92448979|NCT01690780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448980|NCT01690780|Analgesics|analgesics|mesh-ancestor
92448981|NCT01690780|Sensory System Agents|sensory system agents|mesh-ancestor
92448982|NCT01690780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92448983|NCT01690780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92448984|NCT01690780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92448985|NCT01690780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92448986|NCT01690780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92448987|NCT01690780|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92448988|NCT01690780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92448989|NCT01690780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448990|NCT01690832|Fenoldopam|fenoldopam|mesh-list
92448991|NCT01690832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92448992|NCT01690832|Vasodilator Agents|vasodilator agents|mesh-ancestor
92448993|NCT01690832|Dopamine Agonists|dopamine agonists|mesh-ancestor
92448994|NCT01690832|Dopamine Agents|dopamine agents|mesh-ancestor
92448995|NCT01690832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92448996|NCT01690832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92448997|NCT01690832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92448998|NCT01690871|Dactolisib|dactolisib|mesh-list
92448999|NCT01690871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449000|NCT01690884|Adenosine|adenosine|mesh-list
92449001|NCT01690884|Analgesics|analgesics|mesh-ancestor
92449002|NCT01690884|Sensory System Agents|sensory system agents|mesh-ancestor
92449003|NCT01690884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449004|NCT01690884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449005|NCT01690884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92449006|NCT01690884|Vasodilator Agents|vasodilator agents|mesh-ancestor
92449007|NCT01690884|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92449008|NCT01690884|Purinergic Agonists|purinergic agonists|mesh-ancestor
92449009|NCT01690884|Purinergic Agents|purinergic agents|mesh-ancestor
92449010|NCT01690884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449011|NCT01690884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449012|NCT01690962|Vitamins|vitamins|mesh-list
92449013|NCT01690962|Hydroxocobalamin|hydroxocobalamin|mesh-list
92347082|NCT01766310|Folic Acid|folic acid|mesh-list
92449014|NCT01690962|Vitamin B 12|vitamin b 12|mesh-list
92449015|NCT01690962|Vitamin B Complex|vitamin b complex|mesh-list
92449016|NCT01690962|Micronutrients|micronutrients|mesh-ancestor
92449017|NCT01690962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449018|NCT01690962|Hematinics|hematinics|mesh-ancestor
92449019|NCT01690975|Benzonatate|benzonatate|mesh-list
92449020|NCT01690975|Antitussive Agents|antitussive agents|mesh-ancestor
92449021|NCT01690975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449022|NCT01691001|Dexmedetomidine|dexmedetomidine|mesh-list
92449023|NCT01691001|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92449024|NCT01691001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449025|NCT01691001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449026|NCT01691001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449028|NCT01691001|Sensory System Agents|sensory system agents|mesh-ancestor
92449029|NCT01691001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449030|NCT01691001|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92449031|NCT01691001|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92449032|NCT01691001|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92449033|NCT01691001|Adrenergic Agents|adrenergic agents|mesh-ancestor
92449034|NCT01691001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449035|NCT01691001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449036|NCT01691053|Spironolactone|spironolactone|mesh-list
92449037|NCT01691053|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92449038|NCT01691053|Hormone Antagonists|hormone antagonists|mesh-ancestor
92449039|NCT01691053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449040|NCT01691053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449041|NCT01691053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92449042|NCT01691053|Diuretics|diuretics|mesh-ancestor
92449043|NCT01691053|Natriuretic Agents|natriuretic agents|mesh-ancestor
92449044|NCT01691118|Antihypertensive Agents|antihypertensive agents|mesh-list
92449045|NCT01691209|Hydrocortisone|hydrocortisone|mesh-list
92449046|NCT01691209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449047|NCT01691365|Vitamins|vitamins|mesh-list
92449048|NCT01691365|Vitamin B Complex|vitamin b complex|mesh-list
92449049|NCT01691365|Antioxidants|antioxidants|mesh-list
92449050|NCT01691365|Micronutrients|micronutrients|mesh-ancestor
92449051|NCT01691365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449052|NCT01691365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449053|NCT01691365|Protective Agents|protective agents|mesh-ancestor
92449054|NCT01691404|Quercetin|quercetin|mesh-list
92449055|NCT01691404|Antioxidants|antioxidants|mesh-ancestor
92449056|NCT01691404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449057|NCT01691404|Protective Agents|protective agents|mesh-ancestor
92449058|NCT01691404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449059|NCT01691456|Montelukast|montelukast|mesh-list
92449060|NCT01691456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92449061|NCT01691456|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449062|NCT01691456|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92449063|NCT01691456|Hormone Antagonists|hormone antagonists|mesh-ancestor
92449064|NCT01691456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449065|NCT01691456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449066|NCT01691456|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92449067|NCT01691456|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92449068|NCT01691456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449069|NCT01691469|Montelukast|montelukast|mesh-list
92449070|NCT01691469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92449071|NCT01691469|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449072|NCT01691469|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92449073|NCT01691469|Hormone Antagonists|hormone antagonists|mesh-ancestor
92449074|NCT01691469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449075|NCT01691469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449076|NCT01691469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92449077|NCT01691469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92449078|NCT01691469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449079|NCT01691495|PENTA|penta|mesh-list
92449080|NCT01691495|Fondaparinux|fondaparinux|mesh-list
92449081|NCT01691495|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92449082|NCT01691495|Antithrombins|antithrombins|mesh-ancestor
92449083|NCT01691495|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92449084|NCT01691495|Protease Inhibitors|protease inhibitors|mesh-ancestor
92449085|NCT01691495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449086|NCT01691495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449087|NCT01691495|Anticoagulants|anticoagulants|mesh-ancestor
92449088|NCT01691495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92449089|NCT01691495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92449090|NCT01691625|Immunomodulating Agents|immunomodulating agents|mesh-list
92449091|NCT01691625|Immunologic Factors|immunologic factors|mesh-ancestor
92449092|NCT01691625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449093|NCT01691651|Botulinum Toxins|botulinum toxins|mesh-list
92449094|NCT01691651|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92449095|NCT01691651|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92449096|NCT01691651|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92449097|NCT01691651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449098|NCT01691651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449099|NCT01691651|Cholinergic Agents|cholinergic agents|mesh-ancestor
92449100|NCT01691651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449101|NCT01691651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449102|NCT01691651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92449103|NCT01691651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449104|NCT01691677|Beclomethasone|beclomethasone|mesh-list
92449105|NCT01691677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449106|NCT01691677|Glucocorticoids|glucocorticoids|mesh-ancestor
92449107|NCT01691677|Hormones|hormones|mesh-ancestor
92449108|NCT01691677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449109|NCT01691677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449110|NCT01691677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92449111|NCT01691677|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449112|NCT01691742|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92449113|NCT01691742|Laxatives|laxatives|mesh-list
92449114|NCT01691742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449115|NCT01691807|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92449116|NCT01691807|Ofatumumab|ofatumumab|mesh-list
92449117|NCT01691807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92449118|NCT01691807|Alkylating Agents|alkylating agents|mesh-ancestor
92449119|NCT01691807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449120|NCT01691807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449121|NCT01691872|Ezogabine|ezogabine|mesh-list
92449122|NCT01691872|Anticonvulsants|anticonvulsants|mesh-ancestor
92449123|NCT01691872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449124|NCT01691872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449125|NCT01691937|Sufentanil|sufentanil|mesh-list
92449126|NCT01691937|Ropivacaine|ropivacaine|mesh-list
92449127|NCT01691937|Anesthetics, Local|anesthetics, local|mesh-ancestor
92449128|NCT01691937|Anesthetics|anesthetics|mesh-ancestor
92449129|NCT01691937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449130|NCT01691937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449131|NCT01691937|Sensory System Agents|sensory system agents|mesh-ancestor
92449132|NCT01691937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449133|NCT01691937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92449134|NCT01691937|Narcotics|narcotics|mesh-ancestor
92449135|NCT01691937|Analgesics|analgesics|mesh-ancestor
92449136|NCT01691937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92449137|NCT01691937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92449138|NCT01691937|Anesthetics, General|anesthetics, general|mesh-ancestor
92449139|NCT01691976|Estrogens|estrogens|mesh-list
92449140|NCT01691976|Hormones|hormones|mesh-ancestor
92449141|NCT01691976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449142|NCT01691976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449143|NCT01692132|Prucalopride|prucalopride|mesh-list
92449144|NCT01692132|Laxatives|laxatives|mesh-ancestor
92449145|NCT01692132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449146|NCT01692132|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92449147|NCT01692132|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92449148|NCT01692132|Serotonin Agents|serotonin agents|mesh-ancestor
92449149|NCT01692132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449150|NCT01692132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449151|NCT01692132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449152|NCT01692210|Dexmedetomidine|dexmedetomidine|mesh-list
92449153|NCT01692210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92449154|NCT01692210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449155|NCT01692210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449156|NCT01692210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449157|NCT01692210|Analgesics|analgesics|mesh-ancestor
92449158|NCT01692210|Sensory System Agents|sensory system agents|mesh-ancestor
92449159|NCT01692210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449160|NCT01692210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92449161|NCT01692210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92449162|NCT01692210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92449163|NCT01692210|Adrenergic Agents|adrenergic agents|mesh-ancestor
92449164|NCT01692210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449165|NCT01692210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449166|NCT01692457|Golimumab|golimumab|mesh-list
92449167|NCT01692457|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92449168|NCT01692457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449169|NCT01692457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449170|NCT01692457|Immunologic Factors|immunologic factors|mesh-ancestor
92449171|NCT01692457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449172|NCT01692483|Prednisone|prednisone|mesh-list
92449173|NCT01692483|Abiraterone Acetate|abiraterone acetate|mesh-list
92449174|NCT01692483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449175|NCT01692483|Glucocorticoids|glucocorticoids|mesh-ancestor
92449176|NCT01692483|Hormones|hormones|mesh-ancestor
92449177|NCT01692483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449178|NCT01692483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449179|NCT01692483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92449180|NCT01692483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449181|NCT01692483|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92449182|NCT01692483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449183|NCT01692483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449184|NCT01692483|Hormone Antagonists|hormone antagonists|mesh-ancestor
92449185|NCT01692483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92449186|NCT01692652|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92449187|NCT01692652|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92449188|NCT01692678|Dacarbazine|dacarbazine|mesh-list
92449189|NCT01692678|Trabectedin|trabectedin|mesh-list
92449190|NCT01692678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92449191|NCT01692678|Alkylating Agents|alkylating agents|mesh-ancestor
92449192|NCT01692678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449193|NCT01692678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449194|NCT01692704|Gemcitabine|gemcitabine|mesh-list
92449195|NCT01692704|Floxuridine|floxuridine|mesh-list
92449196|NCT01692704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449197|NCT01692704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449198|NCT01692704|Antimetabolites|antimetabolites|mesh-ancestor
92449199|NCT01692704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449200|NCT01692808|Vitamin D|vitamin d|mesh-list
92449201|NCT01692808|Ergocalciferols|ergocalciferols|mesh-list
92449202|NCT01692808|Cholecalciferol|cholecalciferol|mesh-list
92449204|NCT01692808|Micronutrients|micronutrients|mesh-ancestor
92449205|NCT01692808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449206|NCT01692808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92449207|NCT01692808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92449208|NCT01692834|Cyclosporine|cyclosporine|mesh-list
92449209|NCT01692834|Cyclosporins|cyclosporins|mesh-list
92449210|NCT01692834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449211|NCT01692834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449212|NCT01692834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449213|NCT01692834|Immunologic Factors|immunologic factors|mesh-ancestor
92449214|NCT01692834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449215|NCT01692834|Antifungal Agents|antifungal agents|mesh-ancestor
92449216|NCT01692834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449217|NCT01692834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449218|NCT01692834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449219|NCT01692834|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92449220|NCT01692886|Vaccines|vaccines|mesh-list
92449221|NCT01692886|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92449222|NCT01692886|Immunologic Factors|immunologic factors|mesh-ancestor
92449223|NCT01692886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449224|NCT01692925|Factor VIII|factor viii|mesh-list
92449225|NCT01692925|Coagulants|coagulants|mesh-ancestor
92449226|NCT01693003|Tiotropium Bromide|tiotropium bromide|mesh-list
92449227|NCT01693003|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92449228|NCT01693003|Autonomic Agents|autonomic agents|mesh-ancestor
92449229|NCT01693003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449230|NCT01693003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449231|NCT01693003|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92449232|NCT01693003|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449233|NCT01693003|Parasympatholytics|parasympatholytics|mesh-ancestor
92449234|NCT01693003|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92449235|NCT01693003|Cholinergic Agents|cholinergic agents|mesh-ancestor
92449236|NCT01693003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449237|NCT01693003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449239|NCT01693081|Emetics|emetics|mesh-ancestor
92449240|NCT01693081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449241|NCT01693081|Autonomic Agents|autonomic agents|mesh-ancestor
92449242|NCT01693081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449243|NCT01693081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449244|NCT01693081|Dopamine Agonists|dopamine agonists|mesh-ancestor
92449245|NCT01693081|Dopamine Agents|dopamine agents|mesh-ancestor
92449246|NCT01693081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449247|NCT01693081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449248|NCT01693159|Ethyl 2-cyanoacrylate|ethyl 2-cyanoacrylate|mesh-list
92449249|NCT01693159|Hemostatics|hemostatics|mesh-ancestor
92449250|NCT01693159|Coagulants|coagulants|mesh-ancestor
92449251|NCT01693276|Paclitaxel|paclitaxel|mesh-list
92449252|NCT01693276|Gemcitabine|gemcitabine|mesh-list
92449253|NCT01693276|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92449254|NCT01693276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92449255|NCT01693276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449256|NCT01693276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449257|NCT01693276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449258|NCT01693276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449259|NCT01693276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449260|NCT01693276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449261|NCT01693276|Antimetabolites|antimetabolites|mesh-ancestor
92449262|NCT01693289|Metformin|metformin|mesh-list
92449263|NCT01693289|Letrozole|letrozole|mesh-list
92449264|NCT01693289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92449265|NCT01693289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449266|NCT01693289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449267|NCT01693289|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92449268|NCT01693289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92449269|NCT01693289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449270|NCT01693289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449271|NCT01693289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92449272|NCT01693289|Hormone Antagonists|hormone antagonists|mesh-ancestor
92449273|NCT01693289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449274|NCT01693302|Insulin|insulin|mesh-list
92449275|NCT01693302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92449276|NCT01693302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92449277|NCT01693302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449278|NCT01693328|Fentanyl|fentanyl|mesh-list
92449280|NCT01693328|Narcotics|narcotics|mesh-ancestor
92449281|NCT01693328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449282|NCT01693328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449283|NCT01693328|Analgesics|analgesics|mesh-ancestor
92449284|NCT01693328|Sensory System Agents|sensory system agents|mesh-ancestor
92449285|NCT01693328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449286|NCT01693328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92449287|NCT01693328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92449288|NCT01693328|Anesthetics, General|anesthetics, general|mesh-ancestor
92449289|NCT01693328|Anesthetics|anesthetics|mesh-ancestor
92449290|NCT01693393|Cyclosporine|cyclosporine|mesh-list
92449291|NCT01693393|Cyclosporins|cyclosporins|mesh-list
92449292|NCT01693393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449293|NCT01693393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449294|NCT01693393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449295|NCT01693393|Immunologic Factors|immunologic factors|mesh-ancestor
92449296|NCT01693393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449297|NCT01693393|Antifungal Agents|antifungal agents|mesh-ancestor
92449298|NCT01693393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449299|NCT01693393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449300|NCT01693393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449301|NCT01693393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92449302|NCT01693419|Gemcitabine|gemcitabine|mesh-list
92449303|NCT01693419|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92449304|NCT01693419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449305|NCT01693419|Antimetabolites|antimetabolites|mesh-ancestor
92449306|NCT01693419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449307|NCT01693419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449308|NCT01693419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92449309|NCT01693419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449310|NCT01693432|Docetaxel|docetaxel|mesh-list
92449311|NCT01693432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449312|NCT01693432|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449313|NCT01693432|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449314|NCT01693432|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449315|NCT01693432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449316|NCT01693445|Oxaliplatin|oxaliplatin|mesh-list
92449317|NCT01693445|Irinotecan|irinotecan|mesh-list
92449318|NCT01693445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449319|NCT01693445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92449320|NCT01693445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92449321|NCT01693445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449322|NCT01693445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449323|NCT01693601|Panobinostat|panobinostat|mesh-list
92449324|NCT01693601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449325|NCT01693601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92449326|NCT01693601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449327|NCT01693601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449328|NCT01693640|Abatacept|abatacept|mesh-list
92449329|NCT01693640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92449330|NCT01693640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449331|NCT01693640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92449332|NCT01693640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449333|NCT01693640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449334|NCT01693640|Immunologic Factors|immunologic factors|mesh-ancestor
92449335|NCT01693640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449336|NCT01693640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449337|NCT01693679|Lamivudine|lamivudine|mesh-list
92449338|NCT01693679|Adefovir|adefovir|mesh-list
92449339|NCT01693679|Telbivudine|telbivudine|mesh-list
92449340|NCT01693679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92449341|NCT01693679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92449342|NCT01693679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449343|NCT01693679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449344|NCT01693679|Antiviral Agents|antiviral agents|mesh-ancestor
92449345|NCT01693679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449346|NCT01693679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92449347|NCT01693679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92449348|NCT01693718|Fluorouracil|fluorouracil|mesh-list
92449349|NCT01693718|Hydroxyurea|hydroxyurea|mesh-list
92449350|NCT01693718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449351|NCT01693718|Antimetabolites|antimetabolites|mesh-ancestor
92449352|NCT01693718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174238|NCT04123379|Nivolumab|nivolumab|mesh-list
92449353|NCT01693718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449354|NCT01693718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449355|NCT01693718|Immunologic Factors|immunologic factors|mesh-ancestor
92449356|NCT01693718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449357|NCT01693718|Antisickling Agents|antisickling agents|mesh-ancestor
92449358|NCT01693718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449359|NCT01693718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92449360|NCT01693809|Caffeine|caffeine|mesh-list
92449361|NCT01693809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92449362|NCT01693809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449363|NCT01693809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92449364|NCT01693809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449365|NCT01693809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449366|NCT01693809|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92449367|NCT01693809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92449368|NCT01693809|Purinergic Agents|purinergic agents|mesh-ancestor
92449369|NCT01693809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449370|NCT01693822|Axitinib|axitinib|mesh-list
92449371|NCT01693822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449372|NCT01693822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92449373|NCT01693822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449374|NCT01693822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449375|NCT01694017|Tenofovir|tenofovir|mesh-list
92449376|NCT01694017|Zidovudine|zidovudine|mesh-list
92449377|NCT01694017|Antiviral Agents|antiviral agents|mesh-ancestor
92449378|NCT01694017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449379|NCT01694017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92449380|NCT01694017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92449381|NCT01694017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449382|NCT01694017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449383|NCT01694017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92449384|NCT01694017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92449385|NCT01694017|Antimetabolites|antimetabolites|mesh-ancestor
92449386|NCT05288816|Ravulizumab|ravulizumab|mesh-list
92449387|NCT05288816|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92449388|NCT05288816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449389|NCT05288816|Immunologic Factors|immunologic factors|mesh-ancestor
92449390|NCT05288816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449391|NCT05288738|Dexmedetomidine|dexmedetomidine|mesh-list
92449392|NCT05288738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92449393|NCT05288738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449394|NCT05288738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449395|NCT05288738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449397|NCT05288738|Sensory System Agents|sensory system agents|mesh-ancestor
92449398|NCT05288738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449399|NCT05288738|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92449400|NCT05288738|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92449401|NCT05288738|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92449402|NCT05288738|Adrenergic Agents|adrenergic agents|mesh-ancestor
92449403|NCT05288738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449404|NCT05288738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449405|NCT05288725|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92449406|NCT05288725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449407|NCT05288725|Glucocorticoids|glucocorticoids|mesh-ancestor
92449409|NCT05288725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449410|NCT05288725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449411|NCT05288725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449412|NCT05288725|Immunologic Factors|immunologic factors|mesh-ancestor
92449413|NCT05288465|Cerebrolysin|cerebrolysin|mesh-list
92449414|NCT05288465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92449415|NCT05288465|Protective Agents|protective agents|mesh-ancestor
92449416|NCT05288465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449417|NCT05288465|Nootropic Agents|nootropic agents|mesh-ancestor
92449418|NCT05288374|Celecoxib|celecoxib|mesh-list
92449419|NCT05288374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92449420|NCT05288374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449421|NCT05288374|Analgesics|analgesics|mesh-ancestor
92449422|NCT05288374|Sensory System Agents|sensory system agents|mesh-ancestor
92449423|NCT05288374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449424|NCT05288374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449425|NCT05288374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449426|NCT05288374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449428|NCT05288374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92449429|NCT05288374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449430|NCT05288374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449431|NCT05288192|Triamcinolone|triamcinolone|mesh-list
92449432|NCT05288192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92449433|NCT05288192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92449434|NCT05288192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92449435|NCT05288192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449436|NCT05288192|Glucocorticoids|glucocorticoids|mesh-ancestor
92449437|NCT05288192|Hormones|hormones|mesh-ancestor
92449438|NCT05288192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449439|NCT05288192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449440|NCT05288192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449441|NCT05288192|Immunologic Factors|immunologic factors|mesh-ancestor
92449442|NCT05288192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449443|NCT05288192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449444|NCT05288179|Pirfenidone|pirfenidone|mesh-list
92449445|NCT05288179|Analgesics|analgesics|mesh-ancestor
92449446|NCT05288179|Sensory System Agents|sensory system agents|mesh-ancestor
92449447|NCT05288179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449448|NCT05288179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449449|NCT05288179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92449450|NCT05288179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449451|NCT05288179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449452|NCT05288179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449453|NCT05288179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449454|NCT05288127|Talazoparib|talazoparib|mesh-list
92449455|NCT05288127|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92449456|NCT05288127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449457|NCT05288127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449458|NCT05288127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449459|NCT05291455|Lacosamide|lacosamide|mesh-list
92449460|NCT05291455|Phenobarbital|phenobarbital|mesh-list
92449461|NCT05291455|Anticonvulsants|anticonvulsants|mesh-ancestor
92449462|NCT05291455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92449463|NCT05291455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92449464|NCT05291455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449465|NCT05291455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449466|NCT05291455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92449467|NCT05291455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449468|NCT05291455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449469|NCT05291455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92449470|NCT05291455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92449471|NCT05291455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449472|NCT05291455|GABA Modulators|gaba modulators|mesh-ancestor
92449473|NCT05291455|GABA Agents|gaba agents|mesh-ancestor
92449474|NCT05291455|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92449475|NCT05291455|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92449476|NCT05291455|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92449477|NCT05291195|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92449478|NCT05291195|Eusol|eusol|mesh-list
92449479|NCT05291195|Disinfectants|disinfectants|mesh-ancestor
92449480|NCT05291195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449481|NCT05291104|Folic Acid|folic acid|mesh-list
92449482|NCT05291104|Choline|choline|mesh-list
92449483|NCT05291104|Hematinics|hematinics|mesh-ancestor
92449484|NCT05291104|Vitamin B Complex|vitamin b complex|mesh-ancestor
92449485|NCT05291104|Vitamins|vitamins|mesh-ancestor
92449486|NCT05291104|Micronutrients|micronutrients|mesh-ancestor
92449487|NCT05291104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449488|NCT05291104|Lipotropic Agents|lipotropic agents|mesh-ancestor
92449489|NCT05291104|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92449490|NCT05291104|Antimetabolites|antimetabolites|mesh-ancestor
92449491|NCT05291104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449492|NCT05291104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449493|NCT05291104|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92449494|NCT05291104|Nootropic Agents|nootropic agents|mesh-ancestor
92449495|NCT05291052|Capecitabine|capecitabine|mesh-list
92449496|NCT05291052|Oxaliplatin|oxaliplatin|mesh-list
92449497|NCT05291052|Lenvatinib|lenvatinib|mesh-list
92449498|NCT05291052|Tislelizumab|tislelizumab|mesh-list
92449499|NCT05291052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449500|NCT05291052|Antimetabolites|antimetabolites|mesh-ancestor
92174381|NCT03046758|Fosfomycin|fosfomycin|mesh-list
92449501|NCT05291052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449502|NCT05291052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449503|NCT05291052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92449504|NCT05291052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449505|NCT05291052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92449507|NCT05290948|Acetazolamide|acetazolamide|mesh-list
92449508|NCT05290948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92449509|NCT05290948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449510|NCT05290948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92449511|NCT05290948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92449512|NCT05290948|Growth Substances|growth substances|mesh-ancestor
92449513|NCT05290948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449514|NCT05290948|Growth Inhibitors|growth inhibitors|mesh-ancestor
92449515|NCT05290948|Anticonvulsants|anticonvulsants|mesh-ancestor
92449516|NCT05290948|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92449517|NCT05290948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449518|NCT05290948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449519|NCT05290948|Diuretics|diuretics|mesh-ancestor
92449520|NCT05290948|Natriuretic Agents|natriuretic agents|mesh-ancestor
92449521|NCT05290935|Paclitaxel|paclitaxel|mesh-list
92449522|NCT05290935|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92449523|NCT05290935|Antibodies|antibodies|mesh-list
92449524|NCT05290935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92449525|NCT05290935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449526|NCT05290935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449527|NCT05290935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449528|NCT05290935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449529|NCT05290935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449530|NCT05290935|Immunologic Factors|immunologic factors|mesh-ancestor
92449531|NCT05290935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449532|NCT05290857|Hemostatics|hemostatics|mesh-list
92449533|NCT05290857|Coagulants|coagulants|mesh-ancestor
92449534|NCT05290506|Linagliptin|linagliptin|mesh-list
92449535|NCT05290506|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92449536|NCT05290506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92449537|NCT05290506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449538|NCT05290506|Incretins|incretins|mesh-ancestor
92449539|NCT05290506|Hormones|hormones|mesh-ancestor
92449540|NCT05290506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449541|NCT05290506|Protease Inhibitors|protease inhibitors|mesh-ancestor
92449542|NCT05290506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449543|NCT05290506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449544|NCT05290337|Zanubrutinib|zanubrutinib|mesh-list
92449545|NCT05290337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449546|NCT05290337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92449547|NCT05290337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449548|NCT05290337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449549|NCT05290324|Midazolam|midazolam|mesh-list
92449550|NCT05290324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92449551|NCT05290324|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92449552|NCT05290324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449553|NCT05290324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449554|NCT05290324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92449555|NCT05290324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92449556|NCT05290324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92449557|NCT05290324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92449558|NCT05290324|Anesthetics, General|anesthetics, general|mesh-ancestor
92449559|NCT05290324|Anesthetics|anesthetics|mesh-ancestor
92449560|NCT05290324|GABA Modulators|gaba modulators|mesh-ancestor
92449561|NCT05290324|GABA Agents|gaba agents|mesh-ancestor
92449562|NCT05290324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449563|NCT05290324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449564|NCT05290090|Rituximab|rituximab|mesh-list
92449565|NCT05290090|Lenalidomide|lenalidomide|mesh-list
92449566|NCT05290090|Zanubrutinib|zanubrutinib|mesh-list
92449567|NCT05290090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92449568|NCT05290090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449569|NCT05290090|Immunologic Factors|immunologic factors|mesh-ancestor
92449570|NCT05290090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449571|NCT05290090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449572|NCT05290090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92449573|NCT05290090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92449574|NCT05290090|Growth Substances|growth substances|mesh-ancestor
92449575|NCT05290090|Growth Inhibitors|growth inhibitors|mesh-ancestor
92449576|NCT05290090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92449577|NCT05290090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449578|NCT05290090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449580|NCT05292742|Trastuzumab|trastuzumab|mesh-list
92449581|NCT05292742|Pertuzumab|pertuzumab|mesh-list
92449582|NCT05292742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449583|NCT05292742|Antimetabolites|antimetabolites|mesh-ancestor
92449584|NCT05292742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449585|NCT05292742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449586|NCT05292742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92449587|NCT05292677|Anesthetics|anesthetics|mesh-list
92449588|NCT05292677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449589|NCT05292677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449590|NCT05292573|Metformin|metformin|mesh-list
92449591|NCT05292573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92449592|NCT05292573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449593|NCT05291910|Paclitaxel|paclitaxel|mesh-list
92449594|NCT05291910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92449595|NCT05291910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92449596|NCT05291910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449597|NCT05291910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449598|NCT05291910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449599|NCT05291910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449600|NCT05291910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449601|NCT05291793|Methylprednisolone|methylprednisolone|mesh-list
92449602|NCT05291793|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92449603|NCT05291793|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92449604|NCT05291793|Prednisolone|prednisolone|mesh-list
92531335|NCT04380207|QPX7728|qpx7728|mesh-list
92449605|NCT05291793|Prednisolone acetate|prednisolone acetate|mesh-list
92449606|NCT05291793|Tenoxicam|tenoxicam|mesh-list
92449607|NCT05291793|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92449608|NCT05291793|Prednisolone phosphate|prednisolone phosphate|mesh-list
92449609|NCT05291793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449610|NCT05291793|Antiemetics|antiemetics|mesh-ancestor
92449611|NCT05291793|Autonomic Agents|autonomic agents|mesh-ancestor
92449612|NCT05291793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449613|NCT05291793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449614|NCT05291793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449615|NCT05291793|Glucocorticoids|glucocorticoids|mesh-ancestor
92449616|NCT05291793|Hormones|hormones|mesh-ancestor
92449617|NCT05291793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449618|NCT05291793|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92449619|NCT05291793|Protective Agents|protective agents|mesh-ancestor
92449620|NCT05291793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92449621|NCT05291793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449622|NCT05291793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92449623|NCT05291793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449624|NCT05291793|Analgesics|analgesics|mesh-ancestor
92449625|NCT05291793|Sensory System Agents|sensory system agents|mesh-ancestor
92449626|NCT05291793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449627|NCT05291793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92449628|NCT05291793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449629|NCT05291793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449630|NCT05294926|Rocuronium|rocuronium|mesh-list
92449631|NCT05294926|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92449632|NCT05294926|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92449633|NCT05294926|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92449634|NCT05294926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449635|NCT05294926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449636|NCT05294887|Bisoprolol|bisoprolol|mesh-list
92449637|NCT05294887|Diltiazem|diltiazem|mesh-list
92449638|NCT05294887|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92449639|NCT05294887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92449640|NCT05294887|Adrenergic Agents|adrenergic agents|mesh-ancestor
92449641|NCT05294887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449642|NCT05294887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449643|NCT05294887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449644|NCT05294887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92449645|NCT05294887|Sympatholytics|sympatholytics|mesh-ancestor
92449646|NCT05294887|Autonomic Agents|autonomic agents|mesh-ancestor
92449647|NCT05294887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449648|NCT05294887|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92449649|NCT05294887|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92449650|NCT05294887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449651|NCT05294887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92449652|NCT05294887|Vasodilator Agents|vasodilator agents|mesh-ancestor
92449654|NCT05294822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92449655|NCT05294822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449656|NCT05294744|Acetylcysteine|acetylcysteine|mesh-list
92449657|NCT05294744|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92449658|NCT05294744|Antiviral Agents|antiviral agents|mesh-ancestor
92449659|NCT05294744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449660|NCT05294744|Expectorants|expectorants|mesh-ancestor
92449661|NCT05294744|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449662|NCT05294744|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92449663|NCT05294744|Antioxidants|antioxidants|mesh-ancestor
92449664|NCT05294744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449665|NCT05294744|Protective Agents|protective agents|mesh-ancestor
92449666|NCT05294744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449667|NCT05294744|Antidotes|antidotes|mesh-ancestor
92449668|NCT05294679|Propofol|propofol|mesh-list
92449669|NCT05294679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92449670|NCT05294679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449671|NCT05294679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449672|NCT05294679|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92449673|NCT05294679|Anesthetics, General|anesthetics, general|mesh-ancestor
92449674|NCT05294679|Anesthetics|anesthetics|mesh-ancestor
92449675|NCT05294666|Cyclosporine|cyclosporine|mesh-list
92449676|NCT05294666|Tacrolimus|tacrolimus|mesh-list
92449677|NCT05294666|Cyclosporins|cyclosporins|mesh-list
92449678|NCT05294666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449679|NCT05294666|Immunologic Factors|immunologic factors|mesh-ancestor
92449680|NCT05294666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449681|NCT05294666|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92449683|NCT05294666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449684|NCT05294666|Antifungal Agents|antifungal agents|mesh-ancestor
92449686|NCT05294666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449687|NCT05294666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449688|NCT05294640|Lidocaine|lidocaine|mesh-list
92449689|NCT05294640|Epinephrine|epinephrine|mesh-list
92449690|NCT05294640|Anesthetics, Local|anesthetics, local|mesh-list
92449691|NCT05294640|Anesthetics|anesthetics|mesh-list
92449692|NCT05294640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449693|NCT05294640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449694|NCT05294640|Sensory System Agents|sensory system agents|mesh-ancestor
92449695|NCT05294640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449696|NCT05294640|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92449697|NCT05294640|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92449698|NCT05294640|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92449699|NCT05294640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449700|NCT05294640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449701|NCT05294640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92449702|NCT05294640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92449703|NCT05294640|Adrenergic Agents|adrenergic agents|mesh-ancestor
92449704|NCT05294640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449705|NCT05294640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92449706|NCT05294640|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92449707|NCT05294640|Autonomic Agents|autonomic agents|mesh-ancestor
92449708|NCT05294640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92449709|NCT05294640|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449710|NCT05294640|Mydriatics|mydriatics|mesh-ancestor
92449711|NCT05294640|Sympathomimetics|sympathomimetics|mesh-ancestor
92449712|NCT05294640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92449713|NCT05294536|Liraglutide|liraglutide|mesh-list
92449714|NCT05294536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92449715|NCT05294536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449716|NCT05294536|Incretins|incretins|mesh-ancestor
92449717|NCT05294536|Hormones|hormones|mesh-ancestor
92449718|NCT05294536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92449719|NCT05294484|Indapamide|indapamide|mesh-list
92449720|NCT05294484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92449721|NCT05294484|Diuretics|diuretics|mesh-ancestor
92347127|NCT01780974|Vitamins|vitamins|mesh-ancestor
92449722|NCT05294484|Natriuretic Agents|natriuretic agents|mesh-ancestor
92449723|NCT05294484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449724|NCT05294484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92449725|NCT05294484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449726|NCT05294484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449727|NCT05294406|Piperaquine|piperaquine|mesh-list
92449728|NCT05294406|Artenimol|artenimol|mesh-list
92449729|NCT05294406|Antimalarials|antimalarials|mesh-ancestor
92449730|NCT05294406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92449731|NCT05294406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92449732|NCT05294406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449733|NCT05294393|Magnesium Sulfate|magnesium sulfate|mesh-list
92449734|NCT05294393|Ropivacaine|ropivacaine|mesh-list
92449735|NCT05294393|Anesthetics, Local|anesthetics, local|mesh-ancestor
92449736|NCT05294393|Anesthetics|anesthetics|mesh-ancestor
92449737|NCT05294393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449738|NCT05294393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449739|NCT05294393|Sensory System Agents|sensory system agents|mesh-ancestor
92449740|NCT05294393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449741|NCT05294393|Analgesics|analgesics|mesh-ancestor
92449742|NCT05294393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92449743|NCT05294393|Anticonvulsants|anticonvulsants|mesh-ancestor
92449744|NCT05294393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92449745|NCT05294393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449746|NCT05294393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449747|NCT05294393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92449748|NCT05294393|Tocolytic Agents|tocolytic agents|mesh-ancestor
92449749|NCT05294393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92449750|NCT05293977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92449751|NCT05293977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449752|NCT05293808|Aspirin|aspirin|mesh-list
92449753|NCT05293808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92449754|NCT05293808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449755|NCT05293808|Analgesics|analgesics|mesh-ancestor
92449756|NCT05293808|Sensory System Agents|sensory system agents|mesh-ancestor
92449757|NCT05293808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449758|NCT05293808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449759|NCT05293808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449760|NCT05293808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449761|NCT05293808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92449762|NCT05293808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92449763|NCT05293808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449764|NCT05293808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92449765|NCT05293808|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92449766|NCT05293808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449767|NCT05293808|Antipyretics|antipyretics|mesh-ancestor
92449768|NCT05293704|Mizoribine|mizoribine|mesh-list
92449769|NCT05293704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92449770|NCT05293704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449771|NCT05293704|Analgesics|analgesics|mesh-ancestor
92449772|NCT05293704|Sensory System Agents|sensory system agents|mesh-ancestor
92449773|NCT05293704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449774|NCT05293704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449775|NCT05293704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449776|NCT05293704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449777|NCT05293704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92449778|NCT05293704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449779|NCT05293704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92449780|NCT05293704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449781|NCT05293704|Antimalarials|antimalarials|mesh-ancestor
92449782|NCT05293704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92449783|NCT05293704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92449784|NCT05293704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449785|NCT05293704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449786|NCT05293704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449787|NCT05293704|Immunologic Factors|immunologic factors|mesh-ancestor
92449788|NCT05293574|Norethindrone|norethindrone|mesh-list
92449789|NCT05293574|Norethindrone Acetate|norethindrone acetate|mesh-list
92449790|NCT05293574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92449791|NCT05293574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92449792|NCT05293574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92449793|NCT05293574|Contraceptive Agents|contraceptive agents|mesh-ancestor
92449794|NCT05293574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92449795|NCT05293574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449796|NCT05293574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92449797|NCT05293574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92449798|NCT05293119|Mometasone Furoate|mometasone furoate|mesh-list
92449799|NCT05293119|Tofacitinib|tofacitinib|mesh-list
92174683|NCT04877106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92449800|NCT05293119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449801|NCT05293119|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449802|NCT05293119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92449803|NCT05293119|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92449804|NCT05293119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92449805|NCT05293119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449806|NCT05293119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449807|NCT05293080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92449808|NCT05296863|Minoxidil|minoxidil|mesh-list
92449809|NCT05296863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92449810|NCT05296863|Vasodilator Agents|vasodilator agents|mesh-ancestor
92449811|NCT05296564|Aldesleukin|aldesleukin|mesh-list
92449812|NCT05296564|Cyclophosphamide|cyclophosphamide|mesh-list
92449813|NCT05296564|Interleukin-2|interleukin-2|mesh-list
92449814|NCT05296564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449815|NCT05296564|Immunologic Factors|immunologic factors|mesh-ancestor
92449816|NCT05296564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449817|NCT05296564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449818|NCT05296564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92449819|NCT05296564|Alkylating Agents|alkylating agents|mesh-ancestor
92449820|NCT05296564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449821|NCT05296564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449822|NCT05296564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92449823|NCT05296564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92449824|NCT05296564|Analgesics|analgesics|mesh-ancestor
92449825|NCT05296564|Sensory System Agents|sensory system agents|mesh-ancestor
92449826|NCT05296564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449827|NCT05296564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92449828|NCT05296564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92449829|NCT05296564|Antiviral Agents|antiviral agents|mesh-ancestor
92449830|NCT05296564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449831|NCT05296369|Folic Acid|folic acid|mesh-list
92449832|NCT05296369|Hematinics|hematinics|mesh-ancestor
92449833|NCT05296369|Vitamin B Complex|vitamin b complex|mesh-ancestor
92449834|NCT05296369|Vitamins|vitamins|mesh-ancestor
92449835|NCT05296369|Micronutrients|micronutrients|mesh-ancestor
92449836|NCT05296369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449837|NCT05296317|Cyclophosphamide|cyclophosphamide|mesh-list
92449838|NCT05296317|Epirubicin|epirubicin|mesh-list
92449839|NCT05296317|Lenograstim|lenograstim|mesh-list
92449840|NCT05296317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449841|NCT05296317|Immunologic Factors|immunologic factors|mesh-ancestor
92449842|NCT05296317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449843|NCT05296317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449844|NCT05296317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92449845|NCT05296317|Alkylating Agents|alkylating agents|mesh-ancestor
92449846|NCT05296317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449847|NCT05296317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449848|NCT05296317|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92449849|NCT05296317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92449850|NCT05296317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92449851|NCT05296317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92449852|NCT05296317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92449853|NCT05296317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449854|NCT05296005|Leucovorin|leucovorin|mesh-list
92449855|NCT05296005|Docetaxel|docetaxel|mesh-list
92449856|NCT05296005|Fluorouracil|fluorouracil|mesh-list
92449857|NCT05296005|Capecitabine|capecitabine|mesh-list
92449858|NCT05296005|Oxaliplatin|oxaliplatin|mesh-list
92449859|NCT05296005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449860|NCT05296005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449861|NCT05296005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449862|NCT05296005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449863|NCT05296005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449864|NCT05296005|Antimetabolites|antimetabolites|mesh-ancestor
92449865|NCT05296005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449866|NCT05296005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449867|NCT05296005|Immunologic Factors|immunologic factors|mesh-ancestor
92449868|NCT05296005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449869|NCT05296005|Antidotes|antidotes|mesh-ancestor
92449870|NCT05296005|Protective Agents|protective agents|mesh-ancestor
92449871|NCT05296005|Vitamin B Complex|vitamin b complex|mesh-ancestor
92449872|NCT05296005|Vitamins|vitamins|mesh-ancestor
92449873|NCT05296005|Micronutrients|micronutrients|mesh-ancestor
92449874|NCT05295836|Glycerol|glycerol|mesh-list
92449875|NCT05295836|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92449876|NCT05295836|Protective Agents|protective agents|mesh-ancestor
92449877|NCT05295836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449878|NCT05294900|Paclitaxel|paclitaxel|mesh-list
92449879|NCT05294900|Carboplatin|carboplatin|mesh-list
92449880|NCT05294900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92449881|NCT05294900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449882|NCT05294900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449883|NCT05294900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449884|NCT05294900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449885|NCT05294900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449886|NCT05280405|Infliximab|infliximab|mesh-list
92449887|NCT05280405|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92449888|NCT05280405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449889|NCT05280405|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449890|NCT05280405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449891|NCT05280405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449892|NCT05275647|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92449893|NCT05275647|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92449894|NCT05275647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449895|NCT05275647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449896|NCT05275647|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92449897|NCT05275647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449898|NCT05275647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449899|NCT05275647|Cholinergic Agents|cholinergic agents|mesh-ancestor
92449900|NCT05275647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449901|NCT05273242|Artesunate|artesunate|mesh-list
92449902|NCT05273242|Infliximab|infliximab|mesh-list
92449903|NCT05273242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449904|NCT05273242|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92449905|NCT05273242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92449906|NCT05273242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449907|NCT05273242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92449908|NCT05273242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449909|NCT05273242|Antimalarials|antimalarials|mesh-ancestor
92449910|NCT05273242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92449911|NCT05273242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92449912|NCT05273242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449913|NCT05273242|Antiviral Agents|antiviral agents|mesh-ancestor
92449914|NCT05273242|Schistosomicides|schistosomicides|mesh-ancestor
92449915|NCT05273242|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92449916|NCT05273242|Anthelmintics|anthelmintics|mesh-ancestor
92449917|NCT05269095|Anesthetics|anesthetics|mesh-list
92449918|NCT05269095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449919|NCT05269095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449920|NCT05267938|Lidocaine|lidocaine|mesh-list
92449921|NCT05267938|Epinephrine|epinephrine|mesh-list
92449922|NCT05267938|Anesthetics, Local|anesthetics, local|mesh-list
92449923|NCT05267938|Anesthetics|anesthetics|mesh-list
92449924|NCT05267938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92449925|NCT05267938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449926|NCT05267938|Sensory System Agents|sensory system agents|mesh-ancestor
92449927|NCT05267938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92449928|NCT05267938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92449929|NCT05267938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92449930|NCT05267938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92449931|NCT05267938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92449932|NCT05267938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449933|NCT05267938|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92449934|NCT05267938|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92449935|NCT05267938|Adrenergic Agents|adrenergic agents|mesh-ancestor
92449936|NCT05267938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449937|NCT05267938|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92449938|NCT05267938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92449939|NCT05267938|Autonomic Agents|autonomic agents|mesh-ancestor
92449940|NCT05267938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92449941|NCT05267938|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449942|NCT05267938|Mydriatics|mydriatics|mesh-ancestor
92449943|NCT05267938|Sympathomimetics|sympathomimetics|mesh-ancestor
92449944|NCT05267938|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92449945|NCT05267431|Methotrexate|methotrexate|mesh-list
92449946|NCT05267431|Hydroquinone|hydroquinone|mesh-list
92449947|NCT05267431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92449948|NCT05267431|Abortifacient Agents|abortifacient agents|mesh-ancestor
92449949|NCT05267431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92449950|NCT05267431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449951|NCT05267431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92449952|NCT05267431|Antimetabolites|antimetabolites|mesh-ancestor
92449953|NCT05267431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449954|NCT05267431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449955|NCT05267431|Dermatologic Agents|dermatologic agents|mesh-ancestor
92449956|NCT05267431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449957|NCT05267431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92449958|NCT05267431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92449959|NCT05267431|Immunologic Factors|immunologic factors|mesh-ancestor
92449960|NCT05267431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92449961|NCT05267431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92449962|NCT05267431|Antioxidants|antioxidants|mesh-ancestor
92449963|NCT05267431|Protective Agents|protective agents|mesh-ancestor
92449964|NCT05267431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92449965|NCT05266248|Caffeine|caffeine|mesh-list
92449966|NCT05266248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92449967|NCT05266248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449968|NCT05266248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92449969|NCT05266248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92449970|NCT05266248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449971|NCT05266248|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92449972|NCT05266248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92449973|NCT05266248|Purinergic Agents|purinergic agents|mesh-ancestor
92449974|NCT05266248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92449975|NCT05264896|Leucovorin|leucovorin|mesh-list
92449976|NCT05264896|Docetaxel|docetaxel|mesh-list
92449977|NCT05264896|Oxaliplatin|oxaliplatin|mesh-list
92449978|NCT05264896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92449979|NCT05264896|Tubulin Modulators|tubulin modulators|mesh-ancestor
92449980|NCT05264896|Antimitotic Agents|antimitotic agents|mesh-ancestor
92449981|NCT05264896|Mitosis Modulators|mitosis modulators|mesh-ancestor
92449982|NCT05264896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449983|NCT05264896|Antidotes|antidotes|mesh-ancestor
92449984|NCT05264896|Protective Agents|protective agents|mesh-ancestor
92449985|NCT05264896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92449986|NCT05264896|Vitamin B Complex|vitamin b complex|mesh-ancestor
92449987|NCT05264896|Vitamins|vitamins|mesh-ancestor
92449988|NCT05264896|Micronutrients|micronutrients|mesh-ancestor
92449989|NCT05264584|Acetylcysteine|acetylcysteine|mesh-list
92449990|NCT05264584|Febuxostat|febuxostat|mesh-list
92449991|NCT05264584|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92449992|NCT05264584|Antiviral Agents|antiviral agents|mesh-ancestor
92449993|NCT05264584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92449994|NCT05264584|Expectorants|expectorants|mesh-ancestor
92449995|NCT05264584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92449996|NCT05264584|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92449997|NCT05264584|Antioxidants|antioxidants|mesh-ancestor
92449998|NCT05264584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92449999|NCT05264584|Protective Agents|protective agents|mesh-ancestor
92450000|NCT05264584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450001|NCT05264584|Antidotes|antidotes|mesh-ancestor
92450002|NCT05264584|Gout Suppressants|gout suppressants|mesh-ancestor
92450003|NCT05264584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450004|NCT05262686|Aldesleukin|aldesleukin|mesh-list
92450005|NCT05262686|Interleukin-2|interleukin-2|mesh-list
92450006|NCT05262686|Belimumab|belimumab|mesh-list
92450007|NCT05262686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450008|NCT05262686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450009|NCT05262686|Analgesics|analgesics|mesh-ancestor
92450010|NCT05262686|Sensory System Agents|sensory system agents|mesh-ancestor
92450011|NCT05262686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450012|NCT05262686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450013|NCT05262686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450014|NCT05262686|Immunologic Factors|immunologic factors|mesh-ancestor
92450015|NCT05262686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92450016|NCT05262686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92450017|NCT05262686|Antiviral Agents|antiviral agents|mesh-ancestor
92450018|NCT05262686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450019|NCT05238714|Venglustat|venglustat|mesh-list
92450020|NCT05238714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450021|NCT05238714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450022|NCT05238506|Lidocaine|lidocaine|mesh-list
92450023|NCT05238506|Anesthetics, Local|anesthetics, local|mesh-ancestor
92450024|NCT05238506|Anesthetics|anesthetics|mesh-ancestor
92450025|NCT05238506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450026|NCT05238506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450027|NCT05238506|Sensory System Agents|sensory system agents|mesh-ancestor
92450028|NCT05238506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450029|NCT05238506|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92450030|NCT05238506|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92450031|NCT05238506|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92450032|NCT05238506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92450033|NCT05238506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450035|NCT05236608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450036|NCT05236608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450037|NCT05236608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450038|NCT05236608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450039|NCT05225402|Norepinephrine|norepinephrine|mesh-list
92450040|NCT05225402|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92450041|NCT05225402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92450042|NCT05225402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92450043|NCT05225402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450044|NCT05225402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450045|NCT05225402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450046|NCT05225402|Sympathomimetics|sympathomimetics|mesh-ancestor
92450047|NCT05225402|Autonomic Agents|autonomic agents|mesh-ancestor
92450048|NCT05225402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450049|NCT05225402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92450050|NCT05220826|Ethanol|ethanol|mesh-list
92450052|NCT05220826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92450053|NCT05220826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450054|NCT05220826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450055|NCT05220826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450056|NCT05220826|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92450057|NCT05220826|Growth Substances|growth substances|mesh-ancestor
92450058|NCT05210413|Spartalizumab|spartalizumab|mesh-list
92450059|NCT05210413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450060|NCT05210413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450061|NCT05210413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450062|NCT05210413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450063|NCT05203705|Enoxaparin|enoxaparin|mesh-list
92450064|NCT05203705|Anticoagulants|anticoagulants|mesh-ancestor
92450065|NCT05203705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92450066|NCT05203705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92450067|NCT05203705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450068|NCT05202561|Vaccines|vaccines|mesh-list
92450069|NCT05202561|Immunologic Factors|immunologic factors|mesh-ancestor
92450070|NCT05202561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450071|NCT05192629|Midazolam|midazolam|mesh-list
92450072|NCT05192629|Dexmedetomidine|dexmedetomidine|mesh-list
92450073|NCT05192629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92450074|NCT05192629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450075|NCT05192629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450076|NCT05192629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450077|NCT05192629|Analgesics|analgesics|mesh-ancestor
92450078|NCT05192629|Sensory System Agents|sensory system agents|mesh-ancestor
92450079|NCT05192629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450080|NCT05192629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92450081|NCT05192629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92450082|NCT05192629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92450083|NCT05192629|Adrenergic Agents|adrenergic agents|mesh-ancestor
92450084|NCT05192629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450085|NCT05192629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450086|NCT05192629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92450087|NCT05192629|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92450088|NCT05192629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92450089|NCT05192629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92450090|NCT05192629|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92450091|NCT05192629|Anesthetics, General|anesthetics, general|mesh-ancestor
92450092|NCT05192629|Anesthetics|anesthetics|mesh-ancestor
92450093|NCT05192629|GABA Modulators|gaba modulators|mesh-ancestor
92450094|NCT05192629|GABA Agents|gaba agents|mesh-ancestor
92450095|NCT05189444|Amoxicillin|amoxicillin|mesh-list
92450096|NCT05189444|Clarithromycin|clarithromycin|mesh-list
92450097|NCT05189444|Potassium Citrate|potassium citrate|mesh-list
92450098|NCT05189444|Esomeprazole|esomeprazole|mesh-list
92450099|NCT05189444|Bismuth|bismuth|mesh-list
92450100|NCT05189444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450101|NCT05189444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450102|NCT05189444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450103|NCT05189444|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92450104|NCT05189444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450105|NCT05189444|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92450106|NCT05189444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450107|NCT05189444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92450108|NCT05189444|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92450109|NCT05189444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92450111|NCT05189444|Diuretics|diuretics|mesh-ancestor
92450112|NCT05189444|Natriuretic Agents|natriuretic agents|mesh-ancestor
92450113|NCT05189444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450114|NCT05189444|Expectorants|expectorants|mesh-ancestor
92450115|NCT05189444|Respiratory System Agents|respiratory system agents|mesh-ancestor
92450116|NCT05175274|Colchicine|colchicine|mesh-list
92450117|NCT05175274|Gout Suppressants|gout suppressants|mesh-ancestor
92450118|NCT05175274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450119|NCT05175274|Tubulin Modulators|tubulin modulators|mesh-ancestor
92450120|NCT05175274|Antimitotic Agents|antimitotic agents|mesh-ancestor
92450121|NCT05175274|Mitosis Modulators|mitosis modulators|mesh-ancestor
92450122|NCT05175274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450123|NCT05175274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450124|NCT05129137|Acetaminophen|acetaminophen|mesh-list
92450125|NCT05129137|Nefopam|nefopam|mesh-list
92450126|NCT05129137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450127|NCT05129137|Analgesics|analgesics|mesh-ancestor
92450128|NCT05129137|Sensory System Agents|sensory system agents|mesh-ancestor
92450129|NCT05129137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450130|NCT05129137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450131|NCT05129137|Antipyretics|antipyretics|mesh-ancestor
92450132|NCT05110898|Olmesartan|olmesartan|mesh-list
92450133|NCT05110898|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92450134|NCT05110898|Indapamide|indapamide|mesh-list
92450135|NCT05110898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92450136|NCT05110898|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92450137|NCT05110898|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92450138|NCT05110898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450139|NCT05110898|Diuretics|diuretics|mesh-ancestor
92450140|NCT05110898|Natriuretic Agents|natriuretic agents|mesh-ancestor
92450141|NCT05110898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450142|NCT05110898|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92450143|NCT05110898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92450144|NCT05098041|Rifampin|rifampin|mesh-list
92450145|NCT05098041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92450146|NCT05098041|Antitubercular Agents|antitubercular agents|mesh-ancestor
92450147|NCT05098041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450148|NCT05098041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450149|NCT05098041|Leprostatic Agents|leprostatic agents|mesh-ancestor
92450150|NCT05098041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92450151|NCT05098041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450152|NCT05098041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450153|NCT05098041|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92450154|NCT05098041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92450155|NCT05098041|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92450156|NCT05098041|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92450157|NCT05098041|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92450158|NCT05098041|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92450159|NCT05096325|Insulin|insulin|mesh-list
92450160|NCT05096325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92450161|NCT05096325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450162|NCT05096065|Leuprolide|leuprolide|mesh-list
92450163|NCT05096065|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92450164|NCT05096065|Fertility Agents|fertility agents|mesh-ancestor
92450165|NCT05096065|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92450166|NCT05096065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450167|NCT05096065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92450168|NCT05096065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450169|NCT05083572|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92450170|NCT05083572|Rifaximin|rifaximin|mesh-list
92450171|NCT05083572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450172|NCT05083572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450173|NCT05030025|Lamivudine|lamivudine|mesh-list
92450174|NCT05030025|Abacavir|abacavir|mesh-list
92450175|NCT05030025|Dideoxynucleosides|dideoxynucleosides|mesh-list
92450176|NCT05030025|Dolutegravir|dolutegravir|mesh-list
92450177|NCT05030025|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
92450178|NCT05030025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92450179|NCT05030025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92450180|NCT05030025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175060|NCT01308619|Doxycycline|doxycycline|mesh-list
92450181|NCT05030025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450182|NCT05030025|Antiviral Agents|antiviral agents|mesh-ancestor
92450183|NCT05030025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450184|NCT05030025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92450185|NCT05030025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92450186|NCT05030025|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92450187|NCT05030025|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92450188|NCT05030025|Antimetabolites|antimetabolites|mesh-ancestor
92450189|NCT05013567|Ibuprofen|ibuprofen|mesh-list
92450190|NCT05013567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92450191|NCT05013567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450192|NCT05013567|Analgesics|analgesics|mesh-ancestor
92450193|NCT05013567|Sensory System Agents|sensory system agents|mesh-ancestor
92450194|NCT05013567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450195|NCT05013567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450196|NCT05013567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92450197|NCT05013567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450198|NCT05013567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92450199|NCT05013567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450200|NCT05013567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450202|NCT05008926|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92450203|NCT05008926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450204|NCT05008926|Sensory System Agents|sensory system agents|mesh-ancestor
92450205|NCT05008926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450206|NCT04989621|Rituximab|rituximab|mesh-list
92450207|NCT04989621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450208|NCT04989621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450209|NCT04989621|Immunologic Factors|immunologic factors|mesh-ancestor
92450210|NCT04989621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450211|NCT04989621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450212|NCT04989049|Folic Acid|folic acid|mesh-list
92450213|NCT04989049|Hematinics|hematinics|mesh-ancestor
92450214|NCT04989049|Vitamin B Complex|vitamin b complex|mesh-ancestor
92450215|NCT04989049|Vitamins|vitamins|mesh-ancestor
92450216|NCT04989049|Micronutrients|micronutrients|mesh-ancestor
92450217|NCT04989049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450218|NCT04984044|Vitamin D|vitamin d|mesh-list
92450219|NCT04984044|Cholecalciferol|cholecalciferol|mesh-list
92450220|NCT04984044|Vitamins|vitamins|mesh-ancestor
92450221|NCT04984044|Micronutrients|micronutrients|mesh-ancestor
92450222|NCT04984044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450223|NCT04984044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92450224|NCT04984044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92450225|NCT04975802|Caffeine|caffeine|mesh-list
92347159|NCT01762800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92450226|NCT04975802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92450227|NCT04975802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450228|NCT04975802|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92450229|NCT04975802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450230|NCT04975802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450231|NCT04975802|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92450232|NCT04975802|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92450233|NCT04975802|Purinergic Agents|purinergic agents|mesh-ancestor
92450234|NCT04975802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450235|NCT04964700|Natalizumab|natalizumab|mesh-list
92450236|NCT04964700|Immunologic Factors|immunologic factors|mesh-ancestor
92450237|NCT04964700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450238|NCT04950868|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92450239|NCT04950868|Antidepressive Agents|antidepressive agents|mesh-ancestor
92450240|NCT04950868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92450241|NCT04950868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92450242|NCT04950868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92450243|NCT04950868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450244|NCT04950868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450245|NCT04921527|Paclitaxel|paclitaxel|mesh-list
92450246|NCT04921527|Chiauranib|chiauranib|mesh-list
92450247|NCT04921527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92450248|NCT04921527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450249|NCT04921527|Tubulin Modulators|tubulin modulators|mesh-ancestor
92450250|NCT04921527|Antimitotic Agents|antimitotic agents|mesh-ancestor
92450251|NCT04921527|Mitosis Modulators|mitosis modulators|mesh-ancestor
92450252|NCT04921527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450253|NCT04921527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92450254|NCT04921527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450255|NCT04899843|Zinc Sulfate|zinc sulfate|mesh-list
92450256|NCT04899843|Astringents|astringents|mesh-ancestor
92450257|NCT04899843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450258|NCT04899843|Dermatologic Agents|dermatologic agents|mesh-ancestor
92450259|NCT04897802|Exenatide|exenatide|mesh-list
92450260|NCT04897802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92450261|NCT04897802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450262|NCT04897802|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92450263|NCT04897802|Incretins|incretins|mesh-ancestor
92450264|NCT04897802|Hormones|hormones|mesh-ancestor
92450265|NCT04897802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450266|NCT04883749|Acalabrutinib|acalabrutinib|mesh-list
92450267|NCT04883749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450268|NCT04882332|Vitamin B 12|vitamin b 12|mesh-list
92450269|NCT04882332|Hydroxocobalamin|hydroxocobalamin|mesh-list
92450270|NCT04882332|Vitamins|vitamins|mesh-ancestor
92450271|NCT04882332|Micronutrients|micronutrients|mesh-ancestor
92450272|NCT04882332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450273|NCT04882332|Vitamin B Complex|vitamin b complex|mesh-ancestor
92450274|NCT04882332|Hematinics|hematinics|mesh-ancestor
92450275|NCT04882202|Acetaminophen|acetaminophen|mesh-list
92450276|NCT04882202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450277|NCT04882202|Analgesics|analgesics|mesh-ancestor
92450278|NCT04882202|Sensory System Agents|sensory system agents|mesh-ancestor
92450279|NCT04882202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450280|NCT04882202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450281|NCT04882202|Antipyretics|antipyretics|mesh-ancestor
92450282|NCT04871425|Fentanyl|fentanyl|mesh-list
92450283|NCT04871425|Ketamine|ketamine|mesh-list
92450284|NCT04871425|Analgesics|analgesics|mesh-ancestor
92450285|NCT04871425|Sensory System Agents|sensory system agents|mesh-ancestor
92450286|NCT04871425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450287|NCT04871425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450288|NCT04871425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92450289|NCT04871425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92450290|NCT04871425|Anesthetics, General|anesthetics, general|mesh-ancestor
92450291|NCT04871425|Anesthetics|anesthetics|mesh-ancestor
92450292|NCT04871425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450293|NCT04871425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92450294|NCT04871425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92450295|NCT04871425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450296|NCT04871425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450297|NCT04871425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92450299|NCT04871425|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92450300|NCT04869605|Chrysarobin|chrysarobin|mesh-list
92450301|NCT04869605|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92450302|NCT04869605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450303|NCT04869605|Analgesics|analgesics|mesh-ancestor
92450304|NCT04869605|Sensory System Agents|sensory system agents|mesh-ancestor
92450305|NCT04869605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450306|NCT04869605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450307|NCT04869605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92450308|NCT04869605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450309|NCT04835584|Dasatinib|dasatinib|mesh-list
92450310|NCT04835584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450311|NCT04835584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92450312|NCT04835584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450313|NCT04835584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450314|NCT04774315|Omalizumab|omalizumab|mesh-list
92450315|NCT04774315|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92450316|NCT04774315|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92450317|NCT04774315|Respiratory System Agents|respiratory system agents|mesh-ancestor
92450318|NCT04767503|Propofol|propofol|mesh-list
92450319|NCT04767503|Desflurane|desflurane|mesh-list
92450320|NCT04767503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92450321|NCT04767503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450322|NCT04767503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450323|NCT04767503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92450324|NCT04767503|Anesthetics, General|anesthetics, general|mesh-ancestor
92450325|NCT04767503|Anesthetics|anesthetics|mesh-ancestor
92450326|NCT04767503|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92450327|NCT04750967|Lidocaine|lidocaine|mesh-list
92450328|NCT04750967|Amitriptyline|amitriptyline|mesh-list
92450329|NCT04750967|Anesthetics, Local|anesthetics, local|mesh-ancestor
92450330|NCT04750967|Anesthetics|anesthetics|mesh-ancestor
92450331|NCT04750967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450332|NCT04750967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450333|NCT04750967|Sensory System Agents|sensory system agents|mesh-ancestor
92450334|NCT04750967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450335|NCT04750967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92450336|NCT04750967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92450337|NCT04750967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92450338|NCT04750967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92450339|NCT04750967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450340|NCT04750967|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92450341|NCT04750967|Antidepressive Agents|antidepressive agents|mesh-ancestor
92450342|NCT04750967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92450343|NCT04750967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450344|NCT04750967|Analgesics|analgesics|mesh-ancestor
92450345|NCT04750967|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92450346|NCT04750967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92450347|NCT04750967|Adrenergic Agents|adrenergic agents|mesh-ancestor
92450348|NCT04750967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450349|NCT04722679|Anticoagulants|anticoagulants|mesh-list
92450350|NCT04696380|Nicotine|nicotine|mesh-list
92450351|NCT04696380|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92450352|NCT04696380|Autonomic Agents|autonomic agents|mesh-ancestor
92450353|NCT04696380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450354|NCT04696380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450355|NCT04696380|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92450356|NCT04696380|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92450357|NCT04696380|Cholinergic Agents|cholinergic agents|mesh-ancestor
92450358|NCT04696380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450359|NCT04696380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450360|NCT04672772|Paclitaxel|paclitaxel|mesh-list
92450361|NCT04672772|Cetuximab|cetuximab|mesh-list
92450362|NCT04672772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92450363|NCT04672772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450364|NCT04672772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92450365|NCT04672772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92450366|NCT04672772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92450367|NCT04672772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450368|NCT04672772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450370|NCT04671082|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92450371|NCT04671082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450372|NCT04671082|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92450373|NCT04671082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450374|NCT04669587|Palbociclib|palbociclib|mesh-list
92450375|NCT04669587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450376|NCT04669587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92450377|NCT04669587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450378|NCT04669587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450379|NCT04659941|BCG Vaccine|bcg vaccine|mesh-list
92450380|NCT04659941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92450381|NCT04659941|Immunologic Factors|immunologic factors|mesh-ancestor
92450382|NCT04659941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450383|NCT04659382|Bevacizumab|bevacizumab|mesh-list
92450384|NCT04659382|Atezolizumab|atezolizumab|mesh-list
92450385|NCT04659382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450386|NCT04659382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450387|NCT04659382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92450388|NCT04659382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92450389|NCT04659382|Growth Substances|growth substances|mesh-ancestor
92450390|NCT04659382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450391|NCT04659382|Growth Inhibitors|growth inhibitors|mesh-ancestor
92450392|NCT04659382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450393|NCT04659382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450394|NCT04658823|Vitamin E|vitamin e|mesh-list
92450395|NCT04658823|Tocopherols|tocopherols|mesh-list
92450396|NCT04658823|Tocotrienols|tocotrienols|mesh-list
92450397|NCT04658823|Tocovid|tocovid|mesh-list
92450398|NCT04658823|Vitamins|vitamins|mesh-ancestor
92450399|NCT04658823|Micronutrients|micronutrients|mesh-ancestor
92450400|NCT04658823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450401|NCT04658823|Antioxidants|antioxidants|mesh-ancestor
92450402|NCT04658823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450403|NCT04658823|Protective Agents|protective agents|mesh-ancestor
92450404|NCT04648241|Vaccines|vaccines|mesh-list
92450405|NCT04648241|Immunologic Factors|immunologic factors|mesh-ancestor
92450406|NCT04648241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450407|NCT04640818|Rituximab|rituximab|mesh-list
92175284|NCT01659307|Analgesics|analgesics|mesh-ancestor
92450408|NCT04640818|Cladribine|cladribine|mesh-list
92450409|NCT04640818|Ocrelizumab|ocrelizumab|mesh-list
92450410|NCT04640818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450411|NCT04640818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450412|NCT04640818|Immunologic Factors|immunologic factors|mesh-ancestor
92450413|NCT04640818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450414|NCT04640818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450415|NCT04640818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450416|NCT04640493|Dapagliflozin|dapagliflozin|mesh-list
92450417|NCT04640493|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92450418|NCT04640493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450419|NCT04640493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531358|NCT00046033|Ritonavir|ritonavir|mesh-list
92450420|NCT04640493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450422|NCT04602078|Atezolizumab|atezolizumab|mesh-list
92450423|NCT04602078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450424|NCT04602078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92450425|NCT04602078|Antimetabolites|antimetabolites|mesh-ancestor
92450426|NCT04602078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450427|NCT04602078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450428|NCT04602078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450429|NCT04588857|Dexamethasone|dexamethasone|mesh-list
92450430|NCT04588857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92450431|NCT04588857|Antiemetics|antiemetics|mesh-ancestor
92450432|NCT04588857|Autonomic Agents|autonomic agents|mesh-ancestor
92450433|NCT04588857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450434|NCT04588857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450435|NCT04588857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450436|NCT04588857|Glucocorticoids|glucocorticoids|mesh-ancestor
92450437|NCT04588857|Hormones|hormones|mesh-ancestor
92450438|NCT04588857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450439|NCT04588857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92450440|NCT04588857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450441|NCT04569448|Brexpiprazole|brexpiprazole|mesh-list
92450442|NCT04569448|Serotonin Agents|serotonin agents|mesh-ancestor
92450443|NCT04569448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450444|NCT04569448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450445|NCT04569448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450446|NCT04569448|Dopamine Agonists|dopamine agonists|mesh-ancestor
92450447|NCT04569448|Dopamine Agents|dopamine agents|mesh-ancestor
92450448|NCT04562831|Niacinamide|niacinamide|mesh-list
92450450|NCT04562831|Nicotinic Acids|nicotinic acids|mesh-list
92450451|NCT04562831|Vitamin B Complex|vitamin b complex|mesh-ancestor
92450452|NCT04562831|Vitamins|vitamins|mesh-ancestor
92450453|NCT04562831|Micronutrients|micronutrients|mesh-ancestor
92450454|NCT04562831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450455|NCT04562831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92450456|NCT04562831|Antimetabolites|antimetabolites|mesh-ancestor
92450457|NCT04562831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450458|NCT04562831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92450459|NCT04562831|Vasodilator Agents|vasodilator agents|mesh-ancestor
92450460|NCT04545242|Dexamethasone|dexamethasone|mesh-list
92450461|NCT04545242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92450462|NCT04545242|Antiemetics|antiemetics|mesh-ancestor
92450463|NCT04545242|Autonomic Agents|autonomic agents|mesh-ancestor
92450464|NCT04545242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450465|NCT04545242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450466|NCT04545242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450467|NCT04545242|Glucocorticoids|glucocorticoids|mesh-ancestor
92450468|NCT04545242|Hormones|hormones|mesh-ancestor
92450469|NCT04545242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450470|NCT04545242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92450471|NCT04545242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450472|NCT04542980|Autoantibodies|autoantibodies|mesh-list
92450473|NCT04542980|Immunologic Factors|immunologic factors|mesh-ancestor
92450474|NCT04542980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450475|NCT04529499|Favipiravir|favipiravir|mesh-list
92450476|NCT04529499|Antiviral Agents|antiviral agents|mesh-ancestor
92450477|NCT04529499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450478|NCT04523428|Venetoclax|venetoclax|mesh-list
92450479|NCT04523428|Acalabrutinib|acalabrutinib|mesh-list
92450480|NCT04523428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450481|NCT04508504|Ropivacaine|ropivacaine|mesh-list
92450482|NCT04508504|Anesthetics, Local|anesthetics, local|mesh-ancestor
92450483|NCT04508504|Anesthetics|anesthetics|mesh-ancestor
92450484|NCT04508504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450485|NCT04508504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450487|NCT04508504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450488|NCT04490707|Lenalidomide|lenalidomide|mesh-list
92450489|NCT04490707|Azacitidine|azacitidine|mesh-list
92450490|NCT04490707|Immunologic Factors|immunologic factors|mesh-ancestor
92450491|NCT04490707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450492|NCT04490707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92450493|NCT04490707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92450494|NCT04490707|Growth Substances|growth substances|mesh-ancestor
92450495|NCT04490707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531361|NCT00046033|Amprenavir|amprenavir|mesh-list
92450497|NCT04490707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92450498|NCT04490707|Antimetabolites|antimetabolites|mesh-ancestor
92347189|NCT01778010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450499|NCT04490707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450500|NCT04490707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450501|NCT04464577|Itraconazole|itraconazole|mesh-list
92450502|NCT04464577|Fluconazole|fluconazole|mesh-list
92450503|NCT04464577|Bupropion|bupropion|mesh-list
92450504|NCT04464577|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92450505|NCT04464577|Antidepressive Agents|antidepressive agents|mesh-ancestor
92450506|NCT04464577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92450507|NCT04464577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92450508|NCT04464577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92450509|NCT04464577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92450510|NCT04464577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450511|NCT04464577|Dopamine Agents|dopamine agents|mesh-ancestor
92450512|NCT04464577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450513|NCT04464577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450514|NCT04464577|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92450515|NCT04464577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92450516|NCT04464577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450517|NCT04464577|Antifungal Agents|antifungal agents|mesh-ancestor
92450518|NCT04464577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450519|NCT04464577|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92450520|NCT04464577|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92450521|NCT04464577|Hormone Antagonists|hormone antagonists|mesh-ancestor
92450522|NCT04464577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450523|NCT04464577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92450524|NCT04464577|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92450525|NCT04464577|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92450526|NCT04460924|Integrase Inhibitors|integrase inhibitors|mesh-list
92450527|NCT04460924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450528|NCT04460924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450529|NCT04402658|Albuterol|albuterol|mesh-list
92450530|NCT04402658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92450531|NCT04402658|Autonomic Agents|autonomic agents|mesh-ancestor
92450532|NCT04402658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450533|NCT04402658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450534|NCT04402658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92450535|NCT04402658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92450536|NCT04402658|Tocolytic Agents|tocolytic agents|mesh-ancestor
92450537|NCT04402658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92450538|NCT04402658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92450539|NCT04402658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92450540|NCT04402658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92450541|NCT04402658|Adrenergic Agents|adrenergic agents|mesh-ancestor
92450542|NCT04402658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450543|NCT04402658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450544|NCT04391179|Dipyridamole|dipyridamole|mesh-list
92450545|NCT04391179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92450546|NCT04391179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450547|NCT04391179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450548|NCT04391179|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92450549|NCT04391179|Vasodilator Agents|vasodilator agents|mesh-ancestor
92450550|NCT04375683|Flumatinib|flumatinib|mesh-list
92450551|NCT04375683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92450552|NCT04375683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450553|NCT04375683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450554|NCT04356742|Metformin|metformin|mesh-list
92450555|NCT04356742|Dapagliflozin|dapagliflozin|mesh-list
92450556|NCT04356742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175479|NCT02610816|Xhance|xhance|mesh-list
92450557|NCT04356742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450558|NCT04356742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92450559|NCT04356742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450561|NCT04353284|Camostat|camostat|mesh-list
92450562|NCT04353284|Protease Inhibitors|protease inhibitors|mesh-ancestor
92450563|NCT04353284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450564|NCT04353284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450565|NCT04353284|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92450566|NCT04353284|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92450567|NCT04353284|Anticoagulants|anticoagulants|mesh-ancestor
92450568|NCT04348864|Antibodies|antibodies|mesh-list
92450569|NCT04348864|Immunologic Factors|immunologic factors|mesh-ancestor
92450570|NCT04348864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450571|NCT04328012|Losartan|losartan|mesh-list
92450572|NCT04328012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92450573|NCT04328012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92450574|NCT04328012|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92450575|NCT04328012|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92450576|NCT04328012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450577|NCT04310150|Hemostatics|hemostatics|mesh-list
92450578|NCT04310150|Coagulants|coagulants|mesh-ancestor
92450579|NCT04294914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92450580|NCT04294147|Erenumab|erenumab|mesh-list
92450581|NCT04294147|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92450582|NCT04294147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450583|NCT04294147|Analgesics|analgesics|mesh-ancestor
92450584|NCT04294147|Sensory System Agents|sensory system agents|mesh-ancestor
92450585|NCT04294147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450586|NCT04294147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450587|NCT04292873|Vitamin D|vitamin d|mesh-list
92450588|NCT04292873|Vitamins|vitamins|mesh-ancestor
92450589|NCT04292873|Micronutrients|micronutrients|mesh-ancestor
92450590|NCT04292873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450591|NCT04292873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92450592|NCT04264637|Azelastine|azelastine|mesh-list
92450593|NCT04264637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92450594|NCT04264637|Autonomic Agents|autonomic agents|mesh-ancestor
92450595|NCT04264637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450596|NCT04264637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450597|NCT04264637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92450598|NCT04264637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92450599|NCT04264637|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92450600|NCT04264637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450601|NCT04264637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450602|NCT04264637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92450603|NCT04264637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92450604|NCT04264637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92450605|NCT04264637|Histamine Antagonists|histamine antagonists|mesh-ancestor
92450606|NCT04264637|Histamine Agents|histamine agents|mesh-ancestor
92450607|NCT04264637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450608|NCT04262687|Bevacizumab|bevacizumab|mesh-list
92450609|NCT04262687|Pembrolizumab|pembrolizumab|mesh-list
92450610|NCT04262687|Capecitabine|capecitabine|mesh-list
92450611|NCT04262687|Oxaliplatin|oxaliplatin|mesh-list
92450612|NCT04262687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450613|NCT04262687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450614|NCT04262687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92450615|NCT04262687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92450616|NCT04262687|Growth Substances|growth substances|mesh-ancestor
92450617|NCT04262687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450618|NCT04262687|Growth Inhibitors|growth inhibitors|mesh-ancestor
92450619|NCT04262687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450620|NCT04262687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450621|NCT04262687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92450622|NCT04262687|Antimetabolites|antimetabolites|mesh-ancestor
92450623|NCT04238546|Sirolimus|sirolimus|mesh-list
92450624|NCT04238546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450625|NCT04238546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450626|NCT04238546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92450627|NCT04238546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450628|NCT04238546|Antifungal Agents|antifungal agents|mesh-ancestor
92450629|NCT04238546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450630|NCT04238546|Immunologic Factors|immunologic factors|mesh-ancestor
92450631|NCT04238546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450632|NCT04238091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92450633|NCT04238091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450634|NCT04233801|Empagliflozin|empagliflozin|mesh-list
92450635|NCT04233801|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92450636|NCT04233801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450637|NCT04233801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92450638|NCT04233801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450639|NCT04223570|Protoporphyrin IX|protoporphyrin ix|mesh-list
92450640|NCT04223570|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92450641|NCT04223570|Levulinic acid|levulinic acid|mesh-list
92450642|NCT04223570|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92450643|NCT04223570|Dermatologic Agents|dermatologic agents|mesh-ancestor
92450644|NCT04223570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450645|NCT04223570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450646|NCT04180085|Abatacept|abatacept|mesh-list
92450647|NCT04180085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450648|NCT04180085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450649|NCT04180085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450650|NCT04180085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450651|NCT04180085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450652|NCT04180085|Immunologic Factors|immunologic factors|mesh-ancestor
92450653|NCT04180085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450654|NCT04180085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450655|NCT04169451|Letrozole|letrozole|mesh-list
92450656|NCT04169451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450657|NCT04169451|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92450658|NCT04169451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92450659|NCT04169451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450660|NCT04169451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450661|NCT04169451|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92450662|NCT04169451|Hormone Antagonists|hormone antagonists|mesh-ancestor
92450663|NCT04169451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450664|NCT04169451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450665|NCT04169438|Petrolatum|petrolatum|mesh-list
92450666|NCT04169438|Emollients|emollients|mesh-ancestor
92450667|NCT04169438|Dermatologic Agents|dermatologic agents|mesh-ancestor
92450668|NCT04159818|Doxorubicin|doxorubicin|mesh-list
92450669|NCT04159818|Nivolumab|nivolumab|mesh-list
92450670|NCT04159818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450671|NCT04159818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92450672|NCT04159818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92450673|NCT04159818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92450674|NCT04159818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450675|NCT04159818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450676|NCT04159818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450677|NCT04159818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450678|NCT04157881|Rabeprazole|rabeprazole|mesh-list
92450679|NCT04157881|Dabigatran|dabigatran|mesh-list
92450680|NCT04157881|Antithrombins|antithrombins|mesh-ancestor
92450681|NCT04157881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92450682|NCT04157881|Protease Inhibitors|protease inhibitors|mesh-ancestor
92450683|NCT04157881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450684|NCT04157881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450685|NCT04157881|Anticoagulants|anticoagulants|mesh-ancestor
92450686|NCT04157881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92450687|NCT04157881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450688|NCT04157881|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92450689|NCT04151563|Docetaxel|docetaxel|mesh-list
92450690|NCT04151563|Nivolumab|nivolumab|mesh-list
92450691|NCT04151563|Ipilimumab|ipilimumab|mesh-list
92450692|NCT04151563|Ramucirumab|ramucirumab|mesh-list
92450693|NCT04151563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450694|NCT04151563|Tubulin Modulators|tubulin modulators|mesh-ancestor
92450695|NCT04151563|Antimitotic Agents|antimitotic agents|mesh-ancestor
92450696|NCT04151563|Mitosis Modulators|mitosis modulators|mesh-ancestor
92450697|NCT04151563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450698|NCT04151563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450699|NCT04151563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450700|NCT04136262|Methotrexate|methotrexate|mesh-list
92450701|NCT04136262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92450702|NCT04136262|Abortifacient Agents|abortifacient agents|mesh-ancestor
92450703|NCT04136262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92450704|NCT04136262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175584|NCT00198991|Etoposide|etoposide|mesh-list
92450705|NCT04136262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92450706|NCT04136262|Antimetabolites|antimetabolites|mesh-ancestor
92450707|NCT04136262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450708|NCT04136262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450709|NCT04136262|Dermatologic Agents|dermatologic agents|mesh-ancestor
92450710|NCT04136262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450711|NCT04136262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92450712|NCT04136262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450713|NCT04136262|Immunologic Factors|immunologic factors|mesh-ancestor
92450714|NCT04136262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450715|NCT04136262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92450716|NCT04133922|Insulin|insulin|mesh-list
92450717|NCT04133922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92450718|NCT04133922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450719|NCT04115059|Dasatinib|dasatinib|mesh-list
92450720|NCT04115059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450721|NCT04115059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92450722|NCT04115059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450723|NCT04115059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450724|NCT04114890|Tenofovir|tenofovir|mesh-list
92450725|NCT04114890|Antiviral Agents|antiviral agents|mesh-ancestor
92450726|NCT04114890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450727|NCT04114890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92450728|NCT04114890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92450729|NCT04114890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450730|NCT04114890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450731|NCT04114890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92450732|NCT04114890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92450733|NCT04096066|Dexamethasone|dexamethasone|mesh-list
92450734|NCT04096066|Lenalidomide|lenalidomide|mesh-list
92450735|NCT04096066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92450736|NCT04096066|Antiemetics|antiemetics|mesh-ancestor
92450737|NCT04096066|Autonomic Agents|autonomic agents|mesh-ancestor
92450738|NCT04096066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450739|NCT04096066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450741|NCT04096066|Glucocorticoids|glucocorticoids|mesh-ancestor
92450742|NCT04096066|Hormones|hormones|mesh-ancestor
92450743|NCT04096066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450744|NCT04096066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92450745|NCT04096066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450746|NCT04096066|Immunologic Factors|immunologic factors|mesh-ancestor
92450747|NCT04096066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92450748|NCT04096066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92450749|NCT04096066|Growth Substances|growth substances|mesh-ancestor
92450750|NCT04096066|Growth Inhibitors|growth inhibitors|mesh-ancestor
92450751|NCT04082676|Bupivacaine|bupivacaine|mesh-list
92450752|NCT04082676|Anesthetics, Local|anesthetics, local|mesh-ancestor
92450753|NCT04082676|Anesthetics|anesthetics|mesh-ancestor
92450754|NCT04082676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450755|NCT04082676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450756|NCT04082676|Sensory System Agents|sensory system agents|mesh-ancestor
92450757|NCT04082676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450758|NCT04012177|Niacinamide|niacinamide|mesh-list
92450759|NCT04012177|Niacin|niacin|mesh-list
92450760|NCT04012177|Nicotinic Acids|nicotinic acids|mesh-list
92450761|NCT04012177|Azithromycin|azithromycin|mesh-list
92450762|NCT04012177|Choline|choline|mesh-list
92450763|NCT04012177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450764|NCT04012177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450765|NCT04012177|Lipotropic Agents|lipotropic agents|mesh-ancestor
92450766|NCT04012177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92450767|NCT04012177|Antimetabolites|antimetabolites|mesh-ancestor
92450768|NCT04012177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450769|NCT04012177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450770|NCT04012177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92450771|NCT04012177|Nootropic Agents|nootropic agents|mesh-ancestor
92450772|NCT04012177|Vitamin B Complex|vitamin b complex|mesh-ancestor
92450773|NCT04012177|Vitamins|vitamins|mesh-ancestor
92450774|NCT04012177|Micronutrients|micronutrients|mesh-ancestor
92347222|NCT01777542|Insulin|insulin|mesh-list
92450775|NCT04012177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450776|NCT04012177|Vasodilator Agents|vasodilator agents|mesh-ancestor
92450777|NCT04007289|Apixaban|apixaban|mesh-list
92450778|NCT04007289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92450779|NCT04007289|Antithrombins|antithrombins|mesh-ancestor
92450780|NCT04007289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92175688|NCT01456481|Midodrine|midodrine|mesh-list
92450781|NCT04007289|Protease Inhibitors|protease inhibitors|mesh-ancestor
92450782|NCT04007289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450783|NCT04007289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450784|NCT04007289|Anticoagulants|anticoagulants|mesh-ancestor
92450785|NCT04004910|Antineoplastic Agents|antineoplastic agents|mesh-list
92450787|NCT04002518|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92450788|NCT04002518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92450789|NCT04002518|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92450790|NCT04002518|Histamine Antagonists|histamine antagonists|mesh-ancestor
92450791|NCT04002518|Histamine Agents|histamine agents|mesh-ancestor
92450792|NCT04002518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450793|NCT04002518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450794|NCT04002518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450795|NCT04002518|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92450796|NCT04002518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92450797|NCT04002518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450799|NCT03993249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450800|NCT03993249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450801|NCT03993249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450802|NCT03993249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450803|NCT03990883|Lidocaine|lidocaine|mesh-list
92450804|NCT03990883|Anesthetics, Local|anesthetics, local|mesh-ancestor
92450805|NCT03990883|Anesthetics|anesthetics|mesh-ancestor
92450806|NCT03990883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450807|NCT03990883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450808|NCT03990883|Sensory System Agents|sensory system agents|mesh-ancestor
92450809|NCT03990883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450810|NCT03990883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92450811|NCT03990883|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92450812|NCT03990883|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92450813|NCT03990883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92450814|NCT03990883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450815|NCT03984890|Vitamin D|vitamin d|mesh-list
92450816|NCT03984890|Cholecalciferol|cholecalciferol|mesh-list
92450817|NCT03984890|Vitamins|vitamins|mesh-ancestor
92450818|NCT03984890|Micronutrients|micronutrients|mesh-ancestor
92450819|NCT03984890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450820|NCT03984890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92450821|NCT03984890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92450822|NCT03926091|Cyclophosphamide|cyclophosphamide|mesh-list
92450823|NCT03926091|Docetaxel|docetaxel|mesh-list
92450824|NCT03926091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450825|NCT03926091|Immunologic Factors|immunologic factors|mesh-ancestor
92450826|NCT03926091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450827|NCT03926091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450828|NCT03926091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92450829|NCT03926091|Alkylating Agents|alkylating agents|mesh-ancestor
92450830|NCT03926091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450831|NCT03926091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450832|NCT03926091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92450833|NCT03926091|Tubulin Modulators|tubulin modulators|mesh-ancestor
92450834|NCT03926091|Antimitotic Agents|antimitotic agents|mesh-ancestor
92450835|NCT03926091|Mitosis Modulators|mitosis modulators|mesh-ancestor
92450836|NCT03924427|Deucravacitinib|deucravacitinib|mesh-list
92450837|NCT03924427|Dermatologic Agents|dermatologic agents|mesh-ancestor
92450838|NCT03924427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92450839|NCT03924427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450840|NCT03924427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450841|NCT03922451|Cefazolin|cefazolin|mesh-list
92450842|NCT03922451|Tazobactam|tazobactam|mesh-list
92450843|NCT03922451|Piperacillin|piperacillin|mesh-list
92450844|NCT03922451|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92450845|NCT03922451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450846|NCT03922451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450847|NCT03922451|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92450848|NCT03922451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450849|NCT03922451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450850|NCT05802433|Vitamin D|vitamin d|mesh-list
92450851|NCT05802433|Cholecalciferol|cholecalciferol|mesh-list
92450852|NCT05802433|Vitamins|vitamins|mesh-ancestor
92450853|NCT05802433|Micronutrients|micronutrients|mesh-ancestor
92450854|NCT05802433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175737|NCT01455233|Moxifloxacin|moxifloxacin|mesh-list
92450855|NCT05802433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92450856|NCT05802433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92450857|NCT05802303|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92450858|NCT05802303|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92450859|NCT05802303|Estradiol|estradiol|mesh-list
92450860|NCT05802303|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92450861|NCT05802303|Estrogens|estrogens|mesh-ancestor
92450862|NCT05802303|Hormones|hormones|mesh-ancestor
92450863|NCT05802303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92450864|NCT05802303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450865|NCT05802303|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92450866|NCT05802303|Contraceptive Agents|contraceptive agents|mesh-ancestor
92450867|NCT05802303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92450868|NCT05802303|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92450869|NCT05802290|Nivolumab|nivolumab|mesh-list
92450870|NCT05802290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450871|NCT05802290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200154|NCT01923129|Prazosin|prazosin|mesh-list
92450872|NCT05802290|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92450873|NCT05802290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450874|NCT05802264|Amphotericin B|amphotericin b|mesh-list
92450875|NCT05802264|Amebicides|amebicides|mesh-ancestor
92450876|NCT05802264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92450877|NCT05802264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92450878|NCT05802264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450879|NCT05802264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450880|NCT05802264|Antifungal Agents|antifungal agents|mesh-ancestor
92450881|NCT05802225|Pertuzumab|pertuzumab|mesh-list
92450882|NCT05802225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92450883|NCT05802225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450884|NCT05802212|Metformin|metformin|mesh-list
92450885|NCT05802212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92450886|NCT05802212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450887|NCT05802121|Acetic Acid|acetic acid|mesh-list
92450888|NCT05802121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450889|NCT05802121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450890|NCT05802108|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92450891|NCT05802108|Evolocumab|evolocumab|mesh-list
92450892|NCT05802108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92450893|NCT05802108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92450894|NCT05802108|Antimetabolites|antimetabolites|mesh-ancestor
92450895|NCT05802108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450896|NCT05802108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450897|NCT05802108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92450898|NCT05802108|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92450899|NCT05802108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92450900|NCT05802108|Protease Inhibitors|protease inhibitors|mesh-ancestor
92450901|NCT05802082|Anesthetics|anesthetics|mesh-list
92450902|NCT05802082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450903|NCT05802082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450904|NCT05801900|Ibuprofen|ibuprofen|mesh-list
92450905|NCT05801900|Ketorolac|ketorolac|mesh-list
92450906|NCT05801900|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92450907|NCT05801900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92450908|NCT05801900|Analgesics|analgesics|mesh-ancestor
92450909|NCT05801900|Sensory System Agents|sensory system agents|mesh-ancestor
92450910|NCT05801900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450911|NCT05801900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450912|NCT05801900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92450913|NCT05801900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92450914|NCT05801900|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92450915|NCT05801900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450916|NCT05801900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450917|NCT05801835|Cytarabine|cytarabine|mesh-list
92450918|NCT05801835|Daunorubicin|daunorubicin|mesh-list
92450919|NCT05801835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92450920|NCT05801835|Antimetabolites|antimetabolites|mesh-ancestor
92450921|NCT05801835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450922|NCT05801835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450923|NCT05801835|Antiviral Agents|antiviral agents|mesh-ancestor
92450924|NCT05801835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450925|NCT05801835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92450926|NCT05801835|Immunologic Factors|immunologic factors|mesh-ancestor
92450927|NCT05801835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450928|NCT05801835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92450929|NCT05801835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92450930|NCT05801835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92450931|NCT05801835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450932|NCT05801523|Ethanol|ethanol|mesh-list
92450933|NCT05801523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92450934|NCT05801523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450935|NCT05801523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450936|NCT05801523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450937|NCT05801484|Linezolid|linezolid|mesh-list
92450938|NCT05801484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92450939|NCT05801484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450940|NCT05801484|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92450941|NCT05801484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450942|NCT05801484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450943|NCT05801380|Memantine|memantine|mesh-list
92450944|NCT05801380|Donepezil|donepezil|mesh-list
92450945|NCT05801380|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92450946|NCT05801380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450947|NCT05801380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450948|NCT05801380|Cholinergic Agents|cholinergic agents|mesh-ancestor
92450949|NCT05801380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92450950|NCT05801380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450951|NCT05801380|Nootropic Agents|nootropic agents|mesh-ancestor
92450952|NCT05801380|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92450953|NCT05801380|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92450954|NCT05801380|Dopamine Agents|dopamine agents|mesh-ancestor
92450955|NCT05801380|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92450956|NCT05801380|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92450957|NCT05801367|Allyl sulfide|allyl sulfide|mesh-list
92450958|NCT05801367|Antioxidants|antioxidants|mesh-ancestor
92450959|NCT05801367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450960|NCT05801367|Protective Agents|protective agents|mesh-ancestor
92450961|NCT05801367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450962|NCT05801367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92450963|NCT05801367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450964|NCT05801367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92450965|NCT05801367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92450966|NCT05801328|Salicylic Acid|salicylic acid|mesh-list
92450967|NCT05801328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92450968|NCT05801328|Antifungal Agents|antifungal agents|mesh-ancestor
92450969|NCT05801328|Keratolytic Agents|keratolytic agents|mesh-ancestor
92450970|NCT05801328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92450971|NCT05801289|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92450972|NCT05801289|Antidepressive Agents|antidepressive agents|mesh-ancestor
92450973|NCT05801289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92450974|NCT05801289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92450975|NCT05801289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92450976|NCT05801289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450977|NCT05801289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450978|NCT05801237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92450979|NCT05801237|Antibodies|antibodies|mesh-list
92450980|NCT05801237|Immunoglobulins|immunoglobulins|mesh-list
92450981|NCT05801237|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92450982|NCT05801237|Immunologic Factors|immunologic factors|mesh-ancestor
92450983|NCT05801237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450984|NCT05801237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92450985|NCT05801172|Ketoprofen|ketoprofen|mesh-list
92450986|NCT05801172|Lidocaine|lidocaine|mesh-list
92450987|NCT05801172|Anesthetics|anesthetics|mesh-list
92450988|NCT05801172|Anesthetics, Local|anesthetics, local|mesh-ancestor
92450989|NCT05801172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92450990|NCT05801172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92450991|NCT05801172|Sensory System Agents|sensory system agents|mesh-ancestor
92347228|NCT01777542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92450992|NCT05801172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92450993|NCT05801172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92450994|NCT05801172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92450995|NCT05801172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92450996|NCT05801172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92450997|NCT05801172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92450998|NCT05801172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92450999|NCT05801172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451000|NCT05801172|Analgesics|analgesics|mesh-ancestor
92451001|NCT05801172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451002|NCT05801172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451003|NCT05801172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92451004|NCT05801172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451005|NCT05801133|Pirfenidone|pirfenidone|mesh-list
92451006|NCT05801133|Analgesics|analgesics|mesh-ancestor
92451007|NCT05801133|Sensory System Agents|sensory system agents|mesh-ancestor
92451008|NCT05801133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451009|NCT05801133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451010|NCT05801133|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92451011|NCT05801133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451012|NCT05801133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451013|NCT05801133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451014|NCT05801133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451015|NCT05801068|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
92451016|NCT05801068|Antithrombins|antithrombins|mesh-ancestor
92451017|NCT05801068|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92451018|NCT05801068|Protease Inhibitors|protease inhibitors|mesh-ancestor
92451019|NCT05801068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451020|NCT05801068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451021|NCT05801068|Anticoagulants|anticoagulants|mesh-ancestor
92451023|NCT05801029|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92451024|NCT05801029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451025|NCT05801029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451026|NCT05801029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451027|NCT05801029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451028|NCT05801029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451029|NCT05800847|Gabapentin|gabapentin|mesh-list
92451030|NCT05800847|Analgesics|analgesics|mesh-ancestor
92451031|NCT05800847|Sensory System Agents|sensory system agents|mesh-ancestor
92451032|NCT05800847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451033|NCT05800847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451034|NCT05800847|Anticonvulsants|anticonvulsants|mesh-ancestor
92451035|NCT05800847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92451036|NCT05800847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92451037|NCT05800847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451038|NCT05800847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92451039|NCT05800847|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92451040|NCT05800847|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92451041|NCT05800847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451042|NCT05800847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451043|NCT05800847|Antimanic Agents|antimanic agents|mesh-ancestor
92451044|NCT05800834|Lidocaine|lidocaine|mesh-list
92451045|NCT05800834|Morphine|morphine|mesh-list
92451046|NCT05800834|Anesthetics, Local|anesthetics, local|mesh-ancestor
92451047|NCT05800834|Anesthetics|anesthetics|mesh-ancestor
92451048|NCT05800834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451049|NCT05800834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451050|NCT05800834|Sensory System Agents|sensory system agents|mesh-ancestor
92451051|NCT05800834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451052|NCT05800834|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92451053|NCT05800834|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92451054|NCT05800834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92451055|NCT05800834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92451056|NCT05800834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451057|NCT05800834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92451058|NCT05800834|Narcotics|narcotics|mesh-ancestor
92451059|NCT05800834|Analgesics|analgesics|mesh-ancestor
92451060|NCT05800756|Trastuzumab|trastuzumab|mesh-list
92451061|NCT05800756|Letrozole|letrozole|mesh-list
92451062|NCT05800756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451063|NCT05800756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451064|NCT05800756|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92451065|NCT05800756|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92451066|NCT05800756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451067|NCT05800756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451068|NCT05800756|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92451069|NCT05800756|Hormone Antagonists|hormone antagonists|mesh-ancestor
92451070|NCT05800756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451071|NCT05800756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451072|NCT05800197|Tamoxifen|tamoxifen|mesh-list
92451073|NCT05800197|Letrozole|letrozole|mesh-list
92451074|NCT05800197|Anastrozole|anastrozole|mesh-list
92451075|NCT05800197|Goserelin|goserelin|mesh-list
92451076|NCT05800197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92451077|NCT05800197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451078|NCT05800197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92451079|NCT05800197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92451080|NCT05800197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451081|NCT05800197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451082|NCT05800197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92451083|NCT05800197|Hormone Antagonists|hormone antagonists|mesh-ancestor
92451084|NCT05800197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451085|NCT05800197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451086|NCT05800197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92451087|NCT05800197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92451088|NCT05800197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92451089|NCT05800197|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92451090|NCT05800197|Luteolytic Agents|luteolytic agents|mesh-ancestor
92451091|NCT05800197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92451092|NCT05800197|Contraceptive Agents|contraceptive agents|mesh-ancestor
92451093|NCT05800197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92451094|NCT05800197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92451096|NCT05798663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451097|NCT05798663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451098|NCT05798663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451099|NCT05798663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451100|NCT05797597|Aspirin|aspirin|mesh-list
92451101|NCT05797597|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92451102|NCT05797597|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451103|NCT05797597|Analgesics|analgesics|mesh-ancestor
92451104|NCT05797597|Sensory System Agents|sensory system agents|mesh-ancestor
92451105|NCT05797597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451106|NCT05797597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451107|NCT05797597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451108|NCT05797597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451109|NCT05797597|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92451110|NCT05797597|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92451111|NCT05797597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451112|NCT05797597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92451113|NCT05797597|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92451114|NCT05797597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451115|NCT05797597|Antipyretics|antipyretics|mesh-ancestor
92451116|NCT05796661|Citric Acid|citric acid|mesh-list
92451117|NCT05796661|Sodium Citrate|sodium citrate|mesh-list
92451118|NCT05796661|Anticoagulants|anticoagulants|mesh-ancestor
92451119|NCT05796661|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92451120|NCT05796661|Chelating Agents|chelating agents|mesh-ancestor
92451121|NCT05796661|Sequestering Agents|sequestering agents|mesh-ancestor
92451122|NCT05796661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451123|NCT05794750|Capecitabine|capecitabine|mesh-list
92451124|NCT05794750|Oxaliplatin|oxaliplatin|mesh-list
92451125|NCT05794750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451126|NCT05794750|Antimetabolites|antimetabolites|mesh-ancestor
92451127|NCT05794750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451128|NCT05794750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451129|NCT05792293|Atorvastatin|atorvastatin|mesh-list
92451130|NCT05792293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92451131|NCT05792293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92451132|NCT05792293|Antimetabolites|antimetabolites|mesh-ancestor
92451133|NCT05792293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451134|NCT05792293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92451135|NCT05792293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92451136|NCT05792293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451137|NCT05785689|Dexmedetomidine|dexmedetomidine|mesh-list
92451138|NCT05785689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92451139|NCT05785689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451140|NCT05785689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451141|NCT05785689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451142|NCT05785689|Analgesics|analgesics|mesh-ancestor
92451143|NCT05785689|Sensory System Agents|sensory system agents|mesh-ancestor
92451144|NCT05785689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451145|NCT05785689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92451146|NCT05785689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92451147|NCT05785689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92451148|NCT05785689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92451149|NCT05785689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451150|NCT05785689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176044|NCT04848246|Dopamine Agents|dopamine agents|mesh-ancestor
92451152|NCT05759156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92451153|NCT05759156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92451154|NCT05759156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451155|NCT05759156|Hemostatics|hemostatics|mesh-ancestor
92451156|NCT05759156|Coagulants|coagulants|mesh-ancestor
92451157|NCT05753644|Ropivacaine|ropivacaine|mesh-list
92451158|NCT05753644|Anesthetics, Local|anesthetics, local|mesh-ancestor
92451159|NCT05753644|Anesthetics|anesthetics|mesh-ancestor
92451160|NCT05753644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451161|NCT05753644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451162|NCT05753644|Sensory System Agents|sensory system agents|mesh-ancestor
92451163|NCT05753644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451164|NCT05752201|Vaccines|vaccines|mesh-list
92451165|NCT05752201|Immunologic Factors|immunologic factors|mesh-ancestor
92451166|NCT05752201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451167|NCT05756504|Ketorolac|ketorolac|mesh-list
92451168|NCT05756504|Tramadol|tramadol|mesh-list
92451169|NCT05756504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92451170|NCT05756504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451171|NCT05756504|Analgesics|analgesics|mesh-ancestor
92451172|NCT05756504|Sensory System Agents|sensory system agents|mesh-ancestor
92451173|NCT05756504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451174|NCT05756504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451175|NCT05756504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451176|NCT05756504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451177|NCT05756504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92451178|NCT05756504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451179|NCT05756504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451180|NCT05756504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92451181|NCT05756504|Narcotics|narcotics|mesh-ancestor
92451182|NCT05756504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451183|NCT05699603|Fluorouracil|fluorouracil|mesh-list
92451184|NCT05699603|Calcipotriene|calcipotriene|mesh-list
92451185|NCT05699603|Antimetabolites|antimetabolites|mesh-ancestor
92451186|NCT05699603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451187|NCT05699603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451188|NCT05699603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451189|NCT05699603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451190|NCT05699603|Immunologic Factors|immunologic factors|mesh-ancestor
92451191|NCT05699603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451192|NCT05699603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451193|NCT05697510|Siltuximab|siltuximab|mesh-list
92451194|NCT05697510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451195|NCT05691400|Palbociclib|palbociclib|mesh-list
92451196|NCT05691400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451197|NCT05691400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451198|NCT05691400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451199|NCT05691400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451200|NCT05657925|Ondansetron|ondansetron|mesh-list
92451201|NCT05657925|Antiemetics|antiemetics|mesh-ancestor
92451202|NCT05657925|Autonomic Agents|autonomic agents|mesh-ancestor
92451203|NCT05657925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451204|NCT05657925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451205|NCT05657925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92451206|NCT05657925|Antipruritics|antipruritics|mesh-ancestor
92451207|NCT05657925|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451208|NCT05657925|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92451209|NCT05657925|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92451210|NCT05657925|Serotonin Agents|serotonin agents|mesh-ancestor
92451211|NCT05657925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451212|NCT05657925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451213|NCT05656508|Vaccines|vaccines|mesh-list
92451214|NCT05656508|Immunologic Factors|immunologic factors|mesh-ancestor
92451215|NCT05656508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451216|NCT05622812|Lidocaine|lidocaine|mesh-list
92451217|NCT05622812|Anesthetics, Local|anesthetics, local|mesh-ancestor
92451218|NCT05622812|Anesthetics|anesthetics|mesh-ancestor
92451219|NCT05622812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451220|NCT05622812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451221|NCT05622812|Sensory System Agents|sensory system agents|mesh-ancestor
92451222|NCT05622812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451223|NCT05622812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92451224|NCT05622812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92451225|NCT05622812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92451226|NCT05622812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92451227|NCT05622812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451229|NCT05611229|Nivolumab|nivolumab|mesh-list
92451230|NCT05611229|Ipilimumab|ipilimumab|mesh-list
92451231|NCT05611229|Trametinib|trametinib|mesh-list
92451232|NCT05611229|Vemurafenib|vemurafenib|mesh-list
92451233|NCT05611229|Dabrafenib|dabrafenib|mesh-list
92451234|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451235|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451236|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451237|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451238|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451239|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451240|NCT05601154|Listerine|listerine|mesh-list
92451242|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
92451243|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
92451244|NCT05601154|Protective Agents|protective agents|mesh-ancestor
92451245|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451246|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92451247|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451248|NCT05566665|Meropenem|meropenem|mesh-list
92451249|NCT05566665|Tazobactam|tazobactam|mesh-list
92451250|NCT05566665|Ceftazidime|ceftazidime|mesh-list
92451251|NCT05566665|Avibactam|avibactam|mesh-list
92451252|NCT05566665|Ceftolozane|ceftolozane|mesh-list
92451253|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92451254|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92451255|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92451256|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451257|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92451258|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451259|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451260|NCT05566665|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92451261|NCT05559476|Vaccines|vaccines|mesh-list
92451262|NCT05559476|Immunologic Factors|immunologic factors|mesh-ancestor
92451263|NCT05559476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451264|NCT05544565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92451265|NCT05544565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451266|NCT05534529|Rezafungin|rezafungin|mesh-list
92451267|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
92451268|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451269|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
92451270|NCT05521984|Carmustine|carmustine|mesh-list
92451271|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92451272|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451273|NCT05521984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92451274|NCT05521984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451275|NCT05521984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92451276|NCT05521984|Alkylating Agents|alkylating agents|mesh-ancestor
92451277|NCT05521984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451278|NCT05520138|Abiraterone Acetate|abiraterone acetate|mesh-list
92451279|NCT05520138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451280|NCT05520138|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92451281|NCT05520138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451282|NCT05520138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451283|NCT05520138|Hormone Antagonists|hormone antagonists|mesh-ancestor
92451284|NCT05520138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451285|NCT05520138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451286|NCT05520138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92451287|NCT05497323|Adapalene|adapalene|mesh-list
92451288|NCT05497323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92451289|NCT05497323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451290|NCT05497323|Analgesics|analgesics|mesh-ancestor
92451291|NCT05497323|Sensory System Agents|sensory system agents|mesh-ancestor
92451292|NCT05497323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451293|NCT05497323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451294|NCT05497323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451295|NCT05497323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451296|NCT05497323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451297|NCT05463965|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92451298|NCT05463965|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92451299|NCT05463965|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92451300|NCT05463965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451301|NCT05463965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451302|NCT05463965|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92451303|NCT05463965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92451304|NCT05463965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451305|NCT05463965|Cholinergic Agents|cholinergic agents|mesh-ancestor
92451306|NCT05463965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451308|NCT05371886|Morphine|morphine|mesh-list
92451309|NCT05371886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92451310|NCT05371886|Narcotics|narcotics|mesh-ancestor
92451311|NCT05371886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451312|NCT05371886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451313|NCT05371886|Analgesics|analgesics|mesh-ancestor
92451314|NCT05371886|Sensory System Agents|sensory system agents|mesh-ancestor
92200170|NCT01925469|Anesthetics|anesthetics|mesh-ancestor
92451315|NCT05371886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451316|NCT05371886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92451317|NCT05371886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92451318|NCT05371886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92451319|NCT05371886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92451320|NCT05371886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92451321|NCT05371886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92451322|NCT05371886|Anesthetics, General|anesthetics, general|mesh-ancestor
92451323|NCT05371886|Anesthetics|anesthetics|mesh-ancestor
92451324|NCT05371886|GABA Modulators|gaba modulators|mesh-ancestor
92451325|NCT05371886|GABA Agents|gaba agents|mesh-ancestor
92451326|NCT05371886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451327|NCT05371886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451328|NCT05345782|Bupivacaine|bupivacaine|mesh-list
92451329|NCT05345782|Anesthetics, Local|anesthetics, local|mesh-ancestor
92451330|NCT05345782|Anesthetics|anesthetics|mesh-ancestor
92451331|NCT05345782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451332|NCT05345782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451333|NCT05345782|Sensory System Agents|sensory system agents|mesh-ancestor
92451334|NCT05345782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451335|NCT05309655|Adenosine|adenosine|mesh-list
92451336|NCT05309655|Analgesics|analgesics|mesh-ancestor
92451337|NCT05309655|Sensory System Agents|sensory system agents|mesh-ancestor
92451338|NCT05309655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451339|NCT05309655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451340|NCT05309655|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92451341|NCT05309655|Vasodilator Agents|vasodilator agents|mesh-ancestor
92451342|NCT05309655|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92451343|NCT05309655|Purinergic Agonists|purinergic agonists|mesh-ancestor
92451344|NCT05309655|Purinergic Agents|purinergic agents|mesh-ancestor
92451345|NCT05309655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451346|NCT05309655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451347|NCT05297903|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92451348|NCT05297903|Immunologic Factors|immunologic factors|mesh-ancestor
92451349|NCT05297903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451350|NCT05265767|Factor VIII|factor viii|mesh-list
92451351|NCT05265767|Coagulants|coagulants|mesh-ancestor
92451352|NCT05219799|Propranolol|propranolol|mesh-list
92451353|NCT05219799|Phentolamine|phentolamine|mesh-list
92451354|NCT05219799|Isoproterenol|isoproterenol|mesh-list
92451355|NCT05219799|Norepinephrine|norepinephrine|mesh-list
92451356|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92451357|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92451358|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
92451359|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451360|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451361|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451362|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92451363|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92451364|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
92451365|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92451366|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92451367|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
92451368|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
92451369|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531380|NCT04369560|Hematinics|hematinics|mesh-ancestor
92451370|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92451371|NCT05219799|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92451372|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92451373|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92451374|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92451375|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92176267|NCT04772521|Nicotine|nicotine|mesh-list
92451376|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92451377|NCT05219799|Protective Agents|protective agents|mesh-ancestor
92451378|NCT05215951|Osimertinib|osimertinib|mesh-list
92451379|NCT05215951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451380|NCT05215951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451381|NCT05215951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451382|NCT05215951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451383|NCT05161468|Triamcinolone|triamcinolone|mesh-list
92451384|NCT05161468|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92451385|NCT05161468|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92451386|NCT05161468|Lidocaine|lidocaine|mesh-list
92451387|NCT05161468|Acid citrate dextrose|acid citrate dextrose|mesh-list
92451388|NCT05161468|Glucocorticoids|glucocorticoids|mesh-list
92451389|NCT05161468|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92451390|NCT05161468|Anesthetics, Local|anesthetics, local|mesh-ancestor
92451391|NCT05161468|Anesthetics|anesthetics|mesh-ancestor
92451392|NCT05161468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451393|NCT05161468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451394|NCT05161468|Sensory System Agents|sensory system agents|mesh-ancestor
92451395|NCT05161468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451396|NCT05161468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92451397|NCT05161468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92451398|NCT05161468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92451399|NCT05161468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92451400|NCT05161468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451401|NCT05161468|Anticoagulants|anticoagulants|mesh-ancestor
92451402|NCT05161468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451403|NCT05161468|Hormones|hormones|mesh-ancestor
92451404|NCT05161468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451405|NCT05161468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451406|NCT05161468|Immunologic Factors|immunologic factors|mesh-ancestor
92451407|NCT05161468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451408|NCT05108389|Hemostatics|hemostatics|mesh-list
92451409|NCT05108389|Coagulants|coagulants|mesh-ancestor
92451410|NCT05104762|Immunoglobulins|immunoglobulins|mesh-list
92451411|NCT05104762|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92451412|NCT05104762|Antibodies|antibodies|mesh-list
92451413|NCT05104762|gamma-Globulins|gamma-globulins|mesh-list
92451414|NCT05104762|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92451415|NCT05104762|Immunologic Factors|immunologic factors|mesh-ancestor
92451416|NCT05104762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451417|NCT05083312|Fluticasone|fluticasone|mesh-list
92451418|NCT05083312|Xhance|xhance|mesh-list
92451419|NCT05083312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451420|NCT05083312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92451421|NCT05083312|Autonomic Agents|autonomic agents|mesh-ancestor
92451422|NCT05083312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451423|NCT05083312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451424|NCT05083312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92451425|NCT05083312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92451426|NCT05083312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451427|NCT05083312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92451428|NCT05027425|Durvalumab|durvalumab|mesh-list
92451429|NCT05027425|Tremelimumab|tremelimumab|mesh-list
92451430|NCT05027425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451431|NCT05027425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451432|NCT05003648|Pramipexole|pramipexole|mesh-list
92451433|NCT05003648|Antioxidants|antioxidants|mesh-ancestor
92451434|NCT05003648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451435|NCT05003648|Protective Agents|protective agents|mesh-ancestor
92451436|NCT05003648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451437|NCT05003648|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92451438|NCT05003648|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92451439|NCT05003648|Dopamine Agonists|dopamine agonists|mesh-ancestor
92451440|NCT05003648|Dopamine Agents|dopamine agents|mesh-ancestor
92451441|NCT05003648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451442|NCT04991480|Niraparib|niraparib|mesh-list
92451443|NCT04991480|Talazoparib|talazoparib|mesh-list
92451444|NCT04991480|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92451446|NCT04991480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451447|NCT04991480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451448|NCT04892043|Nivolumab|nivolumab|mesh-list
92451449|NCT04892043|Ipilimumab|ipilimumab|mesh-list
92451450|NCT04892043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451451|NCT04892043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451452|NCT04892043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451453|NCT04892043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451455|NCT04880278|Antiemetics|antiemetics|mesh-ancestor
92451456|NCT04880278|Autonomic Agents|autonomic agents|mesh-ancestor
92451457|NCT04880278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451458|NCT04880278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451459|NCT04880278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92451460|NCT04880278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92451461|NCT04880278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92451462|NCT04880278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451463|NCT04880278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92451464|NCT04858425|Niclosamide|niclosamide|mesh-list
92451465|NCT04858425|Anticestodal Agents|anticestodal agents|mesh-ancestor
92451466|NCT04858425|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92451467|NCT04858425|Anthelmintics|anthelmintics|mesh-ancestor
92451468|NCT04858425|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92451469|NCT04858425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451470|NCT04858425|Antinematodal Agents|antinematodal agents|mesh-ancestor
92451471|NCT04845035|Cytarabine|cytarabine|mesh-list
92451472|NCT04845035|Methotrexate|methotrexate|mesh-list
92451473|NCT04845035|Dasatinib|dasatinib|mesh-list
92451474|NCT04845035|Ponatinib|ponatinib|mesh-list
92451475|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92451476|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
92451477|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92451478|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451479|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451480|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
92451481|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451482|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451483|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451484|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451485|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92451486|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451487|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
92451488|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451489|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92451490|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
92451491|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451492|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451493|NCT04835506|Infliximab|infliximab|mesh-list
92451494|NCT04835506|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92451495|NCT04835506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451496|NCT04835506|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451497|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92451498|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451499|NCT04824092|Prednisone|prednisone|mesh-list
92451500|NCT04824092|Cyclophosphamide|cyclophosphamide|mesh-list
92451501|NCT04824092|Rituximab|rituximab|mesh-list
92451502|NCT04824092|Doxorubicin|doxorubicin|mesh-list
92451503|NCT04824092|Vincristine|vincristine|mesh-list
92451504|NCT04824092|Lenalidomide|lenalidomide|mesh-list
92451505|NCT04824092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451506|NCT04824092|Immunologic Factors|immunologic factors|mesh-ancestor
92451507|NCT04824092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451508|NCT04824092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451509|NCT04824092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92451510|NCT04824092|Alkylating Agents|alkylating agents|mesh-ancestor
92451511|NCT04824092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451512|NCT04824092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451513|NCT04824092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92451514|NCT04824092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451515|NCT04824092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92451516|NCT04824092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92451517|NCT04824092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92451518|NCT04824092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451519|NCT04824092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451521|NCT04824092|Hormones|hormones|mesh-ancestor
92451522|NCT04824092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451523|NCT04824092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92451524|NCT04824092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92451525|NCT04824092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92451526|NCT04824092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92451527|NCT04824092|Mitosis Modulators|mitosis modulators|mesh-ancestor
92451528|NCT04824092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92451529|NCT04824092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92451530|NCT04824092|Growth Substances|growth substances|mesh-ancestor
92451531|NCT04824092|Growth Inhibitors|growth inhibitors|mesh-ancestor
92451532|NCT04762758|Naltrexone|naltrexone|mesh-list
92451533|NCT04762758|Baclofen|baclofen|mesh-list
92451534|NCT04762758|Sorbitol|sorbitol|mesh-list
92451535|NCT04762758|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92451536|NCT04762758|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92451537|NCT04762758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451538|NCT04762758|Sensory System Agents|sensory system agents|mesh-ancestor
92451539|NCT04762758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451540|NCT04762758|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92451541|NCT04762758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92451542|NCT04762758|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92451543|NCT04762758|GABA Agonists|gaba agonists|mesh-ancestor
92451544|NCT04762758|GABA Agents|gaba agents|mesh-ancestor
92451545|NCT04762758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451546|NCT04762758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451547|NCT04762758|Cathartics|cathartics|mesh-ancestor
92451548|NCT04762758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92451550|NCT04732065|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92451551|NCT04732065|Sympathomimetics|sympathomimetics|mesh-ancestor
92451552|NCT04732065|Autonomic Agents|autonomic agents|mesh-ancestor
92451553|NCT04732065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451554|NCT04732065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451555|NCT04732065|Dopamine Agents|dopamine agents|mesh-ancestor
92451556|NCT04732065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451557|NCT04732065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451558|NCT04732065|Protective Agents|protective agents|mesh-ancestor
92451559|NCT04717908|Linezolid|linezolid|mesh-list
92451560|NCT04717908|Cycloserine|cycloserine|mesh-list
92451561|NCT04717908|Pyrazinamide|pyrazinamide|mesh-list
92451562|NCT04717908|Bedaquiline|bedaquiline|mesh-list
92451563|NCT04717908|Clofazimine|clofazimine|mesh-list
92451564|NCT04717908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92451565|NCT04717908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451566|NCT04717908|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92451567|NCT04717908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451568|NCT04717908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451569|NCT04717908|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92451570|NCT04717908|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92451571|NCT04717908|Antitubercular Agents|antitubercular agents|mesh-ancestor
92451572|NCT04717908|Antimetabolites|antimetabolites|mesh-ancestor
92451573|NCT04717908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451574|NCT04717908|Leprostatic Agents|leprostatic agents|mesh-ancestor
92451575|NCT04665895|Fluticasone|fluticasone|mesh-list
92451576|NCT04665895|Xhance|xhance|mesh-list
92451577|NCT04665895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451578|NCT04665895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92451579|NCT04665895|Autonomic Agents|autonomic agents|mesh-ancestor
92451580|NCT04665895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451581|NCT04665895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451582|NCT04665895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92451583|NCT04665895|Respiratory System Agents|respiratory system agents|mesh-ancestor
92451584|NCT04665895|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451585|NCT04665895|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92451586|NCT04594187|Immunomodulating Agents|immunomodulating agents|mesh-list
92451587|NCT04594187|Immunologic Factors|immunologic factors|mesh-ancestor
92451588|NCT04594187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451589|NCT04559230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92451590|NCT04559230|Immunoconjugates|immunoconjugates|mesh-ancestor
92451591|NCT04559230|Immunologic Factors|immunologic factors|mesh-ancestor
92451592|NCT04559230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451593|NCT04549792|Ustekinumab|ustekinumab|mesh-list
92451594|NCT04549792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92451595|NCT04545554|Vitamin D|vitamin d|mesh-list
92451596|NCT04545554|Calcium|calcium|mesh-list
92451597|NCT04545554|Vitamins|vitamins|mesh-ancestor
92451598|NCT04545554|Micronutrients|micronutrients|mesh-ancestor
92451599|NCT04545554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451600|NCT04545554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92451601|NCT04545554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92451602|NCT04530058|Metformin|metformin|mesh-list
92451603|NCT04530058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92451604|NCT04530058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451605|NCT04510311|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92451606|NCT04510311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451607|NCT04510311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451608|NCT04510311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451610|NCT04500574|Latanoprost|latanoprost|mesh-list
92451611|NCT04500574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92451612|NCT04500574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92451613|NCT04483505|Fulvestrant|fulvestrant|mesh-list
92451614|NCT04483505|Palbociclib|palbociclib|mesh-list
92451615|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92451616|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451617|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92451618|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92451619|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92451620|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451621|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451622|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451623|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451624|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451625|NCT04461535|Hormones|hormones|mesh-list
92451626|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92451627|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92451628|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
92451629|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451630|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451631|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451632|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451633|NCT04445662|Varenicline|varenicline|mesh-list
92451634|NCT04445662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92451635|NCT04445662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92451636|NCT04445662|Cholinergic Agents|cholinergic agents|mesh-ancestor
92451637|NCT04445662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451638|NCT04445662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451639|NCT04445662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451640|NCT04416282|Terlipressin|terlipressin|mesh-list
92451641|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92451642|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92451643|NCT04395469|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92451644|NCT04395469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92451645|NCT04395469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451646|NCT04375150|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92451647|NCT04375150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451648|NCT04375150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451649|NCT04375150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451650|NCT04359784|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92451651|NCT04359784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451652|NCT04323046|Nivolumab|nivolumab|mesh-list
92451653|NCT04323046|Ipilimumab|ipilimumab|mesh-list
92451654|NCT04323046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451655|NCT04323046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451656|NCT04323046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451657|NCT04323046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451658|NCT04170946|Talazoparib|talazoparib|mesh-list
92451659|NCT04170946|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92451660|NCT04170946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451661|NCT04170946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451662|NCT04170946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451663|NCT04152551|Risedronic Acid|risedronic acid|mesh-list
92451664|NCT04152551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92451665|NCT04152551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92451666|NCT04152551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451667|NCT04152551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92451668|NCT04152551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451669|NCT04152551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92451671|NCT04112498|Relatlimab|relatlimab|mesh-list
92451672|NCT04112498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451673|NCT04112498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451674|NCT04112498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451675|NCT04112498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451676|NCT04104893|Pembrolizumab|pembrolizumab|mesh-list
92176573|NCT04778917|Tinzaparin|tinzaparin|mesh-list
92451677|NCT04104893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451678|NCT04104893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451679|NCT04104893|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451680|NCT04104893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451681|NCT04042051|Trastuzumab|trastuzumab|mesh-list
92451682|NCT04042051|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92451683|NCT04042051|Maytansine|maytansine|mesh-list
92451684|NCT04042051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451685|NCT04042051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451686|NCT04042051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92451687|NCT04042051|Tubulin Modulators|tubulin modulators|mesh-ancestor
92451688|NCT04042051|Antimitotic Agents|antimitotic agents|mesh-ancestor
92451689|NCT04042051|Mitosis Modulators|mitosis modulators|mesh-ancestor
92451690|NCT04042051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451691|NCT04042051|Immunotoxins|immunotoxins|mesh-ancestor
92451692|NCT04042051|Immunoconjugates|immunoconjugates|mesh-ancestor
92451693|NCT04042051|Immunologic Factors|immunologic factors|mesh-ancestor
92451694|NCT04042051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451695|NCT04033991|Sunitinib|sunitinib|mesh-list
92451696|NCT04033991|Axitinib|axitinib|mesh-list
92451697|NCT04033991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451698|NCT04033991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92451699|NCT04033991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92451700|NCT04033991|Growth Substances|growth substances|mesh-ancestor
92451701|NCT04033991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451702|NCT04033991|Growth Inhibitors|growth inhibitors|mesh-ancestor
92451703|NCT04033991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92451704|NCT04033991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451705|NCT04033991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451706|NCT03961360|Aspirin|aspirin|mesh-list
92451707|NCT03961360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92451708|NCT03961360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451709|NCT03961360|Analgesics|analgesics|mesh-ancestor
92451710|NCT03961360|Sensory System Agents|sensory system agents|mesh-ancestor
92451711|NCT03961360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451712|NCT03961360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451713|NCT03961360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451714|NCT03961360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451715|NCT03961360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92451716|NCT03961360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92451717|NCT03961360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451718|NCT03961360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92451719|NCT03961360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92451720|NCT03961360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451721|NCT03961360|Antipyretics|antipyretics|mesh-ancestor
92451722|NCT03924401|Abatacept|abatacept|mesh-list
92451723|NCT03924401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451724|NCT03924401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451725|NCT03924401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451726|NCT03924401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451727|NCT03924401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451728|NCT03924401|Immunologic Factors|immunologic factors|mesh-ancestor
92451729|NCT03924401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451730|NCT03924401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451731|NCT03769285|Niacinamide|niacinamide|mesh-list
92451732|NCT03769285|Niacin|niacin|mesh-list
92451733|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
92451734|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
92451735|NCT03769285|Vitamins|vitamins|mesh-ancestor
92451736|NCT03769285|Micronutrients|micronutrients|mesh-ancestor
92451737|NCT03769285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451738|NCT03769285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92451739|NCT03769285|Antimetabolites|antimetabolites|mesh-ancestor
92451740|NCT03769285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451741|NCT03769285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92451742|NCT03769285|Vasodilator Agents|vasodilator agents|mesh-ancestor
92451743|NCT03749187|Temozolomide|temozolomide|mesh-list
92451744|NCT03749187|Pamiparib|pamiparib|mesh-list
92451745|NCT03749187|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92451746|NCT03749187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92451747|NCT03749187|Alkylating Agents|alkylating agents|mesh-ancestor
92451748|NCT03749187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451749|NCT03749187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451750|NCT03749187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451751|NCT03738553|Trastuzumab|trastuzumab|mesh-list
92451752|NCT03738553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451753|NCT03738553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451754|NCT03710902|Antihypertensive Agents|antihypertensive agents|mesh-list
92451755|NCT03705806|Immunomodulating Agents|immunomodulating agents|mesh-list
92451756|NCT03705806|Immunologic Factors|immunologic factors|mesh-ancestor
92451757|NCT03705806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451758|NCT03642132|Bevacizumab|bevacizumab|mesh-list
92451759|NCT03642132|Avelumab|avelumab|mesh-list
92451760|NCT03642132|Talazoparib|talazoparib|mesh-list
92451761|NCT03642132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451762|NCT03642132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451763|NCT03642132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92451764|NCT03642132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92451765|NCT03642132|Growth Substances|growth substances|mesh-ancestor
92451766|NCT03642132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451767|NCT03642132|Growth Inhibitors|growth inhibitors|mesh-ancestor
92451768|NCT03642132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92451769|NCT03642132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451770|NCT03642132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451771|NCT03632330|Midazolam|midazolam|mesh-list
92451772|NCT03632330|Dexmedetomidine|dexmedetomidine|mesh-list
92451773|NCT03632330|Propofol|propofol|mesh-list
92451774|NCT03632330|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92451775|NCT03632330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451776|NCT03632330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451777|NCT03632330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347268|NCT01733316|Cysteamine|cysteamine|mesh-list
92451778|NCT03632330|Analgesics|analgesics|mesh-ancestor
92451779|NCT03632330|Sensory System Agents|sensory system agents|mesh-ancestor
92451780|NCT03632330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451781|NCT03632330|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92451782|NCT03632330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92451783|NCT03632330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92451784|NCT03632330|Adrenergic Agents|adrenergic agents|mesh-ancestor
92451785|NCT03632330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451786|NCT03632330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451787|NCT03632330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92451788|NCT03632330|Anesthetics, General|anesthetics, general|mesh-ancestor
92451789|NCT03632330|Anesthetics|anesthetics|mesh-ancestor
92451790|NCT03632330|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92451791|NCT03632330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92451792|NCT03632330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92451793|NCT03632330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92451794|NCT03632330|GABA Modulators|gaba modulators|mesh-ancestor
92451795|NCT03632330|GABA Agents|gaba agents|mesh-ancestor
92451796|NCT03575949|Deoxyglucose|deoxyglucose|mesh-list
92451797|NCT03575949|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92451798|NCT03575949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92451799|NCT03575949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451800|NCT03575949|Antimetabolites|antimetabolites|mesh-ancestor
92451801|NCT03575949|Antiviral Agents|antiviral agents|mesh-ancestor
92451802|NCT03575949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451803|NCT03572764|Cytarabine|cytarabine|mesh-list
92451804|NCT03572764|Daunorubicin|daunorubicin|mesh-list
92451805|NCT03572764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451806|NCT03572764|Antimetabolites|antimetabolites|mesh-ancestor
92451807|NCT03572764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451808|NCT03572764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451809|NCT03572764|Antiviral Agents|antiviral agents|mesh-ancestor
92451810|NCT03572764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451811|NCT03572764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451812|NCT03572764|Immunologic Factors|immunologic factors|mesh-ancestor
92451813|NCT03572764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451814|NCT03572764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92451815|NCT03572764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92451816|NCT03572764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92451817|NCT03572764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451818|NCT03560752|Vaccines|vaccines|mesh-list
92451819|NCT03560752|Immunologic Factors|immunologic factors|mesh-ancestor
92451820|NCT03560752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451821|NCT03506061|Ivacaftor|ivacaftor|mesh-list
92451822|NCT03506061|Elexacaftor|elexacaftor|mesh-list
92451823|NCT03506061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92451824|NCT03506061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92451825|NCT03506061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451826|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
92451827|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92451828|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92451829|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451831|NCT03475342|Coagulants|coagulants|mesh-ancestor
92451832|NCT03466151|Sirolimus|sirolimus|mesh-list
92451833|NCT03466151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92451834|NCT03466151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451835|NCT03466151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92451836|NCT03466151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451837|NCT03466151|Antifungal Agents|antifungal agents|mesh-ancestor
92451838|NCT03466151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451839|NCT03466151|Immunologic Factors|immunologic factors|mesh-ancestor
92451840|NCT03466151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451841|NCT03452930|Benzimidazole|benzimidazole|mesh-list
92451842|NCT03452930|Anthelmintics|anthelmintics|mesh-ancestor
92451843|NCT03452930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92451844|NCT03452930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451845|NCT03418818|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92451846|NCT03418818|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92451847|NCT03418818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451848|NCT03253289|Meclizine|meclizine|mesh-list
92451849|NCT03253289|Antiemetics|antiemetics|mesh-ancestor
92451850|NCT03253289|Autonomic Agents|autonomic agents|mesh-ancestor
92451851|NCT03253289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451852|NCT03253289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451853|NCT03253289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92451854|NCT03253289|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92451855|NCT03253289|Histamine Antagonists|histamine antagonists|mesh-ancestor
92451856|NCT03253289|Histamine Agents|histamine agents|mesh-ancestor
92451857|NCT03253289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451858|NCT03253289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451859|NCT03253289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92451860|NCT03253289|Cholinergic Agents|cholinergic agents|mesh-ancestor
92451861|NCT03253289|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92451862|NCT03227705|Progesterone|progesterone|mesh-list
92451863|NCT03227705|Progestins|progestins|mesh-ancestor
92451864|NCT03227705|Hormones|hormones|mesh-ancestor
92451865|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451866|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451867|NCT03219268|Margetuximab|margetuximab|mesh-list
92451868|NCT03219268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451869|NCT03176953|Topiramate|topiramate|mesh-list
92451870|NCT03176953|Anticonvulsants|anticonvulsants|mesh-ancestor
92451871|NCT03176953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92451872|NCT03176953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451873|NCT03150004|Cytarabine|cytarabine|mesh-list
92451874|NCT03150004|Mitoxantrone|mitoxantrone|mesh-list
92451875|NCT03150004|Cladribine|cladribine|mesh-list
92451876|NCT03150004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451877|NCT03150004|Antimetabolites|antimetabolites|mesh-ancestor
92451878|NCT03150004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451879|NCT03150004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451880|NCT03150004|Antiviral Agents|antiviral agents|mesh-ancestor
92451881|NCT03150004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451882|NCT03150004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451883|NCT03150004|Immunologic Factors|immunologic factors|mesh-ancestor
92451884|NCT03150004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451885|NCT03150004|Analgesics|analgesics|mesh-ancestor
92451886|NCT03150004|Sensory System Agents|sensory system agents|mesh-ancestor
92451887|NCT03150004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451888|NCT03150004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92451889|NCT03150004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92451890|NCT03150004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451891|NCT03149822|Pembrolizumab|pembrolizumab|mesh-list
92451892|NCT03149822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451893|NCT03149822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451894|NCT03149822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451895|NCT03149822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451896|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
92451897|NCT03082534|Cetuximab|cetuximab|mesh-list
92451898|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451899|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451900|NCT03082534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451901|NCT03082534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451902|NCT03056339|Cyclophosphamide|cyclophosphamide|mesh-list
92451903|NCT03056339|Fludarabine|fludarabine|mesh-list
92451904|NCT03056339|Fludarabine phosphate|fludarabine phosphate|mesh-list
92451905|NCT03056339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92451906|NCT03056339|Immunologic Factors|immunologic factors|mesh-ancestor
92451907|NCT03056339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451908|NCT03056339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92451909|NCT03056339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92451910|NCT03056339|Alkylating Agents|alkylating agents|mesh-ancestor
92451911|NCT03056339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451912|NCT03056339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451913|NCT03056339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92451914|NCT03056339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451915|NCT03056339|Antimetabolites|antimetabolites|mesh-ancestor
92451917|NCT02960230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451918|NCT02960230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451919|NCT02960230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451920|NCT02960230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451921|NCT02816021|Pembrolizumab|pembrolizumab|mesh-list
92451922|NCT02816021|Azacitidine|azacitidine|mesh-list
92451923|NCT02816021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451924|NCT02816021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451925|NCT02816021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451926|NCT02816021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451927|NCT02816021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92451928|NCT02816021|Antimetabolites|antimetabolites|mesh-ancestor
92451929|NCT02816021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451930|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
92451931|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451932|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451933|NCT02777385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451934|NCT02777385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451935|NCT02701699|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92451936|NCT02701699|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92451937|NCT02701699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451938|NCT02682511|Ifetroban|ifetroban|mesh-list
92451939|NCT02682511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92451940|NCT02351869|Midazolam|midazolam|mesh-list
92451941|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
92451942|NCT02351869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92451943|NCT02351869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92451944|NCT02351869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92451945|NCT02351869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451946|NCT02351869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92451947|NCT02351869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92451948|NCT02351869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92451949|NCT02351869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92451950|NCT02351869|Anesthetics, General|anesthetics, general|mesh-ancestor
92451951|NCT02351869|Anesthetics|anesthetics|mesh-ancestor
92451952|NCT02351869|GABA Modulators|gaba modulators|mesh-ancestor
92451953|NCT02351869|GABA Agents|gaba agents|mesh-ancestor
92451954|NCT02351869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92451955|NCT02351869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451956|NCT02351869|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92451957|NCT02351869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92451958|NCT02351869|Analgesics|analgesics|mesh-ancestor
92451959|NCT02351869|Sensory System Agents|sensory system agents|mesh-ancestor
92451960|NCT02351869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451961|NCT02311582|Pembrolizumab|pembrolizumab|mesh-list
92451962|NCT02311582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92451963|NCT02311582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451964|NCT02311582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92451965|NCT02311582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451966|NCT02237820|Dexamethasone|dexamethasone|mesh-list
92451967|NCT02237820|Prednisone|prednisone|mesh-list
92451968|NCT02237820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451969|NCT02237820|Antiemetics|antiemetics|mesh-ancestor
92451970|NCT02237820|Autonomic Agents|autonomic agents|mesh-ancestor
92451971|NCT02237820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92451972|NCT02237820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451973|NCT02237820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92451974|NCT02237820|Glucocorticoids|glucocorticoids|mesh-ancestor
92451975|NCT02237820|Hormones|hormones|mesh-ancestor
92451976|NCT02237820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176875|NCT01488279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92451977|NCT02237820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92451978|NCT02237820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451979|NCT02160353|Prednisolone|prednisolone|mesh-list
92451980|NCT02160353|Abiraterone Acetate|abiraterone acetate|mesh-list
92451981|NCT02160353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92451982|NCT02160353|Glucocorticoids|glucocorticoids|mesh-ancestor
92451983|NCT02160353|Hormones|hormones|mesh-ancestor
92451984|NCT02160353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92451985|NCT02160353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92451986|NCT02160353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92451987|NCT02160353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92451988|NCT02160353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92451989|NCT02160353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92451990|NCT02160353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92451991|NCT02160353|Hormone Antagonists|hormone antagonists|mesh-ancestor
92451992|NCT02160353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92451993|NCT02152358|Acyclovir|acyclovir|mesh-list
92451994|NCT02152358|Ganciclovir|ganciclovir|mesh-list
92451995|NCT02152358|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92451996|NCT02152358|Antiviral Agents|antiviral agents|mesh-ancestor
92451997|NCT02152358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92451998|NCT02152358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92451999|NCT02152358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452000|NCT02152358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452001|NCT01892371|Cytarabine|cytarabine|mesh-list
92452002|NCT01892371|Azacitidine|azacitidine|mesh-list
92452003|NCT01892371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452004|NCT01892371|Antimetabolites|antimetabolites|mesh-ancestor
92452005|NCT01892371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452006|NCT01892371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452007|NCT01892371|Antiviral Agents|antiviral agents|mesh-ancestor
92452008|NCT01892371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452009|NCT01892371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452010|NCT01892371|Immunologic Factors|immunologic factors|mesh-ancestor
92452011|NCT01892371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452012|NCT01892371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452013|NCT01819064|Atropine|atropine|mesh-list
92452014|NCT01819064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92452015|NCT01819064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92452016|NCT01819064|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92452017|NCT01819064|Autonomic Agents|autonomic agents|mesh-ancestor
92452018|NCT01819064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452019|NCT01819064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452020|NCT01819064|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92452021|NCT01819064|Respiratory System Agents|respiratory system agents|mesh-ancestor
92452022|NCT01819064|Mydriatics|mydriatics|mesh-ancestor
92452023|NCT01819064|Parasympatholytics|parasympatholytics|mesh-ancestor
92452024|NCT01819064|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92452025|NCT01819064|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92452026|NCT01819064|Cholinergic Agents|cholinergic agents|mesh-ancestor
92452027|NCT01819064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452028|NCT01819064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452029|NCT01817751|Sorafenib|sorafenib|mesh-list
92452030|NCT01817751|Sildenafil Citrate|sildenafil citrate|mesh-list
92452031|NCT01817751|Valproic Acid|valproic acid|mesh-list
92531392|NCT00001724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452032|NCT01817751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452033|NCT01817751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452034|NCT01817751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452035|NCT01817751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452036|NCT01817751|Vasodilator Agents|vasodilator agents|mesh-ancestor
92452037|NCT01817751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92452038|NCT01817751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92452039|NCT01817751|Urological Agents|urological agents|mesh-ancestor
92452040|NCT01817751|Anticonvulsants|anticonvulsants|mesh-ancestor
92452041|NCT01817751|GABA Agents|gaba agents|mesh-ancestor
92452042|NCT01817751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452043|NCT01817751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452044|NCT01817751|Antimanic Agents|antimanic agents|mesh-ancestor
92452045|NCT01817751|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92452046|NCT01817751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452047|NCT01817751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92452048|NCT02744053|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92452049|NCT02744053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92452050|NCT02744053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452051|NCT01748149|Vemurafenib|vemurafenib|mesh-list
92452052|NCT01748149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452053|NCT01748149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452054|NCT01748149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452055|NCT01748149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452056|NCT01549730|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92452057|NCT01549730|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92452058|NCT01549730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452059|NCT00812669|Cyclophosphamide|cyclophosphamide|mesh-list
92452060|NCT00812669|Rituximab|rituximab|mesh-list
92452061|NCT00812669|Fludarabine|fludarabine|mesh-list
92452062|NCT00812669|Fludarabine phosphate|fludarabine phosphate|mesh-list
92452063|NCT00812669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452064|NCT00812669|Immunologic Factors|immunologic factors|mesh-ancestor
92452065|NCT00812669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452066|NCT00812669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92452067|NCT00812669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92452068|NCT00812669|Alkylating Agents|alkylating agents|mesh-ancestor
92452069|NCT00812669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452070|NCT00812669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452071|NCT00812669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92452072|NCT00812669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452073|NCT00812669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452074|NCT00812669|Antimetabolites|antimetabolites|mesh-ancestor
92452075|NCT00188539|Anesthetics|anesthetics|mesh-list
92452076|NCT00188539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452077|NCT00188539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452078|NCT03893448|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92452079|NCT03893448|Immunologic Factors|immunologic factors|mesh-ancestor
92452080|NCT03893448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452081|NCT03889314|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92452082|NCT03889314|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92452083|NCT03889314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92452084|NCT03889314|Antimetabolites|antimetabolites|mesh-ancestor
92452085|NCT03889314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452086|NCT03889314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92452087|NCT03889314|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92452088|NCT03889314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452089|NCT03870880|Risperidone|risperidone|mesh-list
92452090|NCT03870880|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92452091|NCT03870880|Serotonin Agents|serotonin agents|mesh-ancestor
92452092|NCT03870880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452093|NCT03870880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452094|NCT03870880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452095|NCT03870880|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92452096|NCT03870880|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92452097|NCT03870880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452098|NCT03870880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92452099|NCT03870880|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92452100|NCT03870880|Dopamine Agents|dopamine agents|mesh-ancestor
92452101|NCT03861377|Remifentanil|remifentanil|mesh-list
92452102|NCT03861377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92452103|NCT03861377|Narcotics|narcotics|mesh-ancestor
92452104|NCT03861377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452105|NCT03861377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452106|NCT03861377|Analgesics|analgesics|mesh-ancestor
92452107|NCT03861377|Sensory System Agents|sensory system agents|mesh-ancestor
92452108|NCT03861377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452109|NCT03844100|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92452110|NCT03844100|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92452111|NCT03844100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452112|NCT03836144|Potassium Citrate|potassium citrate|mesh-list
92452113|NCT03836144|Diuretics|diuretics|mesh-ancestor
92452114|NCT03836144|Natriuretic Agents|natriuretic agents|mesh-ancestor
92452115|NCT03836144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452116|NCT03836144|Expectorants|expectorants|mesh-ancestor
92452117|NCT03836144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92452118|NCT03796416|Misoprostol|misoprostol|mesh-list
92452119|NCT03796416|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92452120|NCT03796416|Abortifacient Agents|abortifacient agents|mesh-ancestor
92452121|NCT03796416|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92452122|NCT03796416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452123|NCT03796416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92452124|NCT03796416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177024|NCT02415413|Hormones|hormones|mesh-ancestor
92452125|NCT03796416|Oxytocics|oxytocics|mesh-ancestor
92452127|NCT03785106|Pyridoxine|pyridoxine|mesh-list
92452128|NCT03785106|Pyridoxal|pyridoxal|mesh-list
92452129|NCT03785106|Vitamin B 6|vitamin b 6|mesh-list
92452130|NCT03785106|Vitamin B Complex|vitamin b complex|mesh-list
92452131|NCT03785106|Isoniazid|isoniazid|mesh-list
92452132|NCT03785106|Rifapentine|rifapentine|mesh-list
92452133|NCT03785106|Rifampin|rifampin|mesh-list
92452134|NCT03785106|Micronutrients|micronutrients|mesh-ancestor
92452135|NCT03785106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452136|NCT03785106|Antitubercular Agents|antitubercular agents|mesh-ancestor
92452137|NCT03785106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92452138|NCT03785106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452139|NCT03785106|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92452140|NCT03785106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92452141|NCT03785106|Antimetabolites|antimetabolites|mesh-ancestor
92452142|NCT03785106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452143|NCT03785106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92452144|NCT03785106|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92452145|NCT03785106|Leprostatic Agents|leprostatic agents|mesh-ancestor
92452146|NCT03785106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452147|NCT03785106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452148|NCT03785106|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92452149|NCT03785106|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92452150|NCT03785106|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92452151|NCT03785106|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92452152|NCT03785106|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92452153|NCT03785106|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92452154|NCT03782142|Tenofovir|tenofovir|mesh-list
92452155|NCT03782142|Dolutegravir|dolutegravir|mesh-list
92452156|NCT03782142|Rilpivirine|rilpivirine|mesh-list
92452157|NCT03782142|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92452158|NCT03782142|Antiviral Agents|antiviral agents|mesh-ancestor
92452159|NCT03782142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452160|NCT03782142|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92452161|NCT03782142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452162|NCT03782142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452163|NCT03782142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452164|NCT03782142|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92452165|NCT03782142|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92452166|NCT03782142|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92452167|NCT03782142|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92452168|NCT03782142|Protease Inhibitors|protease inhibitors|mesh-ancestor
92452169|NCT03782142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92452170|NCT03782142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92452171|NCT03770299|Paclitaxel|paclitaxel|mesh-list
92452172|NCT03770299|Vinorelbine|vinorelbine|mesh-list
92452173|NCT03770299|Docetaxel|docetaxel|mesh-list
92452174|NCT03770299|Carboplatin|carboplatin|mesh-list
92452175|NCT03770299|Gemcitabine|gemcitabine|mesh-list
92452176|NCT03770299|Nivolumab|nivolumab|mesh-list
92452177|NCT03770299|Pemetrexed|pemetrexed|mesh-list
92452178|NCT03770299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92452180|NCT03770299|Tubulin Modulators|tubulin modulators|mesh-ancestor
92452181|NCT03770299|Antimitotic Agents|antimitotic agents|mesh-ancestor
92452182|NCT03770299|Mitosis Modulators|mitosis modulators|mesh-ancestor
92452183|NCT03770299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452184|NCT03770299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452185|NCT03770299|Antimetabolites|antimetabolites|mesh-ancestor
92452186|NCT03770299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452187|NCT03770299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92452188|NCT03770299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452189|NCT03770299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92452190|NCT03770299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452191|NCT03760835|Dexamethasone|dexamethasone|mesh-list
92452192|NCT03760835|Prednisone|prednisone|mesh-list
92452193|NCT03760835|Prednisolone|prednisolone|mesh-list
92452194|NCT03760835|Hydrocortisone|hydrocortisone|mesh-list
92452195|NCT03760835|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92452196|NCT03760835|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92452197|NCT03760835|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92452198|NCT03760835|Cortisone|cortisone|mesh-list
92452199|NCT03760835|Glucocorticoids|glucocorticoids|mesh-list
92452200|NCT03760835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452201|NCT03760835|Antiemetics|antiemetics|mesh-ancestor
92452202|NCT03760835|Autonomic Agents|autonomic agents|mesh-ancestor
92452203|NCT03760835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452204|NCT03760835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452205|NCT03760835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452207|NCT03760835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452208|NCT03760835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92452209|NCT03760835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452210|NCT03759496|Durvalumab|durvalumab|mesh-list
92452211|NCT03759496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452212|NCT03759496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452214|NCT03759184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452215|NCT03759184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452216|NCT03748784|Aflibercept|aflibercept|mesh-list
92452217|NCT03748784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92452218|NCT03748784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92452219|NCT03748784|Growth Substances|growth substances|mesh-ancestor
92452220|NCT03748784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452221|NCT03748784|Growth Inhibitors|growth inhibitors|mesh-ancestor
92452222|NCT03748784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452223|NCT03727750|Gemtuzumab|gemtuzumab|mesh-list
92452224|NCT03727750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452225|NCT03727750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452226|NCT03727750|Immunotoxins|immunotoxins|mesh-ancestor
92452227|NCT03727750|Immunoconjugates|immunoconjugates|mesh-ancestor
92452228|NCT03727750|Immunologic Factors|immunologic factors|mesh-ancestor
92452229|NCT03727750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452230|NCT03724409|Octreotide|octreotide|mesh-list
92452231|NCT03724409|Edotreotide|edotreotide|mesh-list
92452232|NCT03724409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452233|NCT03724409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92452234|NCT03724409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452235|NCT03724409|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92452236|NCT03724409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452237|NCT03715829|PF-06700841|pf-06700841|mesh-list
92452238|NCT03715829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452239|NCT03715829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452240|NCT03715829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452241|NCT03712254|Fosphenytoin|fosphenytoin|mesh-list
92452242|NCT03712254|Anticonvulsants|anticonvulsants|mesh-ancestor
92452243|NCT03712254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92452244|NCT03712254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92452245|NCT03712254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452246|NCT03704441|Bupivacaine|bupivacaine|mesh-list
92452247|NCT03704441|Anesthetics, Local|anesthetics, local|mesh-ancestor
92452248|NCT03704441|Anesthetics|anesthetics|mesh-ancestor
92452249|NCT03704441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452250|NCT03704441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452251|NCT03704441|Sensory System Agents|sensory system agents|mesh-ancestor
92452252|NCT03704441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452253|NCT03693677|Paclitaxel|paclitaxel|mesh-list
92452254|NCT03693677|Gemcitabine|gemcitabine|mesh-list
92452255|NCT03693677|Irinotecan|irinotecan|mesh-list
92452256|NCT03693677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92452257|NCT03693677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452258|NCT03693677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92452259|NCT03693677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92452260|NCT03693677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92452261|NCT03693677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452262|NCT03693677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452263|NCT03693677|Antimetabolites|antimetabolites|mesh-ancestor
92452264|NCT03693677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92452265|NCT03693677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92452266|NCT03693677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452267|NCT03673826|Dexamethasone|dexamethasone|mesh-list
92452268|NCT03673826|Lenalidomide|lenalidomide|mesh-list
92452269|NCT03673826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452270|NCT03673826|Antiemetics|antiemetics|mesh-ancestor
92452271|NCT03673826|Autonomic Agents|autonomic agents|mesh-ancestor
92452272|NCT03673826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452273|NCT03673826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452274|NCT03673826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452275|NCT03673826|Glucocorticoids|glucocorticoids|mesh-ancestor
92452276|NCT03673826|Hormones|hormones|mesh-ancestor
92452277|NCT03673826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452278|NCT03673826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92452279|NCT03673826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452280|NCT03673826|Immunologic Factors|immunologic factors|mesh-ancestor
92452281|NCT03673826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92452282|NCT03673826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92452283|NCT03673826|Growth Substances|growth substances|mesh-ancestor
92452284|NCT03673826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92452285|NCT03660839|Artefenomel|artefenomel|mesh-list
92452286|NCT03660839|Ferroquine|ferroquine|mesh-list
92452287|NCT03660839|Antimalarials|antimalarials|mesh-ancestor
92452288|NCT03660839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92452289|NCT03660839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92452290|NCT03660839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452291|NCT03660241|Abrocitinib|abrocitinib|mesh-list
92452292|NCT03660241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452293|NCT03660241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452294|NCT03660241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452295|NCT03651102|Thalidomide|thalidomide|mesh-list
92452296|NCT03651102|Hydroxyurea|hydroxyurea|mesh-list
92452297|NCT03651102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452298|NCT03651102|Immunologic Factors|immunologic factors|mesh-ancestor
92452299|NCT03651102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452300|NCT03651102|Leprostatic Agents|leprostatic agents|mesh-ancestor
92452301|NCT03651102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92452302|NCT03651102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452303|NCT03651102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92452304|NCT03651102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92452305|NCT03651102|Growth Substances|growth substances|mesh-ancestor
92452306|NCT03651102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92452307|NCT03651102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452308|NCT03651102|Antisickling Agents|antisickling agents|mesh-ancestor
92452309|NCT03651102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452310|NCT03651102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452311|NCT03651102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452312|NCT03649802|Vitamin D|vitamin d|mesh-list
92452313|NCT03649802|Ergocalciferols|ergocalciferols|mesh-list
92452314|NCT03649802|Cholecalciferol|cholecalciferol|mesh-list
92452315|NCT03649802|Vitamins|vitamins|mesh-list
92452316|NCT03649802|Micronutrients|micronutrients|mesh-ancestor
92452317|NCT03649802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452318|NCT03649802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92452319|NCT03649802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92452320|NCT03643198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92452321|NCT03643198|Metronidazole|metronidazole|mesh-list
92452322|NCT03643198|Ciprofloxacin|ciprofloxacin|mesh-list
92452323|NCT03643198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452324|NCT03643198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92452325|NCT03643198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92452326|NCT03643198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92452327|NCT03643198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92452328|NCT03643198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452329|NCT03643198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452330|NCT03643198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452331|NCT03643198|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92452332|NCT03643198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92452333|NCT03606980|Dexamethasone|dexamethasone|mesh-list
92452334|NCT03606980|Dexamethasone acetate|dexamethasone acetate|mesh-list
92452335|NCT03606980|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92452336|NCT03606980|BB 1101|bb 1101|mesh-list
92452337|NCT03606980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452338|NCT03606980|Antiemetics|antiemetics|mesh-ancestor
92452339|NCT03606980|Autonomic Agents|autonomic agents|mesh-ancestor
92452340|NCT03606980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452341|NCT03606980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452342|NCT03606980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452343|NCT03606980|Glucocorticoids|glucocorticoids|mesh-ancestor
92452344|NCT03606980|Hormones|hormones|mesh-ancestor
92452345|NCT03606980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452346|NCT03606980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92452347|NCT03606980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452348|NCT03606980|Protease Inhibitors|protease inhibitors|mesh-ancestor
92452349|NCT03606980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452350|NCT03606980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452351|NCT03576417|Nivolumab|nivolumab|mesh-list
92452352|NCT03576417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452353|NCT03576417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452354|NCT03576417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92452355|NCT03576417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452357|NCT03573115|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92452358|NCT03573115|Dermatologic Agents|dermatologic agents|mesh-ancestor
92452359|NCT03573115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92452360|NCT03573115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92452361|NCT03573115|Analgesics|analgesics|mesh-ancestor
92452362|NCT03573115|Sensory System Agents|sensory system agents|mesh-ancestor
92452363|NCT03573115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452364|NCT03573115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452365|NCT03573115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452366|NCT03573115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92452368|NCT03569475|Fluoxetine|fluoxetine|mesh-list
92452369|NCT03569475|Levomilnacipran|levomilnacipran|mesh-list
92452370|NCT03569475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92452371|NCT03569475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92452372|NCT03569475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92452373|NCT03569475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452374|NCT03569475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452375|NCT03569475|Serotonin Agents|serotonin agents|mesh-ancestor
92452376|NCT03569475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452377|NCT03569475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92452378|NCT03569475|Antidepressive Agents|antidepressive agents|mesh-ancestor
92452379|NCT03569475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92452380|NCT03569475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92452381|NCT03569475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92452382|NCT03569475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452383|NCT03569475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92452384|NCT03569475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92452385|NCT03569475|Analgesics|analgesics|mesh-ancestor
92452386|NCT03569475|Sensory System Agents|sensory system agents|mesh-ancestor
92452387|NCT03569475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452388|NCT03546556|Alovudine|alovudine|mesh-list
92452389|NCT03546556|Dideoxynucleosides|dideoxynucleosides|mesh-list
92452390|NCT03546556|Antiviral Agents|antiviral agents|mesh-ancestor
92452391|NCT03546556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452392|NCT03546556|Antimetabolites|antimetabolites|mesh-ancestor
92452393|NCT03546556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452394|NCT03546556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92452395|NCT03546556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452396|NCT03546556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452397|NCT03533712|Folic Acid|folic acid|mesh-list
92452398|NCT03533712|Hematinics|hematinics|mesh-ancestor
92452399|NCT03533712|Vitamin B Complex|vitamin b complex|mesh-ancestor
92452400|NCT03533712|Vitamins|vitamins|mesh-ancestor
92452401|NCT03533712|Micronutrients|micronutrients|mesh-ancestor
92452402|NCT03533712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452403|NCT03523520|Naltrexone|naltrexone|mesh-list
92452404|NCT03523520|Bromides|bromides|mesh-list
92452405|NCT03523520|Methylnaltrexone|methylnaltrexone|mesh-list
92452406|NCT03523520|Naloxegol|naloxegol|mesh-list
92452407|NCT03523520|Anticonvulsants|anticonvulsants|mesh-ancestor
92452408|NCT03523520|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92452409|NCT03523520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452410|NCT03523520|Sensory System Agents|sensory system agents|mesh-ancestor
92452411|NCT03523520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452412|NCT03523520|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92452413|NCT03518242|Cyclophosphamide|cyclophosphamide|mesh-list
92452414|NCT03518242|Capecitabine|capecitabine|mesh-list
92452415|NCT03518242|Methotrexate|methotrexate|mesh-list
92452416|NCT03518242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452417|NCT03518242|Immunologic Factors|immunologic factors|mesh-ancestor
92452418|NCT03518242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452419|NCT03518242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92452420|NCT03518242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92452421|NCT03518242|Alkylating Agents|alkylating agents|mesh-ancestor
92452422|NCT03518242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452423|NCT03518242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452424|NCT03518242|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92452425|NCT03518242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452426|NCT03518242|Antimetabolites|antimetabolites|mesh-ancestor
92452427|NCT03518242|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92452428|NCT03518242|Abortifacient Agents|abortifacient agents|mesh-ancestor
92452429|NCT03518242|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92452430|NCT03518242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92452431|NCT03518242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452432|NCT03518242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92452433|NCT03518242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452435|NCT03500549|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92452436|NCT03500549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452437|NCT03500549|Immunologic Factors|immunologic factors|mesh-ancestor
92452438|NCT03500549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452439|NCT03435185|Lidocaine|lidocaine|mesh-list
92452440|NCT03435185|Anesthetics, Local|anesthetics, local|mesh-ancestor
92452441|NCT03435185|Anesthetics|anesthetics|mesh-ancestor
92452442|NCT03435185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452443|NCT03435185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452444|NCT03435185|Sensory System Agents|sensory system agents|mesh-ancestor
92452445|NCT03435185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452446|NCT03435185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92452447|NCT03435185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92452448|NCT03435185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92452449|NCT03435185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92452450|NCT03435185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452451|NCT03426293|Heparin|heparin|mesh-list
92452452|NCT03426293|Anticoagulants|anticoagulants|mesh-ancestor
92452453|NCT03426293|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92452454|NCT03426293|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92452455|NCT03426293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452456|NCT03383380|Sirolimus|sirolimus|mesh-list
92452457|NCT03383380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92452458|NCT03383380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452459|NCT03383380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92452460|NCT03383380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452461|NCT03383380|Antifungal Agents|antifungal agents|mesh-ancestor
92452462|NCT03383380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452463|NCT03383380|Immunologic Factors|immunologic factors|mesh-ancestor
92452464|NCT03383380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452465|NCT03325439|Brivaracetam|brivaracetam|mesh-list
92452466|NCT03325439|Anticonvulsants|anticonvulsants|mesh-ancestor
92452467|NCT03242772|Amphetamine|amphetamine|mesh-list
92452468|NCT03242772|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92452469|NCT03242772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452470|NCT03242772|Sympathomimetics|sympathomimetics|mesh-ancestor
92452471|NCT03242772|Autonomic Agents|autonomic agents|mesh-ancestor
92452472|NCT03242772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452473|NCT03242772|Dopamine Agents|dopamine agents|mesh-ancestor
92452474|NCT03242772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452475|NCT03242772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452476|NCT03242772|Adrenergic Agents|adrenergic agents|mesh-ancestor
92452477|NCT03242772|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92452478|NCT03242772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92452479|NCT03242772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92452481|NCT03236311|Adenosine|adenosine|mesh-list
92452482|NCT03236311|Regadenoson|regadenoson|mesh-list
92452483|NCT03236311|Analgesics|analgesics|mesh-ancestor
92452484|NCT03236311|Sensory System Agents|sensory system agents|mesh-ancestor
92452485|NCT03236311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452486|NCT03236311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452487|NCT03236311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92452488|NCT03236311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92452489|NCT03236311|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92452490|NCT03236311|Purinergic Agonists|purinergic agonists|mesh-ancestor
92452491|NCT03236311|Purinergic Agents|purinergic agents|mesh-ancestor
92452492|NCT03236311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452493|NCT03236311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452494|NCT03236311|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92452495|NCT03234686|Deferiprone|deferiprone|mesh-list
92452496|NCT03234686|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92452497|NCT03234686|Chelating Agents|chelating agents|mesh-ancestor
92452498|NCT03234686|Sequestering Agents|sequestering agents|mesh-ancestor
92452499|NCT03234686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452500|NCT03223974|Paclitaxel|paclitaxel|mesh-list
92452501|NCT03223974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92177420|NCT02099591|Naloxegol|naloxegol|mesh-list
92452502|NCT03223974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452503|NCT03223974|Tubulin Modulators|tubulin modulators|mesh-ancestor
92452504|NCT03223974|Antimitotic Agents|antimitotic agents|mesh-ancestor
92452505|NCT03223974|Mitosis Modulators|mitosis modulators|mesh-ancestor
92452506|NCT03223974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452507|NCT03192046|Carbon Fiber|carbon fiber|mesh-list
92452508|NCT03192046|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92452509|NCT03192046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452510|NCT03190369|Hylan|hylan|mesh-list
92452511|NCT03190369|Viscosupplements|viscosupplements|mesh-ancestor
92452512|NCT03190369|Protective Agents|protective agents|mesh-ancestor
92452513|NCT03190369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452514|NCT05438342|Immunomodulating Agents|immunomodulating agents|mesh-list
92452515|NCT05438342|Immunologic Factors|immunologic factors|mesh-ancestor
92452516|NCT05438342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452517|NCT05438108|Bevacizumab|bevacizumab|mesh-list
92452518|NCT05438108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452519|NCT05438108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452520|NCT05438108|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92452521|NCT05438108|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92452522|NCT05438108|Growth Substances|growth substances|mesh-ancestor
92452523|NCT05438108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452524|NCT05438108|Growth Inhibitors|growth inhibitors|mesh-ancestor
92452525|NCT05437783|Azithromycin|azithromycin|mesh-list
92452526|NCT05437783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92452527|NCT05437783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452528|NCT05437718|Ropivacaine|ropivacaine|mesh-list
92452529|NCT05437718|Anesthetics, Local|anesthetics, local|mesh-ancestor
92452530|NCT05437718|Anesthetics|anesthetics|mesh-ancestor
92452531|NCT05437718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452532|NCT05437718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452533|NCT05437718|Sensory System Agents|sensory system agents|mesh-ancestor
92452534|NCT05437718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452535|NCT05437497|Propofol|propofol|mesh-list
92452536|NCT05437497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92452537|NCT05437497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452538|NCT05437497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452539|NCT05437497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92452540|NCT05437497|Anesthetics, General|anesthetics, general|mesh-ancestor
92452541|NCT05437497|Anesthetics|anesthetics|mesh-ancestor
92452542|NCT05437471|Letrozole|letrozole|mesh-list
92452543|NCT05437471|Dydrogesterone|dydrogesterone|mesh-list
92452544|NCT05437471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452545|NCT05437471|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92452546|NCT05437471|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92452547|NCT05437471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452548|NCT05437471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452549|NCT05437471|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92452550|NCT05437471|Hormone Antagonists|hormone antagonists|mesh-ancestor
92452551|NCT05437471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452552|NCT05437471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452554|NCT05437471|Hormones|hormones|mesh-ancestor
92452555|NCT05437432|Lithium Carbonate|lithium carbonate|mesh-list
92452556|NCT05437432|Methamphetamine|methamphetamine|mesh-list
92452557|NCT05437432|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92452558|NCT05437432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452559|NCT05437432|Sympathomimetics|sympathomimetics|mesh-ancestor
92452560|NCT05437432|Autonomic Agents|autonomic agents|mesh-ancestor
92452561|NCT05437432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452562|NCT05437432|Dopamine Agents|dopamine agents|mesh-ancestor
92452563|NCT05437432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452564|NCT05437432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452565|NCT05437432|Adrenergic Agents|adrenergic agents|mesh-ancestor
92452566|NCT05437432|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92452567|NCT05437432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92452568|NCT05437432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92452569|NCT05437432|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92452570|NCT05437432|Antidepressive Agents|antidepressive agents|mesh-ancestor
92452571|NCT05437432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92452572|NCT05437432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452573|NCT05437432|Antimanic Agents|antimanic agents|mesh-ancestor
92452574|NCT05437432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92452575|NCT05437432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452576|NCT05437224|Ambrisentan|ambrisentan|mesh-list
92452577|NCT05437224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92452578|NCT05436990|Pembrolizumab|pembrolizumab|mesh-list
92452579|NCT05436990|Vactosertib|vactosertib|mesh-list
92452580|NCT05436990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452581|NCT05436990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452582|NCT05436990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92452583|NCT05436990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452584|NCT05436990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452585|NCT05436990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452586|NCT05436964|Dexmedetomidine|dexmedetomidine|mesh-list
92200177|NCT01925781|Autonomic Agents|autonomic agents|mesh-ancestor
92452587|NCT05436964|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92452588|NCT05436964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452589|NCT05436964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452590|NCT05436964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92452592|NCT05436964|Sensory System Agents|sensory system agents|mesh-ancestor
92452593|NCT05436964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452594|NCT05436964|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92452595|NCT05436964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92452596|NCT05436964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92452597|NCT05436964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92452598|NCT05436964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452599|NCT05436964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452600|NCT05426811|Raltitrexed|raltitrexed|mesh-list
92452601|NCT05426811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452602|NCT05426811|Antimetabolites|antimetabolites|mesh-ancestor
92452603|NCT05426811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452604|NCT05426811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452605|NCT05426811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92452606|NCT05426811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452607|NCT05357859|Vitamin D|vitamin d|mesh-list
92452608|NCT05357859|Cholecalciferol|cholecalciferol|mesh-list
92452609|NCT05357859|Vitamins|vitamins|mesh-ancestor
92452610|NCT05357859|Micronutrients|micronutrients|mesh-ancestor
92452611|NCT05357859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452612|NCT05357859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92452613|NCT05357859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92452614|NCT04970381|Rivaroxaban|rivaroxaban|mesh-list
92452615|NCT04970381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92452616|NCT04970381|Antithrombins|antithrombins|mesh-ancestor
92452617|NCT04970381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92452618|NCT04970381|Protease Inhibitors|protease inhibitors|mesh-ancestor
92452619|NCT04970381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452620|NCT04970381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452621|NCT04970381|Anticoagulants|anticoagulants|mesh-ancestor
92452622|NCT04895046|Niraparib|niraparib|mesh-list
92452623|NCT04895046|Dostarlimab|dostarlimab|mesh-list
92452624|NCT04895046|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92452625|NCT04895046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452626|NCT04895046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452627|NCT04895046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452628|NCT04765514|Temozolomide|temozolomide|mesh-list
92452629|NCT04765514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92452630|NCT04765514|Alkylating Agents|alkylating agents|mesh-ancestor
92452631|NCT04765514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452632|NCT04765514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452633|NCT04590586|Thalidomide|thalidomide|mesh-list
92452634|NCT04590586|Apremilast|apremilast|mesh-list
92452635|NCT04590586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92452636|NCT04590586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92452637|NCT04590586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92452638|NCT04590586|Analgesics|analgesics|mesh-ancestor
92452639|NCT04590586|Sensory System Agents|sensory system agents|mesh-ancestor
92452640|NCT04590586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452641|NCT04590586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452642|NCT04590586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452643|NCT04590586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92452644|NCT04590586|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92452645|NCT04590586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92452646|NCT04590586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452647|NCT04590586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452648|NCT04590586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452649|NCT04590586|Immunologic Factors|immunologic factors|mesh-ancestor
92452650|NCT04590586|Leprostatic Agents|leprostatic agents|mesh-ancestor
92452651|NCT04590586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92452652|NCT04590586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452653|NCT04590586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92452654|NCT04590586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92452655|NCT04590586|Growth Substances|growth substances|mesh-ancestor
92452656|NCT04590586|Growth Inhibitors|growth inhibitors|mesh-ancestor
92452657|NCT04590586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452658|NCT04312009|Losartan|losartan|mesh-list
92452659|NCT04312009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92452660|NCT04312009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92452661|NCT04312009|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92452662|NCT04312009|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92452663|NCT04312009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452664|NCT04100096|Brexpiprazole|brexpiprazole|mesh-list
92452665|NCT04100096|Serotonin Agents|serotonin agents|mesh-ancestor
92452666|NCT04100096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452667|NCT04100096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452668|NCT04100096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452669|NCT04100096|Dopamine Agonists|dopamine agonists|mesh-ancestor
92452670|NCT04100096|Dopamine Agents|dopamine agents|mesh-ancestor
92452671|NCT03850483|PF-06700841|pf-06700841|mesh-list
92452672|NCT03850483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92452673|NCT03850483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452674|NCT03850483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452675|NCT03563742|Tenofovir|tenofovir|mesh-list
92452676|NCT03563742|Lamivudine|lamivudine|mesh-list
92452677|NCT03563742|Rilpivirine|rilpivirine|mesh-list
92452678|NCT03563742|Antiviral Agents|antiviral agents|mesh-ancestor
92452679|NCT03563742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452680|NCT03563742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92452681|NCT03563742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92452682|NCT03563742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452683|NCT03563742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452684|NCT03563742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92452685|NCT03563742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92452686|NCT03473925|Pembrolizumab|pembrolizumab|mesh-list
92452687|NCT03473925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452688|NCT03473925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452689|NCT03473925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92452690|NCT03473925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452691|NCT03424122|Rituximab|rituximab|mesh-list
92452692|NCT03424122|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92452693|NCT03424122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452694|NCT03424122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452695|NCT03424122|Immunologic Factors|immunologic factors|mesh-ancestor
92452696|NCT03424122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452697|NCT03424122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92452698|NCT03424122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92452699|NCT03424122|Alkylating Agents|alkylating agents|mesh-ancestor
92452700|NCT03424122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452702|NCT03230097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92452703|NCT03230097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452704|NCT03230097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452705|NCT02968940|Avelumab|avelumab|mesh-list
92452706|NCT02968940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452707|NCT02968940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452708|NCT02663908|Leuprolide|leuprolide|mesh-list
92452709|NCT02663908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92452710|NCT02663908|Fertility Agents|fertility agents|mesh-ancestor
92452711|NCT02663908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92452712|NCT02663908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452713|NCT02663908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92452714|NCT02663908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452715|NCT02333292|Ritonavir|ritonavir|mesh-list
92452716|NCT02333292|Sofosbuvir|sofosbuvir|mesh-list
92452717|NCT02333292|Grazoprevir|grazoprevir|mesh-list
92452718|NCT02333292|Ledipasvir|ledipasvir|mesh-list
92452719|NCT02333292|Velpatasvir|velpatasvir|mesh-list
92452720|NCT02333292|Simeprevir|simeprevir|mesh-list
92452721|NCT02333292|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92452722|NCT02333292|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92452723|NCT02333292|Protease Inhibitors|protease inhibitors|mesh-ancestor
92452724|NCT02333292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452725|NCT02333292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452726|NCT02333292|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92452727|NCT02333292|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92452728|NCT02333292|Antiviral Agents|antiviral agents|mesh-ancestor
92452729|NCT02333292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452730|NCT02333292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92452731|NCT02333292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92452732|NCT02203773|Posaconazole|posaconazole|mesh-list
92452733|NCT02203773|Azacitidine|azacitidine|mesh-list
92452734|NCT02203773|Decitabine|decitabine|mesh-list
92452735|NCT02203773|Venetoclax|venetoclax|mesh-list
92452736|NCT02203773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452738|NCT02203773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452739|NCT02203773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452740|NCT02203773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452741|NCT02203773|Antifungal Agents|antifungal agents|mesh-ancestor
92452742|NCT02203773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452743|NCT02203773|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92452744|NCT02203773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92452745|NCT02203773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92452746|NCT02203773|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92452747|NCT02203773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92452748|NCT02203773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92452749|NCT02203773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92452750|NCT02203773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452751|NCT02203773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452752|NCT02175030|Copper|copper|mesh-list
92452753|NCT02175030|Levonorgestrel|levonorgestrel|mesh-list
92452754|NCT02175030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92452755|NCT02175030|Contraceptive Agents|contraceptive agents|mesh-ancestor
92452756|NCT02175030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92452757|NCT02175030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452758|NCT02175030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92452759|NCT02175030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92452760|NCT02175030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92452761|NCT02175030|Trace Elements|trace elements|mesh-ancestor
92452762|NCT02175030|Micronutrients|micronutrients|mesh-ancestor
92452763|NCT01555541|Cytarabine|cytarabine|mesh-list
92452764|NCT01555541|Etoposide|etoposide|mesh-list
92452765|NCT01555541|Ofatumumab|ofatumumab|mesh-list
92452766|NCT01555541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92452767|NCT01555541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452768|NCT01555541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92452769|NCT01555541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92452770|NCT01555541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452771|NCT01555541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452772|NCT01555541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452773|NCT01555541|Antimetabolites|antimetabolites|mesh-ancestor
92452774|NCT01555541|Antiviral Agents|antiviral agents|mesh-ancestor
92452775|NCT01555541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452776|NCT01555541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92452777|NCT01555541|Immunologic Factors|immunologic factors|mesh-ancestor
92452778|NCT01555541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452779|NCT01398852|Riboflavin|riboflavin|mesh-list
92452780|NCT01398852|Vitamin B Complex|vitamin b complex|mesh-ancestor
92452781|NCT01398852|Vitamins|vitamins|mesh-ancestor
92452782|NCT01398852|Micronutrients|micronutrients|mesh-ancestor
92452783|NCT01398852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452784|NCT01398852|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92452785|NCT01398852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92452786|NCT01398839|Riboflavin|riboflavin|mesh-list
92452787|NCT01398839|Vitamin B Complex|vitamin b complex|mesh-ancestor
92452788|NCT01398839|Vitamins|vitamins|mesh-ancestor
92452789|NCT01398839|Micronutrients|micronutrients|mesh-ancestor
92452790|NCT01398839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452791|NCT01398839|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92452792|NCT01398839|Dermatologic Agents|dermatologic agents|mesh-ancestor
92452793|NCT00496795|Docetaxel|docetaxel|mesh-list
92452794|NCT00496795|Epirubicin|epirubicin|mesh-list
92452795|NCT00496795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452796|NCT00496795|Tubulin Modulators|tubulin modulators|mesh-ancestor
92452797|NCT00496795|Antimitotic Agents|antimitotic agents|mesh-ancestor
92452798|NCT00496795|Mitosis Modulators|mitosis modulators|mesh-ancestor
92452799|NCT00496795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452800|NCT00496795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92452801|NCT00496795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92452802|NCT00496795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92452803|NCT00496795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452804|NCT03164889|Entecavir|entecavir|mesh-list
92452806|NCT03164889|Sargramostim|sargramostim|mesh-list
92452807|NCT03164889|Antiviral Agents|antiviral agents|mesh-ancestor
92452808|NCT03164889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452809|NCT03164889|Immunologic Factors|immunologic factors|mesh-ancestor
92452810|NCT03164889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452811|NCT03164889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452812|NCT03133260|Aspirin|aspirin|mesh-list
92452813|NCT03133260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92452814|NCT03133260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92452815|NCT03133260|Analgesics|analgesics|mesh-ancestor
92452816|NCT03133260|Sensory System Agents|sensory system agents|mesh-ancestor
92452817|NCT03133260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452818|NCT03133260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452819|NCT03133260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92452820|NCT03133260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92452821|NCT03133260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92452822|NCT03133260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92452823|NCT03133260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452824|NCT03133260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92452825|NCT03133260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92452826|NCT03133260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452827|NCT03133260|Antipyretics|antipyretics|mesh-ancestor
92452828|NCT03096834|Erenumab|erenumab|mesh-list
92452829|NCT03096834|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92452830|NCT03096834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452831|NCT03096834|Analgesics|analgesics|mesh-ancestor
92452832|NCT03096834|Sensory System Agents|sensory system agents|mesh-ancestor
92452833|NCT03096834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452834|NCT03096834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452835|NCT03056014|Acetylcysteine|acetylcysteine|mesh-list
92452836|NCT03056014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92452837|NCT03056014|Antiviral Agents|antiviral agents|mesh-ancestor
92452838|NCT03056014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452839|NCT03056014|Expectorants|expectorants|mesh-ancestor
92452840|NCT03056014|Respiratory System Agents|respiratory system agents|mesh-ancestor
92452841|NCT03056014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92452842|NCT03056014|Antioxidants|antioxidants|mesh-ancestor
92452843|NCT03056014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452844|NCT03056014|Protective Agents|protective agents|mesh-ancestor
92452845|NCT03056014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452846|NCT03056014|Antidotes|antidotes|mesh-ancestor
92452847|NCT03054181|Immunoglobulins|immunoglobulins|mesh-list
92452848|NCT03054181|Immunologic Factors|immunologic factors|mesh-ancestor
92452849|NCT03054181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452851|NCT03126812|Carboplatin|carboplatin|mesh-list
92452852|NCT03126812|Pembrolizumab|pembrolizumab|mesh-list
92452853|NCT03126812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92452854|NCT03126812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452855|NCT03126812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92452856|NCT03126812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92452857|NCT03126812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92452858|NCT03126812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452859|NCT03126812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452860|NCT03126812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92452861|NCT03026972|Vaccines|vaccines|mesh-list
92452862|NCT03026972|Immunologic Factors|immunologic factors|mesh-ancestor
92452863|NCT03026972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452864|NCT03012815|Chlordiazepoxide|chlordiazepoxide|mesh-list
92452865|NCT03012815|Gabapentin|gabapentin|mesh-list
92452866|NCT03012815|Lorazepam|lorazepam|mesh-list
92452867|NCT03012815|Valproic Acid|valproic acid|mesh-list
92452868|NCT03012815|Analgesics|analgesics|mesh-ancestor
92452869|NCT03012815|Sensory System Agents|sensory system agents|mesh-ancestor
92452870|NCT03012815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452871|NCT03012815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452872|NCT03012815|Anticonvulsants|anticonvulsants|mesh-ancestor
92452873|NCT03012815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92452874|NCT03012815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92452875|NCT03012815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452876|NCT03012815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92452877|NCT03012815|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92452878|NCT03012815|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92452879|NCT03012815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177779|NCT01456299|Analgesics|analgesics|mesh-ancestor
92452880|NCT03012815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452882|NCT03012815|Antiemetics|antiemetics|mesh-ancestor
92452883|NCT03012815|Autonomic Agents|autonomic agents|mesh-ancestor
92452884|NCT03012815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452885|NCT03012815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92452886|NCT03012815|GABA Modulators|gaba modulators|mesh-ancestor
92452887|NCT03012815|GABA Agents|gaba agents|mesh-ancestor
92452888|NCT03012815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452889|NCT03012815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92452890|NCT03003065|Temoporfin|temoporfin|mesh-list
92452891|NCT03003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452892|NCT03003065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92452893|NCT03003065|Dermatologic Agents|dermatologic agents|mesh-ancestor
92452894|NCT03001011|Sevelamer|sevelamer|mesh-list
92452895|NCT03001011|Chelating Agents|chelating agents|mesh-ancestor
92452896|NCT03001011|Sequestering Agents|sequestering agents|mesh-ancestor
92452897|NCT03001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452898|NCT02993757|Vaccines|vaccines|mesh-list
92452899|NCT02993757|Immunologic Factors|immunologic factors|mesh-ancestor
92452900|NCT02993757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452901|NCT02979535|Vaccines|vaccines|mesh-list
92452902|NCT02979535|Immunologic Factors|immunologic factors|mesh-ancestor
92452903|NCT02979535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452904|NCT02978716|Carboplatin|carboplatin|mesh-list
92452905|NCT02978716|Gemcitabine|gemcitabine|mesh-list
92452906|NCT02978716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452907|NCT02978716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92452908|NCT02978716|Antimetabolites|antimetabolites|mesh-ancestor
92452909|NCT02978716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452910|NCT02973321|Metformin|metformin|mesh-list
92452911|NCT02973321|Liraglutide|liraglutide|mesh-list
92452912|NCT02973321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92452913|NCT02973321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452914|NCT02973321|Incretins|incretins|mesh-ancestor
92452915|NCT02973321|Hormones|hormones|mesh-ancestor
92452916|NCT02973321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452917|NCT02967250|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92452918|NCT02967250|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92452919|NCT02967250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92452920|NCT02943785|Edoxaban|edoxaban|mesh-list
92452921|NCT02943785|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92452922|NCT02943785|Antithrombins|antithrombins|mesh-ancestor
92452923|NCT02943785|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92452924|NCT02943785|Protease Inhibitors|protease inhibitors|mesh-ancestor
92452925|NCT02943785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92452926|NCT02943785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452927|NCT02943785|Anticoagulants|anticoagulants|mesh-ancestor
92452928|NCT02908334|Sertraline|sertraline|mesh-list
92452929|NCT02908334|Antidepressive Agents|antidepressive agents|mesh-ancestor
92452930|NCT02908334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92452931|NCT02908334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92452932|NCT02908334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92452933|NCT02908334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92452934|NCT02908334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452935|NCT02908334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92452936|NCT02908334|Serotonin Agents|serotonin agents|mesh-ancestor
92452937|NCT02908334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452938|NCT02886286|Fentanyl|fentanyl|mesh-list
92452939|NCT02886286|Morphine|morphine|mesh-list
92452940|NCT02886286|Hydromorphone|hydromorphone|mesh-list
92452941|NCT02886286|Bupivacaine|bupivacaine|mesh-list
92452942|NCT02886286|Anesthetics, Local|anesthetics, local|mesh-ancestor
92452943|NCT02886286|Anesthetics|anesthetics|mesh-ancestor
92452944|NCT02886286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452945|NCT02886286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452946|NCT02886286|Sensory System Agents|sensory system agents|mesh-ancestor
92452947|NCT02886286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92452948|NCT02886286|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92452949|NCT02886286|Narcotics|narcotics|mesh-ancestor
92452950|NCT02886286|Analgesics|analgesics|mesh-ancestor
92452951|NCT02886286|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92452952|NCT02886286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92452953|NCT02886286|Anesthetics, General|anesthetics, general|mesh-ancestor
92452954|NCT02865187|Vitamin D|vitamin d|mesh-list
92452955|NCT02865187|Vitamins|vitamins|mesh-ancestor
92452956|NCT02865187|Micronutrients|micronutrients|mesh-ancestor
92452957|NCT02865187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452958|NCT02865187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92452959|NCT02787551|Metformin|metformin|mesh-list
92452960|NCT02787551|Insulin Glargine|insulin glargine|mesh-list
92452961|NCT02787551|Pioglitazone|pioglitazone|mesh-list
92452962|NCT02787551|Liraglutide|liraglutide|mesh-list
92452963|NCT02787551|Exenatide|exenatide|mesh-list
92452964|NCT02787551|Dulaglutide|dulaglutide|mesh-list
92452965|NCT02787551|Lixisenatide|lixisenatide|mesh-list
92452966|NCT02787551|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92452967|NCT02787551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92452968|NCT02787551|rGLP-1 protein|rglp-1 protein|mesh-list
92452969|NCT02787551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452970|NCT02787551|Incretins|incretins|mesh-ancestor
92452971|NCT02787551|Hormones|hormones|mesh-ancestor
92452972|NCT02787551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92452973|NCT02787551|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92452974|NCT02787551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452975|NCT02735044|Insulin|insulin|mesh-list
92452976|NCT02735044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92452977|NCT02735044|Insulin Glargine|insulin glargine|mesh-list
92452978|NCT02735044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92452979|NCT02735044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452980|NCT02692651|Vancomycin|vancomycin|mesh-list
92452981|NCT02692651|Fidaxomicin|fidaxomicin|mesh-list
92452982|NCT02692651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92452983|NCT02692651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92452984|NCT02674061|Pembrolizumab|pembrolizumab|mesh-list
92452985|NCT02674061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452986|NCT02674061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452987|NCT02674061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92452988|NCT02674061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452989|NCT02654314|Melatonin|melatonin|mesh-list
92452990|NCT02654314|Antioxidants|antioxidants|mesh-ancestor
92452991|NCT02654314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92452992|NCT02654314|Protective Agents|protective agents|mesh-ancestor
92452993|NCT02654314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92452994|NCT02654314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92452995|NCT02626962|Nivolumab|nivolumab|mesh-list
92452996|NCT02626962|Ipilimumab|ipilimumab|mesh-list
92452997|NCT02626962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92452998|NCT02626962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92452999|NCT02626962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453000|NCT02626962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453001|NCT02623998|Metformin|metformin|mesh-list
92453002|NCT02623998|Insulin Glargine|insulin glargine|mesh-list
92453003|NCT02623998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92453004|NCT02623998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453005|NCT02623998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453006|NCT02623998|Incretins|incretins|mesh-ancestor
92453007|NCT02623998|Hormones|hormones|mesh-ancestor
92453008|NCT02623998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453009|NCT02623998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92453010|NCT02623998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92453011|NCT02623998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453012|NCT02623998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453013|NCT02608684|Gemcitabine|gemcitabine|mesh-list
92453014|NCT02608684|Pembrolizumab|pembrolizumab|mesh-list
92453015|NCT02608684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453016|NCT02608684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92453017|NCT02608684|Antimetabolites|antimetabolites|mesh-ancestor
92453018|NCT02608684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453019|NCT02608684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453020|NCT02608684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453021|NCT02587520|Vaccines|vaccines|mesh-list
92453022|NCT02587520|Immunologic Factors|immunologic factors|mesh-ancestor
92453023|NCT02587520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453024|NCT02584829|Interferons|interferons|mesh-list
92453025|NCT02584829|Interferon-beta|interferon-beta|mesh-list
92453026|NCT02584829|Avelumab|avelumab|mesh-list
92453027|NCT02584829|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92453028|NCT02584829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453029|NCT02584829|Antiviral Agents|antiviral agents|mesh-ancestor
92453030|NCT02584829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453031|NCT02584829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453032|NCT02584829|Immunologic Factors|immunologic factors|mesh-ancestor
92453033|NCT02584829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453034|NCT02557321|Pembrolizumab|pembrolizumab|mesh-list
92453035|NCT02557321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453036|NCT02557321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453037|NCT02557321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453038|NCT02557321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453039|NCT02512172|Pembrolizumab|pembrolizumab|mesh-list
92453040|NCT02512172|Azacitidine|azacitidine|mesh-list
92453042|NCT02512172|Cc-486|cc-486|mesh-list
92453043|NCT02512172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453044|NCT02512172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453045|NCT02512172|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453046|NCT02512172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453047|NCT02512172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92453048|NCT02512172|Antimetabolites|antimetabolites|mesh-ancestor
92453049|NCT02512172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453050|NCT02512172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92453051|NCT02512172|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92453052|NCT02499367|Cyclophosphamide|cyclophosphamide|mesh-list
92453053|NCT02499367|Doxorubicin|doxorubicin|mesh-list
92453054|NCT02499367|Nivolumab|nivolumab|mesh-list
92453055|NCT02499367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453056|NCT02499367|Immunologic Factors|immunologic factors|mesh-ancestor
92453057|NCT02499367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453058|NCT02499367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453059|NCT02499367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92453060|NCT02499367|Alkylating Agents|alkylating agents|mesh-ancestor
92453061|NCT02499367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453062|NCT02499367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453063|NCT02499367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92347356|NCT04413864|Analgesics|analgesics|mesh-ancestor
92453064|NCT02499367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92453065|NCT02499367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92453066|NCT02499367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92453067|NCT02499367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453068|NCT02499367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453069|NCT02499367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453070|NCT02497612|Artefenomel|artefenomel|mesh-list
92453071|NCT02497612|Ferroquine|ferroquine|mesh-list
92453072|NCT02497612|Antimalarials|antimalarials|mesh-ancestor
92453073|NCT02497612|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92453074|NCT02497612|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92453075|NCT02497612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453076|NCT02497131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92453077|NCT02497131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453078|NCT02497131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453080|NCT02497131|Immunoconjugates|immunoconjugates|mesh-ancestor
92453081|NCT02497131|Immunologic Factors|immunologic factors|mesh-ancestor
92453082|NCT02497131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453083|NCT02491333|Metformin|metformin|mesh-list
92453084|NCT02491333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453085|NCT02491333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453086|NCT02469987|Bevacizumab|bevacizumab|mesh-list
92453087|NCT02469987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453088|NCT02469987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453089|NCT02469987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92453090|NCT02469987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92453091|NCT02469987|Growth Substances|growth substances|mesh-ancestor
92453092|NCT02469987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453093|NCT02469987|Growth Inhibitors|growth inhibitors|mesh-ancestor
92453094|NCT02439307|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92453095|NCT02439307|Rifaximin|rifaximin|mesh-list
92453096|NCT02439307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453097|NCT02439307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453098|NCT02381652|Triamcinolone|triamcinolone|mesh-list
92453099|NCT02381652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92453100|NCT02381652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92453101|NCT02381652|Hyaluronic Acid|hyaluronic acid|mesh-list
92453102|NCT02381652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92453103|NCT02381652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453104|NCT02381652|Glucocorticoids|glucocorticoids|mesh-ancestor
92453105|NCT02381652|Hormones|hormones|mesh-ancestor
92453106|NCT02381652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453107|NCT02381652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453108|NCT02381652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453109|NCT02381652|Immunologic Factors|immunologic factors|mesh-ancestor
92453110|NCT02381652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453111|NCT02381652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453112|NCT02381652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92453113|NCT02381652|Viscosupplements|viscosupplements|mesh-ancestor
92453114|NCT02381652|Protective Agents|protective agents|mesh-ancestor
92453115|NCT02368301|Dexamethasone|dexamethasone|mesh-list
92453116|NCT02368301|Lenalidomide|lenalidomide|mesh-list
92453117|NCT02368301|Elotuzumab|elotuzumab|mesh-list
92453118|NCT02368301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453119|NCT02368301|Antiemetics|antiemetics|mesh-ancestor
92453120|NCT02368301|Autonomic Agents|autonomic agents|mesh-ancestor
92453121|NCT02368301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453122|NCT02368301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453123|NCT02368301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453124|NCT02368301|Glucocorticoids|glucocorticoids|mesh-ancestor
92453125|NCT02368301|Hormones|hormones|mesh-ancestor
92453126|NCT02368301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453127|NCT02368301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92453128|NCT02368301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453129|NCT02368301|Immunologic Factors|immunologic factors|mesh-ancestor
92453130|NCT02368301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92453131|NCT02368301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92453132|NCT02368301|Growth Substances|growth substances|mesh-ancestor
92453133|NCT02368301|Growth Inhibitors|growth inhibitors|mesh-ancestor
92453134|NCT02367794|Paclitaxel|paclitaxel|mesh-list
92453135|NCT02367794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92453136|NCT02367794|Carboplatin|carboplatin|mesh-list
92453137|NCT02367794|Atezolizumab|atezolizumab|mesh-list
92453138|NCT02367794|Antibodies|antibodies|mesh-list
92453139|NCT02367794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92453140|NCT02367794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453141|NCT02367794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92453142|NCT02367794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92453143|NCT02367794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92453144|NCT02367794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453145|NCT02367794|Immunologic Factors|immunologic factors|mesh-ancestor
92453146|NCT02367794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453147|NCT02367794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453148|NCT02367794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453149|NCT02363998|Lofexidine|lofexidine|mesh-list
92453150|NCT02363998|Clonidine|clonidine|mesh-list
92453151|NCT02363998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92453152|NCT02363998|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92453153|NCT02363998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453154|NCT02363998|Sensory System Agents|sensory system agents|mesh-ancestor
92453155|NCT02363998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453156|NCT02363998|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92453157|NCT02363998|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92453158|NCT02363998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92453159|NCT02363998|Adrenergic Agents|adrenergic agents|mesh-ancestor
92453160|NCT02363998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453161|NCT02363998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453163|NCT02363998|Sympatholytics|sympatholytics|mesh-ancestor
92453164|NCT02363998|Autonomic Agents|autonomic agents|mesh-ancestor
92453165|NCT02355379|Capecitabine|capecitabine|mesh-list
92453166|NCT02355379|Fluorouracil|fluorouracil|mesh-list
92453167|NCT02355379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92453168|NCT02355379|Antimetabolites|antimetabolites|mesh-ancestor
92453169|NCT02355379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453170|NCT02355379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453171|NCT02355379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453172|NCT02355379|Immunologic Factors|immunologic factors|mesh-ancestor
92453173|NCT02355379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453174|NCT02325466|Aspirin|aspirin|mesh-list
92453175|NCT02325466|Ticagrelor|ticagrelor|mesh-list
92453176|NCT02325466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92453177|NCT02325466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92453178|NCT02325466|Analgesics|analgesics|mesh-ancestor
92453179|NCT02325466|Sensory System Agents|sensory system agents|mesh-ancestor
92453180|NCT02325466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453181|NCT02325466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453182|NCT02325466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453183|NCT02325466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453184|NCT02325466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92453185|NCT02325466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92453186|NCT02325466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453187|NCT02325466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92453188|NCT02325466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92453189|NCT02325466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453190|NCT02325466|Antipyretics|antipyretics|mesh-ancestor
92453191|NCT02325466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92453192|NCT02325466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92453193|NCT02325466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92453194|NCT02325466|Purinergic Agents|purinergic agents|mesh-ancestor
92453195|NCT02325466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453196|NCT02323100|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92453197|NCT02323100|Glycerol|glycerol|mesh-list
92453198|NCT02323100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92453199|NCT02323100|Protective Agents|protective agents|mesh-ancestor
92453200|NCT02323100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453201|NCT02323100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453202|NCT02322710|Petrolatum|petrolatum|mesh-list
92453203|NCT02322710|Emollients|emollients|mesh-ancestor
92453204|NCT02322710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92453205|NCT02283281|Dronabinol|dronabinol|mesh-list
92453206|NCT02283281|Hallucinogens|hallucinogens|mesh-ancestor
92453207|NCT02283281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453208|NCT02283281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92453209|NCT02283281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92453210|NCT02283281|Analgesics|analgesics|mesh-ancestor
92453211|NCT02283281|Sensory System Agents|sensory system agents|mesh-ancestor
92453212|NCT02283281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453213|NCT02283281|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92453214|NCT02283281|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92453215|NCT02283281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453216|NCT02283281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453217|NCT02283281|Hormones|hormones|mesh-ancestor
92453218|NCT02283281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453219|NCT02162563|Leucovorin|leucovorin|mesh-list
92453220|NCT02162563|Bevacizumab|bevacizumab|mesh-list
92453221|NCT02162563|Panitumumab|panitumumab|mesh-list
92453222|NCT02162563|Fluorouracil|fluorouracil|mesh-list
92453223|NCT02162563|Oxaliplatin|oxaliplatin|mesh-list
92453225|NCT02162563|Levoleucovorin|levoleucovorin|mesh-list
92453226|NCT02162563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453227|NCT02162563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453228|NCT02162563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92453229|NCT02162563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92453230|NCT02162563|Growth Substances|growth substances|mesh-ancestor
92453231|NCT02162563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453232|NCT02162563|Growth Inhibitors|growth inhibitors|mesh-ancestor
92453233|NCT02162563|Antimetabolites|antimetabolites|mesh-ancestor
92453234|NCT02162563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453235|NCT02162563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92453236|NCT02162563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453237|NCT02162563|Immunologic Factors|immunologic factors|mesh-ancestor
92453238|NCT02162563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92453239|NCT02162563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92453240|NCT02162563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453241|NCT02162563|Antidotes|antidotes|mesh-ancestor
92453242|NCT02162563|Protective Agents|protective agents|mesh-ancestor
92453243|NCT02162563|Vitamin B Complex|vitamin b complex|mesh-ancestor
92453244|NCT02162563|Vitamins|vitamins|mesh-ancestor
92453245|NCT02162563|Micronutrients|micronutrients|mesh-ancestor
92453246|NCT02127086|Analgesics|analgesics|mesh-list
92453247|NCT02127086|Sensory System Agents|sensory system agents|mesh-ancestor
92453248|NCT02127086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453249|NCT02127086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453250|NCT02120079|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92453251|NCT02120079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92453252|NCT02120079|Lubricant Eye Drops|lubricant eye drops|mesh-list
92453253|NCT02120079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92453254|NCT02120079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92453255|NCT02106195|Belumosudil|belumosudil|mesh-list
92453256|NCT02106195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92453257|NCT02106195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453258|NCT02106195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453259|NCT02075177|Ketoconazole|ketoconazole|mesh-list
92453260|NCT02075177|Fenretinide|fenretinide|mesh-list
92453261|NCT02075177|Antifungal Agents|antifungal agents|mesh-ancestor
92178158|NCT00773357|Guanfacine|guanfacine|mesh-list
92453262|NCT02075177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453263|NCT02075177|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92453264|NCT02075177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92453265|NCT02075177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453266|NCT02075177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453267|NCT02075177|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92453268|NCT02075177|Hormone Antagonists|hormone antagonists|mesh-ancestor
92453269|NCT02075177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453270|NCT02075177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453271|NCT02075177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92453272|NCT02075177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453273|NCT02075177|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92453274|NCT02075177|Protective Agents|protective agents|mesh-ancestor
92453275|NCT02050919|Sorafenib|sorafenib|mesh-list
92453276|NCT02050919|Epirubicin|epirubicin|mesh-list
92453277|NCT02050919|Ifosfamide|ifosfamide|mesh-list
92453278|NCT02050919|Isophosphamide mustard|isophosphamide mustard|mesh-list
92453279|NCT02050919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453280|NCT02050919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92453281|NCT02050919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453282|NCT02050919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453283|NCT02050919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92453284|NCT02050919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92453285|NCT02050919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92453286|NCT02050919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92453287|NCT02050919|Alkylating Agents|alkylating agents|mesh-ancestor
92453288|NCT02040857|Tamoxifen|tamoxifen|mesh-list
92453289|NCT02040857|Letrozole|letrozole|mesh-list
92453290|NCT02040857|Palbociclib|palbociclib|mesh-list
92453291|NCT02040857|Anastrozole|anastrozole|mesh-list
92453292|NCT02040857|Exemestane|exemestane|mesh-list
92453293|NCT02040857|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92453294|NCT02040857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453295|NCT02040857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92453296|NCT02040857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453297|NCT02040857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453298|NCT02040857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92453300|NCT02040857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453301|NCT02040857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453302|NCT02040857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92453303|NCT02040857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92453304|NCT02040857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92453305|NCT02040857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92453306|NCT02040857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92453307|NCT01997463|Albuterol|albuterol|mesh-list
92453308|NCT01997463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92453309|NCT01997463|Autonomic Agents|autonomic agents|mesh-ancestor
92453310|NCT01997463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453311|NCT01997463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453312|NCT01997463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92453313|NCT01997463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92453314|NCT01997463|Tocolytic Agents|tocolytic agents|mesh-ancestor
92453315|NCT01997463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92453316|NCT01997463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92453317|NCT01997463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92453318|NCT01997463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92453319|NCT01997463|Adrenergic Agents|adrenergic agents|mesh-ancestor
92453320|NCT01997463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453321|NCT01997463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453322|NCT01976754|Dexmedetomidine|dexmedetomidine|mesh-list
92453323|NCT01976754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92453324|NCT01976754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453325|NCT01976754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453326|NCT01976754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92453327|NCT01976754|Analgesics|analgesics|mesh-ancestor
92453328|NCT01976754|Sensory System Agents|sensory system agents|mesh-ancestor
92453329|NCT01976754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453330|NCT01976754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92453331|NCT01976754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92453332|NCT01976754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92453333|NCT01976754|Adrenergic Agents|adrenergic agents|mesh-ancestor
92453334|NCT01976754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453335|NCT01976754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453336|NCT01943825|Vaccines|vaccines|mesh-list
92453337|NCT01943825|Immunologic Factors|immunologic factors|mesh-ancestor
92453338|NCT01943825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453339|NCT01916317|Lidocaine|lidocaine|mesh-list
92453340|NCT01916317|Anesthetics, Local|anesthetics, local|mesh-ancestor
92453341|NCT01916317|Anesthetics|anesthetics|mesh-ancestor
92453342|NCT01916317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453343|NCT01916317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453344|NCT01916317|Sensory System Agents|sensory system agents|mesh-ancestor
92453345|NCT01916317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453346|NCT01916317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92453347|NCT01916317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92453348|NCT01916317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92453349|NCT01916317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92453350|NCT01916317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453351|NCT01913730|Dexamethasone|dexamethasone|mesh-list
92453352|NCT01913730|Bortezomib|bortezomib|mesh-list
92453353|NCT01913730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453354|NCT01913730|Antiemetics|antiemetics|mesh-ancestor
92453355|NCT01913730|Autonomic Agents|autonomic agents|mesh-ancestor
92453356|NCT01913730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453357|NCT01913730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453358|NCT01913730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453359|NCT01913730|Glucocorticoids|glucocorticoids|mesh-ancestor
92453360|NCT01913730|Hormones|hormones|mesh-ancestor
92453361|NCT01913730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453362|NCT01913730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92453363|NCT01913730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453364|NCT01863186|Lofexidine|lofexidine|mesh-list
92453365|NCT01863186|Clonidine|clonidine|mesh-list
92453366|NCT01863186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92453367|NCT01863186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92453368|NCT01863186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453369|NCT01863186|Sensory System Agents|sensory system agents|mesh-ancestor
92453370|NCT01863186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453371|NCT01863186|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92453373|NCT01863186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92453374|NCT01863186|Adrenergic Agents|adrenergic agents|mesh-ancestor
92453375|NCT01863186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453376|NCT01863186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453377|NCT01863186|Analgesics|analgesics|mesh-ancestor
92453378|NCT01863186|Sympatholytics|sympatholytics|mesh-ancestor
92453379|NCT01863186|Autonomic Agents|autonomic agents|mesh-ancestor
92453380|NCT01828840|Fentanyl|fentanyl|mesh-list
92453381|NCT01828840|Morphine|morphine|mesh-list
92453382|NCT01828840|Methadone|methadone|mesh-list
92453383|NCT01828840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92453384|NCT01828840|Narcotics|narcotics|mesh-ancestor
92453385|NCT01828840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453386|NCT01828840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453387|NCT01828840|Analgesics|analgesics|mesh-ancestor
92453388|NCT01828840|Sensory System Agents|sensory system agents|mesh-ancestor
92453389|NCT01828840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453390|NCT01828840|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92453391|NCT01828840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92453392|NCT01828840|Anesthetics, General|anesthetics, general|mesh-ancestor
92453393|NCT01828840|Anesthetics|anesthetics|mesh-ancestor
92453395|NCT01828840|Respiratory System Agents|respiratory system agents|mesh-ancestor
92453396|NCT01817426|Infliximab|infliximab|mesh-list
92453397|NCT01817426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92453398|NCT01817426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453399|NCT01817426|Dermatologic Agents|dermatologic agents|mesh-ancestor
92453400|NCT01817426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453401|NCT01817426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453402|NCT01741103|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92453403|NCT01741103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453404|NCT01741103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453405|NCT01741103|Incretins|incretins|mesh-ancestor
92453406|NCT01741103|Hormones|hormones|mesh-ancestor
92453407|NCT01741103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453408|NCT01741103|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92453409|NCT01741103|Protease Inhibitors|protease inhibitors|mesh-ancestor
92453410|NCT01741103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453411|NCT01741103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178307|NCT01454102|Paclitaxel|paclitaxel|mesh-list
92453412|NCT01722331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92453413|NCT01722331|Immunologic Factors|immunologic factors|mesh-ancestor
92453414|NCT01722331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453415|NCT01630590|Androgens|androgens|mesh-list
92453416|NCT01630590|Hormones|hormones|mesh-ancestor
92453417|NCT01630590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453418|NCT01630590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453419|NCT01619085|Nintedanib|nintedanib|mesh-list
92453420|NCT01619085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453421|NCT01619085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92453422|NCT01619085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453423|NCT01619085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453424|NCT01499095|Insulin|insulin|mesh-list
92453425|NCT01499095|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92453426|NCT01499095|Insulin Glargine|insulin glargine|mesh-list
92453427|NCT01499095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453428|NCT01499095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453429|NCT01499082|Insulin|insulin|mesh-list
92453430|NCT01499082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92453431|NCT01499082|Insulin Glargine|insulin glargine|mesh-list
92453432|NCT01499082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453433|NCT01499082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453434|NCT01488890|Vaccines|vaccines|mesh-list
92453435|NCT01488890|Immunologic Factors|immunologic factors|mesh-ancestor
92453436|NCT01488890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453437|NCT01436396|Vaccines|vaccines|mesh-list
92453438|NCT01436396|Immunologic Factors|immunologic factors|mesh-ancestor
92453439|NCT01436396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453440|NCT01414777|Ondansetron|ondansetron|mesh-list
92453441|NCT01414777|Antiemetics|antiemetics|mesh-ancestor
92453442|NCT01414777|Autonomic Agents|autonomic agents|mesh-ancestor
92453443|NCT01414777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453444|NCT01414777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453445|NCT01414777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453446|NCT01414777|Antipruritics|antipruritics|mesh-ancestor
92453447|NCT01414777|Dermatologic Agents|dermatologic agents|mesh-ancestor
92453448|NCT01414777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92453449|NCT01414777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92453450|NCT01414777|Serotonin Agents|serotonin agents|mesh-ancestor
92453451|NCT01414777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453452|NCT01414777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453453|NCT01411241|Vaccines|vaccines|mesh-list
92453454|NCT01411241|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92453455|NCT01411241|Immunologic Factors|immunologic factors|mesh-ancestor
92453456|NCT01411241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453457|NCT01380938|Ribavirin|ribavirin|mesh-list
92453458|NCT01380938|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92453459|NCT01380938|Interferon-alpha|interferon-alpha|mesh-list
92453460|NCT01380938|Antimetabolites|antimetabolites|mesh-ancestor
92453461|NCT01380938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453462|NCT01380938|Antiviral Agents|antiviral agents|mesh-ancestor
92453463|NCT01380938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453464|NCT01380938|Immunologic Factors|immunologic factors|mesh-ancestor
92453465|NCT01380938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453466|NCT01374516|Vaccines|vaccines|mesh-list
92453467|NCT01374516|Immunologic Factors|immunologic factors|mesh-ancestor
92453468|NCT01374516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453469|NCT01373281|Vaccines|vaccines|mesh-list
92453470|NCT01373281|Immunologic Factors|immunologic factors|mesh-ancestor
92453471|NCT01373281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453472|NCT01346787|Dexamethasone|dexamethasone|mesh-list
92453473|NCT01346787|Cyclophosphamide|cyclophosphamide|mesh-list
92453474|NCT01346787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453475|NCT01346787|Immunologic Factors|immunologic factors|mesh-ancestor
92453476|NCT01346787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453477|NCT01346787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453478|NCT01346787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92453479|NCT01346787|Alkylating Agents|alkylating agents|mesh-ancestor
92453480|NCT01346787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453481|NCT01346787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453482|NCT01346787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92453483|NCT01346787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453484|NCT01346787|Antiemetics|antiemetics|mesh-ancestor
92453485|NCT01346787|Autonomic Agents|autonomic agents|mesh-ancestor
92453486|NCT01346787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453487|NCT01346787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453488|NCT01346787|Glucocorticoids|glucocorticoids|mesh-ancestor
92453489|NCT01346787|Hormones|hormones|mesh-ancestor
92453490|NCT01346787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453491|NCT01346787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92453492|NCT01254422|Vaccines|vaccines|mesh-list
92453493|NCT01254422|Immunologic Factors|immunologic factors|mesh-ancestor
92453494|NCT01254422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453495|NCT01204242|Lidocaine|lidocaine|mesh-list
92347375|NCT01730586|Paclitaxel|paclitaxel|mesh-list
92453496|NCT01204242|Anesthetics, Local|anesthetics, local|mesh-ancestor
92453497|NCT01204242|Anesthetics|anesthetics|mesh-ancestor
92453498|NCT01204242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453499|NCT01204242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453500|NCT01204242|Sensory System Agents|sensory system agents|mesh-ancestor
92453501|NCT01204242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453502|NCT01204242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92453503|NCT01204242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92453504|NCT01204242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92453505|NCT01204242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92453506|NCT01204242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453507|NCT01187433|Vaccines|vaccines|mesh-list
92453508|NCT01187433|Immunologic Factors|immunologic factors|mesh-ancestor
92453509|NCT01187433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453510|NCT01150045|Leucovorin|leucovorin|mesh-list
92453511|NCT01150045|Celecoxib|celecoxib|mesh-list
92453512|NCT01150045|Fluorouracil|fluorouracil|mesh-list
92453513|NCT01150045|Oxaliplatin|oxaliplatin|mesh-list
92453514|NCT01150045|Antimetabolites|antimetabolites|mesh-ancestor
92453515|NCT01150045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453516|NCT01150045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92453517|NCT01150045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453518|NCT01150045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453519|NCT01150045|Immunologic Factors|immunologic factors|mesh-ancestor
92453520|NCT01150045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453521|NCT01150045|Antidotes|antidotes|mesh-ancestor
92453522|NCT01150045|Protective Agents|protective agents|mesh-ancestor
92453523|NCT01150045|Vitamin B Complex|vitamin b complex|mesh-ancestor
92453524|NCT01150045|Vitamins|vitamins|mesh-ancestor
92453525|NCT01150045|Micronutrients|micronutrients|mesh-ancestor
92453526|NCT01150045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92453527|NCT01150045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92453528|NCT01150045|Analgesics|analgesics|mesh-ancestor
92453529|NCT01150045|Sensory System Agents|sensory system agents|mesh-ancestor
92453530|NCT01150045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453531|NCT01150045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453532|NCT01150045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453533|NCT01150045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92453534|NCT01150045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92453535|NCT01150045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453536|NCT01098032|Acetylcysteine|acetylcysteine|mesh-list
92453537|NCT01098032|Antiviral Agents|antiviral agents|mesh-ancestor
92453538|NCT01098032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453539|NCT01098032|Expectorants|expectorants|mesh-ancestor
92453540|NCT01098032|Respiratory System Agents|respiratory system agents|mesh-ancestor
92453541|NCT01098032|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92453542|NCT01098032|Antioxidants|antioxidants|mesh-ancestor
92453543|NCT01098032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453544|NCT01098032|Protective Agents|protective agents|mesh-ancestor
92453545|NCT01098032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453546|NCT00945009|Dactinomycin|dactinomycin|mesh-list
92453547|NCT00945009|Cactinomycin|cactinomycin|mesh-list
92453548|NCT00945009|Doxorubicin|doxorubicin|mesh-list
92453549|NCT00945009|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92453550|NCT00945009|Vincristine|vincristine|mesh-list
92453551|NCT00945009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92453552|NCT00945009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453553|NCT00945009|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92453554|NCT00945009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92453555|NCT00945009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453556|NCT00945009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453557|NCT00945009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92453558|NCT00945009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92453559|NCT00945009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92453560|NCT00945009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92453561|NCT00945009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92178458|NCT04782089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453562|NCT00945009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453563|NCT00945009|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92453564|NCT00945009|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92453566|NCT00942877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453567|NCT00942877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92453568|NCT00942877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453569|NCT00942877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453570|NCT00896389|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92453571|NCT00896389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92453572|NCT00896389|Diuretics|diuretics|mesh-ancestor
92453573|NCT00896389|Natriuretic Agents|natriuretic agents|mesh-ancestor
92453574|NCT00896389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453575|NCT00896389|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92453576|NCT00896389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92453577|NCT00896389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453578|NCT00880893|Vaccines|vaccines|mesh-list
92453579|NCT00880893|Immunologic Factors|immunologic factors|mesh-ancestor
92453580|NCT00880893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453581|NCT00579527|Cyclosporine|cyclosporine|mesh-list
92453582|NCT00579527|Mycophenolic Acid|mycophenolic acid|mesh-list
92453583|NCT00579527|Methylprednisolone|methylprednisolone|mesh-list
92453584|NCT00579527|Prednisolone|prednisolone|mesh-list
92453585|NCT00579527|Tacrolimus|tacrolimus|mesh-list
92453586|NCT00579527|Cyclosporins|cyclosporins|mesh-list
92453587|NCT00579527|Thymoglobulin|thymoglobulin|mesh-list
92453588|NCT00579527|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92453589|NCT00579527|Daclizumab|daclizumab|mesh-list
92453590|NCT00579527|Parathyroid Hormone|parathyroid hormone|mesh-list
92453591|NCT00579527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453592|NCT00579527|Immunologic Factors|immunologic factors|mesh-ancestor
92453593|NCT00579527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453594|NCT00579527|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92453595|NCT00579527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453596|NCT00579527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453597|NCT00579527|Antifungal Agents|antifungal agents|mesh-ancestor
92453598|NCT00579527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453599|NCT00579527|Dermatologic Agents|dermatologic agents|mesh-ancestor
92453600|NCT00579527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453601|NCT00579527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92453602|NCT00579527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453603|NCT00579527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92453604|NCT00579527|Antitubercular Agents|antitubercular agents|mesh-ancestor
92453605|NCT00579527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92453606|NCT00579527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453607|NCT00579527|Antiemetics|antiemetics|mesh-ancestor
92453608|NCT00579527|Autonomic Agents|autonomic agents|mesh-ancestor
92453609|NCT00579527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453610|NCT00579527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453611|NCT00579527|Glucocorticoids|glucocorticoids|mesh-ancestor
92453612|NCT00579527|Hormones|hormones|mesh-ancestor
92453613|NCT00579527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453614|NCT00579527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92453615|NCT00579527|Protective Agents|protective agents|mesh-ancestor
92453616|NCT00579527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92453617|NCT00579527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92453618|NCT01904123|Tyrphostins|tyrphostins|mesh-list
92453619|NCT01904123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453620|NCT01904123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453621|NCT01904123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453622|NCT00576836|Parathyroid Hormone|parathyroid hormone|mesh-list
92453623|NCT00576836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92453624|NCT00576836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453625|NCT00531232|Clofarabine|clofarabine|mesh-list
92453626|NCT00531232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92453627|NCT00531232|Antimetabolites|antimetabolites|mesh-ancestor
92453628|NCT00531232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453629|NCT00531232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453630|NCT00066950|Chlorhexidine|chlorhexidine|mesh-list
92453631|NCT00066950|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92453633|NCT00066950|Fluorides, Topical|fluorides, topical|mesh-list
92453634|NCT00066950|Cariostatic Agents|cariostatic agents|mesh-ancestor
92453635|NCT00066950|Protective Agents|protective agents|mesh-ancestor
92453636|NCT00066950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453637|NCT00066950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92453638|NCT00066950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453639|NCT00066950|Disinfectants|disinfectants|mesh-ancestor
92453640|NCT00066950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92453641|NCT01694134|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92453642|NCT01694134|Methylprednisolone|methylprednisolone|mesh-list
92453643|NCT01694134|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92453644|NCT01694134|Prednisolone|prednisolone|mesh-list
92453645|NCT01694134|Prednisolone acetate|prednisolone acetate|mesh-list
92453646|NCT01694134|Lidocaine|lidocaine|mesh-list
92453647|NCT01694134|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92453648|NCT01694134|Prednisolone phosphate|prednisolone phosphate|mesh-list
92453649|NCT01694134|Anesthetics, Local|anesthetics, local|mesh-ancestor
92453650|NCT01694134|Anesthetics|anesthetics|mesh-ancestor
92453651|NCT01694134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453652|NCT01694134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453653|NCT01694134|Sensory System Agents|sensory system agents|mesh-ancestor
92453654|NCT01694134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453655|NCT01694134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92453656|NCT01694134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92453657|NCT01694134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92453658|NCT01694134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92453659|NCT01694134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453660|NCT01694134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453661|NCT01694134|Antiemetics|antiemetics|mesh-ancestor
92453662|NCT01694134|Autonomic Agents|autonomic agents|mesh-ancestor
92453663|NCT01694134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453664|NCT01694134|Glucocorticoids|glucocorticoids|mesh-ancestor
92453665|NCT01694134|Hormones|hormones|mesh-ancestor
92453666|NCT01694134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453667|NCT01694134|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92453668|NCT01694134|Protective Agents|protective agents|mesh-ancestor
92453669|NCT01694134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92531418|NCT00046345|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92453670|NCT01694134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453671|NCT01694212|Diclofenac|diclofenac|mesh-list
92453672|NCT01694212|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92453673|NCT01694212|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92453674|NCT01694212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92453675|NCT01694212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92453676|NCT01694212|Analgesics|analgesics|mesh-ancestor
92453677|NCT01694212|Sensory System Agents|sensory system agents|mesh-ancestor
92453678|NCT01694212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453679|NCT01694212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453680|NCT01694212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453681|NCT01694212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453682|NCT01694212|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92453683|NCT01694212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453684|NCT01694212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453685|NCT01694264|Entecavir|entecavir|mesh-list
92453686|NCT01694264|Antiviral Agents|antiviral agents|mesh-ancestor
92453687|NCT01694264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453688|NCT01694355|Vitamin D|vitamin d|mesh-list
92453689|NCT01694355|Vitamins|vitamins|mesh-ancestor
92453690|NCT01694355|Micronutrients|micronutrients|mesh-ancestor
92453691|NCT01694355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453692|NCT01694355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92453693|NCT01694381|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92453694|NCT01694381|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92453695|NCT01694381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453696|NCT01694381|Immunologic Factors|immunologic factors|mesh-ancestor
92453697|NCT01694381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453698|NCT01694407|Tenofovir|tenofovir|mesh-list
92453699|NCT01694407|Emtricitabine|emtricitabine|mesh-list
92453700|NCT01694407|Antiviral Agents|antiviral agents|mesh-ancestor
92453701|NCT01694407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453702|NCT01694407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92453703|NCT01694407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92453704|NCT01694407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453705|NCT01694407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453706|NCT01694407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92453707|NCT01694407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92453708|NCT01694459|Heparin|heparin|mesh-list
92453709|NCT01694459|Calcium heparin|calcium heparin|mesh-list
92453710|NCT01694459|Anticoagulants|anticoagulants|mesh-ancestor
92453711|NCT01694459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92453712|NCT01694459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92453713|NCT01694459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453714|NCT01694498|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92453715|NCT01694498|Hemostatics|hemostatics|mesh-ancestor
92453716|NCT01694498|Coagulants|coagulants|mesh-ancestor
92453717|NCT01694498|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92453718|NCT01694498|Natriuretic Agents|natriuretic agents|mesh-ancestor
92453719|NCT01694498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453720|NCT01694576|Paclitaxel|paclitaxel|mesh-list
92453721|NCT01694576|Nedaplatin|nedaplatin|mesh-list
92453722|NCT01694576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92453723|NCT01694576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453724|NCT01694576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92453725|NCT01694576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92453726|NCT01694576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92453727|NCT01694576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453728|NCT01694693|Abatacept|abatacept|mesh-list
92453729|NCT01694693|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92453730|NCT01694693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453731|NCT01694693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92453732|NCT01694693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453733|NCT01694693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92453734|NCT01694693|Immunologic Factors|immunologic factors|mesh-ancestor
92453735|NCT01694693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453736|NCT01694693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453737|NCT01694732|Varenicline|varenicline|mesh-list
92453738|NCT01694732|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92453739|NCT01694732|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92453740|NCT01694732|Cholinergic Agents|cholinergic agents|mesh-ancestor
92453741|NCT01694732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453742|NCT01694732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531419|NCT00046345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92453743|NCT01694732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453744|NCT01694797|Metoprolol|metoprolol|mesh-list
92453745|NCT01694797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92453746|NCT01694797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92453747|NCT01694797|Sympatholytics|sympatholytics|mesh-ancestor
92453748|NCT01694797|Autonomic Agents|autonomic agents|mesh-ancestor
92453749|NCT01694797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453750|NCT01694797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453751|NCT01694797|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92453752|NCT01694797|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92453753|NCT01694797|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92453754|NCT01694797|Adrenergic Agents|adrenergic agents|mesh-ancestor
92453755|NCT01694797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453756|NCT01694797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453757|NCT01695005|Prednisone|prednisone|mesh-list
92453758|NCT01695005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453759|NCT01695005|Glucocorticoids|glucocorticoids|mesh-ancestor
92453760|NCT01695005|Hormones|hormones|mesh-ancestor
92453761|NCT01695005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453762|NCT01695005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453763|NCT01695005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92453764|NCT01695005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453765|NCT01695057|Vorinostat|vorinostat|mesh-list
92453766|NCT01695057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453767|NCT01695057|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92453768|NCT01695057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453769|NCT01695057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453770|NCT01695070|Melatonin|melatonin|mesh-list
92453771|NCT01695070|Antioxidants|antioxidants|mesh-ancestor
92453772|NCT01695070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453773|NCT01695070|Protective Agents|protective agents|mesh-ancestor
92453774|NCT01695070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453775|NCT01695070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453776|NCT01695109|Liraglutide|liraglutide|mesh-list
92453777|NCT01695109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453778|NCT01695109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453779|NCT01695109|Incretins|incretins|mesh-ancestor
92453780|NCT01695109|Hormones|hormones|mesh-ancestor
92453781|NCT01695109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453782|NCT01695122|Valproic Acid|valproic acid|mesh-list
92453783|NCT01695122|Anticonvulsants|anticonvulsants|mesh-ancestor
92453784|NCT01695122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453785|NCT01695122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453786|NCT01695122|GABA Agents|gaba agents|mesh-ancestor
92453787|NCT01695122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453788|NCT01695122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453789|NCT01695122|Antimanic Agents|antimanic agents|mesh-ancestor
92453791|NCT01695122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453792|NCT01695122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92453793|NCT01695148|Carotenoids|carotenoids|mesh-list
92453794|NCT01695148|Antioxidants|antioxidants|mesh-ancestor
92453795|NCT01695148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453796|NCT01695148|Protective Agents|protective agents|mesh-ancestor
92453797|NCT01695148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453798|NCT01695174|Rifaximin|rifaximin|mesh-list
92453799|NCT01695174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92453800|NCT01695174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453801|NCT01695174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453802|NCT01695187|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
92453803|NCT01695187|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
92453804|NCT01695187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453805|NCT01695187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453806|NCT01695226|Celecoxib|celecoxib|mesh-list
92453807|NCT01695226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92453808|NCT01695226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92453809|NCT01695226|Analgesics|analgesics|mesh-ancestor
92453810|NCT01695226|Sensory System Agents|sensory system agents|mesh-ancestor
92453811|NCT01695226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453812|NCT01695226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453813|NCT01695226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92453814|NCT01695226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92453815|NCT01695226|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92453816|NCT01695226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92453817|NCT01695226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453818|NCT01695226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453819|NCT01695356|Sunscreening Agents|sunscreening agents|mesh-list
92453820|NCT01695356|Zinc Oxide|zinc oxide|mesh-list
92453821|NCT01695356|Titanium dioxide|titanium dioxide|mesh-list
92453822|NCT01695356|Avobenzone|avobenzone|mesh-list
92453823|NCT01695356|Terephthalylidene dicamphor sulfonic acid|terephthalylidene dicamphor sulfonic acid|mesh-list
92453824|NCT01695356|Benzophenone|benzophenone|mesh-list
92453825|NCT01695356|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92453826|NCT01695356|Protective Agents|protective agents|mesh-ancestor
92453827|NCT01695356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453828|NCT01695356|Dermatologic Agents|dermatologic agents|mesh-ancestor
92453829|NCT01695356|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92453830|NCT01695460|Cholecalciferol|cholecalciferol|mesh-list
92453831|NCT01695460|Vitamins|vitamins|mesh-list
92453832|NCT01695460|Micronutrients|micronutrients|mesh-ancestor
92453833|NCT01695460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453834|NCT01695460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92453835|NCT01695460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92453836|NCT01695707|Pioglitazone|pioglitazone|mesh-list
92453837|NCT01695707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92453838|NCT01695707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453839|NCT01695733|Vaccines|vaccines|mesh-list
92453840|NCT01695733|Immunologic Factors|immunologic factors|mesh-ancestor
92453841|NCT01695733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453842|NCT01695759|Epoetin Alfa|epoetin alfa|mesh-list
92453843|NCT01695759|Hematinics|hematinics|mesh-ancestor
92453844|NCT01695798|Vaccines|vaccines|mesh-list
92453845|NCT01695798|Immunologic Factors|immunologic factors|mesh-ancestor
92453846|NCT01695798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453847|NCT01695824|Warfarin|warfarin|mesh-list
92453848|NCT01695824|Anticoagulants|anticoagulants|mesh-ancestor
92453849|NCT01695850|Sennosides|sennosides|mesh-list
92453850|NCT01695850|Laxatives|laxatives|mesh-ancestor
92453851|NCT01695850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453852|NCT01695902|Levonorgestrel|levonorgestrel|mesh-list
92453853|NCT01695902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92453854|NCT01695902|Contraceptive Agents|contraceptive agents|mesh-ancestor
92121630|NCT00105027|Triamcinolone|triamcinolone|mesh-list
92453855|NCT01695902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92453856|NCT01695902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453857|NCT01695902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92453858|NCT01695902|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92453859|NCT01695902|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92453860|NCT01696110|Heparin|heparin|mesh-list
92453861|NCT01696110|Calcium heparin|calcium heparin|mesh-list
92453862|NCT01696110|Tirofiban|tirofiban|mesh-list
92453863|NCT01696110|Bivalirudin|bivalirudin|mesh-list
92453864|NCT01696110|Anticoagulants|anticoagulants|mesh-ancestor
92453865|NCT01696110|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92453866|NCT01696110|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92453867|NCT01696110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453868|NCT01696110|Antithrombins|antithrombins|mesh-ancestor
92453869|NCT01696110|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92453870|NCT01696110|Protease Inhibitors|protease inhibitors|mesh-ancestor
92453871|NCT01696110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453872|NCT01696110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92453873|NCT01696240|Udenafil|udenafil|mesh-list
92453874|NCT01696240|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92453875|NCT01696240|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92453876|NCT01696240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453877|NCT01696240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453878|NCT01696370|Trimetazidine|trimetazidine|mesh-list
92453879|NCT01696370|Vasodilator Agents|vasodilator agents|mesh-ancestor
92453880|NCT01696383|Timolol|timolol|mesh-list
92453881|NCT01696383|Travoprost|travoprost|mesh-list
92453882|NCT01696383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92453883|NCT01696383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92453884|NCT01696383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92453885|NCT01696383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453886|NCT01696383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453887|NCT01696383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453888|NCT01696383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92453889|NCT01696383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92453890|NCT01696409|Vitamin D|vitamin d|mesh-list
92453891|NCT01696409|Ergocalciferols|ergocalciferols|mesh-list
92453892|NCT01696409|Cholecalciferol|cholecalciferol|mesh-list
92453893|NCT01696409|Vitamins|vitamins|mesh-list
92453894|NCT01696409|Micronutrients|micronutrients|mesh-ancestor
92453895|NCT01696409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453896|NCT01696409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92453897|NCT01696409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92453899|NCT01696422|Immunologic Factors|immunologic factors|mesh-ancestor
92453900|NCT01696422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453901|NCT01696448|Thioctic Acid|thioctic acid|mesh-list
92453902|NCT01696448|Antioxidants|antioxidants|mesh-ancestor
92453903|NCT01696448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453904|NCT01696448|Protective Agents|protective agents|mesh-ancestor
92453905|NCT01696448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453906|NCT01696448|Vitamin B Complex|vitamin b complex|mesh-ancestor
92453907|NCT01696448|Vitamins|vitamins|mesh-ancestor
92453908|NCT01696448|Micronutrients|micronutrients|mesh-ancestor
92453909|NCT01696461|Plerixafor|plerixafor|mesh-list
92453910|NCT01696461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92453911|NCT01696461|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92453912|NCT01696461|Antiviral Agents|antiviral agents|mesh-ancestor
92453913|NCT01696461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453914|NCT01696474|Bortezomib|bortezomib|mesh-list
92453915|NCT01696474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92453916|NCT01696500|Immunoglobulins|immunoglobulins|mesh-list
92453917|NCT01696500|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92453918|NCT01696500|Antibodies|antibodies|mesh-list
92453919|NCT01696500|gamma-Globulins|gamma-globulins|mesh-list
92453920|NCT01696500|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92453921|NCT01696500|Immunologic Factors|immunologic factors|mesh-ancestor
92453922|NCT01696500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453923|NCT01696526|Vitamin D|vitamin d|mesh-list
92453924|NCT01696526|Vitamins|vitamins|mesh-ancestor
92453925|NCT01696526|Micronutrients|micronutrients|mesh-ancestor
92453926|NCT01696526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453927|NCT01696526|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92453928|NCT01696552|Cimetidine|cimetidine|mesh-list
92453929|NCT01696552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92453930|NCT01696552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453931|NCT01696552|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92453932|NCT01696552|Histamine Antagonists|histamine antagonists|mesh-ancestor
92453933|NCT01696552|Histamine Agents|histamine agents|mesh-ancestor
92453934|NCT01696552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453935|NCT01696552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453936|NCT01696552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453937|NCT01696552|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92453938|NCT01696552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92453939|NCT01696552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453940|NCT01696617|Aripiprazole|aripiprazole|mesh-list
92453941|NCT01696617|Antidepressive Agents|antidepressive agents|mesh-ancestor
92453942|NCT01696617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92453943|NCT01696617|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92453944|NCT01696617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92453945|NCT01696617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453946|NCT01696617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453947|NCT01696617|Dopamine Agonists|dopamine agonists|mesh-ancestor
92453949|NCT01696617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92453950|NCT01696617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453951|NCT01696617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92453952|NCT01696617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92453953|NCT01696617|Serotonin Agents|serotonin agents|mesh-ancestor
92453954|NCT01696617|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92453955|NCT01696617|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92453956|NCT01696617|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92453957|NCT01696617|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92453958|NCT01696630|Desflurane|desflurane|mesh-list
92453959|NCT01696630|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92453960|NCT01696630|Anesthetics, General|anesthetics, general|mesh-ancestor
92453961|NCT01696630|Anesthetics|anesthetics|mesh-ancestor
92453962|NCT01696630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453963|NCT01696630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453964|NCT01696656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92453965|NCT01696656|Gastrointestinal Agents|gastrointestinal agents|mesh-list
92453966|NCT01696656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453967|NCT01696799|Econazole|econazole|mesh-list
92453968|NCT01696799|Antifungal Agents|antifungal agents|mesh-ancestor
92453969|NCT01696799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92453970|NCT01696799|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92453971|NCT01696799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92453972|NCT01696799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453973|NCT01696799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92453974|NCT01696799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92453975|NCT01696799|Hormone Antagonists|hormone antagonists|mesh-ancestor
92453976|NCT01696799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92453977|NCT01696799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453978|NCT01696825|Diazepam|diazepam|mesh-list
92453979|NCT01696825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92453980|NCT01696825|Anticonvulsants|anticonvulsants|mesh-ancestor
92453981|NCT01696825|Antiemetics|antiemetics|mesh-ancestor
92453982|NCT01696825|Autonomic Agents|autonomic agents|mesh-ancestor
92453983|NCT01696825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92453984|NCT01696825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92453985|NCT01696825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92453986|NCT01696825|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92453987|NCT01696825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92453988|NCT01696825|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92453989|NCT01696825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92453990|NCT01696825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92453991|NCT01696825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92453992|NCT01696825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92453993|NCT01696825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92453994|NCT01696825|Anesthetics, General|anesthetics, general|mesh-ancestor
92453995|NCT01696825|Anesthetics|anesthetics|mesh-ancestor
92453996|NCT01696825|GABA Modulators|gaba modulators|mesh-ancestor
92453997|NCT01696825|GABA Agents|gaba agents|mesh-ancestor
92453998|NCT01696825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347405|NCT01754376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92453999|NCT01696825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454000|NCT01697020|Mercaptopurine|mercaptopurine|mesh-list
92454001|NCT01697020|Antimetabolites|antimetabolites|mesh-ancestor
92454002|NCT01697020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454003|NCT01697020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92454004|NCT01697020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454005|NCT01697020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454006|NCT01697020|Immunologic Factors|immunologic factors|mesh-ancestor
92454007|NCT01697020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454008|NCT01697020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92454009|NCT01697020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454010|NCT01697046|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92454011|NCT01697046|Raltegravir Potassium|raltegravir potassium|mesh-list
92454012|NCT01697046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92454013|NCT01697046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92454014|NCT01697046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454015|NCT01697046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454016|NCT01697046|Antiviral Agents|antiviral agents|mesh-ancestor
92454017|NCT01697046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454018|NCT01697046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92454019|NCT01697046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92454020|NCT01697046|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92454021|NCT01697046|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92454022|NCT01697059|Amoxicillin|amoxicillin|mesh-list
92454023|NCT01697059|Piperacillin|piperacillin|mesh-list
92454024|NCT01697059|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92454025|NCT01697059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454026|NCT01697059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454027|NCT01697059|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92454028|NCT01697059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454029|NCT01697059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454030|NCT01697098|Dexamethasone|dexamethasone|mesh-list
92454031|NCT01697098|Dexamethasone acetate|dexamethasone acetate|mesh-list
92454032|NCT01697098|Glucocorticoids|glucocorticoids|mesh-list
92454034|NCT01697098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454035|NCT01697098|Antiemetics|antiemetics|mesh-ancestor
92454036|NCT01697098|Autonomic Agents|autonomic agents|mesh-ancestor
92454037|NCT01697098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454038|NCT01697098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454039|NCT01697098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454040|NCT01697098|Hormones|hormones|mesh-ancestor
92454041|NCT01697098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454042|NCT01697098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454043|NCT01697098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454044|NCT01697098|Protease Inhibitors|protease inhibitors|mesh-ancestor
92454045|NCT01697098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454046|NCT01697098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454047|NCT01697111|Dienogest|dienogest|mesh-list
92454048|NCT01697111|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92454049|NCT01697111|Contraceptive Agents|contraceptive agents|mesh-ancestor
92454050|NCT01697111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92454051|NCT01697111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454052|NCT01697111|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92454053|NCT01697111|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92454054|NCT01697111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92454055|NCT01697111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92454056|NCT01697111|Hormone Antagonists|hormone antagonists|mesh-ancestor
92454057|NCT01697111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454058|NCT01697111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454059|NCT01697111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454060|NCT01697150|Pancrelipase|pancrelipase|mesh-list
92454061|NCT01697150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454062|NCT01697228|Vitamin D|vitamin d|mesh-list
92454063|NCT01697228|Vitamins|vitamins|mesh-ancestor
92454064|NCT01697228|Micronutrients|micronutrients|mesh-ancestor
92454065|NCT01697228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121845|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
92454066|NCT01697228|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92454067|NCT01697293|Paclitaxel|paclitaxel|mesh-list
92454068|NCT01697293|Cyclophosphamide|cyclophosphamide|mesh-list
92454069|NCT01697293|Doxorubicin|doxorubicin|mesh-list
92454070|NCT01697293|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92454071|NCT01697293|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92454072|NCT01697293|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92454073|NCT01697293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454074|NCT01697293|Tubulin Modulators|tubulin modulators|mesh-ancestor
92454075|NCT01697293|Antimitotic Agents|antimitotic agents|mesh-ancestor
92454076|NCT01697293|Mitosis Modulators|mitosis modulators|mesh-ancestor
92454077|NCT01697293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454078|NCT01697293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454079|NCT01697293|Immunologic Factors|immunologic factors|mesh-ancestor
92454080|NCT01697293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454081|NCT01697293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92454082|NCT01697293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92454083|NCT01697293|Alkylating Agents|alkylating agents|mesh-ancestor
92454084|NCT01697293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92454085|NCT01697293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92454086|NCT01697293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92454087|NCT01697293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92454088|NCT01697293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454089|NCT01697306|Gemcitabine|gemcitabine|mesh-list
92454090|NCT01697306|BCG Vaccine|bcg vaccine|mesh-list
92454091|NCT01697306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92454092|NCT01697306|Antimetabolites|antimetabolites|mesh-ancestor
92454093|NCT01697306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454094|NCT01697306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454095|NCT01697306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92454096|NCT01697306|Immunologic Factors|immunologic factors|mesh-ancestor
92454097|NCT01697306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454098|NCT01697410|Terlipressin|terlipressin|mesh-list
92454099|NCT01697410|Norepinephrine|norepinephrine|mesh-list
92454100|NCT01697410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92454101|NCT01697410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92454102|NCT01697410|Adrenergic Agents|adrenergic agents|mesh-ancestor
92454103|NCT01697410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454104|NCT01697410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454105|NCT01697410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454106|NCT01697410|Sympathomimetics|sympathomimetics|mesh-ancestor
92454107|NCT01697410|Autonomic Agents|autonomic agents|mesh-ancestor
92454108|NCT01697410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454109|NCT01697410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92454110|NCT01697410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92454111|NCT01697436|Ribavirin|ribavirin|mesh-list
92454112|NCT01697436|Antimetabolites|antimetabolites|mesh-ancestor
92454113|NCT01697436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454114|NCT01697436|Antiviral Agents|antiviral agents|mesh-ancestor
92454115|NCT01697436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454116|NCT01697605|Infigratinib|infigratinib|mesh-list
92454117|NCT01697605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454118|NCT01697618|Insulin|insulin|mesh-list
92454119|NCT01697618|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92454120|NCT01697618|Insulin Aspart|insulin aspart|mesh-list
92454121|NCT01697618|Biphasic Insulins|biphasic insulins|mesh-list
92454122|NCT01697618|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92454123|NCT01697618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92454124|NCT01697618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454125|NCT01697631|Insulin|insulin|mesh-list
92454126|NCT01697631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92454127|NCT01697631|Insulin Aspart|insulin aspart|mesh-list
92454128|NCT01697631|Insulin, Long-Acting|insulin, long-acting|mesh-list
92454129|NCT01697631|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92454130|NCT01697631|Biphasic Insulins|biphasic insulins|mesh-list
92454131|NCT01697631|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92454132|NCT01697631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92454133|NCT01697631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454134|NCT01697657|Insulin|insulin|mesh-list
92454135|NCT01697657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92454136|NCT01697657|Insulin Aspart|insulin aspart|mesh-list
92454137|NCT01697657|Insulin Detemir|insulin detemir|mesh-list
92454138|NCT01697657|Isophane Insulin, Human|isophane insulin, human|mesh-list
92454139|NCT01697657|Insulin, Isophane|insulin, isophane|mesh-list
92454140|NCT01697657|Isophane insulin, beef|isophane insulin, beef|mesh-list
92454141|NCT01697657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92454142|NCT01697657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454143|NCT01697670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92454144|NCT01697670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92454145|NCT01697670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92454146|NCT01697722|Beclomethasone|beclomethasone|mesh-list
92454147|NCT01697722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454148|NCT01697722|Glucocorticoids|glucocorticoids|mesh-ancestor
92454150|NCT01697722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454151|NCT01697722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454152|NCT01697722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92454153|NCT01697722|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454154|NCT01697735|Atorvastatin|atorvastatin|mesh-list
92454155|NCT01697735|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92454156|NCT01697735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92454157|NCT01697735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92454158|NCT01697735|Antimetabolites|antimetabolites|mesh-ancestor
92454159|NCT01697735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454160|NCT01697735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92454161|NCT01697735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92454162|NCT01697735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454163|NCT01697787|Artesunate|artesunate|mesh-list
92454164|NCT01697787|Lumefantrine|lumefantrine|mesh-list
92454165|NCT01697787|Artemether|artemether|mesh-list
92454166|NCT01697787|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92454167|NCT01697787|Amodiaquine|amodiaquine|mesh-list
92454168|NCT01697787|Antimalarials|antimalarials|mesh-ancestor
92454169|NCT01697787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92454170|NCT01697787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92454171|NCT01697787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454172|NCT01697787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454173|NCT01697787|Antiviral Agents|antiviral agents|mesh-ancestor
92454174|NCT01697787|Schistosomicides|schistosomicides|mesh-ancestor
92454175|NCT01697787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92454176|NCT01697787|Anthelmintics|anthelmintics|mesh-ancestor
92454177|NCT01697826|Clindamycin|clindamycin|mesh-list
92454178|NCT01697826|Clindamycin palmitate|clindamycin palmitate|mesh-list
92454179|NCT01697826|Clindamycin phosphate|clindamycin phosphate|mesh-list
92454180|NCT01697826|Clotrimazole|clotrimazole|mesh-list
92454181|NCT01697826|Miconazole|miconazole|mesh-list
92454182|NCT01697826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454183|NCT01697826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454184|NCT01697826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92454185|NCT01697826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454186|NCT01697826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454187|NCT01697826|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92454188|NCT01697826|Antifungal Agents|antifungal agents|mesh-ancestor
92454189|NCT01697826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92454190|NCT01697826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92454191|NCT01697826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92454192|NCT01697826|Hormone Antagonists|hormone antagonists|mesh-ancestor
92454193|NCT01697826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454194|NCT01697826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454195|NCT01697826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92454196|NCT01697826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92454197|NCT01698164|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92454198|NCT01698164|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92454199|NCT01698164|Estradiol|estradiol|mesh-list
92454200|NCT01698164|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92454201|NCT01698164|Progesterone|progesterone|mesh-list
92454202|NCT01698164|Estrogens|estrogens|mesh-ancestor
92454203|NCT01698164|Hormones|hormones|mesh-ancestor
92454204|NCT01698164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454205|NCT01698164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454206|NCT01698164|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92454207|NCT01698164|Contraceptive Agents|contraceptive agents|mesh-ancestor
92454208|NCT01698164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92454209|NCT01698164|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92454210|NCT01698164|Progestins|progestins|mesh-ancestor
92454211|NCT01698177|Vaccines|vaccines|mesh-list
92454212|NCT01698177|Immunologic Factors|immunologic factors|mesh-ancestor
92454213|NCT01698177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454214|NCT01698203|Ropivacaine|ropivacaine|mesh-list
92454215|NCT01698203|Anesthetics, Local|anesthetics, local|mesh-ancestor
92454216|NCT01698203|Anesthetics|anesthetics|mesh-ancestor
92454217|NCT01698203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454218|NCT01698203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454219|NCT01698203|Sensory System Agents|sensory system agents|mesh-ancestor
92454220|NCT01698203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454221|NCT01698476|Vitamin D|vitamin d|mesh-list
92454222|NCT01698476|Cholecalciferol|cholecalciferol|mesh-list
92454223|NCT01698476|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92454224|NCT01698476|Vitamins|vitamins|mesh-ancestor
92454225|NCT01698476|Micronutrients|micronutrients|mesh-ancestor
92454226|NCT01698476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454227|NCT01698476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92454228|NCT01698476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92454229|NCT01698476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454230|NCT01698541|Tacrolimus|tacrolimus|mesh-list
92454231|NCT01698541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454232|NCT01698541|Immunologic Factors|immunologic factors|mesh-ancestor
92454233|NCT01698541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454234|NCT01698541|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92454235|NCT01698541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454236|NCT01698541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454237|NCT01698567|Antithrombins|antithrombins|mesh-list
92454238|NCT01698567|Antithrombin III|antithrombin iii|mesh-list
92454239|NCT01698567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92454240|NCT01698567|Protease Inhibitors|protease inhibitors|mesh-ancestor
92454241|NCT01698567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454242|NCT01698567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454243|NCT01698567|Anticoagulants|anticoagulants|mesh-ancestor
92454245|NCT01698593|Bupivacaine|bupivacaine|mesh-list
92454246|NCT01698593|Anesthetics, Local|anesthetics, local|mesh-ancestor
92454247|NCT01698593|Anesthetics|anesthetics|mesh-ancestor
92454248|NCT01698593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454249|NCT01698593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454250|NCT01698593|Sensory System Agents|sensory system agents|mesh-ancestor
92454251|NCT01698593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454252|NCT01698593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92454253|NCT01698593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92454254|NCT01698593|Adrenergic Agents|adrenergic agents|mesh-ancestor
92454255|NCT01698593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454256|NCT01698593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454257|NCT01698593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92454258|NCT01698593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92454259|NCT01698593|Autonomic Agents|autonomic agents|mesh-ancestor
92454260|NCT01698593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92454261|NCT01698593|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454262|NCT01698593|Mydriatics|mydriatics|mesh-ancestor
92454263|NCT01698593|Sympathomimetics|sympathomimetics|mesh-ancestor
92454264|NCT01698593|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92454265|NCT01698645|Fentanyl|fentanyl|mesh-list
92454266|NCT01698645|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92454267|NCT01698645|Narcotics|narcotics|mesh-ancestor
92454268|NCT01698645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454269|NCT01698645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454270|NCT01698645|Analgesics|analgesics|mesh-ancestor
92454271|NCT01698645|Sensory System Agents|sensory system agents|mesh-ancestor
92454272|NCT01698645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454273|NCT01698645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92454274|NCT01698645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92454275|NCT01698645|Anesthetics, General|anesthetics, general|mesh-ancestor
92454276|NCT01698645|Anesthetics|anesthetics|mesh-ancestor
92454277|NCT01698697|Insulin Aspart|insulin aspart|mesh-list
92454278|NCT01698697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92454279|NCT01698697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454281|NCT01698723|Antimetabolites|antimetabolites|mesh-ancestor
92454282|NCT01698723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454283|NCT01698723|Antiviral Agents|antiviral agents|mesh-ancestor
92454284|NCT01698723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454285|NCT01698749|Dexamethasone|dexamethasone|mesh-list
92454286|NCT01698749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454287|NCT01698749|Antiemetics|antiemetics|mesh-ancestor
92454288|NCT01698749|Autonomic Agents|autonomic agents|mesh-ancestor
92454289|NCT01698749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454290|NCT01698749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454291|NCT01698749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454292|NCT01698749|Glucocorticoids|glucocorticoids|mesh-ancestor
92454293|NCT01698749|Hormones|hormones|mesh-ancestor
92454294|NCT01698749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454295|NCT01698749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454296|NCT01698749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454297|NCT01698788|Dexamethasone|dexamethasone|mesh-list
92454298|NCT01698788|Dexamethasone acetate|dexamethasone acetate|mesh-list
92454299|NCT01698788|BB 1101|bb 1101|mesh-list
92454300|NCT01698788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454301|NCT01698788|Antiemetics|antiemetics|mesh-ancestor
92454302|NCT01698788|Autonomic Agents|autonomic agents|mesh-ancestor
92454303|NCT01698788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454304|NCT01698788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454305|NCT01698788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454306|NCT01698788|Glucocorticoids|glucocorticoids|mesh-ancestor
92454307|NCT01698788|Hormones|hormones|mesh-ancestor
92454308|NCT01698788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454309|NCT01698788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454310|NCT01698788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454311|NCT01698788|Protease Inhibitors|protease inhibitors|mesh-ancestor
92454312|NCT01698788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454313|NCT01698788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454314|NCT01698931|Glyburide|glyburide|mesh-list
92454315|NCT01698931|Repaglinide|repaglinide|mesh-list
92454316|NCT01698931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92454317|NCT01698931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179216|NCT01527045|Calcium|calcium|mesh-list
92454318|NCT01699113|Rabeprazole|rabeprazole|mesh-list
92454319|NCT01699113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92454320|NCT01699113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454321|NCT01699113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92454322|NCT01699113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454323|NCT01699113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454324|NCT01699126|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92454325|NCT01699126|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92454326|NCT01699126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92454327|NCT01699126|Antimetabolites|antimetabolites|mesh-ancestor
92454328|NCT01699126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454329|NCT01699126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92454330|NCT01699126|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92454331|NCT01699126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454332|NCT01699204|Acetylcysteine|acetylcysteine|mesh-list
92454333|NCT01699204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92454334|NCT01699204|Antiviral Agents|antiviral agents|mesh-ancestor
92454335|NCT01699204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454336|NCT01699204|Expectorants|expectorants|mesh-ancestor
92454337|NCT01699204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454338|NCT01699204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92454339|NCT01699204|Antioxidants|antioxidants|mesh-ancestor
92454340|NCT01699204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454341|NCT01699204|Protective Agents|protective agents|mesh-ancestor
92454342|NCT01699204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454343|NCT01699204|Antidotes|antidotes|mesh-ancestor
92454344|NCT01699282|Antivitamins K|antivitamins k|mesh-list
92454345|NCT01699282|Anticoagulants|anticoagulants|mesh-ancestor
92454346|NCT01699347|Picibanil|picibanil|mesh-list
92454347|NCT01699347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454348|NCT01699360|Cyclosporine|cyclosporine|mesh-list
92454349|NCT01699360|Sirolimus|sirolimus|mesh-list
92454350|NCT01699360|Tacrolimus|tacrolimus|mesh-list
92454351|NCT01699360|Cyclosporins|cyclosporins|mesh-list
92454352|NCT01699360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454353|NCT01699360|Immunologic Factors|immunologic factors|mesh-ancestor
92454354|NCT01699360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454355|NCT01699360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92454356|NCT01699360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454357|NCT01699360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454358|NCT01699360|Antifungal Agents|antifungal agents|mesh-ancestor
92454359|NCT01699360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454360|NCT01699360|Dermatologic Agents|dermatologic agents|mesh-ancestor
92454361|NCT01699360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92454362|NCT01699360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454363|NCT01699360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92454364|NCT01699360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454365|NCT01699412|Dexamethasone|dexamethasone|mesh-list
92454366|NCT01699412|Clobetasol|clobetasol|mesh-list
92454367|NCT01699412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454368|NCT01699412|Antiemetics|antiemetics|mesh-ancestor
92454369|NCT01699412|Autonomic Agents|autonomic agents|mesh-ancestor
92454370|NCT01699412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454371|NCT01699412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454372|NCT01699412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454373|NCT01699412|Glucocorticoids|glucocorticoids|mesh-ancestor
92454374|NCT01699412|Hormones|hormones|mesh-ancestor
92454375|NCT01699412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454376|NCT01699412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454377|NCT01699412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454378|NCT01699438|Mesalamine|mesalamine|mesh-list
92454379|NCT01699438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92454380|NCT01699438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92454381|NCT01699438|Analgesics|analgesics|mesh-ancestor
92454382|NCT01699438|Sensory System Agents|sensory system agents|mesh-ancestor
92454383|NCT01699438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454384|NCT01699438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454385|NCT01699438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454386|NCT01699438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92454387|NCT01699490|Valsartan|valsartan|mesh-list
92454388|NCT01699490|Fluoxetine|fluoxetine|mesh-list
92454389|NCT01699490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92454390|NCT01699490|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92454391|NCT01699490|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92454392|NCT01699490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454393|NCT01699490|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92454394|NCT01699490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92454395|NCT01699490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92454396|NCT01699490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454397|NCT01699490|Serotonin Agents|serotonin agents|mesh-ancestor
92454398|NCT01699490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454399|NCT01699490|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92454400|NCT01699490|Antidepressive Agents|antidepressive agents|mesh-ancestor
92454401|NCT01699490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92454402|NCT01699490|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92454403|NCT01699490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92454404|NCT01699490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454405|NCT01699594|Mannitol|mannitol|mesh-list
92454406|NCT01699594|Methacholine Chloride|methacholine chloride|mesh-list
92454407|NCT01699594|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92454408|NCT01699594|Diuretics|diuretics|mesh-ancestor
92454409|NCT01699594|Natriuretic Agents|natriuretic agents|mesh-ancestor
92454410|NCT01699594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454411|NCT01699594|Miotics|miotics|mesh-ancestor
92454412|NCT01699594|Autonomic Agents|autonomic agents|mesh-ancestor
92454413|NCT01699594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454414|NCT01699594|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92454415|NCT01699594|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92454416|NCT01699594|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454417|NCT01699594|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92454418|NCT01699594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92454419|NCT01699594|Cholinergic Agents|cholinergic agents|mesh-ancestor
92454420|NCT01699594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454421|NCT01699594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454422|NCT01699659|Immunomodulating Agents|immunomodulating agents|mesh-list
92454423|NCT01699659|Immunologic Factors|immunologic factors|mesh-ancestor
92454424|NCT01699659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454425|NCT01699711|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92454426|NCT01699711|Antioxidants|antioxidants|mesh-ancestor
92454427|NCT01699711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454428|NCT01699711|Protective Agents|protective agents|mesh-ancestor
92454429|NCT01699711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454430|NCT01699711|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92454431|NCT01699711|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92454432|NCT01699711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454433|NCT01699711|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92454434|NCT01699724|Sertraline|sertraline|mesh-list
92454435|NCT01699724|Antidepressive Agents|antidepressive agents|mesh-ancestor
92454436|NCT01699724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92454437|NCT01699724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92454438|NCT01699724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92454439|NCT01699724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92454440|NCT01699724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454441|NCT01699724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454442|NCT01699724|Serotonin Agents|serotonin agents|mesh-ancestor
92454443|NCT01699724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454444|NCT01699776|Digoxin|digoxin|mesh-list
92454445|NCT01699776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92454446|NCT01699776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92454447|NCT01699776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454448|NCT01699776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454449|NCT01699776|Protective Agents|protective agents|mesh-ancestor
92454450|NCT01699776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454452|NCT01699802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454453|NCT01699802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454455|NCT01699828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92454456|NCT01699828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92454457|NCT01699828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454458|NCT01699828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454459|NCT01699828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92454460|NCT01699828|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92454461|NCT01699828|Serotonin Agents|serotonin agents|mesh-ancestor
92454462|NCT01699828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454463|NCT01699828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454464|NCT01699854|Capsaicin|capsaicin|mesh-list
92454465|NCT01699854|Antipruritics|antipruritics|mesh-ancestor
92454466|NCT01699854|Dermatologic Agents|dermatologic agents|mesh-ancestor
92454467|NCT01699854|Sensory System Agents|sensory system agents|mesh-ancestor
92454468|NCT01699854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454469|NCT01699854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454470|NCT01699919|Lidocaine|lidocaine|mesh-list
92454471|NCT01699919|Anesthetics, Local|anesthetics, local|mesh-ancestor
92454472|NCT01699919|Anesthetics|anesthetics|mesh-ancestor
92454473|NCT01699919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454474|NCT01699919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454475|NCT01699919|Sensory System Agents|sensory system agents|mesh-ancestor
92454476|NCT01699919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454477|NCT01699919|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92454478|NCT01699919|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92454479|NCT01699919|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92454480|NCT01699919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92454481|NCT01699919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454482|NCT01699932|Metformin|metformin|mesh-list
92454483|NCT01699932|Glimepiride|glimepiride|mesh-list
92454484|NCT01699932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92454485|NCT01699932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454486|NCT01699932|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92454487|NCT01699932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454488|NCT01699932|Immunologic Factors|immunologic factors|mesh-ancestor
92454489|NCT01699997|Oxytocin|oxytocin|mesh-list
92454490|NCT01699997|Oxytocics|oxytocics|mesh-ancestor
92454491|NCT01699997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92454492|NCT01699997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454493|NCT01700010|Paclitaxel|paclitaxel|mesh-list
92454494|NCT01700010|Lapatinib|lapatinib|mesh-list
92454495|NCT01700010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92454496|NCT01700010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454497|NCT01700010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92454498|NCT01700010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92454499|NCT01700010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92454500|NCT01700010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454501|NCT01700010|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92454502|NCT01700010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454503|NCT01700270|Fluvoxamine|fluvoxamine|mesh-list
92454504|NCT01700270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92454505|NCT01700270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92454506|NCT01700270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454507|NCT01700270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454508|NCT01700270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92454509|NCT01700270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92454510|NCT01700270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92454511|NCT01700270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92454512|NCT01700270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454513|NCT01700270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454514|NCT01700270|Serotonin Agents|serotonin agents|mesh-ancestor
92454515|NCT01700270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92454516|NCT01700270|Antidepressive Agents|antidepressive agents|mesh-ancestor
92454517|NCT01700270|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92454518|NCT01700270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92454519|NCT01700270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454520|NCT01700270|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92454521|NCT01700322|Clopidogrel|clopidogrel|mesh-list
92454522|NCT01700322|Ticagrelor|ticagrelor|mesh-list
92454524|NCT01700322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92454525|NCT01700322|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92454526|NCT01700322|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92454527|NCT01700322|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92454528|NCT01700322|Purinergic Agents|purinergic agents|mesh-ancestor
92454529|NCT01700322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454530|NCT01700322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454531|NCT01700322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454532|NCT01700400|Bevacizumab|bevacizumab|mesh-list
92454533|NCT01700400|Carboplatin|carboplatin|mesh-list
92454534|NCT01700400|Pemetrexed|pemetrexed|mesh-list
92454535|NCT01700400|Everolimus|everolimus|mesh-list
92454536|NCT01700400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92454537|NCT01700400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454538|NCT01700400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92454539|NCT01700400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92454540|NCT01700400|Growth Substances|growth substances|mesh-ancestor
92454541|NCT01700400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454542|NCT01700400|Growth Inhibitors|growth inhibitors|mesh-ancestor
92454543|NCT01700400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454544|NCT01700400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454546|NCT01700400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92454547|NCT01700400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92454548|NCT01700400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92454549|NCT01700400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454550|NCT01700400|Immunologic Factors|immunologic factors|mesh-ancestor
92454551|NCT01700413|Idarubicin|idarubicin|mesh-list
92454552|NCT01700413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92454553|NCT01700413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454554|NCT01700413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92454555|NCT01700413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92454556|NCT01700413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454557|NCT01700413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454558|NCT01700426|Vitamins|vitamins|mesh-list
92454559|NCT01700426|Vitamin E|vitamin e|mesh-list
92454560|NCT01700426|Tocopherols|tocopherols|mesh-list
92454561|NCT01700426|Tocotrienols|tocotrienols|mesh-list
92454562|NCT01700426|alpha-Tocopherol|alpha-tocopherol|mesh-list
92454563|NCT01700426|Micronutrients|micronutrients|mesh-ancestor
92454564|NCT01700426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454565|NCT01700426|Antioxidants|antioxidants|mesh-ancestor
92454566|NCT01700426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454567|NCT01700426|Protective Agents|protective agents|mesh-ancestor
92454568|NCT01700478|Vasopressins|vasopressins|mesh-list
92454569|NCT01700478|Arginine Vasopressin|arginine vasopressin|mesh-list
92454570|NCT01700478|Misoprostol|misoprostol|mesh-list
92454571|NCT01700478|Diuretics|diuretics|mesh-list
92454572|NCT01700478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454573|NCT01700478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92454574|NCT01700478|Abortifacient Agents|abortifacient agents|mesh-ancestor
92454575|NCT01700478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92454576|NCT01700478|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92454577|NCT01700478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454578|NCT01700478|Oxytocics|oxytocics|mesh-ancestor
92454579|NCT01700478|Natriuretic Agents|natriuretic agents|mesh-ancestor
92454580|NCT01700478|Hemostatics|hemostatics|mesh-ancestor
92454581|NCT01700478|Coagulants|coagulants|mesh-ancestor
92454582|NCT01700478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92454583|NCT01700478|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92454584|NCT01700491|Ropivacaine|ropivacaine|mesh-list
92454585|NCT01700491|Anesthetics, Local|anesthetics, local|mesh-ancestor
92454586|NCT01700491|Anesthetics|anesthetics|mesh-ancestor
92454587|NCT01700491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454588|NCT01700491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454589|NCT01700491|Sensory System Agents|sensory system agents|mesh-ancestor
92454590|NCT01700491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454591|NCT01700504|Gentamicins|gentamicins|mesh-list
92454592|NCT01700504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454593|NCT01700504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454594|NCT01700504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92454595|NCT01700504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454596|NCT01700504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454597|NCT01700608|Plerixafor|plerixafor|mesh-list
92454598|NCT01700608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92454599|NCT01700608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92454601|NCT01700608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454602|NCT01700751|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92454603|NCT01700751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92454604|NCT01700751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454605|NCT01700751|Immunotoxins|immunotoxins|mesh-ancestor
92454606|NCT01700751|Immunoconjugates|immunoconjugates|mesh-ancestor
92454607|NCT01700751|Immunologic Factors|immunologic factors|mesh-ancestor
92454608|NCT01700751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454609|NCT01700790|Ritonavir|ritonavir|mesh-list
92454610|NCT01700790|Lopinavir|lopinavir|mesh-list
92454611|NCT01700790|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92454612|NCT01700790|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92454613|NCT01700790|Protease Inhibitors|protease inhibitors|mesh-ancestor
92454614|NCT01700790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454615|NCT01700790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454616|NCT01700790|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92454617|NCT01700790|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92454618|NCT01700790|Antiviral Agents|antiviral agents|mesh-ancestor
92454619|NCT01700790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454620|NCT01700790|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92454621|NCT01700790|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92454622|NCT01700803|Iodine|iodine|mesh-list
92454623|NCT01700803|Cadexomer iodine|cadexomer iodine|mesh-list
92454624|NCT01700803|Povidone-Iodine|povidone-iodine|mesh-list
92454625|NCT01700803|Povidone|povidone|mesh-list
92454626|NCT01700803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92454627|NCT01700803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454628|NCT01700803|Trace Elements|trace elements|mesh-ancestor
92454629|NCT01700803|Micronutrients|micronutrients|mesh-ancestor
92454630|NCT01700803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454631|NCT01700803|Plasma Substitutes|plasma substitutes|mesh-ancestor
92454632|NCT01700803|Blood Substitutes|blood substitutes|mesh-ancestor
92454633|NCT01700881|Vitamin E|vitamin e|mesh-list
92454634|NCT01700881|Vitamins|vitamins|mesh-ancestor
92454635|NCT01700881|Micronutrients|micronutrients|mesh-ancestor
92454636|NCT01700881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454637|NCT01700881|Antioxidants|antioxidants|mesh-ancestor
92454638|NCT01700881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454639|NCT01700881|Protective Agents|protective agents|mesh-ancestor
92454640|NCT01701076|Dexamethasone|dexamethasone|mesh-list
92454641|NCT01701076|Lenalidomide|lenalidomide|mesh-list
92454642|NCT01701076|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92454643|NCT01701076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454644|NCT01701076|Antiemetics|antiemetics|mesh-ancestor
92454645|NCT01701076|Autonomic Agents|autonomic agents|mesh-ancestor
92454646|NCT01701076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454647|NCT01701076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454648|NCT01701076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454649|NCT01701076|Glucocorticoids|glucocorticoids|mesh-ancestor
92454650|NCT01701076|Hormones|hormones|mesh-ancestor
92454651|NCT01701076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454652|NCT01701076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454653|NCT01701076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454654|NCT01701076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454655|NCT01701076|Immunologic Factors|immunologic factors|mesh-ancestor
92454656|NCT01701076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92454657|NCT01701076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92454658|NCT01701076|Growth Substances|growth substances|mesh-ancestor
92454659|NCT01701076|Growth Inhibitors|growth inhibitors|mesh-ancestor
92454660|NCT01701076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92454661|NCT01701076|Alkylating Agents|alkylating agents|mesh-ancestor
92454662|NCT01701089|Selegiline|selegiline|mesh-list
92454663|NCT01701089|Antidepressive Agents|antidepressive agents|mesh-ancestor
92454664|NCT01701089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92454665|NCT01701089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92454666|NCT01701089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92454667|NCT01701089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92454668|NCT01701089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454669|NCT01701089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454670|NCT01701089|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92454671|NCT01701089|Protective Agents|protective agents|mesh-ancestor
92454672|NCT01701089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454673|NCT01701180|Oxytocin|oxytocin|mesh-list
92454674|NCT01701180|Oxytocics|oxytocics|mesh-ancestor
92454675|NCT01701180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92454676|NCT01701180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454677|NCT01701219|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92454678|NCT01701219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454679|NCT01701219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454680|NCT01701232|Rituximab|rituximab|mesh-list
92454681|NCT01701232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92454682|NCT01701232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454683|NCT01701232|Immunologic Factors|immunologic factors|mesh-ancestor
92454684|NCT01701232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454685|NCT01701232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92454686|NCT01701297|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92454687|NCT01701297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92454688|NCT01701297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454689|NCT01701297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454690|NCT01701297|Antimalarials|antimalarials|mesh-ancestor
92454691|NCT01701297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92454692|NCT01701297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92454693|NCT01701323|Cytarabine|cytarabine|mesh-list
92454694|NCT01701323|Fludarabine|fludarabine|mesh-list
92454695|NCT01701323|Fludarabine phosphate|fludarabine phosphate|mesh-list
92454696|NCT01701323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454697|NCT01701323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92454698|NCT01701323|Antimetabolites|antimetabolites|mesh-ancestor
92454699|NCT01701323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454700|NCT01701323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454701|NCT01701323|Immunologic Factors|immunologic factors|mesh-ancestor
92454702|NCT01701323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454703|NCT01701323|Antiviral Agents|antiviral agents|mesh-ancestor
92454704|NCT01701323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454705|NCT01701336|Cloricromen|cloricromen|mesh-list
92454706|NCT01701336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92454707|NCT01701349|Paclitaxel|paclitaxel|mesh-list
92454708|NCT01701349|Fosbretabulin|fosbretabulin|mesh-list
92454709|NCT01701349|Combretastatin|combretastatin|mesh-list
92454710|NCT01701349|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92454711|NCT01701349|Carboplatin|carboplatin|mesh-list
92454712|NCT01701349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92454713|NCT01701349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454714|NCT01701349|Tubulin Modulators|tubulin modulators|mesh-ancestor
92454715|NCT01701349|Antimitotic Agents|antimitotic agents|mesh-ancestor
92454716|NCT01701349|Mitosis Modulators|mitosis modulators|mesh-ancestor
92454717|NCT01701349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454718|NCT01701453|Clopidogrel|clopidogrel|mesh-list
92454719|NCT01701453|Ticagrelor|ticagrelor|mesh-list
92454720|NCT01701453|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92454721|NCT01701453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92454722|NCT01701453|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92454723|NCT01701453|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92454724|NCT01701453|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92454725|NCT01701453|Purinergic Agents|purinergic agents|mesh-ancestor
92454726|NCT01701453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454727|NCT01701453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454728|NCT01701453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454729|NCT01701466|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92454730|NCT01701466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92454731|NCT01701466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454732|NCT01701479|Aldesleukin|aldesleukin|mesh-list
92454733|NCT01701479|Interleukin-2|interleukin-2|mesh-list
92454734|NCT01701479|Dinutuximab|dinutuximab|mesh-list
92454735|NCT01701479|Isotretinoin|isotretinoin|mesh-list
92454736|NCT01701479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454737|NCT01701479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92454738|NCT01701479|Analgesics|analgesics|mesh-ancestor
92454739|NCT01701479|Sensory System Agents|sensory system agents|mesh-ancestor
92454740|NCT01701479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454741|NCT01701479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454742|NCT01701479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92454743|NCT01701479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92454744|NCT01701479|Antiviral Agents|antiviral agents|mesh-ancestor
92454745|NCT01701479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454746|NCT01701479|Dermatologic Agents|dermatologic agents|mesh-ancestor
92454747|NCT01701518|Dexamethasone|dexamethasone|mesh-list
92454748|NCT01701518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454749|NCT01701518|Antiemetics|antiemetics|mesh-ancestor
92454750|NCT01701518|Autonomic Agents|autonomic agents|mesh-ancestor
92454751|NCT01701518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454752|NCT01701518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454753|NCT01701518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454754|NCT01701518|Glucocorticoids|glucocorticoids|mesh-ancestor
92454755|NCT01701518|Hormones|hormones|mesh-ancestor
92454756|NCT01701518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454757|NCT01701518|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92454758|NCT01701518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454759|NCT01701583|Omalizumab|omalizumab|mesh-list
92454760|NCT01701583|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92454761|NCT01701583|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92454762|NCT01701583|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454763|NCT01701739|Digoxin|digoxin|mesh-list
92454764|NCT01701739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92454765|NCT01701739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92454766|NCT01701739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454767|NCT01701739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454768|NCT01701739|Protective Agents|protective agents|mesh-ancestor
92454769|NCT01701739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454770|NCT01701778|Dexmedetomidine|dexmedetomidine|mesh-list
92454771|NCT01701778|Sevoflurane|sevoflurane|mesh-list
92454772|NCT01701778|Levobupivacaine|levobupivacaine|mesh-list
92454773|NCT01701778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92454774|NCT01701778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454775|NCT01701778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454776|NCT01701778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92454777|NCT01701778|Analgesics|analgesics|mesh-ancestor
92454778|NCT01701778|Sensory System Agents|sensory system agents|mesh-ancestor
92454779|NCT01701778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454780|NCT01701778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92454781|NCT01701778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92454782|NCT01701778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92454783|NCT01701778|Adrenergic Agents|adrenergic agents|mesh-ancestor
92454784|NCT01701778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92454785|NCT01701778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454786|NCT01701778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92454787|NCT01701778|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92454788|NCT01701778|Anesthetics, General|anesthetics, general|mesh-ancestor
92454789|NCT01701778|Anesthetics|anesthetics|mesh-ancestor
92454790|NCT01701778|Anesthetics, Local|anesthetics, local|mesh-ancestor
92454791|NCT01701843|Cromolyn Sodium|cromolyn sodium|mesh-list
92454792|NCT01701843|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92454793|NCT01701843|Immunologic Factors|immunologic factors|mesh-ancestor
92454794|NCT01701843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454795|NCT01701843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92454796|NCT01701843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454797|NCT01701843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92454798|NCT01701843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454799|NCT01701856|Interferons|interferons|mesh-list
92454800|NCT01701856|Interferon-beta|interferon-beta|mesh-list
92454801|NCT01701856|Interferon beta-1b|interferon beta-1b|mesh-list
92454802|NCT01701856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454803|NCT01701856|Antiviral Agents|antiviral agents|mesh-ancestor
92454804|NCT01701856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454805|NCT01701856|Immunologic Factors|immunologic factors|mesh-ancestor
92454806|NCT01701856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454807|NCT01701856|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92454808|NCT01701882|Tenofovir|tenofovir|mesh-list
92454809|NCT01701882|Emtricitabine|emtricitabine|mesh-list
92454810|NCT01701882|Rilpivirine|rilpivirine|mesh-list
92454811|NCT01701882|Antiviral Agents|antiviral agents|mesh-ancestor
92454812|NCT01701882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454813|NCT01701882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92454814|NCT01701882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92454815|NCT01701882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454816|NCT01701882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454817|NCT01701882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92454818|NCT01701882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92454819|NCT01701921|Pregabalin|pregabalin|mesh-list
92454820|NCT01701921|Analgesics|analgesics|mesh-ancestor
92454821|NCT01701921|Sensory System Agents|sensory system agents|mesh-ancestor
92454822|NCT01701921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454823|NCT01701921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454824|NCT01701921|Anticonvulsants|anticonvulsants|mesh-ancestor
92454825|NCT01701921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92454826|NCT01701921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92454827|NCT01701921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454828|NCT01701921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92454829|NCT01701921|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92454830|NCT01701921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92454831|NCT01701921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454832|NCT01701921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92454834|NCT01702038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92454835|NCT01702038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454836|NCT01702038|Immunologic Factors|immunologic factors|mesh-ancestor
92454837|NCT01702038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454838|NCT01702038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92454839|NCT01702090|Ritonavir|ritonavir|mesh-list
92454840|NCT01702090|Darunavir|darunavir|mesh-list
92454841|NCT01702090|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92454842|NCT01702090|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92454843|NCT01702090|Protease Inhibitors|protease inhibitors|mesh-ancestor
92454844|NCT01702090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454845|NCT01702090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454846|NCT01702090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92454847|NCT01702090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92454848|NCT01702090|Antiviral Agents|antiviral agents|mesh-ancestor
92454849|NCT01702090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454850|NCT01702090|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92454851|NCT01702090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92454852|NCT01702103|Mometasone Furoate|mometasone furoate|mesh-list
92454853|NCT01702103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454854|NCT01702103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92454855|NCT01702103|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92454857|NCT01702129|Cetuximab|cetuximab|mesh-list
92454858|NCT01702129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92454859|NCT01702129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454860|NCT01702129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92454861|NCT01702129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92454862|NCT01702129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454863|NCT01702129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454864|NCT01702129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92454865|NCT01702181|Tacrolimus|tacrolimus|mesh-list
92454866|NCT01702181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454867|NCT01702181|Immunologic Factors|immunologic factors|mesh-ancestor
92454868|NCT01702181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454869|NCT01702181|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92454870|NCT01702181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454871|NCT01702181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454872|NCT01702207|Tacrolimus|tacrolimus|mesh-list
92454873|NCT01702207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92454874|NCT01702207|Immunologic Factors|immunologic factors|mesh-ancestor
92454875|NCT01702207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454876|NCT01702207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92454877|NCT01702207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454878|NCT01702207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454879|NCT01702376|Moxifloxacin|moxifloxacin|mesh-list
92454880|NCT01702376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92454881|NCT01702376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454882|NCT01702376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92454883|NCT01702376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92454884|NCT01702376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454885|NCT01702376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454886|NCT01702376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454887|NCT01702389|Remifentanil|remifentanil|mesh-list
92454888|NCT01702389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92454889|NCT01702389|Narcotics|narcotics|mesh-ancestor
92454890|NCT01702389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454891|NCT01702389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454892|NCT01702389|Analgesics|analgesics|mesh-ancestor
92454893|NCT01702389|Sensory System Agents|sensory system agents|mesh-ancestor
92454894|NCT01702389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454895|NCT01702415|Zoledronic Acid|zoledronic acid|mesh-list
92454896|NCT01702415|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92454897|NCT01702415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454898|NCT01702506|Antacids|antacids|mesh-list
92454899|NCT01702506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454900|NCT01702506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454901|NCT01702610|Temozolomide|temozolomide|mesh-list
92454902|NCT01702610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92454903|NCT01702610|Alkylating Agents|alkylating agents|mesh-ancestor
92454904|NCT01702610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454905|NCT01702610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454906|NCT01702623|Oxcarbazepine|oxcarbazepine|mesh-list
92454907|NCT01702623|Anticonvulsants|anticonvulsants|mesh-ancestor
92454908|NCT01702623|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92454909|NCT01702623|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92454910|NCT01702623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92454911|NCT01702623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454912|NCT01702623|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92454913|NCT01702623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92454914|NCT01702636|Tranexamic Acid|tranexamic acid|mesh-list
92454915|NCT01702636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92454916|NCT01702636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92454917|NCT01702636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454918|NCT01702636|Hemostatics|hemostatics|mesh-ancestor
92454919|NCT01702636|Coagulants|coagulants|mesh-ancestor
92454920|NCT01702649|Biapenem|biapenem|mesh-list
92454921|NCT01702649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454922|NCT01702688|Angiotensin II|angiotensin ii|mesh-list
92454923|NCT01702688|Giapreza|giapreza|mesh-list
92179827|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
92454925|NCT01702688|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92454926|NCT01702688|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92454927|NCT01702688|Protease Inhibitors|protease inhibitors|mesh-ancestor
92454928|NCT01702688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92454929|NCT01702688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454930|NCT01702701|Fluticasone|fluticasone|mesh-list
92454931|NCT01702701|Montelukast|montelukast|mesh-list
92454932|NCT01702701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92454933|NCT01702701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92454934|NCT01702701|Autonomic Agents|autonomic agents|mesh-ancestor
92454935|NCT01702701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92454936|NCT01702701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454937|NCT01702701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92454938|NCT01702701|Respiratory System Agents|respiratory system agents|mesh-ancestor
92454939|NCT01702701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92454940|NCT01702701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92454941|NCT01702701|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92454942|NCT01702701|Hormone Antagonists|hormone antagonists|mesh-ancestor
92454943|NCT01702701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92454944|NCT01702701|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92454945|NCT01702701|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92454946|NCT01702701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454947|NCT01702714|Paclitaxel|paclitaxel|mesh-list
92454948|NCT01702714|Carboplatin|carboplatin|mesh-list
92454949|NCT01702714|Gemcitabine|gemcitabine|mesh-list
92454950|NCT01702714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92454951|NCT01702714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454952|NCT01702714|Tubulin Modulators|tubulin modulators|mesh-ancestor
92454953|NCT01702714|Antimitotic Agents|antimitotic agents|mesh-ancestor
92454954|NCT01702714|Mitosis Modulators|mitosis modulators|mesh-ancestor
92454955|NCT01702714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454956|NCT01702714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92454957|NCT01702714|Antimetabolites|antimetabolites|mesh-ancestor
92454958|NCT01702792|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92454959|NCT01702792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92454960|NCT01702792|Immunologic Factors|immunologic factors|mesh-ancestor
92454961|NCT01702792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454962|NCT01702857|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92454963|NCT01702857|Vaccines|vaccines|mesh-list
92454964|NCT01702857|Aluminum sulfate|aluminum sulfate|mesh-list
92454965|NCT01702857|Immunologic Factors|immunologic factors|mesh-ancestor
92454966|NCT01702857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454967|NCT01702857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92454968|NCT01702857|Antacids|antacids|mesh-ancestor
92454969|NCT01702857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454970|NCT01702857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92454971|NCT01702974|Vitamin D|vitamin d|mesh-list
92454972|NCT01702974|Cholecalciferol|cholecalciferol|mesh-list
92454973|NCT01702974|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92454974|NCT01702974|Vitamins|vitamins|mesh-ancestor
92454975|NCT01702974|Micronutrients|micronutrients|mesh-ancestor
92454976|NCT01702974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454977|NCT01702974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92454978|NCT01702974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92454979|NCT01702974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92454980|NCT01703104|Folic Acid|folic acid|mesh-list
92454981|NCT01703104|Vitamin B Complex|vitamin b complex|mesh-list
92454982|NCT01703104|Proguanil|proguanil|mesh-list
92454983|NCT01703104|Hematinics|hematinics|mesh-ancestor
92454984|NCT01703104|Vitamins|vitamins|mesh-ancestor
92454985|NCT01703104|Micronutrients|micronutrients|mesh-ancestor
92454986|NCT01703104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454987|NCT01703104|Antimalarials|antimalarials|mesh-ancestor
92454988|NCT01703104|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92454989|NCT01703104|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92454990|NCT01703104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92454991|NCT01703104|Antimetabolites|antimetabolites|mesh-ancestor
92454992|NCT01703104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92454993|NCT01703130|Ropivacaine|ropivacaine|mesh-list
92454994|NCT01703130|Anesthetics, Local|anesthetics, local|mesh-ancestor
92454995|NCT01703130|Anesthetics|anesthetics|mesh-ancestor
92454996|NCT01703130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92454997|NCT01703130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92454998|NCT01703130|Sensory System Agents|sensory system agents|mesh-ancestor
92179905|NCT04790838|Glucocorticoids|glucocorticoids|mesh-ancestor
92454999|NCT01703130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455001|NCT01703234|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92455002|NCT01703234|Protease Inhibitors|protease inhibitors|mesh-ancestor
92455003|NCT01703234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455004|NCT01703234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455005|NCT01703234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92455006|NCT01703312|Omalizumab|omalizumab|mesh-list
92455007|NCT01703312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92455008|NCT01703312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92455009|NCT01703312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92455010|NCT01703325|Triamcinolone|triamcinolone|mesh-list
92455011|NCT01703325|Clobetasol|clobetasol|mesh-list
92455012|NCT01703325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92455013|NCT01703325|Glucocorticoids|glucocorticoids|mesh-ancestor
92455014|NCT01703325|Hormones|hormones|mesh-ancestor
92455015|NCT01703325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455016|NCT01703325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455017|NCT01703351|Fentanyl|fentanyl|mesh-list
92455018|NCT01703351|Ropivacaine|ropivacaine|mesh-list
92455019|NCT01703351|Anesthetics, Local|anesthetics, local|mesh-ancestor
92455020|NCT01703351|Anesthetics|anesthetics|mesh-ancestor
92455021|NCT01703351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455022|NCT01703351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455023|NCT01703351|Sensory System Agents|sensory system agents|mesh-ancestor
92455024|NCT01703351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455025|NCT01703351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92455026|NCT01703351|Narcotics|narcotics|mesh-ancestor
92455027|NCT01703351|Analgesics|analgesics|mesh-ancestor
92455028|NCT01703351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92455029|NCT01703351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92455030|NCT01703351|Anesthetics, General|anesthetics, general|mesh-ancestor
92455031|NCT01703364|Lenalidomide|lenalidomide|mesh-list
92455032|NCT01703364|Immunologic Factors|immunologic factors|mesh-ancestor
92455033|NCT01703364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455034|NCT01703364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92455035|NCT01703364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92455036|NCT01703364|Growth Substances|growth substances|mesh-ancestor
92455037|NCT01703364|Growth Inhibitors|growth inhibitors|mesh-ancestor
92455038|NCT01703364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455039|NCT01703390|Cetuximab|cetuximab|mesh-list
92455040|NCT01703390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455041|NCT01703390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455042|NCT01703455|Sorafenib|sorafenib|mesh-list
92455043|NCT01703455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455044|NCT01703455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455045|NCT01703455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455046|NCT01703455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455047|NCT01703468|Oxcarbazepine|oxcarbazepine|mesh-list
92455048|NCT01703468|Anticonvulsants|anticonvulsants|mesh-ancestor
92455049|NCT01703468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92455050|NCT01703468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455051|NCT01703468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455052|NCT01703468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455053|NCT01703468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92455054|NCT01703468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92455056|NCT01703559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92455057|NCT01703559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92455058|NCT01703559|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92455059|NCT01703559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92455060|NCT01703559|Adrenergic Agents|adrenergic agents|mesh-ancestor
92455061|NCT01703559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455062|NCT01703559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455063|NCT01703559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455064|NCT01703559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92455065|NCT01703624|Glycopyrrolate|glycopyrrolate|mesh-list
92455066|NCT01703624|Bromides|bromides|mesh-list
92455067|NCT01703624|Anticonvulsants|anticonvulsants|mesh-ancestor
92455068|NCT01703624|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92455069|NCT01703624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92455070|NCT01703624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92455071|NCT01703624|Cholinergic Agents|cholinergic agents|mesh-ancestor
92455072|NCT01703624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455073|NCT01703624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455074|NCT01703624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455075|NCT01703637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92455076|NCT01703637|Vildagliptin|vildagliptin|mesh-list
92455077|NCT01703637|Saxagliptin|saxagliptin|mesh-list
92455078|NCT01703637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455079|NCT01703637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455080|NCT01703637|Incretins|incretins|mesh-ancestor
92455081|NCT01703637|Hormones|hormones|mesh-ancestor
92455082|NCT01703637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455083|NCT01703637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92455084|NCT01703637|Protease Inhibitors|protease inhibitors|mesh-ancestor
92455085|NCT01703637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455086|NCT01703637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455087|NCT01703728|Menotropins|menotropins|mesh-list
92455088|NCT01703728|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92455089|NCT01703728|Fertility Agents|fertility agents|mesh-ancestor
92455090|NCT01703728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92455091|NCT01703728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455092|NCT01703754|Isophosphamide mustard|isophosphamide mustard|mesh-list
92455093|NCT01703754|Ifosfamide|ifosfamide|mesh-list
92455094|NCT01703754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92455095|NCT01703754|Alkylating Agents|alkylating agents|mesh-ancestor
92455096|NCT01703754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455097|NCT01703754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455098|NCT01703910|Paclitaxel|paclitaxel|mesh-list
92455099|NCT01703910|Etoposide|etoposide|mesh-list
92455100|NCT01703910|Vinorelbine|vinorelbine|mesh-list
92455101|NCT01703910|Docetaxel|docetaxel|mesh-list
92455102|NCT01703910|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92455103|NCT01703910|Cisplatin|cisplatin|mesh-list
92455104|NCT01703910|Gemcitabine|gemcitabine|mesh-list
92455105|NCT01703910|Doxorubicin|doxorubicin|mesh-list
92455106|NCT01703910|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92455107|NCT01703910|Fluorouracil|fluorouracil|mesh-list
92455108|NCT01703910|Capecitabine|capecitabine|mesh-list
92455109|NCT01703910|Oxaliplatin|oxaliplatin|mesh-list
92455110|NCT01703910|Irinotecan|irinotecan|mesh-list
92455111|NCT01703910|Etoposide phosphate|etoposide phosphate|mesh-list
92455112|NCT01703910|Pemetrexed|pemetrexed|mesh-list
92455113|NCT01703910|Cetuximab|cetuximab|mesh-list
92455114|NCT01703910|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92455115|NCT01703910|Sorafenib|sorafenib|mesh-list
92455116|NCT01703910|Topotecan|topotecan|mesh-list
92455117|NCT01703910|Dasatinib|dasatinib|mesh-list
92455118|NCT01703910|Mitomycins|mitomycins|mesh-list
92455119|NCT01703910|Mitomycin|mitomycin|mesh-list
92455120|NCT01703910|Raltitrexed|raltitrexed|mesh-list
92455121|NCT01703910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92455122|NCT01703910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455123|NCT01703910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92455124|NCT01703910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92455125|NCT01703910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92455126|NCT01703910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455127|NCT01703910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92455128|NCT01703910|Antimetabolites|antimetabolites|mesh-ancestor
92455129|NCT01703910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92455130|NCT01703910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92455131|NCT01703910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92455132|NCT01703910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455133|NCT01703910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92455134|NCT01703910|Immunologic Factors|immunologic factors|mesh-ancestor
92455135|NCT01703910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455136|NCT01703910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92455137|NCT01703910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92455138|NCT01703910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92455139|NCT01703910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455140|NCT01703910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455141|NCT01703910|Alkylating Agents|alkylating agents|mesh-ancestor
92455142|NCT01704027|Androgens|androgens|mesh-list
92455143|NCT01704027|Hormones|hormones|mesh-ancestor
92455144|NCT01704027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455145|NCT01704027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455146|NCT01704092|Dexmedetomidine|dexmedetomidine|mesh-list
92455147|NCT01704092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92455148|NCT01704092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455149|NCT01704092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455150|NCT01704092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455151|NCT01704092|Analgesics|analgesics|mesh-ancestor
92455152|NCT01704092|Sensory System Agents|sensory system agents|mesh-ancestor
92455153|NCT01704092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455154|NCT01704092|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92455155|NCT01704092|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92455156|NCT01704092|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92455157|NCT01704092|Adrenergic Agents|adrenergic agents|mesh-ancestor
92455158|NCT01704092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455159|NCT01704092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455160|NCT01704248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92455161|NCT01704248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92455163|NCT01704339|Antipruritics|antipruritics|mesh-ancestor
92455164|NCT01704339|Dermatologic Agents|dermatologic agents|mesh-ancestor
92455165|NCT01704339|Sensory System Agents|sensory system agents|mesh-ancestor
92455166|NCT01704339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455167|NCT01704339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455168|NCT01704378|Insulin Aspart|insulin aspart|mesh-list
92455169|NCT01704378|Biphasic Insulins|biphasic insulins|mesh-list
92455170|NCT01704378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455171|NCT01704378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455172|NCT01704417|Insulin|insulin|mesh-list
92455173|NCT01704417|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92455174|NCT01704417|Insulin Glargine|insulin glargine|mesh-list
92455175|NCT01704417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455176|NCT01704417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455177|NCT01704469|Anesthetics|anesthetics|mesh-list
92455178|NCT01704469|Anesthetics, Local|anesthetics, local|mesh-list
92455179|NCT01704469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455180|NCT01704469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455181|NCT01704469|Sensory System Agents|sensory system agents|mesh-ancestor
92455182|NCT01704469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455183|NCT01704482|Acetylcysteine|acetylcysteine|mesh-list
92455184|NCT01704482|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92455185|NCT01704482|Antiviral Agents|antiviral agents|mesh-ancestor
92455186|NCT01704482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455187|NCT01704482|Expectorants|expectorants|mesh-ancestor
92455188|NCT01704482|Respiratory System Agents|respiratory system agents|mesh-ancestor
92455189|NCT01704482|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92455190|NCT01704482|Antioxidants|antioxidants|mesh-ancestor
92455191|NCT01704482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455192|NCT01704482|Protective Agents|protective agents|mesh-ancestor
92455193|NCT01704482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455194|NCT01704482|Antidotes|antidotes|mesh-ancestor
92455195|NCT01704508|Lumefantrine|lumefantrine|mesh-list
92455196|NCT01704508|Artemether|artemether|mesh-list
92455197|NCT01704508|Piperaquine|piperaquine|mesh-list
92455198|NCT01704508|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92455199|NCT01704508|Artenimol|artenimol|mesh-list
92455200|NCT01704508|Antimalarials|antimalarials|mesh-ancestor
92455201|NCT01704508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92455202|NCT01704508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92455203|NCT01704508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455204|NCT01704534|Ustekinumab|ustekinumab|mesh-list
92455205|NCT01704534|Dermatologic Agents|dermatologic agents|mesh-ancestor
92455206|NCT01704612|Ropivacaine|ropivacaine|mesh-list
92455207|NCT01704612|Anesthetics, Local|anesthetics, local|mesh-ancestor
92455208|NCT01704612|Anesthetics|anesthetics|mesh-ancestor
92455209|NCT01704612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455210|NCT01704612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455211|NCT01704612|Sensory System Agents|sensory system agents|mesh-ancestor
92455212|NCT01704612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455214|NCT01704638|Fluvoxamine|fluvoxamine|mesh-list
92455215|NCT01704638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92455216|NCT01704638|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92455217|NCT01704638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455218|NCT01704638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455219|NCT01704638|Protective Agents|protective agents|mesh-ancestor
92455220|NCT01704638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455221|NCT01704638|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92455222|NCT01704638|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92455223|NCT01704638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455224|NCT01704638|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92455225|NCT01704638|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92455226|NCT01704638|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92347473|NCT01729728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92455227|NCT01704638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455228|NCT01704638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455229|NCT01704638|Serotonin Agents|serotonin agents|mesh-ancestor
92455230|NCT01704638|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92455231|NCT01704638|Antidepressive Agents|antidepressive agents|mesh-ancestor
92455232|NCT01704638|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92455233|NCT01704638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92455234|NCT01704638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92455235|NCT01704690|Paclitaxel|paclitaxel|mesh-list
92455236|NCT01704690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92455237|NCT01704690|Cisplatin|cisplatin|mesh-list
92455238|NCT01704690|Fluorouracil|fluorouracil|mesh-list
92455239|NCT01704690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92455240|NCT01704690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455241|NCT01704690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92455242|NCT01704690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92455243|NCT01704690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92455244|NCT01704690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455245|NCT01704690|Antimetabolites|antimetabolites|mesh-ancestor
92455246|NCT01704690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92455247|NCT01704690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92455248|NCT01704690|Immunologic Factors|immunologic factors|mesh-ancestor
92455249|NCT01704690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455250|NCT01704703|Panitumumab|panitumumab|mesh-list
92455251|NCT01704703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455252|NCT01704703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455253|NCT01704716|Aldesleukin|aldesleukin|mesh-list
92455254|NCT01704716|Cyclophosphamide|cyclophosphamide|mesh-list
92455255|NCT01704716|Melphalan|melphalan|mesh-list
92455256|NCT01704716|Busulfan|busulfan|mesh-list
92455257|NCT01704716|Carboplatin|carboplatin|mesh-list
92455258|NCT01704716|Doxorubicin|doxorubicin|mesh-list
92455259|NCT01704716|Etoposide|etoposide|mesh-list
92455260|NCT01704716|Vincristine|vincristine|mesh-list
92455261|NCT01704716|Interleukin-2|interleukin-2|mesh-list
92455262|NCT01704716|Dinutuximab|dinutuximab|mesh-list
92455263|NCT01704716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92455264|NCT01704716|Immunologic Factors|immunologic factors|mesh-ancestor
92455265|NCT01704716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455266|NCT01704716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455267|NCT01704716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92455268|NCT01704716|Alkylating Agents|alkylating agents|mesh-ancestor
92455269|NCT01704716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455270|NCT01704716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455271|NCT01704716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92455272|NCT01704716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92455273|NCT01704716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92455274|NCT01704716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92455275|NCT01704716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455276|NCT01704716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92455277|NCT01704716|Tubulin Modulators|tubulin modulators|mesh-ancestor
92455278|NCT01704716|Antimitotic Agents|antimitotic agents|mesh-ancestor
92455279|NCT01704716|Mitosis Modulators|mitosis modulators|mesh-ancestor
92455280|NCT01704716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455281|NCT01704716|Analgesics|analgesics|mesh-ancestor
92455282|NCT01704716|Sensory System Agents|sensory system agents|mesh-ancestor
92455283|NCT01704716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455284|NCT01704716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92455285|NCT01704716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92455286|NCT01704716|Antiviral Agents|antiviral agents|mesh-ancestor
92455287|NCT01704716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455288|NCT01704794|Folic Acid|folic acid|mesh-list
92455289|NCT01704794|Vitamin B Complex|vitamin b complex|mesh-list
92455290|NCT01704794|Proguanil|proguanil|mesh-list
92455291|NCT01704794|Hematinics|hematinics|mesh-ancestor
92455292|NCT01704794|Vitamins|vitamins|mesh-ancestor
92455293|NCT01704794|Micronutrients|micronutrients|mesh-ancestor
92455294|NCT01704794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455295|NCT01704794|Antimalarials|antimalarials|mesh-ancestor
92455296|NCT01704794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92455297|NCT01704794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92455298|NCT01704794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455299|NCT01704794|Antimetabolites|antimetabolites|mesh-ancestor
92455300|NCT01704794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455301|NCT01704872|Dinutuximab|dinutuximab|mesh-list
92455302|NCT01704872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455303|NCT01704898|Efavirenz|efavirenz|mesh-list
92455304|NCT01704898|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92455305|NCT01704898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92455306|NCT01704898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455307|NCT01704898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455309|NCT01704898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455310|NCT01704898|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92455311|NCT01704898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92455312|NCT01704898|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92455313|NCT01704898|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92455314|NCT01704898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92455315|NCT01704898|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92455316|NCT01705002|Bevacizumab|bevacizumab|mesh-list
92455317|NCT01705002|Capecitabine|capecitabine|mesh-list
92455318|NCT01705002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455319|NCT01705002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455320|NCT01705002|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92455321|NCT01705002|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92455322|NCT01705002|Growth Substances|growth substances|mesh-ancestor
92455323|NCT01705002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455324|NCT01705002|Growth Inhibitors|growth inhibitors|mesh-ancestor
92455325|NCT01705002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92455326|NCT01705002|Antimetabolites|antimetabolites|mesh-ancestor
92455327|NCT01705002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455328|NCT01705041|Liver Extracts|liver extracts|mesh-list
92455329|NCT01705041|Hematinics|hematinics|mesh-ancestor
92455330|NCT01705158|Carboplatin|carboplatin|mesh-list
92455331|NCT01705158|Doxorubicin|doxorubicin|mesh-list
92455332|NCT01705158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92455333|NCT01705158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455334|NCT01705158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92455335|NCT01705158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92455336|NCT01705158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92455337|NCT01705158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455338|NCT01705158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455339|NCT01705223|Vaccines|vaccines|mesh-list
92455340|NCT01705223|Immunologic Factors|immunologic factors|mesh-ancestor
92455341|NCT01705223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455342|NCT01705249|Norethindrone|norethindrone|mesh-list
92455343|NCT01705249|Norethindrone Acetate|norethindrone acetate|mesh-list
92455344|NCT01705249|Estradiol|estradiol|mesh-list
92455345|NCT01705249|Estrogens|estrogens|mesh-ancestor
92455346|NCT01705249|Hormones|hormones|mesh-ancestor
92455347|NCT01705249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455348|NCT01705249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455349|NCT01705249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92455350|NCT01705249|Contraceptive Agents|contraceptive agents|mesh-ancestor
92455351|NCT01705249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92455352|NCT01705249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92455353|NCT01705249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92455354|NCT01705249|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92455355|NCT01705249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92455356|NCT01705314|Vitamin D|vitamin d|mesh-list
92455357|NCT01705314|Vitamins|vitamins|mesh-ancestor
92455358|NCT01705314|Micronutrients|micronutrients|mesh-ancestor
92455359|NCT01705314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455360|NCT01705314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92455361|NCT01705340|Trastuzumab|trastuzumab|mesh-list
92455362|NCT01705340|Lapatinib|lapatinib|mesh-list
92455363|NCT01705340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455364|NCT01705340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455365|NCT01705340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455366|NCT01705340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455367|NCT01705340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455368|NCT01705379|Lactitol|lactitol|mesh-list
92455369|NCT01705379|Cathartics|cathartics|mesh-ancestor
92455370|NCT01705379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92455371|NCT01705392|Bevacizumab|bevacizumab|mesh-list
92455372|NCT01705392|Dacarbazine|dacarbazine|mesh-list
92455374|NCT01705392|Enalapril|enalapril|mesh-list
92455375|NCT01705392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455376|NCT01705392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455377|NCT01705392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92455378|NCT01705392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92455379|NCT01705392|Growth Substances|growth substances|mesh-ancestor
92455380|NCT01705392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455381|NCT01705392|Growth Inhibitors|growth inhibitors|mesh-ancestor
92180274|NCT00083551|Growth Substances|growth substances|mesh-ancestor
92455382|NCT01705392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92455383|NCT01705392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92455384|NCT01705392|Adrenergic Agents|adrenergic agents|mesh-ancestor
92455385|NCT01705392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455386|NCT01705392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455387|NCT01705392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92455388|NCT01705392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92455389|NCT01705392|Vasodilator Agents|vasodilator agents|mesh-ancestor
92455390|NCT01705392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92455391|NCT01705392|Alkylating Agents|alkylating agents|mesh-ancestor
92455392|NCT01705392|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92455393|NCT01705392|Protease Inhibitors|protease inhibitors|mesh-ancestor
92455394|NCT01705392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455396|NCT01705457|Retinol palmitate|retinol palmitate|mesh-list
92455397|NCT01705457|Vitamins|vitamins|mesh-ancestor
92455398|NCT01705457|Micronutrients|micronutrients|mesh-ancestor
92455399|NCT01705457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455400|NCT01705457|Antioxidants|antioxidants|mesh-ancestor
92455401|NCT01705457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455402|NCT01705457|Protective Agents|protective agents|mesh-ancestor
92455403|NCT01705457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92455404|NCT01705457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455405|NCT01705470|Furosemide|furosemide|mesh-list
92455406|NCT01705470|Diuretics|diuretics|mesh-ancestor
92455407|NCT01705470|Natriuretic Agents|natriuretic agents|mesh-ancestor
92455408|NCT01705470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455409|NCT01705470|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92455410|NCT01705470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455411|NCT01705470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455412|NCT01705483|Paclitaxel|paclitaxel|mesh-list
92455413|NCT01705483|Docetaxel|docetaxel|mesh-list
92455414|NCT01705483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92455415|NCT01705483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455416|NCT01705483|Tubulin Modulators|tubulin modulators|mesh-ancestor
92455417|NCT01705483|Antimitotic Agents|antimitotic agents|mesh-ancestor
92455418|NCT01705483|Mitosis Modulators|mitosis modulators|mesh-ancestor
92455419|NCT01705483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455420|NCT01705639|Melatonin|melatonin|mesh-list
92455421|NCT01705639|Antioxidants|antioxidants|mesh-ancestor
92455422|NCT01705639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455423|NCT01705639|Protective Agents|protective agents|mesh-ancestor
92455424|NCT01705639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455425|NCT01705639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455426|NCT01705743|Nitrous Oxide|nitrous oxide|mesh-list
92455427|NCT01705743|Sevoflurane|sevoflurane|mesh-list
92455428|NCT01705743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92455429|NCT01705743|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92455431|NCT01705743|Anesthetics|anesthetics|mesh-ancestor
92455432|NCT01705743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455433|NCT01705743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455434|NCT01705743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455435|NCT01705743|Analgesics|analgesics|mesh-ancestor
92455436|NCT01705743|Sensory System Agents|sensory system agents|mesh-ancestor
92455437|NCT01705743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455438|NCT01705756|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92455439|NCT01705756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455440|NCT01705769|Micronutrients|micronutrients|mesh-list
92455441|NCT01705769|Trace Elements|trace elements|mesh-list
92455442|NCT01705769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455443|NCT01705795|Antibodies|antibodies|mesh-list
92455444|NCT01705795|Immunologic Factors|immunologic factors|mesh-ancestor
92455445|NCT01705795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455446|NCT01705808|Protein C|protein c|mesh-list
92455447|NCT01705808|Anticoagulants|anticoagulants|mesh-ancestor
92455448|NCT01705808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92455449|NCT01705808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92455450|NCT01705808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455451|NCT01705938|Dolcanatide|dolcanatide|mesh-list
92455452|NCT01705938|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92455453|NCT01705938|Enzyme Activators|enzyme activators|mesh-ancestor
92455454|NCT01705938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455455|NCT01705938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92455456|NCT01705951|Nicotine|nicotine|mesh-list
92455457|NCT01705951|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92455458|NCT01705951|Autonomic Agents|autonomic agents|mesh-ancestor
92455459|NCT01705951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455460|NCT01705951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455461|NCT01705951|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92455462|NCT01705951|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92455463|NCT01705951|Cholinergic Agents|cholinergic agents|mesh-ancestor
92455464|NCT01705951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455465|NCT01705951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455466|NCT01706055|Interferons|interferons|mesh-list
92455467|NCT01706055|Interferon-beta|interferon-beta|mesh-list
92455468|NCT01706055|Interferon beta-1b|interferon beta-1b|mesh-list
92455469|NCT01706055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455470|NCT01706055|Antiviral Agents|antiviral agents|mesh-ancestor
92455471|NCT01706055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455472|NCT01706055|Immunologic Factors|immunologic factors|mesh-ancestor
92455473|NCT01706055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455474|NCT01706055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92455476|NCT01706172|Anesthetics, Local|anesthetics, local|mesh-ancestor
92455477|NCT01706172|Anesthetics|anesthetics|mesh-ancestor
92455478|NCT01706172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455479|NCT01706172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455480|NCT01706172|Sensory System Agents|sensory system agents|mesh-ancestor
92455481|NCT01706172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455482|NCT01706172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92455483|NCT01706172|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92455484|NCT01706172|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455485|NCT01706172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455486|NCT01706172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455487|NCT01706211|Rosiglitazone|rosiglitazone|mesh-list
92455488|NCT01706211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455489|NCT01706211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455490|NCT01706315|Gepotidacin|gepotidacin|mesh-list
92455491|NCT01706315|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92455492|NCT01706315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455493|NCT01706315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455494|NCT01706315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455495|NCT01706341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92455496|NCT01706354|Anesthetics|anesthetics|mesh-list
92455497|NCT01706354|Anesthetics, Local|anesthetics, local|mesh-list
92455498|NCT01706354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455499|NCT01706354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455500|NCT01706354|Sensory System Agents|sensory system agents|mesh-ancestor
92455501|NCT01706354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455502|NCT01706367|Vaccines|vaccines|mesh-list
92455503|NCT01706367|Immunologic Factors|immunologic factors|mesh-ancestor
92455504|NCT01706367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455505|NCT01706471|Mycophenolic Acid|mycophenolic acid|mesh-list
92455506|NCT01706471|Everolimus|everolimus|mesh-list
92455507|NCT01706471|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92455508|NCT01706471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455509|NCT01706471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455510|NCT01706471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455511|NCT01706471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92455512|NCT01706471|Immunologic Factors|immunologic factors|mesh-ancestor
92455513|NCT01706471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455514|NCT01706471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455515|NCT01706471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92455516|NCT01706471|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92455517|NCT01706471|Antitubercular Agents|antitubercular agents|mesh-ancestor
92455518|NCT01706471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92455519|NCT01706471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455520|NCT01706510|Clopidogrel|clopidogrel|mesh-list
92455521|NCT01706510|Ticagrelor|ticagrelor|mesh-list
92455522|NCT01706510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92455523|NCT01706510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92455524|NCT01706510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92455525|NCT01706510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92455526|NCT01706510|Purinergic Agents|purinergic agents|mesh-ancestor
92123291|NCT01703741|Hormones|hormones|mesh-ancestor
92455527|NCT01706510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455528|NCT01706510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455529|NCT01706510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455530|NCT01706562|Itraconazole|itraconazole|mesh-list
92455531|NCT01706562|Antifungal Agents|antifungal agents|mesh-ancestor
92455532|NCT01706562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455533|NCT01706562|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92455534|NCT01706562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92455535|NCT01706562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455536|NCT01706562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455537|NCT01706562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92455538|NCT01706562|Hormone Antagonists|hormone antagonists|mesh-ancestor
92455539|NCT01706562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455540|NCT01706562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455541|NCT01706562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92455543|NCT01706627|Antioxidants|antioxidants|mesh-ancestor
92455544|NCT01706627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455545|NCT01706627|Protective Agents|protective agents|mesh-ancestor
92455546|NCT01706627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455547|NCT01706627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455548|NCT01706679|Moxifloxacin|moxifloxacin|mesh-list
92455549|NCT01706679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92455550|NCT01706679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455551|NCT01706679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92455552|NCT01706679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92455553|NCT01706679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455554|NCT01706679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455555|NCT01706679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455556|NCT01706874|Listerine|listerine|mesh-list
92455557|NCT01706874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92455558|NCT01706874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455559|NCT01706887|Amiloride|amiloride|mesh-list
92455560|NCT01706887|Diuretics|diuretics|mesh-ancestor
92455561|NCT01706887|Natriuretic Agents|natriuretic agents|mesh-ancestor
92455562|NCT01706887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455563|NCT01706887|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92455564|NCT01706887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455565|NCT01706887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455566|NCT01706887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455567|NCT01706887|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92455568|NCT01706887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92455569|NCT01707082|Midazolam|midazolam|mesh-list
92455570|NCT01707082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92455571|NCT01707082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92455572|NCT01707082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455573|NCT01707082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455574|NCT01707082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92455575|NCT01707082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92455576|NCT01707082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92455577|NCT01707082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92455578|NCT01707082|Anesthetics, General|anesthetics, general|mesh-ancestor
92455579|NCT01707082|Anesthetics|anesthetics|mesh-ancestor
92455580|NCT01707082|GABA Modulators|gaba modulators|mesh-ancestor
92455581|NCT01707082|GABA Agents|gaba agents|mesh-ancestor
92455582|NCT01707082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455583|NCT01707082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455584|NCT01707134|Insulin|insulin|mesh-list
92455585|NCT01707134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92455586|NCT01707134|Insulin Aspart|insulin aspart|mesh-list
92455587|NCT01707134|Isophane Insulin, Human|isophane insulin, human|mesh-list
92455588|NCT01707134|Insulin, Isophane|insulin, isophane|mesh-list
92455589|NCT01707134|Isophane insulin, beef|isophane insulin, beef|mesh-list
92455590|NCT01707134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455591|NCT01707134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455592|NCT01707160|Insulin|insulin|mesh-list
92455593|NCT01707160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92455595|NCT01707160|Biphasic Insulins|biphasic insulins|mesh-list
92455596|NCT01707160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92455597|NCT01707160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455598|NCT01707160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455599|NCT01707199|Artesunate|artesunate|mesh-list
92455600|NCT01707199|Pyrimethamine|pyrimethamine|mesh-list
92455601|NCT01707199|Sulfadoxine|sulfadoxine|mesh-list
92455602|NCT01707199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92455603|NCT01707199|Antimalarials|antimalarials|mesh-ancestor
92455604|NCT01707199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92455605|NCT01707199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92455606|NCT01707199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455607|NCT01707199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455608|NCT01707199|Antiviral Agents|antiviral agents|mesh-ancestor
92455609|NCT01707199|Schistosomicides|schistosomicides|mesh-ancestor
92455610|NCT01707199|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92455611|NCT01707199|Anthelmintics|anthelmintics|mesh-ancestor
92455612|NCT01707199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92455613|NCT01707199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455614|NCT01707199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455615|NCT01707199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92455616|NCT01707251|Ibuprofen|ibuprofen|mesh-list
92455617|NCT01707251|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92455618|NCT01707251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455619|NCT01707251|Analgesics|analgesics|mesh-ancestor
92455620|NCT01707251|Sensory System Agents|sensory system agents|mesh-ancestor
92455621|NCT01707251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455622|NCT01707251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455623|NCT01707251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92455624|NCT01707251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455625|NCT01707251|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92455626|NCT01707251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455627|NCT01707251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455628|NCT01707316|Canagliflozin|canagliflozin|mesh-list
92455629|NCT01707316|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92455630|NCT01707316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455631|NCT01707316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455632|NCT01707316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455633|NCT01707342|Simeprevir|simeprevir|mesh-list
92455634|NCT01707342|Antiviral Agents|antiviral agents|mesh-ancestor
92455635|NCT01707342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455636|NCT01707342|Protease Inhibitors|protease inhibitors|mesh-ancestor
92455637|NCT01707342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455638|NCT01707342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455639|NCT01707394|Apixaban|apixaban|mesh-list
92455640|NCT01707394|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92455641|NCT01707394|Antithrombins|antithrombins|mesh-ancestor
92455642|NCT01707394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92455643|NCT01707394|Protease Inhibitors|protease inhibitors|mesh-ancestor
92455644|NCT01707394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455645|NCT01707394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455646|NCT01707394|Anticoagulants|anticoagulants|mesh-ancestor
92455647|NCT01707407|Ketoconazole|ketoconazole|mesh-list
92455648|NCT01707407|Pomalidomide|pomalidomide|mesh-list
92455649|NCT01707407|Carbamazepine|carbamazepine|mesh-list
92455650|NCT01707407|Fluvoxamine|fluvoxamine|mesh-list
92455651|NCT01707407|Immunologic Factors|immunologic factors|mesh-ancestor
92455652|NCT01707407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455653|NCT01707407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92455654|NCT01707407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92455655|NCT01707407|Growth Substances|growth substances|mesh-ancestor
92455656|NCT01707407|Growth Inhibitors|growth inhibitors|mesh-ancestor
92455657|NCT01707407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455658|NCT01707407|Antifungal Agents|antifungal agents|mesh-ancestor
92455659|NCT01707407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455660|NCT01707407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92455661|NCT01707407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92455662|NCT01707407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455663|NCT01707407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455664|NCT01707407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92455665|NCT01707407|Hormone Antagonists|hormone antagonists|mesh-ancestor
92455666|NCT01707407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455667|NCT01707407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92455668|NCT01707407|Anticonvulsants|anticonvulsants|mesh-ancestor
92455669|NCT01707407|Antimanic Agents|antimanic agents|mesh-ancestor
92455670|NCT01707407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92455671|NCT01707407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455672|NCT01707407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92455673|NCT01707407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455674|NCT01707407|Analgesics|analgesics|mesh-ancestor
92455675|NCT01707407|Sensory System Agents|sensory system agents|mesh-ancestor
92455676|NCT01707407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455677|NCT01707407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455678|NCT01707407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455679|NCT01707407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92455680|NCT01707407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92455681|NCT01707407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92455682|NCT01707407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92455683|NCT01707407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92455684|NCT01707407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455685|NCT01707407|Serotonin Agents|serotonin agents|mesh-ancestor
92455686|NCT01707407|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92455687|NCT01707407|Antidepressive Agents|antidepressive agents|mesh-ancestor
92455688|NCT01707407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92455689|NCT01707407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92455690|NCT01707537|Vaccines|vaccines|mesh-list
92455691|NCT01707537|Immunologic Factors|immunologic factors|mesh-ancestor
92455692|NCT01707537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455693|NCT01707615|Proanthocyanidin|proanthocyanidin|mesh-list
92455694|NCT01707615|Antioxidants|antioxidants|mesh-ancestor
92455695|NCT01707615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455696|NCT01707615|Protective Agents|protective agents|mesh-ancestor
92455697|NCT01707615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455698|NCT01707615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92455699|NCT01707615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92455700|NCT01707615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455701|NCT01707732|Enoxaparin|enoxaparin|mesh-list
92455702|NCT01707732|Anticoagulants|anticoagulants|mesh-ancestor
92455703|NCT01707732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92455704|NCT01707732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92455705|NCT01707732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455706|NCT01707745|Bevacizumab|bevacizumab|mesh-list
92455707|NCT01707745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92455708|NCT01707745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455709|NCT01707745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92455710|NCT01707745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92455711|NCT01707745|Growth Substances|growth substances|mesh-ancestor
92455712|NCT01707745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455713|NCT01707745|Growth Inhibitors|growth inhibitors|mesh-ancestor
92455714|NCT01707823|Aspirin|aspirin|mesh-list
92455715|NCT01707823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92455716|NCT01707823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455717|NCT01707823|Analgesics|analgesics|mesh-ancestor
92455718|NCT01707823|Sensory System Agents|sensory system agents|mesh-ancestor
92455719|NCT01707823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455720|NCT01707823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455721|NCT01707823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92455722|NCT01707823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455723|NCT01707823|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92455724|NCT01707823|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92455725|NCT01707823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455726|NCT01707823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92455727|NCT01707823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92455728|NCT01707823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455729|NCT01707823|Antipyretics|antipyretics|mesh-ancestor
92455730|NCT01707849|Everolimus|everolimus|mesh-list
92455731|NCT01707849|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92455732|NCT01707849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455733|NCT01707849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455734|NCT01707849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455735|NCT01707849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92455736|NCT01707849|Immunologic Factors|immunologic factors|mesh-ancestor
92455737|NCT01707849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455738|NCT01707849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455739|NCT01707940|Ketoconazole|ketoconazole|mesh-list
92455740|NCT01707940|Antifungal Agents|antifungal agents|mesh-ancestor
92455741|NCT01707940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455742|NCT01707940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92455743|NCT01707940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92455744|NCT01707940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455745|NCT01707940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455746|NCT01707940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92455747|NCT01707940|Hormone Antagonists|hormone antagonists|mesh-ancestor
92455748|NCT01707940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455749|NCT01707940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455750|NCT01707940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92180646|NCT03849651|Thiotepa|thiotepa|mesh-list
92455752|NCT01707953|Sympathomimetics|sympathomimetics|mesh-ancestor
92455753|NCT01707953|Autonomic Agents|autonomic agents|mesh-ancestor
92455754|NCT01707953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455755|NCT01707953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455756|NCT01707953|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92455757|NCT01707953|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92455758|NCT01707953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92455759|NCT01707953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92455760|NCT01707953|Adrenergic Agents|adrenergic agents|mesh-ancestor
92455761|NCT01707953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455762|NCT01707953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455763|NCT01708005|Vitamin D|vitamin d|mesh-list
92455764|NCT01708005|Cholecalciferol|cholecalciferol|mesh-list
92455765|NCT01708005|Vitamins|vitamins|mesh-ancestor
92455766|NCT01708005|Micronutrients|micronutrients|mesh-ancestor
92455767|NCT01708005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455768|NCT01708005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92455769|NCT01708005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92455770|NCT01708044|Pramlintide|pramlintide|mesh-list
92455771|NCT01708044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92455772|NCT01708044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455773|NCT01708239|Fibrin fragment D|fibrin fragment d|mesh-list
92455774|NCT01708239|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92455775|NCT01708239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92455776|NCT01708239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455777|NCT01708239|Hemostatics|hemostatics|mesh-ancestor
92455778|NCT01708239|Coagulants|coagulants|mesh-ancestor
92455779|NCT01708330|Lidocaine|lidocaine|mesh-list
92455780|NCT01708330|Anesthetics, Local|anesthetics, local|mesh-ancestor
92455781|NCT01708330|Anesthetics|anesthetics|mesh-ancestor
92455782|NCT01708330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455783|NCT01708330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455784|NCT01708330|Sensory System Agents|sensory system agents|mesh-ancestor
92455785|NCT01708330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455786|NCT01708330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92455787|NCT01708330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92455788|NCT01708330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455789|NCT01708330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455790|NCT01708330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455791|NCT01708369|Aspirin|aspirin|mesh-list
92455792|NCT01708369|Ethanol|ethanol|mesh-list
92455793|NCT01708369|Oseltamivir|oseltamivir|mesh-list
92455794|NCT01708369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92455795|NCT01708369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455796|NCT01708369|Analgesics|analgesics|mesh-ancestor
92455797|NCT01708369|Sensory System Agents|sensory system agents|mesh-ancestor
92455798|NCT01708369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455799|NCT01708369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455801|NCT01708369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455802|NCT01708369|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92455803|NCT01708369|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92455804|NCT01708369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455805|NCT01708369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92455806|NCT01708369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92455807|NCT01708369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455808|NCT01708369|Antipyretics|antipyretics|mesh-ancestor
92455809|NCT01708369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92455810|NCT01708369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531468|NCT00046384|Dopamine Agonists|dopamine agonists|mesh-ancestor
92455811|NCT01708369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455812|NCT01708369|Antiviral Agents|antiviral agents|mesh-ancestor
92455813|NCT01708447|Lidocaine|lidocaine|mesh-list
92455814|NCT01708447|Anesthetics, Local|anesthetics, local|mesh-list
92455815|NCT01708447|Anesthetics|anesthetics|mesh-list
92455816|NCT01708447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455817|NCT01708447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455818|NCT01708447|Sensory System Agents|sensory system agents|mesh-ancestor
92455819|NCT01708447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455820|NCT01708447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92455821|NCT01708447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92455822|NCT01708447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455823|NCT01708447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455824|NCT01708447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180721|NCT00187681|Metformin|metformin|mesh-list
92455825|NCT01708616|Risperidone|risperidone|mesh-list
92455826|NCT01708616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92455827|NCT01708616|Serotonin Agents|serotonin agents|mesh-ancestor
92455828|NCT01708616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455829|NCT01708616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455830|NCT01708616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455831|NCT01708616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92455832|NCT01708616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92455833|NCT01708616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455834|NCT01708616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92455835|NCT01708616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92455836|NCT01708616|Dopamine Agents|dopamine agents|mesh-ancestor
92455837|NCT01708642|Epinephrine|epinephrine|mesh-list
92455838|NCT01708642|Racepinephrine|racepinephrine|mesh-list
92455839|NCT01708642|Epinephryl borate|epinephryl borate|mesh-list
92455840|NCT01708642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92455841|NCT01708642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92455842|NCT01708642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92455843|NCT01708642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455844|NCT01708642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455845|NCT01708642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455846|NCT01708642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92455847|NCT01708642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92455848|NCT01708642|Autonomic Agents|autonomic agents|mesh-ancestor
92455849|NCT01708642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455850|NCT01708642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92455851|NCT01708642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92455852|NCT01708642|Mydriatics|mydriatics|mesh-ancestor
92455853|NCT01708642|Sympathomimetics|sympathomimetics|mesh-ancestor
92455854|NCT01708642|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92455855|NCT01708707|Morphine|morphine|mesh-list
92455856|NCT01708707|Buprenorphine|buprenorphine|mesh-list
92455857|NCT01708707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92455858|NCT01708707|Narcotics|narcotics|mesh-ancestor
92455859|NCT01708707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455860|NCT01708707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455861|NCT01708707|Analgesics|analgesics|mesh-ancestor
92455862|NCT01708707|Sensory System Agents|sensory system agents|mesh-ancestor
92347514|NCT01751802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92455863|NCT01708707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455864|NCT01708707|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92455865|NCT01708720|Vaccines|vaccines|mesh-list
92455866|NCT01708720|Immunologic Factors|immunologic factors|mesh-ancestor
92455867|NCT01708720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455868|NCT01708798|Eplerenone|eplerenone|mesh-list
92455869|NCT01708798|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92455870|NCT01708798|Hormone Antagonists|hormone antagonists|mesh-ancestor
92455871|NCT01708798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455872|NCT01708798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455873|NCT01708798|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92455874|NCT01708798|Diuretics|diuretics|mesh-ancestor
92455875|NCT01708798|Natriuretic Agents|natriuretic agents|mesh-ancestor
92455876|NCT01708798|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92455877|NCT01708837|Propofol|propofol|mesh-list
92455878|NCT01708837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92455879|NCT01708837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455880|NCT01708837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455881|NCT01708837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92455882|NCT01708837|Anesthetics, General|anesthetics, general|mesh-ancestor
92455883|NCT01708837|Anesthetics|anesthetics|mesh-ancestor
92455884|NCT01708850|Rivaroxaban|rivaroxaban|mesh-list
92455885|NCT01708850|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92455886|NCT01708850|Antithrombins|antithrombins|mesh-ancestor
92455887|NCT01708850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92455888|NCT01708850|Protease Inhibitors|protease inhibitors|mesh-ancestor
92455889|NCT01708850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455890|NCT01708850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455891|NCT01708850|Anticoagulants|anticoagulants|mesh-ancestor
92455892|NCT01708876|Artesunate|artesunate|mesh-list
92455893|NCT01708876|Chloroquine|chloroquine|mesh-list
92455894|NCT01708876|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92455895|NCT01708876|Primaquine|primaquine|mesh-list
92455896|NCT01708876|Mefloquine|mefloquine|mesh-list
92455897|NCT01708876|Antimalarials|antimalarials|mesh-ancestor
92455898|NCT01708876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92455899|NCT01708876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92455900|NCT01708876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92455901|NCT01708876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455902|NCT01708876|Antiviral Agents|antiviral agents|mesh-ancestor
92455903|NCT01708876|Schistosomicides|schistosomicides|mesh-ancestor
92455904|NCT01708876|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92455905|NCT01708876|Anthelmintics|anthelmintics|mesh-ancestor
92455906|NCT01708876|Amebicides|amebicides|mesh-ancestor
92455907|NCT01708876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455908|NCT01708876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92455909|NCT01708876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455910|NCT01708876|Analgesics|analgesics|mesh-ancestor
92455911|NCT01708876|Sensory System Agents|sensory system agents|mesh-ancestor
92455912|NCT01708876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455913|NCT01708876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455914|NCT01708876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92455915|NCT01708876|Filaricides|filaricides|mesh-ancestor
92455916|NCT01708876|Antinematodal Agents|antinematodal agents|mesh-ancestor
92455917|NCT01708993|Docetaxel|docetaxel|mesh-list
92455918|NCT01708993|Pemetrexed|pemetrexed|mesh-list
92455919|NCT01708993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455920|NCT01708993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92455921|NCT01708993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92455922|NCT01708993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92455923|NCT01708993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455924|NCT01708993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455925|NCT01708993|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92455926|NCT01708993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92455927|NCT01709019|Vaccines|vaccines|mesh-list
92455928|NCT01709019|Immunologic Factors|immunologic factors|mesh-ancestor
92455929|NCT01709019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455930|NCT01709071|Vaccines|vaccines|mesh-list
92455931|NCT01709071|Immunologic Factors|immunologic factors|mesh-ancestor
92455932|NCT01709071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455933|NCT01709292|Vemurafenib|vemurafenib|mesh-list
92455934|NCT01709292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455935|NCT01709292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455936|NCT01709292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455937|NCT01709292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455938|NCT01709370|Letrozole|letrozole|mesh-list
92455939|NCT01709370|Palbociclib|palbociclib|mesh-list
92455940|NCT01709370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92455941|NCT01709370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92455942|NCT01709370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92455943|NCT01709370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455944|NCT01709370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455945|NCT01709370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92455946|NCT01709370|Hormone Antagonists|hormone antagonists|mesh-ancestor
92455947|NCT01709370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92455948|NCT01709370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455949|NCT01709370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92455950|NCT01709630|Magnesium Sulfate|magnesium sulfate|mesh-list
92455951|NCT01709630|Analgesics|analgesics|mesh-ancestor
92455952|NCT01709630|Sensory System Agents|sensory system agents|mesh-ancestor
92455953|NCT01709630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455954|NCT01709630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455955|NCT01709630|Anesthetics|anesthetics|mesh-ancestor
92455956|NCT01709630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92455957|NCT01709630|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92455958|NCT01709630|Anticonvulsants|anticonvulsants|mesh-ancestor
92455959|NCT01709630|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92455960|NCT01709630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455961|NCT01709630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455962|NCT01709630|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92455963|NCT01709630|Tocolytic Agents|tocolytic agents|mesh-ancestor
92455964|NCT01709630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92455965|NCT01709656|Celecoxib|celecoxib|mesh-list
92455966|NCT01709656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92455967|NCT01709656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92455968|NCT01709656|Analgesics|analgesics|mesh-ancestor
92455969|NCT01709656|Sensory System Agents|sensory system agents|mesh-ancestor
92455970|NCT01709656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455971|NCT01709656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455972|NCT01709656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92455973|NCT01709656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92455974|NCT01709656|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92455975|NCT01709656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92455976|NCT01709656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717880|NCT02902055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92455977|NCT01709656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455978|NCT01709682|Amiodarone|amiodarone|mesh-list
92455979|NCT01709682|Sotalol|sotalol|mesh-list
92455980|NCT01709682|Flecainide|flecainide|mesh-list
92455981|NCT01709682|Propafenone|propafenone|mesh-list
92455982|NCT01709682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92455983|NCT01709682|Vasodilator Agents|vasodilator agents|mesh-ancestor
92455984|NCT01709682|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92455985|NCT01709682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92455986|NCT01709682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92455987|NCT01709682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92455988|NCT01709682|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92455989|NCT01709682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92455990|NCT01709682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92455991|NCT01709682|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92455992|NCT01709682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92455993|NCT01709682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92455994|NCT01709682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92455995|NCT01709682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92455996|NCT01709682|Adrenergic Agents|adrenergic agents|mesh-ancestor
92455997|NCT01709682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92455998|NCT01709682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92455999|NCT01709682|Sympatholytics|sympatholytics|mesh-ancestor
92456000|NCT01709682|Autonomic Agents|autonomic agents|mesh-ancestor
92456001|NCT01709682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456002|NCT01709682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92456003|NCT01709760|Methotrexate|methotrexate|mesh-list
92456004|NCT01709760|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92456005|NCT01709760|Abortifacient Agents|abortifacient agents|mesh-ancestor
92456006|NCT01709760|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456007|NCT01709760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456008|NCT01709760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92456009|NCT01709760|Antimetabolites|antimetabolites|mesh-ancestor
92456010|NCT01709760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456011|NCT01709760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456012|NCT01709760|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456013|NCT01709760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456014|NCT01709760|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92456015|NCT01709760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92456016|NCT01709760|Immunologic Factors|immunologic factors|mesh-ancestor
92456017|NCT01709760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92456018|NCT01709760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92456019|NCT01709825|Sulfalene|sulfalene|mesh-list
92456020|NCT01709825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456021|NCT01709825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92456022|NCT01709825|Antimalarials|antimalarials|mesh-ancestor
92456023|NCT01709825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92456024|NCT01709825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92456025|NCT01709929|Insulin Detemir|insulin detemir|mesh-list
92456026|NCT01709929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92456027|NCT01709929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456028|NCT01709942|Cetrorelix|cetrorelix|mesh-list
92456029|NCT01709942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92456030|NCT01709942|Fertility Agents|fertility agents|mesh-ancestor
92456031|NCT01709942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456032|NCT01709942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456033|NCT01709942|Hormone Antagonists|hormone antagonists|mesh-ancestor
92456034|NCT01709942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456035|NCT01709955|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92456036|NCT01709955|Cathartics|cathartics|mesh-ancestor
92456037|NCT01709955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456038|NCT01709994|Aspirin|aspirin|mesh-list
92456039|NCT01709994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92456040|NCT01709994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92456041|NCT01709994|Analgesics|analgesics|mesh-ancestor
92456042|NCT01709994|Sensory System Agents|sensory system agents|mesh-ancestor
92456043|NCT01709994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456044|NCT01709994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456045|NCT01709994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456046|NCT01709994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92456047|NCT01709994|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92456048|NCT01709994|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92456049|NCT01709994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180967|NCT05474664|Camostat|camostat|mesh-list
92456050|NCT01709994|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92456051|NCT01709994|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92456052|NCT01709994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456053|NCT01709994|Antipyretics|antipyretics|mesh-ancestor
92456054|NCT01710059|Adrenergic Agents|adrenergic agents|mesh-list
92456055|NCT01710059|Adrenergic Agonists|adrenergic agonists|mesh-list
92456056|NCT01710059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456057|NCT01710059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456058|NCT01710059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456059|NCT01710072|Aspirin|aspirin|mesh-list
92456060|NCT01710072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92456061|NCT01710072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92456062|NCT01710072|Analgesics|analgesics|mesh-ancestor
92456063|NCT01710072|Sensory System Agents|sensory system agents|mesh-ancestor
92456064|NCT01710072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456065|NCT01710072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456066|NCT01710072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456067|NCT01710072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92456068|NCT01710072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92456069|NCT01710072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92456070|NCT01710072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456071|NCT01710072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92456072|NCT01710072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92456073|NCT01710072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456074|NCT01710072|Antipyretics|antipyretics|mesh-ancestor
92456075|NCT01710163|Aripiprazole|aripiprazole|mesh-list
92456076|NCT01710163|Antidepressive Agents|antidepressive agents|mesh-ancestor
92456077|NCT01710163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456078|NCT01710163|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92456079|NCT01710163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92456080|NCT01710163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456081|NCT01710163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456082|NCT01710163|Dopamine Agonists|dopamine agonists|mesh-ancestor
92456083|NCT01710163|Dopamine Agents|dopamine agents|mesh-ancestor
92456084|NCT01710163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456085|NCT01710163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456086|NCT01710163|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92456087|NCT01710163|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92456088|NCT01710163|Serotonin Agents|serotonin agents|mesh-ancestor
92456089|NCT01710163|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92456090|NCT01710163|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92456091|NCT01710163|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92456092|NCT01710163|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92456093|NCT01710202|Hydrocortisone|hydrocortisone|mesh-list
92456094|NCT01710202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456095|NCT01710228|Methylprednisolone|methylprednisolone|mesh-list
92456096|NCT01710228|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92456097|NCT01710228|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92456098|NCT01710228|Prednisolone|prednisolone|mesh-list
92456099|NCT01710228|Prednisolone acetate|prednisolone acetate|mesh-list
92456100|NCT01710228|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92456101|NCT01710228|Prednisolone phosphate|prednisolone phosphate|mesh-list
92456102|NCT01710228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456104|NCT01710228|Autonomic Agents|autonomic agents|mesh-ancestor
92456105|NCT01710228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456106|NCT01710228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456107|NCT01710228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456108|NCT01710228|Glucocorticoids|glucocorticoids|mesh-ancestor
92456109|NCT01710228|Hormones|hormones|mesh-ancestor
92456110|NCT01710228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456111|NCT01710228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92456112|NCT01710228|Protective Agents|protective agents|mesh-ancestor
92456113|NCT01710228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92456114|NCT01710228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456115|NCT01710384|Betamethasone|betamethasone|mesh-list
92456116|NCT01710384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456117|NCT01710384|Glucocorticoids|glucocorticoids|mesh-ancestor
92456118|NCT01710384|Hormones|hormones|mesh-ancestor
92456119|NCT01710384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456120|NCT01710384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456121|NCT01710384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92456122|NCT01710384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456123|NCT01710462|Domperidone|domperidone|mesh-list
92456124|NCT01710462|Pantoprazole|pantoprazole|mesh-list
92456126|NCT01710462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456127|NCT01710462|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92456128|NCT01710462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456129|NCT01710462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456130|NCT01710462|Antiemetics|antiemetics|mesh-ancestor
92456131|NCT01710462|Autonomic Agents|autonomic agents|mesh-ancestor
92456132|NCT01710462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456133|NCT01710462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456134|NCT01710462|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92456135|NCT01710462|Dopamine Agents|dopamine agents|mesh-ancestor
92456136|NCT01710462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456137|NCT01710488|Levofloxacin|levofloxacin|mesh-list
92456138|NCT01710488|Prulifloxacin|prulifloxacin|mesh-list
92456139|NCT01710488|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92456140|NCT01710488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456141|NCT01710488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92456142|NCT01710488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92456143|NCT01710488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92456144|NCT01710488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456145|NCT01710488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456146|NCT01710488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456147|NCT01710488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92456148|NCT01710488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92456149|NCT01710540|Metformin|metformin|mesh-list
92456150|NCT01710540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92456151|NCT01710540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456152|NCT01710553|Metformin|metformin|mesh-list
92456153|NCT01710553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92456154|NCT01710553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456155|NCT01710566|Misoprostol|misoprostol|mesh-list
92456156|NCT01710566|Oxytocin|oxytocin|mesh-list
92456157|NCT01710566|Oxytocics|oxytocics|mesh-ancestor
92456158|NCT01710566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456159|NCT01710566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456160|NCT01710566|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92456161|NCT01710566|Abortifacient Agents|abortifacient agents|mesh-ancestor
92456162|NCT01710566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92456163|NCT01710566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456164|NCT01710592|Docetaxel|docetaxel|mesh-list
92456165|NCT01710592|Capecitabine|capecitabine|mesh-list
92456166|NCT01710592|Oxaliplatin|oxaliplatin|mesh-list
92456167|NCT01710592|Epirubicin|epirubicin|mesh-list
92456168|NCT01710592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456169|NCT01710592|Tubulin Modulators|tubulin modulators|mesh-ancestor
92456170|NCT01710592|Antimitotic Agents|antimitotic agents|mesh-ancestor
92456171|NCT01710592|Mitosis Modulators|mitosis modulators|mesh-ancestor
92456172|NCT01710592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456173|NCT01710592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92456174|NCT01710592|Antimetabolites|antimetabolites|mesh-ancestor
92456175|NCT01710592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92456176|NCT01710592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92456177|NCT01710592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92456178|NCT01710592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456179|NCT01710631|Eszopiclone|eszopiclone|mesh-list
92456180|NCT01710631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92456181|NCT01710631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456182|NCT01710631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456184|NCT01710670|Brivaracetam|brivaracetam|mesh-list
92456185|NCT01710670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92456186|NCT01710670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456187|NCT01710670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456188|NCT01710670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456189|NCT01710670|Anticonvulsants|anticonvulsants|mesh-ancestor
92456190|NCT01710696|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92456191|NCT01710696|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92456192|NCT01710696|Estradiol|estradiol|mesh-list
92456193|NCT01710696|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92456194|NCT01710696|Estrogens|estrogens|mesh-ancestor
92456195|NCT01710696|Hormones|hormones|mesh-ancestor
92347607|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92456196|NCT01710696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456197|NCT01710696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456198|NCT01710696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92456199|NCT01710696|Contraceptive Agents|contraceptive agents|mesh-ancestor
92181100|NCT00006227|Paclitaxel|paclitaxel|mesh-list
92456200|NCT01710696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456201|NCT01710696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92456203|NCT01710722|Pseudoephedrine|pseudoephedrine|mesh-list
92456204|NCT01710722|Caffeine|caffeine|mesh-list
92456205|NCT01710722|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92456206|NCT01710722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456207|NCT01710722|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92456208|NCT01710722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456209|NCT01710722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456210|NCT01710722|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92456211|NCT01710722|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92456212|NCT01710722|Purinergic Agents|purinergic agents|mesh-ancestor
92456213|NCT01710722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456214|NCT01710722|Sympathomimetics|sympathomimetics|mesh-ancestor
92456215|NCT01710722|Autonomic Agents|autonomic agents|mesh-ancestor
92456216|NCT01710722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456217|NCT01710722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92456218|NCT01710722|Adrenergic Agents|adrenergic agents|mesh-ancestor
92456219|NCT01710722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92456220|NCT01710722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92456221|NCT01710722|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456222|NCT01710722|Nasal Decongestants|nasal decongestants|mesh-ancestor
92456223|NCT01710748|Everolimus|everolimus|mesh-list
92456224|NCT01710748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92456225|NCT01710748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92456226|NCT01710748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456227|NCT01710748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456228|NCT01710748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92456229|NCT01710748|Immunologic Factors|immunologic factors|mesh-ancestor
92456230|NCT01710748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456231|NCT01710748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456232|NCT01710826|Venglustat|venglustat|mesh-list
92456233|NCT01710826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456234|NCT01710826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456235|NCT01710904|Oxycodone|oxycodone|mesh-list
92456236|NCT01710904|Naloxone|naloxone|mesh-list
92456237|NCT01710904|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92456238|NCT01710904|Narcotics|narcotics|mesh-ancestor
92456239|NCT01710904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456240|NCT01710904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456241|NCT01710904|Analgesics|analgesics|mesh-ancestor
92200194|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
92456242|NCT01710904|Sensory System Agents|sensory system agents|mesh-ancestor
92456243|NCT01710904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456245|NCT01710995|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92456246|NCT01710995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92456247|NCT01710995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456248|NCT01710995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456249|NCT01711060|Oxytocin|oxytocin|mesh-list
92456250|NCT01711060|Oxytocics|oxytocics|mesh-ancestor
92456251|NCT01711060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456252|NCT01711060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456253|NCT01711073|Plerixafor|plerixafor|mesh-list
92456254|NCT01711073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92456255|NCT01711073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92456256|NCT01711073|Antiviral Agents|antiviral agents|mesh-ancestor
92456257|NCT01711073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456258|NCT01711086|Formoterol Fumarate|formoterol fumarate|mesh-list
92456259|NCT01711086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92456260|NCT01711086|Autonomic Agents|autonomic agents|mesh-ancestor
92456261|NCT01711086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456262|NCT01711086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456263|NCT01711086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92456264|NCT01711086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456265|NCT01711086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92456266|NCT01711086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92456267|NCT01711086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92456268|NCT01711086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92456269|NCT01711086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456270|NCT01711086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456271|NCT01711112|Docetaxel|docetaxel|mesh-list
92456272|NCT01711112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456273|NCT01711112|Tubulin Modulators|tubulin modulators|mesh-ancestor
92456274|NCT01711112|Antimitotic Agents|antimitotic agents|mesh-ancestor
92456275|NCT01711112|Mitosis Modulators|mitosis modulators|mesh-ancestor
92456276|NCT01711112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456277|NCT01711125|Baclofen|baclofen|mesh-list
92456278|NCT01711125|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92456279|NCT01711125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456280|NCT01711125|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92456281|NCT01711125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456282|NCT01711125|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92456283|NCT01711125|GABA Agonists|gaba agonists|mesh-ancestor
92456284|NCT01711125|GABA Agents|gaba agents|mesh-ancestor
92456285|NCT01711125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456286|NCT01711125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456287|NCT01711229|Acetaminophen|acetaminophen|mesh-list
92456288|NCT01711229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92456289|NCT01711229|Analgesics|analgesics|mesh-ancestor
92456290|NCT01711229|Sensory System Agents|sensory system agents|mesh-ancestor
92456291|NCT01711229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456292|NCT01711229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456293|NCT01711229|Antipyretics|antipyretics|mesh-ancestor
92456294|NCT01711320|Omeprazole|omeprazole|mesh-list
92456295|NCT01711320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92456296|NCT01711320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456297|NCT01711320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92456298|NCT01711320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456299|NCT01711320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456300|NCT01711437|Ascorbic Acid|ascorbic acid|mesh-list
92456301|NCT01711437|Simethicone|simethicone|mesh-list
92456302|NCT01711437|Picosulfate sodium|picosulfate sodium|mesh-list
92456303|NCT01711437|Magnesium Oxide|magnesium oxide|mesh-list
92456304|NCT01711437|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92456305|NCT01711437|Citric Acid|citric acid|mesh-list
92456306|NCT01711437|Sodium Citrate|sodium citrate|mesh-list
92456307|NCT01711437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92456308|NCT01711437|Anticoagulants|anticoagulants|mesh-ancestor
92456309|NCT01711437|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92456310|NCT01711437|Chelating Agents|chelating agents|mesh-ancestor
92456311|NCT01711437|Sequestering Agents|sequestering agents|mesh-ancestor
92456312|NCT01711437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456313|NCT01711437|Antioxidants|antioxidants|mesh-ancestor
92456314|NCT01711437|Protective Agents|protective agents|mesh-ancestor
92456315|NCT01711437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456316|NCT01711437|Vitamins|vitamins|mesh-ancestor
92456317|NCT01711437|Micronutrients|micronutrients|mesh-ancestor
92456319|NCT01711437|Emollients|emollients|mesh-ancestor
92456320|NCT01711437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456321|NCT01711437|Cathartics|cathartics|mesh-ancestor
92456322|NCT01711437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456323|NCT01711437|Antacids|antacids|mesh-ancestor
92456324|NCT01711437|Laxatives|laxatives|mesh-ancestor
92456325|NCT01711463|Fluticasone|fluticasone|mesh-list
92456326|NCT01711463|Xhance|xhance|mesh-list
92456327|NCT01711463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456328|NCT01711463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92456329|NCT01711463|Autonomic Agents|autonomic agents|mesh-ancestor
92456330|NCT01711463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456331|NCT01711463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456332|NCT01711463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92456333|NCT01711463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456334|NCT01711463|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456335|NCT01711463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92456336|NCT01711476|Complement Factor H|complement factor h|mesh-list
92456337|NCT01711476|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92456338|NCT01711476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92456339|NCT01711476|Immunologic Factors|immunologic factors|mesh-ancestor
92456340|NCT01711476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456341|NCT01711489|Mycophenolic Acid|mycophenolic acid|mesh-list
92456342|NCT01711489|Isavuconazole|isavuconazole|mesh-list
92456343|NCT01711489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92456344|NCT01711489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456345|NCT01711489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92456346|NCT01711489|Antitubercular Agents|antitubercular agents|mesh-ancestor
92456347|NCT01711489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92456348|NCT01711489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456349|NCT01711489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456350|NCT01711489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456351|NCT01711489|Antifungal Agents|antifungal agents|mesh-ancestor
92456352|NCT01711515|Cisplatin|cisplatin|mesh-list
92456353|NCT01711515|Ipilimumab|ipilimumab|mesh-list
92456354|NCT01711515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456355|NCT01711515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92456356|NCT01711515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92456357|NCT01711515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456358|NCT01711528|Dexamethasone|dexamethasone|mesh-list
92456359|NCT01711528|Dexamethasone acetate|dexamethasone acetate|mesh-list
92456360|NCT01711528|Bortezomib|bortezomib|mesh-list
92456361|NCT01711528|Ichthammol|ichthammol|mesh-list
92456362|NCT01711528|BB 1101|bb 1101|mesh-list
92456363|NCT01711528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456364|NCT01711528|Antiemetics|antiemetics|mesh-ancestor
92456365|NCT01711528|Autonomic Agents|autonomic agents|mesh-ancestor
92456366|NCT01711528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456367|NCT01711528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456368|NCT01711528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456369|NCT01711528|Glucocorticoids|glucocorticoids|mesh-ancestor
92456370|NCT01711528|Hormones|hormones|mesh-ancestor
92456371|NCT01711528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456372|NCT01711528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92456373|NCT01711528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456374|NCT01711528|Protease Inhibitors|protease inhibitors|mesh-ancestor
92456375|NCT01711528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456376|NCT01711528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456377|NCT01711528|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456378|NCT01711567|Tenofovir|tenofovir|mesh-list
92456379|NCT01711567|Entecavir|entecavir|mesh-list
92456380|NCT01711567|Antiviral Agents|antiviral agents|mesh-ancestor
92456381|NCT01711567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456382|NCT01711567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92456383|NCT01711567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92456384|NCT01711567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456385|NCT01711567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456386|NCT01711567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92456387|NCT01711567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92456388|NCT01711593|Dimercaprol|dimercaprol|mesh-list
92456389|NCT01711593|Chelating Agents|chelating agents|mesh-ancestor
92456390|NCT01711593|Sequestering Agents|sequestering agents|mesh-ancestor
92456391|NCT01711593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456392|NCT01711671|Dexamethasone|dexamethasone|mesh-list
92456393|NCT01711671|Lenalidomide|lenalidomide|mesh-list
92456394|NCT01711671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456396|NCT01711671|Autonomic Agents|autonomic agents|mesh-ancestor
92456397|NCT01711671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456398|NCT01711671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456399|NCT01711671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456400|NCT01711671|Glucocorticoids|glucocorticoids|mesh-ancestor
92456401|NCT01711671|Hormones|hormones|mesh-ancestor
92456402|NCT01711671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456403|NCT01711671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92456404|NCT01711671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456405|NCT01711671|Immunologic Factors|immunologic factors|mesh-ancestor
92456406|NCT01711671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92456407|NCT01711671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92456408|NCT01711671|Growth Substances|growth substances|mesh-ancestor
92456409|NCT01711671|Growth Inhibitors|growth inhibitors|mesh-ancestor
92456410|NCT01711697|Paclitaxel|paclitaxel|mesh-list
92456411|NCT01711697|Carboplatin|carboplatin|mesh-list
92456412|NCT01711697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92456413|NCT01711697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456414|NCT01711697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92456415|NCT01711697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92456416|NCT01711697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92456417|NCT01711697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456418|NCT01711723|Darapladib|darapladib|mesh-list
92456419|NCT01711723|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92456420|NCT01711723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456421|NCT01711723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456422|NCT01711749|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92456423|NCT01711749|Calcium|calcium|mesh-list
92456424|NCT01711749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92456425|NCT01711749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456426|NCT01711749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92456427|NCT01711749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92181363|NCT01654107|Nicotine|nicotine|mesh-list
92456428|NCT01711749|Antimetabolites|antimetabolites|mesh-ancestor
92456429|NCT01711749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456430|NCT01711749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92456431|NCT01711749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92456432|NCT01711749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456433|NCT01711814|Peficitinib|peficitinib|mesh-list
92456434|NCT01711814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456435|NCT01711814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456436|NCT01711814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92456437|NCT01711814|Immunologic Factors|immunologic factors|mesh-ancestor
92456438|NCT01711814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456439|NCT01711827|Isavuconazole|isavuconazole|mesh-list
92456440|NCT01711827|Prednisone|prednisone|mesh-list
92456441|NCT01711827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456442|NCT01711827|Glucocorticoids|glucocorticoids|mesh-ancestor
92456443|NCT01711827|Hormones|hormones|mesh-ancestor
92456444|NCT01711827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456445|NCT01711827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456446|NCT01711827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92456447|NCT01711827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456448|NCT01711827|Antifungal Agents|antifungal agents|mesh-ancestor
92456449|NCT01711827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456450|NCT01711905|Vitamin D|vitamin d|mesh-list
92456451|NCT01711905|Cholecalciferol|cholecalciferol|mesh-list
92456452|NCT01711905|Vitamins|vitamins|mesh-ancestor
92456453|NCT01711905|Micronutrients|micronutrients|mesh-ancestor
92456454|NCT01711905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456455|NCT01711905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92456456|NCT01711905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92456457|NCT01711931|Everolimus|everolimus|mesh-list
92456458|NCT01711931|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92456459|NCT01711931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92456460|NCT01711931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456461|NCT01711931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456462|NCT01711931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92456463|NCT01711931|Immunologic Factors|immunologic factors|mesh-ancestor
92456464|NCT01711931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456465|NCT01711931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456466|NCT01711957|Liver Extracts|liver extracts|mesh-list
92456467|NCT01711957|Hematinics|hematinics|mesh-ancestor
92456468|NCT01711970|Paclitaxel|paclitaxel|mesh-list
92456469|NCT01711970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92456470|NCT01711970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456471|NCT01711970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92456472|NCT01711970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92456473|NCT01711970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92456474|NCT01711970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456476|NCT01712100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456477|NCT01712100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92456478|NCT01712100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92456479|NCT01712100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456481|NCT01712113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456482|NCT01712113|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92456483|NCT01712113|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92456484|NCT01712113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456485|NCT01712126|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92456486|NCT01712126|Irbesartan|irbesartan|mesh-list
92456487|NCT01712126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456488|NCT01712126|Diuretics|diuretics|mesh-ancestor
92456489|NCT01712126|Natriuretic Agents|natriuretic agents|mesh-ancestor
92456490|NCT01712126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456491|NCT01712126|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92456492|NCT01712126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456493|NCT01712126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456494|NCT01712126|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92456495|NCT01712126|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92456496|NCT01712139|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92456497|NCT01712139|Irbesartan|irbesartan|mesh-list
92456498|NCT01712139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456499|NCT01712139|Diuretics|diuretics|mesh-ancestor
92456500|NCT01712139|Natriuretic Agents|natriuretic agents|mesh-ancestor
92456501|NCT01712139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181409|NCT01451606|Analgesics|analgesics|mesh-ancestor
92456502|NCT01712139|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92456503|NCT01712139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456504|NCT01712139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456505|NCT01712139|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92456506|NCT01712139|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92456507|NCT01712295|Salicylic Acid|salicylic acid|mesh-list
92456508|NCT01712295|Salicylates|salicylates|mesh-list
92456509|NCT01712295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92456510|NCT01712295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92456511|NCT01712295|Analgesics|analgesics|mesh-ancestor
92456512|NCT01712295|Sensory System Agents|sensory system agents|mesh-ancestor
92456513|NCT01712295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456514|NCT01712295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456515|NCT01712295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456516|NCT01712295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92456517|NCT01712295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92456518|NCT01712295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456519|NCT01712295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456520|NCT01712295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456521|NCT01712295|Antifungal Agents|antifungal agents|mesh-ancestor
92456522|NCT01712295|Keratolytic Agents|keratolytic agents|mesh-ancestor
92456523|NCT01712295|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456524|NCT01712321|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92456525|NCT01712321|Antidepressive Agents|antidepressive agents|mesh-ancestor
92456526|NCT01712321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456527|NCT01712321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92456528|NCT01712321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92456529|NCT01712321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456530|NCT01712321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456531|NCT01712321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456532|NCT01712321|Serotonin Agents|serotonin agents|mesh-ancestor
92456533|NCT01712321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456534|NCT01712321|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92456535|NCT01712321|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92456536|NCT01712347|Bevacizumab|bevacizumab|mesh-list
92456537|NCT01712347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92456538|NCT01712347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456539|NCT01712347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92456540|NCT01712347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92456541|NCT01712347|Growth Substances|growth substances|mesh-ancestor
92456542|NCT01712347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456543|NCT01712347|Growth Inhibitors|growth inhibitors|mesh-ancestor
92456545|NCT01712464|Oxytocics|oxytocics|mesh-ancestor
92456546|NCT01712464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456547|NCT01712464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456548|NCT01712477|Midazolam|midazolam|mesh-list
92456549|NCT01712477|Propofol|propofol|mesh-list
92456550|NCT01712477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92456551|NCT01712477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456552|NCT01712477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456553|NCT01712477|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92456554|NCT01712477|Anesthetics, General|anesthetics, general|mesh-ancestor
92456555|NCT01712477|Anesthetics|anesthetics|mesh-ancestor
92456556|NCT01712477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92456557|NCT01712477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92456558|NCT01712477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92456559|NCT01712477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456560|NCT01712477|GABA Modulators|gaba modulators|mesh-ancestor
92456561|NCT01712477|GABA Agents|gaba agents|mesh-ancestor
92456562|NCT01712477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456563|NCT01712477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456564|NCT01710761|Caffeine|caffeine|mesh-list
92456565|NCT01710761|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92456566|NCT01710761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456567|NCT01710761|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92456568|NCT01710761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456569|NCT01710761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456570|NCT01710761|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92456571|NCT01710761|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92456572|NCT01710761|Purinergic Agents|purinergic agents|mesh-ancestor
92456573|NCT01710761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456574|NCT01712568|Ropinirole|ropinirole|mesh-list
92456576|NCT01712568|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92456577|NCT01712568|Dopamine Agonists|dopamine agonists|mesh-ancestor
92456578|NCT01712568|Dopamine Agents|dopamine agents|mesh-ancestor
92456579|NCT01712568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456580|NCT01712568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456581|NCT01712568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456582|NCT01712646|Oxytocin|oxytocin|mesh-list
92456583|NCT01712646|Oxytocics|oxytocics|mesh-ancestor
92456584|NCT01712646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456585|NCT01712646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456586|NCT01712828|Diphenhydramine|diphenhydramine|mesh-list
92456587|NCT01712828|Promethazine|promethazine|mesh-list
92456588|NCT01712828|Sirolimus|sirolimus|mesh-list
92456589|NCT01712828|Quinidine|quinidine|mesh-list
92456590|NCT01712828|Lenalidomide|lenalidomide|mesh-list
92456591|NCT01712828|Temsirolimus|temsirolimus|mesh-list
92456592|NCT01712828|MTOR Inhibitors|mtor inhibitors|mesh-list
92456593|NCT01712828|Immunologic Factors|immunologic factors|mesh-ancestor
92456594|NCT01712828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456595|NCT01712828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92456596|NCT01712828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92456597|NCT01712828|Growth Substances|growth substances|mesh-ancestor
92456598|NCT01712828|Growth Inhibitors|growth inhibitors|mesh-ancestor
92456599|NCT01712828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456600|NCT01712828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92456601|NCT01712828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456602|NCT01712828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456603|NCT01712828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92456604|NCT01712828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92456605|NCT01712828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456606|NCT01712828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92456607|NCT01712828|Antifungal Agents|antifungal agents|mesh-ancestor
92456608|NCT01712828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92456609|NCT01712828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92456610|NCT01712828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456611|NCT01712828|Anesthetics, Local|anesthetics, local|mesh-ancestor
92456612|NCT01712828|Anesthetics|anesthetics|mesh-ancestor
92456613|NCT01712828|Sensory System Agents|sensory system agents|mesh-ancestor
92456614|NCT01712828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456615|NCT01712828|Antiemetics|antiemetics|mesh-ancestor
92456616|NCT01712828|Autonomic Agents|autonomic agents|mesh-ancestor
92456617|NCT01712828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456618|NCT01712828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92456619|NCT01712828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92456620|NCT01712828|Histamine Agents|histamine agents|mesh-ancestor
92456621|NCT01712828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456622|NCT01712828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92456623|NCT01712828|Antipruritics|antipruritics|mesh-ancestor
92456624|NCT01712828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456625|NCT01712828|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92456626|NCT01712828|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92456627|NCT01712828|Adrenergic Agents|adrenergic agents|mesh-ancestor
92456628|NCT01712828|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92456629|NCT01712828|Antimalarials|antimalarials|mesh-ancestor
92456630|NCT01712828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92456631|NCT01712828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92456632|NCT01712828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92456633|NCT01712828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92456634|NCT01712828|Cholinergic Agents|cholinergic agents|mesh-ancestor
92456635|NCT01712828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92456636|NCT01712828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92456637|NCT01712828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456638|NCT01712828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92456639|NCT01712828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92456640|NCT01712893|Goserelin|goserelin|mesh-list
92456641|NCT01712893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92456642|NCT01712893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456643|NCT01712919|Paclitaxel|paclitaxel|mesh-list
92456644|NCT01712919|Cetuximab|cetuximab|mesh-list
92456645|NCT01712919|Nedaplatin|nedaplatin|mesh-list
92456646|NCT01712919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92456647|NCT01712919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456648|NCT01712919|Tubulin Modulators|tubulin modulators|mesh-ancestor
92456649|NCT01712919|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181549|NCT00040937|Dexamethasone|dexamethasone|mesh-list
92456650|NCT01712919|Mitosis Modulators|mitosis modulators|mesh-ancestor
92456651|NCT01712919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456652|NCT01712919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92456653|NCT01712945|Alemtuzumab|alemtuzumab|mesh-list
92456654|NCT01712945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92456655|NCT01712945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456656|NCT01712997|Bosentan|bosentan|mesh-list
92456657|NCT01712997|Iloprost|iloprost|mesh-list
92456658|NCT01712997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456659|NCT01712997|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92456660|NCT01712997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456661|NCT01712997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92456662|NCT01712997|Vasodilator Agents|vasodilator agents|mesh-ancestor
92456663|NCT01713049|Alovudine|alovudine|mesh-list
92456664|NCT01713049|Antiviral Agents|antiviral agents|mesh-ancestor
92456665|NCT01713049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456666|NCT01713101|Tranylcypromine|tranylcypromine|mesh-list
92456667|NCT01713101|Tranexamic Acid|tranexamic acid|mesh-list
92456668|NCT01713101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
92456669|NCT01713101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92456670|NCT01713101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456671|NCT01713101|Hemostatics|hemostatics|mesh-ancestor
92456672|NCT01713101|Coagulants|coagulants|mesh-ancestor
92456673|NCT01713101|Antidepressive Agents|antidepressive agents|mesh-ancestor
92456674|NCT01713101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456675|NCT01713101|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92456676|NCT01713101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456677|NCT01713101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92456678|NCT01713101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92456679|NCT01713101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456680|NCT01713101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456681|NCT01713127|Remifentanil|remifentanil|mesh-list
92456682|NCT01713127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92456683|NCT01713127|Narcotics|narcotics|mesh-ancestor
92456684|NCT01713127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456685|NCT01713127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456686|NCT01713127|Analgesics|analgesics|mesh-ancestor
92456687|NCT01713127|Sensory System Agents|sensory system agents|mesh-ancestor
92456688|NCT01713127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456689|NCT01713153|Misoprostol|misoprostol|mesh-list
92456690|NCT01713153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92456691|NCT01713153|Abortifacient Agents|abortifacient agents|mesh-ancestor
92456692|NCT01713153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456693|NCT01713153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456694|NCT01713153|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92456695|NCT01713153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456696|NCT01713153|Oxytocics|oxytocics|mesh-ancestor
92531486|NCT00046462|Metformin|metformin|mesh-list
92456698|NCT01713166|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92456699|NCT01713166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92456700|NCT01713179|Ambroxol|ambroxol|mesh-list
92456701|NCT01713179|Expectorants|expectorants|mesh-ancestor
92456702|NCT01713179|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456703|NCT01713218|Gemcitabine|gemcitabine|mesh-list
92456704|NCT01713218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92456705|NCT01713218|Antimetabolites|antimetabolites|mesh-ancestor
92456706|NCT01713218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347803|NCT01720524|Urological Agents|urological agents|mesh-ancestor
92456707|NCT01713218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456708|NCT01713231|Vitamin D|vitamin d|mesh-list
92456709|NCT01713231|Ergocalciferols|ergocalciferols|mesh-list
92456710|NCT01713231|Cholecalciferol|cholecalciferol|mesh-list
92456711|NCT01713231|Vitamins|vitamins|mesh-list
92456712|NCT01713231|Micronutrients|micronutrients|mesh-ancestor
92456713|NCT01713231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456714|NCT01713231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92456715|NCT01713231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92456716|NCT01713309|Lenograstim|lenograstim|mesh-list
92456717|NCT01713309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92456718|NCT01713309|Immunologic Factors|immunologic factors|mesh-ancestor
92456719|NCT01713309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456720|NCT01713361|Enoxaparin|enoxaparin|mesh-list
92456721|NCT01713361|Anticoagulants|anticoagulants|mesh-ancestor
92456722|NCT01713361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92456723|NCT01713361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92456724|NCT01713361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456725|NCT01713387|Gemcitabine|gemcitabine|mesh-list
92456726|NCT01713387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92456727|NCT01713387|Antimetabolites|antimetabolites|mesh-ancestor
92456728|NCT01713387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456730|NCT01713426|Pregabalin|pregabalin|mesh-list
92456731|NCT01713426|Capsaicin|capsaicin|mesh-list
92456732|NCT01713426|Analgesics|analgesics|mesh-ancestor
92456733|NCT01713426|Sensory System Agents|sensory system agents|mesh-ancestor
92456734|NCT01713426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456735|NCT01713426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456736|NCT01713426|Anticonvulsants|anticonvulsants|mesh-ancestor
92456737|NCT01713426|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92456738|NCT01713426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456739|NCT01713426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456740|NCT01713426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92456741|NCT01713426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92456742|NCT01713426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92456743|NCT01713426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456744|NCT01713426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456745|NCT01713426|Antipruritics|antipruritics|mesh-ancestor
92456746|NCT01713426|Dermatologic Agents|dermatologic agents|mesh-ancestor
92456747|NCT01713556|Propranolol|propranolol|mesh-list
92456748|NCT01713556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92456749|NCT01713556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92456750|NCT01713556|Adrenergic Agents|adrenergic agents|mesh-ancestor
92456751|NCT01713556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456752|NCT01713556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456753|NCT01713556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456754|NCT01713556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92456755|NCT01713556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456756|NCT01713556|Vasodilator Agents|vasodilator agents|mesh-ancestor
92456757|NCT01713647|Losartan|losartan|mesh-list
92456758|NCT01713647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92456759|NCT01713647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456760|NCT01713647|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92456761|NCT01713647|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92456762|NCT01713647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456763|NCT01713725|Omalizumab|omalizumab|mesh-list
92456764|NCT01713725|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92456765|NCT01713725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92456766|NCT01713725|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456767|NCT01713738|Rituximab|rituximab|mesh-list
92456768|NCT01713738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92456769|NCT01713738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456770|NCT01713738|Immunologic Factors|immunologic factors|mesh-ancestor
92456771|NCT01713738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456772|NCT01713738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92456773|NCT01713777|Lamotrigine|lamotrigine|mesh-list
92456774|NCT01713777|Anticonvulsants|anticonvulsants|mesh-list
92456775|NCT01713777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92456776|NCT01713777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456777|NCT01713777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456778|NCT01713777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92456779|NCT01713777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456780|NCT01713777|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92456781|NCT01713777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92456782|NCT01713777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456783|NCT01713777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456784|NCT01713777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92456785|NCT01713803|Buprenorphine|buprenorphine|mesh-list
92456786|NCT01713803|Naloxone|naloxone|mesh-list
92456787|NCT01713803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92456788|NCT01713803|Narcotics|narcotics|mesh-ancestor
92456789|NCT01713803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456790|NCT01713803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456791|NCT01713803|Analgesics|analgesics|mesh-ancestor
92456792|NCT01713803|Sensory System Agents|sensory system agents|mesh-ancestor
92456793|NCT01713803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456794|NCT01713803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92456795|NCT01713920|Amlodipine|amlodipine|mesh-list
92456796|NCT01713920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92456797|NCT01713920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92456798|NCT01713920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92456799|NCT01713920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456800|NCT01713920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92456801|NCT01713920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456802|NCT01713920|Vasodilator Agents|vasodilator agents|mesh-ancestor
92456803|NCT01713972|Dabrafenib|dabrafenib|mesh-list
92456804|NCT01713972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456805|NCT01713972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92456806|NCT01713972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456807|NCT01713972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456808|NCT01714011|Aripiprazole|aripiprazole|mesh-list
92456809|NCT01714011|Ziprasidone|ziprasidone|mesh-list
92456810|NCT01714011|Antidepressive Agents|antidepressive agents|mesh-ancestor
92456811|NCT01714011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92456812|NCT01714011|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92456813|NCT01714011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92456814|NCT01714011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456815|NCT01714011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456816|NCT01714011|Dopamine Agonists|dopamine agonists|mesh-ancestor
92456817|NCT01714011|Dopamine Agents|dopamine agents|mesh-ancestor
92456818|NCT01714011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456819|NCT01714011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456820|NCT01714011|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92456821|NCT01714011|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92456822|NCT01714011|Serotonin Agents|serotonin agents|mesh-ancestor
92456823|NCT01714011|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92456824|NCT01714011|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92456825|NCT01714011|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92456826|NCT01714011|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92456827|NCT01714037|Gemcitabine|gemcitabine|mesh-list
92456828|NCT01714037|Docetaxel|docetaxel|mesh-list
92456829|NCT01714037|Pemetrexed|pemetrexed|mesh-list
92456830|NCT01714037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456831|NCT01714037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92456832|NCT01714037|Antimetabolites|antimetabolites|mesh-ancestor
92456833|NCT01714037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456834|NCT01714037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92456835|NCT01714037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92456836|NCT01714037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92456837|NCT01714037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456838|NCT01714037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92456839|NCT01714037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92456840|NCT01714089|Interferons|interferons|mesh-list
92456841|NCT01714089|Interferon-beta|interferon-beta|mesh-list
92456842|NCT01714089|Interferon beta-1a|interferon beta-1a|mesh-list
92456844|NCT01714089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456845|NCT01714089|Antiviral Agents|antiviral agents|mesh-ancestor
92456846|NCT01714089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456847|NCT01714089|Immunologic Factors|immunologic factors|mesh-ancestor
92456848|NCT01714089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456849|NCT01714089|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92456850|NCT01714089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92456851|NCT01714089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92456852|NCT01714089|Analgesics|analgesics|mesh-ancestor
92456853|NCT01714089|Sensory System Agents|sensory system agents|mesh-ancestor
92456854|NCT01714089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456855|NCT01714089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456856|NCT01714089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92456857|NCT01714089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92456858|NCT01714102|Resveratrol|resveratrol|mesh-list
92456859|NCT01714102|Antioxidants|antioxidants|mesh-ancestor
92456860|NCT01714102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456861|NCT01714102|Protective Agents|protective agents|mesh-ancestor
92456862|NCT01714102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456863|NCT01714102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456864|NCT01714102|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92456865|NCT01714115|Aflibercept|aflibercept|mesh-list
92456866|NCT01714115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92456867|NCT01714115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92456868|NCT01714115|Growth Substances|growth substances|mesh-ancestor
92456869|NCT01714115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456870|NCT01714115|Growth Inhibitors|growth inhibitors|mesh-ancestor
92456871|NCT01714115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456872|NCT01714128|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92456873|NCT01714128|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92456874|NCT01714128|Estradiol|estradiol|mesh-list
92456875|NCT01714128|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92456876|NCT01714128|Estrogens|estrogens|mesh-ancestor
92456877|NCT01714128|Hormones|hormones|mesh-ancestor
92456878|NCT01714128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456879|NCT01714128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456880|NCT01714128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92456881|NCT01714128|Contraceptive Agents|contraceptive agents|mesh-ancestor
92456882|NCT01714128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456883|NCT01714128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92456885|NCT01714154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92456886|NCT01714154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92456887|NCT01714154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92456888|NCT01714154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456889|NCT01714154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456890|NCT01714154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92456891|NCT01714154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92456892|NCT01714154|Antiviral Agents|antiviral agents|mesh-ancestor
92456893|NCT01714154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456894|NCT01714154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92456895|NCT01714154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92456896|NCT01714193|Canagliflozin|canagliflozin|mesh-list
92456897|NCT01714193|Contraceptive Agents|contraceptive agents|mesh-list
92456898|NCT01714193|Contraceptives, Oral|contraceptives, oral|mesh-list
92456899|NCT01714193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456900|NCT01714193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456901|NCT01714193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92456902|NCT01714193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456903|NCT01714193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92456904|NCT01714193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92456905|NCT01714206|Canagliflozin|canagliflozin|mesh-list
92456906|NCT01714206|Digoxin|digoxin|mesh-list
92456907|NCT01714206|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92456908|NCT01714206|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92456909|NCT01714206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456910|NCT01714206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456911|NCT01714206|Protective Agents|protective agents|mesh-ancestor
92456912|NCT01714206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456913|NCT01714206|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92456914|NCT01714206|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92456916|NCT01714297|Tinzaparin|tinzaparin|mesh-list
92456917|NCT01714297|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92456918|NCT01714297|Anticoagulants|anticoagulants|mesh-ancestor
92456919|NCT01714297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92456920|NCT01714297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92347819|NCT01745094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92456921|NCT01714297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456922|NCT01714388|Remifentanil|remifentanil|mesh-list
92456923|NCT01714388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92456924|NCT01714388|Narcotics|narcotics|mesh-ancestor
92456925|NCT01714388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92456926|NCT01714388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456927|NCT01714388|Analgesics|analgesics|mesh-ancestor
92456928|NCT01714388|Sensory System Agents|sensory system agents|mesh-ancestor
92456929|NCT01714388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456930|NCT01714401|Albuterol|albuterol|mesh-list
92456931|NCT01714401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92456932|NCT01714401|Autonomic Agents|autonomic agents|mesh-ancestor
92456933|NCT01714401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456934|NCT01714401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456935|NCT01714401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92456936|NCT01714401|Respiratory System Agents|respiratory system agents|mesh-ancestor
92456937|NCT01714401|Tocolytic Agents|tocolytic agents|mesh-ancestor
92456938|NCT01714401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456939|NCT01714401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92456940|NCT01714401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92456941|NCT01714401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92456942|NCT01714401|Adrenergic Agents|adrenergic agents|mesh-ancestor
92456943|NCT01714401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92456944|NCT01714401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456945|NCT01714414|Lamivudine|lamivudine|mesh-list
92456946|NCT01714414|Zidovudine|zidovudine|mesh-list
92456947|NCT01714414|Efavirenz|efavirenz|mesh-list
92456948|NCT01714414|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92456949|NCT01714414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92456950|NCT01714414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181852|NCT03431987|Ethanol|ethanol|mesh-list
92456951|NCT01714414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456952|NCT01714414|Antiviral Agents|antiviral agents|mesh-ancestor
92456953|NCT01714414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456954|NCT01714414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92456955|NCT01714414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92456956|NCT01714414|Antimetabolites|antimetabolites|mesh-ancestor
92456957|NCT01714414|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92456958|NCT01714414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92456959|NCT01714414|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92456960|NCT01714414|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92456961|NCT01714414|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92456962|NCT01714414|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92456963|NCT01714427|Dexamethasone|dexamethasone|mesh-list
92456964|NCT01714427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92456965|NCT01714427|Antiemetics|antiemetics|mesh-ancestor
92456966|NCT01714427|Autonomic Agents|autonomic agents|mesh-ancestor
92456967|NCT01714427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92456968|NCT01714427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92456969|NCT01714427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92456970|NCT01714427|Glucocorticoids|glucocorticoids|mesh-ancestor
92456971|NCT01714427|Hormones|hormones|mesh-ancestor
92456972|NCT01714427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92456973|NCT01714427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92456974|NCT01714427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92456975|NCT01714557|Tazobactam|tazobactam|mesh-list
92456976|NCT01714557|Piperacillin|piperacillin|mesh-list
92456977|NCT01714557|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92456978|NCT01714557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92456979|NCT01714557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456980|NCT01714557|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92456981|NCT01714557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456982|NCT01714557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456983|NCT01714570|Tazobactam|tazobactam|mesh-list
92456984|NCT01714570|Piperacillin|piperacillin|mesh-list
92456985|NCT01714570|Imipenem|imipenem|mesh-list
92456986|NCT01714570|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92456987|NCT01714570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92456988|NCT01714570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347824|NCT01717326|Antiviral Agents|antiviral agents|mesh-ancestor
92456989|NCT01714570|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92456990|NCT01714570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92456991|NCT01714570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92456992|NCT01714596|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92456993|NCT01714596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92456994|NCT01714648|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92456995|NCT01714648|Luteolytic Agents|luteolytic agents|mesh-ancestor
92456996|NCT01714648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92456997|NCT01714648|Contraceptive Agents|contraceptive agents|mesh-ancestor
92456998|NCT01714648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92456999|NCT01714648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457000|NCT01714648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92457001|NCT01714648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92457002|NCT01714648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457003|NCT01714765|Everolimus|everolimus|mesh-list
92457004|NCT01714765|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92457005|NCT01714765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92457006|NCT01714765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457007|NCT01714765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457008|NCT01714765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457009|NCT01714765|Immunologic Factors|immunologic factors|mesh-ancestor
92457010|NCT01714765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457011|NCT01714765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457012|NCT01714817|Mycophenolic Acid|mycophenolic acid|mesh-list
92457013|NCT01714817|Prednisone|prednisone|mesh-list
92457014|NCT01714817|Abatacept|abatacept|mesh-list
92457015|NCT01714817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457016|NCT01714817|Glucocorticoids|glucocorticoids|mesh-ancestor
92457017|NCT01714817|Hormones|hormones|mesh-ancestor
92457018|NCT01714817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457019|NCT01714817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457020|NCT01714817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92457021|NCT01714817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457022|NCT01714817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92457023|NCT01714817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92457024|NCT01714817|Antitubercular Agents|antitubercular agents|mesh-ancestor
92457025|NCT01714817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92457026|NCT01714817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457027|NCT01714817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457028|NCT01714817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457029|NCT01714817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92457030|NCT01714817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457031|NCT01714817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457032|NCT01714817|Immunologic Factors|immunologic factors|mesh-ancestor
92457033|NCT01714817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457034|NCT01714843|Linaclotide|linaclotide|mesh-list
92457035|NCT01714843|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92457036|NCT01714843|Enzyme Activators|enzyme activators|mesh-ancestor
92457037|NCT01714843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457038|NCT01714843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457039|NCT01714856|Ropinirole|ropinirole|mesh-list
92457040|NCT01714856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92457041|NCT01714856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92457042|NCT01714856|Dopamine Agonists|dopamine agonists|mesh-ancestor
92457043|NCT01714856|Dopamine Agents|dopamine agents|mesh-ancestor
92457044|NCT01714856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457045|NCT01714856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457046|NCT01714856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457047|NCT01714895|Insulin|insulin|mesh-list
92457048|NCT01714895|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92457049|NCT01714895|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92457050|NCT01714895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457051|NCT01714908|Etoposide|etoposide|mesh-list
92457052|NCT01714908|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92457053|NCT01714908|Cisplatin|cisplatin|mesh-list
92457054|NCT01714908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92457055|NCT01714908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457056|NCT01714908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92457057|NCT01714908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92457058|NCT01714908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457059|NCT01714908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457060|NCT01714908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92457061|NCT01714960|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92457062|NCT01714960|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92457063|NCT01715077|Ipilimumab|ipilimumab|mesh-list
92457064|NCT01715077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457065|NCT01715077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457066|NCT01715077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92457067|NCT01715077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457068|NCT01715090|Insulin|insulin|mesh-list
92457069|NCT01715090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457070|NCT01715090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457072|NCT01715142|Gemcitabine|gemcitabine|mesh-list
92457073|NCT01715142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92457074|NCT01715142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92457075|NCT01715142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457076|NCT01715142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92457077|NCT01715142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92457078|NCT01715142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92457079|NCT01715142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457080|NCT01715142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457081|NCT01715142|Antimetabolites|antimetabolites|mesh-ancestor
92457082|NCT01715168|Doxorubicin|doxorubicin|mesh-list
92457083|NCT01715168|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92457084|NCT01715168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92457085|NCT01715168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457086|NCT01715168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92457087|NCT01715168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92457088|NCT01715168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457089|NCT01715168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457090|NCT01715220|Nitroglycerin|nitroglycerin|mesh-list
92457091|NCT01715220|Vasodilator Agents|vasodilator agents|mesh-ancestor
92457092|NCT01715259|Abiraterone Acetate|abiraterone acetate|mesh-list
92457093|NCT01715259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457094|NCT01715259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92457095|NCT01715259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457096|NCT01715259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457097|NCT01715259|Hormone Antagonists|hormone antagonists|mesh-ancestor
92457098|NCT01715259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457099|NCT01715259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457100|NCT01715259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92457101|NCT01715311|Tiotropium Bromide|tiotropium bromide|mesh-list
92457102|NCT01715311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92457103|NCT01715311|Autonomic Agents|autonomic agents|mesh-ancestor
92457104|NCT01715311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457105|NCT01715311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457106|NCT01715311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92457107|NCT01715311|Respiratory System Agents|respiratory system agents|mesh-ancestor
92457108|NCT01715311|Parasympatholytics|parasympatholytics|mesh-ancestor
92457109|NCT01715311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92457110|NCT01715311|Cholinergic Agents|cholinergic agents|mesh-ancestor
92457111|NCT01715311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457112|NCT01715311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457113|NCT01715363|Leucovorin|leucovorin|mesh-list
92457114|NCT01715363|Folic Acid|folic acid|mesh-list
92457115|NCT01715363|Oxaliplatin|oxaliplatin|mesh-list
92457116|NCT01715363|Levoleucovorin|levoleucovorin|mesh-list
92457117|NCT01715363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457118|NCT01715363|Antidotes|antidotes|mesh-ancestor
92457119|NCT01715363|Protective Agents|protective agents|mesh-ancestor
92457120|NCT01715363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457121|NCT01715363|Vitamin B Complex|vitamin b complex|mesh-ancestor
92457122|NCT01715363|Vitamins|vitamins|mesh-ancestor
92457123|NCT01715363|Micronutrients|micronutrients|mesh-ancestor
92457124|NCT01715363|Hematinics|hematinics|mesh-ancestor
92457125|NCT01715441|Irinotecan|irinotecan|mesh-list
92457126|NCT01715441|Sorafenib|sorafenib|mesh-list
92457127|NCT01715441|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92457128|NCT01715441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92457129|NCT01715441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457130|NCT01715441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457131|NCT01715441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457132|NCT01715441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92457133|NCT01715493|Muramidase|muramidase|mesh-list
92457134|NCT01715493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457135|NCT01715519|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92457136|NCT01715519|Antidepressive Agents|antidepressive agents|mesh-ancestor
92457137|NCT01715519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92457138|NCT01715519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92457139|NCT01715519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92457140|NCT01715519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457141|NCT01715519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457142|NCT01715519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457143|NCT01715519|Serotonin Agents|serotonin agents|mesh-ancestor
92457144|NCT01715519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457145|NCT01715519|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92457146|NCT01715519|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92457147|NCT01715584|Nitrous Oxide|nitrous oxide|mesh-list
92457148|NCT01715584|Sevoflurane|sevoflurane|mesh-list
92457149|NCT01715584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92457150|NCT01715584|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92457151|NCT01715584|Anesthetics, General|anesthetics, general|mesh-ancestor
92457152|NCT01715584|Anesthetics|anesthetics|mesh-ancestor
92457153|NCT01715584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457154|NCT01715584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457155|NCT01715584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92457156|NCT01715584|Analgesics|analgesics|mesh-ancestor
92457157|NCT01715584|Sensory System Agents|sensory system agents|mesh-ancestor
92457158|NCT01715584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457159|NCT01715597|Ascorbic Acid|ascorbic acid|mesh-list
92457160|NCT01715597|Antioxidants|antioxidants|mesh-ancestor
92457161|NCT01715597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457162|NCT01715597|Protective Agents|protective agents|mesh-ancestor
92457163|NCT01715597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457164|NCT01715597|Vitamins|vitamins|mesh-ancestor
92457165|NCT01715597|Micronutrients|micronutrients|mesh-ancestor
92457166|NCT01715610|Clindamycin|clindamycin|mesh-list
92457167|NCT01715610|Clindamycin palmitate|clindamycin palmitate|mesh-list
92457168|NCT01715610|Clindamycin phosphate|clindamycin phosphate|mesh-list
92457169|NCT01715610|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92457170|NCT01715610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92457171|NCT01715610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457172|NCT01715610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92457173|NCT01715610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457174|NCT01715610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457175|NCT01715610|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92457177|NCT01715636|Emtricitabine|emtricitabine|mesh-list
92457178|NCT01715636|Rilpivirine|rilpivirine|mesh-list
92457179|NCT01715636|Antiviral Agents|antiviral agents|mesh-ancestor
92457180|NCT01715636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457181|NCT01715636|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92457182|NCT01715636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92457183|NCT01715636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457184|NCT01715636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457185|NCT01715636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92457186|NCT01715636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92457187|NCT01715688|Lidocaine|lidocaine|mesh-list
92457188|NCT01715688|Anesthetics, Local|anesthetics, local|mesh-ancestor
92457189|NCT01715688|Anesthetics|anesthetics|mesh-ancestor
92457190|NCT01715688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457191|NCT01715688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457192|NCT01715688|Sensory System Agents|sensory system agents|mesh-ancestor
92457193|NCT01715688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457194|NCT01715688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92457195|NCT01715688|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92457196|NCT01715688|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92457197|NCT01715688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457198|NCT01715688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457199|NCT01715701|Iodine|iodine|mesh-list
92457200|NCT01715701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92457201|NCT01715701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457202|NCT01715701|Trace Elements|trace elements|mesh-ancestor
92457203|NCT01715701|Micronutrients|micronutrients|mesh-ancestor
92457204|NCT01715701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457205|NCT01715909|Oseltamivir|oseltamivir|mesh-list
92457206|NCT01715909|Antiviral Agents|antiviral agents|mesh-ancestor
92457207|NCT01715909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457208|NCT01715909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457209|NCT01715909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457210|NCT01715922|Fluconazole|fluconazole|mesh-list
92457211|NCT01715922|Flucytosine|flucytosine|mesh-list
92457212|NCT01715922|Antifungal Agents|antifungal agents|mesh-ancestor
92457213|NCT01715922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457214|NCT01715922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92457215|NCT01715922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92457216|NCT01715922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457217|NCT01715922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457218|NCT01715922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92457219|NCT01715922|Hormone Antagonists|hormone antagonists|mesh-ancestor
92457220|NCT01715922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457221|NCT01715922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457222|NCT01715922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92457223|NCT01715922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92457224|NCT01715922|Antimetabolites|antimetabolites|mesh-ancestor
92457225|NCT01715935|Everolimus|everolimus|mesh-list
92457226|NCT01715935|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92457227|NCT01715935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92457228|NCT01715935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457229|NCT01715935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457230|NCT01715935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457231|NCT01715935|Immunologic Factors|immunologic factors|mesh-ancestor
92457232|NCT01715935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457233|NCT01715935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457234|NCT01715987|Tenofovir|tenofovir|mesh-list
92457235|NCT01715987|Entecavir|entecavir|mesh-list
92457236|NCT01715987|Antiviral Agents|antiviral agents|mesh-ancestor
92457237|NCT01715987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457238|NCT01715987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92457239|NCT01715987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92457240|NCT01715987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457241|NCT01715987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457242|NCT01715987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92457243|NCT01715987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92457244|NCT01716273|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92457245|NCT01716273|Laxatives|laxatives|mesh-ancestor
92457246|NCT01716273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457247|NCT01716338|Glyburide|glyburide|mesh-list
92457248|NCT01716338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457249|NCT01716338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347857|NCT01739790|Acetylcysteine|acetylcysteine|mesh-list
92457250|NCT01716377|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92457251|NCT01716377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92457252|NCT01716377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92457253|NCT01716377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457254|NCT01716377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457255|NCT01716377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457256|NCT01716377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457257|NCT01716377|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92457258|NCT01716377|Antidepressive Agents|antidepressive agents|mesh-ancestor
92457259|NCT01716377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92457260|NCT01716416|Cetuximab|cetuximab|mesh-list
92457261|NCT01716416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457262|NCT01716416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457263|NCT01716442|Rituximab|rituximab|mesh-list
92457264|NCT01716442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457265|NCT01716442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457266|NCT01716442|Immunologic Factors|immunologic factors|mesh-ancestor
92457267|NCT01716442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457268|NCT01716442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457269|NCT01716572|Erythromycin|erythromycin|mesh-list
92457270|NCT01716572|Erythromycin Estolate|erythromycin estolate|mesh-list
92457271|NCT01716572|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92457272|NCT01716572|Erythromycin stearate|erythromycin stearate|mesh-list
92457273|NCT01716572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92457274|NCT01716572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457275|NCT01716572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457276|NCT01716572|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92457277|NCT01716572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457278|NCT01716572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457279|NCT01716611|Tolvaptan|tolvaptan|mesh-list
92457280|NCT01716611|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92457281|NCT01716611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457282|NCT01716611|Natriuretic Agents|natriuretic agents|mesh-ancestor
92457283|NCT01716611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457285|NCT01716624|Botulinum Toxins|botulinum toxins|mesh-list
92531496|NCT00001766|Efavirenz|efavirenz|mesh-list
92457286|NCT01716624|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92457287|NCT01716624|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92457288|NCT01716624|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92457289|NCT01716624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457290|NCT01716624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457291|NCT01716624|Cholinergic Agents|cholinergic agents|mesh-ancestor
92457292|NCT01716624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457293|NCT01716624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457294|NCT01716624|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92457295|NCT01716624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457296|NCT01716624|Parasympatholytics|parasympatholytics|mesh-ancestor
92457297|NCT01716624|Autonomic Agents|autonomic agents|mesh-ancestor
92457298|NCT01716624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92457299|NCT01716624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92457300|NCT01716624|Urological Agents|urological agents|mesh-ancestor
92457302|NCT01716637|Curcumin|curcumin|mesh-list
92457303|NCT01716637|Resveratrol|resveratrol|mesh-list
92457304|NCT01716637|Quercetin|quercetin|mesh-list
92457305|NCT01716637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92457306|NCT01716637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92457307|NCT01716637|Analgesics|analgesics|mesh-ancestor
92457308|NCT01716637|Sensory System Agents|sensory system agents|mesh-ancestor
92457309|NCT01716637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457310|NCT01716637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457311|NCT01716637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457312|NCT01716637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457313|NCT01716637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457314|NCT01716637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457315|NCT01716637|Immunologic Factors|immunologic factors|mesh-ancestor
92457316|NCT01716637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457317|NCT01716637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457318|NCT01716637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457319|NCT01716637|Antioxidants|antioxidants|mesh-ancestor
92457320|NCT01716637|Protective Agents|protective agents|mesh-ancestor
92457321|NCT01716637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92457322|NCT01716689|Cyclophosphamide|cyclophosphamide|mesh-list
92457323|NCT01716689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457324|NCT01716689|Immunologic Factors|immunologic factors|mesh-ancestor
92457325|NCT01716689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457326|NCT01716689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457327|NCT01716689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92457328|NCT01716689|Alkylating Agents|alkylating agents|mesh-ancestor
92457329|NCT01716689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457330|NCT01716689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457331|NCT01716689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92457332|NCT01716767|Analgesics|analgesics|mesh-list
92457333|NCT01716767|Menthol|menthol|mesh-list
92457334|NCT01716767|Sensory System Agents|sensory system agents|mesh-ancestor
92457335|NCT01716767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457336|NCT01716767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457337|NCT01716767|Antipruritics|antipruritics|mesh-ancestor
92457338|NCT01716767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92457339|NCT01716858|Sulforaphane|sulforaphane|mesh-list
92457340|NCT01716858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92457341|NCT01716858|Protective Agents|protective agents|mesh-ancestor
92457342|NCT01716858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457343|NCT01716858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457344|NCT01716949|Fluorouracil|fluorouracil|mesh-list
92457345|NCT01716949|Capecitabine|capecitabine|mesh-list
92457346|NCT01716949|Oxaliplatin|oxaliplatin|mesh-list
92457347|NCT01716949|Antimetabolites|antimetabolites|mesh-ancestor
92457348|NCT01716949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457349|NCT01716949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457350|NCT01716949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457351|NCT01716949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457352|NCT01716949|Immunologic Factors|immunologic factors|mesh-ancestor
92457353|NCT01716949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457354|NCT01717027|Oxycodone|oxycodone|mesh-list
92457355|NCT01717027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92457356|NCT01717027|Narcotics|narcotics|mesh-ancestor
92457357|NCT01717027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457358|NCT01717027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457359|NCT01717027|Analgesics|analgesics|mesh-ancestor
92457360|NCT01717027|Sensory System Agents|sensory system agents|mesh-ancestor
92457361|NCT01717027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457362|NCT01717066|Ginsenoside Rg3|ginsenoside rg3|mesh-list
92457363|NCT01717066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92457364|NCT01717066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457366|NCT01717118|Immunologic Factors|immunologic factors|mesh-ancestor
92457367|NCT01717118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457368|NCT01717157|Fentanyl|fentanyl|mesh-list
92457369|NCT01717157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92457370|NCT01717157|Narcotics|narcotics|mesh-ancestor
92457371|NCT01717157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457372|NCT01717157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457373|NCT01717157|Analgesics|analgesics|mesh-ancestor
92457374|NCT01717157|Sensory System Agents|sensory system agents|mesh-ancestor
92457375|NCT01717157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457376|NCT01717157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92457377|NCT01717157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92457378|NCT01717157|Anesthetics, General|anesthetics, general|mesh-ancestor
92457379|NCT01717157|Anesthetics|anesthetics|mesh-ancestor
92457380|NCT01717222|Lidocaine|lidocaine|mesh-list
92457381|NCT01717222|Anesthetics, Local|anesthetics, local|mesh-ancestor
92457382|NCT01717222|Anesthetics|anesthetics|mesh-ancestor
92457383|NCT01717222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457384|NCT01717222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457385|NCT01717222|Sensory System Agents|sensory system agents|mesh-ancestor
92457386|NCT01717222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457387|NCT01717222|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92457388|NCT01717222|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92457389|NCT01717222|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92457390|NCT01717222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457391|NCT01717222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457392|NCT01717235|Ropinirole|ropinirole|mesh-list
92457393|NCT01717235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92457394|NCT01717235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92457395|NCT01717235|Dopamine Agonists|dopamine agonists|mesh-ancestor
92457396|NCT01717235|Dopamine Agents|dopamine agents|mesh-ancestor
92457397|NCT01717235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457398|NCT01717235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457399|NCT01717235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457400|NCT01717300|Oxazolidinones|oxazolidinones|mesh-list
92457401|NCT01717300|Anacetrapib|anacetrapib|mesh-list
92457402|NCT01717300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92457403|NCT01717300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92457404|NCT01717300|Antimetabolites|antimetabolites|mesh-ancestor
92457405|NCT01717300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457406|NCT01717300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92457407|NCT01717300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457408|NCT01717300|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92457409|NCT01717300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457410|NCT01717404|Mexiletine|mexiletine|mesh-list
92457411|NCT01717404|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92457412|NCT01717404|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92457413|NCT01717404|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92457414|NCT01717404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457415|NCT01717404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457416|NCT01717599|Diclofenac|diclofenac|mesh-list
92457417|NCT01717599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92457418|NCT01717599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92457419|NCT01717599|Analgesics|analgesics|mesh-ancestor
92457420|NCT01717599|Sensory System Agents|sensory system agents|mesh-ancestor
92457421|NCT01717599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457422|NCT01717599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457423|NCT01717599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457424|NCT01717599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457425|NCT01717599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92457426|NCT01717599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457427|NCT01717599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457428|NCT01717612|Thrombin|thrombin|mesh-list
92457429|NCT01717612|Hemostatics|hemostatics|mesh-ancestor
92457430|NCT01717612|Coagulants|coagulants|mesh-ancestor
92457431|NCT01717625|Montelukast|montelukast|mesh-list
92457432|NCT01717625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92531502|NCT00001766|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92457433|NCT01717625|Respiratory System Agents|respiratory system agents|mesh-ancestor
92457434|NCT01717625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92457435|NCT01717625|Hormone Antagonists|hormone antagonists|mesh-ancestor
92457436|NCT01717625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457437|NCT01717625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457438|NCT01717625|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92457439|NCT01717625|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92457440|NCT01717625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457441|NCT01717690|Chlorhexidine|chlorhexidine|mesh-list
92457442|NCT01717690|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92457443|NCT01717690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92457444|NCT01717690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457445|NCT01717690|Disinfectants|disinfectants|mesh-ancestor
92457446|NCT01717690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92457448|NCT01717729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92457449|NCT01717729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457450|NCT01717729|Trace Elements|trace elements|mesh-ancestor
92457451|NCT01717729|Micronutrients|micronutrients|mesh-ancestor
92457452|NCT01717729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457453|NCT01716260|Chloroquine|chloroquine|mesh-list
92457454|NCT01716260|Primaquine|primaquine|mesh-list
92457455|NCT01716260|Amebicides|amebicides|mesh-ancestor
92457456|NCT01716260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92457457|NCT01716260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92457458|NCT01716260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457459|NCT01716260|Antimalarials|antimalarials|mesh-ancestor
92457460|NCT01716260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457461|NCT01717807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92457462|NCT01717807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457463|NCT01717807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92457464|NCT01717807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457465|NCT01717807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457466|NCT01717846|Abatacept|abatacept|mesh-list
92457467|NCT01717846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92347872|NCT01696032|Doxorubicin|doxorubicin|mesh-list
92457468|NCT01717846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457469|NCT01717846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457470|NCT01717846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457471|NCT01717846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457472|NCT01717846|Immunologic Factors|immunologic factors|mesh-ancestor
92182378|NCT00063635|Vitamin E|vitamin e|mesh-list
92457473|NCT01717846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457474|NCT01717846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457476|NCT01717911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92457477|NCT01717911|Isophane Insulin, Human|isophane insulin, human|mesh-list
92457478|NCT01717911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457479|NCT01717911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457480|NCT01717911|Incretins|incretins|mesh-ancestor
92457481|NCT01717911|Hormones|hormones|mesh-ancestor
92457482|NCT01717911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457483|NCT01717911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92457484|NCT01717911|Protease Inhibitors|protease inhibitors|mesh-ancestor
92457485|NCT01717911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457486|NCT01717911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457487|NCT01717950|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92457488|NCT01717950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92457489|NCT01717950|Immunologic Factors|immunologic factors|mesh-ancestor
92457490|NCT01717950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457491|NCT01717950|Antacids|antacids|mesh-ancestor
92457492|NCT01717950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457493|NCT01717950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457494|NCT01717963|Naltrexone|naltrexone|mesh-list
92457495|NCT01717963|Buprenorphine|buprenorphine|mesh-list
92457496|NCT01717963|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92457497|NCT01717963|Naloxone|naloxone|mesh-list
92457498|NCT01717963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92457499|NCT01717963|Narcotics|narcotics|mesh-ancestor
92457500|NCT01717963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457501|NCT01717963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457502|NCT01717963|Analgesics|analgesics|mesh-ancestor
92457503|NCT01717963|Sensory System Agents|sensory system agents|mesh-ancestor
92457504|NCT01717963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457505|NCT01717963|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92457506|NCT01717963|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92457507|NCT01718054|Chloroquine|chloroquine|mesh-list
92457509|NCT01718054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92457510|NCT01718054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92457511|NCT01718054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457512|NCT01718054|Antimalarials|antimalarials|mesh-ancestor
92457513|NCT01718054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457514|NCT01718093|Metformin|metformin|mesh-list
92457515|NCT01718093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92457516|NCT01718093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457517|NCT01718093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457518|NCT01718093|Incretins|incretins|mesh-ancestor
92457519|NCT01718093|Hormones|hormones|mesh-ancestor
92457520|NCT01718093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457521|NCT01718093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92457522|NCT01718093|Protease Inhibitors|protease inhibitors|mesh-ancestor
92457523|NCT01718093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457524|NCT01718093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457525|NCT01718223|Temoporfin|temoporfin|mesh-list
92457526|NCT01718223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457527|NCT01718223|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92457528|NCT01718223|Dermatologic Agents|dermatologic agents|mesh-ancestor
92457529|NCT01718236|Rocuronium|rocuronium|mesh-list
92457530|NCT01718236|Succinylcholine|succinylcholine|mesh-list
92457531|NCT01718236|Neostigmine|neostigmine|mesh-list
92457532|NCT01718236|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92457533|NCT01718236|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92457534|NCT01718236|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92457535|NCT01718236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457536|NCT01718236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457537|NCT01718236|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92457538|NCT01718236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457539|NCT01718236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457540|NCT01718236|Cholinergic Agents|cholinergic agents|mesh-ancestor
92347875|NCT01696032|Guadecitabine|guadecitabine|mesh-list
92457541|NCT01718236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457542|NCT01718236|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92457543|NCT01718236|Autonomic Agents|autonomic agents|mesh-ancestor
92457544|NCT01718236|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92457545|NCT01718288|Aspirin|aspirin|mesh-list
92457546|NCT01718288|Iloprost|iloprost|mesh-list
92457547|NCT01718288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92457548|NCT01718288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92457549|NCT01718288|Analgesics|analgesics|mesh-ancestor
92457550|NCT01718288|Sensory System Agents|sensory system agents|mesh-ancestor
92457551|NCT01718288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457552|NCT01718288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457553|NCT01718288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457554|NCT01718288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457555|NCT01718288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92457556|NCT01718288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92457557|NCT01718288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457558|NCT01718288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92457559|NCT01718288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92457560|NCT01718288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457561|NCT01718288|Antipyretics|antipyretics|mesh-ancestor
92457562|NCT01718288|Vasodilator Agents|vasodilator agents|mesh-ancestor
92457563|NCT01718301|Ribavirin|ribavirin|mesh-list
92457564|NCT01718301|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92457565|NCT01718301|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92457566|NCT01718301|Antimetabolites|antimetabolites|mesh-ancestor
92457567|NCT01718301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457568|NCT01718301|Antiviral Agents|antiviral agents|mesh-ancestor
92457569|NCT01718301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457570|NCT01718314|Lidocaine|lidocaine|mesh-list
92457571|NCT01718314|Misoprostol|misoprostol|mesh-list
92457572|NCT01718314|Anesthetics, Local|anesthetics, local|mesh-ancestor
92457573|NCT01718314|Anesthetics|anesthetics|mesh-ancestor
92457574|NCT01718314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457575|NCT01718314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457576|NCT01718314|Sensory System Agents|sensory system agents|mesh-ancestor
92457577|NCT01718314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457578|NCT01718314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92457579|NCT01718314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92457580|NCT01718314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92457581|NCT01718314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457582|NCT01718314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457584|NCT01718314|Abortifacient Agents|abortifacient agents|mesh-ancestor
92457585|NCT01718314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92457586|NCT01718314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92457587|NCT01718314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457588|NCT01718314|Oxytocics|oxytocics|mesh-ancestor
92457589|NCT01718327|Sunitinib|sunitinib|mesh-list
92457590|NCT01718327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457591|NCT01718327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92457592|NCT01718327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92457593|NCT01718327|Growth Substances|growth substances|mesh-ancestor
92457594|NCT01718327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457595|NCT01718327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92457596|NCT01718327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92457597|NCT01718327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457598|NCT01718327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457599|NCT01718340|Metformin|metformin|mesh-list
92457600|NCT01718340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457601|NCT01718340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457602|NCT01718366|Vitamin D|vitamin d|mesh-list
92457603|NCT01718366|Azacitidine|azacitidine|mesh-list
92457604|NCT01718366|Deferasirox|deferasirox|mesh-list
92457605|NCT01718366|Vitamins|vitamins|mesh-ancestor
92457606|NCT01718366|Micronutrients|micronutrients|mesh-ancestor
92457607|NCT01718366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457608|NCT01718366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92457609|NCT01718366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457610|NCT01718366|Antimetabolites|antimetabolites|mesh-ancestor
92457611|NCT01718366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457612|NCT01718366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457613|NCT01718366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457614|NCT01718366|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92457615|NCT01718366|Chelating Agents|chelating agents|mesh-ancestor
92457616|NCT01718366|Sequestering Agents|sequestering agents|mesh-ancestor
92457617|NCT01718379|Lenalidomide|lenalidomide|mesh-list
92457618|NCT01718379|Immunologic Factors|immunologic factors|mesh-ancestor
92457619|NCT01718379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457620|NCT01718379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92457621|NCT01718379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92457622|NCT01718379|Growth Substances|growth substances|mesh-ancestor
92457623|NCT01718379|Growth Inhibitors|growth inhibitors|mesh-ancestor
92457624|NCT01718379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457625|NCT01718496|Morphine|morphine|mesh-list
92457626|NCT01718496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92457627|NCT01718496|Narcotics|narcotics|mesh-ancestor
92457628|NCT01718496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457629|NCT01718496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457630|NCT01718496|Analgesics|analgesics|mesh-ancestor
92457631|NCT01718496|Sensory System Agents|sensory system agents|mesh-ancestor
92457632|NCT01718496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457633|NCT01718587|Lamivudine|lamivudine|mesh-list
92457634|NCT01718587|Antiviral Agents|antiviral agents|mesh-list
92457635|NCT01718587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92457636|NCT01718587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92457637|NCT01718587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457638|NCT01718587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457639|NCT01718587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457640|NCT01718587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92457641|NCT01718587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92457642|NCT01718613|Vasopressins|vasopressins|mesh-list
92457643|NCT01718613|Arginine Vasopressin|arginine vasopressin|mesh-list
92457644|NCT01718613|Norepinephrine|norepinephrine|mesh-list
92457645|NCT01718613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92457646|NCT01718613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92457647|NCT01718613|Adrenergic Agents|adrenergic agents|mesh-ancestor
92457648|NCT01718613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457649|NCT01718613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457650|NCT01718613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457651|NCT01718613|Sympathomimetics|sympathomimetics|mesh-ancestor
92457652|NCT01718613|Autonomic Agents|autonomic agents|mesh-ancestor
92457653|NCT01718613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457654|NCT01718613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92457655|NCT01718613|Hemostatics|hemostatics|mesh-ancestor
92457656|NCT01718613|Coagulants|coagulants|mesh-ancestor
92457657|NCT01718613|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92457658|NCT01718613|Natriuretic Agents|natriuretic agents|mesh-ancestor
92457660|NCT01718626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457661|NCT01718626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92457662|NCT01718626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92457663|NCT01718626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92457664|NCT01718626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457665|NCT01718652|Canagliflozin|canagliflozin|mesh-list
92457666|NCT01718652|Cyclosporine|cyclosporine|mesh-list
92457667|NCT01718652|Cyclosporins|cyclosporins|mesh-list
92457668|NCT01718652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457669|NCT01718652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457670|NCT01718652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457671|NCT01718652|Immunologic Factors|immunologic factors|mesh-ancestor
92457672|NCT01718652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457673|NCT01718652|Antifungal Agents|antifungal agents|mesh-ancestor
92457674|NCT01718652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457675|NCT01718652|Dermatologic Agents|dermatologic agents|mesh-ancestor
92457676|NCT01718652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457677|NCT01718652|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92457678|NCT01718652|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92457679|NCT01718652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457680|NCT01718678|Melatonin|melatonin|mesh-list
92457681|NCT01718678|Antioxidants|antioxidants|mesh-ancestor
92457682|NCT01718678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457683|NCT01718678|Protective Agents|protective agents|mesh-ancestor
92457684|NCT01718678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457685|NCT01718678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457686|NCT01718717|Morphine|morphine|mesh-list
92457687|NCT01718717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92457688|NCT01718717|Narcotics|narcotics|mesh-ancestor
92457689|NCT01718717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457690|NCT01718717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457691|NCT01718717|Analgesics|analgesics|mesh-ancestor
92457692|NCT01718717|Sensory System Agents|sensory system agents|mesh-ancestor
92457693|NCT01718717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457694|NCT01718808|Capecitabine|capecitabine|mesh-list
92457695|NCT01718808|Cetuximab|cetuximab|mesh-list
92457696|NCT01718808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457697|NCT01718808|Antimetabolites|antimetabolites|mesh-ancestor
92457698|NCT01718808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457699|NCT01718808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457700|NCT01718808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457701|NCT01718834|Vaccines|vaccines|mesh-list
92457702|NCT01718834|Immunologic Factors|immunologic factors|mesh-ancestor
92457703|NCT01718834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457704|NCT01718899|Lenalidomide|lenalidomide|mesh-list
92457705|NCT01718899|Immunologic Factors|immunologic factors|mesh-ancestor
92457706|NCT01718899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457707|NCT01718899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92457708|NCT01718899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92457709|NCT01718899|Growth Substances|growth substances|mesh-ancestor
92457710|NCT01718899|Growth Inhibitors|growth inhibitors|mesh-ancestor
92457711|NCT01718899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457712|NCT01718912|Metronidazole|metronidazole|mesh-list
92457713|NCT01718912|Nystatin|nystatin|mesh-list
92457714|NCT01718912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457715|NCT01718912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92457716|NCT01718912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92457717|NCT01718912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92457718|NCT01718912|Antifungal Agents|antifungal agents|mesh-ancestor
92457719|NCT01718912|Ionophores|ionophores|mesh-ancestor
92457720|NCT01718912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457721|NCT01718912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457722|NCT01718951|Pamidronate|pamidronate|mesh-list
92457723|NCT01718951|Golimumab|golimumab|mesh-list
92457724|NCT01718951|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92457725|NCT01718951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457726|NCT01718951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457727|NCT01718951|Immunologic Factors|immunologic factors|mesh-ancestor
92457728|NCT01718951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457729|NCT01718951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92457730|NCT01718964|Hydrocortisone|hydrocortisone|mesh-list
92457731|NCT01718964|Mannitol|mannitol|mesh-list
92457732|NCT01718964|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92457733|NCT01718964|Diuretics|diuretics|mesh-ancestor
92457734|NCT01718964|Natriuretic Agents|natriuretic agents|mesh-ancestor
92457735|NCT01718964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457736|NCT01718964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457738|NCT01719042|Antiemetics|antiemetics|mesh-ancestor
92457739|NCT01719042|Autonomic Agents|autonomic agents|mesh-ancestor
92457740|NCT01719042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457741|NCT01719042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457742|NCT01719042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457743|NCT01719042|Antipruritics|antipruritics|mesh-ancestor
92457744|NCT01719042|Dermatologic Agents|dermatologic agents|mesh-ancestor
92457745|NCT01719042|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92457746|NCT01719042|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92457747|NCT01719042|Serotonin Agents|serotonin agents|mesh-ancestor
92457748|NCT01719042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457749|NCT01719042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457750|NCT01719133|Histamine|histamine|mesh-list
92457751|NCT01719133|Histamine phosphate|histamine phosphate|mesh-list
92457752|NCT01719133|Histamine Agonists|histamine agonists|mesh-ancestor
92457753|NCT01719133|Histamine Agents|histamine agents|mesh-ancestor
92457754|NCT01719133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457755|NCT01719133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457756|NCT01719133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457757|NCT01719159|Rituximab|rituximab|mesh-list
92457758|NCT01719159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457759|NCT01719159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457760|NCT01719159|Immunologic Factors|immunologic factors|mesh-ancestor
92457761|NCT01719159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457762|NCT01719159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457763|NCT01719185|Vitamin B 12|vitamin b 12|mesh-list
92457764|NCT01719185|Phentermine|phentermine|mesh-list
92457765|NCT01719185|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92457766|NCT01719185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457767|NCT01719185|Appetite Depressants|appetite depressants|mesh-ancestor
92457768|NCT01719185|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92457769|NCT01719185|Sympathomimetics|sympathomimetics|mesh-ancestor
92457770|NCT01719185|Autonomic Agents|autonomic agents|mesh-ancestor
92457771|NCT01719185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457772|NCT01719185|Adrenergic Agents|adrenergic agents|mesh-ancestor
92457773|NCT01719185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457774|NCT01719185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457775|NCT01719185|Vitamin B Complex|vitamin b complex|mesh-ancestor
92457776|NCT01719185|Vitamins|vitamins|mesh-ancestor
92457777|NCT01719185|Micronutrients|micronutrients|mesh-ancestor
92457778|NCT01719302|Gemcitabine|gemcitabine|mesh-list
92457779|NCT01719302|Docetaxel|docetaxel|mesh-list
92457780|NCT01719302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457781|NCT01719302|Antimetabolites|antimetabolites|mesh-ancestor
92457782|NCT01719302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457783|NCT01719302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457784|NCT01719302|Tubulin Modulators|tubulin modulators|mesh-ancestor
92457785|NCT01719302|Antimitotic Agents|antimitotic agents|mesh-ancestor
92457786|NCT01719302|Mitosis Modulators|mitosis modulators|mesh-ancestor
92457788|NCT01719419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457789|NCT01719419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457790|NCT01719419|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92457791|NCT01719419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92457792|NCT01719588|Tapentadol|tapentadol|mesh-list
92457793|NCT01719588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92457794|NCT01719588|Narcotics|narcotics|mesh-ancestor
92457795|NCT01719588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457796|NCT01719588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457797|NCT01719588|Analgesics|analgesics|mesh-ancestor
92457798|NCT01719588|Sensory System Agents|sensory system agents|mesh-ancestor
92457799|NCT01719588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457800|NCT01719588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92457801|NCT01719588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92457802|NCT01719588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457803|NCT01719588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457804|NCT01719588|Adrenergic Agents|adrenergic agents|mesh-ancestor
92457805|NCT01719588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457806|NCT01719601|Tapentadol|tapentadol|mesh-list
92457807|NCT01719601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92347916|NCT01694706|Omeprazole|omeprazole|mesh-list
92457808|NCT01719601|Narcotics|narcotics|mesh-ancestor
92457809|NCT01719601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457810|NCT01719601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457811|NCT01719601|Analgesics|analgesics|mesh-ancestor
92457813|NCT01719601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457814|NCT01719601|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92457815|NCT01719601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92457816|NCT01719601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457817|NCT01719601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457818|NCT01719601|Adrenergic Agents|adrenergic agents|mesh-ancestor
92457819|NCT01719601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457820|NCT01719614|Metformin|metformin|mesh-list
92457821|NCT01719614|Rilpivirine|rilpivirine|mesh-list
92457822|NCT01719614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92457823|NCT01719614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457824|NCT01719614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92457825|NCT01719614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92457826|NCT01719614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457827|NCT01719614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457828|NCT01719614|Antiviral Agents|antiviral agents|mesh-ancestor
92457829|NCT01719614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457830|NCT01719614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92457831|NCT01719614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92457832|NCT01719627|Maraviroc|maraviroc|mesh-list
92457833|NCT01719627|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92457834|NCT01719627|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92457835|NCT01719627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457836|NCT01719627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92457837|NCT01719627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92457838|NCT01719627|Antiviral Agents|antiviral agents|mesh-ancestor
92457839|NCT01719627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457840|NCT01719627|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92457841|NCT01719692|Rituximab|rituximab|mesh-list
92457842|NCT01719692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92457843|NCT01719692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457844|NCT01719692|Immunologic Factors|immunologic factors|mesh-ancestor
92457845|NCT01719692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457846|NCT01719692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457847|NCT01719705|Pregabalin|pregabalin|mesh-list
92457848|NCT01719705|Analgesics|analgesics|mesh-ancestor
92457849|NCT01719705|Sensory System Agents|sensory system agents|mesh-ancestor
92457850|NCT01719705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457851|NCT01719705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457852|NCT01719705|Anticonvulsants|anticonvulsants|mesh-ancestor
92457853|NCT01719705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92457854|NCT01719705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92457855|NCT01719705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457856|NCT01719705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92457857|NCT01719705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92457858|NCT01719705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92457859|NCT01719705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457860|NCT01719705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92457861|NCT01719770|Rocuronium|rocuronium|mesh-list
92457862|NCT01719770|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92457863|NCT01719770|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92457864|NCT01719770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92457865|NCT01719770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457866|NCT01719770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457867|NCT01719835|Methylprednisolone|methylprednisolone|mesh-list
92457868|NCT01719835|Prednisolone|prednisolone|mesh-list
92457869|NCT01719835|Cyclophosphamide|cyclophosphamide|mesh-list
92457870|NCT01719835|Gemcitabine|gemcitabine|mesh-list
92457871|NCT01719835|Doxorubicin|doxorubicin|mesh-list
92457872|NCT01719835|Vincristine|vincristine|mesh-list
92457873|NCT01719835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92457874|NCT01719835|Immunologic Factors|immunologic factors|mesh-ancestor
92457875|NCT01719835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457876|NCT01719835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457877|NCT01719835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92457878|NCT01719835|Alkylating Agents|alkylating agents|mesh-ancestor
92457879|NCT01719835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457880|NCT01719835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92457881|NCT01719835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92457882|NCT01719835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92457883|NCT01719835|Antimetabolites|antimetabolites|mesh-ancestor
92457884|NCT01719835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92457885|NCT01719835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92457886|NCT01719835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92457887|NCT01719835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457888|NCT01719835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92457889|NCT01719835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92457890|NCT01719835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92457891|NCT01719835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92457892|NCT01719835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457893|NCT01719835|Antiemetics|antiemetics|mesh-ancestor
92457894|NCT01719835|Autonomic Agents|autonomic agents|mesh-ancestor
92457895|NCT01719835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457896|NCT01719835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92457897|NCT01719835|Glucocorticoids|glucocorticoids|mesh-ancestor
92457899|NCT01719835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92457900|NCT01719835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92457901|NCT01719835|Protective Agents|protective agents|mesh-ancestor
92457902|NCT01719835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92457903|NCT01719926|Indomethacin|indomethacin|mesh-list
92457904|NCT01719926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92457905|NCT01719926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92457906|NCT01719926|Analgesics|analgesics|mesh-ancestor
92457907|NCT01719926|Sensory System Agents|sensory system agents|mesh-ancestor
92457908|NCT01719926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457909|NCT01719926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457910|NCT01719926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457911|NCT01719926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457912|NCT01719926|Gout Suppressants|gout suppressants|mesh-ancestor
92457913|NCT01719926|Tocolytic Agents|tocolytic agents|mesh-ancestor
92457914|NCT01719926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92457915|NCT01719926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92457916|NCT01719926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457917|NCT01719926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457918|NCT01719952|Oxytocin|oxytocin|mesh-list
92457919|NCT01719952|Carbetocin|carbetocin|mesh-list
92457920|NCT01719952|Oxytocics|oxytocics|mesh-ancestor
92457921|NCT01719952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92457922|NCT01719952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457923|NCT01719978|Epinephrine|epinephrine|mesh-list
92457924|NCT01719978|Racepinephrine|racepinephrine|mesh-list
92457925|NCT01719978|Mepivacaine|mepivacaine|mesh-list
92457926|NCT01719978|Epinephryl borate|epinephryl borate|mesh-list
92182831|NCT01691313|Vanoxerine|vanoxerine|mesh-list
92457927|NCT01719978|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92457928|NCT01719978|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92457929|NCT01719978|Adrenergic Agents|adrenergic agents|mesh-ancestor
92457930|NCT01719978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457931|NCT01719978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457932|NCT01719978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457933|NCT01719978|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92457934|NCT01719978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92457935|NCT01719978|Autonomic Agents|autonomic agents|mesh-ancestor
92457936|NCT01719978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92457937|NCT01719978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92457938|NCT01719978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92457939|NCT01719978|Mydriatics|mydriatics|mesh-ancestor
92457940|NCT01719978|Sympathomimetics|sympathomimetics|mesh-ancestor
92457941|NCT01719978|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92457942|NCT01719978|Anesthetics, Local|anesthetics, local|mesh-ancestor
92457943|NCT01719978|Anesthetics|anesthetics|mesh-ancestor
92457944|NCT01719978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92457945|NCT01719978|Sensory System Agents|sensory system agents|mesh-ancestor
92457946|NCT01720459|Resveratrol|resveratrol|mesh-list
92457947|NCT01720459|Antioxidants|antioxidants|mesh-ancestor
92457948|NCT01720459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457949|NCT01720459|Protective Agents|protective agents|mesh-ancestor
92457950|NCT01720459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457951|NCT01720459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457952|NCT01720459|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92457953|NCT01720537|Bococizumab|bococizumab|mesh-list
92457954|NCT01720537|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92457955|NCT01720537|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92457956|NCT01720537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92457957|NCT01720537|Antimetabolites|antimetabolites|mesh-ancestor
92457958|NCT01720537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457959|NCT01720537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92457960|NCT01720537|Immunologic Factors|immunologic factors|mesh-ancestor
92457961|NCT01720537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457962|NCT01720719|Vitamin E|vitamin e|mesh-list
92457963|NCT01720719|Atorvastatin|atorvastatin|mesh-list
92457964|NCT01720719|Vitamins|vitamins|mesh-ancestor
92457965|NCT01720719|Micronutrients|micronutrients|mesh-ancestor
92457966|NCT01720719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457967|NCT01720719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92457968|NCT01720719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92457969|NCT01720719|Antimetabolites|antimetabolites|mesh-ancestor
92457970|NCT01720719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457971|NCT01720719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92457972|NCT01720719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92457973|NCT01720719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92457974|NCT01720719|Antioxidants|antioxidants|mesh-ancestor
92457975|NCT01720719|Protective Agents|protective agents|mesh-ancestor
92457976|NCT01722214|Adalimumab|adalimumab|mesh-list
92457977|NCT01722214|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92457978|NCT01722214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92457979|NCT01722214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92457980|NCT01722578|N-Methylaspartate|n-methylaspartate|mesh-list
92457981|NCT01722578|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92457982|NCT01722578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92457983|NCT01722578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92457984|NCT01722578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92457985|NCT01722578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457986|NCT01723852|Vitamin D|vitamin d|mesh-list
92457987|NCT01723852|Ergocalciferols|ergocalciferols|mesh-list
92457988|NCT01723852|Cholecalciferol|cholecalciferol|mesh-list
92457989|NCT01723852|Vitamins|vitamins|mesh-list
92457990|NCT01723852|Micronutrients|micronutrients|mesh-ancestor
92457991|NCT01723852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92457992|NCT01723852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92457993|NCT01723852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92457994|NCT01724229|Antifungal Agents|antifungal agents|mesh-list
92457995|NCT01724229|Clotrimazole|clotrimazole|mesh-list
92457996|NCT01724229|Miconazole|miconazole|mesh-list
92457997|NCT01724229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92457998|NCT01724229|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92457999|NCT01724229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92458000|NCT01724229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92458001|NCT01724229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458002|NCT01724229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458003|NCT01724229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92458004|NCT01724229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92458005|NCT01724229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458006|NCT01724229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458007|NCT01724229|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92458008|NCT01724229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92458009|NCT01724450|Carvedilol|carvedilol|mesh-list
92458010|NCT01724450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92458011|NCT01724450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92458012|NCT01724450|Adrenergic Agents|adrenergic agents|mesh-ancestor
92458013|NCT01724450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458014|NCT01724450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458015|NCT01724450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458016|NCT01724450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92458017|NCT01724450|Antioxidants|antioxidants|mesh-ancestor
92458018|NCT01724450|Protective Agents|protective agents|mesh-ancestor
92458019|NCT01724450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92458020|NCT01724450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92458021|NCT01724450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458022|NCT01724450|Vasodilator Agents|vasodilator agents|mesh-ancestor
92458023|NCT01724450|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92458024|NCT01724450|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92458025|NCT01724723|Entecavir|entecavir|mesh-list
92458026|NCT01724723|Antiviral Agents|antiviral agents|mesh-ancestor
92458027|NCT01724723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458028|NCT01724892|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92458029|NCT01724892|Dexamethasone|dexamethasone|mesh-list
92458030|NCT01724892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458031|NCT01724892|Antiemetics|antiemetics|mesh-ancestor
92458032|NCT01724892|Autonomic Agents|autonomic agents|mesh-ancestor
92458033|NCT01724892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458035|NCT01724892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458036|NCT01724892|Glucocorticoids|glucocorticoids|mesh-ancestor
92458037|NCT01724892|Hormones|hormones|mesh-ancestor
92458038|NCT01724892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458039|NCT01724892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92458040|NCT01724892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458041|NCT01724892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92458042|NCT01725256|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92458043|NCT01727427|Aspirin|aspirin|mesh-list
92458044|NCT01727427|Vitamin K|vitamin k|mesh-list
92458045|NCT01727427|Heparin|heparin|mesh-list
92458046|NCT01727427|Enoxaparin|enoxaparin|mesh-list
92458047|NCT01727427|Dalteparin|dalteparin|mesh-list
92458048|NCT01727427|Tinzaparin|tinzaparin|mesh-list
92458049|NCT01727427|PENTA|penta|mesh-list
92458050|NCT01727427|Nadroparin|nadroparin|mesh-list
92458051|NCT01727427|Warfarin|warfarin|mesh-list
92458052|NCT01727427|Rivaroxaban|rivaroxaban|mesh-list
92458053|NCT01727427|Dabigatran|dabigatran|mesh-list
92458054|NCT01727427|Apixaban|apixaban|mesh-list
92458055|NCT01727427|Fondaparinux|fondaparinux|mesh-list
92458056|NCT01727427|Acenocoumarol|acenocoumarol|mesh-list
92458057|NCT01727427|Phenprocoumon|phenprocoumon|mesh-list
92458058|NCT01727427|Bemiparin|bemiparin|mesh-list
92458059|NCT01727427|Vitamins|vitamins|mesh-ancestor
92458060|NCT01727427|Micronutrients|micronutrients|mesh-ancestor
92458061|NCT01727427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458062|NCT01727427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458063|NCT01727427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458064|NCT01727427|Analgesics|analgesics|mesh-ancestor
92458065|NCT01727427|Sensory System Agents|sensory system agents|mesh-ancestor
92458066|NCT01727427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458067|NCT01727427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347954|NCT01737840|Pantoprazole|pantoprazole|mesh-list
92458068|NCT01727427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458069|NCT01727427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92458070|NCT01727427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92458071|NCT01727427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458072|NCT01727427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92458073|NCT01727427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92458074|NCT01727427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458075|NCT01727427|Antipyretics|antipyretics|mesh-ancestor
92458076|NCT01727427|Anticoagulants|anticoagulants|mesh-ancestor
92458077|NCT01727427|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92458078|NCT01727427|Antithrombins|antithrombins|mesh-ancestor
92458079|NCT01727427|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92458080|NCT01727427|Protease Inhibitors|protease inhibitors|mesh-ancestor
92458081|NCT01727427|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92458082|NCT01727427|Hemostatics|hemostatics|mesh-ancestor
92458083|NCT01727427|Coagulants|coagulants|mesh-ancestor
92458084|NCT01727778|Antibodies|antibodies|mesh-list
92458085|NCT01727778|Immunoglobulin M|immunoglobulin m|mesh-list
92458086|NCT01727778|Immunologic Factors|immunologic factors|mesh-ancestor
92458087|NCT01727778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458088|NCT01728025|Ranolazine|ranolazine|mesh-list
92458089|NCT01728025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92458090|NCT01728025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92458091|NCT01728025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458092|NCT01729195|Ciprofloxacin|ciprofloxacin|mesh-list
92458093|NCT01729195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92458094|NCT01729195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458095|NCT01729195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92458096|NCT01729195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92458097|NCT01729195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458098|NCT01729195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458099|NCT01729195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458100|NCT01729195|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92458101|NCT01729195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92458102|NCT01730014|Insulin Glargine|insulin glargine|mesh-list
92458103|NCT01730014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92458104|NCT01730014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458105|NCT01730157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92458106|NCT01730157|Ipilimumab|ipilimumab|mesh-list
92458107|NCT01730157|Antibodies|antibodies|mesh-list
92458108|NCT01730157|Immunoglobulins|immunoglobulins|mesh-list
92458109|NCT01730157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92458110|NCT01730157|Immunologic Factors|immunologic factors|mesh-ancestor
92458111|NCT01730157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458112|NCT01730157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458114|NCT01730157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458115|NCT01730209|Everolimus|everolimus|mesh-list
92458116|NCT01730209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92458117|NCT01730209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92458118|NCT01730209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458119|NCT01730209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458120|NCT01730209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92458121|NCT01730209|Immunologic Factors|immunologic factors|mesh-ancestor
92458122|NCT01730209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458123|NCT01730209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458124|NCT01730222|Paclitaxel|paclitaxel|mesh-list
92458125|NCT01730222|Gemcitabine|gemcitabine|mesh-list
92458126|NCT01730222|Capecitabine|capecitabine|mesh-list
92458127|NCT01730222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92458128|NCT01730222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458129|NCT01730222|Tubulin Modulators|tubulin modulators|mesh-ancestor
92458130|NCT01730222|Antimitotic Agents|antimitotic agents|mesh-ancestor
92458131|NCT01730222|Mitosis Modulators|mitosis modulators|mesh-ancestor
92458132|NCT01730222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458133|NCT01730222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92458134|NCT01730222|Antimetabolites|antimetabolites|mesh-ancestor
92458135|NCT01730287|Calcium, Dietary|calcium, dietary|mesh-list
92458136|NCT01730287|Calcium|calcium|mesh-list
92458137|NCT01730287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458138|NCT01730287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458139|NCT01730287|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92458140|NCT01730326|Acetaminophen|acetaminophen|mesh-list
92458141|NCT01730326|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92458142|NCT01730326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458143|NCT01730326|Analgesics|analgesics|mesh-ancestor
92458144|NCT01730326|Sensory System Agents|sensory system agents|mesh-ancestor
92458145|NCT01730326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458146|NCT01730326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458147|NCT01730326|Antipyretics|antipyretics|mesh-ancestor
92458148|NCT01730326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458149|NCT01730326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458150|NCT01730326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458151|NCT01730417|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92458152|NCT01730417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458153|NCT01730417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458154|NCT01730417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183048|NCT00245635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92458155|NCT01730417|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92458156|NCT01730495|Etanercept|etanercept|mesh-list
92458157|NCT01730495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458159|NCT01730495|Analgesics|analgesics|mesh-ancestor
92458160|NCT01730495|Sensory System Agents|sensory system agents|mesh-ancestor
92458161|NCT01730495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458162|NCT01730495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458163|NCT01730495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458164|NCT01730495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458165|NCT01730495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458166|NCT01730495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92458167|NCT01730495|Immunologic Factors|immunologic factors|mesh-ancestor
92458168|NCT01730508|Interferons|interferons|mesh-list
92458169|NCT01730508|Interferon-alpha|interferon-alpha|mesh-list
92458170|NCT01730508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458171|NCT01730508|Antiviral Agents|antiviral agents|mesh-ancestor
92458172|NCT01730508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458173|NCT01730508|Immunologic Factors|immunologic factors|mesh-ancestor
92458174|NCT01730508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458175|NCT01726400|Interferons|interferons|mesh-list
92458176|NCT01726400|Ribavirin|ribavirin|mesh-list
92458177|NCT01726400|Interferon-alpha|interferon-alpha|mesh-list
92458178|NCT01726400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458179|NCT01726400|Antiviral Agents|antiviral agents|mesh-ancestor
92458180|NCT01726400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458181|NCT01726400|Antimetabolites|antimetabolites|mesh-ancestor
92458182|NCT01726400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458183|NCT01726400|Immunologic Factors|immunologic factors|mesh-ancestor
92458184|NCT01726400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458185|NCT01730612|Histamine|histamine|mesh-list
92458186|NCT01730612|Glycine|glycine|mesh-list
92458187|NCT01730612|Histamine Agonists|histamine agonists|mesh-ancestor
92458188|NCT01730612|Histamine Agents|histamine agents|mesh-ancestor
92458189|NCT01730612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458190|NCT01730612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458191|NCT01730612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458192|NCT01730612|Glycine Agents|glycine agents|mesh-ancestor
92458194|NCT01730664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92458195|NCT01730664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458196|NCT01730677|Vinorelbine|vinorelbine|mesh-list
92458197|NCT01730677|Lapatinib|lapatinib|mesh-list
92458198|NCT01730677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92458199|NCT01730677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458200|NCT01730677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92458201|NCT01730677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92458202|NCT01730677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92458203|NCT01730677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458204|NCT01730677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92458205|NCT01730677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458206|NCT01730976|Vitamin D|vitamin d|mesh-list
92458207|NCT01730976|Vitamins|vitamins|mesh-list
92458208|NCT01730976|Micronutrients|micronutrients|mesh-ancestor
92458209|NCT01730976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458210|NCT01730976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92458211|NCT01731067|Fexofenadine|fexofenadine|mesh-list
92458212|NCT01731067|Flurbiprofen|flurbiprofen|mesh-list
92458213|NCT01731067|Midazolam|midazolam|mesh-list
92458214|NCT01731067|Dextromethorphan|dextromethorphan|mesh-list
92458215|NCT01731067|Caffeine|caffeine|mesh-list
92458216|NCT01731067|Bupropion|bupropion|mesh-list
92458217|NCT01731067|Omeprazole|omeprazole|mesh-list
92458218|NCT01731067|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92458219|NCT01731067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92458220|NCT01731067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458221|NCT01731067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458222|NCT01731067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92458223|NCT01731067|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92458224|NCT01731067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92458225|NCT01731067|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92458226|NCT01731067|Anesthetics, General|anesthetics, general|mesh-ancestor
92458227|NCT01731067|Anesthetics|anesthetics|mesh-ancestor
92458228|NCT01731067|GABA Modulators|gaba modulators|mesh-ancestor
92458229|NCT01731067|GABA Agents|gaba agents|mesh-ancestor
92458230|NCT01731067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458231|NCT01731067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458232|NCT01731067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92458233|NCT01731067|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92458234|NCT01731067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458235|NCT01731067|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92458236|NCT01731067|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92458237|NCT01731067|Purinergic Agents|purinergic agents|mesh-ancestor
92458238|NCT01731067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92458239|NCT01731067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458240|NCT01731067|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92458241|NCT01731067|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92458242|NCT01731067|Antidepressive Agents|antidepressive agents|mesh-ancestor
92458243|NCT01731067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92458244|NCT01731067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92458245|NCT01731067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92458246|NCT01731067|Dopamine Agents|dopamine agents|mesh-ancestor
92458247|NCT01731067|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92458248|NCT01731067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92458249|NCT01731067|Antitussive Agents|antitussive agents|mesh-ancestor
92458250|NCT01731067|Respiratory System Agents|respiratory system agents|mesh-ancestor
92458251|NCT01731067|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92458252|NCT01731067|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92458253|NCT01731067|Analgesics|analgesics|mesh-ancestor
92458254|NCT01731067|Sensory System Agents|sensory system agents|mesh-ancestor
92458255|NCT01731067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458256|NCT01731067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458257|NCT01731067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458258|NCT01731067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458259|NCT01731067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458260|NCT01731067|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92458261|NCT01731067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92458262|NCT01731067|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92458263|NCT01731067|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92458264|NCT01731067|Histamine Antagonists|histamine antagonists|mesh-ancestor
92458265|NCT01731067|Histamine Agents|histamine agents|mesh-ancestor
92458267|NCT01731132|Levonorgestrel|levonorgestrel|mesh-list
92458268|NCT01731132|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92458269|NCT01731132|Contraceptive Agents|contraceptive agents|mesh-ancestor
92458270|NCT01731132|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92458271|NCT01731132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458272|NCT01731132|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92458273|NCT01731132|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92458274|NCT01731132|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92458275|NCT01731132|Trace Elements|trace elements|mesh-ancestor
92458276|NCT01731132|Micronutrients|micronutrients|mesh-ancestor
92458277|NCT01731158|Interferon alpha-2|interferon alpha-2|mesh-list
92458278|NCT01731158|Bevacizumab|bevacizumab|mesh-list
92458279|NCT01731158|Sunitinib|sunitinib|mesh-list
92458280|NCT01731158|Everolimus|everolimus|mesh-list
92458281|NCT01731158|Sorafenib|sorafenib|mesh-list
92458282|NCT01731158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92458283|NCT01731158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458284|NCT01731158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92458285|NCT01731158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92458286|NCT01731158|Growth Substances|growth substances|mesh-ancestor
92458287|NCT01731158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458288|NCT01731158|Growth Inhibitors|growth inhibitors|mesh-ancestor
92458289|NCT01731158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92458290|NCT01731158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92458291|NCT01731158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458292|NCT01731158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458293|NCT01731158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92458294|NCT01731158|Immunologic Factors|immunologic factors|mesh-ancestor
92458295|NCT01731158|Antiviral Agents|antiviral agents|mesh-ancestor
92458296|NCT01731158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458297|NCT01731184|Midazolam|midazolam|mesh-list
92458298|NCT01731184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92458299|NCT01731184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92458300|NCT01731184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458301|NCT01731184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458302|NCT01731184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92458303|NCT01731184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92458304|NCT01731184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92458305|NCT01731184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92458306|NCT01731184|Anesthetics, General|anesthetics, general|mesh-ancestor
92458307|NCT01731184|Anesthetics|anesthetics|mesh-ancestor
92458308|NCT01731184|GABA Modulators|gaba modulators|mesh-ancestor
92458309|NCT01731184|GABA Agents|gaba agents|mesh-ancestor
92458310|NCT01731184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458311|NCT01731184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458312|NCT01731275|Quetmolimab|quetmolimab|mesh-list
92458313|NCT01731275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92458314|NCT01731275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458315|NCT01731275|Immunologic Factors|immunologic factors|mesh-ancestor
92458316|NCT01731275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458317|NCT01731301|Ribavirin|ribavirin|mesh-list
92458318|NCT01731301|Antimetabolites|antimetabolites|mesh-ancestor
92458319|NCT01731301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458320|NCT01731301|Antiviral Agents|antiviral agents|mesh-ancestor
92458321|NCT01731301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458322|NCT01731327|Tofacitinib|tofacitinib|mesh-list
92458323|NCT01731327|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92458324|NCT01731327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92458325|NCT01731327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458326|NCT01731327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458327|NCT01731340|Calcium, Dietary|calcium, dietary|mesh-list
92458328|NCT01731340|Calcium|calcium|mesh-list
92458329|NCT01731340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458330|NCT01731340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458331|NCT01731340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92458332|NCT01731431|Glyburide|glyburide|mesh-list
92458333|NCT01731431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92458334|NCT01731431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458335|NCT01731457|Etanercept|etanercept|mesh-list
92458336|NCT01731457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458337|NCT01731457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458339|NCT01731457|Sensory System Agents|sensory system agents|mesh-ancestor
92458340|NCT01731457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458341|NCT01731457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458342|NCT01731457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458343|NCT01731457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458344|NCT01731457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458345|NCT01731457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92458346|NCT01731457|Immunologic Factors|immunologic factors|mesh-ancestor
92458347|NCT01731561|Rituximab|rituximab|mesh-list
92458348|NCT01731561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92458349|NCT01731561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458350|NCT01731561|Immunologic Factors|immunologic factors|mesh-ancestor
92458351|NCT01731561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458352|NCT01731561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458353|NCT01731574|Dapivirine|dapivirine|mesh-list
92458354|NCT01731574|Miconazole|miconazole|mesh-list
92458355|NCT01731574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92458356|NCT01731574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92458357|NCT01731574|Antiviral Agents|antiviral agents|mesh-ancestor
92458358|NCT01731574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458359|NCT01731574|Antifungal Agents|antifungal agents|mesh-ancestor
92458360|NCT01731574|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92458361|NCT01731574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92458362|NCT01731574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458363|NCT01731574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458364|NCT01731574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92458365|NCT01731574|Hormone Antagonists|hormone antagonists|mesh-ancestor
92458366|NCT01731574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458367|NCT01731574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458368|NCT01731574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92458369|NCT01731574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92458370|NCT01731587|Cyclophosphamide|cyclophosphamide|mesh-list
92458371|NCT01731587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92458372|NCT01731587|Immunologic Factors|immunologic factors|mesh-ancestor
92458373|NCT01731587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458374|NCT01731587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458375|NCT01731587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92458376|NCT01731587|Alkylating Agents|alkylating agents|mesh-ancestor
92458377|NCT01731587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458378|NCT01731587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458379|NCT01731587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92458380|NCT01731652|Imiquimod|imiquimod|mesh-list
92458381|NCT01731652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92458382|NCT01731652|Immunologic Factors|immunologic factors|mesh-ancestor
92458383|NCT01731652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458384|NCT01731652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458385|NCT01731652|Interferon Inducers|interferon inducers|mesh-ancestor
92458386|NCT01731756|Salicylic Acid|salicylic acid|mesh-list
92458387|NCT01731756|Salicylates|salicylates|mesh-list
92458388|NCT01731756|Petrolatum|petrolatum|mesh-list
92458389|NCT01731756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458390|NCT01731756|Antifungal Agents|antifungal agents|mesh-ancestor
92458391|NCT01731756|Keratolytic Agents|keratolytic agents|mesh-ancestor
92458392|NCT01731756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92458393|NCT01731756|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458394|NCT01731756|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458395|NCT01731756|Analgesics|analgesics|mesh-ancestor
92458396|NCT01731756|Sensory System Agents|sensory system agents|mesh-ancestor
92458397|NCT01731756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458398|NCT01731756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458399|NCT01731756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458400|NCT01731756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458401|NCT01731756|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92458402|NCT01731756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458403|NCT01731756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458404|NCT01731756|Emollients|emollients|mesh-ancestor
92458405|NCT01731795|Dexamethasone|dexamethasone|mesh-list
92458406|NCT01731795|Dexamethasone acetate|dexamethasone acetate|mesh-list
92458407|NCT01731795|BB 1101|bb 1101|mesh-list
92458408|NCT01731795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458409|NCT01731795|Antiemetics|antiemetics|mesh-ancestor
92458410|NCT01731795|Autonomic Agents|autonomic agents|mesh-ancestor
92458411|NCT01731795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458412|NCT01731795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458413|NCT01731795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458414|NCT01731795|Glucocorticoids|glucocorticoids|mesh-ancestor
92458415|NCT01731795|Hormones|hormones|mesh-ancestor
92458416|NCT01731795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458417|NCT01731795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92458418|NCT01731795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458419|NCT01731795|Protease Inhibitors|protease inhibitors|mesh-ancestor
92458420|NCT01731795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458421|NCT01731795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458422|NCT01731899|Agomelatine|agomelatine|mesh-list
92458423|NCT01731899|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92458424|NCT01731899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458425|NCT01731899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458426|NCT01731925|Sunitinib|sunitinib|mesh-list
92458427|NCT01731925|Lanreotide|lanreotide|mesh-list
92458428|NCT01731925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458429|NCT01731925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92458430|NCT01731925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92458431|NCT01731925|Growth Substances|growth substances|mesh-ancestor
92458432|NCT01731925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458433|NCT01731925|Growth Inhibitors|growth inhibitors|mesh-ancestor
92458434|NCT01731925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92458435|NCT01731925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458436|NCT01731925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458437|NCT01732055|Antidepressive Agents|antidepressive agents|mesh-list
92458438|NCT01732055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92347973|NCT01691508|Prednisone|prednisone|mesh-list
92458439|NCT01732068|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92458440|NCT01732068|Luteolytic Agents|luteolytic agents|mesh-ancestor
92458441|NCT01732068|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92458442|NCT01732068|Contraceptive Agents|contraceptive agents|mesh-ancestor
92458443|NCT01732068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92458444|NCT01732068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458445|NCT01732068|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92458446|NCT01732068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92458447|NCT01732068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458448|NCT01732094|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92458449|NCT01732094|Luteolytic Agents|luteolytic agents|mesh-ancestor
92458450|NCT01732094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92458451|NCT01732094|Contraceptive Agents|contraceptive agents|mesh-ancestor
92458452|NCT01732094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92458453|NCT01732094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458454|NCT01732094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92458455|NCT01732094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92458456|NCT01732094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458457|NCT01732146|Epoetin Alfa|epoetin alfa|mesh-list
92458458|NCT01732146|Hematinics|hematinics|mesh-ancestor
92458459|NCT01732198|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92458460|NCT01732198|Immunologic Factors|immunologic factors|mesh-ancestor
92458461|NCT01732198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458462|NCT01732224|Tenofovir|tenofovir|mesh-list
92458463|NCT01732224|Telbivudine|telbivudine|mesh-list
92458464|NCT01732224|Antiviral Agents|antiviral agents|mesh-ancestor
92458465|NCT01732224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458466|NCT01732224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92458467|NCT01732224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92458468|NCT01732224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458469|NCT01732224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458470|NCT01732224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92458471|NCT01732224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92458472|NCT01732250|Meropenem|meropenem|mesh-list
92458473|NCT01732250|Colistin|colistin|mesh-list
92458474|NCT01732250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92458475|NCT01732250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458476|NCT01732276|Gefitinib|gefitinib|mesh-list
92458477|NCT01732276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458478|NCT01732276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92458479|NCT01732276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458480|NCT01732276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458481|NCT01732328|Vitamin D|vitamin d|mesh-list
92458482|NCT01732328|Calcium|calcium|mesh-list
92458483|NCT01732328|Vitamins|vitamins|mesh-ancestor
92458484|NCT01732328|Micronutrients|micronutrients|mesh-ancestor
92458485|NCT01732328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458486|NCT01732328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458487|NCT01732328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92458490|NCT01732367|Adefovir|adefovir|mesh-list
92458491|NCT01732367|Antiviral Agents|antiviral agents|mesh-ancestor
92458492|NCT01732367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458493|NCT01732367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92458494|NCT01732367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92458495|NCT01732367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458496|NCT01732367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458497|NCT01732367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92458498|NCT01732367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92458499|NCT01732380|Oxaliplatin|oxaliplatin|mesh-list
92458500|NCT01732380|Raltitrexed|raltitrexed|mesh-list
92458501|NCT01732380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458502|NCT01732380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92458503|NCT01732380|Antimetabolites|antimetabolites|mesh-ancestor
92458504|NCT01732380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458505|NCT01732380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92458506|NCT01732380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458507|NCT01732393|Quercetin|quercetin|mesh-list
92458508|NCT01732393|Antioxidants|antioxidants|mesh-ancestor
92458509|NCT01732393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458510|NCT01732393|Protective Agents|protective agents|mesh-ancestor
92458511|NCT01732393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458512|NCT01732666|Remifentanil|remifentanil|mesh-list
92458513|NCT01732666|Nefopam|nefopam|mesh-list
92458514|NCT01732666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92458515|NCT01732666|Narcotics|narcotics|mesh-ancestor
92458516|NCT01732666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458517|NCT01732666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458518|NCT01732666|Analgesics|analgesics|mesh-ancestor
92458519|NCT01732666|Sensory System Agents|sensory system agents|mesh-ancestor
92458520|NCT01732666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458521|NCT01732666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458522|NCT01732744|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92458523|NCT01732744|Eusol|eusol|mesh-list
92458524|NCT01732744|Castor Oil|castor oil|mesh-list
92458525|NCT01732744|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92458526|NCT01732744|Disinfectants|disinfectants|mesh-ancestor
92458527|NCT01732744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458528|NCT01732744|Cathartics|cathartics|mesh-ancestor
92458529|NCT01732744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458530|NCT01732861|Lenalidomide|lenalidomide|mesh-list
92458531|NCT01732861|Immunologic Factors|immunologic factors|mesh-ancestor
92458532|NCT01732861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458533|NCT01732861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92458534|NCT01732861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92458535|NCT01732861|Growth Substances|growth substances|mesh-ancestor
92458536|NCT01732861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92458537|NCT01732861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458538|NCT01733017|Lycopene|lycopene|mesh-list
92458539|NCT01733017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458540|NCT01733017|Antioxidants|antioxidants|mesh-ancestor
92458541|NCT01733017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458542|NCT01733017|Protective Agents|protective agents|mesh-ancestor
92458543|NCT01733017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458544|NCT01733017|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92458545|NCT01733017|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92458546|NCT01733017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458547|NCT01733030|Cycloserine|cycloserine|mesh-list
92458548|NCT01733030|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92458549|NCT01733030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458550|NCT01733030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92458551|NCT01733030|Antitubercular Agents|antitubercular agents|mesh-ancestor
92458552|NCT01733030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92458553|NCT01733030|Antimetabolites|antimetabolites|mesh-ancestor
92458554|NCT01733030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458555|NCT01733043|Dexmedetomidine|dexmedetomidine|mesh-list
92458556|NCT01733043|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92458557|NCT01733043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458558|NCT01733043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458559|NCT01733043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458560|NCT01733043|Analgesics|analgesics|mesh-ancestor
92458561|NCT01733043|Sensory System Agents|sensory system agents|mesh-ancestor
92458562|NCT01733043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458563|NCT01733043|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92458564|NCT01733043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92458565|NCT01733043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92458566|NCT01733043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92458567|NCT01733043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458568|NCT01733043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458569|NCT01733095|Ambrisentan|ambrisentan|mesh-list
92458570|NCT01733095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92458571|NCT01733108|Canagliflozin|canagliflozin|mesh-list
92458572|NCT01733108|Glyburide|glyburide|mesh-list
92458573|NCT01733108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92458574|NCT01733108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458575|NCT01733108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92458576|NCT01733108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458577|NCT01733134|Tolvaptan|tolvaptan|mesh-list
92458578|NCT01733134|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92458579|NCT01733134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458580|NCT01733134|Natriuretic Agents|natriuretic agents|mesh-ancestor
92458581|NCT01733134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458582|NCT01733290|Botulinum Toxins|botulinum toxins|mesh-list
92458583|NCT01733290|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92458584|NCT01733290|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92458585|NCT01733290|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92458586|NCT01733290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92458587|NCT01733290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458588|NCT01733290|Cholinergic Agents|cholinergic agents|mesh-ancestor
92458589|NCT01733290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458590|NCT01733290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458591|NCT01733290|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92458592|NCT01733290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458593|NCT01733342|Anesthetics|anesthetics|mesh-list
92458594|NCT01733342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458595|NCT01733342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458596|NCT01733394|Lamotrigine|lamotrigine|mesh-list
92458597|NCT01733394|Anticonvulsants|anticonvulsants|mesh-list
92458598|NCT01733394|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92458599|NCT01733394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92458600|NCT01733394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458601|NCT01733394|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458602|NCT01733394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458603|NCT01733394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92458604|NCT01733394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92458605|NCT01733394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458606|NCT01733394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92458607|NCT01733394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92458608|NCT01733459|Metformin|metformin|mesh-list
92458609|NCT01733459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92458610|NCT01733459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458611|NCT01733485|Aspirin|aspirin|mesh-list
92458612|NCT01733485|Indomethacin|indomethacin|mesh-list
92458613|NCT01733485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458614|NCT01733485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458615|NCT01733485|Analgesics|analgesics|mesh-ancestor
92458616|NCT01733485|Sensory System Agents|sensory system agents|mesh-ancestor
92458617|NCT01733485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458618|NCT01733485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458619|NCT01733485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458620|NCT01733485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458621|NCT01733485|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92458622|NCT01733485|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92458623|NCT01733485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458624|NCT01733485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92458625|NCT01733485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92458626|NCT01733485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458627|NCT01733485|Antipyretics|antipyretics|mesh-ancestor
92458628|NCT01733485|Gout Suppressants|gout suppressants|mesh-ancestor
92458629|NCT01733485|Tocolytic Agents|tocolytic agents|mesh-ancestor
92458630|NCT01733485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92458632|NCT01733589|Cisplatin|cisplatin|mesh-list
92458633|NCT01733589|Endostatins|endostatins|mesh-list
92458634|NCT01733589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92458635|NCT01733589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458636|NCT01733589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92458637|NCT01733589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92458638|NCT01733589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458639|NCT01733589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458640|NCT01733589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92458641|NCT01733589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92458642|NCT01733589|Growth Substances|growth substances|mesh-ancestor
92458643|NCT01733589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458644|NCT01733589|Growth Inhibitors|growth inhibitors|mesh-ancestor
92458645|NCT01733706|Nicotine|nicotine|mesh-list
92458646|NCT01733706|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92458647|NCT01733706|Autonomic Agents|autonomic agents|mesh-ancestor
92458648|NCT01733706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458649|NCT01733706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458650|NCT01733706|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92458651|NCT01733706|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92458652|NCT01733706|Cholinergic Agents|cholinergic agents|mesh-ancestor
92458653|NCT01733706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458654|NCT01733706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458655|NCT01733823|Nimorazole|nimorazole|mesh-list
92458656|NCT01733823|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92458657|NCT01733823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92458658|NCT01733823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92458659|NCT01733823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458660|NCT01733836|Metformin|metformin|mesh-list
92458661|NCT01733836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92458662|NCT01733836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458663|NCT01733966|Amoxicillin|amoxicillin|mesh-list
92458664|NCT01733966|Clavulanic Acids|clavulanic acids|mesh-list
92458665|NCT01733966|Clavulanic Acid|clavulanic acid|mesh-list
92458666|NCT01733966|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92458667|NCT01733966|Ciprofloxacin|ciprofloxacin|mesh-list
92458668|NCT01733966|Secnidazole|secnidazole|mesh-list
92458669|NCT01733966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92458670|NCT01733966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458671|NCT01733966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458672|NCT01733966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458673|NCT01733966|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92458674|NCT01733966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92458675|NCT01733966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92458676|NCT01733966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92458677|NCT01733966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92458678|NCT01733966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458679|NCT01733966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92458680|NCT01733966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92458682|NCT01733979|Trace Elements|trace elements|mesh-ancestor
92458683|NCT01733979|Micronutrients|micronutrients|mesh-ancestor
92458684|NCT01733979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458685|NCT01733992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92183566|NCT04467723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458686|NCT01733992|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92458687|NCT01734044|Dexamethasone|dexamethasone|mesh-list
92458688|NCT01734044|Dexamethasone acetate|dexamethasone acetate|mesh-list
92458689|NCT01734044|BB 1101|bb 1101|mesh-list
92458690|NCT01734044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458691|NCT01734044|Antiemetics|antiemetics|mesh-ancestor
92458692|NCT01734044|Autonomic Agents|autonomic agents|mesh-ancestor
92458693|NCT01734044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458694|NCT01734044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458695|NCT01734044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458696|NCT01734044|Glucocorticoids|glucocorticoids|mesh-ancestor
92458697|NCT01734044|Hormones|hormones|mesh-ancestor
92458698|NCT01734044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458699|NCT01734044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92458700|NCT01734044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458701|NCT01734044|Protease Inhibitors|protease inhibitors|mesh-ancestor
92458702|NCT01734044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458703|NCT01734044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458704|NCT01734057|Dexamethasone|dexamethasone|mesh-list
92458705|NCT01734057|Rituximab|rituximab|mesh-list
92458706|NCT01734057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92458707|NCT01734057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458708|NCT01734057|Immunologic Factors|immunologic factors|mesh-ancestor
92458709|NCT01734057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458710|NCT01734057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458711|NCT01734057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458712|NCT01734057|Antiemetics|antiemetics|mesh-ancestor
92458713|NCT01734057|Autonomic Agents|autonomic agents|mesh-ancestor
92458714|NCT01734057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458715|NCT01734057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458716|NCT01734057|Glucocorticoids|glucocorticoids|mesh-ancestor
92458717|NCT01734057|Hormones|hormones|mesh-ancestor
92458718|NCT01734057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458719|NCT01734057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92458720|NCT01734096|Candesartan|candesartan|mesh-list
92458721|NCT01734096|Candesartan cilexetil|candesartan cilexetil|mesh-list
92458722|NCT01734096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92458723|NCT01734096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92458724|NCT01734096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92458725|NCT01734096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458726|NCT01734252|Argatroban|argatroban|mesh-list
92458727|NCT01734252|Antithrombins|antithrombins|mesh-ancestor
92458728|NCT01734252|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92458729|NCT01734252|Protease Inhibitors|protease inhibitors|mesh-ancestor
92458730|NCT01734252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458731|NCT01734252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458732|NCT01734252|Anticoagulants|anticoagulants|mesh-ancestor
92458733|NCT01734252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92458734|NCT01734330|Nicotine|nicotine|mesh-list
92458735|NCT01734330|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92458736|NCT01734330|Autonomic Agents|autonomic agents|mesh-ancestor
92458737|NCT01734330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458738|NCT01734330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458739|NCT01734330|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92458740|NCT01734330|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92458741|NCT01734330|Cholinergic Agents|cholinergic agents|mesh-ancestor
92458742|NCT01734330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458743|NCT01734330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458744|NCT01734408|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92458745|NCT01734408|Aluminum sulfate|aluminum sulfate|mesh-list
92458746|NCT01734408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92458747|NCT01734408|Immunologic Factors|immunologic factors|mesh-ancestor
92458748|NCT01734408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458749|NCT01734408|Antacids|antacids|mesh-ancestor
92458750|NCT01734408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458751|NCT01734408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458752|NCT01734473|Caseins|caseins|mesh-list
92458753|NCT01734473|Chelating Agents|chelating agents|mesh-ancestor
92458754|NCT01734473|Sequestering Agents|sequestering agents|mesh-ancestor
92458755|NCT01734473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458756|NCT01734564|Poly I-C|poly i-c|mesh-list
92458757|NCT01734564|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92458758|NCT01734564|Poly ICLC|poly iclc|mesh-list
92458759|NCT01734564|Interferon Inducers|interferon inducers|mesh-ancestor
92458760|NCT01734564|Immunologic Factors|immunologic factors|mesh-ancestor
92458761|NCT01734564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458762|NCT01734564|Laxatives|laxatives|mesh-ancestor
92458763|NCT01734564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458764|NCT01734564|Antiviral Agents|antiviral agents|mesh-ancestor
92458765|NCT01734564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458766|NCT01734798|Gemcitabine|gemcitabine|mesh-list
92458767|NCT01734798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458768|NCT01734798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92458769|NCT01734798|Antimetabolites|antimetabolites|mesh-ancestor
92458770|NCT01734798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458771|NCT01734824|Denosumab|denosumab|mesh-list
92458772|NCT01734824|Teriparatide|teriparatide|mesh-list
92458773|NCT01734824|Parathyroid Hormone|parathyroid hormone|mesh-list
92458774|NCT01734824|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92458775|NCT01734824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458776|NCT01734824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458777|NCT01734915|Iproplatin|iproplatin|mesh-list
92458778|NCT01734915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458779|NCT01734954|Midazolam|midazolam|mesh-list
92458780|NCT01734954|Analgesics|analgesics|mesh-list
92458781|NCT01734954|Anesthetics|anesthetics|mesh-list
92458782|NCT01734954|Levobupivacaine|levobupivacaine|mesh-list
92458783|NCT01734954|Anesthetics, Local|anesthetics, local|mesh-list
92458784|NCT01734954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458785|NCT01734954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458786|NCT01734954|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92458787|NCT01734954|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92458788|NCT01734954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92458789|NCT01734954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92458790|NCT01734954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92458791|NCT01734954|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92458792|NCT01734954|Anesthetics, General|anesthetics, general|mesh-ancestor
92458793|NCT01734954|GABA Modulators|gaba modulators|mesh-ancestor
92458794|NCT01734954|GABA Agents|gaba agents|mesh-ancestor
92458795|NCT01734954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458796|NCT01734954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458797|NCT01734954|Sensory System Agents|sensory system agents|mesh-ancestor
92458798|NCT01734954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458799|NCT01735006|Vaccines|vaccines|mesh-list
92458800|NCT01735006|Immunologic Factors|immunologic factors|mesh-ancestor
92458801|NCT01735006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458802|NCT01735019|Remifentanil|remifentanil|mesh-list
92458803|NCT01735019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92458804|NCT01735019|Narcotics|narcotics|mesh-ancestor
92458805|NCT01735019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458806|NCT01735019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458807|NCT01735019|Analgesics|analgesics|mesh-ancestor
92458808|NCT01735019|Sensory System Agents|sensory system agents|mesh-ancestor
92458809|NCT01735019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458810|NCT01735058|Hyaluronic Acid|hyaluronic acid|mesh-list
92458811|NCT01735058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92458812|NCT01735058|Immunologic Factors|immunologic factors|mesh-ancestor
92458813|NCT01735058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458814|NCT01735058|Viscosupplements|viscosupplements|mesh-ancestor
92458815|NCT01735058|Protective Agents|protective agents|mesh-ancestor
92458816|NCT01735071|Bevacizumab|bevacizumab|mesh-list
92458817|NCT01735071|Carboplatin|carboplatin|mesh-list
92458818|NCT01735071|Trabectedin|trabectedin|mesh-list
92458819|NCT01735071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92458820|NCT01735071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458821|NCT01735071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92458822|NCT01735071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92458823|NCT01735071|Growth Substances|growth substances|mesh-ancestor
92458824|NCT01735071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458825|NCT01735071|Growth Inhibitors|growth inhibitors|mesh-ancestor
92458826|NCT01735071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92458827|NCT01735071|Alkylating Agents|alkylating agents|mesh-ancestor
92458828|NCT01735071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458829|NCT01735084|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92458830|NCT01735084|Immunologic Factors|immunologic factors|mesh-ancestor
92458831|NCT01735084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458832|NCT01735097|Vitamin E|vitamin e|mesh-list
92458833|NCT01735097|Vitamins|vitamins|mesh-ancestor
92458834|NCT01735097|Micronutrients|micronutrients|mesh-ancestor
92458835|NCT01735097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458836|NCT01735097|Antioxidants|antioxidants|mesh-ancestor
92458837|NCT01735097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458838|NCT01735097|Protective Agents|protective agents|mesh-ancestor
92458839|NCT01735123|Caseins|caseins|mesh-list
92458840|NCT01735123|Chelating Agents|chelating agents|mesh-ancestor
92458841|NCT01735123|Sequestering Agents|sequestering agents|mesh-ancestor
92458842|NCT01735123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458843|NCT01735227|Omeprazole|omeprazole|mesh-list
92458844|NCT01735227|Pantoprazole|pantoprazole|mesh-list
92458845|NCT01735227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92458846|NCT01735227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92458847|NCT01735227|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92458848|NCT01735227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458849|NCT01735227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458850|NCT01735240|Ketoconazole|ketoconazole|mesh-list
92458851|NCT01735240|Antifungal Agents|antifungal agents|mesh-ancestor
92458852|NCT01735240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92458853|NCT01735240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92458854|NCT01735240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92458855|NCT01735240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458856|NCT01735240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458857|NCT01735240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92458858|NCT01735240|Hormone Antagonists|hormone antagonists|mesh-ancestor
92458859|NCT01735240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458860|NCT01735240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458861|NCT01735240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92458862|NCT01735318|Lisinopril|lisinopril|mesh-list
92458863|NCT01735318|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92458864|NCT01735318|Protease Inhibitors|protease inhibitors|mesh-ancestor
92458865|NCT01735318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458866|NCT01735318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458867|NCT01735318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92458868|NCT01735318|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92458869|NCT01735318|Protective Agents|protective agents|mesh-ancestor
92458870|NCT01735318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458871|NCT01735344|Lisinopril|lisinopril|mesh-list
92458872|NCT01735344|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92458873|NCT01735344|Protease Inhibitors|protease inhibitors|mesh-ancestor
92458874|NCT01735344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458875|NCT01735344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458876|NCT01735344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92458877|NCT01735344|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92458878|NCT01735344|Protective Agents|protective agents|mesh-ancestor
92458879|NCT01735344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458880|NCT01735370|Etodolac|etodolac|mesh-list
92458881|NCT01735370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458882|NCT01735370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458883|NCT01735370|Analgesics|analgesics|mesh-ancestor
92458884|NCT01735370|Sensory System Agents|sensory system agents|mesh-ancestor
92458885|NCT01735370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458886|NCT01735370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458887|NCT01735370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458888|NCT01735370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458889|NCT01735370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92458890|NCT01735370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92458891|NCT01735370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458892|NCT01735370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458893|NCT01735383|Etodolac|etodolac|mesh-list
92458894|NCT01735383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92458895|NCT01735383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458896|NCT01735383|Analgesics|analgesics|mesh-ancestor
92458897|NCT01735383|Sensory System Agents|sensory system agents|mesh-ancestor
92458898|NCT01735383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458899|NCT01735383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458900|NCT01735383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92458901|NCT01735383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92458902|NCT01735383|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92458903|NCT01735383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92458904|NCT01735383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458905|NCT01735383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458906|NCT01735487|Nicotine|nicotine|mesh-list
92458907|NCT01735487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92458908|NCT01735487|Autonomic Agents|autonomic agents|mesh-ancestor
92458909|NCT01735487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458910|NCT01735487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458911|NCT01735487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92458912|NCT01735487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92458913|NCT01735487|Cholinergic Agents|cholinergic agents|mesh-ancestor
92458914|NCT01735487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458915|NCT01735487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458916|NCT01735669|Remifentanil|remifentanil|mesh-list
92458917|NCT01735669|Nitrous Oxide|nitrous oxide|mesh-list
92458918|NCT01735669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92458919|NCT01735669|Narcotics|narcotics|mesh-ancestor
92458920|NCT01735669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458921|NCT01735669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458922|NCT01735669|Analgesics|analgesics|mesh-ancestor
92458923|NCT01735669|Sensory System Agents|sensory system agents|mesh-ancestor
92458924|NCT01735669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458925|NCT01735669|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92458926|NCT01735669|Anesthetics, General|anesthetics, general|mesh-ancestor
92458928|NCT01735669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458929|NCT01735747|Vincristine|vincristine|mesh-list
92458930|NCT01735747|Temozolomide|temozolomide|mesh-list
92458931|NCT01735747|Nedaplatin|nedaplatin|mesh-list
92458932|NCT01735747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92458933|NCT01735747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458934|NCT01735747|Tubulin Modulators|tubulin modulators|mesh-ancestor
92458935|NCT01735747|Antimitotic Agents|antimitotic agents|mesh-ancestor
92458936|NCT01735747|Mitosis Modulators|mitosis modulators|mesh-ancestor
92458937|NCT01735747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458938|NCT01735747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92458939|NCT01735747|Alkylating Agents|alkylating agents|mesh-ancestor
92458940|NCT01735864|Indirubin|indirubin|mesh-list
92458941|NCT01735864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92458942|NCT01735864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92458943|NCT01735890|Amlodipine|amlodipine|mesh-list
92458944|NCT01735890|Valsartan|valsartan|mesh-list
92458945|NCT01735890|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92458946|NCT01735890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92458947|NCT01735890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92458948|NCT01735890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92458949|NCT01735890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458950|NCT01735890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92458951|NCT01735890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458952|NCT01735890|Vasodilator Agents|vasodilator agents|mesh-ancestor
92458953|NCT01735890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92458954|NCT01735890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92458955|NCT01736020|Dexmedetomidine|dexmedetomidine|mesh-list
92458956|NCT01736020|Nitrous Oxide|nitrous oxide|mesh-list
92458957|NCT01736020|Ketamine|ketamine|mesh-list
92458958|NCT01736020|Propofol|propofol|mesh-list
92458959|NCT01736020|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92458960|NCT01736020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92458961|NCT01736020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458962|NCT01736020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92458963|NCT01736020|Analgesics|analgesics|mesh-ancestor
92458964|NCT01736020|Sensory System Agents|sensory system agents|mesh-ancestor
92458965|NCT01736020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92458966|NCT01736020|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92458967|NCT01736020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92458968|NCT01736020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92458969|NCT01736020|Adrenergic Agents|adrenergic agents|mesh-ancestor
92458970|NCT01736020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458971|NCT01736020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458972|NCT01736020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92458973|NCT01736020|Anesthetics, General|anesthetics, general|mesh-ancestor
92458974|NCT01736020|Anesthetics|anesthetics|mesh-ancestor
92458975|NCT01736020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92458976|NCT01736020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92458977|NCT01736020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92458978|NCT01736020|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92458979|NCT01736033|Tamsulosin|tamsulosin|mesh-list
92458980|NCT01736033|Finasteride|finasteride|mesh-list
92458981|NCT01736033|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92458982|NCT01736033|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92458983|NCT01736033|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92458984|NCT01736033|Adrenergic Agents|adrenergic agents|mesh-ancestor
92458985|NCT01736033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92458986|NCT01736033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458987|NCT01736033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92458988|NCT01736033|Urological Agents|urological agents|mesh-ancestor
92458989|NCT01736033|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92458990|NCT01736033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92458991|NCT01736033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92458992|NCT01736033|Hormone Antagonists|hormone antagonists|mesh-ancestor
92458993|NCT01736033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92458994|NCT01736150|Sevelamer|sevelamer|mesh-list
92458995|NCT01736150|Chelating Agents|chelating agents|mesh-ancestor
92458996|NCT01736150|Sequestering Agents|sequestering agents|mesh-ancestor
92458997|NCT01736150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92458998|NCT01736163|Hormones|hormones|mesh-list
92458999|NCT01736163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459000|NCT01736163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459001|NCT01736371|Propofol|propofol|mesh-list
92459002|NCT01736371|Sevoflurane|sevoflurane|mesh-list
92348009|NCT01681992|Vaccines|vaccines|mesh-list
92459003|NCT01736371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92459004|NCT01736371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459005|NCT01736371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459006|NCT01736371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92459007|NCT01736371|Anesthetics, General|anesthetics, general|mesh-ancestor
92459008|NCT01736371|Anesthetics|anesthetics|mesh-ancestor
92459009|NCT01736371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92459010|NCT01736371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92459011|NCT01736410|Trastuzumab|trastuzumab|mesh-list
92459012|NCT01736410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459013|NCT01736410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92459014|NCT01736423|Ramosetron|ramosetron|mesh-list
92459015|NCT01736423|Antiemetics|antiemetics|mesh-ancestor
92459016|NCT01736423|Autonomic Agents|autonomic agents|mesh-ancestor
92459017|NCT01736423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459018|NCT01736423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459019|NCT01736423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92459020|NCT01736423|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92459021|NCT01736423|Serotonin Agents|serotonin agents|mesh-ancestor
92459022|NCT01736423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459023|NCT01736423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459024|NCT01736449|Bevacizumab|bevacizumab|mesh-list
92459025|NCT01736449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92459026|NCT01736449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459027|NCT01736449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92459028|NCT01736449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92459029|NCT01736449|Growth Substances|growth substances|mesh-ancestor
92459030|NCT01736449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459031|NCT01736449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92459032|NCT01736488|Atenolol|atenolol|mesh-list
92459033|NCT01736488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92459034|NCT01736488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92459035|NCT01736488|Sympatholytics|sympatholytics|mesh-ancestor
92459036|NCT01736488|Autonomic Agents|autonomic agents|mesh-ancestor
92459037|NCT01736488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459038|NCT01736488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459039|NCT01736488|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92459040|NCT01736488|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92459041|NCT01736488|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92459042|NCT01736488|Adrenergic Agents|adrenergic agents|mesh-ancestor
92459043|NCT01736488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459044|NCT01736488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459045|NCT01736514|Allopurinol|allopurinol|mesh-list
92459046|NCT01736514|Febuxostat|febuxostat|mesh-list
92459047|NCT01736514|Antimetabolites|antimetabolites|mesh-ancestor
92459048|NCT01736514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459049|NCT01736514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459050|NCT01736514|Gout Suppressants|gout suppressants|mesh-ancestor
92459051|NCT01736514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459052|NCT01736514|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92459053|NCT01736514|Antioxidants|antioxidants|mesh-ancestor
92459054|NCT01736514|Protective Agents|protective agents|mesh-ancestor
92459055|NCT01736514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459056|NCT01736670|Triamcinolone|triamcinolone|mesh-list
92459057|NCT01736670|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92459058|NCT01736670|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92459059|NCT01736670|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92183948|NCT02243007|Folfirinox|folfirinox|mesh-list
92459060|NCT01736670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459061|NCT01736670|Glucocorticoids|glucocorticoids|mesh-ancestor
92459062|NCT01736670|Hormones|hormones|mesh-ancestor
92459063|NCT01736670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459064|NCT01736670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459065|NCT01736670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92459066|NCT01736670|Immunologic Factors|immunologic factors|mesh-ancestor
92459067|NCT01736670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459068|NCT01736670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459069|NCT01736761|Ritonavir|ritonavir|mesh-list
92459070|NCT01736761|Darunavir|darunavir|mesh-list
92459071|NCT01736761|Rilpivirine|rilpivirine|mesh-list
92459072|NCT01736761|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92348014|NCT01687998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92459073|NCT01736761|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92459074|NCT01736761|Protease Inhibitors|protease inhibitors|mesh-ancestor
92459075|NCT01736761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459076|NCT01736761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459077|NCT01736761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92459078|NCT01736761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92459079|NCT01736761|Antiviral Agents|antiviral agents|mesh-ancestor
92459080|NCT01736761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459081|NCT01736761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92459082|NCT01736761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92459083|NCT01736761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92459084|NCT01736761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92459085|NCT01736800|Temozolomide|temozolomide|mesh-list
92459086|NCT01736800|Topotecan|topotecan|mesh-list
92459087|NCT01736800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92459088|NCT01736800|Alkylating Agents|alkylating agents|mesh-ancestor
92459089|NCT01736800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459090|NCT01736800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459091|NCT01736800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92459092|NCT01736800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92459093|NCT01736800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459094|NCT01736813|Maraviroc|maraviroc|mesh-list
92459095|NCT01736813|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92459096|NCT01736813|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92459097|NCT01736813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459098|NCT01736813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92459099|NCT01736813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92459100|NCT01736813|Antiviral Agents|antiviral agents|mesh-ancestor
92459101|NCT01736813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459102|NCT01736813|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92459103|NCT01736878|Sorafenib|sorafenib|mesh-list
92459104|NCT01736878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459105|NCT01736878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92459106|NCT01736878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459107|NCT01736878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459108|NCT01736891|Rasagiline|rasagiline|mesh-list
92459109|NCT01736891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92459110|NCT01736891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459111|NCT01736891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459112|NCT01736891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92459113|NCT01736891|Protective Agents|protective agents|mesh-ancestor
92459114|NCT01736891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459115|NCT01737008|Cisplatin|cisplatin|mesh-list
92459116|NCT01737008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459117|NCT01737073|Analgesics, Opioid|analgesics, opioid|mesh-list
92459118|NCT01737073|Narcotics|narcotics|mesh-ancestor
92459119|NCT01737073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459120|NCT01737073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459121|NCT01737073|Analgesics|analgesics|mesh-ancestor
92459122|NCT01737073|Sensory System Agents|sensory system agents|mesh-ancestor
92459123|NCT01737073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459124|NCT01737086|Zinc Sulfate|zinc sulfate|mesh-list
92459125|NCT01737086|Astringents|astringents|mesh-ancestor
92459126|NCT01737086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459127|NCT01737086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459128|NCT01737112|HYNIC-3PRGD(2)|hynic-3prgd(2)|mesh-list
92459129|NCT01737112|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92459130|NCT01737112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459131|NCT01737177|Rituximab|rituximab|mesh-list
92459132|NCT01737177|Lenalidomide|lenalidomide|mesh-list
92459133|NCT01737177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92459134|NCT01737177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92459135|NCT01737177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459136|NCT01737177|Immunologic Factors|immunologic factors|mesh-ancestor
92459137|NCT01737177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459138|NCT01737177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459139|NCT01737177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92459140|NCT01737177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92459141|NCT01737177|Growth Substances|growth substances|mesh-ancestor
92459142|NCT01737177|Growth Inhibitors|growth inhibitors|mesh-ancestor
92459143|NCT01737177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92459144|NCT01737177|Alkylating Agents|alkylating agents|mesh-ancestor
92459145|NCT01737177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459146|NCT01737203|Sildenafil Citrate|sildenafil citrate|mesh-list
92459147|NCT01737203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459148|NCT01737203|Vasodilator Agents|vasodilator agents|mesh-ancestor
92459149|NCT01737203|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92459150|NCT01737203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92459151|NCT01737203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459152|NCT01737203|Urological Agents|urological agents|mesh-ancestor
92459153|NCT01737216|Zoledronic Acid|zoledronic acid|mesh-list
92459154|NCT01737216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92459155|NCT01737216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459157|NCT01737294|Antipruritics|antipruritics|mesh-ancestor
92459158|NCT01737294|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459159|NCT01737294|Sensory System Agents|sensory system agents|mesh-ancestor
92459160|NCT01737294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459161|NCT01737294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459162|NCT01737307|Fluorides|fluorides|mesh-list
92459163|NCT01737307|Fluorides, Topical|fluorides, topical|mesh-list
92459164|NCT01737307|Cariostatic Agents|cariostatic agents|mesh-ancestor
92459165|NCT01737307|Protective Agents|protective agents|mesh-ancestor
92459166|NCT01737307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459167|NCT01737320|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92459168|NCT01737320|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92459169|NCT01737320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459170|NCT01737320|Antitubercular Agents|antitubercular agents|mesh-ancestor
92459171|NCT01737346|Lomustine|lomustine|mesh-list
92459172|NCT01737346|Procarbazine|procarbazine|mesh-list
92459173|NCT01737346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92459174|NCT01737346|Alkylating Agents|alkylating agents|mesh-ancestor
92459175|NCT01737346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459176|NCT01737346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459177|NCT01737359|Tenofovir|tenofovir|mesh-list
92459178|NCT01737359|Antiviral Agents|antiviral agents|mesh-ancestor
92459179|NCT01737359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459180|NCT01737359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92459181|NCT01737359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92459182|NCT01737359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459183|NCT01737359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459184|NCT01737359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92459185|NCT01737359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92459186|NCT01737411|Solifenacin Succinate|solifenacin succinate|mesh-list
92459187|NCT01737411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92459188|NCT01737411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92459189|NCT01737411|Cholinergic Agents|cholinergic agents|mesh-ancestor
92459190|NCT01737411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459191|NCT01737411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459192|NCT01737411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459193|NCT01737411|Urological Agents|urological agents|mesh-ancestor
92459194|NCT01737541|Fluoxetine|fluoxetine|mesh-list
92459195|NCT01737541|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92459196|NCT01737541|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92459197|NCT01737541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92459198|NCT01737541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459199|NCT01737541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459200|NCT01737541|Serotonin Agents|serotonin agents|mesh-ancestor
92459201|NCT01737541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459202|NCT01737541|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92459203|NCT01737541|Antidepressive Agents|antidepressive agents|mesh-ancestor
92459204|NCT01737541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459205|NCT01737541|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92459206|NCT01737541|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92459207|NCT01737541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459208|NCT01737671|Leucovorin|leucovorin|mesh-list
92459209|NCT01737671|Methotrexate|methotrexate|mesh-list
92459210|NCT01737671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92459211|NCT01737671|Abortifacient Agents|abortifacient agents|mesh-ancestor
92459212|NCT01737671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92459213|NCT01737671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459214|NCT01737671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92459215|NCT01737671|Antimetabolites|antimetabolites|mesh-ancestor
92459216|NCT01737671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459217|NCT01737671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459218|NCT01737671|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459219|NCT01737671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459220|NCT01737671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92459221|NCT01737671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92459222|NCT01737671|Immunologic Factors|immunologic factors|mesh-ancestor
92459223|NCT01737671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459224|NCT01737671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92459225|NCT01737671|Antidotes|antidotes|mesh-ancestor
92459226|NCT01737671|Protective Agents|protective agents|mesh-ancestor
92459227|NCT01737671|Vitamin B Complex|vitamin b complex|mesh-ancestor
92459228|NCT01737671|Vitamins|vitamins|mesh-ancestor
92459230|NCT01737918|Solifenacin Succinate|solifenacin succinate|mesh-list
92459231|NCT01737918|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92459232|NCT01737918|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92459233|NCT01737918|Cholinergic Agents|cholinergic agents|mesh-ancestor
92459234|NCT01737918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459235|NCT01737918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459236|NCT01737918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459237|NCT01737918|Urological Agents|urological agents|mesh-ancestor
92459238|NCT01738035|Budesonide|budesonide|mesh-list
92459239|NCT01738035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459240|NCT01738035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92459241|NCT01738035|Autonomic Agents|autonomic agents|mesh-ancestor
92459242|NCT01738035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459243|NCT01738035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459244|NCT01738035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92459245|NCT01738035|Respiratory System Agents|respiratory system agents|mesh-ancestor
92459246|NCT01738035|Glucocorticoids|glucocorticoids|mesh-ancestor
92459247|NCT01738035|Hormones|hormones|mesh-ancestor
92459248|NCT01738035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459249|NCT01738087|Fluticasone|fluticasone|mesh-list
92459250|NCT01738087|Xhance|xhance|mesh-list
92459251|NCT01738087|Formoterol Fumarate|formoterol fumarate|mesh-list
92459252|NCT01738087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459253|NCT01738087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92459254|NCT01738087|Autonomic Agents|autonomic agents|mesh-ancestor
92459255|NCT01738087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459256|NCT01738087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459257|NCT01738087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92459258|NCT01738087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92459259|NCT01738087|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459260|NCT01738087|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92459261|NCT01738087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92459262|NCT01738087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92459263|NCT01738087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92459264|NCT01738087|Adrenergic Agents|adrenergic agents|mesh-ancestor
92459265|NCT01738087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459266|NCT01738087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459267|NCT01738100|Morphine|morphine|mesh-list
92459268|NCT01738100|Clopidogrel|clopidogrel|mesh-list
92459269|NCT01738100|Ticagrelor|ticagrelor|mesh-list
92459270|NCT01738100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92459271|NCT01738100|Narcotics|narcotics|mesh-ancestor
92459272|NCT01738100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459273|NCT01738100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459274|NCT01738100|Analgesics|analgesics|mesh-ancestor
92459275|NCT01738100|Sensory System Agents|sensory system agents|mesh-ancestor
92459276|NCT01738100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459277|NCT01738100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92459278|NCT01738100|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92459279|NCT01738100|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92459280|NCT01738100|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92459281|NCT01738100|Purinergic Agents|purinergic agents|mesh-ancestor
92459282|NCT01738100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459283|NCT01738100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459284|NCT01738178|Caffeine|caffeine|mesh-list
92459285|NCT01738178|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92459286|NCT01738178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348026|NCT01687296|Fluticasone|fluticasone|mesh-list
92459287|NCT01738178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92459288|NCT01738178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459289|NCT01738178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459290|NCT01738178|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92459291|NCT01738178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92459292|NCT01738178|Purinergic Agents|purinergic agents|mesh-ancestor
92459293|NCT01738178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459294|NCT01738243|Hyaluronic Acid|hyaluronic acid|mesh-list
92459295|NCT01738243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92459296|NCT01738243|Immunologic Factors|immunologic factors|mesh-ancestor
92459297|NCT01738243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459298|NCT01738243|Viscosupplements|viscosupplements|mesh-ancestor
92459299|NCT01738243|Protective Agents|protective agents|mesh-ancestor
92459300|NCT01738282|Baclofen|baclofen|mesh-list
92459301|NCT01738282|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92459302|NCT01738282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459303|NCT01738282|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92459304|NCT01738282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459305|NCT01738282|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92459306|NCT01738282|GABA Agonists|gaba agonists|mesh-ancestor
92459307|NCT01738282|GABA Agents|gaba agents|mesh-ancestor
92459308|NCT01738282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459309|NCT01738282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459310|NCT01738295|Donepezil|donepezil|mesh-list
92459311|NCT01738295|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92459312|NCT01738295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459313|NCT01738295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459314|NCT01738295|Cholinergic Agents|cholinergic agents|mesh-ancestor
92459315|NCT01738295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459316|NCT01738295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459317|NCT01738295|Nootropic Agents|nootropic agents|mesh-ancestor
92459318|NCT01738360|Arsenic Trioxide|arsenic trioxide|mesh-list
92459319|NCT01738360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459320|NCT01738373|Plerixafor|plerixafor|mesh-list
92459321|NCT01738373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92459322|NCT01738373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92459323|NCT01738373|Antiviral Agents|antiviral agents|mesh-ancestor
92459324|NCT01738373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459325|NCT01738425|Hydrogen Sulfide|hydrogen sulfide|mesh-list
92459326|NCT01738425|Gasotransmitters|gasotransmitters|mesh-ancestor
92459327|NCT01738425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459328|NCT01738425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459329|NCT01738425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459330|NCT01738451|Dabrafenib|dabrafenib|mesh-list
92459331|NCT01738451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459332|NCT01738451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92459333|NCT01738451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459334|NCT01738451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459335|NCT01738542|Antihypertensive Agents|antihypertensive agents|mesh-list
92459336|NCT01738542|Bosentan|bosentan|mesh-list
92459337|NCT01738542|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92459338|NCT01738542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459339|NCT01738724|Goserelin|goserelin|mesh-list
92459340|NCT01738724|Dienogest|dienogest|mesh-list
92459341|NCT01738724|Desogestrel|desogestrel|mesh-list
92459342|NCT01738724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92459343|NCT01738724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459344|NCT01738724|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92459345|NCT01738724|Contraceptive Agents|contraceptive agents|mesh-ancestor
92459346|NCT01738724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92459347|NCT01738724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459348|NCT01738724|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92459349|NCT01738724|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92459350|NCT01738724|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92459351|NCT01738724|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92459352|NCT01738724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92459353|NCT01738724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459354|NCT01738724|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92459355|NCT01738724|Progestins|progestins|mesh-ancestor
92459356|NCT01738724|Hormones|hormones|mesh-ancestor
92459357|NCT01738763|Inositol|inositol|mesh-list
92459358|NCT01738763|Vitamin B Complex|vitamin b complex|mesh-ancestor
92459359|NCT01738763|Vitamins|vitamins|mesh-ancestor
92459360|NCT01738763|Micronutrients|micronutrients|mesh-ancestor
92459361|NCT01738763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459362|NCT01738802|Micronutrients|micronutrients|mesh-list
92459363|NCT01738802|Trace Elements|trace elements|mesh-list
92459364|NCT01738802|Antioxidants|antioxidants|mesh-list
92459365|NCT01738802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459366|NCT01738802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459367|NCT01738802|Protective Agents|protective agents|mesh-ancestor
92459368|NCT01738815|Valproic Acid|valproic acid|mesh-list
92459369|NCT01738815|Anticonvulsants|anticonvulsants|mesh-ancestor
92459370|NCT01738815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459371|NCT01738815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459372|NCT01738815|GABA Agents|gaba agents|mesh-ancestor
92459373|NCT01738815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459374|NCT01738815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459375|NCT01738815|Antimanic Agents|antimanic agents|mesh-ancestor
92459376|NCT01738815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92459377|NCT01738815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459379|NCT01738867|Naltrexone|naltrexone|mesh-list
92459380|NCT01738867|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92459381|NCT01738867|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92459382|NCT01738867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459383|NCT01738867|Sensory System Agents|sensory system agents|mesh-ancestor
92459384|NCT01738867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459385|NCT01738893|Gabapentin|gabapentin|mesh-list
92459386|NCT01738893|Analgesics|analgesics|mesh-ancestor
92459387|NCT01738893|Sensory System Agents|sensory system agents|mesh-ancestor
92459388|NCT01738893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459389|NCT01738893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459390|NCT01738893|Anticonvulsants|anticonvulsants|mesh-ancestor
92459391|NCT01738893|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92459392|NCT01738893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92459393|NCT01738893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459394|NCT01738893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459395|NCT01738893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92459396|NCT01738893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92459397|NCT01738893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459398|NCT01738893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459399|NCT01738893|Antimanic Agents|antimanic agents|mesh-ancestor
92459400|NCT01738945|Amlodipine|amlodipine|mesh-list
92459401|NCT01738945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92459402|NCT01738945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92459403|NCT01738945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92459404|NCT01738945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459405|NCT01738945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92459406|NCT01738945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459407|NCT01738945|Vasodilator Agents|vasodilator agents|mesh-ancestor
92459408|NCT01739049|Liraglutide|liraglutide|mesh-list
92459409|NCT01739049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92459410|NCT01739049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459411|NCT01739049|Incretins|incretins|mesh-ancestor
92459412|NCT01739049|Hormones|hormones|mesh-ancestor
92459413|NCT01739049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459414|NCT01739127|Risperidone|risperidone|mesh-list
92459415|NCT01739127|Aripiprazole|aripiprazole|mesh-list
92459416|NCT01739127|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92459417|NCT01739127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92459418|NCT01739127|Serotonin Agents|serotonin agents|mesh-ancestor
92459419|NCT01739127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459420|NCT01739127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459421|NCT01739127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459422|NCT01739127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92459423|NCT01739127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92459424|NCT01739127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459425|NCT01739127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459426|NCT01739127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92459427|NCT01739127|Dopamine Agents|dopamine agents|mesh-ancestor
92459428|NCT01739127|Antidepressive Agents|antidepressive agents|mesh-ancestor
92459429|NCT01739127|Dopamine Agonists|dopamine agonists|mesh-ancestor
92459430|NCT01739127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92459431|NCT01739127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92459432|NCT01739127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92459433|NCT01739127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92459434|NCT01739192|Bupropion|bupropion|mesh-list
92459435|NCT01739192|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92459436|NCT01739192|Antidepressive Agents|antidepressive agents|mesh-ancestor
92459437|NCT01739192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459438|NCT01739192|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92459439|NCT01739192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92459440|NCT01739192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92459441|NCT01739192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459442|NCT01739192|Dopamine Agents|dopamine agents|mesh-ancestor
92459443|NCT01739192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459444|NCT01739192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459445|NCT01739192|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92459446|NCT01739192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92459447|NCT01739192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459449|NCT01739218|Bevacizumab|bevacizumab|mesh-list
92459450|NCT01739218|Carboplatin|carboplatin|mesh-list
92459451|NCT01739218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92459452|NCT01739218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459453|NCT01739218|Tubulin Modulators|tubulin modulators|mesh-ancestor
92459454|NCT01739218|Antimitotic Agents|antimitotic agents|mesh-ancestor
92459455|NCT01739218|Mitosis Modulators|mitosis modulators|mesh-ancestor
92459456|NCT01739218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459457|NCT01739218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92459458|NCT01739218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92459459|NCT01739218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92459460|NCT01739218|Growth Substances|growth substances|mesh-ancestor
92459461|NCT01739218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459462|NCT01739218|Growth Inhibitors|growth inhibitors|mesh-ancestor
92459463|NCT01739413|Anesthetics|anesthetics|mesh-list
92459464|NCT01739413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459465|NCT01739413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459466|NCT01739439|Gemcitabine|gemcitabine|mesh-list
92459467|NCT01739439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92459468|NCT01739439|Antimetabolites|antimetabolites|mesh-ancestor
92459469|NCT01739439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459470|NCT01739439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459471|NCT01739504|Anesthetics|anesthetics|mesh-list
92459472|NCT01739504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459473|NCT01739504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459474|NCT01739556|Aspirin|aspirin|mesh-list
92459475|NCT01739556|Ticagrelor|ticagrelor|mesh-list
92459476|NCT01739556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92459477|NCT01739556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459478|NCT01739556|Analgesics|analgesics|mesh-ancestor
92459479|NCT01739556|Sensory System Agents|sensory system agents|mesh-ancestor
92459480|NCT01739556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459481|NCT01739556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459482|NCT01739556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459483|NCT01739556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459484|NCT01739556|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92459485|NCT01739556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92459486|NCT01739556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459487|NCT01739556|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92459488|NCT01739556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92459489|NCT01739556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459490|NCT01739556|Antipyretics|antipyretics|mesh-ancestor
92459491|NCT01739556|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92459492|NCT01739556|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92459493|NCT01739556|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92459494|NCT01739556|Purinergic Agents|purinergic agents|mesh-ancestor
92459495|NCT01739556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459496|NCT01739582|Enclomiphene|enclomiphene|mesh-list
92459497|NCT01739582|Clomiphene|clomiphene|mesh-list
92459498|NCT01739582|Zuclomiphene|zuclomiphene|mesh-list
92459499|NCT01739582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92459500|NCT01739582|Hormone Antagonists|hormone antagonists|mesh-ancestor
92459501|NCT01739582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459502|NCT01739582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459503|NCT01739582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92459504|NCT01739582|Fertility Agents|fertility agents|mesh-ancestor
92459505|NCT01739582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184401|NCT00168389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459506|NCT01739582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92459507|NCT01739582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92459509|NCT01739634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
92459510|NCT01739634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92459511|NCT01739673|Riboflavin|riboflavin|mesh-list
92459512|NCT01739673|Vitamin B Complex|vitamin b complex|mesh-ancestor
92459513|NCT01739673|Vitamins|vitamins|mesh-ancestor
92459514|NCT01739673|Micronutrients|micronutrients|mesh-ancestor
92459515|NCT01739673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459516|NCT01739673|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92459517|NCT01739673|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459518|NCT01739855|Ergocalciferols|ergocalciferols|mesh-list
92459519|NCT01739855|Calcium Carbonate|calcium carbonate|mesh-list
92459520|NCT01739855|Calcium|calcium|mesh-list
92459521|NCT01739855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92459522|NCT01739855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459523|NCT01739855|Antacids|antacids|mesh-ancestor
92459524|NCT01739855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459525|NCT01739855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92459526|NCT01739855|Vitamins|vitamins|mesh-ancestor
92459527|NCT01739855|Micronutrients|micronutrients|mesh-ancestor
92459528|NCT01739855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92459529|NCT01739894|Paclitaxel|paclitaxel|mesh-list
92459530|NCT01739894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92459531|NCT01739894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459532|NCT01739894|Tubulin Modulators|tubulin modulators|mesh-ancestor
92459533|NCT01739894|Antimitotic Agents|antimitotic agents|mesh-ancestor
92459534|NCT01739894|Mitosis Modulators|mitosis modulators|mesh-ancestor
92459535|NCT01739894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459536|NCT01739907|Vitamin D|vitamin d|mesh-list
92459537|NCT01739907|Vitamins|vitamins|mesh-ancestor
92459538|NCT01739907|Micronutrients|micronutrients|mesh-ancestor
92459539|NCT01739907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459540|NCT01739907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92459541|NCT01739920|Povidone-Iodine|povidone-iodine|mesh-list
92459542|NCT01739920|Povidone|povidone|mesh-list
92459543|NCT01739920|Plasma Substitutes|plasma substitutes|mesh-ancestor
92459544|NCT01739920|Blood Substitutes|blood substitutes|mesh-ancestor
92459545|NCT01739920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92459546|NCT01739920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459547|NCT01739985|Dexamethasone|dexamethasone|mesh-list
92459548|NCT01739985|Dexamethasone acetate|dexamethasone acetate|mesh-list
92459549|NCT01739985|Droperidol|droperidol|mesh-list
92459550|NCT01739985|Ondansetron|ondansetron|mesh-list
92459551|NCT01739985|BB 1101|bb 1101|mesh-list
92459552|NCT01739985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459553|NCT01739985|Antiemetics|antiemetics|mesh-ancestor
92459554|NCT01739985|Autonomic Agents|autonomic agents|mesh-ancestor
92459555|NCT01739985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459556|NCT01739985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459557|NCT01739985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92459558|NCT01739985|Glucocorticoids|glucocorticoids|mesh-ancestor
92459559|NCT01739985|Hormones|hormones|mesh-ancestor
92459560|NCT01739985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459561|NCT01739985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92459562|NCT01739985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459563|NCT01739985|Protease Inhibitors|protease inhibitors|mesh-ancestor
92459564|NCT01739985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459565|NCT01739985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459566|NCT01739985|Antipruritics|antipruritics|mesh-ancestor
92459567|NCT01739985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459568|NCT01739985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92459569|NCT01739985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92459570|NCT01739985|Serotonin Agents|serotonin agents|mesh-ancestor
92459571|NCT01739985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459572|NCT01739985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92459573|NCT01739985|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92459574|NCT01739985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92459575|NCT01739985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459576|NCT01739985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459577|NCT01739985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92459578|NCT01739985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92459579|NCT01739985|Dopamine Agents|dopamine agents|mesh-ancestor
92459580|NCT01740245|Biguanides|biguanides|mesh-list
92459581|NCT01740245|Chlorhexidine|chlorhexidine|mesh-list
92459582|NCT01740245|Polihexanide|polihexanide|mesh-list
92459583|NCT01740245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92459584|NCT01740245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459586|NCT01740245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92459587|NCT01740245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459589|NCT01740271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92459590|NCT01740271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459591|NCT01740271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92459592|NCT01740271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92459593|NCT01740271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459594|NCT01740271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459595|NCT01740336|Paclitaxel|paclitaxel|mesh-list
92459596|NCT01740336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92459597|NCT01740336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459598|NCT01740336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92459599|NCT01740336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92459600|NCT01740336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92459601|NCT01740336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459602|NCT01740453|Ropivacaine|ropivacaine|mesh-list
92459603|NCT01740453|Anesthetics, Local|anesthetics, local|mesh-ancestor
92459604|NCT01740453|Anesthetics|anesthetics|mesh-ancestor
92459605|NCT01740453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459606|NCT01740453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459607|NCT01740453|Sensory System Agents|sensory system agents|mesh-ancestor
92459608|NCT01740453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459609|NCT01740518|Ascorbic Acid|ascorbic acid|mesh-list
92459610|NCT01740518|Antioxidants|antioxidants|mesh-ancestor
92459611|NCT01740518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459612|NCT01740518|Protective Agents|protective agents|mesh-ancestor
92459613|NCT01740518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459614|NCT01740518|Vitamins|vitamins|mesh-ancestor
92459615|NCT01740518|Micronutrients|micronutrients|mesh-ancestor
92459616|NCT01740921|Aspirin|aspirin|mesh-list
92459617|NCT01740921|Liraglutide|liraglutide|mesh-list
92459618|NCT01740921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92459619|NCT01740921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459620|NCT01740921|Analgesics|analgesics|mesh-ancestor
92459621|NCT01740921|Sensory System Agents|sensory system agents|mesh-ancestor
92459622|NCT01740921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459623|NCT01740921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459624|NCT01740921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459625|NCT01740921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459626|NCT01740921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92459627|NCT01740921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92459628|NCT01740921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459629|NCT01740921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92459630|NCT01740921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92459631|NCT01740921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459632|NCT01740921|Antipyretics|antipyretics|mesh-ancestor
92459633|NCT01740921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92459634|NCT01740921|Incretins|incretins|mesh-ancestor
92459635|NCT01740921|Hormones|hormones|mesh-ancestor
92459636|NCT01740921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459637|NCT01740947|Amphotericin B|amphotericin b|mesh-list
92459638|NCT01740947|Tobramycin|tobramycin|mesh-list
92459639|NCT01740947|Colistin|colistin|mesh-list
92459640|NCT01740947|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92459641|NCT01740947|Amebicides|amebicides|mesh-ancestor
92459642|NCT01740947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92459643|NCT01740947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92459644|NCT01740947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459645|NCT01740947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92459646|NCT01740947|Antifungal Agents|antifungal agents|mesh-ancestor
92459647|NCT01740960|Dronabinol|dronabinol|mesh-list
92459648|NCT01740960|Hallucinogens|hallucinogens|mesh-ancestor
92459649|NCT01740960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459650|NCT01740960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459651|NCT01740960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459652|NCT01740960|Analgesics|analgesics|mesh-ancestor
92459653|NCT01740960|Sensory System Agents|sensory system agents|mesh-ancestor
92459654|NCT01740960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459655|NCT01740960|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92459656|NCT01740960|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92459657|NCT01740960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459658|NCT01740960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459659|NCT01740960|Hormones|hormones|mesh-ancestor
92459660|NCT01740960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459662|NCT01741038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92459663|NCT01741038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459664|NCT01741077|Folic Acid|folic acid|mesh-list
92459665|NCT01741077|Hematinics|hematinics|mesh-ancestor
92459666|NCT01741077|Vitamin B Complex|vitamin b complex|mesh-ancestor
92459667|NCT01741077|Vitamins|vitamins|mesh-ancestor
92459668|NCT01741077|Micronutrients|micronutrients|mesh-ancestor
92459669|NCT01741077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459670|NCT01741142|Escitalopram|escitalopram|mesh-list
92459671|NCT01741142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92459672|NCT01741142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92459673|NCT01741142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92459674|NCT01741142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459675|NCT01741142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459676|NCT01741142|Serotonin Agents|serotonin agents|mesh-ancestor
92459677|NCT01741142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459678|NCT01741181|Vitamin D|vitamin d|mesh-list
92459679|NCT01741181|Ergocalciferols|ergocalciferols|mesh-list
92459680|NCT01741181|Cholecalciferol|cholecalciferol|mesh-list
92459681|NCT01741181|Vitamins|vitamins|mesh-list
92459682|NCT01741181|Micronutrients|micronutrients|mesh-ancestor
92459683|NCT01741181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459684|NCT01741181|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92459685|NCT01741181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92459686|NCT01741285|Fluticasone|fluticasone|mesh-list
92459687|NCT01741285|Beclomethasone|beclomethasone|mesh-list
92459688|NCT01741285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459689|NCT01741285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92459690|NCT01741285|Autonomic Agents|autonomic agents|mesh-ancestor
92459691|NCT01741285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459692|NCT01741285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459693|NCT01741285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92459694|NCT01741285|Respiratory System Agents|respiratory system agents|mesh-ancestor
92459695|NCT01741285|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459696|NCT01741285|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92459697|NCT01741285|Glucocorticoids|glucocorticoids|mesh-ancestor
92459698|NCT01741285|Hormones|hormones|mesh-ancestor
92459699|NCT01741285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459700|NCT01741324|Vitamin D|vitamin d|mesh-list
92459701|NCT01741324|Ergocalciferols|ergocalciferols|mesh-list
92459702|NCT01741324|Cholecalciferol|cholecalciferol|mesh-list
92459703|NCT01741324|Vitamins|vitamins|mesh-list
92459704|NCT01741324|Micronutrients|micronutrients|mesh-ancestor
92459705|NCT01741324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459706|NCT01741324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92459707|NCT01741324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92459708|NCT01741376|Progesterone|progesterone|mesh-list
92459709|NCT01741376|Progestins|progestins|mesh-ancestor
92459710|NCT01741376|Hormones|hormones|mesh-ancestor
92459711|NCT01741376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459712|NCT01741376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459713|NCT01741389|Melatonin|melatonin|mesh-list
92459714|NCT01741389|Antioxidants|antioxidants|mesh-ancestor
92459715|NCT01741389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459716|NCT01741389|Protective Agents|protective agents|mesh-ancestor
92459717|NCT01741389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459718|NCT01741389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459719|NCT01741493|Upadacitinib|upadacitinib|mesh-list
92459720|NCT01741493|Tofacitinib|tofacitinib|mesh-list
92459721|NCT01741493|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92459722|NCT01741493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92459723|NCT01741493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459724|NCT01741493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459725|NCT01741493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459726|NCT01741506|Dalteparin|dalteparin|mesh-list
92459727|NCT01741506|Tinzaparin|tinzaparin|mesh-list
92459728|NCT01741506|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92459729|NCT01741506|Anticoagulants|anticoagulants|mesh-ancestor
92459730|NCT01741506|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92459731|NCT01741506|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92459732|NCT01741506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459733|NCT01741519|Landiolol|landiolol|mesh-list
92184626|NCT05577000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92459735|NCT01741519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92459736|NCT01741519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92459737|NCT01741519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92459738|NCT01741519|Adrenergic Agents|adrenergic agents|mesh-ancestor
92459739|NCT01741519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459740|NCT01741519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459741|NCT01741519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459742|NCT01741519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92459743|NCT01741558|Riboflavin|riboflavin|mesh-list
92459744|NCT01741558|Methotrexate|methotrexate|mesh-list
92459745|NCT01741558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92459746|NCT01741558|Abortifacient Agents|abortifacient agents|mesh-ancestor
92459747|NCT01741558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92459748|NCT01741558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459749|NCT01741558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92459750|NCT01741558|Antimetabolites|antimetabolites|mesh-ancestor
92459751|NCT01741558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459752|NCT01741558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459753|NCT01741558|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459755|NCT01741558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92459756|NCT01741558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92459757|NCT01741558|Immunologic Factors|immunologic factors|mesh-ancestor
92459758|NCT01741558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459759|NCT01741558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92459760|NCT01741558|Vitamin B Complex|vitamin b complex|mesh-ancestor
92459761|NCT01741558|Vitamins|vitamins|mesh-ancestor
92459762|NCT01741558|Micronutrients|micronutrients|mesh-ancestor
92459763|NCT01741558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92459764|NCT01741623|Bisoprolol|bisoprolol|mesh-list
92459765|NCT01741623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92459766|NCT01741623|Sympatholytics|sympatholytics|mesh-ancestor
92459767|NCT01741623|Autonomic Agents|autonomic agents|mesh-ancestor
92459768|NCT01741623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459769|NCT01741623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459770|NCT01741623|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92459771|NCT01741623|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92459772|NCT01741623|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92459773|NCT01741623|Adrenergic Agents|adrenergic agents|mesh-ancestor
92459774|NCT01741623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459775|NCT01741623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459776|NCT01741649|Povidone|povidone|mesh-list
92459777|NCT01741649|Plasma Substitutes|plasma substitutes|mesh-ancestor
92459778|NCT01741649|Blood Substitutes|blood substitutes|mesh-ancestor
92459779|NCT01741727|ABT-414|abt-414|mesh-list
92459780|NCT01741727|Immunoconjugates|immunoconjugates|mesh-ancestor
92459781|NCT01741727|Immunologic Factors|immunologic factors|mesh-ancestor
92459782|NCT01741727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459783|NCT01741753|Prednisone|prednisone|mesh-list
92459784|NCT01741753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459785|NCT01741753|Glucocorticoids|glucocorticoids|mesh-ancestor
92459786|NCT01741753|Hormones|hormones|mesh-ancestor
92348050|NCT01687296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92459787|NCT01741753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459788|NCT01741753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459789|NCT01741753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92459790|NCT01741753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459791|NCT01741831|Darunavir|darunavir|mesh-list
92459792|NCT01741831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92459793|NCT01741831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92459794|NCT01741831|Protease Inhibitors|protease inhibitors|mesh-ancestor
92459795|NCT01741831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459796|NCT01741831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459797|NCT01741831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92459798|NCT01741831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92459799|NCT01741831|Antiviral Agents|antiviral agents|mesh-ancestor
92459800|NCT01741831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459801|NCT01741948|Contraceptive Agents|contraceptive agents|mesh-list
92459802|NCT01741948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92459803|NCT01741948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459804|NCT01742247|Palmidrol|palmidrol|mesh-list
92459805|NCT01742247|Analgesics|analgesics|mesh-ancestor
92459806|NCT01742247|Sensory System Agents|sensory system agents|mesh-ancestor
92459807|NCT01742247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459808|NCT01742247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459809|NCT01742247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92459810|NCT01742247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459811|NCT01742247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459812|NCT01742247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459813|NCT01742247|Antiviral Agents|antiviral agents|mesh-ancestor
92459814|NCT01742247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459815|NCT01742247|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92459816|NCT01742247|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92459817|NCT01742247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459818|NCT01742247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459819|NCT01742247|Hormones|hormones|mesh-ancestor
92459820|NCT01742247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459821|NCT01742273|Vitamin K|vitamin k|mesh-list
92459822|NCT01742273|Vitamin K 1|vitamin k 1|mesh-list
92459823|NCT01742273|Vitamins|vitamins|mesh-ancestor
92459824|NCT01742273|Micronutrients|micronutrients|mesh-ancestor
92459825|NCT01742273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459826|NCT01742273|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92459827|NCT01742273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92459828|NCT01742273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459829|NCT01742273|Hemostatics|hemostatics|mesh-ancestor
92459830|NCT01742273|Coagulants|coagulants|mesh-ancestor
92459831|NCT01742338|Prednisone|prednisone|mesh-list
92459832|NCT01742338|Methylprednisolone|methylprednisolone|mesh-list
92459833|NCT01742338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92459834|NCT01742338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92459835|NCT01742338|Prednisolone|prednisolone|mesh-list
92459836|NCT01742338|Prednisolone acetate|prednisolone acetate|mesh-list
92459837|NCT01742338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92459838|NCT01742338|Prednisolone phosphate|prednisolone phosphate|mesh-list
92459839|NCT01742338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459840|NCT01742338|Glucocorticoids|glucocorticoids|mesh-ancestor
92459841|NCT01742338|Hormones|hormones|mesh-ancestor
92459842|NCT01742338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459843|NCT01742338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459844|NCT01742338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92459845|NCT01742338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459846|NCT01742338|Antiemetics|antiemetics|mesh-ancestor
92459847|NCT01742338|Autonomic Agents|autonomic agents|mesh-ancestor
92459848|NCT01742338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459849|NCT01742338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92459850|NCT01742338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92459851|NCT01742338|Protective Agents|protective agents|mesh-ancestor
92459852|NCT01742390|Risperidone|risperidone|mesh-list
92459853|NCT01742390|Aripiprazole|aripiprazole|mesh-list
92459854|NCT01742390|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92459855|NCT01742390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92459856|NCT01742390|Serotonin Agents|serotonin agents|mesh-ancestor
92459857|NCT01742390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459858|NCT01742390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459859|NCT01742390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459860|NCT01742390|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92459861|NCT01742390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92459862|NCT01742390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92459863|NCT01742390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92459864|NCT01742390|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92459865|NCT01742390|Dopamine Agents|dopamine agents|mesh-ancestor
92459866|NCT01742390|Antidepressive Agents|antidepressive agents|mesh-ancestor
92459867|NCT01742390|Dopamine Agonists|dopamine agonists|mesh-ancestor
92459868|NCT01742390|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92459869|NCT01742390|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92459870|NCT01742390|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92459871|NCT01742390|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92459872|NCT01742429|Amoxicillin|amoxicillin|mesh-list
92459873|NCT01742429|Metronidazole|metronidazole|mesh-list
92459874|NCT01742429|Levofloxacin|levofloxacin|mesh-list
92459875|NCT01742429|Tetracycline|tetracycline|mesh-list
92459876|NCT01742429|Bismuth|bismuth|mesh-list
92459877|NCT01742429|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92459878|NCT01742429|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92459879|NCT01742429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92459880|NCT01742429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459881|NCT01742429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92459882|NCT01742429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92459883|NCT01742429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92459884|NCT01742429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92459885|NCT01742429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92459886|NCT01742429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459887|NCT01742429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459888|NCT01742429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459889|NCT01742429|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92459890|NCT01742429|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92459891|NCT01742429|Antacids|antacids|mesh-ancestor
92459892|NCT01742429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92459893|NCT01742429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92459894|NCT01742429|Antidiarrheals|antidiarrheals|mesh-ancestor
92459895|NCT01742533|Hormones|hormones|mesh-list
92459896|NCT01742533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92459897|NCT01742533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459898|NCT01742624|Mycophenolic Acid|mycophenolic acid|mesh-list
92459899|NCT01742624|Tacrolimus|tacrolimus|mesh-list
92459900|NCT01742624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92459901|NCT01742624|Immunologic Factors|immunologic factors|mesh-ancestor
92459902|NCT01742624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459903|NCT01742624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92459904|NCT01742624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459905|NCT01742624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459906|NCT01742624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92459907|NCT01742624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459908|NCT01742624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92459909|NCT01742624|Antitubercular Agents|antitubercular agents|mesh-ancestor
92459910|NCT01742624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92459911|NCT01742624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92459912|NCT01742637|Adapalene|adapalene|mesh-list
92459913|NCT01742637|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92459914|NCT01742637|Dermatologic Agents|dermatologic agents|mesh-ancestor
92459915|NCT01742637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92459916|NCT01742637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459917|NCT01742637|Analgesics|analgesics|mesh-ancestor
92459918|NCT01742637|Sensory System Agents|sensory system agents|mesh-ancestor
92459919|NCT01742637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459920|NCT01742637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459921|NCT01742637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459922|NCT01742637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459923|NCT01742663|Diclofenac|diclofenac|mesh-list
92459924|NCT01742663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92459925|NCT01742663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459926|NCT01742663|Analgesics|analgesics|mesh-ancestor
92459927|NCT01742663|Sensory System Agents|sensory system agents|mesh-ancestor
92459928|NCT01742663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459929|NCT01742663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459930|NCT01742663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459931|NCT01742663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459932|NCT01742663|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92459933|NCT01742663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459934|NCT01742663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459935|NCT01742676|Tacrolimus|tacrolimus|mesh-list
92459936|NCT01742676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92459937|NCT01742676|Immunologic Factors|immunologic factors|mesh-ancestor
92459938|NCT01742676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459939|NCT01742676|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92459940|NCT01742676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459941|NCT01742676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459942|NCT01742689|Indomethacin|indomethacin|mesh-list
92459943|NCT01742689|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92459944|NCT01742689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92459945|NCT01742689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92459946|NCT01742689|Analgesics|analgesics|mesh-ancestor
92459947|NCT01742689|Sensory System Agents|sensory system agents|mesh-ancestor
92459948|NCT01742689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459949|NCT01742689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459950|NCT01742689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459951|NCT01742689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92459952|NCT01742689|Gout Suppressants|gout suppressants|mesh-ancestor
92459953|NCT01742689|Tocolytic Agents|tocolytic agents|mesh-ancestor
92459954|NCT01742689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92459955|NCT01742689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92459956|NCT01742689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92459957|NCT01742689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459958|NCT01742689|Hemostatics|hemostatics|mesh-ancestor
92459959|NCT01742689|Coagulants|coagulants|mesh-ancestor
92459960|NCT01742689|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92459961|NCT01742689|Natriuretic Agents|natriuretic agents|mesh-ancestor
92459962|NCT01742702|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92459964|NCT01742702|Nitroglycerin|nitroglycerin|mesh-list
92459965|NCT01742702|Albuterol|albuterol|mesh-list
92459966|NCT01742702|Caseins|caseins|mesh-list
92459967|NCT01742702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92459968|NCT01742702|Autonomic Agents|autonomic agents|mesh-ancestor
92459969|NCT01742702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92459970|NCT01742702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92459971|NCT01742702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92459972|NCT01742702|Respiratory System Agents|respiratory system agents|mesh-ancestor
92459973|NCT01742702|Tocolytic Agents|tocolytic agents|mesh-ancestor
92459974|NCT01742702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92459975|NCT01742702|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92459976|NCT01742702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92459977|NCT01742702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92459978|NCT01742702|Adrenergic Agents|adrenergic agents|mesh-ancestor
92459979|NCT01742702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92459980|NCT01742702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459981|NCT01742702|Vasodilator Agents|vasodilator agents|mesh-ancestor
92459982|NCT01742702|Chelating Agents|chelating agents|mesh-ancestor
92459983|NCT01742702|Sequestering Agents|sequestering agents|mesh-ancestor
92459984|NCT01742702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92459985|NCT01742702|Sympatholytics|sympatholytics|mesh-ancestor
92459986|NCT01742702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92459987|NCT01742702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92459988|NCT01742702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92459989|NCT01742702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92459990|NCT01742767|Pemetrexed|pemetrexed|mesh-list
92459991|NCT01742767|Cisplatin|cisplatin|mesh-list
92459992|NCT01742767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92459993|NCT01742767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348078|NCT01568112|Antipyretics|antipyretics|mesh-ancestor
92459994|NCT01742767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92459995|NCT01742767|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92459996|NCT01742767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92459997|NCT01742793|Lenalidomide|lenalidomide|mesh-list
92459998|NCT01742793|Romidepsin|romidepsin|mesh-list
92459999|NCT01742793|Immunologic Factors|immunologic factors|mesh-ancestor
92460000|NCT01742793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460001|NCT01742793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460002|NCT01742793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460003|NCT01742793|Growth Substances|growth substances|mesh-ancestor
92460004|NCT01742793|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460005|NCT01742793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460006|NCT01742793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92460007|NCT01742793|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92460008|NCT01742793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460009|NCT01742793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460010|NCT01742845|Ropivacaine|ropivacaine|mesh-list
92460011|NCT01742845|Anesthetics, Local|anesthetics, local|mesh-ancestor
92460012|NCT01742845|Anesthetics|anesthetics|mesh-ancestor
92460013|NCT01742845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460014|NCT01742845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460015|NCT01742845|Sensory System Agents|sensory system agents|mesh-ancestor
92460016|NCT01742845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460017|NCT01742988|Rituximab|rituximab|mesh-list
92460018|NCT01742988|Venetoclax|venetoclax|mesh-list
92460019|NCT01742988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92460020|NCT01742988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460021|NCT01742988|Immunologic Factors|immunologic factors|mesh-ancestor
92460022|NCT01742988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460023|NCT01742988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460024|NCT01743014|Ramipril|ramipril|mesh-list
92460025|NCT01743014|Clopidogrel|clopidogrel|mesh-list
92460026|NCT01743014|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92460027|NCT01743014|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92460028|NCT01743014|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92460029|NCT01743014|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92460030|NCT01743014|Purinergic Agents|purinergic agents|mesh-ancestor
92460031|NCT01743014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460032|NCT01743014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460033|NCT01743014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460034|NCT01743014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92460035|NCT01743014|Protease Inhibitors|protease inhibitors|mesh-ancestor
92460036|NCT01743014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460037|NCT01743014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460038|NCT01743066|Vitamin E|vitamin e|mesh-list
92460039|NCT01743066|Vitamins|vitamins|mesh-ancestor
92460040|NCT01743066|Micronutrients|micronutrients|mesh-ancestor
92460041|NCT01743066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460042|NCT01743066|Antioxidants|antioxidants|mesh-ancestor
92460043|NCT01743066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460044|NCT01743066|Protective Agents|protective agents|mesh-ancestor
92460045|NCT01743079|Lamivudine|lamivudine|mesh-list
92460046|NCT01743079|Telbivudine|telbivudine|mesh-list
92460047|NCT01743079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92460048|NCT01743079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92460049|NCT01743079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460050|NCT01743079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460051|NCT01743079|Antiviral Agents|antiviral agents|mesh-ancestor
92460052|NCT01743079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460053|NCT01743079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92460054|NCT01743079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92460055|NCT01743118|Calcipotriene|calcipotriene|mesh-list
92460056|NCT01743118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460057|NCT01743144|Magnesium Sulfate|magnesium sulfate|mesh-list
92460058|NCT01743144|Analgesics|analgesics|mesh-ancestor
92460059|NCT01743144|Sensory System Agents|sensory system agents|mesh-ancestor
92460060|NCT01743144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460061|NCT01743144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460062|NCT01743144|Anesthetics|anesthetics|mesh-ancestor
92460063|NCT01743144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460064|NCT01743144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92460065|NCT01743144|Anticonvulsants|anticonvulsants|mesh-ancestor
92348084|NCT01568034|Opicapone|opicapone|mesh-list
92460066|NCT01743144|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92460067|NCT01743144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460068|NCT01743144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460069|NCT01743144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460070|NCT01743144|Tocolytic Agents|tocolytic agents|mesh-ancestor
92460071|NCT01743144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92460072|NCT01743157|Bevacizumab|bevacizumab|mesh-list
92460073|NCT01743157|Ipilimumab|ipilimumab|mesh-list
92460074|NCT01743157|Interleukin-2|interleukin-2|mesh-list
92460075|NCT01743157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92460076|NCT01743157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460077|NCT01743157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460078|NCT01743157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460079|NCT01743157|Growth Substances|growth substances|mesh-ancestor
92460080|NCT01743157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460081|NCT01743157|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460082|NCT01743157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92460083|NCT01743157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460084|NCT01743157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460085|NCT01743157|Analgesics|analgesics|mesh-ancestor
92460086|NCT01743157|Sensory System Agents|sensory system agents|mesh-ancestor
92460087|NCT01743157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460088|NCT01743235|Buspirone|buspirone|mesh-list
92460089|NCT01743235|Testosterone|testosterone|mesh-list
92460090|NCT01743235|Androgens|androgens|mesh-ancestor
92460091|NCT01743235|Hormones|hormones|mesh-ancestor
92460092|NCT01743235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460093|NCT01743235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460094|NCT01743235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92460095|NCT01743235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460096|NCT01743235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531550|NCT00046852|Melphalan|melphalan|mesh-list
92460097|NCT01743235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460098|NCT01743235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92460099|NCT01743235|Serotonin Agents|serotonin agents|mesh-ancestor
92460100|NCT01743235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460101|NCT01743235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460102|NCT01743300|Sunitinib|sunitinib|mesh-list
92460103|NCT01743300|Midazolam|midazolam|mesh-list
92460104|NCT01743300|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92460105|NCT01743300|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92460106|NCT01743300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460107|NCT01743300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460108|NCT01743300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92185012|NCT02099461|Denosumab|denosumab|mesh-list
92460109|NCT01743300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460110|NCT01743300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460111|NCT01743300|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92460112|NCT01743300|Anesthetics, General|anesthetics, general|mesh-ancestor
92460113|NCT01743300|Anesthetics|anesthetics|mesh-ancestor
92460114|NCT01743300|GABA Modulators|gaba modulators|mesh-ancestor
92460115|NCT01743300|GABA Agents|gaba agents|mesh-ancestor
92460116|NCT01743300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460117|NCT01743300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460118|NCT01743300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460119|NCT01743300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460120|NCT01743300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460121|NCT01743300|Growth Substances|growth substances|mesh-ancestor
92460122|NCT01743300|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460123|NCT01743300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460124|NCT01743300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460125|NCT01743326|Anesthetics|anesthetics|mesh-list
92460126|NCT01743326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460127|NCT01743326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460128|NCT01743365|Afatinib|afatinib|mesh-list
92460129|NCT01743365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460130|NCT01743365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460131|NCT01743365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460132|NCT01743365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460133|NCT01743378|Ropivacaine|ropivacaine|mesh-list
92460134|NCT01743378|Anesthetics, Local|anesthetics, local|mesh-ancestor
92460135|NCT01743378|Anesthetics|anesthetics|mesh-ancestor
92460136|NCT01743378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460137|NCT01743378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460138|NCT01743378|Sensory System Agents|sensory system agents|mesh-ancestor
92460139|NCT01743378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460140|NCT01743456|Anesthetics|anesthetics|mesh-list
92460141|NCT01743456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460142|NCT01743456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460143|NCT01743508|Misoprostol|misoprostol|mesh-list
92460144|NCT01743508|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92460145|NCT01743508|Abortifacient Agents|abortifacient agents|mesh-ancestor
92460146|NCT01743508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92460147|NCT01743508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460148|NCT01743508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92460149|NCT01743508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460150|NCT01743508|Oxytocics|oxytocics|mesh-ancestor
92460151|NCT01743690|Nystatin|nystatin|mesh-list
92460152|NCT01743690|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92460153|NCT01743690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460154|NCT01743690|Glucocorticoids|glucocorticoids|mesh-ancestor
92460155|NCT01743690|Hormones|hormones|mesh-ancestor
92460156|NCT01743690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460157|NCT01743690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460158|NCT01743690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92460159|NCT01743690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460160|NCT01743690|Antifungal Agents|antifungal agents|mesh-ancestor
92460161|NCT01743690|Ionophores|ionophores|mesh-ancestor
92460162|NCT01743690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460163|NCT01743690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460164|NCT01743755|Dexamethasone|dexamethasone|mesh-list
92460165|NCT01743755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460166|NCT01743755|Antiemetics|antiemetics|mesh-ancestor
92460167|NCT01743755|Autonomic Agents|autonomic agents|mesh-ancestor
92460168|NCT01743755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460169|NCT01743755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460170|NCT01743755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460171|NCT01743755|Glucocorticoids|glucocorticoids|mesh-ancestor
92460172|NCT01743755|Hormones|hormones|mesh-ancestor
92460173|NCT01743755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460174|NCT01743755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92460175|NCT01743755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460176|NCT01743794|Ropivacaine|ropivacaine|mesh-list
92460177|NCT01743794|Anesthetics, Local|anesthetics, local|mesh-ancestor
92460178|NCT01743794|Anesthetics|anesthetics|mesh-ancestor
92460179|NCT01743794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460180|NCT01743794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460181|NCT01743794|Sensory System Agents|sensory system agents|mesh-ancestor
92460182|NCT01743794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460183|NCT01743820|Primaquine|primaquine|mesh-list
92460184|NCT01743820|Piperaquine|piperaquine|mesh-list
92460185|NCT01743820|Artenimol|artenimol|mesh-list
92460186|NCT01743820|Antimalarials|antimalarials|mesh-ancestor
92460187|NCT01743820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92460188|NCT01743820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92460189|NCT01743820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460190|NCT01743885|Propranolol|propranolol|mesh-list
92460191|NCT01743885|Acebutolol|acebutolol|mesh-list
92460192|NCT01743885|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92460193|NCT01743885|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92460194|NCT01743885|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460195|NCT01743885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460196|NCT01743885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460197|NCT01743885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460198|NCT01743885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92460199|NCT01743885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460200|NCT01743885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92460202|NCT01743885|Autonomic Agents|autonomic agents|mesh-ancestor
92460203|NCT01743885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460204|NCT01743885|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92460205|NCT01743898|Rivaroxaban|rivaroxaban|mesh-list
92460206|NCT01743898|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92460207|NCT01743898|Antithrombins|antithrombins|mesh-ancestor
92460208|NCT01743898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92460209|NCT01743898|Protease Inhibitors|protease inhibitors|mesh-ancestor
92460210|NCT01743898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460211|NCT01743898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460212|NCT01743898|Anticoagulants|anticoagulants|mesh-ancestor
92460213|NCT01743911|Tadalafil|tadalafil|mesh-list
92460214|NCT01743911|Vasodilator Agents|vasodilator agents|mesh-ancestor
92460215|NCT01743911|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92460216|NCT01743911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92460217|NCT01743911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460218|NCT01743911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460219|NCT01743911|Urological Agents|urological agents|mesh-ancestor
92460220|NCT01744106|Pseudoephedrine|pseudoephedrine|mesh-list
92460221|NCT01744106|Ephedrine|ephedrine|mesh-list
92460222|NCT01744106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92460223|NCT01744106|Autonomic Agents|autonomic agents|mesh-ancestor
92460224|NCT01744106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460225|NCT01744106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460226|NCT01744106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92460227|NCT01744106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92460228|NCT01744106|Nasal Decongestants|nasal decongestants|mesh-ancestor
92460229|NCT01744106|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92460230|NCT01744106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92460231|NCT01744106|Sympathomimetics|sympathomimetics|mesh-ancestor
92460232|NCT01744106|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460233|NCT01744106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460234|NCT01744106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460235|NCT01744184|Midazolam|midazolam|mesh-list
92460236|NCT01744184|Nitrous Oxide|nitrous oxide|mesh-list
92460237|NCT01744184|Entonox|entonox|mesh-list
92460238|NCT01744184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92460239|NCT01744184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92460240|NCT01744184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460241|NCT01744184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460242|NCT01744184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92460243|NCT01744184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460244|NCT01744184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460245|NCT01744184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92460246|NCT01744184|Anesthetics, General|anesthetics, general|mesh-ancestor
92460247|NCT01744184|Anesthetics|anesthetics|mesh-ancestor
92460248|NCT01744184|GABA Modulators|gaba modulators|mesh-ancestor
92460249|NCT01744184|GABA Agents|gaba agents|mesh-ancestor
92460250|NCT01744184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460251|NCT01744184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460252|NCT01744184|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92460253|NCT01744184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460254|NCT01744184|Analgesics|analgesics|mesh-ancestor
92460255|NCT01744184|Sensory System Agents|sensory system agents|mesh-ancestor
92460256|NCT01744184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460257|NCT01744184|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92460258|NCT01744236|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92460259|NCT01744236|Liraglutide|liraglutide|mesh-list
92460260|NCT01744236|Exenatide|exenatide|mesh-list
92460261|NCT01744236|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92460262|NCT01744236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185147|NCT01465802|Hormones|hormones|mesh-ancestor
92460263|NCT01744236|Incretins|incretins|mesh-ancestor
92460264|NCT01744236|Hormones|hormones|mesh-ancestor
92460265|NCT01744236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460266|NCT01744236|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92460267|NCT01744236|Protease Inhibitors|protease inhibitors|mesh-ancestor
92460268|NCT01744236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460269|NCT01744236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460270|NCT01744236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92460271|NCT01744249|Axitinib|axitinib|mesh-list
92460272|NCT01744249|Octreotide|octreotide|mesh-list
92460273|NCT01744249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460274|NCT01744249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460276|NCT01744249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460277|NCT01744249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460278|NCT01744249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92460279|NCT01744288|Clopidogrel|clopidogrel|mesh-list
92460280|NCT01744288|Ticagrelor|ticagrelor|mesh-list
92460281|NCT01744288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92460282|NCT01744288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92460283|NCT01744288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92460284|NCT01744288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92460285|NCT01744288|Purinergic Agents|purinergic agents|mesh-ancestor
92460286|NCT01744288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460287|NCT01744288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460288|NCT01744288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460289|NCT01744314|Indomethacin|indomethacin|mesh-list
92460290|NCT01744314|Pantoprazole|pantoprazole|mesh-list
92460291|NCT01744314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92460292|NCT01744314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460293|NCT01744314|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92460294|NCT01744314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460295|NCT01744314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460296|NCT01744314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92460297|NCT01744314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460298|NCT01744314|Analgesics|analgesics|mesh-ancestor
92460299|NCT01744314|Sensory System Agents|sensory system agents|mesh-ancestor
92460300|NCT01744314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460301|NCT01744314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460302|NCT01744314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460303|NCT01744314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460304|NCT01744314|Gout Suppressants|gout suppressants|mesh-ancestor
92460305|NCT01744314|Tocolytic Agents|tocolytic agents|mesh-ancestor
92460306|NCT01744314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92460307|NCT01744314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92460308|NCT01744366|Goserelin|goserelin|mesh-list
92460309|NCT01744366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92460310|NCT01744366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460311|NCT01744379|Lesinurad|lesinurad|mesh-list
92460312|NCT01744379|Gout Suppressants|gout suppressants|mesh-ancestor
92460313|NCT01744379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460314|NCT01744379|Uricosuric Agents|uricosuric agents|mesh-ancestor
92460315|NCT01744444|Gabapentin|gabapentin|mesh-list
92460316|NCT01744444|Memantine|memantine|mesh-list
92460317|NCT01744444|Analgesics|analgesics|mesh-ancestor
92460318|NCT01744444|Sensory System Agents|sensory system agents|mesh-ancestor
92460319|NCT01744444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460320|NCT01744444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460321|NCT01744444|Anticonvulsants|anticonvulsants|mesh-ancestor
92460322|NCT01744444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92460323|NCT01744444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460324|NCT01744444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460325|NCT01744444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460326|NCT01744444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92460327|NCT01744444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92460328|NCT01744444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460329|NCT01744444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460330|NCT01744444|Antimanic Agents|antimanic agents|mesh-ancestor
92460331|NCT01744444|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92460332|NCT01744444|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92460333|NCT01744444|Dopamine Agents|dopamine agents|mesh-ancestor
92460334|NCT01744470|Tacrolimus|tacrolimus|mesh-list
92460335|NCT01744470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92460336|NCT01744470|Immunologic Factors|immunologic factors|mesh-ancestor
92460337|NCT01744470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460338|NCT01744470|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92460340|NCT01744470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460341|NCT01744587|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92460342|NCT01744587|Antioxidants|antioxidants|mesh-ancestor
92460343|NCT01744587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460344|NCT01744587|Protective Agents|protective agents|mesh-ancestor
92460345|NCT01744587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460346|NCT01744587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92460347|NCT01744587|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92460348|NCT01744587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460349|NCT01744587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92460350|NCT01744262|Anesthetics|anesthetics|mesh-list
92460351|NCT01744262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460352|NCT01744262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460353|NCT01744756|Bevacizumab|bevacizumab|mesh-list
92460354|NCT01744756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92460355|NCT01744756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460356|NCT01744756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460357|NCT01744756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460358|NCT01744756|Growth Substances|growth substances|mesh-ancestor
92460359|NCT01744756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460360|NCT01744756|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460361|NCT01744873|Bisoprolol|bisoprolol|mesh-list
92460362|NCT01744873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460363|NCT01744873|Sympatholytics|sympatholytics|mesh-ancestor
92460364|NCT01744873|Autonomic Agents|autonomic agents|mesh-ancestor
92460365|NCT01744873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460366|NCT01744873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460367|NCT01744873|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92460368|NCT01744873|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92460369|NCT01744873|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92460370|NCT01744873|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460371|NCT01744873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460372|NCT01744873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460373|NCT01744886|Benzocaine|benzocaine|mesh-list
92460374|NCT01744886|Anesthetics, Local|anesthetics, local|mesh-ancestor
92460375|NCT01744886|Anesthetics|anesthetics|mesh-ancestor
92460376|NCT01744886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460377|NCT01744886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460378|NCT01744886|Sensory System Agents|sensory system agents|mesh-ancestor
92460379|NCT01744886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460380|NCT01744626|Rituximab|rituximab|mesh-list
92460381|NCT01744626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92460382|NCT01744626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460383|NCT01744626|Immunologic Factors|immunologic factors|mesh-ancestor
92460384|NCT01744626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460385|NCT01744626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460386|NCT01744964|Apomorphine|apomorphine|mesh-list
92460387|NCT01744964|Emetics|emetics|mesh-ancestor
92460388|NCT01744964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460389|NCT01744964|Autonomic Agents|autonomic agents|mesh-ancestor
92460390|NCT01744964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460391|NCT01744964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460392|NCT01744964|Dopamine Agonists|dopamine agonists|mesh-ancestor
92460393|NCT01744964|Dopamine Agents|dopamine agents|mesh-ancestor
92460395|NCT01744964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460396|NCT01745081|Mannitol|mannitol|mesh-list
92460397|NCT01745081|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92460398|NCT01745081|Diuretics|diuretics|mesh-ancestor
92460399|NCT01745081|Natriuretic Agents|natriuretic agents|mesh-ancestor
92460400|NCT01745081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460401|NCT01745159|Tacrolimus|tacrolimus|mesh-list
92460402|NCT01745159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92460403|NCT01745159|Immunologic Factors|immunologic factors|mesh-ancestor
92460404|NCT01745159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460405|NCT01745159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92460406|NCT01745159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460407|NCT01745159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460408|NCT01745263|Vitamin D|vitamin d|mesh-list
92460409|NCT01745263|Cholecalciferol|cholecalciferol|mesh-list
92185297|NCT01818063|Cyclophosphamide|cyclophosphamide|mesh-list
92460410|NCT01745263|Vitamins|vitamins|mesh-ancestor
92460411|NCT01745263|Micronutrients|micronutrients|mesh-ancestor
92460412|NCT01745263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460413|NCT01745263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92460414|NCT01745263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460415|NCT01745302|Gefitinib|gefitinib|mesh-list
92460416|NCT01745302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460417|NCT01745302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460418|NCT01745302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460419|NCT01745302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460420|NCT01745328|Amoxicillin|amoxicillin|mesh-list
92460421|NCT01745328|Levofloxacin|levofloxacin|mesh-list
92460422|NCT01745328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92460423|NCT01745328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460424|NCT01745328|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92460425|NCT01745328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92460426|NCT01745328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92460427|NCT01745328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460428|NCT01745328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460429|NCT01745328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460430|NCT01745328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92460431|NCT01745328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92460433|NCT01745549|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92460434|NCT01745549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92460435|NCT01745549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460436|NCT01745562|Alprazolam|alprazolam|mesh-list
92460437|NCT01745562|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92460438|NCT01745562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460439|NCT01745562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460440|NCT01745562|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92460441|NCT01745562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460442|NCT01745562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460443|NCT01745562|GABA Modulators|gaba modulators|mesh-ancestor
92460444|NCT01745562|GABA Agents|gaba agents|mesh-ancestor
92460445|NCT01745562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460446|NCT01745562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460447|NCT01745575|Alprazolam|alprazolam|mesh-list
92460448|NCT01745575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92460449|NCT01745575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460450|NCT01745575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460451|NCT01745575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92460452|NCT01745575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460453|NCT01745575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460454|NCT01745575|GABA Modulators|gaba modulators|mesh-ancestor
92460455|NCT01745575|GABA Agents|gaba agents|mesh-ancestor
92460456|NCT01745575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460457|NCT01745575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460458|NCT01745601|Dexetimide|dexetimide|mesh-list
92460459|NCT01745601|Citalopram|citalopram|mesh-list
92460460|NCT01745601|Escitalopram|escitalopram|mesh-list
92460461|NCT01745601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92460462|NCT01745601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92460463|NCT01745601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460464|NCT01745601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460465|NCT01745601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460466|NCT01745601|Serotonin Agents|serotonin agents|mesh-ancestor
92460467|NCT01745601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460469|NCT01745601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92460470|NCT01745601|Parasympatholytics|parasympatholytics|mesh-ancestor
92460471|NCT01745601|Autonomic Agents|autonomic agents|mesh-ancestor
92460472|NCT01745601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460473|NCT01745601|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92460474|NCT01745601|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92460475|NCT01745601|Cholinergic Agents|cholinergic agents|mesh-ancestor
92460476|NCT01745601|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92460477|NCT01745601|Antidepressive Agents|antidepressive agents|mesh-ancestor
92460478|NCT01745601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460479|NCT01745614|Nimesulide|nimesulide|mesh-list
92460480|NCT01745614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92460481|NCT01745614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460482|NCT01745614|Analgesics|analgesics|mesh-ancestor
92460483|NCT01745614|Sensory System Agents|sensory system agents|mesh-ancestor
92460484|NCT01745614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460485|NCT01745614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460486|NCT01745614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460487|NCT01745614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460488|NCT01745614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92460489|NCT01745614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460490|NCT01745614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460492|NCT01745640|Pomalidomide|pomalidomide|mesh-list
92460493|NCT01745640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460494|NCT01745640|Antiemetics|antiemetics|mesh-ancestor
92460495|NCT01745640|Autonomic Agents|autonomic agents|mesh-ancestor
92460496|NCT01745640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460497|NCT01745640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460498|NCT01745640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460499|NCT01745640|Glucocorticoids|glucocorticoids|mesh-ancestor
92460500|NCT01745640|Hormones|hormones|mesh-ancestor
92460501|NCT01745640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460502|NCT01745640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92460503|NCT01745640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460504|NCT01745640|Immunologic Factors|immunologic factors|mesh-ancestor
92460505|NCT01745640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460506|NCT01745640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460507|NCT01745640|Growth Substances|growth substances|mesh-ancestor
92460508|NCT01745640|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460509|NCT01745666|Epinephrine|epinephrine|mesh-list
92460510|NCT01745666|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92460511|NCT01745666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92460512|NCT01745666|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460513|NCT01745666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460514|NCT01745666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460515|NCT01745666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460516|NCT01745666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92460517|NCT01745666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92460518|NCT01745666|Autonomic Agents|autonomic agents|mesh-ancestor
92460519|NCT01745666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460520|NCT01745666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92460521|NCT01745666|Respiratory System Agents|respiratory system agents|mesh-ancestor
92460522|NCT01745666|Mydriatics|mydriatics|mesh-ancestor
92460523|NCT01745666|Sympathomimetics|sympathomimetics|mesh-ancestor
92460524|NCT01745666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92460525|NCT01745679|Ceftriaxone|ceftriaxone|mesh-list
92460526|NCT01745679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92460527|NCT01745679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460528|NCT01745692|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92460529|NCT01745692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92460530|NCT01745692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92460531|NCT01745692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460532|NCT01745770|Mesalamine|mesalamine|mesh-list
92460533|NCT01745770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92460534|NCT01745770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460535|NCT01745770|Analgesics|analgesics|mesh-ancestor
92460536|NCT01745770|Sensory System Agents|sensory system agents|mesh-ancestor
92460537|NCT01745770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460538|NCT01745770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460539|NCT01745770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460540|NCT01745770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460541|NCT01745809|Dimercaprol|dimercaprol|mesh-list
92460543|NCT01745809|Sequestering Agents|sequestering agents|mesh-ancestor
92460544|NCT01745809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460545|NCT01745835|Bisacodyl|bisacodyl|mesh-list
92460546|NCT01745835|Cathartics|cathartics|mesh-ancestor
92460547|NCT01745835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460548|NCT01745835|Laxatives|laxatives|mesh-ancestor
92460549|NCT01746199|Pyrimethamine|pyrimethamine|mesh-list
92460550|NCT01746199|Sulfadoxine|sulfadoxine|mesh-list
92460551|NCT01746199|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92460552|NCT01746199|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92460553|NCT01746199|Sulfamethoxazole|sulfamethoxazole|mesh-list
92460554|NCT01746199|Antimalarials|antimalarials|mesh-ancestor
92460555|NCT01746199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92460556|NCT01746199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92460557|NCT01746199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460558|NCT01746199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92460559|NCT01746199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460560|NCT01746199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460561|NCT01746199|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92460562|NCT01746199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92460563|NCT01746251|Afatinib|afatinib|mesh-list
92460564|NCT01746251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460565|NCT01746251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460566|NCT01746251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460567|NCT01746251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460568|NCT01746277|Docetaxel|docetaxel|mesh-list
92460569|NCT01746277|Pemetrexed|pemetrexed|mesh-list
92460570|NCT01746277|Gefitinib|gefitinib|mesh-list
92460571|NCT01746277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460572|NCT01746277|Tubulin Modulators|tubulin modulators|mesh-ancestor
92460573|NCT01746277|Antimitotic Agents|antimitotic agents|mesh-ancestor
92460574|NCT01746277|Mitosis Modulators|mitosis modulators|mesh-ancestor
92460575|NCT01746277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460576|NCT01746277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460577|NCT01746277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92460578|NCT01746277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92460579|NCT01746277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460580|NCT01746485|Treprostinil|treprostinil|mesh-list
92460581|NCT01746485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460582|NCT01746563|Ranibizumab|ranibizumab|mesh-list
92460583|NCT01746563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460584|NCT01746563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460585|NCT01746563|Growth Substances|growth substances|mesh-ancestor
92460586|NCT01746563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460587|NCT01746563|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460588|NCT01746563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460589|NCT01746602|Timolol|timolol|mesh-list
92460590|NCT01746602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92460591|NCT01746602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92460592|NCT01746602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460593|NCT01746602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460594|NCT01746602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460595|NCT01746602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460596|NCT01746602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92460597|NCT01746602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460598|NCT01746641|Remifentanil|remifentanil|mesh-list
92460599|NCT01746641|Propofol|propofol|mesh-list
92460600|NCT01746641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92460601|NCT01746641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460602|NCT01746641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460603|NCT01746641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92460604|NCT01746641|Anesthetics, General|anesthetics, general|mesh-ancestor
92460605|NCT01746641|Anesthetics|anesthetics|mesh-ancestor
92460606|NCT01746641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92460607|NCT01746641|Narcotics|narcotics|mesh-ancestor
92460608|NCT01746641|Analgesics|analgesics|mesh-ancestor
92460609|NCT01746641|Sensory System Agents|sensory system agents|mesh-ancestor
92460610|NCT01746641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460611|NCT01746680|Methotrexate|methotrexate|mesh-list
92460612|NCT01746680|Tacrolimus|tacrolimus|mesh-list
92460613|NCT01746680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92460614|NCT01746680|Abortifacient Agents|abortifacient agents|mesh-ancestor
92460615|NCT01746680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92460616|NCT01746680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531558|NCT00046852|Alkylating Agents|alkylating agents|mesh-ancestor
92460617|NCT01746680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92460618|NCT01746680|Antimetabolites|antimetabolites|mesh-ancestor
92460619|NCT01746680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460620|NCT01746680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460621|NCT01746680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460622|NCT01746680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149557|NCT03358875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92460623|NCT01746680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92460624|NCT01746680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92460625|NCT01746680|Immunologic Factors|immunologic factors|mesh-ancestor
92460626|NCT01746680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460627|NCT01746680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92460628|NCT01746680|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92460629|NCT01746719|Etodolac|etodolac|mesh-list
92460630|NCT01746719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92460631|NCT01746719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460632|NCT01746719|Analgesics|analgesics|mesh-ancestor
92460633|NCT01746719|Sensory System Agents|sensory system agents|mesh-ancestor
92460634|NCT01746719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460635|NCT01746719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460636|NCT01746719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460637|NCT01746719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460638|NCT01746719|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92460639|NCT01746719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92460640|NCT01746719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460641|NCT01746719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460642|NCT01746771|Paclitaxel|paclitaxel|mesh-list
92460643|NCT01746771|Trastuzumab|trastuzumab|mesh-list
92460644|NCT01746771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92460645|NCT01746771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460646|NCT01746771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92460648|NCT01746771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92460649|NCT01746771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460650|NCT01746771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92460651|NCT01746823|Cyclosporine|cyclosporine|mesh-list
92460652|NCT01746823|Cyclosporins|cyclosporins|mesh-list
92460653|NCT01746823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460654|NCT01746823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460655|NCT01746823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92460656|NCT01746823|Immunologic Factors|immunologic factors|mesh-ancestor
92460657|NCT01746823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460658|NCT01746823|Antifungal Agents|antifungal agents|mesh-ancestor
92460659|NCT01746823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460660|NCT01746823|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460661|NCT01746823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460662|NCT01746823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92460663|NCT01746875|Aflibercept|aflibercept|mesh-list
92460664|NCT01746875|Verteporfin|verteporfin|mesh-list
92460665|NCT01746875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92460666|NCT01746875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92460667|NCT01746875|Growth Substances|growth substances|mesh-ancestor
92460668|NCT01746875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460669|NCT01746875|Growth Inhibitors|growth inhibitors|mesh-ancestor
92460670|NCT01746875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460671|NCT01746875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92460672|NCT01746875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460673|NCT01746992|Prednisone|prednisone|mesh-list
92460674|NCT01746992|Cyclophosphamide|cyclophosphamide|mesh-list
92460675|NCT01746992|Ifosfamide|ifosfamide|mesh-list
92460676|NCT01746992|Doxorubicin|doxorubicin|mesh-list
92460677|NCT01746992|Methotrexate|methotrexate|mesh-list
92460678|NCT01746992|Etoposide|etoposide|mesh-list
92460679|NCT01746992|Vincristine|vincristine|mesh-list
92460680|NCT01746992|Etoposide phosphate|etoposide phosphate|mesh-list
92460681|NCT01746992|Pirarubicin|pirarubicin|mesh-list
92460682|NCT01746992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92460683|NCT01746992|Immunologic Factors|immunologic factors|mesh-ancestor
92460684|NCT01746992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460685|NCT01746992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460686|NCT01746992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92460687|NCT01746992|Alkylating Agents|alkylating agents|mesh-ancestor
92460688|NCT01746992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460689|NCT01746992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460690|NCT01746992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92460691|NCT01746992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92460692|NCT01746992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92460693|NCT01746992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92460694|NCT01746992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460695|NCT01746992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460696|NCT01746992|Glucocorticoids|glucocorticoids|mesh-ancestor
92460697|NCT01746992|Hormones|hormones|mesh-ancestor
92460698|NCT01746992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460699|NCT01746992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92460700|NCT01746992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92460701|NCT01746992|Abortifacient Agents|abortifacient agents|mesh-ancestor
92460702|NCT01746992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92460703|NCT01746992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92460704|NCT01746992|Antimetabolites|antimetabolites|mesh-ancestor
92460705|NCT01746992|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460706|NCT01746992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92460707|NCT01746992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92460708|NCT01746992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92460709|NCT01746992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92460710|NCT01746992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92460711|NCT01746992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92460712|NCT01747044|Milnacipran|milnacipran|mesh-list
92460713|NCT01747044|Levomilnacipran|levomilnacipran|mesh-list
92460714|NCT01747044|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92460715|NCT01747044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92460716|NCT01747044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460717|NCT01747044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460718|NCT01747044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460719|NCT01747044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460720|NCT01747044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92460722|NCT01747044|Sensory System Agents|sensory system agents|mesh-ancestor
92460723|NCT01747044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460724|NCT01747044|Antidepressive Agents|antidepressive agents|mesh-ancestor
92460725|NCT01747044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460726|NCT01747083|Metformin|metformin|mesh-list
92460727|NCT01747083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92460728|NCT01747083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460729|NCT01747135|Betadex|betadex|mesh-list
92460730|NCT01747135|Sequestering Agents|sequestering agents|mesh-ancestor
92460731|NCT01747135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460732|NCT01747148|Radavirsen|radavirsen|mesh-list
92460733|NCT01747148|Antiviral Agents|antiviral agents|mesh-ancestor
92460734|NCT01747148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460735|NCT01747161|Botulinum Toxins|botulinum toxins|mesh-list
92460736|NCT01747161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92460737|NCT01747161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460738|NCT01747161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460739|NCT01747161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92460740|NCT01747161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460741|NCT01747161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460742|NCT01747174|Adenosine|adenosine|mesh-list
92460743|NCT01747174|Nitroprusside|nitroprusside|mesh-list
92460744|NCT01747174|Analgesics|analgesics|mesh-ancestor
92460745|NCT01747174|Sensory System Agents|sensory system agents|mesh-ancestor
92460746|NCT01747174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460747|NCT01747174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460748|NCT01747174|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92460749|NCT01747174|Vasodilator Agents|vasodilator agents|mesh-ancestor
92460750|NCT01747174|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92460751|NCT01747174|Purinergic Agonists|purinergic agonists|mesh-ancestor
92460752|NCT01747174|Purinergic Agents|purinergic agents|mesh-ancestor
92460753|NCT01747174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460754|NCT01747174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460755|NCT01747174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460756|NCT01747174|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92460757|NCT01747226|Fluorides|fluorides|mesh-list
92460758|NCT01747226|Cariostatic Agents|cariostatic agents|mesh-ancestor
92460759|NCT01747226|Protective Agents|protective agents|mesh-ancestor
92460760|NCT01747226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460761|NCT01747252|Resveratrol|resveratrol|mesh-list
92460762|NCT01747252|Antioxidants|antioxidants|mesh-ancestor
92460763|NCT01747252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460764|NCT01747252|Protective Agents|protective agents|mesh-ancestor
92460765|NCT01747252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460766|NCT01747252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348138|NCT01603602|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92460767|NCT01747252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92460768|NCT01747278|Trimethoprim|trimethoprim|mesh-list
92460769|NCT01747278|Sulfamethoxazole|sulfamethoxazole|mesh-list
92460770|NCT01747278|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92460771|NCT01747278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460772|NCT01747278|Antimalarials|antimalarials|mesh-ancestor
92460773|NCT01747278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92460774|NCT01747278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92460775|NCT01747278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92460776|NCT01747278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460777|NCT01747278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460778|NCT01747278|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92460779|NCT01747278|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92460780|NCT01747278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92460781|NCT01747564|Mirabegron|mirabegron|mesh-list
92460782|NCT01747564|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92460783|NCT01747564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92460784|NCT01747564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92460785|NCT01747564|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460786|NCT01747564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460787|NCT01747564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460788|NCT01747564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460789|NCT01747564|Urological Agents|urological agents|mesh-ancestor
92460790|NCT01747590|Zolpidem|zolpidem|mesh-list
92460791|NCT01747590|Alprazolam|alprazolam|mesh-list
92460792|NCT01747590|Caffeine|caffeine|mesh-list
92460793|NCT01747590|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92460794|NCT01747590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460795|NCT01747590|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92460796|NCT01747590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460797|NCT01747590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460798|NCT01747590|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92460799|NCT01747590|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92460800|NCT01747590|Purinergic Agents|purinergic agents|mesh-ancestor
92460801|NCT01747590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460802|NCT01747590|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92460803|NCT01747590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92460804|NCT01747590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92460805|NCT01747590|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92460806|NCT01747590|GABA Agonists|gaba agonists|mesh-ancestor
92460807|NCT01747590|GABA Agents|gaba agents|mesh-ancestor
92460808|NCT01747590|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92460809|NCT01747590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92460810|NCT01747590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92460811|NCT01747590|GABA Modulators|gaba modulators|mesh-ancestor
92460812|NCT01747616|Acetylcysteine|acetylcysteine|mesh-list
92460813|NCT01747616|Chitosan|chitosan|mesh-list
92460814|NCT01747616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92460815|NCT01747616|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92460816|NCT01747616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92460817|NCT01747616|Antiviral Agents|antiviral agents|mesh-ancestor
92460818|NCT01747616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460819|NCT01747616|Expectorants|expectorants|mesh-ancestor
92460820|NCT01747616|Respiratory System Agents|respiratory system agents|mesh-ancestor
92460821|NCT01747616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92460822|NCT01747616|Antioxidants|antioxidants|mesh-ancestor
92460823|NCT01747616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460824|NCT01747616|Protective Agents|protective agents|mesh-ancestor
92460825|NCT01747616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460826|NCT01747616|Antidotes|antidotes|mesh-ancestor
92460827|NCT01747616|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92460828|NCT01747616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92460829|NCT01747616|Antimetabolites|antimetabolites|mesh-ancestor
92460830|NCT01747616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92460831|NCT01747616|Chelating Agents|chelating agents|mesh-ancestor
92460832|NCT01747616|Sequestering Agents|sequestering agents|mesh-ancestor
92460833|NCT01747616|Hemostatics|hemostatics|mesh-ancestor
92460834|NCT01747616|Coagulants|coagulants|mesh-ancestor
92460835|NCT01747642|Sorafenib|sorafenib|mesh-list
92460836|NCT01747642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460837|NCT01747642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92460838|NCT01747642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460839|NCT01747642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460840|NCT01747668|Tocopherols|tocopherols|mesh-list
92460841|NCT01747668|alpha-Tocopherol|alpha-tocopherol|mesh-list
92460842|NCT01747668|Vitamin E|vitamin e|mesh-list
92460843|NCT01747668|Vitamins|vitamins|mesh-ancestor
92460844|NCT01747668|Micronutrients|micronutrients|mesh-ancestor
92460845|NCT01747668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460846|NCT01747668|Antioxidants|antioxidants|mesh-ancestor
92460847|NCT01747668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460848|NCT01747668|Protective Agents|protective agents|mesh-ancestor
92460849|NCT01747707|Docetaxel|docetaxel|mesh-list
92460850|NCT01747707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460851|NCT01747707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92460852|NCT01747707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92460853|NCT01747707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92460854|NCT01747707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460855|NCT01747720|Vitamin D|vitamin d|mesh-list
92460856|NCT01747720|Cholecalciferol|cholecalciferol|mesh-list
92460857|NCT01747720|Vitamins|vitamins|mesh-ancestor
92460858|NCT01747720|Micronutrients|micronutrients|mesh-ancestor
92460859|NCT01747720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460860|NCT01747720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92460861|NCT01747720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460862|NCT01747746|Enoxaparin|enoxaparin|mesh-list
92460863|NCT01747746|Warfarin|warfarin|mesh-list
92460864|NCT01747746|Rivaroxaban|rivaroxaban|mesh-list
92460865|NCT01747746|Anticoagulants|anticoagulants|mesh-ancestor
92460867|NCT01747746|Antithrombins|antithrombins|mesh-ancestor
92460868|NCT01747746|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92460869|NCT01747746|Protease Inhibitors|protease inhibitors|mesh-ancestor
92460870|NCT01747746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460871|NCT01747746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460872|NCT01747746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92460873|NCT01747746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92460874|NCT01747798|Auranofin|auranofin|mesh-list
92460875|NCT01747798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460877|NCT01747993|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92460878|NCT01747993|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92460879|NCT01747993|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92460880|NCT01747993|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460881|NCT01747993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460882|NCT01747993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460883|NCT01747993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460884|NCT01747993|Urological Agents|urological agents|mesh-ancestor
92460885|NCT01748019|Namitecan|namitecan|mesh-list
92460886|NCT01748019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92460887|NCT01748019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460888|NCT01748084|Rituximab|rituximab|mesh-list
92460889|NCT01748084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92460890|NCT01748084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460891|NCT01748084|Immunologic Factors|immunologic factors|mesh-ancestor
92460892|NCT01748084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460893|NCT01748084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92460894|NCT01748123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92460895|NCT01748123|Chlorthalidone|chlorthalidone|mesh-list
92460896|NCT01748123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460897|NCT01748123|Diuretics|diuretics|mesh-ancestor
92460898|NCT01748123|Natriuretic Agents|natriuretic agents|mesh-ancestor
92460899|NCT01748123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460900|NCT01748123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92460901|NCT01748123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460902|NCT01748123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460903|NCT01748253|Amlodipine|amlodipine|mesh-list
92460904|NCT01748253|Telmisartan|telmisartan|mesh-list
92460905|NCT01748253|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92460906|NCT01748253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92460907|NCT01748253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92460908|NCT01748253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460909|NCT01748253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460910|NCT01748253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460911|NCT01748253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460912|NCT01748253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92460913|NCT01748253|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92460914|NCT01748253|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92460915|NCT01748279|Atorvastatin|atorvastatin|mesh-list
92460916|NCT01748279|Formoterol Fumarate|formoterol fumarate|mesh-list
92460918|NCT01748279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92460919|NCT01748279|Antimetabolites|antimetabolites|mesh-ancestor
92460920|NCT01748279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460921|NCT01748279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92460922|NCT01748279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92460923|NCT01748279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92460924|NCT01748279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92460925|NCT01748279|Autonomic Agents|autonomic agents|mesh-ancestor
92460926|NCT01748279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460927|NCT01748279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460928|NCT01748279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92460929|NCT01748279|Respiratory System Agents|respiratory system agents|mesh-ancestor
92460930|NCT01748279|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92460931|NCT01748279|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92460932|NCT01748279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92460933|NCT01748279|Adrenergic Agents|adrenergic agents|mesh-ancestor
92460934|NCT01748279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92460935|NCT01748318|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92460936|NCT01748318|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92460937|NCT01748318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92460938|NCT01748318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92460939|NCT01748318|Antimalarials|antimalarials|mesh-ancestor
92460940|NCT01748318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92460941|NCT01748318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92460942|NCT01748344|Cetirizine|cetirizine|mesh-list
92460943|NCT01748344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92460944|NCT01748344|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92460945|NCT01748344|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92460946|NCT01748344|Histamine Antagonists|histamine antagonists|mesh-ancestor
92460947|NCT01748344|Histamine Agents|histamine agents|mesh-ancestor
92460949|NCT01748344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460950|NCT01748344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460951|NCT01748370|Vitamin D|vitamin d|mesh-list
92460952|NCT01748370|Ergocalciferols|ergocalciferols|mesh-list
92460953|NCT01748370|Cholecalciferol|cholecalciferol|mesh-list
92460954|NCT01748370|Vitamins|vitamins|mesh-list
92460955|NCT01748370|Micronutrients|micronutrients|mesh-ancestor
92460956|NCT01748370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460957|NCT01748370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92460958|NCT01748370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460959|NCT01748396|Calcitriol|calcitriol|mesh-list
92460960|NCT01748396|Calcium Carbonate|calcium carbonate|mesh-list
92460961|NCT01748396|Calcium|calcium|mesh-list
92460962|NCT01748396|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92460963|NCT01748396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460964|NCT01748396|Antacids|antacids|mesh-ancestor
92460965|NCT01748396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92460966|NCT01748396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460967|NCT01748396|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92460968|NCT01748396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92460969|NCT01748396|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92460970|NCT01748396|Vitamins|vitamins|mesh-ancestor
92460971|NCT01748396|Micronutrients|micronutrients|mesh-ancestor
92460972|NCT01748396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92460973|NCT01748422|Capsaicin|capsaicin|mesh-list
92460974|NCT01748422|Antipruritics|antipruritics|mesh-ancestor
92460975|NCT01748422|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460976|NCT01748422|Sensory System Agents|sensory system agents|mesh-ancestor
92460977|NCT01748422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460978|NCT01748422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460979|NCT01748435|Capsaicin|capsaicin|mesh-list
92460980|NCT01748435|Antipruritics|antipruritics|mesh-ancestor
92460981|NCT01748435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92460982|NCT01748435|Sensory System Agents|sensory system agents|mesh-ancestor
92460983|NCT01748435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92460984|NCT01748435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460985|NCT01748487|Dexamethasone|dexamethasone|mesh-list
92460986|NCT01748487|Dexamethasone acetate|dexamethasone acetate|mesh-list
92460987|NCT01748487|BB 1101|bb 1101|mesh-list
92460988|NCT01748487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92460989|NCT01748487|Antiemetics|antiemetics|mesh-ancestor
92460990|NCT01748487|Autonomic Agents|autonomic agents|mesh-ancestor
92460991|NCT01748487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531563|NCT00046969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460992|NCT01748487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92460993|NCT01748487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92460994|NCT01748487|Glucocorticoids|glucocorticoids|mesh-ancestor
92460995|NCT01748487|Hormones|hormones|mesh-ancestor
92460996|NCT01748487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92460997|NCT01748487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92460998|NCT01748487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92460999|NCT01748487|Protease Inhibitors|protease inhibitors|mesh-ancestor
92461000|NCT01748487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461001|NCT01748487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461002|NCT01748500|Pantoprazole|pantoprazole|mesh-list
92461003|NCT01748500|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92461004|NCT01748500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461005|NCT01748500|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92461006|NCT01748500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461007|NCT01748500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461008|NCT01748526|Canagliflozin|canagliflozin|mesh-list
92461009|NCT01748526|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92461010|NCT01748526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461011|NCT01748526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92461012|NCT01748526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185893|NCT01829919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461013|NCT01748539|Brodalumab|brodalumab|mesh-list
92461014|NCT01748539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92461015|NCT01748630|Fentanyl|fentanyl|mesh-list
92461016|NCT01748630|Midazolam|midazolam|mesh-list
92461017|NCT01748630|Dexmedetomidine|dexmedetomidine|mesh-list
92461018|NCT01748630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92461019|NCT01748630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461020|NCT01748630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461021|NCT01748630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92461023|NCT01748630|Sensory System Agents|sensory system agents|mesh-ancestor
92461024|NCT01748630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461025|NCT01748630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92461026|NCT01748630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92461027|NCT01748630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92461028|NCT01748630|Adrenergic Agents|adrenergic agents|mesh-ancestor
92461029|NCT01748630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461030|NCT01748630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461031|NCT01748630|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461032|NCT01748630|Narcotics|narcotics|mesh-ancestor
92461033|NCT01748630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92461034|NCT01748630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461035|NCT01748630|Anesthetics, General|anesthetics, general|mesh-ancestor
92461036|NCT01748630|Anesthetics|anesthetics|mesh-ancestor
92461037|NCT01748630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92461038|NCT01748630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461039|NCT01748630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92461040|NCT01748630|GABA Modulators|gaba modulators|mesh-ancestor
92461041|NCT01748630|GABA Agents|gaba agents|mesh-ancestor
92461042|NCT01748669|Allyl sulfide|allyl sulfide|mesh-list
92461043|NCT01748669|Antioxidants|antioxidants|mesh-ancestor
92461044|NCT01748669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461045|NCT01748669|Protective Agents|protective agents|mesh-ancestor
92461046|NCT01748669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461047|NCT01748669|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92461048|NCT01748669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461049|NCT01748669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92461050|NCT01748669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461052|NCT01748721|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92461053|NCT01748721|Immunologic Factors|immunologic factors|mesh-ancestor
92348156|NCT01684722|Vitamin D|vitamin d|mesh-list
92461054|NCT01748721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461055|NCT01748747|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92461056|NCT01748747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92461057|NCT01748747|Immunologic Factors|immunologic factors|mesh-ancestor
92461058|NCT01748747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461059|NCT01748773|Capecitabine|capecitabine|mesh-list
92461060|NCT01748773|Oxaliplatin|oxaliplatin|mesh-list
92461061|NCT01748773|Trastuzumab|trastuzumab|mesh-list
92461062|NCT01748773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92461063|NCT01748773|Antimetabolites|antimetabolites|mesh-ancestor
92461064|NCT01748773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461065|NCT01748773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531564|NCT00001805|Rituximab|rituximab|mesh-list
92461066|NCT01748773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92461067|NCT01748838|Mannitol|mannitol|mesh-list
92461068|NCT01748838|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92461069|NCT01748838|Diuretics|diuretics|mesh-ancestor
92461070|NCT01748838|Natriuretic Agents|natriuretic agents|mesh-ancestor
92461071|NCT01748838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461072|NCT01748929|Albendazole|albendazole|mesh-list
92461073|NCT01748929|Anthelmintics|anthelmintics|mesh-ancestor
92461074|NCT01748929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92461075|NCT01748929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461076|NCT01748929|Anticestodal Agents|anticestodal agents|mesh-ancestor
92461077|NCT01748929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92461078|NCT01748929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92461079|NCT01748929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92461080|NCT01748929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92461081|NCT01748929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92461082|NCT01748929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461083|NCT01748929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461084|NCT01749072|Vinorelbine|vinorelbine|mesh-list
92461085|NCT01749072|Ifosfamide|ifosfamide|mesh-list
92461086|NCT01749072|Gefitinib|gefitinib|mesh-list
92461087|NCT01749072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92461088|NCT01749072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185967|NCT01786239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92461089|NCT01749072|Tubulin Modulators|tubulin modulators|mesh-ancestor
92461090|NCT01749072|Antimitotic Agents|antimitotic agents|mesh-ancestor
92461091|NCT01749072|Mitosis Modulators|mitosis modulators|mesh-ancestor
92461092|NCT01749072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461093|NCT01749072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92461094|NCT01749072|Alkylating Agents|alkylating agents|mesh-ancestor
92461095|NCT01749072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92461096|NCT01749072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461097|NCT01749085|Ketoconazole|ketoconazole|mesh-list
92461098|NCT01749085|Antifungal Agents|antifungal agents|mesh-ancestor
92461099|NCT01749085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461100|NCT01749085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92461101|NCT01749085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92461102|NCT01749085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461103|NCT01749085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461104|NCT01749085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92461105|NCT01749085|Hormone Antagonists|hormone antagonists|mesh-ancestor
92461106|NCT01749085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461107|NCT01749085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461108|NCT01749085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92461109|NCT01749098|Ketamine|ketamine|mesh-list
92461110|NCT01749098|Analgesics|analgesics|mesh-ancestor
92461111|NCT01749098|Sensory System Agents|sensory system agents|mesh-ancestor
92461112|NCT01749098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461113|NCT01749098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461114|NCT01749098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92461115|NCT01749098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461116|NCT01749098|Anesthetics, General|anesthetics, general|mesh-ancestor
92461117|NCT01749098|Anesthetics|anesthetics|mesh-ancestor
92461118|NCT01749098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461119|NCT01749098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92461120|NCT01749098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92348157|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
92461121|NCT01749098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461122|NCT01749098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461123|NCT01749111|Cyclophosphamide|cyclophosphamide|mesh-list
92461124|NCT01749111|Methotrexate|methotrexate|mesh-list
92461125|NCT01749111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92461126|NCT01749111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92461127|NCT01749111|Immunologic Factors|immunologic factors|mesh-ancestor
92461128|NCT01749111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461129|NCT01749111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461130|NCT01749111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92461131|NCT01749111|Alkylating Agents|alkylating agents|mesh-ancestor
92461132|NCT01749111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461133|NCT01749111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461134|NCT01749111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92461135|NCT01749111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92461136|NCT01749111|Abortifacient Agents|abortifacient agents|mesh-ancestor
92461137|NCT01749111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92461138|NCT01749111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92461139|NCT01749111|Antimetabolites|antimetabolites|mesh-ancestor
92461140|NCT01749111|Dermatologic Agents|dermatologic agents|mesh-ancestor
92461141|NCT01749111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461142|NCT01749111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92461143|NCT01749111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92461144|NCT01749150|Ritonavir|ritonavir|mesh-list
92461145|NCT01749150|Ribavirin|ribavirin|mesh-list
92461146|NCT01749150|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92461147|NCT01749150|Interferon-alpha|interferon-alpha|mesh-list
92461148|NCT01749150|Lactams|lactams|mesh-list
92461149|NCT01749150|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92461150|NCT01749150|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92461151|NCT01749150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92461152|NCT01749150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461153|NCT01749150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461154|NCT01749150|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92461155|NCT01749150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92461156|NCT01749150|Antiviral Agents|antiviral agents|mesh-ancestor
92461157|NCT01749150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461158|NCT01749150|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92461159|NCT01749150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92461160|NCT01749150|Antimetabolites|antimetabolites|mesh-ancestor
92461161|NCT01749150|Immunologic Factors|immunologic factors|mesh-ancestor
92461162|NCT01749150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461163|NCT01749150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92461165|NCT01749228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92461166|NCT01749228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92461167|NCT01749228|Analgesics|analgesics|mesh-ancestor
92461168|NCT01749228|Sensory System Agents|sensory system agents|mesh-ancestor
92461169|NCT01749228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461170|NCT01749228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461171|NCT01749228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92461172|NCT01749228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461173|NCT01749228|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92461174|NCT01749228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92461175|NCT01749228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461176|NCT01749228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461177|NCT01749241|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92461178|NCT01749241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92461180|NCT01749319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92461181|NCT01749319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461182|NCT01749319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92461183|NCT01749319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461184|NCT01749319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92461185|NCT01749319|GABA Agonists|gaba agonists|mesh-ancestor
92461186|NCT01749319|GABA Agents|gaba agents|mesh-ancestor
92461187|NCT01749319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348163|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92461188|NCT01749319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461189|NCT01749371|Vitamins|vitamins|mesh-list
92461190|NCT01749371|Vitamin E|vitamin e|mesh-list
92461191|NCT01749371|Tocopherols|tocopherols|mesh-list
92461192|NCT01749371|Tocotrienols|tocotrienols|mesh-list
92461193|NCT01749371|alpha-Tocopherol|alpha-tocopherol|mesh-list
92461194|NCT01749371|Micronutrients|micronutrients|mesh-ancestor
92461195|NCT01749371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461196|NCT01749371|Antioxidants|antioxidants|mesh-ancestor
92461197|NCT01749371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461198|NCT01749371|Protective Agents|protective agents|mesh-ancestor
92461199|NCT01749384|Bevacizumab|bevacizumab|mesh-list
92461200|NCT01749384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92461201|NCT01749384|Endothelial Growth Factors|endothelial growth factors|mesh-list
92461202|NCT01749384|Antibodies|antibodies|mesh-list
92461203|NCT01749384|Immunoglobulins|immunoglobulins|mesh-list
92461204|NCT01749384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92461205|NCT01749384|Immunoglobulin G|immunoglobulin g|mesh-list
92461206|NCT01749384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461207|NCT01749384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92461208|NCT01749384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92461209|NCT01749384|Growth Substances|growth substances|mesh-ancestor
92461210|NCT01749384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461211|NCT01749384|Growth Inhibitors|growth inhibitors|mesh-ancestor
92461212|NCT01749384|Immunologic Factors|immunologic factors|mesh-ancestor
92461213|NCT01749397|Fluorouracil|fluorouracil|mesh-list
92461215|NCT01749397|Veliparib|veliparib|mesh-list
92461216|NCT01749397|Deoxyuridine|deoxyuridine|mesh-list
92461217|NCT01749397|Antimetabolites|antimetabolites|mesh-ancestor
92461218|NCT01749397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461219|NCT01749397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92461220|NCT01749397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461221|NCT01749397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92461222|NCT01749397|Immunologic Factors|immunologic factors|mesh-ancestor
92461223|NCT01749397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461224|NCT01749397|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92461225|NCT01749397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461226|NCT01749423|Botulinum Toxins|botulinum toxins|mesh-list
92461227|NCT01749423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92461228|NCT01749423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92461229|NCT01749423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92461230|NCT01749423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461231|NCT01749423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461232|NCT01749423|Cholinergic Agents|cholinergic agents|mesh-ancestor
92461233|NCT01749423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461234|NCT01749423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461235|NCT01749423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92461236|NCT01749423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461237|NCT01749475|Midazolam|midazolam|mesh-list
92461238|NCT01749475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92461239|NCT01749475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92461240|NCT01749475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461241|NCT01749475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461242|NCT01749475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92461243|NCT01749475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461244|NCT01749475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92461245|NCT01749475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461248|NCT01749475|GABA Modulators|gaba modulators|mesh-ancestor
92461249|NCT01749475|GABA Agents|gaba agents|mesh-ancestor
92461250|NCT01749475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461251|NCT01749475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461252|NCT01749514|Luspatercept|luspatercept|mesh-list
92461253|NCT01749514|Hematinics|hematinics|mesh-ancestor
92461254|NCT01749540|Luspatercept|luspatercept|mesh-list
92461255|NCT01749540|Hematinics|hematinics|mesh-ancestor
92461256|NCT01749566|Maraviroc|maraviroc|mesh-list
92461257|NCT01749566|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92461258|NCT01749566|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92461259|NCT01749566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461260|NCT01749566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92461261|NCT01749566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92461262|NCT01749566|Antiviral Agents|antiviral agents|mesh-ancestor
92461263|NCT01749566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461264|NCT01749566|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92461265|NCT01749579|Fentanyl|fentanyl|mesh-list
92461266|NCT01749579|Midazolam|midazolam|mesh-list
92461267|NCT01749579|Propofol|propofol|mesh-list
92461268|NCT01749579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92461269|NCT01749579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461270|NCT01749579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461271|NCT01749579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461272|NCT01749579|Anesthetics, General|anesthetics, general|mesh-ancestor
92461273|NCT01749579|Anesthetics|anesthetics|mesh-ancestor
92461274|NCT01749579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461275|NCT01749579|Narcotics|narcotics|mesh-ancestor
92461276|NCT01749579|Analgesics|analgesics|mesh-ancestor
92461277|NCT01749579|Sensory System Agents|sensory system agents|mesh-ancestor
92461278|NCT01749579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461279|NCT01749579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92461280|NCT01749579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92461281|NCT01749579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461282|NCT01749579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92461283|NCT01749579|GABA Modulators|gaba modulators|mesh-ancestor
92461284|NCT01749579|GABA Agents|gaba agents|mesh-ancestor
92461285|NCT01749579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461286|NCT01749579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461287|NCT01750060|Fentanyl|fentanyl|mesh-list
92461288|NCT01750060|Naltrexone|naltrexone|mesh-list
92461289|NCT01750060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461290|NCT01750060|Narcotics|narcotics|mesh-ancestor
92461291|NCT01750060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461292|NCT01750060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461293|NCT01750060|Analgesics|analgesics|mesh-ancestor
92461294|NCT01750060|Sensory System Agents|sensory system agents|mesh-ancestor
92461295|NCT01750060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461296|NCT01750060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92461297|NCT01750060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461298|NCT01750060|Anesthetics, General|anesthetics, general|mesh-ancestor
92461299|NCT01750060|Anesthetics|anesthetics|mesh-ancestor
92461300|NCT01750060|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92461301|NCT01750060|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92461302|NCT01750099|Lidocaine|lidocaine|mesh-list
92461303|NCT01750099|Epinephrine|epinephrine|mesh-list
92461304|NCT01750099|Fentanyl|fentanyl|mesh-list
92461305|NCT01750099|Bupivacaine|bupivacaine|mesh-list
92461306|NCT01750099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92461307|NCT01750099|Anesthetics|anesthetics|mesh-ancestor
92461308|NCT01750099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461309|NCT01750099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461310|NCT01750099|Sensory System Agents|sensory system agents|mesh-ancestor
92461311|NCT01750099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461312|NCT01750099|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92461313|NCT01750099|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92461314|NCT01750099|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92461315|NCT01750099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461316|NCT01750099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461317|NCT01750099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461318|NCT01750099|Narcotics|narcotics|mesh-ancestor
92461319|NCT01750099|Analgesics|analgesics|mesh-ancestor
92461320|NCT01750099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92461321|NCT01750099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461322|NCT01750099|Anesthetics, General|anesthetics, general|mesh-ancestor
92461323|NCT01750099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92461324|NCT01750099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92461326|NCT01750099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461327|NCT01750099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92461328|NCT01750099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92461329|NCT01750099|Autonomic Agents|autonomic agents|mesh-ancestor
92461330|NCT01750099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92461331|NCT01750099|Respiratory System Agents|respiratory system agents|mesh-ancestor
92461332|NCT01750099|Mydriatics|mydriatics|mesh-ancestor
92461333|NCT01750099|Sympathomimetics|sympathomimetics|mesh-ancestor
92461334|NCT01750099|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92461335|NCT01750359|Curcumin|curcumin|mesh-list
92348179|NCT01592292|Analgesics|analgesics|mesh-ancestor
92461336|NCT01750359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92461337|NCT01750359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92461338|NCT01750359|Analgesics|analgesics|mesh-ancestor
92461339|NCT01750359|Sensory System Agents|sensory system agents|mesh-ancestor
92461340|NCT01750359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461341|NCT01750359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461342|NCT01750359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92461343|NCT01750359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461344|NCT01750359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461345|NCT01750359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461346|NCT01750359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461347|NCT01750385|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92461348|NCT01750385|Cephalosporins|cephalosporins|mesh-list
92461349|NCT01750385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461350|NCT01750437|Esomeprazole|esomeprazole|mesh-list
92461351|NCT01750437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92461352|NCT01750437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461353|NCT01750437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92461354|NCT01750437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461355|NCT01750437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461356|NCT01750463|Chrysarobin|chrysarobin|mesh-list
92461357|NCT01750463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92461358|NCT01750463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92461359|NCT01750463|Analgesics|analgesics|mesh-ancestor
92461360|NCT01750463|Sensory System Agents|sensory system agents|mesh-ancestor
92461361|NCT01750463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461362|NCT01750463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461363|NCT01750463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92461364|NCT01750463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461365|NCT01750476|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92461366|NCT01750476|Medroxyprogesterone|medroxyprogesterone|mesh-list
92461367|NCT01750476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92461368|NCT01750476|Contraceptive Agents|contraceptive agents|mesh-ancestor
92461369|NCT01750476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92461370|NCT01750476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461371|NCT01750476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92461372|NCT01750476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92461373|NCT01750476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92461374|NCT01750476|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92461375|NCT01750476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92461376|NCT01750476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461377|NCT01750476|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92461378|NCT01750541|Valproic Acid|valproic acid|mesh-list
92461379|NCT01750541|Haloperidol|haloperidol|mesh-list
92461380|NCT01750541|Haloperidol decanoate|haloperidol decanoate|mesh-list
92461381|NCT01750541|Antiemetics|antiemetics|mesh-ancestor
92461382|NCT01750541|Autonomic Agents|autonomic agents|mesh-ancestor
92461383|NCT01750541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461384|NCT01750541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461385|NCT01750541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461386|NCT01750541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92461387|NCT01750541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461388|NCT01750541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461389|NCT01750541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92461390|NCT01750541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92461391|NCT01750541|Dopamine Agents|dopamine agents|mesh-ancestor
92461392|NCT01750541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461393|NCT01750541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461394|NCT01750541|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92461395|NCT01750541|Anticonvulsants|anticonvulsants|mesh-ancestor
92461396|NCT01750541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461397|NCT01750541|GABA Agents|gaba agents|mesh-ancestor
92461398|NCT01750541|Antimanic Agents|antimanic agents|mesh-ancestor
92461399|NCT01750580|Ipilimumab|ipilimumab|mesh-list
92461400|NCT01750580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92461401|NCT01750580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461402|NCT01750580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92461403|NCT01750580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461404|NCT01750645|Botulinum Toxins|botulinum toxins|mesh-list
92461405|NCT01750645|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92348183|NCT01565850|Darunavir|darunavir|mesh-list
92461406|NCT01750645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461407|NCT01750645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461408|NCT01750645|Cholinergic Agents|cholinergic agents|mesh-ancestor
92461409|NCT01750645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461410|NCT01750645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461411|NCT01750723|Acetazolamide|acetazolamide|mesh-list
92461412|NCT01750723|Anticonvulsants|anticonvulsants|mesh-ancestor
92461413|NCT01750723|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92461414|NCT01750723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461415|NCT01750723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461416|NCT01750723|Diuretics|diuretics|mesh-ancestor
92461417|NCT01750723|Natriuretic Agents|natriuretic agents|mesh-ancestor
92461418|NCT01750723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461419|NCT01750762|Lenalidomide|lenalidomide|mesh-list
92461420|NCT01750762|Immunologic Factors|immunologic factors|mesh-ancestor
92461421|NCT01750762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461422|NCT01750762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92461423|NCT01750762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92461424|NCT01750762|Growth Substances|growth substances|mesh-ancestor
92461425|NCT01750762|Growth Inhibitors|growth inhibitors|mesh-ancestor
92461426|NCT01750762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461427|NCT01750788|Rivaroxaban|rivaroxaban|mesh-list
92461428|NCT01750788|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92461429|NCT01750788|Antithrombins|antithrombins|mesh-ancestor
92461430|NCT01750788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92461431|NCT01750788|Protease Inhibitors|protease inhibitors|mesh-ancestor
92461432|NCT01750788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461433|NCT01750788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461434|NCT01750788|Anticoagulants|anticoagulants|mesh-ancestor
92461435|NCT01750801|Chlorhexidine|chlorhexidine|mesh-list
92461436|NCT01750801|Propolis|propolis|mesh-list
92461437|NCT01750801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92461438|NCT01750801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461439|NCT01750801|Disinfectants|disinfectants|mesh-ancestor
92461440|NCT01750866|Prednisone|prednisone|mesh-list
92461441|NCT01750866|Lenograstim|lenograstim|mesh-list
92461442|NCT01750866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92461443|NCT01750866|Glucocorticoids|glucocorticoids|mesh-ancestor
92461444|NCT01750866|Hormones|hormones|mesh-ancestor
92461445|NCT01750866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461446|NCT01750866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461447|NCT01750866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92461448|NCT01750866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461449|NCT01750866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92461450|NCT01750866|Immunologic Factors|immunologic factors|mesh-ancestor
92461451|NCT01750983|Lenalidomide|lenalidomide|mesh-list
92461452|NCT01750983|Ipilimumab|ipilimumab|mesh-list
92461453|NCT01750983|Immunologic Factors|immunologic factors|mesh-ancestor
92461454|NCT01750983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461455|NCT01750983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92461456|NCT01750983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92461457|NCT01750983|Growth Substances|growth substances|mesh-ancestor
92461458|NCT01750983|Growth Inhibitors|growth inhibitors|mesh-ancestor
92461459|NCT01750983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461460|NCT01750983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92461461|NCT01750983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92461462|NCT01750983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461463|NCT01751009|Vitamins|vitamins|mesh-list
92461464|NCT01751009|Vitamin A|vitamin a|mesh-list
92461465|NCT01751009|Retinol palmitate|retinol palmitate|mesh-list
92461466|NCT01751009|Micronutrients|micronutrients|mesh-ancestor
92461467|NCT01751009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461468|NCT01751009|Antioxidants|antioxidants|mesh-ancestor
92461469|NCT01751009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461470|NCT01751009|Protective Agents|protective agents|mesh-ancestor
92461471|NCT01751009|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92461472|NCT01751009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461473|NCT01751074|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92461474|NCT01751074|Darapladib|darapladib|mesh-list
92461475|NCT01751074|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92461477|NCT01751074|Antimetabolites|antimetabolites|mesh-ancestor
92461478|NCT01751074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461479|NCT01751074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92461480|NCT01751074|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92461481|NCT01751074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461482|NCT01751074|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92461483|NCT01751204|Calcium, Dietary|calcium, dietary|mesh-list
92461484|NCT01751204|Calcium|calcium|mesh-list
92461485|NCT01751204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92461486|NCT01751204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461487|NCT01751204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92461488|NCT01751269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92461489|NCT01751269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461490|NCT01751269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461491|NCT01751269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92461492|NCT01751269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461493|NCT01751295|Atorvastatin|atorvastatin|mesh-list
92461494|NCT01751295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92461495|NCT01751295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92461496|NCT01751295|Antimetabolites|antimetabolites|mesh-ancestor
92461497|NCT01751295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461498|NCT01751295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92461499|NCT01751295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92461500|NCT01751295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461501|NCT01751321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92461502|NCT01751321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92461503|NCT01751321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461504|NCT01751321|Incretins|incretins|mesh-ancestor
92461505|NCT01751321|Hormones|hormones|mesh-ancestor
92461506|NCT01751321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461507|NCT01751321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92461508|NCT01751321|Protease Inhibitors|protease inhibitors|mesh-ancestor
92461509|NCT01751321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461510|NCT01751321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461511|NCT01751347|Lidocaine|lidocaine|mesh-list
92461512|NCT01751347|Bupivacaine|bupivacaine|mesh-list
92461513|NCT01751347|Anesthetics, Local|anesthetics, local|mesh-ancestor
92461514|NCT01751347|Anesthetics|anesthetics|mesh-ancestor
92461515|NCT01751347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461516|NCT01751347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461517|NCT01751347|Sensory System Agents|sensory system agents|mesh-ancestor
92461518|NCT01751347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461519|NCT01751347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92461520|NCT01751347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92461521|NCT01751347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92461522|NCT01751347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461523|NCT01751347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461524|NCT01751373|Botulinum Toxins|botulinum toxins|mesh-list
92461525|NCT01751373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92461526|NCT01751373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92461527|NCT01751373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461528|NCT01751373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461529|NCT01751373|Cholinergic Agents|cholinergic agents|mesh-ancestor
92461530|NCT01751373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461531|NCT01751373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461532|NCT01751373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92461533|NCT01751373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461534|NCT01751763|Sorafenib|sorafenib|mesh-list
92461535|NCT01751763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461536|NCT01751763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92461537|NCT01751763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461538|NCT01751763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461539|NCT01751828|Sertraline|sertraline|mesh-list
92461540|NCT01751828|Antidepressive Agents|antidepressive agents|mesh-ancestor
92461542|NCT01751828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92461543|NCT01751828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92461544|NCT01751828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461545|NCT01751828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461546|NCT01751828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461548|NCT01751828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461549|NCT01751854|Escitalopram|escitalopram|mesh-list
92461550|NCT01751854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92461551|NCT01751854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92461552|NCT01751854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348187|NCT01565850|Antiviral Agents|antiviral agents|mesh-ancestor
92461553|NCT01751854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461554|NCT01751854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461555|NCT01751854|Serotonin Agents|serotonin agents|mesh-ancestor
92461556|NCT01751854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461557|NCT01751919|Imatinib Mesylate|imatinib mesylate|mesh-list
92461558|NCT01751919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461559|NCT01751919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92461560|NCT01751919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461561|NCT01751919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461562|NCT01752010|Immunologic Factors|immunologic factors|mesh-list
92461563|NCT01752010|Immunomodulating Agents|immunomodulating agents|mesh-list
92461564|NCT01752010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461565|NCT01752075|Lenalidomide|lenalidomide|mesh-list
92461566|NCT01752075|Immunologic Factors|immunologic factors|mesh-ancestor
92461567|NCT01752075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461568|NCT01752075|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92461569|NCT01752075|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92461570|NCT01752075|Growth Substances|growth substances|mesh-ancestor
92461571|NCT01752075|Growth Inhibitors|growth inhibitors|mesh-ancestor
92461572|NCT01752075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461573|NCT01752153|Silymarin|silymarin|mesh-list
92461574|NCT01752153|Deferoxamine|deferoxamine|mesh-list
92461575|NCT01752153|Antioxidants|antioxidants|mesh-ancestor
92461576|NCT01752153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461577|NCT01752153|Protective Agents|protective agents|mesh-ancestor
92461578|NCT01752153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461579|NCT01752153|Siderophores|siderophores|mesh-ancestor
92461580|NCT01752153|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92461581|NCT01752153|Chelating Agents|chelating agents|mesh-ancestor
92461582|NCT01752153|Sequestering Agents|sequestering agents|mesh-ancestor
92461583|NCT01752205|Paclitaxel|paclitaxel|mesh-list
92461584|NCT01752205|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92461585|NCT01752205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92461586|NCT01752205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461587|NCT01752205|Tubulin Modulators|tubulin modulators|mesh-ancestor
92461588|NCT01752205|Antimitotic Agents|antimitotic agents|mesh-ancestor
92461590|NCT01752205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461591|NCT01752205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92461592|NCT01752205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461593|NCT01752244|Alfacalcidol|alfacalcidol|mesh-list
92461594|NCT01752244|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92461595|NCT01752244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92461596|NCT01752244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461597|NCT01752244|Vitamins|vitamins|mesh-ancestor
92461598|NCT01752244|Micronutrients|micronutrients|mesh-ancestor
92461599|NCT01752270|Cyproterone Acetate|cyproterone acetate|mesh-list
92461600|NCT01752270|Cyproterone|cyproterone|mesh-list
92461601|NCT01752270|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
92461602|NCT01752270|Androgen Antagonists|androgen antagonists|mesh-ancestor
92461603|NCT01752270|Hormone Antagonists|hormone antagonists|mesh-ancestor
92461604|NCT01752270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461605|NCT01752270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461606|NCT01752270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461607|NCT01752270|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92461608|NCT01752270|Contraceptive Agents|contraceptive agents|mesh-ancestor
92461609|NCT01752270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92461610|NCT01752322|Lidocaine|lidocaine|mesh-list
92461611|NCT01752322|Anesthetics, Local|anesthetics, local|mesh-ancestor
92461612|NCT01752322|Anesthetics|anesthetics|mesh-ancestor
92186497|NCT01727193|Azathioprine|azathioprine|mesh-list
92461613|NCT01752322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461614|NCT01752322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461616|NCT01752322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461617|NCT01752322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92461618|NCT01752322|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92461619|NCT01752322|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92461620|NCT01752322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461621|NCT01752322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461622|NCT01752517|Vinorelbine|vinorelbine|mesh-list
92461623|NCT01752517|Ifosfamide|ifosfamide|mesh-list
92461624|NCT01752517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92461625|NCT01752517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461626|NCT01752517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92461627|NCT01752517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92461628|NCT01752517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92461629|NCT01752517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461630|NCT01752517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92461631|NCT01752517|Alkylating Agents|alkylating agents|mesh-ancestor
92461632|NCT01752543|Conivaptan|conivaptan|mesh-list
92461633|NCT01752543|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92461634|NCT01752543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461635|NCT01752543|Natriuretic Agents|natriuretic agents|mesh-ancestor
92461636|NCT01752543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461637|NCT01752686|Carboplatin|carboplatin|mesh-list
92461638|NCT01752686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461639|NCT01752699|Methadone|methadone|mesh-list
92461640|NCT01752699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461641|NCT01752699|Narcotics|narcotics|mesh-ancestor
92461642|NCT01752699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461643|NCT01752699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461644|NCT01752699|Analgesics|analgesics|mesh-ancestor
92461645|NCT01752699|Sensory System Agents|sensory system agents|mesh-ancestor
92461646|NCT01752699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461647|NCT01752699|Antitussive Agents|antitussive agents|mesh-ancestor
92461648|NCT01752699|Respiratory System Agents|respiratory system agents|mesh-ancestor
92461649|NCT01752790|Azathioprine|azathioprine|mesh-list
92461650|NCT01752790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461651|NCT01752790|Antimetabolites|antimetabolites|mesh-ancestor
92461652|NCT01752790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461653|NCT01752790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92461654|NCT01752790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461655|NCT01752790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92461656|NCT01752790|Immunologic Factors|immunologic factors|mesh-ancestor
92461657|NCT01752790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461658|NCT01752881|Vaccines|vaccines|mesh-list
92461659|NCT01752881|Immunologic Factors|immunologic factors|mesh-ancestor
92461660|NCT01752881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461661|NCT01752959|Remifentanil|remifentanil|mesh-list
92461663|NCT01752959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461664|NCT01752959|Narcotics|narcotics|mesh-ancestor
92461665|NCT01752959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461666|NCT01752959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461667|NCT01752959|Analgesics|analgesics|mesh-ancestor
92461668|NCT01752959|Sensory System Agents|sensory system agents|mesh-ancestor
92461669|NCT01752959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461670|NCT01752959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92461671|NCT01752959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92461672|NCT01752959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92461673|NCT01752959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92461674|NCT01752959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461675|NCT01752959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461676|NCT01752998|Analgesics, Opioid|analgesics, opioid|mesh-list
92461677|NCT01752998|Narcotics|narcotics|mesh-ancestor
92461678|NCT01752998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461679|NCT01752998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461680|NCT01752998|Analgesics|analgesics|mesh-ancestor
92461681|NCT01752998|Sensory System Agents|sensory system agents|mesh-ancestor
92461682|NCT01752998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461683|NCT01753037|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92461684|NCT01753037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92461685|NCT01753037|Immunologic Factors|immunologic factors|mesh-ancestor
92461686|NCT01753037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461687|NCT01753102|Estradiol|estradiol|mesh-list
92461688|NCT01753102|Estrogens|estrogens|mesh-ancestor
92461689|NCT01753102|Hormones|hormones|mesh-ancestor
92461690|NCT01753102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461691|NCT01753102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461692|NCT01753128|Imipramine|imipramine|mesh-list
92461693|NCT01753128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92461694|NCT01753128|Antidepressive Agents|antidepressive agents|mesh-ancestor
92461695|NCT01753128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92129418|NCT04645602|Pembrolizumab|pembrolizumab|mesh-list
92461696|NCT01753128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92461697|NCT01753128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92461698|NCT01753128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461699|NCT01753128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461700|NCT01753128|Adrenergic Agents|adrenergic agents|mesh-ancestor
92461701|NCT01753128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461702|NCT01753128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461703|NCT01753154|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92461704|NCT01753349|Botulinum Toxins|botulinum toxins|mesh-list
92461705|NCT01753349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92461706|NCT01753349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92461707|NCT01753349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92461708|NCT01753349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461709|NCT01753349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461710|NCT01753349|Cholinergic Agents|cholinergic agents|mesh-ancestor
92461711|NCT01753349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461712|NCT01753349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461713|NCT01753349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92461714|NCT01753349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461715|NCT01753375|Vitamin D|vitamin d|mesh-list
92461716|NCT01753375|Cholecalciferol|cholecalciferol|mesh-list
92461717|NCT01753375|Vitamins|vitamins|mesh-ancestor
92461718|NCT01753375|Micronutrients|micronutrients|mesh-ancestor
92461719|NCT01753375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461720|NCT01753375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92461721|NCT01753375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92461722|NCT01753453|Plerixafor|plerixafor|mesh-list
92461723|NCT01753453|Lenograstim|lenograstim|mesh-list
92461724|NCT01753453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92461725|NCT01753453|Immunologic Factors|immunologic factors|mesh-ancestor
92461726|NCT01753453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461727|NCT01753453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92461728|NCT01753453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92461729|NCT01753453|Antiviral Agents|antiviral agents|mesh-ancestor
92461730|NCT01753453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461731|NCT01753596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92461732|NCT01753596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92461733|NCT01753752|Acetylcysteine|acetylcysteine|mesh-list
92461734|NCT01753752|Chitosan|chitosan|mesh-list
92461735|NCT01753752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92531573|NCT00047047|Antimetabolites|antimetabolites|mesh-ancestor
92461736|NCT01753752|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92461737|NCT01753752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92461738|NCT01753752|Antiviral Agents|antiviral agents|mesh-ancestor
92461739|NCT01753752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461740|NCT01753752|Expectorants|expectorants|mesh-ancestor
92461741|NCT01753752|Respiratory System Agents|respiratory system agents|mesh-ancestor
92461742|NCT01753752|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92461743|NCT01753752|Antioxidants|antioxidants|mesh-ancestor
92461744|NCT01753752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461745|NCT01753752|Protective Agents|protective agents|mesh-ancestor
92461746|NCT01753752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461747|NCT01753752|Antidotes|antidotes|mesh-ancestor
92461748|NCT01753752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92461749|NCT01753752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92461750|NCT01753752|Antimetabolites|antimetabolites|mesh-ancestor
92461751|NCT01753752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92461752|NCT01753752|Chelating Agents|chelating agents|mesh-ancestor
92461753|NCT01753752|Sequestering Agents|sequestering agents|mesh-ancestor
92461754|NCT01753752|Hemostatics|hemostatics|mesh-ancestor
92461755|NCT01753752|Coagulants|coagulants|mesh-ancestor
92461756|NCT01753882|Escitalopram|escitalopram|mesh-list
92461757|NCT01753882|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92461758|NCT01753882|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92461759|NCT01753882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92461760|NCT01753882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186649|NCT00299221|Tacrolimus|tacrolimus|mesh-list
92461761|NCT01753882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461762|NCT01753882|Serotonin Agents|serotonin agents|mesh-ancestor
92461763|NCT01753882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461764|NCT01754116|Cabotegravir|cabotegravir|mesh-list
92461765|NCT01754116|Midazolam|midazolam|mesh-list
92461766|NCT01754116|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92461767|NCT01754116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92461768|NCT01754116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461769|NCT01754116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461770|NCT01754116|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92461771|NCT01754116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461772|NCT01754116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92461773|NCT01754116|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92461774|NCT01754116|Anesthetics, General|anesthetics, general|mesh-ancestor
92461775|NCT01754116|Anesthetics|anesthetics|mesh-ancestor
92461776|NCT01754116|GABA Modulators|gaba modulators|mesh-ancestor
92461777|NCT01754116|GABA Agents|gaba agents|mesh-ancestor
92461778|NCT01754116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461779|NCT01754116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461780|NCT01754116|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92461781|NCT01754116|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92461782|NCT01754116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461783|NCT01754116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92461784|NCT01754116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92461785|NCT01754116|Antiviral Agents|antiviral agents|mesh-ancestor
92461786|NCT01754116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461787|NCT01754181|Insulin|insulin|mesh-list
92461788|NCT01754181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92461789|NCT01754181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461790|NCT01754220|Montelukast|montelukast|mesh-list
92461791|NCT01754220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92461792|NCT01754220|Respiratory System Agents|respiratory system agents|mesh-ancestor
92461793|NCT01754220|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92461794|NCT01754220|Hormone Antagonists|hormone antagonists|mesh-ancestor
92461795|NCT01754220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461796|NCT01754220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461797|NCT01754220|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92461798|NCT01754220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92461799|NCT01754220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461800|NCT01754285|Octreotide|octreotide|mesh-list
92461801|NCT01754285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461802|NCT01754285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92461803|NCT01754285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461804|NCT01754324|Methadone|methadone|mesh-list
92461805|NCT01754324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92461806|NCT01754324|Narcotics|narcotics|mesh-ancestor
92461807|NCT01754324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461808|NCT01754324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461809|NCT01754324|Analgesics|analgesics|mesh-ancestor
92461810|NCT01754324|Sensory System Agents|sensory system agents|mesh-ancestor
92461811|NCT01754324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461812|NCT01754324|Antitussive Agents|antitussive agents|mesh-ancestor
92461813|NCT01754324|Respiratory System Agents|respiratory system agents|mesh-ancestor
92461814|NCT01754649|Misoprostol|misoprostol|mesh-list
92461815|NCT01754649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92461816|NCT01754649|Abortifacient Agents|abortifacient agents|mesh-ancestor
92461817|NCT01754649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92461818|NCT01754649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461819|NCT01754649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92461820|NCT01754649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461821|NCT01754649|Oxytocics|oxytocics|mesh-ancestor
92461822|NCT01754701|Iron|iron|mesh-list
92461823|NCT01754701|Trace Elements|trace elements|mesh-ancestor
92461824|NCT01754701|Micronutrients|micronutrients|mesh-ancestor
92461825|NCT01754701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461826|NCT01754805|Methotrexate|methotrexate|mesh-list
92461827|NCT01754805|Peficitinib|peficitinib|mesh-list
92461828|NCT01754805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92461829|NCT01754805|Abortifacient Agents|abortifacient agents|mesh-ancestor
92461830|NCT01754805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92461831|NCT01754805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461832|NCT01754805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92461833|NCT01754805|Antimetabolites|antimetabolites|mesh-ancestor
92461834|NCT01754805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461835|NCT01754805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461836|NCT01754805|Dermatologic Agents|dermatologic agents|mesh-ancestor
92461837|NCT01754805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461838|NCT01754805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92461839|NCT01754805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92461840|NCT01754805|Immunologic Factors|immunologic factors|mesh-ancestor
92461841|NCT01754805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461842|NCT01754805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92461843|NCT01754831|Fluorides|fluorides|mesh-list
92461844|NCT01754831|Fluorides, Topical|fluorides, topical|mesh-list
92461845|NCT01754831|Cariostatic Agents|cariostatic agents|mesh-ancestor
92461846|NCT01754831|Protective Agents|protective agents|mesh-ancestor
92461847|NCT01754831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461848|NCT01754844|AZD7624|azd7624|mesh-list
92461849|NCT01754844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92461850|NCT01754844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461851|NCT01754844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461852|NCT01754870|Rituximab|rituximab|mesh-list
92461853|NCT01754870|Lenalidomide|lenalidomide|mesh-list
92461854|NCT01754870|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92461855|NCT01754870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92461856|NCT01754870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461857|NCT01754870|Immunologic Factors|immunologic factors|mesh-ancestor
92461858|NCT01754870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461859|NCT01754870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461860|NCT01754870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92461861|NCT01754870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92461862|NCT01754870|Growth Substances|growth substances|mesh-ancestor
92461863|NCT01754870|Growth Inhibitors|growth inhibitors|mesh-ancestor
92461864|NCT01754870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92461865|NCT01754870|Alkylating Agents|alkylating agents|mesh-ancestor
92461866|NCT01754870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461867|NCT01754883|Lithium Carbonate|lithium carbonate|mesh-list
92461868|NCT01754883|Antidepressive Agents|antidepressive agents|mesh-ancestor
92461869|NCT01754883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92461870|NCT01754883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461871|NCT01754883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461872|NCT01754883|Antimanic Agents|antimanic agents|mesh-ancestor
92461873|NCT01754883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92461874|NCT01754883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461875|NCT01754883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461876|NCT01754961|Vitamin D|vitamin d|mesh-list
92461877|NCT01754961|Ergocalciferols|ergocalciferols|mesh-list
92461878|NCT01754961|Cholecalciferol|cholecalciferol|mesh-list
92461879|NCT01754961|Vitamins|vitamins|mesh-list
92461880|NCT01754961|Micronutrients|micronutrients|mesh-ancestor
92461881|NCT01754961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461882|NCT01754961|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92461883|NCT01754961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92461884|NCT01754974|Ribavirin|ribavirin|mesh-list
92461885|NCT01754974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92461886|NCT01754974|Antimetabolites|antimetabolites|mesh-ancestor
92461887|NCT01754974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461888|NCT01754974|Antiviral Agents|antiviral agents|mesh-ancestor
92461889|NCT01754974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461890|NCT01755078|Calcium, Dietary|calcium, dietary|mesh-list
92461891|NCT01755078|Calcium Carbonate|calcium carbonate|mesh-list
92461892|NCT01755078|Calcium|calcium|mesh-list
92461893|NCT01755078|Sevelamer|sevelamer|mesh-list
92461894|NCT01755078|Calcium acetate|calcium acetate|mesh-list
92461895|NCT01755078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92461896|NCT01755078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461897|NCT01755078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92461898|NCT01755078|Antacids|antacids|mesh-ancestor
92461899|NCT01755078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461900|NCT01755078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461901|NCT01755078|Chelating Agents|chelating agents|mesh-ancestor
92461902|NCT01755078|Sequestering Agents|sequestering agents|mesh-ancestor
92461903|NCT01755117|Ropivacaine|ropivacaine|mesh-list
92461904|NCT01755117|Anesthetics, Local|anesthetics, local|mesh-ancestor
92461905|NCT01755117|Anesthetics|anesthetics|mesh-ancestor
92461906|NCT01755117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92461907|NCT01755117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461908|NCT01755117|Sensory System Agents|sensory system agents|mesh-ancestor
92461909|NCT01755117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186795|NCT04350645|Hemostatics|hemostatics|mesh-ancestor
92461910|NCT01755182|Somatostatin|somatostatin|mesh-list
92461911|NCT01755182|Hormones|hormones|mesh-ancestor
92717881|NCT02902055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461912|NCT01755182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461913|NCT01755182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461915|NCT01755286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92461916|NCT01755286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461917|NCT01755286|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92461918|NCT01755286|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92461919|NCT01755286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461920|NCT01755286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461921|NCT01755286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461922|NCT01755286|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92461923|NCT01755286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92461924|NCT01755299|Caffeine|caffeine|mesh-list
92461925|NCT01755299|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92461926|NCT01755299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461927|NCT01755299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92461928|NCT01755299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461929|NCT01755299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461930|NCT01755299|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92461931|NCT01755299|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92461932|NCT01755299|Purinergic Agents|purinergic agents|mesh-ancestor
92461933|NCT01755299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92461934|NCT01755338|Methylprednisolone|methylprednisolone|mesh-list
92461935|NCT01755338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92461936|NCT01755338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92461937|NCT01755338|Prednisolone|prednisolone|mesh-list
92461938|NCT01755338|Prednisolone acetate|prednisolone acetate|mesh-list
92461939|NCT01755338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92461940|NCT01755338|Prednisolone phosphate|prednisolone phosphate|mesh-list
92461941|NCT01755338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92461942|NCT01755338|Antiemetics|antiemetics|mesh-ancestor
92461943|NCT01755338|Autonomic Agents|autonomic agents|mesh-ancestor
92461944|NCT01755338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461945|NCT01755338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461946|NCT01755338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92461947|NCT01755338|Glucocorticoids|glucocorticoids|mesh-ancestor
92461948|NCT01755338|Hormones|hormones|mesh-ancestor
92461949|NCT01755338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461950|NCT01755338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92461951|NCT01755338|Protective Agents|protective agents|mesh-ancestor
92461952|NCT01755338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92461953|NCT01755338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92461954|NCT01755377|Benzonidazole|benzonidazole|mesh-list
92461955|NCT01755377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92461956|NCT01755377|Immunologic Factors|immunologic factors|mesh-ancestor
92461957|NCT01755377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461958|NCT01755377|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92461959|NCT01755377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92461960|NCT01755377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92461961|NCT01755377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461962|NCT01755403|Benzonidazole|benzonidazole|mesh-list
92461963|NCT01755403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92461964|NCT01755403|Immunologic Factors|immunologic factors|mesh-ancestor
92461965|NCT01755403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461966|NCT01755403|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92461967|NCT01755403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92461968|NCT01755403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92461969|NCT01755403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92461970|NCT01755468|Insulin|insulin|mesh-list
92461971|NCT01755468|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92461972|NCT01755468|Metformin|metformin|mesh-list
92461973|NCT01755468|Insulin Glargine|insulin glargine|mesh-list
92461974|NCT01755468|Insulin Lispro|insulin lispro|mesh-list
92461975|NCT01755468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92461976|NCT01755468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461977|NCT01755494|Metformin|metformin|mesh-list
92461978|NCT01755494|Saxagliptin|saxagliptin|mesh-list
92461979|NCT01755494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92461980|NCT01755494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461981|NCT01755494|Incretins|incretins|mesh-ancestor
92461982|NCT01755494|Hormones|hormones|mesh-ancestor
92461983|NCT01755494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92461984|NCT01755494|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92461985|NCT01755494|Protease Inhibitors|protease inhibitors|mesh-ancestor
92461986|NCT01755494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92461987|NCT01755494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92461989|NCT01755520|Ticagrelor|ticagrelor|mesh-list
92461990|NCT01755520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92461991|NCT01755520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92461992|NCT01755520|Analgesics|analgesics|mesh-ancestor
92461993|NCT01755520|Sensory System Agents|sensory system agents|mesh-ancestor
92461994|NCT01755520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92461995|NCT01755520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92461996|NCT01755520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92461997|NCT01755520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92461998|NCT01755520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92461999|NCT01755520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92462000|NCT01755520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462001|NCT01755520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92462002|NCT01755520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92462003|NCT01755520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462004|NCT01755520|Antipyretics|antipyretics|mesh-ancestor
92462005|NCT01755520|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92462006|NCT01755520|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92462007|NCT01755520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92462008|NCT01755520|Purinergic Agents|purinergic agents|mesh-ancestor
92462009|NCT01755520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462010|NCT01755559|Artesunate|artesunate|mesh-list
92462011|NCT01755559|Lumefantrine|lumefantrine|mesh-list
92462012|NCT01755559|Artemether|artemether|mesh-list
92462013|NCT01755559|Piperaquine|piperaquine|mesh-list
92462014|NCT01755559|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92462015|NCT01755559|Amodiaquine|amodiaquine|mesh-list
92462016|NCT01755559|Artenimol|artenimol|mesh-list
92462017|NCT01755559|Antimalarials|antimalarials|mesh-ancestor
92462018|NCT01755559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92462019|NCT01755559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92462020|NCT01755559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462021|NCT01755559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462022|NCT01755559|Antiviral Agents|antiviral agents|mesh-ancestor
92462023|NCT01755559|Schistosomicides|schistosomicides|mesh-ancestor
92462024|NCT01755559|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92462025|NCT01755559|Anthelmintics|anthelmintics|mesh-ancestor
92462026|NCT01755572|Liraglutide|liraglutide|mesh-list
92462027|NCT01755572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462028|NCT01755572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462029|NCT01755572|Incretins|incretins|mesh-ancestor
92462030|NCT01755572|Hormones|hormones|mesh-ancestor
92462031|NCT01755572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462032|NCT01755611|Minocycline|minocycline|mesh-list
92462033|NCT01755611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92462034|NCT01755611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462035|NCT01755663|Metoprolol|metoprolol|mesh-list
92462036|NCT01755663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92462037|NCT01755663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92462038|NCT01755663|Sympatholytics|sympatholytics|mesh-ancestor
92462039|NCT01755663|Autonomic Agents|autonomic agents|mesh-ancestor
92462040|NCT01755663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462041|NCT01755663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462042|NCT01755663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92462043|NCT01755663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92462044|NCT01755663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92462045|NCT01755663|Adrenergic Agents|adrenergic agents|mesh-ancestor
92462046|NCT01755663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462047|NCT01755663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462049|NCT01754792|Vitamin B Complex|vitamin b complex|mesh-ancestor
92462050|NCT01754792|Vitamins|vitamins|mesh-ancestor
92462051|NCT01754792|Micronutrients|micronutrients|mesh-ancestor
92462052|NCT01754792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462053|NCT01755676|Orlistat|orlistat|mesh-list
92462054|NCT01755676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462055|NCT01755676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462056|NCT01755676|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92462057|NCT01755676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92462058|NCT01755728|Acetaminophen|acetaminophen|mesh-list
92462059|NCT01755728|Ibuprofen|ibuprofen|mesh-list
92462060|NCT01755728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92462061|NCT01755728|Analgesics|analgesics|mesh-ancestor
92462062|NCT01755728|Sensory System Agents|sensory system agents|mesh-ancestor
92462063|NCT01755728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462064|NCT01755728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462065|NCT01755728|Antipyretics|antipyretics|mesh-ancestor
92462066|NCT01755728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92462067|NCT01755728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462068|NCT01755728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462069|NCT01755728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92462070|NCT01755728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462071|NCT01755728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462072|NCT01755845|Paclitaxel|paclitaxel|mesh-list
92462073|NCT01755845|Cisplatin|cisplatin|mesh-list
92462074|NCT01755845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92462075|NCT01755845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462076|NCT01755845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92462077|NCT01755845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92462078|NCT01755845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92462079|NCT01755845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462080|NCT01755871|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92462081|NCT01755871|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92462082|NCT01755871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462083|NCT01755871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462084|NCT01755871|Immunologic Factors|immunologic factors|mesh-ancestor
92462085|NCT01755871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462086|NCT01755884|Immunomodulating Agents|immunomodulating agents|mesh-list
92462087|NCT01755884|Immunologic Factors|immunologic factors|mesh-ancestor
92462088|NCT01755884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462089|NCT01755923|Docetaxel|docetaxel|mesh-list
92462090|NCT01755923|Gefitinib|gefitinib|mesh-list
92462091|NCT01755923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462092|NCT01755923|Tubulin Modulators|tubulin modulators|mesh-ancestor
92462093|NCT01755923|Antimitotic Agents|antimitotic agents|mesh-ancestor
92462094|NCT01755923|Mitosis Modulators|mitosis modulators|mesh-ancestor
92462095|NCT01755923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462096|NCT01755923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92462097|NCT01755923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462098|NCT01756040|Lactulose|lactulose|mesh-list
92462099|NCT01756040|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92462100|NCT01756040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92462101|NCT01756105|Insulin|insulin|mesh-list
92462102|NCT01756105|Metformin|metformin|mesh-list
92462103|NCT01756105|Insulin, Isophane|insulin, isophane|mesh-list
92462104|NCT01756105|Isophane Insulin, Human|isophane insulin, human|mesh-list
92462105|NCT01756105|Isophane insulin, beef|isophane insulin, beef|mesh-list
92462106|NCT01756105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462107|NCT01756105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462108|NCT01756131|Cabotegravir|cabotegravir|mesh-list
92462109|NCT01756131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92462110|NCT01756131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92462111|NCT01756131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462112|NCT01756131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462113|NCT01756131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92462114|NCT01756131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92462115|NCT01756131|Antiviral Agents|antiviral agents|mesh-ancestor
92462116|NCT01756131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462117|NCT01756170|Paclitaxel|paclitaxel|mesh-list
92462118|NCT01756170|Cisplatin|cisplatin|mesh-list
92462119|NCT01756170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92462120|NCT01756170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462121|NCT01756170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92462122|NCT01756170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92462123|NCT01756170|Mitosis Modulators|mitosis modulators|mesh-ancestor
92462124|NCT01756170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462125|NCT01756183|Paclitaxel|paclitaxel|mesh-list
92462126|NCT01756183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92462127|NCT01756183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462128|NCT01756183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92462129|NCT01756183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92462130|NCT01756183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92462131|NCT01756183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462132|NCT01756261|Aflibercept|aflibercept|mesh-list
92462133|NCT01756261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92462134|NCT01756261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92462135|NCT01756261|Growth Substances|growth substances|mesh-ancestor
92462136|NCT01756261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462137|NCT01756261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92462138|NCT01756261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462139|NCT01756404|Canagliflozin|canagliflozin|mesh-list
92462140|NCT01756404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92462141|NCT01756404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462142|NCT01756404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462143|NCT01756404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462144|NCT01756417|Metformin|metformin|mesh-list
92462145|NCT01756417|Canagliflozin|canagliflozin|mesh-list
92462146|NCT01756417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462147|NCT01756417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462148|NCT01756417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92462149|NCT01756417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462150|NCT01756430|Carvedilol|carvedilol|mesh-list
92462151|NCT01756430|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92462152|NCT01756430|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92462153|NCT01756430|Adrenergic Agents|adrenergic agents|mesh-ancestor
92462154|NCT01756430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462155|NCT01756430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462156|NCT01756430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462157|NCT01756430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92462158|NCT01756430|Antioxidants|antioxidants|mesh-ancestor
92462159|NCT01756430|Protective Agents|protective agents|mesh-ancestor
92462160|NCT01756430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92462161|NCT01756430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92462162|NCT01756430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92462163|NCT01756430|Vasodilator Agents|vasodilator agents|mesh-ancestor
92462164|NCT01756430|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92462165|NCT01756430|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92462166|NCT01756443|Lidocaine|lidocaine|mesh-list
92462167|NCT01756443|Epinephrine|epinephrine|mesh-list
92462168|NCT01756443|Racepinephrine|racepinephrine|mesh-list
92462169|NCT01756443|Bupivacaine|bupivacaine|mesh-list
92462170|NCT01756443|Epinephryl borate|epinephryl borate|mesh-list
92462171|NCT01756443|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462172|NCT01756443|Anesthetics|anesthetics|mesh-ancestor
92462173|NCT01756443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462174|NCT01756443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462175|NCT01756443|Sensory System Agents|sensory system agents|mesh-ancestor
92462176|NCT01756443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462177|NCT01756443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92462178|NCT01756443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92462179|NCT01756443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92462180|NCT01756443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531580|NCT04733781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462181|NCT01756443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462182|NCT01756443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92462183|NCT01756443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92462184|NCT01756443|Adrenergic Agents|adrenergic agents|mesh-ancestor
92462185|NCT01756443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462186|NCT01756443|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92462187|NCT01756443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92462188|NCT01756443|Autonomic Agents|autonomic agents|mesh-ancestor
92462189|NCT01756443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92462190|NCT01756443|Respiratory System Agents|respiratory system agents|mesh-ancestor
92462191|NCT01756443|Mydriatics|mydriatics|mesh-ancestor
92462192|NCT01756443|Sympathomimetics|sympathomimetics|mesh-ancestor
92462193|NCT01756443|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92462194|NCT01756495|Moxifloxacin|moxifloxacin|mesh-list
92462195|NCT01756495|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92462196|NCT01756495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92462197|NCT01756495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462198|NCT01756495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92462199|NCT01756495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92462200|NCT01756495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462201|NCT01756495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462202|NCT01756495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462203|NCT01756495|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92462204|NCT01756495|Contraceptive Agents|contraceptive agents|mesh-ancestor
92462205|NCT01756495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462206|NCT01756495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462207|NCT01756495|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92462208|NCT01756495|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92462209|NCT01756495|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92462210|NCT01756508|Eculizumab|eculizumab|mesh-list
92462211|NCT01756508|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92462212|NCT01756508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462213|NCT01756508|Immunologic Factors|immunologic factors|mesh-ancestor
92462214|NCT01756508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462216|NCT01756521|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92462217|NCT01756521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462218|NCT01756521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92462219|NCT01756521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92462220|NCT01756521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462221|NCT01756521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462222|NCT01756521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462223|NCT01756547|Potassium Citrate|potassium citrate|mesh-list
92462224|NCT01756547|Diuretics|diuretics|mesh-ancestor
92462225|NCT01756547|Natriuretic Agents|natriuretic agents|mesh-ancestor
92462226|NCT01756547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462227|NCT01756547|Expectorants|expectorants|mesh-ancestor
92462228|NCT01756547|Respiratory System Agents|respiratory system agents|mesh-ancestor
92462229|NCT01756612|Epoetin Alfa|epoetin alfa|mesh-list
92462230|NCT01756612|Hematinics|hematinics|mesh-ancestor
92462231|NCT01756638|Prednisolone|prednisolone|mesh-list
92462232|NCT01756638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462233|NCT01756638|Glucocorticoids|glucocorticoids|mesh-ancestor
92462234|NCT01756638|Hormones|hormones|mesh-ancestor
92462235|NCT01756638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462236|NCT01756638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462237|NCT01756638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462238|NCT01756638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462239|NCT01756651|Fentanyl|fentanyl|mesh-list
92462240|NCT01756651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92462241|NCT01756651|Narcotics|narcotics|mesh-ancestor
92462242|NCT01756651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462243|NCT01756651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462244|NCT01756651|Analgesics|analgesics|mesh-ancestor
92462245|NCT01756651|Sensory System Agents|sensory system agents|mesh-ancestor
92462246|NCT01756651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462247|NCT01756651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92462248|NCT01756651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92462249|NCT01756651|Anesthetics, General|anesthetics, general|mesh-ancestor
92462250|NCT01756651|Anesthetics|anesthetics|mesh-ancestor
92462251|NCT01756664|Sunscreening Agents|sunscreening agents|mesh-list
92462252|NCT01756664|Petrolatum|petrolatum|mesh-list
92462253|NCT01756664|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92462254|NCT01756664|Protective Agents|protective agents|mesh-ancestor
92462255|NCT01756664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462256|NCT01756664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462257|NCT01756664|Emollients|emollients|mesh-ancestor
92462258|NCT01756768|Palbociclib|palbociclib|mesh-list
92462259|NCT01756768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462260|NCT01756768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92462261|NCT01756768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462262|NCT01756768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462263|NCT01756781|Palbociclib|palbociclib|mesh-list
92462265|NCT01756781|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92462266|NCT01756781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92462267|NCT01756781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462268|NCT01756781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462269|NCT01756781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92462270|NCT01756781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92462271|NCT01756781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92462272|NCT01756781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92462273|NCT01756781|Anesthetics, General|anesthetics, general|mesh-ancestor
92462274|NCT01756781|Anesthetics|anesthetics|mesh-ancestor
92462275|NCT01756781|GABA Modulators|gaba modulators|mesh-ancestor
92462276|NCT01756781|GABA Agents|gaba agents|mesh-ancestor
92462277|NCT01756781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462278|NCT01756781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462279|NCT01756781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462280|NCT01756781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92462281|NCT01756781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462282|NCT01756989|Thalidomide|thalidomide|mesh-list
92187168|NCT05936086|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92187169|NCT05930028|Atorvastatin|atorvastatin|mesh-list
92187170|NCT05930028|Ezetimibe|ezetimibe|mesh-list
92187171|NCT05930028|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92187172|NCT05930028|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92187173|NCT05930028|Antimetabolites|antimetabolites|mesh-ancestor
92462283|NCT01756989|Celecoxib|celecoxib|mesh-list
92462284|NCT01756989|Etoposide|etoposide|mesh-list
92462285|NCT01756989|Etoposide phosphate|etoposide phosphate|mesh-list
92462286|NCT01756989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92462287|NCT01756989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462288|NCT01756989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92462289|NCT01756989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92462290|NCT01756989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462291|NCT01756989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462292|NCT01756989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92462293|NCT01756989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92462294|NCT01756989|Analgesics|analgesics|mesh-ancestor
92462295|NCT01756989|Sensory System Agents|sensory system agents|mesh-ancestor
92462296|NCT01756989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462297|NCT01756989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462298|NCT01756989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462299|NCT01756989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462300|NCT01756989|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92462301|NCT01756989|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92462302|NCT01756989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462303|NCT01756989|Immunologic Factors|immunologic factors|mesh-ancestor
92462304|NCT01756989|Leprostatic Agents|leprostatic agents|mesh-ancestor
92462305|NCT01756989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92462306|NCT01756989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462307|NCT01756989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92462308|NCT01756989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92462309|NCT01756989|Growth Substances|growth substances|mesh-ancestor
92462310|NCT01756989|Growth Inhibitors|growth inhibitors|mesh-ancestor
92462311|NCT01757015|Glycopyrrolate|glycopyrrolate|mesh-list
92462312|NCT01757015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92462313|NCT01757015|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92462314|NCT01757015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92462315|NCT01757015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92462316|NCT01757015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462317|NCT01757015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462318|NCT01757015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462319|NCT01757106|Sevoflurane|sevoflurane|mesh-list
92462320|NCT01757106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92462321|NCT01757106|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92462322|NCT01757106|Anesthetics, General|anesthetics, general|mesh-ancestor
92462323|NCT01757106|Anesthetics|anesthetics|mesh-ancestor
92462324|NCT01757106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462325|NCT01757106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462326|NCT01757236|Vancomycin|vancomycin|mesh-list
92462327|NCT01757236|Rifampin|rifampin|mesh-list
92462328|NCT01757236|Clindamycin|clindamycin|mesh-list
92462329|NCT01757236|Ceftriaxone|ceftriaxone|mesh-list
92462330|NCT01757236|Linezolid|linezolid|mesh-list
92462331|NCT01757236|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92462332|NCT01757236|Fluoroquinolones|fluoroquinolones|mesh-list
92462333|NCT01757236|Trimethoprim|trimethoprim|mesh-list
92462334|NCT01757236|Sulfamethoxazole|sulfamethoxazole|mesh-list
92462335|NCT01757236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92462336|NCT01757236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462337|NCT01757236|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92462338|NCT01757236|Antitubercular Agents|antitubercular agents|mesh-ancestor
92462339|NCT01757236|Leprostatic Agents|leprostatic agents|mesh-ancestor
92462340|NCT01757236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92462341|NCT01757236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462342|NCT01757236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462343|NCT01757236|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92462344|NCT01757236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92462345|NCT01757236|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92462346|NCT01757236|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92462347|NCT01757236|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92462348|NCT01757236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92462349|NCT01757236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92462350|NCT01757236|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92462351|NCT01757236|Antimalarials|antimalarials|mesh-ancestor
92462352|NCT01757236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92462353|NCT01757236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92462354|NCT01757236|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92462355|NCT01757236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92462356|NCT01757236|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92462357|NCT01757236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92187248|NCT05718297|Durvalumab|durvalumab|mesh-list
92462358|NCT01757249|Contraceptive Agents|contraceptive agents|mesh-list
92462359|NCT01757249|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92462360|NCT01757249|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92462361|NCT01757249|Contraceptives, Oral|contraceptives, oral|mesh-list
92462362|NCT01757249|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92462363|NCT01757249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462364|NCT01757249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462365|NCT01757249|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92462366|NCT01757249|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92462367|NCT01757249|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92462368|NCT01757249|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92462369|NCT01757249|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92462370|NCT01757249|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92462371|NCT01757249|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92462372|NCT01757262|Clopidogrel|clopidogrel|mesh-list
92462373|NCT01757262|Ticagrelor|ticagrelor|mesh-list
92462374|NCT01757262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92462375|NCT01757262|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92462376|NCT01757262|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92462377|NCT01757262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92462378|NCT01757262|Purinergic Agents|purinergic agents|mesh-ancestor
92462379|NCT01757262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462380|NCT01757262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462381|NCT01757262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462382|NCT01757366|Ginsenoside Rg3|ginsenoside rg3|mesh-list
92462383|NCT01757366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92462384|NCT01757366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462385|NCT01757431|Eculizumab|eculizumab|mesh-list
92462386|NCT01757431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92462387|NCT01757431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462388|NCT01757431|Immunologic Factors|immunologic factors|mesh-ancestor
92462389|NCT01757431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462390|NCT01757457|Abciximab|abciximab|mesh-list
92462391|NCT01757457|Anticoagulants|anticoagulants|mesh-ancestor
92462392|NCT01757457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92462393|NCT01757574|Alemtuzumab|alemtuzumab|mesh-list
92462394|NCT01757574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92462395|NCT01757574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462397|NCT01757587|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92462398|NCT01757587|Metformin|metformin|mesh-list
92462399|NCT01757587|Vildagliptin|vildagliptin|mesh-list
92462400|NCT01757587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462401|NCT01757587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462402|NCT01757587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92462403|NCT01757587|Protease Inhibitors|protease inhibitors|mesh-ancestor
92462404|NCT01757587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462405|NCT01757587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462407|NCT01757639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92462408|NCT01757639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462409|NCT01757639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92462410|NCT01757639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462411|NCT01757756|Midazolam|midazolam|mesh-list
92462412|NCT01757756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92462413|NCT01757756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92462414|NCT01757756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462415|NCT01757756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462416|NCT01757756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92462417|NCT01757756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92462418|NCT01757756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92462419|NCT01757756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92462420|NCT01757756|Anesthetics, General|anesthetics, general|mesh-ancestor
92462421|NCT01757756|Anesthetics|anesthetics|mesh-ancestor
92462422|NCT01757756|GABA Modulators|gaba modulators|mesh-ancestor
92462423|NCT01757756|GABA Agents|gaba agents|mesh-ancestor
92462424|NCT01757756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462425|NCT01757756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462426|NCT01757769|Silodosin|silodosin|mesh-list
92462427|NCT01757769|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92462428|NCT01757769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92462429|NCT01757769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92462430|NCT01757769|Adrenergic Agents|adrenergic agents|mesh-ancestor
92462431|NCT01757769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462432|NCT01757769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462433|NCT01757769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462434|NCT01757769|Urological Agents|urological agents|mesh-ancestor
92462436|NCT01757795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92462437|NCT01757795|Protective Agents|protective agents|mesh-ancestor
92462438|NCT01757795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462439|NCT01757808|Ranolazine|ranolazine|mesh-list
92462440|NCT01757808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92462441|NCT01757808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92462442|NCT01757808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462443|NCT01757860|Vitamin D|vitamin d|mesh-list
92462444|NCT01757860|Vitamins|vitamins|mesh-ancestor
92462445|NCT01757860|Micronutrients|micronutrients|mesh-ancestor
92462446|NCT01757860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462447|NCT01757860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92462448|NCT01757899|Methylprednisolone|methylprednisolone|mesh-list
92462449|NCT01757899|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92462450|NCT01757899|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92462451|NCT01757899|Prednisolone|prednisolone|mesh-list
92462452|NCT01757899|Prednisolone acetate|prednisolone acetate|mesh-list
92462453|NCT01757899|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92462454|NCT01757899|Prednisolone phosphate|prednisolone phosphate|mesh-list
92462455|NCT01757899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462456|NCT01757899|Antiemetics|antiemetics|mesh-ancestor
92462457|NCT01757899|Autonomic Agents|autonomic agents|mesh-ancestor
92462458|NCT01757899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462459|NCT01757899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462460|NCT01757899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92462461|NCT01757899|Glucocorticoids|glucocorticoids|mesh-ancestor
92462462|NCT01757899|Hormones|hormones|mesh-ancestor
92462463|NCT01757899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462464|NCT01757899|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92462465|NCT01757899|Protective Agents|protective agents|mesh-ancestor
92462466|NCT01757899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462467|NCT01757899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462468|NCT01758029|Methyltestosterone|methyltestosterone|mesh-list
92462469|NCT01758029|Testosterone|testosterone|mesh-list
92462470|NCT01758029|Testosterone undecanoate|testosterone undecanoate|mesh-list
92462471|NCT01758029|Testosterone enanthate|testosterone enanthate|mesh-list
92462472|NCT01758029|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92462473|NCT01758029|Androgens|androgens|mesh-ancestor
92462475|NCT01758029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462476|NCT01758029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462477|NCT01758029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462478|NCT01758029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462479|NCT01758029|Anabolic Agents|anabolic agents|mesh-ancestor
92462480|NCT01758094|Testosterone|testosterone|mesh-list
92462481|NCT01758094|Androgens|androgens|mesh-ancestor
92462482|NCT01758094|Hormones|hormones|mesh-ancestor
92462483|NCT01758094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462484|NCT01758094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462485|NCT01758107|Cyclosporine|cyclosporine|mesh-list
92462486|NCT01758107|Cyclosporins|cyclosporins|mesh-list
92462487|NCT01758107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462488|NCT01758107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462489|NCT01758107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462490|NCT01758107|Immunologic Factors|immunologic factors|mesh-ancestor
92462491|NCT01758107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462492|NCT01758107|Antifungal Agents|antifungal agents|mesh-ancestor
92462493|NCT01758107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462494|NCT01758107|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462495|NCT01758107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462496|NCT01758107|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92462497|NCT01758120|Prednisone|prednisone|mesh-list
92462498|NCT01758120|Cyclophosphamide|cyclophosphamide|mesh-list
92187395|NCT05507658|Tislelizumab|tislelizumab|mesh-list
92187396|NCT05507658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92187397|NCT05507658|Antimetabolites|antimetabolites|mesh-ancestor
92187398|NCT05507658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187399|NCT05507658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187400|NCT05507658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92462499|NCT01758120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462500|NCT01758120|Immunologic Factors|immunologic factors|mesh-ancestor
92462501|NCT01758120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462502|NCT01758120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462503|NCT01758120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92462504|NCT01758120|Alkylating Agents|alkylating agents|mesh-ancestor
92462505|NCT01758120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462506|NCT01758120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462507|NCT01758120|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92462508|NCT01758120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462509|NCT01758120|Glucocorticoids|glucocorticoids|mesh-ancestor
92462510|NCT01758120|Hormones|hormones|mesh-ancestor
92462511|NCT01758120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462512|NCT01758120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462513|NCT01758146|Tamoxifen|tamoxifen|mesh-list
92462514|NCT01758146|Letrozole|letrozole|mesh-list
92462515|NCT01758146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462516|NCT01758146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92462517|NCT01758146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92462518|NCT01758146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462519|NCT01758146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462520|NCT01758146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92462521|NCT01758146|Hormone Antagonists|hormone antagonists|mesh-ancestor
92462522|NCT01758146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462523|NCT01758146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462524|NCT01758146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462525|NCT01758146|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92462526|NCT01758146|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92462527|NCT01758146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92462528|NCT01758172|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92462529|NCT01758172|Plasma Substitutes|plasma substitutes|mesh-ancestor
92462530|NCT01758172|Blood Substitutes|blood substitutes|mesh-ancestor
92462531|NCT01758185|Vaccines|vaccines|mesh-list
92462532|NCT01758185|Immunologic Factors|immunologic factors|mesh-ancestor
92462533|NCT01758185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462534|NCT01758198|Methotrexate|methotrexate|mesh-list
92462535|NCT01758198|Abatacept|abatacept|mesh-list
92462536|NCT01758198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92462537|NCT01758198|Abortifacient Agents|abortifacient agents|mesh-ancestor
92462538|NCT01758198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462539|NCT01758198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462540|NCT01758198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92462541|NCT01758198|Antimetabolites|antimetabolites|mesh-ancestor
92462542|NCT01758198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462543|NCT01758198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462544|NCT01758198|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462545|NCT01758198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462546|NCT01758198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92462547|NCT01758198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462548|NCT01758198|Immunologic Factors|immunologic factors|mesh-ancestor
92462549|NCT01758198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462550|NCT01758198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92462551|NCT01758198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92462552|NCT01758198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92462553|NCT01758263|Metoprolol|metoprolol|mesh-list
92462554|NCT01758263|Nebivolol|nebivolol|mesh-list
92462555|NCT01758263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92462556|NCT01758263|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92462557|NCT01758263|Sympatholytics|sympatholytics|mesh-ancestor
92462558|NCT01758263|Autonomic Agents|autonomic agents|mesh-ancestor
92462559|NCT01758263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462560|NCT01758263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462561|NCT01758263|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92462562|NCT01758263|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92462563|NCT01758263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92462564|NCT01758263|Adrenergic Agents|adrenergic agents|mesh-ancestor
92462565|NCT01758263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462566|NCT01758263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462567|NCT01758263|Vasodilator Agents|vasodilator agents|mesh-ancestor
92462568|NCT01758263|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92462569|NCT01758263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92462570|NCT01758263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92462571|NCT01758367|Decitabine|decitabine|mesh-list
92187480|NCT05398757|Midazolam|midazolam|mesh-list
92462572|NCT01758367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92462573|NCT01758367|Antimetabolites|antimetabolites|mesh-ancestor
92462574|NCT01758367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462575|NCT01758367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462576|NCT01758367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462577|NCT01758380|Metformin|metformin|mesh-list
92462578|NCT01758380|Vildagliptin|vildagliptin|mesh-list
92462579|NCT01758380|Gliclazide|gliclazide|mesh-list
92462580|NCT01758380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462581|NCT01758380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462582|NCT01758380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92462583|NCT01758380|Protease Inhibitors|protease inhibitors|mesh-ancestor
92462584|NCT01758380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462585|NCT01758380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462586|NCT01758393|Prednisone|prednisone|mesh-list
92462587|NCT01758393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462588|NCT01758393|Glucocorticoids|glucocorticoids|mesh-ancestor
92462589|NCT01758393|Hormones|hormones|mesh-ancestor
92462590|NCT01758393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462591|NCT01758393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462592|NCT01758393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462593|NCT01758393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462594|NCT01758471|Acarbose|acarbose|mesh-list
92462595|NCT01758471|Glipizide|glipizide|mesh-list
92462596|NCT01758471|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92462597|NCT01758471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462598|NCT01758471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462599|NCT01758471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462600|NCT01758471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462601|NCT01758627|Icodextrin|icodextrin|mesh-list
92462602|NCT01758627|Dialysis Solutions|dialysis solutions|mesh-ancestor
92462603|NCT01758627|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92462604|NCT01758640|Warfarin|warfarin|mesh-list
92462605|NCT01758640|Phenindione|phenindione|mesh-list
92462606|NCT01758640|Anticoagulants|anticoagulants|mesh-ancestor
92462607|NCT01758666|Leucovorin|leucovorin|mesh-list
92462608|NCT01758666|Methotrexate|methotrexate|mesh-list
92462609|NCT01758666|Calcium|calcium|mesh-list
92462610|NCT01758666|Levoleucovorin|levoleucovorin|mesh-list
92462611|NCT01758666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92462612|NCT01758666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462613|NCT01758666|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92462614|NCT01758666|Abortifacient Agents|abortifacient agents|mesh-ancestor
92462615|NCT01758666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462616|NCT01758666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92462617|NCT01758666|Antimetabolites|antimetabolites|mesh-ancestor
92462618|NCT01758666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462619|NCT01758666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462620|NCT01758666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462621|NCT01758666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462622|NCT01758666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92462623|NCT01758666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462624|NCT01758666|Immunologic Factors|immunologic factors|mesh-ancestor
92462625|NCT01758666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462626|NCT01758666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92462627|NCT01758666|Antidotes|antidotes|mesh-ancestor
92462628|NCT01758666|Protective Agents|protective agents|mesh-ancestor
92462629|NCT01758666|Vitamin B Complex|vitamin b complex|mesh-ancestor
92462630|NCT01758666|Vitamins|vitamins|mesh-ancestor
92462631|NCT01758666|Micronutrients|micronutrients|mesh-ancestor
92462632|NCT01758744|Treprostinil|treprostinil|mesh-list
92462633|NCT01758744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92462634|NCT01758809|Bupivacaine|bupivacaine|mesh-list
92462635|NCT01758809|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462636|NCT01758809|Anesthetics|anesthetics|mesh-ancestor
92462637|NCT01758809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462638|NCT01758809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462639|NCT01758809|Sensory System Agents|sensory system agents|mesh-ancestor
92462640|NCT01758809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462641|NCT01758835|Calpastatin|calpastatin|mesh-list
92462642|NCT01758835|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92462643|NCT01758835|Protease Inhibitors|protease inhibitors|mesh-ancestor
92462644|NCT01758835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462645|NCT01758835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462646|NCT01758913|Ibuprofen|ibuprofen|mesh-list
92462647|NCT01758913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92462648|NCT01758913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92462649|NCT01758913|Analgesics|analgesics|mesh-ancestor
92462650|NCT01758913|Sensory System Agents|sensory system agents|mesh-ancestor
92462651|NCT01758913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462652|NCT01758913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462653|NCT01758913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462654|NCT01758913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462655|NCT01758913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92462656|NCT01758913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462657|NCT01758913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462658|NCT01758978|Hydrocodone|hydrocodone|mesh-list
92462659|NCT01758978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92462660|NCT01758978|Narcotics|narcotics|mesh-ancestor
92462661|NCT01758978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462662|NCT01758978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462663|NCT01758978|Analgesics|analgesics|mesh-ancestor
92462664|NCT01758978|Sensory System Agents|sensory system agents|mesh-ancestor
92462665|NCT01758978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462666|NCT01758978|Antitussive Agents|antitussive agents|mesh-ancestor
92462667|NCT01758978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92462668|NCT01759030|Rituximab|rituximab|mesh-list
92462669|NCT01759030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92462670|NCT01759030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462671|NCT01759030|Immunologic Factors|immunologic factors|mesh-ancestor
92462672|NCT01759030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462673|NCT01759030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462674|NCT01759108|Rebamipide|rebamipide|mesh-list
92462675|NCT01759108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92462676|NCT01759108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92462677|NCT01759108|Antioxidants|antioxidants|mesh-ancestor
92462678|NCT01759108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462679|NCT01759108|Protective Agents|protective agents|mesh-ancestor
92462680|NCT01759108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462681|NCT01759108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462682|NCT01759394|Maleic acid|maleic acid|mesh-list
92462684|NCT01759394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462685|NCT01759485|Vitamin D|vitamin d|mesh-list
92462686|NCT01759485|Cholecalciferol|cholecalciferol|mesh-list
92462687|NCT01759485|Vitamins|vitamins|mesh-ancestor
92462688|NCT01759485|Micronutrients|micronutrients|mesh-ancestor
92462689|NCT01759485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462690|NCT01759485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92462691|NCT01759485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92462692|NCT01759524|Lidocaine|lidocaine|mesh-list
92462693|NCT01759524|Clonidine|clonidine|mesh-list
92462694|NCT01759524|Bupivacaine|bupivacaine|mesh-list
92462695|NCT01759524|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462696|NCT01759524|Anesthetics|anesthetics|mesh-ancestor
92462697|NCT01759524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462698|NCT01759524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462699|NCT01759524|Sensory System Agents|sensory system agents|mesh-ancestor
92462700|NCT01759524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462701|NCT01759524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92462702|NCT01759524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92462703|NCT01759524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92462704|NCT01759524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92462705|NCT01759524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462706|NCT01759524|Analgesics|analgesics|mesh-ancestor
92462707|NCT01759524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92462708|NCT01759524|Sympatholytics|sympatholytics|mesh-ancestor
92462709|NCT01759524|Autonomic Agents|autonomic agents|mesh-ancestor
92462710|NCT01759524|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92462711|NCT01759524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92462712|NCT01759524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92462713|NCT01759524|Adrenergic Agents|adrenergic agents|mesh-ancestor
92462714|NCT01759524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462715|NCT01759576|Canagliflozin|canagliflozin|mesh-list
92462716|NCT01759576|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92462717|NCT01759576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462718|NCT01759576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462719|NCT01759576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462720|NCT01759589|Remifentanil|remifentanil|mesh-list
92462721|NCT01759589|Propofol|propofol|mesh-list
92462722|NCT01759589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92462723|NCT01759589|Anesthetics|anesthetics|mesh-list
92462724|NCT01759589|Sevoflurane|sevoflurane|mesh-list
92462725|NCT01759589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92462726|NCT01759589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462727|NCT01759589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462728|NCT01759589|Anesthetics, General|anesthetics, general|mesh-ancestor
92462729|NCT01759589|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92462730|NCT01759589|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92462731|NCT01759589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92462732|NCT01759589|Narcotics|narcotics|mesh-ancestor
92462733|NCT01759589|Analgesics|analgesics|mesh-ancestor
92462734|NCT01759589|Sensory System Agents|sensory system agents|mesh-ancestor
92462735|NCT01759589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462736|NCT01759706|Dexamethasone|dexamethasone|mesh-list
92462737|NCT01759706|Sufentanil|sufentanil|mesh-list
92462738|NCT01759706|Diazepam|diazepam|mesh-list
92462739|NCT01759706|Ondansetron|ondansetron|mesh-list
92462740|NCT01759706|Anesthetics|anesthetics|mesh-list
92462741|NCT01759706|Ropivacaine|ropivacaine|mesh-list
92462742|NCT01759706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462743|NCT01759706|Antiemetics|antiemetics|mesh-ancestor
92462744|NCT01759706|Autonomic Agents|autonomic agents|mesh-ancestor
92462745|NCT01759706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462746|NCT01759706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462747|NCT01759706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92462748|NCT01759706|Glucocorticoids|glucocorticoids|mesh-ancestor
92462749|NCT01759706|Hormones|hormones|mesh-ancestor
92462750|NCT01759706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462751|NCT01759706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462752|NCT01759706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462753|NCT01759706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462754|NCT01759706|Antipruritics|antipruritics|mesh-ancestor
92462755|NCT01759706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462756|NCT01759706|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92462757|NCT01759706|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92462758|NCT01759706|Serotonin Agents|serotonin agents|mesh-ancestor
92462759|NCT01759706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462760|NCT01759706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462762|NCT01759706|Narcotics|narcotics|mesh-ancestor
92462763|NCT01759706|Analgesics|analgesics|mesh-ancestor
92462764|NCT01759706|Sensory System Agents|sensory system agents|mesh-ancestor
92462765|NCT01759706|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92462766|NCT01759706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92462767|NCT01759706|Anesthetics, General|anesthetics, general|mesh-ancestor
92462768|NCT01759706|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462769|NCT01759706|Anticonvulsants|anticonvulsants|mesh-ancestor
92462770|NCT01759706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92462771|NCT01759706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92462772|NCT01759706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92462773|NCT01759706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92462774|NCT01759706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92462775|NCT01759706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92462776|NCT01759706|GABA Modulators|gaba modulators|mesh-ancestor
92462777|NCT01759706|GABA Agents|gaba agents|mesh-ancestor
92462778|NCT01759719|Chromium|chromium|mesh-list
92462779|NCT01759719|Trace Elements|trace elements|mesh-ancestor
92462780|NCT01759719|Micronutrients|micronutrients|mesh-ancestor
92462781|NCT01759719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462782|NCT01759732|Cyclophosphamide|cyclophosphamide|mesh-list
92187693|NCT05125224|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92187694|NCT05125224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187695|NCT05125224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187696|NCT05104723|Tofacitinib|tofacitinib|mesh-list
92187697|NCT05104723|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92187698|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187699|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187700|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187701|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
92187702|NCT05104567|Cetuximab|cetuximab|mesh-list
92187703|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187704|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187705|NCT05104567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187706|NCT05104567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187709|NCT05057247|Docetaxel|docetaxel|mesh-list
92187710|NCT05057247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462783|NCT01759732|Fludarabine|fludarabine|mesh-list
92462784|NCT01759732|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92462785|NCT01759732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462786|NCT01759732|Immunologic Factors|immunologic factors|mesh-ancestor
92462787|NCT01759732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462788|NCT01759732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462789|NCT01759732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92462790|NCT01759732|Alkylating Agents|alkylating agents|mesh-ancestor
92462791|NCT01759732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462792|NCT01759732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462793|NCT01759732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92462794|NCT01759771|Vitamin D|vitamin d|mesh-list
92462795|NCT01759771|Cholecalciferol|cholecalciferol|mesh-list
92462796|NCT01759771|Vitamins|vitamins|mesh-ancestor
92462797|NCT01759771|Micronutrients|micronutrients|mesh-ancestor
92462798|NCT01759771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462799|NCT01759771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92462800|NCT01759771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92462801|NCT01759810|Vaccines|vaccines|mesh-list
92462802|NCT01759810|Immunologic Factors|immunologic factors|mesh-ancestor
92462803|NCT01759810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462804|NCT01759875|Ritonavir|ritonavir|mesh-list
92462805|NCT01759875|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92462806|NCT01759875|Rabeprazole|rabeprazole|mesh-list
92462807|NCT01759875|Betaine|betaine|mesh-list
92462808|NCT01759875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92462809|NCT01759875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92462810|NCT01759875|Protease Inhibitors|protease inhibitors|mesh-ancestor
92462811|NCT01759875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462812|NCT01759875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462813|NCT01759875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92462814|NCT01759875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92462815|NCT01759875|Antiviral Agents|antiviral agents|mesh-ancestor
92462816|NCT01759875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462817|NCT01759875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92462818|NCT01759875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92462819|NCT01759875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92462820|NCT01759875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92462821|NCT01759875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92462822|NCT01759875|Lipotropic Agents|lipotropic agents|mesh-ancestor
92462823|NCT01759875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92462824|NCT01759875|Antimetabolites|antimetabolites|mesh-ancestor
92462825|NCT01759875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92462826|NCT01759940|Ropivacaine|ropivacaine|mesh-list
92462827|NCT01759940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462828|NCT01759940|Anesthetics|anesthetics|mesh-ancestor
92462829|NCT01759940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462830|NCT01759940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462831|NCT01759940|Sensory System Agents|sensory system agents|mesh-ancestor
92462832|NCT01759940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462833|NCT01760018|Desflurane|desflurane|mesh-list
92462834|NCT01760018|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92462835|NCT01760018|Anesthetics, General|anesthetics, general|mesh-ancestor
92462836|NCT01760018|Anesthetics|anesthetics|mesh-ancestor
92462837|NCT01760018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462838|NCT01760018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462839|NCT01760096|Cyclosporine|cyclosporine|mesh-list
92462840|NCT01760096|Levamisole|levamisole|mesh-list
92462841|NCT01760096|Cyclosporins|cyclosporins|mesh-list
92462842|NCT01760096|Glucocorticoids|glucocorticoids|mesh-list
92462843|NCT01760096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462844|NCT01760096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462845|NCT01760096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462846|NCT01760096|Immunologic Factors|immunologic factors|mesh-ancestor
92462847|NCT01760096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462848|NCT01760096|Antifungal Agents|antifungal agents|mesh-ancestor
92462849|NCT01760096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462850|NCT01760096|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462851|NCT01760096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462852|NCT01760096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92462853|NCT01760096|Hormones|hormones|mesh-ancestor
92462854|NCT01760096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462855|NCT01760096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92462856|NCT01760096|Antinematodal Agents|antinematodal agents|mesh-ancestor
92462857|NCT01760096|Anthelmintics|anthelmintics|mesh-ancestor
92462858|NCT01760096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92462859|NCT01760109|Piperacillin|piperacillin|mesh-list
92187769|NCT04895709|Docetaxel|docetaxel|mesh-list
92187770|NCT04895709|Nivolumab|nivolumab|mesh-list
92187771|NCT04895709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462860|NCT01760109|Sulbactam|sulbactam|mesh-list
92462861|NCT01760109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92462862|NCT01760109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462863|NCT01760109|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92462864|NCT01760109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462865|NCT01760109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462866|NCT01760122|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92462867|NCT01760122|Antiviral Agents|antiviral agents|mesh-ancestor
92462868|NCT01760122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462869|NCT01760148|Interferons|interferons|mesh-list
92462870|NCT01760148|Ribavirin|ribavirin|mesh-list
92462871|NCT01760148|Interferon-alpha|interferon-alpha|mesh-list
92462872|NCT01760148|Interferon alpha-2|interferon alpha-2|mesh-list
92462873|NCT01760148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462874|NCT01760148|Antiviral Agents|antiviral agents|mesh-ancestor
92462875|NCT01760148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462876|NCT01760148|Antimetabolites|antimetabolites|mesh-ancestor
92462877|NCT01760148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462878|NCT01760148|Immunologic Factors|immunologic factors|mesh-ancestor
92462879|NCT01760148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462880|NCT01760161|Ropivacaine|ropivacaine|mesh-list
92462881|NCT01760161|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462882|NCT01760161|Anesthetics|anesthetics|mesh-ancestor
92462883|NCT01760161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462884|NCT01760161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462885|NCT01760161|Sensory System Agents|sensory system agents|mesh-ancestor
92462886|NCT01760161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462887|NCT01760174|Bupivacaine|bupivacaine|mesh-list
92462888|NCT01760174|Ropivacaine|ropivacaine|mesh-list
92462889|NCT01760174|Anesthetics, Local|anesthetics, local|mesh-ancestor
92462890|NCT01760174|Anesthetics|anesthetics|mesh-ancestor
92462891|NCT01760174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92462892|NCT01760174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462893|NCT01760174|Sensory System Agents|sensory system agents|mesh-ancestor
92462894|NCT01760174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462896|NCT01760226|Cyclophosphamide|cyclophosphamide|mesh-list
92462898|NCT01760226|Doxorubicin|doxorubicin|mesh-list
92462899|NCT01760226|Methotrexate|methotrexate|mesh-list
92462900|NCT01760226|Etoposide|etoposide|mesh-list
92462901|NCT01760226|Vincristine|vincristine|mesh-list
92462902|NCT01760226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92462903|NCT01760226|Immunologic Factors|immunologic factors|mesh-ancestor
92462904|NCT01760226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462905|NCT01760226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462906|NCT01760226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92462907|NCT01760226|Alkylating Agents|alkylating agents|mesh-ancestor
92462908|NCT01760226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462909|NCT01760226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462910|NCT01760226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92462911|NCT01760226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92462912|NCT01760226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92462913|NCT01760226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92462914|NCT01760226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92462915|NCT01760226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462916|NCT01760226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92462917|NCT01760226|Glucocorticoids|glucocorticoids|mesh-ancestor
92462918|NCT01760226|Hormones|hormones|mesh-ancestor
92462919|NCT01760226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462920|NCT01760226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92462921|NCT01760226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92462922|NCT01760226|Abortifacient Agents|abortifacient agents|mesh-ancestor
92462923|NCT01760226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462924|NCT01760226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92462925|NCT01760226|Antimetabolites|antimetabolites|mesh-ancestor
92462926|NCT01760226|Dermatologic Agents|dermatologic agents|mesh-ancestor
92462927|NCT01760226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92462928|NCT01760226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92462929|NCT01760226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92462930|NCT01760226|Tubulin Modulators|tubulin modulators|mesh-ancestor
92462931|NCT01760226|Antimitotic Agents|antimitotic agents|mesh-ancestor
92462932|NCT01760226|Mitosis Modulators|mitosis modulators|mesh-ancestor
92462933|NCT01760252|Capecitabine|capecitabine|mesh-list
92462934|NCT01760252|Oxaliplatin|oxaliplatin|mesh-list
92462935|NCT01760252|Irinotecan|irinotecan|mesh-list
92462936|NCT01760252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92462937|NCT01760252|Antimetabolites|antimetabolites|mesh-ancestor
92462938|NCT01760252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462939|NCT01760252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92462940|NCT01760252|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92462941|NCT01760252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92462942|NCT01760252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462944|NCT01760278|Hormones|hormones|mesh-list
92462945|NCT01760278|Progesterone|progesterone|mesh-list
92462946|NCT01760278|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92462947|NCT01760278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92462948|NCT01760278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462949|NCT01760278|Progestins|progestins|mesh-ancestor
92462950|NCT01760278|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92462951|NCT01760278|Fertility Agents|fertility agents|mesh-ancestor
92462952|NCT01760278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92462953|NCT01760278|Hormone Antagonists|hormone antagonists|mesh-ancestor
92462954|NCT01760330|Acetaminophen|acetaminophen|mesh-list
92462955|NCT01760330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92462956|NCT01760330|Analgesics|analgesics|mesh-ancestor
92462957|NCT01760330|Sensory System Agents|sensory system agents|mesh-ancestor
92462958|NCT01760330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92462959|NCT01760330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462960|NCT01760330|Antipyretics|antipyretics|mesh-ancestor
92462961|NCT01760421|Hydroxychloroquine|hydroxychloroquine|mesh-list
92462962|NCT01760421|Antimalarials|antimalarials|mesh-ancestor
92462963|NCT01760421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92462964|NCT01760421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92462965|NCT01760421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462966|NCT01760421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462967|NCT01760421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462968|NCT01760421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92462969|NCT01760460|Oxazolidinones|oxazolidinones|mesh-list
92462970|NCT01760460|Anacetrapib|anacetrapib|mesh-list
92462971|NCT01760460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92462972|NCT01760460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92462973|NCT01760460|Antimetabolites|antimetabolites|mesh-ancestor
92462974|NCT01760460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462975|NCT01760460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92462976|NCT01760460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462977|NCT01760460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92462978|NCT01760460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462979|NCT01760564|Miglustat|miglustat|mesh-list
92462980|NCT01760564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92462981|NCT01760564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462982|NCT01760564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92462983|NCT01760564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92462984|NCT01760564|Antiviral Agents|antiviral agents|mesh-ancestor
92462985|NCT01760564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92462986|NCT01760564|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92462987|NCT01760564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92462988|NCT01760564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462989|NCT01760577|Botulinum Toxins|botulinum toxins|mesh-list
92462990|NCT01760577|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92462991|NCT01760577|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92462992|NCT01760577|Hyaluronic Acid|hyaluronic acid|mesh-list
92462993|NCT01760577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92462994|NCT01760577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92462995|NCT01760577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92462996|NCT01760577|Cholinergic Agents|cholinergic agents|mesh-ancestor
92462997|NCT01760577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92462998|NCT01760577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92462999|NCT01760577|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92463000|NCT01760577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463001|NCT01760577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92463002|NCT01760577|Immunologic Factors|immunologic factors|mesh-ancestor
92463003|NCT01760577|Viscosupplements|viscosupplements|mesh-ancestor
92463004|NCT01760577|Protective Agents|protective agents|mesh-ancestor
92463005|NCT01760642|Rifampin|rifampin|mesh-list
92463006|NCT01760642|Ketoconazole|ketoconazole|mesh-list
92463007|NCT01760642|Midazolam|midazolam|mesh-list
92463008|NCT01760642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92463009|NCT01760642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92463010|NCT01760642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463011|NCT01760642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463012|NCT01760642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92187918|NCT04609566|Pembrolizumab|pembrolizumab|mesh-list
92463013|NCT01760642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92463014|NCT01760642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92463015|NCT01760642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92463016|NCT01760642|Anesthetics, General|anesthetics, general|mesh-ancestor
92463017|NCT01760642|Anesthetics|anesthetics|mesh-ancestor
92463018|NCT01760642|GABA Modulators|gaba modulators|mesh-ancestor
92463019|NCT01760642|GABA Agents|gaba agents|mesh-ancestor
92463020|NCT01760642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463021|NCT01760642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463022|NCT01760642|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92463023|NCT01760642|Antitubercular Agents|antitubercular agents|mesh-ancestor
92463024|NCT01760642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463025|NCT01760642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463026|NCT01760642|Leprostatic Agents|leprostatic agents|mesh-ancestor
92463027|NCT01760642|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92463028|NCT01760642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463029|NCT01760642|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92463030|NCT01760642|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92463031|NCT01760642|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92463032|NCT01760642|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92463033|NCT01760642|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92463034|NCT01760642|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92463035|NCT01760642|Antifungal Agents|antifungal agents|mesh-ancestor
92463036|NCT01760642|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92463037|NCT01760642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92463038|NCT01760642|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92463039|NCT01760642|Hormone Antagonists|hormone antagonists|mesh-ancestor
92463040|NCT01760642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463041|NCT01760642|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92463044|NCT01760694|Irinotecan|irinotecan|mesh-list
92463045|NCT01760694|Folfirinox|folfirinox|mesh-list
92463046|NCT01760694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463047|NCT01760694|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92463048|NCT01760694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92463049|NCT01760694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463050|NCT01760694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463051|NCT01760694|Antidotes|antidotes|mesh-ancestor
92463052|NCT01760694|Protective Agents|protective agents|mesh-ancestor
92463053|NCT01760694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463054|NCT01760694|Vitamin B Complex|vitamin b complex|mesh-ancestor
92463055|NCT01760694|Vitamins|vitamins|mesh-ancestor
92463056|NCT01760694|Micronutrients|micronutrients|mesh-ancestor
92463057|NCT01760746|Bevacizumab|bevacizumab|mesh-list
92463058|NCT01760746|Ranibizumab|ranibizumab|mesh-list
92463059|NCT01760746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92463060|NCT01760746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463061|NCT01760746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92463062|NCT01760746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92463063|NCT01760746|Growth Substances|growth substances|mesh-ancestor
92463064|NCT01760746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463065|NCT01760746|Growth Inhibitors|growth inhibitors|mesh-ancestor
92463066|NCT01760798|Teriparatide|teriparatide|mesh-list
92463067|NCT01760798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92463068|NCT01760798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463069|NCT01760798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92463070|NCT01760811|Cetuximab|cetuximab|mesh-list
92463071|NCT01760811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92463072|NCT01760811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463073|NCT01760824|Amoxicillin|amoxicillin|mesh-list
92463074|NCT01760824|Metronidazole|metronidazole|mesh-list
92463075|NCT01760824|Clarithromycin|clarithromycin|mesh-list
92463076|NCT01760824|Tetracycline|tetracycline|mesh-list
92463077|NCT01760824|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92463078|NCT01760824|Esomeprazole|esomeprazole|mesh-list
92463079|NCT01760824|Bismuth|bismuth|mesh-list
92463080|NCT01760824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463081|NCT01760824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463082|NCT01760824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92463083|NCT01760824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92463084|NCT01760824|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92463085|NCT01760824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463086|NCT01760824|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92463087|NCT01760824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463088|NCT01760824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463089|NCT01760824|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92463090|NCT01760824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92463091|NCT01760824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92463092|NCT01760824|Antacids|antacids|mesh-ancestor
92463093|NCT01760863|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92463094|NCT01760863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463095|NCT01760967|Dexmedetomidine|dexmedetomidine|mesh-list
92463096|NCT01760967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92463097|NCT01760967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463098|NCT01760967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463099|NCT01760967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463100|NCT01760967|Analgesics|analgesics|mesh-ancestor
92463101|NCT01760967|Sensory System Agents|sensory system agents|mesh-ancestor
92463102|NCT01760967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463103|NCT01760967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92463104|NCT01760967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92463105|NCT01760967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92463106|NCT01760967|Adrenergic Agents|adrenergic agents|mesh-ancestor
92463107|NCT01760967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463108|NCT01760967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463109|NCT01760980|Exemestane|exemestane|mesh-list
92463110|NCT01760980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463111|NCT01760980|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92463112|NCT01760980|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92463113|NCT01760980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463114|NCT01760980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463116|NCT01760980|Hormone Antagonists|hormone antagonists|mesh-ancestor
92463117|NCT01760980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463118|NCT01760980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463119|NCT01761071|Diclofenac|diclofenac|mesh-list
92463120|NCT01761071|Ketorolac|ketorolac|mesh-list
92463121|NCT01761071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463122|NCT01761071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463123|NCT01761071|Analgesics|analgesics|mesh-ancestor
92463124|NCT01761071|Sensory System Agents|sensory system agents|mesh-ancestor
92463125|NCT01761071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463126|NCT01761071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463127|NCT01761071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463128|NCT01761071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463129|NCT01761071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92463130|NCT01761071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463131|NCT01761071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463132|NCT01761110|Buprenorphine|buprenorphine|mesh-list
92463133|NCT01761110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92463134|NCT01761110|Narcotics|narcotics|mesh-ancestor
92463135|NCT01761110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463136|NCT01761110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463137|NCT01761110|Analgesics|analgesics|mesh-ancestor
92463138|NCT01761110|Sensory System Agents|sensory system agents|mesh-ancestor
92463139|NCT01761110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463140|NCT01761110|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92463141|NCT01761149|Remifentanil|remifentanil|mesh-list
92463142|NCT01761149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92463143|NCT01761149|Narcotics|narcotics|mesh-ancestor
92463144|NCT01761149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463145|NCT01761149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463146|NCT01761149|Analgesics|analgesics|mesh-ancestor
92463147|NCT01761149|Sensory System Agents|sensory system agents|mesh-ancestor
92463148|NCT01761149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463149|NCT01761201|Levofloxacin|levofloxacin|mesh-list
92463150|NCT01761201|Ofloxacin|ofloxacin|mesh-list
92463151|NCT01761201|Isoniazid|isoniazid|mesh-list
92463152|NCT01761201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92463153|NCT01761201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463154|NCT01761201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92348293|NCT01562028|Growth Substances|growth substances|mesh-ancestor
92463155|NCT01761201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92463156|NCT01761201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92463157|NCT01761201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463158|NCT01761201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463159|NCT01761201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463160|NCT01761201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92463161|NCT01761201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92463162|NCT01761201|Antitubercular Agents|antitubercular agents|mesh-ancestor
92463163|NCT01761201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92463164|NCT01761201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463165|NCT01761201|Antimetabolites|antimetabolites|mesh-ancestor
92463166|NCT01761201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463167|NCT01761214|Amoxicillin|amoxicillin|mesh-list
92463168|NCT01761214|Moxifloxacin|moxifloxacin|mesh-list
92463169|NCT01761214|Ciprofloxacin|ciprofloxacin|mesh-list
92463170|NCT01761214|Clavulanic Acid|clavulanic acid|mesh-list
92463171|NCT01761214|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92463172|NCT01761214|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92463173|NCT01761214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463174|NCT01761214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463175|NCT01761214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92463176|NCT01761214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92463177|NCT01761214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463178|NCT01761214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463179|NCT01761214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463180|NCT01761214|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92463181|NCT01761214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92463182|NCT01761318|Liraglutide|liraglutide|mesh-list
92463183|NCT01761318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92463184|NCT01761318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463185|NCT01761318|Incretins|incretins|mesh-ancestor
92463186|NCT01761318|Hormones|hormones|mesh-ancestor
92463187|NCT01761318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463188|NCT01761344|Hydrocortisone|hydrocortisone|mesh-list
92463189|NCT01761344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463190|NCT01761461|Oxaliplatin|oxaliplatin|mesh-list
92463191|NCT01761461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463192|NCT01761487|Gentamicins|gentamicins|mesh-list
92463193|NCT01761487|Polymyxins|polymyxins|mesh-list
92463194|NCT01761487|Colistin|colistin|mesh-list
92463195|NCT01761487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463196|NCT01761487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463197|NCT01761487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92463198|NCT01761487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463199|NCT01761487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463200|NCT01761513|Esomeprazole|esomeprazole|mesh-list
92463201|NCT01761513|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92463202|NCT01761513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463203|NCT01761513|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92463204|NCT01761513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463205|NCT01761513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463206|NCT01761526|Rotigotine|rotigotine|mesh-list
92463207|NCT01761526|Dopamine Agonists|dopamine agonists|mesh-ancestor
92463208|NCT01761526|Dopamine Agents|dopamine agents|mesh-ancestor
92463209|NCT01761526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463210|NCT01761526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463211|NCT01761526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463212|NCT01761552|Atropine|atropine|mesh-list
92463213|NCT01761552|Neostigmine|neostigmine|mesh-list
92463214|NCT01761552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92463215|NCT01761552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92463216|NCT01761552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92463217|NCT01761552|Autonomic Agents|autonomic agents|mesh-ancestor
92463218|NCT01761552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463219|NCT01761552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463220|NCT01761552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92463221|NCT01761552|Respiratory System Agents|respiratory system agents|mesh-ancestor
92463222|NCT01761552|Mydriatics|mydriatics|mesh-ancestor
92463223|NCT01761552|Parasympatholytics|parasympatholytics|mesh-ancestor
92463224|NCT01761552|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92463225|NCT01761552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92463226|NCT01761552|Cholinergic Agents|cholinergic agents|mesh-ancestor
92463227|NCT01761552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463228|NCT01761552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463229|NCT01761552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92463230|NCT01761552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463231|NCT01761552|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92463232|NCT01761656|Atorvastatin|atorvastatin|mesh-list
92463233|NCT01761656|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92463234|NCT01761656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463235|NCT01761656|Antimetabolites|antimetabolites|mesh-ancestor
92463236|NCT01761656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188145|NCT04093323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463237|NCT01761656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463238|NCT01761656|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92463239|NCT01761656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463240|NCT01761669|Vitamin D|vitamin d|mesh-list
92463241|NCT01761669|Vitamins|vitamins|mesh-ancestor
92463242|NCT01761669|Micronutrients|micronutrients|mesh-ancestor
92463243|NCT01761669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463244|NCT01761669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92463245|NCT01761916|Clonidine|clonidine|mesh-list
92463246|NCT01761916|Captopril|captopril|mesh-list
92463247|NCT01761916|Analgesics|analgesics|mesh-ancestor
92463248|NCT01761916|Sensory System Agents|sensory system agents|mesh-ancestor
92463249|NCT01761916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463250|NCT01761916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463251|NCT01761916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92463252|NCT01761916|Sympatholytics|sympatholytics|mesh-ancestor
92463253|NCT01761916|Autonomic Agents|autonomic agents|mesh-ancestor
92463254|NCT01761916|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92463255|NCT01761916|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92463256|NCT01761916|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92463257|NCT01761916|Adrenergic Agents|adrenergic agents|mesh-ancestor
92463258|NCT01761916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463259|NCT01761916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463260|NCT01761916|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92463261|NCT01761916|Protease Inhibitors|protease inhibitors|mesh-ancestor
92463262|NCT01761916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531598|NCT04733781|Sympathomimetics|sympathomimetics|mesh-ancestor
92463263|NCT01761968|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92463264|NCT01761968|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92463265|NCT01761968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463266|NCT01761968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463267|NCT01761994|Nafamostat|nafamostat|mesh-list
92463268|NCT01761994|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463269|NCT01761994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463270|NCT01761994|Analgesics|analgesics|mesh-ancestor
92463271|NCT01761994|Sensory System Agents|sensory system agents|mesh-ancestor
92463272|NCT01761994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463273|NCT01761994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463274|NCT01761994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463275|NCT01761994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463276|NCT01761994|Anticoagulants|anticoagulants|mesh-ancestor
92463277|NCT01761994|Protease Inhibitors|protease inhibitors|mesh-ancestor
92463278|NCT01761994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463279|NCT01761994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463280|NCT01761994|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92463281|NCT01761994|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92463282|NCT01761994|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92463283|NCT01761994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92463284|NCT01761994|Immunologic Factors|immunologic factors|mesh-ancestor
92463285|NCT01762046|Metformin|metformin|mesh-list
92463286|NCT01762046|Glipizide|glipizide|mesh-list
92463287|NCT01762046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92463288|NCT01762046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463289|NCT01762150|Gemcitabine|gemcitabine|mesh-list
92463290|NCT01762150|Sorafenib|sorafenib|mesh-list
92463291|NCT01762150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463292|NCT01762150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92463293|NCT01762150|Antimetabolites|antimetabolites|mesh-ancestor
92463294|NCT01762150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463295|NCT01762150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92463296|NCT01762150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463297|NCT01762163|Aspirin|aspirin|mesh-list
92463298|NCT01762163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463299|NCT01762163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463300|NCT01762163|Analgesics|analgesics|mesh-ancestor
92463301|NCT01762163|Sensory System Agents|sensory system agents|mesh-ancestor
92463302|NCT01762163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463303|NCT01762163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463304|NCT01762163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463305|NCT01762163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463306|NCT01762163|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92463307|NCT01762163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92463308|NCT01762163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463309|NCT01762163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92463310|NCT01762163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92463311|NCT01762163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463312|NCT01762163|Antipyretics|antipyretics|mesh-ancestor
92463313|NCT01762202|Cyclophosphamide|cyclophosphamide|mesh-list
92463314|NCT01762202|Fludarabine|fludarabine|mesh-list
92463315|NCT01762202|Ofatumumab|ofatumumab|mesh-list
92463316|NCT01762202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92463317|NCT01762202|Immunologic Factors|immunologic factors|mesh-ancestor
92463318|NCT01762202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463319|NCT01762202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463320|NCT01762202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92463321|NCT01762202|Alkylating Agents|alkylating agents|mesh-ancestor
92463322|NCT01762202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463323|NCT01762202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463324|NCT01762202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92463325|NCT01762306|Folic Acid|folic acid|mesh-list
92463326|NCT01762306|Diclofenac|diclofenac|mesh-list
92463327|NCT01762306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463328|NCT01762306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463329|NCT01762306|Analgesics|analgesics|mesh-ancestor
92463330|NCT01762306|Sensory System Agents|sensory system agents|mesh-ancestor
92463331|NCT01762306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463332|NCT01762306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463333|NCT01762306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463334|NCT01762306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463335|NCT01762306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92463336|NCT01762306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463337|NCT01762306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463338|NCT01762306|Hematinics|hematinics|mesh-ancestor
92463339|NCT01762306|Vitamin B Complex|vitamin b complex|mesh-ancestor
92463340|NCT01762306|Vitamins|vitamins|mesh-ancestor
92463341|NCT01762306|Micronutrients|micronutrients|mesh-ancestor
92463342|NCT01762319|Vitamin B 6|vitamin b 6|mesh-list
92463343|NCT01762319|Pyridoxal|pyridoxal|mesh-list
92463344|NCT01762319|Pyridoxine|pyridoxine|mesh-list
92463345|NCT01762319|Misoprostol|misoprostol|mesh-list
92463346|NCT01762319|Vitamins|vitamins|mesh-ancestor
92463347|NCT01762319|Micronutrients|micronutrients|mesh-ancestor
92463348|NCT01762319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463349|NCT01762319|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92463350|NCT01762319|Abortifacient Agents|abortifacient agents|mesh-ancestor
92463351|NCT01762319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92463352|NCT01762319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92463353|NCT01762319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463354|NCT01762319|Oxytocics|oxytocics|mesh-ancestor
92463355|NCT01762319|Vitamin B Complex|vitamin b complex|mesh-ancestor
92463356|NCT01762332|Remifentanil|remifentanil|mesh-list
92463357|NCT01762332|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92463358|NCT01762332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92463359|NCT01762332|Narcotics|narcotics|mesh-ancestor
92463360|NCT01762332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463361|NCT01762332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463362|NCT01762332|Analgesics|analgesics|mesh-ancestor
92463363|NCT01762332|Sensory System Agents|sensory system agents|mesh-ancestor
92463364|NCT01762332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463365|NCT01762332|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92463366|NCT01762332|Adrenergic Agents|adrenergic agents|mesh-ancestor
92463367|NCT01762332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463368|NCT01762332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463369|NCT01762436|Atenolol|atenolol|mesh-list
92463370|NCT01762436|Bisoprolol|bisoprolol|mesh-list
92463371|NCT01762436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92463372|NCT01762436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92463373|NCT01762436|Sympatholytics|sympatholytics|mesh-ancestor
92463374|NCT01762436|Autonomic Agents|autonomic agents|mesh-ancestor
92463375|NCT01762436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463376|NCT01762436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463377|NCT01762436|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92463378|NCT01762436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92463379|NCT01762436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92463380|NCT01762436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92463381|NCT01762436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463382|NCT01762436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463383|NCT01762475|Sildenafil Citrate|sildenafil citrate|mesh-list
92463384|NCT01762475|Vasodilator Agents|vasodilator agents|mesh-ancestor
92463385|NCT01762475|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92463386|NCT01762475|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92463387|NCT01762475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463388|NCT01762475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463389|NCT01762475|Urological Agents|urological agents|mesh-ancestor
92463390|NCT01762514|Amifostine|amifostine|mesh-list
92463391|NCT01762514|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92463392|NCT01762514|Protective Agents|protective agents|mesh-ancestor
92463393|NCT01762514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463394|NCT01762540|Prednisolone|prednisolone|mesh-list
92463395|NCT01762540|Calcium|calcium|mesh-list
92463396|NCT01762540|Glucocorticoids|glucocorticoids|mesh-list
92463397|NCT01762540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92463398|NCT01762540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463399|NCT01762540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463400|NCT01762540|Hormones|hormones|mesh-ancestor
92463401|NCT01762540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463402|NCT01762540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92463403|NCT01762540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463404|NCT01762644|Cyclosporine|cyclosporine|mesh-list
92463405|NCT01762644|Omeprazole|omeprazole|mesh-list
92463406|NCT01762644|Cyclosporins|cyclosporins|mesh-list
92463407|NCT01762644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463408|NCT01762644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463409|NCT01762644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92463410|NCT01762644|Immunologic Factors|immunologic factors|mesh-ancestor
92463411|NCT01762644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463412|NCT01762644|Antifungal Agents|antifungal agents|mesh-ancestor
92463413|NCT01762644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463414|NCT01762644|Dermatologic Agents|dermatologic agents|mesh-ancestor
92463415|NCT01762644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463416|NCT01762644|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92463417|NCT01762644|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92463418|NCT01762644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463419|NCT01762644|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92463420|NCT01762657|Cyclosporine|cyclosporine|mesh-list
92463421|NCT01762657|Lansoprazole|lansoprazole|mesh-list
92463422|NCT01762657|Dexlansoprazole|dexlansoprazole|mesh-list
92463423|NCT01762657|Cyclosporins|cyclosporins|mesh-list
92463424|NCT01762657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463425|NCT01762657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463426|NCT01762657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92463427|NCT01762657|Immunologic Factors|immunologic factors|mesh-ancestor
92463428|NCT01762657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463429|NCT01762657|Antifungal Agents|antifungal agents|mesh-ancestor
92463430|NCT01762657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463431|NCT01762657|Dermatologic Agents|dermatologic agents|mesh-ancestor
92463432|NCT01762657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463433|NCT01762657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92463434|NCT01762657|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92463435|NCT01762657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463436|NCT01762657|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92463437|NCT01762670|Metronidazole|metronidazole|mesh-list
92463438|NCT01762670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463439|NCT01762670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463440|NCT01762670|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92463441|NCT01762670|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92463442|NCT01762787|Aspirin|aspirin|mesh-list
92463443|NCT01762787|Prednisolone|prednisolone|mesh-list
92463444|NCT01762787|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92463445|NCT01762787|Methylprednisolone|methylprednisolone|mesh-list
92463446|NCT01762787|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92463447|NCT01762787|Prednisolone acetate|prednisolone acetate|mesh-list
92463448|NCT01762787|Cantharidin|cantharidin|mesh-list
92463449|NCT01762787|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92463450|NCT01762787|Prednisolone phosphate|prednisolone phosphate|mesh-list
92463451|NCT01762787|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463452|NCT01762787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463453|NCT01762787|Analgesics|analgesics|mesh-ancestor
92463454|NCT01762787|Sensory System Agents|sensory system agents|mesh-ancestor
92463455|NCT01762787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463456|NCT01762787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463457|NCT01762787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463458|NCT01762787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463459|NCT01762787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92463460|NCT01762787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92463461|NCT01762787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463462|NCT01762787|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92463463|NCT01762787|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92463464|NCT01762787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463465|NCT01762787|Antipyretics|antipyretics|mesh-ancestor
92463466|NCT01762787|Glucocorticoids|glucocorticoids|mesh-ancestor
92463468|NCT01762787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463469|NCT01762787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92463470|NCT01762787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463471|NCT01762787|Antiemetics|antiemetics|mesh-ancestor
92463472|NCT01762787|Autonomic Agents|autonomic agents|mesh-ancestor
92463473|NCT01762787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463474|NCT01762787|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92463475|NCT01762787|Protective Agents|protective agents|mesh-ancestor
92463476|NCT01762826|Inositol|inositol|mesh-list
92463477|NCT01762826|Vitamin B Complex|vitamin b complex|mesh-ancestor
92463478|NCT01762826|Vitamins|vitamins|mesh-ancestor
92463479|NCT01762826|Micronutrients|micronutrients|mesh-ancestor
92463480|NCT01762826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463481|NCT01762839|Moxifloxacin|moxifloxacin|mesh-list
92463482|NCT01762839|Oritavancin|oritavancin|mesh-list
92463483|NCT01762839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463484|NCT01762839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463485|NCT01762839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92463486|NCT01762839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92463487|NCT01762839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463488|NCT01762839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463489|NCT01762839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463490|NCT01762852|Belimumab|belimumab|mesh-list
92463491|NCT01762852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92463492|NCT01762852|Immunologic Factors|immunologic factors|mesh-ancestor
92463493|NCT01762852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463494|NCT01762878|Nemiralisib|nemiralisib|mesh-list
92463495|NCT01762878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92463496|NCT01762878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463497|NCT01762878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463498|NCT01762891|Acetaminophen|acetaminophen|mesh-list
92463499|NCT01762891|Celecoxib|celecoxib|mesh-list
92463500|NCT01762891|Rofecoxib|rofecoxib|mesh-list
92463501|NCT01762891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463502|NCT01762891|Analgesics|analgesics|mesh-ancestor
92463503|NCT01762891|Sensory System Agents|sensory system agents|mesh-ancestor
92463504|NCT01762891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463505|NCT01762891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463506|NCT01762891|Antipyretics|antipyretics|mesh-ancestor
92463507|NCT01762891|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92463508|NCT01762891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463509|NCT01762891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463510|NCT01762891|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92463511|NCT01762891|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92463512|NCT01762891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348312|NCT01537068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463513|NCT01762891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463514|NCT01762995|Ferrous fumarate|ferrous fumarate|mesh-list
92463515|NCT01762995|Dolutegravir|dolutegravir|mesh-list
92463516|NCT01762995|Calcium Carbonate|calcium carbonate|mesh-list
92463517|NCT01762995|Calcium|calcium|mesh-list
92463518|NCT01762995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92463519|NCT01762995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463520|NCT01762995|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92463521|NCT01762995|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92463522|NCT01762995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463523|NCT01762995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463524|NCT01762995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92463525|NCT01762995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92463526|NCT01762995|Antiviral Agents|antiviral agents|mesh-ancestor
92463527|NCT01762995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463528|NCT01762995|Antacids|antacids|mesh-ancestor
92463529|NCT01762995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463530|NCT01762995|Trace Elements|trace elements|mesh-ancestor
92463531|NCT01762995|Micronutrients|micronutrients|mesh-ancestor
92463532|NCT01763021|Rifampin|rifampin|mesh-list
92463533|NCT01763021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92463534|NCT01763021|Antitubercular Agents|antitubercular agents|mesh-ancestor
92463535|NCT01763021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463536|NCT01763021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463537|NCT01763021|Leprostatic Agents|leprostatic agents|mesh-ancestor
92463538|NCT01763021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92463539|NCT01763021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463540|NCT01763021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463541|NCT01763021|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92463542|NCT01763021|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92463543|NCT01763021|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92463544|NCT01763021|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92463545|NCT01763021|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92463546|NCT01763021|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92463547|NCT01763281|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92463549|NCT01763281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463550|NCT01763281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463551|NCT01763385|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92463552|NCT01763385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463553|NCT01763385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92463554|NCT01763385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463555|NCT01763385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463556|NCT01763437|Tetracycline|tetracycline|mesh-list
92463557|NCT01763437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463558|NCT01763437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463559|NCT01763437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92463560|NCT01763437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463561|NCT01763437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463562|NCT01763450|Bevacizumab|bevacizumab|mesh-list
92463563|NCT01763450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92463564|NCT01763450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463565|NCT01763450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92463566|NCT01763450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92463567|NCT01763450|Growth Substances|growth substances|mesh-ancestor
92463568|NCT01763450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463569|NCT01763450|Growth Inhibitors|growth inhibitors|mesh-ancestor
92463570|NCT01763463|Fluticasone|fluticasone|mesh-list
92463571|NCT01763463|Xhance|xhance|mesh-list
92463572|NCT01763463|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92463573|NCT01763463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92463574|NCT01763463|Bronchodilator Agents|bronchodilator agents|mesh-list
92463575|NCT01763463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463576|NCT01763463|Autonomic Agents|autonomic agents|mesh-ancestor
92463577|NCT01763463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463578|NCT01763463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463579|NCT01763463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92463580|NCT01763463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92463581|NCT01763463|Dermatologic Agents|dermatologic agents|mesh-ancestor
92463582|NCT01763463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92463583|NCT01763463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92463584|NCT01763463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92463585|NCT01763463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92463586|NCT01763463|Adrenergic Agents|adrenergic agents|mesh-ancestor
92463587|NCT01763463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463588|NCT01763463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463589|NCT01763463|Glucocorticoids|glucocorticoids|mesh-ancestor
92463590|NCT01763463|Hormones|hormones|mesh-ancestor
92463591|NCT01763463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463592|NCT01763463|Sympathomimetics|sympathomimetics|mesh-ancestor
92463593|NCT01763476|Paclitaxel|paclitaxel|mesh-list
92463594|NCT01763476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92463595|NCT01763476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463596|NCT01763476|Tubulin Modulators|tubulin modulators|mesh-ancestor
92463597|NCT01763476|Antimitotic Agents|antimitotic agents|mesh-ancestor
92463598|NCT01763476|Mitosis Modulators|mitosis modulators|mesh-ancestor
92463599|NCT01763476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463600|NCT01763541|Anastrozole|anastrozole|mesh-list
92463601|NCT01763541|Leuprolide|leuprolide|mesh-list
92463602|NCT01763541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92463603|NCT01763541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463604|NCT01763541|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92463605|NCT01763541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92463606|NCT01763541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463607|NCT01763541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463608|NCT01763541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92463609|NCT01763541|Hormone Antagonists|hormone antagonists|mesh-ancestor
92463610|NCT01763541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463611|NCT01763541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463612|NCT01763541|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92463613|NCT01763541|Fertility Agents|fertility agents|mesh-ancestor
92463614|NCT01763541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92463616|NCT01763658|Prednisolone|prednisolone|mesh-list
92463617|NCT01763658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92463618|NCT01763658|Immunoglobulins|immunoglobulins|mesh-list
92463619|NCT01763658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92463620|NCT01763658|gamma-Globulins|gamma-globulins|mesh-list
92463621|NCT01763658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92463622|NCT01763658|Antioxidants|antioxidants|mesh-list
92463623|NCT01763658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92463624|NCT01763658|Antiemetics|antiemetics|mesh-ancestor
92463625|NCT01763658|Autonomic Agents|autonomic agents|mesh-ancestor
92463626|NCT01763658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463627|NCT01763658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463628|NCT01763658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463629|NCT01763658|Glucocorticoids|glucocorticoids|mesh-ancestor
92463630|NCT01763658|Hormones|hormones|mesh-ancestor
92463631|NCT01763658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463632|NCT01763658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92463633|NCT01763658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463634|NCT01763658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463635|NCT01763658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92463636|NCT01763658|Protective Agents|protective agents|mesh-ancestor
92463637|NCT01763658|Immunologic Factors|immunologic factors|mesh-ancestor
92463638|NCT01763710|Paclitaxel|paclitaxel|mesh-list
92463639|NCT01763710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92463640|NCT01763710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92463641|NCT01763710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463642|NCT01763710|Tubulin Modulators|tubulin modulators|mesh-ancestor
92463643|NCT01763710|Antimitotic Agents|antimitotic agents|mesh-ancestor
92463644|NCT01763710|Mitosis Modulators|mitosis modulators|mesh-ancestor
92463645|NCT01763710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463646|NCT01763749|Clopidogrel|clopidogrel|mesh-list
92463647|NCT01763749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92463648|NCT01763749|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92463649|NCT01763749|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92463650|NCT01763749|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92463651|NCT01763749|Purinergic Agents|purinergic agents|mesh-ancestor
92463652|NCT01763749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463653|NCT01763749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463654|NCT01763749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463655|NCT01763788|Gemcitabine|gemcitabine|mesh-list
92463656|NCT01763788|Necitumumab|necitumumab|mesh-list
92463657|NCT01763788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463658|NCT01763788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92463659|NCT01763788|Antimetabolites|antimetabolites|mesh-ancestor
92463660|NCT01763788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463661|NCT01763788|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92463662|NCT01764087|Paclitaxel|paclitaxel|mesh-list
92463663|NCT01764087|Tirbanibulin|tirbanibulin|mesh-list
92463664|NCT01764087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92463665|NCT01764087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463666|NCT01764087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92463667|NCT01764087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92463668|NCT01764087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92463669|NCT01764087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463670|NCT01764087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463671|NCT01764126|Vaccines|vaccines|mesh-list
92463672|NCT01764126|Immunologic Factors|immunologic factors|mesh-ancestor
92463673|NCT01764126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463674|NCT01764139|Vitamin D|vitamin d|mesh-list
92463675|NCT01764139|Vitamins|vitamins|mesh-ancestor
92463676|NCT01764139|Micronutrients|micronutrients|mesh-ancestor
92463677|NCT01764139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463678|NCT01764139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92463679|NCT01764178|Valsartan|valsartan|mesh-list
92463680|NCT01764178|Pitavastatin|pitavastatin|mesh-list
92463681|NCT01764178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92463682|NCT01764178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92463683|NCT01764178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92463684|NCT01764178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463685|NCT01764178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92463686|NCT01764178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92463687|NCT01764178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463688|NCT01764178|Antimetabolites|antimetabolites|mesh-ancestor
92463689|NCT01764178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463690|NCT01764178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463691|NCT01764230|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92463692|NCT01764230|Luteolytic Agents|luteolytic agents|mesh-ancestor
92463693|NCT01764230|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92463694|NCT01764230|Contraceptive Agents|contraceptive agents|mesh-ancestor
92463695|NCT01764230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92463696|NCT01764230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463697|NCT01764230|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92463698|NCT01764230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92463699|NCT01764230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463700|NCT01764295|Olmesartan|olmesartan|mesh-list
92463701|NCT01764295|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92463702|NCT01764295|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92463703|NCT01764295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463704|NCT01764295|Antimetabolites|antimetabolites|mesh-ancestor
92463705|NCT01764295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463706|NCT01764295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463707|NCT01764295|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92463708|NCT01764295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463709|NCT01764295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92463710|NCT01764295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92463711|NCT01764295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92463712|NCT01764451|Simvastatin|simvastatin|mesh-list
92463714|NCT01764451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463715|NCT01764451|Antimetabolites|antimetabolites|mesh-ancestor
92463716|NCT01764451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463717|NCT01764451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463718|NCT01764451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92463719|NCT01764451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463720|NCT01763424|Calcitriol|calcitriol|mesh-list
92463721|NCT01763424|Niacinamide|niacinamide|mesh-list
92463722|NCT01763424|Niacin|niacin|mesh-list
92463723|NCT01763424|Nicotinic Acids|nicotinic acids|mesh-list
92463724|NCT01763424|Calcipotriene|calcipotriene|mesh-list
92463725|NCT01763424|Vitamin B Complex|vitamin b complex|mesh-ancestor
92463726|NCT01763424|Vitamins|vitamins|mesh-ancestor
92463727|NCT01763424|Micronutrients|micronutrients|mesh-ancestor
92463728|NCT01763424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463729|NCT01763424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463730|NCT01763424|Antimetabolites|antimetabolites|mesh-ancestor
92463731|NCT01763424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463732|NCT01763424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463733|NCT01763424|Vasodilator Agents|vasodilator agents|mesh-ancestor
92463734|NCT01763424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92463735|NCT01763424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92463736|NCT01763424|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92463737|NCT01763424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463738|NCT01763424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92463739|NCT01763424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92463740|NCT01764555|Acetaminophen|acetaminophen|mesh-list
92463741|NCT01764555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92463742|NCT01764555|Analgesics|analgesics|mesh-ancestor
92463743|NCT01764555|Sensory System Agents|sensory system agents|mesh-ancestor
92463744|NCT01764555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463745|NCT01764555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463746|NCT01764555|Antipyretics|antipyretics|mesh-ancestor
92463747|NCT01764581|Tacrolimus|tacrolimus|mesh-list
92463748|NCT01764581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92463749|NCT01764581|Immunologic Factors|immunologic factors|mesh-ancestor
92463750|NCT01764581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463751|NCT01764581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92463752|NCT01764581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463753|NCT01764581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463754|NCT01764672|Methylphenidate|methylphenidate|mesh-list
92463755|NCT01764672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92463756|NCT01764672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463757|NCT01764672|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92463758|NCT01764672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92463759|NCT01764672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463760|NCT01764672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463761|NCT01764672|Dopamine Agents|dopamine agents|mesh-ancestor
92463762|NCT01764672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463763|NCT01764750|Vancomycin|vancomycin|mesh-list
92463764|NCT01764750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463765|NCT01764750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463766|NCT01764828|Gemcitabine|gemcitabine|mesh-list
92463767|NCT01764828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92463768|NCT01764828|Antimetabolites|antimetabolites|mesh-ancestor
92463769|NCT01764828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463770|NCT01764828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463771|NCT01764867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92463772|NCT01764867|Dexetimide|dexetimide|mesh-list
92463773|NCT01764867|Mirtazapine|mirtazapine|mesh-list
92463774|NCT01764867|Fluvoxamine|fluvoxamine|mesh-list
92463775|NCT01764867|Trazodone|trazodone|mesh-list
92463776|NCT01764867|Citalopram|citalopram|mesh-list
92463777|NCT01764867|Bupropion|bupropion|mesh-list
92463778|NCT01764867|Fluoxetine|fluoxetine|mesh-list
92463779|NCT01764867|Paroxetine|paroxetine|mesh-list
92463780|NCT01764867|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92463781|NCT01764867|Sertraline|sertraline|mesh-list
92463782|NCT01764867|Escitalopram|escitalopram|mesh-list
92463783|NCT01764867|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92463784|NCT01764867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92463785|NCT01764867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463786|NCT01764867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463787|NCT01764867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463788|NCT01764867|Serotonin Agents|serotonin agents|mesh-ancestor
92463789|NCT01764867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463790|NCT01764867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92463791|NCT01764867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92463792|NCT01764867|Parasympatholytics|parasympatholytics|mesh-ancestor
92463793|NCT01764867|Autonomic Agents|autonomic agents|mesh-ancestor
92463794|NCT01764867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463795|NCT01764867|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92463796|NCT01764867|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92463797|NCT01764867|Cholinergic Agents|cholinergic agents|mesh-ancestor
92463798|NCT01764867|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92463799|NCT01764867|Antidepressive Agents|antidepressive agents|mesh-ancestor
92463800|NCT01764867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92463801|NCT01764867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92463802|NCT01764867|Dopamine Agents|dopamine agents|mesh-ancestor
92463803|NCT01764867|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92463804|NCT01764867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92463805|NCT01764867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463806|NCT01764867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92463807|NCT01764867|Analgesics|analgesics|mesh-ancestor
92463808|NCT01764867|Sensory System Agents|sensory system agents|mesh-ancestor
92463809|NCT01764867|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92463810|NCT01764867|Histamine Antagonists|histamine antagonists|mesh-ancestor
92463811|NCT01764867|Histamine Agents|histamine agents|mesh-ancestor
92463812|NCT01764867|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92463813|NCT01764867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92463814|NCT01764867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463815|NCT01764867|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92463816|NCT01764867|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92463817|NCT01764867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92463818|NCT01764867|Adrenergic Agents|adrenergic agents|mesh-ancestor
92463819|NCT01764867|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92463820|NCT01764867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92463821|NCT01764867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92463822|NCT01764867|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92463823|NCT01764867|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92463824|NCT01764893|Solifenacin Succinate|solifenacin succinate|mesh-list
92463825|NCT01764893|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92463826|NCT01764893|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92463827|NCT01764893|Cholinergic Agents|cholinergic agents|mesh-ancestor
92463828|NCT01764893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463829|NCT01764893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463830|NCT01764893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463831|NCT01764893|Urological Agents|urological agents|mesh-ancestor
92463832|NCT01765010|Cholecalciferol|cholecalciferol|mesh-list
92463833|NCT01765010|Vitamin D|vitamin d|mesh-list
92463834|NCT01765010|Calcitriol|calcitriol|mesh-list
92463835|NCT01765010|Alfacalcidol|alfacalcidol|mesh-list
92463836|NCT01765010|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92463837|NCT01765010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92717882|NCT02901977|Ramipril|ramipril|mesh-list
92463838|NCT01765010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463839|NCT01765010|Vitamins|vitamins|mesh-ancestor
92463840|NCT01765010|Micronutrients|micronutrients|mesh-ancestor
92463841|NCT01765010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92463842|NCT01765010|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92463843|NCT01765010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463844|NCT01765010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463845|NCT01765010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92463846|NCT01765023|Metformin|metformin|mesh-list
92463847|NCT01765023|Atorvastatin|atorvastatin|mesh-list
92463848|NCT01765023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92463849|NCT01765023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463850|NCT01765023|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92463851|NCT01765023|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92463852|NCT01765023|Antimetabolites|antimetabolites|mesh-ancestor
92463853|NCT01765023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463854|NCT01765023|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92463855|NCT01765023|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92463856|NCT01765023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463857|NCT01765088|Temozolomide|temozolomide|mesh-list
92463858|NCT01765088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92463859|NCT01765088|Alkylating Agents|alkylating agents|mesh-ancestor
92463860|NCT01765088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463861|NCT01765088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463862|NCT01765231|Entecavir|entecavir|mesh-list
92463863|NCT01765231|Antiviral Agents|antiviral agents|mesh-ancestor
92463864|NCT01765231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463865|NCT01765257|Rasagiline|rasagiline|mesh-list
92463866|NCT01765257|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92463867|NCT01765257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463868|NCT01765257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463869|NCT01765257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92463870|NCT01765257|Protective Agents|protective agents|mesh-ancestor
92463871|NCT01765257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463872|NCT01765309|Botulinum Toxins|botulinum toxins|mesh-list
92463873|NCT01765309|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92463874|NCT01765309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463875|NCT01765309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463876|NCT01765309|Cholinergic Agents|cholinergic agents|mesh-ancestor
92463877|NCT01765309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463878|NCT01765309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463879|NCT01765374|Rituximab|rituximab|mesh-list
92463880|NCT01765374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92463881|NCT01765374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463882|NCT01765374|Immunologic Factors|immunologic factors|mesh-ancestor
92463883|NCT01765374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463884|NCT01765374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463885|NCT01765452|Clopidogrel|clopidogrel|mesh-list
92463886|NCT01765452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92463887|NCT01765452|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92463888|NCT01765452|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92463889|NCT01765452|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92463890|NCT01765452|Purinergic Agents|purinergic agents|mesh-ancestor
92463891|NCT01765452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463892|NCT01765452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463893|NCT01765452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463894|NCT01765556|Ketoconazole|ketoconazole|mesh-list
92463895|NCT01765556|Vemurafenib|vemurafenib|mesh-list
92463896|NCT01765556|Antifungal Agents|antifungal agents|mesh-ancestor
92463897|NCT01765556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463898|NCT01765556|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92463899|NCT01765556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92463900|NCT01765556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463901|NCT01765556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463902|NCT01765556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92463903|NCT01765556|Hormone Antagonists|hormone antagonists|mesh-ancestor
92463904|NCT01765556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92463905|NCT01765556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463906|NCT01765556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92463907|NCT01765556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463908|NCT01765556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92463909|NCT01765608|Zonisamide|zonisamide|mesh-list
92463910|NCT01765608|Anticonvulsants|anticonvulsants|mesh-ancestor
92463911|NCT01765608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92463912|NCT01765608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463913|NCT01765608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463914|NCT01765608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92463915|NCT01765608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463916|NCT01765738|Minocycline|minocycline|mesh-list
92463917|NCT01765738|Rifampin|rifampin|mesh-list
92463918|NCT01765738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92463919|NCT01765738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92463920|NCT01765738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92463921|NCT01765738|Antitubercular Agents|antitubercular agents|mesh-ancestor
92463922|NCT01765738|Leprostatic Agents|leprostatic agents|mesh-ancestor
92463923|NCT01765738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92463924|NCT01765738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463925|NCT01765738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463926|NCT01765738|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92463927|NCT01765738|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92463928|NCT01765738|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92463929|NCT01765738|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92463930|NCT01765738|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92463931|NCT01765738|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92463932|NCT01765790|Antibodies|antibodies|mesh-list
92463933|NCT01765790|Immunoglobulins|immunoglobulins|mesh-list
92463934|NCT01765790|Immunologic Factors|immunologic factors|mesh-ancestor
92463935|NCT01765790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463936|NCT01765829|Droperidol|droperidol|mesh-list
92463937|NCT01765829|Haloperidol|haloperidol|mesh-list
92463938|NCT01765829|Pimozide|pimozide|mesh-list
92463939|NCT01765829|Olanzapine|olanzapine|mesh-list
92463940|NCT01765829|Chlorpromazine|chlorpromazine|mesh-list
92463941|NCT01765829|Trifluoperazine|trifluoperazine|mesh-list
92463942|NCT01765829|Risperidone|risperidone|mesh-list
92463943|NCT01765829|Aripiprazole|aripiprazole|mesh-list
92463944|NCT01765829|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92463945|NCT01765829|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92463946|NCT01765829|Ziprasidone|ziprasidone|mesh-list
92463947|NCT01765829|Antipsychotic Agents|antipsychotic agents|mesh-list
92463948|NCT01765829|Clozapine|clozapine|mesh-list
92463949|NCT01765829|Asenapine|asenapine|mesh-list
92463950|NCT01765829|Amisulpride|amisulpride|mesh-list
92463951|NCT01765829|Perphenazine|perphenazine|mesh-list
92463952|NCT01765829|Sertindole|sertindole|mesh-list
92463953|NCT01765829|Sulpiride|sulpiride|mesh-list
92463954|NCT01765829|Clopenthixol|clopenthixol|mesh-list
92463955|NCT01765829|Clothiapine|clothiapine|mesh-list
92463956|NCT01765829|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92463957|NCT01765829|Serotonin Agents|serotonin agents|mesh-ancestor
92463958|NCT01765829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92463959|NCT01765829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463960|NCT01765829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463961|NCT01765829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92463962|NCT01765829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92463963|NCT01765829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92463964|NCT01765829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92463965|NCT01765829|Dopamine Agents|dopamine agents|mesh-ancestor
92463966|NCT01765829|Antiemetics|antiemetics|mesh-ancestor
92463967|NCT01765829|Autonomic Agents|autonomic agents|mesh-ancestor
92463968|NCT01765829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92463969|NCT01765829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92463970|NCT01765829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92463971|NCT01765829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92463972|NCT01765829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92463973|NCT01765829|Antidepressive Agents|antidepressive agents|mesh-ancestor
92463974|NCT01765829|Dopamine Agonists|dopamine agonists|mesh-ancestor
92463975|NCT01765829|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92463976|NCT01765829|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92463977|NCT01765829|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92463978|NCT01765829|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92463979|NCT01765829|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92463980|NCT01765829|GABA Antagonists|gaba antagonists|mesh-ancestor
92463981|NCT01765829|GABA Agents|gaba agents|mesh-ancestor
92463982|NCT01765829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92463983|NCT01765829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92463984|NCT01765842|Rituximab|rituximab|mesh-list
92463985|NCT01765842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92463986|NCT01765842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92463987|NCT01765842|Immunologic Factors|immunologic factors|mesh-ancestor
92463988|NCT01765842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92463989|NCT01765842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92463991|NCT01765855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92463992|NCT01765855|Antithrombins|antithrombins|mesh-ancestor
92463993|NCT01765855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92463994|NCT01765855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92463995|NCT01765855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92463996|NCT01765855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92463997|NCT01765855|Anticoagulants|anticoagulants|mesh-ancestor
92463998|NCT01765868|Betrixaban|betrixaban|mesh-list
92463999|NCT01765868|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92464000|NCT01765868|Antithrombins|antithrombins|mesh-ancestor
92464001|NCT01765868|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92464002|NCT01765868|Protease Inhibitors|protease inhibitors|mesh-ancestor
92464003|NCT01765868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464004|NCT01765868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464005|NCT01765868|Anticoagulants|anticoagulants|mesh-ancestor
92464006|NCT01765881|Misoprostol|misoprostol|mesh-list
92464007|NCT01765881|Dinoprostone|dinoprostone|mesh-list
92464008|NCT01765881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92464009|NCT01765881|Abortifacient Agents|abortifacient agents|mesh-ancestor
92464010|NCT01765881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92464011|NCT01765881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464012|NCT01765881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92464013|NCT01765881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464014|NCT01765881|Oxytocics|oxytocics|mesh-ancestor
92464015|NCT01765946|Metformin|metformin|mesh-list
92464016|NCT01765946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92464017|NCT01765946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464018|NCT01766063|Interferons|interferons|mesh-list
92464019|NCT01766063|Interferon-beta|interferon-beta|mesh-list
92464020|NCT01766063|Interferon beta-1b|interferon beta-1b|mesh-list
92464021|NCT01766063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464022|NCT01766063|Antiviral Agents|antiviral agents|mesh-ancestor
92464023|NCT01766063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464024|NCT01766063|Immunologic Factors|immunologic factors|mesh-ancestor
92464025|NCT01766063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464026|NCT01766063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92464027|NCT01766089|Dexmedetomidine|dexmedetomidine|mesh-list
92464028|NCT01766089|Remifentanil|remifentanil|mesh-list
92464029|NCT01766089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92464030|NCT01766089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464031|NCT01766089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464032|NCT01766089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92464033|NCT01766089|Analgesics|analgesics|mesh-ancestor
92464034|NCT01766089|Sensory System Agents|sensory system agents|mesh-ancestor
92464035|NCT01766089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464036|NCT01766089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92464037|NCT01766089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92464038|NCT01766089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92464039|NCT01766089|Adrenergic Agents|adrenergic agents|mesh-ancestor
92464040|NCT01766089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464041|NCT01766089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464042|NCT01766089|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92464043|NCT01766089|Narcotics|narcotics|mesh-ancestor
92464044|NCT01766154|Tirofiban|tirofiban|mesh-list
92464045|NCT01766154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92464046|NCT01766154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92464047|NCT01766154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464048|NCT01766154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92464049|NCT01766180|Resveratrol|resveratrol|mesh-list
92464050|NCT01766180|Antioxidants|antioxidants|mesh-ancestor
92464051|NCT01766180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464052|NCT01766180|Protective Agents|protective agents|mesh-ancestor
92464053|NCT01766180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464054|NCT01766180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464055|NCT01766180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92464056|NCT01766258|Carbidopa|carbidopa|mesh-list
92464057|NCT01766258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92464058|NCT01766258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92464059|NCT01766258|Dopamine Agents|dopamine agents|mesh-ancestor
92464060|NCT01766258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464061|NCT01766258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464062|NCT01766258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464063|NCT01766258|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92464064|NCT01766258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464066|NCT01766323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92464067|NCT01766323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464068|NCT01766323|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92464069|NCT01766323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92464070|NCT01766323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92464071|NCT01766323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464072|NCT01766375|Cyclosporine|cyclosporine|mesh-list
92464073|NCT01766375|Mycophenolic Acid|mycophenolic acid|mesh-list
92464074|NCT01766375|Methotrexate|methotrexate|mesh-list
92464075|NCT01766375|Cyclosporins|cyclosporins|mesh-list
92464076|NCT01766375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92464077|NCT01766375|Abortifacient Agents|abortifacient agents|mesh-ancestor
92464078|NCT01766375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92464079|NCT01766375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464080|NCT01766375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92464081|NCT01766375|Antimetabolites|antimetabolites|mesh-ancestor
92464082|NCT01766375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464083|NCT01766375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464084|NCT01766375|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464085|NCT01766375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464086|NCT01766375|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92464087|NCT01766375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464088|NCT01766375|Immunologic Factors|immunologic factors|mesh-ancestor
92464089|NCT01766375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92464090|NCT01766375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92464091|NCT01766375|Antifungal Agents|antifungal agents|mesh-ancestor
92464092|NCT01766375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464093|NCT01766375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92464094|NCT01766375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92464095|NCT01766375|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92464096|NCT01766375|Antitubercular Agents|antitubercular agents|mesh-ancestor
92464097|NCT01766375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464098|NCT01766414|Complement C1s|complement c1s|mesh-list
92464099|NCT01766414|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92464100|NCT01766414|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92464101|NCT01766414|Immunologic Factors|immunologic factors|mesh-ancestor
92464102|NCT01766414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464103|NCT01766414|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92464104|NCT01766414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464105|NCT01766518|Mycophenolic Acid|mycophenolic acid|mesh-list
92464106|NCT01766518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92464107|NCT01766518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464108|NCT01766518|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92464109|NCT01766518|Antitubercular Agents|antitubercular agents|mesh-ancestor
92464110|NCT01766518|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464111|NCT01766518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464112|NCT01766518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464113|NCT01766518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464114|NCT01766583|Lenalidomide|lenalidomide|mesh-list
92464115|NCT01766583|Immunologic Factors|immunologic factors|mesh-ancestor
92464116|NCT01766583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464117|NCT01766583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92464118|NCT01766583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92464119|NCT01766583|Growth Substances|growth substances|mesh-ancestor
92464120|NCT01766583|Growth Inhibitors|growth inhibitors|mesh-ancestor
92464121|NCT01766583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464122|NCT01766609|Triamcinolone|triamcinolone|mesh-list
92464123|NCT01766609|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92464124|NCT01766609|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92464125|NCT01766609|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92464126|NCT01766609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464127|NCT01766609|Glucocorticoids|glucocorticoids|mesh-ancestor
92464129|NCT01766609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464130|NCT01766609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464131|NCT01766609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464132|NCT01766609|Immunologic Factors|immunologic factors|mesh-ancestor
92464133|NCT01766609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464134|NCT01766609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464135|NCT01766830|Immunoglobulin G|immunoglobulin g|mesh-list
92464136|NCT01766830|Immunoglobulin M|immunoglobulin m|mesh-list
92464137|NCT01766830|Immunologic Factors|immunologic factors|mesh-ancestor
92464138|NCT01766830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464139|NCT01766843|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92464140|NCT01766843|Charcoal|charcoal|mesh-list
92531618|NCT00047242|Irinotecan|irinotecan|mesh-list
92464141|NCT01766843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92464142|NCT01766843|Autonomic Agents|autonomic agents|mesh-ancestor
92464143|NCT01766843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464144|NCT01766843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464145|NCT01766843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92464146|NCT01766843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464147|NCT01766843|Glucocorticoids|glucocorticoids|mesh-ancestor
92464148|NCT01766843|Hormones|hormones|mesh-ancestor
92348349|NCT01585038|Efavirenz|efavirenz|mesh-list
92464149|NCT01766843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464150|NCT01766843|Sympathomimetics|sympathomimetics|mesh-ancestor
92464151|NCT01766843|Antidotes|antidotes|mesh-ancestor
92464152|NCT01766843|Protective Agents|protective agents|mesh-ancestor
92464153|NCT01766960|Morphine|morphine|mesh-list
92464154|NCT01766960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92464155|NCT01766960|Narcotics|narcotics|mesh-ancestor
92464156|NCT01766960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464157|NCT01766960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464158|NCT01766960|Analgesics|analgesics|mesh-ancestor
92464159|NCT01766960|Sensory System Agents|sensory system agents|mesh-ancestor
92464160|NCT01766960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464161|NCT01767025|Oxytocin|oxytocin|mesh-list
92464162|NCT01767025|Oxytocics|oxytocics|mesh-ancestor
92464163|NCT01767025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92464164|NCT01767025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464165|NCT01767090|Leuprolide|leuprolide|mesh-list
92464166|NCT01767090|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92464167|NCT01767090|Fertility Agents|fertility agents|mesh-ancestor
92464168|NCT01767090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92464169|NCT01767090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464170|NCT01767090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92464171|NCT01767090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464172|NCT01767259|Valsartan|valsartan|mesh-list
92464173|NCT01767259|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92464174|NCT01767259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92464175|NCT01767259|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92464176|NCT01767259|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92464177|NCT01767259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464178|NCT01767259|Diuretics|diuretics|mesh-ancestor
92464179|NCT01767259|Natriuretic Agents|natriuretic agents|mesh-ancestor
92464180|NCT01767259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464181|NCT01767259|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92464182|NCT01767259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464183|NCT01767272|Fexofenadine|fexofenadine|mesh-list
92464184|NCT01767272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92464185|NCT01767272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92464186|NCT01767272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92464187|NCT01767272|Histamine Antagonists|histamine antagonists|mesh-ancestor
92464188|NCT01767272|Histamine Agents|histamine agents|mesh-ancestor
92464189|NCT01767272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464190|NCT01767272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464191|NCT01767272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464192|NCT01767298|Valsartan|valsartan|mesh-list
92464193|NCT01767298|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92464194|NCT01767298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92464195|NCT01767298|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92464196|NCT01767298|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92464197|NCT01767298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464198|NCT01767298|Diuretics|diuretics|mesh-ancestor
92464199|NCT01767298|Natriuretic Agents|natriuretic agents|mesh-ancestor
92464200|NCT01767298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464201|NCT01767298|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92464202|NCT01767298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464203|NCT01767363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92464204|NCT01767363|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
92464205|NCT01767363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92464206|NCT01767363|Adrenergic Agents|adrenergic agents|mesh-ancestor
92464207|NCT01767363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464208|NCT01767363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189128|NCT01791751|Clomiphene|clomiphene|mesh-list
92464209|NCT01767363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464210|NCT01767363|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92464211|NCT01767363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464212|NCT01767363|Hormone Antagonists|hormone antagonists|mesh-ancestor
92464213|NCT01767363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464214|NCT01767389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92464215|NCT01767389|Protease Inhibitors|protease inhibitors|mesh-ancestor
92464216|NCT01767389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464217|NCT01767389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464218|NCT01767389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92464219|NCT01767389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464220|NCT01767402|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92464221|NCT01767402|Immunologic Factors|immunologic factors|mesh-ancestor
92464222|NCT01767402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464223|NCT01767428|Acetaminophen|acetaminophen|mesh-list
92464224|NCT01767428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92464225|NCT01767428|Analgesics|analgesics|mesh-ancestor
92464227|NCT01767428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464228|NCT01767428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464229|NCT01767428|Antipyretics|antipyretics|mesh-ancestor
92464230|NCT01767454|Ipilimumab|ipilimumab|mesh-list
92464231|NCT01767454|Trametinib|trametinib|mesh-list
92464232|NCT01767454|Dabrafenib|dabrafenib|mesh-list
92464233|NCT01767454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92464234|NCT01767454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464235|NCT01767454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92464236|NCT01767454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464237|NCT01767454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92464238|NCT01767454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464239|NCT01767532|Cephalexin|cephalexin|mesh-list
92464240|NCT01767532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464241|NCT01767532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464242|NCT01767545|Dexamethasone|dexamethasone|mesh-list
92464243|NCT01767545|Bevacizumab|bevacizumab|mesh-list
92464244|NCT01767545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92464245|NCT01767545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464246|NCT01767545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92464247|NCT01767545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92464248|NCT01767545|Growth Substances|growth substances|mesh-ancestor
92464249|NCT01767545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464250|NCT01767545|Growth Inhibitors|growth inhibitors|mesh-ancestor
92464251|NCT01767545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464252|NCT01767545|Antiemetics|antiemetics|mesh-ancestor
92464253|NCT01767545|Autonomic Agents|autonomic agents|mesh-ancestor
92464254|NCT01767545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464255|NCT01767545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464256|NCT01767545|Glucocorticoids|glucocorticoids|mesh-ancestor
92464257|NCT01767545|Hormones|hormones|mesh-ancestor
92464258|NCT01767545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464259|NCT01767545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92464260|NCT01767571|Cephalexin|cephalexin|mesh-list
92464261|NCT01767571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464262|NCT01767571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464263|NCT01767584|Cephalexin|cephalexin|mesh-list
92464264|NCT01767584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464265|NCT01767584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464266|NCT01767623|Vemurafenib|vemurafenib|mesh-list
92464267|NCT01767623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464268|NCT01767623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92464269|NCT01767623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464270|NCT01767623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464271|NCT01767714|Plerixafor|plerixafor|mesh-list
92464272|NCT01767714|Lenograstim|lenograstim|mesh-list
92464273|NCT01767714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92464274|NCT01767714|Immunologic Factors|immunologic factors|mesh-ancestor
92464275|NCT01767714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464276|NCT01767714|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92464277|NCT01767714|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92464278|NCT01767714|Antiviral Agents|antiviral agents|mesh-ancestor
92464279|NCT01767714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464280|NCT01767896|Vaccines|vaccines|mesh-list
92464281|NCT01767896|Immunologic Factors|immunologic factors|mesh-ancestor
92464282|NCT01767896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464283|NCT01768039|Vitamin D|vitamin d|mesh-list
92189196|NCT04005599|Analgesics|analgesics|mesh-ancestor
92464284|NCT01768039|Vitamins|vitamins|mesh-ancestor
92464285|NCT01768039|Micronutrients|micronutrients|mesh-ancestor
92464286|NCT01768039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464287|NCT01768039|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92464288|NCT01767610|Infliximab|infliximab|mesh-list
92464289|NCT01767610|Fenofibrate|fenofibrate|mesh-list
92464290|NCT01767610|Pitavastatin|pitavastatin|mesh-list
92464291|NCT01767610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92464292|NCT01767610|Antimetabolites|antimetabolites|mesh-ancestor
92464293|NCT01767610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464294|NCT01767610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92464295|NCT01767610|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92464296|NCT01767610|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92464297|NCT01767610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464298|NCT01767610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92464299|NCT01767610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464300|NCT01767610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464301|NCT01767610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464302|NCT01767610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92464303|NCT01768078|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92464304|NCT01768078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92464305|NCT01768078|Betamethasone|betamethasone|mesh-list
92464306|NCT01768078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464307|NCT01768078|Antitubercular Agents|antitubercular agents|mesh-ancestor
92464308|NCT01768078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464309|NCT01768078|Glucocorticoids|glucocorticoids|mesh-ancestor
92464310|NCT01768078|Hormones|hormones|mesh-ancestor
92464311|NCT01768078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464312|NCT01768078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464313|NCT01768078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92464314|NCT01768078|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464315|NCT01768182|Leucovorin|leucovorin|mesh-list
92464316|NCT01768182|Folic Acid|folic acid|mesh-list
92464317|NCT01768182|Levoleucovorin|levoleucovorin|mesh-list
92464318|NCT01768182|Antidotes|antidotes|mesh-ancestor
92464319|NCT01768182|Protective Agents|protective agents|mesh-ancestor
92464320|NCT01768182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464321|NCT01768182|Vitamin B Complex|vitamin b complex|mesh-ancestor
92464322|NCT01768182|Vitamins|vitamins|mesh-ancestor
92464323|NCT01768182|Micronutrients|micronutrients|mesh-ancestor
92464324|NCT01768182|Hematinics|hematinics|mesh-ancestor
92464325|NCT01768195|Entecavir|entecavir|mesh-list
92464326|NCT01768195|Antiviral Agents|antiviral agents|mesh-ancestor
92464327|NCT01768195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464328|NCT01768208|Saxagliptin|saxagliptin|mesh-list
92464329|NCT01768208|Incretins|incretins|mesh-ancestor
92464330|NCT01768208|Hormones|hormones|mesh-ancestor
92464331|NCT01768208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464332|NCT01768208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464333|NCT01768208|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92464334|NCT01768208|Protease Inhibitors|protease inhibitors|mesh-ancestor
92464335|NCT01768208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464336|NCT01768208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464337|NCT01768208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92464338|NCT01768247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92464339|NCT01768247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92464340|NCT01768247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464341|NCT01768260|Aspirin|aspirin|mesh-list
92464342|NCT01768260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92464343|NCT01768260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92464344|NCT01768260|Analgesics|analgesics|mesh-ancestor
92464345|NCT01768260|Sensory System Agents|sensory system agents|mesh-ancestor
92464346|NCT01768260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464347|NCT01768260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464348|NCT01768260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464349|NCT01768260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92464350|NCT01768260|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92464351|NCT01768260|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92464352|NCT01768260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464353|NCT01768260|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92464354|NCT01768260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92464355|NCT01768260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464356|NCT01768260|Antipyretics|antipyretics|mesh-ancestor
92464357|NCT01768273|Midazolam|midazolam|mesh-list
92189270|NCT01790087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464358|NCT01768273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92464359|NCT01768273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92717883|NCT02901977|Doxazosin|doxazosin|mesh-list
92348360|NCT01585038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92464360|NCT01768273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464361|NCT01768273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464363|NCT01768273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92464364|NCT01768273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92464365|NCT01768273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92464366|NCT01768273|Anesthetics, General|anesthetics, general|mesh-ancestor
92464367|NCT01768273|Anesthetics|anesthetics|mesh-ancestor
92464368|NCT01768273|GABA Modulators|gaba modulators|mesh-ancestor
92464369|NCT01768273|GABA Agents|gaba agents|mesh-ancestor
92464370|NCT01768273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464371|NCT01768273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464372|NCT01768299|Misoprostol|misoprostol|mesh-list
92464373|NCT01768299|Mifepristone|mifepristone|mesh-list
92464374|NCT01768299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92464375|NCT01768299|Abortifacient Agents|abortifacient agents|mesh-ancestor
92464376|NCT01768299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92464377|NCT01768299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464378|NCT01768299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92464379|NCT01768299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464380|NCT01768299|Oxytocics|oxytocics|mesh-ancestor
92464381|NCT01768299|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92464382|NCT01768299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92464383|NCT01768299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92464384|NCT01768299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92464385|NCT01768299|Contraceptive Agents|contraceptive agents|mesh-ancestor
92464386|NCT01768299|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92464387|NCT01768299|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92464388|NCT01768299|Hormone Antagonists|hormone antagonists|mesh-ancestor
92464389|NCT01768299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464390|NCT01768299|Luteolytic Agents|luteolytic agents|mesh-ancestor
92464391|NCT01768299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92464392|NCT01768299|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92464393|NCT01768312|Cyclosporine|cyclosporine|mesh-list
92464394|NCT01768312|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92464395|NCT01768312|Cyclosporins|cyclosporins|mesh-list
92464396|NCT01768312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464397|NCT01768312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464398|NCT01768312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464399|NCT01768312|Immunologic Factors|immunologic factors|mesh-ancestor
92464400|NCT01768312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464401|NCT01768312|Antifungal Agents|antifungal agents|mesh-ancestor
92464402|NCT01768312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464403|NCT01768312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464404|NCT01768312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92464405|NCT01768312|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92464406|NCT01768312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92464407|NCT01768351|Calcitriol|calcitriol|mesh-list
92464408|NCT01768351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92464409|NCT01768351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464410|NCT01768351|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92464411|NCT01768351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464412|NCT01768351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464413|NCT01768351|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92464414|NCT01768351|Vitamins|vitamins|mesh-ancestor
92464415|NCT01768351|Micronutrients|micronutrients|mesh-ancestor
92464416|NCT01768351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92464417|NCT01768364|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92464418|NCT01768364|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92464419|NCT01768364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464420|NCT01768364|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92464421|NCT01768364|Antimalarials|antimalarials|mesh-ancestor
92464422|NCT01768364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92464423|NCT01768364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92464424|NCT01768377|Lidocaine|lidocaine|mesh-list
92464425|NCT01768377|Fentanyl|fentanyl|mesh-list
92464426|NCT01768377|Midazolam|midazolam|mesh-list
92464427|NCT01768377|Anesthetics, Local|anesthetics, local|mesh-ancestor
92464428|NCT01768377|Anesthetics|anesthetics|mesh-ancestor
92464429|NCT01768377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464430|NCT01768377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464431|NCT01768377|Sensory System Agents|sensory system agents|mesh-ancestor
92464432|NCT01768377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464434|NCT01768377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92464436|NCT01768377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464437|NCT01768377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464438|NCT01768377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92464439|NCT01768377|Narcotics|narcotics|mesh-ancestor
92464440|NCT01768377|Analgesics|analgesics|mesh-ancestor
92464441|NCT01768377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92464442|NCT01768377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92464443|NCT01768377|Anesthetics, General|anesthetics, general|mesh-ancestor
92464444|NCT01768377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92464445|NCT01768377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92464446|NCT01768377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92464447|NCT01768377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92464448|NCT01768377|GABA Modulators|gaba modulators|mesh-ancestor
92464449|NCT01768377|GABA Agents|gaba agents|mesh-ancestor
92464450|NCT01768377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464451|NCT01768390|Fluorides|fluorides|mesh-list
92464452|NCT01768390|Cariostatic Agents|cariostatic agents|mesh-ancestor
92464453|NCT01768390|Protective Agents|protective agents|mesh-ancestor
92464454|NCT01768390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464455|NCT01768455|Glimepiride|glimepiride|mesh-list
92464456|NCT01768455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92464457|NCT01768455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92464458|NCT01768455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464459|NCT01768455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464460|NCT01768455|Immunologic Factors|immunologic factors|mesh-ancestor
92464461|NCT01768481|Atorvastatin|atorvastatin|mesh-list
92464462|NCT01768481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92464463|NCT01768481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92464464|NCT01768481|Antimetabolites|antimetabolites|mesh-ancestor
92464465|NCT01768481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464466|NCT01768481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92464467|NCT01768481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92464468|NCT01768481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464469|NCT01768507|Resveratrol|resveratrol|mesh-list
92464470|NCT01768507|Antioxidants|antioxidants|mesh-ancestor
92464471|NCT01768507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464472|NCT01768507|Protective Agents|protective agents|mesh-ancestor
92464473|NCT01768507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464474|NCT01768507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464475|NCT01768507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92464476|NCT01768663|Itraconazole|itraconazole|mesh-list
92464477|NCT01768663|Ciprofloxacin|ciprofloxacin|mesh-list
92464478|NCT01768663|Rifampin|rifampin|mesh-list
92464479|NCT01768663|Ivacaftor|ivacaftor|mesh-list
92464480|NCT01768663|Antifungal Agents|antifungal agents|mesh-ancestor
92464481|NCT01768663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464482|NCT01768663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92464483|NCT01768663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92464484|NCT01768663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464485|NCT01768663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464486|NCT01768663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92464487|NCT01768663|Hormone Antagonists|hormone antagonists|mesh-ancestor
92464488|NCT01768663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464489|NCT01768663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464490|NCT01768663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92464491|NCT01768663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464492|NCT01768663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92464493|NCT01768663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92464494|NCT01768663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464495|NCT01768663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92464496|NCT01768663|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92464497|NCT01768663|Antitubercular Agents|antitubercular agents|mesh-ancestor
92464498|NCT01768663|Leprostatic Agents|leprostatic agents|mesh-ancestor
92464499|NCT01768663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92464500|NCT01768663|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92464501|NCT01768663|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92464502|NCT01768663|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92464503|NCT01768663|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92464504|NCT01768663|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92464505|NCT01768663|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92189424|NCT04046744|Lidocaine|lidocaine|mesh-list
92464507|NCT01768663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464508|NCT01768741|Liver Extracts|liver extracts|mesh-list
92464509|NCT01768741|Hematinics|hematinics|mesh-ancestor
92464510|NCT01768780|Glycopyrrolate|glycopyrrolate|mesh-list
92464511|NCT01768780|Bupivacaine|bupivacaine|mesh-list
92464512|NCT01768780|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92464513|NCT01768780|Anesthetics, Local|anesthetics, local|mesh-ancestor
92464514|NCT01768780|Anesthetics|anesthetics|mesh-ancestor
92464515|NCT01768780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464516|NCT01768780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464517|NCT01768780|Sensory System Agents|sensory system agents|mesh-ancestor
92464518|NCT01768780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464519|NCT01768780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92464520|NCT01768780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92464521|NCT01768780|Cholinergic Agents|cholinergic agents|mesh-ancestor
92464522|NCT01768780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464523|NCT01768780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464524|NCT01768884|Nitric Oxide|nitric oxide|mesh-list
92464525|NCT01768884|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92464526|NCT01768884|Autonomic Agents|autonomic agents|mesh-ancestor
92464527|NCT01768884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464528|NCT01768884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464529|NCT01768884|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92464530|NCT01768884|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464531|NCT01768884|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92464532|NCT01768884|Antioxidants|antioxidants|mesh-ancestor
92464533|NCT01768884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464534|NCT01768884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464535|NCT01768884|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92464536|NCT01768884|Vasodilator Agents|vasodilator agents|mesh-ancestor
92464537|NCT01768884|Gasotransmitters|gasotransmitters|mesh-ancestor
92464538|NCT01768884|Protective Agents|protective agents|mesh-ancestor
92464539|NCT01768897|Thioctic Acid|thioctic acid|mesh-list
92464540|NCT01768897|Cytarabine|cytarabine|mesh-list
92464541|NCT01768897|Mitoxantrone|mitoxantrone|mesh-list
92464542|NCT01768897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92464543|NCT01768897|Antimetabolites|antimetabolites|mesh-ancestor
92464544|NCT01768897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464545|NCT01768897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464546|NCT01768897|Antiviral Agents|antiviral agents|mesh-ancestor
92464547|NCT01768897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464548|NCT01768897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464549|NCT01768897|Immunologic Factors|immunologic factors|mesh-ancestor
92464550|NCT01768897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464551|NCT01768897|Analgesics|analgesics|mesh-ancestor
92464552|NCT01768897|Sensory System Agents|sensory system agents|mesh-ancestor
92464553|NCT01768897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464554|NCT01768897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92464555|NCT01768897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92464556|NCT01768897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464557|NCT01768897|Antioxidants|antioxidants|mesh-ancestor
92464558|NCT01768897|Protective Agents|protective agents|mesh-ancestor
92464559|NCT01768897|Vitamin B Complex|vitamin b complex|mesh-ancestor
92464560|NCT01768897|Vitamins|vitamins|mesh-ancestor
92464561|NCT01768897|Micronutrients|micronutrients|mesh-ancestor
92464562|NCT01768988|Pregabalin|pregabalin|mesh-list
92464563|NCT01768988|Analgesics|analgesics|mesh-ancestor
92464564|NCT01768988|Sensory System Agents|sensory system agents|mesh-ancestor
92464565|NCT01768988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464566|NCT01768988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464567|NCT01768988|Anticonvulsants|anticonvulsants|mesh-ancestor
92464568|NCT01768988|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92464569|NCT01768988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464570|NCT01768988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464571|NCT01768988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92464572|NCT01768988|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92464573|NCT01768988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92464574|NCT01768988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464575|NCT01768988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92464576|NCT01769040|Rifaximin|rifaximin|mesh-list
92464577|NCT01769040|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464578|NCT01769040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464579|NCT01769040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464580|NCT01769066|Pemetrexed|pemetrexed|mesh-list
92464581|NCT01769066|Gefitinib|gefitinib|mesh-list
92464582|NCT01769066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464583|NCT01769066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464584|NCT01769066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464585|NCT01769066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92464586|NCT01769066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92464587|NCT01769066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92464588|NCT01769079|Isosorbide|isosorbide|mesh-list
92464589|NCT01769079|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92464590|NCT01769079|Diuretics|diuretics|mesh-ancestor
92464591|NCT01769079|Natriuretic Agents|natriuretic agents|mesh-ancestor
92464592|NCT01769079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464593|NCT01769118|Caffeine|caffeine|mesh-list
92464594|NCT01769118|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92464595|NCT01769118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464596|NCT01769118|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92464597|NCT01769118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464598|NCT01769118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464599|NCT01769118|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92464600|NCT01769118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92464601|NCT01769118|Purinergic Agents|purinergic agents|mesh-ancestor
92464602|NCT01769118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464604|NCT01769183|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92464605|NCT01769183|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92464606|NCT01769183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464607|NCT01769183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464608|NCT01769183|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92464609|NCT01769183|Protective Agents|protective agents|mesh-ancestor
92464610|NCT01769183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464611|NCT01769183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464612|NCT01769183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92464613|NCT01769183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92464614|NCT01769183|Growth Substances|growth substances|mesh-ancestor
92464615|NCT01769183|Growth Inhibitors|growth inhibitors|mesh-ancestor
92464616|NCT01769235|Clindamycin|clindamycin|mesh-list
92464617|NCT01769235|Clindamycin palmitate|clindamycin palmitate|mesh-list
92464618|NCT01769235|Clindamycin phosphate|clindamycin phosphate|mesh-list
92464619|NCT01769235|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92464620|NCT01769235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464621|NCT01769235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464622|NCT01769235|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92464623|NCT01769235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464624|NCT01769235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464625|NCT01769235|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464626|NCT01769482|Udenafil|udenafil|mesh-list
92464627|NCT01769482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92464628|NCT01769482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92464629|NCT01769482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464630|NCT01769482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464631|NCT01769625|Vitamin D|vitamin d|mesh-list
92464632|NCT01769625|Cholecalciferol|cholecalciferol|mesh-list
92464633|NCT01769625|Celecoxib|celecoxib|mesh-list
92464634|NCT01769625|Vitamins|vitamins|mesh-ancestor
92464635|NCT01769625|Micronutrients|micronutrients|mesh-ancestor
92464636|NCT01769625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464637|NCT01769625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92464638|NCT01769625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92464639|NCT01769625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92464640|NCT01769625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92464641|NCT01769625|Analgesics|analgesics|mesh-ancestor
92464642|NCT01769625|Sensory System Agents|sensory system agents|mesh-ancestor
92464643|NCT01769625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464644|NCT01769625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464645|NCT01769625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92464646|NCT01769625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92464647|NCT01769625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92464648|NCT01769625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464649|NCT01769625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464650|NCT01769651|Methadone|methadone|mesh-list
92464651|NCT01769651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92464652|NCT01769651|Narcotics|narcotics|mesh-ancestor
92464653|NCT01769651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464654|NCT01769651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464656|NCT01769651|Sensory System Agents|sensory system agents|mesh-ancestor
92464657|NCT01769651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464659|NCT01769651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464660|NCT01769664|Clindamycin|clindamycin|mesh-list
92464661|NCT01769664|Clindamycin palmitate|clindamycin palmitate|mesh-list
92464662|NCT01769664|Clindamycin phosphate|clindamycin phosphate|mesh-list
92464663|NCT01769664|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92464664|NCT01769664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464665|NCT01769664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464666|NCT01769664|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92464667|NCT01769664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464668|NCT01769664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464669|NCT01769664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464670|NCT01769677|Hydrocodone|hydrocodone|mesh-list
92464671|NCT01769677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92464672|NCT01769677|Narcotics|narcotics|mesh-ancestor
92464673|NCT01769677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464674|NCT01769677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464676|NCT01769677|Sensory System Agents|sensory system agents|mesh-ancestor
92464677|NCT01769677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464678|NCT01769677|Antitussive Agents|antitussive agents|mesh-ancestor
92464679|NCT01769677|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464680|NCT01769703|Dabigatran|dabigatran|mesh-list
92464681|NCT01769703|Antithrombins|antithrombins|mesh-ancestor
92464682|NCT01769703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92464683|NCT01769703|Protease Inhibitors|protease inhibitors|mesh-ancestor
92464684|NCT01769703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464685|NCT01769703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464686|NCT01769703|Anticoagulants|anticoagulants|mesh-ancestor
92464687|NCT01769768|Bupropion|bupropion|mesh-list
92464688|NCT01769768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92464689|NCT01769768|Antidepressive Agents|antidepressive agents|mesh-ancestor
92464690|NCT01769768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92464691|NCT01769768|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92464692|NCT01769768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92464693|NCT01769768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464694|NCT01769768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464695|NCT01769768|Dopamine Agents|dopamine agents|mesh-ancestor
92464696|NCT01769768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464697|NCT01769768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464698|NCT01769768|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92464699|NCT01769768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92464700|NCT01769768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464701|NCT01769781|Anastrozole|anastrozole|mesh-list
92464702|NCT01769781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92464703|NCT01769781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464704|NCT01769781|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92348388|NCT01559454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92464705|NCT01769781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92464706|NCT01769781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464707|NCT01769781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464708|NCT01769781|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92464709|NCT01769781|Hormone Antagonists|hormone antagonists|mesh-ancestor
92464710|NCT01769781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464711|NCT01769781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464712|NCT01769820|Dexamethasone|dexamethasone|mesh-list
92464713|NCT01769820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464714|NCT01769820|Antiemetics|antiemetics|mesh-ancestor
92464715|NCT01769820|Autonomic Agents|autonomic agents|mesh-ancestor
92464716|NCT01769820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464717|NCT01769820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464718|NCT01769820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464719|NCT01769820|Glucocorticoids|glucocorticoids|mesh-ancestor
92464720|NCT01769820|Hormones|hormones|mesh-ancestor
92464721|NCT01769820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464722|NCT01769820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92464723|NCT01769820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464724|NCT01769833|Interferons|interferons|mesh-list
92464725|NCT01769833|Interferon-alpha|interferon-alpha|mesh-list
92464726|NCT01769833|Interferon alpha-2|interferon alpha-2|mesh-list
92464727|NCT01769833|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92464728|NCT01769833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464729|NCT01769833|Antiviral Agents|antiviral agents|mesh-ancestor
92464730|NCT01769833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464731|NCT01769833|Immunologic Factors|immunologic factors|mesh-ancestor
92464732|NCT01769833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464733|NCT01769898|Budesonide|budesonide|mesh-list
92464734|NCT01769898|Theophylline|theophylline|mesh-list
92464735|NCT01769898|Formoterol Fumarate|formoterol fumarate|mesh-list
92464736|NCT01769898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464737|NCT01769898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92464738|NCT01769898|Autonomic Agents|autonomic agents|mesh-ancestor
92464739|NCT01769898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464740|NCT01769898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464741|NCT01769898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92464742|NCT01769898|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464743|NCT01769898|Glucocorticoids|glucocorticoids|mesh-ancestor
92464744|NCT01769898|Hormones|hormones|mesh-ancestor
92464745|NCT01769898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464746|NCT01769898|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92464747|NCT01769898|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92464748|NCT01769898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92464749|NCT01769898|Adrenergic Agents|adrenergic agents|mesh-ancestor
92464750|NCT01769898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464751|NCT01769898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464752|NCT01769898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92464753|NCT01769898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464754|NCT01769898|Vasodilator Agents|vasodilator agents|mesh-ancestor
92464755|NCT01769898|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92464756|NCT01769898|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92464757|NCT01769898|Purinergic Agents|purinergic agents|mesh-ancestor
92464758|NCT01769911|Cytarabine|cytarabine|mesh-list
92464759|NCT01769911|Etoposide|etoposide|mesh-list
92464760|NCT01769911|Etoposide phosphate|etoposide phosphate|mesh-list
92464761|NCT01769911|Melphalan|melphalan|mesh-list
92464762|NCT01769911|Carmustine|carmustine|mesh-list
92464763|NCT01769911|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92464764|NCT01769911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92464765|NCT01769911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464766|NCT01769911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92464767|NCT01769911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92464768|NCT01769911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464769|NCT01769911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464770|NCT01769911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92464771|NCT01769911|Antimetabolites|antimetabolites|mesh-ancestor
92464772|NCT01769911|Antiviral Agents|antiviral agents|mesh-ancestor
92464773|NCT01769911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464774|NCT01769911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464775|NCT01769911|Immunologic Factors|immunologic factors|mesh-ancestor
92464776|NCT01769911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464777|NCT01769911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92464778|NCT01769911|Alkylating Agents|alkylating agents|mesh-ancestor
92464779|NCT01769911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92464780|NCT01769950|Choline|choline|mesh-list
92464781|NCT01769950|Lipotropic Agents|lipotropic agents|mesh-ancestor
92464782|NCT01769950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92464783|NCT01769950|Antimetabolites|antimetabolites|mesh-ancestor
92464784|NCT01769950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464785|NCT01769950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464786|NCT01769950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92464787|NCT01769950|Nootropic Agents|nootropic agents|mesh-ancestor
92464788|NCT01770041|Acetaminophen|acetaminophen|mesh-list
92464789|NCT01770041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92464790|NCT01770041|Analgesics|analgesics|mesh-ancestor
92464791|NCT01770041|Sensory System Agents|sensory system agents|mesh-ancestor
92464792|NCT01770041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464793|NCT01770041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464794|NCT01770041|Antipyretics|antipyretics|mesh-ancestor
92464795|NCT01770080|Peppermint oil|peppermint oil|mesh-list
92464796|NCT01770080|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92464797|NCT01770080|Antiemetics|antiemetics|mesh-ancestor
92464798|NCT01770080|Autonomic Agents|autonomic agents|mesh-ancestor
92464799|NCT01770080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464800|NCT01770080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464801|NCT01770080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92464802|NCT01770080|Parasympatholytics|parasympatholytics|mesh-ancestor
92464803|NCT01770106|Denosumab|denosumab|mesh-list
92464804|NCT01770106|Alendronate|alendronate|mesh-list
92464805|NCT01770106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92464806|NCT01770106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464807|NCT01770132|Gemcitabine|gemcitabine|mesh-list
92464808|NCT01770132|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92464809|NCT01770132|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92464810|NCT01770132|Trioxsalen|trioxsalen|mesh-list
92464811|NCT01770132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92464812|NCT01770132|Antimetabolites|antimetabolites|mesh-ancestor
92464813|NCT01770132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464814|NCT01770132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464815|NCT01770132|Dermatologic Agents|dermatologic agents|mesh-ancestor
92464816|NCT01770132|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92464817|NCT01770171|Paclitaxel|paclitaxel|mesh-list
92464818|NCT01770171|Bevacizumab|bevacizumab|mesh-list
92464819|NCT01770171|Carboplatin|carboplatin|mesh-list
92464820|NCT01770171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92464821|NCT01770171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464822|NCT01770171|Tubulin Modulators|tubulin modulators|mesh-ancestor
92464823|NCT01770171|Antimitotic Agents|antimitotic agents|mesh-ancestor
92464824|NCT01770171|Mitosis Modulators|mitosis modulators|mesh-ancestor
92464825|NCT01770171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464826|NCT01770171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92464827|NCT01770171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92464828|NCT01770171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92464829|NCT01770171|Growth Substances|growth substances|mesh-ancestor
92464830|NCT01770171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464831|NCT01770171|Growth Inhibitors|growth inhibitors|mesh-ancestor
92464832|NCT01770197|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92464833|NCT01770197|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92464834|NCT01770197|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92464835|NCT01770197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464836|NCT01770210|Atorvastatin|atorvastatin|mesh-list
92464837|NCT01770210|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92464838|NCT01770210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92464839|NCT01770210|Antimetabolites|antimetabolites|mesh-ancestor
92464840|NCT01770210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464841|NCT01770210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92464842|NCT01770210|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92464843|NCT01770210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464845|NCT01770223|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92464846|NCT01770223|Antimetabolites|antimetabolites|mesh-ancestor
92464847|NCT01770223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464848|NCT01770223|Antiviral Agents|antiviral agents|mesh-ancestor
92464849|NCT01770223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464850|NCT01770236|Acetaminophen|acetaminophen|mesh-list
92464851|NCT01770236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92464852|NCT01770236|Analgesics|analgesics|mesh-ancestor
92464853|NCT01770236|Sensory System Agents|sensory system agents|mesh-ancestor
92464854|NCT01770236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464855|NCT01770236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464856|NCT01770236|Antipyretics|antipyretics|mesh-ancestor
92464857|NCT01770301|Paclitaxel|paclitaxel|mesh-list
92464858|NCT01770301|Bevacizumab|bevacizumab|mesh-list
92464859|NCT01770301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92464860|NCT01770301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464861|NCT01770301|Tubulin Modulators|tubulin modulators|mesh-ancestor
92464862|NCT01770301|Antimitotic Agents|antimitotic agents|mesh-ancestor
92464863|NCT01770301|Mitosis Modulators|mitosis modulators|mesh-ancestor
92464864|NCT01770301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464865|NCT01770301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92464866|NCT01770301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92464867|NCT01770301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92464868|NCT01770301|Growth Substances|growth substances|mesh-ancestor
92464869|NCT01770301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464870|NCT01770301|Growth Inhibitors|growth inhibitors|mesh-ancestor
92464871|NCT01770444|Cytarabine|cytarabine|mesh-list
92464872|NCT01770444|Thioguanine|thioguanine|mesh-list
92464873|NCT01770444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92464874|NCT01770444|Antimetabolites|antimetabolites|mesh-ancestor
92464875|NCT01770444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464876|NCT01770444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464877|NCT01770444|Antiviral Agents|antiviral agents|mesh-ancestor
92464878|NCT01770444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464879|NCT01770444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92464880|NCT01770444|Immunologic Factors|immunologic factors|mesh-ancestor
92464881|NCT01770444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464882|NCT01770470|Chitosan|chitosan|mesh-list
92189796|NCT00397813|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92464883|NCT01770470|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92464884|NCT01770470|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92464885|NCT01770470|Antimetabolites|antimetabolites|mesh-ancestor
92464886|NCT01770470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464887|NCT01770470|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92464888|NCT01770470|Chelating Agents|chelating agents|mesh-ancestor
92464889|NCT01770470|Sequestering Agents|sequestering agents|mesh-ancestor
92464890|NCT01770470|Hemostatics|hemostatics|mesh-ancestor
92464891|NCT01770470|Coagulants|coagulants|mesh-ancestor
92464892|NCT01770600|Risperidone|risperidone|mesh-list
92464893|NCT01770600|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92464894|NCT01770600|Serotonin Agents|serotonin agents|mesh-ancestor
92464895|NCT01770600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464896|NCT01770600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464897|NCT01770600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464898|NCT01770600|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92464899|NCT01770600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92464900|NCT01770600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464901|NCT01770600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92464902|NCT01770600|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92464904|NCT01770769|Cloxacillin|cloxacillin|mesh-list
92464905|NCT01770769|Cephalothin|cephalothin|mesh-list
92464906|NCT01770769|Dalteparin|dalteparin|mesh-list
92464907|NCT01770769|Tinzaparin|tinzaparin|mesh-list
92464908|NCT01770769|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92464909|NCT01770769|Anticoagulants|anticoagulants|mesh-ancestor
92464910|NCT01770769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92464911|NCT01770769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92464912|NCT01770769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464913|NCT01770769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92464914|NCT01770769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92464915|NCT01770795|Gemcitabine|gemcitabine|mesh-list
92464916|NCT01770795|genexol-PM|genexol-pm|mesh-list
92464917|NCT01770795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92464918|NCT01770795|Antimetabolites|antimetabolites|mesh-ancestor
92464919|NCT01770795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464920|NCT01770795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464921|NCT01770795|Tubulin Modulators|tubulin modulators|mesh-ancestor
92464922|NCT01770795|Antimitotic Agents|antimitotic agents|mesh-ancestor
92464923|NCT01770795|Mitosis Modulators|mitosis modulators|mesh-ancestor
92464924|NCT01770899|Montelukast|montelukast|mesh-list
92464925|NCT01770899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92464926|NCT01770899|Respiratory System Agents|respiratory system agents|mesh-ancestor
92464927|NCT01770899|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92464928|NCT01770899|Hormone Antagonists|hormone antagonists|mesh-ancestor
92464929|NCT01770899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92464930|NCT01770899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464931|NCT01770899|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92464932|NCT01770899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92464933|NCT01770899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464934|NCT01770964|Pregabalin|pregabalin|mesh-list
92464935|NCT01770964|Analgesics|analgesics|mesh-ancestor
92464936|NCT01770964|Sensory System Agents|sensory system agents|mesh-ancestor
92464937|NCT01770964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92464938|NCT01770964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464939|NCT01770964|Anticonvulsants|anticonvulsants|mesh-ancestor
92464940|NCT01770964|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92464941|NCT01770964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92464942|NCT01770964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464943|NCT01770964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92464944|NCT01770964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92464945|NCT01770964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92464946|NCT01770964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92464947|NCT01770964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92464948|NCT01771081|Ranibizumab|ranibizumab|mesh-list
92464949|NCT01771081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92464950|NCT01771081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92464952|NCT01771081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464953|NCT01771081|Growth Inhibitors|growth inhibitors|mesh-ancestor
92464954|NCT01771081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464955|NCT01771146|Oxaliplatin|oxaliplatin|mesh-list
92464956|NCT01771146|Irinotecan|irinotecan|mesh-list
92464957|NCT01771146|Folfirinox|folfirinox|mesh-list
92189874|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
92464958|NCT01771146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464959|NCT01771146|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92464960|NCT01771146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92464961|NCT01771146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464962|NCT01771146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464963|NCT01771185|Metformin|metformin|mesh-list
92464964|NCT01771185|Gliclazide|gliclazide|mesh-list
92464965|NCT01771185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92464966|NCT01771185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464967|NCT01771198|Simvastatin|simvastatin|mesh-list
92464968|NCT01771198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92464969|NCT01771198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92464970|NCT01771198|Antimetabolites|antimetabolites|mesh-ancestor
92464971|NCT01771198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464972|NCT01771198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92464973|NCT01771198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92464974|NCT01771198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92464975|NCT01771289|Docetaxel|docetaxel|mesh-list
92464976|NCT01771289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92464977|NCT01771289|Tubulin Modulators|tubulin modulators|mesh-ancestor
92464978|NCT01771289|Antimitotic Agents|antimitotic agents|mesh-ancestor
92464979|NCT01771289|Mitosis Modulators|mitosis modulators|mesh-ancestor
92464980|NCT01771289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464981|NCT01771302|Calcium|calcium|mesh-list
92464982|NCT01771302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92464983|NCT01771302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464984|NCT01771328|Hydrocortisone|hydrocortisone|mesh-list
92464985|NCT01771328|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92464986|NCT01771328|Cortisone|cortisone|mesh-list
92464987|NCT01771328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92464988|NCT01771406|Nebivolol|nebivolol|mesh-list
92464989|NCT01771406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92464990|NCT01771406|Vasodilator Agents|vasodilator agents|mesh-ancestor
92464991|NCT01771406|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92464992|NCT01771406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92464993|NCT01771406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92464994|NCT01771406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92464995|NCT01771406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92464996|NCT01771406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92464997|NCT01771406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92464998|NCT01771432|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92464999|NCT01771432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465000|NCT01771445|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92465001|NCT01771445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465002|NCT01771458|Tamoxifen|tamoxifen|mesh-list
92465003|NCT01771458|Trastuzumab|trastuzumab|mesh-list
92465004|NCT01771458|Everolimus|everolimus|mesh-list
92465005|NCT01771458|Sorafenib|sorafenib|mesh-list
92465006|NCT01771458|Letrozole|letrozole|mesh-list
92465007|NCT01771458|Dasatinib|dasatinib|mesh-list
92465008|NCT01771458|Lapatinib|lapatinib|mesh-list
92465009|NCT01771458|Vemurafenib|vemurafenib|mesh-list
92465010|NCT01771458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92465011|NCT01771458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465012|NCT01771458|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92465013|NCT01771458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92465014|NCT01771458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465015|NCT01771458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465016|NCT01771458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465017|NCT01771458|Immunologic Factors|immunologic factors|mesh-ancestor
92465018|NCT01771458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465019|NCT01771458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92465020|NCT01771458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92465021|NCT01771458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92465022|NCT01771458|Hormone Antagonists|hormone antagonists|mesh-ancestor
92465023|NCT01771458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465024|NCT01771458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92465025|NCT01771458|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92465026|NCT01771458|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92465027|NCT01771458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92465028|NCT05318365|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92465029|NCT05318365|Laxatives|laxatives|mesh-ancestor
92465030|NCT05318365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465031|NCT01771783|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92465032|NCT01771783|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92465033|NCT01771783|Renin Inhibitors|renin inhibitors|mesh-list
92465034|NCT01771783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92465035|NCT01771783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465036|NCT01771783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92465037|NCT01771822|Ibuprofen|ibuprofen|mesh-list
92465038|NCT01771822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92465039|NCT01771822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465040|NCT01771822|Analgesics|analgesics|mesh-ancestor
92465041|NCT01771822|Sensory System Agents|sensory system agents|mesh-ancestor
92465042|NCT01771822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465043|NCT01771822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465044|NCT01771822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465045|NCT01771822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465046|NCT01771822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92465047|NCT01771822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465048|NCT01771822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465049|NCT01771874|Bupropion|bupropion|mesh-list
92465050|NCT01771874|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92465051|NCT01771874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92465052|NCT01771874|Antidepressive Agents|antidepressive agents|mesh-ancestor
92465053|NCT01771874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92465054|NCT01771874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92465055|NCT01771874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92465056|NCT01771874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465057|NCT01771874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465058|NCT01771874|Dopamine Agents|dopamine agents|mesh-ancestor
92465059|NCT01771874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465060|NCT01771874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465061|NCT01771874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92465062|NCT01771874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92465063|NCT01771874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465064|NCT01771874|Hallucinogens|hallucinogens|mesh-ancestor
92465065|NCT01771874|Serotonin Agents|serotonin agents|mesh-ancestor
92465066|NCT01771874|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92465067|NCT01771874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92465068|NCT01771978|Diltiazem|diltiazem|mesh-list
92465069|NCT01771978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92465070|NCT01771978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92465071|NCT01771978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465072|NCT01771978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465073|NCT01771978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92465074|NCT01771978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465075|NCT01771978|Vasodilator Agents|vasodilator agents|mesh-ancestor
92465076|NCT01772056|Fluticasone|fluticasone|mesh-list
92465077|NCT01772056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465078|NCT01772056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92465079|NCT01772056|Autonomic Agents|autonomic agents|mesh-ancestor
92465080|NCT01772056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465081|NCT01772056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465082|NCT01772056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92465083|NCT01772056|Respiratory System Agents|respiratory system agents|mesh-ancestor
92465084|NCT01772056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92465085|NCT01772056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92465086|NCT01772212|Terbinafine|terbinafine|mesh-list
92465087|NCT01772212|Antifungal Agents|antifungal agents|mesh-ancestor
92465088|NCT01772212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465089|NCT01772212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465090|NCT01772212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465091|NCT01772238|Amoxicillin|amoxicillin|mesh-list
92465092|NCT01772238|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92465093|NCT01772238|Clavulanic Acids|clavulanic acids|mesh-list
92465094|NCT01772238|Clavulanic Acid|clavulanic acid|mesh-list
92465095|NCT01772238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465096|NCT01772238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465097|NCT01772238|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92465098|NCT01772238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465099|NCT01772238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465100|NCT01772251|Insulin|insulin|mesh-list
92465101|NCT01772251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465102|NCT01772251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465103|NCT01772290|Itraconazole|itraconazole|mesh-list
92465104|NCT01772290|Fluconazole|fluconazole|mesh-list
92465105|NCT01772290|Rabeprazole|rabeprazole|mesh-list
92465106|NCT01772290|Antifungal Agents|antifungal agents|mesh-ancestor
92465107|NCT01772290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465108|NCT01772290|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92465109|NCT01772290|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92465110|NCT01772290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465111|NCT01772290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465112|NCT01772290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92465113|NCT01772290|Hormone Antagonists|hormone antagonists|mesh-ancestor
92465114|NCT01772290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465115|NCT01772290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465116|NCT01772290|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92465117|NCT01772290|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92465118|NCT01772290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465119|NCT01772290|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92465120|NCT01772290|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92465121|NCT01772290|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92465122|NCT01772381|Dexamethasone|dexamethasone|mesh-list
92465123|NCT01772381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465124|NCT01772381|Antiemetics|antiemetics|mesh-ancestor
92465125|NCT01772381|Autonomic Agents|autonomic agents|mesh-ancestor
92465126|NCT01772381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465127|NCT01772381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465128|NCT01772381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465129|NCT01772381|Glucocorticoids|glucocorticoids|mesh-ancestor
92465130|NCT01772381|Hormones|hormones|mesh-ancestor
92465131|NCT01772381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465132|NCT01772381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92465133|NCT01772381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465134|NCT01772563|Itraconazole|itraconazole|mesh-list
92465135|NCT01772563|Antifungal Agents|antifungal agents|mesh-ancestor
92465136|NCT01772563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465137|NCT01772563|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92465138|NCT01772563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92465139|NCT01772563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465140|NCT01772563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465141|NCT01772563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92465142|NCT01772563|Hormone Antagonists|hormone antagonists|mesh-ancestor
92465143|NCT01772563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465144|NCT01772563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465145|NCT01772563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92465146|NCT01772589|Pyrithione zinc|pyrithione zinc|mesh-list
92465147|NCT01772589|Keratolytic Agents|keratolytic agents|mesh-ancestor
92465148|NCT01772589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92465149|NCT01772615|Ciprofloxacin|ciprofloxacin|mesh-list
92465150|NCT01772615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465151|NCT01772615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465152|NCT01772615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92465153|NCT01772615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92465154|NCT01772615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465155|NCT01772615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465156|NCT01772615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465157|NCT01772615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92465158|NCT01772615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92465159|NCT01772641|Varenicline|varenicline|mesh-list
92465160|NCT01772641|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92465161|NCT01772641|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92465162|NCT01772641|Cholinergic Agents|cholinergic agents|mesh-ancestor
92465163|NCT01772641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465164|NCT01772641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465165|NCT01772641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465166|NCT01772797|Ceritinib|ceritinib|mesh-list
92465167|NCT01772797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465168|NCT01772797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92465169|NCT01772797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465170|NCT01772797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465171|NCT01772836|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92465172|NCT01772836|Biapenem|biapenem|mesh-list
92465173|NCT01772836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465174|NCT01772836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465175|NCT01772836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465176|NCT01772836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465177|NCT01772940|Ritonavir|ritonavir|mesh-list
92465178|NCT01772940|Lopinavir|lopinavir|mesh-list
92465180|NCT01772940|Lamivudine|lamivudine|mesh-list
92465181|NCT01772940|Emtricitabine|emtricitabine|mesh-list
92465182|NCT01772940|Zidovudine|zidovudine|mesh-list
92465183|NCT01772940|Nevirapine|nevirapine|mesh-list
92465184|NCT01772940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92465185|NCT01772940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92465186|NCT01772940|Protease Inhibitors|protease inhibitors|mesh-ancestor
92465187|NCT01772940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465188|NCT01772940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465189|NCT01772940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92465190|NCT01772940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92465191|NCT01772940|Antiviral Agents|antiviral agents|mesh-ancestor
92465192|NCT01772940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465193|NCT01772940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92465194|NCT01772940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92465195|NCT01772940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92348426|NCT01582308|Incretins|incretins|mesh-ancestor
92465196|NCT01772940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92465197|NCT01772940|Antimetabolites|antimetabolites|mesh-ancestor
92465198|NCT01772940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92465199|NCT01772940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92465200|NCT01772953|Treosulfan|treosulfan|mesh-list
92465201|NCT01772953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92465202|NCT01772953|Alkylating Agents|alkylating agents|mesh-ancestor
92465203|NCT01772953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465204|NCT01772953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465205|NCT01772979|Trabectedin|trabectedin|mesh-list
92465206|NCT01772979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92465207|NCT01772979|Alkylating Agents|alkylating agents|mesh-ancestor
92465208|NCT01772979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465209|NCT01772979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465210|NCT01773005|Acetaminophen|acetaminophen|mesh-list
92465211|NCT01773005|Ibuprofen|ibuprofen|mesh-list
92465212|NCT01773005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465213|NCT01773005|Analgesics|analgesics|mesh-ancestor
92465214|NCT01773005|Sensory System Agents|sensory system agents|mesh-ancestor
92465215|NCT01773005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465216|NCT01773005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465217|NCT01773005|Antipyretics|antipyretics|mesh-ancestor
92465218|NCT01773005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92465219|NCT01773005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465220|NCT01773005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465221|NCT01773005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92465222|NCT01773005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465223|NCT01773005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465224|NCT01773044|Lidocaine|lidocaine|mesh-list
92465225|NCT01773044|Anesthetics, Local|anesthetics, local|mesh-ancestor
92465226|NCT01773044|Anesthetics|anesthetics|mesh-ancestor
92465227|NCT01773044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465228|NCT01773044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465229|NCT01773044|Sensory System Agents|sensory system agents|mesh-ancestor
92465230|NCT01773044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465231|NCT01773044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92465232|NCT01773044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92465233|NCT01773044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92465234|NCT01773044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465235|NCT01773044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465236|NCT01773096|Methylnaltrexone|methylnaltrexone|mesh-list
92465237|NCT01773096|Bisacodyl|bisacodyl|mesh-list
92465239|NCT01773096|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92465240|NCT01773096|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92465241|NCT01773096|Cathartics|cathartics|mesh-ancestor
92465242|NCT01773096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465243|NCT01773096|Laxatives|laxatives|mesh-ancestor
92465244|NCT01773096|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92465245|NCT01773096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465246|NCT01773096|Sensory System Agents|sensory system agents|mesh-ancestor
92465247|NCT01773096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465248|NCT01773096|Antacids|antacids|mesh-ancestor
92465249|NCT01773096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465250|NCT01773096|Antidiarrheals|antidiarrheals|mesh-ancestor
92465251|NCT01773174|Dabigatran|dabigatran|mesh-list
92465252|NCT01773174|Antithrombins|antithrombins|mesh-ancestor
92465253|NCT01773174|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92465255|NCT01773174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465256|NCT01773174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465257|NCT01773174|Anticoagulants|anticoagulants|mesh-ancestor
92465258|NCT01773408|Cytarabine|cytarabine|mesh-list
92465259|NCT01773408|Daunorubicin|daunorubicin|mesh-list
92465260|NCT01773408|Idarubicin|idarubicin|mesh-list
92465261|NCT01773408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92465263|NCT01773408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465264|NCT01773408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465265|NCT01773408|Antiviral Agents|antiviral agents|mesh-ancestor
92465266|NCT01773408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465267|NCT01773408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465268|NCT01773408|Immunologic Factors|immunologic factors|mesh-ancestor
92465269|NCT01773408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465270|NCT01773408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92465271|NCT01773408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92465272|NCT01773408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92465273|NCT01773408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465274|NCT01773460|Everolimus|everolimus|mesh-list
92465275|NCT01773460|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92465276|NCT01773460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92465277|NCT01773460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465278|NCT01773460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465279|NCT01773460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465280|NCT01773460|Immunologic Factors|immunologic factors|mesh-ancestor
92465281|NCT01773460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465282|NCT01773460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465283|NCT01773512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92465284|NCT01773512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92465285|NCT01773512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92465286|NCT01773512|Antimetabolites|antimetabolites|mesh-ancestor
92465287|NCT01773512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465288|NCT01773512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92465289|NCT01773512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92465290|NCT01773512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465291|NCT01773538|Rifaximin|rifaximin|mesh-list
92465292|NCT01773538|Lactulose|lactulose|mesh-list
92465293|NCT01773538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465294|NCT01773538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465295|NCT01773538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465296|NCT01773616|Mycophenolic Acid|mycophenolic acid|mesh-list
92465297|NCT01773616|Prednisolone|prednisolone|mesh-list
92465298|NCT01773616|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92465299|NCT01773616|Methylprednisolone|methylprednisolone|mesh-list
92465300|NCT01773616|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92465301|NCT01773616|Prednisolone acetate|prednisolone acetate|mesh-list
92465302|NCT01773616|Rituximab|rituximab|mesh-list
92465303|NCT01773616|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92465304|NCT01773616|Prednisolone phosphate|prednisolone phosphate|mesh-list
92465305|NCT01773616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92465306|NCT01773616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465307|NCT01773616|Immunologic Factors|immunologic factors|mesh-ancestor
92465308|NCT01773616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465309|NCT01773616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465310|NCT01773616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92465311|NCT01773616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92465312|NCT01773616|Antitubercular Agents|antitubercular agents|mesh-ancestor
92465313|NCT01773616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465314|NCT01773616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465315|NCT01773616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465316|NCT01773616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465317|NCT01773616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465318|NCT01773616|Glucocorticoids|glucocorticoids|mesh-ancestor
92465319|NCT01773616|Hormones|hormones|mesh-ancestor
92465320|NCT01773616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465321|NCT01773616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92465322|NCT01773616|Antiemetics|antiemetics|mesh-ancestor
92465323|NCT01773616|Autonomic Agents|autonomic agents|mesh-ancestor
92465324|NCT01773616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465325|NCT01773616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465326|NCT01773616|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92465327|NCT01773616|Protective Agents|protective agents|mesh-ancestor
92465328|NCT01773681|Certolizumab Pegol|certolizumab pegol|mesh-list
92465330|NCT01773681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465331|NCT01773681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465332|NCT01773681|Immunologic Factors|immunologic factors|mesh-ancestor
92465333|NCT01773681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465334|NCT01773681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465335|NCT01773772|Progesterone|progesterone|mesh-list
92465336|NCT01773772|Progestins|progestins|mesh-ancestor
92465337|NCT01773772|Hormones|hormones|mesh-ancestor
92465338|NCT01773772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465339|NCT01773772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465340|NCT01773798|Insulin|insulin|mesh-list
92465341|NCT01773798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92465342|NCT01773798|Insulin Aspart|insulin aspart|mesh-list
92465343|NCT01773798|Insulin, Long-Acting|insulin, long-acting|mesh-list
92465344|NCT01773798|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92465345|NCT01773798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465346|NCT01773798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465347|NCT01773824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92465348|NCT01773824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465349|NCT01773837|Methylphenidate|methylphenidate|mesh-list
92465350|NCT01773837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92465351|NCT01773837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465352|NCT01773837|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92465353|NCT01773837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92465354|NCT01773837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465355|NCT01773837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465356|NCT01773837|Dopamine Agents|dopamine agents|mesh-ancestor
92465357|NCT01773837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465358|NCT01773876|Micafungin|micafungin|mesh-list
92465359|NCT01773876|Antifungal Agents|antifungal agents|mesh-ancestor
92465360|NCT01773876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465361|NCT01774370|Dabigatran|dabigatran|mesh-list
92465362|NCT01774370|Antithrombins|antithrombins|mesh-ancestor
92465363|NCT01774370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92465364|NCT01774370|Protease Inhibitors|protease inhibitors|mesh-ancestor
92465365|NCT01774370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465366|NCT01774370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465367|NCT01774370|Anticoagulants|anticoagulants|mesh-ancestor
92465368|NCT01774396|Lidocaine|lidocaine|mesh-list
92465369|NCT01774396|Anesthetics, Local|anesthetics, local|mesh-ancestor
92465370|NCT01774396|Anesthetics|anesthetics|mesh-ancestor
92465371|NCT01774396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465372|NCT01774396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465373|NCT01774396|Sensory System Agents|sensory system agents|mesh-ancestor
92465374|NCT01774396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465375|NCT01774396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92465376|NCT01774396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92465377|NCT01774396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92465378|NCT01774396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465379|NCT01774396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465380|NCT01774474|Dexamethasone|dexamethasone|mesh-list
92465381|NCT01774474|Dexamethasone acetate|dexamethasone acetate|mesh-list
92465382|NCT01774474|Triamcinolone|triamcinolone|mesh-list
92465383|NCT01774474|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92465384|NCT01774474|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92465385|NCT01774474|Bromfenac|bromfenac|mesh-list
92465386|NCT01774474|Bevacizumab|bevacizumab|mesh-list
92465387|NCT01774474|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92465389|NCT01774474|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92465390|NCT01774474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92465391|NCT01774474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465392|NCT01774474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92465393|NCT01774474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92465394|NCT01774474|Growth Substances|growth substances|mesh-ancestor
92465395|NCT01774474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465396|NCT01774474|Growth Inhibitors|growth inhibitors|mesh-ancestor
92465397|NCT01774474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465398|NCT01774474|Antiemetics|antiemetics|mesh-ancestor
92465399|NCT01774474|Autonomic Agents|autonomic agents|mesh-ancestor
92465400|NCT01774474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465401|NCT01774474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465402|NCT01774474|Glucocorticoids|glucocorticoids|mesh-ancestor
92465403|NCT01774474|Hormones|hormones|mesh-ancestor
92465404|NCT01774474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465405|NCT01774474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92465406|NCT01774474|Protease Inhibitors|protease inhibitors|mesh-ancestor
92465407|NCT01774474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465408|NCT01774474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465409|NCT01774474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92465410|NCT01774474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465411|NCT01774474|Immunologic Factors|immunologic factors|mesh-ancestor
92465412|NCT01774474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92465413|NCT01774474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465415|NCT01774474|Sensory System Agents|sensory system agents|mesh-ancestor
92465416|NCT01774474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465417|NCT01774565|Insulin|insulin|mesh-list
92465418|NCT01774565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92465419|NCT01774565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465420|NCT01774565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465421|NCT01774812|Ergocalciferols|ergocalciferols|mesh-list
92465422|NCT01774812|Vitamin D|vitamin d|mesh-list
92465423|NCT01774812|Alfacalcidol|alfacalcidol|mesh-list
92465424|NCT01774812|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92465425|NCT01774812|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92465426|NCT01774812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465427|NCT01774812|Vitamins|vitamins|mesh-ancestor
92465428|NCT01774812|Micronutrients|micronutrients|mesh-ancestor
92465429|NCT01774812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92465430|NCT01774838|Clopidogrel|clopidogrel|mesh-list
92465431|NCT01774838|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92465432|NCT01774838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92465433|NCT01774838|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92465434|NCT01774838|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92465435|NCT01774838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92465436|NCT01774838|Purinergic Agents|purinergic agents|mesh-ancestor
92465437|NCT01774838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465438|NCT01774838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465439|NCT01774838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465440|NCT01774864|Udenafil|udenafil|mesh-list
92465441|NCT01774864|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92465442|NCT01774864|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92465443|NCT01774864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465444|NCT01774864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465445|NCT01774877|Leflunomide|leflunomide|mesh-list
92465446|NCT01774877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465447|NCT01774877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465448|NCT01774877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465449|NCT01774877|Immunologic Factors|immunologic factors|mesh-ancestor
92465450|NCT01774877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465451|NCT01775098|Allopurinol|allopurinol|mesh-list
92465452|NCT01775098|Antimetabolites|antimetabolites|mesh-ancestor
92465453|NCT01775098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465454|NCT01775098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465455|NCT01775098|Gout Suppressants|gout suppressants|mesh-ancestor
92465456|NCT01775098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465457|NCT01775098|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92465458|NCT01775098|Antioxidants|antioxidants|mesh-ancestor
92465459|NCT01775098|Protective Agents|protective agents|mesh-ancestor
92465460|NCT01775098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465461|NCT01775215|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92465462|NCT01775215|Natriuretic Agents|natriuretic agents|mesh-ancestor
92465463|NCT01775215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465464|NCT01775397|Vancomycin|vancomycin|mesh-list
92465465|NCT01775397|Fidaxomicin|fidaxomicin|mesh-list
92465466|NCT01775397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465467|NCT01775397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465468|NCT01775540|Dexamethasone|dexamethasone|mesh-list
92465469|NCT01775540|Lubricant Eye Drops|lubricant eye drops|mesh-list
92465470|NCT01775540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465471|NCT01775540|Antiemetics|antiemetics|mesh-ancestor
92465472|NCT01775540|Autonomic Agents|autonomic agents|mesh-ancestor
92465473|NCT01775540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465474|NCT01775540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465475|NCT01775540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465476|NCT01775540|Glucocorticoids|glucocorticoids|mesh-ancestor
92465477|NCT01775540|Hormones|hormones|mesh-ancestor
92190396|NCT00411619|Everolimus|everolimus|mesh-list
92465478|NCT01775540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465479|NCT01775540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92465480|NCT01775540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465481|NCT01775540|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92465482|NCT01775540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92465484|NCT01775579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92465485|NCT01775579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465486|NCT01775579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465487|NCT01775579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92465488|NCT01775579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92465489|NCT01775579|Antimetabolites|antimetabolites|mesh-ancestor
92465490|NCT01775579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465491|NCT01775579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92465492|NCT01775579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92465493|NCT01775579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465495|NCT01775618|Coagulants|coagulants|mesh-ancestor
92465496|NCT01775631|Rituximab|rituximab|mesh-list
92465497|NCT01775631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92465498|NCT01775631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465499|NCT01775631|Immunologic Factors|immunologic factors|mesh-ancestor
92465500|NCT01775631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465501|NCT01775631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465502|NCT01775761|Moxifloxacin|moxifloxacin|mesh-list
92465503|NCT01775761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465504|NCT01775761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465505|NCT01775761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92465506|NCT01775761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92465507|NCT01775761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465508|NCT01775761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465509|NCT01775761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465510|NCT01775839|Aspirin|aspirin|mesh-list
92465511|NCT01775839|Digoxin|digoxin|mesh-list
92465512|NCT01775839|Clopidogrel|clopidogrel|mesh-list
92465513|NCT01775839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92465514|NCT01775839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465515|NCT01775839|Analgesics|analgesics|mesh-ancestor
92465516|NCT01775839|Sensory System Agents|sensory system agents|mesh-ancestor
92465517|NCT01775839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465518|NCT01775839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465519|NCT01775839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465520|NCT01775839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465521|NCT01775839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92465522|NCT01775839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92465523|NCT01775839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465524|NCT01775839|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92465525|NCT01775839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92465526|NCT01775839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465527|NCT01775839|Antipyretics|antipyretics|mesh-ancestor
92465528|NCT01775839|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92465529|NCT01775839|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92465530|NCT01775839|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92465531|NCT01775839|Purinergic Agents|purinergic agents|mesh-ancestor
92465532|NCT01775839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465533|NCT01775839|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92465534|NCT01775839|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92465535|NCT01775839|Protective Agents|protective agents|mesh-ancestor
92465536|NCT01775891|Flecainide|flecainide|mesh-list
92465537|NCT01775891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92465538|NCT01775891|Propafenone|propafenone|mesh-list
92465539|NCT01775891|Pilsicainide|pilsicainide|mesh-list
92465540|NCT01775891|Lidocaine|lidocaine|mesh-list
92465541|NCT01775891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92465542|NCT01775891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92465543|NCT01775891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465544|NCT01775891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465545|NCT01775891|Anesthetics, Local|anesthetics, local|mesh-ancestor
92465546|NCT01775891|Anesthetics|anesthetics|mesh-ancestor
92465547|NCT01775891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465548|NCT01775891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465549|NCT01775891|Sensory System Agents|sensory system agents|mesh-ancestor
92465550|NCT01775891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465551|NCT01776047|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92465552|NCT01776047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92465553|NCT01776203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92465554|NCT01776203|Medroxyprogesterone|medroxyprogesterone|mesh-list
92465555|NCT01776203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92465556|NCT01776203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92465557|NCT01776203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92465558|NCT01776203|Contraceptive Agents|contraceptive agents|mesh-ancestor
92465559|NCT01776203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92465560|NCT01776203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465561|NCT01776203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92465562|NCT01776203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92465563|NCT01776203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92465564|NCT01776203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92465565|NCT01776203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465566|NCT01776320|Alprostadil|alprostadil|mesh-list
92465567|NCT01776320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92465568|NCT01776320|Vasodilator Agents|vasodilator agents|mesh-ancestor
92465569|NCT01776320|Urological Agents|urological agents|mesh-ancestor
92465570|NCT01776437|Talazoparib|talazoparib|mesh-list
92465571|NCT01776437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92465572|NCT01776437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465573|NCT01776437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465574|NCT01776437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465575|NCT01776515|Acetaminophen|acetaminophen|mesh-list
92465577|NCT01776515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465578|NCT01776515|Analgesics|analgesics|mesh-ancestor
92465579|NCT01776515|Sensory System Agents|sensory system agents|mesh-ancestor
92465580|NCT01776515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465581|NCT01776515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465582|NCT01776515|Antipyretics|antipyretics|mesh-ancestor
92465583|NCT01776515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92465584|NCT01776515|Narcotics|narcotics|mesh-ancestor
92465585|NCT01776515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465586|NCT01776567|Everolimus|everolimus|mesh-list
92465587|NCT01776567|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92465588|NCT01776567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92465589|NCT01776567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465590|NCT01776567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465591|NCT01776567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465592|NCT01776567|Immunologic Factors|immunologic factors|mesh-ancestor
92465593|NCT01776567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465594|NCT01776567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465595|NCT01776671|Gabapentin|gabapentin|mesh-list
92465596|NCT01776671|Analgesics|analgesics|mesh-ancestor
92465597|NCT01776671|Sensory System Agents|sensory system agents|mesh-ancestor
92465598|NCT01776671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465599|NCT01776671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465600|NCT01776671|Anticonvulsants|anticonvulsants|mesh-ancestor
92465601|NCT01776671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92465602|NCT01776671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92465603|NCT01776671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465604|NCT01776671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92465605|NCT01776671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92465606|NCT01776671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92465607|NCT01776671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465608|NCT01776671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465609|NCT01776671|Antimanic Agents|antimanic agents|mesh-ancestor
92465610|NCT01776684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92465611|NCT01776684|Gefitinib|gefitinib|mesh-list
92465612|NCT01776684|Afatinib|afatinib|mesh-list
92465613|NCT01776684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465614|NCT01776684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92465615|NCT01776684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465616|NCT01776684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465617|NCT01776788|Insulin|insulin|mesh-list
92465618|NCT01776788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92465619|NCT01776788|Exenatide|exenatide|mesh-list
92465620|NCT01776788|Insulin Lispro|insulin lispro|mesh-list
92465621|NCT01776788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465622|NCT01776788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465623|NCT01776788|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92465624|NCT01776788|Incretins|incretins|mesh-ancestor
92465625|NCT01776788|Hormones|hormones|mesh-ancestor
92465626|NCT01776788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465627|NCT01776853|Levan|levan|mesh-list
92465628|NCT01776853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465629|NCT01776970|Nabiximols|nabiximols|mesh-list
92465630|NCT01776970|Analgesics|analgesics|mesh-ancestor
92465631|NCT01776970|Sensory System Agents|sensory system agents|mesh-ancestor
92465632|NCT01776970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348451|NCT01534962|Ranolazine|ranolazine|mesh-list
92465633|NCT01776970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465634|NCT01777087|Capsaicin|capsaicin|mesh-list
92465635|NCT01777087|Antipruritics|antipruritics|mesh-ancestor
92465636|NCT01777087|Dermatologic Agents|dermatologic agents|mesh-ancestor
92465637|NCT01777087|Sensory System Agents|sensory system agents|mesh-ancestor
92465638|NCT01777087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465639|NCT01777087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465640|NCT01777100|Sufentanil|sufentanil|mesh-list
92465641|NCT01777100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92465642|NCT01777100|Narcotics|narcotics|mesh-ancestor
92465643|NCT01777100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465644|NCT01777100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465645|NCT01777100|Analgesics|analgesics|mesh-ancestor
92465646|NCT01777100|Sensory System Agents|sensory system agents|mesh-ancestor
92465647|NCT01777100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465648|NCT01777100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92465649|NCT01777100|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92465650|NCT01777100|Anesthetics, General|anesthetics, general|mesh-ancestor
92465651|NCT01777100|Anesthetics|anesthetics|mesh-ancestor
92465652|NCT01777347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92465653|NCT01777464|Histamine|histamine|mesh-list
92465654|NCT01777464|Histamine Agonists|histamine agonists|mesh-ancestor
92465655|NCT01777464|Histamine Agents|histamine agents|mesh-ancestor
92465656|NCT01777464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465657|NCT01777464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465658|NCT01777464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465659|NCT01777477|Chloroquine|chloroquine|mesh-list
92465660|NCT01777477|Gemcitabine|gemcitabine|mesh-list
92465661|NCT01777477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92465662|NCT01777477|Antimetabolites|antimetabolites|mesh-ancestor
92465663|NCT01777477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465664|NCT01777477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465665|NCT01777477|Amebicides|amebicides|mesh-ancestor
92465666|NCT01777477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92465667|NCT01777477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92465668|NCT01777477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465669|NCT01777477|Antimalarials|antimalarials|mesh-ancestor
92465670|NCT01777477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465671|NCT01777503|Clopidogrel|clopidogrel|mesh-list
92465672|NCT01777503|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92465673|NCT01777503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92465674|NCT01777503|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92465675|NCT01777503|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92465676|NCT01777503|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92465677|NCT01777503|Purinergic Agents|purinergic agents|mesh-ancestor
92465678|NCT01777503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465679|NCT01777503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465680|NCT01777503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465681|NCT01777685|Sulpiride|sulpiride|mesh-list
92465682|NCT01777685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92465683|NCT01777685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92531644|NCT00047281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465684|NCT01777685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465685|NCT01777685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465686|NCT01777685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92465687|NCT01777685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92465688|NCT01777685|Dopamine Agents|dopamine agents|mesh-ancestor
92465689|NCT01777685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465690|NCT01777685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465691|NCT01777685|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92465692|NCT01777685|Antidepressive Agents|antidepressive agents|mesh-ancestor
92465693|NCT01777737|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92465694|NCT01777737|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92465695|NCT01777737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465696|NCT01777737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465697|NCT01777737|Antimalarials|antimalarials|mesh-ancestor
92465698|NCT01777737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92465699|NCT01777737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92465700|NCT01777867|Methacholine Chloride|methacholine chloride|mesh-list
92465701|NCT01777867|Miotics|miotics|mesh-ancestor
92465702|NCT01777867|Autonomic Agents|autonomic agents|mesh-ancestor
92465703|NCT01777867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149634|NCT04397653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92465704|NCT01777867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465705|NCT01777867|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92465706|NCT01777867|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92465707|NCT01777867|Respiratory System Agents|respiratory system agents|mesh-ancestor
92465708|NCT01777867|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92465709|NCT01777867|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92465710|NCT01777867|Cholinergic Agents|cholinergic agents|mesh-ancestor
92465711|NCT01777867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465712|NCT01777867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465713|NCT01777919|Copper|copper|mesh-list
92465714|NCT01777919|Temozolomide|temozolomide|mesh-list
92465715|NCT01777919|Disulfiram|disulfiram|mesh-list
92465716|NCT01777919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92465717|NCT01777919|Alkylating Agents|alkylating agents|mesh-ancestor
92465718|NCT01777919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465719|NCT01777919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465720|NCT01777919|Trace Elements|trace elements|mesh-ancestor
92465721|NCT01777919|Micronutrients|micronutrients|mesh-ancestor
92465722|NCT01777919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465723|NCT01777919|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92465724|NCT01777919|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92465725|NCT01777919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465726|NCT01778075|Acetaminophen|acetaminophen|mesh-list
92465727|NCT01778075|Tramadol|tramadol|mesh-list
92465728|NCT01778075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465729|NCT01778075|Analgesics|analgesics|mesh-ancestor
92465730|NCT01778075|Sensory System Agents|sensory system agents|mesh-ancestor
92465731|NCT01778075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465732|NCT01778075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465733|NCT01778075|Antipyretics|antipyretics|mesh-ancestor
92465734|NCT01778075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92465735|NCT01778075|Narcotics|narcotics|mesh-ancestor
92465736|NCT01778075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465737|NCT01778101|Lansoprazole|lansoprazole|mesh-list
92465738|NCT01778101|Dexlansoprazole|dexlansoprazole|mesh-list
92465739|NCT01778101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92465740|NCT01778101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465741|NCT01778101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92465742|NCT01778101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465743|NCT01778101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465744|NCT01778114|Vitamin D|vitamin d|mesh-list
92465745|NCT01778114|Ergocalciferols|ergocalciferols|mesh-list
92465746|NCT01778114|Cholecalciferol|cholecalciferol|mesh-list
92465747|NCT01778114|Vitamins|vitamins|mesh-list
92465748|NCT01778114|Micronutrients|micronutrients|mesh-ancestor
92465749|NCT01778114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465750|NCT01778114|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92465751|NCT01778114|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92465752|NCT01778192|Magnesium citrate|magnesium citrate|mesh-list
92465753|NCT01778192|Picosulfate sodium|picosulfate sodium|mesh-list
92465754|NCT01778192|Citric Acid|citric acid|mesh-list
92465755|NCT01778192|Sodium Citrate|sodium citrate|mesh-list
92465756|NCT01778192|Anticoagulants|anticoagulants|mesh-ancestor
92465757|NCT01778192|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92465759|NCT01778192|Sequestering Agents|sequestering agents|mesh-ancestor
92465760|NCT01778192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465761|NCT01778192|Cathartics|cathartics|mesh-ancestor
92465762|NCT01778192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92465763|NCT01778218|Deoxyglucose|deoxyglucose|mesh-list
92465764|NCT01778218|Antimetabolites|antimetabolites|mesh-ancestor
92465765|NCT01778218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465766|NCT01778218|Antiviral Agents|antiviral agents|mesh-ancestor
92465767|NCT01778218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465768|NCT01778244|Metformin|metformin|mesh-list
92465769|NCT01778244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465770|NCT01778244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465771|NCT01778283|Dialysis Solutions|dialysis solutions|mesh-list
92465772|NCT01778283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92465773|NCT01778309|Acetylcysteine|acetylcysteine|mesh-list
92465774|NCT01778309|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92465775|NCT01778309|Antiviral Agents|antiviral agents|mesh-ancestor
92465776|NCT01778309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465777|NCT01778309|Expectorants|expectorants|mesh-ancestor
92465778|NCT01778309|Respiratory System Agents|respiratory system agents|mesh-ancestor
92348455|NCT01582152|Bevacizumab|bevacizumab|mesh-list
92465779|NCT01778309|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92465780|NCT01778309|Antioxidants|antioxidants|mesh-ancestor
92465781|NCT01778309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465782|NCT01778309|Protective Agents|protective agents|mesh-ancestor
92465783|NCT01778309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465784|NCT01778309|Antidotes|antidotes|mesh-ancestor
92465785|NCT01778400|Ethanol|ethanol|mesh-list
92465786|NCT01778400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92465787|NCT01778400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465788|NCT01778400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465789|NCT01778400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465790|NCT01778413|Tenofovir|tenofovir|mesh-list
92465791|NCT01778413|Emtricitabine|emtricitabine|mesh-list
92465792|NCT01778413|Efavirenz|efavirenz|mesh-list
92465793|NCT01778413|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92465794|NCT01778413|Antiviral Agents|antiviral agents|mesh-ancestor
92465795|NCT01778413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465796|NCT01778413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92465797|NCT01778413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92465798|NCT01778413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465799|NCT01778413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465800|NCT01778413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92465801|NCT01778413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92465802|NCT01778413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92465803|NCT01778413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92465804|NCT01778413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92465805|NCT01778413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92465806|NCT01778413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92465807|NCT01778413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92465808|NCT01778647|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92465809|NCT01778647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465810|NCT01778686|Pindolol|pindolol|mesh-list
92465811|NCT01778686|Citalopram|citalopram|mesh-list
92465812|NCT01778686|Tryptophan|tryptophan|mesh-list
92465813|NCT01778686|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92465814|NCT01778686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92465815|NCT01778686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92465816|NCT01778686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465817|NCT01778686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465818|NCT01778686|Serotonin Agents|serotonin agents|mesh-ancestor
92465819|NCT01778686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465820|NCT01778686|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92465821|NCT01778686|Antidepressive Agents|antidepressive agents|mesh-ancestor
92465822|NCT01778686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92465823|NCT01778686|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92465824|NCT01778686|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92465825|NCT01778686|Adrenergic Agents|adrenergic agents|mesh-ancestor
92465826|NCT01778686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92465827|NCT01778686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92465828|NCT01778686|Vasodilator Agents|vasodilator agents|mesh-ancestor
92465830|NCT01778803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92465831|NCT01778803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465832|NCT01778803|Tubulin Modulators|tubulin modulators|mesh-ancestor
92465833|NCT01778803|Antimitotic Agents|antimitotic agents|mesh-ancestor
92465834|NCT01778803|Mitosis Modulators|mitosis modulators|mesh-ancestor
92465835|NCT01778803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465836|NCT01778842|Clopidogrel|clopidogrel|mesh-list
92465837|NCT01778842|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92465838|NCT01778842|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92465839|NCT01778842|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92465840|NCT01778842|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92465841|NCT01778842|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92465842|NCT01778842|Purinergic Agents|purinergic agents|mesh-ancestor
92465843|NCT01778842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348463|NCT01557504|Metformin|metformin|mesh-list
92465844|NCT01778842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465845|NCT01778842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465846|NCT01779089|Minocycline|minocycline|mesh-list
92465847|NCT01779089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92465848|NCT01779089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465849|NCT01779232|Danazol|danazol|mesh-list
92465850|NCT01779232|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92465851|NCT01779232|Hormone Antagonists|hormone antagonists|mesh-ancestor
92465852|NCT01779232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465853|NCT01779232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465854|NCT01779245|Calcium|calcium|mesh-list
92465855|NCT01779245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92465856|NCT01779245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465857|NCT01779258|Desonide|desonide|mesh-list
92465858|NCT01779258|Glycerol|glycerol|mesh-list
92465859|NCT01779258|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92465860|NCT01779258|Protective Agents|protective agents|mesh-ancestor
92465861|NCT01779258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465862|NCT01779258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465863|NCT01779271|Loxoprofen|loxoprofen|mesh-list
92465864|NCT01779271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92465865|NCT01779271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465866|NCT01779271|Analgesics|analgesics|mesh-ancestor
92465867|NCT01779271|Sensory System Agents|sensory system agents|mesh-ancestor
92465868|NCT01779271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465869|NCT01779271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465870|NCT01779271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465871|NCT01779271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465872|NCT01779284|Timolol|timolol|mesh-list
92465873|NCT01779284|Travoprost|travoprost|mesh-list
92465874|NCT01779284|Latanoprost|latanoprost|mesh-list
92465875|NCT01779284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92465876|NCT01779284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92465877|NCT01779284|Adrenergic Agents|adrenergic agents|mesh-ancestor
92465878|NCT01779284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465879|NCT01779284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465880|NCT01779284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465881|NCT01779284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92465882|NCT01779284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92465883|NCT01779284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92465884|NCT01779284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92465885|NCT01779362|Metformin|metformin|mesh-list
92465886|NCT01779362|Insulin Glargine|insulin glargine|mesh-list
92465887|NCT01779362|Liraglutide|liraglutide|mesh-list
92465888|NCT01779362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465889|NCT01779362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465890|NCT01779362|Incretins|incretins|mesh-ancestor
92465891|NCT01779362|Hormones|hormones|mesh-ancestor
92465892|NCT01779362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92465893|NCT01779401|Aspirin|aspirin|mesh-list
92465894|NCT01779401|Cilostazol|cilostazol|mesh-list
92465895|NCT01779401|Clopidogrel|clopidogrel|mesh-list
92465896|NCT01779401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92465897|NCT01779401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92465898|NCT01779401|Analgesics|analgesics|mesh-ancestor
92465899|NCT01779401|Sensory System Agents|sensory system agents|mesh-ancestor
92465900|NCT01779401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465901|NCT01779401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465902|NCT01779401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92465903|NCT01779401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92465904|NCT01779401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92465905|NCT01779401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92465906|NCT01779401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465907|NCT01779401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92465908|NCT01779401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92465909|NCT01779401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465910|NCT01779401|Antipyretics|antipyretics|mesh-ancestor
92348466|NCT01557504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92465911|NCT01779401|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92465912|NCT01779401|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92465913|NCT01779401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92465914|NCT01779401|Purinergic Agents|purinergic agents|mesh-ancestor
92465915|NCT01779401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465916|NCT01779401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92465917|NCT01779401|Autonomic Agents|autonomic agents|mesh-ancestor
92465918|NCT01779401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92465919|NCT01779401|Respiratory System Agents|respiratory system agents|mesh-ancestor
92465920|NCT01779401|Vasodilator Agents|vasodilator agents|mesh-ancestor
92465921|NCT01779401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92465922|NCT01779401|Protective Agents|protective agents|mesh-ancestor
92465923|NCT01779401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92465924|NCT01779401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92465925|NCT01779466|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92465926|NCT01779466|Hemostatics|hemostatics|mesh-ancestor
92465927|NCT01779466|Coagulants|coagulants|mesh-ancestor
92465928|NCT01779466|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92465929|NCT01779466|Natriuretic Agents|natriuretic agents|mesh-ancestor
92465930|NCT01779466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465931|NCT01779479|Paclitaxel|paclitaxel|mesh-list
92465932|NCT01779479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92465933|NCT01779479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465934|NCT01779479|Tubulin Modulators|tubulin modulators|mesh-ancestor
92465935|NCT01779479|Antimitotic Agents|antimitotic agents|mesh-ancestor
92465936|NCT01779479|Mitosis Modulators|mitosis modulators|mesh-ancestor
92465937|NCT01779479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465938|NCT01779492|Oxycodone|oxycodone|mesh-list
92465939|NCT01779492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92465940|NCT01779492|Narcotics|narcotics|mesh-ancestor
92465941|NCT01779492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465942|NCT01779492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465943|NCT01779492|Analgesics|analgesics|mesh-ancestor
92465944|NCT01779492|Sensory System Agents|sensory system agents|mesh-ancestor
92465945|NCT01779492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92465946|NCT01779518|Interferons|interferons|mesh-list
92465947|NCT01779518|Ribavirin|ribavirin|mesh-list
92465948|NCT01779518|Sofosbuvir|sofosbuvir|mesh-list
92465949|NCT01779518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465950|NCT01779518|Antiviral Agents|antiviral agents|mesh-ancestor
92465951|NCT01779518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465952|NCT01779518|Antimetabolites|antimetabolites|mesh-ancestor
92465953|NCT01779518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465954|NCT01779596|Bosentan|bosentan|mesh-list
92465955|NCT01779596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92465956|NCT01779596|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92465957|NCT01779596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465958|NCT01779609|Bosentan|bosentan|mesh-list
92465959|NCT01779609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92465960|NCT01779609|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92465961|NCT01779609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465962|NCT01779687|Raltegravir Potassium|raltegravir potassium|mesh-list
92465963|NCT01779687|Atorvastatin|atorvastatin|mesh-list
92465964|NCT01779687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92465965|NCT01779687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92465966|NCT01779687|Antimetabolites|antimetabolites|mesh-ancestor
92465967|NCT01779687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465968|NCT01779687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92465969|NCT01779687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92465970|NCT01779687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92465971|NCT01779687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92465972|NCT01779687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92465973|NCT01779687|Antiviral Agents|antiviral agents|mesh-ancestor
92465974|NCT01779687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465975|NCT01779687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92465976|NCT01779687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92465977|NCT01779830|Zolpidem|zolpidem|mesh-list
92465978|NCT01779830|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92465979|NCT01779830|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92465980|NCT01779830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92465981|NCT01779830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465982|NCT01779830|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92465983|NCT01779830|GABA Agonists|gaba agonists|mesh-ancestor
92465984|NCT01779830|GABA Agents|gaba agents|mesh-ancestor
92465985|NCT01779830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92465986|NCT01779830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465987|NCT01779843|Cytarabine|cytarabine|mesh-list
92465988|NCT01779843|Idarubicin|idarubicin|mesh-list
92465989|NCT01779843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92465990|NCT01779843|Antimetabolites|antimetabolites|mesh-ancestor
92465991|NCT01779843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92465992|NCT01779843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92465993|NCT01779843|Antiviral Agents|antiviral agents|mesh-ancestor
92465994|NCT01779843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92465995|NCT01779843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92465996|NCT01779843|Immunologic Factors|immunologic factors|mesh-ancestor
92465997|NCT01779843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92465998|NCT01779843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92465999|NCT01779843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92466000|NCT01779843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92466001|NCT01779843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466002|NCT01779882|Cyclophosphamide|cyclophosphamide|mesh-list
92466003|NCT01779882|Busulfan|busulfan|mesh-list
92466004|NCT01779882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466005|NCT01779882|Immunologic Factors|immunologic factors|mesh-ancestor
92466006|NCT01779882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466008|NCT01779882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92466010|NCT01779882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466011|NCT01779882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466012|NCT01779882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92466013|NCT01779908|Vitamin D|vitamin d|mesh-list
92466014|NCT01779908|Vitamins|vitamins|mesh-ancestor
92466015|NCT01779908|Micronutrients|micronutrients|mesh-ancestor
92466016|NCT01779908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466017|NCT01779908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92466018|NCT01779921|Thrombin|thrombin|mesh-list
92466019|NCT01779921|Hemostatics|hemostatics|mesh-ancestor
92466020|NCT01779921|Coagulants|coagulants|mesh-ancestor
92466021|NCT01780051|Metformin|metformin|mesh-list
92466022|NCT01780051|Repaglinide|repaglinide|mesh-list
92466023|NCT01780051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92466024|NCT01780051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466025|NCT01780181|Gemcitabine|gemcitabine|mesh-list
92466026|NCT01780181|Docetaxel|docetaxel|mesh-list
92466027|NCT01780181|Vinorelbine|vinorelbine|mesh-list
92466028|NCT01780181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466029|NCT01780181|Antimetabolites|antimetabolites|mesh-ancestor
92466030|NCT01780181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466031|NCT01780181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466032|NCT01780181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92466033|NCT01780181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92466034|NCT01780181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92466035|NCT01780181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92466036|NCT01780233|Fentanyl|fentanyl|mesh-list
92466037|NCT01780233|Naltrexone|naltrexone|mesh-list
92466038|NCT01780233|Citric Acid|citric acid|mesh-list
92466039|NCT01780233|Sodium Citrate|sodium citrate|mesh-list
92466040|NCT01780233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92466041|NCT01780233|Narcotics|narcotics|mesh-ancestor
92466042|NCT01780233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466043|NCT01780233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466044|NCT01780233|Analgesics|analgesics|mesh-ancestor
92466045|NCT01780233|Sensory System Agents|sensory system agents|mesh-ancestor
92466046|NCT01780233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466047|NCT01780233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92466048|NCT01780233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92466049|NCT01780233|Anesthetics, General|anesthetics, general|mesh-ancestor
92466050|NCT01780233|Anesthetics|anesthetics|mesh-ancestor
92466051|NCT01780233|Anticoagulants|anticoagulants|mesh-ancestor
92466052|NCT01780233|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92466053|NCT01780233|Chelating Agents|chelating agents|mesh-ancestor
92466054|NCT01780233|Sequestering Agents|sequestering agents|mesh-ancestor
92466055|NCT01780233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466056|NCT01780233|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92466057|NCT01780233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92466058|NCT01780259|Triazolam|triazolam|mesh-list
92466059|NCT01780259|Esketamine|esketamine|mesh-list
92466060|NCT01780259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92466061|NCT01780259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92466062|NCT01780259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92466063|NCT01780259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92466064|NCT01780259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92466065|NCT01780259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466066|NCT01780259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466067|NCT01780259|GABA Modulators|gaba modulators|mesh-ancestor
92466068|NCT01780259|GABA Agents|gaba agents|mesh-ancestor
92466069|NCT01780259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466070|NCT01780259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466071|NCT01780311|Sotalol|sotalol|mesh-list
92466072|NCT01780311|Flecainide|flecainide|mesh-list
92466073|NCT01780311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92466074|NCT01780311|Propafenone|propafenone|mesh-list
92466075|NCT01780311|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92466076|NCT01780311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92466077|NCT01780311|Adrenergic Agents|adrenergic agents|mesh-ancestor
92466078|NCT01780311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466079|NCT01780311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466080|NCT01780311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466081|NCT01780311|Sympatholytics|sympatholytics|mesh-ancestor
92466082|NCT01780311|Autonomic Agents|autonomic agents|mesh-ancestor
92466083|NCT01780311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466084|NCT01780311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92466085|NCT01780311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92466086|NCT01780311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92466088|NCT01780467|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92466089|NCT01780467|Sympathomimetics|sympathomimetics|mesh-ancestor
92466090|NCT01780467|Autonomic Agents|autonomic agents|mesh-ancestor
92466091|NCT01780467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466092|NCT01780467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466093|NCT01780467|Dopamine Agents|dopamine agents|mesh-ancestor
92466094|NCT01780467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466095|NCT01780467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466096|NCT01780467|Protective Agents|protective agents|mesh-ancestor
92466097|NCT01780519|Lorazepam|lorazepam|mesh-list
92466098|NCT01780519|Anticonvulsants|anticonvulsants|mesh-ancestor
92466099|NCT01780519|Antiemetics|antiemetics|mesh-ancestor
92466100|NCT01780519|Autonomic Agents|autonomic agents|mesh-ancestor
92466101|NCT01780519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466102|NCT01780519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466103|NCT01780519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466104|NCT01780519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92466105|NCT01780519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466106|NCT01780519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92466107|NCT01780519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92466108|NCT01780519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92466109|NCT01780519|GABA Modulators|gaba modulators|mesh-ancestor
92466110|NCT01780519|GABA Agents|gaba agents|mesh-ancestor
92466111|NCT01780519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466112|NCT01780519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466113|NCT01780558|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92466114|NCT01780558|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92466115|NCT01780558|Hormones|hormones|mesh-list
92466116|NCT01780558|Estradiol|estradiol|mesh-list
92466117|NCT01780558|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92466118|NCT01780558|Progesterone|progesterone|mesh-list
92466119|NCT01780558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466120|NCT01780558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466121|NCT01780558|Estrogens|estrogens|mesh-ancestor
92466122|NCT01780558|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92466123|NCT01780558|Contraceptive Agents|contraceptive agents|mesh-ancestor
92466124|NCT01780558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92466125|NCT01780558|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92466126|NCT01780558|Progestins|progestins|mesh-ancestor
92466127|NCT01780610|Letrozole|letrozole|mesh-list
92466128|NCT01780610|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92466129|NCT01780610|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92466130|NCT01780610|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92466131|NCT01780610|Hormones|hormones|mesh-list
92466132|NCT01780610|Estradiol|estradiol|mesh-list
92466133|NCT01780610|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92466134|NCT01780610|Progesterone|progesterone|mesh-list
92466135|NCT01780610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466136|NCT01780610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466137|NCT01780610|Estrogens|estrogens|mesh-ancestor
92466138|NCT01780610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92466139|NCT01780610|Contraceptive Agents|contraceptive agents|mesh-ancestor
92466140|NCT01780610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92466141|NCT01780610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92466142|NCT01780610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466143|NCT01780610|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92466144|NCT01780610|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92466145|NCT01780610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466146|NCT01780610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466147|NCT01780610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92466148|NCT01780610|Hormone Antagonists|hormone antagonists|mesh-ancestor
92466149|NCT01780610|Progestins|progestins|mesh-ancestor
92466150|NCT01780740|Atorvastatin|atorvastatin|mesh-list
92466151|NCT01780740|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92466152|NCT01780740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92466153|NCT01780740|Antimetabolites|antimetabolites|mesh-ancestor
92466154|NCT01780740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466155|NCT01780740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92466156|NCT01780740|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92466157|NCT01780740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466158|NCT01780753|Primaquine|primaquine|mesh-list
92191071|NCT01424228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466159|NCT01780753|Antimalarials|antimalarials|mesh-ancestor
92466160|NCT01780753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92466161|NCT01780753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92466162|NCT01780753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466163|NCT01780909|Paromomycin|paromomycin|mesh-list
92466165|NCT01780909|Loperamide|loperamide|mesh-list
92466166|NCT01780909|Antidiarrheals|antidiarrheals|mesh-list
92466167|NCT01780909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466168|NCT01780909|Antiemetics|antiemetics|mesh-ancestor
92466169|NCT01780909|Autonomic Agents|autonomic agents|mesh-ancestor
92466170|NCT01780909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466171|NCT01780909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466172|NCT01780909|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92466173|NCT01780909|Dopamine Agents|dopamine agents|mesh-ancestor
92466174|NCT01780909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466175|NCT01780909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466176|NCT01780909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466177|NCT01780909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466178|NCT01780909|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92466179|NCT01780909|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92466180|NCT01780948|Everolimus|everolimus|mesh-list
92466181|NCT01780948|Atorvastatin|atorvastatin|mesh-list
92466182|NCT01780948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92466183|NCT01780948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92466184|NCT01780948|Antimetabolites|antimetabolites|mesh-ancestor
92466185|NCT01780948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466186|NCT01780948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92466187|NCT01780948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92466188|NCT01780948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466189|NCT01780948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92466190|NCT01780948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466191|NCT01780948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466192|NCT01780948|Immunologic Factors|immunologic factors|mesh-ancestor
92466193|NCT01780948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466194|NCT01780948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466195|NCT01781052|Iloprost|iloprost|mesh-list
92466196|NCT01781052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92466197|NCT01781052|Vasodilator Agents|vasodilator agents|mesh-ancestor
92466198|NCT01781273|Ethanol|ethanol|mesh-list
92466199|NCT01781273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92466200|NCT01781273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466201|NCT01781273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466202|NCT01781273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466203|NCT01781377|Metoclopramide|metoclopramide|mesh-list
92466204|NCT01781377|Propofol|propofol|mesh-list
92466205|NCT01781377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92466206|NCT01781377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466207|NCT01781377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466208|NCT01781377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92466209|NCT01781377|Anesthetics, General|anesthetics, general|mesh-ancestor
92466210|NCT01781377|Anesthetics|anesthetics|mesh-ancestor
92466211|NCT01781377|Antiemetics|antiemetics|mesh-ancestor
92466212|NCT01781377|Autonomic Agents|autonomic agents|mesh-ancestor
92466213|NCT01781377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466214|NCT01781377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466215|NCT01781377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92466216|NCT01781377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92466217|NCT01781377|Dopamine Agents|dopamine agents|mesh-ancestor
92466218|NCT01781377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466219|NCT01781377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466220|NCT01781442|Sirolimus|sirolimus|mesh-list
92466221|NCT01781442|Temsirolimus|temsirolimus|mesh-list
92466222|NCT01781442|MTOR Inhibitors|mtor inhibitors|mesh-list
92466223|NCT01781442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466224|NCT01781442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466225|NCT01781442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466226|NCT01781442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466227|NCT01781442|Immunologic Factors|immunologic factors|mesh-ancestor
92466228|NCT01781442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466229|NCT01781442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466230|NCT01781442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466231|NCT01781442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466232|NCT01781442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92466233|NCT01781442|Antifungal Agents|antifungal agents|mesh-ancestor
92466234|NCT01781507|Cetirizine|cetirizine|mesh-list
92466235|NCT01781507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92466236|NCT01781507|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92466237|NCT01781507|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92466238|NCT01781507|Histamine Antagonists|histamine antagonists|mesh-ancestor
92466239|NCT01781507|Histamine Agents|histamine agents|mesh-ancestor
92466240|NCT01781507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466241|NCT01781507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466242|NCT01781507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466243|NCT01781663|Petrolatum|petrolatum|mesh-list
92466244|NCT01781663|Emollients|emollients|mesh-ancestor
92466245|NCT01781663|Dermatologic Agents|dermatologic agents|mesh-ancestor
92466246|NCT01781702|Celecoxib|celecoxib|mesh-list
92466247|NCT01781702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92466248|NCT01781702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466249|NCT01781702|Analgesics|analgesics|mesh-ancestor
92466250|NCT01781702|Sensory System Agents|sensory system agents|mesh-ancestor
92466251|NCT01781702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466252|NCT01781702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466253|NCT01781702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466254|NCT01781702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466255|NCT01781702|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92466256|NCT01781702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92466257|NCT01781702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466258|NCT01781702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466259|NCT01781871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92466260|NCT01781871|Immunologic Factors|immunologic factors|mesh-ancestor
92466261|NCT01781871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466262|NCT01781884|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92466263|NCT01781884|GABA Agents|gaba agents|mesh-ancestor
92466264|NCT01781884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466265|NCT01781884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466266|NCT01781884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466267|NCT01781897|Mosapride|mosapride|mesh-list
92466268|NCT01781897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466269|NCT01781897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92466270|NCT01781897|Serotonin Agents|serotonin agents|mesh-ancestor
92466271|NCT01781897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116533|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466272|NCT01781897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466273|NCT01781897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466274|NCT01781936|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92466275|NCT01781936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466276|NCT01781936|Glucocorticoids|glucocorticoids|mesh-ancestor
92466277|NCT01781936|Hormones|hormones|mesh-ancestor
92466278|NCT01781936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466279|NCT01781936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466280|NCT01781988|Carboplatin|carboplatin|mesh-list
92466282|NCT01781988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466283|NCT01781988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466284|NCT01781988|Antimetabolites|antimetabolites|mesh-ancestor
92466285|NCT01781988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466286|NCT01782001|Vitamins|vitamins|mesh-list
92466287|NCT01782001|Vitamin A|vitamin a|mesh-list
92466288|NCT01782001|Retinol palmitate|retinol palmitate|mesh-list
92466289|NCT01782001|Micronutrients|micronutrients|mesh-ancestor
92466290|NCT01782001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466291|NCT01782001|Antioxidants|antioxidants|mesh-ancestor
92466292|NCT01782001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466293|NCT01782001|Protective Agents|protective agents|mesh-ancestor
92466294|NCT01782001|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92466295|NCT01782001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466296|NCT01782261|Liraglutide|liraglutide|mesh-list
92466297|NCT01782261|Saxagliptin|saxagliptin|mesh-list
92466298|NCT01782261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92466299|NCT01782261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466300|NCT01782261|Incretins|incretins|mesh-ancestor
92466301|NCT01782261|Hormones|hormones|mesh-ancestor
92466302|NCT01782261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466303|NCT01782261|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92466304|NCT01782261|Protease Inhibitors|protease inhibitors|mesh-ancestor
92466305|NCT01782261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466306|NCT01782261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466307|NCT01782274|Vaccines|vaccines|mesh-list
92466308|NCT01782274|Immunologic Factors|immunologic factors|mesh-ancestor
92466309|NCT01782274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466310|NCT01782287|Vaccines|vaccines|mesh-list
92466311|NCT01782287|Immunologic Factors|immunologic factors|mesh-ancestor
92466312|NCT01782287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466313|NCT01782300|Vaccines|vaccines|mesh-list
92466314|NCT01782300|Immunologic Factors|immunologic factors|mesh-ancestor
92466316|NCT01782404|Chlorhexidine|chlorhexidine|mesh-list
92466317|NCT01782404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92466318|NCT01782404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466319|NCT01782404|Disinfectants|disinfectants|mesh-ancestor
92466320|NCT01782508|Interferons|interferons|mesh-list
92466321|NCT01782508|Imatinib Mesylate|imatinib mesylate|mesh-list
92466322|NCT01782508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466323|NCT01782508|Antiviral Agents|antiviral agents|mesh-ancestor
92466324|NCT01782508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466325|NCT01782508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466326|NCT01782508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466327|NCT01782508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466328|NCT01782560|Omeprazole|omeprazole|mesh-list
92466329|NCT01782560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92466330|NCT01782560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466331|NCT01782560|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92466332|NCT01782560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466333|NCT01782560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466334|NCT01782573|Chlorhexidine|chlorhexidine|mesh-list
92466335|NCT01782573|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92466336|NCT01782573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92466337|NCT01782573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466338|NCT01782573|Disinfectants|disinfectants|mesh-ancestor
92466339|NCT01782573|Dermatologic Agents|dermatologic agents|mesh-ancestor
92466340|NCT01782599|Nicotine|nicotine|mesh-list
92466341|NCT01782599|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92466342|NCT01782599|Autonomic Agents|autonomic agents|mesh-ancestor
92466343|NCT01782599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466344|NCT01782599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466345|NCT01782599|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92466346|NCT01782599|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92466347|NCT01782599|Cholinergic Agents|cholinergic agents|mesh-ancestor
92466348|NCT01782599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466349|NCT01782599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466350|NCT01782612|Analgesics|analgesics|mesh-list
92466351|NCT01782612|Sensory System Agents|sensory system agents|mesh-ancestor
92466352|NCT01782612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466353|NCT01782612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466354|NCT01782651|Capecitabine|capecitabine|mesh-list
92466355|NCT01782651|Lapatinib|lapatinib|mesh-list
92466356|NCT01782651|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466358|NCT01782651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466359|NCT01782651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466360|NCT01782651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466361|NCT01782651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466362|NCT01782781|Epinephrine|epinephrine|mesh-list
92466363|NCT01782781|Ropivacaine|ropivacaine|mesh-list
92466364|NCT01782781|Anesthetics, Local|anesthetics, local|mesh-ancestor
92466365|NCT01782781|Anesthetics|anesthetics|mesh-ancestor
92466366|NCT01782781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466367|NCT01782781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466368|NCT01782781|Sensory System Agents|sensory system agents|mesh-ancestor
92466369|NCT01782781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466370|NCT01782781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92466371|NCT01782781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92466372|NCT01782781|Adrenergic Agents|adrenergic agents|mesh-ancestor
92466373|NCT01782781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466374|NCT01782781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466375|NCT01782781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92466376|NCT01782781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92466377|NCT01782781|Autonomic Agents|autonomic agents|mesh-ancestor
92466378|NCT01782781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92466379|NCT01782781|Respiratory System Agents|respiratory system agents|mesh-ancestor
92466380|NCT01782781|Mydriatics|mydriatics|mesh-ancestor
92466381|NCT01782781|Sympathomimetics|sympathomimetics|mesh-ancestor
92466382|NCT01782781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92466383|NCT01782846|Codeine|codeine|mesh-list
92466384|NCT01782846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92466385|NCT01782846|Narcotics|narcotics|mesh-ancestor
92466386|NCT01782846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466387|NCT01782846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191294|NCT00448201|Methotrexate|methotrexate|mesh-list
92466388|NCT01782846|Analgesics|analgesics|mesh-ancestor
92466389|NCT01782846|Sensory System Agents|sensory system agents|mesh-ancestor
92466391|NCT01782846|Antitussive Agents|antitussive agents|mesh-ancestor
92466392|NCT01782846|Respiratory System Agents|respiratory system agents|mesh-ancestor
92466393|NCT01782911|Resveratrol|resveratrol|mesh-list
92466394|NCT01782911|Antioxidants|antioxidants|mesh-ancestor
92466395|NCT01782911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466396|NCT01782911|Protective Agents|protective agents|mesh-ancestor
92466397|NCT01782911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466398|NCT01782911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466399|NCT01782911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92466401|NCT01782924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92466402|NCT01782937|Brodalumab|brodalumab|mesh-list
92466403|NCT01782937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92466404|NCT01782950|Rifampin|rifampin|mesh-list
92466405|NCT01782950|Isoniazid|isoniazid|mesh-list
92466406|NCT01782950|Pyrazinamide|pyrazinamide|mesh-list
92466407|NCT01782950|Ethambutol|ethambutol|mesh-list
92466408|NCT01782950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92466409|NCT01782950|Antitubercular Agents|antitubercular agents|mesh-ancestor
92466410|NCT01782950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466411|NCT01782950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466412|NCT01782950|Leprostatic Agents|leprostatic agents|mesh-ancestor
92466413|NCT01782950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92466414|NCT01782950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466415|NCT01782950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466416|NCT01782950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92466417|NCT01782950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92466418|NCT01782950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92466419|NCT01782950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92466420|NCT01782950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92466421|NCT01782950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92466422|NCT01782950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92466423|NCT01782950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92466424|NCT01782950|Antimetabolites|antimetabolites|mesh-ancestor
92466425|NCT01782950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92466426|NCT01782976|Bevacizumab|bevacizumab|mesh-list
92466427|NCT01782976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92466428|NCT01782976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466429|NCT01782976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92466430|NCT01782976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92466431|NCT01782976|Growth Substances|growth substances|mesh-ancestor
92466432|NCT01782976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466433|NCT01782976|Growth Inhibitors|growth inhibitors|mesh-ancestor
92466434|NCT01783002|Carbon-11 methionine|carbon-11 methionine|mesh-list
92466435|NCT01783002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92466436|NCT01783002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466437|NCT01783106|Hydroxychloroquine|hydroxychloroquine|mesh-list
92466438|NCT01783106|Doxycycline|doxycycline|mesh-list
92466439|NCT01783106|Ciprofloxacin|ciprofloxacin|mesh-list
92466440|NCT01783106|Budesonide|budesonide|mesh-list
92466441|NCT01783106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466442|NCT01783106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92466443|NCT01783106|Autonomic Agents|autonomic agents|mesh-ancestor
92466444|NCT01783106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466445|NCT01783106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466446|NCT01783106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92466447|NCT01783106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92466448|NCT01783106|Glucocorticoids|glucocorticoids|mesh-ancestor
92466449|NCT01783106|Hormones|hormones|mesh-ancestor
92466450|NCT01783106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466451|NCT01783106|Antimalarials|antimalarials|mesh-ancestor
92466452|NCT01783106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92466453|NCT01783106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92466454|NCT01783106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466455|NCT01783106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466456|NCT01783106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466457|NCT01783106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466458|NCT01783106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466459|NCT01783106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92466460|NCT01783106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92466461|NCT01783106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466462|NCT01783106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92466463|NCT01783106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92466465|NCT01783197|Carboplatin|carboplatin|mesh-list
92466466|NCT01783197|Pemetrexed|pemetrexed|mesh-list
92466467|NCT01783197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92466468|NCT01783197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466469|NCT01783197|Tubulin Modulators|tubulin modulators|mesh-ancestor
92466470|NCT01783197|Antimitotic Agents|antimitotic agents|mesh-ancestor
92466471|NCT01783197|Mitosis Modulators|mitosis modulators|mesh-ancestor
92466472|NCT01783197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466473|NCT01783197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466474|NCT01783197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92466475|NCT01783197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92466476|NCT01783340|Azithromycin|azithromycin|mesh-list
92466477|NCT01783340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466478|NCT01783340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466479|NCT01783379|Micafungin|micafungin|mesh-list
92466480|NCT01783379|Antifungal Agents|antifungal agents|mesh-ancestor
92466481|NCT01783379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466482|NCT01783431|Poly ICLC|poly iclc|mesh-list
92466483|NCT01783431|Interferon Inducers|interferon inducers|mesh-ancestor
92466484|NCT01783431|Immunologic Factors|immunologic factors|mesh-ancestor
92466485|NCT01783431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466486|NCT01783587|Docetaxel|docetaxel|mesh-list
92466487|NCT01783587|Afatinib|afatinib|mesh-list
92466488|NCT01783587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466489|NCT01783587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92466490|NCT01783587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92466491|NCT01783587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92466492|NCT01783587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466493|NCT01783587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466494|NCT01783587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466495|NCT01783717|Exenatide|exenatide|mesh-list
92466496|NCT01783717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92466497|NCT01783717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466498|NCT01783717|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92466499|NCT01783717|Incretins|incretins|mesh-ancestor
92466500|NCT01783717|Hormones|hormones|mesh-ancestor
92466501|NCT01783717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466502|NCT01783756|Capecitabine|capecitabine|mesh-list
92466503|NCT01783756|Everolimus|everolimus|mesh-list
92466504|NCT01783756|Lapatinib|lapatinib|mesh-list
92466505|NCT01783756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466506|NCT01783756|Antimetabolites|antimetabolites|mesh-ancestor
92466507|NCT01783756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466509|NCT01783756|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92466510|NCT01783756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466511|NCT01783756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466512|NCT01783756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466513|NCT01783756|Immunologic Factors|immunologic factors|mesh-ancestor
92466514|NCT01783756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466515|NCT01783834|Pemetrexed|pemetrexed|mesh-list
92466516|NCT01783834|Gefitinib|gefitinib|mesh-list
92466517|NCT01783834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466518|NCT01783834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466519|NCT01783834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466520|NCT01783834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92466521|NCT01783834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92466522|NCT01783834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466523|NCT01783925|Aflibercept|aflibercept|mesh-list
92466524|NCT01783925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92466525|NCT01783925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92466526|NCT01783925|Growth Substances|growth substances|mesh-ancestor
92466527|NCT01783925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466528|NCT01783925|Growth Inhibitors|growth inhibitors|mesh-ancestor
92466529|NCT01783925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466530|NCT01783951|Cisplatin|cisplatin|mesh-list
92466531|NCT01783951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466532|NCT01783964|Cytarabine|cytarabine|mesh-list
92466533|NCT01783964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466534|NCT01783964|Antimetabolites|antimetabolites|mesh-ancestor
92466535|NCT01783964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466536|NCT01783964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466537|NCT01783964|Antiviral Agents|antiviral agents|mesh-ancestor
92466538|NCT01783964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466539|NCT01783964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466540|NCT01783964|Immunologic Factors|immunologic factors|mesh-ancestor
92466541|NCT01783964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466542|NCT01783977|Vaccines|vaccines|mesh-list
92466543|NCT01783977|Immunologic Factors|immunologic factors|mesh-ancestor
92466544|NCT01783977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466545|NCT01784107|Ifosfamide|ifosfamide|mesh-list
92466546|NCT01784107|Belotecan|belotecan|mesh-list
92466547|NCT01784107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92466548|NCT01784107|Alkylating Agents|alkylating agents|mesh-ancestor
92466549|NCT01784107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466550|NCT01784107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466551|NCT01784107|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92466552|NCT01784107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92466553|NCT01784107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466554|NCT01784120|Doxorubicin|doxorubicin|mesh-list
92466555|NCT01784120|genexol-PM|genexol-pm|mesh-list
92466556|NCT01784120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92466557|NCT01784120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466558|NCT01784120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92466559|NCT01784120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92466560|NCT01784120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466561|NCT01784120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466562|NCT01784120|Tubulin Modulators|tubulin modulators|mesh-ancestor
92466563|NCT01784120|Antimitotic Agents|antimitotic agents|mesh-ancestor
92466564|NCT01784120|Mitosis Modulators|mitosis modulators|mesh-ancestor
92466565|NCT01784250|Propranolol|propranolol|mesh-list
92466566|NCT01784250|Clonidine|clonidine|mesh-list
92466567|NCT01784250|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92466568|NCT01784250|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92466569|NCT01784250|Adrenergic Agents|adrenergic agents|mesh-ancestor
92466570|NCT01784250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348504|NCT01579812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92466571|NCT01784250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466572|NCT01784250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466573|NCT01784250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92466574|NCT01784250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92466575|NCT01784250|Vasodilator Agents|vasodilator agents|mesh-ancestor
92466576|NCT01784250|Analgesics|analgesics|mesh-ancestor
92466577|NCT01784250|Sensory System Agents|sensory system agents|mesh-ancestor
92466578|NCT01784250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466579|NCT01784250|Sympatholytics|sympatholytics|mesh-ancestor
92466580|NCT01784250|Autonomic Agents|autonomic agents|mesh-ancestor
92466581|NCT01784250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92466582|NCT01784250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92466583|NCT01784250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92466584|NCT01784302|Raltegravir Potassium|raltegravir potassium|mesh-list
92466585|NCT01784302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92466586|NCT01784302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92466587|NCT01784302|Antiviral Agents|antiviral agents|mesh-ancestor
92466588|NCT01784302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466589|NCT01784302|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92466590|NCT01784302|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92466591|NCT01784302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466592|NCT01784302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466593|NCT01784315|Chloroquine|chloroquine|mesh-list
92466594|NCT01784315|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92466595|NCT01784315|Primaquine|primaquine|mesh-list
92466596|NCT01784315|Artemisinins|artemisinins|mesh-list
92466597|NCT01784315|Artemisinin|artemisinin|mesh-list
92466598|NCT01784315|Amebicides|amebicides|mesh-ancestor
92466599|NCT01784315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92466600|NCT01784315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92466601|NCT01784315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466602|NCT01784315|Antimalarials|antimalarials|mesh-ancestor
92466603|NCT01784315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466604|NCT01784315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92466605|NCT01784315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466606|NCT01784315|Analgesics|analgesics|mesh-ancestor
92466607|NCT01784315|Sensory System Agents|sensory system agents|mesh-ancestor
92466608|NCT01784315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466609|NCT01784315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466610|NCT01784315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466611|NCT01784315|Filaricides|filaricides|mesh-ancestor
92466612|NCT01784315|Antinematodal Agents|antinematodal agents|mesh-ancestor
92466613|NCT01784315|Anthelmintics|anthelmintics|mesh-ancestor
92466614|NCT01784380|Metformin|metformin|mesh-list
92466615|NCT01784380|Clomiphene|clomiphene|mesh-list
92466616|NCT01784380|Enclomiphene|enclomiphene|mesh-list
92466617|NCT01784380|Zuclomiphene|zuclomiphene|mesh-list
92466618|NCT01784380|Menotropins|menotropins|mesh-list
92466619|NCT01784380|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
92466620|NCT01784380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92466621|NCT01784380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466622|NCT01784380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92466623|NCT01784380|Hormone Antagonists|hormone antagonists|mesh-ancestor
92466624|NCT01784380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466625|NCT01784380|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92466626|NCT01784380|Fertility Agents|fertility agents|mesh-ancestor
92466627|NCT01784380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92466628|NCT01784380|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92466629|NCT01784380|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92466630|NCT01784380|Androgen Antagonists|androgen antagonists|mesh-ancestor
92466631|NCT01784445|Ceftazidime|ceftazidime|mesh-list
92466632|NCT01784445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466633|NCT01784445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466634|NCT01784536|Oritavancin|oritavancin|mesh-list
92466635|NCT01784536|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466636|NCT01784536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466637|NCT01784549|Gemcitabine|gemcitabine|mesh-list
92466638|NCT01784549|Docetaxel|docetaxel|mesh-list
92466639|NCT01784549|Pemetrexed|pemetrexed|mesh-list
92466640|NCT01784549|Vinorelbine|vinorelbine|mesh-list
92466641|NCT01784549|Gefitinib|gefitinib|mesh-list
92466642|NCT01784549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466643|NCT01784549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466644|NCT01784549|Antimetabolites|antimetabolites|mesh-ancestor
92466645|NCT01784549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466646|NCT01784549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92466647|NCT01784549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92466648|NCT01784549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92466649|NCT01784549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466650|NCT01784549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92466651|NCT01784549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92466652|NCT01784549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92466653|NCT01784549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466654|NCT01784562|Riociguat|riociguat|mesh-list
92466655|NCT01784562|Enzyme Activators|enzyme activators|mesh-ancestor
92466656|NCT01784562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466657|NCT01784640|Pemetrexed|pemetrexed|mesh-list
92466658|NCT01784640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466659|NCT01784640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466660|NCT01784640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466661|NCT01784640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92466662|NCT01784640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92466663|NCT01784718|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92466664|NCT01784718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466665|NCT01784900|Catumaxomab|catumaxomab|mesh-list
92466666|NCT01784900|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92466667|NCT01784900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466668|NCT01784900|Immunologic Factors|immunologic factors|mesh-ancestor
92466669|NCT01784900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466670|NCT01784913|Sargramostim|sargramostim|mesh-list
92466671|NCT01784913|Immunologic Factors|immunologic factors|mesh-ancestor
92466672|NCT01784913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466673|NCT01784978|Everolimus|everolimus|mesh-list
92466674|NCT01784978|Sunitinib|sunitinib|mesh-list
92466675|NCT01784978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92466676|NCT01784978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92466677|NCT01784978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466678|NCT01784978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466679|NCT01784978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466680|NCT01784978|Immunologic Factors|immunologic factors|mesh-ancestor
92466681|NCT01784978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466682|NCT01784978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466683|NCT01784978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92466684|NCT01784978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92466685|NCT01784978|Growth Substances|growth substances|mesh-ancestor
92466686|NCT01784978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92466687|NCT01785004|Vitamin D|vitamin d|mesh-list
92466688|NCT01785004|Cholecalciferol|cholecalciferol|mesh-list
92466689|NCT01785004|Vitamins|vitamins|mesh-ancestor
92466690|NCT01785004|Micronutrients|micronutrients|mesh-ancestor
92466691|NCT01785004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191600|NCT00472849|Antimetabolites|antimetabolites|mesh-ancestor
92466692|NCT01785004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92466693|NCT01785004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92466694|NCT01785030|Nitrous Oxide|nitrous oxide|mesh-list
92466695|NCT01785030|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92466696|NCT01785030|Anesthetics, General|anesthetics, general|mesh-ancestor
92466697|NCT01785030|Anesthetics|anesthetics|mesh-ancestor
92466698|NCT01785030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466699|NCT01785030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466700|NCT01785030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466701|NCT01785030|Analgesics|analgesics|mesh-ancestor
92466702|NCT01785030|Sensory System Agents|sensory system agents|mesh-ancestor
92466703|NCT01785030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466704|NCT01785043|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92466705|NCT01785043|Liraglutide|liraglutide|mesh-list
92466706|NCT01785043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92466707|NCT01785043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466708|NCT01785043|Incretins|incretins|mesh-ancestor
92466709|NCT01785043|Hormones|hormones|mesh-ancestor
92466710|NCT01785043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466711|NCT01785043|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92466712|NCT01785043|Protease Inhibitors|protease inhibitors|mesh-ancestor
92466713|NCT01785043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466714|NCT01785043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466715|NCT01785056|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92466716|NCT01785056|Immunologic Factors|immunologic factors|mesh-ancestor
92466717|NCT01785056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466718|NCT01785108|Vitamin D|vitamin d|mesh-list
92466719|NCT01785108|Ibuprofen|ibuprofen|mesh-list
92466720|NCT01785108|Aluminum sulfate|aluminum sulfate|mesh-list
92466721|NCT01785108|Vitamins|vitamins|mesh-ancestor
92466722|NCT01785108|Micronutrients|micronutrients|mesh-ancestor
92466723|NCT01785108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466724|NCT01785108|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92466725|NCT01785108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92466726|NCT01785108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466727|NCT01785108|Analgesics|analgesics|mesh-ancestor
92466728|NCT01785108|Sensory System Agents|sensory system agents|mesh-ancestor
92466729|NCT01785108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466730|NCT01785108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466731|NCT01785108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466732|NCT01785108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92466734|NCT01785108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466735|NCT01785108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92466736|NCT01785108|Immunologic Factors|immunologic factors|mesh-ancestor
92466737|NCT01785290|Haloperidol|haloperidol|mesh-list
92466738|NCT01785290|Haloperidol decanoate|haloperidol decanoate|mesh-list
92466739|NCT01785290|Antiemetics|antiemetics|mesh-ancestor
92466740|NCT01785290|Autonomic Agents|autonomic agents|mesh-ancestor
92466741|NCT01785290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466742|NCT01785290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466743|NCT01785290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466744|NCT01785290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92466745|NCT01785290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92466746|NCT01785290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466747|NCT01785290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92466748|NCT01785290|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92466749|NCT01785290|Dopamine Agents|dopamine agents|mesh-ancestor
92466750|NCT01785290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466751|NCT01785290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466752|NCT01785290|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92466753|NCT01785329|Alirocumab|alirocumab|mesh-list
92466754|NCT01785329|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92466755|NCT01785329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92466756|NCT01785329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92466757|NCT01785329|Antimetabolites|antimetabolites|mesh-ancestor
92466758|NCT01785329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466759|NCT01785329|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92466760|NCT01785329|Protease Inhibitors|protease inhibitors|mesh-ancestor
92466761|NCT01785329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466762|NCT01785329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92466763|NCT01785446|Sufentanil|sufentanil|mesh-list
92466764|NCT01785446|Dexmedetomidine|dexmedetomidine|mesh-list
92466765|NCT01785446|Dsuvia|dsuvia|mesh-list
92466766|NCT01785446|Atracurium|atracurium|mesh-list
92466767|NCT01785446|Cisatracurium|cisatracurium|mesh-list
92466768|NCT01785446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92191668|NCT01797757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466769|NCT01785446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466770|NCT01785446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466771|NCT01785446|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466773|NCT01785446|Sensory System Agents|sensory system agents|mesh-ancestor
92466774|NCT01785446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466775|NCT01785446|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92466776|NCT01785446|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92466777|NCT01785446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92466778|NCT01785446|Adrenergic Agents|adrenergic agents|mesh-ancestor
92466779|NCT01785446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466780|NCT01785446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466781|NCT01785446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92466782|NCT01785446|Narcotics|narcotics|mesh-ancestor
92466783|NCT01785446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92466784|NCT01785446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92466785|NCT01785446|Anesthetics, General|anesthetics, general|mesh-ancestor
92466786|NCT01785446|Anesthetics|anesthetics|mesh-ancestor
92466787|NCT01785446|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92466788|NCT01785446|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92466789|NCT01785446|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92466790|NCT01785446|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92466791|NCT01785446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92466792|NCT01785446|Cholinergic Agents|cholinergic agents|mesh-ancestor
92466793|NCT01785589|Adenosine|adenosine|mesh-list
92466794|NCT01785589|Analgesics|analgesics|mesh-ancestor
92466795|NCT01785589|Sensory System Agents|sensory system agents|mesh-ancestor
92466796|NCT01785589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466797|NCT01785589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466798|NCT01785589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92466799|NCT01785589|Vasodilator Agents|vasodilator agents|mesh-ancestor
92466800|NCT01785589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92466801|NCT01785589|Purinergic Agonists|purinergic agonists|mesh-ancestor
92466802|NCT01785589|Purinergic Agents|purinergic agents|mesh-ancestor
92466803|NCT01785589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466804|NCT01785589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466805|NCT01785641|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92466806|NCT01785641|Ciprofloxacin|ciprofloxacin|mesh-list
92466807|NCT01785641|Gentamicins|gentamicins|mesh-list
92466808|NCT01785641|Cefazolin|cefazolin|mesh-list
92466809|NCT01785641|Ceftazidime|ceftazidime|mesh-list
92466810|NCT01785641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92466811|NCT01785641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466812|NCT01785641|Antitubercular Agents|antitubercular agents|mesh-ancestor
92466813|NCT01785641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92466814|NCT01785641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92466815|NCT01785641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466816|NCT01785641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466817|NCT01785641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466818|NCT01785641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92466819|NCT01785641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92466820|NCT01785641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92466821|NCT01785693|Clonidine|clonidine|mesh-list
92466822|NCT01785693|Levobupivacaine|levobupivacaine|mesh-list
92466823|NCT01785693|Analgesics|analgesics|mesh-ancestor
92466824|NCT01785693|Sensory System Agents|sensory system agents|mesh-ancestor
92466825|NCT01785693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466826|NCT01785693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466827|NCT01785693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92466828|NCT01785693|Sympatholytics|sympatholytics|mesh-ancestor
92466829|NCT01785693|Autonomic Agents|autonomic agents|mesh-ancestor
92466830|NCT01785693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92466831|NCT01785693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92466832|NCT01785693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92466833|NCT01785693|Adrenergic Agents|adrenergic agents|mesh-ancestor
92466834|NCT01785693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466835|NCT01785693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466836|NCT01785693|Anesthetics, Local|anesthetics, local|mesh-ancestor
92466837|NCT01785693|Anesthetics|anesthetics|mesh-ancestor
92466838|NCT01785693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466839|NCT01785797|Silicon|silicon|mesh-list
92466840|NCT01785797|Trace Elements|trace elements|mesh-ancestor
92466841|NCT01785797|Micronutrients|micronutrients|mesh-ancestor
92466842|NCT01785797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466843|NCT01785836|Dapsone|dapsone|mesh-list
92466844|NCT01785836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466845|NCT01785836|Antimalarials|antimalarials|mesh-ancestor
92466846|NCT01785836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92466847|NCT01785836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92466848|NCT01785836|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92466849|NCT01785836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466850|NCT01785836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466851|NCT01785836|Leprostatic Agents|leprostatic agents|mesh-ancestor
92466852|NCT01785836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92466853|NCT01785862|Ibuprofen|ibuprofen|mesh-list
92466854|NCT01785862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92466855|NCT01785862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466856|NCT01785862|Analgesics|analgesics|mesh-ancestor
92466857|NCT01785862|Sensory System Agents|sensory system agents|mesh-ancestor
92466858|NCT01785862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466859|NCT01785862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466860|NCT01785862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466861|NCT01785862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466862|NCT01785862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92466863|NCT01785862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466864|NCT01785862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466865|NCT01785979|Chloroquine|chloroquine|mesh-list
92466866|NCT01785979|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92466867|NCT01785979|Prednisone|prednisone|mesh-list
92466868|NCT01785979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466869|NCT01785979|Glucocorticoids|glucocorticoids|mesh-ancestor
92466870|NCT01785979|Hormones|hormones|mesh-ancestor
92466871|NCT01785979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466872|NCT01785979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466873|NCT01785979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92466874|NCT01785979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466875|NCT01785979|Amebicides|amebicides|mesh-ancestor
92466876|NCT01785979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92466877|NCT01785979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92466878|NCT01785979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466879|NCT01785979|Antimalarials|antimalarials|mesh-ancestor
92466880|NCT01785979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466881|NCT01785979|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92466882|NCT01785979|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466883|NCT01785979|Analgesics|analgesics|mesh-ancestor
92466884|NCT01785979|Sensory System Agents|sensory system agents|mesh-ancestor
92466885|NCT01785979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466886|NCT01785979|Filaricides|filaricides|mesh-ancestor
92466887|NCT01785979|Antinematodal Agents|antinematodal agents|mesh-ancestor
92466888|NCT01785979|Anthelmintics|anthelmintics|mesh-ancestor
92466889|NCT01786018|Cyclosporine|cyclosporine|mesh-list
92466890|NCT01786018|Methotrexate|methotrexate|mesh-list
92466891|NCT01786018|Busulfan|busulfan|mesh-list
92466892|NCT01786018|Thiotepa|thiotepa|mesh-list
92466893|NCT01786018|Cyclosporins|cyclosporins|mesh-list
92466894|NCT01786018|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92466895|NCT01786018|Abortifacient Agents|abortifacient agents|mesh-ancestor
92466896|NCT01786018|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92466897|NCT01786018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466898|NCT01786018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466899|NCT01786018|Antimetabolites|antimetabolites|mesh-ancestor
92466900|NCT01786018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466901|NCT01786018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466902|NCT01786018|Dermatologic Agents|dermatologic agents|mesh-ancestor
92466903|NCT01786018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466904|NCT01786018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92466905|NCT01786018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466906|NCT01786018|Immunologic Factors|immunologic factors|mesh-ancestor
92466907|NCT01786018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466908|NCT01786018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92466909|NCT01786018|Antifungal Agents|antifungal agents|mesh-ancestor
92466910|NCT01786018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92466911|NCT01786018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92466912|NCT01786018|Alkylating Agents|alkylating agents|mesh-ancestor
92466913|NCT01786018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92466914|NCT01786018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92466915|NCT01786070|Budesonide|budesonide|mesh-list
92466916|NCT01786070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466917|NCT01786070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92466918|NCT01786070|Autonomic Agents|autonomic agents|mesh-ancestor
92466919|NCT01786070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466920|NCT01786070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191821|NCT00410423|Antimetabolites|antimetabolites|mesh-ancestor
92466921|NCT01786070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92466922|NCT01786070|Respiratory System Agents|respiratory system agents|mesh-ancestor
92466923|NCT01786070|Glucocorticoids|glucocorticoids|mesh-ancestor
92466924|NCT01786070|Hormones|hormones|mesh-ancestor
92466925|NCT01786070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466926|NCT01786200|Aspirin|aspirin|mesh-list
92466927|NCT01786200|Ibuprofen|ibuprofen|mesh-list
92466928|NCT01786200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92466929|NCT01786200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92466930|NCT01786200|Analgesics|analgesics|mesh-ancestor
92466931|NCT01786200|Sensory System Agents|sensory system agents|mesh-ancestor
92466932|NCT01786200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92466933|NCT01786200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466934|NCT01786200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92466935|NCT01786200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92466936|NCT01786200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92466937|NCT01786200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92466938|NCT01786200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466939|NCT01786200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92348516|NCT01578486|Analgesics|analgesics|mesh-ancestor
92466940|NCT01786200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92466941|NCT01786200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466942|NCT01786200|Antipyretics|antipyretics|mesh-ancestor
92466943|NCT01786226|Mifepristone|mifepristone|mesh-list
92466944|NCT01786226|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92466945|NCT01786226|Abortifacient Agents|abortifacient agents|mesh-ancestor
92466946|NCT01786226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92466947|NCT01786226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466948|NCT01786226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92466949|NCT01786226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92466950|NCT01786226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92466951|NCT01786226|Contraceptive Agents|contraceptive agents|mesh-ancestor
92466952|NCT01786226|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92466953|NCT01786226|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92466954|NCT01786226|Hormone Antagonists|hormone antagonists|mesh-ancestor
92466955|NCT01786226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92466956|NCT01786226|Luteolytic Agents|luteolytic agents|mesh-ancestor
92466957|NCT01786226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92466958|NCT01786226|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92466960|NCT01786382|Omeprazole|omeprazole|mesh-list
92466961|NCT01786382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92466962|NCT01786382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92466963|NCT01786382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92466964|NCT01786382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466965|NCT01786382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92466966|NCT01786382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92466967|NCT01786382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92466968|NCT01786382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92466969|NCT01786382|Anesthetics, General|anesthetics, general|mesh-ancestor
92466970|NCT01786382|Anesthetics|anesthetics|mesh-ancestor
92466971|NCT01786382|GABA Modulators|gaba modulators|mesh-ancestor
92466972|NCT01786382|GABA Agents|gaba agents|mesh-ancestor
92466973|NCT01786382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92466974|NCT01786382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466975|NCT01786382|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92466976|NCT01786382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92466977|NCT01786382|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92466978|NCT01786382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92466979|NCT01786395|Isopropyl unoprostone|isopropyl unoprostone|mesh-list
92466980|NCT01786395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92466981|NCT01786538|Leucovorin|leucovorin|mesh-list
92466982|NCT01786538|Fluorouracil|fluorouracil|mesh-list
92466983|NCT01786538|Oxaliplatin|oxaliplatin|mesh-list
92466984|NCT01786538|Antimetabolites|antimetabolites|mesh-ancestor
92466985|NCT01786538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92466986|NCT01786538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92466987|NCT01786538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92466988|NCT01786538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92466989|NCT01786538|Immunologic Factors|immunologic factors|mesh-ancestor
92466990|NCT01786538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92466991|NCT01786538|Antidotes|antidotes|mesh-ancestor
92191895|NCT00412841|Atorvastatin|atorvastatin|mesh-list
92466992|NCT01786538|Protective Agents|protective agents|mesh-ancestor
92466993|NCT01786538|Vitamin B Complex|vitamin b complex|mesh-ancestor
92466994|NCT01786538|Vitamins|vitamins|mesh-ancestor
92466995|NCT01786538|Micronutrients|micronutrients|mesh-ancestor
92466996|NCT01786616|Formoterol Fumarate|formoterol fumarate|mesh-list
92466997|NCT01786616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92466998|NCT01786616|Autonomic Agents|autonomic agents|mesh-ancestor
92466999|NCT01786616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467000|NCT01786616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467001|NCT01786616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92467002|NCT01786616|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467003|NCT01786616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92467004|NCT01786616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92467005|NCT01786616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92467006|NCT01786616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92467007|NCT01786616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467008|NCT01786616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467009|NCT01786655|Epinephrine|epinephrine|mesh-list
92467010|NCT01786655|Bupivacaine|bupivacaine|mesh-list
92467011|NCT01786655|Neosaxitoxin|neosaxitoxin|mesh-list
92467012|NCT01786655|Anesthetics, Local|anesthetics, local|mesh-ancestor
92467013|NCT01786655|Anesthetics|anesthetics|mesh-ancestor
92467014|NCT01786655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467015|NCT01786655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467016|NCT01786655|Sensory System Agents|sensory system agents|mesh-ancestor
92467017|NCT01786655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467018|NCT01786655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92467019|NCT01786655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92467020|NCT01786655|Adrenergic Agents|adrenergic agents|mesh-ancestor
92467021|NCT01786655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467022|NCT01786655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467023|NCT01786655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92467024|NCT01786655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92467025|NCT01786655|Autonomic Agents|autonomic agents|mesh-ancestor
92467026|NCT01786655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92467027|NCT01786655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467028|NCT01786655|Mydriatics|mydriatics|mesh-ancestor
92467029|NCT01786655|Sympathomimetics|sympathomimetics|mesh-ancestor
92467030|NCT01786655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92467031|NCT01786655|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92467032|NCT01786655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92467033|NCT01786759|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92467034|NCT01786759|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92467035|NCT01786759|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92467036|NCT01786759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92467037|NCT01787123|Cerebrolysin|cerebrolysin|mesh-list
92467038|NCT01787123|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92467039|NCT01787123|Protective Agents|protective agents|mesh-ancestor
92467040|NCT01787123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467041|NCT01787123|Nootropic Agents|nootropic agents|mesh-ancestor
92467042|NCT01787136|Dextromethorphan|dextromethorphan|mesh-list
92467043|NCT01787136|Antitussive Agents|antitussive agents|mesh-ancestor
92467044|NCT01787136|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467045|NCT01787136|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92467046|NCT01787136|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92467047|NCT01787136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467048|NCT01787136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467049|NCT01787136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467050|NCT01787344|Botulinum Toxins|botulinum toxins|mesh-list
92467051|NCT01787344|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92467052|NCT01787344|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92467053|NCT01787344|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92467054|NCT01787344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467055|NCT01787344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467056|NCT01787344|Cholinergic Agents|cholinergic agents|mesh-ancestor
92467057|NCT01787344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467058|NCT01787344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467059|NCT01787344|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92467060|NCT01787344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467061|NCT01787357|Canagliflozin|canagliflozin|mesh-list
92467062|NCT01787357|Moxifloxacin|moxifloxacin|mesh-list
92467063|NCT01787357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92467064|NCT01787357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467065|NCT01787357|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92467066|NCT01787357|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92467067|NCT01787357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467068|NCT01787357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191966|NCT00455975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92467069|NCT01787357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467070|NCT01787357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467071|NCT01787357|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92467072|NCT01787357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467074|NCT01787396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467075|NCT01787396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467076|NCT01787474|Cytarabine|cytarabine|mesh-list
92467077|NCT01787474|Fludarabine|fludarabine|mesh-list
92467078|NCT01787474|Fludarabine phosphate|fludarabine phosphate|mesh-list
92467079|NCT01787474|Lenograstim|lenograstim|mesh-list
92467080|NCT01787474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467081|NCT01787474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92467082|NCT01787474|Antimetabolites|antimetabolites|mesh-ancestor
92467083|NCT01787474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467084|NCT01787474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467085|NCT01787474|Immunologic Factors|immunologic factors|mesh-ancestor
92467086|NCT01787474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467087|NCT01787474|Antiviral Agents|antiviral agents|mesh-ancestor
92467088|NCT01787474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467089|NCT01787474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92467090|NCT01787630|Hyaluronic Acid|hyaluronic acid|mesh-list
92467091|NCT01787630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92467092|NCT01787630|Immunologic Factors|immunologic factors|mesh-ancestor
92467093|NCT01787630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467094|NCT01787630|Viscosupplements|viscosupplements|mesh-ancestor
92467095|NCT01787630|Protective Agents|protective agents|mesh-ancestor
92467096|NCT01787669|Dexamethasone|dexamethasone|mesh-list
92467097|NCT01787669|Bevacizumab|bevacizumab|mesh-list
92467098|NCT01787669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92467099|NCT01787669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467100|NCT01787669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92467101|NCT01787669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92467102|NCT01787669|Growth Substances|growth substances|mesh-ancestor
92467103|NCT01787669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467104|NCT01787669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92467105|NCT01787669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467106|NCT01787669|Antiemetics|antiemetics|mesh-ancestor
92467107|NCT01787669|Autonomic Agents|autonomic agents|mesh-ancestor
92467108|NCT01787669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467109|NCT01787669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467110|NCT01787669|Glucocorticoids|glucocorticoids|mesh-ancestor
92467111|NCT01787669|Hormones|hormones|mesh-ancestor
92467112|NCT01787669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467113|NCT01787669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92467114|NCT01788007|Imiquimod|imiquimod|mesh-list
92467115|NCT01788007|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92467116|NCT01788007|Immunologic Factors|immunologic factors|mesh-ancestor
92467117|NCT01788007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467118|NCT01788007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467119|NCT01788007|Interferon Inducers|interferon inducers|mesh-ancestor
92467120|NCT01788072|Oxytocin|oxytocin|mesh-list
92467121|NCT01788072|Oxytocics|oxytocics|mesh-ancestor
92467122|NCT01788072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467123|NCT01788072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467124|NCT01788176|Zoledronic Acid|zoledronic acid|mesh-list
92467125|NCT01788176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92467126|NCT01788176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467127|NCT01788189|Lenalidomide|lenalidomide|mesh-list
92467128|NCT01788189|Immunologic Factors|immunologic factors|mesh-ancestor
92467129|NCT01788189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467130|NCT01788189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92467131|NCT01788189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92467132|NCT01788189|Growth Substances|growth substances|mesh-ancestor
92467133|NCT01788189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92467134|NCT01788189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467135|NCT01788254|Talinolol|talinolol|mesh-list
92467136|NCT01788254|Torsemide|torsemide|mesh-list
92467137|NCT01788254|Midazolam|midazolam|mesh-list
92467138|NCT01788254|Codeine|codeine|mesh-list
92467139|NCT01788254|Pravastatin|pravastatin|mesh-list
92467140|NCT01788254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92467141|NCT01788254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92467142|NCT01788254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467143|NCT01788254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467144|NCT01788254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92467145|NCT01788254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92467146|NCT01788254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92467147|NCT01788254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92467148|NCT01788254|Anesthetics, General|anesthetics, general|mesh-ancestor
92467149|NCT01788254|Anesthetics|anesthetics|mesh-ancestor
92467150|NCT01788254|GABA Modulators|gaba modulators|mesh-ancestor
92467151|NCT01788254|GABA Agents|gaba agents|mesh-ancestor
92467152|NCT01788254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467153|NCT01788254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467154|NCT01788254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92467155|NCT01788254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92467156|NCT01788254|Antimetabolites|antimetabolites|mesh-ancestor
92467157|NCT01788254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92467158|NCT01788254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92467159|NCT01788254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467160|NCT01788254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92467161|NCT01788254|Narcotics|narcotics|mesh-ancestor
92467162|NCT01788254|Analgesics|analgesics|mesh-ancestor
92467163|NCT01788254|Sensory System Agents|sensory system agents|mesh-ancestor
92467164|NCT01788254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467165|NCT01788254|Antitussive Agents|antitussive agents|mesh-ancestor
92467166|NCT01788254|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467167|NCT01788254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92467168|NCT01788254|Diuretics|diuretics|mesh-ancestor
92467169|NCT01788254|Natriuretic Agents|natriuretic agents|mesh-ancestor
92467170|NCT01788254|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92467171|NCT01788254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467172|NCT01788254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92467173|NCT01788254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92467174|NCT01788254|Adrenergic Agents|adrenergic agents|mesh-ancestor
92467175|NCT01788254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92467176|NCT01788280|Bevacizumab|bevacizumab|mesh-list
92467177|NCT01788280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92467178|NCT01788280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467179|NCT01788280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92467180|NCT01788280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92467181|NCT01788280|Growth Substances|growth substances|mesh-ancestor
92467182|NCT01788280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467183|NCT01788280|Growth Inhibitors|growth inhibitors|mesh-ancestor
92467185|NCT01788332|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92467186|NCT01788332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467187|NCT01788332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467188|NCT01788332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467189|NCT01788371|Lamivudine|lamivudine|mesh-list
92467190|NCT01788371|Telbivudine|telbivudine|mesh-list
92467191|NCT01788371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92467192|NCT01788371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92467193|NCT01788371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467194|NCT01788371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467195|NCT01788371|Antiviral Agents|antiviral agents|mesh-ancestor
92467196|NCT01788371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467197|NCT01788371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92467198|NCT01788371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92467199|NCT01788384|Clindamycin|clindamycin|mesh-list
92467200|NCT01788384|Clindamycin palmitate|clindamycin palmitate|mesh-list
92467201|NCT01788384|Clindamycin phosphate|clindamycin phosphate|mesh-list
92467202|NCT01788384|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92467203|NCT01788384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92467204|NCT01788384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467205|NCT01788384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92467206|NCT01788384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467207|NCT01788384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467208|NCT01788384|Dermatologic Agents|dermatologic agents|mesh-ancestor
92467209|NCT01788462|Tesamorelin|tesamorelin|mesh-list
92467210|NCT01788462|Growth Substances|growth substances|mesh-ancestor
92467211|NCT01788462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467212|NCT01788501|Cyclosporine|cyclosporine|mesh-list
92467213|NCT01788501|Methotrexate|methotrexate|mesh-list
92467214|NCT01788501|Tacrolimus|tacrolimus|mesh-list
92467215|NCT01788501|Cyclosporins|cyclosporins|mesh-list
92467216|NCT01788501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92467217|NCT01788501|Abortifacient Agents|abortifacient agents|mesh-ancestor
92467218|NCT01788501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467219|NCT01788501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467220|NCT01788501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92467221|NCT01788501|Antimetabolites|antimetabolites|mesh-ancestor
92467222|NCT01788501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467223|NCT01788501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467224|NCT01788501|Dermatologic Agents|dermatologic agents|mesh-ancestor
92467225|NCT01788501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467226|NCT01788501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92467227|NCT01788501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467228|NCT01788501|Immunologic Factors|immunologic factors|mesh-ancestor
92467229|NCT01788501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92467230|NCT01788501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92467231|NCT01788501|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92467232|NCT01788501|Antifungal Agents|antifungal agents|mesh-ancestor
92467233|NCT01788501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467234|NCT01788540|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92467235|NCT01788540|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92467236|NCT01788540|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92467237|NCT01788540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92467238|NCT01788605|Ramosetron|ramosetron|mesh-list
92467239|NCT01788605|Antiemetics|antiemetics|mesh-ancestor
92467240|NCT01788605|Autonomic Agents|autonomic agents|mesh-ancestor
92467241|NCT01788605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467242|NCT01788605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467243|NCT01788605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467244|NCT01788605|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92467245|NCT01788605|Serotonin Agents|serotonin agents|mesh-ancestor
92467246|NCT01788605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467247|NCT01788605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467248|NCT01788670|Ethanol|ethanol|mesh-list
92467249|NCT01788670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92467250|NCT01788670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467251|NCT01788670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467252|NCT01788670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467253|NCT01788722|Dienogest|dienogest|mesh-list
92467254|NCT01788722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92467255|NCT01788722|Contraceptive Agents|contraceptive agents|mesh-ancestor
92467256|NCT01788722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467257|NCT01788722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467258|NCT01788722|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92467259|NCT01788722|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92467260|NCT01788722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92467261|NCT01788722|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92467262|NCT01788722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92467263|NCT01788722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467264|NCT01788722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92467265|NCT01788722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467266|NCT01788774|Risperidone|risperidone|mesh-list
92467267|NCT01788774|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92467268|NCT01788774|Serotonin Agents|serotonin agents|mesh-ancestor
92467269|NCT01788774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467270|NCT01788774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467271|NCT01788774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467272|NCT01788774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92467273|NCT01788774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92467274|NCT01788774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467275|NCT01788774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92467276|NCT01788774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92467277|NCT01788774|Dopamine Agents|dopamine agents|mesh-ancestor
92467278|NCT01788969|Escitalopram|escitalopram|mesh-list
92467279|NCT01788969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92467280|NCT01788969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92467281|NCT01788969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467282|NCT01788969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467283|NCT01788969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467284|NCT01788969|Serotonin Agents|serotonin agents|mesh-ancestor
92467285|NCT01788969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467286|NCT01788982|Nintedanib|nintedanib|mesh-list
92467287|NCT01788982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322409|NCT00002120|Vitamins|vitamins|mesh-ancestor
92467289|NCT01788982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467290|NCT01788982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467291|NCT01789086|Liraglutide|liraglutide|mesh-list
92467292|NCT01789086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467293|NCT01789086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467294|NCT01789086|Incretins|incretins|mesh-ancestor
92467295|NCT01789086|Hormones|hormones|mesh-ancestor
92467296|NCT01789086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467297|NCT01789099|Sargramostim|sargramostim|mesh-list
92467298|NCT01789099|Immunologic Factors|immunologic factors|mesh-ancestor
92467299|NCT01789099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467300|NCT01789125|Nicotine|nicotine|mesh-list
92467301|NCT01789125|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92467302|NCT01789125|Autonomic Agents|autonomic agents|mesh-ancestor
92467303|NCT01789125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467304|NCT01789125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467305|NCT01789125|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92467306|NCT01789125|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92467307|NCT01789125|Cholinergic Agents|cholinergic agents|mesh-ancestor
92467308|NCT01789125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467309|NCT01789125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467310|NCT01789216|Ketorolac|ketorolac|mesh-list
92467311|NCT01789216|Meloxicam|meloxicam|mesh-list
92467312|NCT01789216|Pregabalin|pregabalin|mesh-list
92467313|NCT01789216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92467314|NCT01789216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467315|NCT01789216|Analgesics|analgesics|mesh-ancestor
92467316|NCT01789216|Sensory System Agents|sensory system agents|mesh-ancestor
92467317|NCT01789216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467318|NCT01789216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467319|NCT01789216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467320|NCT01789216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92467321|NCT01789216|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92467322|NCT01789216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467323|NCT01789216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467324|NCT01789216|Anticonvulsants|anticonvulsants|mesh-ancestor
92467325|NCT01789216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92467326|NCT01789216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467327|NCT01789216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92467328|NCT01789216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92467329|NCT01789216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92467330|NCT01789216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467331|NCT01789216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92467332|NCT01789216|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92467333|NCT01789242|Dexamethasone|dexamethasone|mesh-list
92467334|NCT01789242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467335|NCT01789242|Antiemetics|antiemetics|mesh-ancestor
92467336|NCT01789242|Autonomic Agents|autonomic agents|mesh-ancestor
92467337|NCT01789242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467338|NCT01789242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467339|NCT01789242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467340|NCT01789242|Glucocorticoids|glucocorticoids|mesh-ancestor
92467341|NCT01789242|Hormones|hormones|mesh-ancestor
92467342|NCT01789242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467343|NCT01789242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92467344|NCT01789242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467345|NCT01789294|Mesalamine|mesalamine|mesh-list
92467346|NCT01789294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92467347|NCT01789294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467348|NCT01789294|Analgesics|analgesics|mesh-ancestor
92467349|NCT01789294|Sensory System Agents|sensory system agents|mesh-ancestor
92467350|NCT01789294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467351|NCT01789294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467352|NCT01789294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467353|NCT01789294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92467354|NCT01789385|Dexmedetomidine|dexmedetomidine|mesh-list
92467355|NCT01789385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92467356|NCT01789385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467357|NCT01789385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467358|NCT01789385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467359|NCT01789385|Analgesics|analgesics|mesh-ancestor
92467360|NCT01789385|Sensory System Agents|sensory system agents|mesh-ancestor
92467361|NCT01789385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467362|NCT01789385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92467363|NCT01789385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92467364|NCT01789385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92467365|NCT01789385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92467366|NCT01789385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467367|NCT01789385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467368|NCT01789437|Dexamethasone|dexamethasone|mesh-list
92467369|NCT01789437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467371|NCT01789437|Autonomic Agents|autonomic agents|mesh-ancestor
92467372|NCT01789437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467373|NCT01789437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467374|NCT01789437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467375|NCT01789437|Glucocorticoids|glucocorticoids|mesh-ancestor
92467376|NCT01789437|Hormones|hormones|mesh-ancestor
92467377|NCT01789437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149635|NCT04397653|Antimetabolites|antimetabolites|mesh-ancestor
92467378|NCT01789437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92467379|NCT01789437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467380|NCT01789619|Tacrolimus|tacrolimus|mesh-list
92467381|NCT01789619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467382|NCT01789619|Immunologic Factors|immunologic factors|mesh-ancestor
92467383|NCT01789619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467384|NCT01789619|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92467385|NCT01789619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467386|NCT01789619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467387|NCT01789710|Bupropion|bupropion|mesh-list
92467388|NCT01789710|Nicotine|nicotine|mesh-list
92467389|NCT01789710|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92467390|NCT01789710|Autonomic Agents|autonomic agents|mesh-ancestor
92467391|NCT01789710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467392|NCT01789710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467393|NCT01789710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92467394|NCT01789710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92467395|NCT01789710|Cholinergic Agents|cholinergic agents|mesh-ancestor
92467396|NCT01789710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467397|NCT01789710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467398|NCT01789710|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92467399|NCT01789710|Antidepressive Agents|antidepressive agents|mesh-ancestor
92467400|NCT01789710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92467401|NCT01789710|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92467402|NCT01789710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92467403|NCT01789710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467404|NCT01789710|Dopamine Agents|dopamine agents|mesh-ancestor
92467405|NCT01789710|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92467406|NCT01789710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92467407|NCT01789710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467408|NCT01789723|Leucovorin|leucovorin|mesh-list
92467409|NCT01789723|Levoleucovorin|levoleucovorin|mesh-list
92467410|NCT01789723|Antidotes|antidotes|mesh-ancestor
92467411|NCT01789723|Protective Agents|protective agents|mesh-ancestor
92467412|NCT01789723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467413|NCT01789723|Vitamin B Complex|vitamin b complex|mesh-ancestor
92467414|NCT01789723|Vitamins|vitamins|mesh-ancestor
92467415|NCT01789723|Micronutrients|micronutrients|mesh-ancestor
92467416|NCT01789827|Interleukin-2|interleukin-2|mesh-list
92467417|NCT01789827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467418|NCT01789827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467419|NCT01789827|Analgesics|analgesics|mesh-ancestor
92467420|NCT01789827|Sensory System Agents|sensory system agents|mesh-ancestor
92467421|NCT01789827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467422|NCT01789827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467423|NCT01789879|Efavirenz|efavirenz|mesh-list
92467424|NCT01789879|Nevirapine|nevirapine|mesh-list
92467425|NCT01789879|Levonorgestrel|levonorgestrel|mesh-list
92467426|NCT01789879|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92467427|NCT01789879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92467428|NCT01789879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467429|NCT01789879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467430|NCT01789879|Antiviral Agents|antiviral agents|mesh-ancestor
92467431|NCT01789879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467432|NCT01789879|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92467433|NCT01789879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92467434|NCT01789879|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92467435|NCT01789879|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92467436|NCT01789879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92467437|NCT01789879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92467438|NCT01789879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92467440|NCT01789879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467441|NCT01789879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192343|NCT00427973|Cediranib|cediranib|mesh-list
92467442|NCT01789879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92467443|NCT01789879|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92467444|NCT01789879|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92467445|NCT01789879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92467446|NCT01789879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92467447|NCT01789892|Methylprednisolone|methylprednisolone|mesh-list
92467448|NCT01789892|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92467449|NCT01789892|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92467450|NCT01789892|Prednisolone|prednisolone|mesh-list
92467451|NCT01789892|Prednisolone acetate|prednisolone acetate|mesh-list
92467452|NCT01789892|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92467453|NCT01789892|Prednisolone phosphate|prednisolone phosphate|mesh-list
92467454|NCT01789892|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92467455|NCT01789892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467456|NCT01789892|Antiemetics|antiemetics|mesh-ancestor
92467457|NCT01789892|Autonomic Agents|autonomic agents|mesh-ancestor
92467458|NCT01789892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467459|NCT01789892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467460|NCT01789892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467461|NCT01789892|Glucocorticoids|glucocorticoids|mesh-ancestor
92467462|NCT01789892|Hormones|hormones|mesh-ancestor
92467463|NCT01789892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467464|NCT01789892|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92467465|NCT01789892|Protective Agents|protective agents|mesh-ancestor
92467466|NCT01789892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92467467|NCT01789892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467468|NCT01789892|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92467469|NCT01789892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467470|NCT01789957|Exenatide|exenatide|mesh-list
92467471|NCT01789957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467472|NCT01789957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467473|NCT01789957|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92467474|NCT01789957|Incretins|incretins|mesh-ancestor
92467475|NCT01789957|Hormones|hormones|mesh-ancestor
92467476|NCT01789957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467477|NCT01790854|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92467478|NCT01790854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92467479|NCT01792063|Sevoflurane|sevoflurane|mesh-list
92467480|NCT01792063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92467481|NCT01792063|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92467482|NCT01792063|Anesthetics, General|anesthetics, general|mesh-ancestor
92467483|NCT01792063|Anesthetics|anesthetics|mesh-ancestor
92467484|NCT01792063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467485|NCT01792063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467486|NCT01792570|Darunavir|darunavir|mesh-list
92467487|NCT01792570|Rilpivirine|rilpivirine|mesh-list
92467488|NCT01792570|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92467489|NCT01792570|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92467490|NCT01792570|Protease Inhibitors|protease inhibitors|mesh-ancestor
92467491|NCT01792570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467492|NCT01792570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467493|NCT01792570|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92467494|NCT01792570|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92467495|NCT01792570|Antiviral Agents|antiviral agents|mesh-ancestor
92467496|NCT01792570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467497|NCT01792570|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92467498|NCT01792570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92467499|NCT01792804|Vancomycin|vancomycin|mesh-list
92467500|NCT01792804|Clindamycin|clindamycin|mesh-list
92467501|NCT01792804|Cefazolin|cefazolin|mesh-list
92467502|NCT01792804|Linezolid|linezolid|mesh-list
92467503|NCT01792804|Daptomycin|daptomycin|mesh-list
92467504|NCT01792804|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92467505|NCT01792804|Floxacillin|floxacillin|mesh-list
92467506|NCT01792804|Cloxacillin|cloxacillin|mesh-list
92467507|NCT01792804|Trimethoprim|trimethoprim|mesh-list
92467508|NCT01792804|Sulfamethoxazole|sulfamethoxazole|mesh-list
92467509|NCT01792804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92467510|NCT01792804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467511|NCT01792804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92467512|NCT01792804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467513|NCT01792804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467514|NCT01792804|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92467515|NCT01792804|Antimalarials|antimalarials|mesh-ancestor
92467516|NCT01792804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92467517|NCT01792804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92467518|NCT01792804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92467520|NCT01792804|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92467521|NCT01792804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92467522|NCT01793038|Clomiphene|clomiphene|mesh-list
92467523|NCT01793038|Enclomiphene|enclomiphene|mesh-list
92467524|NCT01793038|Zuclomiphene|zuclomiphene|mesh-list
92467525|NCT01793038|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92348531|NCT03028428|Immunologic Factors|immunologic factors|mesh-ancestor
92467526|NCT01793038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467527|NCT01793038|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92467528|NCT01793038|Hormone Antagonists|hormone antagonists|mesh-ancestor
92467529|NCT01793038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467530|NCT01793038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467531|NCT01793038|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92467532|NCT01793038|Fertility Agents|fertility agents|mesh-ancestor
92467533|NCT01793038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467534|NCT01793038|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92467535|NCT01793038|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92467536|NCT01793038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92467537|NCT01793038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467538|NCT01794182|Glyburide|glyburide|mesh-list
92467539|NCT01794182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467540|NCT01794182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467541|NCT01794208|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92467542|NCT01794208|Hormones|hormones|mesh-ancestor
92467543|NCT01794208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467544|NCT01794208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467545|NCT01794247|Lidocaine|lidocaine|mesh-list
92467546|NCT01794247|Magnesium Sulfate|magnesium sulfate|mesh-list
92467547|NCT01794247|Fentanyl|fentanyl|mesh-list
92467548|NCT01794247|Anesthetics, Local|anesthetics, local|mesh-ancestor
92467549|NCT01794247|Anesthetics|anesthetics|mesh-ancestor
92467550|NCT01794247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467551|NCT01794247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467552|NCT01794247|Sensory System Agents|sensory system agents|mesh-ancestor
92467553|NCT01794247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467554|NCT01794247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92467555|NCT01794247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92467556|NCT01794247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92467557|NCT01794247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467558|NCT01794247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467559|NCT01794247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92467560|NCT01794247|Narcotics|narcotics|mesh-ancestor
92467561|NCT01794247|Analgesics|analgesics|mesh-ancestor
92467562|NCT01794247|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92467563|NCT01794247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92467564|NCT01794247|Anesthetics, General|anesthetics, general|mesh-ancestor
92467565|NCT01794247|Anticonvulsants|anticonvulsants|mesh-ancestor
92467566|NCT01794247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92467567|NCT01794247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92467568|NCT01794247|Tocolytic Agents|tocolytic agents|mesh-ancestor
92467569|NCT01794247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467570|NCT01794429|Exenatide|exenatide|mesh-list
92467571|NCT01794429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467572|NCT01794429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467573|NCT01794429|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92467574|NCT01794429|Incretins|incretins|mesh-ancestor
92467575|NCT01794429|Hormones|hormones|mesh-ancestor
92467576|NCT01794429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467577|NCT01795248|Liraglutide|liraglutide|mesh-list
92467578|NCT01795248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467579|NCT01795248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467580|NCT01795248|Incretins|incretins|mesh-ancestor
92467581|NCT01795248|Hormones|hormones|mesh-ancestor
92467582|NCT01795248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467583|NCT01796132|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92467584|NCT01796132|Fluvoxamine|fluvoxamine|mesh-list
92467586|NCT01796132|Fluoxetine|fluoxetine|mesh-list
92467587|NCT01796132|Paroxetine|paroxetine|mesh-list
92467588|NCT01796132|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92467589|NCT01796132|Sertraline|sertraline|mesh-list
92467590|NCT01796132|Escitalopram|escitalopram|mesh-list
92467591|NCT01796132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92467592|NCT01796132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92192483|NCT00535613|Anesthetics|anesthetics|mesh-ancestor
92467593|NCT01796132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467594|NCT01796132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467595|NCT01796132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467596|NCT01796132|Serotonin Agents|serotonin agents|mesh-ancestor
92467597|NCT01796132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467598|NCT01796132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467599|NCT01796132|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92467600|NCT01796132|Antidepressive Agents|antidepressive agents|mesh-ancestor
92467601|NCT01796132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92467602|NCT01796132|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92467603|NCT01796132|Analgesics|analgesics|mesh-ancestor
92467604|NCT01796132|Sensory System Agents|sensory system agents|mesh-ancestor
92467605|NCT01796132|Dopamine Agents|dopamine agents|mesh-ancestor
92467606|NCT01796132|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92467607|NCT01796132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92467608|NCT01796132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467609|NCT01796132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92467610|NCT01796132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92467611|NCT01796132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467612|NCT01796132|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92467613|NCT01796132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92467614|NCT01796418|Beraprost|beraprost|mesh-list
92467615|NCT01796418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92467616|NCT01796418|Vasodilator Agents|vasodilator agents|mesh-ancestor
92467617|NCT01796522|Nifedipine|nifedipine|mesh-list
92467618|NCT01796522|Progesterone|progesterone|mesh-list
92467619|NCT01796522|Progestins|progestins|mesh-ancestor
92467620|NCT01796522|Hormones|hormones|mesh-ancestor
92467621|NCT01796522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467622|NCT01796522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467623|NCT01796522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92467624|NCT01796522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467625|NCT01796522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467626|NCT01796522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92467627|NCT01796522|Vasodilator Agents|vasodilator agents|mesh-ancestor
92467628|NCT01796522|Tocolytic Agents|tocolytic agents|mesh-ancestor
92467629|NCT01796522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467630|NCT01796730|Bambuterol|bambuterol|mesh-list
92467631|NCT01796730|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92467632|NCT01796730|Autonomic Agents|autonomic agents|mesh-ancestor
92467633|NCT01796730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467634|NCT01796730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467635|NCT01796730|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92467636|NCT01796730|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467637|NCT01796808|Lidocaine|lidocaine|mesh-list
92467638|NCT01796808|Epinephrine|epinephrine|mesh-list
92467639|NCT01796808|Anesthetics, Local|anesthetics, local|mesh-list
92467640|NCT01796808|Anesthetics|anesthetics|mesh-list
92467641|NCT01796808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467642|NCT01796808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467643|NCT01796808|Sensory System Agents|sensory system agents|mesh-ancestor
92467644|NCT01796808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467645|NCT01796808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92467646|NCT01796808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92467647|NCT01796808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92467648|NCT01796808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92467649|NCT01796808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467650|NCT01796808|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92467651|NCT01796808|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92467652|NCT01796808|Adrenergic Agents|adrenergic agents|mesh-ancestor
92467653|NCT01796808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467654|NCT01796808|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92467655|NCT01796808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92467656|NCT01796808|Autonomic Agents|autonomic agents|mesh-ancestor
92467657|NCT01796808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92467658|NCT01796808|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467659|NCT01796808|Mydriatics|mydriatics|mesh-ancestor
92467660|NCT01796808|Sympathomimetics|sympathomimetics|mesh-ancestor
92467661|NCT01796808|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92467662|NCT01797289|Fibrin fragment D|fibrin fragment d|mesh-list
92467663|NCT01797289|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92467664|NCT01797289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92192559|NCT00211172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92467665|NCT01797289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467666|NCT01797289|Hemostatics|hemostatics|mesh-ancestor
92467667|NCT01797289|Coagulants|coagulants|mesh-ancestor
92467669|NCT01797718|Testosterone|testosterone|mesh-list
92467670|NCT01797718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467671|NCT01797718|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92467672|NCT01797718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92467673|NCT01797718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467674|NCT01797718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467675|NCT01797718|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92467676|NCT01797718|Hormone Antagonists|hormone antagonists|mesh-ancestor
92467677|NCT01797718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467678|NCT01797718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467679|NCT01797718|Androgens|androgens|mesh-ancestor
92467680|NCT01797718|Hormones|hormones|mesh-ancestor
92467681|NCT01797796|Capsaicin|capsaicin|mesh-list
92467682|NCT01797796|Antipruritics|antipruritics|mesh-ancestor
92467683|NCT01797796|Dermatologic Agents|dermatologic agents|mesh-ancestor
92467684|NCT01797796|Sensory System Agents|sensory system agents|mesh-ancestor
92467685|NCT01797796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467686|NCT01797796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467687|NCT01798108|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92467688|NCT01798108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467689|NCT01798446|Axitinib|axitinib|mesh-list
92467690|NCT01798446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467691|NCT01798446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92467692|NCT01798446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467693|NCT01798446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467694|NCT01798680|Vitamin D|vitamin d|mesh-list
92467695|NCT01798680|Cholecalciferol|cholecalciferol|mesh-list
92467696|NCT01798680|Vitamins|vitamins|mesh-ancestor
92467697|NCT01798680|Micronutrients|micronutrients|mesh-ancestor
92467698|NCT01798680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467699|NCT01798680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92467700|NCT01798680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92467701|NCT01798836|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92467702|NCT01798836|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92467703|NCT01798836|Estradiol|estradiol|mesh-list
92467704|NCT01798836|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92467705|NCT01798836|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92467706|NCT01798836|Estrogens|estrogens|mesh-ancestor
92467707|NCT01798836|Hormones|hormones|mesh-ancestor
92467708|NCT01798836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467709|NCT01798836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467710|NCT01798836|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92467711|NCT01798836|Contraceptive Agents|contraceptive agents|mesh-ancestor
92467712|NCT01798836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467713|NCT01798836|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92467714|NCT01798901|Decitabine|decitabine|mesh-list
92467715|NCT01798901|Azacitidine|azacitidine|mesh-list
92467716|NCT01798901|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92467717|NCT01798901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92467718|NCT01798901|Antimetabolites|antimetabolites|mesh-ancestor
92467719|NCT01798901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467720|NCT01798901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467721|NCT01798901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467722|NCT01799863|Ketorolac|ketorolac|mesh-list
92467723|NCT01799863|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92467724|NCT01799863|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92467725|NCT01799863|Lubricant Eye Drops|lubricant eye drops|mesh-list
92467726|NCT01799863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92467727|NCT01799863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467728|NCT01799863|Analgesics|analgesics|mesh-ancestor
92467729|NCT01799863|Sensory System Agents|sensory system agents|mesh-ancestor
92467730|NCT01799863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467731|NCT01799863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467732|NCT01799863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467733|NCT01799863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92467734|NCT01799863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92467735|NCT01799863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467736|NCT01799863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467737|NCT01799863|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92467738|NCT01799863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92467739|NCT01799863|Laxatives|laxatives|mesh-ancestor
92467740|NCT01799863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467741|NCT01800006|Rivaroxaban|rivaroxaban|mesh-list
92467742|NCT01800006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92467743|NCT01800006|Antithrombins|antithrombins|mesh-ancestor
92467744|NCT01800006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92467745|NCT01800006|Protease Inhibitors|protease inhibitors|mesh-ancestor
92467746|NCT01800006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467747|NCT01800006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467748|NCT01800006|Anticoagulants|anticoagulants|mesh-ancestor
92467749|NCT01800019|Nicotine|nicotine|mesh-list
92467750|NCT01800019|Varenicline|varenicline|mesh-list
92467751|NCT01800019|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92467752|NCT01800019|Autonomic Agents|autonomic agents|mesh-ancestor
92467753|NCT01800019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467754|NCT01800019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467755|NCT01800019|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92467756|NCT01800019|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92467757|NCT01800019|Cholinergic Agents|cholinergic agents|mesh-ancestor
92467758|NCT01800019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467759|NCT01800019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467760|NCT01800097|Modafinil|modafinil|mesh-list
92467761|NCT01800097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92467762|NCT01800097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467763|NCT01800097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92467764|NCT01800097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92467765|NCT01800097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92467766|NCT01800097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467767|NCT01800227|Metformin|metformin|mesh-list
92467768|NCT01800227|Pioglitazone|pioglitazone|mesh-list
92467769|NCT01800227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467770|NCT01800227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467771|NCT01800240|Metformin|metformin|mesh-list
92467772|NCT01800240|Pioglitazone|pioglitazone|mesh-list
92467773|NCT01800240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92467774|NCT01800240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467775|NCT01800292|Sildenafil Citrate|sildenafil citrate|mesh-list
92467776|NCT01800292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467777|NCT01800292|Vasodilator Agents|vasodilator agents|mesh-ancestor
92467778|NCT01800292|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92467779|NCT01800292|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92467780|NCT01800292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467781|NCT01800292|Urological Agents|urological agents|mesh-ancestor
92467782|NCT01800357|Aspirin|aspirin|mesh-list
92467783|NCT01800357|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
92467784|NCT01800357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92467785|NCT01800357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467786|NCT01800357|Analgesics|analgesics|mesh-ancestor
92467787|NCT01800357|Sensory System Agents|sensory system agents|mesh-ancestor
92467788|NCT01800357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467789|NCT01800357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467790|NCT01800357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467791|NCT01800357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92467792|NCT01800357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92467793|NCT01800357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92467794|NCT01800357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467795|NCT01800357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92467796|NCT01800357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92467797|NCT01800357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467798|NCT01800357|Antipyretics|antipyretics|mesh-ancestor
92467799|NCT01800357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92467800|NCT01800357|Immunologic Factors|immunologic factors|mesh-ancestor
92467801|NCT01800396|Caseins|caseins|mesh-list
92467802|NCT01800396|Chelating Agents|chelating agents|mesh-ancestor
92467803|NCT01800396|Sequestering Agents|sequestering agents|mesh-ancestor
92467804|NCT01800396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467805|NCT01800422|Progesterone|progesterone|mesh-list
92467806|NCT01800422|Progestins|progestins|mesh-ancestor
92467807|NCT01800422|Hormones|hormones|mesh-ancestor
92467808|NCT01800422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467809|NCT01800422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467810|NCT01800435|Tranexamic Acid|tranexamic acid|mesh-list
92467811|NCT01800435|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92467812|NCT01800435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92467813|NCT01800435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92467814|NCT01800435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467815|NCT01800435|Hemostatics|hemostatics|mesh-ancestor
92467816|NCT01800435|Coagulants|coagulants|mesh-ancestor
92467817|NCT01800487|Silymarin|silymarin|mesh-list
92467818|NCT01800487|Antioxidants|antioxidants|mesh-ancestor
92467819|NCT01800487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467820|NCT01800487|Protective Agents|protective agents|mesh-ancestor
92467821|NCT01800487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467822|NCT01800526|Acetylcysteine|acetylcysteine|mesh-list
92467823|NCT01800526|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92467824|NCT01800526|Antiviral Agents|antiviral agents|mesh-ancestor
92467825|NCT01800526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467826|NCT01800526|Expectorants|expectorants|mesh-ancestor
92467827|NCT01800526|Respiratory System Agents|respiratory system agents|mesh-ancestor
92467828|NCT01800526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92467829|NCT01800526|Antioxidants|antioxidants|mesh-ancestor
92467830|NCT01800526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467831|NCT01800526|Protective Agents|protective agents|mesh-ancestor
92467832|NCT01800526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467833|NCT01800526|Antidotes|antidotes|mesh-ancestor
92467834|NCT01800630|Gemcitabine|gemcitabine|mesh-list
92467835|NCT01800630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92467836|NCT01800630|Antimetabolites|antimetabolites|mesh-ancestor
92467837|NCT01800630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467838|NCT01800630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467839|NCT01800643|Busulfan|busulfan|mesh-list
92467840|NCT01800643|Alkylating Agents|alkylating agents|mesh-ancestor
92467841|NCT01800643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467842|NCT01800643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467843|NCT01800643|Immunologic Factors|immunologic factors|mesh-ancestor
92467844|NCT01800643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467845|NCT01800643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92467846|NCT01800643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467847|NCT01800643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92467848|NCT01800695|Temozolomide|temozolomide|mesh-list
92467849|NCT01800695|ABT-414|abt-414|mesh-list
92467850|NCT01800695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92467851|NCT01800695|Alkylating Agents|alkylating agents|mesh-ancestor
92467852|NCT01800695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467853|NCT01800695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467854|NCT01800695|Immunoconjugates|immunoconjugates|mesh-ancestor
92467855|NCT01800695|Immunologic Factors|immunologic factors|mesh-ancestor
92467856|NCT01800695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467857|NCT01800708|Prednisolone|prednisolone|mesh-list
92467858|NCT01800708|Triamcinolone|triamcinolone|mesh-list
92467859|NCT01800708|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92467860|NCT01800708|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92467861|NCT01800708|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92467862|NCT01800708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467863|NCT01800708|Glucocorticoids|glucocorticoids|mesh-ancestor
92467864|NCT01800708|Hormones|hormones|mesh-ancestor
92467865|NCT01800708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467866|NCT01800708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467867|NCT01800708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92467868|NCT01800708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467869|NCT01800708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467870|NCT01800708|Immunologic Factors|immunologic factors|mesh-ancestor
92467871|NCT01800708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467872|NCT01800708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467873|NCT01800747|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92467874|NCT01800747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467875|NCT01800799|Anti-Infective Agents|anti-infective agents|mesh-list
92467876|NCT01800799|Celecoxib|celecoxib|mesh-list
92467877|NCT01800799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92467878|NCT01800799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92467879|NCT01800799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92467880|NCT01800799|Analgesics|analgesics|mesh-ancestor
92467881|NCT01800799|Sensory System Agents|sensory system agents|mesh-ancestor
92467882|NCT01800799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467883|NCT01800799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467884|NCT01800799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92467885|NCT01800799|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92467886|NCT01800799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92467887|NCT01800799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192812|NCT05630222|Ibuprofen|ibuprofen|mesh-list
92467888|NCT01800799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467889|NCT01800825|Clindamycin|clindamycin|mesh-list
92467890|NCT01800825|Clindamycin palmitate|clindamycin palmitate|mesh-list
92467891|NCT01800825|Clindamycin phosphate|clindamycin phosphate|mesh-list
92467892|NCT01800825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92467893|NCT01800825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467894|NCT01800825|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92467895|NCT01800825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467896|NCT01800825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467897|NCT01800942|Azithromycin|azithromycin|mesh-list
92467898|NCT01800942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92467899|NCT01800942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467900|NCT01801046|Cytarabine|cytarabine|mesh-list
92467901|NCT01801046|Mitoxantrone|mitoxantrone|mesh-list
92467902|NCT01801046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92467903|NCT01801046|Antimetabolites|antimetabolites|mesh-ancestor
92467904|NCT01801046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467905|NCT01801046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467906|NCT01801046|Antiviral Agents|antiviral agents|mesh-ancestor
92467907|NCT01801046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92467908|NCT01801046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467909|NCT01801046|Immunologic Factors|immunologic factors|mesh-ancestor
92467910|NCT01801046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467911|NCT01801046|Analgesics|analgesics|mesh-ancestor
92467912|NCT01801046|Sensory System Agents|sensory system agents|mesh-ancestor
92467913|NCT01801046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92467914|NCT01801046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92467915|NCT01801046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92467916|NCT01801046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467917|NCT01801137|Everolimus|everolimus|mesh-list
92467918|NCT01801137|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92467919|NCT01801137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92467920|NCT01801137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467921|NCT01801137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467922|NCT01801137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467923|NCT01801137|Immunologic Factors|immunologic factors|mesh-ancestor
92467924|NCT01801137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467925|NCT01801137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467926|NCT01801163|Sorafenib|sorafenib|mesh-list
92467927|NCT01801163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467928|NCT01801163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92467929|NCT01801163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467930|NCT01801163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467931|NCT01801228|Eplerenone|eplerenone|mesh-list
92467932|NCT01801228|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92467933|NCT01801228|Hormone Antagonists|hormone antagonists|mesh-ancestor
92467934|NCT01801228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467935|NCT01801228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467936|NCT01801228|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92467937|NCT01801228|Diuretics|diuretics|mesh-ancestor
92467938|NCT01801228|Natriuretic Agents|natriuretic agents|mesh-ancestor
92467939|NCT01801228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92467940|NCT01801410|Misoprostol|misoprostol|mesh-list
92467941|NCT01801410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92467942|NCT01801410|Abortifacient Agents|abortifacient agents|mesh-ancestor
92467943|NCT01801410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92467944|NCT01801410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467945|NCT01801410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92467946|NCT01801410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92467947|NCT01801410|Oxytocics|oxytocics|mesh-ancestor
92467948|NCT01801423|Hydroxyurea|hydroxyurea|mesh-list
92467949|NCT01801423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467950|NCT01801423|Antisickling Agents|antisickling agents|mesh-ancestor
92467951|NCT01801423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467952|NCT01801423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467953|NCT01801423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92467954|NCT01801644|Cisplatin|cisplatin|mesh-list
92467955|NCT01801644|Gemcitabine|gemcitabine|mesh-list
92467956|NCT01801644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92467957|NCT01801644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92467958|NCT01801644|Antimetabolites|antimetabolites|mesh-ancestor
92467959|NCT01801644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467960|NCT01801774|Triamcinolone|triamcinolone|mesh-list
92467961|NCT01801774|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92467962|NCT01801774|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92467963|NCT01801774|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92467964|NCT01801774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92467965|NCT01801774|Glucocorticoids|glucocorticoids|mesh-ancestor
92467966|NCT01801774|Hormones|hormones|mesh-ancestor
92467967|NCT01801774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92467968|NCT01801774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467969|NCT01801774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467970|NCT01801774|Immunologic Factors|immunologic factors|mesh-ancestor
92467971|NCT01801774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467972|NCT01801774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467973|NCT01802255|Midazolam|midazolam|mesh-list
92467974|NCT01802255|Sevoflurane|sevoflurane|mesh-list
92467975|NCT01802255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92467976|NCT01802255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92467977|NCT01802255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92467978|NCT01802255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467979|NCT01802255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92467980|NCT01802255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92467981|NCT01802255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92467982|NCT01802255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92467983|NCT01802255|Anesthetics, General|anesthetics, general|mesh-ancestor
92467984|NCT01802255|Anesthetics|anesthetics|mesh-ancestor
92467985|NCT01802255|GABA Modulators|gaba modulators|mesh-ancestor
92467986|NCT01802255|GABA Agents|gaba agents|mesh-ancestor
92467987|NCT01802255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92467988|NCT01802255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467989|NCT01802255|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92467990|NCT01802255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92467991|NCT01802268|Sirolimus|sirolimus|mesh-list
92467992|NCT01802268|Tacrolimus|tacrolimus|mesh-list
92467993|NCT01802268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92467994|NCT01802268|Immunologic Factors|immunologic factors|mesh-ancestor
92467995|NCT01802268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92467996|NCT01802268|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92467997|NCT01802268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92467998|NCT01802268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92467999|NCT01802268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468000|NCT01802268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468001|NCT01802268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92468002|NCT01802268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468003|NCT01802268|Antifungal Agents|antifungal agents|mesh-ancestor
92468004|NCT01802450|Dasatinib|dasatinib|mesh-list
92468005|NCT01802450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468006|NCT01802450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92468007|NCT01802450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468008|NCT01802450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468009|NCT01802476|Palbociclib|palbociclib|mesh-list
92468010|NCT01802476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468011|NCT01802476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92468012|NCT01802476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468013|NCT01802476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468014|NCT01802489|Amiloride|amiloride|mesh-list
92468015|NCT01802489|Diuretics|diuretics|mesh-ancestor
92468016|NCT01802489|Natriuretic Agents|natriuretic agents|mesh-ancestor
92468017|NCT01802489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468018|NCT01802489|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92468019|NCT01802489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468020|NCT01802489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468021|NCT01802489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348554|NCT01577160|Dopamine Agents|dopamine agents|mesh-ancestor
92468022|NCT01802489|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92468023|NCT01802489|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92468024|NCT01802502|Rifampin|rifampin|mesh-list
92468025|NCT01802502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92468026|NCT01802502|Antitubercular Agents|antitubercular agents|mesh-ancestor
92468027|NCT01802502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468028|NCT01802502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468029|NCT01802502|Leprostatic Agents|leprostatic agents|mesh-ancestor
92468030|NCT01802502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468031|NCT01802502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468032|NCT01802502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468033|NCT01802502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92468034|NCT01802502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92468035|NCT01802502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92192951|NCT03592082|Bismuth|bismuth|mesh-list
92468036|NCT01802502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92468037|NCT01802502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92468038|NCT01802502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92468039|NCT01802593|Methotrexate|methotrexate|mesh-list
92468040|NCT01802593|Mercaptopurine|mercaptopurine|mesh-list
92468041|NCT01802593|Azathioprine|azathioprine|mesh-list
92468042|NCT01802593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92468043|NCT01802593|Abortifacient Agents|abortifacient agents|mesh-ancestor
92468044|NCT01802593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92468045|NCT01802593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468046|NCT01802593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468047|NCT01802593|Antimetabolites|antimetabolites|mesh-ancestor
92468048|NCT01802593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468049|NCT01802593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468050|NCT01802593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468051|NCT01802593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468052|NCT01802593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92468053|NCT01802593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468054|NCT01802593|Immunologic Factors|immunologic factors|mesh-ancestor
92468055|NCT01802593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468056|NCT01802593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468057|NCT01802619|Nitric Oxide|nitric oxide|mesh-list
92468058|NCT01802619|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92468059|NCT01802619|Autonomic Agents|autonomic agents|mesh-ancestor
92468060|NCT01802619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468061|NCT01802619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468062|NCT01802619|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92468063|NCT01802619|Respiratory System Agents|respiratory system agents|mesh-ancestor
92468064|NCT01802619|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92468065|NCT01802619|Antioxidants|antioxidants|mesh-ancestor
92468066|NCT01802619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468067|NCT01802619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468068|NCT01802619|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92468069|NCT01802619|Vasodilator Agents|vasodilator agents|mesh-ancestor
92468070|NCT01802619|Gasotransmitters|gasotransmitters|mesh-ancestor
92468071|NCT01802619|Protective Agents|protective agents|mesh-ancestor
92468072|NCT01802645|Leucovorin|leucovorin|mesh-list
92468073|NCT01802645|Folic Acid|folic acid|mesh-list
92468074|NCT01802645|Bevacizumab|bevacizumab|mesh-list
92468075|NCT01802645|Cetuximab|cetuximab|mesh-list
92468076|NCT01802645|Fluorouracil|fluorouracil|mesh-list
92468077|NCT01802645|Oxaliplatin|oxaliplatin|mesh-list
92468078|NCT01802645|Irinotecan|irinotecan|mesh-list
92468079|NCT01802645|Levoleucovorin|levoleucovorin|mesh-list
92468080|NCT01802645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468081|NCT01802645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468082|NCT01802645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348559|NCT01554618|Incretins|incretins|mesh-ancestor
92468083|NCT01802645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92468084|NCT01802645|Growth Substances|growth substances|mesh-ancestor
92468085|NCT01802645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468086|NCT01802645|Growth Inhibitors|growth inhibitors|mesh-ancestor
92468087|NCT01802645|Antimetabolites|antimetabolites|mesh-ancestor
92468088|NCT01802645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468089|NCT01802645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468090|NCT01802645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468091|NCT01802645|Immunologic Factors|immunologic factors|mesh-ancestor
92468092|NCT01802645|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92468093|NCT01802645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92468094|NCT01802645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468095|NCT01802645|Antidotes|antidotes|mesh-ancestor
92468096|NCT01802645|Protective Agents|protective agents|mesh-ancestor
92468097|NCT01802645|Vitamin B Complex|vitamin b complex|mesh-ancestor
92468098|NCT01802645|Vitamins|vitamins|mesh-ancestor
92468099|NCT01802645|Micronutrients|micronutrients|mesh-ancestor
92468100|NCT01802645|Hematinics|hematinics|mesh-ancestor
92468101|NCT01802658|Zoledronic Acid|zoledronic acid|mesh-list
92468102|NCT01802658|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92468103|NCT01802658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468104|NCT01802684|Aflibercept|aflibercept|mesh-list
92468105|NCT01802684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92468106|NCT01802684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92468107|NCT01802684|Growth Substances|growth substances|mesh-ancestor
92468108|NCT01802684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468109|NCT01802684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92468110|NCT01802684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468111|NCT01802814|Epratuzumab|epratuzumab|mesh-list
92468112|NCT01802814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468113|NCT01802814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468114|NCT01802892|Plerixafor|plerixafor|mesh-list
92468115|NCT01802892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92468116|NCT01802892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92468117|NCT01802892|Antiviral Agents|antiviral agents|mesh-ancestor
92468118|NCT01802892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468119|NCT01802918|Ritonavir|ritonavir|mesh-list
92468120|NCT01802918|GSK-2838232|gsk-2838232|mesh-list
92468121|NCT01802918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92468122|NCT01802918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92468123|NCT01802918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92468124|NCT01802918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531691|NCT00047710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92468125|NCT01802918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468127|NCT01802918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92468128|NCT01802918|Antiviral Agents|antiviral agents|mesh-ancestor
92468129|NCT01802918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468130|NCT01802918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92468131|NCT01802918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92468132|NCT01802931|Ketoconazole|ketoconazole|mesh-list
92468133|NCT01802931|Antifungal Agents|antifungal agents|mesh-ancestor
92468134|NCT01802931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468135|NCT01802931|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92468136|NCT01802931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92468137|NCT01802931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468138|NCT01802931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468139|NCT01802931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92468140|NCT01802931|Hormone Antagonists|hormone antagonists|mesh-ancestor
92468141|NCT01802931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468142|NCT01802931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468143|NCT01802931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92468144|NCT01802944|Insulin|insulin|mesh-list
92468145|NCT01802944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92468146|NCT01802944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468147|NCT01802970|Paclitaxel|paclitaxel|mesh-list
92468148|NCT01802970|Vinorelbine|vinorelbine|mesh-list
92468149|NCT01802970|Capecitabine|capecitabine|mesh-list
92468150|NCT01802970|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92468151|NCT01802970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92468152|NCT01802970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468153|NCT01802970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92468154|NCT01802970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92468155|NCT01802970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92468156|NCT01802970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468157|NCT01802970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468158|NCT01802970|Antimetabolites|antimetabolites|mesh-ancestor
92468159|NCT01802970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468160|NCT01803087|Formoterol Fumarate|formoterol fumarate|mesh-list
92468161|NCT01803087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92468162|NCT01803087|Autonomic Agents|autonomic agents|mesh-ancestor
92468163|NCT01803087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468164|NCT01803087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468165|NCT01803087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92468166|NCT01803087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92468167|NCT01803087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92468168|NCT01803087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92468169|NCT01803087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92468170|NCT01803087|Adrenergic Agents|adrenergic agents|mesh-ancestor
92468171|NCT01803087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468172|NCT01803087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468173|NCT01803191|Ciprofloxacin|ciprofloxacin|mesh-list
92468174|NCT01803191|Fosfomycin|fosfomycin|mesh-list
92468175|NCT01803191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468176|NCT01803191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468177|NCT01803191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92468178|NCT01803191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92468179|NCT01803191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468180|NCT01803191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468181|NCT01803191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468182|NCT01803191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92468183|NCT01803191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92468184|NCT01803321|Rilonacept|rilonacept|mesh-list
92468185|NCT01803321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193101|NCT00504751|Dexamethasone|dexamethasone|mesh-list
92468186|NCT01803347|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92468187|NCT01803347|Hemostatics|hemostatics|mesh-ancestor
92468188|NCT01803347|Coagulants|coagulants|mesh-ancestor
92468189|NCT01803399|Moxifloxacin|moxifloxacin|mesh-list
92468190|NCT01803399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468191|NCT01803399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468192|NCT01803399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92468193|NCT01803399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92468194|NCT01803399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468195|NCT01803399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468196|NCT01803399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468197|NCT01803438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92468198|NCT01803503|Docetaxel|docetaxel|mesh-list
92468199|NCT01803503|Sunitinib|sunitinib|mesh-list
92468200|NCT01803503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468201|NCT01803503|Tubulin Modulators|tubulin modulators|mesh-ancestor
92468202|NCT01803503|Antimitotic Agents|antimitotic agents|mesh-ancestor
92468203|NCT01803503|Mitosis Modulators|mitosis modulators|mesh-ancestor
92468204|NCT01803503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468205|NCT01803503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92468206|NCT01803503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92468207|NCT01803503|Growth Substances|growth substances|mesh-ancestor
92468208|NCT01803503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468209|NCT01803503|Growth Inhibitors|growth inhibitors|mesh-ancestor
92468210|NCT01803503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92468211|NCT01803503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468212|NCT01803659|Vitamin A|vitamin a|mesh-list
92468213|NCT01803659|Retinol palmitate|retinol palmitate|mesh-list
92468214|NCT01803659|Carotenoids|carotenoids|mesh-list
92468215|NCT01803659|Antioxidants|antioxidants|mesh-ancestor
92468216|NCT01803659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468217|NCT01803659|Protective Agents|protective agents|mesh-ancestor
92468218|NCT01803659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468219|NCT01803659|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92468220|NCT01803659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468221|NCT01803659|Vitamins|vitamins|mesh-ancestor
92468222|NCT01803659|Micronutrients|micronutrients|mesh-ancestor
92468223|NCT01803763|Omalizumab|omalizumab|mesh-list
92468224|NCT01803763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92468225|NCT01803763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92468226|NCT01803763|Respiratory System Agents|respiratory system agents|mesh-ancestor
92468227|NCT01803828|Tadalafil|tadalafil|mesh-list
92468228|NCT01803828|Vasodilator Agents|vasodilator agents|mesh-ancestor
92468229|NCT01803828|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92468230|NCT01803828|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92468231|NCT01803828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468232|NCT01803828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468233|NCT01803828|Urological Agents|urological agents|mesh-ancestor
92468234|NCT01804127|Rituximab|rituximab|mesh-list
92468235|NCT01804127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468236|NCT01804127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468237|NCT01804127|Immunologic Factors|immunologic factors|mesh-ancestor
92468238|NCT01804127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468239|NCT01804127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468240|NCT01804205|Magnesium Sulfate|magnesium sulfate|mesh-list
92468241|NCT01804205|Analgesics|analgesics|mesh-ancestor
92468242|NCT01804205|Sensory System Agents|sensory system agents|mesh-ancestor
92468243|NCT01804205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468244|NCT01804205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468245|NCT01804205|Anesthetics|anesthetics|mesh-ancestor
92468246|NCT01804205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468247|NCT01804205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468248|NCT01804205|Anticonvulsants|anticonvulsants|mesh-ancestor
92468249|NCT01804205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92468250|NCT01804205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468251|NCT01804205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468252|NCT01804205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92468253|NCT01804205|Tocolytic Agents|tocolytic agents|mesh-ancestor
92468254|NCT01804205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92468255|NCT01804218|Nadolol|nadolol|mesh-list
92468256|NCT01804218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92468257|NCT01804218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92468258|NCT01804218|Adrenergic Agents|adrenergic agents|mesh-ancestor
92468259|NCT01804218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193169|NCT00506155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468260|NCT01804218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468261|NCT01804218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468262|NCT01804218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468263|NCT01804218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92468264|NCT01804218|Sympatholytics|sympatholytics|mesh-ancestor
92468265|NCT01804218|Autonomic Agents|autonomic agents|mesh-ancestor
92468266|NCT01804218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468267|NCT01804244|Rilpivirine|rilpivirine|mesh-list
92468268|NCT01804244|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92468269|NCT01804244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468270|NCT01804244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468271|NCT01804244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468272|NCT01804244|Antiviral Agents|antiviral agents|mesh-ancestor
92468273|NCT01804244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468274|NCT01804244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92468275|NCT01804244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92468276|NCT01804335|Trifarotene|trifarotene|mesh-list
92468277|NCT01804335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468278|NCT01804361|Cyclosporine|cyclosporine|mesh-list
92468279|NCT01804361|Cyclosporins|cyclosporins|mesh-list
92468280|NCT01804361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468281|NCT01804361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468282|NCT01804361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468283|NCT01804361|Immunologic Factors|immunologic factors|mesh-ancestor
92468284|NCT01804361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468285|NCT01804361|Antifungal Agents|antifungal agents|mesh-ancestor
92468286|NCT01804361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468287|NCT01804361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468288|NCT01804361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468289|NCT01804361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92468291|NCT01804374|Sorafenib|sorafenib|mesh-list
92468292|NCT01804374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92468293|NCT01804374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92468294|NCT01804374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468295|NCT01804374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468296|NCT01804374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468297|NCT01804374|Immunologic Factors|immunologic factors|mesh-ancestor
92468298|NCT01804374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468299|NCT01804374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468300|NCT01804387|Lamivudine|lamivudine|mesh-list
92468301|NCT01804387|Adefovir|adefovir|mesh-list
92468302|NCT01804387|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92468303|NCT01804387|Telbivudine|telbivudine|mesh-list
92468304|NCT01804387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92468305|NCT01804387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468306|NCT01804387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468307|NCT01804387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468308|NCT01804387|Antiviral Agents|antiviral agents|mesh-ancestor
92468309|NCT01804387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468310|NCT01804387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92468311|NCT01804387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92468312|NCT01804400|Montelukast|montelukast|mesh-list
92468313|NCT01804400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92468314|NCT01804400|Respiratory System Agents|respiratory system agents|mesh-ancestor
92468315|NCT01804400|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92468316|NCT01804400|Hormone Antagonists|hormone antagonists|mesh-ancestor
92468317|NCT01804400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468318|NCT01804400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468319|NCT01804400|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92468320|NCT01804400|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92468321|NCT01804400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468323|NCT01804413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92468324|NCT01804413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92468325|NCT01804413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468326|NCT01804543|Ranolazine|ranolazine|mesh-list
92468327|NCT01804543|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468328|NCT01804543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468329|NCT01804543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468330|NCT01804595|Sunscreening Agents|sunscreening agents|mesh-list
92468331|NCT01804595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92468332|NCT01804595|Protective Agents|protective agents|mesh-ancestor
92468333|NCT01804595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468334|NCT01804595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468335|NCT01804712|Rituximab|rituximab|mesh-list
92468336|NCT01804712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468337|NCT01804712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468338|NCT01804712|Immunologic Factors|immunologic factors|mesh-ancestor
92468339|NCT01804712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468340|NCT01804712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468341|NCT01804777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92468342|NCT01804777|Amiloride|amiloride|mesh-list
92468343|NCT01804777|Diuretics|diuretics|mesh-ancestor
92468344|NCT01804777|Natriuretic Agents|natriuretic agents|mesh-ancestor
92468345|NCT01804777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468346|NCT01804777|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92468347|NCT01804777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468348|NCT01804777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468349|NCT01804777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468350|NCT01804777|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92468351|NCT01804777|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92468352|NCT01804777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92468353|NCT01804777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92468354|NCT01804985|Imatinib Mesylate|imatinib mesylate|mesh-list
92468355|NCT01804985|Dasatinib|dasatinib|mesh-list
92468356|NCT01804985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468357|NCT01804985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92468358|NCT01804985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468359|NCT01804985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468360|NCT01805115|Misoprostol|misoprostol|mesh-list
92468361|NCT01805115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92468362|NCT01805115|Abortifacient Agents|abortifacient agents|mesh-ancestor
92468363|NCT01805115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92468364|NCT01805115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468365|NCT01805115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92468366|NCT01805115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468367|NCT01805115|Oxytocics|oxytocics|mesh-ancestor
92468368|NCT01805232|Artesunate|artesunate|mesh-list
92468369|NCT01805232|Quinine|quinine|mesh-list
92468370|NCT01805232|Antimalarials|antimalarials|mesh-ancestor
92468371|NCT01805232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92468372|NCT01805232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92468373|NCT01805232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468374|NCT01805232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468375|NCT01805232|Antiviral Agents|antiviral agents|mesh-ancestor
92468376|NCT01805232|Schistosomicides|schistosomicides|mesh-ancestor
92468377|NCT01805232|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92468378|NCT01805232|Anthelmintics|anthelmintics|mesh-ancestor
92468379|NCT01805232|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92468380|NCT01805232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468381|NCT01805232|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92468382|NCT01805232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468383|NCT01805232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92468384|NCT01805232|Analgesics|analgesics|mesh-ancestor
92468385|NCT01805232|Sensory System Agents|sensory system agents|mesh-ancestor
92468386|NCT01805258|Efavirenz|efavirenz|mesh-list
92468387|NCT01805258|Nevirapine|nevirapine|mesh-list
92468388|NCT01805258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92468389|NCT01805258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468390|NCT01805258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468391|NCT01805258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468392|NCT01805258|Antiviral Agents|antiviral agents|mesh-ancestor
92468393|NCT01805258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468394|NCT01805258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92468395|NCT01805258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92468396|NCT01805258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92468397|NCT01805258|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92468398|NCT01805258|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92468399|NCT01805258|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92468400|NCT01805258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92468401|NCT01805258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92468402|NCT01805310|Magnesium citrate|magnesium citrate|mesh-list
92468403|NCT01805310|Cathartics|cathartics|mesh-ancestor
92468404|NCT01805310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468405|NCT01805388|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92468406|NCT01805388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468407|NCT01807741|Asenapine|asenapine|mesh-list
92468408|NCT01807741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92468409|NCT01807741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92468410|NCT01807741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468411|NCT01807741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468412|NCT01807741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92468413|NCT01807767|Mycophenolic Acid|mycophenolic acid|mesh-list
92468414|NCT01807767|Everolimus|everolimus|mesh-list
92468415|NCT01807767|Tacrolimus|tacrolimus|mesh-list
92468416|NCT01807767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468417|NCT01807767|Immunologic Factors|immunologic factors|mesh-ancestor
92468418|NCT01807767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468419|NCT01807767|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92468420|NCT01807767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468421|NCT01807767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468422|NCT01807767|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92468423|NCT01807767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92468424|NCT01807767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468425|NCT01807767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92468426|NCT01807767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92468427|NCT01807767|Antitubercular Agents|antitubercular agents|mesh-ancestor
92468428|NCT01807767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468429|NCT01807767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468430|NCT01807832|Capsaicin|capsaicin|mesh-list
92468431|NCT01807832|Antipruritics|antipruritics|mesh-ancestor
92468432|NCT01807832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468433|NCT01807832|Sensory System Agents|sensory system agents|mesh-ancestor
92468434|NCT01807832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468435|NCT01807832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468436|NCT01807910|Choline|choline|mesh-list
92468437|NCT01807910|Lipotropic Agents|lipotropic agents|mesh-ancestor
92468438|NCT01807910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92468439|NCT01807910|Antimetabolites|antimetabolites|mesh-ancestor
92468440|NCT01807910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468441|NCT01807910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468442|NCT01807910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92468443|NCT01807910|Nootropic Agents|nootropic agents|mesh-ancestor
92468444|NCT01807962|Lidocaine|lidocaine|mesh-list
92468445|NCT01807962|Anesthetics, Local|anesthetics, local|mesh-ancestor
92468446|NCT01807962|Anesthetics|anesthetics|mesh-ancestor
92468447|NCT01807962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468448|NCT01807962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468449|NCT01807962|Sensory System Agents|sensory system agents|mesh-ancestor
92468450|NCT01807962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468451|NCT01807962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468452|NCT01807962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92468453|NCT01807962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468454|NCT01807962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468455|NCT01807962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468456|NCT01808014|Nefopam|nefopam|mesh-list
92468457|NCT01808014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92468458|NCT01808014|Analgesics|analgesics|mesh-ancestor
92468459|NCT01808014|Sensory System Agents|sensory system agents|mesh-ancestor
92468460|NCT01808014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468461|NCT01808014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468462|NCT01808131|Lesinurad|lesinurad|mesh-list
92468463|NCT01808131|Gout Suppressants|gout suppressants|mesh-ancestor
92468464|NCT01808131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468465|NCT01808131|Uricosuric Agents|uricosuric agents|mesh-ancestor
92468466|NCT01808300|Thioctic Acid|thioctic acid|mesh-list
92468467|NCT01808300|Pregabalin|pregabalin|mesh-list
92468468|NCT01808300|Analgesics|analgesics|mesh-ancestor
92468469|NCT01808300|Sensory System Agents|sensory system agents|mesh-ancestor
92468470|NCT01808300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468471|NCT01808300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468472|NCT01808300|Anticonvulsants|anticonvulsants|mesh-ancestor
92468473|NCT01808300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92468474|NCT01808300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468475|NCT01808300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468476|NCT01808300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92468477|NCT01808300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92468478|NCT01808300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92468479|NCT01808300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468480|NCT01808300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92468481|NCT01808300|Antioxidants|antioxidants|mesh-ancestor
92468482|NCT01808300|Protective Agents|protective agents|mesh-ancestor
92468483|NCT01808300|Vitamin B Complex|vitamin b complex|mesh-ancestor
92468484|NCT01808300|Vitamins|vitamins|mesh-ancestor
92468485|NCT01808300|Micronutrients|micronutrients|mesh-ancestor
92468486|NCT01808469|Antibodies|antibodies|mesh-list
92468487|NCT01808469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92468488|NCT01808469|Immunologic Factors|immunologic factors|mesh-ancestor
92468489|NCT01808469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468491|NCT01808495|Mitomycin|mitomycin|mesh-list
92468492|NCT01808495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92468493|NCT01808495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468495|NCT01808495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468496|NCT01808495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468497|NCT01808495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468498|NCT01808521|Acetylcysteine|acetylcysteine|mesh-list
92468499|NCT01808521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92468500|NCT01808521|Antiviral Agents|antiviral agents|mesh-ancestor
92468501|NCT01808521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468502|NCT01808521|Expectorants|expectorants|mesh-ancestor
92468503|NCT01808521|Respiratory System Agents|respiratory system agents|mesh-ancestor
92468504|NCT01808521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92468505|NCT01808521|Antioxidants|antioxidants|mesh-ancestor
92468506|NCT01808521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468507|NCT01808521|Protective Agents|protective agents|mesh-ancestor
92468508|NCT01808521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468509|NCT01808521|Antidotes|antidotes|mesh-ancestor
92468510|NCT01808586|Dexamethasone|dexamethasone|mesh-list
92468511|NCT01808586|Betamethasone|betamethasone|mesh-list
92468512|NCT01808586|Lidocaine|lidocaine|mesh-list
92468513|NCT01808586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92468514|NCT01808586|Antiemetics|antiemetics|mesh-ancestor
92468515|NCT01808586|Autonomic Agents|autonomic agents|mesh-ancestor
92468516|NCT01808586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468517|NCT01808586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468518|NCT01808586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468519|NCT01808586|Glucocorticoids|glucocorticoids|mesh-ancestor
92468520|NCT01808586|Hormones|hormones|mesh-ancestor
92468521|NCT01808586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468522|NCT01808586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92468523|NCT01808586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468524|NCT01808586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92468525|NCT01808586|Anesthetics|anesthetics|mesh-ancestor
92468526|NCT01808586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468527|NCT01808586|Sensory System Agents|sensory system agents|mesh-ancestor
92468528|NCT01808586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468529|NCT01808586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92468530|NCT01808586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468531|NCT01808586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468532|NCT01808586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468534|NCT01808586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92468535|NCT01808638|Gemcitabine|gemcitabine|mesh-list
92468536|NCT01808638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468537|NCT01808638|Antimetabolites|antimetabolites|mesh-ancestor
92468538|NCT01808638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468539|NCT01808638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468540|NCT01808768|Alcaftadine|alcaftadine|mesh-list
92468541|NCT01808768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92468542|NCT01808768|Histamine Antagonists|histamine antagonists|mesh-ancestor
92468543|NCT01808768|Histamine Agents|histamine agents|mesh-ancestor
92468544|NCT01808768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468545|NCT01808768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468546|NCT01808768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468547|NCT01808898|Bupivacaine|bupivacaine|mesh-list
92468548|NCT01808898|Anesthetics, Local|anesthetics, local|mesh-list
92468549|NCT01808898|Mepivacaine|mepivacaine|mesh-list
92468550|NCT01808898|Anesthetics|anesthetics|mesh-list
92468551|NCT01808898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468552|NCT01808898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468553|NCT01808898|Sensory System Agents|sensory system agents|mesh-ancestor
92468554|NCT01808898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468555|NCT01808911|Cyclophosphamide|cyclophosphamide|mesh-list
92468556|NCT01808911|Rituximab|rituximab|mesh-list
92468557|NCT01808911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468558|NCT01808911|Immunologic Factors|immunologic factors|mesh-ancestor
92468559|NCT01808911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468560|NCT01808911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468561|NCT01808911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92468562|NCT01808911|Alkylating Agents|alkylating agents|mesh-ancestor
92468563|NCT01808911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468564|NCT01808911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468565|NCT01808911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92468566|NCT01808911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468569|NCT01809158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468570|NCT01809171|Vitamin D|vitamin d|mesh-list
92468571|NCT01809171|Cholecalciferol|cholecalciferol|mesh-list
92468572|NCT01809171|Vitamins|vitamins|mesh-ancestor
92468573|NCT01809171|Micronutrients|micronutrients|mesh-ancestor
92468574|NCT01809171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468575|NCT01809171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92468576|NCT01809171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92468577|NCT01809184|Insulin|insulin|mesh-list
92468578|NCT01809184|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92468579|NCT01809184|Insulin Glargine|insulin glargine|mesh-list
92468580|NCT01809184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92468581|NCT01809184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468582|NCT01809301|Niacin|niacin|mesh-list
92468583|NCT01809301|Nicotinic Acids|nicotinic acids|mesh-list
92468584|NCT01809301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92468585|NCT01809301|Antimetabolites|antimetabolites|mesh-ancestor
92468586|NCT01809301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468587|NCT01809301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92468588|NCT01809301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92468589|NCT01809301|Vitamin B Complex|vitamin b complex|mesh-ancestor
92468590|NCT01809301|Vitamins|vitamins|mesh-ancestor
92468591|NCT01809301|Micronutrients|micronutrients|mesh-ancestor
92468592|NCT01809301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468593|NCT01809340|Minocycline|minocycline|mesh-list
92468594|NCT01809340|Ketamine|ketamine|mesh-list
92468595|NCT01809340|Analgesics|analgesics|mesh-ancestor
92136344|NCT01447927|Metformin|metformin|mesh-list
92468596|NCT01809340|Sensory System Agents|sensory system agents|mesh-ancestor
92468597|NCT01809340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468598|NCT01809340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468599|NCT01809340|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92468600|NCT01809340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92468601|NCT01809340|Anesthetics, General|anesthetics, general|mesh-ancestor
92468602|NCT01809340|Anesthetics|anesthetics|mesh-ancestor
92468603|NCT01809340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468604|NCT01809340|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92468605|NCT01809340|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92468606|NCT01809340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468607|NCT01809340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468608|NCT01809340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468609|NCT01809340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468611|NCT01809392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468612|NCT01809392|Antimetabolites|antimetabolites|mesh-ancestor
92468613|NCT01809392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468614|NCT01809392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468615|NCT01809392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468616|NCT01809444|Doxycycline|doxycycline|mesh-list
92468617|NCT01809444|Prednisone|prednisone|mesh-list
92468618|NCT01809444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92468619|NCT01809444|Glucocorticoids|glucocorticoids|mesh-ancestor
92468620|NCT01809444|Hormones|hormones|mesh-ancestor
92468621|NCT01809444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468622|NCT01809444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468623|NCT01809444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92468624|NCT01809444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468625|NCT01809444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468626|NCT01809444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468627|NCT01809444|Antimalarials|antimalarials|mesh-ancestor
92468628|NCT01809444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92468629|NCT01809444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92468630|NCT01809626|Zolpidem|zolpidem|mesh-list
92468631|NCT01809626|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92468632|NCT01809626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92468633|NCT01809626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468634|NCT01809626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468635|NCT01809626|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92468636|NCT01809626|GABA Agonists|gaba agonists|mesh-ancestor
92468637|NCT01809626|GABA Agents|gaba agents|mesh-ancestor
92468638|NCT01809626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468639|NCT01809626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468640|NCT01809743|Adenosine|adenosine|mesh-list
92468641|NCT01809743|Regadenoson|regadenoson|mesh-list
92468642|NCT01809743|Analgesics|analgesics|mesh-ancestor
92468643|NCT01809743|Sensory System Agents|sensory system agents|mesh-ancestor
92468644|NCT01809743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468645|NCT01809743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468646|NCT01809743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468648|NCT01809743|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92468649|NCT01809743|Purinergic Agonists|purinergic agonists|mesh-ancestor
92468650|NCT01809743|Purinergic Agents|purinergic agents|mesh-ancestor
92468651|NCT01809743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468652|NCT01809743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468653|NCT01809743|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92468654|NCT01809847|Ofatumumab|ofatumumab|mesh-list
92468655|NCT01809847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468656|NCT01809860|Sirolimus|sirolimus|mesh-list
92468657|NCT01809860|Isavuconazole|isavuconazole|mesh-list
92468658|NCT01809860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468659|NCT01809860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468660|NCT01809860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92468661|NCT01809860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468662|NCT01809860|Antifungal Agents|antifungal agents|mesh-ancestor
92468663|NCT01809860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468664|NCT01809860|Immunologic Factors|immunologic factors|mesh-ancestor
92468665|NCT01809860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468666|NCT01809886|Neostigmine|neostigmine|mesh-list
92468667|NCT01809886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92468668|NCT01809886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468669|NCT01809886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348591|NCT01553136|Varenicline|varenicline|mesh-list
92468670|NCT01809886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92468671|NCT01809886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468672|NCT01809886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468673|NCT01809886|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92468674|NCT01809886|Autonomic Agents|autonomic agents|mesh-ancestor
92468675|NCT01809886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468676|NCT01809925|Psyllium|psyllium|mesh-list
92468677|NCT01809925|Calcium polycarbophil|calcium polycarbophil|mesh-list
92468678|NCT01809925|Cathartics|cathartics|mesh-ancestor
92468679|NCT01809925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468680|NCT01809925|Antidiarrheals|antidiarrheals|mesh-ancestor
92468681|NCT01810185|Naltrexone|naltrexone|mesh-list
92468682|NCT01810185|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92468683|NCT01810185|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92468684|NCT01810185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468685|NCT01810185|Sensory System Agents|sensory system agents|mesh-ancestor
92468686|NCT01810185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468687|NCT01810237|Dabigatran|dabigatran|mesh-list
92468688|NCT01810237|Antithrombins|antithrombins|mesh-ancestor
92468689|NCT01810237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92468690|NCT01810237|Protease Inhibitors|protease inhibitors|mesh-ancestor
92468691|NCT01810237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468692|NCT01810237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468693|NCT01810237|Anticoagulants|anticoagulants|mesh-ancestor
92468694|NCT01810315|Estradiol|estradiol|mesh-list
92468695|NCT01810315|Estrogens|estrogens|mesh-ancestor
92468696|NCT01810315|Hormones|hormones|mesh-ancestor
92468697|NCT01810315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468698|NCT01810315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468699|NCT01810354|Cefazolin|cefazolin|mesh-list
92468700|NCT01810354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468701|NCT01810354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468702|NCT01810367|Cisplatin|cisplatin|mesh-list
92468703|NCT01810367|Gemcitabine|gemcitabine|mesh-list
92468704|NCT01810367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468705|NCT01810367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468706|NCT01810367|Antimetabolites|antimetabolites|mesh-ancestor
92468707|NCT01810367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468708|NCT01810393|Trastuzumab|trastuzumab|mesh-list
92468709|NCT01810393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468710|NCT01810393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468711|NCT01810458|Acetaminophen|acetaminophen|mesh-list
92468712|NCT01810458|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92468713|NCT01810458|Lidocaine|lidocaine|mesh-list
92468714|NCT01810458|Fentanyl|fentanyl|mesh-list
92468715|NCT01810458|Midazolam|midazolam|mesh-list
92468716|NCT01810458|Oxycodone|oxycodone|mesh-list
92468717|NCT01810458|Lorazepam|lorazepam|mesh-list
92468718|NCT01810458|Ondansetron|ondansetron|mesh-list
92468719|NCT01810458|Liver Extracts|liver extracts|mesh-list
92468720|NCT01810458|Anesthetics, Local|anesthetics, local|mesh-ancestor
92468721|NCT01810458|Anesthetics|anesthetics|mesh-ancestor
92468722|NCT01810458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468723|NCT01810458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468725|NCT01810458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468726|NCT01810458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468727|NCT01810458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92468728|NCT01810458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468729|NCT01810458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468730|NCT01810458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468731|NCT01810458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92468732|NCT01810458|Narcotics|narcotics|mesh-ancestor
92468733|NCT01810458|Analgesics|analgesics|mesh-ancestor
92468734|NCT01810458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92468735|NCT01810458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92468736|NCT01810458|Anesthetics, General|anesthetics, general|mesh-ancestor
92468737|NCT01810458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92468738|NCT01810458|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92468739|NCT01810458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92468740|NCT01810458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92468741|NCT01810458|GABA Modulators|gaba modulators|mesh-ancestor
92468742|NCT01810458|GABA Agents|gaba agents|mesh-ancestor
92468743|NCT01810458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468744|NCT01810458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92468745|NCT01810458|Antipyretics|antipyretics|mesh-ancestor
92468746|NCT01810458|Hematinics|hematinics|mesh-ancestor
92468747|NCT01810458|Antiemetics|antiemetics|mesh-ancestor
92468748|NCT01810458|Autonomic Agents|autonomic agents|mesh-ancestor
92468749|NCT01810458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468750|NCT01810458|Antipruritics|antipruritics|mesh-ancestor
92468751|NCT01810458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468752|NCT01810458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92468753|NCT01810458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92468754|NCT01810458|Serotonin Agents|serotonin agents|mesh-ancestor
92468755|NCT01810458|Anticonvulsants|anticonvulsants|mesh-ancestor
92468756|NCT01810458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92468757|NCT01810458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92468758|NCT01810458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468759|NCT01810549|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92468760|NCT01810549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468761|NCT01810601|Progesterone|progesterone|mesh-list
92468762|NCT01810601|Progestins|progestins|mesh-ancestor
92468763|NCT01810601|Hormones|hormones|mesh-ancestor
92468764|NCT01810601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468765|NCT01810601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468766|NCT01810640|Liver Extracts|liver extracts|mesh-list
92468767|NCT01810640|Hematinics|hematinics|mesh-ancestor
92468768|NCT01810731|Vaccines|vaccines|mesh-list
92468769|NCT01810731|Immunologic Factors|immunologic factors|mesh-ancestor
92468770|NCT01810731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468771|NCT01810770|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92468772|NCT01810770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468773|NCT01810796|Ranolazine|ranolazine|mesh-list
92468774|NCT01810796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92468775|NCT01810796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468776|NCT01810796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468778|NCT01810809|Hyaluronic Acid|hyaluronic acid|mesh-list
92468779|NCT01810809|Viscosupplements|viscosupplements|mesh-ancestor
92468780|NCT01810809|Protective Agents|protective agents|mesh-ancestor
92468781|NCT01810809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468782|NCT01810809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92468783|NCT01810809|Immunologic Factors|immunologic factors|mesh-ancestor
92468784|NCT01810848|Hyaluronic Acid|hyaluronic acid|mesh-list
92468785|NCT01810848|Hylan|hylan|mesh-list
92468786|NCT01810848|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92468787|NCT01810848|Immunologic Factors|immunologic factors|mesh-ancestor
92468788|NCT01810848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468789|NCT01810848|Viscosupplements|viscosupplements|mesh-ancestor
92468790|NCT01810848|Protective Agents|protective agents|mesh-ancestor
92193696|NCT05560165|Listerine|listerine|mesh-list
92468791|NCT01810887|Ritonavir|ritonavir|mesh-list
92468792|NCT01810887|Darunavir|darunavir|mesh-list
92468793|NCT01810887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92468794|NCT01810887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92468795|NCT01810887|Protease Inhibitors|protease inhibitors|mesh-ancestor
92468796|NCT01810887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468797|NCT01810887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468798|NCT01810887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92468799|NCT01810887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92468800|NCT01810887|Antiviral Agents|antiviral agents|mesh-ancestor
92468801|NCT01810887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468802|NCT01810887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92468803|NCT01810887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92468804|NCT01810926|Cyclosporine|cyclosporine|mesh-list
92468805|NCT01810926|Rituximab|rituximab|mesh-list
92468806|NCT01810926|Methotrexate|methotrexate|mesh-list
92468807|NCT01810926|Fludarabine|fludarabine|mesh-list
92468808|NCT01810926|Thiotepa|thiotepa|mesh-list
92468809|NCT01810926|Treosulfan|treosulfan|mesh-list
92468810|NCT01810926|Antibodies|antibodies|mesh-list
92468811|NCT01810926|Cyclosporins|cyclosporins|mesh-list
92468812|NCT01810926|Immunologic Factors|immunologic factors|mesh-ancestor
92468813|NCT01810926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468814|NCT01810926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92468815|NCT01810926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468816|NCT01810926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468817|NCT01810926|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92468818|NCT01810926|Abortifacient Agents|abortifacient agents|mesh-ancestor
92468819|NCT01810926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92468820|NCT01810926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468821|NCT01810926|Antimetabolites|antimetabolites|mesh-ancestor
92468822|NCT01810926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468823|NCT01810926|Dermatologic Agents|dermatologic agents|mesh-ancestor
92468824|NCT01810926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468825|NCT01810926|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92468826|NCT01810926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468827|NCT01810926|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92468828|NCT01810926|Antifungal Agents|antifungal agents|mesh-ancestor
92468829|NCT01810926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468830|NCT01810926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92468831|NCT01810926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92468832|NCT01810926|Alkylating Agents|alkylating agents|mesh-ancestor
92468833|NCT01810926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92468834|NCT01811056|Mifepristone|mifepristone|mesh-list
92468835|NCT01811056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92468836|NCT01811056|Abortifacient Agents|abortifacient agents|mesh-ancestor
92468837|NCT01811056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92468838|NCT01811056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468839|NCT01811056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92468840|NCT01811056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92468841|NCT01811056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92468842|NCT01811056|Contraceptive Agents|contraceptive agents|mesh-ancestor
92468843|NCT01811056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92468844|NCT01811056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92468845|NCT01811056|Hormone Antagonists|hormone antagonists|mesh-ancestor
92468846|NCT01811056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468847|NCT01811056|Luteolytic Agents|luteolytic agents|mesh-ancestor
92468848|NCT01811056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92468849|NCT01811056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92468850|NCT01811160|Melatonin|melatonin|mesh-list
92468851|NCT01811160|Antioxidants|antioxidants|mesh-ancestor
92468852|NCT01811160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468853|NCT01811160|Protective Agents|protective agents|mesh-ancestor
92468854|NCT01811160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468855|NCT01811160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468856|NCT01811251|Dexamethasone|dexamethasone|mesh-list
92468857|NCT01811251|Pregabalin|pregabalin|mesh-list
92468858|NCT01811251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92468859|NCT01811251|Antiemetics|antiemetics|mesh-ancestor
92468860|NCT01811251|Autonomic Agents|autonomic agents|mesh-ancestor
92468861|NCT01811251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468862|NCT01811251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468863|NCT01811251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468864|NCT01811251|Glucocorticoids|glucocorticoids|mesh-ancestor
92468865|NCT01811251|Hormones|hormones|mesh-ancestor
92468866|NCT01811251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468867|NCT01811251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92468868|NCT01811251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193773|NCT05559619|Vitamin D|vitamin d|mesh-list
92468870|NCT01811251|Sensory System Agents|sensory system agents|mesh-ancestor
92468871|NCT01811251|Anticonvulsants|anticonvulsants|mesh-ancestor
92468872|NCT01811251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92468873|NCT01811251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92468874|NCT01811251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468875|NCT01811251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92468876|NCT01811251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92468877|NCT01811251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92468878|NCT01811251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468879|NCT01811251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92468880|NCT01811277|Oxaliplatin|oxaliplatin|mesh-list
92468881|NCT01811277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468882|NCT01811381|Curcumin|curcumin|mesh-list
92468883|NCT01811381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92468884|NCT01811381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92468885|NCT01811381|Analgesics|analgesics|mesh-ancestor
92468886|NCT01811381|Sensory System Agents|sensory system agents|mesh-ancestor
92468887|NCT01811381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468888|NCT01811381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468889|NCT01811381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92468890|NCT01811381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92468891|NCT01811381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468892|NCT01811381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468893|NCT01811381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468894|NCT01811459|Haloperidol|haloperidol|mesh-list
92468895|NCT01811459|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92468896|NCT01811459|Haloperidol decanoate|haloperidol decanoate|mesh-list
92468897|NCT01811459|Antidepressive Agents|antidepressive agents|mesh-ancestor
92468898|NCT01811459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92468899|NCT01811459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92468900|NCT01811459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92468901|NCT01811459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468902|NCT01811459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468903|NCT01811459|Antiemetics|antiemetics|mesh-ancestor
92468904|NCT01811459|Autonomic Agents|autonomic agents|mesh-ancestor
92468905|NCT01811459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92468906|NCT01811459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92468907|NCT01811459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92468908|NCT01811459|Dopamine Agents|dopamine agents|mesh-ancestor
92468909|NCT01811459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468910|NCT01811459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468911|NCT01811459|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92468912|NCT01811615|Ethanol|ethanol|mesh-list
92468913|NCT01811615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92468914|NCT01811615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468915|NCT01811615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92468916|NCT01811615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468917|NCT01811667|Sirolimus|sirolimus|mesh-list
92468918|NCT01811667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92468919|NCT01811667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92468920|NCT01811667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92468921|NCT01811667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468922|NCT01811667|Antifungal Agents|antifungal agents|mesh-ancestor
92468923|NCT01811667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468924|NCT01811667|Immunologic Factors|immunologic factors|mesh-ancestor
92468925|NCT01811667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468926|NCT01811810|Androgens|androgens|mesh-list
92468927|NCT01811810|Hormones|hormones|mesh-ancestor
92468928|NCT01811810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468929|NCT01811810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468930|NCT01811836|Zinc|zinc|mesh-list
92468931|NCT01811836|Trace Elements|trace elements|mesh-ancestor
92468932|NCT01811836|Micronutrients|micronutrients|mesh-ancestor
92468933|NCT01811836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468934|NCT01811849|Insulin|insulin|mesh-list
92468935|NCT01811849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92468936|NCT01811849|Insulin Lispro|insulin lispro|mesh-list
92468937|NCT01811849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92468938|NCT01811849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468939|NCT01812018|Gemcitabine|gemcitabine|mesh-list
92468940|NCT01812018|Docetaxel|docetaxel|mesh-list
92468941|NCT01812018|Endostar protein|endostar protein|mesh-list
92468942|NCT01812018|Endostatins|endostatins|mesh-list
92468943|NCT01812018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92468944|NCT01812018|Antimetabolites|antimetabolites|mesh-ancestor
92468945|NCT01812018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468947|NCT01812018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92468948|NCT01812018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92468949|NCT01812018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92468950|NCT01812018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92468951|NCT01812018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92468952|NCT01812018|Growth Substances|growth substances|mesh-ancestor
92468953|NCT01812018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468954|NCT01812018|Growth Inhibitors|growth inhibitors|mesh-ancestor
92468955|NCT01812096|Bortezomib|bortezomib|mesh-list
92468956|NCT01812096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92468957|NCT01812122|Glimepiride|glimepiride|mesh-list
92468958|NCT01812122|Vildagliptin|vildagliptin|mesh-list
92468959|NCT01812122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92468960|NCT01812122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92468961|NCT01812122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468962|NCT01812122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92468963|NCT01812122|Immunologic Factors|immunologic factors|mesh-ancestor
92468964|NCT01812122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92468965|NCT01812122|Protease Inhibitors|protease inhibitors|mesh-ancestor
92468966|NCT01812122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468967|NCT01812122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468968|NCT01812135|Vaccines|vaccines|mesh-list
92468969|NCT01812135|Immunologic Factors|immunologic factors|mesh-ancestor
92468970|NCT01812135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468971|NCT01812200|Rivaroxaban|rivaroxaban|mesh-list
92468972|NCT01812200|Dabigatran|dabigatran|mesh-list
92468973|NCT01812200|Phenprocoumon|phenprocoumon|mesh-list
92468974|NCT01812200|Ticagrelor|ticagrelor|mesh-list
92468975|NCT01812200|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92468976|NCT01812200|Antithrombins|antithrombins|mesh-ancestor
92468977|NCT01812200|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92468978|NCT01812200|Protease Inhibitors|protease inhibitors|mesh-ancestor
92468979|NCT01812200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92468980|NCT01812200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92468981|NCT01812200|Anticoagulants|anticoagulants|mesh-ancestor
92468982|NCT01812200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92468983|NCT01812200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92468984|NCT01812200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92468985|NCT01812200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92468986|NCT01812200|Purinergic Agents|purinergic agents|mesh-ancestor
92468987|NCT01812200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92468988|NCT01812200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468989|NCT01812239|Progesterone|progesterone|mesh-list
92468990|NCT01812239|Progestins|progestins|mesh-list
92468991|NCT01812239|Hormones|hormones|mesh-ancestor
92468992|NCT01812239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92468993|NCT01812239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92468994|NCT01812330|Clopidogrel|clopidogrel|mesh-list
92468995|NCT01812330|Ticagrelor|ticagrelor|mesh-list
92468996|NCT01812330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92468997|NCT01812330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92468998|NCT01812330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92468999|NCT01812330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92469000|NCT01812330|Purinergic Agents|purinergic agents|mesh-ancestor
92469001|NCT01812330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469002|NCT01812330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469003|NCT01812330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469004|NCT01812356|Nitrous Oxide|nitrous oxide|mesh-list
92469005|NCT01812356|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92469006|NCT01812356|Anesthetics, General|anesthetics, general|mesh-ancestor
92469007|NCT01812356|Anesthetics|anesthetics|mesh-ancestor
92469008|NCT01812356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469009|NCT01812356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469010|NCT01812356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469011|NCT01812356|Analgesics|analgesics|mesh-ancestor
92469012|NCT01812356|Sensory System Agents|sensory system agents|mesh-ancestor
92469013|NCT01812356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469014|NCT01812369|Gemcitabine|gemcitabine|mesh-list
92469015|NCT01812369|Doxorubicin|doxorubicin|mesh-list
92469016|NCT01812369|Vinblastine|vinblastine|mesh-list
92469017|NCT01812369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469018|NCT01812369|Antimetabolites|antimetabolites|mesh-ancestor
92469019|NCT01812369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469020|NCT01812369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469021|NCT01812369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92469022|NCT01812369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92469023|NCT01812369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92469024|NCT01812369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469025|NCT01812369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92469026|NCT01812369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92469027|NCT01812369|Antimitotic Agents|antimitotic agents|mesh-ancestor
92469028|NCT01812369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92469029|NCT01812382|Retapamulin|retapamulin|mesh-list
92469030|NCT01812382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469031|NCT01812382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469032|NCT01812434|Sildenafil Citrate|sildenafil citrate|mesh-list
92469033|NCT01812434|Vasodilator Agents|vasodilator agents|mesh-ancestor
92469034|NCT01812434|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92469035|NCT01812434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92469036|NCT01812434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469037|NCT01812434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469038|NCT01812434|Urological Agents|urological agents|mesh-ancestor
92469039|NCT01812538|Diclofenac|diclofenac|mesh-list
92469040|NCT01812538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92469041|NCT01812538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469042|NCT01812538|Analgesics|analgesics|mesh-ancestor
92469043|NCT01812538|Sensory System Agents|sensory system agents|mesh-ancestor
92469044|NCT01812538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469045|NCT01812538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469046|NCT01812538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469047|NCT01812538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469048|NCT01812538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92469049|NCT01812538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469050|NCT01812538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469051|NCT01812551|Alendronate|alendronate|mesh-list
92469052|NCT01812551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92469053|NCT01812551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469054|NCT01812642|N-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|n-(1-(3,4-difluorobenzyl)piperidin-4-yl)-6-(trifluoromethyl)pyridazin-3-amine|mesh-list
92469055|NCT01812642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92469056|NCT01812642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92469057|NCT01812642|Dopamine Agents|dopamine agents|mesh-ancestor
92469058|NCT01812642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469059|NCT01812642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469060|NCT01812642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469061|NCT01812720|Dexamethasone|dexamethasone|mesh-list
92469062|NCT01812720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469063|NCT01812720|Antiemetics|antiemetics|mesh-ancestor
92469064|NCT01812720|Autonomic Agents|autonomic agents|mesh-ancestor
92469065|NCT01812720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469066|NCT01812720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469067|NCT01812720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469068|NCT01812720|Glucocorticoids|glucocorticoids|mesh-ancestor
92469069|NCT01812720|Hormones|hormones|mesh-ancestor
92469070|NCT01812720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469071|NCT01812720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469072|NCT01812720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469073|NCT01812889|TOL-463|tol-463|mesh-list
92469074|NCT01812889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469075|NCT01812928|Diclofenac|diclofenac|mesh-list
92469076|NCT01812928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92469077|NCT01812928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92469078|NCT01812928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469079|NCT01812928|Analgesics|analgesics|mesh-ancestor
92469080|NCT01812928|Sensory System Agents|sensory system agents|mesh-ancestor
92469081|NCT01812928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469082|NCT01812928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469083|NCT01812928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469084|NCT01812928|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92469085|NCT01812928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469086|NCT01812928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469087|NCT01812954|Cyclosporine|cyclosporine|mesh-list
92469088|NCT01812954|Adalimumab|adalimumab|mesh-list
92469089|NCT01812954|Infliximab|infliximab|mesh-list
92469090|NCT01812954|Etanercept|etanercept|mesh-list
92469091|NCT01812954|Methotrexate|methotrexate|mesh-list
92469092|NCT01812954|Ustekinumab|ustekinumab|mesh-list
92469093|NCT01812954|Acitretin|acitretin|mesh-list
92469094|NCT01812954|Cyclosporins|cyclosporins|mesh-list
92194000|NCT03946202|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92469095|NCT01812954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92469096|NCT01812954|Abortifacient Agents|abortifacient agents|mesh-ancestor
92469097|NCT01812954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92469098|NCT01812954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469099|NCT01812954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469101|NCT01812954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469102|NCT01812954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469103|NCT01812954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92469104|NCT01812954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469105|NCT01812954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92469106|NCT01812954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469107|NCT01812954|Immunologic Factors|immunologic factors|mesh-ancestor
92469108|NCT01812954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469109|NCT01812954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92469110|NCT01812954|Antifungal Agents|antifungal agents|mesh-ancestor
92469111|NCT01812954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469112|NCT01812954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92469113|NCT01812954|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92469114|NCT01812954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469115|NCT01812954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469116|NCT01812954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92469117|NCT01812954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469118|NCT01812954|Analgesics|analgesics|mesh-ancestor
92469119|NCT01812954|Sensory System Agents|sensory system agents|mesh-ancestor
92469120|NCT01812954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469121|NCT01812954|Keratolytic Agents|keratolytic agents|mesh-ancestor
92469122|NCT01812967|Caseins|caseins|mesh-list
92469123|NCT01812967|Chelating Agents|chelating agents|mesh-ancestor
92469124|NCT01812967|Sequestering Agents|sequestering agents|mesh-ancestor
92469125|NCT01812967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469126|NCT01813162|Tenofovir|tenofovir|mesh-list
92469127|NCT01813162|Metronidazole|metronidazole|mesh-list
92469128|NCT01813162|Terconazole|terconazole|mesh-list
92469129|NCT01813162|Contraceptive Agents|contraceptive agents|mesh-list
92469130|NCT01813162|Antiviral Agents|antiviral agents|mesh-ancestor
92469131|NCT01813162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469132|NCT01813162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92469133|NCT01813162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92469134|NCT01813162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469135|NCT01813162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469136|NCT01813162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92469137|NCT01813162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92469138|NCT01813162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469139|NCT01813162|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92469140|NCT01813162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92469141|NCT01813162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92469142|NCT01813162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469143|NCT01813162|Antifungal Agents|antifungal agents|mesh-ancestor
92469144|NCT01813201|Methyltestosterone|methyltestosterone|mesh-list
92469145|NCT01813201|Testosterone|testosterone|mesh-list
92469146|NCT01813201|Testosterone undecanoate|testosterone undecanoate|mesh-list
92469147|NCT01813201|Testosterone enanthate|testosterone enanthate|mesh-list
92469148|NCT01813201|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92469149|NCT01813201|Androgens|androgens|mesh-ancestor
92469150|NCT01813201|Hormones|hormones|mesh-ancestor
92469151|NCT01813201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469152|NCT01813201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469153|NCT01813201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469154|NCT01813201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469155|NCT01813201|Anabolic Agents|anabolic agents|mesh-ancestor
92469156|NCT01813240|Minocycline|minocycline|mesh-list
92469157|NCT01813240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469158|NCT01813240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469159|NCT01813253|Irinotecan|irinotecan|mesh-list
92469160|NCT01813253|Nimotuzumab|nimotuzumab|mesh-list
92469161|NCT01813253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92469162|NCT01813253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92469163|NCT01813253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469164|NCT01813253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469165|NCT01813253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469166|NCT01813253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92469167|NCT01813318|Acamprosate|acamprosate|mesh-list
92469168|NCT01813318|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92469170|NCT01813448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469171|NCT01813448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469172|NCT01813461|Isavuconazole|isavuconazole|mesh-list
92469173|NCT01813461|Antifungal Agents|antifungal agents|mesh-ancestor
92469174|NCT01813461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469175|NCT01813487|Entecavir|entecavir|mesh-list
92469176|NCT01813487|Antiviral Agents|antiviral agents|mesh-ancestor
92469177|NCT01813487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469178|NCT01813513|Simeprevir|simeprevir|mesh-list
92469179|NCT01813513|Antiviral Agents|antiviral agents|mesh-ancestor
92469180|NCT01813513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469181|NCT01813513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92469182|NCT01813513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469183|NCT01813513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469184|NCT01813552|Ritonavir|ritonavir|mesh-list
92469185|NCT01813552|Omeprazole|omeprazole|mesh-list
92469186|NCT01813552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92469187|NCT01813552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92469188|NCT01813552|Protease Inhibitors|protease inhibitors|mesh-ancestor
92469189|NCT01813552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469190|NCT01813552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469191|NCT01813552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92136948|NCT00604461|Bevacizumab|bevacizumab|mesh-list
92469192|NCT01813552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92469193|NCT01813552|Antiviral Agents|antiviral agents|mesh-ancestor
92469194|NCT01813552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469195|NCT01813552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92469196|NCT01813552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92469197|NCT01813552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92469198|NCT01813552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469199|NCT01813552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92469200|NCT01813565|Hyaluronic Acid|hyaluronic acid|mesh-list
92469201|NCT01813565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92469202|NCT01813565|Immunologic Factors|immunologic factors|mesh-ancestor
92469203|NCT01813565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469204|NCT01813565|Viscosupplements|viscosupplements|mesh-ancestor
92469205|NCT01813565|Protective Agents|protective agents|mesh-ancestor
92469206|NCT01813591|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92469207|NCT01813591|Hormones|hormones|mesh-ancestor
92469208|NCT01813591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469209|NCT01813591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469210|NCT01813604|Vaccines|vaccines|mesh-list
92469211|NCT01813604|Immunologic Factors|immunologic factors|mesh-ancestor
92469212|NCT01813604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469213|NCT01813617|Prednisone|prednisone|mesh-list
92469214|NCT01813617|Methotrexate|methotrexate|mesh-list
92469215|NCT01813617|Azathioprine|azathioprine|mesh-list
92469216|NCT01813617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92469217|NCT01813617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469218|NCT01813617|Glucocorticoids|glucocorticoids|mesh-ancestor
92469220|NCT01813617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469221|NCT01813617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469222|NCT01813617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469223|NCT01813617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469224|NCT01813617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92469225|NCT01813617|Abortifacient Agents|abortifacient agents|mesh-ancestor
92469226|NCT01813617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92469227|NCT01813617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469228|NCT01813617|Antimetabolites|antimetabolites|mesh-ancestor
92469229|NCT01813617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469230|NCT01813617|Dermatologic Agents|dermatologic agents|mesh-ancestor
92469231|NCT01813617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469232|NCT01813617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92469233|NCT01813617|Immunologic Factors|immunologic factors|mesh-ancestor
92469234|NCT01813617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469235|NCT01813617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92469236|NCT01813643|Risperidone|risperidone|mesh-list
92469237|NCT01813643|Aripiprazole|aripiprazole|mesh-list
92469238|NCT01813643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92469239|NCT01813643|Serotonin Agents|serotonin agents|mesh-ancestor
92469240|NCT01813643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469241|NCT01813643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469242|NCT01813643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194146|NCT04192292|Protease Inhibitors|protease inhibitors|mesh-ancestor
92469243|NCT01813643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92469244|NCT01813643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92469245|NCT01813643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469246|NCT01813643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92469247|NCT01813643|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92469249|NCT01813643|Antidepressive Agents|antidepressive agents|mesh-ancestor
92469250|NCT01813643|Dopamine Agonists|dopamine agonists|mesh-ancestor
92469251|NCT01813643|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92469252|NCT01813643|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92469253|NCT01813643|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92469254|NCT01813643|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92469255|NCT01813656|Aripiprazole|aripiprazole|mesh-list
92469256|NCT01813656|Antidepressive Agents|antidepressive agents|mesh-ancestor
92469257|NCT01813656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92469258|NCT01813656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92469259|NCT01813656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92469260|NCT01813656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469261|NCT01813656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469262|NCT01813656|Dopamine Agonists|dopamine agonists|mesh-ancestor
92469263|NCT01813656|Dopamine Agents|dopamine agents|mesh-ancestor
92469264|NCT01813656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469265|NCT01813656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469266|NCT01813656|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92469267|NCT01813656|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92469268|NCT01813656|Serotonin Agents|serotonin agents|mesh-ancestor
92469269|NCT01813656|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92469270|NCT01813656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92469271|NCT01813656|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92469272|NCT01813656|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92469273|NCT01813773|Aflibercept|aflibercept|mesh-list
92469274|NCT01813773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92469275|NCT01813773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92469276|NCT01813773|Growth Substances|growth substances|mesh-ancestor
92469277|NCT01813773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469278|NCT01813773|Growth Inhibitors|growth inhibitors|mesh-ancestor
92469279|NCT01813773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469280|NCT01813812|Rebamipide|rebamipide|mesh-list
92469281|NCT01813812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92469282|NCT01813812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469283|NCT01813812|Antioxidants|antioxidants|mesh-ancestor
92469284|NCT01813812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469285|NCT01813812|Protective Agents|protective agents|mesh-ancestor
92469286|NCT01813812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469287|NCT01813812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469288|NCT01813955|Papaverine|papaverine|mesh-list
92469289|NCT01813955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92469290|NCT01813955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469291|NCT01813955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469292|NCT01813955|Vasodilator Agents|vasodilator agents|mesh-ancestor
92469293|NCT01813955|Urological Agents|urological agents|mesh-ancestor
92469294|NCT01813981|Caffeine|caffeine|mesh-list
92469295|NCT01813981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92469296|NCT01813981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469297|NCT01813981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92469298|NCT01813981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469299|NCT01813981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469300|NCT01813981|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92469301|NCT01813981|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92469302|NCT01813981|Purinergic Agents|purinergic agents|mesh-ancestor
92469303|NCT01813981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469304|NCT01813994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92469305|NCT01813994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92469306|NCT01813994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92469307|NCT01813994|Antimetabolites|antimetabolites|mesh-ancestor
92469308|NCT01813994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469309|NCT01813994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469310|NCT01813994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92469311|NCT01814059|Sirolimus|sirolimus|mesh-list
92469312|NCT01814059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469313|NCT01814059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469314|NCT01814059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92469315|NCT01814059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469316|NCT01814059|Antifungal Agents|antifungal agents|mesh-ancestor
92469317|NCT01814059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469319|NCT01814059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469320|NCT01814085|Escitalopram|escitalopram|mesh-list
92469321|NCT01814085|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92469322|NCT01814085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92469323|NCT01814085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469324|NCT01814085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469325|NCT01814085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469326|NCT01814085|Serotonin Agents|serotonin agents|mesh-ancestor
92469327|NCT01814085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469328|NCT01814098|Escitalopram|escitalopram|mesh-list
92469329|NCT01814098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92469330|NCT01814098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92469331|NCT01814098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469332|NCT01814098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469333|NCT01814098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469334|NCT01814098|Serotonin Agents|serotonin agents|mesh-ancestor
92469335|NCT01814098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469336|NCT01814163|Paclitaxel|paclitaxel|mesh-list
92469337|NCT01814163|Bevacizumab|bevacizumab|mesh-list
92469338|NCT01814163|Carboplatin|carboplatin|mesh-list
92469339|NCT01814163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92469340|NCT01814163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469341|NCT01814163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92469342|NCT01814163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92469343|NCT01814163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92469344|NCT01814163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469345|NCT01814163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92469346|NCT01814163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92469347|NCT01814163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92469348|NCT01814163|Growth Substances|growth substances|mesh-ancestor
92469349|NCT01814163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469350|NCT01814163|Growth Inhibitors|growth inhibitors|mesh-ancestor
92469351|NCT01814189|Promethazine|promethazine|mesh-list
92469352|NCT01814189|Diphenhydramine|diphenhydramine|mesh-list
92469353|NCT01814189|Sumatriptan|sumatriptan|mesh-list
92469354|NCT01814189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92469355|NCT01814189|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92469356|NCT01814189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92469357|NCT01814189|Serotonin Agents|serotonin agents|mesh-ancestor
92469358|NCT01814189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469359|NCT01814189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469360|NCT01814189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469361|NCT01814189|Antipruritics|antipruritics|mesh-ancestor
92469362|NCT01814189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92469363|NCT01814189|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92469364|NCT01814189|Histamine Antagonists|histamine antagonists|mesh-ancestor
92469365|NCT01814189|Histamine Agents|histamine agents|mesh-ancestor
92469366|NCT01814189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92469367|NCT01814189|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92469368|NCT01814189|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92469369|NCT01814189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469370|NCT01814189|Anesthetics, Local|anesthetics, local|mesh-ancestor
92469371|NCT01814189|Anesthetics|anesthetics|mesh-ancestor
92469372|NCT01814189|Sensory System Agents|sensory system agents|mesh-ancestor
92469373|NCT01814189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469374|NCT01814189|Antiemetics|antiemetics|mesh-ancestor
92469375|NCT01814189|Autonomic Agents|autonomic agents|mesh-ancestor
92469376|NCT01814189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469378|NCT01814319|Uricosuric Agents|uricosuric agents|mesh-ancestor
92469379|NCT01814319|Gout Suppressants|gout suppressants|mesh-ancestor
92469380|NCT01814319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469381|NCT01814410|Ethanol|ethanol|mesh-list
92469382|NCT01814410|Nicotine|nicotine|mesh-list
92469383|NCT01814410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92469384|NCT01814410|Autonomic Agents|autonomic agents|mesh-ancestor
92469385|NCT01814410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469386|NCT01814410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469387|NCT01814410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92469388|NCT01814410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92469389|NCT01814410|Cholinergic Agents|cholinergic agents|mesh-ancestor
92469390|NCT01814410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469391|NCT01814410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469393|NCT01814410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469394|NCT01814410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469395|NCT01814423|Chloroquine|chloroquine|mesh-list
92469396|NCT01814423|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92469397|NCT01814423|Amebicides|amebicides|mesh-ancestor
92469398|NCT01814423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92469399|NCT01814423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92469400|NCT01814423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469401|NCT01814423|Antimalarials|antimalarials|mesh-ancestor
92469402|NCT01814423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469403|NCT01814423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92469404|NCT01814423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469405|NCT01814423|Analgesics|analgesics|mesh-ancestor
92469406|NCT01814423|Sensory System Agents|sensory system agents|mesh-ancestor
92469407|NCT01814423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469408|NCT01814423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469409|NCT01814423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469410|NCT01814423|Filaricides|filaricides|mesh-ancestor
92469411|NCT01814423|Antinematodal Agents|antinematodal agents|mesh-ancestor
92469412|NCT01814423|Anthelmintics|anthelmintics|mesh-ancestor
92469413|NCT01814449|Letrozole|letrozole|mesh-list
92469414|NCT01814449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469415|NCT01814449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92469416|NCT01814449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92469417|NCT01814449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469418|NCT01814449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469419|NCT01814449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92469420|NCT01814449|Hormone Antagonists|hormone antagonists|mesh-ancestor
92469421|NCT01814449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469422|NCT01814449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469423|NCT01814475|Vidarabine|vidarabine|mesh-list
92469424|NCT01814475|Fludarabine|fludarabine|mesh-list
92469425|NCT01814475|Fludarabine phosphate|fludarabine phosphate|mesh-list
92469426|NCT01814475|Busulfan|busulfan|mesh-list
92469427|NCT01814475|Thiotepa|thiotepa|mesh-list
92469428|NCT01814475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469429|NCT01814475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469430|NCT01814475|Antimetabolites|antimetabolites|mesh-ancestor
92469431|NCT01814475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469432|NCT01814475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469433|NCT01814475|Immunologic Factors|immunologic factors|mesh-ancestor
92469434|NCT01814475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469435|NCT01814475|Antiviral Agents|antiviral agents|mesh-ancestor
92469436|NCT01814475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469437|NCT01814475|Alkylating Agents|alkylating agents|mesh-ancestor
92469438|NCT01814475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92469439|NCT01814475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92469440|NCT01814501|Leucovorin|leucovorin|mesh-list
92469441|NCT01814501|Fluorouracil|fluorouracil|mesh-list
92469442|NCT01814501|Irinotecan|irinotecan|mesh-list
92469443|NCT01814501|Panitumumab|panitumumab|mesh-list
92469444|NCT01814501|Calcium|calcium|mesh-list
92469445|NCT01814501|Levoleucovorin|levoleucovorin|mesh-list
92469446|NCT01814501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469447|NCT01814501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469448|NCT01814501|Antimetabolites|antimetabolites|mesh-ancestor
92469449|NCT01814501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469450|NCT01814501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469451|NCT01814501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469452|NCT01814501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469453|NCT01814501|Immunologic Factors|immunologic factors|mesh-ancestor
92469454|NCT01814501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92469455|NCT01814501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92469456|NCT01814501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469457|NCT01814501|Antidotes|antidotes|mesh-ancestor
92469458|NCT01814501|Protective Agents|protective agents|mesh-ancestor
92469459|NCT01814501|Vitamin B Complex|vitamin b complex|mesh-ancestor
92469460|NCT01814501|Vitamins|vitamins|mesh-ancestor
92469461|NCT01814501|Micronutrients|micronutrients|mesh-ancestor
92469462|NCT01814501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92469463|NCT01814514|Timolol|timolol|mesh-list
92469464|NCT01814514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92469465|NCT01814514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92469466|NCT01814514|Adrenergic Agents|adrenergic agents|mesh-ancestor
92469467|NCT01814514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469468|NCT01814514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469469|NCT01814514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469470|NCT01814514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92469471|NCT01814514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92469473|NCT01814618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469474|NCT01814618|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92469475|NCT01814618|Autonomic Agents|autonomic agents|mesh-ancestor
92469476|NCT01814618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469477|NCT01814618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469478|NCT01814618|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92469479|NCT01814618|Respiratory System Agents|respiratory system agents|mesh-ancestor
92469480|NCT01814618|Glucocorticoids|glucocorticoids|mesh-ancestor
92469481|NCT01814618|Hormones|hormones|mesh-ancestor
92469482|NCT01814618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469483|NCT01814683|Primaquine|primaquine|mesh-list
92469484|NCT01814683|Antimalarials|antimalarials|mesh-ancestor
92469485|NCT01814683|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92469486|NCT01814683|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92469487|NCT01814683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469488|NCT01814709|Itraconazole|itraconazole|mesh-list
92469489|NCT01814709|Rifampin|rifampin|mesh-list
92469490|NCT01814709|Antifungal Agents|antifungal agents|mesh-ancestor
92469491|NCT01814709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469492|NCT01814709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92469493|NCT01814709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92469494|NCT01814709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469495|NCT01814709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469496|NCT01814709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92469497|NCT01814709|Hormone Antagonists|hormone antagonists|mesh-ancestor
92469498|NCT01814709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469499|NCT01814709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469500|NCT01814709|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92469501|NCT01814709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92469502|NCT01814709|Antitubercular Agents|antitubercular agents|mesh-ancestor
92469503|NCT01814709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469504|NCT01814709|Leprostatic Agents|leprostatic agents|mesh-ancestor
92469505|NCT01814709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92469506|NCT01814709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92469507|NCT01814709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92469508|NCT01814709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92469509|NCT01814709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92469510|NCT01814709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92322422|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
92469511|NCT01814709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92469512|NCT01814826|Azacitidine|azacitidine|mesh-list
92469513|NCT01814826|Pevonedistat|pevonedistat|mesh-list
92469514|NCT01814826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469515|NCT01814826|Antimetabolites|antimetabolites|mesh-ancestor
92469516|NCT01814826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469517|NCT01814826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469518|NCT01814826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469519|NCT01814865|Prednisone|prednisone|mesh-list
92469520|NCT01814865|Anastrozole|anastrozole|mesh-list
92469521|NCT01814865|Abiraterone Acetate|abiraterone acetate|mesh-list
92469522|NCT01814865|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92469523|NCT01814865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469524|NCT01814865|Glucocorticoids|glucocorticoids|mesh-ancestor
92469525|NCT01814865|Hormones|hormones|mesh-ancestor
92469526|NCT01814865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469527|NCT01814865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469528|NCT01814865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469529|NCT01814865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469530|NCT01814865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92469531|NCT01814865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469532|NCT01814865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469533|NCT01814865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92469534|NCT01814865|Hormone Antagonists|hormone antagonists|mesh-ancestor
92469535|NCT01814865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92469536|NCT01814891|Vitamin A|vitamin a|mesh-list
92469537|NCT01814891|Vitamins|vitamins|mesh-ancestor
92469538|NCT01814891|Micronutrients|micronutrients|mesh-ancestor
92469539|NCT01814891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469540|NCT01814904|Bile Acids and Salts|bile acids and salts|mesh-list
92469541|NCT01814904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469542|NCT01814930|Contraceptive Agents|contraceptive agents|mesh-list
92469543|NCT01814930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92469544|NCT01814930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469545|NCT01815021|Calcium, Dietary|calcium, dietary|mesh-list
92469546|NCT01815021|Calcium Carbonate|calcium carbonate|mesh-list
92469547|NCT01815021|Calcium|calcium|mesh-list
92469548|NCT01815021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469549|NCT01815021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469550|NCT01815021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92469551|NCT01815021|Antacids|antacids|mesh-ancestor
92469552|NCT01815021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469553|NCT01815021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469554|NCT01815047|Vitamin D|vitamin d|mesh-list
92469555|NCT01815047|Cholecalciferol|cholecalciferol|mesh-list
92469556|NCT01815047|Vitamins|vitamins|mesh-ancestor
92469557|NCT01815047|Micronutrients|micronutrients|mesh-ancestor
92469558|NCT01815047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469559|NCT01815047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92137303|NCT01532648|Hormones|hormones|mesh-ancestor
92469560|NCT01815047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469561|NCT01815073|Vaccines|vaccines|mesh-list
92469562|NCT01815073|Immunologic Factors|immunologic factors|mesh-ancestor
92469563|NCT01815073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469564|NCT01815125|Ondansetron|ondansetron|mesh-list
92469565|NCT01815125|Antiemetics|antiemetics|mesh-ancestor
92469566|NCT01815125|Autonomic Agents|autonomic agents|mesh-ancestor
92469567|NCT01815125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469568|NCT01815125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469569|NCT01815125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469570|NCT01815125|Antipruritics|antipruritics|mesh-ancestor
92469571|NCT01815125|Dermatologic Agents|dermatologic agents|mesh-ancestor
92469572|NCT01815125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92469573|NCT01815125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92469574|NCT01815125|Serotonin Agents|serotonin agents|mesh-ancestor
92469575|NCT01815125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469576|NCT01815125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469577|NCT01815203|Caffeine|caffeine|mesh-list
92469578|NCT01815203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92469579|NCT01815203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469580|NCT01815203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92469581|NCT01815203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469582|NCT01815203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469583|NCT01815203|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92469584|NCT01815203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92469585|NCT01815203|Purinergic Agents|purinergic agents|mesh-ancestor
92469586|NCT01815203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469588|NCT01815255|Antiviral Agents|antiviral agents|mesh-ancestor
92469589|NCT01815255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469590|NCT01815255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92469591|NCT01815255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92469592|NCT01815255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469593|NCT01815255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469594|NCT01815255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92469595|NCT01815255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92469596|NCT01815268|Vaccines|vaccines|mesh-list
92469597|NCT01815268|Immunologic Factors|immunologic factors|mesh-ancestor
92469598|NCT01815268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469599|NCT01815294|Doxorubicin|doxorubicin|mesh-list
92469600|NCT01815294|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92469601|NCT01815294|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92469602|NCT01815294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469603|NCT01815294|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92469604|NCT01815294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92469605|NCT01815294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469606|NCT01815294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469607|NCT01815307|Gemcitabine|gemcitabine|mesh-list
92469608|NCT01815307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469609|NCT01815307|Antimetabolites|antimetabolites|mesh-ancestor
92469610|NCT01815307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469611|NCT01815307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469612|NCT01815437|Vitamin D|vitamin d|mesh-list
92469613|NCT01815437|Ergocalciferols|ergocalciferols|mesh-list
92469614|NCT01815437|Cholecalciferol|cholecalciferol|mesh-list
92194518|NCT00565669|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92469616|NCT01815437|Micronutrients|micronutrients|mesh-ancestor
92469617|NCT01815437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469618|NCT01815437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92469619|NCT01815437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469620|NCT01815528|Catumaxomab|catumaxomab|mesh-list
92469621|NCT01815528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469622|NCT01815541|Teicoplanin|teicoplanin|mesh-list
92469623|NCT01815541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469624|NCT01815541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469625|NCT01815658|Carbon Fiber|carbon fiber|mesh-list
92469626|NCT01815658|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92469627|NCT01815658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469628|NCT01815723|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92469629|NCT01815723|Dermatologic Agents|dermatologic agents|mesh-ancestor
92469630|NCT01815723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469631|NCT01815723|Immunologic Factors|immunologic factors|mesh-ancestor
92469632|NCT01815723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469633|NCT01815892|Furosemide|furosemide|mesh-list
92469634|NCT01815892|Diuretics|diuretics|mesh-ancestor
92469635|NCT01815892|Natriuretic Agents|natriuretic agents|mesh-ancestor
92469636|NCT01815892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469637|NCT01815892|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92469638|NCT01815892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469639|NCT01815892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469640|NCT01815944|Ropivacaine|ropivacaine|mesh-list
92469641|NCT01815944|Anesthetics, Local|anesthetics, local|mesh-ancestor
92469642|NCT01815944|Anesthetics|anesthetics|mesh-ancestor
92469643|NCT01815944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469644|NCT01815944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469645|NCT01815944|Sensory System Agents|sensory system agents|mesh-ancestor
92469646|NCT01815944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469647|NCT01816009|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92469648|NCT01816009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469649|NCT01816035|Trastuzumab|trastuzumab|mesh-list
92469650|NCT01816035|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92469651|NCT01816035|Maytansine|maytansine|mesh-list
92469652|NCT01816035|Immunoconjugates|immunoconjugates|mesh-list
92469653|NCT01816035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92469654|NCT01816035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469655|NCT01816035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92469656|NCT01816035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92469657|NCT01816035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92469658|NCT01816035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92469659|NCT01816035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469660|NCT01816035|Immunotoxins|immunotoxins|mesh-ancestor
92469661|NCT01816035|Immunologic Factors|immunologic factors|mesh-ancestor
92469662|NCT01816035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469663|NCT01816191|Diltiazem|diltiazem|mesh-list
92469664|NCT01816191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92469665|NCT01816191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92469666|NCT01816191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469667|NCT01816191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469668|NCT01816191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469669|NCT01816191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469670|NCT01816191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92469671|NCT01816321|Ganirelix|ganirelix|mesh-list
92469672|NCT01816321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92469673|NCT01816321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469674|NCT01816321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469675|NCT01816334|Methylprednisolone|methylprednisolone|mesh-list
92469676|NCT01816334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92469677|NCT01816334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92469678|NCT01816334|Prednisolone|prednisolone|mesh-list
92469679|NCT01816334|Prednisolone acetate|prednisolone acetate|mesh-list
92469680|NCT01816334|Ketoprofen|ketoprofen|mesh-list
92469681|NCT01816334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92469682|NCT01816334|Prednisolone phosphate|prednisolone phosphate|mesh-list
92469683|NCT01816334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469684|NCT01816334|Antiemetics|antiemetics|mesh-ancestor
92469685|NCT01816334|Autonomic Agents|autonomic agents|mesh-ancestor
92469686|NCT01816334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469687|NCT01816334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469688|NCT01816334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194594|NCT00568087|Antidotes|antidotes|mesh-ancestor
92469689|NCT01816334|Glucocorticoids|glucocorticoids|mesh-ancestor
92469690|NCT01816334|Hormones|hormones|mesh-ancestor
92469691|NCT01816334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469692|NCT01816334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92469693|NCT01816334|Protective Agents|protective agents|mesh-ancestor
92469694|NCT01816334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469695|NCT01816334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469696|NCT01816334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92469697|NCT01816334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469698|NCT01816334|Analgesics|analgesics|mesh-ancestor
92469699|NCT01816334|Sensory System Agents|sensory system agents|mesh-ancestor
92469700|NCT01816334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469701|NCT01816334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92469702|NCT01816334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469703|NCT01816334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469704|NCT01816412|Paclitaxel|paclitaxel|mesh-list
92469705|NCT01816412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92469706|NCT01816412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469707|NCT01816412|Tubulin Modulators|tubulin modulators|mesh-ancestor
92469708|NCT01816412|Antimitotic Agents|antimitotic agents|mesh-ancestor
92469709|NCT01816412|Mitosis Modulators|mitosis modulators|mesh-ancestor
92469710|NCT01816412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469711|NCT01816490|Silybin|silybin|mesh-list
92469712|NCT01816490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92469713|NCT01816490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469714|NCT01816490|Protective Agents|protective agents|mesh-ancestor
92469715|NCT01816490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469716|NCT01816529|Diltiazem|diltiazem|mesh-list
92469717|NCT01816529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92469718|NCT01816529|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92469719|NCT01816529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469720|NCT01816529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469721|NCT01816529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469722|NCT01816529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469723|NCT01816529|Vasodilator Agents|vasodilator agents|mesh-ancestor
92469724|NCT01816555|Vitamin D|vitamin d|mesh-list
92469725|NCT01816555|Vitamins|vitamins|mesh-ancestor
92469726|NCT01816555|Micronutrients|micronutrients|mesh-ancestor
92469727|NCT01816555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469728|NCT01816555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92469729|NCT01816581|Morphine|morphine|mesh-list
92469730|NCT01816581|Naloxone|naloxone|mesh-list
92469731|NCT01816581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92469732|NCT01816581|Narcotics|narcotics|mesh-ancestor
92469733|NCT01816581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469734|NCT01816581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469735|NCT01816581|Analgesics|analgesics|mesh-ancestor
92469736|NCT01816581|Sensory System Agents|sensory system agents|mesh-ancestor
92469737|NCT01816581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469738|NCT01816581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92469739|NCT01816620|Dexamethasone|dexamethasone|mesh-list
92469740|NCT01816620|Lenalidomide|lenalidomide|mesh-list
92469741|NCT01816620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469742|NCT01816620|Antiemetics|antiemetics|mesh-ancestor
92469743|NCT01816620|Autonomic Agents|autonomic agents|mesh-ancestor
92469744|NCT01816620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469745|NCT01816620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469746|NCT01816620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469747|NCT01816620|Glucocorticoids|glucocorticoids|mesh-ancestor
92469748|NCT01816620|Hormones|hormones|mesh-ancestor
92469749|NCT01816620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469750|NCT01816620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469751|NCT01816620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469752|NCT01816620|Immunologic Factors|immunologic factors|mesh-ancestor
92469753|NCT01816620|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92469754|NCT01816620|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92469755|NCT01816620|Growth Substances|growth substances|mesh-ancestor
92469756|NCT01816620|Growth Inhibitors|growth inhibitors|mesh-ancestor
92469757|NCT01816646|Cidofovir|cidofovir|mesh-list
92469759|NCT01816646|Uricosuric Agents|uricosuric agents|mesh-ancestor
92469760|NCT01816646|Gout Suppressants|gout suppressants|mesh-ancestor
92469761|NCT01816646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469762|NCT01816646|Antiviral Agents|antiviral agents|mesh-ancestor
92469763|NCT01816646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194669|NCT00489281|Antitubercular Agents|antitubercular agents|mesh-ancestor
92469764|NCT01816646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469765|NCT01816646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469766|NCT01816659|Metformin|metformin|mesh-list
92469767|NCT01816659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92469768|NCT01816659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469769|NCT01816789|Buserelin|buserelin|mesh-list
92469770|NCT01816789|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92469771|NCT01816789|Fertility Agents|fertility agents|mesh-ancestor
92469772|NCT01816789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92469773|NCT01816789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469774|NCT01816958|Ketamine|ketamine|mesh-list
92469775|NCT01816958|Analgesics|analgesics|mesh-ancestor
92348619|NCT01529346|Ibuprofen|ibuprofen|mesh-list
92469776|NCT01816958|Sensory System Agents|sensory system agents|mesh-ancestor
92469777|NCT01816958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469778|NCT01816958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469779|NCT01816958|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92469780|NCT01816958|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92469781|NCT01816958|Anesthetics, General|anesthetics, general|mesh-ancestor
92469782|NCT01816958|Anesthetics|anesthetics|mesh-ancestor
92469783|NCT01816958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469784|NCT01816958|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92469785|NCT01816958|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92469786|NCT01816958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469787|NCT01816958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469788|NCT01816997|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92469789|NCT01816997|Pravastatin|pravastatin|mesh-list
92469790|NCT01816997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92469791|NCT01816997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92469792|NCT01816997|Antimetabolites|antimetabolites|mesh-ancestor
92469793|NCT01816997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469794|NCT01816997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92469795|NCT01816997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92469796|NCT01816997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469797|NCT01817023|Cisplatin|cisplatin|mesh-list
92469798|NCT01817023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469799|NCT01817036|Vitamin D|vitamin d|mesh-list
92469800|NCT01817036|Vitamins|vitamins|mesh-ancestor
92469801|NCT01817036|Micronutrients|micronutrients|mesh-ancestor
92469802|NCT01817036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469803|NCT01817036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92469804|NCT01817153|Hydrocortisone|hydrocortisone|mesh-list
92469805|NCT01817153|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92469806|NCT01817153|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92469807|NCT01817153|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92469808|NCT01817153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469809|NCT01817218|Anti-Infective Agents|anti-infective agents|mesh-list
92469810|NCT01817218|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92469812|NCT01817257|Enoxaparin|enoxaparin|mesh-list
92469813|NCT01817257|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92469814|NCT01817257|Tinzaparin|tinzaparin|mesh-list
92469815|NCT01817257|Dalteparin|dalteparin|mesh-list
92469816|NCT01817257|Anticoagulants|anticoagulants|mesh-ancestor
92469817|NCT01817257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92469818|NCT01817257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92469819|NCT01817257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469820|NCT01817283|Triptolide|triptolide|mesh-list
92469821|NCT01817283|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92469822|NCT01817283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469823|NCT01817283|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92469824|NCT01817283|Contraceptive Agents|contraceptive agents|mesh-ancestor
92469825|NCT01817283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92469826|NCT01817283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469827|NCT01817283|Immunologic Factors|immunologic factors|mesh-ancestor
92469828|NCT01817283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92469829|NCT01817283|Alkylating Agents|alkylating agents|mesh-ancestor
92469830|NCT01817283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469831|NCT01817283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469832|NCT01817322|Mycophenolic Acid|mycophenolic acid|mesh-list
92469834|NCT01817322|Prednisolone|prednisolone|mesh-list
92469835|NCT01817322|Deflazacort|deflazacort|mesh-list
92469836|NCT01817322|Basiliximab|basiliximab|mesh-list
92469837|NCT01817322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469838|NCT01817322|Antiemetics|antiemetics|mesh-ancestor
92469839|NCT01817322|Autonomic Agents|autonomic agents|mesh-ancestor
92469840|NCT01817322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469841|NCT01817322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469842|NCT01817322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92469843|NCT01817322|Glucocorticoids|glucocorticoids|mesh-ancestor
92469844|NCT01817322|Hormones|hormones|mesh-ancestor
92469845|NCT01817322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469846|NCT01817322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92469847|NCT01817322|Protective Agents|protective agents|mesh-ancestor
92469848|NCT01817322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92469849|NCT01817322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469850|NCT01817322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92469851|NCT01817322|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92469852|NCT01817322|Antitubercular Agents|antitubercular agents|mesh-ancestor
92469853|NCT01817322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92469854|NCT01817322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469855|NCT01817322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469856|NCT01817322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469857|NCT01817322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469858|NCT01817322|Immunologic Factors|immunologic factors|mesh-ancestor
92469859|NCT01817348|Lidocaine|lidocaine|mesh-list
92469860|NCT01817348|Anesthetics, Local|anesthetics, local|mesh-ancestor
92469861|NCT01817348|Anesthetics|anesthetics|mesh-ancestor
92469862|NCT01817348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92469863|NCT01817348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469864|NCT01817348|Sensory System Agents|sensory system agents|mesh-ancestor
92469865|NCT01817348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469866|NCT01817348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92469867|NCT01817348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92469868|NCT01817348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92469869|NCT01817348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469870|NCT01817348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469871|NCT01817400|Aspirin|aspirin|mesh-list
92469872|NCT01817400|Pioglitazone|pioglitazone|mesh-list
92469873|NCT01817400|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92469874|NCT01817400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92469875|NCT01817400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469876|NCT01817400|Analgesics|analgesics|mesh-ancestor
92469877|NCT01817400|Sensory System Agents|sensory system agents|mesh-ancestor
92469878|NCT01817400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469879|NCT01817400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469880|NCT01817400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469881|NCT01817400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469882|NCT01817400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92469883|NCT01817400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92469884|NCT01817400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469885|NCT01817400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92469886|NCT01817400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92469887|NCT01817400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469888|NCT01817400|Antipyretics|antipyretics|mesh-ancestor
92469889|NCT01817400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92469890|NCT01817400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92469891|NCT01817439|Amiodarone|amiodarone|mesh-list
92469892|NCT01817439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92469893|NCT01817439|Vasodilator Agents|vasodilator agents|mesh-ancestor
92469894|NCT01817439|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92469895|NCT01817439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469896|NCT01817439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469897|NCT01817439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92469898|NCT01817439|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92469899|NCT01817439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92469900|NCT01817439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469901|NCT01817439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92469902|NCT01817439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92469903|NCT01817439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92469904|NCT01817699|Vitamin D|vitamin d|mesh-list
92469905|NCT01817699|Cholecalciferol|cholecalciferol|mesh-list
92469906|NCT01817699|Vitamins|vitamins|mesh-ancestor
92469907|NCT01817699|Micronutrients|micronutrients|mesh-ancestor
92469908|NCT01817699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469909|NCT01817699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92469910|NCT01817699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92469911|NCT01817803|Metolazone|metolazone|mesh-list
92469912|NCT01817803|Furosemide|furosemide|mesh-list
92194830|NCT04147286|Atorvastatin|atorvastatin|mesh-list
92469913|NCT01817803|Spironolactone|spironolactone|mesh-list
92469914|NCT01817803|Diuretics|diuretics|mesh-ancestor
92469915|NCT01817803|Natriuretic Agents|natriuretic agents|mesh-ancestor
92469916|NCT01817803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469917|NCT01817803|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92469918|NCT01817803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469919|NCT01817803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469920|NCT01817803|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92469921|NCT01817803|Hormone Antagonists|hormone antagonists|mesh-ancestor
92469922|NCT01817803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92469923|NCT01817803|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92469924|NCT01817803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92469925|NCT01817803|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92469926|NCT01817816|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92469927|NCT01817816|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92469928|NCT01817816|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92469929|NCT01817816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469930|NCT01817816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469931|NCT01817816|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92469932|NCT01817816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92469933|NCT01817816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469934|NCT01817816|Cholinergic Agents|cholinergic agents|mesh-ancestor
92469935|NCT01817816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469936|NCT01817829|Acetaminophen|acetaminophen|mesh-list
92469937|NCT01817829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92469938|NCT01817829|Analgesics|analgesics|mesh-ancestor
92469939|NCT01817829|Sensory System Agents|sensory system agents|mesh-ancestor
92469940|NCT01817829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92469941|NCT01817829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469942|NCT01817829|Antipyretics|antipyretics|mesh-ancestor
92469943|NCT01817868|Factor VIII|factor viii|mesh-list
92469944|NCT01817868|Coagulants|coagulants|mesh-ancestor
92469945|NCT01817894|Eflornithine|eflornithine|mesh-list
92469946|NCT01817894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469947|NCT01817894|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92469948|NCT01817894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92469949|NCT01817894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92469950|NCT01817894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469951|NCT01817894|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92469952|NCT01817894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469953|NCT01817894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469954|NCT01817972|Certolizumab Pegol|certolizumab pegol|mesh-list
92469955|NCT01817972|Azathioprine|azathioprine|mesh-list
92469956|NCT01817972|Antimetabolites|antimetabolites|mesh-ancestor
92469957|NCT01817972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469958|NCT01817972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92469959|NCT01817972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469960|NCT01817972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92469961|NCT01817972|Immunologic Factors|immunologic factors|mesh-ancestor
92469962|NCT01817972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469963|NCT01817972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92469964|NCT01817972|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92469965|NCT01817972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92469966|NCT01817985|Velpatasvir|velpatasvir|mesh-list
92469967|NCT01817985|Antiviral Agents|antiviral agents|mesh-ancestor
92469968|NCT01817985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92469969|NCT01818024|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92469970|NCT01818024|Immunologic Factors|immunologic factors|mesh-ancestor
92469971|NCT01818024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469972|NCT01818232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92469973|NCT01818232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92469974|NCT01818232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469976|NCT01818232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469977|NCT01818648|Exenatide|exenatide|mesh-list
92469978|NCT01818648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92469979|NCT01818648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469980|NCT01818648|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92469981|NCT01818648|Incretins|incretins|mesh-ancestor
92469982|NCT01818648|Hormones|hormones|mesh-ancestor
92469983|NCT01818648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194898|NCT00550589|Cidofovir|cidofovir|mesh-list
92469984|NCT01818713|Doxorubicin|doxorubicin|mesh-list
92469985|NCT01818713|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92469986|NCT01818713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92469987|NCT01818713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92469988|NCT01818713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92469989|NCT01818713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92469990|NCT01818713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92469991|NCT01818713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469992|NCT01818843|Carbon Monoxide|carbon monoxide|mesh-list
92469993|NCT01818843|Antimetabolites|antimetabolites|mesh-ancestor
92469994|NCT01818843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92469995|NCT01818843|Gasotransmitters|gasotransmitters|mesh-ancestor
92469996|NCT01818843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92469997|NCT01818843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92469998|NCT01818856|Ritonavir|ritonavir|mesh-list
92469999|NCT01818856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92470000|NCT01818856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92470001|NCT01818856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92470002|NCT01818856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92470003|NCT01818856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470004|NCT01818856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470005|NCT01818856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92470006|NCT01818856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92470007|NCT01818856|Antiviral Agents|antiviral agents|mesh-ancestor
92470008|NCT01818856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470009|NCT01818856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92470010|NCT01818856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92470011|NCT01818869|Adenosine|adenosine|mesh-list
92470012|NCT01818869|Analgesics|analgesics|mesh-ancestor
92470013|NCT01818869|Sensory System Agents|sensory system agents|mesh-ancestor
92470014|NCT01818869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470015|NCT01818869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470016|NCT01818869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92470017|NCT01818869|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470018|NCT01818869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92470019|NCT01818869|Purinergic Agonists|purinergic agonists|mesh-ancestor
92470020|NCT01818869|Purinergic Agents|purinergic agents|mesh-ancestor
92470021|NCT01818869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470022|NCT01818869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470023|NCT01818908|Prednisone|prednisone|mesh-list
92470024|NCT01818908|Cyclophosphamide|cyclophosphamide|mesh-list
92470025|NCT01818908|Doxorubicin|doxorubicin|mesh-list
92470026|NCT01818908|Etoposide|etoposide|mesh-list
92470027|NCT01818908|Vincristine|vincristine|mesh-list
92470028|NCT01818908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92470029|NCT01818908|Immunologic Factors|immunologic factors|mesh-ancestor
92470030|NCT01818908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470031|NCT01818908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92470032|NCT01818908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92470033|NCT01818908|Alkylating Agents|alkylating agents|mesh-ancestor
92470034|NCT01818908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470035|NCT01818908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470036|NCT01818908|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92470037|NCT01818908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92470038|NCT01818908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92470039|NCT01818908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92470040|NCT01818908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470041|NCT01818908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92470042|NCT01818908|Glucocorticoids|glucocorticoids|mesh-ancestor
92470043|NCT01818908|Hormones|hormones|mesh-ancestor
92470044|NCT01818908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470045|NCT01818908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92470046|NCT01818908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92470047|NCT01818908|Tubulin Modulators|tubulin modulators|mesh-ancestor
92470048|NCT01818908|Antimitotic Agents|antimitotic agents|mesh-ancestor
92470049|NCT01818908|Mitosis Modulators|mitosis modulators|mesh-ancestor
92470050|NCT01818973|Bevacizumab|bevacizumab|mesh-list
92470051|NCT01818973|Capecitabine|capecitabine|mesh-list
92470052|NCT01818973|Oxaliplatin|oxaliplatin|mesh-list
92470053|NCT01818973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92470054|NCT01818973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470055|NCT01818973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92470056|NCT01818973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92470057|NCT01818973|Growth Substances|growth substances|mesh-ancestor
92470058|NCT01818973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470060|NCT01818973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92470061|NCT01818973|Antimetabolites|antimetabolites|mesh-ancestor
92470062|NCT01818973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470063|NCT01819012|Isoflurane|isoflurane|mesh-list
92470064|NCT01819012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92470065|NCT01819012|Anesthetics, General|anesthetics, general|mesh-ancestor
92470066|NCT01819012|Anesthetics|anesthetics|mesh-ancestor
92470067|NCT01819012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470068|NCT01819012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470069|NCT01819051|Anti-Infective Agents|anti-infective agents|mesh-list
92470070|NCT01819051|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92470071|NCT01819155|Vaccines|vaccines|mesh-list
92470072|NCT01819155|Immunologic Factors|immunologic factors|mesh-ancestor
92470073|NCT01819155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470074|NCT01819220|Amlodipine|amlodipine|mesh-list
92470075|NCT01819220|Valsartan|valsartan|mesh-list
92470076|NCT01819220|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92470077|NCT01819220|Telmisartan|telmisartan|mesh-list
92470078|NCT01819220|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92470079|NCT01819220|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92470080|NCT01819220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470081|NCT01819220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470082|NCT01819220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470083|NCT01819220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470084|NCT01819220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470085|NCT01819220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470086|NCT01819220|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470087|NCT01819220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92470088|NCT01819220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92470089|NCT01819220|Diuretics|diuretics|mesh-ancestor
92470090|NCT01819220|Natriuretic Agents|natriuretic agents|mesh-ancestor
92470091|NCT01819220|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92470092|NCT01819259|Nicotine|nicotine|mesh-list
92470093|NCT01819259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92470094|NCT01819259|Autonomic Agents|autonomic agents|mesh-ancestor
92470095|NCT01819259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470096|NCT01819259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470097|NCT01819259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92470098|NCT01819259|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92470099|NCT01819259|Cholinergic Agents|cholinergic agents|mesh-ancestor
92470100|NCT01819259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470101|NCT01819259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470102|NCT01819285|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92470103|NCT01819285|Hormones|hormones|mesh-ancestor
92470104|NCT01819285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470105|NCT01819285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470106|NCT01819389|Imatinib Mesylate|imatinib mesylate|mesh-list
92470107|NCT01819389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470108|NCT01819389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92470109|NCT01819389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470110|NCT01819389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470111|NCT01819402|Pioglitazone|pioglitazone|mesh-list
92470112|NCT01819402|Glimepiride|glimepiride|mesh-list
92470113|NCT01819402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92470114|NCT01819402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470115|NCT01819402|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92470116|NCT01819402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92470117|NCT01819402|Immunologic Factors|immunologic factors|mesh-ancestor
92470118|NCT01819441|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92470119|NCT01819441|Perindopril|perindopril|mesh-list
92470120|NCT01819441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470121|NCT01819441|Diuretics|diuretics|mesh-ancestor
92470122|NCT01819441|Natriuretic Agents|natriuretic agents|mesh-ancestor
92470123|NCT01819441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470124|NCT01819441|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92470125|NCT01819441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470126|NCT01819441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470127|NCT01819441|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92470128|NCT01819441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92470129|NCT01819441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470130|NCT01819610|Ketorolac|ketorolac|mesh-list
92195046|NCT03919292|Valproic Acid|valproic acid|mesh-list
92470131|NCT01819610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92470132|NCT01819610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92470133|NCT01819610|Analgesics|analgesics|mesh-ancestor
92470134|NCT01819610|Sensory System Agents|sensory system agents|mesh-ancestor
92470135|NCT01819610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470136|NCT01819610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470137|NCT01819610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92470138|NCT01819610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92470139|NCT01819610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92470140|NCT01819610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470141|NCT01819610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470142|NCT01819649|Selenium|selenium|mesh-list
92470143|NCT01819649|Antioxidants|antioxidants|mesh-ancestor
92470144|NCT01819649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470145|NCT01819649|Protective Agents|protective agents|mesh-ancestor
92470146|NCT01819649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470147|NCT01819649|Trace Elements|trace elements|mesh-ancestor
92470148|NCT01819649|Micronutrients|micronutrients|mesh-ancestor
92470149|NCT01819701|Ubiquinone|ubiquinone|mesh-list
92470150|NCT01819701|Coenzyme Q10|coenzyme q10|mesh-list
92470151|NCT01819701|Micronutrients|micronutrients|mesh-ancestor
92470152|NCT01819701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470153|NCT01819701|Vitamins|vitamins|mesh-ancestor
92470154|NCT01819779|Amlodipine|amlodipine|mesh-list
92470155|NCT01819779|Valsartan|valsartan|mesh-list
92470156|NCT01819779|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92470157|NCT01819779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470158|NCT01819779|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470159|NCT01819779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470160|NCT01819779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470161|NCT01819779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470162|NCT01819779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470163|NCT01819779|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470164|NCT01819779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92470165|NCT01819779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92470166|NCT01819857|Ondansetron|ondansetron|mesh-list
92470167|NCT01819857|Antiemetics|antiemetics|mesh-ancestor
92470168|NCT01819857|Autonomic Agents|autonomic agents|mesh-ancestor
92470169|NCT01819857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470170|NCT01819857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470171|NCT01819857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470172|NCT01819857|Antipruritics|antipruritics|mesh-ancestor
92470173|NCT01819857|Dermatologic Agents|dermatologic agents|mesh-ancestor
92470174|NCT01819857|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92470175|NCT01819857|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92470176|NCT01819857|Serotonin Agents|serotonin agents|mesh-ancestor
92470177|NCT01819857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470178|NCT01819857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470179|NCT01819870|Carvedilol|carvedilol|mesh-list
92470180|NCT01819870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92470181|NCT01819870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92470182|NCT01819870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92470183|NCT01819870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470184|NCT01819870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470185|NCT01819870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470186|NCT01819870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470187|NCT01819870|Antioxidants|antioxidants|mesh-ancestor
92470188|NCT01819870|Protective Agents|protective agents|mesh-ancestor
92470189|NCT01819870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470190|NCT01819870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470191|NCT01819870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470192|NCT01819870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92531717|NCT00047827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470193|NCT01819870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92470194|NCT01819870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92470195|NCT01819961|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92470196|NCT01819961|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92470197|NCT01819961|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92470198|NCT01819961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92470199|NCT01820026|Amoxicillin|amoxicillin|mesh-list
92470200|NCT01820026|Azithromycin|azithromycin|mesh-list
92470201|NCT01820026|Vancomycin|vancomycin|mesh-list
92470202|NCT01820026|Imipenem|imipenem|mesh-list
92470203|NCT01820026|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92195117|NCT04142840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92470205|NCT01820026|Cefoxitin|cefoxitin|mesh-list
92470206|NCT01820026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470207|NCT01820026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470208|NCT01820026|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92470209|NCT01820026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470210|NCT01820026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470211|NCT01820091|Levoleucovorin|levoleucovorin|mesh-list
92470212|NCT01820091|Antidotes|antidotes|mesh-ancestor
92470213|NCT01820091|Protective Agents|protective agents|mesh-ancestor
92470214|NCT01820091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470215|NCT01820104|Lansoprazole|lansoprazole|mesh-list
92470216|NCT01820104|Dexlansoprazole|dexlansoprazole|mesh-list
92470217|NCT01820104|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92470218|NCT01820104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470219|NCT01820104|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92470220|NCT01820104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470221|NCT01820104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470222|NCT01820143|Esomeprazole|esomeprazole|mesh-list
92470223|NCT01820143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92470224|NCT01820143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470225|NCT01820143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92470226|NCT01820143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470227|NCT01820143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470228|NCT01820299|Vitamin D|vitamin d|mesh-list
92470229|NCT01820299|Grape Seed Extract|grape seed extract|mesh-list
92470230|NCT01820299|Vitamins|vitamins|mesh-ancestor
92470231|NCT01820299|Micronutrients|micronutrients|mesh-ancestor
92470232|NCT01820299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470233|NCT01820299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92470234|NCT01820299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92470235|NCT01820299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470236|NCT01820299|Antioxidants|antioxidants|mesh-ancestor
92470237|NCT01820299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470238|NCT01820299|Protective Agents|protective agents|mesh-ancestor
92470239|NCT01820312|Paclitaxel|paclitaxel|mesh-list
92470240|NCT01820312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92470241|NCT01820312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470242|NCT01820312|Tubulin Modulators|tubulin modulators|mesh-ancestor
92470243|NCT01820312|Antimitotic Agents|antimitotic agents|mesh-ancestor
92470244|NCT01820312|Mitosis Modulators|mitosis modulators|mesh-ancestor
92470245|NCT01820312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470246|NCT01820325|Paclitaxel|paclitaxel|mesh-list
92470247|NCT01820325|Carboplatin|carboplatin|mesh-list
92470248|NCT01820325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92470249|NCT01820325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470250|NCT01820325|Tubulin Modulators|tubulin modulators|mesh-ancestor
92470251|NCT01820325|Antimitotic Agents|antimitotic agents|mesh-ancestor
92470252|NCT01820325|Mitosis Modulators|mitosis modulators|mesh-ancestor
92470253|NCT01820325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470255|NCT01820442|Clonidine|clonidine|mesh-list
92470256|NCT01820442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470257|NCT01820442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92470258|NCT01820442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470259|NCT01820442|Sensory System Agents|sensory system agents|mesh-ancestor
92470260|NCT01820442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470261|NCT01820442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92470262|NCT01820442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92470263|NCT01820442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92470264|NCT01820442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92470265|NCT01820442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470266|NCT01820442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470267|NCT01820442|Analgesics|analgesics|mesh-ancestor
92470268|NCT01820442|Sympatholytics|sympatholytics|mesh-ancestor
92470269|NCT01820442|Autonomic Agents|autonomic agents|mesh-ancestor
92470270|NCT01820455|Chlorhexidine|chlorhexidine|mesh-list
92470271|NCT01820455|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92470272|NCT01820455|Mupirocin|mupirocin|mesh-list
92470273|NCT01820455|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92470274|NCT01820455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470275|NCT01820455|Disinfectants|disinfectants|mesh-ancestor
92470276|NCT01820455|Dermatologic Agents|dermatologic agents|mesh-ancestor
92470277|NCT01820455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470278|NCT01820455|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92470279|NCT01820455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470280|NCT01820455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470281|NCT01820624|Tretinoin|tretinoin|mesh-list
92470282|NCT01820624|Lithium Carbonate|lithium carbonate|mesh-list
92470283|NCT01820624|Antidepressive Agents|antidepressive agents|mesh-ancestor
92470284|NCT01820624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92470285|NCT01820624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470286|NCT01820624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470287|NCT01820624|Antimanic Agents|antimanic agents|mesh-ancestor
92470288|NCT01820624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92470289|NCT01820624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470290|NCT01820624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470291|NCT01820624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470292|NCT01820624|Keratolytic Agents|keratolytic agents|mesh-ancestor
92470293|NCT01820624|Dermatologic Agents|dermatologic agents|mesh-ancestor
92470294|NCT01820767|Ergocalciferols|ergocalciferols|mesh-list
92470295|NCT01820767|Atorvastatin|atorvastatin|mesh-list
92470296|NCT01820767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92470297|NCT01820767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92470298|NCT01820767|Antimetabolites|antimetabolites|mesh-ancestor
92470299|NCT01820767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470300|NCT01820767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92470301|NCT01820767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92470302|NCT01820767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470303|NCT01820767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470304|NCT01820767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470305|NCT01820767|Vitamins|vitamins|mesh-ancestor
92470306|NCT01820767|Micronutrients|micronutrients|mesh-ancestor
92470307|NCT01820767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92470308|NCT01820793|Cefoxitin|cefoxitin|mesh-list
92470309|NCT01820793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470310|NCT01820793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470311|NCT01820832|Cholecalciferol|cholecalciferol|mesh-list
92470312|NCT01820832|Calcitriol|calcitriol|mesh-list
92470313|NCT01820832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470314|NCT01820832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470315|NCT01820832|Vitamins|vitamins|mesh-ancestor
92470316|NCT01820832|Micronutrients|micronutrients|mesh-ancestor
92470317|NCT01820832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92470318|NCT01820832|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92470319|NCT01820832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470320|NCT01820832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470321|NCT01820832|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92470323|NCT01820897|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92470324|NCT01820897|Sulfamethoxazole|sulfamethoxazole|mesh-list
92470325|NCT01820897|Fosfomycin|fosfomycin|mesh-list
92470326|NCT01820897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92470327|NCT01820897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470328|NCT01820897|Antimalarials|antimalarials|mesh-ancestor
92470329|NCT01820897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92470330|NCT01820897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92470331|NCT01820897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92470332|NCT01820897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470333|NCT01820897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470334|NCT01820897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92470335|NCT01820897|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92470336|NCT01820897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92470337|NCT01820897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470338|NCT01820962|Heparin|heparin|mesh-list
92470339|NCT01820962|Anticoagulants|anticoagulants|mesh-ancestor
92470340|NCT01820962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470341|NCT01820962|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92470342|NCT01820962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92470343|NCT01821001|Bromocriptine|bromocriptine|mesh-list
92470344|NCT01821001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92470345|NCT01821001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92470346|NCT01821001|Hormone Antagonists|hormone antagonists|mesh-ancestor
92470347|NCT01821001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470348|NCT01821001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470349|NCT01821001|Dopamine Agonists|dopamine agonists|mesh-ancestor
92470350|NCT01821001|Dopamine Agents|dopamine agents|mesh-ancestor
92470351|NCT01821001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470352|NCT01821001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195269|NCT00609739|Hormones|hormones|mesh-ancestor
92470353|NCT01821027|Canagliflozin|canagliflozin|mesh-list
92470354|NCT01821027|Simvastatin|simvastatin|mesh-list
92470355|NCT01821027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92470356|NCT01821027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92470357|NCT01821027|Antimetabolites|antimetabolites|mesh-ancestor
92470358|NCT01821027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470359|NCT01821027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92470360|NCT01821027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92470361|NCT01821027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470362|NCT01821027|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92470363|NCT01821027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92470364|NCT01821027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470365|NCT01821040|Prednisone|prednisone|mesh-list
92470366|NCT01821040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92470367|NCT01821040|Glucocorticoids|glucocorticoids|mesh-ancestor
92470368|NCT01821040|Hormones|hormones|mesh-ancestor
92470369|NCT01821040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470370|NCT01821040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470371|NCT01821040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92470372|NCT01821040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470373|NCT01821066|Tamoxifen|tamoxifen|mesh-list
92470374|NCT01821066|Palbociclib|palbociclib|mesh-list
92470375|NCT01821066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92470376|NCT01821066|Hormone Antagonists|hormone antagonists|mesh-ancestor
92470377|NCT01821066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470378|NCT01821066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470379|NCT01821066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92470380|NCT01821066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470381|NCT01821066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92470382|NCT01821066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92470383|NCT01821066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92470384|NCT01821066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92470385|NCT01821066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470386|NCT01821066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470387|NCT01821170|Methylphenidate|methylphenidate|mesh-list
92470388|NCT01821170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92470389|NCT01821170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470390|NCT01821170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92470391|NCT01821170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92470392|NCT01821170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470393|NCT01821170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470394|NCT01821170|Dopamine Agents|dopamine agents|mesh-ancestor
92470395|NCT01821170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470397|NCT01821235|Analgesics|analgesics|mesh-ancestor
92470398|NCT01821235|Sensory System Agents|sensory system agents|mesh-ancestor
92470399|NCT01821235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470400|NCT01821235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470401|NCT01821235|Anticonvulsants|anticonvulsants|mesh-ancestor
92470402|NCT01821235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92470403|NCT01821235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92470404|NCT01821235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470405|NCT01821235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92470406|NCT01821235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92348651|NCT01528254|Vildagliptin|vildagliptin|mesh-list
92470407|NCT01821235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92470408|NCT01821235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470409|NCT01821235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470410|NCT01821235|Antimanic Agents|antimanic agents|mesh-ancestor
92470411|NCT01821248|Cisplatin|cisplatin|mesh-list
92470412|NCT01821248|Gemcitabine|gemcitabine|mesh-list
92470413|NCT01821248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470414|NCT01821248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92470415|NCT01821248|Antimetabolites|antimetabolites|mesh-ancestor
92470416|NCT01821248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470417|NCT01821261|Chlorhexidine|chlorhexidine|mesh-list
92470418|NCT01821261|Fluorides|fluorides|mesh-list
92470419|NCT01821261|Cariostatic Agents|cariostatic agents|mesh-ancestor
92470420|NCT01821261|Protective Agents|protective agents|mesh-ancestor
92470421|NCT01821261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470422|NCT01821261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92470423|NCT01821261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470424|NCT01821261|Disinfectants|disinfectants|mesh-ancestor
92470425|NCT01821274|Diltiazem|diltiazem|mesh-list
92470426|NCT01821274|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470427|NCT01821274|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470428|NCT01821274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470429|NCT01821274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470430|NCT01821274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470431|NCT01821274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470432|NCT01821274|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470433|NCT01821404|Atorvastatin|atorvastatin|mesh-list
92470434|NCT01821404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92470435|NCT01821404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92470436|NCT01821404|Antimetabolites|antimetabolites|mesh-ancestor
92470437|NCT01821404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470438|NCT01821404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92470439|NCT01821404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92470440|NCT01821404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470441|NCT01821430|Pregabalin|pregabalin|mesh-list
92470442|NCT01821430|Analgesics|analgesics|mesh-ancestor
92470443|NCT01821430|Sensory System Agents|sensory system agents|mesh-ancestor
92470444|NCT01821430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470445|NCT01821430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470446|NCT01821430|Anticonvulsants|anticonvulsants|mesh-ancestor
92470447|NCT01821430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470448|NCT01821430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470449|NCT01821430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470450|NCT01821430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470451|NCT01821430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92470452|NCT01821430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92470453|NCT01821430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470454|NCT01821430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92470455|NCT01821456|Antiviral Agents|antiviral agents|mesh-list
92470456|NCT01821456|Anti-Infective Agents|anti-infective agents|mesh-list
92470457|NCT01821573|Botulinum Toxins|botulinum toxins|mesh-list
92470458|NCT01821573|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92470459|NCT01821573|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92470460|NCT01821573|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92470461|NCT01821573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470462|NCT01821573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470463|NCT01821573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92470464|NCT01821573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470465|NCT01821573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470466|NCT01821573|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92470467|NCT01821573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470468|NCT01821612|Leucovorin|leucovorin|mesh-list
92470469|NCT01821612|Gemcitabine|gemcitabine|mesh-list
92470470|NCT01821612|Fluorouracil|fluorouracil|mesh-list
92470471|NCT01821612|Capecitabine|capecitabine|mesh-list
92470472|NCT01821612|Oxaliplatin|oxaliplatin|mesh-list
92470473|NCT01821612|Irinotecan|irinotecan|mesh-list
92470474|NCT01821612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92470475|NCT01821612|Antimetabolites|antimetabolites|mesh-ancestor
92470476|NCT01821612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470477|NCT01821612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470478|NCT01821612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92470479|NCT01821612|Immunologic Factors|immunologic factors|mesh-ancestor
92470480|NCT01821612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470481|NCT01821612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92470482|NCT01821612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92470483|NCT01821612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470485|NCT01821612|Protective Agents|protective agents|mesh-ancestor
92470486|NCT01821612|Vitamin B Complex|vitamin b complex|mesh-ancestor
92470487|NCT01821612|Vitamins|vitamins|mesh-ancestor
92470488|NCT01821612|Micronutrients|micronutrients|mesh-ancestor
92470489|NCT01821664|Heparin|heparin|mesh-list
92470490|NCT01821664|Anticoagulants|anticoagulants|mesh-ancestor
92470491|NCT01821664|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92470492|NCT01821664|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92470493|NCT01821664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470494|NCT01821703|Spironolactone|spironolactone|mesh-list
92470495|NCT01821703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92470496|NCT01821703|Hormone Antagonists|hormone antagonists|mesh-ancestor
92470497|NCT01821703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470498|NCT01821703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470499|NCT01821703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92470500|NCT01821703|Diuretics|diuretics|mesh-ancestor
92470501|NCT01821703|Natriuretic Agents|natriuretic agents|mesh-ancestor
92470502|NCT01821846|Liraglutide|liraglutide|mesh-list
92470503|NCT01821846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92470504|NCT01821846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470505|NCT01821846|Incretins|incretins|mesh-ancestor
92470506|NCT01821846|Hormones|hormones|mesh-ancestor
92470507|NCT01821846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470508|NCT01821872|Acetaminophen|acetaminophen|mesh-list
92470509|NCT01821872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92470510|NCT01821872|Analgesics|analgesics|mesh-ancestor
92470511|NCT01821872|Sensory System Agents|sensory system agents|mesh-ancestor
92470512|NCT01821872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470513|NCT01821872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470514|NCT01821872|Antipyretics|antipyretics|mesh-ancestor
92470515|NCT01821989|Lactoferrin|lactoferrin|mesh-list
92470516|NCT01821989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470517|NCT01822028|Miglustat|miglustat|mesh-list
92470518|NCT01822028|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
92470519|NCT01822028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470520|NCT01822028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470521|NCT01822028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92470522|NCT01822028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92470523|NCT01822028|Antiviral Agents|antiviral agents|mesh-ancestor
92470524|NCT01822028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470525|NCT01822028|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92470526|NCT01822028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92470527|NCT01822028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470528|NCT01822080|Dienogest|dienogest|mesh-list
92470529|NCT01822080|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92470530|NCT01822080|Contraceptive Agents|contraceptive agents|mesh-ancestor
92470531|NCT01822080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92470532|NCT01822080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470533|NCT01822080|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92470534|NCT01822080|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92470535|NCT01822080|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92470536|NCT01822080|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92470537|NCT01822080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92470538|NCT01822080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470539|NCT01822080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92470540|NCT01822080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470541|NCT01822210|Botulinum Toxins|botulinum toxins|mesh-list
92470542|NCT01822210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92470543|NCT01822210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470544|NCT01822210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470545|NCT01822210|Cholinergic Agents|cholinergic agents|mesh-ancestor
92470546|NCT01822210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470547|NCT01822210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470548|NCT01822405|Tocopherols|tocopherols|mesh-list
92470550|NCT01822405|Tocotrienols|tocotrienols|mesh-list
92470551|NCT01822405|alpha-Tocopherol|alpha-tocopherol|mesh-list
92470552|NCT01822405|Pentoxifylline|pentoxifylline|mesh-list
92470553|NCT01822405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92470554|NCT01822405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470555|NCT01822405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470556|NCT01822405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92531725|NCT00048139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470557|NCT01822405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92470558|NCT01822405|Protective Agents|protective agents|mesh-ancestor
92470559|NCT01822405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470560|NCT01822405|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470561|NCT01822405|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92470563|NCT01822405|Vitamins|vitamins|mesh-ancestor
92470564|NCT01822405|Micronutrients|micronutrients|mesh-ancestor
92470565|NCT01822418|Agomelatine|agomelatine|mesh-list
92470566|NCT01822418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92470567|NCT01822418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470568|NCT01822418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470569|NCT01822431|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92470570|NCT01822431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470571|NCT01822431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470572|NCT01822431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470573|NCT01822431|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92470574|NCT01822483|Mycophenolic Acid|mycophenolic acid|mesh-list
92470575|NCT01822483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92470576|NCT01822483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470577|NCT01822483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92470578|NCT01822483|Antitubercular Agents|antitubercular agents|mesh-ancestor
92470579|NCT01822483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470580|NCT01822483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470581|NCT01822483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470582|NCT01822483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470583|NCT01822600|Omeprazole|omeprazole|mesh-list
92470584|NCT01822600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92470585|NCT01822600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470586|NCT01822600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92470587|NCT01822600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470588|NCT01822600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470589|NCT01822613|Paclitaxel|paclitaxel|mesh-list
92470590|NCT01822613|Docetaxel|docetaxel|mesh-list
92470591|NCT01822613|Irinotecan|irinotecan|mesh-list
92470592|NCT01822613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92470593|NCT01822613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470594|NCT01822613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92470595|NCT01822613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92470596|NCT01822613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92470597|NCT01822613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470598|NCT01822613|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92470599|NCT01822613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92470600|NCT01822613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470601|NCT01822639|Amlodipine|amlodipine|mesh-list
92470602|NCT01822639|Enalapril|enalapril|mesh-list
92470603|NCT01822639|Enalaprilat|enalaprilat|mesh-list
92470604|NCT01822639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470605|NCT01822639|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470606|NCT01822639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470607|NCT01822639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470608|NCT01822639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470609|NCT01822639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470610|NCT01822639|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470611|NCT01822639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470612|NCT01822639|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92470613|NCT01822639|Protease Inhibitors|protease inhibitors|mesh-ancestor
92470614|NCT01822730|Risperidone|risperidone|mesh-list
92470615|NCT01822730|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92470616|NCT01822730|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92470617|NCT01822730|Serotonin Agents|serotonin agents|mesh-ancestor
92470618|NCT01822730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470619|NCT01822730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470620|NCT01822730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470621|NCT01822730|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92470622|NCT01822730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92470623|NCT01822730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470624|NCT01822730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92470625|NCT01822730|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92470626|NCT01822730|Dopamine Agents|dopamine agents|mesh-ancestor
92470627|NCT01822730|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92470628|NCT01822730|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92470629|NCT01822808|Hydralazine|hydralazine|mesh-list
92470630|NCT01822808|Isosorbide|isosorbide|mesh-list
92470631|NCT01822808|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92470632|NCT01822808|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92470633|NCT01822808|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92470634|NCT01822808|Diuretics|diuretics|mesh-ancestor
92470635|NCT01822808|Natriuretic Agents|natriuretic agents|mesh-ancestor
92470636|NCT01822808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470637|NCT01822808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470638|NCT01822808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92470639|NCT01822808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470640|NCT01822808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470641|NCT01822860|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92470642|NCT01822860|Chlorthalidone|chlorthalidone|mesh-list
92470643|NCT01822860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92470644|NCT01822860|Diuretics|diuretics|mesh-ancestor
92470645|NCT01822860|Natriuretic Agents|natriuretic agents|mesh-ancestor
92470646|NCT01822860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470647|NCT01822860|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92470648|NCT01822860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470649|NCT01822860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470650|NCT01822951|Cerebrolysin|cerebrolysin|mesh-list
92470652|NCT01822951|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92470653|NCT01822951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470654|NCT01822951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470655|NCT01822951|Cholinergic Agents|cholinergic agents|mesh-ancestor
92470656|NCT01822951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470657|NCT01822951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470658|NCT01822951|Nootropic Agents|nootropic agents|mesh-ancestor
92470659|NCT01822951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92470660|NCT01822951|Protective Agents|protective agents|mesh-ancestor
92470661|NCT01822977|Omeprazole|omeprazole|mesh-list
92470662|NCT01822977|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92470663|NCT01822977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470664|NCT01822977|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92470665|NCT01822977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470666|NCT01822977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470667|NCT01823029|Epoetin Alfa|epoetin alfa|mesh-list
92470668|NCT01823029|Hematinics|hematinics|mesh-ancestor
92470669|NCT01822509|Nivolumab|nivolumab|mesh-list
92470670|NCT01822509|Ipilimumab|ipilimumab|mesh-list
92470671|NCT01822509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92470672|NCT01822509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470673|NCT01822509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92470674|NCT01822509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470675|NCT01823042|Azathioprine|azathioprine|mesh-list
92470676|NCT01823042|Antimetabolites|antimetabolites|mesh-ancestor
92470677|NCT01823042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470678|NCT01823042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92470679|NCT01823042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470680|NCT01823042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92470681|NCT01823042|Immunologic Factors|immunologic factors|mesh-ancestor
92470682|NCT01823042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470683|NCT01823042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92470684|NCT01823081|Bevacizumab|bevacizumab|mesh-list
92470685|NCT01823081|Fasudil|fasudil|mesh-list
92470686|NCT01823081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92470687|NCT01823081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470688|NCT01823081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92470689|NCT01823081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92470690|NCT01823081|Growth Substances|growth substances|mesh-ancestor
92470691|NCT01823081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470692|NCT01823081|Growth Inhibitors|growth inhibitors|mesh-ancestor
92470693|NCT01823081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92470694|NCT01823081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470695|NCT01823081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470696|NCT01823081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92470697|NCT01823081|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470698|NCT01823081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92470699|NCT01823081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470700|NCT01823133|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92470701|NCT01823133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92470702|NCT01823133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92470703|NCT01823133|Antimetabolites|antimetabolites|mesh-ancestor
92531727|NCT00048139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92470704|NCT01823133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470705|NCT01823133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92470706|NCT01823133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92470707|NCT01823133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470709|NCT01823159|Anticonvulsants|anticonvulsants|mesh-ancestor
92470710|NCT01823159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470711|NCT01823159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470712|NCT01823172|Methylene Blue|methylene blue|mesh-list
92470713|NCT01823172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470714|NCT01823172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470715|NCT01823185|Clopidogrel|clopidogrel|mesh-list
92470716|NCT01823185|Ticagrelor|ticagrelor|mesh-list
92470717|NCT01823185|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92470718|NCT01823185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92470719|NCT01823185|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92470720|NCT01823185|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92470721|NCT01823185|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92470722|NCT01823185|Purinergic Agents|purinergic agents|mesh-ancestor
92470723|NCT01823185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470724|NCT01823185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470725|NCT01823185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470726|NCT01823393|Heparin|heparin|mesh-list
92470727|NCT01823393|Calcium heparin|calcium heparin|mesh-list
92470728|NCT01823393|Anticoagulants|anticoagulants|mesh-ancestor
92470729|NCT01823393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92470730|NCT01823393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92470731|NCT01823393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470732|NCT01823523|Clindamycin|clindamycin|mesh-list
92470733|NCT01823523|Clindamycin palmitate|clindamycin palmitate|mesh-list
92470734|NCT01823523|Clindamycin phosphate|clindamycin phosphate|mesh-list
92470735|NCT01823523|Cefazolin|cefazolin|mesh-list
92470736|NCT01823523|Cephalexin|cephalexin|mesh-list
92470737|NCT01823523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470738|NCT01823523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470739|NCT01823523|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92470740|NCT01823523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470741|NCT01823523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470742|NCT01823744|Micronutrients|micronutrients|mesh-list
92470743|NCT01823744|Trace Elements|trace elements|mesh-list
92470744|NCT01823744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470745|NCT01823770|Rotigotine|rotigotine|mesh-list
92470746|NCT01823770|Dopamine Agonists|dopamine agonists|mesh-ancestor
92470747|NCT01823770|Dopamine Agents|dopamine agents|mesh-ancestor
92470748|NCT01823770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470749|NCT01823770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470750|NCT01823770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470751|NCT01823809|Adenosine|adenosine|mesh-list
92470752|NCT01823809|Analgesics|analgesics|mesh-ancestor
92470753|NCT01823809|Sensory System Agents|sensory system agents|mesh-ancestor
92470754|NCT01823809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470755|NCT01823809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470756|NCT01823809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92470757|NCT01823809|Vasodilator Agents|vasodilator agents|mesh-ancestor
92470758|NCT01823809|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92470759|NCT01823809|Purinergic Agonists|purinergic agonists|mesh-ancestor
92470760|NCT01823809|Purinergic Agents|purinergic agents|mesh-ancestor
92470761|NCT01823809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470762|NCT01823809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470763|NCT01823848|Mineral Oil|mineral oil|mesh-list
92470764|NCT01823848|Emollients|emollients|mesh-ancestor
92470765|NCT01823848|Dermatologic Agents|dermatologic agents|mesh-ancestor
92470766|NCT01823965|Ranibizumab|ranibizumab|mesh-list
92470767|NCT01823965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92470768|NCT01823965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92470769|NCT01823965|Growth Substances|growth substances|mesh-ancestor
92470770|NCT01823965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470771|NCT01823965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92470772|NCT01823965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470773|NCT01824056|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92470774|NCT01824056|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92470775|NCT01824056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470776|NCT01824199|Omeprazole|omeprazole|mesh-list
92531729|NCT00048334|Romidepsin|romidepsin|mesh-list
92470777|NCT01824199|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92470778|NCT01824199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470779|NCT01824199|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92470780|NCT01824199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470781|NCT01824199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470782|NCT01824225|Aflibercept|aflibercept|mesh-list
92470783|NCT01824225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92470784|NCT01824225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92470785|NCT01824225|Growth Substances|growth substances|mesh-ancestor
92470786|NCT01824225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470787|NCT01824225|Growth Inhibitors|growth inhibitors|mesh-ancestor
92470788|NCT01824225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470789|NCT01824238|Oxazolidinones|oxazolidinones|mesh-list
92470790|NCT01824238|Anacetrapib|anacetrapib|mesh-list
92470791|NCT01824238|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92470792|NCT01824238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92470793|NCT01824238|Antimetabolites|antimetabolites|mesh-ancestor
92470794|NCT01824238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470795|NCT01824238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92470796|NCT01824238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470797|NCT01824238|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92470798|NCT01824238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470799|NCT01824251|Immunoglobulins|immunoglobulins|mesh-list
92470800|NCT01824251|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92470801|NCT01824251|gamma-Globulins|gamma-globulins|mesh-list
92470802|NCT01824251|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92470803|NCT01824251|Immunologic Factors|immunologic factors|mesh-ancestor
92470804|NCT01824251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470805|NCT01824264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92470806|NCT01824264|Licogliflozin|licogliflozin|mesh-list
92470807|NCT01824264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92470808|NCT01824264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470809|NCT01824264|Incretins|incretins|mesh-ancestor
92470810|NCT01824264|Hormones|hormones|mesh-ancestor
92470811|NCT01824264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470812|NCT01824264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92470813|NCT01824264|Protease Inhibitors|protease inhibitors|mesh-ancestor
92470814|NCT01824264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470815|NCT01824264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470816|NCT01824264|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92470817|NCT01824420|Mandelic Acids|mandelic acids|mesh-list
92470818|NCT01824420|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92470819|NCT01824420|Oxybutynin|oxybutynin|mesh-list
92470820|NCT01824420|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92470821|NCT01824420|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92470822|NCT01824420|Cholinergic Agents|cholinergic agents|mesh-ancestor
92470823|NCT01824420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470824|NCT01824420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470825|NCT01824420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470826|NCT01824420|Urological Agents|urological agents|mesh-ancestor
92470827|NCT01824420|Parasympatholytics|parasympatholytics|mesh-ancestor
92470828|NCT01824420|Autonomic Agents|autonomic agents|mesh-ancestor
92470829|NCT01824420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470830|NCT01824420|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92470831|NCT01824420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470832|NCT01824433|Fluoxetine|fluoxetine|mesh-list
92470833|NCT01824433|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92470834|NCT01824433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92470835|NCT01824433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92348668|NCT01526148|Antimanic Agents|antimanic agents|mesh-ancestor
92470836|NCT01824433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470837|NCT01824433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470838|NCT01824433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470839|NCT01824433|Serotonin Agents|serotonin agents|mesh-ancestor
92470840|NCT01824433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470841|NCT01824433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92470842|NCT01824433|Antidepressive Agents|antidepressive agents|mesh-ancestor
92470843|NCT01824433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92470844|NCT01824433|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92470845|NCT01824433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92470846|NCT01824433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470847|NCT01824433|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92470848|NCT01824459|Oxaliplatin|oxaliplatin|mesh-list
92470849|NCT01824459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470850|NCT01824524|Hydromorphone|hydromorphone|mesh-list
92470851|NCT01824524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92470852|NCT01824524|Narcotics|narcotics|mesh-ancestor
92470853|NCT01824524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470854|NCT01824524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470855|NCT01824524|Analgesics|analgesics|mesh-ancestor
92470856|NCT01824524|Sensory System Agents|sensory system agents|mesh-ancestor
92470857|NCT01824524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470858|NCT01824615|Sunitinib|sunitinib|mesh-list
92470859|NCT01824615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470860|NCT01824615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92470861|NCT01824615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92470862|NCT01824615|Growth Substances|growth substances|mesh-ancestor
92470863|NCT01824615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470864|NCT01824615|Growth Inhibitors|growth inhibitors|mesh-ancestor
92470865|NCT01824615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92470866|NCT01824615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470867|NCT01824615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470868|NCT01824758|Lidocaine|lidocaine|mesh-list
92470869|NCT01824758|Rocuronium|rocuronium|mesh-list
92470870|NCT01824758|Esmolol|esmolol|mesh-list
92470871|NCT01824758|Anesthetics, Local|anesthetics, local|mesh-ancestor
92470872|NCT01824758|Anesthetics|anesthetics|mesh-ancestor
92470873|NCT01824758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470874|NCT01824758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470875|NCT01824758|Sensory System Agents|sensory system agents|mesh-ancestor
92470876|NCT01824758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470877|NCT01824758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92470878|NCT01824758|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92470879|NCT01824758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92470880|NCT01824758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470881|NCT01824758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470882|NCT01824758|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92470883|NCT01824758|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92470884|NCT01824758|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92470885|NCT01824758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92470886|NCT01824758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92470887|NCT01824758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92470888|NCT01824758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92470889|NCT01824758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470890|NCT01824888|Anti-Infective Agents|anti-infective agents|mesh-list
92470891|NCT01824888|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92470892|NCT01824927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92470893|NCT01824927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92470894|NCT01824992|Interferons|interferons|mesh-list
92470895|NCT01824992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470896|NCT01824992|Antiviral Agents|antiviral agents|mesh-ancestor
92470897|NCT01824992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470898|NCT01825031|Azithromycin|azithromycin|mesh-list
92470899|NCT01825031|Isoniazid|isoniazid|mesh-list
92470900|NCT01825031|Raltegravir Potassium|raltegravir potassium|mesh-list
92470901|NCT01825031|Fluconazole|fluconazole|mesh-list
92470902|NCT01825031|Albendazole|albendazole|mesh-list
92470903|NCT01825031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470904|NCT01825031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470905|NCT01825031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92470906|NCT01825031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92470907|NCT01825031|Antiviral Agents|antiviral agents|mesh-ancestor
92470908|NCT01825031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92470909|NCT01825031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92470910|NCT01825031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470911|NCT01825031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470912|NCT01825031|Antifungal Agents|antifungal agents|mesh-ancestor
92470913|NCT01825031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92470914|NCT01825031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92470915|NCT01825031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92470916|NCT01825031|Hormone Antagonists|hormone antagonists|mesh-ancestor
92470917|NCT01825031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92470918|NCT01825031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470919|NCT01825031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92470920|NCT01825031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92470921|NCT01825031|Antitubercular Agents|antitubercular agents|mesh-ancestor
92470922|NCT01825031|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92470923|NCT01825031|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92470925|NCT01825031|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92470926|NCT01825031|Anthelmintics|anthelmintics|mesh-ancestor
92470927|NCT01825031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92470928|NCT01825031|Anticestodal Agents|anticestodal agents|mesh-ancestor
92470929|NCT01825031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92470930|NCT01825031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92470931|NCT01825031|Tubulin Modulators|tubulin modulators|mesh-ancestor
92470932|NCT01825031|Antimitotic Agents|antimitotic agents|mesh-ancestor
92470933|NCT01825031|Mitosis Modulators|mitosis modulators|mesh-ancestor
92470934|NCT01825031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92470935|NCT01825044|Cyclosporine|cyclosporine|mesh-list
92470936|NCT01825044|Cyclosporins|cyclosporins|mesh-list
92470937|NCT01825044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470938|NCT01825044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470939|NCT01825044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92470940|NCT01825044|Immunologic Factors|immunologic factors|mesh-ancestor
92470941|NCT01825044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470942|NCT01825044|Antifungal Agents|antifungal agents|mesh-ancestor
92470943|NCT01825044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470944|NCT01825044|Dermatologic Agents|dermatologic agents|mesh-ancestor
92470945|NCT01825044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92470946|NCT01825044|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92470947|NCT01825083|Ketamine|ketamine|mesh-list
92470948|NCT01825083|Analgesics|analgesics|mesh-ancestor
92470949|NCT01825083|Sensory System Agents|sensory system agents|mesh-ancestor
92470950|NCT01825083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470951|NCT01825083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470952|NCT01825083|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92470953|NCT01825083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92470954|NCT01825083|Anesthetics, General|anesthetics, general|mesh-ancestor
92470955|NCT01825083|Anesthetics|anesthetics|mesh-ancestor
92470956|NCT01825083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470957|NCT01825083|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92470958|NCT01825083|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92470959|NCT01825083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92470960|NCT01825083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470961|NCT01825109|Vaccines|vaccines|mesh-list
92470962|NCT01825109|Immunologic Factors|immunologic factors|mesh-ancestor
92470963|NCT01825109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470964|NCT01825395|Amifampridine|amifampridine|mesh-list
92470965|NCT01825395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92470966|NCT01825395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470967|NCT01825395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470968|NCT01825395|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92470969|NCT01825395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92470970|NCT01825395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470971|NCT01825421|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92470972|NCT01825421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470973|NCT01825447|Naltrexone|naltrexone|mesh-list
92470974|NCT01825447|Oxycodone|oxycodone|mesh-list
92470975|NCT01825447|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92470976|NCT01825447|Narcotics|narcotics|mesh-ancestor
92470977|NCT01825447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348679|NCT01549002|Narcotics|narcotics|mesh-ancestor
92470978|NCT01825447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470979|NCT01825447|Analgesics|analgesics|mesh-ancestor
92470980|NCT01825447|Sensory System Agents|sensory system agents|mesh-ancestor
92470981|NCT01825447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92470982|NCT01825447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92470983|NCT01825447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92470984|NCT01825473|Erythromycin|erythromycin|mesh-list
92470985|NCT01825473|Erythromycin Estolate|erythromycin estolate|mesh-list
92470986|NCT01825473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92470987|NCT01825473|Erythromycin stearate|erythromycin stearate|mesh-list
92470988|NCT01825473|Phenobarbital|phenobarbital|mesh-list
92470989|NCT01825473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92470990|NCT01825473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92470991|NCT01825473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92470992|NCT01825473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92470993|NCT01825473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92470994|NCT01825473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92470995|NCT01825473|Anticonvulsants|anticonvulsants|mesh-ancestor
92470996|NCT01825473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92470997|NCT01825473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92470998|NCT01825473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92470999|NCT01825473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92471000|NCT01825473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92471001|NCT01825473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471002|NCT01825473|GABA Modulators|gaba modulators|mesh-ancestor
92471003|NCT01825473|GABA Agents|gaba agents|mesh-ancestor
92471004|NCT01825473|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92471005|NCT01825473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92471006|NCT01825473|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92471007|NCT01824043|Ranibizumab|ranibizumab|mesh-list
92471008|NCT01824043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92471009|NCT01824043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92471010|NCT01824043|Growth Substances|growth substances|mesh-ancestor
92471011|NCT01824043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471012|NCT01824043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92471013|NCT01824043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471014|NCT01825551|Lenograstim|lenograstim|mesh-list
92471015|NCT01825551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92471016|NCT01825551|Immunologic Factors|immunologic factors|mesh-ancestor
92471017|NCT01825551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471018|NCT01825590|Dialysis Solutions|dialysis solutions|mesh-list
92471019|NCT01825590|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92471021|NCT01825603|Gemcitabine|gemcitabine|mesh-list
92471022|NCT01825603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471023|NCT01825603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92471025|NCT01825603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471026|NCT01825616|Vitamin D|vitamin d|mesh-list
92471027|NCT01825616|Ergocalciferols|ergocalciferols|mesh-list
92471028|NCT01825616|Vitamins|vitamins|mesh-ancestor
92471029|NCT01825616|Micronutrients|micronutrients|mesh-ancestor
92471030|NCT01825616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471031|NCT01825616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92471032|NCT01825616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92471033|NCT01825720|Insulin|insulin|mesh-list
92471034|NCT01825720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92471035|NCT01825720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471036|NCT01825733|Palonosetron|palonosetron|mesh-list
92471037|NCT01825733|Ramosetron|ramosetron|mesh-list
92471038|NCT01825733|Antiemetics|antiemetics|mesh-ancestor
92471039|NCT01825733|Autonomic Agents|autonomic agents|mesh-ancestor
92471040|NCT01825733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471041|NCT01825733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471042|NCT01825733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471043|NCT01825733|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92471044|NCT01825733|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92471045|NCT01825733|Serotonin Agents|serotonin agents|mesh-ancestor
92471046|NCT01825733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471047|NCT01825733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471048|NCT01825850|Irbesartan|irbesartan|mesh-list
92471049|NCT01825850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92348682|NCT01549002|Analgesics|analgesics|mesh-ancestor
92471050|NCT01825850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92471051|NCT01825850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92471052|NCT01825850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471053|NCT01825863|Ropivacaine|ropivacaine|mesh-list
92471054|NCT01825863|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471055|NCT01825863|Anesthetics|anesthetics|mesh-ancestor
92471056|NCT01825863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471057|NCT01825863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471058|NCT01825863|Sensory System Agents|sensory system agents|mesh-ancestor
92471059|NCT01825863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471060|NCT01825902|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92471061|NCT01825902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92471062|NCT01825902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471063|NCT01825928|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92471064|NCT01825928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92471065|NCT01825928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92471066|NCT01825928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471067|NCT01825928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471068|NCT01825928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92471069|NCT01825928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92471070|NCT01825928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92471071|NCT01825928|Serotonin Agents|serotonin agents|mesh-ancestor
92471072|NCT01825928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471073|NCT01825928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471074|NCT01825928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92471075|NCT01825928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92471076|NCT01825928|Dopamine Agents|dopamine agents|mesh-ancestor
92471077|NCT01825993|Morphine|morphine|mesh-list
92471078|NCT01825993|Bupivacaine|bupivacaine|mesh-list
92471079|NCT01825993|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471080|NCT01825993|Anesthetics|anesthetics|mesh-ancestor
92471081|NCT01825993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471082|NCT01825993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471083|NCT01825993|Sensory System Agents|sensory system agents|mesh-ancestor
92471084|NCT01825993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471085|NCT01825993|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92471086|NCT01825993|Narcotics|narcotics|mesh-ancestor
92471087|NCT01825993|Analgesics|analgesics|mesh-ancestor
92471088|NCT01826149|Propofol|propofol|mesh-list
92471089|NCT01826149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92471090|NCT01826149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471091|NCT01826149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471092|NCT01826149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92471093|NCT01826149|Anesthetics, General|anesthetics, general|mesh-ancestor
92471094|NCT01826149|Anesthetics|anesthetics|mesh-ancestor
92471095|NCT01826175|Clopidogrel|clopidogrel|mesh-list
92471096|NCT01826175|Ticagrelor|ticagrelor|mesh-list
92196021|NCT00580333|Immunologic Factors|immunologic factors|mesh-ancestor
92471097|NCT01826175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92471098|NCT01826175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92471099|NCT01826175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92471100|NCT01826175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92471101|NCT01826175|Purinergic Agents|purinergic agents|mesh-ancestor
92471102|NCT01826175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471103|NCT01826175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471104|NCT01826175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471105|NCT01826253|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92471106|NCT01826253|Plasma Substitutes|plasma substitutes|mesh-ancestor
92471107|NCT01826253|Blood Substitutes|blood substitutes|mesh-ancestor
92471108|NCT01826279|Resveratrol|resveratrol|mesh-list
92471109|NCT01826279|Antioxidants|antioxidants|mesh-ancestor
92471110|NCT01826279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471111|NCT01826279|Protective Agents|protective agents|mesh-ancestor
92471112|NCT01826279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471113|NCT01826279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471114|NCT01826279|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92471115|NCT01826396|Irinotecan|irinotecan|mesh-list
92471116|NCT01826396|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92471117|NCT01826396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92471118|NCT01826396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471119|NCT01826396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471120|NCT01826396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471121|NCT01826526|Taurolidine|taurolidine|mesh-list
92471122|NCT01826526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471123|NCT01826526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92471124|NCT01826526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471125|NCT01826747|Progesterone|progesterone|mesh-list
92471126|NCT01826747|Progestins|progestins|mesh-ancestor
92471127|NCT01826747|Hormones|hormones|mesh-ancestor
92471128|NCT01826747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471129|NCT01826747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471130|NCT01826773|Palmitic Acid|palmitic acid|mesh-list
92471131|NCT01826773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471132|NCT01826773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471133|NCT01826786|JNJ-42165279|jnj-42165279|mesh-list
92471134|NCT01826786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471135|NCT01826786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471136|NCT01826864|Sargramostim|sargramostim|mesh-list
92471137|NCT01826864|Immunologic Factors|immunologic factors|mesh-ancestor
92471138|NCT01826864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471139|NCT01826916|Ecallantide|ecallantide|mesh-list
92471140|NCT01826916|Analgesics|analgesics|mesh-ancestor
92471141|NCT01826916|Sensory System Agents|sensory system agents|mesh-ancestor
92471142|NCT01826916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471143|NCT01826916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531733|NCT00048334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471144|NCT01826916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92471145|NCT01826916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92471146|NCT01826916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471147|NCT01826916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92471148|NCT01827007|Polygeline|polygeline|mesh-list
92471149|NCT01827007|Plasma Substitutes|plasma substitutes|mesh-ancestor
92471150|NCT01827007|Blood Substitutes|blood substitutes|mesh-ancestor
92471151|NCT01827020|Lidocaine|lidocaine|mesh-list
92471152|NCT01827020|Ketamine|ketamine|mesh-list
92471153|NCT01827020|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471154|NCT01827020|Anesthetics|anesthetics|mesh-ancestor
92471155|NCT01827020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471156|NCT01827020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471157|NCT01827020|Sensory System Agents|sensory system agents|mesh-ancestor
92471158|NCT01827020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471159|NCT01827020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471160|NCT01827020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92471161|NCT01827020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92471162|NCT01827020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471163|NCT01827020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471164|NCT01827020|Analgesics|analgesics|mesh-ancestor
92471165|NCT01827020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92471166|NCT01827020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92471167|NCT01827020|Anesthetics, General|anesthetics, general|mesh-ancestor
92471168|NCT01827020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92471169|NCT01827020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92471170|NCT01827020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471171|NCT01827059|Bosentan|bosentan|mesh-list
92471172|NCT01827059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471173|NCT01827059|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92471174|NCT01827059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471175|NCT01827072|Immunoglobulins|immunoglobulins|mesh-list
92471176|NCT01827072|Immunologic Factors|immunologic factors|mesh-ancestor
92471177|NCT01827072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471178|NCT01827124|Oxytocin|oxytocin|mesh-list
92471179|NCT01827124|Carbetocin|carbetocin|mesh-list
92471180|NCT01827124|Oxytocics|oxytocics|mesh-ancestor
92348688|NCT01549002|Anesthetics|anesthetics|mesh-ancestor
92471181|NCT01827124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92471182|NCT01827124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471183|NCT01827137|Lenalidomide|lenalidomide|mesh-list
92471184|NCT01827137|Molgramostim|molgramostim|mesh-list
92471185|NCT01827137|Sargramostim|sargramostim|mesh-list
92471186|NCT01827137|Immunologic Factors|immunologic factors|mesh-ancestor
92471187|NCT01827137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471188|NCT01827137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92471189|NCT01827137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92471190|NCT01827137|Growth Substances|growth substances|mesh-ancestor
92471191|NCT01827137|Growth Inhibitors|growth inhibitors|mesh-ancestor
92471192|NCT01827137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471193|NCT01827202|Candesartan|candesartan|mesh-list
92471194|NCT01827202|Candesartan cilexetil|candesartan cilexetil|mesh-list
92471195|NCT01827202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471196|NCT01827202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92471197|NCT01827202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92471198|NCT01827202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471199|NCT01827228|HIV Antibodies|hiv antibodies|mesh-list
92471200|NCT01827228|Immunologic Factors|immunologic factors|mesh-ancestor
92471201|NCT01827228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471202|NCT01827280|Vildagliptin|vildagliptin|mesh-list
92471203|NCT01827280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92471204|NCT01827280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471205|NCT01827280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92471206|NCT01827280|Protease Inhibitors|protease inhibitors|mesh-ancestor
92471207|NCT01827280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471208|NCT01827280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471209|NCT01827293|Promethazine|promethazine|mesh-list
92471210|NCT01827293|Diphenhydramine|diphenhydramine|mesh-list
92471211|NCT01827293|Lorazepam|lorazepam|mesh-list
92471212|NCT01827293|Anticonvulsants|anticonvulsants|mesh-ancestor
92471213|NCT01827293|Antiemetics|antiemetics|mesh-ancestor
92471214|NCT01827293|Autonomic Agents|autonomic agents|mesh-ancestor
92471215|NCT01827293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471216|NCT01827293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471217|NCT01827293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471218|NCT01827293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92471219|NCT01827293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471220|NCT01827293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92471221|NCT01827293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92471222|NCT01827293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92471224|NCT01827293|GABA Agents|gaba agents|mesh-ancestor
92471225|NCT01827293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471226|NCT01827293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471227|NCT01827293|Antipruritics|antipruritics|mesh-ancestor
92471228|NCT01827293|Dermatologic Agents|dermatologic agents|mesh-ancestor
92471229|NCT01827293|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92471230|NCT01827293|Histamine Antagonists|histamine antagonists|mesh-ancestor
92471231|NCT01827293|Histamine Agents|histamine agents|mesh-ancestor
92471232|NCT01827293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92471233|NCT01827293|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92471234|NCT01827293|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471235|NCT01827293|Anesthetics|anesthetics|mesh-ancestor
92471236|NCT01827293|Sensory System Agents|sensory system agents|mesh-ancestor
92471237|NCT01827345|Vitamin D|vitamin d|mesh-list
92471238|NCT01827345|Vitamins|vitamins|mesh-ancestor
92471239|NCT01827345|Micronutrients|micronutrients|mesh-ancestor
92471240|NCT01827345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471241|NCT01827345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92471242|NCT01827397|Vaccines|vaccines|mesh-list
92471243|NCT01827397|Immunologic Factors|immunologic factors|mesh-ancestor
92471244|NCT01827397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471245|NCT01827540|Dolutegravir|dolutegravir|mesh-list
92471246|NCT01827540|Cenicriviroc|cenicriviroc|mesh-list
92471247|NCT01827540|Midazolam|midazolam|mesh-list
92471248|NCT01827540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92471249|NCT01827540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92471250|NCT01827540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471251|NCT01827540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471252|NCT01827540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92471253|NCT01827540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92471254|NCT01827540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92471255|NCT01827540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92471256|NCT01827540|Anesthetics, General|anesthetics, general|mesh-ancestor
92471258|NCT01827540|GABA Modulators|gaba modulators|mesh-ancestor
92471259|NCT01827540|GABA Agents|gaba agents|mesh-ancestor
92471260|NCT01827540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471261|NCT01827540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471262|NCT01827540|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92471263|NCT01827540|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92471264|NCT01827540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471265|NCT01827540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92471266|NCT01827540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92471267|NCT01827540|Antiviral Agents|antiviral agents|mesh-ancestor
92471268|NCT01827540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471269|NCT01827540|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92471270|NCT01827618|Sirolimus|sirolimus|mesh-list
92471271|NCT01827618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92471272|NCT01827618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471273|NCT01827618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92471274|NCT01827618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471275|NCT01827618|Antifungal Agents|antifungal agents|mesh-ancestor
92471276|NCT01827618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92471277|NCT01827618|Immunologic Factors|immunologic factors|mesh-ancestor
92471278|NCT01827618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471279|NCT01827722|Dexamethasone|dexamethasone|mesh-list
92471280|NCT01827722|Dexamethasone acetate|dexamethasone acetate|mesh-list
92471281|NCT01827722|Ranibizumab|ranibizumab|mesh-list
92471282|NCT01827722|BB 1101|bb 1101|mesh-list
92471283|NCT01827722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471284|NCT01827722|Antiemetics|antiemetics|mesh-ancestor
92471285|NCT01827722|Autonomic Agents|autonomic agents|mesh-ancestor
92471286|NCT01827722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471287|NCT01827722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471288|NCT01827722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471289|NCT01827722|Glucocorticoids|glucocorticoids|mesh-ancestor
92471290|NCT01827722|Hormones|hormones|mesh-ancestor
92471291|NCT01827722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471292|NCT01827722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92471293|NCT01827722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471294|NCT01827722|Protease Inhibitors|protease inhibitors|mesh-ancestor
92471295|NCT01827722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471296|NCT01827722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471297|NCT01827722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92471298|NCT01827722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92471299|NCT01827722|Growth Substances|growth substances|mesh-ancestor
92471300|NCT01827722|Growth Inhibitors|growth inhibitors|mesh-ancestor
92471301|NCT01827735|Aldesleukin|aldesleukin|mesh-list
92471302|NCT01827735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471303|NCT01827735|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92471304|NCT01827735|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92471305|NCT01827735|Antiviral Agents|antiviral agents|mesh-ancestor
92471306|NCT01827735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471307|NCT01827865|Etodolac|etodolac|mesh-list
92471308|NCT01827865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92471309|NCT01827865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92471310|NCT01827865|Analgesics|analgesics|mesh-ancestor
92471311|NCT01827865|Sensory System Agents|sensory system agents|mesh-ancestor
92471312|NCT01827865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471313|NCT01827865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471314|NCT01827865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471315|NCT01827865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92471316|NCT01827865|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92471317|NCT01827865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92471318|NCT01827865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471319|NCT01827865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471320|NCT01827878|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92471321|NCT01827878|Lisinopril|lisinopril|mesh-list
92471322|NCT01827878|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
92471323|NCT01827878|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471324|NCT01827878|Diuretics|diuretics|mesh-ancestor
92471325|NCT01827878|Natriuretic Agents|natriuretic agents|mesh-ancestor
92471326|NCT01827878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471327|NCT01827878|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92471328|NCT01827878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471329|NCT01827878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471330|NCT01827878|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92471331|NCT01827878|Protease Inhibitors|protease inhibitors|mesh-ancestor
92471332|NCT01827878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471333|NCT01827878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92471334|NCT01827878|Protective Agents|protective agents|mesh-ancestor
92471335|NCT01828125|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92471336|NCT01828125|Glucagon|glucagon|mesh-list
92471337|NCT01828125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471338|NCT01828125|Hormones|hormones|mesh-ancestor
92471339|NCT01828125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471340|NCT01828125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471341|NCT01828203|Minocycline|minocycline|mesh-list
92471342|NCT01828203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92471343|NCT01828203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471344|NCT01828294|Immunoglobulins|immunoglobulins|mesh-list
92471345|NCT01828294|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92471346|NCT01828294|Antibodies|antibodies|mesh-list
92471347|NCT01828294|Immunologic Factors|immunologic factors|mesh-ancestor
92471348|NCT01828294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471349|NCT01828346|Azacitidine|azacitidine|mesh-list
92471350|NCT01828346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92471351|NCT01828346|Antimetabolites|antimetabolites|mesh-ancestor
92471352|NCT01828346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471353|NCT01828346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471354|NCT01828346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471355|NCT01828359|Losartan|losartan|mesh-list
92471356|NCT01828359|Amlodipine|amlodipine|mesh-list
92471357|NCT01828359|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471358|NCT01828359|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92471359|NCT01828359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471360|NCT01828359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471361|NCT01828359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92471362|NCT01828359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471363|NCT01828359|Vasodilator Agents|vasodilator agents|mesh-ancestor
92471364|NCT01828359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471365|NCT01828359|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92471366|NCT01828359|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92471367|NCT01828385|Magnesium Sulfate|magnesium sulfate|mesh-list
92471368|NCT01828385|Analgesics|analgesics|mesh-ancestor
92471369|NCT01828385|Sensory System Agents|sensory system agents|mesh-ancestor
92471370|NCT01828385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471371|NCT01828385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471372|NCT01828385|Anesthetics|anesthetics|mesh-ancestor
92471373|NCT01828385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471374|NCT01828385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471375|NCT01828385|Anticonvulsants|anticonvulsants|mesh-ancestor
92471376|NCT01828385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92471377|NCT01828385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348729|NCT01547286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92471378|NCT01828385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471379|NCT01828385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92471380|NCT01828385|Tocolytic Agents|tocolytic agents|mesh-ancestor
92471381|NCT01828385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92471383|NCT01828437|Prednisolone|prednisolone|mesh-list
92471384|NCT01828437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92471385|NCT01828437|Methylprednisolone|methylprednisolone|mesh-list
92471386|NCT01828437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92471387|NCT01828437|Prednisolone acetate|prednisolone acetate|mesh-list
92471388|NCT01828437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92471389|NCT01828437|Prednisolone phosphate|prednisolone phosphate|mesh-list
92471390|NCT01828437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471391|NCT01828437|Glucocorticoids|glucocorticoids|mesh-ancestor
92471392|NCT01828437|Hormones|hormones|mesh-ancestor
92471393|NCT01828437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471394|NCT01828437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471395|NCT01828437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92471396|NCT01828437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471397|NCT01828437|Antiemetics|antiemetics|mesh-ancestor
92471398|NCT01828437|Autonomic Agents|autonomic agents|mesh-ancestor
92471399|NCT01828437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471400|NCT01828437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471401|NCT01828437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92471402|NCT01828437|Protective Agents|protective agents|mesh-ancestor
92471403|NCT01828437|Vitamin B Complex|vitamin b complex|mesh-ancestor
92471404|NCT01828437|Vitamins|vitamins|mesh-ancestor
92471405|NCT01828437|Micronutrients|micronutrients|mesh-ancestor
92471406|NCT01828463|Nitisinone|nitisinone|mesh-list
92471407|NCT01828463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471408|NCT01828463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471409|NCT01828489|Mitoxantrone|mitoxantrone|mesh-list
92471410|NCT01828489|Analgesics|analgesics|mesh-ancestor
92471411|NCT01828489|Sensory System Agents|sensory system agents|mesh-ancestor
92471412|NCT01828489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471413|NCT01828489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471414|NCT01828489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471415|NCT01828489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92471416|NCT01828489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92471417|NCT01828489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471418|NCT01828489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471419|NCT01828606|Monensin|monensin|mesh-list
92471420|NCT01828606|Antifungal Agents|antifungal agents|mesh-ancestor
92471421|NCT01828606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471422|NCT01828606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92471423|NCT01828606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92471424|NCT01828606|Coccidiostats|coccidiostats|mesh-ancestor
92471425|NCT01828606|Proton Ionophores|proton ionophores|mesh-ancestor
92471426|NCT01828606|Uncoupling Agents|uncoupling agents|mesh-ancestor
92471427|NCT01828606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471428|NCT01828606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471429|NCT01828606|Ionophores|ionophores|mesh-ancestor
92471430|NCT01828606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471431|NCT01828606|Sodium Ionophores|sodium ionophores|mesh-ancestor
92471432|NCT01828736|Cisplatin|cisplatin|mesh-list
92471433|NCT01828736|Carboplatin|carboplatin|mesh-list
92471434|NCT01828736|Gemcitabine|gemcitabine|mesh-list
92471435|NCT01828736|Trastuzumab|trastuzumab|mesh-list
92471436|NCT01828736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471437|NCT01828736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92471438|NCT01828736|Antimetabolites|antimetabolites|mesh-ancestor
92471439|NCT01828736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471440|NCT01828736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92471441|NCT01828788|Ropivacaine|ropivacaine|mesh-list
92471442|NCT01828788|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471443|NCT01828788|Anesthetics|anesthetics|mesh-ancestor
92471444|NCT01828788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471445|NCT01828788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471446|NCT01828788|Sensory System Agents|sensory system agents|mesh-ancestor
92471447|NCT01828788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471448|NCT01828879|Tacrolimus|tacrolimus|mesh-list
92471449|NCT01828879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92471450|NCT01828879|Immunologic Factors|immunologic factors|mesh-ancestor
92471451|NCT01828879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471452|NCT01828879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92471453|NCT01828879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471454|NCT01828879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471455|NCT01828892|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92471456|NCT01828892|Vancomycin|vancomycin|mesh-list
92471457|NCT01828892|Meropenem|meropenem|mesh-list
92471458|NCT01828892|Ceftazidime|ceftazidime|mesh-list
92471459|NCT01828892|Cefotaxime|cefotaxime|mesh-list
92471460|NCT01828892|Cefoxitin|cefoxitin|mesh-list
92471461|NCT01828892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471462|NCT01828970|Insulin Aspart|insulin aspart|mesh-list
92471463|NCT01828970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92471464|NCT01828970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471465|NCT01829178|Cisplatin|cisplatin|mesh-list
92471466|NCT01829178|Docetaxel|docetaxel|mesh-list
92471467|NCT01829178|Fluorouracil|fluorouracil|mesh-list
92471468|NCT01829178|Silymarin|silymarin|mesh-list
92471469|NCT01829178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471470|NCT01829178|Tubulin Modulators|tubulin modulators|mesh-ancestor
92471471|NCT01829178|Antimitotic Agents|antimitotic agents|mesh-ancestor
92471472|NCT01829178|Mitosis Modulators|mitosis modulators|mesh-ancestor
92471473|NCT01829178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471474|NCT01829178|Antimetabolites|antimetabolites|mesh-ancestor
92471475|NCT01829178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92471476|NCT01829178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92471477|NCT01829178|Immunologic Factors|immunologic factors|mesh-ancestor
92471478|NCT01829178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471480|NCT01829178|Protective Agents|protective agents|mesh-ancestor
92471481|NCT01829334|Listerine|listerine|mesh-list
92471482|NCT01829334|Fluorides|fluorides|mesh-list
92471483|NCT01829334|Sodium Fluoride|sodium fluoride|mesh-list
92471484|NCT01829334|Fluorides, Topical|fluorides, topical|mesh-list
92471485|NCT01829334|Cariostatic Agents|cariostatic agents|mesh-ancestor
92471486|NCT01829334|Protective Agents|protective agents|mesh-ancestor
92471487|NCT01829334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471488|NCT01829334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92471489|NCT01829334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471490|NCT01829451|Hyaluronic Acid|hyaluronic acid|mesh-list
92471491|NCT01829451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92471492|NCT01829451|Immunologic Factors|immunologic factors|mesh-ancestor
92471493|NCT01829451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471494|NCT01829451|Viscosupplements|viscosupplements|mesh-ancestor
92471495|NCT01829451|Protective Agents|protective agents|mesh-ancestor
92471496|NCT01829529|Amoxicillin|amoxicillin|mesh-list
92471497|NCT01829529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92471498|NCT01829529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471499|NCT01829659|Ticagrelor|ticagrelor|mesh-list
92471500|NCT01829659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92471501|NCT01829659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92471502|NCT01829659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92471503|NCT01829659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92471504|NCT01829659|Purinergic Agents|purinergic agents|mesh-ancestor
92471505|NCT01829659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471506|NCT01829659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471507|NCT01829659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471508|NCT01829685|Entecavir|entecavir|mesh-list
92471509|NCT01829685|Adefovir|adefovir|mesh-list
92471510|NCT01829685|Antiviral Agents|antiviral agents|mesh-ancestor
92471511|NCT01829685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471512|NCT01829685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92471513|NCT01829685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92471514|NCT01829685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471515|NCT01829685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471516|NCT01829698|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92471517|NCT01829698|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92471518|NCT01829698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471519|NCT01829711|Immunotoxin HA22|immunotoxin ha22|mesh-list
92471520|NCT01829711|Protective Agents|protective agents|mesh-list
92471521|NCT01829711|Immunotoxins|immunotoxins|mesh-ancestor
92471522|NCT01829711|Immunoconjugates|immunoconjugates|mesh-ancestor
92471523|NCT01829711|Immunologic Factors|immunologic factors|mesh-ancestor
92471524|NCT01829711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471525|NCT01829711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471527|NCT01829802|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92471528|NCT01829802|Raltegravir Potassium|raltegravir potassium|mesh-list
92471529|NCT01829802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92471530|NCT01829802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92471531|NCT01829802|Protease Inhibitors|protease inhibitors|mesh-ancestor
92471532|NCT01829802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471533|NCT01829802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471534|NCT01829802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92471535|NCT01829802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92471536|NCT01829802|Antiviral Agents|antiviral agents|mesh-ancestor
92471537|NCT01829802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471538|NCT01829802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92471539|NCT01829802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92471540|NCT01829802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92471541|NCT01829802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92471542|NCT01829841|Sunitinib|sunitinib|mesh-list
92471543|NCT01829841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471544|NCT01829841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92471545|NCT01829841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92471546|NCT01829841|Growth Substances|growth substances|mesh-ancestor
92471547|NCT01829841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471548|NCT01829841|Growth Inhibitors|growth inhibitors|mesh-ancestor
92471549|NCT01829841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92471550|NCT01829841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471551|NCT01829841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471552|NCT01829893|Tamsulosin|tamsulosin|mesh-list
92471553|NCT01829893|Finasteride|finasteride|mesh-list
92471554|NCT01829893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92471556|NCT01829893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92471557|NCT01829893|Adrenergic Agents|adrenergic agents|mesh-ancestor
92471558|NCT01829893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471559|NCT01829893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471560|NCT01829893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471561|NCT01829893|Urological Agents|urological agents|mesh-ancestor
92471562|NCT01829893|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92471563|NCT01829893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92471564|NCT01829893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471565|NCT01829893|Hormone Antagonists|hormone antagonists|mesh-ancestor
92471566|NCT01829893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471567|NCT01830153|Everolimus|everolimus|mesh-list
92471568|NCT01830153|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92471569|NCT01830153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92471570|NCT01830153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471571|NCT01830153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471572|NCT01830153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92471573|NCT01830153|Immunologic Factors|immunologic factors|mesh-ancestor
92471574|NCT01830153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471575|NCT01830153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471576|NCT01830244|Paclitaxel|paclitaxel|mesh-list
92471577|NCT01830244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92471578|NCT01830244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471579|NCT01830244|Tubulin Modulators|tubulin modulators|mesh-ancestor
92471580|NCT01830244|Antimitotic Agents|antimitotic agents|mesh-ancestor
92471581|NCT01830244|Mitosis Modulators|mitosis modulators|mesh-ancestor
92471582|NCT01830244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471583|NCT01830270|Paclitaxel|paclitaxel|mesh-list
92471584|NCT01830270|Epirubicin|epirubicin|mesh-list
92471585|NCT01830270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92471586|NCT01830270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471587|NCT01830270|Tubulin Modulators|tubulin modulators|mesh-ancestor
92471588|NCT01830270|Antimitotic Agents|antimitotic agents|mesh-ancestor
92471589|NCT01830270|Mitosis Modulators|mitosis modulators|mesh-ancestor
92471590|NCT01830270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471591|NCT01830270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92471593|NCT01830270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92471594|NCT01830270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471595|NCT01830530|Telmisartan|telmisartan|mesh-list
92471596|NCT01830530|Nifedipine|nifedipine|mesh-list
92471597|NCT01830530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471598|NCT01830530|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92471599|NCT01830530|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92471600|NCT01830530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471601|NCT01830530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92471602|NCT01830530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471603|NCT01830530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92471604|NCT01830530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471605|NCT01830530|Vasodilator Agents|vasodilator agents|mesh-ancestor
92471606|NCT01830530|Tocolytic Agents|tocolytic agents|mesh-ancestor
92471607|NCT01830530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92471608|NCT01830907|Vitamins|vitamins|mesh-list
92471609|NCT01830907|Micronutrients|micronutrients|mesh-ancestor
92471610|NCT01830907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471611|NCT01831050|Vaccines|vaccines|mesh-list
92471612|NCT01831050|Immunologic Factors|immunologic factors|mesh-ancestor
92471613|NCT01831050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471614|NCT01831440|Antidepressive Agents|antidepressive agents|mesh-list
92471615|NCT01831440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92471616|NCT01832311|Ketorolac|ketorolac|mesh-list
92471617|NCT01832311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92471618|NCT01832311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92471619|NCT01832311|Analgesics|analgesics|mesh-ancestor
92471620|NCT01832311|Sensory System Agents|sensory system agents|mesh-ancestor
92471621|NCT01832311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471622|NCT01832311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471623|NCT01832311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471624|NCT01832311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92471625|NCT01832311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92471626|NCT01832311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196549|NCT01799005|Micronutrients|micronutrients|mesh-list
92471627|NCT01832311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471628|NCT01832350|Quinidine|quinidine|mesh-list
92471629|NCT01832350|Dextromethorphan|dextromethorphan|mesh-list
92471630|NCT01832350|Antitussive Agents|antitussive agents|mesh-ancestor
92471631|NCT01832350|Respiratory System Agents|respiratory system agents|mesh-ancestor
92471632|NCT01832350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92471633|NCT01832350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92471634|NCT01832350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471635|NCT01832350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471636|NCT01832350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471637|NCT01832350|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92471638|NCT01832350|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92471639|NCT01832350|Adrenergic Agents|adrenergic agents|mesh-ancestor
92471640|NCT01832350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471641|NCT01832350|Antimalarials|antimalarials|mesh-ancestor
92471642|NCT01832350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92471643|NCT01832350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92471644|NCT01832350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471645|NCT01832350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471646|NCT01832350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92471647|NCT01832350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92471648|NCT01832350|Cholinergic Agents|cholinergic agents|mesh-ancestor
92471649|NCT01832350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92471650|NCT01832350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92471651|NCT01832350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471652|NCT01832350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92471653|NCT01832350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92471654|NCT01833221|Lidocaine|lidocaine|mesh-list
92471655|NCT01833221|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471656|NCT01833221|Anesthetics|anesthetics|mesh-ancestor
92471657|NCT01833221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471658|NCT01833221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471659|NCT01833221|Sensory System Agents|sensory system agents|mesh-ancestor
92471660|NCT01833221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471661|NCT01833221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471662|NCT01833221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92471663|NCT01833221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92471664|NCT01833221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471665|NCT01833221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471666|NCT01834820|Dexamethasone|dexamethasone|mesh-list
92471667|NCT01834820|Epinephrine|epinephrine|mesh-list
92471668|NCT01834820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471669|NCT01834820|Antiemetics|antiemetics|mesh-ancestor
92471670|NCT01834820|Autonomic Agents|autonomic agents|mesh-ancestor
92471671|NCT01834820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471672|NCT01834820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471673|NCT01834820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471674|NCT01834820|Glucocorticoids|glucocorticoids|mesh-ancestor
92471675|NCT01834820|Hormones|hormones|mesh-ancestor
92471676|NCT01834820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471677|NCT01834820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92471678|NCT01834820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471679|NCT01834820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92471680|NCT01834820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92471681|NCT01834820|Adrenergic Agents|adrenergic agents|mesh-ancestor
92471682|NCT01834820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471683|NCT01834820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471684|NCT01834820|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92471685|NCT01834820|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92471686|NCT01834820|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92471687|NCT01834820|Respiratory System Agents|respiratory system agents|mesh-ancestor
92471688|NCT01834820|Mydriatics|mydriatics|mesh-ancestor
92471689|NCT01834820|Sympathomimetics|sympathomimetics|mesh-ancestor
92471690|NCT01834820|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92471691|NCT01835197|Abrocitinib|abrocitinib|mesh-list
92471692|NCT01835197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92471693|NCT01835197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471694|NCT01835197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471695|NCT01835418|Amlodipine|amlodipine|mesh-list
92471696|NCT01835418|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471697|NCT01835418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92471698|NCT01835418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196617|NCT00516503|GABA Agonists|gaba agonists|mesh-ancestor
92471699|NCT01835418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471700|NCT01835418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92471701|NCT01835418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471702|NCT01835418|Vasodilator Agents|vasodilator agents|mesh-ancestor
92471703|NCT01835678|Linagliptin|linagliptin|mesh-list
92471704|NCT01835678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92471705|NCT01835678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471706|NCT01835678|Incretins|incretins|mesh-ancestor
92471707|NCT01835678|Hormones|hormones|mesh-ancestor
92471708|NCT01835678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471709|NCT01835678|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92471710|NCT01835678|Protease Inhibitors|protease inhibitors|mesh-ancestor
92471711|NCT01835678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471712|NCT01835678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471713|NCT01836614|Lidocaine|lidocaine|mesh-list
92471714|NCT01836614|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471715|NCT01836614|Anesthetics|anesthetics|mesh-ancestor
92471716|NCT01836614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471717|NCT01836614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471718|NCT01836614|Sensory System Agents|sensory system agents|mesh-ancestor
92471719|NCT01836614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471720|NCT01836614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471721|NCT01836614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92471722|NCT01836614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92471723|NCT01836614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471724|NCT01836614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471725|NCT01837251|Bevacizumab|bevacizumab|mesh-list
92471726|NCT01837251|Carboplatin|carboplatin|mesh-list
92471727|NCT01837251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92471728|NCT01837251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471729|NCT01837251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92471730|NCT01837251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92471731|NCT01837251|Growth Substances|growth substances|mesh-ancestor
92471732|NCT01837251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471733|NCT01837251|Growth Inhibitors|growth inhibitors|mesh-ancestor
92471734|NCT01837290|Midazolam|midazolam|mesh-list
92471735|NCT01837290|Dexmedetomidine|dexmedetomidine|mesh-list
92471736|NCT01837290|Bupivacaine|bupivacaine|mesh-list
92471737|NCT01837290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471738|NCT01837290|Anesthetics|anesthetics|mesh-ancestor
92471739|NCT01837290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471740|NCT01837290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471741|NCT01837290|Sensory System Agents|sensory system agents|mesh-ancestor
92471742|NCT01837290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471743|NCT01837290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92471744|NCT01837290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92471745|NCT01837290|Analgesics|analgesics|mesh-ancestor
92471746|NCT01837290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92471747|NCT01837290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92471748|NCT01837290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92471749|NCT01837290|Adrenergic Agents|adrenergic agents|mesh-ancestor
92471750|NCT01837290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471751|NCT01837290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471752|NCT01837290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92471753|NCT01837290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92471754|NCT01837290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92471755|NCT01837290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92471756|NCT01837290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92471757|NCT01837290|Anesthetics, General|anesthetics, general|mesh-ancestor
92471758|NCT01837290|GABA Modulators|gaba modulators|mesh-ancestor
92471759|NCT01837290|GABA Agents|gaba agents|mesh-ancestor
92471760|NCT01837433|Prednisone|prednisone|mesh-list
92471761|NCT01837433|Glucocorticoids|glucocorticoids|mesh-list
92471762|NCT01837433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471763|NCT01837433|Hormones|hormones|mesh-ancestor
92471764|NCT01837433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471765|NCT01837433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471766|NCT01837433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92471767|NCT01837433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471768|NCT01837446|Diphenhydramine|diphenhydramine|mesh-list
92471769|NCT01837446|Promethazine|promethazine|mesh-list
92471770|NCT01837446|Lidocaine|lidocaine|mesh-list
92471771|NCT01837446|Morphine|morphine|mesh-list
92471772|NCT01837446|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92196691|NCT00636805|Antiemetics|antiemetics|mesh-ancestor
92471773|NCT01837446|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
92471774|NCT01837446|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471775|NCT01837446|Anesthetics|anesthetics|mesh-ancestor
92471776|NCT01837446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471777|NCT01837446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471778|NCT01837446|Sensory System Agents|sensory system agents|mesh-ancestor
92471779|NCT01837446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471780|NCT01837446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92471781|NCT01837446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92471782|NCT01837446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92471783|NCT01837446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471784|NCT01837446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471785|NCT01837446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92471786|NCT01837446|Narcotics|narcotics|mesh-ancestor
92471787|NCT01837446|Analgesics|analgesics|mesh-ancestor
92471788|NCT01837446|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92471789|NCT01837446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92471790|NCT01837446|Antiemetics|antiemetics|mesh-ancestor
92471791|NCT01837446|Autonomic Agents|autonomic agents|mesh-ancestor
92471792|NCT01837446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471793|NCT01837446|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92471794|NCT01837446|Histamine Antagonists|histamine antagonists|mesh-ancestor
92471795|NCT01837446|Histamine Agents|histamine agents|mesh-ancestor
92471796|NCT01837446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471797|NCT01837446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92471798|NCT01837446|Antipruritics|antipruritics|mesh-ancestor
92471799|NCT01837446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92471800|NCT01837446|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92471801|NCT01837446|Immunologic Factors|immunologic factors|mesh-ancestor
92471802|NCT01837446|Antacids|antacids|mesh-ancestor
92471803|NCT01838850|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92471804|NCT01838850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92471805|NCT01838850|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92471806|NCT01838850|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92471807|NCT01838850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471808|NCT01839344|Acarbose|acarbose|mesh-list
92471809|NCT01839344|Quercetin|quercetin|mesh-list
92471810|NCT01839344|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92471811|NCT01839344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471812|NCT01839344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471813|NCT01839344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92471814|NCT01839344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471815|NCT01839344|Antioxidants|antioxidants|mesh-ancestor
92471816|NCT01839344|Protective Agents|protective agents|mesh-ancestor
92471817|NCT01839578|Heparin|heparin|mesh-list
92471818|NCT01839578|Calcium heparin|calcium heparin|mesh-list
92471819|NCT01839578|Anticoagulants|anticoagulants|mesh-ancestor
92471820|NCT01839578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471821|NCT01839578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92471822|NCT01839578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92471823|NCT01839994|Androgens|androgens|mesh-list
92471824|NCT01839994|Hormones|hormones|mesh-ancestor
92471825|NCT01839994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471826|NCT01839994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471827|NCT01840189|Hydrocortisone|hydrocortisone|mesh-list
92471828|NCT01840189|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92471829|NCT01840189|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92471830|NCT01840189|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92471831|NCT01840189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471832|NCT01840254|Dexmedetomidine|dexmedetomidine|mesh-list
92471833|NCT01840254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92471834|NCT01840254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471835|NCT01840254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471836|NCT01840254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92471837|NCT01840254|Analgesics|analgesics|mesh-ancestor
92471838|NCT01840254|Sensory System Agents|sensory system agents|mesh-ancestor
92471839|NCT01840254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471840|NCT01840254|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92471841|NCT01840254|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92471842|NCT01840254|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92471843|NCT01840254|Adrenergic Agents|adrenergic agents|mesh-ancestor
92471844|NCT01840254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471845|NCT01840254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471846|NCT01840384|Micronutrients|micronutrients|mesh-list
92471847|NCT01840384|Trace Elements|trace elements|mesh-list
92471848|NCT01840384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471849|NCT01840423|Levodopa|levodopa|mesh-list
92471850|NCT01840423|Carbidopa|carbidopa|mesh-list
92471851|NCT01840423|Entacapone|entacapone|mesh-list
92471852|NCT01840423|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92471853|NCT01840423|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92471854|NCT01840423|Dopamine Agents|dopamine agents|mesh-ancestor
92471855|NCT01840423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471856|NCT01840423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471857|NCT01840423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471858|NCT01840423|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92471859|NCT01840423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471860|NCT01840423|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92471861|NCT01840449|Lanreotide|lanreotide|mesh-list
92471862|NCT01840449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92471863|NCT01840683|Heparin|heparin|mesh-list
92471864|NCT01840683|Anticoagulants|anticoagulants|mesh-ancestor
92471865|NCT01840683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92471866|NCT01840683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92471867|NCT01840683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471868|NCT01840696|Regadenoson|regadenoson|mesh-list
92471869|NCT01840696|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92471870|NCT01840696|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92471871|NCT01840696|Purinergic Agonists|purinergic agonists|mesh-ancestor
92471872|NCT01840696|Purinergic Agents|purinergic agents|mesh-ancestor
92471873|NCT01840696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471874|NCT01840696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471875|NCT01840696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471876|NCT01840774|Ketamine|ketamine|mesh-list
92471877|NCT01840774|Analgesics|analgesics|mesh-list
92471878|NCT01840774|Sensory System Agents|sensory system agents|mesh-ancestor
92471879|NCT01840774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471880|NCT01840774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531743|NCT00048373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92471882|NCT01840774|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92471883|NCT01840774|Anesthetics, General|anesthetics, general|mesh-ancestor
92471884|NCT01840774|Anesthetics|anesthetics|mesh-ancestor
92471885|NCT01840774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471886|NCT01840774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92471887|NCT01840774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92471888|NCT01840774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471889|NCT01840774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471891|NCT01840800|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471892|NCT01840800|Anesthetics|anesthetics|mesh-ancestor
92471893|NCT01840800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471894|NCT01840800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471895|NCT01840800|Sensory System Agents|sensory system agents|mesh-ancestor
92471896|NCT01840800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471897|NCT01840813|Misoprostol|misoprostol|mesh-list
92471898|NCT01840813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92471899|NCT01840813|Abortifacient Agents|abortifacient agents|mesh-ancestor
92471900|NCT01840813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92471901|NCT01840813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471902|NCT01840813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92471903|NCT01840813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92471904|NCT01840813|Oxytocics|oxytocics|mesh-ancestor
92471905|NCT01841008|Tacrolimus|tacrolimus|mesh-list
92471906|NCT01841008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92471907|NCT01841008|Immunologic Factors|immunologic factors|mesh-ancestor
92471908|NCT01841008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471909|NCT01841008|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92471910|NCT01841008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471911|NCT01841008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471912|NCT01841099|Mesalamine|mesalamine|mesh-list
92471913|NCT01841099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92471914|NCT01841099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92471915|NCT01841099|Analgesics|analgesics|mesh-ancestor
92471916|NCT01841099|Sensory System Agents|sensory system agents|mesh-ancestor
92471917|NCT01841099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471918|NCT01841099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471919|NCT01841099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471920|NCT01841099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196845|NCT00641641|Tenofovir|tenofovir|mesh-list
92471921|NCT01841112|BI 409306|bi 409306|mesh-list
92471922|NCT01841112|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92471923|NCT01841112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92471924|NCT01841112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471925|NCT01841125|Escitalopram|escitalopram|mesh-list
92471926|NCT01841125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92471927|NCT01841125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92471928|NCT01841125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471929|NCT01841125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471930|NCT01841125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92471931|NCT01841125|Serotonin Agents|serotonin agents|mesh-ancestor
92471932|NCT01841125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471933|NCT01841164|Montelukast|montelukast|mesh-list
92471934|NCT01841164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92471935|NCT01841164|Respiratory System Agents|respiratory system agents|mesh-ancestor
92471936|NCT01841164|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92471937|NCT01841164|Hormone Antagonists|hormone antagonists|mesh-ancestor
92471938|NCT01841164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92471939|NCT01841164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471940|NCT01841164|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92471941|NCT01841164|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92471942|NCT01841164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471943|NCT01841242|Chlorhexidine|chlorhexidine|mesh-list
92471944|NCT01841242|Povidone-Iodine|povidone-iodine|mesh-list
92471945|NCT01841242|Povidone|povidone|mesh-list
92471946|NCT01841242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92471947|NCT01841242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471948|NCT01841242|Disinfectants|disinfectants|mesh-ancestor
92471949|NCT01841242|Plasma Substitutes|plasma substitutes|mesh-ancestor
92471950|NCT01841242|Blood Substitutes|blood substitutes|mesh-ancestor
92471951|NCT01841294|Lidocaine|lidocaine|mesh-list
92471952|NCT01841294|Anesthetics, Local|anesthetics, local|mesh-ancestor
92471953|NCT01841294|Anesthetics|anesthetics|mesh-ancestor
92471954|NCT01841294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471955|NCT01841294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471957|NCT01841294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471958|NCT01841294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92139721|NCT04041973|Artemether|artemether|mesh-list
92471959|NCT01841294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92471960|NCT01841294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92471961|NCT01841294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92471962|NCT01841294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471963|NCT01841307|Cromolyn Sodium|cromolyn sodium|mesh-list
92471964|NCT01841307|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92471965|NCT01841307|Immunologic Factors|immunologic factors|mesh-ancestor
92471966|NCT01841307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471967|NCT01841307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92471968|NCT01841307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92471969|NCT01841307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92471970|NCT01841307|Respiratory System Agents|respiratory system agents|mesh-ancestor
92471971|NCT01841320|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92471972|NCT01841320|Methadone|methadone|mesh-list
92471973|NCT01841320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92471974|NCT01841320|Narcotics|narcotics|mesh-ancestor
92471975|NCT01841320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92471976|NCT01841320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471977|NCT01841320|Analgesics|analgesics|mesh-ancestor
92471978|NCT01841320|Sensory System Agents|sensory system agents|mesh-ancestor
92471979|NCT01841320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92471980|NCT01841320|Antitussive Agents|antitussive agents|mesh-ancestor
92471981|NCT01841320|Respiratory System Agents|respiratory system agents|mesh-ancestor
92471982|NCT01841320|Antiviral Agents|antiviral agents|mesh-ancestor
92471983|NCT01841320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471984|NCT01841411|Metronidazole|metronidazole|mesh-list
92471985|NCT01841411|Acetylcysteine|acetylcysteine|mesh-list
92471986|NCT01841411|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92471987|NCT01841411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92471988|NCT01841411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92471989|NCT01841411|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92471990|NCT01841411|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92471991|NCT01841411|Antiviral Agents|antiviral agents|mesh-ancestor
92471992|NCT01841411|Expectorants|expectorants|mesh-ancestor
92471993|NCT01841411|Respiratory System Agents|respiratory system agents|mesh-ancestor
92471994|NCT01841411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92471995|NCT01841411|Antioxidants|antioxidants|mesh-ancestor
92471996|NCT01841411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92471997|NCT01841411|Protective Agents|protective agents|mesh-ancestor
92471998|NCT01841411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92471999|NCT01841411|Antidotes|antidotes|mesh-ancestor
92472000|NCT01841424|Benzocaine|benzocaine|mesh-list
92472001|NCT01841424|Anesthetics, Local|anesthetics, local|mesh-ancestor
92472002|NCT01841424|Anesthetics|anesthetics|mesh-ancestor
92472003|NCT01841424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472004|NCT01841424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472005|NCT01841424|Sensory System Agents|sensory system agents|mesh-ancestor
92472006|NCT01841424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472007|NCT01841463|Vemurafenib|vemurafenib|mesh-list
92472008|NCT01841463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472009|NCT01841463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472010|NCT01841463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472011|NCT01841463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472012|NCT01841502|Paroxetine|paroxetine|mesh-list
92472013|NCT01841502|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92472014|NCT01841502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92472015|NCT01841502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472016|NCT01841502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472017|NCT01841502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472018|NCT01841502|Serotonin Agents|serotonin agents|mesh-ancestor
92472019|NCT01841502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472020|NCT01841502|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92472021|NCT01841502|Antidepressive Agents|antidepressive agents|mesh-ancestor
92472022|NCT01841502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92472023|NCT01841502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92472024|NCT01841502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92472025|NCT01841502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472026|NCT01841515|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92472027|NCT01841515|Hemostatics|hemostatics|mesh-ancestor
92472028|NCT01841515|Coagulants|coagulants|mesh-ancestor
92472029|NCT01841515|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92472030|NCT01841515|Natriuretic Agents|natriuretic agents|mesh-ancestor
92472031|NCT01841515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472032|NCT01841658|Folic Acid|folic acid|mesh-list
92472033|NCT01841658|Hematinics|hematinics|mesh-ancestor
92472034|NCT01841658|Vitamin B Complex|vitamin b complex|mesh-ancestor
92472035|NCT01841658|Vitamins|vitamins|mesh-ancestor
92472036|NCT01841658|Micronutrients|micronutrients|mesh-ancestor
92472037|NCT01841658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472038|NCT01841684|Anacetrapib|anacetrapib|mesh-list
92472039|NCT01841684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92472040|NCT01841684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92472041|NCT01841684|Antimetabolites|antimetabolites|mesh-ancestor
92472042|NCT01841684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472043|NCT01841684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92472044|NCT01841775|Interferons|interferons|mesh-list
92472045|NCT01841775|Ribavirin|ribavirin|mesh-list
92472046|NCT01841775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472047|NCT01841775|Antiviral Agents|antiviral agents|mesh-ancestor
92472048|NCT01841775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472049|NCT01841775|Antimetabolites|antimetabolites|mesh-ancestor
92472050|NCT01841775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472051|NCT01841827|Cilostazol|cilostazol|mesh-list
92472052|NCT01841827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92472053|NCT01841827|Autonomic Agents|autonomic agents|mesh-ancestor
92472054|NCT01841827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472055|NCT01841827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472056|NCT01841827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92472057|NCT01841827|Respiratory System Agents|respiratory system agents|mesh-ancestor
92472058|NCT01841827|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92472059|NCT01841827|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92472060|NCT01841827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472061|NCT01841827|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92472062|NCT01841827|Vasodilator Agents|vasodilator agents|mesh-ancestor
92472063|NCT01841827|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92472064|NCT01841827|Protective Agents|protective agents|mesh-ancestor
92472065|NCT01841827|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92472066|NCT01841827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92472067|NCT01841827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472068|NCT01841996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92472069|NCT01842074|Bortezomib|bortezomib|mesh-list
92472070|NCT01842074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472072|NCT01842087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472073|NCT01842100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92472074|NCT01842100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472075|NCT01842113|Rifaximin|rifaximin|mesh-list
92472076|NCT01842113|Lactulose|lactulose|mesh-list
92472077|NCT01842113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472078|NCT01842113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472079|NCT01842113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472080|NCT01842139|Poly I-C|poly i-c|mesh-list
92472081|NCT01842139|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92472082|NCT01842139|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92472083|NCT01842139|Poly ICLC|poly iclc|mesh-list
92472084|NCT01842139|Basiliximab|basiliximab|mesh-list
92472085|NCT01842139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92472086|NCT01842139|Immunologic Factors|immunologic factors|mesh-ancestor
92472087|NCT01842139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472088|NCT01842139|Interferon Inducers|interferon inducers|mesh-ancestor
92472089|NCT01842139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472090|NCT01842139|Laxatives|laxatives|mesh-ancestor
92472091|NCT01842139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472092|NCT01842139|Antiviral Agents|antiviral agents|mesh-ancestor
92472093|NCT01842139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472094|NCT01842230|Niacin|niacin|mesh-list
92472095|NCT01842230|Amlodipine|amlodipine|mesh-list
92472096|NCT01842230|Telmisartan|telmisartan|mesh-list
92472097|NCT01842230|Atorvastatin|atorvastatin|mesh-list
92472098|NCT01842230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92472099|NCT01842230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92472100|NCT01842230|Antimetabolites|antimetabolites|mesh-ancestor
92472101|NCT01842230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472102|NCT01842230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92472103|NCT01842230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92472104|NCT01842230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472105|NCT01842230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92472106|NCT01842230|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92472107|NCT01842230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472108|NCT01842230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92472109|NCT01842230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472110|NCT01842230|Vasodilator Agents|vasodilator agents|mesh-ancestor
92472111|NCT01842230|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92472112|NCT01842230|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92472113|NCT01842230|Vitamin B Complex|vitamin b complex|mesh-ancestor
92472115|NCT01842230|Micronutrients|micronutrients|mesh-ancestor
92472117|NCT01842256|Telmisartan|telmisartan|mesh-list
92472118|NCT01842256|Atorvastatin|atorvastatin|mesh-list
92472119|NCT01842256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92472120|NCT01842256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92472121|NCT01842256|Antimetabolites|antimetabolites|mesh-ancestor
92472122|NCT01842256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472123|NCT01842256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92472124|NCT01842256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92472125|NCT01842256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472126|NCT01842256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92472127|NCT01842256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92472128|NCT01842256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472129|NCT01842256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92472130|NCT01842256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472131|NCT01842256|Vasodilator Agents|vasodilator agents|mesh-ancestor
92472132|NCT01842256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92472133|NCT01842256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92472134|NCT01842269|Mycophenolic Acid|mycophenolic acid|mesh-list
92472135|NCT01842269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92472136|NCT01842269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472137|NCT01842269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92472138|NCT01842269|Antitubercular Agents|antitubercular agents|mesh-ancestor
92472139|NCT01842269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472140|NCT01842269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472141|NCT01842269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472142|NCT01842269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472143|NCT01842321|Abiraterone Acetate|abiraterone acetate|mesh-list
92472144|NCT01842321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472145|NCT01842321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92472146|NCT01842321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472147|NCT01842321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472148|NCT01842321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92472149|NCT01842321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472150|NCT01842321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472151|NCT01842321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92472152|NCT01842373|Lidocaine|lidocaine|mesh-list
92472153|NCT01842373|Tetracaine|tetracaine|mesh-list
92472154|NCT01842373|Benzocaine|benzocaine|mesh-list
92472155|NCT01842373|Anesthetics, Local|anesthetics, local|mesh-ancestor
92472156|NCT01842373|Anesthetics|anesthetics|mesh-ancestor
92472157|NCT01842373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472158|NCT01842373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472159|NCT01842373|Sensory System Agents|sensory system agents|mesh-ancestor
92472160|NCT01842373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472161|NCT01842373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92472162|NCT01842373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92472163|NCT01842373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92472164|NCT01842373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472165|NCT01842373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472166|NCT01842516|Delpazolid|delpazolid|mesh-list
92472167|NCT01842516|Oxazolidinones|oxazolidinones|mesh-list
92472168|NCT01842516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472169|NCT01842516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472170|NCT01842516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92472171|NCT01842516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472172|NCT01842516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472173|NCT01842529|Botulinum Toxins|botulinum toxins|mesh-list
92472174|NCT01842529|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92472175|NCT01842529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472176|NCT01842529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472178|NCT01842529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472179|NCT01842529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472180|NCT01842893|Fentanyl|fentanyl|mesh-list
92472181|NCT01842893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92472183|NCT01842893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472184|NCT01842893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472185|NCT01842893|Analgesics|analgesics|mesh-ancestor
92472186|NCT01842893|Sensory System Agents|sensory system agents|mesh-ancestor
92472187|NCT01842893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472188|NCT01842893|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92472189|NCT01842893|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92472190|NCT01842893|Anesthetics, General|anesthetics, general|mesh-ancestor
92472191|NCT01842893|Anesthetics|anesthetics|mesh-ancestor
92472192|NCT01842932|Bromides|bromides|mesh-list
92472193|NCT01842932|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92472194|NCT01842932|Cimetropium|cimetropium|mesh-list
92472195|NCT01842932|Anticonvulsants|anticonvulsants|mesh-ancestor
92472196|NCT01842932|Cholinergic Agents|cholinergic agents|mesh-ancestor
92472197|NCT01842932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472198|NCT01842932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472199|NCT01842932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472200|NCT01842932|Parasympatholytics|parasympatholytics|mesh-ancestor
92472201|NCT01842932|Autonomic Agents|autonomic agents|mesh-ancestor
92472202|NCT01842932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472203|NCT01843010|Parecoxib|parecoxib|mesh-list
92472204|NCT01843010|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92472205|NCT01843010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92472206|NCT01843010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472207|NCT01843010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472208|NCT01843010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92472209|NCT01843010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92472210|NCT01843010|Analgesics|analgesics|mesh-ancestor
92472211|NCT01843010|Sensory System Agents|sensory system agents|mesh-ancestor
92472212|NCT01843010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472213|NCT01843010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197145|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92197146|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92197147|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197148|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197149|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
92197150|NCT01674686|Atorvastatin|atorvastatin|mesh-list
92472214|NCT01843010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472215|NCT01843010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92472217|NCT01843075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92472218|NCT01843075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472219|NCT01843075|Incretins|incretins|mesh-ancestor
92472220|NCT01843075|Hormones|hormones|mesh-ancestor
92472221|NCT01843075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472222|NCT01843088|Mannitol|mannitol|mesh-list
92472223|NCT01843088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92472224|NCT01843088|Diuretics|diuretics|mesh-ancestor
92472225|NCT01843088|Natriuretic Agents|natriuretic agents|mesh-ancestor
92472226|NCT01843088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472227|NCT01843127|Exenatide|exenatide|mesh-list
92472228|NCT01843127|Ranolazine|ranolazine|mesh-list
92472229|NCT01843127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92472230|NCT01843127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472231|NCT01843127|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92472232|NCT01843127|Incretins|incretins|mesh-ancestor
92472233|NCT01843127|Hormones|hormones|mesh-ancestor
92472234|NCT01843127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472235|NCT01843127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92472236|NCT01843127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472237|NCT01843127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472238|NCT01843153|Ropivacaine|ropivacaine|mesh-list
92472239|NCT01843153|Anesthetics, Local|anesthetics, local|mesh-ancestor
92472240|NCT01843153|Anesthetics|anesthetics|mesh-ancestor
92472241|NCT01843153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472242|NCT01843153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472243|NCT01843153|Sensory System Agents|sensory system agents|mesh-ancestor
92472244|NCT01843153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472245|NCT01843166|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92472246|NCT01843166|Estrogens|estrogens|mesh-ancestor
92472247|NCT01843166|Hormones|hormones|mesh-ancestor
92472248|NCT01843166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472249|NCT01843166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472250|NCT01843179|Cytarabine|cytarabine|mesh-list
92472251|NCT01843179|Sulindac|sulindac|mesh-list
92472252|NCT01843179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472253|NCT01843179|Antimetabolites|antimetabolites|mesh-ancestor
92472254|NCT01843179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472255|NCT01843179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472256|NCT01843179|Antiviral Agents|antiviral agents|mesh-ancestor
92472257|NCT01843179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472258|NCT01843179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472259|NCT01843179|Immunologic Factors|immunologic factors|mesh-ancestor
92472260|NCT01843179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472261|NCT01843179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92472262|NCT01843179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92472263|NCT01843179|Analgesics|analgesics|mesh-ancestor
92472264|NCT01843179|Sensory System Agents|sensory system agents|mesh-ancestor
92472265|NCT01843179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472266|NCT01843179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472267|NCT01843179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92472268|NCT01843179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92472269|NCT01843179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472270|NCT01843257|Ethanol|ethanol|mesh-list
92472271|NCT01843257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92472272|NCT01843257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472273|NCT01843257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472274|NCT01843257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472275|NCT01843296|Magnesium Sulfate|magnesium sulfate|mesh-list
92472276|NCT01843296|Fentanyl|fentanyl|mesh-list
92472277|NCT01843296|Bupivacaine|bupivacaine|mesh-list
92472278|NCT01843296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92472279|NCT01843296|Anesthetics|anesthetics|mesh-ancestor
92472280|NCT01843296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472281|NCT01843296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472282|NCT01843296|Sensory System Agents|sensory system agents|mesh-ancestor
92472283|NCT01843296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472284|NCT01843296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92472285|NCT01843296|Narcotics|narcotics|mesh-ancestor
92472286|NCT01843296|Analgesics|analgesics|mesh-ancestor
92472287|NCT01843296|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92472288|NCT01843296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92472289|NCT01843296|Anesthetics, General|anesthetics, general|mesh-ancestor
92472290|NCT01843296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92472291|NCT01843296|Anticonvulsants|anticonvulsants|mesh-ancestor
92472292|NCT01843296|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92472293|NCT01843296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472294|NCT01843296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472295|NCT01843296|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92472296|NCT01843296|Tocolytic Agents|tocolytic agents|mesh-ancestor
92472297|NCT01843296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92472298|NCT01843309|Spironolactone|spironolactone|mesh-list
92472299|NCT01843309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92472300|NCT01843309|Hormone Antagonists|hormone antagonists|mesh-ancestor
92472301|NCT01843309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472302|NCT01843309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472303|NCT01843309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92472304|NCT01843309|Diuretics|diuretics|mesh-ancestor
92472305|NCT01843309|Natriuretic Agents|natriuretic agents|mesh-ancestor
92472306|NCT01843439|Pyridoxine|pyridoxine|mesh-list
92472307|NCT01843439|Vitamin B Complex|vitamin b complex|mesh-ancestor
92472308|NCT01843439|Vitamins|vitamins|mesh-ancestor
92472309|NCT01843439|Micronutrients|micronutrients|mesh-ancestor
92472310|NCT01843439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472311|NCT01843452|Capecitabine|capecitabine|mesh-list
92472312|NCT01843452|Mitomycins|mitomycins|mesh-list
92472313|NCT01843452|Mitomycin|mitomycin|mesh-list
92472314|NCT01843452|Panitumumab|panitumumab|mesh-list
92472315|NCT01843452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472316|NCT01843452|Antimetabolites|antimetabolites|mesh-ancestor
92472317|NCT01843452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472318|NCT01843452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472319|NCT01843452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92472320|NCT01843452|Alkylating Agents|alkylating agents|mesh-ancestor
92472321|NCT01843452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92472322|NCT01843452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472323|NCT01843452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92472324|NCT01843530|Cortisone|cortisone|mesh-list
92472325|NCT01843530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472326|NCT01843647|Cisplatin|cisplatin|mesh-list
92472327|NCT01843647|Vinorelbine|vinorelbine|mesh-list
92472328|NCT01843647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472329|NCT01843647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92472330|NCT01843647|Tubulin Modulators|tubulin modulators|mesh-ancestor
92472331|NCT01843647|Antimitotic Agents|antimitotic agents|mesh-ancestor
92472332|NCT01843647|Mitosis Modulators|mitosis modulators|mesh-ancestor
92472333|NCT01843647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472335|NCT01843699|Anticonvulsants|anticonvulsants|mesh-ancestor
92472336|NCT01843699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92472337|NCT01843699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472338|NCT01843725|Capecitabine|capecitabine|mesh-list
92472339|NCT01843725|Aflibercept|aflibercept|mesh-list
92472340|NCT01843725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472341|NCT01843725|Antimetabolites|antimetabolites|mesh-ancestor
92472342|NCT01843725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472343|NCT01843725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472344|NCT01843725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92472345|NCT01843725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92472346|NCT01843725|Growth Substances|growth substances|mesh-ancestor
92472347|NCT01843725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472348|NCT01843725|Growth Inhibitors|growth inhibitors|mesh-ancestor
92472349|NCT01843738|Vemurafenib|vemurafenib|mesh-list
92472350|NCT01843738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472351|NCT01843738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472352|NCT01843738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472353|NCT01843738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472354|NCT01843829|Paclitaxel|paclitaxel|mesh-list
92472355|NCT01843829|Carboplatin|carboplatin|mesh-list
92472356|NCT01843829|Capecitabine|capecitabine|mesh-list
92472357|NCT01843829|Oxaliplatin|oxaliplatin|mesh-list
92472358|NCT01843829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92472359|NCT01843829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472360|NCT01843829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92472361|NCT01843829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92472362|NCT01843829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92472363|NCT01843829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472364|NCT01843829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92197296|NCT00680797|Testosterone|testosterone|mesh-list
92472365|NCT01843829|Antimetabolites|antimetabolites|mesh-ancestor
92472366|NCT01843868|Prednisolone|prednisolone|mesh-list
92472367|NCT01843868|Cyclophosphamide|cyclophosphamide|mesh-list
92472368|NCT01843868|Doxorubicin|doxorubicin|mesh-list
92472369|NCT01843868|Vincristine|vincristine|mesh-list
92472370|NCT01843868|Lorazepam|lorazepam|mesh-list
92472371|NCT01843868|Ondansetron|ondansetron|mesh-list
92472372|NCT01843868|Aprepitant|aprepitant|mesh-list
92472373|NCT01843868|Palonosetron|palonosetron|mesh-list
92472374|NCT01843868|Metoclopramide|metoclopramide|mesh-list
92472375|NCT01843868|Granisetron|granisetron|mesh-list
92472376|NCT01843868|Prochlorperazine|prochlorperazine|mesh-list
92472377|NCT01843868|Tropisetron|tropisetron|mesh-list
92472378|NCT01843868|Antiemetics|antiemetics|mesh-list
92472379|NCT01843868|Emetics|emetics|mesh-list
92472380|NCT01843868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472381|NCT01843868|Immunologic Factors|immunologic factors|mesh-ancestor
92472382|NCT01843868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472383|NCT01843868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92472384|NCT01843868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92472385|NCT01843868|Alkylating Agents|alkylating agents|mesh-ancestor
92472386|NCT01843868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472387|NCT01843868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472388|NCT01843868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92472389|NCT01843868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92472390|NCT01843868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92472391|NCT01843868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92472392|NCT01843868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472393|NCT01843868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92472394|NCT01843868|Tubulin Modulators|tubulin modulators|mesh-ancestor
92472395|NCT01843868|Antimitotic Agents|antimitotic agents|mesh-ancestor
92472396|NCT01843868|Mitosis Modulators|mitosis modulators|mesh-ancestor
92472397|NCT01843868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472398|NCT01843868|Glucocorticoids|glucocorticoids|mesh-ancestor
92472399|NCT01843868|Hormones|hormones|mesh-ancestor
92472400|NCT01843868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472401|NCT01843868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92472402|NCT01843868|Autonomic Agents|autonomic agents|mesh-ancestor
92472403|NCT01843868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472404|NCT01843868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472405|NCT01843868|Antipruritics|antipruritics|mesh-ancestor
92472406|NCT01843868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92472407|NCT01843868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92472408|NCT01843868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92472409|NCT01843868|Serotonin Agents|serotonin agents|mesh-ancestor
92472410|NCT01843868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472411|NCT01843868|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92472412|NCT01843868|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92472413|NCT01843868|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92472414|NCT01843868|Dopamine Agents|dopamine agents|mesh-ancestor
92472415|NCT01843868|Anticonvulsants|anticonvulsants|mesh-ancestor
92472416|NCT01843868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92472417|NCT01843868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472418|NCT01843868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92472419|NCT01843868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92472420|NCT01843868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92472421|NCT01843868|GABA Modulators|gaba modulators|mesh-ancestor
92472422|NCT01843868|GABA Agents|gaba agents|mesh-ancestor
92472423|NCT01843868|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92472424|NCT01843998|Sirolimus|sirolimus|mesh-list
92472425|NCT01843998|Temsirolimus|temsirolimus|mesh-list
92472426|NCT01843998|MTOR Inhibitors|mtor inhibitors|mesh-list
92472427|NCT01843998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472428|NCT01843998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472429|NCT01843998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92472430|NCT01843998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472431|NCT01843998|Antifungal Agents|antifungal agents|mesh-ancestor
92472432|NCT01843998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472433|NCT01843998|Immunologic Factors|immunologic factors|mesh-ancestor
92472434|NCT01843998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472435|NCT01843998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472436|NCT01843998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472437|NCT01843998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472438|NCT01844024|Misoprostol|misoprostol|mesh-list
92472439|NCT01844024|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92472440|NCT01844024|Abortifacient Agents|abortifacient agents|mesh-ancestor
92472441|NCT01844024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92472442|NCT01844024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472443|NCT01844024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92472444|NCT01844024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472445|NCT01844024|Oxytocics|oxytocics|mesh-ancestor
92472446|NCT01844063|Antiviral Agents|antiviral agents|mesh-list
92472447|NCT01844063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472448|NCT01844141|Ethanol|ethanol|mesh-list
92472449|NCT01844141|Chlorhexidine|chlorhexidine|mesh-list
92472450|NCT01844141|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92472451|NCT01844141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92472452|NCT01844141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472453|NCT01844141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472454|NCT01844141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472455|NCT01844141|Disinfectants|disinfectants|mesh-ancestor
92472456|NCT01844141|Dermatologic Agents|dermatologic agents|mesh-ancestor
92472457|NCT01844323|Palbociclib|palbociclib|mesh-list
92472458|NCT01844323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472459|NCT01844323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472460|NCT01844323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472461|NCT01844323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472462|NCT01844401|Albuterol|albuterol|mesh-list
92472463|NCT01844401|Procaterol|procaterol|mesh-list
92472464|NCT01844401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92472465|NCT01844401|Autonomic Agents|autonomic agents|mesh-ancestor
92348766|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472466|NCT01844401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472467|NCT01844401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472468|NCT01844401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92472469|NCT01844401|Respiratory System Agents|respiratory system agents|mesh-ancestor
92472470|NCT01844401|Tocolytic Agents|tocolytic agents|mesh-ancestor
92472471|NCT01844401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92531754|NCT05641337|Incretins|incretins|mesh-ancestor
92472472|NCT01844401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92472473|NCT01844401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92472474|NCT01844401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92472475|NCT01844401|Adrenergic Agents|adrenergic agents|mesh-ancestor
92472476|NCT01844401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472477|NCT01844401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472478|NCT01844401|Sympathomimetics|sympathomimetics|mesh-ancestor
92472479|NCT01844427|Memantine|memantine|mesh-list
92472480|NCT01844427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92472481|NCT01844427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92472482|NCT01844427|Dopamine Agents|dopamine agents|mesh-ancestor
92472483|NCT01844427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472484|NCT01844427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472485|NCT01844427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472486|NCT01844427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92472487|NCT01844427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92472488|NCT01844622|Domperidone|domperidone|mesh-list
92472489|NCT01844622|Antiemetics|antiemetics|mesh-ancestor
92472490|NCT01844622|Autonomic Agents|autonomic agents|mesh-ancestor
92472491|NCT01844622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472492|NCT01844622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472493|NCT01844622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472494|NCT01844622|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92472495|NCT01844622|Dopamine Agents|dopamine agents|mesh-ancestor
92472496|NCT01844622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472497|NCT01844622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472498|NCT01844635|Thymoglobulin|thymoglobulin|mesh-list
92472499|NCT01844635|Immunologic Factors|immunologic factors|mesh-ancestor
92472500|NCT01844635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472501|NCT01844635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472502|NCT01844648|Tropicamide|tropicamide|mesh-list
92472503|NCT01844648|Mydriatics|mydriatics|mesh-ancestor
92472504|NCT01844648|Autonomic Agents|autonomic agents|mesh-ancestor
92472505|NCT01844648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472506|NCT01844648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472507|NCT01844648|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92472508|NCT01844648|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92472509|NCT01844648|Cholinergic Agents|cholinergic agents|mesh-ancestor
92472510|NCT01844648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472511|NCT01844648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472512|NCT01844674|Vemurafenib|vemurafenib|mesh-list
92472513|NCT01844674|Tizanidine|tizanidine|mesh-list
92472514|NCT01844674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472515|NCT01844674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472516|NCT01844674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472517|NCT01844674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197451|NCT03818672|Rifaximin|rifaximin|mesh-list
92472518|NCT01844674|Analgesics|analgesics|mesh-ancestor
92472519|NCT01844674|Sensory System Agents|sensory system agents|mesh-ancestor
92472520|NCT01844674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472521|NCT01844674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472522|NCT01844674|Anticonvulsants|anticonvulsants|mesh-ancestor
92472523|NCT01844674|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92472524|NCT01844674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92472525|NCT01844674|Parasympatholytics|parasympatholytics|mesh-ancestor
92472526|NCT01844674|Autonomic Agents|autonomic agents|mesh-ancestor
92472527|NCT01844674|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92472528|NCT01844674|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92472529|NCT01844674|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92472530|NCT01844674|Adrenergic Agents|adrenergic agents|mesh-ancestor
92472531|NCT01844674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472532|NCT01844791|Pentamidine|pentamidine|mesh-list
92472533|NCT01844791|Gemcitabine|gemcitabine|mesh-list
92472534|NCT01844791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472535|NCT01844791|Antimetabolites|antimetabolites|mesh-ancestor
92472536|NCT01844791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472537|NCT01844791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472538|NCT01844791|Antifungal Agents|antifungal agents|mesh-ancestor
92472539|NCT01844791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472540|NCT01844791|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92472541|NCT01844791|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92472542|NCT01844791|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92472543|NCT01844804|Infliximab|infliximab|mesh-list
92472544|NCT01844804|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92472545|NCT01844804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472546|NCT01844804|Dermatologic Agents|dermatologic agents|mesh-ancestor
92472547|NCT01844804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472548|NCT01844804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92472549|NCT01844869|Homoharringtonine|homoharringtonine|mesh-list
92472550|NCT01844869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92472551|NCT01844869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472552|NCT01844869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92472553|NCT01844869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472554|NCT01844869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472555|NCT01844947|Sorafenib|sorafenib|mesh-list
92472556|NCT01844947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472557|NCT01844947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472558|NCT01844947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472559|NCT01844947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472560|NCT01845012|Dialysis Solutions|dialysis solutions|mesh-list
92472561|NCT01845012|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92472562|NCT01845038|Timolol|timolol|mesh-list
92472563|NCT01845038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472564|NCT01845038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92472565|NCT01845038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92472566|NCT01845038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92472567|NCT01845038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472568|NCT01845038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472569|NCT01845038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92472570|NCT01845038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92472571|NCT01845064|Kallikreins|kallikreins|mesh-list
92472572|NCT01845064|Coagulants|coagulants|mesh-ancestor
92472573|NCT01845064|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92472574|NCT01845064|Fertility Agents|fertility agents|mesh-ancestor
92472575|NCT01845064|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92472576|NCT01845064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472577|NCT01845090|Calcium Carbonate|calcium carbonate|mesh-list
92472578|NCT01845090|Calcium|calcium|mesh-list
92472579|NCT01845090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92472580|NCT01845090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472581|NCT01845090|Antacids|antacids|mesh-ancestor
92472582|NCT01845090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472583|NCT01845090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472584|NCT01845142|Vitamin D|vitamin d|mesh-list
92472585|NCT01845142|Cholecalciferol|cholecalciferol|mesh-list
92472586|NCT01845142|Vitamins|vitamins|mesh-ancestor
92472587|NCT01845142|Micronutrients|micronutrients|mesh-ancestor
92472588|NCT01845142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472589|NCT01845142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92472590|NCT01845142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92197553|NCT01101464|Asenapine|asenapine|mesh-list
92472591|NCT01845194|Metoprolol|metoprolol|mesh-list
92472592|NCT01845194|Talinolol|talinolol|mesh-list
92472593|NCT01845194|Torsemide|torsemide|mesh-list
92472594|NCT01845194|Midazolam|midazolam|mesh-list
92472595|NCT01845194|Codeine|codeine|mesh-list
92472596|NCT01845194|Caffeine|caffeine|mesh-list
92472597|NCT01845194|Pravastatin|pravastatin|mesh-list
92472598|NCT01845194|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92472599|NCT01845194|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92472600|NCT01845194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472601|NCT01845194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472602|NCT01845194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92472603|NCT01845194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92472604|NCT01845194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92472605|NCT01845194|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92472606|NCT01845194|Anesthetics, General|anesthetics, general|mesh-ancestor
92472607|NCT01845194|Anesthetics|anesthetics|mesh-ancestor
92472608|NCT01845194|GABA Modulators|gaba modulators|mesh-ancestor
92472609|NCT01845194|GABA Agents|gaba agents|mesh-ancestor
92472610|NCT01845194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472611|NCT01845194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472612|NCT01845194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92472613|NCT01845194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92472614|NCT01845194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472615|NCT01845194|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92472616|NCT01845194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92472617|NCT01845194|Purinergic Agents|purinergic agents|mesh-ancestor
92472618|NCT01845194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92472619|NCT01845194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92472620|NCT01845194|Sympatholytics|sympatholytics|mesh-ancestor
92472621|NCT01845194|Autonomic Agents|autonomic agents|mesh-ancestor
92472622|NCT01845194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472623|NCT01845194|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92472624|NCT01845194|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92472625|NCT01845194|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92472626|NCT01845194|Adrenergic Agents|adrenergic agents|mesh-ancestor
92472627|NCT01845194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92472628|NCT01845194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92472629|NCT01845194|Antimetabolites|antimetabolites|mesh-ancestor
92472630|NCT01845194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92472631|NCT01845194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92472632|NCT01845194|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92472633|NCT01845194|Narcotics|narcotics|mesh-ancestor
92472634|NCT01845194|Analgesics|analgesics|mesh-ancestor
92472635|NCT01845194|Sensory System Agents|sensory system agents|mesh-ancestor
92472636|NCT01845194|Antitussive Agents|antitussive agents|mesh-ancestor
92472637|NCT01845194|Respiratory System Agents|respiratory system agents|mesh-ancestor
92472638|NCT01845194|Diuretics|diuretics|mesh-ancestor
92472639|NCT01845194|Natriuretic Agents|natriuretic agents|mesh-ancestor
92472640|NCT01845194|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92472641|NCT01845194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472642|NCT01845246|Colistin|colistin|mesh-list
92472643|NCT01845246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472644|NCT01845246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472645|NCT01845259|Liraglutide|liraglutide|mesh-list
92472646|NCT01845259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92472647|NCT01845259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472648|NCT01845259|Incretins|incretins|mesh-ancestor
92472649|NCT01845259|Hormones|hormones|mesh-ancestor
92472650|NCT01845259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472651|NCT01845272|Amlodipine|amlodipine|mesh-list
92472652|NCT01845272|Candesartan|candesartan|mesh-list
92472653|NCT01845272|Candesartan cilexetil|candesartan cilexetil|mesh-list
92472654|NCT01845272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92472655|NCT01845272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92472656|NCT01845272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92472657|NCT01845272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472658|NCT01845272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92472659|NCT01845272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472660|NCT01845272|Vasodilator Agents|vasodilator agents|mesh-ancestor
92472661|NCT01845272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92472662|NCT01845272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92472663|NCT01845298|Rifampin|rifampin|mesh-list
92472664|NCT01845298|Rifamycins|rifamycins|mesh-list
92472665|NCT01845298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92472666|NCT01845298|Antitubercular Agents|antitubercular agents|mesh-ancestor
92472667|NCT01845298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197604|NCT03778580|Pyridoxamine|pyridoxamine|mesh-list
92472668|NCT01845298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472669|NCT01845298|Leprostatic Agents|leprostatic agents|mesh-ancestor
92472670|NCT01845298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92472671|NCT01845298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472672|NCT01845298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472673|NCT01845298|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92472674|NCT01845298|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92472675|NCT01845298|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92472676|NCT01845298|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92472677|NCT01845298|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92472678|NCT01845298|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92472679|NCT01845363|Anti-Infective Agents|anti-infective agents|mesh-list
92472680|NCT01845363|Cefazolin|cefazolin|mesh-list
92472681|NCT01845363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92472682|NCT01845376|Anesthetics|anesthetics|mesh-list
92472683|NCT01845376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472684|NCT01845376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472685|NCT01845428|Pravastatin|pravastatin|mesh-list
92472686|NCT01845428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92472687|NCT01845428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92472688|NCT01845428|Antimetabolites|antimetabolites|mesh-ancestor
92472689|NCT01845428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472690|NCT01845428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92472691|NCT01845428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92472692|NCT01845428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472693|NCT01845493|Sulforaphane|sulforaphane|mesh-list
92472694|NCT01845493|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92472695|NCT01845493|Protective Agents|protective agents|mesh-ancestor
92472696|NCT01845493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472697|NCT01845493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472698|NCT01845532|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92472699|NCT01845532|Anesthetics, Local|anesthetics, local|mesh-ancestor
92472700|NCT01845532|Anesthetics|anesthetics|mesh-ancestor
92472701|NCT01845532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472702|NCT01845532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472703|NCT01845532|Sensory System Agents|sensory system agents|mesh-ancestor
92472704|NCT01845532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472705|NCT01845532|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92472706|NCT01845558|Wobenzym|wobenzym|mesh-list
92472707|NCT01845558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92472708|NCT01845558|Immunologic Factors|immunologic factors|mesh-ancestor
92472709|NCT01845558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472710|NCT01845584|Immunoglobulins|immunoglobulins|mesh-list
92472711|NCT01845584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92472712|NCT01845584|gamma-Globulins|gamma-globulins|mesh-list
92472713|NCT01845584|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92472714|NCT01845584|Immunologic Factors|immunologic factors|mesh-ancestor
92472715|NCT01845584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472716|NCT01845610|Manganese|manganese|mesh-list
92472717|NCT01845610|Trace Elements|trace elements|mesh-ancestor
92472718|NCT01845610|Micronutrients|micronutrients|mesh-ancestor
92472719|NCT01845610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472720|NCT01845675|Temozolomide|temozolomide|mesh-list
92472721|NCT01845675|Dacarbazine|dacarbazine|mesh-list
92472722|NCT01845675|Endostatins|endostatins|mesh-list
92472723|NCT01845675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92472724|NCT01845675|Alkylating Agents|alkylating agents|mesh-ancestor
92472725|NCT01845675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472726|NCT01845675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472727|NCT01845675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92472728|NCT01845675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92472729|NCT01845675|Growth Substances|growth substances|mesh-ancestor
92472730|NCT01845675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472731|NCT01845675|Growth Inhibitors|growth inhibitors|mesh-ancestor
92472732|NCT01845701|Artesunate|artesunate|mesh-list
92472733|NCT01845701|Lumefantrine|lumefantrine|mesh-list
92472734|NCT01845701|Artemether|artemether|mesh-list
92472735|NCT01845701|Piperaquine|piperaquine|mesh-list
92472736|NCT01845701|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92472737|NCT01845701|Amodiaquine|amodiaquine|mesh-list
92472738|NCT01845701|Artenimol|artenimol|mesh-list
92472739|NCT01845701|Antimalarials|antimalarials|mesh-ancestor
92472740|NCT01845701|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92472741|NCT01845701|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92472742|NCT01845701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472743|NCT01845701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197677|NCT03714620|Ketamine|ketamine|mesh-list
92472744|NCT01845701|Antiviral Agents|antiviral agents|mesh-ancestor
92472745|NCT01845701|Schistosomicides|schistosomicides|mesh-ancestor
92472746|NCT01845701|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92472747|NCT01845701|Anthelmintics|anthelmintics|mesh-ancestor
92472748|NCT01845727|Amphotericin B|amphotericin b|mesh-list
92472749|NCT01845727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92472750|NCT01845727|Amebicides|amebicides|mesh-ancestor
92472751|NCT01845727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92472752|NCT01845727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92140531|NCT01396057|Hormones|hormones|mesh-ancestor
92472753|NCT01845727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472754|NCT01845727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472755|NCT01845727|Antifungal Agents|antifungal agents|mesh-ancestor
92472756|NCT01845844|Ranibizumab|ranibizumab|mesh-list
92472757|NCT01845844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92472758|NCT01845844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92472759|NCT01845844|Growth Substances|growth substances|mesh-ancestor
92472760|NCT01845844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472761|NCT01845844|Growth Inhibitors|growth inhibitors|mesh-ancestor
92472762|NCT01845844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472763|NCT01846026|Vitamin D|vitamin d|mesh-list
92472764|NCT01846026|Cholecalciferol|cholecalciferol|mesh-list
92472765|NCT01846026|Vitamins|vitamins|mesh-ancestor
92472766|NCT01846026|Micronutrients|micronutrients|mesh-ancestor
92472767|NCT01846026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472768|NCT01846026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92472769|NCT01846026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92472770|NCT01846117|Vitamin D|vitamin d|mesh-list
92472771|NCT01846117|Secoisolariciresinol|secoisolariciresinol|mesh-list
92472772|NCT01846117|Vitamins|vitamins|mesh-ancestor
92472773|NCT01846117|Micronutrients|micronutrients|mesh-ancestor
92472774|NCT01846117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472775|NCT01846117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92472776|NCT01846117|Phytoestrogens|phytoestrogens|mesh-ancestor
92472777|NCT01846117|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92472778|NCT01846117|Estrogens|estrogens|mesh-ancestor
92472779|NCT01846117|Hormones|hormones|mesh-ancestor
92472780|NCT01846117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472781|NCT01846143|Poly ICLC|poly iclc|mesh-list
92472782|NCT01846143|Immunologic Factors|immunologic factors|mesh-ancestor
92472783|NCT01846143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472784|NCT01846143|Interferon Inducers|interferon inducers|mesh-ancestor
92472785|NCT01846273|Ranibizumab|ranibizumab|mesh-list
92472786|NCT01846273|Verteporfin|verteporfin|mesh-list
92472787|NCT01846273|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92472788|NCT01846273|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92472789|NCT01846273|Growth Substances|growth substances|mesh-ancestor
92472790|NCT01846273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472791|NCT01846273|Growth Inhibitors|growth inhibitors|mesh-ancestor
92472792|NCT01846273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472793|NCT01846273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92472794|NCT01846273|Dermatologic Agents|dermatologic agents|mesh-ancestor
92472795|NCT01846325|Vitamin E|vitamin e|mesh-list
92472796|NCT01846325|Vitamins|vitamins|mesh-ancestor
92472797|NCT01846325|Micronutrients|micronutrients|mesh-ancestor
92472798|NCT01846325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472799|NCT01846325|Antioxidants|antioxidants|mesh-ancestor
92472800|NCT01846325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472801|NCT01846325|Protective Agents|protective agents|mesh-ancestor
92472802|NCT01846364|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92472803|NCT01846364|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92472804|NCT01846364|Protective Agents|protective agents|mesh-ancestor
92472805|NCT01846364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472806|NCT01846364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472807|NCT01846390|Dexamethasone|dexamethasone|mesh-list
92472808|NCT01846390|Gemcitabine|gemcitabine|mesh-list
92472809|NCT01846390|Romidepsin|romidepsin|mesh-list
92472810|NCT01846390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472811|NCT01846390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472812|NCT01846390|Antiemetics|antiemetics|mesh-ancestor
92472813|NCT01846390|Autonomic Agents|autonomic agents|mesh-ancestor
92472814|NCT01846390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472815|NCT01846390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472816|NCT01846390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472817|NCT01846390|Glucocorticoids|glucocorticoids|mesh-ancestor
92472818|NCT01846390|Hormones|hormones|mesh-ancestor
92472819|NCT01846390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472820|NCT01846390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92472821|NCT01846390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472822|NCT01846390|Antimetabolites|antimetabolites|mesh-ancestor
92472823|NCT01846390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472824|NCT01846390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92472825|NCT01846390|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92472827|NCT01846559|Clopidogrel|clopidogrel|mesh-list
92472828|NCT01846559|Ticagrelor|ticagrelor|mesh-list
92472829|NCT01846559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92472830|NCT01846559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92472831|NCT01846559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92472832|NCT01846559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92472833|NCT01846559|Purinergic Agents|purinergic agents|mesh-ancestor
92472834|NCT01846559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472835|NCT01846559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472836|NCT01846559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472837|NCT01846650|Capecitabine|capecitabine|mesh-list
92472838|NCT01846650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472839|NCT01846650|Antimetabolites|antimetabolites|mesh-ancestor
92472840|NCT01846650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472842|NCT01846806|Rifaximin|rifaximin|mesh-list
92472843|NCT01846806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472844|NCT01846806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472845|NCT01846806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472846|NCT01846832|Interferons|interferons|mesh-list
92472847|NCT01846832|Ribavirin|ribavirin|mesh-list
92472848|NCT01846832|Interferon-alpha|interferon-alpha|mesh-list
92472849|NCT01846832|Interferon alpha-2|interferon alpha-2|mesh-list
92472850|NCT01846832|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92472851|NCT01846832|Simeprevir|simeprevir|mesh-list
92472852|NCT01846832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472853|NCT01846832|Antiviral Agents|antiviral agents|mesh-ancestor
92472854|NCT01846832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472855|NCT01846832|Antimetabolites|antimetabolites|mesh-ancestor
92472856|NCT01846832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472857|NCT01846832|Immunologic Factors|immunologic factors|mesh-ancestor
92472858|NCT01846832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472859|NCT01846832|Protease Inhibitors|protease inhibitors|mesh-ancestor
92472860|NCT01846832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472861|NCT01846962|Fluticasone|fluticasone|mesh-list
92472862|NCT01846962|Budesonide|budesonide|mesh-list
92472863|NCT01846962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472864|NCT01846962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92472865|NCT01846962|Autonomic Agents|autonomic agents|mesh-ancestor
92472866|NCT01846962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472867|NCT01846962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472868|NCT01846962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92472869|NCT01846962|Respiratory System Agents|respiratory system agents|mesh-ancestor
92472870|NCT01846962|Dermatologic Agents|dermatologic agents|mesh-ancestor
92472871|NCT01846962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92472872|NCT01846962|Glucocorticoids|glucocorticoids|mesh-ancestor
92472873|NCT01846962|Hormones|hormones|mesh-ancestor
92472874|NCT01846962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472875|NCT01846975|Abatacept|abatacept|mesh-list
92472876|NCT01846975|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92472877|NCT01846975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472878|NCT01846975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92472879|NCT01846975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472880|NCT01846975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92472881|NCT01846975|Immunologic Factors|immunologic factors|mesh-ancestor
92472882|NCT01846975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472883|NCT01846975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92472884|NCT01847144|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92472885|NCT01847144|Gliclazide|gliclazide|mesh-list
92472886|NCT01847144|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92472887|NCT01847144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92472888|NCT01847144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472889|NCT01847144|Incretins|incretins|mesh-ancestor
92472890|NCT01847144|Hormones|hormones|mesh-ancestor
92472891|NCT01847144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92472892|NCT01847144|Protease Inhibitors|protease inhibitors|mesh-ancestor
92472893|NCT01847144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472894|NCT01847144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472895|NCT01847157|Anesthetics|anesthetics|mesh-list
92472896|NCT01847157|Prilocaine|prilocaine|mesh-list
92197826|NCT03610490|Analgesics|analgesics|mesh-ancestor
92472897|NCT01847157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472898|NCT01847157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472899|NCT01847157|Anesthetics, Local|anesthetics, local|mesh-ancestor
92348788|NCT01571232|Hormones|hormones|mesh-ancestor
92472900|NCT01847157|Sensory System Agents|sensory system agents|mesh-ancestor
92472901|NCT01847157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472902|NCT01847235|Temozolomide|temozolomide|mesh-list
92472903|NCT01847235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92472904|NCT01847235|Alkylating Agents|alkylating agents|mesh-ancestor
92472905|NCT01847235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472906|NCT01847235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472907|NCT01847339|Bupivacaine|bupivacaine|mesh-list
92472908|NCT01847339|Anesthetics, Local|anesthetics, local|mesh-ancestor
92472909|NCT01847339|Anesthetics|anesthetics|mesh-ancestor
92472910|NCT01847339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92472911|NCT01847339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472912|NCT01847339|Sensory System Agents|sensory system agents|mesh-ancestor
92472913|NCT01847339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472914|NCT01847404|Pantoprazole|pantoprazole|mesh-list
92472915|NCT01847404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472916|NCT01847404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472917|NCT01847404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92472918|NCT01847404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472919|NCT01847404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92472920|NCT01847417|Pantoprazole|pantoprazole|mesh-list
92472921|NCT01847417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92472922|NCT01847417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92472923|NCT01847417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92472924|NCT01847417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472925|NCT01847417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472926|NCT01847456|Insulin|insulin|mesh-list
92472927|NCT01847456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92472928|NCT01847456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92472929|NCT01847456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472931|NCT01847495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92472932|NCT01847495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92472933|NCT01847495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472934|NCT01847495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472935|NCT01847495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472936|NCT01847521|Quercetin|quercetin|mesh-list
92472937|NCT01847521|Antioxidants|antioxidants|mesh-ancestor
92472938|NCT01847521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472939|NCT01847521|Protective Agents|protective agents|mesh-ancestor
92472940|NCT01847521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472941|NCT01847599|Capecitabine|capecitabine|mesh-list
92472942|NCT01847599|Lapatinib|lapatinib|mesh-list
92472943|NCT01847599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92472944|NCT01847599|Antimetabolites|antimetabolites|mesh-ancestor
92472945|NCT01847599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472946|NCT01847599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472947|NCT01847599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92472948|NCT01847599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472949|NCT01847612|Methylene Blue|methylene blue|mesh-list
92472950|NCT01847612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92472951|NCT01847612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472952|NCT01847664|Rifamycins|rifamycins|mesh-list
92472953|NCT01847664|Rifamycin SV|rifamycin sv|mesh-list
92472954|NCT01847664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472955|NCT01847664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472956|NCT01847664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92472957|NCT01847677|Paclitaxel|paclitaxel|mesh-list
92472958|NCT01847677|Bevacizumab|bevacizumab|mesh-list
92472959|NCT01847677|Carboplatin|carboplatin|mesh-list
92472960|NCT01847677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92472961|NCT01847677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92472962|NCT01847677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92472963|NCT01847677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92472964|NCT01847677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92472965|NCT01847677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472966|NCT01847677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92472967|NCT01847677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92472968|NCT01847677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92472969|NCT01847677|Growth Substances|growth substances|mesh-ancestor
92472970|NCT01847677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472971|NCT01847677|Growth Inhibitors|growth inhibitors|mesh-ancestor
92472973|NCT01847690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92472974|NCT01847768|Methacholine Chloride|methacholine chloride|mesh-list
92472975|NCT01847768|Dimercaprol|dimercaprol|mesh-list
92472976|NCT01847768|Chelating Agents|chelating agents|mesh-ancestor
92472977|NCT01847768|Sequestering Agents|sequestering agents|mesh-ancestor
92472978|NCT01847768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92472979|NCT01847768|Miotics|miotics|mesh-ancestor
92472980|NCT01847768|Autonomic Agents|autonomic agents|mesh-ancestor
92472981|NCT01847768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92472982|NCT01847768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472983|NCT01847768|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92472984|NCT01847768|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92472985|NCT01847768|Respiratory System Agents|respiratory system agents|mesh-ancestor
92472986|NCT01847768|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92472987|NCT01847768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92472988|NCT01847768|Cholinergic Agents|cholinergic agents|mesh-ancestor
92472989|NCT01847768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92472990|NCT01847781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92472991|NCT01847781|Immunologic Factors|immunologic factors|mesh-ancestor
92472992|NCT01847781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472994|NCT01847872|Immunologic Factors|immunologic factors|mesh-ancestor
92472995|NCT01847872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92472996|NCT01847976|Doxycycline|doxycycline|mesh-list
92472997|NCT01847976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92472998|NCT01847976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92472999|NCT01847976|Antimalarials|antimalarials|mesh-ancestor
92473000|NCT01847976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92473001|NCT01847976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92473002|NCT01848106|Bivalirudin|bivalirudin|mesh-list
92473003|NCT01848106|Antithrombins|antithrombins|mesh-ancestor
92473004|NCT01848106|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92473005|NCT01848106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92473006|NCT01848106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473007|NCT01848106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473008|NCT01848106|Anticoagulants|anticoagulants|mesh-ancestor
92473009|NCT01848119|Gabapentin|gabapentin|mesh-list
92473010|NCT01848119|Analgesics|analgesics|mesh-ancestor
92473011|NCT01848119|Sensory System Agents|sensory system agents|mesh-ancestor
92473012|NCT01848119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473013|NCT01848119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473014|NCT01848119|Anticonvulsants|anticonvulsants|mesh-ancestor
92473015|NCT01848119|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92473016|NCT01848119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92473017|NCT01848119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473018|NCT01848119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92473019|NCT01848119|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92473020|NCT01848119|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92473021|NCT01848119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473022|NCT01848119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473023|NCT01848119|Antimanic Agents|antimanic agents|mesh-ancestor
92473024|NCT01848132|Prednisone|prednisone|mesh-list
92473025|NCT01848132|Cyclophosphamide|cyclophosphamide|mesh-list
92473026|NCT01848132|Rituximab|rituximab|mesh-list
92473027|NCT01848132|Doxorubicin|doxorubicin|mesh-list
92473028|NCT01848132|Vincristine|vincristine|mesh-list
92473029|NCT01848132|Bortezomib|bortezomib|mesh-list
92473030|NCT01848132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473031|NCT01848132|Immunologic Factors|immunologic factors|mesh-ancestor
92473032|NCT01848132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473033|NCT01848132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473034|NCT01848132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92473035|NCT01848132|Alkylating Agents|alkylating agents|mesh-ancestor
92473036|NCT01848132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473037|NCT01848132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473038|NCT01848132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92473039|NCT01848132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92473040|NCT01848132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92473041|NCT01848132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92473042|NCT01848132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92473043|NCT01848132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473044|NCT01848132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473045|NCT01848132|Glucocorticoids|glucocorticoids|mesh-ancestor
92473046|NCT01848132|Hormones|hormones|mesh-ancestor
92473047|NCT01848132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473048|NCT01848132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92473049|NCT01848132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92473050|NCT01848132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92473051|NCT01848132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92473052|NCT01848132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92473054|NCT01848197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92473055|NCT01848197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473056|NCT01848197|Tubulin Modulators|tubulin modulators|mesh-ancestor
92473057|NCT01848197|Antimitotic Agents|antimitotic agents|mesh-ancestor
92473058|NCT01848197|Mitosis Modulators|mitosis modulators|mesh-ancestor
92473059|NCT01848197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473060|NCT01848236|Vitamin D|vitamin d|mesh-list
92473061|NCT01848236|Ergocalciferols|ergocalciferols|mesh-list
92473062|NCT01848236|Cholecalciferol|cholecalciferol|mesh-list
92473063|NCT01848236|Vitamins|vitamins|mesh-list
92473064|NCT01848236|Micronutrients|micronutrients|mesh-ancestor
92473065|NCT01848236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473066|NCT01848236|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92473067|NCT01848236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473068|NCT01848262|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92473069|NCT01848262|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473070|NCT01848301|Acetylcholine|acetylcholine|mesh-list
92473071|NCT01848301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473072|NCT01848301|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92473073|NCT01848301|Cholinergic Agents|cholinergic agents|mesh-ancestor
92473074|NCT01848301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473075|NCT01848301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473076|NCT01848301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473077|NCT01848340|Cabotegravir|cabotegravir|mesh-list
92473078|NCT01848340|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92473079|NCT01848340|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92473080|NCT01848340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473081|NCT01848340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473082|NCT01848340|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92473083|NCT01848340|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92473084|NCT01848340|Antiviral Agents|antiviral agents|mesh-ancestor
92473085|NCT01848340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473086|NCT01848379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92473087|NCT01848379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473088|NCT01848613|Vinorelbine|vinorelbine|mesh-list
92473089|NCT01848613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92473090|NCT01848613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473091|NCT01848613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92473092|NCT01848613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92473093|NCT01848613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92473094|NCT01848613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473095|NCT01848652|Doxorubicin|doxorubicin|mesh-list
92473096|NCT01848652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92473097|NCT01848652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473098|NCT01848652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92473099|NCT01848652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92473100|NCT01848652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473101|NCT01848652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473102|NCT01848665|Indomethacin|indomethacin|mesh-list
92473103|NCT01848665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92473104|NCT01848665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473105|NCT01848665|Analgesics|analgesics|mesh-ancestor
92473106|NCT01848665|Sensory System Agents|sensory system agents|mesh-ancestor
92473107|NCT01848665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473108|NCT01848665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473109|NCT01848665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473110|NCT01848665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473111|NCT01848665|Gout Suppressants|gout suppressants|mesh-ancestor
92473112|NCT01848665|Tocolytic Agents|tocolytic agents|mesh-ancestor
92473113|NCT01848665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92473114|NCT01848665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92473115|NCT01848665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473116|NCT01848665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473117|NCT01848691|Carbon Monoxide|carbon monoxide|mesh-list
92473118|NCT01848691|Antimetabolites|antimetabolites|mesh-ancestor
92473119|NCT01848691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473120|NCT01848691|Gasotransmitters|gasotransmitters|mesh-ancestor
92348791|NCT01522950|Atenolol|atenolol|mesh-list
92473121|NCT01848691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473122|NCT01848691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473124|NCT01848743|Lamivudine|lamivudine|mesh-list
92473125|NCT01848743|Antiviral Agents|antiviral agents|mesh-ancestor
92473126|NCT01848743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473127|NCT01848743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92473128|NCT01848743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92473129|NCT01848743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473130|NCT01848743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473131|NCT01848743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92473132|NCT01848743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92473133|NCT01848769|Beclomethasone|beclomethasone|mesh-list
92473134|NCT01848769|Formoterol Fumarate|formoterol fumarate|mesh-list
92473135|NCT01848769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92473136|NCT01848769|Autonomic Agents|autonomic agents|mesh-ancestor
92473137|NCT01848769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473138|NCT01848769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473139|NCT01848769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92473140|NCT01848769|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473141|NCT01848769|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92473142|NCT01848769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92473143|NCT01848769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473144|NCT01848769|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473145|NCT01848769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473146|NCT01848769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473147|NCT01848769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473148|NCT01848769|Glucocorticoids|glucocorticoids|mesh-ancestor
92473150|NCT01848769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473151|NCT01848808|Wobenzym|wobenzym|mesh-list
92473152|NCT01848808|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92473153|NCT01848808|Immunologic Factors|immunologic factors|mesh-ancestor
92473154|NCT01848808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473155|NCT01848873|Amlodipine|amlodipine|mesh-list
92473156|NCT01848873|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92473158|NCT01848873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473159|NCT01848873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473160|NCT01848873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473161|NCT01848873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473162|NCT01848873|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473163|NCT01848925|Hydroxyurea|hydroxyurea|mesh-list
92473164|NCT01848925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473165|NCT01848925|Antisickling Agents|antisickling agents|mesh-ancestor
92473166|NCT01848925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473167|NCT01848925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473168|NCT01848925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92473169|NCT01849016|Acetylcysteine|acetylcysteine|mesh-list
92473170|NCT01849016|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92473171|NCT01849016|Antiviral Agents|antiviral agents|mesh-ancestor
92473172|NCT01849016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473173|NCT01849016|Expectorants|expectorants|mesh-ancestor
92473174|NCT01849016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473175|NCT01849016|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92473176|NCT01849016|Antioxidants|antioxidants|mesh-ancestor
92473177|NCT01849016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473178|NCT01849016|Protective Agents|protective agents|mesh-ancestor
92473179|NCT01849016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473180|NCT01849016|Antidotes|antidotes|mesh-ancestor
92473181|NCT01849042|Donepezil|donepezil|mesh-list
92473182|NCT01849042|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92473183|NCT01849042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473184|NCT01849042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473185|NCT01849042|Cholinergic Agents|cholinergic agents|mesh-ancestor
92473186|NCT01849042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473187|NCT01849042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473188|NCT01849042|Nootropic Agents|nootropic agents|mesh-ancestor
92473189|NCT01849094|Milrinone|milrinone|mesh-list
92473190|NCT01849094|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92473191|NCT01849094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92473192|NCT01849094|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473193|NCT01849094|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92198124|NCT00006110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473194|NCT01849094|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92473195|NCT01849094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473196|NCT01849094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473197|NCT01849094|Protective Agents|protective agents|mesh-ancestor
92473198|NCT01849094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473199|NCT01849211|Rocuronium|rocuronium|mesh-list
92473200|NCT01849211|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92473201|NCT01849211|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92473202|NCT01849211|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92473203|NCT01849211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473204|NCT01849211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473205|NCT01849406|Budesonide|budesonide|mesh-list
92473206|NCT01849406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473207|NCT01849406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92473208|NCT01849406|Autonomic Agents|autonomic agents|mesh-ancestor
92473209|NCT01849406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473210|NCT01849406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473211|NCT01849406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92473212|NCT01849406|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473213|NCT01849406|Glucocorticoids|glucocorticoids|mesh-ancestor
92473214|NCT01849406|Hormones|hormones|mesh-ancestor
92473215|NCT01849406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473216|NCT01849640|Primaquine|primaquine|mesh-list
92473217|NCT01849640|Piperaquine|piperaquine|mesh-list
92473218|NCT01849640|Antimalarials|antimalarials|mesh-ancestor
92473219|NCT01849640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92473220|NCT01849640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92473221|NCT01849640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473222|NCT01849666|Vemurafenib|vemurafenib|mesh-list
92473223|NCT01849666|Phenprocoumon|phenprocoumon|mesh-list
92473224|NCT01849666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473225|NCT01849666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92473226|NCT01849666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473227|NCT01849666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473228|NCT01849666|Anticoagulants|anticoagulants|mesh-ancestor
92473229|NCT01849757|Plasma-lyte 148|plasma-lyte 148|mesh-list
92473230|NCT01849757|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92473231|NCT01849757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92473233|NCT01849835|Antipruritics|antipruritics|mesh-ancestor
92473234|NCT01849835|Dermatologic Agents|dermatologic agents|mesh-ancestor
92473235|NCT01849861|Methimazole|methimazole|mesh-list
92473236|NCT01849861|Antithyroid Agents|antithyroid agents|mesh-ancestor
92473237|NCT01849861|Hormone Antagonists|hormone antagonists|mesh-ancestor
92473238|NCT01849861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473239|NCT01849861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473240|NCT01849926|Amdinocillin|amdinocillin|mesh-list
92473241|NCT01849926|Ibuprofen|ibuprofen|mesh-list
92473242|NCT01849926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92473243|NCT01849926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473244|NCT01849926|Analgesics|analgesics|mesh-ancestor
92473245|NCT01849926|Sensory System Agents|sensory system agents|mesh-ancestor
92473246|NCT01849926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473247|NCT01849926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473248|NCT01849926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473249|NCT01849926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473250|NCT01849926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92473251|NCT01849926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473252|NCT01849926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473253|NCT01849926|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92473254|NCT01849926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473255|NCT01849926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473256|NCT01849939|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92473257|NCT01849939|Immunologic Factors|immunologic factors|mesh-ancestor
92473258|NCT01849939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473259|NCT01850017|Dexmedetomidine|dexmedetomidine|mesh-list
92473260|NCT01850017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92473261|NCT01850017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473262|NCT01850017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473263|NCT01850017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473264|NCT01850017|Analgesics|analgesics|mesh-ancestor
92473265|NCT01850017|Sensory System Agents|sensory system agents|mesh-ancestor
92473266|NCT01850017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473267|NCT01850017|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92141038|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473268|NCT01850017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92473269|NCT01850017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473270|NCT01850017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473271|NCT01850017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473272|NCT01850017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473274|NCT01850095|Estradiol|estradiol|mesh-list
92473275|NCT01850095|Estrogens|estrogens|mesh-ancestor
92473276|NCT01850095|Hormones|hormones|mesh-ancestor
92473277|NCT01850095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473278|NCT01850095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473279|NCT01850095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473280|NCT01850095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92473281|NCT01850121|Infliximab|infliximab|mesh-list
92473282|NCT01850121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92473283|NCT01850121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473284|NCT01850121|Dermatologic Agents|dermatologic agents|mesh-ancestor
92473285|NCT01850121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473286|NCT01850121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473288|NCT01850147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473289|NCT01850147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92473290|NCT01850147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92473291|NCT01850147|Growth Substances|growth substances|mesh-ancestor
92473292|NCT01850147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473293|NCT01850147|Growth Inhibitors|growth inhibitors|mesh-ancestor
92473294|NCT01850147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92473295|NCT01850147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473296|NCT01850147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473297|NCT01850160|Valsartan|valsartan|mesh-list
92473298|NCT01850160|Antihypertensive Agents|antihypertensive agents|mesh-list
92473299|NCT01850160|Chlorthalidone|chlorthalidone|mesh-list
92473300|NCT01850160|Angiotensin II|angiotensin ii|mesh-list
92473301|NCT01850160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92473302|NCT01850160|Diuretics|diuretics|mesh-list
92473303|NCT01850160|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92473304|NCT01850160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92473305|NCT01850160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473306|NCT01850160|Natriuretic Agents|natriuretic agents|mesh-ancestor
92473307|NCT01850160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473308|NCT01850160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473309|NCT01850160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92473310|NCT01850251|Vitamin D|vitamin d|mesh-list
92473311|NCT01850251|Vitamins|vitamins|mesh-ancestor
92473312|NCT01850251|Micronutrients|micronutrients|mesh-ancestor
92473313|NCT01850251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473314|NCT01850251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92473315|NCT01850277|Amiodarone|amiodarone|mesh-list
92473316|NCT01850277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473317|NCT01850277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92473318|NCT01850277|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473319|NCT01850277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92473320|NCT01850277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473321|NCT01850277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92473322|NCT01850277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92473323|NCT01850277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92473324|NCT01850277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473325|NCT01850277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92473326|NCT01850277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92473327|NCT01850277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92473328|NCT01850511|Phenylephrine|phenylephrine|mesh-list
92473329|NCT01850511|Oxymetazoline|oxymetazoline|mesh-list
92473330|NCT01850511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92473331|NCT01850511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473332|NCT01850511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473333|NCT01850511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473334|NCT01850511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473335|NCT01850511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473336|NCT01850511|Sympathomimetics|sympathomimetics|mesh-ancestor
92473337|NCT01850511|Autonomic Agents|autonomic agents|mesh-ancestor
92473338|NCT01850511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473339|NCT01850511|Nasal Decongestants|nasal decongestants|mesh-ancestor
92473340|NCT01850511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92473341|NCT01850511|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473342|NCT01850511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92473343|NCT01850511|Mydriatics|mydriatics|mesh-ancestor
92473344|NCT01850511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92473345|NCT01850511|Protective Agents|protective agents|mesh-ancestor
92473347|NCT01850628|Trastuzumab|trastuzumab|mesh-list
92473348|NCT01850628|Pertuzumab|pertuzumab|mesh-list
92473349|NCT01850628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92473350|NCT01850628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473351|NCT01850628|Tubulin Modulators|tubulin modulators|mesh-ancestor
92473352|NCT01850628|Antimitotic Agents|antimitotic agents|mesh-ancestor
92473353|NCT01850628|Mitosis Modulators|mitosis modulators|mesh-ancestor
92473354|NCT01850628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473355|NCT01850628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92473356|NCT01850680|Folic Acid|folic acid|mesh-list
92473357|NCT01850680|Methotrexate|methotrexate|mesh-list
92473358|NCT01850680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92473359|NCT01850680|Abortifacient Agents|abortifacient agents|mesh-ancestor
92473360|NCT01850680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92473361|NCT01850680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473362|NCT01850680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92473363|NCT01850680|Antimetabolites|antimetabolites|mesh-ancestor
92473364|NCT01850680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473365|NCT01850680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473366|NCT01850680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92473367|NCT01850680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473368|NCT01850680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92473369|NCT01850680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473370|NCT01850680|Immunologic Factors|immunologic factors|mesh-ancestor
92473371|NCT01850680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473372|NCT01850680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92473373|NCT01850680|Hematinics|hematinics|mesh-ancestor
92473374|NCT01850680|Vitamin B Complex|vitamin b complex|mesh-ancestor
92473375|NCT01850680|Vitamins|vitamins|mesh-ancestor
92473376|NCT01850680|Micronutrients|micronutrients|mesh-ancestor
92473377|NCT01850940|Tolvaptan|tolvaptan|mesh-list
92473378|NCT01850940|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92473379|NCT01850940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473380|NCT01850940|Natriuretic Agents|natriuretic agents|mesh-ancestor
92473381|NCT01850940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473382|NCT01850953|Varenicline|varenicline|mesh-list
92473383|NCT01850953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92473384|NCT01850953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92473385|NCT01850953|Cholinergic Agents|cholinergic agents|mesh-ancestor
92473386|NCT01850953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473387|NCT01850953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473388|NCT01850953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473389|NCT01850979|Tacrolimus|tacrolimus|mesh-list
92473390|NCT01850979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473391|NCT01850979|Immunologic Factors|immunologic factors|mesh-ancestor
92473392|NCT01850979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473393|NCT01850979|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92473394|NCT01850979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473395|NCT01850979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473396|NCT01851005|Dexmedetomidine|dexmedetomidine|mesh-list
92473397|NCT01851005|Remifentanil|remifentanil|mesh-list
92473398|NCT01851005|Anesthetics|anesthetics|mesh-list
92473399|NCT01851005|Propofol|propofol|mesh-list
92473400|NCT01851005|Sevoflurane|sevoflurane|mesh-list
92473401|NCT01851005|Rocuronium|rocuronium|mesh-list
92473402|NCT01851005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473403|NCT01851005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473404|NCT01851005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92473405|NCT01851005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473406|NCT01851005|Analgesics|analgesics|mesh-ancestor
92473407|NCT01851005|Sensory System Agents|sensory system agents|mesh-ancestor
92473408|NCT01851005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473409|NCT01851005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92473410|NCT01851005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92473411|NCT01851005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473412|NCT01851005|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473413|NCT01851005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473414|NCT01851005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473415|NCT01851005|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92473416|NCT01851005|Anesthetics, General|anesthetics, general|mesh-ancestor
92473417|NCT01851005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92198342|NCT04703621|Daratumumab|daratumumab|mesh-list
92473418|NCT01851005|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92473419|NCT01851005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92473420|NCT01851005|Narcotics|narcotics|mesh-ancestor
92473421|NCT01851005|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92473422|NCT01851005|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92473423|NCT01851005|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92473424|NCT01851148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
92473425|NCT01851148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92473426|NCT01851148|Serotonin Agents|serotonin agents|mesh-ancestor
92473427|NCT01851148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473428|NCT01851148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473429|NCT01851148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473430|NCT01851200|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92473431|NCT01851200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92473432|NCT01851200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473433|NCT01851200|Immunotoxins|immunotoxins|mesh-ancestor
92473434|NCT01851200|Immunoconjugates|immunoconjugates|mesh-ancestor
92473435|NCT01851200|Immunologic Factors|immunologic factors|mesh-ancestor
92473436|NCT01851200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473438|NCT01851265|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92473439|NCT01851265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473440|NCT01851265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473441|NCT01851265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473442|NCT01851278|Triamcinolone|triamcinolone|mesh-list
92473443|NCT01851278|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92473444|NCT01851278|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92473445|NCT01851278|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92473446|NCT01851278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473447|NCT01851278|Glucocorticoids|glucocorticoids|mesh-ancestor
92473448|NCT01851278|Hormones|hormones|mesh-ancestor
92473449|NCT01851278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473450|NCT01851278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473451|NCT01851278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473452|NCT01851278|Immunologic Factors|immunologic factors|mesh-ancestor
92473453|NCT01851278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473454|NCT01851278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473455|NCT01851408|Sirolimus|sirolimus|mesh-list
92473456|NCT01851408|Sorafenib|sorafenib|mesh-list
92473457|NCT01851408|Temsirolimus|temsirolimus|mesh-list
92473458|NCT01851408|MTOR Inhibitors|mtor inhibitors|mesh-list
92473459|NCT01851408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473460|NCT01851408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92473461|NCT01851408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473462|NCT01851408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473463|NCT01851408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473464|NCT01851408|Immunologic Factors|immunologic factors|mesh-ancestor
92473465|NCT01851408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473466|NCT01851408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473467|NCT01851408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473468|NCT01851408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92473469|NCT01851408|Antifungal Agents|antifungal agents|mesh-ancestor
92473470|NCT01851473|Quinine|quinine|mesh-list
92473471|NCT01851473|Acetazolamide|acetazolamide|mesh-list
92473472|NCT01851473|Cocaine|cocaine|mesh-list
92473473|NCT01851473|Anticonvulsants|anticonvulsants|mesh-ancestor
92473474|NCT01851473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92473475|NCT01851473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473476|NCT01851473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473477|NCT01851473|Diuretics|diuretics|mesh-ancestor
92473478|NCT01851473|Natriuretic Agents|natriuretic agents|mesh-ancestor
92473479|NCT01851473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473480|NCT01851473|Anesthetics, Local|anesthetics, local|mesh-ancestor
92473481|NCT01851473|Anesthetics|anesthetics|mesh-ancestor
92473482|NCT01851473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473483|NCT01851473|Sensory System Agents|sensory system agents|mesh-ancestor
92473484|NCT01851473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473485|NCT01851473|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92141256|NCT00731055|Varenicline|varenicline|mesh-list
92473486|NCT01851473|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92473487|NCT01851473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92473488|NCT01851473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473489|NCT01851473|Dopamine Agents|dopamine agents|mesh-ancestor
92473490|NCT01851473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473491|NCT01851473|Antimalarials|antimalarials|mesh-ancestor
92473492|NCT01851473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92473493|NCT01851473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92473494|NCT01851473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473495|NCT01851473|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92473496|NCT01851473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92473497|NCT01851473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473498|NCT01851473|Analgesics|analgesics|mesh-ancestor
92473499|NCT01851486|Clonidine|clonidine|mesh-list
92473500|NCT01851486|Naloxone|naloxone|mesh-list
92473501|NCT01851486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92473502|NCT01851486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473503|NCT01851486|Sensory System Agents|sensory system agents|mesh-ancestor
92473504|NCT01851486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473505|NCT01851486|Analgesics|analgesics|mesh-ancestor
92473506|NCT01851486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92473507|NCT01851486|Sympatholytics|sympatholytics|mesh-ancestor
92473508|NCT01851486|Autonomic Agents|autonomic agents|mesh-ancestor
92473509|NCT01851486|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92473510|NCT01851486|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92473511|NCT01851486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473512|NCT01851486|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473513|NCT01851486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473514|NCT01851486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473515|NCT01851512|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92473516|NCT01851512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92473517|NCT01851512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473518|NCT01851551|Rituximab|rituximab|mesh-list
92473519|NCT01851551|Vincristine|vincristine|mesh-list
92473520|NCT01851551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92473521|NCT01851551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473522|NCT01851551|Immunologic Factors|immunologic factors|mesh-ancestor
92473523|NCT01851551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473524|NCT01851551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92473525|NCT01851551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92473526|NCT01851551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92473527|NCT01851551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92473528|NCT01851551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92473529|NCT01851551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473530|NCT01851681|Amoxicillin|amoxicillin|mesh-list
92473531|NCT01851681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473532|NCT01851681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473533|NCT01851733|Doxorubicin|doxorubicin|mesh-list
92473534|NCT01851733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92473535|NCT01851733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473536|NCT01851733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92473537|NCT01851733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92473538|NCT01851733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473539|NCT01851733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473540|NCT01851759|Cinepazide|cinepazide|mesh-list
92473541|NCT01851759|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473542|NCT01851824|Vemurafenib|vemurafenib|mesh-list
92473543|NCT01851824|Acenocoumarol|acenocoumarol|mesh-list
92473544|NCT01851824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473545|NCT01851824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92473546|NCT01851824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473547|NCT01851824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473548|NCT01851824|Anticoagulants|anticoagulants|mesh-ancestor
92473549|NCT01851850|Opicapone|opicapone|mesh-list
92473550|NCT01851850|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92473551|NCT01851850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473552|NCT01851850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473553|NCT01851850|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92473554|NCT01851850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92473555|NCT01851941|Leucovorin|leucovorin|mesh-list
92473556|NCT01851941|Folic Acid|folic acid|mesh-list
92473557|NCT01851941|Fluorouracil|fluorouracil|mesh-list
92473558|NCT01851941|Oxaliplatin|oxaliplatin|mesh-list
92473559|NCT01851941|Levoleucovorin|levoleucovorin|mesh-list
92473560|NCT01851941|Antimetabolites|antimetabolites|mesh-ancestor
92473561|NCT01851941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149864|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
92473562|NCT01851941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92473563|NCT01851941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473564|NCT01851941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473565|NCT01851941|Immunologic Factors|immunologic factors|mesh-ancestor
92473566|NCT01851941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473567|NCT01851941|Antidotes|antidotes|mesh-ancestor
92473568|NCT01851941|Protective Agents|protective agents|mesh-ancestor
92473569|NCT01851941|Vitamin B Complex|vitamin b complex|mesh-ancestor
92473570|NCT01851941|Vitamins|vitamins|mesh-ancestor
92473571|NCT01851941|Micronutrients|micronutrients|mesh-ancestor
92473572|NCT01851941|Hematinics|hematinics|mesh-ancestor
92473573|NCT01851954|Clarithromycin|clarithromycin|mesh-list
92473574|NCT01851954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473575|NCT01851954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473576|NCT01851954|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92473577|NCT01851954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473578|NCT01851954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473579|NCT01851954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92473580|NCT01851954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92473581|NCT01851980|Furosemide|furosemide|mesh-list
92473582|NCT01851980|Diuretics|diuretics|mesh-ancestor
92473583|NCT01851980|Natriuretic Agents|natriuretic agents|mesh-ancestor
92473584|NCT01851980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473585|NCT01851980|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92473586|NCT01851980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473587|NCT01851980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473588|NCT01851993|Ondansetron|ondansetron|mesh-list
92473589|NCT01851993|Antiemetics|antiemetics|mesh-ancestor
92473590|NCT01851993|Autonomic Agents|autonomic agents|mesh-ancestor
92473591|NCT01851993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473592|NCT01851993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473593|NCT01851993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473594|NCT01851993|Antipruritics|antipruritics|mesh-ancestor
92473595|NCT01851993|Dermatologic Agents|dermatologic agents|mesh-ancestor
92473596|NCT01851993|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92473597|NCT01851993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92473598|NCT01851993|Serotonin Agents|serotonin agents|mesh-ancestor
92473599|NCT01851993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473600|NCT01851993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473601|NCT01852253|Chlorhexidine|chlorhexidine|mesh-list
92473602|NCT01852253|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92473603|NCT01852253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92473604|NCT01852253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473605|NCT01852253|Disinfectants|disinfectants|mesh-ancestor
92473606|NCT01852253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92473608|NCT01852266|Immunologic Factors|immunologic factors|mesh-ancestor
92473609|NCT01852266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473610|NCT01852318|Fexofenadine|fexofenadine|mesh-list
92473611|NCT01852318|Pregabalin|pregabalin|mesh-list
92473612|NCT01852318|Analgesics|analgesics|mesh-ancestor
92473613|NCT01852318|Sensory System Agents|sensory system agents|mesh-ancestor
92473614|NCT01852318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473615|NCT01852318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473616|NCT01852318|Anticonvulsants|anticonvulsants|mesh-ancestor
92473617|NCT01852318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92473618|NCT01852318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473619|NCT01852318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473620|NCT01852318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473621|NCT01852318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92473622|NCT01852318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92473623|NCT01852318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473624|NCT01852318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92473625|NCT01852318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92473626|NCT01852318|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92473627|NCT01852318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92473628|NCT01852318|Histamine Antagonists|histamine antagonists|mesh-ancestor
92473629|NCT01852318|Histamine Agents|histamine agents|mesh-ancestor
92473630|NCT01852318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473631|NCT01852409|Bevacizumab|bevacizumab|mesh-list
92473632|NCT01852409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92473633|NCT01852409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473634|NCT01852409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92473635|NCT01852409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92473636|NCT01852409|Growth Substances|growth substances|mesh-ancestor
92473637|NCT01852409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473638|NCT01852409|Growth Inhibitors|growth inhibitors|mesh-ancestor
92473639|NCT01852461|Poractant alfa|poractant alfa|mesh-list
92473640|NCT01852461|Beractant|beractant|mesh-list
92473641|NCT01852461|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92473642|NCT01852461|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473643|NCT01852539|Dexmedetomidine|dexmedetomidine|mesh-list
92473644|NCT01852539|Propofol|propofol|mesh-list
92473645|NCT01852539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92473646|NCT01852539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473647|NCT01852539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473648|NCT01852539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473649|NCT01852539|Analgesics|analgesics|mesh-ancestor
92473650|NCT01852539|Sensory System Agents|sensory system agents|mesh-ancestor
92473651|NCT01852539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473652|NCT01852539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92473653|NCT01852539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92473654|NCT01852539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473656|NCT01852539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473657|NCT01852539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473658|NCT01852539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92473659|NCT01852539|Anesthetics, General|anesthetics, general|mesh-ancestor
92473660|NCT01852539|Anesthetics|anesthetics|mesh-ancestor
92473661|NCT01852565|Diltiazem|diltiazem|mesh-list
92473662|NCT01852565|Darapladib|darapladib|mesh-list
92473663|NCT01852565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92473664|NCT01852565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92473665|NCT01852565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92473666|NCT01852565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473667|NCT01852565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473668|NCT01852565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473669|NCT01852565|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473670|NCT01852565|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92473671|NCT01852565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473672|NCT01852604|Interferons|interferons|mesh-list
92473673|NCT01852604|Ritonavir|ritonavir|mesh-list
92473674|NCT01852604|Ribavirin|ribavirin|mesh-list
92473675|NCT01852604|Simeprevir|simeprevir|mesh-list
92473676|NCT01852604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473677|NCT01852604|Antiviral Agents|antiviral agents|mesh-ancestor
92473678|NCT01852604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473679|NCT01852604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92473680|NCT01852604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92473681|NCT01852604|Protease Inhibitors|protease inhibitors|mesh-ancestor
92473682|NCT01852604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473683|NCT01852604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473684|NCT01852604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92473685|NCT01852604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92473686|NCT01852604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92473687|NCT01852604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92473688|NCT01852604|Antimetabolites|antimetabolites|mesh-ancestor
92473689|NCT01852630|Imipenem|imipenem|mesh-list
92473690|NCT01852630|Cefepime|cefepime|mesh-list
92473691|NCT01852630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473692|NCT01852630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473693|NCT01852786|Contraceptive Agents|contraceptive agents|mesh-list
92473694|NCT01852786|Contraceptives, Oral|contraceptives, oral|mesh-list
92473695|NCT01852786|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92473696|NCT01852786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92473697|NCT01852786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473698|NCT01852786|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92473699|NCT01852903|Vitamins|vitamins|mesh-list
92473700|NCT01852903|Ascorbic Acid|ascorbic acid|mesh-list
92473701|NCT01852903|Calcium ascorbate|calcium ascorbate|mesh-list
92473702|NCT01852903|Calcium|calcium|mesh-list
92473703|NCT01852903|Micronutrients|micronutrients|mesh-ancestor
92473704|NCT01852903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473705|NCT01852903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473706|NCT01852903|Antioxidants|antioxidants|mesh-ancestor
92473707|NCT01852903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473708|NCT01852903|Protective Agents|protective agents|mesh-ancestor
92473709|NCT01852994|Methyltestosterone|methyltestosterone|mesh-list
92473710|NCT01852994|Testosterone|testosterone|mesh-list
92473711|NCT01852994|Testosterone undecanoate|testosterone undecanoate|mesh-list
92473712|NCT01852994|Testosterone enanthate|testosterone enanthate|mesh-list
92473713|NCT01852994|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92473714|NCT01852994|Androgens|androgens|mesh-ancestor
92473715|NCT01852994|Hormones|hormones|mesh-ancestor
92473716|NCT01852994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473717|NCT01852994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473718|NCT01852994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92473719|NCT01852994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198643|NCT00596167|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92473720|NCT01852994|Anabolic Agents|anabolic agents|mesh-ancestor
92473721|NCT01853111|Aldesleukin|aldesleukin|mesh-list
92473722|NCT01853111|Interleukin-2|interleukin-2|mesh-list
92473723|NCT01853111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473724|NCT01853111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92473725|NCT01853111|Analgesics|analgesics|mesh-ancestor
92473726|NCT01853111|Sensory System Agents|sensory system agents|mesh-ancestor
92473727|NCT01853111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473728|NCT01853111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473730|NCT01853111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92473731|NCT01853111|Antiviral Agents|antiviral agents|mesh-ancestor
92473732|NCT01853111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473733|NCT01853306|Veliparib|veliparib|mesh-list
92473734|NCT01853306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92473735|NCT01853306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473736|NCT01853306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473737|NCT01853306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473738|NCT01853423|Sirolimus|sirolimus|mesh-list
92473739|NCT01853423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473740|NCT01853423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473741|NCT01853423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92473742|NCT01853423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473743|NCT01853423|Antifungal Agents|antifungal agents|mesh-ancestor
92473744|NCT01853423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473745|NCT01853423|Immunologic Factors|immunologic factors|mesh-ancestor
92473746|NCT01853423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473747|NCT01853449|Fentanyl|fentanyl|mesh-list
92473748|NCT01853449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92473749|NCT01853449|Narcotics|narcotics|mesh-ancestor
92473750|NCT01853449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473751|NCT01853449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473752|NCT01853449|Analgesics|analgesics|mesh-ancestor
92473753|NCT01853449|Sensory System Agents|sensory system agents|mesh-ancestor
92473754|NCT01853449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473755|NCT01853449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92473756|NCT01853449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92473757|NCT01853449|Anesthetics, General|anesthetics, general|mesh-ancestor
92473758|NCT01853449|Anesthetics|anesthetics|mesh-ancestor
92473759|NCT01853540|Sildenafil Citrate|sildenafil citrate|mesh-list
92473760|NCT01853540|Vasodilator Agents|vasodilator agents|mesh-ancestor
92473761|NCT01853540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92473762|NCT01853540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92473763|NCT01853540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473764|NCT01853540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473765|NCT01853540|Urological Agents|urological agents|mesh-ancestor
92473766|NCT01853566|Hormones|hormones|mesh-list
92473767|NCT01853566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473768|NCT01853566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473769|NCT01853709|Bisacodyl|bisacodyl|mesh-list
92473770|NCT01853709|Cathartics|cathartics|mesh-ancestor
92473771|NCT01853709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473772|NCT01853709|Laxatives|laxatives|mesh-ancestor
92473773|NCT01853787|Formoterol Fumarate|formoterol fumarate|mesh-list
92473774|NCT01853787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92473775|NCT01853787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92473776|NCT01853787|Autonomic Agents|autonomic agents|mesh-ancestor
92141543|NCT04585854|Caffeine|caffeine|mesh-list
92473777|NCT01853787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473778|NCT01853787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473779|NCT01853787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92473780|NCT01853787|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473781|NCT01853787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92473782|NCT01853787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92473783|NCT01853787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92473784|NCT01853787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92473785|NCT01853787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473786|NCT01853787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473787|NCT01853800|Rivaroxaban|rivaroxaban|mesh-list
92473788|NCT01853800|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92473789|NCT01853800|Antithrombins|antithrombins|mesh-ancestor
92473790|NCT01853800|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92473791|NCT01853800|Protease Inhibitors|protease inhibitors|mesh-ancestor
92473792|NCT01853800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473793|NCT01853800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473795|NCT01853813|Bevacizumab|bevacizumab|mesh-list
92473796|NCT01853813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92473798|NCT01853813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92473799|NCT01853813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92473800|NCT01853813|Growth Substances|growth substances|mesh-ancestor
92473801|NCT01853813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473802|NCT01853813|Growth Inhibitors|growth inhibitors|mesh-ancestor
92473803|NCT01853852|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
92473804|NCT01853852|Antiviral Agents|antiviral agents|mesh-ancestor
92473805|NCT01853852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473806|NCT01853852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473807|NCT01853852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473809|NCT01853956|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92473810|NCT01853956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473811|NCT01853956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473812|NCT01853956|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92473813|NCT01853956|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92473814|NCT01853956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92473815|NCT01853956|GABA Modulators|gaba modulators|mesh-ancestor
92473816|NCT01853956|GABA Agents|gaba agents|mesh-ancestor
92473817|NCT01853956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473818|NCT01853956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473819|NCT01854021|Anesthetics|anesthetics|mesh-list
92473820|NCT01854021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473821|NCT01854021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473822|NCT01854073|Scopolamine|scopolamine|mesh-list
92473823|NCT01854073|Bromides|bromides|mesh-list
92473824|NCT01854073|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92473825|NCT01854073|Anticonvulsants|anticonvulsants|mesh-ancestor
92473826|NCT01854073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92473827|NCT01854073|Antiemetics|antiemetics|mesh-ancestor
92473828|NCT01854073|Autonomic Agents|autonomic agents|mesh-ancestor
92473829|NCT01854073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473830|NCT01854073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473831|NCT01854073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473832|NCT01854073|Mydriatics|mydriatics|mesh-ancestor
92473833|NCT01854073|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92473834|NCT01854073|Cholinergic Agents|cholinergic agents|mesh-ancestor
92473835|NCT01854073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473836|NCT01854073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473837|NCT01854073|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92473838|NCT01854073|Parasympatholytics|parasympatholytics|mesh-ancestor
92473839|NCT01854086|Diphosphonates|diphosphonates|mesh-list
92473840|NCT01854086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92473841|NCT01854086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473842|NCT01854203|Cisplatin|cisplatin|mesh-list
92473843|NCT01854203|Gemcitabine|gemcitabine|mesh-list
92473844|NCT01854203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473845|NCT01854203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92473846|NCT01854203|Antimetabolites|antimetabolites|mesh-ancestor
92473847|NCT01854203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473848|NCT01854216|Rotigotine|rotigotine|mesh-list
92473849|NCT01854216|Dopamine Agonists|dopamine agonists|mesh-ancestor
92473850|NCT01854216|Dopamine Agents|dopamine agents|mesh-ancestor
92473851|NCT01854216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473852|NCT01854216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473853|NCT01854216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473854|NCT01854411|Analgesics|analgesics|mesh-list
92473855|NCT01854411|Sensory System Agents|sensory system agents|mesh-ancestor
92473856|NCT01854411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473858|NCT01854424|Dimercaprol|dimercaprol|mesh-list
92473859|NCT01854424|Chelating Agents|chelating agents|mesh-ancestor
92473860|NCT01854424|Sequestering Agents|sequestering agents|mesh-ancestor
92473861|NCT01854424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473862|NCT01854463|Vitamin D|vitamin d|mesh-list
92473863|NCT01854463|Cholecalciferol|cholecalciferol|mesh-list
92473864|NCT01854463|Vitamins|vitamins|mesh-ancestor
92473865|NCT01854463|Micronutrients|micronutrients|mesh-ancestor
92473866|NCT01854463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473867|NCT01854463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473868|NCT01854463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92473869|NCT01854476|Tranexamic Acid|tranexamic acid|mesh-list
92473870|NCT01854476|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92473871|NCT01854476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92473872|NCT01854476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473874|NCT01854476|Coagulants|coagulants|mesh-ancestor
92473875|NCT01854489|Rifampin|rifampin|mesh-list
92473876|NCT01854489|Buprenorphine|buprenorphine|mesh-list
92473877|NCT01854489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92473878|NCT01854489|Narcotics|narcotics|mesh-ancestor
92473879|NCT01854489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473880|NCT01854489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473881|NCT01854489|Analgesics|analgesics|mesh-ancestor
92473882|NCT01854489|Sensory System Agents|sensory system agents|mesh-ancestor
92473883|NCT01854489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473884|NCT01854489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92473885|NCT01854489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92473886|NCT01854489|Antitubercular Agents|antitubercular agents|mesh-ancestor
92473887|NCT01854489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92473888|NCT01854489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473889|NCT01854489|Leprostatic Agents|leprostatic agents|mesh-ancestor
92473890|NCT01854489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92473891|NCT01854489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473892|NCT01854489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473893|NCT01854489|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92473894|NCT01854489|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92473895|NCT01854489|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92473896|NCT01854489|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92473897|NCT01854489|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92473898|NCT01854489|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92473899|NCT01854502|Fluorides|fluorides|mesh-list
92473900|NCT01854502|Cariostatic Agents|cariostatic agents|mesh-ancestor
92473901|NCT01854502|Protective Agents|protective agents|mesh-ancestor
92473902|NCT01854502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473903|NCT01854515|Dexamethasone|dexamethasone|mesh-list
92473904|NCT01854515|Budesonide|budesonide|mesh-list
92473905|NCT01854515|Dexamethasone acetate|dexamethasone acetate|mesh-list
92473906|NCT01854515|BB 1101|bb 1101|mesh-list
92473907|NCT01854515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92473908|NCT01854515|Antiemetics|antiemetics|mesh-ancestor
92473909|NCT01854515|Autonomic Agents|autonomic agents|mesh-ancestor
92473910|NCT01854515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92473911|NCT01854515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473912|NCT01854515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473913|NCT01854515|Glucocorticoids|glucocorticoids|mesh-ancestor
92473914|NCT01854515|Hormones|hormones|mesh-ancestor
92473915|NCT01854515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92473916|NCT01854515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92473917|NCT01854515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473918|NCT01854515|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92473919|NCT01854515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92473920|NCT01854515|Respiratory System Agents|respiratory system agents|mesh-ancestor
92473921|NCT01854515|Protease Inhibitors|protease inhibitors|mesh-ancestor
92473922|NCT01854515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473923|NCT01854515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473924|NCT01854606|Everolimus|everolimus|mesh-list
92473925|NCT01854606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92473926|NCT01854606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92473927|NCT01854606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473928|NCT01854606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473929|NCT01854606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92473930|NCT01854606|Immunologic Factors|immunologic factors|mesh-ancestor
92473931|NCT01854606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473932|NCT01854606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473933|NCT01854619|Anti-Infective Agents|anti-infective agents|mesh-list
92473934|NCT01854619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92473935|NCT01854723|Insulin|insulin|mesh-list
92473936|NCT01854723|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92473937|NCT01854723|Insulin Glargine|insulin glargine|mesh-list
92473938|NCT01854723|Insulin, Isophane|insulin, isophane|mesh-list
92473939|NCT01854723|Isophane Insulin, Human|isophane insulin, human|mesh-list
92473940|NCT01854723|Isophane insulin, beef|isophane insulin, beef|mesh-list
92473941|NCT01854723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92473942|NCT01854723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473943|NCT01854749|Cisplatin|cisplatin|mesh-list
92473944|NCT01854749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92473945|NCT01854762|Ritonavir|ritonavir|mesh-list
92473946|NCT01854762|Lopinavir|lopinavir|mesh-list
92473947|NCT01854762|Raltegravir Potassium|raltegravir potassium|mesh-list
92473948|NCT01854762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92473949|NCT01854762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92473950|NCT01854762|Protease Inhibitors|protease inhibitors|mesh-ancestor
92473951|NCT01854762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473952|NCT01854762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473953|NCT01854762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92473954|NCT01854762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92473955|NCT01854762|Antiviral Agents|antiviral agents|mesh-ancestor
92473956|NCT01854762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92473957|NCT01854762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92473958|NCT01854762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92473959|NCT01854762|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92473960|NCT01854762|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92473961|NCT01854970|Esomeprazole|esomeprazole|mesh-list
92473962|NCT01854970|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92473963|NCT01854970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473964|NCT01854970|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92473965|NCT01854970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92473966|NCT01854970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473967|NCT01855009|Calcium, Dietary|calcium, dietary|mesh-list
92473968|NCT01855009|Vitamin D|vitamin d|mesh-list
92473969|NCT01855009|Cholecalciferol|cholecalciferol|mesh-list
92473970|NCT01855009|Calcium Carbonate|calcium carbonate|mesh-list
92473971|NCT01855009|Calcium|calcium|mesh-list
92473972|NCT01855009|Vitamins|vitamins|mesh-ancestor
92473973|NCT01855009|Micronutrients|micronutrients|mesh-ancestor
92473974|NCT01855009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473975|NCT01855009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92473976|NCT01855009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92473977|NCT01855009|Antacids|antacids|mesh-ancestor
92473978|NCT01855009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473979|NCT01855009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92473980|NCT01855061|Midazolam|midazolam|mesh-list
92473981|NCT01855061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92473982|NCT01855061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92473983|NCT01855061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92473984|NCT01855061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92473985|NCT01855061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92473986|NCT01855061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92473987|NCT01855061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92473988|NCT01855061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92473989|NCT01855061|Anesthetics, General|anesthetics, general|mesh-ancestor
92473990|NCT01855061|Anesthetics|anesthetics|mesh-ancestor
92473991|NCT01855061|GABA Modulators|gaba modulators|mesh-ancestor
92473992|NCT01855061|GABA Agents|gaba agents|mesh-ancestor
92473993|NCT01855061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92473994|NCT01855061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92473995|NCT01855100|Rivaroxaban|rivaroxaban|mesh-list
92473996|NCT01855100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92473997|NCT01855100|Antithrombins|antithrombins|mesh-ancestor
92473998|NCT01855100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92473999|NCT01855100|Protease Inhibitors|protease inhibitors|mesh-ancestor
92474000|NCT01855100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474001|NCT01855100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474002|NCT01855100|Anticoagulants|anticoagulants|mesh-ancestor
92474003|NCT01855139|Rivaroxaban|rivaroxaban|mesh-list
92474004|NCT01855139|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92474005|NCT01855139|Antithrombins|antithrombins|mesh-ancestor
92474006|NCT01855139|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92474007|NCT01855139|Protease Inhibitors|protease inhibitors|mesh-ancestor
92474008|NCT01855139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474009|NCT01855139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474010|NCT01855139|Anticoagulants|anticoagulants|mesh-ancestor
92474011|NCT01855256|Oxybutynin|oxybutynin|mesh-list
92474012|NCT01855256|Parasympatholytics|parasympatholytics|mesh-ancestor
92474013|NCT01855256|Autonomic Agents|autonomic agents|mesh-ancestor
92474014|NCT01855256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474015|NCT01855256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474016|NCT01855256|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92474017|NCT01855256|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92474018|NCT01855256|Cholinergic Agents|cholinergic agents|mesh-ancestor
92474019|NCT01855256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474020|NCT01855256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474021|NCT01855256|Urological Agents|urological agents|mesh-ancestor
92474022|NCT01855321|Vitamin D|vitamin d|mesh-list
92474023|NCT01855321|Cholecalciferol|cholecalciferol|mesh-list
92474024|NCT01855321|Vitamins|vitamins|mesh-ancestor
92474025|NCT01855321|Micronutrients|micronutrients|mesh-ancestor
92474026|NCT01855321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474027|NCT01855321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92474028|NCT01855321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92474029|NCT01855334|Spironolactone|spironolactone|mesh-list
92474030|NCT01855334|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92474031|NCT01855334|Hormone Antagonists|hormone antagonists|mesh-ancestor
92474032|NCT01855334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474033|NCT01855334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474034|NCT01855334|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92474035|NCT01855334|Diuretics|diuretics|mesh-ancestor
92474036|NCT01855334|Natriuretic Agents|natriuretic agents|mesh-ancestor
92474037|NCT01855386|Liver Extracts|liver extracts|mesh-list
92474038|NCT01855386|Hematinics|hematinics|mesh-ancestor
92474039|NCT01855490|Exenatide|exenatide|mesh-list
92474040|NCT01855490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92474041|NCT01855490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474042|NCT01855490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92474043|NCT01855490|Incretins|incretins|mesh-ancestor
92474044|NCT01855490|Hormones|hormones|mesh-ancestor
92474045|NCT01855490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474046|NCT01855516|Heparin|heparin|mesh-list
92474047|NCT01855516|Anticoagulants|anticoagulants|mesh-ancestor
92474048|NCT01855516|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92474049|NCT01855516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92474050|NCT01855516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474051|NCT01855529|Ropivacaine|ropivacaine|mesh-list
92474052|NCT01855529|Anesthetics, Local|anesthetics, local|mesh-ancestor
92474053|NCT01855529|Anesthetics|anesthetics|mesh-ancestor
92474054|NCT01855529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474055|NCT01855529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474056|NCT01855529|Sensory System Agents|sensory system agents|mesh-ancestor
92474057|NCT01855529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474058|NCT01855542|Plasma-lyte 148|plasma-lyte 148|mesh-list
92474059|NCT01855542|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92474060|NCT01855542|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92474061|NCT01855555|Propofol|propofol|mesh-list
92474062|NCT01855555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92474063|NCT01855555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474064|NCT01855555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474065|NCT01855555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92474066|NCT01855555|Anesthetics, General|anesthetics, general|mesh-ancestor
92474067|NCT01855555|Anesthetics|anesthetics|mesh-ancestor
92474068|NCT01855568|Methotrexate|methotrexate|mesh-list
92474069|NCT01855568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92474070|NCT01855568|Abortifacient Agents|abortifacient agents|mesh-ancestor
92474071|NCT01855568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92474072|NCT01855568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474073|NCT01855568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92474074|NCT01855568|Antimetabolites|antimetabolites|mesh-ancestor
92474075|NCT01855568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474076|NCT01855568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474077|NCT01855568|Dermatologic Agents|dermatologic agents|mesh-ancestor
92474078|NCT01855568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474079|NCT01855568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92474080|NCT01855568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474081|NCT01855568|Immunologic Factors|immunologic factors|mesh-ancestor
92474082|NCT01855568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474083|NCT01855568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92474085|NCT01855581|Propofol|propofol|mesh-list
92474086|NCT01855581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92474087|NCT01855581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474088|NCT01855581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474089|NCT01855581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92474090|NCT01855581|Anesthetics, General|anesthetics, general|mesh-ancestor
92474091|NCT01855581|Anesthetics|anesthetics|mesh-ancestor
92474092|NCT01855581|Analgesics|analgesics|mesh-ancestor
92474093|NCT01855581|Sensory System Agents|sensory system agents|mesh-ancestor
92474094|NCT01855581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474095|NCT01855581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92474096|NCT01855581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92474097|NCT01855581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92474098|NCT01855581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474099|NCT01855581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474100|NCT01855594|Lithium Carbonate|lithium carbonate|mesh-list
92474101|NCT01855594|Antidepressive Agents|antidepressive agents|mesh-ancestor
92474102|NCT01855594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92474103|NCT01855594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531775|NCT00048607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474104|NCT01855594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474105|NCT01855594|Antimanic Agents|antimanic agents|mesh-ancestor
92474106|NCT01855594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92474107|NCT01855594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474108|NCT01855594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474109|NCT01855711|Alosetron|alosetron|mesh-list
92474110|NCT01855711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474111|NCT01855711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92474112|NCT01855711|Serotonin Agents|serotonin agents|mesh-ancestor
92474113|NCT01855711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474114|NCT01855711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474115|NCT01855711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474116|NCT01855724|Gemcitabine|gemcitabine|mesh-list
92474117|NCT01855724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92474118|NCT01855724|Antimetabolites|antimetabolites|mesh-ancestor
92141882|NCT03832465|Ofloxacin|ofloxacin|mesh-list
92474119|NCT01855724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474120|NCT01855724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474121|NCT01855737|Warfarin|warfarin|mesh-list
92474122|NCT01855737|Anticoagulants|anticoagulants|mesh-ancestor
92474123|NCT01855763|Insulin|insulin|mesh-list
92474124|NCT01855763|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92474125|NCT01855763|Metformin|metformin|mesh-list
92474126|NCT01855763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92474127|NCT01855763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474128|NCT01855971|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92474129|NCT01855971|Antioxidants|antioxidants|mesh-ancestor
92474130|NCT01855971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474131|NCT01855971|Protective Agents|protective agents|mesh-ancestor
92474132|NCT01855971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474133|NCT01855971|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92474134|NCT01855971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92474135|NCT01855971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474136|NCT01855971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92474137|NCT01855984|Tocotrienols|tocotrienols|mesh-list
92474138|NCT01855984|Vitamin E|vitamin e|mesh-list
92474139|NCT01855984|Tocopherols|tocopherols|mesh-list
92474140|NCT01855984|Tocovid|tocovid|mesh-list
92474141|NCT01855984|Antioxidants|antioxidants|mesh-ancestor
92474142|NCT01855984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474143|NCT01855984|Protective Agents|protective agents|mesh-ancestor
92474144|NCT01855984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474145|NCT01855984|Vitamins|vitamins|mesh-ancestor
92474146|NCT01855984|Micronutrients|micronutrients|mesh-ancestor
92474147|NCT01856023|Aldesleukin|aldesleukin|mesh-list
92474148|NCT01856023|Ipilimumab|ipilimumab|mesh-list
92474149|NCT01856023|Interleukin-2|interleukin-2|mesh-list
92474150|NCT01856023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92474151|NCT01856023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474152|NCT01856023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92474153|NCT01856023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474154|NCT01856023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474155|NCT01856023|Analgesics|analgesics|mesh-ancestor
92474156|NCT01856023|Sensory System Agents|sensory system agents|mesh-ancestor
92474157|NCT01856023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474158|NCT01856023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474159|NCT01856023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92474160|NCT01856023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92474161|NCT01856023|Antiviral Agents|antiviral agents|mesh-ancestor
92474162|NCT01856023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474163|NCT01856062|Dexamethasone|dexamethasone|mesh-list
92474164|NCT01856062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474165|NCT01856062|Antiemetics|antiemetics|mesh-ancestor
92474166|NCT01856062|Autonomic Agents|autonomic agents|mesh-ancestor
92474167|NCT01856062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474168|NCT01856062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474169|NCT01856062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474170|NCT01856062|Glucocorticoids|glucocorticoids|mesh-ancestor
92474171|NCT01856062|Hormones|hormones|mesh-ancestor
92474172|NCT01856062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474173|NCT01856062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92474174|NCT01856062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474175|NCT01856101|Dactolisib|dactolisib|mesh-list
92474176|NCT01856101|MTOR Inhibitors|mtor inhibitors|mesh-list
92474177|NCT01856101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474178|NCT01856101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92474179|NCT01856101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474180|NCT01856101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474181|NCT01856101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474182|NCT01856101|Immunologic Factors|immunologic factors|mesh-ancestor
92474183|NCT01856101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474184|NCT01856127|Sertraline|sertraline|mesh-list
92474185|NCT01856127|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92474186|NCT01856127|Antidepressive Agents|antidepressive agents|mesh-ancestor
92474187|NCT01856127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92474188|NCT01856127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92474189|NCT01856127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92474190|NCT01856127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92474191|NCT01856127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474192|NCT01856127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474193|NCT01856127|Serotonin Agents|serotonin agents|mesh-ancestor
92474194|NCT01856127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474195|NCT01856127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92474196|NCT01856127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92474197|NCT01856166|Sufentanil|sufentanil|mesh-list
92474198|NCT01856166|Levobupivacaine|levobupivacaine|mesh-list
92474199|NCT01856166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92474200|NCT01856166|Narcotics|narcotics|mesh-ancestor
92474201|NCT01856166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474202|NCT01856166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474203|NCT01856166|Analgesics|analgesics|mesh-ancestor
92474204|NCT01856166|Sensory System Agents|sensory system agents|mesh-ancestor
92474205|NCT01856166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474206|NCT01856166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92474207|NCT01856166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92474208|NCT01856166|Anesthetics, General|anesthetics, general|mesh-ancestor
92474209|NCT01856166|Anesthetics|anesthetics|mesh-ancestor
92474210|NCT01856166|Anesthetics, Local|anesthetics, local|mesh-ancestor
92474211|NCT01856205|Immunoglobulins|immunoglobulins|mesh-list
92474212|NCT01856205|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92474213|NCT01856205|Antibodies|antibodies|mesh-list
92474214|NCT01856205|gamma-Globulins|gamma-globulins|mesh-list
92474215|NCT01856205|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92474216|NCT01856205|Immunologic Factors|immunologic factors|mesh-ancestor
92474217|NCT01856205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474218|NCT01856348|Vitamin D|vitamin d|mesh-list
92474219|NCT01856348|Vitamins|vitamins|mesh-ancestor
92474220|NCT01856348|Micronutrients|micronutrients|mesh-ancestor
92474221|NCT01856348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474222|NCT01856348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92474223|NCT01856374|Sirolimus|sirolimus|mesh-list
92474224|NCT01856374|Everolimus|everolimus|mesh-list
92474225|NCT01856374|Atorvastatin|atorvastatin|mesh-list
92474226|NCT01856374|Pravastatin|pravastatin|mesh-list
92474227|NCT01856374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92474228|NCT01856374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92474229|NCT01856374|Antimetabolites|antimetabolites|mesh-ancestor
92474230|NCT01856374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474231|NCT01856374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92474232|NCT01856374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92474233|NCT01856374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474234|NCT01856374|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92474235|NCT01856374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92474236|NCT01856374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474237|NCT01856374|Immunologic Factors|immunologic factors|mesh-ancestor
92474238|NCT01856374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474239|NCT01856374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474240|NCT01856374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92474241|NCT01856374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474242|NCT01856374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92474243|NCT01856374|Antifungal Agents|antifungal agents|mesh-ancestor
92474244|NCT01856413|Immunoglobulins|immunoglobulins|mesh-list
92474245|NCT01856413|Immunologic Factors|immunologic factors|mesh-ancestor
92474246|NCT01856413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474247|NCT01856517|Clonidine|clonidine|mesh-list
92474248|NCT01856517|Analgesics|analgesics|mesh-ancestor
92474249|NCT01856517|Sensory System Agents|sensory system agents|mesh-ancestor
92474250|NCT01856517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474251|NCT01856517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474252|NCT01856517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92474253|NCT01856517|Sympatholytics|sympatholytics|mesh-ancestor
92474254|NCT01856517|Autonomic Agents|autonomic agents|mesh-ancestor
92474255|NCT01856517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92474256|NCT01856517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92474257|NCT01856517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92474258|NCT01856517|Adrenergic Agents|adrenergic agents|mesh-ancestor
92474259|NCT01856517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474260|NCT01856517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474262|NCT01856556|Glycine Agents|glycine agents|mesh-ancestor
92474263|NCT01856556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474264|NCT01856556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474265|NCT01856556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474266|NCT01856621|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92474267|NCT01856621|Charcoal|charcoal|mesh-list
92474268|NCT01856621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92474269|NCT01856621|Autonomic Agents|autonomic agents|mesh-ancestor
92474270|NCT01856621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474271|NCT01856621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474272|NCT01856621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92474273|NCT01856621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474274|NCT01856621|Glucocorticoids|glucocorticoids|mesh-ancestor
92474275|NCT01856621|Hormones|hormones|mesh-ancestor
92474276|NCT01856621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474277|NCT01856621|Sympathomimetics|sympathomimetics|mesh-ancestor
92474278|NCT01856621|Antidotes|antidotes|mesh-ancestor
92474279|NCT01856621|Protective Agents|protective agents|mesh-ancestor
92474280|NCT01856738|Rivastigmine|rivastigmine|mesh-list
92474281|NCT01856738|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92474282|NCT01856738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474283|NCT01856738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474284|NCT01856738|Cholinergic Agents|cholinergic agents|mesh-ancestor
92474285|NCT01856738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474286|NCT01856738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474287|NCT01856738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92474288|NCT01856738|Protective Agents|protective agents|mesh-ancestor
92474289|NCT01856803|Thymoglobulin|thymoglobulin|mesh-list
92474290|NCT01856803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92474291|NCT01856803|Immunologic Factors|immunologic factors|mesh-ancestor
92474292|NCT01856803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474293|NCT01856803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474294|NCT01856946|Vitamin D|vitamin d|mesh-list
92474295|NCT01856946|Cholecalciferol|cholecalciferol|mesh-list
92474296|NCT01856946|Vitamins|vitamins|mesh-ancestor
92474297|NCT01856946|Micronutrients|micronutrients|mesh-ancestor
92474298|NCT01856946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474299|NCT01856946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92474300|NCT01856946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92474302|NCT01856959|Albuterol|albuterol|mesh-list
92474303|NCT01856959|Analgesics|analgesics|mesh-ancestor
92474304|NCT01856959|Sensory System Agents|sensory system agents|mesh-ancestor
92474305|NCT01856959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474306|NCT01856959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474307|NCT01856959|Anesthetics|anesthetics|mesh-ancestor
92474308|NCT01856959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474309|NCT01856959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92474310|NCT01856959|Anticonvulsants|anticonvulsants|mesh-ancestor
92474311|NCT01856959|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92474312|NCT01856959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92474313|NCT01856959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474314|NCT01856959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92474315|NCT01856959|Tocolytic Agents|tocolytic agents|mesh-ancestor
92474316|NCT01856959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92474317|NCT01856959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92474318|NCT01856959|Autonomic Agents|autonomic agents|mesh-ancestor
92474319|NCT01856959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92474320|NCT01856959|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474321|NCT01856959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92474322|NCT01856959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92474323|NCT01856959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92474324|NCT01856959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92531782|NCT00048607|Antiemetics|antiemetics|mesh-ancestor
92474325|NCT01856959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474326|NCT01856985|Misoprostol|misoprostol|mesh-list
92474327|NCT01856985|Mifepristone|mifepristone|mesh-list
92474328|NCT01856985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92474329|NCT01856985|Abortifacient Agents|abortifacient agents|mesh-ancestor
92474330|NCT01856985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92474331|NCT01856985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474332|NCT01856985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92474333|NCT01856985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474334|NCT01856985|Oxytocics|oxytocics|mesh-ancestor
92474335|NCT01856985|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92474336|NCT01856985|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92474337|NCT01856985|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92474338|NCT01856985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92474339|NCT01856985|Contraceptive Agents|contraceptive agents|mesh-ancestor
92474340|NCT01856985|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92474341|NCT01856985|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92474342|NCT01856985|Hormone Antagonists|hormone antagonists|mesh-ancestor
92474343|NCT01856985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474344|NCT01856985|Luteolytic Agents|luteolytic agents|mesh-ancestor
92474345|NCT01856985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92474346|NCT01856985|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92474347|NCT01856998|Propofol|propofol|mesh-list
92474348|NCT01856998|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92474349|NCT01856998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474350|NCT01856998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474351|NCT01856998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92474352|NCT01856998|Anesthetics, General|anesthetics, general|mesh-ancestor
92474353|NCT01856998|Anesthetics|anesthetics|mesh-ancestor
92474354|NCT01857011|Iron|iron|mesh-list
92474355|NCT01857011|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92474356|NCT01857011|Teferrol|teferrol|mesh-list
92474357|NCT01857011|Ferric Compounds|ferric compounds|mesh-list
92474358|NCT01857011|Trace Elements|trace elements|mesh-ancestor
92474359|NCT01857011|Micronutrients|micronutrients|mesh-ancestor
92474360|NCT01857011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474361|NCT01857011|Hematinics|hematinics|mesh-ancestor
92474362|NCT01857024|Sevelamer|sevelamer|mesh-list
92474363|NCT01857024|Chelating Agents|chelating agents|mesh-ancestor
92474364|NCT01857024|Sequestering Agents|sequestering agents|mesh-ancestor
92322486|NCT03774745|Hormones|hormones|mesh-ancestor
92474365|NCT01857024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474366|NCT01857141|Dexmedetomidine|dexmedetomidine|mesh-list
92474367|NCT01857141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92474368|NCT01857141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474369|NCT01857141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474370|NCT01857141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474371|NCT01857141|Analgesics|analgesics|mesh-ancestor
92474372|NCT01857141|Sensory System Agents|sensory system agents|mesh-ancestor
92474373|NCT01857141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474374|NCT01857141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92474375|NCT01857141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92474376|NCT01857141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92474377|NCT01857141|Adrenergic Agents|adrenergic agents|mesh-ancestor
92474378|NCT01857141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474379|NCT01857141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474380|NCT01857154|Calcium, Dietary|calcium, dietary|mesh-list
92474381|NCT01857154|Vitamin D|vitamin d|mesh-list
92474382|NCT01857154|Cholecalciferol|cholecalciferol|mesh-list
92474383|NCT01857154|Calcium Carbonate|calcium carbonate|mesh-list
92474384|NCT01857154|Calcium|calcium|mesh-list
92474385|NCT01857154|Vitamins|vitamins|mesh-ancestor
92474386|NCT01857154|Micronutrients|micronutrients|mesh-ancestor
92474387|NCT01857154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474388|NCT01857154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92474389|NCT01857154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92474390|NCT01857154|Antacids|antacids|mesh-ancestor
92474391|NCT01857154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474392|NCT01857154|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474393|NCT01857193|Everolimus|everolimus|mesh-list
92474394|NCT01857193|Exemestane|exemestane|mesh-list
92474395|NCT01857193|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92474396|NCT01857193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92474397|NCT01857193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474398|NCT01857193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474399|NCT01857193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474400|NCT01857193|Immunologic Factors|immunologic factors|mesh-ancestor
92474401|NCT01857193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474402|NCT01857193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474403|NCT01857193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92474404|NCT01857193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92474405|NCT01857193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92474406|NCT01857193|Hormone Antagonists|hormone antagonists|mesh-ancestor
92474407|NCT01857193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474408|NCT01857284|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92474409|NCT01857284|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92474410|NCT01857284|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92474411|NCT01857284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474412|NCT01857284|Antiviral Agents|antiviral agents|mesh-ancestor
92474413|NCT01857284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474415|NCT01857349|Chlorhexidine|chlorhexidine|mesh-list
92474416|NCT01857349|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92474417|NCT01857349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92474418|NCT01857349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474419|NCT01857349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474420|NCT01857349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474421|NCT01857349|Disinfectants|disinfectants|mesh-ancestor
92474422|NCT01857349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92474423|NCT01857375|Insulin|insulin|mesh-list
92474424|NCT01857375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92474425|NCT01857375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474426|NCT01857453|Etoposide|etoposide|mesh-list
92474427|NCT01857453|Carboplatin|carboplatin|mesh-list
92474428|NCT01857453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92474429|NCT01857453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474430|NCT01857453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92474431|NCT01857453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474432|NCT01857453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474433|NCT01857453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474434|NCT01857479|Amphotericin B|amphotericin b|mesh-list
92474435|NCT01857479|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92474436|NCT01857479|Budesonide|budesonide|mesh-list
92474437|NCT01857479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474438|NCT01857479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92474440|NCT01857479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474441|NCT01857479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474442|NCT01857479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92474443|NCT01857479|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474444|NCT01857479|Glucocorticoids|glucocorticoids|mesh-ancestor
92474445|NCT01857479|Hormones|hormones|mesh-ancestor
92474446|NCT01857479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474447|NCT01857479|Amebicides|amebicides|mesh-ancestor
92474448|NCT01857479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92474449|NCT01857479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92474450|NCT01857479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474451|NCT01857479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92474452|NCT01857479|Antifungal Agents|antifungal agents|mesh-ancestor
92474453|NCT01857544|Aflibercept|aflibercept|mesh-list
92474454|NCT01857544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92474455|NCT01857544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92474456|NCT01857544|Growth Substances|growth substances|mesh-ancestor
92474457|NCT01857544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474458|NCT01857544|Growth Inhibitors|growth inhibitors|mesh-ancestor
92474459|NCT01857544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474460|NCT01857596|Trazodone|trazodone|mesh-list
92474461|NCT01857596|Bupropion|bupropion|mesh-list
92474462|NCT01857596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92474463|NCT01857596|Antidepressive Agents|antidepressive agents|mesh-ancestor
92474464|NCT01857596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92474465|NCT01857596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92474466|NCT01857596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92474467|NCT01857596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92474468|NCT01857596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474469|NCT01857596|Dopamine Agents|dopamine agents|mesh-ancestor
92474470|NCT01857596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474471|NCT01857596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474472|NCT01857596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92474473|NCT01857596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92474474|NCT01857596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474475|NCT01857596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92474476|NCT01857596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92199395|NCT01950039|Betaine|betaine|mesh-list
92474477|NCT01857596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474478|NCT01857596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92474479|NCT01857596|Serotonin Agents|serotonin agents|mesh-ancestor
92474480|NCT01857609|Metformin|metformin|mesh-list
92474481|NCT01857609|Rabeprazole|rabeprazole|mesh-list
92474482|NCT01857609|Pantoprazole|pantoprazole|mesh-list
92474483|NCT01857609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92474484|NCT01857609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474485|NCT01857609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92474486|NCT01857609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474487|NCT01857609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92474488|NCT01857609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474489|NCT01857609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474490|NCT01857726|Doxorubicin|doxorubicin|mesh-list
92474491|NCT01857726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474492|NCT01857726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92474493|NCT01857726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92474494|NCT01857726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474495|NCT01857726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474496|NCT01857726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474497|NCT01857752|Temozolomide|temozolomide|mesh-list
92474498|NCT01857752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92474499|NCT01857752|Alkylating Agents|alkylating agents|mesh-ancestor
92474500|NCT01857752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474501|NCT01857752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474502|NCT01857804|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92474503|NCT01857804|Amoxicillin|amoxicillin|mesh-list
92474504|NCT01857804|Chlorhexidine|chlorhexidine|mesh-list
92474505|NCT01857804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92474506|NCT01857804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474507|NCT01857804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92474508|NCT01857804|Disinfectants|disinfectants|mesh-ancestor
92474509|NCT01857804|Dermatologic Agents|dermatologic agents|mesh-ancestor
92474510|NCT01857817|Etodolac|etodolac|mesh-list
92474511|NCT01857817|Propranolol|propranolol|mesh-list
92474513|NCT01857817|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92474514|NCT01857817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92474515|NCT01857817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474516|NCT01857817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474517|NCT01857817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474518|NCT01857817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92474519|NCT01857817|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92474520|NCT01857817|Vasodilator Agents|vasodilator agents|mesh-ancestor
92474521|NCT01857817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474522|NCT01857817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474523|NCT01857817|Analgesics|analgesics|mesh-ancestor
92474524|NCT01857817|Sensory System Agents|sensory system agents|mesh-ancestor
92474525|NCT01857817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474526|NCT01857817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474527|NCT01857817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474528|NCT01857817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92474529|NCT01857817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92474530|NCT01857817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474531|NCT01857843|Everolimus|everolimus|mesh-list
92474532|NCT01857843|Simvastatin|simvastatin|mesh-list
92474533|NCT01857843|Ezetimibe|ezetimibe|mesh-list
92474534|NCT01857843|Pravastatin|pravastatin|mesh-list
92474535|NCT01857843|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92474536|NCT01857843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92474537|NCT01857843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474538|NCT01857843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474539|NCT01857843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474540|NCT01857843|Immunologic Factors|immunologic factors|mesh-ancestor
92474541|NCT01857843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474542|NCT01857843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474543|NCT01857843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92474544|NCT01857843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92474545|NCT01857843|Antimetabolites|antimetabolites|mesh-ancestor
92474546|NCT01857843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92474547|NCT01857843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92474548|NCT01857856|Eplerenone|eplerenone|mesh-list
92474549|NCT01857856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92474550|NCT01857856|Hormone Antagonists|hormone antagonists|mesh-ancestor
92474551|NCT01857856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474552|NCT01857856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474553|NCT01857856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92474554|NCT01857856|Diuretics|diuretics|mesh-ancestor
92474555|NCT01857856|Natriuretic Agents|natriuretic agents|mesh-ancestor
92474556|NCT01857856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92474557|NCT01857895|Exenatide|exenatide|mesh-list
92474558|NCT01857895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92474559|NCT01857895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474560|NCT01857895|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92474561|NCT01857895|Incretins|incretins|mesh-ancestor
92474562|NCT01857895|Hormones|hormones|mesh-ancestor
92474563|NCT01857895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474564|NCT01857921|Trimetazidine|trimetazidine|mesh-list
92474565|NCT01857921|Atorvastatin|atorvastatin|mesh-list
92474566|NCT01857921|Pravastatin|pravastatin|mesh-list
92474567|NCT01857921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92474568|NCT01857921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92474569|NCT01857921|Antimetabolites|antimetabolites|mesh-ancestor
92474570|NCT01857921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474571|NCT01857921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92474572|NCT01857921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92474573|NCT01857921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474574|NCT01857921|Vasodilator Agents|vasodilator agents|mesh-ancestor
92474575|NCT01857999|Losartan|losartan|mesh-list
92474576|NCT01857999|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92474577|NCT01857999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92474578|NCT01857999|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92474579|NCT01857999|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92474580|NCT01857999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474581|NCT01858025|Fluorouracil|fluorouracil|mesh-list
92474582|NCT01858025|Mitomycins|mitomycins|mesh-list
92474583|NCT01858025|Mitomycin|mitomycin|mesh-list
92474584|NCT01858025|Antimetabolites|antimetabolites|mesh-ancestor
92474585|NCT01858025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474586|NCT01858025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92474587|NCT01858025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474588|NCT01858025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474589|NCT01858025|Immunologic Factors|immunologic factors|mesh-ancestor
92474590|NCT01858025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474591|NCT01858025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92474592|NCT01858025|Alkylating Agents|alkylating agents|mesh-ancestor
92474593|NCT01858025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92474594|NCT01858025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474595|NCT01858051|Cholecalciferol|cholecalciferol|mesh-list
92474596|NCT01858051|Vitamin D|vitamin d|mesh-list
92474597|NCT01858051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92474598|NCT01858051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474599|NCT01858051|Vitamins|vitamins|mesh-ancestor
92474600|NCT01858051|Micronutrients|micronutrients|mesh-ancestor
92474601|NCT01858051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92474602|NCT01858077|Everolimus|everolimus|mesh-list
92474603|NCT01858077|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92474604|NCT01858077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92474605|NCT01858077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474606|NCT01858077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474607|NCT01858077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474608|NCT01858077|Immunologic Factors|immunologic factors|mesh-ancestor
92474609|NCT01858077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474610|NCT01858077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474611|NCT01858090|Diphenhydramine|diphenhydramine|mesh-list
92474612|NCT01858090|Promethazine|promethazine|mesh-list
92474613|NCT01858090|Diclofenac|diclofenac|mesh-list
92474614|NCT01858090|Atropine|atropine|mesh-list
92474615|NCT01858090|Ephedrine|ephedrine|mesh-list
92474616|NCT01858090|Fentanyl|fentanyl|mesh-list
92474617|NCT01858090|Sufentanil|sufentanil|mesh-list
92474618|NCT01858090|Meperidine|meperidine|mesh-list
92474619|NCT01858090|Metoclopramide|metoclopramide|mesh-list
92474620|NCT01858090|Propofol|propofol|mesh-list
92474622|NCT01858090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92474623|NCT01858090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474624|NCT01858090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474625|NCT01858090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92474626|NCT01858090|Anesthetics, General|anesthetics, general|mesh-ancestor
92474627|NCT01858090|Anesthetics|anesthetics|mesh-ancestor
92474628|NCT01858090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92474629|NCT01858090|Narcotics|narcotics|mesh-ancestor
92474630|NCT01858090|Analgesics|analgesics|mesh-ancestor
92474631|NCT01858090|Sensory System Agents|sensory system agents|mesh-ancestor
92474632|NCT01858090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474633|NCT01858090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92474634|NCT01858090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474635|NCT01858090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474636|NCT01858090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474637|NCT01858090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474638|NCT01858090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92474639|NCT01858090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474640|NCT01858090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474641|NCT01858090|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92474642|NCT01858090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92474644|NCT01858090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92474645|NCT01858090|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474646|NCT01858090|Mydriatics|mydriatics|mesh-ancestor
92474647|NCT01858090|Parasympatholytics|parasympatholytics|mesh-ancestor
92474648|NCT01858090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92474649|NCT01858090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92474650|NCT01858090|Cholinergic Agents|cholinergic agents|mesh-ancestor
92474651|NCT01858090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474652|NCT01858090|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92474653|NCT01858090|Anesthetics, Local|anesthetics, local|mesh-ancestor
92474654|NCT01858090|Antiemetics|antiemetics|mesh-ancestor
92474655|NCT01858090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474656|NCT01858090|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92474657|NCT01858090|Histamine Antagonists|histamine antagonists|mesh-ancestor
92474658|NCT01858090|Histamine Agents|histamine agents|mesh-ancestor
92474659|NCT01858090|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92474660|NCT01858090|Antipruritics|antipruritics|mesh-ancestor
92474661|NCT01858090|Dermatologic Agents|dermatologic agents|mesh-ancestor
92474663|NCT01858090|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92474664|NCT01858090|Dopamine Agents|dopamine agents|mesh-ancestor
92474665|NCT01858090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92474666|NCT01858090|Sympathomimetics|sympathomimetics|mesh-ancestor
92474667|NCT01858090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92474668|NCT01858090|Adrenergic Agents|adrenergic agents|mesh-ancestor
92474669|NCT01858155|Melatonin|melatonin|mesh-list
92474670|NCT01858155|Antioxidants|antioxidants|mesh-ancestor
92474671|NCT01858155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474672|NCT01858155|Protective Agents|protective agents|mesh-ancestor
92474673|NCT01858155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474674|NCT01858155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474675|NCT01858168|Irinotecan|irinotecan|mesh-list
92474676|NCT01858168|Temozolomide|temozolomide|mesh-list
92474677|NCT01858168|Olaparib|olaparib|mesh-list
92474678|NCT01858168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92474679|NCT01858168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474680|NCT01858168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474681|NCT01858168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474682|NCT01858168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474683|NCT01858168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92474684|NCT01858168|Alkylating Agents|alkylating agents|mesh-ancestor
92474685|NCT01858168|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92474686|NCT01858207|Doxorubicin|doxorubicin|mesh-list
92474687|NCT01858207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92474688|NCT01858207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474689|NCT01858207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92474690|NCT01858207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474691|NCT01858207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474692|NCT01858207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474693|NCT01858311|Tocotrienols|tocotrienols|mesh-list
92474694|NCT01858311|Vitamin E|vitamin e|mesh-list
92474695|NCT01858311|Tocopherols|tocopherols|mesh-list
92474696|NCT01858311|Antioxidants|antioxidants|mesh-ancestor
92474697|NCT01858311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474698|NCT01858311|Protective Agents|protective agents|mesh-ancestor
92474699|NCT01858311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474700|NCT01858311|Vitamins|vitamins|mesh-ancestor
92474701|NCT01858311|Micronutrients|micronutrients|mesh-ancestor
92474702|NCT01858402|Acetaminophen|acetaminophen|mesh-list
92474703|NCT01858402|Dipyrone|dipyrone|mesh-list
92474704|NCT01858402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474705|NCT01858402|Analgesics|analgesics|mesh-ancestor
92474706|NCT01858402|Sensory System Agents|sensory system agents|mesh-ancestor
92474707|NCT01858402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474708|NCT01858402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474709|NCT01858402|Antipyretics|antipyretics|mesh-ancestor
92474710|NCT01858402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474711|NCT01858402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474712|NCT01858402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474713|NCT01858441|Abiraterone Acetate|abiraterone acetate|mesh-list
92474714|NCT01858441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474715|NCT01858441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92474716|NCT01858441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474717|NCT01858441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474718|NCT01858441|Hormone Antagonists|hormone antagonists|mesh-ancestor
92474719|NCT01858441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474720|NCT01858441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474721|NCT01858441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92474722|NCT01858571|Thalidomide|thalidomide|mesh-list
92474723|NCT01858571|Celecoxib|celecoxib|mesh-list
92474724|NCT01858571|Cyclophosphamide|cyclophosphamide|mesh-list
92474725|NCT01858571|Etoposide|etoposide|mesh-list
92474726|NCT01858571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474727|NCT01858571|Immunologic Factors|immunologic factors|mesh-ancestor
92474728|NCT01858571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474729|NCT01858571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474730|NCT01858571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92474731|NCT01858571|Alkylating Agents|alkylating agents|mesh-ancestor
92474732|NCT01858571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474733|NCT01858571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474734|NCT01858571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92474735|NCT01858571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92474736|NCT01858571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92474737|NCT01858571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474738|NCT01858571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474739|NCT01858571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474740|NCT01858571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474741|NCT01858571|Analgesics|analgesics|mesh-ancestor
92474742|NCT01858571|Sensory System Agents|sensory system agents|mesh-ancestor
92474743|NCT01858571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474744|NCT01858571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474745|NCT01858571|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92474746|NCT01858571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92474747|NCT01858571|Leprostatic Agents|leprostatic agents|mesh-ancestor
92474748|NCT01858571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92474749|NCT01858571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474750|NCT01858571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92474751|NCT01858571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92474752|NCT01858571|Growth Substances|growth substances|mesh-ancestor
92474753|NCT01858571|Growth Inhibitors|growth inhibitors|mesh-ancestor
92474754|NCT01858610|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92474755|NCT01858610|Irbesartan|irbesartan|mesh-list
92474756|NCT01858610|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92474757|NCT01858610|Diuretics|diuretics|mesh-ancestor
92474758|NCT01858610|Natriuretic Agents|natriuretic agents|mesh-ancestor
92474759|NCT01858610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474760|NCT01858610|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92474761|NCT01858610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92474762|NCT01858610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474763|NCT01858610|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92474764|NCT01858610|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92474765|NCT01858623|Losartan|losartan|mesh-list
92474766|NCT01858623|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92474767|NCT01858623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92474768|NCT01858623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92474769|NCT01858623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92474770|NCT01858623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92474771|NCT01858623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474773|NCT01858623|Natriuretic Agents|natriuretic agents|mesh-ancestor
92474774|NCT01858623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474775|NCT01858623|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92474776|NCT01858623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92474777|NCT01858649|Bevacizumab|bevacizumab|mesh-list
92474778|NCT01858649|Oxaliplatin|oxaliplatin|mesh-list
92474779|NCT01858649|Irinotecan|irinotecan|mesh-list
92199691|NCT01896921|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92474780|NCT01858649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92474781|NCT01858649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474782|NCT01858649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92474783|NCT01858649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92474784|NCT01858649|Growth Substances|growth substances|mesh-ancestor
92474785|NCT01858649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474786|NCT01858649|Growth Inhibitors|growth inhibitors|mesh-ancestor
92474787|NCT01858649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92474788|NCT01858649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474789|NCT01858649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149865|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92474790|NCT01858649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474791|NCT01858662|Leucovorin|leucovorin|mesh-list
92474792|NCT01858662|Oxaliplatin|oxaliplatin|mesh-list
92474793|NCT01858662|Irinotecan|irinotecan|mesh-list
92474794|NCT01858662|Cetuximab|cetuximab|mesh-list
92474795|NCT01858662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474796|NCT01858662|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92474797|NCT01858662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474798|NCT01858662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474799|NCT01858662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474800|NCT01858662|Antidotes|antidotes|mesh-ancestor
92474801|NCT01858662|Protective Agents|protective agents|mesh-ancestor
92474802|NCT01858662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474803|NCT01858662|Vitamin B Complex|vitamin b complex|mesh-ancestor
92474804|NCT01858662|Vitamins|vitamins|mesh-ancestor
92474805|NCT01858662|Micronutrients|micronutrients|mesh-ancestor
92474806|NCT01858662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92474807|NCT01858792|Belimumab|belimumab|mesh-list
92474808|NCT01858792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92474809|NCT01858792|Immunologic Factors|immunologic factors|mesh-ancestor
92474810|NCT01858792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474812|NCT01858831|Proguanil|proguanil|mesh-list
92474813|NCT01858831|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92474814|NCT01858831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474815|NCT01858831|Antimalarials|antimalarials|mesh-ancestor
92474816|NCT01858831|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92474817|NCT01858831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92474818|NCT01858831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474819|NCT01858831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474820|NCT01858831|Antimetabolites|antimetabolites|mesh-ancestor
92474821|NCT01858870|Lacosamide|lacosamide|mesh-list
92474822|NCT01858870|Anticonvulsants|anticonvulsants|mesh-ancestor
92474823|NCT01858870|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92474824|NCT01858870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92474825|NCT01858870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92474826|NCT01858870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474827|NCT01858909|Melatonin|melatonin|mesh-list
92474828|NCT01858909|Antioxidants|antioxidants|mesh-ancestor
92474829|NCT01858909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474830|NCT01858909|Protective Agents|protective agents|mesh-ancestor
92474831|NCT01858909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474832|NCT01858909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92474833|NCT01858961|Interferons|interferons|mesh-list
92474834|NCT01858961|Ribavirin|ribavirin|mesh-list
92474835|NCT01858961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474836|NCT01858961|Antiviral Agents|antiviral agents|mesh-ancestor
92474837|NCT01858961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474838|NCT01858961|Antimetabolites|antimetabolites|mesh-ancestor
92474839|NCT01858961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474840|NCT01859234|Bevacizumab|bevacizumab|mesh-list
92474841|NCT01859234|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
92474842|NCT01859234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92474843|NCT01859234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474844|NCT01859234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92474845|NCT01859234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92474846|NCT01859234|Growth Substances|growth substances|mesh-ancestor
92474847|NCT01859234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474848|NCT01859234|Growth Inhibitors|growth inhibitors|mesh-ancestor
92474849|NCT01859234|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92474850|NCT01859234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474851|NCT01859377|Ibuprofen|ibuprofen|mesh-list
92474852|NCT01859377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474853|NCT01859377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474854|NCT01859377|Analgesics|analgesics|mesh-ancestor
92474855|NCT01859377|Sensory System Agents|sensory system agents|mesh-ancestor
92474856|NCT01859377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474857|NCT01859377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474858|NCT01859377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474859|NCT01859377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474860|NCT01859377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92474861|NCT01859377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474862|NCT01859377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474863|NCT01859455|Atorvastatin|atorvastatin|mesh-list
92474864|NCT01859455|Simvastatin|simvastatin|mesh-list
92474865|NCT01859455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92474866|NCT01859455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92474867|NCT01859455|Antimetabolites|antimetabolites|mesh-ancestor
92474868|NCT01859455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474869|NCT01859455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92474870|NCT01859455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92474871|NCT01859455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474872|NCT01859468|Calcium Carbonate|calcium carbonate|mesh-list
92474873|NCT01859468|Calcium|calcium|mesh-list
92474874|NCT01859468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92474875|NCT01859468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474876|NCT01859468|Antacids|antacids|mesh-ancestor
92474877|NCT01859468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474878|NCT01859468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92474879|NCT01859481|Eletriptan|eletriptan|mesh-list
92474880|NCT01859481|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92474881|NCT01859481|Serotonin Agents|serotonin agents|mesh-ancestor
92474882|NCT01859481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474883|NCT01859481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474884|NCT01859481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474885|NCT01859585|Ketorolac|ketorolac|mesh-list
92474886|NCT01859585|Parecoxib|parecoxib|mesh-list
92474887|NCT01859585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474888|NCT01859585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474889|NCT01859585|Analgesics|analgesics|mesh-ancestor
92474890|NCT01859585|Sensory System Agents|sensory system agents|mesh-ancestor
92474891|NCT01859585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474892|NCT01859585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474893|NCT01859585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474894|NCT01859585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92474895|NCT01859585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92474896|NCT01859585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474897|NCT01859585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474898|NCT01859585|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92474899|NCT01859624|Albuterol|albuterol|mesh-list
92474900|NCT01859624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92474901|NCT01859624|Autonomic Agents|autonomic agents|mesh-ancestor
92474902|NCT01859624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474903|NCT01859624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474904|NCT01859624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92474905|NCT01859624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474906|NCT01859624|Tocolytic Agents|tocolytic agents|mesh-ancestor
92474907|NCT01859624|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92474908|NCT01859624|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92474909|NCT01859624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92474910|NCT01859624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92474911|NCT01859624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92474912|NCT01859624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474913|NCT01859624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474914|NCT01859728|Cisplatin|cisplatin|mesh-list
92474915|NCT01859728|Gemcitabine|gemcitabine|mesh-list
92474916|NCT01859728|Irinotecan|irinotecan|mesh-list
92474917|NCT01859728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474918|NCT01859728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92474919|NCT01859728|Antimetabolites|antimetabolites|mesh-ancestor
92474920|NCT01859728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474921|NCT01859728|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92474922|NCT01859728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474923|NCT01859728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474924|NCT01859754|gamma-Globulins|gamma-globulins|mesh-list
92474925|NCT01859754|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92474926|NCT01859754|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92474927|NCT01859754|Immunologic Factors|immunologic factors|mesh-ancestor
92474928|NCT01859754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474929|NCT01859858|Curcumin|curcumin|mesh-list
92474931|NCT01859858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92474932|NCT01859858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92474933|NCT01859858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474934|NCT01859858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474935|NCT01859858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474936|NCT01859858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92474937|NCT01859858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92474938|NCT01859858|Analgesics|analgesics|mesh-ancestor
92474939|NCT01859858|Sensory System Agents|sensory system agents|mesh-ancestor
92474940|NCT01859858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474941|NCT01859858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474942|NCT01859858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474944|NCT01860014|Poractant alfa|poractant alfa|mesh-list
92474945|NCT01860014|Beractant|beractant|mesh-list
92474946|NCT01860014|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92474947|NCT01860014|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474948|NCT01860066|Fluticasone|fluticasone|mesh-list
92474949|NCT01860066|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92474950|NCT01860066|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92474951|NCT01860066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92474952|NCT01860066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92474953|NCT01860066|Autonomic Agents|autonomic agents|mesh-ancestor
92474954|NCT01860066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474955|NCT01860066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474956|NCT01860066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92474957|NCT01860066|Respiratory System Agents|respiratory system agents|mesh-ancestor
92474958|NCT01860066|Dermatologic Agents|dermatologic agents|mesh-ancestor
92474959|NCT01860066|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92474960|NCT01860066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92474961|NCT01860066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92474962|NCT01860066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92474963|NCT01860066|Adrenergic Agents|adrenergic agents|mesh-ancestor
92474964|NCT01860066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474965|NCT01860066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474966|NCT01860066|Glucocorticoids|glucocorticoids|mesh-ancestor
92474967|NCT01860066|Hormones|hormones|mesh-ancestor
92474968|NCT01860066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92474969|NCT01860066|Sympathomimetics|sympathomimetics|mesh-ancestor
92474970|NCT01860105|Clopidogrel|clopidogrel|mesh-list
92474971|NCT01860105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92474972|NCT01860105|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92474973|NCT01860105|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92474974|NCT01860105|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92474975|NCT01860105|Purinergic Agents|purinergic agents|mesh-ancestor
92474976|NCT01860105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92474977|NCT01860105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474978|NCT01860105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474979|NCT01860144|Bevacizumab|bevacizumab|mesh-list
92474980|NCT01860144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92474981|NCT01860144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474982|NCT01860144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92474983|NCT01860144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92474984|NCT01860144|Growth Substances|growth substances|mesh-ancestor
92474985|NCT01860144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92474987|NCT01860183|Mycophenolic Acid|mycophenolic acid|mesh-list
92474988|NCT01860183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92474989|NCT01860183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92474990|NCT01860183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92474991|NCT01860183|Antitubercular Agents|antitubercular agents|mesh-ancestor
92474992|NCT01860183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92474993|NCT01860183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92474994|NCT01860183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92474995|NCT01860183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92474996|NCT01860196|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92474997|NCT01860196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92474998|NCT01860196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92474999|NCT01860196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475000|NCT01860196|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92475001|NCT01860196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475002|NCT01860196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475003|NCT01860196|Cholinergic Agents|cholinergic agents|mesh-ancestor
92475004|NCT01860196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475005|NCT01860235|Anesthetics|anesthetics|mesh-list
92475006|NCT01860235|Benzocaine|benzocaine|mesh-list
92475007|NCT01860235|Anesthetics, Local|anesthetics, local|mesh-list
92475008|NCT01860235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475009|NCT01860235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475010|NCT01860235|Sensory System Agents|sensory system agents|mesh-ancestor
92475011|NCT01860235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475012|NCT01860300|Amoxicillin|amoxicillin|mesh-list
92475013|NCT01860300|Clavulanic Acid|clavulanic acid|mesh-list
92475014|NCT01860300|Clavulanic Acids|clavulanic acids|mesh-list
92475015|NCT01860300|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92475016|NCT01860300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475017|NCT01860300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475018|NCT01860300|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92475019|NCT01860300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475020|NCT01860300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475021|NCT01860391|Fluorides|fluorides|mesh-list
92475022|NCT01860391|Cariostatic Agents|cariostatic agents|mesh-ancestor
92475023|NCT01860391|Protective Agents|protective agents|mesh-ancestor
92475024|NCT01860391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475025|NCT01860417|Mepivacaine|mepivacaine|mesh-list
92475026|NCT01860417|Anesthetics, Local|anesthetics, local|mesh-ancestor
92475027|NCT01860417|Anesthetics|anesthetics|mesh-ancestor
92475028|NCT01860417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475029|NCT01860417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475030|NCT01860417|Sensory System Agents|sensory system agents|mesh-ancestor
92475031|NCT01860417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475032|NCT01860469|Vancomycin|vancomycin|mesh-list
92475033|NCT01860469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475034|NCT01860469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475035|NCT01860482|Rabeprazole|rabeprazole|mesh-list
92475036|NCT01860482|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92475037|NCT01860482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475038|NCT01860482|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92475039|NCT01860482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475040|NCT01860482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475041|NCT01860508|Carboplatin|carboplatin|mesh-list
92475042|NCT01860508|Pemetrexed|pemetrexed|mesh-list
92475043|NCT01860508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475044|NCT01860508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475045|NCT01860508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475046|NCT01860508|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92475047|NCT01860508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92475048|NCT01860625|Donepezil|donepezil|mesh-list
92475049|NCT01860625|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92475050|NCT01860625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475051|NCT01860625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475052|NCT01860625|Cholinergic Agents|cholinergic agents|mesh-ancestor
92475053|NCT01860625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475054|NCT01860625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475055|NCT01860625|Nootropic Agents|nootropic agents|mesh-ancestor
92475056|NCT01860638|Bevacizumab|bevacizumab|mesh-list
92475057|NCT01860638|Temozolomide|temozolomide|mesh-list
92475058|NCT01860638|Lomustine|lomustine|mesh-list
92531802|NCT00048763|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92475059|NCT01860638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92475060|NCT01860638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475061|NCT01860638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92475062|NCT01860638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92475063|NCT01860638|Growth Substances|growth substances|mesh-ancestor
92475064|NCT01860638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475065|NCT01860638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92475066|NCT01860638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92475067|NCT01860638|Alkylating Agents|alkylating agents|mesh-ancestor
92475068|NCT01860638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475069|NCT01860664|Hydrocortisone|hydrocortisone|mesh-list
92475070|NCT01860664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475071|NCT01860690|Methotrexate|methotrexate|mesh-list
92475072|NCT01860690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92475073|NCT01860690|Abortifacient Agents|abortifacient agents|mesh-ancestor
92475074|NCT01860690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92475075|NCT01860690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475076|NCT01860690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92475077|NCT01860690|Antimetabolites|antimetabolites|mesh-ancestor
92475078|NCT01860690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475079|NCT01860690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475080|NCT01860690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92475081|NCT01860690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475082|NCT01860690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92475083|NCT01860690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475084|NCT01860690|Immunologic Factors|immunologic factors|mesh-ancestor
92475085|NCT01860690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475086|NCT01860690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92475087|NCT01860716|Melatonin|melatonin|mesh-list
92475088|NCT01860716|Antioxidants|antioxidants|mesh-ancestor
92475089|NCT01860716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475090|NCT01860716|Protective Agents|protective agents|mesh-ancestor
92475091|NCT01860716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475092|NCT01860716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475093|NCT01860729|Anacetrapib|anacetrapib|mesh-list
92475094|NCT01860729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92475095|NCT01860729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92475096|NCT01860729|Antimetabolites|antimetabolites|mesh-ancestor
92475097|NCT01860729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475098|NCT01860729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92475099|NCT01860742|Interferons|interferons|mesh-list
92475100|NCT01860742|Interferon-alpha|interferon-alpha|mesh-list
92475101|NCT01860742|Interferon alpha-2|interferon alpha-2|mesh-list
92475102|NCT01860742|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92475103|NCT01860742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475104|NCT01860742|Antiviral Agents|antiviral agents|mesh-ancestor
92475105|NCT01860742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475106|NCT01860742|Immunologic Factors|immunologic factors|mesh-ancestor
92475107|NCT01860742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475108|NCT01860742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92475109|NCT01860742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475110|NCT01860781|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92475111|NCT01860781|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92475112|NCT01860781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475113|NCT01860781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475114|NCT01860781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475115|NCT01860781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475116|NCT01860781|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92475117|NCT01860781|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92475118|NCT01860781|Serotonin Agents|serotonin agents|mesh-ancestor
92475119|NCT01860781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475120|NCT01860781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475121|NCT01860781|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92475122|NCT01860781|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92475123|NCT01860781|Dopamine Agents|dopamine agents|mesh-ancestor
92475124|NCT01860833|Ibuprofen|ibuprofen|mesh-list
92475125|NCT01860833|Celecoxib|celecoxib|mesh-list
92475126|NCT01860833|Diclofenac|diclofenac|mesh-list
92475127|NCT01860833|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92475128|NCT01860833|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92475129|NCT01860833|Analgesics|analgesics|mesh-ancestor
92475130|NCT01860833|Sensory System Agents|sensory system agents|mesh-ancestor
92475131|NCT01860833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475132|NCT01860833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475133|NCT01860833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475134|NCT01860833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475135|NCT01860833|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92475136|NCT01860833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475137|NCT01860833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475138|NCT01860833|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92475139|NCT01860911|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92475140|NCT01860911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475141|NCT01860911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475142|NCT01861015|Vasopressins|vasopressins|mesh-list
92475143|NCT01861015|Arginine Vasopressin|arginine vasopressin|mesh-list
92475144|NCT01861015|Epinephrine|epinephrine|mesh-list
92475145|NCT01861015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92475146|NCT01861015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92475147|NCT01861015|Adrenergic Agents|adrenergic agents|mesh-ancestor
92475148|NCT01861015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475149|NCT01861015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475150|NCT01861015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475151|NCT01861015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92475152|NCT01861015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92475153|NCT01861015|Autonomic Agents|autonomic agents|mesh-ancestor
92475154|NCT01861015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475155|NCT01861015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92475156|NCT01861015|Respiratory System Agents|respiratory system agents|mesh-ancestor
92475157|NCT01861015|Mydriatics|mydriatics|mesh-ancestor
92475158|NCT01861015|Sympathomimetics|sympathomimetics|mesh-ancestor
92475159|NCT01861015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92475160|NCT01861015|Hemostatics|hemostatics|mesh-ancestor
92475161|NCT01861015|Coagulants|coagulants|mesh-ancestor
92475162|NCT01861015|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92475163|NCT01861015|Natriuretic Agents|natriuretic agents|mesh-ancestor
92475164|NCT01861041|Bupivacaine|bupivacaine|mesh-list
92475165|NCT01861041|Anesthetics, Local|anesthetics, local|mesh-ancestor
92475166|NCT01861041|Anesthetics|anesthetics|mesh-ancestor
92475167|NCT01861041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475168|NCT01861041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475169|NCT01861041|Sensory System Agents|sensory system agents|mesh-ancestor
92475170|NCT01861041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475171|NCT01861145|Mometasone Furoate|mometasone furoate|mesh-list
92475172|NCT01861145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475173|NCT01861145|Dermatologic Agents|dermatologic agents|mesh-ancestor
92475174|NCT01861145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92475176|NCT01861223|Nimotuzumab|nimotuzumab|mesh-list
92475177|NCT01861223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475178|NCT01861223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92475179|NCT01861223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475180|NCT01861223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475181|NCT01861223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92475182|NCT01861340|Dexamethasone|dexamethasone|mesh-list
92475183|NCT01861340|Lenalidomide|lenalidomide|mesh-list
92475184|NCT01861340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475185|NCT01861340|Antiemetics|antiemetics|mesh-ancestor
92475186|NCT01861340|Autonomic Agents|autonomic agents|mesh-ancestor
92475187|NCT01861340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475188|NCT01861340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475189|NCT01861340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475190|NCT01861340|Glucocorticoids|glucocorticoids|mesh-ancestor
92475191|NCT01861340|Hormones|hormones|mesh-ancestor
92475192|NCT01861340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92475193|NCT01861340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92475194|NCT01861340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475195|NCT01861340|Immunologic Factors|immunologic factors|mesh-ancestor
92475196|NCT01861340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92475197|NCT01861340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92475198|NCT01861340|Growth Substances|growth substances|mesh-ancestor
92475199|NCT01861340|Growth Inhibitors|growth inhibitors|mesh-ancestor
92475200|NCT01861535|Imiquimod|imiquimod|mesh-list
92475201|NCT01861535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92475202|NCT01861535|Immunologic Factors|immunologic factors|mesh-ancestor
92475203|NCT01861535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475204|NCT01861535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475205|NCT01861535|Interferon Inducers|interferon inducers|mesh-ancestor
92475206|NCT01861561|Cyclophosphamide|cyclophosphamide|mesh-list
92475207|NCT01861561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475208|NCT01861561|Immunologic Factors|immunologic factors|mesh-ancestor
92475209|NCT01861561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475210|NCT01861561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475211|NCT01861561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92475212|NCT01861561|Alkylating Agents|alkylating agents|mesh-ancestor
92475213|NCT01861561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475214|NCT01861561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475215|NCT01861561|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92475216|NCT01861626|Isotretinoin|isotretinoin|mesh-list
92475217|NCT01861626|Dermatologic Agents|dermatologic agents|mesh-ancestor
92475218|NCT01861912|Arsenic Trioxide|arsenic trioxide|mesh-list
92475219|NCT01861912|Ethiodized Oil|ethiodized oil|mesh-list
92475220|NCT01861912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475221|NCT01861951|Doxorubicin|doxorubicin|mesh-list
92475222|NCT01861951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92475223|NCT01861951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475224|NCT01861951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92475225|NCT01861951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92475226|NCT01861951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475227|NCT01861951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475228|NCT01861990|Valproic Acid|valproic acid|mesh-list
92475229|NCT01861990|Anticonvulsants|anticonvulsants|mesh-ancestor
92475230|NCT01861990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475231|NCT01861990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475232|NCT01861990|GABA Agents|gaba agents|mesh-ancestor
92475233|NCT01861990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475234|NCT01861990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475235|NCT01861990|Antimanic Agents|antimanic agents|mesh-ancestor
92475236|NCT01861990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475237|NCT01861990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475238|NCT01861990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475240|NCT01862003|Folic Acid|folic acid|mesh-list
92475241|NCT01862003|Fluorouracil|fluorouracil|mesh-list
92475242|NCT01862003|Irinotecan|irinotecan|mesh-list
92475243|NCT01862003|Levoleucovorin|levoleucovorin|mesh-list
92475244|NCT01862003|Antimetabolites|antimetabolites|mesh-ancestor
92475245|NCT01862003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475246|NCT01862003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92475247|NCT01862003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475248|NCT01862003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475249|NCT01862003|Immunologic Factors|immunologic factors|mesh-ancestor
92475250|NCT01862003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475251|NCT01862003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92475252|NCT01862003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92475253|NCT01862003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475254|NCT01862003|Antidotes|antidotes|mesh-ancestor
92475255|NCT01862003|Protective Agents|protective agents|mesh-ancestor
92475256|NCT01862003|Vitamin B Complex|vitamin b complex|mesh-ancestor
92475257|NCT01862003|Vitamins|vitamins|mesh-ancestor
92475258|NCT01862003|Micronutrients|micronutrients|mesh-ancestor
92475259|NCT01862003|Hematinics|hematinics|mesh-ancestor
92475260|NCT01862081|Paclitaxel|paclitaxel|mesh-list
92475261|NCT01862081|Docetaxel|docetaxel|mesh-list
92475262|NCT01862081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92475263|NCT01862081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475264|NCT01862081|Tubulin Modulators|tubulin modulators|mesh-ancestor
92475265|NCT01862081|Antimitotic Agents|antimitotic agents|mesh-ancestor
92475266|NCT01862081|Mitosis Modulators|mitosis modulators|mesh-ancestor
92475267|NCT01862081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475268|NCT01862120|Interleukin-2|interleukin-2|mesh-list
92475269|NCT01862120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475270|NCT01862120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92475271|NCT01862120|Analgesics|analgesics|mesh-ancestor
92475272|NCT01862120|Sensory System Agents|sensory system agents|mesh-ancestor
92475273|NCT01862120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475274|NCT01862120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475275|NCT01862263|Vildagliptin|vildagliptin|mesh-list
92475276|NCT01862263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475277|NCT01862263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475278|NCT01862263|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92475279|NCT01862263|Protease Inhibitors|protease inhibitors|mesh-ancestor
92475280|NCT01862263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475281|NCT01862263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475282|NCT01862302|Haloperidol|haloperidol|mesh-list
92475283|NCT01862302|Haloperidol decanoate|haloperidol decanoate|mesh-list
92475284|NCT01862302|Antiemetics|antiemetics|mesh-ancestor
92475285|NCT01862302|Autonomic Agents|autonomic agents|mesh-ancestor
92475286|NCT01862302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475287|NCT01862302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475288|NCT01862302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475289|NCT01862302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92475290|NCT01862302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475291|NCT01862302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475292|NCT01862302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475293|NCT01862302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92475294|NCT01862302|Dopamine Agents|dopamine agents|mesh-ancestor
92475295|NCT01862302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475296|NCT01862302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475297|NCT01862302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92200216|NCT01929759|Antiviral Agents|antiviral agents|mesh-ancestor
92475298|NCT01862354|Anesthetics|anesthetics|mesh-list
92475299|NCT01862354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475300|NCT01862354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475301|NCT01862497|Carvedilol|carvedilol|mesh-list
92475302|NCT01862497|Prazosin|prazosin|mesh-list
92475303|NCT01862497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92475304|NCT01862497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92475305|NCT01862497|Adrenergic Agents|adrenergic agents|mesh-ancestor
92475306|NCT01862497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475307|NCT01862497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475308|NCT01862497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475309|NCT01862497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92475310|NCT01862497|Antioxidants|antioxidants|mesh-ancestor
92475311|NCT01862497|Protective Agents|protective agents|mesh-ancestor
92475312|NCT01862497|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92475313|NCT01862497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475314|NCT01862497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475315|NCT01862497|Vasodilator Agents|vasodilator agents|mesh-ancestor
92475316|NCT01862497|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92475317|NCT01862497|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92475318|NCT01862523|Capsaicin|capsaicin|mesh-list
92475319|NCT01862523|Antipruritics|antipruritics|mesh-ancestor
92475320|NCT01862523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92475321|NCT01862523|Sensory System Agents|sensory system agents|mesh-ancestor
92475322|NCT01862523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475323|NCT01862523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475324|NCT01862835|Anastrozole|anastrozole|mesh-list
92475325|NCT01862835|Testosterone|testosterone|mesh-list
92475326|NCT01862835|Estrogens|estrogens|mesh-list
92475327|NCT01862835|Androgens|androgens|mesh-ancestor
92475328|NCT01862835|Hormones|hormones|mesh-ancestor
92475329|NCT01862835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92475330|NCT01862835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475331|NCT01862835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92475332|NCT01862835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475333|NCT01862835|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92475334|NCT01862835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92475335|NCT01862835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475336|NCT01862835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475337|NCT01862835|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92475338|NCT01862835|Hormone Antagonists|hormone antagonists|mesh-ancestor
92475339|NCT01862887|Moxifloxacin|moxifloxacin|mesh-list
92475340|NCT01862887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475341|NCT01862887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475342|NCT01862887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92475343|NCT01862887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92475344|NCT01862887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475345|NCT01862887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475346|NCT01862887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475347|NCT01862926|Cyclophosphamide|cyclophosphamide|mesh-list
92475348|NCT01862926|Rituximab|rituximab|mesh-list
92475349|NCT01862926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475350|NCT01862926|Immunologic Factors|immunologic factors|mesh-ancestor
92475351|NCT01862926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475352|NCT01862926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475353|NCT01862926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92475354|NCT01862926|Alkylating Agents|alkylating agents|mesh-ancestor
92475355|NCT01862926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475356|NCT01862926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475357|NCT01862926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92475358|NCT01862926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92475359|NCT01862978|Heparin|heparin|mesh-list
92475360|NCT01862978|Nadroparin|nadroparin|mesh-list
92475361|NCT01862978|Anticoagulants|anticoagulants|mesh-ancestor
92475362|NCT01862978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92475363|NCT01862978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92475364|NCT01862978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475365|NCT01863004|Bortezomib|bortezomib|mesh-list
92475366|NCT01863004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475367|NCT01863069|Interferons|interferons|mesh-list
92475368|NCT01863069|Interferon-beta|interferon-beta|mesh-list
92475369|NCT01863069|Interferon beta-1a|interferon beta-1a|mesh-list
92475370|NCT01863069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475371|NCT01863069|Antiviral Agents|antiviral agents|mesh-ancestor
92475372|NCT01863069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475373|NCT01863069|Immunologic Factors|immunologic factors|mesh-ancestor
92475374|NCT01863069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475375|NCT01863069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92475376|NCT01863147|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92475377|NCT01863147|Acarbose|acarbose|mesh-list
92475378|NCT01863147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475379|NCT01863147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475380|NCT01863147|Incretins|incretins|mesh-ancestor
92475382|NCT01863147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92475383|NCT01863147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92475384|NCT01863147|Protease Inhibitors|protease inhibitors|mesh-ancestor
92475385|NCT01863147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475386|NCT01863147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475387|NCT01863147|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92475388|NCT01863173|Metoprolol|metoprolol|mesh-list
92475389|NCT01863173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92475390|NCT01863173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92475391|NCT01863173|Sympatholytics|sympatholytics|mesh-ancestor
92475392|NCT01863173|Autonomic Agents|autonomic agents|mesh-ancestor
92475393|NCT01863173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475394|NCT01863173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475395|NCT01863173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92475396|NCT01863173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92475397|NCT01863173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92475398|NCT01863173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92475399|NCT01863173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475400|NCT01863173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475401|NCT01863199|Ranibizumab|ranibizumab|mesh-list
92475402|NCT01863199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92475403|NCT01863199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92475404|NCT01863199|Growth Substances|growth substances|mesh-ancestor
92475405|NCT01863199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475406|NCT01863199|Growth Inhibitors|growth inhibitors|mesh-ancestor
92475407|NCT01863199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475408|NCT01863225|Atorvastatin|atorvastatin|mesh-list
92475409|NCT01863225|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92475410|NCT01863225|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92475411|NCT01863225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92475412|NCT01863225|Antimetabolites|antimetabolites|mesh-ancestor
92475413|NCT01863225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475414|NCT01863225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92475415|NCT01863225|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92475416|NCT01863225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475417|NCT01863238|Ivacaftor|ivacaftor|mesh-list
92475418|NCT01863238|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92475419|NCT01863238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475420|NCT01863238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475421|NCT01863251|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92475422|NCT01863251|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92475423|NCT01863251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92475424|NCT01863251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475425|NCT01863251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475426|NCT01863251|Adrenergic Agents|adrenergic agents|mesh-ancestor
92475427|NCT01863251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475428|NCT01863251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475429|NCT01863277|Melatonin|melatonin|mesh-list
92475430|NCT01863277|Antioxidants|antioxidants|mesh-ancestor
92475431|NCT01863277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475432|NCT01863277|Protective Agents|protective agents|mesh-ancestor
92475433|NCT01863277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475434|NCT01863277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475435|NCT01863355|Fentanyl|fentanyl|mesh-list
92475436|NCT01863355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92475437|NCT01863355|Narcotics|narcotics|mesh-ancestor
92475438|NCT01863355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475439|NCT01863355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475440|NCT01863355|Analgesics|analgesics|mesh-ancestor
92475441|NCT01863355|Sensory System Agents|sensory system agents|mesh-ancestor
92475442|NCT01863355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475443|NCT01863355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92475444|NCT01863355|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92475445|NCT01863355|Anesthetics, General|anesthetics, general|mesh-ancestor
92475446|NCT01863355|Anesthetics|anesthetics|mesh-ancestor
92475447|NCT01863407|Metronidazole|metronidazole|mesh-list
92475448|NCT01863407|Dexamethasone|dexamethasone|mesh-list
92475449|NCT01863407|Allantoin|allantoin|mesh-list
92475450|NCT01863407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475451|NCT01863407|Antiemetics|antiemetics|mesh-ancestor
92475452|NCT01863407|Autonomic Agents|autonomic agents|mesh-ancestor
92475453|NCT01863407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475454|NCT01863407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475455|NCT01863407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475457|NCT01863407|Hormones|hormones|mesh-ancestor
92475458|NCT01863407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92475459|NCT01863407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92475460|NCT01863407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475461|NCT01863407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475462|NCT01863407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475463|NCT01863407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92475464|NCT01863407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92475465|NCT01863407|Dermatologic Agents|dermatologic agents|mesh-ancestor
92475466|NCT01863459|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92475467|NCT01863459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92475468|NCT01863459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475469|NCT01863459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92475470|NCT01863459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92475471|NCT01863459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475472|NCT01863459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475473|NCT01863459|Dopamine Agents|dopamine agents|mesh-ancestor
92475474|NCT01863459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475476|NCT01863485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92475477|NCT01863485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475478|NCT01863485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475479|NCT01863511|Tolvaptan|tolvaptan|mesh-list
92475480|NCT01863511|Diuretics|diuretics|mesh-list
92475481|NCT01863511|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92475482|NCT01863511|Natriuretic Agents|natriuretic agents|mesh-ancestor
92475483|NCT01863511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475484|NCT01863511|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92475485|NCT01863511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475486|NCT01863511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475487|NCT01863589|Adefovir|adefovir|mesh-list
92475488|NCT01863589|Antiviral Agents|antiviral agents|mesh-ancestor
92475489|NCT01863589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475490|NCT01863589|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92475491|NCT01863589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92475492|NCT01863589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475493|NCT01863589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475494|NCT01863602|Lamotrigine|lamotrigine|mesh-list
92475495|NCT01863602|Anticonvulsants|anticonvulsants|mesh-ancestor
92475496|NCT01863602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92475497|NCT01863602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475498|NCT01863602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475499|NCT01863602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475500|NCT01863602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475501|NCT01863602|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92475502|NCT01863602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475503|NCT01863602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475504|NCT01863602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475505|NCT01863602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92475506|NCT01863615|Isotretinoin|isotretinoin|mesh-list
92475507|NCT01863615|Dermatologic Agents|dermatologic agents|mesh-ancestor
92475508|NCT01863641|Calcitriol|calcitriol|mesh-list
92475509|NCT01863641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475510|NCT01863641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475511|NCT01863641|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92475512|NCT01863641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475513|NCT01863641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475514|NCT01863641|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92475515|NCT01863641|Vitamins|vitamins|mesh-ancestor
92475516|NCT01863641|Micronutrients|micronutrients|mesh-ancestor
92475517|NCT01863641|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92475518|NCT01863654|Montelukast|montelukast|mesh-list
92475519|NCT01863654|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92475520|NCT01863654|Respiratory System Agents|respiratory system agents|mesh-ancestor
92475521|NCT01863654|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92475522|NCT01863654|Hormone Antagonists|hormone antagonists|mesh-ancestor
92475523|NCT01863654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200451|NCT05346146|Paclitaxel|paclitaxel|mesh-list
92475524|NCT01863654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475525|NCT01863654|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92475526|NCT01863654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92475527|NCT01863654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475528|NCT01863706|Misoprostol|misoprostol|mesh-list
92475529|NCT01863706|Oxytocin|oxytocin|mesh-list
92475530|NCT01863706|Oxytocics|oxytocics|mesh-ancestor
92475531|NCT01863706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92475532|NCT01863706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475533|NCT01863706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92475534|NCT01863706|Abortifacient Agents|abortifacient agents|mesh-ancestor
92475535|NCT01863706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92475536|NCT01863706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475537|NCT01863719|Colistin|colistin|mesh-list
92475538|NCT01863719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475539|NCT01863719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475540|NCT01863810|Pregabalin|pregabalin|mesh-list
92475541|NCT01863810|Analgesics|analgesics|mesh-ancestor
92475542|NCT01863810|Sensory System Agents|sensory system agents|mesh-ancestor
92475543|NCT01863810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475544|NCT01863810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475545|NCT01863810|Anticonvulsants|anticonvulsants|mesh-ancestor
92475546|NCT01863810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92475547|NCT01863810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475548|NCT01863810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475549|NCT01863810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475550|NCT01863810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92475551|NCT01863810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475552|NCT01863810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475553|NCT01863810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475554|NCT01863823|Amoxicillin|amoxicillin|mesh-list
92475555|NCT01863823|Tetracycline|tetracycline|mesh-list
92475556|NCT01863823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475557|NCT01863823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475558|NCT01863823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92475559|NCT01863823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475560|NCT01863823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475561|NCT01863888|Teriflunomide|teriflunomide|mesh-list
92475562|NCT01863888|Cholestyramine Resin|cholestyramine resin|mesh-list
92475563|NCT01863888|Charcoal|charcoal|mesh-list
92475564|NCT01863888|Antidotes|antidotes|mesh-ancestor
92475565|NCT01863888|Protective Agents|protective agents|mesh-ancestor
92475566|NCT01863888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475567|NCT01863888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92475568|NCT01863888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92475569|NCT01863888|Analgesics|analgesics|mesh-ancestor
92475570|NCT01863888|Sensory System Agents|sensory system agents|mesh-ancestor
92475571|NCT01863888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475572|NCT01863888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475573|NCT01863888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531809|NCT05576298|Insulin|insulin|mesh-list
92475574|NCT01863888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475576|NCT01863888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92475577|NCT01863888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92475578|NCT01863888|Antimetabolites|antimetabolites|mesh-ancestor
92475579|NCT01863888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475580|NCT01863888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92475581|NCT01863914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92475582|NCT01863914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92475583|NCT01863914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92475584|NCT01863914|Antimetabolites|antimetabolites|mesh-ancestor
92475585|NCT01863914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475586|NCT01863914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92475587|NCT01863914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92475588|NCT01863914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475589|NCT01864057|Thiamine|thiamine|mesh-list
92475590|NCT01864057|Vitamin B Complex|vitamin b complex|mesh-ancestor
92475591|NCT01864057|Vitamins|vitamins|mesh-ancestor
92475592|NCT01864057|Micronutrients|micronutrients|mesh-ancestor
92475593|NCT01864057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475594|NCT01864070|Everolimus|everolimus|mesh-list
92475595|NCT01864070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92475596|NCT01864070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92475597|NCT01864070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475598|NCT01864070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475599|NCT01864070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475600|NCT01864070|Immunologic Factors|immunologic factors|mesh-ancestor
92475601|NCT01864070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475602|NCT01864070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475603|NCT01864083|Fluorides|fluorides|mesh-list
92475604|NCT01864083|Cariostatic Agents|cariostatic agents|mesh-ancestor
92475605|NCT01864083|Protective Agents|protective agents|mesh-ancestor
92475606|NCT01864083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475607|NCT01864096|Metformin|metformin|mesh-list
92475608|NCT01864096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475609|NCT01864096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475610|NCT01864161|Iron|iron|mesh-list
92475611|NCT01864161|Trace Elements|trace elements|mesh-ancestor
92475612|NCT01864161|Micronutrients|micronutrients|mesh-ancestor
92475613|NCT01864161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475614|NCT01864187|Dexmedetomidine|dexmedetomidine|mesh-list
92475615|NCT01864187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92475616|NCT01864187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475617|NCT01864187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475618|NCT01864187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92475619|NCT01864187|Analgesics|analgesics|mesh-ancestor
92475620|NCT01864187|Sensory System Agents|sensory system agents|mesh-ancestor
92475621|NCT01864187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475622|NCT01864187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92475623|NCT01864187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92475624|NCT01864187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92475625|NCT01864187|Adrenergic Agents|adrenergic agents|mesh-ancestor
92475626|NCT01864187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475627|NCT01864187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475628|NCT01864213|Tetracaine|tetracaine|mesh-list
92475629|NCT01864213|Anesthetics, Local|anesthetics, local|mesh-ancestor
92475630|NCT01864213|Anesthetics|anesthetics|mesh-ancestor
92475631|NCT01864213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475632|NCT01864213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475633|NCT01864213|Sensory System Agents|sensory system agents|mesh-ancestor
92475634|NCT01864213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475635|NCT01864252|Nitroglycerin|nitroglycerin|mesh-list
92475636|NCT01864252|Vasodilator Agents|vasodilator agents|mesh-ancestor
92475637|NCT01864265|Certolizumab Pegol|certolizumab pegol|mesh-list
92475638|NCT01864265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92475639|NCT01864265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475640|NCT01864265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475641|NCT01864265|Immunologic Factors|immunologic factors|mesh-ancestor
92475642|NCT01864265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475643|NCT01864265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475644|NCT01864551|Lamotrigine|lamotrigine|mesh-list
92475645|NCT01864551|Olanzapine|olanzapine|mesh-list
92475646|NCT01864551|Antiemetics|antiemetics|mesh-ancestor
92475647|NCT01864551|Autonomic Agents|autonomic agents|mesh-ancestor
92475648|NCT01864551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475649|NCT01864551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475650|NCT01864551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475651|NCT01864551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92475652|NCT01864551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475653|NCT01864551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475654|NCT01864551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475655|NCT01864551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92475656|NCT01864551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92475657|NCT01864551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475658|NCT01864551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475659|NCT01864551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475660|NCT01864551|Serotonin Agents|serotonin agents|mesh-ancestor
92475661|NCT01864551|Anticonvulsants|anticonvulsants|mesh-ancestor
92475662|NCT01864551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92143434|NCT03158857|Sofosbuvir|sofosbuvir|mesh-list
92475663|NCT01864551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475664|NCT01864551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92475665|NCT01864616|Vitamin D|vitamin d|mesh-list
92475666|NCT01864616|Cholecalciferol|cholecalciferol|mesh-list
92475667|NCT01864616|Vitamins|vitamins|mesh-ancestor
92475668|NCT01864616|Micronutrients|micronutrients|mesh-ancestor
92475669|NCT01864616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475670|NCT01864616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92475671|NCT01864616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475672|NCT01864655|Saracatinib|saracatinib|mesh-list
92475673|NCT01864655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475674|NCT01864655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475675|NCT01864655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475676|NCT01864681|Metformin|metformin|mesh-list
92475677|NCT01864681|Gefitinib|gefitinib|mesh-list
92475678|NCT01864681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475679|NCT01864681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475680|NCT01864681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475681|NCT01864681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92475682|NCT01864681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475683|NCT01864681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475684|NCT01864798|Denosumab|denosumab|mesh-list
92475685|NCT01864798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92475686|NCT01864798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475687|NCT01864824|Vitamins|vitamins|mesh-list
92475688|NCT01864824|Folic Acid|folic acid|mesh-list
92475689|NCT01864824|Vitamin B 12|vitamin b 12|mesh-list
92475690|NCT01864824|Vitamin B 6|vitamin b 6|mesh-list
92475691|NCT01864824|Vitamin B Complex|vitamin b complex|mesh-list
92475692|NCT01864824|Micronutrients|micronutrients|mesh-ancestor
92475693|NCT01864824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475694|NCT01864824|Hematinics|hematinics|mesh-ancestor
92475695|NCT01864863|Bosentan|bosentan|mesh-list
92475696|NCT01864863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92475697|NCT01864863|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92475698|NCT01864863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475699|NCT01864915|Prucalopride|prucalopride|mesh-list
92475700|NCT01864915|Laxatives|laxatives|mesh-ancestor
92475701|NCT01864915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475702|NCT01864915|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92475703|NCT01864915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92475704|NCT01864915|Serotonin Agents|serotonin agents|mesh-ancestor
92475705|NCT01864915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475706|NCT01864915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475707|NCT01864915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475708|NCT01865175|Iron|iron|mesh-list
92475709|NCT01865175|Trace Elements|trace elements|mesh-ancestor
92475710|NCT01865175|Micronutrients|micronutrients|mesh-ancestor
92475711|NCT01865175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475712|NCT01865188|Amlodipine|amlodipine|mesh-list
92475713|NCT01865188|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92475714|NCT01865188|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92475715|NCT01865188|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92475716|NCT01865188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475717|NCT01865188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475718|NCT01865188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475719|NCT01865188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475720|NCT01865188|Vasodilator Agents|vasodilator agents|mesh-ancestor
92475721|NCT01865188|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92475723|NCT01865201|Edaravone|edaravone|mesh-list
92475724|NCT01865201|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92475725|NCT01865201|Diuretics|diuretics|mesh-ancestor
92475726|NCT01865201|Natriuretic Agents|natriuretic agents|mesh-ancestor
92475727|NCT01865201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475728|NCT01865201|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92475729|NCT01865201|Antioxidants|antioxidants|mesh-ancestor
92475730|NCT01865201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475731|NCT01865201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92475732|NCT01865201|Protective Agents|protective agents|mesh-ancestor
92475733|NCT01865279|Insulin|insulin|mesh-list
92475734|NCT01865279|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92475735|NCT01865279|Insulin, Long-Acting|insulin, long-acting|mesh-list
92475736|NCT01865279|Isophane Insulin, Human|isophane insulin, human|mesh-list
92475737|NCT01865279|Insulin, Isophane|insulin, isophane|mesh-list
92475738|NCT01865279|Isophane insulin, beef|isophane insulin, beef|mesh-list
92475739|NCT01865279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475740|NCT01865279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475741|NCT01865292|Insulin|insulin|mesh-list
92475742|NCT01865292|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92475743|NCT01865292|Insulin Glargine|insulin glargine|mesh-list
92475744|NCT01865292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475745|NCT01865292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475746|NCT01865305|Insulin|insulin|mesh-list
92475747|NCT01865305|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92475748|NCT01865305|Insulin Aspart|insulin aspart|mesh-list
92475749|NCT01865305|Insulin, Long-Acting|insulin, long-acting|mesh-list
92475750|NCT01865305|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92200663|NCT05434533|Hemostatics|hemostatics|mesh-ancestor
92475752|NCT01865305|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92475753|NCT01865305|Insulin, Isophane|insulin, isophane|mesh-list
92475754|NCT01865305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475755|NCT01865305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475756|NCT01865318|Insulin|insulin|mesh-list
92475757|NCT01865318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475758|NCT01865318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475759|NCT01865331|Insulin|insulin|mesh-list
92475760|NCT01865331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92475761|NCT01865331|Insulin Aspart|insulin aspart|mesh-list
92475762|NCT01865331|Insulin, Long-Acting|insulin, long-acting|mesh-list
92475763|NCT01865331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475764|NCT01865331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475765|NCT01865500|Prednisolone|prednisolone|mesh-list
92475766|NCT01865500|Budesonide|budesonide|mesh-list
92475767|NCT01865500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475768|NCT01865500|Glucocorticoids|glucocorticoids|mesh-ancestor
92475769|NCT01865500|Hormones|hormones|mesh-ancestor
92475770|NCT01865500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92475771|NCT01865500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475772|NCT01865500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92475773|NCT01865500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475774|NCT01865500|Autonomic Agents|autonomic agents|mesh-ancestor
92475775|NCT01865500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475776|NCT01865500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92475777|NCT01865500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92475778|NCT01865500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92475779|NCT01865630|Etanercept|etanercept|mesh-list
92475780|NCT01865630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92475781|NCT01865630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92475782|NCT01865630|Analgesics|analgesics|mesh-ancestor
92475783|NCT01865630|Sensory System Agents|sensory system agents|mesh-ancestor
92475784|NCT01865630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475785|NCT01865630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475786|NCT01865630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475787|NCT01865630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475788|NCT01865630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475789|NCT01865630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92475790|NCT01865630|Immunologic Factors|immunologic factors|mesh-ancestor
92475791|NCT01865669|Oxytocin|oxytocin|mesh-list
92475792|NCT01865669|Oxytocics|oxytocics|mesh-ancestor
92475793|NCT01865669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92475794|NCT01865669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475795|NCT01865721|Entonox|entonox|mesh-list
92475796|NCT01865721|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92475797|NCT01865721|Anesthetics|anesthetics|mesh-ancestor
92475798|NCT01865721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475799|NCT01865721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475801|NCT01865760|Somatostatin|somatostatin|mesh-list
92475802|NCT01865760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475803|NCT01865760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92475804|NCT01865760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475805|NCT01865760|Hormones|hormones|mesh-ancestor
92475806|NCT01865760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92475807|NCT01865760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475808|NCT01865916|Ascorbic Acid|ascorbic acid|mesh-list
92475809|NCT01865916|Bisacodyl|bisacodyl|mesh-list
92475810|NCT01865916|Antioxidants|antioxidants|mesh-ancestor
92475811|NCT01865916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475812|NCT01865916|Protective Agents|protective agents|mesh-ancestor
92475813|NCT01865916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475814|NCT01865916|Vitamins|vitamins|mesh-ancestor
92475815|NCT01865916|Micronutrients|micronutrients|mesh-ancestor
92475817|NCT01865916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475818|NCT01865916|Laxatives|laxatives|mesh-ancestor
92475819|NCT01865968|Vaccines|vaccines|mesh-list
92475820|NCT01865968|Immunologic Factors|immunologic factors|mesh-ancestor
92475821|NCT01865968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475822|NCT01866007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92475823|NCT01866007|Immunologic Factors|immunologic factors|mesh-ancestor
92475824|NCT01866007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475825|NCT01866059|Methamphetamine|methamphetamine|mesh-list
92475826|NCT01866059|Calcium|calcium|mesh-list
92475827|NCT01866059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92475828|NCT01866059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475829|NCT01866059|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92475830|NCT01866059|Sympathomimetics|sympathomimetics|mesh-ancestor
92475831|NCT01866059|Autonomic Agents|autonomic agents|mesh-ancestor
92475832|NCT01866059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475833|NCT01866059|Dopamine Agents|dopamine agents|mesh-ancestor
92475834|NCT01866059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475835|NCT01866059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475836|NCT01866059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92475837|NCT01866059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92475838|NCT01866059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92475839|NCT01866059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475840|NCT01866059|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92475841|NCT01866241|Misoprostol|misoprostol|mesh-list
92475842|NCT01866241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92475843|NCT01866241|Abortifacient Agents|abortifacient agents|mesh-ancestor
92475844|NCT01866241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92475845|NCT01866241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475846|NCT01866241|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92475847|NCT01866241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475848|NCT01866241|Oxytocics|oxytocics|mesh-ancestor
92475849|NCT01866254|Morphine|morphine|mesh-list
92475850|NCT01866254|Hydromorphone|hydromorphone|mesh-list
92475851|NCT01866254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92475852|NCT01866254|Narcotics|narcotics|mesh-ancestor
92475853|NCT01866254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475854|NCT01866254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475855|NCT01866254|Analgesics|analgesics|mesh-ancestor
92475856|NCT01866254|Sensory System Agents|sensory system agents|mesh-ancestor
92475857|NCT01866254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475858|NCT01866267|Maraviroc|maraviroc|mesh-list
92475859|NCT01866267|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92475860|NCT01866267|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92475861|NCT01866267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475862|NCT01866267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92475863|NCT01866267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92475864|NCT01866267|Antiviral Agents|antiviral agents|mesh-ancestor
92475865|NCT01866267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475866|NCT01866267|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92475867|NCT01866397|Cidofovir|cidofovir|mesh-list
92475868|NCT01866397|Antiviral Agents|antiviral agents|mesh-ancestor
92475869|NCT01866397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475870|NCT01866397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475871|NCT01866397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475872|NCT01866488|Misoprostol|misoprostol|mesh-list
92475873|NCT01866488|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92475874|NCT01866488|Abortifacient Agents|abortifacient agents|mesh-ancestor
92475875|NCT01866488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92475876|NCT01866488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475877|NCT01866488|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92475878|NCT01866488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475879|NCT01866488|Oxytocics|oxytocics|mesh-ancestor
92475880|NCT01866514|Lidocaine|lidocaine|mesh-list
92475881|NCT01866514|Anesthetics, Local|anesthetics, local|mesh-ancestor
92475882|NCT01866514|Anesthetics|anesthetics|mesh-ancestor
92475883|NCT01866514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475884|NCT01866514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475885|NCT01866514|Sensory System Agents|sensory system agents|mesh-ancestor
92475886|NCT01866514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475887|NCT01866514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92475888|NCT01866514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92475889|NCT01866514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92475890|NCT01866514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475891|NCT01866514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475893|NCT01866553|Interferon-alpha|interferon-alpha|mesh-list
92475894|NCT01866553|Interferon alpha-2|interferon alpha-2|mesh-list
92475895|NCT01866553|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92475896|NCT01866553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92475897|NCT01866553|Antiviral Agents|antiviral agents|mesh-ancestor
92475898|NCT01866553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200811|NCT03431168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92475899|NCT01866553|Immunologic Factors|immunologic factors|mesh-ancestor
92475900|NCT01866553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475901|NCT01866605|Midazolam|midazolam|mesh-list
92475902|NCT01866605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92475903|NCT01866605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92475904|NCT01866605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92475905|NCT01866605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475906|NCT01866605|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92475907|NCT01866605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92475908|NCT01866605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475909|NCT01866605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92475910|NCT01866605|Anesthetics, General|anesthetics, general|mesh-ancestor
92475911|NCT01866605|Anesthetics|anesthetics|mesh-ancestor
92475912|NCT01866605|GABA Modulators|gaba modulators|mesh-ancestor
92475913|NCT01866605|GABA Agents|gaba agents|mesh-ancestor
92475914|NCT01866605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475915|NCT01866605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475916|NCT01866644|Acetylcysteine|acetylcysteine|mesh-list
92475917|NCT01866644|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92475918|NCT01866644|Antiviral Agents|antiviral agents|mesh-ancestor
92475919|NCT01866644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475920|NCT01866644|Expectorants|expectorants|mesh-ancestor
92475921|NCT01866644|Respiratory System Agents|respiratory system agents|mesh-ancestor
92475922|NCT01866644|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92475923|NCT01866644|Antioxidants|antioxidants|mesh-ancestor
92475924|NCT01866644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475925|NCT01866644|Protective Agents|protective agents|mesh-ancestor
92475926|NCT01866644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475927|NCT01866644|Antidotes|antidotes|mesh-ancestor
92475928|NCT01867138|Vancomycin|vancomycin|mesh-list
92475929|NCT01867138|Cefazolin|cefazolin|mesh-list
92475930|NCT01867138|Amikacin|amikacin|mesh-list
92475931|NCT01867138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92475932|NCT01867138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92475933|NCT01867255|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92475934|NCT01867255|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92475935|NCT01867255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92475936|NCT01867255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92475937|NCT01867255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475938|NCT01867255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92475939|NCT01867255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475940|NCT01867255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92475941|NCT01867255|Antidepressive Agents|antidepressive agents|mesh-ancestor
92475942|NCT01867255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92475943|NCT01867268|Acetazolamide|acetazolamide|mesh-list
92475944|NCT01867268|Anticonvulsants|anticonvulsants|mesh-ancestor
92475945|NCT01867268|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92475946|NCT01867268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475947|NCT01867268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475948|NCT01867268|Diuretics|diuretics|mesh-ancestor
92475949|NCT01867268|Natriuretic Agents|natriuretic agents|mesh-ancestor
92475950|NCT01867268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475952|NCT01867281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92475953|NCT01867281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92475954|NCT01867281|Analgesics|analgesics|mesh-ancestor
92475955|NCT01867281|Sensory System Agents|sensory system agents|mesh-ancestor
92475956|NCT01867281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92475957|NCT01867281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475958|NCT01867281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92475959|NCT01867281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92475960|NCT01867281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92475961|NCT01867281|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92475962|NCT01867281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143732|NCT03156907|Buprenorphine|buprenorphine|mesh-list
92475963|NCT01867281|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92475964|NCT01867281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92475965|NCT01867281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475966|NCT01867281|Antipyretics|antipyretics|mesh-ancestor
92475967|NCT01867463|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92475968|NCT01867463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92475969|NCT01867463|Immunologic Factors|immunologic factors|mesh-ancestor
92475970|NCT01867463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475971|NCT01867463|Antacids|antacids|mesh-ancestor
92475972|NCT01867463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475973|NCT01867463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92475974|NCT01867502|Metformin|metformin|mesh-list
92475975|NCT01867502|Vildagliptin|vildagliptin|mesh-list
92475976|NCT01867502|Glyburide|glyburide|mesh-list
92475977|NCT01867502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92475978|NCT01867502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475979|NCT01867502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92475980|NCT01867502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92475981|NCT01867502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92475982|NCT01867502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475983|NCT01867593|Carbon-11 methionine|carbon-11 methionine|mesh-list
92475984|NCT01867593|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92475985|NCT01867593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92475986|NCT01867645|Immunoglobulins|immunoglobulins|mesh-list
92475987|NCT01867645|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92475988|NCT01867645|Antibodies|antibodies|mesh-list
92475989|NCT01867645|gamma-Globulins|gamma-globulins|mesh-list
92475990|NCT01867645|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92475991|NCT01867645|Immunologic Factors|immunologic factors|mesh-ancestor
92475992|NCT01867645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92475993|NCT01867697|Leucovorin|leucovorin|mesh-list
92475994|NCT01867697|Folic Acid|folic acid|mesh-list
92475995|NCT01867697|Oxaliplatin|oxaliplatin|mesh-list
92475996|NCT01867697|Irinotecan|irinotecan|mesh-list
92475997|NCT01867697|Cetuximab|cetuximab|mesh-list
92475998|NCT01867697|Calcium Carbonate|calcium carbonate|mesh-list
92475999|NCT01867697|Levoleucovorin|levoleucovorin|mesh-list
92476000|NCT01867697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476001|NCT01867697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476002|NCT01867697|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92476003|NCT01867697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92476004|NCT01867697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476005|NCT01867697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476006|NCT01867697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92476007|NCT01867697|Antidotes|antidotes|mesh-ancestor
92476008|NCT01867697|Protective Agents|protective agents|mesh-ancestor
92476009|NCT01867697|Vitamin B Complex|vitamin b complex|mesh-ancestor
92476010|NCT01867697|Vitamins|vitamins|mesh-ancestor
92476011|NCT01867697|Micronutrients|micronutrients|mesh-ancestor
92476012|NCT01867697|Hematinics|hematinics|mesh-ancestor
92476013|NCT01867697|Antacids|antacids|mesh-ancestor
92476014|NCT01867697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476015|NCT01867775|Mirtazapine|mirtazapine|mesh-list
92476016|NCT01867775|Antidepressive Agents|antidepressive agents|mesh-ancestor
92476017|NCT01867775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476018|NCT01867775|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92476019|NCT01867775|Histamine Antagonists|histamine antagonists|mesh-ancestor
92476020|NCT01867775|Histamine Agents|histamine agents|mesh-ancestor
92476021|NCT01867775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476022|NCT01867775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476023|NCT01867775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476024|NCT01867775|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92476025|NCT01867775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92476026|NCT01867775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476027|NCT01867775|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92476028|NCT01867775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92476029|NCT01867775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92476030|NCT01867775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92476031|NCT01867775|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92476032|NCT01867775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92476033|NCT01867775|Serotonin Agents|serotonin agents|mesh-ancestor
92476034|NCT01867775|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92476035|NCT01867866|Trifluridine|trifluridine|mesh-list
92476036|NCT01867866|Antimetabolites|antimetabolites|mesh-ancestor
92348900|NCT01514448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476037|NCT01867866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476038|NCT01867866|Antiviral Agents|antiviral agents|mesh-ancestor
92476039|NCT01867866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476040|NCT01867892|Leucovorin|leucovorin|mesh-list
92476041|NCT01867892|Gemcitabine|gemcitabine|mesh-list
92476042|NCT01867892|Fluorouracil|fluorouracil|mesh-list
92476043|NCT01867892|Irinotecan|irinotecan|mesh-list
92476044|NCT01867892|Levoleucovorin|levoleucovorin|mesh-list
92476045|NCT01867892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92476046|NCT01867892|Antimetabolites|antimetabolites|mesh-ancestor
92476047|NCT01867892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476048|NCT01867892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476049|NCT01867892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92476050|NCT01867892|Immunologic Factors|immunologic factors|mesh-ancestor
92476051|NCT01867892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476052|NCT01867892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92476053|NCT01867892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92476054|NCT01867892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476055|NCT01867892|Antidotes|antidotes|mesh-ancestor
92476056|NCT01867892|Protective Agents|protective agents|mesh-ancestor
92476057|NCT01867892|Vitamin B Complex|vitamin b complex|mesh-ancestor
92476058|NCT01867892|Vitamins|vitamins|mesh-ancestor
92476059|NCT01867892|Micronutrients|micronutrients|mesh-ancestor
92476060|NCT01868048|Nabiximols|nabiximols|mesh-list
92476061|NCT01868048|Analgesics|analgesics|mesh-ancestor
92476062|NCT01868048|Sensory System Agents|sensory system agents|mesh-ancestor
92476063|NCT01868048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476064|NCT01868048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476065|NCT01868113|Fluticasone|fluticasone|mesh-list
92476066|NCT01868113|Xhance|xhance|mesh-list
92476067|NCT01868113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476068|NCT01868113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92476069|NCT01868113|Autonomic Agents|autonomic agents|mesh-ancestor
92476070|NCT01868113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476071|NCT01868113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476072|NCT01868113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92476073|NCT01868113|Respiratory System Agents|respiratory system agents|mesh-ancestor
92476074|NCT01868113|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476075|NCT01868113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92476076|NCT01868126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92476077|NCT01868126|Latanoprost|latanoprost|mesh-list
92476078|NCT01868126|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92476079|NCT01868191|Thiamine|thiamine|mesh-list
92476080|NCT01868191|Benphothiamine|benphothiamine|mesh-list
92476081|NCT01868191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92476082|NCT01868191|Immunologic Factors|immunologic factors|mesh-ancestor
92476083|NCT01868191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476084|NCT01868191|Chelating Agents|chelating agents|mesh-ancestor
92476085|NCT01868191|Sequestering Agents|sequestering agents|mesh-ancestor
92476086|NCT01868191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476087|NCT01868191|Vitamin B Complex|vitamin b complex|mesh-ancestor
92476088|NCT01868191|Vitamins|vitamins|mesh-ancestor
92476089|NCT01868191|Micronutrients|micronutrients|mesh-ancestor
92476090|NCT01868360|Aflibercept|aflibercept|mesh-list
92476091|NCT01868360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92476092|NCT01868360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92476093|NCT01868360|Growth Substances|growth substances|mesh-ancestor
92476094|NCT01868360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476095|NCT01868360|Growth Inhibitors|growth inhibitors|mesh-ancestor
92476096|NCT01868360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476098|NCT01868438|Pyronaridine|pyronaridine|mesh-list
92476099|NCT01868438|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92476100|NCT01868438|Antimalarials|antimalarials|mesh-ancestor
92476101|NCT01868438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92476102|NCT01868438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92476103|NCT01868438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476104|NCT01868438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476105|NCT01868438|Antiviral Agents|antiviral agents|mesh-ancestor
92476106|NCT01868438|Schistosomicides|schistosomicides|mesh-ancestor
92476107|NCT01868438|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92476108|NCT01868438|Anthelmintics|anthelmintics|mesh-ancestor
92476110|NCT01868464|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92476111|NCT01868464|Immunologic Factors|immunologic factors|mesh-ancestor
92476112|NCT01868464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476113|NCT01868529|Insulin|insulin|mesh-list
92476114|NCT01868529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92476115|NCT01868529|Insulin Glargine|insulin glargine|mesh-list
92476116|NCT01868529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476117|NCT01868529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476118|NCT01868555|Insulin|insulin|mesh-list
92476119|NCT01868555|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92476120|NCT01868555|Insulin Aspart|insulin aspart|mesh-list
92476121|NCT01868555|Insulin, Long-Acting|insulin, long-acting|mesh-list
92476122|NCT01868555|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92476123|NCT01868555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476124|NCT01868555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476125|NCT01868568|Insulin|insulin|mesh-list
92476126|NCT01868568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92476127|NCT01868568|Insulin Aspart|insulin aspart|mesh-list
92476128|NCT01868568|Insulin, Long-Acting|insulin, long-acting|mesh-list
92476129|NCT01868568|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92476130|NCT01868568|Biphasic Insulins|biphasic insulins|mesh-list
92476131|NCT01868568|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92476132|NCT01868568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476133|NCT01868568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476134|NCT01868581|Insulin|insulin|mesh-list
92476135|NCT01868581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92476136|NCT01868581|Insulin Aspart|insulin aspart|mesh-list
92476137|NCT01868581|Insulin, Long-Acting|insulin, long-acting|mesh-list
92476138|NCT01868581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476139|NCT01868581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476140|NCT01868750|Calcitriol|calcitriol|mesh-list
92476141|NCT01868750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92476142|NCT01868750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476143|NCT01868750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92476144|NCT01868750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92476145|NCT01868750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476146|NCT01868750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92476147|NCT01868750|Vitamins|vitamins|mesh-ancestor
92476148|NCT01868750|Micronutrients|micronutrients|mesh-ancestor
92476149|NCT01868750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92476150|NCT01868802|Ketamine|ketamine|mesh-list
92476151|NCT01868802|Analgesics|analgesics|mesh-ancestor
92476152|NCT01868802|Sensory System Agents|sensory system agents|mesh-ancestor
92476153|NCT01868802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476154|NCT01868802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476155|NCT01868802|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92476156|NCT01868802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92476157|NCT01868802|Anesthetics, General|anesthetics, general|mesh-ancestor
92476158|NCT01868802|Anesthetics|anesthetics|mesh-ancestor
92476159|NCT01868802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476160|NCT01868802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92476161|NCT01868802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92476162|NCT01868802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476163|NCT01868802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476164|NCT01868906|Temozolomide|temozolomide|mesh-list
92476165|NCT01868906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92476166|NCT01868906|Alkylating Agents|alkylating agents|mesh-ancestor
92476167|NCT01868906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476168|NCT01868906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476169|NCT01868945|Vitamin D|vitamin d|mesh-list
92476170|NCT01868945|Cholecalciferol|cholecalciferol|mesh-list
92476171|NCT01868945|Calcifediol|calcifediol|mesh-list
92476172|NCT01868945|Vitamins|vitamins|mesh-ancestor
92476173|NCT01868945|Micronutrients|micronutrients|mesh-ancestor
92476174|NCT01868945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476175|NCT01868945|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92476176|NCT01868945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92476177|NCT01868984|Paclitaxel|paclitaxel|mesh-list
92476178|NCT01868984|Heparin|heparin|mesh-list
92476179|NCT01868984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92476180|NCT01868984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476181|NCT01868984|Tubulin Modulators|tubulin modulators|mesh-ancestor
92476182|NCT01868984|Antimitotic Agents|antimitotic agents|mesh-ancestor
92476183|NCT01868984|Mitosis Modulators|mitosis modulators|mesh-ancestor
92476184|NCT01868984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476185|NCT01868984|Anticoagulants|anticoagulants|mesh-ancestor
92476186|NCT01868984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92476187|NCT01868984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92476188|NCT01869010|Tenofovir|tenofovir|mesh-list
92476189|NCT01869010|Antiviral Agents|antiviral agents|mesh-ancestor
92476190|NCT01869010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476191|NCT01869010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92476192|NCT01869010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92476193|NCT01869010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476194|NCT01869010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476195|NCT01869010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92476196|NCT01869010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92476197|NCT01869023|Gemcitabine|gemcitabine|mesh-list
92476198|NCT01869023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476199|NCT01869023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92476200|NCT01869023|Antimetabolites|antimetabolites|mesh-ancestor
92476201|NCT01869023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476202|NCT01869036|Morphine|morphine|mesh-list
92476203|NCT01869036|Anesthetics|anesthetics|mesh-list
92476204|NCT01869036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476205|NCT01869036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476206|NCT01869036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92476207|NCT01869036|Narcotics|narcotics|mesh-ancestor
92476208|NCT01869036|Analgesics|analgesics|mesh-ancestor
92476209|NCT01869036|Sensory System Agents|sensory system agents|mesh-ancestor
92476210|NCT01869036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476211|NCT01869205|Ivermectin|ivermectin|mesh-list
92476212|NCT01869205|Abamectin|abamectin|mesh-list
92476213|NCT01869205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92476214|NCT01869205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476215|NCT01869205|Anthelmintics|anthelmintics|mesh-ancestor
92476216|NCT01869257|Triclosan|triclosan|mesh-list
92476217|NCT01869257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92476218|NCT01869257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476219|NCT01869257|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92476220|NCT01869257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92476221|NCT01869257|Antimetabolites|antimetabolites|mesh-ancestor
92476222|NCT01869257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476223|NCT01869257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92476224|NCT01869309|Ticagrelor|ticagrelor|mesh-list
92476225|NCT01869309|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92476226|NCT01869309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92476227|NCT01869309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92476228|NCT01869309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92476229|NCT01869309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92476230|NCT01869309|Purinergic Agents|purinergic agents|mesh-ancestor
92476231|NCT01869309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476232|NCT01869309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476233|NCT01869309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476234|NCT01869491|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
92476235|NCT01869491|Antacids|antacids|mesh-ancestor
92476236|NCT01869491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476237|NCT01869491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476238|NCT01869556|Oxytocin|oxytocin|mesh-list
92476239|NCT01869556|Carboprost|carboprost|mesh-list
92476240|NCT01869556|Carboprost tromethamine|carboprost tromethamine|mesh-list
92476241|NCT01869556|Ergonovine|ergonovine|mesh-list
92476242|NCT01869556|Oxytocics|oxytocics|mesh-ancestor
92476243|NCT01869556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92476244|NCT01869556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476245|NCT01869556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92476246|NCT01869556|Abortifacient Agents|abortifacient agents|mesh-ancestor
92476248|NCT01869569|Analgesics|analgesics|mesh-ancestor
92476249|NCT01869569|Sensory System Agents|sensory system agents|mesh-ancestor
92476250|NCT01869569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476251|NCT01869569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476252|NCT01869569|Anticonvulsants|anticonvulsants|mesh-ancestor
92476253|NCT01869569|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92476254|NCT01869569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92476255|NCT01869569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476256|NCT01869569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92476257|NCT01869569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92476258|NCT01869569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92476259|NCT01869569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476260|NCT01869569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476261|NCT01869621|Metformin|metformin|mesh-list
92476262|NCT01869621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476263|NCT01869621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476264|NCT01869673|Anesthetics|anesthetics|mesh-list
92476265|NCT01869673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476266|NCT01869673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476267|NCT01869751|Prucalopride|prucalopride|mesh-list
92476268|NCT01869751|Laxatives|laxatives|mesh-ancestor
92476269|NCT01869751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476270|NCT01869751|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92476271|NCT01869751|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92476272|NCT01869751|Serotonin Agents|serotonin agents|mesh-ancestor
92476273|NCT01869751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476274|NCT01869751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476275|NCT01869751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476276|NCT01869803|Gemtuzumab|gemtuzumab|mesh-list
92476277|NCT01869803|Calicheamicins|calicheamicins|mesh-list
92476278|NCT01869803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92476279|NCT01869803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476280|NCT01869803|Immunotoxins|immunotoxins|mesh-ancestor
92476281|NCT01869803|Immunoconjugates|immunoconjugates|mesh-ancestor
92476282|NCT01869803|Immunologic Factors|immunologic factors|mesh-ancestor
92476283|NCT01869803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476284|NCT01869803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92476285|NCT01869881|Sarpogrelate|sarpogrelate|mesh-list
92476286|NCT01869881|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92476287|NCT01869881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92476288|NCT01869881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476289|NCT01869881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92476290|NCT01869881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92476291|NCT01869881|Serotonin Agents|serotonin agents|mesh-ancestor
92476292|NCT01869881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476293|NCT01869881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476294|NCT01869907|Minocycline|minocycline|mesh-list
92476295|NCT01869907|Amitriptyline|amitriptyline|mesh-list
92476296|NCT01869907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92476297|NCT01869907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476298|NCT01869907|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92476299|NCT01869907|Antidepressive Agents|antidepressive agents|mesh-ancestor
92476300|NCT01869907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476301|NCT01869907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476302|NCT01869907|Analgesics|analgesics|mesh-ancestor
92476303|NCT01869907|Sensory System Agents|sensory system agents|mesh-ancestor
92476304|NCT01869907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476305|NCT01869907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476306|NCT01869907|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92476307|NCT01869907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92476308|NCT01869907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92476309|NCT01869907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476310|NCT01869907|Adrenergic Agents|adrenergic agents|mesh-ancestor
92476311|NCT01869907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476312|NCT01869946|Ropivacaine|ropivacaine|mesh-list
92476313|NCT01869946|Anesthetics, Local|anesthetics, local|mesh-ancestor
92476314|NCT01869946|Anesthetics|anesthetics|mesh-ancestor
92476315|NCT01869946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476316|NCT01869946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476317|NCT01869946|Sensory System Agents|sensory system agents|mesh-ancestor
92476318|NCT01869946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476319|NCT01870011|Anesthetics|anesthetics|mesh-list
92476321|NCT01870011|Desflurane|desflurane|mesh-list
92476322|NCT01870011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476323|NCT01870011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476324|NCT01870011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92476325|NCT01870011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92476326|NCT01870011|Anesthetics, General|anesthetics, general|mesh-ancestor
92476327|NCT01870011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92476328|NCT01870024|Fosphenytoin|fosphenytoin|mesh-list
92476329|NCT01870024|Lorazepam|lorazepam|mesh-list
92476330|NCT01870024|Clonazepam|clonazepam|mesh-list
92476331|NCT01870024|Anticonvulsants|anticonvulsants|mesh-ancestor
92476332|NCT01870024|Antiemetics|antiemetics|mesh-ancestor
92476333|NCT01870024|Autonomic Agents|autonomic agents|mesh-ancestor
92348908|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
92476334|NCT01870024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476335|NCT01870024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476336|NCT01870024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476337|NCT01870024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92476338|NCT01870024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476339|NCT01870024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92476340|NCT01870024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92476341|NCT01870024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476342|NCT01870024|GABA Modulators|gaba modulators|mesh-ancestor
92476343|NCT01870024|GABA Agents|gaba agents|mesh-ancestor
92476344|NCT01870024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476345|NCT01870024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476346|NCT01870024|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92476347|NCT01870024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92476348|NCT01870050|Dapsone|dapsone|mesh-list
92476349|NCT01870050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476350|NCT01870050|Antimalarials|antimalarials|mesh-ancestor
92476351|NCT01870050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92476352|NCT01870050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92476353|NCT01870050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92476354|NCT01870050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476355|NCT01870050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476356|NCT01870050|Leprostatic Agents|leprostatic agents|mesh-ancestor
92476357|NCT01870050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92476358|NCT01870115|Vitamin D|vitamin d|mesh-list
92476359|NCT01870115|Cholecalciferol|cholecalciferol|mesh-list
92201261|NCT05686616|Dapagliflozin|dapagliflozin|mesh-list
92476360|NCT01870115|Melatonin|melatonin|mesh-list
92476361|NCT01870115|Vitamins|vitamins|mesh-ancestor
92476362|NCT01870115|Micronutrients|micronutrients|mesh-ancestor
92476363|NCT01870115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476364|NCT01870115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92476365|NCT01870115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476366|NCT01870115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92476367|NCT01870115|Antioxidants|antioxidants|mesh-ancestor
92476368|NCT01870115|Protective Agents|protective agents|mesh-ancestor
92476369|NCT01870115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476370|NCT01870128|Hydroxychloroquine|hydroxychloroquine|mesh-list
92476371|NCT01870128|Sulfasalazine|sulfasalazine|mesh-list
92476372|NCT01870128|Methylprednisolone|methylprednisolone|mesh-list
92476373|NCT01870128|Methotrexate|methotrexate|mesh-list
92476374|NCT01870128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92476375|NCT01870128|Abortifacient Agents|abortifacient agents|mesh-ancestor
92476376|NCT01870128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92476377|NCT01870128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476378|NCT01870128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92476379|NCT01870128|Antimetabolites|antimetabolites|mesh-ancestor
92476380|NCT01870128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476381|NCT01870128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476382|NCT01870128|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476383|NCT01870128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476384|NCT01870128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92476385|NCT01870128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92476386|NCT01870128|Immunologic Factors|immunologic factors|mesh-ancestor
92476387|NCT01870128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476388|NCT01870128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92476389|NCT01870128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476390|NCT01870128|Antiemetics|antiemetics|mesh-ancestor
92476391|NCT01870128|Autonomic Agents|autonomic agents|mesh-ancestor
92476392|NCT01870128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476393|NCT01870128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476394|NCT01870128|Glucocorticoids|glucocorticoids|mesh-ancestor
92476395|NCT01870128|Hormones|hormones|mesh-ancestor
92476396|NCT01870128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92476397|NCT01870128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92476398|NCT01870128|Protective Agents|protective agents|mesh-ancestor
92476399|NCT01870128|Antimalarials|antimalarials|mesh-ancestor
92476400|NCT01870128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92476401|NCT01870128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92476402|NCT01870128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476403|NCT01870128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92476404|NCT01870128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476405|NCT01870128|Analgesics|analgesics|mesh-ancestor
92476406|NCT01870128|Sensory System Agents|sensory system agents|mesh-ancestor
92150099|NCT01456130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476407|NCT01870167|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92476408|NCT01870167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92476409|NCT01870167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476410|NCT01870167|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92476411|NCT01870167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476412|NCT01870167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476413|NCT01870219|Ketamine|ketamine|mesh-list
92476414|NCT01870219|Anesthetics|anesthetics|mesh-list
92476415|NCT01870219|Sevoflurane|sevoflurane|mesh-list
92476416|NCT01870219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92476417|NCT01870219|Analgesics|analgesics|mesh-ancestor
92476418|NCT01870219|Sensory System Agents|sensory system agents|mesh-ancestor
92476419|NCT01870219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476420|NCT01870219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476421|NCT01870219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92476422|NCT01870219|Anesthetics, General|anesthetics, general|mesh-ancestor
92476423|NCT01870219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476424|NCT01870219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92476425|NCT01870219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92476426|NCT01870219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476427|NCT01870219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476428|NCT01870219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92476429|NCT01870219|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92476430|NCT01870284|Adalimumab|adalimumab|mesh-list
92476431|NCT01870284|Ixekizumab|ixekizumab|mesh-list
92476432|NCT01870284|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92476433|NCT01870284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476434|NCT01870284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476435|NCT01870284|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476436|NCT01870427|Aflibercept|aflibercept|mesh-list
92476437|NCT01870427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92476438|NCT01870427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92476439|NCT01870427|Growth Substances|growth substances|mesh-ancestor
92476440|NCT01870427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476441|NCT01870427|Growth Inhibitors|growth inhibitors|mesh-ancestor
92476442|NCT01870427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476443|NCT01868880|Bisoprolol|bisoprolol|mesh-list
92476444|NCT01868880|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92476445|NCT01868880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92476446|NCT01868880|Adrenergic Agents|adrenergic agents|mesh-ancestor
92476447|NCT01868880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476448|NCT01868880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476449|NCT01868880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476450|NCT01868880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92476451|NCT01868880|Sympatholytics|sympatholytics|mesh-ancestor
92476452|NCT01868880|Autonomic Agents|autonomic agents|mesh-ancestor
92476453|NCT01868880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476454|NCT01868880|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92476455|NCT01870440|Dexamethasone|dexamethasone|mesh-list
92476456|NCT01870440|Dexamethasone acetate|dexamethasone acetate|mesh-list
92476457|NCT01870440|BB 1101|bb 1101|mesh-list
92476458|NCT01870440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476459|NCT01870440|Antiemetics|antiemetics|mesh-ancestor
92476460|NCT01870440|Autonomic Agents|autonomic agents|mesh-ancestor
92476461|NCT01870440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476462|NCT01870440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476463|NCT01870440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476464|NCT01870440|Glucocorticoids|glucocorticoids|mesh-ancestor
92476465|NCT01870440|Hormones|hormones|mesh-ancestor
92476466|NCT01870440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92476467|NCT01870440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92476468|NCT01870440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476469|NCT01870440|Protease Inhibitors|protease inhibitors|mesh-ancestor
92476470|NCT01870440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476471|NCT01870440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476473|NCT01870466|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92476474|NCT01870466|Simvastatin|simvastatin|mesh-list
92476475|NCT01870466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92476476|NCT01870466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92476477|NCT01870466|Antimetabolites|antimetabolites|mesh-ancestor
92476478|NCT01870466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476479|NCT01870466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92348914|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476480|NCT01870466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92476481|NCT01870466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476482|NCT01870466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92476483|NCT01870466|Autonomic Agents|autonomic agents|mesh-ancestor
92476484|NCT01870466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476485|NCT01870466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476486|NCT01870466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92476487|NCT01870466|Respiratory System Agents|respiratory system agents|mesh-ancestor
92476488|NCT01870466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92476489|NCT01870466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92476490|NCT01870466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92476491|NCT01870466|Vasodilator Agents|vasodilator agents|mesh-ancestor
92476492|NCT01870466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92476493|NCT01870466|Protective Agents|protective agents|mesh-ancestor
92476494|NCT01870466|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92476495|NCT01870466|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92476496|NCT01870492|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92476497|NCT01870492|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92476498|NCT01870492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92476499|NCT01870492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476500|NCT01870635|Ondansetron|ondansetron|mesh-list
92476501|NCT01870635|Antiemetics|antiemetics|mesh-ancestor
92476502|NCT01870635|Autonomic Agents|autonomic agents|mesh-ancestor
92476503|NCT01870635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476504|NCT01870635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476505|NCT01870635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476506|NCT01870635|Antipruritics|antipruritics|mesh-ancestor
92201407|NCT00632411|Autonomic Agents|autonomic agents|mesh-ancestor
92476507|NCT01870635|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476508|NCT01870635|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92476509|NCT01870635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92476510|NCT01870635|Serotonin Agents|serotonin agents|mesh-ancestor
92476511|NCT01870635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476512|NCT01870635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476513|NCT01870648|Ondansetron|ondansetron|mesh-list
92476514|NCT01870648|Antiemetics|antiemetics|mesh-ancestor
92476515|NCT01870648|Autonomic Agents|autonomic agents|mesh-ancestor
92476516|NCT01870648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476517|NCT01870648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476518|NCT01870648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476519|NCT01870648|Antipruritics|antipruritics|mesh-ancestor
92476520|NCT01870648|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476521|NCT01870648|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92476522|NCT01870648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92476523|NCT01870648|Serotonin Agents|serotonin agents|mesh-ancestor
92476524|NCT01870648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476525|NCT01870648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476526|NCT01870674|Prucalopride|prucalopride|mesh-list
92476527|NCT01870674|YH12852|yh12852|mesh-list
92476528|NCT01870674|Laxatives|laxatives|mesh-ancestor
92476529|NCT01870674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476530|NCT01870674|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92476531|NCT01870674|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92476532|NCT01870674|Serotonin Agents|serotonin agents|mesh-ancestor
92476533|NCT01870674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476534|NCT01870674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476535|NCT01870674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476536|NCT01870804|Atorvastatin|atorvastatin|mesh-list
92476537|NCT01870804|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92476538|NCT01870804|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92476539|NCT01870804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92476540|NCT01870804|Antimetabolites|antimetabolites|mesh-ancestor
92476541|NCT01870804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476542|NCT01870804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92476543|NCT01870804|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92476544|NCT01870804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476545|NCT01870895|Ramosetron|ramosetron|mesh-list
92476546|NCT01870895|Antiemetics|antiemetics|mesh-ancestor
92476547|NCT01870895|Autonomic Agents|autonomic agents|mesh-ancestor
92476548|NCT01870895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476549|NCT01870895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476550|NCT01870895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476551|NCT01870895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92476552|NCT01870895|Serotonin Agents|serotonin agents|mesh-ancestor
92476553|NCT01870895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476554|NCT01870895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476555|NCT01870908|Tacrolimus|tacrolimus|mesh-list
92476556|NCT01870908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92476557|NCT01870908|Immunologic Factors|immunologic factors|mesh-ancestor
92476558|NCT01870908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476559|NCT01870908|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92476560|NCT01870908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476561|NCT01870908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476562|NCT01870986|Adalimumab|adalimumab|mesh-list
92476563|NCT01870986|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92476564|NCT01870986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476565|NCT01870986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476566|NCT01871129|Dexmedetomidine|dexmedetomidine|mesh-list
92476567|NCT01871129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92476568|NCT01871129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476569|NCT01871129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476570|NCT01871129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476571|NCT01871129|Analgesics|analgesics|mesh-ancestor
92476572|NCT01871129|Sensory System Agents|sensory system agents|mesh-ancestor
92476573|NCT01871129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476574|NCT01871129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92476575|NCT01871129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92476576|NCT01871129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92476577|NCT01871129|Adrenergic Agents|adrenergic agents|mesh-ancestor
92476578|NCT01871129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476579|NCT01871129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476580|NCT01871363|Capecitabine|capecitabine|mesh-list
92476581|NCT01871363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476582|NCT01871363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92476583|NCT01871363|Antimetabolites|antimetabolites|mesh-ancestor
92476584|NCT01871363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476585|NCT01871376|Aflibercept|aflibercept|mesh-list
92476586|NCT01871376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92476587|NCT01871376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92476588|NCT01871376|Growth Substances|growth substances|mesh-ancestor
92476589|NCT01871376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476590|NCT01871376|Growth Inhibitors|growth inhibitors|mesh-ancestor
92476591|NCT01871376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476592|NCT01871454|Pentoxifylline|pentoxifylline|mesh-list
92476593|NCT01871454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92476594|NCT01871454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476595|NCT01871454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476596|NCT01871454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92476597|NCT01871454|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92476598|NCT01871454|Protective Agents|protective agents|mesh-ancestor
92476599|NCT01871454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476600|NCT01871454|Vasodilator Agents|vasodilator agents|mesh-ancestor
92476601|NCT01871454|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92476602|NCT01871454|Antioxidants|antioxidants|mesh-ancestor
92476603|NCT01871467|Sargramostim|sargramostim|mesh-list
92476604|NCT01871467|Immunologic Factors|immunologic factors|mesh-ancestor
92476605|NCT01871467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476606|NCT01871480|Gefitinib|gefitinib|mesh-list
92476607|NCT01871480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476608|NCT01871480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92476609|NCT01871480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476610|NCT01871480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476612|NCT01871493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476613|NCT01871493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476614|NCT01871649|Golimumab|golimumab|mesh-list
92476616|NCT01871649|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92476617|NCT01871649|Abortifacient Agents|abortifacient agents|mesh-ancestor
92476618|NCT01871649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92476619|NCT01871649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476620|NCT01871649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92476621|NCT01871649|Antimetabolites|antimetabolites|mesh-ancestor
92476622|NCT01871649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476623|NCT01871649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476624|NCT01871649|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476625|NCT01871649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144390|NCT03841357|Abatacept|abatacept|mesh-list
92476626|NCT01871649|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92476627|NCT01871649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92476628|NCT01871649|Immunologic Factors|immunologic factors|mesh-ancestor
92476629|NCT01871649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476630|NCT01871649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92476631|NCT01871649|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92476632|NCT01871649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476633|NCT01871662|Interferons|interferons|mesh-list
92476634|NCT01871662|Ribavirin|ribavirin|mesh-list
92476635|NCT01871662|Interferon-alpha|interferon-alpha|mesh-list
92476636|NCT01871662|Interferon alpha-2|interferon alpha-2|mesh-list
92476637|NCT01871662|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92476638|NCT01871662|Silybin|silybin|mesh-list
92476639|NCT01871662|Silymarin|silymarin|mesh-list
92476640|NCT01871662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476641|NCT01871662|Antiviral Agents|antiviral agents|mesh-ancestor
92476642|NCT01871662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476643|NCT01871662|Antimetabolites|antimetabolites|mesh-ancestor
92476644|NCT01871662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476645|NCT01871662|Immunologic Factors|immunologic factors|mesh-ancestor
92476646|NCT01871662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476647|NCT01871662|Antioxidants|antioxidants|mesh-ancestor
92476648|NCT01871662|Protective Agents|protective agents|mesh-ancestor
92476649|NCT01871662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92476650|NCT01871675|Rituximab|rituximab|mesh-list
92476651|NCT01871675|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92476652|NCT01871675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92476653|NCT01871675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476654|NCT01871675|Immunologic Factors|immunologic factors|mesh-ancestor
92476655|NCT01871675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476656|NCT01871675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476657|NCT01871675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92476658|NCT01871675|Alkylating Agents|alkylating agents|mesh-ancestor
92476659|NCT01871675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476660|NCT01871701|Moxifloxacin|moxifloxacin|mesh-list
92476661|NCT01871701|Dexetimide|dexetimide|mesh-list
92476662|NCT01871701|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92476663|NCT01871701|Citalopram|citalopram|mesh-list
92476664|NCT01871701|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92476665|NCT01871701|Escitalopram|escitalopram|mesh-list
92476666|NCT01871701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92476667|NCT01871701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476668|NCT01871701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92476669|NCT01871701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92476670|NCT01871701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476671|NCT01871701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476672|NCT01871701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476673|NCT01871701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92476674|NCT01871701|Contraceptive Agents|contraceptive agents|mesh-ancestor
92476675|NCT01871701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92476676|NCT01871701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476677|NCT01871701|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92476678|NCT01871701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92476679|NCT01871701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92476680|NCT01871701|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92476681|NCT01871701|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92476682|NCT01871701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92476683|NCT01871701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476685|NCT01871701|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92476686|NCT01871701|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92476687|NCT01871701|Parasympatholytics|parasympatholytics|mesh-ancestor
92476688|NCT01871701|Autonomic Agents|autonomic agents|mesh-ancestor
92476689|NCT01871701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476690|NCT01871701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92476691|NCT01871701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92476692|NCT01871701|Cholinergic Agents|cholinergic agents|mesh-ancestor
92476693|NCT01871701|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92476694|NCT01871701|Antidepressive Agents|antidepressive agents|mesh-ancestor
92476695|NCT01871701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476696|NCT01871701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92476697|NCT01871701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92348917|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476698|NCT01871701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476699|NCT01871740|Folic Acid|folic acid|mesh-list
92476700|NCT01871740|Enalapril|enalapril|mesh-list
92476701|NCT01871740|Enalaprilat|enalaprilat|mesh-list
92476702|NCT01871740|Maleic acid|maleic acid|mesh-list
92476703|NCT01871740|Hematinics|hematinics|mesh-ancestor
92476704|NCT01871740|Vitamin B Complex|vitamin b complex|mesh-ancestor
92476705|NCT01871740|Vitamins|vitamins|mesh-ancestor
92476706|NCT01871740|Micronutrients|micronutrients|mesh-ancestor
92476707|NCT01871740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476708|NCT01871740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476709|NCT01871740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476710|NCT01871740|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92476711|NCT01871740|Protease Inhibitors|protease inhibitors|mesh-ancestor
92476712|NCT01871740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92476713|NCT01871753|Anti-Infective Agents|anti-infective agents|mesh-list
92476714|NCT01871792|Pitavastatin|pitavastatin|mesh-list
92476715|NCT01871792|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92476716|NCT01871792|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92476717|NCT01871792|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92476718|NCT01871792|Antimetabolites|antimetabolites|mesh-ancestor
92476719|NCT01871792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476720|NCT01871792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476721|NCT01871792|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92476722|NCT01871844|Octreotide|octreotide|mesh-list
92476723|NCT01871844|Somatostatin|somatostatin|mesh-list
92476724|NCT01871844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476725|NCT01871844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92476726|NCT01871844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476727|NCT01871844|Hormones|hormones|mesh-ancestor
92476728|NCT01871844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92476729|NCT01871844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476730|NCT01871857|Epinephrine|epinephrine|mesh-list
92476731|NCT01871857|Racepinephrine|racepinephrine|mesh-list
92476732|NCT01871857|Epinephryl borate|epinephryl borate|mesh-list
92476733|NCT01871857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92476734|NCT01871857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92476735|NCT01871857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92476736|NCT01871857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476737|NCT01871857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476738|NCT01871857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476739|NCT01871857|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92476740|NCT01871857|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92476741|NCT01871857|Autonomic Agents|autonomic agents|mesh-ancestor
92476742|NCT01871857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476743|NCT01871857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92476744|NCT01871857|Respiratory System Agents|respiratory system agents|mesh-ancestor
92476745|NCT01871857|Mydriatics|mydriatics|mesh-ancestor
92476746|NCT01871857|Sympathomimetics|sympathomimetics|mesh-ancestor
92476747|NCT01871857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92476748|NCT01871922|Atropine|atropine|mesh-list
92476749|NCT01871922|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92476750|NCT01871922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92476751|NCT01871922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92476752|NCT01871922|Autonomic Agents|autonomic agents|mesh-ancestor
92476753|NCT01871922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476754|NCT01871922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476755|NCT01871922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92476756|NCT01871922|Respiratory System Agents|respiratory system agents|mesh-ancestor
92476757|NCT01871922|Mydriatics|mydriatics|mesh-ancestor
92476758|NCT01871922|Parasympatholytics|parasympatholytics|mesh-ancestor
92476759|NCT01871922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92476760|NCT01871922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92476761|NCT01871922|Cholinergic Agents|cholinergic agents|mesh-ancestor
92476762|NCT01871922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476763|NCT01871922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476764|NCT01871935|Sufentanil|sufentanil|mesh-list
92476765|NCT01871935|Remifentanil|remifentanil|mesh-list
92476766|NCT01871935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92476767|NCT01871935|Narcotics|narcotics|mesh-ancestor
92476768|NCT01871935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476769|NCT01871935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476770|NCT01871935|Analgesics|analgesics|mesh-ancestor
92476771|NCT01871935|Sensory System Agents|sensory system agents|mesh-ancestor
92476772|NCT01871935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476773|NCT01871935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92476774|NCT01871935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92476775|NCT01871935|Anesthetics, General|anesthetics, general|mesh-ancestor
92476776|NCT01871935|Anesthetics|anesthetics|mesh-ancestor
92476777|NCT01871961|Methotrexate|methotrexate|mesh-list
92476778|NCT01871961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92476779|NCT01871961|Abortifacient Agents|abortifacient agents|mesh-ancestor
92476780|NCT01871961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92476781|NCT01871961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476782|NCT01871961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92476783|NCT01871961|Antimetabolites|antimetabolites|mesh-ancestor
92476784|NCT01871961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476785|NCT01871961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476786|NCT01871961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92476787|NCT01871961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476788|NCT01871961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92476789|NCT01871961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92476790|NCT01871961|Immunologic Factors|immunologic factors|mesh-ancestor
92476791|NCT01871961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476792|NCT01871961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92476793|NCT01871974|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92476794|NCT01871974|Antidepressive Agents|antidepressive agents|mesh-ancestor
92476795|NCT01871974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476796|NCT01871974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92476797|NCT01871974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92476798|NCT01871974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476799|NCT01871974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476800|NCT01871987|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92476801|NCT01871987|Antidepressive Agents|antidepressive agents|mesh-ancestor
92476802|NCT01871987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92476803|NCT01871987|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92476804|NCT01871987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92476805|NCT01871987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476806|NCT01871987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476807|NCT01872013|ASP7991|asp7991|mesh-list
92476808|NCT01872013|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92201707|NCT02980497|Ethanol|ethanol|mesh-list
92476809|NCT01872013|Hormone Antagonists|hormone antagonists|mesh-ancestor
92476810|NCT01872013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92476811|NCT01872013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476812|NCT01872026|ASP7991|asp7991|mesh-list
92476813|NCT01872026|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92476814|NCT01872026|Hormone Antagonists|hormone antagonists|mesh-ancestor
92476815|NCT01872026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92476816|NCT01872026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476817|NCT01872039|Nicardipine|nicardipine|mesh-list
92476818|NCT01872039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92476819|NCT01872039|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92476820|NCT01872039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92476821|NCT01872039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476822|NCT01872039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92476823|NCT01872039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476824|NCT01872039|Vasodilator Agents|vasodilator agents|mesh-ancestor
92476825|NCT01871311|Cetuximab|cetuximab|mesh-list
92476826|NCT01871311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92476827|NCT01871311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476828|NCT01872351|Thioctic Acid|thioctic acid|mesh-list
92476829|NCT01872351|Acetylcarnitine|acetylcarnitine|mesh-list
92476830|NCT01872351|Antioxidants|antioxidants|mesh-ancestor
92476831|NCT01872351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476832|NCT01872351|Protective Agents|protective agents|mesh-ancestor
92476833|NCT01872351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476834|NCT01872351|Vitamin B Complex|vitamin b complex|mesh-ancestor
92476835|NCT01872351|Vitamins|vitamins|mesh-ancestor
92476836|NCT01872351|Micronutrients|micronutrients|mesh-ancestor
92476837|NCT01872351|Nootropic Agents|nootropic agents|mesh-ancestor
92476838|NCT01872403|Paclitaxel|paclitaxel|mesh-list
92476839|NCT01872403|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92476840|NCT01872403|Carboplatin|carboplatin|mesh-list
92476841|NCT01872403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92476842|NCT01872403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476843|NCT01872403|Tubulin Modulators|tubulin modulators|mesh-ancestor
92476844|NCT01872403|Antimitotic Agents|antimitotic agents|mesh-ancestor
92476845|NCT01872403|Mitosis Modulators|mitosis modulators|mesh-ancestor
92476846|NCT01872403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476847|NCT01872416|Doxorubicin|doxorubicin|mesh-list
92476848|NCT01872416|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92476849|NCT01872416|Ifosfamide|ifosfamide|mesh-list
92476850|NCT01872416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92476851|NCT01872416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476852|NCT01872416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92476853|NCT01872416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92476854|NCT01872416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476855|NCT01872416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476856|NCT01872416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92476857|NCT01872416|Alkylating Agents|alkylating agents|mesh-ancestor
92476858|NCT01872442|Interferons|interferons|mesh-list
92476859|NCT01872442|Interferon-alpha|interferon-alpha|mesh-list
92476860|NCT01872442|Interferon alpha-2|interferon alpha-2|mesh-list
92476861|NCT01872442|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92476862|NCT01872442|Dasatinib|dasatinib|mesh-list
92476863|NCT01872442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476864|NCT01872442|Antiviral Agents|antiviral agents|mesh-ancestor
92476865|NCT01872442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476866|NCT01872442|Immunologic Factors|immunologic factors|mesh-ancestor
92476867|NCT01872442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476868|NCT01872442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92476869|NCT01872442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476870|NCT01872442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476871|NCT01872494|Flurbiprofen|flurbiprofen|mesh-list
92476872|NCT01872494|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92476873|NCT01872494|Pentazocine|pentazocine|mesh-list
92476874|NCT01872494|Palonosetron|palonosetron|mesh-list
92476875|NCT01872494|Ropivacaine|ropivacaine|mesh-list
92476876|NCT01872494|Anesthetics, Local|anesthetics, local|mesh-ancestor
92476877|NCT01872494|Anesthetics|anesthetics|mesh-ancestor
92476878|NCT01872494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476879|NCT01872494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476880|NCT01872494|Sensory System Agents|sensory system agents|mesh-ancestor
92476881|NCT01872494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476882|NCT01872494|Antiemetics|antiemetics|mesh-ancestor
92476883|NCT01872494|Autonomic Agents|autonomic agents|mesh-ancestor
92476884|NCT01872494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476885|NCT01872494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92476886|NCT01872494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92476887|NCT01872494|Serotonin Agents|serotonin agents|mesh-ancestor
92476888|NCT01872494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92476889|NCT01872494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476890|NCT01872494|Analgesics|analgesics|mesh-ancestor
92476891|NCT01872494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92476892|NCT01872494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476893|NCT01872494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476894|NCT01872494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476895|NCT01872494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92476896|NCT01872494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476897|NCT01872494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92476898|NCT01872494|Narcotics|narcotics|mesh-ancestor
92476899|NCT01872494|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92476900|NCT01872494|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92476902|NCT01872546|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92476903|NCT01872546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476904|NCT01872546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476905|NCT01872702|Primaquine|primaquine|mesh-list
92476906|NCT01872702|Piperaquine|piperaquine|mesh-list
92476907|NCT01872702|Artenimol|artenimol|mesh-list
92476908|NCT01872702|Antimalarials|antimalarials|mesh-ancestor
92476909|NCT01872702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92476910|NCT01872702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92476911|NCT01872702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92476913|NCT01872728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476914|NCT01872728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476915|NCT01872754|Remifentanil|remifentanil|mesh-list
92476916|NCT01872754|Propofol|propofol|mesh-list
92476917|NCT01872754|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92476918|NCT01872754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476919|NCT01872754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476920|NCT01872754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92476921|NCT01872754|Anesthetics, General|anesthetics, general|mesh-ancestor
92476922|NCT01872754|Anesthetics|anesthetics|mesh-ancestor
92476923|NCT01872754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92476924|NCT01872754|Narcotics|narcotics|mesh-ancestor
92476925|NCT01872754|Analgesics|analgesics|mesh-ancestor
92476926|NCT01872754|Sensory System Agents|sensory system agents|mesh-ancestor
92476927|NCT01872754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476928|NCT01872780|Rosiglitazone|rosiglitazone|mesh-list
92476929|NCT01872780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92476930|NCT01872780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476931|NCT01872832|Verinurad|verinurad|mesh-list
92476932|NCT01872832|Gout Suppressants|gout suppressants|mesh-ancestor
92476933|NCT01872832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476934|NCT01872845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92476935|NCT01872845|Pravastatin|pravastatin|mesh-list
92476936|NCT01872845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92476937|NCT01872845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92476938|NCT01872845|Antimetabolites|antimetabolites|mesh-ancestor
92476939|NCT01872845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476940|NCT01872845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92476941|NCT01872845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92476942|NCT01872845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476943|NCT01872858|Aspirin|aspirin|mesh-list
92476944|NCT01872858|Cilostazol|cilostazol|mesh-list
92476945|NCT01872858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92476946|NCT01872858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476947|NCT01872858|Analgesics|analgesics|mesh-ancestor
92476948|NCT01872858|Sensory System Agents|sensory system agents|mesh-ancestor
92476949|NCT01872858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476950|NCT01872858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476951|NCT01872858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92476952|NCT01872858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92476953|NCT01872858|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92476954|NCT01872858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92476955|NCT01872858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476956|NCT01872858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92201857|NCT04683315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476957|NCT01872858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92476958|NCT01872858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92476959|NCT01872858|Antipyretics|antipyretics|mesh-ancestor
92476960|NCT01872858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92476961|NCT01872858|Autonomic Agents|autonomic agents|mesh-ancestor
92476962|NCT01872858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92476963|NCT01872858|Respiratory System Agents|respiratory system agents|mesh-ancestor
92476964|NCT01872858|Vasodilator Agents|vasodilator agents|mesh-ancestor
92476965|NCT01872858|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92476966|NCT01872858|Protective Agents|protective agents|mesh-ancestor
92476967|NCT01872858|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92476968|NCT01872858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92476969|NCT01872871|Acetaminophen|acetaminophen|mesh-list
92476970|NCT01872871|Anesthetics|anesthetics|mesh-list
92476971|NCT01872871|Anesthetics, Local|anesthetics, local|mesh-list
92476972|NCT01872871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476973|NCT01872871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476974|NCT01872871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92476975|NCT01872871|Analgesics|analgesics|mesh-ancestor
92476976|NCT01872871|Sensory System Agents|sensory system agents|mesh-ancestor
92476977|NCT01872871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476978|NCT01872871|Antipyretics|antipyretics|mesh-ancestor
92476979|NCT01872884|Remifentanil|remifentanil|mesh-list
92476980|NCT01872884|Sevoflurane|sevoflurane|mesh-list
92476981|NCT01872884|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92476982|NCT01872884|Narcotics|narcotics|mesh-ancestor
92476983|NCT01872884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92476984|NCT01872884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92476985|NCT01872884|Analgesics|analgesics|mesh-ancestor
92476986|NCT01872884|Sensory System Agents|sensory system agents|mesh-ancestor
92476987|NCT01872884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92476988|NCT01872884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92476989|NCT01872884|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92476990|NCT01872884|Anesthetics, General|anesthetics, general|mesh-ancestor
92476991|NCT01872884|Anesthetics|anesthetics|mesh-ancestor
92476992|NCT01872897|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
92476993|NCT01872897|Antacids|antacids|mesh-ancestor
92476994|NCT01872897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92476995|NCT01872897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92476996|NCT01872923|Bleomycin|bleomycin|mesh-list
92476997|NCT01872923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92476998|NCT01872923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92476999|NCT01872936|Ribavirin|ribavirin|mesh-list
92477000|NCT01872936|Antimetabolites|antimetabolites|mesh-ancestor
92477001|NCT01872936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477002|NCT01872936|Antiviral Agents|antiviral agents|mesh-ancestor
92477003|NCT01872936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477004|NCT01872962|Cisplatin|cisplatin|mesh-list
92477005|NCT01872962|Gemcitabine|gemcitabine|mesh-list
92477006|NCT01872962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477007|NCT01872962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92477008|NCT01872962|Antimetabolites|antimetabolites|mesh-ancestor
92477009|NCT01872962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477010|NCT01872988|Tenofovir|tenofovir|mesh-list
92477011|NCT01872988|Antiviral Agents|antiviral agents|mesh-ancestor
92477012|NCT01872988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477013|NCT01872988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92477014|NCT01872988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92477015|NCT01872988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477016|NCT01872988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477017|NCT01872988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92477018|NCT01872988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92477019|NCT01873001|Pioglitazone|pioglitazone|mesh-list
92477020|NCT01873001|Abiraterone Acetate|abiraterone acetate|mesh-list
92477021|NCT01873001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92477022|NCT01873001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477023|NCT01873001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477024|NCT01873001|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92477025|NCT01873001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477026|NCT01873001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477027|NCT01873001|Hormone Antagonists|hormone antagonists|mesh-ancestor
92477028|NCT01873001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477029|NCT01873001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92477030|NCT01873027|Sirolimus|sirolimus|mesh-list
92477031|NCT01873027|Umirolimus|umirolimus|mesh-list
92477032|NCT01873027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92477033|NCT01873027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477034|NCT01873027|Immunologic Factors|immunologic factors|mesh-ancestor
92477035|NCT01873027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477037|NCT01873027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477038|NCT01873027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92477039|NCT01873027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477040|NCT01873027|Antifungal Agents|antifungal agents|mesh-ancestor
92477041|NCT01873079|Esomeprazole|esomeprazole|mesh-list
92477042|NCT01873079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92477043|NCT01873079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477044|NCT01873079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92477045|NCT01873079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477046|NCT01873079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477047|NCT05855811|Dostarlimab|dostarlimab|mesh-list
92477048|NCT05855811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477049|NCT05855746|Colchicine|colchicine|mesh-list
92477050|NCT05855746|Gout Suppressants|gout suppressants|mesh-ancestor
92477051|NCT05855746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92477052|NCT05855746|Tubulin Modulators|tubulin modulators|mesh-ancestor
92477053|NCT05855746|Antimitotic Agents|antimitotic agents|mesh-ancestor
92477054|NCT05855746|Mitosis Modulators|mitosis modulators|mesh-ancestor
92477055|NCT05855746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477056|NCT05855746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477057|NCT05855629|Inositol|inositol|mesh-list
92477058|NCT05855629|Adapalene|adapalene|mesh-list
92477059|NCT05855629|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92477060|NCT05855629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477061|NCT05855629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92477062|NCT05855629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92477065|NCT05855629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477066|NCT05855629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477067|NCT05855629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92477068|NCT05855629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92477069|NCT05855629|Vitamin B Complex|vitamin b complex|mesh-ancestor
92477070|NCT05855629|Vitamins|vitamins|mesh-ancestor
92477071|NCT05855629|Micronutrients|micronutrients|mesh-ancestor
92477072|NCT05855616|Chlorhexidine|chlorhexidine|mesh-list
92477073|NCT05855616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92477074|NCT05855616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477075|NCT05855616|Disinfectants|disinfectants|mesh-ancestor
92477076|NCT05855590|Tranexamic Acid|tranexamic acid|mesh-list
92477077|NCT05855590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92477078|NCT05855590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92477079|NCT05855590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477080|NCT05855590|Hemostatics|hemostatics|mesh-ancestor
92477081|NCT05855590|Coagulants|coagulants|mesh-ancestor
92477082|NCT05855577|Terazosin|terazosin|mesh-list
92477083|NCT05855577|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92477084|NCT05855577|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92477085|NCT05855577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92477086|NCT05855577|Adrenergic Agents|adrenergic agents|mesh-ancestor
92477087|NCT05855577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477088|NCT05855577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477089|NCT05855577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477090|NCT05855577|Urological Agents|urological agents|mesh-ancestor
92477091|NCT05855486|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92477092|NCT05855486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92477093|NCT05855200|Dostarlimab|dostarlimab|mesh-list
92477094|NCT05855200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477095|NCT05855187|Modafinil|modafinil|mesh-list
92477096|NCT05855187|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92477097|NCT05855187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477098|NCT05855187|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92477099|NCT05855187|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92477100|NCT05855187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92477101|NCT05855187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477102|NCT05855070|Verapamil|verapamil|mesh-list
92477103|NCT05855070|Hyaluronic Acid|hyaluronic acid|mesh-list
92477104|NCT05855070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92477105|NCT05855070|Immunologic Factors|immunologic factors|mesh-ancestor
92477106|NCT05855070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477107|NCT05855070|Viscosupplements|viscosupplements|mesh-ancestor
92477108|NCT05855070|Protective Agents|protective agents|mesh-ancestor
92202003|NCT02209545|Micronutrients|micronutrients|mesh-ancestor
92477109|NCT05855070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477110|NCT05855070|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92477111|NCT05855070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477112|NCT05855070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477113|NCT05855070|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92477114|NCT05855070|Vasodilator Agents|vasodilator agents|mesh-ancestor
92477115|NCT05855018|Atropine|atropine|mesh-list
92477116|NCT05855018|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92477117|NCT05855018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92477118|NCT05855018|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92477119|NCT05855018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477120|NCT05855018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92477121|NCT05855018|Autonomic Agents|autonomic agents|mesh-ancestor
92477122|NCT05855018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477123|NCT05855018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477124|NCT05855018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92477125|NCT05855018|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477126|NCT05855018|Mydriatics|mydriatics|mesh-ancestor
92477127|NCT05855018|Parasympatholytics|parasympatholytics|mesh-ancestor
92477128|NCT05855018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92477129|NCT05855018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92477130|NCT05855018|Cholinergic Agents|cholinergic agents|mesh-ancestor
92477131|NCT05855018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477132|NCT05855018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477133|NCT05854992|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-list
92477134|NCT05854992|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92477135|NCT05854992|Serotonin Agents|serotonin agents|mesh-ancestor
92477136|NCT05854992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477137|NCT05854992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477138|NCT05854992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477139|NCT05854849|Gemcitabine|gemcitabine|mesh-list
92477140|NCT05854849|Apatinib|apatinib|mesh-list
92477141|NCT05854849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477142|NCT05854849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92477143|NCT05854849|Antimetabolites|antimetabolites|mesh-ancestor
92477144|NCT05854849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477145|NCT05854849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92477146|NCT05854849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477147|NCT05854667|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92477148|NCT05854667|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92477149|NCT05854667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477150|NCT05854667|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92477151|NCT05854667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92477152|NCT05854667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477153|NCT05854667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477154|NCT05854667|Dopamine Agents|dopamine agents|mesh-ancestor
92477155|NCT05854667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477156|NCT05854537|Lidocaine|lidocaine|mesh-list
92477157|NCT05854537|Bupivacaine|bupivacaine|mesh-list
92477158|NCT05854537|Anesthetics, Local|anesthetics, local|mesh-ancestor
92477159|NCT05854537|Anesthetics|anesthetics|mesh-ancestor
92477160|NCT05854537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477161|NCT05854537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477162|NCT05854537|Sensory System Agents|sensory system agents|mesh-ancestor
92477163|NCT05854537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477164|NCT05854537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477165|NCT05854537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92477166|NCT05854537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92477167|NCT05854537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477168|NCT05854537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477169|NCT05854511|Sofosbuvir|sofosbuvir|mesh-list
92477170|NCT05854511|Antiviral Agents|antiviral agents|mesh-ancestor
92477171|NCT05854511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477172|NCT05854342|Calcium|calcium|mesh-list
92477173|NCT05854342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92477174|NCT05854342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477175|NCT05854225|Thiotepa|thiotepa|mesh-list
92477176|NCT05854225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92477177|NCT05854225|Alkylating Agents|alkylating agents|mesh-ancestor
92477178|NCT05854225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477179|NCT05854225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477180|NCT05854225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92477181|NCT05854225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477182|NCT05854225|Immunologic Factors|immunologic factors|mesh-ancestor
92477183|NCT05854225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477184|NCT05854082|Lidocaine|lidocaine|mesh-list
92477185|NCT05854082|Anesthetics, Local|anesthetics, local|mesh-ancestor
92477186|NCT05854082|Anesthetics|anesthetics|mesh-ancestor
92477187|NCT05854082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477188|NCT05854082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477189|NCT05854082|Sensory System Agents|sensory system agents|mesh-ancestor
92477190|NCT05854082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477191|NCT05854082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477192|NCT05854082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92477193|NCT05854082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92477194|NCT05854082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477195|NCT05854082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477196|NCT05853965|Venetoclax|venetoclax|mesh-list
92477197|NCT05853965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477198|NCT05853718|Tenofovir|tenofovir|mesh-list
92477199|NCT05853718|Antiviral Agents|antiviral agents|mesh-ancestor
92477200|NCT05853718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477201|NCT05853718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92477202|NCT05853718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92477203|NCT05853718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477204|NCT05853718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477205|NCT05853718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92477206|NCT05853718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92477207|NCT05853627|Propranolol|propranolol|mesh-list
92477208|NCT05853627|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92477209|NCT05853627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92477210|NCT05853627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92477211|NCT05853627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477212|NCT05853627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477213|NCT05853627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477214|NCT05853627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477215|NCT05853627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92477216|NCT05853627|Vasodilator Agents|vasodilator agents|mesh-ancestor
92477217|NCT05853601|Theophylline|theophylline|mesh-list
92477218|NCT05853601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92477219|NCT05853601|Autonomic Agents|autonomic agents|mesh-ancestor
92477220|NCT05853601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477221|NCT05853601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477222|NCT05853601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92477223|NCT05853601|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477224|NCT05853601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92477225|NCT05853601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477226|NCT05853601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477227|NCT05853601|Vasodilator Agents|vasodilator agents|mesh-ancestor
92477228|NCT05853601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92477229|NCT05853601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92477230|NCT05853601|Purinergic Agents|purinergic agents|mesh-ancestor
92477231|NCT05853601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477232|NCT05852730|Promethazine|promethazine|mesh-list
92477233|NCT05852730|Diphenhydramine|diphenhydramine|mesh-list
92477234|NCT05852730|Meclizine|meclizine|mesh-list
92477235|NCT05852730|Scopolamine|scopolamine|mesh-list
92477236|NCT05852730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92477237|NCT05852730|Antiemetics|antiemetics|mesh-ancestor
92477238|NCT05852730|Autonomic Agents|autonomic agents|mesh-ancestor
92477239|NCT05852730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477240|NCT05852730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477241|NCT05852730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477242|NCT05852730|Mydriatics|mydriatics|mesh-ancestor
92477243|NCT05852730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92477244|NCT05852730|Cholinergic Agents|cholinergic agents|mesh-ancestor
92477245|NCT05852730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477246|NCT05852730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477247|NCT05852730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92477248|NCT05852730|Antipruritics|antipruritics|mesh-ancestor
92477249|NCT05852730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477250|NCT05852730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92477251|NCT05852730|Histamine Antagonists|histamine antagonists|mesh-ancestor
92477252|NCT05852730|Histamine Agents|histamine agents|mesh-ancestor
92477253|NCT05852730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92477254|NCT05852730|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92477255|NCT05852730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92477256|NCT05852730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477257|NCT05852730|Anesthetics, Local|anesthetics, local|mesh-ancestor
92477258|NCT05852730|Anesthetics|anesthetics|mesh-ancestor
92477259|NCT05852730|Sensory System Agents|sensory system agents|mesh-ancestor
92477260|NCT05852041|Fluorides|fluorides|mesh-list
92477261|NCT05852041|Cariostatic Agents|cariostatic agents|mesh-ancestor
92477262|NCT05852041|Protective Agents|protective agents|mesh-ancestor
92477263|NCT05852041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477264|NCT05845489|Anticoagulants|anticoagulants|mesh-list
92477265|NCT05845489|Clopidogrel|clopidogrel|mesh-list
92477266|NCT05845489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92477267|NCT05845489|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92477268|NCT05845489|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92477269|NCT05845489|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92477270|NCT05845489|Purinergic Agents|purinergic agents|mesh-ancestor
92477271|NCT05845489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477272|NCT05845489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477273|NCT05845489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477274|NCT05831774|Vancomycin|vancomycin|mesh-list
92477275|NCT05831774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477276|NCT05831774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477277|NCT05826873|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92477278|NCT05826873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477279|NCT05823532|Infliximab|infliximab|mesh-list
92477280|NCT05823532|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92477281|NCT05823532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92477282|NCT05823532|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477283|NCT05823532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477284|NCT05823532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92477285|NCT05815602|Mebeverine|mebeverine|mesh-list
92477286|NCT05815602|Ebastine|ebastine|mesh-list
92477287|NCT05815602|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92477288|NCT05815602|Histamine Antagonists|histamine antagonists|mesh-ancestor
92477289|NCT05815602|Histamine Agents|histamine agents|mesh-ancestor
92477290|NCT05815602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477291|NCT05815602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477292|NCT05815602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477293|NCT05815602|Anticonvulsants|anticonvulsants|mesh-ancestor
92477294|NCT05815602|Parasympatholytics|parasympatholytics|mesh-ancestor
92477295|NCT05815602|Autonomic Agents|autonomic agents|mesh-ancestor
92477296|NCT05815602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477297|NCT05755737|Ondansetron|ondansetron|mesh-list
92477298|NCT05755737|Antiemetics|antiemetics|mesh-ancestor
92477299|NCT05755737|Autonomic Agents|autonomic agents|mesh-ancestor
92477300|NCT05755737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477301|NCT05755737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477302|NCT05755737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477303|NCT05755737|Antipruritics|antipruritics|mesh-ancestor
92477304|NCT05755737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477305|NCT05755737|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92477306|NCT05755737|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92477307|NCT05755737|Serotonin Agents|serotonin agents|mesh-ancestor
92477308|NCT05755737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477309|NCT05755737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477310|NCT05739292|Vaccines|vaccines|mesh-list
92477311|NCT05739292|Immunologic Factors|immunologic factors|mesh-ancestor
92477312|NCT05739292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477313|NCT05736952|Topotecan|topotecan|mesh-list
92477314|NCT05736952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92477315|NCT05736952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92477316|NCT05736952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477317|NCT05736952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477318|NCT05736952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477319|NCT05732506|Edoxaban|edoxaban|mesh-list
92477320|NCT05732506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92477321|NCT05732506|Antithrombins|antithrombins|mesh-ancestor
92477322|NCT05732506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92477323|NCT05732506|Protease Inhibitors|protease inhibitors|mesh-ancestor
92477324|NCT05732506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477325|NCT05732506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477326|NCT05732506|Anticoagulants|anticoagulants|mesh-ancestor
92477327|NCT05694260|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92477328|NCT05694260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92477329|NCT05694260|Antimetabolites|antimetabolites|mesh-ancestor
92477330|NCT05694260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477331|NCT05694260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92477332|NCT05694260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477333|NCT05694260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92477335|NCT05674656|Dolutegravir|dolutegravir|mesh-list
92477336|NCT05674656|Rilpivirine|rilpivirine|mesh-list
92477337|NCT05674656|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
92477338|NCT05674656|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92477339|NCT05674656|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92477340|NCT05674656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477341|NCT05674656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477342|NCT05674656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92477343|NCT05674656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92477344|NCT05674656|Antiviral Agents|antiviral agents|mesh-ancestor
92477345|NCT05674656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477346|NCT05674656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92477347|NCT05674656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92477348|NCT05664789|Acetylcysteine|acetylcysteine|mesh-list
92477349|NCT05664789|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92477350|NCT05664789|Antiviral Agents|antiviral agents|mesh-ancestor
92477351|NCT05664789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477352|NCT05664789|Expectorants|expectorants|mesh-ancestor
92477353|NCT05664789|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477354|NCT05664789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92477355|NCT05664789|Antioxidants|antioxidants|mesh-ancestor
92531836|NCT00048802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477356|NCT05664789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477357|NCT05664789|Protective Agents|protective agents|mesh-ancestor
92477358|NCT05664789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477359|NCT05664789|Antidotes|antidotes|mesh-ancestor
92477360|NCT05656443|Ritonavir|ritonavir|mesh-list
92477361|NCT05656443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92477362|NCT05656443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92477363|NCT05656443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92477364|NCT05656443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477365|NCT05656443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477366|NCT05656443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92477367|NCT05656443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92477368|NCT05656443|Antiviral Agents|antiviral agents|mesh-ancestor
92477369|NCT05656443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477370|NCT05656443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92477371|NCT05656443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92477372|NCT05651633|Lidocaine|lidocaine|mesh-list
92477373|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92477374|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
92477375|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477376|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477377|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
92477378|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477379|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477380|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92477381|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92477382|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477383|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477384|NCT05648448|Oseltamivir|oseltamivir|mesh-list
92477385|NCT05648448|Favipiravir|favipiravir|mesh-list
92477386|NCT05648448|Zanamivir|zanamivir|mesh-list
92477387|NCT05648448|Molnupiravir|molnupiravir|mesh-list
92477388|NCT05648448|Peramivir|peramivir|mesh-list
92477389|NCT05648448|Baloxavir|baloxavir|mesh-list
92477390|NCT05648448|Laninamivir|laninamivir|mesh-list
92477391|NCT05648448|Antiviral Agents|antiviral agents|mesh-ancestor
92477392|NCT05648448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477393|NCT05648448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477394|NCT05648448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477395|NCT05641064|Dexmedetomidine|dexmedetomidine|mesh-list
92477396|NCT05641064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92477397|NCT05641064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477398|NCT05641064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477399|NCT05641064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92477400|NCT05641064|Analgesics|analgesics|mesh-ancestor
92477401|NCT05641064|Sensory System Agents|sensory system agents|mesh-ancestor
92477402|NCT05641064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477403|NCT05641064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92477404|NCT05641064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92477405|NCT05641064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92477406|NCT05641064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202302|NCT00655811|Capsaicin|capsaicin|mesh-list
92477407|NCT05641064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477408|NCT05641064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477409|NCT05634967|Ofatumumab|ofatumumab|mesh-list
92477410|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477411|NCT05625776|Capsaicin|capsaicin|mesh-list
92477412|NCT05625776|Antipruritics|antipruritics|mesh-ancestor
92477413|NCT05625776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477414|NCT05625776|Sensory System Agents|sensory system agents|mesh-ancestor
92477415|NCT05625776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477416|NCT05625776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477417|NCT05563558|Carboplatin|carboplatin|mesh-list
92477418|NCT05563558|Pembrolizumab|pembrolizumab|mesh-list
92477419|NCT05563558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477420|NCT05563558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92477421|NCT05563558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92477422|NCT05563558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477423|NCT05557838|Durvalumab|durvalumab|mesh-list
92477424|NCT05557838|Tremelimumab|tremelimumab|mesh-list
92477425|NCT05557838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92477426|NCT05557838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477427|NCT05545735|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92477428|NCT05545735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477429|NCT05531994|Montelukast|montelukast|mesh-list
92477430|NCT05531994|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92477431|NCT05531994|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477432|NCT05531994|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92477434|NCT05531994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477435|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477436|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92477437|NCT05531994|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92477438|NCT05531994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477439|NCT05528718|Midazolam|midazolam|mesh-list
92477440|NCT05528718|Nitrous Oxide|nitrous oxide|mesh-list
92477441|NCT05528718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92477442|NCT05528718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92477443|NCT05528718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477444|NCT05528718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477445|NCT05528718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92477446|NCT05528718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92477447|NCT05528718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92477448|NCT05528718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92477449|NCT05528718|Anesthetics, General|anesthetics, general|mesh-ancestor
92477450|NCT05528718|Anesthetics|anesthetics|mesh-ancestor
92477451|NCT05528718|GABA Modulators|gaba modulators|mesh-ancestor
92477452|NCT05528718|GABA Agents|gaba agents|mesh-ancestor
92477453|NCT05528718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477454|NCT05528718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477455|NCT05528718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92477456|NCT05528718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92477457|NCT05528718|Analgesics|analgesics|mesh-ancestor
92477458|NCT05528718|Sensory System Agents|sensory system agents|mesh-ancestor
92477459|NCT05528718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477460|NCT05528198|Montelukast|montelukast|mesh-list
92477461|NCT05528198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92477462|NCT05528198|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477463|NCT05528198|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92477464|NCT05528198|Hormone Antagonists|hormone antagonists|mesh-ancestor
92477465|NCT05528198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477466|NCT05528198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477467|NCT05528198|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92477468|NCT05528198|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92477469|NCT05528198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477470|NCT05514899|Dronabinol|dronabinol|mesh-list
92477471|NCT05514899|Cannabidiol|cannabidiol|mesh-list
92477472|NCT05514899|Anticonvulsants|anticonvulsants|mesh-ancestor
92477473|NCT05514899|Hallucinogens|hallucinogens|mesh-ancestor
92477474|NCT05514899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477475|NCT05514899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92477476|NCT05514899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92477477|NCT05514899|Analgesics|analgesics|mesh-ancestor
92477478|NCT05514899|Sensory System Agents|sensory system agents|mesh-ancestor
92477479|NCT05514899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477480|NCT05514899|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92477481|NCT05514899|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92477482|NCT05514899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477483|NCT05514899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477484|NCT05514899|Hormones|hormones|mesh-ancestor
92477485|NCT05514899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477486|NCT05458401|Trastuzumab|trastuzumab|mesh-list
92477487|NCT05458401|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92477488|NCT05458401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92477489|NCT05458401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477490|NCT05458401|Immunoconjugates|immunoconjugates|mesh-ancestor
92477491|NCT05458401|Immunologic Factors|immunologic factors|mesh-ancestor
92477492|NCT05458401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477493|NCT05458375|Estradiol|estradiol|mesh-list
92477494|NCT05458375|Estrogens|estrogens|mesh-ancestor
92477495|NCT05458375|Hormones|hormones|mesh-ancestor
92477496|NCT05458375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477497|NCT05458375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477498|NCT05420584|Tislelizumab|tislelizumab|mesh-list
92477499|NCT05420584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92477500|NCT05420584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477502|NCT05416580|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92477503|NCT05416580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92477504|NCT05416580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477505|NCT05416580|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92477506|NCT05416580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477507|NCT05413980|Moxifloxacin|moxifloxacin|mesh-list
92477508|NCT05413980|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92477509|NCT05413980|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92477510|NCT05413980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92477511|NCT05413980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477512|NCT05413980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477513|NCT05413980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92477514|NCT05413980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92477515|NCT05413980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477516|NCT05413980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477517|NCT05413980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477518|NCT05413980|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92477519|NCT05413980|Contraceptive Agents|contraceptive agents|mesh-ancestor
92477520|NCT05413980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92477521|NCT05413980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477522|NCT05413980|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92477523|NCT05413980|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92477524|NCT05413980|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92477525|NCT05413551|Isoniazid|isoniazid|mesh-list
92477526|NCT05413551|Antitubercular Agents|antitubercular agents|mesh-ancestor
92477527|NCT05413551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477528|NCT05413551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477529|NCT05413551|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92477530|NCT05413551|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92477531|NCT05413551|Antimetabolites|antimetabolites|mesh-ancestor
92477532|NCT05413551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477533|NCT05413551|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92477534|NCT05385406|Acetic Acid|acetic acid|mesh-list
92477535|NCT05385406|Retinol acetate|retinol acetate|mesh-list
92477536|NCT05385406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477537|NCT05385406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477538|NCT05385406|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92477539|NCT05385406|Immunologic Factors|immunologic factors|mesh-ancestor
92477540|NCT05385406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477541|NCT05385406|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92477542|NCT05385406|Protective Agents|protective agents|mesh-ancestor
92477543|NCT05385406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477544|NCT05375760|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92477545|NCT05375760|Antiviral Agents|antiviral agents|mesh-ancestor
92477546|NCT05375760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477547|NCT05357547|Buspirone|buspirone|mesh-list
92477548|NCT05357547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92477549|NCT05357547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92477550|NCT05357547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477551|NCT05357547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477552|NCT05357547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92477553|NCT05357547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92477554|NCT05357547|Serotonin Agents|serotonin agents|mesh-ancestor
92477555|NCT05357547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477556|NCT05357547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477557|NCT05344833|Lenalidomide|lenalidomide|mesh-list
92477558|NCT05344833|Immunologic Factors|immunologic factors|mesh-ancestor
92477559|NCT05344833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477560|NCT05344833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92477561|NCT05344833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92477562|NCT05344833|Growth Substances|growth substances|mesh-ancestor
92477563|NCT05344833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92477564|NCT05344833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477565|NCT05323838|Complement System Proteins|complement system proteins|mesh-list
92477566|NCT05323838|Immunologic Factors|immunologic factors|mesh-ancestor
92477567|NCT05323838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477569|NCT05302999|Analgesics|analgesics|mesh-ancestor
92477570|NCT05302999|Sensory System Agents|sensory system agents|mesh-ancestor
92477571|NCT05302999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477572|NCT05302999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477573|NCT05302999|Anticonvulsants|anticonvulsants|mesh-ancestor
92477574|NCT05302999|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92477575|NCT05302999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92348944|NCT01519518|Heparin|heparin|mesh-list
92477576|NCT05302999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477577|NCT05302999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92477578|NCT05302999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92477579|NCT05302999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92477580|NCT05302999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477581|NCT05302999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477582|NCT05302999|Antimanic Agents|antimanic agents|mesh-ancestor
92477583|NCT05294965|Fenoterol|fenoterol|mesh-list
92477584|NCT05294965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92477585|NCT05294965|Autonomic Agents|autonomic agents|mesh-ancestor
92477586|NCT05294965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477587|NCT05294965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477588|NCT05294965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92477589|NCT05294965|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477590|NCT05294965|Sympathomimetics|sympathomimetics|mesh-ancestor
92477591|NCT05294965|Tocolytic Agents|tocolytic agents|mesh-ancestor
92477592|NCT05294965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92477593|NCT05294965|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92477594|NCT05294965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92477595|NCT05294965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92477596|NCT05294965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92477597|NCT05294965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477598|NCT05294965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477599|NCT05265806|Oxytocin|oxytocin|mesh-list
92477600|NCT05265806|Oxytocics|oxytocics|mesh-ancestor
92477601|NCT05265806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92477602|NCT05265806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477603|NCT05252585|Everolimus|everolimus|mesh-list
92477604|NCT05252585|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92477605|NCT05252585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92477606|NCT05252585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477607|NCT05252585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477608|NCT05252585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477609|NCT05252585|Immunologic Factors|immunologic factors|mesh-ancestor
92477610|NCT05252585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477611|NCT05252585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477612|NCT05242419|Huperzine A|huperzine a|mesh-list
92477613|NCT05242419|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92477614|NCT05242419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477615|NCT05242419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477616|NCT05242419|Cholinergic Agents|cholinergic agents|mesh-ancestor
92477617|NCT05242419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477618|NCT05242419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477619|NCT05242419|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92477620|NCT05242419|Protective Agents|protective agents|mesh-ancestor
92477621|NCT05232227|Primaquine|primaquine|mesh-list
92477622|NCT05232227|Antimalarials|antimalarials|mesh-ancestor
92477623|NCT05232227|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92477624|NCT05232227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92477625|NCT05232227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477626|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
92477627|NCT05225363|Fludarabine|fludarabine|mesh-list
92477628|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477629|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
92477630|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477631|NCT05225363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92477632|NCT05225363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92477633|NCT05225363|Alkylating Agents|alkylating agents|mesh-ancestor
92477634|NCT05225363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477635|NCT05225363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477636|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92477637|NCT05221229|Liraglutide|liraglutide|mesh-list
92477638|NCT05221229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92477639|NCT05221229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477640|NCT05221229|Incretins|incretins|mesh-ancestor
92477641|NCT05221229|Hormones|hormones|mesh-ancestor
92477642|NCT05221229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477643|NCT05216432|Fulvestrant|fulvestrant|mesh-list
92477644|NCT05216432|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92477645|NCT05216432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477646|NCT05216432|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92477647|NCT05216432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92477648|NCT05216432|Hormone Antagonists|hormone antagonists|mesh-ancestor
92477649|NCT05216432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477650|NCT05216432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477651|NCT05184842|Decitabine|decitabine|mesh-list
92477652|NCT05184842|Venetoclax|venetoclax|mesh-list
92477654|NCT05184842|Antimetabolites|antimetabolites|mesh-ancestor
92477655|NCT05184842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477656|NCT05184842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477657|NCT05184842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477658|NCT05139420|Topiramate|topiramate|mesh-list
92477659|NCT05139420|Phentermine|phentermine|mesh-list
92477660|NCT05139420|Anticonvulsants|anticonvulsants|mesh-ancestor
92477661|NCT05139420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92477662|NCT05139420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477663|NCT05139420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92477664|NCT05139420|Appetite Depressants|appetite depressants|mesh-ancestor
92477665|NCT05139420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92477666|NCT05139420|Sympathomimetics|sympathomimetics|mesh-ancestor
92477667|NCT05139420|Autonomic Agents|autonomic agents|mesh-ancestor
92477668|NCT05139420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477669|NCT05139420|Adrenergic Agents|adrenergic agents|mesh-ancestor
92477670|NCT05139420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477671|NCT05139420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477672|NCT05135650|Sotrovimab|sotrovimab|mesh-list
92477673|NCT05135650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92477674|NCT05135650|Antibodies|antibodies|mesh-list
92477675|NCT05135650|Immunoglobulins|immunoglobulins|mesh-list
92477676|NCT05135650|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92477677|NCT05135650|Immunologic Factors|immunologic factors|mesh-ancestor
92477678|NCT05135650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477679|NCT05135650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477680|NCT05135650|Antiviral Agents|antiviral agents|mesh-ancestor
92477681|NCT05135650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477682|NCT05073822|Mycophenolic Acid|mycophenolic acid|mesh-list
92477683|NCT05073822|Tacrolimus|tacrolimus|mesh-list
92477684|NCT05073822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477685|NCT05073822|Immunologic Factors|immunologic factors|mesh-ancestor
92477686|NCT05073822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477687|NCT05073822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92477688|NCT05073822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477689|NCT05073822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477690|NCT05073822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92477691|NCT05073822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477692|NCT05073822|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92477693|NCT05073822|Antitubercular Agents|antitubercular agents|mesh-ancestor
92477694|NCT05073822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477695|NCT05073822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477696|NCT05047952|Vortioxetine|vortioxetine|mesh-list
92477697|NCT05047952|Antidepressive Agents|antidepressive agents|mesh-ancestor
92477698|NCT05047952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92477699|NCT05047952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92477700|NCT05047952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92477701|NCT05047952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477702|NCT05047952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477703|NCT05047952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92477704|NCT05047952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92202597|NCT01968057|Cyclosporine|cyclosporine|mesh-list
92477705|NCT05047952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477706|NCT05047952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477707|NCT05047952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477708|NCT05047952|Serotonin Agents|serotonin agents|mesh-ancestor
92477709|NCT05047952|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92477710|NCT05047952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92477711|NCT05047952|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92477712|NCT05047952|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92477713|NCT05001828|Azacitidine|azacitidine|mesh-list
92477714|NCT05001828|Venetoclax|venetoclax|mesh-list
92477715|NCT05001828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92477716|NCT05001828|Antimetabolites|antimetabolites|mesh-ancestor
92477717|NCT05001828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477718|NCT05001828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477719|NCT05001828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477720|NCT04965454|Choline|choline|mesh-list
92477721|NCT04965454|Lipotropic Agents|lipotropic agents|mesh-ancestor
92477722|NCT04965454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92477723|NCT04965454|Antimetabolites|antimetabolites|mesh-ancestor
92477724|NCT04965454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477725|NCT04965454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477726|NCT04965454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92477727|NCT04965454|Nootropic Agents|nootropic agents|mesh-ancestor
92477729|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92477730|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477731|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92477732|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477733|NCT04933552|Siponimod|siponimod|mesh-list
92477734|NCT04933552|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92477735|NCT04933552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477736|NCT04933552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477737|NCT04933552|Immunologic Factors|immunologic factors|mesh-ancestor
92477738|NCT04933552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477739|NCT04917484|Octreotide|octreotide|mesh-list
92477740|NCT04917484|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92477741|NCT04917484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477742|NCT04917484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92477743|NCT04917484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477744|NCT04917484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92477745|NCT04917484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477746|NCT04916613|Androgens|androgens|mesh-list
92477747|NCT04916613|Hormones|hormones|mesh-ancestor
92477748|NCT04916613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477749|NCT04916613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477750|NCT04893525|Buprenorphine|buprenorphine|mesh-list
92477751|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92477752|NCT04893525|Naloxone|naloxone|mesh-list
92477753|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92477754|NCT04893525|Narcotics|narcotics|mesh-ancestor
92477755|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477756|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477757|NCT04893525|Analgesics|analgesics|mesh-ancestor
92477758|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
92477759|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477760|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92477761|NCT04865848|Anesthetics|anesthetics|mesh-list
92477762|NCT04865848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477763|NCT04865848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477764|NCT04859322|Glucagon|glucagon|mesh-list
92477765|NCT04859322|Somatostatin|somatostatin|mesh-list
92477766|NCT04859322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477767|NCT04859322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92477768|NCT04859322|Hormones|hormones|mesh-ancestor
92477769|NCT04859322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477770|NCT04839666|Propofol|propofol|mesh-list
92477771|NCT04839666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92477772|NCT04839666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477773|NCT04839666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477774|NCT04839666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92477775|NCT04839666|Anesthetics, General|anesthetics, general|mesh-ancestor
92477776|NCT04839666|Anesthetics|anesthetics|mesh-ancestor
92477777|NCT04804007|Etoposide|etoposide|mesh-list
92202679|NCT00541697|Atorvastatin|atorvastatin|mesh-list
92477778|NCT04804007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92477779|NCT04804007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477780|NCT04804007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92477781|NCT04804007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92477783|NCT04804007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477784|NCT04788667|Erenumab|erenumab|mesh-list
92477785|NCT04788667|Botulinum Toxins|botulinum toxins|mesh-list
92477786|NCT04788667|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92477787|NCT04788667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477788|NCT04788667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477789|NCT04788667|Cholinergic Agents|cholinergic agents|mesh-ancestor
92477790|NCT04788667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477791|NCT04788667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150415|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92477792|NCT04788667|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92477793|NCT04788667|Analgesics|analgesics|mesh-ancestor
92477795|NCT04788667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477796|NCT04782180|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92477797|NCT04782180|Antiviral Agents|antiviral agents|mesh-ancestor
92477798|NCT04782180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477799|NCT04782180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92477800|NCT04782180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92477801|NCT04782180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477802|NCT04782180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477803|NCT04782180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92477804|NCT04782180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92477805|NCT04757584|Propranolol|propranolol|mesh-list
92477806|NCT04757584|Metoprolol|metoprolol|mesh-list
92477807|NCT04757584|Atenolol|atenolol|mesh-list
92477808|NCT04757584|Sotalol|sotalol|mesh-list
92477809|NCT04757584|Nadolol|nadolol|mesh-list
92477810|NCT04757584|Acebutolol|acebutolol|mesh-list
92477811|NCT04757584|Carvedilol|carvedilol|mesh-list
92477812|NCT04757584|Nebivolol|nebivolol|mesh-list
92477813|NCT04757584|Bisoprolol|bisoprolol|mesh-list
92477814|NCT04757584|Labetalol|labetalol|mesh-list
92477815|NCT04757584|Pindolol|pindolol|mesh-list
92477816|NCT04757584|Betaxolol|betaxolol|mesh-list
92477817|NCT04757584|Penbutolol|penbutolol|mesh-list
92477818|NCT04757584|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92477819|NCT04757584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92477820|NCT04757584|Adrenergic Agents|adrenergic agents|mesh-ancestor
92477821|NCT04757584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477822|NCT04757584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477823|NCT04757584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477824|NCT04757584|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92477825|NCT04757584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92477826|NCT04757584|Vasodilator Agents|vasodilator agents|mesh-ancestor
92477827|NCT04757584|Sympatholytics|sympatholytics|mesh-ancestor
92477828|NCT04757584|Autonomic Agents|autonomic agents|mesh-ancestor
92477829|NCT04757584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477830|NCT04757584|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92477831|NCT04757584|Antioxidants|antioxidants|mesh-ancestor
92477832|NCT04757584|Protective Agents|protective agents|mesh-ancestor
92477833|NCT04757584|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92477834|NCT04757584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477835|NCT04757584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92477836|NCT04757584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92477837|NCT04757584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92477838|NCT04757584|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92477839|NCT04757584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92477840|NCT04757584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92477841|NCT04757584|Sympathomimetics|sympathomimetics|mesh-ancestor
92477842|NCT04757584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92477843|NCT04757584|Serotonin Agents|serotonin agents|mesh-ancestor
92477844|NCT04756791|Anesthetics|anesthetics|mesh-list
92477845|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92477846|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477847|NCT04752475|Furosemide|furosemide|mesh-list
92477848|NCT04752475|Diuretics|diuretics|mesh-ancestor
92477849|NCT04752475|Natriuretic Agents|natriuretic agents|mesh-ancestor
92477850|NCT04752475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477851|NCT04752475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92477852|NCT04752475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92477853|NCT04752475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477854|NCT04720326|Tacrolimus|tacrolimus|mesh-list
92477855|NCT04720326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477856|NCT04720326|Immunologic Factors|immunologic factors|mesh-ancestor
92477857|NCT04720326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477858|NCT04720326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92477859|NCT04720326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477860|NCT04720326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477861|NCT04717362|Methyltestosterone|methyltestosterone|mesh-list
92477862|NCT04717362|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92477863|NCT04717362|Testosterone|testosterone|mesh-list
92477864|NCT04717362|Testosterone undecanoate|testosterone undecanoate|mesh-list
92477865|NCT04717362|Testosterone enanthate|testosterone enanthate|mesh-list
92477866|NCT04717362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92477867|NCT04717362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477868|NCT04717362|Anabolic Agents|anabolic agents|mesh-ancestor
92477869|NCT04717362|Hormones|hormones|mesh-ancestor
92477870|NCT04717362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477871|NCT04717362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477872|NCT04717362|Androgens|androgens|mesh-ancestor
92477873|NCT04708054|Fludarabine|fludarabine|mesh-list
92477874|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
92477875|NCT04708054|Busulfan|busulfan|mesh-list
92477876|NCT04708054|Venetoclax|venetoclax|mesh-list
92477877|NCT04708054|Thiotepa|thiotepa|mesh-list
92477878|NCT04708054|Cladribine|cladribine|mesh-list
92477879|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92477880|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477881|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92477882|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
92477883|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477884|NCT04708054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92477885|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
92477886|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477887|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
92477888|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92477889|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92477890|NCT04700826|Rivaroxaban|rivaroxaban|mesh-list
92477891|NCT04700826|Apixaban|apixaban|mesh-list
92477892|NCT04700826|Edoxaban|edoxaban|mesh-list
92477893|NCT04700826|Dabigatran|dabigatran|mesh-list
92477894|NCT04700826|Anticoagulants|anticoagulants|mesh-list
92477895|NCT04700826|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92477896|NCT04700826|Antithrombins|antithrombins|mesh-ancestor
92477897|NCT04700826|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92477898|NCT04700826|Protease Inhibitors|protease inhibitors|mesh-ancestor
92477899|NCT04700826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477900|NCT04700826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477901|NCT04648033|Atovaquone|atovaquone|mesh-list
92477902|NCT04648033|Cisplatin|cisplatin|mesh-list
92477903|NCT04648033|Vinorelbine|vinorelbine|mesh-list
92477904|NCT04648033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477905|NCT04648033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92477906|NCT04648033|Tubulin Modulators|tubulin modulators|mesh-ancestor
92477907|NCT04648033|Antimitotic Agents|antimitotic agents|mesh-ancestor
92477908|NCT04648033|Mitosis Modulators|mitosis modulators|mesh-ancestor
92477909|NCT04648033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477910|NCT04648033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477911|NCT04648033|Antimalarials|antimalarials|mesh-ancestor
92477912|NCT04648033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92477913|NCT04648033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92477914|NCT04648033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477915|NCT04604782|Regadenoson|regadenoson|mesh-list
92477916|NCT04604782|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92477917|NCT04604782|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92477918|NCT04604782|Purinergic Agonists|purinergic agonists|mesh-ancestor
92477919|NCT04604782|Purinergic Agents|purinergic agents|mesh-ancestor
92477920|NCT04604782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92477921|NCT04604782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477922|NCT04604782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477923|NCT04573946|Vitamin D|vitamin d|mesh-list
92477924|NCT04573946|Ergocalciferols|ergocalciferols|mesh-list
92477925|NCT04573946|Cholecalciferol|cholecalciferol|mesh-list
92477926|NCT04573946|Vitamins|vitamins|mesh-list
92477927|NCT04573946|Micronutrients|micronutrients|mesh-ancestor
92477928|NCT04573946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202826|NCT00702299|Paclitaxel|paclitaxel|mesh-list
92477929|NCT04573946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92477930|NCT04573946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92477931|NCT04549207|Denosumab|denosumab|mesh-list
92477932|NCT04549207|Zoledronic Acid|zoledronic acid|mesh-list
92477933|NCT04549207|Pamidronate|pamidronate|mesh-list
92477934|NCT04549207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92477935|NCT04549207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477936|NCT04319328|Ciprofloxacin|ciprofloxacin|mesh-list
92477937|NCT04319328|Cefazolin|cefazolin|mesh-list
92477938|NCT04319328|Ceftazidime|ceftazidime|mesh-list
92477939|NCT04319328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477940|NCT04319328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477941|NCT04319328|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92477942|NCT04319328|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92477943|NCT04319328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477944|NCT04319328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477945|NCT04319328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477946|NCT04319328|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92477947|NCT04319328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92477948|NCT04306315|Brodalumab|brodalumab|mesh-list
92477949|NCT04306315|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477950|NCT04267926|Ubiquinone|ubiquinone|mesh-list
92477951|NCT04267926|Micronutrients|micronutrients|mesh-ancestor
92477952|NCT04267926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477954|NCT04255160|Estrogens|estrogens|mesh-ancestor
92477955|NCT04255160|Hormones|hormones|mesh-ancestor
92477956|NCT04255160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477957|NCT04255160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477958|NCT04141501|Psilocybin|psilocybin|mesh-list
92477959|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
92477960|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477961|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92477962|NCT04098718|Prednisolone|prednisolone|mesh-list
92477963|NCT04098718|Benralizumab|benralizumab|mesh-list
92477964|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92477965|NCT04098718|Glucocorticoids|glucocorticoids|mesh-ancestor
92477966|NCT04098718|Hormones|hormones|mesh-ancestor
92477967|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477968|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477969|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92477970|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477971|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92477972|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92477973|NCT04097730|Riboflavin|riboflavin|mesh-list
92477974|NCT04097730|Moxifloxacin|moxifloxacin|mesh-list
92477975|NCT04097730|Difluprednate|difluprednate|mesh-list
92477976|NCT04097730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92477977|NCT04097730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92477978|NCT04097730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92477979|NCT04097730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92477980|NCT04097730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92477981|NCT04097730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92477982|NCT04097730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92477983|NCT04097730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477984|NCT04097730|Vitamin B Complex|vitamin b complex|mesh-ancestor
92477985|NCT04097730|Vitamins|vitamins|mesh-ancestor
92477986|NCT04097730|Micronutrients|micronutrients|mesh-ancestor
92477987|NCT04097730|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92477988|NCT04097730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92477989|NCT04097730|Glucocorticoids|glucocorticoids|mesh-ancestor
92477990|NCT04097730|Hormones|hormones|mesh-ancestor
92477991|NCT04097730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92477992|NCT04092387|Nicotine|nicotine|mesh-list
92477993|NCT04092387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92477994|NCT04092387|Autonomic Agents|autonomic agents|mesh-ancestor
92477995|NCT04092387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92477996|NCT04092387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92477997|NCT04092387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92477998|NCT04092387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92477999|NCT04092387|Cholinergic Agents|cholinergic agents|mesh-ancestor
92478000|NCT04092387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478001|NCT04092387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478002|NCT04074330|Rituximab|rituximab|mesh-list
92478003|NCT04074330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478004|NCT04074330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478005|NCT04074330|Immunologic Factors|immunologic factors|mesh-ancestor
92478006|NCT04074330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478007|NCT04074330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478008|NCT04069156|Aspirin|aspirin|mesh-list
92478009|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92478010|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92478011|NCT04069156|Analgesics|analgesics|mesh-ancestor
92478012|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
92478013|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478014|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478015|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478016|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478017|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92478019|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478020|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92478021|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92478022|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478023|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
92478024|NCT04062656|Leucovorin|leucovorin|mesh-list
92478025|NCT04062656|Folic Acid|folic acid|mesh-list
92478026|NCT04062656|Docetaxel|docetaxel|mesh-list
92478028|NCT04062656|Oxaliplatin|oxaliplatin|mesh-list
92478029|NCT04062656|Nivolumab|nivolumab|mesh-list
92478030|NCT04062656|Relatlimab|relatlimab|mesh-list
92478031|NCT04062656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478032|NCT04062656|Tubulin Modulators|tubulin modulators|mesh-ancestor
92478033|NCT04062656|Antimitotic Agents|antimitotic agents|mesh-ancestor
92478034|NCT04062656|Mitosis Modulators|mitosis modulators|mesh-ancestor
92478035|NCT04062656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478036|NCT04062656|Antimetabolites|antimetabolites|mesh-ancestor
92478037|NCT04062656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92478038|NCT04062656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478039|NCT04062656|Immunologic Factors|immunologic factors|mesh-ancestor
92478040|NCT04062656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478041|NCT04062656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478042|NCT04062656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478043|NCT04062656|Antidotes|antidotes|mesh-ancestor
92478044|NCT04062656|Protective Agents|protective agents|mesh-ancestor
92478045|NCT04062656|Vitamin B Complex|vitamin b complex|mesh-ancestor
92478046|NCT04062656|Vitamins|vitamins|mesh-ancestor
92478047|NCT04062656|Micronutrients|micronutrients|mesh-ancestor
92478048|NCT04062656|Hematinics|hematinics|mesh-ancestor
92478049|NCT04041050|Celecoxib|celecoxib|mesh-list
92478050|NCT04041050|Navitoclax|navitoclax|mesh-list
92478051|NCT04041050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92478052|NCT04041050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92478053|NCT04041050|Analgesics|analgesics|mesh-ancestor
92478054|NCT04041050|Sensory System Agents|sensory system agents|mesh-ancestor
92478055|NCT04041050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478056|NCT04041050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478057|NCT04041050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478058|NCT04041050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478059|NCT04041050|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92478060|NCT04041050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92478061|NCT04041050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478062|NCT04041050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478063|NCT04041050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478064|NCT04018313|Omalizumab|omalizumab|mesh-list
92478065|NCT04018313|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92478066|NCT04018313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92478067|NCT04018313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92478068|NCT04018313|Respiratory System Agents|respiratory system agents|mesh-ancestor
92478069|NCT04018313|Immunologic Factors|immunologic factors|mesh-ancestor
92478070|NCT04018313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478071|NCT03976518|Atezolizumab|atezolizumab|mesh-list
92478072|NCT03976518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478073|NCT03976518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478074|NCT03976518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478075|NCT03976518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478076|NCT03973203|Niacin|niacin|mesh-list
92478077|NCT03973203|Nicotinic Acids|nicotinic acids|mesh-list
92478078|NCT03973203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92478079|NCT03973203|Antimetabolites|antimetabolites|mesh-ancestor
92478080|NCT03973203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478081|NCT03973203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92478082|NCT03973203|Vasodilator Agents|vasodilator agents|mesh-ancestor
92478083|NCT03973203|Vitamin B Complex|vitamin b complex|mesh-ancestor
92478084|NCT03973203|Vitamins|vitamins|mesh-ancestor
92478085|NCT03973203|Micronutrients|micronutrients|mesh-ancestor
92478086|NCT03973203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478087|NCT03916926|Fluorides|fluorides|mesh-list
92478088|NCT03916926|Fluorides, Topical|fluorides, topical|mesh-list
92478089|NCT03916926|Cariostatic Agents|cariostatic agents|mesh-ancestor
92478090|NCT03916926|Protective Agents|protective agents|mesh-ancestor
92478091|NCT03916926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478092|NCT03899857|Pembrolizumab|pembrolizumab|mesh-list
92478093|NCT03899857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478094|NCT03899857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478095|NCT03899857|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478096|NCT03899857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478097|NCT03879694|Octreotide|octreotide|mesh-list
92478098|NCT03879694|Sargramostim|sargramostim|mesh-list
92478099|NCT03879694|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92478100|NCT03879694|Freund's Adjuvant|freund's adjuvant|mesh-list
92478101|NCT03879694|Immunologic Factors|immunologic factors|mesh-ancestor
92478102|NCT03879694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478103|NCT03879694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478104|NCT03879694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92478105|NCT03879694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92478106|NCT03879694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92478107|NCT03871491|Azithromycin|azithromycin|mesh-list
92478108|NCT03871491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478109|NCT03871491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478110|NCT03840967|Niraparib|niraparib|mesh-list
92478111|NCT03840967|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92478112|NCT03840967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478113|NCT03840967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478114|NCT03840967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478115|NCT03839914|Vancomycin|vancomycin|mesh-list
92478116|NCT03839914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478117|NCT03839914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478118|NCT03838263|Cisplatin|cisplatin|mesh-list
92478119|NCT03838263|Nivolumab|nivolumab|mesh-list
92478120|NCT03838263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478121|NCT03838263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478122|NCT03838263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478123|NCT03838263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478124|NCT03801642|Dapagliflozin|dapagliflozin|mesh-list
92478125|NCT03801642|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92478126|NCT03801642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478127|NCT03801642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92478128|NCT03801642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478129|NCT03792490|Fasudil|fasudil|mesh-list
92478130|NCT03792490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92478131|NCT03792490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92478132|NCT03792490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478133|NCT03792490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92478134|NCT03792490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478135|NCT03792490|Vasodilator Agents|vasodilator agents|mesh-ancestor
92478136|NCT03792490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478137|NCT03792490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478138|NCT03783429|Digoxin|digoxin|mesh-list
92478139|NCT03783429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92478140|NCT03783429|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92478141|NCT03783429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478142|NCT03783429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478143|NCT03783429|Protective Agents|protective agents|mesh-ancestor
92478144|NCT03783429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478145|NCT03770338|Teriparatide|teriparatide|mesh-list
92478146|NCT03770338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92478147|NCT03770338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478148|NCT03770338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92478149|NCT03721653|Leucovorin|leucovorin|mesh-list
92478150|NCT03721653|Bevacizumab|bevacizumab|mesh-list
92478151|NCT03721653|Atezolizumab|atezolizumab|mesh-list
92478152|NCT03721653|Fluorouracil|fluorouracil|mesh-list
92478153|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
92478154|NCT03721653|Irinotecan|irinotecan|mesh-list
92478155|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
92478156|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478157|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203045|NCT03219086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478158|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92478159|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92478160|NCT03721653|Growth Substances|growth substances|mesh-ancestor
92478161|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478162|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
92478163|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
92478164|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478165|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92478166|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478167|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
92478168|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92478169|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478170|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478171|NCT03721653|Antidotes|antidotes|mesh-ancestor
92478172|NCT03721653|Protective Agents|protective agents|mesh-ancestor
92478173|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
92478174|NCT03721653|Vitamins|vitamins|mesh-ancestor
92478175|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
92478176|NCT03721653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478177|NCT03713645|Tacrolimus|tacrolimus|mesh-list
92478178|NCT03713645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478179|NCT03713645|Immunologic Factors|immunologic factors|mesh-ancestor
92478180|NCT03713645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478181|NCT03713645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92478182|NCT03713645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478183|NCT03713645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478184|NCT03705507|Dexamethasone|dexamethasone|mesh-list
92478185|NCT03705507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478186|NCT03705507|Antiemetics|antiemetics|mesh-ancestor
92478187|NCT03705507|Autonomic Agents|autonomic agents|mesh-ancestor
92478188|NCT03705507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478189|NCT03705507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478190|NCT03705507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92478191|NCT03705507|Glucocorticoids|glucocorticoids|mesh-ancestor
92478192|NCT03705507|Hormones|hormones|mesh-ancestor
92478193|NCT03705507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478194|NCT03705507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92478195|NCT03705507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478196|NCT03664687|Zoledronic Acid|zoledronic acid|mesh-list
92478197|NCT03664687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92478198|NCT03664687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478199|NCT03663504|Metronidazole|metronidazole|mesh-list
92478200|NCT03663504|Neomycin|neomycin|mesh-list
92478201|NCT03663504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478202|NCT03663504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478203|NCT03663504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92478204|NCT03663504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92478205|NCT03663504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92478206|NCT03663504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478207|NCT03663504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478208|NCT03654066|Botulinum Toxins|botulinum toxins|mesh-list
92478209|NCT03654066|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92478210|NCT03654066|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92478211|NCT03654066|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92478212|NCT03654066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92478213|NCT03654066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478214|NCT03654066|Cholinergic Agents|cholinergic agents|mesh-ancestor
92478215|NCT03654066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478216|NCT03654066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478217|NCT03654066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92478218|NCT03654066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478219|NCT03582488|Corticosterone|corticosterone|mesh-list
92478220|NCT03582488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478221|NCT03553810|Valsartan|valsartan|mesh-list
92478222|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92478223|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92478224|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92478225|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92478226|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478227|NCT03528694|Durvalumab|durvalumab|mesh-list
92478228|NCT03528694|BCG Vaccine|bcg vaccine|mesh-list
92478229|NCT03528694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478230|NCT03528694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478231|NCT03528694|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92478232|NCT03528694|Immunologic Factors|immunologic factors|mesh-ancestor
92478233|NCT03528694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478234|NCT03476798|Bevacizumab|bevacizumab|mesh-list
92478235|NCT03476798|Rucaparib|rucaparib|mesh-list
92478236|NCT03476798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478237|NCT03476798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478238|NCT03476798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92478239|NCT03476798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92478240|NCT03476798|Growth Substances|growth substances|mesh-ancestor
92478241|NCT03476798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478242|NCT03476798|Growth Inhibitors|growth inhibitors|mesh-ancestor
92478243|NCT03476798|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92478244|NCT03476798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478245|NCT03476798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478246|NCT03404596|Nicotine|nicotine|mesh-list
92478247|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92478248|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
92478249|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478250|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478251|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92478252|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92478253|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92478254|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478255|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478257|NCT03340220|Antifungal Agents|antifungal agents|mesh-ancestor
92478258|NCT03340220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478259|NCT03340220|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92478260|NCT03340220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92478261|NCT03340220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478262|NCT03340220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478263|NCT03340220|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92478264|NCT03340220|Hormone Antagonists|hormone antagonists|mesh-ancestor
92478265|NCT03340220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478266|NCT03340220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478267|NCT03340220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92478268|NCT03334253|Atropine|atropine|mesh-list
92478269|NCT03334253|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92478270|NCT03334253|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92478271|NCT03334253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92478272|NCT03334253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92478273|NCT03334253|Autonomic Agents|autonomic agents|mesh-ancestor
92478274|NCT03334253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478275|NCT03334253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478276|NCT03334253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92478277|NCT03334253|Respiratory System Agents|respiratory system agents|mesh-ancestor
92478278|NCT03334253|Mydriatics|mydriatics|mesh-ancestor
92478279|NCT03334253|Parasympatholytics|parasympatholytics|mesh-ancestor
92478280|NCT03334253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92478281|NCT03334253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92478282|NCT03334253|Cholinergic Agents|cholinergic agents|mesh-ancestor
92478283|NCT03334253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478284|NCT03334253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478285|NCT03334253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92478286|NCT03317158|Gemcitabine|gemcitabine|mesh-list
92478287|NCT03317158|Docetaxel|docetaxel|mesh-list
92478288|NCT03317158|Durvalumab|durvalumab|mesh-list
92478289|NCT03317158|Tremelimumab|tremelimumab|mesh-list
92478290|NCT03317158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92478291|NCT03317158|BCG Vaccine|bcg vaccine|mesh-list
92478292|NCT03317158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92478293|NCT03317158|Antimetabolites|antimetabolites|mesh-ancestor
92478294|NCT03317158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478295|NCT03317158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478296|NCT03317158|Tubulin Modulators|tubulin modulators|mesh-ancestor
92478297|NCT03317158|Antimitotic Agents|antimitotic agents|mesh-ancestor
92478298|NCT03317158|Mitosis Modulators|mitosis modulators|mesh-ancestor
92478299|NCT03317158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478300|NCT03317158|Immunologic Factors|immunologic factors|mesh-ancestor
92478301|NCT03317158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478302|NCT03317158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92478303|NCT03202316|Atezolizumab|atezolizumab|mesh-list
92478304|NCT03202316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92478305|NCT03202316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478306|NCT03202316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478307|NCT03202316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478309|NCT03202316|Immunologic Factors|immunologic factors|mesh-ancestor
92478310|NCT03202316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478312|NCT03147859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92478313|NCT03131219|Ravulizumab|ravulizumab|mesh-list
92478314|NCT03131219|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92478315|NCT03131219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478316|NCT03131219|Immunologic Factors|immunologic factors|mesh-ancestor
92478317|NCT03131219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478318|NCT02914613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92478319|NCT02914613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92478320|NCT02783092|Cannabidiol|cannabidiol|mesh-list
92478321|NCT02783092|Anticonvulsants|anticonvulsants|mesh-ancestor
92478322|NCT02713945|Simvastatin|simvastatin|mesh-list
92478323|NCT02713945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92478324|NCT02713945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92478325|NCT02713945|Antimetabolites|antimetabolites|mesh-ancestor
92478326|NCT02713945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478327|NCT02713945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92478328|NCT02713945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92478329|NCT02713945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478330|NCT02685605|Temozolomide|temozolomide|mesh-list
92478331|NCT02685605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92478332|NCT02685605|Alkylating Agents|alkylating agents|mesh-ancestor
92478333|NCT02685605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478334|NCT02685605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478336|NCT02664935|Durvalumab|durvalumab|mesh-list
92478337|NCT02664935|Palbociclib|palbociclib|mesh-list
92478338|NCT02664935|Osimertinib|osimertinib|mesh-list
92478339|NCT02664935|Crizotinib|crizotinib|mesh-list
92478340|NCT02664935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478341|NCT02664935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92478342|NCT02664935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92478343|NCT02664935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92478344|NCT02664935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478345|NCT02664935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478346|NCT02664935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478347|NCT02664935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478348|NCT02586207|Cisplatin|cisplatin|mesh-list
92478349|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
92478350|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478351|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478352|NCT02586207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478353|NCT02586207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478354|NCT02573324|Temozolomide|temozolomide|mesh-list
92478355|NCT02573324|ABT-414|abt-414|mesh-list
92478356|NCT02573324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92478357|NCT02573324|Alkylating Agents|alkylating agents|mesh-ancestor
92478358|NCT02573324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478359|NCT02573324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478360|NCT02573324|Immunoconjugates|immunoconjugates|mesh-ancestor
92478361|NCT02573324|Immunologic Factors|immunologic factors|mesh-ancestor
92478362|NCT02573324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478363|NCT02553642|Nivolumab|nivolumab|mesh-list
92478364|NCT02553642|Ipilimumab|ipilimumab|mesh-list
92478365|NCT02553642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478366|NCT02553642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478367|NCT02553642|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478368|NCT02553642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478369|NCT02523092|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92478370|NCT02523092|Hormones|hormones|mesh-ancestor
92478371|NCT02523092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478372|NCT02523092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478373|NCT02450773|Furosemide|furosemide|mesh-list
92478374|NCT02450773|Diuretics|diuretics|mesh-ancestor
92478375|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
92478376|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478377|NCT02450773|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92478378|NCT02450773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92478379|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478380|NCT02445248|Tisagenlecleucel|tisagenlecleucel|mesh-list
92478381|NCT02445248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478382|NCT02445248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478384|NCT02412566|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92478385|NCT02412566|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92478386|NCT02412566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92478388|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478389|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478390|NCT02296684|Cisplatin|cisplatin|mesh-list
92478391|NCT02296684|Pembrolizumab|pembrolizumab|mesh-list
92478392|NCT02296684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478393|NCT02296684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478394|NCT02296684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478395|NCT02296684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478396|NCT01939275|Copper|copper|mesh-list
92478397|NCT01939275|Trastuzumab|trastuzumab|mesh-list
92478398|NCT01939275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478399|NCT01939275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478400|NCT01939275|Trace Elements|trace elements|mesh-ancestor
92478401|NCT01939275|Micronutrients|micronutrients|mesh-ancestor
92478402|NCT01939275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478404|NCT01900574|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92478405|NCT01900574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478406|NCT01900574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478407|NCT01900574|Immunologic Factors|immunologic factors|mesh-ancestor
92478408|NCT01900574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478409|NCT01342367|Bicalutamide|bicalutamide|mesh-list
92478410|NCT01342367|Finasteride|finasteride|mesh-list
92478411|NCT01342367|Dutasteride|dutasteride|mesh-list
92478412|NCT01342367|Androgen Antagonists|androgen antagonists|mesh-ancestor
92478413|NCT01342367|Hormone Antagonists|hormone antagonists|mesh-ancestor
92478414|NCT01342367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478415|NCT01342367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478416|NCT01342367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478417|NCT01342367|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92478418|NCT01342367|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92478419|NCT01342367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478420|NCT01342367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478421|NCT01342367|Urological Agents|urological agents|mesh-ancestor
92478422|NCT01185171|Gefitinib|gefitinib|mesh-list
92478423|NCT01185171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478424|NCT01185171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478425|NCT01185171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478426|NCT01185171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478427|NCT00896493|Cyclosporine|cyclosporine|mesh-list
92478428|NCT00896493|Cyclosporins|cyclosporins|mesh-list
92478429|NCT00896493|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92478430|NCT00896493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478431|NCT00896493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478432|NCT00896493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478433|NCT00896493|Immunologic Factors|immunologic factors|mesh-ancestor
92478434|NCT00896493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478435|NCT00896493|Antifungal Agents|antifungal agents|mesh-ancestor
92478436|NCT00896493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478437|NCT00896493|Dermatologic Agents|dermatologic agents|mesh-ancestor
92478438|NCT00896493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478439|NCT00896493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92478440|NCT00813423|Hydroxychloroquine|hydroxychloroquine|mesh-list
92478441|NCT00813423|Sunitinib|sunitinib|mesh-list
92478442|NCT00813423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478443|NCT00813423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92478444|NCT00813423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92478445|NCT00813423|Growth Substances|growth substances|mesh-ancestor
92478446|NCT00813423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478447|NCT00813423|Growth Inhibitors|growth inhibitors|mesh-ancestor
92478448|NCT00813423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478449|NCT00813423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478450|NCT00813423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478451|NCT00813423|Antimalarials|antimalarials|mesh-ancestor
92478452|NCT00813423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92478453|NCT00813423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92478454|NCT00813423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478455|NCT00813423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478456|NCT00790010|Bevacizumab|bevacizumab|mesh-list
92478457|NCT00790010|Ipilimumab|ipilimumab|mesh-list
92478458|NCT00790010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478459|NCT00790010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478460|NCT00790010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92478461|NCT00790010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92478462|NCT00790010|Growth Substances|growth substances|mesh-ancestor
92478463|NCT00790010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478464|NCT00790010|Growth Inhibitors|growth inhibitors|mesh-ancestor
92478465|NCT00790010|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478466|NCT00790010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478467|NCT00444093|Antidiarrheals|antidiarrheals|mesh-list
92478468|NCT00444093|Loperamide|loperamide|mesh-list
92478469|NCT00444093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92478470|NCT00408005|Calcium, Dietary|calcium, dietary|mesh-list
92478471|NCT00408005|Leucovorin|leucovorin|mesh-list
92478472|NCT00408005|Folic Acid|folic acid|mesh-list
92478473|NCT00408005|Cytarabine|cytarabine|mesh-list
92478474|NCT00408005|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
92478475|NCT00408005|Dexamethasone|dexamethasone|mesh-list
92478476|NCT00408005|Dexamethasone acetate|dexamethasone acetate|mesh-list
92478477|NCT00408005|Prednisone|prednisone|mesh-list
92478478|NCT00408005|Cortisone|cortisone|mesh-list
92478479|NCT00408005|Cyclophosphamide|cyclophosphamide|mesh-list
92478480|NCT00408005|Doxorubicin|doxorubicin|mesh-list
92478481|NCT00408005|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92478482|NCT00408005|Methotrexate|methotrexate|mesh-list
92478483|NCT00408005|Vincristine|vincristine|mesh-list
92478484|NCT00408005|Daunorubicin|daunorubicin|mesh-list
92478485|NCT00408005|Asparaginase|asparaginase|mesh-list
92478486|NCT00408005|Mercaptopurine|mercaptopurine|mesh-list
92478487|NCT00408005|Pegaspargase|pegaspargase|mesh-list
92478488|NCT00408005|Thioguanine|thioguanine|mesh-list
92478489|NCT00408005|BB 1101|bb 1101|mesh-list
92478490|NCT00408005|Calcium|calcium|mesh-list
92478491|NCT00408005|2-Aminopurine|2-aminopurine|mesh-list
92478492|NCT00408005|Levoleucovorin|levoleucovorin|mesh-list
92478493|NCT00408005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478494|NCT00408005|Immunologic Factors|immunologic factors|mesh-ancestor
92478495|NCT00408005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478496|NCT00408005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478497|NCT00408005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92478498|NCT00408005|Alkylating Agents|alkylating agents|mesh-ancestor
92478499|NCT00408005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478500|NCT00408005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478501|NCT00408005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92478502|NCT00408005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478503|NCT00408005|Antiemetics|antiemetics|mesh-ancestor
92478504|NCT00408005|Autonomic Agents|autonomic agents|mesh-ancestor
92478505|NCT00408005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478506|NCT00408005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92478507|NCT00408005|Glucocorticoids|glucocorticoids|mesh-ancestor
92478508|NCT00408005|Hormones|hormones|mesh-ancestor
92478509|NCT00408005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478510|NCT00408005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92478511|NCT00408005|Protease Inhibitors|protease inhibitors|mesh-ancestor
92478512|NCT00408005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478513|NCT00408005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92478514|NCT00408005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92478515|NCT00408005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478516|NCT00408005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92478517|NCT00408005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92478518|NCT00408005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92478519|NCT00408005|Abortifacient Agents|abortifacient agents|mesh-ancestor
92478520|NCT00408005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92478521|NCT00408005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92478522|NCT00408005|Antimetabolites|antimetabolites|mesh-ancestor
92478523|NCT00408005|Dermatologic Agents|dermatologic agents|mesh-ancestor
92478524|NCT00408005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92478525|NCT00408005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92478526|NCT00408005|Antiviral Agents|antiviral agents|mesh-ancestor
92478527|NCT00408005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478528|NCT00408005|Antidotes|antidotes|mesh-ancestor
92478529|NCT00408005|Protective Agents|protective agents|mesh-ancestor
92478530|NCT00408005|Vitamin B Complex|vitamin b complex|mesh-ancestor
92478531|NCT00408005|Vitamins|vitamins|mesh-ancestor
92478532|NCT00408005|Micronutrients|micronutrients|mesh-ancestor
92478533|NCT00408005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92478534|NCT00408005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92478535|NCT00408005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92478536|NCT00408005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92478537|NCT00408005|Hematinics|hematinics|mesh-ancestor
92478538|NCT00003042|Tamoxifen|tamoxifen|mesh-list
92478539|NCT00003042|Paclitaxel|paclitaxel|mesh-list
92478540|NCT00003042|Cyclophosphamide|cyclophosphamide|mesh-list
92478541|NCT00003042|Doxorubicin|doxorubicin|mesh-list
92478542|NCT00003042|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92478543|NCT00003042|Melphalan|melphalan|mesh-list
92478544|NCT00003042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92478545|NCT00003042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478546|NCT00003042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92478547|NCT00003042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92478548|NCT00003042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92478549|NCT00003042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478550|NCT00003042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478551|NCT00003042|Immunologic Factors|immunologic factors|mesh-ancestor
92478552|NCT00003042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478553|NCT00003042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478554|NCT00003042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92478555|NCT00003042|Alkylating Agents|alkylating agents|mesh-ancestor
92478556|NCT00003042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92478557|NCT00003042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92478558|NCT00003042|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92478559|NCT00003042|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478560|NCT00003042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478561|NCT00003042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92478562|NCT00003042|Hormone Antagonists|hormone antagonists|mesh-ancestor
92478563|NCT00003042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478564|NCT00003042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92478565|NCT00003042|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92478566|NCT00003042|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92478567|NCT00003042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92478569|NCT01873144|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92478570|NCT01873144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92478571|NCT01873144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92478572|NCT01873144|Adrenergic Agents|adrenergic agents|mesh-ancestor
92478573|NCT01873144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478574|NCT01873144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478575|NCT01873144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478576|NCT01873144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92478577|NCT01873144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92478578|NCT01873144|Autonomic Agents|autonomic agents|mesh-ancestor
92478579|NCT01873144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478580|NCT01873144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92478581|NCT01873144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92478582|NCT01873144|Mydriatics|mydriatics|mesh-ancestor
92478583|NCT01873144|Sympathomimetics|sympathomimetics|mesh-ancestor
92478584|NCT01873144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92478585|NCT01873157|Bortezomib|bortezomib|mesh-list
92478586|NCT01873157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478587|NCT01873222|Sirolimus|sirolimus|mesh-list
92478588|NCT01873222|Umirolimus|umirolimus|mesh-list
92478589|NCT01873222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478590|NCT01873222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478591|NCT01873222|Immunologic Factors|immunologic factors|mesh-ancestor
92478592|NCT01873222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478593|NCT01873222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478594|NCT01873222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478595|NCT01873222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92478596|NCT01873222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478597|NCT01873222|Antifungal Agents|antifungal agents|mesh-ancestor
92478598|NCT01873313|Ropivacaine|ropivacaine|mesh-list
92478599|NCT01873313|Anesthetics, Local|anesthetics, local|mesh-ancestor
92478600|NCT01873313|Anesthetics|anesthetics|mesh-ancestor
92478601|NCT01873313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478602|NCT01873313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478603|NCT01873313|Sensory System Agents|sensory system agents|mesh-ancestor
92478604|NCT01873313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478605|NCT01873339|Midazolam|midazolam|mesh-list
92478606|NCT01873339|Darapladib|darapladib|mesh-list
92478607|NCT01873339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92478608|NCT01873339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92478609|NCT01873339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478610|NCT01873339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478611|NCT01873339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92478612|NCT01873339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92478613|NCT01873339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92478614|NCT01873339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92478615|NCT01873339|Anesthetics, General|anesthetics, general|mesh-ancestor
92478616|NCT01873339|Anesthetics|anesthetics|mesh-ancestor
92478617|NCT01873339|GABA Modulators|gaba modulators|mesh-ancestor
92478618|NCT01873339|GABA Agents|gaba agents|mesh-ancestor
92478619|NCT01873339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478620|NCT01873339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478621|NCT01873339|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92478622|NCT01873339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478623|NCT01873378|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92478624|NCT01873378|Luteolytic Agents|luteolytic agents|mesh-ancestor
92478625|NCT01873378|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92478626|NCT01873378|Contraceptive Agents|contraceptive agents|mesh-ancestor
92478627|NCT01873378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92478628|NCT01873378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478629|NCT01873378|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92478630|NCT01873378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92478631|NCT01873378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478633|NCT01873430|Antioxidants|antioxidants|mesh-ancestor
92478634|NCT01873430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478635|NCT01873430|Protective Agents|protective agents|mesh-ancestor
92478636|NCT01873430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478637|NCT01873430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478638|NCT01873443|Folic Acid|folic acid|mesh-list
92478639|NCT01873443|Rituximab|rituximab|mesh-list
92478640|NCT01873443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478641|NCT01873443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478642|NCT01873443|Immunologic Factors|immunologic factors|mesh-ancestor
92478643|NCT01873443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478644|NCT01873443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478645|NCT01873443|Hematinics|hematinics|mesh-ancestor
92478646|NCT01873443|Vitamin B Complex|vitamin b complex|mesh-ancestor
92478647|NCT01873443|Vitamins|vitamins|mesh-ancestor
92478648|NCT01873443|Micronutrients|micronutrients|mesh-ancestor
92478649|NCT01873573|Triamcinolone|triamcinolone|mesh-list
92478650|NCT01873573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478651|NCT01873573|Glucocorticoids|glucocorticoids|mesh-ancestor
92478652|NCT01873573|Hormones|hormones|mesh-ancestor
92478653|NCT01873573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478654|NCT01873573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478655|NCT01873690|Ciprofloxacin|ciprofloxacin|mesh-list
92478656|NCT01873690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478657|NCT01873690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478658|NCT01873690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92478659|NCT01873690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478660|NCT01873690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478661|NCT01873690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478662|NCT01873690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478663|NCT01873690|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92478664|NCT01873690|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92478665|NCT01873768|Tranexamic Acid|tranexamic acid|mesh-list
92478666|NCT01873768|Aminocaproic Acid|aminocaproic acid|mesh-list
92478667|NCT01873768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92478668|NCT01873768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92478669|NCT01873768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478670|NCT01873768|Hemostatics|hemostatics|mesh-ancestor
92478671|NCT01873768|Coagulants|coagulants|mesh-ancestor
92478672|NCT01873807|Cyclophosphamide|cyclophosphamide|mesh-list
92478673|NCT01873807|Etoposide|etoposide|mesh-list
92478674|NCT01873807|Idarubicin|idarubicin|mesh-list
92478675|NCT01873807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478676|NCT01873807|Immunologic Factors|immunologic factors|mesh-ancestor
92478677|NCT01873807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478678|NCT01873807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478679|NCT01873807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92478680|NCT01873807|Alkylating Agents|alkylating agents|mesh-ancestor
92478681|NCT01873807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478682|NCT01873807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478683|NCT01873807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92478684|NCT01873807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92478685|NCT01873807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203568|NCT03085628|Oxytocin|oxytocin|mesh-list
92478686|NCT01873807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478687|NCT01873807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146444|NCT00086281|Modafinil|modafinil|mesh-list
92478688|NCT01873807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92478689|NCT01873820|Ascorbic Acid|ascorbic acid|mesh-list
92478690|NCT01873820|Calcium ascorbate|calcium ascorbate|mesh-list
92478691|NCT01873820|Calcium|calcium|mesh-list
92478692|NCT01873820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92478693|NCT01873820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478694|NCT01873820|Antioxidants|antioxidants|mesh-ancestor
92478695|NCT01873820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478696|NCT01873820|Protective Agents|protective agents|mesh-ancestor
92478697|NCT01873820|Vitamins|vitamins|mesh-ancestor
92478698|NCT01873820|Micronutrients|micronutrients|mesh-ancestor
92478699|NCT01873833|Cyclophosphamide|cyclophosphamide|mesh-list
92478700|NCT01873833|Capecitabine|capecitabine|mesh-list
92478701|NCT01873833|Trastuzumab|trastuzumab|mesh-list
92478702|NCT01873833|Lapatinib|lapatinib|mesh-list
92478703|NCT01873833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478704|NCT01873833|Immunologic Factors|immunologic factors|mesh-ancestor
92478705|NCT01873833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478706|NCT01873833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478707|NCT01873833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92478708|NCT01873833|Alkylating Agents|alkylating agents|mesh-ancestor
92478709|NCT01873833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478710|NCT01873833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478711|NCT01873833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92478712|NCT01873833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92478713|NCT01873833|Antimetabolites|antimetabolites|mesh-ancestor
92478714|NCT01873833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478715|NCT01873833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478716|NCT01873833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478717|NCT01873885|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
92478718|NCT01873885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92478719|NCT01874002|Sirolimus|sirolimus|mesh-list
92478720|NCT01874002|Temsirolimus|temsirolimus|mesh-list
92478721|NCT01874002|MTOR Inhibitors|mtor inhibitors|mesh-list
92478722|NCT01874002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478723|NCT01874002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478724|NCT01874002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92478725|NCT01874002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478726|NCT01874002|Antifungal Agents|antifungal agents|mesh-ancestor
92478727|NCT01874002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478728|NCT01874002|Immunologic Factors|immunologic factors|mesh-ancestor
92478729|NCT01874002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478730|NCT01874002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478731|NCT01874002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478732|NCT01874002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478733|NCT01874028|Trientine|trientine|mesh-list
92478734|NCT01874028|Chelating Agents|chelating agents|mesh-ancestor
92478735|NCT01874028|Sequestering Agents|sequestering agents|mesh-ancestor
92478736|NCT01874028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478737|NCT01874041|Salicylic Acid|salicylic acid|mesh-list
92478738|NCT01874041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478739|NCT01874041|Antifungal Agents|antifungal agents|mesh-ancestor
92478740|NCT01874041|Keratolytic Agents|keratolytic agents|mesh-ancestor
92478741|NCT01874041|Dermatologic Agents|dermatologic agents|mesh-ancestor
92478742|NCT01874080|Metformin|metformin|mesh-list
92478743|NCT01874080|Saxagliptin|saxagliptin|mesh-list
92478744|NCT01874080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92478745|NCT01874080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478746|NCT01874080|Incretins|incretins|mesh-ancestor
92478747|NCT01874080|Hormones|hormones|mesh-ancestor
92478748|NCT01874080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478749|NCT01874080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92478750|NCT01874080|Protease Inhibitors|protease inhibitors|mesh-ancestor
92478751|NCT01874080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478752|NCT01874080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478753|NCT01874171|Cetuximab|cetuximab|mesh-list
92478754|NCT01874171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478755|NCT01874171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478756|NCT01874236|Bupivacaine|bupivacaine|mesh-list
92478757|NCT01874236|Anesthetics, Local|anesthetics, local|mesh-ancestor
92478758|NCT01874236|Anesthetics|anesthetics|mesh-ancestor
92478759|NCT01874236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478760|NCT01874236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478761|NCT01874236|Sensory System Agents|sensory system agents|mesh-ancestor
92478762|NCT01874236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478763|NCT01874314|Moxifloxacin|moxifloxacin|mesh-list
92478765|NCT01874314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478766|NCT01874314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92478767|NCT01874314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478768|NCT01874314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478769|NCT01874314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478770|NCT01874314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478771|NCT01874470|Antihypertensive Agents|antihypertensive agents|mesh-list
92478772|NCT01874470|Diuretics|diuretics|mesh-list
92478773|NCT01874470|Natriuretic Agents|natriuretic agents|mesh-ancestor
92478774|NCT01874470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478775|NCT01874561|Moxifloxacin|moxifloxacin|mesh-list
92478776|NCT01874561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478777|NCT01874561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478778|NCT01874561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92478779|NCT01874561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478780|NCT01874561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478781|NCT01874561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478782|NCT01874561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478783|NCT01874574|Triamcinolone|triamcinolone|mesh-list
92478784|NCT01874574|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92478785|NCT01874574|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92478786|NCT01874574|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92478787|NCT01874574|Hylan|hylan|mesh-list
92478788|NCT01874574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478789|NCT01874574|Glucocorticoids|glucocorticoids|mesh-ancestor
92478790|NCT01874574|Hormones|hormones|mesh-ancestor
92478791|NCT01874574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92478792|NCT01874574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478793|NCT01874574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478794|NCT01874574|Immunologic Factors|immunologic factors|mesh-ancestor
92478795|NCT01874574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478796|NCT01874574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478797|NCT01874574|Viscosupplements|viscosupplements|mesh-ancestor
92478798|NCT01874574|Protective Agents|protective agents|mesh-ancestor
92478799|NCT01874639|Hemostatics|hemostatics|mesh-list
92478800|NCT01874639|Coagulants|coagulants|mesh-ancestor
92478801|NCT01874678|Cisplatin|cisplatin|mesh-list
92478802|NCT01874678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478803|NCT01874717|Midazolam|midazolam|mesh-list
92478804|NCT01874717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92478805|NCT01874717|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92478806|NCT01874717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478807|NCT01874717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478808|NCT01874717|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92478809|NCT01874717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92478810|NCT01874717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92478811|NCT01874717|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92478812|NCT01874717|Anesthetics, General|anesthetics, general|mesh-ancestor
92478813|NCT01874717|Anesthetics|anesthetics|mesh-ancestor
92478814|NCT01874717|GABA Modulators|gaba modulators|mesh-ancestor
92478815|NCT01874717|GABA Agents|gaba agents|mesh-ancestor
92478816|NCT01874717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478817|NCT01874717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478818|NCT01874730|Anesthetics|anesthetics|mesh-list
92478819|NCT01874730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478820|NCT01874730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478821|NCT01874743|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92478822|NCT01874743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92478823|NCT01874743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92478824|NCT01874743|Antimetabolites|antimetabolites|mesh-ancestor
92478825|NCT01874743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478826|NCT01874743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92478827|NCT01874743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92478828|NCT01874743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478829|NCT01874847|Melatonin|melatonin|mesh-list
92409369|NCT05814627|Adalimumab|adalimumab|mesh-list
92478830|NCT01874847|Antioxidants|antioxidants|mesh-ancestor
92478831|NCT01874847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478832|NCT01874847|Protective Agents|protective agents|mesh-ancestor
92478833|NCT01874847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478834|NCT01874847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478835|NCT01874964|Methadone|methadone|mesh-list
92478836|NCT01874964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92478837|NCT01874964|Narcotics|narcotics|mesh-ancestor
92478838|NCT01874964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92478839|NCT01874964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478840|NCT01874964|Analgesics|analgesics|mesh-ancestor
92478841|NCT01874964|Sensory System Agents|sensory system agents|mesh-ancestor
92478842|NCT01874964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478843|NCT01874964|Antitussive Agents|antitussive agents|mesh-ancestor
92478844|NCT01874964|Respiratory System Agents|respiratory system agents|mesh-ancestor
92478846|NCT01875107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92478847|NCT01875107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478848|NCT01875172|Bupropion|bupropion|mesh-list
92478849|NCT01875172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92478850|NCT01875172|Antidepressive Agents|antidepressive agents|mesh-ancestor
92478851|NCT01875172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92478852|NCT01875172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92478853|NCT01875172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92478854|NCT01875172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92478855|NCT01875172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478857|NCT01875172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92478858|NCT01875172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478859|NCT01875172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92478860|NCT01875172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92478861|NCT01875172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478862|NCT01875185|Aspirin|aspirin|mesh-list
92478863|NCT01875185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92478864|NCT01875185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92478865|NCT01875185|Analgesics|analgesics|mesh-ancestor
92478866|NCT01875185|Sensory System Agents|sensory system agents|mesh-ancestor
92478867|NCT01875185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478868|NCT01875185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478869|NCT01875185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478870|NCT01875185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478871|NCT01875185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92478872|NCT01875185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92478873|NCT01875185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478874|NCT01875185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92478875|NCT01875185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92478876|NCT01875185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478877|NCT01875185|Antipyretics|antipyretics|mesh-ancestor
92478878|NCT01875224|Abatacept|abatacept|mesh-list
92478879|NCT01875224|Tacrolimus|tacrolimus|mesh-list
92478880|NCT01875224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478881|NCT01875224|Immunologic Factors|immunologic factors|mesh-ancestor
92478882|NCT01875224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478883|NCT01875224|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92478884|NCT01875224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478885|NCT01875224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478886|NCT01875224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92478887|NCT01875224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478888|NCT01875224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478889|NCT01875224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478890|NCT01875263|Levofloxacin|levofloxacin|mesh-list
92478891|NCT01875263|Cloxacillin|cloxacillin|mesh-list
92478892|NCT01875263|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92478893|NCT01875263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478894|NCT01875263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478895|NCT01875263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92478896|NCT01875263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92478897|NCT01875263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478898|NCT01875263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478899|NCT01875263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478900|NCT01875263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92478901|NCT01875263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92478902|NCT01875653|Molgramostim|molgramostim|mesh-list
92478903|NCT01875653|Sargramostim|sargramostim|mesh-list
92478904|NCT01875653|Immunologic Factors|immunologic factors|mesh-ancestor
92478905|NCT01875653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478906|NCT01875653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478907|NCT01875666|Trastuzumab|trastuzumab|mesh-list
92478908|NCT01875666|Pertuzumab|pertuzumab|mesh-list
92478909|NCT01875666|Lapatinib|lapatinib|mesh-list
92478910|NCT01875666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92478911|NCT01875666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203815|NCT02991599|Vaccines|vaccines|mesh-list
92478912|NCT01875666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478913|NCT01875666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478914|NCT01875666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478915|NCT01875705|Ravoxertinib|ravoxertinib|mesh-list
92478916|NCT01875705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478917|NCT01875705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92478918|NCT01875705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478919|NCT01875705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478920|NCT01875757|Vitamin D|vitamin d|mesh-list
92478921|NCT01875757|Cholecalciferol|cholecalciferol|mesh-list
92478922|NCT01875757|Vitamins|vitamins|mesh-ancestor
92478923|NCT01875757|Micronutrients|micronutrients|mesh-ancestor
92478925|NCT01875757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92478926|NCT01875757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92478927|NCT01875822|Curcumin|curcumin|mesh-list
92478928|NCT01875822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92478929|NCT01875822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92478930|NCT01875822|Analgesics|analgesics|mesh-ancestor
92478931|NCT01875822|Sensory System Agents|sensory system agents|mesh-ancestor
92478932|NCT01875822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478933|NCT01875822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478934|NCT01875822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478935|NCT01875822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478936|NCT01875822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478937|NCT01875822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478938|NCT01875822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478939|NCT01875926|Gontivimab|gontivimab|mesh-list
92478940|NCT01875926|Antiviral Agents|antiviral agents|mesh-ancestor
92478941|NCT01875926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478942|NCT01875939|Levonadifloxacin|levonadifloxacin|mesh-list
92478943|NCT01875939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92478944|NCT01875939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478945|NCT01875939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478946|NCT01875939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478947|NCT01875939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478948|NCT01875952|Isoniazid|isoniazid|mesh-list
92478949|NCT01875952|Antitubercular Agents|antitubercular agents|mesh-ancestor
92478950|NCT01875952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478951|NCT01875952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478952|NCT01875952|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92478953|NCT01875952|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92478954|NCT01875952|Antimetabolites|antimetabolites|mesh-ancestor
92478955|NCT01875952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478956|NCT01875952|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92478957|NCT01876004|Methotrexate|methotrexate|mesh-list
92478958|NCT01876004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92478959|NCT01876004|Abortifacient Agents|abortifacient agents|mesh-ancestor
92478960|NCT01876004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92478961|NCT01876004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478962|NCT01876004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92478963|NCT01876004|Antimetabolites|antimetabolites|mesh-ancestor
92478964|NCT01876004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478965|NCT01876004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92478966|NCT01876004|Dermatologic Agents|dermatologic agents|mesh-ancestor
92478967|NCT01876004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478968|NCT01876004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92478969|NCT01876004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92478970|NCT01876004|Immunologic Factors|immunologic factors|mesh-ancestor
92478971|NCT01876004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478972|NCT01876004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92478973|NCT01876108|Amoxicillin|amoxicillin|mesh-list
92478974|NCT01876108|Azithromycin|azithromycin|mesh-list
92478975|NCT01876108|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92478976|NCT01876108|Omeprazole|omeprazole|mesh-list
92478977|NCT01876108|Bismuth|bismuth|mesh-list
92478978|NCT01876108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92478979|NCT01876108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92478980|NCT01876108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92478981|NCT01876108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92478982|NCT01876108|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92478983|NCT01876108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92478984|NCT01876108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478985|NCT01876108|Antacids|antacids|mesh-ancestor
92203878|NCT01278017|Ceftriaxone|ceftriaxone|mesh-list
92478986|NCT01876121|Celecoxib|celecoxib|mesh-list
92478987|NCT01876121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92478988|NCT01876121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92478989|NCT01876121|Analgesics|analgesics|mesh-ancestor
92478990|NCT01876121|Sensory System Agents|sensory system agents|mesh-ancestor
92478991|NCT01876121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92478992|NCT01876121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92478993|NCT01876121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92478994|NCT01876121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92478995|NCT01876121|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92478996|NCT01876121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92478998|NCT01876121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92478999|NCT01876186|Solifenacin Succinate|solifenacin succinate|mesh-list
92479000|NCT01876186|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92479001|NCT01876186|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92479002|NCT01876186|Cholinergic Agents|cholinergic agents|mesh-ancestor
92479003|NCT01876186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479004|NCT01876186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479005|NCT01876186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479006|NCT01876186|Urological Agents|urological agents|mesh-ancestor
92479007|NCT01876290|Dexamethasone|dexamethasone|mesh-list
92479008|NCT01876290|Ondansetron|ondansetron|mesh-list
92479009|NCT01876290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479010|NCT01876290|Antiemetics|antiemetics|mesh-ancestor
92479011|NCT01876290|Autonomic Agents|autonomic agents|mesh-ancestor
92479012|NCT01876290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479013|NCT01876290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479014|NCT01876290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479015|NCT01876290|Glucocorticoids|glucocorticoids|mesh-ancestor
92479016|NCT01876290|Hormones|hormones|mesh-ancestor
92479017|NCT01876290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479018|NCT01876290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479019|NCT01876290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479020|NCT01876290|Antipruritics|antipruritics|mesh-ancestor
92479021|NCT01876290|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479022|NCT01876290|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92479023|NCT01876290|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92479024|NCT01876290|Serotonin Agents|serotonin agents|mesh-ancestor
92479025|NCT01876290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479026|NCT01876290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479027|NCT01876316|Moxifloxacin|moxifloxacin|mesh-list
92479028|NCT01876316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479029|NCT01876316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479030|NCT01876316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92479031|NCT01876316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92479032|NCT01876316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479033|NCT01876316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479034|NCT01876316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479035|NCT01876433|Mirabegron|mirabegron|mesh-list
92479036|NCT01876433|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92479037|NCT01876433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92479038|NCT01876433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92479039|NCT01876433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92479040|NCT01876433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479041|NCT01876433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479042|NCT01876433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479043|NCT01876433|Urological Agents|urological agents|mesh-ancestor
92479044|NCT01876550|Mupirocin|mupirocin|mesh-list
92479045|NCT01876550|Calcium|calcium|mesh-list
92479046|NCT01876550|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479047|NCT01876550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479048|NCT01876550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479049|NCT01876550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479050|NCT01876550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92479051|NCT01876550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479052|NCT01876550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479053|NCT01876563|Vitamin D|vitamin d|mesh-list
92479054|NCT01876563|Vitamins|vitamins|mesh-ancestor
92479055|NCT01876563|Micronutrients|micronutrients|mesh-ancestor
92479056|NCT01876563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479057|NCT01876563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92479058|NCT01876615|Diclofenac|diclofenac|mesh-list
92479059|NCT01876615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92479060|NCT01876615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92479061|NCT01876615|Analgesics|analgesics|mesh-ancestor
92479062|NCT01876615|Sensory System Agents|sensory system agents|mesh-ancestor
92479063|NCT01876615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479064|NCT01876615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479065|NCT01876615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479066|NCT01876615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479067|NCT01876615|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92479068|NCT01876615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479069|NCT01876615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479072|NCT01876641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479073|NCT01876641|Antimetabolites|antimetabolites|mesh-ancestor
92479074|NCT01876641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479075|NCT01876641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479076|NCT01876641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479077|NCT01876641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92479078|NCT01876797|Ticagrelor|ticagrelor|mesh-list
92479079|NCT01876797|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92479080|NCT01876797|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92479081|NCT01876797|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92479082|NCT01876797|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92479083|NCT01876797|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92479084|NCT01876797|Purinergic Agents|purinergic agents|mesh-ancestor
92479085|NCT01876797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479086|NCT01876797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479087|NCT01876797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479088|NCT01876849|Exenatide|exenatide|mesh-list
92479089|NCT01876849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92479090|NCT01876849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479091|NCT01876849|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92479092|NCT01876849|Incretins|incretins|mesh-ancestor
92479093|NCT01876849|Hormones|hormones|mesh-ancestor
92479094|NCT01876849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479095|NCT01876862|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92479096|NCT01876862|Antiviral Agents|antiviral agents|mesh-ancestor
92479097|NCT01876862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479098|NCT01876966|Ritonavir|ritonavir|mesh-list
92479099|NCT01876966|Darunavir|darunavir|mesh-list
92479100|NCT01876966|Lumefantrine|lumefantrine|mesh-list
92479101|NCT01876966|Artemether|artemether|mesh-list
92479102|NCT01876966|Etravirine|etravirine|mesh-list
92479103|NCT01876966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92479104|NCT01876966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92479105|NCT01876966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92479106|NCT01876966|Protease Inhibitors|protease inhibitors|mesh-ancestor
92479107|NCT01876966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479108|NCT01876966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479109|NCT01876966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92479110|NCT01876966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92479111|NCT01876966|Antiviral Agents|antiviral agents|mesh-ancestor
92479112|NCT01876966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479113|NCT01876966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92479114|NCT01876966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92479115|NCT01876966|Antimalarials|antimalarials|mesh-ancestor
92479116|NCT01876966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92479117|NCT01876966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92479118|NCT01876966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92479119|NCT01876966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92479120|NCT01877122|Ibuprofen|ibuprofen|mesh-list
92479121|NCT01877122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92479122|NCT01877122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92479123|NCT01877122|Analgesics|analgesics|mesh-ancestor
92479124|NCT01877122|Sensory System Agents|sensory system agents|mesh-ancestor
92479125|NCT01877122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479126|NCT01877122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479127|NCT01877122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479128|NCT01877122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479129|NCT01877122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92479130|NCT01877122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479131|NCT01877122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479132|NCT01877226|Tapentadol|tapentadol|mesh-list
92479133|NCT01877226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204024|NCT02994875|Antidotes|antidotes|mesh-ancestor
92479135|NCT01877226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479136|NCT01877226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479137|NCT01877226|Analgesics|analgesics|mesh-ancestor
92479138|NCT01877226|Sensory System Agents|sensory system agents|mesh-ancestor
92479139|NCT01877226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479140|NCT01877226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92479141|NCT01877226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92479142|NCT01877226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479143|NCT01877226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479144|NCT01877226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92479145|NCT01877226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479146|NCT01877356|Anesthetics|anesthetics|mesh-list
92479147|NCT01877356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479148|NCT01877356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479149|NCT01877512|Hormones|hormones|mesh-list
92479150|NCT01877512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479151|NCT01877512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479152|NCT01877577|Vitamin D|vitamin d|mesh-list
92479153|NCT01877577|Ergocalciferols|ergocalciferols|mesh-list
92479154|NCT01877577|Cholecalciferol|cholecalciferol|mesh-list
92479155|NCT01877577|Vitamins|vitamins|mesh-list
92479156|NCT01877577|Micronutrients|micronutrients|mesh-ancestor
92479157|NCT01877577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479158|NCT01877577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92479159|NCT01877577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479160|NCT01877590|Thioctic Acid|thioctic acid|mesh-list
92479161|NCT01877590|Antioxidants|antioxidants|mesh-ancestor
92479162|NCT01877590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479163|NCT01877590|Protective Agents|protective agents|mesh-ancestor
92479164|NCT01877590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479165|NCT01877590|Vitamin B Complex|vitamin b complex|mesh-ancestor
92479166|NCT01877590|Vitamins|vitamins|mesh-ancestor
92479167|NCT01877590|Micronutrients|micronutrients|mesh-ancestor
92479168|NCT01877746|Prednisone|prednisone|mesh-list
92479169|NCT01877746|Azathioprine|azathioprine|mesh-list
92479170|NCT01877746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479171|NCT01877746|Glucocorticoids|glucocorticoids|mesh-ancestor
92479172|NCT01877746|Hormones|hormones|mesh-ancestor
92479173|NCT01877746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479174|NCT01877746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479175|NCT01877746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479176|NCT01877746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479177|NCT01877746|Antimetabolites|antimetabolites|mesh-ancestor
92479178|NCT01877746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479179|NCT01877746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479180|NCT01877746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479181|NCT01877746|Immunologic Factors|immunologic factors|mesh-ancestor
92479182|NCT01877746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479183|NCT01877811|Agerafenib|agerafenib|mesh-list
92479184|NCT01877811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92479185|NCT01877811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479186|NCT01877811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479187|NCT01877889|Dapagliflozin|dapagliflozin|mesh-list
92479188|NCT01877889|Canagliflozin|canagliflozin|mesh-list
92479189|NCT01877889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92479190|NCT01877889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479191|NCT01877889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92479192|NCT01877889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479193|NCT01877954|Fluticasone|fluticasone|mesh-list
92479194|NCT01877954|Xhance|xhance|mesh-list
92479195|NCT01877954|Beclomethasone|beclomethasone|mesh-list
92479196|NCT01877954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479197|NCT01877954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92479198|NCT01877954|Autonomic Agents|autonomic agents|mesh-ancestor
92479199|NCT01877954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479200|NCT01877954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479201|NCT01877954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92479202|NCT01877954|Respiratory System Agents|respiratory system agents|mesh-ancestor
92479203|NCT01877954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479204|NCT01877954|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92479205|NCT01877954|Glucocorticoids|glucocorticoids|mesh-ancestor
92479206|NCT01877954|Hormones|hormones|mesh-ancestor
92479207|NCT01877954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479208|NCT01878136|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92479209|NCT01878136|Plasminogen|plasminogen|mesh-list
92479210|NCT01878136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92479211|NCT01878136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92479212|NCT01878136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479213|NCT01878188|BCG Vaccine|bcg vaccine|mesh-list
92479214|NCT01878188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92479215|NCT01878188|Immunologic Factors|immunologic factors|mesh-ancestor
92479217|NCT01878201|Valsartan|valsartan|mesh-list
92479218|NCT01878201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92479219|NCT01878201|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92479220|NCT01878201|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92479221|NCT01878201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479222|NCT01878227|Fenofibrate|fenofibrate|mesh-list
92479223|NCT01878227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92479224|NCT01878227|Antimetabolites|antimetabolites|mesh-ancestor
92479225|NCT01878227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479226|NCT01878227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92479227|NCT01878318|Methotrexate|methotrexate|mesh-list
92479228|NCT01878318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92479229|NCT01878318|Abortifacient Agents|abortifacient agents|mesh-ancestor
92479230|NCT01878318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92479231|NCT01878318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479232|NCT01878318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479233|NCT01878318|Antimetabolites|antimetabolites|mesh-ancestor
92531913|NCT05640791|Antimetabolites|antimetabolites|mesh-ancestor
92479234|NCT01878318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479235|NCT01878318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479236|NCT01878318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479237|NCT01878318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479238|NCT01878318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92479239|NCT01878318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479240|NCT01878318|Immunologic Factors|immunologic factors|mesh-ancestor
92479241|NCT01878318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479242|NCT01878318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92479243|NCT01878357|Primaquine|primaquine|mesh-list
92479244|NCT01878357|Piperaquine|piperaquine|mesh-list
92479245|NCT01878357|Artenimol|artenimol|mesh-list
92479246|NCT01878357|Antimalarials|antimalarials|mesh-ancestor
92479247|NCT01878357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92479248|NCT01878357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92479249|NCT01878357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479250|NCT01878422|Leucovorin|leucovorin|mesh-list
92479251|NCT01878422|Bevacizumab|bevacizumab|mesh-list
92479252|NCT01878422|Cetuximab|cetuximab|mesh-list
92479253|NCT01878422|Fluorouracil|fluorouracil|mesh-list
92479254|NCT01878422|Oxaliplatin|oxaliplatin|mesh-list
92479255|NCT01878422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92479256|NCT01878422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479257|NCT01878422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92479258|NCT01878422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92479259|NCT01878422|Growth Substances|growth substances|mesh-ancestor
92479260|NCT01878422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479261|NCT01878422|Growth Inhibitors|growth inhibitors|mesh-ancestor
92479262|NCT01878422|Antimetabolites|antimetabolites|mesh-ancestor
92479263|NCT01878422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479264|NCT01878422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479265|NCT01878422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479266|NCT01878422|Immunologic Factors|immunologic factors|mesh-ancestor
92479267|NCT01878422|Antidotes|antidotes|mesh-ancestor
92479268|NCT01878422|Protective Agents|protective agents|mesh-ancestor
92479269|NCT01878422|Vitamin B Complex|vitamin b complex|mesh-ancestor
92479270|NCT01878422|Vitamins|vitamins|mesh-ancestor
92479271|NCT01878422|Micronutrients|micronutrients|mesh-ancestor
92479272|NCT01878513|Risperidone|risperidone|mesh-list
92479273|NCT01878513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92479274|NCT01878513|Serotonin Agents|serotonin agents|mesh-ancestor
92479275|NCT01878513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348990|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479276|NCT01878513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479277|NCT01878513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479278|NCT01878513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92479279|NCT01878513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92479280|NCT01878513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479281|NCT01878513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92479282|NCT01878513|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92204169|NCT02144675|Salicylates|salicylates|mesh-list
92479283|NCT01878513|Dopamine Agents|dopamine agents|mesh-ancestor
92479285|NCT01878578|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92479286|NCT01878578|Phenytoin|phenytoin|mesh-list
92479287|NCT01878578|Anticonvulsants|anticonvulsants|mesh-ancestor
92479288|NCT01878578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92479289|NCT01878578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92479290|NCT01878578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479291|NCT01878578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479293|NCT01878578|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92479294|NCT01878643|Vancomycin|vancomycin|mesh-list
92479295|NCT01878643|Gentamicins|gentamicins|mesh-list
92479296|NCT01878643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479297|NCT01878643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479298|NCT01878643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92479299|NCT01878643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479300|NCT01878643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479301|NCT01878695|Acetylcysteine|acetylcysteine|mesh-list
92479302|NCT01878695|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92479303|NCT01878695|Antiviral Agents|antiviral agents|mesh-ancestor
92479304|NCT01878695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479305|NCT01878695|Expectorants|expectorants|mesh-ancestor
92479306|NCT01878695|Respiratory System Agents|respiratory system agents|mesh-ancestor
92479307|NCT01878695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92479308|NCT01878695|Antioxidants|antioxidants|mesh-ancestor
92479309|NCT01878695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479310|NCT01878695|Protective Agents|protective agents|mesh-ancestor
92479311|NCT01878695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479312|NCT01878695|Antidotes|antidotes|mesh-ancestor
92479313|NCT01878708|Dexamethasone|dexamethasone|mesh-list
92479314|NCT01878708|Dexamethasone acetate|dexamethasone acetate|mesh-list
92479315|NCT01878708|Asparaginase|asparaginase|mesh-list
92479316|NCT01878708|Pegaspargase|pegaspargase|mesh-list
92479317|NCT01878708|BB 1101|bb 1101|mesh-list
92479318|NCT01878708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479319|NCT01878708|Antiemetics|antiemetics|mesh-ancestor
92479320|NCT01878708|Autonomic Agents|autonomic agents|mesh-ancestor
92479321|NCT01878708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479322|NCT01878708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479323|NCT01878708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479324|NCT01878708|Glucocorticoids|glucocorticoids|mesh-ancestor
92479325|NCT01878708|Hormones|hormones|mesh-ancestor
92479326|NCT01878708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479327|NCT01878708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479328|NCT01878708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479329|NCT01878708|Protease Inhibitors|protease inhibitors|mesh-ancestor
92479330|NCT01878708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479331|NCT01878708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479332|NCT01878734|Micronutrients|micronutrients|mesh-list
92479333|NCT01878734|Trace Elements|trace elements|mesh-list
92479334|NCT01878734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479335|NCT01878864|Lidocaine|lidocaine|mesh-list
92479336|NCT01878864|Bupivacaine|bupivacaine|mesh-list
92479337|NCT01878864|Anesthetics, Local|anesthetics, local|mesh-ancestor
92479338|NCT01878864|Anesthetics|anesthetics|mesh-ancestor
92479339|NCT01878864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479340|NCT01878864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479341|NCT01878864|Sensory System Agents|sensory system agents|mesh-ancestor
92479342|NCT01878864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479343|NCT01878864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92479344|NCT01878864|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92479345|NCT01878864|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92479346|NCT01878864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479347|NCT01878864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348993|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479348|NCT01878942|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92479349|NCT01878942|Hallucinogens|hallucinogens|mesh-ancestor
92479350|NCT01878942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479351|NCT01878942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92479352|NCT01878942|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92479353|NCT01878942|Serotonin Agents|serotonin agents|mesh-ancestor
92479354|NCT01878942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479355|NCT01878942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479356|NCT01878942|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92479357|NCT01879007|Gemifloxacin|gemifloxacin|mesh-list
92479358|NCT01879007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479359|NCT01879007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479360|NCT01879007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92479361|NCT01879007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92479362|NCT01879007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479363|NCT01879007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479364|NCT01879007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479365|NCT01879033|Insulin|insulin|mesh-list
92479366|NCT01879033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92479367|NCT01879033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479368|NCT01879202|Methylphenidate|methylphenidate|mesh-list
92479369|NCT01879202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92479370|NCT01879202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479371|NCT01879202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92479372|NCT01879202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92479373|NCT01879202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479374|NCT01879202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479375|NCT01879202|Dopamine Agents|dopamine agents|mesh-ancestor
92479376|NCT01879202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479377|NCT01879293|Metformin|metformin|mesh-list
92479378|NCT01879293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92479379|NCT01879293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479380|NCT01879358|Sirolimus|sirolimus|mesh-list
92479381|NCT01879358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479382|NCT01879358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479383|NCT01879358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92479384|NCT01879358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479385|NCT01879358|Antifungal Agents|antifungal agents|mesh-ancestor
92479386|NCT01879358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479387|NCT01879358|Immunologic Factors|immunologic factors|mesh-ancestor
92479388|NCT01879358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479389|NCT01879423|Lamotrigine|lamotrigine|mesh-list
92479390|NCT01879423|Anticonvulsants|anticonvulsants|mesh-list
92479391|NCT01879423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92479392|NCT01879423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479393|NCT01879423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479394|NCT01879423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479395|NCT01879423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479396|NCT01879423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92479397|NCT01879423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92479398|NCT01879423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479399|NCT01879423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92479400|NCT01879423|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92479401|NCT01879488|Edetic Acid|edetic acid|mesh-list
92479402|NCT01879488|Pentetic Acid|pentetic acid|mesh-list
92479403|NCT01879488|Antidotes|antidotes|mesh-ancestor
92479404|NCT01879488|Protective Agents|protective agents|mesh-ancestor
92479405|NCT01879488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479406|NCT01879488|Chelating Agents|chelating agents|mesh-ancestor
92479407|NCT01879488|Sequestering Agents|sequestering agents|mesh-ancestor
92479408|NCT01879488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479409|NCT01879488|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92479410|NCT01879488|Anticoagulants|anticoagulants|mesh-ancestor
92479411|NCT01879488|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92479412|NCT01879514|Prednisone|prednisone|mesh-list
92479413|NCT01879514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479414|NCT01879514|Glucocorticoids|glucocorticoids|mesh-ancestor
92479415|NCT01879514|Hormones|hormones|mesh-ancestor
92479416|NCT01879514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479417|NCT01879514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479418|NCT01879514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479419|NCT01879514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479420|NCT01879527|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92479421|NCT01879527|Amiloride|amiloride|mesh-list
92479422|NCT01879527|Amiloride, hydrochlorothiazide drug combination|amiloride, hydrochlorothiazide drug combination|mesh-list
92479423|NCT01879527|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92479424|NCT01879527|Diuretics|diuretics|mesh-ancestor
92479425|NCT01879527|Natriuretic Agents|natriuretic agents|mesh-ancestor
92479426|NCT01879527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479427|NCT01879527|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92479428|NCT01879527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479429|NCT01879527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479430|NCT01879527|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92204319|NCT00735449|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92479431|NCT01879527|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92479432|NCT01879527|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92479433|NCT01879527|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92479434|NCT01879605|Bisacodyl|bisacodyl|mesh-list
92479435|NCT01879605|Sorbitol|sorbitol|mesh-list
92479436|NCT01879605|Cathartics|cathartics|mesh-ancestor
92479437|NCT01879605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479438|NCT01879605|Laxatives|laxatives|mesh-ancestor
92479439|NCT01879748|Rasagiline|rasagiline|mesh-list
92479440|NCT01879748|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92479441|NCT01879748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479442|NCT01879748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479443|NCT01879748|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92479444|NCT01879748|Protective Agents|protective agents|mesh-ancestor
92479445|NCT01879748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479446|NCT01879917|Liraglutide|liraglutide|mesh-list
92479447|NCT01879917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92479448|NCT01879917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479449|NCT01879917|Incretins|incretins|mesh-ancestor
92479450|NCT01879917|Hormones|hormones|mesh-ancestor
92479451|NCT01879917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479452|NCT01879930|Doxycycline|doxycycline|mesh-list
92479453|NCT01879930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479454|NCT01879930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479455|NCT01879930|Antimalarials|antimalarials|mesh-ancestor
92479456|NCT01879930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92479457|NCT01879930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92479458|NCT01880112|Cefazolin|cefazolin|mesh-list
92479459|NCT01880112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479460|NCT01880112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479461|NCT01880125|Acetaminophen|acetaminophen|mesh-list
92479462|NCT01880125|Tramadol|tramadol|mesh-list
92479463|NCT01880125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92479464|NCT01880125|Analgesics|analgesics|mesh-ancestor
92479465|NCT01880125|Sensory System Agents|sensory system agents|mesh-ancestor
92479466|NCT01880125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479467|NCT01880125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479468|NCT01880125|Antipyretics|antipyretics|mesh-ancestor
92479469|NCT01880125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92479470|NCT01880125|Narcotics|narcotics|mesh-ancestor
92479471|NCT01880125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479472|NCT01880138|Anesthetics|anesthetics|mesh-list
92479473|NCT01880138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479474|NCT01880138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479475|NCT01880216|Enoxaparin|enoxaparin|mesh-list
92479476|NCT01880216|Enoxaparin sodium|enoxaparin sodium|mesh-list
92479477|NCT01880216|Bemiparin|bemiparin|mesh-list
92479478|NCT01880216|Anticoagulants|anticoagulants|mesh-ancestor
92479479|NCT01880216|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92479480|NCT01880216|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92479481|NCT01880216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479482|NCT01880307|Prednisolone|prednisolone|mesh-list
92479483|NCT01880307|Infliximab|infliximab|mesh-list
92479484|NCT01880307|Azathioprine|azathioprine|mesh-list
92479485|NCT01880307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479486|NCT01880307|Glucocorticoids|glucocorticoids|mesh-ancestor
92479487|NCT01880307|Hormones|hormones|mesh-ancestor
92479488|NCT01880307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479489|NCT01880307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479490|NCT01880307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479491|NCT01880307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479492|NCT01880307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479493|NCT01880307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92479494|NCT01880307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479495|NCT01880307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479496|NCT01880307|Antimetabolites|antimetabolites|mesh-ancestor
92479497|NCT01880307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479498|NCT01880307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479499|NCT01880307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479500|NCT01880307|Immunologic Factors|immunologic factors|mesh-ancestor
92479501|NCT01880346|Vitamin D|vitamin d|mesh-list
92479502|NCT01880346|Ergocalciferols|ergocalciferols|mesh-list
92479503|NCT01880346|Cholecalciferol|cholecalciferol|mesh-list
92479504|NCT01880346|Vitamins|vitamins|mesh-list
92479505|NCT01880346|Micronutrients|micronutrients|mesh-ancestor
92479506|NCT01880346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479507|NCT01880346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92479508|NCT01880346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479509|NCT01880372|Thioctic Acid|thioctic acid|mesh-list
92479510|NCT01880372|Antioxidants|antioxidants|mesh-ancestor
92479511|NCT01880372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479512|NCT01880372|Protective Agents|protective agents|mesh-ancestor
92479513|NCT01880372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479514|NCT01880372|Vitamin B Complex|vitamin b complex|mesh-ancestor
92479515|NCT01880372|Vitamins|vitamins|mesh-ancestor
92479516|NCT01880372|Micronutrients|micronutrients|mesh-ancestor
92479517|NCT01880385|Cyclophosphamide|cyclophosphamide|mesh-list
92479518|NCT01880385|Bevacizumab|bevacizumab|mesh-list
92479519|NCT01880385|Docetaxel|docetaxel|mesh-list
92479520|NCT01880385|Fluorouracil|fluorouracil|mesh-list
92479521|NCT01880385|Trastuzumab|trastuzumab|mesh-list
92479522|NCT01880385|Epirubicin|epirubicin|mesh-list
92479523|NCT01880385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479524|NCT01880385|Immunologic Factors|immunologic factors|mesh-ancestor
92479525|NCT01880385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479526|NCT01880385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479527|NCT01880385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92479528|NCT01880385|Alkylating Agents|alkylating agents|mesh-ancestor
92479529|NCT01880385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479530|NCT01880385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479531|NCT01880385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92479532|NCT01880385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92479533|NCT01880385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92479534|NCT01880385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92479536|NCT01880385|Growth Inhibitors|growth inhibitors|mesh-ancestor
92479537|NCT01880385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92479538|NCT01880385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92479539|NCT01880385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92479540|NCT01880385|Antimetabolites|antimetabolites|mesh-ancestor
92479541|NCT01880385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479542|NCT01880385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92479543|NCT01880385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92479544|NCT01880385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92479545|NCT01880385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479546|NCT01880463|Vitamin D|vitamin d|mesh-list
92479547|NCT01880463|Ergocalciferols|ergocalciferols|mesh-list
92479548|NCT01880463|Cholecalciferol|cholecalciferol|mesh-list
92479549|NCT01880463|Vitamins|vitamins|mesh-list
92479550|NCT01880463|Micronutrients|micronutrients|mesh-ancestor
92479551|NCT01880463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479552|NCT01880463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92479553|NCT01880463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479554|NCT01880619|Tamsulosin|tamsulosin|mesh-list
92479555|NCT01880619|Solifenacin Succinate|solifenacin succinate|mesh-list
92479556|NCT01880619|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92479557|NCT01880619|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92479558|NCT01880619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92479559|NCT01880619|Adrenergic Agents|adrenergic agents|mesh-ancestor
92479560|NCT01880619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479561|NCT01880619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479562|NCT01880619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479563|NCT01880619|Urological Agents|urological agents|mesh-ancestor
92479564|NCT01880619|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92479565|NCT01880619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92479566|NCT01880619|Cholinergic Agents|cholinergic agents|mesh-ancestor
92479567|NCT01880658|Capecitabine|capecitabine|mesh-list
92479568|NCT01880658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479569|NCT01880658|Antimetabolites|antimetabolites|mesh-ancestor
92479570|NCT01880658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479571|NCT01880658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479572|NCT01880749|Everolimus|everolimus|mesh-list
92479573|NCT01880749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92479574|NCT01880749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92479575|NCT01880749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479576|NCT01880749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479577|NCT01880749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479578|NCT01880749|Immunologic Factors|immunologic factors|mesh-ancestor
92479579|NCT01880749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479580|NCT01880749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479581|NCT01880775|Bupivacaine|bupivacaine|mesh-list
92479582|NCT01880775|Prilocaine|prilocaine|mesh-list
92479583|NCT01880775|Anesthetics, Local|anesthetics, local|mesh-ancestor
92479584|NCT01880775|Anesthetics|anesthetics|mesh-ancestor
92479585|NCT01880775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479586|NCT01880775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479587|NCT01880775|Sensory System Agents|sensory system agents|mesh-ancestor
92479588|NCT01880775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479589|NCT01879241|Rasagiline|rasagiline|mesh-list
92479590|NCT01879241|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92479591|NCT01879241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479592|NCT01879241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479593|NCT01879241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92479594|NCT01879241|Protective Agents|protective agents|mesh-ancestor
92479595|NCT01879241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479597|NCT01880931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92479598|NCT01880931|Narcotics|narcotics|mesh-ancestor
92479599|NCT01880931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479600|NCT01880931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479601|NCT01880931|Analgesics|analgesics|mesh-ancestor
92479602|NCT01880931|Sensory System Agents|sensory system agents|mesh-ancestor
92479603|NCT01880931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479604|NCT01881074|Listerine|listerine|mesh-list
92479605|NCT01881074|Triclosan|triclosan|mesh-list
92479606|NCT01881074|Sodium Fluoride|sodium fluoride|mesh-list
92479607|NCT01881074|Cariostatic Agents|cariostatic agents|mesh-ancestor
92479608|NCT01881074|Protective Agents|protective agents|mesh-ancestor
92479609|NCT01881074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479610|NCT01881074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92479611|NCT01881074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479612|NCT01881074|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92479613|NCT01881074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92479614|NCT01881074|Antimetabolites|antimetabolites|mesh-ancestor
92479615|NCT01881074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479616|NCT01881074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92479617|NCT01881100|Listerine|listerine|mesh-list
92479618|NCT01881100|Fluorides|fluorides|mesh-list
92479619|NCT01881100|Fluorides, Topical|fluorides, topical|mesh-list
92479620|NCT01881100|Sodium Fluoride|sodium fluoride|mesh-list
92479621|NCT01881100|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92479622|NCT01881100|Cariostatic Agents|cariostatic agents|mesh-ancestor
92479623|NCT01881100|Protective Agents|protective agents|mesh-ancestor
92479624|NCT01881100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479625|NCT01881100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92479626|NCT01881100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479627|NCT01881347|Resveratrol|resveratrol|mesh-list
92479628|NCT01881347|Antioxidants|antioxidants|mesh-ancestor
92479629|NCT01881347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479630|NCT01881347|Protective Agents|protective agents|mesh-ancestor
92479631|NCT01881347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479632|NCT01881347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479633|NCT01881347|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92479634|NCT01881464|Adalimumab|adalimumab|mesh-list
92479635|NCT01881464|Infliximab|infliximab|mesh-list
92479636|NCT01881464|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92479637|NCT01881464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479638|NCT01881464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479639|NCT01881464|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479640|NCT01881464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479641|NCT01881503|HBOC 201|hboc 201|mesh-list
92479642|NCT01881503|Blood Substitutes|blood substitutes|mesh-ancestor
92479643|NCT01881568|Tranexamic Acid|tranexamic acid|mesh-list
92479644|NCT01881568|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92479645|NCT01881568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92479646|NCT01881568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479647|NCT01881568|Hemostatics|hemostatics|mesh-ancestor
92479648|NCT01881568|Coagulants|coagulants|mesh-ancestor
92479649|NCT01881919|Quercetin|quercetin|mesh-list
92479650|NCT01881919|Antioxidants|antioxidants|mesh-ancestor
92479651|NCT01881919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479652|NCT01881919|Protective Agents|protective agents|mesh-ancestor
92479653|NCT01881919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479654|NCT01881971|Calcium|calcium|mesh-list
92479655|NCT01881971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479656|NCT01881971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479657|NCT01881997|Fentanyl|fentanyl|mesh-list
92479658|NCT01881997|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92479659|NCT01881997|Narcotics|narcotics|mesh-ancestor
92479660|NCT01881997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479661|NCT01881997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204545|NCT00762853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92479662|NCT01881997|Analgesics|analgesics|mesh-ancestor
92479663|NCT01881997|Sensory System Agents|sensory system agents|mesh-ancestor
92322554|NCT04713254|Anesthetics|anesthetics|mesh-ancestor
92479665|NCT01881997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92479666|NCT01881997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92479667|NCT01881997|Anesthetics, General|anesthetics, general|mesh-ancestor
92479668|NCT01881997|Anesthetics|anesthetics|mesh-ancestor
92479669|NCT01882010|Sargramostim|sargramostim|mesh-list
92479670|NCT01882010|Immunologic Factors|immunologic factors|mesh-ancestor
92479671|NCT01882010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479672|NCT01882075|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92479673|NCT01882075|Plasma Substitutes|plasma substitutes|mesh-ancestor
92479674|NCT01882075|Blood Substitutes|blood substitutes|mesh-ancestor
92479675|NCT01882127|Dexamethasone|dexamethasone|mesh-list
92479676|NCT01882127|Tretinoin|tretinoin|mesh-list
92479677|NCT01882127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479678|NCT01882127|Antiemetics|antiemetics|mesh-ancestor
92479679|NCT01882127|Autonomic Agents|autonomic agents|mesh-ancestor
92479680|NCT01882127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479681|NCT01882127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479682|NCT01882127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479683|NCT01882127|Glucocorticoids|glucocorticoids|mesh-ancestor
92479684|NCT01882127|Hormones|hormones|mesh-ancestor
92479685|NCT01882127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479686|NCT01882127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479687|NCT01882127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479688|NCT01882127|Keratolytic Agents|keratolytic agents|mesh-ancestor
92479689|NCT01882127|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479690|NCT01882179|Canrenoic Acid|canrenoic acid|mesh-list
92479691|NCT01882179|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92479692|NCT01882179|Mineralocorticoids|mineralocorticoids|mesh-list
92479693|NCT01882179|Hormone Antagonists|hormone antagonists|mesh-ancestor
92479694|NCT01882179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479695|NCT01882179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479696|NCT01882179|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92479697|NCT01882179|Diuretics|diuretics|mesh-ancestor
92479698|NCT01882179|Natriuretic Agents|natriuretic agents|mesh-ancestor
92479699|NCT01882179|Hormones|hormones|mesh-ancestor
92479700|NCT01882296|Pantoprazole|pantoprazole|mesh-list
92479701|NCT01882296|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92479702|NCT01882296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92479703|NCT01882296|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92479704|NCT01882296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479705|NCT01882296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479706|NCT01882322|Tacrolimus|tacrolimus|mesh-list
92479707|NCT01882322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479708|NCT01882322|Immunologic Factors|immunologic factors|mesh-ancestor
92479709|NCT01882322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479710|NCT01882322|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92479711|NCT01882322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479712|NCT01882322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479713|NCT01882361|Naltrexone|naltrexone|mesh-list
92479714|NCT01882361|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92479715|NCT01882361|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92479716|NCT01882361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479717|NCT01882361|Sensory System Agents|sensory system agents|mesh-ancestor
92479718|NCT01882361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479719|NCT01882374|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92479720|NCT01882374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92479721|NCT01882374|Vasodilator Agents|vasodilator agents|mesh-ancestor
92479722|NCT01882387|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92479723|NCT01882387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92479724|NCT01882387|Vasodilator Agents|vasodilator agents|mesh-ancestor
92479725|NCT01882400|Alendronate|alendronate|mesh-list
92479726|NCT01882400|Risedronic Acid|risedronic acid|mesh-list
92479727|NCT01882400|Diphosphonates|diphosphonates|mesh-list
92479728|NCT01882400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92479729|NCT01882400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479730|NCT01882400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92479731|NCT01882400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479732|NCT01882400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479733|NCT01882400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92479734|NCT01882530|Acetaminophen|acetaminophen|mesh-list
92479735|NCT01882530|Ketoprofen|ketoprofen|mesh-list
92479736|NCT01882530|Morphine|morphine|mesh-list
92479737|NCT01882530|Nefopam|nefopam|mesh-list
92479738|NCT01882530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92479739|NCT01882530|Narcotics|narcotics|mesh-ancestor
92479740|NCT01882530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479741|NCT01882530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479742|NCT01882530|Analgesics|analgesics|mesh-ancestor
92479743|NCT01882530|Sensory System Agents|sensory system agents|mesh-ancestor
92479744|NCT01882530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479745|NCT01882530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92479746|NCT01882530|Antipyretics|antipyretics|mesh-ancestor
92479747|NCT01882530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92479748|NCT01882530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479749|NCT01882530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479750|NCT01882530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92479751|NCT01882530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479752|NCT01882530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479753|NCT01882556|Botulinum Toxins|botulinum toxins|mesh-list
92479754|NCT01882556|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92479755|NCT01882556|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92479756|NCT01882556|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92479757|NCT01882556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479758|NCT01882556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479759|NCT01882556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92479760|NCT01882556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479761|NCT01882556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479762|NCT01882556|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92479763|NCT01882556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479764|NCT01882920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92479765|NCT01883011|Piracetam|piracetam|mesh-list
92479766|NCT01883011|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92479767|NCT01883011|Protective Agents|protective agents|mesh-ancestor
92479768|NCT01883011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479769|NCT01883011|Nootropic Agents|nootropic agents|mesh-ancestor
92479770|NCT01883102|Capsaicin|capsaicin|mesh-list
92479771|NCT01883102|Antipruritics|antipruritics|mesh-ancestor
92479772|NCT01883102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479773|NCT01883102|Sensory System Agents|sensory system agents|mesh-ancestor
92479774|NCT01883102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479775|NCT01883102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479776|NCT01883167|Febuxostat|febuxostat|mesh-list
92479777|NCT01883167|Verinurad|verinurad|mesh-list
92479778|NCT01883167|Gout Suppressants|gout suppressants|mesh-ancestor
92479779|NCT01883167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479780|NCT01883193|Micronutrients|micronutrients|mesh-list
92479781|NCT01883193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479782|NCT01883232|Lidocaine|lidocaine|mesh-list
92479783|NCT01883232|Epinephrine|epinephrine|mesh-list
92479784|NCT01883232|Anesthetics, Local|anesthetics, local|mesh-ancestor
92479785|NCT01883232|Anesthetics|anesthetics|mesh-ancestor
92479786|NCT01883232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479787|NCT01883232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479788|NCT01883232|Sensory System Agents|sensory system agents|mesh-ancestor
92479789|NCT01883232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479790|NCT01883232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92479791|NCT01883232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92479792|NCT01883232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92479793|NCT01883232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479794|NCT01883232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479795|NCT01883232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92479796|NCT01883232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92479797|NCT01883232|Adrenergic Agents|adrenergic agents|mesh-ancestor
92479798|NCT01883232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479799|NCT01883232|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92479800|NCT01883232|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92479801|NCT01883232|Autonomic Agents|autonomic agents|mesh-ancestor
92479802|NCT01883232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92479803|NCT01883232|Respiratory System Agents|respiratory system agents|mesh-ancestor
92479804|NCT01883232|Mydriatics|mydriatics|mesh-ancestor
92479805|NCT01883232|Sympathomimetics|sympathomimetics|mesh-ancestor
92479806|NCT01883232|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92479807|NCT01883323|Aldesleukin|aldesleukin|mesh-list
92479808|NCT01883323|Cyclophosphamide|cyclophosphamide|mesh-list
92479809|NCT01883323|Fludarabine|fludarabine|mesh-list
92479810|NCT01883323|Interleukin-2|interleukin-2|mesh-list
92479811|NCT01883323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92479812|NCT01883323|Immunologic Factors|immunologic factors|mesh-ancestor
92479813|NCT01883323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479814|NCT01883323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479815|NCT01883323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92479816|NCT01883323|Alkylating Agents|alkylating agents|mesh-ancestor
92479817|NCT01883323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479818|NCT01883323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479819|NCT01883323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92479820|NCT01883323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92479822|NCT01883323|Sensory System Agents|sensory system agents|mesh-ancestor
92479823|NCT01883323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479824|NCT01883323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92479825|NCT01883323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92479826|NCT01883323|Antiviral Agents|antiviral agents|mesh-ancestor
92479827|NCT01883323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479829|NCT01883505|Carbidopa|carbidopa|mesh-list
92479830|NCT01883505|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92479831|NCT01883505|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92479832|NCT01883505|Dopamine Agents|dopamine agents|mesh-ancestor
92479833|NCT01883505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479834|NCT01883505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479835|NCT01883505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479836|NCT01883505|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92479837|NCT01883505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479838|NCT01883518|Vaccines|vaccines|mesh-list
92479839|NCT01883518|Immunologic Factors|immunologic factors|mesh-ancestor
92479840|NCT01883518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479841|NCT01883531|Mannitol|mannitol|mesh-list
92479842|NCT01883531|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92479843|NCT01883531|Diuretics|diuretics|mesh-ancestor
92479844|NCT01883531|Natriuretic Agents|natriuretic agents|mesh-ancestor
92479845|NCT01883531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479846|NCT01883596|Chlorhexidine|chlorhexidine|mesh-list
92479847|NCT01883596|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92479848|NCT01883596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479849|NCT01883596|Disinfectants|disinfectants|mesh-ancestor
92479850|NCT01883869|Ticagrelor|ticagrelor|mesh-list
92479851|NCT01883869|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92479852|NCT01883869|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92479853|NCT01883869|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92479854|NCT01883869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92479855|NCT01883869|Purinergic Agents|purinergic agents|mesh-ancestor
92479856|NCT01883869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92479857|NCT01883869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479858|NCT01883869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479859|NCT01883882|Analgesics, Opioid|analgesics, opioid|mesh-list
92479860|NCT01883882|Narcotics|narcotics|mesh-ancestor
92479861|NCT01883882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479862|NCT01883882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479863|NCT01883882|Analgesics|analgesics|mesh-ancestor
92479864|NCT01883882|Sensory System Agents|sensory system agents|mesh-ancestor
92479865|NCT01883882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479866|NCT01883921|Immunoglobulins|immunoglobulins|mesh-list
92479867|NCT01883921|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92479868|NCT01883921|Antibodies|antibodies|mesh-list
92479869|NCT01883921|Immunologic Factors|immunologic factors|mesh-ancestor
92479870|NCT01883921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479871|NCT01884038|Treprostinil|treprostinil|mesh-list
92479872|NCT01884038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92479873|NCT01884116|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92479874|NCT01884116|Capsaicin|capsaicin|mesh-list
92479875|NCT01884116|Antipruritics|antipruritics|mesh-ancestor
92479876|NCT01884116|Dermatologic Agents|dermatologic agents|mesh-ancestor
92479877|NCT01884116|Sensory System Agents|sensory system agents|mesh-ancestor
92479878|NCT01884116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479879|NCT01884116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479880|NCT01884116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92479881|NCT01884116|Analgesics|analgesics|mesh-ancestor
92479882|NCT01884116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479883|NCT01884116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479884|NCT01884168|Immunomodulating Agents|immunomodulating agents|mesh-list
92479885|NCT01884168|Immunologic Factors|immunologic factors|mesh-ancestor
92479886|NCT01884168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479887|NCT01884272|Naproxen|naproxen|mesh-list
92479888|NCT01884272|Indomethacin|indomethacin|mesh-list
92479889|NCT01884272|Lesinurad|lesinurad|mesh-list
92479890|NCT01884272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92479892|NCT01884272|Analgesics|analgesics|mesh-ancestor
92479893|NCT01884272|Sensory System Agents|sensory system agents|mesh-ancestor
92479894|NCT01884272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479895|NCT01884272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479896|NCT01884272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479897|NCT01884272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92479898|NCT01884272|Gout Suppressants|gout suppressants|mesh-ancestor
92479899|NCT01884272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92479900|NCT01884272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479901|NCT01884272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479902|NCT01884272|Tocolytic Agents|tocolytic agents|mesh-ancestor
92479903|NCT01884272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92479904|NCT01884272|Uricosuric Agents|uricosuric agents|mesh-ancestor
92479905|NCT01884285|Abiraterone Acetate|abiraterone acetate|mesh-list
92479906|NCT01884285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479907|NCT01884285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92479908|NCT01884285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479909|NCT01884285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479910|NCT01884285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92479911|NCT01884285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479912|NCT01884285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479913|NCT01884285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92479915|NCT01884298|Remifentanil|remifentanil|mesh-list
92479916|NCT01884298|Anesthetics, Local|anesthetics, local|mesh-ancestor
92479917|NCT01884298|Anesthetics|anesthetics|mesh-ancestor
92479918|NCT01884298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92479919|NCT01884298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479920|NCT01884298|Sensory System Agents|sensory system agents|mesh-ancestor
92479921|NCT01884298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92479922|NCT01884298|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92479923|NCT01884298|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92479924|NCT01884298|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92479925|NCT01884298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92479926|NCT01884298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479927|NCT01884298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92479928|NCT01884298|Narcotics|narcotics|mesh-ancestor
92479929|NCT01884298|Analgesics|analgesics|mesh-ancestor
92479930|NCT01884402|Ribavirin|ribavirin|mesh-list
92479931|NCT01884402|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92479932|NCT01884402|Antimetabolites|antimetabolites|mesh-ancestor
92479933|NCT01884402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479934|NCT01884402|Antiviral Agents|antiviral agents|mesh-ancestor
92479935|NCT01884402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479936|NCT01884415|Vaccines|vaccines|mesh-list
92479937|NCT01884415|Immunologic Factors|immunologic factors|mesh-ancestor
92479938|NCT01884415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479939|NCT01884428|Prednisolone|prednisolone|mesh-list
92479940|NCT01884428|Gemcitabine|gemcitabine|mesh-list
92479941|NCT01884428|Vinorelbine|vinorelbine|mesh-list
92479942|NCT01884428|Ifosfamide|ifosfamide|mesh-list
92479943|NCT01884428|Panobinostat|panobinostat|mesh-list
92479944|NCT01884428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479945|NCT01884428|Antimetabolites|antimetabolites|mesh-ancestor
92479946|NCT01884428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479947|NCT01884428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479948|NCT01884428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92479949|NCT01884428|Glucocorticoids|glucocorticoids|mesh-ancestor
92479950|NCT01884428|Hormones|hormones|mesh-ancestor
92479951|NCT01884428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92479952|NCT01884428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479953|NCT01884428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92479954|NCT01884428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92479955|NCT01884428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92479956|NCT01884428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92479957|NCT01884428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92479958|NCT01884428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92479959|NCT01884428|Alkylating Agents|alkylating agents|mesh-ancestor
92479960|NCT01884428|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92479961|NCT01884428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479962|NCT01884441|Gemcitabine|gemcitabine|mesh-list
92479963|NCT01884441|Vinorelbine|vinorelbine|mesh-list
92479964|NCT01884441|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92479965|NCT01884441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92479967|NCT01884441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479968|NCT01884441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92479969|NCT01884441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92479970|NCT01884441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92479971|NCT01884441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92479972|NCT01884441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92479973|NCT01884441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92479974|NCT01884441|Alkylating Agents|alkylating agents|mesh-ancestor
92479975|NCT01884467|Gentamicins|gentamicins|mesh-list
92479976|NCT01884467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92479977|NCT01884467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479978|NCT01884467|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92479979|NCT01884467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92479980|NCT01884467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479983|NCT01884506|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92479984|NCT01884506|Trace Elements|trace elements|mesh-ancestor
92479985|NCT01884506|Micronutrients|micronutrients|mesh-ancestor
92479986|NCT01884506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479987|NCT01884506|Antioxidants|antioxidants|mesh-ancestor
92479988|NCT01884506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92479989|NCT01884506|Protective Agents|protective agents|mesh-ancestor
92479990|NCT01884506|Vitamins|vitamins|mesh-ancestor
92479991|NCT01884558|Metformin|metformin|mesh-list
92479992|NCT01884558|Isavuconazole|isavuconazole|mesh-list
92479993|NCT01884558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92479994|NCT01884558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92479995|NCT01884558|Antifungal Agents|antifungal agents|mesh-ancestor
92479996|NCT01884558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92479997|NCT01884623|Methotrexate|methotrexate|mesh-list
92479998|NCT01884623|Cetuximab|cetuximab|mesh-list
92479999|NCT01884623|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92480000|NCT01884623|Abortifacient Agents|abortifacient agents|mesh-ancestor
92480001|NCT01884623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92480002|NCT01884623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480003|NCT01884623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92480004|NCT01884623|Antimetabolites|antimetabolites|mesh-ancestor
92480005|NCT01884623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480006|NCT01884623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480007|NCT01884623|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480008|NCT01884623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480009|NCT01884623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92480010|NCT01884623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480011|NCT01884623|Immunologic Factors|immunologic factors|mesh-ancestor
92480012|NCT01884623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480013|NCT01884623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92480014|NCT01884623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92480015|NCT01884636|Isavuconazole|isavuconazole|mesh-list
92480016|NCT01884636|Methotrexate|methotrexate|mesh-list
92480017|NCT01884636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92480018|NCT01884636|Abortifacient Agents|abortifacient agents|mesh-ancestor
92480019|NCT01884636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92480020|NCT01884636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480021|NCT01884636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92480022|NCT01884636|Antimetabolites|antimetabolites|mesh-ancestor
92480023|NCT01884636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480024|NCT01884636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480025|NCT01884636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480026|NCT01884636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480027|NCT01884636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92480028|NCT01884636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480029|NCT01884636|Immunologic Factors|immunologic factors|mesh-ancestor
92480030|NCT01884636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480031|NCT01884636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92480032|NCT01884636|Antifungal Agents|antifungal agents|mesh-ancestor
92480033|NCT01884636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480034|NCT01884857|Metoprolol|metoprolol|mesh-list
92480035|NCT01884857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92480036|NCT01884857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480037|NCT01884857|Sympatholytics|sympatholytics|mesh-ancestor
92480038|NCT01884857|Autonomic Agents|autonomic agents|mesh-ancestor
92480039|NCT01884857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480040|NCT01884857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480041|NCT01884857|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92480042|NCT01884857|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92480043|NCT01884857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92480044|NCT01884857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480045|NCT01884857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480046|NCT01884857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480047|NCT01884896|Metoprolol|metoprolol|mesh-list
92480048|NCT01884896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92480049|NCT01884896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480050|NCT01884896|Sympatholytics|sympatholytics|mesh-ancestor
92480051|NCT01884896|Autonomic Agents|autonomic agents|mesh-ancestor
92480052|NCT01884896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480053|NCT01884896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480054|NCT01884896|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92480055|NCT01884896|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92480056|NCT01884896|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92480057|NCT01884896|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480058|NCT01884896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480059|NCT01884896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480060|NCT01884909|Metoprolol|metoprolol|mesh-list
92480061|NCT01884909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92480062|NCT01884909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480063|NCT01884909|Sympatholytics|sympatholytics|mesh-ancestor
92480064|NCT01884909|Autonomic Agents|autonomic agents|mesh-ancestor
92480065|NCT01884909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480066|NCT01884909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480067|NCT01884909|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92480068|NCT01884909|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92480069|NCT01884909|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92480070|NCT01884909|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480071|NCT01884909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480072|NCT01884909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480073|NCT01884935|Natalizumab|natalizumab|mesh-list
92480074|NCT01884935|Immunologic Factors|immunologic factors|mesh-ancestor
92480075|NCT01884935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480076|NCT01885013|Metformin|metformin|mesh-list
92480077|NCT01885013|Cyclophosphamide|cyclophosphamide|mesh-list
92480078|NCT01885013|Doxorubicin|doxorubicin|mesh-list
92480079|NCT01885013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480080|NCT01885013|Immunologic Factors|immunologic factors|mesh-ancestor
92480081|NCT01885013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480082|NCT01885013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480083|NCT01885013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92480084|NCT01885013|Alkylating Agents|alkylating agents|mesh-ancestor
92480085|NCT01885013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480086|NCT01885013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480087|NCT01885013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92480088|NCT01885013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92480089|NCT01885013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92480090|NCT01885013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92480091|NCT01885013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92480092|NCT01885013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480093|NCT01885091|Kinetin|kinetin|mesh-list
92480094|NCT01885091|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92480095|NCT01885091|Growth Substances|growth substances|mesh-ancestor
92480096|NCT01885091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480097|NCT01885338|Acetylcysteine|acetylcysteine|mesh-list
92480098|NCT01885338|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92480099|NCT01885338|Antiviral Agents|antiviral agents|mesh-ancestor
92480100|NCT01885338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480102|NCT01885338|Respiratory System Agents|respiratory system agents|mesh-ancestor
92480103|NCT01885338|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92480104|NCT01885338|Antioxidants|antioxidants|mesh-ancestor
92480105|NCT01885338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480106|NCT01885338|Protective Agents|protective agents|mesh-ancestor
92480107|NCT01885338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480108|NCT01885338|Antidotes|antidotes|mesh-ancestor
92480109|NCT01885364|Remifentanil|remifentanil|mesh-list
92480110|NCT01885364|Propofol|propofol|mesh-list
92480111|NCT01885364|Esmolol|esmolol|mesh-list
92480112|NCT01885364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92480113|NCT01885364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480114|NCT01885364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480115|NCT01885364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92480116|NCT01885364|Anesthetics, General|anesthetics, general|mesh-ancestor
92480117|NCT01885364|Anesthetics|anesthetics|mesh-ancestor
92480118|NCT01885364|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92480119|NCT01885364|Narcotics|narcotics|mesh-ancestor
92480120|NCT01885364|Analgesics|analgesics|mesh-ancestor
92480121|NCT01885364|Sensory System Agents|sensory system agents|mesh-ancestor
92480122|NCT01885364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480123|NCT01885364|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92480124|NCT01885364|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92480125|NCT01885364|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92480126|NCT01885364|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480127|NCT01885364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480128|NCT01885364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480129|NCT01885481|Dexamethasone|dexamethasone|mesh-list
92480130|NCT01885481|Dexamethasone acetate|dexamethasone acetate|mesh-list
92480131|NCT01885481|Betamethasone|betamethasone|mesh-list
92480132|NCT01885481|Betamethasone Valerate|betamethasone valerate|mesh-list
92480133|NCT01885481|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92480134|NCT01885481|Betamethasone benzoate|betamethasone benzoate|mesh-list
92480135|NCT01885481|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92480137|NCT01885481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92480138|NCT01885481|Antiemetics|antiemetics|mesh-ancestor
92480139|NCT01885481|Autonomic Agents|autonomic agents|mesh-ancestor
92480140|NCT01885481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480141|NCT01885481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480142|NCT01885481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480143|NCT01885481|Glucocorticoids|glucocorticoids|mesh-ancestor
92480144|NCT01885481|Hormones|hormones|mesh-ancestor
92480145|NCT01885481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480146|NCT01885481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92480147|NCT01885481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480148|NCT01885481|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480149|NCT01885481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480150|NCT01885481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480151|NCT01885481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92480152|NCT01885481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92480153|NCT01885585|Apixaban|apixaban|mesh-list
92480154|NCT01885585|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92480155|NCT01885585|Antithrombins|antithrombins|mesh-ancestor
92480156|NCT01885585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92480157|NCT01885585|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480158|NCT01885585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349023|NCT01462344|Fluticasone|fluticasone|mesh-list
92480159|NCT01885585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480160|NCT01885585|Anticoagulants|anticoagulants|mesh-ancestor
92480161|NCT01885598|Apixaban|apixaban|mesh-list
92480162|NCT01885598|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92480163|NCT01885598|Antithrombins|antithrombins|mesh-ancestor
92480164|NCT01885598|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92480165|NCT01885598|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480166|NCT01885598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480167|NCT01885598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480168|NCT01885598|Anticoagulants|anticoagulants|mesh-ancestor
92480169|NCT01885715|Neostigmine|neostigmine|mesh-list
92480170|NCT01885715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92480171|NCT01885715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480172|NCT01885715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480173|NCT01885715|Cholinergic Agents|cholinergic agents|mesh-ancestor
92480174|NCT01885715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480175|NCT01885715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480176|NCT01885715|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92480177|NCT01885715|Autonomic Agents|autonomic agents|mesh-ancestor
92480178|NCT01885715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480179|NCT01885988|Nebivolol|nebivolol|mesh-list
92480180|NCT01885988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480181|NCT01885988|Vasodilator Agents|vasodilator agents|mesh-ancestor
92480182|NCT01885988|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92480183|NCT01885988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92480184|NCT01885988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92480185|NCT01885988|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480186|NCT01885988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480187|NCT01885988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480188|NCT01885988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480189|NCT01886001|Chlorhexidine|chlorhexidine|mesh-list
92480190|NCT01886001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92480191|NCT01886001|Povidone-Iodine|povidone-iodine|mesh-list
92480193|NCT01886001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92480194|NCT01886001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480195|NCT01886001|Disinfectants|disinfectants|mesh-ancestor
92480196|NCT01886001|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480197|NCT01886001|Plasma Substitutes|plasma substitutes|mesh-ancestor
92480198|NCT01886001|Blood Substitutes|blood substitutes|mesh-ancestor
92480199|NCT01886014|Oxytocin|oxytocin|mesh-list
92480200|NCT01886014|Oxytocics|oxytocics|mesh-ancestor
92480201|NCT01886014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92480202|NCT01886014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480203|NCT01886053|Ertapenem|ertapenem|mesh-list
92480204|NCT01886053|beta-Lactams|beta-lactams|mesh-list
92480205|NCT01886053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92480206|NCT01886053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480207|NCT01886079|Dexmedetomidine|dexmedetomidine|mesh-list
92480208|NCT01886079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92480209|NCT01886079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480210|NCT01886079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480211|NCT01886079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480212|NCT01886079|Analgesics|analgesics|mesh-ancestor
92480213|NCT01886079|Sensory System Agents|sensory system agents|mesh-ancestor
92480214|NCT01886079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349026|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92480215|NCT01886079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92480216|NCT01886079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92480217|NCT01886079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92480218|NCT01886079|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480219|NCT01886079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480220|NCT01886079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480221|NCT01886196|Ibuprofen|ibuprofen|mesh-list
92480222|NCT01886196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92480223|NCT01886196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92480224|NCT01886196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480225|NCT01886196|Analgesics|analgesics|mesh-ancestor
92480226|NCT01886196|Sensory System Agents|sensory system agents|mesh-ancestor
92480227|NCT01886196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480228|NCT01886196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480229|NCT01886196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480230|NCT01886196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92480231|NCT01886196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480232|NCT01886196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480233|NCT01886209|Prednisone|prednisone|mesh-list
92480234|NCT01886209|Methylprednisolone|methylprednisolone|mesh-list
92480235|NCT01886209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92480236|NCT01886209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92480237|NCT01886209|Prednisolone|prednisolone|mesh-list
92480238|NCT01886209|Prednisolone acetate|prednisolone acetate|mesh-list
92480239|NCT01886209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92480240|NCT01886209|Prednisolone phosphate|prednisolone phosphate|mesh-list
92480241|NCT01886209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92480242|NCT01886209|Glucocorticoids|glucocorticoids|mesh-ancestor
92480243|NCT01886209|Hormones|hormones|mesh-ancestor
92480244|NCT01886209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480245|NCT01886209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480246|NCT01886209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92480247|NCT01886209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480248|NCT01886209|Antiemetics|antiemetics|mesh-ancestor
92480249|NCT01886209|Autonomic Agents|autonomic agents|mesh-ancestor
92480250|NCT01886209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480251|NCT01886209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480252|NCT01886209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92480253|NCT01886209|Protective Agents|protective agents|mesh-ancestor
92480254|NCT01886248|Antithrombins|antithrombins|mesh-list
92480255|NCT01886248|Antithrombin III|antithrombin iii|mesh-list
92480256|NCT01886248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92480257|NCT01886248|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480258|NCT01886248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480259|NCT01886248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480260|NCT01886248|Anticoagulants|anticoagulants|mesh-ancestor
92480261|NCT01886352|Levobupivacaine|levobupivacaine|mesh-list
92480262|NCT01886352|Anesthetics, Local|anesthetics, local|mesh-ancestor
92480263|NCT01886352|Anesthetics|anesthetics|mesh-ancestor
92480264|NCT01886352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480265|NCT01886352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205153|NCT00786643|Antidotes|antidotes|mesh-ancestor
92480266|NCT01886352|Sensory System Agents|sensory system agents|mesh-ancestor
92480267|NCT01886352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480268|NCT01886365|Insulin|insulin|mesh-list
92480269|NCT01886365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92480270|NCT01886365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480271|NCT01886404|Efavirenz|efavirenz|mesh-list
92480272|NCT01886404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92480273|NCT01886404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92480274|NCT01886404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480275|NCT01886404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480276|NCT01886404|Antiviral Agents|antiviral agents|mesh-ancestor
92480277|NCT01886404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480278|NCT01886404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92480279|NCT01886404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92480280|NCT01886404|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92480281|NCT01886404|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92480282|NCT01886404|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92480283|NCT01886404|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92480284|NCT01886443|Tocopherols|tocopherols|mesh-list
92480285|NCT01886443|Vitamin E|vitamin e|mesh-list
92480286|NCT01886443|alpha-Tocopherol|alpha-tocopherol|mesh-list
92480287|NCT01886443|Infliximab|infliximab|mesh-list
92480288|NCT01886443|Epoprostenol|epoprostenol|mesh-list
92480289|NCT01886443|Tezosentan|tezosentan|mesh-list
92480290|NCT01886443|Melatonin|melatonin|mesh-list
92480291|NCT01886443|Antithrombins|antithrombins|mesh-list
92480292|NCT01886443|Antithrombin III|antithrombin iii|mesh-list
92480293|NCT01886443|Epoetin Alfa|epoetin alfa|mesh-list
92480294|NCT01886443|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92480295|NCT01886443|Antioxidants|antioxidants|mesh-ancestor
92480296|NCT01886443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480297|NCT01886443|Protective Agents|protective agents|mesh-ancestor
92480298|NCT01886443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480299|NCT01886443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480300|NCT01886443|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92480301|NCT01886443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92480302|NCT01886443|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480303|NCT01886443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480304|NCT01886443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480305|NCT01886443|Hematinics|hematinics|mesh-ancestor
92480306|NCT01886443|Vitamins|vitamins|mesh-ancestor
92480307|NCT01886443|Micronutrients|micronutrients|mesh-ancestor
92480308|NCT01886443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92480309|NCT01886443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480310|NCT01886443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480311|NCT01886443|Anticoagulants|anticoagulants|mesh-ancestor
92480312|NCT01886443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480313|NCT01886443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92480314|NCT01886443|Vasodilator Agents|vasodilator agents|mesh-ancestor
92480315|NCT01886443|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92480316|NCT01886443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480317|NCT01886443|Immunologic Factors|immunologic factors|mesh-ancestor
92480318|NCT01886534|Diuretics|diuretics|mesh-list
92480319|NCT01886534|Natriuretic Agents|natriuretic agents|mesh-ancestor
92480320|NCT01886534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480321|NCT01886560|Doxycycline|doxycycline|mesh-list
92480322|NCT01886560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92480323|NCT01886560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480324|NCT01886560|Antimalarials|antimalarials|mesh-ancestor
92480325|NCT01886560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92480326|NCT01886560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92480327|NCT01886573|Azacitidine|azacitidine|mesh-list
92480329|NCT01886573|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92480330|NCT01886573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92480331|NCT01886573|Antimetabolites|antimetabolites|mesh-ancestor
92480332|NCT01886573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480333|NCT01886573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480334|NCT01886573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480335|NCT01886599|Asunaprevir|asunaprevir|mesh-list
92480336|NCT01886599|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480337|NCT01886599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480338|NCT01886599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480339|NCT01886638|Abacavir|abacavir|mesh-list
92480340|NCT01886638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92480341|NCT01886638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92480342|NCT01886638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480343|NCT01886638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480344|NCT01886638|Antiviral Agents|antiviral agents|mesh-ancestor
92480345|NCT01886638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480346|NCT01886638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92480347|NCT01886638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92480348|NCT01886664|Sevoflurane|sevoflurane|mesh-list
92480349|NCT01886664|Desflurane|desflurane|mesh-list
92480350|NCT01886664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92480351|NCT01886664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92480352|NCT01886664|Anesthetics, General|anesthetics, general|mesh-ancestor
92480353|NCT01886664|Anesthetics|anesthetics|mesh-ancestor
92480354|NCT01886664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480355|NCT01886664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480356|NCT01886768|Anesthetics|anesthetics|mesh-list
92480357|NCT01886768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480358|NCT01886768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480359|NCT01887119|Eplerenone|eplerenone|mesh-list
92349047|NCT01462266|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92480360|NCT01887119|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92480361|NCT01887119|Hormone Antagonists|hormone antagonists|mesh-ancestor
92480362|NCT01887119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480363|NCT01887119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480364|NCT01887119|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92480365|NCT01887119|Diuretics|diuretics|mesh-ancestor
92480366|NCT01887119|Natriuretic Agents|natriuretic agents|mesh-ancestor
92480367|NCT01887119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480368|NCT01887158|Bisacodyl|bisacodyl|mesh-list
92480369|NCT01887158|Cathartics|cathartics|mesh-ancestor
92480370|NCT01887158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480371|NCT01887158|Laxatives|laxatives|mesh-ancestor
92480372|NCT01887184|Dexmedetomidine|dexmedetomidine|mesh-list
92480373|NCT01887184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92480374|NCT01887184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480375|NCT01887184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480376|NCT01887184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480377|NCT01887184|Analgesics|analgesics|mesh-ancestor
92480378|NCT01887184|Sensory System Agents|sensory system agents|mesh-ancestor
92480379|NCT01887184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480380|NCT01887184|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92480381|NCT01887184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92480382|NCT01887184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92480383|NCT01887184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480384|NCT01887184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480385|NCT01887184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480386|NCT01887197|Mannitol|mannitol|mesh-list
92480387|NCT01887197|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92480388|NCT01887197|Diuretics|diuretics|mesh-ancestor
92480389|NCT01887197|Natriuretic Agents|natriuretic agents|mesh-ancestor
92480390|NCT01887197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480391|NCT01887223|Timolol|timolol|mesh-list
92480392|NCT01887223|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92480393|NCT01887223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92480394|NCT01887223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92480395|NCT01887223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92480396|NCT01887223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92480397|NCT01887223|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480398|NCT01887223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480399|NCT01887223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480400|NCT01887223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480401|NCT01887223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92480402|NCT01887223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92480403|NCT01887223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92480404|NCT01887249|Metronidazole|metronidazole|mesh-list
92480405|NCT01887249|Clarithromycin|clarithromycin|mesh-list
92480406|NCT01887249|Esomeprazole|esomeprazole|mesh-list
92480407|NCT01887249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480408|NCT01887249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92480409|NCT01887249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92480410|NCT01887249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92480411|NCT01887249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92480412|NCT01887249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480413|NCT01887249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92480414|NCT01887249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480415|NCT01887249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480416|NCT01887249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92480417|NCT01887249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92480418|NCT01887249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92480420|NCT01887275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480421|NCT01887275|Antiviral Agents|antiviral agents|mesh-ancestor
92480422|NCT01887275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480423|NCT01887340|Carboplatin|carboplatin|mesh-list
92480424|NCT01887340|Etoposide|etoposide|mesh-list
92480425|NCT01887340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480426|NCT01887340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92480427|NCT01887340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92480428|NCT01887340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92480429|NCT01887340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480430|NCT01887340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480431|NCT01887379|Furosemide|furosemide|mesh-list
92480432|NCT01887379|Diuretics|diuretics|mesh-ancestor
92480433|NCT01887379|Natriuretic Agents|natriuretic agents|mesh-ancestor
92150416|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480434|NCT01887379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480435|NCT01887379|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92480436|NCT01887379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480437|NCT01887379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480438|NCT01887405|Epinephrine|epinephrine|mesh-list
92480439|NCT01887405|Racepinephrine|racepinephrine|mesh-list
92480440|NCT01887405|Epinephryl borate|epinephryl borate|mesh-list
92480441|NCT01887405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92480442|NCT01887405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92480443|NCT01887405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480444|NCT01887405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480445|NCT01887405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480446|NCT01887405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480447|NCT01887405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92480448|NCT01887405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92480449|NCT01887405|Autonomic Agents|autonomic agents|mesh-ancestor
92480450|NCT01887405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480451|NCT01887405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92480452|NCT01887405|Respiratory System Agents|respiratory system agents|mesh-ancestor
92480453|NCT01887405|Mydriatics|mydriatics|mesh-ancestor
92480454|NCT01887405|Sympathomimetics|sympathomimetics|mesh-ancestor
92480455|NCT01887405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92480456|NCT01887457|Voriconazole|voriconazole|mesh-list
92480457|NCT01887457|Antifungal Agents|antifungal agents|mesh-ancestor
92480458|NCT01887457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480459|NCT01887457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92480460|NCT01887457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92480461|NCT01887457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480462|NCT01887457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480463|NCT01887457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92480464|NCT01887457|Hormone Antagonists|hormone antagonists|mesh-ancestor
92480465|NCT01887457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480466|NCT01887457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480467|NCT01887457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92480468|NCT01887561|Dasatinib|dasatinib|mesh-list
92480469|NCT01887561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480470|NCT01887561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92480471|NCT01887561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480472|NCT01887561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480473|NCT01887613|Gabapentin|gabapentin|mesh-list
92480474|NCT01887613|Analgesics|analgesics|mesh-ancestor
92480475|NCT01887613|Sensory System Agents|sensory system agents|mesh-ancestor
92480476|NCT01887613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480477|NCT01887613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480478|NCT01887613|Anticonvulsants|anticonvulsants|mesh-ancestor
92480479|NCT01887613|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92480480|NCT01887613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480481|NCT01887613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480482|NCT01887613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480483|NCT01887613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92480484|NCT01887613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92480485|NCT01887613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480486|NCT01887613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480487|NCT01887613|Antimanic Agents|antimanic agents|mesh-ancestor
92480488|NCT01887626|Ticagrelor|ticagrelor|mesh-list
92480489|NCT01887626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92205383|NCT00775411|Glucocorticoids|glucocorticoids|mesh-ancestor
92480490|NCT01887626|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92480491|NCT01887626|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92480492|NCT01887626|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92480493|NCT01887626|Purinergic Agents|purinergic agents|mesh-ancestor
92480494|NCT01887626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480495|NCT01887626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480496|NCT01887626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480497|NCT01887691|Eszopiclone|eszopiclone|mesh-list
92480498|NCT01887691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92480499|NCT01887691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480500|NCT01887691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480501|NCT01887704|Aspirin|aspirin|mesh-list
92480502|NCT01887704|Sirolimus|sirolimus|mesh-list
92480503|NCT01887704|Paclitaxel|paclitaxel|mesh-list
92480504|NCT01887704|Everolimus|everolimus|mesh-list
92480505|NCT01887704|Clopidogrel|clopidogrel|mesh-list
92480506|NCT01887704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92480507|NCT01887704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480508|NCT01887704|Tubulin Modulators|tubulin modulators|mesh-ancestor
92480509|NCT01887704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92480510|NCT01887704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92480511|NCT01887704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480512|NCT01887704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92480513|NCT01887704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480514|NCT01887704|Analgesics|analgesics|mesh-ancestor
92480515|NCT01887704|Sensory System Agents|sensory system agents|mesh-ancestor
92480516|NCT01887704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480517|NCT01887704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480518|NCT01887704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92480519|NCT01887704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480520|NCT01887704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92480521|NCT01887704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92480522|NCT01887704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92480523|NCT01887704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92480524|NCT01887704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480525|NCT01887704|Antipyretics|antipyretics|mesh-ancestor
92480526|NCT01887704|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92480527|NCT01887704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92480528|NCT01887704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480529|NCT01887704|Immunologic Factors|immunologic factors|mesh-ancestor
92480530|NCT01887704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92480531|NCT01887704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92480532|NCT01887704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92480533|NCT01887704|Purinergic Agents|purinergic agents|mesh-ancestor
92480534|NCT01887704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480535|NCT01887704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92480536|NCT01887704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480537|NCT01887704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92480538|NCT01887704|Antifungal Agents|antifungal agents|mesh-ancestor
92480539|NCT01887743|Pantoprazole|pantoprazole|mesh-list
92480540|NCT01887743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92480541|NCT01887743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480542|NCT01887743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92480543|NCT01887743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480544|NCT01887743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480545|NCT01887795|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92480546|NCT01887795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480547|NCT01887795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92480548|NCT01887795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480549|NCT01887795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480550|NCT01887821|Chloroquine|chloroquine|mesh-list
92480551|NCT01887821|Piperaquine|piperaquine|mesh-list
92480552|NCT01887821|Artenimol|artenimol|mesh-list
92480553|NCT01887821|Amebicides|amebicides|mesh-ancestor
92480554|NCT01887821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92480555|NCT01887821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92480556|NCT01887821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480557|NCT01887821|Antimalarials|antimalarials|mesh-ancestor
92480558|NCT01887821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480559|NCT01887847|Nicotine|nicotine|mesh-list
92480560|NCT01887847|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92480561|NCT01887847|Autonomic Agents|autonomic agents|mesh-ancestor
92480562|NCT01887847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480563|NCT01887847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480564|NCT01887847|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92480565|NCT01887847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92480566|NCT01887847|Cholinergic Agents|cholinergic agents|mesh-ancestor
92480567|NCT01887847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480568|NCT01887847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480569|NCT01887873|Hyaluronic Acid|hyaluronic acid|mesh-list
92480570|NCT01887873|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92480571|NCT01887873|Immunologic Factors|immunologic factors|mesh-ancestor
92480572|NCT01887873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480573|NCT01887873|Viscosupplements|viscosupplements|mesh-ancestor
92480574|NCT01887873|Protective Agents|protective agents|mesh-ancestor
92480575|NCT01887951|Tramadol|tramadol|mesh-list
92480576|NCT01887951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92480577|NCT01887951|Narcotics|narcotics|mesh-ancestor
92480578|NCT01887951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150644|NCT01720095|Vitamins|vitamins|mesh-ancestor
92480579|NCT01887951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480580|NCT01887951|Analgesics|analgesics|mesh-ancestor
92480581|NCT01887951|Sensory System Agents|sensory system agents|mesh-ancestor
92480582|NCT01887951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480583|NCT01888042|Everolimus|everolimus|mesh-list
92480584|NCT01888042|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92480585|NCT01888042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92480586|NCT01888042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480587|NCT01888042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480588|NCT01888042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480589|NCT01888042|Immunologic Factors|immunologic factors|mesh-ancestor
92480590|NCT01888042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480591|NCT01888042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480592|NCT01888107|Risperidone|risperidone|mesh-list
92480593|NCT01888107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92480594|NCT01888107|Serotonin Agents|serotonin agents|mesh-ancestor
92480595|NCT01888107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480596|NCT01888107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480597|NCT01888107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480598|NCT01888107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92480599|NCT01888107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480600|NCT01888107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480601|NCT01888107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480602|NCT01888107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92480603|NCT01888107|Dopamine Agents|dopamine agents|mesh-ancestor
92480604|NCT01888120|Ziconotide|ziconotide|mesh-list
92480605|NCT01888120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92480606|NCT01888120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480607|NCT01888120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480608|NCT01888120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480609|NCT01888120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480610|NCT01888120|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92480611|NCT01888120|Protective Agents|protective agents|mesh-ancestor
92480612|NCT01888120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480613|NCT01888120|Analgesics|analgesics|mesh-ancestor
92480614|NCT01888120|Sensory System Agents|sensory system agents|mesh-ancestor
92480615|NCT01888120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480616|NCT01888224|Isotretinoin|isotretinoin|mesh-list
92480617|NCT01888224|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480618|NCT01888250|Lamotrigine|lamotrigine|mesh-list
92480619|NCT01888250|Anticonvulsants|anticonvulsants|mesh-ancestor
92480620|NCT01888250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92480621|NCT01888250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480622|NCT01888250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480623|NCT01888250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480624|NCT01888250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480625|NCT01888250|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92480626|NCT01888250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480627|NCT01888250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480628|NCT01888250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480629|NCT01888250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92480630|NCT01888263|Lamotrigine|lamotrigine|mesh-list
92480631|NCT01888263|Anticonvulsants|anticonvulsants|mesh-ancestor
92480632|NCT01888263|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92480633|NCT01888263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480634|NCT01888263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480635|NCT01888263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480636|NCT01888263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480637|NCT01888263|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92480638|NCT01888263|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480639|NCT01888263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480640|NCT01888263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480641|NCT01888263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92480642|NCT01888289|Isotretinoin|isotretinoin|mesh-list
92480643|NCT01888289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480644|NCT01888302|Sirolimus|sirolimus|mesh-list
92480645|NCT01888302|Cisplatin|cisplatin|mesh-list
92480646|NCT01888302|Gemcitabine|gemcitabine|mesh-list
92480647|NCT01888302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480648|NCT01888302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92480649|NCT01888302|Antimetabolites|antimetabolites|mesh-ancestor
92480650|NCT01888302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480651|NCT01888302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92480652|NCT01888302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480653|NCT01888302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92480654|NCT01888302|Antifungal Agents|antifungal agents|mesh-ancestor
92480655|NCT01888302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480656|NCT01888302|Immunologic Factors|immunologic factors|mesh-ancestor
92480657|NCT01888302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480658|NCT01888328|Isotretinoin|isotretinoin|mesh-list
92480659|NCT01888328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480660|NCT01888341|Isotretinoin|isotretinoin|mesh-list
92480661|NCT01888341|Dermatologic Agents|dermatologic agents|mesh-ancestor
92480662|NCT01888354|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92480663|NCT01888354|Hormones|hormones|mesh-ancestor
92480664|NCT01888354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480665|NCT01888354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480666|NCT01888393|Ivacaftor|ivacaftor|mesh-list
92480667|NCT01888393|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92480668|NCT01888393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480669|NCT01888393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480670|NCT01888445|Darbepoetin alfa|darbepoetin alfa|mesh-list
92480671|NCT01888445|Hematinics|hematinics|mesh-ancestor
92480672|NCT01888458|Micafungin|micafungin|mesh-list
92480673|NCT01888458|Antifungal Agents|antifungal agents|mesh-ancestor
92480674|NCT01888458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480675|NCT01888536|Pregabalin|pregabalin|mesh-list
92480676|NCT01888536|Alprostadil|alprostadil|mesh-list
92480677|NCT01888536|Analgesics|analgesics|mesh-ancestor
92480678|NCT01888536|Sensory System Agents|sensory system agents|mesh-ancestor
92480679|NCT01888536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480680|NCT01888536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480681|NCT01888536|Anticonvulsants|anticonvulsants|mesh-ancestor
92480682|NCT01888536|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92480683|NCT01888536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480684|NCT01888536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480685|NCT01888536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480686|NCT01888536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92480687|NCT01888536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480688|NCT01888536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480689|NCT01888536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480690|NCT01888536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92480691|NCT01888536|Vasodilator Agents|vasodilator agents|mesh-ancestor
92480692|NCT01888536|Urological Agents|urological agents|mesh-ancestor
92480693|NCT01888562|Ponatinib|ponatinib|mesh-list
92480694|NCT01888562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480695|NCT01888562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92480696|NCT01888562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480697|NCT01888562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480698|NCT01888575|Aspirin|aspirin|mesh-list
92480699|NCT01888575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92480700|NCT01888575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480701|NCT01888575|Analgesics|analgesics|mesh-ancestor
92480702|NCT01888575|Sensory System Agents|sensory system agents|mesh-ancestor
92480703|NCT01888575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480704|NCT01888575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480705|NCT01888575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92480706|NCT01888575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92480707|NCT01888575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92480708|NCT01888575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92480709|NCT01888575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480710|NCT01888575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92480711|NCT01888575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92480712|NCT01888575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480713|NCT01888575|Antipyretics|antipyretics|mesh-ancestor
92480714|NCT01888718|Fexofenadine|fexofenadine|mesh-list
92480715|NCT01888718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92480716|NCT01888718|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92480717|NCT01888718|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92480718|NCT01888718|Histamine Antagonists|histamine antagonists|mesh-ancestor
92480719|NCT01888718|Histamine Agents|histamine agents|mesh-ancestor
92531942|NCT00049660|Antimetabolites|antimetabolites|mesh-ancestor
92480720|NCT01888718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480721|NCT01888718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480722|NCT01888718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480723|NCT01888731|Lamotrigine|lamotrigine|mesh-list
92480724|NCT01888731|Anticonvulsants|anticonvulsants|mesh-ancestor
92480725|NCT01888731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92480726|NCT01888731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480727|NCT01888731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480728|NCT01888731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480729|NCT01888731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480730|NCT01888731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92480731|NCT01888731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480732|NCT01888731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480733|NCT01888731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480734|NCT01888731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92480735|NCT01888744|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92480736|NCT01888744|Cetrorelix|cetrorelix|mesh-list
92480737|NCT01888744|Progesterone|progesterone|mesh-list
92480738|NCT01888744|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92480739|NCT01888744|Ganirelix|ganirelix|mesh-list
92480740|NCT01888744|Progestins|progestins|mesh-ancestor
92480741|NCT01888744|Hormones|hormones|mesh-ancestor
92480742|NCT01888744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480743|NCT01888744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480744|NCT01888744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92480745|NCT01888744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92480746|NCT01888744|Fertility Agents|fertility agents|mesh-ancestor
92480747|NCT01888744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92480748|NCT01888757|Lamotrigine|lamotrigine|mesh-list
92480749|NCT01888757|Anticonvulsants|anticonvulsants|mesh-ancestor
92480750|NCT01888757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92480751|NCT01888757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92480752|NCT01888757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480753|NCT01888757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480754|NCT01888757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480755|NCT01888757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92480756|NCT01888757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480757|NCT01888757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480758|NCT01888757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480759|NCT01888757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92480760|NCT01888796|Linagliptin|linagliptin|mesh-list
92480761|NCT01888796|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92480762|NCT01888796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480763|NCT01888796|Incretins|incretins|mesh-ancestor
92480764|NCT01888796|Hormones|hormones|mesh-ancestor
92480765|NCT01888796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92480766|NCT01888796|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92480767|NCT01888796|Protease Inhibitors|protease inhibitors|mesh-ancestor
92480768|NCT01888796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480769|NCT01888796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480771|NCT01888822|Ampicillin|ampicillin|mesh-list
92480772|NCT01888822|Sulbactam|sulbactam|mesh-list
92480773|NCT01888822|Sultamicillin|sultamicillin|mesh-list
92480774|NCT01888822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92480775|NCT01888822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480776|NCT01888822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92480777|NCT01888822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92480778|NCT01888822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480779|NCT01888822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480780|NCT01888822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480781|NCT01888822|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92480782|NCT01888822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92480783|NCT01888822|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92480784|NCT01888835|Mirtazapine|mirtazapine|mesh-list
92480785|NCT01888835|Antidepressive Agents|antidepressive agents|mesh-ancestor
92480786|NCT01888835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480787|NCT01888835|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92480788|NCT01888835|Histamine Antagonists|histamine antagonists|mesh-ancestor
92205683|NCT02305329|Opicapone|opicapone|mesh-list
92480790|NCT01888835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480791|NCT01888835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480792|NCT01888835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480793|NCT01888835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92480794|NCT01888835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480795|NCT01888835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480796|NCT01888835|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92480797|NCT01888835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92480798|NCT01888835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92480799|NCT01888835|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480800|NCT01888835|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92480801|NCT01888835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92480802|NCT01888835|Serotonin Agents|serotonin agents|mesh-ancestor
92480803|NCT01888835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92480804|NCT01888861|Thioctic Acid|thioctic acid|mesh-list
92480805|NCT01888861|Antioxidants|antioxidants|mesh-ancestor
92480806|NCT01888861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480807|NCT01888861|Protective Agents|protective agents|mesh-ancestor
92480808|NCT01888861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480809|NCT01888861|Vitamin B Complex|vitamin b complex|mesh-ancestor
92480810|NCT01888861|Vitamins|vitamins|mesh-ancestor
92480811|NCT01888861|Micronutrients|micronutrients|mesh-ancestor
92480812|NCT01888978|Leucovorin|leucovorin|mesh-list
92480813|NCT01888978|Gemcitabine|gemcitabine|mesh-list
92480814|NCT01888978|Fluorouracil|fluorouracil|mesh-list
92480815|NCT01888978|Docetaxel|docetaxel|mesh-list
92480816|NCT01888978|Oxaliplatin|oxaliplatin|mesh-list
92480817|NCT01888978|Irinotecan|irinotecan|mesh-list
92480818|NCT01888978|Levoleucovorin|levoleucovorin|mesh-list
92480819|NCT01888978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92480820|NCT01888978|Antimetabolites|antimetabolites|mesh-ancestor
92480821|NCT01888978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480822|NCT01888978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480823|NCT01888978|Tubulin Modulators|tubulin modulators|mesh-ancestor
92480824|NCT01888978|Antimitotic Agents|antimitotic agents|mesh-ancestor
92480825|NCT01888978|Mitosis Modulators|mitosis modulators|mesh-ancestor
92480826|NCT01888978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480827|NCT01888978|Immunologic Factors|immunologic factors|mesh-ancestor
92480828|NCT01888978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480829|NCT01888978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92480830|NCT01888978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92480831|NCT01888978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480832|NCT01888978|Antidotes|antidotes|mesh-ancestor
92480833|NCT01888978|Protective Agents|protective agents|mesh-ancestor
92480834|NCT01888978|Vitamin B Complex|vitamin b complex|mesh-ancestor
92480835|NCT01888978|Vitamins|vitamins|mesh-ancestor
92480836|NCT01888978|Micronutrients|micronutrients|mesh-ancestor
92480837|NCT01889004|Dexmedetomidine|dexmedetomidine|mesh-list
92480838|NCT01889004|Propofol|propofol|mesh-list
92480839|NCT01889004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92480840|NCT01889004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480841|NCT01889004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480842|NCT01889004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92480843|NCT01889004|Analgesics|analgesics|mesh-ancestor
92480844|NCT01889004|Sensory System Agents|sensory system agents|mesh-ancestor
92480845|NCT01889004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480846|NCT01889004|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92480847|NCT01889004|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92480848|NCT01889004|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92480849|NCT01889004|Adrenergic Agents|adrenergic agents|mesh-ancestor
92480850|NCT01889004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480851|NCT01889004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480852|NCT01889004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92480853|NCT01889004|Anesthetics, General|anesthetics, general|mesh-ancestor
92480854|NCT01889004|Anesthetics|anesthetics|mesh-ancestor
92480855|NCT01889056|Epoetin Alfa|epoetin alfa|mesh-list
92480856|NCT01889056|Hematinics|hematinics|mesh-ancestor
92480857|NCT01889095|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92480858|NCT01889095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92480859|NCT01889095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480860|NCT01889134|Alendronate|alendronate|mesh-list
92480861|NCT01889134|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92148631|NCT00860847|Ubiquinone|ubiquinone|mesh-list
92480862|NCT01889134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205775|NCT00797797|Milnacipran|milnacipran|mesh-list
92480863|NCT01889173|Cyclobenzaprine|cyclobenzaprine|mesh-list
92480864|NCT01889173|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92480865|NCT01889173|Antidepressive Agents|antidepressive agents|mesh-ancestor
92480866|NCT01889173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92480867|NCT01889173|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92480868|NCT01889173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480869|NCT01889173|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92480870|NCT01889173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480871|NCT01889173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92480872|NCT01889173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480873|NCT01889212|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92480874|NCT01889212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480875|NCT01889212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92480876|NCT01889212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480877|NCT01889212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480878|NCT01889290|Methylnaltrexone|methylnaltrexone|mesh-list
92480879|NCT01889290|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92480880|NCT01889290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480881|NCT01889290|Sensory System Agents|sensory system agents|mesh-ancestor
92480882|NCT01889290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480883|NCT01889368|Grape Seed Extract|grape seed extract|mesh-list
92480884|NCT01889368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92480885|NCT01889368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480886|NCT01889368|Antioxidants|antioxidants|mesh-ancestor
92480887|NCT01889368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480888|NCT01889368|Protective Agents|protective agents|mesh-ancestor
92480889|NCT01889368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480890|NCT01889407|Idarubicin|idarubicin|mesh-list
92480891|NCT01889407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92480892|NCT01889407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480893|NCT01889407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92480894|NCT01889407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92480895|NCT01889407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480896|NCT01889407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480897|NCT01889433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92480898|NCT01889433|Antiviral Agents|antiviral agents|mesh-ancestor
92480899|NCT01889433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480900|NCT01889446|Calcium|calcium|mesh-list
92480901|NCT01889446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92480902|NCT01889446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480903|NCT01889498|Acetazolamide|acetazolamide|mesh-list
92480904|NCT01889498|Anticonvulsants|anticonvulsants|mesh-ancestor
92480905|NCT01889498|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92480906|NCT01889498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480907|NCT01889498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480908|NCT01889498|Diuretics|diuretics|mesh-ancestor
92480909|NCT01889498|Natriuretic Agents|natriuretic agents|mesh-ancestor
92480910|NCT01889498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480911|NCT01889576|Magnesium Oxide|magnesium oxide|mesh-list
92480912|NCT01889576|Antacids|antacids|mesh-ancestor
92480913|NCT01889576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480914|NCT01889576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480915|NCT01889680|Leucovorin|leucovorin|mesh-list
92480916|NCT01889680|Fluorouracil|fluorouracil|mesh-list
92480918|NCT01889680|Aflibercept|aflibercept|mesh-list
92480919|NCT01889680|Levoleucovorin|levoleucovorin|mesh-list
92480920|NCT01889680|Antimetabolites|antimetabolites|mesh-ancestor
92480921|NCT01889680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480922|NCT01889680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92480923|NCT01889680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92480924|NCT01889680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92480925|NCT01889680|Immunologic Factors|immunologic factors|mesh-ancestor
92480926|NCT01889680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480927|NCT01889680|Antidotes|antidotes|mesh-ancestor
92480928|NCT01889680|Protective Agents|protective agents|mesh-ancestor
92480929|NCT01889680|Vitamin B Complex|vitamin b complex|mesh-ancestor
92480930|NCT01889680|Vitamins|vitamins|mesh-ancestor
92480931|NCT01889680|Micronutrients|micronutrients|mesh-ancestor
92480932|NCT01889680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92480933|NCT01889680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92480934|NCT01889680|Growth Substances|growth substances|mesh-ancestor
92480935|NCT01889680|Growth Inhibitors|growth inhibitors|mesh-ancestor
92480936|NCT01889758|Tacrolimus|tacrolimus|mesh-list
92480937|NCT01889758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205831|NCT02151487|Sympatholytics|sympatholytics|mesh-ancestor
92480938|NCT01889758|Immunologic Factors|immunologic factors|mesh-ancestor
92480939|NCT01889758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480940|NCT01889758|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92480941|NCT01889758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480942|NCT01889758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480943|NCT01889771|Nicotine|nicotine|mesh-list
92480944|NCT01889771|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92480945|NCT01889771|Autonomic Agents|autonomic agents|mesh-ancestor
92480946|NCT01889771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480947|NCT01889771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480948|NCT01889771|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92480949|NCT01889771|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92480950|NCT01889771|Cholinergic Agents|cholinergic agents|mesh-ancestor
92480951|NCT01889771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480952|NCT01889771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480953|NCT01889849|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92480954|NCT01889849|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92480955|NCT01889849|Antiviral Agents|antiviral agents|mesh-ancestor
92480956|NCT01889849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480957|NCT01889914|Insulin|insulin|mesh-list
92480958|NCT01889914|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92480959|NCT01889914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92480960|NCT01889914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480961|NCT01889966|Sildenafil Citrate|sildenafil citrate|mesh-list
92480962|NCT01889966|Vasodilator Agents|vasodilator agents|mesh-ancestor
92480963|NCT01889966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92480964|NCT01889966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92480965|NCT01889966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92480966|NCT01889966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480967|NCT01889966|Urological Agents|urological agents|mesh-ancestor
92480968|NCT01889979|Tramadol|tramadol|mesh-list
92480969|NCT01889979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92480970|NCT01889979|Narcotics|narcotics|mesh-ancestor
92480971|NCT01889979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92480972|NCT01889979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480973|NCT01889979|Analgesics|analgesics|mesh-ancestor
92480974|NCT01889979|Sensory System Agents|sensory system agents|mesh-ancestor
92480975|NCT01889979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480976|NCT01890538|Dimenhydrinate|dimenhydrinate|mesh-list
92480977|NCT01890538|Piracetam|piracetam|mesh-list
92480978|NCT01890538|Antiemetics|antiemetics|mesh-ancestor
92480979|NCT01890538|Autonomic Agents|autonomic agents|mesh-ancestor
92480980|NCT01890538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92480981|NCT01890538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92480982|NCT01890538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92480983|NCT01890538|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92480984|NCT01890538|Histamine Antagonists|histamine antagonists|mesh-ancestor
92480985|NCT01890538|Histamine Agents|histamine agents|mesh-ancestor
92480986|NCT01890538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92480987|NCT01890538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92480988|NCT01890538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92480989|NCT01890538|Protective Agents|protective agents|mesh-ancestor
92480990|NCT01890538|Nootropic Agents|nootropic agents|mesh-ancestor
92480991|NCT01891292|Acetylcysteine|acetylcysteine|mesh-list
92480992|NCT01891292|Enalapril|enalapril|mesh-list
92480994|NCT01891292|Antiviral Agents|antiviral agents|mesh-ancestor
92480995|NCT01891292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92480996|NCT01891292|Expectorants|expectorants|mesh-ancestor
92480997|NCT01891292|Respiratory System Agents|respiratory system agents|mesh-ancestor
92480998|NCT01891292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92480999|NCT01891292|Antioxidants|antioxidants|mesh-ancestor
92481000|NCT01891292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481001|NCT01891292|Protective Agents|protective agents|mesh-ancestor
92481002|NCT01891292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481003|NCT01891292|Antidotes|antidotes|mesh-ancestor
92481004|NCT01891292|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92481005|NCT01891292|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481006|NCT01891292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481007|NCT01891292|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481008|NCT01891487|Bimatoprost|bimatoprost|mesh-list
92481009|NCT01891487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481010|NCT01891981|Immunotoxin HA22|immunotoxin ha22|mesh-list
92481011|NCT01891981|Immunotoxins|immunotoxins|mesh-ancestor
92481012|NCT01891981|Immunoconjugates|immunoconjugates|mesh-ancestor
92481013|NCT01891981|Immunologic Factors|immunologic factors|mesh-ancestor
92481014|NCT01891981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481015|NCT01891981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481016|NCT01892319|Insulin Detemir|insulin detemir|mesh-list
92481017|NCT01892319|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92481018|NCT01892319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481019|NCT01893229|Oxcarbazepine|oxcarbazepine|mesh-list
92481020|NCT01893229|Valproic Acid|valproic acid|mesh-list
92481021|NCT01893229|Olanzapine|olanzapine|mesh-list
92481022|NCT01893229|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92481023|NCT01893229|Ziprasidone|ziprasidone|mesh-list
92481024|NCT01893229|Lithium Carbonate|lithium carbonate|mesh-list
92481025|NCT01893229|Antiemetics|antiemetics|mesh-ancestor
92481026|NCT01893229|Autonomic Agents|autonomic agents|mesh-ancestor
92481027|NCT01893229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481028|NCT01893229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481029|NCT01893229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481030|NCT01893229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92481031|NCT01893229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92481032|NCT01893229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481033|NCT01893229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481034|NCT01893229|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92481035|NCT01893229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92481036|NCT01893229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481037|NCT01893229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481038|NCT01893229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481039|NCT01893229|Serotonin Agents|serotonin agents|mesh-ancestor
92481040|NCT01893229|Antidepressive Agents|antidepressive agents|mesh-ancestor
92481041|NCT01893229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481042|NCT01893229|Antimanic Agents|antimanic agents|mesh-ancestor
92481043|NCT01893229|Anticonvulsants|anticonvulsants|mesh-ancestor
92481044|NCT01893229|GABA Agents|gaba agents|mesh-ancestor
92481045|NCT01893229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92481046|NCT01893229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92481047|NCT01893229|Dopamine Agents|dopamine agents|mesh-ancestor
92481048|NCT01893229|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92481049|NCT01893229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92481050|NCT01893229|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92481051|NCT01893229|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92481052|NCT01894269|Lamivudine|lamivudine|mesh-list
92481053|NCT01894269|Entecavir|entecavir|mesh-list
92481054|NCT01894269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92481055|NCT01894269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92481056|NCT01894269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481057|NCT01894269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481058|NCT01894269|Antiviral Agents|antiviral agents|mesh-ancestor
92481059|NCT01894269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481060|NCT01894269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92481061|NCT01894269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92481062|NCT01894789|Clopidogrel|clopidogrel|mesh-list
92481063|NCT01894789|Ticagrelor|ticagrelor|mesh-list
92481064|NCT01894789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92481065|NCT01894789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92481066|NCT01894789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92481067|NCT01894789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92481068|NCT01894789|Purinergic Agents|purinergic agents|mesh-ancestor
92481069|NCT01894789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481070|NCT01894789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481071|NCT01894789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481072|NCT01894815|Dexetimide|dexetimide|mesh-list
92481073|NCT01894815|Citalopram|citalopram|mesh-list
92481074|NCT01894815|Escitalopram|escitalopram|mesh-list
92481075|NCT01894815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92481076|NCT01894815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92481077|NCT01894815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481078|NCT01894815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481079|NCT01894815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481080|NCT01894815|Serotonin Agents|serotonin agents|mesh-ancestor
92481081|NCT01894815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481082|NCT01894815|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92481083|NCT01894815|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92481084|NCT01894815|Parasympatholytics|parasympatholytics|mesh-ancestor
92481085|NCT01894815|Autonomic Agents|autonomic agents|mesh-ancestor
92481086|NCT01894815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481087|NCT01894815|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92481088|NCT01894815|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92481089|NCT01894815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92481090|NCT01894815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92481091|NCT01894815|Antidepressive Agents|antidepressive agents|mesh-ancestor
92481092|NCT01894815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481094|NCT01895049|Prednisone|prednisone|mesh-list
92481095|NCT01895049|Everolimus|everolimus|mesh-list
92481096|NCT01895049|Tacrolimus|tacrolimus|mesh-list
92481097|NCT01895049|Thymoglobulin|thymoglobulin|mesh-list
92481098|NCT01895049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92481099|NCT01895049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92481100|NCT01895049|Glucocorticoids|glucocorticoids|mesh-ancestor
92481101|NCT01895049|Hormones|hormones|mesh-ancestor
92481102|NCT01895049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481103|NCT01895049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481104|NCT01895049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92481105|NCT01895049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481106|NCT01895049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481107|NCT01895049|Immunologic Factors|immunologic factors|mesh-ancestor
92481108|NCT01895049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92481109|NCT01895049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481110|NCT01895049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481111|NCT01895049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92481112|NCT01895049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92481113|NCT01895049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92481114|NCT01895049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92481115|NCT01895049|Antitubercular Agents|antitubercular agents|mesh-ancestor
92481116|NCT01895049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481117|NCT01895049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481118|NCT01896622|Ritonavir|ritonavir|mesh-list
92481119|NCT01896622|Cobicistat|cobicistat|mesh-list
92481120|NCT01896622|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92481121|NCT01896622|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92481122|NCT01896622|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481123|NCT01896622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481124|NCT01896622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481125|NCT01896622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92481126|NCT01896622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92481127|NCT01896622|Antiviral Agents|antiviral agents|mesh-ancestor
92481128|NCT01896622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481129|NCT01896622|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92481130|NCT01896622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92481131|NCT01897051|Rifaximin|rifaximin|mesh-list
92481132|NCT01897051|Propranolol|propranolol|mesh-list
92481133|NCT01897051|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92481134|NCT01897051|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92481135|NCT01897051|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481136|NCT01897051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481137|NCT01897051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481138|NCT01897051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481139|NCT01897051|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92481140|NCT01897051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481141|NCT01897051|Vasodilator Agents|vasodilator agents|mesh-ancestor
92481142|NCT01897051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481143|NCT01897051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481144|NCT01897051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481145|NCT01897740|Sildenafil Citrate|sildenafil citrate|mesh-list
92481146|NCT01897740|Vasodilator Agents|vasodilator agents|mesh-ancestor
92481147|NCT01897740|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92481148|NCT01897740|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92481149|NCT01897740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481150|NCT01897740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481151|NCT01897740|Urological Agents|urological agents|mesh-ancestor
92481152|NCT01897753|Hormones|hormones|mesh-list
92481153|NCT01897753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481154|NCT01897753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481155|NCT01898065|Misonidazole|misonidazole|mesh-list
92481156|NCT01898065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481157|NCT01898065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92481158|NCT01898065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92481159|NCT01898065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481160|NCT01898221|Ethanol|ethanol|mesh-list
92481161|NCT01898221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92481162|NCT01898221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481163|NCT01898221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531947|NCT00049660|Antimitotic Agents|antimitotic agents|mesh-ancestor
92481164|NCT01898221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481165|NCT01898338|Daptomycin|daptomycin|mesh-list
92481166|NCT01898338|Fosfomycin|fosfomycin|mesh-list
92481167|NCT01898338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481168|NCT01898338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481170|NCT01899105|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92481171|NCT01899105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481172|NCT01899105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481173|NCT01900015|Efavirenz|efavirenz|mesh-list
92481174|NCT01900015|Raltegravir Potassium|raltegravir potassium|mesh-list
92481175|NCT01900015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92481176|NCT01900015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92481177|NCT01900015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481178|NCT01900015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481179|NCT01900015|Antiviral Agents|antiviral agents|mesh-ancestor
92481180|NCT01900015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481181|NCT01900015|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92481182|NCT01900015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92481183|NCT01900015|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92481184|NCT01900015|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92481185|NCT01900015|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92481186|NCT01900015|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92481187|NCT01900015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92481188|NCT01900015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92481189|NCT01900015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92481190|NCT01900015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92481191|NCT01900028|Itraconazole|itraconazole|mesh-list
92481192|NCT01900028|Olaparib|olaparib|mesh-list
92481193|NCT01900028|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92481194|NCT01900028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481195|NCT01900028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481196|NCT01900028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481197|NCT01900028|Antifungal Agents|antifungal agents|mesh-ancestor
92481198|NCT01900028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481199|NCT01900028|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92481200|NCT01900028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92481201|NCT01900028|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92481202|NCT01900028|Hormone Antagonists|hormone antagonists|mesh-ancestor
92481203|NCT01900028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481204|NCT01900028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481205|NCT01900028|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92481206|NCT01900041|Minoxidil|minoxidil|mesh-list
92481207|NCT01900041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481208|NCT01900041|Vasodilator Agents|vasodilator agents|mesh-ancestor
92481209|NCT01900093|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92481210|NCT01900093|Hormones|hormones|mesh-ancestor
92481211|NCT01900093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481212|NCT01900093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481213|NCT01900106|Ritonavir|ritonavir|mesh-list
92481214|NCT01900106|Darunavir|darunavir|mesh-list
92481215|NCT01900106|Lamivudine|lamivudine|mesh-list
92481216|NCT01900106|Raltegravir Potassium|raltegravir potassium|mesh-list
92481217|NCT01900106|Abacavir|abacavir|mesh-list
92481218|NCT01900106|Dideoxynucleosides|dideoxynucleosides|mesh-list
92481219|NCT01900106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92481220|NCT01900106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92481221|NCT01900106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481222|NCT01900106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349078|NCT01508676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481223|NCT01900106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481224|NCT01900106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92481225|NCT01900106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92481226|NCT01900106|Antiviral Agents|antiviral agents|mesh-ancestor
92481227|NCT01900106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481228|NCT01900106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92481229|NCT01900106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92481230|NCT01900106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92481231|NCT01900106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92481232|NCT01900106|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92481233|NCT01900106|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92481234|NCT01900106|Antimetabolites|antimetabolites|mesh-ancestor
92481235|NCT01900158|Cisplatin|cisplatin|mesh-list
92481236|NCT01900158|Gemcitabine|gemcitabine|mesh-list
92481237|NCT01900158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481238|NCT01900158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92481239|NCT01900158|Antimetabolites|antimetabolites|mesh-ancestor
92481240|NCT01900158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481241|NCT01900197|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92481242|NCT01900197|Hematinics|hematinics|mesh-ancestor
92481243|NCT01900301|Scopolamine|scopolamine|mesh-list
92481244|NCT01900301|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92481245|NCT01900301|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92481246|NCT01900301|Antiemetics|antiemetics|mesh-ancestor
92481247|NCT01900301|Autonomic Agents|autonomic agents|mesh-ancestor
92481248|NCT01900301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481249|NCT01900301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481250|NCT01900301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481251|NCT01900301|Mydriatics|mydriatics|mesh-ancestor
92481252|NCT01900301|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92481253|NCT01900301|Cholinergic Agents|cholinergic agents|mesh-ancestor
92481254|NCT01900301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481255|NCT01900301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481256|NCT01900301|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92481257|NCT01900301|Parasympatholytics|parasympatholytics|mesh-ancestor
92481258|NCT01900327|Gemcitabine|gemcitabine|mesh-list
92481259|NCT01900327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92481260|NCT01900327|Antimetabolites|antimetabolites|mesh-ancestor
92481261|NCT01900327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481262|NCT01900327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481263|NCT01900405|Dexmedetomidine|dexmedetomidine|mesh-list
92481264|NCT01900405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92481265|NCT01900405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481266|NCT01900405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481267|NCT01900405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92481268|NCT01900405|Analgesics|analgesics|mesh-ancestor
92481269|NCT01900405|Sensory System Agents|sensory system agents|mesh-ancestor
92481270|NCT01900405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481271|NCT01900405|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92481272|NCT01900405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92481273|NCT01900405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92481274|NCT01900405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481275|NCT01900405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481276|NCT01900405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481277|NCT01900496|Rituximab|rituximab|mesh-list
92481278|NCT01900496|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92481279|NCT01900496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92481280|NCT01900496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481281|NCT01900496|Immunologic Factors|immunologic factors|mesh-ancestor
92481282|NCT01900496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481283|NCT01900496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481284|NCT01900496|Immunotoxins|immunotoxins|mesh-ancestor
92481285|NCT01900496|Immunoconjugates|immunoconjugates|mesh-ancestor
92481286|NCT01900509|Dexamethasone|dexamethasone|mesh-list
92481287|NCT01900509|Etoposide|etoposide|mesh-list
92481288|NCT01900509|Etoposide phosphate|etoposide phosphate|mesh-list
92481289|NCT01900509|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92481290|NCT01900509|Clofarabine|clofarabine|mesh-list
92481291|NCT01900509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92481292|NCT01900509|Antiemetics|antiemetics|mesh-ancestor
92481293|NCT01900509|Autonomic Agents|autonomic agents|mesh-ancestor
92481294|NCT01900509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481295|NCT01900509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481296|NCT01900509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481297|NCT01900509|Glucocorticoids|glucocorticoids|mesh-ancestor
92481298|NCT01900509|Hormones|hormones|mesh-ancestor
92481299|NCT01900509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481300|NCT01900509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92481301|NCT01900509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481302|NCT01900509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92481303|NCT01900509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92481304|NCT01900509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92481305|NCT01900509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481306|NCT01900509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481307|NCT01900509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92481308|NCT01900509|Alkylating Agents|alkylating agents|mesh-ancestor
92531951|NCT05640713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481309|NCT01900509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92481310|NCT01900509|Antimetabolites|antimetabolites|mesh-ancestor
92481311|NCT01900587|Tapentadol|tapentadol|mesh-list
92481312|NCT01900587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92481313|NCT01900587|Narcotics|narcotics|mesh-ancestor
92481314|NCT01900587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481315|NCT01900587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481316|NCT01900587|Analgesics|analgesics|mesh-ancestor
92481317|NCT01900587|Sensory System Agents|sensory system agents|mesh-ancestor
92481318|NCT01900587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481319|NCT01900587|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92481320|NCT01900587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92481321|NCT01900587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481322|NCT01900587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481323|NCT01900587|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481324|NCT01900587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481325|NCT01900639|Aspirin|aspirin|mesh-list
92481326|NCT01900639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92481327|NCT01900639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92481328|NCT01900639|Analgesics|analgesics|mesh-ancestor
92481329|NCT01900639|Sensory System Agents|sensory system agents|mesh-ancestor
92481330|NCT01900639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481331|NCT01900639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481332|NCT01900639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92481333|NCT01900639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481334|NCT01900639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92481335|NCT01900639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92481336|NCT01900639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481337|NCT01900639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92481338|NCT01900639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92481339|NCT01900639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481340|NCT01900639|Antipyretics|antipyretics|mesh-ancestor
92481341|NCT01900717|Leucovorin|leucovorin|mesh-list
92481342|NCT01900717|Bevacizumab|bevacizumab|mesh-list
92481343|NCT01900717|Fluorouracil|fluorouracil|mesh-list
92481344|NCT01900717|Oxaliplatin|oxaliplatin|mesh-list
92481345|NCT01900717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92481346|NCT01900717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481347|NCT01900717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92481348|NCT01900717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92481349|NCT01900717|Growth Substances|growth substances|mesh-ancestor
92481350|NCT01900717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481351|NCT01900717|Growth Inhibitors|growth inhibitors|mesh-ancestor
92481352|NCT01900717|Antimetabolites|antimetabolites|mesh-ancestor
92481353|NCT01900717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481354|NCT01900717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92481355|NCT01900717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481356|NCT01900717|Immunologic Factors|immunologic factors|mesh-ancestor
92481357|NCT01900717|Antidotes|antidotes|mesh-ancestor
92481358|NCT01900717|Protective Agents|protective agents|mesh-ancestor
92481359|NCT01900717|Vitamin B Complex|vitamin b complex|mesh-ancestor
92481360|NCT01900717|Vitamins|vitamins|mesh-ancestor
92481361|NCT01900717|Micronutrients|micronutrients|mesh-ancestor
92481362|NCT01900795|Ibuprofen|ibuprofen|mesh-list
92481363|NCT01900795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92481364|NCT01900795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92481365|NCT01900795|Analgesics|analgesics|mesh-ancestor
92481366|NCT01900795|Sensory System Agents|sensory system agents|mesh-ancestor
92481367|NCT01900795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481368|NCT01900795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481369|NCT01900795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92481370|NCT01900795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481371|NCT01900795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92481372|NCT01900795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481373|NCT01900795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481374|NCT01900860|Vitamin D|vitamin d|mesh-list
92481375|NCT01900860|Ergocalciferols|ergocalciferols|mesh-list
92481376|NCT01900860|Cholecalciferol|cholecalciferol|mesh-list
92481377|NCT01900860|Vitamins|vitamins|mesh-list
92481378|NCT01900860|Micronutrients|micronutrients|mesh-ancestor
92481379|NCT01900860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481380|NCT01900860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92481381|NCT01900860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92481382|NCT01900886|Ribavirin|ribavirin|mesh-list
92481383|NCT01900886|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92481384|NCT01900886|Antimetabolites|antimetabolites|mesh-ancestor
92481385|NCT01900886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481386|NCT01900886|Antiviral Agents|antiviral agents|mesh-ancestor
92481387|NCT01900886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481388|NCT01900938|Midazolam|midazolam|mesh-list
92481389|NCT01900938|Propofol|propofol|mesh-list
92481390|NCT01900938|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92481391|NCT01900938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481392|NCT01900938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481393|NCT01900938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92481394|NCT01900938|Anesthetics, General|anesthetics, general|mesh-ancestor
92481395|NCT01900938|Anesthetics|anesthetics|mesh-ancestor
92481396|NCT01900938|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92481397|NCT01900938|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92481398|NCT01900938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92481399|NCT01900938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481400|NCT01900938|GABA Modulators|gaba modulators|mesh-ancestor
92481401|NCT01900938|GABA Agents|gaba agents|mesh-ancestor
92481402|NCT01900938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481403|NCT01900938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481404|NCT01900951|Temozolomide|temozolomide|mesh-list
92481405|NCT01900951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92481406|NCT01900951|Alkylating Agents|alkylating agents|mesh-ancestor
92481407|NCT01900951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481408|NCT01900951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481409|NCT01901003|Lorazepam|lorazepam|mesh-list
92481410|NCT01901003|Anticonvulsants|anticonvulsants|mesh-ancestor
92481411|NCT01901003|Antiemetics|antiemetics|mesh-ancestor
92481412|NCT01901003|Autonomic Agents|autonomic agents|mesh-ancestor
92481413|NCT01901003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481414|NCT01901003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481415|NCT01901003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481416|NCT01901003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92481417|NCT01901003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481418|NCT01901003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92481419|NCT01901003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92481420|NCT01901003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481421|NCT01901003|GABA Modulators|gaba modulators|mesh-ancestor
92481422|NCT01901003|GABA Agents|gaba agents|mesh-ancestor
92481423|NCT01901003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481424|NCT01901003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481425|NCT01901120|Mirabegron|mirabegron|mesh-list
92481426|NCT01901120|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92481427|NCT01901120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92481428|NCT01901120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92481429|NCT01901120|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481430|NCT01901120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481431|NCT01901120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481432|NCT01901120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481433|NCT01901120|Urological Agents|urological agents|mesh-ancestor
92481434|NCT01901172|Posaconazole|posaconazole|mesh-list
92481435|NCT01901172|Antifungal Agents|antifungal agents|mesh-ancestor
92481436|NCT01901172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481437|NCT01901172|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92481438|NCT01901172|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92481439|NCT01901172|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92349082|NCT02985372|Cytarabine|cytarabine|mesh-list
92481440|NCT01901172|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92481441|NCT01901172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92481442|NCT01901172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481443|NCT01901172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481444|NCT01901172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92481445|NCT01901172|Hormone Antagonists|hormone antagonists|mesh-ancestor
92481446|NCT01901172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481447|NCT01901172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481449|NCT01901198|Interferon-alpha|interferon-alpha|mesh-list
92481450|NCT01901198|Interferon alpha-2|interferon alpha-2|mesh-list
92481451|NCT01901198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481452|NCT01901198|Antiviral Agents|antiviral agents|mesh-ancestor
92481453|NCT01901198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481454|NCT01901198|Immunologic Factors|immunologic factors|mesh-ancestor
92481455|NCT01901198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481456|NCT01901276|Omeprazole|omeprazole|mesh-list
92481457|NCT01901276|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92481458|NCT01901276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481459|NCT01901276|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92481461|NCT01901276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481462|NCT01901380|Caseins|caseins|mesh-list
92481463|NCT01901380|Chelating Agents|chelating agents|mesh-ancestor
92481464|NCT01901380|Sequestering Agents|sequestering agents|mesh-ancestor
92481465|NCT01901380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481466|NCT01901432|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92481467|NCT01901432|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92481468|NCT01901432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481469|NCT01901432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481470|NCT01901471|Cyclosporine|cyclosporine|mesh-list
92481471|NCT01901471|Cyclosporins|cyclosporins|mesh-list
92481472|NCT01901471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481473|NCT01901471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481474|NCT01901471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481475|NCT01901471|Immunologic Factors|immunologic factors|mesh-ancestor
92481476|NCT01901471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481477|NCT01901471|Antifungal Agents|antifungal agents|mesh-ancestor
92481478|NCT01901471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481479|NCT01901471|Dermatologic Agents|dermatologic agents|mesh-ancestor
92481480|NCT01901471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481481|NCT01901471|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92481482|NCT01901484|Praziquantel|praziquantel|mesh-list
92481483|NCT01901484|Anthelmintics|anthelmintics|mesh-ancestor
92481484|NCT01901484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92481485|NCT01901484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481486|NCT01901549|Metoprolol|metoprolol|mesh-list
92481487|NCT01901549|Lisinopril|lisinopril|mesh-list
92481488|NCT01901549|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92481489|NCT01901549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481490|NCT01901549|Sympatholytics|sympatholytics|mesh-ancestor
92481491|NCT01901549|Autonomic Agents|autonomic agents|mesh-ancestor
92481492|NCT01901549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481493|NCT01901549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481494|NCT01901549|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92481495|NCT01901549|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92481496|NCT01901549|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92481497|NCT01901549|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481498|NCT01901549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481499|NCT01901549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481500|NCT01901549|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92481501|NCT01901549|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481502|NCT01901549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481503|NCT01901549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92481504|NCT01901549|Protective Agents|protective agents|mesh-ancestor
92481505|NCT01901601|Anesthetics|anesthetics|mesh-list
92481506|NCT01901601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481507|NCT01901601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481508|NCT01901640|Udenafil|udenafil|mesh-list
92481509|NCT01901640|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92481510|NCT01901640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92481511|NCT01901640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481512|NCT01901640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481513|NCT01901666|Hormones|hormones|mesh-list
92322564|NCT04713254|Dopamine Agents|dopamine agents|mesh-ancestor
92481514|NCT01901666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481515|NCT01901666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481516|NCT01901692|Sorafenib|sorafenib|mesh-list
92481517|NCT01901692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481518|NCT01901692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92481519|NCT01901692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481520|NCT01901692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481521|NCT01902017|Ketotifen|ketotifen|mesh-list
92481522|NCT01902017|Antipruritics|antipruritics|mesh-ancestor
92481523|NCT01902017|Dermatologic Agents|dermatologic agents|mesh-ancestor
92481524|NCT01902017|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92481525|NCT01902017|Histamine Antagonists|histamine antagonists|mesh-ancestor
92481526|NCT01902017|Histamine Agents|histamine agents|mesh-ancestor
92481527|NCT01902017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481528|NCT01902017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481529|NCT01902017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481530|NCT01902017|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92481531|NCT01902108|Clonidine|clonidine|mesh-list
92481532|NCT01902108|Bupivacaine|bupivacaine|mesh-list
92481533|NCT01902108|Anesthetics, Local|anesthetics, local|mesh-ancestor
92481534|NCT01902108|Anesthetics|anesthetics|mesh-ancestor
92481535|NCT01902108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481536|NCT01902108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481537|NCT01902108|Sensory System Agents|sensory system agents|mesh-ancestor
92481538|NCT01902108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481539|NCT01902108|Analgesics|analgesics|mesh-ancestor
92481540|NCT01902108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481541|NCT01902108|Sympatholytics|sympatholytics|mesh-ancestor
92481542|NCT01902108|Autonomic Agents|autonomic agents|mesh-ancestor
92481543|NCT01902108|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92481544|NCT01902108|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92481545|NCT01902108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92481546|NCT01902108|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481547|NCT01902108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481548|NCT01902108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481549|NCT01902121|Insulin|insulin|mesh-list
92481550|NCT01902121|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92481551|NCT01902121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92481552|NCT01902121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481553|NCT01902160|Sirolimus|sirolimus|mesh-list
92481554|NCT01902160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92481555|NCT01902160|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92481556|NCT01902160|Temsirolimus|temsirolimus|mesh-list
92481557|NCT01902160|MTOR Inhibitors|mtor inhibitors|mesh-list
92481558|NCT01902160|Antibodies|antibodies|mesh-list
92481559|NCT01902160|Immunoglobulins|immunoglobulins|mesh-list
92481560|NCT01902160|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92481561|NCT01902160|Immunoconjugates|immunoconjugates|mesh-list
92481562|NCT01902160|Immunologic Factors|immunologic factors|mesh-ancestor
92481563|NCT01902160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481564|NCT01902160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481565|NCT01902160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481566|NCT01902160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481567|NCT01902160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92481568|NCT01902160|Antifungal Agents|antifungal agents|mesh-ancestor
92481569|NCT01902160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481570|NCT01902160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92481571|NCT01902160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481572|NCT01902160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481573|NCT01902160|Immunotoxins|immunotoxins|mesh-ancestor
92481574|NCT01902186|Ritonavir|ritonavir|mesh-list
92481575|NCT01902186|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92481576|NCT01902186|Tenofovir|tenofovir|mesh-list
92481577|NCT01902186|Emtricitabine|emtricitabine|mesh-list
92481578|NCT01902186|Raltegravir Potassium|raltegravir potassium|mesh-list
92481579|NCT01902186|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92481580|NCT01902186|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92481581|NCT01902186|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481582|NCT01902186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481583|NCT01902186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481584|NCT01902186|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92481585|NCT01902186|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92481586|NCT01902186|Antiviral Agents|antiviral agents|mesh-ancestor
92481587|NCT01902186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481588|NCT01902186|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92481589|NCT01902186|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92481590|NCT01902186|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92481591|NCT01902186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92481592|NCT01902186|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92481593|NCT01902186|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92481594|NCT01901861|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92481595|NCT01901861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92481596|NCT01901861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481597|NCT01901861|Incretins|incretins|mesh-ancestor
92481598|NCT01901861|Hormones|hormones|mesh-ancestor
92481599|NCT01901861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481600|NCT01901861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92481601|NCT01901861|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481603|NCT01901861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481604|NCT01902225|Doxorubicin|doxorubicin|mesh-list
92481605|NCT01902225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92481606|NCT01902225|Romidepsin|romidepsin|mesh-list
92481607|NCT01902225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92481608|NCT01902225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481609|NCT01902225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92481610|NCT01902225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92481611|NCT01902225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481612|NCT01902225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481613|NCT01902225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92481614|NCT01902238|Ethanol|ethanol|mesh-list
92481615|NCT01902238|Ethiodized Oil|ethiodized oil|mesh-list
92481616|NCT01902238|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92481617|NCT01902238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481618|NCT01902238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481619|NCT01902238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481620|NCT01902238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481621|NCT01902342|Oseltamivir|oseltamivir|mesh-list
92481622|NCT01902342|Antiviral Agents|antiviral agents|mesh-ancestor
92481623|NCT01902342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481624|NCT01902342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481625|NCT01902342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481626|NCT01902446|Chlorhexidine|chlorhexidine|mesh-list
92481627|NCT01902446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92481628|NCT01902446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92481629|NCT01902446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481630|NCT01902446|Disinfectants|disinfectants|mesh-ancestor
92481631|NCT01902446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92481632|NCT01902485|Contraceptive Agents|contraceptive agents|mesh-list
92481633|NCT01902485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92481634|NCT01902485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481635|NCT01902498|Aspirin|aspirin|mesh-list
92481636|NCT01902498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92481637|NCT01902498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92481638|NCT01902498|Analgesics|analgesics|mesh-ancestor
92481639|NCT01902498|Sensory System Agents|sensory system agents|mesh-ancestor
92481640|NCT01902498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481641|NCT01902498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481642|NCT01902498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92481643|NCT01902498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481644|NCT01902498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92481645|NCT01902498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92481646|NCT01902498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481647|NCT01902498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92481648|NCT01902498|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92481649|NCT01902498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481650|NCT01902498|Antipyretics|antipyretics|mesh-ancestor
92481651|NCT01902511|Epoetin Alfa|epoetin alfa|mesh-list
92481652|NCT01902511|Lenograstim|lenograstim|mesh-list
92481653|NCT01902511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92481654|NCT01902511|Immunologic Factors|immunologic factors|mesh-ancestor
92481655|NCT01902511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481656|NCT01902511|Hematinics|hematinics|mesh-ancestor
92481657|NCT01902524|Fentanyl|fentanyl|mesh-list
92349094|NCT02985216|Pregabalin|pregabalin|mesh-list
92481658|NCT01902524|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92481659|NCT01902524|Narcotics|narcotics|mesh-ancestor
92481660|NCT01902524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481661|NCT01902524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481662|NCT01902524|Analgesics|analgesics|mesh-ancestor
92481663|NCT01902524|Sensory System Agents|sensory system agents|mesh-ancestor
92481664|NCT01902524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481665|NCT01902524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92481666|NCT01902524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92481667|NCT01902524|Anesthetics, General|anesthetics, general|mesh-ancestor
92481668|NCT01902524|Anesthetics|anesthetics|mesh-ancestor
92481669|NCT01902537|Prucalopride|prucalopride|mesh-list
92481670|NCT01902537|Laxatives|laxatives|mesh-ancestor
92481671|NCT01902537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481672|NCT01902537|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92481673|NCT01902537|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92481674|NCT01902537|Serotonin Agents|serotonin agents|mesh-ancestor
92481675|NCT01902537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481676|NCT01902537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481677|NCT01902537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481679|NCT01902550|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92481680|NCT01902550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481681|NCT01902550|Sympatholytics|sympatholytics|mesh-ancestor
92481682|NCT01902550|Autonomic Agents|autonomic agents|mesh-ancestor
92481683|NCT01902550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481684|NCT01902550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481685|NCT01902550|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92481686|NCT01902550|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92481687|NCT01902550|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92481688|NCT01902550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481689|NCT01902550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481690|NCT01902550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481691|NCT01902641|Rocuronium|rocuronium|mesh-list
92481692|NCT01902641|Succinylcholine|succinylcholine|mesh-list
92481693|NCT01902641|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92481694|NCT01902641|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92481695|NCT01902641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92481696|NCT01902641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481697|NCT01902641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481698|NCT01902641|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92481699|NCT01902771|Imiquimod|imiquimod|mesh-list
92481700|NCT01902771|Vaccines|vaccines|mesh-list
92481701|NCT01902771|Immunologic Factors|immunologic factors|mesh-ancestor
92481702|NCT01902771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481703|NCT01902771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92481704|NCT01902771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481705|NCT01902771|Interferon Inducers|interferon inducers|mesh-ancestor
92481706|NCT01902810|Propranolol|propranolol|mesh-list
92481707|NCT01902810|Metoprolol|metoprolol|mesh-list
92481708|NCT01902810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92481709|NCT01902810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92481710|NCT01902810|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481711|NCT01902810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481712|NCT01902810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481713|NCT01902810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481714|NCT01902810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92481715|NCT01902810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92481716|NCT01902810|Vasodilator Agents|vasodilator agents|mesh-ancestor
92481717|NCT01902810|Sympatholytics|sympatholytics|mesh-ancestor
92481718|NCT01902810|Autonomic Agents|autonomic agents|mesh-ancestor
92481719|NCT01902810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481720|NCT01902810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92481721|NCT01902862|Rituximab|rituximab|mesh-list
92481722|NCT01902862|Bortezomib|bortezomib|mesh-list
92481723|NCT01902862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92481724|NCT01902862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481725|NCT01902862|Immunologic Factors|immunologic factors|mesh-ancestor
92481726|NCT01902862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481727|NCT01902862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92481728|NCT01902875|Paclitaxel|paclitaxel|mesh-list
92481729|NCT01902875|Cisplatin|cisplatin|mesh-list
92481730|NCT01902875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92481731|NCT01902875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481732|NCT01902875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92481733|NCT01902875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92481734|NCT01902875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92481735|NCT01902875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481736|NCT01903018|Cisplatin|cisplatin|mesh-list
92481738|NCT01903057|Azithromycin|azithromycin|mesh-list
92481739|NCT01903057|Ivermectin|ivermectin|mesh-list
92481740|NCT01903057|Albendazole|albendazole|mesh-list
92481741|NCT01903057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481742|NCT01903057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481743|NCT01903057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92481744|NCT01903057|Anthelmintics|anthelmintics|mesh-ancestor
92481745|NCT01903057|Anticestodal Agents|anticestodal agents|mesh-ancestor
92481746|NCT01903057|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92481747|NCT01903057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92481748|NCT01903057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92481749|NCT01903057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92481750|NCT01903057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92481751|NCT01903057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481752|NCT01903057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481753|NCT01903070|Linagliptin|linagliptin|mesh-list
92481754|NCT01903070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92481755|NCT01903070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481756|NCT01903070|Incretins|incretins|mesh-ancestor
92481757|NCT01903070|Hormones|hormones|mesh-ancestor
92481758|NCT01903070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481759|NCT01903070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92481760|NCT01903070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481761|NCT01903070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481762|NCT01903070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481763|NCT01903083|Gemcitabine|gemcitabine|mesh-list
92481764|NCT01903083|Tadalafil|tadalafil|mesh-list
92481765|NCT01903083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92481766|NCT01903083|Antimetabolites|antimetabolites|mesh-ancestor
92481767|NCT01903083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481768|NCT01903083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481769|NCT01903083|Vasodilator Agents|vasodilator agents|mesh-ancestor
92481770|NCT01903083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92481771|NCT01903083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92481772|NCT01903083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481773|NCT01903083|Urological Agents|urological agents|mesh-ancestor
92481774|NCT01903096|Antidepressive Agents|antidepressive agents|mesh-list
92481775|NCT01903096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481776|NCT01903109|Cevimeline|cevimeline|mesh-list
92481777|NCT01903109|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92481778|NCT01903109|Autonomic Agents|autonomic agents|mesh-ancestor
92481779|NCT01903109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481780|NCT01903109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481781|NCT01903109|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92481782|NCT01903109|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92481783|NCT01903109|Cholinergic Agents|cholinergic agents|mesh-ancestor
92481784|NCT01903109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481785|NCT01903109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481786|NCT01903122|Cevimeline|cevimeline|mesh-list
92481787|NCT01903122|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92481788|NCT01903122|Autonomic Agents|autonomic agents|mesh-ancestor
92481789|NCT01903122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481790|NCT01903122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481791|NCT01903122|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92481792|NCT01903122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92481793|NCT01903122|Cholinergic Agents|cholinergic agents|mesh-ancestor
92481794|NCT01903122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481795|NCT01903122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481796|NCT01903200|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92481797|NCT01903200|Antidepressive Agents|antidepressive agents|mesh-ancestor
92481798|NCT01903200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481799|NCT01903200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92481800|NCT01903200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92481801|NCT01903200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481802|NCT01903200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481803|NCT01903278|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92481804|NCT01903278|Antiviral Agents|antiviral agents|mesh-ancestor
92481805|NCT01903278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481806|NCT01903291|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92481807|NCT01903291|Dermatologic Agents|dermatologic agents|mesh-ancestor
92481808|NCT01903291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481809|NCT01903291|Immunologic Factors|immunologic factors|mesh-ancestor
92481810|NCT01903291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481811|NCT01903681|Melatonin|melatonin|mesh-list
92481812|NCT01903681|Antioxidants|antioxidants|mesh-ancestor
92481813|NCT01903681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481814|NCT01903681|Protective Agents|protective agents|mesh-ancestor
92481815|NCT01903681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481816|NCT01903681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481818|NCT01903694|Pravastatin|pravastatin|mesh-list
92481819|NCT01903694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481820|NCT01903694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92481821|NCT01903694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481822|NCT01903694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481823|NCT01903694|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92481824|NCT01903694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92481825|NCT01903694|Antimetabolites|antimetabolites|mesh-ancestor
92481826|NCT01903694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92481827|NCT01903694|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92481829|NCT01903785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92481830|NCT01903785|Autonomic Agents|autonomic agents|mesh-ancestor
92481831|NCT01903785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481832|NCT01903785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481833|NCT01903785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92481834|NCT01903785|Respiratory System Agents|respiratory system agents|mesh-ancestor
92481835|NCT01903785|Tocolytic Agents|tocolytic agents|mesh-ancestor
92481836|NCT01903785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92481837|NCT01903785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92481838|NCT01903785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92481839|NCT01903785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92481840|NCT01903785|Adrenergic Agents|adrenergic agents|mesh-ancestor
92481841|NCT01903785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481842|NCT01903785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481843|NCT01903824|Modafinil|modafinil|mesh-list
92481845|NCT01903824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92481846|NCT01903824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481847|NCT01903824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481848|NCT01903824|Cholinergic Agents|cholinergic agents|mesh-ancestor
92481849|NCT01903824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481850|NCT01903824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481851|NCT01903824|Nootropic Agents|nootropic agents|mesh-ancestor
92481852|NCT01903824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92481853|NCT01903824|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92481854|NCT01903824|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92481855|NCT01903824|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92481856|NCT01904045|Tacrolimus|tacrolimus|mesh-list
92481857|NCT01904045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481858|NCT01904045|Immunologic Factors|immunologic factors|mesh-ancestor
92481859|NCT01904045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481860|NCT01904045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92481861|NCT01904045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481862|NCT01904045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481863|NCT01904097|Pregabalin|pregabalin|mesh-list
92481864|NCT01904097|Analgesics|analgesics|mesh-ancestor
92481865|NCT01904097|Sensory System Agents|sensory system agents|mesh-ancestor
92481866|NCT01904097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481867|NCT01904097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481868|NCT01904097|Anticonvulsants|anticonvulsants|mesh-ancestor
92481869|NCT01904097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92481870|NCT01904097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481871|NCT01904097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481872|NCT01904097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92481873|NCT01904097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92481874|NCT01904097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92481875|NCT01904097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92481876|NCT01904097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92481877|NCT01904110|Cholecalciferol|cholecalciferol|mesh-list
92481878|NCT01904110|Vitamin D|vitamin d|mesh-list
92481879|NCT01904110|Risedronic Acid|risedronic acid|mesh-list
92481880|NCT01904110|Etidronic Acid|etidronic acid|mesh-list
92481881|NCT01904110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92481882|NCT01904110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481883|NCT01904110|Vitamins|vitamins|mesh-ancestor
92481884|NCT01904110|Micronutrients|micronutrients|mesh-ancestor
92481885|NCT01904110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92481886|NCT01904110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92481887|NCT01904110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481888|NCT01904110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481889|NCT01904162|Finafloxacin|finafloxacin|mesh-list
92481890|NCT01904162|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92481891|NCT01904162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481892|NCT01904162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481893|NCT01904162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92481894|NCT01904162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92481895|NCT01904162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481896|NCT01904162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481897|NCT01904162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481899|NCT01904214|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92481900|NCT01904214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481901|NCT01904214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481902|NCT01904214|Immunologic Factors|immunologic factors|mesh-ancestor
92481903|NCT01904214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481904|NCT01904253|Topotecan|topotecan|mesh-list
92481905|NCT01904253|Amrubicin|amrubicin|mesh-list
92481906|NCT01904253|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92481907|NCT01904253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92481908|NCT01904253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481909|NCT01904253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481910|NCT01904253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481911|NCT01904357|Cefazolin|cefazolin|mesh-list
92481912|NCT01904357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481913|NCT01904357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481914|NCT01904487|Tiagabine|tiagabine|mesh-list
92481915|NCT01904487|Flumazenil|flumazenil|mesh-list
92481916|NCT01904487|Antidotes|antidotes|mesh-ancestor
92481917|NCT01904487|Protective Agents|protective agents|mesh-ancestor
92481918|NCT01904487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481919|NCT01904487|GABA Modulators|gaba modulators|mesh-ancestor
92481920|NCT01904487|GABA Agents|gaba agents|mesh-ancestor
92481921|NCT01904487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92481922|NCT01904487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481923|NCT01904487|Anticonvulsants|anticonvulsants|mesh-ancestor
92481924|NCT01904487|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92481925|NCT01904487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92481926|NCT01904487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481927|NCT01904500|Cefazolin|cefazolin|mesh-list
92481928|NCT01904500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92481929|NCT01904500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481930|NCT01904539|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92481931|NCT01904539|Cathartics|cathartics|mesh-ancestor
92481932|NCT01904539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92481933|NCT01904591|Vitamin E|vitamin e|mesh-list
92481934|NCT01904591|Selenium|selenium|mesh-list
92481935|NCT01904591|Vitamins|vitamins|mesh-ancestor
92481936|NCT01904591|Micronutrients|micronutrients|mesh-ancestor
92481937|NCT01904591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481938|NCT01904591|Antioxidants|antioxidants|mesh-ancestor
92481939|NCT01904591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481940|NCT01904591|Protective Agents|protective agents|mesh-ancestor
92481941|NCT01904591|Trace Elements|trace elements|mesh-ancestor
92481942|NCT01904643|Cytarabine|cytarabine|mesh-list
92481943|NCT01904643|Etoposide|etoposide|mesh-list
92481944|NCT01904643|Mitoxantrone|mitoxantrone|mesh-list
92481945|NCT01904643|Lenalidomide|lenalidomide|mesh-list
92481946|NCT01904643|Etoposide phosphate|etoposide phosphate|mesh-list
92481947|NCT01904643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92481948|NCT01904643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481949|NCT01904643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92481950|NCT01904643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92481951|NCT01904643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349103|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92481952|NCT01904643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481953|NCT01904643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92481954|NCT01904643|Antimetabolites|antimetabolites|mesh-ancestor
92481955|NCT01904643|Antiviral Agents|antiviral agents|mesh-ancestor
92481956|NCT01904643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92481957|NCT01904643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92481958|NCT01904643|Immunologic Factors|immunologic factors|mesh-ancestor
92481959|NCT01904643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481960|NCT01904643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92481961|NCT01904643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92481962|NCT01904643|Growth Substances|growth substances|mesh-ancestor
92481963|NCT01904643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92481964|NCT01904643|Analgesics|analgesics|mesh-ancestor
92481965|NCT01904643|Sensory System Agents|sensory system agents|mesh-ancestor
92481966|NCT01904643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92481967|NCT01904682|ON 01910|on 01910|mesh-list
92481968|NCT01904682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481969|NCT01904682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92481970|NCT01904682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481971|NCT01904682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481972|NCT01904695|Antihypertensive Agents|antihypertensive agents|mesh-list
92481973|NCT01904695|Diuretics|diuretics|mesh-list
92481974|NCT01904695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92481975|NCT01904695|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92481976|NCT01904695|Natriuretic Agents|natriuretic agents|mesh-ancestor
92481977|NCT01904695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481978|NCT01904695|Protease Inhibitors|protease inhibitors|mesh-ancestor
92481979|NCT01904695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481980|NCT01904695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481981|NCT01904695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92481982|NCT01904734|Clomiphene|clomiphene|mesh-list
92481983|NCT01904734|Enclomiphene|enclomiphene|mesh-list
92481984|NCT01904734|Zuclomiphene|zuclomiphene|mesh-list
92481985|NCT01904734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92481986|NCT01904734|Hormone Antagonists|hormone antagonists|mesh-ancestor
92481987|NCT01904734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92481988|NCT01904734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92481989|NCT01904734|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92481990|NCT01904734|Fertility Agents|fertility agents|mesh-ancestor
92481991|NCT01904734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92481992|NCT01904734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92206883|NCT02359305|Acetaminophen|acetaminophen|mesh-list
92481993|NCT01904734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92481994|NCT01904747|Palbociclib|palbociclib|mesh-list
92481995|NCT01904747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92481996|NCT01904747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92481997|NCT01904747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92481998|NCT01904747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92481999|NCT01904786|Melatonin|melatonin|mesh-list
92482000|NCT01904786|Antioxidants|antioxidants|mesh-ancestor
92482001|NCT01904786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482002|NCT01904786|Protective Agents|protective agents|mesh-ancestor
92482003|NCT01904786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482004|NCT01904786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482005|NCT01904981|Atenolol|atenolol|mesh-list
92482006|NCT01904981|Valsartan|valsartan|mesh-list
92482007|NCT01904981|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92482008|NCT01904981|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92482009|NCT01904981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92482010|NCT01904981|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92482011|NCT01904981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482012|NCT01904981|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92482013|NCT01904981|Adrenergic Agents|adrenergic agents|mesh-ancestor
92482014|NCT01904981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482015|NCT01904981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482016|NCT01904981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92482017|NCT01904981|Sympatholytics|sympatholytics|mesh-ancestor
92482018|NCT01904981|Autonomic Agents|autonomic agents|mesh-ancestor
92482019|NCT01904981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482020|NCT01904981|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92482021|NCT01904994|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92482022|NCT01904994|Antiviral Agents|antiviral agents|mesh-ancestor
92482023|NCT01904994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482024|NCT01905059|Lamivudine|lamivudine|mesh-list
92482025|NCT01905059|Lopinavir|lopinavir|mesh-list
92482026|NCT01905059|Darunavir|darunavir|mesh-list
92482027|NCT01905059|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92482028|NCT01905059|Protease Inhibitors|protease inhibitors|mesh-list
92482029|NCT01905059|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92482030|NCT01905059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92482031|NCT01905059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482032|NCT01905059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482033|NCT01905059|Antiviral Agents|antiviral agents|mesh-ancestor
92482034|NCT01905059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482035|NCT01905059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92482036|NCT01905059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92482037|NCT01905059|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92482038|NCT01905059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92482039|NCT01905059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92482040|NCT01905137|Botulinum Toxins|botulinum toxins|mesh-list
92482041|NCT01905137|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92482042|NCT01905137|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92482043|NCT01905137|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92482044|NCT01905137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482045|NCT01905137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482046|NCT01905137|Cholinergic Agents|cholinergic agents|mesh-ancestor
92482047|NCT01905137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482048|NCT01905137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482049|NCT01905137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92482050|NCT01905137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482051|NCT01905150|Leucovorin|leucovorin|mesh-list
92482052|NCT01905150|Ascorbic Acid|ascorbic acid|mesh-list
92482053|NCT01905150|Gemcitabine|gemcitabine|mesh-list
92482054|NCT01905150|Fluorouracil|fluorouracil|mesh-list
92482055|NCT01905150|Docetaxel|docetaxel|mesh-list
92482056|NCT01905150|Oxaliplatin|oxaliplatin|mesh-list
92482057|NCT01905150|Irinotecan|irinotecan|mesh-list
92482058|NCT01905150|Mitomycins|mitomycins|mesh-list
92482059|NCT01905150|Mitomycin|mitomycin|mesh-list
92482060|NCT01905150|Levoleucovorin|levoleucovorin|mesh-list
92482061|NCT01905150|Vitamins|vitamins|mesh-ancestor
92482062|NCT01905150|Micronutrients|micronutrients|mesh-ancestor
92482063|NCT01905150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482064|NCT01905150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92482065|NCT01905150|Antimetabolites|antimetabolites|mesh-ancestor
92482066|NCT01905150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482067|NCT01905150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482068|NCT01905150|Tubulin Modulators|tubulin modulators|mesh-ancestor
92482069|NCT01905150|Antimitotic Agents|antimitotic agents|mesh-ancestor
92482070|NCT01905150|Mitosis Modulators|mitosis modulators|mesh-ancestor
92482071|NCT01905150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482072|NCT01905150|Immunologic Factors|immunologic factors|mesh-ancestor
92482073|NCT01905150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92482074|NCT01905150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482075|NCT01905150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482077|NCT01905150|Protective Agents|protective agents|mesh-ancestor
92482078|NCT01905150|Vitamin B Complex|vitamin b complex|mesh-ancestor
92482079|NCT01905150|Antioxidants|antioxidants|mesh-ancestor
92482080|NCT01905150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92482081|NCT01905150|Alkylating Agents|alkylating agents|mesh-ancestor
92482082|NCT01905150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92482083|NCT01905215|Vaccines|vaccines|mesh-list
92482084|NCT01905215|Immunologic Factors|immunologic factors|mesh-ancestor
92482085|NCT01905215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482086|NCT01905371|Amphetamine|amphetamine|mesh-list
92482087|NCT01905371|Dextroamphetamine|dextroamphetamine|mesh-list
92482088|NCT01905371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92482089|NCT01905371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482090|NCT01905371|Sympathomimetics|sympathomimetics|mesh-ancestor
92482091|NCT01905371|Autonomic Agents|autonomic agents|mesh-ancestor
92482092|NCT01905371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482093|NCT01905371|Dopamine Agents|dopamine agents|mesh-ancestor
92482094|NCT01905371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482095|NCT01905371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482096|NCT01905371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92482097|NCT01905371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92482098|NCT01905371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92482099|NCT01905371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482100|NCT01905371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92482101|NCT01905501|Anesthetics|anesthetics|mesh-list
92482102|NCT01905501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482103|NCT01905501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482104|NCT01905566|Clopidogrel|clopidogrel|mesh-list
92482105|NCT01905566|Ticagrelor|ticagrelor|mesh-list
92482106|NCT01905566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92482107|NCT01905566|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92482108|NCT01905566|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92482109|NCT01905566|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92482110|NCT01905566|Purinergic Agents|purinergic agents|mesh-ancestor
92482111|NCT01905566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482112|NCT01905566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482113|NCT01905566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482114|NCT01905618|Nicotine|nicotine|mesh-list
92482115|NCT01905618|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92482116|NCT01905618|Autonomic Agents|autonomic agents|mesh-ancestor
92482117|NCT01905618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482118|NCT01905618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482119|NCT01905618|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92482120|NCT01905618|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92482121|NCT01905618|Cholinergic Agents|cholinergic agents|mesh-ancestor
92482122|NCT01905618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482123|NCT01905618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482125|NCT01905696|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92482126|NCT01905696|Antiviral Agents|antiviral agents|mesh-ancestor
92482127|NCT01905696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482128|NCT01905696|Expectorants|expectorants|mesh-ancestor
92482129|NCT01905696|Respiratory System Agents|respiratory system agents|mesh-ancestor
92482130|NCT01905696|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92482131|NCT01905696|Antioxidants|antioxidants|mesh-ancestor
92482132|NCT01905696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482133|NCT01905696|Protective Agents|protective agents|mesh-ancestor
92482134|NCT01905696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482135|NCT01905696|Antidotes|antidotes|mesh-ancestor
92482136|NCT01905774|Deferasirox|deferasirox|mesh-list
92482137|NCT01905774|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92482138|NCT01905774|Chelating Agents|chelating agents|mesh-ancestor
92482139|NCT01905774|Sequestering Agents|sequestering agents|mesh-ancestor
92482140|NCT01905774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207035|NCT00768599|Econazole|econazole|mesh-list
92482141|NCT01905904|Sevoflurane|sevoflurane|mesh-list
92482142|NCT01905904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92482143|NCT01905904|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92482144|NCT01905904|Anesthetics, General|anesthetics, general|mesh-ancestor
92482145|NCT01905904|Anesthetics|anesthetics|mesh-ancestor
92482146|NCT01905904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482147|NCT01905904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482149|NCT01906073|Morphine|morphine|mesh-list
92482150|NCT01906073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92482151|NCT01906073|Narcotics|narcotics|mesh-ancestor
92482152|NCT01906073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482153|NCT01906073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482154|NCT01906073|Analgesics|analgesics|mesh-ancestor
92482155|NCT01906073|Sensory System Agents|sensory system agents|mesh-ancestor
92482156|NCT01906073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482157|NCT01906073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92482158|NCT01906073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92482159|NCT01906073|Anesthetics, General|anesthetics, general|mesh-ancestor
92482160|NCT01906073|Anesthetics|anesthetics|mesh-ancestor
92482161|NCT01906125|Palbociclib|palbociclib|mesh-list
92482162|NCT01906125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482163|NCT01906125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92482164|NCT01906125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482165|NCT01906125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482166|NCT01906216|Sorafenib|sorafenib|mesh-list
92482167|NCT01906216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482168|NCT01906216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92482169|NCT01906216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482170|NCT01906216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482171|NCT01906242|Chlorhexidine|chlorhexidine|mesh-list
92482172|NCT01906242|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92482173|NCT01906242|Eusol|eusol|mesh-list
92482174|NCT01906242|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92482175|NCT01906242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482176|NCT01906242|Disinfectants|disinfectants|mesh-ancestor
92482177|NCT01906294|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92482178|NCT01906294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482179|NCT01906307|Angiotensin II|angiotensin ii|mesh-list
92482180|NCT01906307|Giapreza|giapreza|mesh-list
92482181|NCT01906307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92482182|NCT01906411|Dopamine|dopamine|mesh-list
92482183|NCT01906411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92482184|NCT01906411|Sympathomimetics|sympathomimetics|mesh-ancestor
92482185|NCT01906411|Autonomic Agents|autonomic agents|mesh-ancestor
92482186|NCT01906411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482187|NCT01906411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482189|NCT01906411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482190|NCT01906411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482191|NCT01906411|Protective Agents|protective agents|mesh-ancestor
92482192|NCT01906450|Azithromycin|azithromycin|mesh-list
92482193|NCT01906450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482194|NCT01906450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482195|NCT01906528|Mivacurium|mivacurium|mesh-list
92482196|NCT01906528|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92482197|NCT01906528|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92482198|NCT01906528|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92482199|NCT01906528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482200|NCT01906528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482201|NCT01906580|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92482202|NCT01906580|Entecavir|entecavir|mesh-list
92482203|NCT01906580|Antiviral Agents|antiviral agents|mesh-ancestor
92482204|NCT01906580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482205|NCT01906632|Immunomodulating Agents|immunomodulating agents|mesh-list
92482206|NCT01906632|Immunologic Factors|immunologic factors|mesh-ancestor
92482207|NCT01906632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482208|NCT01906671|Mercaptopurine|mercaptopurine|mesh-list
92482209|NCT01906671|Antimetabolites|antimetabolites|mesh-ancestor
92482210|NCT01906671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482211|NCT01906671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92482212|NCT01906671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482213|NCT01906671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482214|NCT01906671|Immunologic Factors|immunologic factors|mesh-ancestor
92482215|NCT01906671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482216|NCT01906671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92482217|NCT01906671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482218|NCT01906749|Colchicine|colchicine|mesh-list
92482219|NCT01906749|Gout Suppressants|gout suppressants|mesh-ancestor
92482220|NCT01906749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482221|NCT01906749|Tubulin Modulators|tubulin modulators|mesh-ancestor
92482222|NCT01906749|Antimitotic Agents|antimitotic agents|mesh-ancestor
92482223|NCT01906749|Mitosis Modulators|mitosis modulators|mesh-ancestor
92482224|NCT01906749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482225|NCT01906749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482226|NCT01906762|Acetaminophen|acetaminophen|mesh-list
92482227|NCT01906762|Morphine|morphine|mesh-list
92482228|NCT01906762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92482229|NCT01906762|Narcotics|narcotics|mesh-ancestor
92482230|NCT01906762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482231|NCT01906762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482232|NCT01906762|Analgesics|analgesics|mesh-ancestor
92482233|NCT01906762|Sensory System Agents|sensory system agents|mesh-ancestor
92482234|NCT01906762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482235|NCT01906762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92482236|NCT01906762|Antipyretics|antipyretics|mesh-ancestor
92482237|NCT01906788|Lumefantrine|lumefantrine|mesh-list
92482238|NCT01906788|Artemether|artemether|mesh-list
92482239|NCT01906788|Primaquine|primaquine|mesh-list
92482240|NCT01906788|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92482241|NCT01906788|Antimalarials|antimalarials|mesh-ancestor
92482242|NCT01906788|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92482243|NCT01906788|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92482244|NCT01906788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482245|NCT01906801|Diacerein|diacerein|mesh-list
92482246|NCT01906801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482247|NCT01906879|Bismuth|bismuth|mesh-list
92482248|NCT01906879|Antacids|antacids|mesh-ancestor
92482249|NCT01906879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482250|NCT01906879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482251|NCT01906944|Triamcinolone|triamcinolone|mesh-list
92482252|NCT01906944|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92482253|NCT01906944|Bupivacaine|bupivacaine|mesh-list
92482254|NCT01906944|Anesthetics, Local|anesthetics, local|mesh-ancestor
92482255|NCT01906944|Anesthetics|anesthetics|mesh-ancestor
92482256|NCT01906944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482257|NCT01906944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482258|NCT01906944|Sensory System Agents|sensory system agents|mesh-ancestor
92482259|NCT01906944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482260|NCT01906944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482261|NCT01906944|Glucocorticoids|glucocorticoids|mesh-ancestor
92482262|NCT01906944|Hormones|hormones|mesh-ancestor
92482263|NCT01906944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482264|NCT01906944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482265|NCT01906944|Immunologic Factors|immunologic factors|mesh-ancestor
92482266|NCT01907048|Rivaroxaban|rivaroxaban|mesh-list
92482267|NCT01907048|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92482268|NCT01907048|Antithrombins|antithrombins|mesh-ancestor
92482269|NCT01907048|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92482270|NCT01907048|Protease Inhibitors|protease inhibitors|mesh-ancestor
92482271|NCT01907048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482272|NCT01907048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482274|NCT01907061|Acetylcysteine|acetylcysteine|mesh-list
92482275|NCT01907061|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92482276|NCT01907061|Antiviral Agents|antiviral agents|mesh-ancestor
92482277|NCT01907061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482278|NCT01907061|Expectorants|expectorants|mesh-ancestor
92482279|NCT01907061|Respiratory System Agents|respiratory system agents|mesh-ancestor
92482280|NCT01907061|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92482281|NCT01907061|Antioxidants|antioxidants|mesh-ancestor
92482282|NCT01907061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482283|NCT01907061|Protective Agents|protective agents|mesh-ancestor
92482284|NCT01907061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482285|NCT01907061|Antidotes|antidotes|mesh-ancestor
92482286|NCT01907074|Cholic Acids|cholic acids|mesh-list
92482287|NCT01907074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482288|NCT01907165|Copper|copper|mesh-list
92482289|NCT01907165|Temozolomide|temozolomide|mesh-list
92482290|NCT01907165|Disulfiram|disulfiram|mesh-list
92482291|NCT01907165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92482292|NCT01907165|Alkylating Agents|alkylating agents|mesh-ancestor
92482293|NCT01907165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482294|NCT01907165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482295|NCT01907165|Trace Elements|trace elements|mesh-ancestor
92482296|NCT01907165|Micronutrients|micronutrients|mesh-ancestor
92482297|NCT01907165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482298|NCT01907165|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92482299|NCT01907165|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92482300|NCT01907165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482301|NCT01907204|Methylprednisolone|methylprednisolone|mesh-list
92482302|NCT01907204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92482303|NCT01907204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92482304|NCT01907204|Prednisolone|prednisolone|mesh-list
92482305|NCT01907204|Prednisolone acetate|prednisolone acetate|mesh-list
92482306|NCT01907204|Budesonide|budesonide|mesh-list
92482307|NCT01907204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92482308|NCT01907204|Prednisolone phosphate|prednisolone phosphate|mesh-list
92482309|NCT01907204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482310|NCT01907204|Antiemetics|antiemetics|mesh-ancestor
92482311|NCT01907204|Autonomic Agents|autonomic agents|mesh-ancestor
92482312|NCT01907204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482313|NCT01907204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482314|NCT01907204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482315|NCT01907204|Glucocorticoids|glucocorticoids|mesh-ancestor
92482316|NCT01907204|Hormones|hormones|mesh-ancestor
92482317|NCT01907204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482318|NCT01907204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92482319|NCT01907204|Protective Agents|protective agents|mesh-ancestor
92482320|NCT01907204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92482321|NCT01907204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482322|NCT01907204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92482323|NCT01907204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92482324|NCT01907204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92482325|NCT01907230|Entecavir|entecavir|mesh-list
92482326|NCT01907230|Antiviral Agents|antiviral agents|mesh-ancestor
92482327|NCT01907230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482328|NCT01907308|Docetaxel|docetaxel|mesh-list
92482329|NCT01907308|Trebananib|trebananib|mesh-list
92482330|NCT01907308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482331|NCT01907308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92482332|NCT01907308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92482333|NCT01907308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92482334|NCT01907308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482335|NCT01907308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92482336|NCT01907308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92482337|NCT01907308|Growth Substances|growth substances|mesh-ancestor
92482338|NCT01907308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482339|NCT01907308|Growth Inhibitors|growth inhibitors|mesh-ancestor
92482340|NCT01907373|Probenecid|probenecid|mesh-list
92482341|NCT01907373|Olmesartan|olmesartan|mesh-list
92482342|NCT01907373|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92482343|NCT01907373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92482344|NCT01907373|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92482345|NCT01907373|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92482346|NCT01907373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482347|NCT01907373|Uricosuric Agents|uricosuric agents|mesh-ancestor
92482348|NCT01907373|Gout Suppressants|gout suppressants|mesh-ancestor
92482349|NCT01907373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482350|NCT01907529|Cyclophosphamide|cyclophosphamide|mesh-list
92482351|NCT01907529|Docetaxel|docetaxel|mesh-list
92482352|NCT01907529|Epirubicin|epirubicin|mesh-list
92482353|NCT01907529|Endostar protein|endostar protein|mesh-list
92482354|NCT01907529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482355|NCT01907529|Immunologic Factors|immunologic factors|mesh-ancestor
92482356|NCT01907529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482357|NCT01907529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482358|NCT01907529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92482359|NCT01907529|Alkylating Agents|alkylating agents|mesh-ancestor
92482360|NCT01907529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482361|NCT01907529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482362|NCT01907529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92482363|NCT01907529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92482364|NCT01907529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92482365|NCT01907529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92482366|NCT01907529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92482367|NCT01907529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92482368|NCT01907529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482369|NCT01907529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482370|NCT01907529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92482371|NCT01907529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92482372|NCT01907529|Growth Substances|growth substances|mesh-ancestor
92482373|NCT01907529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92482374|NCT01907594|Cycloserine|cycloserine|mesh-list
92482375|NCT01907594|Nicotine|nicotine|mesh-list
92482376|NCT01907594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92482377|NCT01907594|Autonomic Agents|autonomic agents|mesh-ancestor
92482378|NCT01907594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482379|NCT01907594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482380|NCT01907594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92482381|NCT01907594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92482382|NCT01907594|Cholinergic Agents|cholinergic agents|mesh-ancestor
92482383|NCT01907594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482384|NCT01907594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482385|NCT01907594|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92482386|NCT01907594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482387|NCT01907594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92482388|NCT01907594|Antitubercular Agents|antitubercular agents|mesh-ancestor
92482389|NCT01907594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482390|NCT01907594|Antimetabolites|antimetabolites|mesh-ancestor
92482391|NCT01907633|Domperidone|domperidone|mesh-list
92482392|NCT01907633|Antiemetics|antiemetics|mesh-ancestor
92482393|NCT01907633|Autonomic Agents|autonomic agents|mesh-ancestor
92482394|NCT01907633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482395|NCT01907633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482396|NCT01907633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482397|NCT01907633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92482398|NCT01907633|Dopamine Agents|dopamine agents|mesh-ancestor
92482399|NCT01907633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482400|NCT01907633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482401|NCT01907685|Docetaxel|docetaxel|mesh-list
92482402|NCT01907685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482403|NCT01907685|Tubulin Modulators|tubulin modulators|mesh-ancestor
92482404|NCT01907685|Antimitotic Agents|antimitotic agents|mesh-ancestor
92482405|NCT01907685|Mitosis Modulators|mitosis modulators|mesh-ancestor
92482406|NCT01907685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482407|NCT01907724|Simeprevir|simeprevir|mesh-list
92482408|NCT01907724|Antiviral Agents|antiviral agents|mesh-ancestor
92482409|NCT01907724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482410|NCT01907724|Protease Inhibitors|protease inhibitors|mesh-ancestor
92482411|NCT01907724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482412|NCT01907724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482413|NCT01907776|Arbekacin|arbekacin|mesh-list
92482414|NCT01907776|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92482415|NCT01907776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482416|NCT01907776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482417|NCT01907802|Dabrafenib|dabrafenib|mesh-list
92482418|NCT01907802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482419|NCT01907802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92482420|NCT01907802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531973|NCT00049777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482421|NCT01907802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482423|NCT01907867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92482424|NCT01907867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482425|NCT01907867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482426|NCT01907867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92482427|NCT01907867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482428|NCT01907867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482429|NCT01907867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482430|NCT01907867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482431|NCT01907880|Zoledronic Acid|zoledronic acid|mesh-list
92482432|NCT01907880|Pamidronate|pamidronate|mesh-list
92482433|NCT01907880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92482434|NCT01907880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482435|NCT01907984|Diclofenac|diclofenac|mesh-list
92482436|NCT01907984|Midazolam|midazolam|mesh-list
92482437|NCT01907984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92482438|NCT01907984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92482439|NCT01907984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482440|NCT01907984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482441|NCT01907984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92482442|NCT01907984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92482443|NCT01907984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92482444|NCT01907984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92482445|NCT01907984|Anesthetics, General|anesthetics, general|mesh-ancestor
92482446|NCT01907984|Anesthetics|anesthetics|mesh-ancestor
92482447|NCT01907984|GABA Modulators|gaba modulators|mesh-ancestor
92482448|NCT01907984|GABA Agents|gaba agents|mesh-ancestor
92482449|NCT01907984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482450|NCT01907984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207340|NCT00775931|Cyclophosphamide|cyclophosphamide|mesh-list
92482451|NCT01907984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92482452|NCT01907984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92482453|NCT01907984|Analgesics|analgesics|mesh-ancestor
92482454|NCT01907984|Sensory System Agents|sensory system agents|mesh-ancestor
92482455|NCT01907984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482456|NCT01907984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482457|NCT01907984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482458|NCT01907984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92482459|NCT01907984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482460|NCT01907997|Lidocaine|lidocaine|mesh-list
92482461|NCT01907997|Anesthetics, Local|anesthetics, local|mesh-ancestor
92482462|NCT01907997|Anesthetics|anesthetics|mesh-ancestor
92482463|NCT01907997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482464|NCT01907997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482465|NCT01907997|Sensory System Agents|sensory system agents|mesh-ancestor
92482466|NCT01907997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482467|NCT01907997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92482468|NCT01907997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92482469|NCT01907997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92482470|NCT01907997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482471|NCT01907997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349118|NCT01506726|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92482472|NCT01908075|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92482473|NCT01908075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92482474|NCT01908075|Autonomic Agents|autonomic agents|mesh-ancestor
92482475|NCT01908075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482476|NCT01908075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482477|NCT01908075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92482478|NCT01908075|Respiratory System Agents|respiratory system agents|mesh-ancestor
92482479|NCT01908075|Glucocorticoids|glucocorticoids|mesh-ancestor
92482480|NCT01908075|Hormones|hormones|mesh-ancestor
92482481|NCT01908075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482482|NCT01908075|Sympathomimetics|sympathomimetics|mesh-ancestor
92482483|NCT01908114|Vaccines|vaccines|mesh-list
92482484|NCT01908114|Immunologic Factors|immunologic factors|mesh-ancestor
92482485|NCT01908114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482486|NCT01908257|Lesinurad|lesinurad|mesh-list
92482487|NCT01908257|Ranitidine|ranitidine|mesh-list
92482488|NCT01908257|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92482489|NCT01908257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92482490|NCT01908257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482491|NCT01908257|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92482492|NCT01908257|Histamine Antagonists|histamine antagonists|mesh-ancestor
92482493|NCT01908257|Histamine Agents|histamine agents|mesh-ancestor
92482494|NCT01908257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482495|NCT01908257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482496|NCT01908257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482497|NCT01908257|Gout Suppressants|gout suppressants|mesh-ancestor
92482498|NCT01908257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482499|NCT01908257|Uricosuric Agents|uricosuric agents|mesh-ancestor
92482500|NCT01908283|Vaccines|vaccines|mesh-list
92482501|NCT01908283|Immunologic Factors|immunologic factors|mesh-ancestor
92482502|NCT01908283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482503|NCT01908296|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92482504|NCT01908296|Fluvoxamine|fluvoxamine|mesh-list
92482505|NCT01908296|Antidepressive Agents|antidepressive agents|mesh-ancestor
92482506|NCT01908296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92482507|NCT01908296|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92482508|NCT01908296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92482509|NCT01908296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482510|NCT01908296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482511|NCT01908296|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92482512|NCT01908296|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92482513|NCT01908296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92482514|NCT01908296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482515|NCT01908296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482516|NCT01908296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482517|NCT01908296|Serotonin Agents|serotonin agents|mesh-ancestor
92482518|NCT01908296|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92482519|NCT01908296|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92482520|NCT01908296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92482521|NCT01908296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482522|NCT01908296|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92207416|NCT04345445|Antiemetics|antiemetics|mesh-ancestor
92482523|NCT01908322|Sorafenib|sorafenib|mesh-list
92482524|NCT01908322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482525|NCT01908322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92482526|NCT01908322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482527|NCT01908322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482528|NCT01908335|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92482529|NCT01908335|Interferon-alpha|interferon-alpha|mesh-list
92482530|NCT01908335|Antiviral Agents|antiviral agents|mesh-ancestor
92482531|NCT01908335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482532|NCT01908335|Immunologic Factors|immunologic factors|mesh-ancestor
92482533|NCT01908335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482534|NCT01908348|Erythritol|erythritol|mesh-list
92482535|NCT01908348|Vasodilator Agents|vasodilator agents|mesh-ancestor
92482536|NCT01908387|Azacitidine|azacitidine|mesh-list
92482537|NCT01908387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92482538|NCT01908387|Antimetabolites|antimetabolites|mesh-ancestor
92482539|NCT01908387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482540|NCT01908387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482541|NCT01908387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482542|NCT01908452|Pyridoxine|pyridoxine|mesh-list
92482543|NCT01908452|Vitamin B Complex|vitamin b complex|mesh-ancestor
92482544|NCT01908452|Vitamins|vitamins|mesh-ancestor
92482545|NCT01908452|Micronutrients|micronutrients|mesh-ancestor
92482546|NCT01908452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482547|NCT01908478|Gemcitabine|gemcitabine|mesh-list
92482548|NCT01908478|Veliparib|veliparib|mesh-list
92482549|NCT01908478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92482550|NCT01908478|Antimetabolites|antimetabolites|mesh-ancestor
92482551|NCT01908478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482552|NCT01908478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482553|NCT01908478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92482554|NCT01908478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482555|NCT01908556|Letrozole|letrozole|mesh-list
92482556|NCT01908556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482557|NCT01908556|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92482558|NCT01908556|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92482559|NCT01908556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482560|NCT01908556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482561|NCT01908556|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92482562|NCT01908556|Hormone Antagonists|hormone antagonists|mesh-ancestor
92482563|NCT01908556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482564|NCT01908556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482566|NCT01908621|Lenograstim|lenograstim|mesh-list
92482567|NCT01908621|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92482568|NCT01908621|Immunologic Factors|immunologic factors|mesh-ancestor
92482569|NCT01908621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482570|NCT01908621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92482571|NCT01908621|Antimetabolites|antimetabolites|mesh-ancestor
92482572|NCT01908621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482573|NCT01908621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482574|NCT01908621|Antiviral Agents|antiviral agents|mesh-ancestor
92482575|NCT01908621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482576|NCT01908621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482577|NCT01908660|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92482578|NCT01908660|Antiviral Agents|antiviral agents|mesh-ancestor
92482579|NCT01908660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482580|NCT01908894|Insulin Lispro|insulin lispro|mesh-list
92482581|NCT01908894|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92482582|NCT01908894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482583|NCT01909037|Curcumin|curcumin|mesh-list
92482584|NCT01909037|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92482585|NCT01909037|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92482586|NCT01909037|Analgesics|analgesics|mesh-ancestor
92482587|NCT01909037|Sensory System Agents|sensory system agents|mesh-ancestor
92482588|NCT01909037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482589|NCT01909037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482590|NCT01909037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482591|NCT01909037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482592|NCT01909037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482593|NCT01909037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482594|NCT01909037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482595|NCT01909063|Vitamin D|vitamin d|mesh-list
92482596|NCT01909063|Ergocalciferols|ergocalciferols|mesh-list
92207492|NCT04876131|Cephalexin|cephalexin|mesh-list
92482597|NCT01909063|Cholecalciferol|cholecalciferol|mesh-list
92482598|NCT01909063|Vitamins|vitamins|mesh-list
92482600|NCT01909063|Vitamin A|vitamin a|mesh-list
92482601|NCT01909063|Micronutrients|micronutrients|mesh-ancestor
92482602|NCT01909063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482603|NCT01909063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92482604|NCT01909063|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92482605|NCT01909063|Antioxidants|antioxidants|mesh-ancestor
92482606|NCT01909063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482607|NCT01909063|Protective Agents|protective agents|mesh-ancestor
92482608|NCT01909115|Vitamin D|vitamin d|mesh-list
92482609|NCT01909115|Ergocalciferols|ergocalciferols|mesh-list
92482610|NCT01909115|Cholecalciferol|cholecalciferol|mesh-list
92482611|NCT01909115|Vitamins|vitamins|mesh-list
92482612|NCT01909115|Micronutrients|micronutrients|mesh-ancestor
92482613|NCT01909115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482614|NCT01909115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92482615|NCT01909115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92482616|NCT01909219|Magnesium citrate|magnesium citrate|mesh-list
92482617|NCT01909219|Picosulfate sodium|picosulfate sodium|mesh-list
92482618|NCT01909219|Cathartics|cathartics|mesh-ancestor
92482619|NCT01909219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482620|NCT01909557|Acetylcarnitine|acetylcarnitine|mesh-list
92482621|NCT01909557|Vitamin B Complex|vitamin b complex|mesh-ancestor
92482622|NCT01909557|Vitamins|vitamins|mesh-ancestor
92482623|NCT01909557|Micronutrients|micronutrients|mesh-ancestor
92482624|NCT01909557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482625|NCT01909557|Nootropic Agents|nootropic agents|mesh-ancestor
92482626|NCT01909622|Vitamin D|vitamin d|mesh-list
92482627|NCT01909622|Ergocalciferols|ergocalciferols|mesh-list
92482628|NCT01909622|Cholecalciferol|cholecalciferol|mesh-list
92482629|NCT01909622|Vitamins|vitamins|mesh-list
92482630|NCT01909622|Micronutrients|micronutrients|mesh-ancestor
92482631|NCT01909622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482632|NCT01909622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92482633|NCT01909622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92482634|NCT01909661|Caseins|caseins|mesh-list
92482635|NCT01909661|Chelating Agents|chelating agents|mesh-ancestor
92482636|NCT01909661|Sequestering Agents|sequestering agents|mesh-ancestor
92482637|NCT01909661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482638|NCT01909752|Cyclophosphamide|cyclophosphamide|mesh-list
92482639|NCT01909752|Imiquimod|imiquimod|mesh-list
92482640|NCT01909752|Vaccines|vaccines|mesh-list
92482641|NCT01909752|Immunologic Factors|immunologic factors|mesh-ancestor
92482642|NCT01909752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482643|NCT01909752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482644|NCT01909752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482645|NCT01909752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92482646|NCT01909752|Alkylating Agents|alkylating agents|mesh-ancestor
92482647|NCT01909752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482648|NCT01909752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482649|NCT01909752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92482650|NCT01909752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92482651|NCT01909752|Interferon Inducers|interferon inducers|mesh-ancestor
92482653|NCT01909830|Pemetrexed|pemetrexed|mesh-list
92482654|NCT01909830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92482655|NCT01909830|Antimetabolites|antimetabolites|mesh-ancestor
92482656|NCT01909830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482657|NCT01909830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482658|NCT01909830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482659|NCT01909830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92482660|NCT01909830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92482661|NCT01909843|Gontivimab|gontivimab|mesh-list
92482662|NCT01909843|Antiviral Agents|antiviral agents|mesh-ancestor
92482663|NCT01909843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482664|NCT01909856|Dexamethasone|dexamethasone|mesh-list
92482665|NCT01909856|Palonosetron|palonosetron|mesh-list
92482666|NCT01909856|Granisetron|granisetron|mesh-list
92482667|NCT01909856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482668|NCT01909856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482669|NCT01909856|Antiemetics|antiemetics|mesh-ancestor
92482670|NCT01909856|Autonomic Agents|autonomic agents|mesh-ancestor
92482671|NCT01909856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482672|NCT01909856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482673|NCT01909856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482674|NCT01909856|Glucocorticoids|glucocorticoids|mesh-ancestor
92482675|NCT01909856|Hormones|hormones|mesh-ancestor
92482676|NCT01909856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482677|NCT01909856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92482678|NCT01909856|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92482679|NCT01909856|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92482680|NCT01909856|Serotonin Agents|serotonin agents|mesh-ancestor
92482681|NCT01909856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482682|NCT01909856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482683|NCT01910077|Tacrolimus|tacrolimus|mesh-list
92482684|NCT01910077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482685|NCT01910077|Immunologic Factors|immunologic factors|mesh-ancestor
92482686|NCT01910077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482687|NCT01910077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92482688|NCT01910077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482689|NCT01910077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482690|NCT01910090|Flurbiprofen|flurbiprofen|mesh-list
92482691|NCT01910090|Famotidine|famotidine|mesh-list
92482692|NCT01910090|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92482693|NCT01910090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482694|NCT01910090|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92482695|NCT01910090|Histamine Antagonists|histamine antagonists|mesh-ancestor
92482696|NCT01910090|Histamine Agents|histamine agents|mesh-ancestor
92482697|NCT01910090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150471|NCT01381679|Ezetimibe|ezetimibe|mesh-list
92482698|NCT01910090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482699|NCT01910090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482700|NCT01910090|Analgesics|analgesics|mesh-ancestor
92482701|NCT01910090|Sensory System Agents|sensory system agents|mesh-ancestor
92482702|NCT01910090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482703|NCT01910090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92482704|NCT01910090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92482705|NCT01910090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482706|NCT01910090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482707|NCT01910090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92482708|NCT01910090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482709|NCT01910142|Vitamin K|vitamin k|mesh-list
92482710|NCT01910142|Calcium|calcium|mesh-list
92482711|NCT01910142|Vitamins|vitamins|mesh-ancestor
92482712|NCT01910142|Micronutrients|micronutrients|mesh-ancestor
92482713|NCT01910142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482714|NCT01910142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92482715|NCT01910142|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92482716|NCT01910142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92531982|NCT00049972|Paroxetine|paroxetine|mesh-list
92482717|NCT01910142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482718|NCT01910142|Hemostatics|hemostatics|mesh-ancestor
92482719|NCT01910142|Coagulants|coagulants|mesh-ancestor
92482720|NCT01910155|Ciprofloxacin|ciprofloxacin|mesh-list
92482721|NCT01910155|Dexamethasone|dexamethasone|mesh-list
92482722|NCT01910155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482723|NCT01910155|Antiemetics|antiemetics|mesh-ancestor
92482724|NCT01910155|Autonomic Agents|autonomic agents|mesh-ancestor
92482725|NCT01910155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482726|NCT01910155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482727|NCT01910155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482728|NCT01910155|Glucocorticoids|glucocorticoids|mesh-ancestor
92482730|NCT01910155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482731|NCT01910155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92482732|NCT01910155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482733|NCT01910155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482734|NCT01910155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482735|NCT01910155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92482736|NCT01910155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482737|NCT01910155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482738|NCT01910155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482739|NCT01910155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92482740|NCT01910155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92482741|NCT01910194|Insulin Glargine|insulin glargine|mesh-list
92482742|NCT01910194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92482743|NCT01910194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482744|NCT01910246|Metformin|metformin|mesh-list
92482745|NCT01910246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92482746|NCT01910246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482747|NCT01910259|Amiloride|amiloride|mesh-list
92482748|NCT01910259|Riluzole|riluzole|mesh-list
92482749|NCT01910259|Fluoxetine|fluoxetine|mesh-list
92482750|NCT01910259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92482751|NCT01910259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92482752|NCT01910259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482753|NCT01910259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482754|NCT01910259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482755|NCT01910259|Serotonin Agents|serotonin agents|mesh-ancestor
92482756|NCT01910259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482757|NCT01910259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92482758|NCT01910259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92482759|NCT01910259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92482760|NCT01910259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92482761|NCT01910259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92482762|NCT01910259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482763|NCT01910259|Anticonvulsants|anticonvulsants|mesh-ancestor
92482764|NCT01910259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92482765|NCT01910259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92482766|NCT01910259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92482767|NCT01910259|Protective Agents|protective agents|mesh-ancestor
92482768|NCT01910259|Diuretics|diuretics|mesh-ancestor
92482769|NCT01910259|Natriuretic Agents|natriuretic agents|mesh-ancestor
92482770|NCT01910259|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92482771|NCT01910259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92482772|NCT01910259|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92482773|NCT01910259|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92482774|NCT01910285|Sufentanil|sufentanil|mesh-list
92482775|NCT01910285|Dsuvia|dsuvia|mesh-list
92482776|NCT01910285|Remifentanil|remifentanil|mesh-list
92482777|NCT01910285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92482778|NCT01910285|Narcotics|narcotics|mesh-ancestor
92482779|NCT01910285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482780|NCT01910285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482781|NCT01910285|Analgesics|analgesics|mesh-ancestor
92482782|NCT01910285|Sensory System Agents|sensory system agents|mesh-ancestor
92482783|NCT01910285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482784|NCT01910285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92482785|NCT01910285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92482786|NCT01910285|Anesthetics, General|anesthetics, general|mesh-ancestor
92482787|NCT01910285|Anesthetics|anesthetics|mesh-ancestor
92482788|NCT01910363|Botulinum Toxins|botulinum toxins|mesh-list
92482789|NCT01910363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92482790|NCT01910363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92482791|NCT01910363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92482792|NCT01910363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482793|NCT01910363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482794|NCT01910363|Cholinergic Agents|cholinergic agents|mesh-ancestor
92482795|NCT01910363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482796|NCT01910363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482797|NCT01910363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92482798|NCT01910363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482800|NCT01910415|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92482801|NCT01910415|Ivacaftor|ivacaftor|mesh-list
92482802|NCT01910415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482803|NCT01910415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482804|NCT01910415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92482805|NCT01910415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482806|NCT01910415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482807|NCT01910415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482808|NCT01910415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482809|NCT01910415|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92482810|NCT01910415|Contraceptive Agents|contraceptive agents|mesh-ancestor
92482811|NCT01910415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92482812|NCT01910415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482813|NCT01910415|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92482814|NCT01910415|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92482815|NCT01910415|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92482816|NCT01910415|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92482817|NCT01910415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482818|NCT01910428|Asparaginase|asparaginase|mesh-list
92482819|NCT01910428|Eryaspase|eryaspase|mesh-list
92482820|NCT01910428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482821|NCT01910480|Ketoconazole|ketoconazole|mesh-list
92482822|NCT01910480|Antifungal Agents|antifungal agents|mesh-ancestor
92482823|NCT01910480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482824|NCT01910480|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92482825|NCT01910480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92482826|NCT01910480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482827|NCT01910480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482828|NCT01910480|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92482829|NCT01910480|Hormone Antagonists|hormone antagonists|mesh-ancestor
92482830|NCT01910480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482831|NCT01910480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482832|NCT01910480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92482833|NCT01910506|Verinurad|verinurad|mesh-list
92482834|NCT01910506|Gout Suppressants|gout suppressants|mesh-ancestor
92482835|NCT01910506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482836|NCT01910532|Clevidipine|clevidipine|mesh-list
92482837|NCT01910532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92482838|NCT01910532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482839|NCT01910532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482840|NCT01910532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92482841|NCT01910532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482842|NCT01910545|OTS167|ots167|mesh-list
92482843|NCT01910545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92482844|NCT01910545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482845|NCT01910545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482846|NCT01910610|Bevacizumab|bevacizumab|mesh-list
92482847|NCT01910610|Cetuximab|cetuximab|mesh-list
92482848|NCT01910610|Panitumumab|panitumumab|mesh-list
92482849|NCT01910610|Irinotecan|irinotecan|mesh-list
92482850|NCT01910610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92482851|NCT01910610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482852|NCT01910610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92482853|NCT01910610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92482854|NCT01910610|Growth Substances|growth substances|mesh-ancestor
92482855|NCT01910610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482856|NCT01910610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92482857|NCT01910610|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92482858|NCT01910610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482859|NCT01910610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482860|NCT01910610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482862|NCT01910766|Coenzyme Q10|coenzyme q10|mesh-list
92482863|NCT01910766|Clomiphene|clomiphene|mesh-list
92482864|NCT01910766|Enclomiphene|enclomiphene|mesh-list
92482865|NCT01910766|Zuclomiphene|zuclomiphene|mesh-list
92482866|NCT01910766|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92482867|NCT01910766|Hormone Antagonists|hormone antagonists|mesh-ancestor
92482868|NCT01910766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482869|NCT01910766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482870|NCT01910766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92482871|NCT01910766|Fertility Agents|fertility agents|mesh-ancestor
92482872|NCT01910766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92482873|NCT01910766|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92482874|NCT01910766|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92482875|NCT01910766|Micronutrients|micronutrients|mesh-ancestor
92482876|NCT01910766|Vitamins|vitamins|mesh-ancestor
92482877|NCT01910844|Cyclophosphamide|cyclophosphamide|mesh-list
92482878|NCT01910844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482879|NCT01910844|Immunologic Factors|immunologic factors|mesh-ancestor
92482880|NCT01910844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482881|NCT01910844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482882|NCT01910844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92482883|NCT01910844|Alkylating Agents|alkylating agents|mesh-ancestor
92482884|NCT01910844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482885|NCT01910844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482886|NCT01910844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92482887|NCT01910870|Cyclophosphamide|cyclophosphamide|mesh-list
92482888|NCT01910870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92482889|NCT01910870|Immunologic Factors|immunologic factors|mesh-ancestor
92482890|NCT01910870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482891|NCT01910870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92482892|NCT01910870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92482893|NCT01910870|Alkylating Agents|alkylating agents|mesh-ancestor
92482894|NCT01910870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482895|NCT01910870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482896|NCT01910870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92482897|NCT01910883|Finafloxacin|finafloxacin|mesh-list
92482898|NCT01910883|Fluoroquinolones|fluoroquinolones|mesh-list
92482899|NCT01910883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92482900|NCT01910883|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92482901|NCT01910883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482902|NCT01910883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92482903|NCT01910883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92482904|NCT01910883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92482906|NCT01910883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482907|NCT01910883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482908|NCT01910883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92482909|NCT01910987|Dexamethasone|dexamethasone|mesh-list
92482910|NCT01910987|Dexamethasone acetate|dexamethasone acetate|mesh-list
92482911|NCT01910987|Bortezomib|bortezomib|mesh-list
92482912|NCT01910987|BB 1101|bb 1101|mesh-list
92482913|NCT01910987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92482914|NCT01910987|Antiemetics|antiemetics|mesh-ancestor
92482915|NCT01910987|Autonomic Agents|autonomic agents|mesh-ancestor
92482916|NCT01910987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482917|NCT01910987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482918|NCT01910987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482919|NCT01910987|Glucocorticoids|glucocorticoids|mesh-ancestor
92482920|NCT01910987|Hormones|hormones|mesh-ancestor
92482921|NCT01910987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482922|NCT01910987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92482923|NCT01910987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482924|NCT01910987|Protease Inhibitors|protease inhibitors|mesh-ancestor
92482925|NCT01910987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92482926|NCT01910987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482927|NCT01911195|Isoflurane|isoflurane|mesh-list
92482928|NCT01911195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92482929|NCT01911195|Anesthetics, General|anesthetics, general|mesh-ancestor
92482930|NCT01911195|Anesthetics|anesthetics|mesh-ancestor
92482931|NCT01911195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482932|NCT01911195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482933|NCT01911234|Freund's Adjuvant|freund's adjuvant|mesh-list
92482934|NCT01911234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92482936|NCT01911234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482937|NCT01911247|Metformin|metformin|mesh-list
92482938|NCT01911247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92482939|NCT01911247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482940|NCT01911299|Choline|choline|mesh-list
92482941|NCT01911299|Glycerol|glycerol|mesh-list
92482942|NCT01911299|Lipotropic Agents|lipotropic agents|mesh-ancestor
92482943|NCT01911299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92482944|NCT01911299|Antimetabolites|antimetabolites|mesh-ancestor
92482945|NCT01911299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482946|NCT01911299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92482947|NCT01911299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92482948|NCT01911299|Nootropic Agents|nootropic agents|mesh-ancestor
92482949|NCT01911299|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92482950|NCT01911299|Protective Agents|protective agents|mesh-ancestor
92482951|NCT01911299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482952|NCT01911325|Docetaxel|docetaxel|mesh-list
92482953|NCT01911325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92482954|NCT01911325|Tubulin Modulators|tubulin modulators|mesh-ancestor
92482955|NCT01911325|Antimitotic Agents|antimitotic agents|mesh-ancestor
92482956|NCT01911325|Mitosis Modulators|mitosis modulators|mesh-ancestor
92482957|NCT01911325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482958|NCT01911364|Tiotropium Bromide|tiotropium bromide|mesh-list
92482959|NCT01911364|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92482960|NCT01911364|Autonomic Agents|autonomic agents|mesh-ancestor
92482961|NCT01911364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482962|NCT01911364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482963|NCT01911364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92482964|NCT01911364|Respiratory System Agents|respiratory system agents|mesh-ancestor
92482965|NCT01911364|Parasympatholytics|parasympatholytics|mesh-ancestor
92482966|NCT01911364|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92482967|NCT01911364|Cholinergic Agents|cholinergic agents|mesh-ancestor
92482968|NCT01911364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482969|NCT01911364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482970|NCT01911377|Botulinum Toxins|botulinum toxins|mesh-list
92482971|NCT01911377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92482972|NCT01911377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92482973|NCT01911377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92482974|NCT01911377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92482975|NCT01911377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92482976|NCT01911377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92482977|NCT01911377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92482978|NCT01911377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482979|NCT01911377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92482980|NCT01911377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482981|NCT01911455|Acamprosate|acamprosate|mesh-list
92482982|NCT01911455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92482983|NCT01911468|Metformin|metformin|mesh-list
92482984|NCT01911468|Liraglutide|liraglutide|mesh-list
92482985|NCT01911468|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92482986|NCT01911468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92482987|NCT01911468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482988|NCT01911468|Incretins|incretins|mesh-ancestor
92482989|NCT01911468|Hormones|hormones|mesh-ancestor
92349131|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92482990|NCT01911468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92482991|NCT01911494|Magnesium Sulfate|magnesium sulfate|mesh-list
92482992|NCT01911494|Methyldopa|methyldopa|mesh-list
92482993|NCT01911494|Analgesics|analgesics|mesh-ancestor
92482994|NCT01911494|Sensory System Agents|sensory system agents|mesh-ancestor
92482995|NCT01911494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92482996|NCT01911494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92482997|NCT01911494|Anesthetics|anesthetics|mesh-ancestor
92482998|NCT01911494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92482999|NCT01911494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92483000|NCT01911494|Anticonvulsants|anticonvulsants|mesh-ancestor
92483001|NCT01911494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92483002|NCT01911494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483003|NCT01911494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483004|NCT01911494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92483005|NCT01911494|Tocolytic Agents|tocolytic agents|mesh-ancestor
92483006|NCT01911494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92483007|NCT01911494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92483008|NCT01911494|Sympatholytics|sympatholytics|mesh-ancestor
92483009|NCT01911494|Autonomic Agents|autonomic agents|mesh-ancestor
92483010|NCT01911494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92483011|NCT01911494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92483012|NCT01911494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92483013|NCT01911494|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483014|NCT01911494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483015|NCT01911507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92483016|NCT01911507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483017|NCT01911507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92483018|NCT01911507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483019|NCT01911507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483021|NCT01911598|Carboplatin|carboplatin|mesh-list
92483022|NCT01911598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92483023|NCT01911598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483024|NCT01911598|Tubulin Modulators|tubulin modulators|mesh-ancestor
92483025|NCT01911598|Antimitotic Agents|antimitotic agents|mesh-ancestor
92483026|NCT01911598|Mitosis Modulators|mitosis modulators|mesh-ancestor
92483027|NCT01911598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483028|NCT01911624|Enoxaparin|enoxaparin|mesh-list
92483029|NCT01911624|Dabigatran|dabigatran|mesh-list
92483030|NCT01911624|Argatroban|argatroban|mesh-list
92483031|NCT01911624|Thrombin|thrombin|mesh-list
92483032|NCT01911624|Anticoagulants|anticoagulants|mesh-ancestor
92483033|NCT01911624|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92483034|NCT01911624|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92483035|NCT01911624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483036|NCT01911624|Antithrombins|antithrombins|mesh-ancestor
92483037|NCT01911624|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92483038|NCT01911624|Protease Inhibitors|protease inhibitors|mesh-ancestor
92483039|NCT01911624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483040|NCT01911624|Hemostatics|hemostatics|mesh-ancestor
92483041|NCT01911624|Coagulants|coagulants|mesh-ancestor
92483042|NCT01911624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92483043|NCT01911728|Pioglitazone|pioglitazone|mesh-list
92483044|NCT01911728|Midazolam|midazolam|mesh-list
92483045|NCT01911728|Omeprazole|omeprazole|mesh-list
92483046|NCT01911728|Warfarin|warfarin|mesh-list
92483047|NCT01911728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92483048|NCT01911728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92483049|NCT01911728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483050|NCT01911728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483051|NCT01911728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92483052|NCT01911728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92483053|NCT01911728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92483054|NCT01911728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92483055|NCT01911728|Anesthetics, General|anesthetics, general|mesh-ancestor
92483056|NCT01911728|Anesthetics|anesthetics|mesh-ancestor
92483057|NCT01911728|GABA Modulators|gaba modulators|mesh-ancestor
92483058|NCT01911728|GABA Agents|gaba agents|mesh-ancestor
92483059|NCT01911728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483060|NCT01911728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483061|NCT01911728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483062|NCT01911728|Anticoagulants|anticoagulants|mesh-ancestor
92483063|NCT01911728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92483064|NCT01911728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483065|NCT01911728|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92483066|NCT01911728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483067|NCT01911949|Epinephrine|epinephrine|mesh-list
92483068|NCT01911949|Bupivacaine|bupivacaine|mesh-list
92483069|NCT01911949|Anesthetics, Local|anesthetics, local|mesh-ancestor
92483070|NCT01911949|Anesthetics|anesthetics|mesh-ancestor
92483071|NCT01911949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483072|NCT01911949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483073|NCT01911949|Sensory System Agents|sensory system agents|mesh-ancestor
92483074|NCT01911949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483075|NCT01911949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92483076|NCT01911949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92483077|NCT01911949|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483078|NCT01911949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483079|NCT01911949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483080|NCT01911949|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92483081|NCT01911949|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92483082|NCT01911949|Autonomic Agents|autonomic agents|mesh-ancestor
92483083|NCT01911949|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92483084|NCT01911949|Respiratory System Agents|respiratory system agents|mesh-ancestor
92483085|NCT01911949|Mydriatics|mydriatics|mesh-ancestor
92483086|NCT01911949|Sympathomimetics|sympathomimetics|mesh-ancestor
92483087|NCT01911949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92483089|NCT01911975|Anticonvulsants|anticonvulsants|mesh-ancestor
92483090|NCT01911975|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92483091|NCT01911975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92483092|NCT01911975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483093|NCT01911975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483094|NCT01912053|Gemcitabine|gemcitabine|mesh-list
92483095|NCT01912053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483096|NCT01912053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92483097|NCT01912053|Antimetabolites|antimetabolites|mesh-ancestor
92483098|NCT01912053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483099|NCT01912066|Aceclofenac|aceclofenac|mesh-list
92483100|NCT01912066|Misoprostol|misoprostol|mesh-list
92483101|NCT01912066|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92483102|NCT01912066|Abortifacient Agents|abortifacient agents|mesh-ancestor
92483103|NCT01912066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92483104|NCT01912066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483105|NCT01912066|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92483106|NCT01912066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483107|NCT01912066|Oxytocics|oxytocics|mesh-ancestor
92483108|NCT01912066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92483109|NCT01912066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92483110|NCT01912066|Analgesics|analgesics|mesh-ancestor
92483111|NCT01912066|Sensory System Agents|sensory system agents|mesh-ancestor
92483112|NCT01912066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483113|NCT01912066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483114|NCT01912066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92483115|NCT01912118|Remifentanil|remifentanil|mesh-list
92483116|NCT01912118|Propofol|propofol|mesh-list
92483117|NCT01912118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92483118|NCT01912118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483119|NCT01912118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483120|NCT01912118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92483121|NCT01912118|Anesthetics, General|anesthetics, general|mesh-ancestor
92483122|NCT01912118|Anesthetics|anesthetics|mesh-ancestor
92483123|NCT01912118|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92483124|NCT01912118|Narcotics|narcotics|mesh-ancestor
92483125|NCT01912118|Analgesics|analgesics|mesh-ancestor
92208049|NCT00845039|Irinotecan|irinotecan|mesh-list
92483126|NCT01912118|Sensory System Agents|sensory system agents|mesh-ancestor
92483127|NCT01912118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483128|NCT01912261|Iron|iron|mesh-list
92483129|NCT01912261|Trace Elements|trace elements|mesh-ancestor
92483130|NCT01912261|Micronutrients|micronutrients|mesh-ancestor
92483131|NCT01912261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483132|NCT01912378|Oxytocin|oxytocin|mesh-list
92483133|NCT01912378|Oxytocics|oxytocics|mesh-ancestor
92483134|NCT01912378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92483135|NCT01912378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483136|NCT01912391|Selegiline|selegiline|mesh-list
92483137|NCT01912391|Antidepressive Agents|antidepressive agents|mesh-ancestor
92483138|NCT01912391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92483139|NCT01912391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92483140|NCT01912391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92483141|NCT01912391|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92483142|NCT01912391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483143|NCT01912391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483144|NCT01912391|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92483145|NCT01912391|Protective Agents|protective agents|mesh-ancestor
92483146|NCT01912391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483147|NCT01912443|Bevacizumab|bevacizumab|mesh-list
92483148|NCT01912443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483149|NCT01912443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483150|NCT01912443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92483151|NCT01912443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92483152|NCT01912443|Growth Substances|growth substances|mesh-ancestor
92483153|NCT01912443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483154|NCT01912443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92483155|NCT01912534|Valsartan|valsartan|mesh-list
92483156|NCT01912534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92483157|NCT01912534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92483158|NCT01912534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92483159|NCT01912534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483160|NCT01912573|Naloxone|naloxone|mesh-list
92483162|NCT01912573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483163|NCT01912573|Sensory System Agents|sensory system agents|mesh-ancestor
92483164|NCT01912573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483165|NCT01912586|Sildenafil Citrate|sildenafil citrate|mesh-list
92483166|NCT01912586|Vasodilator Agents|vasodilator agents|mesh-ancestor
92483167|NCT01912586|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92483168|NCT01912586|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92483169|NCT01912586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483170|NCT01912586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483171|NCT01912586|Urological Agents|urological agents|mesh-ancestor
92483172|NCT01912638|Hyaluronic Acid|hyaluronic acid|mesh-list
92483173|NCT01912638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92483174|NCT01912638|Immunologic Factors|immunologic factors|mesh-ancestor
92483175|NCT01912638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483176|NCT01912638|Viscosupplements|viscosupplements|mesh-ancestor
92483177|NCT01912638|Protective Agents|protective agents|mesh-ancestor
92483178|NCT01912677|Labetalol|labetalol|mesh-list
92483179|NCT01912677|Methyldopa|methyldopa|mesh-list
92483180|NCT01912677|Nifedipine|nifedipine|mesh-list
92483181|NCT01912677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92483182|NCT01912677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483183|NCT01912677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483184|NCT01912677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92483185|NCT01912677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483186|NCT01912677|Vasodilator Agents|vasodilator agents|mesh-ancestor
92483187|NCT01912677|Tocolytic Agents|tocolytic agents|mesh-ancestor
92483188|NCT01912677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92483189|NCT01912677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92483190|NCT01912677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92483191|NCT01912677|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483192|NCT01912677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483193|NCT01912677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92483194|NCT01912677|Sympathomimetics|sympathomimetics|mesh-ancestor
92483195|NCT01912677|Autonomic Agents|autonomic agents|mesh-ancestor
92483196|NCT01912677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483197|NCT01912677|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92483198|NCT01912677|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92483199|NCT01912677|Sympatholytics|sympatholytics|mesh-ancestor
92483200|NCT01912677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92483201|NCT01912677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92483202|NCT01912677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92483203|NCT01912755|Lidocaine|lidocaine|mesh-list
92483204|NCT01912755|Epinephrine|epinephrine|mesh-list
92483205|NCT01912755|Racepinephrine|racepinephrine|mesh-list
92483206|NCT01912755|Carticaine|carticaine|mesh-list
92483207|NCT01912755|Epinephryl borate|epinephryl borate|mesh-list
92483208|NCT01912755|Anesthetics, Local|anesthetics, local|mesh-ancestor
92483209|NCT01912755|Anesthetics|anesthetics|mesh-ancestor
92483210|NCT01912755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483211|NCT01912755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483212|NCT01912755|Sensory System Agents|sensory system agents|mesh-ancestor
92483213|NCT01912755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483214|NCT01912755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92150645|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
92483215|NCT01912755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92483216|NCT01912755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92483217|NCT01912755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483218|NCT01912755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483219|NCT01912755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92483220|NCT01912755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92483221|NCT01912755|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483222|NCT01912755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483223|NCT01912755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92483224|NCT01912755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92483225|NCT01912755|Autonomic Agents|autonomic agents|mesh-ancestor
92483226|NCT01912755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92483227|NCT01912755|Respiratory System Agents|respiratory system agents|mesh-ancestor
92483228|NCT01912755|Mydriatics|mydriatics|mesh-ancestor
92483229|NCT01912755|Sympathomimetics|sympathomimetics|mesh-ancestor
92483230|NCT01912755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92483231|NCT01912820|Quercetin|quercetin|mesh-list
92483232|NCT01912820|Antioxidants|antioxidants|mesh-ancestor
92483233|NCT01912820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483234|NCT01912820|Protective Agents|protective agents|mesh-ancestor
92483235|NCT01912820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483237|NCT01912898|Ergocalciferols|ergocalciferols|mesh-list
92483238|NCT01912898|Cholecalciferol|cholecalciferol|mesh-list
92483239|NCT01912898|Vitamins|vitamins|mesh-list
92483240|NCT01912898|Micronutrients|micronutrients|mesh-ancestor
92483241|NCT01912898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483242|NCT01912898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92483243|NCT01912898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92483244|NCT01912976|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92483245|NCT01912976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92483246|NCT01912976|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483247|NCT01913002|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92483248|NCT01913002|Moxifloxacin|moxifloxacin|mesh-list
92483249|NCT01913002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92483250|NCT01913002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483251|NCT01913002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92483252|NCT01913002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92483253|NCT01913002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483254|NCT01913002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483255|NCT01913002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483256|NCT01913002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483257|NCT01913002|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92483258|NCT01913002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483259|NCT01913015|Abiraterone Acetate|abiraterone acetate|mesh-list
92483260|NCT01913015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483261|NCT01913015|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92483262|NCT01913015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483263|NCT01913015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483264|NCT01913015|Hormone Antagonists|hormone antagonists|mesh-ancestor
92483265|NCT01913015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483266|NCT01913015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483267|NCT01913015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92483268|NCT01913054|Fentanyl|fentanyl|mesh-list
92483269|NCT01913054|Propofol|propofol|mesh-list
92483270|NCT01913054|Etomidate|etomidate|mesh-list
92483271|NCT01913054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92483272|NCT01913054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483273|NCT01913054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483274|NCT01913054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92483275|NCT01913054|Anesthetics, General|anesthetics, general|mesh-ancestor
92483276|NCT01913054|Anesthetics|anesthetics|mesh-ancestor
92483277|NCT01913054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92483278|NCT01913054|Narcotics|narcotics|mesh-ancestor
92483279|NCT01913054|Analgesics|analgesics|mesh-ancestor
92483280|NCT01913054|Sensory System Agents|sensory system agents|mesh-ancestor
92483281|NCT01913054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483282|NCT01913054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92483283|NCT01913106|Valacyclovir|valacyclovir|mesh-list
92483284|NCT01913106|Antiviral Agents|antiviral agents|mesh-ancestor
92483285|NCT01913106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483286|NCT01913119|Romidepsin|romidepsin|mesh-list
92483287|NCT01913119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92483288|NCT01913119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483289|NCT01913119|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92483290|NCT01913119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483291|NCT01913119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483292|NCT01913379|Itraconazole|itraconazole|mesh-list
92483293|NCT01913379|Gemfibrozil|gemfibrozil|mesh-list
92483294|NCT01913379|Antifungal Agents|antifungal agents|mesh-ancestor
92483295|NCT01913379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483296|NCT01913379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92483297|NCT01913379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92483298|NCT01913379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483299|NCT01913379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483300|NCT01913379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92483301|NCT01913379|Hormone Antagonists|hormone antagonists|mesh-ancestor
92483302|NCT01913379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483303|NCT01913379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483304|NCT01913379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92483305|NCT01913379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92483306|NCT01913379|Antimetabolites|antimetabolites|mesh-ancestor
92483307|NCT01913379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92483308|NCT01913379|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92483309|NCT01913431|Entecavir|entecavir|mesh-list
92483310|NCT01913431|Antiviral Agents|antiviral agents|mesh-ancestor
92483311|NCT01913431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483312|NCT01913444|Antithrombins|antithrombins|mesh-list
92483313|NCT01913444|Antithrombin III|antithrombin iii|mesh-list
92483314|NCT01913444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92483315|NCT01913444|Protease Inhibitors|protease inhibitors|mesh-ancestor
92483316|NCT01913444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483317|NCT01913444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483318|NCT01913444|Anticoagulants|anticoagulants|mesh-ancestor
92483319|NCT01913691|Ipilimumab|ipilimumab|mesh-list
92483320|NCT01913691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483321|NCT01913691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483322|NCT01913691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92483323|NCT01913691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483324|NCT01913808|Iron|iron|mesh-list
92483325|NCT01913808|Glycine|glycine|mesh-list
92483326|NCT01913808|Trace Elements|trace elements|mesh-ancestor
92483327|NCT01913808|Micronutrients|micronutrients|mesh-ancestor
92483328|NCT01913808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483329|NCT01913808|Glycine Agents|glycine agents|mesh-ancestor
92483330|NCT01913808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483331|NCT01913808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483332|NCT01913834|Teriparatide|teriparatide|mesh-list
92483333|NCT01913834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92483334|NCT01913834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483335|NCT01913834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92483336|NCT01913847|Sildenafil Citrate|sildenafil citrate|mesh-list
92483337|NCT01913847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92483338|NCT01913847|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92483339|NCT01913847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92483340|NCT01913847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483341|NCT01913847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483342|NCT01913847|Urological Agents|urological agents|mesh-ancestor
92483343|NCT01913860|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92483344|NCT01913860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483345|NCT01913964|Acetylcarnitine|acetylcarnitine|mesh-list
92483346|NCT01913964|Vitamin B Complex|vitamin b complex|mesh-ancestor
92483347|NCT01913964|Vitamins|vitamins|mesh-ancestor
92483348|NCT01913964|Micronutrients|micronutrients|mesh-ancestor
92483349|NCT01913964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483350|NCT01913964|Nootropic Agents|nootropic agents|mesh-ancestor
92208241|NCT05105074|Morphine|morphine|mesh-list
92483351|NCT01913990|Dexamethasone|dexamethasone|mesh-list
92483352|NCT01913990|Ondansetron|ondansetron|mesh-list
92483353|NCT01913990|Aprepitant|aprepitant|mesh-list
92483354|NCT01913990|Antiemetics|antiemetics|mesh-list
92483355|NCT01913990|Emetics|emetics|mesh-list
92483356|NCT01913990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483357|NCT01913990|Autonomic Agents|autonomic agents|mesh-ancestor
92483358|NCT01913990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483359|NCT01913990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483360|NCT01913990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483361|NCT01913990|Glucocorticoids|glucocorticoids|mesh-ancestor
92483362|NCT01913990|Hormones|hormones|mesh-ancestor
92483363|NCT01913990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483364|NCT01913990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92483365|NCT01913990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483366|NCT01913990|Antipruritics|antipruritics|mesh-ancestor
92483367|NCT01913990|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483368|NCT01913990|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92483369|NCT01913990|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92483370|NCT01913990|Serotonin Agents|serotonin agents|mesh-ancestor
92483371|NCT01913990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483372|NCT01913990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483373|NCT01913990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92483374|NCT01914042|Morphine|morphine|mesh-list
92483375|NCT01914042|Milnacipran|milnacipran|mesh-list
92483376|NCT01914042|Levomilnacipran|levomilnacipran|mesh-list
92483377|NCT01914042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92483378|NCT01914042|Narcotics|narcotics|mesh-ancestor
92483379|NCT01914042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483380|NCT01914042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483382|NCT01914042|Sensory System Agents|sensory system agents|mesh-ancestor
92483383|NCT01914042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483384|NCT01914042|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92483385|NCT01914042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92483386|NCT01914042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483387|NCT01914042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483388|NCT01914042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483389|NCT01914042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92483390|NCT01914042|Antidepressive Agents|antidepressive agents|mesh-ancestor
92483391|NCT01914042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92483392|NCT01914081|Resveratrol|resveratrol|mesh-list
92483393|NCT01914081|Antioxidants|antioxidants|mesh-ancestor
92483394|NCT01914081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483395|NCT01914081|Protective Agents|protective agents|mesh-ancestor
92483396|NCT01914081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483397|NCT01914081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483398|NCT01914081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92483399|NCT01914133|Acarbose|acarbose|mesh-list
92483400|NCT01914133|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92483401|NCT01914133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483402|NCT01914133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483403|NCT01914133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483404|NCT01914133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483405|NCT01914146|Insulin|insulin|mesh-list
92483406|NCT01914146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92483407|NCT01914146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483408|NCT01914146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483409|NCT01914211|Tranexamic Acid|tranexamic acid|mesh-list
92483410|NCT01914211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92483411|NCT01914211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92483412|NCT01914211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483413|NCT01914211|Hemostatics|hemostatics|mesh-ancestor
92483414|NCT01914211|Coagulants|coagulants|mesh-ancestor
92483415|NCT01914237|Castor Oil|castor oil|mesh-list
92483416|NCT01914237|Cathartics|cathartics|mesh-ancestor
92483417|NCT01914237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483418|NCT01914250|Analgesics|analgesics|mesh-list
92483419|NCT01914250|Tetracaine|tetracaine|mesh-list
92483420|NCT01914250|Sensory System Agents|sensory system agents|mesh-ancestor
92483421|NCT01914250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483422|NCT01914250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483423|NCT01914250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92483424|NCT01914250|Anesthetics|anesthetics|mesh-ancestor
92483425|NCT01914250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483426|NCT01914380|Aflibercept|aflibercept|mesh-list
92208312|NCT01733693|Analgesics|analgesics|mesh-ancestor
92483427|NCT01914380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92483428|NCT01914380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92483429|NCT01914380|Growth Substances|growth substances|mesh-ancestor
92483430|NCT01914380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483431|NCT01914380|Growth Inhibitors|growth inhibitors|mesh-ancestor
92483432|NCT01914380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483433|NCT01914419|Oxytocin|oxytocin|mesh-list
92483434|NCT01914419|Oxytocics|oxytocics|mesh-ancestor
92483435|NCT01914419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92483436|NCT01914419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483437|NCT01914432|Telmisartan|telmisartan|mesh-list
92483438|NCT01914432|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92483439|NCT01914432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92483440|NCT01914432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92483441|NCT01914432|Antimetabolites|antimetabolites|mesh-ancestor
92483442|NCT01914432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483443|NCT01914432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92483444|NCT01914432|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92483445|NCT01914432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483446|NCT01914432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92483447|NCT01914432|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92483448|NCT01914432|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92483449|NCT01914562|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92483450|NCT01914562|Cathartics|cathartics|mesh-ancestor
92483451|NCT01914562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483452|NCT01914627|Salicylic Acid|salicylic acid|mesh-list
92483453|NCT01914627|Salicylates|salicylates|mesh-list
92483454|NCT01914627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483455|NCT01914627|Antifungal Agents|antifungal agents|mesh-ancestor
92483456|NCT01914627|Keratolytic Agents|keratolytic agents|mesh-ancestor
92483457|NCT01914627|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483458|NCT01914627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92483459|NCT01914627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92483461|NCT01914627|Sensory System Agents|sensory system agents|mesh-ancestor
92483462|NCT01914627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483463|NCT01914627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483464|NCT01914627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483465|NCT01914627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92483466|NCT01914627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92483467|NCT01914627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483468|NCT01914627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483469|NCT01914692|Somatostatin|somatostatin|mesh-list
92483470|NCT01914692|Hormones|hormones|mesh-ancestor
92483471|NCT01914692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483472|NCT01914692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483473|NCT01914718|Rituximab|rituximab|mesh-list
92483474|NCT01914718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483475|NCT01914718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483476|NCT01914718|Immunologic Factors|immunologic factors|mesh-ancestor
92483477|NCT01914718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483478|NCT01914718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92483479|NCT01914744|Lamivudine|lamivudine|mesh-list
92483480|NCT01914744|Entecavir|entecavir|mesh-list
92483481|NCT01914744|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92483482|NCT01914744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92483483|NCT01914744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483484|NCT01914744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483485|NCT01914744|Antiviral Agents|antiviral agents|mesh-ancestor
92483486|NCT01914744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483487|NCT01914744|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92483488|NCT01914744|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92483489|NCT01914770|Belimumab|belimumab|mesh-list
92483490|NCT01914770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92483491|NCT01914770|Immunologic Factors|immunologic factors|mesh-ancestor
92483492|NCT01914770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483493|NCT01914822|Methylphenidate|methylphenidate|mesh-list
92483494|NCT01914822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92483495|NCT01914822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483496|NCT01914822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92483497|NCT01914822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92483498|NCT01914822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483499|NCT01914822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483500|NCT01914822|Dopamine Agents|dopamine agents|mesh-ancestor
92483501|NCT01914822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483502|NCT01914900|Docetaxel|docetaxel|mesh-list
92483503|NCT01914900|Fluorouracil|fluorouracil|mesh-list
92483504|NCT01914900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483505|NCT01914900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92483506|NCT01914900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92483507|NCT01914900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92483508|NCT01914900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483509|NCT01914900|Antimetabolites|antimetabolites|mesh-ancestor
92483510|NCT01914900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92483511|NCT01914900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92483512|NCT01914900|Immunologic Factors|immunologic factors|mesh-ancestor
92483513|NCT01914900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483514|NCT01914939|Oxytocin|oxytocin|mesh-list
92483515|NCT01914939|Oxytocics|oxytocics|mesh-ancestor
92483516|NCT01914939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92483517|NCT01914939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483518|NCT01914965|Bupropion|bupropion|mesh-list
92483519|NCT01914965|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92483520|NCT01914965|Antidepressive Agents|antidepressive agents|mesh-ancestor
92483521|NCT01914965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92483522|NCT01914965|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92483523|NCT01914965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92483524|NCT01914965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483525|NCT01914965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483527|NCT01914965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483528|NCT01914965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483530|NCT01914965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92483531|NCT01914965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483532|NCT01915069|Cilostazol|cilostazol|mesh-list
92483533|NCT01915069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92483534|NCT01915069|Autonomic Agents|autonomic agents|mesh-ancestor
92483535|NCT01915069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483536|NCT01915069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483537|NCT01915069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92483538|NCT01915069|Respiratory System Agents|respiratory system agents|mesh-ancestor
92483539|NCT01915069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92483540|NCT01915069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92483541|NCT01915069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483542|NCT01915069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92483543|NCT01915069|Vasodilator Agents|vasodilator agents|mesh-ancestor
92483544|NCT01915069|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92483545|NCT01915069|Protective Agents|protective agents|mesh-ancestor
92483546|NCT01915069|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92483547|NCT01915069|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92483548|NCT01915069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483549|NCT01915082|Azithromycin|azithromycin|mesh-list
92483550|NCT01915082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92483551|NCT01915082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483552|NCT01915134|Cisplatin|cisplatin|mesh-list
92483553|NCT01915134|Gemcitabine|gemcitabine|mesh-list
92483554|NCT01915134|Endostatins|endostatins|mesh-list
92483555|NCT01915134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483556|NCT01915134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92483557|NCT01915134|Antimetabolites|antimetabolites|mesh-ancestor
92483558|NCT01915134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483559|NCT01915134|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92483560|NCT01915134|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92483561|NCT01915134|Growth Substances|growth substances|mesh-ancestor
92483562|NCT01915134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483563|NCT01915134|Growth Inhibitors|growth inhibitors|mesh-ancestor
92483564|NCT01915186|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92483565|NCT01915186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92483566|NCT01915186|Immunologic Factors|immunologic factors|mesh-ancestor
92483567|NCT01915186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483568|NCT01915264|Metformin|metformin|mesh-list
92483569|NCT01915264|Acarbose|acarbose|mesh-list
92483570|NCT01915264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483571|NCT01915264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483572|NCT01915264|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92483573|NCT01915264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483574|NCT01915264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483575|NCT01915277|Dexmedetomidine|dexmedetomidine|mesh-list
92483576|NCT01915277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92483577|NCT01915277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483578|NCT01915277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483579|NCT01915277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92483580|NCT01915277|Analgesics|analgesics|mesh-ancestor
92483581|NCT01915277|Sensory System Agents|sensory system agents|mesh-ancestor
92483582|NCT01915277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483583|NCT01915277|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92483584|NCT01915277|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92483585|NCT01915277|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92483586|NCT01915277|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483587|NCT01915277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483588|NCT01915277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483589|NCT01915459|Botulinum Toxins|botulinum toxins|mesh-list
92483590|NCT01915459|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92483591|NCT01915459|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92483592|NCT01915459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92483593|NCT01915459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483594|NCT01915459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483595|NCT01915459|Cholinergic Agents|cholinergic agents|mesh-ancestor
92483596|NCT01915459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483597|NCT01915459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483598|NCT01915459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92483599|NCT01915459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483600|NCT01915472|Irinotecan|irinotecan|mesh-list
92483601|NCT01915472|Labetuzumab|labetuzumab|mesh-list
92483603|NCT01915472|Immunologic Factors|immunologic factors|mesh-ancestor
92483604|NCT01915472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483605|NCT01915472|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92483606|NCT01915472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92483607|NCT01915472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483608|NCT01915472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483609|NCT01915472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483610|NCT01915472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483611|NCT01915537|Infliximab|infliximab|mesh-list
92483612|NCT01915537|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92483613|NCT01915537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483614|NCT01915537|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483615|NCT01915537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483616|NCT01915537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92483617|NCT01915550|Insulin|insulin|mesh-list
92483618|NCT01915550|Metformin|metformin|mesh-list
92483619|NCT01915550|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92483620|NCT01915550|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
92483621|NCT01915550|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483622|NCT01915550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483623|NCT01915602|Sorafenib|sorafenib|mesh-list
92483624|NCT01915602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483625|NCT01915602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92483626|NCT01915602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483627|NCT01915602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483628|NCT01915758|Clindamycin|clindamycin|mesh-list
92483629|NCT01915758|Clindamycin palmitate|clindamycin palmitate|mesh-list
92483630|NCT01915758|Clindamycin phosphate|clindamycin phosphate|mesh-list
92483631|NCT01915758|Tretinoin|tretinoin|mesh-list
92483632|NCT01915758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92483633|NCT01915758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483634|NCT01915758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92483635|NCT01915758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483636|NCT01915758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483637|NCT01915758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483638|NCT01915758|Keratolytic Agents|keratolytic agents|mesh-ancestor
92483639|NCT01915758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483640|NCT01915901|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92483641|NCT01915901|Bismuth|bismuth|mesh-list
92483642|NCT01915901|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92483643|NCT01915901|Antacids|antacids|mesh-ancestor
92483644|NCT01915901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483645|NCT01915901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483646|NCT01915901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483647|NCT01915901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92483648|NCT01915901|Immunologic Factors|immunologic factors|mesh-ancestor
92483649|NCT01915901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483650|NCT01915901|Antidiarrheals|antidiarrheals|mesh-ancestor
92483652|NCT01915979|Mitogens|mitogens|mesh-list
92483653|NCT01915979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92483654|NCT01915979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483655|NCT01915979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483656|NCT01915979|Glucocorticoids|glucocorticoids|mesh-ancestor
92483657|NCT01915979|Hormones|hormones|mesh-ancestor
92483658|NCT01915979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483659|NCT01915979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483660|NCT01915979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92483661|NCT01915979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92483662|NCT01916057|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92483663|NCT01916057|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92483664|NCT01916057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483665|NCT01916174|Insulin|insulin|mesh-list
92483666|NCT01916174|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92483667|NCT01916174|Liraglutide|liraglutide|mesh-list
92483668|NCT01916174|Insulin, Long-Acting|insulin, long-acting|mesh-list
92483669|NCT01916174|Xultophy|xultophy|mesh-list
92483670|NCT01916174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483671|NCT01916174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483672|NCT01916174|Incretins|incretins|mesh-ancestor
92483673|NCT01916174|Hormones|hormones|mesh-ancestor
92483674|NCT01916174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483675|NCT01916187|Imetelstat|imetelstat|mesh-list
92483676|NCT01916187|Motesanib diphosphate|motesanib diphosphate|mesh-list
92483677|NCT01916187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483678|NCT01916187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483679|NCT01916187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92483680|NCT01916200|Paroxetine|paroxetine|mesh-list
92483681|NCT01916200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92483682|NCT01916200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92483683|NCT01916200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483684|NCT01916200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483685|NCT01916200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483686|NCT01916200|Serotonin Agents|serotonin agents|mesh-ancestor
92483687|NCT01916200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483688|NCT01916200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92483689|NCT01916200|Antidepressive Agents|antidepressive agents|mesh-ancestor
92483690|NCT01916200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92483691|NCT01916200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92483692|NCT01916200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92483693|NCT01916200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483694|NCT01916213|Hyaluronic Acid|hyaluronic acid|mesh-list
92483695|NCT01916213|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92483696|NCT01916213|Immunologic Factors|immunologic factors|mesh-ancestor
92483697|NCT01916213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483698|NCT01916213|Viscosupplements|viscosupplements|mesh-ancestor
92483699|NCT01916213|Protective Agents|protective agents|mesh-ancestor
92483700|NCT01916252|Dexamethasone|dexamethasone|mesh-list
92483701|NCT01916252|Dexamethasone acetate|dexamethasone acetate|mesh-list
92483702|NCT01916252|Lenalidomide|lenalidomide|mesh-list
92483703|NCT01916252|Bortezomib|bortezomib|mesh-list
92483704|NCT01916252|Melphalan|melphalan|mesh-list
92483705|NCT01916252|Busulfan|busulfan|mesh-list
92483706|NCT01916252|BB 1101|bb 1101|mesh-list
92483707|NCT01916252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483708|NCT01916252|Antiemetics|antiemetics|mesh-ancestor
92483709|NCT01916252|Autonomic Agents|autonomic agents|mesh-ancestor
92483710|NCT01916252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483711|NCT01916252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483712|NCT01916252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483713|NCT01916252|Glucocorticoids|glucocorticoids|mesh-ancestor
92483714|NCT01916252|Hormones|hormones|mesh-ancestor
92483715|NCT01916252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483716|NCT01916252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92483717|NCT01916252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483718|NCT01916252|Immunologic Factors|immunologic factors|mesh-ancestor
92483719|NCT01916252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92483720|NCT01916252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92483721|NCT01916252|Growth Substances|growth substances|mesh-ancestor
92483722|NCT01916252|Growth Inhibitors|growth inhibitors|mesh-ancestor
92483723|NCT01916252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92483724|NCT01916252|Alkylating Agents|alkylating agents|mesh-ancestor
92208616|NCT00835159|Protective Agents|protective agents|mesh-ancestor
92483725|NCT01916252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483726|NCT01916252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92483727|NCT01916252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92483728|NCT01916252|Protease Inhibitors|protease inhibitors|mesh-ancestor
92483729|NCT01916252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483730|NCT01916265|Glucagon|glucagon|mesh-list
92483731|NCT01916265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92483732|NCT01916265|Hormones|hormones|mesh-ancestor
92483733|NCT01916265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483734|NCT01916265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483735|NCT01916382|Nitisinone|nitisinone|mesh-list
92483736|NCT01916382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483737|NCT01916382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483738|NCT01916395|Sumatriptan|sumatriptan|mesh-list
92483739|NCT01916395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92483740|NCT01916395|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92483741|NCT01916395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92483742|NCT01916395|Serotonin Agents|serotonin agents|mesh-ancestor
92483743|NCT01916395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483744|NCT01916395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483745|NCT01916395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483746|NCT01916408|Wobenzym|wobenzym|mesh-list
92483747|NCT01916408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92483748|NCT01916408|Immunologic Factors|immunologic factors|mesh-ancestor
92483749|NCT01916408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483751|NCT01916447|Irinotecan|irinotecan|mesh-list
92483752|NCT01916447|Camptothecin|camptothecin|mesh-list
92483753|NCT01916447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483754|NCT01916447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483755|NCT01916447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92483756|NCT01916447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92483757|NCT01916447|Growth Substances|growth substances|mesh-ancestor
92483758|NCT01916447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483759|NCT01916447|Growth Inhibitors|growth inhibitors|mesh-ancestor
92483760|NCT01916447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92483761|NCT01916447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92483762|NCT01916447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483763|NCT01916447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483764|NCT01916447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92483765|NCT01916577|Plerixafor|plerixafor|mesh-list
92483766|NCT01916577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92483767|NCT01916577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92483768|NCT01916577|Antiviral Agents|antiviral agents|mesh-ancestor
92483769|NCT01916577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483770|NCT01916642|Lidocaine|lidocaine|mesh-list
92483771|NCT01916642|Etomidate|etomidate|mesh-list
92483772|NCT01916642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92483773|NCT01916642|Anesthetics|anesthetics|mesh-ancestor
92483774|NCT01916642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483775|NCT01916642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483776|NCT01916642|Sensory System Agents|sensory system agents|mesh-ancestor
92483777|NCT01916642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483778|NCT01916642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92483779|NCT01916642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92483780|NCT01916642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92483781|NCT01916642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483782|NCT01916642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483783|NCT01916642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92483784|NCT01916642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92483785|NCT01916642|Anesthetics, General|anesthetics, general|mesh-ancestor
92483786|NCT01916707|Enoxaparin|enoxaparin|mesh-list
92483787|NCT01916707|Anticoagulants|anticoagulants|mesh-ancestor
92483788|NCT01916707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92483789|NCT01916707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92483790|NCT01916707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483791|NCT01916720|Darapladib|darapladib|mesh-list
92483792|NCT01916720|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92483793|NCT01916720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483794|NCT01916720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483795|NCT01916733|Insulin|insulin|mesh-list
92483796|NCT01916733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483797|NCT01916733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483798|NCT01916785|Dasatinib|dasatinib|mesh-list
92483799|NCT01916785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483800|NCT01916785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92483801|NCT01916785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483802|NCT01916785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483803|NCT01916798|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92483804|NCT01916798|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92483805|NCT01916798|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92483806|NCT01916798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92483807|NCT01916850|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92483808|NCT01916850|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92483809|NCT01916850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483810|NCT01916850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483811|NCT01916850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483812|NCT01916863|Canagliflozin|canagliflozin|mesh-list
92483813|NCT01916863|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92483814|NCT01916863|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92483815|NCT01916863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483816|NCT01916863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92483817|NCT01916863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483818|NCT01916902|Ticagrelor|ticagrelor|mesh-list
92483819|NCT01916902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92483820|NCT01916902|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92483821|NCT01916902|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92483822|NCT01916902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92483823|NCT01916902|Purinergic Agents|purinergic agents|mesh-ancestor
92483824|NCT01916902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483825|NCT01916902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483826|NCT01916902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483827|NCT01916915|Tramadol|tramadol|mesh-list
92483828|NCT01916915|Levobupivacaine|levobupivacaine|mesh-list
92483829|NCT01916915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92483830|NCT01916915|Narcotics|narcotics|mesh-ancestor
92483831|NCT01916915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483832|NCT01916915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483833|NCT01916915|Analgesics|analgesics|mesh-ancestor
92483834|NCT01916915|Sensory System Agents|sensory system agents|mesh-ancestor
92483835|NCT01916915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483836|NCT01916915|Anesthetics, Local|anesthetics, local|mesh-ancestor
92483837|NCT01916915|Anesthetics|anesthetics|mesh-ancestor
92483838|NCT01916954|Lumefantrine|lumefantrine|mesh-list
92483839|NCT01916954|Artemether|artemether|mesh-list
92483840|NCT01916954|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92483841|NCT01916954|Antimalarials|antimalarials|mesh-ancestor
92483842|NCT01916954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92483843|NCT01916954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92483844|NCT01916954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92483845|NCT01917019|4-Aminopyridine|4-aminopyridine|mesh-list
92483846|NCT01917019|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92483847|NCT01917019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92483848|NCT01917019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483849|NCT01917032|Folic Acid|folic acid|mesh-list
92483850|NCT01917032|Vitamin A|vitamin a|mesh-list
92483851|NCT01917032|Micronutrients|micronutrients|mesh-list
92483852|NCT01917032|Trace Elements|trace elements|mesh-list
92483853|NCT01917032|Tretinoin|tretinoin|mesh-list
92483854|NCT01917032|Vitamins|vitamins|mesh-ancestor
92483855|NCT01917032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483856|NCT01917032|Hematinics|hematinics|mesh-ancestor
92483857|NCT01917032|Vitamin B Complex|vitamin b complex|mesh-ancestor
92483858|NCT01917032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483859|NCT01917032|Keratolytic Agents|keratolytic agents|mesh-ancestor
92483860|NCT01917032|Dermatologic Agents|dermatologic agents|mesh-ancestor
92483861|NCT01917045|Sufentanil|sufentanil|mesh-list
92483862|NCT01917045|Morphine|morphine|mesh-list
92483864|NCT01917045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92483865|NCT01917045|Narcotics|narcotics|mesh-ancestor
92483866|NCT01917045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483867|NCT01917045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483868|NCT01917045|Analgesics|analgesics|mesh-ancestor
92483869|NCT01917045|Sensory System Agents|sensory system agents|mesh-ancestor
92483870|NCT01917045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483871|NCT01917045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92483872|NCT01917045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92483873|NCT01917045|Anesthetics, General|anesthetics, general|mesh-ancestor
92483875|NCT01917058|Abatacept|abatacept|mesh-list
92483876|NCT01917058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92483877|NCT01917058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483878|NCT01917058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483879|NCT01917058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483880|NCT01917058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92483881|NCT01917058|Immunologic Factors|immunologic factors|mesh-ancestor
92483882|NCT01917058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483883|NCT01917058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92483884|NCT01917097|Dexmedetomidine|dexmedetomidine|mesh-list
92483885|NCT01917097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92483886|NCT01917097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483887|NCT01917097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483888|NCT01917097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92483889|NCT01917097|Analgesics|analgesics|mesh-ancestor
92483890|NCT01917097|Sensory System Agents|sensory system agents|mesh-ancestor
92483891|NCT01917097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483892|NCT01917097|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92483893|NCT01917097|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92483895|NCT01917097|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483896|NCT01917097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483897|NCT01917097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483898|NCT01917149|Metoprolol|metoprolol|mesh-list
92483899|NCT01917149|Valsartan|valsartan|mesh-list
92483900|NCT01917149|Benazepril|benazepril|mesh-list
92483901|NCT01917149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92483902|NCT01917149|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92483903|NCT01917149|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92483904|NCT01917149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483905|NCT01917149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92483906|NCT01917149|Sympatholytics|sympatholytics|mesh-ancestor
92483907|NCT01917149|Autonomic Agents|autonomic agents|mesh-ancestor
92483908|NCT01917149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483909|NCT01917149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483910|NCT01917149|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92483911|NCT01917149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92483912|NCT01917149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92483913|NCT01917149|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483914|NCT01917149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483915|NCT01917149|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92483916|NCT01917149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92483917|NCT01917149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483918|NCT01917279|Docetaxel|docetaxel|mesh-list
92483919|NCT01917279|Capecitabine|capecitabine|mesh-list
92483920|NCT01917279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483921|NCT01917279|Tubulin Modulators|tubulin modulators|mesh-ancestor
92483922|NCT01917279|Antimitotic Agents|antimitotic agents|mesh-ancestor
92483923|NCT01917279|Mitosis Modulators|mitosis modulators|mesh-ancestor
92483924|NCT01917279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483925|NCT01917279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92483926|NCT01917279|Antimetabolites|antimetabolites|mesh-ancestor
92483927|NCT01917318|Iloperidone|iloperidone|mesh-list
92483928|NCT01917318|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92483929|NCT01917318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92483930|NCT01917318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483931|NCT01917318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483932|NCT01917318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92483933|NCT01917331|Beclomethasone|beclomethasone|mesh-list
92483934|NCT01917331|Glycopyrrolate|glycopyrrolate|mesh-list
92483935|NCT01917331|Formoterol Fumarate|formoterol fumarate|mesh-list
92483936|NCT01917331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92483937|NCT01917331|Autonomic Agents|autonomic agents|mesh-ancestor
92483938|NCT01917331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483939|NCT01917331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483940|NCT01917331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92483941|NCT01917331|Respiratory System Agents|respiratory system agents|mesh-ancestor
92483942|NCT01917331|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92483943|NCT01917331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92483944|NCT01917331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92483945|NCT01917331|Adrenergic Agents|adrenergic agents|mesh-ancestor
92483946|NCT01917331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92483947|NCT01917331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483948|NCT01917331|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92483949|NCT01917331|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92483950|NCT01917331|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92483951|NCT01917331|Cholinergic Agents|cholinergic agents|mesh-ancestor
92483952|NCT01917331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92483953|NCT01917331|Glucocorticoids|glucocorticoids|mesh-ancestor
92483954|NCT01917331|Hormones|hormones|mesh-ancestor
92483955|NCT01917331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92483956|NCT01917448|Morphine|morphine|mesh-list
92483957|NCT01917448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92483958|NCT01917448|Narcotics|narcotics|mesh-ancestor
92483959|NCT01917448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92483960|NCT01917448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483961|NCT01917448|Analgesics|analgesics|mesh-ancestor
92483962|NCT01917448|Sensory System Agents|sensory system agents|mesh-ancestor
92483963|NCT01917448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92483964|NCT01917578|Paclitaxel|paclitaxel|mesh-list
92483965|NCT01917578|Docetaxel|docetaxel|mesh-list
92483966|NCT01917578|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92483967|NCT01917578|Cyclophosphamide|cyclophosphamide|mesh-list
92483968|NCT01917578|Carboplatin|carboplatin|mesh-list
92483969|NCT01917578|Doxorubicin|doxorubicin|mesh-list
92483970|NCT01917578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92483971|NCT01917578|Fluorouracil|fluorouracil|mesh-list
92483972|NCT01917578|Trastuzumab|trastuzumab|mesh-list
92483973|NCT01917578|Epirubicin|epirubicin|mesh-list
92483974|NCT01917578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92483975|NCT01917578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483976|NCT01917578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92483977|NCT01917578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92483978|NCT01917578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92483979|NCT01917578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92483980|NCT01917578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92483981|NCT01917578|Immunologic Factors|immunologic factors|mesh-ancestor
92483982|NCT01917578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92483983|NCT01917578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92483984|NCT01917578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92483985|NCT01917578|Alkylating Agents|alkylating agents|mesh-ancestor
92483986|NCT01917578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92483987|NCT01917578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92483988|NCT01917578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92483989|NCT01917578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92483990|NCT01917578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92483991|NCT01917578|Antimetabolites|antimetabolites|mesh-ancestor
92483992|NCT01917578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92483993|NCT01917578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92483994|NCT01917617|Cisplatin|cisplatin|mesh-list
92483995|NCT01917617|Gemcitabine|gemcitabine|mesh-list
92483996|NCT01917617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92483997|NCT01917617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92483998|NCT01917617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92483999|NCT01917617|Antimetabolites|antimetabolites|mesh-ancestor
92484000|NCT01917617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484001|NCT01917708|Abatacept|abatacept|mesh-list
92484002|NCT01917708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92484003|NCT01917708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484004|NCT01917708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92484005|NCT01917708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484006|NCT01917708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484007|NCT01917708|Immunologic Factors|immunologic factors|mesh-ancestor
92484008|NCT01917708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484009|NCT01917708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484010|NCT01917721|Doxycycline|doxycycline|mesh-list
92484011|NCT01917721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484012|NCT01917721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484013|NCT01917721|Antimalarials|antimalarials|mesh-ancestor
92484014|NCT01917721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92484015|NCT01917721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92484016|NCT01917799|Aspirin|aspirin|mesh-list
92484017|NCT01917799|Heparin|heparin|mesh-list
92484018|NCT01917799|Enoxaparin|enoxaparin|mesh-list
92349159|NCT01480596|Belimumab|belimumab|mesh-list
92484019|NCT01917799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92484020|NCT01917799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484021|NCT01917799|Analgesics|analgesics|mesh-ancestor
92484022|NCT01917799|Sensory System Agents|sensory system agents|mesh-ancestor
92484023|NCT01917799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484024|NCT01917799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484025|NCT01917799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92484026|NCT01917799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484027|NCT01917799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92484028|NCT01917799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92484029|NCT01917799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484030|NCT01917799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92484031|NCT01917799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92484032|NCT01917799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484033|NCT01917799|Antipyretics|antipyretics|mesh-ancestor
92484034|NCT01917799|Anticoagulants|anticoagulants|mesh-ancestor
92484035|NCT01917890|Curcumin|curcumin|mesh-list
92484036|NCT01917890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92484037|NCT01917890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484038|NCT01917890|Analgesics|analgesics|mesh-ancestor
92484039|NCT01917890|Sensory System Agents|sensory system agents|mesh-ancestor
92484040|NCT01917890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484041|NCT01917890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484042|NCT01917890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92484043|NCT01917890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484044|NCT01917890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484045|NCT01917890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484046|NCT01917890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484047|NCT01918098|Oxycodone|oxycodone|mesh-list
92484048|NCT01918098|Naloxone|naloxone|mesh-list
92484049|NCT01918098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484050|NCT01918098|Narcotics|narcotics|mesh-ancestor
92484051|NCT01918098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484052|NCT01918098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484053|NCT01918098|Analgesics|analgesics|mesh-ancestor
92484054|NCT01918098|Sensory System Agents|sensory system agents|mesh-ancestor
92484055|NCT01918098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484056|NCT01918098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92484057|NCT01918111|Adenosine|adenosine|mesh-list
92484058|NCT01918111|Analgesics|analgesics|mesh-ancestor
92484059|NCT01918111|Sensory System Agents|sensory system agents|mesh-ancestor
92484060|NCT01918111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484061|NCT01918111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484062|NCT01918111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92484063|NCT01918111|Vasodilator Agents|vasodilator agents|mesh-ancestor
92484064|NCT01918111|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92484065|NCT01918111|Purinergic Agonists|purinergic agonists|mesh-ancestor
92484066|NCT01918111|Purinergic Agents|purinergic agents|mesh-ancestor
92484067|NCT01918111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484068|NCT01918111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484069|NCT01918124|Paclitaxel|paclitaxel|mesh-list
92484070|NCT01918124|Cyclophosphamide|cyclophosphamide|mesh-list
92484071|NCT01918124|Cisplatin|cisplatin|mesh-list
92484072|NCT01918124|Carboplatin|carboplatin|mesh-list
92484073|NCT01918124|Doxorubicin|doxorubicin|mesh-list
92484074|NCT01918124|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92484075|NCT01918124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484076|NCT01918124|Tubulin Modulators|tubulin modulators|mesh-ancestor
92484077|NCT01918124|Antimitotic Agents|antimitotic agents|mesh-ancestor
92484078|NCT01918124|Mitosis Modulators|mitosis modulators|mesh-ancestor
92484079|NCT01918124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484080|NCT01918124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484081|NCT01918124|Immunologic Factors|immunologic factors|mesh-ancestor
92484082|NCT01918124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484083|NCT01918124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484084|NCT01918124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92484085|NCT01918124|Alkylating Agents|alkylating agents|mesh-ancestor
92484086|NCT01918124|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92484087|NCT01918124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92484088|NCT01918124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92484089|NCT01918124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92484090|NCT01918124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484091|NCT01918150|Cobalt|cobalt|mesh-list
92484092|NCT01918150|Chromium|chromium|mesh-list
92484093|NCT01918150|Trace Elements|trace elements|mesh-ancestor
92484094|NCT01918150|Micronutrients|micronutrients|mesh-ancestor
92484095|NCT01918150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484096|NCT01918176|Palbociclib|palbociclib|mesh-list
92484097|NCT01918176|Rabeprazole|rabeprazole|mesh-list
92484098|NCT01918176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484099|NCT01918176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484100|NCT01918176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484101|NCT01918176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484102|NCT01918176|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92484103|NCT01918176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92484104|NCT01918176|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92484106|NCT01918241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92484107|NCT01918241|Immunologic Factors|immunologic factors|mesh-ancestor
92484108|NCT01918241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484109|NCT01918254|Paclitaxel|paclitaxel|mesh-list
92484110|NCT01918254|Pertuzumab|pertuzumab|mesh-list
92484111|NCT01918254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92484112|NCT01918254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484113|NCT01918254|Tubulin Modulators|tubulin modulators|mesh-ancestor
92484114|NCT01918254|Antimitotic Agents|antimitotic agents|mesh-ancestor
92484115|NCT01918254|Mitosis Modulators|mitosis modulators|mesh-ancestor
92484116|NCT01918254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484117|NCT01918254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92484118|NCT01918358|Valsartan|valsartan|mesh-list
92484119|NCT01918358|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92484120|NCT01918358|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92484121|NCT01918358|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92484122|NCT01918358|Antimetabolites|antimetabolites|mesh-ancestor
92484123|NCT01918358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484124|NCT01918358|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92484125|NCT01918358|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92484126|NCT01918358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484127|NCT01918358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92484128|NCT01918358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92484129|NCT01918358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92484130|NCT01918384|Arbekacin|arbekacin|mesh-list
92484131|NCT01918384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484132|NCT01918384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484133|NCT01918475|Carbetocin|carbetocin|mesh-list
92484134|NCT01918475|Oxytocics|oxytocics|mesh-ancestor
92484135|NCT01918475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484136|NCT01918475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484137|NCT01918488|Amiloride|amiloride|mesh-list
92484138|NCT01918488|Triamterene|triamterene|mesh-list
92484139|NCT01918488|Diuretics|diuretics|mesh-ancestor
92484140|NCT01918488|Natriuretic Agents|natriuretic agents|mesh-ancestor
92484141|NCT01918488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484142|NCT01918488|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92484143|NCT01918488|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92484144|NCT01918488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92484145|NCT01918488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484146|NCT01918488|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92484147|NCT01918488|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92484148|NCT01918514|Magnesium Sulfate|magnesium sulfate|mesh-list
92484149|NCT01918514|Analgesics|analgesics|mesh-ancestor
92484150|NCT01918514|Sensory System Agents|sensory system agents|mesh-ancestor
92484151|NCT01918514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484152|NCT01918514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484153|NCT01918514|Anesthetics|anesthetics|mesh-ancestor
92484154|NCT01918514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484155|NCT01918514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92484156|NCT01918514|Anticonvulsants|anticonvulsants|mesh-ancestor
92484157|NCT01918514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92484158|NCT01918514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92484159|NCT01918514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484160|NCT01918514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92484161|NCT01918514|Tocolytic Agents|tocolytic agents|mesh-ancestor
92484162|NCT01918514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484163|NCT01918631|Tenofovir|tenofovir|mesh-list
92484164|NCT01918631|Entecavir|entecavir|mesh-list
92484165|NCT01918631|Antiviral Agents|antiviral agents|mesh-ancestor
92484166|NCT01918631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151935|NCT01046565|Adapalene|adapalene|mesh-list
92484167|NCT01918631|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92484168|NCT01918631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92484169|NCT01918631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484170|NCT01918631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484171|NCT01918631|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92484172|NCT01918631|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92484173|NCT01918709|Valsartan|valsartan|mesh-list
92209062|NCT00867139|Oseltamivir|oseltamivir|mesh-list
92484174|NCT01918709|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92484175|NCT01918709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92484176|NCT01918709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92484177|NCT01918709|Antimetabolites|antimetabolites|mesh-ancestor
92484178|NCT01918709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484179|NCT01918709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92484180|NCT01918709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92484181|NCT01918709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484182|NCT01918709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92484183|NCT01918709|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92484184|NCT01918709|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92484186|NCT01918813|Mupirocin|mupirocin|mesh-list
92484187|NCT01918813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484188|NCT01918813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484189|NCT01918813|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92484190|NCT01918813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484191|NCT01918813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484192|NCT01918852|Bevacizumab|bevacizumab|mesh-list
92484194|NCT01918852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92484195|NCT01918852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484196|NCT01918852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92484197|NCT01918852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92484198|NCT01918852|Growth Substances|growth substances|mesh-ancestor
92484199|NCT01918852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484200|NCT01918852|Growth Inhibitors|growth inhibitors|mesh-ancestor
92484201|NCT01918852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92484202|NCT01918852|Antimetabolites|antimetabolites|mesh-ancestor
92484203|NCT01918852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484204|NCT01918865|Metformin|metformin|mesh-list
92484205|NCT01918865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92484206|NCT01918865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484207|NCT01918878|Aflibercept|aflibercept|mesh-list
92484208|NCT01918878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92484209|NCT01918878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92484210|NCT01918878|Growth Substances|growth substances|mesh-ancestor
92484211|NCT01918878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484212|NCT01918878|Growth Inhibitors|growth inhibitors|mesh-ancestor
92484213|NCT01918878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484214|NCT01918904|Sodium thiosulfate|sodium thiosulfate|mesh-list
92484215|NCT01918904|Antidotes|antidotes|mesh-ancestor
92484216|NCT01918904|Protective Agents|protective agents|mesh-ancestor
92484217|NCT01918904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484218|NCT01918904|Antioxidants|antioxidants|mesh-ancestor
92484219|NCT01918904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484220|NCT01918904|Antitubercular Agents|antitubercular agents|mesh-ancestor
92484221|NCT01918904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484222|NCT01918904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484223|NCT01918904|Chelating Agents|chelating agents|mesh-ancestor
92484224|NCT01918904|Sequestering Agents|sequestering agents|mesh-ancestor
92484225|NCT01918917|Dexmedetomidine|dexmedetomidine|mesh-list
92484226|NCT01918917|Morphine|morphine|mesh-list
92484227|NCT01918917|Levobupivacaine|levobupivacaine|mesh-list
92484228|NCT01918917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92484229|NCT01918917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484230|NCT01918917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484231|NCT01918917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484232|NCT01918917|Analgesics|analgesics|mesh-ancestor
92484233|NCT01918917|Sensory System Agents|sensory system agents|mesh-ancestor
92484234|NCT01918917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484235|NCT01918917|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92484236|NCT01918917|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92484237|NCT01918917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92484238|NCT01918917|Adrenergic Agents|adrenergic agents|mesh-ancestor
92484239|NCT01918917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484240|NCT01918917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484241|NCT01918917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484242|NCT01918917|Narcotics|narcotics|mesh-ancestor
92484243|NCT01918917|Anesthetics, Local|anesthetics, local|mesh-ancestor
92484244|NCT01918917|Anesthetics|anesthetics|mesh-ancestor
92484245|NCT01918995|Regadenoson|regadenoson|mesh-list
92484246|NCT01918995|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92484247|NCT01918995|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92484248|NCT01918995|Purinergic Agonists|purinergic agonists|mesh-ancestor
92484249|NCT01918995|Purinergic Agents|purinergic agents|mesh-ancestor
92484250|NCT01918995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484251|NCT01918995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484252|NCT01918995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484253|NCT01919008|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92484254|NCT01919008|Antidepressive Agents|antidepressive agents|mesh-ancestor
92484255|NCT01919008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92484256|NCT01919008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92484257|NCT01919008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92484258|NCT01919008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484259|NCT01919008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484260|NCT01919047|Mirabegron|mirabegron|mesh-list
92484261|NCT01919047|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92484262|NCT01919047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92484263|NCT01919047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92484264|NCT01919047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92484265|NCT01919047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484266|NCT01919047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484267|NCT01919047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484268|NCT01919047|Urological Agents|urological agents|mesh-ancestor
92484269|NCT01919203|Remifentanil|remifentanil|mesh-list
92484270|NCT01919203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484271|NCT01919203|Narcotics|narcotics|mesh-ancestor
92484272|NCT01919203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484273|NCT01919203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484274|NCT01919203|Analgesics|analgesics|mesh-ancestor
92484275|NCT01919203|Sensory System Agents|sensory system agents|mesh-ancestor
92484276|NCT01919203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484277|NCT01919255|Picosulfate sodium|picosulfate sodium|mesh-list
92484278|NCT01919255|Sodium sulfate|sodium sulfate|mesh-list
92484279|NCT01919255|Magnesium Oxide|magnesium oxide|mesh-list
92484280|NCT01919255|Sodium Citrate|sodium citrate|mesh-list
92484281|NCT01919255|Citric Acid|citric acid|mesh-list
92484282|NCT01919255|Anticoagulants|anticoagulants|mesh-ancestor
92484283|NCT01919255|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92484284|NCT01919255|Chelating Agents|chelating agents|mesh-ancestor
92484285|NCT01919255|Sequestering Agents|sequestering agents|mesh-ancestor
92484286|NCT01919255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484287|NCT01919255|Cathartics|cathartics|mesh-ancestor
92484288|NCT01919255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92484289|NCT01919255|Antacids|antacids|mesh-ancestor
92484290|NCT01919294|Methyltestosterone|methyltestosterone|mesh-list
92484291|NCT01919294|Testosterone|testosterone|mesh-list
92484292|NCT01919294|Testosterone undecanoate|testosterone undecanoate|mesh-list
92484293|NCT01919294|Testosterone enanthate|testosterone enanthate|mesh-list
92484294|NCT01919294|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92484295|NCT01919294|Androgens|androgens|mesh-ancestor
92484296|NCT01919294|Hormones|hormones|mesh-ancestor
92484297|NCT01919294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484298|NCT01919294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484299|NCT01919294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92484300|NCT01919294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484301|NCT01919294|Anabolic Agents|anabolic agents|mesh-ancestor
92484302|NCT01919346|Eculizumab|eculizumab|mesh-list
92484303|NCT01919346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92484304|NCT01919346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484305|NCT01919346|Immunologic Factors|immunologic factors|mesh-ancestor
92484306|NCT01919346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484307|NCT01919424|Methacholine Chloride|methacholine chloride|mesh-list
92484308|NCT01919424|Miotics|miotics|mesh-ancestor
92484309|NCT01919424|Autonomic Agents|autonomic agents|mesh-ancestor
92484310|NCT01919424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484311|NCT01919424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484312|NCT01919424|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92484313|NCT01919424|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92484314|NCT01919424|Respiratory System Agents|respiratory system agents|mesh-ancestor
92484315|NCT01919424|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92484316|NCT01919424|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92484317|NCT01919424|Cholinergic Agents|cholinergic agents|mesh-ancestor
92484318|NCT01919424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484319|NCT01919424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484320|NCT01919593|Chlorhexidine|chlorhexidine|mesh-list
92484321|NCT01919593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92484322|NCT01919593|Povidone-Iodine|povidone-iodine|mesh-list
92484323|NCT01919593|Povidone|povidone|mesh-list
92484324|NCT01919593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92484325|NCT01919593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484326|NCT01919593|Disinfectants|disinfectants|mesh-ancestor
92484327|NCT01919593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92484328|NCT01919593|Plasma Substitutes|plasma substitutes|mesh-ancestor
92484329|NCT01919593|Blood Substitutes|blood substitutes|mesh-ancestor
92484330|NCT01919788|Insulin|insulin|mesh-list
92484331|NCT01919788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92484332|NCT01919788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484333|NCT01919879|Cetuximab|cetuximab|mesh-list
92484334|NCT01919879|Afatinib|afatinib|mesh-list
92322576|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
92484335|NCT01919879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92484336|NCT01919879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484337|NCT01919879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484338|NCT01919879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484339|NCT01919879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484340|NCT01919892|Lithium Carbonate|lithium carbonate|mesh-list
92484341|NCT01919892|Antidepressive Agents|antidepressive agents|mesh-ancestor
92484342|NCT01919892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92484343|NCT01919892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484344|NCT01919892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484345|NCT01919892|Antimanic Agents|antimanic agents|mesh-ancestor
92484346|NCT01919892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92484347|NCT01919892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484348|NCT01919892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484350|NCT01919905|Vitamins|vitamins|mesh-ancestor
92484351|NCT01919905|Micronutrients|micronutrients|mesh-ancestor
92484352|NCT01919905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484353|NCT01919905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92484354|NCT01919918|Adenosine|adenosine|mesh-list
92484355|NCT01919918|Analgesics|analgesics|mesh-ancestor
92484356|NCT01919918|Sensory System Agents|sensory system agents|mesh-ancestor
92484357|NCT01919918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484358|NCT01919918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484359|NCT01919918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92484360|NCT01919918|Vasodilator Agents|vasodilator agents|mesh-ancestor
92484361|NCT01919918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92484362|NCT01919918|Purinergic Agonists|purinergic agonists|mesh-ancestor
92484363|NCT01919918|Purinergic Agents|purinergic agents|mesh-ancestor
92484364|NCT01919918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484365|NCT01919918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484366|NCT01920022|Contraceptive Agents|contraceptive agents|mesh-list
92484367|NCT01920022|Mifepristone|mifepristone|mesh-list
92484368|NCT01920022|Etonogestrel|etonogestrel|mesh-list
92484369|NCT01920022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484370|NCT01920022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484371|NCT01920022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92484372|NCT01920022|Abortifacient Agents|abortifacient agents|mesh-ancestor
92484373|NCT01920022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92484374|NCT01920022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92484375|NCT01920022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92484376|NCT01920022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92484377|NCT01920022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92484378|NCT01920022|Hormone Antagonists|hormone antagonists|mesh-ancestor
92484379|NCT01920022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484380|NCT01920022|Luteolytic Agents|luteolytic agents|mesh-ancestor
92484381|NCT01920022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92484382|NCT01920022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92484383|NCT01920074|Nitroglycerin|nitroglycerin|mesh-list
92349163|NCT01459614|Gemcitabine|gemcitabine|mesh-list
92484384|NCT01920074|Vasodilator Agents|vasodilator agents|mesh-ancestor
92484385|NCT01920516|Melphalan|melphalan|mesh-list
92484386|NCT01920516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92484387|NCT01920516|Alkylating Agents|alkylating agents|mesh-ancestor
92484388|NCT01920516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484389|NCT01920516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484390|NCT01920516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92484391|NCT01920516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484392|NCT01920516|Immunologic Factors|immunologic factors|mesh-ancestor
92484393|NCT01920516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484394|NCT01920984|Bevacizumab|bevacizumab|mesh-list
92484395|NCT01920984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92484396|NCT01920984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484397|NCT01920984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92484398|NCT01920984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92484399|NCT01920984|Growth Substances|growth substances|mesh-ancestor
92209291|NCT02710630|Dabigatran|dabigatran|mesh-list
92484400|NCT01920984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484401|NCT01920984|Growth Inhibitors|growth inhibitors|mesh-ancestor
92484403|NCT01921374|Interferons|interferons|mesh-list
92484404|NCT01921374|Interferon-gamma|interferon-gamma|mesh-list
92484405|NCT01921374|Interleukin-2|interleukin-2|mesh-list
92484406|NCT01921374|Interleukin-4|interleukin-4|mesh-list
92484407|NCT01921374|Dinoprostone|dinoprostone|mesh-list
92484408|NCT01921374|Hormones|hormones|mesh-list
92484409|NCT01921374|Estradiol|estradiol|mesh-list
92484410|NCT01921374|Testosterone|testosterone|mesh-list
92484411|NCT01921374|Progesterone|progesterone|mesh-list
92484412|NCT01921374|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92484413|NCT01921374|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92484414|NCT01921374|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92484415|NCT01921374|Immunoglobulins|immunoglobulins|mesh-list
92484416|NCT01921374|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92484417|NCT01921374|Antibodies|antibodies|mesh-list
92484418|NCT01921374|Immunoglobulin G|immunoglobulin g|mesh-list
92484419|NCT01921374|Complement System Proteins|complement system proteins|mesh-list
92484420|NCT01921374|Immunoglobulin A|immunoglobulin a|mesh-list
92484421|NCT01921374|Immunoglobulin M|immunoglobulin m|mesh-list
92484422|NCT01921374|beta-Endorphin|beta-endorphin|mesh-list
92484423|NCT01921374|Uric Acid|uric acid|mesh-list
92484424|NCT01921374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484425|NCT01921374|Vitamins|vitamins|mesh-ancestor
92484426|NCT01921374|Micronutrients|micronutrients|mesh-ancestor
92484427|NCT01921374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484428|NCT01921374|Antiviral Agents|antiviral agents|mesh-ancestor
92484429|NCT01921374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484430|NCT01921374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484431|NCT01921374|Estrogens|estrogens|mesh-ancestor
92484432|NCT01921374|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484433|NCT01921374|Immunologic Factors|immunologic factors|mesh-ancestor
92484434|NCT01921374|Androgens|androgens|mesh-ancestor
92484435|NCT01921374|Progestins|progestins|mesh-ancestor
92484436|NCT01921374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484437|NCT01921374|Analgesics|analgesics|mesh-ancestor
92484438|NCT01921374|Sensory System Agents|sensory system agents|mesh-ancestor
92484439|NCT01921374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484440|NCT01921374|Vitamin B Complex|vitamin b complex|mesh-ancestor
92484441|NCT01921374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484442|NCT01921374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484443|NCT01921374|Antioxidants|antioxidants|mesh-ancestor
92484444|NCT01921374|Protective Agents|protective agents|mesh-ancestor
92484445|NCT01921374|Oxytocics|oxytocics|mesh-ancestor
92484446|NCT01921374|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92484447|NCT01921374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484448|NCT01921972|Memantine|memantine|mesh-list
92484449|NCT01921972|Galantamine|galantamine|mesh-list
92484450|NCT01921972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92484451|NCT01921972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92484452|NCT01921972|Dopamine Agents|dopamine agents|mesh-ancestor
92484453|NCT01921972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484454|NCT01921972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484455|NCT01921972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484456|NCT01921972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92484457|NCT01921972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92349170|NCT01459614|Tubulin Modulators|tubulin modulators|mesh-ancestor
92484458|NCT01921972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92484459|NCT01921972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484460|NCT01921972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92484461|NCT01921972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92484462|NCT01921972|Autonomic Agents|autonomic agents|mesh-ancestor
92484463|NCT01921972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484464|NCT01921972|Nootropic Agents|nootropic agents|mesh-ancestor
92484465|NCT01923454|Acetazolamide|acetazolamide|mesh-list
92484466|NCT01923454|Anticonvulsants|anticonvulsants|mesh-ancestor
92484467|NCT01923454|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92484468|NCT01923454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484469|NCT01923454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484470|NCT01923454|Diuretics|diuretics|mesh-ancestor
92484471|NCT01923454|Natriuretic Agents|natriuretic agents|mesh-ancestor
92484472|NCT01923454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484473|NCT01923935|Melphalan|melphalan|mesh-list
92484474|NCT01923935|Busulfan|busulfan|mesh-list
92484475|NCT01923935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92484476|NCT01923935|Alkylating Agents|alkylating agents|mesh-ancestor
92200215|NCT01929759|Elvitegravir|elvitegravir|mesh-list
92484477|NCT01923935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484478|NCT01923935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484479|NCT01923935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92484480|NCT01923935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484481|NCT01923935|Immunologic Factors|immunologic factors|mesh-ancestor
92484482|NCT01923935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484483|NCT01923974|Melatonin|melatonin|mesh-list
92484484|NCT01923974|Antioxidants|antioxidants|mesh-ancestor
92484485|NCT01923974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484486|NCT01923974|Protective Agents|protective agents|mesh-ancestor
92484487|NCT01923974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484488|NCT01923974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484489|NCT01924013|Vitamin D|vitamin d|mesh-list
92484490|NCT01924013|Cholecalciferol|cholecalciferol|mesh-list
92484491|NCT01924013|Vitamins|vitamins|mesh-ancestor
92484492|NCT01924013|Micronutrients|micronutrients|mesh-ancestor
92484493|NCT01924013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484494|NCT01924013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92484495|NCT01924013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92484497|NCT01924676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484498|NCT01924676|Narcotics|narcotics|mesh-ancestor
92484499|NCT01924676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484500|NCT01924676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484501|NCT01924676|Analgesics|analgesics|mesh-ancestor
92484502|NCT01924676|Sensory System Agents|sensory system agents|mesh-ancestor
92484503|NCT01924676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484504|NCT01925066|Vancomycin|vancomycin|mesh-list
92484505|NCT01925066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484506|NCT01925066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484507|NCT01927640|Cocaine|cocaine|mesh-list
92484508|NCT01927640|Dexmedetomidine|dexmedetomidine|mesh-list
92484509|NCT01927640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92484510|NCT01927640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484511|NCT01927640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484512|NCT01927640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484513|NCT01927640|Analgesics|analgesics|mesh-ancestor
92484514|NCT01927640|Sensory System Agents|sensory system agents|mesh-ancestor
92484515|NCT01927640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484516|NCT01927640|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92484517|NCT01927640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92484518|NCT01927640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92484519|NCT01927640|Adrenergic Agents|adrenergic agents|mesh-ancestor
92484520|NCT01927640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484521|NCT01927640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484522|NCT01927640|Anesthetics, Local|anesthetics, local|mesh-ancestor
92484523|NCT01927640|Anesthetics|anesthetics|mesh-ancestor
92484524|NCT01927640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92484525|NCT01927640|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92484526|NCT01927640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92484527|NCT01927640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92484528|NCT01927640|Dopamine Agents|dopamine agents|mesh-ancestor
92484529|NCT01927679|Vitamin E|vitamin e|mesh-list
92484530|NCT01927679|Antioxidants|antioxidants|mesh-list
92484531|NCT01927679|Vitamins|vitamins|mesh-ancestor
92484532|NCT01927679|Micronutrients|micronutrients|mesh-ancestor
92484533|NCT01927679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484534|NCT01927679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484535|NCT01927679|Protective Agents|protective agents|mesh-ancestor
92484536|NCT01927965|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
92484537|NCT01927965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92484538|NCT01927965|Alkylating Agents|alkylating agents|mesh-ancestor
92484539|NCT01927965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484540|NCT01927965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484541|NCT01928407|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92484542|NCT01928407|Darunavir|darunavir|mesh-list
92484543|NCT01928407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92484544|NCT01928407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92484545|NCT01928407|Protease Inhibitors|protease inhibitors|mesh-ancestor
92484546|NCT01928407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484547|NCT01928407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484548|NCT01928407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92484549|NCT01928407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92484550|NCT01928407|Antiviral Agents|antiviral agents|mesh-ancestor
92484551|NCT01928407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484552|NCT01928875|Anesthetics|anesthetics|mesh-list
92484553|NCT01928875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484554|NCT01928875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484555|NCT01929486|Mogamulizumab|mogamulizumab|mesh-list
92484556|NCT01929486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484557|NCT01929590|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92484558|NCT01929590|Laxatives|laxatives|mesh-ancestor
92484559|NCT01929590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92484561|NCT01930019|Etomidate|etomidate|mesh-list
92484562|NCT01930019|Anesthetics|anesthetics|mesh-ancestor
92484563|NCT01930019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484564|NCT01930019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484565|NCT01930019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92484566|NCT01930019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92484567|NCT01930019|Anesthetics, General|anesthetics, general|mesh-ancestor
92484568|NCT01930019|Anticonvulsants|anticonvulsants|mesh-ancestor
92484569|NCT01930019|GABA Modulators|gaba modulators|mesh-ancestor
92484570|NCT01930019|GABA Agents|gaba agents|mesh-ancestor
92484571|NCT01930019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484572|NCT01930019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484573|NCT01930201|Anesthetics|anesthetics|mesh-list
92484574|NCT01930201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484575|NCT01930201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484576|NCT01930292|Paclitaxel|paclitaxel|mesh-list
92484577|NCT01930292|Carboplatin|carboplatin|mesh-list
92484578|NCT01930292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92484579|NCT01930292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484580|NCT01930292|Tubulin Modulators|tubulin modulators|mesh-ancestor
92484581|NCT01930292|Antimitotic Agents|antimitotic agents|mesh-ancestor
92484582|NCT01930292|Mitosis Modulators|mitosis modulators|mesh-ancestor
92484583|NCT01930292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484584|NCT01930318|Parecoxib|parecoxib|mesh-list
92484585|NCT01930318|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92484586|NCT01930318|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92484587|NCT01930318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484588|NCT01930318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484589|NCT01930318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92484590|NCT01930318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484591|NCT01930318|Analgesics|analgesics|mesh-ancestor
92484592|NCT01930318|Sensory System Agents|sensory system agents|mesh-ancestor
92484593|NCT01930318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484594|NCT01930318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484595|NCT01930318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92484596|NCT01930318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484597|NCT01930331|Piperaquine|piperaquine|mesh-list
92484598|NCT01930331|Artenimol|artenimol|mesh-list
92484599|NCT01930331|Artemisinins|artemisinins|mesh-list
92484600|NCT01930331|Artemisinin|artemisinin|mesh-list
92484601|NCT01930331|Antimalarials|antimalarials|mesh-ancestor
92484602|NCT01930331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92484603|NCT01930331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92484604|NCT01930331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484605|NCT01930370|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92484606|NCT01930370|Hemodialysis Solutions|hemodialysis solutions|mesh-list
92484607|NCT01930370|Dialysis Solutions|dialysis solutions|mesh-ancestor
92484608|NCT01930396|Heparin|heparin|mesh-list
92484609|NCT01930396|Calcium heparin|calcium heparin|mesh-list
92484610|NCT01930396|Tinzaparin|tinzaparin|mesh-list
92484611|NCT01930396|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92484612|NCT01930396|Dalteparin|dalteparin|mesh-list
92484613|NCT01930396|Anticoagulants|anticoagulants|mesh-ancestor
92484614|NCT01930396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92484615|NCT01930396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92484616|NCT01930396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484617|NCT01930461|Immunomodulating Agents|immunomodulating agents|mesh-list
92484618|NCT01930461|Immunologic Factors|immunologic factors|mesh-list
92484619|NCT01930461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484620|NCT01930552|Leucovorin|leucovorin|mesh-list
92484621|NCT01930552|Fluorouracil|fluorouracil|mesh-list
92484622|NCT01930552|Irinotecan|irinotecan|mesh-list
92484623|NCT01930552|Aflibercept|aflibercept|mesh-list
92484624|NCT01930552|Antimetabolites|antimetabolites|mesh-ancestor
92484625|NCT01930552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484626|NCT01930552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92484627|NCT01930552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484628|NCT01930552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484629|NCT01930552|Immunologic Factors|immunologic factors|mesh-ancestor
92484630|NCT01930552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484631|NCT01930552|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92484632|NCT01930552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92484633|NCT01930552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484634|NCT01930552|Antidotes|antidotes|mesh-ancestor
92484635|NCT01930552|Protective Agents|protective agents|mesh-ancestor
92484636|NCT01930552|Vitamin B Complex|vitamin b complex|mesh-ancestor
92484637|NCT01930552|Vitamins|vitamins|mesh-ancestor
92484638|NCT01930552|Micronutrients|micronutrients|mesh-ancestor
92484639|NCT01930552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92484640|NCT01930552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92484641|NCT01930552|Growth Substances|growth substances|mesh-ancestor
92484642|NCT01930552|Growth Inhibitors|growth inhibitors|mesh-ancestor
92484643|NCT01930591|Clopidogrel|clopidogrel|mesh-list
92484644|NCT01930591|Ticagrelor|ticagrelor|mesh-list
92484645|NCT01930591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92484646|NCT01930591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92484647|NCT01930591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92484648|NCT01930591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92484649|NCT01930591|Purinergic Agents|purinergic agents|mesh-ancestor
92484650|NCT01930591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484651|NCT01930591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484652|NCT01930591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484653|NCT01930604|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92484654|NCT01930604|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92484655|NCT01930604|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92484656|NCT01930604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92484657|NCT01930604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484658|NCT01930604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484659|NCT01930604|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92484660|NCT01930604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92484661|NCT01930604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484662|NCT01930604|Cholinergic Agents|cholinergic agents|mesh-ancestor
92484663|NCT01930604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484664|NCT01930604|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92484665|NCT01930682|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92484666|NCT01930682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92484667|NCT01930682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92484668|NCT01930682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484669|NCT01930708|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92484670|NCT01930708|Dermatologic Agents|dermatologic agents|mesh-ancestor
92484671|NCT01930708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484672|NCT01930708|Immunologic Factors|immunologic factors|mesh-ancestor
92484673|NCT01930708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484674|NCT01930734|Dobutamine|dobutamine|mesh-list
92484675|NCT01930734|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92484676|NCT01930734|Sympathomimetics|sympathomimetics|mesh-ancestor
92484677|NCT01930734|Autonomic Agents|autonomic agents|mesh-ancestor
92484678|NCT01930734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484679|NCT01930734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484680|NCT01930734|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92484681|NCT01930734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92484682|NCT01930734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92484683|NCT01930734|Adrenergic Agents|adrenergic agents|mesh-ancestor
92484684|NCT01930734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484685|NCT01930734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484686|NCT01930734|Protective Agents|protective agents|mesh-ancestor
92484687|NCT01930773|Clopidogrel|clopidogrel|mesh-list
92484688|NCT01930773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92484689|NCT01930773|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92484690|NCT01930773|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92484691|NCT01930773|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92484692|NCT01930773|Purinergic Agents|purinergic agents|mesh-ancestor
92484693|NCT01930773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484694|NCT01930773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484695|NCT01930773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484696|NCT01930786|Botulinum Toxins|botulinum toxins|mesh-list
92484697|NCT01930786|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92484698|NCT01930786|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92484699|NCT01930786|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92484700|NCT01930786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92484701|NCT01930786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484702|NCT01930786|Cholinergic Agents|cholinergic agents|mesh-ancestor
92484703|NCT01930786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484704|NCT01930786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484705|NCT01930786|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92484706|NCT01930786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484708|NCT01930812|Fluorides|fluorides|mesh-list
92484709|NCT01930812|Sodium Fluoride|sodium fluoride|mesh-list
92484710|NCT01930812|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92484711|NCT01930812|Cariostatic Agents|cariostatic agents|mesh-ancestor
92484712|NCT01930812|Protective Agents|protective agents|mesh-ancestor
92484713|NCT01930812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484714|NCT01930812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92484715|NCT01930812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484716|NCT01930812|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92484717|NCT01930812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484718|NCT01930864|Metformin|metformin|mesh-list
92484720|NCT01930864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92484721|NCT01930864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484722|NCT01930864|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92484723|NCT01930864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92484724|NCT01930864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484725|NCT01930864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484726|NCT01930864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484727|NCT01930877|Lidocaine|lidocaine|mesh-list
92484728|NCT01930877|Anesthetics, Local|anesthetics, local|mesh-ancestor
92484729|NCT01930877|Anesthetics|anesthetics|mesh-ancestor
92484730|NCT01930877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484731|NCT01930877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484732|NCT01930877|Sensory System Agents|sensory system agents|mesh-ancestor
92484733|NCT01930877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484734|NCT01930877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92484735|NCT01930877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92484736|NCT01930877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92484737|NCT01930877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92484738|NCT01930877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484739|NCT01930916|Anticoagulants|anticoagulants|mesh-list
92484740|NCT01930916|Antibodies|antibodies|mesh-list
92484741|NCT01930916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
92484742|NCT01930916|Lupus Coagulation Inhibitor|lupus coagulation inhibitor|mesh-list
92484743|NCT01930916|Immunologic Factors|immunologic factors|mesh-ancestor
92484744|NCT01930916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484745|NCT01931085|Triclabendazole|triclabendazole|mesh-list
92484746|NCT01931085|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92484747|NCT01931085|Anthelmintics|anthelmintics|mesh-ancestor
92484748|NCT01931085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92484749|NCT01931085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484750|NCT01931098|Topotecan|topotecan|mesh-list
92484751|NCT01931098|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92484752|NCT01931098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92484753|NCT01931098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484754|NCT01931098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484755|NCT01931098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484756|NCT01931137|Insulin|insulin|mesh-list
92484757|NCT01931137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92484758|NCT01931137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484759|NCT01931189|Infliximab|infliximab|mesh-list
92484760|NCT01931189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92484761|NCT01931189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92484762|NCT01931189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92484763|NCT01931189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92484764|NCT01931189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484765|NCT01931215|Clonidine|clonidine|mesh-list
92484766|NCT01931215|Morphine|morphine|mesh-list
92484767|NCT01931215|Ropivacaine|ropivacaine|mesh-list
92484768|NCT01931215|Anesthetics|anesthetics|mesh-ancestor
92484769|NCT01931215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484770|NCT01931215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484771|NCT01931215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484772|NCT01931215|Narcotics|narcotics|mesh-ancestor
92484773|NCT01931215|Analgesics|analgesics|mesh-ancestor
92484774|NCT01931215|Sensory System Agents|sensory system agents|mesh-ancestor
92484775|NCT01931215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484776|NCT01931215|Anesthetics, Local|anesthetics, local|mesh-ancestor
92484777|NCT01931215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92209677|NCT05444218|Amoxicillin|amoxicillin|mesh-list
92484778|NCT01931215|Sympatholytics|sympatholytics|mesh-ancestor
92484779|NCT01931215|Autonomic Agents|autonomic agents|mesh-ancestor
92484780|NCT01931215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92484781|NCT01931215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92484782|NCT01931215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92484783|NCT01931215|Adrenergic Agents|adrenergic agents|mesh-ancestor
92484784|NCT01931215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484785|NCT01931215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484786|NCT01931293|Folic Acid|folic acid|mesh-list
92484787|NCT01931293|Vitamin B Complex|vitamin b complex|mesh-list
92484788|NCT01931293|Vitamins|vitamins|mesh-ancestor
92484789|NCT01931293|Micronutrients|micronutrients|mesh-ancestor
92484790|NCT01931293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484791|NCT01931293|Hematinics|hematinics|mesh-ancestor
92484792|NCT01931306|Afatinib|afatinib|mesh-list
92484793|NCT01931306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484794|NCT01931306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484795|NCT01931306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484796|NCT01931306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484797|NCT01931319|Baclofen|baclofen|mesh-list
92484798|NCT01931319|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92484799|NCT01931319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484800|NCT01931319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92484801|NCT01931319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484802|NCT01931319|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92484803|NCT01931319|GABA Agonists|gaba agonists|mesh-ancestor
92484804|NCT01931319|GABA Agents|gaba agents|mesh-ancestor
92484805|NCT01931319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92484806|NCT01931319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484807|NCT01931332|Heroin|heroin|mesh-list
92484808|NCT01931332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484809|NCT01931332|Narcotics|narcotics|mesh-ancestor
92484810|NCT01931332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484811|NCT01931332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484812|NCT01931332|Analgesics|analgesics|mesh-ancestor
92484813|NCT01931332|Sensory System Agents|sensory system agents|mesh-ancestor
92484814|NCT01931332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484815|NCT01931384|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92484816|NCT01931384|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484817|NCT01931384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484818|NCT01931410|Misoprostol|misoprostol|mesh-list
92484819|NCT01931410|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92484820|NCT01931410|Abortifacient Agents|abortifacient agents|mesh-ancestor
92484821|NCT01931410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484822|NCT01931410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484823|NCT01931410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92484824|NCT01931410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92484825|NCT01931410|Oxytocics|oxytocics|mesh-ancestor
92484826|NCT01931501|Montelukast|montelukast|mesh-list
92484827|NCT01931501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92484828|NCT01931501|Respiratory System Agents|respiratory system agents|mesh-ancestor
92484829|NCT01931501|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92484830|NCT01931501|Hormone Antagonists|hormone antagonists|mesh-ancestor
92484831|NCT01931501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484832|NCT01931501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484833|NCT01931501|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92484834|NCT01931501|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92200227|NCT03437330|Insulin Glargine|insulin glargine|mesh-list
92484835|NCT01931501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484836|NCT01931514|Montelukast|montelukast|mesh-list
92484837|NCT01931514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92484838|NCT01931514|Respiratory System Agents|respiratory system agents|mesh-ancestor
92484839|NCT01931514|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92484840|NCT01931514|Hormone Antagonists|hormone antagonists|mesh-ancestor
92484841|NCT01931514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484842|NCT01931514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484843|NCT01931514|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92484844|NCT01931514|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92484845|NCT01931514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484846|NCT01931592|Gentamicins|gentamicins|mesh-list
92484847|NCT01931592|Colistin|colistin|mesh-list
92484848|NCT01931592|Fosfomycin|fosfomycin|mesh-list
92484849|NCT01931592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484850|NCT01931592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484851|NCT01931592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92484852|NCT01931592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484853|NCT01931592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484854|NCT01931657|Mifepristone|mifepristone|mesh-list
92484856|NCT01931657|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92484857|NCT01931657|Abortifacient Agents|abortifacient agents|mesh-ancestor
92484858|NCT01931657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92484859|NCT01931657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484860|NCT01931657|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92484861|NCT01931657|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92484862|NCT01931657|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92484863|NCT01931657|Contraceptive Agents|contraceptive agents|mesh-ancestor
92484864|NCT01931657|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92484865|NCT01931657|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92484866|NCT01931657|Hormone Antagonists|hormone antagonists|mesh-ancestor
92484867|NCT01931657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484868|NCT01931657|Luteolytic Agents|luteolytic agents|mesh-ancestor
92484869|NCT01931657|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92484870|NCT01931657|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92484871|NCT01931683|Remifentanil|remifentanil|mesh-list
92484872|NCT01931683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92484873|NCT01931683|Narcotics|narcotics|mesh-ancestor
92484874|NCT01931683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484875|NCT01931683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484876|NCT01931683|Analgesics|analgesics|mesh-ancestor
92484877|NCT01931683|Sensory System Agents|sensory system agents|mesh-ancestor
92484878|NCT01931683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484879|NCT01931787|Thioctic Acid|thioctic acid|mesh-list
92484880|NCT01931787|Antioxidants|antioxidants|mesh-ancestor
92484881|NCT01931787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484882|NCT01931787|Protective Agents|protective agents|mesh-ancestor
92484883|NCT01931787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484884|NCT01931787|Vitamin B Complex|vitamin b complex|mesh-ancestor
92484885|NCT01931787|Vitamins|vitamins|mesh-ancestor
92484886|NCT01931787|Micronutrients|micronutrients|mesh-ancestor
92484887|NCT01931982|Liraglutide|liraglutide|mesh-list
92484888|NCT01931982|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92484889|NCT01931982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484890|NCT01931982|Incretins|incretins|mesh-ancestor
92484891|NCT01931982|Hormones|hormones|mesh-ancestor
92484892|NCT01931982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484893|NCT01932151|Terlipressin|terlipressin|mesh-list
92484894|NCT01932151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92484895|NCT01932151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92484896|NCT01932177|Everolimus|everolimus|mesh-list
92484897|NCT01932177|Sorafenib|sorafenib|mesh-list
92484898|NCT01932177|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92484899|NCT01932177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484900|NCT01932177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484901|NCT01932177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484902|NCT01932177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484903|NCT01932177|Immunologic Factors|immunologic factors|mesh-ancestor
92484904|NCT01932177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484905|NCT01932177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484906|NCT01932203|Aspirin|aspirin|mesh-list
92484907|NCT01932203|Cilostazol|cilostazol|mesh-list
92484908|NCT01932203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92484909|NCT01932203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484911|NCT01932203|Sensory System Agents|sensory system agents|mesh-ancestor
92484912|NCT01932203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484913|NCT01932203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484914|NCT01932203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92484915|NCT01932203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92484916|NCT01932203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92484917|NCT01932203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92484918|NCT01932203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484919|NCT01932203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92484920|NCT01932203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92484921|NCT01932203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484922|NCT01932203|Antipyretics|antipyretics|mesh-ancestor
92484923|NCT01932203|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92484924|NCT01932203|Autonomic Agents|autonomic agents|mesh-ancestor
92484925|NCT01932203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92484926|NCT01932203|Respiratory System Agents|respiratory system agents|mesh-ancestor
92484927|NCT01932203|Vasodilator Agents|vasodilator agents|mesh-ancestor
92484928|NCT01932203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92209820|NCT05441254|Tubulin Modulators|tubulin modulators|mesh-ancestor
92484929|NCT01932203|Protective Agents|protective agents|mesh-ancestor
92484930|NCT01932203|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92484931|NCT01932203|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92484933|NCT01932229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484934|NCT01932229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484935|NCT01932229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484936|NCT01932229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484937|NCT01932268|Rifampin|rifampin|mesh-list
92484938|NCT01932268|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92484939|NCT01932268|Antitubercular Agents|antitubercular agents|mesh-ancestor
92484940|NCT01932268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92484941|NCT01932268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484942|NCT01932268|Leprostatic Agents|leprostatic agents|mesh-ancestor
92484943|NCT01932268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92484944|NCT01932268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484945|NCT01932268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484946|NCT01932268|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92484947|NCT01932268|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92484948|NCT01932268|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92484949|NCT01932268|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92484950|NCT01932268|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92484951|NCT01932268|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92484952|NCT01932320|Ketoconazole|ketoconazole|mesh-list
92484953|NCT01932320|Antifungal Agents|antifungal agents|mesh-ancestor
92484954|NCT01932320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92484955|NCT01932320|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92484956|NCT01932320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92484957|NCT01932320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484958|NCT01932320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484959|NCT01932320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92484960|NCT01932320|Hormone Antagonists|hormone antagonists|mesh-ancestor
92484961|NCT01932320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92484962|NCT01932320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484963|NCT01932320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92484964|NCT01932372|Etanercept|etanercept|mesh-list
92484965|NCT01932372|Antirheumatic Agents|antirheumatic agents|mesh-list
92484966|NCT01932372|Tofacitinib|tofacitinib|mesh-list
92484967|NCT01932372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92484968|NCT01932372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92484969|NCT01932372|Analgesics|analgesics|mesh-ancestor
92484970|NCT01932372|Sensory System Agents|sensory system agents|mesh-ancestor
92484971|NCT01932372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92484972|NCT01932372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484973|NCT01932372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92484974|NCT01932372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92484975|NCT01932372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92484976|NCT01932372|Immunologic Factors|immunologic factors|mesh-ancestor
92484977|NCT01932372|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92484978|NCT01932372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484979|NCT01932372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322579|NCT00002156|Fomivirsen|fomivirsen|mesh-list
92484980|NCT01932372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484981|NCT01932385|Sorafenib|sorafenib|mesh-list
92484982|NCT01932385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92484983|NCT01932385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92484984|NCT01932385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92484985|NCT01932385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92484986|NCT01932424|Propofol|propofol|mesh-list
92484987|NCT01932424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92484988|NCT01932424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484989|NCT01932424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92484990|NCT01932424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92484991|NCT01932424|Anesthetics, General|anesthetics, general|mesh-ancestor
92484992|NCT01932424|Anesthetics|anesthetics|mesh-ancestor
92484993|NCT01932450|Antihypertensive Agents|antihypertensive agents|mesh-list
92484994|NCT01932502|Clobazam|clobazam|mesh-list
92484995|NCT01932502|Anticonvulsants|anticonvulsants|mesh-ancestor
92484996|NCT01932502|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92484997|NCT01932502|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92484998|NCT01932502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92484999|NCT01932502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485000|NCT01932502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485001|NCT01932502|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92485002|NCT01932502|GABA Agonists|gaba agonists|mesh-ancestor
92485004|NCT01932502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485005|NCT01932502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485006|NCT01932541|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92485007|NCT01932541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92485008|NCT01932541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92485009|NCT01932541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485010|NCT01932541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485011|NCT01932541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485012|NCT01932541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92485013|NCT01932541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92485014|NCT01932541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92485015|NCT01932541|Adrenergic Agents|adrenergic agents|mesh-ancestor
92485016|NCT01932541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485017|NCT01932541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485018|NCT01932541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92485019|NCT01932541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92485020|NCT01932541|Serotonin Agents|serotonin agents|mesh-ancestor
92485021|NCT01932541|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92485022|NCT01932541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92485023|NCT01932541|Dopamine Agents|dopamine agents|mesh-ancestor
92485025|NCT01932554|Fentanyl|fentanyl|mesh-list
92485026|NCT01932554|Morphine|morphine|mesh-list
92485027|NCT01932554|Hydromorphone|hydromorphone|mesh-list
92485028|NCT01932554|Narcotics|narcotics|mesh-list
92485029|NCT01932554|Abciximab|abciximab|mesh-list
92485030|NCT01932554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485031|NCT01932554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485032|NCT01932554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485033|NCT01932554|Analgesics|analgesics|mesh-ancestor
92485034|NCT01932554|Sensory System Agents|sensory system agents|mesh-ancestor
92485035|NCT01932554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485036|NCT01932554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485037|NCT01932554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485038|NCT01932554|Anesthetics, General|anesthetics, general|mesh-ancestor
92485039|NCT01932554|Anesthetics|anesthetics|mesh-ancestor
92485040|NCT01932554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485041|NCT01932554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485042|NCT01932554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485043|NCT01932554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485044|NCT01932554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485045|NCT01932554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485046|NCT01932554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485047|NCT01932554|Anticoagulants|anticoagulants|mesh-ancestor
92485048|NCT01932554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92485049|NCT01932580|Docetaxel|docetaxel|mesh-list
92485050|NCT01932580|Fluorouracil|fluorouracil|mesh-list
92485051|NCT01932580|Oxaliplatin|oxaliplatin|mesh-list
92485052|NCT01932580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485053|NCT01932580|Tubulin Modulators|tubulin modulators|mesh-ancestor
92485054|NCT01932580|Antimitotic Agents|antimitotic agents|mesh-ancestor
92485055|NCT01932580|Mitosis Modulators|mitosis modulators|mesh-ancestor
92485056|NCT01932580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485057|NCT01932580|Antimetabolites|antimetabolites|mesh-ancestor
92485058|NCT01932580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92485059|NCT01932580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92485060|NCT01932580|Immunologic Factors|immunologic factors|mesh-ancestor
92485061|NCT01932580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485062|NCT01932918|Ketorolac|ketorolac|mesh-list
92485063|NCT01932918|Morphine|morphine|mesh-list
92485064|NCT01932918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485065|NCT01932918|Narcotics|narcotics|mesh-ancestor
92485066|NCT01932918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485067|NCT01932918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485068|NCT01932918|Analgesics|analgesics|mesh-ancestor
92485069|NCT01932918|Sensory System Agents|sensory system agents|mesh-ancestor
92485070|NCT01932918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485071|NCT01932918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485072|NCT01932918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485073|NCT01932918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92209976|NCT03166228|Glycine|glycine|mesh-list
92485074|NCT01932918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485075|NCT01932918|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485076|NCT01932918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485077|NCT01932918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485078|NCT01932931|Vitamin D|vitamin d|mesh-list
92485079|NCT01932931|Cholecalciferol|cholecalciferol|mesh-list
92485080|NCT01932931|Vitamins|vitamins|mesh-ancestor
92485081|NCT01932931|Micronutrients|micronutrients|mesh-ancestor
92485082|NCT01932931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485083|NCT01932931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92485084|NCT01932931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92485085|NCT01933022|Leuprolide|leuprolide|mesh-list
92485086|NCT01933022|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92485087|NCT01933022|Fertility Agents|fertility agents|mesh-ancestor
92485088|NCT01933022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92485089|NCT01933022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485090|NCT01933022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92485091|NCT01933022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485092|NCT01933061|Paclitaxel|paclitaxel|mesh-list
92485093|NCT01933061|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92485094|NCT01933061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92485095|NCT01933061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485096|NCT01933061|Tubulin Modulators|tubulin modulators|mesh-ancestor
92485097|NCT01933061|Antimitotic Agents|antimitotic agents|mesh-ancestor
92485098|NCT01933061|Mitosis Modulators|mitosis modulators|mesh-ancestor
92485099|NCT01933061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485100|NCT01933152|Ranibizumab|ranibizumab|mesh-list
92485101|NCT01933152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92485102|NCT01933152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92485103|NCT01933152|Growth Substances|growth substances|mesh-ancestor
92485104|NCT01933152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485105|NCT01933152|Growth Inhibitors|growth inhibitors|mesh-ancestor
92485106|NCT01933152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485107|NCT01933347|Gefitinib|gefitinib|mesh-list
92485108|NCT01933347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485109|NCT01933347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485110|NCT01933347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349198|NCT01458366|Ofatumumab|ofatumumab|mesh-list
92485111|NCT01933347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485112|NCT01933360|Misoprostol|misoprostol|mesh-list
92485113|NCT01933360|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92485114|NCT01933360|Abortifacient Agents|abortifacient agents|mesh-ancestor
92485115|NCT01933360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92485116|NCT01933360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485117|NCT01933360|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92485118|NCT01933360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485119|NCT01933360|Oxytocics|oxytocics|mesh-ancestor
92485120|NCT01933412|Vaccines|vaccines|mesh-list
92485121|NCT01933412|Immunologic Factors|immunologic factors|mesh-ancestor
92485122|NCT01933412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485123|NCT01933490|Insulin Aspart|insulin aspart|mesh-list
92485124|NCT01933490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485125|NCT01933490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485126|NCT01933503|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92485127|NCT01933503|Cathartics|cathartics|mesh-ancestor
92485128|NCT01933503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485129|NCT01933516|Rituximab|rituximab|mesh-list
92485130|NCT01933516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92322580|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
92485131|NCT01933516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485132|NCT01933516|Immunologic Factors|immunologic factors|mesh-ancestor
92485133|NCT01933516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485134|NCT01933516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485135|NCT01933542|Morphine|morphine|mesh-list
92485136|NCT01933542|Chlorzoxazone|chlorzoxazone|mesh-list
92485137|NCT01933542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485138|NCT01933542|Narcotics|narcotics|mesh-ancestor
92485139|NCT01933542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485140|NCT01933542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485141|NCT01933542|Analgesics|analgesics|mesh-ancestor
92485142|NCT01933542|Sensory System Agents|sensory system agents|mesh-ancestor
92485143|NCT01933542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485144|NCT01933542|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92485145|NCT01933542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92485146|NCT01933568|Cisplatin|cisplatin|mesh-list
92485147|NCT01933568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485148|NCT01933698|Amoxicillin|amoxicillin|mesh-list
92485149|NCT01933698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485150|NCT01933698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485151|NCT01933711|Rituximab|rituximab|mesh-list
92485152|NCT01933711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92485153|NCT01933711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485154|NCT01933711|Immunologic Factors|immunologic factors|mesh-ancestor
92532023|NCT00050245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485155|NCT01933711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485156|NCT01933711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485158|NCT01933906|Interferon-alpha|interferon-alpha|mesh-list
92485159|NCT01933906|Interferon alpha-2|interferon alpha-2|mesh-list
92485160|NCT01933906|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92485161|NCT01933906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485162|NCT01933906|Antiviral Agents|antiviral agents|mesh-ancestor
92485163|NCT01933906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485164|NCT01933906|Immunologic Factors|immunologic factors|mesh-ancestor
92485165|NCT01933906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485166|NCT01933945|Sorafenib|sorafenib|mesh-list
92485167|NCT01933945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485168|NCT01933945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485169|NCT01933945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485170|NCT01933945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485171|NCT01933971|Lenograstim|lenograstim|mesh-list
92485172|NCT01933971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92485173|NCT01933971|Immunologic Factors|immunologic factors|mesh-ancestor
92485174|NCT01933971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485175|NCT01933997|Pyridoxine|pyridoxine|mesh-list
92485176|NCT01933997|Metadoxine|metadoxine|mesh-list
92485177|NCT01933997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92485178|NCT01933997|Vitamin B Complex|vitamin b complex|mesh-ancestor
92485179|NCT01933997|Vitamins|vitamins|mesh-ancestor
92485180|NCT01933997|Micronutrients|micronutrients|mesh-ancestor
92485181|NCT01933997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485182|NCT01934023|Varenicline|varenicline|mesh-list
92485183|NCT01934023|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92485184|NCT01934023|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92485185|NCT01934023|Cholinergic Agents|cholinergic agents|mesh-ancestor
92485186|NCT01934023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485187|NCT01934023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485188|NCT01934023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485189|NCT01934049|Anesthetics|anesthetics|mesh-list
92485190|NCT01934049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485191|NCT01934049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485192|NCT01934088|Fentanyl|fentanyl|mesh-list
92485193|NCT01934088|Midazolam|midazolam|mesh-list
92485194|NCT01934088|Propofol|propofol|mesh-list
92485195|NCT01934088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485196|NCT01934088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485197|NCT01934088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485198|NCT01934088|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485199|NCT01934088|Anesthetics, General|anesthetics, general|mesh-ancestor
92485200|NCT01934088|Anesthetics|anesthetics|mesh-ancestor
92485201|NCT01934088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485202|NCT01934088|Narcotics|narcotics|mesh-ancestor
92485203|NCT01934088|Analgesics|analgesics|mesh-ancestor
92485204|NCT01934088|Sensory System Agents|sensory system agents|mesh-ancestor
92485205|NCT01934088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485206|NCT01934088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485207|NCT01934088|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92485208|NCT01934088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92485209|NCT01934088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485210|NCT01934088|GABA Modulators|gaba modulators|mesh-ancestor
92485211|NCT01934088|GABA Agents|gaba agents|mesh-ancestor
92485212|NCT01934088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485213|NCT01934088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485214|NCT01934127|Vaccines|vaccines|mesh-list
92485215|NCT01934127|Immunologic Factors|immunologic factors|mesh-ancestor
92485216|NCT01934127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485217|NCT01934166|Nalmefene|nalmefene|mesh-list
92485218|NCT01934166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92485219|NCT01934166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485220|NCT01934166|Sensory System Agents|sensory system agents|mesh-ancestor
92485221|NCT01934166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485222|NCT01934205|Gepotidacin|gepotidacin|mesh-list
92485223|NCT01934205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92485224|NCT01934205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485225|NCT01934205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485226|NCT01934205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485227|NCT01934361|Carboplatin|carboplatin|mesh-list
92485228|NCT01934361|Lomustine|lomustine|mesh-list
92485229|NCT01934361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485230|NCT01934361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92485231|NCT01934361|Alkylating Agents|alkylating agents|mesh-ancestor
92532024|NCT00050362|Rofecoxib|rofecoxib|mesh-list
92485232|NCT01934361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485233|NCT01934569|Losartan|losartan|mesh-list
92485234|NCT01934569|Midazolam|midazolam|mesh-list
92485235|NCT01934569|Caffeine|caffeine|mesh-list
92485236|NCT01934569|Omeprazole|omeprazole|mesh-list
92485237|NCT01934569|Pravastatin|pravastatin|mesh-list
92485238|NCT01934569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485239|NCT01934569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485240|NCT01934569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485241|NCT01934569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485242|NCT01934569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92485243|NCT01934569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92485244|NCT01934569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485245|NCT01934569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485246|NCT01934569|Anesthetics, General|anesthetics, general|mesh-ancestor
92485247|NCT01934569|Anesthetics|anesthetics|mesh-ancestor
92485248|NCT01934569|GABA Modulators|gaba modulators|mesh-ancestor
92485249|NCT01934569|GABA Agents|gaba agents|mesh-ancestor
92485250|NCT01934569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485251|NCT01934569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485252|NCT01934569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92485253|NCT01934569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92485254|NCT01934569|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92485255|NCT01934569|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92485256|NCT01934569|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92485257|NCT01934569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92485258|NCT01934569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485259|NCT01934569|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92485260|NCT01934569|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92485261|NCT01934569|Purinergic Agents|purinergic agents|mesh-ancestor
92485262|NCT01934569|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92485263|NCT01934569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485264|NCT01934569|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92485265|NCT01934569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92485266|NCT01934569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92485267|NCT01934569|Antimetabolites|antimetabolites|mesh-ancestor
92485268|NCT01934569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92485269|NCT01934569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92485270|NCT01934634|Paclitaxel|paclitaxel|mesh-list
92485271|NCT01934634|Gemcitabine|gemcitabine|mesh-list
92485272|NCT01934634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92485273|NCT01934634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485274|NCT01934634|Tubulin Modulators|tubulin modulators|mesh-ancestor
92485275|NCT01934634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92485276|NCT01934634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92485277|NCT01934634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485278|NCT01934634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92485279|NCT01934634|Antimetabolites|antimetabolites|mesh-ancestor
92485280|NCT01934712|Insulin|insulin|mesh-list
92485281|NCT01934712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92485282|NCT01934712|Insulin Aspart|insulin aspart|mesh-list
92485283|NCT01934712|Insulin, Long-Acting|insulin, long-acting|mesh-list
92485284|NCT01934712|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92485285|NCT01934712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485286|NCT01934712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485287|NCT01934777|Vitamin E|vitamin e|mesh-list
92485288|NCT01934777|Choline|choline|mesh-list
92485289|NCT01934777|Vitamins|vitamins|mesh-ancestor
92485290|NCT01934777|Micronutrients|micronutrients|mesh-ancestor
92485291|NCT01934777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485292|NCT01934777|Antioxidants|antioxidants|mesh-ancestor
92485293|NCT01934777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485294|NCT01934777|Protective Agents|protective agents|mesh-ancestor
92485295|NCT01934777|Lipotropic Agents|lipotropic agents|mesh-ancestor
92485296|NCT01934777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92485297|NCT01934777|Antimetabolites|antimetabolites|mesh-ancestor
92485298|NCT01934777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485299|NCT01934777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92485300|NCT01934777|Nootropic Agents|nootropic agents|mesh-ancestor
92485301|NCT01934816|Liraglutide|liraglutide|mesh-list
92485302|NCT01934816|Exenatide|exenatide|mesh-list
92485303|NCT01934816|Glucagon|glucagon|mesh-list
92485304|NCT01934816|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92485305|NCT01934816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485306|NCT01934816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485307|NCT01934816|Incretins|incretins|mesh-ancestor
92485308|NCT01934816|Hormones|hormones|mesh-ancestor
92485309|NCT01934816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92485310|NCT01934816|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92485311|NCT01934816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485312|NCT01934829|Sorafenib|sorafenib|mesh-list
92485313|NCT01934829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485314|NCT01934829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485315|NCT01934829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485316|NCT01934829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485317|NCT01934933|Celecoxib|celecoxib|mesh-list
92485318|NCT01934933|Etanercept|etanercept|mesh-list
92485319|NCT01934933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485320|NCT01934933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485321|NCT01934933|Analgesics|analgesics|mesh-ancestor
92485322|NCT01934933|Sensory System Agents|sensory system agents|mesh-ancestor
92485323|NCT01934933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485324|NCT01934933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485325|NCT01934933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485326|NCT01934933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485327|NCT01934933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92485328|NCT01934933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485329|NCT01934933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485330|NCT01934933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485331|NCT01934933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485332|NCT01934933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92485333|NCT01934933|Immunologic Factors|immunologic factors|mesh-ancestor
92485334|NCT01935063|Lidocaine|lidocaine|mesh-list
92485335|NCT01935063|Anesthetics, Local|anesthetics, local|mesh-ancestor
92485336|NCT01935063|Anesthetics|anesthetics|mesh-ancestor
92485337|NCT01935063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485338|NCT01935063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485339|NCT01935063|Sensory System Agents|sensory system agents|mesh-ancestor
92485340|NCT01935063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485341|NCT01935063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92485342|NCT01935063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92485343|NCT01935063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92485344|NCT01935063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485345|NCT01935063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485346|NCT01935115|Ketamine|ketamine|mesh-list
92485347|NCT01935115|Propofol|propofol|mesh-list
92485348|NCT01935115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485349|NCT01935115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485350|NCT01935115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485351|NCT01935115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485352|NCT01935115|Anesthetics, General|anesthetics, general|mesh-ancestor
92485353|NCT01935115|Anesthetics|anesthetics|mesh-ancestor
92485354|NCT01935115|Analgesics|analgesics|mesh-ancestor
92485355|NCT01935115|Sensory System Agents|sensory system agents|mesh-ancestor
92485356|NCT01935115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485357|NCT01935115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92485358|NCT01935115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92485359|NCT01935115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92485360|NCT01935115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485361|NCT01935115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485363|NCT01935141|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92485364|NCT01935141|Growth Substances|growth substances|mesh-ancestor
92485365|NCT01935141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485366|NCT01935193|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
92485367|NCT01935193|Analgesics|analgesics|mesh-ancestor
92485368|NCT01935193|Sensory System Agents|sensory system agents|mesh-ancestor
92485369|NCT01935193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485370|NCT01935193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485371|NCT01935193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485372|NCT01935193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485373|NCT01935193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485374|NCT01935193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485375|NCT01935193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92485376|NCT01935193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485377|NCT01935193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485378|NCT01935193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485379|NCT01935206|Naloxone|naloxone|mesh-list
92485380|NCT01935206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92485381|NCT01935206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485382|NCT01935206|Sensory System Agents|sensory system agents|mesh-ancestor
92485383|NCT01935206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485385|NCT01935310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92485386|NCT01935310|Immunologic Factors|immunologic factors|mesh-ancestor
92485387|NCT01935310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485388|NCT01935310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485389|NCT01935310|Interferon Inducers|interferon inducers|mesh-ancestor
92485390|NCT01935492|Paclitaxel|paclitaxel|mesh-list
92485391|NCT01935492|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92485392|NCT01935492|Bevacizumab|bevacizumab|mesh-list
92485393|NCT01935492|Doxorubicin|doxorubicin|mesh-list
92485394|NCT01935492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92485395|NCT01935492|Capecitabine|capecitabine|mesh-list
92485396|NCT01935492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92485397|NCT01935492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485398|NCT01935492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92485399|NCT01935492|Antimitotic Agents|antimitotic agents|mesh-ancestor
92485400|NCT01935492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92485401|NCT01935492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485402|NCT01935492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92485403|NCT01935492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92485404|NCT01935492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92485405|NCT01935492|Growth Substances|growth substances|mesh-ancestor
92485406|NCT01935492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485407|NCT01935492|Growth Inhibitors|growth inhibitors|mesh-ancestor
92485408|NCT01935492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92485409|NCT01935492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92485410|NCT01935492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92485411|NCT01935492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485412|NCT01935492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92485413|NCT01935492|Antimetabolites|antimetabolites|mesh-ancestor
92485414|NCT01935505|Bupropion|bupropion|mesh-list
92485415|NCT01935505|Nicotine|nicotine|mesh-list
92485416|NCT01935505|Varenicline|varenicline|mesh-list
92485417|NCT01935505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92485418|NCT01935505|Autonomic Agents|autonomic agents|mesh-ancestor
92485419|NCT01935505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485420|NCT01935505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485421|NCT01935505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92485422|NCT01935505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92485423|NCT01935505|Cholinergic Agents|cholinergic agents|mesh-ancestor
92485424|NCT01935505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485425|NCT01935505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485426|NCT01935505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92485427|NCT01935505|Antidepressive Agents|antidepressive agents|mesh-ancestor
92485428|NCT01935505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485429|NCT01935505|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92485430|NCT01935505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92485431|NCT01935505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485432|NCT01935505|Dopamine Agents|dopamine agents|mesh-ancestor
92485433|NCT01935505|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92485434|NCT01935505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92485435|NCT01935505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485436|NCT01935518|Fasudil|fasudil|mesh-list
92485437|NCT01935518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92485438|NCT01935518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485439|NCT01935518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485440|NCT01935518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92485441|NCT01935518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485442|NCT01935518|Vasodilator Agents|vasodilator agents|mesh-ancestor
92485443|NCT01935518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485444|NCT01935518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485445|NCT01935531|Diclofenac|diclofenac|mesh-list
92485446|NCT01935531|Hyaluronic Acid|hyaluronic acid|mesh-list
92485447|NCT01935531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485448|NCT01935531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485449|NCT01935531|Analgesics|analgesics|mesh-ancestor
92485450|NCT01935531|Sensory System Agents|sensory system agents|mesh-ancestor
92485451|NCT01935531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532030|NCT00050362|Sensory System Agents|sensory system agents|mesh-ancestor
92485452|NCT01935531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485453|NCT01935531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485454|NCT01935531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210344|NCT00894517|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92485455|NCT01935531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485457|NCT01935531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485458|NCT01935531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92485459|NCT01935531|Immunologic Factors|immunologic factors|mesh-ancestor
92485460|NCT01935531|Viscosupplements|viscosupplements|mesh-ancestor
92485461|NCT01935531|Protective Agents|protective agents|mesh-ancestor
92485462|NCT01935544|Botulinum Toxins|botulinum toxins|mesh-list
92485463|NCT01935544|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92485464|NCT01935544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485465|NCT01935544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485466|NCT01935544|Cholinergic Agents|cholinergic agents|mesh-ancestor
92485467|NCT01935544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485468|NCT01935544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485469|NCT01935557|Heparin|heparin|mesh-list
92485470|NCT01935557|Calcium heparin|calcium heparin|mesh-list
92485471|NCT01935557|Anticoagulants|anticoagulants|mesh-ancestor
92485472|NCT01935557|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92485473|NCT01935557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92485474|NCT01935557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485475|NCT01935596|Ropivacaine|ropivacaine|mesh-list
92485476|NCT01935596|Levobupivacaine|levobupivacaine|mesh-list
92485477|NCT01935596|Anesthetics, Local|anesthetics, local|mesh-ancestor
92485478|NCT01935596|Anesthetics|anesthetics|mesh-ancestor
92485479|NCT01935596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485480|NCT01935596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485481|NCT01935596|Sensory System Agents|sensory system agents|mesh-ancestor
92485482|NCT01935596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485483|NCT01935648|Ropivacaine|ropivacaine|mesh-list
92485484|NCT01935648|Anesthetics, Local|anesthetics, local|mesh-ancestor
92485485|NCT01935648|Anesthetics|anesthetics|mesh-ancestor
92485486|NCT01935648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485487|NCT01935648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485488|NCT01935648|Sensory System Agents|sensory system agents|mesh-ancestor
92485489|NCT01935648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485490|NCT01935674|Ritonavir|ritonavir|mesh-list
92485491|NCT01935674|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92485492|NCT01935674|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92485493|NCT01935674|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92485494|NCT01935674|Protease Inhibitors|protease inhibitors|mesh-ancestor
92485495|NCT01935674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485496|NCT01935674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485497|NCT01935674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92485498|NCT01935674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92485499|NCT01935674|Antiviral Agents|antiviral agents|mesh-ancestor
92485500|NCT01935674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485501|NCT01935674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92485502|NCT01935674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92485503|NCT01935674|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92485504|NCT01935674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92485505|NCT01935674|Antimetabolites|antimetabolites|mesh-ancestor
92485506|NCT01935674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92485507|NCT01935674|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92485508|NCT01935713|Nicotine|nicotine|mesh-list
92485509|NCT01935713|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92485510|NCT01935713|Autonomic Agents|autonomic agents|mesh-ancestor
92485511|NCT01935713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485512|NCT01935713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485513|NCT01935713|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92485514|NCT01935713|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92485515|NCT01935713|Cholinergic Agents|cholinergic agents|mesh-ancestor
92485516|NCT01935713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485517|NCT01935713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485518|NCT01935804|Metformin|metformin|mesh-list
92485519|NCT01935804|Pioglitazone|pioglitazone|mesh-list
92485520|NCT01935804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485521|NCT01935804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485522|NCT01935817|Vitamin E|vitamin e|mesh-list
92485523|NCT01935817|Silybin|silybin|mesh-list
92485524|NCT01935817|Vitamins|vitamins|mesh-ancestor
92485525|NCT01935817|Micronutrients|micronutrients|mesh-ancestor
92485526|NCT01935817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485527|NCT01935817|Antioxidants|antioxidants|mesh-ancestor
92485528|NCT01935817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485529|NCT01935817|Protective Agents|protective agents|mesh-ancestor
92485531|NCT01935817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485532|NCT01935830|Ritonavir|ritonavir|mesh-list
92485533|NCT01935830|Efavirenz|efavirenz|mesh-list
92485534|NCT01935830|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92485535|NCT01935830|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92485536|NCT01935830|Protease Inhibitors|protease inhibitors|mesh-ancestor
92485537|NCT01935830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485538|NCT01935830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485539|NCT01935830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92485540|NCT01935830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92485541|NCT01935830|Antiviral Agents|antiviral agents|mesh-ancestor
92485542|NCT01935830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485543|NCT01935830|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92485544|NCT01935830|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92485545|NCT01935830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92485546|NCT01935830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92485547|NCT01935830|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92485548|NCT01935830|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92485549|NCT01935830|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92485550|NCT01935830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92485551|NCT01935830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92485552|NCT01935869|Petrolatum|petrolatum|mesh-list
92485553|NCT01935869|Emollients|emollients|mesh-ancestor
92485554|NCT01935869|Dermatologic Agents|dermatologic agents|mesh-ancestor
92485555|NCT01935882|Lumefantrine|lumefantrine|mesh-list
92485556|NCT01935882|Artemether|artemether|mesh-list
92485557|NCT01935882|Primaquine|primaquine|mesh-list
92485558|NCT01935882|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92485559|NCT01935882|Antimalarials|antimalarials|mesh-ancestor
92485560|NCT01935882|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92485561|NCT01935882|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92485562|NCT01935882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485563|NCT01935908|Levetiracetam|levetiracetam|mesh-list
92485564|NCT01935908|Anticonvulsants|anticonvulsants|mesh-ancestor
92485565|NCT01935908|Nootropic Agents|nootropic agents|mesh-ancestor
92485566|NCT01935973|Trametinib|trametinib|mesh-list
92485567|NCT01935973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485568|NCT01935973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485569|NCT01935973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485570|NCT01935973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485571|NCT01936012|Lisinopril|lisinopril|mesh-list
92485572|NCT01936012|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92485573|NCT01936012|Protease Inhibitors|protease inhibitors|mesh-ancestor
92485574|NCT01936012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485575|NCT01936012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485576|NCT01936012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92485577|NCT01936012|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92485578|NCT01936012|Protective Agents|protective agents|mesh-ancestor
92485579|NCT01936012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485581|NCT01936025|Dextromethorphan|dextromethorphan|mesh-list
92485582|NCT01936025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485583|NCT01936025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485584|NCT01936025|Incretins|incretins|mesh-ancestor
92485585|NCT01936025|Hormones|hormones|mesh-ancestor
92485586|NCT01936025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92485587|NCT01936025|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92485588|NCT01936025|Protease Inhibitors|protease inhibitors|mesh-ancestor
92485589|NCT01936025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485590|NCT01936025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485591|NCT01936025|Antitussive Agents|antitussive agents|mesh-ancestor
92485592|NCT01936025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92485593|NCT01936025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92485594|NCT01936025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92485595|NCT01936025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485596|NCT01936064|Cyclophosphamide|cyclophosphamide|mesh-list
92485597|NCT01936064|Epirubicin|epirubicin|mesh-list
92485598|NCT01936064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92485599|NCT01936064|Immunologic Factors|immunologic factors|mesh-ancestor
92485600|NCT01936064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485601|NCT01936064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485602|NCT01936064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92485603|NCT01936064|Alkylating Agents|alkylating agents|mesh-ancestor
92485604|NCT01936064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485605|NCT01936064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485606|NCT01936064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92485607|NCT01936064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92485608|NCT01936064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92485609|NCT01936064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92485610|NCT01936064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485612|NCT01936090|Melphalan|melphalan|mesh-list
92485613|NCT01936090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485614|NCT01936090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92485615|NCT01936090|Alkylating Agents|alkylating agents|mesh-ancestor
92485616|NCT01936090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485617|NCT01936090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92485618|NCT01936090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92485619|NCT01936090|Immunologic Factors|immunologic factors|mesh-ancestor
92485620|NCT01936090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485621|NCT01936103|Atorvastatin|atorvastatin|mesh-list
92485622|NCT01936103|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92485623|NCT01936103|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92485624|NCT01936103|Antimetabolites|antimetabolites|mesh-ancestor
92485625|NCT01936103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485626|NCT01936103|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92485627|NCT01936103|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92485628|NCT01936103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485629|NCT01936129|Glatiramer Acetate|glatiramer acetate|mesh-list
92485630|NCT01936129|(T,G)-A-L|(t,g)-a-l|mesh-list
92485631|NCT01936129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92485632|NCT01936129|Immunologic Factors|immunologic factors|mesh-ancestor
92485633|NCT01936129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485634|NCT01936129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92485635|NCT01936129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485636|NCT01936220|Antipsychotic Agents|antipsychotic agents|mesh-list
92485637|NCT01936220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92485638|NCT01936220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485639|NCT01936220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485640|NCT01936220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485641|NCT01936233|Aspirin|aspirin|mesh-list
92485642|NCT01936233|Lamivudine|lamivudine|mesh-list
92485643|NCT01936233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485644|NCT01936233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485645|NCT01936233|Analgesics|analgesics|mesh-ancestor
92485646|NCT01936233|Sensory System Agents|sensory system agents|mesh-ancestor
92485647|NCT01936233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485648|NCT01936233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485649|NCT01936233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485650|NCT01936233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485651|NCT01936233|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92485652|NCT01936233|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92485653|NCT01936233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485654|NCT01936233|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92485655|NCT01936233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485656|NCT01936233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485657|NCT01936233|Antipyretics|antipyretics|mesh-ancestor
92485658|NCT01936233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92485659|NCT01936233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92485660|NCT01936233|Antiviral Agents|antiviral agents|mesh-ancestor
92485661|NCT01936233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485662|NCT01936233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92485663|NCT01936233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92485664|NCT01936285|Colchicine|colchicine|mesh-list
92485665|NCT01936285|Gout Suppressants|gout suppressants|mesh-ancestor
92485666|NCT01936285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485667|NCT01936285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92485668|NCT01936285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92485669|NCT01936285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92485670|NCT01936285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485671|NCT01936285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485672|NCT01936350|Sildenafil Citrate|sildenafil citrate|mesh-list
92485673|NCT01936350|Vasodilator Agents|vasodilator agents|mesh-ancestor
92485674|NCT01936350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92485675|NCT01936350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92485676|NCT01936350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485677|NCT01936350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485678|NCT01936350|Urological Agents|urological agents|mesh-ancestor
92485680|NCT01936532|Lenalidomide|lenalidomide|mesh-list
92485681|NCT01936532|Ixazomib|ixazomib|mesh-list
92485682|NCT01936532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485683|NCT01936532|Antiemetics|antiemetics|mesh-ancestor
92485684|NCT01936532|Autonomic Agents|autonomic agents|mesh-ancestor
92485685|NCT01936532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485686|NCT01936532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485687|NCT01936532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485688|NCT01936532|Glucocorticoids|glucocorticoids|mesh-ancestor
92485689|NCT01936532|Hormones|hormones|mesh-ancestor
92485690|NCT01936532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92485691|NCT01936532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92485692|NCT01936532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485693|NCT01936532|Immunologic Factors|immunologic factors|mesh-ancestor
92485694|NCT01936532|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92485695|NCT01936532|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92485696|NCT01936532|Growth Substances|growth substances|mesh-ancestor
92485697|NCT01936532|Growth Inhibitors|growth inhibitors|mesh-ancestor
92485698|NCT01936532|Protease Inhibitors|protease inhibitors|mesh-ancestor
92485699|NCT01936532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485700|NCT01936532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485701|NCT01936545|Propofol|propofol|mesh-list
92485702|NCT01936545|Desflurane|desflurane|mesh-list
92485703|NCT01936545|Liver Extracts|liver extracts|mesh-list
92485704|NCT01936545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485705|NCT01936545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485706|NCT01936545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485707|NCT01936545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485708|NCT01936545|Anesthetics, General|anesthetics, general|mesh-ancestor
92485709|NCT01936545|Anesthetics|anesthetics|mesh-ancestor
92485710|NCT01936545|Hematinics|hematinics|mesh-ancestor
92485711|NCT01936545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92485712|NCT01936636|Fentanyl|fentanyl|mesh-list
92485713|NCT01936636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485714|NCT01936636|Narcotics|narcotics|mesh-ancestor
92485715|NCT01936636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485716|NCT01936636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485717|NCT01936636|Analgesics|analgesics|mesh-ancestor
92485718|NCT01936636|Sensory System Agents|sensory system agents|mesh-ancestor
92485719|NCT01936636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485720|NCT01936636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485721|NCT01936636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485722|NCT01936636|Anesthetics, General|anesthetics, general|mesh-ancestor
92485723|NCT01936636|Anesthetics|anesthetics|mesh-ancestor
92485724|NCT01936805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92485725|NCT01936805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92485726|NCT01936805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92485727|NCT01936805|Antimetabolites|antimetabolites|mesh-ancestor
92485728|NCT01936805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485729|NCT01936805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92485730|NCT01936805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92485731|NCT01936805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485732|NCT01936961|Antibodies|antibodies|mesh-list
92485733|NCT01936961|Immunologic Factors|immunologic factors|mesh-ancestor
92485734|NCT01936961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485735|NCT01937013|Oxytocin|oxytocin|mesh-list
92485736|NCT01937013|Oxytocics|oxytocics|mesh-ancestor
92485737|NCT01937013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92485738|NCT01937013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485739|NCT01937078|Famotidine|famotidine|mesh-list
92485740|NCT01937078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92485741|NCT01937078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485742|NCT01937078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92485743|NCT01937078|Histamine Antagonists|histamine antagonists|mesh-ancestor
92485744|NCT01937078|Histamine Agents|histamine agents|mesh-ancestor
92485745|NCT01937078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485746|NCT01937078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485747|NCT01937078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485748|NCT01937104|Remifentanil|remifentanil|mesh-list
92485750|NCT01937104|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485751|NCT01937104|Narcotics|narcotics|mesh-ancestor
92485752|NCT01937104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485753|NCT01937104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485754|NCT01937104|Analgesics|analgesics|mesh-ancestor
92485755|NCT01937104|Sensory System Agents|sensory system agents|mesh-ancestor
92485756|NCT01937104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485757|NCT01937104|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92485758|NCT01937104|Anesthetics, General|anesthetics, general|mesh-ancestor
92485759|NCT01937104|Anesthetics|anesthetics|mesh-ancestor
92485760|NCT01937169|Levodopa|levodopa|mesh-list
92485761|NCT01937169|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92485762|NCT01937169|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92485763|NCT01937169|Dopamine Agents|dopamine agents|mesh-ancestor
92485764|NCT01937169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485765|NCT01937169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485766|NCT01937169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485767|NCT01937182|Citalopram|citalopram|mesh-list
92485768|NCT01937182|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92485769|NCT01937182|Serotonin|serotonin|mesh-list
92485770|NCT01937182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92485771|NCT01937182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485772|NCT01937182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485773|NCT01937182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485774|NCT01937182|Serotonin Agents|serotonin agents|mesh-ancestor
92485775|NCT01937182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485776|NCT01937182|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92485777|NCT01937182|Antidepressive Agents|antidepressive agents|mesh-ancestor
92485778|NCT01937182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485779|NCT01937182|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92485780|NCT01937234|Metoclopramide|metoclopramide|mesh-list
92485781|NCT01937234|Antiemetics|antiemetics|mesh-ancestor
92485782|NCT01937234|Autonomic Agents|autonomic agents|mesh-ancestor
92485783|NCT01937234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153566|NCT04372407|Itraconazole|itraconazole|mesh-list
92485784|NCT01937234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485785|NCT01937234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485786|NCT01937234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92485787|NCT01937234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92485788|NCT01937234|Dopamine Agents|dopamine agents|mesh-ancestor
92485789|NCT01937234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485790|NCT01937234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485791|NCT01937325|Ivacaftor|ivacaftor|mesh-list
92485792|NCT01937325|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92485793|NCT01937325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485794|NCT01937325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485795|NCT01937338|AZD7624|azd7624|mesh-list
92485796|NCT01937338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485797|NCT01937338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485798|NCT01937338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485799|NCT01937442|Thalidomide|thalidomide|mesh-list
92485800|NCT01937442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92485801|NCT01937442|Immunologic Factors|immunologic factors|mesh-ancestor
92485802|NCT01937442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485803|NCT01937442|Leprostatic Agents|leprostatic agents|mesh-ancestor
92485804|NCT01937442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485805|NCT01937442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485806|NCT01937442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92485807|NCT01937442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92485808|NCT01937442|Growth Substances|growth substances|mesh-ancestor
92485809|NCT01937442|Growth Inhibitors|growth inhibitors|mesh-ancestor
92485810|NCT01937442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485811|NCT01937494|Benzyl Alcohol|benzyl alcohol|mesh-list
92485812|NCT01937494|Histamine|histamine|mesh-list
92485813|NCT01937494|Histamine Agonists|histamine agonists|mesh-ancestor
92485814|NCT01937494|Histamine Agents|histamine agents|mesh-ancestor
92485815|NCT01937494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485816|NCT01937494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485817|NCT01937494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485818|NCT01937494|Anesthetics, Local|anesthetics, local|mesh-ancestor
92485819|NCT01937494|Anesthetics|anesthetics|mesh-ancestor
92485820|NCT01937494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485821|NCT01937494|Sensory System Agents|sensory system agents|mesh-ancestor
92485822|NCT01937494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704585|NCT04397692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704586|NCT04397692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704587|NCT04397692|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92704588|NCT04397692|Vasodilator Agents|vasodilator agents|mesh-ancestor
92704589|NCT04397692|Gasotransmitters|gasotransmitters|mesh-ancestor
92704590|NCT04397692|Protective Agents|protective agents|mesh-ancestor
92704591|NCT02203643|Dexamethasone|dexamethasone|mesh-list
92485823|NCT01937611|Midazolam|midazolam|mesh-list
92485824|NCT01937611|Dexmedetomidine|dexmedetomidine|mesh-list
92485825|NCT01937611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485826|NCT01937611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485827|NCT01937611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485828|NCT01937611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485829|NCT01937611|Analgesics|analgesics|mesh-ancestor
92485830|NCT01937611|Sensory System Agents|sensory system agents|mesh-ancestor
92485831|NCT01937611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485832|NCT01937611|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92485833|NCT01937611|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92485834|NCT01937611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92485835|NCT01937611|Adrenergic Agents|adrenergic agents|mesh-ancestor
92485836|NCT01937611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485837|NCT01937611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485838|NCT01937611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485839|NCT01937611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92485840|NCT01937611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92485841|NCT01937611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485842|NCT01937611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485843|NCT01937611|Anesthetics, General|anesthetics, general|mesh-ancestor
92485844|NCT01937611|Anesthetics|anesthetics|mesh-ancestor
92485845|NCT01937611|GABA Modulators|gaba modulators|mesh-ancestor
92485846|NCT01937611|GABA Agents|gaba agents|mesh-ancestor
92485847|NCT01937650|Metronidazole|metronidazole|mesh-list
92485848|NCT01937650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349210|NCT01458210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485849|NCT01937650|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485850|NCT01937650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92485851|NCT01937650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92485852|NCT01937728|Interferons|interferons|mesh-list
92485853|NCT01937728|Ribavirin|ribavirin|mesh-list
92485854|NCT01937728|Interferon-alpha|interferon-alpha|mesh-list
92485855|NCT01937728|Interferon alpha-2|interferon alpha-2|mesh-list
92485856|NCT01937728|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92485857|NCT01937728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485858|NCT01937728|Antiviral Agents|antiviral agents|mesh-ancestor
92485859|NCT01937728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485860|NCT01937728|Antimetabolites|antimetabolites|mesh-ancestor
92485861|NCT01937728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485862|NCT01937728|Immunologic Factors|immunologic factors|mesh-ancestor
92485863|NCT01937728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485864|NCT01937754|Nitric Oxide|nitric oxide|mesh-list
92485865|NCT01937754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92485866|NCT01937754|Autonomic Agents|autonomic agents|mesh-ancestor
92485867|NCT01937754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485868|NCT01937754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485869|NCT01937754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92485870|NCT01937754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92485871|NCT01937754|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92485872|NCT01937754|Antioxidants|antioxidants|mesh-ancestor
92485873|NCT01937754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485874|NCT01937754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485875|NCT01937754|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92485876|NCT01937754|Vasodilator Agents|vasodilator agents|mesh-ancestor
92485877|NCT01937754|Gasotransmitters|gasotransmitters|mesh-ancestor
92485878|NCT01937754|Protective Agents|protective agents|mesh-ancestor
92485880|NCT01937767|Remifentanil|remifentanil|mesh-list
92485881|NCT01937767|Propofol|propofol|mesh-list
92485882|NCT01937767|Sevoflurane|sevoflurane|mesh-list
92485883|NCT01937767|Rocuronium|rocuronium|mesh-list
92485884|NCT01937767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485885|NCT01937767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485886|NCT01937767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485887|NCT01937767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485888|NCT01937767|Anesthetics, General|anesthetics, general|mesh-ancestor
92485889|NCT01937767|Anesthetics|anesthetics|mesh-ancestor
92485890|NCT01937767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92485891|NCT01937767|Narcotics|narcotics|mesh-ancestor
92485892|NCT01937767|Analgesics|analgesics|mesh-ancestor
92485893|NCT01937767|Sensory System Agents|sensory system agents|mesh-ancestor
92485894|NCT01937767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485895|NCT01937767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485896|NCT01937767|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92485897|NCT01937767|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92485898|NCT01937767|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92485899|NCT01937767|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92485900|NCT01937767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92485901|NCT01937806|Tenofovir|tenofovir|mesh-list
92485902|NCT01937806|Antiviral Agents|antiviral agents|mesh-ancestor
92485903|NCT01937806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485904|NCT01937806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92485905|NCT01937806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92485906|NCT01937806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485907|NCT01937806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485908|NCT01937806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92485909|NCT01937806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92485910|NCT01937832|Ertapenem|ertapenem|mesh-list
92485911|NCT01937832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485912|NCT01937832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485913|NCT01938092|Diazepam|diazepam|mesh-list
92485914|NCT01938092|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92485915|NCT01938092|Anticonvulsants|anticonvulsants|mesh-ancestor
92485916|NCT01938092|Antiemetics|antiemetics|mesh-ancestor
92485917|NCT01938092|Autonomic Agents|autonomic agents|mesh-ancestor
92485918|NCT01938092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485919|NCT01938092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485920|NCT01938092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92485921|NCT01938092|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92485922|NCT01938092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485923|NCT01938092|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92485924|NCT01938092|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92485925|NCT01938092|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92485926|NCT01938092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92485927|NCT01938092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92485928|NCT01938092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92485929|NCT01938092|Anesthetics, General|anesthetics, general|mesh-ancestor
92485930|NCT01938092|Anesthetics|anesthetics|mesh-ancestor
92485931|NCT01938092|GABA Modulators|gaba modulators|mesh-ancestor
92485932|NCT01938092|GABA Agents|gaba agents|mesh-ancestor
92485933|NCT01938092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92485934|NCT01938092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485935|NCT01938105|Nimotuzumab|nimotuzumab|mesh-list
92485936|NCT01938105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92485937|NCT01938105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485938|NCT01938144|Acetaminophen|acetaminophen|mesh-list
92485939|NCT01938144|Ibuprofen|ibuprofen|mesh-list
92485940|NCT01938144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92485941|NCT01938144|Analgesics|analgesics|mesh-ancestor
92485942|NCT01938144|Sensory System Agents|sensory system agents|mesh-ancestor
92485943|NCT01938144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485944|NCT01938144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485945|NCT01938144|Antipyretics|antipyretics|mesh-ancestor
92485946|NCT01938144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92485947|NCT01938144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92485948|NCT01938144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92485949|NCT01938144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92485950|NCT01938144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485951|NCT01938144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485952|NCT01938183|Metronidazole|metronidazole|mesh-list
92485953|NCT01938183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485954|NCT01938183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485955|NCT01938183|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92485956|NCT01938183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92485957|NCT01938235|Exenatide|exenatide|mesh-list
92485958|NCT01938235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92485959|NCT01938235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485960|NCT01938235|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92485961|NCT01938235|Incretins|incretins|mesh-ancestor
92485962|NCT01938235|Hormones|hormones|mesh-ancestor
92485963|NCT01938235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92485964|NCT01938300|Magnesium Sulfate|magnesium sulfate|mesh-list
92485965|NCT01938300|Analgesics|analgesics|mesh-ancestor
92485966|NCT01938300|Sensory System Agents|sensory system agents|mesh-ancestor
92485967|NCT01938300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92485968|NCT01938300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92485969|NCT01938300|Anesthetics|anesthetics|mesh-ancestor
92485970|NCT01938300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92485971|NCT01938300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92485972|NCT01938300|Anticonvulsants|anticonvulsants|mesh-ancestor
92485973|NCT01938300|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92485974|NCT01938300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92485975|NCT01938300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485976|NCT01938300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92485977|NCT01938300|Tocolytic Agents|tocolytic agents|mesh-ancestor
92485978|NCT01938300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92485979|NCT01938417|Tobramycin|tobramycin|mesh-list
92485980|NCT01938417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485981|NCT01938417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485982|NCT01938443|Trametinib|trametinib|mesh-list
92485983|NCT01938443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485984|NCT01938443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485985|NCT01938443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485986|NCT01938443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485987|NCT01938456|Docetaxel|docetaxel|mesh-list
92485988|NCT01938456|Trametinib|trametinib|mesh-list
92485989|NCT01938456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92485990|NCT01938456|Tubulin Modulators|tubulin modulators|mesh-ancestor
92485991|NCT01938456|Antimitotic Agents|antimitotic agents|mesh-ancestor
92485992|NCT01938456|Mitosis Modulators|mitosis modulators|mesh-ancestor
92485993|NCT01938456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92485994|NCT01938456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92485995|NCT01938456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92485996|NCT01938508|Minocycline|minocycline|mesh-list
92485997|NCT01938508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92485998|NCT01938508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92485999|NCT01938612|Durvalumab|durvalumab|mesh-list
92486000|NCT01938612|Tremelimumab|tremelimumab|mesh-list
92486001|NCT01938612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486002|NCT01938612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486003|NCT01938729|Dexamethasone|dexamethasone|mesh-list
92486004|NCT01938729|Gemcitabine|gemcitabine|mesh-list
92486005|NCT01938729|Floxuridine|floxuridine|mesh-list
92486006|NCT01938729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92486007|NCT01938729|Antiemetics|antiemetics|mesh-ancestor
92486008|NCT01938729|Autonomic Agents|autonomic agents|mesh-ancestor
92486009|NCT01938729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486010|NCT01938729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486011|NCT01938729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92486012|NCT01938729|Glucocorticoids|glucocorticoids|mesh-ancestor
92486014|NCT01938729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486015|NCT01938729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92486016|NCT01938729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486017|NCT01938729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486018|NCT01938729|Antimetabolites|antimetabolites|mesh-ancestor
92486019|NCT01938729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486020|NCT01938755|Levobupivacaine|levobupivacaine|mesh-list
92486021|NCT01938755|Anesthetics, Local|anesthetics, local|mesh-ancestor
92486022|NCT01938755|Anesthetics|anesthetics|mesh-ancestor
92486023|NCT01938755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486024|NCT01938755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486025|NCT01938755|Sensory System Agents|sensory system agents|mesh-ancestor
92486026|NCT01938755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486027|NCT01938781|Entecavir|entecavir|mesh-list
92486028|NCT01938781|Antiviral Agents|antiviral agents|mesh-ancestor
92486029|NCT01938781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486030|NCT01938820|Entecavir|entecavir|mesh-list
92486031|NCT01938820|Antiviral Agents|antiviral agents|mesh-ancestor
92486032|NCT01938820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486033|NCT01938859|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92486034|NCT01938859|Antidepressive Agents|antidepressive agents|mesh-ancestor
92486035|NCT01938859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486036|NCT01938859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92486037|NCT01938859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486038|NCT01938859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486039|NCT01938859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486040|NCT01938872|Paclitaxel|paclitaxel|mesh-list
92486041|NCT01938872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92486042|NCT01938872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486044|NCT01938872|Antimitotic Agents|antimitotic agents|mesh-ancestor
92486045|NCT01938872|Mitosis Modulators|mitosis modulators|mesh-ancestor
92486046|NCT01938872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486047|NCT01938911|Oxytocin|oxytocin|mesh-list
92486048|NCT01938911|Oxytocics|oxytocics|mesh-ancestor
92486049|NCT01938911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486050|NCT01938911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486051|NCT01939054|Docetaxel|docetaxel|mesh-list
92210952|NCT00869141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92486052|NCT01939054|Capecitabine|capecitabine|mesh-list
92486053|NCT01939054|Nimotuzumab|nimotuzumab|mesh-list
92486054|NCT01939054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486055|NCT01939054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92486056|NCT01939054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92486057|NCT01939054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92486058|NCT01939054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486059|NCT01939054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486060|NCT01939054|Antimetabolites|antimetabolites|mesh-ancestor
92486061|NCT01939054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486062|NCT01939093|Thiamine|thiamine|mesh-list
92486063|NCT01939093|Cinnarizine|cinnarizine|mesh-list
92486064|NCT01939093|Diazepam|diazepam|mesh-list
92486065|NCT01939093|Vitamins|vitamins|mesh-ancestor
92486066|NCT01939093|Micronutrients|micronutrients|mesh-ancestor
92486067|NCT01939093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486068|NCT01939093|Vitamin B Complex|vitamin b complex|mesh-ancestor
92486069|NCT01939093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92486070|NCT01939093|Anticonvulsants|anticonvulsants|mesh-ancestor
92486071|NCT01939093|Antiemetics|antiemetics|mesh-ancestor
92486072|NCT01939093|Autonomic Agents|autonomic agents|mesh-ancestor
92349214|NCT01458210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92486073|NCT01939093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486074|NCT01939093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92486075|NCT01939093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92486076|NCT01939093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486077|NCT01939093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92486078|NCT01939093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92486079|NCT01939093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92486080|NCT01939093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486081|NCT01939093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486082|NCT01939093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92486083|NCT01939093|Anesthetics, General|anesthetics, general|mesh-ancestor
92486084|NCT01939093|Anesthetics|anesthetics|mesh-ancestor
92486085|NCT01939093|GABA Modulators|gaba modulators|mesh-ancestor
92486086|NCT01939093|GABA Agents|gaba agents|mesh-ancestor
92486087|NCT01939093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486088|NCT01939093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486089|NCT01939093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92486090|NCT01939093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486091|NCT01939093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486092|NCT01939093|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92486093|NCT01939093|Histamine Antagonists|histamine antagonists|mesh-ancestor
92486094|NCT01939093|Histamine Agents|histamine agents|mesh-ancestor
92486095|NCT01939171|Thymoglobulin|thymoglobulin|mesh-list
92486096|NCT01939171|Immunologic Factors|immunologic factors|mesh-ancestor
92486097|NCT01939171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486098|NCT01939171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486099|NCT01939327|Rituximab|rituximab|mesh-list
92486100|NCT01939327|Lenalidomide|lenalidomide|mesh-list
92486101|NCT01939327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486102|NCT01939327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486103|NCT01939327|Immunologic Factors|immunologic factors|mesh-ancestor
92486104|NCT01939327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486105|NCT01939327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486106|NCT01939327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92486107|NCT01939327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92486108|NCT01939327|Growth Substances|growth substances|mesh-ancestor
92486109|NCT01939327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92486110|NCT01939379|Acetaminophen|acetaminophen|mesh-list
92486111|NCT01939379|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92486112|NCT01939379|Morphine|morphine|mesh-list
92486113|NCT01939379|Oxycodone|oxycodone|mesh-list
92486114|NCT01939379|Analgesics|analgesics|mesh-list
92486115|NCT01939379|Ropivacaine|ropivacaine|mesh-list
92486116|NCT01939379|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92486117|NCT01939379|Narcotics|narcotics|mesh-ancestor
92486118|NCT01939379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532039|NCT00050362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92486119|NCT01939379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486120|NCT01939379|Sensory System Agents|sensory system agents|mesh-ancestor
92486121|NCT01939379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486122|NCT01939379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92486123|NCT01939379|Anesthetics|anesthetics|mesh-ancestor
92486124|NCT01939379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92486125|NCT01939379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92486126|NCT01939379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92486127|NCT01939379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486128|NCT01939379|Antipyretics|antipyretics|mesh-ancestor
92486129|NCT01939418|Gemcitabine|gemcitabine|mesh-list
92486130|NCT01939418|Everolimus|everolimus|mesh-list
92486131|NCT01939418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486132|NCT01939418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486133|NCT01939418|Antimetabolites|antimetabolites|mesh-ancestor
92486134|NCT01939418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486135|NCT01939418|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92486136|NCT01939418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92486137|NCT01939418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486138|NCT01939418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486139|NCT01939418|Immunologic Factors|immunologic factors|mesh-ancestor
92486140|NCT01939418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486141|NCT01939444|Naloxone|naloxone|mesh-list
92486142|NCT01939444|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92486143|NCT01939444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486144|NCT01939444|Sensory System Agents|sensory system agents|mesh-ancestor
92486145|NCT01939444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486146|NCT01939457|Misoprostol|misoprostol|mesh-list
92486147|NCT01939457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92486148|NCT01939457|Abortifacient Agents|abortifacient agents|mesh-ancestor
92486149|NCT01939457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486150|NCT01939457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486151|NCT01939457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92486152|NCT01939457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92486153|NCT01939457|Oxytocics|oxytocics|mesh-ancestor
92486154|NCT01939483|Irinotecan|irinotecan|mesh-list
92486155|NCT01939483|Camptothecin|camptothecin|mesh-list
92486156|NCT01939483|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92486157|NCT01939483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92486158|NCT01939483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486159|NCT01939483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486160|NCT01939483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486161|NCT01939483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92486162|NCT01939509|Atenolol|atenolol|mesh-list
92486163|NCT01939509|Bisoprolol|bisoprolol|mesh-list
92486164|NCT01939509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92486165|NCT01939509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92486166|NCT01939509|Sympatholytics|sympatholytics|mesh-ancestor
92486167|NCT01939509|Autonomic Agents|autonomic agents|mesh-ancestor
92486168|NCT01939509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486169|NCT01939509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486170|NCT01939509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92486171|NCT01939509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92486172|NCT01939509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92486173|NCT01939509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92486174|NCT01939509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486175|NCT01939509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486176|NCT01939522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92486177|NCT01939522|Immunologic Factors|immunologic factors|mesh-ancestor
92486178|NCT01939522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486179|NCT01939561|Lamotrigine|lamotrigine|mesh-list
92486180|NCT01939561|Anticonvulsants|anticonvulsants|mesh-ancestor
92486181|NCT01939561|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92486182|NCT01939561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486183|NCT01939561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486184|NCT01939561|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486185|NCT01939561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486186|NCT01939561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92486187|NCT01939561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486188|NCT01939561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486189|NCT01939561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486190|NCT01939561|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92486191|NCT01939574|Bevacizumab|bevacizumab|mesh-list
92486192|NCT01939574|Temozolomide|temozolomide|mesh-list
92486193|NCT01939574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486194|NCT01939574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486195|NCT01939574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92486196|NCT01939574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92486197|NCT01939574|Growth Substances|growth substances|mesh-ancestor
92486198|NCT01939574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486199|NCT01939574|Growth Inhibitors|growth inhibitors|mesh-ancestor
92486200|NCT01939574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92486201|NCT01939574|Alkylating Agents|alkylating agents|mesh-ancestor
92486202|NCT01939574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486203|NCT01939639|Oxytocin|oxytocin|mesh-list
92486204|NCT01939639|Oxytocics|oxytocics|mesh-ancestor
92486205|NCT01939639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486206|NCT01939639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486208|NCT01939691|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92486209|NCT01939691|Methylprednisolone|methylprednisolone|mesh-list
92486210|NCT01939691|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92486211|NCT01939691|Prednisolone acetate|prednisolone acetate|mesh-list
92486212|NCT01939691|Nepafenac|nepafenac|mesh-list
92486213|NCT01939691|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92486214|NCT01939691|Prednisolone phosphate|prednisolone phosphate|mesh-list
92486215|NCT01939691|Difluprednate|difluprednate|mesh-list
92486216|NCT01939691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92486217|NCT01939691|Glucocorticoids|glucocorticoids|mesh-ancestor
92486218|NCT01939691|Hormones|hormones|mesh-ancestor
92486219|NCT01939691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486220|NCT01939691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486221|NCT01939691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92486222|NCT01939691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486223|NCT01939691|Antiemetics|antiemetics|mesh-ancestor
92486224|NCT01939691|Autonomic Agents|autonomic agents|mesh-ancestor
92486225|NCT01939691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486226|NCT01939691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92486227|NCT01939691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92486228|NCT01939691|Protective Agents|protective agents|mesh-ancestor
92486229|NCT01939691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92486230|NCT01939691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92486231|NCT01939691|Analgesics|analgesics|mesh-ancestor
92486232|NCT01939691|Sensory System Agents|sensory system agents|mesh-ancestor
92486233|NCT01939691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486234|NCT01939730|Rituximab|rituximab|mesh-list
92486235|NCT01939730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486236|NCT01939730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486237|NCT01939730|Immunologic Factors|immunologic factors|mesh-ancestor
92486238|NCT01939730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486239|NCT01939730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486241|NCT01939743|Lidocaine|lidocaine|mesh-list
92486242|NCT01939743|Anesthetics, Local|anesthetics, local|mesh-ancestor
92486243|NCT01939743|Anesthetics|anesthetics|mesh-ancestor
92486244|NCT01939743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486245|NCT01939743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486246|NCT01939743|Sensory System Agents|sensory system agents|mesh-ancestor
92486247|NCT01939743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486248|NCT01939743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92486249|NCT01939743|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92486250|NCT01939743|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92486251|NCT01939743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486252|NCT01939743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486253|NCT01939743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92486254|NCT01939743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92486255|NCT01939743|Analgesics|analgesics|mesh-ancestor
92486256|NCT01939743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92486257|NCT01939743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486258|NCT01939743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92486259|NCT01939743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486260|NCT01939834|Insulin|insulin|mesh-list
92486261|NCT01939834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92486262|NCT01939834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486263|NCT01939886|Artesunate|artesunate|mesh-list
92486264|NCT01939886|Lumefantrine|lumefantrine|mesh-list
92486265|NCT01939886|Artemether|artemether|mesh-list
92486266|NCT01939886|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92486267|NCT01939886|Mefloquine|mefloquine|mesh-list
92486268|NCT01939886|Antimalarials|antimalarials|mesh-ancestor
92486269|NCT01939886|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92486270|NCT01939886|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92486271|NCT01939886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486272|NCT01939886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486273|NCT01939886|Antiviral Agents|antiviral agents|mesh-ancestor
92486274|NCT01939886|Schistosomicides|schistosomicides|mesh-ancestor
92486275|NCT01939886|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92486276|NCT01939886|Anthelmintics|anthelmintics|mesh-ancestor
92486277|NCT01939912|Adenosine|adenosine|mesh-list
92486278|NCT01939912|Analgesics|analgesics|mesh-ancestor
92486279|NCT01939912|Sensory System Agents|sensory system agents|mesh-ancestor
92486280|NCT01939912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211180|NCT01723735|Fenofibrate|fenofibrate|mesh-list
92486281|NCT01939912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486282|NCT01939912|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92486283|NCT01939912|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486284|NCT01939912|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92486285|NCT01939912|Purinergic Agonists|purinergic agonists|mesh-ancestor
92486286|NCT01939912|Purinergic Agents|purinergic agents|mesh-ancestor
92486287|NCT01939912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486288|NCT01939912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486290|NCT01939990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92486291|NCT01939990|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486292|NCT01939990|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92486293|NCT01939990|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92486294|NCT01939990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92486295|NCT01939990|Adrenergic Agents|adrenergic agents|mesh-ancestor
92486296|NCT01939990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486297|NCT01939990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486298|NCT01939990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486299|NCT01940081|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92486300|NCT01940081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486301|NCT01940081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486302|NCT01940081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486303|NCT01940081|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92486304|NCT01940172|Conatumumab|conatumumab|mesh-list
92486305|NCT01940172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486306|NCT01940172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486307|NCT01940224|Pregabalin|pregabalin|mesh-list
92486308|NCT01940224|Morphine|morphine|mesh-list
92486309|NCT01940224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92486310|NCT01940224|Narcotics|narcotics|mesh-ancestor
92486311|NCT01940224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486312|NCT01940224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486313|NCT01940224|Analgesics|analgesics|mesh-ancestor
92486314|NCT01940224|Sensory System Agents|sensory system agents|mesh-ancestor
92486315|NCT01940224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486316|NCT01940224|Anticonvulsants|anticonvulsants|mesh-ancestor
92486317|NCT01940224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92486318|NCT01940224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486319|NCT01940224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486320|NCT01940224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486321|NCT01940224|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92486322|NCT01940224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486323|NCT01940224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486324|NCT01940250|Magnesium Sulfate|magnesium sulfate|mesh-list
92486325|NCT01940250|Analgesics|analgesics|mesh-ancestor
92486326|NCT01940250|Sensory System Agents|sensory system agents|mesh-ancestor
92486327|NCT01940250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486328|NCT01940250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486329|NCT01940250|Anesthetics|anesthetics|mesh-ancestor
92486330|NCT01940250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486331|NCT01940250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92486332|NCT01940250|Anticonvulsants|anticonvulsants|mesh-ancestor
92486333|NCT01940250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92486334|NCT01940250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486335|NCT01940250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486336|NCT01940250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486337|NCT01940250|Tocolytic Agents|tocolytic agents|mesh-ancestor
92486338|NCT01940250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486339|NCT01940393|Cetirizine|cetirizine|mesh-list
92486340|NCT01940393|Fexofenadine|fexofenadine|mesh-list
92486341|NCT01940393|Desloratadine|desloratadine|mesh-list
92486342|NCT01940393|Ebastine|ebastine|mesh-list
92486343|NCT01940393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92486344|NCT01940393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92486345|NCT01940393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92486346|NCT01940393|Histamine Antagonists|histamine antagonists|mesh-ancestor
92486347|NCT01940393|Histamine Agents|histamine agents|mesh-ancestor
92486348|NCT01940393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486349|NCT01940393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486350|NCT01940393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486351|NCT01940393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92486352|NCT01940393|Cholinergic Agents|cholinergic agents|mesh-ancestor
92486353|NCT01940419|Tranexamic Acid|tranexamic acid|mesh-list
92486354|NCT01940419|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92486355|NCT01940419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92486356|NCT01940419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486357|NCT01940419|Hemostatics|hemostatics|mesh-ancestor
92486358|NCT01940419|Coagulants|coagulants|mesh-ancestor
92486359|NCT01940536|Tranexamic Acid|tranexamic acid|mesh-list
92349229|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486360|NCT01940536|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92486361|NCT01940536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92486362|NCT01940536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486363|NCT01940536|Hemostatics|hemostatics|mesh-ancestor
92486364|NCT01940536|Coagulants|coagulants|mesh-ancestor
92486365|NCT01940601|Lenograstim|lenograstim|mesh-list
92486366|NCT01940601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92486367|NCT01940601|Immunologic Factors|immunologic factors|mesh-ancestor
92486368|NCT01940601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486369|NCT01940627|Ubiquinone|ubiquinone|mesh-list
92486370|NCT01940627|Coenzyme Q10|coenzyme q10|mesh-list
92486371|NCT01940627|Micronutrients|micronutrients|mesh-ancestor
92486372|NCT01940627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486373|NCT01940627|Vitamins|vitamins|mesh-ancestor
92486374|NCT01940653|Estradiol|estradiol|mesh-list
92486375|NCT01940653|Progesterone|progesterone|mesh-list
92486376|NCT01940653|Estrogens|estrogens|mesh-ancestor
92486377|NCT01940653|Hormones|hormones|mesh-ancestor
92486378|NCT01940653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486379|NCT01940653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486380|NCT01940653|Progestins|progestins|mesh-ancestor
92486381|NCT01940692|Tranexamic Acid|tranexamic acid|mesh-list
92486382|NCT01940692|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92486383|NCT01940692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92486384|NCT01940692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486385|NCT01940692|Hemostatics|hemostatics|mesh-ancestor
92486386|NCT01940692|Coagulants|coagulants|mesh-ancestor
92486387|NCT01940718|Methyltestosterone|methyltestosterone|mesh-list
92486388|NCT01940718|Testosterone|testosterone|mesh-list
92486389|NCT01940718|Testosterone undecanoate|testosterone undecanoate|mesh-list
92486390|NCT01940718|Testosterone enanthate|testosterone enanthate|mesh-list
92486391|NCT01940718|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92486392|NCT01940718|Androgens|androgens|mesh-ancestor
92486393|NCT01940718|Hormones|hormones|mesh-ancestor
92486394|NCT01940718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486395|NCT01940718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486396|NCT01940718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92486397|NCT01940718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486398|NCT01940718|Anabolic Agents|anabolic agents|mesh-ancestor
92486399|NCT01940796|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92486400|NCT01940796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486401|NCT01940796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486402|NCT01940796|Immunotoxins|immunotoxins|mesh-ancestor
92486403|NCT01940796|Immunoconjugates|immunoconjugates|mesh-ancestor
92486404|NCT01940796|Immunologic Factors|immunologic factors|mesh-ancestor
92486405|NCT01940796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486406|NCT01940952|Donepezil|donepezil|mesh-list
92486407|NCT01940952|Udenafil|udenafil|mesh-list
92486408|NCT01940952|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92486409|NCT01940952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486410|NCT01940952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486411|NCT01940952|Cholinergic Agents|cholinergic agents|mesh-ancestor
92486412|NCT01940952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486413|NCT01940952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486414|NCT01940952|Nootropic Agents|nootropic agents|mesh-ancestor
92486415|NCT01940952|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92486416|NCT01940952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92486417|NCT01940965|Lixisenatide|lixisenatide|mesh-list
92486418|NCT01940965|Biguanides|biguanides|mesh-list
92486419|NCT01940965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92486420|NCT01940965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486421|NCT01940978|Cyproheptadine|cyproheptadine|mesh-list
92486422|NCT01940978|Methylphenidate|methylphenidate|mesh-list
92486423|NCT01940978|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92486424|NCT01940978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486425|NCT01940978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92486426|NCT01940978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92486427|NCT01940978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486428|NCT01940978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486429|NCT01940978|Dopamine Agents|dopamine agents|mesh-ancestor
92486430|NCT01940978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486431|NCT01940978|Antipruritics|antipruritics|mesh-ancestor
92486432|NCT01940978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92486433|NCT01940978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92486434|NCT01940978|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92486435|NCT01940978|Histamine Antagonists|histamine antagonists|mesh-ancestor
92486436|NCT01940978|Histamine Agents|histamine agents|mesh-ancestor
92486437|NCT01940978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92486438|NCT01940978|Serotonin Agents|serotonin agents|mesh-ancestor
92486439|NCT01940978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92486440|NCT01941004|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92486441|NCT01941004|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92486442|NCT01941004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486443|NCT01941004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486444|NCT01941004|Immunologic Factors|immunologic factors|mesh-ancestor
92486445|NCT01941004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486446|NCT01941056|Vaccines|vaccines|mesh-list
92486447|NCT01941056|Immunologic Factors|immunologic factors|mesh-ancestor
92486448|NCT01941056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486449|NCT01941134|Levonorgestrel|levonorgestrel|mesh-list
92486450|NCT01941134|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92486451|NCT01941134|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92486452|NCT01941134|Contraceptive Agents|contraceptive agents|mesh-list
92486453|NCT01941134|Contraceptives, Oral|contraceptives, oral|mesh-list
92486454|NCT01941134|Estradiol|estradiol|mesh-list
92486455|NCT01941134|Estrogens|estrogens|mesh-ancestor
92486456|NCT01941134|Hormones|hormones|mesh-ancestor
92486457|NCT01941134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486458|NCT01941134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486459|NCT01941134|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92486460|NCT01941134|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486461|NCT01941134|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92486462|NCT01941134|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92486463|NCT01941134|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92486464|NCT01941134|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92486465|NCT01941173|Leucovorin|leucovorin|mesh-list
92486466|NCT01941173|Fluorouracil|fluorouracil|mesh-list
92486467|NCT01941173|Irinotecan|irinotecan|mesh-list
92486468|NCT01941173|Aflibercept|aflibercept|mesh-list
92486469|NCT01941173|Calcium|calcium|mesh-list
92486470|NCT01941173|Levoleucovorin|levoleucovorin|mesh-list
92486471|NCT01941173|Endothelial Growth Factors|endothelial growth factors|mesh-list
92486472|NCT01941173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486473|NCT01941173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486474|NCT01941173|Antimetabolites|antimetabolites|mesh-ancestor
92486475|NCT01941173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486476|NCT01941173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486477|NCT01941173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486478|NCT01941173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486479|NCT01941173|Immunologic Factors|immunologic factors|mesh-ancestor
92486480|NCT01941173|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92486481|NCT01941173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92486482|NCT01941173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486483|NCT01941173|Antidotes|antidotes|mesh-ancestor
92486484|NCT01941173|Protective Agents|protective agents|mesh-ancestor
92486485|NCT01941173|Vitamin B Complex|vitamin b complex|mesh-ancestor
92486486|NCT01941173|Vitamins|vitamins|mesh-ancestor
92486487|NCT01941173|Micronutrients|micronutrients|mesh-ancestor
92486488|NCT01941173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92486490|NCT01941173|Growth Substances|growth substances|mesh-ancestor
92486491|NCT01941173|Growth Inhibitors|growth inhibitors|mesh-ancestor
92486492|NCT01941199|Metformin|metformin|mesh-list
92486493|NCT01941199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92486494|NCT01941199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486495|NCT01941225|Iloprost|iloprost|mesh-list
92486496|NCT01941225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92486497|NCT01941225|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486498|NCT01941264|Lumefantrine|lumefantrine|mesh-list
92486499|NCT01941264|Artemether|artemether|mesh-list
92486500|NCT01941264|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92486501|NCT01941264|Antimalarials|antimalarials|mesh-ancestor
92486502|NCT01941264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92486503|NCT01941264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92486504|NCT01941264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486505|NCT01941316|Irinotecan|irinotecan|mesh-list
92486506|NCT01941316|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92486507|NCT01941316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92486508|NCT01941316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486509|NCT01941316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486510|NCT01941316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486511|NCT01941329|Ranibizumab|ranibizumab|mesh-list
92486512|NCT01941329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92486513|NCT01941329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92486514|NCT01941329|Growth Substances|growth substances|mesh-ancestor
92486515|NCT01941329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486516|NCT01941329|Growth Inhibitors|growth inhibitors|mesh-ancestor
92486517|NCT01941329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486518|NCT01941407|Bevacizumab|bevacizumab|mesh-list
92486519|NCT01941407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486520|NCT01941407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486521|NCT01941407|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92486522|NCT01941407|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92486523|NCT01941407|Growth Substances|growth substances|mesh-ancestor
92486524|NCT01941407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486525|NCT01941407|Growth Inhibitors|growth inhibitors|mesh-ancestor
92486526|NCT01941524|Poractant alfa|poractant alfa|mesh-list
92486527|NCT01941524|Beractant|beractant|mesh-list
92486528|NCT01941524|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92486529|NCT01941524|Respiratory System Agents|respiratory system agents|mesh-ancestor
92486530|NCT01941576|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92486531|NCT01941576|Natriuretic Agents|natriuretic agents|mesh-ancestor
92486532|NCT01941576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486533|NCT01941602|Enoxaparin|enoxaparin|mesh-list
92486534|NCT01941602|Anticoagulants|anticoagulants|mesh-ancestor
92486535|NCT01941602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92486536|NCT01941602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92486537|NCT01941602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486538|NCT01941732|Sildenafil Citrate|sildenafil citrate|mesh-list
92486539|NCT01941732|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486540|NCT01941732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92486541|NCT01941732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92486542|NCT01941732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486543|NCT01941732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486544|NCT01941732|Urological Agents|urological agents|mesh-ancestor
92486545|NCT01941758|Vaccines|vaccines|mesh-list
92486546|NCT01941758|Immunologic Factors|immunologic factors|mesh-ancestor
92486547|NCT01941758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486548|NCT01941771|Capecitabine|capecitabine|mesh-list
92486549|NCT01941771|Vinorelbine|vinorelbine|mesh-list
92486550|NCT01941771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486551|NCT01941771|Antimetabolites|antimetabolites|mesh-ancestor
92486552|NCT01941771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486553|NCT01941771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486554|NCT01941771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92486555|NCT01941771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92486556|NCT01941771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92486557|NCT01941771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92486558|NCT01941810|Lactoferrin|lactoferrin|mesh-list
92486559|NCT01941810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486560|NCT01941888|Midazolam|midazolam|mesh-list
92486561|NCT01941888|Propofol|propofol|mesh-list
92486562|NCT01941888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92486563|NCT01941888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486564|NCT01941888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486565|NCT01941888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92486566|NCT01941888|Anesthetics, General|anesthetics, general|mesh-ancestor
92486568|NCT01941888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92486569|NCT01941888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92486570|NCT01941888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486571|NCT01941888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486572|NCT01941888|GABA Modulators|gaba modulators|mesh-ancestor
92486573|NCT01941888|GABA Agents|gaba agents|mesh-ancestor
92486574|NCT01941888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486575|NCT01941888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486576|NCT01941901|Calcium, Dietary|calcium, dietary|mesh-list
92486577|NCT01941901|Bleomycin|bleomycin|mesh-list
92486578|NCT01941901|Calcium|calcium|mesh-list
92486579|NCT01941901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486580|NCT01941901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486581|NCT01941901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92486582|NCT01941901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92486583|NCT01941901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486584|NCT01941914|Calcium, Dietary|calcium, dietary|mesh-list
92486585|NCT01941914|Calcium|calcium|mesh-list
92486586|NCT01941914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486587|NCT01941914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486588|NCT01941914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92486589|NCT01941953|Metformin|metformin|mesh-list
92486590|NCT01941953|Fluorouracil|fluorouracil|mesh-list
92486591|NCT01941953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92486592|NCT01941953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486593|NCT01941953|Antimetabolites|antimetabolites|mesh-ancestor
92486594|NCT01941953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486595|NCT01941953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486596|NCT01941953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486597|NCT01941953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486598|NCT01941953|Immunologic Factors|immunologic factors|mesh-ancestor
92486599|NCT01941966|Capecitabine|capecitabine|mesh-list
92486600|NCT01941966|Mitomycins|mitomycins|mesh-list
92486601|NCT01941966|Mitomycin|mitomycin|mesh-list
92486602|NCT01941966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486603|NCT01941966|Antimetabolites|antimetabolites|mesh-ancestor
92486604|NCT01941966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486605|NCT01941966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486606|NCT01941966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92486607|NCT01941966|Alkylating Agents|alkylating agents|mesh-ancestor
92486608|NCT01941966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92486609|NCT01941966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486610|NCT01941979|Leucovorin|leucovorin|mesh-list
92486611|NCT01941979|Capecitabine|capecitabine|mesh-list
92486612|NCT01941979|Oxaliplatin|oxaliplatin|mesh-list
92486613|NCT01941979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486614|NCT01941979|Antimetabolites|antimetabolites|mesh-ancestor
92486615|NCT01941979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486616|NCT01941979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486617|NCT01941979|Antidotes|antidotes|mesh-ancestor
92486618|NCT01941979|Protective Agents|protective agents|mesh-ancestor
92486619|NCT01941979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486620|NCT01941979|Vitamin B Complex|vitamin b complex|mesh-ancestor
92486621|NCT01941979|Vitamins|vitamins|mesh-ancestor
92486622|NCT01941979|Micronutrients|micronutrients|mesh-ancestor
92486623|NCT01942070|Everolimus|everolimus|mesh-list
92486624|NCT01942070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92486625|NCT01942070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92486626|NCT01942070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486627|NCT01942070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486628|NCT01942070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486629|NCT01942070|Immunologic Factors|immunologic factors|mesh-ancestor
92486630|NCT01942070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486631|NCT01942070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486632|NCT01942109|Torsemide|torsemide|mesh-list
92486633|NCT01942109|Furosemide|furosemide|mesh-list
92486634|NCT01942109|Diuretics|diuretics|mesh-ancestor
92486635|NCT01942109|Natriuretic Agents|natriuretic agents|mesh-ancestor
92486636|NCT01942109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486637|NCT01942109|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92486638|NCT01942109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486639|NCT01942109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486640|NCT01942109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92486641|NCT01942174|Methotrexate|methotrexate|mesh-list
92486642|NCT01942174|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92486643|NCT01942174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92486644|NCT01942174|Abortifacient Agents|abortifacient agents|mesh-ancestor
92486645|NCT01942174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486646|NCT01942174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486647|NCT01942174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92486648|NCT01942174|Antimetabolites|antimetabolites|mesh-ancestor
92486649|NCT01942174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486650|NCT01942174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486651|NCT01942174|Dermatologic Agents|dermatologic agents|mesh-ancestor
92486652|NCT01942174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486653|NCT01942174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92486654|NCT01942174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486655|NCT01942174|Immunologic Factors|immunologic factors|mesh-ancestor
92486656|NCT01942174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486657|NCT01942174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92486658|NCT01942187|Aripiprazole|aripiprazole|mesh-list
92486659|NCT01942187|Bupropion|bupropion|mesh-list
92486660|NCT01942187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92486661|NCT01942187|Antidepressive Agents|antidepressive agents|mesh-ancestor
92486662|NCT01942187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486663|NCT01942187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92486664|NCT01942187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92486665|NCT01942187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486666|NCT01942187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486667|NCT01942187|Dopamine Agents|dopamine agents|mesh-ancestor
92486668|NCT01942187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486669|NCT01942187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486670|NCT01942187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92486671|NCT01942187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92486672|NCT01942187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486673|NCT01942187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92486674|NCT01942187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486675|NCT01942187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486676|NCT01942187|Dopamine Agonists|dopamine agonists|mesh-ancestor
92486677|NCT01942187|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92486678|NCT01942187|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92486679|NCT01942187|Serotonin Agents|serotonin agents|mesh-ancestor
92486680|NCT01942187|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92486681|NCT01942187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92486682|NCT01942187|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92486683|NCT01942187|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92486684|NCT01942291|Niacin|niacin|mesh-list
92486685|NCT01942291|Nicotinic Acids|nicotinic acids|mesh-list
92486686|NCT01942291|Vitamins|vitamins|mesh-ancestor
92486687|NCT01942291|Micronutrients|micronutrients|mesh-ancestor
92486688|NCT01942291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486689|NCT01942291|Vitamin B Complex|vitamin b complex|mesh-ancestor
92486690|NCT01942291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92486691|NCT01942291|Antimetabolites|antimetabolites|mesh-ancestor
92486692|NCT01942291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486693|NCT01942291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92486694|NCT01942291|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486695|NCT01942304|Calcium|calcium|mesh-list
92486696|NCT01942304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486697|NCT01942304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486698|NCT01942343|Droperidol|droperidol|mesh-list
92486699|NCT01942343|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92486700|NCT01942343|Antiemetics|antiemetics|mesh-ancestor
92486701|NCT01942343|Autonomic Agents|autonomic agents|mesh-ancestor
92486702|NCT01942343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486703|NCT01942343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486704|NCT01942343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92486705|NCT01942343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92486706|NCT01942343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486707|NCT01942343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486708|NCT01942343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486709|NCT01942343|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92486710|NCT01942343|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92486711|NCT01942343|Dopamine Agents|dopamine agents|mesh-ancestor
92486712|NCT01942343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486713|NCT01942343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486714|NCT01942369|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92486715|NCT01942369|Luteolytic Agents|luteolytic agents|mesh-ancestor
92486716|NCT01942369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92486717|NCT01942369|Contraceptive Agents|contraceptive agents|mesh-ancestor
92486718|NCT01942369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486719|NCT01942369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486720|NCT01942369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92486721|NCT01942369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92486722|NCT01942369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486723|NCT01942382|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92486724|NCT01942382|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92486725|NCT01942382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92486726|NCT01942382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486727|NCT01942382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486728|NCT01942382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92486729|NCT01942382|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92486730|NCT01942382|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92486731|NCT01942382|Serotonin Agents|serotonin agents|mesh-ancestor
92486732|NCT01942382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486733|NCT01942382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486734|NCT01942382|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92486735|NCT01942382|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92486736|NCT01942382|Dopamine Agents|dopamine agents|mesh-ancestor
92486737|NCT01942447|Vancomycin|vancomycin|mesh-list
92486738|NCT01942447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92486739|NCT01942447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486740|NCT01942460|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92486741|NCT01942460|Hematinics|hematinics|mesh-ancestor
92486742|NCT01942460|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92486743|NCT01942460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92486744|NCT01942551|Tadalafil|tadalafil|mesh-list
92486745|NCT01942551|Dutasteride|dutasteride|mesh-list
92486746|NCT01942551|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486747|NCT01942551|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92486748|NCT01942551|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92486749|NCT01942551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486750|NCT01942551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486751|NCT01942551|Urological Agents|urological agents|mesh-ancestor
92486752|NCT01942551|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92486753|NCT01942551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92486754|NCT01942551|Hormone Antagonists|hormone antagonists|mesh-ancestor
92486755|NCT01942551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486756|NCT01942551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486757|NCT01942577|Protective Agents|protective agents|mesh-list
92486758|NCT01942577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486759|NCT01942681|Propiverine|propiverine|mesh-list
92486760|NCT01942681|Parasympatholytics|parasympatholytics|mesh-ancestor
92486761|NCT01942681|Autonomic Agents|autonomic agents|mesh-ancestor
92486762|NCT01942681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486763|NCT01942681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486764|NCT01942681|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92486765|NCT01942681|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92486766|NCT01942681|Cholinergic Agents|cholinergic agents|mesh-ancestor
92486767|NCT01942681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486768|NCT01942681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486769|NCT01942681|Urological Agents|urological agents|mesh-ancestor
92486770|NCT01942889|Antioxidants|antioxidants|mesh-list
92486771|NCT01942889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486772|NCT01942889|Protective Agents|protective agents|mesh-ancestor
92486773|NCT01942889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486774|NCT01943019|Linagliptin|linagliptin|mesh-list
92486775|NCT01943019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92486776|NCT01943019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486777|NCT01943019|Incretins|incretins|mesh-ancestor
92486778|NCT01943019|Hormones|hormones|mesh-ancestor
92486779|NCT01943019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486780|NCT01943019|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92486781|NCT01943019|Protease Inhibitors|protease inhibitors|mesh-ancestor
92486782|NCT01943019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486783|NCT01943019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486784|NCT01943058|Megestrol|megestrol|mesh-list
92486785|NCT01943058|Megestrol Acetate|megestrol acetate|mesh-list
92486786|NCT01943058|Levonorgestrel|levonorgestrel|mesh-list
92486787|NCT01943058|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92486788|NCT01943058|Contraceptive Agents|contraceptive agents|mesh-ancestor
92486789|NCT01943058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486790|NCT01943058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486791|NCT01943058|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92486792|NCT01943058|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92486793|NCT01943058|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92486794|NCT01943058|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92486795|NCT01943058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92486796|NCT01943058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486797|NCT01943058|Appetite Stimulants|appetite stimulants|mesh-ancestor
92486798|NCT01943058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92486799|NCT01943136|Mupirocin|mupirocin|mesh-list
92486800|NCT01943136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92486801|NCT01943136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486802|NCT01943136|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92486803|NCT01943136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486804|NCT01943136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486805|NCT01943188|Cyclophosphamide|cyclophosphamide|mesh-list
92486806|NCT01943188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92486807|NCT01943188|Immunologic Factors|immunologic factors|mesh-ancestor
92211707|NCT05515770|Cabotegravir|cabotegravir|mesh-list
92486808|NCT01943188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486809|NCT01943188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486810|NCT01943188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92486811|NCT01943188|Alkylating Agents|alkylating agents|mesh-ancestor
92486812|NCT01943188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486813|NCT01943188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486814|NCT01943188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92486816|NCT01943240|Anesthetics, Local|anesthetics, local|mesh-ancestor
92486817|NCT01943240|Anesthetics|anesthetics|mesh-ancestor
92486818|NCT01943240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486819|NCT01943240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486820|NCT01943240|Sensory System Agents|sensory system agents|mesh-ancestor
92486821|NCT01943240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486822|NCT01943305|Vaccines|vaccines|mesh-list
92486823|NCT01943305|Immunologic Factors|immunologic factors|mesh-ancestor
92486824|NCT01943305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486825|NCT01943409|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92486826|NCT01943409|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92486827|NCT01943409|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92486829|NCT01943422|Interferons|interferons|mesh-list
92486830|NCT01943422|Interferon-alpha|interferon-alpha|mesh-list
92486831|NCT01943422|Interferon alpha-2|interferon alpha-2|mesh-list
92486832|NCT01943422|Vemurafenib|vemurafenib|mesh-list
92486833|NCT01943422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486834|NCT01943422|Antiviral Agents|antiviral agents|mesh-ancestor
92486835|NCT01943422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486836|NCT01943422|Immunologic Factors|immunologic factors|mesh-ancestor
92486837|NCT01943422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486838|NCT01943422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92486839|NCT01943422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486840|NCT01943422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486841|NCT01943487|Verapamil|verapamil|mesh-list
92486842|NCT01943487|Tamsulosin|tamsulosin|mesh-list
92486843|NCT01943487|Solifenacin Succinate|solifenacin succinate|mesh-list
92486844|NCT01943487|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92486845|NCT01943487|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92486846|NCT01943487|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92486847|NCT01943487|Adrenergic Agents|adrenergic agents|mesh-ancestor
92486848|NCT01943487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486849|NCT01943487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486850|NCT01943487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486851|NCT01943487|Urological Agents|urological agents|mesh-ancestor
92486852|NCT01943487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92486853|NCT01943487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92486854|NCT01943487|Cholinergic Agents|cholinergic agents|mesh-ancestor
92486855|NCT01943487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92532057|NCT00050440|Hormones|hormones|mesh-ancestor
92486856|NCT01943487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92486857|NCT01943487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92486858|NCT01943487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92486859|NCT01943487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92486860|NCT01943526|Natalizumab|natalizumab|mesh-list
92486861|NCT01943526|Immunologic Factors|immunologic factors|mesh-ancestor
92486862|NCT01943526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486864|NCT01943617|Antiviral Agents|antiviral agents|mesh-ancestor
92486865|NCT01943617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486866|NCT01943630|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92486867|NCT01943630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92486868|NCT01943630|Immunologic Factors|immunologic factors|mesh-ancestor
92486869|NCT01943630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486870|NCT01943630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486871|NCT01943630|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92486872|NCT01943630|Protective Agents|protective agents|mesh-ancestor
92486873|NCT01943630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92486874|NCT01943630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92486875|NCT01943630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486876|NCT01943630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486877|NCT01943630|Antiviral Agents|antiviral agents|mesh-ancestor
92200274|NCT00610883|Antimetabolites|antimetabolites|mesh-ancestor
92486879|NCT01943760|Tramadol|tramadol|mesh-list
92486880|NCT01943760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92486881|NCT01943760|Narcotics|narcotics|mesh-ancestor
92486882|NCT01943760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92486883|NCT01943760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486884|NCT01943760|Analgesics|analgesics|mesh-ancestor
92486885|NCT01943760|Sensory System Agents|sensory system agents|mesh-ancestor
92486886|NCT01943760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486887|NCT01943786|Cetuximab|cetuximab|mesh-list
92486888|NCT01943786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92486889|NCT01943786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92486890|NCT01943812|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92486891|NCT01943812|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92486892|NCT01943812|Estradiol|estradiol|mesh-list
92486893|NCT01943812|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92486894|NCT01943812|Progesterone|progesterone|mesh-list
92486895|NCT01943812|Estrogens|estrogens|mesh-ancestor
92486896|NCT01943812|Hormones|hormones|mesh-ancestor
92486897|NCT01943812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486898|NCT01943812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486899|NCT01943812|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92486900|NCT01943812|Contraceptive Agents|contraceptive agents|mesh-ancestor
92486901|NCT01943812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486902|NCT01943812|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92486903|NCT01943812|Progestins|progestins|mesh-ancestor
92486904|NCT01943877|Propolis|propolis|mesh-list
92486905|NCT01943877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486906|NCT01943942|Montelukast|montelukast|mesh-list
92486907|NCT01943942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92486908|NCT01943942|Respiratory System Agents|respiratory system agents|mesh-ancestor
92486909|NCT01943942|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92486910|NCT01943942|Hormone Antagonists|hormone antagonists|mesh-ancestor
92486911|NCT01943942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486912|NCT01943942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486913|NCT01943942|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92486914|NCT01943942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92486915|NCT01943942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486916|NCT01944033|Terbutaline|terbutaline|mesh-list
92486917|NCT01944033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92486918|NCT01944033|Autonomic Agents|autonomic agents|mesh-ancestor
92486919|NCT01944033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486920|NCT01944033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486921|NCT01944033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92486922|NCT01944033|Respiratory System Agents|respiratory system agents|mesh-ancestor
92486923|NCT01944033|Sympathomimetics|sympathomimetics|mesh-ancestor
92486924|NCT01944033|Tocolytic Agents|tocolytic agents|mesh-ancestor
92486925|NCT01944033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92486926|NCT01944033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92486927|NCT01944033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92486928|NCT01944033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92486929|NCT01944033|Adrenergic Agents|adrenergic agents|mesh-ancestor
92486930|NCT01944033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486931|NCT01944033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486932|NCT01944085|Acetaminophen|acetaminophen|mesh-list
92486933|NCT01944085|Ascorbic Acid|ascorbic acid|mesh-list
92486934|NCT01944085|Ibuprofen|ibuprofen|mesh-list
92486935|NCT01944085|Vitamins|vitamins|mesh-ancestor
92486936|NCT01944085|Micronutrients|micronutrients|mesh-ancestor
92486937|NCT01944085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486938|NCT01944085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92486939|NCT01944085|Analgesics|analgesics|mesh-ancestor
92486940|NCT01944085|Sensory System Agents|sensory system agents|mesh-ancestor
92486941|NCT01944085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486942|NCT01944085|Antipyretics|antipyretics|mesh-ancestor
92486943|NCT01944085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92486944|NCT01944085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92486945|NCT01944085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92486946|NCT01944085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92486947|NCT01944085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486948|NCT01944085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486949|NCT01944085|Antioxidants|antioxidants|mesh-ancestor
92486950|NCT01944085|Protective Agents|protective agents|mesh-ancestor
92486951|NCT01944176|Simvastatin|simvastatin|mesh-list
92486952|NCT01944176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92486953|NCT01944176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92486954|NCT01944176|Antimetabolites|antimetabolites|mesh-ancestor
92486955|NCT01944176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486956|NCT01944176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92486957|NCT01944176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92486958|NCT01944176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486959|NCT01944189|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92486960|NCT01944189|Antimalarials|antimalarials|mesh-ancestor
92486961|NCT01944189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92486962|NCT01944189|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92486963|NCT01944189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92486965|NCT01944215|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92486966|NCT01944215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486967|NCT01944215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92486968|NCT01944215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486969|NCT01944215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486970|NCT01944215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92486971|NCT01944215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92486972|NCT01944215|Purinergic Agents|purinergic agents|mesh-ancestor
92486973|NCT01944215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486974|NCT01944384|Spironolactone|spironolactone|mesh-list
92486975|NCT01944384|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92486976|NCT01944384|Hormone Antagonists|hormone antagonists|mesh-ancestor
92486977|NCT01944384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92486978|NCT01944384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486979|NCT01944384|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92486980|NCT01944384|Diuretics|diuretics|mesh-ancestor
92486981|NCT01944384|Natriuretic Agents|natriuretic agents|mesh-ancestor
92486982|NCT01944410|Mitogens|mitogens|mesh-list
92486983|NCT01944410|Mitosis Modulators|mitosis modulators|mesh-ancestor
92486984|NCT01944410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486985|NCT01944436|Rivastigmine|rivastigmine|mesh-list
92486986|NCT01944436|Donepezil|donepezil|mesh-list
92486987|NCT01944436|Galantamine|galantamine|mesh-list
92486988|NCT01944436|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92486989|NCT01944436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92486990|NCT01944436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92486991|NCT01944436|Cholinergic Agents|cholinergic agents|mesh-ancestor
92486992|NCT01944436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92486993|NCT01944436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92486994|NCT01944436|Nootropic Agents|nootropic agents|mesh-ancestor
92486995|NCT01944436|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92486996|NCT01944436|Autonomic Agents|autonomic agents|mesh-ancestor
92486997|NCT01944436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92486998|NCT01944436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92486999|NCT01944436|Protective Agents|protective agents|mesh-ancestor
92487000|NCT01944618|Dapagliflozin|dapagliflozin|mesh-list
92487001|NCT01944618|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92487002|NCT01944618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487003|NCT01944618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92487004|NCT01944618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487005|NCT01944657|Antidepressive Agents|antidepressive agents|mesh-list
92487006|NCT01944657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487007|NCT01944683|Midazolam|midazolam|mesh-list
92487008|NCT01944683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92487009|NCT01944683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92487010|NCT01944683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487011|NCT01944683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487012|NCT01944683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92487013|NCT01944683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92487014|NCT01944683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487015|NCT01944683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92487016|NCT01944683|Anesthetics, General|anesthetics, general|mesh-ancestor
92487017|NCT01944683|Anesthetics|anesthetics|mesh-ancestor
92487018|NCT01944683|GABA Modulators|gaba modulators|mesh-ancestor
92487019|NCT01944683|GABA Agents|gaba agents|mesh-ancestor
92487020|NCT01944683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487021|NCT01944683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487022|NCT01944735|Mannitol|mannitol|mesh-list
92487023|NCT01944735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92487024|NCT01944735|Diuretics|diuretics|mesh-ancestor
92487025|NCT01944735|Natriuretic Agents|natriuretic agents|mesh-ancestor
92487026|NCT01944735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487027|NCT01944852|Icodextrin|icodextrin|mesh-list
92487028|NCT01944852|Dialysis Solutions|dialysis solutions|mesh-ancestor
92487029|NCT01944852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92487030|NCT01945021|Crizotinib|crizotinib|mesh-list
92487031|NCT01945021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487032|NCT01945021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92487033|NCT01945021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487034|NCT01945021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487035|NCT01945047|Midazolam|midazolam|mesh-list
92487036|NCT01945047|Ketamine|ketamine|mesh-list
92487037|NCT01945047|Analgesics|analgesics|mesh-ancestor
92487038|NCT01945047|Sensory System Agents|sensory system agents|mesh-ancestor
92487039|NCT01945047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487040|NCT01945047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487041|NCT01945047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92487042|NCT01945047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92487043|NCT01945047|Anesthetics, General|anesthetics, general|mesh-ancestor
92487044|NCT01945047|Anesthetics|anesthetics|mesh-ancestor
92487045|NCT01945047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487046|NCT01945047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92487047|NCT01945047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92487048|NCT01945047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487049|NCT01945047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487050|NCT01945047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92487051|NCT01945047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92487052|NCT01945047|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92487053|NCT01945047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92487054|NCT01945047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487055|NCT01945047|GABA Modulators|gaba modulators|mesh-ancestor
92487056|NCT01945047|GABA Agents|gaba agents|mesh-ancestor
92487057|NCT01945099|Insulin|insulin|mesh-list
92487058|NCT01945099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92487059|NCT01945099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487060|NCT01945268|Vaccines|vaccines|mesh-list
92487061|NCT01945268|Immunologic Factors|immunologic factors|mesh-ancestor
92487062|NCT01945268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487063|NCT01945437|Magnesium Sulfate|magnesium sulfate|mesh-list
92487064|NCT01945437|Analgesics|analgesics|mesh-ancestor
92487065|NCT01945437|Sensory System Agents|sensory system agents|mesh-ancestor
92487066|NCT01945437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487067|NCT01945437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487068|NCT01945437|Anesthetics|anesthetics|mesh-ancestor
92487069|NCT01945437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487070|NCT01945437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92487071|NCT01945437|Anticonvulsants|anticonvulsants|mesh-ancestor
92487072|NCT01945437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92487073|NCT01945437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487074|NCT01945437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487075|NCT01945437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92487076|NCT01945437|Tocolytic Agents|tocolytic agents|mesh-ancestor
92487077|NCT01945437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92487078|NCT01945450|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92487079|NCT01945450|Clindamycin|clindamycin|mesh-list
92487080|NCT01945450|Clindamycin palmitate|clindamycin palmitate|mesh-list
92487081|NCT01945450|Clindamycin phosphate|clindamycin phosphate|mesh-list
92487082|NCT01945450|Gentamicins|gentamicins|mesh-list
92487083|NCT01945450|Ampicillin|ampicillin|mesh-list
92487084|NCT01945450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487085|NCT01945450|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92487086|NCT01945450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487087|NCT01945450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487088|NCT01945476|Midazolam|midazolam|mesh-list
92487089|NCT01945476|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92487090|NCT01945476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92487091|NCT01945476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487092|NCT01945476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487093|NCT01945476|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92487094|NCT01945476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92487095|NCT01945476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487096|NCT01945476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92487097|NCT01945476|Anesthetics, General|anesthetics, general|mesh-ancestor
92487098|NCT01945476|Anesthetics|anesthetics|mesh-ancestor
92487099|NCT01945476|GABA Modulators|gaba modulators|mesh-ancestor
92487101|NCT01945476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487102|NCT01945476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487103|NCT01945528|Lidocaine|lidocaine|mesh-list
92487104|NCT01945528|Anesthetics, Local|anesthetics, local|mesh-list
92487105|NCT01945528|Anesthetics|anesthetics|mesh-list
92487106|NCT01945528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487107|NCT01945528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487108|NCT01945528|Sensory System Agents|sensory system agents|mesh-ancestor
92487109|NCT01945528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487110|NCT01945528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92487111|NCT01945528|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92487112|NCT01945528|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92487113|NCT01945528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487114|NCT01945528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487115|NCT01945554|Bupivacaine|bupivacaine|mesh-list
92487116|NCT01945554|Anesthetics, Local|anesthetics, local|mesh-ancestor
92487117|NCT01945554|Anesthetics|anesthetics|mesh-ancestor
92487118|NCT01945554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487119|NCT01945554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487120|NCT01945554|Sensory System Agents|sensory system agents|mesh-ancestor
92487121|NCT01945554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487122|NCT01945684|Botulinum Toxins|botulinum toxins|mesh-list
92487123|NCT01945684|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92487124|NCT01945684|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92487125|NCT01945684|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92487126|NCT01945684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487127|NCT01945684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487128|NCT01945684|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487129|NCT01945684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487130|NCT01945684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487131|NCT01945684|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92487132|NCT01945684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487133|NCT01945736|Methadone|methadone|mesh-list
92487134|NCT01945736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92487135|NCT01945736|Narcotics|narcotics|mesh-ancestor
92487136|NCT01945736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487137|NCT01945736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487138|NCT01945736|Analgesics|analgesics|mesh-ancestor
92487139|NCT01945736|Sensory System Agents|sensory system agents|mesh-ancestor
92487140|NCT01945736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487141|NCT01945736|Antitussive Agents|antitussive agents|mesh-ancestor
92487142|NCT01945736|Respiratory System Agents|respiratory system agents|mesh-ancestor
92487143|NCT01945788|Teriparatide|teriparatide|mesh-list
92487144|NCT01945788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92487145|NCT01945788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487146|NCT01945788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92487147|NCT01945801|Furosemide|furosemide|mesh-list
92487148|NCT01945801|Spironolactone|spironolactone|mesh-list
92487149|NCT01945801|Diuretics|diuretics|mesh-ancestor
92487150|NCT01945801|Natriuretic Agents|natriuretic agents|mesh-ancestor
92487151|NCT01945801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487152|NCT01945801|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92487153|NCT01945801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487154|NCT01945801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487155|NCT01945801|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92487156|NCT01945801|Hormone Antagonists|hormone antagonists|mesh-ancestor
92487157|NCT01945801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487158|NCT01945801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92487159|NCT05410782|Vitamins|vitamins|mesh-list
92487160|NCT05410782|Micronutrients|micronutrients|mesh-ancestor
92487161|NCT05410782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487162|NCT05410626|Methylphenidate|methylphenidate|mesh-list
92487163|NCT05410626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92487164|NCT05410626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487165|NCT05410626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92487166|NCT05410626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92487167|NCT05410626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487168|NCT05410626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487169|NCT05410626|Dopamine Agents|dopamine agents|mesh-ancestor
92487170|NCT05410626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487171|NCT05410535|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92487172|NCT05410535|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92487173|NCT05410535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487174|NCT05410483|Docetaxel|docetaxel|mesh-list
92487175|NCT05410483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487176|NCT05410483|Tubulin Modulators|tubulin modulators|mesh-ancestor
92487177|NCT05410483|Antimitotic Agents|antimitotic agents|mesh-ancestor
92487178|NCT05410483|Mitosis Modulators|mitosis modulators|mesh-ancestor
92487179|NCT05410483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487180|NCT05410314|Inositol|inositol|mesh-list
92487181|NCT05410314|Vitamin B Complex|vitamin b complex|mesh-ancestor
92487182|NCT05410314|Vitamins|vitamins|mesh-ancestor
92487183|NCT05410314|Micronutrients|micronutrients|mesh-ancestor
92487184|NCT05410314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487185|NCT05410275|Rivaroxaban|rivaroxaban|mesh-list
92487186|NCT05410275|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92487187|NCT05410275|Antithrombins|antithrombins|mesh-ancestor
92487188|NCT05410275|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92487189|NCT05410275|Protease Inhibitors|protease inhibitors|mesh-ancestor
92487190|NCT05410275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487191|NCT05410275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487192|NCT05410275|Anticoagulants|anticoagulants|mesh-ancestor
92487193|NCT05410093|Vitamin E|vitamin e|mesh-list
92487194|NCT05410093|Tocopherols|tocopherols|mesh-list
92487195|NCT05410093|Resveratrol|resveratrol|mesh-list
92487196|NCT05410093|Vitamins|vitamins|mesh-ancestor
92487197|NCT05410093|Micronutrients|micronutrients|mesh-ancestor
92487198|NCT05410093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487199|NCT05410093|Antioxidants|antioxidants|mesh-ancestor
92487200|NCT05410093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487201|NCT05410093|Protective Agents|protective agents|mesh-ancestor
92487202|NCT05410093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487203|NCT05410093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92487204|NCT05409820|Anesthetics|anesthetics|mesh-list
92487205|NCT05409820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487206|NCT05409820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487207|NCT05409339|Mannitol|mannitol|mesh-list
92487208|NCT05409339|Caffeine|caffeine|mesh-list
92487209|NCT05409339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92487210|NCT05409339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487211|NCT05409339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92487212|NCT05409339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487213|NCT05409339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487214|NCT05409339|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92487215|NCT05409339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92487216|NCT05409339|Purinergic Agents|purinergic agents|mesh-ancestor
92487217|NCT05409339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487218|NCT05409339|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92487219|NCT05409339|Diuretics|diuretics|mesh-ancestor
92487220|NCT05409339|Natriuretic Agents|natriuretic agents|mesh-ancestor
92487221|NCT05155527|Ivermectin|ivermectin|mesh-list
92487222|NCT05155527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92487223|NCT05155527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487224|NCT05151146|Metformin|metformin|mesh-list
92487225|NCT05151146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92487226|NCT05151146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487227|NCT05068063|Bupivacaine|bupivacaine|mesh-list
92487228|NCT05068063|Anesthetics, Local|anesthetics, local|mesh-ancestor
92487229|NCT05068063|Anesthetics|anesthetics|mesh-ancestor
92487230|NCT05068063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487231|NCT05068063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487232|NCT05068063|Sensory System Agents|sensory system agents|mesh-ancestor
92487233|NCT05068063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487234|NCT04967378|Psychotropic Drugs|psychotropic drugs|mesh-list
92487235|NCT04946396|Dexmedetomidine|dexmedetomidine|mesh-list
92487236|NCT04946396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92487237|NCT04946396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487238|NCT04946396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487239|NCT04946396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92487240|NCT04946396|Analgesics|analgesics|mesh-ancestor
92487241|NCT04946396|Sensory System Agents|sensory system agents|mesh-ancestor
92487242|NCT04946396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487243|NCT04946396|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92487244|NCT04946396|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92487245|NCT04946396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92487246|NCT04946396|Adrenergic Agents|adrenergic agents|mesh-ancestor
92487247|NCT04946396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487248|NCT04946396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487249|NCT04908657|Sildenafil Citrate|sildenafil citrate|mesh-list
92487250|NCT04908657|Vasodilator Agents|vasodilator agents|mesh-ancestor
92487251|NCT04908657|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92487252|NCT04908657|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92487253|NCT04908657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487254|NCT04908657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487255|NCT04908657|Urological Agents|urological agents|mesh-ancestor
92487256|NCT04887389|Listerine|listerine|mesh-list
92487257|NCT04887389|Fluorides|fluorides|mesh-list
92487258|NCT04887389|Sodium Fluoride|sodium fluoride|mesh-list
92487259|NCT04887389|Fluorides, Topical|fluorides, topical|mesh-list
92487260|NCT04887389|Cariostatic Agents|cariostatic agents|mesh-ancestor
92487261|NCT04887389|Protective Agents|protective agents|mesh-ancestor
92487262|NCT04887389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487263|NCT04887389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92487264|NCT04887389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487265|NCT04773392|Mycophenolic Acid|mycophenolic acid|mesh-list
92487266|NCT04773392|Prednisone|prednisone|mesh-list
92487267|NCT04773392|Methylprednisolone|methylprednisolone|mesh-list
92487268|NCT04773392|Azathioprine|azathioprine|mesh-list
92487269|NCT04773392|Tacrolimus|tacrolimus|mesh-list
92487270|NCT04773392|Thymoglobulin|thymoglobulin|mesh-list
92487271|NCT04773392|Basiliximab|basiliximab|mesh-list
92487272|NCT04773392|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92487273|NCT04773392|Antimetabolites|antimetabolites|mesh-list
92487274|NCT04773392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487275|NCT04773392|Glucocorticoids|glucocorticoids|mesh-ancestor
92487276|NCT04773392|Hormones|hormones|mesh-ancestor
92487277|NCT04773392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487278|NCT04773392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487279|NCT04773392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92487280|NCT04773392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487281|NCT04773392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92487282|NCT04773392|Immunologic Factors|immunologic factors|mesh-ancestor
92487283|NCT04773392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92487284|NCT04773392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487285|NCT04773392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487286|NCT04773392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92487287|NCT04773392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92487288|NCT04773392|Antitubercular Agents|antitubercular agents|mesh-ancestor
92487289|NCT04773392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92487290|NCT04773392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487291|NCT04773392|Antiemetics|antiemetics|mesh-ancestor
92487292|NCT04773392|Autonomic Agents|autonomic agents|mesh-ancestor
92487293|NCT04773392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487294|NCT04773392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487296|NCT04773392|Protective Agents|protective agents|mesh-ancestor
92487297|NCT04773392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92487298|NCT04773392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487299|NCT04724655|Mineral Oil|mineral oil|mesh-list
92487300|NCT04724655|Emollients|emollients|mesh-ancestor
92487301|NCT04724655|Dermatologic Agents|dermatologic agents|mesh-ancestor
92487302|NCT04722835|Albuterol|albuterol|mesh-list
92487303|NCT04722835|Dimercaprol|dimercaprol|mesh-list
92487304|NCT04722835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92487305|NCT04722835|Autonomic Agents|autonomic agents|mesh-ancestor
92487306|NCT04722835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487307|NCT04722835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487308|NCT04722835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92487309|NCT04722835|Respiratory System Agents|respiratory system agents|mesh-ancestor
92487310|NCT04722835|Tocolytic Agents|tocolytic agents|mesh-ancestor
92487311|NCT04722835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92487312|NCT04722835|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92487313|NCT04722835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92487314|NCT04722835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92487315|NCT04722835|Adrenergic Agents|adrenergic agents|mesh-ancestor
92487316|NCT04722835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487317|NCT04722835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487318|NCT04722835|Chelating Agents|chelating agents|mesh-ancestor
92487319|NCT04722835|Sequestering Agents|sequestering agents|mesh-ancestor
92487320|NCT04538053|Cefazolin|cefazolin|mesh-list
92487321|NCT04538053|Cephalexin|cephalexin|mesh-list
92487322|NCT04538053|Floxacillin|floxacillin|mesh-list
92487323|NCT04538053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92487324|NCT04538053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487325|NCT04487990|Heparin|heparin|mesh-list
92487326|NCT04487990|Calcium heparin|calcium heparin|mesh-list
92487327|NCT04487990|Anticoagulants|anticoagulants|mesh-ancestor
92487328|NCT04487990|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92487329|NCT04487990|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92487330|NCT04487990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487331|NCT04476979|Dexamethasone|dexamethasone|mesh-list
92487332|NCT04476979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487333|NCT04476979|Antiemetics|antiemetics|mesh-ancestor
92487334|NCT04476979|Autonomic Agents|autonomic agents|mesh-ancestor
92487335|NCT04476979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487336|NCT04476979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487337|NCT04476979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487338|NCT04476979|Glucocorticoids|glucocorticoids|mesh-ancestor
92487340|NCT04476979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487341|NCT04476979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92487342|NCT04476979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487343|NCT04411953|Haloperidol|haloperidol|mesh-list
92487344|NCT04411953|Benztropine|benztropine|mesh-list
92487345|NCT04411953|Haloperidol decanoate|haloperidol decanoate|mesh-list
92487346|NCT04411953|Antiemetics|antiemetics|mesh-ancestor
92487347|NCT04411953|Autonomic Agents|autonomic agents|mesh-ancestor
92487348|NCT04411953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487349|NCT04411953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487350|NCT04411953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487351|NCT04411953|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92487352|NCT04411953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92487353|NCT04411953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487354|NCT04411953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487355|NCT04411953|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92487356|NCT04411953|Dopamine Agents|dopamine agents|mesh-ancestor
92487357|NCT04411953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487358|NCT04411953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487359|NCT04411953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92487360|NCT04411953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92487361|NCT04411953|Parasympatholytics|parasympatholytics|mesh-ancestor
92487362|NCT04411953|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92487363|NCT04411953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92487364|NCT04411953|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487365|NCT04411953|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92487366|NCT04411953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92487367|NCT04411953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487368|NCT04411940|Haloperidol|haloperidol|mesh-list
92487369|NCT04411940|Benztropine|benztropine|mesh-list
92487370|NCT04411940|Haloperidol decanoate|haloperidol decanoate|mesh-list
92487371|NCT04411940|Antiemetics|antiemetics|mesh-ancestor
92487372|NCT04411940|Autonomic Agents|autonomic agents|mesh-ancestor
92487373|NCT04411940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487374|NCT04411940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487375|NCT04411940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487376|NCT04411940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92487377|NCT04411940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92487378|NCT04411940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487379|NCT04411940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487380|NCT04411940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92487381|NCT04411940|Dopamine Agents|dopamine agents|mesh-ancestor
92487382|NCT04411940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487383|NCT04411940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487384|NCT04411940|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92487385|NCT04411940|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92487386|NCT04411940|Parasympatholytics|parasympatholytics|mesh-ancestor
92487387|NCT04411940|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92487388|NCT04411940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92487389|NCT04411940|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487390|NCT04411940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92487391|NCT04411940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92487392|NCT04411940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487393|NCT04035109|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92487394|NCT04035109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487396|NCT04030429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487397|NCT04030429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92487398|NCT04030429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487399|NCT04030429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487400|NCT03970694|Capecitabine|capecitabine|mesh-list
92487401|NCT03970694|Oxaliplatin|oxaliplatin|mesh-list
92487402|NCT03970694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92487403|NCT03970694|Antimetabolites|antimetabolites|mesh-ancestor
92487404|NCT03970694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487405|NCT03970694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487406|NCT03941132|Ustekinumab|ustekinumab|mesh-list
92487407|NCT03941132|Dermatologic Agents|dermatologic agents|mesh-ancestor
92487408|NCT03873246|Varenicline|varenicline|mesh-list
92487409|NCT03873246|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92487410|NCT03873246|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92487411|NCT03873246|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487412|NCT03873246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487413|NCT03873246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487414|NCT03873246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487415|NCT03714880|Mifepristone|mifepristone|mesh-list
92487416|NCT03714880|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92487417|NCT03714880|Abortifacient Agents|abortifacient agents|mesh-ancestor
92487418|NCT03714880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92487419|NCT03714880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487420|NCT03714880|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92487421|NCT03714880|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92487422|NCT03714880|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92487423|NCT03714880|Contraceptive Agents|contraceptive agents|mesh-ancestor
92487424|NCT03714880|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92487425|NCT03714880|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92487426|NCT03714880|Hormone Antagonists|hormone antagonists|mesh-ancestor
92487427|NCT03714880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487428|NCT03714880|Luteolytic Agents|luteolytic agents|mesh-ancestor
92487429|NCT03714880|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92487430|NCT03714880|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92487431|NCT03619850|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92487432|NCT03619850|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92487433|NCT03619850|Hematinics|hematinics|mesh-ancestor
92487434|NCT03619850|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92487435|NCT03619850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92487436|NCT03559686|Certolizumab Pegol|certolizumab pegol|mesh-list
92487437|NCT03559686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92487438|NCT03559686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487439|NCT03559686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92487440|NCT03559686|Immunologic Factors|immunologic factors|mesh-ancestor
92487441|NCT03559686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487442|NCT03559686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487443|NCT03559660|Certolizumab Pegol|certolizumab pegol|mesh-list
92532067|NCT00050479|Analgesics|analgesics|mesh-ancestor
92487444|NCT03559660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92487445|NCT03559660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487446|NCT03559660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92487447|NCT03559660|Immunologic Factors|immunologic factors|mesh-ancestor
92487448|NCT03559660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487449|NCT03559660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487450|NCT03532516|Brivaracetam|brivaracetam|mesh-list
92487451|NCT03532516|Anticonvulsants|anticonvulsants|mesh-ancestor
92487452|NCT03333005|Antifungal Agents|antifungal agents|mesh-list
92487453|NCT03333005|Clotrimazole|clotrimazole|mesh-list
92487454|NCT03333005|Miconazole|miconazole|mesh-list
92487455|NCT03333005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487456|NCT03333005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92487457|NCT03333005|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92487458|NCT03333005|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92487459|NCT03333005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487460|NCT03333005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487461|NCT03333005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92487462|NCT03333005|Hormone Antagonists|hormone antagonists|mesh-ancestor
92151562|NCT04377789|Antioxidants|antioxidants|mesh-ancestor
92487463|NCT03333005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487464|NCT03333005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487465|NCT03333005|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92487466|NCT03333005|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92487467|NCT03148366|Levofloxacin|levofloxacin|mesh-list
92487468|NCT03148366|Bismuth|bismuth|mesh-list
92487469|NCT03148366|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92487470|NCT03148366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487471|NCT03148366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92487472|NCT03148366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92487473|NCT03148366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92487474|NCT03148366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487475|NCT03148366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487476|NCT03148366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487477|NCT03148366|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92487478|NCT03148366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92487479|NCT03148366|Antacids|antacids|mesh-ancestor
92487480|NCT03148366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487481|NCT03122496|Durvalumab|durvalumab|mesh-list
92487482|NCT03122496|Tremelimumab|tremelimumab|mesh-list
92487483|NCT03122496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487484|NCT03122496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487485|NCT03073694|Melphalan|melphalan|mesh-list
92487486|NCT03073694|Mitomycins|mitomycins|mesh-list
92487487|NCT03073694|Mitomycin|mitomycin|mesh-list
92487488|NCT03073694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92487489|NCT03073694|Alkylating Agents|alkylating agents|mesh-ancestor
92487490|NCT03073694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487491|NCT03073694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487492|NCT03073694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92487493|NCT03073694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92487494|NCT03073694|Immunologic Factors|immunologic factors|mesh-ancestor
92487495|NCT03073694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487496|NCT03073694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92487497|NCT03073694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92487498|NCT03073694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487499|NCT03069703|Rituximab|rituximab|mesh-list
92487500|NCT03069703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487501|NCT03069703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487502|NCT03069703|Immunologic Factors|immunologic factors|mesh-ancestor
92487503|NCT03069703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487504|NCT03069703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487505|NCT02955082|Carboplatin|carboplatin|mesh-list
92487506|NCT02955082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487507|NCT02862548|Antiviral Agents|antiviral agents|mesh-list
92487508|NCT02862548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487509|NCT02818738|Levamisole|levamisole|mesh-list
92487510|NCT02818738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92487511|NCT02818738|Immunologic Factors|immunologic factors|mesh-ancestor
92487512|NCT02818738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487513|NCT02818738|Antinematodal Agents|antinematodal agents|mesh-ancestor
92487514|NCT02818738|Anthelmintics|anthelmintics|mesh-ancestor
92487515|NCT02818738|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92487516|NCT02818738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487517|NCT02818738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487518|NCT02335099|Ticagrelor|ticagrelor|mesh-list
92487519|NCT02335099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92487520|NCT02335099|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92487521|NCT02335099|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92487522|NCT02335099|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92487523|NCT02335099|Purinergic Agents|purinergic agents|mesh-ancestor
92487524|NCT02335099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487525|NCT02335099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487526|NCT02335099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487527|NCT02330562|Bevacizumab|bevacizumab|mesh-list
92487528|NCT02330562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487529|NCT02330562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487530|NCT02330562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92487531|NCT02330562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92487532|NCT02330562|Growth Substances|growth substances|mesh-ancestor
92487533|NCT02330562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487534|NCT02330562|Growth Inhibitors|growth inhibitors|mesh-ancestor
92487535|NCT02053363|Tranexamic Acid|tranexamic acid|mesh-list
92487536|NCT02053363|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92487537|NCT02053363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92487538|NCT02053363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487539|NCT02053363|Hemostatics|hemostatics|mesh-ancestor
92487540|NCT02053363|Coagulants|coagulants|mesh-ancestor
92487541|NCT01100775|Galantamine|galantamine|mesh-list
92487542|NCT01100775|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92487543|NCT01100775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487544|NCT01100775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487545|NCT01100775|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487546|NCT01100775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487547|NCT01100775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487548|NCT01100775|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92487549|NCT01100775|Autonomic Agents|autonomic agents|mesh-ancestor
92487550|NCT01100775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487551|NCT01100775|Nootropic Agents|nootropic agents|mesh-ancestor
92487552|NCT00504712|Testosterone|testosterone|mesh-list
92487553|NCT00504712|Androgens|androgens|mesh-ancestor
92487554|NCT00504712|Hormones|hormones|mesh-ancestor
92487555|NCT00504712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487556|NCT00504712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487557|NCT05413200|Isotretinoin|isotretinoin|mesh-list
92487558|NCT05413200|Dermatologic Agents|dermatologic agents|mesh-ancestor
92212463|NCT04334824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92487560|NCT05412589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487561|NCT05412589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92487562|NCT05412589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487563|NCT05412589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487564|NCT05412576|Lidocaine|lidocaine|mesh-list
92487565|NCT05412576|Anesthetics, Local|anesthetics, local|mesh-ancestor
92487566|NCT05412576|Anesthetics|anesthetics|mesh-ancestor
92487567|NCT05412576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487568|NCT05412576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487569|NCT05412576|Sensory System Agents|sensory system agents|mesh-ancestor
92487570|NCT05412576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487571|NCT05412576|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92487572|NCT05412576|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92487573|NCT05412576|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92487574|NCT05412576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487575|NCT05412576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487576|NCT05412472|Avasopasem manganese|avasopasem manganese|mesh-list
92487577|NCT05412472|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92487578|NCT05412472|Antioxidants|antioxidants|mesh-ancestor
92487579|NCT05412472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487580|NCT05412472|Protective Agents|protective agents|mesh-ancestor
92487581|NCT05412472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487582|NCT05412394|Prednisolone|prednisolone|mesh-list
92487583|NCT05412394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487584|NCT05412394|Glucocorticoids|glucocorticoids|mesh-ancestor
92487585|NCT05412394|Hormones|hormones|mesh-ancestor
92487586|NCT05412394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487587|NCT05412394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487588|NCT05412394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92487589|NCT05412394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487590|NCT05412147|Vitamins|vitamins|mesh-list
92487591|NCT05412147|Micronutrients|micronutrients|mesh-ancestor
92487592|NCT05412147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487593|NCT05411900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92487594|NCT05411900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92487595|NCT05411900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487596|NCT05411900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487597|NCT05411900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92487598|NCT05411900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487599|NCT05411900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487600|NCT05411900|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487601|NCT05411900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487602|NCT05411757|Bevacizumab|bevacizumab|mesh-list
92487603|NCT05411757|Lenvatinib|lenvatinib|mesh-list
92487604|NCT05411757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487605|NCT05411757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487606|NCT05411757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92487607|NCT05411757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92487608|NCT05411757|Growth Substances|growth substances|mesh-ancestor
92487609|NCT05411757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487610|NCT05411757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92487611|NCT05411757|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92487612|NCT05411757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487613|NCT05411757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487614|NCT05411666|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92487615|NCT05411276|Maleic acid|maleic acid|mesh-list
92487616|NCT05411276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487617|NCT05411276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487618|NCT05396781|Proflavine|proflavine|mesh-list
92487619|NCT05396781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92487620|NCT05396781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487621|NCT05384951|Vitamin D|vitamin d|mesh-list
92487622|NCT05384951|Cholecalciferol|cholecalciferol|mesh-list
92487623|NCT05384951|Vitamins|vitamins|mesh-ancestor
92487624|NCT05384951|Micronutrients|micronutrients|mesh-ancestor
92487625|NCT05384951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487626|NCT05384951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92487627|NCT05384951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92487628|NCT05303038|Bevacizumab|bevacizumab|mesh-list
92487629|NCT05303038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487630|NCT05303038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487631|NCT05303038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92487632|NCT05303038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92487633|NCT05303038|Growth Substances|growth substances|mesh-ancestor
92487634|NCT05303038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487635|NCT05303038|Growth Inhibitors|growth inhibitors|mesh-ancestor
92487636|NCT05275894|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92487637|NCT05275894|Metronidazole|metronidazole|mesh-list
92487638|NCT05275894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487639|NCT05275894|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92487640|NCT05275894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92487642|NCT05077800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92487643|NCT05077800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92487644|NCT05077800|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92487645|NCT05077800|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92487646|NCT05077800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487647|NCT05062902|Botulinum Toxins|botulinum toxins|mesh-list
92487648|NCT05062902|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92487649|NCT05062902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487650|NCT05062902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487651|NCT05062902|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487652|NCT05062902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487653|NCT05062902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487654|NCT05042674|Ergothioneine|ergothioneine|mesh-list
92487655|NCT05042674|Antioxidants|antioxidants|mesh-ancestor
92487656|NCT05042674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487657|NCT05042674|Protective Agents|protective agents|mesh-ancestor
92487658|NCT05042674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487659|NCT04927585|Vaccines|vaccines|mesh-list
92487660|NCT04927585|Immunologic Factors|immunologic factors|mesh-ancestor
92487661|NCT04927585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487662|NCT04917055|Dexamethasone|dexamethasone|mesh-list
92487663|NCT04917055|Epinephrine|epinephrine|mesh-list
92487665|NCT04917055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487666|NCT04917055|Antiemetics|antiemetics|mesh-ancestor
92487667|NCT04917055|Autonomic Agents|autonomic agents|mesh-ancestor
92487668|NCT04917055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487669|NCT04917055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487670|NCT04917055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487671|NCT04917055|Glucocorticoids|glucocorticoids|mesh-ancestor
92487672|NCT04917055|Hormones|hormones|mesh-ancestor
92487673|NCT04917055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487674|NCT04917055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92487675|NCT04917055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487676|NCT04917055|Anesthetics, Local|anesthetics, local|mesh-ancestor
92487677|NCT04917055|Anesthetics|anesthetics|mesh-ancestor
92487678|NCT04917055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487679|NCT04917055|Sensory System Agents|sensory system agents|mesh-ancestor
92487680|NCT04917055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92487681|NCT04917055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92487682|NCT04917055|Adrenergic Agents|adrenergic agents|mesh-ancestor
92487683|NCT04917055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487684|NCT04917055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487685|NCT04917055|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92487686|NCT04917055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92487687|NCT04917055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92487688|NCT04917055|Respiratory System Agents|respiratory system agents|mesh-ancestor
92487689|NCT04917055|Mydriatics|mydriatics|mesh-ancestor
92487690|NCT04917055|Sympathomimetics|sympathomimetics|mesh-ancestor
92487691|NCT04917055|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92487692|NCT04898478|Analgesics, Opioid|analgesics, opioid|mesh-list
92487693|NCT04898478|Narcotics|narcotics|mesh-ancestor
92487694|NCT04898478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487695|NCT04898478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487697|NCT04898478|Sensory System Agents|sensory system agents|mesh-ancestor
92487698|NCT04898478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487699|NCT04755244|Azacitidine|azacitidine|mesh-list
92487700|NCT04755244|Venetoclax|venetoclax|mesh-list
92487701|NCT04755244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92487702|NCT04755244|Antimetabolites|antimetabolites|mesh-ancestor
92487703|NCT04755244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487704|NCT04755244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487705|NCT04755244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212618|NCT00918931|Obatoclax|obatoclax|mesh-list
92487707|NCT04725864|Progestins|progestins|mesh-ancestor
92487708|NCT04725864|Hormones|hormones|mesh-ancestor
92487709|NCT04725864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487710|NCT04725864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487711|NCT04721821|Tofacitinib|tofacitinib|mesh-list
92487712|NCT04721821|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92487713|NCT04721821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92487714|NCT04721821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487715|NCT04721821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487716|NCT04721353|Prazosin|prazosin|mesh-list
92487717|NCT04721353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92487718|NCT04721353|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92487719|NCT04721353|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92487720|NCT04721353|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92487721|NCT04721353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92487722|NCT04721353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487723|NCT04721353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487724|NCT04721353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487725|NCT04655391|Decitabine|decitabine|mesh-list
92487726|NCT04655391|Venetoclax|venetoclax|mesh-list
92487727|NCT04655391|Ivosidenib|ivosidenib|mesh-list
92487728|NCT04655391|Maleic acid|maleic acid|mesh-list
92487729|NCT04655391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92487730|NCT04655391|Antimetabolites|antimetabolites|mesh-ancestor
92487731|NCT04655391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487732|NCT04655391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487733|NCT04655391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487734|NCT04609098|Piperaquine|piperaquine|mesh-list
92487735|NCT04609098|Artenimol|artenimol|mesh-list
92487736|NCT04609098|Tafenoquine|tafenoquine|mesh-list
92487737|NCT04609098|Antimalarials|antimalarials|mesh-ancestor
92487738|NCT04609098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92487739|NCT04609098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92487740|NCT04609098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487741|NCT04605614|Copper|copper|mesh-list
92487742|NCT04605614|Pembrolizumab|pembrolizumab|mesh-list
92487743|NCT04605614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487744|NCT04605614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487745|NCT04605614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92487746|NCT04605614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487747|NCT04605614|Trace Elements|trace elements|mesh-ancestor
92487748|NCT04605614|Micronutrients|micronutrients|mesh-ancestor
92487749|NCT04605614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487750|NCT04475016|Paclitaxel|paclitaxel|mesh-list
92487751|NCT04475016|Ifosfamide|ifosfamide|mesh-list
92487752|NCT04475016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92487753|NCT04475016|Nimotuzumab|nimotuzumab|mesh-list
92487754|NCT04475016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92487755|NCT04475016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487756|NCT04475016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92487757|NCT04475016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92487758|NCT04475016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92487759|NCT04475016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487760|NCT04475016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92487762|NCT04475016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487763|NCT04321551|Letrozole|letrozole|mesh-list
92487764|NCT04321551|Methyltestosterone|methyltestosterone|mesh-list
92487765|NCT04321551|Testosterone|testosterone|mesh-list
92487766|NCT04321551|Testosterone undecanoate|testosterone undecanoate|mesh-list
92487767|NCT04321551|Testosterone enanthate|testosterone enanthate|mesh-list
92487768|NCT04321551|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92487769|NCT04321551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487770|NCT04321551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92487771|NCT04321551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92487772|NCT04321551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487773|NCT04321551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487774|NCT04321551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92487775|NCT04321551|Hormone Antagonists|hormone antagonists|mesh-ancestor
92487776|NCT04321551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487777|NCT04321551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487778|NCT04321551|Androgens|androgens|mesh-ancestor
92487779|NCT04321551|Hormones|hormones|mesh-ancestor
92487780|NCT04321551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92487781|NCT04321551|Anabolic Agents|anabolic agents|mesh-ancestor
92487782|NCT04174781|Immunomodulating Agents|immunomodulating agents|mesh-list
92487783|NCT04174781|Immunologic Factors|immunologic factors|mesh-ancestor
92487784|NCT04174781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487785|NCT04074460|Propofol|propofol|mesh-list
92487786|NCT04074460|Sevoflurane|sevoflurane|mesh-list
92487787|NCT04074460|Desflurane|desflurane|mesh-list
92487788|NCT04074460|Isoflurane|isoflurane|mesh-list
92487789|NCT04074460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92487790|NCT04074460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487791|NCT04074460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487792|NCT04074460|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92487793|NCT04074460|Anesthetics, General|anesthetics, general|mesh-ancestor
92487794|NCT04074460|Anesthetics|anesthetics|mesh-ancestor
92487795|NCT04074460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92487796|NCT04074460|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92487797|NCT03817125|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92487798|NCT03817125|Vancomycin|vancomycin|mesh-list
92487799|NCT03817125|Nivolumab|nivolumab|mesh-list
92487800|NCT03817125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487801|NCT03817125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487802|NCT03817125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92487803|NCT03817125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487804|NCT03817125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487805|NCT03703102|KHK4083|khk4083|mesh-list
92487806|NCT03703102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92487807|NCT03581370|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92487808|NCT03581370|Cephalosporins|cephalosporins|mesh-list
92487809|NCT03581370|Penicillanic Acid|penicillanic acid|mesh-list
92487810|NCT03581370|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92487811|NCT03581370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487812|NCT03581370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92487813|NCT03581370|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92487814|NCT03581370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487815|NCT03581370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487816|NCT03568604|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92487817|NCT03568604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92487818|NCT03568604|Immunologic Factors|immunologic factors|mesh-ancestor
92487819|NCT03568604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487820|NCT03539055|Dabigatran|dabigatran|mesh-list
92487821|NCT03539055|Antithrombins|antithrombins|mesh-ancestor
92487822|NCT03539055|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92487823|NCT03539055|Protease Inhibitors|protease inhibitors|mesh-ancestor
92487824|NCT03539055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487825|NCT03539055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487826|NCT03539055|Anticoagulants|anticoagulants|mesh-ancestor
92487827|NCT03485534|Tenofovir|tenofovir|mesh-list
92487828|NCT03485534|Antiviral Agents|antiviral agents|mesh-ancestor
92487829|NCT03485534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487830|NCT03485534|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92487831|NCT03485534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92487832|NCT03485534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487833|NCT03485534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487834|NCT03485534|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92487835|NCT03485534|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92487837|NCT03427736|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92487838|NCT03427736|Ketamine|ketamine|mesh-list
92487839|NCT03427736|Morphine|morphine|mesh-list
92487840|NCT03427736|Oxycodone|oxycodone|mesh-list
92487841|NCT03427736|Hydromorphone|hydromorphone|mesh-list
92487842|NCT03427736|Analgesics|analgesics|mesh-ancestor
92487843|NCT03427736|Sensory System Agents|sensory system agents|mesh-ancestor
92487844|NCT03427736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487845|NCT03427736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487846|NCT03427736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92487847|NCT03427736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92487848|NCT03427736|Anesthetics, General|anesthetics, general|mesh-ancestor
92487849|NCT03427736|Anesthetics|anesthetics|mesh-ancestor
92487850|NCT03427736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487851|NCT03427736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92487852|NCT03427736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92487853|NCT03427736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487854|NCT03427736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487855|NCT03427736|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92487856|NCT03427736|Narcotics|narcotics|mesh-ancestor
92487857|NCT03427736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92704592|NCT02203643|Cyclophosphamide|cyclophosphamide|mesh-list
92487858|NCT03427736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92487859|NCT03427736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92487860|NCT03427736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92487861|NCT03427736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92487862|NCT03427736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487863|NCT03395704|Hepcidins|hepcidins|mesh-list
92487864|NCT03395704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92487865|NCT03246503|Bilirubin|bilirubin|mesh-list
92487866|NCT03246503|Antioxidants|antioxidants|mesh-ancestor
92487867|NCT03246503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487868|NCT03246503|Protective Agents|protective agents|mesh-ancestor
92487869|NCT03246503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487870|NCT03091881|Granisetron|granisetron|mesh-list
92487871|NCT03091881|Antiemetics|antiemetics|mesh-ancestor
92487872|NCT03091881|Autonomic Agents|autonomic agents|mesh-ancestor
92487873|NCT03091881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487874|NCT03091881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487875|NCT03091881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92487876|NCT03091881|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92487877|NCT03091881|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92487878|NCT03091881|Serotonin Agents|serotonin agents|mesh-ancestor
92487879|NCT03091881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487880|NCT03091881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487881|NCT02897063|Midodrine|midodrine|mesh-list
92487882|NCT02897063|Droxidopa|droxidopa|mesh-list
92487883|NCT02897063|Sympathomimetics|sympathomimetics|mesh-ancestor
92487884|NCT02897063|Autonomic Agents|autonomic agents|mesh-ancestor
92487885|NCT02897063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487886|NCT02897063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487887|NCT02897063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92487888|NCT02897063|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92487889|NCT02897063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92487890|NCT02897063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92487891|NCT02897063|Adrenergic Agents|adrenergic agents|mesh-ancestor
92406639|NCT01440400|Anesthetics|anesthetics|mesh-list
92487892|NCT02897063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487893|NCT02897063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487894|NCT02897063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92487895|NCT02897063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92487897|NCT02864368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92487898|NCT02864368|Alkylating Agents|alkylating agents|mesh-ancestor
92487899|NCT02864368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487900|NCT02864368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487901|NCT02856698|Midazolam|midazolam|mesh-list
92487902|NCT02856698|Morphine|morphine|mesh-list
92487903|NCT02856698|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92487904|NCT02856698|Narcotics|narcotics|mesh-ancestor
92487905|NCT02856698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487906|NCT02856698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487907|NCT02856698|Analgesics|analgesics|mesh-ancestor
92487908|NCT02856698|Sensory System Agents|sensory system agents|mesh-ancestor
92487909|NCT02856698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487910|NCT02856698|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92487911|NCT02856698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92487912|NCT02856698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92487913|NCT02856698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92487914|NCT02856698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92487915|NCT02856698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92487916|NCT02856698|Anesthetics, General|anesthetics, general|mesh-ancestor
92487917|NCT02856698|Anesthetics|anesthetics|mesh-ancestor
92487918|NCT02856698|GABA Modulators|gaba modulators|mesh-ancestor
92487919|NCT02856698|GABA Agents|gaba agents|mesh-ancestor
92487920|NCT02856698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487921|NCT02856698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487922|NCT02793375|Montelukast|montelukast|mesh-list
92487923|NCT02793375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92487924|NCT02793375|Respiratory System Agents|respiratory system agents|mesh-ancestor
92487925|NCT02793375|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92487926|NCT02793375|Hormone Antagonists|hormone antagonists|mesh-ancestor
92487927|NCT02793375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92487928|NCT02793375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487929|NCT02793375|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92487930|NCT02793375|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92487931|NCT02793375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487932|NCT02625610|Leucovorin|leucovorin|mesh-list
92487933|NCT02625610|Fluorouracil|fluorouracil|mesh-list
92487934|NCT02625610|Capecitabine|capecitabine|mesh-list
92487935|NCT02625610|Oxaliplatin|oxaliplatin|mesh-list
92487936|NCT02625610|Avelumab|avelumab|mesh-list
92487937|NCT02625610|Levoleucovorin|levoleucovorin|mesh-list
92487938|NCT02625610|Antimetabolites|antimetabolites|mesh-ancestor
92487939|NCT02625610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487940|NCT02625610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92487941|NCT02625610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487942|NCT02625610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92487943|NCT02625610|Immunologic Factors|immunologic factors|mesh-ancestor
92487944|NCT02625610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487945|NCT02625610|Antidotes|antidotes|mesh-ancestor
92487946|NCT02625610|Protective Agents|protective agents|mesh-ancestor
92487947|NCT02625610|Vitamin B Complex|vitamin b complex|mesh-ancestor
92487948|NCT02625610|Vitamins|vitamins|mesh-ancestor
92487949|NCT02625610|Micronutrients|micronutrients|mesh-ancestor
92487950|NCT02625610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92487951|NCT02515591|Dimercaprol|dimercaprol|mesh-list
92487952|NCT02515591|Chelating Agents|chelating agents|mesh-ancestor
92487953|NCT02515591|Sequestering Agents|sequestering agents|mesh-ancestor
92487954|NCT02515591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487955|NCT02514447|Topotecan|topotecan|mesh-list
92487956|NCT02514447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92487957|NCT02514447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92487958|NCT02514447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487959|NCT02514447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487960|NCT02514447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487962|NCT02257346|Anesthetics, Local|anesthetics, local|mesh-ancestor
92487963|NCT02257346|Anesthetics|anesthetics|mesh-ancestor
92487964|NCT02257346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92349286|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
92487965|NCT02257346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487966|NCT02257346|Sensory System Agents|sensory system agents|mesh-ancestor
92487967|NCT02257346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92487968|NCT02257346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92487969|NCT02257346|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92487970|NCT02257346|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92487971|NCT02257346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92487972|NCT02257346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487973|NCT02167477|Pyrithione zinc|pyrithione zinc|mesh-list
92487974|NCT02167477|Keratolytic Agents|keratolytic agents|mesh-ancestor
92487975|NCT02167477|Dermatologic Agents|dermatologic agents|mesh-ancestor
92487976|NCT01618357|Veliparib|veliparib|mesh-list
92487977|NCT01618357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92487978|NCT01618357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92487979|NCT01618357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487980|NCT01618357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92487981|NCT00712322|Darifenacin|darifenacin|mesh-list
92487982|NCT00712322|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92487983|NCT00712322|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92487984|NCT00712322|Cholinergic Agents|cholinergic agents|mesh-ancestor
92487985|NCT00712322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92487986|NCT00712322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487987|NCT00712322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92487988|NCT00712322|Urological Agents|urological agents|mesh-ancestor
92487990|NCT00323856|Coagulants|coagulants|mesh-ancestor
92487991|NCT05415150|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92487992|NCT05415150|Eptifibatide|eptifibatide|mesh-list
92487993|NCT05415150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92487994|NCT05415150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92487995|NCT05415150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92487996|NCT05414942|Analgesics, Opioid|analgesics, opioid|mesh-list
92487997|NCT05414942|Narcotics|narcotics|mesh-ancestor
92487998|NCT05414942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92487999|NCT05414942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488000|NCT05414942|Analgesics|analgesics|mesh-ancestor
92488001|NCT05414942|Sensory System Agents|sensory system agents|mesh-ancestor
92488002|NCT05414942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488003|NCT05414721|Anesthetics|anesthetics|mesh-list
92488004|NCT05414721|Desflurane|desflurane|mesh-list
92488005|NCT05414721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488006|NCT05414721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488007|NCT05414721|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92488008|NCT05414721|Anesthetics, General|anesthetics, general|mesh-ancestor
92488009|NCT05414669|Allopurinol|allopurinol|mesh-list
92488010|NCT05414669|Antimetabolites|antimetabolites|mesh-ancestor
92488011|NCT05414669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488012|NCT05414669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488013|NCT05414669|Gout Suppressants|gout suppressants|mesh-ancestor
92488014|NCT05414669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488015|NCT05414669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92488016|NCT05414669|Antioxidants|antioxidants|mesh-ancestor
92488017|NCT05414669|Protective Agents|protective agents|mesh-ancestor
92488018|NCT05414669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488019|NCT05414474|Ascorbic Acid|ascorbic acid|mesh-list
92488020|NCT05414474|Antioxidants|antioxidants|mesh-ancestor
92488021|NCT05414474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488022|NCT05414474|Protective Agents|protective agents|mesh-ancestor
92488023|NCT05414474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488024|NCT05414474|Vitamins|vitamins|mesh-ancestor
92488025|NCT05414474|Micronutrients|micronutrients|mesh-ancestor
92488026|NCT05414292|Sirolimus|sirolimus|mesh-list
92488027|NCT05414292|Temsirolimus|temsirolimus|mesh-list
92488028|NCT05414292|MTOR Inhibitors|mtor inhibitors|mesh-list
92488029|NCT05414292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488030|NCT05414292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488031|NCT05414292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92488032|NCT05414292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488033|NCT05414292|Antifungal Agents|antifungal agents|mesh-ancestor
92488034|NCT05414292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92488035|NCT05414292|Immunologic Factors|immunologic factors|mesh-ancestor
92488036|NCT05414292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488037|NCT05414292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406795|NCT01441232|Incretins|incretins|mesh-ancestor
92488038|NCT05414292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488039|NCT05414292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488041|NCT05414149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92488042|NCT05414149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92488043|NCT05414149|Growth Substances|growth substances|mesh-ancestor
92488044|NCT05414149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488045|NCT05414149|Growth Inhibitors|growth inhibitors|mesh-ancestor
92488046|NCT05414149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488047|NCT05413902|Acetaminophen|acetaminophen|mesh-list
92488048|NCT05413902|Methylprednisolone|methylprednisolone|mesh-list
92488049|NCT05413902|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92488050|NCT05413902|Lidocaine|lidocaine|mesh-list
92488051|NCT05413902|Epinephrine|epinephrine|mesh-list
92488052|NCT05413902|Morphine|morphine|mesh-list
92488053|NCT05413902|Narcotics|narcotics|mesh-list
92488054|NCT05413902|Gabapentin|gabapentin|mesh-list
92488055|NCT05413902|Orphenadrine|orphenadrine|mesh-list
92488056|NCT05413902|Bupivacaine|bupivacaine|mesh-list
92488057|NCT05413902|Anesthetics, Local|anesthetics, local|mesh-ancestor
92488058|NCT05413902|Anesthetics|anesthetics|mesh-ancestor
92488059|NCT05413902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488060|NCT05413902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488061|NCT05413902|Sensory System Agents|sensory system agents|mesh-ancestor
92488062|NCT05413902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488063|NCT05413902|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92488064|NCT05413902|Analgesics|analgesics|mesh-ancestor
92488065|NCT05413902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488066|NCT05413902|Antipyretics|antipyretics|mesh-ancestor
92488067|NCT05413902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488068|NCT05413902|Antiemetics|antiemetics|mesh-ancestor
92488069|NCT05413902|Autonomic Agents|autonomic agents|mesh-ancestor
92488070|NCT05413902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488071|NCT05413902|Glucocorticoids|glucocorticoids|mesh-ancestor
92488072|NCT05413902|Hormones|hormones|mesh-ancestor
92488073|NCT05413902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488074|NCT05413902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92488075|NCT05413902|Protective Agents|protective agents|mesh-ancestor
92488076|NCT05413902|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92488077|NCT05413902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92488078|NCT05413902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92488079|NCT05413902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488080|NCT05413902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488081|NCT05413902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92488082|NCT05413902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92212996|NCT02240641|Lacidipine|lacidipine|mesh-list
92488083|NCT05413902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92488084|NCT05413902|Respiratory System Agents|respiratory system agents|mesh-ancestor
92488085|NCT05413902|Mydriatics|mydriatics|mesh-ancestor
92488086|NCT05413902|Sympathomimetics|sympathomimetics|mesh-ancestor
92488087|NCT05413902|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92488089|NCT05413902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92488090|NCT05413902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92488091|NCT05413902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92488092|NCT05413902|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92488093|NCT05413902|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92488094|NCT05413902|Antimanic Agents|antimanic agents|mesh-ancestor
92488095|NCT05413902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92488096|NCT05413902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92488097|NCT05413902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92488098|NCT05413902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488099|NCT05413902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92488100|NCT05413902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488101|NCT05413902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92488102|NCT05413902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488103|NCT05413902|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92488104|NCT05413902|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92488105|NCT05413902|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92488106|NCT05413902|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92488107|NCT05413902|Parasympatholytics|parasympatholytics|mesh-ancestor
92488108|NCT05413902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92488109|NCT05413902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92488110|NCT05413902|Cholinergic Agents|cholinergic agents|mesh-ancestor
92488111|NCT05413902|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
92488112|NCT05413902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92488113|NCT05413746|Antioxidants|antioxidants|mesh-list
92488114|NCT05413746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488115|NCT05413746|Protective Agents|protective agents|mesh-ancestor
92488116|NCT05413746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488117|NCT05409365|Antibodies|antibodies|mesh-list
92488118|NCT05409365|Immunoglobulins|immunoglobulins|mesh-list
92488119|NCT05409365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92488120|NCT05409365|Immunologic Factors|immunologic factors|mesh-ancestor
92488121|NCT05409365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488122|NCT05397587|Vaccines|vaccines|mesh-list
92488123|NCT05397587|Immunologic Factors|immunologic factors|mesh-ancestor
92488124|NCT05397587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488125|NCT05378880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92488126|NCT05378880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488127|NCT05352178|Ascorbic Acid|ascorbic acid|mesh-list
92488128|NCT05352178|Methyltestosterone|methyltestosterone|mesh-list
92488129|NCT05352178|Androgens|androgens|mesh-list
92488130|NCT05352178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92488131|NCT05352178|Hormones|hormones|mesh-ancestor
92488132|NCT05352178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488133|NCT05352178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488134|NCT05352178|Antioxidants|antioxidants|mesh-ancestor
92488135|NCT05352178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488136|NCT05352178|Protective Agents|protective agents|mesh-ancestor
92488137|NCT05352178|Vitamins|vitamins|mesh-ancestor
92488138|NCT05352178|Micronutrients|micronutrients|mesh-ancestor
92488139|NCT05352178|Estrogens|estrogens|mesh-ancestor
92488140|NCT05352178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488141|NCT05352178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488142|NCT05352178|Anabolic Agents|anabolic agents|mesh-ancestor
92488143|NCT05328141|Ascorbic Acid|ascorbic acid|mesh-list
92488144|NCT05328141|Antioxidants|antioxidants|mesh-ancestor
92488145|NCT05328141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488146|NCT05328141|Protective Agents|protective agents|mesh-ancestor
92488147|NCT05328141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488148|NCT05328141|Vitamins|vitamins|mesh-ancestor
92488149|NCT05328141|Micronutrients|micronutrients|mesh-ancestor
92488150|NCT05310916|Dapagliflozin|dapagliflozin|mesh-list
92488151|NCT05310916|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92488152|NCT05310916|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92488153|NCT05310916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488154|NCT05310916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488155|NCT05251493|Iron|iron|mesh-list
92488156|NCT05251493|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92488157|NCT05251493|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92488158|NCT05251493|Trace Elements|trace elements|mesh-ancestor
92488159|NCT05251493|Micronutrients|micronutrients|mesh-ancestor
92488160|NCT05251493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488161|NCT05251493|Hematinics|hematinics|mesh-ancestor
92488162|NCT05233709|Fesoterodine|fesoterodine|mesh-list
92488163|NCT05233709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92488164|NCT05233709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92488165|NCT05233709|Cholinergic Agents|cholinergic agents|mesh-ancestor
92488166|NCT05233709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488167|NCT05233709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488168|NCT05233709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488169|NCT05233709|Urological Agents|urological agents|mesh-ancestor
92488170|NCT05173896|Tadalafil|tadalafil|mesh-list
92488171|NCT05173896|Vasodilator Agents|vasodilator agents|mesh-ancestor
92488172|NCT05173896|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92488173|NCT05173896|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92488174|NCT05173896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488175|NCT05173896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488176|NCT05173896|Urological Agents|urological agents|mesh-ancestor
92488177|NCT05150236|Nivolumab|nivolumab|mesh-list
92488178|NCT05150236|Ipilimumab|ipilimumab|mesh-list
92488179|NCT05150236|177Lu-PSMA-617|177lu-psma-617|mesh-list
92488180|NCT05150236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488181|NCT05150236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488182|NCT05150236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92488183|NCT05150236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488184|NCT05150236|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92488185|NCT05111821|Deferiprone|deferiprone|mesh-list
92488186|NCT05111821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92488187|NCT05111821|Chelating Agents|chelating agents|mesh-ancestor
92488188|NCT05111821|Sequestering Agents|sequestering agents|mesh-ancestor
92488189|NCT05111821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488190|NCT05105282|Anesthetics|anesthetics|mesh-list
92488191|NCT05105282|Anesthetics, Local|anesthetics, local|mesh-list
92488192|NCT05105282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488193|NCT05105282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488194|NCT05105282|Sensory System Agents|sensory system agents|mesh-ancestor
92488195|NCT05105282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488196|NCT05005455|Bevacizumab|bevacizumab|mesh-list
92488197|NCT05005455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488198|NCT05005455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488199|NCT05005455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92488200|NCT05005455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92488201|NCT05005455|Growth Substances|growth substances|mesh-ancestor
92488202|NCT05005455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488203|NCT05005455|Growth Inhibitors|growth inhibitors|mesh-ancestor
92488204|NCT04742010|Zoledronic Acid|zoledronic acid|mesh-list
92488205|NCT04742010|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92488206|NCT04742010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488207|NCT04641234|Aflibercept|aflibercept|mesh-list
92488208|NCT04641234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92488209|NCT04641234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92488210|NCT04641234|Growth Substances|growth substances|mesh-ancestor
92488211|NCT04641234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488212|NCT04641234|Growth Inhibitors|growth inhibitors|mesh-ancestor
92488213|NCT04641234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488214|NCT04636034|Anesthetics|anesthetics|mesh-list
92488215|NCT04636034|Anesthetics, Local|anesthetics, local|mesh-list
92488216|NCT04636034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488217|NCT04636034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488218|NCT04636034|Sensory System Agents|sensory system agents|mesh-ancestor
92488219|NCT04636034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488220|NCT04524663|Camostat|camostat|mesh-list
92488221|NCT04524663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92488222|NCT04524663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488223|NCT04524663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488224|NCT04524663|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92488225|NCT04524663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92488226|NCT04435795|Ciclesonide|ciclesonide|mesh-list
92488227|NCT04435795|Glucocorticoids|glucocorticoids|mesh-ancestor
92488228|NCT04435795|Hormones|hormones|mesh-ancestor
92488229|NCT04435795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488230|NCT04435795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488231|NCT04435795|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92488232|NCT04350593|Dapagliflozin|dapagliflozin|mesh-list
92488233|NCT04350593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92488234|NCT04350593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488235|NCT04350593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92488236|NCT04350593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488237|NCT04222283|Emtricitabine|emtricitabine|mesh-list
92488238|NCT04222283|Antiviral Agents|antiviral agents|mesh-ancestor
92488239|NCT04222283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488240|NCT04222283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92488241|NCT04222283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92488242|NCT04222283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488243|NCT04222283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488244|NCT04222283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92488245|NCT04222283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92488246|NCT04131504|Adalimumab|adalimumab|mesh-list
92488247|NCT04131504|Infliximab|infliximab|mesh-list
92488248|NCT04131504|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92488249|NCT04131504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488250|NCT04131504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488251|NCT04131504|Dermatologic Agents|dermatologic agents|mesh-ancestor
92488252|NCT04131504|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488253|NCT04070352|Fidaxomicin|fidaxomicin|mesh-list
92488254|NCT04070352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488255|NCT04070352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488256|NCT04065152|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92488257|NCT04065152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488258|NCT04065152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488259|NCT03962998|Lactulose|lactulose|mesh-list
92488260|NCT03962998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488261|NCT03926143|Maytansine|maytansine|mesh-list
92488262|NCT03926143|Tubulin Modulators|tubulin modulators|mesh-list
92488263|NCT03926143|Anetumab ravtansine|anetumab ravtansine|mesh-list
92488264|NCT03926143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92488265|NCT03926143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488266|NCT03926143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92488267|NCT03926143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92488268|NCT03926143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488269|NCT03926143|Immunoconjugates|immunoconjugates|mesh-ancestor
92488270|NCT03926143|Immunologic Factors|immunologic factors|mesh-ancestor
92488271|NCT03926143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488272|NCT03859635|Bupivacaine|bupivacaine|mesh-list
92488273|NCT03859635|Anesthetics, Local|anesthetics, local|mesh-ancestor
92488274|NCT03859635|Anesthetics|anesthetics|mesh-ancestor
92488275|NCT03859635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488276|NCT03859635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488277|NCT03859635|Sensory System Agents|sensory system agents|mesh-ancestor
92488278|NCT03859635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488279|NCT03783013|Lycopene|lycopene|mesh-list
92488280|NCT03783013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488281|NCT03783013|Antioxidants|antioxidants|mesh-ancestor
92488282|NCT03783013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488283|NCT03783013|Protective Agents|protective agents|mesh-ancestor
92488284|NCT03783013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488285|NCT03783013|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92488286|NCT03783013|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92488287|NCT03783013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488288|NCT03726229|Cholic Acids|cholic acids|mesh-list
92488289|NCT03726229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488290|NCT03712228|Antibodies|antibodies|mesh-list
92488291|NCT03712228|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92488292|NCT03712228|Immunologic Factors|immunologic factors|mesh-ancestor
92488293|NCT03712228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488294|NCT03626922|Folic Acid|folic acid|mesh-list
92488295|NCT03626922|Vitamin B 12|vitamin b 12|mesh-list
92488296|NCT03626922|Dexamethasone|dexamethasone|mesh-list
92488297|NCT03626922|Pembrolizumab|pembrolizumab|mesh-list
92488298|NCT03626922|Oxaliplatin|oxaliplatin|mesh-list
92488299|NCT03626922|Pemetrexed|pemetrexed|mesh-list
92488300|NCT03626922|Vitamins|vitamins|mesh-ancestor
92488301|NCT03626922|Micronutrients|micronutrients|mesh-ancestor
92488302|NCT03626922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488303|NCT03626922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488304|NCT03626922|Antiemetics|antiemetics|mesh-ancestor
92488305|NCT03626922|Autonomic Agents|autonomic agents|mesh-ancestor
92488306|NCT03626922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488307|NCT03626922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488308|NCT03626922|Glucocorticoids|glucocorticoids|mesh-ancestor
92488309|NCT03626922|Hormones|hormones|mesh-ancestor
92488310|NCT03626922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488311|NCT03626922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488312|NCT03626922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488313|NCT03626922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488314|NCT03626922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92488315|NCT03626922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488316|NCT03626922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488317|NCT03626922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92488318|NCT03626922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92488319|NCT03626922|Hematinics|hematinics|mesh-ancestor
92488320|NCT03626922|Vitamin B Complex|vitamin b complex|mesh-ancestor
92488321|NCT03600818|Prednisone|prednisone|mesh-list
92488322|NCT03600818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488323|NCT03600818|Glucocorticoids|glucocorticoids|mesh-ancestor
92488324|NCT03600818|Hormones|hormones|mesh-ancestor
92488325|NCT03600818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488326|NCT03600818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488327|NCT03600818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488328|NCT03600818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488329|NCT03578276|Gatifloxacin|gatifloxacin|mesh-list
92488330|NCT03578276|Prednisolone|prednisolone|mesh-list
92488331|NCT03578276|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92488332|NCT03578276|Methylprednisolone|methylprednisolone|mesh-list
92488333|NCT03578276|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92488334|NCT03578276|Prednisolone acetate|prednisolone acetate|mesh-list
92488336|NCT03578276|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92488337|NCT03578276|Prednisolone phosphate|prednisolone phosphate|mesh-list
92488338|NCT03578276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488339|NCT03578276|Glucocorticoids|glucocorticoids|mesh-ancestor
92488340|NCT03578276|Hormones|hormones|mesh-ancestor
92488341|NCT03578276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488342|NCT03578276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488343|NCT03578276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488344|NCT03578276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488345|NCT03578276|Antiemetics|antiemetics|mesh-ancestor
92488346|NCT03578276|Autonomic Agents|autonomic agents|mesh-ancestor
92488347|NCT03578276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488348|NCT03578276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488349|NCT03578276|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92488350|NCT03578276|Protective Agents|protective agents|mesh-ancestor
92488351|NCT03578276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92488352|NCT03578276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488353|NCT03578276|Analgesics|analgesics|mesh-ancestor
92488354|NCT03578276|Sensory System Agents|sensory system agents|mesh-ancestor
92488355|NCT03578276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488356|NCT03578276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488357|NCT03578276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488358|NCT03578276|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92488359|NCT03578276|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92488360|NCT03578276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92488361|NCT03578276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92488362|NCT03578276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488363|NCT03578276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488364|NCT03532477|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92488365|NCT03532477|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92488366|NCT03532477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92488367|NCT03532477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488368|NCT03532477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488369|NCT03532477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488370|NCT03532477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488371|NCT03532477|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92488372|NCT03532477|Antidepressive Agents|antidepressive agents|mesh-ancestor
92488373|NCT03532477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92488374|NCT03491267|Tretinoin|tretinoin|mesh-list
92488375|NCT03491267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488376|NCT03491267|Keratolytic Agents|keratolytic agents|mesh-ancestor
92488377|NCT03491267|Dermatologic Agents|dermatologic agents|mesh-ancestor
92488378|NCT03174184|Amoxicillin|amoxicillin|mesh-list
92488379|NCT03174184|Rifampin|rifampin|mesh-list
92488380|NCT03174184|Meropenem|meropenem|mesh-list
92488381|NCT03174184|Clavulanic Acid|clavulanic acid|mesh-list
92488382|NCT03174184|Clavulanic Acids|clavulanic acids|mesh-list
92488383|NCT03174184|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92488384|NCT03174184|Rifamycins|rifamycins|mesh-list
92488385|NCT03174184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488386|NCT03174184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488387|NCT03174184|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92488388|NCT03174184|Antitubercular Agents|antitubercular agents|mesh-ancestor
92488389|NCT03174184|Leprostatic Agents|leprostatic agents|mesh-ancestor
92488390|NCT03174184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92488391|NCT03174184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488392|NCT03174184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488393|NCT03174184|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92488394|NCT03174184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92488395|NCT03174184|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92488396|NCT03174184|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92488397|NCT03174184|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92488398|NCT03174184|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92488399|NCT03174184|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92488400|NCT03052933|Gemcitabine|gemcitabine|mesh-list
92488401|NCT03052933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92488402|NCT03052933|Antimetabolites|antimetabolites|mesh-ancestor
92488403|NCT03052933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488404|NCT03052933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488405|NCT02959697|Lidocaine|lidocaine|mesh-list
92488406|NCT02959697|Anesthetics, Local|anesthetics, local|mesh-ancestor
92488407|NCT02959697|Anesthetics|anesthetics|mesh-ancestor
92488408|NCT02959697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488409|NCT02959697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488410|NCT02959697|Sensory System Agents|sensory system agents|mesh-ancestor
92488411|NCT02959697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488412|NCT02959697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92488413|NCT02959697|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92488414|NCT02959697|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92488415|NCT02959697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488416|NCT02959697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488417|NCT02900560|Pembrolizumab|pembrolizumab|mesh-list
92488418|NCT02900560|Azacitidine|azacitidine|mesh-list
92488420|NCT02900560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488421|NCT02900560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488422|NCT02900560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92488423|NCT02900560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488424|NCT02900560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92488425|NCT02900560|Antimetabolites|antimetabolites|mesh-ancestor
92488426|NCT02900560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488427|NCT02877550|Venetoclax|venetoclax|mesh-list
92488428|NCT02877550|Obinutuzumab|obinutuzumab|mesh-list
92488429|NCT02877550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488430|NCT02877550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488431|NCT02775812|Pembrolizumab|pembrolizumab|mesh-list
92488432|NCT02775812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488433|NCT02775812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92488434|NCT02775812|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92488435|NCT02775812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488436|NCT02679170|Crizotinib|crizotinib|mesh-list
92488437|NCT02679170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488438|NCT02679170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92488439|NCT02679170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488440|NCT02679170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488441|NCT02518009|Estrogens|estrogens|mesh-list
92488442|NCT02518009|Androgens|androgens|mesh-list
92488443|NCT02518009|Hormones|hormones|mesh-ancestor
92488444|NCT02518009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488445|NCT02518009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488446|NCT02238496|Sirolimus|sirolimus|mesh-list
92488447|NCT02238496|Temsirolimus|temsirolimus|mesh-list
92488448|NCT02238496|MTOR Inhibitors|mtor inhibitors|mesh-list
92488449|NCT02238496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92488450|NCT02238496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488451|NCT02238496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488452|NCT02238496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92488453|NCT02238496|Immunologic Factors|immunologic factors|mesh-ancestor
92488454|NCT02238496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488455|NCT02238496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488456|NCT02238496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488457|NCT02238496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488458|NCT02238496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92488459|NCT02238496|Antifungal Agents|antifungal agents|mesh-ancestor
92488460|NCT02034110|Trametinib|trametinib|mesh-list
92488461|NCT02034110|Dabrafenib|dabrafenib|mesh-list
92488462|NCT02034110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488463|NCT02034110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92488464|NCT02034110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488465|NCT02034110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488466|NCT01968213|Rucaparib|rucaparib|mesh-list
92488467|NCT01968213|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92488468|NCT01968213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488469|NCT01968213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488470|NCT01968213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488471|NCT01503632|Mercaptopurine|mercaptopurine|mesh-list
92488472|NCT01503632|Antimetabolites|antimetabolites|mesh-ancestor
92488473|NCT01503632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488474|NCT01503632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92488475|NCT01503632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488476|NCT01503632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92488477|NCT01503632|Immunologic Factors|immunologic factors|mesh-ancestor
92488478|NCT01503632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488479|NCT01503632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92488481|NCT01498458|Capecitabine|capecitabine|mesh-list
92488482|NCT01498458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92488483|NCT01498458|Antimetabolites|antimetabolites|mesh-ancestor
92488484|NCT01498458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488485|NCT01498458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488486|NCT01427712|Pancrelipase|pancrelipase|mesh-list
92488487|NCT01427712|Pancreatin|pancreatin|mesh-list
92488488|NCT01427712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488489|NCT01369147|Clevidipine|clevidipine|mesh-list
92488490|NCT01369147|Propofol|propofol|mesh-list
92488491|NCT01369147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92488492|NCT01369147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488493|NCT01369147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488494|NCT01369147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92488495|NCT01369147|Anesthetics, General|anesthetics, general|mesh-ancestor
92488496|NCT01369147|Anesthetics|anesthetics|mesh-ancestor
92488497|NCT01369147|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92488498|NCT01369147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488499|NCT01369147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488500|NCT01369147|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92488501|NCT01197066|Certolizumab Pegol|certolizumab pegol|mesh-list
92488502|NCT01197066|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92488503|NCT01197066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488504|NCT01197066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92488505|NCT01197066|Immunologic Factors|immunologic factors|mesh-ancestor
92488506|NCT01197066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488507|NCT01197066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488508|NCT01945840|Hormones|hormones|mesh-list
92488509|NCT01945840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488510|NCT01945840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488512|NCT01945879|Enoxaparin|enoxaparin|mesh-list
92488513|NCT01945879|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92488514|NCT01945879|Tinzaparin|tinzaparin|mesh-list
92488515|NCT01945879|Dalteparin|dalteparin|mesh-list
92488516|NCT01945879|Anticoagulants|anticoagulants|mesh-ancestor
92488517|NCT01945879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92488518|NCT01945879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92488519|NCT01945879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488520|NCT01945892|Dexamethasone|dexamethasone|mesh-list
92488521|NCT01945892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488522|NCT01945892|Antiemetics|antiemetics|mesh-ancestor
92488523|NCT01945892|Autonomic Agents|autonomic agents|mesh-ancestor
92488524|NCT01945892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488525|NCT01945892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488526|NCT01945892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488527|NCT01945892|Glucocorticoids|glucocorticoids|mesh-ancestor
92488528|NCT01945892|Hormones|hormones|mesh-ancestor
92488529|NCT01945892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488530|NCT01945892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488531|NCT01945892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488532|NCT01945957|Oxytocin|oxytocin|mesh-list
92488533|NCT01945957|Oxytocics|oxytocics|mesh-ancestor
92488534|NCT01945957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92488535|NCT01945957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488536|NCT01945983|Norepinephrine|norepinephrine|mesh-list
92213444|NCT01839851|Hormones|hormones|mesh-ancestor
92488537|NCT01945983|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92488538|NCT01945983|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92488539|NCT01945983|Adrenergic Agents|adrenergic agents|mesh-ancestor
92488540|NCT01945983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488541|NCT01945983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488542|NCT01945983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488543|NCT01945983|Sympathomimetics|sympathomimetics|mesh-ancestor
92488544|NCT01945983|Autonomic Agents|autonomic agents|mesh-ancestor
92488545|NCT01945983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488546|NCT01945983|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92488547|NCT01946009|Cidofovir|cidofovir|mesh-list
92488548|NCT01946009|Antiviral Agents|antiviral agents|mesh-ancestor
92488549|NCT01946009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488550|NCT01946009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488551|NCT01946009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488552|NCT01946035|Doxazosin|doxazosin|mesh-list
92488553|NCT01946035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92488554|NCT01946035|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92488555|NCT01946035|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92488556|NCT01946035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92488557|NCT01946035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92488558|NCT01946035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488559|NCT01946035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488560|NCT01946035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488561|NCT01946061|Oxaliplatin|oxaliplatin|mesh-list
92488562|NCT01946061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488563|NCT01946256|Amoxicillin|amoxicillin|mesh-list
92488564|NCT01946256|Erythromycin|erythromycin|mesh-list
92488565|NCT01946256|Erythromycin Estolate|erythromycin estolate|mesh-list
92488566|NCT01946256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92488567|NCT01946256|Erythromycin stearate|erythromycin stearate|mesh-list
92488568|NCT01946256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488569|NCT01946256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488570|NCT01946256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488571|NCT01946256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92488572|NCT01946256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488573|NCT01946256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488574|NCT01946295|Famotidine|famotidine|mesh-list
92488575|NCT01946295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92488576|NCT01946295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488577|NCT01946295|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92488578|NCT01946295|Histamine Antagonists|histamine antagonists|mesh-ancestor
92488579|NCT01946295|Histamine Agents|histamine agents|mesh-ancestor
92488580|NCT01946295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488581|NCT01946295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488582|NCT01946295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488583|NCT01946386|Betamethasone|betamethasone|mesh-list
92488584|NCT01946386|Betamethasone Valerate|betamethasone valerate|mesh-list
92488585|NCT01946386|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92488586|NCT01946386|Betamethasone benzoate|betamethasone benzoate|mesh-list
92488587|NCT01946386|Clobetasol|clobetasol|mesh-list
92488588|NCT01946386|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92488589|NCT01946386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488590|NCT01946386|Glucocorticoids|glucocorticoids|mesh-ancestor
92488591|NCT01946386|Hormones|hormones|mesh-ancestor
92488592|NCT01946386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488593|NCT01946386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488594|NCT01946386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92488595|NCT01946386|Respiratory System Agents|respiratory system agents|mesh-ancestor
92488596|NCT01946399|Dexamethasone|dexamethasone|mesh-list
92488597|NCT01946399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488598|NCT01946399|Antiemetics|antiemetics|mesh-ancestor
92488599|NCT01946399|Autonomic Agents|autonomic agents|mesh-ancestor
92488600|NCT01946399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488601|NCT01946399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488602|NCT01946399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488603|NCT01946399|Glucocorticoids|glucocorticoids|mesh-ancestor
92488604|NCT01946399|Hormones|hormones|mesh-ancestor
92488605|NCT01946399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488606|NCT01946399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488607|NCT01946399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488608|NCT01946555|Fentanyl|fentanyl|mesh-list
92488609|NCT01946555|Morphine|morphine|mesh-list
92488610|NCT01946555|Oxycodone|oxycodone|mesh-list
92488611|NCT01946555|Buprenorphine|buprenorphine|mesh-list
92488612|NCT01946555|Methadone|methadone|mesh-list
92488614|NCT01946555|Tapentadol|tapentadol|mesh-list
92488615|NCT01946555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92488616|NCT01946555|Narcotics|narcotics|mesh-ancestor
92488617|NCT01946555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488618|NCT01946555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488619|NCT01946555|Analgesics|analgesics|mesh-ancestor
92488620|NCT01946555|Sensory System Agents|sensory system agents|mesh-ancestor
92488621|NCT01946555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488622|NCT01946555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92488623|NCT01946555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92488624|NCT01946555|Anesthetics, General|anesthetics, general|mesh-ancestor
92488625|NCT01946555|Anesthetics|anesthetics|mesh-ancestor
92488626|NCT01946555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92488627|NCT01946555|Antitussive Agents|antitussive agents|mesh-ancestor
92488628|NCT01946555|Respiratory System Agents|respiratory system agents|mesh-ancestor
92532086|NCT00050635|Octreotide|octreotide|mesh-list
92488629|NCT01946555|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92488630|NCT01946555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92488631|NCT01946555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488632|NCT01946555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488633|NCT01946555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92349297|NCT01453998|Immunologic Factors|immunologic factors|mesh-ancestor
92488634|NCT01946555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488635|NCT01946568|Dalbavancin|dalbavancin|mesh-list
92488636|NCT01946568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488637|NCT01946568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488638|NCT01946594|Acetaminophen|acetaminophen|mesh-list
92488639|NCT01946594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488640|NCT01946594|Analgesics|analgesics|mesh-ancestor
92488641|NCT01946594|Sensory System Agents|sensory system agents|mesh-ancestor
92488642|NCT01946594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488643|NCT01946594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488644|NCT01946594|Antipyretics|antipyretics|mesh-ancestor
92488646|NCT01946607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92488647|NCT01946607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92488648|NCT01946607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488649|NCT01946607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488650|NCT01946607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488651|NCT01946607|Serotonin Agents|serotonin agents|mesh-ancestor
92488652|NCT01946607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488653|NCT01946607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92488654|NCT01946607|Antidepressive Agents|antidepressive agents|mesh-ancestor
92488655|NCT01946607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92488656|NCT01946620|Formoterol Fumarate|formoterol fumarate|mesh-list
92488657|NCT01946620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92488658|NCT01946620|Autonomic Agents|autonomic agents|mesh-ancestor
92488659|NCT01946620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488660|NCT01946620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488661|NCT01946620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92488662|NCT01946620|Respiratory System Agents|respiratory system agents|mesh-ancestor
92488663|NCT01946620|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92488664|NCT01946620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92488665|NCT01946620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92488666|NCT01946620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92488667|NCT01946620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488668|NCT01946620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488670|NCT01946906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488671|NCT01946906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488672|NCT01946906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488673|NCT01946971|Lansoprazole|lansoprazole|mesh-list
92488674|NCT01946971|Dexlansoprazole|dexlansoprazole|mesh-list
92488675|NCT01946971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92488676|NCT01946971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488677|NCT01946971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92488678|NCT01946971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488679|NCT01946971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488680|NCT01946984|Diclofenac|diclofenac|mesh-list
92488681|NCT01946984|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92488682|NCT01946984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92488683|NCT01946984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488684|NCT01946984|Analgesics|analgesics|mesh-ancestor
92488685|NCT01946984|Sensory System Agents|sensory system agents|mesh-ancestor
92488686|NCT01946984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488687|NCT01946984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488688|NCT01946984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488689|NCT01946984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488690|NCT01946984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92488691|NCT01946984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488692|NCT01946984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488693|NCT01947010|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92488694|NCT01947010|Immunologic Factors|immunologic factors|mesh-ancestor
92488695|NCT01947010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488696|NCT01947062|Cyclophosphamide|cyclophosphamide|mesh-list
92488697|NCT01947062|Cisplatin|cisplatin|mesh-list
92488698|NCT01947062|Etoposide|etoposide|mesh-list
92488699|NCT01947062|Etoposide phosphate|etoposide phosphate|mesh-list
92488700|NCT01947062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92488701|NCT01947062|Immunologic Factors|immunologic factors|mesh-ancestor
92488702|NCT01947062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488704|NCT01947062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92488705|NCT01947062|Alkylating Agents|alkylating agents|mesh-ancestor
92349298|NCT01453998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488706|NCT01947062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488707|NCT01947062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488708|NCT01947062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92488709|NCT01947062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92488710|NCT01947062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92488711|NCT01947062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92488712|NCT01947062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488713|NCT01947114|Ketamine|ketamine|mesh-list
92488714|NCT01947114|Remifentanil|remifentanil|mesh-list
92488715|NCT01947114|Propofol|propofol|mesh-list
92488716|NCT01947114|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92488717|NCT01947114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488718|NCT01947114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488719|NCT01947114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92488720|NCT01947114|Anesthetics, General|anesthetics, general|mesh-ancestor
92488721|NCT01947114|Anesthetics|anesthetics|mesh-ancestor
92488722|NCT01947114|Analgesics|analgesics|mesh-ancestor
92488723|NCT01947114|Sensory System Agents|sensory system agents|mesh-ancestor
92488724|NCT01947114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488725|NCT01947114|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92488726|NCT01947114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92488727|NCT01947114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92488728|NCT01947114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488729|NCT01947114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488730|NCT01947114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92488731|NCT01947114|Narcotics|narcotics|mesh-ancestor
92488732|NCT01947192|Chlorhexidine|chlorhexidine|mesh-list
92488733|NCT01947192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92488734|NCT01947192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488735|NCT01947192|Disinfectants|disinfectants|mesh-ancestor
92488736|NCT01947205|Acetaminophen|acetaminophen|mesh-list
92488737|NCT01947205|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92488738|NCT01947205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488739|NCT01947205|Analgesics|analgesics|mesh-ancestor
92488740|NCT01947205|Sensory System Agents|sensory system agents|mesh-ancestor
92488741|NCT01947205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488742|NCT01947205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488743|NCT01947205|Antipyretics|antipyretics|mesh-ancestor
92488744|NCT01947205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92488745|NCT01947205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488746|NCT01947205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488747|NCT01947309|Lenalidomide|lenalidomide|mesh-list
92488748|NCT01947309|Immunologic Factors|immunologic factors|mesh-ancestor
92488749|NCT01947309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488750|NCT01947309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92488751|NCT01947309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92488752|NCT01947309|Growth Substances|growth substances|mesh-ancestor
92488753|NCT01947309|Growth Inhibitors|growth inhibitors|mesh-ancestor
92488754|NCT01947309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488756|NCT01947465|Immunologic Factors|immunologic factors|mesh-ancestor
92488757|NCT01947465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488758|NCT01947556|Insulin Aspart|insulin aspart|mesh-list
92488759|NCT01947556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92488760|NCT01947556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488761|NCT01947608|Ceritinib|ceritinib|mesh-list
92488762|NCT01947608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488763|NCT01947608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92488764|NCT01947608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488765|NCT01947608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488766|NCT01947660|Anesthetics|anesthetics|mesh-list
92488767|NCT01947660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488768|NCT01947660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488769|NCT01947699|Glyburide|glyburide|mesh-list
92488770|NCT01947699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92488771|NCT01947699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488772|NCT01947777|Rifampin|rifampin|mesh-list
92488773|NCT01947777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92488774|NCT01947777|Antitubercular Agents|antitubercular agents|mesh-ancestor
92488775|NCT01947777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92488776|NCT01947777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92488777|NCT01947777|Leprostatic Agents|leprostatic agents|mesh-ancestor
92349302|NCT01453374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488778|NCT01947777|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92488779|NCT01947777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488780|NCT01947777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488781|NCT01947777|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92488782|NCT01947777|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92488783|NCT01947777|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92488784|NCT01947777|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92488785|NCT01947777|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92488786|NCT01947777|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92488787|NCT01947790|Metformin|metformin|mesh-list
92488788|NCT01947790|Pioglitazone|pioglitazone|mesh-list
92488789|NCT01947790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92488790|NCT01947790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488791|NCT01947803|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92488792|NCT01947803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92488793|NCT01947803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92488794|NCT01947803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488795|NCT01947803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488796|NCT01947803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92488797|NCT01947803|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92488798|NCT01947803|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92488799|NCT01947803|Serotonin Agents|serotonin agents|mesh-ancestor
92488800|NCT01947803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488801|NCT01947803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488802|NCT01947803|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92488803|NCT01947803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92488804|NCT01947803|Dopamine Agents|dopamine agents|mesh-ancestor
92488805|NCT01947920|Tramadol|tramadol|mesh-list
92488806|NCT01947920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92488807|NCT01947920|Narcotics|narcotics|mesh-ancestor
92488808|NCT01947920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488809|NCT01947920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488810|NCT01947920|Analgesics|analgesics|mesh-ancestor
92488811|NCT01947920|Sensory System Agents|sensory system agents|mesh-ancestor
92488812|NCT01947920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488813|NCT01947933|Mirikizumab|mirikizumab|mesh-list
92488814|NCT01947933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92488815|NCT01947933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488816|NCT01947933|Analgesics|analgesics|mesh-ancestor
92488817|NCT01947933|Sensory System Agents|sensory system agents|mesh-ancestor
92488818|NCT01947933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488819|NCT01947933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488820|NCT01947933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488821|NCT01947933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92488822|NCT01947933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92488823|NCT01947933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488824|NCT01947959|Rivaroxaban|rivaroxaban|mesh-list
92488825|NCT01947959|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92488826|NCT01947959|Antithrombins|antithrombins|mesh-ancestor
92488827|NCT01947959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92488828|NCT01947959|Protease Inhibitors|protease inhibitors|mesh-ancestor
92488829|NCT01947959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488830|NCT01947959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488831|NCT01947959|Anticoagulants|anticoagulants|mesh-ancestor
92488832|NCT01947985|Rivaroxaban|rivaroxaban|mesh-list
92488833|NCT01947985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92488834|NCT01947985|Antithrombins|antithrombins|mesh-ancestor
92488835|NCT01947985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92213735|NCT03835871|Beclomethasone|beclomethasone|mesh-list
92488836|NCT01947985|Protease Inhibitors|protease inhibitors|mesh-ancestor
92488837|NCT01947985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488838|NCT01947985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488839|NCT01947985|Anticoagulants|anticoagulants|mesh-ancestor
92488841|NCT01947998|Rivaroxaban|rivaroxaban|mesh-list
92488842|NCT01947998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92488843|NCT01947998|Anticoagulants|anticoagulants|mesh-ancestor
92488844|NCT01947998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92488845|NCT01947998|Antithrombins|antithrombins|mesh-ancestor
92488846|NCT01947998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92488847|NCT01947998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92488848|NCT01947998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488849|NCT01947998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488850|NCT01948011|Racecadotril|racecadotril|mesh-list
92488852|NCT01948011|Antidiarrheals|antidiarrheals|mesh-ancestor
92488853|NCT01948011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92488854|NCT01948011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92488855|NCT01948011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488856|NCT01948011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488857|NCT01948024|Asenapine|asenapine|mesh-list
92488858|NCT01948024|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92488859|NCT01948024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92488860|NCT01948024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488861|NCT01948024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488862|NCT01948024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92488863|NCT01948115|Nitrous Oxide|nitrous oxide|mesh-list
92488864|NCT01948115|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92488865|NCT01948115|Anesthetics, General|anesthetics, general|mesh-ancestor
92488866|NCT01948115|Anesthetics|anesthetics|mesh-ancestor
92488867|NCT01948115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488868|NCT01948115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488869|NCT01948115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488870|NCT01948115|Analgesics|analgesics|mesh-ancestor
92488871|NCT01948115|Sensory System Agents|sensory system agents|mesh-ancestor
92488872|NCT01948115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488873|NCT01948128|Vitamin D|vitamin d|mesh-list
92488874|NCT01948128|Ergocalciferols|ergocalciferols|mesh-list
92488875|NCT01948128|Cholecalciferol|cholecalciferol|mesh-list
92488876|NCT01948128|Vitamins|vitamins|mesh-list
92488877|NCT01948128|Micronutrients|micronutrients|mesh-ancestor
92488878|NCT01948128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488879|NCT01948128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92488880|NCT01948128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92488881|NCT01948232|Perindopril|perindopril|mesh-list
92488882|NCT01948232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92488883|NCT01948232|Protease Inhibitors|protease inhibitors|mesh-ancestor
92488884|NCT01948232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488885|NCT01948232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488886|NCT01948232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92488887|NCT01948336|Dexmedetomidine|dexmedetomidine|mesh-list
92488888|NCT01948336|Ketamine|ketamine|mesh-list
92488889|NCT01948336|Propofol|propofol|mesh-list
92488890|NCT01948336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92488891|NCT01948336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488892|NCT01948336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488893|NCT01948336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92488894|NCT01948336|Analgesics|analgesics|mesh-ancestor
92488895|NCT01948336|Sensory System Agents|sensory system agents|mesh-ancestor
92488896|NCT01948336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488897|NCT01948336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92488898|NCT01948336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92488899|NCT01948336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92488900|NCT01948336|Adrenergic Agents|adrenergic agents|mesh-ancestor
92488901|NCT01948336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488902|NCT01948336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488903|NCT01948336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92488904|NCT01948336|Anesthetics, General|anesthetics, general|mesh-ancestor
92488905|NCT01948336|Anesthetics|anesthetics|mesh-ancestor
92488906|NCT01948336|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92488907|NCT01948336|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92488908|NCT01948336|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92488909|NCT01948362|Sulforaphane|sulforaphane|mesh-list
92488910|NCT01948362|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92488911|NCT01948362|Protective Agents|protective agents|mesh-ancestor
92488912|NCT01948362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488913|NCT01948362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488915|NCT01948401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92488916|NCT01948401|Glucocorticoids|glucocorticoids|mesh-ancestor
92488917|NCT01948401|Hormones|hormones|mesh-ancestor
92488918|NCT01948401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488919|NCT01948401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488920|NCT01948401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92488921|NCT01948401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488922|NCT01948583|Hyaluronic Acid|hyaluronic acid|mesh-list
92488923|NCT01948583|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92488924|NCT01948583|Immunologic Factors|immunologic factors|mesh-ancestor
92488925|NCT01948583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488927|NCT01948583|Protective Agents|protective agents|mesh-ancestor
92488928|NCT01948648|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92488929|NCT01948648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92488930|NCT01948648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92488931|NCT01948648|Antimetabolites|antimetabolites|mesh-ancestor
92488932|NCT01948648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488933|NCT01948648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92488934|NCT01948765|Propofol|propofol|mesh-list
92488935|NCT01948765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92488936|NCT01948765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488937|NCT01948765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488938|NCT01948765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92488939|NCT01948765|Anesthetics, General|anesthetics, general|mesh-ancestor
92488940|NCT01948765|Anesthetics|anesthetics|mesh-ancestor
92488941|NCT01948804|Letrozole|letrozole|mesh-list
92488942|NCT01948804|Clomiphene|clomiphene|mesh-list
92488943|NCT01948804|Cetrorelix|cetrorelix|mesh-list
92488944|NCT01948804|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92488945|NCT01948804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488946|NCT01948804|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92488947|NCT01948804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92488948|NCT01948804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488949|NCT01948804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488950|NCT01948804|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92488951|NCT01948804|Hormone Antagonists|hormone antagonists|mesh-ancestor
92488952|NCT01948804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92488953|NCT01948804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488954|NCT01948804|Hormones|hormones|mesh-ancestor
92488955|NCT01948804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92488956|NCT01948804|Fertility Agents|fertility agents|mesh-ancestor
92488957|NCT01948804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92488958|NCT01948804|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92488959|NCT01948804|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92488960|NCT01948817|Deferasirox|deferasirox|mesh-list
92488961|NCT01948817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92488962|NCT01948817|Chelating Agents|chelating agents|mesh-ancestor
92488963|NCT01948817|Sequestering Agents|sequestering agents|mesh-ancestor
92488964|NCT01948817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488965|NCT01948895|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92488966|NCT01948895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92488967|NCT01948895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92488968|NCT01948895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92488969|NCT01948895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488970|NCT01948895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92488971|NCT01948895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488972|NCT01948895|Antidepressive Agents|antidepressive agents|mesh-ancestor
92488973|NCT01948895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92488974|NCT01948921|Meperidine|meperidine|mesh-list
92488975|NCT01948921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92488976|NCT01948921|Narcotics|narcotics|mesh-ancestor
92488977|NCT01948921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488978|NCT01948921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488979|NCT01948921|Analgesics|analgesics|mesh-ancestor
92488980|NCT01948921|Sensory System Agents|sensory system agents|mesh-ancestor
92488981|NCT01948921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92488982|NCT01948921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92488983|NCT01948960|Everolimus|everolimus|mesh-list
92488984|NCT01948960|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92488985|NCT01948960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92488986|NCT01948960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92488987|NCT01948960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92488988|NCT01948960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92488989|NCT01948960|Immunologic Factors|immunologic factors|mesh-ancestor
92488990|NCT01948960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488991|NCT01948960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92488992|NCT01948999|Anesthetics|anesthetics|mesh-list
92488993|NCT01948999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488994|NCT01948999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488995|NCT01949038|Alprazolam|alprazolam|mesh-list
92488996|NCT01949038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92532090|NCT00050674|Lenograstim|lenograstim|mesh-list
92488997|NCT01949038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92488998|NCT01949038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92488999|NCT01949038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92489000|NCT01949038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92489001|NCT01949038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489002|NCT01949038|GABA Modulators|gaba modulators|mesh-ancestor
92489003|NCT01949038|GABA Agents|gaba agents|mesh-ancestor
92489004|NCT01949038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489005|NCT01949038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489006|NCT01949064|Salicylic Acid|salicylic acid|mesh-list
92489007|NCT01949064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489008|NCT01949064|Antifungal Agents|antifungal agents|mesh-ancestor
92489009|NCT01949064|Keratolytic Agents|keratolytic agents|mesh-ancestor
92489010|NCT01949064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92489011|NCT01949129|Cyclophosphamide|cyclophosphamide|mesh-list
92489012|NCT01949129|Busulfan|busulfan|mesh-list
92489013|NCT01949129|Thiotepa|thiotepa|mesh-list
92489014|NCT01949129|Treosulfan|treosulfan|mesh-list
92489015|NCT01949129|Fludarabine|fludarabine|mesh-list
92489016|NCT01949129|Etoposide|etoposide|mesh-list
92489017|NCT01949129|Thymoglobulin|thymoglobulin|mesh-list
92489018|NCT01949129|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92489019|NCT01949129|Immunoglobulins|immunoglobulins|mesh-list
92489020|NCT01949129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489021|NCT01949129|Immunologic Factors|immunologic factors|mesh-ancestor
92489022|NCT01949129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489023|NCT01949129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489024|NCT01949129|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92489025|NCT01949129|Alkylating Agents|alkylating agents|mesh-ancestor
92489026|NCT01949129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489027|NCT01949129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489028|NCT01949129|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92489029|NCT01949129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92489030|NCT01949129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92489031|NCT01949129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92489032|NCT01949129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489033|NCT01949168|Ribavirin|ribavirin|mesh-list
92489035|NCT01949168|Antimetabolites|antimetabolites|mesh-ancestor
92489036|NCT01949168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489037|NCT01949168|Antiviral Agents|antiviral agents|mesh-ancestor
92489038|NCT01949168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489039|NCT01949233|Doxycycline|doxycycline|mesh-list
92489040|NCT01949233|Irbesartan|irbesartan|mesh-list
92489041|NCT01949233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92489042|NCT01949233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489043|NCT01949233|Antimalarials|antimalarials|mesh-ancestor
92489044|NCT01949233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92489045|NCT01949233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92489046|NCT01949233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92489047|NCT01949233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92489048|NCT01949233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92489049|NCT01949233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489050|NCT01949363|Cefixime|cefixime|mesh-list
92489051|NCT01949363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92489052|NCT01949363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489053|NCT01949454|Fluorometholone|fluorometholone|mesh-list
92489054|NCT01949454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92489055|NCT01949454|Lubricant Eye Drops|lubricant eye drops|mesh-list
92489056|NCT01949454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92489057|NCT01949454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489058|NCT01949454|Glucocorticoids|glucocorticoids|mesh-ancestor
92489059|NCT01949454|Hormones|hormones|mesh-ancestor
92489060|NCT01949454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489061|NCT01949454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213965|NCT01721915|Vitamin D|vitamin d|mesh-list
92489062|NCT01949454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92489063|NCT01949519|Lycopene|lycopene|mesh-list
92489064|NCT01949519|Docetaxel|docetaxel|mesh-list
92489065|NCT01949519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489066|NCT01949519|Tubulin Modulators|tubulin modulators|mesh-ancestor
92489067|NCT01949519|Antimitotic Agents|antimitotic agents|mesh-ancestor
92489068|NCT01949519|Mitosis Modulators|mitosis modulators|mesh-ancestor
92489069|NCT01949519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489070|NCT01949519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489071|NCT01949519|Antioxidants|antioxidants|mesh-ancestor
92489072|NCT01949519|Protective Agents|protective agents|mesh-ancestor
92489073|NCT01949519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489074|NCT01949519|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92489075|NCT01949519|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92489076|NCT01949571|Mirtazapine|mirtazapine|mesh-list
92489077|NCT01949571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92489078|NCT01949571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489079|NCT01949571|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92489080|NCT01949571|Histamine Antagonists|histamine antagonists|mesh-ancestor
92489081|NCT01949571|Histamine Agents|histamine agents|mesh-ancestor
92489082|NCT01949571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489083|NCT01949571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489084|NCT01949571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489085|NCT01949571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92489086|NCT01949571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92489087|NCT01949571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489088|NCT01949571|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92489089|NCT01949571|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92489090|NCT01949571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92489091|NCT01949571|Adrenergic Agents|adrenergic agents|mesh-ancestor
92489092|NCT01949571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92489093|NCT01949571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92489094|NCT01949571|Serotonin Agents|serotonin agents|mesh-ancestor
92489095|NCT01949571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92489096|NCT01949675|Vaccines|vaccines|mesh-list
92489097|NCT01949675|Immunologic Factors|immunologic factors|mesh-ancestor
92489098|NCT01949675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489099|NCT01949766|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92489100|NCT01949766|Glycerol|glycerol|mesh-list
92489101|NCT01949766|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92489102|NCT01949766|Protective Agents|protective agents|mesh-ancestor
92489103|NCT01949766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489104|NCT01949766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489105|NCT01948245|Taurolidine|taurolidine|mesh-list
92489106|NCT01948245|Heparin|heparin|mesh-list
92489107|NCT01948245|Calcium heparin|calcium heparin|mesh-list
92489108|NCT01948245|Anticoagulants|anticoagulants|mesh-ancestor
92489109|NCT01948245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489110|NCT01948245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92489111|NCT01948245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92489112|NCT01948245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489113|NCT01948245|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92489114|NCT01948245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489115|NCT01949805|Interferon alpha-2|interferon alpha-2|mesh-list
92489116|NCT01949805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92489117|NCT01949805|Hydroxyurea|hydroxyurea|mesh-list
92489118|NCT01949805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489119|NCT01949805|Antisickling Agents|antisickling agents|mesh-ancestor
92489120|NCT01949805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489121|NCT01949805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489122|NCT01949805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92489123|NCT01949805|Antiviral Agents|antiviral agents|mesh-ancestor
92489124|NCT01949805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489125|NCT01949818|Prednisone|prednisone|mesh-list
92489126|NCT01949818|Prednisolone|prednisolone|mesh-list
92489127|NCT01949818|Cyclophosphamide|cyclophosphamide|mesh-list
92489128|NCT01949818|Doxorubicin|doxorubicin|mesh-list
92489129|NCT01949818|Vincristine|vincristine|mesh-list
92489130|NCT01949818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489131|NCT01949818|Immunologic Factors|immunologic factors|mesh-ancestor
92489132|NCT01949818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489133|NCT01949818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489134|NCT01949818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92489135|NCT01949818|Alkylating Agents|alkylating agents|mesh-ancestor
92489136|NCT01949818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489137|NCT01949818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704593|NCT02203643|Lenalidomide|lenalidomide|mesh-list
92214036|NCT04357093|Listerine|listerine|mesh-list
92489138|NCT01949818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92489139|NCT01949818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92489140|NCT01949818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92489141|NCT01949818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92489142|NCT01949818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489143|NCT01949818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489144|NCT01949818|Glucocorticoids|glucocorticoids|mesh-ancestor
92489145|NCT01949818|Hormones|hormones|mesh-ancestor
92489146|NCT01949818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489147|NCT01949818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92489148|NCT01949818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92489149|NCT01949818|Tubulin Modulators|tubulin modulators|mesh-ancestor
92489150|NCT01949818|Antimitotic Agents|antimitotic agents|mesh-ancestor
92489151|NCT01949818|Mitosis Modulators|mitosis modulators|mesh-ancestor
92489152|NCT01949857|Vaccines|vaccines|mesh-list
92489153|NCT01949857|Immunologic Factors|immunologic factors|mesh-ancestor
92489154|NCT01949857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489155|NCT01949909|Aluminum sulfate|aluminum sulfate|mesh-list
92489156|NCT01949909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92489157|NCT01949909|Immunologic Factors|immunologic factors|mesh-ancestor
92489158|NCT01949909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489159|NCT01949935|Mupirocin|mupirocin|mesh-list
92489160|NCT01949935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92489161|NCT01949935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489162|NCT01949935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92489163|NCT01949935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489164|NCT01949935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489165|NCT01949948|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92489166|NCT01949948|Tenecteplase|tenecteplase|mesh-list
92489167|NCT01949948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92489168|NCT01949948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92489169|NCT01949948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489170|NCT01950000|Fentanyl|fentanyl|mesh-list
92489171|NCT01950000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92489172|NCT01950000|Narcotics|narcotics|mesh-ancestor
92489173|NCT01950000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489174|NCT01950000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489175|NCT01950000|Analgesics|analgesics|mesh-ancestor
92489176|NCT01950000|Sensory System Agents|sensory system agents|mesh-ancestor
92489177|NCT01950000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489178|NCT01950000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92489179|NCT01950000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92489180|NCT01950000|Anesthetics, General|anesthetics, general|mesh-ancestor
92489181|NCT01950000|Anesthetics|anesthetics|mesh-ancestor
92489182|NCT01950182|Tamoxifen|tamoxifen|mesh-list
92489183|NCT01950182|Gemcitabine|gemcitabine|mesh-list
92489184|NCT01950182|Capecitabine|capecitabine|mesh-list
92489185|NCT01950182|Trastuzumab|trastuzumab|mesh-list
92489186|NCT01950182|Vinorelbine|vinorelbine|mesh-list
92489187|NCT01950182|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92489188|NCT01950182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92489189|NCT01950182|Antimetabolites|antimetabolites|mesh-ancestor
92489190|NCT01950182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489191|NCT01950182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489192|NCT01950182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489193|NCT01950182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92489194|NCT01950182|Tubulin Modulators|tubulin modulators|mesh-ancestor
92489195|NCT01950182|Antimitotic Agents|antimitotic agents|mesh-ancestor
92489196|NCT01950182|Mitosis Modulators|mitosis modulators|mesh-ancestor
92489197|NCT01950182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92489198|NCT01950182|Hormone Antagonists|hormone antagonists|mesh-ancestor
92489199|NCT01950182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489200|NCT01950182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489201|NCT01950182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92489202|NCT01950182|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92489203|NCT01950182|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92489204|NCT01950182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92489205|NCT01950182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92489206|NCT01950182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489207|NCT01950195|Ipilimumab|ipilimumab|mesh-list
92489208|NCT01950195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489209|NCT01950195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489210|NCT01950195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92489211|NCT01950195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489212|NCT01950416|Clopidogrel|clopidogrel|mesh-list
92489213|NCT01950416|Ticagrelor|ticagrelor|mesh-list
92489214|NCT01950416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92489215|NCT01950416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92489216|NCT01950416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92489217|NCT01950416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92489218|NCT01950416|Purinergic Agents|purinergic agents|mesh-ancestor
92489219|NCT01950416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489220|NCT01950416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489221|NCT01950416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489222|NCT01950481|Ceritinib|ceritinib|mesh-list
92489223|NCT01950481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489224|NCT01950481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92489225|NCT01950481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489226|NCT01950481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489227|NCT01950494|Hand Sanitizers|hand sanitizers|mesh-list
92489228|NCT01950494|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92489229|NCT01950494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489230|NCT01950494|Disinfectants|disinfectants|mesh-ancestor
92489231|NCT01950507|Fluconazole|fluconazole|mesh-list
92489232|NCT01950507|Voriconazole|voriconazole|mesh-list
92489233|NCT01950507|Micafungin|micafungin|mesh-list
92489234|NCT01950507|Budesonide|budesonide|mesh-list
92489235|NCT01950507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489236|NCT01950507|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92489237|NCT01950507|Autonomic Agents|autonomic agents|mesh-ancestor
92489238|NCT01950507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489239|NCT01950507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489240|NCT01950507|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92489241|NCT01950507|Respiratory System Agents|respiratory system agents|mesh-ancestor
92489242|NCT01950507|Glucocorticoids|glucocorticoids|mesh-ancestor
92489243|NCT01950507|Hormones|hormones|mesh-ancestor
92489244|NCT01950507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489245|NCT01950507|Antifungal Agents|antifungal agents|mesh-ancestor
92489246|NCT01950507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489247|NCT01950507|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92489248|NCT01950507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92489249|NCT01950507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489250|NCT01950507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489251|NCT01950507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92489252|NCT01950507|Hormone Antagonists|hormone antagonists|mesh-ancestor
92489253|NCT01950507|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92489254|NCT01950507|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92489255|NCT01950507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92489257|NCT01950546|Cariostatic Agents|cariostatic agents|mesh-ancestor
92489258|NCT01950546|Protective Agents|protective agents|mesh-ancestor
92489259|NCT01950546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489260|NCT01950585|Hydroxyurea|hydroxyurea|mesh-list
92489261|NCT01950585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489262|NCT01950585|Antisickling Agents|antisickling agents|mesh-ancestor
92489263|NCT01950585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489264|NCT01950585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489265|NCT01950585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92489266|NCT01950611|Bortezomib|bortezomib|mesh-list
92489267|NCT01950611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489268|NCT01950689|Nimorazole|nimorazole|mesh-list
92489269|NCT01950689|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92489270|NCT01950689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92489271|NCT01950689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92489272|NCT01950689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489273|NCT01950793|Triamcinolone|triamcinolone|mesh-list
92489274|NCT01950793|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92489275|NCT01950793|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92489276|NCT01950793|Hyaluronic Acid|hyaluronic acid|mesh-list
92489277|NCT01950793|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92489278|NCT01950793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489279|NCT01950793|Glucocorticoids|glucocorticoids|mesh-ancestor
92489280|NCT01950793|Hormones|hormones|mesh-ancestor
92489281|NCT01950793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489282|NCT01950793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489283|NCT01950793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489284|NCT01950793|Immunologic Factors|immunologic factors|mesh-ancestor
92489285|NCT01950793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704594|NCT02203643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489286|NCT01950793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489287|NCT01950793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92489288|NCT01950793|Viscosupplements|viscosupplements|mesh-ancestor
92489289|NCT01950793|Protective Agents|protective agents|mesh-ancestor
92489290|NCT01950884|Ezetimibe|ezetimibe|mesh-list
92489291|NCT01950884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92489292|NCT01950884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92489294|NCT01950884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489295|NCT01950884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92489296|NCT01950923|Sildenafil Citrate|sildenafil citrate|mesh-list
92489297|NCT01950923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489298|NCT01950923|Vasodilator Agents|vasodilator agents|mesh-ancestor
92489299|NCT01950923|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92489300|NCT01950923|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92489301|NCT01950923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489302|NCT01950923|Urological Agents|urological agents|mesh-ancestor
92489303|NCT01950949|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92489304|NCT01950949|Plasma Substitutes|plasma substitutes|mesh-ancestor
92489305|NCT01950949|Blood Substitutes|blood substitutes|mesh-ancestor
92489306|NCT01951001|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92489307|NCT01951001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92489308|NCT01951027|Lenograstim|lenograstim|mesh-list
92489309|NCT01951027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92489310|NCT01951027|Immunologic Factors|immunologic factors|mesh-ancestor
92489311|NCT01951027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489312|NCT01951053|Citalopram|citalopram|mesh-list
92489313|NCT01951053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92489314|NCT01951053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92489315|NCT01951053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92489316|NCT01951053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489317|NCT01951053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489318|NCT01951053|Serotonin Agents|serotonin agents|mesh-ancestor
92489319|NCT01951053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489320|NCT01951053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92489321|NCT01951053|Antidepressive Agents|antidepressive agents|mesh-ancestor
92489322|NCT01951053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489323|NCT01951079|Digoxin|digoxin|mesh-list
92489324|NCT01951079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92489325|NCT01951079|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92489326|NCT01951079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489327|NCT01951079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489328|NCT01951079|Protective Agents|protective agents|mesh-ancestor
92489329|NCT01951079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489330|NCT01951144|Lorazepam|lorazepam|mesh-list
92489331|NCT01951144|PF-06372865|pf-06372865|mesh-list
92489332|NCT01951144|Anticonvulsants|anticonvulsants|mesh-ancestor
92489333|NCT01951144|Antiemetics|antiemetics|mesh-ancestor
92489334|NCT01951144|Autonomic Agents|autonomic agents|mesh-ancestor
92489335|NCT01951144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489336|NCT01951144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489337|NCT01951144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489338|NCT01951144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92489339|NCT01951144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489340|NCT01951144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92489341|NCT01951144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92489342|NCT01951144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489343|NCT01951144|GABA Modulators|gaba modulators|mesh-ancestor
92489344|NCT01951144|GABA Agents|gaba agents|mesh-ancestor
92489345|NCT01951144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489346|NCT01951144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489347|NCT01951209|Rifaximin|rifaximin|mesh-list
92489348|NCT01951209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92489349|NCT01951209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489350|NCT01951209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489351|NCT01951404|Allopurinol|allopurinol|mesh-list
92489352|NCT01951404|Antimetabolites|antimetabolites|mesh-ancestor
92489353|NCT01951404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489354|NCT01951404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489355|NCT01951404|Gout Suppressants|gout suppressants|mesh-ancestor
92489356|NCT01951404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489357|NCT01951404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92489358|NCT01951404|Antioxidants|antioxidants|mesh-ancestor
92489359|NCT01951404|Protective Agents|protective agents|mesh-ancestor
92489360|NCT01951404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489361|NCT01951430|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92489362|NCT01951430|Cephalosporins|cephalosporins|mesh-list
92489363|NCT01951430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92489364|NCT01951430|Itraconazole|itraconazole|mesh-list
92489365|NCT01951430|Fluconazole|fluconazole|mesh-list
92489367|NCT01951430|Antifungal Agents|antifungal agents|mesh-list
92489368|NCT01951430|Clotrimazole|clotrimazole|mesh-list
92489369|NCT01951430|Miconazole|miconazole|mesh-list
92489370|NCT01951430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489371|NCT01951430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92489372|NCT01951430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92489373|NCT01951430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489374|NCT01951430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489375|NCT01951430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92489376|NCT01951430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92489377|NCT01951430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489378|NCT01951430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489379|NCT01951430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92489380|NCT01951430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92489381|NCT01951430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92489382|NCT01951430|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92489383|NCT01951430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92489384|NCT01951430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92489385|NCT01951430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92489386|NCT01951430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92489387|NCT01951430|Antimalarials|antimalarials|mesh-ancestor
92489388|NCT01951482|Bevacizumab|bevacizumab|mesh-list
92489389|NCT01951482|Cisplatin|cisplatin|mesh-list
92489390|NCT01951482|Pemetrexed|pemetrexed|mesh-list
92489391|NCT01951482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489392|NCT01951482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489393|NCT01951482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92489394|NCT01951482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92489395|NCT01951482|Growth Substances|growth substances|mesh-ancestor
92489396|NCT01951482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489397|NCT01951482|Growth Inhibitors|growth inhibitors|mesh-ancestor
92489398|NCT01951482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489399|NCT01951482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489400|NCT01951482|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92489401|NCT01951482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92489402|NCT01951508|Methylphenidate|methylphenidate|mesh-list
92489403|NCT01951508|Modafinil|modafinil|mesh-list
92489404|NCT01951508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92489405|NCT01951508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489406|NCT01951508|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92489407|NCT01951508|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92489408|NCT01951508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92489409|NCT01951508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489410|NCT01951508|Dopamine Agents|dopamine agents|mesh-ancestor
92489411|NCT01951508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489412|NCT01951508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92489413|NCT01951508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92489414|NCT01951508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92489415|NCT01951560|Valproic Acid|valproic acid|mesh-list
92489416|NCT01951560|Anticonvulsants|anticonvulsants|mesh-ancestor
92489417|NCT01951560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489418|NCT01951560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489419|NCT01951560|GABA Agents|gaba agents|mesh-ancestor
92489420|NCT01951560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489421|NCT01951560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489422|NCT01951560|Antimanic Agents|antimanic agents|mesh-ancestor
92489423|NCT01951560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92489424|NCT01951560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489425|NCT01951560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489426|NCT01951599|Osimertinib|osimertinib|mesh-list
92489427|NCT01951599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489428|NCT01951599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92489429|NCT01951599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489430|NCT01951599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489431|NCT01951677|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92489432|NCT01951677|Immunologic Factors|immunologic factors|mesh-ancestor
92489433|NCT01951677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489434|NCT01951677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92489435|NCT01951677|Antacids|antacids|mesh-ancestor
92489436|NCT01951677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489437|NCT01951677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489439|NCT01951729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92489440|NCT01951729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92489441|NCT01951729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92489442|NCT01951729|Autonomic Agents|autonomic agents|mesh-ancestor
92489443|NCT01951729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489444|NCT01951729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489445|NCT01951729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92489446|NCT01951729|Respiratory System Agents|respiratory system agents|mesh-ancestor
92489447|NCT01951729|Mydriatics|mydriatics|mesh-ancestor
92489448|NCT01951729|Parasympatholytics|parasympatholytics|mesh-ancestor
92489449|NCT01951729|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92489450|NCT01951729|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92489451|NCT01951729|Cholinergic Agents|cholinergic agents|mesh-ancestor
92489452|NCT01951729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489453|NCT01951729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489454|NCT01951846|Nintedanib|nintedanib|mesh-list
92489455|NCT01951846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489456|NCT01951846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92489457|NCT01951846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489458|NCT01951846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489459|NCT01951872|Caffeine|caffeine|mesh-list
92489460|NCT01951872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92489461|NCT01951872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489462|NCT01951872|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92489463|NCT01951872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489464|NCT01951872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489465|NCT01951872|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92489466|NCT01951872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92489467|NCT01951872|Purinergic Agents|purinergic agents|mesh-ancestor
92489468|NCT01951872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489469|NCT01951898|Montelukast|montelukast|mesh-list
92489470|NCT01951898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92489471|NCT01951898|Respiratory System Agents|respiratory system agents|mesh-ancestor
92489472|NCT01951898|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92489473|NCT01951898|Hormone Antagonists|hormone antagonists|mesh-ancestor
92489474|NCT01951898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489475|NCT01951898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489476|NCT01951898|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92489477|NCT01951898|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92489478|NCT01951898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489479|NCT01951911|Ketamine|ketamine|mesh-list
92489480|NCT01951911|Analgesics|analgesics|mesh-ancestor
92489481|NCT01951911|Sensory System Agents|sensory system agents|mesh-ancestor
92489482|NCT01951911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489483|NCT01951911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489484|NCT01951911|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92489485|NCT01951911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92489486|NCT01951911|Anesthetics, General|anesthetics, general|mesh-ancestor
92489487|NCT01951911|Anesthetics|anesthetics|mesh-ancestor
92489488|NCT01951911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489489|NCT01951911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92489490|NCT01951911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92489491|NCT01951911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489492|NCT01951911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489493|NCT01951924|Immunoglobulins|immunoglobulins|mesh-list
92489494|NCT01951924|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92489495|NCT01951924|Antibodies|antibodies|mesh-list
92489496|NCT01951924|Immunoglobulin G|immunoglobulin g|mesh-list
92489497|NCT01951924|Immunologic Factors|immunologic factors|mesh-ancestor
92489498|NCT01951924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489499|NCT01952314|Naftopidil|naftopidil|mesh-list
92489500|NCT01952314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92489501|NCT01952314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92489502|NCT01952314|Adrenergic Agents|adrenergic agents|mesh-ancestor
92489503|NCT01952314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489504|NCT01952314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489505|NCT01952314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489506|NCT01952314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92489507|NCT01952314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92489508|NCT01952314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92489509|NCT01952314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92489510|NCT01952314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92489511|NCT01952561|Dapivirine|dapivirine|mesh-list
92489512|NCT01952561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92489513|NCT01952561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92489514|NCT01952561|Antiviral Agents|antiviral agents|mesh-ancestor
92489515|NCT01952561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489516|NCT01952626|Ondansetron|ondansetron|mesh-list
92489517|NCT01952626|Palonosetron|palonosetron|mesh-list
92489518|NCT01952626|Antiemetics|antiemetics|mesh-ancestor
92489519|NCT01952626|Autonomic Agents|autonomic agents|mesh-ancestor
92489520|NCT01952626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489521|NCT01952626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489522|NCT01952626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489523|NCT01952626|Antipruritics|antipruritics|mesh-ancestor
92489524|NCT01952626|Dermatologic Agents|dermatologic agents|mesh-ancestor
92489525|NCT01952626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92489526|NCT01952626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92489527|NCT01952626|Serotonin Agents|serotonin agents|mesh-ancestor
92489528|NCT01952626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489529|NCT01952626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489530|NCT01952652|Naproxen|naproxen|mesh-list
92489531|NCT01952652|Codeine|codeine|mesh-list
92489532|NCT01952652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92489533|NCT01952652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489534|NCT01952652|Analgesics|analgesics|mesh-ancestor
92489535|NCT01952652|Sensory System Agents|sensory system agents|mesh-ancestor
92489536|NCT01952652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489537|NCT01952652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489538|NCT01952652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489539|NCT01952652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489540|NCT01952652|Gout Suppressants|gout suppressants|mesh-ancestor
92489541|NCT01952652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92489542|NCT01952652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489543|NCT01952652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489544|NCT01952652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92489545|NCT01952652|Narcotics|narcotics|mesh-ancestor
92322581|NCT00002156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489546|NCT01952652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489547|NCT01952652|Antitussive Agents|antitussive agents|mesh-ancestor
92489548|NCT01952652|Respiratory System Agents|respiratory system agents|mesh-ancestor
92489550|NCT01952756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92489551|NCT01952756|Autonomic Agents|autonomic agents|mesh-ancestor
92489552|NCT01952756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489553|NCT01952756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489554|NCT01952756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92489555|NCT01952756|Respiratory System Agents|respiratory system agents|mesh-ancestor
92489556|NCT01952756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92489557|NCT01952756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92489558|NCT01952756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489559|NCT01952756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92489560|NCT01952756|Vasodilator Agents|vasodilator agents|mesh-ancestor
92489561|NCT01952756|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92489562|NCT01952756|Protective Agents|protective agents|mesh-ancestor
92489563|NCT01952756|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92489564|NCT01952756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92489565|NCT01952756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489566|NCT01952769|Pidilizumab|pidilizumab|mesh-list
92489567|NCT01952769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489568|NCT01952769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489569|NCT05876598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92489570|NCT05876598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489571|NCT05876585|Ondansetron|ondansetron|mesh-list
92489572|NCT05876585|Metoclopramide|metoclopramide|mesh-list
92489573|NCT05876585|Antiemetics|antiemetics|mesh-ancestor
92489574|NCT05876585|Autonomic Agents|autonomic agents|mesh-ancestor
92489575|NCT05876585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489576|NCT05876585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489577|NCT05876585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489578|NCT05876585|Antipruritics|antipruritics|mesh-ancestor
92489579|NCT05876585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92489580|NCT05876585|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92489581|NCT05876585|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92489582|NCT05876585|Serotonin Agents|serotonin agents|mesh-ancestor
92489583|NCT05876585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489584|NCT05876585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489585|NCT05876585|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92489586|NCT05876585|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92489587|NCT05876585|Dopamine Agents|dopamine agents|mesh-ancestor
92489589|NCT05876481|Hallucinogens|hallucinogens|mesh-ancestor
92489590|NCT05876481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489591|NCT05876481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489592|NCT05876390|Acetaminophen|acetaminophen|mesh-list
92489593|NCT05876390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489594|NCT05876390|Analgesics|analgesics|mesh-ancestor
92489595|NCT05876390|Sensory System Agents|sensory system agents|mesh-ancestor
92489596|NCT05876390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489597|NCT05876390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489598|NCT05876390|Antipyretics|antipyretics|mesh-ancestor
92489599|NCT05876377|Vaccines|vaccines|mesh-list
92489600|NCT05876377|Immunologic Factors|immunologic factors|mesh-ancestor
92489601|NCT05876377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489602|NCT05876351|Eculizumab|eculizumab|mesh-list
92489603|NCT05876351|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92489604|NCT05876351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489605|NCT05876351|Immunologic Factors|immunologic factors|mesh-ancestor
92489606|NCT05876351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489607|NCT05876195|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92489608|NCT05876195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92489609|NCT05876195|Freund's Adjuvant|freund's adjuvant|mesh-list
92489610|NCT05876195|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92489611|NCT05876195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92489612|NCT05876195|Immunologic Factors|immunologic factors|mesh-ancestor
92489613|NCT05876195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489614|NCT05876195|Antacids|antacids|mesh-ancestor
92489615|NCT05876195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489616|NCT05876195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489617|NCT05876169|Salicylic Acid|salicylic acid|mesh-list
92489618|NCT05876169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489619|NCT05876169|Antifungal Agents|antifungal agents|mesh-ancestor
92489620|NCT05876169|Keratolytic Agents|keratolytic agents|mesh-ancestor
92489621|NCT05876169|Dermatologic Agents|dermatologic agents|mesh-ancestor
92489622|NCT05876039|Remifentanil|remifentanil|mesh-list
92489623|NCT05876039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92489625|NCT05876039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489626|NCT05876039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489627|NCT05876039|Analgesics|analgesics|mesh-ancestor
92489628|NCT05876039|Sensory System Agents|sensory system agents|mesh-ancestor
92489629|NCT05876039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489630|NCT05875948|Terlipressin|terlipressin|mesh-list
92489631|NCT05875948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92489632|NCT05875948|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92489633|NCT05875714|Apremilast|apremilast|mesh-list
92489634|NCT05875714|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92489635|NCT05875714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489636|NCT05875714|Analgesics|analgesics|mesh-ancestor
92489637|NCT05875714|Sensory System Agents|sensory system agents|mesh-ancestor
92489638|NCT05875714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489639|NCT05875714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489640|NCT05875714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489641|NCT05875714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489642|NCT05875714|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92489643|NCT05875714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92489644|NCT05875714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349331|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
92489645|NCT05875714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489646|NCT05875701|Vaccines|vaccines|mesh-list
92489647|NCT05875701|Immunologic Factors|immunologic factors|mesh-ancestor
92489648|NCT05875701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489649|NCT05875675|Pioglitazone|pioglitazone|mesh-list
92489650|NCT05875675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92489651|NCT05875675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489652|NCT05875610|Gabapentin|gabapentin|mesh-list
92489653|NCT05875610|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92489654|NCT05875610|Analgesics|analgesics|mesh-ancestor
92489655|NCT05875610|Sensory System Agents|sensory system agents|mesh-ancestor
92489656|NCT05875610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214574|NCT00944047|Paclitaxel|paclitaxel|mesh-list
92489657|NCT05875610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489658|NCT05875610|Anticonvulsants|anticonvulsants|mesh-ancestor
92489659|NCT05875610|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92489660|NCT05875610|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92489661|NCT05875610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489662|NCT05875610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489663|NCT05875610|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92489664|NCT05875610|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92489665|NCT05875610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489666|NCT05875610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489667|NCT05875610|Antimanic Agents|antimanic agents|mesh-ancestor
92489668|NCT05875610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92489669|NCT05875610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92489670|NCT05875610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92489671|NCT05875610|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92489672|NCT05875610|Antidepressive Agents|antidepressive agents|mesh-ancestor
92489673|NCT05875571|Ketorolac|ketorolac|mesh-list
92489674|NCT05875571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92489675|NCT05875571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489676|NCT05875571|Analgesics|analgesics|mesh-ancestor
92489677|NCT05875571|Sensory System Agents|sensory system agents|mesh-ancestor
92489678|NCT05875571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489679|NCT05875571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489680|NCT05875571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489681|NCT05875571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489682|NCT05875571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92489683|NCT05875571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489684|NCT05875571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489685|NCT05875519|Nordefrin|nordefrin|mesh-list
92489686|NCT05875519|Mepivacaine|mepivacaine|mesh-list
92489687|NCT05875519|Anesthetics|anesthetics|mesh-ancestor
92489688|NCT05875519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489689|NCT05875519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489690|NCT05875519|Anesthetics, Local|anesthetics, local|mesh-ancestor
92489691|NCT05875519|Sensory System Agents|sensory system agents|mesh-ancestor
92489692|NCT05875519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489693|NCT05875519|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92489694|NCT05875428|Mitoxantrone|mitoxantrone|mesh-list
92489695|NCT05875428|Analgesics|analgesics|mesh-ancestor
92489696|NCT05875428|Sensory System Agents|sensory system agents|mesh-ancestor
92489697|NCT05875428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489698|NCT05875428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489699|NCT05875428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489700|NCT05875428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92489701|NCT05875428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92489702|NCT05875428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489703|NCT05875428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489704|NCT05875285|Methotrexate|methotrexate|mesh-list
92489705|NCT05875285|Coal Tar|coal tar|mesh-list
92489706|NCT05875285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92489707|NCT05875285|Abortifacient Agents|abortifacient agents|mesh-ancestor
92489708|NCT05875285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92489709|NCT05875285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489710|NCT05875285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92489711|NCT05875285|Antimetabolites|antimetabolites|mesh-ancestor
92489712|NCT05875285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489713|NCT05875285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489714|NCT05875285|Dermatologic Agents|dermatologic agents|mesh-ancestor
92489715|NCT05875285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489716|NCT05875285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92489717|NCT05875285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489718|NCT05875285|Immunologic Factors|immunologic factors|mesh-ancestor
92489719|NCT05875285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489720|NCT05875285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92489721|NCT05875285|Keratolytic Agents|keratolytic agents|mesh-ancestor
92489722|NCT05875077|Dexmedetomidine|dexmedetomidine|mesh-list
92489723|NCT05875077|Propofol|propofol|mesh-list
92489724|NCT05875077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92489725|NCT05875077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489726|NCT05875077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489727|NCT05875077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489728|NCT05875077|Analgesics|analgesics|mesh-ancestor
92489729|NCT05875077|Sensory System Agents|sensory system agents|mesh-ancestor
92489730|NCT05875077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489731|NCT05875077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92489732|NCT05875077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92489733|NCT05875077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92489734|NCT05875077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92489735|NCT05875077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489736|NCT05875077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489737|NCT05875077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92489738|NCT05875077|Anesthetics, General|anesthetics, general|mesh-ancestor
92489739|NCT05875077|Anesthetics|anesthetics|mesh-ancestor
92489740|NCT05875025|Norflurane|norflurane|mesh-list
92489741|NCT05875025|Anesthetics|anesthetics|mesh-ancestor
92489742|NCT05875025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489743|NCT05875025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489744|NCT05874921|Mitomycins|mitomycins|mesh-list
92489745|NCT05874921|Mitomycin|mitomycin|mesh-list
92489746|NCT05874921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92489747|NCT05874921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489748|NCT05874921|Alkylating Agents|alkylating agents|mesh-ancestor
92489749|NCT05874921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489750|NCT05874921|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92489751|NCT05874921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489752|NCT05874882|Chlorhexidine|chlorhexidine|mesh-list
92489753|NCT05874882|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92489754|NCT05874882|Resveratrol|resveratrol|mesh-list
92489755|NCT05874882|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92489756|NCT05874882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489757|NCT05874882|Disinfectants|disinfectants|mesh-ancestor
92489758|NCT05874882|Dermatologic Agents|dermatologic agents|mesh-ancestor
92489759|NCT05874882|Antioxidants|antioxidants|mesh-ancestor
92489760|NCT05874882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489761|NCT05874882|Protective Agents|protective agents|mesh-ancestor
92489762|NCT05874882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489763|NCT05874882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489764|NCT05874882|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92489765|NCT05874778|Prednisone|prednisone|mesh-list
92489766|NCT05874778|Cyclophosphamide|cyclophosphamide|mesh-list
92489767|NCT05874778|Vincristine|vincristine|mesh-list
92489768|NCT05874778|Rituximab|rituximab|mesh-list
92489769|NCT05874778|Doxorubicin|doxorubicin|mesh-list
92489770|NCT05874778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489771|NCT05874778|Immunologic Factors|immunologic factors|mesh-ancestor
92489772|NCT05874778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489773|NCT05874778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489774|NCT05874778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92489775|NCT05874778|Alkylating Agents|alkylating agents|mesh-ancestor
92489776|NCT05874778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489777|NCT05874778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489778|NCT05874778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92489779|NCT05874778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489780|NCT05874778|Glucocorticoids|glucocorticoids|mesh-ancestor
92489781|NCT05874778|Hormones|hormones|mesh-ancestor
92489782|NCT05874778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489783|NCT05874778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92489784|NCT05874778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92489785|NCT05874778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92489786|NCT05874778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92489787|NCT05874778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92489788|NCT05874778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489789|NCT05874778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92489790|NCT05874778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92489791|NCT05874778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92489792|NCT05874778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489793|NCT05874700|Sivelestat|sivelestat|mesh-list
92489794|NCT05874700|Glycine|glycine|mesh-list
92489795|NCT05874700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92489796|NCT05874700|Protease Inhibitors|protease inhibitors|mesh-ancestor
92489797|NCT05874700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489798|NCT05874700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489799|NCT05874700|Glycine Agents|glycine agents|mesh-ancestor
92489800|NCT05874700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489801|NCT05874700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489802|NCT05874674|Nafamostat|nafamostat|mesh-list
92489803|NCT05874674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92489804|NCT05874674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92489805|NCT05874674|Analgesics|analgesics|mesh-ancestor
92489806|NCT05874674|Sensory System Agents|sensory system agents|mesh-ancestor
92489807|NCT05874674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489808|NCT05874674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489809|NCT05874674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489810|NCT05874674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489811|NCT05874674|Anticoagulants|anticoagulants|mesh-ancestor
92489812|NCT05874674|Protease Inhibitors|protease inhibitors|mesh-ancestor
92489813|NCT05874674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489814|NCT05874674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489815|NCT05874674|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92489816|NCT05874674|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92489817|NCT05874674|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92489818|NCT05874674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489819|NCT05874674|Immunologic Factors|immunologic factors|mesh-ancestor
92489820|NCT05874583|Tranexamic Acid|tranexamic acid|mesh-list
92489821|NCT05874583|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92489822|NCT05874583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92489823|NCT05874583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489824|NCT05874583|Hemostatics|hemostatics|mesh-ancestor
92489825|NCT05874583|Coagulants|coagulants|mesh-ancestor
92489826|NCT05874544|Amoxicillin|amoxicillin|mesh-list
92489827|NCT05874544|Metronidazole|metronidazole|mesh-list
92489828|NCT05874544|Tetracycline|tetracycline|mesh-list
92489830|NCT05874544|Potassium Citrate|potassium citrate|mesh-list
92489831|NCT05874544|Bismuth|bismuth|mesh-list
92489832|NCT05874544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489833|NCT05874544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92489834|NCT05874544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489835|NCT05874544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92489836|NCT05874544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92489837|NCT05874544|Antacids|antacids|mesh-ancestor
92489838|NCT05874544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489839|NCT05874544|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92489840|NCT05874544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489841|NCT05874544|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92489842|NCT05874544|Antitubercular Agents|antitubercular agents|mesh-ancestor
92489843|NCT05874544|Diuretics|diuretics|mesh-ancestor
92489844|NCT05874544|Natriuretic Agents|natriuretic agents|mesh-ancestor
92489845|NCT05874544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489846|NCT05874544|Expectorants|expectorants|mesh-ancestor
92489847|NCT05874544|Respiratory System Agents|respiratory system agents|mesh-ancestor
92489848|NCT05874518|Letrozole|letrozole|mesh-list
92489849|NCT05874518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489850|NCT05874518|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92489851|NCT05874518|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92489852|NCT05874518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489853|NCT05874518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489854|NCT05874518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92489855|NCT05874518|Hormone Antagonists|hormone antagonists|mesh-ancestor
92489856|NCT05874518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489857|NCT05874518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489858|NCT05874505|Adalimumab|adalimumab|mesh-list
92489859|NCT05874505|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92489860|NCT05874505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489861|NCT05874505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489862|NCT05872789|Diazepam|diazepam|mesh-list
92489863|NCT05872789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92489864|NCT05872789|Anticonvulsants|anticonvulsants|mesh-ancestor
92489865|NCT05872789|Antiemetics|antiemetics|mesh-ancestor
92489866|NCT05872789|Autonomic Agents|autonomic agents|mesh-ancestor
92489867|NCT05872789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489868|NCT05872789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489869|NCT05872789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489870|NCT05872789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92489871|NCT05872789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92489872|NCT05872789|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92489873|NCT05872789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92489874|NCT05872789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92489875|NCT05872789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92489876|NCT05872789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92489877|NCT05872789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92489879|NCT05872789|Anesthetics|anesthetics|mesh-ancestor
92489880|NCT05872789|GABA Modulators|gaba modulators|mesh-ancestor
92489881|NCT05872789|GABA Agents|gaba agents|mesh-ancestor
92489882|NCT05872789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489883|NCT05872789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489884|NCT05872412|Paclitaxel|paclitaxel|mesh-list
92489885|NCT05872412|Cyclophosphamide|cyclophosphamide|mesh-list
92489886|NCT05872412|Carboplatin|carboplatin|mesh-list
92489887|NCT05872412|Doxorubicin|doxorubicin|mesh-list
92489888|NCT05872412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92489889|NCT05872412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489890|NCT05872412|Tubulin Modulators|tubulin modulators|mesh-ancestor
92489891|NCT05872412|Antimitotic Agents|antimitotic agents|mesh-ancestor
92489892|NCT05872412|Mitosis Modulators|mitosis modulators|mesh-ancestor
92489893|NCT05872412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489894|NCT05872412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92489895|NCT05872412|Immunologic Factors|immunologic factors|mesh-ancestor
92489896|NCT05872412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489897|NCT05872412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489898|NCT05872412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92489899|NCT05872412|Alkylating Agents|alkylating agents|mesh-ancestor
92489900|NCT05872412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92489901|NCT05872412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92489902|NCT05872412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92489903|NCT05872412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92489904|NCT05872412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489905|NCT05871476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92489906|NCT05871476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489907|NCT05864144|Cemiplimab|cemiplimab|mesh-list
92489908|NCT05864144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489909|NCT05864144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489910|NCT05860439|Polidocanol|polidocanol|mesh-list
92489911|NCT05860439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92489912|NCT05860439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92489913|NCT05849610|Dexamethasone|dexamethasone|mesh-list
92489914|NCT05849610|Lenalidomide|lenalidomide|mesh-list
92489915|NCT05849610|Bortezomib|bortezomib|mesh-list
92489916|NCT05849610|Daratumumab|daratumumab|mesh-list
92489917|NCT05849610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489918|NCT05849610|Antiemetics|antiemetics|mesh-ancestor
92489919|NCT05849610|Autonomic Agents|autonomic agents|mesh-ancestor
92489920|NCT05849610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489921|NCT05849610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489922|NCT05849610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489923|NCT05849610|Glucocorticoids|glucocorticoids|mesh-ancestor
92489924|NCT05849610|Hormones|hormones|mesh-ancestor
92489925|NCT05849610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489926|NCT05849610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92489927|NCT05849610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489928|NCT05849610|Immunologic Factors|immunologic factors|mesh-ancestor
92489929|NCT05849610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92489930|NCT05849610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92489931|NCT05849610|Growth Substances|growth substances|mesh-ancestor
92489932|NCT05849610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92489933|NCT05823675|Methylprednisolone|methylprednisolone|mesh-list
92489934|NCT05823675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92489935|NCT05823675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92489936|NCT05823675|Prednisolone|prednisolone|mesh-list
92489937|NCT05823675|Prednisolone acetate|prednisolone acetate|mesh-list
92489938|NCT05823675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92489939|NCT05823675|Prednisolone phosphate|prednisolone phosphate|mesh-list
92489940|NCT05823675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92489941|NCT05823675|Antiemetics|antiemetics|mesh-ancestor
92489942|NCT05823675|Autonomic Agents|autonomic agents|mesh-ancestor
92489943|NCT05823675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92489944|NCT05823675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489945|NCT05823675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92489946|NCT05823675|Glucocorticoids|glucocorticoids|mesh-ancestor
92489947|NCT05823675|Hormones|hormones|mesh-ancestor
92489948|NCT05823675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92489949|NCT05823675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92489950|NCT05823675|Protective Agents|protective agents|mesh-ancestor
92489951|NCT05823675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92489952|NCT05823675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489953|NCT05874869|Piperaquine|piperaquine|mesh-list
92489954|NCT05874869|Artenimol|artenimol|mesh-list
92489955|NCT05874869|Antimalarials|antimalarials|mesh-ancestor
92489956|NCT05874869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92489957|NCT05874869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92489958|NCT05874869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92489959|NCT05818735|Escitalopram|escitalopram|mesh-list
92489960|NCT05818735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92489961|NCT05818735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92489962|NCT05818735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92489963|NCT05818735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489964|NCT05818735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489965|NCT05818735|Serotonin Agents|serotonin agents|mesh-ancestor
92489966|NCT05818735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489967|NCT05799820|Bevacizumab|bevacizumab|mesh-list
92489968|NCT05799820|Capecitabine|capecitabine|mesh-list
92489969|NCT05799820|Oxaliplatin|oxaliplatin|mesh-list
92489970|NCT05799820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92489971|NCT05799820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489972|NCT05799820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92489973|NCT05799820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92489974|NCT05799820|Growth Substances|growth substances|mesh-ancestor
92489975|NCT05799820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489976|NCT05799820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92489977|NCT05799820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92489978|NCT05799820|Antimetabolites|antimetabolites|mesh-ancestor
92489979|NCT05799820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489980|NCT05790161|Caffeine|caffeine|mesh-list
92489981|NCT05790161|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92489982|NCT05790161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489983|NCT05790161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92489984|NCT05790161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92489985|NCT05790161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92489986|NCT05790161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92489987|NCT05790161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92489988|NCT05790161|Purinergic Agents|purinergic agents|mesh-ancestor
92489989|NCT05790161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92489990|NCT05786040|Rituximab|rituximab|mesh-list
92489991|NCT05786040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92489992|NCT05786040|Antibodies|antibodies|mesh-list
92489993|NCT05786040|Immunoglobulins|immunoglobulins|mesh-list
92489994|NCT05786040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92489995|NCT05786040|Immunologic Factors|immunologic factors|mesh-ancestor
92489996|NCT05786040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92489997|NCT05786040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92489998|NCT05786040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92489999|NCT05775809|Serotonin|serotonin|mesh-list
92490000|NCT05775809|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92490001|NCT05775809|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92490002|NCT05775809|Serotonin Agents|serotonin agents|mesh-ancestor
92490003|NCT05775809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490004|NCT05775809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490005|NCT05775809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490006|NCT05775809|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92490007|NCT05775809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92490008|NCT05723601|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92490009|NCT05723601|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92490010|NCT05723601|Estradiol|estradiol|mesh-list
92490011|NCT05723601|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92490012|NCT05723601|Estrogens|estrogens|mesh-ancestor
92490013|NCT05723601|Hormones|hormones|mesh-ancestor
92490014|NCT05723601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490015|NCT05723601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490016|NCT05723601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92490017|NCT05723601|Contraceptive Agents|contraceptive agents|mesh-ancestor
92490018|NCT05723601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490019|NCT05723601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92490020|NCT05701527|Pembrolizumab|pembrolizumab|mesh-list
92490021|NCT05701527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490022|NCT05701527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490023|NCT05701527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92490024|NCT05701527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490025|NCT05698407|Sufentanil|sufentanil|mesh-list
92490026|NCT05698407|Dexmedetomidine|dexmedetomidine|mesh-list
92490028|NCT05698407|Ropivacaine|ropivacaine|mesh-list
92490029|NCT05698407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92490030|NCT05698407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490031|NCT05698407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490032|NCT05698407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92490033|NCT05698407|Analgesics|analgesics|mesh-ancestor
92490034|NCT05698407|Sensory System Agents|sensory system agents|mesh-ancestor
92214938|NCT02935738|Hormones|hormones|mesh-ancestor
92490035|NCT05698407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490036|NCT05698407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92490037|NCT05698407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92490038|NCT05698407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92490039|NCT05698407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92490040|NCT05698407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490041|NCT05698407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490042|NCT05698407|Anesthetics, Local|anesthetics, local|mesh-ancestor
92490043|NCT05698407|Anesthetics|anesthetics|mesh-ancestor
92490044|NCT05698407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92490045|NCT05698407|Narcotics|narcotics|mesh-ancestor
92490046|NCT05698407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92490047|NCT05698407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92490048|NCT05698407|Anesthetics, General|anesthetics, general|mesh-ancestor
92490049|NCT05696236|Tin Fluorides|tin fluorides|mesh-list
92490050|NCT05696236|Cariostatic Agents|cariostatic agents|mesh-ancestor
92490051|NCT05696236|Protective Agents|protective agents|mesh-ancestor
92490052|NCT05696236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490053|NCT05671315|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92490054|NCT05671315|Antiviral Agents|antiviral agents|mesh-ancestor
92490055|NCT05671315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490056|NCT05641467|Methamphetamine|methamphetamine|mesh-list
92490057|NCT05641467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92490058|NCT05641467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490059|NCT05641467|Sympathomimetics|sympathomimetics|mesh-ancestor
92490060|NCT05641467|Autonomic Agents|autonomic agents|mesh-ancestor
92490061|NCT05641467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490062|NCT05641467|Dopamine Agents|dopamine agents|mesh-ancestor
92490063|NCT05641467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490064|NCT05641467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490065|NCT05641467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92490066|NCT05641467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92490067|NCT05641467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92490068|NCT05641467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200402|NCT03404180|Anesthetics, General|anesthetics, general|mesh-ancestor
92490069|NCT05641467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92490070|NCT05627245|Belinostat|belinostat|mesh-list
92490071|NCT05627245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490072|NCT05627245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92490073|NCT05627245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490074|NCT05627245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490075|NCT05611710|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92490076|NCT05611710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490077|NCT05590624|Phentermine|phentermine|mesh-list
92490078|NCT05590624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92490079|NCT05590624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490080|NCT05590624|Appetite Depressants|appetite depressants|mesh-ancestor
92490081|NCT05590624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92490082|NCT05590624|Sympathomimetics|sympathomimetics|mesh-ancestor
92490083|NCT05590624|Autonomic Agents|autonomic agents|mesh-ancestor
92490084|NCT05590624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490085|NCT05590624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92490086|NCT05590624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490087|NCT05590624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490088|NCT05574712|Leuprolide|leuprolide|mesh-list
92490089|NCT05574712|Abiraterone Acetate|abiraterone acetate|mesh-list
92490090|NCT05574712|Belzutifan|belzutifan|mesh-list
92490091|NCT05574712|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92490092|NCT05574712|Fertility Agents|fertility agents|mesh-ancestor
92490093|NCT05574712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490094|NCT05574712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490095|NCT05574712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490096|NCT05574712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490097|NCT05574712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92490098|NCT05574712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490099|NCT05574712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490100|NCT05574712|Hormone Antagonists|hormone antagonists|mesh-ancestor
92490101|NCT05574712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490102|NCT05574712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92490103|NCT05510063|Adalimumab|adalimumab|mesh-list
92490104|NCT05510063|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92490105|NCT05510063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490106|NCT05510063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490107|NCT05508815|Methotrexate|methotrexate|mesh-list
92215036|NCT03033121|Hormones|hormones|mesh-list
92490108|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92490109|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
92490110|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490111|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490112|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490113|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
92490114|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490115|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490116|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92490117|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490118|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490119|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490120|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
92490121|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490122|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490123|NCT05500508|Eflornithine|eflornithine|mesh-list
92490124|NCT05500508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490125|NCT05500508|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92490126|NCT05500508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92490127|NCT05500508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92490128|NCT05500508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490129|NCT05500508|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92490130|NCT05500508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490131|NCT05500508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490132|NCT05463861|Lemborexant|lemborexant|mesh-list
92490133|NCT05463861|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92490134|NCT05463861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490135|NCT05463861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490136|NCT05463861|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92490137|NCT05463861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92490138|NCT05463861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490139|NCT05463861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490140|NCT05353439|Pembrolizumab|pembrolizumab|mesh-list
92490141|NCT05353439|Topotecan|topotecan|mesh-list
92490142|NCT05353439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490143|NCT05353439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490144|NCT05353439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92490145|NCT05353439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490146|NCT05353439|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92490147|NCT05353439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490148|NCT05353439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490149|NCT05346588|Propofol|propofol|mesh-list
92490150|NCT05346588|Anesthetics|anesthetics|mesh-list
92490151|NCT05346588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92490152|NCT05346588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490153|NCT05346588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490154|NCT05346588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92490155|NCT05346588|Anesthetics, General|anesthetics, general|mesh-ancestor
92490156|NCT05327530|Avelumab|avelumab|mesh-list
92490157|NCT05327530|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92490158|NCT05327530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490159|NCT05327530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490160|NCT05327530|Immunoconjugates|immunoconjugates|mesh-ancestor
92490161|NCT05327530|Immunologic Factors|immunologic factors|mesh-ancestor
92490162|NCT05327530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490163|NCT05323708|Denosumab|denosumab|mesh-list
92490164|NCT05323708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92490165|NCT05323708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490166|NCT05312645|Diclofenac|diclofenac|mesh-list
92490167|NCT05312645|Petrolatum|petrolatum|mesh-list
92490168|NCT05312645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92490169|NCT05312645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92490171|NCT05312645|Sensory System Agents|sensory system agents|mesh-ancestor
92490172|NCT05312645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490173|NCT05312645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490174|NCT05312645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490175|NCT05312645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490176|NCT05312645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92490177|NCT05312645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490178|NCT05312645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490179|NCT05312645|Emollients|emollients|mesh-ancestor
92490180|NCT05312645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92490181|NCT05285566|Lidocaine|lidocaine|mesh-list
92490182|NCT05285566|Bupivacaine|bupivacaine|mesh-list
92490183|NCT05285566|Anesthetics, Local|anesthetics, local|mesh-ancestor
92490184|NCT05285566|Anesthetics|anesthetics|mesh-ancestor
92490185|NCT05285566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490186|NCT05285566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490187|NCT05285566|Sensory System Agents|sensory system agents|mesh-ancestor
92490188|NCT05285566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490189|NCT05285566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92490190|NCT05285566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92490191|NCT05285566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92490192|NCT05285566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92490193|NCT05285566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490194|NCT05184712|Carboplatin|carboplatin|mesh-list
92490195|NCT05184712|Pemetrexed|pemetrexed|mesh-list
92490196|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490197|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490198|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490199|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490200|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490201|NCT05129722|Empagliflozin|empagliflozin|mesh-list
92490202|NCT05129722|Eplerenone|eplerenone|mesh-list
92490203|NCT05129722|Bumetanide|bumetanide|mesh-list
92490204|NCT05129722|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92490205|NCT05129722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490206|NCT05129722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92490207|NCT05129722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490208|NCT05129722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92490209|NCT05129722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92490210|NCT05129722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490211|NCT05129722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92490212|NCT05129722|Diuretics|diuretics|mesh-ancestor
92490213|NCT05129722|Natriuretic Agents|natriuretic agents|mesh-ancestor
92490214|NCT05129722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92490215|NCT05129722|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92490216|NCT05129722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92490217|NCT05052957|Temozolomide|temozolomide|mesh-list
92490218|NCT05052957|Carmustine|carmustine|mesh-list
92490219|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92490220|NCT05052957|Lenograstim|lenograstim|mesh-list
92490221|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92490222|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
92490223|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490224|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92490225|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
92490226|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490227|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490228|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490229|NCT05044962|Rilpivirine|rilpivirine|mesh-list
92490230|NCT05044962|Cabotegravir|cabotegravir|mesh-list
92490231|NCT05044962|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92490232|NCT05044962|Levonorgestrel|levonorgestrel|mesh-list
92490233|NCT05044962|Medroxyprogesterone|medroxyprogesterone|mesh-list
92490234|NCT05044962|Etonogestrel|etonogestrel|mesh-list
92490235|NCT05044962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92490236|NCT05044962|Contraceptive Agents|contraceptive agents|mesh-ancestor
92490237|NCT05044962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490238|NCT05044962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490239|NCT05044962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92490240|NCT05044962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92490241|NCT05044962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92490242|NCT05044962|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92490243|NCT05044962|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92490244|NCT05044962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490246|NCT05044962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92490247|NCT05044962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490248|NCT05044962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490249|NCT05044962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490250|NCT05044962|Antiviral Agents|antiviral agents|mesh-ancestor
92490251|NCT05044962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490252|NCT05044962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92490253|NCT05044962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92215172|NCT02946034|Ribavirin|ribavirin|mesh-list
92490254|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92490255|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92490256|NCT05041101|Halichondrin B|halichondrin b|mesh-list
92490257|NCT05041101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490258|NCT05041101|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490259|NCT05041101|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490260|NCT05041101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490261|NCT05041101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490262|NCT05027919|Lofexidine|lofexidine|mesh-list
92490263|NCT05027919|Clonidine|clonidine|mesh-list
92490264|NCT05027919|Morphine|morphine|mesh-list
92490265|NCT05027919|Naloxone|naloxone|mesh-list
92490266|NCT05027919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92490267|NCT05027919|Narcotics|narcotics|mesh-ancestor
92490268|NCT05027919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490269|NCT05027919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490270|NCT05027919|Analgesics|analgesics|mesh-ancestor
92490271|NCT05027919|Sensory System Agents|sensory system agents|mesh-ancestor
92490272|NCT05027919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490273|NCT05027919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92490274|NCT05027919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92490275|NCT05027919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92490276|NCT05027919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92490277|NCT05027919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92490278|NCT05027919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92490279|NCT05027919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490280|NCT05027919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490281|NCT05027919|Sympatholytics|sympatholytics|mesh-ancestor
92490282|NCT05027919|Autonomic Agents|autonomic agents|mesh-ancestor
92490283|NCT04994431|Tamsulosin|tamsulosin|mesh-list
92490284|NCT04994431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92490285|NCT04994431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92200406|NCT02780609|Fosaprepitant|fosaprepitant|mesh-list
92490286|NCT04994431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92490287|NCT04994431|Adrenergic Agents|adrenergic agents|mesh-ancestor
92490288|NCT04994431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490289|NCT04994431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490290|NCT04994431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490291|NCT04994431|Urological Agents|urological agents|mesh-ancestor
92490292|NCT04985760|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92490293|NCT04985760|Vaccines|vaccines|mesh-list
92490294|NCT04985760|Aluminum sulfate|aluminum sulfate|mesh-list
92490295|NCT04985760|Immunologic Factors|immunologic factors|mesh-ancestor
92490296|NCT04985760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490297|NCT04985760|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92490298|NCT04985760|Antacids|antacids|mesh-ancestor
92490299|NCT04985760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490300|NCT04985760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490301|NCT04966546|Memantine|memantine|mesh-list
92490302|NCT04966546|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92490303|NCT04966546|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92490304|NCT04966546|Dopamine Agents|dopamine agents|mesh-ancestor
92490305|NCT04966546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490306|NCT04966546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490307|NCT04966546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490308|NCT04966546|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92490309|NCT04966546|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92490310|NCT04912063|Azacitidine|azacitidine|mesh-list
92490311|NCT04912063|Venetoclax|venetoclax|mesh-list
92490312|NCT04912063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490313|NCT04912063|Antimetabolites|antimetabolites|mesh-ancestor
92490314|NCT04912063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490315|NCT04912063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490316|NCT04912063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490317|NCT04853446|Dexamethasone|dexamethasone|mesh-list
92490318|NCT04853446|Dexamethasone acetate|dexamethasone acetate|mesh-list
92490319|NCT04853446|BB 1101|bb 1101|mesh-list
92490320|NCT04853446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490321|NCT04853446|Antiemetics|antiemetics|mesh-ancestor
92490322|NCT04853446|Autonomic Agents|autonomic agents|mesh-ancestor
92490323|NCT04853446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490324|NCT04853446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490325|NCT04853446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490326|NCT04853446|Glucocorticoids|glucocorticoids|mesh-ancestor
92490327|NCT04853446|Hormones|hormones|mesh-ancestor
92490328|NCT04853446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490329|NCT04853446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490330|NCT04853446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490331|NCT04853446|Protease Inhibitors|protease inhibitors|mesh-ancestor
92490332|NCT04853446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490333|NCT04853446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490334|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92490335|NCT04846231|Red yeast rice|red yeast rice|mesh-list
92490336|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92490337|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92490338|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
92490339|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490340|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92490341|NCT04846231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92490342|NCT04846231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490343|NCT04756401|Dexamethasone|dexamethasone|mesh-list
92490344|NCT04756401|Dexamethasone acetate|dexamethasone acetate|mesh-list
92490345|NCT04756401|Daratumumab|daratumumab|mesh-list
92490346|NCT04756401|Ichthammol|ichthammol|mesh-list
92490347|NCT04756401|BB 1101|bb 1101|mesh-list
92490348|NCT04756401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490349|NCT04756401|Antiemetics|antiemetics|mesh-ancestor
92490350|NCT04756401|Autonomic Agents|autonomic agents|mesh-ancestor
92490351|NCT04756401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490352|NCT04756401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490353|NCT04756401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490354|NCT04756401|Glucocorticoids|glucocorticoids|mesh-ancestor
92490355|NCT04756401|Hormones|hormones|mesh-ancestor
92490356|NCT04756401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490357|NCT04756401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490358|NCT04756401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490359|NCT04756401|Protease Inhibitors|protease inhibitors|mesh-ancestor
92490360|NCT04756401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490361|NCT04756401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490362|NCT04756401|Dermatologic Agents|dermatologic agents|mesh-ancestor
92490363|NCT04705428|Fluorides|fluorides|mesh-list
92490364|NCT04705428|Cariostatic Agents|cariostatic agents|mesh-ancestor
92490365|NCT04705428|Protective Agents|protective agents|mesh-ancestor
92490366|NCT04705428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490367|NCT04677387|Naloxone|naloxone|mesh-list
92490368|NCT04677387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92490369|NCT04677387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490370|NCT04677387|Sensory System Agents|sensory system agents|mesh-ancestor
92490371|NCT04677387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490372|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
92490373|NCT04664933|Protective Agents|protective agents|mesh-ancestor
92490374|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490375|NCT04663347|Cytarabine|cytarabine|mesh-list
92490376|NCT04663347|Dexamethasone|dexamethasone|mesh-list
92490377|NCT04663347|Prednisone|prednisone|mesh-list
92490378|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
92490379|NCT04663347|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92490380|NCT04663347|Ifosfamide|ifosfamide|mesh-list
92490381|NCT04663347|Rituximab|rituximab|mesh-list
92490382|NCT04663347|Carboplatin|carboplatin|mesh-list
92490383|NCT04663347|Gemcitabine|gemcitabine|mesh-list
92490384|NCT04663347|Doxorubicin|doxorubicin|mesh-list
92490385|NCT04663347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92490386|NCT04663347|Oxaliplatin|oxaliplatin|mesh-list
92490387|NCT04663347|Etoposide|etoposide|mesh-list
92490388|NCT04663347|Vincristine|vincristine|mesh-list
92490389|NCT04663347|Lenalidomide|lenalidomide|mesh-list
92490390|NCT04663347|Etoposide phosphate|etoposide phosphate|mesh-list
92490391|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490392|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
92532114|NCT00050947|Anticonvulsants|anticonvulsants|mesh-ancestor
92490393|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490395|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92490396|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
92490397|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490398|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490399|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92490400|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490401|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215314|NCT03016741|Hormones|hormones|mesh-ancestor
92490402|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
92490403|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
92490404|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490405|NCT04663347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490406|NCT04663347|Glucocorticoids|glucocorticoids|mesh-ancestor
92490407|NCT04663347|Hormones|hormones|mesh-ancestor
92490408|NCT04663347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490409|NCT04663347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490410|NCT04663347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490411|NCT04663347|Antimetabolites|antimetabolites|mesh-ancestor
92490412|NCT04663347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92490413|NCT04663347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92490414|NCT04663347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490415|NCT04663347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490416|NCT04663347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92490417|NCT04663347|Antiviral Agents|antiviral agents|mesh-ancestor
92490418|NCT04663347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490419|NCT04663347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490420|NCT04663347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490421|NCT04663347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490422|NCT04663347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92490423|NCT04663347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92490424|NCT04663347|Growth Substances|growth substances|mesh-ancestor
92490425|NCT04663347|Growth Inhibitors|growth inhibitors|mesh-ancestor
92490426|NCT04660760|Trifluridine|trifluridine|mesh-list
92490427|NCT04660760|Paclitaxel|paclitaxel|mesh-list
92490428|NCT04660760|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92490429|NCT04660760|Ramucirumab|ramucirumab|mesh-list
92490430|NCT04660760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92490431|NCT04660760|Antibodies|antibodies|mesh-list
92490432|NCT04660760|Immunoglobulins|immunoglobulins|mesh-list
92490433|NCT04660760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92490434|NCT04660760|Lexatumumab|lexatumumab|mesh-list
92490435|NCT04660760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92490436|NCT04660760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490437|NCT04660760|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490438|NCT04660760|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490439|NCT04660760|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490440|NCT04660760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490441|NCT04660760|Immunologic Factors|immunologic factors|mesh-ancestor
92490442|NCT04660760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490443|NCT04660760|Antimetabolites|antimetabolites|mesh-ancestor
92490444|NCT04660760|Antiviral Agents|antiviral agents|mesh-ancestor
92490445|NCT04660760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490446|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
92490447|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92490448|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92490449|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490450|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
92490451|NCT04650698|Coagulants|coagulants|mesh-ancestor
92490452|NCT04507217|Carboplatin|carboplatin|mesh-list
92490453|NCT04507217|Pemetrexed|pemetrexed|mesh-list
92490454|NCT04507217|Tislelizumab|tislelizumab|mesh-list
92490455|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490456|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490457|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490458|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490459|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490460|NCT04507217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490461|NCT04495452|Fentanyl|fentanyl|mesh-list
92490462|NCT04495452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92490463|NCT04495452|Narcotics|narcotics|mesh-ancestor
92490464|NCT04495452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490465|NCT04495452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490466|NCT04495452|Analgesics|analgesics|mesh-ancestor
92490467|NCT04495452|Sensory System Agents|sensory system agents|mesh-ancestor
92490468|NCT04495452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490469|NCT04495452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92490470|NCT04495452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92490471|NCT04495452|Anesthetics, General|anesthetics, general|mesh-ancestor
92490472|NCT04495452|Anesthetics|anesthetics|mesh-ancestor
92490473|NCT04447846|Cannabidiol|cannabidiol|mesh-list
92490474|NCT04447846|Anticonvulsants|anticonvulsants|mesh-ancestor
92490475|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92490476|NCT04405245|Latanoprost|latanoprost|mesh-list
92490477|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92490478|NCT04335968|Melatonin|melatonin|mesh-list
92490479|NCT04335968|Antioxidants|antioxidants|mesh-ancestor
92490480|NCT04335968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490481|NCT04335968|Protective Agents|protective agents|mesh-ancestor
92490482|NCT04335968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490483|NCT04335968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490484|NCT04318678|Cyclophosphamide|cyclophosphamide|mesh-list
92490485|NCT04318678|Rituximab|rituximab|mesh-list
92490486|NCT04318678|Fludarabine|fludarabine|mesh-list
92490487|NCT04318678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490488|NCT04318678|Immunologic Factors|immunologic factors|mesh-ancestor
92490489|NCT04318678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490490|NCT04318678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490491|NCT04318678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92490492|NCT04318678|Alkylating Agents|alkylating agents|mesh-ancestor
92490493|NCT04318678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490494|NCT04318678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490495|NCT04318678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92490496|NCT04318678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490497|NCT04262024|Cabergoline|cabergoline|mesh-list
92490498|NCT04262024|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92490499|NCT04262024|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92490500|NCT04262024|Dopamine Agonists|dopamine agonists|mesh-ancestor
92490501|NCT04262024|Dopamine Agents|dopamine agents|mesh-ancestor
92490502|NCT04262024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490503|NCT04262024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490504|NCT04262024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490505|NCT04237103|Methotrexate|methotrexate|mesh-list
92490506|NCT04237103|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92490507|NCT04237103|Abortifacient Agents|abortifacient agents|mesh-ancestor
92490508|NCT04237103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490509|NCT04237103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490510|NCT04237103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490511|NCT04237103|Antimetabolites|antimetabolites|mesh-ancestor
92490512|NCT04237103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490514|NCT04237103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92490515|NCT04237103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490516|NCT04237103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490517|NCT04237103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490518|NCT04237103|Immunologic Factors|immunologic factors|mesh-ancestor
92490519|NCT04237103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490520|NCT04237103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490521|NCT04226690|Dronabinol|dronabinol|mesh-list
92490522|NCT04226690|Hallucinogens|hallucinogens|mesh-ancestor
92490523|NCT04226690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490524|NCT04226690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92490525|NCT04226690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92490526|NCT04226690|Analgesics|analgesics|mesh-ancestor
92490527|NCT04226690|Sensory System Agents|sensory system agents|mesh-ancestor
92490528|NCT04226690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490529|NCT04226690|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92490530|NCT04226690|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92490531|NCT04226690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490532|NCT04226690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490533|NCT04226690|Hormones|hormones|mesh-ancestor
92490534|NCT04226690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490535|NCT04201964|Tenecteplase|tenecteplase|mesh-list
92490536|NCT04201964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92490537|NCT04201964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92490538|NCT04201964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490540|NCT04198805|Vitamin E|vitamin e|mesh-list
92490541|NCT04198805|Tocopherols|tocopherols|mesh-list
92490542|NCT04198805|Tocotrienols|tocotrienols|mesh-list
92490543|NCT04198805|alpha-Tocopherol|alpha-tocopherol|mesh-list
92490544|NCT04198805|Micronutrients|micronutrients|mesh-ancestor
92490545|NCT04198805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490546|NCT04198805|Antioxidants|antioxidants|mesh-ancestor
92490547|NCT04198805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490548|NCT04198805|Protective Agents|protective agents|mesh-ancestor
92490549|NCT04179890|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92490550|NCT04179890|Gefitinib|gefitinib|mesh-list
92490551|NCT04179890|Osimertinib|osimertinib|mesh-list
92490552|NCT04179890|Afatinib|afatinib|mesh-list
92490553|NCT04179890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490554|NCT04179890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92490555|NCT04179890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490556|NCT04179890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490557|NCT04166331|Dobutamine|dobutamine|mesh-list
92490558|NCT04166331|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92490559|NCT04166331|Sympathomimetics|sympathomimetics|mesh-ancestor
92490560|NCT04166331|Autonomic Agents|autonomic agents|mesh-ancestor
92490561|NCT04166331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490562|NCT04166331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490563|NCT04166331|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92490564|NCT04166331|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92490565|NCT04166331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92490566|NCT04166331|Adrenergic Agents|adrenergic agents|mesh-ancestor
92490567|NCT04166331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490568|NCT04166331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490569|NCT04166331|Protective Agents|protective agents|mesh-ancestor
92490571|NCT04084210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92490572|NCT04084210|Autonomic Agents|autonomic agents|mesh-ancestor
92490573|NCT04084210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490574|NCT04084210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490575|NCT04084210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92490576|NCT04084210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92490577|NCT04084210|Cholinergic Agents|cholinergic agents|mesh-ancestor
92490578|NCT04084210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490579|NCT04084210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490580|NCT04030026|Nalbuphine|nalbuphine|mesh-list
92490581|NCT04030026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92490582|NCT04030026|Narcotics|narcotics|mesh-ancestor
92490583|NCT04030026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490584|NCT04030026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490585|NCT04030026|Analgesics|analgesics|mesh-ancestor
92490586|NCT04030026|Sensory System Agents|sensory system agents|mesh-ancestor
92200410|NCT02780609|Autonomic Agents|autonomic agents|mesh-ancestor
92490587|NCT04030026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490588|NCT04006457|Vaccines|vaccines|mesh-list
92490589|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
92490590|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490591|NCT04006210|Levodopa|levodopa|mesh-list
92490592|NCT04006210|Carbidopa|carbidopa|mesh-list
92490593|NCT04006210|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92490594|NCT04006210|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92490595|NCT04006210|Dopamine Agents|dopamine agents|mesh-ancestor
92490596|NCT04006210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490597|NCT04006210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490598|NCT04006210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490599|NCT04006210|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92490600|NCT04006210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490601|NCT03927274|Topotecan|topotecan|mesh-list
92490602|NCT03927274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92490603|NCT03927274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490604|NCT03927274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490605|NCT03927274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490606|NCT03927274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490607|NCT03923699|Anesthetics|anesthetics|mesh-list
92490608|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490609|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490610|NCT03918278|Paclitaxel|paclitaxel|mesh-list
92490611|NCT03918278|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92490612|NCT03918278|Carboplatin|carboplatin|mesh-list
92490613|NCT03918278|Gemcitabine|gemcitabine|mesh-list
92490614|NCT03918278|Pembrolizumab|pembrolizumab|mesh-list
92490615|NCT03918278|Pemetrexed|pemetrexed|mesh-list
92490616|NCT03918278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92490617|NCT03918278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490618|NCT03918278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490619|NCT03918278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490620|NCT03918278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490621|NCT03918278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490622|NCT03918278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490623|NCT03918278|Antimetabolites|antimetabolites|mesh-ancestor
92490624|NCT03918278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490625|NCT03918278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92490626|NCT03918278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490627|NCT03918278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490628|NCT03918278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490629|NCT03883880|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92490630|NCT03883880|Capsaicin|capsaicin|mesh-list
92490631|NCT03883880|Antipruritics|antipruritics|mesh-ancestor
92490632|NCT03883880|Dermatologic Agents|dermatologic agents|mesh-ancestor
92490633|NCT03883880|Sensory System Agents|sensory system agents|mesh-ancestor
92490634|NCT03883880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215531|NCT05717361|Narcotics|narcotics|mesh-ancestor
92490635|NCT03883880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490636|NCT03883880|Antioxidants|antioxidants|mesh-ancestor
92490637|NCT03883880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490638|NCT03883880|Protective Agents|protective agents|mesh-ancestor
92490639|NCT03883880|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92490640|NCT03883880|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92490641|NCT03883880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490642|NCT03883880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92490643|NCT03853798|Mitapivat|mitapivat|mesh-list
92490644|NCT03853798|Enzyme Activators|enzyme activators|mesh-ancestor
92490645|NCT03853798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490646|NCT03801369|Durvalumab|durvalumab|mesh-list
92490647|NCT03801369|Olaparib|olaparib|mesh-list
92490648|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92490649|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
92490650|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92490651|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
92490652|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490653|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490654|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
92490655|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490656|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490657|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490658|NCT03649659|Fluorides|fluorides|mesh-list
92490659|NCT03649659|Cariostatic Agents|cariostatic agents|mesh-ancestor
92490660|NCT03649659|Protective Agents|protective agents|mesh-ancestor
92490661|NCT03649659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490662|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
92490663|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
92490664|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490665|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490666|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490667|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
92490668|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
92490669|NCT03563716|Atezolizumab|atezolizumab|mesh-list
92490670|NCT03563716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92490671|NCT03563716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490672|NCT03563716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490673|NCT03563716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490674|NCT03543969|Nivolumab|nivolumab|mesh-list
92490675|NCT03543969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490676|NCT03543969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490677|NCT03543969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92490678|NCT03543969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490679|NCT03493048|Leucovorin|leucovorin|mesh-list
92490680|NCT03493048|Fluorouracil|fluorouracil|mesh-list
92490681|NCT03493048|Oxaliplatin|oxaliplatin|mesh-list
92490682|NCT03493048|Irinotecan|irinotecan|mesh-list
92490683|NCT03493048|Cetuximab|cetuximab|mesh-list
92490684|NCT03493048|Antimetabolites|antimetabolites|mesh-ancestor
92490685|NCT03493048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490686|NCT03493048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490687|NCT03493048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490688|NCT03493048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490689|NCT03493048|Immunologic Factors|immunologic factors|mesh-ancestor
92490690|NCT03493048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490691|NCT03493048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92490692|NCT03493048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490693|NCT03493048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490694|NCT03493048|Antidotes|antidotes|mesh-ancestor
92490695|NCT03493048|Protective Agents|protective agents|mesh-ancestor
92490696|NCT03493048|Vitamin B Complex|vitamin b complex|mesh-ancestor
92490697|NCT03493048|Vitamins|vitamins|mesh-ancestor
92490698|NCT03493048|Micronutrients|micronutrients|mesh-ancestor
92490699|NCT03493048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490700|NCT03486106|Propofol|propofol|mesh-list
92490701|NCT03486106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92490702|NCT03486106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490703|NCT03486106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490704|NCT03486106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92490705|NCT03486106|Anesthetics, General|anesthetics, general|mesh-ancestor
92490706|NCT03486106|Anesthetics|anesthetics|mesh-ancestor
92490707|NCT03434275|Meloxicam|meloxicam|mesh-list
92490708|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92490709|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215618|NCT05716347|Vaccines|vaccines|mesh-list
92490710|NCT03434275|Analgesics|analgesics|mesh-ancestor
92490711|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
92490712|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490713|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490714|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490715|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490716|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92490717|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92490718|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490719|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490721|NCT03354013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92490722|NCT03354013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490723|NCT03348423|Fentanyl|fentanyl|mesh-list
92490724|NCT03348423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92490725|NCT03348423|Narcotics|narcotics|mesh-ancestor
92490726|NCT03348423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92490727|NCT03348423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490729|NCT03348423|Sensory System Agents|sensory system agents|mesh-ancestor
92490730|NCT03348423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490731|NCT03348423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92490732|NCT03348423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92490733|NCT03348423|Anesthetics, General|anesthetics, general|mesh-ancestor
92490734|NCT03348423|Anesthetics|anesthetics|mesh-ancestor
92490735|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
92490736|NCT03337087|Leucovorin|leucovorin|mesh-list
92490737|NCT03337087|Folic Acid|folic acid|mesh-list
92490738|NCT03337087|Fluorouracil|fluorouracil|mesh-list
92490739|NCT03337087|Irinotecan|irinotecan|mesh-list
92490740|NCT03337087|Rucaparib|rucaparib|mesh-list
92490741|NCT03337087|Calcium|calcium|mesh-list
92490742|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
92490743|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92490744|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490745|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92490746|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
92490747|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490748|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490749|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490750|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490751|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
92490752|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92490753|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490754|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490755|NCT03337087|Antidotes|antidotes|mesh-ancestor
92490756|NCT03337087|Protective Agents|protective agents|mesh-ancestor
92490757|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
92490758|NCT03337087|Vitamins|vitamins|mesh-ancestor
92490759|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
92490760|NCT03337087|Hematinics|hematinics|mesh-ancestor
92490761|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92490762|NCT03262935|Capecitabine|capecitabine|mesh-list
92490763|NCT03262935|Trastuzumab|trastuzumab|mesh-list
92490764|NCT03262935|Vinorelbine|vinorelbine|mesh-list
92490765|NCT03262935|Lapatinib|lapatinib|mesh-list
92490766|NCT03262935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490767|NCT03262935|Antimetabolites|antimetabolites|mesh-ancestor
92490768|NCT03262935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490769|NCT03262935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490770|NCT03262935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490771|NCT03262935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92490772|NCT03262935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490773|NCT03262935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490774|NCT03262935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490775|NCT03262935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92490776|NCT03262935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490777|NCT03262142|Ciprofloxacin|ciprofloxacin|mesh-list
92490778|NCT03262142|Tazobactam|tazobactam|mesh-list
92490779|NCT03262142|Piperacillin|piperacillin|mesh-list
92490780|NCT03262142|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92490781|NCT03262142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92490782|NCT03262142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490783|NCT03262142|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92490784|NCT03262142|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490785|NCT03262142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490786|NCT03262142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490787|NCT03262142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490788|NCT03262142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92490789|NCT03262142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92490790|NCT03262142|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92490791|NCT03150810|Temozolomide|temozolomide|mesh-list
92490793|NCT03150810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92490794|NCT03150810|Alkylating Agents|alkylating agents|mesh-ancestor
92490795|NCT03150810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490796|NCT03150810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490797|NCT03150810|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92490798|NCT03150810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490799|NCT03117998|Volagidemab|volagidemab|mesh-list
92490800|NCT03117998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92490801|NCT03117998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490802|NCT03117751|Cytarabine|cytarabine|mesh-list
92490803|NCT03117751|Dexamethasone|dexamethasone|mesh-list
92490804|NCT03117751|Prednisone|prednisone|mesh-list
92490805|NCT03117751|Prednisolone|prednisolone|mesh-list
92490806|NCT03117751|Cyclophosphamide|cyclophosphamide|mesh-list
92490807|NCT03117751|Doxorubicin|doxorubicin|mesh-list
92490808|NCT03117751|Methotrexate|methotrexate|mesh-list
92490809|NCT03117751|Etoposide|etoposide|mesh-list
92490810|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
92490811|NCT03117751|Vincristine|vincristine|mesh-list
92490812|NCT03117751|Bortezomib|bortezomib|mesh-list
92490813|NCT03117751|Daunorubicin|daunorubicin|mesh-list
92490814|NCT03117751|Asparaginase|asparaginase|mesh-list
92490815|NCT03117751|Dasatinib|dasatinib|mesh-list
92490816|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
92490817|NCT03117751|Vorinostat|vorinostat|mesh-list
92490818|NCT03117751|Idarubicin|idarubicin|mesh-list
92490819|NCT03117751|Clofarabine|clofarabine|mesh-list
92490820|NCT03117751|Pegaspargase|pegaspargase|mesh-list
92490821|NCT03117751|Thioguanine|thioguanine|mesh-list
92490822|NCT03117751|Blinatumomab|blinatumomab|mesh-list
92490823|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
92490824|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490825|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
92490826|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490827|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92490828|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92490829|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
92490830|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490831|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490832|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92490833|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490834|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
92490835|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
92490836|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490837|NCT03117751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490838|NCT03117751|Glucocorticoids|glucocorticoids|mesh-ancestor
92490839|NCT03117751|Hormones|hormones|mesh-ancestor
92490840|NCT03117751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490841|NCT03117751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490842|NCT03117751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92490843|NCT03117751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92490844|NCT03117751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92490845|NCT03117751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490846|NCT03117751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92490847|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
92490848|NCT03117751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490849|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490850|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
92490851|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
92490852|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490853|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490854|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92490855|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
92490856|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490857|NCT03117751|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490858|NCT03117751|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490859|NCT03117751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490860|NCT03117751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92490861|NCT03117751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92490862|NCT03114865|Dexamethasone|dexamethasone|mesh-list
92490863|NCT03114865|Blinatumomab|blinatumomab|mesh-list
92490864|NCT03114865|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92490865|NCT03114865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92490866|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
92490867|NCT03114865|Autonomic Agents|autonomic agents|mesh-ancestor
92490868|NCT03114865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92490869|NCT03114865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490870|NCT03114865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490871|NCT03114865|Glucocorticoids|glucocorticoids|mesh-ancestor
92490872|NCT03114865|Hormones|hormones|mesh-ancestor
92490873|NCT03114865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490874|NCT03114865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200414|NCT02780609|Glucocorticoids|glucocorticoids|mesh-ancestor
92490875|NCT03114865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490876|NCT03114865|Immunologic Factors|immunologic factors|mesh-ancestor
92490877|NCT02920008|Guadecitabine|guadecitabine|mesh-list
92490878|NCT02920008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490879|NCT02866747|Durvalumab|durvalumab|mesh-list
92490880|NCT02866747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490881|NCT02866747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490882|NCT02766335|Docetaxel|docetaxel|mesh-list
92490883|NCT02766335|Durvalumab|durvalumab|mesh-list
92490884|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
92490885|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92490886|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
92490887|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490888|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490889|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490890|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490891|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490892|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490893|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
92490894|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490895|NCT02739711|polysaccharide-K|polysaccharide-k|mesh-list
92490896|NCT02739711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92490897|NCT02739711|Immunologic Factors|immunologic factors|mesh-ancestor
92490898|NCT02739711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490899|NCT02739711|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92490900|NCT02739711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490901|NCT02739711|Antiviral Agents|antiviral agents|mesh-ancestor
92490902|NCT02739711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490903|NCT02739711|Interferon Inducers|interferon inducers|mesh-ancestor
92490904|NCT02739711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92490905|NCT02739711|Protective Agents|protective agents|mesh-ancestor
92490906|NCT02607423|Deoxyglucose|deoxyglucose|mesh-list
92490907|NCT02607423|Cisplatin|cisplatin|mesh-list
92490908|NCT02607423|Gemcitabine|gemcitabine|mesh-list
92490909|NCT02607423|Docetaxel|docetaxel|mesh-list
92490910|NCT02607423|Pemetrexed|pemetrexed|mesh-list
92490911|NCT02607423|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92490912|NCT02607423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490913|NCT02607423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490914|NCT02607423|Antimetabolites|antimetabolites|mesh-ancestor
92490915|NCT02607423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490916|NCT02607423|Tubulin Modulators|tubulin modulators|mesh-ancestor
92490917|NCT02607423|Antimitotic Agents|antimitotic agents|mesh-ancestor
92490918|NCT02607423|Mitosis Modulators|mitosis modulators|mesh-ancestor
92490919|NCT02607423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490920|NCT02607423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92490921|NCT02607423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92490922|NCT02607423|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92490923|NCT02607423|Antiviral Agents|antiviral agents|mesh-ancestor
92490924|NCT02607423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92490925|NCT02577523|Levodopa|levodopa|mesh-list
92490926|NCT02577523|Carbidopa|carbidopa|mesh-list
92490927|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92490928|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92490929|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92490930|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
92490931|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92490932|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490933|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490934|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92490935|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490936|NCT02516241|Carboplatin|carboplatin|mesh-list
92490937|NCT02516241|Gemcitabine|gemcitabine|mesh-list
92490938|NCT02516241|Durvalumab|durvalumab|mesh-list
92490939|NCT02516241|Tremelimumab|tremelimumab|mesh-list
92490940|NCT02516241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490941|NCT02516241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490942|NCT02516241|Antimetabolites|antimetabolites|mesh-ancestor
92490943|NCT02516241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490944|NCT02516241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490945|NCT02499328|Durvalumab|durvalumab|mesh-list
92490946|NCT02499328|Tremelimumab|tremelimumab|mesh-list
92490947|NCT02499328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490948|NCT02499328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490949|NCT02388906|Nivolumab|nivolumab|mesh-list
92490950|NCT02388906|Ipilimumab|ipilimumab|mesh-list
92490951|NCT02388906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92490952|NCT02388906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490953|NCT02388906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92490954|NCT02388906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490955|NCT02344810|Leucovorin|leucovorin|mesh-list
92490956|NCT02344810|Fluorouracil|fluorouracil|mesh-list
92490957|NCT02344810|Oxaliplatin|oxaliplatin|mesh-list
92490958|NCT02344810|Calcium|calcium|mesh-list
92490959|NCT02344810|Levoleucovorin|levoleucovorin|mesh-list
92490960|NCT02344810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92490961|NCT02344810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490962|NCT02344810|Antimetabolites|antimetabolites|mesh-ancestor
92490963|NCT02344810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490964|NCT02344810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92490965|NCT02344810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490966|NCT02344810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490967|NCT02344810|Immunologic Factors|immunologic factors|mesh-ancestor
92490968|NCT02344810|Antidotes|antidotes|mesh-ancestor
92490969|NCT02344810|Protective Agents|protective agents|mesh-ancestor
92490970|NCT02344810|Vitamin B Complex|vitamin b complex|mesh-ancestor
92490971|NCT02344810|Vitamins|vitamins|mesh-ancestor
92490972|NCT02344810|Micronutrients|micronutrients|mesh-ancestor
92490973|NCT02333565|Everolimus|everolimus|mesh-list
92490974|NCT02333565|Octreotide|octreotide|mesh-list
92490975|NCT02333565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92490976|NCT02333565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92490977|NCT02333565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92490978|NCT02333565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92490979|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92490980|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
92490981|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490982|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490983|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92490984|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490985|NCT02278185|Leuprolide|leuprolide|mesh-list
92490986|NCT02278185|Goserelin|goserelin|mesh-list
92490987|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92490988|NCT02278185|Tryptophan|tryptophan|mesh-list
92490989|NCT02278185|Androgens|androgens|mesh-list
92490990|NCT02278185|Hormones|hormones|mesh-ancestor
92490991|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92490992|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92490993|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92490994|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
92490995|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92490996|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92490997|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92490998|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
92490999|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92491000|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
92491001|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92491002|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92491003|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
92491004|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92491005|NCT02177695|Gemcitabine|gemcitabine|mesh-list
92491006|NCT02177695|Doxorubicin|doxorubicin|mesh-list
92491007|NCT02177695|Methotrexate|methotrexate|mesh-list
92491008|NCT02177695|Vinblastine|vinblastine|mesh-list
92491009|NCT02177695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491010|NCT02177695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491011|NCT02177695|Antimetabolites|antimetabolites|mesh-ancestor
92491012|NCT02177695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491013|NCT02177695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92491014|NCT02177695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92215911|NCT00359151|Analgesics|analgesics|mesh-ancestor
92491015|NCT02177695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92491016|NCT02177695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491017|NCT02177695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92491018|NCT02177695|Abortifacient Agents|abortifacient agents|mesh-ancestor
92491019|NCT02177695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491020|NCT02177695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491021|NCT02177695|Dermatologic Agents|dermatologic agents|mesh-ancestor
92491022|NCT02177695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92491023|NCT02177695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491024|NCT02177695|Immunologic Factors|immunologic factors|mesh-ancestor
92491025|NCT02177695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491026|NCT02177695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491027|NCT02177695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491028|NCT02177695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491029|NCT02177695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491030|NCT02177695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491031|NCT02106572|Viscum album peptide|viscum album peptide|mesh-list
92491033|NCT02106572|Mitomycin|mitomycin|mesh-list
92491034|NCT02106572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92491035|NCT02106572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491036|NCT02106572|Alkylating Agents|alkylating agents|mesh-ancestor
92491037|NCT02106572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491038|NCT02106572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491039|NCT02106572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491040|NCT02106572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92491041|NCT02106572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92491042|NCT02106572|Antiviral Agents|antiviral agents|mesh-ancestor
92491043|NCT02106572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491044|NCT02096601|Levodopa|levodopa|mesh-list
92491045|NCT02096601|Carbidopa|carbidopa|mesh-list
92491046|NCT02096601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92491047|NCT02096601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92491048|NCT02096601|Dopamine Agents|dopamine agents|mesh-ancestor
92491049|NCT02096601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491050|NCT02096601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491051|NCT02096601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491052|NCT02096601|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92491053|NCT02096601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491054|NCT01840566|Cytarabine|cytarabine|mesh-list
92491055|NCT01840566|Etoposide|etoposide|mesh-list
92491056|NCT01840566|Melphalan|melphalan|mesh-list
92491057|NCT01840566|Carmustine|carmustine|mesh-list
92491058|NCT01840566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491059|NCT01840566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491060|NCT01840566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92491061|NCT01840566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92491062|NCT01840566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491063|NCT01840566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491064|NCT01840566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491065|NCT01840566|Antimetabolites|antimetabolites|mesh-ancestor
92491066|NCT01840566|Antiviral Agents|antiviral agents|mesh-ancestor
92491067|NCT01840566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491068|NCT01840566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491069|NCT01840566|Immunologic Factors|immunologic factors|mesh-ancestor
92491070|NCT01840566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491071|NCT01840566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92491072|NCT01840566|Alkylating Agents|alkylating agents|mesh-ancestor
92491073|NCT01840566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92491074|NCT01725802|Levodopa|levodopa|mesh-list
92491075|NCT01725802|Carbidopa|carbidopa|mesh-list
92491076|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92491077|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92491078|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
92491079|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491080|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491081|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491082|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92491083|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491084|NCT01719237|Ropivacaine|ropivacaine|mesh-list
92491085|NCT01719237|Chloroprocaine|chloroprocaine|mesh-list
92491086|NCT01719237|Anesthetics, Local|anesthetics, local|mesh-ancestor
92491087|NCT01719237|Anesthetics|anesthetics|mesh-ancestor
92491088|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491089|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491090|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
92491091|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491092|NCT01257594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92491093|NCT01257594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491094|NCT01257594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92491095|NCT01257594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491096|NCT01257594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491097|NCT01004731|Carboplatin|carboplatin|mesh-list
92491098|NCT01004731|Gemcitabine|gemcitabine|mesh-list
92491099|NCT01004731|Cetuximab|cetuximab|mesh-list
92491100|NCT01004731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491101|NCT01004731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491102|NCT01004731|Antimetabolites|antimetabolites|mesh-ancestor
92491103|NCT01004731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491104|NCT01004731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92491106|NCT00771017|Goserelin|goserelin|mesh-list
92491107|NCT00771017|Bicalutamide|bicalutamide|mesh-list
92491108|NCT00771017|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92491109|NCT00771017|Fertility Agents|fertility agents|mesh-ancestor
92491110|NCT00771017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491111|NCT00771017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491112|NCT00771017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92491113|NCT00771017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491114|NCT00771017|Androgen Antagonists|androgen antagonists|mesh-ancestor
92491115|NCT00771017|Hormone Antagonists|hormone antagonists|mesh-ancestor
92491116|NCT00771017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491117|NCT00707473|Cisplatin|cisplatin|mesh-list
92491118|NCT00707473|Carboplatin|carboplatin|mesh-list
92491119|NCT00707473|Docetaxel|docetaxel|mesh-list
92491120|NCT00707473|Fluorouracil|fluorouracil|mesh-list
92491121|NCT00707473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491122|NCT00707473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491123|NCT00707473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491124|NCT00707473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491125|NCT00707473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491126|NCT00707473|Antimetabolites|antimetabolites|mesh-ancestor
92491127|NCT00707473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491128|NCT00707473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491129|NCT00707473|Immunologic Factors|immunologic factors|mesh-ancestor
92491130|NCT00707473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491131|NCT00499291|Paclitaxel|paclitaxel|mesh-list
92491132|NCT00499291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92491133|NCT00499291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491134|NCT00499291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491135|NCT00499291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491136|NCT00499291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491137|NCT00499291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491138|NCT00499291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491139|NCT00445627|Metformin|metformin|mesh-list
92491140|NCT00445627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92491141|NCT00445627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491142|NCT00318903|Docetaxel|docetaxel|mesh-list
92491143|NCT00318903|Irinotecan|irinotecan|mesh-list
92491144|NCT00318903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491145|NCT00318903|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491146|NCT00318903|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491147|NCT00318903|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491148|NCT00318903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491149|NCT00318903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92491150|NCT00318903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92491151|NCT00318903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491152|NCT00129090|Rituximab|rituximab|mesh-list
92491153|NCT00129090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92491154|NCT00129090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491155|NCT00129090|Immunologic Factors|immunologic factors|mesh-ancestor
92491156|NCT00129090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491157|NCT00129090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491158|NCT01952886|Ondansetron|ondansetron|mesh-list
92491159|NCT01952886|Granisetron|granisetron|mesh-list
92491160|NCT01952886|Antiemetics|antiemetics|mesh-ancestor
92491161|NCT01952886|Autonomic Agents|autonomic agents|mesh-ancestor
92491162|NCT01952886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491163|NCT01952886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491164|NCT01952886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491165|NCT01952886|Antipruritics|antipruritics|mesh-ancestor
92491166|NCT01952886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92491167|NCT01952886|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92491168|NCT01952886|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92491169|NCT01952886|Serotonin Agents|serotonin agents|mesh-ancestor
92491170|NCT01952886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704595|NCT02203643|Immunologic Factors|immunologic factors|mesh-ancestor
92491171|NCT01952886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491172|NCT01952951|Fluorouracil|fluorouracil|mesh-list
92491173|NCT01952951|Capecitabine|capecitabine|mesh-list
92491174|NCT01952951|Oxaliplatin|oxaliplatin|mesh-list
92491175|NCT01952951|Antimetabolites|antimetabolites|mesh-ancestor
92491176|NCT01952951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491177|NCT01952951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491178|NCT01952951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491179|NCT01952951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491180|NCT01952951|Immunologic Factors|immunologic factors|mesh-ancestor
92491181|NCT01952951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491182|NCT01953107|Ferrous fumarate|ferrous fumarate|mesh-list
92491183|NCT01953107|Trace Elements|trace elements|mesh-ancestor
92491184|NCT01953107|Micronutrients|micronutrients|mesh-ancestor
92491185|NCT01953107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491186|NCT01953172|Tocotrienols|tocotrienols|mesh-list
92491187|NCT01953172|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
92491188|NCT01953172|Antioxidants|antioxidants|mesh-ancestor
92491189|NCT01953172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491190|NCT01953172|Protective Agents|protective agents|mesh-ancestor
92491191|NCT01953172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491193|NCT01953172|Micronutrients|micronutrients|mesh-ancestor
92491194|NCT01953367|Tobramycin|tobramycin|mesh-list
92491195|NCT01953367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92491196|NCT01953367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491197|NCT01953406|Fluorouracil|fluorouracil|mesh-list
92491198|NCT01953406|Mitomycins|mitomycins|mesh-list
92491200|NCT01953406|Antimetabolites|antimetabolites|mesh-ancestor
92491201|NCT01953406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491202|NCT01953406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491203|NCT01953406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491204|NCT01953406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491205|NCT01953406|Immunologic Factors|immunologic factors|mesh-ancestor
92491206|NCT01953406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491207|NCT01953406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92491208|NCT01953406|Alkylating Agents|alkylating agents|mesh-ancestor
92491209|NCT01953406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491210|NCT01953406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491211|NCT01953419|Pemetrexed|pemetrexed|mesh-list
92491212|NCT01953419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491213|NCT01953419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491214|NCT01953419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491215|NCT01953419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92491216|NCT01953419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491217|NCT01953445|Paclitaxel|paclitaxel|mesh-list
92491218|NCT01953445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491219|NCT01953445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491220|NCT01953445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491221|NCT01953445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491222|NCT01953445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491223|NCT01953445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491224|NCT01953536|Folic Acid|folic acid|mesh-list
92491225|NCT01953536|Paclitaxel|paclitaxel|mesh-list
92491226|NCT01953536|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92491227|NCT01953536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491228|NCT01953536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491229|NCT01953536|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491230|NCT01953536|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491231|NCT01953536|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491232|NCT01953536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491233|NCT01953536|Hematinics|hematinics|mesh-ancestor
92491234|NCT01953536|Vitamin B Complex|vitamin b complex|mesh-ancestor
92491235|NCT01953536|Vitamins|vitamins|mesh-ancestor
92491236|NCT01953536|Micronutrients|micronutrients|mesh-ancestor
92491237|NCT01953536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491238|NCT01953679|Ulipristal acetate|ulipristal acetate|mesh-list
92491239|NCT01953679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92491240|NCT01953679|Contraceptive Agents|contraceptive agents|mesh-ancestor
92491241|NCT01953679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491242|NCT01953679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491243|NCT01953679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92491244|NCT01953731|Rifampin|rifampin|mesh-list
92491245|NCT01953731|Palbociclib|palbociclib|mesh-list
92491246|NCT01953731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491247|NCT01953731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92491248|NCT01953731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491249|NCT01953731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491250|NCT01953731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92491251|NCT01953731|Antitubercular Agents|antitubercular agents|mesh-ancestor
92491252|NCT01953731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92491253|NCT01953731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491254|NCT01953731|Leprostatic Agents|leprostatic agents|mesh-ancestor
92491255|NCT01953731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491256|NCT01953731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92491257|NCT01953731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92491258|NCT01953731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92491259|NCT01953731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92491260|NCT01953731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92491261|NCT01953731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92491263|NCT01953744|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92491264|NCT01953744|Antifungal Agents|antifungal agents|mesh-ancestor
92491265|NCT01953744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491266|NCT01953744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92491267|NCT01953744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92491268|NCT01953744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491269|NCT01953744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491270|NCT01953744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92491271|NCT01953744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92491272|NCT01953744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491274|NCT01953744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92491275|NCT01953744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92491276|NCT01953744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92491277|NCT01953744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92491279|NCT01953757|Hydroxocobalamin|hydroxocobalamin|mesh-list
92491280|NCT01953757|Vitamin B 12|vitamin b 12|mesh-list
92491281|NCT01953757|Vitamin B Complex|vitamin b complex|mesh-list
92491282|NCT01953757|Micronutrients|micronutrients|mesh-ancestor
92491283|NCT01953757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491284|NCT01953757|Hematinics|hematinics|mesh-ancestor
92491285|NCT01953770|Cytarabine|cytarabine|mesh-list
92491286|NCT01953770|Prednisone|prednisone|mesh-list
92491287|NCT01953770|Methotrexate|methotrexate|mesh-list
92491288|NCT01953770|Daunorubicin|daunorubicin|mesh-list
92491289|NCT01953770|Asparaginase|asparaginase|mesh-list
92491290|NCT01953770|Pegaspargase|pegaspargase|mesh-list
92491291|NCT01953770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92491292|NCT01953770|Glucocorticoids|glucocorticoids|mesh-ancestor
92491293|NCT01953770|Hormones|hormones|mesh-ancestor
92491294|NCT01953770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491295|NCT01953770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491296|NCT01953770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92491297|NCT01953770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491298|NCT01953770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92491299|NCT01953770|Abortifacient Agents|abortifacient agents|mesh-ancestor
92491300|NCT01953770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491301|NCT01953770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491302|NCT01953770|Antimetabolites|antimetabolites|mesh-ancestor
92491303|NCT01953770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491304|NCT01953770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92491305|NCT01953770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491306|NCT01953770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92491307|NCT01953770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491308|NCT01953770|Immunologic Factors|immunologic factors|mesh-ancestor
92491309|NCT01953770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491310|NCT01953770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491311|NCT01953770|Antiviral Agents|antiviral agents|mesh-ancestor
92491312|NCT01953770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491313|NCT01953770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92491314|NCT01953770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92491315|NCT01953770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92491316|NCT01953796|Clomiphene|clomiphene|mesh-list
92491317|NCT01953796|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92491318|NCT01953796|Hormone Antagonists|hormone antagonists|mesh-ancestor
92491319|NCT01953796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216213|NCT04368377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92491320|NCT01953796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491321|NCT01953796|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92491322|NCT01953796|Fertility Agents|fertility agents|mesh-ancestor
92491323|NCT01953796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491324|NCT01953796|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92491325|NCT01953796|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92491326|NCT01953835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92491327|NCT01953835|Simvastatin|simvastatin|mesh-list
92491328|NCT01953835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92491329|NCT01953835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92491330|NCT01953835|Antimetabolites|antimetabolites|mesh-ancestor
92491331|NCT01953835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491332|NCT01953835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92491333|NCT01953835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92491334|NCT01953835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491335|NCT01953848|Tamsulosin|tamsulosin|mesh-list
92491336|NCT01953848|Solifenacin Succinate|solifenacin succinate|mesh-list
92349392|NCT04408326|Angiotensinogen|angiotensinogen|mesh-list
92491337|NCT01953848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92491338|NCT01953848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92491339|NCT01953848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92491340|NCT01953848|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491341|NCT01953848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491342|NCT01953848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491343|NCT01953848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491344|NCT01953848|Urological Agents|urological agents|mesh-ancestor
92491346|NCT01953848|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92491347|NCT01953848|Cholinergic Agents|cholinergic agents|mesh-ancestor
92491348|NCT01953887|Tamsulosin|tamsulosin|mesh-list
92491349|NCT01953887|Solifenacin Succinate|solifenacin succinate|mesh-list
92491350|NCT01953887|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92491351|NCT01953887|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92491352|NCT01953887|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92491353|NCT01953887|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491354|NCT01953887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491355|NCT01953887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491356|NCT01953887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491357|NCT01953887|Urological Agents|urological agents|mesh-ancestor
92491358|NCT01953887|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92491359|NCT01953887|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92491360|NCT01953887|Cholinergic Agents|cholinergic agents|mesh-ancestor
92491361|NCT01953952|Cisplatin|cisplatin|mesh-list
92491362|NCT01953952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491363|NCT01953978|Acetaminophen|acetaminophen|mesh-list
92491364|NCT01953978|Dexamethasone|dexamethasone|mesh-list
92491365|NCT01953978|Ibuprofen|ibuprofen|mesh-list
92491366|NCT01953978|Morphine|morphine|mesh-list
92491367|NCT01953978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92491368|NCT01953978|Antiemetics|antiemetics|mesh-ancestor
92491369|NCT01953978|Autonomic Agents|autonomic agents|mesh-ancestor
92491370|NCT01953978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491371|NCT01953978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491372|NCT01953978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491373|NCT01953978|Glucocorticoids|glucocorticoids|mesh-ancestor
92491374|NCT01953978|Hormones|hormones|mesh-ancestor
92491375|NCT01953978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491376|NCT01953978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92491377|NCT01953978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491378|NCT01953978|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92491379|NCT01953978|Narcotics|narcotics|mesh-ancestor
92491380|NCT01953978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491381|NCT01953978|Analgesics|analgesics|mesh-ancestor
92491382|NCT01953978|Sensory System Agents|sensory system agents|mesh-ancestor
92491383|NCT01953978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92491384|NCT01953978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92491385|NCT01953978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491386|NCT01953978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92491387|NCT01953978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491388|NCT01953978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491389|NCT01953978|Antipyretics|antipyretics|mesh-ancestor
92491390|NCT01954030|Bevacizumab|bevacizumab|mesh-list
92491391|NCT01954030|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92491392|NCT01954030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92491393|NCT01954030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491394|NCT01954030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92491395|NCT01954030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92491396|NCT01954030|Growth Substances|growth substances|mesh-ancestor
92491397|NCT01954030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491398|NCT01954030|Growth Inhibitors|growth inhibitors|mesh-ancestor
92491399|NCT01954030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92491400|NCT01954030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491401|NCT01954030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491402|NCT01954030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92491403|NCT01954043|Rifampin|rifampin|mesh-list
92491404|NCT01954043|Dabrafenib|dabrafenib|mesh-list
92491405|NCT01954043|Rabeprazole|rabeprazole|mesh-list
92491406|NCT01954043|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92491407|NCT01954043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491408|NCT01954043|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92491409|NCT01954043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491410|NCT01954043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349394|NCT04408326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92491411|NCT01954043|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92491412|NCT01954043|Antitubercular Agents|antitubercular agents|mesh-ancestor
92491413|NCT01954043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92491414|NCT01954043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491415|NCT01954043|Leprostatic Agents|leprostatic agents|mesh-ancestor
92491416|NCT01954043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92491417|NCT01954043|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92491418|NCT01954043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92491420|NCT01954043|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92491421|NCT01954043|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92491422|NCT01954043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92491423|NCT01954043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491424|NCT01954043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92491425|NCT01954108|Hyaluronic Acid|hyaluronic acid|mesh-list
92491426|NCT01954108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92491427|NCT01954108|Immunologic Factors|immunologic factors|mesh-ancestor
92491428|NCT01954108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491429|NCT01954108|Viscosupplements|viscosupplements|mesh-ancestor
92491430|NCT01954108|Protective Agents|protective agents|mesh-ancestor
92491431|NCT01954186|Oxytocin|oxytocin|mesh-list
92491432|NCT01954186|Oxytocics|oxytocics|mesh-ancestor
92491433|NCT01954186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491434|NCT01954186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491435|NCT01954238|Rivaroxaban|rivaroxaban|mesh-list
92491436|NCT01954238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92491437|NCT01954238|Antithrombins|antithrombins|mesh-ancestor
92491438|NCT01954238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92491439|NCT01954238|Protease Inhibitors|protease inhibitors|mesh-ancestor
92491440|NCT01954238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491441|NCT01954238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491442|NCT01954238|Anticoagulants|anticoagulants|mesh-ancestor
92491443|NCT01954290|Mannitol|mannitol|mesh-list
92491444|NCT01954290|Conivaptan|conivaptan|mesh-list
92491445|NCT01954290|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92491446|NCT01954290|Diuretics|diuretics|mesh-ancestor
92491447|NCT01954290|Natriuretic Agents|natriuretic agents|mesh-ancestor
92491448|NCT01954290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491449|NCT01954290|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92491450|NCT01954290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491451|NCT01954355|Paclitaxel|paclitaxel|mesh-list
92491452|NCT01954355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491453|NCT01954355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491454|NCT01954355|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491455|NCT01954355|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491456|NCT01954355|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491457|NCT01954355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491458|NCT01954368|Sufentanil|sufentanil|mesh-list
92491459|NCT01954368|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92491460|NCT01954368|Narcotics|narcotics|mesh-ancestor
92491461|NCT01954368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491462|NCT01954368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491463|NCT01954368|Analgesics|analgesics|mesh-ancestor
92491464|NCT01954368|Sensory System Agents|sensory system agents|mesh-ancestor
92491465|NCT01954368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491466|NCT01954368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92491467|NCT01954368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92491468|NCT01954368|Anesthetics, General|anesthetics, general|mesh-ancestor
92491469|NCT01954368|Anesthetics|anesthetics|mesh-ancestor
92491470|NCT01954693|Everolimus|everolimus|mesh-list
92491471|NCT01954693|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92491472|NCT01954693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92491473|NCT01954693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491474|NCT01954693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491475|NCT01954693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491476|NCT01954693|Immunologic Factors|immunologic factors|mesh-ancestor
92491477|NCT01954693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491478|NCT01954693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491479|NCT01954732|Metformin|metformin|mesh-list
92491480|NCT01954732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92491481|NCT01954732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491482|NCT01954784|Cyclosporine|cyclosporine|mesh-list
92491483|NCT01954784|Mycophenolic Acid|mycophenolic acid|mesh-list
92491484|NCT01954784|Fludarabine|fludarabine|mesh-list
92491485|NCT01954784|Fludarabine phosphate|fludarabine phosphate|mesh-list
92491486|NCT01954784|Lenalidomide|lenalidomide|mesh-list
92491487|NCT01954784|Bortezomib|bortezomib|mesh-list
92491488|NCT01954784|Cyclosporins|cyclosporins|mesh-list
92491489|NCT01954784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491490|NCT01954784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491491|NCT01954784|Antimetabolites|antimetabolites|mesh-ancestor
92491492|NCT01954784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491493|NCT01954784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491494|NCT01954784|Immunologic Factors|immunologic factors|mesh-ancestor
92491495|NCT01954784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491496|NCT01954784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491497|NCT01954784|Antifungal Agents|antifungal agents|mesh-ancestor
92491498|NCT01954784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491499|NCT01954784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92491500|NCT01954784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491501|NCT01954784|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92491502|NCT01954784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92491503|NCT01954784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92491504|NCT01954784|Growth Substances|growth substances|mesh-ancestor
92491505|NCT01954784|Growth Inhibitors|growth inhibitors|mesh-ancestor
92491506|NCT01954784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92491507|NCT01954784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92491508|NCT01954784|Antitubercular Agents|antitubercular agents|mesh-ancestor
92491509|NCT01954784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92491511|NCT01954914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92491512|NCT01954914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92491513|NCT01954914|Antiviral Agents|antiviral agents|mesh-ancestor
92491514|NCT01954914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491515|NCT01954992|Fluorouracil|fluorouracil|mesh-list
92491516|NCT01954992|Antimetabolites|antimetabolites|mesh-ancestor
92491517|NCT01954992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491518|NCT01954992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92491519|NCT01954992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491520|NCT01954992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491521|NCT01954992|Immunologic Factors|immunologic factors|mesh-ancestor
92491522|NCT01954992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491523|NCT01955057|Carbon Monoxide|carbon monoxide|mesh-list
92491524|NCT01955057|Antimetabolites|antimetabolites|mesh-ancestor
92491525|NCT01955057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491526|NCT01955057|Gasotransmitters|gasotransmitters|mesh-ancestor
92491527|NCT01955057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491528|NCT01955057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491529|NCT01955070|Ketamine|ketamine|mesh-list
92491530|NCT01955070|Analgesics|analgesics|mesh-ancestor
92491531|NCT01955070|Sensory System Agents|sensory system agents|mesh-ancestor
92491532|NCT01955070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491533|NCT01955070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491534|NCT01955070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92491535|NCT01955070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92491536|NCT01955070|Anesthetics, General|anesthetics, general|mesh-ancestor
92491537|NCT01955070|Anesthetics|anesthetics|mesh-ancestor
92491538|NCT01955070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491539|NCT01955070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92491540|NCT01955070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92491541|NCT01955070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491542|NCT01955070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491543|NCT01955135|Ketamine|ketamine|mesh-list
92216434|NCT04344405|Vitamin D|vitamin d|mesh-list
92491544|NCT01955135|Propofol|propofol|mesh-list
92491545|NCT01955135|Sevoflurane|sevoflurane|mesh-list
92491546|NCT01955135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92491547|NCT01955135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491548|NCT01955135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491549|NCT01955135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92491550|NCT01955135|Anesthetics, General|anesthetics, general|mesh-ancestor
92491551|NCT01955135|Anesthetics|anesthetics|mesh-ancestor
92491552|NCT01955135|Analgesics|analgesics|mesh-ancestor
92491553|NCT01955135|Sensory System Agents|sensory system agents|mesh-ancestor
92491554|NCT01955135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491555|NCT01955135|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92491556|NCT01955135|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92491557|NCT01955135|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92491558|NCT01955135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491559|NCT01955135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491560|NCT01955135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92491561|NCT01955135|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92491562|NCT01955174|Botulinum Toxins|botulinum toxins|mesh-list
92491563|NCT01955174|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92491564|NCT01955174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491565|NCT01955174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491566|NCT01955174|Cholinergic Agents|cholinergic agents|mesh-ancestor
92491567|NCT01955174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491568|NCT01955174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491569|NCT01955187|Methylprednisolone|methylprednisolone|mesh-list
92491570|NCT01955187|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92491571|NCT01955187|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92491572|NCT01955187|Prednisolone|prednisolone|mesh-list
92491573|NCT01955187|Prednisolone acetate|prednisolone acetate|mesh-list
92491574|NCT01955187|Cyclophosphamide|cyclophosphamide|mesh-list
92491575|NCT01955187|Rituximab|rituximab|mesh-list
92491576|NCT01955187|Tacrolimus|tacrolimus|mesh-list
92491577|NCT01955187|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92491578|NCT01955187|Prednisolone phosphate|prednisolone phosphate|mesh-list
92491579|NCT01955187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92491580|NCT01955187|Immunologic Factors|immunologic factors|mesh-ancestor
92491581|NCT01955187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491582|NCT01955187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491583|NCT01955187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92491584|NCT01955187|Alkylating Agents|alkylating agents|mesh-ancestor
92491585|NCT01955187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491586|NCT01955187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491587|NCT01955187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92491588|NCT01955187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92491589|NCT01955187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92491590|NCT01955187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491591|NCT01955187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92491592|NCT01955187|Antiemetics|antiemetics|mesh-ancestor
92491593|NCT01955187|Autonomic Agents|autonomic agents|mesh-ancestor
92491594|NCT01955187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491595|NCT01955187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491596|NCT01955187|Glucocorticoids|glucocorticoids|mesh-ancestor
92491597|NCT01955187|Hormones|hormones|mesh-ancestor
92491598|NCT01955187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491599|NCT01955187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92491600|NCT01955187|Protective Agents|protective agents|mesh-ancestor
92491601|NCT01955187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92491602|NCT01955200|Cilostazol|cilostazol|mesh-list
92491603|NCT01955200|Clopidogrel|clopidogrel|mesh-list
92491604|NCT01955200|Ticagrelor|ticagrelor|mesh-list
92491605|NCT01955200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92491606|NCT01955200|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92491607|NCT01955200|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92491608|NCT01955200|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92491609|NCT01955200|Purinergic Agents|purinergic agents|mesh-ancestor
92491610|NCT01955200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491611|NCT01955200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491612|NCT01955200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491613|NCT01955200|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92491615|NCT01955200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491616|NCT01955200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92491617|NCT01955200|Respiratory System Agents|respiratory system agents|mesh-ancestor
92491618|NCT01955200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92491619|NCT01955200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92491620|NCT01955200|Vasodilator Agents|vasodilator agents|mesh-ancestor
92491621|NCT01955200|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92491622|NCT01955200|Protective Agents|protective agents|mesh-ancestor
92491623|NCT01955200|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92491624|NCT01955200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92491625|NCT01955200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491626|NCT01955213|Methylnaltrexone|methylnaltrexone|mesh-list
92491627|NCT01955213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92491628|NCT01955213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491629|NCT01955213|Sensory System Agents|sensory system agents|mesh-ancestor
92491630|NCT01955213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491631|NCT01955252|Azithromycin|azithromycin|mesh-list
92491632|NCT01955252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92491633|NCT01955252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491634|NCT01955317|Chlorhexidine|chlorhexidine|mesh-list
92491635|NCT01955317|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92491636|NCT01955317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92491637|NCT01955317|Disinfectants|disinfectants|mesh-ancestor
92491638|NCT01955408|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92491639|NCT01955408|Cholinergic Agents|cholinergic agents|mesh-ancestor
92491640|NCT01955408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491641|NCT01955408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491642|NCT01955408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491643|NCT01955421|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92491644|NCT01955421|Gefitinib|gefitinib|mesh-list
92491645|NCT01955421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491646|NCT01955421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92491647|NCT01955421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491648|NCT01955421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491649|NCT01955577|Vitamin D|vitamin d|mesh-list
92491650|NCT01955577|Cholecalciferol|cholecalciferol|mesh-list
92491651|NCT01955577|Vitamins|vitamins|mesh-ancestor
92491652|NCT01955577|Micronutrients|micronutrients|mesh-ancestor
92491653|NCT01955577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491654|NCT01955577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92491655|NCT01955577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92491656|NCT01955642|Clopidogrel|clopidogrel|mesh-list
92491657|NCT01955642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92491658|NCT01955642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92491659|NCT01955642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92491660|NCT01955642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92491661|NCT01955642|Purinergic Agents|purinergic agents|mesh-ancestor
92491662|NCT01955642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491663|NCT01955642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491664|NCT01955642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491665|NCT01955655|Baclofen|baclofen|mesh-list
92491666|NCT01955655|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92491667|NCT01955655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491668|NCT01955655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92491669|NCT01955655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491670|NCT01955655|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92491671|NCT01955655|GABA Agonists|gaba agonists|mesh-ancestor
92491672|NCT01955655|GABA Agents|gaba agents|mesh-ancestor
92491673|NCT01955655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491674|NCT01955655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491675|NCT01955694|Eplerenone|eplerenone|mesh-list
92491676|NCT01955694|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92491677|NCT01955694|Hormone Antagonists|hormone antagonists|mesh-ancestor
92491678|NCT01955694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491679|NCT01955694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491680|NCT01955694|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92491681|NCT01955694|Diuretics|diuretics|mesh-ancestor
92491682|NCT01955694|Natriuretic Agents|natriuretic agents|mesh-ancestor
92491683|NCT01955694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92491684|NCT01955759|Amiodarone|amiodarone|mesh-list
92491685|NCT01955759|Bisoprolol|bisoprolol|mesh-list
92491686|NCT01955759|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92491687|NCT01955759|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92491688|NCT01955759|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92491689|NCT01955759|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92491690|NCT01955759|Antimetabolites|antimetabolites|mesh-ancestor
92491691|NCT01955759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491692|NCT01955759|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92491693|NCT01955759|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92491694|NCT01955759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491695|NCT01955759|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92491696|NCT01955759|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491697|NCT01955759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491698|NCT01955759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491699|NCT01955759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92491701|NCT01955759|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92491702|NCT01955759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491703|NCT01955759|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92491704|NCT01955759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92491705|NCT01955759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92491706|NCT01955759|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92491707|NCT01955759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92491708|NCT01955759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92491709|NCT01955759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92491710|NCT01955759|Sympatholytics|sympatholytics|mesh-ancestor
92491711|NCT01955759|Autonomic Agents|autonomic agents|mesh-ancestor
92491712|NCT01955759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491713|NCT01955759|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92491714|NCT01955824|Lidocaine|lidocaine|mesh-list
92491715|NCT01955824|Anesthetics, Local|anesthetics, local|mesh-ancestor
92491716|NCT01955824|Anesthetics|anesthetics|mesh-ancestor
92491717|NCT01955824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491718|NCT01955824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491719|NCT01955824|Sensory System Agents|sensory system agents|mesh-ancestor
92491720|NCT01955824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491721|NCT01955824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92491722|NCT01955824|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92491723|NCT01955824|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92491724|NCT01955824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491725|NCT01955824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491726|NCT01955967|Lidocaine|lidocaine|mesh-list
92491727|NCT01955967|Anesthetics, Local|anesthetics, local|mesh-ancestor
92491728|NCT01955967|Anesthetics|anesthetics|mesh-ancestor
92491729|NCT01955967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491730|NCT01955967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491731|NCT01955967|Sensory System Agents|sensory system agents|mesh-ancestor
92491732|NCT01955967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491733|NCT01955967|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92491734|NCT01955967|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92491735|NCT01955967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92491736|NCT01955967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491737|NCT01955967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491738|NCT01956006|Milrinone|milrinone|mesh-list
92491739|NCT01956006|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92491740|NCT01956006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92491741|NCT01956006|Vasodilator Agents|vasodilator agents|mesh-ancestor
92491742|NCT01956006|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92491743|NCT01956006|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92491744|NCT01956006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491745|NCT01956006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491746|NCT01956006|Protective Agents|protective agents|mesh-ancestor
92491747|NCT01956006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491748|NCT01956201|Atorvastatin|atorvastatin|mesh-list
92491749|NCT01956201|Fenofibrate|fenofibrate|mesh-list
92491750|NCT01956201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92491751|NCT01956201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92491752|NCT01956201|Antimetabolites|antimetabolites|mesh-ancestor
92491753|NCT01956201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491754|NCT01956201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92491755|NCT01956201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92491756|NCT01956201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491757|NCT01956305|Metformin|metformin|mesh-list
92491758|NCT01956305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92491759|NCT01956305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491760|NCT01956474|Riboflavin|riboflavin|mesh-list
92491761|NCT01956474|Vitamin B Complex|vitamin b complex|mesh-ancestor
92491762|NCT01956474|Vitamins|vitamins|mesh-ancestor
92491763|NCT01956474|Micronutrients|micronutrients|mesh-ancestor
92491764|NCT01956474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491765|NCT01956474|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92491766|NCT01956474|Dermatologic Agents|dermatologic agents|mesh-ancestor
92491768|NCT01956487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92491769|NCT01956487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92491770|NCT01956487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92491771|NCT01956487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491772|NCT01956487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491773|NCT01956591|Oxybutynin|oxybutynin|mesh-list
92491774|NCT01956591|Parasympatholytics|parasympatholytics|mesh-ancestor
92491775|NCT01956591|Autonomic Agents|autonomic agents|mesh-ancestor
92491776|NCT01956591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491777|NCT01956591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491778|NCT01956591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92491779|NCT01956591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92491780|NCT01956591|Cholinergic Agents|cholinergic agents|mesh-ancestor
92491781|NCT01956591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491782|NCT01956591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491783|NCT01956591|Urological Agents|urological agents|mesh-ancestor
92491784|NCT01956604|Clonidine|clonidine|mesh-list
92491785|NCT01956604|Analgesics|analgesics|mesh-ancestor
92491786|NCT01956604|Sensory System Agents|sensory system agents|mesh-ancestor
92491787|NCT01956604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491788|NCT01956604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491789|NCT01956604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92491790|NCT01956604|Sympatholytics|sympatholytics|mesh-ancestor
92491791|NCT01956604|Autonomic Agents|autonomic agents|mesh-ancestor
92491792|NCT01956604|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92491793|NCT01956604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92491794|NCT01956604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92491795|NCT01956604|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491796|NCT01956604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491797|NCT01956604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491798|NCT01956695|Rituximab|rituximab|mesh-list
92491799|NCT01956695|Lenalidomide|lenalidomide|mesh-list
92491800|NCT01956695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92491801|NCT01956695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491802|NCT01956695|Immunologic Factors|immunologic factors|mesh-ancestor
92491803|NCT01956695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491804|NCT01956695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92491805|NCT01956695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92491806|NCT01956695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92491807|NCT01956695|Growth Substances|growth substances|mesh-ancestor
92491808|NCT01956695|Growth Inhibitors|growth inhibitors|mesh-ancestor
92491809|NCT01956734|Temozolomide|temozolomide|mesh-list
92491810|NCT01956734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92491811|NCT01956734|Alkylating Agents|alkylating agents|mesh-ancestor
92491812|NCT01956734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491813|NCT01956734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491814|NCT01956786|Amlodipine|amlodipine|mesh-list
92491815|NCT01956786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92491816|NCT01956786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92491817|NCT01956786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491818|NCT01956786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491819|NCT01956786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92491820|NCT01956786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491821|NCT01956786|Vasodilator Agents|vasodilator agents|mesh-ancestor
92491822|NCT01956864|Vitamin D|vitamin d|mesh-list
92491823|NCT01956864|Vitamins|vitamins|mesh-ancestor
92491824|NCT01956864|Micronutrients|micronutrients|mesh-ancestor
92491825|NCT01956864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491826|NCT01956864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92491827|NCT01956929|Metformin|metformin|mesh-list
92491828|NCT01956929|Lactulose|lactulose|mesh-list
92491829|NCT01956929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92532289|NCT00052351|Metronidazole|metronidazole|mesh-list
92491830|NCT01956929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491831|NCT01956929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491832|NCT01956955|Heparin|heparin|mesh-list
92491833|NCT01956955|Enoxaparin|enoxaparin|mesh-list
92491834|NCT01956955|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92491835|NCT01956955|Calcium heparin|calcium heparin|mesh-list
92491836|NCT01956955|Anticoagulants|anticoagulants|mesh-ancestor
92491837|NCT01956955|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92491838|NCT01956955|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92491839|NCT01956955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491840|NCT01956981|Magnesium Sulfate|magnesium sulfate|mesh-list
92491841|NCT01956981|Dexmedetomidine|dexmedetomidine|mesh-list
92491842|NCT01956981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92491843|NCT01956981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491844|NCT01956981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491845|NCT01956981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92491846|NCT01956981|Analgesics|analgesics|mesh-ancestor
92491847|NCT01956981|Sensory System Agents|sensory system agents|mesh-ancestor
92491848|NCT01956981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491849|NCT01956981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92491850|NCT01956981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92491851|NCT01956981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92491852|NCT01956981|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491853|NCT01956981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491854|NCT01956981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491855|NCT01956981|Anesthetics|anesthetics|mesh-ancestor
92491856|NCT01956981|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92491857|NCT01956981|Anticonvulsants|anticonvulsants|mesh-ancestor
92491858|NCT01956981|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92491859|NCT01956981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92491860|NCT01956981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92491862|NCT01956981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491863|NCT01957007|Docetaxel|docetaxel|mesh-list
92491864|NCT01957007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491865|NCT01957007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491866|NCT01957007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491867|NCT01957007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491868|NCT01957007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491869|NCT01957046|Laxatives|laxatives|mesh-list
92491870|NCT01957046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491871|NCT01957189|Tamsulosin|tamsulosin|mesh-list
92491872|NCT01957189|Dutasteride|dutasteride|mesh-list
92491873|NCT01957189|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92491874|NCT01957189|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92491875|NCT01957189|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92491876|NCT01957189|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491877|NCT01957189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491878|NCT01957189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491879|NCT01957189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491880|NCT01957189|Urological Agents|urological agents|mesh-ancestor
92491881|NCT01957189|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92491882|NCT01957189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92491883|NCT01957189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491884|NCT01957189|Hormone Antagonists|hormone antagonists|mesh-ancestor
92491885|NCT01957189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491886|NCT01957293|Albuterol|albuterol|mesh-list
92491887|NCT01957293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92491888|NCT01957293|Autonomic Agents|autonomic agents|mesh-ancestor
92491889|NCT01957293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491890|NCT01957293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491891|NCT01957293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92491892|NCT01957293|Respiratory System Agents|respiratory system agents|mesh-ancestor
92491893|NCT01957293|Tocolytic Agents|tocolytic agents|mesh-ancestor
92491894|NCT01957293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92491895|NCT01957293|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92491896|NCT01957293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92491897|NCT01957293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92491898|NCT01957293|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491899|NCT01957293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491900|NCT01957293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491901|NCT01957319|Vitamin E|vitamin e|mesh-list
92491902|NCT01957319|Silybin|silybin|mesh-list
92491903|NCT01957319|Vitamins|vitamins|mesh-ancestor
92491904|NCT01957319|Micronutrients|micronutrients|mesh-ancestor
92491905|NCT01957319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491906|NCT01957319|Antioxidants|antioxidants|mesh-ancestor
92491907|NCT01957319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491908|NCT01957319|Protective Agents|protective agents|mesh-ancestor
92491909|NCT01957319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92491910|NCT01957319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491911|NCT01957436|Docetaxel|docetaxel|mesh-list
92491912|NCT01957436|Abiraterone Acetate|abiraterone acetate|mesh-list
92491913|NCT01957436|Androgens|androgens|mesh-list
92491914|NCT01957436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491915|NCT01957436|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491916|NCT01957436|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491917|NCT01957436|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491918|NCT01957436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491919|NCT01957436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92491920|NCT01957436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92491921|NCT01957436|Hormone Antagonists|hormone antagonists|mesh-ancestor
92491922|NCT01957436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491923|NCT01957436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491924|NCT01957436|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92491925|NCT01957436|Hormones|hormones|mesh-ancestor
92491926|NCT01957449|Propranolol|propranolol|mesh-list
92491927|NCT01957449|Metoprolol|metoprolol|mesh-list
92491928|NCT01957449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92491929|NCT01957449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92491930|NCT01957449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92491931|NCT01957449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491932|NCT01957449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491933|NCT01957449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491934|NCT01957449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92491935|NCT01957449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92491936|NCT01957449|Vasodilator Agents|vasodilator agents|mesh-ancestor
92491937|NCT01957449|Sympatholytics|sympatholytics|mesh-ancestor
92491938|NCT01957449|Autonomic Agents|autonomic agents|mesh-ancestor
92491939|NCT01957449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491940|NCT01957449|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92491941|NCT01957540|Ticagrelor|ticagrelor|mesh-list
92491942|NCT01957540|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92491943|NCT01957540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92491944|NCT01957540|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92491945|NCT01957540|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92491946|NCT01957540|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92491947|NCT01957540|Purinergic Agents|purinergic agents|mesh-ancestor
92491948|NCT01957540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491949|NCT01957540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491950|NCT01957540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491951|NCT01957631|Methylprednisolone|methylprednisolone|mesh-list
92491952|NCT01957631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92491953|NCT01957631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92491954|NCT01957631|Prednisolone|prednisolone|mesh-list
92491955|NCT01957631|Prednisolone acetate|prednisolone acetate|mesh-list
92491956|NCT01957631|Bupivacaine|bupivacaine|mesh-list
92491957|NCT01957631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92491958|NCT01957631|Prednisolone phosphate|prednisolone phosphate|mesh-list
92491959|NCT01957631|Anesthetics, Local|anesthetics, local|mesh-ancestor
92491960|NCT01957631|Anesthetics|anesthetics|mesh-ancestor
92491961|NCT01957631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92491962|NCT01957631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491963|NCT01957631|Sensory System Agents|sensory system agents|mesh-ancestor
92491964|NCT01957631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92491965|NCT01957631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92491966|NCT01957631|Antiemetics|antiemetics|mesh-ancestor
92491967|NCT01957631|Autonomic Agents|autonomic agents|mesh-ancestor
92491968|NCT01957631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92491969|NCT01957631|Glucocorticoids|glucocorticoids|mesh-ancestor
92491971|NCT01957631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92491972|NCT01957631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92491973|NCT01957631|Protective Agents|protective agents|mesh-ancestor
92491974|NCT01957631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92491975|NCT01957631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92491976|NCT01957839|Cabergoline|cabergoline|mesh-list
92491977|NCT01957839|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92491978|NCT01957839|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92491979|NCT01957839|Dopamine Agonists|dopamine agonists|mesh-ancestor
92491980|NCT01957839|Dopamine Agents|dopamine agents|mesh-ancestor
92491981|NCT01957839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92491982|NCT01957839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491983|NCT01957839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92491984|NCT01957852|Thrombin|thrombin|mesh-list
92491985|NCT01957852|Hemostatics|hemostatics|mesh-ancestor
92491986|NCT01957852|Coagulants|coagulants|mesh-ancestor
92491987|NCT01957943|SMOFlipid|smoflipid|mesh-list
92491988|NCT01957943|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92491989|NCT01957943|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92491990|NCT01957943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92491991|NCT01957995|Docetaxel|docetaxel|mesh-list
92491993|NCT01957995|Tubulin Modulators|tubulin modulators|mesh-ancestor
92491994|NCT01957995|Antimitotic Agents|antimitotic agents|mesh-ancestor
92491995|NCT01957995|Mitosis Modulators|mitosis modulators|mesh-ancestor
92491996|NCT01957995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92491997|NCT01958138|Propofol|propofol|mesh-list
92491998|NCT01958138|Isoflurane|isoflurane|mesh-list
92491999|NCT01958138|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92492000|NCT01958138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492001|NCT01958138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492002|NCT01958138|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92492003|NCT01958138|Anesthetics, General|anesthetics, general|mesh-ancestor
92492004|NCT01958138|Anesthetics|anesthetics|mesh-ancestor
92492005|NCT01958138|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92492006|NCT01958216|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92492007|NCT01958216|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92492008|NCT01958216|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92492009|NCT01958216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92492010|NCT01958372|Etoposide|etoposide|mesh-list
92492011|NCT01958372|Pemetrexed|pemetrexed|mesh-list
92492012|NCT01958372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492013|NCT01958372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92492014|NCT01958372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92492015|NCT01958372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492016|NCT01958372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492017|NCT01958372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492018|NCT01958372|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92492019|NCT01958372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92492020|NCT01958580|Gemcitabine|gemcitabine|mesh-list
92492021|NCT01958580|Docetaxel|docetaxel|mesh-list
92492022|NCT01958580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492023|NCT01958580|Antimetabolites|antimetabolites|mesh-ancestor
92492024|NCT01958580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492025|NCT01958580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492026|NCT01958580|Tubulin Modulators|tubulin modulators|mesh-ancestor
92492027|NCT01958580|Antimitotic Agents|antimitotic agents|mesh-ancestor
92492028|NCT01958580|Mitosis Modulators|mitosis modulators|mesh-ancestor
92492029|NCT01958684|Copper|copper|mesh-list
92492030|NCT01958684|Levonorgestrel|levonorgestrel|mesh-list
92492031|NCT01958684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92492032|NCT01958684|Contraceptive Agents|contraceptive agents|mesh-ancestor
92492033|NCT01958684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92492034|NCT01958684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492035|NCT01958684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92492036|NCT01958684|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92492037|NCT01958684|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92492038|NCT01958684|Trace Elements|trace elements|mesh-ancestor
92492039|NCT01958684|Micronutrients|micronutrients|mesh-ancestor
92492040|NCT01958775|Glucagon|glucagon|mesh-list
92492041|NCT01958775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92492042|NCT01958775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92492043|NCT01958775|Hormones|hormones|mesh-ancestor
92492044|NCT01958775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492045|NCT01958775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492046|NCT01958775|Incretins|incretins|mesh-ancestor
92492047|NCT01958814|Albuterol|albuterol|mesh-list
92492048|NCT01958814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492049|NCT01958814|Autonomic Agents|autonomic agents|mesh-ancestor
92492050|NCT01958814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492051|NCT01958814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492052|NCT01958814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92492053|NCT01958814|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492054|NCT01958814|Tocolytic Agents|tocolytic agents|mesh-ancestor
92492055|NCT01958814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92492056|NCT01958814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92492057|NCT01958814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92492058|NCT01958814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492059|NCT01958814|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492060|NCT01958814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492061|NCT01958814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492062|NCT01958866|Acetaminophen|acetaminophen|mesh-list
92492063|NCT01958866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492064|NCT01958866|Analgesics|analgesics|mesh-ancestor
92492065|NCT01958866|Sensory System Agents|sensory system agents|mesh-ancestor
92492066|NCT01958866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492067|NCT01958866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492068|NCT01958866|Antipyretics|antipyretics|mesh-ancestor
92492069|NCT01958905|Lumefantrine|lumefantrine|mesh-list
92492070|NCT01958905|Artemether|artemether|mesh-list
92492071|NCT01958905|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92492072|NCT01958905|Antimalarials|antimalarials|mesh-ancestor
92492073|NCT01958905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92492074|NCT01958905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92492075|NCT01958905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92492076|NCT01958944|Nitric Oxide|nitric oxide|mesh-list
92492077|NCT01958944|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492078|NCT01958944|Autonomic Agents|autonomic agents|mesh-ancestor
92492079|NCT01958944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492080|NCT01958944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492081|NCT01958944|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92492082|NCT01958944|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492083|NCT01958944|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92492084|NCT01958944|Antioxidants|antioxidants|mesh-ancestor
92492085|NCT01958944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492086|NCT01958944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492087|NCT01958944|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92492088|NCT01958944|Vasodilator Agents|vasodilator agents|mesh-ancestor
92492089|NCT01958944|Gasotransmitters|gasotransmitters|mesh-ancestor
92492090|NCT01958944|Protective Agents|protective agents|mesh-ancestor
92492091|NCT01958996|Idarubicin|idarubicin|mesh-list
92492092|NCT01958996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92492093|NCT01958996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492094|NCT01958996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92492095|NCT01958996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492096|NCT01958996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492097|NCT01958996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492098|NCT01959022|Doxazosin|doxazosin|mesh-list
92492099|NCT01959022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92492100|NCT01959022|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92492101|NCT01959022|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92492102|NCT01959022|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92492103|NCT01959022|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492104|NCT01959022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492105|NCT01959022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492106|NCT01959022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492107|NCT01959061|Oxaliplatin|oxaliplatin|mesh-list
92492108|NCT01959061|Ethiodized Oil|ethiodized oil|mesh-list
92492109|NCT01959061|Raltitrexed|raltitrexed|mesh-list
92492110|NCT01959061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492111|NCT01959061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492112|NCT01959061|Antimetabolites|antimetabolites|mesh-ancestor
92492113|NCT01959061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492114|NCT01959061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92492115|NCT01959061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492116|NCT01959074|Aceclofenac|aceclofenac|mesh-list
92492117|NCT01959074|Naftopidil|naftopidil|mesh-list
92492118|NCT01959074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92492119|NCT01959074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492120|NCT01959074|Analgesics|analgesics|mesh-ancestor
92492121|NCT01959074|Sensory System Agents|sensory system agents|mesh-ancestor
92492122|NCT01959074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492123|NCT01959074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492124|NCT01959074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492125|NCT01959074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492126|NCT01959074|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92492127|NCT01959074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92492128|NCT01959074|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492129|NCT01959074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492130|NCT01959074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492131|NCT01959074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92492132|NCT01959074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92492133|NCT01959074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492134|NCT01959074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92492135|NCT01959074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92492136|NCT01959100|Azithromycin|azithromycin|mesh-list
92492137|NCT01959100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92492138|NCT01959100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92492139|NCT01959152|Imidacloprid|imidacloprid|mesh-list
92492140|NCT01959152|Cholinergic Agents|cholinergic agents|mesh-ancestor
92492141|NCT01959152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492142|NCT01959152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492143|NCT01959152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492144|NCT01959191|Aspirin|aspirin|mesh-list
92492145|NCT01959191|Clopidogrel|clopidogrel|mesh-list
92492146|NCT01959191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92492147|NCT01959191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492148|NCT01959191|Analgesics|analgesics|mesh-ancestor
92492149|NCT01959191|Sensory System Agents|sensory system agents|mesh-ancestor
92492150|NCT01959191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492151|NCT01959191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492152|NCT01959191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492153|NCT01959191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492154|NCT01959191|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92492155|NCT01959191|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92492156|NCT01959191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492157|NCT01959191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92492158|NCT01959191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92492159|NCT01959191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492160|NCT01959191|Antipyretics|antipyretics|mesh-ancestor
92492161|NCT01959191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92492162|NCT01959191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92492163|NCT01959191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92492164|NCT01959191|Purinergic Agents|purinergic agents|mesh-ancestor
92492165|NCT01959191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492166|NCT01959386|Trastuzumab|trastuzumab|mesh-list
92492167|NCT01959386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92492168|NCT01959386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492169|NCT01959399|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92492170|NCT01959399|Peficitinib|peficitinib|mesh-list
92492171|NCT01959399|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92492172|NCT01959399|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92492173|NCT01959399|Antimetabolites|antimetabolites|mesh-ancestor
92492174|NCT01959399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492175|NCT01959399|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92492176|NCT01959399|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92492177|NCT01959399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492178|NCT01959399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92492179|NCT01959399|Immunologic Factors|immunologic factors|mesh-ancestor
92492180|NCT01959399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492181|NCT01959438|Selenious Acid|selenious acid|mesh-list
92492182|NCT01959438|Sodium Selenite|sodium selenite|mesh-list
92492183|NCT01959438|Trace Elements|trace elements|mesh-ancestor
92492184|NCT01959438|Micronutrients|micronutrients|mesh-ancestor
92492185|NCT01959438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492186|NCT01959451|Clopidogrel|clopidogrel|mesh-list
92492187|NCT01959451|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92492188|NCT01959451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92492189|NCT01959451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92492190|NCT01959451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92492191|NCT01959451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92492192|NCT01959451|Purinergic Agents|purinergic agents|mesh-ancestor
92492193|NCT01959451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492194|NCT01959451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492195|NCT01959451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492196|NCT01959477|Cyclophosphamide|cyclophosphamide|mesh-list
92492197|NCT01959477|Busulfan|busulfan|mesh-list
92492198|NCT01959477|Etoposide|etoposide|mesh-list
92492199|NCT01959477|Etoposide phosphate|etoposide phosphate|mesh-list
92492200|NCT01959477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92492201|NCT01959477|Immunologic Factors|immunologic factors|mesh-ancestor
92492202|NCT01959477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492203|NCT01959477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492204|NCT01959477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92492205|NCT01959477|Alkylating Agents|alkylating agents|mesh-ancestor
92492206|NCT01959477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492207|NCT01959477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492208|NCT01959477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92492209|NCT01959477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92492210|NCT01959477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92492211|NCT01959477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492212|NCT01959477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492213|NCT01959828|Nitric Oxide|nitric oxide|mesh-list
92492214|NCT01959828|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492215|NCT01959828|Autonomic Agents|autonomic agents|mesh-ancestor
92492216|NCT01959828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492217|NCT01959828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492218|NCT01959828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92492219|NCT01959828|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492220|NCT01959828|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92492221|NCT01959828|Antioxidants|antioxidants|mesh-ancestor
92492222|NCT01959828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492223|NCT01959828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492224|NCT01959828|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92492225|NCT01959828|Vasodilator Agents|vasodilator agents|mesh-ancestor
92492226|NCT01959828|Gasotransmitters|gasotransmitters|mesh-ancestor
92492227|NCT01959828|Protective Agents|protective agents|mesh-ancestor
92492228|NCT01959854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92492229|NCT01959854|Laxatives|laxatives|mesh-ancestor
92492230|NCT01959854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92492231|NCT01959971|Alirocumab|alirocumab|mesh-list
92492232|NCT01959971|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92492233|NCT01959971|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92492234|NCT01959971|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92492235|NCT01959971|Antimetabolites|antimetabolites|mesh-ancestor
92492236|NCT01959971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492237|NCT01959971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92492238|NCT01959971|Protease Inhibitors|protease inhibitors|mesh-ancestor
92492239|NCT01959971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492240|NCT01959971|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92492241|NCT01960023|Cetuximab|cetuximab|mesh-list
92492242|NCT01960023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92492243|NCT01960023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492244|NCT01960049|Ropivacaine|ropivacaine|mesh-list
92492245|NCT01960049|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492246|NCT01960049|Anesthetics|anesthetics|mesh-ancestor
92492247|NCT01960049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492248|NCT01960049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492249|NCT01960049|Sensory System Agents|sensory system agents|mesh-ancestor
92492250|NCT01960049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492251|NCT01960153|Tadalafil|tadalafil|mesh-list
92492252|NCT01960153|Vasodilator Agents|vasodilator agents|mesh-ancestor
92492253|NCT01960153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92492254|NCT01960153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92492255|NCT01960153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492256|NCT01960153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492257|NCT01960153|Urological Agents|urological agents|mesh-ancestor
92492258|NCT01960179|Lixisenatide|lixisenatide|mesh-list
92492259|NCT01960179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92492260|NCT01960179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492261|NCT01960205|Metformin|metformin|mesh-list
92492262|NCT01960205|Saxagliptin|saxagliptin|mesh-list
92492263|NCT01960205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92492264|NCT01960205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492265|NCT01960205|Incretins|incretins|mesh-ancestor
92492266|NCT01960205|Hormones|hormones|mesh-ancestor
92492267|NCT01960205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492268|NCT01960205|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92492269|NCT01960205|Protease Inhibitors|protease inhibitors|mesh-ancestor
92492270|NCT01960205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492271|NCT01960205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492272|NCT01960283|Methotrexate|methotrexate|mesh-list
92492273|NCT01960283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92492274|NCT01960283|Abortifacient Agents|abortifacient agents|mesh-ancestor
92492275|NCT01960283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92492276|NCT01960283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492277|NCT01960283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492278|NCT01960283|Antimetabolites|antimetabolites|mesh-ancestor
92492279|NCT01960283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492280|NCT01960283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492281|NCT01960283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92492282|NCT01960283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492283|NCT01960283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92492284|NCT01960283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92492285|NCT01960283|Immunologic Factors|immunologic factors|mesh-ancestor
92492286|NCT01960283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492287|NCT01960283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92492288|NCT01960426|Adalimumab|adalimumab|mesh-list
92492289|NCT01960426|Infliximab|infliximab|mesh-list
92492290|NCT01960426|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92492291|NCT01960426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492292|NCT01960426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492293|NCT01960426|Dermatologic Agents|dermatologic agents|mesh-ancestor
92492294|NCT01960426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92492296|NCT01960543|Bupivacaine|bupivacaine|mesh-list
92492297|NCT01960543|Levobupivacaine|levobupivacaine|mesh-list
92492298|NCT01960543|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492299|NCT01960543|Anesthetics|anesthetics|mesh-ancestor
92492300|NCT01960543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492301|NCT01960543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492302|NCT01960543|Sensory System Agents|sensory system agents|mesh-ancestor
92492303|NCT01960543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492304|NCT01960543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92492305|NCT01960543|Narcotics|narcotics|mesh-ancestor
92492306|NCT01960543|Analgesics|analgesics|mesh-ancestor
92492307|NCT01960543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92492308|NCT01960543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92492309|NCT01960543|Anesthetics, General|anesthetics, general|mesh-ancestor
92492310|NCT01960569|Hirudins|hirudins|mesh-list
92492311|NCT01960569|Antithrombins|antithrombins|mesh-ancestor
92492312|NCT01960569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92492313|NCT01960569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92492314|NCT01960569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492315|NCT01960569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492316|NCT01960569|Anticoagulants|anticoagulants|mesh-ancestor
92492317|NCT01960569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92492318|NCT01960569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92492319|NCT01960595|Fentanyl|fentanyl|mesh-list
92492320|NCT01960595|Bupivacaine|bupivacaine|mesh-list
92492321|NCT01960595|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492322|NCT01960595|Anesthetics|anesthetics|mesh-ancestor
92492323|NCT01960595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492324|NCT01960595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492325|NCT01960595|Sensory System Agents|sensory system agents|mesh-ancestor
92492326|NCT01960595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492327|NCT01960595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92492328|NCT01960595|Narcotics|narcotics|mesh-ancestor
92492329|NCT01960595|Analgesics|analgesics|mesh-ancestor
92492330|NCT01960595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92492331|NCT01960595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92492332|NCT01960595|Anesthetics, General|anesthetics, general|mesh-ancestor
92492333|NCT01960647|Paclitaxel|paclitaxel|mesh-list
92492334|NCT01960647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92492335|NCT01960647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492336|NCT01960647|Tubulin Modulators|tubulin modulators|mesh-ancestor
92492337|NCT01960647|Antimitotic Agents|antimitotic agents|mesh-ancestor
92492338|NCT01960647|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532582|NCT00054106|Fertility Agents|fertility agents|mesh-ancestor
92492339|NCT01960647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492340|NCT01960764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92492341|NCT01960764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92492342|NCT01960829|Everolimus|everolimus|mesh-list
92492343|NCT01960829|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92492344|NCT01960829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92492345|NCT01960829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492346|NCT01960829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492347|NCT01960829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92492348|NCT01960829|Immunologic Factors|immunologic factors|mesh-ancestor
92492349|NCT01960829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492350|NCT01960829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492351|NCT01961154|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92492352|NCT01961154|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92492353|NCT01961154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92492354|NCT01961154|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492355|NCT01961154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492356|NCT01961154|Autonomic Agents|autonomic agents|mesh-ancestor
92492357|NCT01961154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492358|NCT01961154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492359|NCT01961154|Glucocorticoids|glucocorticoids|mesh-ancestor
92492360|NCT01961154|Hormones|hormones|mesh-ancestor
92492361|NCT01961154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492362|NCT01961154|Sympathomimetics|sympathomimetics|mesh-ancestor
92492363|NCT01961180|Escitalopram|escitalopram|mesh-list
92492364|NCT01961180|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92217254|NCT00987415|Allopurinol|allopurinol|mesh-list
92492365|NCT01961180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92492366|NCT01961180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492367|NCT01961180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492368|NCT01961180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492369|NCT01961180|Serotonin Agents|serotonin agents|mesh-ancestor
92492370|NCT01961180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492372|NCT01961193|Trace Elements|trace elements|mesh-ancestor
92492373|NCT01961193|Micronutrients|micronutrients|mesh-ancestor
92492374|NCT01961193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492375|NCT01961219|Anesthetics|anesthetics|mesh-list
92492376|NCT01961219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492377|NCT01961219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492378|NCT01961336|Testosterone|testosterone|mesh-list
92492379|NCT01961336|Androgens|androgens|mesh-ancestor
92492380|NCT01961336|Hormones|hormones|mesh-ancestor
92492381|NCT01961336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492382|NCT01961336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492383|NCT01961388|Metformin|metformin|mesh-list
92492384|NCT01961388|Acarbose|acarbose|mesh-list
92492385|NCT01961388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92492386|NCT01961388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492387|NCT01961388|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92492388|NCT01961388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492389|NCT01961388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492390|NCT01961414|Aflibercept|aflibercept|mesh-list
92492391|NCT01961414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92492392|NCT01961414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92492393|NCT01961414|Growth Substances|growth substances|mesh-ancestor
92492394|NCT01961414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492395|NCT01961414|Growth Inhibitors|growth inhibitors|mesh-ancestor
92492396|NCT01961414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492397|NCT01961453|Isosorbide|isosorbide|mesh-list
92492398|NCT01961453|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92492399|NCT01961453|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92492400|NCT01961453|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92492401|NCT01961453|Diuretics|diuretics|mesh-ancestor
92492402|NCT01961453|Natriuretic Agents|natriuretic agents|mesh-ancestor
92492403|NCT01961453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492404|NCT01961453|Vasodilator Agents|vasodilator agents|mesh-ancestor
92492405|NCT01961453|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92492406|NCT01961453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492407|NCT01961635|Cimetidine|cimetidine|mesh-list
92492408|NCT01961635|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92492409|NCT01961635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92492410|NCT01961635|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92492411|NCT01961635|Histamine Antagonists|histamine antagonists|mesh-ancestor
92492412|NCT01961635|Histamine Agents|histamine agents|mesh-ancestor
92492413|NCT01961635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492414|NCT01961635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492415|NCT01961635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492416|NCT01961635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92492417|NCT01961635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92492418|NCT01961635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492419|NCT01961739|Lidocaine|lidocaine|mesh-list
92492420|NCT01961739|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492421|NCT01961739|Anesthetics|anesthetics|mesh-ancestor
92492422|NCT01961739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492423|NCT01961739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492424|NCT01961739|Sensory System Agents|sensory system agents|mesh-ancestor
92492425|NCT01961739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492426|NCT01961739|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92492427|NCT01961739|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92492428|NCT01961739|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92492429|NCT01961739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492430|NCT01961739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492431|NCT01961752|Triamcinolone|triamcinolone|mesh-list
92492432|NCT01961752|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92492433|NCT01961752|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92492434|NCT01961752|Bupivacaine|bupivacaine|mesh-list
92492435|NCT01961752|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92492436|NCT01961752|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492437|NCT01961752|Anesthetics|anesthetics|mesh-ancestor
92492438|NCT01961752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492439|NCT01961752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492440|NCT01961752|Sensory System Agents|sensory system agents|mesh-ancestor
92492441|NCT01961752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492442|NCT01961752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492443|NCT01961752|Glucocorticoids|glucocorticoids|mesh-ancestor
92492444|NCT01961752|Hormones|hormones|mesh-ancestor
92492445|NCT01961752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492446|NCT01961752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92492447|NCT01961752|Immunologic Factors|immunologic factors|mesh-ancestor
92492448|NCT01961752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492449|NCT01961752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492450|NCT01961830|Arbekacin|arbekacin|mesh-list
92492451|NCT01961830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92492452|NCT01961830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92492453|NCT01961843|Prednisone|prednisone|mesh-list
92492454|NCT01961843|Abiraterone Acetate|abiraterone acetate|mesh-list
92492455|NCT01961843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492456|NCT01961843|Glucocorticoids|glucocorticoids|mesh-ancestor
92492457|NCT01961843|Hormones|hormones|mesh-ancestor
92492458|NCT01961843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492459|NCT01961843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492460|NCT01961843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92492461|NCT01961843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492462|NCT01961843|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92492463|NCT01961843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492464|NCT01961843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492465|NCT01961843|Hormone Antagonists|hormone antagonists|mesh-ancestor
92492466|NCT01961843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92492467|NCT01961856|Clopidogrel|clopidogrel|mesh-list
92492468|NCT01961856|Ticagrelor|ticagrelor|mesh-list
92492469|NCT01961856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92492470|NCT01961856|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92492471|NCT01961856|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92492472|NCT01961856|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92492473|NCT01961856|Purinergic Agents|purinergic agents|mesh-ancestor
92492474|NCT01961856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492475|NCT01961856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492476|NCT01961856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492477|NCT01961947|Vaccines|vaccines|mesh-list
92492478|NCT01961947|Immunologic Factors|immunologic factors|mesh-ancestor
92492479|NCT01961947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492480|NCT01962116|Heparin|heparin|mesh-list
92492481|NCT01962116|Calcium heparin|calcium heparin|mesh-list
92492482|NCT01962116|Anticoagulants|anticoagulants|mesh-ancestor
92492483|NCT01962116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492484|NCT01962116|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92492485|NCT01962116|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92492486|NCT01962181|Methylphenidate|methylphenidate|mesh-list
92492487|NCT01962181|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92492488|NCT01962181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492489|NCT01962181|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92492490|NCT01962181|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92492491|NCT01962181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492492|NCT01962181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492493|NCT01962181|Dopamine Agents|dopamine agents|mesh-ancestor
92492494|NCT01962181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492495|NCT01962285|Propofol|propofol|mesh-list
92492496|NCT01962285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92492497|NCT01962285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492498|NCT01962285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492499|NCT01962285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92492500|NCT01962285|Anesthetics, General|anesthetics, general|mesh-ancestor
92492501|NCT01962285|Anesthetics|anesthetics|mesh-ancestor
92492502|NCT01962363|Tocotrienols|tocotrienols|mesh-list
92492503|NCT01962363|Tocotrienol, alpha|tocotrienol, alpha|mesh-list
92492504|NCT01962363|Antioxidants|antioxidants|mesh-ancestor
92492505|NCT01962363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492506|NCT01962363|Protective Agents|protective agents|mesh-ancestor
92492507|NCT01962363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492508|NCT01962363|Vitamins|vitamins|mesh-ancestor
92492509|NCT01962363|Micronutrients|micronutrients|mesh-ancestor
92492510|NCT01962376|Bevacizumab|bevacizumab|mesh-list
92492511|NCT01962376|Capecitabine|capecitabine|mesh-list
92492512|NCT01962376|Oxaliplatin|oxaliplatin|mesh-list
92217404|NCT03018535|Hormones|hormones|mesh-ancestor
92492513|NCT01962376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92492514|NCT01962376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492515|NCT01962376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92492516|NCT01962376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92492517|NCT01962376|Growth Substances|growth substances|mesh-ancestor
92492518|NCT01962376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492519|NCT01962376|Growth Inhibitors|growth inhibitors|mesh-ancestor
92492520|NCT01962376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492522|NCT01962376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492523|NCT01962454|Methyltestosterone|methyltestosterone|mesh-list
92492524|NCT01962454|Testosterone|testosterone|mesh-list
92492525|NCT01962454|Testosterone undecanoate|testosterone undecanoate|mesh-list
92492526|NCT01962454|Testosterone enanthate|testosterone enanthate|mesh-list
92492527|NCT01962454|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92492528|NCT01962454|Androgens|androgens|mesh-ancestor
92492529|NCT01962454|Hormones|hormones|mesh-ancestor
92492530|NCT01962454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492531|NCT01962454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492532|NCT01962454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92492533|NCT01962454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492534|NCT01962454|Anabolic Agents|anabolic agents|mesh-ancestor
92492535|NCT01962571|Epoetin Alfa|epoetin alfa|mesh-list
92492536|NCT01962571|Hematinics|hematinics|mesh-ancestor
92492537|NCT01962831|Dinoprostone|dinoprostone|mesh-list
92492538|NCT01962831|Oxytocics|oxytocics|mesh-ancestor
92492539|NCT01962831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92492540|NCT01962831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492541|NCT01963039|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92492542|NCT01963039|Vasodilator Agents|vasodilator agents|mesh-ancestor
92492543|NCT01963039|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92492544|NCT01963039|Protective Agents|protective agents|mesh-ancestor
92492545|NCT01963039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492546|NCT01963182|Irinotecan|irinotecan|mesh-list
92492547|NCT01963182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92492548|NCT01963182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492549|NCT01963182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492550|NCT01963182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492551|NCT01963182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492552|NCT01963221|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92492553|NCT01963221|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92492554|NCT01963221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492555|NCT01963299|Clonidine|clonidine|mesh-list
92492557|NCT01963299|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492558|NCT01963299|Anesthetics|anesthetics|mesh-ancestor
92492559|NCT01963299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492560|NCT01963299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492561|NCT01963299|Sensory System Agents|sensory system agents|mesh-ancestor
92492562|NCT01963299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492563|NCT01963299|Analgesics|analgesics|mesh-ancestor
92492564|NCT01963299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92492565|NCT01963299|Sympatholytics|sympatholytics|mesh-ancestor
92492566|NCT01963299|Autonomic Agents|autonomic agents|mesh-ancestor
92492567|NCT01963299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92492568|NCT01963299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92492569|NCT01963299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492570|NCT01963299|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492571|NCT01963299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492572|NCT01963299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492573|NCT01963325|Paclitaxel|paclitaxel|mesh-list
92492574|NCT01963325|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92492575|NCT01963325|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92492576|NCT01963325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492577|NCT01963325|Tubulin Modulators|tubulin modulators|mesh-ancestor
92349427|NCT01473732|Tacrolimus|tacrolimus|mesh-list
92492578|NCT01963325|Antimitotic Agents|antimitotic agents|mesh-ancestor
92492579|NCT01963325|Mitosis Modulators|mitosis modulators|mesh-ancestor
92492580|NCT01963325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492581|NCT01963390|Testosterone|testosterone|mesh-list
92492582|NCT01963390|Androgens|androgens|mesh-ancestor
92492583|NCT01963390|Hormones|hormones|mesh-ancestor
92492584|NCT01963390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492585|NCT01963390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492586|NCT01963416|Micronutrients|micronutrients|mesh-list
92492587|NCT01963416|Trace Elements|trace elements|mesh-list
92492588|NCT01963416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492589|NCT01963442|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92492590|NCT01963442|Lactams|lactams|mesh-list
92492591|NCT01963442|beta-Lactams|beta-lactams|mesh-list
92492592|NCT01963442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92492593|NCT01963442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92492594|NCT01963442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92492595|NCT01963442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492596|NCT01963442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492597|NCT01963546|Dexmedetomidine|dexmedetomidine|mesh-list
92492598|NCT01963546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492599|NCT01963546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492600|NCT01963546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92492601|NCT01963546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492602|NCT01963546|Analgesics|analgesics|mesh-ancestor
92492603|NCT01963546|Sensory System Agents|sensory system agents|mesh-ancestor
92492604|NCT01963546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492605|NCT01963546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92492606|NCT01963546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92492607|NCT01963546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492608|NCT01963546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492609|NCT01963546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492610|NCT01963546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492611|NCT01963559|Lidocaine|lidocaine|mesh-list
92492612|NCT01963559|Prilocaine|prilocaine|mesh-list
92492613|NCT01963559|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92492614|NCT01963559|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492615|NCT01963559|Anesthetics|anesthetics|mesh-ancestor
92492616|NCT01963559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492617|NCT01963559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492618|NCT01963559|Sensory System Agents|sensory system agents|mesh-ancestor
92492619|NCT01963559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492620|NCT01963559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92492621|NCT01963559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92492622|NCT01963559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92492623|NCT01963559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492624|NCT01963559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492625|NCT01963559|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92492626|NCT01963663|Metformin|metformin|mesh-list
92492627|NCT01963663|Pioglitazone|pioglitazone|mesh-list
92492628|NCT01963663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92492629|NCT01963663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492630|NCT01963702|Capecitabine|capecitabine|mesh-list
92492631|NCT01963702|Oxaliplatin|oxaliplatin|mesh-list
92492632|NCT01963702|Docetaxel|docetaxel|mesh-list
92492633|NCT01963702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492634|NCT01963702|Antimetabolites|antimetabolites|mesh-ancestor
92492635|NCT01963702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492636|NCT01963702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492637|NCT01963702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92492638|NCT01963702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92492639|NCT01963702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92492640|NCT01963741|Histamine|histamine|mesh-list
92492641|NCT01963741|Histamine Agonists|histamine agonists|mesh-ancestor
92492642|NCT01963741|Histamine Agents|histamine agents|mesh-ancestor
92492643|NCT01963741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492644|NCT01963741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492645|NCT01963741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492646|NCT01963754|Epinephrine|epinephrine|mesh-list
92492647|NCT01963754|Racepinephrine|racepinephrine|mesh-list
92492648|NCT01963754|Anesthetics|anesthetics|mesh-list
92492649|NCT01963754|Carticaine|carticaine|mesh-list
92492650|NCT01963754|Epinephryl borate|epinephryl borate|mesh-list
92492651|NCT01963754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492652|NCT01963754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492653|NCT01963754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92492654|NCT01963754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492655|NCT01963754|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492656|NCT01963754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492657|NCT01963754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492658|NCT01963754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92492659|NCT01963754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492660|NCT01963754|Autonomic Agents|autonomic agents|mesh-ancestor
92492661|NCT01963754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217559|NCT03161158|Diuretics|diuretics|mesh-list
92492663|NCT01963754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492664|NCT01963754|Mydriatics|mydriatics|mesh-ancestor
92492665|NCT01963754|Sympathomimetics|sympathomimetics|mesh-ancestor
92492666|NCT01963754|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92492667|NCT01963754|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492668|NCT01963754|Sensory System Agents|sensory system agents|mesh-ancestor
92492669|NCT01963832|Fluoxetine|fluoxetine|mesh-list
92492670|NCT01963832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92492671|NCT01963832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92492672|NCT01963832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492673|NCT01963832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492674|NCT01963832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492675|NCT01963832|Serotonin Agents|serotonin agents|mesh-ancestor
92492676|NCT01963832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492677|NCT01963832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92492678|NCT01963832|Antidepressive Agents|antidepressive agents|mesh-ancestor
92492679|NCT01963832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92492680|NCT01963832|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92492681|NCT01963832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92492682|NCT01963832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492683|NCT01963910|Mannitol|mannitol|mesh-list
92492684|NCT01963910|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92492685|NCT01963910|Diuretics|diuretics|mesh-ancestor
92492686|NCT01963910|Natriuretic Agents|natriuretic agents|mesh-ancestor
92492687|NCT01963910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492688|NCT01963962|Copper|copper|mesh-list
92492689|NCT01963962|Levonorgestrel|levonorgestrel|mesh-list
92492690|NCT01963962|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92492691|NCT01963962|Contraceptive Agents|contraceptive agents|mesh-ancestor
92492692|NCT01963962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92492693|NCT01963962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492694|NCT01963962|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92492695|NCT01963962|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92492696|NCT01963962|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92492697|NCT01963962|Trace Elements|trace elements|mesh-ancestor
92492698|NCT01963962|Micronutrients|micronutrients|mesh-ancestor
92492699|NCT01964001|Vitamins|vitamins|mesh-list
92492700|NCT01964001|Coenzyme Q10|coenzyme q10|mesh-list
92492701|NCT01964001|Vitamin B 6|vitamin b 6|mesh-list
92492702|NCT01964001|Pyridoxal|pyridoxal|mesh-list
92492703|NCT01964001|Pyridoxine|pyridoxine|mesh-list
92492704|NCT01964001|Vitamin B Complex|vitamin b complex|mesh-list
92492705|NCT01964001|Ubiquinone|ubiquinone|mesh-list
92492706|NCT01964001|Micronutrients|micronutrients|mesh-ancestor
92492707|NCT01964001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492708|NCT01964027|Irinotecan|irinotecan|mesh-list
92492709|NCT01964027|Epirubicin|epirubicin|mesh-list
92492710|NCT01964027|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92492711|NCT01964027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492712|NCT01964027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492713|NCT01964027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492714|NCT01964027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492715|NCT01964027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92492716|NCT01964027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92492717|NCT01964040|Dexmedetomidine|dexmedetomidine|mesh-list
92492718|NCT01964040|Bupivacaine|bupivacaine|mesh-list
92492719|NCT01964040|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492720|NCT01964040|Anesthetics|anesthetics|mesh-ancestor
92492721|NCT01964040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492722|NCT01964040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492723|NCT01964040|Sensory System Agents|sensory system agents|mesh-ancestor
92492724|NCT01964040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492725|NCT01964040|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92492726|NCT01964040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492727|NCT01964040|Analgesics|analgesics|mesh-ancestor
92492728|NCT01964040|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92492729|NCT01964040|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92492730|NCT01964040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492731|NCT01964040|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492732|NCT01964040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492733|NCT01964040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492734|NCT01964079|Losartan|losartan|mesh-list
92492735|NCT01964079|Amlodipine|amlodipine|mesh-list
92492736|NCT01964079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92492737|NCT01964079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92492738|NCT01964079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492739|NCT01964079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492740|NCT01964079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92492741|NCT01964079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492742|NCT01964079|Vasodilator Agents|vasodilator agents|mesh-ancestor
92492743|NCT01964079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92492744|NCT01964079|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92492745|NCT01964079|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92492746|NCT01964157|Ceritinib|ceritinib|mesh-list
92492747|NCT01964157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492748|NCT01964157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92492749|NCT01964157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492750|NCT01964157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492751|NCT01964170|Goserelin|goserelin|mesh-list
92492752|NCT01964170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92492753|NCT01964170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492754|NCT01964183|Mirabegron|mirabegron|mesh-list
92492755|NCT01964183|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92492756|NCT01964183|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92492757|NCT01964183|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92492758|NCT01964183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492759|NCT01964183|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492760|NCT01964183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492761|NCT01964183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492762|NCT01964183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492763|NCT01964183|Urological Agents|urological agents|mesh-ancestor
92492764|NCT01964183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92492765|NCT01964183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92492766|NCT01964183|Cholinergic Agents|cholinergic agents|mesh-ancestor
92492767|NCT01964248|Lidocaine|lidocaine|mesh-list
92492768|NCT01964248|Prilocaine|prilocaine|mesh-list
92492769|NCT01964248|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92492770|NCT01964248|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492771|NCT01964248|Anesthetics|anesthetics|mesh-ancestor
92492772|NCT01964248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492773|NCT01964248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492774|NCT01964248|Sensory System Agents|sensory system agents|mesh-ancestor
92492775|NCT01964248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492776|NCT01964248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92492777|NCT01964248|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92492778|NCT01964248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92492779|NCT01964248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492780|NCT01964248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492781|NCT01964248|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92492782|NCT01964287|Leucovorin|leucovorin|mesh-list
92492783|NCT01964287|Paclitaxel|paclitaxel|mesh-list
92492784|NCT01964287|Gemcitabine|gemcitabine|mesh-list
92492785|NCT01964287|Oxaliplatin|oxaliplatin|mesh-list
92492786|NCT01964287|Irinotecan|irinotecan|mesh-list
92492787|NCT01964287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92492788|NCT01964287|Folfirinox|folfirinox|mesh-list
92492789|NCT01964287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92492790|NCT01964287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492791|NCT01964287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92492792|NCT01964287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92492793|NCT01964287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92492794|NCT01964287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492795|NCT01964287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492796|NCT01964287|Antimetabolites|antimetabolites|mesh-ancestor
92492797|NCT01964287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92492798|NCT01964287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492799|NCT01964287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492800|NCT01964287|Antidotes|antidotes|mesh-ancestor
92492801|NCT01964287|Protective Agents|protective agents|mesh-ancestor
92492802|NCT01964287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492803|NCT01964287|Vitamin B Complex|vitamin b complex|mesh-ancestor
92492804|NCT01964287|Vitamins|vitamins|mesh-ancestor
92492805|NCT01964287|Micronutrients|micronutrients|mesh-ancestor
92492806|NCT01964365|Fenofibric acid|fenofibric acid|mesh-list
92492807|NCT01964365|Fenofibrate|fenofibrate|mesh-list
92492808|NCT01964365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92492809|NCT01964365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92492810|NCT01964365|Antimetabolites|antimetabolites|mesh-ancestor
92492811|NCT01964365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492812|NCT01964365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92492813|NCT01964391|Paclitaxel|paclitaxel|mesh-list
92492814|NCT01964391|Docetaxel|docetaxel|mesh-list
92492815|NCT01964391|Cyclophosphamide|cyclophosphamide|mesh-list
92492816|NCT01964391|Carboplatin|carboplatin|mesh-list
92492817|NCT01964391|Doxorubicin|doxorubicin|mesh-list
92492818|NCT01964391|Trastuzumab|trastuzumab|mesh-list
92492819|NCT01964391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92492820|NCT01964391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492821|NCT01964391|Tubulin Modulators|tubulin modulators|mesh-ancestor
92492822|NCT01964391|Antimitotic Agents|antimitotic agents|mesh-ancestor
92492823|NCT01964391|Mitosis Modulators|mitosis modulators|mesh-ancestor
92492824|NCT01964391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492825|NCT01964391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92492826|NCT01964391|Immunologic Factors|immunologic factors|mesh-ancestor
92492827|NCT01964391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492828|NCT01964391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492829|NCT01964391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92492830|NCT01964391|Alkylating Agents|alkylating agents|mesh-ancestor
92492831|NCT01964391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92492832|NCT01964391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92492833|NCT01964391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92492834|NCT01964391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92492835|NCT01964391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492836|NCT01964391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92492837|NCT01964404|Dronabinol|dronabinol|mesh-list
92492838|NCT01964404|Hallucinogens|hallucinogens|mesh-ancestor
92492839|NCT01964404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492840|NCT01964404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92492841|NCT01964404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492842|NCT01964404|Analgesics|analgesics|mesh-ancestor
92492843|NCT01964404|Sensory System Agents|sensory system agents|mesh-ancestor
92492844|NCT01964404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492845|NCT01964404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92492846|NCT01964404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92492847|NCT01964404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492848|NCT01964404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492849|NCT01964404|Hormones|hormones|mesh-ancestor
92532596|NCT00054340|Methotrexate|methotrexate|mesh-list
92492850|NCT01964404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492851|NCT01964534|Gemcitabine|gemcitabine|mesh-list
92492852|NCT01964534|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92492853|NCT01964534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92492854|NCT01964534|Antimetabolites|antimetabolites|mesh-ancestor
92492855|NCT01964534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492856|NCT01964534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492857|NCT01964573|Rotigotine|rotigotine|mesh-list
92492858|NCT01964573|Dopamine Agonists|dopamine agonists|mesh-ancestor
92492859|NCT01964573|Dopamine Agents|dopamine agents|mesh-ancestor
92492860|NCT01964573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492861|NCT01964573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492862|NCT01964573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492863|NCT01964586|Lidocaine|lidocaine|mesh-list
92492864|NCT01964586|Epinephrine|epinephrine|mesh-list
92492865|NCT01964586|Racepinephrine|racepinephrine|mesh-list
92492866|NCT01964586|Dexmedetomidine|dexmedetomidine|mesh-list
92492867|NCT01964586|Epinephryl borate|epinephryl borate|mesh-list
92492868|NCT01964586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492869|NCT01964586|Anesthetics|anesthetics|mesh-ancestor
92492870|NCT01964586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492871|NCT01964586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492872|NCT01964586|Sensory System Agents|sensory system agents|mesh-ancestor
92492873|NCT01964586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492874|NCT01964586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92492875|NCT01964586|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92492876|NCT01964586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92492877|NCT01964586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92492878|NCT01964586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492879|NCT01964586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92492880|NCT01964586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492881|NCT01964586|Analgesics|analgesics|mesh-ancestor
92492882|NCT01964586|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92492883|NCT01964586|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92492884|NCT01964586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492885|NCT01964586|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492886|NCT01964586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492887|NCT01964586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92492888|NCT01964586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492889|NCT01964586|Autonomic Agents|autonomic agents|mesh-ancestor
92492890|NCT01964586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92492891|NCT01964586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492892|NCT01964586|Mydriatics|mydriatics|mesh-ancestor
92492893|NCT01964586|Sympathomimetics|sympathomimetics|mesh-ancestor
92492894|NCT01964586|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92492895|NCT01964651|JNJ-42165279|jnj-42165279|mesh-list
92492896|NCT01964651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492897|NCT01964651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492898|NCT01964781|Epinephrine|epinephrine|mesh-list
92492899|NCT01964781|Racepinephrine|racepinephrine|mesh-list
92492900|NCT01964781|Bupivacaine|bupivacaine|mesh-list
92492901|NCT01964781|Tranexamic Acid|tranexamic acid|mesh-list
92492902|NCT01964781|Epinephryl borate|epinephryl borate|mesh-list
92492903|NCT01964781|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492904|NCT01964781|Anesthetics|anesthetics|mesh-ancestor
92492905|NCT01964781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492906|NCT01964781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492907|NCT01964781|Sensory System Agents|sensory system agents|mesh-ancestor
92492908|NCT01964781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492909|NCT01964781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92492910|NCT01964781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92492911|NCT01964781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492912|NCT01964781|Hemostatics|hemostatics|mesh-ancestor
92492913|NCT01964781|Coagulants|coagulants|mesh-ancestor
92492914|NCT01964781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92492915|NCT01964781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92492916|NCT01964781|Adrenergic Agents|adrenergic agents|mesh-ancestor
92492917|NCT01964781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492918|NCT01964781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92492919|NCT01964781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92492920|NCT01964781|Autonomic Agents|autonomic agents|mesh-ancestor
92492921|NCT01964781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92492922|NCT01964781|Respiratory System Agents|respiratory system agents|mesh-ancestor
92492923|NCT01964781|Mydriatics|mydriatics|mesh-ancestor
92492924|NCT01964781|Sympathomimetics|sympathomimetics|mesh-ancestor
92492925|NCT01964781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92492927|NCT01964846|Resveratrol|resveratrol|mesh-list
92492928|NCT01964846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92492929|NCT01964846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92492930|NCT01964846|Analgesics|analgesics|mesh-ancestor
92492931|NCT01964846|Sensory System Agents|sensory system agents|mesh-ancestor
92492932|NCT01964846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492933|NCT01964846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492934|NCT01964846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492935|NCT01964846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92492936|NCT01964846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492937|NCT01964846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492938|NCT01964846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492939|NCT01964846|Antioxidants|antioxidants|mesh-ancestor
92492940|NCT01964846|Protective Agents|protective agents|mesh-ancestor
92492941|NCT01964846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92492942|NCT01964911|Ropivacaine|ropivacaine|mesh-list
92492943|NCT01964911|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492944|NCT01964911|Anesthetics|anesthetics|mesh-ancestor
92492945|NCT01964911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492946|NCT01964911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492947|NCT01964911|Sensory System Agents|sensory system agents|mesh-ancestor
92492948|NCT01964911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492949|NCT01965041|Aflibercept|aflibercept|mesh-list
92492950|NCT01965041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92492951|NCT01965041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92492952|NCT01965041|Growth Substances|growth substances|mesh-ancestor
92492953|NCT01965041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492954|NCT01965041|Growth Inhibitors|growth inhibitors|mesh-ancestor
92492955|NCT01965041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492956|NCT01965080|Exemestane|exemestane|mesh-list
92492957|NCT01965080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492958|NCT01965080|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92492959|NCT01965080|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92492960|NCT01965080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492961|NCT01965080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492962|NCT01965080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92492963|NCT01965080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92492964|NCT01965080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92492965|NCT01965080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492966|NCT01965275|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92492967|NCT01965275|Gefitinib|gefitinib|mesh-list
92492968|NCT01965275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92492969|NCT01965275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92492970|NCT01965275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92492971|NCT01965275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492972|NCT01965301|Diphenhydramine|diphenhydramine|mesh-list
92492973|NCT01965301|Promethazine|promethazine|mesh-list
92492974|NCT01965301|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92492975|NCT01965301|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92492976|NCT01965301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92492977|NCT01965301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92492978|NCT01965301|Anesthetics, Local|anesthetics, local|mesh-ancestor
92492979|NCT01965301|Anesthetics|anesthetics|mesh-ancestor
92492980|NCT01965301|Sensory System Agents|sensory system agents|mesh-ancestor
92492981|NCT01965301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92492982|NCT01965301|Antiemetics|antiemetics|mesh-ancestor
92492983|NCT01965301|Autonomic Agents|autonomic agents|mesh-ancestor
92492984|NCT01965301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92492985|NCT01965301|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92492986|NCT01965301|Histamine Antagonists|histamine antagonists|mesh-ancestor
92492987|NCT01965301|Histamine Agents|histamine agents|mesh-ancestor
92492988|NCT01965301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92492989|NCT01965301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92492990|NCT01965301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92492991|NCT01965301|Antipruritics|antipruritics|mesh-ancestor
92492992|NCT01965301|Dermatologic Agents|dermatologic agents|mesh-ancestor
92492993|NCT01965353|Dexamethasone|dexamethasone|mesh-list
92492994|NCT01965353|Lenalidomide|lenalidomide|mesh-list
92492995|NCT01965353|Bortezomib|bortezomib|mesh-list
92492996|NCT01965353|Panobinostat|panobinostat|mesh-list
92492997|NCT01965353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92492998|NCT01965353|Antiemetics|antiemetics|mesh-ancestor
92492999|NCT01965353|Autonomic Agents|autonomic agents|mesh-ancestor
92493000|NCT01965353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493001|NCT01965353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493002|NCT01965353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493003|NCT01965353|Glucocorticoids|glucocorticoids|mesh-ancestor
92493004|NCT01965353|Hormones|hormones|mesh-ancestor
92493005|NCT01965353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493006|NCT01965353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92493007|NCT01965353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493008|NCT01965353|Immunologic Factors|immunologic factors|mesh-ancestor
92493009|NCT01965353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493010|NCT01965353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493011|NCT01965353|Growth Substances|growth substances|mesh-ancestor
92493012|NCT01965353|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493013|NCT01965353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92493014|NCT01965353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493015|NCT01965353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493016|NCT01965522|Vitamin D|vitamin d|mesh-list
92493017|NCT01965522|Ergocalciferols|ergocalciferols|mesh-list
92493018|NCT01965522|Cholecalciferol|cholecalciferol|mesh-list
92493019|NCT01965522|Vitamins|vitamins|mesh-list
92493020|NCT01965522|Melatonin|melatonin|mesh-list
92493021|NCT01965522|Micronutrients|micronutrients|mesh-ancestor
92493022|NCT01965522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493023|NCT01965522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493024|NCT01965522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92493025|NCT01965522|Antioxidants|antioxidants|mesh-ancestor
92493026|NCT01965522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493027|NCT01965522|Protective Agents|protective agents|mesh-ancestor
92493028|NCT01965522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493029|NCT01965587|Levonorgestrel|levonorgestrel|mesh-list
92493030|NCT01965587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92493031|NCT01965587|Contraceptive Agents|contraceptive agents|mesh-ancestor
92493032|NCT01965587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92493033|NCT01965587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493034|NCT01965587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92493035|NCT01965587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92493036|NCT01965587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92493037|NCT01965626|Oseltamivir|oseltamivir|mesh-list
92493038|NCT01965626|Dexamethasone|dexamethasone|mesh-list
92493039|NCT01965626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493040|NCT01965626|Antiemetics|antiemetics|mesh-ancestor
92493041|NCT01965626|Autonomic Agents|autonomic agents|mesh-ancestor
92493042|NCT01965626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493043|NCT01965626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493044|NCT01965626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493045|NCT01965626|Glucocorticoids|glucocorticoids|mesh-ancestor
92493046|NCT01965626|Hormones|hormones|mesh-ancestor
92493047|NCT01965626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493048|NCT01965626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92493049|NCT01965626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493050|NCT01965626|Antiviral Agents|antiviral agents|mesh-ancestor
92493051|NCT01965626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493052|NCT01965626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493053|NCT01965626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493054|NCT01965730|Aminocaproic Acid|aminocaproic acid|mesh-list
92493055|NCT01965730|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92493056|NCT01965730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92493057|NCT01965730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493058|NCT01965730|Hemostatics|hemostatics|mesh-ancestor
92493059|NCT01965730|Coagulants|coagulants|mesh-ancestor
92493060|NCT01965405|Bupropion|bupropion|mesh-list
92493061|NCT01965405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92493062|NCT01965405|Antidepressive Agents|antidepressive agents|mesh-ancestor
92493063|NCT01965405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92493064|NCT01965405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92493065|NCT01965405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92493066|NCT01965405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493067|NCT01965405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493068|NCT01965405|Dopamine Agents|dopamine agents|mesh-ancestor
92493069|NCT01965405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493070|NCT01965405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493071|NCT01965405|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92493072|NCT01965405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92493073|NCT01965405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493074|NCT01965925|Modafinil|modafinil|mesh-list
92493075|NCT01965925|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92493076|NCT01965925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493077|NCT01965925|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92493078|NCT01965925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92493079|NCT01965925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92493080|NCT01965925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493081|NCT01965977|Bortezomib|bortezomib|mesh-list
92493082|NCT01965977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493083|NCT01966055|Solithromycin|solithromycin|mesh-list
92493084|NCT01966055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92493085|NCT01966055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493086|NCT01966133|Doxorubicin|doxorubicin|mesh-list
92493087|NCT01966133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92493088|NCT01966133|Ethiodized Oil|ethiodized oil|mesh-list
92493089|NCT01966133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92493090|NCT01966133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493091|NCT01966133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92493092|NCT01966133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92493093|NCT01966133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493094|NCT01966133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493095|NCT01966172|Acetaminophen|acetaminophen|mesh-list
92493096|NCT01966172|Ibuprofen|ibuprofen|mesh-list
92493097|NCT01966172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92493098|NCT01966172|Morphine|morphine|mesh-list
92493099|NCT01966172|Gabapentin|gabapentin|mesh-list
92493100|NCT01966172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92493101|NCT01966172|Narcotics|narcotics|mesh-ancestor
92493102|NCT01966172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493103|NCT01966172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493104|NCT01966172|Analgesics|analgesics|mesh-ancestor
92493105|NCT01966172|Sensory System Agents|sensory system agents|mesh-ancestor
92493106|NCT01966172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493107|NCT01966172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92493108|NCT01966172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493109|NCT01966172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493110|NCT01966172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92493111|NCT01966172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493112|NCT01966172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493113|NCT01966172|Antipyretics|antipyretics|mesh-ancestor
92493114|NCT01966172|Anticonvulsants|anticonvulsants|mesh-ancestor
92493115|NCT01966172|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92493116|NCT01966172|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92493117|NCT01966172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92493118|NCT01966172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92493119|NCT01966172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92493120|NCT01966172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493121|NCT01966172|Antimanic Agents|antimanic agents|mesh-ancestor
92493122|NCT01966276|Methylphenidate|methylphenidate|mesh-list
92493123|NCT01966276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92493124|NCT01966276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493125|NCT01966276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92493126|NCT01966276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92493127|NCT01966276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493128|NCT01966276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493129|NCT01966276|Dopamine Agents|dopamine agents|mesh-ancestor
92493130|NCT01966276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493131|NCT01966289|Cyclophosphamide|cyclophosphamide|mesh-list
92493132|NCT01966289|Guadecitabine|guadecitabine|mesh-list
92493133|NCT01966289|Immunologic Factors|immunologic factors|mesh-ancestor
92493134|NCT01966289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493135|NCT01966289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493136|NCT01966289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493137|NCT01966289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92493138|NCT01966289|Alkylating Agents|alkylating agents|mesh-ancestor
92493139|NCT01966289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493140|NCT01966289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493141|NCT01966289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92493142|NCT01966302|Beraprost|beraprost|mesh-list
92493143|NCT01966302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92493144|NCT01966302|Vasodilator Agents|vasodilator agents|mesh-ancestor
92493145|NCT01966341|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92493146|NCT01966341|Laxatives|laxatives|mesh-list
92493147|NCT01966341|Parasympatholytics|parasympatholytics|mesh-list
92493148|NCT01966341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493149|NCT01966341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493150|NCT01966341|Autonomic Agents|autonomic agents|mesh-ancestor
92493151|NCT01966341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493152|NCT01966341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493153|NCT01966484|Succinylcholine|succinylcholine|mesh-list
92493154|NCT01966484|Mivacurium|mivacurium|mesh-list
92493155|NCT01966484|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92493156|NCT01966484|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92493157|NCT01966484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92493158|NCT01966484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493159|NCT01966484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493160|NCT01966484|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92493161|NCT01966575|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92493162|NCT01966575|Medroxyprogesterone|medroxyprogesterone|mesh-list
92493163|NCT01966575|Progestins|progestins|mesh-list
92493164|NCT01966575|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92493165|NCT01966575|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92493166|NCT01966575|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92493167|NCT01966575|Contraceptive Agents|contraceptive agents|mesh-ancestor
92493168|NCT01966575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92493169|NCT01966575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493170|NCT01966575|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92493171|NCT01966575|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92493172|NCT01966575|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92493173|NCT01966575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92493174|NCT01966575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493176|NCT01966575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493177|NCT01966627|Liver Extracts|liver extracts|mesh-list
92493178|NCT01966627|Hematinics|hematinics|mesh-ancestor
92493179|NCT01966653|Fosfomycin|fosfomycin|mesh-list
92493180|NCT01966653|Nitrofurantoin|nitrofurantoin|mesh-list
92493181|NCT01966653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92493182|NCT01966653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493183|NCT01966653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92493184|NCT01966692|Fluticasone|fluticasone|mesh-list
92493185|NCT01966692|Xhance|xhance|mesh-list
92493186|NCT01966692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493187|NCT01966692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92493188|NCT01966692|Autonomic Agents|autonomic agents|mesh-ancestor
92493189|NCT01966692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493190|NCT01966692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493191|NCT01966692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92493192|NCT01966692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92493193|NCT01966692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92493194|NCT01966692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92493195|NCT01966783|Budesonide|budesonide|mesh-list
92493196|NCT01966783|Mesalamine|mesalamine|mesh-list
92493197|NCT01966783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493198|NCT01966783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92493199|NCT01966783|Autonomic Agents|autonomic agents|mesh-ancestor
92493200|NCT01966783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493201|NCT01966783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493202|NCT01966783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92493203|NCT01966783|Respiratory System Agents|respiratory system agents|mesh-ancestor
92493204|NCT01966783|Glucocorticoids|glucocorticoids|mesh-ancestor
92493205|NCT01966783|Hormones|hormones|mesh-ancestor
92493206|NCT01966783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493207|NCT01966783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92493208|NCT01966783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493209|NCT01966783|Analgesics|analgesics|mesh-ancestor
92493210|NCT01966783|Sensory System Agents|sensory system agents|mesh-ancestor
92493211|NCT01966783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493212|NCT01966822|Ritonavir|ritonavir|mesh-list
92493213|NCT01966822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92493214|NCT01966822|Dolutegravir|dolutegravir|mesh-list
92493215|NCT01966822|Protease Inhibitors|protease inhibitors|mesh-list
92493216|NCT01966822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92493217|NCT01966822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493218|NCT01966822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493219|NCT01966822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92493220|NCT01966822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92493221|NCT01966822|Antiviral Agents|antiviral agents|mesh-ancestor
92493222|NCT01966822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493223|NCT01966822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92493224|NCT01966822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92493225|NCT01966822|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92493226|NCT01966822|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92493227|NCT01966913|Bevacizumab|bevacizumab|mesh-list
92493228|NCT01966913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92493229|NCT01966913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493230|NCT01966913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493231|NCT01966913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493232|NCT01966913|Growth Substances|growth substances|mesh-ancestor
92493233|NCT01966913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493234|NCT01966913|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493235|NCT01967017|Lidocaine|lidocaine|mesh-list
92493236|NCT01967017|Anesthetics, Local|anesthetics, local|mesh-ancestor
92493237|NCT01967017|Anesthetics|anesthetics|mesh-ancestor
92493238|NCT01967017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493239|NCT01967017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493240|NCT01967017|Sensory System Agents|sensory system agents|mesh-ancestor
92493241|NCT01967017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493242|NCT01967017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92493243|NCT01967017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92493244|NCT01967017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92493245|NCT01967017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493246|NCT01967017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493247|NCT01967095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92493248|NCT01967095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493249|NCT01967095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92493250|NCT01967095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493251|NCT01967095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493252|NCT01967199|Paclitaxel|paclitaxel|mesh-list
92493253|NCT01967199|Everolimus|everolimus|mesh-list
92493254|NCT01967199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493255|NCT01967199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493256|NCT01967199|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493257|NCT01967199|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493258|NCT01967199|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493259|NCT01967199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493260|NCT01967199|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92493261|NCT01967199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92493262|NCT01967199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493263|NCT01967199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493264|NCT01967199|Immunologic Factors|immunologic factors|mesh-ancestor
92493265|NCT01967199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493266|NCT01967251|Udenafil|udenafil|mesh-list
92493267|NCT01967251|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92493268|NCT01967251|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92493269|NCT01967251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493270|NCT01967251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493271|NCT01967264|Udenafil|udenafil|mesh-list
92493272|NCT01967264|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92493273|NCT01967264|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92493274|NCT01967264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493275|NCT01967264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493276|NCT01967368|Vaccines|vaccines|mesh-list
92493277|NCT01967368|Immunologic Factors|immunologic factors|mesh-ancestor
92493278|NCT01967368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493279|NCT01967381|Methamphetamine|methamphetamine|mesh-list
92493280|NCT01967381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92493281|NCT01967381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493282|NCT01967381|Sympathomimetics|sympathomimetics|mesh-ancestor
92493283|NCT01967381|Autonomic Agents|autonomic agents|mesh-ancestor
92493284|NCT01967381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493285|NCT01967381|Dopamine Agents|dopamine agents|mesh-ancestor
92493286|NCT01967381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493287|NCT01967381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493288|NCT01967381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92493289|NCT01967381|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92493290|NCT01967381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92493291|NCT01967381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493292|NCT01967381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92493293|NCT01967459|Cholecalciferol|cholecalciferol|mesh-list
92493294|NCT01967459|Vitamin D|vitamin d|mesh-list
92493295|NCT01967459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92493296|NCT01967459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493297|NCT01967459|Vitamins|vitamins|mesh-ancestor
92493298|NCT01967459|Micronutrients|micronutrients|mesh-ancestor
92493299|NCT01967459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493300|NCT01967472|Artesunate|artesunate|mesh-list
92493301|NCT01967472|Lumefantrine|lumefantrine|mesh-list
92493302|NCT01967472|Artemether|artemether|mesh-list
92493303|NCT01967472|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92493304|NCT01967472|Amodiaquine|amodiaquine|mesh-list
92493305|NCT01967472|Antimalarials|antimalarials|mesh-ancestor
92493306|NCT01967472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92493307|NCT01967472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92493308|NCT01967472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493309|NCT01967472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493310|NCT01967472|Antiviral Agents|antiviral agents|mesh-ancestor
92493311|NCT01967472|Schistosomicides|schistosomicides|mesh-ancestor
92493312|NCT01967472|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92493313|NCT01967472|Anthelmintics|anthelmintics|mesh-ancestor
92493314|NCT01967498|Montelukast|montelukast|mesh-list
92493315|NCT01967498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92493316|NCT01967498|Respiratory System Agents|respiratory system agents|mesh-ancestor
92493317|NCT01967498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92493318|NCT01967498|Hormone Antagonists|hormone antagonists|mesh-ancestor
92493319|NCT01967498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493320|NCT01967498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493321|NCT01967498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92493322|NCT01967498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92493323|NCT01967498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493324|NCT01967524|Ropivacaine|ropivacaine|mesh-list
92493325|NCT01967524|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92493326|NCT01967524|Botulinum Toxins|botulinum toxins|mesh-list
92493327|NCT01967524|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92493328|NCT01967524|Anesthetics, Local|anesthetics, local|mesh-ancestor
92493329|NCT01967524|Anesthetics|anesthetics|mesh-ancestor
92493330|NCT01967524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493331|NCT01967524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493332|NCT01967524|Sensory System Agents|sensory system agents|mesh-ancestor
92493333|NCT01967524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493334|NCT01967524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92493335|NCT01967524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493336|NCT01967524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493337|NCT01967524|Cholinergic Agents|cholinergic agents|mesh-ancestor
92493338|NCT01967524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493339|NCT01967524|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92493340|NCT01967758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92493342|NCT01967758|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92493343|NCT01967758|Trimethoprim|trimethoprim|mesh-list
92493344|NCT01967758|Sulfamethoxazole|sulfamethoxazole|mesh-list
92493345|NCT01967758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493346|NCT01967758|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92493347|NCT01967758|Antimalarials|antimalarials|mesh-ancestor
92493348|NCT01967758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92493349|NCT01967758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92493350|NCT01967758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92493351|NCT01967758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493352|NCT01967758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493353|NCT01967758|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92493354|NCT01967758|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92493355|NCT01967758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92493356|NCT01967758|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92493357|NCT01967823|Aldesleukin|aldesleukin|mesh-list
92493358|NCT01967823|Cyclophosphamide|cyclophosphamide|mesh-list
92493359|NCT01967823|Fludarabine|fludarabine|mesh-list
92493360|NCT01967823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493361|NCT01967823|Immunologic Factors|immunologic factors|mesh-ancestor
92493362|NCT01967823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493363|NCT01967823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493364|NCT01967823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92493365|NCT01967823|Alkylating Agents|alkylating agents|mesh-ancestor
92493366|NCT01967823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493367|NCT01967823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493368|NCT01967823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92493369|NCT01967823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92493370|NCT01967823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92493371|NCT01967823|Antiviral Agents|antiviral agents|mesh-ancestor
92493372|NCT01967823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493373|NCT01967875|Docetaxel|docetaxel|mesh-list
92493374|NCT01967875|Capecitabine|capecitabine|mesh-list
92493375|NCT01967875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493376|NCT01967875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493377|NCT01967875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493378|NCT01967875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493379|NCT01967875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493380|NCT01967875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92493381|NCT01967875|Antimetabolites|antimetabolites|mesh-ancestor
92493382|NCT01967927|Imidazole|imidazole|mesh-list
92493383|NCT01967927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493384|NCT01967927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493385|NCT01967979|Itraconazole|itraconazole|mesh-list
92493386|NCT01967979|Fluoxetine|fluoxetine|mesh-list
92493387|NCT01967979|Antifungal Agents|antifungal agents|mesh-ancestor
92493388|NCT01967979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493389|NCT01967979|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92493390|NCT01967979|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92493391|NCT01967979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493392|NCT01967979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493393|NCT01967979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92493394|NCT01967979|Hormone Antagonists|hormone antagonists|mesh-ancestor
92493395|NCT01967979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493396|NCT01967979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493397|NCT01967979|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92493398|NCT01967979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92493399|NCT01967979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92493400|NCT01967979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493401|NCT01967979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493402|NCT01967979|Serotonin Agents|serotonin agents|mesh-ancestor
92493403|NCT01967979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92493404|NCT01967979|Antidepressive Agents|antidepressive agents|mesh-ancestor
92493405|NCT01967979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92493406|NCT01967979|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92493407|NCT01968005|Etodolac|etodolac|mesh-list
92493408|NCT01968005|Lidocaine|lidocaine|mesh-list
92493409|NCT01968005|Anesthetics, Local|anesthetics, local|mesh-ancestor
92493410|NCT01968005|Anesthetics|anesthetics|mesh-ancestor
92493411|NCT01968005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493412|NCT01968005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493413|NCT01968005|Sensory System Agents|sensory system agents|mesh-ancestor
92493414|NCT01968005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493415|NCT01968005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92493416|NCT01968005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92493417|NCT01968005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92493418|NCT01968005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493419|NCT01968005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493420|NCT01968005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92493421|NCT01968005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493422|NCT01968005|Analgesics|analgesics|mesh-ancestor
92493423|NCT01968005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493424|NCT01968005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493425|NCT01968005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92493426|NCT01968005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92493427|NCT01968005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493428|NCT01968018|Acetaminophen|acetaminophen|mesh-list
92493429|NCT01968018|Tramadol|tramadol|mesh-list
92493430|NCT01968018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493431|NCT01968018|Analgesics|analgesics|mesh-ancestor
92493432|NCT01968018|Sensory System Agents|sensory system agents|mesh-ancestor
92493433|NCT01968018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493434|NCT01968018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493435|NCT01968018|Antipyretics|antipyretics|mesh-ancestor
92493436|NCT01968018|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92493437|NCT01968018|Narcotics|narcotics|mesh-ancestor
92493438|NCT01968018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493439|NCT01968044|Linagliptin|linagliptin|mesh-list
92493440|NCT01968044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493441|NCT01968044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493442|NCT01968044|Incretins|incretins|mesh-ancestor
92493443|NCT01968044|Hormones|hormones|mesh-ancestor
92493444|NCT01968044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493445|NCT01968044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92493446|NCT01968044|Protease Inhibitors|protease inhibitors|mesh-ancestor
92493447|NCT01968044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493448|NCT01968044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493449|NCT01968083|Vaccines|vaccines|mesh-list
92493450|NCT01968083|Immunologic Factors|immunologic factors|mesh-ancestor
92493451|NCT01968083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493452|NCT01968161|Asenapine|asenapine|mesh-list
92493453|NCT01968161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92493454|NCT01968161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92493455|NCT01968161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493456|NCT01968161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493457|NCT01968161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92493458|NCT01968239|Ranibizumab|ranibizumab|mesh-list
92493459|NCT01968239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493460|NCT01968239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493461|NCT01968239|Growth Substances|growth substances|mesh-ancestor
92493462|NCT01968239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493463|NCT01968239|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493464|NCT01968239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493465|NCT01968395|Caspofungin|caspofungin|mesh-list
92493466|NCT01968395|Antifungal Agents|antifungal agents|mesh-ancestor
92493467|NCT01968395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493468|NCT01968395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493469|NCT01968395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493470|NCT01968486|Ranibizumab|ranibizumab|mesh-list
92493471|NCT01968486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493472|NCT01968486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493473|NCT01968486|Growth Substances|growth substances|mesh-ancestor
92493474|NCT01968486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493475|NCT01968486|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493476|NCT01968486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493477|NCT01968564|Curcumin|curcumin|mesh-list
92493478|NCT01968564|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92493479|NCT01968564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493480|NCT01968564|Analgesics|analgesics|mesh-ancestor
92493481|NCT01968564|Sensory System Agents|sensory system agents|mesh-ancestor
92493482|NCT01968564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493483|NCT01968564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493484|NCT01968564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493485|NCT01968564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493486|NCT01968564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493487|NCT01968564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704596|NCT02203643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493488|NCT01968564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493489|NCT01968577|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92493490|NCT01968577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92493491|NCT01968577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92493492|NCT01968577|Antimetabolites|antimetabolites|mesh-ancestor
92493493|NCT01968577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493494|NCT01968577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92493495|NCT01968577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92493496|NCT01968577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493497|NCT01968616|Ranibizumab|ranibizumab|mesh-list
92493498|NCT01968616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493499|NCT01968616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493500|NCT01968616|Growth Substances|growth substances|mesh-ancestor
92493501|NCT01968616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493502|NCT01968616|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493503|NCT01968616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493504|NCT01968655|Factor VIII|factor viii|mesh-list
92493505|NCT01968655|Coagulants|coagulants|mesh-ancestor
92493506|NCT01968759|Ramipril|ramipril|mesh-list
92493507|NCT01968759|Irbesartan|irbesartan|mesh-list
92493508|NCT01968759|Sevelamer|sevelamer|mesh-list
92493509|NCT01968759|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92493510|NCT01968759|Protease Inhibitors|protease inhibitors|mesh-ancestor
92493511|NCT01968759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493512|NCT01968759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493513|NCT01968759|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92493514|NCT01968759|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92493515|NCT01968759|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92493516|NCT01968759|Chelating Agents|chelating agents|mesh-ancestor
92493517|NCT01968759|Sequestering Agents|sequestering agents|mesh-ancestor
92493518|NCT01968798|Aspirin|aspirin|mesh-list
92493519|NCT01968798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92493520|NCT01968798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493521|NCT01968798|Analgesics|analgesics|mesh-ancestor
92493522|NCT01968798|Sensory System Agents|sensory system agents|mesh-ancestor
92493523|NCT01968798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493524|NCT01968798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493525|NCT01968798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493526|NCT01968798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493527|NCT01968798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92493528|NCT01968798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92493529|NCT01968798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493530|NCT01968798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92493531|NCT01968798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92493532|NCT01968798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493533|NCT01968798|Antipyretics|antipyretics|mesh-ancestor
92493534|NCT01968850|Vitamin D|vitamin d|mesh-list
92493535|NCT01968850|Alendronate|alendronate|mesh-list
92493536|NCT01968850|Vitamins|vitamins|mesh-ancestor
92493537|NCT01968850|Micronutrients|micronutrients|mesh-ancestor
92493538|NCT01968850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493539|NCT01968850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493540|NCT01968915|Paclitaxel|paclitaxel|mesh-list
92493541|NCT01968915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493542|NCT01968915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493543|NCT01968915|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493544|NCT01968915|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493545|NCT01968915|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493546|NCT01968915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493547|NCT01969006|Bupivacaine|bupivacaine|mesh-list
92493548|NCT01969006|Anesthetics, Local|anesthetics, local|mesh-ancestor
92493549|NCT01969006|Anesthetics|anesthetics|mesh-ancestor
92493550|NCT01969006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493551|NCT01969006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493552|NCT01969006|Sensory System Agents|sensory system agents|mesh-ancestor
92493553|NCT01969006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493554|NCT01969019|Prednisone|prednisone|mesh-list
92493555|NCT01969019|Methylprednisolone|methylprednisolone|mesh-list
92493556|NCT01969019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92493557|NCT01969019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92493558|NCT01969019|Prednisolone|prednisolone|mesh-list
92493559|NCT01969019|Prednisolone acetate|prednisolone acetate|mesh-list
92493560|NCT01969019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92218463|NCT00633464|Cetuximab|cetuximab|mesh-list
92493561|NCT01969019|Prednisolone phosphate|prednisolone phosphate|mesh-list
92493562|NCT01969019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493563|NCT01969019|Glucocorticoids|glucocorticoids|mesh-ancestor
92493564|NCT01969019|Hormones|hormones|mesh-ancestor
92493565|NCT01969019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493566|NCT01969019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493567|NCT01969019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92493568|NCT01969019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493569|NCT01969019|Antiemetics|antiemetics|mesh-ancestor
92493570|NCT01969019|Autonomic Agents|autonomic agents|mesh-ancestor
92493571|NCT01969019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493572|NCT01969019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493573|NCT01969019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92493574|NCT01969019|Protective Agents|protective agents|mesh-ancestor
92493575|NCT01969032|Paclitaxel|paclitaxel|mesh-list
92493576|NCT01969032|Doxorubicin|doxorubicin|mesh-list
92493577|NCT01969032|Capecitabine|capecitabine|mesh-list
92493578|NCT01969032|Cyclophosphamide|cyclophosphamide|mesh-list
92493579|NCT01969032|Carboplatin|carboplatin|mesh-list
92493580|NCT01969032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493581|NCT01969032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493582|NCT01969032|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493583|NCT01969032|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493584|NCT01969032|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493585|NCT01969032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493586|NCT01969032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92493587|NCT01969032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92493588|NCT01969032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92493589|NCT01969032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493590|NCT01969032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92493591|NCT01969032|Antimetabolites|antimetabolites|mesh-ancestor
92493592|NCT01969032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493593|NCT01969032|Immunologic Factors|immunologic factors|mesh-ancestor
92493594|NCT01969032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493595|NCT01969032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493596|NCT01969032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92493597|NCT01969032|Alkylating Agents|alkylating agents|mesh-ancestor
92493598|NCT01969032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92493599|NCT01969071|Simendan|simendan|mesh-list
92493600|NCT01969071|Dobutamine|dobutamine|mesh-list
92493601|NCT01969071|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92493602|NCT01969071|Vasodilator Agents|vasodilator agents|mesh-ancestor
92493603|NCT01969071|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92493604|NCT01969071|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92493605|NCT01969071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493606|NCT01969071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493607|NCT01969071|Protective Agents|protective agents|mesh-ancestor
92493608|NCT01969071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493609|NCT01969071|Sympathomimetics|sympathomimetics|mesh-ancestor
92493610|NCT01969071|Autonomic Agents|autonomic agents|mesh-ancestor
92493611|NCT01969071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493612|NCT01969071|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92493613|NCT01969071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92493614|NCT01969071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92493615|NCT01969071|Adrenergic Agents|adrenergic agents|mesh-ancestor
92493616|NCT01969071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493617|NCT01969149|Insulin|insulin|mesh-list
92493618|NCT01969149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92493619|NCT01969149|Exenatide|exenatide|mesh-list
92493620|NCT01969149|Insulin Lispro|insulin lispro|mesh-list
92493621|NCT01969149|Incretins|incretins|mesh-list
92493622|NCT01969149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493623|NCT01969149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493624|NCT01969149|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92493625|NCT01969149|Hormones|hormones|mesh-ancestor
92493626|NCT01969149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493627|NCT01969318|Metformin|metformin|mesh-list
92493628|NCT01969318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493629|NCT01969318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493630|NCT01969357|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92493631|NCT01969357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493632|NCT01969357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493633|NCT01969357|Incretins|incretins|mesh-ancestor
92493634|NCT01969357|Hormones|hormones|mesh-ancestor
92493635|NCT01969357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493636|NCT01969357|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92493637|NCT01969357|Protease Inhibitors|protease inhibitors|mesh-ancestor
92493638|NCT01969357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704597|NCT02203643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532620|NCT00054418|Vitamin D|vitamin d|mesh-list
92493639|NCT01969357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493641|NCT01969617|Nalmefene|nalmefene|mesh-list
92493642|NCT01969617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92493643|NCT01969617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493644|NCT01969617|Sensory System Agents|sensory system agents|mesh-ancestor
92493645|NCT01969617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493646|NCT01969617|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92493647|NCT01969656|Calcitriol|calcitriol|mesh-list
92493648|NCT01969656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92493649|NCT01969656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493650|NCT01969656|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92493651|NCT01969656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493652|NCT01969656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493653|NCT01969656|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92493654|NCT01969656|Vitamins|vitamins|mesh-ancestor
92493655|NCT01969656|Micronutrients|micronutrients|mesh-ancestor
92493656|NCT01969656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493657|NCT01969669|Ketoconazole|ketoconazole|mesh-list
92493658|NCT01969669|Venetoclax|venetoclax|mesh-list
92493659|NCT01969669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493660|NCT01969669|Antifungal Agents|antifungal agents|mesh-ancestor
92493661|NCT01969669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493662|NCT01969669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92493663|NCT01969669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92493664|NCT01969669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493665|NCT01969669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493666|NCT01969669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92493667|NCT01969669|Hormone Antagonists|hormone antagonists|mesh-ancestor
92493668|NCT01969669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493669|NCT01969669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493670|NCT01969669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92493671|NCT01969682|Rifampin|rifampin|mesh-list
92493672|NCT01969682|Venetoclax|venetoclax|mesh-list
92493673|NCT01969682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493674|NCT01969682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92493675|NCT01969682|Antitubercular Agents|antitubercular agents|mesh-ancestor
92493676|NCT01969682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92493677|NCT01969682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493678|NCT01969682|Leprostatic Agents|leprostatic agents|mesh-ancestor
92493679|NCT01969682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92493680|NCT01969682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493681|NCT01969682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493682|NCT01969682|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92493683|NCT01969682|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92493684|NCT01969682|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92493685|NCT01969682|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92493686|NCT01969682|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92493687|NCT01969682|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92493688|NCT01969695|Venetoclax|venetoclax|mesh-list
92493689|NCT01969695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493690|NCT01969773|Botulinum Toxins|botulinum toxins|mesh-list
92493691|NCT01969773|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92493692|NCT01969773|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92493693|NCT01969773|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92493694|NCT01969773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493695|NCT01969773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493696|NCT01969773|Cholinergic Agents|cholinergic agents|mesh-ancestor
92493697|NCT01969773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493698|NCT01969773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493699|NCT01969773|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92493700|NCT01969773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493701|NCT01969877|Cetuximab|cetuximab|mesh-list
92493702|NCT01969877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493703|NCT01969877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92493704|NCT01969903|Dexmedetomidine|dexmedetomidine|mesh-list
92493705|NCT01969903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92493706|NCT01969903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493707|NCT01969903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493708|NCT01969903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92493709|NCT01969903|Analgesics|analgesics|mesh-ancestor
92493710|NCT01969903|Sensory System Agents|sensory system agents|mesh-ancestor
92493711|NCT01969903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493712|NCT01969903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92493713|NCT01969903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92493714|NCT01969903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92493715|NCT01969903|Adrenergic Agents|adrenergic agents|mesh-ancestor
92493716|NCT01969903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493717|NCT01969903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493718|NCT01969942|Melphalan|melphalan|mesh-list
92493719|NCT01969942|Busulfan|busulfan|mesh-list
92493720|NCT01969942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92493721|NCT01969942|Alkylating Agents|alkylating agents|mesh-ancestor
92493722|NCT01969942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493723|NCT01969942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493724|NCT01969942|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92493725|NCT01969942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493726|NCT01969942|Immunologic Factors|immunologic factors|mesh-ancestor
92493727|NCT01969942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493728|NCT01969955|Paclitaxel|paclitaxel|mesh-list
92493729|NCT01969955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92493730|NCT01969955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493731|NCT01969955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493732|NCT01969955|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493733|NCT01969955|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493734|NCT01969955|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493735|NCT01969955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493736|NCT01970046|Metformin|metformin|mesh-list
92493737|NCT01970046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493738|NCT01970046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493739|NCT01970059|Metoprolol|metoprolol|mesh-list
92493740|NCT01970059|Carvedilol|carvedilol|mesh-list
92493741|NCT01970059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92493742|NCT01970059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92493743|NCT01970059|Sympatholytics|sympatholytics|mesh-ancestor
92493744|NCT01970059|Autonomic Agents|autonomic agents|mesh-ancestor
92493745|NCT01970059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493746|NCT01970059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493747|NCT01970059|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92493748|NCT01970059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92493749|NCT01970059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92493750|NCT01970059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92493751|NCT01970059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493752|NCT01970059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493753|NCT01970059|Antioxidants|antioxidants|mesh-ancestor
92493754|NCT01970059|Protective Agents|protective agents|mesh-ancestor
92493755|NCT01970059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92493756|NCT01970059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92493757|NCT01970059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92493758|NCT01970059|Vasodilator Agents|vasodilator agents|mesh-ancestor
92493759|NCT01970059|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92493760|NCT01970059|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92493761|NCT01970072|Midazolam|midazolam|mesh-list
92493762|NCT01970072|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92493763|NCT01970072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92493764|NCT01970072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493765|NCT01970072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493766|NCT01970072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92493767|NCT01970072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92493768|NCT01970072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92493769|NCT01970072|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92493770|NCT01970072|Anesthetics, General|anesthetics, general|mesh-ancestor
92493771|NCT01970072|Anesthetics|anesthetics|mesh-ancestor
92493772|NCT01970072|GABA Modulators|gaba modulators|mesh-ancestor
92493773|NCT01970072|GABA Agents|gaba agents|mesh-ancestor
92493774|NCT01970072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493775|NCT01970072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493776|NCT01970202|Enoxaparin|enoxaparin|mesh-list
92493777|NCT01970202|Enoxaparin sodium|enoxaparin sodium|mesh-list
92493778|NCT01970202|Anticoagulants|anticoagulants|mesh-ancestor
92493779|NCT01970202|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92493780|NCT01970202|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92493781|NCT01970202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493782|NCT01970215|Atorvastatin|atorvastatin|mesh-list
92493783|NCT01970215|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92493784|NCT01970215|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92493785|NCT01970215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92493786|NCT01970215|Antimetabolites|antimetabolites|mesh-ancestor
92493787|NCT01970215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493788|NCT01970215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92493789|NCT01970215|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92493790|NCT01970215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493791|NCT01970280|Enoxaparin|enoxaparin|mesh-list
92493792|NCT01970280|Anticoagulants|anticoagulants|mesh-ancestor
92493793|NCT01970280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92493794|NCT01970280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92493795|NCT01970280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493796|NCT01970358|Poly ICLC|poly iclc|mesh-list
92493797|NCT01970358|Interferon Inducers|interferon inducers|mesh-ancestor
92493798|NCT01970358|Immunologic Factors|immunologic factors|mesh-ancestor
92493799|NCT01970358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493800|NCT01970449|Vaccines|vaccines|mesh-list
92493801|NCT01970449|Immunologic Factors|immunologic factors|mesh-ancestor
92493802|NCT01970449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493803|NCT01970553|Gemcitabine|gemcitabine|mesh-list
92493804|NCT01970553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92493805|NCT01970553|Antimetabolites|antimetabolites|mesh-ancestor
92493806|NCT01970553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493807|NCT01970553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493808|NCT01970579|Paclitaxel|paclitaxel|mesh-list
92493809|NCT01970579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493810|NCT01970579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493811|NCT01970579|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493812|NCT01970579|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493813|NCT01970579|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493814|NCT01970579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493815|NCT01970748|Propranolol|propranolol|mesh-list
92493816|NCT01970748|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92493817|NCT01970748|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92493818|NCT01970748|Adrenergic Agents|adrenergic agents|mesh-ancestor
92493819|NCT01970748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493820|NCT01970748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493821|NCT01970748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493822|NCT01970748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92493823|NCT01970748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92493824|NCT01970748|Vasodilator Agents|vasodilator agents|mesh-ancestor
92493825|NCT01970800|Hormones|hormones|mesh-list
92493826|NCT01970800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493827|NCT01970800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493828|NCT01970904|Ribavirin|ribavirin|mesh-list
92493829|NCT01970904|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92493830|NCT01970904|Antimetabolites|antimetabolites|mesh-ancestor
92493831|NCT01970904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493832|NCT01970904|Antiviral Agents|antiviral agents|mesh-ancestor
92493833|NCT01970904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493834|NCT01970917|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92493835|NCT01970917|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92493836|NCT01971034|Metformin|metformin|mesh-list
92493837|NCT01971034|Paclitaxel|paclitaxel|mesh-list
92493838|NCT01971034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493839|NCT01971034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493840|NCT01971034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493841|NCT01971034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493842|NCT01971034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493843|NCT01971034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493844|NCT01971034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493845|NCT01971034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493846|NCT01971047|Insulin|insulin|mesh-list
92493847|NCT01971047|Insulin Lispro|insulin lispro|mesh-list
92493848|NCT01971047|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92493849|NCT01971047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493850|NCT01971047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493852|NCT01971190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493853|NCT01971190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493854|NCT01971190|Growth Substances|growth substances|mesh-ancestor
92493855|NCT01971190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493856|NCT01971190|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493857|NCT01971190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493858|NCT01971242|Exenatide|exenatide|mesh-list
92493859|NCT01971242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92493860|NCT01971242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493861|NCT01971242|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92493862|NCT01971242|Incretins|incretins|mesh-ancestor
92493863|NCT01971242|Hormones|hormones|mesh-ancestor
92493864|NCT01971242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493865|NCT01971268|Cimetidine|cimetidine|mesh-list
92493866|NCT01971268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92493867|NCT01971268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493868|NCT01971268|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92493869|NCT01971268|Histamine Antagonists|histamine antagonists|mesh-ancestor
92493870|NCT01971268|Histamine Agents|histamine agents|mesh-ancestor
92493871|NCT01971268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92493872|NCT01971268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493873|NCT01971268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493874|NCT01971268|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92493875|NCT01971268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92493876|NCT01971268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493877|NCT01971281|Paclitaxel|paclitaxel|mesh-list
92493878|NCT01971281|Gemcitabine|gemcitabine|mesh-list
92493879|NCT01971281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92493880|NCT01971281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493881|NCT01971281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92493882|NCT01971281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92493883|NCT01971281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92493884|NCT01971281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493885|NCT01971281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92493886|NCT01971281|Antimetabolites|antimetabolites|mesh-ancestor
92493887|NCT01971411|Calcium, Dietary|calcium, dietary|mesh-list
92493888|NCT01971411|Vitamin D|vitamin d|mesh-list
92493889|NCT01971411|Ergocalciferols|ergocalciferols|mesh-list
92493890|NCT01971411|Cholecalciferol|cholecalciferol|mesh-list
92493891|NCT01971411|Vitamins|vitamins|mesh-list
92493892|NCT01971411|Calcium|calcium|mesh-list
92493893|NCT01971411|Micronutrients|micronutrients|mesh-ancestor
92493894|NCT01971411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493895|NCT01971411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92493896|NCT01971411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493897|NCT01971424|Magnesium Oxide|magnesium oxide|mesh-list
92493898|NCT01971424|Antacids|antacids|mesh-ancestor
92493899|NCT01971424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493900|NCT01971424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493901|NCT01971450|Iloprost|iloprost|mesh-list
92493902|NCT01971450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92493903|NCT01971450|Vasodilator Agents|vasodilator agents|mesh-ancestor
92493904|NCT01971515|Tamoxifen|tamoxifen|mesh-list
92493905|NCT01971515|Trastuzumab|trastuzumab|mesh-list
92493906|NCT01971515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92493907|NCT01971515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493908|NCT01971515|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92493909|NCT01971515|Hormone Antagonists|hormone antagonists|mesh-ancestor
92493910|NCT01971515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493911|NCT01971515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493912|NCT01971515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92493913|NCT01971515|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92493914|NCT01971515|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92493915|NCT01971515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493916|NCT01971606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92493917|NCT01971606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92493918|NCT01971606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92493919|NCT01971606|Antimetabolites|antimetabolites|mesh-ancestor
92493920|NCT01971606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493921|NCT01971606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92493922|NCT01971606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92493923|NCT01971606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493924|NCT01971632|Oxycodone|oxycodone|mesh-list
92493925|NCT01971632|Naloxone|naloxone|mesh-list
92493926|NCT01971632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92493927|NCT01971632|Narcotics|narcotics|mesh-ancestor
92493928|NCT01971632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92493929|NCT01971632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493930|NCT01971632|Analgesics|analgesics|mesh-ancestor
92493931|NCT01971632|Sensory System Agents|sensory system agents|mesh-ancestor
92493932|NCT01971632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493933|NCT01971632|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92493934|NCT01971658|Thalidomide|thalidomide|mesh-list
92493935|NCT01971658|Dexamethasone|dexamethasone|mesh-list
92493936|NCT01971658|Cyclophosphamide|cyclophosphamide|mesh-list
92493938|NCT01971658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493939|NCT01971658|Immunologic Factors|immunologic factors|mesh-ancestor
92493940|NCT01971658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493941|NCT01971658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493942|NCT01971658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92493943|NCT01971658|Alkylating Agents|alkylating agents|mesh-ancestor
92493944|NCT01971658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493945|NCT01971658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493946|NCT01971658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92493947|NCT01971658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493948|NCT01971658|Antiemetics|antiemetics|mesh-ancestor
92493949|NCT01971658|Autonomic Agents|autonomic agents|mesh-ancestor
92493950|NCT01971658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92493951|NCT01971658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493952|NCT01971658|Glucocorticoids|glucocorticoids|mesh-ancestor
92493953|NCT01971658|Hormones|hormones|mesh-ancestor
92493954|NCT01971658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92493955|NCT01971658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92493956|NCT01971658|Leprostatic Agents|leprostatic agents|mesh-ancestor
92493957|NCT01971658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92493958|NCT01971658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493959|NCT01971658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92493960|NCT01971658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92493961|NCT01971658|Growth Substances|growth substances|mesh-ancestor
92493962|NCT01971658|Growth Inhibitors|growth inhibitors|mesh-ancestor
92493963|NCT01971684|Mycophenolic Acid|mycophenolic acid|mesh-list
92493964|NCT01971684|Sirolimus|sirolimus|mesh-list
92493965|NCT01971684|Mercaptopurine|mercaptopurine|mesh-list
92493966|NCT01971684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92493967|NCT01971684|Immunologic Factors|immunologic factors|mesh-ancestor
92493968|NCT01971684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493969|NCT01971684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92493970|NCT01971684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92493971|NCT01971684|Antitubercular Agents|antitubercular agents|mesh-ancestor
92493972|NCT01971684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92493973|NCT01971684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92493974|NCT01971684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92493975|NCT01971684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92493976|NCT01971684|Antifungal Agents|antifungal agents|mesh-ancestor
92493977|NCT01971684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92493978|NCT01971684|Antimetabolites|antimetabolites|mesh-ancestor
92493979|NCT01971684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92493980|NCT01971684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92493981|NCT01971801|Vitamin D|vitamin d|mesh-list
92493982|NCT01971801|Cholecalciferol|cholecalciferol|mesh-list
92493983|NCT01971801|Vitamins|vitamins|mesh-ancestor
92493984|NCT01971801|Micronutrients|micronutrients|mesh-ancestor
92493985|NCT01971801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493986|NCT01971801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92493987|NCT01971801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92493988|NCT01971814|Infliximab|infliximab|mesh-list
92493989|NCT01971814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92493990|NCT01971814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92493991|NCT01971814|Dermatologic Agents|dermatologic agents|mesh-ancestor
92493992|NCT01971814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92493993|NCT01971814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92493994|NCT01971918|Antibodies|antibodies|mesh-list
92493995|NCT01971918|Immunologic Factors|immunologic factors|mesh-ancestor
92493996|NCT01971918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92493997|NCT01972113|Vitamins|vitamins|mesh-list
92493998|NCT01972113|Vitamin K|vitamin k|mesh-list
92493999|NCT01972113|Vitamin K 2|vitamin k 2|mesh-list
92494000|NCT01972113|Menaquinone 7|menaquinone 7|mesh-list
92494001|NCT01972113|Micronutrients|micronutrients|mesh-ancestor
92494002|NCT01972113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494003|NCT01972113|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92494004|NCT01972113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92494005|NCT01972113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494006|NCT01972113|Hemostatics|hemostatics|mesh-ancestor
92494007|NCT01972113|Coagulants|coagulants|mesh-ancestor
92494008|NCT01972230|Remifentanil|remifentanil|mesh-list
92494009|NCT01972230|Sevoflurane|sevoflurane|mesh-list
92494010|NCT01972230|Propofol|propofol|mesh-list
92494011|NCT01972230|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92494012|NCT01972230|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92494013|NCT01972230|Anesthetics, General|anesthetics, general|mesh-ancestor
92494014|NCT01972230|Anesthetics|anesthetics|mesh-ancestor
92494015|NCT01972230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494016|NCT01972230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494017|NCT01972230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92494018|NCT01972230|Narcotics|narcotics|mesh-ancestor
92494019|NCT01972230|Analgesics|analgesics|mesh-ancestor
92494020|NCT01972230|Sensory System Agents|sensory system agents|mesh-ancestor
92494021|NCT01972230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494022|NCT01972230|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92494023|NCT01972230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92494024|NCT01972269|Lidocaine|lidocaine|mesh-list
92494025|NCT01972269|Fentanyl|fentanyl|mesh-list
92494026|NCT01972269|Bupivacaine|bupivacaine|mesh-list
92494027|NCT01972269|Anesthetics, Local|anesthetics, local|mesh-ancestor
92494028|NCT01972269|Anesthetics|anesthetics|mesh-ancestor
92494029|NCT01972269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494030|NCT01972269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494031|NCT01972269|Sensory System Agents|sensory system agents|mesh-ancestor
92494032|NCT01972269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494033|NCT01972269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92494034|NCT01972269|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92494035|NCT01972269|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92494036|NCT01972269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494037|NCT01972269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494038|NCT01972269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92494039|NCT01972269|Narcotics|narcotics|mesh-ancestor
92494040|NCT01972269|Analgesics|analgesics|mesh-ancestor
92494041|NCT01972269|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92494042|NCT01972269|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92494043|NCT01972269|Anesthetics, General|anesthetics, general|mesh-ancestor
92494044|NCT01972373|Bevacizumab|bevacizumab|mesh-list
92494045|NCT01972373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494046|NCT01972373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494047|NCT01972373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92494048|NCT01972373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92494049|NCT01972373|Growth Substances|growth substances|mesh-ancestor
92494050|NCT01972373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494051|NCT01972373|Growth Inhibitors|growth inhibitors|mesh-ancestor
92494052|NCT01972490|Bevacizumab|bevacizumab|mesh-list
92494053|NCT01972490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494054|NCT01972490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494055|NCT01972490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92494056|NCT01972490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92494057|NCT01972490|Growth Substances|growth substances|mesh-ancestor
92494058|NCT01972490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494059|NCT01972490|Growth Inhibitors|growth inhibitors|mesh-ancestor
92494060|NCT01972503|Oxaliplatin|oxaliplatin|mesh-list
92494061|NCT01972503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494062|NCT01972620|Bupivacaine|bupivacaine|mesh-list
92494063|NCT01972620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92494064|NCT01972620|Anesthetics|anesthetics|mesh-ancestor
92494065|NCT01972620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494066|NCT01972620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494067|NCT01972620|Sensory System Agents|sensory system agents|mesh-ancestor
92494068|NCT01972620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494069|NCT01972711|Amisulpride|amisulpride|mesh-list
92494070|NCT01972711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92494071|NCT01972711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92494072|NCT01972711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494073|NCT01972711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494074|NCT01972711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494075|NCT01972711|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92494076|NCT01972711|Dopamine Agents|dopamine agents|mesh-ancestor
92494077|NCT01972711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494078|NCT01972711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494079|NCT01972711|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92494080|NCT01972711|Antidepressive Agents|antidepressive agents|mesh-ancestor
92494081|NCT01972763|Ranibizumab|ranibizumab|mesh-list
92494082|NCT01972763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92494083|NCT01972763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92494084|NCT01972763|Growth Substances|growth substances|mesh-ancestor
92494085|NCT01972763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494086|NCT01972763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92494087|NCT01972763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494088|NCT01972828|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92494089|NCT01972828|Plasma Substitutes|plasma substitutes|mesh-ancestor
92494090|NCT01972828|Blood Substitutes|blood substitutes|mesh-ancestor
92494091|NCT01972880|Ipragliflozin|ipragliflozin|mesh-list
92494092|NCT01972880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92494093|NCT01972880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494094|NCT01972880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92494095|NCT01972880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494096|NCT01972906|Ibuprofen|ibuprofen|mesh-list
92494097|NCT01972906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92494098|NCT01972906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494099|NCT01972906|Analgesics|analgesics|mesh-ancestor
92494100|NCT01972906|Sensory System Agents|sensory system agents|mesh-ancestor
92494101|NCT01972906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494102|NCT01972906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494103|NCT01972906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494104|NCT01972906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494105|NCT01972906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92494106|NCT01972906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494107|NCT01972906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494108|NCT01972984|Anastrozole|anastrozole|mesh-list
92494109|NCT01972984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494110|NCT01972984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494111|NCT01972984|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92494112|NCT01972984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92494113|NCT01972984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494114|NCT01972984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494115|NCT01972984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92494116|NCT01972984|Hormone Antagonists|hormone antagonists|mesh-ancestor
92494117|NCT01972984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494118|NCT01972984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494119|NCT01973010|Ibuprofen|ibuprofen|mesh-list
92494120|NCT01973010|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92494121|NCT01973010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494122|NCT01973010|Analgesics|analgesics|mesh-ancestor
92494123|NCT01973010|Sensory System Agents|sensory system agents|mesh-ancestor
92494124|NCT01973010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494125|NCT01973010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494126|NCT01973010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494127|NCT01973010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494128|NCT01973010|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92494129|NCT01973010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494130|NCT01973010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494131|NCT01973101|Cisplatin|cisplatin|mesh-list
92494132|NCT01973101|Gemcitabine|gemcitabine|mesh-list
92494133|NCT01973101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494134|NCT01973101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92494135|NCT01973101|Antimetabolites|antimetabolites|mesh-ancestor
92494136|NCT01973101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494137|NCT01973114|Latanoprost|latanoprost|mesh-list
92494138|NCT01973114|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92494139|NCT01973114|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92494140|NCT01973140|Tolvaptan|tolvaptan|mesh-list
92494141|NCT01973140|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92494142|NCT01973140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494143|NCT01973140|Natriuretic Agents|natriuretic agents|mesh-ancestor
92494144|NCT01973140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494145|NCT01973309|Paclitaxel|paclitaxel|mesh-list
92494146|NCT01973309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92494147|NCT01973309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494148|NCT01973309|Tubulin Modulators|tubulin modulators|mesh-ancestor
92494149|NCT01973309|Antimitotic Agents|antimitotic agents|mesh-ancestor
92494150|NCT01973309|Mitosis Modulators|mitosis modulators|mesh-ancestor
92494151|NCT01973309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494153|NCT01973322|Complement Factor H|complement factor h|mesh-list
92494154|NCT01973322|Immunologic Factors|immunologic factors|mesh-ancestor
92494155|NCT01973322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494156|NCT01973322|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92494157|NCT01973322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92494158|NCT01973400|Tocotrienols|tocotrienols|mesh-list
92494159|NCT01973400|Vitamin E|vitamin e|mesh-list
92494160|NCT01973400|Tocopherols|tocopherols|mesh-list
92494161|NCT01973400|Antioxidants|antioxidants|mesh-ancestor
92704598|NCT02203643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92219066|NCT01925300|Calcium|calcium|mesh-list
92494162|NCT01973400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494163|NCT01973400|Protective Agents|protective agents|mesh-ancestor
92494164|NCT01973400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494165|NCT01973400|Vitamins|vitamins|mesh-ancestor
92494166|NCT01973400|Micronutrients|micronutrients|mesh-ancestor
92494167|NCT01973504|Chrysarobin|chrysarobin|mesh-list
92494168|NCT01973504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92494169|NCT01973504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494170|NCT01973504|Analgesics|analgesics|mesh-ancestor
92494171|NCT01973504|Sensory System Agents|sensory system agents|mesh-ancestor
92494172|NCT01973504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494173|NCT01973504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494174|NCT01973504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494175|NCT01973504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494176|NCT01973517|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92494177|NCT01973517|Hematinics|hematinics|mesh-ancestor
92494178|NCT01973517|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92494179|NCT01973517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92494180|NCT01973660|Tamoxifen|tamoxifen|mesh-list
92494181|NCT01973660|Paclitaxel|paclitaxel|mesh-list
92494182|NCT01973660|Trastuzumab|trastuzumab|mesh-list
92494183|NCT01973660|Letrozole|letrozole|mesh-list
92494184|NCT01973660|Lapatinib|lapatinib|mesh-list
92494185|NCT01973660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92494186|NCT01973660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494187|NCT01973660|Tubulin Modulators|tubulin modulators|mesh-ancestor
92494188|NCT01973660|Antimitotic Agents|antimitotic agents|mesh-ancestor
92494189|NCT01973660|Mitosis Modulators|mitosis modulators|mesh-ancestor
92494190|NCT01973660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494191|NCT01973660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494192|NCT01973660|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92494193|NCT01973660|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92494194|NCT01973660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494195|NCT01973660|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92494196|NCT01973660|Hormone Antagonists|hormone antagonists|mesh-ancestor
92494197|NCT01973660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494198|NCT01973660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494199|NCT01973660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494200|NCT01973660|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92494201|NCT01973660|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92494202|NCT01973660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92494203|NCT01973660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92494204|NCT01973751|Budesonide|budesonide|mesh-list
92494205|NCT01973751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494206|NCT01973751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92494207|NCT01973751|Autonomic Agents|autonomic agents|mesh-ancestor
92494208|NCT01973751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494209|NCT01973751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494210|NCT01973751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92494211|NCT01973751|Respiratory System Agents|respiratory system agents|mesh-ancestor
92494212|NCT01973751|Glucocorticoids|glucocorticoids|mesh-ancestor
92494213|NCT01973751|Hormones|hormones|mesh-ancestor
92494214|NCT01973751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494215|NCT01973790|Z 338|z 338|mesh-list
92494216|NCT01973790|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92494217|NCT01973790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494218|NCT01973790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494219|NCT01973790|Cholinergic Agents|cholinergic agents|mesh-ancestor
92494220|NCT01973790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494221|NCT01973790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494222|NCT01973790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494223|NCT01973816|Cyproterone Acetate|cyproterone acetate|mesh-list
92494224|NCT01973816|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92494225|NCT01973816|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92494226|NCT01973816|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92494227|NCT01973816|Estradiol|estradiol|mesh-list
92494228|NCT01973816|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92494229|NCT01973816|Cyproterone|cyproterone|mesh-list
92494230|NCT01973816|Estrogens|estrogens|mesh-ancestor
92494231|NCT01973816|Hormones|hormones|mesh-ancestor
92494232|NCT01973816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494233|NCT01973816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494234|NCT01973816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92494235|NCT01973816|Contraceptive Agents|contraceptive agents|mesh-ancestor
92494236|NCT01973816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92494237|NCT01973816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92494238|NCT01973816|Androgen Antagonists|androgen antagonists|mesh-ancestor
92494239|NCT01973816|Hormone Antagonists|hormone antagonists|mesh-ancestor
92494240|NCT01973816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494241|NCT01973816|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92494242|NCT01973816|Luteolytic Agents|luteolytic agents|mesh-ancestor
92494243|NCT01973816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494244|NCT01973842|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92494245|NCT01973842|Luteolytic Agents|luteolytic agents|mesh-ancestor
92494246|NCT01973842|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92494247|NCT01973842|Contraceptive Agents|contraceptive agents|mesh-ancestor
92494248|NCT01973842|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92494249|NCT01973842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494250|NCT01973842|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92494251|NCT01973842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494252|NCT01973842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494253|NCT01973855|Ribavirin|ribavirin|mesh-list
92494254|NCT01973855|Antimetabolites|antimetabolites|mesh-ancestor
92494255|NCT01973855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494256|NCT01973855|Antiviral Agents|antiviral agents|mesh-ancestor
92494257|NCT01973855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494258|NCT01973868|Cetuximab|cetuximab|mesh-list
92494259|NCT01973868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494260|NCT01973868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494261|NCT01973920|Insulin|insulin|mesh-list
92494262|NCT01973920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92494263|NCT01973920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494264|NCT01973933|Metformin|metformin|mesh-list
92494265|NCT01973933|Pyrimethamine|pyrimethamine|mesh-list
92494266|NCT01973933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92494267|NCT01973933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494268|NCT01973933|Antimalarials|antimalarials|mesh-ancestor
92494269|NCT01973933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92494270|NCT01973933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92494271|NCT01973933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494272|NCT01973933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92494273|NCT01973933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494274|NCT01973933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494275|NCT01974024|Methylprednisolone|methylprednisolone|mesh-list
92494276|NCT01974024|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92494277|NCT01974024|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92494278|NCT01974024|Prednisolone|prednisolone|mesh-list
92494279|NCT01974024|Prednisolone acetate|prednisolone acetate|mesh-list
92494280|NCT01974024|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92494281|NCT01974024|Prednisolone phosphate|prednisolone phosphate|mesh-list
92494282|NCT01974024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494283|NCT01974024|Antiemetics|antiemetics|mesh-ancestor
92494284|NCT01974024|Autonomic Agents|autonomic agents|mesh-ancestor
92494285|NCT01974024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494286|NCT01974024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494287|NCT01974024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494288|NCT01974024|Glucocorticoids|glucocorticoids|mesh-ancestor
92494289|NCT01974024|Hormones|hormones|mesh-ancestor
92494290|NCT01974024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494291|NCT01974024|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92494292|NCT01974024|Protective Agents|protective agents|mesh-ancestor
92494293|NCT01974024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494294|NCT01974024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494295|NCT01974037|Capsaicin|capsaicin|mesh-list
92494296|NCT01974037|Antipruritics|antipruritics|mesh-ancestor
92494297|NCT01974037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92494298|NCT01974037|Sensory System Agents|sensory system agents|mesh-ancestor
92494299|NCT01974037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494300|NCT01974037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494301|NCT01974167|Alfacalcidol|alfacalcidol|mesh-list
92494302|NCT01974167|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92494303|NCT01974167|Eldecalcitol|eldecalcitol|mesh-list
92494304|NCT01974167|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92494305|NCT01974167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494306|NCT01974167|Vitamins|vitamins|mesh-ancestor
92494307|NCT01974167|Micronutrients|micronutrients|mesh-ancestor
92494308|NCT01974258|Vemurafenib|vemurafenib|mesh-list
92494309|NCT01974258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494310|NCT01974258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92494311|NCT01974258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494312|NCT01974258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494313|NCT01974297|Atorvastatin|atorvastatin|mesh-list
92494314|NCT01974297|Fenofibric acid|fenofibric acid|mesh-list
92494315|NCT01974297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92494316|NCT01974297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92494317|NCT01974297|Antimetabolites|antimetabolites|mesh-ancestor
92494318|NCT01974297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494319|NCT01974297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92494320|NCT01974297|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92494321|NCT01974297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494322|NCT01974336|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92494323|NCT01974336|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92494324|NCT01974336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494325|NCT01974375|Fluconazole|fluconazole|mesh-list
92494326|NCT01974375|Micafungin|micafungin|mesh-list
92494327|NCT01974375|Antifungal Agents|antifungal agents|mesh-ancestor
92494328|NCT01974375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494329|NCT01974375|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92494330|NCT01974375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92494331|NCT01974375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494332|NCT01974375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494333|NCT01974375|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92494334|NCT01974375|Hormone Antagonists|hormone antagonists|mesh-ancestor
92494335|NCT01974375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494336|NCT01974375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494337|NCT01974375|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92494338|NCT01974375|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92494339|NCT01974401|Chlorhexidine|chlorhexidine|mesh-list
92494340|NCT01974401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92494341|NCT01974401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494342|NCT01974401|Disinfectants|disinfectants|mesh-ancestor
92494343|NCT01974518|Cyclophosphamide|cyclophosphamide|mesh-list
92494344|NCT01974518|Rituximab|rituximab|mesh-list
92494345|NCT01974518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92494346|NCT01974518|Immunologic Factors|immunologic factors|mesh-ancestor
92494347|NCT01974518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494348|NCT01974518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494349|NCT01974518|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92494350|NCT01974518|Alkylating Agents|alkylating agents|mesh-ancestor
92494351|NCT01974518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494352|NCT01974518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494353|NCT01974518|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92494354|NCT01974518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494355|NCT01974622|Verteporfin|verteporfin|mesh-list
92494356|NCT01974622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92494357|NCT01974622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92494358|NCT01974648|Remifentanil|remifentanil|mesh-list
92494359|NCT01974648|Propofol|propofol|mesh-list
92494360|NCT01974648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92494361|NCT01974648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494362|NCT01974648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494363|NCT01974648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92494364|NCT01974648|Anesthetics, General|anesthetics, general|mesh-ancestor
92494365|NCT01974648|Anesthetics|anesthetics|mesh-ancestor
92494366|NCT01974648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92494368|NCT01974648|Analgesics|analgesics|mesh-ancestor
92494369|NCT01974648|Sensory System Agents|sensory system agents|mesh-ancestor
92494370|NCT01974648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494371|NCT01974843|Bupivacaine|bupivacaine|mesh-list
92494372|NCT01974843|Levobupivacaine|levobupivacaine|mesh-list
92494373|NCT01974843|Anesthetics, Local|anesthetics, local|mesh-ancestor
92494374|NCT01974843|Anesthetics|anesthetics|mesh-ancestor
92494375|NCT01974843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494376|NCT01974843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494377|NCT01974843|Sensory System Agents|sensory system agents|mesh-ancestor
92494378|NCT01974843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494379|NCT01974934|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92494380|NCT01974934|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92494381|NCT01974934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92494382|NCT01974934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494383|NCT01974934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494384|NCT01974934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494385|NCT01974934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494386|NCT01974934|Antidepressive Agents|antidepressive agents|mesh-ancestor
92494387|NCT01974934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494388|NCT01975012|Rilpivirine|rilpivirine|mesh-list
92494389|NCT01975012|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92494390|NCT01975012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92494391|NCT01975012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494392|NCT01975012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494393|NCT01975012|Antiviral Agents|antiviral agents|mesh-ancestor
92494394|NCT01975012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494395|NCT01975012|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92494396|NCT01975012|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92494397|NCT01975051|Miltefosine|miltefosine|mesh-list
92494398|NCT01975051|Antifungal Agents|antifungal agents|mesh-ancestor
92494399|NCT01975051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494400|NCT01975051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494401|NCT01975051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92494402|NCT01975051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92494403|NCT01975129|Oxytocin|oxytocin|mesh-list
92494404|NCT01975129|Oxytocics|oxytocics|mesh-ancestor
92494405|NCT01975129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92494406|NCT01975129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494407|NCT01975142|Trastuzumab|trastuzumab|mesh-list
92494408|NCT01975142|Maytansine|maytansine|mesh-list
92494409|NCT01975142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494410|NCT01975142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494411|NCT01975142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92494412|NCT01975142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92494413|NCT01975142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92494414|NCT01975142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92494415|NCT01975142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494416|NCT01975194|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92494417|NCT01975194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92494418|NCT01975194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92494419|NCT01975194|Antimetabolites|antimetabolites|mesh-ancestor
92494420|NCT01975194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494421|NCT01975194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92494422|NCT01975194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92494423|NCT01975194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494424|NCT01975259|Glucagon|glucagon|mesh-list
92494425|NCT01975259|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92494426|NCT01975259|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92494427|NCT01975259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494428|NCT01975259|Hormones|hormones|mesh-ancestor
92494429|NCT01975259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494430|NCT01975259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494431|NCT01975259|Incretins|incretins|mesh-ancestor
92494432|NCT01975324|4-Aminopyridine|4-aminopyridine|mesh-list
92494433|NCT01975324|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92494434|NCT01975324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494435|NCT01975324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494437|NCT01975363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92494438|NCT01975363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494439|NCT01975363|Analgesics|analgesics|mesh-ancestor
92494440|NCT01975363|Sensory System Agents|sensory system agents|mesh-ancestor
92494441|NCT01975363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494442|NCT01975363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494443|NCT01975363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494444|NCT01975363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494445|NCT01975363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494446|NCT01975363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494447|NCT01975363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494448|NCT01975441|Ivermectin|ivermectin|mesh-list
92494449|NCT01975441|Albendazole|albendazole|mesh-list
92494450|NCT01975441|Diethylcarbamazine|diethylcarbamazine|mesh-list
92494451|NCT01975441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92494452|NCT01975441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494453|NCT01975441|Anthelmintics|anthelmintics|mesh-ancestor
92494454|NCT01975441|Anticestodal Agents|anticestodal agents|mesh-ancestor
92494455|NCT01975441|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92494456|NCT01975441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92494457|NCT01975441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92494458|NCT01975441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92494459|NCT01975441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92494460|NCT01975441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494461|NCT01975441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494462|NCT01975441|Filaricides|filaricides|mesh-ancestor
92494463|NCT01975441|Antinematodal Agents|antinematodal agents|mesh-ancestor
92494464|NCT01975441|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92494465|NCT01975441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494466|NCT01975454|Capecitabine|capecitabine|mesh-list
92494467|NCT01975454|Oxaliplatin|oxaliplatin|mesh-list
92494506|NCT01975727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494507|NCT01975727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494508|NCT01975727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494510|NCT01975727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494511|NCT01975727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494512|NCT01975753|Fentanyl|fentanyl|mesh-list
92494513|NCT01975753|Morphine|morphine|mesh-list
92494514|NCT01975753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92494515|NCT01975753|Narcotics|narcotics|mesh-ancestor
92494516|NCT01975753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494517|NCT01975753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494518|NCT01975753|Analgesics|analgesics|mesh-ancestor
92494519|NCT01975753|Sensory System Agents|sensory system agents|mesh-ancestor
92494520|NCT01975753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494521|NCT01975753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92494522|NCT01975753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92494523|NCT01975753|Anesthetics, General|anesthetics, general|mesh-ancestor
92494524|NCT01975753|Anesthetics|anesthetics|mesh-ancestor
92494525|NCT01975779|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92494526|NCT01975779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92494527|NCT01975779|Serotonin Agents|serotonin agents|mesh-ancestor
92494528|NCT01975779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494529|NCT01975779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494530|NCT01975779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494531|NCT01975805|Chlorhexidine|chlorhexidine|mesh-list
92494532|NCT01975805|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92494533|NCT01975805|Povidone-Iodine|povidone-iodine|mesh-list
92494534|NCT01975805|Povidone|povidone|mesh-list
92494535|NCT01975805|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92494536|NCT01975805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494537|NCT01975805|Disinfectants|disinfectants|mesh-ancestor
92494538|NCT01975805|Dermatologic Agents|dermatologic agents|mesh-ancestor
92494539|NCT01975805|Plasma Substitutes|plasma substitutes|mesh-ancestor
92494540|NCT01975805|Blood Substitutes|blood substitutes|mesh-ancestor
92494541|NCT01975961|Telmisartan|telmisartan|mesh-list
92494542|NCT01975961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92494543|NCT01975961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92494544|NCT01975961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92494545|NCT01975961|Antimetabolites|antimetabolites|mesh-ancestor
92494546|NCT01975961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494547|NCT01975961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92494548|NCT01975961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92494549|NCT01975961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494550|NCT01975961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92494551|NCT01975961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92494552|NCT01975961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92494553|NCT01976078|Midazolam|midazolam|mesh-list
92494554|NCT01976078|Esomeprazole|esomeprazole|mesh-list
92494555|NCT01976078|Ranitidine|ranitidine|mesh-list
92494556|NCT01976078|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92494557|NCT01976078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92494558|NCT01976078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92494559|NCT01976078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494560|NCT01976078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494561|NCT01976078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92494562|NCT01976078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92494563|NCT01976078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494564|NCT01976078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92494565|NCT01976078|Anesthetics, General|anesthetics, general|mesh-ancestor
92494566|NCT01976078|Anesthetics|anesthetics|mesh-ancestor
92494567|NCT01976078|GABA Modulators|gaba modulators|mesh-ancestor
92494568|NCT01976078|GABA Agents|gaba agents|mesh-ancestor
92494569|NCT01976078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494570|NCT01976078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494571|NCT01976078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92494572|NCT01976078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494573|NCT01976078|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92494574|NCT01976078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494575|NCT01976078|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92494576|NCT01976078|Histamine Antagonists|histamine antagonists|mesh-ancestor
92494577|NCT01976078|Histamine Agents|histamine agents|mesh-ancestor
92494578|NCT01976143|Etirinotecan pegol|etirinotecan pegol|mesh-list
92494579|NCT01976143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494580|NCT01976143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92494581|NCT01976143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92494583|NCT01976143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494584|NCT01976195|Thalidomide|thalidomide|mesh-list
92494585|NCT01976195|Dexamethasone|dexamethasone|mesh-list
92494586|NCT01976195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494587|NCT01976195|Antiemetics|antiemetics|mesh-ancestor
92494588|NCT01976195|Autonomic Agents|autonomic agents|mesh-ancestor
92494589|NCT01976195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494590|NCT01976195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494591|NCT01976195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494592|NCT01976195|Glucocorticoids|glucocorticoids|mesh-ancestor
92494593|NCT01976195|Hormones|hormones|mesh-ancestor
92494594|NCT01976195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494595|NCT01976195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494596|NCT01976195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494597|NCT01976195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92494598|NCT01976195|Immunologic Factors|immunologic factors|mesh-ancestor
92494599|NCT01976195|Leprostatic Agents|leprostatic agents|mesh-ancestor
92494600|NCT01976195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92494601|NCT01976195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494602|NCT01976195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92494603|NCT01976195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92494604|NCT01976195|Growth Substances|growth substances|mesh-ancestor
92494605|NCT01976195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92494606|NCT01976208|Omalizumab|omalizumab|mesh-list
92494607|NCT01976208|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92494608|NCT01976208|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92494609|NCT01976208|Respiratory System Agents|respiratory system agents|mesh-ancestor
92494610|NCT01976520|Vaccines|vaccines|mesh-list
92494611|NCT01976520|Immunologic Factors|immunologic factors|mesh-ancestor
92494612|NCT01976520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219520|NCT00376480|Hormones|hormones|mesh-ancestor
92494613|NCT01976611|Botulinum Toxins|botulinum toxins|mesh-list
92494614|NCT01976611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92494615|NCT01976611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92494616|NCT01976611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92494617|NCT01976611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494618|NCT01976611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494619|NCT01976611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92494620|NCT01976611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494621|NCT01976611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494622|NCT01976611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92494623|NCT01976611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494625|NCT01976676|Hematinics|hematinics|mesh-ancestor
92494626|NCT01976676|Vitamin B Complex|vitamin b complex|mesh-ancestor
92494627|NCT01976676|Vitamins|vitamins|mesh-ancestor
92494628|NCT01976676|Micronutrients|micronutrients|mesh-ancestor
92494629|NCT01976676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494630|NCT01976780|Artesunate|artesunate|mesh-list
92494631|NCT01976780|Lumefantrine|lumefantrine|mesh-list
92494632|NCT01976780|Artemether|artemether|mesh-list
92494633|NCT01976780|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92494634|NCT01976780|Mefloquine|mefloquine|mesh-list
92494635|NCT01976780|Antimalarials|antimalarials|mesh-ancestor
92494636|NCT01976780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92494637|NCT01976780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92494638|NCT01976780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494639|NCT01976780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494640|NCT01976780|Antiviral Agents|antiviral agents|mesh-ancestor
92494641|NCT01976780|Schistosomicides|schistosomicides|mesh-ancestor
92494642|NCT01976780|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92494643|NCT01976780|Anthelmintics|anthelmintics|mesh-ancestor
92494644|NCT01976923|Bevacizumab|bevacizumab|mesh-list
92494645|NCT01976923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92494646|NCT01976923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494647|NCT01976923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92494648|NCT01976923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92494649|NCT01976923|Growth Substances|growth substances|mesh-ancestor
92494650|NCT01976923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494651|NCT01976923|Growth Inhibitors|growth inhibitors|mesh-ancestor
92494652|NCT01976936|Lovastatin|lovastatin|mesh-list
92494653|NCT01976936|L 647318|l 647318|mesh-list
92494654|NCT01976936|Dihydromevinolin|dihydromevinolin|mesh-list
92494655|NCT01976936|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92494656|NCT01976936|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92494657|NCT01976936|Antimetabolites|antimetabolites|mesh-ancestor
92494658|NCT01976936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494659|NCT01976936|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92494660|NCT01976936|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92494661|NCT01976936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494662|NCT01977118|Streptokinase|streptokinase|mesh-list
92494663|NCT01977118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92494664|NCT01977118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92494665|NCT01977118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494667|NCT01977209|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92494668|NCT01977209|Contraceptive Agents|contraceptive agents|mesh-ancestor
92494669|NCT01977209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92494670|NCT01977209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494671|NCT01977300|Valproic Acid|valproic acid|mesh-list
92494672|NCT01977300|Olanzapine|olanzapine|mesh-list
92494673|NCT01977300|Risperidone|risperidone|mesh-list
92494674|NCT01977300|Lithium Carbonate|lithium carbonate|mesh-list
92494675|NCT01977300|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92494676|NCT01977300|Serotonin Agents|serotonin agents|mesh-ancestor
92494677|NCT01977300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494678|NCT01977300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494679|NCT01977300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494680|NCT01977300|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92494681|NCT01977300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92494682|NCT01977300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494683|NCT01977300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494684|NCT01977300|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92494685|NCT01977300|Dopamine Agents|dopamine agents|mesh-ancestor
92494686|NCT01977300|Antiemetics|antiemetics|mesh-ancestor
92494687|NCT01977300|Autonomic Agents|autonomic agents|mesh-ancestor
92494688|NCT01977300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494689|NCT01977300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92494690|NCT01977300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92494691|NCT01977300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92494692|NCT01977300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494693|NCT01977300|Antidepressive Agents|antidepressive agents|mesh-ancestor
92494694|NCT01977300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494695|NCT01977300|Antimanic Agents|antimanic agents|mesh-ancestor
92494696|NCT01977300|Anticonvulsants|anticonvulsants|mesh-ancestor
92494697|NCT01977300|GABA Agents|gaba agents|mesh-ancestor
92494698|NCT01977339|Bupivacaine|bupivacaine|mesh-list
92494699|NCT01977339|Anesthetics, Local|anesthetics, local|mesh-ancestor
92494700|NCT01977339|Anesthetics|anesthetics|mesh-ancestor
92494701|NCT01977339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494702|NCT01977339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494703|NCT01977339|Sensory System Agents|sensory system agents|mesh-ancestor
92494704|NCT01977339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494705|NCT01977378|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92494706|NCT01977378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92494707|NCT01977378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92494708|NCT01977378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92494709|NCT01977378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494710|NCT01977378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494711|NCT01977378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494712|NCT01977378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494713|NCT01977378|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92494714|NCT01977378|Antidepressive Agents|antidepressive agents|mesh-ancestor
92494715|NCT01977378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494716|NCT01977417|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92494717|NCT01977417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92200430|NCT03086096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494718|NCT01977417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494719|NCT01977417|Analgesics|analgesics|mesh-ancestor
92494720|NCT01977417|Sensory System Agents|sensory system agents|mesh-ancestor
92494721|NCT01977417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494722|NCT01977417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494723|NCT01977417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494724|NCT01977417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494725|NCT01977430|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92494726|NCT01977430|Furosemide|furosemide|mesh-list
92494727|NCT01977430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92494728|NCT01977430|Diuretics|diuretics|mesh-ancestor
92494729|NCT01977430|Natriuretic Agents|natriuretic agents|mesh-ancestor
92494730|NCT01977430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494731|NCT01977430|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92494732|NCT01977430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494733|NCT01977430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494734|NCT01977430|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92494736|NCT01977235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494737|NCT01977235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92494738|NCT01977235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92494739|NCT01977235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494740|NCT01977235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494741|NCT01977443|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92494742|NCT01977443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92494743|NCT01977859|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92494744|NCT01977859|Natriuretic Agents|natriuretic agents|mesh-ancestor
92494745|NCT01977859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494746|NCT01977989|Vancomycin|vancomycin|mesh-list
92494747|NCT01977989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92494748|NCT01977989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494749|NCT01978015|Timolol|timolol|mesh-list
92494750|NCT01978015|Bimatoprost|bimatoprost|mesh-list
92494751|NCT01978015|Travoprost|travoprost|mesh-list
92494752|NCT01978015|Dextrans|dextrans|mesh-list
92494753|NCT01978015|Latanoprost|latanoprost|mesh-list
92494754|NCT01978015|Maleic acid|maleic acid|mesh-list
92494755|NCT01978015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494756|NCT01978015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494757|NCT01978015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92494758|NCT01978015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92494759|NCT01978015|Adrenergic Agents|adrenergic agents|mesh-ancestor
92494760|NCT01978015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494761|NCT01978015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494762|NCT01978015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92494763|NCT01978015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92219674|NCT03374176|Amoxicillin|amoxicillin|mesh-list
92494764|NCT01978015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92494765|NCT01978015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92494766|NCT01978015|Anticoagulants|anticoagulants|mesh-ancestor
92494767|NCT01978015|Plasma Substitutes|plasma substitutes|mesh-ancestor
92494768|NCT01978015|Blood Substitutes|blood substitutes|mesh-ancestor
92494769|NCT01978041|Fluorides|fluorides|mesh-list
92494770|NCT01978041|Cariostatic Agents|cariostatic agents|mesh-ancestor
92494771|NCT01978041|Protective Agents|protective agents|mesh-ancestor
92494772|NCT01978041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494773|NCT01978301|Triamcinolone|triamcinolone|mesh-list
92494774|NCT01978301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92494775|NCT01978301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92494776|NCT01978301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92494777|NCT01978301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494778|NCT01978301|Glucocorticoids|glucocorticoids|mesh-ancestor
92494779|NCT01978301|Hormones|hormones|mesh-ancestor
92494780|NCT01978301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494781|NCT01978301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494782|NCT01978301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92494783|NCT01978301|Immunologic Factors|immunologic factors|mesh-ancestor
92494784|NCT01978301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494785|NCT01978301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494786|NCT01978405|Thioctic Acid|thioctic acid|mesh-list
92494787|NCT01978405|Antioxidants|antioxidants|mesh-ancestor
92494788|NCT01978405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494789|NCT01978405|Protective Agents|protective agents|mesh-ancestor
92494790|NCT01978405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494791|NCT01978405|Vitamin B Complex|vitamin b complex|mesh-ancestor
92494793|NCT01978405|Micronutrients|micronutrients|mesh-ancestor
92494794|NCT01978418|Albuterol|albuterol|mesh-list
92494795|NCT01978418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92494796|NCT01978418|Autonomic Agents|autonomic agents|mesh-ancestor
92494797|NCT01978418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494798|NCT01978418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494799|NCT01978418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92494800|NCT01978418|Respiratory System Agents|respiratory system agents|mesh-ancestor
92494801|NCT01978418|Tocolytic Agents|tocolytic agents|mesh-ancestor
92494802|NCT01978418|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92494803|NCT01978418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92494804|NCT01978418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92494805|NCT01978418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92494806|NCT01978418|Adrenergic Agents|adrenergic agents|mesh-ancestor
92494807|NCT01978418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494808|NCT01978418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494809|NCT01978457|Propranolol|propranolol|mesh-list
92494811|NCT01978457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92494812|NCT01978457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92494813|NCT01978457|Adrenergic Agents|adrenergic agents|mesh-ancestor
92494814|NCT01978457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494815|NCT01978457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494816|NCT01978457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494817|NCT01978457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92494818|NCT01978457|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92494819|NCT01978457|Vasodilator Agents|vasodilator agents|mesh-ancestor
92494820|NCT01978457|Anesthetics, Local|anesthetics, local|mesh-ancestor
92494821|NCT01978457|Anesthetics|anesthetics|mesh-ancestor
92494822|NCT01978457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494823|NCT01978457|Sensory System Agents|sensory system agents|mesh-ancestor
92494824|NCT01978457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494825|NCT01978457|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92494826|NCT01978457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92494827|NCT01978457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92494828|NCT01978457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494829|NCT01978457|Dopamine Agents|dopamine agents|mesh-ancestor
92494830|NCT01978483|Denosumab|denosumab|mesh-list
92494831|NCT01978483|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92494832|NCT01978483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494833|NCT01978496|Eletriptan|eletriptan|mesh-list
92494834|NCT01978496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92494835|NCT01978496|Serotonin Agents|serotonin agents|mesh-ancestor
92494836|NCT01978496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494837|NCT01978496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494838|NCT01978496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494840|NCT01978665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494841|NCT01978665|Glucocorticoids|glucocorticoids|mesh-ancestor
92494842|NCT01978665|Hormones|hormones|mesh-ancestor
92494843|NCT01978665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494844|NCT01978665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494845|NCT01978665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494846|NCT01978665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494847|NCT01978678|Budesonide|budesonide|mesh-list
92494848|NCT01978678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494849|NCT01978678|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92494850|NCT01978678|Autonomic Agents|autonomic agents|mesh-ancestor
92494851|NCT01978678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494852|NCT01978678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494853|NCT01978678|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92494854|NCT01978678|Respiratory System Agents|respiratory system agents|mesh-ancestor
92494855|NCT01978678|Glucocorticoids|glucocorticoids|mesh-ancestor
92494856|NCT01978678|Hormones|hormones|mesh-ancestor
92494857|NCT01978678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494858|NCT01978704|Insulin|insulin|mesh-list
92494859|NCT01978704|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92494860|NCT01978704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92494861|NCT01978704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494862|NCT01978717|Anesthetics|anesthetics|mesh-list
92494863|NCT01978717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494864|NCT01978717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494865|NCT01978782|Raltegravir Potassium|raltegravir potassium|mesh-list
92494866|NCT01978782|Citalopram|citalopram|mesh-list
92494868|NCT01978782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92494869|NCT01978782|Antiviral Agents|antiviral agents|mesh-ancestor
92494870|NCT01978782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92494871|NCT01978782|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92494872|NCT01978782|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92494873|NCT01978782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494874|NCT01978782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494875|NCT01978782|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92494876|NCT01978782|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92494877|NCT01978782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494878|NCT01978782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494879|NCT01978782|Serotonin Agents|serotonin agents|mesh-ancestor
92494880|NCT01978782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494881|NCT01978782|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92494882|NCT01978782|Antidepressive Agents|antidepressive agents|mesh-ancestor
92494883|NCT01978782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494884|NCT01978873|Ascorbic Acid|ascorbic acid|mesh-list
92494885|NCT01978873|Methyltestosterone|methyltestosterone|mesh-list
92494886|NCT01978873|Androgens|androgens|mesh-list
92494887|NCT01978873|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92494888|NCT01978873|Hormones|hormones|mesh-ancestor
92494889|NCT01978873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92494890|NCT01978873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494891|NCT01978873|Antioxidants|antioxidants|mesh-ancestor
92494892|NCT01978873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494893|NCT01978873|Protective Agents|protective agents|mesh-ancestor
92494894|NCT01978873|Vitamins|vitamins|mesh-ancestor
92494895|NCT01978873|Micronutrients|micronutrients|mesh-ancestor
92494896|NCT01978873|Estrogens|estrogens|mesh-ancestor
92494897|NCT01978873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494898|NCT01978873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494899|NCT01978873|Anabolic Agents|anabolic agents|mesh-ancestor
92494900|NCT01979341|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92494901|NCT01979341|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92494902|NCT01979341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494903|NCT01979341|Luteolytic Agents|luteolytic agents|mesh-ancestor
92494904|NCT01979341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92494905|NCT01979341|Contraceptive Agents|contraceptive agents|mesh-ancestor
92494906|NCT01979341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92494907|NCT01979341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92494908|NCT01979341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92494909|NCT01979341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92494910|NCT01979354|Morphine|morphine|mesh-list
92494911|NCT01979354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92494912|NCT01979354|Narcotics|narcotics|mesh-ancestor
92494913|NCT01979354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494914|NCT01979354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494915|NCT01979354|Analgesics|analgesics|mesh-ancestor
92494916|NCT01979354|Sensory System Agents|sensory system agents|mesh-ancestor
92494917|NCT01979354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494918|NCT01979406|Vaccines|vaccines|mesh-list
92494919|NCT01979406|Immunologic Factors|immunologic factors|mesh-ancestor
92494920|NCT01979406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494921|NCT01979510|Acetaminophen|acetaminophen|mesh-list
92494922|NCT01979510|Etoricoxib|etoricoxib|mesh-list
92494923|NCT01979510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494924|NCT01979510|Analgesics|analgesics|mesh-ancestor
92494925|NCT01979510|Sensory System Agents|sensory system agents|mesh-ancestor
92494926|NCT01979510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494927|NCT01979510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494928|NCT01979510|Antipyretics|antipyretics|mesh-ancestor
92494929|NCT01979510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92494930|NCT01979510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92494931|NCT01979510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92494932|NCT01979510|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92494933|NCT01979510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92494934|NCT01979510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494935|NCT01979510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494936|NCT01979653|Midazolam|midazolam|mesh-list
92494937|NCT01979653|Dexmedetomidine|dexmedetomidine|mesh-list
92494938|NCT01979653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92494939|NCT01979653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494940|NCT01979653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494941|NCT01979653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92494943|NCT01979653|Sensory System Agents|sensory system agents|mesh-ancestor
92494944|NCT01979653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494945|NCT01979653|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92494946|NCT01979653|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92494947|NCT01979653|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92494948|NCT01979653|Adrenergic Agents|adrenergic agents|mesh-ancestor
92494949|NCT01979653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494950|NCT01979653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494951|NCT01979653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92494952|NCT01979653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92494953|NCT01979653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92494954|NCT01979653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494955|NCT01979653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92494956|NCT01979653|Anesthetics, General|anesthetics, general|mesh-ancestor
92494958|NCT01979653|GABA Modulators|gaba modulators|mesh-ancestor
92494959|NCT01979653|GABA Agents|gaba agents|mesh-ancestor
92494960|NCT01979679|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92494961|NCT01979679|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92494962|NCT01979679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92494963|NCT01979679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92494964|NCT01979679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494965|NCT01979679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92494966|NCT01979679|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92494967|NCT01979679|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92494968|NCT01979679|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92494969|NCT01979679|Adrenergic Agents|adrenergic agents|mesh-ancestor
92494970|NCT01979679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494971|NCT01979679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494972|NCT01979679|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92494973|NCT01979679|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92494974|NCT01979679|Serotonin Agents|serotonin agents|mesh-ancestor
92494975|NCT01979679|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92494976|NCT01979679|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92494977|NCT01979679|Dopamine Agents|dopamine agents|mesh-ancestor
92494978|NCT01979965|Ranolazine|ranolazine|mesh-list
92494979|NCT01979965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92494980|NCT01979965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92494981|NCT01979965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494982|NCT01980004|Potassium Citrate|potassium citrate|mesh-list
92494983|NCT01980004|Diuretics|diuretics|mesh-ancestor
92494984|NCT01980004|Natriuretic Agents|natriuretic agents|mesh-ancestor
92494985|NCT01980004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494986|NCT01980004|Expectorants|expectorants|mesh-ancestor
92494987|NCT01980004|Respiratory System Agents|respiratory system agents|mesh-ancestor
92494988|NCT01980069|Neostigmine|neostigmine|mesh-list
92494989|NCT01980069|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92494990|NCT01980069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92494991|NCT01980069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92494992|NCT01980069|Cholinergic Agents|cholinergic agents|mesh-ancestor
92494993|NCT01980069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92494994|NCT01980069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92494995|NCT01980069|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92494996|NCT01980069|Autonomic Agents|autonomic agents|mesh-ancestor
92494997|NCT01980069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92494998|NCT01980082|Cefazolin|cefazolin|mesh-list
92494999|NCT01980082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92495000|NCT01980082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495001|NCT01980277|Paclitaxel|paclitaxel|mesh-list
92495002|NCT01980277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92495003|NCT01980277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495004|NCT01980277|Tubulin Modulators|tubulin modulators|mesh-ancestor
92495005|NCT01980277|Antimitotic Agents|antimitotic agents|mesh-ancestor
92495006|NCT01980277|Mitosis Modulators|mitosis modulators|mesh-ancestor
92495007|NCT01980277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495008|NCT01980303|Esketamine|esketamine|mesh-list
92495009|NCT01980303|Antidepressive Agents|antidepressive agents|mesh-ancestor
92495010|NCT01980303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92495011|NCT01980316|Heparin|heparin|mesh-list
92495012|NCT01980316|Calcium heparin|calcium heparin|mesh-list
92495013|NCT01980316|Argatroban|argatroban|mesh-list
92495014|NCT01980316|Anticoagulants|anticoagulants|mesh-ancestor
92495015|NCT01980316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92495016|NCT01980316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92495017|NCT01980316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495018|NCT01980316|Antithrombins|antithrombins|mesh-ancestor
92495019|NCT01980316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92495020|NCT01980316|Protease Inhibitors|protease inhibitors|mesh-ancestor
92495021|NCT01980316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532660|NCT00054496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495022|NCT01980316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92495023|NCT01980329|Maraviroc|maraviroc|mesh-list
92495024|NCT01980329|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92495025|NCT01980329|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92495026|NCT01980329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495027|NCT01980329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92495028|NCT01980329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92495029|NCT01980329|Antiviral Agents|antiviral agents|mesh-ancestor
92495030|NCT01980329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495031|NCT01980329|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92495032|NCT01980407|Leucovorin|leucovorin|mesh-list
92495033|NCT01980407|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92495034|NCT01980407|Oxaliplatin|oxaliplatin|mesh-list
92495035|NCT01980407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495036|NCT01980407|Antidotes|antidotes|mesh-ancestor
92495037|NCT01980407|Protective Agents|protective agents|mesh-ancestor
92495038|NCT01980407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495039|NCT01980407|Vitamin B Complex|vitamin b complex|mesh-ancestor
92495040|NCT01980407|Vitamins|vitamins|mesh-ancestor
92495041|NCT01980407|Micronutrients|micronutrients|mesh-ancestor
92495042|NCT01980472|Paclitaxel|paclitaxel|mesh-list
92495043|NCT01980472|Bevacizumab|bevacizumab|mesh-list
92495044|NCT01980472|Carboplatin|carboplatin|mesh-list
92495045|NCT01980472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92495046|NCT01980472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495047|NCT01980472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92495048|NCT01980472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92495049|NCT01980472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92495050|NCT01980472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495051|NCT01980472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92495052|NCT01980472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92495053|NCT01980472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92495054|NCT01980472|Growth Substances|growth substances|mesh-ancestor
92495055|NCT01980472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495056|NCT01980472|Growth Inhibitors|growth inhibitors|mesh-ancestor
92495057|NCT01980498|Fentanyl|fentanyl|mesh-list
92495058|NCT01980498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92495059|NCT01980498|Narcotics|narcotics|mesh-ancestor
92495060|NCT01980498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495061|NCT01980498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495062|NCT01980498|Analgesics|analgesics|mesh-ancestor
92495063|NCT01980498|Sensory System Agents|sensory system agents|mesh-ancestor
92495064|NCT01980498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495065|NCT01980498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92495066|NCT01980498|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92495067|NCT01980498|Anesthetics, General|anesthetics, general|mesh-ancestor
92495068|NCT01980498|Anesthetics|anesthetics|mesh-ancestor
92495069|NCT01980550|Nicotine|nicotine|mesh-list
92495070|NCT01980550|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92495071|NCT01980550|Autonomic Agents|autonomic agents|mesh-ancestor
92495072|NCT01980550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495073|NCT01980550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495074|NCT01980550|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92495075|NCT01980550|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92495076|NCT01980550|Cholinergic Agents|cholinergic agents|mesh-ancestor
92495077|NCT01980550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495078|NCT01980550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495079|NCT01980615|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92495080|NCT01980615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92495081|NCT01980615|Respiratory System Agents|respiratory system agents|mesh-ancestor
92495082|NCT01980667|Cisplatin|cisplatin|mesh-list
92495083|NCT01980667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495084|NCT01980680|Estradiol|estradiol|mesh-list
92495085|NCT01980680|Progesterone|progesterone|mesh-list
92495086|NCT01980680|Estrogens|estrogens|mesh-ancestor
92495087|NCT01980680|Hormones|hormones|mesh-ancestor
92495088|NCT01980680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495089|NCT01980680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495090|NCT01980680|Progestins|progestins|mesh-ancestor
92495091|NCT01980745|Chloroquine|chloroquine|mesh-list
92495092|NCT01980745|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92495093|NCT01980745|Amebicides|amebicides|mesh-ancestor
92495094|NCT01980745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92495095|NCT01980745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92495096|NCT01980745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495097|NCT01980745|Antimalarials|antimalarials|mesh-ancestor
92495098|NCT01980745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495099|NCT01980745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92495100|NCT01980745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92495101|NCT01980745|Analgesics|analgesics|mesh-ancestor
92152324|NCT05039580|Hormones|hormones|mesh-ancestor
92495102|NCT01980745|Sensory System Agents|sensory system agents|mesh-ancestor
92495103|NCT01980745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495104|NCT01980745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495105|NCT01980745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495106|NCT01980745|Filaricides|filaricides|mesh-ancestor
92495107|NCT01980745|Antinematodal Agents|antinematodal agents|mesh-ancestor
92495108|NCT01980745|Anthelmintics|anthelmintics|mesh-ancestor
92495109|NCT01980810|Paclitaxel|paclitaxel|mesh-list
92495110|NCT01980810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92495111|NCT01980810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92495112|NCT01980810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495113|NCT01980810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92495114|NCT01980810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92495115|NCT01980810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92495116|NCT01980810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495117|NCT01980849|Nadroparin|nadroparin|mesh-list
92495118|NCT01980849|Anticoagulants|anticoagulants|mesh-ancestor
92495119|NCT01980849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92495120|NCT01980849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92495121|NCT01980849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495122|NCT01980966|Oseltamivir|oseltamivir|mesh-list
92495123|NCT01980966|Antiviral Agents|antiviral agents|mesh-ancestor
92495124|NCT01980966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495125|NCT01980966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495126|NCT01980966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495127|NCT01980979|Treprostinil|treprostinil|mesh-list
92495128|NCT01980979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92495129|NCT01981031|Insulin Lispro|insulin lispro|mesh-list
92495130|NCT01981031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92495131|NCT01981031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495132|NCT01981278|Tapentadol|tapentadol|mesh-list
92495133|NCT01981278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92495134|NCT01981278|Narcotics|narcotics|mesh-ancestor
92495135|NCT01981278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495136|NCT01981278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495137|NCT01981278|Analgesics|analgesics|mesh-ancestor
92495138|NCT01981278|Sensory System Agents|sensory system agents|mesh-ancestor
92495139|NCT01981278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495140|NCT01981278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92495141|NCT01981278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92495142|NCT01981278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92495143|NCT01981278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495144|NCT01981278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92495145|NCT01981278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495146|NCT01981291|Anesthetics|anesthetics|mesh-list
92495147|NCT01981291|Mepivacaine|mepivacaine|mesh-list
92495148|NCT01981291|Anesthetics, Local|anesthetics, local|mesh-list
92495149|NCT01981291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495150|NCT01981291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495151|NCT01981291|Sensory System Agents|sensory system agents|mesh-ancestor
92495152|NCT01981291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495153|NCT01981330|Hyaluronic Acid|hyaluronic acid|mesh-list
92495154|NCT01981330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92495155|NCT01981330|Immunologic Factors|immunologic factors|mesh-ancestor
92495156|NCT01981330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495157|NCT01981330|Viscosupplements|viscosupplements|mesh-ancestor
92495158|NCT01981330|Protective Agents|protective agents|mesh-ancestor
92495159|NCT01981369|Dexmedetomidine|dexmedetomidine|mesh-list
92495160|NCT01981369|Propofol|propofol|mesh-list
92495161|NCT01981369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92495162|NCT01981369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495163|NCT01981369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495164|NCT01981369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92495165|NCT01981369|Analgesics|analgesics|mesh-ancestor
92495166|NCT01981369|Sensory System Agents|sensory system agents|mesh-ancestor
92495167|NCT01981369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495168|NCT01981369|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92495169|NCT01981369|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92495170|NCT01981369|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92495171|NCT01981369|Adrenergic Agents|adrenergic agents|mesh-ancestor
92495172|NCT01981369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495173|NCT01981369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495174|NCT01981369|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92495175|NCT01981369|Anesthetics, General|anesthetics, general|mesh-ancestor
92495176|NCT01981369|Anesthetics|anesthetics|mesh-ancestor
92495177|NCT01981447|Lacosamide|lacosamide|mesh-list
92495178|NCT01981447|Anticonvulsants|anticonvulsants|mesh-ancestor
92495179|NCT01981447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92495180|NCT01981447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92495181|NCT01981447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92495182|NCT01981447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495183|NCT01981460|Methylene Blue|methylene blue|mesh-list
92495184|NCT01981460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495185|NCT01981460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495186|NCT01981499|Cetirizine|cetirizine|mesh-list
92495187|NCT01981499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92495188|NCT01981499|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92495189|NCT01981499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92495190|NCT01981499|Histamine Antagonists|histamine antagonists|mesh-ancestor
92495191|NCT01981499|Histamine Agents|histamine agents|mesh-ancestor
92495192|NCT01981499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495193|NCT01981499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495194|NCT01981499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495195|NCT01981525|Metformin|metformin|mesh-list
92495196|NCT01981525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92495197|NCT01981525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495198|NCT01981707|Choline|choline|mesh-list
92495199|NCT01981707|Lipotropic Agents|lipotropic agents|mesh-ancestor
92495200|NCT01981707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92495201|NCT01981707|Antimetabolites|antimetabolites|mesh-ancestor
92495202|NCT01981707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495203|NCT01981707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495204|NCT01981707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92495205|NCT01981707|Nootropic Agents|nootropic agents|mesh-ancestor
92495206|NCT01981746|Ropivacaine|ropivacaine|mesh-list
92495207|NCT01981746|Anesthetics, Local|anesthetics, local|mesh-ancestor
92495208|NCT01981746|Anesthetics|anesthetics|mesh-ancestor
92495209|NCT01981746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495210|NCT01981746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495211|NCT01981746|Sensory System Agents|sensory system agents|mesh-ancestor
92495212|NCT01981746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495213|NCT01981811|Aripiprazole|aripiprazole|mesh-list
92495214|NCT01981811|Antidepressive Agents|antidepressive agents|mesh-ancestor
92495215|NCT01981811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92495216|NCT01981811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92220114|NCT03014323|Cholinergic Agents|cholinergic agents|mesh-ancestor
92495217|NCT01981811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92495218|NCT01981811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495219|NCT01981811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495220|NCT01981811|Dopamine Agonists|dopamine agonists|mesh-ancestor
92495221|NCT01981811|Dopamine Agents|dopamine agents|mesh-ancestor
92495222|NCT01981811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495223|NCT01981811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495224|NCT01981811|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92495225|NCT01981811|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92495226|NCT01981811|Serotonin Agents|serotonin agents|mesh-ancestor
92495227|NCT01981811|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92495228|NCT01981811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92495229|NCT01981811|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92495230|NCT01981811|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92495232|NCT01981889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495233|NCT01981889|Glucocorticoids|glucocorticoids|mesh-ancestor
92495234|NCT01981889|Hormones|hormones|mesh-ancestor
92495235|NCT01981889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495236|NCT01981889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495237|NCT01981889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92495238|NCT01981889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495239|NCT01981941|Gabapentin|gabapentin|mesh-list
92495240|NCT01981941|Analgesics|analgesics|mesh-ancestor
92495241|NCT01981941|Sensory System Agents|sensory system agents|mesh-ancestor
92495242|NCT01981941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495243|NCT01981941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495244|NCT01981941|Anticonvulsants|anticonvulsants|mesh-ancestor
92495245|NCT01981941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92495246|NCT01981941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92495247|NCT01981941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495248|NCT01981941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92349563|NCT01446042|Methyltestosterone|methyltestosterone|mesh-list
92495249|NCT01981941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92495250|NCT01981941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92495251|NCT01981941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495252|NCT01981941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495253|NCT01981941|Antimanic Agents|antimanic agents|mesh-ancestor
92495254|NCT01982019|Hormones|hormones|mesh-list
92495255|NCT01982019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495256|NCT01982019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495257|NCT01982071|Micafungin|micafungin|mesh-list
92495258|NCT01982071|Antifungal Agents|antifungal agents|mesh-ancestor
92495259|NCT01982071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495260|NCT01982097|Sorafenib|sorafenib|mesh-list
92495261|NCT01982097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495262|NCT01982097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92495263|NCT01982097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495264|NCT01982097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495265|NCT01982201|Lesinurad|lesinurad|mesh-list
92495266|NCT01982201|Gout Suppressants|gout suppressants|mesh-ancestor
92495267|NCT01982201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495268|NCT01982201|Uricosuric Agents|uricosuric agents|mesh-ancestor
92495269|NCT01982396|Lamivudine|lamivudine|mesh-list
92495270|NCT01982396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92495271|NCT01982396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92495272|NCT01982396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495273|NCT01982396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495274|NCT01982396|Antiviral Agents|antiviral agents|mesh-ancestor
92495275|NCT01982396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495276|NCT01982396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92495277|NCT01982396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92495278|NCT01982461|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92495279|NCT01982461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92495280|NCT01982461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92495281|NCT01982461|Antimetabolites|antimetabolites|mesh-ancestor
92495282|NCT01982461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495283|NCT01982461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92495284|NCT01982461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92495285|NCT01982461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495286|NCT01982578|Genistein|genistein|mesh-list
92495287|NCT01982578|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92495288|NCT01982578|Protective Agents|protective agents|mesh-ancestor
92495289|NCT01982578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220190|NCT00948935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495290|NCT01982578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495291|NCT01982578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92495292|NCT01982578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495293|NCT01982578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495294|NCT01982578|Phytoestrogens|phytoestrogens|mesh-ancestor
92495295|NCT01982578|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92495296|NCT01982578|Estrogens|estrogens|mesh-ancestor
92495297|NCT01982578|Hormones|hormones|mesh-ancestor
92495298|NCT01982578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495299|NCT01982734|Curcumin|curcumin|mesh-list
92495300|NCT01982734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92495301|NCT01982734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92495302|NCT01982734|Analgesics|analgesics|mesh-ancestor
92495303|NCT01982734|Sensory System Agents|sensory system agents|mesh-ancestor
92495304|NCT01982734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495305|NCT01982734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495306|NCT01982734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495307|NCT01982734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495308|NCT01982734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495309|NCT01982734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495310|NCT01982734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495311|NCT01982760|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92495312|NCT01982760|Hemostatics|hemostatics|mesh-ancestor
92495313|NCT01982760|Coagulants|coagulants|mesh-ancestor
92495314|NCT01982760|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92495315|NCT01982760|Natriuretic Agents|natriuretic agents|mesh-ancestor
92495316|NCT01982760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495317|NCT01982799|Acetaminophen|acetaminophen|mesh-list
92495318|NCT01982799|Ibuprofen|ibuprofen|mesh-list
92495319|NCT01982799|Naproxen|naproxen|mesh-list
92495320|NCT01982799|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92495321|NCT01982799|Hydrocodone|hydrocodone|mesh-list
92495322|NCT01982799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92495323|NCT01982799|Analgesics|analgesics|mesh-ancestor
92495324|NCT01982799|Sensory System Agents|sensory system agents|mesh-ancestor
92495325|NCT01982799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495326|NCT01982799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495327|NCT01982799|Antipyretics|antipyretics|mesh-ancestor
92495328|NCT01982799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92495329|NCT01982799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495330|NCT01982799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495331|NCT01982799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92495332|NCT01982799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495333|NCT01982799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495334|NCT01982799|Gout Suppressants|gout suppressants|mesh-ancestor
92495335|NCT01982799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92495336|NCT01982799|Narcotics|narcotics|mesh-ancestor
92495337|NCT01982799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495338|NCT01982799|Antitussive Agents|antitussive agents|mesh-ancestor
92495339|NCT01982799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92495340|NCT01982864|Gentamicins|gentamicins|mesh-list
92495341|NCT01982864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92495342|NCT01982864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495343|NCT01982864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92495344|NCT01982864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495345|NCT01982864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495346|NCT01982929|Epinephrine|epinephrine|mesh-list
92495347|NCT01982929|Bupivacaine|bupivacaine|mesh-list
92495348|NCT01982929|Anesthetics, Local|anesthetics, local|mesh-ancestor
92495349|NCT01982929|Anesthetics|anesthetics|mesh-ancestor
92495350|NCT01982929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495351|NCT01982929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495352|NCT01982929|Sensory System Agents|sensory system agents|mesh-ancestor
92495353|NCT01982929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495354|NCT01982929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92495355|NCT01982929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92495356|NCT01982929|Adrenergic Agents|adrenergic agents|mesh-ancestor
92495357|NCT01982929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495358|NCT01982929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495359|NCT01982929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92495360|NCT01982929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92495361|NCT01982929|Autonomic Agents|autonomic agents|mesh-ancestor
92495362|NCT01982929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92495363|NCT01982929|Respiratory System Agents|respiratory system agents|mesh-ancestor
92495364|NCT01982929|Mydriatics|mydriatics|mesh-ancestor
92495365|NCT01982929|Sympathomimetics|sympathomimetics|mesh-ancestor
92495366|NCT01982929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92495367|NCT01983124|Vemurafenib|vemurafenib|mesh-list
92495368|NCT01983124|Fotemustine|fotemustine|mesh-list
92495369|NCT01983124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495370|NCT01983124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92495371|NCT01983124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495372|NCT01983124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495373|NCT01983137|Oxycodone|oxycodone|mesh-list
92495374|NCT01983137|Naloxone|naloxone|mesh-list
92495375|NCT01983137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92495376|NCT01983137|Narcotics|narcotics|mesh-ancestor
92495377|NCT01983137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495378|NCT01983137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495379|NCT01983137|Analgesics|analgesics|mesh-ancestor
92495380|NCT01983137|Sensory System Agents|sensory system agents|mesh-ancestor
92495381|NCT01983137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495382|NCT01983137|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92495383|NCT01983371|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92495384|NCT01983371|Hematinics|hematinics|mesh-ancestor
92495385|NCT01983371|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92495386|NCT01983371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92495387|NCT01983384|Anesthetics|anesthetics|mesh-list
92495388|NCT01983384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495389|NCT01983384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495390|NCT01983449|Dexamethasone|dexamethasone|mesh-list
92495391|NCT01983449|Dexamethasone acetate|dexamethasone acetate|mesh-list
92495392|NCT01983449|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92495393|NCT01983449|BB 1101|bb 1101|mesh-list
92495394|NCT01983449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495395|NCT01983449|Antiemetics|antiemetics|mesh-ancestor
92495396|NCT01983449|Autonomic Agents|autonomic agents|mesh-ancestor
92495397|NCT01983449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495398|NCT01983449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495399|NCT01983449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495400|NCT01983449|Glucocorticoids|glucocorticoids|mesh-ancestor
92495402|NCT01983449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495403|NCT01983449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92495404|NCT01983449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495405|NCT01983449|Protease Inhibitors|protease inhibitors|mesh-ancestor
92495406|NCT01983449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495407|NCT01983449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495408|NCT01983475|Denosumab|denosumab|mesh-list
92495409|NCT01983475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92495410|NCT01983475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495411|NCT01983501|Tucatinib|tucatinib|mesh-list
92495412|NCT01983501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495413|NCT01983501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495414|NCT01983501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92495415|NCT01983501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495416|NCT01983514|Oxytocin|oxytocin|mesh-list
92495417|NCT01983514|Oxytocics|oxytocics|mesh-ancestor
92495418|NCT01983514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92495419|NCT01983514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495420|NCT01983527|Methylprednisolone|methylprednisolone|mesh-list
92495421|NCT01983527|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92495422|NCT01983527|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92495423|NCT01983527|Prednisolone|prednisolone|mesh-list
92495424|NCT01983527|Prednisolone acetate|prednisolone acetate|mesh-list
92495425|NCT01983527|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92495426|NCT01983527|Prednisolone phosphate|prednisolone phosphate|mesh-list
92495427|NCT01983527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495428|NCT01983527|Antiemetics|antiemetics|mesh-ancestor
92495429|NCT01983527|Autonomic Agents|autonomic agents|mesh-ancestor
92495430|NCT01983527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495431|NCT01983527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495432|NCT01983527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495433|NCT01983527|Glucocorticoids|glucocorticoids|mesh-ancestor
92495434|NCT01983527|Hormones|hormones|mesh-ancestor
92495435|NCT01983527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495436|NCT01983527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92495437|NCT01983527|Protective Agents|protective agents|mesh-ancestor
92495438|NCT01983527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92495439|NCT01983527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495440|NCT01983540|Vaccines|vaccines|mesh-list
92704599|NCT02203643|Alkylating Agents|alkylating agents|mesh-ancestor
92495441|NCT01983540|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92495442|NCT01983540|Immunologic Factors|immunologic factors|mesh-ancestor
92495443|NCT01983540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495444|NCT01983657|Molgramostim|molgramostim|mesh-list
92495445|NCT01983657|Sargramostim|sargramostim|mesh-list
92495446|NCT01983657|Immunologic Factors|immunologic factors|mesh-ancestor
92495447|NCT01983657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495448|NCT01983657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495449|NCT01983722|Stiripentol|stiripentol|mesh-list
92495450|NCT01983722|Anticonvulsants|anticonvulsants|mesh-ancestor
92495451|NCT01983735|Niacin|niacin|mesh-list
92495452|NCT01983735|Amlodipine|amlodipine|mesh-list
92495453|NCT01983735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92495454|NCT01983735|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92495455|NCT01983735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92495456|NCT01983735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495457|NCT01983735|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92495458|NCT01983735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495459|NCT01983735|Vasodilator Agents|vasodilator agents|mesh-ancestor
92495460|NCT01983735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92495461|NCT01983735|Antimetabolites|antimetabolites|mesh-ancestor
92495462|NCT01983735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92495463|NCT01983735|Vitamin B Complex|vitamin b complex|mesh-ancestor
92495464|NCT01983735|Vitamins|vitamins|mesh-ancestor
92495465|NCT01983735|Micronutrients|micronutrients|mesh-ancestor
92495466|NCT01983761|Vidarabine|vidarabine|mesh-list
92495467|NCT01983761|Mycophenolic Acid|mycophenolic acid|mesh-list
92495468|NCT01983761|Fludarabine|fludarabine|mesh-list
92495469|NCT01983761|Fludarabine phosphate|fludarabine phosphate|mesh-list
92495470|NCT01983761|Melphalan|melphalan|mesh-list
92495471|NCT01983761|Busulfan|busulfan|mesh-list
92495472|NCT01983761|Clofarabine|clofarabine|mesh-list
92495473|NCT01983761|Tacrolimus|tacrolimus|mesh-list
92495474|NCT01983761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495475|NCT01983761|Immunologic Factors|immunologic factors|mesh-ancestor
92495476|NCT01983761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495477|NCT01983761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92495478|NCT01983761|Antimetabolites|antimetabolites|mesh-ancestor
92495479|NCT01983761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495480|NCT01983761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92495481|NCT01983761|Antiviral Agents|antiviral agents|mesh-ancestor
92495482|NCT01983761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495483|NCT01983761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92495484|NCT01983761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495485|NCT01983761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92495486|NCT01983761|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92495487|NCT01983761|Antitubercular Agents|antitubercular agents|mesh-ancestor
92495488|NCT01983761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92495489|NCT01983761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92495490|NCT01983761|Alkylating Agents|alkylating agents|mesh-ancestor
92495491|NCT01983761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92495492|NCT01983800|Midazolam|midazolam|mesh-list
92495493|NCT01983800|Propofol|propofol|mesh-list
92495494|NCT01983800|Isoflurane|isoflurane|mesh-list
92495495|NCT01983800|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92495496|NCT01983800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495497|NCT01983800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495498|NCT01983800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92495499|NCT01983800|Anesthetics, General|anesthetics, general|mesh-ancestor
92495500|NCT01983800|Anesthetics|anesthetics|mesh-ancestor
92495501|NCT01983800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92495502|NCT01983800|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92495503|NCT01983800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92495504|NCT01983800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92495505|NCT01983800|GABA Modulators|gaba modulators|mesh-ancestor
92495506|NCT01983800|GABA Agents|gaba agents|mesh-ancestor
92495507|NCT01983800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495508|NCT01983800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495509|NCT01983800|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92495510|NCT01983943|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92495511|NCT01983943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495512|NCT01983943|Antioxidants|antioxidants|mesh-ancestor
92495513|NCT01983943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495514|NCT01983943|Protective Agents|protective agents|mesh-ancestor
92495515|NCT01983943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495516|NCT01983943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92495517|NCT01984008|Picosulfate sodium|picosulfate sodium|mesh-list
92495518|NCT01984008|Magnesium Oxide|magnesium oxide|mesh-list
92495519|NCT01984008|Citric Acid|citric acid|mesh-list
92495520|NCT01984008|Sodium Citrate|sodium citrate|mesh-list
92495521|NCT01984008|Cathartics|cathartics|mesh-ancestor
92495522|NCT01984008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495523|NCT01984008|Anticoagulants|anticoagulants|mesh-ancestor
92495524|NCT01984008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92495525|NCT01984008|Chelating Agents|chelating agents|mesh-ancestor
92495526|NCT01984008|Sequestering Agents|sequestering agents|mesh-ancestor
92495527|NCT01984008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495528|NCT01984008|Antacids|antacids|mesh-ancestor
92495529|NCT01984073|Niacin|niacin|mesh-list
92495530|NCT01984073|Niacinamide|niacinamide|mesh-list
92495531|NCT01984073|Nicotinic Acids|nicotinic acids|mesh-list
92495532|NCT01984073|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92495533|NCT01984073|Antimetabolites|antimetabolites|mesh-ancestor
92495534|NCT01984073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495535|NCT01984073|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92495536|NCT01984073|Vasodilator Agents|vasodilator agents|mesh-ancestor
92495537|NCT01984073|Vitamin B Complex|vitamin b complex|mesh-ancestor
92495538|NCT01984073|Vitamins|vitamins|mesh-ancestor
92495539|NCT01984073|Micronutrients|micronutrients|mesh-ancestor
92495540|NCT01984073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495541|NCT01984086|Albuterol|albuterol|mesh-list
92495542|NCT01984086|Charcoal|charcoal|mesh-list
92495543|NCT01984086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92495544|NCT01984086|Autonomic Agents|autonomic agents|mesh-ancestor
92495545|NCT01984086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495546|NCT01984086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495547|NCT01984086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92495548|NCT01984086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92495549|NCT01984086|Tocolytic Agents|tocolytic agents|mesh-ancestor
92495550|NCT01984086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92495551|NCT01984086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92495552|NCT01984086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92495553|NCT01984086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92495554|NCT01984086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92495555|NCT01984086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495556|NCT01984086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495557|NCT01984086|Antidotes|antidotes|mesh-ancestor
92495558|NCT01984086|Protective Agents|protective agents|mesh-ancestor
92495559|NCT01984099|Folic Acid|folic acid|mesh-list
92495560|NCT01984099|Vitamin B Complex|vitamin b complex|mesh-list
92495561|NCT01984099|Methotrexate|methotrexate|mesh-list
92495562|NCT01984099|Vitamins|vitamins|mesh-ancestor
92495563|NCT01984099|Micronutrients|micronutrients|mesh-ancestor
92495564|NCT01984099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495565|NCT01984099|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92495566|NCT01984099|Abortifacient Agents|abortifacient agents|mesh-ancestor
92495567|NCT01984099|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92495568|NCT01984099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92495569|NCT01984099|Antimetabolites|antimetabolites|mesh-ancestor
92495570|NCT01984099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495571|NCT01984099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495572|NCT01984099|Dermatologic Agents|dermatologic agents|mesh-ancestor
92495573|NCT01984099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495574|NCT01984099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92495575|NCT01984099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92495576|NCT01984099|Immunologic Factors|immunologic factors|mesh-ancestor
92495577|NCT01984099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495578|NCT01984099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92495579|NCT01984099|Hematinics|hematinics|mesh-ancestor
92495580|NCT01984177|Hormones|hormones|mesh-list
92495581|NCT01984177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92495582|NCT01984177|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92495583|NCT01984177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495584|NCT01984177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495585|NCT01984255|Ipilimumab|ipilimumab|mesh-list
92495586|NCT01984255|Bavituximab|bavituximab|mesh-list
92495587|NCT01984255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92495588|NCT01984255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495589|NCT01984255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92220490|NCT01097395|Antimetabolites|antimetabolites|mesh-ancestor
92495590|NCT01984255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495591|NCT01984372|Insulin|insulin|mesh-list
92495592|NCT01984372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92495593|NCT01984372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495594|NCT01984463|Fentanyl|fentanyl|mesh-list
92495595|NCT01984463|Morphine|morphine|mesh-list
92495596|NCT01984463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92495597|NCT01984463|Narcotics|narcotics|mesh-ancestor
92495598|NCT01984463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495599|NCT01984463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495600|NCT01984463|Analgesics|analgesics|mesh-ancestor
92495601|NCT01984463|Sensory System Agents|sensory system agents|mesh-ancestor
92495602|NCT01984463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495603|NCT01984463|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92495604|NCT01984463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92495605|NCT01984463|Anesthetics, General|anesthetics, general|mesh-ancestor
92495606|NCT01984463|Anesthetics|anesthetics|mesh-ancestor
92495607|NCT01984567|Vitamin E|vitamin e|mesh-list
92495608|NCT01984567|Thioctic Acid|thioctic acid|mesh-list
92495609|NCT01984567|Vitamins|vitamins|mesh-ancestor
92495610|NCT01984567|Micronutrients|micronutrients|mesh-ancestor
92495611|NCT01984567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495612|NCT01984567|Antioxidants|antioxidants|mesh-ancestor
92495613|NCT01984567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495614|NCT01984567|Protective Agents|protective agents|mesh-ancestor
92495615|NCT01984567|Vitamin B Complex|vitamin b complex|mesh-ancestor
92495616|NCT01984606|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92495617|NCT01984606|Empagliflozin|empagliflozin|mesh-list
92495618|NCT01984606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92495619|NCT01984606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495620|NCT01984606|Incretins|incretins|mesh-ancestor
92495621|NCT01984606|Hormones|hormones|mesh-ancestor
92495622|NCT01984606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495623|NCT01984606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92495624|NCT01984606|Protease Inhibitors|protease inhibitors|mesh-ancestor
92495625|NCT01984606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495626|NCT01984606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495627|NCT01984606|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92495628|NCT01984749|Febuxostat|febuxostat|mesh-list
92495629|NCT01984749|Gout Suppressants|gout suppressants|mesh-ancestor
92495630|NCT01984749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495631|NCT01984827|Moxifloxacin|moxifloxacin|mesh-list
92495632|NCT01984827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92495633|NCT01984827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495634|NCT01984827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92495635|NCT01984827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92495636|NCT01984827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495637|NCT01984827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495638|NCT01984827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495639|NCT01984931|Medazepam|medazepam|mesh-list
92495640|NCT01984931|Metoclopramide|metoclopramide|mesh-list
92495641|NCT01984931|Bromazepam|bromazepam|mesh-list
92495642|NCT01984931|Simethicone|simethicone|mesh-list
92495643|NCT01984931|Trimebutine|trimebutine|mesh-list
92495644|NCT01984931|Mosapride|mosapride|mesh-list
92495645|NCT01984931|Maleic acid|maleic acid|mesh-list
92495646|NCT01984931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495647|NCT01984931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495648|NCT01984931|Antiemetics|antiemetics|mesh-ancestor
92495649|NCT01984931|Autonomic Agents|autonomic agents|mesh-ancestor
92495650|NCT01984931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495651|NCT01984931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495652|NCT01984931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495653|NCT01984931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92495654|NCT01984931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92495655|NCT01984931|Dopamine Agents|dopamine agents|mesh-ancestor
92495656|NCT01984931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495657|NCT01984931|Parasympatholytics|parasympatholytics|mesh-ancestor
92495658|NCT01984931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92495659|NCT01984931|Serotonin Agents|serotonin agents|mesh-ancestor
92495660|NCT01984931|Antifoaming Agents|antifoaming agents|mesh-ancestor
92495661|NCT01984931|Emollients|emollients|mesh-ancestor
92495662|NCT01984931|Dermatologic Agents|dermatologic agents|mesh-ancestor
92495663|NCT01984931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92495664|NCT01984931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92495665|NCT01984931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495666|NCT01984931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92495667|NCT01984931|GABA Modulators|gaba modulators|mesh-ancestor
92495668|NCT01984931|GABA Agents|gaba agents|mesh-ancestor
92495669|NCT01984931|Anticonvulsants|anticonvulsants|mesh-ancestor
92495670|NCT01984931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92495671|NCT01984931|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92495672|NCT01984931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92495673|NCT01985061|Busulfan|busulfan|mesh-list
92495674|NCT01985061|Alkylating Agents|alkylating agents|mesh-ancestor
92495675|NCT01985061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495676|NCT01985061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92495677|NCT01985061|Immunologic Factors|immunologic factors|mesh-ancestor
92495678|NCT01985061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495679|NCT01985061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92495680|NCT01985061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495681|NCT01985061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92495682|NCT01985087|Temozolomide|temozolomide|mesh-list
92495683|NCT01985087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92495684|NCT01985087|Alkylating Agents|alkylating agents|mesh-ancestor
92495685|NCT01985087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495686|NCT01985087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495687|NCT01985152|Choline|choline|mesh-list
92495688|NCT01985152|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92495689|NCT01985152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92495690|NCT01985152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92495691|NCT01985152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495692|NCT01985152|Lipotropic Agents|lipotropic agents|mesh-ancestor
92495693|NCT01985152|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92495694|NCT01985152|Antimetabolites|antimetabolites|mesh-ancestor
92495695|NCT01985152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495696|NCT01985152|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92495697|NCT01985152|Nootropic Agents|nootropic agents|mesh-ancestor
92495698|NCT01985256|Flucytosine|flucytosine|mesh-list
92495699|NCT01985256|Antifungal Agents|antifungal agents|mesh-ancestor
92495700|NCT01985256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92495701|NCT01985256|Antimetabolites|antimetabolites|mesh-ancestor
92495702|NCT01985256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495703|NCT01985373|Immunoglobulins|immunoglobulins|mesh-list
92495704|NCT01985373|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92495705|NCT01985373|Antibodies|antibodies|mesh-list
92495706|NCT01985373|gamma-Globulins|gamma-globulins|mesh-list
92495707|NCT01985373|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92495708|NCT01985373|Immunologic Factors|immunologic factors|mesh-ancestor
92495709|NCT01985373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495710|NCT01985451|Temozolomide|temozolomide|mesh-list
92495711|NCT01985451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92495712|NCT01985451|Alkylating Agents|alkylating agents|mesh-ancestor
92495713|NCT01985451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495714|NCT01985451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495715|NCT01985477|Dexamethasone|dexamethasone|mesh-list
92495716|NCT01985477|Lenalidomide|lenalidomide|mesh-list
92495717|NCT01985477|Tretinoin|tretinoin|mesh-list
92495718|NCT01985477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495719|NCT01985477|Antiemetics|antiemetics|mesh-ancestor
92495720|NCT01985477|Autonomic Agents|autonomic agents|mesh-ancestor
92495721|NCT01985477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495722|NCT01985477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495723|NCT01985477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495724|NCT01985477|Glucocorticoids|glucocorticoids|mesh-ancestor
92495725|NCT01985477|Hormones|hormones|mesh-ancestor
92495726|NCT01985477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495727|NCT01985477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92495728|NCT01985477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495729|NCT01985477|Immunologic Factors|immunologic factors|mesh-ancestor
92495730|NCT01985477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92495731|NCT01985477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92495732|NCT01985477|Growth Substances|growth substances|mesh-ancestor
92495733|NCT01985477|Growth Inhibitors|growth inhibitors|mesh-ancestor
92495734|NCT01985477|Keratolytic Agents|keratolytic agents|mesh-ancestor
92495735|NCT01985477|Dermatologic Agents|dermatologic agents|mesh-ancestor
92495736|NCT01985594|Nifedipine|nifedipine|mesh-list
92495737|NCT01985594|Progesterone|progesterone|mesh-list
92495738|NCT01985594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92495739|NCT01985594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92495740|NCT01985594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495741|NCT01985594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92495742|NCT01985594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495743|NCT01985594|Vasodilator Agents|vasodilator agents|mesh-ancestor
92495744|NCT01985594|Tocolytic Agents|tocolytic agents|mesh-ancestor
92495745|NCT01985594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92495746|NCT01985594|Progestins|progestins|mesh-ancestor
92495747|NCT01985594|Hormones|hormones|mesh-ancestor
92495748|NCT01985594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495749|NCT01985724|Cyclophosphamide|cyclophosphamide|mesh-list
92495750|NCT01985724|Docetaxel|docetaxel|mesh-list
92495751|NCT01985724|Epirubicin|epirubicin|mesh-list
92495752|NCT01985724|Fluorouracil|fluorouracil|mesh-list
92495753|NCT01985724|Lenograstim|lenograstim|mesh-list
92495754|NCT01985724|Mitogens|mitogens|mesh-list
92495755|NCT01985724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92495756|NCT01985724|Immunologic Factors|immunologic factors|mesh-ancestor
92495757|NCT01985724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495758|NCT01985724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495759|NCT01985724|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92495760|NCT01985724|Alkylating Agents|alkylating agents|mesh-ancestor
92495761|NCT01985724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495762|NCT01985724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495763|NCT01985724|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92495764|NCT01985724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92495765|NCT01985724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92495766|NCT01985724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92495767|NCT01985724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92495768|NCT01985724|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92495769|NCT01985724|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92495770|NCT01985724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495771|NCT01985724|Antimetabolites|antimetabolites|mesh-ancestor
92495772|NCT01985724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92495773|NCT01985724|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92495775|NCT01985750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92495777|NCT01985750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92495778|NCT01985750|Antitubercular Agents|antitubercular agents|mesh-ancestor
92495779|NCT01985750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92495780|NCT01985750|Antimetabolites|antimetabolites|mesh-ancestor
92495781|NCT01985750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495782|NCT01985789|Diphenhydramine|diphenhydramine|mesh-list
92495783|NCT01985789|Promethazine|promethazine|mesh-list
92495784|NCT01985789|Cetirizine|cetirizine|mesh-list
92495785|NCT01985789|Desloratadine|desloratadine|mesh-list
92495786|NCT01985789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92495787|NCT01985789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92495788|NCT01985789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495789|NCT01985789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495790|NCT01985789|Anesthetics, Local|anesthetics, local|mesh-ancestor
92495791|NCT01985789|Anesthetics|anesthetics|mesh-ancestor
92495792|NCT01985789|Sensory System Agents|sensory system agents|mesh-ancestor
92495793|NCT01985789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495794|NCT01985789|Antiemetics|antiemetics|mesh-ancestor
92495795|NCT01985789|Autonomic Agents|autonomic agents|mesh-ancestor
92495796|NCT01985789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495797|NCT01985789|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92495798|NCT01985789|Histamine Antagonists|histamine antagonists|mesh-ancestor
92495799|NCT01985789|Histamine Agents|histamine agents|mesh-ancestor
92495800|NCT01985789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495801|NCT01985789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495802|NCT01985789|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92495803|NCT01985789|Antipruritics|antipruritics|mesh-ancestor
92495804|NCT01985789|Dermatologic Agents|dermatologic agents|mesh-ancestor
92495805|NCT01985789|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92495806|NCT01985789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92495807|NCT01985789|Cholinergic Agents|cholinergic agents|mesh-ancestor
92495808|NCT01985828|Androgens|androgens|mesh-list
92495809|NCT01985828|Hormones|hormones|mesh-ancestor
92495810|NCT01985828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495811|NCT01985828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495812|NCT01985841|Cyclophosphamide|cyclophosphamide|mesh-list
92495813|NCT01985841|Docetaxel|docetaxel|mesh-list
92495814|NCT01985841|Fluorouracil|fluorouracil|mesh-list
92495815|NCT01985841|Epirubicin|epirubicin|mesh-list
92495816|NCT01985841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92495817|NCT01985841|Immunologic Factors|immunologic factors|mesh-ancestor
92495818|NCT01985841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495819|NCT01985841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495820|NCT01985841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92495821|NCT01985841|Alkylating Agents|alkylating agents|mesh-ancestor
92495822|NCT01985841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495823|NCT01985841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495824|NCT01985841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92495825|NCT01985841|Tubulin Modulators|tubulin modulators|mesh-ancestor
92220717|NCT04900038|Antiviral Agents|antiviral agents|mesh-ancestor
92495826|NCT01985841|Antimitotic Agents|antimitotic agents|mesh-ancestor
92495827|NCT01985841|Mitosis Modulators|mitosis modulators|mesh-ancestor
92495828|NCT01985841|Antimetabolites|antimetabolites|mesh-ancestor
92495829|NCT01985841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92495830|NCT01985841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92495831|NCT01985841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92495832|NCT01985841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92495833|NCT01985841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495834|NCT01985854|Propofol|propofol|mesh-list
92495835|NCT01985854|Desflurane|desflurane|mesh-list
92495836|NCT01985854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92495837|NCT01985854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495838|NCT01985854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495839|NCT01985854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92495840|NCT01985854|Anesthetics, General|anesthetics, general|mesh-ancestor
92495841|NCT01985854|Anesthetics|anesthetics|mesh-ancestor
92495842|NCT01985854|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92495843|NCT01985893|Trastuzumab|trastuzumab|mesh-list
92495844|NCT01985893|Lapatinib|lapatinib|mesh-list
92495845|NCT01985893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92495846|NCT01985893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495847|NCT01985893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92495848|NCT01985893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495849|NCT01985893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495851|NCT01986036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92495852|NCT01986036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495853|NCT01986049|Bupivacaine|bupivacaine|mesh-list
92495854|NCT01986049|Anesthetics, Local|anesthetics, local|mesh-ancestor
92495855|NCT01986049|Anesthetics|anesthetics|mesh-ancestor
92495856|NCT01986049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495857|NCT01986049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495858|NCT01986049|Sensory System Agents|sensory system agents|mesh-ancestor
92495859|NCT01986049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495860|NCT01986088|Sumatriptan|sumatriptan|mesh-list
92495861|NCT01986088|Eletriptan|eletriptan|mesh-list
92495862|NCT01986088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92495863|NCT01986088|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92495864|NCT01986088|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92495865|NCT01986088|Serotonin Agents|serotonin agents|mesh-ancestor
92495866|NCT01986088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495867|NCT01986088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495868|NCT01986088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495869|NCT01986127|Adalimumab|adalimumab|mesh-list
92495870|NCT01986127|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92495871|NCT01986127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495872|NCT01986127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495873|NCT01986192|Warfarin|warfarin|mesh-list
92495874|NCT01986192|Rivaroxaban|rivaroxaban|mesh-list
92495875|NCT01986192|Anticoagulants|anticoagulants|mesh-ancestor
92495876|NCT01986192|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92495877|NCT01986192|Antithrombins|antithrombins|mesh-ancestor
92495878|NCT01986192|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92495879|NCT01986192|Protease Inhibitors|protease inhibitors|mesh-ancestor
92495880|NCT01986192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495881|NCT01986192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495882|NCT01986218|BMS-986115|bms-986115|mesh-list
92495883|NCT01986218|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92495884|NCT01986218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495885|NCT01986218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495886|NCT01986270|Sumatriptan|sumatriptan|mesh-list
92495887|NCT01986270|Eletriptan|eletriptan|mesh-list
92495888|NCT01986270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92495889|NCT01986270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92495890|NCT01986270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92495891|NCT01986270|Serotonin Agents|serotonin agents|mesh-ancestor
92495892|NCT01986270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495893|NCT01986270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495894|NCT01986270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495895|NCT01986283|Oxycodone|oxycodone|mesh-list
92495896|NCT01986283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92495897|NCT01986283|Narcotics|narcotics|mesh-ancestor
92495898|NCT01986283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495899|NCT01986283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495900|NCT01986283|Analgesics|analgesics|mesh-ancestor
92495901|NCT01986283|Sensory System Agents|sensory system agents|mesh-ancestor
92495902|NCT01986283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495903|NCT01986309|Lidocaine|lidocaine|mesh-list
92495904|NCT01986309|Anesthetics, Local|anesthetics, local|mesh-ancestor
92495905|NCT01986309|Anesthetics|anesthetics|mesh-ancestor
92495906|NCT01986309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92495907|NCT01986309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495908|NCT01986309|Sensory System Agents|sensory system agents|mesh-ancestor
92495909|NCT01986309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495910|NCT01986309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92495911|NCT01986309|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92495912|NCT01986309|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92495913|NCT01986309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92495914|NCT01986309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495915|NCT01986322|Vaccines|vaccines|mesh-list
92495916|NCT01986322|Immunologic Factors|immunologic factors|mesh-ancestor
92495917|NCT01986322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495918|NCT01986426|Pembrolizumab|pembrolizumab|mesh-list
92495919|NCT01986426|Ipilimumab|ipilimumab|mesh-list
92495920|NCT01986426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92495921|NCT01986426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495922|NCT01986426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92495923|NCT01986426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495924|NCT01986465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92495925|NCT01986465|Methylprednisolone|methylprednisolone|mesh-list
92495926|NCT01986465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92495927|NCT01986465|Prednisolone|prednisolone|mesh-list
92495928|NCT01986465|Prednisolone acetate|prednisolone acetate|mesh-list
92495929|NCT01986465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92495930|NCT01986465|Prednisolone phosphate|prednisolone phosphate|mesh-list
92495931|NCT01986465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495932|NCT01986465|Antiemetics|antiemetics|mesh-ancestor
92495933|NCT01986465|Autonomic Agents|autonomic agents|mesh-ancestor
92495934|NCT01986465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495935|NCT01986465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495936|NCT01986465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92495937|NCT01986465|Glucocorticoids|glucocorticoids|mesh-ancestor
92495938|NCT01986465|Hormones|hormones|mesh-ancestor
92495939|NCT01986465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495940|NCT01986465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92495941|NCT01986465|Protective Agents|protective agents|mesh-ancestor
92495942|NCT01986465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92495943|NCT01986465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92495944|NCT01986556|Lesinurad|lesinurad|mesh-list
92495945|NCT01986556|Gout Suppressants|gout suppressants|mesh-ancestor
92495946|NCT01986556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495947|NCT01986556|Uricosuric Agents|uricosuric agents|mesh-ancestor
92495948|NCT01986582|Phenylephrine|phenylephrine|mesh-list
92495949|NCT01986582|Oxymetazoline|oxymetazoline|mesh-list
92495950|NCT01986582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92495951|NCT01986582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92495952|NCT01986582|Adrenergic Agents|adrenergic agents|mesh-ancestor
92495953|NCT01986582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92495954|NCT01986582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495955|NCT01986582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495956|NCT01986582|Sympathomimetics|sympathomimetics|mesh-ancestor
92495957|NCT01986582|Autonomic Agents|autonomic agents|mesh-ancestor
92495958|NCT01986582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495959|NCT01986582|Nasal Decongestants|nasal decongestants|mesh-ancestor
92495960|NCT01986582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92495961|NCT01986582|Respiratory System Agents|respiratory system agents|mesh-ancestor
92495962|NCT01986582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92495963|NCT01986582|Mydriatics|mydriatics|mesh-ancestor
92495964|NCT01986582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92495965|NCT01986582|Protective Agents|protective agents|mesh-ancestor
92495966|NCT01986608|Lacosamide|lacosamide|mesh-list
92495967|NCT01986608|Anticonvulsants|anticonvulsants|mesh-ancestor
92495968|NCT01986608|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92495969|NCT01986608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92495970|NCT01986608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92495971|NCT01986608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495972|NCT01986660|Ibuprofen|ibuprofen|mesh-list
92495973|NCT01986660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92495974|NCT01986660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92495975|NCT01986660|Analgesics|analgesics|mesh-ancestor
92220869|NCT03017807|Antibodies|antibodies|mesh-list
92349599|NCT04073316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495976|NCT01986660|Sensory System Agents|sensory system agents|mesh-ancestor
92532691|NCT02970097|Fentanyl|fentanyl|mesh-list
92495977|NCT01986660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92495978|NCT01986660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495979|NCT01986660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92495980|NCT01986660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92495981|NCT01986660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92495982|NCT01986660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495983|NCT01986660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495985|NCT01986673|Vasodilator Agents|vasodilator agents|mesh-ancestor
92495986|NCT01986673|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92495987|NCT01986673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92495988|NCT01986673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92495989|NCT01986673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92495990|NCT01986673|Urological Agents|urological agents|mesh-ancestor
92495991|NCT01986764|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92495992|NCT01986764|Estradiol|estradiol|mesh-list
92495993|NCT01986764|Estrogens|estrogens|mesh-list
92495994|NCT01986764|Hormones|hormones|mesh-ancestor
92495995|NCT01986764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92495996|NCT01986764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92495997|NCT01986764|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92495998|NCT01986764|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92495999|NCT01986764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92496000|NCT01986764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496001|NCT01986764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496003|NCT01986764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496004|NCT01986777|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92496005|NCT01986777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92496006|NCT01986777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496007|NCT01986777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92496008|NCT01986777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92496009|NCT01986777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496010|NCT01986777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496011|NCT01986777|Dopamine Agents|dopamine agents|mesh-ancestor
92496012|NCT01986777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496013|NCT01986894|Moxifloxacin|moxifloxacin|mesh-list
92496014|NCT01986894|Thalidomide|thalidomide|mesh-list
92496015|NCT01986894|Pomalidomide|pomalidomide|mesh-list
92496016|NCT01986894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496017|NCT01986894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496018|NCT01986894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92496019|NCT01986894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92496020|NCT01986894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496021|NCT01986894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496022|NCT01986894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496023|NCT01986894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496024|NCT01986894|Immunologic Factors|immunologic factors|mesh-ancestor
92496025|NCT01986894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92496026|NCT01986894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92496027|NCT01986894|Growth Substances|growth substances|mesh-ancestor
92496028|NCT01986894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92496029|NCT01986894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92496030|NCT01986894|Leprostatic Agents|leprostatic agents|mesh-ancestor
92496031|NCT01986998|Methylprednisolone|methylprednisolone|mesh-list
92496032|NCT01986998|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92496033|NCT01986998|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92496034|NCT01986998|Prednisolone|prednisolone|mesh-list
92496035|NCT01986998|Prednisolone acetate|prednisolone acetate|mesh-list
92496036|NCT01986998|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92496037|NCT01986998|Prednisolone phosphate|prednisolone phosphate|mesh-list
92496038|NCT01986998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496039|NCT01986998|Antiemetics|antiemetics|mesh-ancestor
92496040|NCT01986998|Autonomic Agents|autonomic agents|mesh-ancestor
92496041|NCT01986998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496042|NCT01986998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496043|NCT01986998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496044|NCT01986998|Glucocorticoids|glucocorticoids|mesh-ancestor
92496045|NCT01986998|Hormones|hormones|mesh-ancestor
92614806|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496046|NCT01986998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496047|NCT01986998|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92496048|NCT01986998|Protective Agents|protective agents|mesh-ancestor
92496049|NCT01986998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92496050|NCT01986998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496052|NCT01987076|Clobetasol|clobetasol|mesh-list
92496053|NCT01987076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496054|NCT01987076|Glucocorticoids|glucocorticoids|mesh-ancestor
92496055|NCT01987076|Hormones|hormones|mesh-ancestor
92496056|NCT01987076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496057|NCT01987076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496058|NCT01987076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92496059|NCT01987076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496060|NCT01987128|Ropivacaine|ropivacaine|mesh-list
92496061|NCT01987128|Anesthetics, Local|anesthetics, local|mesh-ancestor
92496062|NCT01987128|Anesthetics|anesthetics|mesh-ancestor
92496063|NCT01987128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496064|NCT01987128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496066|NCT01987128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496067|NCT01987154|Caseins|caseins|mesh-list
92496068|NCT01987154|Chelating Agents|chelating agents|mesh-ancestor
92496069|NCT01987154|Sequestering Agents|sequestering agents|mesh-ancestor
92496070|NCT01987154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496071|NCT01987167|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92496072|NCT01987167|Hormones|hormones|mesh-ancestor
92496073|NCT01987167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496074|NCT01987167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496075|NCT01987297|Cytarabine|cytarabine|mesh-list
92496076|NCT01987297|Daunorubicin|daunorubicin|mesh-list
92496077|NCT01987297|Idarubicin|idarubicin|mesh-list
92496078|NCT01987297|Tretinoin|tretinoin|mesh-list
92496079|NCT01987297|Arsenic Trioxide|arsenic trioxide|mesh-list
92496080|NCT01987297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92496081|NCT01987297|Antimetabolites|antimetabolites|mesh-ancestor
92496082|NCT01987297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496083|NCT01987297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496084|NCT01987297|Antiviral Agents|antiviral agents|mesh-ancestor
92496085|NCT01987297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496086|NCT01987297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92496087|NCT01987297|Immunologic Factors|immunologic factors|mesh-ancestor
92496088|NCT01987297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496089|NCT01987297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92496090|NCT01987297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92496091|NCT01987297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92496092|NCT01987297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496093|NCT01987297|Keratolytic Agents|keratolytic agents|mesh-ancestor
92496094|NCT01987297|Dermatologic Agents|dermatologic agents|mesh-ancestor
92496095|NCT01987310|Atorvastatin|atorvastatin|mesh-list
92496096|NCT01987310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92496097|NCT01987310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92496098|NCT01987310|Antimetabolites|antimetabolites|mesh-ancestor
92496099|NCT01987310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496100|NCT01987310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92496101|NCT01987310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92496102|NCT01987310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496103|NCT01987323|Latanoprost|latanoprost|mesh-list
92496104|NCT01987323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92496105|NCT01987323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92496106|NCT01987375|Cetuximab|cetuximab|mesh-list
92496107|NCT01987375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496108|NCT01987375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496109|NCT01987570|Allopurinol|allopurinol|mesh-list
92496110|NCT01987570|Antimetabolites|antimetabolites|mesh-ancestor
92496111|NCT01987570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496112|NCT01987570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496113|NCT01987570|Gout Suppressants|gout suppressants|mesh-ancestor
92496114|NCT01987570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92496115|NCT01987570|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92496116|NCT01987570|Antioxidants|antioxidants|mesh-ancestor
92496117|NCT01987570|Protective Agents|protective agents|mesh-ancestor
92496118|NCT01987570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496119|NCT01987739|Zolpidem|zolpidem|mesh-list
92750747|NCT05936606|Clopidogrel|clopidogrel|mesh-list
92496120|NCT01987739|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92496121|NCT01987739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92496122|NCT01987739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221018|NCT01006655|Hormones|hormones|mesh-ancestor
92496123|NCT01987739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496125|NCT01987739|GABA Agonists|gaba agonists|mesh-ancestor
92496126|NCT01987739|GABA Agents|gaba agents|mesh-ancestor
92496127|NCT01987739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496128|NCT01987739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496129|NCT01987804|Oxytocin|oxytocin|mesh-list
92496130|NCT01987804|Oxytocics|oxytocics|mesh-ancestor
92496131|NCT01987804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496132|NCT01987804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496133|NCT01988077|Ipilimumab|ipilimumab|mesh-list
92496134|NCT01988077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496135|NCT01988077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496136|NCT01988077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92496137|NCT01988077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496138|NCT01988116|Calcitriol|calcitriol|mesh-list
92496139|NCT01988116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496140|NCT01988116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496141|NCT01988116|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92496142|NCT01988116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496143|NCT01988116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496144|NCT01988116|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92496145|NCT01988116|Vitamins|vitamins|mesh-ancestor
92496146|NCT01988116|Micronutrients|micronutrients|mesh-ancestor
92496147|NCT01988116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496148|NCT01988298|Acetaminophen|acetaminophen|mesh-list
92496149|NCT01988298|Ibuprofen|ibuprofen|mesh-list
92496150|NCT01988298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496151|NCT01988298|Analgesics|analgesics|mesh-ancestor
92496152|NCT01988298|Sensory System Agents|sensory system agents|mesh-ancestor
92496153|NCT01988298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496154|NCT01988298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496155|NCT01988298|Antipyretics|antipyretics|mesh-ancestor
92496156|NCT01988298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92496157|NCT01988298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496158|NCT01988298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92496159|NCT01988298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92496160|NCT01988298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496161|NCT01988298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496162|NCT01988311|Psilocybin|psilocybin|mesh-list
92496163|NCT01988311|Hallucinogens|hallucinogens|mesh-ancestor
92496164|NCT01988311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496165|NCT01988311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496166|NCT01988428|Ceftriaxone|ceftriaxone|mesh-list
92496167|NCT01988428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496168|NCT01988428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496169|NCT01988506|Interleukin-2|interleukin-2|mesh-list
92496170|NCT01988506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496171|NCT01988506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496172|NCT01988506|Analgesics|analgesics|mesh-ancestor
92496173|NCT01988506|Sensory System Agents|sensory system agents|mesh-ancestor
92496174|NCT01988506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496175|NCT01988506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496176|NCT01988545|Exenatide|exenatide|mesh-list
92496177|NCT01988545|Glucagon|glucagon|mesh-list
92496178|NCT01988545|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92496179|NCT01988545|Incretins|incretins|mesh-ancestor
92496180|NCT01988545|Hormones|hormones|mesh-ancestor
92496181|NCT01988545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496182|NCT01988545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496183|NCT01988545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496184|NCT01988545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92496185|NCT01988545|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92496186|NCT01988610|Mifepristone|mifepristone|mesh-list
92496187|NCT01988610|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92496188|NCT01988610|Abortifacient Agents|abortifacient agents|mesh-ancestor
92496189|NCT01988610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496190|NCT01988610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349607|NCT04089852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496191|NCT01988610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92496192|NCT01988610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92496193|NCT01988610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92496194|NCT01988610|Contraceptive Agents|contraceptive agents|mesh-ancestor
92496195|NCT01988610|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92496196|NCT01988610|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92496197|NCT01988610|Hormone Antagonists|hormone antagonists|mesh-ancestor
92221092|NCT00377104|Alvocidib|alvocidib|mesh-list
92496198|NCT01988610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496199|NCT01988610|Luteolytic Agents|luteolytic agents|mesh-ancestor
92496200|NCT01988610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92496201|NCT01988610|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92496203|NCT01988649|Oxytocics|oxytocics|mesh-ancestor
92496204|NCT01988649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496205|NCT01988649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496206|NCT01988831|Propranolol|propranolol|mesh-list
92496207|NCT01988831|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92496208|NCT01988831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92496209|NCT01988831|Adrenergic Agents|adrenergic agents|mesh-ancestor
92496210|NCT01988831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496211|NCT01988831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200455|NCT05346146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92496212|NCT01988831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496213|NCT01988831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92496214|NCT01988831|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92496215|NCT01988831|Vasodilator Agents|vasodilator agents|mesh-ancestor
92496216|NCT01988896|Atezolizumab|atezolizumab|mesh-list
92496217|NCT01988896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92496218|NCT01988896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496219|NCT01988896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496220|NCT01988896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496221|NCT01988961|Golimumab|golimumab|mesh-list
92496222|NCT01988961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92496223|NCT01988961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496224|NCT01988961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92496225|NCT01988961|Immunologic Factors|immunologic factors|mesh-ancestor
92496226|NCT01988961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496227|NCT01989000|Gemcitabine|gemcitabine|mesh-list
92496228|NCT01989000|Imidazole|imidazole|mesh-list
92496229|NCT01989000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92496230|NCT01989000|Antimetabolites|antimetabolites|mesh-ancestor
92496231|NCT01989000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496232|NCT01989000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496233|NCT01989000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496234|NCT01989052|Lomustine|lomustine|mesh-list
92496235|NCT01989052|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92496236|NCT01989052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92496237|NCT01989052|Alkylating Agents|alkylating agents|mesh-ancestor
92496238|NCT01989052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496239|NCT01989052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496240|NCT01989052|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92496241|NCT01989052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496242|NCT01989052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496243|NCT01989052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496244|NCT01989078|Losartan|losartan|mesh-list
92496245|NCT01989078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92496246|NCT01989078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92496247|NCT01989078|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92496248|NCT01989078|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92496249|NCT01989078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496250|NCT01989091|Heparin|heparin|mesh-list
92496251|NCT01989091|Anticoagulants|anticoagulants|mesh-ancestor
92496252|NCT01989091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92496253|NCT01989091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92496254|NCT01989091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496255|NCT01989312|Lidocaine|lidocaine|mesh-list
92496256|NCT01989312|Epinephrine|epinephrine|mesh-list
92496257|NCT01989312|Midazolam|midazolam|mesh-list
92496258|NCT01989312|Levobupivacaine|levobupivacaine|mesh-list
92496259|NCT01989312|Anesthetics, Local|anesthetics, local|mesh-ancestor
92496260|NCT01989312|Anesthetics|anesthetics|mesh-ancestor
92496261|NCT01989312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496262|NCT01989312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496263|NCT01989312|Sensory System Agents|sensory system agents|mesh-ancestor
92496264|NCT01989312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496265|NCT01989312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92496266|NCT01989312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92496267|NCT01989312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92496268|NCT01989312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496269|NCT01989312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496271|NCT01989312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92496272|NCT01989312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92496273|NCT01989312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92496274|NCT01989312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496275|NCT01989312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92496276|NCT01989312|Anesthetics, General|anesthetics, general|mesh-ancestor
92496277|NCT01989312|GABA Modulators|gaba modulators|mesh-ancestor
92496278|NCT01989312|GABA Agents|gaba agents|mesh-ancestor
92496279|NCT01989312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496280|NCT01989312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92496281|NCT01989312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92496282|NCT01989312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92496283|NCT01989312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92496284|NCT01989312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92496285|NCT01989312|Autonomic Agents|autonomic agents|mesh-ancestor
92496286|NCT01989312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92496287|NCT01989312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92496288|NCT01989312|Mydriatics|mydriatics|mesh-ancestor
92496289|NCT01989312|Sympathomimetics|sympathomimetics|mesh-ancestor
92496290|NCT01989312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92496291|NCT01989416|Chlorhexidine|chlorhexidine|mesh-list
92496292|NCT01989416|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92496293|NCT01989416|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92496294|NCT01989416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496295|NCT01989416|Disinfectants|disinfectants|mesh-ancestor
92496296|NCT01989416|Dermatologic Agents|dermatologic agents|mesh-ancestor
92496297|NCT01989507|Nicotine|nicotine|mesh-list
92496298|NCT01989507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92496299|NCT01989507|Autonomic Agents|autonomic agents|mesh-ancestor
92496300|NCT01989507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496301|NCT01989507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496302|NCT01989507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92496303|NCT01989507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92496304|NCT01989507|Cholinergic Agents|cholinergic agents|mesh-ancestor
92496305|NCT01989507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496306|NCT01989507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496307|NCT01989559|Vaccines|vaccines|mesh-list
92496308|NCT01989559|Immunologic Factors|immunologic factors|mesh-ancestor
92496309|NCT01989559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496310|NCT01989611|Tenofovir|tenofovir|mesh-list
92496311|NCT01989611|Emtricitabine|emtricitabine|mesh-list
92496312|NCT01989611|Antiviral Agents|antiviral agents|mesh-ancestor
92496313|NCT01989611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496314|NCT01989611|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92496315|NCT01989611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92496316|NCT01989611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496317|NCT01989611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496318|NCT01989611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92496319|NCT01989611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92496320|NCT01989663|Tenofovir|tenofovir|mesh-list
92496321|NCT01989663|Antiviral Agents|antiviral agents|mesh-ancestor
92496322|NCT01989663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496323|NCT01989663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92496324|NCT01989663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92496325|NCT01989663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496326|NCT01989663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496327|NCT01989663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92496328|NCT01989663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92496329|NCT01989676|Paclitaxel|paclitaxel|mesh-list
92496330|NCT01989676|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92496331|NCT01989676|Trastuzumab|trastuzumab|mesh-list
92496332|NCT01989676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92496333|NCT01989676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496334|NCT01989676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92496335|NCT01989676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92496336|NCT01989676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92496337|NCT01989676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496338|NCT01989676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496339|NCT01989845|Rivaroxaban|rivaroxaban|mesh-list
92496340|NCT01989845|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92496341|NCT01989845|Antithrombins|antithrombins|mesh-ancestor
92496342|NCT01989845|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92496343|NCT01989845|Protease Inhibitors|protease inhibitors|mesh-ancestor
92496344|NCT01989845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496345|NCT01989845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496346|NCT01989845|Anticoagulants|anticoagulants|mesh-ancestor
92496347|NCT01989884|IDN 5109|idn 5109|mesh-list
92496348|NCT01989884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496349|NCT01989897|Phenol|phenol|mesh-list
92496350|NCT01989897|Histamine|histamine|mesh-list
92496351|NCT01989897|Histamine Agonists|histamine agonists|mesh-ancestor
92496352|NCT01989897|Histamine Agents|histamine agents|mesh-ancestor
92496353|NCT01989897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496354|NCT01989897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496355|NCT01989897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496356|NCT01989897|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92496357|NCT01989897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496358|NCT01989897|Disinfectants|disinfectants|mesh-ancestor
92496359|NCT01989897|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92496360|NCT01989897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92496361|NCT01989923|Nicotine|nicotine|mesh-list
92496362|NCT01989923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92496363|NCT01989923|Autonomic Agents|autonomic agents|mesh-ancestor
92496364|NCT01989923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496365|NCT01989923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496366|NCT01989923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92496367|NCT01989923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92496368|NCT01989923|Cholinergic Agents|cholinergic agents|mesh-ancestor
92496369|NCT01989923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496370|NCT01989923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496371|NCT01989936|Eletriptan|eletriptan|mesh-list
92496372|NCT01989936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92496373|NCT01989936|Serotonin Agents|serotonin agents|mesh-ancestor
92496374|NCT01989936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496375|NCT01989936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496376|NCT01989936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496377|NCT01990079|Bupropion|bupropion|mesh-list
92496378|NCT01990079|Nicotine|nicotine|mesh-list
92496379|NCT01990079|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92496380|NCT01990079|Autonomic Agents|autonomic agents|mesh-ancestor
92496381|NCT01990079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496382|NCT01990079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496383|NCT01990079|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92496384|NCT01990079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92496385|NCT01990079|Cholinergic Agents|cholinergic agents|mesh-ancestor
92496386|NCT01990079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496387|NCT01990079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496388|NCT01990079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92496389|NCT01990079|Antidepressive Agents|antidepressive agents|mesh-ancestor
92496390|NCT01990079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496391|NCT01990079|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92496392|NCT01990079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92496393|NCT01990079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496394|NCT01990079|Dopamine Agents|dopamine agents|mesh-ancestor
92496395|NCT01990079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92496396|NCT01990079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92496397|NCT01990079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496398|NCT01990118|Cyclosporine|cyclosporine|mesh-list
92496399|NCT01990118|Cyclosporins|cyclosporins|mesh-list
92496400|NCT01990118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532700|NCT02970097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496401|NCT01990118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496402|NCT01990118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92496403|NCT01990118|Immunologic Factors|immunologic factors|mesh-ancestor
92496404|NCT01990118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496405|NCT01990118|Antifungal Agents|antifungal agents|mesh-ancestor
92496406|NCT01990118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496407|NCT01990118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92496408|NCT01990118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92496409|NCT01990118|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92496410|NCT01990144|Rituximab|rituximab|mesh-list
92496411|NCT01990144|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92496412|NCT01990144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496413|NCT01990144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496414|NCT01990144|Immunologic Factors|immunologic factors|mesh-ancestor
92496415|NCT01990144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496416|NCT01990144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92496417|NCT01990144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92496418|NCT01990144|Alkylating Agents|alkylating agents|mesh-ancestor
92496419|NCT01990144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496420|NCT01990378|Rabeprazole|rabeprazole|mesh-list
92496421|NCT01990378|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92496422|NCT01990378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496423|NCT01990378|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92496424|NCT01990378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496425|NCT01990378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496426|NCT01990404|Nitrous Oxide|nitrous oxide|mesh-list
92496427|NCT01990404|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92496428|NCT01990404|Anesthetics, General|anesthetics, general|mesh-ancestor
92496429|NCT01990404|Anesthetics|anesthetics|mesh-ancestor
92496430|NCT01990404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496431|NCT01990404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496432|NCT01990404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496433|NCT01990404|Analgesics|analgesics|mesh-ancestor
92496434|NCT01990404|Sensory System Agents|sensory system agents|mesh-ancestor
92496435|NCT01990404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496436|NCT01990443|Reslizumab|reslizumab|mesh-list
92496437|NCT01990443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92496438|NCT01990443|Respiratory System Agents|respiratory system agents|mesh-ancestor
92496439|NCT01990586|Rabeprazole|rabeprazole|mesh-list
92496440|NCT01990586|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92496441|NCT01990586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496442|NCT01990586|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92496443|NCT01990586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496444|NCT01990586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496445|NCT01990690|Antioxidants|antioxidants|mesh-list
92496446|NCT01990690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496447|NCT01990690|Protective Agents|protective agents|mesh-ancestor
92496448|NCT01990690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496449|NCT01990755|Chlordesmethyldiazepam|chlordesmethyldiazepam|mesh-list
92496450|NCT01990755|Olanzapine|olanzapine|mesh-list
92496451|NCT01990755|Antiemetics|antiemetics|mesh-ancestor
92496452|NCT01990755|Autonomic Agents|autonomic agents|mesh-ancestor
92496453|NCT01990755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496454|NCT01990755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496455|NCT01990755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496456|NCT01990755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92496457|NCT01990755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92496458|NCT01990755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496459|NCT01990755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496460|NCT01990755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92496461|NCT01990755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92496462|NCT01990755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496463|NCT01990755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496464|NCT01990755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496465|NCT01990755|Serotonin Agents|serotonin agents|mesh-ancestor
92496466|NCT01990755|Anticonvulsants|anticonvulsants|mesh-ancestor
92496467|NCT01990781|Dexamethasone|dexamethasone|mesh-list
92496468|NCT01990781|Dexamethasone acetate|dexamethasone acetate|mesh-list
92496469|NCT01990781|Lidocaine|lidocaine|mesh-list
92496470|NCT01990781|BB 1101|bb 1101|mesh-list
92496471|NCT01990781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496472|NCT01990781|Antiemetics|antiemetics|mesh-ancestor
92496473|NCT01990781|Autonomic Agents|autonomic agents|mesh-ancestor
92496474|NCT01990781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496475|NCT01990781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496477|NCT01990781|Glucocorticoids|glucocorticoids|mesh-ancestor
92496478|NCT01990781|Hormones|hormones|mesh-ancestor
92496479|NCT01990781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496480|NCT01990781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92496481|NCT01990781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496482|NCT01990781|Protease Inhibitors|protease inhibitors|mesh-ancestor
92496483|NCT01990781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496484|NCT01990781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496485|NCT01990781|Anesthetics, Local|anesthetics, local|mesh-ancestor
92496486|NCT01990781|Anesthetics|anesthetics|mesh-ancestor
92496487|NCT01990781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496488|NCT01990781|Sensory System Agents|sensory system agents|mesh-ancestor
92496489|NCT01990781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92496490|NCT01990781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92496491|NCT01990781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92496492|NCT01990781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496493|NCT01990807|Idarubicin|idarubicin|mesh-list
92496494|NCT01990807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92496495|NCT01990807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221399|NCT04323592|Prednisolone|prednisolone|mesh-list
92496496|NCT01990807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92496497|NCT01990807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92496498|NCT01990807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496499|NCT01990807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496501|NCT01990872|Cholecalciferol|cholecalciferol|mesh-list
92496502|NCT01990872|Vitamins|vitamins|mesh-ancestor
92496503|NCT01990872|Micronutrients|micronutrients|mesh-ancestor
92496504|NCT01990872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496505|NCT01990872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496506|NCT01990872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496507|NCT01990937|Midazolam|midazolam|mesh-list
92496508|NCT01990937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92496509|NCT01990937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92496510|NCT01990937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496511|NCT01990937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496512|NCT01990937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92496513|NCT01990937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92496514|NCT01990937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496515|NCT01990937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92496516|NCT01990937|Anesthetics, General|anesthetics, general|mesh-ancestor
92496517|NCT01990937|Anesthetics|anesthetics|mesh-ancestor
92496518|NCT01990937|GABA Modulators|gaba modulators|mesh-ancestor
92496519|NCT01990937|GABA Agents|gaba agents|mesh-ancestor
92496520|NCT01990937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496521|NCT01990937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496522|NCT01991028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92496523|NCT01991054|Vitamin D|vitamin d|mesh-list
92496524|NCT01991054|Cholecalciferol|cholecalciferol|mesh-list
92496525|NCT01991054|Vitamins|vitamins|mesh-ancestor
92496526|NCT01991054|Micronutrients|micronutrients|mesh-ancestor
92496527|NCT01991054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496528|NCT01991054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496529|NCT01991054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496530|NCT01991119|Dronedarone|dronedarone|mesh-list
92496531|NCT01991119|Propafenone|propafenone|mesh-list
92496532|NCT01991119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92496533|NCT01991119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92496534|NCT01991119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92496535|NCT01991119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496536|NCT01991119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496537|NCT01991145|Epoetin Alfa|epoetin alfa|mesh-list
92496538|NCT01991145|Hematinics|hematinics|mesh-ancestor
92496539|NCT01991158|Dexamethasone|dexamethasone|mesh-list
92496540|NCT01991158|Gemcitabine|gemcitabine|mesh-list
92496541|NCT01991158|Methotrexate|methotrexate|mesh-list
92496542|NCT01991158|Pegaspargase|pegaspargase|mesh-list
92496543|NCT01991158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496544|NCT01991158|Antiemetics|antiemetics|mesh-ancestor
92496545|NCT01991158|Autonomic Agents|autonomic agents|mesh-ancestor
92496546|NCT01991158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496547|NCT01991158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496548|NCT01991158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496549|NCT01991158|Glucocorticoids|glucocorticoids|mesh-ancestor
92496550|NCT01991158|Hormones|hormones|mesh-ancestor
92496551|NCT01991158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496552|NCT01991158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92496553|NCT01991158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496554|NCT01991158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92496555|NCT01991158|Antimetabolites|antimetabolites|mesh-ancestor
92496556|NCT01991158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496557|NCT01991158|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92496558|NCT01991158|Abortifacient Agents|abortifacient agents|mesh-ancestor
92496559|NCT01991158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496560|NCT01991158|Dermatologic Agents|dermatologic agents|mesh-ancestor
92496561|NCT01991158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496562|NCT01991158|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92496563|NCT01991158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92496564|NCT01991158|Immunologic Factors|immunologic factors|mesh-ancestor
92496565|NCT01991158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92496566|NCT01991158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92496567|NCT01991275|Morphine|morphine|mesh-list
92496568|NCT01991275|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92496569|NCT01991275|Narcotics|narcotics|mesh-ancestor
92496570|NCT01991275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496571|NCT01991275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496572|NCT01991275|Analgesics|analgesics|mesh-ancestor
92496573|NCT01991275|Sensory System Agents|sensory system agents|mesh-ancestor
92496574|NCT01991275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496575|NCT01991288|Epinephrine|epinephrine|mesh-list
92496576|NCT01991288|Racepinephrine|racepinephrine|mesh-list
92496577|NCT01991288|Bupivacaine|bupivacaine|mesh-list
92496578|NCT01991288|Levobupivacaine|levobupivacaine|mesh-list
92496579|NCT01991288|Epinephryl borate|epinephryl borate|mesh-list
92496580|NCT01991288|Anesthetics, Local|anesthetics, local|mesh-ancestor
92496581|NCT01991288|Anesthetics|anesthetics|mesh-ancestor
92496582|NCT01991288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496583|NCT01991288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496584|NCT01991288|Sensory System Agents|sensory system agents|mesh-ancestor
92496585|NCT01991288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496586|NCT01991288|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92496587|NCT01991288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92496588|NCT01991288|Adrenergic Agents|adrenergic agents|mesh-ancestor
92496589|NCT01991288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496590|NCT01991288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496591|NCT01991288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92496592|NCT01991288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92496593|NCT01991288|Autonomic Agents|autonomic agents|mesh-ancestor
92496594|NCT01991288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92496595|NCT01991288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92496596|NCT01991288|Mydriatics|mydriatics|mesh-ancestor
92496597|NCT01991288|Sympathomimetics|sympathomimetics|mesh-ancestor
92496598|NCT01991288|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92496599|NCT01991327|Enclomiphene|enclomiphene|mesh-list
92496600|NCT01991327|Clomiphene|clomiphene|mesh-list
92496601|NCT01991327|Zuclomiphene|zuclomiphene|mesh-list
92496602|NCT01991327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92496603|NCT01991327|Hormone Antagonists|hormone antagonists|mesh-ancestor
92496604|NCT01991327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496605|NCT01991327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496606|NCT01991327|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92496607|NCT01991327|Fertility Agents|fertility agents|mesh-ancestor
92496608|NCT01991327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496609|NCT01991327|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92496610|NCT01991327|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92496611|NCT01991561|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92496612|NCT01991561|Vaccines|vaccines|mesh-list
92496613|NCT01991561|Immunologic Factors|immunologic factors|mesh-ancestor
92496614|NCT01991561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496615|NCT01991561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92496616|NCT01991561|Antacids|antacids|mesh-ancestor
92496617|NCT01991561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496618|NCT01991561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496619|NCT01991574|Calcium|calcium|mesh-list
92496620|NCT01991574|Calcium acetate|calcium acetate|mesh-list
92496621|NCT01991574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496622|NCT01991574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496623|NCT01991574|Chelating Agents|chelating agents|mesh-ancestor
92496624|NCT01991574|Sequestering Agents|sequestering agents|mesh-ancestor
92496625|NCT01991574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496626|NCT01991587|Vaccines|vaccines|mesh-list
92496627|NCT01991587|Immunologic Factors|immunologic factors|mesh-ancestor
92496628|NCT01991587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496629|NCT01991626|Iron|iron|mesh-list
92496630|NCT01991626|Trace Elements|trace elements|mesh-list
92496631|NCT01991626|Micronutrients|micronutrients|mesh-list
92496632|NCT01991626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496633|NCT01991678|Etirinotecan pegol|etirinotecan pegol|mesh-list
92496634|NCT01991678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496635|NCT01991678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92496636|NCT01991678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92496637|NCT01991678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496638|NCT01991678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496639|NCT01991834|Cefazolin|cefazolin|mesh-list
92496640|NCT01991834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496641|NCT01991834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496642|NCT01991951|Warfarin|warfarin|mesh-list
92496643|NCT01991951|Anticoagulants|anticoagulants|mesh-ancestor
92496644|NCT01992133|Vitamin D|vitamin d|mesh-list
92496645|NCT01992133|Cholecalciferol|cholecalciferol|mesh-list
92496646|NCT01992133|Vitamins|vitamins|mesh-ancestor
92496647|NCT01992133|Micronutrients|micronutrients|mesh-ancestor
92221541|NCT03012607|Antiviral Agents|antiviral agents|mesh-ancestor
92496648|NCT01992133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496649|NCT01992133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496650|NCT01992133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496651|NCT01992146|Naloxone|naloxone|mesh-list
92496652|NCT01992146|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92496653|NCT01992146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496654|NCT01992146|Sensory System Agents|sensory system agents|mesh-ancestor
92496655|NCT01992146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496656|NCT01992198|Chlorhexidine|chlorhexidine|mesh-list
92496657|NCT01992198|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92496658|NCT01992198|Metronidazole|metronidazole|mesh-list
92496659|NCT01992198|Meropenem|meropenem|mesh-list
92496660|NCT01992198|Cefoperazone|cefoperazone|mesh-list
92496661|NCT01992198|Sulperazone|sulperazone|mesh-list
92496662|NCT01992198|Somatostatin|somatostatin|mesh-list
92496663|NCT01992198|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92496664|NCT01992198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496665|NCT01992198|Disinfectants|disinfectants|mesh-ancestor
92496666|NCT01992198|Dermatologic Agents|dermatologic agents|mesh-ancestor
92496667|NCT01992198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496668|NCT01992198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92496669|NCT01992198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92496670|NCT01992198|Hormones|hormones|mesh-ancestor
92496671|NCT01992198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496672|NCT01992198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496673|NCT01992198|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92496674|NCT01992211|Metformin|metformin|mesh-list
92496675|NCT01992211|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92496676|NCT01992211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92496677|NCT01992211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496678|NCT01992211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92496679|NCT01992211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92496680|NCT01992211|Antimetabolites|antimetabolites|mesh-ancestor
92496681|NCT01992211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496682|NCT01992211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92496683|NCT01992211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92496684|NCT01992211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496685|NCT01992263|Vitamin D|vitamin d|mesh-list
92496686|NCT01992263|Ergocalciferols|ergocalciferols|mesh-list
92496687|NCT01992263|Cholecalciferol|cholecalciferol|mesh-list
92496688|NCT01992263|Vitamins|vitamins|mesh-list
92496689|NCT01992263|Micronutrients|micronutrients|mesh-ancestor
92496690|NCT01992263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496691|NCT01992263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496692|NCT01992263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496693|NCT01992328|Immunoglobulins|immunoglobulins|mesh-list
92496694|NCT01992328|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92496695|NCT01992328|Antibodies|antibodies|mesh-list
92496696|NCT01992328|Immunoglobulin G|immunoglobulin g|mesh-list
92496697|NCT01992328|gamma-Globulins|gamma-globulins|mesh-list
92496698|NCT01992328|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92496699|NCT01992328|Immunologic Factors|immunologic factors|mesh-ancestor
92496700|NCT01992328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496701|NCT01992341|Paclitaxel|paclitaxel|mesh-list
92496702|NCT01992341|Trebananib|trebananib|mesh-list
92496703|NCT01992341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92496704|NCT01992341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496705|NCT01992341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92496706|NCT01992341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92496707|NCT01992341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92496708|NCT01992341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496709|NCT01992341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92496710|NCT01992341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92496711|NCT01992341|Growth Substances|growth substances|mesh-ancestor
92496712|NCT01992341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496713|NCT01992341|Growth Inhibitors|growth inhibitors|mesh-ancestor
92496714|NCT01992562|Ziconotide|ziconotide|mesh-list
92496715|NCT01992562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92496716|NCT01992562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496717|NCT01992562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496718|NCT01992562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496719|NCT01992562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496720|NCT01992562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92496721|NCT01992562|Protective Agents|protective agents|mesh-ancestor
92496722|NCT01992562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496723|NCT01992562|Analgesics|analgesics|mesh-ancestor
92496724|NCT01992562|Sensory System Agents|sensory system agents|mesh-ancestor
92496725|NCT01992562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496726|NCT01992588|Insulin|insulin|mesh-list
92496727|NCT01992588|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92496729|NCT01992588|Insulin, Long-Acting|insulin, long-acting|mesh-list
92496730|NCT01992588|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92496731|NCT01992588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92496732|NCT01992588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496733|NCT01992601|Telmisartan|telmisartan|mesh-list
92496734|NCT01992601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92496735|NCT01992601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92496736|NCT01992601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92496737|NCT01992601|Antimetabolites|antimetabolites|mesh-ancestor
92496738|NCT01992601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496739|NCT01992601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92496740|NCT01992601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92496741|NCT01992601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496742|NCT01992601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92496743|NCT01992601|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92496744|NCT01992601|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92496745|NCT01992705|Fluorouracil|fluorouracil|mesh-list
92496746|NCT01992705|Oxaliplatin|oxaliplatin|mesh-list
92496747|NCT01992705|Irinotecan|irinotecan|mesh-list
92496748|NCT01992705|Folfirinox|folfirinox|mesh-list
92496749|NCT01992705|Antimetabolites|antimetabolites|mesh-ancestor
92496750|NCT01992705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496751|NCT01992705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92496752|NCT01992705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496753|NCT01992705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92496754|NCT01992705|Immunologic Factors|immunologic factors|mesh-ancestor
92496755|NCT01992705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496756|NCT01992705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92496757|NCT01992705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92496758|NCT01992705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496759|NCT01992796|Telmisartan|telmisartan|mesh-list
92496760|NCT01992796|Candesartan|candesartan|mesh-list
92496761|NCT01992796|Olmesartan|olmesartan|mesh-list
92496762|NCT01992796|Irbesartan|irbesartan|mesh-list
92496763|NCT01992796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92496764|NCT01992796|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92496765|NCT01992796|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92496766|NCT01992796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496767|NCT01992900|Piperaquine|piperaquine|mesh-list
92496768|NCT01992900|Artenimol|artenimol|mesh-list
92496769|NCT01992900|Artemisinins|artemisinins|mesh-list
92496770|NCT01992900|Antimalarials|antimalarials|mesh-ancestor
92496771|NCT01992900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92496772|NCT01992900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92496773|NCT01992900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496774|NCT01993134|Cefazolin|cefazolin|mesh-list
92496775|NCT01993134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496776|NCT01993134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496777|NCT01993173|Vaccines|vaccines|mesh-list
92496778|NCT01993173|Immunologic Factors|immunologic factors|mesh-ancestor
92496779|NCT01993173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496780|NCT01993212|Enclomiphene|enclomiphene|mesh-list
92496781|NCT01993212|Testosterone|testosterone|mesh-list
92496782|NCT01993212|Androgens|androgens|mesh-ancestor
92496783|NCT01993212|Hormones|hormones|mesh-ancestor
92496784|NCT01993212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496785|NCT01993212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496786|NCT01993212|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92496787|NCT01993212|Hormone Antagonists|hormone antagonists|mesh-ancestor
92496788|NCT01993212|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92496789|NCT01993212|Fertility Agents|fertility agents|mesh-ancestor
92496790|NCT01993212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496791|NCT01993212|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92496792|NCT01993212|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92496793|NCT01993225|Enclomiphene|enclomiphene|mesh-list
92496794|NCT01993225|Testosterone|testosterone|mesh-list
92496795|NCT01993225|Androgens|androgens|mesh-ancestor
92496796|NCT01993225|Hormones|hormones|mesh-ancestor
92496797|NCT01993225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496798|NCT01993225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221710|NCT04822363|Aspirin|aspirin|mesh-list
92496799|NCT01993225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92496800|NCT01993225|Hormone Antagonists|hormone antagonists|mesh-ancestor
92496801|NCT01993225|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92496802|NCT01993225|Fertility Agents|fertility agents|mesh-ancestor
92496803|NCT01993225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496804|NCT01993225|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92496805|NCT01993225|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92496806|NCT01993251|Melatonin|melatonin|mesh-list
92496807|NCT01993251|Antioxidants|antioxidants|mesh-ancestor
92496808|NCT01993251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496809|NCT01993251|Protective Agents|protective agents|mesh-ancestor
92496810|NCT01993251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496811|NCT01993251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496813|NCT01993290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92496814|NCT01993290|Anesthetics|anesthetics|mesh-ancestor
92496815|NCT01993290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496816|NCT01993290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496817|NCT01993290|Sensory System Agents|sensory system agents|mesh-ancestor
92496818|NCT01993290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496819|NCT01993459|Midazolam|midazolam|mesh-list
92496820|NCT01993459|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92496821|NCT01993459|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92496822|NCT01993459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92496823|NCT01993459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496824|NCT01993459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496825|NCT01993459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92496826|NCT01993459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92496827|NCT01993459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496828|NCT01993459|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92496829|NCT01993459|Anesthetics, General|anesthetics, general|mesh-ancestor
92496830|NCT01993459|Anesthetics|anesthetics|mesh-ancestor
92496831|NCT01993459|GABA Modulators|gaba modulators|mesh-ancestor
92496832|NCT01993459|GABA Agents|gaba agents|mesh-ancestor
92496833|NCT01993459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496834|NCT01993459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496835|NCT01993472|Andrographolide|andrographolide|mesh-list
92496836|NCT01993472|Capecitabine|capecitabine|mesh-list
92496837|NCT01993472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92496838|NCT01993472|Antimetabolites|antimetabolites|mesh-ancestor
92496839|NCT01993472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496840|NCT01993472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496841|NCT01993472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496842|NCT01993472|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92496843|NCT01993472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496844|NCT01993472|Analgesics|analgesics|mesh-ancestor
92496845|NCT01993472|Sensory System Agents|sensory system agents|mesh-ancestor
92496846|NCT01993472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496847|NCT01993472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496848|NCT01993472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92496849|NCT01993472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92496850|NCT01993472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92496851|NCT01993472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496852|NCT01993472|Antiviral Agents|antiviral agents|mesh-ancestor
92496853|NCT01993472|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92496854|NCT01993537|Vitamin D|vitamin d|mesh-list
92496855|NCT01993537|Vitamins|vitamins|mesh-ancestor
92496856|NCT01993537|Micronutrients|micronutrients|mesh-ancestor
92496857|NCT01993537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496858|NCT01993537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496859|NCT01993589|Acetaminophen|acetaminophen|mesh-list
92496860|NCT01993589|Analgesics|analgesics|mesh-list
92496861|NCT01993589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92496862|NCT01993589|Sensory System Agents|sensory system agents|mesh-ancestor
92496863|NCT01993589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496864|NCT01993589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496865|NCT01993589|Antipyretics|antipyretics|mesh-ancestor
92496866|NCT01993680|Fludrocortisone|fludrocortisone|mesh-list
92496867|NCT01993680|Bromides|bromides|mesh-list
92496868|NCT01993680|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92496869|NCT01993680|Anticonvulsants|anticonvulsants|mesh-ancestor
92496870|NCT01993680|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92496871|NCT01993680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496872|NCT01993680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496873|NCT01993680|Cholinergic Agents|cholinergic agents|mesh-ancestor
92496874|NCT01993680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496875|NCT01993680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496876|NCT01993680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496877|NCT01993771|Anesthetics|anesthetics|mesh-list
92496878|NCT01993771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496879|NCT01993771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496880|NCT01993784|Nimotuzumab|nimotuzumab|mesh-list
92496881|NCT01993784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92496882|NCT01993784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496883|NCT01993979|Cisplatin|cisplatin|mesh-list
92496884|NCT01993979|Carboplatin|carboplatin|mesh-list
92496885|NCT01993979|Gemcitabine|gemcitabine|mesh-list
92496886|NCT01993979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496887|NCT01993979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92496889|NCT01993979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496890|NCT01994031|Paclitaxel|paclitaxel|mesh-list
92496891|NCT01994031|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92496892|NCT01994031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92496893|NCT01994031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496894|NCT01994031|Tubulin Modulators|tubulin modulators|mesh-ancestor
92496895|NCT01994031|Antimitotic Agents|antimitotic agents|mesh-ancestor
92496896|NCT01994031|Mitosis Modulators|mitosis modulators|mesh-ancestor
92496897|NCT01994031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496898|NCT01994070|Procainamide|procainamide|mesh-list
92496899|NCT01994070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92496900|NCT01994070|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92496901|NCT01994070|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92496902|NCT01994070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92496903|NCT01994070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496904|NCT01994096|Caspofungin|caspofungin|mesh-list
92496905|NCT01994096|Antifungal Agents|antifungal agents|mesh-ancestor
92496906|NCT01994096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496907|NCT01994096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496908|NCT01994096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496909|NCT01994265|Warfarin|warfarin|mesh-list
92496910|NCT01994265|Dabigatran|dabigatran|mesh-list
92496911|NCT01994265|Anticoagulants|anticoagulants|mesh-ancestor
92496912|NCT01994265|Antithrombins|antithrombins|mesh-ancestor
92496913|NCT01994265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92496914|NCT01994265|Protease Inhibitors|protease inhibitors|mesh-ancestor
92496915|NCT01994265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496916|NCT01994265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496917|NCT01994330|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92496918|NCT01994330|Hemostatics|hemostatics|mesh-ancestor
92496919|NCT01994330|Coagulants|coagulants|mesh-ancestor
92496920|NCT01994330|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92496921|NCT01994330|Natriuretic Agents|natriuretic agents|mesh-ancestor
92496922|NCT01994330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496923|NCT01994356|Contraceptive Agents|contraceptive agents|mesh-list
92496924|NCT01994356|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92496925|NCT01994356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496927|NCT01994460|Ethambutol|ethambutol|mesh-list
92496928|NCT01994460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496929|NCT01994460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496930|NCT01994460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92496931|NCT01994460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496932|NCT01994460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496933|NCT01994460|Antitubercular Agents|antitubercular agents|mesh-ancestor
92496934|NCT01994642|Ciprofloxacin|ciprofloxacin|mesh-list
92496935|NCT01994642|Dexamethasone|dexamethasone|mesh-list
92496936|NCT01994642|Dexamethasone acetate|dexamethasone acetate|mesh-list
92496937|NCT01994642|BB 1101|bb 1101|mesh-list
92496938|NCT01994642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496939|NCT01994642|Antiemetics|antiemetics|mesh-ancestor
92496940|NCT01994642|Autonomic Agents|autonomic agents|mesh-ancestor
92496941|NCT01994642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496942|NCT01994642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496943|NCT01994642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496944|NCT01994642|Glucocorticoids|glucocorticoids|mesh-ancestor
92496945|NCT01994642|Hormones|hormones|mesh-ancestor
92496946|NCT01994642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92496947|NCT01994642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92496948|NCT01994642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92496949|NCT01994642|Protease Inhibitors|protease inhibitors|mesh-ancestor
92496950|NCT01994642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92496951|NCT01994642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496952|NCT01994642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92496953|NCT01994642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92496954|NCT01994642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92496955|NCT01994642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92496956|NCT01994642|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92496957|NCT01994642|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92496959|NCT01994668|Anticonvulsants|anticonvulsants|mesh-ancestor
92496960|NCT01994668|Antiemetics|antiemetics|mesh-ancestor
92496961|NCT01994668|Autonomic Agents|autonomic agents|mesh-ancestor
92496962|NCT01994668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496963|NCT01994668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496964|NCT01994668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496965|NCT01994668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92496966|NCT01994668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92496967|NCT01994668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92496968|NCT01994668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92496969|NCT01994668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92496970|NCT01994668|GABA Modulators|gaba modulators|mesh-ancestor
92496971|NCT01994668|GABA Agents|gaba agents|mesh-ancestor
92496972|NCT01994668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92496973|NCT01994668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496974|NCT01994733|Calcium, Dietary|calcium, dietary|mesh-list
92496975|NCT01994733|Calcium Carbonate|calcium carbonate|mesh-list
92496976|NCT01994733|Calcium|calcium|mesh-list
92496977|NCT01994733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92496978|NCT01994733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496979|NCT01994733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92496980|NCT01994733|Antacids|antacids|mesh-ancestor
92496981|NCT01994733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92496982|NCT01994733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496983|NCT01994759|Methylprednisolone|methylprednisolone|mesh-list
92496984|NCT01994759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92496985|NCT01994759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92496986|NCT01994759|Antiemetics|antiemetics|mesh-ancestor
92496987|NCT01994759|Autonomic Agents|autonomic agents|mesh-ancestor
92496988|NCT01994759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92496989|NCT01994759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92496990|NCT01994759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92496991|NCT01994759|Glucocorticoids|glucocorticoids|mesh-ancestor
92496992|NCT01994759|Hormones|hormones|mesh-ancestor
92496993|NCT01994759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532729|NCT00055120|Ritonavir|ritonavir|mesh-list
92496994|NCT01994759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92496995|NCT01994759|Protective Agents|protective agents|mesh-ancestor
92496996|NCT01994824|Thymoglobulin|thymoglobulin|mesh-list
92496997|NCT01994824|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92496998|NCT01994824|Immunologic Factors|immunologic factors|mesh-ancestor
92496999|NCT01994824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497000|NCT01994824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497001|NCT01994941|Clopidogrel|clopidogrel|mesh-list
92497002|NCT01994941|Ticagrelor|ticagrelor|mesh-list
92497003|NCT01994941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92497004|NCT01994941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92497005|NCT01994941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92497006|NCT01994941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92497007|NCT01994941|Purinergic Agents|purinergic agents|mesh-ancestor
92497008|NCT01994941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497009|NCT01994941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497010|NCT01994941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497011|NCT01994967|Bupivacaine|bupivacaine|mesh-list
92497012|NCT01994967|Levobupivacaine|levobupivacaine|mesh-list
92497013|NCT01994967|Anesthetics, Local|anesthetics, local|mesh-ancestor
92497014|NCT01994967|Anesthetics|anesthetics|mesh-ancestor
92497015|NCT01994967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497016|NCT01994967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497017|NCT01994967|Sensory System Agents|sensory system agents|mesh-ancestor
92497018|NCT01994967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497019|NCT01995006|Dipyrone|dipyrone|mesh-list
92497020|NCT01995006|Naproxen|naproxen|mesh-list
92497021|NCT01995006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497022|NCT01995006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497023|NCT01995006|Analgesics|analgesics|mesh-ancestor
92497024|NCT01995006|Sensory System Agents|sensory system agents|mesh-ancestor
92497025|NCT01995006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497026|NCT01995006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497027|NCT01995006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497028|NCT01995006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497029|NCT01995006|Gout Suppressants|gout suppressants|mesh-ancestor
92497030|NCT01995006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92497032|NCT01995006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497033|NCT01995006|Antipyretics|antipyretics|mesh-ancestor
92497034|NCT01995019|Methylprednisolone|methylprednisolone|mesh-list
92497035|NCT01995019|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92497036|NCT01995019|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92497037|NCT01995019|Prednisolone|prednisolone|mesh-list
92497038|NCT01995019|Prednisolone acetate|prednisolone acetate|mesh-list
92497039|NCT01995019|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92497040|NCT01995019|Prednisolone phosphate|prednisolone phosphate|mesh-list
92497041|NCT01995019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497042|NCT01995019|Antiemetics|antiemetics|mesh-ancestor
92497043|NCT01995019|Autonomic Agents|autonomic agents|mesh-ancestor
92497044|NCT01995019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497045|NCT01995019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497046|NCT01995019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497047|NCT01995019|Glucocorticoids|glucocorticoids|mesh-ancestor
92497048|NCT01995019|Hormones|hormones|mesh-ancestor
92497049|NCT01995019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497050|NCT01995019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92497051|NCT01995019|Protective Agents|protective agents|mesh-ancestor
92497052|NCT01995019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92497053|NCT01995019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497054|NCT01995032|Metformin|metformin|mesh-list
92497055|NCT01995032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92497056|NCT01995032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497057|NCT01995058|Prednisone|prednisone|mesh-list
92497058|NCT01995058|Abiraterone Acetate|abiraterone acetate|mesh-list
92497059|NCT01995058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497060|NCT01995058|Glucocorticoids|glucocorticoids|mesh-ancestor
92497061|NCT01995058|Hormones|hormones|mesh-ancestor
92497062|NCT01995058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497063|NCT01995058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497064|NCT01995058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92497065|NCT01995058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497066|NCT01995058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92497067|NCT01995058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497068|NCT01995058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497069|NCT01995058|Hormone Antagonists|hormone antagonists|mesh-ancestor
92497070|NCT01995058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92497071|NCT01995084|Imidazole|imidazole|mesh-list
92497072|NCT01995084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497073|NCT01995084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497074|NCT01995188|Bevacizumab|bevacizumab|mesh-list
92497075|NCT01995188|Carboplatin|carboplatin|mesh-list
92497076|NCT01995188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92497077|NCT01995188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497078|NCT01995188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92497079|NCT01995188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92497080|NCT01995188|Growth Substances|growth substances|mesh-ancestor
92497081|NCT01995188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497082|NCT01995188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92497083|NCT01995214|Propofol|propofol|mesh-list
92497084|NCT01995214|Sevoflurane|sevoflurane|mesh-list
92497085|NCT01995214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92497086|NCT01995214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497087|NCT01995214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497088|NCT01995214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92497089|NCT01995214|Anesthetics, General|anesthetics, general|mesh-ancestor
92497090|NCT01995214|Anesthetics|anesthetics|mesh-ancestor
92497091|NCT01995214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92497092|NCT01995214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92497093|NCT01995292|Anesthetics|anesthetics|mesh-list
92497094|NCT01995292|Anesthetics, Local|anesthetics, local|mesh-list
92497095|NCT01995292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497096|NCT01995292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497097|NCT01995292|Sensory System Agents|sensory system agents|mesh-ancestor
92497098|NCT01995292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497099|NCT01995331|Cyclosporine|cyclosporine|mesh-list
92497100|NCT01995331|Cyclophosphamide|cyclophosphamide|mesh-list
92497101|NCT01995331|Cyclosporins|cyclosporins|mesh-list
92497102|NCT01995331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497103|NCT01995331|Immunologic Factors|immunologic factors|mesh-ancestor
92221989|NCT00983372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92497104|NCT01995331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497106|NCT01995331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92497107|NCT01995331|Alkylating Agents|alkylating agents|mesh-ancestor
92497108|NCT01995331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497109|NCT01995331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497110|NCT01995331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92497111|NCT01995331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497112|NCT01995331|Antifungal Agents|antifungal agents|mesh-ancestor
92497113|NCT01995331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497114|NCT01995331|Dermatologic Agents|dermatologic agents|mesh-ancestor
92497115|NCT01995331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92497116|NCT01995370|Aspirin|aspirin|mesh-list
92497117|NCT01995370|Cilostazol|cilostazol|mesh-list
92497118|NCT01995370|Clopidogrel|clopidogrel|mesh-list
92497119|NCT01995370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497120|NCT01995370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497121|NCT01995370|Analgesics|analgesics|mesh-ancestor
92497122|NCT01995370|Sensory System Agents|sensory system agents|mesh-ancestor
92497123|NCT01995370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497124|NCT01995370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497125|NCT01995370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497126|NCT01995370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497127|NCT01995370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92497128|NCT01995370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92497129|NCT01995370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497130|NCT01995370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92497131|NCT01995370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92497132|NCT01995370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497133|NCT01995370|Antipyretics|antipyretics|mesh-ancestor
92497134|NCT01995370|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92497135|NCT01995370|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92497136|NCT01995370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92497137|NCT01995370|Purinergic Agents|purinergic agents|mesh-ancestor
92497138|NCT01995370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497139|NCT01995370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92497140|NCT01995370|Autonomic Agents|autonomic agents|mesh-ancestor
92497141|NCT01995370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92497142|NCT01995370|Respiratory System Agents|respiratory system agents|mesh-ancestor
92349643|NCT01443078|Carboplatin|carboplatin|mesh-list
92497143|NCT01995370|Vasodilator Agents|vasodilator agents|mesh-ancestor
92497144|NCT01995370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92497145|NCT01995370|Protective Agents|protective agents|mesh-ancestor
92497146|NCT01995370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92497147|NCT01995370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92497148|NCT01995656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92497149|NCT01995695|Vaccines|vaccines|mesh-list
92497150|NCT01995695|Immunologic Factors|immunologic factors|mesh-ancestor
92497151|NCT01995695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497152|NCT01995734|Pasireotide|pasireotide|mesh-list
92497153|NCT01995734|Hormones|hormones|mesh-ancestor
92497154|NCT01995734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497155|NCT01995734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497156|NCT01995799|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92497157|NCT01995799|Hematinics|hematinics|mesh-ancestor
92497158|NCT01995799|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92497159|NCT01995799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92497160|NCT01995890|Nepafenac|nepafenac|mesh-list
92497161|NCT01995890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497162|NCT01995890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497163|NCT01995890|Analgesics|analgesics|mesh-ancestor
92497164|NCT01995890|Sensory System Agents|sensory system agents|mesh-ancestor
92497165|NCT01995890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497166|NCT01995890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497167|NCT01995890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497168|NCT01995890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497169|NCT01996085|Amlodipine|amlodipine|mesh-list
92497170|NCT01996085|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92497171|NCT01996085|Telmisartan|telmisartan|mesh-list
92497172|NCT01996085|Lisinopril|lisinopril|mesh-list
92497173|NCT01996085|Nebivolol|nebivolol|mesh-list
92497174|NCT01996085|Indapamide|indapamide|mesh-list
92497175|NCT01996085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92497176|NCT01996085|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92497177|NCT01996085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497178|NCT01996085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497179|NCT01996085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92497180|NCT01996085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497181|NCT01996085|Vasodilator Agents|vasodilator agents|mesh-ancestor
92497182|NCT01996085|Diuretics|diuretics|mesh-ancestor
92497183|NCT01996085|Natriuretic Agents|natriuretic agents|mesh-ancestor
92497184|NCT01996085|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92497185|NCT01996085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92497186|NCT01996085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92497187|NCT01996085|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92497188|NCT01996085|Protease Inhibitors|protease inhibitors|mesh-ancestor
92497189|NCT01996085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497190|NCT01996085|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92497191|NCT01996085|Protective Agents|protective agents|mesh-ancestor
92497192|NCT01996085|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92497193|NCT01996085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92497194|NCT01996085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92497195|NCT01996085|Adrenergic Agents|adrenergic agents|mesh-ancestor
92497196|NCT01996085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497197|NCT01996150|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92497198|NCT01996150|Eusol|eusol|mesh-list
92497199|NCT01996150|Disinfectants|disinfectants|mesh-ancestor
92497200|NCT01996150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497201|NCT01996189|Insulin|insulin|mesh-list
92497202|NCT01996189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92497203|NCT01996189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497204|NCT01996306|Leucovorin|leucovorin|mesh-list
92497205|NCT01996306|Bevacizumab|bevacizumab|mesh-list
92497206|NCT01996306|Fluorouracil|fluorouracil|mesh-list
92497207|NCT01996306|Capecitabine|capecitabine|mesh-list
92497208|NCT01996306|Irinotecan|irinotecan|mesh-list
92497209|NCT01996306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92497210|NCT01996306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497211|NCT01996306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92497212|NCT01996306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92497213|NCT01996306|Growth Substances|growth substances|mesh-ancestor
92497214|NCT01996306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497215|NCT01996306|Growth Inhibitors|growth inhibitors|mesh-ancestor
92497216|NCT01996306|Antimetabolites|antimetabolites|mesh-ancestor
92497217|NCT01996306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497218|NCT01996306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92497219|NCT01996306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497220|NCT01996306|Immunologic Factors|immunologic factors|mesh-ancestor
92497221|NCT01996306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92497222|NCT01996306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92497223|NCT01996306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497225|NCT01996306|Protective Agents|protective agents|mesh-ancestor
92497226|NCT01996306|Vitamin B Complex|vitamin b complex|mesh-ancestor
92497227|NCT01996306|Vitamins|vitamins|mesh-ancestor
92497228|NCT01996306|Micronutrients|micronutrients|mesh-ancestor
92497229|NCT01996358|Rocuronium|rocuronium|mesh-list
92497230|NCT01996358|Succinylcholine|succinylcholine|mesh-list
92497231|NCT01996358|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92497232|NCT01996358|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92497233|NCT01996358|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92497234|NCT01996358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497235|NCT01996358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497236|NCT01996358|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92497237|NCT01996384|Lidocaine|lidocaine|mesh-list
92497238|NCT01996384|Anesthetics, Local|anesthetics, local|mesh-ancestor
92497239|NCT01996384|Anesthetics|anesthetics|mesh-ancestor
92497240|NCT01996384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497241|NCT01996384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497242|NCT01996384|Sensory System Agents|sensory system agents|mesh-ancestor
92497243|NCT01996384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497244|NCT01996384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92497245|NCT01996384|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92497246|NCT01996384|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92497247|NCT01996384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497248|NCT01996384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497249|NCT01996423|Vitamin D|vitamin d|mesh-list
92497250|NCT01996423|Cholecalciferol|cholecalciferol|mesh-list
92497251|NCT01996423|Vitamins|vitamins|mesh-ancestor
92497252|NCT01996423|Micronutrients|micronutrients|mesh-ancestor
92497253|NCT01996423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497254|NCT01996423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92497255|NCT01996423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92497256|NCT01996462|Dexetimide|dexetimide|mesh-list
92497257|NCT01996462|Citalopram|citalopram|mesh-list
92497258|NCT01996462|Escitalopram|escitalopram|mesh-list
92497259|NCT01996462|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92497260|NCT01996462|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92200460|NCT05346146|Antimetabolites|antimetabolites|mesh-ancestor
92497261|NCT01996462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497262|NCT01996462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497263|NCT01996462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497264|NCT01996462|Serotonin Agents|serotonin agents|mesh-ancestor
92497265|NCT01996462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497266|NCT01996462|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92497267|NCT01996462|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92497268|NCT01996462|Parasympatholytics|parasympatholytics|mesh-ancestor
92497269|NCT01996462|Autonomic Agents|autonomic agents|mesh-ancestor
92497270|NCT01996462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497271|NCT01996462|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92497272|NCT01996462|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92497273|NCT01996462|Cholinergic Agents|cholinergic agents|mesh-ancestor
92497274|NCT01996462|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92497275|NCT01996462|Antidepressive Agents|antidepressive agents|mesh-ancestor
92497276|NCT01996462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497277|NCT01996475|Dexetimide|dexetimide|mesh-list
92497278|NCT01996475|Citalopram|citalopram|mesh-list
92497279|NCT01996475|Escitalopram|escitalopram|mesh-list
92497280|NCT01996475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92497281|NCT01996475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92497282|NCT01996475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497283|NCT01996475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497284|NCT01996475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497285|NCT01996475|Serotonin Agents|serotonin agents|mesh-ancestor
92497286|NCT01996475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497287|NCT01996475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92497288|NCT01996475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92497289|NCT01996475|Parasympatholytics|parasympatholytics|mesh-ancestor
92497290|NCT01996475|Autonomic Agents|autonomic agents|mesh-ancestor
92497291|NCT01996475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497292|NCT01996475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92497293|NCT01996475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92497294|NCT01996475|Cholinergic Agents|cholinergic agents|mesh-ancestor
92497295|NCT01996475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92497296|NCT01996475|Antidepressive Agents|antidepressive agents|mesh-ancestor
92497297|NCT01996475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497298|NCT01996488|Olanzapine|olanzapine|mesh-list
92497299|NCT01996488|Antiemetics|antiemetics|mesh-ancestor
92497300|NCT01996488|Autonomic Agents|autonomic agents|mesh-ancestor
92497301|NCT01996488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497302|NCT01996488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497303|NCT01996488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497304|NCT01996488|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92497305|NCT01996488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92497306|NCT01996488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497307|NCT01996488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497308|NCT01996488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92497309|NCT01996488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92497310|NCT01996488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497311|NCT01996488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497312|NCT01996488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497313|NCT01996488|Serotonin Agents|serotonin agents|mesh-ancestor
92497314|NCT01996501|Olanzapine|olanzapine|mesh-list
92497315|NCT01996501|Antiemetics|antiemetics|mesh-ancestor
92497316|NCT01996501|Autonomic Agents|autonomic agents|mesh-ancestor
92497317|NCT01996501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497318|NCT01996501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497319|NCT01996501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497320|NCT01996501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92497321|NCT01996501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92497322|NCT01996501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497323|NCT01996501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497324|NCT01996501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92497325|NCT01996501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92497326|NCT01996501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497327|NCT01996501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497328|NCT01996501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497329|NCT01996501|Serotonin Agents|serotonin agents|mesh-ancestor
92497330|NCT01996579|Lactoferrin|lactoferrin|mesh-list
92497331|NCT01996579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497332|NCT01996618|Ranolazine|ranolazine|mesh-list
92497333|NCT01996618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92497334|NCT01996618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497335|NCT01996618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497337|NCT01996683|Deferoxamine|deferoxamine|mesh-list
92497338|NCT01996683|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92497339|NCT01996683|Chelating Agents|chelating agents|mesh-ancestor
92497340|NCT01996683|Sequestering Agents|sequestering agents|mesh-ancestor
92497341|NCT01996683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497342|NCT01996683|Siderophores|siderophores|mesh-ancestor
92497343|NCT01996696|Metformin|metformin|mesh-list
92497344|NCT01996696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92497345|NCT01996696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497346|NCT01996735|Ticagrelor|ticagrelor|mesh-list
92497347|NCT01996735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92497348|NCT01996735|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92497349|NCT01996735|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92497350|NCT01996735|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92497351|NCT01996735|Purinergic Agents|purinergic agents|mesh-ancestor
92497352|NCT01996735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497353|NCT01996735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497354|NCT01996735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497355|NCT01996761|Cerebrolysin|cerebrolysin|mesh-list
92497356|NCT01996761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92497357|NCT01996761|Protective Agents|protective agents|mesh-ancestor
92497358|NCT01996761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497359|NCT01996761|Nootropic Agents|nootropic agents|mesh-ancestor
92497360|NCT01996891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92497361|NCT01996930|Silver Nitrate|silver nitrate|mesh-list
92497362|NCT01996930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92497363|NCT01996930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497364|NCT01997099|Diazepam|diazepam|mesh-list
92497365|NCT01997099|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92497366|NCT01997099|Anticonvulsants|anticonvulsants|mesh-ancestor
92497367|NCT01997099|Antiemetics|antiemetics|mesh-ancestor
92497368|NCT01997099|Autonomic Agents|autonomic agents|mesh-ancestor
92497369|NCT01997099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497370|NCT01997099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497371|NCT01997099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497372|NCT01997099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92497373|NCT01997099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497374|NCT01997099|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92497375|NCT01997099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92497376|NCT01997099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92497377|NCT01997099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92497378|NCT01997099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497379|NCT01997099|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92497380|NCT01997099|Anesthetics, General|anesthetics, general|mesh-ancestor
92497381|NCT01997099|Anesthetics|anesthetics|mesh-ancestor
92497382|NCT01997099|GABA Modulators|gaba modulators|mesh-ancestor
92497383|NCT01997099|GABA Agents|gaba agents|mesh-ancestor
92497384|NCT01997099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497385|NCT01997099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497386|NCT01997112|Acetaminophen|acetaminophen|mesh-list
92497387|NCT01997112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497388|NCT01997112|Analgesics|analgesics|mesh-ancestor
92497389|NCT01997112|Sensory System Agents|sensory system agents|mesh-ancestor
92497390|NCT01997112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497391|NCT01997112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497392|NCT01997112|Antipyretics|antipyretics|mesh-ancestor
92497393|NCT01997138|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92497394|NCT01997138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497395|NCT01997164|Aflibercept|aflibercept|mesh-list
92497396|NCT01997164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92497397|NCT01997164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92497398|NCT01997164|Growth Substances|growth substances|mesh-ancestor
92497399|NCT01997164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497401|NCT01997164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497402|NCT01997190|Valacyclovir|valacyclovir|mesh-list
92497403|NCT01997190|Antiviral Agents|antiviral agents|mesh-ancestor
92497404|NCT01997190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497405|NCT01997203|Vitamin D|vitamin d|mesh-list
92497406|NCT01997203|Interferons|interferons|mesh-list
92497407|NCT01997203|Ribavirin|ribavirin|mesh-list
92497408|NCT01997203|Vitamins|vitamins|mesh-ancestor
92497409|NCT01997203|Micronutrients|micronutrients|mesh-ancestor
92497410|NCT01997203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497411|NCT01997203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92497412|NCT01997203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497413|NCT01997203|Antiviral Agents|antiviral agents|mesh-ancestor
92497414|NCT01997203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497415|NCT01997203|Antimetabolites|antimetabolites|mesh-ancestor
92497416|NCT01997203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497417|NCT01997255|Everolimus|everolimus|mesh-list
92497418|NCT01997255|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92497419|NCT01997255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92497420|NCT01997255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497421|NCT01997255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497422|NCT01997255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497423|NCT01997255|Immunologic Factors|immunologic factors|mesh-ancestor
92497424|NCT01997255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497425|NCT01997255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497426|NCT01997294|Atorvastatin|atorvastatin|mesh-list
92497427|NCT01997294|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92497428|NCT01997294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92497429|NCT01997294|Antimetabolites|antimetabolites|mesh-ancestor
92497430|NCT01997294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497431|NCT01997294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92497432|NCT01997294|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92497433|NCT01997294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497434|NCT01997580|Escitalopram|escitalopram|mesh-list
92497435|NCT01997580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92497436|NCT01997580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92497437|NCT01997580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497438|NCT01997580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497439|NCT01997580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497440|NCT01997580|Serotonin Agents|serotonin agents|mesh-ancestor
92497441|NCT01997580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497442|NCT01997593|Ropivacaine|ropivacaine|mesh-list
92497443|NCT01997593|Anesthetics, Local|anesthetics, local|mesh-ancestor
92497444|NCT01997593|Anesthetics|anesthetics|mesh-ancestor
92497445|NCT01997593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497446|NCT01997593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497447|NCT01997593|Sensory System Agents|sensory system agents|mesh-ancestor
92497448|NCT01997593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497449|NCT01997632|Vaccines|vaccines|mesh-list
92497450|NCT01997632|Immunologic Factors|immunologic factors|mesh-ancestor
92497451|NCT01997632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497452|NCT01997658|Methylprednisolone|methylprednisolone|mesh-list
92497453|NCT01997658|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92497454|NCT01997658|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92497455|NCT01997658|Prednisolone|prednisolone|mesh-list
92497456|NCT01997658|Prednisolone acetate|prednisolone acetate|mesh-list
92497457|NCT01997658|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92497458|NCT01997658|Prednisolone phosphate|prednisolone phosphate|mesh-list
92497459|NCT01997658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497460|NCT01997658|Antiemetics|antiemetics|mesh-ancestor
92497461|NCT01997658|Autonomic Agents|autonomic agents|mesh-ancestor
92497462|NCT01997658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497463|NCT01997658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497464|NCT01997658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497465|NCT01997658|Glucocorticoids|glucocorticoids|mesh-ancestor
92497466|NCT01997658|Hormones|hormones|mesh-ancestor
92497467|NCT01997658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497468|NCT01997658|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92497469|NCT01997658|Protective Agents|protective agents|mesh-ancestor
92497470|NCT01997658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92497471|NCT01997658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497472|NCT01997762|Resveratrol|resveratrol|mesh-list
92497473|NCT01997762|Antioxidants|antioxidants|mesh-ancestor
92497474|NCT01997762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497475|NCT01997762|Protective Agents|protective agents|mesh-ancestor
92497476|NCT01997762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497477|NCT01997762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497478|NCT01997762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92222373|NCT02185339|Rocuronium|rocuronium|mesh-list
92497479|NCT01997775|Metformin|metformin|mesh-list
92497480|NCT01997775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92497481|NCT01997775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497482|NCT01997788|Morphine|morphine|mesh-list
92497483|NCT01997788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497484|NCT01997788|Narcotics|narcotics|mesh-ancestor
92497485|NCT01997788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497486|NCT01997788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497487|NCT01997788|Analgesics|analgesics|mesh-ancestor
92497488|NCT01997788|Sensory System Agents|sensory system agents|mesh-ancestor
92497489|NCT01997788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497490|NCT01997801|Ketamine|ketamine|mesh-list
92497491|NCT01997801|Analgesics|analgesics|mesh-ancestor
92497492|NCT01997801|Sensory System Agents|sensory system agents|mesh-ancestor
92497493|NCT01997801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497494|NCT01997801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497495|NCT01997801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92497496|NCT01997801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92497497|NCT01997801|Anesthetics, General|anesthetics, general|mesh-ancestor
92497498|NCT01997801|Anesthetics|anesthetics|mesh-ancestor
92497499|NCT01997801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497500|NCT01997801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92497501|NCT01997801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92497502|NCT01997801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497503|NCT01997801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497504|NCT01997814|Immunologic Factors|immunologic factors|mesh-list
92497505|NCT01997814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92497506|NCT01997814|Immunomodulating Agents|immunomodulating agents|mesh-list
92497507|NCT01997814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497508|NCT01997879|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92497509|NCT01997879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92497510|NCT01997944|Interferons|interferons|mesh-list
92497511|NCT01997944|Interferon-alpha|interferon-alpha|mesh-list
92497512|NCT01997944|Interferon alpha-2|interferon alpha-2|mesh-list
92497513|NCT01997944|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92497514|NCT01997944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497515|NCT01997944|Antiviral Agents|antiviral agents|mesh-ancestor
92497516|NCT01997944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497517|NCT01997944|Immunologic Factors|immunologic factors|mesh-ancestor
92497518|NCT01997944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497519|NCT01997983|Botulinum Toxins|botulinum toxins|mesh-list
92497520|NCT01997983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92497521|NCT01997983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497522|NCT01997983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497523|NCT01997983|Cholinergic Agents|cholinergic agents|mesh-ancestor
92497524|NCT01997983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497525|NCT01997983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497526|NCT01998061|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92497527|NCT01998061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92497528|NCT01998061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497529|NCT01998061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497530|NCT01998113|Insulin|insulin|mesh-list
92497531|NCT01998113|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92497532|NCT01998113|Metformin|metformin|mesh-list
92497533|NCT01998113|Glyburide|glyburide|mesh-list
92497534|NCT01998113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92497535|NCT01998113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497536|NCT01998126|Nivolumab|nivolumab|mesh-list
92497537|NCT01998126|Ipilimumab|ipilimumab|mesh-list
92497538|NCT01998126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92497539|NCT01998126|Crizotinib|crizotinib|mesh-list
92497540|NCT01998126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92497541|NCT01998126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497542|NCT01998126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92497543|NCT01998126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497544|NCT01998126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92497545|NCT01998126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497546|NCT01998165|Remifentanil|remifentanil|mesh-list
92497547|NCT01998165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497548|NCT01998165|Narcotics|narcotics|mesh-ancestor
92497549|NCT01998165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497550|NCT01998165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497552|NCT01998165|Sensory System Agents|sensory system agents|mesh-ancestor
92497553|NCT01998165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497554|NCT01998217|Flurbiprofen|flurbiprofen|mesh-list
92497555|NCT01998217|Remifentanil|remifentanil|mesh-list
92497556|NCT01998217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497557|NCT01998217|Narcotics|narcotics|mesh-ancestor
92497558|NCT01998217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497559|NCT01998217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497560|NCT01998217|Analgesics|analgesics|mesh-ancestor
92497561|NCT01998217|Sensory System Agents|sensory system agents|mesh-ancestor
92497562|NCT01998217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497563|NCT01998217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497564|NCT01998217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497565|NCT01998217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497566|NCT01998217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497567|NCT01998217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92497568|NCT01998217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497569|NCT01998217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497570|NCT01998295|Lumefantrine|lumefantrine|mesh-list
92497571|NCT01998295|Artemether|artemether|mesh-list
92497572|NCT01998295|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92497573|NCT01998295|Antimalarials|antimalarials|mesh-ancestor
92497574|NCT01998295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92349669|NCT01469364|Aztreonam|aztreonam|mesh-list
92497575|NCT01998295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92497576|NCT01998295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497577|NCT01998308|Hyaluronic Acid|hyaluronic acid|mesh-list
92497578|NCT01998308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92497579|NCT01998308|Immunologic Factors|immunologic factors|mesh-ancestor
92497580|NCT01998308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497581|NCT01998308|Viscosupplements|viscosupplements|mesh-ancestor
92497582|NCT01998308|Protective Agents|protective agents|mesh-ancestor
92497583|NCT01998347|Paclitaxel|paclitaxel|mesh-list
92497584|NCT01998347|Fluorouracil|fluorouracil|mesh-list
92497585|NCT01998347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92497586|NCT01998347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497587|NCT01998347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92497588|NCT01998347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92497589|NCT01998347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92497590|NCT01998347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497591|NCT01998347|Antimetabolites|antimetabolites|mesh-ancestor
92497592|NCT01998347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92497593|NCT01998347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497594|NCT01998347|Immunologic Factors|immunologic factors|mesh-ancestor
92497595|NCT01998347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497596|NCT01998386|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92497597|NCT01998386|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92497598|NCT01998386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497599|NCT01998451|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92497600|NCT01998451|Antiviral Agents|antiviral agents|mesh-ancestor
92497601|NCT01998451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497602|NCT01998451|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92497603|NCT01998451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497604|NCT01998503|Dexamethasone|dexamethasone|mesh-list
92497605|NCT01998503|Bortezomib|bortezomib|mesh-list
92497606|NCT01998503|Melphalan|melphalan|mesh-list
92497607|NCT01998503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497608|NCT01998503|Antiemetics|antiemetics|mesh-ancestor
92497609|NCT01998503|Autonomic Agents|autonomic agents|mesh-ancestor
92497610|NCT01998503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497611|NCT01998503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497612|NCT01998503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497613|NCT01998503|Glucocorticoids|glucocorticoids|mesh-ancestor
92497614|NCT01998503|Hormones|hormones|mesh-ancestor
92497615|NCT01998503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497616|NCT01998503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92497617|NCT01998503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497618|NCT01998503|Immunologic Factors|immunologic factors|mesh-ancestor
92497619|NCT01998503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92497620|NCT01998503|Alkylating Agents|alkylating agents|mesh-ancestor
92497621|NCT01998503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497622|NCT01998503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92497623|NCT01998503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497624|NCT01998685|Fentanyl|fentanyl|mesh-list
92497625|NCT01998685|Midazolam|midazolam|mesh-list
92497626|NCT01998685|Remifentanil|remifentanil|mesh-list
92497628|NCT01998685|Sevoflurane|sevoflurane|mesh-list
92497629|NCT01998685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92497630|NCT01998685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497631|NCT01998685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497632|NCT01998685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92497633|NCT01998685|Anesthetics, General|anesthetics, general|mesh-ancestor
92497634|NCT01998685|Anesthetics|anesthetics|mesh-ancestor
92497635|NCT01998685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497636|NCT01998685|Narcotics|narcotics|mesh-ancestor
92497637|NCT01998685|Analgesics|analgesics|mesh-ancestor
92497638|NCT01998685|Sensory System Agents|sensory system agents|mesh-ancestor
92497639|NCT01998685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497640|NCT01998685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92497641|NCT01998685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92497642|NCT01998685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92497643|NCT01998685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497644|NCT01998685|GABA Modulators|gaba modulators|mesh-ancestor
92497645|NCT01998685|GABA Agents|gaba agents|mesh-ancestor
92497646|NCT01998685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497647|NCT01998685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497648|NCT01998685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92497649|NCT01998685|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92497650|NCT01998698|Lidocaine|lidocaine|mesh-list
92497651|NCT01998698|Dipivefrin|dipivefrin|mesh-list
92497652|NCT01998698|Hyaluronic Acid|hyaluronic acid|mesh-list
92497653|NCT01998698|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92497654|NCT01998698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92497655|NCT01998698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497656|NCT01998698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497657|NCT01998698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497658|NCT01998698|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92497659|NCT01998698|Immunologic Factors|immunologic factors|mesh-ancestor
92497660|NCT01998698|Viscosupplements|viscosupplements|mesh-ancestor
92497661|NCT01998698|Protective Agents|protective agents|mesh-ancestor
92497662|NCT01998698|Anesthetics, Local|anesthetics, local|mesh-ancestor
92497663|NCT01998698|Anesthetics|anesthetics|mesh-ancestor
92497664|NCT01998698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497665|NCT01998698|Sensory System Agents|sensory system agents|mesh-ancestor
92497666|NCT01998698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497667|NCT01998698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92497668|NCT01998698|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92497669|NCT01998698|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92497670|NCT01998698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497671|NCT01998763|Vitamin D|vitamin d|mesh-list
92497672|NCT01998763|Cholecalciferol|cholecalciferol|mesh-list
92497673|NCT01998763|Vitamins|vitamins|mesh-ancestor
92497674|NCT01998763|Micronutrients|micronutrients|mesh-ancestor
92497675|NCT01998763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497676|NCT01998763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92497677|NCT01998763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92497678|NCT01998776|Misoprostol|misoprostol|mesh-list
92497679|NCT01998776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92497680|NCT01998776|Abortifacient Agents|abortifacient agents|mesh-ancestor
92497681|NCT01998776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92497682|NCT01998776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497683|NCT01998776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92497684|NCT01998776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92497685|NCT01998776|Oxytocics|oxytocics|mesh-ancestor
92497686|NCT01998789|Everolimus|everolimus|mesh-list
92497687|NCT01998789|Tacrolimus|tacrolimus|mesh-list
92497688|NCT01998789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497689|NCT01998789|Immunologic Factors|immunologic factors|mesh-ancestor
92497690|NCT01998789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497691|NCT01998789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92497692|NCT01998789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497693|NCT01998789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497694|NCT01998789|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92497695|NCT01998789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92497696|NCT01998789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497697|NCT01999153|Ropivacaine|ropivacaine|mesh-list
92497698|NCT01999153|Anesthetics, Local|anesthetics, local|mesh-ancestor
92497699|NCT01999153|Anesthetics|anesthetics|mesh-ancestor
92497700|NCT01999153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497701|NCT01999153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497702|NCT01999153|Sensory System Agents|sensory system agents|mesh-ancestor
92497703|NCT01999153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497704|NCT01999270|Bevacizumab|bevacizumab|mesh-list
92497705|NCT01999270|Irinotecan|irinotecan|mesh-list
92497706|NCT01999270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92497707|NCT01999270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497708|NCT01999270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92497709|NCT01999270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92497710|NCT01999270|Growth Substances|growth substances|mesh-ancestor
92497711|NCT01999270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497712|NCT01999270|Growth Inhibitors|growth inhibitors|mesh-ancestor
92497713|NCT01999270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92497714|NCT01999270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92497715|NCT01999270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497716|NCT01999270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497717|NCT01999309|Simvastatin|simvastatin|mesh-list
92497718|NCT01999309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92497719|NCT01999309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92497720|NCT01999309|Antimetabolites|antimetabolites|mesh-ancestor
92497721|NCT01999309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497722|NCT01999309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92532751|NCT05527704|Autonomic Agents|autonomic agents|mesh-ancestor
92497723|NCT01999309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92497724|NCT01999309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497725|NCT01999413|Cytarabine|cytarabine|mesh-list
92497726|NCT01999413|Daunorubicin|daunorubicin|mesh-list
92497727|NCT01999413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92497728|NCT01999413|Antimetabolites|antimetabolites|mesh-ancestor
92497729|NCT01999413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497730|NCT01999413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497731|NCT01999413|Antiviral Agents|antiviral agents|mesh-ancestor
92497732|NCT01999413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497733|NCT01999413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92497734|NCT01999413|Immunologic Factors|immunologic factors|mesh-ancestor
92497735|NCT01999413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497736|NCT01999413|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92497737|NCT01999413|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92497738|NCT01999413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92497739|NCT01999413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497740|NCT01999647|Ropivacaine|ropivacaine|mesh-list
92497741|NCT01999647|Anesthetics, Local|anesthetics, local|mesh-list
92497742|NCT01999647|Anesthetics|anesthetics|mesh-list
92497743|NCT01999647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497744|NCT01999647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497745|NCT01999647|Sensory System Agents|sensory system agents|mesh-ancestor
92497746|NCT01999647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497747|NCT01999673|Docetaxel|docetaxel|mesh-list
92497748|NCT01999673|Bavituximab|bavituximab|mesh-list
92497749|NCT01999673|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92497750|NCT01999673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497751|NCT01999673|Tubulin Modulators|tubulin modulators|mesh-ancestor
92497752|NCT01999673|Antimitotic Agents|antimitotic agents|mesh-ancestor
92497753|NCT01999673|Mitosis Modulators|mitosis modulators|mesh-ancestor
92497754|NCT01999673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497755|NCT01999673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92497756|NCT01999673|Immunologic Factors|immunologic factors|mesh-ancestor
92497757|NCT01999673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497758|NCT01999686|Metformin|metformin|mesh-list
92497760|NCT01999686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497761|NCT01999738|Folic Acid|folic acid|mesh-list
92497762|NCT01999738|Hematinics|hematinics|mesh-ancestor
92497763|NCT01999738|Vitamin B Complex|vitamin b complex|mesh-ancestor
92497764|NCT01999738|Vitamins|vitamins|mesh-ancestor
92497765|NCT01999738|Micronutrients|micronutrients|mesh-ancestor
92497766|NCT01999738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497767|NCT01999829|Caffeine|caffeine|mesh-list
92497768|NCT01999829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497769|NCT01999829|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92497770|NCT01999829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497771|NCT01999829|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92497772|NCT01999829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497773|NCT01999829|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92497774|NCT01999829|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92497775|NCT01999829|Purinergic Agents|purinergic agents|mesh-ancestor
92497776|NCT01999829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497777|NCT01999842|Vaccines|vaccines|mesh-list
92497778|NCT01999842|Immunologic Factors|immunologic factors|mesh-ancestor
92497779|NCT01999842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497780|NCT01999907|Vitamin D|vitamin d|mesh-list
92497781|NCT01999907|Ergocalciferols|ergocalciferols|mesh-list
92497782|NCT01999907|Cholecalciferol|cholecalciferol|mesh-list
92497783|NCT01999907|Vitamins|vitamins|mesh-list
92497784|NCT01999907|Micronutrients|micronutrients|mesh-ancestor
92497785|NCT01999907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497786|NCT01999907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92497787|NCT01999907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92497789|NCT01999933|Docetaxel|docetaxel|mesh-list
92497790|NCT01999933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497791|NCT01999933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92497792|NCT01999933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92497793|NCT01999933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92497794|NCT01999933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497795|NCT02000102|Aflibercept|aflibercept|mesh-list
92497796|NCT02000102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92497797|NCT02000102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92497798|NCT02000102|Growth Substances|growth substances|mesh-ancestor
92497799|NCT02000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497800|NCT02000102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92497801|NCT02000102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497803|NCT02000193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92497804|NCT02000193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497805|NCT02000193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92497806|NCT02000193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92497807|NCT02000193|Hormone Antagonists|hormone antagonists|mesh-ancestor
92497808|NCT02000193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497809|NCT02000193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497810|NCT02000206|Ketamine|ketamine|mesh-list
92497811|NCT02000206|Alfentanil|alfentanil|mesh-list
92497812|NCT02000206|Propofol|propofol|mesh-list
92497813|NCT02000206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92497814|NCT02000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497815|NCT02000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497816|NCT02000206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92497817|NCT02000206|Anesthetics, General|anesthetics, general|mesh-ancestor
92497818|NCT02000206|Anesthetics|anesthetics|mesh-ancestor
92497819|NCT02000206|Analgesics|analgesics|mesh-ancestor
92497820|NCT02000206|Sensory System Agents|sensory system agents|mesh-ancestor
92497821|NCT02000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497822|NCT02000206|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92497823|NCT02000206|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92497824|NCT02000206|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92497825|NCT02000206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497826|NCT02000206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497827|NCT02000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497828|NCT02000206|Narcotics|narcotics|mesh-ancestor
92497829|NCT02000336|Prednisolone|prednisolone|mesh-list
92497830|NCT02000336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497831|NCT02000336|Glucocorticoids|glucocorticoids|mesh-ancestor
92497832|NCT02000336|Hormones|hormones|mesh-ancestor
92497833|NCT02000336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92497834|NCT02000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497835|NCT02000336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92497836|NCT02000336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497837|NCT02000375|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92497838|NCT02000375|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92497839|NCT02000375|Immunologic Factors|immunologic factors|mesh-ancestor
92497840|NCT02000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497841|NCT02000388|Ketorolac|ketorolac|mesh-list
92497842|NCT02000388|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92497843|NCT02000388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497844|NCT02000388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497845|NCT02000388|Analgesics|analgesics|mesh-ancestor
92497846|NCT02000388|Sensory System Agents|sensory system agents|mesh-ancestor
92497847|NCT02000388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497848|NCT02000388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497849|NCT02000388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497850|NCT02000388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497851|NCT02000388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92497852|NCT02000388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497853|NCT02000388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497854|NCT02000401|Ketorolac|ketorolac|mesh-list
92497855|NCT02000401|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92497856|NCT02000401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497857|NCT02000401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497858|NCT02000401|Analgesics|analgesics|mesh-ancestor
92497859|NCT02000401|Sensory System Agents|sensory system agents|mesh-ancestor
92497860|NCT02000401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497861|NCT02000401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497862|NCT02000401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497863|NCT02000401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497864|NCT02000401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92497865|NCT02000401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497866|NCT02000401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497867|NCT02000414|Daptomycin|daptomycin|mesh-list
92497868|NCT02000414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92497869|NCT02000414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497871|NCT02000674|Succinylcholine|succinylcholine|mesh-list
92497872|NCT02000674|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92497873|NCT02000674|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92497874|NCT02000674|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92497875|NCT02000674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497876|NCT02000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497877|NCT02000674|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92497878|NCT02000700|Canagliflozin|canagliflozin|mesh-list
92497879|NCT02000700|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92497880|NCT02000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497881|NCT02000700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92497882|NCT02000700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497883|NCT02000726|Antidepressive Agents|antidepressive agents|mesh-list
92497884|NCT02000726|Citalopram|citalopram|mesh-list
92497885|NCT02000726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92497886|NCT02000726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92497887|NCT02000726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92497888|NCT02000726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497889|NCT02000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497890|NCT02000726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497891|NCT02000726|Serotonin Agents|serotonin agents|mesh-ancestor
92497892|NCT02000726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497893|NCT02000726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92497894|NCT02000765|Gepotidacin|gepotidacin|mesh-list
92497895|NCT02000765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92497896|NCT02000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497897|NCT02000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497898|NCT02000765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497899|NCT02000804|Darapladib|darapladib|mesh-list
92497900|NCT02000804|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92497901|NCT02000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497902|NCT02000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497903|NCT02000830|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92497904|NCT02000830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497905|NCT02000830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497907|NCT02000947|Tremelimumab|tremelimumab|mesh-list
92497908|NCT02000947|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92497909|NCT02000947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92497910|NCT02000947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497911|NCT02000947|Immunologic Factors|immunologic factors|mesh-ancestor
92497912|NCT02000947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497913|NCT02001012|Lumefantrine|lumefantrine|mesh-list
92497914|NCT02001012|Chloroquine|chloroquine|mesh-list
92497915|NCT02001012|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92497916|NCT02001012|Artemether|artemether|mesh-list
92497917|NCT02001012|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92497918|NCT02001012|Antimalarials|antimalarials|mesh-ancestor
92497919|NCT02001012|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92497920|NCT02001012|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92497921|NCT02001012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92497922|NCT02001012|Amebicides|amebicides|mesh-ancestor
92497923|NCT02001012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92497924|NCT02001012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92497925|NCT02001012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92497926|NCT02001012|Analgesics|analgesics|mesh-ancestor
92497927|NCT02001012|Sensory System Agents|sensory system agents|mesh-ancestor
92497928|NCT02001012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497929|NCT02001012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497930|NCT02001012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497931|NCT02001012|Filaricides|filaricides|mesh-ancestor
92497932|NCT02001012|Antinematodal Agents|antinematodal agents|mesh-ancestor
92497933|NCT02001012|Anthelmintics|anthelmintics|mesh-ancestor
92497934|NCT02001103|Memantine|memantine|mesh-list
92497935|NCT02001103|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92497936|NCT02001103|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92497937|NCT02001103|Dopamine Agents|dopamine agents|mesh-ancestor
92497938|NCT02001103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92497939|NCT02001103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497940|NCT02001103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497941|NCT02001103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92497942|NCT02001103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92497943|NCT02001168|Docetaxel|docetaxel|mesh-list
92497944|NCT02001168|Pemetrexed|pemetrexed|mesh-list
92497945|NCT02001168|Cisplatin|cisplatin|mesh-list
92497946|NCT02001168|Endostatins|endostatins|mesh-list
92497947|NCT02001168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497948|NCT02001168|Tubulin Modulators|tubulin modulators|mesh-ancestor
92497949|NCT02001168|Antimitotic Agents|antimitotic agents|mesh-ancestor
92497950|NCT02001168|Mitosis Modulators|mitosis modulators|mesh-ancestor
92497951|NCT02001168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497952|NCT02001168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92497953|NCT02001168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92497954|NCT02001168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92497955|NCT02001168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92497956|NCT02001168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92497957|NCT02001168|Growth Substances|growth substances|mesh-ancestor
92497958|NCT02001168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497959|NCT02001168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92497960|NCT02001207|Hydrocortisone|hydrocortisone|mesh-list
92497961|NCT02001207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92497962|NCT02001259|Lidocaine|lidocaine|mesh-list
92497963|NCT02001259|Anesthetics, Local|anesthetics, local|mesh-ancestor
92497964|NCT02001259|Anesthetics|anesthetics|mesh-ancestor
92497965|NCT02001259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497966|NCT02001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497967|NCT02001259|Sensory System Agents|sensory system agents|mesh-ancestor
92497968|NCT02001259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497969|NCT02001259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92497970|NCT02001259|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92497971|NCT02001259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92497972|NCT02001259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92497973|NCT02001259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497974|NCT02001272|Paclitaxel|paclitaxel|mesh-list
92497975|NCT02001272|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92497976|NCT02001272|Carboplatin|carboplatin|mesh-list
92497977|NCT02001272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92497978|NCT02001272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92497979|NCT02001272|Tubulin Modulators|tubulin modulators|mesh-ancestor
92497980|NCT02001272|Antimitotic Agents|antimitotic agents|mesh-ancestor
92497981|NCT02001272|Mitosis Modulators|mitosis modulators|mesh-ancestor
92497982|NCT02001272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92497984|NCT02001285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497985|NCT02001285|Narcotics|narcotics|mesh-ancestor
92497986|NCT02001285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497987|NCT02001285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497988|NCT02001285|Analgesics|analgesics|mesh-ancestor
92497989|NCT02001285|Sensory System Agents|sensory system agents|mesh-ancestor
92497990|NCT02001285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92497991|NCT02001298|Nitroprusside|nitroprusside|mesh-list
92497992|NCT02001298|Remifentanil|remifentanil|mesh-list
92497993|NCT02001298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92497994|NCT02001298|Narcotics|narcotics|mesh-ancestor
92497995|NCT02001298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92497996|NCT02001298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92497997|NCT02001298|Analgesics|analgesics|mesh-ancestor
92497998|NCT02001298|Sensory System Agents|sensory system agents|mesh-ancestor
92497999|NCT02001298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498000|NCT02001298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92498001|NCT02001298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92498002|NCT02001298|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92498003|NCT02001298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498004|NCT02001311|Chlorhexidine|chlorhexidine|mesh-list
92498005|NCT02001311|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92498006|NCT02001311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92498007|NCT02001311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498008|NCT02001311|Disinfectants|disinfectants|mesh-ancestor
92498009|NCT02001311|Dermatologic Agents|dermatologic agents|mesh-ancestor
92498010|NCT02001363|Liraglutide|liraglutide|mesh-list
92498011|NCT02001363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92498012|NCT02001363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498013|NCT02001363|Incretins|incretins|mesh-ancestor
92498014|NCT02001363|Hormones|hormones|mesh-ancestor
92498015|NCT02001363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498016|NCT02001428|Piperaquine|piperaquine|mesh-list
92498017|NCT02001428|Artenimol|artenimol|mesh-list
92498018|NCT02001428|Antimalarials|antimalarials|mesh-ancestor
92498019|NCT02001428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92498020|NCT02001428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92498021|NCT02001428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498022|NCT02001506|Docetaxel|docetaxel|mesh-list
92498023|NCT02001506|Epirubicin|epirubicin|mesh-list
92498024|NCT02001506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498025|NCT02001506|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498026|NCT02001506|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498027|NCT02001506|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498028|NCT02001506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498029|NCT02001506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92498030|NCT02001506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92498031|NCT02001506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92498032|NCT02001506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498033|NCT02001571|Abiraterone Acetate|abiraterone acetate|mesh-list
92498034|NCT02001571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498035|NCT02001571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92498036|NCT02001571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498037|NCT02001571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498038|NCT02001571|Hormone Antagonists|hormone antagonists|mesh-ancestor
92498039|NCT02001571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498040|NCT02001571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498041|NCT02001571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92498042|NCT02001584|Memantine|memantine|mesh-list
92498043|NCT02001584|Baclofen|baclofen|mesh-list
92498044|NCT02001584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92498045|NCT02001584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92498046|NCT02001584|Dopamine Agents|dopamine agents|mesh-ancestor
92498047|NCT02001584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498048|NCT02001584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498049|NCT02001584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498050|NCT02001584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92498051|NCT02001584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92498052|NCT02001584|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92498053|NCT02001584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92498054|NCT02001584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498055|NCT02001584|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92498056|NCT02001584|GABA Agonists|gaba agonists|mesh-ancestor
92498058|NCT02001740|Lidocaine|lidocaine|mesh-list
92498059|NCT02001740|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498060|NCT02001740|Anesthetics|anesthetics|mesh-ancestor
92498061|NCT02001740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498062|NCT02001740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498063|NCT02001740|Sensory System Agents|sensory system agents|mesh-ancestor
92498064|NCT02001740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498065|NCT02001740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92498066|NCT02001740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92498067|NCT02001740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92498068|NCT02001740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498069|NCT02001740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498070|NCT02001857|Hemostatics|hemostatics|mesh-list
92498071|NCT02001857|Coagulants|coagulants|mesh-ancestor
92498072|NCT02001883|Policosanol|policosanol|mesh-list
92498073|NCT02001883|Atorvastatin|atorvastatin|mesh-list
92498074|NCT02001883|Simvastatin|simvastatin|mesh-list
92498075|NCT02001883|Red yeast rice|red yeast rice|mesh-list
92498076|NCT02001883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92498077|NCT02001883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92498078|NCT02001883|Antimetabolites|antimetabolites|mesh-ancestor
92498079|NCT02001883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498080|NCT02001883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92498081|NCT02001883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92498082|NCT02001883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498083|NCT02001883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92498085|NCT02001896|Gemcitabine|gemcitabine|mesh-list
92498086|NCT02001896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92498087|NCT02001896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498088|NCT02001896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498090|NCT02001896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498091|NCT02001896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92498092|NCT02001896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498093|NCT02001909|Neomycin|neomycin|mesh-list
92498094|NCT02001909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92498095|NCT02001909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498096|NCT02001909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92498097|NCT02001909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498098|NCT02001909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498099|NCT02001935|Theophylline|theophylline|mesh-list
92498100|NCT02001935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92498101|NCT02001935|Autonomic Agents|autonomic agents|mesh-ancestor
92498102|NCT02001935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498103|NCT02001935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498104|NCT02001935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92498105|NCT02001935|Respiratory System Agents|respiratory system agents|mesh-ancestor
92498106|NCT02001935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92498107|NCT02001935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498108|NCT02001935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498109|NCT02001935|Vasodilator Agents|vasodilator agents|mesh-ancestor
92498110|NCT02001935|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92498111|NCT02001935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92498112|NCT02001935|Purinergic Agents|purinergic agents|mesh-ancestor
92498113|NCT02001935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498114|NCT02001948|Morphine|morphine|mesh-list
92498115|NCT02001948|Bupivacaine|bupivacaine|mesh-list
92498116|NCT02001948|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498117|NCT02001948|Anesthetics|anesthetics|mesh-ancestor
92498118|NCT02001948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498119|NCT02001948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498120|NCT02001948|Sensory System Agents|sensory system agents|mesh-ancestor
92498121|NCT02001948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498122|NCT02001948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92498123|NCT02001948|Narcotics|narcotics|mesh-ancestor
92498124|NCT02001948|Analgesics|analgesics|mesh-ancestor
92498125|NCT02001974|Paclitaxel|paclitaxel|mesh-list
92498126|NCT02001974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92498127|NCT02001974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498128|NCT02001974|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498129|NCT02001974|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498130|NCT02001974|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498131|NCT02001974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498132|NCT02002000|Vitamin D|vitamin d|mesh-list
92498133|NCT02002000|Cholecalciferol|cholecalciferol|mesh-list
92498134|NCT02002000|Vitamins|vitamins|mesh-ancestor
92498135|NCT02002000|Micronutrients|micronutrients|mesh-ancestor
92498136|NCT02002000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498137|NCT02002000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92498138|NCT02002000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92498139|NCT02002039|Epoetin Alfa|epoetin alfa|mesh-list
92498140|NCT02002039|Hematinics|hematinics|mesh-ancestor
92498141|NCT02002065|Vaccines|vaccines|mesh-list
92498142|NCT02002065|Immunologic Factors|immunologic factors|mesh-ancestor
92498143|NCT02002065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498144|NCT02002078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92498145|NCT02002078|Methylprednisolone|methylprednisolone|mesh-list
92498146|NCT02002078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92498147|NCT02002078|Prednisolone|prednisolone|mesh-list
92498148|NCT02002078|Prednisolone acetate|prednisolone acetate|mesh-list
92498149|NCT02002078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92498150|NCT02002078|Prednisolone phosphate|prednisolone phosphate|mesh-list
92498151|NCT02002078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498152|NCT02002078|Antiemetics|antiemetics|mesh-ancestor
92498153|NCT02002078|Autonomic Agents|autonomic agents|mesh-ancestor
92498154|NCT02002078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498155|NCT02002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498156|NCT02002078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498157|NCT02002078|Glucocorticoids|glucocorticoids|mesh-ancestor
92498158|NCT02002078|Hormones|hormones|mesh-ancestor
92498159|NCT02002078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498160|NCT02002078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92498161|NCT02002078|Protective Agents|protective agents|mesh-ancestor
92498162|NCT02002078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92498163|NCT02002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498164|NCT02002156|Vaccines|vaccines|mesh-list
92498165|NCT02002156|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92498166|NCT02002156|BCG Vaccine|bcg vaccine|mesh-list
92498167|NCT02002156|Immunologic Factors|immunologic factors|mesh-ancestor
92498168|NCT02002156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498169|NCT02002156|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92498170|NCT02002195|Leucovorin|leucovorin|mesh-list
92498171|NCT02002195|Fluorouracil|fluorouracil|mesh-list
92498172|NCT02002195|Capecitabine|capecitabine|mesh-list
92498173|NCT02002195|Oxaliplatin|oxaliplatin|mesh-list
92498174|NCT02002195|Antimetabolites|antimetabolites|mesh-ancestor
92498175|NCT02002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498176|NCT02002195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498177|NCT02002195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498178|NCT02002195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498179|NCT02002195|Immunologic Factors|immunologic factors|mesh-ancestor
92498180|NCT02002195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498181|NCT02002195|Antidotes|antidotes|mesh-ancestor
92498182|NCT02002195|Protective Agents|protective agents|mesh-ancestor
92498183|NCT02002195|Vitamin B Complex|vitamin b complex|mesh-ancestor
92498184|NCT02002195|Vitamins|vitamins|mesh-ancestor
92498185|NCT02002195|Micronutrients|micronutrients|mesh-ancestor
92498186|NCT02002247|Selenium|selenium|mesh-list
92498187|NCT02002247|Selenious Acid|selenious acid|mesh-list
92498188|NCT02002247|Sodium Selenite|sodium selenite|mesh-list
92498189|NCT02002247|Antioxidants|antioxidants|mesh-ancestor
92498190|NCT02002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498191|NCT02002247|Protective Agents|protective agents|mesh-ancestor
92498192|NCT02002247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498193|NCT02002247|Trace Elements|trace elements|mesh-ancestor
92498194|NCT02002247|Micronutrients|micronutrients|mesh-ancestor
92498195|NCT02002260|Levonorgestrel|levonorgestrel|mesh-list
92498196|NCT02002260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92498197|NCT02002260|Contraceptive Agents|contraceptive agents|mesh-list
92498198|NCT02002260|Contraceptives, Oral|contraceptives, oral|mesh-list
92498199|NCT02002260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92498200|NCT02002260|Estradiol|estradiol|mesh-list
92498201|NCT02002260|Estrogens|estrogens|mesh-ancestor
92498202|NCT02002260|Hormones|hormones|mesh-ancestor
92498203|NCT02002260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498204|NCT02002260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498205|NCT02002260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92498206|NCT02002260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92498207|NCT02002260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92498208|NCT02002260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92498209|NCT02002260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92498210|NCT02002286|Triptolide|triptolide|mesh-list
92498211|NCT02002286|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92498212|NCT02002286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498213|NCT02002286|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92498214|NCT02002286|Contraceptive Agents|contraceptive agents|mesh-ancestor
92498215|NCT02002286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92498216|NCT02002286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498217|NCT02002286|Immunologic Factors|immunologic factors|mesh-ancestor
92498218|NCT02002286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92498219|NCT02002286|Alkylating Agents|alkylating agents|mesh-ancestor
92498220|NCT02002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498221|NCT02002286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498222|NCT02002312|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92498223|NCT02002312|Chelating Agents|chelating agents|mesh-ancestor
92498224|NCT02002312|Sequestering Agents|sequestering agents|mesh-ancestor
92498225|NCT02002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498226|NCT02002325|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92498227|NCT02002325|Plasminogen|plasminogen|mesh-list
92498228|NCT02002325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92498229|NCT02002325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92498230|NCT02002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498231|NCT02002377|Aflibercept|aflibercept|mesh-list
92498232|NCT02002377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92498233|NCT02002377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92498234|NCT02002377|Growth Substances|growth substances|mesh-ancestor
92223126|NCT02338076|Petrolatum|petrolatum|mesh-list
92498235|NCT02002377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498236|NCT02002377|Growth Inhibitors|growth inhibitors|mesh-ancestor
92498237|NCT02002377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498238|NCT02002390|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92498239|NCT02002390|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92498240|NCT02002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498241|NCT02002390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498242|NCT02002390|Immunologic Factors|immunologic factors|mesh-ancestor
92498243|NCT02002390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498244|NCT02002403|Danazol|danazol|mesh-list
92498245|NCT02002403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92498246|NCT02002403|Hormone Antagonists|hormone antagonists|mesh-ancestor
92498247|NCT02002403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498248|NCT02002403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498249|NCT02002442|Chlorhexidine|chlorhexidine|mesh-list
92498250|NCT02002442|Cetylpyridinium|cetylpyridinium|mesh-list
92498251|NCT02002442|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92498252|NCT02002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498253|NCT02002442|Disinfectants|disinfectants|mesh-ancestor
92498254|NCT02002598|Dexamethasone|dexamethasone|mesh-list
92498255|NCT02002598|Dexamethasone acetate|dexamethasone acetate|mesh-list
92498256|NCT02002598|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92498257|NCT02002598|BB 1101|bb 1101|mesh-list
92498258|NCT02002598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498259|NCT02002598|Antiemetics|antiemetics|mesh-ancestor
92498260|NCT02002598|Autonomic Agents|autonomic agents|mesh-ancestor
92498261|NCT02002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498262|NCT02002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498263|NCT02002598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498264|NCT02002598|Glucocorticoids|glucocorticoids|mesh-ancestor
92498265|NCT02002598|Hormones|hormones|mesh-ancestor
92498266|NCT02002598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498267|NCT02002598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92498268|NCT02002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498269|NCT02002598|Protease Inhibitors|protease inhibitors|mesh-ancestor
92498270|NCT02002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498271|NCT02002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498272|NCT02002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92498273|NCT02002598|Alkylating Agents|alkylating agents|mesh-ancestor
92498274|NCT02002611|Warfarin|warfarin|mesh-list
92498275|NCT02002611|Anticoagulants|anticoagulants|mesh-ancestor
92498276|NCT02002663|Methylprednisolone|methylprednisolone|mesh-list
92498277|NCT02002663|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92498278|NCT02002663|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92498279|NCT02002663|Prednisolone|prednisolone|mesh-list
92498280|NCT02002663|Prednisolone acetate|prednisolone acetate|mesh-list
92498281|NCT02002663|Morphine|morphine|mesh-list
92498282|NCT02002663|Ropivacaine|ropivacaine|mesh-list
92498283|NCT02002663|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92498284|NCT02002663|Prednisolone phosphate|prednisolone phosphate|mesh-list
92498285|NCT02002663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92498286|NCT02002663|Narcotics|narcotics|mesh-ancestor
92498287|NCT02002663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498288|NCT02002663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498289|NCT02002663|Analgesics|analgesics|mesh-ancestor
92498290|NCT02002663|Sensory System Agents|sensory system agents|mesh-ancestor
92498291|NCT02002663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498292|NCT02002663|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498293|NCT02002663|Anesthetics|anesthetics|mesh-ancestor
92498294|NCT02002663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498295|NCT02002663|Antiemetics|antiemetics|mesh-ancestor
92498296|NCT02002663|Autonomic Agents|autonomic agents|mesh-ancestor
92498297|NCT02002663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498298|NCT02002663|Glucocorticoids|glucocorticoids|mesh-ancestor
92498299|NCT02002663|Hormones|hormones|mesh-ancestor
92498300|NCT02002663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498301|NCT02002663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92498302|NCT02002663|Protective Agents|protective agents|mesh-ancestor
92498303|NCT02002663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92498304|NCT02002663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498305|NCT02002715|Budesonide|budesonide|mesh-list
92498306|NCT02002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498307|NCT02002715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92498308|NCT02002715|Autonomic Agents|autonomic agents|mesh-ancestor
92498309|NCT02002715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498310|NCT02002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498311|NCT02002715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92498312|NCT02002715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92498313|NCT02002715|Glucocorticoids|glucocorticoids|mesh-ancestor
92498314|NCT02002715|Hormones|hormones|mesh-ancestor
92498315|NCT02002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498316|NCT02002741|Acetaminophen|acetaminophen|mesh-list
92498317|NCT02002741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498318|NCT02002741|Analgesics|analgesics|mesh-ancestor
92498319|NCT02002741|Sensory System Agents|sensory system agents|mesh-ancestor
92498320|NCT02002741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498321|NCT02002741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498322|NCT02002741|Antipyretics|antipyretics|mesh-ancestor
92498323|NCT02002754|Bambuterol|bambuterol|mesh-list
92498324|NCT02002754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92498325|NCT02002754|Autonomic Agents|autonomic agents|mesh-ancestor
92498326|NCT02002754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498327|NCT02002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498328|NCT02002754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92498329|NCT02002754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92498330|NCT02002806|Ethanol|ethanol|mesh-list
92498331|NCT02002806|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92498332|NCT02002806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498333|NCT02002806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498334|NCT02002806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498335|NCT02002858|Nicotine|nicotine|mesh-list
92498336|NCT02002858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92498337|NCT02002858|Autonomic Agents|autonomic agents|mesh-ancestor
92498338|NCT02002858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498339|NCT02002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498340|NCT02002858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92498341|NCT02002858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92498342|NCT02002858|Cholinergic Agents|cholinergic agents|mesh-ancestor
92498343|NCT02002858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498344|NCT02002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498345|NCT02002923|Botulinum Toxins|botulinum toxins|mesh-list
92498346|NCT02002923|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92498347|NCT02002923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498348|NCT02002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498349|NCT02002923|Cholinergic Agents|cholinergic agents|mesh-ancestor
92498350|NCT02002923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498351|NCT02002923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498352|NCT02002962|Botulinum Toxins|botulinum toxins|mesh-list
92498353|NCT02002962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92498354|NCT02002962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92498355|NCT02002962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92498356|NCT02002962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498357|NCT02002962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498358|NCT02002962|Cholinergic Agents|cholinergic agents|mesh-ancestor
92498359|NCT02002962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498360|NCT02002962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498361|NCT02002962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92498362|NCT02002962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498363|NCT02003001|Botulinum Toxins|botulinum toxins|mesh-list
92498364|NCT02003001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92498365|NCT02003001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498366|NCT02003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498367|NCT02003001|Cholinergic Agents|cholinergic agents|mesh-ancestor
92498368|NCT02003001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498369|NCT02003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498370|NCT02001818|Interferons|interferons|mesh-list
92498371|NCT02001818|Interferon-alpha|interferon-alpha|mesh-list
92498372|NCT02001818|Interferon alpha-2|interferon alpha-2|mesh-list
92498373|NCT02001818|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92498374|NCT02001818|Imatinib Mesylate|imatinib mesylate|mesh-list
92498375|NCT02001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498376|NCT02001818|Antiviral Agents|antiviral agents|mesh-ancestor
92498377|NCT02001818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498378|NCT02001818|Immunologic Factors|immunologic factors|mesh-ancestor
92498379|NCT02001818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498380|NCT02001818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92498381|NCT02001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498382|NCT02001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498383|NCT02003313|Vaccines|vaccines|mesh-list
92498384|NCT02003313|Immunologic Factors|immunologic factors|mesh-ancestor
92498385|NCT02003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498386|NCT02003456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92498387|NCT02003456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92498388|NCT02003456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498389|NCT02003495|Vaccines|vaccines|mesh-list
92498390|NCT02003495|Immunologic Factors|immunologic factors|mesh-ancestor
92498391|NCT02003495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498392|NCT02003664|Baclofen|baclofen|mesh-list
92498393|NCT02003664|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92498394|NCT02003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498395|NCT02003664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92498396|NCT02003664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498397|NCT02003664|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92498398|NCT02003664|GABA Agonists|gaba agonists|mesh-ancestor
92498399|NCT02003664|GABA Agents|gaba agents|mesh-ancestor
92498400|NCT02003664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498401|NCT02003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498402|NCT02003677|Insulin|insulin|mesh-list
92498403|NCT02003677|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92498404|NCT02003677|Insulin Aspart|insulin aspart|mesh-list
92498405|NCT02003677|Insulin, Long-Acting|insulin, long-acting|mesh-list
92498406|NCT02003677|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92498407|NCT02003677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92498408|NCT02003677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498409|NCT02003768|Propofol|propofol|mesh-list
92498410|NCT02003768|Desflurane|desflurane|mesh-list
92498411|NCT02003768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92498412|NCT02003768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498413|NCT02003768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498414|NCT02003768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92498415|NCT02003768|Anesthetics, General|anesthetics, general|mesh-ancestor
92498416|NCT02003768|Anesthetics|anesthetics|mesh-ancestor
92498417|NCT02003768|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92498418|NCT02003885|Desflurane|desflurane|mesh-list
92498419|NCT02003885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92498420|NCT02003885|Anesthetics, General|anesthetics, general|mesh-ancestor
92498421|NCT02003885|Anesthetics|anesthetics|mesh-ancestor
92498422|NCT02003885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498423|NCT02003885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498424|NCT02004067|Cyclosporine|cyclosporine|mesh-list
92498425|NCT02004067|Castor Oil|castor oil|mesh-list
92498426|NCT02004067|Cyclosporins|cyclosporins|mesh-list
92498427|NCT02004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498428|NCT02004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498429|NCT02004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498430|NCT02004067|Immunologic Factors|immunologic factors|mesh-ancestor
92498431|NCT02004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498432|NCT02004067|Antifungal Agents|antifungal agents|mesh-ancestor
92498433|NCT02004067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498434|NCT02004067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92498435|NCT02004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498436|NCT02004067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92498437|NCT02004067|Cathartics|cathartics|mesh-ancestor
92498438|NCT02004067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498439|NCT02004171|Nicotine|nicotine|mesh-list
92498440|NCT02004171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92498441|NCT02004171|Autonomic Agents|autonomic agents|mesh-ancestor
92498442|NCT02004171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498443|NCT02004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498444|NCT02004171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92498445|NCT02004171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92498446|NCT02004171|Cholinergic Agents|cholinergic agents|mesh-ancestor
92498447|NCT02004171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498448|NCT02004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498449|NCT02004184|Pemetrexed|pemetrexed|mesh-list
92498450|NCT02004184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498451|NCT02004184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498452|NCT02004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498453|NCT02004184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92498454|NCT02004184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92498455|NCT02004197|Amoxicillin|amoxicillin|mesh-list
92498456|NCT02004197|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92498457|NCT02004197|Bismuth|bismuth|mesh-list
92498458|NCT02004197|Ranitidine|ranitidine|mesh-list
92223355|NCT02939300|Nivolumab|nivolumab|mesh-list
92498459|NCT02004197|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92498460|NCT02004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498461|NCT02004197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92498462|NCT02004197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498464|NCT02004197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498465|NCT02004197|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92498466|NCT02004197|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92498467|NCT02004197|Histamine Antagonists|histamine antagonists|mesh-ancestor
92498468|NCT02004197|Histamine Agents|histamine agents|mesh-ancestor
92498469|NCT02004197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498470|NCT02004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498471|NCT02004301|Diclofenac|diclofenac|mesh-list
92498472|NCT02004301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92498473|NCT02004301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498474|NCT02004301|Analgesics|analgesics|mesh-ancestor
92498475|NCT02004301|Sensory System Agents|sensory system agents|mesh-ancestor
92498476|NCT02004301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498477|NCT02004301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498478|NCT02004301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498479|NCT02004301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498480|NCT02004301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92498481|NCT02004301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498482|NCT02004301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498483|NCT02004314|Chloroquine|chloroquine|mesh-list
92498484|NCT02004314|Amebicides|amebicides|mesh-ancestor
92498485|NCT02004314|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92498486|NCT02004314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92498487|NCT02004314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498488|NCT02004314|Antimalarials|antimalarials|mesh-ancestor
92498489|NCT02004314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498490|NCT02004418|Choline|choline|mesh-list
92498491|NCT02004418|Lipotropic Agents|lipotropic agents|mesh-ancestor
92498492|NCT02004418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92498493|NCT02004418|Antimetabolites|antimetabolites|mesh-ancestor
92498494|NCT02004418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498495|NCT02004418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498496|NCT02004418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92498497|NCT02004418|Nootropic Agents|nootropic agents|mesh-ancestor
92498498|NCT02004509|Anticoagulants|anticoagulants|mesh-list
92498499|NCT02004574|Betamethasone|betamethasone|mesh-list
92498500|NCT02004574|Betamethasone Valerate|betamethasone valerate|mesh-list
92498501|NCT02004574|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92498502|NCT02004574|Betamethasone benzoate|betamethasone benzoate|mesh-list
92498503|NCT02004574|Calcipotriene|calcipotriene|mesh-list
92498504|NCT02004574|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92498505|NCT02004574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498506|NCT02004574|Glucocorticoids|glucocorticoids|mesh-ancestor
92498507|NCT02004574|Hormones|hormones|mesh-ancestor
92498508|NCT02004574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498509|NCT02004574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498510|NCT02004574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92498511|NCT02004574|Respiratory System Agents|respiratory system agents|mesh-ancestor
92498512|NCT02004574|Dermatologic Agents|dermatologic agents|mesh-ancestor
92498513|NCT02004652|Prucalopride|prucalopride|mesh-list
92498514|NCT02004652|Laxatives|laxatives|mesh-ancestor
92498515|NCT02004652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498516|NCT02004652|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92498517|NCT02004652|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92498518|NCT02004652|Serotonin Agents|serotonin agents|mesh-ancestor
92498519|NCT02004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498520|NCT02004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498521|NCT02004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498522|NCT02004769|Docetaxel|docetaxel|mesh-list
92498523|NCT02004769|Capecitabine|capecitabine|mesh-list
92498524|NCT02004769|Trastuzumab|trastuzumab|mesh-list
92498525|NCT02004769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498526|NCT02004769|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498527|NCT02004769|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498528|NCT02004769|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498529|NCT02004769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498530|NCT02004769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498531|NCT02004769|Antimetabolites|antimetabolites|mesh-ancestor
92498532|NCT02004769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92498533|NCT02004860|Ciclopirox|ciclopirox|mesh-list
92498534|NCT02004860|Tacrolimus|tacrolimus|mesh-list
92498535|NCT02004860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498536|NCT02004860|Immunologic Factors|immunologic factors|mesh-ancestor
92223427|NCT04124822|Prednisolone|prednisolone|mesh-list
92498537|NCT02004860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498538|NCT02004860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92498539|NCT02004860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498540|NCT02004860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498541|NCT02004860|Antifungal Agents|antifungal agents|mesh-ancestor
92498542|NCT02004860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498543|NCT02004899|Fentanyl|fentanyl|mesh-list
92498544|NCT02004899|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92498545|NCT02004899|Narcotics|narcotics|mesh-ancestor
92498546|NCT02004899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498547|NCT02004899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498548|NCT02004899|Analgesics|analgesics|mesh-ancestor
92498549|NCT02004899|Sensory System Agents|sensory system agents|mesh-ancestor
92498550|NCT02004899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498551|NCT02004899|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92498552|NCT02004899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92498553|NCT02004899|Anesthetics, General|anesthetics, general|mesh-ancestor
92498554|NCT02004899|Anesthetics|anesthetics|mesh-ancestor
92498555|NCT02005068|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92498556|NCT02005068|Cephalosporins|cephalosporins|mesh-list
92498557|NCT02005068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92498558|NCT02005068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498559|NCT02005107|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92498560|NCT02005107|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92498561|NCT02005107|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92498562|NCT02005107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498563|NCT02005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498564|NCT02005107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498565|NCT02005107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498566|NCT02005107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92498567|NCT02005107|Antidepressive Agents|antidepressive agents|mesh-ancestor
92498568|NCT02005107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92498569|NCT02005120|Bevacizumab|bevacizumab|mesh-list
92498570|NCT02005120|Endostatins|endostatins|mesh-list
92498571|NCT02005120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92498572|NCT02005120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498573|NCT02005120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92498574|NCT02005120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92498575|NCT02005120|Growth Substances|growth substances|mesh-ancestor
92498576|NCT02005120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498577|NCT02005120|Growth Inhibitors|growth inhibitors|mesh-ancestor
92498578|NCT02005302|Vitamin D|vitamin d|mesh-list
92498579|NCT02005302|Ergocalciferols|ergocalciferols|mesh-list
92498580|NCT02005302|Cholecalciferol|cholecalciferol|mesh-list
92498581|NCT02005302|Vitamins|vitamins|mesh-list
92498582|NCT02005302|Micronutrients|micronutrients|mesh-ancestor
92498583|NCT02005302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498584|NCT02005302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92498585|NCT02005302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92498586|NCT02005315|Paclitaxel|paclitaxel|mesh-list
92498587|NCT02005315|Gemcitabine|gemcitabine|mesh-list
92498588|NCT02005315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92498589|NCT02005315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498590|NCT02005315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498591|NCT02005315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498592|NCT02005315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498593|NCT02005315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498594|NCT02005315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498595|NCT02005315|Antimetabolites|antimetabolites|mesh-ancestor
92498596|NCT02005419|Metformin|metformin|mesh-list
92498597|NCT02005419|Gemcitabine|gemcitabine|mesh-list
92498598|NCT02005419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498599|NCT02005419|Antimetabolites|antimetabolites|mesh-ancestor
92498600|NCT02005419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498601|NCT02005419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498602|NCT02005419|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92498603|NCT02005419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498604|NCT02005523|RNS60|rns60|mesh-list
92498605|NCT02005523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92498606|NCT02005523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498607|NCT02005523|Analgesics|analgesics|mesh-ancestor
92498609|NCT02005523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498610|NCT02005523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498611|NCT02005523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498612|NCT02005523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498613|NCT02005523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92498614|NCT02005575|Dexamethasone|dexamethasone|mesh-list
92498615|NCT02005575|Bupivacaine|bupivacaine|mesh-list
92498616|NCT02005575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498617|NCT02005575|Antiemetics|antiemetics|mesh-ancestor
92498618|NCT02005575|Autonomic Agents|autonomic agents|mesh-ancestor
92498619|NCT02005575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498620|NCT02005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498621|NCT02005575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498622|NCT02005575|Glucocorticoids|glucocorticoids|mesh-ancestor
92498623|NCT02005575|Hormones|hormones|mesh-ancestor
92498624|NCT02005575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498625|NCT02005575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92498626|NCT02005575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498627|NCT02005575|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498628|NCT02005575|Anesthetics|anesthetics|mesh-ancestor
92498629|NCT02005575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498630|NCT02005575|Sensory System Agents|sensory system agents|mesh-ancestor
92498631|NCT02005588|Iron|iron|mesh-list
92498632|NCT02005588|Ferrous fumarate|ferrous fumarate|mesh-list
92498633|NCT02005588|Iron Chelating Agents|iron chelating agents|mesh-list
92498634|NCT02005588|Trace Elements|trace elements|mesh-ancestor
92498635|NCT02005588|Micronutrients|micronutrients|mesh-ancestor
92498636|NCT02005588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498637|NCT02005588|Chelating Agents|chelating agents|mesh-ancestor
92498638|NCT02005588|Sequestering Agents|sequestering agents|mesh-ancestor
92498639|NCT02005588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498640|NCT02005653|Doxycycline|doxycycline|mesh-list
92498641|NCT02005653|Albendazole|albendazole|mesh-list
92498642|NCT02005653|Diethylcarbamazine|diethylcarbamazine|mesh-list
92498643|NCT02005653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92498644|NCT02005653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498645|NCT02005653|Antimalarials|antimalarials|mesh-ancestor
92498646|NCT02005653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92498647|NCT02005653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92498648|NCT02005653|Anthelmintics|anthelmintics|mesh-ancestor
92498649|NCT02005653|Anticestodal Agents|anticestodal agents|mesh-ancestor
92498650|NCT02005653|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92498651|NCT02005653|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498652|NCT02005653|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498653|NCT02005653|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498654|NCT02005653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498655|NCT02005653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498656|NCT02005653|Filaricides|filaricides|mesh-ancestor
92498657|NCT02005653|Antinematodal Agents|antinematodal agents|mesh-ancestor
92498658|NCT02005653|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92498659|NCT02005653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498660|NCT02005718|Cholecalciferol|cholecalciferol|mesh-list
92498661|NCT02005718|Vitamin D|vitamin d|mesh-list
92498662|NCT02005718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92498663|NCT02005718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498664|NCT02005718|Vitamins|vitamins|mesh-ancestor
92498665|NCT02005718|Micronutrients|micronutrients|mesh-ancestor
92498666|NCT02005718|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92498667|NCT02005757|Mizoribine|mizoribine|mesh-list
92498668|NCT02005757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92498669|NCT02005757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498670|NCT02005757|Analgesics|analgesics|mesh-ancestor
92498671|NCT02005757|Sensory System Agents|sensory system agents|mesh-ancestor
92498672|NCT02005757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498673|NCT02005757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498674|NCT02005757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498675|NCT02005757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498676|NCT02005757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92498677|NCT02005757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498678|NCT02005757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92498679|NCT02005757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498680|NCT02005757|Antimalarials|antimalarials|mesh-ancestor
92498681|NCT02005757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92532772|NCT05525325|Anesthetics|anesthetics|mesh-list
92498683|NCT02005757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498684|NCT02005757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498685|NCT02005757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498686|NCT02005757|Immunologic Factors|immunologic factors|mesh-ancestor
92498687|NCT02005770|Propofol|propofol|mesh-list
92498688|NCT02005770|Sevoflurane|sevoflurane|mesh-list
92498689|NCT02005770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92498690|NCT02005770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498691|NCT02005770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349696|NCT01442376|Ondansetron|ondansetron|mesh-list
92498692|NCT02005770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92498693|NCT02005770|Anesthetics, General|anesthetics, general|mesh-ancestor
92498694|NCT02005770|Anesthetics|anesthetics|mesh-ancestor
92498695|NCT02005770|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92498696|NCT02005770|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92498697|NCT02005783|Cyclophosphamide|cyclophosphamide|mesh-list
92498698|NCT02005783|Docetaxel|docetaxel|mesh-list
92498699|NCT02005783|Epirubicin|epirubicin|mesh-list
92498700|NCT02005783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498701|NCT02005783|Immunologic Factors|immunologic factors|mesh-ancestor
92498702|NCT02005783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498703|NCT02005783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498704|NCT02005783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92498705|NCT02005783|Alkylating Agents|alkylating agents|mesh-ancestor
92498706|NCT02005783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498707|NCT02005783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498708|NCT02005783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92498709|NCT02005783|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498710|NCT02005783|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498711|NCT02005783|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498712|NCT02005783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92498713|NCT02005783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92498714|NCT02005783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92498715|NCT02005783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498716|NCT02005822|Valganciclovir|valganciclovir|mesh-list
92498717|NCT02005822|Antiviral Agents|antiviral agents|mesh-ancestor
92498718|NCT02005822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498719|NCT02005848|Protease Inhibitors|protease inhibitors|mesh-list
92498720|NCT02005848|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92498721|NCT02005848|Protein C Inhibitor|protein c inhibitor|mesh-list
92498722|NCT02005848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498723|NCT02005848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498724|NCT02005848|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92498725|NCT02005848|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92498726|NCT02006043|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92498727|NCT02006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498728|NCT02006043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92498729|NCT02006043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498730|NCT02006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498731|NCT02006173|Lidocaine|lidocaine|mesh-list
92498732|NCT02006173|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498733|NCT02006173|Anesthetics|anesthetics|mesh-ancestor
92498734|NCT02006173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498735|NCT02006173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498736|NCT02006173|Sensory System Agents|sensory system agents|mesh-ancestor
92498737|NCT02006173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498738|NCT02006173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92498739|NCT02006173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92498740|NCT02006173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92498741|NCT02006173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498742|NCT02006173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498743|NCT02006225|Plerixafor|plerixafor|mesh-list
92498744|NCT02006225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92498745|NCT02006225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92498746|NCT02006225|Antiviral Agents|antiviral agents|mesh-ancestor
92498747|NCT02006225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498748|NCT02006277|Crizotinib|crizotinib|mesh-list
92498749|NCT02006277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92498750|NCT02006277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498751|NCT02006277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92498752|NCT02006277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498753|NCT02006277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498754|NCT02006355|Ropivacaine|ropivacaine|mesh-list
92498755|NCT02006355|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498756|NCT02006355|Anesthetics|anesthetics|mesh-ancestor
92498757|NCT02006355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498758|NCT02006355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498759|NCT02006355|Sensory System Agents|sensory system agents|mesh-ancestor
92498760|NCT02006355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498761|NCT02006485|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92498762|NCT02006485|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92498763|NCT02006485|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92498764|NCT02006485|Alkylating Agents|alkylating agents|mesh-ancestor
92498765|NCT02006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498766|NCT02006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498767|NCT02006485|Immunologic Factors|immunologic factors|mesh-ancestor
92498768|NCT02006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498770|NCT02006498|Antioxidants|antioxidants|mesh-ancestor
92498771|NCT02006498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498772|NCT02006498|Protective Agents|protective agents|mesh-ancestor
92498773|NCT02006498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498774|NCT02006589|Candesartan|candesartan|mesh-list
92498775|NCT02006589|Candesartan cilexetil|candesartan cilexetil|mesh-list
92498776|NCT02006589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92498777|NCT02006589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92498778|NCT02006589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92498779|NCT02006589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498780|NCT02006602|Candesartan|candesartan|mesh-list
92498781|NCT02006602|Candesartan cilexetil|candesartan cilexetil|mesh-list
92498782|NCT02006602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92498783|NCT02006602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92498784|NCT02006602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92498785|NCT02006602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498786|NCT02006745|Ribavirin|ribavirin|mesh-list
92498787|NCT02006745|Antimetabolites|antimetabolites|mesh-ancestor
92498788|NCT02006745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498789|NCT02006745|Antiviral Agents|antiviral agents|mesh-ancestor
92498790|NCT02006745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498791|NCT02006849|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92498792|NCT02006849|Hormones|hormones|mesh-ancestor
92498793|NCT02006849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92498794|NCT02006849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498795|NCT02006914|Chromium|chromium|mesh-list
92498796|NCT02006914|Picolinic acid|picolinic acid|mesh-list
92498797|NCT02006914|Trace Elements|trace elements|mesh-ancestor
92498798|NCT02006914|Micronutrients|micronutrients|mesh-ancestor
92498799|NCT02006914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498800|NCT02006914|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92498801|NCT02006914|Chelating Agents|chelating agents|mesh-ancestor
92498802|NCT02006914|Sequestering Agents|sequestering agents|mesh-ancestor
92498803|NCT02006914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498804|NCT02006966|Lidocaine|lidocaine|mesh-list
92498805|NCT02006966|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498806|NCT02006966|Anesthetics|anesthetics|mesh-ancestor
92498807|NCT02006966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498808|NCT02006966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498809|NCT02006966|Sensory System Agents|sensory system agents|mesh-ancestor
92498810|NCT02006966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498811|NCT02006966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92498812|NCT02006966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92498813|NCT02006966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92498814|NCT02006966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498815|NCT02006966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498816|NCT02007005|Viscum album peptide|viscum album peptide|mesh-list
92498817|NCT02007005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498818|NCT02007005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92498819|NCT02007005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92498820|NCT02007005|Antiviral Agents|antiviral agents|mesh-ancestor
92498821|NCT02007005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498822|NCT02007148|Docetaxel|docetaxel|mesh-list
92498823|NCT02007148|Capecitabine|capecitabine|mesh-list
92498824|NCT02007148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498825|NCT02007148|Tubulin Modulators|tubulin modulators|mesh-ancestor
92498826|NCT02007148|Antimitotic Agents|antimitotic agents|mesh-ancestor
92498827|NCT02007148|Mitosis Modulators|mitosis modulators|mesh-ancestor
92498828|NCT02007148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498829|NCT02007148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498830|NCT02007148|Antimetabolites|antimetabolites|mesh-ancestor
92498831|NCT02007161|Diclofenac|diclofenac|mesh-list
92498832|NCT02007161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92498833|NCT02007161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498834|NCT02007161|Analgesics|analgesics|mesh-ancestor
92498835|NCT02007161|Sensory System Agents|sensory system agents|mesh-ancestor
92498836|NCT02007161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498837|NCT02007161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498838|NCT02007161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498839|NCT02007161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498840|NCT02007161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92498841|NCT02007161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498842|NCT02007161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498843|NCT02007174|Bevacizumab|bevacizumab|mesh-list
92498844|NCT02007174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92498845|NCT02007174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498846|NCT02007174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92498847|NCT02007174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92498848|NCT02007174|Growth Substances|growth substances|mesh-ancestor
92498849|NCT02007174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498850|NCT02007174|Growth Inhibitors|growth inhibitors|mesh-ancestor
92498851|NCT02007330|Lidocaine|lidocaine|mesh-list
92498852|NCT02007330|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498853|NCT02007330|Anesthetics|anesthetics|mesh-ancestor
92498854|NCT02007330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498855|NCT02007330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498856|NCT02007330|Sensory System Agents|sensory system agents|mesh-ancestor
92498857|NCT02007330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498858|NCT02007330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92498859|NCT02007330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92498860|NCT02007330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92498861|NCT02007330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498862|NCT02007330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498863|NCT02007408|Lidocaine|lidocaine|mesh-list
92498864|NCT02007408|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498865|NCT02007408|Anesthetics|anesthetics|mesh-ancestor
92498866|NCT02007408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498867|NCT02007408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498868|NCT02007408|Sensory System Agents|sensory system agents|mesh-ancestor
92498869|NCT02007408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498870|NCT02007408|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92498871|NCT02007408|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92498872|NCT02007408|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92498873|NCT02007408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498874|NCT02007408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498875|NCT02007447|Oxytocin|oxytocin|mesh-list
92498876|NCT02007447|Oxytocics|oxytocics|mesh-ancestor
92498877|NCT02007447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92498878|NCT02007447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498879|NCT02007603|Amoxicillin|amoxicillin|mesh-list
92498880|NCT02007603|Clavulanic Acids|clavulanic acids|mesh-list
92498881|NCT02007603|Clavulanic Acid|clavulanic acid|mesh-list
92498882|NCT02007603|Ampicillin|ampicillin|mesh-list
92498883|NCT02007603|Sulbactam|sulbactam|mesh-list
92498884|NCT02007603|Sultamicillin|sultamicillin|mesh-list
92498885|NCT02007603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92498886|NCT02007603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498887|NCT02007603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498888|NCT02007603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498889|NCT02007603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92498890|NCT02007629|Riociguat|riociguat|mesh-list
92498891|NCT02007629|Enzyme Activators|enzyme activators|mesh-ancestor
92498892|NCT02007629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498893|NCT02007746|Liver Extracts|liver extracts|mesh-list
92498894|NCT02007746|Hematinics|hematinics|mesh-ancestor
92498895|NCT02007798|Dexmedetomidine|dexmedetomidine|mesh-list
92498896|NCT02007798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92498897|NCT02007798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498898|NCT02007798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498899|NCT02007798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498900|NCT02007798|Analgesics|analgesics|mesh-ancestor
92498901|NCT02007798|Sensory System Agents|sensory system agents|mesh-ancestor
92498902|NCT02007798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498903|NCT02007798|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92498904|NCT02007798|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92498905|NCT02007798|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92498906|NCT02007798|Adrenergic Agents|adrenergic agents|mesh-ancestor
92498907|NCT02007798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498908|NCT02007798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498909|NCT02007837|Aspirin|aspirin|mesh-list
92498910|NCT02007837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223803|NCT05325762|Analgesics|analgesics|mesh-ancestor
92498911|NCT02007837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92498912|NCT02007837|Analgesics|analgesics|mesh-ancestor
92498913|NCT02007837|Sensory System Agents|sensory system agents|mesh-ancestor
92498914|NCT02007837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498915|NCT02007837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498916|NCT02007837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92498917|NCT02007837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92498918|NCT02007837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92498919|NCT02007837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92498920|NCT02007837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498921|NCT02007837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92498922|NCT02007837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92498923|NCT02007837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498924|NCT02007837|Antipyretics|antipyretics|mesh-ancestor
92498925|NCT02007850|Ropivacaine|ropivacaine|mesh-list
92498926|NCT02007850|Anesthetics, Local|anesthetics, local|mesh-ancestor
92498927|NCT02007850|Anesthetics|anesthetics|mesh-ancestor
92498928|NCT02007850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498929|NCT02007850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498930|NCT02007850|Sensory System Agents|sensory system agents|mesh-ancestor
92498931|NCT02007850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498932|NCT02007915|Pamidronate|pamidronate|mesh-list
92498933|NCT02007915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92498934|NCT02007915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498935|NCT02007928|Olanzapine|olanzapine|mesh-list
92498936|NCT02007928|Risperidone|risperidone|mesh-list
92498937|NCT02007928|Aripiprazole|aripiprazole|mesh-list
92498938|NCT02007928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92498939|NCT02007928|Serotonin Agents|serotonin agents|mesh-ancestor
92498940|NCT02007928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498941|NCT02007928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498942|NCT02007928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498943|NCT02007928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92498944|NCT02007928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92498945|NCT02007928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92498946|NCT02007928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92498947|NCT02007928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92498948|NCT02007928|Dopamine Agents|dopamine agents|mesh-ancestor
92498949|NCT02007928|Antiemetics|antiemetics|mesh-ancestor
92498950|NCT02007928|Autonomic Agents|autonomic agents|mesh-ancestor
92498951|NCT02007928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92498952|NCT02007928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92498953|NCT02007928|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92498954|NCT02007928|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92498955|NCT02007928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92498956|NCT02007928|Antidepressive Agents|antidepressive agents|mesh-ancestor
92498957|NCT02007928|Dopamine Agonists|dopamine agonists|mesh-ancestor
92498958|NCT02007928|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92498959|NCT02007928|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92498960|NCT02007928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92498961|NCT02007928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92498963|NCT02008006|Etoposide|etoposide|mesh-list
92498964|NCT02008006|Melphalan|melphalan|mesh-list
92498965|NCT02008006|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92498966|NCT02008006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92498967|NCT02008006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498968|NCT02008006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92498969|NCT02008006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92498970|NCT02008006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498971|NCT02008006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498972|NCT02008006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92498973|NCT02008006|Antimetabolites|antimetabolites|mesh-ancestor
92498974|NCT02008006|Antiviral Agents|antiviral agents|mesh-ancestor
92498975|NCT02008006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92498976|NCT02008006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498977|NCT02008006|Immunologic Factors|immunologic factors|mesh-ancestor
92498978|NCT02008006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498979|NCT02008006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92498980|NCT02008006|Alkylating Agents|alkylating agents|mesh-ancestor
92498981|NCT02008006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92498982|NCT02008019|Everolimus|everolimus|mesh-list
92498983|NCT02008019|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92498984|NCT02008019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92498985|NCT02008019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92498986|NCT02008019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498987|NCT02008019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92498988|NCT02008019|Immunologic Factors|immunologic factors|mesh-ancestor
92498989|NCT02008019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498990|NCT02008019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92498991|NCT02008123|Primidone|primidone|mesh-list
92498992|NCT02008123|Anticonvulsants|anticonvulsants|mesh-ancestor
92498993|NCT02008123|GABA Modulators|gaba modulators|mesh-ancestor
92498994|NCT02008123|GABA Agents|gaba agents|mesh-ancestor
92498995|NCT02008123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92498996|NCT02008123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92498997|NCT02008123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92498998|NCT02008136|Botulinum Toxins|botulinum toxins|mesh-list
92498999|NCT02008136|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92499000|NCT02008136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499001|NCT02008136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499002|NCT02008136|Cholinergic Agents|cholinergic agents|mesh-ancestor
92499003|NCT02008136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499004|NCT02008136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499005|NCT02008162|Bromides|bromides|mesh-list
92499006|NCT02008162|Albuterol|albuterol|mesh-list
92499007|NCT02008162|Tiotropium Bromide|tiotropium bromide|mesh-list
92499008|NCT02008162|Bronchodilator Agents|bronchodilator agents|mesh-list
92499009|NCT02008162|Autonomic Agents|autonomic agents|mesh-ancestor
92499010|NCT02008162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499011|NCT02008162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499012|NCT02008162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92499013|NCT02008162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92499014|NCT02008162|Parasympatholytics|parasympatholytics|mesh-ancestor
92499015|NCT02008162|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92499016|NCT02008162|Cholinergic Agents|cholinergic agents|mesh-ancestor
92499017|NCT02008162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499018|NCT02008162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499019|NCT02008162|Anticonvulsants|anticonvulsants|mesh-ancestor
92499020|NCT02008162|Tocolytic Agents|tocolytic agents|mesh-ancestor
92499021|NCT02008162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92499022|NCT02008162|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92499023|NCT02008162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92499024|NCT02008162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92499025|NCT02008162|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499026|NCT02008201|Vitamin D|vitamin d|mesh-list
92499027|NCT02008201|Vitamins|vitamins|mesh-ancestor
92499028|NCT02008201|Micronutrients|micronutrients|mesh-ancestor
92499029|NCT02008201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499030|NCT02008201|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92499031|NCT02008214|Pentoxifylline|pentoxifylline|mesh-list
92499032|NCT02008214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92499033|NCT02008214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499034|NCT02008214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499035|NCT02008214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92499036|NCT02008214|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92499037|NCT02008214|Protective Agents|protective agents|mesh-ancestor
92499038|NCT02008214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499039|NCT02008214|Vasodilator Agents|vasodilator agents|mesh-ancestor
92499040|NCT02008214|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92499041|NCT02008214|Antioxidants|antioxidants|mesh-ancestor
92499042|NCT02008383|Panitumumab|panitumumab|mesh-list
92499043|NCT02008383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499044|NCT02008383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499045|NCT02008422|Oxaliplatin|oxaliplatin|mesh-list
92499046|NCT02008422|Tegafur|tegafur|mesh-list
92499047|NCT02008422|Endostar protein|endostar protein|mesh-list
92499048|NCT02008422|Endostatins|endostatins|mesh-list
92499049|NCT02008422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499050|NCT02008422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92499051|NCT02008422|Antimetabolites|antimetabolites|mesh-ancestor
92499052|NCT02008422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499053|NCT02008422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92499054|NCT02008422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92499055|NCT02008422|Growth Substances|growth substances|mesh-ancestor
92499056|NCT02008422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499057|NCT02008422|Growth Inhibitors|growth inhibitors|mesh-ancestor
92499058|NCT02008461|Botulinum Toxins|botulinum toxins|mesh-list
92499059|NCT02008461|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92499060|NCT02008461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499061|NCT02008461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499062|NCT02008461|Cholinergic Agents|cholinergic agents|mesh-ancestor
92499063|NCT02008461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499064|NCT02008461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499065|NCT02008578|Immunoglobulins|immunoglobulins|mesh-list
92499066|NCT02008578|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92499067|NCT02008578|Antibodies|antibodies|mesh-list
92499068|NCT02008578|Immunologic Factors|immunologic factors|mesh-ancestor
92499069|NCT02008578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499070|NCT02008721|Neuroprotective Agents|neuroprotective agents|mesh-list
92499071|NCT02008721|Protective Agents|protective agents|mesh-ancestor
92499072|NCT02008721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499073|NCT02008734|Palbociclib|palbociclib|mesh-list
92499074|NCT02008734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499075|NCT02008734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92499076|NCT02008734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499077|NCT02008734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499078|NCT02008747|Magnesium Sulfate|magnesium sulfate|mesh-list
92499079|NCT02008747|Analgesics|analgesics|mesh-ancestor
92499080|NCT02008747|Sensory System Agents|sensory system agents|mesh-ancestor
92499081|NCT02008747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499082|NCT02008747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499083|NCT02008747|Anesthetics|anesthetics|mesh-ancestor
92499084|NCT02008747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499085|NCT02008747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92499086|NCT02008747|Anticonvulsants|anticonvulsants|mesh-ancestor
92499087|NCT02008747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92499088|NCT02008747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499089|NCT02008747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499090|NCT02008747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92499091|NCT02008747|Tocolytic Agents|tocolytic agents|mesh-ancestor
92499092|NCT02008747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92499093|NCT02008786|Ramipril|ramipril|mesh-list
92499094|NCT02008786|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92499095|NCT02008786|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92499096|NCT02008786|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92499097|NCT02008786|Antimetabolites|antimetabolites|mesh-ancestor
92499098|NCT02008786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499099|NCT02008786|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92499100|NCT02008786|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92499101|NCT02008786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499102|NCT02008786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92499103|NCT02008786|Protease Inhibitors|protease inhibitors|mesh-ancestor
92499104|NCT02008786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92499105|NCT02008968|Allopurinol|allopurinol|mesh-list
92499106|NCT02008968|Antimetabolites|antimetabolites|mesh-ancestor
92499107|NCT02008968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499108|NCT02008968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499109|NCT02008968|Gout Suppressants|gout suppressants|mesh-ancestor
92499110|NCT02008968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499111|NCT02008968|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92499112|NCT02008968|Antioxidants|antioxidants|mesh-ancestor
92499113|NCT02008968|Protective Agents|protective agents|mesh-ancestor
92499114|NCT02008968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499115|NCT02008981|Aspirin|aspirin|mesh-list
92499116|NCT02008981|Turmeric extract|turmeric extract|mesh-list
92499117|NCT02008981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92499118|NCT02008981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92499120|NCT02008981|Sensory System Agents|sensory system agents|mesh-ancestor
92499121|NCT02008981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499122|NCT02008981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499123|NCT02008981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499124|NCT02008981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499125|NCT02008981|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92349710|NCT01442064|Ranibizumab|ranibizumab|mesh-list
92499126|NCT02008981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92499127|NCT02008981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499128|NCT02008981|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92499129|NCT02008981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92499130|NCT02008981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499131|NCT02008981|Antipyretics|antipyretics|mesh-ancestor
92499132|NCT02008981|Antioxidants|antioxidants|mesh-ancestor
92499133|NCT02008981|Protective Agents|protective agents|mesh-ancestor
92499134|NCT02009007|Phenylephrine|phenylephrine|mesh-list
92499135|NCT02009007|Dopamine|dopamine|mesh-list
92499137|NCT02009007|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92499138|NCT02009007|Mydriatics|mydriatics|mesh-ancestor
92499139|NCT02009007|Autonomic Agents|autonomic agents|mesh-ancestor
92499140|NCT02009007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499141|NCT02009007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499142|NCT02009007|Sympathomimetics|sympathomimetics|mesh-ancestor
92499143|NCT02009007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92499144|NCT02009007|Nasal Decongestants|nasal decongestants|mesh-ancestor
92499145|NCT02009007|Respiratory System Agents|respiratory system agents|mesh-ancestor
92499146|NCT02009007|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92499147|NCT02009007|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92499148|NCT02009007|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92499149|NCT02009007|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499150|NCT02009007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499151|NCT02009007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499152|NCT02009007|Protective Agents|protective agents|mesh-ancestor
92499153|NCT02009007|Dopamine Agents|dopamine agents|mesh-ancestor
92499154|NCT02009098|Cefuroxime|cefuroxime|mesh-list
92499155|NCT02009098|Cefuroxime axetil|cefuroxime axetil|mesh-list
92499156|NCT02009098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499157|NCT02009098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499158|NCT02009189|Taurolidine|taurolidine|mesh-list
92499159|NCT02009189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499160|NCT02009189|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92499161|NCT02009189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499162|NCT02009202|Picosulfate sodium|picosulfate sodium|mesh-list
92499163|NCT02009202|Cathartics|cathartics|mesh-ancestor
92499164|NCT02009202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499165|NCT02009215|Piperaquine|piperaquine|mesh-list
92499166|NCT02009215|Artenimol|artenimol|mesh-list
92499167|NCT02009215|Antimalarials|antimalarials|mesh-ancestor
92499168|NCT02009215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92499169|NCT02009215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92499170|NCT02009215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499171|NCT05778825|Minoxidil|minoxidil|mesh-list
92499172|NCT05778825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92499173|NCT05778825|Vasodilator Agents|vasodilator agents|mesh-ancestor
92499174|NCT05778461|N-Methylaspartate|n-methylaspartate|mesh-list
92499175|NCT05778461|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92499176|NCT05778461|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92499177|NCT05778461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499178|NCT05778461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200485|NCT00587483|Anesthetics, Local|anesthetics, local|mesh-ancestor
92499179|NCT05778461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499180|NCT05778305|Dexmedetomidine|dexmedetomidine|mesh-list
92499181|NCT05778305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92499182|NCT05778305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499183|NCT05778305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499184|NCT05778305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92499185|NCT05778305|Analgesics|analgesics|mesh-ancestor
92499186|NCT05778305|Sensory System Agents|sensory system agents|mesh-ancestor
92499187|NCT05778305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499188|NCT05778305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92499189|NCT05778305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92499190|NCT05778305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92499191|NCT05778305|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499192|NCT05778305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499193|NCT05778305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499194|NCT05778227|Etidronic Acid|etidronic acid|mesh-list
92499195|NCT05778227|Acetic Acid|acetic acid|mesh-list
92499196|NCT05778227|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92499198|NCT05778227|Retinol acetate|retinol acetate|mesh-list
92499199|NCT05778227|Ethylene|ethylene|mesh-list
92499200|NCT05778227|Maleic acid|maleic acid|mesh-list
92349713|NCT01442064|Growth Substances|growth substances|mesh-ancestor
92499201|NCT05778227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499202|NCT05778227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499203|NCT05778227|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92499204|NCT05778227|Immunologic Factors|immunologic factors|mesh-ancestor
92499205|NCT05778227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499206|NCT05778227|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92499207|NCT05778227|Protective Agents|protective agents|mesh-ancestor
92499208|NCT05778227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499209|NCT05778227|Disinfectants|disinfectants|mesh-ancestor
92499210|NCT05778227|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92499211|NCT05778227|Growth Substances|growth substances|mesh-ancestor
92499212|NCT05778227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499213|NCT05778227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499214|NCT05778227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92499215|NCT05778097|Androgens|androgens|mesh-list
92499216|NCT05778097|Hormones|hormones|mesh-ancestor
92499217|NCT05778097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499218|NCT05778097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499219|NCT05778084|Empagliflozin|empagliflozin|mesh-list
92499220|NCT05778084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92499221|NCT05778084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499222|NCT05778084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92499223|NCT05778084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499224|NCT05777902|Ozanimod|ozanimod|mesh-list
92499225|NCT05777902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92499226|NCT05777902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499227|NCT05777902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92499228|NCT05777902|Immunologic Factors|immunologic factors|mesh-ancestor
92499229|NCT05777902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499230|NCT05777824|Antibodies|antibodies|mesh-list
92499231|NCT05777824|Immunologic Factors|immunologic factors|mesh-ancestor
92499232|NCT05777824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499233|NCT05777733|Acetylcysteine|acetylcysteine|mesh-list
92499234|NCT05777733|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92499235|NCT05777733|Antidotes|antidotes|mesh-ancestor
92499236|NCT05777733|Protective Agents|protective agents|mesh-ancestor
92499237|NCT05777733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499238|NCT05777733|Antioxidants|antioxidants|mesh-ancestor
92499239|NCT05777733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499240|NCT05777733|Antiviral Agents|antiviral agents|mesh-ancestor
92499241|NCT05777733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499242|NCT05777733|Expectorants|expectorants|mesh-ancestor
92499243|NCT05777733|Respiratory System Agents|respiratory system agents|mesh-ancestor
92499244|NCT05777733|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92499245|NCT05777707|Paclitaxel|paclitaxel|mesh-list
92499246|NCT05777707|Carboplatin|carboplatin|mesh-list
92499247|NCT05777707|Nedaplatin|nedaplatin|mesh-list
92499248|NCT05777707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92499249|NCT05777707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499250|NCT05777707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499251|NCT05777707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499252|NCT05777707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499253|NCT05777707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499255|NCT05777694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499256|NCT05777694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499257|NCT05777369|Prednisone|prednisone|mesh-list
92499258|NCT05777369|Cyclophosphamide|cyclophosphamide|mesh-list
92499259|NCT05777369|Rituximab|rituximab|mesh-list
92499260|NCT05777369|Vincristine|vincristine|mesh-list
92499261|NCT05777369|Mitoxantrone|mitoxantrone|mesh-list
92499262|NCT05777369|Vindesine|vindesine|mesh-list
92499263|NCT05777369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92499264|NCT05777369|Immunologic Factors|immunologic factors|mesh-ancestor
92499265|NCT05777369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499266|NCT05777369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532783|NCT00055393|Dopamine Agents|dopamine agents|mesh-ancestor
92499267|NCT05777369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92499268|NCT05777369|Alkylating Agents|alkylating agents|mesh-ancestor
92499269|NCT05777369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499270|NCT05777369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499271|NCT05777369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92499272|NCT05777369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499273|NCT05777369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499274|NCT05777369|Glucocorticoids|glucocorticoids|mesh-ancestor
92499275|NCT05777369|Hormones|hormones|mesh-ancestor
92152400|NCT03595397|Anesthetics, Local|anesthetics, local|mesh-ancestor
92499276|NCT05777369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499277|NCT05777369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92499278|NCT05777369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92499279|NCT05777369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499280|NCT05777369|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499281|NCT05777369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499282|NCT05777369|Analgesics|analgesics|mesh-ancestor
92499283|NCT05777369|Sensory System Agents|sensory system agents|mesh-ancestor
92499284|NCT05777369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499285|NCT05777369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92499286|NCT05777369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92499287|NCT05777369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499288|NCT05777278|Docetaxel|docetaxel|mesh-list
92499289|NCT05777278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499290|NCT05777278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499291|NCT05777278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499292|NCT05777278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499293|NCT05777278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499294|NCT05777122|Lidocaine|lidocaine|mesh-list
92499295|NCT05777122|Anesthetics, Local|anesthetics, local|mesh-ancestor
92499296|NCT05777122|Anesthetics|anesthetics|mesh-ancestor
92499297|NCT05777122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499298|NCT05777122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499299|NCT05777122|Sensory System Agents|sensory system agents|mesh-ancestor
92499300|NCT05777122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499301|NCT05777122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92499302|NCT05777122|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92499303|NCT05777122|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92499304|NCT05777122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499305|NCT05777122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499306|NCT05777109|Denosumab|denosumab|mesh-list
92499307|NCT05777109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92499308|NCT05777109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499309|NCT05753306|Cisplatin|cisplatin|mesh-list
92499310|NCT05753306|Docetaxel|docetaxel|mesh-list
92499311|NCT05753306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499312|NCT05753306|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499313|NCT05753306|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499314|NCT05753306|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499315|NCT05753306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499316|NCT05616390|Bevacizumab|bevacizumab|mesh-list
92499317|NCT05616390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499318|NCT05616390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499319|NCT05616390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92499320|NCT05616390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92499321|NCT05616390|Growth Substances|growth substances|mesh-ancestor
92499322|NCT05616390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499323|NCT05616390|Growth Inhibitors|growth inhibitors|mesh-ancestor
92499324|NCT05613413|Pembrolizumab|pembrolizumab|mesh-list
92499325|NCT05613413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499326|NCT05613413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499327|NCT05613413|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92499328|NCT05613413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499329|NCT05597150|Magnesium citrate|magnesium citrate|mesh-list
92499330|NCT05597150|Cathartics|cathartics|mesh-ancestor
92499331|NCT05597150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499333|NCT05587894|Remdesivir|remdesivir|mesh-list
92499334|NCT05587894|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92499335|NCT05587894|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92499336|NCT05587894|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92499337|NCT05587894|Protease Inhibitors|protease inhibitors|mesh-ancestor
92499338|NCT05587894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499339|NCT05587894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499341|NCT05587894|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92499342|NCT05587894|Antiviral Agents|antiviral agents|mesh-ancestor
92499343|NCT05587894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499344|NCT05587894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92499345|NCT05587894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92499346|NCT05587894|Antimetabolites|antimetabolites|mesh-ancestor
92499347|NCT05548270|Scopolamine|scopolamine|mesh-list
92499348|NCT05548270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92499349|NCT05548270|Antiemetics|antiemetics|mesh-ancestor
92499350|NCT05548270|Autonomic Agents|autonomic agents|mesh-ancestor
92499351|NCT05548270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499352|NCT05548270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499353|NCT05548270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499354|NCT05548270|Mydriatics|mydriatics|mesh-ancestor
92499355|NCT05548270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92499356|NCT05548270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92499357|NCT05548270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499358|NCT05548270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499359|NCT05548270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92499360|NCT05534620|Fludarabine|fludarabine|mesh-list
92499361|NCT05534620|Treosulfan|treosulfan|mesh-list
92499362|NCT05534620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499363|NCT05534620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499364|NCT05534620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92499365|NCT05534620|Alkylating Agents|alkylating agents|mesh-ancestor
92499366|NCT05514197|Ascorbic Acid|ascorbic acid|mesh-list
92499367|NCT05514197|Antioxidants|antioxidants|mesh-ancestor
92499368|NCT05514197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499369|NCT05514197|Protective Agents|protective agents|mesh-ancestor
92499370|NCT05514197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499371|NCT05514197|Vitamins|vitamins|mesh-ancestor
92499372|NCT05514197|Micronutrients|micronutrients|mesh-ancestor
92499373|NCT05499052|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92499374|NCT05499052|Hormones|hormones|mesh-ancestor
92499375|NCT05499052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499376|NCT05499052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499377|NCT05493735|Lidocaine|lidocaine|mesh-list
92499378|NCT05493735|Anesthetics, Local|anesthetics, local|mesh-ancestor
92499379|NCT05493735|Anesthetics|anesthetics|mesh-ancestor
92499380|NCT05493735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499381|NCT05493735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499382|NCT05493735|Sensory System Agents|sensory system agents|mesh-ancestor
92499383|NCT05493735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499384|NCT05493735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92499385|NCT05493735|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92499386|NCT05493735|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92499387|NCT05493735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499388|NCT05493735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499389|NCT05410158|Ketamine|ketamine|mesh-list
92499390|NCT05410158|Analgesics|analgesics|mesh-ancestor
92499391|NCT05410158|Sensory System Agents|sensory system agents|mesh-ancestor
92499392|NCT05410158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499393|NCT05410158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499394|NCT05410158|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92499395|NCT05410158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92499396|NCT05410158|Anesthetics, General|anesthetics, general|mesh-ancestor
92499397|NCT05410158|Anesthetics|anesthetics|mesh-ancestor
92499398|NCT05410158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499399|NCT05410158|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92499400|NCT05410158|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92499401|NCT05410158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499402|NCT05410158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499403|NCT05291403|Erythromycin|erythromycin|mesh-list
92499404|NCT05291403|Erythromycin Estolate|erythromycin estolate|mesh-list
92499405|NCT05291403|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92499406|NCT05291403|Erythromycin stearate|erythromycin stearate|mesh-list
92499407|NCT05291403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499408|NCT05291403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499409|NCT05291403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499410|NCT05291403|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92499411|NCT05291403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499412|NCT05291403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499413|NCT05279690|Colchicine|colchicine|mesh-list
92499414|NCT05279690|Gout Suppressants|gout suppressants|mesh-ancestor
92499415|NCT05279690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499416|NCT05279690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499417|NCT05279690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499418|NCT05279690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499419|NCT05279690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499420|NCT05279690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499421|NCT05255302|Pembrolizumab|pembrolizumab|mesh-list
92499422|NCT05255302|Pemetrexed|pemetrexed|mesh-list
92499423|NCT05255302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499424|NCT05255302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499425|NCT05255302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92499426|NCT05255302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499427|NCT05255302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499428|NCT05255302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92499429|NCT05255302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92499430|NCT05138068|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92499431|NCT05138068|Hallucinogens|hallucinogens|mesh-ancestor
92499432|NCT05138068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499433|NCT05138068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92499434|NCT05138068|Serotonin Agents|serotonin agents|mesh-ancestor
92224331|NCT04713904|Estradiol|estradiol|mesh-list
92499435|NCT05138068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499436|NCT05138068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499437|NCT05138068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92499438|NCT05138068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92499439|NCT05138068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499440|NCT05138068|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499441|NCT05121168|Bupivacaine|bupivacaine|mesh-list
92499442|NCT05121168|Anesthetics, Local|anesthetics, local|mesh-ancestor
92499443|NCT05121168|Anesthetics|anesthetics|mesh-ancestor
92499444|NCT05121168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499445|NCT05121168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499446|NCT05121168|Sensory System Agents|sensory system agents|mesh-ancestor
92499447|NCT05121168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499448|NCT05091905|Ropivacaine|ropivacaine|mesh-list
92499449|NCT05091905|Anesthetics, Local|anesthetics, local|mesh-list
92499450|NCT05091905|Anesthetics|anesthetics|mesh-list
92499451|NCT05091905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499452|NCT05091905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499453|NCT05091905|Sensory System Agents|sensory system agents|mesh-ancestor
92499454|NCT05091905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499455|NCT05085873|Midazolam|midazolam|mesh-list
92499456|NCT05085873|Sodium Oxybate|sodium oxybate|mesh-list
92499457|NCT05085873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92499458|NCT05085873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92499459|NCT05085873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499460|NCT05085873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499461|NCT05085873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92499462|NCT05085873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92499463|NCT05085873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92499464|NCT05085873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92499465|NCT05085873|Anesthetics, General|anesthetics, general|mesh-ancestor
92499466|NCT05085873|Anesthetics|anesthetics|mesh-ancestor
92499467|NCT05085873|GABA Modulators|gaba modulators|mesh-ancestor
92499468|NCT05085873|GABA Agents|gaba agents|mesh-ancestor
92499469|NCT05085873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499470|NCT05085873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499471|NCT04983589|Pilocarpine|pilocarpine|mesh-list
92499472|NCT04983589|Miotics|miotics|mesh-ancestor
92499473|NCT04983589|Autonomic Agents|autonomic agents|mesh-ancestor
92499474|NCT04983589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499475|NCT04983589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499476|NCT04983589|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92499477|NCT04983589|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92499478|NCT04983589|Cholinergic Agents|cholinergic agents|mesh-ancestor
92499479|NCT04983589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499480|NCT04983589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499481|NCT04961580|Ceftazidime|ceftazidime|mesh-list
92499482|NCT04961580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499483|NCT04961580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499484|NCT04886154|Vaccines|vaccines|mesh-list
92499485|NCT04886154|Immunologic Factors|immunologic factors|mesh-ancestor
92499486|NCT04886154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499487|NCT04861922|Heparin|heparin|mesh-list
92499488|NCT04861922|Calcium heparin|calcium heparin|mesh-list
92499489|NCT04861922|Anticoagulants|anticoagulants|mesh-ancestor
92499490|NCT04861922|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92499491|NCT04861922|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92499492|NCT04861922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499493|NCT04840472|Panitumumab|panitumumab|mesh-list
92499494|NCT04840472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499495|NCT04840472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499496|NCT04794517|Dapagliflozin|dapagliflozin|mesh-list
92499497|NCT04794517|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92499498|NCT04794517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499499|NCT04794517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92499500|NCT04794517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499501|NCT04782830|Midodrine|midodrine|mesh-list
92499502|NCT04782830|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92499503|NCT04782830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92499504|NCT04782830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92499505|NCT04782830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499506|NCT04782830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499507|NCT04782830|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499508|NCT04782830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224410|NCT05025644|Dobutamine|dobutamine|mesh-list
92499509|NCT04782830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499510|NCT04782830|Sympathomimetics|sympathomimetics|mesh-ancestor
92499511|NCT04782830|Autonomic Agents|autonomic agents|mesh-ancestor
92499512|NCT04782830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499513|NCT04782830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92499514|NCT04782830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92499515|NCT04782830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92499516|NCT04782830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92499517|NCT04771000|Ambrisentan|ambrisentan|mesh-list
92499518|NCT04771000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92499519|NCT04711109|Denosumab|denosumab|mesh-list
92499520|NCT04711109|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92499521|NCT04711109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499522|NCT04620382|Midodrine|midodrine|mesh-list
92499523|NCT04620382|Sympathomimetics|sympathomimetics|mesh-ancestor
92499524|NCT04620382|Autonomic Agents|autonomic agents|mesh-ancestor
92499525|NCT04620382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499526|NCT04620382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499527|NCT04620382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92499528|NCT04620382|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92499529|NCT04620382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92499530|NCT04620382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92499531|NCT04620382|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499532|NCT04620382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499533|NCT04620382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499534|NCT04567420|Fulvestrant|fulvestrant|mesh-list
92499535|NCT04567420|Palbociclib|palbociclib|mesh-list
92499536|NCT04567420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92499537|NCT04567420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499538|NCT04567420|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92499539|NCT04567420|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92499540|NCT04567420|Hormone Antagonists|hormone antagonists|mesh-ancestor
92499541|NCT04567420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499542|NCT04567420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499543|NCT04567420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92499544|NCT04567420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499545|NCT04567420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499546|NCT04565483|Benralizumab|benralizumab|mesh-list
92499547|NCT04565483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92499548|NCT04565483|Respiratory System Agents|respiratory system agents|mesh-ancestor
92499549|NCT04495855|Dienogest|dienogest|mesh-list
92499550|NCT04495855|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92499551|NCT04495855|Contraceptive Agents|contraceptive agents|mesh-ancestor
92499552|NCT04495855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92499553|NCT04495855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499554|NCT04495855|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92499555|NCT04495855|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92499556|NCT04495855|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92499557|NCT04495855|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92499558|NCT04495855|Hormone Antagonists|hormone antagonists|mesh-ancestor
92499559|NCT04495855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499560|NCT04495855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92499561|NCT04495855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499562|NCT04461587|Pirfenidone|pirfenidone|mesh-list
92499563|NCT04461587|Analgesics|analgesics|mesh-ancestor
92499564|NCT04461587|Sensory System Agents|sensory system agents|mesh-ancestor
92499565|NCT04461587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499566|NCT04461587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499567|NCT04461587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92499568|NCT04461587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92499569|NCT04461587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499570|NCT04461587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499571|NCT04461587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499572|NCT04371107|Azithromycin|azithromycin|mesh-list
92499573|NCT04371107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499574|NCT04371107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499575|NCT04364984|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92499576|NCT04364984|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92499577|NCT04364984|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92499578|NCT04364984|Renin Inhibitors|renin inhibitors|mesh-list
92499579|NCT04364984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499580|NCT04364984|Protease Inhibitors|protease inhibitors|mesh-ancestor
92224481|NCT03150160|Travoprost|travoprost|mesh-list
92499582|NCT04278833|Triamcinolone|triamcinolone|mesh-list
92499583|NCT04278833|Betamethasone|betamethasone|mesh-list
92499584|NCT04278833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499585|NCT04278833|Antiemetics|antiemetics|mesh-ancestor
92499586|NCT04278833|Autonomic Agents|autonomic agents|mesh-ancestor
92499587|NCT04278833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499588|NCT04278833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499589|NCT04278833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499590|NCT04278833|Glucocorticoids|glucocorticoids|mesh-ancestor
92499591|NCT04278833|Hormones|hormones|mesh-ancestor
92499592|NCT04278833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499593|NCT04278833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92499594|NCT04278833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499595|NCT04278833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92499596|NCT04278833|Respiratory System Agents|respiratory system agents|mesh-ancestor
92499597|NCT04225065|Chlorhexidine|chlorhexidine|mesh-list
92499598|NCT04225065|Povidone-Iodine|povidone-iodine|mesh-list
92499599|NCT04225065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92499600|NCT04225065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499601|NCT04225065|Disinfectants|disinfectants|mesh-ancestor
92499602|NCT04221087|Dexamethasone|dexamethasone|mesh-list
92499603|NCT04221087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499604|NCT04221087|Antiemetics|antiemetics|mesh-ancestor
92499605|NCT04221087|Autonomic Agents|autonomic agents|mesh-ancestor
92499606|NCT04221087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499607|NCT04221087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499608|NCT04221087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499609|NCT04221087|Glucocorticoids|glucocorticoids|mesh-ancestor
92499610|NCT04221087|Hormones|hormones|mesh-ancestor
92499611|NCT04221087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499612|NCT04221087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92499613|NCT04221087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499614|NCT04200911|Sirolimus|sirolimus|mesh-list
92499615|NCT04200911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499616|NCT04200911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499617|NCT04200911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92499618|NCT04200911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499619|NCT04200911|Antifungal Agents|antifungal agents|mesh-ancestor
92499620|NCT04200911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92499621|NCT04200911|Immunologic Factors|immunologic factors|mesh-ancestor
92499622|NCT04200911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499623|NCT04112641|Niacinamide|niacinamide|mesh-list
92499624|NCT04112641|Niacin|niacin|mesh-list
92499625|NCT04112641|Nicotinic Acids|nicotinic acids|mesh-list
92499626|NCT04112641|Vitamin B Complex|vitamin b complex|mesh-ancestor
92499627|NCT04112641|Vitamins|vitamins|mesh-ancestor
92499629|NCT04112641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499630|NCT04112641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92499631|NCT04112641|Antimetabolites|antimetabolites|mesh-ancestor
92499632|NCT04112641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499633|NCT04112641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92499634|NCT04112641|Vasodilator Agents|vasodilator agents|mesh-ancestor
92499635|NCT04062591|Piroxicam|piroxicam|mesh-list
92499636|NCT04062591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92499637|NCT04062591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92499638|NCT04062591|Analgesics|analgesics|mesh-ancestor
92499639|NCT04062591|Sensory System Agents|sensory system agents|mesh-ancestor
92499640|NCT04062591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499641|NCT04062591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499642|NCT04062591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499643|NCT04062591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499644|NCT04062591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92499645|NCT04062591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499646|NCT04062591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499647|NCT04059770|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92499648|NCT04059770|Amphotericin B|amphotericin b|mesh-list
92499649|NCT04059770|Antifungal Agents|antifungal agents|mesh-ancestor
92499650|NCT04059770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499651|NCT04059770|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92499652|NCT04059770|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92499653|NCT04059770|Amebicides|amebicides|mesh-ancestor
92499654|NCT04059770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92499655|NCT04050280|Cytarabine|cytarabine|mesh-list
92499656|NCT04050280|Cladribine|cladribine|mesh-list
92499657|NCT04050280|Gemtuzumab|gemtuzumab|mesh-list
92499658|NCT04050280|Lenograstim|lenograstim|mesh-list
92499659|NCT04050280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92499660|NCT04050280|Antimetabolites|antimetabolites|mesh-ancestor
92499661|NCT04050280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499662|NCT04050280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499663|NCT04050280|Antiviral Agents|antiviral agents|mesh-ancestor
92499664|NCT04050280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499665|NCT04050280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92499666|NCT04050280|Immunologic Factors|immunologic factors|mesh-ancestor
92499667|NCT04050280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499668|NCT04050280|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92499669|NCT04050280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499670|NCT04050280|Immunotoxins|immunotoxins|mesh-ancestor
92499671|NCT04050280|Immunoconjugates|immunoconjugates|mesh-ancestor
92499672|NCT04018755|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92499673|NCT04018755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499674|NCT03994731|Acetaminophen|acetaminophen|mesh-list
92499675|NCT03994731|Folic Acid|folic acid|mesh-list
92499676|NCT03994731|Fexofenadine|fexofenadine|mesh-list
92499677|NCT03994731|Methylprednisolone|methylprednisolone|mesh-list
92499678|NCT03994731|Methotrexate|methotrexate|mesh-list
92499679|NCT03994731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92499680|NCT03994731|Abortifacient Agents|abortifacient agents|mesh-ancestor
92499681|NCT03994731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92499682|NCT03994731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499683|NCT03994731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92499684|NCT03994731|Antimetabolites|antimetabolites|mesh-ancestor
92499685|NCT03994731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499686|NCT03994731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499687|NCT03994731|Dermatologic Agents|dermatologic agents|mesh-ancestor
92499688|NCT03994731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499689|NCT03994731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92499690|NCT03994731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92499691|NCT03994731|Immunologic Factors|immunologic factors|mesh-ancestor
92499692|NCT03994731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499693|NCT03994731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92499694|NCT03994731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92499695|NCT03994731|Analgesics|analgesics|mesh-ancestor
92499696|NCT03994731|Sensory System Agents|sensory system agents|mesh-ancestor
92499697|NCT03994731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499698|NCT03994731|Antipyretics|antipyretics|mesh-ancestor
92499699|NCT03994731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499701|NCT03994731|Autonomic Agents|autonomic agents|mesh-ancestor
92532792|NCT00055432|Antimetabolites|antimetabolites|mesh-ancestor
92499702|NCT03994731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499703|NCT03994731|Glucocorticoids|glucocorticoids|mesh-ancestor
92499704|NCT03994731|Hormones|hormones|mesh-ancestor
92499705|NCT03994731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499706|NCT03994731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92499707|NCT03994731|Protective Agents|protective agents|mesh-ancestor
92499708|NCT03994731|Hematinics|hematinics|mesh-ancestor
92499709|NCT03994731|Vitamin B Complex|vitamin b complex|mesh-ancestor
92499710|NCT03994731|Vitamins|vitamins|mesh-ancestor
92499711|NCT03994731|Micronutrients|micronutrients|mesh-ancestor
92499712|NCT03994731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92499713|NCT03994731|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92499714|NCT03994731|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92499715|NCT03994731|Histamine Antagonists|histamine antagonists|mesh-ancestor
92499716|NCT03994731|Histamine Agents|histamine agents|mesh-ancestor
92499717|NCT03994731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499718|NCT03984357|Gemcitabine|gemcitabine|mesh-list
92499719|NCT03984357|Antibodies|antibodies|mesh-list
92499720|NCT03984357|Antibodies, Blocking|antibodies, blocking|mesh-list
92499721|NCT03984357|Immunologic Factors|immunologic factors|mesh-ancestor
92499722|NCT03984357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499723|NCT03984357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499724|NCT03984357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92499725|NCT03984357|Antimetabolites|antimetabolites|mesh-ancestor
92499726|NCT03984357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499727|NCT03829683|Ascorbic Acid|ascorbic acid|mesh-list
92499728|NCT03829683|Vitamins|vitamins|mesh-ancestor
92499729|NCT03829683|Micronutrients|micronutrients|mesh-ancestor
92499730|NCT03829683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499731|NCT03829683|Antioxidants|antioxidants|mesh-ancestor
92499732|NCT03829683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499733|NCT03829683|Protective Agents|protective agents|mesh-ancestor
92499734|NCT03824522|BAX 855|bax 855|mesh-list
92499735|NCT03824522|Coagulants|coagulants|mesh-ancestor
92499736|NCT03812991|Calcitonin|calcitonin|mesh-list
92499737|NCT03812991|Salmon calcitonin|salmon calcitonin|mesh-list
92499738|NCT03812991|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92499739|NCT03812991|Katacalcin|katacalcin|mesh-list
92499740|NCT03812991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92499741|NCT03812991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499742|NCT03812991|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92499743|NCT03812991|Vasodilator Agents|vasodilator agents|mesh-ancestor
92499744|NCT03737968|Durvalumab|durvalumab|mesh-list
92499745|NCT03737968|Tremelimumab|tremelimumab|mesh-list
92499746|NCT03737968|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92499747|NCT03737968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499748|NCT03737968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499749|NCT03737968|Immunologic Factors|immunologic factors|mesh-ancestor
92499750|NCT03737968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499751|NCT03652753|Acetylcysteine|acetylcysteine|mesh-list
92499752|NCT03652753|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92499753|NCT03652753|Antiviral Agents|antiviral agents|mesh-ancestor
92499754|NCT03652753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499755|NCT03652753|Expectorants|expectorants|mesh-ancestor
92499756|NCT03652753|Respiratory System Agents|respiratory system agents|mesh-ancestor
92499757|NCT03652753|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92499758|NCT03652753|Antioxidants|antioxidants|mesh-ancestor
92499759|NCT03652753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499760|NCT03652753|Protective Agents|protective agents|mesh-ancestor
92499761|NCT03652753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499762|NCT03652753|Antidotes|antidotes|mesh-ancestor
92499763|NCT03581877|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92499764|NCT03581877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92499765|NCT03581877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92499766|NCT03581877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499767|NCT03556202|Mirikizumab|mirikizumab|mesh-list
92499768|NCT03556202|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92499769|NCT03556202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92499770|NCT03556202|Analgesics|analgesics|mesh-ancestor
92499771|NCT03556202|Sensory System Agents|sensory system agents|mesh-ancestor
92499772|NCT03556202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499773|NCT03556202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499774|NCT03556202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499775|NCT03556202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499776|NCT03556202|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92499777|NCT03556202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499778|NCT03480438|Blinatumomab|blinatumomab|mesh-list
92499779|NCT03480438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499780|NCT03463876|Apatinib|apatinib|mesh-list
92499781|NCT03463876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499782|NCT03463876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92499783|NCT03463876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499784|NCT03463876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499785|NCT03461120|Anesthetics|anesthetics|mesh-list
92499786|NCT03461120|Anesthetics, Local|anesthetics, local|mesh-list
92499787|NCT03461120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499788|NCT03461120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499789|NCT03461120|Sensory System Agents|sensory system agents|mesh-ancestor
92499790|NCT03461120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499791|NCT03396588|Clonidine|clonidine|mesh-list
92499792|NCT03396588|Morphine|morphine|mesh-list
92499793|NCT03396588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92499794|NCT03396588|Narcotics|narcotics|mesh-ancestor
92499795|NCT03396588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499796|NCT03396588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499797|NCT03396588|Analgesics|analgesics|mesh-ancestor
92499798|NCT03396588|Sensory System Agents|sensory system agents|mesh-ancestor
92499799|NCT03396588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499800|NCT03396588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92499801|NCT03396588|Sympatholytics|sympatholytics|mesh-ancestor
92499802|NCT03396588|Autonomic Agents|autonomic agents|mesh-ancestor
92499803|NCT03396588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92499804|NCT03396588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92499805|NCT03396588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92499806|NCT03396588|Adrenergic Agents|adrenergic agents|mesh-ancestor
92499807|NCT03396588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499808|NCT03396588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499809|NCT03361852|Rituximab|rituximab|mesh-list
92499810|NCT03361852|Pembrolizumab|pembrolizumab|mesh-list
92499811|NCT03361852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499812|NCT03361852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499813|NCT03361852|Immunologic Factors|immunologic factors|mesh-ancestor
92499814|NCT03361852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499815|NCT03361852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499816|NCT03361852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92499817|NCT03361852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499818|NCT03350516|Calcium, Dietary|calcium, dietary|mesh-list
92499819|NCT03350516|Calcium Carbonate|calcium carbonate|mesh-list
92499820|NCT03350516|Calcium|calcium|mesh-list
92499821|NCT03350516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92499822|NCT03350516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499823|NCT03350516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92499824|NCT03350516|Antacids|antacids|mesh-ancestor
92499825|NCT03350516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499826|NCT03350516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499827|NCT03350451|Lumasiran|lumasiran|mesh-list
92499828|NCT03350451|Renal Agents|renal agents|mesh-ancestor
92499829|NCT03329508|Pramipexole|pramipexole|mesh-list
92499830|NCT03329508|Rasagiline|rasagiline|mesh-list
92499831|NCT03329508|Antioxidants|antioxidants|mesh-ancestor
92499832|NCT03329508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499833|NCT03329508|Protective Agents|protective agents|mesh-ancestor
92499834|NCT03329508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499835|NCT03329508|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92499836|NCT03329508|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92499837|NCT03329508|Dopamine Agonists|dopamine agonists|mesh-ancestor
92499838|NCT03329508|Dopamine Agents|dopamine agents|mesh-ancestor
92499839|NCT03329508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499840|NCT03329508|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92499841|NCT03329508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499842|NCT03329508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92499843|NCT03289039|Fulvestrant|fulvestrant|mesh-list
92499844|NCT03289039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92499845|NCT03289039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499846|NCT03289039|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92499847|NCT03289039|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92499848|NCT03289039|Hormone Antagonists|hormone antagonists|mesh-ancestor
92532798|NCT00055549|Lorazepam|lorazepam|mesh-list
92499849|NCT03289039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92499850|NCT03289039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499852|NCT03281304|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92499853|NCT03281304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92499854|NCT03281304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499855|NCT03281304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499856|NCT03153319|Adalimumab|adalimumab|mesh-list
92499857|NCT03153319|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92499858|NCT03153319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499859|NCT03153319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499860|NCT03145272|Oxycodone|oxycodone|mesh-list
92499861|NCT03145272|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92499862|NCT03145272|Narcotics|narcotics|mesh-ancestor
92499863|NCT03145272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92499864|NCT03145272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499865|NCT03145272|Analgesics|analgesics|mesh-ancestor
92499866|NCT03145272|Sensory System Agents|sensory system agents|mesh-ancestor
92499867|NCT03145272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499868|NCT03127007|Atezolizumab|atezolizumab|mesh-list
92499869|NCT03127007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92499870|NCT03127007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499871|NCT03127007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499872|NCT03127007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499873|NCT03109093|Blinatumomab|blinatumomab|mesh-list
92499874|NCT03109093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499875|NCT02726711|Trimethaphan|trimethaphan|mesh-list
92499876|NCT02726711|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
92499877|NCT02726711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92499878|NCT02726711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92499879|NCT02726711|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92499880|NCT02726711|Autonomic Agents|autonomic agents|mesh-ancestor
92499881|NCT02726711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499882|NCT02726711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499883|NCT02726711|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92499884|NCT02726711|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92499885|NCT02726711|Cholinergic Agents|cholinergic agents|mesh-ancestor
92499886|NCT02726711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499887|NCT02726711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499888|NCT02726711|Vasodilator Agents|vasodilator agents|mesh-ancestor
92499889|NCT02691065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
92499890|NCT02691065|Integrase Inhibitors|integrase inhibitors|mesh-list
92499891|NCT02691065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499892|NCT02691065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499893|NCT02691065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92499894|NCT02691065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92499895|NCT02691065|Antiviral Agents|antiviral agents|mesh-ancestor
92499896|NCT02691065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92499897|NCT02649998|Furosemide|furosemide|mesh-list
92499898|NCT02649998|Isosorbide|isosorbide|mesh-list
92499899|NCT02649998|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92499900|NCT02649998|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92499901|NCT02649998|Diuretics|diuretics|mesh-ancestor
92499902|NCT02649998|Natriuretic Agents|natriuretic agents|mesh-ancestor
92499903|NCT02649998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499904|NCT02649998|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92499905|NCT02649998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92499906|NCT02649998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499907|NCT02649998|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92499908|NCT02649998|Vasodilator Agents|vasodilator agents|mesh-ancestor
92499909|NCT02649998|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92499910|NCT02503358|Paclitaxel|paclitaxel|mesh-list
92499911|NCT02503358|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92499912|NCT02503358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92499913|NCT02503358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499914|NCT02503358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499915|NCT02503358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499916|NCT02503358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499917|NCT02503358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499918|NCT02432963|Pembrolizumab|pembrolizumab|mesh-list
92499919|NCT02432963|Vaccines|vaccines|mesh-list
92499920|NCT02432963|Immunologic Factors|immunologic factors|mesh-ancestor
92499921|NCT02432963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499922|NCT02432963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499923|NCT02432963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499924|NCT02432963|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92499925|NCT02432963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499926|NCT02358538|Ganaxolone|ganaxolone|mesh-list
92499927|NCT02358538|Neurosteroids|neurosteroids|mesh-ancestor
92499928|NCT02358538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92499929|NCT02358538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499930|NCT02358538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499931|NCT02358538|GABA Modulators|gaba modulators|mesh-ancestor
92499932|NCT02358538|GABA Agents|gaba agents|mesh-ancestor
92499933|NCT02349906|Treosulfan|treosulfan|mesh-list
92499934|NCT02349906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92499935|NCT02349906|Alkylating Agents|alkylating agents|mesh-ancestor
92499936|NCT02349906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499937|NCT02349906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499938|NCT02336087|Metformin|metformin|mesh-list
92499939|NCT02336087|Paclitaxel|paclitaxel|mesh-list
92499940|NCT02336087|Gemcitabine|gemcitabine|mesh-list
92499941|NCT02336087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92499942|NCT02336087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92499943|NCT02336087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499944|NCT02336087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92499945|NCT02336087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92499946|NCT02336087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92499947|NCT02336087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499948|NCT02336087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92499949|NCT02336087|Antimetabolites|antimetabolites|mesh-ancestor
92499950|NCT02336087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92499951|NCT02336087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499952|NCT02332980|Pembrolizumab|pembrolizumab|mesh-list
92499953|NCT02332980|Idelalisib|idelalisib|mesh-list
92499954|NCT02332980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92499955|NCT02332980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499956|NCT02332980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92499957|NCT02332980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499958|NCT02332980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92499959|NCT02087826|Metformin|metformin|mesh-list
92499960|NCT02087826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92499961|NCT02087826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499962|NCT02048813|Cyclophosphamide|cyclophosphamide|mesh-list
92499963|NCT02048813|Rituximab|rituximab|mesh-list
92499964|NCT02048813|Fludarabine|fludarabine|mesh-list
92499965|NCT02048813|Fludarabine phosphate|fludarabine phosphate|mesh-list
92499966|NCT02048813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92499967|NCT02048813|Antibodies|antibodies|mesh-list
92499968|NCT02048813|Immunoglobulins|immunoglobulins|mesh-list
92499969|NCT02048813|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92499970|NCT02048813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92499971|NCT02048813|Immunologic Factors|immunologic factors|mesh-ancestor
92499972|NCT02048813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499973|NCT02048813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92499974|NCT02048813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92499975|NCT02048813|Alkylating Agents|alkylating agents|mesh-ancestor
92499976|NCT02048813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92499977|NCT02048813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92499978|NCT02048813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92499979|NCT02048813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92499980|NCT02048813|Antimetabolites|antimetabolites|mesh-ancestor
92499981|NCT02048150|Antibodies|antibodies|mesh-list
92499982|NCT02048150|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92499983|NCT02048150|Immunologic Factors|immunologic factors|mesh-ancestor
92499984|NCT02048150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499985|NCT02038452|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92499986|NCT02038452|Methylprednisolone|methylprednisolone|mesh-list
92499987|NCT02038452|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92499988|NCT02038452|Prednisolone|prednisolone|mesh-list
92499989|NCT02038452|Prednisolone acetate|prednisolone acetate|mesh-list
92499990|NCT02038452|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92499991|NCT02038452|Prednisolone phosphate|prednisolone phosphate|mesh-list
92499992|NCT02038452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92499993|NCT02038452|Antiemetics|antiemetics|mesh-ancestor
92499994|NCT02038452|Autonomic Agents|autonomic agents|mesh-ancestor
92499995|NCT02038452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92499996|NCT02038452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92499997|NCT02038452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92499998|NCT02038452|Glucocorticoids|glucocorticoids|mesh-ancestor
92499999|NCT02038452|Hormones|hormones|mesh-ancestor
92500000|NCT02038452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500001|NCT02038452|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92500003|NCT02038452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92500004|NCT02038452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500005|NCT01748448|Vitamin D|vitamin d|mesh-list
92500006|NCT01748448|Cholecalciferol|cholecalciferol|mesh-list
92500007|NCT01748448|Vitamins|vitamins|mesh-ancestor
92500008|NCT01748448|Micronutrients|micronutrients|mesh-ancestor
92500009|NCT01748448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500010|NCT01748448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92500011|NCT01748448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500012|NCT01476839|Cytarabine|cytarabine|mesh-list
92500013|NCT01476839|Etoposide|etoposide|mesh-list
92500014|NCT01476839|Etoposide phosphate|etoposide phosphate|mesh-list
92500015|NCT01476839|Melphalan|melphalan|mesh-list
92500016|NCT01476839|Carmustine|carmustine|mesh-list
92500017|NCT01476839|Basiliximab|basiliximab|mesh-list
92500018|NCT01476839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92500019|NCT01476839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500020|NCT01476839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92500021|NCT01476839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92500022|NCT01476839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500023|NCT01476839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500024|NCT01476839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92500025|NCT01476839|Antimetabolites|antimetabolites|mesh-ancestor
92500026|NCT01476839|Antiviral Agents|antiviral agents|mesh-ancestor
92500027|NCT01476839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500028|NCT01476839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500029|NCT01476839|Immunologic Factors|immunologic factors|mesh-ancestor
92500030|NCT01476839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500031|NCT01476839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92500032|NCT01476839|Alkylating Agents|alkylating agents|mesh-ancestor
92500033|NCT01476839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92500034|NCT01332097|Prednisone|prednisone|mesh-list
92500035|NCT01332097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92500036|NCT01332097|Glucocorticoids|glucocorticoids|mesh-ancestor
92500037|NCT01332097|Hormones|hormones|mesh-ancestor
92500038|NCT01332097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500039|NCT01332097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500040|NCT01332097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92500041|NCT01332097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500043|NCT01163357|Fludarabine|fludarabine|mesh-list
92500044|NCT01163357|Fludarabine phosphate|fludarabine phosphate|mesh-list
92500045|NCT01163357|Bortezomib|bortezomib|mesh-list
92500046|NCT01163357|Melphalan|melphalan|mesh-list
92500047|NCT01163357|Tacrolimus|tacrolimus|mesh-list
92500048|NCT01163357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500049|NCT01163357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92500050|NCT01163357|Antimetabolites|antimetabolites|mesh-ancestor
92500051|NCT01163357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500052|NCT01163357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500053|NCT01163357|Immunologic Factors|immunologic factors|mesh-ancestor
92500054|NCT01163357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500055|NCT01163357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92500056|NCT01163357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500057|NCT01163357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92500058|NCT01163357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500059|NCT01163357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92500060|NCT01163357|Antifungal Agents|antifungal agents|mesh-ancestor
92500061|NCT01163357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92500062|NCT01163357|Alkylating Agents|alkylating agents|mesh-ancestor
92500063|NCT01163357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92500064|NCT00967005|Acetylcysteine|acetylcysteine|mesh-list
92500065|NCT00967005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92500066|NCT00967005|Antiviral Agents|antiviral agents|mesh-ancestor
92500067|NCT00967005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500068|NCT00967005|Expectorants|expectorants|mesh-ancestor
92500069|NCT00967005|Respiratory System Agents|respiratory system agents|mesh-ancestor
92500070|NCT00967005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92500071|NCT00967005|Antioxidants|antioxidants|mesh-ancestor
92532806|NCT00055549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500072|NCT00967005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500073|NCT00967005|Protective Agents|protective agents|mesh-ancestor
92500074|NCT00967005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500075|NCT00967005|Antidotes|antidotes|mesh-ancestor
92500076|NCT00863369|Rituximab|rituximab|mesh-list
92500077|NCT00863369|Gemcitabine|gemcitabine|mesh-list
92500078|NCT00863369|Bortezomib|bortezomib|mesh-list
92500079|NCT00863369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500080|NCT00863369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500082|NCT00863369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500083|NCT00863369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92500084|NCT00863369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92500085|NCT00863369|Antimetabolites|antimetabolites|mesh-ancestor
92500086|NCT00863369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500087|NCT00538031|Celecoxib|celecoxib|mesh-list
92500088|NCT00538031|Cyclophosphamide|cyclophosphamide|mesh-list
92500089|NCT00538031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500090|NCT00538031|Immunologic Factors|immunologic factors|mesh-ancestor
92500091|NCT00538031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500092|NCT00538031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92500093|NCT00538031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92500094|NCT00538031|Alkylating Agents|alkylating agents|mesh-ancestor
92500095|NCT00538031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500096|NCT00538031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500097|NCT00538031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92500098|NCT00538031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92500099|NCT00538031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92500100|NCT00538031|Analgesics|analgesics|mesh-ancestor
92500101|NCT00538031|Sensory System Agents|sensory system agents|mesh-ancestor
92500102|NCT00538031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500103|NCT00538031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92500104|NCT00538031|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92500105|NCT00538031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92500106|NCT00538031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500107|NCT00203996|Pioglitazone|pioglitazone|mesh-list
92500108|NCT00203996|Leuprolide|leuprolide|mesh-list
92500109|NCT00203996|Estrogens|estrogens|mesh-list
92500110|NCT00203996|Progestins|progestins|mesh-list
92500111|NCT00203996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92500112|NCT00203996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500113|NCT00203996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92500114|NCT00203996|Fertility Agents|fertility agents|mesh-ancestor
92500115|NCT00203996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92500116|NCT00203996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225015|NCT01202110|Propranolol|propranolol|mesh-list
92500117|NCT00203996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500118|NCT00203996|Hormones|hormones|mesh-ancestor
92500119|NCT00203996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500120|NCT02009280|Anesthetics|anesthetics|mesh-list
92500121|NCT02009280|Propofol|propofol|mesh-list
92500122|NCT02009280|Sevoflurane|sevoflurane|mesh-list
92500123|NCT02009280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500124|NCT02009280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500125|NCT02009280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500126|NCT02009280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500127|NCT02009280|Anesthetics, General|anesthetics, general|mesh-ancestor
92500128|NCT02009280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92500129|NCT02009280|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92500130|NCT02009306|Fentanyl|fentanyl|mesh-list
92500131|NCT02009306|Midazolam|midazolam|mesh-list
92500132|NCT02009306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92500133|NCT02009306|Narcotics|narcotics|mesh-ancestor
92500134|NCT02009306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500135|NCT02009306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500136|NCT02009306|Analgesics|analgesics|mesh-ancestor
92500137|NCT02009306|Sensory System Agents|sensory system agents|mesh-ancestor
92500138|NCT02009306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500139|NCT02009306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92500140|NCT02009306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500141|NCT02009306|Anesthetics, General|anesthetics, general|mesh-ancestor
92500142|NCT02009306|Anesthetics|anesthetics|mesh-ancestor
92500143|NCT02009306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500144|NCT02009306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92500145|NCT02009306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92500146|NCT02009306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500147|NCT02009306|GABA Modulators|gaba modulators|mesh-ancestor
92500148|NCT02009306|GABA Agents|gaba agents|mesh-ancestor
92500149|NCT02009306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500150|NCT02009306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500151|NCT02009410|Pancrelipase|pancrelipase|mesh-list
92500152|NCT02009410|Pancreatin|pancreatin|mesh-list
92500153|NCT02009410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500154|NCT02009436|Azacitidine|azacitidine|mesh-list
92500155|NCT02009436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92500156|NCT02009436|Antimetabolites|antimetabolites|mesh-ancestor
92500157|NCT02009436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500158|NCT02009436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500159|NCT02009436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500160|NCT02009462|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92500161|NCT02009462|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500162|NCT02009462|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92500163|NCT02009462|Protective Agents|protective agents|mesh-ancestor
92500164|NCT02009462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500165|NCT02009488|Canagliflozin|canagliflozin|mesh-list
92500166|NCT02009488|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92500167|NCT02009488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500168|NCT02009488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92500169|NCT02009488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500170|NCT02009514|Dialysis Solutions|dialysis solutions|mesh-list
92500171|NCT02009514|Hemodialysis Solutions|hemodialysis solutions|mesh-list
92500172|NCT02009514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92500173|NCT02009540|Botulinum Toxins|botulinum toxins|mesh-list
92500174|NCT02009540|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92500175|NCT02009540|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92500176|NCT02009540|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92500177|NCT02009540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500178|NCT02009540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500179|NCT02009540|Cholinergic Agents|cholinergic agents|mesh-ancestor
92500180|NCT02009540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500181|NCT02009540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500182|NCT02009540|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92500183|NCT02009540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500185|NCT02009592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92500186|NCT02009592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500187|NCT02009592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500188|NCT02009618|Rifaximin|rifaximin|mesh-list
92500189|NCT02009618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92500190|NCT02009618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225091|NCT02518750|Antiviral Agents|antiviral agents|mesh-ancestor
92500191|NCT02009618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500192|NCT02009631|Veliparib|veliparib|mesh-list
92500193|NCT02009631|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92500194|NCT02009631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500195|NCT02009631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500196|NCT02009631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500197|NCT02009709|Riboflavin|riboflavin|mesh-list
92500198|NCT02009709|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92500199|NCT02009709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92500200|NCT02009709|Vitamin B Complex|vitamin b complex|mesh-ancestor
92500201|NCT02009709|Vitamins|vitamins|mesh-ancestor
92500202|NCT02009709|Micronutrients|micronutrients|mesh-ancestor
92500203|NCT02009709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500204|NCT02009709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92500205|NCT02009709|Dermatologic Agents|dermatologic agents|mesh-ancestor
92500206|NCT02009748|Vitamin D|vitamin d|mesh-list
92500207|NCT02009748|Vitamins|vitamins|mesh-ancestor
92500208|NCT02009748|Micronutrients|micronutrients|mesh-ancestor
92500209|NCT02009748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500210|NCT02009748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92500211|NCT02009787|Vitamin D|vitamin d|mesh-list
92500212|NCT02009787|Cholecalciferol|cholecalciferol|mesh-list
92500213|NCT02009787|Vitamins|vitamins|mesh-ancestor
92500214|NCT02009787|Micronutrients|micronutrients|mesh-ancestor
92500215|NCT02009787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500216|NCT02009787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92500217|NCT02009787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500218|NCT02009943|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92500219|NCT02009943|Hematinics|hematinics|mesh-ancestor
92500221|NCT02010164|Ubiquinone|ubiquinone|mesh-list
92500222|NCT02010164|Vitamins|vitamins|mesh-ancestor
92500223|NCT02010164|Micronutrients|micronutrients|mesh-ancestor
92500224|NCT02010164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500225|NCT02010411|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92500226|NCT02010411|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92500227|NCT02010411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92500228|NCT02010411|Protease Inhibitors|protease inhibitors|mesh-ancestor
92500229|NCT02010411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500230|NCT02010411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500231|NCT02010437|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
92500232|NCT02010437|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92500233|NCT02010437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92500234|NCT02010723|Polidocanol|polidocanol|mesh-list
92500235|NCT02010723|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92500236|NCT02010723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92500237|NCT02010762|Vitamin D|vitamin d|mesh-list
92500238|NCT02010762|Vitamins|vitamins|mesh-ancestor
92500239|NCT02010762|Micronutrients|micronutrients|mesh-ancestor
92500240|NCT02010762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500241|NCT02010762|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92500242|NCT02010788|Botulinum Toxins|botulinum toxins|mesh-list
92500243|NCT02010788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92500244|NCT02010788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92500245|NCT02010788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92500246|NCT02010788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500247|NCT02010788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500248|NCT02010788|Cholinergic Agents|cholinergic agents|mesh-ancestor
92500249|NCT02010788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500250|NCT02010788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500251|NCT02010788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92500252|NCT02010788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500253|NCT02010827|Glucagon|glucagon|mesh-list
92500254|NCT02010827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500255|NCT02010827|Hormones|hormones|mesh-ancestor
92500256|NCT02010827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500257|NCT02010827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500258|NCT02010905|Losartan|losartan|mesh-list
92500259|NCT02010905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92500260|NCT02010905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92500261|NCT02010905|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92500262|NCT02010905|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92500263|NCT02010905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500264|NCT02010944|Solifenacin Succinate|solifenacin succinate|mesh-list
92500265|NCT02010944|Mirabegron|mirabegron|mesh-list
92500266|NCT02010944|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92500267|NCT02010944|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92500268|NCT02010944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92500269|NCT02010944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500270|NCT02010944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500271|NCT02010944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500272|NCT02010944|Urological Agents|urological agents|mesh-ancestor
92500273|NCT02010944|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92500274|NCT02010944|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92500275|NCT02010944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92500276|NCT02010944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500277|NCT02010957|Etomidate|etomidate|mesh-list
92500278|NCT02010957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500279|NCT02010957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500280|NCT02010957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500281|NCT02010957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500282|NCT02010957|Anesthetics, General|anesthetics, general|mesh-ancestor
92500283|NCT02010957|Anesthetics|anesthetics|mesh-ancestor
92500284|NCT02010970|Itraconazole|itraconazole|mesh-list
92500285|NCT02010970|Diltiazem|diltiazem|mesh-list
92500286|NCT02010970|Calcium Channel Blockers|calcium channel blockers|mesh-list
92500287|NCT02010970|Midazolam|midazolam|mesh-list
92500288|NCT02010970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500289|NCT02010970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500290|NCT02010970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92500291|NCT02010970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500292|NCT02010970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500293|NCT02010970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92500294|NCT02010970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92500295|NCT02010970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500296|NCT02010970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500297|NCT02010970|Anesthetics, General|anesthetics, general|mesh-ancestor
92500298|NCT02010970|Anesthetics|anesthetics|mesh-ancestor
92500299|NCT02010970|GABA Modulators|gaba modulators|mesh-ancestor
92500300|NCT02010970|GABA Agents|gaba agents|mesh-ancestor
92500301|NCT02010970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500302|NCT02010970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500303|NCT02010970|Antifungal Agents|antifungal agents|mesh-ancestor
92500304|NCT02010970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500305|NCT02010970|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92349741|NCT03026478|Clobetasol|clobetasol|mesh-list
92500306|NCT02010970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92500308|NCT02010970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92500309|NCT02010970|Hormone Antagonists|hormone antagonists|mesh-ancestor
92500310|NCT02010970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500311|NCT02010970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92500312|NCT02010970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92500313|NCT02010970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500314|NCT02010970|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500315|NCT02011126|Imetelstat|imetelstat|mesh-list
92500316|NCT02011126|Motesanib diphosphate|motesanib diphosphate|mesh-list
92500317|NCT02011126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500318|NCT02011126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500319|NCT02011126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92500320|NCT02011191|Biotin|biotin|mesh-list
92500321|NCT02011191|Vitamin B Complex|vitamin b complex|mesh-ancestor
92500322|NCT02011191|Vitamins|vitamins|mesh-ancestor
92500323|NCT02011191|Micronutrients|micronutrients|mesh-ancestor
92500324|NCT02011191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500325|NCT02011347|Ketamine|ketamine|mesh-list
92500326|NCT02011347|Analgesics|analgesics|mesh-ancestor
92500327|NCT02011347|Sensory System Agents|sensory system agents|mesh-ancestor
92500328|NCT02011347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500329|NCT02011347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500330|NCT02011347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92500331|NCT02011347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500332|NCT02011347|Anesthetics, General|anesthetics, general|mesh-ancestor
92500333|NCT02011347|Anesthetics|anesthetics|mesh-ancestor
92500334|NCT02011347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500335|NCT02011347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92500336|NCT02011347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92500337|NCT02011347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500338|NCT02011347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500339|NCT02011594|Nimotuzumab|nimotuzumab|mesh-list
92500340|NCT02011594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500341|NCT02011594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500342|NCT02011620|Isosorbide|isosorbide|mesh-list
92500343|NCT02011620|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92500344|NCT02011620|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92500345|NCT02011620|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92500346|NCT02011620|Diuretics|diuretics|mesh-ancestor
92500347|NCT02011620|Natriuretic Agents|natriuretic agents|mesh-ancestor
92500348|NCT02011620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500349|NCT02011620|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500350|NCT02011620|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92500351|NCT02011620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500352|NCT02011633|Metformin|metformin|mesh-list
92500353|NCT02011633|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92500354|NCT02011633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92500355|NCT02011633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500356|NCT02011633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92500357|NCT02011633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92500358|NCT02011633|Antimetabolites|antimetabolites|mesh-ancestor
92500359|NCT02011633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500360|NCT02011633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92500361|NCT02011633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92500362|NCT02011633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500363|NCT02011659|Ramosetron|ramosetron|mesh-list
92500364|NCT02011659|Antiemetics|antiemetics|mesh-ancestor
92500365|NCT02011659|Autonomic Agents|autonomic agents|mesh-ancestor
92500366|NCT02011659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500367|NCT02011659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500368|NCT02011659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500369|NCT02011659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92500370|NCT02011659|Serotonin Agents|serotonin agents|mesh-ancestor
92500371|NCT02011659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500372|NCT02011659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500373|NCT02011737|Naftopidil|naftopidil|mesh-list
92500374|NCT02011737|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92500375|NCT02011737|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92500376|NCT02011737|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500377|NCT02011737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500378|NCT02011737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500379|NCT02011737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500380|NCT02011737|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92500381|NCT02011737|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92500382|NCT02011737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500383|NCT02011737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500384|NCT02011737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92500385|NCT02011750|Valproic Acid|valproic acid|mesh-list
92500386|NCT02011750|Anticonvulsants|anticonvulsants|mesh-ancestor
92500387|NCT02011750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500388|NCT02011750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500389|NCT02011750|GABA Agents|gaba agents|mesh-ancestor
92500390|NCT02011750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500391|NCT02011750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500392|NCT02011750|Antimanic Agents|antimanic agents|mesh-ancestor
92500393|NCT02011750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92500394|NCT02011750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500395|NCT02011750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500396|NCT02011828|Ergocalciferols|ergocalciferols|mesh-list
92500397|NCT02011828|Vitamin D|vitamin d|mesh-list
92500398|NCT02011828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500399|NCT02011828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500400|NCT02011828|Vitamins|vitamins|mesh-ancestor
92500401|NCT02011828|Micronutrients|micronutrients|mesh-ancestor
92500402|NCT02011828|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92500403|NCT02011841|Ciprofloxacin|ciprofloxacin|mesh-list
92500404|NCT02011841|Rifaximin|rifaximin|mesh-list
92500405|NCT02011841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92500406|NCT02011841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500407|NCT02011841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92500408|NCT02011841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92500409|NCT02011841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500410|NCT02011841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500411|NCT02011841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500412|NCT02011841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92500413|NCT02011841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92500414|NCT02011841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500415|NCT02011906|Vitamins|vitamins|mesh-list
92500416|NCT02011906|Vitamin E|vitamin e|mesh-list
92500417|NCT02011906|Tocopherols|tocopherols|mesh-list
92500418|NCT02011906|Tocotrienols|tocotrienols|mesh-list
92225309|NCT05484648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92500419|NCT02011906|alpha-Tocopherol|alpha-tocopherol|mesh-list
92500420|NCT02011906|Micronutrients|micronutrients|mesh-ancestor
92500421|NCT02011906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500422|NCT02011906|Antioxidants|antioxidants|mesh-ancestor
92500423|NCT02011906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500424|NCT02011906|Protective Agents|protective agents|mesh-ancestor
92500425|NCT02011958|Amphotericin B|amphotericin b|mesh-list
92500426|NCT02011958|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92500427|NCT02011958|Miltefosine|miltefosine|mesh-list
92500428|NCT02011958|Amebicides|amebicides|mesh-ancestor
92500429|NCT02011958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92500430|NCT02011958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92500431|NCT02011958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500432|NCT02011958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92500433|NCT02011958|Antifungal Agents|antifungal agents|mesh-ancestor
92500434|NCT02011958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500435|NCT02012036|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92500436|NCT02012036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92500437|NCT02012036|Dermatologic Agents|dermatologic agents|mesh-ancestor
92500438|NCT02012049|Risperidone|risperidone|mesh-list
92500439|NCT02012049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92500440|NCT02012049|Serotonin Agents|serotonin agents|mesh-ancestor
92500441|NCT02012049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500442|NCT02012049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500443|NCT02012049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500444|NCT02012049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92500445|NCT02012049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92500446|NCT02012049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500447|NCT02012049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500448|NCT02012049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92500449|NCT02012049|Dopamine Agents|dopamine agents|mesh-ancestor
92500450|NCT02012062|Nimotuzumab|nimotuzumab|mesh-list
92500451|NCT02012062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500452|NCT02012062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500453|NCT02012075|Metoprolol|metoprolol|mesh-list
92500454|NCT02012075|Carvedilol|carvedilol|mesh-list
92500455|NCT02012075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92500456|NCT02012075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92500457|NCT02012075|Sympatholytics|sympatholytics|mesh-ancestor
92500458|NCT02012075|Autonomic Agents|autonomic agents|mesh-ancestor
92500459|NCT02012075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500460|NCT02012075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500461|NCT02012075|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92500462|NCT02012075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92500463|NCT02012075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92500464|NCT02012075|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500465|NCT02012075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500466|NCT02012075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500467|NCT02012075|Antioxidants|antioxidants|mesh-ancestor
92500468|NCT02012075|Protective Agents|protective agents|mesh-ancestor
92500469|NCT02012075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92500470|NCT02012075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500471|NCT02012075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92500472|NCT02012075|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500473|NCT02012075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92500474|NCT02012075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92500475|NCT02012088|Prednisone|prednisone|mesh-list
92500476|NCT02012088|Cyclophosphamide|cyclophosphamide|mesh-list
92500477|NCT02012088|Rituximab|rituximab|mesh-list
92500478|NCT02012088|Doxorubicin|doxorubicin|mesh-list
92500479|NCT02012088|Vincristine|vincristine|mesh-list
92500480|NCT02012088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500481|NCT02012088|Immunologic Factors|immunologic factors|mesh-ancestor
92500482|NCT02012088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500483|NCT02012088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92500484|NCT02012088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92500485|NCT02012088|Alkylating Agents|alkylating agents|mesh-ancestor
92500486|NCT02012088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500487|NCT02012088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500488|NCT02012088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92500489|NCT02012088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500490|NCT02012088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92500491|NCT02012088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92500492|NCT02012088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92500493|NCT02012088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500494|NCT02012088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92500495|NCT02012088|Glucocorticoids|glucocorticoids|mesh-ancestor
92500496|NCT02012088|Hormones|hormones|mesh-ancestor
92500497|NCT02012088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500498|NCT02012088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92500499|NCT02012088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92500500|NCT02012088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92500501|NCT02012088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92500502|NCT02012088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92500503|NCT02012140|Ticagrelor|ticagrelor|mesh-list
92500504|NCT02012140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92500505|NCT02012140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92500506|NCT02012140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92500507|NCT02012140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92500508|NCT02012140|Purinergic Agents|purinergic agents|mesh-ancestor
92500509|NCT02012140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500510|NCT02012140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500511|NCT02012140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500512|NCT02012166|Insulin|insulin|mesh-list
92500513|NCT02012166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92500515|NCT02012166|Glucagon|glucagon|mesh-list
92500516|NCT02012166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92500517|NCT02012166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500518|NCT02012166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500519|NCT02012166|Hormones|hormones|mesh-ancestor
92500520|NCT02012166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500521|NCT02012166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92500522|NCT02012166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500523|NCT02012244|Fentanyl|fentanyl|mesh-list
92500524|NCT02012244|Anesthetics|anesthetics|mesh-list
92500525|NCT02012244|Anesthetics, Local|anesthetics, local|mesh-list
92500526|NCT02012244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92500527|NCT02012244|Narcotics|narcotics|mesh-ancestor
92500528|NCT02012244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500529|NCT02012244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500530|NCT02012244|Analgesics|analgesics|mesh-ancestor
92500531|NCT02012244|Sensory System Agents|sensory system agents|mesh-ancestor
92500532|NCT02012244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500533|NCT02012244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92500534|NCT02012244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500535|NCT02012244|Anesthetics, General|anesthetics, general|mesh-ancestor
92500536|NCT02012309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92500537|NCT02012309|Immunologic Factors|immunologic factors|mesh-ancestor
92500538|NCT02012309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500539|NCT02012322|Ubiquinone|ubiquinone|mesh-list
92500540|NCT02012322|Coenzyme Q10|coenzyme q10|mesh-list
92500541|NCT02012322|Micronutrients|micronutrients|mesh-ancestor
92500542|NCT02012322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500543|NCT02012322|Vitamins|vitamins|mesh-ancestor
92500544|NCT02012335|Ketamine|ketamine|mesh-list
92500545|NCT02012335|Analgesics|analgesics|mesh-ancestor
92500546|NCT02012335|Sensory System Agents|sensory system agents|mesh-ancestor
92500547|NCT02012335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500548|NCT02012335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500549|NCT02012335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92500550|NCT02012335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500551|NCT02012335|Anesthetics, General|anesthetics, general|mesh-ancestor
92500552|NCT02012335|Anesthetics|anesthetics|mesh-ancestor
92500553|NCT02012335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500554|NCT02012335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92500555|NCT02012335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92500556|NCT02012335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500557|NCT02012335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500558|NCT02012387|Omalizumab|omalizumab|mesh-list
92500559|NCT02012387|Vaccines|vaccines|mesh-list
92500560|NCT02012387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92500561|NCT02012387|Immunologic Factors|immunologic factors|mesh-ancestor
92500562|NCT02012387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500563|NCT02012387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92500564|NCT02012387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92500565|NCT02012387|Respiratory System Agents|respiratory system agents|mesh-ancestor
92500566|NCT02012465|Insulin|insulin|mesh-list
92500567|NCT02012465|Insulin Glargine|insulin glargine|mesh-list
92500568|NCT02012465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92500569|NCT02012465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500570|NCT02012517|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92500572|NCT02012517|Cephalexin|cephalexin|mesh-list
92500573|NCT02012517|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92500574|NCT02012517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500575|NCT02012517|Antitubercular Agents|antitubercular agents|mesh-ancestor
92500576|NCT02012556|Tesamorelin|tesamorelin|mesh-list
92500577|NCT02012556|Growth Substances|growth substances|mesh-ancestor
92500578|NCT02012556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500579|NCT02012569|Hemostatics|hemostatics|mesh-list
92500580|NCT02012569|Coagulants|coagulants|mesh-ancestor
92500581|NCT02012595|Donepezil|donepezil|mesh-list
92500582|NCT02012595|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92500583|NCT02012595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500584|NCT02012595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500585|NCT02012595|Cholinergic Agents|cholinergic agents|mesh-ancestor
92500586|NCT02012595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500587|NCT02012595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500588|NCT02012595|Nootropic Agents|nootropic agents|mesh-ancestor
92500589|NCT02012738|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
92500590|NCT02012738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500592|NCT02012738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500593|NCT02012777|Propranolol|propranolol|mesh-list
92500594|NCT02012777|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92500595|NCT02012777|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92500596|NCT02012777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500597|NCT02012777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500598|NCT02012777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500599|NCT02012777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500600|NCT02012777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92500601|NCT02012777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92349753|NCT04066764|Anticoagulants|anticoagulants|mesh-ancestor
92500602|NCT02012777|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500604|NCT02012920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500605|NCT02012920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92500606|NCT02012920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500607|NCT02012920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500608|NCT02012933|Amifampridine|amifampridine|mesh-list
92500609|NCT02012933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92500610|NCT02012933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500611|NCT02012933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500612|NCT02012933|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92500613|NCT02012933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500614|NCT02012933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500616|NCT02012946|Dobutamine|dobutamine|mesh-list
92500617|NCT02012946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92500618|NCT02012946|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500619|NCT02012946|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92500620|NCT02012946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92500621|NCT02012946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500622|NCT02012946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500623|NCT02012946|Protective Agents|protective agents|mesh-ancestor
92500624|NCT02012946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500625|NCT02012946|Sympathomimetics|sympathomimetics|mesh-ancestor
92500626|NCT02012946|Autonomic Agents|autonomic agents|mesh-ancestor
92500627|NCT02012946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500628|NCT02012946|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92500629|NCT02012946|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92500630|NCT02012946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92500631|NCT02012946|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500632|NCT02012946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500633|NCT02012998|Vaccines|vaccines|mesh-list
92500634|NCT02012998|Immunologic Factors|immunologic factors|mesh-ancestor
92500635|NCT02012998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500636|NCT02013102|Decitabine|decitabine|mesh-list
92500637|NCT02013102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92500638|NCT02013102|Antimetabolites|antimetabolites|mesh-ancestor
92500639|NCT02013102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500640|NCT02013102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500641|NCT02013102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500642|NCT02013115|Budesonide|budesonide|mesh-list
92500643|NCT02013115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92500644|NCT02013115|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92500645|NCT02013115|Autonomic Agents|autonomic agents|mesh-ancestor
92500646|NCT02013115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500647|NCT02013115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500648|NCT02013115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92500649|NCT02013115|Respiratory System Agents|respiratory system agents|mesh-ancestor
92500650|NCT02013115|Glucocorticoids|glucocorticoids|mesh-ancestor
92500651|NCT02013115|Hormones|hormones|mesh-ancestor
92500652|NCT02013115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500653|NCT02013154|Paclitaxel|paclitaxel|mesh-list
92500654|NCT02013154|Pembrolizumab|pembrolizumab|mesh-list
92500655|NCT02013154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92500656|NCT02013154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500657|NCT02013154|Tubulin Modulators|tubulin modulators|mesh-ancestor
92500658|NCT02013154|Antimitotic Agents|antimitotic agents|mesh-ancestor
92500659|NCT02013154|Mitosis Modulators|mitosis modulators|mesh-ancestor
92500660|NCT02013154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500661|NCT02013154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500662|NCT02013154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92500663|NCT02013219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92500664|NCT02013219|Atezolizumab|atezolizumab|mesh-list
92500665|NCT02013219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500666|NCT02013219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92500667|NCT02013219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500668|NCT02013219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500669|NCT02013219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92500670|NCT02013219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500671|NCT02013232|Aripiprazole|aripiprazole|mesh-list
92500672|NCT02013232|Antidepressive Agents|antidepressive agents|mesh-ancestor
92500673|NCT02013232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500674|NCT02013232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92500675|NCT02013232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92349754|NCT04066764|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92500676|NCT02013232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500678|NCT02013232|Dopamine Agonists|dopamine agonists|mesh-ancestor
92500679|NCT02013232|Dopamine Agents|dopamine agents|mesh-ancestor
92500680|NCT02013232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500681|NCT02013232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500682|NCT02013232|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92500683|NCT02013232|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92500684|NCT02013232|Serotonin Agents|serotonin agents|mesh-ancestor
92500685|NCT02013232|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92500686|NCT02013232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92500687|NCT02013232|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92500688|NCT02013232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92500689|NCT02013258|Oxytocin|oxytocin|mesh-list
92500690|NCT02013258|Oxytocics|oxytocics|mesh-ancestor
92500691|NCT02013258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92500692|NCT02013258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500693|NCT02013271|Paclitaxel|paclitaxel|mesh-list
92500694|NCT02013271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92500695|NCT02013271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500696|NCT02013271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92500697|NCT02013271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92500698|NCT02013271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92500699|NCT02013271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500700|NCT02013362|Folic Acid|folic acid|mesh-list
92500701|NCT02013362|Vitamin B 12|vitamin b 12|mesh-list
92500702|NCT02013362|Hydroxocobalamin|hydroxocobalamin|mesh-list
92500703|NCT02013362|Vitamins|vitamins|mesh-ancestor
92500704|NCT02013362|Micronutrients|micronutrients|mesh-ancestor
92500705|NCT02013362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500706|NCT02013362|Hematinics|hematinics|mesh-ancestor
92500707|NCT02013362|Vitamin B Complex|vitamin b complex|mesh-ancestor
92500708|NCT02013453|Paclitaxel|paclitaxel|mesh-list
92500709|NCT02013453|Carboplatin|carboplatin|mesh-list
92500710|NCT02013453|Fluorouracil|fluorouracil|mesh-list
92500711|NCT02013453|Pemetrexed|pemetrexed|mesh-list
92500712|NCT02013453|Omeprazole|omeprazole|mesh-list
92500713|NCT02013453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92500714|NCT02013453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500715|NCT02013453|Tubulin Modulators|tubulin modulators|mesh-ancestor
92500716|NCT02013453|Antimitotic Agents|antimitotic agents|mesh-ancestor
92500717|NCT02013453|Mitosis Modulators|mitosis modulators|mesh-ancestor
92500718|NCT02013453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500719|NCT02013453|Antimetabolites|antimetabolites|mesh-ancestor
92225608|NCT05474898|Magnesium Sulfate|magnesium sulfate|mesh-list
92500720|NCT02013453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92500721|NCT02013453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500722|NCT02013453|Immunologic Factors|immunologic factors|mesh-ancestor
92500723|NCT02013453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500724|NCT02013453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500725|NCT02013453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92500726|NCT02013453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92500727|NCT02013453|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92500728|NCT02013453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500729|NCT02013453|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92500730|NCT02013570|Dexmedetomidine|dexmedetomidine|mesh-list
92500731|NCT02013570|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500732|NCT02013570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500733|NCT02013570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500734|NCT02013570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92500735|NCT02013570|Analgesics|analgesics|mesh-ancestor
92500736|NCT02013570|Sensory System Agents|sensory system agents|mesh-ancestor
92500737|NCT02013570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500738|NCT02013570|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92500739|NCT02013570|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92500740|NCT02013570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92500741|NCT02013570|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500742|NCT02013570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500743|NCT02013570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500744|NCT02013856|Proanthocyanidin|proanthocyanidin|mesh-list
92500745|NCT02013856|Procyanidin|procyanidin|mesh-list
92500746|NCT02013856|Antioxidants|antioxidants|mesh-ancestor
92500747|NCT02013856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500748|NCT02013856|Protective Agents|protective agents|mesh-ancestor
92500749|NCT02013856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500751|NCT02013856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92500752|NCT02013856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500753|NCT02013895|Technetium Tc 99m DTPA-galactosyl-human serum albumin|technetium tc 99m dtpa-galactosyl-human serum albumin|mesh-list
92500754|NCT02013895|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92500755|NCT02013895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500756|NCT02013960|Misoprostol|misoprostol|mesh-list
92500757|NCT02013960|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92500758|NCT02013960|Abortifacient Agents|abortifacient agents|mesh-ancestor
92500759|NCT02013960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92500760|NCT02013960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500761|NCT02013960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92500762|NCT02013960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500763|NCT02013960|Oxytocics|oxytocics|mesh-ancestor
92500765|NCT02013986|Propofol|propofol|mesh-list
92500766|NCT02013986|Etomidate|etomidate|mesh-list
92500767|NCT02013986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500768|NCT02013986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500769|NCT02013986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500770|NCT02013986|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500771|NCT02013986|Anesthetics, General|anesthetics, general|mesh-ancestor
92500772|NCT02013986|Anesthetics|anesthetics|mesh-ancestor
92500773|NCT02013986|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92500774|NCT02013986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92500775|NCT02013986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92500776|NCT02013986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500777|NCT02013986|GABA Modulators|gaba modulators|mesh-ancestor
92500778|NCT02013986|GABA Agents|gaba agents|mesh-ancestor
92500779|NCT02013986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500780|NCT02013986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500781|NCT02014064|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92500782|NCT02014064|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92500783|NCT02014064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92500784|NCT02014064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92500785|NCT02014064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500786|NCT02014064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500787|NCT02014064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500788|NCT02014064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500789|NCT02013089|Everolimus|everolimus|mesh-list
92500790|NCT02013089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92500791|NCT02013089|Sorafenib|sorafenib|mesh-list
92500792|NCT02013089|Sunitinib|sunitinib|mesh-list
92500793|NCT02013089|Imatinib Mesylate|imatinib mesylate|mesh-list
92500794|NCT02013089|Gefitinib|gefitinib|mesh-list
92500795|NCT02013089|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92500796|NCT02013089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92500798|NCT02013089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500799|NCT02013089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500800|NCT02013089|Immunologic Factors|immunologic factors|mesh-ancestor
92500801|NCT02013089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500802|NCT02013089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500803|NCT02013089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92500804|NCT02013089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92500805|NCT02013089|Growth Substances|growth substances|mesh-ancestor
92500806|NCT02013089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92500807|NCT02014103|Tacrolimus|tacrolimus|mesh-list
92500808|NCT02014103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500809|NCT02014103|Immunologic Factors|immunologic factors|mesh-ancestor
92500810|NCT02014103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500811|NCT02014103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92500812|NCT02014103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500813|NCT02014103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500814|NCT02014337|Mifepristone|mifepristone|mesh-list
92500815|NCT02014337|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92500816|NCT02014337|Abortifacient Agents|abortifacient agents|mesh-ancestor
92500817|NCT02014337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92500818|NCT02014337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500819|NCT02014337|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92500820|NCT02014337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92500821|NCT02014337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92500822|NCT02014337|Contraceptive Agents|contraceptive agents|mesh-ancestor
92500823|NCT02014337|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92500824|NCT02014337|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92500825|NCT02014337|Hormone Antagonists|hormone antagonists|mesh-ancestor
92349757|NCT04066764|Protease Inhibitors|protease inhibitors|mesh-ancestor
92500826|NCT02014337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500827|NCT02014337|Luteolytic Agents|luteolytic agents|mesh-ancestor
92500828|NCT02014337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92500829|NCT02014337|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92500830|NCT02014428|Hyaluronic Acid|hyaluronic acid|mesh-list
92500831|NCT02014428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92500832|NCT02014428|Immunologic Factors|immunologic factors|mesh-ancestor
92500833|NCT02014428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500834|NCT02014428|Viscosupplements|viscosupplements|mesh-ancestor
92500835|NCT02014428|Protective Agents|protective agents|mesh-ancestor
92500837|NCT02014454|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92500838|NCT02014454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92500839|NCT02014454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92500840|NCT02014454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92500841|NCT02014454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92500842|NCT02014454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500843|NCT02014454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500844|NCT02014454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500845|NCT02014454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92500846|NCT02014454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92500847|NCT02014454|Vasodilator Agents|vasodilator agents|mesh-ancestor
92500848|NCT02014506|Cyclophosphamide|cyclophosphamide|mesh-list
92500849|NCT02014506|Fludarabine|fludarabine|mesh-list
92500850|NCT02014506|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92500851|NCT02014506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500852|NCT02014506|Immunologic Factors|immunologic factors|mesh-ancestor
92500853|NCT02014506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500854|NCT02014506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92500855|NCT02014506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92500856|NCT02014506|Alkylating Agents|alkylating agents|mesh-ancestor
92500857|NCT02014506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500858|NCT02014506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500859|NCT02014506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92500860|NCT02014532|Montelukast|montelukast|mesh-list
92500861|NCT02014532|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92500862|NCT02014532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92500863|NCT02014532|Respiratory System Agents|respiratory system agents|mesh-ancestor
92500864|NCT02014532|Hormone Antagonists|hormone antagonists|mesh-ancestor
92500865|NCT02014532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500866|NCT02014532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500867|NCT02014532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92500868|NCT02014532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92500869|NCT02014532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500870|NCT02014545|Lucanthone|lucanthone|mesh-list
92500871|NCT02014545|Schistosomicides|schistosomicides|mesh-ancestor
92500872|NCT02014545|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92500873|NCT02014545|Anthelmintics|anthelmintics|mesh-ancestor
92500874|NCT02014545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92500875|NCT02014545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500876|NCT02014558|Voriconazole|voriconazole|mesh-list
92500877|NCT02014558|Cephalexin|cephalexin|mesh-list
92500878|NCT02014558|Midazolam|midazolam|mesh-list
92500879|NCT02014558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92500880|NCT02014558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92500881|NCT02014558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500882|NCT02014558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500883|NCT02014558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92500884|NCT02014558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92500885|NCT02014558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92500886|NCT02014558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500887|NCT02014558|Anesthetics, General|anesthetics, general|mesh-ancestor
92500888|NCT02014558|Anesthetics|anesthetics|mesh-ancestor
92500889|NCT02014558|GABA Modulators|gaba modulators|mesh-ancestor
92500890|NCT02014558|GABA Agents|gaba agents|mesh-ancestor
92500891|NCT02014558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500892|NCT02014558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500893|NCT02014558|Antifungal Agents|antifungal agents|mesh-ancestor
92500894|NCT02014558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92500895|NCT02014558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92500896|NCT02014558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92500897|NCT02014558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500898|NCT02014558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92500899|NCT02014558|Hormone Antagonists|hormone antagonists|mesh-ancestor
92500900|NCT02014558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500901|NCT02014558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92500902|NCT02014558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92500903|NCT02014623|Immunomodulating Agents|immunomodulating agents|mesh-list
92500904|NCT02014623|Histamine Antagonists|histamine antagonists|mesh-list
92500905|NCT02014623|Immunologic Factors|immunologic factors|mesh-ancestor
92500906|NCT02014623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500907|NCT02014623|Histamine Agents|histamine agents|mesh-ancestor
92500908|NCT02014623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92500909|NCT02014623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500910|NCT02014636|Pembrolizumab|pembrolizumab|mesh-list
92500911|NCT02014636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500912|NCT02014636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500913|NCT02014636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92500914|NCT02014636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500915|NCT02014714|Fentanyl|fentanyl|mesh-list
92500916|NCT02014714|Morphine|morphine|mesh-list
92500917|NCT02014714|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92500918|NCT02014714|Narcotics|narcotics|mesh-ancestor
92500919|NCT02014714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500920|NCT02014714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500921|NCT02014714|Analgesics|analgesics|mesh-ancestor
92500922|NCT02014714|Sensory System Agents|sensory system agents|mesh-ancestor
92500923|NCT02014714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500924|NCT02014714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92500925|NCT02014714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92500926|NCT02014714|Anesthetics, General|anesthetics, general|mesh-ancestor
92500927|NCT02014714|Anesthetics|anesthetics|mesh-ancestor
92500928|NCT02014727|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92500929|NCT02014727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92500930|NCT02014727|Immunologic Factors|immunologic factors|mesh-ancestor
92500931|NCT02014727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500932|NCT02014727|Antacids|antacids|mesh-ancestor
92500933|NCT02014727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500934|NCT02014727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500935|NCT02014753|Cobalt|cobalt|mesh-list
92500936|NCT02014753|Chromium|chromium|mesh-list
92500937|NCT02014753|Everolimus|everolimus|mesh-list
92500938|NCT02014753|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92500939|NCT02014753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92500940|NCT02014753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500941|NCT02014753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225832|NCT00731770|Xhance|xhance|mesh-list
92500942|NCT02014753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92500943|NCT02014753|Immunologic Factors|immunologic factors|mesh-ancestor
92500944|NCT02014753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500945|NCT02014753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500946|NCT02014753|Trace Elements|trace elements|mesh-ancestor
92500947|NCT02014753|Micronutrients|micronutrients|mesh-ancestor
92500948|NCT02014831|Cetuximab|cetuximab|mesh-list
92500949|NCT02014831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500950|NCT02014831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500951|NCT02014922|Vitamin E|vitamin e|mesh-list
92500952|NCT02014922|alpha-Tocopherol|alpha-tocopherol|mesh-list
92500953|NCT02014922|Tocopherols|tocopherols|mesh-list
92500954|NCT02014922|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92500955|NCT02014922|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92500956|NCT02014922|Lubricant Eye Drops|lubricant eye drops|mesh-list
92500957|NCT02014922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92500958|NCT02014922|Laxatives|laxatives|mesh-ancestor
92500959|NCT02014922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92500960|NCT02014922|Antioxidants|antioxidants|mesh-ancestor
92500961|NCT02014922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500962|NCT02014922|Protective Agents|protective agents|mesh-ancestor
92500963|NCT02014922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500964|NCT02014922|Vitamins|vitamins|mesh-ancestor
92500965|NCT02014922|Micronutrients|micronutrients|mesh-ancestor
92500966|NCT02015156|Trastuzumab|trastuzumab|mesh-list
92500967|NCT02015156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92500968|NCT02015156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500969|NCT02015169|Lapatinib|lapatinib|mesh-list
92349762|NCT01437540|Bromides|bromides|mesh-list
92500970|NCT02015169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92500971|NCT02015169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92500972|NCT02015169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500973|NCT02015169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500974|NCT02015182|Bupivacaine|bupivacaine|mesh-list
92500975|NCT02015182|Anesthetics, Local|anesthetics, local|mesh-ancestor
92500976|NCT02015182|Anesthetics|anesthetics|mesh-ancestor
92500977|NCT02015182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92500978|NCT02015182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500979|NCT02015182|Sensory System Agents|sensory system agents|mesh-ancestor
92500980|NCT02015182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92500981|NCT02015260|Citric Acid|citric acid|mesh-list
92500982|NCT02015260|Anticoagulants|anticoagulants|mesh-ancestor
92500983|NCT02015260|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92500984|NCT02015260|Chelating Agents|chelating agents|mesh-ancestor
92500985|NCT02015260|Sequestering Agents|sequestering agents|mesh-ancestor
92500986|NCT02015260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500987|NCT02015299|Linagliptin|linagliptin|mesh-list
92500988|NCT02015299|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92500989|NCT02015299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92500990|NCT02015299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92500991|NCT02015299|Incretins|incretins|mesh-ancestor
92500992|NCT02015299|Hormones|hormones|mesh-ancestor
92500993|NCT02015299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92500994|NCT02015299|Protease Inhibitors|protease inhibitors|mesh-ancestor
92500995|NCT02015299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92500996|NCT02015299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92500997|NCT02015312|Silicon|silicon|mesh-list
92500998|NCT02015312|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92500999|NCT02015312|Mannitol|mannitol|mesh-list
92501000|NCT02015312|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92501001|NCT02015312|Diuretics|diuretics|mesh-ancestor
92501002|NCT02015312|Natriuretic Agents|natriuretic agents|mesh-ancestor
92501003|NCT02015312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501004|NCT02015312|Trace Elements|trace elements|mesh-ancestor
92501005|NCT02015312|Micronutrients|micronutrients|mesh-ancestor
92501006|NCT02015312|Antioxidants|antioxidants|mesh-ancestor
92501007|NCT02015312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501008|NCT02015312|Protective Agents|protective agents|mesh-ancestor
92501009|NCT02015312|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92501010|NCT02015312|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92501011|NCT02015312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501012|NCT02015312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92501013|NCT02015403|Acetylcysteine|acetylcysteine|mesh-list
92501014|NCT02015403|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92501015|NCT02015403|Antiviral Agents|antiviral agents|mesh-ancestor
92501016|NCT02015403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501017|NCT02015403|Expectorants|expectorants|mesh-ancestor
92501018|NCT02015403|Respiratory System Agents|respiratory system agents|mesh-ancestor
92501019|NCT02015403|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92501020|NCT02015403|Antioxidants|antioxidants|mesh-ancestor
92501021|NCT02015403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501022|NCT02015403|Protective Agents|protective agents|mesh-ancestor
92501023|NCT02015403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501024|NCT02015403|Antidotes|antidotes|mesh-ancestor
92501025|NCT02015494|Hemagglutinins|hemagglutinins|mesh-list
92501026|NCT02015494|Immunologic Factors|immunologic factors|mesh-ancestor
92501027|NCT02015494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501028|NCT02015494|Agglutinins|agglutinins|mesh-ancestor
92501029|NCT02015494|Coagulants|coagulants|mesh-ancestor
92501030|NCT02015507|Ciprofloxacin|ciprofloxacin|mesh-list
92501032|NCT02015507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501033|NCT02015507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501034|NCT02015507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92501035|NCT02015507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501036|NCT02015507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501037|NCT02015507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501038|NCT02015507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501039|NCT02015507|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92501040|NCT02015507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92501041|NCT02015507|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92501042|NCT02015507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501043|NCT02015559|Protective Agents|protective agents|mesh-list
92501044|NCT02015559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501045|NCT02015598|Carbocysteine|carbocysteine|mesh-list
92501046|NCT02015598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501047|NCT02015598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501048|NCT02015598|Expectorants|expectorants|mesh-ancestor
92501049|NCT02015598|Respiratory System Agents|respiratory system agents|mesh-ancestor
92501050|NCT02015650|Fluorouracil|fluorouracil|mesh-list
92501052|NCT02015650|Mitomycins|mitomycins|mesh-list
92501054|NCT02015650|Antimetabolites|antimetabolites|mesh-ancestor
92501055|NCT02015650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501056|NCT02015650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501057|NCT02015650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501058|NCT02015650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501059|NCT02015650|Immunologic Factors|immunologic factors|mesh-ancestor
92501060|NCT02015650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501061|NCT02015650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92501062|NCT02015650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92501063|NCT02015650|Alkylating Agents|alkylating agents|mesh-ancestor
92501064|NCT02015650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92501065|NCT02015650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501066|NCT02015728|Etoposide|etoposide|mesh-list
92501067|NCT02015728|Everolimus|everolimus|mesh-list
92501068|NCT02015728|Temozolomide|temozolomide|mesh-list
92501069|NCT02015728|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92501070|NCT02015728|Sorafenib|sorafenib|mesh-list
92501071|NCT02015728|Dasatinib|dasatinib|mesh-list
92501072|NCT02015728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92501073|NCT02015728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501074|NCT02015728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92501075|NCT02015728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501076|NCT02015728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501077|NCT02015728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501078|NCT02015728|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92501079|NCT02015728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92501080|NCT02015728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501081|NCT02015728|Immunologic Factors|immunologic factors|mesh-ancestor
92501082|NCT02015728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501083|NCT02015728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92501084|NCT02015728|Alkylating Agents|alkylating agents|mesh-ancestor
92501085|NCT02015780|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92501086|NCT02015780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501087|NCT02015923|Panitumumab|panitumumab|mesh-list
92501088|NCT02015923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92501089|NCT02015923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501090|NCT02015949|Methylphenidate|methylphenidate|mesh-list
92501091|NCT02015949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92501092|NCT02015949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501093|NCT02015949|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92501094|NCT02015949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92501095|NCT02015949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501096|NCT02015949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501097|NCT02015949|Dopamine Agents|dopamine agents|mesh-ancestor
92501098|NCT02015949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501099|NCT02015988|Simvastatin|simvastatin|mesh-list
92501100|NCT02015988|Fenofibrate|fenofibrate|mesh-list
92501101|NCT02015988|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92501102|NCT02015988|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92501103|NCT02015988|Antimetabolites|antimetabolites|mesh-ancestor
92501104|NCT02015988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501105|NCT02015988|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92501106|NCT02015988|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92501107|NCT02015988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501108|NCT02016001|Fluorides|fluorides|mesh-list
92501109|NCT02016001|Cariostatic Agents|cariostatic agents|mesh-ancestor
92501110|NCT02016001|Protective Agents|protective agents|mesh-ancestor
92501111|NCT02016001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501112|NCT02016157|Moxifloxacin|moxifloxacin|mesh-list
92501113|NCT02016157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501114|NCT02016157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501115|NCT02016157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92501116|NCT02016157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501117|NCT02016157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501118|NCT02016157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501119|NCT02016157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501120|NCT02016196|Rifaximin|rifaximin|mesh-list
92501121|NCT02016196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501122|NCT02016196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501123|NCT02016196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501124|NCT02016209|Paclitaxel|paclitaxel|mesh-list
92501125|NCT02016209|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92501126|NCT02016209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92501128|NCT02016209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92501129|NCT02016209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92501130|NCT02016209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92501131|NCT02016209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501132|NCT02016261|Fluvoxamine|fluvoxamine|mesh-list
92501133|NCT02016261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92501134|NCT02016261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92501135|NCT02016261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501136|NCT02016261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501137|NCT02016261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501138|NCT02016261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92501139|NCT02016261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92501140|NCT02016261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501141|NCT02016261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501142|NCT02016261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501143|NCT02016261|Serotonin Agents|serotonin agents|mesh-ancestor
92501144|NCT02016261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92501145|NCT02016261|Antidepressive Agents|antidepressive agents|mesh-ancestor
92501146|NCT02016261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92501147|NCT02016261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92501148|NCT02016261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501149|NCT02016261|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92501150|NCT02016274|Paclitaxel|paclitaxel|mesh-list
92501151|NCT02016274|Cisplatin|cisplatin|mesh-list
92501152|NCT02016274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92501153|NCT02016274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501154|NCT02016274|Tubulin Modulators|tubulin modulators|mesh-ancestor
92501155|NCT02016274|Antimitotic Agents|antimitotic agents|mesh-ancestor
92501156|NCT02016274|Mitosis Modulators|mitosis modulators|mesh-ancestor
92501157|NCT02016274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501158|NCT02016287|Paclitaxel|paclitaxel|mesh-list
92501159|NCT02016287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92501160|NCT02016287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501161|NCT02016287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92501162|NCT02016287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92501163|NCT02016287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92501164|NCT02016287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501165|NCT02016365|Doxycycline|doxycycline|mesh-list
92501166|NCT02016365|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92501167|NCT02016365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501168|NCT02016365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501169|NCT02016365|Antimalarials|antimalarials|mesh-ancestor
92501171|NCT02016365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92501172|NCT02016365|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92501173|NCT02016365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501174|NCT02016391|Dexmedetomidine|dexmedetomidine|mesh-list
92501175|NCT02016391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92501176|NCT02016391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501177|NCT02016391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501178|NCT02016391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92501179|NCT02016391|Analgesics|analgesics|mesh-ancestor
92501180|NCT02016391|Sensory System Agents|sensory system agents|mesh-ancestor
92501181|NCT02016391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501182|NCT02016391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92501183|NCT02016391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92501184|NCT02016391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92501185|NCT02016391|Adrenergic Agents|adrenergic agents|mesh-ancestor
92501186|NCT02016391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501187|NCT02016391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501188|NCT02016417|Cisplatin|cisplatin|mesh-list
92501189|NCT02016417|Gemcitabine|gemcitabine|mesh-list
92501190|NCT02016417|Docetaxel|docetaxel|mesh-list
92501191|NCT02016417|Fluorouracil|fluorouracil|mesh-list
92501192|NCT02016417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501193|NCT02016417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501194|NCT02016417|Antimetabolites|antimetabolites|mesh-ancestor
92501195|NCT02016417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501196|NCT02016417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92501197|NCT02016417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92501198|NCT02016417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92501199|NCT02016417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501200|NCT02016417|Immunologic Factors|immunologic factors|mesh-ancestor
92501201|NCT02016417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501202|NCT02016443|Tizanidine|tizanidine|mesh-list
92501203|NCT02016443|Analgesics|analgesics|mesh-ancestor
92501204|NCT02016443|Sensory System Agents|sensory system agents|mesh-ancestor
92501205|NCT02016443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501206|NCT02016443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501207|NCT02016443|Anticonvulsants|anticonvulsants|mesh-ancestor
92501208|NCT02016443|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92501209|NCT02016443|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92501210|NCT02016443|Parasympatholytics|parasympatholytics|mesh-ancestor
92501211|NCT02016443|Autonomic Agents|autonomic agents|mesh-ancestor
92501212|NCT02016443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92501213|NCT02016443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92501214|NCT02016443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92501215|NCT02016443|Adrenergic Agents|adrenergic agents|mesh-ancestor
92501216|NCT02016443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501217|NCT02016443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501218|NCT02016495|Thioctic Acid|thioctic acid|mesh-list
92501219|NCT02016495|Antioxidants|antioxidants|mesh-ancestor
92501220|NCT02016495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501221|NCT02016495|Protective Agents|protective agents|mesh-ancestor
92501222|NCT02016495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501223|NCT02016495|Vitamin B Complex|vitamin b complex|mesh-ancestor
92501224|NCT02016495|Vitamins|vitamins|mesh-ancestor
92501225|NCT02016495|Micronutrients|micronutrients|mesh-ancestor
92501226|NCT02016547|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92501227|NCT02016547|Abciximab|abciximab|mesh-list
92501228|NCT02016547|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92501229|NCT02016547|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92501230|NCT02016547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501231|NCT02016547|Anticoagulants|anticoagulants|mesh-ancestor
92501232|NCT02016547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92501233|NCT02016664|Ketamine|ketamine|mesh-list
92501234|NCT02016664|Analgesics|analgesics|mesh-ancestor
92501235|NCT02016664|Sensory System Agents|sensory system agents|mesh-ancestor
92501236|NCT02016664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501237|NCT02016664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501238|NCT02016664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92501239|NCT02016664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92501240|NCT02016664|Anesthetics, General|anesthetics, general|mesh-ancestor
92501241|NCT02016664|Anesthetics|anesthetics|mesh-ancestor
92501242|NCT02016664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501243|NCT02016664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92501244|NCT02016664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92501245|NCT02016664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501246|NCT02016664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501247|NCT02016703|Erythritol|erythritol|mesh-list
92501248|NCT02016703|Vasodilator Agents|vasodilator agents|mesh-ancestor
92501249|NCT02016729|Trametinib|trametinib|mesh-list
92501250|NCT02016729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501251|NCT02016729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92501252|NCT02016729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501253|NCT02016729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501254|NCT02016807|Sucralfate|sucralfate|mesh-list
92501255|NCT02016807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92501256|NCT02016807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501257|NCT02016820|Omeprazole|omeprazole|mesh-list
92501258|NCT02016820|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92501259|NCT02016820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501260|NCT02016820|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92501261|NCT02016820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501262|NCT02016820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501263|NCT02016846|Liraglutide|liraglutide|mesh-list
92501264|NCT02016846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92501265|NCT02016846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501266|NCT02016846|Incretins|incretins|mesh-ancestor
92501267|NCT02016846|Hormones|hormones|mesh-ancestor
92501268|NCT02016846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92501269|NCT02016976|Midazolam|midazolam|mesh-list
92501270|NCT02016976|Meperidine|meperidine|mesh-list
92501271|NCT02016976|Analgesics|analgesics|mesh-list
92501272|NCT02016976|Sensory System Agents|sensory system agents|mesh-ancestor
92501273|NCT02016976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501274|NCT02016976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501275|NCT02016976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92501276|NCT02016976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92501277|NCT02016976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501278|NCT02016976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92501279|NCT02016976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92501280|NCT02016976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501281|NCT02016976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92501282|NCT02016976|Anesthetics, General|anesthetics, general|mesh-ancestor
92501283|NCT02016976|Anesthetics|anesthetics|mesh-ancestor
92501284|NCT02016976|GABA Modulators|gaba modulators|mesh-ancestor
92501285|NCT02016976|GABA Agents|gaba agents|mesh-ancestor
92501286|NCT02016976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501287|NCT02016976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501288|NCT02016976|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92501289|NCT02016976|Narcotics|narcotics|mesh-ancestor
92501290|NCT02017119|Lactulose|lactulose|mesh-list
92501291|NCT02017119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501292|NCT02017197|Warfarin|warfarin|mesh-list
92501293|NCT02017197|Anticoagulants|anticoagulants|mesh-ancestor
92501294|NCT02017314|Morphine|morphine|mesh-list
92501295|NCT02017314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92501296|NCT02017314|Narcotics|narcotics|mesh-ancestor
92501297|NCT02017314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501298|NCT02017314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501299|NCT02017314|Analgesics|analgesics|mesh-ancestor
92501300|NCT02017314|Sensory System Agents|sensory system agents|mesh-ancestor
92501301|NCT02017314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501302|NCT02017340|Nilvadipine|nilvadipine|mesh-list
92501303|NCT02017340|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92501304|NCT02017340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92501305|NCT02017340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501306|NCT02017340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501307|NCT02017340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92501308|NCT02017340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501309|NCT02017392|Lidocaine|lidocaine|mesh-list
92501310|NCT02017392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92501311|NCT02017392|Anesthetics|anesthetics|mesh-ancestor
92501312|NCT02017392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501313|NCT02017392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501314|NCT02017392|Sensory System Agents|sensory system agents|mesh-ancestor
92501315|NCT02017392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501316|NCT02017392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92501317|NCT02017392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92501318|NCT02017392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92501319|NCT02017392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501320|NCT02017392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501321|NCT02017405|Immunoglobulins|immunoglobulins|mesh-list
92501322|NCT02017405|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92501323|NCT02017405|Antibodies|antibodies|mesh-list
92501324|NCT02017405|Immunologic Factors|immunologic factors|mesh-ancestor
92501325|NCT02017405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501326|NCT02017457|Azacitidine|azacitidine|mesh-list
92501327|NCT02017457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501328|NCT02017457|Antimetabolites|antimetabolites|mesh-ancestor
92501329|NCT02017457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501330|NCT02017457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501331|NCT02017457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501332|NCT02017561|Metformin|metformin|mesh-list
92501333|NCT02017561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92501334|NCT02017561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501335|NCT02017600|Fluorouracil|fluorouracil|mesh-list
92501336|NCT02017600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501337|NCT02017600|Antimetabolites|antimetabolites|mesh-ancestor
92750748|NCT05936606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92501338|NCT02017600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501339|NCT02017600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501340|NCT02017600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501341|NCT02017600|Immunologic Factors|immunologic factors|mesh-ancestor
92501342|NCT02017600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501343|NCT02017613|Tenalisib|tenalisib|mesh-list
92501344|NCT02017613|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92501345|NCT02017613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501346|NCT02017613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501347|NCT02017639|Simvastatin|simvastatin|mesh-list
92501348|NCT02017639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92501349|NCT02017639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92501350|NCT02017639|Antimetabolites|antimetabolites|mesh-ancestor
92501351|NCT02017639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501352|NCT02017639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92501353|NCT02017639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92501354|NCT02017639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501355|NCT02017873|Carbamide Peroxide|carbamide peroxide|mesh-list
92501356|NCT02017873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501357|NCT02017873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501359|NCT02018055|Clopidogrel|clopidogrel|mesh-list
92501360|NCT02018055|Ticagrelor|ticagrelor|mesh-list
92501361|NCT02018055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92501362|NCT02018055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92501363|NCT02018055|Analgesics|analgesics|mesh-ancestor
92501364|NCT02018055|Sensory System Agents|sensory system agents|mesh-ancestor
92501365|NCT02018055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501366|NCT02018055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501367|NCT02018055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92501368|NCT02018055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92501369|NCT02018055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92501370|NCT02018055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92501371|NCT02018055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501372|NCT02018055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92501373|NCT02018055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92501374|NCT02018055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501375|NCT02018055|Antipyretics|antipyretics|mesh-ancestor
92501376|NCT02018055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92501377|NCT02018055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92501378|NCT02018055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92501379|NCT02018055|Purinergic Agents|purinergic agents|mesh-ancestor
92501380|NCT02018055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501381|NCT02018081|Levofloxacin|levofloxacin|mesh-list
92501382|NCT02018081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92501383|NCT02018081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501384|NCT02018081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501385|NCT02018081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92501386|NCT02018081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501387|NCT02018081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501388|NCT02018081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501389|NCT02018081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501390|NCT02018081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92532848|NCT00055861|Docetaxel|docetaxel|mesh-list
92501391|NCT02018081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92501393|NCT02018094|Chlorhexidine|chlorhexidine|mesh-list
92501394|NCT02018094|Povidone-Iodine|povidone-iodine|mesh-list
92501395|NCT02018094|Metronidazole|metronidazole|mesh-list
92501396|NCT02018094|Clindamycin|clindamycin|mesh-list
92501397|NCT02018094|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92501398|NCT02018094|Teicoplanin|teicoplanin|mesh-list
92501400|NCT02018094|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501401|NCT02018094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501402|NCT02018094|Disinfectants|disinfectants|mesh-ancestor
92501403|NCT02018094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501404|NCT02018094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92501405|NCT02018094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92501406|NCT02018094|Trace Elements|trace elements|mesh-ancestor
92501407|NCT02018094|Micronutrients|micronutrients|mesh-ancestor
92501408|NCT02018094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501409|NCT02018094|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92501410|NCT02018094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501411|NCT02018094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501412|NCT02018094|Plasma Substitutes|plasma substitutes|mesh-ancestor
92501413|NCT02018094|Blood Substitutes|blood substitutes|mesh-ancestor
92501414|NCT02018094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92501415|NCT02018133|Vitamin D|vitamin d|mesh-list
92501416|NCT02018133|Ergocalciferols|ergocalciferols|mesh-list
92501417|NCT02018133|Vitamins|vitamins|mesh-ancestor
92501418|NCT02018133|Micronutrients|micronutrients|mesh-ancestor
92501419|NCT02018133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501420|NCT02018133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92501421|NCT02018133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92501422|NCT02018159|Menotropins|menotropins|mesh-list
92501423|NCT02018159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92501424|NCT02018159|Fertility Agents|fertility agents|mesh-ancestor
92501425|NCT02018159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92501426|NCT02018159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501427|NCT02018250|Benzyl Alcohol|benzyl alcohol|mesh-list
92501428|NCT02018250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92501429|NCT02018250|Anesthetics|anesthetics|mesh-ancestor
92501430|NCT02018250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501431|NCT02018250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501432|NCT02018250|Sensory System Agents|sensory system agents|mesh-ancestor
92501433|NCT02018250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501434|NCT02018276|Lidocaine|lidocaine|mesh-list
92501435|NCT02018276|Anesthetics, Local|anesthetics, local|mesh-ancestor
92501436|NCT02018276|Anesthetics|anesthetics|mesh-ancestor
92501437|NCT02018276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501438|NCT02018276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501439|NCT02018276|Sensory System Agents|sensory system agents|mesh-ancestor
92501440|NCT02018276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501441|NCT02018276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92501442|NCT02018276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92501443|NCT02018276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92501444|NCT02018276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501445|NCT02018276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501446|NCT02018289|Triclosan|triclosan|mesh-list
92501447|NCT02018289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501448|NCT02018289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501449|NCT02018289|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92501450|NCT02018289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92501451|NCT02018289|Antimetabolites|antimetabolites|mesh-ancestor
92501452|NCT02018289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501453|NCT02018289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92501454|NCT02018328|Curcumin|curcumin|mesh-list
92501455|NCT02018328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92501456|NCT02018328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92501457|NCT02018328|Analgesics|analgesics|mesh-ancestor
92501458|NCT02018328|Sensory System Agents|sensory system agents|mesh-ancestor
92501459|NCT02018328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501460|NCT02018328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501461|NCT02018328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92501462|NCT02018328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92501463|NCT02018328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501464|NCT02018328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501465|NCT02018328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501466|NCT02018367|Proflavine|proflavine|mesh-list
92501467|NCT02018367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501468|NCT02018367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501469|NCT02018419|Vaccines|vaccines|mesh-list
92501470|NCT02018419|Immunologic Factors|immunologic factors|mesh-ancestor
92501471|NCT02018419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501472|NCT02018523|Lenalidomide|lenalidomide|mesh-list
92501473|NCT02018523|Immunologic Factors|immunologic factors|mesh-ancestor
92501474|NCT02018523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501475|NCT02018523|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92501476|NCT02018523|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92501477|NCT02018523|Growth Substances|growth substances|mesh-ancestor
92501478|NCT02018523|Growth Inhibitors|growth inhibitors|mesh-ancestor
92501479|NCT02018523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501480|NCT02018536|Simeprevir|simeprevir|mesh-list
92501481|NCT02018536|Antiviral Agents|antiviral agents|mesh-ancestor
92349782|NCT01467492|Interferons|interferons|mesh-list
92501482|NCT02018536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501483|NCT02018536|Protease Inhibitors|protease inhibitors|mesh-ancestor
92501484|NCT02018536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501485|NCT02018536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501486|NCT02018588|Tryptophan|tryptophan|mesh-list
92501487|NCT02018588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92501488|NCT02018588|Antidepressive Agents|antidepressive agents|mesh-ancestor
92501489|NCT02018588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501490|NCT02018601|Acetaminophen|acetaminophen|mesh-list
92501491|NCT02018601|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92501492|NCT02018601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92501493|NCT02018601|Analgesics|analgesics|mesh-ancestor
92501494|NCT02018601|Sensory System Agents|sensory system agents|mesh-ancestor
92501495|NCT02018601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501496|NCT02018601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501497|NCT02018601|Antipyretics|antipyretics|mesh-ancestor
92501498|NCT02018601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92501499|NCT02018601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92501500|NCT02018601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92501502|NCT02018731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92501503|NCT02018731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501504|NCT02018757|Chlorotrianisene|chlorotrianisene|mesh-list
92501505|NCT02018757|Arsenic Trioxide|arsenic trioxide|mesh-list
92501506|NCT02018757|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92501507|NCT02018757|Estrogens|estrogens|mesh-ancestor
92501508|NCT02018757|Hormones|hormones|mesh-ancestor
92501509|NCT02018757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92501510|NCT02018757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501511|NCT02018757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92501512|NCT02018757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501513|NCT02018783|Listerine|listerine|mesh-list
92501514|NCT02018783|Sodium Fluoride|sodium fluoride|mesh-list
92501515|NCT02018783|Cariostatic Agents|cariostatic agents|mesh-ancestor
92501516|NCT02018783|Protective Agents|protective agents|mesh-ancestor
92501517|NCT02018783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501518|NCT02018783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501519|NCT02018783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501520|NCT02018874|Gemcitabine|gemcitabine|mesh-list
92501521|NCT02018874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501522|NCT02018874|Antimetabolites|antimetabolites|mesh-ancestor
92501523|NCT02018874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501524|NCT02018874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501525|NCT02018965|Vitamins|vitamins|mesh-list
92501526|NCT02018965|Niacin|niacin|mesh-list
92501527|NCT02018965|Niacinamide|niacinamide|mesh-list
92501528|NCT02018965|Nicotinic Acids|nicotinic acids|mesh-list
92501529|NCT02018965|Vitamin B Complex|vitamin b complex|mesh-list
92501530|NCT02018965|Micronutrients|micronutrients|mesh-ancestor
92501531|NCT02018965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501532|NCT02018965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92501533|NCT02018965|Antimetabolites|antimetabolites|mesh-ancestor
92501534|NCT02018965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501535|NCT02018965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92501536|NCT02018965|Vasodilator Agents|vasodilator agents|mesh-ancestor
92501537|NCT02018991|Everolimus|everolimus|mesh-list
92501538|NCT02018991|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92501539|NCT02018991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92501540|NCT02018991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501541|NCT02018991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501542|NCT02018991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501543|NCT02018991|Immunologic Factors|immunologic factors|mesh-ancestor
92501544|NCT02018991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501545|NCT02018991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501546|NCT02019017|Botulinum Toxins|botulinum toxins|mesh-list
92501547|NCT02019017|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92501548|NCT02019017|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92501549|NCT02019017|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92501550|NCT02019017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501551|NCT02019017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501552|NCT02019017|Cholinergic Agents|cholinergic agents|mesh-ancestor
92501553|NCT02019017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501554|NCT02019017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501555|NCT02019017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92501556|NCT02019017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501557|NCT02019056|Pyridoxine|pyridoxine|mesh-list
92501558|NCT02019056|Metadoxine|metadoxine|mesh-list
92501559|NCT02019056|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92501560|NCT02019056|Vitamin B Complex|vitamin b complex|mesh-ancestor
92501561|NCT02019056|Vitamins|vitamins|mesh-ancestor
92501562|NCT02019056|Micronutrients|micronutrients|mesh-ancestor
92501563|NCT02019056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501564|NCT02019095|Dimercaprol|dimercaprol|mesh-list
92501565|NCT02019095|Chelating Agents|chelating agents|mesh-ancestor
92501566|NCT02019095|Sequestering Agents|sequestering agents|mesh-ancestor
92501567|NCT02019095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501568|NCT02019160|Silver Nitrate|silver nitrate|mesh-list
92501569|NCT02019160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92501570|NCT02019160|Fluorides|fluorides|mesh-list
92501571|NCT02019160|Sodium Fluoride|sodium fluoride|mesh-list
92501572|NCT02019160|Cariostatic Agents|cariostatic agents|mesh-ancestor
92501573|NCT02019160|Protective Agents|protective agents|mesh-ancestor
92501574|NCT02019160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501575|NCT02019160|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92501576|NCT02019160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501577|NCT02019186|Vitamins|vitamins|mesh-list
92501578|NCT02019186|Vitamin E|vitamin e|mesh-list
92501579|NCT02019186|Micronutrients|micronutrients|mesh-ancestor
92501580|NCT02019186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501581|NCT02019186|Antioxidants|antioxidants|mesh-ancestor
92501582|NCT02019186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501583|NCT02019186|Protective Agents|protective agents|mesh-ancestor
92501584|NCT02019290|Midazolam|midazolam|mesh-list
92501585|NCT02019290|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92501586|NCT02019290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92501587|NCT02019290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501588|NCT02019290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501589|NCT02019290|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92501590|NCT02019290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92501591|NCT02019290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501592|NCT02019290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92501593|NCT02019290|Anesthetics, General|anesthetics, general|mesh-ancestor
92501594|NCT02019290|Anesthetics|anesthetics|mesh-ancestor
92501595|NCT02019290|GABA Modulators|gaba modulators|mesh-ancestor
92501596|NCT02019290|GABA Agents|gaba agents|mesh-ancestor
92501597|NCT02019290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501598|NCT02019290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501599|NCT02019329|Risperidone|risperidone|mesh-list
92501600|NCT02019329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92501601|NCT02019329|Serotonin Agents|serotonin agents|mesh-ancestor
92501602|NCT02019329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501603|NCT02019329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501604|NCT02019329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501605|NCT02019329|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92501606|NCT02019329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92501607|NCT02019329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501608|NCT02019329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501609|NCT02019329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92501610|NCT02019329|Dopamine Agents|dopamine agents|mesh-ancestor
92501611|NCT02019355|Fluorouracil|fluorouracil|mesh-list
92501612|NCT02019355|Calcipotriene|calcipotriene|mesh-list
92501613|NCT02019355|Petrolatum|petrolatum|mesh-list
92501614|NCT02019355|Antimetabolites|antimetabolites|mesh-ancestor
92501615|NCT02019355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501616|NCT02019355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501617|NCT02019355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501618|NCT02019355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501619|NCT02019355|Immunologic Factors|immunologic factors|mesh-ancestor
92501620|NCT02019355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501621|NCT02019355|Dermatologic Agents|dermatologic agents|mesh-ancestor
92501622|NCT02019355|Emollients|emollients|mesh-ancestor
92501623|NCT02019381|Vitamin D|vitamin d|mesh-list
92501624|NCT02019381|Ergocalciferols|ergocalciferols|mesh-list
92501625|NCT02019381|Cholecalciferol|cholecalciferol|mesh-list
92501627|NCT02019381|Micronutrients|micronutrients|mesh-ancestor
92501628|NCT02019381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501629|NCT02019381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92501630|NCT02019381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92501631|NCT02019394|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92501632|NCT02019394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92501633|NCT02019394|Serotonin Agents|serotonin agents|mesh-ancestor
92501634|NCT02019394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501635|NCT02019394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501636|NCT02019394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501637|NCT02019446|Terbinafine|terbinafine|mesh-list
92501638|NCT02019446|Antifungal Agents|antifungal agents|mesh-ancestor
92501639|NCT02019446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501640|NCT02019446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501641|NCT02019446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501642|NCT02019459|Nicotine|nicotine|mesh-list
92501643|NCT02019459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92501644|NCT02019459|Autonomic Agents|autonomic agents|mesh-ancestor
92501645|NCT02019459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501646|NCT02019459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501647|NCT02019459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92501648|NCT02019459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92501649|NCT02019459|Cholinergic Agents|cholinergic agents|mesh-ancestor
92501650|NCT02019459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501651|NCT02019459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501652|NCT02019485|Tapentadol|tapentadol|mesh-list
92501653|NCT02019485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92501654|NCT02019485|Narcotics|narcotics|mesh-ancestor
92501655|NCT02019485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501656|NCT02019485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501657|NCT02019485|Analgesics|analgesics|mesh-ancestor
92501658|NCT02019485|Sensory System Agents|sensory system agents|mesh-ancestor
92501659|NCT02019485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501660|NCT02019485|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92501661|NCT02019485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92501662|NCT02019485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501663|NCT02019485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501664|NCT02019485|Adrenergic Agents|adrenergic agents|mesh-ancestor
92501665|NCT02019485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501666|NCT02019524|Folic Acid|folic acid|mesh-list
92501667|NCT02019524|Vitamin B Complex|vitamin b complex|mesh-list
92501668|NCT02019524|Molgramostim|molgramostim|mesh-list
92501669|NCT02019524|Vaccines|vaccines|mesh-list
92501670|NCT02019524|Sargramostim|sargramostim|mesh-list
92501671|NCT02019524|Immunologic Factors|immunologic factors|mesh-ancestor
92501672|NCT02019524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501673|NCT02019524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501674|NCT02019524|Hematinics|hematinics|mesh-ancestor
92501675|NCT02019524|Vitamins|vitamins|mesh-ancestor
92501676|NCT02019524|Micronutrients|micronutrients|mesh-ancestor
92501677|NCT02019784|Rifaximin|rifaximin|mesh-list
92501678|NCT02019784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92501679|NCT02019784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501680|NCT02019784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501681|NCT02019797|Desflurane|desflurane|mesh-list
92501682|NCT02019797|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92501683|NCT02019797|Anesthetics, General|anesthetics, general|mesh-ancestor
92532863|NCT00392106|Amiodarone|amiodarone|mesh-list
92501685|NCT02019797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501686|NCT02019797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501687|NCT02019810|Dobutamine|dobutamine|mesh-list
92501688|NCT02019810|Norepinephrine|norepinephrine|mesh-list
92501689|NCT02019810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92501690|NCT02019810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92501691|NCT02019810|Adrenergic Agents|adrenergic agents|mesh-ancestor
92501692|NCT02019810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501693|NCT02019810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501694|NCT02019810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501695|NCT02019810|Sympathomimetics|sympathomimetics|mesh-ancestor
92501696|NCT02019810|Autonomic Agents|autonomic agents|mesh-ancestor
92501697|NCT02019810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501698|NCT02019810|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92501699|NCT02019810|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92501700|NCT02019810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92501702|NCT02019810|Protective Agents|protective agents|mesh-ancestor
92501703|NCT02019836|Vitamin D|vitamin d|mesh-list
92501704|NCT02019836|Vitamins|vitamins|mesh-ancestor
92501705|NCT02019836|Micronutrients|micronutrients|mesh-ancestor
92501706|NCT02019836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501707|NCT02019836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92501708|NCT02020005|Nicotine|nicotine|mesh-list
92501709|NCT02020005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92501710|NCT02020005|Autonomic Agents|autonomic agents|mesh-ancestor
92501711|NCT02020005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501712|NCT02020005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501713|NCT02020005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92501714|NCT02020005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92501715|NCT02020005|Cholinergic Agents|cholinergic agents|mesh-ancestor
92501716|NCT02020005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501717|NCT02020005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501718|NCT02020122|Pregabalin|pregabalin|mesh-list
92501719|NCT02020122|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92501720|NCT02020122|Analgesics|analgesics|mesh-ancestor
92501721|NCT02020122|Sensory System Agents|sensory system agents|mesh-ancestor
92501722|NCT02020122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501723|NCT02020122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501724|NCT02020122|Anticonvulsants|anticonvulsants|mesh-ancestor
92501725|NCT02020122|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92501726|NCT02020122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501727|NCT02020122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501728|NCT02020122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92501729|NCT02020122|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92501730|NCT02020122|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92501731|NCT02020122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501732|NCT02020122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501733|NCT02020122|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92501734|NCT02020122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92501735|NCT02020122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501736|NCT02020122|Antidepressive Agents|antidepressive agents|mesh-ancestor
92501737|NCT02020122|Dopamine Agents|dopamine agents|mesh-ancestor
92501738|NCT02020161|Methotrexate|methotrexate|mesh-list
92501739|NCT02020161|Idarubicin|idarubicin|mesh-list
92501740|NCT02020161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92501741|NCT02020161|Abortifacient Agents|abortifacient agents|mesh-ancestor
92501742|NCT02020161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92501743|NCT02020161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501744|NCT02020161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501745|NCT02020161|Antimetabolites|antimetabolites|mesh-ancestor
92501746|NCT02020161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501747|NCT02020161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501748|NCT02020161|Dermatologic Agents|dermatologic agents|mesh-ancestor
92501749|NCT02020161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501750|NCT02020161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92501751|NCT02020161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501752|NCT02020161|Immunologic Factors|immunologic factors|mesh-ancestor
92501753|NCT02020161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92501754|NCT02020161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92501755|NCT02020161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92501756|NCT02020161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532864|NCT00392106|Flecainide|flecainide|mesh-list
92501757|NCT02020161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501758|NCT02020200|Methylphenidate|methylphenidate|mesh-list
92501759|NCT02020200|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92501760|NCT02020200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501761|NCT02020200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92501762|NCT02020200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92501763|NCT02020200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501764|NCT02020200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501765|NCT02020200|Dopamine Agents|dopamine agents|mesh-ancestor
92501766|NCT02020200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501767|NCT02020213|Posaconazole|posaconazole|mesh-list
92501768|NCT02020213|Antifungal Agents|antifungal agents|mesh-ancestor
92501769|NCT02020213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501770|NCT02020213|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92501771|NCT02020213|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92501772|NCT02020213|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92501773|NCT02020213|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92501774|NCT02020213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92501775|NCT02020213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501776|NCT02020213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501777|NCT02020213|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92501778|NCT02020213|Hormone Antagonists|hormone antagonists|mesh-ancestor
92501779|NCT02020213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92501780|NCT02020213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501782|NCT02020330|Artemether|artemether|mesh-list
92501783|NCT02020330|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92501784|NCT02020330|Antimalarials|antimalarials|mesh-ancestor
92501785|NCT02020330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92501786|NCT02020330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92501787|NCT02020330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501788|NCT02020499|Lanreotide|lanreotide|mesh-list
92501789|NCT02020499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501790|NCT02020551|Lidocaine|lidocaine|mesh-list
92501791|NCT02020551|Anesthetics, Local|anesthetics, local|mesh-ancestor
92501792|NCT02020551|Anesthetics|anesthetics|mesh-ancestor
92501793|NCT02020551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501794|NCT02020551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501795|NCT02020551|Sensory System Agents|sensory system agents|mesh-ancestor
92501796|NCT02020551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501797|NCT02020551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92501798|NCT02020551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92501799|NCT02020551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92501800|NCT02020551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501801|NCT02020551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501802|NCT02020603|Epinephrine|epinephrine|mesh-list
92501803|NCT02020603|Racepinephrine|racepinephrine|mesh-list
92501804|NCT02020603|Hemostatics|hemostatics|mesh-list
92501805|NCT02020603|Epinephryl borate|epinephryl borate|mesh-list
92501806|NCT02020603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92501807|NCT02020603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92501808|NCT02020603|Adrenergic Agents|adrenergic agents|mesh-ancestor
92501809|NCT02020603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501810|NCT02020603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501811|NCT02020603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501812|NCT02020603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92501813|NCT02020603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92501814|NCT02020603|Autonomic Agents|autonomic agents|mesh-ancestor
92501815|NCT02020603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501816|NCT02020603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92501817|NCT02020603|Respiratory System Agents|respiratory system agents|mesh-ancestor
92501818|NCT02020603|Mydriatics|mydriatics|mesh-ancestor
92501819|NCT02020603|Sympathomimetics|sympathomimetics|mesh-ancestor
92501820|NCT02020603|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92501821|NCT02020603|Coagulants|coagulants|mesh-ancestor
92501822|NCT02020629|Lixisenatide|lixisenatide|mesh-list
92501823|NCT02020629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92501824|NCT02020629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501825|NCT02020681|Fluorides|fluorides|mesh-list
92501826|NCT02020681|Cariostatic Agents|cariostatic agents|mesh-ancestor
92501827|NCT02020681|Protective Agents|protective agents|mesh-ancestor
92501828|NCT02020681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501829|NCT02018796|Misoprostol|misoprostol|mesh-list
92501830|NCT02018796|Mifepristone|mifepristone|mesh-list
92501831|NCT02018796|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92501832|NCT02018796|Abortifacient Agents|abortifacient agents|mesh-ancestor
92501833|NCT02018796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92501834|NCT02018796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501835|NCT02018796|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92501836|NCT02018796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501837|NCT02018796|Oxytocics|oxytocics|mesh-ancestor
92501838|NCT02018796|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92501839|NCT02018796|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92501840|NCT02018796|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92501841|NCT02018796|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92501842|NCT02018796|Contraceptive Agents|contraceptive agents|mesh-ancestor
92501843|NCT02018796|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92501844|NCT02018796|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92501845|NCT02018796|Hormone Antagonists|hormone antagonists|mesh-ancestor
92501846|NCT02018796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226739|NCT00000916|Lamivudine|lamivudine|mesh-list
92501847|NCT02018796|Luteolytic Agents|luteolytic agents|mesh-ancestor
92501848|NCT02018796|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92501849|NCT02018796|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92501850|NCT02021097|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92501851|NCT02021097|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92501852|NCT02021097|Levonorgestrel|levonorgestrel|mesh-list
92501853|NCT02021097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92501854|NCT02021097|Estradiol|estradiol|mesh-list
92501855|NCT02021097|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92501856|NCT02021097|Estrogens|estrogens|mesh-ancestor
92501857|NCT02021097|Hormones|hormones|mesh-ancestor
92501858|NCT02021097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92501859|NCT02021097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501860|NCT02021097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92501861|NCT02021097|Contraceptive Agents|contraceptive agents|mesh-ancestor
92501862|NCT02021097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92501863|NCT02021097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92501864|NCT02021097|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92501865|NCT02021097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92501866|NCT02021097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92501867|NCT02021110|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92501868|NCT02021110|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92501869|NCT02021110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501870|NCT02021123|Anidulafungin|anidulafungin|mesh-list
92501871|NCT02021123|Antifungal Agents|antifungal agents|mesh-ancestor
92501872|NCT02021123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92501873|NCT02021201|Risperidone|risperidone|mesh-list
92501874|NCT02021201|Sertindole|sertindole|mesh-list
92501875|NCT02021201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92501876|NCT02021201|Serotonin Agents|serotonin agents|mesh-ancestor
92501877|NCT02021201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501878|NCT02021201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501879|NCT02021201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501880|NCT02021201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92501881|NCT02021201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92501882|NCT02021201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501883|NCT02021201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92501884|NCT02021201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92501885|NCT02021201|Dopamine Agents|dopamine agents|mesh-ancestor
92501886|NCT02021214|Methylphenidate|methylphenidate|mesh-list
92501887|NCT02021214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92501888|NCT02021214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501889|NCT02021214|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92501890|NCT02021214|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92501891|NCT02021214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501892|NCT02021214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501893|NCT02021214|Dopamine Agents|dopamine agents|mesh-ancestor
92501894|NCT02021214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501895|NCT02021240|Dexamethasone|dexamethasone|mesh-list
92501896|NCT02021240|Ketamine|ketamine|mesh-list
92501897|NCT02021240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92501899|NCT02021240|Autonomic Agents|autonomic agents|mesh-ancestor
92501900|NCT02021240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501901|NCT02021240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501902|NCT02021240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501903|NCT02021240|Glucocorticoids|glucocorticoids|mesh-ancestor
92501904|NCT02021240|Hormones|hormones|mesh-ancestor
92501905|NCT02021240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92501906|NCT02021240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92501907|NCT02021240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501908|NCT02021240|Analgesics|analgesics|mesh-ancestor
92501909|NCT02021240|Sensory System Agents|sensory system agents|mesh-ancestor
92501910|NCT02021240|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92501911|NCT02021240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92501912|NCT02021240|Anesthetics, General|anesthetics, general|mesh-ancestor
92501913|NCT02021240|Anesthetics|anesthetics|mesh-ancestor
92501914|NCT02021240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92501915|NCT02021240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92501916|NCT02021240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92501917|NCT02021240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501918|NCT02021240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501919|NCT02021409|Darbepoetin alfa|darbepoetin alfa|mesh-list
92501920|NCT02021409|Hematinics|hematinics|mesh-ancestor
92226817|NCT00001906|Antacids|antacids|mesh-ancestor
92501921|NCT02020980|Botulinum Toxins|botulinum toxins|mesh-list
92501922|NCT02020980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92501923|NCT02020980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92501924|NCT02020980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92501925|NCT02020980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92501926|NCT02020980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501927|NCT02020980|Cholinergic Agents|cholinergic agents|mesh-ancestor
92501928|NCT02020980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501929|NCT02020980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501930|NCT02020980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92501931|NCT02020980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501932|NCT02021422|Fluorouracil|fluorouracil|mesh-list
92501933|NCT02021422|Oxaliplatin|oxaliplatin|mesh-list
92501934|NCT02021422|Irinotecan|irinotecan|mesh-list
92501935|NCT02021422|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92501936|NCT02021422|Antimetabolites|antimetabolites|mesh-ancestor
92501937|NCT02021422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501938|NCT02021422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92501939|NCT02021422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501940|NCT02021422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92501941|NCT02021422|Immunologic Factors|immunologic factors|mesh-ancestor
92501942|NCT02021422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501943|NCT02021422|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92501944|NCT02021422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501945|NCT02021422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501946|NCT02021422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92501947|NCT02021500|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92501948|NCT02021500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501949|NCT02021539|Tocolytic Agents|tocolytic agents|mesh-list
92501950|NCT02021539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92501951|NCT02021539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501952|NCT02021825|Mitoxantrone|mitoxantrone|mesh-list
92501953|NCT02021825|Analgesics|analgesics|mesh-ancestor
92501954|NCT02021825|Sensory System Agents|sensory system agents|mesh-ancestor
92501955|NCT02021825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501956|NCT02021825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501957|NCT02021825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501958|NCT02021825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92501959|NCT02021825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92501960|NCT02021825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501961|NCT02021825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501962|NCT02021851|Dexamethasone|dexamethasone|mesh-list
92501963|NCT02021851|Dexamethasone acetate|dexamethasone acetate|mesh-list
92501964|NCT02021851|Ondansetron|ondansetron|mesh-list
92501965|NCT02021851|Aprepitant|aprepitant|mesh-list
92501966|NCT02021851|BB 1101|bb 1101|mesh-list
92501967|NCT02021851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92501968|NCT02021851|Antiemetics|antiemetics|mesh-ancestor
92501969|NCT02021851|Autonomic Agents|autonomic agents|mesh-ancestor
92501970|NCT02021851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92501971|NCT02021851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501972|NCT02021851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92501973|NCT02021851|Glucocorticoids|glucocorticoids|mesh-ancestor
92501974|NCT02021851|Hormones|hormones|mesh-ancestor
92501975|NCT02021851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92501976|NCT02021851|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92501977|NCT02021851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92501978|NCT02021851|Protease Inhibitors|protease inhibitors|mesh-ancestor
92501979|NCT02021851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92501980|NCT02021851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92501981|NCT02021851|Antipruritics|antipruritics|mesh-ancestor
92501982|NCT02021851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92501983|NCT02021851|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92501984|NCT02021851|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92501985|NCT02021851|Serotonin Agents|serotonin agents|mesh-ancestor
92501986|NCT02021851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92501987|NCT02021851|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92501988|NCT02021864|Vitamin D|vitamin d|mesh-list
92501989|NCT02021864|Cholecalciferol|cholecalciferol|mesh-list
92501990|NCT02021864|Vitamins|vitamins|mesh-ancestor
92501991|NCT02021864|Micronutrients|micronutrients|mesh-ancestor
92501992|NCT02021864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349794|NCT01466790|Ribavirin|ribavirin|mesh-list
92501993|NCT02021864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92501994|NCT02021864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92501995|NCT02022163|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92501997|NCT02022163|Immunologic Factors|immunologic factors|mesh-ancestor
92501998|NCT02022163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92501999|NCT02022163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92502000|NCT02022163|Antacids|antacids|mesh-ancestor
92502001|NCT02022163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502002|NCT02022163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502003|NCT02022215|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92502004|NCT02022228|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92502005|NCT02022228|Luteolytic Agents|luteolytic agents|mesh-ancestor
92502006|NCT02022228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92502007|NCT02022228|Contraceptive Agents|contraceptive agents|mesh-ancestor
92502008|NCT02022228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502009|NCT02022228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502010|NCT02022228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92502011|NCT02022228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92502012|NCT02022228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502013|NCT02022241|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92502014|NCT02022241|Luteolytic Agents|luteolytic agents|mesh-ancestor
92502015|NCT02022241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92502016|NCT02022241|Contraceptive Agents|contraceptive agents|mesh-ancestor
92502017|NCT02022241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502018|NCT02022241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502019|NCT02022241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92502020|NCT02022241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92502021|NCT02022241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502022|NCT02022254|Metformin|metformin|mesh-list
92502023|NCT02022254|Warfarin|warfarin|mesh-list
92502024|NCT02022254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92502025|NCT02022254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502026|NCT02022254|Anticoagulants|anticoagulants|mesh-ancestor
92502027|NCT02022293|Atorvastatin|atorvastatin|mesh-list
92502028|NCT02022293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92502029|NCT02022293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92502030|NCT02022293|Antimetabolites|antimetabolites|mesh-ancestor
92502031|NCT02022293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502032|NCT02022293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502033|NCT02022293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92502034|NCT02022293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502035|NCT02022358|Leucovorin|leucovorin|mesh-list
92502036|NCT02022358|Folic Acid|folic acid|mesh-list
92502037|NCT02022358|Methotrexate|methotrexate|mesh-list
92502038|NCT02022358|Levoleucovorin|levoleucovorin|mesh-list
92502039|NCT02022358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92502040|NCT02022358|Abortifacient Agents|abortifacient agents|mesh-ancestor
92502041|NCT02022358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502042|NCT02022358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502043|NCT02022358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502044|NCT02022358|Antimetabolites|antimetabolites|mesh-ancestor
92502045|NCT02022358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502047|NCT02022358|Dermatologic Agents|dermatologic agents|mesh-ancestor
92502048|NCT02022358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502049|NCT02022358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92502050|NCT02022358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502051|NCT02022358|Immunologic Factors|immunologic factors|mesh-ancestor
92502052|NCT02022358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502053|NCT02022358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92502054|NCT02022358|Antidotes|antidotes|mesh-ancestor
92502055|NCT02022358|Protective Agents|protective agents|mesh-ancestor
92502056|NCT02022358|Vitamin B Complex|vitamin b complex|mesh-ancestor
92502057|NCT02022358|Vitamins|vitamins|mesh-ancestor
92502058|NCT02022358|Micronutrients|micronutrients|mesh-ancestor
92502059|NCT02022358|Hematinics|hematinics|mesh-ancestor
92502060|NCT02022475|Vitamin D|vitamin d|mesh-list
92502061|NCT02022475|Cholecalciferol|cholecalciferol|mesh-list
92502062|NCT02022475|Vitamins|vitamins|mesh-ancestor
92502063|NCT02022475|Micronutrients|micronutrients|mesh-ancestor
92502064|NCT02022475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502065|NCT02022475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92502066|NCT02022475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502067|NCT02022488|Midazolam|midazolam|mesh-list
92502068|NCT02022488|Ketamine|ketamine|mesh-list
92502069|NCT02022488|Alfentanil|alfentanil|mesh-list
92502070|NCT02022488|Analgesics|analgesics|mesh-ancestor
92502071|NCT02022488|Sensory System Agents|sensory system agents|mesh-ancestor
92502072|NCT02022488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502073|NCT02022488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502074|NCT02022488|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92502075|NCT02022488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92502076|NCT02022488|Anesthetics, General|anesthetics, general|mesh-ancestor
92502078|NCT02022488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502079|NCT02022488|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92502080|NCT02022488|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92502081|NCT02022488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502082|NCT02022488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502083|NCT02022488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92502084|NCT02022488|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92502085|NCT02022488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92502086|NCT02022488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92502087|NCT02022488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92502088|NCT02022488|GABA Modulators|gaba modulators|mesh-ancestor
92502089|NCT02022488|GABA Agents|gaba agents|mesh-ancestor
92502090|NCT02022488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92502091|NCT02022488|Narcotics|narcotics|mesh-ancestor
92502092|NCT02022527|Aspirin|aspirin|mesh-list
92502093|NCT02022527|Salicylic Acid|salicylic acid|mesh-list
92502094|NCT02022527|Salicylates|salicylates|mesh-list
92502095|NCT02022527|Warfarin|warfarin|mesh-list
92502096|NCT02022527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92502097|NCT02022527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92502098|NCT02022527|Analgesics|analgesics|mesh-ancestor
92502099|NCT02022527|Sensory System Agents|sensory system agents|mesh-ancestor
92502100|NCT02022527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502101|NCT02022527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502102|NCT02022527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502103|NCT02022527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502104|NCT02022527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92502105|NCT02022527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92502106|NCT02022527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502107|NCT02022527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92502108|NCT02022527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92502109|NCT02022527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502111|NCT02022527|Anticoagulants|anticoagulants|mesh-ancestor
92502112|NCT02022527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502113|NCT02022527|Antifungal Agents|antifungal agents|mesh-ancestor
92502114|NCT02022527|Keratolytic Agents|keratolytic agents|mesh-ancestor
92502115|NCT02022527|Dermatologic Agents|dermatologic agents|mesh-ancestor
92502116|NCT02022540|Ranibizumab|ranibizumab|mesh-list
92502117|NCT02022540|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92502118|NCT02022540|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92502119|NCT02022540|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92502120|NCT02022540|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92502121|NCT02022540|Growth Substances|growth substances|mesh-ancestor
92502122|NCT02022540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502123|NCT02022540|Growth Inhibitors|growth inhibitors|mesh-ancestor
92502124|NCT02022540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502125|NCT02022722|Triamcinolone|triamcinolone|mesh-list
92502126|NCT02022722|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92502127|NCT02022722|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92502128|NCT02022722|Bupivacaine|bupivacaine|mesh-list
92502129|NCT02022722|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92502130|NCT02022722|Anesthetics, Local|anesthetics, local|mesh-ancestor
92502131|NCT02022722|Anesthetics|anesthetics|mesh-ancestor
92502132|NCT02022722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502133|NCT02022722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502134|NCT02022722|Sensory System Agents|sensory system agents|mesh-ancestor
92502135|NCT02022722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502136|NCT02022722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502137|NCT02022722|Glucocorticoids|glucocorticoids|mesh-ancestor
92502138|NCT02022722|Hormones|hormones|mesh-ancestor
92502139|NCT02022722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502140|NCT02022722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502141|NCT02022722|Immunologic Factors|immunologic factors|mesh-ancestor
92502142|NCT02022722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502143|NCT02022722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502144|NCT02022761|Laninamivir|laninamivir|mesh-list
92502145|NCT02022761|Antiviral Agents|antiviral agents|mesh-ancestor
92502146|NCT02022761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502147|NCT02022852|Capecitabine|capecitabine|mesh-list
92502148|NCT02022852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502149|NCT02022852|Antimetabolites|antimetabolites|mesh-ancestor
92502150|NCT02022852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502151|NCT02022852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502152|NCT02022917|Bevacizumab|bevacizumab|mesh-list
92502153|NCT02022917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92502154|NCT02022917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502155|NCT02022917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92502156|NCT02022917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92502157|NCT02022917|Growth Substances|growth substances|mesh-ancestor
92502158|NCT02022917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502159|NCT02022917|Growth Inhibitors|growth inhibitors|mesh-ancestor
92502160|NCT02022930|Triamcinolone|triamcinolone|mesh-list
92502161|NCT02022930|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92502162|NCT02022930|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92502163|NCT02022930|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92502164|NCT02022930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502165|NCT02022930|Glucocorticoids|glucocorticoids|mesh-ancestor
92502166|NCT02022930|Hormones|hormones|mesh-ancestor
92502167|NCT02022930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502168|NCT02022930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502169|NCT02022930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502170|NCT02022930|Immunologic Factors|immunologic factors|mesh-ancestor
92502171|NCT02022930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502172|NCT02022930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502173|NCT02023021|Paclitaxel|paclitaxel|mesh-list
92502174|NCT02023021|Gemcitabine|gemcitabine|mesh-list
92502175|NCT02023021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92502176|NCT02023021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502177|NCT02023021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92502178|NCT02023021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92502179|NCT02023021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92502180|NCT02023021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502181|NCT02023021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502182|NCT02023021|Antimetabolites|antimetabolites|mesh-ancestor
92502183|NCT02023047|Nifedipine|nifedipine|mesh-list
92502184|NCT02023047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92502185|NCT02023047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502186|NCT02023047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502187|NCT02023047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502188|NCT02023047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502189|NCT02023047|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502190|NCT02023047|Tocolytic Agents|tocolytic agents|mesh-ancestor
92502191|NCT02023047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502192|NCT02023086|Tropicamide|tropicamide|mesh-list
92502193|NCT02023086|Mydriatics|mydriatics|mesh-list
92502194|NCT02023086|Autonomic Agents|autonomic agents|mesh-ancestor
92502195|NCT02023086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502196|NCT02023086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502197|NCT02023086|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92502198|NCT02023086|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92502199|NCT02023086|Cholinergic Agents|cholinergic agents|mesh-ancestor
92502200|NCT02023086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502201|NCT02023086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502202|NCT02023164|Diphenhydramine|diphenhydramine|mesh-list
92502203|NCT02023164|Promethazine|promethazine|mesh-list
92502204|NCT02023164|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92502205|NCT02023164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92502206|NCT02023164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502207|NCT02023164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502208|NCT02023164|Anesthetics, Local|anesthetics, local|mesh-ancestor
92502209|NCT02023164|Anesthetics|anesthetics|mesh-ancestor
92502210|NCT02023164|Sensory System Agents|sensory system agents|mesh-ancestor
92502211|NCT02023164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502212|NCT02023164|Antiemetics|antiemetics|mesh-ancestor
92502213|NCT02023164|Autonomic Agents|autonomic agents|mesh-ancestor
92502214|NCT02023164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502215|NCT02023164|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92502216|NCT02023164|Histamine Antagonists|histamine antagonists|mesh-ancestor
92502217|NCT02023164|Histamine Agents|histamine agents|mesh-ancestor
92502218|NCT02023164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349804|NCT01418352|Antidepressive Agents|antidepressive agents|mesh-ancestor
92502219|NCT02023164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502220|NCT02023164|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92502221|NCT02023164|Antipruritics|antipruritics|mesh-ancestor
92227123|NCT01226719|Immunologic Factors|immunologic factors|mesh-ancestor
92502222|NCT02023164|Dermatologic Agents|dermatologic agents|mesh-ancestor
92502223|NCT02023359|Everolimus|everolimus|mesh-list
92502224|NCT02023359|Exemestane|exemestane|mesh-list
92502225|NCT02023359|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92502226|NCT02023359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92502227|NCT02023359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502228|NCT02023359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502229|NCT02023359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502230|NCT02023359|Immunologic Factors|immunologic factors|mesh-ancestor
92502231|NCT02023359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502232|NCT02023359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502233|NCT02023359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92502234|NCT02023359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92502235|NCT02023359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92502236|NCT02023359|Hormone Antagonists|hormone antagonists|mesh-ancestor
92502237|NCT02023359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502238|NCT02023424|Glatiramer Acetate|glatiramer acetate|mesh-list
92502239|NCT02023424|(T,G)-A-L|(t,g)-a-l|mesh-list
92502240|NCT02023424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92502241|NCT02023424|Immunologic Factors|immunologic factors|mesh-ancestor
92502242|NCT02023424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502243|NCT02023424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502244|NCT02023424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502245|NCT02023450|Ritonavir|ritonavir|mesh-list
92502246|NCT02023450|Saquinavir|saquinavir|mesh-list
92502247|NCT02023450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92502248|NCT02023450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92502249|NCT02023450|Protease Inhibitors|protease inhibitors|mesh-ancestor
92502250|NCT02023450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502251|NCT02023450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502252|NCT02023450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92502253|NCT02023450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92502254|NCT02023450|Antiviral Agents|antiviral agents|mesh-ancestor
92502255|NCT02023450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502256|NCT02023450|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92502257|NCT02023450|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92502258|NCT02023554|Azithromycin|azithromycin|mesh-list
92502259|NCT02023554|Theophylline|theophylline|mesh-list
92502260|NCT02023554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502261|NCT02023554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502262|NCT02023554|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92502263|NCT02023554|Autonomic Agents|autonomic agents|mesh-ancestor
92502264|NCT02023554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502265|NCT02023554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502266|NCT02023554|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92502267|NCT02023554|Respiratory System Agents|respiratory system agents|mesh-ancestor
92502268|NCT02023554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92502269|NCT02023554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502270|NCT02023554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502271|NCT02023554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502272|NCT02023554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92502273|NCT02023554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92502274|NCT02023554|Purinergic Agents|purinergic agents|mesh-ancestor
92502275|NCT02023554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502276|NCT02023567|Serotonin|serotonin|mesh-list
92502277|NCT02023567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92502278|NCT02023567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92502279|NCT02023567|Serotonin Agents|serotonin agents|mesh-ancestor
92502280|NCT02023567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502281|NCT02023567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502282|NCT02023567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502283|NCT02023567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92502284|NCT02023567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502285|NCT02023684|Lidocaine|lidocaine|mesh-list
92502286|NCT02023684|Ropivacaine|ropivacaine|mesh-list
92502287|NCT02023684|Anesthetics, Local|anesthetics, local|mesh-ancestor
92502288|NCT02023684|Anesthetics|anesthetics|mesh-ancestor
92502289|NCT02023684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502290|NCT02023684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502291|NCT02023684|Sensory System Agents|sensory system agents|mesh-ancestor
92502292|NCT02023684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502293|NCT02023684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92502294|NCT02023684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92227199|NCT01147627|Incretins|incretins|mesh-ancestor
92502295|NCT02023684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92502296|NCT02023684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502297|NCT02023684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502298|NCT02023710|Paclitaxel|paclitaxel|mesh-list
92502299|NCT02023710|Bevacizumab|bevacizumab|mesh-list
92502300|NCT02023710|Carboplatin|carboplatin|mesh-list
92502301|NCT02023710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92502302|NCT02023710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502303|NCT02023710|Tubulin Modulators|tubulin modulators|mesh-ancestor
92502304|NCT02023710|Antimitotic Agents|antimitotic agents|mesh-ancestor
92502305|NCT02023710|Mitosis Modulators|mitosis modulators|mesh-ancestor
92502306|NCT02023710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502307|NCT02023710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92502308|NCT02023710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92502309|NCT02023710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92502310|NCT02023710|Growth Substances|growth substances|mesh-ancestor
92502311|NCT02023710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502312|NCT02023710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92502313|NCT02023840|Metronidazole|metronidazole|mesh-list
92502314|NCT02023840|Erythritol|erythritol|mesh-list
92502315|NCT02023840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502316|NCT02023840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502317|NCT02023840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92502318|NCT02023840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92502319|NCT02023840|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502320|NCT02023853|Metronidazole|metronidazole|mesh-list
92502321|NCT02023853|Erythritol|erythritol|mesh-list
92502322|NCT02023853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502323|NCT02023853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502324|NCT02023853|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92502325|NCT02023853|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92502326|NCT02023853|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502327|NCT02023892|Atorvastatin|atorvastatin|mesh-list
92502328|NCT02023892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92502329|NCT02023892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92502330|NCT02023892|Antimetabolites|antimetabolites|mesh-ancestor
92502331|NCT02023892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502332|NCT02023892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502333|NCT02023892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92502334|NCT02023892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502335|NCT02023931|Sulforaphane|sulforaphane|mesh-list
92502336|NCT02023931|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92502337|NCT02023931|Protective Agents|protective agents|mesh-ancestor
92502338|NCT02023931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502339|NCT02023931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502341|NCT02024009|Paclitaxel|paclitaxel|mesh-list
92502342|NCT02024009|Gemcitabine|gemcitabine|mesh-list
92502343|NCT02024009|Capecitabine|capecitabine|mesh-list
92502344|NCT02024009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92502345|NCT02024009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502346|NCT02024009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92502347|NCT02024009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92502348|NCT02024009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92502349|NCT02024009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502350|NCT02024009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502351|NCT02024009|Antimetabolites|antimetabolites|mesh-ancestor
92502352|NCT02024009|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92502353|NCT02024009|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92502354|NCT02024009|Protease Inhibitors|protease inhibitors|mesh-ancestor
92502355|NCT02024009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502356|NCT02024009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92502357|NCT02024009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92502358|NCT02024009|Antiviral Agents|antiviral agents|mesh-ancestor
92502359|NCT02024009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502360|NCT02024022|Magnesium citrate|magnesium citrate|mesh-list
92502361|NCT02024022|Picosulfate sodium|picosulfate sodium|mesh-list
92502362|NCT02024022|Cathartics|cathartics|mesh-ancestor
92502363|NCT02024022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502364|NCT02024152|Cetirizine|cetirizine|mesh-list
92502365|NCT02024152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92502366|NCT02024152|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92502367|NCT02024152|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92502368|NCT02024152|Histamine Antagonists|histamine antagonists|mesh-ancestor
92502369|NCT02024152|Histamine Agents|histamine agents|mesh-ancestor
92502370|NCT02024152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502371|NCT02024152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502372|NCT02024152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502373|NCT02024217|Oxaliplatin|oxaliplatin|mesh-list
92502374|NCT02024217|Tegafur|tegafur|mesh-list
92502375|NCT02024217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502376|NCT02024217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502377|NCT02024217|Antimetabolites|antimetabolites|mesh-ancestor
92502378|NCT02024217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502379|NCT02024256|Magnesium Sulfate|magnesium sulfate|mesh-list
92502380|NCT02024256|Analgesics|analgesics|mesh-ancestor
92502381|NCT02024256|Sensory System Agents|sensory system agents|mesh-ancestor
92502382|NCT02024256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502383|NCT02024256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502384|NCT02024256|Anesthetics|anesthetics|mesh-ancestor
92502385|NCT02024256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502386|NCT02024256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92502387|NCT02024256|Anticonvulsants|anticonvulsants|mesh-ancestor
92502388|NCT02024256|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92502389|NCT02024256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502390|NCT02024256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502391|NCT02024256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502392|NCT02024256|Tocolytic Agents|tocolytic agents|mesh-ancestor
92502393|NCT02024256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502394|NCT02024295|Choline|choline|mesh-list
92502395|NCT02024295|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92502396|NCT02024295|Lipotropic Agents|lipotropic agents|mesh-ancestor
92502397|NCT02024295|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92502398|NCT02024295|Antimetabolites|antimetabolites|mesh-ancestor
92502399|NCT02024295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502400|NCT02024295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502401|NCT02024295|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502402|NCT02024295|Nootropic Agents|nootropic agents|mesh-ancestor
92502403|NCT02024308|Cytarabine|cytarabine|mesh-list
92502404|NCT02024308|Fludarabine|fludarabine|mesh-list
92502405|NCT02024308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502406|NCT02024308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502407|NCT02024308|Antimetabolites|antimetabolites|mesh-ancestor
92502408|NCT02024308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502409|NCT02024308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502410|NCT02024308|Immunologic Factors|immunologic factors|mesh-ancestor
92502411|NCT02024308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502412|NCT02024308|Antiviral Agents|antiviral agents|mesh-ancestor
92532880|NCT00055939|Exatecan|exatecan|mesh-list
92502413|NCT02024308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502414|NCT02024334|Leflunomide|leflunomide|mesh-list
92502415|NCT02024334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502416|NCT02024334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502417|NCT02024334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502418|NCT02024334|Immunologic Factors|immunologic factors|mesh-ancestor
92502419|NCT02024334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502420|NCT02024373|Atorvastatin|atorvastatin|mesh-list
92502421|NCT02024373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92502422|NCT02024373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92502423|NCT02024373|Antimetabolites|antimetabolites|mesh-ancestor
92502424|NCT02024373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502425|NCT02024373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502426|NCT02024373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92502427|NCT02024373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502428|NCT02024425|Antioxidants|antioxidants|mesh-list
92502429|NCT02024425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502430|NCT02024425|Protective Agents|protective agents|mesh-ancestor
92502431|NCT02024425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502432|NCT02024555|Azithromycin|azithromycin|mesh-list
92502433|NCT02024555|Levofloxacin|levofloxacin|mesh-list
92502434|NCT02024555|Rifampin|rifampin|mesh-list
92502435|NCT02024555|Ethambutol|ethambutol|mesh-list
92502436|NCT02024555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502437|NCT02024555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502438|NCT02024555|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92502439|NCT02024555|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92502440|NCT02024555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92502441|NCT02024555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502442|NCT02024555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502443|NCT02024555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502444|NCT02024555|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92502445|NCT02024555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92502446|NCT02024555|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92502447|NCT02024555|Antitubercular Agents|antitubercular agents|mesh-ancestor
92502448|NCT02024555|Leprostatic Agents|leprostatic agents|mesh-ancestor
92502449|NCT02024555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92502450|NCT02024555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92502451|NCT02024555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92502452|NCT02024555|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92502453|NCT02024555|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92502454|NCT02024555|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92502455|NCT02024555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92502456|NCT02024568|Pregabalin|pregabalin|mesh-list
92502457|NCT02024568|Analgesics|analgesics|mesh-ancestor
92502458|NCT02024568|Sensory System Agents|sensory system agents|mesh-ancestor
92502459|NCT02024568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502460|NCT02024568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502461|NCT02024568|Anticonvulsants|anticonvulsants|mesh-ancestor
92502462|NCT02024568|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92502463|NCT02024568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502464|NCT02024568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502465|NCT02024568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502466|NCT02024568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92502467|NCT02024568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92502468|NCT02024568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502469|NCT02024568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92502470|NCT02024594|Nitrous Oxide|nitrous oxide|mesh-list
92502471|NCT02024594|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92502472|NCT02024594|Anesthetics, General|anesthetics, general|mesh-ancestor
92502473|NCT02024594|Anesthetics|anesthetics|mesh-ancestor
92502474|NCT02024594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502475|NCT02024594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502476|NCT02024594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92502477|NCT02024594|Analgesics|analgesics|mesh-ancestor
92502478|NCT02024594|Sensory System Agents|sensory system agents|mesh-ancestor
92502479|NCT02024594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502480|NCT02024633|Gemcitabine|gemcitabine|mesh-list
92502481|NCT02024633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502482|NCT02024633|Antimetabolites|antimetabolites|mesh-ancestor
92502483|NCT02024633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502484|NCT02024633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502486|NCT02024659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502487|NCT02024659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92502488|NCT02024659|Autonomic Agents|autonomic agents|mesh-ancestor
92502489|NCT02024659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502490|NCT02024659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502491|NCT02024659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92502492|NCT02024659|Respiratory System Agents|respiratory system agents|mesh-ancestor
92502493|NCT02024659|Glucocorticoids|glucocorticoids|mesh-ancestor
92502494|NCT02024659|Hormones|hormones|mesh-ancestor
92502495|NCT02024659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502496|NCT02024841|Docetaxel|docetaxel|mesh-list
92502497|NCT02024841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502498|NCT02024841|Tubulin Modulators|tubulin modulators|mesh-ancestor
92502499|NCT02024841|Antimitotic Agents|antimitotic agents|mesh-ancestor
92502500|NCT02024841|Mitosis Modulators|mitosis modulators|mesh-ancestor
92502501|NCT02024841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502502|NCT02024906|Caseins|caseins|mesh-list
92502503|NCT02024906|Chelating Agents|chelating agents|mesh-ancestor
92502504|NCT02024906|Sequestering Agents|sequestering agents|mesh-ancestor
92502505|NCT02024906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502506|NCT02024919|Diltiazem|diltiazem|mesh-list
92502507|NCT02024919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92502508|NCT02024919|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92502509|NCT02024919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502510|NCT02024919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502511|NCT02024919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502512|NCT02024919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502513|NCT02024919|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502514|NCT02024945|Propiverine|propiverine|mesh-list
92502515|NCT02024945|Parasympatholytics|parasympatholytics|mesh-ancestor
92502516|NCT02024945|Autonomic Agents|autonomic agents|mesh-ancestor
92502517|NCT02024945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502518|NCT02024945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502519|NCT02024945|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92502520|NCT02024945|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92502521|NCT02024945|Cholinergic Agents|cholinergic agents|mesh-ancestor
92502522|NCT02024945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502523|NCT02024945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502524|NCT02024945|Urological Agents|urological agents|mesh-ancestor
92502525|NCT02024984|Clomiphene|clomiphene|mesh-list
92502526|NCT02024984|Enclomiphene|enclomiphene|mesh-list
92502527|NCT02024984|Zuclomiphene|zuclomiphene|mesh-list
92502528|NCT02024984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92502529|NCT02024984|Hormone Antagonists|hormone antagonists|mesh-ancestor
92502530|NCT02024984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502531|NCT02024984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502532|NCT02024984|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92502533|NCT02024984|Fertility Agents|fertility agents|mesh-ancestor
92502534|NCT02024984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502535|NCT02024984|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92502536|NCT02024984|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92502538|NCT02025023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92502539|NCT02025023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92502540|NCT02025023|Fluorouracil|fluorouracil|mesh-list
92502541|NCT02025023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92502542|NCT02025023|Antimetabolites|antimetabolites|mesh-ancestor
92502543|NCT02025023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502544|NCT02025023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502545|NCT02025023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502546|NCT02025023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502547|NCT02025023|Immunologic Factors|immunologic factors|mesh-ancestor
92502548|NCT02025023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502549|NCT02025023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502550|NCT02025023|Glucocorticoids|glucocorticoids|mesh-ancestor
92502551|NCT02025023|Hormones|hormones|mesh-ancestor
92502552|NCT02025023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502553|NCT02025023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502554|NCT02025140|Anesthetics|anesthetics|mesh-list
92502555|NCT02025140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502556|NCT02025140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502557|NCT02025166|Acetaminophen|acetaminophen|mesh-list
92502558|NCT02025166|Lornoxicam|lornoxicam|mesh-list
92502560|NCT02025166|Analgesics|analgesics|mesh-ancestor
92502561|NCT02025166|Sensory System Agents|sensory system agents|mesh-ancestor
92502562|NCT02025166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502563|NCT02025166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502564|NCT02025166|Antipyretics|antipyretics|mesh-ancestor
92502565|NCT02025166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92502566|NCT02025166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502567|NCT02025166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502568|NCT02025192|Capecitabine|capecitabine|mesh-list
92502569|NCT02025192|Trastuzumab|trastuzumab|mesh-list
92502570|NCT02025192|Tucatinib|tucatinib|mesh-list
92502571|NCT02025192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502572|NCT02025192|Antimetabolites|antimetabolites|mesh-ancestor
92502573|NCT02025192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502574|NCT02025192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502575|NCT02025192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92502576|NCT02025192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92502577|NCT02025192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502578|NCT02025218|Gefitinib|gefitinib|mesh-list
92502579|NCT02025218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502580|NCT02025218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92502581|NCT02025218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502582|NCT02025218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502583|NCT02025348|Metoprolol|metoprolol|mesh-list
92502584|NCT02025348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92502585|NCT02025348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92502586|NCT02025348|Sympatholytics|sympatholytics|mesh-ancestor
92502587|NCT02025348|Autonomic Agents|autonomic agents|mesh-ancestor
92502588|NCT02025348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502589|NCT02025348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502590|NCT02025348|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92502591|NCT02025348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92502592|NCT02025348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92502593|NCT02025348|Adrenergic Agents|adrenergic agents|mesh-ancestor
92502594|NCT02025348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502595|NCT02025348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502597|NCT02025361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92502598|NCT02025361|Anesthetics|anesthetics|mesh-ancestor
92502599|NCT02025361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502600|NCT02025361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502601|NCT02025361|Sensory System Agents|sensory system agents|mesh-ancestor
92502602|NCT02025361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502603|NCT02025361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92502604|NCT02025361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92502605|NCT02025361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92502606|NCT02025361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502607|NCT02025361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502608|NCT02025374|Bupivacaine|bupivacaine|mesh-list
92502609|NCT02025374|Levobupivacaine|levobupivacaine|mesh-list
92502610|NCT02025374|Anesthetics, Local|anesthetics, local|mesh-ancestor
92502611|NCT02025374|Anesthetics|anesthetics|mesh-ancestor
92502612|NCT02025374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502613|NCT02025374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502614|NCT02025374|Sensory System Agents|sensory system agents|mesh-ancestor
92502615|NCT02025374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502616|NCT02025465|Metoprolol|metoprolol|mesh-list
92502617|NCT02025465|Diltiazem|diltiazem|mesh-list
92502618|NCT02025465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92502619|NCT02025465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92502620|NCT02025465|Sympatholytics|sympatholytics|mesh-ancestor
92502621|NCT02025465|Autonomic Agents|autonomic agents|mesh-ancestor
92502622|NCT02025465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502623|NCT02025465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502624|NCT02025465|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92502625|NCT02025465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92502626|NCT02025465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92502627|NCT02025465|Adrenergic Agents|adrenergic agents|mesh-ancestor
92502628|NCT02025465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502629|NCT02025465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502630|NCT02025465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92502631|NCT02025465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92502632|NCT02025465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502633|NCT02025465|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502635|NCT02025491|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92502636|NCT02025491|Amebicides|amebicides|mesh-ancestor
92502637|NCT02025491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92502638|NCT02025491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92502639|NCT02025491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502640|NCT02025491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502641|NCT02025491|Antifungal Agents|antifungal agents|mesh-ancestor
92502642|NCT02025608|Pramipexole|pramipexole|mesh-list
92502643|NCT02025608|Antioxidants|antioxidants|mesh-ancestor
92502644|NCT02025608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502645|NCT02025608|Protective Agents|protective agents|mesh-ancestor
92502646|NCT02025608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502647|NCT02025608|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92502648|NCT02025608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92502649|NCT02025608|Dopamine Agonists|dopamine agonists|mesh-ancestor
92502650|NCT02025608|Dopamine Agents|dopamine agents|mesh-ancestor
92502651|NCT02025608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502652|NCT02025712|Everolimus|everolimus|mesh-list
92502653|NCT02025712|Exemestane|exemestane|mesh-list
92502654|NCT02025712|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92502655|NCT02025712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92502656|NCT02025712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502657|NCT02025712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502658|NCT02025712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502659|NCT02025712|Immunologic Factors|immunologic factors|mesh-ancestor
92502660|NCT02025712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502661|NCT02025712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502662|NCT02025712|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92502663|NCT02025712|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92502664|NCT02025712|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92502665|NCT02025712|Hormone Antagonists|hormone antagonists|mesh-ancestor
92502666|NCT02025712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502667|NCT02025803|Capecitabine|capecitabine|mesh-list
92502668|NCT02025803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502669|NCT02025803|Antimetabolites|antimetabolites|mesh-ancestor
92502670|NCT02025803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502671|NCT02025803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502672|NCT02025855|Methadone|methadone|mesh-list
92502673|NCT02025855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92502674|NCT02025855|Narcotics|narcotics|mesh-ancestor
92502675|NCT02025855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92502676|NCT02025855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502677|NCT02025855|Analgesics|analgesics|mesh-ancestor
92502678|NCT02025855|Sensory System Agents|sensory system agents|mesh-ancestor
92502679|NCT02025855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502680|NCT02025855|Antitussive Agents|antitussive agents|mesh-ancestor
92502681|NCT02025855|Respiratory System Agents|respiratory system agents|mesh-ancestor
92502682|NCT02025868|Raltegravir Potassium|raltegravir potassium|mesh-list
92502683|NCT02025868|Darunavir|darunavir|mesh-list
92502684|NCT02025868|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92502685|NCT02025868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92502686|NCT02025868|Antiviral Agents|antiviral agents|mesh-ancestor
92502687|NCT02025868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502688|NCT02025868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92502689|NCT02025868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92502690|NCT02025868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502691|NCT02025868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502692|NCT02025868|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92502693|NCT02025868|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92502694|NCT02025868|Protease Inhibitors|protease inhibitors|mesh-ancestor
92502695|NCT02025881|Cyclophosphamide|cyclophosphamide|mesh-list
92502696|NCT02025881|Thiotepa|thiotepa|mesh-list
92502697|NCT02025881|Carboplatin|carboplatin|mesh-list
92502698|NCT02025881|Etoposide|etoposide|mesh-list
92502699|NCT02025881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502700|NCT02025881|Immunologic Factors|immunologic factors|mesh-ancestor
92502701|NCT02025881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502702|NCT02025881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502703|NCT02025881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92502705|NCT02025881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502706|NCT02025881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502707|NCT02025881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92502708|NCT02025881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92502709|NCT02025881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92502710|NCT02025881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92502711|NCT02025881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502712|NCT02025998|Ibudilast|ibudilast|mesh-list
92502713|NCT02025998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92502714|NCT02025998|Autonomic Agents|autonomic agents|mesh-ancestor
92502715|NCT02025998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502716|NCT02025998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502717|NCT02025998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92502718|NCT02025998|Respiratory System Agents|respiratory system agents|mesh-ancestor
92502719|NCT02025998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92502720|NCT02025998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502721|NCT02025998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502722|NCT02025998|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92502723|NCT02025998|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502724|NCT02026050|Dexamethasone|dexamethasone|mesh-list
92502725|NCT02026050|Dexamethasone acetate|dexamethasone acetate|mesh-list
92502726|NCT02026050|BB 1101|bb 1101|mesh-list
92502727|NCT02026050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502728|NCT02026050|Antiemetics|antiemetics|mesh-ancestor
92502729|NCT02026050|Autonomic Agents|autonomic agents|mesh-ancestor
92502730|NCT02026050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502731|NCT02026050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502732|NCT02026050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502733|NCT02026050|Glucocorticoids|glucocorticoids|mesh-ancestor
92502734|NCT02026050|Hormones|hormones|mesh-ancestor
92502735|NCT02026050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502736|NCT02026050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92502737|NCT02026050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502738|NCT02026050|Protease Inhibitors|protease inhibitors|mesh-ancestor
92502739|NCT02026050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502740|NCT02026050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502741|NCT02026219|Clopidogrel|clopidogrel|mesh-list
92502742|NCT02026219|Ticagrelor|ticagrelor|mesh-list
92502743|NCT02026219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92227649|NCT00002032|Rifabutin|rifabutin|mesh-list
92502744|NCT02026219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92502745|NCT02026219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92502746|NCT02026219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92502747|NCT02026219|Purinergic Agents|purinergic agents|mesh-ancestor
92502748|NCT02026219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502749|NCT02026219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502750|NCT02026219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502751|NCT02026310|Metformin|metformin|mesh-list
92502752|NCT02026310|Glimepiride|glimepiride|mesh-list
92502753|NCT02026310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92502754|NCT02026310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502755|NCT02026310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92502756|NCT02026310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502757|NCT02026310|Immunologic Factors|immunologic factors|mesh-ancestor
92502758|NCT02026479|Dexamethasone|dexamethasone|mesh-list
92502759|NCT02026479|Dexamethasone acetate|dexamethasone acetate|mesh-list
92502760|NCT02026479|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92502761|NCT02026479|BB 1101|bb 1101|mesh-list
92502762|NCT02026479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502763|NCT02026479|Antiemetics|antiemetics|mesh-ancestor
92502764|NCT02026479|Autonomic Agents|autonomic agents|mesh-ancestor
92502765|NCT02026479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502766|NCT02026479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502767|NCT02026479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502768|NCT02026479|Glucocorticoids|glucocorticoids|mesh-ancestor
92502769|NCT02026479|Hormones|hormones|mesh-ancestor
92502770|NCT02026479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502771|NCT02026479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92502772|NCT02026479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502773|NCT02026479|Protease Inhibitors|protease inhibitors|mesh-ancestor
92502774|NCT02026479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502775|NCT02026479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502776|NCT02026492|Methacholine Chloride|methacholine chloride|mesh-list
92502777|NCT02026492|Miotics|miotics|mesh-ancestor
92502778|NCT02026492|Autonomic Agents|autonomic agents|mesh-ancestor
92502779|NCT02026492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502780|NCT02026492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502781|NCT02026492|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92502782|NCT02026492|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92502783|NCT02026492|Respiratory System Agents|respiratory system agents|mesh-ancestor
92502784|NCT02026492|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92502785|NCT02026492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92502786|NCT02026492|Cholinergic Agents|cholinergic agents|mesh-ancestor
92502787|NCT02026492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502788|NCT02026492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502789|NCT02026505|Bortezomib|bortezomib|mesh-list
92502790|NCT02026505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502791|NCT02026518|Vitamin D|vitamin d|mesh-list
92502792|NCT02026518|Cholecalciferol|cholecalciferol|mesh-list
92502793|NCT02026518|Vitamins|vitamins|mesh-ancestor
92502794|NCT02026518|Micronutrients|micronutrients|mesh-ancestor
92502795|NCT02026518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502796|NCT02026518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92502797|NCT02026518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92502798|NCT02026583|Simvastatin|simvastatin|mesh-list
92502799|NCT02026583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92502800|NCT02026583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92502801|NCT02026583|Antimetabolites|antimetabolites|mesh-ancestor
92502802|NCT02026583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502803|NCT02026583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502804|NCT02026583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92502805|NCT02026583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502806|NCT02026765|Heparin|heparin|mesh-list
92502807|NCT02026765|Anticoagulants|anticoagulants|mesh-ancestor
92502808|NCT02026765|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92502809|NCT02026765|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92502810|NCT02026765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502811|NCT02026778|Betahistine|betahistine|mesh-list
92502812|NCT02026778|Ondansetron|ondansetron|mesh-list
92502813|NCT02026778|Antiemetics|antiemetics|mesh-ancestor
92502814|NCT02026778|Autonomic Agents|autonomic agents|mesh-ancestor
92502815|NCT02026778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502816|NCT02026778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502817|NCT02026778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502818|NCT02026778|Antipruritics|antipruritics|mesh-ancestor
92502819|NCT02026778|Dermatologic Agents|dermatologic agents|mesh-ancestor
92502820|NCT02026778|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92502821|NCT02026778|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92502822|NCT02026778|Serotonin Agents|serotonin agents|mesh-ancestor
92502823|NCT02026778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92502824|NCT02026778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502825|NCT02026778|Vasodilator Agents|vasodilator agents|mesh-ancestor
92502826|NCT02026778|Histamine Agonists|histamine agonists|mesh-ancestor
92502827|NCT02026778|Histamine Agents|histamine agents|mesh-ancestor
92502828|NCT02026817|Metformin|metformin|mesh-list
92502829|NCT02026817|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92502830|NCT02026817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92502831|NCT02026817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502832|NCT02026817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92502833|NCT02026817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92502834|NCT02026817|Antimetabolites|antimetabolites|mesh-ancestor
92502835|NCT02026817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502836|NCT02026817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92502837|NCT02026817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92502838|NCT02026817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502839|NCT02026856|Selenious Acid|selenious acid|mesh-list
92502840|NCT02026856|Sodium Selenite|sodium selenite|mesh-list
92502841|NCT02026856|Trace Elements|trace elements|mesh-ancestor
92502842|NCT02026856|Micronutrients|micronutrients|mesh-ancestor
92502843|NCT02026856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502844|NCT02026869|Metformin|metformin|mesh-list
92502845|NCT02026869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92502846|NCT02026869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502847|NCT02026921|Carboplatin|carboplatin|mesh-list
92502848|NCT02026921|Docetaxel|docetaxel|mesh-list
92502849|NCT02026921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502850|NCT02026921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92502851|NCT02026921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92502852|NCT02026921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92502853|NCT02026921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502854|NCT02026947|Sodium Benzoate|sodium benzoate|mesh-list
92502855|NCT02026947|Antifungal Agents|antifungal agents|mesh-ancestor
92502856|NCT02026947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502857|NCT02026973|Fulvestrant|fulvestrant|mesh-list
92502858|NCT02026973|Anastrozole|anastrozole|mesh-list
92502859|NCT02026973|Somatostatin|somatostatin|mesh-list
92502860|NCT02026973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92502861|NCT02026973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502862|NCT02026973|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92502863|NCT02026973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92502864|NCT02026973|Hormone Antagonists|hormone antagonists|mesh-ancestor
92502865|NCT02026973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502866|NCT02026973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502867|NCT02026973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92502868|NCT02026973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92502869|NCT02026973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502870|NCT02026973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502872|NCT02027064|Interferons|interferons|mesh-list
92502873|NCT02027064|Interferon-alpha|interferon-alpha|mesh-list
92502874|NCT02027064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502875|NCT02027064|Antiviral Agents|antiviral agents|mesh-ancestor
92502876|NCT02027064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502877|NCT02027064|Immunologic Factors|immunologic factors|mesh-ancestor
92502878|NCT02027064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502879|NCT02027103|Metformin|metformin|mesh-list
92502880|NCT02027103|Pioglitazone|pioglitazone|mesh-list
92502881|NCT02027103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92502882|NCT02027103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502883|NCT02027220|Dexamethasone|dexamethasone|mesh-list
92502884|NCT02027220|Cyclophosphamide|cyclophosphamide|mesh-list
92502885|NCT02027220|Bortezomib|bortezomib|mesh-list
92502886|NCT02027220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502887|NCT02027220|Immunologic Factors|immunologic factors|mesh-ancestor
92502888|NCT02027220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502889|NCT02027220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502890|NCT02027220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92502891|NCT02027220|Alkylating Agents|alkylating agents|mesh-ancestor
92502892|NCT02027220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502893|NCT02027220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502894|NCT02027220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92502895|NCT02027220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502896|NCT02027220|Antiemetics|antiemetics|mesh-ancestor
92502897|NCT02027220|Autonomic Agents|autonomic agents|mesh-ancestor
92502898|NCT02027220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502899|NCT02027220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92502900|NCT02027220|Glucocorticoids|glucocorticoids|mesh-ancestor
92502901|NCT02027220|Hormones|hormones|mesh-ancestor
92502902|NCT02027220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502903|NCT02027220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92502904|NCT02027298|Abatacept|abatacept|mesh-list
92502905|NCT02027298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92502906|NCT02027298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502907|NCT02027298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92502908|NCT02027298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502909|NCT02027298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92502910|NCT02027298|Immunologic Factors|immunologic factors|mesh-ancestor
92502911|NCT02027298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502912|NCT02027298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92502913|NCT02027324|Chlorhexidine|chlorhexidine|mesh-list
92502914|NCT02027324|Povidone-Iodine|povidone-iodine|mesh-list
92502915|NCT02027324|Povidone|povidone|mesh-list
92502916|NCT02027324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92502917|NCT02027324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502918|NCT02027324|Disinfectants|disinfectants|mesh-ancestor
92502919|NCT02027324|Plasma Substitutes|plasma substitutes|mesh-ancestor
92502920|NCT02027324|Blood Substitutes|blood substitutes|mesh-ancestor
92502921|NCT02027337|Cyproterone Acetate|cyproterone acetate|mesh-list
92502922|NCT02027337|Drospirenone|drospirenone|mesh-list
92502923|NCT02027337|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92502924|NCT02027337|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92502925|NCT02027337|Cyproterone|cyproterone|mesh-list
92502926|NCT02027337|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
92502927|NCT02027337|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92502928|NCT02027337|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92502929|NCT02027337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92502930|NCT02027337|Contraceptive Agents|contraceptive agents|mesh-ancestor
92502931|NCT02027337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92502932|NCT02027337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502933|NCT02027337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92502935|NCT02027337|Hormones|hormones|mesh-ancestor
92502936|NCT02027337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92502937|NCT02027337|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92502938|NCT02027337|Hormone Antagonists|hormone antagonists|mesh-ancestor
92502939|NCT02027337|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92502940|NCT02027337|Diuretics|diuretics|mesh-ancestor
92502941|NCT02027337|Natriuretic Agents|natriuretic agents|mesh-ancestor
92502942|NCT02027337|Androgen Antagonists|androgen antagonists|mesh-ancestor
92502943|NCT02027337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502944|NCT02027337|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92502945|NCT02027363|Capecitabine|capecitabine|mesh-list
92502946|NCT02027363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92502947|NCT02027363|Antimetabolites|antimetabolites|mesh-ancestor
92349830|NCT04082364|Trastuzumab|trastuzumab|mesh-list
92502948|NCT02027363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502949|NCT02027363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502950|NCT02027454|Moxifloxacin|moxifloxacin|mesh-list
92502951|NCT02027454|Cabotegravir|cabotegravir|mesh-list
92502952|NCT02027454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502953|NCT02027454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502954|NCT02027454|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92502955|NCT02027454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92502956|NCT02027454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502957|NCT02027454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502958|NCT02027454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502959|NCT02027454|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92502960|NCT02027454|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92502961|NCT02027454|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92502962|NCT02027454|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92502963|NCT02027454|Antiviral Agents|antiviral agents|mesh-ancestor
92502964|NCT02027493|Interferons|interferons|mesh-list
92502965|NCT02027493|Ribavirin|ribavirin|mesh-list
92502966|NCT02027493|Interferon-alpha|interferon-alpha|mesh-list
92502967|NCT02027493|Interferon alpha-2|interferon alpha-2|mesh-list
92502968|NCT02027493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92502969|NCT02027493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92502970|NCT02027493|Antiviral Agents|antiviral agents|mesh-ancestor
92502971|NCT02027493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502972|NCT02027493|Antimetabolites|antimetabolites|mesh-ancestor
92502973|NCT02027493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502974|NCT02027493|Immunologic Factors|immunologic factors|mesh-ancestor
92502975|NCT02027493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502977|NCT02027532|Cefazolin|cefazolin|mesh-list
92502978|NCT02027532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92502979|NCT02027532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92502980|NCT02027675|Micronutrients|micronutrients|mesh-list
92502981|NCT02027675|Trace Elements|trace elements|mesh-list
92502982|NCT02027675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502983|NCT02027753|Metformin|metformin|mesh-list
92502984|NCT02027753|Insulin Glargine|insulin glargine|mesh-list
92502985|NCT02027753|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92502986|NCT02027753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92502987|NCT02027753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502988|NCT02027753|Protease Inhibitors|protease inhibitors|mesh-ancestor
92502989|NCT02027753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92502990|NCT02027753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92502991|NCT02027792|Diclofenac|diclofenac|mesh-list
92502992|NCT02027792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92502993|NCT02027792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92502994|NCT02027792|Analgesics|analgesics|mesh-ancestor
92502995|NCT02027792|Sensory System Agents|sensory system agents|mesh-ancestor
92502996|NCT02027792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92502997|NCT02027792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92502998|NCT02027792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92502999|NCT02027792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92503000|NCT02027792|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92503001|NCT02027792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503002|NCT02027792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503003|NCT02027870|Sirolimus|sirolimus|mesh-list
92503004|NCT02027870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503005|NCT02027870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503006|NCT02027870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92503007|NCT02027870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503008|NCT02027870|Antifungal Agents|antifungal agents|mesh-ancestor
92503009|NCT02027870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503010|NCT02027870|Immunologic Factors|immunologic factors|mesh-ancestor
92503011|NCT02027870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503012|NCT02027922|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92503013|NCT02027922|Cariostatic Agents|cariostatic agents|mesh-ancestor
92503014|NCT02027922|Protective Agents|protective agents|mesh-ancestor
92503015|NCT02027922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503016|NCT02027961|Durvalumab|durvalumab|mesh-list
92503017|NCT02027961|Trametinib|trametinib|mesh-list
92503018|NCT02027961|Dabrafenib|dabrafenib|mesh-list
92503019|NCT02027961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92503020|NCT02027961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503021|NCT02027961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92503022|NCT02027961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503023|NCT02027961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503024|NCT02027987|Valproic Acid|valproic acid|mesh-list
92503025|NCT02027987|Anticonvulsants|anticonvulsants|mesh-ancestor
92503026|NCT02027987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503027|NCT02027987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503028|NCT02027987|GABA Agents|gaba agents|mesh-ancestor
92503029|NCT02027987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503030|NCT02027987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503031|NCT02027987|Antimanic Agents|antimanic agents|mesh-ancestor
92503032|NCT02027987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92503033|NCT02027987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503034|NCT02027987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503035|NCT02028026|Citalopram|citalopram|mesh-list
92503036|NCT02028026|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92503037|NCT02028026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92503038|NCT02028026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92503039|NCT02028026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503040|NCT02028026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503041|NCT02028026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503042|NCT02028026|Serotonin Agents|serotonin agents|mesh-ancestor
92503043|NCT02028026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503044|NCT02028026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92503045|NCT02028026|Antidepressive Agents|antidepressive agents|mesh-ancestor
92503046|NCT02028026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503047|NCT02028026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92503048|NCT02028026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92503050|NCT02028078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92503051|NCT02028078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503052|NCT02028078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503054|NCT02028234|Pantoprazole|pantoprazole|mesh-list
92503055|NCT02028234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92503056|NCT02028234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503057|NCT02028234|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92503058|NCT02028234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503059|NCT02028234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503060|NCT02028260|Modafinil|modafinil|mesh-list
92503061|NCT02028260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92503062|NCT02028260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503063|NCT02028260|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92503064|NCT02028260|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92503065|NCT02028260|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92503066|NCT02028260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503067|NCT02028299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92503068|NCT02028312|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92503069|NCT02028312|Lubricant Eye Drops|lubricant eye drops|mesh-list
92503070|NCT02028312|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92503071|NCT02028312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92503072|NCT02028312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92503073|NCT02028403|BMS-936559|bms-936559|mesh-list
92503074|NCT02028403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92503075|NCT02028403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92503076|NCT02028403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503077|NCT02028403|Immunologic Factors|immunologic factors|mesh-ancestor
92503078|NCT02028403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503079|NCT02028416|Thymoglobulin|thymoglobulin|mesh-list
92503080|NCT02028416|Immunologic Factors|immunologic factors|mesh-ancestor
92503081|NCT02028416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503082|NCT02028416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503083|NCT02028429|Sildenafil Citrate|sildenafil citrate|mesh-list
92503084|NCT02028429|Vasodilator Agents|vasodilator agents|mesh-ancestor
92503085|NCT02028429|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92503086|NCT02028429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92503087|NCT02028429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503088|NCT02028429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503089|NCT02028429|Urological Agents|urological agents|mesh-ancestor
92503090|NCT02028494|Capecitabine|capecitabine|mesh-list
92503091|NCT02028494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503092|NCT02028494|Antimetabolites|antimetabolites|mesh-ancestor
92503093|NCT02028494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503094|NCT02028494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503095|NCT02028507|Capecitabine|capecitabine|mesh-list
92503096|NCT02028507|Fulvestrant|fulvestrant|mesh-list
92503097|NCT02028507|Palbociclib|palbociclib|mesh-list
92503098|NCT02028507|Exemestane|exemestane|mesh-list
92503099|NCT02028507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503100|NCT02028507|Antimetabolites|antimetabolites|mesh-ancestor
92503101|NCT02028507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503102|NCT02028507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503103|NCT02028507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92503104|NCT02028507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92503105|NCT02028507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92503106|NCT02028507|Hormone Antagonists|hormone antagonists|mesh-ancestor
92503107|NCT02028507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503108|NCT02028507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503109|NCT02028507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92503110|NCT02028507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503111|NCT02028507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92503112|NCT02028507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92503113|NCT02028533|Oxytocin|oxytocin|mesh-list
92503114|NCT02028533|Oxytocics|oxytocics|mesh-ancestor
92503115|NCT02028533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92503116|NCT02028533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503117|NCT02028598|Sildenafil Citrate|sildenafil citrate|mesh-list
92503118|NCT02028598|Clomipramine|clomipramine|mesh-list
92228022|NCT00000484|Natriuretic Agents|natriuretic agents|mesh-ancestor
92503119|NCT02028598|Citric Acid|citric acid|mesh-list
92503120|NCT02028598|Sodium Citrate|sodium citrate|mesh-list
92503122|NCT02028598|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92503123|NCT02028598|Chelating Agents|chelating agents|mesh-ancestor
92503124|NCT02028598|Sequestering Agents|sequestering agents|mesh-ancestor
92503125|NCT02028598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503126|NCT02028598|Vasodilator Agents|vasodilator agents|mesh-ancestor
92503127|NCT02028598|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92503128|NCT02028598|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92503129|NCT02028598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503130|NCT02028598|Urological Agents|urological agents|mesh-ancestor
92503131|NCT02028598|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92503132|NCT02028598|Antidepressive Agents|antidepressive agents|mesh-ancestor
92503133|NCT02028598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503134|NCT02028598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92503135|NCT02028598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92503136|NCT02028598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503137|NCT02028598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503138|NCT02028598|Serotonin Agents|serotonin agents|mesh-ancestor
92503139|NCT02028598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503140|NCT02028663|Esomeprazole|esomeprazole|mesh-list
92503141|NCT02028663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92503142|NCT02028663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503143|NCT02028663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92503144|NCT02028663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503145|NCT02028663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503147|NCT02028689|Lesinurad|lesinurad|mesh-list
92503148|NCT02028689|Furosemide|furosemide|mesh-list
92503149|NCT02028689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503150|NCT02028689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503151|NCT02028689|Diuretics|diuretics|mesh-ancestor
92503152|NCT02028689|Natriuretic Agents|natriuretic agents|mesh-ancestor
92503153|NCT02028689|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92503154|NCT02028689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503155|NCT02028689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503156|NCT02028689|Gout Suppressants|gout suppressants|mesh-ancestor
92503157|NCT02028689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92503158|NCT02028689|Uricosuric Agents|uricosuric agents|mesh-ancestor
92503159|NCT02028819|Dolutegravir|dolutegravir|mesh-list
92503160|NCT02028819|Ibalizumab|ibalizumab|mesh-list
92503161|NCT02028819|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92503162|NCT02028819|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92503163|NCT02028819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503164|NCT02028819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503165|NCT02028819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92503166|NCT02028819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92503167|NCT02028819|Antiviral Agents|antiviral agents|mesh-ancestor
92503168|NCT02028819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503169|NCT02028910|Ondansetron|ondansetron|mesh-list
92503170|NCT02028910|Antiemetics|antiemetics|mesh-ancestor
92503171|NCT02028910|Autonomic Agents|autonomic agents|mesh-ancestor
92503172|NCT02028910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503173|NCT02028910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503174|NCT02028910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503175|NCT02028910|Antipruritics|antipruritics|mesh-ancestor
92503176|NCT02028910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92503177|NCT02028910|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92503178|NCT02028910|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92503179|NCT02028910|Serotonin Agents|serotonin agents|mesh-ancestor
92503180|NCT02028910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503181|NCT02028910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503182|NCT02028923|Morphine|morphine|mesh-list
92503183|NCT02028923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92503184|NCT02028923|Narcotics|narcotics|mesh-ancestor
92503185|NCT02028923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503186|NCT02028923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503187|NCT02028923|Analgesics|analgesics|mesh-ancestor
92503188|NCT02028923|Sensory System Agents|sensory system agents|mesh-ancestor
92503189|NCT02028923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503190|NCT02028949|Idarubicin|idarubicin|mesh-list
92503191|NCT02028949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92503192|NCT02028949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503193|NCT02028949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92503194|NCT02028949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92503195|NCT02028949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503196|NCT02028949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503197|NCT02029105|Hyaluronic Acid|hyaluronic acid|mesh-list
92503198|NCT02029105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92503199|NCT02029105|Immunologic Factors|immunologic factors|mesh-ancestor
92503200|NCT02029105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503201|NCT02029105|Viscosupplements|viscosupplements|mesh-ancestor
92503202|NCT02029105|Protective Agents|protective agents|mesh-ancestor
92503203|NCT02029118|Aspirin|aspirin|mesh-list
92503204|NCT02029118|Metoprolol|metoprolol|mesh-list
92503205|NCT02029118|Ramipril|ramipril|mesh-list
92503206|NCT02029118|Atorvastatin|atorvastatin|mesh-list
92503207|NCT02029118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92503208|NCT02029118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92503209|NCT02029118|Analgesics|analgesics|mesh-ancestor
92503210|NCT02029118|Sensory System Agents|sensory system agents|mesh-ancestor
92503211|NCT02029118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503212|NCT02029118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503213|NCT02029118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92503214|NCT02029118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92503215|NCT02029118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92503216|NCT02029118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92503217|NCT02029118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503218|NCT02029118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92503219|NCT02029118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92503221|NCT02029118|Antipyretics|antipyretics|mesh-ancestor
92503222|NCT02029118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92503223|NCT02029118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92503224|NCT02029118|Antimetabolites|antimetabolites|mesh-ancestor
92503225|NCT02029118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92503226|NCT02029118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92503227|NCT02029118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92503228|NCT02029118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92503229|NCT02029118|Sympatholytics|sympatholytics|mesh-ancestor
92503230|NCT02029118|Autonomic Agents|autonomic agents|mesh-ancestor
92503231|NCT02029118|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92503232|NCT02029118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92503233|NCT02029118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92503234|NCT02029118|Adrenergic Agents|adrenergic agents|mesh-ancestor
92503235|NCT02029118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503236|NCT02029118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92503237|NCT02029118|Protease Inhibitors|protease inhibitors|mesh-ancestor
92503238|NCT02029313|Montelukast|montelukast|mesh-list
92503239|NCT02029313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92503240|NCT02029313|Respiratory System Agents|respiratory system agents|mesh-ancestor
92503241|NCT02029313|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92503242|NCT02029313|Hormone Antagonists|hormone antagonists|mesh-ancestor
92503243|NCT02029313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503244|NCT02029313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503245|NCT02029313|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92503246|NCT02029313|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92503247|NCT02029313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503248|NCT02029378|Eculizumab|eculizumab|mesh-list
92503249|NCT02029378|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92503250|NCT02029378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503251|NCT02029378|Immunologic Factors|immunologic factors|mesh-ancestor
92503252|NCT02029378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503253|NCT02029456|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92503254|NCT02029456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92503255|NCT02029456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92503256|NCT02029456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503257|NCT02029482|Ponesimod|ponesimod|mesh-list
92503258|NCT02029482|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92503259|NCT02029482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503260|NCT02029482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503261|NCT02029482|Immunologic Factors|immunologic factors|mesh-ancestor
92503262|NCT02029482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503263|NCT02029534|Atorvastatin|atorvastatin|mesh-list
92503264|NCT02029534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92503265|NCT02029534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92503266|NCT02029534|Antimetabolites|antimetabolites|mesh-ancestor
92503267|NCT02029534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503268|NCT02029534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92503269|NCT02029534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92503270|NCT02029534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503272|NCT02029573|Atorvastatin|atorvastatin|mesh-list
92503273|NCT02029573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92503274|NCT02029573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92503275|NCT02029573|Antimetabolites|antimetabolites|mesh-ancestor
92503276|NCT02029573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503277|NCT02029573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92503278|NCT02029573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92503279|NCT02029573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503280|NCT02029573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92503281|NCT02029573|Alkylating Agents|alkylating agents|mesh-ancestor
92503282|NCT02029573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503283|NCT02029586|Beta-lapachone|beta-lapachone|mesh-list
92503284|NCT02029586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503285|NCT02029586|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92503286|NCT02029586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92503287|NCT02029586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532899|NCT00056056|Bexarotene|bexarotene|mesh-list
92503288|NCT02029586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503289|NCT02029586|Antiviral Agents|antiviral agents|mesh-ancestor
92503290|NCT02029599|Acetaminophen|acetaminophen|mesh-list
92503291|NCT02029599|Methotrexate|methotrexate|mesh-list
92503292|NCT02029599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92503293|NCT02029599|Abortifacient Agents|abortifacient agents|mesh-ancestor
92503294|NCT02029599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92503295|NCT02029599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503296|NCT02029599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503297|NCT02029599|Antimetabolites|antimetabolites|mesh-ancestor
92503298|NCT02029599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503299|NCT02029599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503300|NCT02029599|Dermatologic Agents|dermatologic agents|mesh-ancestor
92503301|NCT02029599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503302|NCT02029599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92503303|NCT02029599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503304|NCT02029599|Immunologic Factors|immunologic factors|mesh-ancestor
92503305|NCT02029599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92503306|NCT02029599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92503307|NCT02029599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92503308|NCT02029599|Analgesics|analgesics|mesh-ancestor
92503309|NCT02029599|Sensory System Agents|sensory system agents|mesh-ancestor
92503310|NCT02029599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503311|NCT02029599|Antipyretics|antipyretics|mesh-ancestor
92503312|NCT02029612|Nicotine|nicotine|mesh-list
92503313|NCT02029612|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92503314|NCT02029612|Autonomic Agents|autonomic agents|mesh-ancestor
92503315|NCT02029612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503316|NCT02029612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503317|NCT02029612|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92503318|NCT02029612|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92503319|NCT02029612|Cholinergic Agents|cholinergic agents|mesh-ancestor
92503320|NCT02029612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503321|NCT02029612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503322|NCT02029625|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92503323|NCT02029625|Ezetimibe|ezetimibe|mesh-list
92503324|NCT02029625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92503325|NCT02029625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92503326|NCT02029625|Antimetabolites|antimetabolites|mesh-ancestor
92503327|NCT02029625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503328|NCT02029625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92503329|NCT02029625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92503330|NCT02029625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503331|NCT02029794|Acetic Acid|acetic acid|mesh-list
92503332|NCT02029794|Retinol acetate|retinol acetate|mesh-list
92503333|NCT02029794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503334|NCT02029794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503335|NCT02029794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92503336|NCT02029794|Immunologic Factors|immunologic factors|mesh-ancestor
92503337|NCT02029794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503338|NCT02029794|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92503339|NCT02029794|Protective Agents|protective agents|mesh-ancestor
92503340|NCT02029794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503341|NCT02029898|Remifentanil|remifentanil|mesh-list
92503342|NCT02029898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92503343|NCT02029898|Narcotics|narcotics|mesh-ancestor
92503344|NCT02029898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503345|NCT02029898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503346|NCT02029898|Analgesics|analgesics|mesh-ancestor
92503347|NCT02029898|Sensory System Agents|sensory system agents|mesh-ancestor
92503348|NCT02029898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503349|NCT02029924|Insulin Lispro|insulin lispro|mesh-list
92503350|NCT02029924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503351|NCT02029924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503352|NCT02029937|Proflavine|proflavine|mesh-list
92503353|NCT02029937|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92503354|NCT02029937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503355|NCT02029950|Cytarabine|cytarabine|mesh-list
92503356|NCT02029950|Etoposide|etoposide|mesh-list
92503357|NCT02029950|Podophyllotoxin|podophyllotoxin|mesh-list
92503358|NCT02029950|Daunorubicin|daunorubicin|mesh-list
92503359|NCT02029950|Idarubicin|idarubicin|mesh-list
92503360|NCT02029950|Etoposide phosphate|etoposide phosphate|mesh-list
92503361|NCT02029950|Pomalidomide|pomalidomide|mesh-list
92503362|NCT02029950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92503363|NCT02029950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503364|NCT02029950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92503365|NCT02029950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92503366|NCT02029950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503367|NCT02029950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503368|NCT02029950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503370|NCT02029950|Antiviral Agents|antiviral agents|mesh-ancestor
92503371|NCT02029950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503372|NCT02029950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503373|NCT02029950|Immunologic Factors|immunologic factors|mesh-ancestor
92503374|NCT02029950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503375|NCT02029950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92503376|NCT02029950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92503377|NCT02029950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92503378|NCT02029950|Growth Substances|growth substances|mesh-ancestor
92503379|NCT02029950|Growth Inhibitors|growth inhibitors|mesh-ancestor
92503380|NCT02029950|Keratolytic Agents|keratolytic agents|mesh-ancestor
92503381|NCT02029950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92503382|NCT02029950|Tubulin Modulators|tubulin modulators|mesh-ancestor
92503383|NCT02029950|Antimitotic Agents|antimitotic agents|mesh-ancestor
92503384|NCT02029950|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503385|NCT02030561|Trastuzumab|trastuzumab|mesh-list
92503386|NCT02030561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92503387|NCT02030561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503388|NCT02031367|Triamcinolone|triamcinolone|mesh-list
92503389|NCT02031367|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92503390|NCT02031367|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92503391|NCT02031367|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92503392|NCT02031367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92503393|NCT02031367|Glucocorticoids|glucocorticoids|mesh-ancestor
92503394|NCT02031367|Hormones|hormones|mesh-ancestor
92503395|NCT02031367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503396|NCT02031367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503397|NCT02031367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503398|NCT02031367|Immunologic Factors|immunologic factors|mesh-ancestor
92503399|NCT02031367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503400|NCT02031367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503401|NCT02031692|Cholecalciferol|cholecalciferol|mesh-list
92503402|NCT02031692|Vitamin D|vitamin d|mesh-list
92503403|NCT02031692|Calcium Carbonate|calcium carbonate|mesh-list
92503404|NCT02031692|Calcium|calcium|mesh-list
92503405|NCT02031692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92503406|NCT02031692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503407|NCT02031692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92503408|NCT02031692|Vitamins|vitamins|mesh-ancestor
92503409|NCT02031692|Micronutrients|micronutrients|mesh-ancestor
92503410|NCT02031692|Antacids|antacids|mesh-ancestor
92503411|NCT02031692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228327|NCT00002122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503412|NCT02031692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503413|NCT02031991|Bevacizumab|bevacizumab|mesh-list
92503414|NCT02031991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92503415|NCT02031991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503416|NCT02031991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92503417|NCT02031991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92503418|NCT02031991|Growth Substances|growth substances|mesh-ancestor
92503419|NCT02031991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503420|NCT02031991|Growth Inhibitors|growth inhibitors|mesh-ancestor
92503421|NCT02032043|Ivermectin|ivermectin|mesh-list
92503422|NCT02032043|Albendazole|albendazole|mesh-list
92503423|NCT02032043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92503424|NCT02032043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503425|NCT02032043|Anthelmintics|anthelmintics|mesh-ancestor
92503426|NCT02032043|Anticestodal Agents|anticestodal agents|mesh-ancestor
92503427|NCT02032043|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92503428|NCT02032043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92503429|NCT02032043|Tubulin Modulators|tubulin modulators|mesh-ancestor
92503430|NCT02032043|Antimitotic Agents|antimitotic agents|mesh-ancestor
92503431|NCT02032043|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503432|NCT02032043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503433|NCT02032043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503434|NCT02032134|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92503435|NCT02032134|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92503436|NCT02032134|Protective Agents|protective agents|mesh-ancestor
92503437|NCT02032134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503438|NCT02032134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92503439|NCT02032134|Antioxidants|antioxidants|mesh-ancestor
92503440|NCT02032134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503441|NCT02032186|Magnesium citrate|magnesium citrate|mesh-list
92503442|NCT02032186|Cathartics|cathartics|mesh-ancestor
92503443|NCT02032186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503444|NCT02033356|Lidocaine|lidocaine|mesh-list
92503445|NCT02033356|Anesthetics, Local|anesthetics, local|mesh-ancestor
92503446|NCT02033356|Anesthetics|anesthetics|mesh-ancestor
92503447|NCT02033356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503448|NCT02033356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503449|NCT02033356|Sensory System Agents|sensory system agents|mesh-ancestor
92503450|NCT02033356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503451|NCT02033356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92503452|NCT02033356|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92503453|NCT02033356|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92503454|NCT02033356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503455|NCT02033356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503456|NCT02033733|Cisatracurium|cisatracurium|mesh-list
92503457|NCT02033733|Atracurium|atracurium|mesh-list
92503458|NCT02033733|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92503459|NCT02033733|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92503460|NCT02033733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503461|NCT02033733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503462|NCT02033733|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92503463|NCT02033733|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92503464|NCT02033733|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92503465|NCT02033733|Cholinergic Agents|cholinergic agents|mesh-ancestor
92503466|NCT02033733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503467|NCT02033733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503468|NCT02034253|Risperidone|risperidone|mesh-list
92503469|NCT02034253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92503470|NCT02034253|Serotonin Agents|serotonin agents|mesh-ancestor
92503471|NCT02034253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503472|NCT02034253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503473|NCT02034253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503474|NCT02034253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92503475|NCT02034253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92503476|NCT02034253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503477|NCT02034253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503478|NCT02034253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92503479|NCT02034253|Dopamine Agents|dopamine agents|mesh-ancestor
92503480|NCT02035020|Interferons|interferons|mesh-list
92503481|NCT02035020|Interferon-gamma|interferon-gamma|mesh-list
92503482|NCT02035020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503483|NCT02035020|Antiviral Agents|antiviral agents|mesh-ancestor
92503484|NCT02035020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503485|NCT02035709|Hydromorphone|hydromorphone|mesh-list
92503486|NCT02035709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92503487|NCT02035709|Narcotics|narcotics|mesh-ancestor
92503488|NCT02035709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503489|NCT02035709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503490|NCT02035709|Analgesics|analgesics|mesh-ancestor
92503491|NCT02035709|Sensory System Agents|sensory system agents|mesh-ancestor
92503492|NCT02035709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503493|NCT02035891|Colchicine|colchicine|mesh-list
92503494|NCT02035891|Gout Suppressants|gout suppressants|mesh-ancestor
92503495|NCT02035891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92503496|NCT02035891|Tubulin Modulators|tubulin modulators|mesh-ancestor
92503497|NCT02035891|Antimitotic Agents|antimitotic agents|mesh-ancestor
92503498|NCT02035891|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503499|NCT02035891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503500|NCT02035891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503501|NCT02035956|Vaccines|vaccines|mesh-list
92503502|NCT02035956|Immunologic Factors|immunologic factors|mesh-ancestor
92503503|NCT02035956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503504|NCT02036151|Fluorides|fluorides|mesh-list
92503505|NCT02036151|Fluorides, Topical|fluorides, topical|mesh-list
92503506|NCT02036151|Cariostatic Agents|cariostatic agents|mesh-ancestor
92503507|NCT02036151|Protective Agents|protective agents|mesh-ancestor
92503508|NCT02036151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503509|NCT02036255|Taurolidine|taurolidine|mesh-list
92503510|NCT02036255|Heparin|heparin|mesh-list
92503511|NCT02036255|Anticoagulants|anticoagulants|mesh-ancestor
92503512|NCT02036255|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92503513|NCT02036255|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92503514|NCT02036255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503515|NCT02036255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503516|NCT02036255|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92503517|NCT02036255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503518|NCT02038062|Sevoflurane|sevoflurane|mesh-list
92503519|NCT02038062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92503520|NCT02038062|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92503521|NCT02038062|Anesthetics, General|anesthetics, general|mesh-ancestor
92503522|NCT02038062|Anesthetics|anesthetics|mesh-ancestor
92503523|NCT02038062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503524|NCT02038062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503525|NCT02039453|Fentanyl|fentanyl|mesh-list
92503526|NCT02039453|Meperidine|meperidine|mesh-list
92503527|NCT02039453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92503528|NCT02039453|Narcotics|narcotics|mesh-ancestor
92503529|NCT02039453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503530|NCT02039453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503531|NCT02039453|Analgesics|analgesics|mesh-ancestor
92503532|NCT02039453|Sensory System Agents|sensory system agents|mesh-ancestor
92503533|NCT02039453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503534|NCT02039453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92503535|NCT02039453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92503536|NCT02039453|Anesthetics, General|anesthetics, general|mesh-ancestor
92503537|NCT02039453|Anesthetics|anesthetics|mesh-ancestor
92503538|NCT02039492|Spironolactone|spironolactone|mesh-list
92503539|NCT02039492|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92503540|NCT02039492|Hormone Antagonists|hormone antagonists|mesh-ancestor
92503541|NCT02039492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503542|NCT02039492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503543|NCT02039492|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92503544|NCT02039492|Diuretics|diuretics|mesh-ancestor
92503545|NCT02039492|Natriuretic Agents|natriuretic agents|mesh-ancestor
92503546|NCT02039869|Omeprazole|omeprazole|mesh-list
92503547|NCT02039869|Sucralfate|sucralfate|mesh-list
92503548|NCT02039869|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92503549|NCT02039869|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92503550|NCT02039869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503551|NCT02039869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503552|NCT02039869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503553|NCT02040064|Gefitinib|gefitinib|mesh-list
92503554|NCT02040064|Tremelimumab|tremelimumab|mesh-list
92503555|NCT02040064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503556|NCT02040064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92503557|NCT02040064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503558|NCT02040064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503559|NCT02040142|Mitomycins|mitomycins|mesh-list
92503560|NCT02040142|Mitomycin|mitomycin|mesh-list
92503561|NCT02040142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92503562|NCT02040142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503563|NCT02040142|Alkylating Agents|alkylating agents|mesh-ancestor
92503564|NCT02040142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503565|NCT02040142|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92503566|NCT02040142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503568|NCT02040220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92503569|NCT02040220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92503570|NCT02040220|Growth Substances|growth substances|mesh-ancestor
92503571|NCT02040220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503572|NCT02040220|Growth Inhibitors|growth inhibitors|mesh-ancestor
92503573|NCT02040220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503574|NCT02040246|Metformin|metformin|mesh-list
92503575|NCT02040246|Repaglinide|repaglinide|mesh-list
92503576|NCT02040246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503577|NCT02040246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503578|NCT02040285|Metoclopramide|metoclopramide|mesh-list
92503579|NCT02040285|Bisacodyl|bisacodyl|mesh-list
92503580|NCT02040285|Antiemetics|antiemetics|mesh-ancestor
92503581|NCT02040285|Autonomic Agents|autonomic agents|mesh-ancestor
92503582|NCT02040285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503583|NCT02040285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503584|NCT02040285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503585|NCT02040285|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92503586|NCT02040285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92503587|NCT02040285|Dopamine Agents|dopamine agents|mesh-ancestor
92503588|NCT02040285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503589|NCT02040285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503590|NCT02040285|Cathartics|cathartics|mesh-ancestor
92503591|NCT02040285|Laxatives|laxatives|mesh-ancestor
92503592|NCT02040311|Topiramate|topiramate|mesh-list
92503593|NCT02040311|Anticonvulsants|anticonvulsants|mesh-ancestor
92503594|NCT02040311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503595|NCT02040311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503596|NCT02040350|Pralidoxime|pralidoxime|mesh-list
92503597|NCT02040350|Antidotes|antidotes|mesh-ancestor
92503598|NCT02040350|Protective Agents|protective agents|mesh-ancestor
92503599|NCT02040350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503600|NCT02040350|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
92503601|NCT02040350|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
92503602|NCT02040350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503603|NCT02040350|Cholinergic Agents|cholinergic agents|mesh-ancestor
92503604|NCT02040350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503605|NCT02040402|Vaccines|vaccines|mesh-list
92503606|NCT02040402|Immunologic Factors|immunologic factors|mesh-ancestor
92503607|NCT02040402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503608|NCT02040415|Eperisone|eperisone|mesh-list
92503609|NCT02040415|Anticonvulsants|anticonvulsants|mesh-ancestor
92503610|NCT02040415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92503611|NCT02040415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503612|NCT02040415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503613|NCT02040415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92503614|NCT02040415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503615|NCT02040415|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92503616|NCT02040415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92503617|NCT02040415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503618|NCT02040415|Parasympatholytics|parasympatholytics|mesh-ancestor
92503619|NCT02040415|Autonomic Agents|autonomic agents|mesh-ancestor
92503620|NCT02040415|Vasodilator Agents|vasodilator agents|mesh-ancestor
92503621|NCT02040441|Spironolactone|spironolactone|mesh-list
92503622|NCT02040441|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92503623|NCT02040441|Hormone Antagonists|hormone antagonists|mesh-ancestor
92503624|NCT02040441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503625|NCT02040441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503626|NCT02040441|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92503627|NCT02040441|Diuretics|diuretics|mesh-ancestor
92503628|NCT02040441|Natriuretic Agents|natriuretic agents|mesh-ancestor
92503629|NCT02040454|Paclitaxel|paclitaxel|mesh-list
92503630|NCT02040454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92503631|NCT02040454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503632|NCT02040454|Tubulin Modulators|tubulin modulators|mesh-ancestor
92503633|NCT02040454|Antimitotic Agents|antimitotic agents|mesh-ancestor
92503634|NCT02040454|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503635|NCT02040454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503636|NCT02040571|Insulin|insulin|mesh-list
92503637|NCT02040571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503638|NCT02040571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503639|NCT02040597|Beclomethasone|beclomethasone|mesh-list
92503640|NCT02040597|Glycopyrrolate|glycopyrrolate|mesh-list
92503641|NCT02040597|Formoterol Fumarate|formoterol fumarate|mesh-list
92503642|NCT02040597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92503644|NCT02040597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503645|NCT02040597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228551|NCT00000670|Probenecid|probenecid|mesh-list
92503646|NCT02040597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92503647|NCT02040597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92503648|NCT02040597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92503649|NCT02040597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92503650|NCT02040597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92503651|NCT02040597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92503652|NCT02040597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503653|NCT02040597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503654|NCT02040597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92503655|NCT02040597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92503656|NCT02040597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92503657|NCT02040597|Cholinergic Agents|cholinergic agents|mesh-ancestor
92503658|NCT02040597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92503659|NCT02040597|Glucocorticoids|glucocorticoids|mesh-ancestor
92503661|NCT02040597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503662|NCT02040636|Vaccines|vaccines|mesh-list
92503663|NCT02040636|Immunologic Factors|immunologic factors|mesh-ancestor
92503664|NCT02040636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503665|NCT02040649|Midazolam|midazolam|mesh-list
92503666|NCT02040649|Propofol|propofol|mesh-list
92503667|NCT02040649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92503668|NCT02040649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503669|NCT02040649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503670|NCT02040649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92503671|NCT02040649|Anesthetics, General|anesthetics, general|mesh-ancestor
92503672|NCT02040649|Anesthetics|anesthetics|mesh-ancestor
92503673|NCT02040649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92503674|NCT02040649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92503675|NCT02040649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92503676|NCT02040649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503677|NCT02040649|GABA Modulators|gaba modulators|mesh-ancestor
92503678|NCT02040649|GABA Agents|gaba agents|mesh-ancestor
92503679|NCT02040649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503680|NCT02040649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503681|NCT02040662|Morphine|morphine|mesh-list
92503682|NCT02040662|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92503683|NCT02040662|Narcotics|narcotics|mesh-ancestor
92503684|NCT02040662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503685|NCT02040662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503686|NCT02040662|Analgesics|analgesics|mesh-ancestor
92503687|NCT02040662|Sensory System Agents|sensory system agents|mesh-ancestor
92503688|NCT02040662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503689|NCT02040818|Acetylcysteine|acetylcysteine|mesh-list
92503690|NCT02040818|Tigecycline|tigecycline|mesh-list
92503691|NCT02040818|Heparin|heparin|mesh-list
92503692|NCT02040818|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92503693|NCT02040818|Anticoagulants|anticoagulants|mesh-ancestor
92503694|NCT02040818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92503695|NCT02040818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92503696|NCT02040818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503697|NCT02040818|Antiviral Agents|antiviral agents|mesh-ancestor
92503698|NCT02040818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503699|NCT02040818|Expectorants|expectorants|mesh-ancestor
92503700|NCT02040818|Respiratory System Agents|respiratory system agents|mesh-ancestor
92503701|NCT02040818|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92503702|NCT02040818|Antioxidants|antioxidants|mesh-ancestor
92503703|NCT02040818|Protective Agents|protective agents|mesh-ancestor
92503704|NCT02040818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503705|NCT02040818|Antidotes|antidotes|mesh-ancestor
92503706|NCT02040818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503707|NCT02040818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92503708|NCT02040818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503709|NCT02040831|Vaccines|vaccines|mesh-list
92503710|NCT02040831|Immunologic Factors|immunologic factors|mesh-ancestor
92503711|NCT02040831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503712|NCT02040883|Olanzapine|olanzapine|mesh-list
92503713|NCT02040883|Risperidone|risperidone|mesh-list
92503714|NCT02040883|Aripiprazole|aripiprazole|mesh-list
92503715|NCT02040883|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92503716|NCT02040883|Ziprasidone|ziprasidone|mesh-list
92503717|NCT02040883|Tandospirone|tandospirone|mesh-list
92503718|NCT02040883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92503719|NCT02040883|Serotonin Agents|serotonin agents|mesh-ancestor
92503720|NCT02040883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503721|NCT02040883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503722|NCT02040883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503723|NCT02040883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92503724|NCT02040883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92503725|NCT02040883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503726|NCT02040883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503727|NCT02040883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92503728|NCT02040883|Dopamine Agents|dopamine agents|mesh-ancestor
92503729|NCT02040883|Antiemetics|antiemetics|mesh-ancestor
92503730|NCT02040883|Autonomic Agents|autonomic agents|mesh-ancestor
92503731|NCT02040883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503732|NCT02040883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503733|NCT02040883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92503734|NCT02040883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92503735|NCT02040883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503736|NCT02040883|Antidepressive Agents|antidepressive agents|mesh-ancestor
92503737|NCT02040883|Dopamine Agonists|dopamine agonists|mesh-ancestor
92503738|NCT02040883|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92503739|NCT02040883|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92503740|NCT02040883|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92503741|NCT02040883|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92503742|NCT02040883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92503743|NCT02040909|Propofol|propofol|mesh-list
92503744|NCT02040909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92503745|NCT02040909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503746|NCT02040909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503747|NCT02040909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92503748|NCT02040909|Anesthetics, General|anesthetics, general|mesh-ancestor
92503749|NCT02040909|Anesthetics|anesthetics|mesh-ancestor
92503750|NCT02040935|Trastuzumab|trastuzumab|mesh-list
92503751|NCT02040935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92503752|NCT02040935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503753|NCT02040987|Moxifloxacin|moxifloxacin|mesh-list
92503754|NCT02040987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503755|NCT02040987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503756|NCT02040987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92503757|NCT02040987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92503758|NCT02040987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503759|NCT02040987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503760|NCT02040987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503761|NCT02041117|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92503762|NCT02041117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92503763|NCT02041117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92503764|NCT02041117|Antimetabolites|antimetabolites|mesh-ancestor
92503765|NCT02041117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503766|NCT02041117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92503767|NCT02041117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92503768|NCT02041117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503769|NCT02041143|Caseins|caseins|mesh-list
92503770|NCT02041143|Chelating Agents|chelating agents|mesh-ancestor
92503771|NCT02041143|Sequestering Agents|sequestering agents|mesh-ancestor
92503772|NCT02041143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503773|NCT02041273|Palbociclib|palbociclib|mesh-list
92503774|NCT02041273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503775|NCT02041273|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92503776|NCT02041273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503777|NCT02041273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503778|NCT02041338|Paclitaxel|paclitaxel|mesh-list
92503779|NCT02041338|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92503780|NCT02041338|Carboplatin|carboplatin|mesh-list
92503781|NCT02041338|Epirubicin|epirubicin|mesh-list
92503782|NCT02041338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92503783|NCT02041338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503784|NCT02041338|Tubulin Modulators|tubulin modulators|mesh-ancestor
92503785|NCT02041338|Antimitotic Agents|antimitotic agents|mesh-ancestor
92503786|NCT02041338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503787|NCT02041338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503788|NCT02041338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92503789|NCT02041338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92503790|NCT02041338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92503791|NCT02041338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503792|NCT02041351|Docetaxel|docetaxel|mesh-list
92503793|NCT02041351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503794|NCT02041351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92503795|NCT02041351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92503796|NCT02041351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92503797|NCT02041351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503798|NCT02041455|Amitriptyline|amitriptyline|mesh-list
92503800|NCT02041455|Antioxidants|antioxidants|mesh-ancestor
92503801|NCT02041455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503802|NCT02041455|Protective Agents|protective agents|mesh-ancestor
92503803|NCT02041455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503804|NCT02041455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503805|NCT02041455|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92503806|NCT02041455|Antidepressive Agents|antidepressive agents|mesh-ancestor
92503807|NCT02041455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503808|NCT02041455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92503809|NCT02041455|Analgesics|analgesics|mesh-ancestor
92503810|NCT02041455|Sensory System Agents|sensory system agents|mesh-ancestor
92503811|NCT02041455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503812|NCT02041455|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92503813|NCT02041455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92503814|NCT02041455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503815|NCT02041455|Adrenergic Agents|adrenergic agents|mesh-ancestor
92503816|NCT02041455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503818|NCT02041481|Fluorouracil|fluorouracil|mesh-list
92503819|NCT02041481|Oxaliplatin|oxaliplatin|mesh-list
92503820|NCT02041481|Calcium|calcium|mesh-list
92503821|NCT02041481|Levoleucovorin|levoleucovorin|mesh-list
92503822|NCT02041481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92503823|NCT02041481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503824|NCT02041481|Antimetabolites|antimetabolites|mesh-ancestor
92503825|NCT02041481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503826|NCT02041481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503827|NCT02041481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503828|NCT02041481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503829|NCT02041481|Immunologic Factors|immunologic factors|mesh-ancestor
92503830|NCT02041481|Antidotes|antidotes|mesh-ancestor
92503831|NCT02041481|Protective Agents|protective agents|mesh-ancestor
92503832|NCT02041481|Vitamin B Complex|vitamin b complex|mesh-ancestor
92503833|NCT02041481|Vitamins|vitamins|mesh-ancestor
92503834|NCT02041481|Micronutrients|micronutrients|mesh-ancestor
92503835|NCT02041546|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92503836|NCT02041546|Poractant alfa|poractant alfa|mesh-list
92503837|NCT02041546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92503838|NCT02041650|Ticagrelor|ticagrelor|mesh-list
92503839|NCT02041650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92503840|NCT02041650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92503841|NCT02041650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92503842|NCT02041650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92503843|NCT02041650|Purinergic Agents|purinergic agents|mesh-ancestor
92503844|NCT02041650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503845|NCT02041650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503846|NCT02041650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503847|NCT02041767|Ertapenem|ertapenem|mesh-list
92503848|NCT02041767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503849|NCT02041767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503850|NCT02041819|Nimotuzumab|nimotuzumab|mesh-list
92503851|NCT02041819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92503852|NCT02041819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503853|NCT02042027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92503854|NCT02042027|Immunologic Factors|immunologic factors|mesh-ancestor
92503855|NCT02042027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503856|NCT02042170|Hormones|hormones|mesh-list
92503857|NCT02042170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503858|NCT02042170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503859|NCT02042196|Cetrorelix|cetrorelix|mesh-list
92503860|NCT02042196|Estradiol|estradiol|mesh-list
92503861|NCT02042196|Estrogens|estrogens|mesh-ancestor
92503862|NCT02042196|Hormones|hormones|mesh-ancestor
92503863|NCT02042196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503864|NCT02042196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503865|NCT02042196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92503866|NCT02042196|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92503867|NCT02042196|Fertility Agents|fertility agents|mesh-ancestor
92200509|NCT01270321|Somatostatin|somatostatin|mesh-list
92503868|NCT02042196|Hormone Antagonists|hormone antagonists|mesh-ancestor
92503870|NCT02042222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503871|NCT02042222|Antisickling Agents|antisickling agents|mesh-ancestor
92503872|NCT02042222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503873|NCT02042222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503874|NCT02042222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92503876|NCT02042482|Coenzyme Q10|coenzyme q10|mesh-list
92503877|NCT02042482|Micronutrients|micronutrients|mesh-ancestor
92503878|NCT02042482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503879|NCT02042482|Vitamins|vitamins|mesh-ancestor
92503880|NCT02042495|Metformin|metformin|mesh-list
92503881|NCT02042495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503882|NCT02042495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503883|NCT02042573|Sertraline|sertraline|mesh-list
92503884|NCT02042573|Antidepressive Agents|antidepressive agents|mesh-ancestor
92503885|NCT02042573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92503886|NCT02042573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92503887|NCT02042573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92503888|NCT02042573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92503889|NCT02042573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503890|NCT02042573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92503891|NCT02042573|Serotonin Agents|serotonin agents|mesh-ancestor
92503892|NCT02042573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503893|NCT02042599|Sevoflurane|sevoflurane|mesh-list
92503894|NCT02042599|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92503895|NCT02042599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92503896|NCT02042599|Anesthetics, General|anesthetics, general|mesh-ancestor
92503897|NCT02042599|Anesthetics|anesthetics|mesh-ancestor
92503898|NCT02042599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503899|NCT02042599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503900|NCT02042612|Sevoflurane|sevoflurane|mesh-list
92503901|NCT02042612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92503902|NCT02042612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92503903|NCT02042612|Anesthetics, General|anesthetics, general|mesh-ancestor
92503904|NCT02042612|Anesthetics|anesthetics|mesh-ancestor
92503905|NCT02042612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92503906|NCT02042612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503907|NCT02042638|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92503908|NCT02042638|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92503909|NCT02042638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503910|NCT02042664|Metformin|metformin|mesh-list
92503911|NCT02042664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503912|NCT02042664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503913|NCT02042690|Dexamethasone|dexamethasone|mesh-list
92503914|NCT02042690|Cyclophosphamide|cyclophosphamide|mesh-list
92503915|NCT02042690|Methotrexate|methotrexate|mesh-list
92503916|NCT02042690|Epirubicin|epirubicin|mesh-list
92503917|NCT02042690|Mercaptopurine|mercaptopurine|mesh-list
92503918|NCT02042690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92503919|NCT02042690|Immunologic Factors|immunologic factors|mesh-ancestor
92503920|NCT02042690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503921|NCT02042690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92503922|NCT02042690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92503923|NCT02042690|Alkylating Agents|alkylating agents|mesh-ancestor
92503924|NCT02042690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503925|NCT02042690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503926|NCT02042690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92503927|NCT02042690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92503928|NCT02042690|Antiemetics|antiemetics|mesh-ancestor
92503929|NCT02042690|Autonomic Agents|autonomic agents|mesh-ancestor
92503930|NCT02042690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92503931|NCT02042690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92503932|NCT02042690|Glucocorticoids|glucocorticoids|mesh-ancestor
92503933|NCT02042690|Hormones|hormones|mesh-ancestor
92503934|NCT02042690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503935|NCT02042690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92503936|NCT02042690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503937|NCT02042690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92503938|NCT02042690|Abortifacient Agents|abortifacient agents|mesh-ancestor
92503939|NCT02042690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92503940|NCT02042690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503941|NCT02042690|Antimetabolites|antimetabolites|mesh-ancestor
92503942|NCT02042690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92503943|NCT02042690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92503944|NCT02042690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92503945|NCT02042690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92503946|NCT02042690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92503947|NCT02042690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92503948|NCT02042742|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92503949|NCT02042742|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
92503950|NCT02042742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503952|NCT02042742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503953|NCT02042742|Protective Agents|protective agents|mesh-ancestor
92503954|NCT02042742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503956|NCT02042742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92503957|NCT02042742|Disinfectants|disinfectants|mesh-ancestor
92503958|NCT02043002|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92503959|NCT02043002|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92503960|NCT02043002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503961|NCT02043054|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92503962|NCT02043054|Liraglutide|liraglutide|mesh-list
92503963|NCT02043054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92503964|NCT02043054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503965|NCT02043054|Incretins|incretins|mesh-ancestor
92503967|NCT02043054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92503968|NCT02043054|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92503969|NCT02043054|Protease Inhibitors|protease inhibitors|mesh-ancestor
92503970|NCT02043054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92503971|NCT02043054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503972|NCT02043171|Vitamin D|vitamin d|mesh-list
92503973|NCT02043171|Ergocalciferols|ergocalciferols|mesh-list
92503974|NCT02043171|Cholecalciferol|cholecalciferol|mesh-list
92503975|NCT02043171|Vitamins|vitamins|mesh-list
92503976|NCT02043171|Micronutrients|micronutrients|mesh-ancestor
92503977|NCT02043171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503978|NCT02043171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92503979|NCT02043171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92503980|NCT02043223|Vitamins|vitamins|mesh-list
92503981|NCT02043223|Vitamin A|vitamin a|mesh-list
92503982|NCT02043223|Retinol palmitate|retinol palmitate|mesh-list
92503983|NCT02043223|Micronutrients|micronutrients|mesh-ancestor
92503984|NCT02043223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92503985|NCT02043223|Antioxidants|antioxidants|mesh-ancestor
92503986|NCT02043223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503987|NCT02043223|Protective Agents|protective agents|mesh-ancestor
92503988|NCT02043223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92503989|NCT02043223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503990|NCT02043288|Gemcitabine|gemcitabine|mesh-list
92503991|NCT02043288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92503992|NCT02043288|Antimetabolites|antimetabolites|mesh-ancestor
92503993|NCT02043288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92503994|NCT02043288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92503995|NCT02043314|Isoniazid|isoniazid|mesh-list
92503996|NCT02043314|Antitubercular Agents|antitubercular agents|mesh-ancestor
92503997|NCT02043314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92503998|NCT02043314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92503999|NCT02043314|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92504000|NCT02043314|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92504001|NCT02043314|Antimetabolites|antimetabolites|mesh-ancestor
92504002|NCT02043314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504003|NCT02043314|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92504004|NCT02043340|Photosensitizing Agents|photosensitizing agents|mesh-list
92504005|NCT02043340|Dermatologic Agents|dermatologic agents|mesh-ancestor
92504006|NCT02043717|Vitamin D|vitamin d|mesh-list
92504007|NCT02043717|Vitamins|vitamins|mesh-ancestor
92504008|NCT02043717|Micronutrients|micronutrients|mesh-ancestor
92504009|NCT02043717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504010|NCT02043717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92504011|NCT02043730|Paclitaxel|paclitaxel|mesh-list
92504012|NCT02043730|Gemcitabine|gemcitabine|mesh-list
92504013|NCT02043730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92504014|NCT02043730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504015|NCT02043730|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504016|NCT02043730|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504017|NCT02043730|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504018|NCT02043730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504019|NCT02043730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504020|NCT02043730|Antimetabolites|antimetabolites|mesh-ancestor
92228947|NCT00002212|Bexarotene|bexarotene|mesh-list
92504021|NCT02043756|Mitoxantrone|mitoxantrone|mesh-list
92504022|NCT02043756|Analgesics|analgesics|mesh-ancestor
92504023|NCT02043756|Sensory System Agents|sensory system agents|mesh-ancestor
92504024|NCT02043756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504025|NCT02043756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504026|NCT02043756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504027|NCT02043756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92504028|NCT02043756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504029|NCT02043756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504030|NCT02043756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504031|NCT02043821|Capecitabine|capecitabine|mesh-list
92504032|NCT02043821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504033|NCT02043821|Antimetabolites|antimetabolites|mesh-ancestor
92504034|NCT02043821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504035|NCT02043821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504036|NCT02043886|Acarbose|acarbose|mesh-list
92504037|NCT02043886|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92504038|NCT02043886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504039|NCT02043886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504040|NCT02043886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92504041|NCT02043886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504042|NCT02043912|Haloperidol|haloperidol|mesh-list
92504043|NCT02043912|Haloperidol decanoate|haloperidol decanoate|mesh-list
92504044|NCT02043912|Antiemetics|antiemetics|mesh-ancestor
92504045|NCT02043912|Autonomic Agents|autonomic agents|mesh-ancestor
92504046|NCT02043912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504047|NCT02043912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504048|NCT02043912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504049|NCT02043912|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92504050|NCT02043912|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92504051|NCT02043912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92504052|NCT02043912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92504053|NCT02043912|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92504054|NCT02043912|Dopamine Agents|dopamine agents|mesh-ancestor
92504055|NCT02043912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504056|NCT02043912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504057|NCT02043912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92504058|NCT02043977|Propofol|propofol|mesh-list
92504059|NCT02043977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92504060|NCT02043977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92504061|NCT02043977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504062|NCT02043977|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92504063|NCT02043977|Anesthetics, General|anesthetics, general|mesh-ancestor
92504064|NCT02043977|Anesthetics|anesthetics|mesh-ancestor
92504065|NCT02044120|Irinotecan|irinotecan|mesh-list
92504066|NCT02044120|Temozolomide|temozolomide|mesh-list
92504067|NCT02044120|Niraparib|niraparib|mesh-list
92504068|NCT02044120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92504069|NCT02044120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504070|NCT02044120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504071|NCT02044120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504072|NCT02044120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504073|NCT02044120|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504074|NCT02044120|Alkylating Agents|alkylating agents|mesh-ancestor
92504075|NCT02044120|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92504076|NCT02044133|Vitamin D|vitamin d|mesh-list
92504077|NCT02044133|Vitamins|vitamins|mesh-ancestor
92504078|NCT02044133|Micronutrients|micronutrients|mesh-ancestor
92504079|NCT02044133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504080|NCT02044133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92504081|NCT02044146|Clopidogrel|clopidogrel|mesh-list
92504082|NCT02044146|Ticagrelor|ticagrelor|mesh-list
92504083|NCT02044146|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92504084|NCT02044146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92504085|NCT02044146|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92504086|NCT02044146|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92504087|NCT02044146|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92504088|NCT02044146|Purinergic Agents|purinergic agents|mesh-ancestor
92504089|NCT02044146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504090|NCT02044146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504091|NCT02044146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504092|NCT02044224|Dexmedetomidine|dexmedetomidine|mesh-list
92504093|NCT02044224|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92504094|NCT02044224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92504095|NCT02044224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504096|NCT02044224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504097|NCT02044224|Analgesics|analgesics|mesh-ancestor
92504098|NCT02044224|Sensory System Agents|sensory system agents|mesh-ancestor
92504099|NCT02044224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504100|NCT02044224|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92504101|NCT02044224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92504102|NCT02044224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92504103|NCT02044224|Adrenergic Agents|adrenergic agents|mesh-ancestor
92504104|NCT02044224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504105|NCT02044224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504107|NCT02044250|Clopidogrel|clopidogrel|mesh-list
92504108|NCT02044250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504109|NCT02044250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504110|NCT02044250|Analgesics|analgesics|mesh-ancestor
92504111|NCT02044250|Sensory System Agents|sensory system agents|mesh-ancestor
92504112|NCT02044250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504113|NCT02044250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504114|NCT02044250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504115|NCT02044250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504116|NCT02044250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92504117|NCT02044250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92504118|NCT02044250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504119|NCT02044250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92504120|NCT02044250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92504121|NCT02044250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504122|NCT02044250|Antipyretics|antipyretics|mesh-ancestor
92504123|NCT02044250|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92504124|NCT02044250|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92504125|NCT02044250|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92504126|NCT02044250|Purinergic Agents|purinergic agents|mesh-ancestor
92504127|NCT02044250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504129|NCT02044354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504130|NCT02044354|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504131|NCT02044354|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504132|NCT02044354|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504133|NCT02044354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504134|NCT02044549|Oxytocin|oxytocin|mesh-list
92504135|NCT02044549|Carbetocin|carbetocin|mesh-list
92504136|NCT02044549|Methylergonovine|methylergonovine|mesh-list
92504137|NCT02044549|Syntometrine|syntometrine|mesh-list
92504138|NCT02044549|Oxytocics|oxytocics|mesh-ancestor
92504139|NCT02044549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504140|NCT02044549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504141|NCT02044601|Paclitaxel|paclitaxel|mesh-list
92504142|NCT02044601|Carboplatin|carboplatin|mesh-list
92504143|NCT02044601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92504144|NCT02044601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92504145|NCT02044601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504146|NCT02044601|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504147|NCT02044601|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504148|NCT02044601|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504149|NCT02044601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504150|NCT02044601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92504151|NCT02044601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504152|NCT02044627|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92504153|NCT02044627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92504154|NCT02044627|Antimetabolites|antimetabolites|mesh-ancestor
92504155|NCT02044627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504156|NCT02044627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92504157|NCT02044627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504158|NCT02044627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92504159|NCT02044627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504160|NCT02044653|Darbepoetin alfa|darbepoetin alfa|mesh-list
92504161|NCT02044653|Hematinics|hematinics|mesh-ancestor
92504162|NCT02044809|Cannabidiol|cannabidiol|mesh-list
92504163|NCT02044809|Anticonvulsants|anticonvulsants|mesh-ancestor
92504164|NCT02044952|Mesalamine|mesalamine|mesh-list
92504165|NCT02044952|Triptolide|triptolide|mesh-list
92504166|NCT02044952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504168|NCT02044952|Analgesics|analgesics|mesh-ancestor
92504169|NCT02044952|Sensory System Agents|sensory system agents|mesh-ancestor
92504170|NCT02044952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504171|NCT02044952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504172|NCT02044952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504173|NCT02044952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504174|NCT02044952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504175|NCT02044952|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92504176|NCT02044952|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92504177|NCT02044952|Contraceptive Agents|contraceptive agents|mesh-ancestor
92504178|NCT02044952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504179|NCT02044952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504180|NCT02044952|Immunologic Factors|immunologic factors|mesh-ancestor
92504181|NCT02044952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504182|NCT02044952|Alkylating Agents|alkylating agents|mesh-ancestor
92504183|NCT02044952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504184|NCT02044965|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92504185|NCT02044965|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92504186|NCT02044965|Trimethoprim|trimethoprim|mesh-list
92504187|NCT02044965|Sulfamethoxazole|sulfamethoxazole|mesh-list
92504188|NCT02044965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504189|NCT02044965|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92504190|NCT02044965|Antimalarials|antimalarials|mesh-ancestor
92504191|NCT02044965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92504192|NCT02044965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92504193|NCT02044965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92504194|NCT02044965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504195|NCT02044965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504196|NCT02044965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92504197|NCT02044965|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92504198|NCT02044965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92504199|NCT02044978|Zoledronic Acid|zoledronic acid|mesh-list
92504200|NCT02044978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92349870|NCT01413360|Vitamins|vitamins|mesh-list
92504201|NCT02044978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504202|NCT02045017|Dexamethasone|dexamethasone|mesh-list
92504203|NCT02045017|Pomalidomide|pomalidomide|mesh-list
92504204|NCT02045017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504205|NCT02045017|Antiemetics|antiemetics|mesh-ancestor
92504206|NCT02045017|Autonomic Agents|autonomic agents|mesh-ancestor
92504207|NCT02045017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504208|NCT02045017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504209|NCT02045017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504210|NCT02045017|Glucocorticoids|glucocorticoids|mesh-ancestor
92504211|NCT02045017|Hormones|hormones|mesh-ancestor
92504212|NCT02045017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504213|NCT02045017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92504214|NCT02045017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504215|NCT02045017|Immunologic Factors|immunologic factors|mesh-ancestor
92504216|NCT02045017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92504217|NCT02045017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92504218|NCT02045017|Growth Substances|growth substances|mesh-ancestor
92504219|NCT02045017|Growth Inhibitors|growth inhibitors|mesh-ancestor
92504220|NCT02045030|Aflibercept|aflibercept|mesh-list
92504221|NCT02045030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92504222|NCT02045030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92504223|NCT02045030|Growth Substances|growth substances|mesh-ancestor
92504224|NCT02045030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504225|NCT02045030|Growth Inhibitors|growth inhibitors|mesh-ancestor
92504226|NCT02045030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504227|NCT02045056|Gemfibrozil|gemfibrozil|mesh-list
92504228|NCT02045056|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92504229|NCT02045056|Antimetabolites|antimetabolites|mesh-ancestor
92504230|NCT02045056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504231|NCT02045056|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92504232|NCT02045056|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92504233|NCT02045056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92504234|NCT02045056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504235|NCT02045069|Ivermectin|ivermectin|mesh-list
92504236|NCT02045069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92504237|NCT02045069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504238|NCT02045290|Metformin|metformin|mesh-list
92504239|NCT02045290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92200512|NCT01270321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504240|NCT02045290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504241|NCT02045368|Methotrexate|methotrexate|mesh-list
92504242|NCT02045368|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92504243|NCT02045368|Abortifacient Agents|abortifacient agents|mesh-ancestor
92504244|NCT02045368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504245|NCT02045368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504246|NCT02045368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504247|NCT02045368|Antimetabolites|antimetabolites|mesh-ancestor
92504248|NCT02045368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504249|NCT02045368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504250|NCT02045368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92504251|NCT02045368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504252|NCT02045368|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92504253|NCT02045368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504254|NCT02045368|Immunologic Factors|immunologic factors|mesh-ancestor
92504255|NCT02045368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504256|NCT02045368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92504257|NCT02045589|Gemcitabine|gemcitabine|mesh-list
92504258|NCT02045589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92504259|NCT02045589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504260|NCT02045589|Antimetabolites|antimetabolites|mesh-ancestor
92504261|NCT02045589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504262|NCT02045589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504263|NCT02045602|Gemcitabine|gemcitabine|mesh-list
92504264|NCT02045602|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92504265|NCT02045602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504266|NCT02045602|Antimetabolites|antimetabolites|mesh-ancestor
92504267|NCT02045602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504268|NCT02045602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504269|NCT02045667|Mexiletine|mexiletine|mesh-list
92504270|NCT02045667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92504271|NCT02045667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92504272|NCT02045667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92504273|NCT02045667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92504274|NCT02045667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504275|NCT02045693|Buprenorphine|buprenorphine|mesh-list
92504276|NCT02045693|Methadone|methadone|mesh-list
92504277|NCT02045693|Naloxone|naloxone|mesh-list
92504278|NCT02045693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92504279|NCT02045693|Narcotics|narcotics|mesh-ancestor
92504280|NCT02045693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92504281|NCT02045693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504282|NCT02045693|Analgesics|analgesics|mesh-ancestor
92504283|NCT02045693|Sensory System Agents|sensory system agents|mesh-ancestor
92504284|NCT02045693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504285|NCT02045693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92504286|NCT02045693|Antitussive Agents|antitussive agents|mesh-ancestor
92504287|NCT02045693|Respiratory System Agents|respiratory system agents|mesh-ancestor
92504288|NCT02045797|Gepotidacin|gepotidacin|mesh-list
92504289|NCT02045797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504290|NCT02045797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504291|NCT02045797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504292|NCT02045797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504293|NCT02045810|Levobupivacaine|levobupivacaine|mesh-list
92504294|NCT02045810|Anesthetics, Local|anesthetics, local|mesh-ancestor
92504295|NCT02045810|Anesthetics|anesthetics|mesh-ancestor
92504296|NCT02045810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92504297|NCT02045810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504298|NCT02045810|Sensory System Agents|sensory system agents|mesh-ancestor
92504299|NCT02045810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504300|NCT02045849|Itraconazole|itraconazole|mesh-list
92504301|NCT02045849|Gepotidacin|gepotidacin|mesh-list
92504302|NCT02045849|Antifungal Agents|antifungal agents|mesh-ancestor
92504303|NCT02045849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504304|NCT02045849|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92504305|NCT02045849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92504306|NCT02045849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504307|NCT02045849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504308|NCT02045849|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92504309|NCT02045849|Hormone Antagonists|hormone antagonists|mesh-ancestor
92504310|NCT02045849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504311|NCT02045849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504312|NCT02045849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92504313|NCT02045849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504314|NCT02045849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504316|NCT02045914|Ionophores|ionophores|mesh-list
92504317|NCT02045914|Ionomycin|ionomycin|mesh-list
92504318|NCT02045914|Calcium Ionophores|calcium ionophores|mesh-list
92504319|NCT02045914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92504320|NCT02045914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504321|NCT02045914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92504322|NCT02045914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504323|NCT02045940|GSK2881078|gsk2881078|mesh-list
92504324|NCT02045940|Anabolic Agents|anabolic agents|mesh-ancestor
92504325|NCT02045940|Hormones|hormones|mesh-ancestor
92504326|NCT02045940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504327|NCT02045940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504328|NCT02045953|Albuterol|albuterol|mesh-list
92504329|NCT02045953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92504330|NCT02045953|Autonomic Agents|autonomic agents|mesh-ancestor
92504331|NCT02045953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504332|NCT02045953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504333|NCT02045953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92504334|NCT02045953|Respiratory System Agents|respiratory system agents|mesh-ancestor
92504335|NCT02045953|Tocolytic Agents|tocolytic agents|mesh-ancestor
92504336|NCT02045953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504337|NCT02045953|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92504338|NCT02045953|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92504339|NCT02045953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92504340|NCT02045953|Adrenergic Agents|adrenergic agents|mesh-ancestor
92504341|NCT02045953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504342|NCT02045953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504343|NCT02045992|Caffeine|caffeine|mesh-list
92504344|NCT02045992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92504345|NCT02045992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504346|NCT02045992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92504347|NCT02045992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504348|NCT02045992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504349|NCT02045992|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92504350|NCT02045992|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92504351|NCT02045992|Purinergic Agents|purinergic agents|mesh-ancestor
92504352|NCT02045992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504353|NCT02046044|Digoxin|digoxin|mesh-list
92504354|NCT02046044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92504355|NCT02046044|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92504356|NCT02046044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504357|NCT02046044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504358|NCT02046044|Protective Agents|protective agents|mesh-ancestor
92504359|NCT02046044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504360|NCT02046109|Chlorhexidine|chlorhexidine|mesh-list
92504361|NCT02046109|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92504362|NCT02046109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504363|NCT02046109|Disinfectants|disinfectants|mesh-ancestor
92504364|NCT02046187|Temozolomide|temozolomide|mesh-list
92504365|NCT02046187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504366|NCT02046187|Alkylating Agents|alkylating agents|mesh-ancestor
92504367|NCT02046187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504368|NCT02046187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532947|NCT00056446|Vatalanib|vatalanib|mesh-list
92504369|NCT02046304|Gemcitabine|gemcitabine|mesh-list
92504370|NCT02046304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504371|NCT02046304|Antimetabolites|antimetabolites|mesh-ancestor
92504372|NCT02046304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504373|NCT02046304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504374|NCT02046421|Carboplatin|carboplatin|mesh-list
92504375|NCT02046421|Gemcitabine|gemcitabine|mesh-list
92504376|NCT02046421|Mifepristone|mifepristone|mesh-list
92504377|NCT02046421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504378|NCT02046421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504379|NCT02046421|Antimetabolites|antimetabolites|mesh-ancestor
92504380|NCT02046421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504381|NCT02046421|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92504382|NCT02046421|Abortifacient Agents|abortifacient agents|mesh-ancestor
92504383|NCT02046421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504384|NCT02046421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504385|NCT02046421|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92504386|NCT02046421|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92504387|NCT02046421|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92504388|NCT02046421|Contraceptive Agents|contraceptive agents|mesh-ancestor
92504389|NCT02046421|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92504390|NCT02046421|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92504391|NCT02046421|Hormone Antagonists|hormone antagonists|mesh-ancestor
92504392|NCT02046421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504394|NCT02046421|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92504395|NCT02046421|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92504396|NCT02046447|Trihexyphenidyl|trihexyphenidyl|mesh-list
92504397|NCT02046447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92504398|NCT02046447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92504399|NCT02046447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92504400|NCT02046447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92504401|NCT02046447|Cholinergic Agents|cholinergic agents|mesh-ancestor
92504402|NCT02046447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504403|NCT02046447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504404|NCT02046447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504407|NCT02046460|Warfarin|warfarin|mesh-list
92504408|NCT02046460|Acenocoumarol|acenocoumarol|mesh-list
92504409|NCT02046460|Phenprocoumon|phenprocoumon|mesh-list
92504410|NCT02046460|Vitamins|vitamins|mesh-ancestor
92504411|NCT02046460|Micronutrients|micronutrients|mesh-ancestor
92504412|NCT02046460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504413|NCT02046460|Anticoagulants|anticoagulants|mesh-ancestor
92504414|NCT02046460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504415|NCT02046460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504416|NCT02046460|Analgesics|analgesics|mesh-ancestor
92504417|NCT02046460|Sensory System Agents|sensory system agents|mesh-ancestor
92504418|NCT02046460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504419|NCT02046460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504420|NCT02046460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504421|NCT02046460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92504422|NCT02046460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92504423|NCT02046460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504424|NCT02046460|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92504425|NCT02046460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92504426|NCT02046460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504427|NCT02046460|Antipyretics|antipyretics|mesh-ancestor
92504428|NCT02046460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92504429|NCT02046460|Hemostatics|hemostatics|mesh-ancestor
92504430|NCT02046460|Coagulants|coagulants|mesh-ancestor
92504431|NCT02046486|Ticagrelor|ticagrelor|mesh-list
92504432|NCT02046486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92504433|NCT02046486|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92504434|NCT02046486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92504435|NCT02046486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92504436|NCT02046486|Purinergic Agents|purinergic agents|mesh-ancestor
92504437|NCT02046486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504438|NCT02046486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504439|NCT02046486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504440|NCT02046499|Oxytocin|oxytocin|mesh-list
92504441|NCT02046499|Ergonovine|ergonovine|mesh-list
92504442|NCT02046499|Syntometrine|syntometrine|mesh-list
92504443|NCT02046499|Oxytocics|oxytocics|mesh-ancestor
92504444|NCT02046499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504445|NCT02046499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504447|NCT02046538|Fluorouracil|fluorouracil|mesh-list
92504448|NCT02046538|Oxaliplatin|oxaliplatin|mesh-list
92504449|NCT02046538|Irinotecan|irinotecan|mesh-list
92504450|NCT02046538|Antimetabolites|antimetabolites|mesh-ancestor
92504451|NCT02046538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504452|NCT02046538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504453|NCT02046538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504454|NCT02046538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504455|NCT02046538|Immunologic Factors|immunologic factors|mesh-ancestor
92504456|NCT02046538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504457|NCT02046538|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92504458|NCT02046538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504459|NCT02046538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504460|NCT02046538|Antidotes|antidotes|mesh-ancestor
92504461|NCT02046538|Protective Agents|protective agents|mesh-ancestor
92504462|NCT02046538|Vitamin B Complex|vitamin b complex|mesh-ancestor
92504464|NCT02046538|Micronutrients|micronutrients|mesh-ancestor
92504465|NCT02046551|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92504466|NCT02046551|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92504467|NCT02046551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92504468|NCT02046551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92229396|NCT01897454|Immunologic Factors|immunologic factors|mesh-ancestor
92504469|NCT02046551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504470|NCT02046551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92504471|NCT02046551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504472|NCT02046551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504473|NCT02046577|Vitamin D|vitamin d|mesh-list
92504474|NCT02046577|Cholecalciferol|cholecalciferol|mesh-list
92504475|NCT02046577|Vitamins|vitamins|mesh-ancestor
92504476|NCT02046577|Micronutrients|micronutrients|mesh-ancestor
92504477|NCT02046577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504478|NCT02046577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92504479|NCT02046577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92504480|NCT02046629|Teriflunomide|teriflunomide|mesh-list
92504481|NCT02046629|Cholestyramine Resin|cholestyramine resin|mesh-list
92504482|NCT02046629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504483|NCT02046629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504484|NCT02046629|Analgesics|analgesics|mesh-ancestor
92504485|NCT02046629|Sensory System Agents|sensory system agents|mesh-ancestor
92504486|NCT02046629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504487|NCT02046629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504488|NCT02046629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504489|NCT02046629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504490|NCT02046629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504491|NCT02046629|Immunologic Factors|immunologic factors|mesh-ancestor
92504492|NCT02046629|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92504493|NCT02046629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92504494|NCT02046629|Antimetabolites|antimetabolites|mesh-ancestor
92504495|NCT02046629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504496|NCT02046629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92504497|NCT02046668|Spironolactone|spironolactone|mesh-list
92504498|NCT02046668|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92504499|NCT02046668|Hormone Antagonists|hormone antagonists|mesh-ancestor
92504500|NCT02046668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504501|NCT02046668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504502|NCT02046668|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92504503|NCT02046668|Diuretics|diuretics|mesh-ancestor
92504504|NCT02046668|Natriuretic Agents|natriuretic agents|mesh-ancestor
92504505|NCT02046720|Propofol|propofol|mesh-list
92504506|NCT02046720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92504507|NCT02046720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92504508|NCT02046720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504509|NCT02046720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92504510|NCT02046720|Anesthetics, General|anesthetics, general|mesh-ancestor
92504511|NCT02046720|Anesthetics|anesthetics|mesh-ancestor
92504512|NCT02046733|Nivolumab|nivolumab|mesh-list
92504513|NCT02046733|Ipilimumab|ipilimumab|mesh-list
92504514|NCT02046733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92504515|NCT02046733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532953|NCT00056641|Saquinavir|saquinavir|mesh-list
92504516|NCT02046733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92504517|NCT02046733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504518|NCT02046785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92504519|NCT02046850|Rifampin|rifampin|mesh-list
92504520|NCT02046850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92504521|NCT02046850|Antitubercular Agents|antitubercular agents|mesh-ancestor
92504522|NCT02046850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92504523|NCT02046850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504524|NCT02046850|Leprostatic Agents|leprostatic agents|mesh-ancestor
92504525|NCT02046850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92504526|NCT02046850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504527|NCT02046850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504528|NCT02046850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92504529|NCT02046850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92504530|NCT02046850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92504531|NCT02046850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92504532|NCT02046850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92504533|NCT02046850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92504534|NCT02046915|Dexamethasone|dexamethasone|mesh-list
92504535|NCT02046915|Cyclophosphamide|cyclophosphamide|mesh-list
92504536|NCT02046915|Pomalidomide|pomalidomide|mesh-list
92504537|NCT02046915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504538|NCT02046915|Immunologic Factors|immunologic factors|mesh-ancestor
92504539|NCT02046915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504540|NCT02046915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504541|NCT02046915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504542|NCT02046915|Alkylating Agents|alkylating agents|mesh-ancestor
92504543|NCT02046915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504544|NCT02046915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504545|NCT02046915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92504546|NCT02046915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504547|NCT02046915|Antiemetics|antiemetics|mesh-ancestor
92504548|NCT02046915|Autonomic Agents|autonomic agents|mesh-ancestor
92504549|NCT02046915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504550|NCT02046915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504551|NCT02046915|Glucocorticoids|glucocorticoids|mesh-ancestor
92504552|NCT02046915|Hormones|hormones|mesh-ancestor
92504553|NCT02046915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504554|NCT02046915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92504555|NCT02046915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92504556|NCT02046915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92504557|NCT02046915|Growth Substances|growth substances|mesh-ancestor
92504558|NCT02046915|Growth Inhibitors|growth inhibitors|mesh-ancestor
92504559|NCT02047006|Rivaroxaban|rivaroxaban|mesh-list
92504560|NCT02047006|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92504561|NCT02047006|Antithrombins|antithrombins|mesh-ancestor
92504562|NCT02047006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92504563|NCT02047006|Protease Inhibitors|protease inhibitors|mesh-ancestor
92504564|NCT02047006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504565|NCT02047006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504566|NCT02047006|Anticoagulants|anticoagulants|mesh-ancestor
92504567|NCT02047019|Candesartan|candesartan|mesh-list
92504568|NCT02047019|Candesartan cilexetil|candesartan cilexetil|mesh-list
92504569|NCT02047019|Nifedipine|nifedipine|mesh-list
92504570|NCT02047019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92504571|NCT02047019|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92504572|NCT02047019|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92504573|NCT02047019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504574|NCT02047019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92504575|NCT02047019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92504576|NCT02047019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92504577|NCT02047019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504578|NCT02047019|Vasodilator Agents|vasodilator agents|mesh-ancestor
92504579|NCT02047019|Tocolytic Agents|tocolytic agents|mesh-ancestor
92504580|NCT02047019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504581|NCT02047136|Histamine|histamine|mesh-list
92504582|NCT02047136|Histamine Agonists|histamine agonists|mesh-ancestor
92504583|NCT02047136|Histamine Agents|histamine agents|mesh-ancestor
92504584|NCT02047136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504585|NCT02047136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504586|NCT02047136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504587|NCT02047149|Zileuton|zileuton|mesh-list
92504588|NCT02047149|Dasatinib|dasatinib|mesh-list
92504589|NCT02047149|Hydroxyurea|hydroxyurea|mesh-list
92504590|NCT02047149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504591|NCT02047149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92504592|NCT02047149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504593|NCT02047149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504594|NCT02047149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504595|NCT02047149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504596|NCT02047149|Analgesics|analgesics|mesh-ancestor
92504597|NCT02047149|Sensory System Agents|sensory system agents|mesh-ancestor
92504598|NCT02047149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504599|NCT02047149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504600|NCT02047149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504601|NCT02047149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504602|NCT02047149|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92504603|NCT02047149|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92504604|NCT02047149|Hormone Antagonists|hormone antagonists|mesh-ancestor
92504605|NCT02047149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504606|NCT02047149|Antisickling Agents|antisickling agents|mesh-ancestor
92504607|NCT02047149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92504608|NCT02047162|Bismuth|bismuth|mesh-list
92504609|NCT02047162|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92504610|NCT02047162|Antacids|antacids|mesh-ancestor
92504611|NCT02047162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504612|NCT02047162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504613|NCT02047162|Antidiarrheals|antidiarrheals|mesh-ancestor
92504615|NCT02047175|Amlodipine|amlodipine|mesh-list
92504616|NCT02047175|Telmisartan|telmisartan|mesh-list
92504617|NCT02047175|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92504618|NCT02047175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92504619|NCT02047175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92504620|NCT02047175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92504621|NCT02047175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504622|NCT02047175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92504623|NCT02047175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504624|NCT02047175|Vasodilator Agents|vasodilator agents|mesh-ancestor
92504625|NCT02047175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92504626|NCT02047175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92504627|NCT02047175|Antimetabolites|antimetabolites|mesh-ancestor
92504628|NCT02047175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92504629|NCT02047175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92504630|NCT02047175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504631|NCT02047175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92504632|NCT02047175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92504633|NCT02047175|Vitamin B Complex|vitamin b complex|mesh-ancestor
92504634|NCT02047175|Vitamins|vitamins|mesh-ancestor
92504635|NCT02047175|Micronutrients|micronutrients|mesh-ancestor
92504636|NCT02047201|Docetaxel|docetaxel|mesh-list
92504637|NCT02047201|Fluorouracil|fluorouracil|mesh-list
92504638|NCT02047201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504639|NCT02047201|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504640|NCT02047201|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504641|NCT02047201|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504642|NCT02047201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504643|NCT02047201|Antimetabolites|antimetabolites|mesh-ancestor
92504644|NCT02047201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504645|NCT02047201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504646|NCT02047201|Immunologic Factors|immunologic factors|mesh-ancestor
92504647|NCT02047201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504648|NCT02047292|Tacrine|tacrine|mesh-list
92504649|NCT02047292|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92504650|NCT02047292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504651|NCT02047292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504652|NCT02047292|Cholinergic Agents|cholinergic agents|mesh-ancestor
92504653|NCT02047292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532961|NCT00056641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92504654|NCT02047292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504655|NCT02047292|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92504656|NCT02047292|Autonomic Agents|autonomic agents|mesh-ancestor
92504657|NCT02047292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504658|NCT02047292|Nootropic Agents|nootropic agents|mesh-ancestor
92504660|NCT00005823|Etoposide|etoposide|mesh-list
92504661|NCT00005823|Daunorubicin|daunorubicin|mesh-list
92504662|NCT00005823|Mitoxantrone|mitoxantrone|mesh-list
92504663|NCT00005823|Idarubicin|idarubicin|mesh-list
92504664|NCT00005823|Hydroxyurea|hydroxyurea|mesh-list
92504665|NCT00005823|Tretinoin|tretinoin|mesh-list
92504666|NCT00005823|Thioguanine|thioguanine|mesh-list
92504667|NCT00005823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92504668|NCT00005823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504669|NCT00005823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92504670|NCT00005823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504671|NCT00005823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504672|NCT00005823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504673|NCT00005823|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504674|NCT00005823|Antimetabolites|antimetabolites|mesh-ancestor
92504675|NCT00005823|Antiviral Agents|antiviral agents|mesh-ancestor
92504676|NCT00005823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504677|NCT00005823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504678|NCT00005823|Immunologic Factors|immunologic factors|mesh-ancestor
92504679|NCT00005823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504680|NCT00005823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92504681|NCT00005823|Analgesics|analgesics|mesh-ancestor
92504682|NCT00005823|Sensory System Agents|sensory system agents|mesh-ancestor
92504683|NCT00005823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504684|NCT00005823|Antisickling Agents|antisickling agents|mesh-ancestor
92504685|NCT00005823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92504686|NCT00005823|Keratolytic Agents|keratolytic agents|mesh-ancestor
92504687|NCT00005823|Dermatologic Agents|dermatologic agents|mesh-ancestor
92504689|NCT00005826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504690|NCT00005826|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92504691|NCT00005826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504692|NCT00005826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504693|NCT00005826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504694|NCT00005829|Gemcitabine|gemcitabine|mesh-list
92504695|NCT00005829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504696|NCT00005829|Antimetabolites|antimetabolites|mesh-ancestor
92504697|NCT00005829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504698|NCT00005829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504699|NCT00005832|Tipifarnib|tipifarnib|mesh-list
92504700|NCT00005832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504701|NCT00005838|Paclitaxel|paclitaxel|mesh-list
92504702|NCT00005838|Vinorelbine|vinorelbine|mesh-list
92504703|NCT00005838|Carboplatin|carboplatin|mesh-list
92504704|NCT00005838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92504705|NCT00005838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504706|NCT00005838|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504707|NCT00005838|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504708|NCT00005838|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504709|NCT00005838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504710|NCT00005841|Freund's Adjuvant|freund's adjuvant|mesh-list
92504711|NCT00005841|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92504712|NCT00005841|Immunologic Factors|immunologic factors|mesh-ancestor
92504713|NCT00005841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504714|NCT00005844|Oxaliplatin|oxaliplatin|mesh-list
92504715|NCT00005844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504716|NCT00005850|Gemcitabine|gemcitabine|mesh-list
92504717|NCT00005850|Fluoxetine|fluoxetine|mesh-list
92504718|NCT00005850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504719|NCT00005850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504720|NCT00005850|Antimetabolites|antimetabolites|mesh-ancestor
92504721|NCT00005850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504722|NCT00005850|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92504723|NCT00005850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92504724|NCT00005850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92504725|NCT00005850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504726|NCT00005850|Serotonin Agents|serotonin agents|mesh-ancestor
92504727|NCT00005850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504728|NCT00005850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92504729|NCT00005850|Antidepressive Agents|antidepressive agents|mesh-ancestor
92504730|NCT00005850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92504731|NCT00005850|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92504732|NCT00005850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92504733|NCT00005850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504734|NCT00005853|Etanercept|etanercept|mesh-list
92504735|NCT00005853|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92504736|NCT00005853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504737|NCT00005853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504738|NCT00005853|Analgesics|analgesics|mesh-ancestor
92504739|NCT00005853|Sensory System Agents|sensory system agents|mesh-ancestor
92504740|NCT00005853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504741|NCT00005853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504742|NCT00005853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504743|NCT00005853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504744|NCT00005853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504745|NCT00005853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504746|NCT00005853|Immunologic Factors|immunologic factors|mesh-ancestor
92504747|NCT00005856|Oxaliplatin|oxaliplatin|mesh-list
92504748|NCT00005856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504749|NCT00005859|Tipifarnib|tipifarnib|mesh-list
92504750|NCT00005859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504751|NCT00005862|Semaxinib|semaxinib|mesh-list
92504752|NCT00005862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92504753|NCT00005862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92504754|NCT00005862|Growth Substances|growth substances|mesh-ancestor
92504755|NCT00005862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504756|NCT00005862|Growth Inhibitors|growth inhibitors|mesh-ancestor
92504757|NCT00005862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504758|NCT00005862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92504759|NCT00005862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504760|NCT00005862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504761|NCT00005865|Vinorelbine|vinorelbine|mesh-list
92504762|NCT00005865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92504763|NCT00005865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504764|NCT00005865|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504765|NCT00005865|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504766|NCT00005865|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504767|NCT00005865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504768|NCT00005868|Docetaxel|docetaxel|mesh-list
92504769|NCT00005868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504770|NCT00005868|Tubulin Modulators|tubulin modulators|mesh-ancestor
92504771|NCT00005868|Antimitotic Agents|antimitotic agents|mesh-ancestor
92504772|NCT00005868|Mitosis Modulators|mitosis modulators|mesh-ancestor
92504773|NCT00005868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504774|NCT00005871|Fluorouracil|fluorouracil|mesh-list
92504775|NCT00005871|Rubitecan|rubitecan|mesh-list
92504776|NCT00005871|Antimetabolites|antimetabolites|mesh-ancestor
92504777|NCT00005871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504778|NCT00005871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504779|NCT00005871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504780|NCT00005871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504781|NCT00005871|Immunologic Factors|immunologic factors|mesh-ancestor
92504782|NCT00005871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504783|NCT00005871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92504784|NCT00005871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504785|NCT00005871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504786|NCT00005874|Rubitecan|rubitecan|mesh-list
92504787|NCT00005874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504788|NCT00005874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92504789|NCT00005874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504790|NCT00005874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504791|NCT00005874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504792|NCT00005877|Rubitecan|rubitecan|mesh-list
92504793|NCT00005877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504794|NCT00005877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92504795|NCT00005877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504796|NCT00005877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504797|NCT00005877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504798|NCT00005880|Budesonide|budesonide|mesh-list
92504799|NCT00005880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504800|NCT00005880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92504802|NCT00005880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504803|NCT00005880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504804|NCT00005880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92504805|NCT00005880|Respiratory System Agents|respiratory system agents|mesh-ancestor
92504806|NCT00005880|Glucocorticoids|glucocorticoids|mesh-ancestor
92504807|NCT00005880|Hormones|hormones|mesh-ancestor
92504808|NCT00005880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504809|NCT00005883|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
92504810|NCT00005883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504811|NCT00005883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504812|NCT00005883|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92504813|NCT00005883|Protective Agents|protective agents|mesh-ancestor
92504814|NCT00005883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504815|NCT00005883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504816|NCT00005886|Tamoxifen|tamoxifen|mesh-list
92504817|NCT00005886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92504818|NCT00005886|Hormone Antagonists|hormone antagonists|mesh-ancestor
92504819|NCT00005886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504820|NCT00005886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504821|NCT00005886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92504822|NCT00005886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504823|NCT00005886|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92504824|NCT00005886|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92504825|NCT00005886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92504826|NCT00005889|Glucagon|glucagon|mesh-list
92504827|NCT00005889|Glycerol|glycerol|mesh-list
92504828|NCT00005889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504829|NCT00005889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504830|NCT00005889|Hormones|hormones|mesh-ancestor
92504831|NCT00005889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504832|NCT00005889|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92504833|NCT00005889|Protective Agents|protective agents|mesh-ancestor
92504834|NCT00005892|Cyclophosphamide|cyclophosphamide|mesh-list
92504835|NCT00005892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504836|NCT00005892|Immunologic Factors|immunologic factors|mesh-ancestor
92504837|NCT00005892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504838|NCT00005892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504839|NCT00005892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504840|NCT00005892|Alkylating Agents|alkylating agents|mesh-ancestor
92504841|NCT00005892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504842|NCT00005892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504843|NCT00005892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92504845|NCT00005898|Methylprednisolone|methylprednisolone|mesh-list
92504846|NCT00005898|Cyclophosphamide|cyclophosphamide|mesh-list
92504847|NCT00005898|Fludarabine|fludarabine|mesh-list
92504848|NCT00005898|Cyclosporins|cyclosporins|mesh-list
92504849|NCT00005898|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92504850|NCT00005898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504851|NCT00005898|Immunologic Factors|immunologic factors|mesh-ancestor
92504852|NCT00005898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504853|NCT00005898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504854|NCT00005898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504855|NCT00005898|Alkylating Agents|alkylating agents|mesh-ancestor
92504856|NCT00005898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504857|NCT00005898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504858|NCT00005898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92504859|NCT00005898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504860|NCT00005898|Antifungal Agents|antifungal agents|mesh-ancestor
92504861|NCT00005898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504862|NCT00005898|Dermatologic Agents|dermatologic agents|mesh-ancestor
92504863|NCT00005898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92504864|NCT00005898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504865|NCT00005898|Antiemetics|antiemetics|mesh-ancestor
92504866|NCT00005898|Autonomic Agents|autonomic agents|mesh-ancestor
92504867|NCT00005898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504868|NCT00005898|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92504869|NCT00005898|Glucocorticoids|glucocorticoids|mesh-ancestor
92532971|NCT00398437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92504871|NCT00005898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350339|NCT01396278|Xhance|xhance|mesh-list
92504872|NCT00005898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92504873|NCT00005898|Protective Agents|protective agents|mesh-ancestor
92504874|NCT00386412|Valganciclovir|valganciclovir|mesh-list
92504875|NCT00386412|Antiviral Agents|antiviral agents|mesh-ancestor
92504876|NCT00386412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504877|NCT00386529|Aspirin|aspirin|mesh-list
92504878|NCT00386529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92504879|NCT00386529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504880|NCT00386529|Analgesics|analgesics|mesh-ancestor
92504881|NCT00386529|Sensory System Agents|sensory system agents|mesh-ancestor
92504882|NCT00386529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504883|NCT00386529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504884|NCT00386529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504885|NCT00386529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504886|NCT00386529|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92504887|NCT00386529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92504888|NCT00386529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504889|NCT00386529|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92504890|NCT00386529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92504891|NCT00386529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504892|NCT00386529|Antipyretics|antipyretics|mesh-ancestor
92504893|NCT00005922|Triamcinolone|triamcinolone|mesh-list
92504894|NCT00005922|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92504895|NCT00005922|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92504896|NCT00005922|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92504897|NCT00005922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92504898|NCT00005922|Glucocorticoids|glucocorticoids|mesh-ancestor
92504899|NCT00005922|Hormones|hormones|mesh-ancestor
92504900|NCT00005922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92504901|NCT00005922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504902|NCT00005922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504903|NCT00005922|Immunologic Factors|immunologic factors|mesh-ancestor
92504904|NCT00005922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504905|NCT00005922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504906|NCT00005925|Muscimol|muscimol|mesh-list
92504907|NCT00005925|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92504908|NCT00005925|GABA Agonists|gaba agonists|mesh-ancestor
92504909|NCT00005925|GABA Agents|gaba agents|mesh-ancestor
92504910|NCT00005925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92504911|NCT00005925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504912|NCT00005925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504913|NCT00005928|Ramipril|ramipril|mesh-list
92504914|NCT00005928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92504915|NCT00005928|Protease Inhibitors|protease inhibitors|mesh-ancestor
92504916|NCT00005928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229879|NCT00002494|Cobalt|cobalt|mesh-list
92504917|NCT00005928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504918|NCT00005928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92504919|NCT00005931|Semaxinib|semaxinib|mesh-list
92504920|NCT00005931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92504921|NCT00005931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92504922|NCT00005931|Growth Substances|growth substances|mesh-ancestor
92504923|NCT00005931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504924|NCT00005931|Growth Inhibitors|growth inhibitors|mesh-ancestor
92504925|NCT00005931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504926|NCT00005931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92504927|NCT00005931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504928|NCT00005931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504929|NCT00005934|Azacitidine|azacitidine|mesh-list
92504930|NCT00005934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504931|NCT00005934|Antimetabolites|antimetabolites|mesh-ancestor
92504932|NCT00005934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504933|NCT00005934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504934|NCT00005934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504935|NCT00005940|Iodine|iodine|mesh-list
92504936|NCT00005940|Cyclosporine|cyclosporine|mesh-list
92504937|NCT00005940|Cyclophosphamide|cyclophosphamide|mesh-list
92504938|NCT00005940|Busulfan|busulfan|mesh-list
92504939|NCT00005940|Methotrexate|methotrexate|mesh-list
92504940|NCT00005940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92504941|NCT00005940|Cyclosporins|cyclosporins|mesh-list
92504942|NCT00005940|Antibodies|antibodies|mesh-list
92504943|NCT00005940|Immunoglobulins|immunoglobulins|mesh-list
92504944|NCT00005940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92504945|NCT00005940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504946|NCT00005940|Immunologic Factors|immunologic factors|mesh-ancestor
92504947|NCT00005940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504948|NCT00005940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504949|NCT00005940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504950|NCT00005940|Alkylating Agents|alkylating agents|mesh-ancestor
92504951|NCT00005940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504952|NCT00005940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504953|NCT00005940|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92504954|NCT00005940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92504955|NCT00005940|Abortifacient Agents|abortifacient agents|mesh-ancestor
92504956|NCT00005940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92504957|NCT00005940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92504958|NCT00005940|Antimetabolites|antimetabolites|mesh-ancestor
92504959|NCT00005940|Dermatologic Agents|dermatologic agents|mesh-ancestor
92504960|NCT00005940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504961|NCT00005940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92504962|NCT00005940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92504963|NCT00005940|Antifungal Agents|antifungal agents|mesh-ancestor
92504964|NCT00005940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504965|NCT00005940|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92504966|NCT00005940|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92504967|NCT00005940|Trace Elements|trace elements|mesh-ancestor
92504968|NCT00005940|Micronutrients|micronutrients|mesh-ancestor
92504969|NCT00005943|Aldesleukin|aldesleukin|mesh-list
92504970|NCT00005943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504971|NCT00005943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92504972|NCT00005943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92504973|NCT00005943|Antiviral Agents|antiviral agents|mesh-ancestor
92504974|NCT00005943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92504975|NCT00005946|Cyclophosphamide|cyclophosphamide|mesh-list
92504976|NCT00005946|Etoposide|etoposide|mesh-list
92504977|NCT00005946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92504978|NCT00005946|Immunologic Factors|immunologic factors|mesh-ancestor
92504979|NCT00005946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504980|NCT00005946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92504981|NCT00005946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92504982|NCT00005946|Alkylating Agents|alkylating agents|mesh-ancestor
92504983|NCT00005946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92504984|NCT00005946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504985|NCT00005946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92504986|NCT00005946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92504987|NCT00005946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92504988|NCT00005946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92504989|NCT00005946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92504991|NCT00005949|Interleukin-2|interleukin-2|mesh-list
92504992|NCT00005949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92504993|NCT00005949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92504994|NCT00005949|Analgesics|analgesics|mesh-ancestor
92504995|NCT00005949|Sensory System Agents|sensory system agents|mesh-ancestor
92504996|NCT00005949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92504997|NCT00005949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92504998|NCT00005949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92504999|NCT00005949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92505000|NCT00005949|Antiviral Agents|antiviral agents|mesh-ancestor
92505001|NCT00005949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505002|NCT00005952|Temozolomide|temozolomide|mesh-list
92505003|NCT00005952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505004|NCT00005952|Alkylating Agents|alkylating agents|mesh-ancestor
92505005|NCT00005952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505006|NCT00005952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505007|NCT00005955|Temozolomide|temozolomide|mesh-list
92505008|NCT00005955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505009|NCT00005955|Alkylating Agents|alkylating agents|mesh-ancestor
92505010|NCT00005955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505011|NCT00005955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505012|NCT00005958|Gemcitabine|gemcitabine|mesh-list
92505014|NCT00005958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505015|NCT00005958|Antimetabolites|antimetabolites|mesh-ancestor
92505016|NCT00005958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505017|NCT00005958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505018|NCT00005958|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505019|NCT00005958|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505020|NCT00005958|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505021|NCT00005961|Carmustine|carmustine|mesh-list
92505022|NCT00005961|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92505023|NCT00005961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505024|NCT00005961|Alkylating Agents|alkylating agents|mesh-ancestor
92505025|NCT00005961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505026|NCT00005961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505027|NCT00005961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505028|NCT00005964|Prednisone|prednisone|mesh-list
92505029|NCT00005964|Cyclophosphamide|cyclophosphamide|mesh-list
92505030|NCT00005964|Doxorubicin|doxorubicin|mesh-list
92505031|NCT00005964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92505032|NCT00005964|Etoposide|etoposide|mesh-list
92505033|NCT00005964|Vincristine|vincristine|mesh-list
92505034|NCT00005964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505035|NCT00005964|Immunologic Factors|immunologic factors|mesh-ancestor
92505036|NCT00005964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505037|NCT00005964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505038|NCT00005964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505039|NCT00005964|Alkylating Agents|alkylating agents|mesh-ancestor
92505040|NCT00005964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505041|NCT00005964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505042|NCT00005964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505043|NCT00005964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92505044|NCT00005964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505045|NCT00005964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505046|NCT00005964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505047|NCT00005964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505048|NCT00005964|Glucocorticoids|glucocorticoids|mesh-ancestor
92505049|NCT00005964|Hormones|hormones|mesh-ancestor
92505050|NCT00005964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505051|NCT00005964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505052|NCT00005964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505053|NCT00005964|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505054|NCT00005964|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505055|NCT00005964|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505056|NCT00005967|Tipifarnib|tipifarnib|mesh-list
92505057|NCT00005967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505058|NCT00005970|Tamoxifen|tamoxifen|mesh-list
92505059|NCT00005970|Paclitaxel|paclitaxel|mesh-list
92505060|NCT00005970|Cyclophosphamide|cyclophosphamide|mesh-list
92505061|NCT00005970|Doxorubicin|doxorubicin|mesh-list
92505062|NCT00005970|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92505063|NCT00005970|Trastuzumab|trastuzumab|mesh-list
92505064|NCT00005970|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92505065|NCT00005970|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92505066|NCT00005970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92505067|NCT00005970|Antibodies|antibodies|mesh-list
92505068|NCT00005970|Immunoglobulins|immunoglobulins|mesh-list
92505069|NCT00005970|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92505070|NCT00005970|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92505071|NCT00005970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505072|NCT00005970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505073|NCT00005970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505074|NCT00005970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505075|NCT00005970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505076|NCT00005970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505077|NCT00005970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505078|NCT00005970|Immunologic Factors|immunologic factors|mesh-ancestor
92505079|NCT00005970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505080|NCT00005970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505081|NCT00005970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505082|NCT00005970|Alkylating Agents|alkylating agents|mesh-ancestor
92505083|NCT00005970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505084|NCT00005970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92505085|NCT00005970|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505086|NCT00005970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505087|NCT00005970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505088|NCT00005970|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92505089|NCT00005970|Hormone Antagonists|hormone antagonists|mesh-ancestor
92505090|NCT00005970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505091|NCT00005970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505092|NCT00005970|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92505093|NCT00005970|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92505094|NCT00005970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92505095|NCT00005970|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92505096|NCT00005976|Carboplatin|carboplatin|mesh-list
92505097|NCT00005976|NSC 366140|nsc 366140|mesh-list
92505098|NCT00005976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505099|NCT00005979|Leucovorin|leucovorin|mesh-list
92505100|NCT00005979|Fluorouracil|fluorouracil|mesh-list
92505101|NCT00005979|Irinotecan|irinotecan|mesh-list
92505102|NCT00005979|Calcium|calcium|mesh-list
92505103|NCT00005979|Levoleucovorin|levoleucovorin|mesh-list
92505104|NCT00005979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92505105|NCT00005979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505106|NCT00005979|Antimetabolites|antimetabolites|mesh-ancestor
92505107|NCT00005979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505108|NCT00005979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505109|NCT00005979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505110|NCT00005979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505111|NCT00005979|Immunologic Factors|immunologic factors|mesh-ancestor
92505112|NCT00005979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92505113|NCT00005979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505114|NCT00005979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505115|NCT00005979|Antidotes|antidotes|mesh-ancestor
92505116|NCT00005979|Protective Agents|protective agents|mesh-ancestor
92505117|NCT00005979|Vitamin B Complex|vitamin b complex|mesh-ancestor
92505118|NCT00005979|Vitamins|vitamins|mesh-ancestor
92505119|NCT00005979|Micronutrients|micronutrients|mesh-ancestor
92505120|NCT00005985|Cytarabine|cytarabine|mesh-list
92505121|NCT00005985|Dexamethasone|dexamethasone|mesh-list
92505122|NCT00005985|Cyclophosphamide|cyclophosphamide|mesh-list
92505123|NCT00005985|Carmustine|carmustine|mesh-list
92505124|NCT00005985|Etoposide|etoposide|mesh-list
92505125|NCT00005985|Mitoxantrone|mitoxantrone|mesh-list
92505126|NCT00005985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505127|NCT00005985|Immunologic Factors|immunologic factors|mesh-ancestor
92505128|NCT00005985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505129|NCT00005985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505130|NCT00005985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505131|NCT00005985|Alkylating Agents|alkylating agents|mesh-ancestor
92505132|NCT00005985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505133|NCT00005985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505134|NCT00005985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505135|NCT00005985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505136|NCT00005985|Antiemetics|antiemetics|mesh-ancestor
92505137|NCT00005985|Autonomic Agents|autonomic agents|mesh-ancestor
92505138|NCT00005985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505139|NCT00005985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505140|NCT00005985|Glucocorticoids|glucocorticoids|mesh-ancestor
92505141|NCT00005985|Hormones|hormones|mesh-ancestor
92505142|NCT00005985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505143|NCT00005985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505144|NCT00005985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230082|NCT00002536|Vincristine|vincristine|mesh-list
92505145|NCT00005985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505146|NCT00005985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505147|NCT00005985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505148|NCT00005985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505150|NCT00005985|Antiviral Agents|antiviral agents|mesh-ancestor
92505151|NCT00005985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505152|NCT00005985|Analgesics|analgesics|mesh-ancestor
92505153|NCT00005985|Sensory System Agents|sensory system agents|mesh-ancestor
92505154|NCT00005988|Leucovorin|leucovorin|mesh-list
92505155|NCT00005988|Cyclosporine|cyclosporine|mesh-list
92505156|NCT00005988|Methylprednisolone|methylprednisolone|mesh-list
92505157|NCT00005988|Cyclophosphamide|cyclophosphamide|mesh-list
92505158|NCT00005988|Methotrexate|methotrexate|mesh-list
92505159|NCT00005988|Cyclosporins|cyclosporins|mesh-list
92505160|NCT00005988|Levoleucovorin|levoleucovorin|mesh-list
92505161|NCT00005988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505162|NCT00005988|Immunologic Factors|immunologic factors|mesh-ancestor
92505163|NCT00005988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505164|NCT00005988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505165|NCT00005988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505166|NCT00005988|Alkylating Agents|alkylating agents|mesh-ancestor
92505167|NCT00005988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505168|NCT00005988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505169|NCT00005988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505170|NCT00005988|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92505171|NCT00005988|Abortifacient Agents|abortifacient agents|mesh-ancestor
92505172|NCT00005988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92505173|NCT00005988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505174|NCT00005988|Antimetabolites|antimetabolites|mesh-ancestor
92505175|NCT00005988|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505176|NCT00005988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505177|NCT00005988|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92505178|NCT00005988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92505179|NCT00005988|Antidotes|antidotes|mesh-ancestor
92505180|NCT00005988|Protective Agents|protective agents|mesh-ancestor
92505181|NCT00005988|Vitamin B Complex|vitamin b complex|mesh-ancestor
92505182|NCT00005988|Vitamins|vitamins|mesh-ancestor
92505183|NCT00005988|Micronutrients|micronutrients|mesh-ancestor
92505184|NCT00005988|Antifungal Agents|antifungal agents|mesh-ancestor
92505185|NCT00005988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505186|NCT00005988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92505187|NCT00005988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505188|NCT00005988|Antiemetics|antiemetics|mesh-ancestor
92505189|NCT00005988|Autonomic Agents|autonomic agents|mesh-ancestor
92505190|NCT00005988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505191|NCT00005988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505192|NCT00005988|Glucocorticoids|glucocorticoids|mesh-ancestor
92505193|NCT00005988|Hormones|hormones|mesh-ancestor
92505194|NCT00005988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505195|NCT00005988|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92505196|NCT00005991|Gemcitabine|gemcitabine|mesh-list
92505197|NCT00005991|Doxorubicin|doxorubicin|mesh-list
92505198|NCT00005991|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92505199|NCT00005991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505200|NCT00005991|Antimetabolites|antimetabolites|mesh-ancestor
92505201|NCT00005991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505202|NCT00005991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505203|NCT00005991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92505204|NCT00005991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505205|NCT00005991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505206|NCT00005991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505207|NCT00005994|Ondansetron|ondansetron|mesh-list
92505208|NCT00005994|Antiemetics|antiemetics|mesh-ancestor
92505209|NCT00005994|Autonomic Agents|autonomic agents|mesh-ancestor
92350441|NCT01381692|Antiemetics|antiemetics|mesh-ancestor
92505210|NCT00005994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505211|NCT00005994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505212|NCT00005994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505213|NCT00005994|Antipruritics|antipruritics|mesh-ancestor
92505214|NCT00005994|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505215|NCT00005994|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92505216|NCT00005994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92505217|NCT00005994|Serotonin Agents|serotonin agents|mesh-ancestor
92505218|NCT00005994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505219|NCT00005994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505220|NCT00006000|Irinotecan|irinotecan|mesh-list
92505221|NCT00006000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505222|NCT00006000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92505223|NCT00006000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505224|NCT00006000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505225|NCT00006000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505226|NCT00006003|Semaxinib|semaxinib|mesh-list
92505227|NCT00006003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92505228|NCT00006003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92505229|NCT00006003|Growth Substances|growth substances|mesh-ancestor
92505230|NCT00006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505231|NCT00006003|Growth Inhibitors|growth inhibitors|mesh-ancestor
92505232|NCT00006003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505233|NCT00006003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92505234|NCT00006003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505235|NCT00006003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505236|NCT00006006|Interferons|interferons|mesh-list
92505237|NCT00006006|Interferon-alpha|interferon-alpha|mesh-list
92505238|NCT00006006|Thalidomide|thalidomide|mesh-list
92505239|NCT00006006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505240|NCT00006006|Antiviral Agents|antiviral agents|mesh-ancestor
92505241|NCT00006006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505242|NCT00006006|Immunologic Factors|immunologic factors|mesh-ancestor
92505243|NCT00006006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505244|NCT00006006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505245|NCT00006006|Leprostatic Agents|leprostatic agents|mesh-ancestor
92505246|NCT00006006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505247|NCT00006006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92505248|NCT00006006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92505249|NCT00006006|Growth Substances|growth substances|mesh-ancestor
92505250|NCT00006006|Growth Inhibitors|growth inhibitors|mesh-ancestor
92505251|NCT00006009|Visilizumab|visilizumab|mesh-list
92505252|NCT00006009|Immunologic Factors|immunologic factors|mesh-ancestor
92505253|NCT00006009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505254|NCT00006012|Paclitaxel|paclitaxel|mesh-list
92505255|NCT00006012|Etoposide|etoposide|mesh-list
92505256|NCT00006012|Topotecan|topotecan|mesh-list
92505257|NCT00006012|Amifostine|amifostine|mesh-list
92505258|NCT00006012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505259|NCT00006012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505260|NCT00006012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505261|NCT00006012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505262|NCT00006012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505263|NCT00006012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505264|NCT00006012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505265|NCT00006012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505266|NCT00006012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505267|NCT00006012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505268|NCT00006012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92505269|NCT00006012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92505270|NCT00006012|Protective Agents|protective agents|mesh-ancestor
92505271|NCT00006015|Leucovorin|leucovorin|mesh-list
92505272|NCT00006015|Fluorouracil|fluorouracil|mesh-list
92505273|NCT00006015|Oxaliplatin|oxaliplatin|mesh-list
92505274|NCT00006015|Trastuzumab|trastuzumab|mesh-list
92505275|NCT00006015|Calcium|calcium|mesh-list
92505276|NCT00006015|Levoleucovorin|levoleucovorin|mesh-list
92505277|NCT00006015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92505278|NCT00006015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505279|NCT00006015|Antimetabolites|antimetabolites|mesh-ancestor
92505280|NCT00006015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505281|NCT00006015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505282|NCT00006015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505283|NCT00006015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505284|NCT00006015|Immunologic Factors|immunologic factors|mesh-ancestor
92505285|NCT00006015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505286|NCT00006015|Antidotes|antidotes|mesh-ancestor
92505287|NCT00006015|Protective Agents|protective agents|mesh-ancestor
92505288|NCT00006015|Vitamin B Complex|vitamin b complex|mesh-ancestor
92505289|NCT00006015|Vitamins|vitamins|mesh-ancestor
92505290|NCT00006015|Micronutrients|micronutrients|mesh-ancestor
92505291|NCT00006018|Paclitaxel|paclitaxel|mesh-list
92505292|NCT00006018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505293|NCT00006018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505294|NCT00006018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505295|NCT00006018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505296|NCT00006018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230230|NCT05749900|Nivolumab|nivolumab|mesh-list
92505297|NCT00006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505299|NCT00006021|Arsenic Trioxide|arsenic trioxide|mesh-list
92505300|NCT00006021|Antioxidants|antioxidants|mesh-ancestor
92505301|NCT00006021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505302|NCT00006021|Protective Agents|protective agents|mesh-ancestor
92505303|NCT00006021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505304|NCT00006021|Vitamins|vitamins|mesh-ancestor
92505305|NCT00006021|Micronutrients|micronutrients|mesh-ancestor
92505306|NCT00006021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505307|NCT00006024|Temozolomide|temozolomide|mesh-list
92505308|NCT00006024|Lomustine|lomustine|mesh-list
92505309|NCT00006024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505310|NCT00006024|Alkylating Agents|alkylating agents|mesh-ancestor
92505311|NCT00006024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505312|NCT00006024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505313|NCT00006027|Paclitaxel|paclitaxel|mesh-list
92505314|NCT00006027|Cisplatin|cisplatin|mesh-list
92505315|NCT00006027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505316|NCT00006027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505317|NCT00006027|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505318|NCT00006027|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505319|NCT00006027|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505320|NCT00006027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505321|NCT00386646|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92505322|NCT00386646|Laxatives|laxatives|mesh-ancestor
92505323|NCT00386646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505324|NCT00386685|Trastuzumab|trastuzumab|mesh-list
92505325|NCT00386685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505326|NCT00386685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505327|NCT00006030|Tamoxifen|tamoxifen|mesh-list
92505328|NCT00006030|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92505329|NCT00006030|Hormone Antagonists|hormone antagonists|mesh-ancestor
92505330|NCT00006030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505331|NCT00006030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505332|NCT00006030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505333|NCT00006030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505334|NCT00006030|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92505335|NCT00006030|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92505336|NCT00006030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92505337|NCT00006033|Methotrexate|methotrexate|mesh-list
92505338|NCT00006033|Interleukin-2|interleukin-2|mesh-list
92505339|NCT00006033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92505340|NCT00006033|Abortifacient Agents|abortifacient agents|mesh-ancestor
92505341|NCT00006033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92505342|NCT00006033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505343|NCT00006033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505344|NCT00006033|Antimetabolites|antimetabolites|mesh-ancestor
92505345|NCT00006033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505346|NCT00006033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505347|NCT00006033|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505348|NCT00006033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505349|NCT00006033|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92505350|NCT00006033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505351|NCT00006033|Immunologic Factors|immunologic factors|mesh-ancestor
92505352|NCT00006033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505353|NCT00006033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92505354|NCT00006033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92505355|NCT00006033|Analgesics|analgesics|mesh-ancestor
92505356|NCT00006033|Sensory System Agents|sensory system agents|mesh-ancestor
92505357|NCT00006033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505358|NCT00006036|Lurtotecan|lurtotecan|mesh-list
92505359|NCT00006036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505360|NCT00006039|Interferons|interferons|mesh-list
92505361|NCT00006039|Interferon-alpha|interferon-alpha|mesh-list
92505362|NCT00006039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505363|NCT00006039|Antiviral Agents|antiviral agents|mesh-ancestor
92505364|NCT00006039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505365|NCT00006039|Immunologic Factors|immunologic factors|mesh-ancestor
92505366|NCT00006039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505367|NCT00006042|Mycophenolic Acid|mycophenolic acid|mesh-list
92505368|NCT00006042|Cyclophosphamide|cyclophosphamide|mesh-list
92505369|NCT00006042|Fludarabine|fludarabine|mesh-list
92505370|NCT00006042|Fludarabine phosphate|fludarabine phosphate|mesh-list
92505371|NCT00006042|Tacrolimus|tacrolimus|mesh-list
92505372|NCT00006042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505373|NCT00006042|Immunologic Factors|immunologic factors|mesh-ancestor
92505374|NCT00006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505375|NCT00006042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505376|NCT00006042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505377|NCT00006042|Alkylating Agents|alkylating agents|mesh-ancestor
92505378|NCT00006042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505379|NCT00006042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505380|NCT00006042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505381|NCT00006042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505382|NCT00006042|Antimetabolites|antimetabolites|mesh-ancestor
92505383|NCT00006042|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92505384|NCT00006042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505385|NCT00006042|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92505386|NCT00006042|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92505387|NCT00006042|Antitubercular Agents|antitubercular agents|mesh-ancestor
92505388|NCT00006042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505389|NCT00006042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505390|NCT05680974|Antibodies|antibodies|mesh-list
92505391|NCT05680974|Immunologic Factors|immunologic factors|mesh-ancestor
92505392|NCT05680974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505393|NCT05680857|Ubiquinone|ubiquinone|mesh-list
92505394|NCT05680857|Coenzyme Q10|coenzyme q10|mesh-list
92505395|NCT05680857|Micronutrients|micronutrients|mesh-ancestor
92505396|NCT05680857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505397|NCT05680857|Vitamins|vitamins|mesh-ancestor
92505398|NCT00386763|Lumefantrine|lumefantrine|mesh-list
92505399|NCT00386763|Artemether|artemether|mesh-list
92505400|NCT00386763|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92505401|NCT00386763|Antimalarials|antimalarials|mesh-ancestor
92505402|NCT00386763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92505403|NCT00386763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92505404|NCT00386763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505405|NCT05680662|Metformin|metformin|mesh-list
92505406|NCT05680662|Quercetin|quercetin|mesh-list
92505407|NCT05680662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92505408|NCT05680662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505409|NCT05680662|Antioxidants|antioxidants|mesh-ancestor
92505410|NCT05680662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505411|NCT05680662|Protective Agents|protective agents|mesh-ancestor
92505412|NCT05680545|Sevoflurane|sevoflurane|mesh-list
92505413|NCT05680545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92505414|NCT05680545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92505415|NCT05680545|Anesthetics, General|anesthetics, general|mesh-ancestor
92505416|NCT05680545|Anesthetics|anesthetics|mesh-ancestor
92505417|NCT05680545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92505418|NCT05680545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505419|NCT05680389|Minocycline|minocycline|mesh-list
92505420|NCT05680389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505421|NCT05680389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505422|NCT05680194|Diphosphonates|diphosphonates|mesh-list
92505423|NCT05680194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92505424|NCT05680194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505425|NCT00386802|Antifungal Agents|antifungal agents|mesh-list
92505426|NCT00386802|Clotrimazole|clotrimazole|mesh-list
92505427|NCT00386802|Miconazole|miconazole|mesh-list
92505428|NCT00386802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505429|NCT00386802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92505430|NCT00386802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92505431|NCT00386802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92505432|NCT00386802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505433|NCT00386802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505434|NCT00386802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92505435|NCT00386802|Hormone Antagonists|hormone antagonists|mesh-ancestor
92200518|NCT01270321|Hormones|hormones|mesh-ancestor
92505436|NCT00386802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505437|NCT00386802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505438|NCT00386802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92505439|NCT00386802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92505441|NCT00386841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92505442|NCT00386841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92505443|NCT00386841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92505444|NCT00386841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505445|NCT00386841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505446|NCT00386841|Serotonin Agents|serotonin agents|mesh-ancestor
92505447|NCT00386841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505448|NCT05679453|Etodolac|etodolac|mesh-list
92505449|NCT05679453|Lornoxicam|lornoxicam|mesh-list
92505450|NCT05679453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92505451|NCT05679453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92505452|NCT05679453|Analgesics|analgesics|mesh-ancestor
92505453|NCT05679453|Sensory System Agents|sensory system agents|mesh-ancestor
92505454|NCT05679453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505455|NCT05679453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505456|NCT05679453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505457|NCT05679453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505458|NCT05679453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92505459|NCT05679453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92505460|NCT05679453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505461|NCT05679453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505463|NCT05679375|Analgesics|analgesics|mesh-ancestor
92505464|NCT05679375|Sensory System Agents|sensory system agents|mesh-ancestor
92505465|NCT05679375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505466|NCT05679375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505467|NCT05679375|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92505468|NCT05679375|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92505469|NCT05679375|Anesthetics, General|anesthetics, general|mesh-ancestor
92505470|NCT05679375|Anesthetics|anesthetics|mesh-ancestor
92505471|NCT05679375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92505472|NCT05679375|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92505473|NCT05679375|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92505474|NCT05679375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505475|NCT05679375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505476|NCT05679336|Cyclophosphamide|cyclophosphamide|mesh-list
92505477|NCT05679336|Rituximab|rituximab|mesh-list
92505478|NCT05679336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505479|NCT05679336|Immunologic Factors|immunologic factors|mesh-ancestor
92505480|NCT05679336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505481|NCT05679336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505482|NCT05679336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505483|NCT05679336|Alkylating Agents|alkylating agents|mesh-ancestor
92505484|NCT05679336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505485|NCT05679336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505486|NCT05679336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505487|NCT05679336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505488|NCT05677152|Zoledronic Acid|zoledronic acid|mesh-list
92505489|NCT05677152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92505490|NCT05677152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505491|NCT05626725|Insulin|insulin|mesh-list
92505492|NCT05626725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92505493|NCT05626725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505494|NCT05597163|Atropine|atropine|mesh-list
92505495|NCT05597163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92505496|NCT05597163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92505497|NCT05597163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92505498|NCT05597163|Autonomic Agents|autonomic agents|mesh-ancestor
92505499|NCT05597163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505500|NCT05597163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505501|NCT05597163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92505502|NCT05597163|Respiratory System Agents|respiratory system agents|mesh-ancestor
92505503|NCT05597163|Mydriatics|mydriatics|mesh-ancestor
92505504|NCT05597163|Parasympatholytics|parasympatholytics|mesh-ancestor
92505505|NCT05597163|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92505506|NCT05597163|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92505507|NCT05597163|Cholinergic Agents|cholinergic agents|mesh-ancestor
92505508|NCT05597163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505509|NCT05597163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505510|NCT05550129|Metformin|metformin|mesh-list
92505511|NCT05550129|Sotorasib|sotorasib|mesh-list
92505512|NCT05550129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92505513|NCT05550129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505514|NCT05550129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92505515|NCT05550129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505516|NCT05550129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505517|NCT05550129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505518|NCT00386958|Povidone-Iodine|povidone-iodine|mesh-list
92505519|NCT00386958|Povidone|povidone|mesh-list
92505520|NCT00386958|Plasma Substitutes|plasma substitutes|mesh-ancestor
92505521|NCT00386958|Blood Substitutes|blood substitutes|mesh-ancestor
92505522|NCT00386958|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92505523|NCT00386958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505524|NCT00386997|Amphotericin B|amphotericin b|mesh-list
92505525|NCT00386997|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92505526|NCT00386997|Amebicides|amebicides|mesh-ancestor
92505527|NCT00386997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92505528|NCT00386997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92505529|NCT00386997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505530|NCT00386997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505531|NCT00386997|Antifungal Agents|antifungal agents|mesh-ancestor
92505532|NCT03940131|Panitumumab|panitumumab|mesh-list
92505533|NCT03940131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505534|NCT03940131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505536|NCT05160597|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92505537|NCT05160597|Chelating Agents|chelating agents|mesh-ancestor
92505538|NCT05160597|Sequestering Agents|sequestering agents|mesh-ancestor
92505539|NCT05160597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505540|NCT05160597|Anticoagulants|anticoagulants|mesh-ancestor
92505541|NCT05160597|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92505542|NCT05160597|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92505543|NCT00387309|Methylnaltrexone|methylnaltrexone|mesh-list
92505544|NCT00387309|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92505545|NCT00387309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505546|NCT00387309|Sensory System Agents|sensory system agents|mesh-ancestor
92505547|NCT00387309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505548|NCT04921722|Sirolimus|sirolimus|mesh-list
92505549|NCT04921722|Temsirolimus|temsirolimus|mesh-list
92505550|NCT04921722|MTOR Inhibitors|mtor inhibitors|mesh-list
92505551|NCT04921722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505552|NCT04921722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505553|NCT04921722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92505554|NCT04921722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505555|NCT04921722|Antifungal Agents|antifungal agents|mesh-ancestor
92505556|NCT04921722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505557|NCT04921722|Immunologic Factors|immunologic factors|mesh-ancestor
92505558|NCT04921722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505559|NCT04921722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92505560|NCT04921722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505561|NCT04921722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505562|NCT04833387|Antibodies|antibodies|mesh-list
92505563|NCT04833387|Immunologic Factors|immunologic factors|mesh-ancestor
92505564|NCT04833387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505565|NCT04803084|TEMPO|tempo|mesh-list
92505566|NCT04803084|Antioxidants|antioxidants|mesh-ancestor
92505567|NCT04803084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505568|NCT04803084|Protective Agents|protective agents|mesh-ancestor
92505569|NCT04803084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505570|NCT04793685|Prazosin|prazosin|mesh-list
92505571|NCT04793685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92505572|NCT04793685|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92505573|NCT04793685|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92505574|NCT04793685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92505575|NCT04793685|Adrenergic Agents|adrenergic agents|mesh-ancestor
92505576|NCT04793685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505577|NCT04793685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505578|NCT04793685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505579|NCT04787991|Hydroxychloroquine|hydroxychloroquine|mesh-list
92505580|NCT04787991|Paclitaxel|paclitaxel|mesh-list
92505581|NCT04787991|Gemcitabine|gemcitabine|mesh-list
92505582|NCT04787991|Nivolumab|nivolumab|mesh-list
92505583|NCT04787991|Ipilimumab|ipilimumab|mesh-list
92505584|NCT04787991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505585|NCT04787991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505586|NCT04787991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505587|NCT04787991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505588|NCT04787991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505589|NCT04787991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505590|NCT04787991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505591|NCT04787991|Antimetabolites|antimetabolites|mesh-ancestor
92505592|NCT04787991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505593|NCT04787991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92505594|NCT04787991|Antimalarials|antimalarials|mesh-ancestor
92505595|NCT04787991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92505596|NCT04787991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92505597|NCT04787991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505598|NCT04787991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505599|NCT04787991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505600|NCT04552080|Amoxicillin|amoxicillin|mesh-list
92505601|NCT04552080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505602|NCT04552080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505604|NCT03834909|Emtricitabine|emtricitabine|mesh-list
92505605|NCT03834909|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92505606|NCT03834909|Antiviral Agents|antiviral agents|mesh-ancestor
92505607|NCT03834909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505608|NCT03834909|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92505609|NCT03834909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92505610|NCT03834909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505611|NCT03834909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505612|NCT03834909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92505613|NCT03834909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92505614|NCT04360473|Magnesium Sulfate|magnesium sulfate|mesh-list
92505615|NCT04360473|Ketamine|ketamine|mesh-list
92505616|NCT04360473|Anesthetics|anesthetics|mesh-list
92505617|NCT04360473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92505618|NCT04360473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505619|NCT04360473|Analgesics|analgesics|mesh-ancestor
92505620|NCT04360473|Sensory System Agents|sensory system agents|mesh-ancestor
92505621|NCT04360473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505622|NCT04360473|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92505623|NCT04360473|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92505624|NCT04360473|Anesthetics, General|anesthetics, general|mesh-ancestor
92505625|NCT04360473|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92505626|NCT04360473|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92505627|NCT04360473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152401|NCT03595397|Anesthetics|anesthetics|mesh-ancestor
92505628|NCT04360473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505629|NCT04360473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92505630|NCT04360473|Anticonvulsants|anticonvulsants|mesh-ancestor
92505631|NCT04360473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92505632|NCT04360473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92505633|NCT04360473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92505634|NCT04360473|Tocolytic Agents|tocolytic agents|mesh-ancestor
92505635|NCT04360473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92505636|NCT04305795|Pembrolizumab|pembrolizumab|mesh-list
92505637|NCT04305795|Cemiplimab|cemiplimab|mesh-list
92505638|NCT04305795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505639|NCT04305795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505640|NCT04305795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92505641|NCT04305795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505642|NCT00423384|Ibandronic Acid|ibandronic acid|mesh-list
92505643|NCT00423384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92505644|NCT00423384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505645|NCT04175613|Apremilast|apremilast|mesh-list
92505646|NCT04175613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92505647|NCT04175613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92505648|NCT04175613|Analgesics|analgesics|mesh-ancestor
92505649|NCT04175613|Sensory System Agents|sensory system agents|mesh-ancestor
92505650|NCT04175613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505651|NCT04175613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505652|NCT04175613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505653|NCT04175613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505654|NCT04175613|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92505655|NCT04175613|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92505656|NCT04175613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505657|NCT04175613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505658|NCT03945357|Clindamycin|clindamycin|mesh-list
92505659|NCT03945357|Clindamycin palmitate|clindamycin palmitate|mesh-list
92505660|NCT03945357|Clindamycin phosphate|clindamycin phosphate|mesh-list
92505661|NCT03945357|Gemcitabine|gemcitabine|mesh-list
92505662|NCT03945357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505663|NCT03945357|Antimetabolites|antimetabolites|mesh-ancestor
92505664|NCT03945357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505665|NCT03945357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505666|NCT03945357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505667|NCT03945357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505668|NCT03945357|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92505669|NCT03945357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505670|NCT03913221|Caffeine|caffeine|mesh-list
92505671|NCT03913221|Caffeine citrate|caffeine citrate|mesh-list
92505672|NCT03913221|Citric Acid|citric acid|mesh-list
92505673|NCT03913221|Sodium Citrate|sodium citrate|mesh-list
92505674|NCT03913221|Anticoagulants|anticoagulants|mesh-ancestor
92505675|NCT03913221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92505676|NCT03913221|Chelating Agents|chelating agents|mesh-ancestor
92505677|NCT03913221|Sequestering Agents|sequestering agents|mesh-ancestor
92505678|NCT03913221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505679|NCT03913221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92505680|NCT03913221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505681|NCT03913221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92505682|NCT03913221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505683|NCT03913221|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92505684|NCT03913221|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92505685|NCT03913221|Purinergic Agents|purinergic agents|mesh-ancestor
92505686|NCT03913221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505688|NCT03869736|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92505689|NCT03869736|Anesthetics, General|anesthetics, general|mesh-ancestor
92505690|NCT03869736|Anesthetics|anesthetics|mesh-ancestor
92505691|NCT03869736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92505692|NCT03869736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505693|NCT03869736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92505694|NCT03869736|Analgesics|analgesics|mesh-ancestor
92505695|NCT03869736|Sensory System Agents|sensory system agents|mesh-ancestor
92505696|NCT03869736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505697|NCT03786081|Bevacizumab|bevacizumab|mesh-list
92505698|NCT03786081|Pembrolizumab|pembrolizumab|mesh-list
92505699|NCT03786081|Tisotumab vedotin|tisotumab vedotin|mesh-list
92505700|NCT03786081|Carboplatin|carboplatin|mesh-list
92505701|NCT03786081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505702|NCT03786081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505703|NCT03786081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92505704|NCT03786081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92505705|NCT03786081|Growth Substances|growth substances|mesh-ancestor
92505706|NCT03786081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505707|NCT03786081|Growth Inhibitors|growth inhibitors|mesh-ancestor
92505708|NCT03786081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92505709|NCT03786081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505710|NCT03782259|Dapagliflozin|dapagliflozin|mesh-list
92505711|NCT03782259|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92505712|NCT03782259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505713|NCT03782259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92505714|NCT03782259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505715|NCT03741933|Apremilast|apremilast|mesh-list
92505716|NCT03741933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92505717|NCT03741933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92505718|NCT03741933|Analgesics|analgesics|mesh-ancestor
92505719|NCT03741933|Sensory System Agents|sensory system agents|mesh-ancestor
92505720|NCT03741933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505721|NCT03741933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505722|NCT03741933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505723|NCT03741933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505724|NCT03741933|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92505725|NCT03741933|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92505726|NCT03741933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505727|NCT03741933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505728|NCT03002259|Dexamethasone|dexamethasone|mesh-list
92505729|NCT03002259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505730|NCT03002259|Antiemetics|antiemetics|mesh-ancestor
92505731|NCT03002259|Autonomic Agents|autonomic agents|mesh-ancestor
92505732|NCT03002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505733|NCT03002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505734|NCT03002259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505735|NCT03002259|Glucocorticoids|glucocorticoids|mesh-ancestor
92505736|NCT03002259|Hormones|hormones|mesh-ancestor
92505737|NCT03002259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505738|NCT03002259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505739|NCT03002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505740|NCT03000387|Nicotine|nicotine|mesh-list
92505741|NCT03000387|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92505742|NCT03000387|Autonomic Agents|autonomic agents|mesh-ancestor
92505743|NCT03000387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505744|NCT03000387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505745|NCT03000387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92505746|NCT03000387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92505747|NCT03000387|Cholinergic Agents|cholinergic agents|mesh-ancestor
92505748|NCT03000387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92505749|NCT03000387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505750|NCT00387504|Fenretinide|fenretinide|mesh-list
92505751|NCT00387504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505752|NCT00387504|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92505754|NCT00387504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505755|NCT02936505|Cyclosporine|cyclosporine|mesh-list
92505756|NCT02936505|Mycophenolic Acid|mycophenolic acid|mesh-list
92505757|NCT02936505|Tacrolimus|tacrolimus|mesh-list
92505758|NCT02936505|Cyclosporins|cyclosporins|mesh-list
92505759|NCT02936505|Thymoglobulin|thymoglobulin|mesh-list
92505760|NCT02936505|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92505761|NCT02936505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505762|NCT02936505|Immunologic Factors|immunologic factors|mesh-ancestor
92505763|NCT02936505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505764|NCT02936505|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92505765|NCT02936505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505766|NCT02936505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505767|NCT02936505|Antifungal Agents|antifungal agents|mesh-ancestor
92505768|NCT02936505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505769|NCT02936505|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505770|NCT02936505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505771|NCT02936505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92505772|NCT02936505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505773|NCT02936505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92505774|NCT02936505|Antitubercular Agents|antitubercular agents|mesh-ancestor
92505775|NCT02936505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92505776|NCT02931903|Lithium Carbonate|lithium carbonate|mesh-list
92505777|NCT02931903|Antidepressive Agents|antidepressive agents|mesh-ancestor
92505778|NCT02931903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92505779|NCT02931903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505780|NCT02931903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505781|NCT02931903|Antimanic Agents|antimanic agents|mesh-ancestor
92505782|NCT02931903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92505783|NCT02931903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92505784|NCT02931903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505785|NCT02648997|Nivolumab|nivolumab|mesh-list
92505786|NCT02648997|Ipilimumab|ipilimumab|mesh-list
92505787|NCT02648997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505788|NCT02648997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505789|NCT02648997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92505790|NCT02648997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505791|NCT02593110|Telmisartan|telmisartan|mesh-list
92505792|NCT02593110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92505793|NCT02593110|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92505794|NCT02593110|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92505795|NCT02593110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505796|NCT02373813|Folic Acid|folic acid|mesh-list
92505797|NCT02373813|Etanercept|etanercept|mesh-list
92505798|NCT02373813|Methotrexate|methotrexate|mesh-list
92505799|NCT02373813|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92505800|NCT02373813|Abortifacient Agents|abortifacient agents|mesh-ancestor
92505801|NCT02373813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92505802|NCT02373813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505803|NCT02373813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505804|NCT02373813|Antimetabolites|antimetabolites|mesh-ancestor
92505805|NCT02373813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505806|NCT02373813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505807|NCT02373813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505808|NCT02373813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505809|NCT02373813|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92505810|NCT02373813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505811|NCT02373813|Immunologic Factors|immunologic factors|mesh-ancestor
92505812|NCT02373813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505813|NCT02373813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92505814|NCT02373813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92505815|NCT02373813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92505816|NCT02373813|Analgesics|analgesics|mesh-ancestor
92505817|NCT02373813|Sensory System Agents|sensory system agents|mesh-ancestor
92505818|NCT02373813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505819|NCT02373813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505820|NCT02373813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505821|NCT02373813|Hematinics|hematinics|mesh-ancestor
92230778|NCT00002620|Cobalt|cobalt|mesh-list
92505822|NCT02373813|Vitamin B Complex|vitamin b complex|mesh-ancestor
92505825|NCT01959204|Oxycodone|oxycodone|mesh-list
92505826|NCT01959204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92505827|NCT01959204|Narcotics|narcotics|mesh-ancestor
92505828|NCT01959204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92505829|NCT01959204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505830|NCT01959204|Analgesics|analgesics|mesh-ancestor
92505831|NCT01959204|Sensory System Agents|sensory system agents|mesh-ancestor
92505832|NCT01959204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505833|NCT01853748|Paclitaxel|paclitaxel|mesh-list
92505834|NCT01853748|Maytansine|maytansine|mesh-list
92505835|NCT01853748|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92505836|NCT01853748|Trastuzumab|trastuzumab|mesh-list
92505837|NCT01853748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505838|NCT01853748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505839|NCT01853748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505840|NCT01853748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505841|NCT01853748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505842|NCT01853748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505843|NCT01853748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505844|NCT01853748|Immunotoxins|immunotoxins|mesh-ancestor
92505845|NCT01853748|Immunoconjugates|immunoconjugates|mesh-ancestor
92505846|NCT01853748|Immunologic Factors|immunologic factors|mesh-ancestor
92505847|NCT01853748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505848|NCT00006045|Cytarabine|cytarabine|mesh-list
92505849|NCT00006045|Etoposide|etoposide|mesh-list
92505850|NCT00006045|Mitoxantrone|mitoxantrone|mesh-list
92505851|NCT00006045|Lintuzumab|lintuzumab|mesh-list
92505852|NCT00006045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505853|NCT00006045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505854|NCT00006045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505855|NCT00006045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505856|NCT00006045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505857|NCT00006045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505858|NCT00006045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505859|NCT00006045|Antimetabolites|antimetabolites|mesh-ancestor
92505860|NCT00006045|Antiviral Agents|antiviral agents|mesh-ancestor
92505861|NCT00006045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505862|NCT00006045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505863|NCT00006045|Immunologic Factors|immunologic factors|mesh-ancestor
92505864|NCT00006045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505865|NCT00006045|Analgesics|analgesics|mesh-ancestor
92505866|NCT00006045|Sensory System Agents|sensory system agents|mesh-ancestor
92505867|NCT00006045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505868|NCT00006045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505869|NCT00006048|Gemcitabine|gemcitabine|mesh-list
92505870|NCT00006048|Gefitinib|gefitinib|mesh-list
92505871|NCT00006048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505872|NCT00006048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505873|NCT00006048|Antimetabolites|antimetabolites|mesh-ancestor
92505874|NCT00006048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505875|NCT00006048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92505876|NCT00006048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505877|NCT00006051|Fluorouracil|fluorouracil|mesh-list
92505878|NCT00006051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505879|NCT00006051|Antimetabolites|antimetabolites|mesh-ancestor
92505880|NCT00006051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505881|NCT00006051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505882|NCT00006051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505883|NCT00006051|Immunologic Factors|immunologic factors|mesh-ancestor
92505884|NCT00006051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505885|NCT00006054|Cyclosporine|cyclosporine|mesh-list
92505886|NCT00006054|Prednisone|prednisone|mesh-list
92505887|NCT00006054|Methylprednisolone|methylprednisolone|mesh-list
92505888|NCT00006054|Cyclophosphamide|cyclophosphamide|mesh-list
92505889|NCT00006054|Busulfan|busulfan|mesh-list
92505890|NCT00006054|Methotrexate|methotrexate|mesh-list
92505891|NCT00006054|Etoposide|etoposide|mesh-list
92505892|NCT00006054|Cyclosporins|cyclosporins|mesh-list
92505893|NCT00006054|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92505894|NCT00006054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92505895|NCT00006054|Immunologic Factors|immunologic factors|mesh-ancestor
92505896|NCT00006054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505897|NCT00006054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505898|NCT00006054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92505899|NCT00006054|Alkylating Agents|alkylating agents|mesh-ancestor
92505900|NCT00006054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505901|NCT00006054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505902|NCT00006054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92505903|NCT00006054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505904|NCT00006054|Glucocorticoids|glucocorticoids|mesh-ancestor
92505905|NCT00006054|Hormones|hormones|mesh-ancestor
92505906|NCT00006054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92505907|NCT00006054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92505908|NCT00006054|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92505909|NCT00006054|Abortifacient Agents|abortifacient agents|mesh-ancestor
92505910|NCT00006054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92505911|NCT00006054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505912|NCT00006054|Antimetabolites|antimetabolites|mesh-ancestor
92505913|NCT00006054|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505914|NCT00006054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92505915|NCT00006054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92505916|NCT00006054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92505917|NCT00006054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505918|NCT00006054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92505919|NCT00006054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92505920|NCT00006054|Antifungal Agents|antifungal agents|mesh-ancestor
92505921|NCT00006054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505922|NCT00006054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92505923|NCT00006054|Antiemetics|antiemetics|mesh-ancestor
92505924|NCT00006054|Autonomic Agents|autonomic agents|mesh-ancestor
92505925|NCT00006054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92505926|NCT00006054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505927|NCT00006054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92505928|NCT00006054|Protective Agents|protective agents|mesh-ancestor
92505929|NCT00006063|Pancrelipase|pancrelipase|mesh-list
92505930|NCT00006063|Pancreatin|pancreatin|mesh-list
92505931|NCT00006063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92505932|NCT00006066|Aldesleukin|aldesleukin|mesh-list
92505933|NCT00006066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505934|NCT00006066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92505935|NCT00006066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92505936|NCT00006066|Antiviral Agents|antiviral agents|mesh-ancestor
92505937|NCT00006066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505938|NCT00006072|Rituximab|rituximab|mesh-list
92505939|NCT00006072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505940|NCT00006072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505941|NCT00006072|Immunologic Factors|immunologic factors|mesh-ancestor
92505942|NCT00006072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505943|NCT00006072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92505944|NCT00006075|Chlorhexidine|chlorhexidine|mesh-list
92505945|NCT00006075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92505946|NCT00006075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92505947|NCT00006075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92505948|NCT00006075|Disinfectants|disinfectants|mesh-ancestor
92505949|NCT00006075|Dermatologic Agents|dermatologic agents|mesh-ancestor
92505950|NCT00006078|Lycopene|lycopene|mesh-list
92505951|NCT00006078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92505952|NCT00006078|Antioxidants|antioxidants|mesh-ancestor
92505953|NCT00006078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505954|NCT00006078|Protective Agents|protective agents|mesh-ancestor
92505955|NCT00006078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505956|NCT00006078|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92505957|NCT00006078|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92505958|NCT00006078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505959|NCT00006081|Paclitaxel|paclitaxel|mesh-list
92505960|NCT00006081|Bryostatin 1|bryostatin 1|mesh-list
92505961|NCT00006081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505962|NCT00006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505963|NCT00006081|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505964|NCT00006081|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505965|NCT00006081|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505966|NCT00006081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505967|NCT00006081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92505968|NCT00006081|Immunologic Factors|immunologic factors|mesh-ancestor
92505969|NCT00006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505970|NCT00006084|Lintuzumab|lintuzumab|mesh-list
92505971|NCT00006084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505972|NCT00006084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505973|NCT00006090|Arsenic Trioxide|arsenic trioxide|mesh-list
92505974|NCT00006090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505975|NCT00006096|Cisplatin|cisplatin|mesh-list
92505976|NCT00006096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505977|NCT00006105|Gemcitabine|gemcitabine|mesh-list
92505978|NCT00006105|Amifostine|amifostine|mesh-list
92505979|NCT00006105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505980|NCT00006105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505981|NCT00006105|Antimetabolites|antimetabolites|mesh-ancestor
92505982|NCT00006105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505983|NCT00006105|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92505984|NCT00006105|Protective Agents|protective agents|mesh-ancestor
92505985|NCT00006105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92505986|NCT00006108|Paclitaxel|paclitaxel|mesh-list
92505987|NCT00006108|Capecitabine|capecitabine|mesh-list
92505988|NCT00006108|Trastuzumab|trastuzumab|mesh-list
92505989|NCT00006108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92505990|NCT00006108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92505991|NCT00006108|Tubulin Modulators|tubulin modulators|mesh-ancestor
92505992|NCT00006108|Antimitotic Agents|antimitotic agents|mesh-ancestor
92505993|NCT00006108|Mitosis Modulators|mitosis modulators|mesh-ancestor
92505994|NCT00006108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92505995|NCT00006108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92505996|NCT00006108|Antimetabolites|antimetabolites|mesh-ancestor
92505997|NCT00006108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92505998|NCT00006111|Fluorouracil|fluorouracil|mesh-list
92505999|NCT00006111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506000|NCT00006111|Antimetabolites|antimetabolites|mesh-ancestor
92506001|NCT00006111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506002|NCT00006111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506003|NCT00006111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506004|NCT00006111|Immunologic Factors|immunologic factors|mesh-ancestor
92506005|NCT00006111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506006|NCT00006114|Vinorelbine|vinorelbine|mesh-list
92506007|NCT00006114|Mitoxantrone|mitoxantrone|mesh-list
92506008|NCT00006114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506009|NCT00006114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506010|NCT00006114|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506011|NCT00006114|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506012|NCT00006114|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506013|NCT00006114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506014|NCT00006114|Analgesics|analgesics|mesh-ancestor
92506015|NCT00006114|Sensory System Agents|sensory system agents|mesh-ancestor
92506016|NCT00006114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506017|NCT00006114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506018|NCT00006114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506019|NCT00006114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506020|NCT00006114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506021|NCT00006117|Gemcitabine|gemcitabine|mesh-list
92506022|NCT00006117|Oxaliplatin|oxaliplatin|mesh-list
92506023|NCT00006117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506024|NCT00006117|Antimetabolites|antimetabolites|mesh-ancestor
92506025|NCT00006117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506026|NCT00006117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506027|NCT00006120|Paclitaxel|paclitaxel|mesh-list
92506028|NCT00006120|Docetaxel|docetaxel|mesh-list
92506029|NCT00006120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506030|NCT00006120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506031|NCT00006120|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506032|NCT00006120|Antimitotic Agents|antimitotic agents|mesh-ancestor
92350518|NCT03592212|Albuterol|albuterol|mesh-list
92506033|NCT00006120|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506034|NCT00006120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506035|NCT00006123|Cyclophosphamide|cyclophosphamide|mesh-list
92506036|NCT00006123|Thiotepa|thiotepa|mesh-list
92506037|NCT00006123|Carmustine|carmustine|mesh-list
92506038|NCT00006123|Carboplatin|carboplatin|mesh-list
92506039|NCT00006123|Trastuzumab|trastuzumab|mesh-list
92506040|NCT00006123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506041|NCT00006123|Immunologic Factors|immunologic factors|mesh-ancestor
92506042|NCT00006123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506043|NCT00006123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506044|NCT00006123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506045|NCT00006123|Alkylating Agents|alkylating agents|mesh-ancestor
92506046|NCT00006123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506047|NCT00006123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506048|NCT00006123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506049|NCT00006123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506050|NCT00006126|Cyclophosphamide|cyclophosphamide|mesh-list
92506052|NCT00006126|Fludarabine|fludarabine|mesh-list
92506053|NCT00006126|Fludarabine phosphate|fludarabine phosphate|mesh-list
92506054|NCT00006126|Etoposide|etoposide|mesh-list
92506055|NCT00006126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506056|NCT00006126|Immunologic Factors|immunologic factors|mesh-ancestor
92506057|NCT00006126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506058|NCT00006126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506059|NCT00006126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506060|NCT00006126|Alkylating Agents|alkylating agents|mesh-ancestor
92506061|NCT00006126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506062|NCT00006126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506063|NCT00006126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506064|NCT00006126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506065|NCT00006126|Antimetabolites|antimetabolites|mesh-ancestor
92506066|NCT00006126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506067|NCT00006126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506068|NCT00006126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506069|NCT00006126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506070|NCT00006129|Testosterone|testosterone|mesh-list
92506071|NCT00006129|Androgens|androgens|mesh-ancestor
92506072|NCT00006129|Hormones|hormones|mesh-ancestor
92506073|NCT00006129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506074|NCT00006129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506075|NCT00006132|Acyclovir|acyclovir|mesh-list
92506076|NCT00006132|Antiviral Agents|antiviral agents|mesh-ancestor
92506077|NCT00006132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506078|NCT00006135|Acyclovir|acyclovir|mesh-list
92506079|NCT00006135|Antiviral Agents|antiviral agents|mesh-ancestor
92506080|NCT00006135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506081|NCT00006144|Ritonavir|ritonavir|mesh-list
92506082|NCT00006144|Lopinavir|lopinavir|mesh-list
92506083|NCT00006144|Emtricitabine|emtricitabine|mesh-list
92506084|NCT00006144|Stavudine|stavudine|mesh-list
92506085|NCT00006144|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92506086|NCT00006144|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92506087|NCT00006144|Protease Inhibitors|protease inhibitors|mesh-ancestor
92506088|NCT00006144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506089|NCT00006144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506090|NCT00006144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92506091|NCT00006144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92506092|NCT00006144|Antiviral Agents|antiviral agents|mesh-ancestor
92506093|NCT00006144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506094|NCT00006144|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92506095|NCT00006144|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92506096|NCT00006144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92506097|NCT00006144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506098|NCT00006144|Antimetabolites|antimetabolites|mesh-ancestor
92506099|NCT00006168|Methotrexate|methotrexate|mesh-list
92506100|NCT00006168|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92506101|NCT00006168|Abortifacient Agents|abortifacient agents|mesh-ancestor
92506102|NCT00006168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506103|NCT00006168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506104|NCT00006168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506105|NCT00006168|Antimetabolites|antimetabolites|mesh-ancestor
92506106|NCT00006168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506107|NCT00006168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506108|NCT00006168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506109|NCT00006168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506110|NCT00006168|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92506111|NCT00006168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506112|NCT00006168|Immunologic Factors|immunologic factors|mesh-ancestor
92506113|NCT00006168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506114|NCT00006168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506115|NCT00006174|Letrozole|letrozole|mesh-list
92506116|NCT00006174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506117|NCT00006174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92506118|NCT00006174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92506119|NCT00006174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506120|NCT00006174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506121|NCT00006174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92506122|NCT00006174|Hormone Antagonists|hormone antagonists|mesh-ancestor
92506123|NCT00006174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506124|NCT00006174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506125|NCT00006180|Alendronate|alendronate|mesh-list
92506126|NCT00006180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92506127|NCT00006180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506128|NCT00006195|Olanzapine|olanzapine|mesh-list
92506129|NCT00006195|Risperidone|risperidone|mesh-list
92506130|NCT00006195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92506131|NCT00006195|Serotonin Agents|serotonin agents|mesh-ancestor
92506132|NCT00006195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92506133|NCT00006195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506134|NCT00006195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506135|NCT00006195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92506136|NCT00006195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92506137|NCT00006195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92506138|NCT00006195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92506139|NCT00006195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92506140|NCT00006195|Dopamine Agents|dopamine agents|mesh-ancestor
92506141|NCT00006195|Antiemetics|antiemetics|mesh-ancestor
92506142|NCT00006195|Autonomic Agents|autonomic agents|mesh-ancestor
92506143|NCT00006195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506144|NCT00006195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92506145|NCT00006195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92506146|NCT00006195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92506147|NCT00006195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92506148|NCT00006198|Thalidomide|thalidomide|mesh-list
92506149|NCT00006198|Doxorubicin|doxorubicin|mesh-list
92506150|NCT00006198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506151|NCT00006198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506152|NCT00006198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506153|NCT00006198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506154|NCT00006198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506155|NCT00006198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506156|NCT00006198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506157|NCT00006198|Immunologic Factors|immunologic factors|mesh-ancestor
92506158|NCT00006198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506159|NCT00006198|Leprostatic Agents|leprostatic agents|mesh-ancestor
92506160|NCT00006198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92506161|NCT00006198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506162|NCT00006198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92506163|NCT00006198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92506164|NCT00006198|Growth Substances|growth substances|mesh-ancestor
92506165|NCT00006198|Growth Inhibitors|growth inhibitors|mesh-ancestor
92506166|NCT00006204|Naltrexone|naltrexone|mesh-list
92506167|NCT00006204|Fluoxetine|fluoxetine|mesh-list
92506168|NCT00006204|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92506169|NCT00006204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92506170|NCT00006204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506171|NCT00006204|Sensory System Agents|sensory system agents|mesh-ancestor
92506172|NCT00006204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506173|NCT00006204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92506174|NCT00006204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92506175|NCT00006204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92506176|NCT00006204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506177|NCT00006204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92506178|NCT00006204|Serotonin Agents|serotonin agents|mesh-ancestor
92506179|NCT00006204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92506180|NCT00006204|Antidepressive Agents|antidepressive agents|mesh-ancestor
92506181|NCT00006204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92506182|NCT00006204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92506183|NCT00006204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92506184|NCT00006204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506185|NCT00006216|Ganciclovir|ganciclovir|mesh-list
92506186|NCT00006216|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92506187|NCT00006216|Antiviral Agents|antiviral agents|mesh-ancestor
92506188|NCT00006216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506189|NCT00006216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506190|NCT00006216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506191|NCT00006216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506192|NCT00006219|Clarithromycin|clarithromycin|mesh-list
92506194|NCT00006219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92506195|NCT00006219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506196|NCT00006219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92506197|NCT00006219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506198|NCT00006219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506199|NCT00006219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92506200|NCT00006219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92506201|NCT00006219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92506202|NCT00006219|Immunologic Factors|immunologic factors|mesh-ancestor
92506203|NCT00006219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506204|NCT00387582|Ranibizumab|ranibizumab|mesh-list
92506205|NCT00387582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92506206|NCT00387582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92506207|NCT00387582|Growth Substances|growth substances|mesh-ancestor
92506208|NCT00387582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506209|NCT00387582|Growth Inhibitors|growth inhibitors|mesh-ancestor
92506210|NCT00387582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506211|NCT00006228|Aldesleukin|aldesleukin|mesh-list
92506212|NCT00006228|Trastuzumab|trastuzumab|mesh-list
92506213|NCT00006228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506214|NCT00006228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506215|NCT00006228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92506216|NCT00006228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92506217|NCT00006228|Antiviral Agents|antiviral agents|mesh-ancestor
92506218|NCT00006228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506219|NCT03751800|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92506220|NCT03751800|Dienogest|dienogest|mesh-list
92506221|NCT03751800|Levonorgestrel|levonorgestrel|mesh-list
92506222|NCT03751800|Medroxyprogesterone|medroxyprogesterone|mesh-list
92506223|NCT03751800|Estradiol|estradiol|mesh-list
92506224|NCT03751800|Estrogens|estrogens|mesh-ancestor
92506225|NCT03751800|Hormones|hormones|mesh-ancestor
92506226|NCT03751800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506227|NCT03751800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506228|NCT03751800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92506229|NCT03751800|Contraceptive Agents|contraceptive agents|mesh-ancestor
92506230|NCT03751800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506231|NCT03751800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92506232|NCT03751800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92506233|NCT03751800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92506234|NCT03751800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92506235|NCT03751800|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92506236|NCT03751800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92506237|NCT03751800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506238|NCT03751800|Hormone Antagonists|hormone antagonists|mesh-ancestor
92506239|NCT00006240|Dexamethasone|dexamethasone|mesh-list
92506240|NCT00006240|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92506241|NCT00006240|Sargramostim|sargramostim|mesh-list
92506242|NCT00006240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92506243|NCT00006240|Antiemetics|antiemetics|mesh-ancestor
92506244|NCT00006240|Autonomic Agents|autonomic agents|mesh-ancestor
92506245|NCT00006240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506246|NCT00006240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506247|NCT00006240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92506248|NCT00006240|Glucocorticoids|glucocorticoids|mesh-ancestor
92506249|NCT00006240|Hormones|hormones|mesh-ancestor
92506250|NCT00006240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506251|NCT00006240|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92506252|NCT00006240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506253|NCT00006240|Immunologic Factors|immunologic factors|mesh-ancestor
92506254|NCT02972463|Immunoglobulins|immunoglobulins|mesh-list
92506255|NCT02972463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92506256|NCT02972463|Antibodies|antibodies|mesh-list
92506257|NCT02972463|Immunologic Factors|immunologic factors|mesh-ancestor
92506258|NCT02972463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506259|NCT00006243|Sargramostim|sargramostim|mesh-list
92506260|NCT00006243|Freund's Adjuvant|freund's adjuvant|mesh-list
92506261|NCT00006243|Immunologic Factors|immunologic factors|mesh-ancestor
92506262|NCT00006243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506263|NCT00006243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92506264|NCT00006246|Busulfan|busulfan|mesh-list
92506265|NCT00006246|Alkylating Agents|alkylating agents|mesh-ancestor
92506266|NCT00006246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506267|NCT00006246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506268|NCT00006246|Immunologic Factors|immunologic factors|mesh-ancestor
92506269|NCT00006246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506270|NCT00006246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506271|NCT00006246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506272|NCT00006246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506273|NCT00006249|Interferons|interferons|mesh-list
92506274|NCT00006249|Interferon-alpha|interferon-alpha|mesh-list
92506275|NCT00006249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506277|NCT00006249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506278|NCT00006249|Immunologic Factors|immunologic factors|mesh-ancestor
92506279|NCT00006249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506280|NCT00006252|Cyclophosphamide|cyclophosphamide|mesh-list
92506281|NCT00006252|Fludarabine|fludarabine|mesh-list
92506282|NCT00006252|Fludarabine phosphate|fludarabine phosphate|mesh-list
92506283|NCT00006252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506284|NCT00006252|Immunologic Factors|immunologic factors|mesh-ancestor
92506285|NCT00006252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506286|NCT00006252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506287|NCT00006252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506288|NCT00006252|Alkylating Agents|alkylating agents|mesh-ancestor
92506289|NCT00006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350574|NCT05632692|Antipruritics|antipruritics|mesh-ancestor
92506290|NCT00006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506291|NCT00006252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506292|NCT00006252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506293|NCT00006252|Antimetabolites|antimetabolites|mesh-ancestor
92506294|NCT00006258|Cyclophosphamide|cyclophosphamide|mesh-list
92506295|NCT00006258|Methotrexate|methotrexate|mesh-list
92506296|NCT00006258|Etoposide|etoposide|mesh-list
92506297|NCT00006258|Vincristine|vincristine|mesh-list
92506298|NCT00006258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506299|NCT00006258|Immunologic Factors|immunologic factors|mesh-ancestor
92506300|NCT00006258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506301|NCT00006258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506302|NCT00006258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506303|NCT00006258|Alkylating Agents|alkylating agents|mesh-ancestor
92506304|NCT00006258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506305|NCT00006258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506306|NCT00006258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506307|NCT00006258|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92506308|NCT00006258|Abortifacient Agents|abortifacient agents|mesh-ancestor
92506309|NCT00006258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506310|NCT00006258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506311|NCT00006258|Antimetabolites|antimetabolites|mesh-ancestor
92506312|NCT00006258|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506313|NCT00006258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506314|NCT00006258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92506315|NCT00006258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506316|NCT00006258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506317|NCT00006258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506318|NCT00006258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506319|NCT00006258|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506320|NCT00006258|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506321|NCT00006258|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506322|NCT00006261|Cyclophosphamide|cyclophosphamide|mesh-list
92506323|NCT00006261|Docetaxel|docetaxel|mesh-list
92506324|NCT00006261|Doxorubicin|doxorubicin|mesh-list
92506325|NCT00006261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92506326|NCT00006261|Fludarabine|fludarabine|mesh-list
92506327|NCT00006261|Fludarabine phosphate|fludarabine phosphate|mesh-list
92506328|NCT00006261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506329|NCT00006261|Immunologic Factors|immunologic factors|mesh-ancestor
92506330|NCT00006261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506331|NCT00006261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506332|NCT00006261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506333|NCT00006261|Alkylating Agents|alkylating agents|mesh-ancestor
92506334|NCT00006261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506335|NCT00006261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506336|NCT00006261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506337|NCT00006261|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506338|NCT00006261|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506339|NCT00006261|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506340|NCT00006261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506341|NCT00006261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506342|NCT00006261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506343|NCT00006261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506344|NCT00006261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506345|NCT00006261|Antimetabolites|antimetabolites|mesh-ancestor
92506347|NCT00006264|Aldesleukin|aldesleukin|mesh-list
92506348|NCT00006264|Ganciclovir|ganciclovir|mesh-list
92506349|NCT00006264|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92506350|NCT00006264|Antimetabolites|antimetabolites|mesh-ancestor
92506351|NCT00006264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506352|NCT00006264|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92506353|NCT00006264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506354|NCT00006264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506355|NCT00006264|Antiviral Agents|antiviral agents|mesh-ancestor
92506356|NCT00006264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506357|NCT00006264|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92506358|NCT00006264|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92506359|NCT00006264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506360|NCT00006267|Rubitecan|rubitecan|mesh-list
92506361|NCT00006267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506362|NCT00006267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92506363|NCT00006267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506364|NCT00006267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506365|NCT00006267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506366|NCT00006270|Cosyntropin|cosyntropin|mesh-list
92506367|NCT00006270|Metyrapone|metyrapone|mesh-list
92506368|NCT00006270|Hormones|hormones|mesh-ancestor
92506369|NCT00006270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506370|NCT00006270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506371|NCT00006270|Antimetabolites|antimetabolites|mesh-ancestor
92506372|NCT00006270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506373|NCT00006270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506374|NCT00006276|Paclitaxel|paclitaxel|mesh-list
92506375|NCT00006276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506376|NCT00006276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506377|NCT00006276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506378|NCT00006276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506379|NCT00006276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506380|NCT00006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506381|NCT00006279|Nevirapine|nevirapine|mesh-list
92506382|NCT00006279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92506383|NCT00006279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506384|NCT00006279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506385|NCT00006279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506386|NCT00006279|Antiviral Agents|antiviral agents|mesh-ancestor
92506387|NCT00006279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506388|NCT00006279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92506389|NCT00006279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92506390|NCT00006279|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92506391|NCT00006279|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92506392|NCT00006291|Aldesleukin|aldesleukin|mesh-list
92506393|NCT00006291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506394|NCT00006291|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92506395|NCT00006291|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92506396|NCT00006291|Antiviral Agents|antiviral agents|mesh-ancestor
92506397|NCT00006291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506398|NCT00006294|Amlodipine|amlodipine|mesh-list
92506399|NCT00006294|Lisinopril|lisinopril|mesh-list
92506400|NCT00006294|Chlorthalidone|chlorthalidone|mesh-list
92506401|NCT00006294|Doxazosin|doxazosin|mesh-list
92506402|NCT00006294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92506403|NCT00006294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92506404|NCT00006294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92506405|NCT00006294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506406|NCT00006294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92506407|NCT00006294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915351|NCT02603120|Tenofovir|tenofovir|mesh-list
92506409|NCT00006294|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92506410|NCT00006294|Protease Inhibitors|protease inhibitors|mesh-ancestor
92506411|NCT00006294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506412|NCT00006294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92506413|NCT00006294|Protective Agents|protective agents|mesh-ancestor
92506414|NCT00006294|Diuretics|diuretics|mesh-ancestor
92506415|NCT00006294|Natriuretic Agents|natriuretic agents|mesh-ancestor
92506416|NCT00006294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92506417|NCT00006294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92506418|NCT00006294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92350597|NCT04407312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506419|NCT00006294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92506420|NCT00006294|Adrenergic Agents|adrenergic agents|mesh-ancestor
92506421|NCT00006294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92506422|NCT00005818|Irinotecan|irinotecan|mesh-list
92506423|NCT00005818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92506424|NCT00005818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506425|NCT00005818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506426|NCT00005818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506427|NCT00005818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506428|NCT00006324|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92506429|NCT00006324|Levonorgestrel|levonorgestrel|mesh-list
92506430|NCT00006324|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92506431|NCT00006324|Medroxyprogesterone|medroxyprogesterone|mesh-list
92506432|NCT00006324|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92506433|NCT00006324|Estradiol|estradiol|mesh-list
92506434|NCT00006324|Estrogens|estrogens|mesh-ancestor
92506435|NCT00006324|Hormones|hormones|mesh-ancestor
92506436|NCT00006324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506437|NCT00006324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506438|NCT00006324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92506439|NCT00006324|Contraceptive Agents|contraceptive agents|mesh-ancestor
92506440|NCT00006324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506441|NCT00006324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92506442|NCT00006324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92506443|NCT00006324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92506444|NCT00006324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92506445|NCT00006324|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92506446|NCT00006324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92506447|NCT00006324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506448|NCT00006324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92506449|NCT00005824|Cyclophosphamide|cyclophosphamide|mesh-list
92506450|NCT00005824|Busulfan|busulfan|mesh-list
92506451|NCT00005824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506452|NCT00005824|Immunologic Factors|immunologic factors|mesh-ancestor
92506453|NCT00005824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506454|NCT00005824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506455|NCT00005824|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506456|NCT00005824|Alkylating Agents|alkylating agents|mesh-ancestor
92506457|NCT00005824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506458|NCT00005824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506459|NCT00005824|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506460|NCT00005827|Genistein|genistein|mesh-list
92506461|NCT00005827|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92506462|NCT00005827|Protective Agents|protective agents|mesh-ancestor
92506463|NCT00005827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506464|NCT00005827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506465|NCT00005827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92506466|NCT00005827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506467|NCT00005827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506468|NCT00005827|Phytoestrogens|phytoestrogens|mesh-ancestor
92506469|NCT00005827|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92506470|NCT00005827|Estrogens|estrogens|mesh-ancestor
92506471|NCT00005827|Hormones|hormones|mesh-ancestor
92506472|NCT00005827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506473|NCT00005830|Doxorubicin|doxorubicin|mesh-list
92506474|NCT00005830|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92506475|NCT00005830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506476|NCT00005830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506477|NCT00005830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506478|NCT00005830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506479|NCT00005830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506480|NCT00005830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506481|NCT00005833|Tipifarnib|tipifarnib|mesh-list
92506482|NCT00005833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506483|NCT00005836|Oxaliplatin|oxaliplatin|mesh-list
92506484|NCT00005836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506485|NCT00006330|Digoxin|digoxin|mesh-list
92506486|NCT00006330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92506487|NCT00006330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92506488|NCT00006330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506489|NCT00006330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506490|NCT00006330|Protective Agents|protective agents|mesh-ancestor
92506491|NCT00006330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506492|NCT00005839|Capecitabine|capecitabine|mesh-list
92506493|NCT00005839|Oxaliplatin|oxaliplatin|mesh-list
92506494|NCT00005839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506495|NCT00005839|Antimetabolites|antimetabolites|mesh-ancestor
92506496|NCT00005839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506497|NCT00005839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506498|NCT00005842|Trastuzumab|trastuzumab|mesh-list
92506499|NCT00005842|Tipifarnib|tipifarnib|mesh-list
92231446|NCT01662050|Rituximab|rituximab|mesh-list
92506500|NCT00005842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506501|NCT00005842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506502|NCT00005845|Tipifarnib|tipifarnib|mesh-list
92506503|NCT00005845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506504|NCT00005848|Tipifarnib|tipifarnib|mesh-list
92506505|NCT00005848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506506|NCT00005851|Cyclosporine|cyclosporine|mesh-list
92506507|NCT00005851|Mycophenolic Acid|mycophenolic acid|mesh-list
92506508|NCT00005851|Fludarabine|fludarabine|mesh-list
92506509|NCT00005851|Fludarabine phosphate|fludarabine phosphate|mesh-list
92506510|NCT00005851|Cyclosporins|cyclosporins|mesh-list
92506511|NCT00005851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506512|NCT00005851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506513|NCT00005851|Antimetabolites|antimetabolites|mesh-ancestor
92506514|NCT00005851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506515|NCT00005851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506516|NCT00005851|Immunologic Factors|immunologic factors|mesh-ancestor
92506517|NCT00005851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506518|NCT00005851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506519|NCT00005851|Antifungal Agents|antifungal agents|mesh-ancestor
92506520|NCT00005851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506521|NCT00005851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506522|NCT00005851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506523|NCT00005851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92506524|NCT00005851|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506525|NCT00005851|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92506526|NCT00005851|Antitubercular Agents|antitubercular agents|mesh-ancestor
92506527|NCT00005851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92506528|NCT00005854|Cyclosporine|cyclosporine|mesh-list
92506529|NCT00005854|Cyclophosphamide|cyclophosphamide|mesh-list
92506530|NCT00005854|Methotrexate|methotrexate|mesh-list
92506531|NCT00005854|Cyclosporins|cyclosporins|mesh-list
92506532|NCT00005854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506533|NCT00005854|Immunologic Factors|immunologic factors|mesh-ancestor
92506534|NCT00005854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506535|NCT00005854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506536|NCT00005854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506537|NCT00005854|Alkylating Agents|alkylating agents|mesh-ancestor
92506538|NCT00005854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506539|NCT00005854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506540|NCT00005854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506541|NCT00005854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92506542|NCT00005854|Abortifacient Agents|abortifacient agents|mesh-ancestor
92506543|NCT00005854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506544|NCT00005854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506545|NCT00005854|Antimetabolites|antimetabolites|mesh-ancestor
92506546|NCT00005854|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506547|NCT00005854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506548|NCT00005854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92506549|NCT00005854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506550|NCT00005854|Antifungal Agents|antifungal agents|mesh-ancestor
92506551|NCT00005854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506552|NCT00005854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92506553|NCT00005857|Docetaxel|docetaxel|mesh-list
92506554|NCT00005857|Trastuzumab|trastuzumab|mesh-list
92506555|NCT00005857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506556|NCT00005857|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506557|NCT00005857|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506558|NCT00005857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506559|NCT00005857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506560|NCT00005857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506561|NCT00005860|Leucovorin|leucovorin|mesh-list
92506562|NCT00005860|Oxaliplatin|oxaliplatin|mesh-list
92506563|NCT00005860|Floxuridine|floxuridine|mesh-list
92506564|NCT00005860|Calcium|calcium|mesh-list
92506565|NCT00005860|Levoleucovorin|levoleucovorin|mesh-list
92506566|NCT00005860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92506567|NCT00005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506568|NCT00005860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506569|NCT00005860|Antidotes|antidotes|mesh-ancestor
92506570|NCT00005860|Protective Agents|protective agents|mesh-ancestor
92506571|NCT00005860|Vitamin B Complex|vitamin b complex|mesh-ancestor
92506572|NCT00005860|Vitamins|vitamins|mesh-ancestor
92506573|NCT00005860|Micronutrients|micronutrients|mesh-ancestor
92506574|NCT00005860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506575|NCT00005860|Antimetabolites|antimetabolites|mesh-ancestor
92506576|NCT00005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506577|NCT00005863|Cytarabine|cytarabine|mesh-list
92506578|NCT00005863|Fludarabine|fludarabine|mesh-list
92506579|NCT00005863|Fludarabine phosphate|fludarabine phosphate|mesh-list
92506580|NCT00005863|Etoposide|etoposide|mesh-list
92506581|NCT00005863|Daunorubicin|daunorubicin|mesh-list
92506582|NCT00005863|Tretinoin|tretinoin|mesh-list
92506583|NCT00005863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506584|NCT00005863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506585|NCT00005863|Antimetabolites|antimetabolites|mesh-ancestor
92506586|NCT00005863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506587|NCT00005863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506588|NCT00005863|Immunologic Factors|immunologic factors|mesh-ancestor
92506589|NCT00005863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506590|NCT00005863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506591|NCT00005863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506592|NCT00005863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506593|NCT00005863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506594|NCT00005863|Antiviral Agents|antiviral agents|mesh-ancestor
92506595|NCT00005863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506596|NCT00005863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506597|NCT00005863|Keratolytic Agents|keratolytic agents|mesh-ancestor
92506598|NCT00005863|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506599|NCT00005866|Cyclosporine|cyclosporine|mesh-list
92506600|NCT00005866|Cyclophosphamide|cyclophosphamide|mesh-list
92506601|NCT00005866|Busulfan|busulfan|mesh-list
92506602|NCT00005866|Methotrexate|methotrexate|mesh-list
92506603|NCT00005866|Cyclosporins|cyclosporins|mesh-list
92506604|NCT00005866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506605|NCT00005866|Immunologic Factors|immunologic factors|mesh-ancestor
92506606|NCT00005866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506607|NCT00005866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506608|NCT00005866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506609|NCT00005866|Alkylating Agents|alkylating agents|mesh-ancestor
92506610|NCT00005866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506611|NCT00005866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506612|NCT00005866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506613|NCT00005866|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92506614|NCT00005866|Abortifacient Agents|abortifacient agents|mesh-ancestor
92506615|NCT00005866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506616|NCT00005866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506617|NCT00005866|Antimetabolites|antimetabolites|mesh-ancestor
92506618|NCT00005866|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506619|NCT00005866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506620|NCT00005866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92506621|NCT00005866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506622|NCT00005866|Antifungal Agents|antifungal agents|mesh-ancestor
92506623|NCT00005866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506624|NCT00005866|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92506625|NCT00005869|Gemcitabine|gemcitabine|mesh-list
92506626|NCT00005869|Rubitecan|rubitecan|mesh-list
92506627|NCT00005869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506628|NCT00005869|Antimetabolites|antimetabolites|mesh-ancestor
92506629|NCT00005869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506630|NCT00005869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506631|NCT00005869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92506632|NCT00005869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506633|NCT00005869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506634|NCT00005872|Rubitecan|rubitecan|mesh-list
92506635|NCT00005872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506636|NCT00005872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92506637|NCT00005872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506638|NCT00005872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506639|NCT00005872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506640|NCT00005875|Rubitecan|rubitecan|mesh-list
92506641|NCT00005875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506642|NCT00005875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92506643|NCT00005875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506644|NCT00005875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506645|NCT00005875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506646|NCT00005878|Celecoxib|celecoxib|mesh-list
92506647|NCT00005878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92506648|NCT00005878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92506649|NCT00005878|Analgesics|analgesics|mesh-ancestor
92506650|NCT00005878|Sensory System Agents|sensory system agents|mesh-ancestor
92506651|NCT00005878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506652|NCT00005878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506653|NCT00005878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92506655|NCT00005878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92506656|NCT00005878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92506657|NCT00005878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506658|NCT00005878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506659|NCT00005884|Eflornithine|eflornithine|mesh-list
92506660|NCT00005884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506661|NCT00005884|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92506662|NCT00005884|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92506663|NCT00005884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92506664|NCT00005884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506665|NCT00005884|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92506666|NCT00005884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506667|NCT00005884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506668|NCT00005887|Efaproxiral|efaproxiral|mesh-list
92506669|NCT00005887|Antisickling Agents|antisickling agents|mesh-ancestor
92506670|NCT00006339|Ritonavir|ritonavir|mesh-list
92506671|NCT00006339|Indinavir|indinavir|mesh-list
92506672|NCT00006339|Didanosine|didanosine|mesh-list
92506673|NCT00006339|Stavudine|stavudine|mesh-list
92506674|NCT00006339|Hydroxyurea|hydroxyurea|mesh-list
92506675|NCT00006339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92506676|NCT00006339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92506677|NCT00006339|Protease Inhibitors|protease inhibitors|mesh-ancestor
92506678|NCT00006339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506679|NCT00006339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506680|NCT00006339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92506681|NCT00006339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92506682|NCT00006339|Antiviral Agents|antiviral agents|mesh-ancestor
92506683|NCT00006339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506684|NCT00006339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92506685|NCT00006339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92506686|NCT00006339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506687|NCT00006339|Antisickling Agents|antisickling agents|mesh-ancestor
92506688|NCT00006339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506689|NCT00006339|Antimetabolites|antimetabolites|mesh-ancestor
92506690|NCT00006339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92506691|NCT00005890|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92506692|NCT00005890|Hormones|hormones|mesh-ancestor
92506693|NCT00005890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506694|NCT00005890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506695|NCT00005893|Cyclophosphamide|cyclophosphamide|mesh-list
92506696|NCT00005893|Busulfan|busulfan|mesh-list
92506697|NCT00005893|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92506698|NCT00005893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506699|NCT00005893|Immunologic Factors|immunologic factors|mesh-ancestor
92506700|NCT00005893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506701|NCT00005893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506702|NCT00005893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506703|NCT00005893|Alkylating Agents|alkylating agents|mesh-ancestor
92506704|NCT00005893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506705|NCT00005893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506706|NCT00005893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506707|NCT00005896|Lenograstim|lenograstim|mesh-list
92506708|NCT00005896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92506709|NCT00005896|Immunologic Factors|immunologic factors|mesh-ancestor
92506710|NCT00005896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506711|NCT00386503|Artesunate|artesunate|mesh-list
92506712|NCT00386503|Amodiaquine|amodiaquine|mesh-list
92506713|NCT00386503|Antimalarials|antimalarials|mesh-ancestor
92506714|NCT00386503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92506715|NCT00386503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92506716|NCT00386503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506717|NCT00386503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506718|NCT00386503|Antiviral Agents|antiviral agents|mesh-ancestor
92506719|NCT00386503|Schistosomicides|schistosomicides|mesh-ancestor
92506720|NCT00386503|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92506721|NCT00386503|Anthelmintics|anthelmintics|mesh-ancestor
92506722|NCT00386581|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92506723|NCT00386581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92506724|NCT00386581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92506725|NCT00386581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92506726|NCT00386581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506727|NCT00386581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92506728|NCT00386581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92506729|NCT00386581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506730|NCT00006345|Dexamethasone|dexamethasone|mesh-list
92506731|NCT00006345|Denileukin diftitox|denileukin diftitox|mesh-list
92506732|NCT00006345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92506733|NCT00006345|Antiemetics|antiemetics|mesh-ancestor
92506734|NCT00006345|Autonomic Agents|autonomic agents|mesh-ancestor
92506735|NCT00006345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506736|NCT00006345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506737|NCT00006345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92506738|NCT00006345|Glucocorticoids|glucocorticoids|mesh-ancestor
92506740|NCT00006345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506741|NCT00006345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92506742|NCT00006345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506743|NCT00005920|Caspofungin|caspofungin|mesh-list
92506744|NCT00005920|Antifungal Agents|antifungal agents|mesh-ancestor
92506745|NCT00005920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506746|NCT00005920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506747|NCT00005920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506748|NCT00005926|Gemcitabine|gemcitabine|mesh-list
92506749|NCT00005926|Trastuzumab|trastuzumab|mesh-list
92506750|NCT00005926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506751|NCT00005926|Antimetabolites|antimetabolites|mesh-ancestor
92506752|NCT00005926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506753|NCT00005926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506754|NCT00005926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506755|NCT00005935|Cyclosporine|cyclosporine|mesh-list
92506756|NCT00005935|Mycophenolic Acid|mycophenolic acid|mesh-list
92506757|NCT00005935|Cyclosporins|cyclosporins|mesh-list
92506758|NCT00005935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506759|NCT00005935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506760|NCT00005935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506761|NCT00005935|Immunologic Factors|immunologic factors|mesh-ancestor
92506762|NCT00005935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506763|NCT00005935|Antifungal Agents|antifungal agents|mesh-ancestor
92506764|NCT00005935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506765|NCT00005935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506766|NCT00005935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506767|NCT00005935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92506768|NCT00005935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506769|NCT00005935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506770|NCT00005935|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92506771|NCT00005935|Antitubercular Agents|antitubercular agents|mesh-ancestor
92506772|NCT00005935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92506773|NCT00006348|Ondansetron|ondansetron|mesh-list
92506774|NCT00006348|Antiemetics|antiemetics|mesh-ancestor
92506775|NCT00006348|Autonomic Agents|autonomic agents|mesh-ancestor
92506776|NCT00006348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506777|NCT00006348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506778|NCT00006348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92506779|NCT00006348|Antipruritics|antipruritics|mesh-ancestor
92506780|NCT00006348|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506781|NCT00006348|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92506782|NCT00006348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92506784|NCT00006348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92506785|NCT00006348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506786|NCT00005938|Exatecan|exatecan|mesh-list
92506787|NCT00005938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92506788|NCT00005938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506789|NCT00005938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506790|NCT00005938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506791|NCT00005938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506792|NCT00005941|Cyclosporine|cyclosporine|mesh-list
92506793|NCT00005941|Mycophenolic Acid|mycophenolic acid|mesh-list
92506794|NCT00005941|Fludarabine|fludarabine|mesh-list
92506795|NCT00005941|Fludarabine phosphate|fludarabine phosphate|mesh-list
92506796|NCT00005941|Cyclosporins|cyclosporins|mesh-list
92506797|NCT00005941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506798|NCT00005941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506799|NCT00005941|Antimetabolites|antimetabolites|mesh-ancestor
92506800|NCT00005941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506801|NCT00005941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506802|NCT00005941|Immunologic Factors|immunologic factors|mesh-ancestor
92506803|NCT00005941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506804|NCT00005941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506805|NCT00005941|Antifungal Agents|antifungal agents|mesh-ancestor
92506806|NCT00005941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506807|NCT00005941|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506808|NCT00005941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506809|NCT00005941|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92506810|NCT00005941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506811|NCT00005941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92506812|NCT00005941|Antitubercular Agents|antitubercular agents|mesh-ancestor
92506813|NCT00005941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92506814|NCT00005944|Leucovorin|leucovorin|mesh-list
92506815|NCT00005944|Fluorouracil|fluorouracil|mesh-list
92506816|NCT00005944|Mitomycins|mitomycins|mesh-list
92506817|NCT00005944|Mitomycin|mitomycin|mesh-list
92506818|NCT00005944|Calcium|calcium|mesh-list
92506819|NCT00005944|Levoleucovorin|levoleucovorin|mesh-list
92350664|NCT04407234|Hormones|hormones|mesh-ancestor
92506820|NCT00005944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92506821|NCT00005944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506822|NCT00005944|Antimetabolites|antimetabolites|mesh-ancestor
92506823|NCT00005944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506824|NCT00005944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506825|NCT00005944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506826|NCT00005944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506827|NCT00005944|Immunologic Factors|immunologic factors|mesh-ancestor
92506828|NCT00005944|Antidotes|antidotes|mesh-ancestor
92506829|NCT00005944|Protective Agents|protective agents|mesh-ancestor
92506830|NCT00005944|Vitamin B Complex|vitamin b complex|mesh-ancestor
92506831|NCT00005944|Vitamins|vitamins|mesh-ancestor
92506832|NCT00005944|Micronutrients|micronutrients|mesh-ancestor
92506833|NCT00005944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506834|NCT00005944|Alkylating Agents|alkylating agents|mesh-ancestor
92506835|NCT00005944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506836|NCT00005944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506837|NCT00387699|Bevacizumab|bevacizumab|mesh-list
92506838|NCT00387699|Etoposide|etoposide|mesh-list
92506839|NCT00387699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506840|NCT00387699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506841|NCT00387699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92506842|NCT00387699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92506843|NCT00387699|Growth Substances|growth substances|mesh-ancestor
92506844|NCT00387699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506845|NCT00387699|Growth Inhibitors|growth inhibitors|mesh-ancestor
92506846|NCT00387699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506847|NCT00387699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506848|NCT00387699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506849|NCT00387699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506850|NCT00387699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506851|NCT00005959|Prednisone|prednisone|mesh-list
92506852|NCT00005959|Cyclophosphamide|cyclophosphamide|mesh-list
92506853|NCT00005959|Rituximab|rituximab|mesh-list
92506854|NCT00005959|Doxorubicin|doxorubicin|mesh-list
92506855|NCT00005959|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92506856|NCT00005959|Vincristine|vincristine|mesh-list
92506857|NCT00005959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506858|NCT00005959|Immunologic Factors|immunologic factors|mesh-ancestor
92506859|NCT00005959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506860|NCT00005959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506861|NCT00005959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506862|NCT00005959|Alkylating Agents|alkylating agents|mesh-ancestor
92506863|NCT00005959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506864|NCT00005959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506865|NCT00005959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506866|NCT00005959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92506867|NCT00005959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506868|NCT00005959|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506869|NCT00005959|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506870|NCT00005959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506871|NCT00005959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92506872|NCT00005959|Glucocorticoids|glucocorticoids|mesh-ancestor
92506874|NCT00005959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506875|NCT00005959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92506876|NCT00005959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506877|NCT00005959|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506878|NCT00005959|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506879|NCT00005959|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506880|NCT00387738|Histamine|histamine|mesh-list
92506882|NCT00387738|Histamine Agents|histamine agents|mesh-ancestor
92506883|NCT00387738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92506884|NCT00387738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506885|NCT00387738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506886|NCT00005965|Bryostatin 1|bryostatin 1|mesh-list
92506887|NCT00005965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506888|NCT00005965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92506889|NCT00005965|Immunologic Factors|immunologic factors|mesh-ancestor
92506890|NCT00005965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506891|NCT00005968|Irofulven|irofulven|mesh-list
92506892|NCT00005968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506893|NCT00005968|Alkylating Agents|alkylating agents|mesh-ancestor
92750749|NCT05936606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92506894|NCT00005968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506895|NCT00005968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506896|NCT00387777|Buprenorphine|buprenorphine|mesh-list
92506897|NCT00387777|Analgesics|analgesics|mesh-list
92506898|NCT00387777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92506899|NCT00387777|Narcotics|narcotics|mesh-ancestor
92506900|NCT00387777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92506901|NCT00387777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506902|NCT00387777|Sensory System Agents|sensory system agents|mesh-ancestor
92506903|NCT00387777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506904|NCT00387777|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92506905|NCT00005971|Alvocidib|alvocidib|mesh-list
92506906|NCT00005971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506907|NCT00005971|Growth Inhibitors|growth inhibitors|mesh-ancestor
92506908|NCT00005971|Growth Substances|growth substances|mesh-ancestor
92506909|NCT00005971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506910|NCT00005971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92506911|NCT00005971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506912|NCT00005971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506913|NCT00005974|Alvocidib|alvocidib|mesh-list
92506914|NCT00005974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506915|NCT00005974|Growth Inhibitors|growth inhibitors|mesh-ancestor
92506916|NCT00005974|Growth Substances|growth substances|mesh-ancestor
92506917|NCT00005974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506918|NCT00005974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92506919|NCT00005974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506920|NCT00005974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506921|NCT00005977|Leucovorin|leucovorin|mesh-list
92506922|NCT00005977|Cytarabine|cytarabine|mesh-list
92506923|NCT00005977|Dexamethasone|dexamethasone|mesh-list
92506924|NCT00005977|Cyclophosphamide|cyclophosphamide|mesh-list
92506925|NCT00005977|Ifosfamide|ifosfamide|mesh-list
92506926|NCT00005977|Doxorubicin|doxorubicin|mesh-list
92506927|NCT00005977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92506928|NCT00005977|Methotrexate|methotrexate|mesh-list
92506929|NCT00005977|Etoposide|etoposide|mesh-list
92506931|NCT00005977|Lenograstim|lenograstim|mesh-list
92506932|NCT00005977|Levoleucovorin|levoleucovorin|mesh-list
92506933|NCT00005977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506934|NCT00005977|Immunologic Factors|immunologic factors|mesh-ancestor
92506935|NCT00005977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506936|NCT00005977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506937|NCT00005977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506938|NCT00005977|Alkylating Agents|alkylating agents|mesh-ancestor
92506939|NCT00005977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506940|NCT00005977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506941|NCT00005977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506942|NCT00005977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92506943|NCT00005977|Antiemetics|antiemetics|mesh-ancestor
92506944|NCT00005977|Autonomic Agents|autonomic agents|mesh-ancestor
92506945|NCT00005977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92506946|NCT00005977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92506947|NCT00005977|Glucocorticoids|glucocorticoids|mesh-ancestor
92506948|NCT00005977|Hormones|hormones|mesh-ancestor
92506949|NCT00005977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92506950|NCT00005977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92506951|NCT00005977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506952|NCT00005977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506953|NCT00005977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506954|NCT00005977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506955|NCT00005977|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92506956|NCT00005977|Abortifacient Agents|abortifacient agents|mesh-ancestor
92506957|NCT00005977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92506958|NCT00005977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92506959|NCT00005977|Antimetabolites|antimetabolites|mesh-ancestor
92506960|NCT00005977|Dermatologic Agents|dermatologic agents|mesh-ancestor
92506961|NCT00005977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92506962|NCT00005977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92506963|NCT00005977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92506964|NCT00005977|Antiviral Agents|antiviral agents|mesh-ancestor
92506965|NCT00005977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506966|NCT00005977|Antidotes|antidotes|mesh-ancestor
92506967|NCT00005977|Protective Agents|protective agents|mesh-ancestor
92506968|NCT00005977|Vitamin B Complex|vitamin b complex|mesh-ancestor
92506969|NCT00005977|Vitamins|vitamins|mesh-ancestor
92350666|NCT05632224|Aprepitant|aprepitant|mesh-list
92506970|NCT00005977|Micronutrients|micronutrients|mesh-ancestor
92506971|NCT00005977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92506972|NCT00005977|Tubulin Modulators|tubulin modulators|mesh-ancestor
92506973|NCT00005977|Antimitotic Agents|antimitotic agents|mesh-ancestor
92506974|NCT00005977|Mitosis Modulators|mitosis modulators|mesh-ancestor
92506975|NCT00005980|Doxorubicin|doxorubicin|mesh-list
92506976|NCT00005980|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92506977|NCT00005980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92506978|NCT00005980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506979|NCT00005980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92506980|NCT00005980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92506981|NCT00005980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92506982|NCT00005980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506983|NCT00005986|Interferons|interferons|mesh-list
92506984|NCT00005986|Interferon-alpha|interferon-alpha|mesh-list
92506985|NCT00005986|Cyclophosphamide|cyclophosphamide|mesh-list
92506986|NCT00005986|Busulfan|busulfan|mesh-list
92506987|NCT00005986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92506988|NCT00005986|Immunologic Factors|immunologic factors|mesh-ancestor
92506989|NCT00005986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92506990|NCT00005986|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92506991|NCT00005986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92506992|NCT00005986|Alkylating Agents|alkylating agents|mesh-ancestor
92506993|NCT00005986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92506994|NCT00005986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92506995|NCT00005986|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92506996|NCT00005986|Antiviral Agents|antiviral agents|mesh-ancestor
92506997|NCT00005986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92506998|NCT00005989|Tipifarnib|tipifarnib|mesh-list
92506999|NCT00005989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507000|NCT00005998|Cytarabine|cytarabine|mesh-list
92507001|NCT00005998|Dexamethasone|dexamethasone|mesh-list
92507002|NCT00005998|Cyclophosphamide|cyclophosphamide|mesh-list
92507003|NCT00005998|Carmustine|carmustine|mesh-list
92507004|NCT00005998|Etoposide|etoposide|mesh-list
92507005|NCT00005998|Mitoxantrone|mitoxantrone|mesh-list
92507007|NCT00005998|Immunologic Factors|immunologic factors|mesh-ancestor
92507008|NCT00005998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507009|NCT00005998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507010|NCT00005998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507011|NCT00005998|Alkylating Agents|alkylating agents|mesh-ancestor
92507012|NCT00005998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507013|NCT00005998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507014|NCT00005998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92507015|NCT00005998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507016|NCT00005998|Antiemetics|antiemetics|mesh-ancestor
92507017|NCT00005998|Autonomic Agents|autonomic agents|mesh-ancestor
92507018|NCT00005998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507019|NCT00005998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92507020|NCT00005998|Glucocorticoids|glucocorticoids|mesh-ancestor
92507021|NCT00005998|Hormones|hormones|mesh-ancestor
92507022|NCT00005998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92507023|NCT00005998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92507024|NCT00005998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507025|NCT00005998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507026|NCT00005998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507027|NCT00005998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507028|NCT00005998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507029|NCT00005998|Antimetabolites|antimetabolites|mesh-ancestor
92507030|NCT00005998|Antiviral Agents|antiviral agents|mesh-ancestor
92231974|NCT01158703|Aspirin|aspirin|mesh-list
92507031|NCT00005998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507032|NCT00005998|Analgesics|analgesics|mesh-ancestor
92507033|NCT00005998|Sensory System Agents|sensory system agents|mesh-ancestor
92507034|NCT00006351|Gemcitabine|gemcitabine|mesh-list
92507035|NCT00006351|Lonafarnib|lonafarnib|mesh-list
92507036|NCT00006351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507037|NCT00006351|Antimetabolites|antimetabolites|mesh-ancestor
92507038|NCT00006351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507039|NCT00006351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507040|NCT00006351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507041|NCT00006001|Semaxinib|semaxinib|mesh-list
92507042|NCT00006001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92507043|NCT00006001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92507044|NCT00006001|Growth Substances|growth substances|mesh-ancestor
92507045|NCT00006001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507046|NCT00006001|Growth Inhibitors|growth inhibitors|mesh-ancestor
92507047|NCT00006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507048|NCT00006001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507049|NCT00006001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507050|NCT00006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507051|NCT00006007|Gemcitabine|gemcitabine|mesh-list
92507052|NCT00006007|Pemetrexed|pemetrexed|mesh-list
92507053|NCT00006007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507054|NCT00006007|Antimetabolites|antimetabolites|mesh-ancestor
92507055|NCT00006007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507056|NCT00006007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507057|NCT00006007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507058|NCT00006007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92507059|NCT00006007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507060|NCT00006010|Gemcitabine|gemcitabine|mesh-list
92507061|NCT00006010|Docetaxel|docetaxel|mesh-list
92507062|NCT00006010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507063|NCT00006010|Antimetabolites|antimetabolites|mesh-ancestor
92507064|NCT00006010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507065|NCT00006010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507066|NCT00006010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92507067|NCT00006010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92507068|NCT00006010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92507069|NCT00006013|Semaxinib|semaxinib|mesh-list
92507070|NCT00006013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92507071|NCT00006013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92507072|NCT00006013|Growth Substances|growth substances|mesh-ancestor
92507073|NCT00006013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507074|NCT00006013|Growth Inhibitors|growth inhibitors|mesh-ancestor
92507075|NCT00006013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507076|NCT00006013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507077|NCT00006013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533028|NCT03262454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507078|NCT00006013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507079|NCT00006357|Imatinib Mesylate|imatinib mesylate|mesh-list
92507080|NCT00006357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507081|NCT00006357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507082|NCT00006357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507083|NCT00006357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507084|NCT00006016|Thalidomide|thalidomide|mesh-list
92507085|NCT00006016|Doxorubicin|doxorubicin|mesh-list
92507087|NCT00006016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507088|NCT00006016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507089|NCT00006016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507090|NCT00006016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507091|NCT00006016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507092|NCT00006016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507093|NCT00006016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507094|NCT00006016|Immunologic Factors|immunologic factors|mesh-ancestor
92507095|NCT00006016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507096|NCT00006016|Leprostatic Agents|leprostatic agents|mesh-ancestor
92507097|NCT00006016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92507098|NCT00006016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507099|NCT00006016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92507100|NCT00006016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92507101|NCT00006016|Growth Substances|growth substances|mesh-ancestor
92507102|NCT00006016|Growth Inhibitors|growth inhibitors|mesh-ancestor
92507103|NCT00006019|Azacitidine|azacitidine|mesh-list
92507104|NCT00006019|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92507105|NCT00006019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507106|NCT00006019|Antimetabolites|antimetabolites|mesh-ancestor
92507107|NCT00006019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232052|NCT03089866|Midazolam|midazolam|mesh-list
92507108|NCT00006019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507109|NCT00006019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507110|NCT00006022|Aldesleukin|aldesleukin|mesh-list
92507111|NCT00006022|Bryostatin 1|bryostatin 1|mesh-list
92507112|NCT00006022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507113|NCT00006022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507114|NCT00006022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507115|NCT00006022|Antiviral Agents|antiviral agents|mesh-ancestor
92507116|NCT00006022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507117|NCT00006022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92507118|NCT00006022|Immunologic Factors|immunologic factors|mesh-ancestor
92507119|NCT00006022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507120|NCT00006025|Irinotecan|irinotecan|mesh-list
92507121|NCT00006025|Temozolomide|temozolomide|mesh-list
92507122|NCT00006025|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92507123|NCT00006025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507124|NCT00006025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507125|NCT00006025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507126|NCT00006025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507127|NCT00006025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507128|NCT00006025|Alkylating Agents|alkylating agents|mesh-ancestor
92507129|NCT00386659|Ritonavir|ritonavir|mesh-list
92507130|NCT00386659|Lopinavir|lopinavir|mesh-list
92507131|NCT00386659|Tenofovir|tenofovir|mesh-list
92507132|NCT00386659|Abacavir|abacavir|mesh-list
92507133|NCT00386659|Efavirenz|efavirenz|mesh-list
92507134|NCT00386659|Dideoxynucleosides|dideoxynucleosides|mesh-list
92507135|NCT00386659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92507136|NCT00386659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92507137|NCT00386659|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507138|NCT00386659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507139|NCT00386659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507140|NCT00386659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507141|NCT00386659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507142|NCT00386659|Antiviral Agents|antiviral agents|mesh-ancestor
92507143|NCT00386659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507144|NCT00386659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92507145|NCT00386659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92507146|NCT00386659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92507147|NCT00386659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507148|NCT00386659|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92507149|NCT00386659|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92507150|NCT00386659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92507151|NCT00386659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92507152|NCT00386659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92507154|NCT00006028|Gemcitabine|gemcitabine|mesh-list
92507155|NCT00006028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507156|NCT00006028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507157|NCT00006028|Antimetabolites|antimetabolites|mesh-ancestor
92507158|NCT00006028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507159|NCT00387933|Imatinib Mesylate|imatinib mesylate|mesh-list
92507160|NCT00387933|Hydroxyurea|hydroxyurea|mesh-list
92507161|NCT00387933|Vatalanib|vatalanib|mesh-list
92507162|NCT00387933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507163|NCT00387933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507164|NCT00387933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507165|NCT00387933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507166|NCT00387933|Antisickling Agents|antisickling agents|mesh-ancestor
92507167|NCT00387933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507168|NCT00006034|Doxorubicin|doxorubicin|mesh-list
92507169|NCT00006034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92507170|NCT00006034|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92507171|NCT00006034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507172|NCT00006034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507173|NCT00006034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507174|NCT00006034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507175|NCT00006034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507176|NCT00006034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507177|NCT00006034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92507178|NCT00006034|Immunologic Factors|immunologic factors|mesh-ancestor
92507179|NCT00006034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507180|NCT00006037|Fluorouracil|fluorouracil|mesh-list
92507181|NCT00006037|Irinotecan|irinotecan|mesh-list
92507182|NCT00006037|Antimetabolites|antimetabolites|mesh-ancestor
92507183|NCT00006037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507184|NCT00006037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507185|NCT00006037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507186|NCT00006037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507187|NCT00006037|Immunologic Factors|immunologic factors|mesh-ancestor
92507188|NCT00006037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507189|NCT00006037|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92507190|NCT00006037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507191|NCT00006037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507192|NCT00006040|Etoposide|etoposide|mesh-list
92507193|NCT00006040|Antibodies|antibodies|mesh-list
92507194|NCT00006040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92507195|NCT00006040|Immunologic Factors|immunologic factors|mesh-ancestor
92507196|NCT00006040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507197|NCT00006040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507198|NCT00006040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507199|NCT00006040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507200|NCT00006040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507201|NCT00006040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507202|NCT00006040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507203|NCT00006363|Cytarabine|cytarabine|mesh-list
92507204|NCT00006363|Aldesleukin|aldesleukin|mesh-list
92507205|NCT00006363|Etoposide|etoposide|mesh-list
92507206|NCT00006363|Daunorubicin|daunorubicin|mesh-list
92507207|NCT00006363|Etoposide phosphate|etoposide phosphate|mesh-list
92507208|NCT00006363|Busulfan|busulfan|mesh-list
92507209|NCT00006363|Interleukin-2|interleukin-2|mesh-list
92507210|NCT00006363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507211|NCT00006363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507212|NCT00006363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507213|NCT00006363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507214|NCT00006363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507215|NCT00006363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507216|NCT00006363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507217|NCT00006363|Antimetabolites|antimetabolites|mesh-ancestor
92507218|NCT00006363|Antiviral Agents|antiviral agents|mesh-ancestor
92507219|NCT00006363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507220|NCT00006363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507221|NCT00006363|Immunologic Factors|immunologic factors|mesh-ancestor
92507222|NCT00006363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507224|NCT00006363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507225|NCT00006363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92507226|NCT00006363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507227|NCT00006363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92507228|NCT00006363|Analgesics|analgesics|mesh-ancestor
92507229|NCT00006363|Sensory System Agents|sensory system agents|mesh-ancestor
92507230|NCT00006363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507231|NCT00006363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507232|NCT00006363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507233|NCT05680870|Omeprazole|omeprazole|mesh-list
92507234|NCT05680870|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92507235|NCT05680870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92507236|NCT05680870|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92507237|NCT05680870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507238|NCT05680870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507239|NCT00006366|Fluorouracil|fluorouracil|mesh-list
92507240|NCT00006366|Irinotecan|irinotecan|mesh-list
92507241|NCT00006366|Antimetabolites|antimetabolites|mesh-ancestor
92507242|NCT00006366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507243|NCT00006366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507244|NCT00006366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507245|NCT00006366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507246|NCT00006366|Immunologic Factors|immunologic factors|mesh-ancestor
92507247|NCT00006366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507248|NCT00006366|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92507249|NCT00006366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507250|NCT00006366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507251|NCT05680792|Ritonavir|ritonavir|mesh-list
92507252|NCT05680792|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92507253|NCT05680792|Nitazoxanide|nitazoxanide|mesh-list
92507254|NCT05680792|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92507255|NCT05680792|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92232197|NCT01254877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92507256|NCT05680792|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507257|NCT05680792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507258|NCT05680792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507260|NCT05680792|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507261|NCT05680792|Antiviral Agents|antiviral agents|mesh-ancestor
92507262|NCT05680792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507263|NCT05680792|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92507264|NCT05680792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92507265|NCT05680792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92507266|NCT00006372|Gemcitabine|gemcitabine|mesh-list
92507267|NCT00006372|Doxorubicin|doxorubicin|mesh-list
92507268|NCT00006372|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92507269|NCT00006372|Vinorelbine|vinorelbine|mesh-list
92507270|NCT00006372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507271|NCT00006372|Antimetabolites|antimetabolites|mesh-ancestor
92507272|NCT00006372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507273|NCT00006372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507274|NCT00006372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507275|NCT00006372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507276|NCT00006372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507277|NCT00006372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507278|NCT00006372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507279|NCT00006372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92507280|NCT00006372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92507281|NCT00006372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92507282|NCT00006378|Paclitaxel|paclitaxel|mesh-list
92507283|NCT00006378|Carboplatin|carboplatin|mesh-list
92507284|NCT00006378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507285|NCT00006378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507286|NCT00006378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92507287|NCT00006378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92507288|NCT00006378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92507289|NCT00006378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507290|NCT00006381|Celecoxib|celecoxib|mesh-list
92507291|NCT00006381|Trastuzumab|trastuzumab|mesh-list
92507292|NCT00006381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507293|NCT00006381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507294|NCT00006381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92507295|NCT00006381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92507296|NCT00006381|Analgesics|analgesics|mesh-ancestor
92507297|NCT00006381|Sensory System Agents|sensory system agents|mesh-ancestor
92507298|NCT00006381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507299|NCT00006381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507300|NCT00006381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507301|NCT00006381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507302|NCT00006381|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92507303|NCT00006381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92507304|NCT00006381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507305|NCT00006381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507306|NCT00006384|Interferons|interferons|mesh-list
92507307|NCT00006384|Interferon-alpha|interferon-alpha|mesh-list
92507308|NCT00006384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507309|NCT00006384|Antiviral Agents|antiviral agents|mesh-ancestor
92507310|NCT00006384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507311|NCT00006384|Immunologic Factors|immunologic factors|mesh-ancestor
92507312|NCT00006384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507314|NCT00386815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507315|NCT00386815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507316|NCT00386815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507317|NCT00386815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92507318|NCT00386815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507319|NCT05679388|Ritonavir|ritonavir|mesh-list
92507320|NCT05679388|Itraconazole|itraconazole|mesh-list
92507321|NCT05679388|Relugolix|relugolix|mesh-list
92507322|NCT05679388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92507323|NCT05679388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92507324|NCT05679388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507325|NCT05679388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507326|NCT05679388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507327|NCT05679388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507328|NCT05679388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507329|NCT05679388|Antiviral Agents|antiviral agents|mesh-ancestor
92507330|NCT05679388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507331|NCT05679388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92507332|NCT05679388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92507333|NCT05679388|Antifungal Agents|antifungal agents|mesh-ancestor
92507334|NCT05679388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92507335|NCT05679388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92507336|NCT05679388|Hormone Antagonists|hormone antagonists|mesh-ancestor
92507337|NCT05679388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92507338|NCT05679388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507339|NCT05679388|Androgen Antagonists|androgen antagonists|mesh-ancestor
92507340|NCT05678296|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92507342|NCT05678296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507343|NCT05678296|Sensory System Agents|sensory system agents|mesh-ancestor
92507344|NCT05678296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507345|NCT05678296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507346|NCT05675293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92507347|NCT05675293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507348|NCT00006396|Zidovudine|zidovudine|mesh-list
92507349|NCT00006396|Nevirapine|nevirapine|mesh-list
92507350|NCT00006396|Antimetabolites|antimetabolites|mesh-ancestor
92507351|NCT00006396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507352|NCT00006396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92507353|NCT00006396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507354|NCT00006396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507355|NCT00006396|Antiviral Agents|antiviral agents|mesh-ancestor
92507356|NCT00006396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507357|NCT00006396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507358|NCT00006396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507359|NCT00006396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92507360|NCT00006396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92507361|NCT03996148|Dexmedetomidine|dexmedetomidine|mesh-list
92507362|NCT03996148|Remifentanil|remifentanil|mesh-list
92507363|NCT03996148|Propofol|propofol|mesh-list
92507364|NCT03996148|Desflurane|desflurane|mesh-list
92507365|NCT03996148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92507366|NCT03996148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533038|NCT00057031|Micronutrients|micronutrients|mesh-ancestor
92507367|NCT03996148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507368|NCT03996148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92507369|NCT03996148|Analgesics|analgesics|mesh-ancestor
92507370|NCT03996148|Sensory System Agents|sensory system agents|mesh-ancestor
92507371|NCT03996148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507372|NCT03996148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92507373|NCT03996148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92507374|NCT03996148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92507375|NCT03996148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92507376|NCT03996148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507377|NCT03996148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507378|NCT03996148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92507379|NCT03996148|Anesthetics, General|anesthetics, general|mesh-ancestor
92507380|NCT03996148|Anesthetics|anesthetics|mesh-ancestor
92507381|NCT03996148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92507382|NCT03996148|Narcotics|narcotics|mesh-ancestor
92507383|NCT03996148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92507384|NCT00006399|Donepezil|donepezil|mesh-list
92507385|NCT00006399|Progesterone|progesterone|mesh-list
92507387|NCT00006399|Progestins|progestins|mesh-ancestor
92507388|NCT00006399|Hormones|hormones|mesh-ancestor
92507389|NCT00006399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92507390|NCT00006399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507391|NCT00006399|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92507392|NCT00006399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507393|NCT00006399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507394|NCT00006399|Cholinergic Agents|cholinergic agents|mesh-ancestor
92507395|NCT00006399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507396|NCT00006399|Nootropic Agents|nootropic agents|mesh-ancestor
92507397|NCT05660200|Iron|iron|mesh-list
92507398|NCT05660200|Trace Elements|trace elements|mesh-ancestor
92507399|NCT05660200|Micronutrients|micronutrients|mesh-ancestor
92507400|NCT05660200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507401|NCT05552404|Aminophylline|aminophylline|mesh-list
92507402|NCT05552404|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92507403|NCT05552404|Autonomic Agents|autonomic agents|mesh-ancestor
92507404|NCT05552404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507405|NCT05552404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507406|NCT05552404|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92507407|NCT05552404|Respiratory System Agents|respiratory system agents|mesh-ancestor
92507408|NCT05552404|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92232361|NCT01258153|MEN 11420|men 11420|mesh-list
92507409|NCT05552404|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92507411|NCT05552404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507412|NCT05552404|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92507413|NCT05552404|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92507414|NCT05552404|Purinergic Agents|purinergic agents|mesh-ancestor
92507415|NCT05552404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507416|NCT05552404|Protective Agents|protective agents|mesh-ancestor
92507417|NCT05546320|Aspirin|aspirin|mesh-list
92507418|NCT05546320|Metoprolol|metoprolol|mesh-list
92507419|NCT05546320|Rivaroxaban|rivaroxaban|mesh-list
92507420|NCT05546320|Clopidogrel|clopidogrel|mesh-list
92507421|NCT05546320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92507422|NCT05546320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92507423|NCT05546320|Analgesics|analgesics|mesh-ancestor
92507424|NCT05546320|Sensory System Agents|sensory system agents|mesh-ancestor
92507425|NCT05546320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507426|NCT05546320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507427|NCT05546320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507428|NCT05546320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507429|NCT05546320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92507430|NCT05546320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92507431|NCT05546320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507432|NCT05546320|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92507433|NCT05546320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92507434|NCT05546320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507435|NCT05546320|Antipyretics|antipyretics|mesh-ancestor
92507436|NCT05546320|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92507437|NCT05546320|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92507438|NCT05546320|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92507439|NCT05546320|Purinergic Agents|purinergic agents|mesh-ancestor
92507440|NCT05546320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507441|NCT05546320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92507442|NCT05546320|Antithrombins|antithrombins|mesh-ancestor
92507443|NCT05546320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92507444|NCT05546320|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507445|NCT05546320|Anticoagulants|anticoagulants|mesh-ancestor
92507446|NCT05546320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92507447|NCT05546320|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92507448|NCT05546320|Sympatholytics|sympatholytics|mesh-ancestor
92507449|NCT05546320|Autonomic Agents|autonomic agents|mesh-ancestor
92507450|NCT05546320|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92507451|NCT05546320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92507452|NCT05546320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92507453|NCT05546320|Adrenergic Agents|adrenergic agents|mesh-ancestor
92507454|NCT05535595|Perindopril|perindopril|mesh-list
92507455|NCT05535595|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92507456|NCT05535595|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507457|NCT05535595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507458|NCT05535595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507459|NCT05535595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92507460|NCT05470816|Tranexamic Acid|tranexamic acid|mesh-list
92507461|NCT05470816|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92507462|NCT05470816|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92507463|NCT05470816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507464|NCT05470816|Hemostatics|hemostatics|mesh-ancestor
92507465|NCT05470816|Coagulants|coagulants|mesh-ancestor
92507466|NCT05431543|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92507467|NCT05431543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92507468|NCT05431543|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92507469|NCT05431543|Aceclidine|aceclidine|mesh-list
92507470|NCT05431543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92507471|NCT05431543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92507472|NCT05431543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92507473|NCT05431543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92507474|NCT05431543|Adrenergic Agents|adrenergic agents|mesh-ancestor
92507475|NCT05431543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507476|NCT05431543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507477|NCT05431543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507478|NCT05431543|Miotics|miotics|mesh-ancestor
92507479|NCT05431543|Autonomic Agents|autonomic agents|mesh-ancestor
92507480|NCT05431543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507481|NCT05431543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92507482|NCT05401786|Ipilimumab|ipilimumab|mesh-list
92507483|NCT05401786|Cemiplimab|cemiplimab|mesh-list
92507484|NCT05401786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507485|NCT05401786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507486|NCT05401786|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92507487|NCT05401786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507488|NCT05285683|Levodopa|levodopa|mesh-list
92507489|NCT05285683|Carbidopa|carbidopa|mesh-list
92507490|NCT05285683|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92507491|NCT05285683|Methylphenidate|methylphenidate|mesh-list
92507492|NCT05285683|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92507493|NCT05285683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507494|NCT05285683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92507495|NCT05285683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92507496|NCT05285683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92507497|NCT05285683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507498|NCT05285683|Dopamine Agents|dopamine agents|mesh-ancestor
92507499|NCT05285683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507500|NCT05285683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92507501|NCT05285683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92507502|NCT05285683|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92507503|NCT05285683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507504|NCT05285683|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92507505|NCT05285683|Immunologic Factors|immunologic factors|mesh-ancestor
92507506|NCT05285683|Dopamine Agonists|dopamine agonists|mesh-ancestor
92507507|NCT05247970|Midazolam|midazolam|mesh-list
92507508|NCT05247970|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92507509|NCT05247970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92507510|NCT05247970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92507511|NCT05247970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507512|NCT05247970|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92507513|NCT05247970|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92507514|NCT05247970|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92507515|NCT05247970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92507516|NCT05247970|Anesthetics, General|anesthetics, general|mesh-ancestor
92507518|NCT05247970|GABA Modulators|gaba modulators|mesh-ancestor
92507519|NCT05247970|GABA Agents|gaba agents|mesh-ancestor
92507520|NCT05247970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507521|NCT05247970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507522|NCT00006441|Lamivudine|lamivudine|mesh-list
92507523|NCT00006441|Zidovudine|zidovudine|mesh-list
92507524|NCT00006441|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92507525|NCT00006441|Aldesleukin|aldesleukin|mesh-list
92507526|NCT00006441|Nelfinavir|nelfinavir|mesh-list
92507527|NCT00006441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92507528|NCT00006441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507529|NCT00006441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507530|NCT00006441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507531|NCT00006441|Antiviral Agents|antiviral agents|mesh-ancestor
92507532|NCT00006441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507533|NCT00006441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507534|NCT00006441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507535|NCT00006441|Antimetabolites|antimetabolites|mesh-ancestor
92507536|NCT00006441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507537|NCT00006441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92507538|NCT00006441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92507539|NCT00006441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507541|NCT05147233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507542|NCT05147233|Antiemetics|antiemetics|mesh-ancestor
92507543|NCT05147233|Autonomic Agents|autonomic agents|mesh-ancestor
92507544|NCT05147233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507545|NCT05147233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350760|NCT03986970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507546|NCT05147233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92507547|NCT05147233|Glucocorticoids|glucocorticoids|mesh-ancestor
92507548|NCT05147233|Hormones|hormones|mesh-ancestor
92507549|NCT05147233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92507550|NCT05147233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92507551|NCT05147233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507552|NCT03926845|Thiamidol|thiamidol|mesh-list
92507553|NCT03926845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507554|NCT03926845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507555|NCT00006450|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92507556|NCT00006450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507557|NCT00006453|Carboplatin|carboplatin|mesh-list
92507558|NCT00006453|Gemcitabine|gemcitabine|mesh-list
92507559|NCT00006453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507560|NCT00006453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507561|NCT00006453|Antimetabolites|antimetabolites|mesh-ancestor
92507562|NCT00006453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507563|NCT00387322|Pemetrexed|pemetrexed|mesh-list
92507564|NCT00387322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92507565|NCT00387322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507566|NCT00387322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507567|NCT00387322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507568|NCT00387322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92507569|NCT00387322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507570|NCT00387322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507571|NCT00006459|Paclitaxel|paclitaxel|mesh-list
92507572|NCT00006459|Gemcitabine|gemcitabine|mesh-list
92507573|NCT00006459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507574|NCT00006459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507575|NCT00006459|Tubulin Modulators|tubulin modulators|mesh-ancestor
92507576|NCT00006459|Antimitotic Agents|antimitotic agents|mesh-ancestor
92507577|NCT00006459|Mitosis Modulators|mitosis modulators|mesh-ancestor
92507578|NCT00006459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507579|NCT00006459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507580|NCT00006459|Antimetabolites|antimetabolites|mesh-ancestor
92507581|NCT00387400|Everolimus|everolimus|mesh-list
92507582|NCT00387400|Temozolomide|temozolomide|mesh-list
92507583|NCT00387400|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92507584|NCT00387400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507585|NCT00387400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507586|NCT00387400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507587|NCT00387400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507588|NCT00387400|Immunologic Factors|immunologic factors|mesh-ancestor
92507589|NCT00387400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507590|NCT00387400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507591|NCT00387400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507592|NCT00387400|Alkylating Agents|alkylating agents|mesh-ancestor
92507593|NCT03876106|LUT014|lut014|mesh-list
92507594|NCT03876106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507595|NCT03876106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507596|NCT03876106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507597|NCT00388011|Morphine|morphine|mesh-list
92507598|NCT00388011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92507599|NCT00388011|Narcotics|narcotics|mesh-ancestor
92507600|NCT00388011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92507601|NCT00388011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507602|NCT00388011|Analgesics|analgesics|mesh-ancestor
92507603|NCT00388011|Sensory System Agents|sensory system agents|mesh-ancestor
92507604|NCT00388011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507605|NCT04852978|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92507606|NCT04852978|Antiviral Agents|antiviral agents|mesh-ancestor
92507607|NCT04852978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507608|NCT00388089|Bortezomib|bortezomib|mesh-list
92507609|NCT00388089|Topotecan|topotecan|mesh-list
92507610|NCT00388089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507611|NCT00388089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92507612|NCT00388089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507613|NCT00388089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507614|NCT00388089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507615|NCT04742023|Insulin|insulin|mesh-list
92507616|NCT04742023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92507617|NCT04742023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507618|NCT00388128|Caffeine|caffeine|mesh-list
92507619|NCT00388128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92507620|NCT00388128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507621|NCT00388128|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92507622|NCT00388128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507623|NCT00388128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507624|NCT00388128|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92507625|NCT00388128|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92507626|NCT00388128|Purinergic Agents|purinergic agents|mesh-ancestor
92507627|NCT00388128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507628|NCT00006462|Gemcitabine|gemcitabine|mesh-list
92507629|NCT00006462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507630|NCT00006462|Antimetabolites|antimetabolites|mesh-ancestor
92507631|NCT00006462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507632|NCT00006462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507633|NCT00006465|Capecitabine|capecitabine|mesh-list
92507634|NCT00006465|Oxaliplatin|oxaliplatin|mesh-list
92507635|NCT00006465|Irinotecan|irinotecan|mesh-list
92507636|NCT00006465|Camptothecin|camptothecin|mesh-list
92507637|NCT00006465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507638|NCT00006465|Antimetabolites|antimetabolites|mesh-ancestor
92507639|NCT00006465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507640|NCT00006465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507641|NCT00006465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92507642|NCT00006465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507643|NCT00006465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507644|NCT00006465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507645|NCT04575181|Insulin|insulin|mesh-list
92507646|NCT04575181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92507647|NCT04575181|Insulin Glargine|insulin glargine|mesh-list
92507648|NCT04575181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92507649|NCT04575181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507650|NCT00006468|Leucovorin|leucovorin|mesh-list
92507651|NCT00006468|Fluorouracil|fluorouracil|mesh-list
92507652|NCT00006468|Oxaliplatin|oxaliplatin|mesh-list
92507653|NCT00006468|Calcium|calcium|mesh-list
92507654|NCT00006468|Levoleucovorin|levoleucovorin|mesh-list
92507655|NCT00006468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92507656|NCT00006468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507657|NCT00006468|Antimetabolites|antimetabolites|mesh-ancestor
92507658|NCT00006468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507659|NCT00006468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507660|NCT00006468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507661|NCT00006468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507662|NCT00006468|Immunologic Factors|immunologic factors|mesh-ancestor
92507664|NCT00006468|Protective Agents|protective agents|mesh-ancestor
92507665|NCT00006468|Vitamin B Complex|vitamin b complex|mesh-ancestor
92507666|NCT00006468|Vitamins|vitamins|mesh-ancestor
92507667|NCT00006468|Micronutrients|micronutrients|mesh-ancestor
92507668|NCT00006471|Fenretinide|fenretinide|mesh-list
92507669|NCT00006471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507670|NCT00006471|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92507671|NCT00006471|Protective Agents|protective agents|mesh-ancestor
92507672|NCT00006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507673|NCT00006474|Temozolomide|temozolomide|mesh-list
92350792|NCT03598374|Inositol|inositol|mesh-list
92507674|NCT00006474|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92507675|NCT00006474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507676|NCT00006474|Alkylating Agents|alkylating agents|mesh-ancestor
92507677|NCT00006474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507678|NCT00006474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507679|NCT00006474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507680|NCT04201834|Risperidone|risperidone|mesh-list
92507681|NCT04201834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92507682|NCT04201834|Serotonin Agents|serotonin agents|mesh-ancestor
92507683|NCT04201834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92507684|NCT04201834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507685|NCT04201834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507686|NCT04201834|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92507687|NCT04201834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92507688|NCT04201834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92507689|NCT04201834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92507690|NCT04201834|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92507691|NCT04201834|Dopamine Agents|dopamine agents|mesh-ancestor
92507692|NCT04192435|Tranexamic Acid|tranexamic acid|mesh-list
92507693|NCT04192435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92507694|NCT04192435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92507695|NCT04192435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507696|NCT04192435|Hemostatics|hemostatics|mesh-ancestor
92507697|NCT04192435|Coagulants|coagulants|mesh-ancestor
92507698|NCT03771157|Vaccines|vaccines|mesh-list
92507699|NCT03771157|Immunologic Factors|immunologic factors|mesh-ancestor
92507700|NCT03771157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507701|NCT03765229|Pembrolizumab|pembrolizumab|mesh-list
92507702|NCT03765229|Entinostat|entinostat|mesh-list
92507703|NCT03765229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507704|NCT03765229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507705|NCT03765229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92507706|NCT03765229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507707|NCT03765229|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92507708|NCT03765229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232652|NCT00003436|Antiviral Agents|antiviral agents|mesh-ancestor
92507709|NCT03624517|Octreotide|octreotide|mesh-list
92507710|NCT03624517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92507711|NCT03624517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92507712|NCT03624517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507713|NCT00423397|Interferons|interferons|mesh-list
92507714|NCT00423397|Interferon-alpha|interferon-alpha|mesh-list
92507715|NCT00423397|Interferon alpha-2|interferon alpha-2|mesh-list
92507716|NCT00423397|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92507717|NCT00423397|Gefitinib|gefitinib|mesh-list
92507718|NCT00423397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507719|NCT00423397|Antiviral Agents|antiviral agents|mesh-ancestor
92507720|NCT00423397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507721|NCT00423397|Immunologic Factors|immunologic factors|mesh-ancestor
92507722|NCT00423397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507723|NCT00423397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507724|NCT00423397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507725|NCT00423397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507726|NCT03352765|Rituximab|rituximab|mesh-list
92507727|NCT03352765|Melphalan|melphalan|mesh-list
92507728|NCT03352765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92507729|NCT03352765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507730|NCT03352765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507731|NCT03352765|Immunologic Factors|immunologic factors|mesh-ancestor
92507732|NCT03352765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507733|NCT03352765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507734|NCT03352765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507735|NCT03352765|Alkylating Agents|alkylating agents|mesh-ancestor
92507736|NCT03352765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507738|NCT03352765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507739|NCT03265405|Prednisolone|prednisolone|mesh-list
92507740|NCT03265405|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92507741|NCT03265405|Methylprednisolone|methylprednisolone|mesh-list
92507742|NCT03265405|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92507743|NCT03265405|Prednisolone acetate|prednisolone acetate|mesh-list
92507744|NCT03265405|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92507745|NCT03265405|Prednisolone phosphate|prednisolone phosphate|mesh-list
92507746|NCT03265405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507747|NCT03265405|Glucocorticoids|glucocorticoids|mesh-ancestor
92507748|NCT03265405|Hormones|hormones|mesh-ancestor
92507749|NCT03265405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92507750|NCT03265405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507751|NCT03265405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92507752|NCT03265405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507753|NCT03265405|Antiemetics|antiemetics|mesh-ancestor
92507754|NCT03265405|Autonomic Agents|autonomic agents|mesh-ancestor
92507755|NCT03265405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507756|NCT03265405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92507757|NCT03265405|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92507758|NCT03265405|Protective Agents|protective agents|mesh-ancestor
92507759|NCT03808480|Nivolumab|nivolumab|mesh-list
92507760|NCT03808480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507761|NCT03808480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507762|NCT03808480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92507763|NCT03808480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507764|NCT03003325|Aspirin|aspirin|mesh-list
92507765|NCT03003325|Interferons|interferons|mesh-list
92507766|NCT03003325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507767|NCT03003325|Antiviral Agents|antiviral agents|mesh-ancestor
92507768|NCT03003325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507769|NCT03003325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92507770|NCT03003325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92507771|NCT03003325|Analgesics|analgesics|mesh-ancestor
92507772|NCT03003325|Sensory System Agents|sensory system agents|mesh-ancestor
92507773|NCT03003325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92507774|NCT03003325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507775|NCT03003325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507776|NCT03003325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507777|NCT03003325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92507778|NCT03003325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92507779|NCT03003325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507780|NCT03003325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92507781|NCT03003325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92507782|NCT03003325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507783|NCT03003325|Antipyretics|antipyretics|mesh-ancestor
92507784|NCT02966548|Nivolumab|nivolumab|mesh-list
92507785|NCT02966548|Relatlimab|relatlimab|mesh-list
92507786|NCT02966548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507787|NCT02966548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507788|NCT02966548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92507789|NCT02966548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507790|NCT02890069|Everolimus|everolimus|mesh-list
92507791|NCT02890069|Panobinostat|panobinostat|mesh-list
92507792|NCT02890069|Spartalizumab|spartalizumab|mesh-list
92507793|NCT02890069|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92507794|NCT02890069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92507795|NCT02890069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507796|NCT02890069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507797|NCT02890069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507798|NCT02890069|Immunologic Factors|immunologic factors|mesh-ancestor
92507799|NCT02890069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507800|NCT02890069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507801|NCT02890069|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92507802|NCT02890069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92507803|NCT02890069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507804|NCT02425501|Aflibercept|aflibercept|mesh-list
92507805|NCT02425501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92507806|NCT02425501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92507808|NCT02425501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507809|NCT02425501|Growth Inhibitors|growth inhibitors|mesh-ancestor
92507810|NCT02425501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507811|NCT02409238|Metformin|metformin|mesh-list
92507812|NCT02409238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92507813|NCT02409238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507814|NCT00006480|Aldesleukin|aldesleukin|mesh-list
92507815|NCT00006480|Ganciclovir|ganciclovir|mesh-list
92507816|NCT00006480|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92507817|NCT00006480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507818|NCT00006480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92350807|NCT00217620|Sorafenib|sorafenib|mesh-list
92507819|NCT00006480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507820|NCT00006480|Antiviral Agents|antiviral agents|mesh-ancestor
92507821|NCT00006480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507822|NCT00006480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507823|NCT00006480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507824|NCT00006480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507825|NCT00006483|Sargramostim|sargramostim|mesh-list
92507826|NCT00006483|Immunologic Factors|immunologic factors|mesh-ancestor
92507827|NCT00006483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507828|NCT00006486|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92507829|NCT00006486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507830|NCT00006486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92507831|NCT00006486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92507832|NCT00006486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507833|NCT00006486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92507834|NCT00006486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507835|NCT00006519|Capravirine|capravirine|mesh-list
92507836|NCT00006519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92507837|NCT00006519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507838|NCT00006519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507839|NCT00006519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507840|NCT00006519|Antiviral Agents|antiviral agents|mesh-ancestor
92507841|NCT00006519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507842|NCT00006519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507843|NCT00006519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507844|NCT00006591|Ritonavir|ritonavir|mesh-list
92507845|NCT00006591|Amprenavir|amprenavir|mesh-list
92507846|NCT00006591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92507847|NCT00006591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92507848|NCT00006591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92507849|NCT00006591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507850|NCT00006591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507851|NCT00006591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507852|NCT00006591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507853|NCT00006591|Antiviral Agents|antiviral agents|mesh-ancestor
92507854|NCT00006591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507855|NCT00006591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92507856|NCT00006591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92507857|NCT00006591|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92507858|NCT00006591|Antitubercular Agents|antitubercular agents|mesh-ancestor
92507859|NCT00006591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92507860|NCT00006630|Immunoglobulins|immunoglobulins|mesh-list
92507862|NCT00006630|gamma-Globulins|gamma-globulins|mesh-list
92507863|NCT00006630|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92507864|NCT00006630|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92507865|NCT00006630|Immunologic Factors|immunologic factors|mesh-ancestor
92507866|NCT00006630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507867|NCT00006669|Prednisone|prednisone|mesh-list
92507868|NCT00006669|Cyclophosphamide|cyclophosphamide|mesh-list
92507869|NCT00006669|Rituximab|rituximab|mesh-list
92507870|NCT00006669|Doxorubicin|doxorubicin|mesh-list
92507871|NCT00006669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92507872|NCT00006669|Etoposide|etoposide|mesh-list
92507873|NCT00006669|Vincristine|vincristine|mesh-list
92507874|NCT00006669|Sargramostim|sargramostim|mesh-list
92507875|NCT00006669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507876|NCT00006669|Immunologic Factors|immunologic factors|mesh-ancestor
92507877|NCT00006669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507878|NCT00006669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507879|NCT00006669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507880|NCT00006669|Alkylating Agents|alkylating agents|mesh-ancestor
92507881|NCT00006669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507882|NCT00006669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507883|NCT00006669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92507884|NCT00006669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507885|NCT00006669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507886|NCT00006669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507887|NCT00006669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507888|NCT00006669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507889|NCT00006669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92507890|NCT00006669|Glucocorticoids|glucocorticoids|mesh-ancestor
92507892|NCT00006669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92507893|NCT00006669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92507894|NCT00006669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507895|NCT00006669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92507896|NCT00006669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92507897|NCT00006669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92507898|NCT00006708|Rituximab|rituximab|mesh-list
92507899|NCT00006708|Carboplatin|carboplatin|mesh-list
92507900|NCT00006708|Etoposide|etoposide|mesh-list
92507901|NCT00006708|Ifosfamide|ifosfamide|mesh-list
92507902|NCT00006708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507903|NCT00006708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507904|NCT00006708|Immunologic Factors|immunologic factors|mesh-ancestor
92507905|NCT00006708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507906|NCT00006708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507907|NCT00006708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507908|NCT00006708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507909|NCT00006708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507910|NCT00006708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507911|NCT00006708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507912|NCT00006708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507913|NCT00006708|Alkylating Agents|alkylating agents|mesh-ancestor
92507914|NCT00006747|Cytarabine|cytarabine|mesh-list
92507915|NCT00006747|Methotrexate|methotrexate|mesh-list
92507916|NCT00006747|Etoposide|etoposide|mesh-list
92507917|NCT00006747|Melphalan|melphalan|mesh-list
92507918|NCT00006747|Carmustine|carmustine|mesh-list
92507919|NCT00006747|Tacrolimus|tacrolimus|mesh-list
92507920|NCT00006747|Sargramostim|sargramostim|mesh-list
92507921|NCT00006747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92507922|NCT00006747|Abortifacient Agents|abortifacient agents|mesh-ancestor
92507923|NCT00006747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92507924|NCT00006747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507925|NCT00006747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507926|NCT00006747|Antimetabolites|antimetabolites|mesh-ancestor
92507927|NCT00006747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507928|NCT00006747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507929|NCT00006747|Dermatologic Agents|dermatologic agents|mesh-ancestor
92507930|NCT00006747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507931|NCT00006747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92507932|NCT00006747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507933|NCT00006747|Immunologic Factors|immunologic factors|mesh-ancestor
92507934|NCT00006747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92507935|NCT00006747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92507936|NCT00006747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92507937|NCT00006747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507938|NCT00006747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507939|NCT00006747|Antiviral Agents|antiviral agents|mesh-ancestor
92507940|NCT00006747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507941|NCT00006747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92507942|NCT00006747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92507943|NCT00006747|Alkylating Agents|alkylating agents|mesh-ancestor
92507944|NCT00006747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92507946|NCT00006786|Bevacizumab|bevacizumab|mesh-list
92507947|NCT00006786|Fluorouracil|fluorouracil|mesh-list
92507948|NCT00006786|Irinotecan|irinotecan|mesh-list
92507949|NCT00006786|Calcium|calcium|mesh-list
92507950|NCT00006786|Levoleucovorin|levoleucovorin|mesh-list
92507951|NCT00006786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507952|NCT00006786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507953|NCT00006786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92507954|NCT00006786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92507955|NCT00006786|Growth Substances|growth substances|mesh-ancestor
92507956|NCT00006786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507958|NCT00006786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92507959|NCT00006786|Antimetabolites|antimetabolites|mesh-ancestor
92507960|NCT00006786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507961|NCT00006786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92507962|NCT00006786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92507963|NCT00006786|Immunologic Factors|immunologic factors|mesh-ancestor
92507964|NCT00006786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92507965|NCT00006786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507966|NCT00006786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507967|NCT00006786|Antidotes|antidotes|mesh-ancestor
92507968|NCT00006786|Protective Agents|protective agents|mesh-ancestor
92507969|NCT00006786|Vitamin B Complex|vitamin b complex|mesh-ancestor
92507970|NCT00006786|Vitamins|vitamins|mesh-ancestor
92507971|NCT00006786|Micronutrients|micronutrients|mesh-ancestor
92507972|NCT00006825|Doxorubicin|doxorubicin|mesh-list
92507973|NCT00006825|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92507974|NCT00006825|Trastuzumab|trastuzumab|mesh-list
92507975|NCT00006825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507976|NCT00006825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507977|NCT00006825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92507978|NCT00006825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92507979|NCT00006825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92507980|NCT00006825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92507981|NCT00006825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92507982|NCT00006864|Aldesleukin|aldesleukin|mesh-list
92507983|NCT00006864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507984|NCT00006864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92507985|NCT00006864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92507986|NCT00006864|Antiviral Agents|antiviral agents|mesh-ancestor
92507987|NCT00006864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92507988|NCT00006942|Bryostatin 1|bryostatin 1|mesh-list
92507989|NCT00006942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92507990|NCT00006942|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92507991|NCT00006942|Immunologic Factors|immunologic factors|mesh-ancestor
92507992|NCT00006942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507993|NCT00006981|Immunotoxins|immunotoxins|mesh-list
92507994|NCT00006981|Immunoconjugates|immunoconjugates|mesh-ancestor
92507995|NCT00006981|Immunologic Factors|immunologic factors|mesh-ancestor
92507996|NCT00006981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92507997|NCT00007059|Mycophenolic Acid|mycophenolic acid|mesh-list
92507998|NCT00007059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92507999|NCT00007059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508000|NCT00007059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92508001|NCT00007059|Antitubercular Agents|antitubercular agents|mesh-ancestor
92508002|NCT00007059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92508003|NCT00007059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508004|NCT00007059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508005|NCT00007059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508006|NCT00387556|Ondansetron|ondansetron|mesh-list
92508007|NCT00387556|Antiemetics|antiemetics|mesh-ancestor
92508008|NCT00387556|Autonomic Agents|autonomic agents|mesh-ancestor
92508009|NCT00387556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508010|NCT00387556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508011|NCT00387556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508012|NCT00387556|Antipruritics|antipruritics|mesh-ancestor
92508013|NCT00387556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92508014|NCT00387556|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92508015|NCT00387556|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92508016|NCT00387556|Serotonin Agents|serotonin agents|mesh-ancestor
92508017|NCT00387556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508018|NCT00387556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508019|NCT03780790|Bupivacaine|bupivacaine|mesh-list
92508020|NCT03780790|Anesthetics, Local|anesthetics, local|mesh-ancestor
92508021|NCT03780790|Anesthetics|anesthetics|mesh-ancestor
92508022|NCT03780790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92508023|NCT03780790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508024|NCT03780790|Sensory System Agents|sensory system agents|mesh-ancestor
92508025|NCT03780790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508026|NCT00388167|Caspofungin|caspofungin|mesh-list
92508027|NCT00388167|Antifungal Agents|antifungal agents|mesh-ancestor
92508028|NCT00388167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508029|NCT00388167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508030|NCT00388167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508031|NCT00006043|Temozolomide|temozolomide|mesh-list
92508032|NCT00006043|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508033|NCT00006043|Alkylating Agents|alkylating agents|mesh-ancestor
92508034|NCT00006043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508035|NCT00006043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508037|NCT00006049|Carboplatin|carboplatin|mesh-list
92508038|NCT00006049|Gefitinib|gefitinib|mesh-list
92508039|NCT00006049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508040|NCT00006049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508041|NCT00006049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92508042|NCT00006049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92508043|NCT00006049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92508044|NCT00006049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508045|NCT00006049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92508046|NCT00006049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508047|NCT00006052|Imatinib Mesylate|imatinib mesylate|mesh-list
92508048|NCT00006052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508049|NCT00006052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92508050|NCT00006052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508051|NCT00006052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508052|NCT00006055|Cyclosporine|cyclosporine|mesh-list
92508053|NCT00006055|Prednisone|prednisone|mesh-list
92508054|NCT00006055|Methylprednisolone|methylprednisolone|mesh-list
92508055|NCT00006055|Cyclophosphamide|cyclophosphamide|mesh-list
92508056|NCT00006055|Cyclosporins|cyclosporins|mesh-list
92508057|NCT00006055|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92508058|NCT00006055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508059|NCT00006055|Immunologic Factors|immunologic factors|mesh-ancestor
92508060|NCT00006055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508061|NCT00006055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508062|NCT00006055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508063|NCT00006055|Alkylating Agents|alkylating agents|mesh-ancestor
92508064|NCT00006055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508065|NCT00006055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508066|NCT00006055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92508067|NCT00006055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508068|NCT00006055|Glucocorticoids|glucocorticoids|mesh-ancestor
92508069|NCT00006055|Hormones|hormones|mesh-ancestor
92508070|NCT00006055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508071|NCT00006055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508072|NCT00006055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508073|NCT00006055|Antifungal Agents|antifungal agents|mesh-ancestor
92508074|NCT00006055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508075|NCT00006055|Dermatologic Agents|dermatologic agents|mesh-ancestor
92508076|NCT00006055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92508077|NCT00006055|Antiemetics|antiemetics|mesh-ancestor
92508078|NCT00006055|Autonomic Agents|autonomic agents|mesh-ancestor
92508079|NCT00006055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508080|NCT00006055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508081|NCT00006055|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92508082|NCT00006055|Protective Agents|protective agents|mesh-ancestor
92508083|NCT00006070|Etanercept|etanercept|mesh-list
92508084|NCT00006070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92508085|NCT00006070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92233023|NCT00059228|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92508086|NCT00006070|Analgesics|analgesics|mesh-ancestor
92508087|NCT00006070|Sensory System Agents|sensory system agents|mesh-ancestor
92508088|NCT00006070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508089|NCT00006070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508090|NCT00006070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508091|NCT00006070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508092|NCT00006070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508093|NCT00006070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508094|NCT00006070|Immunologic Factors|immunologic factors|mesh-ancestor
92508095|NCT00006079|Eflornithine|eflornithine|mesh-list
92508096|NCT00006079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508097|NCT00006079|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92508098|NCT00006079|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92508099|NCT00006079|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92508100|NCT00006079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508101|NCT00006079|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92508102|NCT00006079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508103|NCT00006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508104|NCT00006082|Rubitecan|rubitecan|mesh-list
92508105|NCT00006082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508106|NCT00006082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92508107|NCT00006082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508108|NCT00006082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508109|NCT00006082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508110|NCT00006088|Vinorelbine|vinorelbine|mesh-list
92508111|NCT00006088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508112|NCT00006088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508113|NCT00006088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92508114|NCT00006088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92508115|NCT00006088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92508116|NCT00006088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508117|NCT00006091|Arsenic Trioxide|arsenic trioxide|mesh-list
92508118|NCT00006091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508119|NCT00006094|Fluorouracil|fluorouracil|mesh-list
92508120|NCT00006094|Oxaliplatin|oxaliplatin|mesh-list
92508121|NCT00006094|Antimetabolites|antimetabolites|mesh-ancestor
92508122|NCT00006094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508123|NCT00006094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508124|NCT00006094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508125|NCT00006094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508126|NCT00006094|Immunologic Factors|immunologic factors|mesh-ancestor
92508127|NCT00006094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508128|NCT00006100|Aldesleukin|aldesleukin|mesh-list
92508129|NCT00006100|Fludarabine|fludarabine|mesh-list
92508130|NCT00006100|Fludarabine phosphate|fludarabine phosphate|mesh-list
92508131|NCT00006100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508132|NCT00006100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508133|NCT00006100|Antimetabolites|antimetabolites|mesh-ancestor
92508134|NCT00006100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508135|NCT00006100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508136|NCT00006100|Immunologic Factors|immunologic factors|mesh-ancestor
92508137|NCT00006100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508138|NCT00006100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508139|NCT00006100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92508140|NCT00006100|Antiviral Agents|antiviral agents|mesh-ancestor
92508141|NCT00006100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508142|NCT00006103|Leucovorin|leucovorin|mesh-list
92508143|NCT00006103|Fluorouracil|fluorouracil|mesh-list
92508144|NCT00006103|Irinotecan|irinotecan|mesh-list
92508145|NCT00006103|Calcium|calcium|mesh-list
92508146|NCT00006103|Levoleucovorin|levoleucovorin|mesh-list
92508147|NCT00006103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92508148|NCT00006103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508149|NCT00006103|Antimetabolites|antimetabolites|mesh-ancestor
92508150|NCT00006103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508151|NCT00006103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508152|NCT00006103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508153|NCT00006103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508154|NCT00006103|Immunologic Factors|immunologic factors|mesh-ancestor
92508155|NCT00006103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92508156|NCT00006103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508157|NCT00006103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508158|NCT00006103|Antidotes|antidotes|mesh-ancestor
92508159|NCT00006103|Protective Agents|protective agents|mesh-ancestor
92508160|NCT00006103|Vitamin B Complex|vitamin b complex|mesh-ancestor
92508161|NCT00006103|Vitamins|vitamins|mesh-ancestor
92508162|NCT00006103|Micronutrients|micronutrients|mesh-ancestor
92508163|NCT00006106|Fluorouracil|fluorouracil|mesh-list
92508164|NCT00006106|Dl1520|dl1520|mesh-list
92508165|NCT00006106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508166|NCT00006106|Antimetabolites|antimetabolites|mesh-ancestor
92508167|NCT00006106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508168|NCT00006106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508169|NCT00006106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508170|NCT00006106|Immunologic Factors|immunologic factors|mesh-ancestor
92508171|NCT00006106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508172|NCT00006112|Leucovorin|leucovorin|mesh-list
92508173|NCT00006112|Fluorouracil|fluorouracil|mesh-list
92508175|NCT00006112|Mitomycin|mitomycin|mesh-list
92508176|NCT00006112|Calcium|calcium|mesh-list
92508177|NCT00006112|Levoleucovorin|levoleucovorin|mesh-list
92508178|NCT00006112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92508179|NCT00006112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508180|NCT00006112|Antimetabolites|antimetabolites|mesh-ancestor
92508181|NCT00006112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508182|NCT00006112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508183|NCT00006112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508184|NCT00006112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508185|NCT00006112|Immunologic Factors|immunologic factors|mesh-ancestor
92508186|NCT00006112|Antidotes|antidotes|mesh-ancestor
92508187|NCT00006112|Protective Agents|protective agents|mesh-ancestor
92508188|NCT00006112|Vitamin B Complex|vitamin b complex|mesh-ancestor
92508189|NCT00006112|Vitamins|vitamins|mesh-ancestor
92508190|NCT00006112|Micronutrients|micronutrients|mesh-ancestor
92508191|NCT00006112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508192|NCT00006112|Alkylating Agents|alkylating agents|mesh-ancestor
92508193|NCT00006112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508194|NCT00006112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508195|NCT00006115|Leucovorin|leucovorin|mesh-list
92508196|NCT00006115|Fluorouracil|fluorouracil|mesh-list
92508197|NCT00006115|Oxaliplatin|oxaliplatin|mesh-list
92508198|NCT00006115|Irinotecan|irinotecan|mesh-list
92508199|NCT00006115|Calcium|calcium|mesh-list
92508200|NCT00006115|Levoleucovorin|levoleucovorin|mesh-list
92508201|NCT00006115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92508202|NCT00006115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508203|NCT00006115|Antimetabolites|antimetabolites|mesh-ancestor
92508204|NCT00006115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508205|NCT00006115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508206|NCT00006115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508207|NCT00006115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508208|NCT00006115|Immunologic Factors|immunologic factors|mesh-ancestor
92508209|NCT00006115|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92508210|NCT00006115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508211|NCT00006115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508212|NCT00006115|Antidotes|antidotes|mesh-ancestor
92508213|NCT00006115|Protective Agents|protective agents|mesh-ancestor
92508214|NCT00006115|Vitamin B Complex|vitamin b complex|mesh-ancestor
92508215|NCT00006115|Vitamins|vitamins|mesh-ancestor
92508216|NCT00006115|Micronutrients|micronutrients|mesh-ancestor
92508217|NCT00006118|Paclitaxel|paclitaxel|mesh-list
92508218|NCT00006118|Gemcitabine|gemcitabine|mesh-list
92508219|NCT00006118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508220|NCT00006118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508221|NCT00006118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92508222|NCT00006118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92508223|NCT00006118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92508224|NCT00006118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508225|NCT00006118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508226|NCT00006118|Antimetabolites|antimetabolites|mesh-ancestor
92508227|NCT00006121|Oxaliplatin|oxaliplatin|mesh-list
92508228|NCT00006121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508229|NCT00006124|Celecoxib|celecoxib|mesh-list
92508230|NCT00006124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92508231|NCT00006124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92508232|NCT00006124|Analgesics|analgesics|mesh-ancestor
92508233|NCT00006124|Sensory System Agents|sensory system agents|mesh-ancestor
92508234|NCT00006124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508235|NCT00006124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508236|NCT00006124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508237|NCT00006124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508238|NCT00006124|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92508239|NCT00006124|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92508240|NCT00006124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233175|NCT00003610|Capsaicin|capsaicin|mesh-list
92508241|NCT00006124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508242|NCT00006127|Amifostine|amifostine|mesh-list
92508243|NCT00006127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92508244|NCT00006127|Protective Agents|protective agents|mesh-ancestor
92508245|NCT00006127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508246|NCT00006133|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92508247|NCT00006133|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92508248|NCT00006133|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92508249|NCT00006133|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92508250|NCT00006133|Medroxyprogesterone|medroxyprogesterone|mesh-list
92508251|NCT00006133|Norethindrone|norethindrone|mesh-list
92508252|NCT00006133|Norethindrone Acetate|norethindrone acetate|mesh-list
92508253|NCT00006133|Estradiol|estradiol|mesh-list
92508254|NCT00006133|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92508255|NCT00006133|Estrogens|estrogens|mesh-ancestor
92508256|NCT00006133|Hormones|hormones|mesh-ancestor
92508257|NCT00006133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508258|NCT00006133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508259|NCT00006133|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92508260|NCT00006133|Contraceptive Agents|contraceptive agents|mesh-ancestor
92508261|NCT00006133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92508262|NCT00006133|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92508263|NCT00006133|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92508264|NCT00006133|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92508265|NCT00006133|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92508266|NCT00006133|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92508267|NCT00006133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508268|NCT00006133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508269|NCT00006136|Arginine butyrate|arginine butyrate|mesh-list
92508270|NCT00006136|Epoetin Alfa|epoetin alfa|mesh-list
92508271|NCT00006136|Hematinics|hematinics|mesh-ancestor
92508272|NCT00006136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508273|NCT00006145|Valganciclovir|valganciclovir|mesh-list
92508274|NCT00006145|Antiviral Agents|antiviral agents|mesh-ancestor
92508275|NCT00006145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508276|NCT00006154|Ritonavir|ritonavir|mesh-list
92508277|NCT00006154|Indinavir|indinavir|mesh-list
92508278|NCT00006154|Aldesleukin|aldesleukin|mesh-list
92508279|NCT00006154|Abacavir|abacavir|mesh-list
92508280|NCT00006154|Didanosine|didanosine|mesh-list
92508282|NCT00006154|Efavirenz|efavirenz|mesh-list
92508283|NCT00006154|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92508284|NCT00006154|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92508285|NCT00006154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92508286|NCT00006154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508287|NCT00006154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508288|NCT00006154|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508289|NCT00006154|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92508290|NCT00006154|Antiviral Agents|antiviral agents|mesh-ancestor
92508291|NCT00006154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508292|NCT00006154|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92508293|NCT00006154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92508294|NCT00006154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508295|NCT00006154|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92508296|NCT00006154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508297|NCT00006154|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92508298|NCT00006154|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92508299|NCT00006154|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92508300|NCT00006154|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92508301|NCT00006154|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92508302|NCT00006154|Antimetabolites|antimetabolites|mesh-ancestor
92508303|NCT00006157|Desipramine|desipramine|mesh-list
92508304|NCT00006157|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92508305|NCT00006157|Antidepressive Agents|antidepressive agents|mesh-ancestor
92508306|NCT00006157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92508307|NCT00006157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508308|NCT00006157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508309|NCT00006157|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92508310|NCT00006157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92508311|NCT00006157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92508312|NCT00006157|Adrenergic Agents|adrenergic agents|mesh-ancestor
92508313|NCT00006157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508314|NCT00006157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508315|NCT00006190|Lamivudine|lamivudine|mesh-list
92508316|NCT00006190|Efavirenz|efavirenz|mesh-list
92508317|NCT00006190|Stavudine|stavudine|mesh-list
92508318|NCT00006190|Nelfinavir|nelfinavir|mesh-list
92508319|NCT00006190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92508320|NCT00006190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508321|NCT00006190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508322|NCT00006190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508323|NCT00006190|Antiviral Agents|antiviral agents|mesh-ancestor
92508324|NCT00006190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508325|NCT00006190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508326|NCT00006190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92508327|NCT00006190|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92508328|NCT00006190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92508329|NCT00006190|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92508330|NCT00006190|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92508331|NCT00006190|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92508332|NCT00006190|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92508333|NCT00006190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92508334|NCT00006190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92508335|NCT00006190|Protease Inhibitors|protease inhibitors|mesh-ancestor
92508336|NCT00006190|Antimetabolites|antimetabolites|mesh-ancestor
92508337|NCT00006196|Vitamin D|vitamin d|mesh-list
92508338|NCT00006196|Vitamins|vitamins|mesh-ancestor
92508339|NCT00006196|Micronutrients|micronutrients|mesh-ancestor
92508340|NCT00006196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508341|NCT00006196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92508342|NCT00006199|Topotecan|topotecan|mesh-list
92508343|NCT00006199|Tipifarnib|tipifarnib|mesh-list
92508344|NCT00006199|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92508345|NCT00006199|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508346|NCT00006199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508347|NCT00006199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508348|NCT00006199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508349|NCT00006205|Topiramate|topiramate|mesh-list
92508350|NCT00006205|Ondansetron|ondansetron|mesh-list
92508351|NCT00006205|Antiemetics|antiemetics|mesh-ancestor
92508352|NCT00006205|Autonomic Agents|autonomic agents|mesh-ancestor
92508353|NCT00006205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917300|NCT02160301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92508354|NCT00006205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508355|NCT00006205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508356|NCT00006205|Antipruritics|antipruritics|mesh-ancestor
92350866|NCT03592836|Furosemide|furosemide|mesh-list
92508357|NCT00006205|Dermatologic Agents|dermatologic agents|mesh-ancestor
92508358|NCT00006205|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92508359|NCT00006205|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92508360|NCT00006205|Serotonin Agents|serotonin agents|mesh-ancestor
92508361|NCT00006205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508362|NCT00006205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508363|NCT00006205|Anticonvulsants|anticonvulsants|mesh-ancestor
92508364|NCT00006205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92508366|NCT00006208|Efavirenz|efavirenz|mesh-list
92508367|NCT00006208|Didanosine|didanosine|mesh-list
92508368|NCT00006208|Stavudine|stavudine|mesh-list
92508369|NCT00006208|Antiviral Agents|antiviral agents|mesh-ancestor
92508370|NCT00006208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508371|NCT00006208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92508372|NCT00006208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508373|NCT00006208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508374|NCT00006208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508375|NCT00006208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508376|NCT00006208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92508377|NCT00006208|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92508378|NCT00006208|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92508379|NCT00006208|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92508380|NCT00006208|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92508381|NCT00006208|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92508382|NCT00006208|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92508383|NCT00006208|Antimetabolites|antimetabolites|mesh-ancestor
92508384|NCT00006211|Nelfinavir|nelfinavir|mesh-list
92508385|NCT00006211|Capravirine|capravirine|mesh-list
92508386|NCT00006211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92508387|NCT00006211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92508388|NCT00006211|Protease Inhibitors|protease inhibitors|mesh-ancestor
92508389|NCT00006211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508390|NCT00006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508391|NCT00006211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508392|NCT00006211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92508393|NCT00006211|Antiviral Agents|antiviral agents|mesh-ancestor
92508394|NCT00006211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508395|NCT00006211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92508396|NCT00006211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508397|NCT00006214|Flutamide|flutamide|mesh-list
92508398|NCT00006214|Androgen Antagonists|androgen antagonists|mesh-ancestor
92508399|NCT00006214|Hormone Antagonists|hormone antagonists|mesh-ancestor
92508400|NCT00006214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508401|NCT00006214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508402|NCT00006214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508403|NCT00006214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508404|NCT00006220|Arsenic Trioxide|arsenic trioxide|mesh-list
92508405|NCT00006220|Tretinoin|tretinoin|mesh-list
92508406|NCT00006220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508407|NCT00006220|Keratolytic Agents|keratolytic agents|mesh-ancestor
92508408|NCT00006220|Dermatologic Agents|dermatologic agents|mesh-ancestor
92508409|NCT00006223|Flt3 ligand protein|flt3 ligand protein|mesh-list
92508410|NCT00006223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92508411|NCT00006223|Immunologic Factors|immunologic factors|mesh-ancestor
92508412|NCT00006223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508413|NCT00006223|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92508414|NCT00006223|Protective Agents|protective agents|mesh-ancestor
92508415|NCT03761953|Oritavancin|oritavancin|mesh-list
92508416|NCT03761953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92508417|NCT03761953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508418|NCT00006226|Thalidomide|thalidomide|mesh-list
92508419|NCT00006226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508420|NCT00006226|Immunologic Factors|immunologic factors|mesh-ancestor
92508421|NCT00006226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508422|NCT00006226|Leprostatic Agents|leprostatic agents|mesh-ancestor
92508423|NCT00006226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92508424|NCT00006226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508425|NCT00006226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92508426|NCT00006226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92508427|NCT00006226|Growth Substances|growth substances|mesh-ancestor
92508428|NCT00006226|Growth Inhibitors|growth inhibitors|mesh-ancestor
92508429|NCT00006226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508431|NCT00006232|Doxorubicin|doxorubicin|mesh-list
92508432|NCT00006232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92508433|NCT00006232|Vincristine|vincristine|mesh-list
92508434|NCT00006232|Idarubicin|idarubicin|mesh-list
92508435|NCT00006232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508436|NCT00006232|Antiemetics|antiemetics|mesh-ancestor
92508437|NCT00006232|Autonomic Agents|autonomic agents|mesh-ancestor
92508438|NCT00006232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508439|NCT00006232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508440|NCT00006232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508441|NCT00006232|Glucocorticoids|glucocorticoids|mesh-ancestor
92508442|NCT00006232|Hormones|hormones|mesh-ancestor
92508443|NCT00006232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508444|NCT00006232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508445|NCT00006232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508446|NCT00006232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508447|NCT00006232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508448|NCT00006232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508449|NCT00006232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508450|NCT00006232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508451|NCT00006232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508452|NCT00006232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92508453|NCT00006232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92508454|NCT00006232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92508455|NCT00006235|Carboplatin|carboplatin|mesh-list
92508456|NCT00006235|Doxorubicin|doxorubicin|mesh-list
92508457|NCT00006235|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92508458|NCT00006235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508459|NCT00006235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508460|NCT00006235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508461|NCT00006235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508462|NCT00006235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508463|NCT00006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508464|NCT00006241|Lenograstim|lenograstim|mesh-list
92508465|NCT00006241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92508466|NCT00006241|Immunologic Factors|immunologic factors|mesh-ancestor
92508467|NCT00006241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508468|NCT00006247|Semaxinib|semaxinib|mesh-list
92508469|NCT00006247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92533073|NCT00057421|Prednisolone|prednisolone|mesh-list
92508470|NCT00006247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92508471|NCT00006247|Growth Substances|growth substances|mesh-ancestor
92508472|NCT00006247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508473|NCT00006247|Growth Inhibitors|growth inhibitors|mesh-ancestor
92508474|NCT00006247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508475|NCT00006247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92508476|NCT00006247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508477|NCT00006247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508478|NCT00006250|Dexamethasone|dexamethasone|mesh-list
92508479|NCT00006250|Fludarabine|fludarabine|mesh-list
92508480|NCT00006250|Fludarabine phosphate|fludarabine phosphate|mesh-list
92508481|NCT00006250|Mitoxantrone|mitoxantrone|mesh-list
92508482|NCT00006250|Chlorambucil|chlorambucil|mesh-list
92508483|NCT00006250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508484|NCT00006250|Antiemetics|antiemetics|mesh-ancestor
92508485|NCT00006250|Autonomic Agents|autonomic agents|mesh-ancestor
92508486|NCT00006250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508487|NCT00006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508488|NCT00006250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508489|NCT00006250|Glucocorticoids|glucocorticoids|mesh-ancestor
92508491|NCT00006250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508492|NCT00006250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508493|NCT00006250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508494|NCT00006250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508495|NCT00006250|Antimetabolites|antimetabolites|mesh-ancestor
92508496|NCT00006250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508497|NCT00006250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508498|NCT00006250|Immunologic Factors|immunologic factors|mesh-ancestor
92508499|NCT00006250|Analgesics|analgesics|mesh-ancestor
92508500|NCT00006250|Sensory System Agents|sensory system agents|mesh-ancestor
92508501|NCT00006250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508502|NCT00006250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508503|NCT00006250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508504|NCT00006250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508505|NCT00006250|Alkylating Agents|alkylating agents|mesh-ancestor
92508506|NCT00006265|Cytarabine|cytarabine|mesh-list
92508507|NCT00006265|Gemtuzumab|gemtuzumab|mesh-list
92508508|NCT00006265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508509|NCT00006265|Antimetabolites|antimetabolites|mesh-ancestor
92508510|NCT00006265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508511|NCT00006265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508512|NCT00006265|Antiviral Agents|antiviral agents|mesh-ancestor
92508513|NCT00006265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508514|NCT00006265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508515|NCT00006265|Immunologic Factors|immunologic factors|mesh-ancestor
92508516|NCT00006265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508517|NCT00006265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92508518|NCT00006265|Immunotoxins|immunotoxins|mesh-ancestor
92508519|NCT00006265|Immunoconjugates|immunoconjugates|mesh-ancestor
92508520|NCT00007527|Buprenorphine|buprenorphine|mesh-list
92508521|NCT00007527|Naloxone|naloxone|mesh-list
92508522|NCT00007527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92508523|NCT00007527|Narcotics|narcotics|mesh-ancestor
92508524|NCT00007527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92508525|NCT00007527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508526|NCT00007527|Analgesics|analgesics|mesh-ancestor
92508527|NCT00007527|Sensory System Agents|sensory system agents|mesh-ancestor
92508528|NCT00007527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508529|NCT00007527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92508530|NCT00006280|Tobramycin|tobramycin|mesh-list
92508531|NCT00006280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92508532|NCT00006280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508533|NCT00006286|Fluoxetine|fluoxetine|mesh-list
92508534|NCT00006286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92508535|NCT00006286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92508536|NCT00006286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92508537|NCT00006286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508538|NCT00006286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508539|NCT00006286|Serotonin Agents|serotonin agents|mesh-ancestor
92508540|NCT00006286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533074|NCT00057421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508541|NCT00006286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92508542|NCT00006286|Antidepressive Agents|antidepressive agents|mesh-ancestor
92508543|NCT00006286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92508544|NCT00006286|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92508545|NCT00006286|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92508546|NCT00006286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508547|NCT00007605|Amiodarone|amiodarone|mesh-list
92508548|NCT00007605|Sotalol|sotalol|mesh-list
92508549|NCT00007605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92508550|NCT00007605|Vasodilator Agents|vasodilator agents|mesh-ancestor
92508551|NCT00007605|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92508552|NCT00007605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92508553|NCT00007605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508554|NCT00007605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92508555|NCT00007605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92508556|NCT00007605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92508557|NCT00007605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508558|NCT00007605|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92508559|NCT00007605|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92508560|NCT00007605|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92508561|NCT00007605|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92508562|NCT00007605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92508563|NCT00007605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92508564|NCT00007605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508565|NCT00007605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508566|NCT00007605|Sympatholytics|sympatholytics|mesh-ancestor
92508567|NCT00007605|Autonomic Agents|autonomic agents|mesh-ancestor
92508568|NCT00007605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508569|NCT00006292|Infliximab|infliximab|mesh-list
92508570|NCT00006292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92508571|NCT00006292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508572|NCT00006292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92508573|NCT00006292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508574|NCT00006292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508575|NCT03709888|Pregabalin|pregabalin|mesh-list
92508576|NCT03709888|Memantine|memantine|mesh-list
92508577|NCT03709888|Analgesics|analgesics|mesh-ancestor
92508578|NCT03709888|Sensory System Agents|sensory system agents|mesh-ancestor
92508579|NCT03709888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508580|NCT03709888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508581|NCT03709888|Anticonvulsants|anticonvulsants|mesh-ancestor
92508582|NCT03709888|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92508583|NCT03709888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92508584|NCT03709888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508585|NCT03709888|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92508586|NCT03709888|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92508587|NCT03709888|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92508588|NCT03709888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92508589|NCT03709888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92508590|NCT03709888|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92508591|NCT03709888|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92508592|NCT03709888|Dopamine Agents|dopamine agents|mesh-ancestor
92508593|NCT03709888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508594|NCT03709888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92508595|NCT03709888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92508596|NCT00007683|Aspirin|aspirin|mesh-list
92508597|NCT00007683|Warfarin|warfarin|mesh-list
92508598|NCT00007683|Clopidogrel|clopidogrel|mesh-list
92508599|NCT00007683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92508600|NCT00007683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92508601|NCT00007683|Analgesics|analgesics|mesh-ancestor
92508602|NCT00007683|Sensory System Agents|sensory system agents|mesh-ancestor
92508603|NCT00007683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508604|NCT00007683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508605|NCT00007683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92508606|NCT00007683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508607|NCT00007683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92508608|NCT00007683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92508609|NCT00007683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508610|NCT00007683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92508611|NCT00007683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92508613|NCT00007683|Antipyretics|antipyretics|mesh-ancestor
92508614|NCT00007683|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92508615|NCT00007683|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92508616|NCT00007683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92508617|NCT00007683|Purinergic Agents|purinergic agents|mesh-ancestor
92508618|NCT00007683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508619|NCT00007683|Anticoagulants|anticoagulants|mesh-ancestor
92508620|NCT00006325|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92508621|NCT00006325|Antiviral Agents|antiviral agents|mesh-ancestor
92508622|NCT00006325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508623|NCT00006337|Levodopa|levodopa|mesh-list
92508624|NCT00006337|Istradefylline|istradefylline|mesh-list
92508625|NCT00006337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92508626|NCT00006337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92508627|NCT00006337|Dopamine Agents|dopamine agents|mesh-ancestor
92508628|NCT00006337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508629|NCT00006337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508630|NCT00006337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508631|NCT00006337|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92508632|NCT00006337|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92508633|NCT00006337|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92508634|NCT00006337|Purinergic Agents|purinergic agents|mesh-ancestor
92508635|NCT00006340|Ganciclovir|ganciclovir|mesh-list
92508636|NCT00006340|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92508637|NCT00006340|Arginine butyrate|arginine butyrate|mesh-list
92508638|NCT00006340|Antiviral Agents|antiviral agents|mesh-ancestor
92508639|NCT00006340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508640|NCT00006340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508641|NCT00006340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508642|NCT00006340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508643|NCT00006340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508644|NCT00006229|Paclitaxel|paclitaxel|mesh-list
92508645|NCT00006229|Carboplatin|carboplatin|mesh-list
92508646|NCT00006229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508647|NCT00006229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508648|NCT00006229|Tubulin Modulators|tubulin modulators|mesh-ancestor
92508649|NCT00006229|Antimitotic Agents|antimitotic agents|mesh-ancestor
92508650|NCT00006229|Mitosis Modulators|mitosis modulators|mesh-ancestor
92508651|NCT00006229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508652|NCT00006343|Interferons|interferons|mesh-list
92508653|NCT00006343|Cytarabine|cytarabine|mesh-list
92508654|NCT00006343|Interferon-alpha|interferon-alpha|mesh-list
92508655|NCT00006343|Imatinib Mesylate|imatinib mesylate|mesh-list
92508656|NCT00006343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508657|NCT00006343|Antiviral Agents|antiviral agents|mesh-ancestor
92508658|NCT00006343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508659|NCT00006343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508660|NCT00006343|Antimetabolites|antimetabolites|mesh-ancestor
92508661|NCT00006343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508662|NCT00006343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508663|NCT00006343|Immunologic Factors|immunologic factors|mesh-ancestor
92508664|NCT00006343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508665|NCT00006343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92508666|NCT00006343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508667|NCT00387868|Etoposide|etoposide|mesh-list
92508668|NCT00387868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508669|NCT00387868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508670|NCT00387868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508671|NCT00387868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508672|NCT00387868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508673|NCT00387868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508674|NCT03616717|Modafinil|modafinil|mesh-list
92508675|NCT03616717|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92508676|NCT03616717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508677|NCT03616717|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92508678|NCT03616717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92508679|NCT03616717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92508680|NCT03616717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508681|NCT00006349|Vitamin E|vitamin e|mesh-list
92508682|NCT00006349|Donepezil|donepezil|mesh-list
92508683|NCT00006349|Vitamins|vitamins|mesh-ancestor
92508684|NCT00006349|Micronutrients|micronutrients|mesh-ancestor
92508685|NCT00006349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508686|NCT00006349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92508687|NCT00006349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508688|NCT00006349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508689|NCT00006349|Cholinergic Agents|cholinergic agents|mesh-ancestor
92508690|NCT00006349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508691|NCT00006349|Nootropic Agents|nootropic agents|mesh-ancestor
92508692|NCT00006349|Antioxidants|antioxidants|mesh-ancestor
92508693|NCT00006349|Protective Agents|protective agents|mesh-ancestor
92508694|NCT00006352|Antibodies|antibodies|mesh-list
92508695|NCT00006352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92508696|NCT00006352|BCG Vaccine|bcg vaccine|mesh-list
92508697|NCT00006352|Immunologic Factors|immunologic factors|mesh-ancestor
92508698|NCT00006352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508699|NCT00006352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92508700|NCT00007878|Leucovorin|leucovorin|mesh-list
92508701|NCT00007878|Fluorouracil|fluorouracil|mesh-list
92508702|NCT00007878|Bortezomib|bortezomib|mesh-list
92508703|NCT00007878|Calcium|calcium|mesh-list
92508704|NCT00007878|Levoleucovorin|levoleucovorin|mesh-list
92508705|NCT00007878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92508706|NCT00007878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508707|NCT00007878|Antimetabolites|antimetabolites|mesh-ancestor
92508708|NCT00007878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508709|NCT00007878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508710|NCT00007878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508711|NCT00007878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508712|NCT00007878|Immunologic Factors|immunologic factors|mesh-ancestor
92508713|NCT00007878|Antidotes|antidotes|mesh-ancestor
92508714|NCT00007878|Protective Agents|protective agents|mesh-ancestor
92508715|NCT00007878|Vitamin B Complex|vitamin b complex|mesh-ancestor
92508716|NCT00007878|Vitamins|vitamins|mesh-ancestor
92508717|NCT00007878|Micronutrients|micronutrients|mesh-ancestor
92508718|NCT00006355|NSC 366140|nsc 366140|mesh-list
92508719|NCT00006355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508720|NCT00006358|Thalidomide|thalidomide|mesh-list
92508721|NCT00006358|Temozolomide|temozolomide|mesh-list
92508722|NCT00006358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508723|NCT00006358|Alkylating Agents|alkylating agents|mesh-ancestor
92508724|NCT00006358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508725|NCT00006358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508726|NCT00006358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508727|NCT00006358|Immunologic Factors|immunologic factors|mesh-ancestor
92508728|NCT00006358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508729|NCT00006358|Leprostatic Agents|leprostatic agents|mesh-ancestor
92508730|NCT00006358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92508731|NCT00006358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508732|NCT00006358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92508733|NCT00006358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92508734|NCT00006358|Growth Substances|growth substances|mesh-ancestor
92508735|NCT00006358|Growth Inhibitors|growth inhibitors|mesh-ancestor
92508736|NCT00006361|Semaxinib|semaxinib|mesh-list
92508737|NCT00006361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92508738|NCT00006361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92508739|NCT00006361|Growth Substances|growth substances|mesh-ancestor
92508740|NCT00006361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508741|NCT00006361|Growth Inhibitors|growth inhibitors|mesh-ancestor
92508742|NCT00006361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508743|NCT00006361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92508744|NCT00006361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508745|NCT00006361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508746|NCT00006364|Homoharringtonine|homoharringtonine|mesh-list
92508747|NCT00006364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508748|NCT00006364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508749|NCT00006364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92508750|NCT00006364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508751|NCT00006364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508752|NCT00007917|Gemcitabine|gemcitabine|mesh-list
92508753|NCT00007917|Alvocidib|alvocidib|mesh-list
92508754|NCT00007917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508755|NCT00007917|Antimetabolites|antimetabolites|mesh-ancestor
92533082|NCT00057616|Immunologic Factors|immunologic factors|mesh-ancestor
92508756|NCT00007917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508758|NCT00007917|Growth Inhibitors|growth inhibitors|mesh-ancestor
92508759|NCT00007917|Growth Substances|growth substances|mesh-ancestor
92508760|NCT00007917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508761|NCT00007917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92508762|NCT00007917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508763|NCT00006367|Cytarabine|cytarabine|mesh-list
92508764|NCT00006367|Busulfan|busulfan|mesh-list
92508765|NCT00006367|Idarubicin|idarubicin|mesh-list
92508766|NCT00006367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508767|NCT00006367|Antimetabolites|antimetabolites|mesh-ancestor
92508768|NCT00006367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508769|NCT00006367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508770|NCT00006367|Antiviral Agents|antiviral agents|mesh-ancestor
92508771|NCT00006367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508772|NCT00006367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508773|NCT00006367|Immunologic Factors|immunologic factors|mesh-ancestor
92508774|NCT00006367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508775|NCT00006367|Alkylating Agents|alkylating agents|mesh-ancestor
92508776|NCT00006367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508777|NCT00006367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92508778|NCT00006367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508779|NCT00006367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508780|NCT00006367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508781|NCT00006367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508782|NCT00006370|Edotreotide|edotreotide|mesh-list
92508783|NCT00006370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92508784|NCT00006370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508785|NCT00007956|Antibodies|antibodies|mesh-list
92508786|NCT00007956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92508787|NCT00007956|Immunologic Factors|immunologic factors|mesh-ancestor
92508788|NCT00007956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508789|NCT00006373|Etoposide|etoposide|mesh-list
92508790|NCT00006373|Topotecan|topotecan|mesh-list
92508791|NCT00006373|Ifosfamide|ifosfamide|mesh-list
92508792|NCT00006373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508793|NCT00006373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508794|NCT00006373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508795|NCT00006373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508796|NCT00006373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508797|NCT00006373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508798|NCT00006373|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92508799|NCT00006373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200541|NCT00732901|Escitalopram|escitalopram|mesh-list
92508800|NCT00006373|Alkylating Agents|alkylating agents|mesh-ancestor
92508801|NCT00006376|Tipifarnib|tipifarnib|mesh-list
92508802|NCT00006376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508803|NCT00006379|Cyclophosphamide|cyclophosphamide|mesh-list
92508804|NCT00006379|Fludarabine|fludarabine|mesh-list
92508805|NCT00006379|Fludarabine phosphate|fludarabine phosphate|mesh-list
92508806|NCT00006379|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92508807|NCT00006379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508808|NCT00006379|Immunologic Factors|immunologic factors|mesh-ancestor
92508809|NCT00006379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508810|NCT00006379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508811|NCT00006379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508812|NCT00006379|Alkylating Agents|alkylating agents|mesh-ancestor
92508813|NCT00006379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508814|NCT00006379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508815|NCT00006379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92508816|NCT00006379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508817|NCT00006379|Antimetabolites|antimetabolites|mesh-ancestor
92508818|NCT00006385|Interferons|interferons|mesh-list
92508819|NCT00006385|Interferon-alpha|interferon-alpha|mesh-list
92508820|NCT00006385|Sargramostim|sargramostim|mesh-list
92508821|NCT00006385|Freund's Adjuvant|freund's adjuvant|mesh-list
92508822|NCT00006385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508823|NCT00006385|Antiviral Agents|antiviral agents|mesh-ancestor
92508824|NCT00006385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508825|NCT00006385|Immunologic Factors|immunologic factors|mesh-ancestor
92508826|NCT00006385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508827|NCT00006385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92508828|NCT00007995|Interferons|interferons|mesh-list
92508829|NCT00007995|Interferon-alpha|interferon-alpha|mesh-list
92508830|NCT00007995|Cyclophosphamide|cyclophosphamide|mesh-list
92508831|NCT00007995|Melphalan|melphalan|mesh-list
92508832|NCT00007995|Busulfan|busulfan|mesh-list
92508833|NCT00007995|Sargramostim|sargramostim|mesh-list
92508834|NCT00007995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508835|NCT00007995|Immunologic Factors|immunologic factors|mesh-ancestor
92508836|NCT00007995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508837|NCT00007995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508838|NCT00007995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508839|NCT00007995|Alkylating Agents|alkylating agents|mesh-ancestor
92508840|NCT00007995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508841|NCT00007995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508842|NCT00007995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92508843|NCT00007995|Antiviral Agents|antiviral agents|mesh-ancestor
92508844|NCT00007995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508845|NCT00006388|Tamoxifen|tamoxifen|mesh-list
92508846|NCT00006388|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92508847|NCT00006388|Hormone Antagonists|hormone antagonists|mesh-ancestor
92508848|NCT00006388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508849|NCT00006388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508850|NCT00006388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508851|NCT00006388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508852|NCT00006388|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92508853|NCT00006388|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92508854|NCT00006388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92508855|NCT00008034|Cyclophosphamide|cyclophosphamide|mesh-list
92508856|NCT00008034|Capecitabine|capecitabine|mesh-list
92508857|NCT00008034|Epirubicin|epirubicin|mesh-list
92508858|NCT00008034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508859|NCT00008034|Immunologic Factors|immunologic factors|mesh-ancestor
92508860|NCT00008034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508861|NCT00008034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508862|NCT00008034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508863|NCT00008034|Alkylating Agents|alkylating agents|mesh-ancestor
92508864|NCT00008034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508865|NCT00008034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508866|NCT00008034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92508867|NCT00008034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508868|NCT00008034|Antimetabolites|antimetabolites|mesh-ancestor
92508869|NCT00008034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508870|NCT00008034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508871|NCT00008034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508872|NCT00008034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508873|NCT00006391|Oxaliplatin|oxaliplatin|mesh-list
92508874|NCT00006391|Topotecan|topotecan|mesh-list
92508875|NCT00006391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508876|NCT00006391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92508877|NCT00006391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508878|NCT00006391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508879|NCT00006391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508881|NCT00006394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92508882|NCT00006394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508883|NCT00008073|Doxorubicin|doxorubicin|mesh-list
92508884|NCT00008073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92508885|NCT00008073|Octreotide|octreotide|mesh-list
92508886|NCT00008073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508887|NCT00008073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508888|NCT00008073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508889|NCT00008073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508890|NCT00008073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508891|NCT00008073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508892|NCT00008073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92508893|NCT00008073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92508894|NCT00006397|Ritonavir|ritonavir|mesh-list
92508895|NCT00006397|Indinavir|indinavir|mesh-list
92508896|NCT00006397|Didanosine|didanosine|mesh-list
92508897|NCT00006397|Stavudine|stavudine|mesh-list
92508898|NCT00006397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92508899|NCT00006397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92508900|NCT00006397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92508901|NCT00006397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508902|NCT00006397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508903|NCT00006397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508904|NCT00006397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92508905|NCT00006397|Antiviral Agents|antiviral agents|mesh-ancestor
92508906|NCT00006397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508907|NCT00006397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92508908|NCT00006397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92508909|NCT00006397|Antimetabolites|antimetabolites|mesh-ancestor
92508910|NCT00006397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92508911|NCT00006397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508912|NCT00006412|Fenofibrate|fenofibrate|mesh-list
92508913|NCT00006412|Pravastatin|pravastatin|mesh-list
92508914|NCT00006412|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92508915|NCT00006412|Antimetabolites|antimetabolites|mesh-ancestor
92508916|NCT00006412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508917|NCT00006412|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92508918|NCT00006412|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92508919|NCT00006412|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92508920|NCT00006412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508921|NCT00008112|Cisplatin|cisplatin|mesh-list
92508922|NCT00008112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508923|NCT00006427|Amitriptyline|amitriptyline|mesh-list
92508924|NCT00006427|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92508925|NCT00006427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92508926|NCT00006427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92508927|NCT00006427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92508928|NCT00006427|Analgesics|analgesics|mesh-ancestor
92508929|NCT00006427|Sensory System Agents|sensory system agents|mesh-ancestor
92508930|NCT00006427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508931|NCT00006427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508932|NCT00006427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92508933|NCT00006427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92508934|NCT00006427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92508935|NCT00006427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508936|NCT00006427|Adrenergic Agents|adrenergic agents|mesh-ancestor
92508937|NCT00006427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92508938|NCT00008151|Cyclosporine|cyclosporine|mesh-list
92508939|NCT00008151|Mycophenolic Acid|mycophenolic acid|mesh-list
92508940|NCT00008151|Methotrexate|methotrexate|mesh-list
92508941|NCT00008151|Fludarabine phosphate|fludarabine phosphate|mesh-list
92508942|NCT00008151|Fludarabine|fludarabine|mesh-list
92508943|NCT00008151|Gemtuzumab|gemtuzumab|mesh-list
92508944|NCT00008151|Cyclosporins|cyclosporins|mesh-list
92508945|NCT00008151|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92508946|NCT00008151|Abortifacient Agents|abortifacient agents|mesh-ancestor
92508947|NCT00008151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92508948|NCT00008151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508949|NCT00008151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92508950|NCT00008151|Antimetabolites|antimetabolites|mesh-ancestor
91917895|NCT02166853|Anesthetics|anesthetics|mesh-ancestor
92508951|NCT00008151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508952|NCT00008151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508953|NCT00008151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92508954|NCT00008151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508955|NCT00008151|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92508956|NCT00008151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508957|NCT00008151|Immunologic Factors|immunologic factors|mesh-ancestor
92508958|NCT00008151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508959|NCT00008151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92508960|NCT00008151|Antifungal Agents|antifungal agents|mesh-ancestor
92508961|NCT00008151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92508962|NCT00008151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92350949|NCT04196010|Cytarabine|cytarabine|mesh-list
92508963|NCT00008151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92508964|NCT00008151|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92508965|NCT00008151|Antitubercular Agents|antitubercular agents|mesh-ancestor
92508966|NCT00008151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92508967|NCT00008151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92508968|NCT00008151|Immunotoxins|immunotoxins|mesh-ancestor
92508969|NCT00008151|Immunoconjugates|immunoconjugates|mesh-ancestor
92508970|NCT00006448|Methadone|methadone|mesh-list
92508971|NCT00006448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92508972|NCT00006448|Narcotics|narcotics|mesh-ancestor
92508973|NCT00006448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92508974|NCT00006448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508975|NCT00006448|Analgesics|analgesics|mesh-ancestor
92508976|NCT00006448|Sensory System Agents|sensory system agents|mesh-ancestor
92508977|NCT00006448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92508978|NCT00006448|Antitussive Agents|antitussive agents|mesh-ancestor
92508979|NCT00006448|Respiratory System Agents|respiratory system agents|mesh-ancestor
92508980|NCT00008190|Aldesleukin|aldesleukin|mesh-list
92508981|NCT00008190|Cyclophosphamide|cyclophosphamide|mesh-list
92508982|NCT00008190|Melphalan|melphalan|mesh-list
92508983|NCT00008190|Busulfan|busulfan|mesh-list
92508984|NCT00008190|Etoposide|etoposide|mesh-list
92508985|NCT00008190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92508986|NCT00008190|Immunologic Factors|immunologic factors|mesh-ancestor
92508987|NCT00008190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92508988|NCT00008190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92508989|NCT00008190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92508990|NCT00008190|Alkylating Agents|alkylating agents|mesh-ancestor
92508991|NCT00008190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92508992|NCT00008190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92508993|NCT00008190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92508994|NCT00008190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92508995|NCT00008190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92508996|NCT00008190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92508997|NCT00008190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92508998|NCT00008190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92508999|NCT00008190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92509000|NCT00008190|Antiviral Agents|antiviral agents|mesh-ancestor
92509001|NCT00008190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509002|NCT00006451|Cyclosporine|cyclosporine|mesh-list
92509003|NCT00006451|Methylprednisolone|methylprednisolone|mesh-list
92509004|NCT00006451|Cyclophosphamide|cyclophosphamide|mesh-list
92509005|NCT00006451|Methotrexate|methotrexate|mesh-list
92509006|NCT00006451|Cyclosporins|cyclosporins|mesh-list
92509007|NCT00006451|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92509008|NCT00006451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509009|NCT00006451|Immunologic Factors|immunologic factors|mesh-ancestor
92509010|NCT00006451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509011|NCT00006451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509012|NCT00006451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509013|NCT00006451|Alkylating Agents|alkylating agents|mesh-ancestor
92509014|NCT00006451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509015|NCT00006451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509016|NCT00006451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509017|NCT00006451|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92509018|NCT00006451|Abortifacient Agents|abortifacient agents|mesh-ancestor
92509019|NCT00006451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509020|NCT00006451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509021|NCT00006451|Antimetabolites|antimetabolites|mesh-ancestor
92509022|NCT00006451|Dermatologic Agents|dermatologic agents|mesh-ancestor
92509023|NCT00006451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509024|NCT00006451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92509025|NCT00006451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92509026|NCT00006451|Antifungal Agents|antifungal agents|mesh-ancestor
92509027|NCT00006451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509028|NCT00006451|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92509029|NCT00006451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509030|NCT00006451|Antiemetics|antiemetics|mesh-ancestor
92509031|NCT00006451|Autonomic Agents|autonomic agents|mesh-ancestor
92509032|NCT00006451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509033|NCT00006451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509034|NCT00006451|Glucocorticoids|glucocorticoids|mesh-ancestor
92509035|NCT00006451|Hormones|hormones|mesh-ancestor
92509036|NCT00006451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509037|NCT00006451|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92509038|NCT00006451|Protective Agents|protective agents|mesh-ancestor
92509039|NCT00006454|Paclitaxel|paclitaxel|mesh-list
92509040|NCT00006454|Carboplatin|carboplatin|mesh-list
92509041|NCT00006454|Topotecan|topotecan|mesh-list
92509042|NCT00006454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509043|NCT00006454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509044|NCT00006454|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509045|NCT00006454|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509046|NCT00006454|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509047|NCT00006454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509048|NCT00006454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92509049|NCT00006454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92509050|NCT00006454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509051|NCT00008229|Melphalan|melphalan|mesh-list
92509052|NCT00008229|Immunologic Factors|immunologic factors|mesh-ancestor
92509053|NCT00008229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509054|NCT00008229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509055|NCT00008229|Alkylating Agents|alkylating agents|mesh-ancestor
92509056|NCT00008229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509057|NCT00008229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509058|NCT00008229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509059|NCT00008229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509061|NCT00006457|Antiviral Agents|antiviral agents|mesh-ancestor
92509062|NCT00006457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509063|NCT00006457|Schistosomicides|schistosomicides|mesh-ancestor
92509064|NCT00006457|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92509065|NCT00006457|Anthelmintics|anthelmintics|mesh-ancestor
92509066|NCT00006457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92509067|NCT00006457|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92509068|NCT00006457|Protective Agents|protective agents|mesh-ancestor
92509069|NCT00006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509070|NCT00006457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509071|NCT00006457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92509072|NCT00006457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92509073|NCT00006457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750750|NCT05936606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92509074|NCT00006457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509075|NCT00008268|Melphalan|melphalan|mesh-list
92509076|NCT00008268|Immunologic Factors|immunologic factors|mesh-ancestor
92509077|NCT00008268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509078|NCT00008268|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509079|NCT00008268|Alkylating Agents|alkylating agents|mesh-ancestor
92509080|NCT00008268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509081|NCT00008268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509082|NCT00008268|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509083|NCT00008268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509084|NCT00006463|Trabectedin|trabectedin|mesh-list
92509085|NCT00006463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509086|NCT00006463|Alkylating Agents|alkylating agents|mesh-ancestor
92509087|NCT00006463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509088|NCT00006463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509089|NCT00008307|Cyclosporine|cyclosporine|mesh-list
92509090|NCT00008307|Mycophenolic Acid|mycophenolic acid|mesh-list
92509091|NCT00008307|Methylprednisolone|methylprednisolone|mesh-list
92509092|NCT00008307|Fludarabine|fludarabine|mesh-list
92509093|NCT00008307|Fludarabine phosphate|fludarabine phosphate|mesh-list
92509094|NCT00008307|Melphalan|melphalan|mesh-list
92509095|NCT00008307|Cyclosporins|cyclosporins|mesh-list
92509096|NCT00008307|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92509097|NCT00008307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509098|NCT00008307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509099|NCT00008307|Antimetabolites|antimetabolites|mesh-ancestor
92509100|NCT00008307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509101|NCT00008307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509102|NCT00008307|Immunologic Factors|immunologic factors|mesh-ancestor
92509103|NCT00008307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509104|NCT00008307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509105|NCT00008307|Antifungal Agents|antifungal agents|mesh-ancestor
92509106|NCT00008307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509107|NCT00008307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92509108|NCT00008307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509109|NCT00008307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92509110|NCT00008307|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92509111|NCT00008307|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92509112|NCT00008307|Antitubercular Agents|antitubercular agents|mesh-ancestor
92509113|NCT00008307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92509114|NCT00008307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509115|NCT00008307|Antiemetics|antiemetics|mesh-ancestor
92509116|NCT00008307|Autonomic Agents|autonomic agents|mesh-ancestor
92509117|NCT00008307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509118|NCT00008307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509119|NCT00008307|Glucocorticoids|glucocorticoids|mesh-ancestor
92509120|NCT00008307|Hormones|hormones|mesh-ancestor
92509121|NCT00008307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509122|NCT00008307|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92509123|NCT00008307|Protective Agents|protective agents|mesh-ancestor
92509124|NCT00008307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509125|NCT00008307|Alkylating Agents|alkylating agents|mesh-ancestor
92509126|NCT00008307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509127|NCT00006469|Paclitaxel|paclitaxel|mesh-list
92509128|NCT00006469|Carboplatin|carboplatin|mesh-list
92509129|NCT00006469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509130|NCT00006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509131|NCT00006469|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509132|NCT00006469|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509133|NCT00006469|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509134|NCT00006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509136|NCT00006472|Carboplatin|carboplatin|mesh-list
92351006|NCT04194684|Paclitaxel|paclitaxel|mesh-list
92509137|NCT00006472|Fluorouracil|fluorouracil|mesh-list
92509138|NCT00006472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509139|NCT00006472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509140|NCT00006472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509141|NCT00006472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509142|NCT00006472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509143|NCT00006472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509144|NCT00006472|Antimetabolites|antimetabolites|mesh-ancestor
92509145|NCT00006472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509146|NCT00006472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509147|NCT00006472|Immunologic Factors|immunologic factors|mesh-ancestor
92509148|NCT00006472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509149|NCT00006475|Imatinib Mesylate|imatinib mesylate|mesh-list
92509150|NCT00006475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234083|NCT00003994|Carboplatin|carboplatin|mesh-list
92509151|NCT00006475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92509152|NCT00006475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509153|NCT00006475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509154|NCT00008424|Irinotecan|irinotecan|mesh-list
92509155|NCT00008424|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92509156|NCT00008424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92509157|NCT00008424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509158|NCT00008424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509159|NCT00008424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509160|NCT00006484|Paclitaxel|paclitaxel|mesh-list
92509161|NCT00006484|Carboplatin|carboplatin|mesh-list
92509162|NCT00006484|Tirapazamine|tirapazamine|mesh-list
92509163|NCT00006484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509164|NCT00006484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509165|NCT00006484|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509166|NCT00006484|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509167|NCT00006484|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509168|NCT00006484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509169|NCT00006487|Etoposide|etoposide|mesh-list
92509170|NCT00006487|Tirapazamine|tirapazamine|mesh-list
92509171|NCT00006487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509172|NCT00006487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509173|NCT00006487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92509174|NCT00006487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92509175|NCT00006487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918125|NCT04425590|Antimetabolites|antimetabolites|mesh-ancestor
92509176|NCT00006487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509178|NCT00006493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92509179|NCT00006493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509180|NCT00008463|Interferons|interferons|mesh-list
92509181|NCT00008463|Ribavirin|ribavirin|mesh-list
92509182|NCT00008463|Interferon-alpha|interferon-alpha|mesh-list
92509183|NCT00008463|Interferon alpha-2|interferon alpha-2|mesh-list
92509184|NCT00008463|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92509185|NCT00008463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509186|NCT00008463|Antiviral Agents|antiviral agents|mesh-ancestor
92509187|NCT00008463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509188|NCT00008463|Antimetabolites|antimetabolites|mesh-ancestor
92509189|NCT00008463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509190|NCT00008463|Immunologic Factors|immunologic factors|mesh-ancestor
92509191|NCT00008463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509192|NCT00006508|Insulin|insulin|mesh-list
92509193|NCT00006508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92509194|NCT00006508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509195|NCT00006682|Docetaxel|docetaxel|mesh-list
92509196|NCT00006682|Vinorelbine|vinorelbine|mesh-list
92509197|NCT00006682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509198|NCT00006682|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509199|NCT00006682|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509200|NCT00006682|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351018|NCT04194294|Sensory System Agents|sensory system agents|mesh-ancestor
92509201|NCT00006682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509202|NCT00006682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509203|NCT00008697|Arsenic Trioxide|arsenic trioxide|mesh-list
92509204|NCT00008697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509205|NCT00006760|Vinorelbine|vinorelbine|mesh-list
92509206|NCT00006760|Ifosfamide|ifosfamide|mesh-list
92509207|NCT00006760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509208|NCT00006760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509209|NCT00006760|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509210|NCT00006760|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509211|NCT00006760|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509212|NCT00006760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509213|NCT00006760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509214|NCT00006760|Alkylating Agents|alkylating agents|mesh-ancestor
92509215|NCT00008736|Metoclopramide|metoclopramide|mesh-list
92509216|NCT00008736|Antiemetics|antiemetics|mesh-ancestor
92509217|NCT00008736|Autonomic Agents|autonomic agents|mesh-ancestor
92509218|NCT00008736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509219|NCT00008736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509220|NCT00008736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509221|NCT00008736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92509222|NCT00008736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92509223|NCT00008736|Dopamine Agents|dopamine agents|mesh-ancestor
92509224|NCT00008736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509225|NCT00008736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509226|NCT00006799|Megestrol|megestrol|mesh-list
92509227|NCT00006799|Megestrol Acetate|megestrol acetate|mesh-list
92509228|NCT00006799|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92509229|NCT00006799|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92509230|NCT00006799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92509231|NCT00006799|Contraceptive Agents|contraceptive agents|mesh-ancestor
92509232|NCT00006799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509233|NCT00006799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509234|NCT00006799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92509235|NCT00006799|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92509236|NCT00006799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509237|NCT00006799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509238|NCT00006799|Appetite Stimulants|appetite stimulants|mesh-ancestor
92509239|NCT00006799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92509240|NCT00006877|Temozolomide|temozolomide|mesh-list
92509241|NCT00006877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509242|NCT00006877|Alkylating Agents|alkylating agents|mesh-ancestor
92509243|NCT00006877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509244|NCT00006877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509245|NCT00007033|Magnesium Sulfate|magnesium sulfate|mesh-list
92509246|NCT00007033|Analgesics|analgesics|mesh-ancestor
92509247|NCT00007033|Sensory System Agents|sensory system agents|mesh-ancestor
92509248|NCT00007033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509249|NCT00007033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509250|NCT00007033|Anesthetics|anesthetics|mesh-ancestor
92509251|NCT00007033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509252|NCT00007033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509254|NCT00007033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92509255|NCT00007033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509256|NCT00007033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509257|NCT00007033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509258|NCT00007033|Tocolytic Agents|tocolytic agents|mesh-ancestor
92509259|NCT00007033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509260|NCT00388401|Alvimopan|alvimopan|mesh-list
92509261|NCT00388401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509262|NCT00007189|Celecoxib|celecoxib|mesh-list
92509263|NCT00007189|Naproxen|naproxen|mesh-list
92509264|NCT00007189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92509265|NCT00007189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92509266|NCT00007189|Analgesics|analgesics|mesh-ancestor
92509267|NCT00007189|Sensory System Agents|sensory system agents|mesh-ancestor
92509268|NCT00007189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509269|NCT00007189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509270|NCT00007189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509271|NCT00007189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509272|NCT00007189|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92509273|NCT00007189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92509274|NCT00007189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509275|NCT00007189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509276|NCT00007189|Gout Suppressants|gout suppressants|mesh-ancestor
92509277|NCT00388219|Buprenorphine|buprenorphine|mesh-list
92509278|NCT00388219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92509280|NCT00388219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509281|NCT00388219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509282|NCT00388219|Analgesics|analgesics|mesh-ancestor
92509283|NCT00388219|Sensory System Agents|sensory system agents|mesh-ancestor
92509284|NCT00388219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509285|NCT00388219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92509286|NCT00388258|Alvimopan|alvimopan|mesh-list
92509287|NCT00388258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509288|NCT00388336|Epoetin Alfa|epoetin alfa|mesh-list
92509289|NCT00388336|Hematinics|hematinics|mesh-ancestor
92509290|NCT00007306|Hormones|hormones|mesh-list
92509291|NCT00007306|Parathyroid Hormone|parathyroid hormone|mesh-list
92509292|NCT00007306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509293|NCT00007306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509294|NCT00007306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509295|NCT00007423|polysaccharide-K|polysaccharide-k|mesh-list
92509296|NCT00007423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92509297|NCT00007423|Immunologic Factors|immunologic factors|mesh-ancestor
92509298|NCT00007423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509299|NCT00007423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234239|NCT00093782|Sirolimus|sirolimus|mesh-list
92509300|NCT00007423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509301|NCT00007423|Antiviral Agents|antiviral agents|mesh-ancestor
92509302|NCT00007423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509303|NCT00007423|Interferon Inducers|interferon inducers|mesh-ancestor
92509304|NCT00007423|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92509305|NCT00007423|Protective Agents|protective agents|mesh-ancestor
92509306|NCT00007735|Doxycycline|doxycycline|mesh-list
92509307|NCT00007735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92509308|NCT00007735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509309|NCT00007735|Antimalarials|antimalarials|mesh-ancestor
92509310|NCT00007735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92509311|NCT00007735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92509312|NCT00007774|Haloperidol|haloperidol|mesh-list
92509313|NCT00007774|Olanzapine|olanzapine|mesh-list
92509314|NCT00007774|Haloperidol decanoate|haloperidol decanoate|mesh-list
92509315|NCT00007774|Antiemetics|antiemetics|mesh-ancestor
92509316|NCT00007774|Autonomic Agents|autonomic agents|mesh-ancestor
92509317|NCT00007774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509318|NCT00007774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509319|NCT00007774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509320|NCT00007774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92509321|NCT00007774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92509322|NCT00007774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509323|NCT00007774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92509324|NCT00007774|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92509325|NCT00007774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92509326|NCT00007774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509327|NCT00007774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509328|NCT00007774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509329|NCT00007774|Serotonin Agents|serotonin agents|mesh-ancestor
92509330|NCT00007774|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92509331|NCT00007774|Dopamine Agents|dopamine agents|mesh-ancestor
92509332|NCT00007774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92509333|NCT00007813|Cyclophosphamide|cyclophosphamide|mesh-list
92509334|NCT00007813|Carboplatin|carboplatin|mesh-list
92509336|NCT00007813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509337|NCT00007813|Immunologic Factors|immunologic factors|mesh-ancestor
92509338|NCT00007813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509339|NCT00007813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509340|NCT00007813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509341|NCT00007813|Alkylating Agents|alkylating agents|mesh-ancestor
92509342|NCT00007813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509343|NCT00007813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509344|NCT00007813|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509345|NCT00007813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509346|NCT00007813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92509347|NCT00007813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92509348|NCT00007813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509349|NCT00007852|Cytarabine|cytarabine|mesh-list
92509350|NCT00007852|Rituximab|rituximab|mesh-list
92509351|NCT00007852|Etoposide|etoposide|mesh-list
92509352|NCT00007852|Melphalan|melphalan|mesh-list
92509353|NCT00007852|Carmustine|carmustine|mesh-list
92509354|NCT00007852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92509355|NCT00007852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509356|NCT00007852|Immunologic Factors|immunologic factors|mesh-ancestor
92509357|NCT00007852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509358|NCT00007852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509359|NCT00007852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509360|NCT00007852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92509361|NCT00007852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92509362|NCT00007852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509363|NCT00007852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509364|NCT00007852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509365|NCT00007852|Antimetabolites|antimetabolites|mesh-ancestor
92509366|NCT00007852|Antiviral Agents|antiviral agents|mesh-ancestor
92509367|NCT00007852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509368|NCT00007852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509369|NCT00007852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509370|NCT00007852|Alkylating Agents|alkylating agents|mesh-ancestor
92509371|NCT00007852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509372|NCT00007891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92509373|NCT00007891|Antibodies|antibodies|mesh-list
92509374|NCT00007891|Immunoglobulins|immunoglobulins|mesh-list
92509375|NCT00007891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234318|NCT00003346|Carmustine|carmustine|mesh-list
92509376|NCT00007891|Immunologic Factors|immunologic factors|mesh-ancestor
92509377|NCT00007891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509378|NCT00007891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509379|NCT00007969|Verteporfin|verteporfin|mesh-list
92509380|NCT00007969|Detox adjuvant|detox adjuvant|mesh-list
92509381|NCT00007969|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92509382|NCT00007969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92509383|NCT00007969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92509384|NCT00007969|Immunologic Factors|immunologic factors|mesh-ancestor
92509385|NCT00007969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509386|NCT00008008|Cyclophosphamide|cyclophosphamide|mesh-list
92509387|NCT00008008|Thiotepa|thiotepa|mesh-list
92509388|NCT00008008|Sargramostim|sargramostim|mesh-list
92509389|NCT00008008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509390|NCT00008008|Immunologic Factors|immunologic factors|mesh-ancestor
92509391|NCT00008008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509392|NCT00008008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509393|NCT00008008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509394|NCT00008008|Alkylating Agents|alkylating agents|mesh-ancestor
92509395|NCT00008008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509396|NCT00008008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509397|NCT00008008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509398|NCT00008047|Paclitaxel|paclitaxel|mesh-list
92509400|NCT00008047|Hydroxyurea|hydroxyurea|mesh-list
92509401|NCT00008047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509402|NCT00008047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509403|NCT00008047|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509404|NCT00008047|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509405|NCT00008047|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509406|NCT00008047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509407|NCT00008047|Antimetabolites|antimetabolites|mesh-ancestor
92509408|NCT00008047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509409|NCT00008047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509410|NCT00008047|Immunologic Factors|immunologic factors|mesh-ancestor
92509411|NCT00008047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509412|NCT00008047|Antisickling Agents|antisickling agents|mesh-ancestor
92509413|NCT00008047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509414|NCT00008047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92509415|NCT00008086|Calcitriol|calcitriol|mesh-list
92509416|NCT00008086|Carboplatin|carboplatin|mesh-list
92509417|NCT00008086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509418|NCT00008086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509419|NCT00008086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509420|NCT00008086|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92509421|NCT00008086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509422|NCT00008086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509423|NCT00008086|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92509424|NCT00008086|Vitamins|vitamins|mesh-ancestor
92509425|NCT00008086|Micronutrients|micronutrients|mesh-ancestor
92509426|NCT00008086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92509427|NCT00008125|Carboplatin|carboplatin|mesh-list
92509428|NCT00008125|Gemcitabine|gemcitabine|mesh-list
92509429|NCT00008125|Docetaxel|docetaxel|mesh-list
92509430|NCT00008125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509431|NCT00008125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509432|NCT00008125|Antimetabolites|antimetabolites|mesh-ancestor
92509433|NCT00008125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509434|NCT00008125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509435|NCT00008125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509436|NCT00008125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509437|NCT00008203|Interferons|interferons|mesh-list
92509438|NCT00008203|Aldesleukin|aldesleukin|mesh-list
92509439|NCT00008203|Interferon-gamma|interferon-gamma|mesh-list
92509440|NCT00008203|Cyclosporine|cyclosporine|mesh-list
92509441|NCT00008203|Cyclophosphamide|cyclophosphamide|mesh-list
92509442|NCT00008203|Thiotepa|thiotepa|mesh-list
92509443|NCT00008203|Carboplatin|carboplatin|mesh-list
92509444|NCT00008203|Cyclosporins|cyclosporins|mesh-list
92509445|NCT00008203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509446|NCT00008203|Immunologic Factors|immunologic factors|mesh-ancestor
92509447|NCT00008203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509448|NCT00008203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509449|NCT00008203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92509450|NCT00008203|Alkylating Agents|alkylating agents|mesh-ancestor
92509451|NCT00008203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509452|NCT00008203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509453|NCT00008203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92509454|NCT00008203|Antiviral Agents|antiviral agents|mesh-ancestor
92509455|NCT00008203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509456|NCT00008203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509457|NCT00008203|Antifungal Agents|antifungal agents|mesh-ancestor
92509458|NCT00008203|Dermatologic Agents|dermatologic agents|mesh-ancestor
92509459|NCT00008203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92509460|NCT00008203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92509461|NCT00008203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92509462|NCT00008242|Thalidomide|thalidomide|mesh-list
92509463|NCT00008242|Dexamethasone|dexamethasone|mesh-list
92509464|NCT00008242|Doxorubicin|doxorubicin|mesh-list
92509465|NCT00008242|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92509466|NCT00008242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509467|NCT00008242|Antiemetics|antiemetics|mesh-ancestor
92509468|NCT00008242|Autonomic Agents|autonomic agents|mesh-ancestor
92509469|NCT00008242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509470|NCT00008242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509471|NCT00008242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509472|NCT00008242|Glucocorticoids|glucocorticoids|mesh-ancestor
92509473|NCT00008242|Hormones|hormones|mesh-ancestor
92509474|NCT00008242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509475|NCT00008242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509476|NCT00008242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509477|NCT00008242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92509478|NCT00008242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92509479|NCT00008242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92509480|NCT00008242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509481|NCT00008242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509482|NCT00008242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509483|NCT00008242|Immunologic Factors|immunologic factors|mesh-ancestor
92509484|NCT00008242|Leprostatic Agents|leprostatic agents|mesh-ancestor
92509485|NCT00008242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92509486|NCT00008242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509487|NCT00008242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92509488|NCT00008242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92509489|NCT00008242|Growth Substances|growth substances|mesh-ancestor
92509490|NCT00008242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92509491|NCT00008281|Leucovorin|leucovorin|mesh-list
92509492|NCT00008281|Fluorouracil|fluorouracil|mesh-list
92509493|NCT00008281|Oxaliplatin|oxaliplatin|mesh-list
92509494|NCT00008281|Calcium|calcium|mesh-list
92509495|NCT00008281|Levoleucovorin|levoleucovorin|mesh-list
92509496|NCT00008281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509497|NCT00008281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509498|NCT00008281|Antimetabolites|antimetabolites|mesh-ancestor
92509499|NCT00008281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509500|NCT00008281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509501|NCT00008281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509502|NCT00008281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92509503|NCT00008281|Immunologic Factors|immunologic factors|mesh-ancestor
92509504|NCT00008281|Antidotes|antidotes|mesh-ancestor
92509505|NCT00008281|Protective Agents|protective agents|mesh-ancestor
92509506|NCT00008281|Vitamin B Complex|vitamin b complex|mesh-ancestor
92509507|NCT00008281|Vitamins|vitamins|mesh-ancestor
92509508|NCT00008281|Micronutrients|micronutrients|mesh-ancestor
92509509|NCT00008359|Amphotericin B|amphotericin b|mesh-list
92509510|NCT00008359|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92509511|NCT00008359|Caspofungin|caspofungin|mesh-list
92509512|NCT00008359|Amebicides|amebicides|mesh-ancestor
92509513|NCT00008359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92509514|NCT00008359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92509515|NCT00008359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509516|NCT00008359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92509517|NCT00008359|Antifungal Agents|antifungal agents|mesh-ancestor
92509518|NCT00008359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509519|NCT00008359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509520|NCT00008398|Sargramostim|sargramostim|mesh-list
92509521|NCT00008398|Immunologic Factors|immunologic factors|mesh-ancestor
92509522|NCT00008398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509523|NCT00008476|Capsaicin|capsaicin|mesh-list
92509524|NCT00008476|Antipruritics|antipruritics|mesh-ancestor
92509525|NCT00008476|Dermatologic Agents|dermatologic agents|mesh-ancestor
92509526|NCT00008476|Sensory System Agents|sensory system agents|mesh-ancestor
92509527|NCT00008476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509528|NCT00008476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509529|NCT00008515|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92509530|NCT00008515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509532|NCT00008515|Hormones|hormones|mesh-ancestor
92509533|NCT00008515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509534|NCT00008515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509535|NCT00008554|Lamivudine|lamivudine|mesh-list
92509536|NCT00008554|Abacavir|abacavir|mesh-list
92509537|NCT00008554|Nelfinavir|nelfinavir|mesh-list
92509538|NCT00008554|Fosamprenavir|fosamprenavir|mesh-list
92509539|NCT00008554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92509540|NCT00008554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92509541|NCT00008554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509542|NCT00008554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509543|NCT00008554|Antiviral Agents|antiviral agents|mesh-ancestor
92509544|NCT00008554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509545|NCT00008554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92509546|NCT00008554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92509547|NCT00008554|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92509548|NCT00008554|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92509549|NCT00008554|Protease Inhibitors|protease inhibitors|mesh-ancestor
92509550|NCT05636566|Dexmedetomidine|dexmedetomidine|mesh-list
92509551|NCT05636566|Propofol|propofol|mesh-list
92509552|NCT05636566|Sevoflurane|sevoflurane|mesh-list
92509553|NCT05636566|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92509554|NCT05636566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509555|NCT05636566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509556|NCT05636566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92509557|NCT05636566|Analgesics|analgesics|mesh-ancestor
92509558|NCT05636566|Sensory System Agents|sensory system agents|mesh-ancestor
92509559|NCT05636566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509560|NCT05636566|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92509561|NCT05636566|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92509562|NCT05636566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92509563|NCT05636566|Adrenergic Agents|adrenergic agents|mesh-ancestor
92509564|NCT05636566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509565|NCT05636566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509566|NCT05636566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92509567|NCT05636566|Anesthetics, General|anesthetics, general|mesh-ancestor
92509568|NCT05636566|Anesthetics|anesthetics|mesh-ancestor
92509569|NCT05636566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92509570|NCT05636566|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92509571|NCT05637034|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92509572|NCT05637034|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92509573|NCT05637034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509574|NCT05637073|Dienogest|dienogest|mesh-list
92509575|NCT05637073|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92509576|NCT05637073|Contraceptive Agents|contraceptive agents|mesh-ancestor
92509577|NCT05637073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509578|NCT05637073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509579|NCT05637073|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92509580|NCT05637073|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92509581|NCT05637073|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92509582|NCT05637073|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92509583|NCT05637073|Hormone Antagonists|hormone antagonists|mesh-ancestor
92509584|NCT05637073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509585|NCT05637073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509586|NCT05637073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509587|NCT05637268|Paclitaxel|paclitaxel|mesh-list
92509588|NCT05637268|Cisplatin|cisplatin|mesh-list
92509589|NCT05637268|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92509590|NCT05637268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509591|NCT05637268|Tubulin Modulators|tubulin modulators|mesh-ancestor
92509592|NCT05637268|Antimitotic Agents|antimitotic agents|mesh-ancestor
92509593|NCT05637268|Mitosis Modulators|mitosis modulators|mesh-ancestor
92509594|NCT05637268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509595|NCT05637216|Losartan|losartan|mesh-list
92509596|NCT05637216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509597|NCT05637216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92509598|NCT05637216|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92509599|NCT05637216|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92509600|NCT05637216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509601|NCT05638087|Dexamethasone|dexamethasone|mesh-list
92509602|NCT05638087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509603|NCT05638087|Antiemetics|antiemetics|mesh-ancestor
92509604|NCT05638087|Autonomic Agents|autonomic agents|mesh-ancestor
92509605|NCT05638087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509606|NCT05638087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509608|NCT05638087|Glucocorticoids|glucocorticoids|mesh-ancestor
92509609|NCT05638087|Hormones|hormones|mesh-ancestor
92509610|NCT05638087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509611|NCT05638087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509612|NCT05638087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509613|NCT05638633|Vitamins|vitamins|mesh-list
92509614|NCT05638633|Vitamin B Complex|vitamin b complex|mesh-list
92509615|NCT05638633|Prednisolone|prednisolone|mesh-list
92509616|NCT05638633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92509617|NCT05638633|Methylprednisolone|methylprednisolone|mesh-list
92509618|NCT05638633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92509619|NCT05638633|Prednisolone acetate|prednisolone acetate|mesh-list
92509620|NCT05638633|Corticosterone|corticosterone|mesh-list
92509621|NCT05638633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92509622|NCT05638633|Prednisolone phosphate|prednisolone phosphate|mesh-list
92509623|NCT05638633|Micronutrients|micronutrients|mesh-ancestor
92509624|NCT05638633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509625|NCT05638633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509626|NCT05638633|Glucocorticoids|glucocorticoids|mesh-ancestor
92509627|NCT05638633|Hormones|hormones|mesh-ancestor
92509628|NCT05638633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509629|NCT05638633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509630|NCT05638633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509631|NCT05638633|Antiemetics|antiemetics|mesh-ancestor
92509632|NCT05638633|Autonomic Agents|autonomic agents|mesh-ancestor
92509633|NCT05638633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509634|NCT05638633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509635|NCT05638633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92509636|NCT05638633|Protective Agents|protective agents|mesh-ancestor
92509637|NCT05638984|Decitabine|decitabine|mesh-list
92509638|NCT05638984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92509639|NCT05638984|Antimetabolites|antimetabolites|mesh-ancestor
92509640|NCT05638984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509641|NCT05638984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509642|NCT05638984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509643|NCT05639218|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92509644|NCT05639218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92509645|NCT05639218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92509646|NCT05639218|Antimetabolites|antimetabolites|mesh-ancestor
92509647|NCT05639218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509648|NCT05639218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92509649|NCT05639218|Protease Inhibitors|protease inhibitors|mesh-ancestor
92509650|NCT05639218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509651|NCT05639218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92509652|NCT05639257|Mexiletine|mexiletine|mesh-list
92509653|NCT05639257|Lamotrigine|lamotrigine|mesh-list
92509654|NCT05639257|Anticonvulsants|anticonvulsants|mesh-ancestor
92509655|NCT05639257|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92509656|NCT05639257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509657|NCT05639257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509658|NCT05639257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509659|NCT05639257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509660|NCT05639257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92509661|NCT05639257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92509662|NCT05639257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509663|NCT05639257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92509664|NCT05639257|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92509665|NCT05639257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509666|NCT05639257|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92509667|NCT00000115|Acetazolamide|acetazolamide|mesh-list
92509668|NCT00000115|Anticonvulsants|anticonvulsants|mesh-ancestor
92509669|NCT00000115|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92509670|NCT00000115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509671|NCT00000115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509672|NCT00000115|Diuretics|diuretics|mesh-ancestor
92509673|NCT00000115|Natriuretic Agents|natriuretic agents|mesh-ancestor
92509674|NCT00000115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509675|NCT00000136|Ganciclovir|ganciclovir|mesh-list
92509676|NCT00000136|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92509677|NCT00000136|Foscarnet|foscarnet|mesh-list
92509678|NCT00000136|Antiviral Agents|antiviral agents|mesh-ancestor
92509679|NCT00000136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509680|NCT00000136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92509681|NCT00000136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509682|NCT00000136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509683|NCT00000136|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92509684|NCT00000139|Acyclovir|acyclovir|mesh-list
92509685|NCT00000139|Antiviral Agents|antiviral agents|mesh-ancestor
92509686|NCT00000139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509687|NCT00388687|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92509688|NCT00388687|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92509689|NCT00388687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509690|NCT00000142|Cidofovir|cidofovir|mesh-list
92509691|NCT00000142|Antiviral Agents|antiviral agents|mesh-ancestor
92509692|NCT00000142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92509693|NCT00000142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509694|NCT00000142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509696|NCT00000145|Antioxidants|antioxidants|mesh-list
92509697|NCT00000145|Trace Elements|trace elements|mesh-ancestor
92509698|NCT00000145|Micronutrients|micronutrients|mesh-ancestor
92509699|NCT00000145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509700|NCT00000145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509701|NCT00000145|Protective Agents|protective agents|mesh-ancestor
92509702|NCT00000151|Aspirin|aspirin|mesh-list
91918655|NCT02171299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509703|NCT00000151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92509704|NCT00000151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92509705|NCT00000151|Analgesics|analgesics|mesh-ancestor
92509706|NCT00000151|Sensory System Agents|sensory system agents|mesh-ancestor
92509707|NCT00000151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509708|NCT00000151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509709|NCT00000151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509710|NCT00000151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509711|NCT00000151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92509712|NCT00000151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92509713|NCT00000151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509714|NCT00000151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92509715|NCT00000151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92509716|NCT00000151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509717|NCT00000151|Antipyretics|antipyretics|mesh-ancestor
92509718|NCT00000157|Aspirin|aspirin|mesh-list
92509719|NCT00000157|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92509720|NCT00000157|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92509721|NCT00000157|Analgesics|analgesics|mesh-ancestor
92509722|NCT00000157|Sensory System Agents|sensory system agents|mesh-ancestor
92509723|NCT00000157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509724|NCT00000157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509725|NCT00000157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509726|NCT00000157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92509727|NCT00000157|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92509728|NCT00000157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92509729|NCT00000157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509730|NCT00000157|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92509731|NCT00000157|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92509732|NCT00000157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509733|NCT00000157|Antipyretics|antipyretics|mesh-ancestor
92509734|NCT00000172|Galantamine|galantamine|mesh-list
92509735|NCT00000172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92509736|NCT00000172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509737|NCT00000172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509738|NCT00000172|Cholinergic Agents|cholinergic agents|mesh-ancestor
92509739|NCT00000172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509740|NCT00000172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509741|NCT00000172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92509742|NCT00000172|Autonomic Agents|autonomic agents|mesh-ancestor
92509743|NCT00000172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509744|NCT00000172|Nootropic Agents|nootropic agents|mesh-ancestor
92509745|NCT00000175|Testosterone|testosterone|mesh-list
92509746|NCT00000175|Estrogens|estrogens|mesh-list
92509747|NCT00000175|Androgens|androgens|mesh-ancestor
92509748|NCT00000175|Hormones|hormones|mesh-ancestor
92509749|NCT00000175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509750|NCT00000175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509751|NCT00000187|Ritanserin|ritanserin|mesh-list
92509752|NCT00000187|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92509753|NCT00000187|Serotonin Agents|serotonin agents|mesh-ancestor
92234684|NCT00003862|Vitamins|vitamins|mesh-ancestor
92509754|NCT00000187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509755|NCT00000187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509756|NCT00000187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509757|NCT00000187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92509758|NCT00000187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92509759|NCT00000187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509760|NCT00000187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92509761|NCT00000187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92509762|NCT00000187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92509763|NCT00000187|Antidepressive Agents|antidepressive agents|mesh-ancestor
92509764|NCT00000205|Buprenorphine|buprenorphine|mesh-list
92509765|NCT00000205|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92509766|NCT00000205|Narcotics|narcotics|mesh-ancestor
92509767|NCT00000205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509768|NCT00000205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509769|NCT00000205|Analgesics|analgesics|mesh-ancestor
91918730|NCT04728230|Durvalumab|durvalumab|mesh-list
92509770|NCT00000205|Sensory System Agents|sensory system agents|mesh-ancestor
92509771|NCT00000205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509772|NCT00000205|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92509773|NCT00000214|Buprenorphine|buprenorphine|mesh-list
92509774|NCT00000214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92509775|NCT00000214|Narcotics|narcotics|mesh-ancestor
92509776|NCT00000214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509777|NCT00000214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509778|NCT00000214|Analgesics|analgesics|mesh-ancestor
92509779|NCT00000214|Sensory System Agents|sensory system agents|mesh-ancestor
92509780|NCT00000214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509781|NCT00000214|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92509782|NCT00000220|Buprenorphine|buprenorphine|mesh-list
92509783|NCT00000220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92509784|NCT00000220|Narcotics|narcotics|mesh-ancestor
92509785|NCT00000220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509786|NCT00000220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509787|NCT00000220|Analgesics|analgesics|mesh-ancestor
92509788|NCT00000220|Sensory System Agents|sensory system agents|mesh-ancestor
92509789|NCT00000220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509790|NCT00000220|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92509791|NCT00000256|Nitrous Oxide|nitrous oxide|mesh-list
92509792|NCT00000256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92509793|NCT00000256|Anesthetics, General|anesthetics, general|mesh-ancestor
92509794|NCT00000256|Anesthetics|anesthetics|mesh-ancestor
92533100|NCT00057928|Paclitaxel|paclitaxel|mesh-list
92509796|NCT00000256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509797|NCT00000256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92509798|NCT00000256|Analgesics|analgesics|mesh-ancestor
92509799|NCT00000256|Sensory System Agents|sensory system agents|mesh-ancestor
92509800|NCT00000256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509801|NCT03582085|BCG Vaccine|bcg vaccine|mesh-list
92509802|NCT03582085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92509803|NCT03582085|Immunologic Factors|immunologic factors|mesh-ancestor
92509804|NCT03582085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509805|NCT00000421|Prednisone|prednisone|mesh-list
92509806|NCT00000421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92509807|NCT00000421|Glucocorticoids|glucocorticoids|mesh-ancestor
92509808|NCT00000421|Hormones|hormones|mesh-ancestor
92509809|NCT00000421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509810|NCT00000421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509811|NCT00000421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509812|NCT00000421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509813|NCT00000427|Alendronate|alendronate|mesh-list
92509814|NCT00000427|Hormones|hormones|mesh-list
92509815|NCT00000427|Parathyroid Hormone|parathyroid hormone|mesh-list
92509816|NCT00000427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509817|NCT00000427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509818|NCT00000427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92509819|NCT00000427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509820|NCT00000457|Bupropion|bupropion|mesh-list
92509821|NCT00000457|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92509822|NCT00000457|Antidepressive Agents|antidepressive agents|mesh-ancestor
92509823|NCT00000457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92509824|NCT00000457|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92509825|NCT00000457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92509826|NCT00000457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509827|NCT00000457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509828|NCT00000457|Dopamine Agents|dopamine agents|mesh-ancestor
92509829|NCT00000457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509830|NCT00000457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509831|NCT00000457|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92509832|NCT00000457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92509833|NCT00000457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509834|NCT00388479|Alvimopan|alvimopan|mesh-list
92509835|NCT00388479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92509836|NCT00000463|Warfarin|warfarin|mesh-list
92509837|NCT00000463|Lovastatin|lovastatin|mesh-list
92509838|NCT00000463|L 647318|l 647318|mesh-list
92509839|NCT00000463|Dihydromevinolin|dihydromevinolin|mesh-list
92509840|NCT00000463|Cholestyramine Resin|cholestyramine resin|mesh-list
92509841|NCT00000463|Anticoagulants|anticoagulants|mesh-ancestor
92509842|NCT00000463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92509843|NCT00000463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92509844|NCT00000463|Antimetabolites|antimetabolites|mesh-ancestor
92509845|NCT00000463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509846|NCT00000463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92509847|NCT00000463|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92509848|NCT00000463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92509849|NCT00000466|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92509850|NCT00000466|Medroxyprogesterone|medroxyprogesterone|mesh-list
92509851|NCT00000466|Progesterone|progesterone|mesh-list
92509852|NCT00000466|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92509853|NCT00000466|Estrogens|estrogens|mesh-list
92509854|NCT00000466|Progestins|progestins|mesh-ancestor
92509855|NCT00000466|Hormones|hormones|mesh-ancestor
92509856|NCT00000466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92509857|NCT00000466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509858|NCT00000466|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92509859|NCT00000466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92509860|NCT00000466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92509861|NCT00000466|Contraceptive Agents|contraceptive agents|mesh-ancestor
92509862|NCT00000466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509863|NCT00000466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92509864|NCT00000466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92509865|NCT00000466|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92509866|NCT00000466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92509867|NCT00000466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92509868|NCT00000472|Heparin|heparin|mesh-list
92509869|NCT00000472|Plasminogen|plasminogen|mesh-list
92509870|NCT00000472|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92509871|NCT00000472|Anticoagulants|anticoagulants|mesh-ancestor
92509872|NCT00000472|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92509873|NCT00000472|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92509874|NCT00000472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509875|NCT00000478|Atenolol|atenolol|mesh-list
92509876|NCT00000478|Diltiazem|diltiazem|mesh-list
92509877|NCT00000478|Nifedipine|nifedipine|mesh-list
92509878|NCT00000478|Isosorbide|isosorbide|mesh-list
92509879|NCT00000478|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92509880|NCT00000478|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92509881|NCT00000478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92509882|NCT00000478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509883|NCT00000478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509884|NCT00000478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92509885|NCT00000478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509886|NCT00000478|Vasodilator Agents|vasodilator agents|mesh-ancestor
92509887|NCT00000478|Tocolytic Agents|tocolytic agents|mesh-ancestor
92509888|NCT00000478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509889|NCT00000478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509890|NCT00000478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92509891|NCT00000478|Sympatholytics|sympatholytics|mesh-ancestor
92509892|NCT00000478|Autonomic Agents|autonomic agents|mesh-ancestor
92509893|NCT00000478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509894|NCT00000478|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92509895|NCT00000478|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92509896|NCT00000478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92509897|NCT00000478|Adrenergic Agents|adrenergic agents|mesh-ancestor
92509898|NCT00000478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509899|NCT00000478|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92509900|NCT00000478|Diuretics|diuretics|mesh-ancestor
92509901|NCT00000478|Natriuretic Agents|natriuretic agents|mesh-ancestor
92509902|NCT00000478|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92509903|NCT00388882|Bromides|bromides|mesh-list
92509904|NCT00388882|Albuterol|albuterol|mesh-list
92509905|NCT00388882|Tiotropium Bromide|tiotropium bromide|mesh-list
92509906|NCT00388882|Ipratropium|ipratropium|mesh-list
92509907|NCT00388882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92509908|NCT00388882|Autonomic Agents|autonomic agents|mesh-ancestor
92509909|NCT00388882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509910|NCT00388882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509911|NCT00388882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92509912|NCT00388882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92509913|NCT00388882|Parasympatholytics|parasympatholytics|mesh-ancestor
92509914|NCT00388882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92509915|NCT00388882|Cholinergic Agents|cholinergic agents|mesh-ancestor
92509916|NCT00388882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509917|NCT00388882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509918|NCT00388882|Anticonvulsants|anticonvulsants|mesh-ancestor
92509919|NCT00388882|Tocolytic Agents|tocolytic agents|mesh-ancestor
92509920|NCT00388882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92509921|NCT00388882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92509922|NCT00388882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92509923|NCT00388882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92509924|NCT00388882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92509926|NCT00388999|Agglutinins|agglutinins|mesh-ancestor
92509927|NCT00388999|Immunologic Factors|immunologic factors|mesh-ancestor
92509928|NCT00388999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509929|NCT00388999|Coagulants|coagulants|mesh-ancestor
92509930|NCT00000487|Antihypertensive Agents|antihypertensive agents|mesh-list
92509931|NCT00000487|Diuretics|diuretics|mesh-list
92509932|NCT00000487|Natriuretic Agents|natriuretic agents|mesh-ancestor
92509933|NCT00000487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509934|NCT00000493|Propranolol|propranolol|mesh-list
92509935|NCT00000493|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92509936|NCT00000493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92509937|NCT00000493|Adrenergic Agents|adrenergic agents|mesh-ancestor
92509938|NCT00000493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509939|NCT00000493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509940|NCT00000493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509941|NCT00000493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509942|NCT00000493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92509943|NCT00000493|Vasodilator Agents|vasodilator agents|mesh-ancestor
92509944|NCT00000499|Metoprolol|metoprolol|mesh-list
92509945|NCT00000499|Chlorthalidone|chlorthalidone|mesh-list
92509946|NCT00000499|Hydralazine|hydralazine|mesh-list
92509947|NCT00000499|Reserpine|reserpine|mesh-list
92509948|NCT00000499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509949|NCT00000499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92509950|NCT00000499|Sympatholytics|sympatholytics|mesh-ancestor
92509951|NCT00000499|Autonomic Agents|autonomic agents|mesh-ancestor
92509952|NCT00000499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509953|NCT00000499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509954|NCT00000499|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92509955|NCT00000499|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92509956|NCT00000499|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92509957|NCT00000499|Adrenergic Agents|adrenergic agents|mesh-ancestor
92509958|NCT00000499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509959|NCT00000499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509960|NCT00000499|Diuretics|diuretics|mesh-ancestor
92509961|NCT00000499|Natriuretic Agents|natriuretic agents|mesh-ancestor
92509962|NCT00000499|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92509963|NCT00000499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509964|NCT00000499|Vasodilator Agents|vasodilator agents|mesh-ancestor
92509965|NCT00000499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92509966|NCT00000499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92509967|NCT00000499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509968|NCT00000499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92509969|NCT00000499|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92509970|NCT00000499|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92509971|NCT00000514|Atenolol|atenolol|mesh-list
92509972|NCT00000514|Chlorthalidone|chlorthalidone|mesh-list
92509973|NCT00000514|Reserpine|reserpine|mesh-list
92509974|NCT00000514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92509975|NCT00000514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92509976|NCT00000514|Sympatholytics|sympatholytics|mesh-ancestor
92509977|NCT00000514|Autonomic Agents|autonomic agents|mesh-ancestor
92509978|NCT00000514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92509979|NCT00000514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92509980|NCT00000514|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92509981|NCT00000514|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92509982|NCT00000514|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92509983|NCT00000514|Adrenergic Agents|adrenergic agents|mesh-ancestor
92509984|NCT00000514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92509985|NCT00000514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509986|NCT00000514|Diuretics|diuretics|mesh-ancestor
92509987|NCT00000514|Natriuretic Agents|natriuretic agents|mesh-ancestor
92509988|NCT00000514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92509989|NCT00000514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92509990|NCT00000514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92509991|NCT00000514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92509992|NCT00000514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92509993|NCT00000514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92509994|NCT00000514|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92509995|NCT00000514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92509996|NCT05638425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92509997|NCT05638425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92509998|NCT05638425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92509999|NCT05638425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510000|NCT00000517|Warfarin|warfarin|mesh-list
92510001|NCT00000517|Anticoagulants|anticoagulants|mesh-ancestor
92510002|NCT00000520|Aspirin|aspirin|mesh-list
92510003|NCT00000520|Immunoglobulins|immunoglobulins|mesh-list
92510004|NCT00000520|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92510005|NCT00000520|Antibodies|antibodies|mesh-list
92510006|NCT00000520|gamma-Globulins|gamma-globulins|mesh-list
92510007|NCT00000520|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92510008|NCT00000520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92510009|NCT00000520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92510010|NCT00000520|Analgesics|analgesics|mesh-ancestor
92510011|NCT00000520|Sensory System Agents|sensory system agents|mesh-ancestor
92510012|NCT00000520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510013|NCT00000520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510014|NCT00000520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92510015|NCT00000520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92510016|NCT00000520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92510017|NCT00000520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92510018|NCT00000520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510019|NCT00000520|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92510020|NCT00000520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92510021|NCT00000520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510022|NCT00000520|Antipyretics|antipyretics|mesh-ancestor
92510023|NCT00000520|Immunologic Factors|immunologic factors|mesh-ancestor
92510024|NCT00000526|Flecainide|flecainide|mesh-list
92510025|NCT00000526|Moricizine|moricizine|mesh-list
92510026|NCT00000526|Encainide|encainide|mesh-list
92510027|NCT00000526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92510028|NCT00000526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92510029|NCT00000526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92510030|NCT00000526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92510031|NCT00000526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510032|NCT00000529|Tamoxifen|tamoxifen|mesh-list
92510033|NCT00000529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92510034|NCT00000529|Hormone Antagonists|hormone antagonists|mesh-ancestor
92510035|NCT00000529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92510036|NCT00000529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510037|NCT00000529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92510038|NCT00000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510039|NCT00000529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92510040|NCT00000529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92510041|NCT00000529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92510042|NCT00000553|Niacin|niacin|mesh-list
92510043|NCT00000553|Simvastatin|simvastatin|mesh-list
92510044|NCT00000553|Antioxidants|antioxidants|mesh-list
92510045|NCT00000553|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92510046|NCT00000553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92510047|NCT00000553|Antimetabolites|antimetabolites|mesh-ancestor
92510048|NCT00000553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510049|NCT00000553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92510050|NCT00000553|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92510051|NCT00000553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510052|NCT00000553|Vasodilator Agents|vasodilator agents|mesh-ancestor
92510053|NCT00000553|Vitamin B Complex|vitamin b complex|mesh-ancestor
92510054|NCT00000553|Vitamins|vitamins|mesh-ancestor
92510055|NCT00000553|Micronutrients|micronutrients|mesh-ancestor
92510056|NCT00000553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510057|NCT00000553|Protective Agents|protective agents|mesh-ancestor
92510058|NCT00000556|Quinidine|quinidine|mesh-list
92510059|NCT00000556|Digoxin|digoxin|mesh-list
92510060|NCT00000556|Amiodarone|amiodarone|mesh-list
92510061|NCT00000556|Verapamil|verapamil|mesh-list
92510062|NCT00000556|Sotalol|sotalol|mesh-list
92510063|NCT00000556|Flecainide|flecainide|mesh-list
92510064|NCT00000556|Propafenone|propafenone|mesh-list
92510065|NCT00000556|Procainamide|procainamide|mesh-list
92510066|NCT00000556|Moricizine|moricizine|mesh-list
92510067|NCT00000556|Disopyramide|disopyramide|mesh-list
92510068|NCT00000556|Diltiazem|diltiazem|mesh-list
92510069|NCT00000556|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92510070|NCT00000556|Adrenergic Agents|adrenergic agents|mesh-list
92510071|NCT00000556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92510073|NCT00000556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510074|NCT00000556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510075|NCT00000556|Protective Agents|protective agents|mesh-ancestor
92510076|NCT00000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510077|NCT00000556|Vasodilator Agents|vasodilator agents|mesh-ancestor
92510078|NCT00000556|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92510079|NCT00000556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92510080|NCT00000556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92510081|NCT00000556|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92510082|NCT00000556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510083|NCT00000556|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92510084|NCT00000556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92510085|NCT00000556|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510086|NCT00000556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92510087|NCT00000556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92510088|NCT00000556|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92510089|NCT00000556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92510090|NCT00000556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92510092|NCT00000556|Autonomic Agents|autonomic agents|mesh-ancestor
92510093|NCT00000556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510094|NCT00000556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92510095|NCT00000556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92510096|NCT00000556|Antimalarials|antimalarials|mesh-ancestor
92510097|NCT00000556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510098|NCT00000556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510099|NCT00000556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510100|NCT00000556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92510101|NCT00000556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92510102|NCT00000556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92510103|NCT00000559|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92510104|NCT00000559|Medroxyprogesterone|medroxyprogesterone|mesh-list
92510105|NCT00000559|Hormones|hormones|mesh-list
92510106|NCT00000559|Estradiol|estradiol|mesh-list
92510107|NCT00000559|Estrogens|estrogens|mesh-list
92510108|NCT00000559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92510109|NCT00000559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510110|NCT00000559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92510111|NCT00000559|Contraceptive Agents|contraceptive agents|mesh-ancestor
92510112|NCT00000559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92510113|NCT00000559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92510114|NCT00000559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92510115|NCT00000559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92510116|NCT00000559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92510117|NCT00000559|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92510118|NCT00000559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92510119|NCT00000559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510120|NCT00000568|Ipratropium|ipratropium|mesh-list
92510121|NCT00000568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92510122|NCT00000568|Autonomic Agents|autonomic agents|mesh-ancestor
92510123|NCT00000568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510124|NCT00000568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510125|NCT00000568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92510126|NCT00000568|Respiratory System Agents|respiratory system agents|mesh-ancestor
92510127|NCT00000568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92510128|NCT00000568|Cholinergic Agents|cholinergic agents|mesh-ancestor
92510129|NCT00000568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92510130|NCT00000568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510131|NCT00000586|Hydroxyurea|hydroxyurea|mesh-list
92510132|NCT00000586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510133|NCT00000586|Antisickling Agents|antisickling agents|mesh-ancestor
92510134|NCT00000586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510135|NCT00000586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510136|NCT00000586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510137|NCT00000595|Deferoxamine|deferoxamine|mesh-list
92510138|NCT00000595|Siderophores|siderophores|mesh-ancestor
92510139|NCT00000595|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92510140|NCT00000595|Chelating Agents|chelating agents|mesh-ancestor
92510141|NCT00000595|Sequestering Agents|sequestering agents|mesh-ancestor
92200548|NCT00732901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510142|NCT00000595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510144|NCT00000601|Progesterone|progesterone|mesh-list
92510145|NCT00000601|Estrogens|estrogens|mesh-list
92510146|NCT00000601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92510147|NCT00000601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510148|NCT00000601|Progestins|progestins|mesh-ancestor
92510149|NCT00000625|Zidovudine|zidovudine|mesh-list
92510150|NCT00000625|Didanosine|didanosine|mesh-list
92510151|NCT00000625|Zalcitabine|zalcitabine|mesh-list
92510152|NCT00000625|Antimetabolites|antimetabolites|mesh-ancestor
92510153|NCT00000625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510154|NCT00000625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510155|NCT00000625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510156|NCT00000625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510157|NCT00000625|Antiviral Agents|antiviral agents|mesh-ancestor
92510158|NCT00000625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510159|NCT00000625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510160|NCT00000625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510161|NCT00000637|Zidovudine|zidovudine|mesh-list
92510162|NCT00000637|Didanosine|didanosine|mesh-list
92510163|NCT00000637|Antimetabolites|antimetabolites|mesh-ancestor
92510164|NCT00000637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510165|NCT00000637|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510166|NCT00000637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510167|NCT00000637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510168|NCT00000637|Antiviral Agents|antiviral agents|mesh-ancestor
92510169|NCT00000637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510170|NCT00000637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510171|NCT00000637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510172|NCT00000640|Clindamycin|clindamycin|mesh-list
92510173|NCT00000640|Clindamycin palmitate|clindamycin palmitate|mesh-list
92510174|NCT00000640|Clindamycin phosphate|clindamycin phosphate|mesh-list
92510175|NCT00000640|Dapsone|dapsone|mesh-list
92510176|NCT00000640|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92510177|NCT00000640|Primaquine|primaquine|mesh-list
92510178|NCT00000640|Trimethoprim|trimethoprim|mesh-list
92510179|NCT00000640|Sulfamethoxazole|sulfamethoxazole|mesh-list
92510180|NCT00000640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510181|NCT00000640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510182|NCT00000640|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92510183|NCT00000640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510184|NCT00000640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510185|NCT00000640|Antimalarials|antimalarials|mesh-ancestor
92510186|NCT00000640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510187|NCT00000640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510188|NCT00000640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92510189|NCT00000640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510190|NCT00000640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92510191|NCT00000640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92510192|NCT00000640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510193|NCT00000640|Leprostatic Agents|leprostatic agents|mesh-ancestor
92510194|NCT00000646|Pentoxifylline|pentoxifylline|mesh-list
92510195|NCT00000646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92510196|NCT00000646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510197|NCT00000646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510198|NCT00000646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92510199|NCT00000646|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92510200|NCT00000646|Protective Agents|protective agents|mesh-ancestor
92510201|NCT00000646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510202|NCT00000646|Vasodilator Agents|vasodilator agents|mesh-ancestor
92510203|NCT00000646|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92510204|NCT00000646|Antioxidants|antioxidants|mesh-ancestor
92510205|NCT00389038|Amitriptyline|amitriptyline|mesh-list
92510206|NCT00389038|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92510207|NCT00389038|Antidepressive Agents|antidepressive agents|mesh-ancestor
92510208|NCT00389038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92510209|NCT00389038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92510210|NCT00389038|Analgesics|analgesics|mesh-ancestor
92510211|NCT00389038|Sensory System Agents|sensory system agents|mesh-ancestor
92510212|NCT00389038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510213|NCT00389038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510214|NCT00389038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92510215|NCT00389038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92510216|NCT00389038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92510217|NCT00389038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510218|NCT00389038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92510219|NCT00389038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92510220|NCT00000652|Zidovudine|zidovudine|mesh-list
92510221|NCT00000652|Didanosine|didanosine|mesh-list
92510222|NCT00000652|Antimetabolites|antimetabolites|mesh-ancestor
92510223|NCT00000652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510224|NCT00000652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510225|NCT00000652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510226|NCT00000652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510227|NCT00000652|Antiviral Agents|antiviral agents|mesh-ancestor
92510228|NCT00000652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510229|NCT00000652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510230|NCT00000652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510231|NCT00000676|Fluconazole|fluconazole|mesh-list
92510232|NCT00000676|Clotrimazole|clotrimazole|mesh-list
92510233|NCT00000676|Miconazole|miconazole|mesh-list
92510234|NCT00000676|Antifungal Agents|antifungal agents|mesh-ancestor
92510235|NCT00000676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510236|NCT00000676|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92510237|NCT00000676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510238|NCT00000676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510239|NCT00000676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510240|NCT00000676|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92510241|NCT00000676|Hormone Antagonists|hormone antagonists|mesh-ancestor
92510242|NCT00000676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92510243|NCT00000676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510244|NCT00000676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92510245|NCT00000676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92510246|NCT00000676|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92510247|NCT00000676|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510248|NCT00000679|Zidovudine|zidovudine|mesh-list
92510249|NCT00000679|Zalcitabine|zalcitabine|mesh-list
92510250|NCT00000679|Antimetabolites|antimetabolites|mesh-ancestor
92510251|NCT00000679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510252|NCT00000679|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510253|NCT00000679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510254|NCT00000679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510255|NCT00000679|Antiviral Agents|antiviral agents|mesh-ancestor
92510256|NCT00000679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510257|NCT00000679|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510258|NCT00000679|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510259|NCT00000682|Zidovudine|zidovudine|mesh-list
92510260|NCT00000682|Zalcitabine|zalcitabine|mesh-list
92510261|NCT00000682|Antimetabolites|antimetabolites|mesh-ancestor
92510262|NCT00000682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510263|NCT00000682|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92351103|NCT03023358|Vincristine|vincristine|mesh-list
92510264|NCT00000682|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510265|NCT00000682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510266|NCT00000682|Antiviral Agents|antiviral agents|mesh-ancestor
92510267|NCT00000682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510268|NCT00000682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510269|NCT00000682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510270|NCT00000688|Ganciclovir|ganciclovir|mesh-list
92510271|NCT00000688|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92510272|NCT00000688|Antiviral Agents|antiviral agents|mesh-ancestor
92510273|NCT00000688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510274|NCT00000688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510275|NCT00000688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510276|NCT00000688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510277|NCT00000712|Zidovudine|zidovudine|mesh-list
92510278|NCT00000712|Acyclovir|acyclovir|mesh-list
92510279|NCT00000712|Antimetabolites|antimetabolites|mesh-ancestor
92510280|NCT00000712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510281|NCT00000712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510282|NCT00000712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510284|NCT00000712|Antiviral Agents|antiviral agents|mesh-ancestor
92510285|NCT00000712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510286|NCT00000712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510287|NCT00000712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510288|NCT00000715|Trimethoprim|trimethoprim|mesh-list
92510289|NCT00000715|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92510290|NCT00000715|Sulfamethoxazole|sulfamethoxazole|mesh-list
92510291|NCT00000715|Pentamidine|pentamidine|mesh-list
92510292|NCT00000715|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92510293|NCT00000715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510294|NCT00000715|Antimalarials|antimalarials|mesh-ancestor
92510295|NCT00000715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510296|NCT00000715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510297|NCT00000715|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510298|NCT00000715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510299|NCT00000715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510300|NCT00000715|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92510301|NCT00000715|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92510302|NCT00000715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510303|NCT00000715|Antifungal Agents|antifungal agents|mesh-ancestor
92510304|NCT00000715|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92510305|NCT00000715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510306|NCT00000718|Zidovudine|zidovudine|mesh-list
92510307|NCT00000718|Zalcitabine|zalcitabine|mesh-list
92510308|NCT00000718|Antimetabolites|antimetabolites|mesh-ancestor
92510309|NCT00000718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510310|NCT00000718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510311|NCT00000718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510312|NCT00000718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510313|NCT00000718|Antiviral Agents|antiviral agents|mesh-ancestor
92510314|NCT00000718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510315|NCT00000718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510316|NCT00000718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510317|NCT00000739|Dapsone|dapsone|mesh-list
92510318|NCT00000739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510319|NCT00000739|Antimalarials|antimalarials|mesh-ancestor
92510320|NCT00000739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510321|NCT00000739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510322|NCT00000739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510323|NCT00000739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510324|NCT00000739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510325|NCT00000739|Leprostatic Agents|leprostatic agents|mesh-ancestor
92510326|NCT00000739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510327|NCT00000742|Zidovudine|zidovudine|mesh-list
92510328|NCT00000742|Didanosine|didanosine|mesh-list
92510329|NCT00000742|Atevirdine|atevirdine|mesh-list
92510330|NCT00000742|Antimetabolites|antimetabolites|mesh-ancestor
92510331|NCT00000742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510332|NCT00000742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510333|NCT00000742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510334|NCT00000742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510335|NCT00000742|Antiviral Agents|antiviral agents|mesh-ancestor
92510336|NCT00000742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510337|NCT00000742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510338|NCT00000742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510339|NCT00000745|Vaccines|vaccines|mesh-list
92510340|NCT00000745|Immunologic Factors|immunologic factors|mesh-ancestor
92510341|NCT00000745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510342|NCT00000748|Trimethoprim|trimethoprim|mesh-list
92510343|NCT00000748|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92510344|NCT00000748|Sulfamethoxazole|sulfamethoxazole|mesh-list
92510345|NCT00000748|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92510346|NCT00000748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510347|NCT00000748|Antimalarials|antimalarials|mesh-ancestor
92510348|NCT00000748|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510349|NCT00000748|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510350|NCT00000748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510351|NCT00000748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510352|NCT00000748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510353|NCT00000748|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92510354|NCT00000748|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92235288|NCT05144854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92510355|NCT00000748|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510356|NCT00000748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510357|NCT00000751|Zidovudine|zidovudine|mesh-list
92510358|NCT00000751|Immune Sera|immune sera|mesh-list
92510359|NCT00000751|Immunoglobulins|immunoglobulins|mesh-list
92510360|NCT00000751|Antibodies|antibodies|mesh-list
92510361|NCT00000751|Antimetabolites|antimetabolites|mesh-ancestor
92510362|NCT00000751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510363|NCT00000751|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510364|NCT00000751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510365|NCT00000751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510366|NCT00000751|Antiviral Agents|antiviral agents|mesh-ancestor
92510367|NCT00000751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510368|NCT00000751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510369|NCT00000751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510370|NCT00000751|Immunologic Factors|immunologic factors|mesh-ancestor
92510371|NCT00000751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510372|NCT00000754|Interferons|interferons|mesh-list
92510373|NCT00000754|Interferon-alpha|interferon-alpha|mesh-list
92510374|NCT00000754|Interferon alpha-2|interferon alpha-2|mesh-list
92510375|NCT00000754|Zidovudine|zidovudine|mesh-list
92510376|NCT00000754|Zalcitabine|zalcitabine|mesh-list
92510377|NCT00000754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510378|NCT00000754|Antiviral Agents|antiviral agents|mesh-ancestor
92510379|NCT00000754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510380|NCT00000754|Immunologic Factors|immunologic factors|mesh-ancestor
92510381|NCT00000754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510382|NCT00000754|Antimetabolites|antimetabolites|mesh-ancestor
92510383|NCT00000754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510384|NCT00000754|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510385|NCT00000754|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510386|NCT00000754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510387|NCT00000754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510388|NCT00000754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510389|NCT00000760|Zidovudine|zidovudine|mesh-list
92510390|NCT00000760|Didanosine|didanosine|mesh-list
92510391|NCT00000760|Antimetabolites|antimetabolites|mesh-ancestor
92510392|NCT00000760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510393|NCT00000760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510394|NCT00000760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510395|NCT00000760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510396|NCT00000760|Antiviral Agents|antiviral agents|mesh-ancestor
92510397|NCT00000760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510398|NCT00000760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510399|NCT00000760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510400|NCT00000790|Thalidomide|thalidomide|mesh-list
92510401|NCT00000790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92510402|NCT00000790|Immunologic Factors|immunologic factors|mesh-ancestor
92510403|NCT00000790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510404|NCT00000790|Leprostatic Agents|leprostatic agents|mesh-ancestor
92510405|NCT00000790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510406|NCT00000790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510407|NCT00000790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92510408|NCT00000790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92510409|NCT00000790|Growth Substances|growth substances|mesh-ancestor
92510410|NCT00000790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92510411|NCT00000790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510412|NCT00000793|Mexiletine|mexiletine|mesh-list
92510413|NCT00000793|Amitriptyline|amitriptyline|mesh-list
92510414|NCT00000793|Benztropine|benztropine|mesh-list
92510415|NCT00000793|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92510416|NCT00000793|Antidepressive Agents|antidepressive agents|mesh-ancestor
92510417|NCT00000793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92510418|NCT00000793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92510419|NCT00000793|Analgesics|analgesics|mesh-ancestor
92510420|NCT00000793|Sensory System Agents|sensory system agents|mesh-ancestor
92510421|NCT00000793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510422|NCT00000793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510423|NCT00000793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92510424|NCT00000793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92510425|NCT00000793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92510426|NCT00000793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510427|NCT00000793|Adrenergic Agents|adrenergic agents|mesh-ancestor
92510428|NCT00000793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92510429|NCT00000793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92510430|NCT00000793|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92510431|NCT00000793|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92510432|NCT00000793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92510433|NCT00000793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92510434|NCT00000793|Parasympatholytics|parasympatholytics|mesh-ancestor
92510435|NCT00000793|Autonomic Agents|autonomic agents|mesh-ancestor
92510436|NCT00000793|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92510437|NCT00000793|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92510438|NCT00000793|Cholinergic Agents|cholinergic agents|mesh-ancestor
92510439|NCT00000793|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92510440|NCT00000793|Dopamine Agents|dopamine agents|mesh-ancestor
92510441|NCT00000799|Cidofovir|cidofovir|mesh-list
92510442|NCT00000799|Probenecid|probenecid|mesh-list
92510443|NCT00000799|Uricosuric Agents|uricosuric agents|mesh-ancestor
92510444|NCT00000799|Gout Suppressants|gout suppressants|mesh-ancestor
92510445|NCT00000799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92510446|NCT00000799|Antiviral Agents|antiviral agents|mesh-ancestor
92510447|NCT00000799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510448|NCT00000799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510449|NCT00000799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510450|NCT00000817|Amitriptyline|amitriptyline|mesh-list
92510451|NCT00000817|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92510452|NCT00000817|Antidepressive Agents|antidepressive agents|mesh-ancestor
92510453|NCT00000817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92510454|NCT00000817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92510455|NCT00000817|Analgesics|analgesics|mesh-ancestor
92510456|NCT00000817|Sensory System Agents|sensory system agents|mesh-ancestor
92510457|NCT00000817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510458|NCT00000817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510459|NCT00000817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92510460|NCT00000817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92510461|NCT00000817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92510462|NCT00000817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510463|NCT00000817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92510464|NCT00000817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92510465|NCT00000820|Aldesleukin|aldesleukin|mesh-list
92510466|NCT00000820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510467|NCT00000820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510468|NCT00000820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510469|NCT00000820|Antiviral Agents|antiviral agents|mesh-ancestor
92510470|NCT00000820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510471|NCT00000826|Clarithromycin|clarithromycin|mesh-list
92510472|NCT00000826|Dapsone|dapsone|mesh-list
92510473|NCT00000826|Rifabutin|rifabutin|mesh-list
92510474|NCT00000826|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92510475|NCT00000826|Fluconazole|fluconazole|mesh-list
92510476|NCT00000826|Trimethoprim|trimethoprim|mesh-list
92510477|NCT00000826|Sulfamethoxazole|sulfamethoxazole|mesh-list
92510478|NCT00000826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510479|NCT00000826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510480|NCT00000826|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92510481|NCT00000826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510482|NCT00000826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510483|NCT00000826|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510484|NCT00000826|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510485|NCT00000826|Antifungal Agents|antifungal agents|mesh-ancestor
92510486|NCT00000826|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92510487|NCT00000826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92510488|NCT00000826|Hormone Antagonists|hormone antagonists|mesh-ancestor
92510489|NCT00000826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92510490|NCT00000826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510491|NCT00000826|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92510492|NCT00000826|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92510493|NCT00000826|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92510494|NCT00000826|Antimalarials|antimalarials|mesh-ancestor
92510495|NCT00000826|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510496|NCT00000826|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510497|NCT00000826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510498|NCT00000826|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92510499|NCT00000826|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92510500|NCT00000826|Leprostatic Agents|leprostatic agents|mesh-ancestor
92510501|NCT00000826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92510502|NCT00000826|Antitubercular Agents|antitubercular agents|mesh-ancestor
92510503|NCT00000859|Ritonavir|ritonavir|mesh-list
92510504|NCT00000859|Nelfinavir|nelfinavir|mesh-list
92510505|NCT00000859|Indinavir|indinavir|mesh-list
92510506|NCT00000859|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510507|NCT00000859|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510508|NCT00000859|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510509|NCT00000859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510510|NCT00000859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510511|NCT00000859|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510512|NCT00000859|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510513|NCT00000859|Antiviral Agents|antiviral agents|mesh-ancestor
92510514|NCT00000859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510515|NCT00000859|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510516|NCT00000859|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510517|NCT00000877|Indinavir|indinavir|mesh-list
92510518|NCT00000877|Rifabutin|rifabutin|mesh-list
92510519|NCT00000877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510520|NCT00000877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510521|NCT00000877|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510522|NCT00000877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510523|NCT00000877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510524|NCT00000877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510525|NCT00000877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510526|NCT00000877|Antiviral Agents|antiviral agents|mesh-ancestor
92510527|NCT00000877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510528|NCT00000877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510529|NCT00000877|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92510530|NCT00000877|Antitubercular Agents|antitubercular agents|mesh-ancestor
92510531|NCT00000883|Azithromycin|azithromycin|mesh-list
92510532|NCT00000883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510533|NCT00000883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510535|NCT00000892|Nelfinavir|nelfinavir|mesh-list
92510536|NCT00000892|Saquinavir|saquinavir|mesh-list
92510537|NCT00000892|Delavirdine|delavirdine|mesh-list
92510538|NCT00000892|Adefovir|adefovir|mesh-list
92510539|NCT00000892|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92510540|NCT00000892|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510541|NCT00000892|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510542|NCT00000892|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510543|NCT00000892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510544|NCT00000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510545|NCT00000892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510546|NCT00000892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510547|NCT00000892|Antiviral Agents|antiviral agents|mesh-ancestor
92510548|NCT00000892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510549|NCT00000892|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510550|NCT00000892|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510551|NCT00000892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510552|NCT00000892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510553|NCT00000895|Azithromycin|azithromycin|mesh-list
92510554|NCT00000895|Nevirapine|nevirapine|mesh-list
92510555|NCT00000895|Nelfinavir|nelfinavir|mesh-list
92510556|NCT00000895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510557|NCT00000895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510558|NCT00000895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510559|NCT00000895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510560|NCT00000895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510561|NCT00000895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510562|NCT00000895|Antiviral Agents|antiviral agents|mesh-ancestor
92510563|NCT00000895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510564|NCT00000895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510565|NCT00000895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510566|NCT00000895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510567|NCT00000895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510568|NCT00000895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510569|NCT00000895|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510570|NCT00000898|Ritonavir|ritonavir|mesh-list
92510571|NCT00000898|Nelfinavir|nelfinavir|mesh-list
92510572|NCT00000898|Saquinavir|saquinavir|mesh-list
92510573|NCT00000898|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510574|NCT00000898|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510575|NCT00000898|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510576|NCT00000898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510577|NCT00000898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510578|NCT00000898|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510579|NCT00000898|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510580|NCT00000898|Antiviral Agents|antiviral agents|mesh-ancestor
92235520|NCT04140526|Pembrolizumab|pembrolizumab|mesh-list
92510581|NCT00000898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510582|NCT00000898|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510583|NCT00000898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510585|NCT00389233|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92510586|NCT00389233|Antioxidants|antioxidants|mesh-ancestor
92510587|NCT00389233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510588|NCT00389233|Protective Agents|protective agents|mesh-ancestor
92510589|NCT00389233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510590|NCT00389233|Vitamins|vitamins|mesh-ancestor
92510591|NCT00389233|Micronutrients|micronutrients|mesh-ancestor
92510592|NCT00389233|Laxatives|laxatives|mesh-ancestor
92510593|NCT00389233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92510594|NCT00000904|polysaccharide-K|polysaccharide-k|mesh-list
91919553|NCT05033054|Dapagliflozin|dapagliflozin|mesh-list
92510595|NCT00000904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92510596|NCT00000904|Immunologic Factors|immunologic factors|mesh-ancestor
92510597|NCT00000904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510598|NCT00000904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92510599|NCT00000904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510601|NCT00000904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510602|NCT00000904|Interferon Inducers|interferon inducers|mesh-ancestor
92510603|NCT00000904|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92510604|NCT00000904|Protective Agents|protective agents|mesh-ancestor
92510606|NCT00000919|Nelfinavir|nelfinavir|mesh-list
92510607|NCT00000919|Indinavir|indinavir|mesh-list
92510608|NCT00000919|Amprenavir|amprenavir|mesh-list
92510609|NCT00000919|Lamivudine|lamivudine|mesh-list
92510610|NCT00000919|Zidovudine|zidovudine|mesh-list
92510611|NCT00000919|Abacavir|abacavir|mesh-list
92510612|NCT00000919|Didanosine|didanosine|mesh-list
92510613|NCT00000919|Stavudine|stavudine|mesh-list
92510614|NCT00000919|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92510615|NCT00000919|Efavirenz|efavirenz|mesh-list
92510616|NCT00000919|Hydroxyurea|hydroxyurea|mesh-list
92510617|NCT00000919|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510618|NCT00000919|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510619|NCT00000919|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510620|NCT00000919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510621|NCT00000919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510622|NCT00000919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510623|NCT00000919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510624|NCT00000919|Antiviral Agents|antiviral agents|mesh-ancestor
92510625|NCT00000919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510626|NCT00000919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510627|NCT00000919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510628|NCT00000919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510629|NCT00000919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510630|NCT00000919|Antimetabolites|antimetabolites|mesh-ancestor
92510631|NCT00000919|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92510632|NCT00000919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92510633|NCT00000919|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92510634|NCT00000919|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510635|NCT00000919|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510636|NCT00000919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510637|NCT00000919|Antisickling Agents|antisickling agents|mesh-ancestor
92510638|NCT00000919|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92510639|NCT00000919|Antitubercular Agents|antitubercular agents|mesh-ancestor
92510640|NCT00000919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510641|NCT00000922|Lamivudine|lamivudine|mesh-list
92510642|NCT00000922|Efavirenz|efavirenz|mesh-list
92510643|NCT00000922|Nevirapine|nevirapine|mesh-list
92510644|NCT00000922|Abacavir|abacavir|mesh-list
92510645|NCT00000922|Didanosine|didanosine|mesh-list
92510646|NCT00000922|Stavudine|stavudine|mesh-list
92510647|NCT00000922|Nelfinavir|nelfinavir|mesh-list
92510648|NCT00000922|Indinavir|indinavir|mesh-list
92510649|NCT00000922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510650|NCT00000922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510651|NCT00000922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510652|NCT00000922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510653|NCT00000922|Antiviral Agents|antiviral agents|mesh-ancestor
92510654|NCT00000922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510655|NCT00000922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510656|NCT00000922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510657|NCT00000922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92235587|NCT03493490|Analgesics|analgesics|mesh-ancestor
92510658|NCT00000922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510659|NCT00000922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92510660|NCT00000922|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92510661|NCT00000922|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510662|NCT00000922|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510663|NCT00000922|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510664|NCT00000922|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510665|NCT00000922|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510666|NCT00000922|Antimetabolites|antimetabolites|mesh-ancestor
92510667|NCT00000940|Ritonavir|ritonavir|mesh-list
92510668|NCT00000940|Amprenavir|amprenavir|mesh-list
92510669|NCT00000940|Lamivudine|lamivudine|mesh-list
92510670|NCT00000940|Abacavir|abacavir|mesh-list
92510671|NCT00000940|Stavudine|stavudine|mesh-list
91919628|NCT02170831|Dabigatran|dabigatran|mesh-list
92510672|NCT00000940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510673|NCT00000940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510674|NCT00000940|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510675|NCT00000940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510676|NCT00000940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510677|NCT00000940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510678|NCT00000940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510679|NCT00000940|Antiviral Agents|antiviral agents|mesh-ancestor
92510680|NCT00000940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510681|NCT00000940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510682|NCT00000940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510683|NCT00000940|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510684|NCT00000940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510685|NCT00000940|Antimetabolites|antimetabolites|mesh-ancestor
92510686|NCT00000940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92510687|NCT00000940|Antitubercular Agents|antitubercular agents|mesh-ancestor
92510688|NCT00000940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510689|NCT00000943|Vaccines|vaccines|mesh-list
92510690|NCT00000943|Immunologic Factors|immunologic factors|mesh-ancestor
92510691|NCT00000943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510692|NCT00000952|Ritonavir|ritonavir|mesh-list
92510693|NCT00000952|Lamivudine|lamivudine|mesh-list
92510694|NCT00000952|Zidovudine|zidovudine|mesh-list
92510695|NCT00000952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510696|NCT00000952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510697|NCT00000952|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510698|NCT00000952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510699|NCT00000952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510700|NCT00000952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510701|NCT00000952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510702|NCT00000952|Antiviral Agents|antiviral agents|mesh-ancestor
92510703|NCT00000952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510704|NCT00000952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510705|NCT00000952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510706|NCT00000952|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510707|NCT00000952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510708|NCT00000952|Antimetabolites|antimetabolites|mesh-ancestor
92510709|NCT00000643|Leucovorin|leucovorin|mesh-list
92510710|NCT00000643|Pyrimethamine|pyrimethamine|mesh-list
92510711|NCT00000643|Calcium|calcium|mesh-list
92510712|NCT00000643|Levoleucovorin|levoleucovorin|mesh-list
92510713|NCT00000643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92510714|NCT00000643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510715|NCT00000643|Antidotes|antidotes|mesh-ancestor
92510716|NCT00000643|Protective Agents|protective agents|mesh-ancestor
92510717|NCT00000643|Vitamin B Complex|vitamin b complex|mesh-ancestor
92510718|NCT00000643|Vitamins|vitamins|mesh-ancestor
92510719|NCT00000643|Micronutrients|micronutrients|mesh-ancestor
92510720|NCT00000643|Antimalarials|antimalarials|mesh-ancestor
92510721|NCT00000643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510722|NCT00000643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510723|NCT00000643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510724|NCT00000643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510725|NCT00000643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510726|NCT00000643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510727|NCT00000970|Ganciclovir|ganciclovir|mesh-list
92510728|NCT00000970|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92510729|NCT00000970|Foscarnet|foscarnet|mesh-list
92510730|NCT00000970|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92510731|NCT00000970|Antiviral Agents|antiviral agents|mesh-ancestor
92510732|NCT00000970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510733|NCT00000970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510734|NCT00000970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510735|NCT00000970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510736|NCT00000970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510737|NCT00000973|Leucovorin|leucovorin|mesh-list
92510738|NCT00000973|Zidovudine|zidovudine|mesh-list
92510739|NCT00000973|Pyrimethamine|pyrimethamine|mesh-list
92510740|NCT00000973|Calcium|calcium|mesh-list
92510741|NCT00000973|Levoleucovorin|levoleucovorin|mesh-list
92510742|NCT00000973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92510743|NCT00000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510744|NCT00000973|Antidotes|antidotes|mesh-ancestor
92510745|NCT00000973|Protective Agents|protective agents|mesh-ancestor
92510746|NCT00000973|Vitamin B Complex|vitamin b complex|mesh-ancestor
92510747|NCT00000973|Vitamins|vitamins|mesh-ancestor
92510748|NCT00000973|Micronutrients|micronutrients|mesh-ancestor
92510749|NCT00000973|Antimetabolites|antimetabolites|mesh-ancestor
92510750|NCT00000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510751|NCT00000973|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510752|NCT00000973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510753|NCT00000973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510754|NCT00000973|Antiviral Agents|antiviral agents|mesh-ancestor
92510755|NCT00000973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510756|NCT00000973|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510757|NCT00000973|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510758|NCT00000973|Antimalarials|antimalarials|mesh-ancestor
92510759|NCT00000973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510760|NCT00000973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510761|NCT00000973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92510762|NCT00000985|Acyclovir|acyclovir|mesh-list
92510763|NCT00000985|Foscarnet|foscarnet|mesh-list
92510764|NCT00000985|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92510765|NCT00000985|Vidarabine|vidarabine|mesh-list
92510766|NCT00000985|Antiviral Agents|antiviral agents|mesh-ancestor
92510767|NCT00000985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510768|NCT00000985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510769|NCT00000985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510770|NCT00000985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510771|NCT00000985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510772|NCT00000985|Antimetabolites|antimetabolites|mesh-ancestor
92510773|NCT00001000|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92510774|NCT00001000|Antiviral Agents|antiviral agents|mesh-ancestor
92510775|NCT00001000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510776|NCT00001003|Zidovudine|zidovudine|mesh-list
92510777|NCT00001003|Pentamidine|pentamidine|mesh-list
92510778|NCT00001003|Antimetabolites|antimetabolites|mesh-ancestor
92510779|NCT00001003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510780|NCT00001003|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510781|NCT00001003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510782|NCT00001003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510783|NCT00001003|Antiviral Agents|antiviral agents|mesh-ancestor
92510784|NCT00001003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510785|NCT00001003|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510786|NCT00001003|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510787|NCT00001003|Antifungal Agents|antifungal agents|mesh-ancestor
92510788|NCT00001003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92510789|NCT00001003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92510790|NCT00001003|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92510791|NCT00001030|Clarithromycin|clarithromycin|mesh-list
92510792|NCT00001030|Rifabutin|rifabutin|mesh-list
92510793|NCT00001030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510794|NCT00001030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510795|NCT00001030|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92510796|NCT00001030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510797|NCT00001030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510798|NCT00001030|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510799|NCT00001030|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510800|NCT00001030|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92510801|NCT00001030|Antitubercular Agents|antitubercular agents|mesh-ancestor
92510802|NCT05639127|Prednisolone|prednisolone|mesh-list
92510803|NCT05639127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92510804|NCT05639127|Glucocorticoids|glucocorticoids|mesh-ancestor
92510805|NCT05639127|Hormones|hormones|mesh-ancestor
92510806|NCT05639127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92510807|NCT05639127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510808|NCT05639127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92510809|NCT05639127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510810|NCT00001033|Pyridoxine|pyridoxine|mesh-list
92510811|NCT00001033|Vitamin B 6|vitamin b 6|mesh-list
92510812|NCT00001033|Levofloxacin|levofloxacin|mesh-list
92510813|NCT00001033|Rifampin|rifampin|mesh-list
92510814|NCT00001033|Isoniazid|isoniazid|mesh-list
92510815|NCT00001033|Pyrazinamide|pyrazinamide|mesh-list
92510816|NCT00001033|Ethambutol|ethambutol|mesh-list
92510817|NCT00001033|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92510818|NCT00001033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510819|NCT00001033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92510820|NCT00001033|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92510821|NCT00001033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92510822|NCT00001033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510823|NCT00001033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510824|NCT00001033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510825|NCT00001033|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92510826|NCT00001033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510827|NCT00001033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92510828|NCT00001033|Antitubercular Agents|antitubercular agents|mesh-ancestor
92510829|NCT00001033|Leprostatic Agents|leprostatic agents|mesh-ancestor
92510830|NCT00001033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510831|NCT00001033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92510832|NCT00001033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510833|NCT00001033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92510834|NCT00001033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92510835|NCT00001033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92510836|NCT00001033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510837|NCT00001033|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92510838|NCT00001033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92510839|NCT00001033|Antimetabolites|antimetabolites|mesh-ancestor
92510840|NCT00001033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92510841|NCT00001033|Vitamin B Complex|vitamin b complex|mesh-ancestor
92510842|NCT00001033|Vitamins|vitamins|mesh-ancestor
92510843|NCT00001033|Micronutrients|micronutrients|mesh-ancestor
92510844|NCT00001033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510845|NCT00001036|Zidovudine|zidovudine|mesh-list
92510846|NCT00001036|Interleukin-2|interleukin-2|mesh-list
92510847|NCT00001036|Thymalfasin|thymalfasin|mesh-list
92510848|NCT00001036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510849|NCT00001036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92510850|NCT00001036|Analgesics|analgesics|mesh-ancestor
92510851|NCT00001036|Sensory System Agents|sensory system agents|mesh-ancestor
92510852|NCT00001036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92510853|NCT00001036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510854|NCT00001036|Antimetabolites|antimetabolites|mesh-ancestor
92510855|NCT00001036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510856|NCT00001036|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510857|NCT00001036|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510858|NCT00001036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510859|NCT00001036|Antiviral Agents|antiviral agents|mesh-ancestor
92510860|NCT00001036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510861|NCT00001036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510862|NCT00001036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510863|NCT00001036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92510864|NCT00001036|Immunologic Factors|immunologic factors|mesh-ancestor
92510865|NCT00001045|Zidovudine|zidovudine|mesh-list
92510866|NCT00001045|Nevirapine|nevirapine|mesh-list
92510867|NCT00001045|Didanosine|didanosine|mesh-list
92510868|NCT00001045|Antimetabolites|antimetabolites|mesh-ancestor
92510869|NCT00001045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510870|NCT00001045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510871|NCT00001045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510872|NCT00001045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510873|NCT00001045|Antiviral Agents|antiviral agents|mesh-ancestor
92510874|NCT00001045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510875|NCT00001045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510876|NCT00001045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510877|NCT00001045|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510878|NCT00001045|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510879|NCT00001048|Cytarabine|cytarabine|mesh-list
92510880|NCT00001048|Zidovudine|zidovudine|mesh-list
92510881|NCT00001048|Didanosine|didanosine|mesh-list
92510882|NCT00001048|Zalcitabine|zalcitabine|mesh-list
92510883|NCT00001048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92510884|NCT00001048|Antimetabolites|antimetabolites|mesh-ancestor
92510885|NCT00001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510886|NCT00001048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510887|NCT00001048|Antiviral Agents|antiviral agents|mesh-ancestor
92510888|NCT00001048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510889|NCT00001048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92510890|NCT00001048|Immunologic Factors|immunologic factors|mesh-ancestor
92510891|NCT00001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510892|NCT00001048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510893|NCT00001048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510894|NCT00001048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510895|NCT00001048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510896|NCT00001048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510898|NCT00001066|Zidovudine|zidovudine|mesh-list
92510899|NCT00001066|Didanosine|didanosine|mesh-list
92510900|NCT00001066|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510901|NCT00001066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510902|NCT00001066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510903|NCT00001066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510904|NCT00001066|Antiviral Agents|antiviral agents|mesh-ancestor
92510905|NCT00001066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510906|NCT00001066|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510907|NCT00001066|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510908|NCT00001066|Antimetabolites|antimetabolites|mesh-ancestor
92510909|NCT00001075|Ritonavir|ritonavir|mesh-list
92510910|NCT00001075|Lamivudine|lamivudine|mesh-list
92510911|NCT00001075|Zidovudine|zidovudine|mesh-list
92510912|NCT00001075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510913|NCT00001075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510914|NCT00001075|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510915|NCT00001075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510916|NCT00001075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510917|NCT00001075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510918|NCT00001075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510919|NCT00001075|Antiviral Agents|antiviral agents|mesh-ancestor
92510920|NCT00001075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510921|NCT00001075|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510922|NCT00001075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510923|NCT00001075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510924|NCT00001075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510925|NCT00001075|Antimetabolites|antimetabolites|mesh-ancestor
92510926|NCT00001084|Lamivudine|lamivudine|mesh-list
92510927|NCT00001084|Zidovudine|zidovudine|mesh-list
92510928|NCT00001084|Stavudine|stavudine|mesh-list
92510929|NCT00001084|Indinavir|indinavir|mesh-list
92510930|NCT00001084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510931|NCT00001084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510932|NCT00001084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510933|NCT00001084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510934|NCT00001084|Antiviral Agents|antiviral agents|mesh-ancestor
92510935|NCT00001084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510936|NCT00001084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510937|NCT00001084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510938|NCT00001084|Antimetabolites|antimetabolites|mesh-ancestor
92510939|NCT00001084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510940|NCT00001084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510941|NCT00001084|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510942|NCT00001087|Ritonavir|ritonavir|mesh-list
92510943|NCT00001087|Nelfinavir|nelfinavir|mesh-list
92510944|NCT00001087|Saquinavir|saquinavir|mesh-list
92510945|NCT00001087|Lamivudine|lamivudine|mesh-list
92510946|NCT00001087|Zidovudine|zidovudine|mesh-list
92510947|NCT00001087|Didanosine|didanosine|mesh-list
92510948|NCT00001087|Stavudine|stavudine|mesh-list
92510949|NCT00001087|Zalcitabine|zalcitabine|mesh-list
92510950|NCT00001087|Efavirenz|efavirenz|mesh-list
92510951|NCT00001087|Adefovir|adefovir|mesh-list
92510952|NCT00001087|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92510953|NCT00001087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92510954|NCT00001087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92510955|NCT00001087|Protease Inhibitors|protease inhibitors|mesh-ancestor
92510956|NCT00001087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510957|NCT00001087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510958|NCT00001087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510959|NCT00001087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510960|NCT00001087|Antiviral Agents|antiviral agents|mesh-ancestor
92510961|NCT00001087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510962|NCT00001087|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92510963|NCT00001087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92510964|NCT00001087|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510965|NCT00001087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510966|NCT00001087|Antimetabolites|antimetabolites|mesh-ancestor
92510967|NCT00001087|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92510968|NCT00001087|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92510969|NCT00001087|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92510970|NCT00001087|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510971|NCT00001087|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510973|NCT00001105|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92510974|NCT00001105|Immunologic Factors|immunologic factors|mesh-ancestor
92510975|NCT00001105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510976|NCT00001111|Zidovudine|zidovudine|mesh-list
92510977|NCT00001111|Nevirapine|nevirapine|mesh-list
92510978|NCT00001111|Antimetabolites|antimetabolites|mesh-ancestor
92510979|NCT00001111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92510980|NCT00001111|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92510981|NCT00001111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92510982|NCT00001111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92510983|NCT00001111|Antiviral Agents|antiviral agents|mesh-ancestor
92510984|NCT00001111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510985|NCT00001111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92510986|NCT00001111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92510987|NCT00001111|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92510988|NCT00001111|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92510989|NCT00001114|Interferons|interferons|mesh-list
92510990|NCT00001114|Interferon-alpha|interferon-alpha|mesh-list
92510991|NCT00001114|Interferon alpha-2|interferon alpha-2|mesh-list
92510992|NCT00001114|Didanosine|didanosine|mesh-list
92510993|NCT00001114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92510994|NCT00001114|Antiviral Agents|antiviral agents|mesh-ancestor
92510995|NCT00001114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92510996|NCT00001114|Immunologic Factors|immunologic factors|mesh-ancestor
92510997|NCT00001114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92510998|NCT00001114|Antimetabolites|antimetabolites|mesh-ancestor
92510999|NCT00001114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511000|NCT00001114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92511001|NCT00001114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92511002|NCT00001114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511003|NCT00001114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92511004|NCT00001114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92511005|NCT00001165|Doxorubicin|doxorubicin|mesh-list
92511006|NCT00001165|Streptozocin|streptozocin|mesh-list
92511007|NCT00001165|Fluorouracil|fluorouracil|mesh-list
92511008|NCT00001165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92511009|NCT00001165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511010|NCT00001165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92511011|NCT00001165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92511012|NCT00001165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511013|NCT00001165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511014|NCT00001165|Antimetabolites|antimetabolites|mesh-ancestor
92511015|NCT00001165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92511016|NCT00001165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511017|NCT00001165|Immunologic Factors|immunologic factors|mesh-ancestor
92511018|NCT00001165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511019|NCT00001180|Hormones|hormones|mesh-list
92511020|NCT00001180|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92511021|NCT00001180|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92511022|NCT00001180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511023|NCT00001180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511024|NCT00389272|Acetaminophen|acetaminophen|mesh-list
92511025|NCT00389272|Ibuprofen|ibuprofen|mesh-list
92511026|NCT00389272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511027|NCT00389272|Analgesics|analgesics|mesh-ancestor
92511028|NCT00389272|Sensory System Agents|sensory system agents|mesh-ancestor
92511029|NCT00389272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511030|NCT00389272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511031|NCT00389272|Antipyretics|antipyretics|mesh-ancestor
92511032|NCT00389272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92511033|NCT00389272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511034|NCT00389272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92511035|NCT00389272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92511036|NCT00389272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511037|NCT00389272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511038|NCT00389311|Nonoxynol|nonoxynol|mesh-list
92511039|NCT00389311|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92511040|NCT00389311|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92511041|NCT00389311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511042|NCT00389311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92511043|NCT00389311|Contraceptive Agents|contraceptive agents|mesh-ancestor
92235976|NCT00004150|Antidotes|antidotes|mesh-ancestor
92511044|NCT00389311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92511045|NCT00389311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92511046|NCT00001213|Cysteamine|cysteamine|mesh-list
92511047|NCT00001213|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92511048|NCT00001213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511049|NCT00000114|Vitamins|vitamins|mesh-list
92511050|NCT00000114|Vitamin E|vitamin e|mesh-list
92511051|NCT00000114|Vitamin A|vitamin a|mesh-list
92511052|NCT00000114|Micronutrients|micronutrients|mesh-ancestor
92511053|NCT00000114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511054|NCT00000114|Antioxidants|antioxidants|mesh-ancestor
92511055|NCT00000114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511056|NCT00000114|Protective Agents|protective agents|mesh-ancestor
92511057|NCT00001261|gamma-Globulins|gamma-globulins|mesh-list
92511058|NCT00001261|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92511059|NCT00001261|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92511060|NCT00001261|Immunologic Factors|immunologic factors|mesh-ancestor
92511061|NCT00001261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511063|NCT00001267|Didanosine|didanosine|mesh-list
92511064|NCT00001267|Antimetabolites|antimetabolites|mesh-ancestor
92511065|NCT00001267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511066|NCT00001267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92511067|NCT00001267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92511068|NCT00001267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511069|NCT00001267|Antiviral Agents|antiviral agents|mesh-ancestor
92511070|NCT00001267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511071|NCT00001267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92511072|NCT00001267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92511073|NCT00001303|Nitric Oxide|nitric oxide|mesh-list
92511074|NCT00001303|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92511075|NCT00001303|Autonomic Agents|autonomic agents|mesh-ancestor
92511076|NCT00001303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511077|NCT00001303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511078|NCT00001303|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92511079|NCT00001303|Respiratory System Agents|respiratory system agents|mesh-ancestor
92511080|NCT00001303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92511081|NCT00001303|Antioxidants|antioxidants|mesh-ancestor
92511082|NCT00001303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511083|NCT00001303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511084|NCT00001303|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92511085|NCT00001303|Vasodilator Agents|vasodilator agents|mesh-ancestor
92511086|NCT00001303|Gasotransmitters|gasotransmitters|mesh-ancestor
92511087|NCT00001303|Protective Agents|protective agents|mesh-ancestor
92511088|NCT00000120|Erythromycin|erythromycin|mesh-list
92511089|NCT00000120|Erythromycin Estolate|erythromycin estolate|mesh-list
92511090|NCT00000120|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92511091|NCT00000120|Erythromycin stearate|erythromycin stearate|mesh-list
92511092|NCT00000120|Silver Nitrate|silver nitrate|mesh-list
92511093|NCT00000120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92511094|NCT00000120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511095|NCT00000120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92511096|NCT00000120|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92511097|NCT00000120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511098|NCT00000120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511099|NCT00000120|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92511100|NCT00001333|Topotecan|topotecan|mesh-list
92511101|NCT00001333|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92511102|NCT00001333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92511103|NCT00001333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511104|NCT00001333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511105|NCT00001333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511106|NCT00001378|Fenretinide|fenretinide|mesh-list
92511107|NCT00001378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511108|NCT00001378|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92511109|NCT00001378|Protective Agents|protective agents|mesh-ancestor
92511110|NCT00001378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511111|NCT00001387|Paclitaxel|paclitaxel|mesh-list
92511112|NCT00001387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92511113|NCT00001387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511114|NCT00001387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92511115|NCT00001387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92511116|NCT00001387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92511117|NCT00001387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511118|NCT00388557|Ketoconazole|ketoconazole|mesh-list
92511119|NCT00388557|Antifungal Agents|antifungal agents|mesh-ancestor
92511120|NCT00388557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511121|NCT00388557|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92511122|NCT00388557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92511123|NCT00388557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511124|NCT00388557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511125|NCT00388557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92511126|NCT00388557|Hormone Antagonists|hormone antagonists|mesh-ancestor
92511127|NCT00388557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533133|NCT00058045|Antiviral Agents|antiviral agents|mesh-ancestor
92511128|NCT00388557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511129|NCT00388557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92511132|NCT00388635|Bortezomib|bortezomib|mesh-list
92511133|NCT00388635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511134|NCT00388635|Glucocorticoids|glucocorticoids|mesh-ancestor
92511135|NCT00388635|Hormones|hormones|mesh-ancestor
92511136|NCT00388635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511137|NCT00388635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511138|NCT00388635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92511139|NCT00388635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511140|NCT00388635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92511141|NCT00388635|Alkylating Agents|alkylating agents|mesh-ancestor
92511142|NCT00388635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511143|NCT00388635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92511144|NCT00388635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511145|NCT00388635|Immunologic Factors|immunologic factors|mesh-ancestor
92511146|NCT00001474|Interleukin-2|interleukin-2|mesh-list
92511147|NCT00001474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511148|NCT00001474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511149|NCT00001474|Analgesics|analgesics|mesh-ancestor
92511150|NCT00001474|Sensory System Agents|sensory system agents|mesh-ancestor
92511151|NCT00001474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511152|NCT00001474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511153|NCT00001483|Sertraline|sertraline|mesh-list
92511154|NCT00001483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92511155|NCT00001483|Bupropion|bupropion|mesh-list
92511156|NCT00001483|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511157|NCT00001483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511158|NCT00001483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92511159|NCT00001483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511160|NCT00001483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511161|NCT00001483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511162|NCT00001483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511163|NCT00001483|Serotonin Agents|serotonin agents|mesh-ancestor
92511164|NCT00001483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511165|NCT00001483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92511166|NCT00001483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92511167|NCT00001483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92511168|NCT00001483|Dopamine Agents|dopamine agents|mesh-ancestor
92511169|NCT00001483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92511170|NCT00001483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92511171|NCT00001483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511172|NCT00001495|Irinotecan|irinotecan|mesh-list
92511173|NCT00001495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92511174|NCT00001495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92511175|NCT00001495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511176|NCT00001495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511177|NCT00001495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511178|NCT00001507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92511179|NCT00001507|Antibodies|antibodies|mesh-list
92511180|NCT00001507|Immunoglobulins|immunoglobulins|mesh-list
92511181|NCT00001507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92511182|NCT00001507|Immunologic Factors|immunologic factors|mesh-ancestor
92511183|NCT00001507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511184|NCT00001507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511185|NCT00001567|Interferon alpha-2|interferon alpha-2|mesh-list
92511186|NCT00001567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511187|NCT00001567|Antiviral Agents|antiviral agents|mesh-ancestor
92511188|NCT00001567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511189|NCT00001576|Leucovorin|leucovorin|mesh-list
92511190|NCT00001576|Melphalan|melphalan|mesh-list
92511191|NCT00001576|Floxuridine|floxuridine|mesh-list
92511192|NCT00001576|Antidotes|antidotes|mesh-ancestor
92236122|NCT00004192|Hormones|hormones|mesh-ancestor
92511193|NCT00001576|Protective Agents|protective agents|mesh-ancestor
92511194|NCT00001576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511195|NCT00001576|Vitamin B Complex|vitamin b complex|mesh-ancestor
92511196|NCT00001576|Vitamins|vitamins|mesh-ancestor
92511197|NCT00001576|Micronutrients|micronutrients|mesh-ancestor
92511198|NCT00001576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92511199|NCT00001576|Alkylating Agents|alkylating agents|mesh-ancestor
92511200|NCT00001576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511201|NCT00001576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511202|NCT00001576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92511203|NCT00001576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511204|NCT00001576|Immunologic Factors|immunologic factors|mesh-ancestor
92511205|NCT00001576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92511206|NCT00001576|Antimetabolites|antimetabolites|mesh-ancestor
92511208|NCT00000147|Methylprednisolone|methylprednisolone|mesh-list
92511209|NCT00000147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92511210|NCT00000147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92511211|NCT00000147|Prednisolone|prednisolone|mesh-list
92511212|NCT00000147|Prednisolone acetate|prednisolone acetate|mesh-list
92511213|NCT00000147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92511214|NCT00000147|Prednisolone phosphate|prednisolone phosphate|mesh-list
92511215|NCT00000147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511216|NCT00000147|Glucocorticoids|glucocorticoids|mesh-ancestor
92511217|NCT00000147|Hormones|hormones|mesh-ancestor
92511218|NCT00000147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511219|NCT00000147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511220|NCT00000147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92511221|NCT00000147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511222|NCT00000147|Antiemetics|antiemetics|mesh-ancestor
92511223|NCT00000147|Autonomic Agents|autonomic agents|mesh-ancestor
92511224|NCT00000147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511225|NCT00000147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92511226|NCT00000147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92511227|NCT00000147|Protective Agents|protective agents|mesh-ancestor
92511228|NCT00001624|Insulin|insulin|mesh-list
92511229|NCT00001624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92511230|NCT00001624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511231|NCT00001666|Methamphetamine|methamphetamine|mesh-list
92511232|NCT00001666|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92511233|NCT00001666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511234|NCT00001666|Sympathomimetics|sympathomimetics|mesh-ancestor
92511235|NCT00001666|Autonomic Agents|autonomic agents|mesh-ancestor
92511236|NCT00001666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511237|NCT00001666|Dopamine Agents|dopamine agents|mesh-ancestor
92511238|NCT00001666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511239|NCT00001666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511240|NCT00001666|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511241|NCT00001666|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92511242|NCT00001666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511243|NCT00001666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511244|NCT00001666|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92511245|NCT00001669|Mecasermin|mecasermin|mesh-list
92511246|NCT00001669|Growth Substances|growth substances|mesh-ancestor
92511247|NCT00001669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511248|NCT00001693|Celecoxib|celecoxib|mesh-list
92511249|NCT00001693|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92511250|NCT00001693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511251|NCT00001693|Analgesics|analgesics|mesh-ancestor
92511252|NCT00001693|Sensory System Agents|sensory system agents|mesh-ancestor
92511253|NCT00001693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511254|NCT00001693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511255|NCT00001693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511256|NCT00001693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92511257|NCT00001693|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92511258|NCT00001693|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92511259|NCT00001693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511260|NCT00001693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511261|NCT00001696|Genistein|genistein|mesh-list
92511262|NCT00001696|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92511263|NCT00001696|Protective Agents|protective agents|mesh-ancestor
92511264|NCT00001696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511265|NCT00001696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511266|NCT00001696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236193|NCT00005026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92511267|NCT00001696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511268|NCT00001696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511269|NCT00001696|Phytoestrogens|phytoestrogens|mesh-ancestor
92511270|NCT00001696|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92511271|NCT00001696|Estrogens|estrogens|mesh-ancestor
92511272|NCT00001696|Hormones|hormones|mesh-ancestor
92351234|NCT04198662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92511273|NCT00001696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511274|NCT00389428|Cytarabine|cytarabine|mesh-list
92511275|NCT00389428|Daunorubicin|daunorubicin|mesh-list
92511277|NCT00389428|Antimetabolites|antimetabolites|mesh-ancestor
92511278|NCT00389428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511279|NCT00389428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511280|NCT00389428|Antiviral Agents|antiviral agents|mesh-ancestor
92511281|NCT00389428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511282|NCT00389428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511283|NCT00389428|Immunologic Factors|immunologic factors|mesh-ancestor
92511284|NCT00389428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511285|NCT00389428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92511286|NCT00389428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92511287|NCT00389428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92511288|NCT00389428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511289|NCT00001720|Alendronate|alendronate|mesh-list
92511290|NCT00001720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92511291|NCT00001720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511292|NCT00001723|Orlistat|orlistat|mesh-list
92511293|NCT00001723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511294|NCT00001723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511295|NCT00001723|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92511296|NCT00001723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92511297|NCT00001729|Ribavirin|ribavirin|mesh-list
92511298|NCT00001729|Antimetabolites|antimetabolites|mesh-ancestor
92511299|NCT00001729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511300|NCT00001729|Antiviral Agents|antiviral agents|mesh-ancestor
92511301|NCT00001729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511302|NCT00001741|Losartan|losartan|mesh-list
92511303|NCT00001741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92511304|NCT00001741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92511305|NCT00001741|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92511306|NCT00001741|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92511307|NCT00001741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511308|NCT00001777|Sertraline|sertraline|mesh-list
92511309|NCT00001777|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511310|NCT00001777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511311|NCT00001777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92511312|NCT00001777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511313|NCT00001777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511314|NCT00001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511315|NCT00001777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511316|NCT00001777|Serotonin Agents|serotonin agents|mesh-ancestor
92511317|NCT00001777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511318|NCT00000171|Melatonin|melatonin|mesh-list
92511319|NCT00000171|Antioxidants|antioxidants|mesh-ancestor
92511320|NCT00000171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511321|NCT00000171|Protective Agents|protective agents|mesh-ancestor
92511322|NCT00000171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511323|NCT00000171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511324|NCT05641636|Hormones|hormones|mesh-list
92511325|NCT05641636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511326|NCT05641636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511327|NCT00000177|Estrogens|estrogens|mesh-list
92511328|NCT00000177|Hormones|hormones|mesh-ancestor
92511329|NCT00000177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511330|NCT00000177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511331|NCT03444376|Pembrolizumab|pembrolizumab|mesh-list
92511332|NCT03444376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92511333|NCT03444376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511334|NCT03444376|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92511335|NCT03444376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511336|NCT00000216|Buprenorphine|buprenorphine|mesh-list
92511337|NCT00000216|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92511338|NCT00000216|Narcotics|narcotics|mesh-ancestor
92511339|NCT00000216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511340|NCT00000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511341|NCT00000216|Analgesics|analgesics|mesh-ancestor
92511342|NCT00000216|Sensory System Agents|sensory system agents|mesh-ancestor
92511343|NCT00000216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511344|NCT00000216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92511345|NCT00000252|Nitrous Oxide|nitrous oxide|mesh-list
92511346|NCT00000252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92511347|NCT00000252|Anesthetics, General|anesthetics, general|mesh-ancestor
92511348|NCT00000252|Anesthetics|anesthetics|mesh-ancestor
92511349|NCT00000252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511350|NCT00000252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511351|NCT00000252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511352|NCT00000252|Analgesics|analgesics|mesh-ancestor
92511353|NCT00000252|Sensory System Agents|sensory system agents|mesh-ancestor
92511354|NCT00000252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511355|NCT05640817|Pentoxifylline|pentoxifylline|mesh-list
92511356|NCT05640817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92511357|NCT05640817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511358|NCT05640817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511359|NCT05640817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92511360|NCT05640817|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92511361|NCT05640817|Protective Agents|protective agents|mesh-ancestor
92511362|NCT05640817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511363|NCT05640817|Vasodilator Agents|vasodilator agents|mesh-ancestor
92511364|NCT05640817|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92511365|NCT05640817|Antioxidants|antioxidants|mesh-ancestor
92511366|NCT00000255|Nitrous Oxide|nitrous oxide|mesh-list
92511367|NCT00000255|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92511368|NCT00000255|Anesthetics, General|anesthetics, general|mesh-ancestor
92511369|NCT00000255|Anesthetics|anesthetics|mesh-ancestor
92511370|NCT00000255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511371|NCT00000255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511372|NCT00000255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511373|NCT00000255|Analgesics|analgesics|mesh-ancestor
92511374|NCT00000255|Sensory System Agents|sensory system agents|mesh-ancestor
92511375|NCT00000255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511376|NCT00000258|Nitrous Oxide|nitrous oxide|mesh-list
92511377|NCT00000258|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92511378|NCT00000258|Anesthetics, General|anesthetics, general|mesh-ancestor
92511379|NCT00000258|Anesthetics|anesthetics|mesh-ancestor
92511380|NCT00000258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511381|NCT00000258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511382|NCT00000258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511383|NCT00000258|Analgesics|analgesics|mesh-ancestor
92511384|NCT00000258|Sensory System Agents|sensory system agents|mesh-ancestor
92511385|NCT00000258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511386|NCT00389506|Cyclophosphamide|cyclophosphamide|mesh-list
92511387|NCT00389506|Fludarabine|fludarabine|mesh-list
92511388|NCT00389506|Fludarabine phosphate|fludarabine phosphate|mesh-list
92511389|NCT00389506|Immunotoxins|immunotoxins|mesh-list
92511390|NCT00389506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511391|NCT00389506|Immunologic Factors|immunologic factors|mesh-ancestor
92511392|NCT00389506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511393|NCT00389506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92511394|NCT00389506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92511395|NCT00389506|Alkylating Agents|alkylating agents|mesh-ancestor
92511396|NCT00389506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511397|NCT00389506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511398|NCT00389506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92511399|NCT00389506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92511400|NCT00389506|Antimetabolites|antimetabolites|mesh-ancestor
92511401|NCT00389506|Immunoconjugates|immunoconjugates|mesh-ancestor
92511403|NCT00389584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92511404|NCT00389584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92511405|NCT00389584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511406|NCT00389584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511407|NCT00389584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511408|NCT00000324|Tryptophan|tryptophan|mesh-list
92511409|NCT00000324|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92511410|NCT00000324|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511411|NCT00000324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511412|NCT05640427|Dexmedetomidine|dexmedetomidine|mesh-list
92511413|NCT05640427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92511414|NCT05640427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511415|NCT05640427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511416|NCT05640427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511417|NCT05640427|Analgesics|analgesics|mesh-ancestor
92511418|NCT05640427|Sensory System Agents|sensory system agents|mesh-ancestor
92511419|NCT05640427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511420|NCT05640427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92511421|NCT05640427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92511422|NCT05640427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92511423|NCT05640427|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511425|NCT05640427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511426|NCT00000363|Histamine Antagonists|histamine antagonists|mesh-list
92511427|NCT00000363|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92511428|NCT00000363|Histamine Agents|histamine agents|mesh-ancestor
92511429|NCT00000363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511430|NCT00000363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511431|NCT00000363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511432|NCT00000369|Lithium Carbonate|lithium carbonate|mesh-list
92511433|NCT00000369|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511434|NCT00000369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511435|NCT00000369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511436|NCT00000369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511437|NCT00000369|Antimanic Agents|antimanic agents|mesh-ancestor
92511438|NCT00000369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92511439|NCT00000369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511440|NCT00000369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511441|NCT00000375|Nortriptyline|nortriptyline|mesh-list
92511442|NCT00000375|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511443|NCT00000375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511444|NCT00000375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511445|NCT00000375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511446|NCT00000375|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92511447|NCT00000375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92511448|NCT00000375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511449|NCT00000375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511450|NCT00000375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511451|NCT00000375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511452|NCT03295747|Peppermint oil|peppermint oil|mesh-list
92511453|NCT03295747|Antiemetics|antiemetics|mesh-ancestor
92511454|NCT03295747|Autonomic Agents|autonomic agents|mesh-ancestor
92511455|NCT03295747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511456|NCT03295747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511457|NCT03295747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92511458|NCT03295747|Parasympatholytics|parasympatholytics|mesh-ancestor
92511459|NCT05639959|Mometasone Furoate|mometasone furoate|mesh-list
92511460|NCT05639959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511461|NCT05639959|Dermatologic Agents|dermatologic agents|mesh-ancestor
92511462|NCT05639959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92511463|NCT03575208|Interferons|interferons|mesh-list
92511464|NCT03575208|Interferon-alpha|interferon-alpha|mesh-list
92511465|NCT03575208|Immunoglobulins|immunoglobulins|mesh-list
92511466|NCT03575208|Antibodies|antibodies|mesh-list
92511467|NCT03575208|gamma-Globulins|gamma-globulins|mesh-list
92511468|NCT03575208|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92511469|NCT03575208|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92511470|NCT03575208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511471|NCT03575208|Antiviral Agents|antiviral agents|mesh-ancestor
92511472|NCT03575208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511473|NCT03575208|Immunologic Factors|immunologic factors|mesh-ancestor
92511474|NCT03575208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511475|NCT03295552|Carboplatin|carboplatin|mesh-list
92511476|NCT03295552|Decitabine|decitabine|mesh-list
92511477|NCT03295552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511478|NCT03295552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92511479|NCT03295552|Antimetabolites|antimetabolites|mesh-ancestor
92511480|NCT03295552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511481|NCT03295552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511482|NCT05629468|Azithromycin|azithromycin|mesh-list
92511483|NCT05629468|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92511484|NCT05629468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92511485|NCT05629468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511486|NCT05629468|Dermatologic Agents|dermatologic agents|mesh-ancestor
92511487|NCT00000378|Sertraline|sertraline|mesh-list
92511488|NCT00000378|Nortriptyline|nortriptyline|mesh-list
92511489|NCT00000378|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511490|NCT00000378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511491|NCT00000378|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92511492|NCT00000378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511493|NCT00000378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511494|NCT00000378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511495|NCT00000378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511496|NCT00000378|Serotonin Agents|serotonin agents|mesh-ancestor
92511497|NCT00000378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511498|NCT00000378|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92511499|NCT00000378|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92511500|NCT00000378|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511501|NCT05626621|Mometasone Furoate|mometasone furoate|mesh-list
92511503|NCT05626621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511504|NCT05626621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92511505|NCT05626621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92511506|NCT05626621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92511507|NCT05626621|Autonomic Agents|autonomic agents|mesh-ancestor
92511508|NCT05626621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511509|NCT05626621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511510|NCT05626621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92511511|NCT05626621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92511512|NCT05626621|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92511513|NCT05626621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511514|NCT05626621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511515|NCT05626621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92511516|NCT05626621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92511517|NCT05626621|Histamine Antagonists|histamine antagonists|mesh-ancestor
92511518|NCT05626621|Histamine Agents|histamine agents|mesh-ancestor
92511519|NCT05626621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511520|NCT00000381|Fluoxetine|fluoxetine|mesh-list
92511521|NCT00000381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92511522|NCT00000381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511523|NCT00000381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511524|NCT00000381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511525|NCT00000381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511526|NCT00000381|Serotonin Agents|serotonin agents|mesh-ancestor
92511527|NCT00000381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511528|NCT00000381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92511529|NCT00000381|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511530|NCT00000381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511531|NCT00000381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92511532|NCT00000381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92511533|NCT00000381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511534|NCT05631925|Propofol|propofol|mesh-list
92511535|NCT05631925|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92511536|NCT05631925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511537|NCT05631925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511538|NCT05631925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92511539|NCT05631925|Anesthetics, General|anesthetics, general|mesh-ancestor
92511540|NCT05631925|Anesthetics|anesthetics|mesh-ancestor
92511541|NCT00389701|Dexamethasone|dexamethasone|mesh-list
92511542|NCT00389701|Bortezomib|bortezomib|mesh-list
92511543|NCT00389701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511544|NCT00389701|Antiemetics|antiemetics|mesh-ancestor
92511545|NCT00389701|Autonomic Agents|autonomic agents|mesh-ancestor
92511546|NCT00389701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511547|NCT00389701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511548|NCT00389701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92511549|NCT00389701|Glucocorticoids|glucocorticoids|mesh-ancestor
92511550|NCT00389701|Hormones|hormones|mesh-ancestor
92351255|NCT04023630|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92511551|NCT00389701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511552|NCT00389701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92511553|NCT00389701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511554|NCT00000420|Norinyl|norinyl|mesh-list
92511555|NCT00000420|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92511556|NCT00000420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92511557|NCT00000420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92511558|NCT00000420|Contraceptive Agents|contraceptive agents|mesh-ancestor
92511559|NCT00000420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92511560|NCT00000420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511561|NCT00000420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92511562|NCT00000420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92511563|NCT00000426|Calcium|calcium|mesh-list
92236499|NCT00004276|Thalidomide|thalidomide|mesh-list
92511564|NCT00000426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92511565|NCT00000426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511567|NCT05551858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92511568|NCT05551858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92511569|NCT05530174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92511570|NCT05530174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511571|NCT00000456|Naltrexone|naltrexone|mesh-list
92511572|NCT00000456|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92511573|NCT00000456|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92511574|NCT00000456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511575|NCT00000456|Sensory System Agents|sensory system agents|mesh-ancestor
92511576|NCT00000456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511577|NCT05519683|Escitalopram|escitalopram|mesh-list
92511578|NCT05519683|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92511579|NCT05519683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511580|NCT05519683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511581|NCT05519683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511582|NCT05519683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511583|NCT05519683|Serotonin Agents|serotonin agents|mesh-ancestor
92511584|NCT05519683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511585|NCT05442268|Acetaminophen|acetaminophen|mesh-list
92511586|NCT05442268|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92511587|NCT05442268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92511588|NCT05442268|Analgesics|analgesics|mesh-ancestor
92511589|NCT05442268|Sensory System Agents|sensory system agents|mesh-ancestor
92511590|NCT05442268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511591|NCT05442268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511592|NCT05442268|Antipyretics|antipyretics|mesh-ancestor
92511593|NCT05442268|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92511594|NCT05442268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511595|NCT05442268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511596|NCT05442268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511597|NCT05442268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511598|NCT05442268|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511599|NCT05442268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511600|NCT05442268|Dopamine Agents|dopamine agents|mesh-ancestor
92511601|NCT05448820|Doxorubicin|doxorubicin|mesh-list
92511602|NCT05448820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92511603|NCT05448820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511604|NCT05448820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92511605|NCT05448820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92511606|NCT05448820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511607|NCT05448820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511608|NCT00000468|Plasminogen|plasminogen|mesh-list
92511609|NCT00000468|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92511610|NCT00000468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92511611|NCT00000468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92511612|NCT00000468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511613|NCT02972476|Fluticasone|fluticasone|mesh-list
92511614|NCT02972476|Xhance|xhance|mesh-list
92511615|NCT02972476|Budesonide|budesonide|mesh-list
92511616|NCT02972476|Bromides|bromides|mesh-list
92511617|NCT02972476|Formoterol Fumarate|formoterol fumarate|mesh-list
92511618|NCT02972476|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92511619|NCT02972476|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92511620|NCT02972476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511621|NCT02972476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92511622|NCT02972476|Autonomic Agents|autonomic agents|mesh-ancestor
92511623|NCT02972476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511624|NCT02972476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511625|NCT02972476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92511626|NCT02972476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92511627|NCT02972476|Dermatologic Agents|dermatologic agents|mesh-ancestor
92511628|NCT02972476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92511629|NCT02972476|Glucocorticoids|glucocorticoids|mesh-ancestor
92511630|NCT02972476|Hormones|hormones|mesh-ancestor
92511631|NCT02972476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511632|NCT02972476|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92511633|NCT02972476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92511634|NCT02972476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92511635|NCT02972476|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511636|NCT02972476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511637|NCT02972476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511638|NCT02972476|Anticonvulsants|anticonvulsants|mesh-ancestor
92511639|NCT02972476|Sympathomimetics|sympathomimetics|mesh-ancestor
92511640|NCT05418868|Cabotegravir|cabotegravir|mesh-list
92533141|NCT00058084|Hormones|hormones|mesh-ancestor
92511641|NCT05418868|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92511642|NCT05418868|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92511643|NCT05418868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511644|NCT05418868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511645|NCT05418868|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92511646|NCT05418868|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92511647|NCT05418868|Antiviral Agents|antiviral agents|mesh-ancestor
92511648|NCT05418868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511649|NCT02972320|Temozolomide|temozolomide|mesh-list
92511650|NCT02972320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92511651|NCT02972320|Alkylating Agents|alkylating agents|mesh-ancestor
92511652|NCT02972320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511653|NCT02972320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511654|NCT00000480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92511655|NCT05349838|Dolutegravir|dolutegravir|mesh-list
92511656|NCT05349838|Rilpivirine|rilpivirine|mesh-list
92511657|NCT05349838|Protease Inhibitors|protease inhibitors|mesh-list
92511658|NCT05349838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92511659|NCT05349838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92511660|NCT05349838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511661|NCT05349838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511662|NCT05349838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92511663|NCT05349838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92511664|NCT05349838|Antiviral Agents|antiviral agents|mesh-ancestor
92511665|NCT05349838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511666|NCT05349838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92511667|NCT05349838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92511668|NCT03164980|Trabectedin|trabectedin|mesh-list
92511669|NCT03164980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92511670|NCT03164980|Alkylating Agents|alkylating agents|mesh-ancestor
92511671|NCT03164980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511672|NCT03164980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511673|NCT05305456|Vitamins|vitamins|mesh-list
92511674|NCT05305456|Ascorbic Acid|ascorbic acid|mesh-list
92511675|NCT05305456|Micronutrients|micronutrients|mesh-ancestor
92511676|NCT05305456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511677|NCT05305456|Antioxidants|antioxidants|mesh-ancestor
92511678|NCT05305456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511679|NCT05305456|Protective Agents|protective agents|mesh-ancestor
92511680|NCT00388986|Glyburide|glyburide|mesh-list
92511681|NCT00388986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92511682|NCT00388986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511683|NCT05233696|Paclitaxel|paclitaxel|mesh-list
92511684|NCT05233696|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92511685|NCT05233696|Pembrolizumab|pembrolizumab|mesh-list
92511686|NCT05233696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92511687|NCT05233696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511688|NCT05233696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92511689|NCT05233696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92511690|NCT05233696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92511691|NCT05233696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511692|NCT05233696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351265|NCT04023630|Anticoagulants|anticoagulants|mesh-ancestor
92511693|NCT05233696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92511694|NCT05223673|Trifluridine|trifluridine|mesh-list
92511695|NCT05223673|Antimetabolites|antimetabolites|mesh-ancestor
92511696|NCT05223673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511697|NCT05223673|Antiviral Agents|antiviral agents|mesh-ancestor
92511698|NCT05223673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511699|NCT00000492|Propranolol|propranolol|mesh-list
92511700|NCT00000492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92511701|NCT00000492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92511702|NCT00000492|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511703|NCT00000492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511704|NCT00000492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511705|NCT00000492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511706|NCT00000492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92511707|NCT00000492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92511708|NCT00000492|Vasodilator Agents|vasodilator agents|mesh-ancestor
92511709|NCT00000498|Antihypertensive Agents|antihypertensive agents|mesh-list
92511710|NCT00000504|Flecainide|flecainide|mesh-list
92511711|NCT00000504|Moricizine|moricizine|mesh-list
92511712|NCT00000504|Encainide|encainide|mesh-list
92236650|NCT00030992|Anesthetics|anesthetics|mesh-ancestor
92511714|NCT00000504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92511715|NCT00000504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92511716|NCT00000504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92511717|NCT00000504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511718|NCT00000504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511719|NCT00000504|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92511720|NCT00000504|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511721|NCT00000504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511722|NCT00000504|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92511723|NCT00000504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511724|NCT00000504|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511725|NCT00000504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511726|NCT00000504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511727|NCT00389935|Thalidomide|thalidomide|mesh-list
92511728|NCT00389935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511729|NCT00389935|Immunologic Factors|immunologic factors|mesh-ancestor
92511730|NCT00389935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511731|NCT00389935|Leprostatic Agents|leprostatic agents|mesh-ancestor
92511732|NCT00389935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92511733|NCT00389935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511734|NCT00389935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92511735|NCT00389935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92511736|NCT00389935|Growth Substances|growth substances|mesh-ancestor
92511737|NCT00389935|Growth Inhibitors|growth inhibitors|mesh-ancestor
92511738|NCT00389935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511740|NCT05116930|Neostigmine|neostigmine|mesh-list
92511741|NCT05116930|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92511742|NCT05116930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92511743|NCT05116930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92511744|NCT05116930|Autonomic Agents|autonomic agents|mesh-ancestor
92511745|NCT05116930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511746|NCT05116930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511747|NCT05116930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92511748|NCT05116930|Respiratory System Agents|respiratory system agents|mesh-ancestor
92511749|NCT05116930|Mydriatics|mydriatics|mesh-ancestor
92511750|NCT05116930|Parasympatholytics|parasympatholytics|mesh-ancestor
92511751|NCT05116930|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92511752|NCT05116930|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92511753|NCT05116930|Cholinergic Agents|cholinergic agents|mesh-ancestor
92511754|NCT05116930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511755|NCT05116930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511756|NCT05116930|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92511757|NCT05116930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511758|NCT05116930|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92511759|NCT00423475|Goserelin|goserelin|mesh-list
92511760|NCT00423475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92511761|NCT00423475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511762|NCT00000516|Enalapril|enalapril|mesh-list
92511763|NCT00000516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92511764|NCT00000516|Protease Inhibitors|protease inhibitors|mesh-ancestor
92511765|NCT00000516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511766|NCT00000516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511767|NCT00000516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92511768|NCT05049616|Nifedipine|nifedipine|mesh-list
92511769|NCT05049616|Diuretics|diuretics|mesh-list
92511770|NCT05049616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92511771|NCT05049616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92511772|NCT05049616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511773|NCT05049616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511774|NCT05049616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92511775|NCT05049616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511776|NCT05049616|Vasodilator Agents|vasodilator agents|mesh-ancestor
92511777|NCT05049616|Tocolytic Agents|tocolytic agents|mesh-ancestor
92511778|NCT05049616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92511779|NCT05049616|Natriuretic Agents|natriuretic agents|mesh-ancestor
92511780|NCT05049616|Protease Inhibitors|protease inhibitors|mesh-ancestor
92511781|NCT05049616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511782|NCT00000522|Acebutolol|acebutolol|mesh-list
92511783|NCT00000522|Amlodipine|amlodipine|mesh-list
92511784|NCT00000522|Enalapril|enalapril|mesh-list
92511785|NCT00000522|Chlorthalidone|chlorthalidone|mesh-list
92511786|NCT00000522|Doxazosin|doxazosin|mesh-list
92533146|NCT00058084|Analgesics|analgesics|mesh-ancestor
92511787|NCT00000522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92511788|NCT00000522|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92511789|NCT00000522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511790|NCT00000522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511791|NCT00000522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92511792|NCT00000522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511793|NCT00000522|Vasodilator Agents|vasodilator agents|mesh-ancestor
92511794|NCT00000522|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92511795|NCT00000522|Protease Inhibitors|protease inhibitors|mesh-ancestor
92511796|NCT00000522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511797|NCT00000522|Diuretics|diuretics|mesh-ancestor
92511798|NCT00000522|Natriuretic Agents|natriuretic agents|mesh-ancestor
92511799|NCT00000522|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92511800|NCT00000522|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92511801|NCT00000522|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92511802|NCT00000522|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92511803|NCT00000522|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511804|NCT00000522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511805|NCT00000522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92511806|NCT00000522|Sympathomimetics|sympathomimetics|mesh-ancestor
92511807|NCT00000522|Autonomic Agents|autonomic agents|mesh-ancestor
92511808|NCT00000522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511809|NCT00000522|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92511810|NCT00000522|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92511811|NCT03126799|Bevacizumab|bevacizumab|mesh-list
92511812|NCT03126799|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92511813|NCT03126799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92511814|NCT03126799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511815|NCT03126799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92511816|NCT03126799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92511817|NCT03126799|Growth Substances|growth substances|mesh-ancestor
92511818|NCT03126799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511819|NCT03126799|Growth Inhibitors|growth inhibitors|mesh-ancestor
92511820|NCT03126799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92511821|NCT03126799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511822|NCT03126799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511823|NCT00000525|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92511824|NCT00000525|Chlorthalidone|chlorthalidone|mesh-list
92511825|NCT00000525|Triamterene|triamterene|mesh-list
92511826|NCT00000525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92511827|NCT00000525|Diuretics|diuretics|mesh-ancestor
92511828|NCT00000525|Natriuretic Agents|natriuretic agents|mesh-ancestor
92511829|NCT00000525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511830|NCT00000525|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92511831|NCT00000525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511832|NCT00000525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511833|NCT00000525|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92511834|NCT00000525|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92511835|NCT00000525|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92511836|NCT05020483|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92511837|NCT05020483|Coagulants|coagulants|mesh-ancestor
92511838|NCT00000531|Amiodarone|amiodarone|mesh-list
92511839|NCT00000531|Sotalol|sotalol|mesh-list
92511840|NCT00000531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92511841|NCT00000531|Vasodilator Agents|vasodilator agents|mesh-ancestor
92511842|NCT00000531|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92511843|NCT00000531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511844|NCT00000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511845|NCT00000531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92511846|NCT00000531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92511847|NCT00000531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92511848|NCT00000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511849|NCT00000531|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92511850|NCT00000531|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92511851|NCT00000531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92511852|NCT00000531|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92511853|NCT00000531|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92511854|NCT00000531|Adrenergic Agents|adrenergic agents|mesh-ancestor
92511855|NCT00000531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511856|NCT00000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511857|NCT00000531|Sympatholytics|sympatholytics|mesh-ancestor
92511858|NCT00000531|Autonomic Agents|autonomic agents|mesh-ancestor
92511859|NCT00000531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511861|NCT00000534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92511862|NCT00000534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511864|NCT04935814|Arginine Vasopressin|arginine vasopressin|mesh-list
92511865|NCT04935814|Hemostatics|hemostatics|mesh-ancestor
92511866|NCT04935814|Coagulants|coagulants|mesh-ancestor
92511867|NCT04935814|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92511868|NCT04935814|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92511869|NCT04935814|Natriuretic Agents|natriuretic agents|mesh-ancestor
92511870|NCT04935814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511871|NCT00000552|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92511872|NCT00000552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92511873|NCT00000552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511874|NCT00000555|Ascorbic Acid|ascorbic acid|mesh-list
92511875|NCT00000555|Vitamin E|vitamin e|mesh-list
92511876|NCT00000555|Hormones|hormones|mesh-list
92511877|NCT00000555|Progesterone|progesterone|mesh-list
92511878|NCT00000555|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92511879|NCT00000555|Estrogens|estrogens|mesh-list
92511880|NCT00000555|Vitamins|vitamins|mesh-ancestor
92511881|NCT00000555|Micronutrients|micronutrients|mesh-ancestor
92511882|NCT00000555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511883|NCT00000555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511884|NCT00000555|Progestins|progestins|mesh-ancestor
92511885|NCT00000555|Antioxidants|antioxidants|mesh-ancestor
92511886|NCT00000555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511887|NCT00000555|Protective Agents|protective agents|mesh-ancestor
92511888|NCT04888858|Fentanyl|fentanyl|mesh-list
92511889|NCT04888858|Bupivacaine|bupivacaine|mesh-list
92511890|NCT04888858|Anesthetics, Local|anesthetics, local|mesh-ancestor
92511891|NCT04888858|Anesthetics|anesthetics|mesh-ancestor
92511892|NCT04888858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511893|NCT04888858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511894|NCT04888858|Sensory System Agents|sensory system agents|mesh-ancestor
92351290|NCT04021992|Rituximab|rituximab|mesh-list
92511895|NCT04888858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511896|NCT04888858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92511897|NCT04888858|Narcotics|narcotics|mesh-ancestor
92511898|NCT04888858|Analgesics|analgesics|mesh-ancestor
92511899|NCT04888858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92511900|NCT04888858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92511901|NCT04888858|Anesthetics, General|anesthetics, general|mesh-ancestor
92511902|NCT04870957|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92511903|NCT04870957|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92511904|NCT04870957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92511905|NCT04870957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92511906|NCT04870957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511907|NCT04870957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511908|NCT04870957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511909|NCT04870957|Analgesics|analgesics|mesh-ancestor
92511910|NCT04870957|Sensory System Agents|sensory system agents|mesh-ancestor
92511911|NCT04870957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511912|NCT04870957|Antidepressive Agents|antidepressive agents|mesh-ancestor
92511913|NCT04870957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511914|NCT04870957|Dopamine Agents|dopamine agents|mesh-ancestor
92511915|NCT00000558|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92511916|NCT00000558|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92511917|NCT00000558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511918|NCT00000558|Protease Inhibitors|protease inhibitors|mesh-ancestor
92511919|NCT04802746|Alprazolam|alprazolam|mesh-list
92511920|NCT04802746|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92511921|NCT04802746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92511922|NCT04802746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511923|NCT04802746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92511924|NCT04802746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92511925|NCT04802746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92511926|NCT04802746|GABA Modulators|gaba modulators|mesh-ancestor
92511927|NCT04802746|GABA Agents|gaba agents|mesh-ancestor
92511928|NCT04802746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92511929|NCT04802746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511930|NCT00000576|Beclomethasone|beclomethasone|mesh-list
92511931|NCT00000576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236871|NCT00004474|Alkylating Agents|alkylating agents|mesh-ancestor
92511932|NCT00000576|Glucocorticoids|glucocorticoids|mesh-ancestor
92511933|NCT00000576|Hormones|hormones|mesh-ancestor
92511934|NCT00000576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511935|NCT00000576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511936|NCT00000576|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92511937|NCT00000576|Respiratory System Agents|respiratory system agents|mesh-ancestor
92511938|NCT00000579|Ketoconazole|ketoconazole|mesh-list
92511939|NCT00000579|Methylprednisolone|methylprednisolone|mesh-list
92511940|NCT00000579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92511941|NCT00000579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92511942|NCT00000579|Prednisolone|prednisolone|mesh-list
92511943|NCT00000579|Prednisolone acetate|prednisolone acetate|mesh-list
92511944|NCT00000579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92511945|NCT00000579|Prednisolone phosphate|prednisolone phosphate|mesh-list
92511946|NCT00000579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92511947|NCT00000579|Antiemetics|antiemetics|mesh-ancestor
92511948|NCT00000579|Autonomic Agents|autonomic agents|mesh-ancestor
92511949|NCT00000579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92511950|NCT00000579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511951|NCT00000579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92511952|NCT00000579|Glucocorticoids|glucocorticoids|mesh-ancestor
92511953|NCT00000579|Hormones|hormones|mesh-ancestor
92511954|NCT00000579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92511955|NCT00000579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92511956|NCT00000579|Protective Agents|protective agents|mesh-ancestor
92511957|NCT00000579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92511958|NCT00000579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511959|NCT00000579|Antifungal Agents|antifungal agents|mesh-ancestor
92511960|NCT00000579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92511961|NCT00000579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92511962|NCT00000579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92511963|NCT00000579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92511964|NCT00000579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511965|NCT00000579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92511966|NCT00000579|Hormone Antagonists|hormone antagonists|mesh-ancestor
92511967|NCT00000579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92511968|NCT00000588|Pyridoxal|pyridoxal|mesh-list
92511969|NCT00000588|Pyridoxal isonicotinoyl hydrazone|pyridoxal isonicotinoyl hydrazone|mesh-list
92511970|NCT00000588|Vitamin B Complex|vitamin b complex|mesh-ancestor
92511971|NCT00000588|Vitamins|vitamins|mesh-ancestor
92511972|NCT00000588|Micronutrients|micronutrients|mesh-ancestor
92511973|NCT00000588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511974|NCT00000588|Chelating Agents|chelating agents|mesh-ancestor
92511975|NCT00000588|Sequestering Agents|sequestering agents|mesh-ancestor
92511976|NCT00000588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511977|NCT00000588|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92511978|NCT04713514|Pembrolizumab|pembrolizumab|mesh-list
92511979|NCT04713514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92511980|NCT04713514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92511981|NCT04713514|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92511982|NCT04713514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511983|NCT00000594|Cholestyramine Resin|cholestyramine resin|mesh-list
92511984|NCT00000594|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92511985|NCT00000594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92511986|NCT00000594|Antimetabolites|antimetabolites|mesh-ancestor
92511987|NCT00000594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92511988|NCT00000594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92511989|NCT00390091|Abetimus|abetimus|mesh-list
92511990|NCT00390091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92511991|NCT00390091|Immunologic Factors|immunologic factors|mesh-ancestor
92511992|NCT00390091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511993|NCT00390130|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92511994|NCT00390130|Immunologic Factors|immunologic factors|mesh-ancestor
92511995|NCT00390130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92511996|NCT04650880|Vitamin D|vitamin d|mesh-list
92511997|NCT04650880|Vitamins|vitamins|mesh-ancestor
92511998|NCT04650880|Micronutrients|micronutrients|mesh-ancestor
92511999|NCT04650880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512000|NCT04650880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92512001|NCT04601077|Nitric Oxide|nitric oxide|mesh-list
92512002|NCT04601077|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92512003|NCT04601077|Autonomic Agents|autonomic agents|mesh-ancestor
92512004|NCT04601077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512005|NCT04601077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512006|NCT04601077|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92512007|NCT04601077|Respiratory System Agents|respiratory system agents|mesh-ancestor
92512008|NCT04601077|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92512009|NCT04601077|Antioxidants|antioxidants|mesh-ancestor
92512010|NCT04601077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512011|NCT04601077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512012|NCT04601077|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92512013|NCT04601077|Vasodilator Agents|vasodilator agents|mesh-ancestor
92512014|NCT04601077|Gasotransmitters|gasotransmitters|mesh-ancestor
92512015|NCT04601077|Protective Agents|protective agents|mesh-ancestor
92512016|NCT00000609|Amiodarone|amiodarone|mesh-list
92512017|NCT00000609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92512018|NCT00000609|Vasodilator Agents|vasodilator agents|mesh-ancestor
92512019|NCT00000609|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92512020|NCT00000609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92512021|NCT00000609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512022|NCT00000609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92512023|NCT00000609|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92512024|NCT00000609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512025|NCT00000609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512026|NCT00000609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92512027|NCT00000609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92512028|NCT00000609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512029|NCT04547530|Vitamin D|vitamin d|mesh-list
92512030|NCT04547530|Vitamins|vitamins|mesh-ancestor
92512031|NCT04547530|Micronutrients|micronutrients|mesh-ancestor
92512032|NCT04547530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512033|NCT04547530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92512034|NCT04544683|Dexamethasone|dexamethasone|mesh-list
92512035|NCT04544683|Dexamethasone acetate|dexamethasone acetate|mesh-list
92512036|NCT04544683|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92512037|NCT04544683|BB 1101|bb 1101|mesh-list
92512038|NCT04544683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92512039|NCT04544683|Antiemetics|antiemetics|mesh-ancestor
92512040|NCT04544683|Autonomic Agents|autonomic agents|mesh-ancestor
92512041|NCT04544683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512042|NCT04544683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512043|NCT04544683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92512044|NCT04544683|Glucocorticoids|glucocorticoids|mesh-ancestor
92512045|NCT04544683|Hormones|hormones|mesh-ancestor
92512046|NCT04544683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512047|NCT04544683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92512048|NCT04544683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512049|NCT04544683|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512050|NCT04544683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512051|NCT04544683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512052|NCT00000612|Estrogens|estrogens|mesh-list
92512053|NCT00000612|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92512054|NCT00000612|Hormones|hormones|mesh-ancestor
92512055|NCT00000612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512056|NCT00000612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512057|NCT00000639|Itraconazole|itraconazole|mesh-list
92512058|NCT00000639|Fluconazole|fluconazole|mesh-list
92512059|NCT00000639|Amphotericin B|amphotericin b|mesh-list
92512060|NCT00000639|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92512061|NCT00000639|Flucytosine|flucytosine|mesh-list
92512062|NCT00000639|Antifungal Agents|antifungal agents|mesh-ancestor
92512063|NCT00000639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512064|NCT00000639|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92512065|NCT00000639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512066|NCT00000639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512067|NCT00000639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512068|NCT00000639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92512069|NCT00000639|Hormone Antagonists|hormone antagonists|mesh-ancestor
92512070|NCT00000639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512071|NCT00000639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512072|NCT00000639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512073|NCT00000639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92512074|NCT00000639|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92512076|NCT00000639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92512077|NCT00000639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92512078|NCT00000639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512079|NCT00000639|Antimetabolites|antimetabolites|mesh-ancestor
92512080|NCT00000642|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92512081|NCT00000642|Immunologic Factors|immunologic factors|mesh-ancestor
92512082|NCT00000642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512084|NCT00000645|Antidepressive Agents|antidepressive agents|mesh-ancestor
92512085|NCT00000645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92512086|NCT00000645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512087|NCT00000645|Antiviral Agents|antiviral agents|mesh-ancestor
92512088|NCT00000645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512089|NCT00000645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512090|NCT00000645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512091|NCT00000645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92512092|NCT00000645|Immunologic Factors|immunologic factors|mesh-ancestor
92512093|NCT00000645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512094|NCT04495504|Ropivacaine|ropivacaine|mesh-list
92512095|NCT04495504|Anesthetics, Local|anesthetics, local|mesh-ancestor
92512096|NCT04495504|Anesthetics|anesthetics|mesh-ancestor
92512097|NCT04495504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92512098|NCT04495504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512099|NCT04495504|Sensory System Agents|sensory system agents|mesh-ancestor
92512100|NCT04495504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512101|NCT00390208|Dexamethasone|dexamethasone|mesh-list
92512102|NCT00390208|Ranibizumab|ranibizumab|mesh-list
92512103|NCT00390208|Verteporfin|verteporfin|mesh-list
92512104|NCT00390208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92512105|NCT00390208|Antiemetics|antiemetics|mesh-ancestor
92512106|NCT00390208|Autonomic Agents|autonomic agents|mesh-ancestor
92512107|NCT00390208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512108|NCT00390208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512109|NCT00390208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92512110|NCT00390208|Glucocorticoids|glucocorticoids|mesh-ancestor
92512111|NCT00390208|Hormones|hormones|mesh-ancestor
92512112|NCT00390208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512113|NCT00390208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92512114|NCT00390208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512115|NCT00390208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92512116|NCT00390208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92512117|NCT00390208|Growth Substances|growth substances|mesh-ancestor
92512118|NCT00390208|Growth Inhibitors|growth inhibitors|mesh-ancestor
92512119|NCT00390208|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92512120|NCT00390208|Dermatologic Agents|dermatologic agents|mesh-ancestor
92512121|NCT00389025|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92512122|NCT00389025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92512123|NCT00389025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92512124|NCT00389025|Analgesics|analgesics|mesh-ancestor
92512125|NCT00389025|Sensory System Agents|sensory system agents|mesh-ancestor
92512126|NCT00389025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512127|NCT00389025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512128|NCT00389025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92512129|NCT00389025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92512130|NCT00389025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92512131|NCT00389025|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92512132|NCT00389025|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92512133|NCT00389025|Histamine Antagonists|histamine antagonists|mesh-ancestor
92512134|NCT00389025|Histamine Agents|histamine agents|mesh-ancestor
92512135|NCT00389025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512136|NCT00389025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512137|NCT00390247|Thalidomide|thalidomide|mesh-list
92512138|NCT00390247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92512139|NCT00390247|Immunologic Factors|immunologic factors|mesh-ancestor
92512140|NCT00390247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512141|NCT00390247|Leprostatic Agents|leprostatic agents|mesh-ancestor
92512142|NCT00390247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512143|NCT00390247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512144|NCT00390247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92512145|NCT00390247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92512146|NCT00390247|Growth Substances|growth substances|mesh-ancestor
92512147|NCT00390247|Growth Inhibitors|growth inhibitors|mesh-ancestor
92512148|NCT00390247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512149|NCT00000651|Zidovudine|zidovudine|mesh-list
92512150|NCT00000651|Zalcitabine|zalcitabine|mesh-list
92512151|NCT00000651|Antimetabolites|antimetabolites|mesh-ancestor
92512152|NCT00000651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512153|NCT00000651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512154|NCT00000651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512155|NCT00000651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512156|NCT00000651|Antiviral Agents|antiviral agents|mesh-ancestor
92512157|NCT00000651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512158|NCT00000651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512159|NCT00000651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512161|NCT00000666|Antimalarials|antimalarials|mesh-ancestor
92512162|NCT00000666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92512163|NCT00000666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92512164|NCT00000666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512165|NCT00000666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92512166|NCT00000666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512167|NCT00000666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512168|NCT00000672|Didanosine|didanosine|mesh-list
92512169|NCT00000672|Antimetabolites|antimetabolites|mesh-ancestor
92512170|NCT00000672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512171|NCT00000672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512172|NCT00000672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512173|NCT00000672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512174|NCT00000672|Antiviral Agents|antiviral agents|mesh-ancestor
92512175|NCT00000672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512176|NCT00000672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512177|NCT00000672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512178|NCT04321954|Lenvatinib|lenvatinib|mesh-list
92512179|NCT04321954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512180|NCT04321954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92512181|NCT04321954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512182|NCT04321954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512183|NCT00000675|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92512184|NCT00000675|Immunologic Factors|immunologic factors|mesh-ancestor
92512185|NCT00000675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512186|NCT00000678|Zidovudine|zidovudine|mesh-list
92512187|NCT00000678|Zalcitabine|zalcitabine|mesh-list
92512188|NCT00000678|Antimetabolites|antimetabolites|mesh-ancestor
92512189|NCT00000678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512190|NCT00000678|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512191|NCT00000678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512192|NCT00000678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512193|NCT00000678|Antiviral Agents|antiviral agents|mesh-ancestor
92512194|NCT00000678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512195|NCT00000678|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512196|NCT00000678|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512197|NCT00390403|Acetic Acid|acetic acid|mesh-list
92512198|NCT00390403|Temozolomide|temozolomide|mesh-list
92512199|NCT00390403|Retinol acetate|retinol acetate|mesh-list
92512200|NCT00390403|Gossypol acetic acid|gossypol acetic acid|mesh-list
92512201|NCT00390403|Gossypol|gossypol|mesh-list
92512202|NCT00390403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92512203|NCT00390403|Alkylating Agents|alkylating agents|mesh-ancestor
92512204|NCT00390403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512205|NCT00390403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512206|NCT00390403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512207|NCT00390403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512208|NCT00390403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92512209|NCT00390403|Immunologic Factors|immunologic factors|mesh-ancestor
92512210|NCT00390403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512211|NCT00390403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92512212|NCT00390403|Protective Agents|protective agents|mesh-ancestor
92512213|NCT00390403|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92512214|NCT00390403|Contraceptive Agents|contraceptive agents|mesh-ancestor
92512215|NCT00390403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92512216|NCT00390403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92512217|NCT00390403|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92512218|NCT00390403|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92512219|NCT00390403|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92512220|NCT00000681|Zidovudine|zidovudine|mesh-list
92512221|NCT00000681|Doxorubicin|doxorubicin|mesh-list
92512222|NCT00000681|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92512223|NCT00000681|Bleomycin|bleomycin|mesh-list
92512224|NCT00000681|Vincristine|vincristine|mesh-list
92512225|NCT00000681|Sargramostim|sargramostim|mesh-list
92512226|NCT00000681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92512227|NCT00000681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512228|NCT00000681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92512229|NCT00000681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92512230|NCT00000681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512231|NCT00000681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512232|NCT00000681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92512233|NCT00000681|Tubulin Modulators|tubulin modulators|mesh-ancestor
92512235|NCT00000681|Mitosis Modulators|mitosis modulators|mesh-ancestor
92512237|NCT00000681|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512238|NCT00000681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512239|NCT00000681|Antiviral Agents|antiviral agents|mesh-ancestor
92512240|NCT00000681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512241|NCT00000681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512242|NCT00000681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512243|NCT00000681|Immunologic Factors|immunologic factors|mesh-ancestor
92512244|NCT00000681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512245|NCT00000684|Dextrans|dextrans|mesh-list
92512246|NCT00000684|Anticoagulants|anticoagulants|mesh-ancestor
92512247|NCT00000684|Plasma Substitutes|plasma substitutes|mesh-ancestor
92512248|NCT00000684|Blood Substitutes|blood substitutes|mesh-ancestor
92512249|NCT00000687|Interferons|interferons|mesh-list
92512250|NCT00000687|Interferon-alpha|interferon-alpha|mesh-list
92512251|NCT00000687|Interferon alpha-2|interferon alpha-2|mesh-list
92512252|NCT00000687|Zidovudine|zidovudine|mesh-list
92512253|NCT00000687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512254|NCT00000687|Antiviral Agents|antiviral agents|mesh-ancestor
92512255|NCT00000687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512256|NCT00000687|Immunologic Factors|immunologic factors|mesh-ancestor
92512257|NCT00000687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512258|NCT00000687|Antimetabolites|antimetabolites|mesh-ancestor
92512259|NCT00000687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512260|NCT00000687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512261|NCT00000687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512262|NCT00000687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512263|NCT00000687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512264|NCT00000687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512265|NCT00000690|Dextrans|dextrans|mesh-list
92512266|NCT00000690|Anticoagulants|anticoagulants|mesh-ancestor
92512267|NCT00000690|Plasma Substitutes|plasma substitutes|mesh-ancestor
92512268|NCT00000690|Blood Substitutes|blood substitutes|mesh-ancestor
92512269|NCT00000696|Interferons|interferons|mesh-list
92512270|NCT00000696|Interferon-alpha|interferon-alpha|mesh-list
92512271|NCT00000696|Interferon alpha-2|interferon alpha-2|mesh-list
92512272|NCT00000696|Zidovudine|zidovudine|mesh-list
92512273|NCT00000696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512274|NCT00000696|Antiviral Agents|antiviral agents|mesh-ancestor
92512275|NCT00000696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512276|NCT00000696|Immunologic Factors|immunologic factors|mesh-ancestor
92512277|NCT00000696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512278|NCT00000696|Antimetabolites|antimetabolites|mesh-ancestor
92512279|NCT00000696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512280|NCT00000696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512281|NCT00000696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512282|NCT00000696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512283|NCT00000696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512284|NCT00000696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512285|NCT00000705|Zidovudine|zidovudine|mesh-list
92512286|NCT00000705|Antimetabolites|antimetabolites|mesh-ancestor
92512287|NCT00000705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512288|NCT00000705|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512289|NCT00000705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512290|NCT00000705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512291|NCT00000705|Antiviral Agents|antiviral agents|mesh-ancestor
92512292|NCT00000705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512293|NCT00000705|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512294|NCT00000705|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512295|NCT00000708|Fluconazole|fluconazole|mesh-list
92512296|NCT00000708|Amphotericin B|amphotericin b|mesh-list
92512297|NCT00000708|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92512298|NCT00000708|Flucytosine|flucytosine|mesh-list
92512299|NCT00000708|Antifungal Agents|antifungal agents|mesh-ancestor
92351324|NCT04020588|Minocycline|minocycline|mesh-list
92512300|NCT00000708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512301|NCT00000708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92512302|NCT00000708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512303|NCT00000708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512304|NCT00000708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512305|NCT00000708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92512306|NCT00000708|Hormone Antagonists|hormone antagonists|mesh-ancestor
92512307|NCT00000708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512308|NCT00000708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237243|NCT01402375|Respiratory System Agents|respiratory system agents|mesh-ancestor
92512309|NCT00000708|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92512310|NCT00000708|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92512311|NCT00000708|Amebicides|amebicides|mesh-ancestor
92512312|NCT00000708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92512313|NCT00000708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92512314|NCT00000708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512315|NCT00000708|Antimetabolites|antimetabolites|mesh-ancestor
92512317|NCT00000711|Sargramostim|sargramostim|mesh-list
92512318|NCT00000711|Antimetabolites|antimetabolites|mesh-ancestor
92512319|NCT00000711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512320|NCT00000711|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512321|NCT00000711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512322|NCT00000711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512323|NCT00000711|Antiviral Agents|antiviral agents|mesh-ancestor
92512324|NCT00000711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512325|NCT00000711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512326|NCT00000711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512327|NCT00000711|Immunologic Factors|immunologic factors|mesh-ancestor
92512328|NCT00000711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512329|NCT00000717|Clindamycin|clindamycin|mesh-list
92512330|NCT00000717|Clindamycin palmitate|clindamycin palmitate|mesh-list
92512331|NCT00000717|Clindamycin phosphate|clindamycin phosphate|mesh-list
92512332|NCT00000717|Primaquine|primaquine|mesh-list
92512333|NCT00000717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512334|NCT00000717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512335|NCT00000717|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92512336|NCT00000717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512337|NCT00000717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512338|NCT00000717|Antimalarials|antimalarials|mesh-ancestor
92512339|NCT00000717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92512340|NCT00000717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92512341|NCT00000720|Zidovudine|zidovudine|mesh-list
92512342|NCT00000720|Immunoglobulins|immunoglobulins|mesh-list
92512343|NCT00000720|Antibodies|antibodies|mesh-list
92512344|NCT00000720|Antimetabolites|antimetabolites|mesh-ancestor
92512345|NCT00000720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512346|NCT00000720|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512347|NCT00000720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512348|NCT00000720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512349|NCT00000720|Antiviral Agents|antiviral agents|mesh-ancestor
92512350|NCT00000720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512351|NCT00000720|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512352|NCT00000720|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512353|NCT00000720|Immunologic Factors|immunologic factors|mesh-ancestor
92512354|NCT00000720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512355|NCT04142983|Vaccines|vaccines|mesh-list
92512356|NCT04142983|Immunologic Factors|immunologic factors|mesh-ancestor
92512357|NCT04142983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512358|NCT00000726|Foscarnet|foscarnet|mesh-list
92512359|NCT00000726|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92351350|NCT04140786|Gentamicins|gentamicins|mesh-list
92512360|NCT00000726|Antiviral Agents|antiviral agents|mesh-ancestor
92512361|NCT00000726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512362|NCT00000726|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512363|NCT00000726|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512364|NCT00000726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512365|NCT00000726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512366|NCT00000741|Methylprednisolone|methylprednisolone|mesh-list
92512367|NCT00000741|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92512368|NCT00000741|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92512369|NCT00000741|Prednisolone|prednisolone|mesh-list
92512370|NCT00000741|Prednisolone acetate|prednisolone acetate|mesh-list
92512371|NCT00000741|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92512372|NCT00000741|Prednisolone phosphate|prednisolone phosphate|mesh-list
92512373|NCT00000741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92512374|NCT00000741|Antiemetics|antiemetics|mesh-ancestor
92512375|NCT00000741|Autonomic Agents|autonomic agents|mesh-ancestor
92512376|NCT00000741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512377|NCT00000741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512378|NCT00000741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92512379|NCT00000741|Glucocorticoids|glucocorticoids|mesh-ancestor
92512380|NCT00000741|Hormones|hormones|mesh-ancestor
92512381|NCT00000741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512382|NCT00000741|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92512383|NCT00000741|Protective Agents|protective agents|mesh-ancestor
92237323|NCT01409239|Insulin|insulin|mesh-list
92512384|NCT00000741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92512385|NCT00000741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512386|NCT04069897|Botulinum Toxins|botulinum toxins|mesh-list
92512387|NCT04069897|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92512388|NCT04069897|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92512389|NCT04069897|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92512390|NCT04069897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92512391|NCT04069897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512392|NCT04069897|Cholinergic Agents|cholinergic agents|mesh-ancestor
92512393|NCT04069897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512394|NCT04069897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512395|NCT04069897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92512396|NCT04069897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512397|NCT00000744|Fluconazole|fluconazole|mesh-list
92512398|NCT00000744|Antifungal Agents|antifungal agents|mesh-ancestor
92512399|NCT00000744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512400|NCT00000744|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92512401|NCT00000744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512402|NCT00000744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512403|NCT00000744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512404|NCT00000744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92512405|NCT00000744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92512406|NCT00000744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512407|NCT00000744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512408|NCT00000744|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92512409|NCT00000744|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92512410|NCT04039204|Contraceptive Agents|contraceptive agents|mesh-list
92512411|NCT04039204|Contraceptives, Oral|contraceptives, oral|mesh-list
92512412|NCT04039204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92512413|NCT04039204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512414|NCT04039204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92512415|NCT04038346|Acetaminophen|acetaminophen|mesh-list
92512416|NCT04038346|Naproxen|naproxen|mesh-list
92512417|NCT04038346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92512418|NCT04038346|Analgesics|analgesics|mesh-ancestor
92512419|NCT04038346|Sensory System Agents|sensory system agents|mesh-ancestor
92512420|NCT04038346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512421|NCT04038346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512422|NCT04038346|Antipyretics|antipyretics|mesh-ancestor
92512423|NCT04038346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92512424|NCT04038346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92512425|NCT04038346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92512426|NCT04038346|Gout Suppressants|gout suppressants|mesh-ancestor
92512427|NCT04038346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92512428|NCT04038346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351360|NCT04022226|Analgesics|analgesics|mesh-ancestor
92512429|NCT04038346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512430|NCT04020172|Dobutamine|dobutamine|mesh-list
92512431|NCT04020172|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92512432|NCT04020172|Sympathomimetics|sympathomimetics|mesh-ancestor
92512434|NCT04020172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512435|NCT04020172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512436|NCT04020172|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92512437|NCT04020172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92512438|NCT04020172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92512439|NCT04020172|Adrenergic Agents|adrenergic agents|mesh-ancestor
92512440|NCT04020172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512441|NCT04020172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512442|NCT04020172|Protective Agents|protective agents|mesh-ancestor
92512443|NCT00000747|Nevirapine|nevirapine|mesh-list
92512444|NCT00000747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512445|NCT00000747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512446|NCT00000747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512447|NCT00000747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512448|NCT00000747|Antiviral Agents|antiviral agents|mesh-ancestor
92512449|NCT00000747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512450|NCT00000747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512451|NCT00000747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512452|NCT00000747|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92512453|NCT00000747|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92512454|NCT00000753|Zidovudine|zidovudine|mesh-list
92512455|NCT00000753|Didanosine|didanosine|mesh-list
92512456|NCT00000753|Zalcitabine|zalcitabine|mesh-list
92512457|NCT00000753|Atevirdine|atevirdine|mesh-list
92512458|NCT00000753|Antimetabolites|antimetabolites|mesh-ancestor
92512459|NCT00000753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512460|NCT00000753|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512461|NCT00000753|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512462|NCT00000753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512463|NCT00000753|Antiviral Agents|antiviral agents|mesh-ancestor
92512464|NCT00000753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512465|NCT00000753|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512466|NCT00000753|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512467|NCT03991741|Interleukin-2|interleukin-2|mesh-list
92512468|NCT03991741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512469|NCT03991741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92512470|NCT03991741|Analgesics|analgesics|mesh-ancestor
92512471|NCT03991741|Sensory System Agents|sensory system agents|mesh-ancestor
92512472|NCT03991741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512473|NCT03991741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512474|NCT00000768|Ganciclovir|ganciclovir|mesh-list
92512475|NCT00000768|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92512476|NCT00000768|Antiviral Agents|antiviral agents|mesh-ancestor
92512477|NCT00000768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512478|NCT00000768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512479|NCT00000768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512480|NCT00000768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512481|NCT00000789|Zidovudine|zidovudine|mesh-list
92512482|NCT00000789|Stavudine|stavudine|mesh-list
92512483|NCT00000789|Antimetabolites|antimetabolites|mesh-ancestor
92512484|NCT00000789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512485|NCT00000789|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512486|NCT00000789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512487|NCT00000789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512488|NCT00000789|Antiviral Agents|antiviral agents|mesh-ancestor
92512489|NCT00000789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512490|NCT00000789|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512491|NCT00000789|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512492|NCT00000792|Hypericin|hypericin|mesh-list
92512493|NCT00000792|Antidepressive Agents|antidepressive agents|mesh-ancestor
92512494|NCT00000792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92512495|NCT00000792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512496|NCT00000792|Antiviral Agents|antiviral agents|mesh-ancestor
92512497|NCT00000792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512498|NCT00000792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512499|NCT00000792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512500|NCT00000792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92512501|NCT00000792|Immunologic Factors|immunologic factors|mesh-ancestor
92512502|NCT00000792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512503|NCT03937609|Infliximab|infliximab|mesh-list
92512504|NCT03937609|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92512506|NCT03937609|Dermatologic Agents|dermatologic agents|mesh-ancestor
92512507|NCT03937609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92512508|NCT03937609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92512509|NCT00390520|Vildagliptin|vildagliptin|mesh-list
92512510|NCT00390520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92512511|NCT00390520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512512|NCT00390520|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92512513|NCT00390520|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512514|NCT00390520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512515|NCT00390520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512516|NCT00000813|polysaccharide-K|polysaccharide-k|mesh-list
92512517|NCT00000813|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92512518|NCT00000813|Immunologic Factors|immunologic factors|mesh-ancestor
92512519|NCT00000813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512520|NCT00000813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92512521|NCT00000813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512522|NCT00000813|Antiviral Agents|antiviral agents|mesh-ancestor
92512523|NCT00000813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512524|NCT00000813|Interferon Inducers|interferon inducers|mesh-ancestor
92512525|NCT00000813|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92512526|NCT00000813|Protective Agents|protective agents|mesh-ancestor
92512527|NCT03877549|Dexamethasone|dexamethasone|mesh-list
92512528|NCT03877549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92512529|NCT03877549|Antiemetics|antiemetics|mesh-ancestor
92512530|NCT03877549|Autonomic Agents|autonomic agents|mesh-ancestor
92512531|NCT03877549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512532|NCT03877549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512533|NCT03877549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92237473|NCT02092298|Sodium thiosulfate|sodium thiosulfate|mesh-list
92512534|NCT03877549|Glucocorticoids|glucocorticoids|mesh-ancestor
92512535|NCT03877549|Hormones|hormones|mesh-ancestor
92512536|NCT03877549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512537|NCT03877549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92512538|NCT03877549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512539|NCT00390598|Sennosides|sennosides|mesh-list
92512540|NCT00390598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92512541|NCT00390598|Laxatives|laxatives|mesh-ancestor
92512542|NCT00390598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92512543|NCT00000816|Trimethoprim|trimethoprim|mesh-list
92512544|NCT00000816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92512545|NCT00000816|Sulfamethoxazole|sulfamethoxazole|mesh-list
92512546|NCT00000816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92512547|NCT00000816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512548|NCT00000816|Antimalarials|antimalarials|mesh-ancestor
92512549|NCT00000816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92512550|NCT00000816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92512551|NCT00000816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92512552|NCT00000816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512553|NCT00000816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512554|NCT00000816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92512555|NCT00000816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92512556|NCT00000816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512557|NCT00000816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512558|NCT03801031|Lidocaine|lidocaine|mesh-list
92512559|NCT03801031|Anesthetics, Local|anesthetics, local|mesh-ancestor
92512560|NCT03801031|Anesthetics|anesthetics|mesh-ancestor
92512561|NCT03801031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92512562|NCT03801031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512563|NCT03801031|Sensory System Agents|sensory system agents|mesh-ancestor
92512564|NCT03801031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512565|NCT03801031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92512566|NCT03801031|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92512567|NCT03801031|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92512568|NCT03801031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92512569|NCT03801031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512570|NCT00000822|Ritonavir|ritonavir|mesh-list
92512571|NCT00000822|Didanosine|didanosine|mesh-list
92512572|NCT00000822|Stavudine|stavudine|mesh-list
92512573|NCT00000822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512574|NCT00000822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512575|NCT00000822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512576|NCT00000822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512577|NCT00000822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512578|NCT00000822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512579|NCT00000822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512580|NCT00000822|Antiviral Agents|antiviral agents|mesh-ancestor
92512581|NCT00000822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512582|NCT00000822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512583|NCT00000822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512584|NCT00000822|Antimetabolites|antimetabolites|mesh-ancestor
92512585|NCT00000822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512586|NCT00000822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512587|NCT03797560|Pregabalin|pregabalin|mesh-list
92512588|NCT03797560|Analgesics|analgesics|mesh-ancestor
92512589|NCT03797560|Sensory System Agents|sensory system agents|mesh-ancestor
92512590|NCT03797560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512591|NCT03797560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512592|NCT03797560|Anticonvulsants|anticonvulsants|mesh-ancestor
92512593|NCT03797560|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92512594|NCT03797560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92512595|NCT03797560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512596|NCT03797560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92512597|NCT03797560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92512598|NCT03797560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92512599|NCT03797560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92512600|NCT03797560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92512601|NCT03729271|Rifaximin|rifaximin|mesh-list
92512602|NCT03729271|Lactulose|lactulose|mesh-list
92512603|NCT03729271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512604|NCT03729271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512606|NCT03646123|Doxorubicin|doxorubicin|mesh-list
92512607|NCT03646123|Nivolumab|nivolumab|mesh-list
92512608|NCT03646123|Dacarbazine|dacarbazine|mesh-list
92512609|NCT03646123|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92512610|NCT03646123|Vinblastine|vinblastine|mesh-list
92512611|NCT03646123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92512612|NCT03646123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512613|NCT03646123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92512614|NCT03646123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92512615|NCT03646123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512616|NCT03646123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512617|NCT03646123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92512618|NCT03646123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92512619|NCT03646123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92512620|NCT03646123|Alkylating Agents|alkylating agents|mesh-ancestor
92512621|NCT03646123|Immunotoxins|immunotoxins|mesh-ancestor
92512622|NCT03646123|Immunoconjugates|immunoconjugates|mesh-ancestor
92512623|NCT03646123|Immunologic Factors|immunologic factors|mesh-ancestor
92512624|NCT03646123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512625|NCT03646123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92512626|NCT03646123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92512627|NCT03646123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92512628|NCT03646123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92512629|NCT03574402|Carboplatin|carboplatin|mesh-list
92512630|NCT03574402|Gemcitabine|gemcitabine|mesh-list
92512631|NCT03574402|Pemetrexed|pemetrexed|mesh-list
92512632|NCT03574402|Afatinib|afatinib|mesh-list
92512633|NCT03574402|Crizotinib|crizotinib|mesh-list
92512634|NCT03574402|Nimotuzumab|nimotuzumab|mesh-list
92512635|NCT03574402|Ensartinib|ensartinib|mesh-list
92512636|NCT03574402|Maleic acid|maleic acid|mesh-list
92512637|NCT03574402|Abivertinib|abivertinib|mesh-list
92512638|NCT03574402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512639|NCT03574402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92512640|NCT03574402|Antimetabolites|antimetabolites|mesh-ancestor
92512641|NCT03574402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512642|NCT03574402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512643|NCT03574402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92512644|NCT03574402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512645|NCT03574402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92512646|NCT03574402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92512647|NCT03539302|Flecainide|flecainide|mesh-list
92512648|NCT03539302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92512649|NCT03539302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92512650|NCT03539302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92512651|NCT03539302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533179|NCT00058201|Antidotes|antidotes|mesh-ancestor
92512652|NCT03539302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512653|NCT00000831|Lamivudine|lamivudine|mesh-list
92512654|NCT00000831|Zidovudine|zidovudine|mesh-list
92512655|NCT00000831|Didanosine|didanosine|mesh-list
92512656|NCT00000831|Stavudine|stavudine|mesh-list
92512657|NCT00000831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512658|NCT00000831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512659|NCT00000831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512660|NCT00000831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512661|NCT00000831|Antiviral Agents|antiviral agents|mesh-ancestor
92512662|NCT00000831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512663|NCT00000831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512664|NCT00000831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512665|NCT00000831|Antimetabolites|antimetabolites|mesh-ancestor
92512666|NCT00000849|Aldesleukin|aldesleukin|mesh-list
92512667|NCT00000849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512668|NCT00000849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512669|NCT00000849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512670|NCT00000849|Antiviral Agents|antiviral agents|mesh-ancestor
92512671|NCT00000849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512672|NCT03357952|Daratumumab|daratumumab|mesh-list
92512673|NCT03357952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512674|NCT00000855|Zidovudine|zidovudine|mesh-list
92512675|NCT00000855|Antimetabolites|antimetabolites|mesh-ancestor
92512676|NCT00000855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512677|NCT00000855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512678|NCT00000855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512679|NCT00000855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512680|NCT00000855|Antiviral Agents|antiviral agents|mesh-ancestor
92512681|NCT00000855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237626|NCT03047135|Olaparib|olaparib|mesh-list
92512683|NCT00000855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512684|NCT03317392|Olaparib|olaparib|mesh-list
92512685|NCT03317392|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92512686|NCT03317392|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92512687|NCT03317392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512688|NCT03317392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512689|NCT03317392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512690|NCT00000867|Memantine|memantine|mesh-list
92512691|NCT00000867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92512692|NCT00000867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92512693|NCT00000867|Dopamine Agents|dopamine agents|mesh-ancestor
92512694|NCT00000867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512695|NCT00000867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512696|NCT00000867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512697|NCT00000867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92512698|NCT00000867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92512699|NCT00390676|Carboplatin|carboplatin|mesh-list
92512700|NCT00390676|Docetaxel|docetaxel|mesh-list
92512701|NCT00390676|Capecitabine|capecitabine|mesh-list
92512702|NCT00390676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512703|NCT00390676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92512704|NCT00390676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92512705|NCT00390676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92512706|NCT00390676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512707|NCT00390676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92512708|NCT00390676|Antimetabolites|antimetabolites|mesh-ancestor
92512709|NCT00000870|Lamivudine|lamivudine|mesh-list
92512710|NCT00000870|Zidovudine|zidovudine|mesh-list
92512711|NCT00000870|Didanosine|didanosine|mesh-list
92512712|NCT00000870|Stavudine|stavudine|mesh-list
92512713|NCT00000870|Aldesleukin|aldesleukin|mesh-list
92512714|NCT00000870|Indinavir|indinavir|mesh-list
92512715|NCT00000870|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512716|NCT00000870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512717|NCT00000870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512718|NCT00000870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512719|NCT00000870|Antiviral Agents|antiviral agents|mesh-ancestor
92512720|NCT00000870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512721|NCT00000870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512722|NCT00000870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512723|NCT00000870|Antimetabolites|antimetabolites|mesh-ancestor
92512724|NCT00000870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512725|NCT00000870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512726|NCT00000870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512727|NCT00000870|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512728|NCT00390832|Epoetin Alfa|epoetin alfa|mesh-list
92512729|NCT00390832|Hematinics|hematinics|mesh-ancestor
92512730|NCT00390871|Fentanyl|fentanyl|mesh-list
92512731|NCT00390871|Dexmedetomidine|dexmedetomidine|mesh-list
92512732|NCT00390871|Propofol|propofol|mesh-list
92512733|NCT00390871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92512734|NCT00390871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92512735|NCT00390871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512736|NCT00390871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92512737|NCT00390871|Analgesics|analgesics|mesh-ancestor
92512738|NCT00390871|Sensory System Agents|sensory system agents|mesh-ancestor
92512739|NCT00390871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512740|NCT00390871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92512741|NCT00390871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92512742|NCT00390871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92512743|NCT00390871|Adrenergic Agents|adrenergic agents|mesh-ancestor
92512744|NCT00390871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92512745|NCT00390871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512746|NCT00390871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92512747|NCT00390871|Anesthetics, General|anesthetics, general|mesh-ancestor
92512748|NCT00390871|Anesthetics|anesthetics|mesh-ancestor
92512749|NCT00390871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92512750|NCT00390871|Narcotics|narcotics|mesh-ancestor
92512751|NCT00390871|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92512752|NCT03211741|Bevacizumab|bevacizumab|mesh-list
92512753|NCT03211741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92512754|NCT03211741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512755|NCT03211741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92512756|NCT03211741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92512757|NCT03211741|Growth Substances|growth substances|mesh-ancestor
92512758|NCT03211741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512759|NCT03211741|Growth Inhibitors|growth inhibitors|mesh-ancestor
92237703|NCT00118274|Vaccines|vaccines|mesh-list
92512761|NCT03206203|Atezolizumab|atezolizumab|mesh-list
92512762|NCT03206203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512763|NCT03206203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92512764|NCT03206203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512765|NCT03206203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92512766|NCT00000882|Lamivudine|lamivudine|mesh-list
92512767|NCT00000882|Zidovudine|zidovudine|mesh-list
92512768|NCT00000882|Stavudine|stavudine|mesh-list
92512769|NCT00000882|Delavirdine|delavirdine|mesh-list
92512770|NCT00000882|Indinavir|indinavir|mesh-list
92512771|NCT00000882|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512772|NCT00000882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512773|NCT00000882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512774|NCT00000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512775|NCT00000882|Antiviral Agents|antiviral agents|mesh-ancestor
92512776|NCT00000882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512777|NCT00000882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512778|NCT00000882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512779|NCT00000882|Antimetabolites|antimetabolites|mesh-ancestor
92512780|NCT00000882|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512781|NCT00000882|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512782|NCT00000882|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512783|NCT00000888|Ritonavir|ritonavir|mesh-list
92512784|NCT00000888|Lamivudine|lamivudine|mesh-list
92512785|NCT00000888|Zidovudine|zidovudine|mesh-list
92512786|NCT00000888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512787|NCT00000888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512788|NCT00000888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512789|NCT00000888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512790|NCT00000888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512791|NCT00000888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512792|NCT00000888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512793|NCT00000888|Antiviral Agents|antiviral agents|mesh-ancestor
92512794|NCT00000888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512795|NCT00000888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512796|NCT00000888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512797|NCT00000888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512798|NCT00000888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512799|NCT00000888|Antimetabolites|antimetabolites|mesh-ancestor
92512800|NCT00000891|Ritonavir|ritonavir|mesh-list
92512801|NCT00000891|Saquinavir|saquinavir|mesh-list
92512802|NCT00000891|Lamivudine|lamivudine|mesh-list
92512803|NCT00000891|Zidovudine|zidovudine|mesh-list
92512804|NCT00000891|Didanosine|didanosine|mesh-list
92512805|NCT00000891|Stavudine|stavudine|mesh-list
92512806|NCT00000891|Delavirdine|delavirdine|mesh-list
92512807|NCT00000891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512808|NCT00000891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512809|NCT00000891|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512810|NCT00000891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512811|NCT00000891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512812|NCT00000891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512813|NCT00000891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512814|NCT00000891|Antiviral Agents|antiviral agents|mesh-ancestor
92512815|NCT00000891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512816|NCT00000891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512817|NCT00000891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512818|NCT00000891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512819|NCT00000891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512820|NCT00000891|Antimetabolites|antimetabolites|mesh-ancestor
92512821|NCT00000903|Lamivudine|lamivudine|mesh-list
92512822|NCT00000903|Zidovudine|zidovudine|mesh-list
92512823|NCT00000903|Efavirenz|efavirenz|mesh-list
92512824|NCT00000903|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92512825|NCT00000903|Nelfinavir|nelfinavir|mesh-list
92512826|NCT00000903|Indinavir|indinavir|mesh-list
92512827|NCT00000903|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512828|NCT00000903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512829|NCT00000903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512830|NCT00000903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512831|NCT00000903|Antiviral Agents|antiviral agents|mesh-ancestor
92512832|NCT00000903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512833|NCT00000903|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921787|NCT02196805|Antimetabolites|antimetabolites|mesh-ancestor
92512835|NCT00000903|Antimetabolites|antimetabolites|mesh-ancestor
92512836|NCT00000903|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92512837|NCT00000903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512838|NCT00000903|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92512839|NCT00000903|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92512840|NCT00000903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92512841|NCT00000903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92512842|NCT00000903|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512843|NCT00000903|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512844|NCT00000903|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512845|NCT02939365|Abatacept|abatacept|mesh-list
92512846|NCT02939365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92512847|NCT02939365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512848|NCT02939365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92512849|NCT02939365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512850|NCT02939365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92512851|NCT02939365|Immunologic Factors|immunologic factors|mesh-ancestor
92512852|NCT02939365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512853|NCT02939365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92512854|NCT00000906|Ritonavir|ritonavir|mesh-list
92512855|NCT00000906|Saquinavir|saquinavir|mesh-list
92512856|NCT00000906|Methadone|methadone|mesh-list
92512857|NCT00000906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92512858|NCT00000906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92512859|NCT00000906|Protease Inhibitors|protease inhibitors|mesh-ancestor
92512860|NCT00000906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512861|NCT00000906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512862|NCT00000906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512863|NCT00000906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512864|NCT00000906|Antiviral Agents|antiviral agents|mesh-ancestor
92512865|NCT00000906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512866|NCT00000906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512867|NCT00000906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512868|NCT00000906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92512869|NCT00000906|Narcotics|narcotics|mesh-ancestor
92512870|NCT00000906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92512871|NCT00000906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512872|NCT00000906|Analgesics|analgesics|mesh-ancestor
92512873|NCT00000906|Sensory System Agents|sensory system agents|mesh-ancestor
92512874|NCT00000906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92512875|NCT00000906|Antitussive Agents|antitussive agents|mesh-ancestor
92512876|NCT00000906|Respiratory System Agents|respiratory system agents|mesh-ancestor
92512877|NCT02681302|Nivolumab|nivolumab|mesh-list
92512878|NCT02681302|Ipilimumab|ipilimumab|mesh-list
92512879|NCT02681302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92512880|NCT02681302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512881|NCT02681302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92512882|NCT02681302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512883|NCT00000951|Fluconazole|fluconazole|mesh-list
92512884|NCT00000951|Antifungal Agents|antifungal agents|mesh-ancestor
92512885|NCT00000951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512886|NCT00000951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92512887|NCT00000951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512888|NCT00000951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512889|NCT00000951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512890|NCT00000951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92512891|NCT00000951|Hormone Antagonists|hormone antagonists|mesh-ancestor
92512892|NCT00000951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512893|NCT00000951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512894|NCT00000951|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92512895|NCT00000951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92512896|NCT02627443|Carboplatin|carboplatin|mesh-list
92512897|NCT02627443|Gemcitabine|gemcitabine|mesh-list
92512898|NCT02627443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512899|NCT02627443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92512900|NCT02627443|Antimetabolites|antimetabolites|mesh-ancestor
92512901|NCT02627443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512902|NCT00000966|Leucovorin|leucovorin|mesh-list
92512903|NCT00000966|Azithromycin|azithromycin|mesh-list
92512904|NCT00000966|Pyrimethamine|pyrimethamine|mesh-list
92512905|NCT00000966|Calcium|calcium|mesh-list
92512906|NCT00000966|Levoleucovorin|levoleucovorin|mesh-list
92512907|NCT00000966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92512908|NCT00000966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512910|NCT00000966|Protective Agents|protective agents|mesh-ancestor
92512911|NCT00000966|Vitamin B Complex|vitamin b complex|mesh-ancestor
92512912|NCT00000966|Vitamins|vitamins|mesh-ancestor
92512913|NCT00000966|Micronutrients|micronutrients|mesh-ancestor
92512914|NCT00000966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92512915|NCT00000966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512916|NCT00000966|Antimalarials|antimalarials|mesh-ancestor
92512917|NCT00000966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92512918|NCT00000966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92512919|NCT00000966|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92512920|NCT00000966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512921|NCT00000966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512922|NCT00000969|Didanosine|didanosine|mesh-list
92512923|NCT00000969|Zalcitabine|zalcitabine|mesh-list
92512924|NCT00000969|Antimetabolites|antimetabolites|mesh-ancestor
92512925|NCT00000969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512926|NCT00000969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512927|NCT00000969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512928|NCT00000969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512929|NCT00000969|Antiviral Agents|antiviral agents|mesh-ancestor
92512930|NCT00000969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512931|NCT00000969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512932|NCT00000969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512933|NCT00000975|Itraconazole|itraconazole|mesh-list
92512934|NCT00000975|Antifungal Agents|antifungal agents|mesh-ancestor
92512935|NCT00000975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512936|NCT00000975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92512937|NCT00000975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92512938|NCT00000975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512939|NCT00000975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512940|NCT00000975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92512941|NCT00000975|Hormone Antagonists|hormone antagonists|mesh-ancestor
92512942|NCT00000975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92512943|NCT00000975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92512944|NCT00000975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92512945|NCT00000978|Zidovudine|zidovudine|mesh-list
92512946|NCT00000978|Zalcitabine|zalcitabine|mesh-list
92512947|NCT00000978|Antimetabolites|antimetabolites|mesh-ancestor
92512948|NCT00000978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512949|NCT00000978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512950|NCT00000978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512951|NCT00000978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512952|NCT00000978|Antiviral Agents|antiviral agents|mesh-ancestor
92512953|NCT00000978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512954|NCT00000978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512955|NCT00000978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512957|NCT00000999|Antimetabolites|antimetabolites|mesh-ancestor
92512958|NCT00000999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512959|NCT00000999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512960|NCT00000999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512961|NCT00000999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512962|NCT00000999|Antiviral Agents|antiviral agents|mesh-ancestor
92512963|NCT00000999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512964|NCT00000999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512965|NCT00000999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512966|NCT00001002|Zidovudine|zidovudine|mesh-list
92512967|NCT00001002|Foscarnet|foscarnet|mesh-list
92512968|NCT00001002|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92512969|NCT00001002|Antimetabolites|antimetabolites|mesh-ancestor
92512970|NCT00001002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512971|NCT00001002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512972|NCT00001002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512973|NCT00001002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512974|NCT00001002|Antiviral Agents|antiviral agents|mesh-ancestor
92512975|NCT00001002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512976|NCT00001002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512977|NCT00001002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92512978|NCT00005819|Paclitaxel|paclitaxel|mesh-list
92512979|NCT00005819|Fenretinide|fenretinide|mesh-list
92512980|NCT00005819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91921935|NCT02207335|Carboplatin|carboplatin|mesh-list
92512981|NCT00005819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92512982|NCT00005819|Tubulin Modulators|tubulin modulators|mesh-ancestor
92512983|NCT00005819|Antimitotic Agents|antimitotic agents|mesh-ancestor
92512984|NCT00005819|Mitosis Modulators|mitosis modulators|mesh-ancestor
92512985|NCT00005819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512986|NCT00005819|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92512987|NCT00005819|Protective Agents|protective agents|mesh-ancestor
92512988|NCT00005819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237933|NCT03008551|Metformin|metformin|mesh-list
92512989|NCT00001005|Zidovudine|zidovudine|mesh-list
92512990|NCT00001005|Aldesleukin|aldesleukin|mesh-list
92512991|NCT00001005|Antimetabolites|antimetabolites|mesh-ancestor
92512992|NCT00001005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92512993|NCT00001005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92512994|NCT00001005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92512995|NCT00001005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92512996|NCT00001005|Antiviral Agents|antiviral agents|mesh-ancestor
92512997|NCT00001005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92512998|NCT00001005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92512999|NCT00001005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513000|NCT00001005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513001|NCT00391105|Remifentanil|remifentanil|mesh-list
92513002|NCT00391105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92513003|NCT00391105|Narcotics|narcotics|mesh-ancestor
92513004|NCT00391105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92513005|NCT00391105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513006|NCT00391105|Analgesics|analgesics|mesh-ancestor
92513007|NCT00391105|Sensory System Agents|sensory system agents|mesh-ancestor
92513008|NCT00391105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513009|NCT00391144|Triamcinolone|triamcinolone|mesh-list
92513010|NCT00391144|Bevacizumab|bevacizumab|mesh-list
92513011|NCT00391144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92513012|NCT00391144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513013|NCT00391144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92513014|NCT00391144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92513015|NCT00391144|Growth Substances|growth substances|mesh-ancestor
92513016|NCT00391144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513017|NCT00391144|Growth Inhibitors|growth inhibitors|mesh-ancestor
92513018|NCT00391144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513019|NCT00391144|Glucocorticoids|glucocorticoids|mesh-ancestor
92513020|NCT00391144|Hormones|hormones|mesh-ancestor
92513021|NCT00391144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513022|NCT00005822|Tamoxifen|tamoxifen|mesh-list
92513023|NCT00005822|Doxorubicin|doxorubicin|mesh-list
92513024|NCT00005822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92513025|NCT00005822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513026|NCT00005822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513027|NCT00005822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513028|NCT00005822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513029|NCT00005822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513030|NCT00005822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513031|NCT00005822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92513032|NCT00005822|Hormone Antagonists|hormone antagonists|mesh-ancestor
92513033|NCT00005822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513034|NCT00005822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513035|NCT00005822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513036|NCT00005822|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92513037|NCT00005822|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92513038|NCT00005822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92513039|NCT00391261|Metformin|metformin|mesh-list
92513040|NCT00391261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92513041|NCT00391261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513042|NCT00001008|Zidovudine|zidovudine|mesh-list
92513043|NCT00001008|Methadone|methadone|mesh-list
92513044|NCT00001008|Antimetabolites|antimetabolites|mesh-ancestor
92513045|NCT00001008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513046|NCT00001008|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513047|NCT00001008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513048|NCT00001008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513049|NCT00001008|Antiviral Agents|antiviral agents|mesh-ancestor
92513050|NCT00001008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513051|NCT00001008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513052|NCT00001008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513053|NCT00001008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92513054|NCT00001008|Narcotics|narcotics|mesh-ancestor
92513055|NCT00001008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92513056|NCT00001008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513057|NCT00001008|Analgesics|analgesics|mesh-ancestor
92513058|NCT00001008|Sensory System Agents|sensory system agents|mesh-ancestor
92513059|NCT00001008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513060|NCT00001008|Antitussive Agents|antitussive agents|mesh-ancestor
92513061|NCT00001008|Respiratory System Agents|respiratory system agents|mesh-ancestor
92513062|NCT00005825|Vinorelbine|vinorelbine|mesh-list
92513063|NCT00005825|Mitomycins|mitomycins|mesh-list
92513064|NCT00005825|Mitomycin|mitomycin|mesh-list
92513066|NCT00005825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513067|NCT00005825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513068|NCT00005825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513069|NCT00005825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513070|NCT00005825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513071|NCT00005825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513072|NCT00005825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513073|NCT00005825|Alkylating Agents|alkylating agents|mesh-ancestor
92513074|NCT00005825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513075|NCT00005825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513076|NCT00005825|Keratolytic Agents|keratolytic agents|mesh-ancestor
92513077|NCT00005825|Dermatologic Agents|dermatologic agents|mesh-ancestor
92513078|NCT00001011|Zidovudine|zidovudine|mesh-list
92513079|NCT00001011|Antimetabolites|antimetabolites|mesh-ancestor
92513080|NCT00001011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513081|NCT00001011|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513082|NCT00001011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513083|NCT00001011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513084|NCT00001011|Antiviral Agents|antiviral agents|mesh-ancestor
92513085|NCT00001011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513086|NCT00001011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513087|NCT00001011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513088|NCT00001014|Leucovorin|leucovorin|mesh-list
92513089|NCT00001014|Trimethoprim|trimethoprim|mesh-list
92513090|NCT00001014|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92513091|NCT00001014|Sulfamethoxazole|sulfamethoxazole|mesh-list
92513092|NCT00001014|Trimetrexate|trimetrexate|mesh-list
92513093|NCT00001014|Calcium|calcium|mesh-list
92513094|NCT00001014|Levoleucovorin|levoleucovorin|mesh-list
92513095|NCT00001014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92513096|NCT00001014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513097|NCT00001014|Antidotes|antidotes|mesh-ancestor
92513098|NCT00001014|Protective Agents|protective agents|mesh-ancestor
92513099|NCT00001014|Vitamin B Complex|vitamin b complex|mesh-ancestor
92513100|NCT00001014|Vitamins|vitamins|mesh-ancestor
92513101|NCT00001014|Micronutrients|micronutrients|mesh-ancestor
92513102|NCT00001014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92513103|NCT00001014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513104|NCT00001014|Antimalarials|antimalarials|mesh-ancestor
92513105|NCT00001014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92513106|NCT00001014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92513107|NCT00001014|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92513108|NCT00001014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513109|NCT00001014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513110|NCT00001014|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92513111|NCT00001014|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92513112|NCT00001014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513113|NCT00001014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513114|NCT00001014|Antifungal Agents|antifungal agents|mesh-ancestor
92513115|NCT00001014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513116|NCT00001014|Antimetabolites|antimetabolites|mesh-ancestor
92513117|NCT00001014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513118|NCT00005831|Paclitaxel|paclitaxel|mesh-list
92513119|NCT00005831|Carboplatin|carboplatin|mesh-list
92513120|NCT00005831|Gemcitabine|gemcitabine|mesh-list
92513121|NCT00005831|Trastuzumab|trastuzumab|mesh-list
92513122|NCT00005831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513123|NCT00005831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513124|NCT00005831|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513125|NCT00005831|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513126|NCT00005831|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513127|NCT00005831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513128|NCT00005831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513129|NCT00005831|Antimetabolites|antimetabolites|mesh-ancestor
92513130|NCT00005831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92513131|NCT00005834|Thalidomide|thalidomide|mesh-list
92513132|NCT00005834|Dexamethasone|dexamethasone|mesh-list
92513134|NCT00005834|Etoposide|etoposide|mesh-list
92513135|NCT00005834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513136|NCT00005834|Immunologic Factors|immunologic factors|mesh-ancestor
92513137|NCT00005834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513138|NCT00005834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513139|NCT00005834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513140|NCT00005834|Alkylating Agents|alkylating agents|mesh-ancestor
92513141|NCT00005834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513142|NCT00005834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513143|NCT00005834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513144|NCT00005834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513145|NCT00005834|Antiemetics|antiemetics|mesh-ancestor
92513146|NCT00005834|Autonomic Agents|autonomic agents|mesh-ancestor
92513147|NCT00005834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513148|NCT00005834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513149|NCT00005834|Glucocorticoids|glucocorticoids|mesh-ancestor
92513150|NCT00005834|Hormones|hormones|mesh-ancestor
92513151|NCT00005834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513152|NCT00005834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513153|NCT00005834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513154|NCT00005834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513155|NCT00005834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513156|NCT00005834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513157|NCT00005834|Leprostatic Agents|leprostatic agents|mesh-ancestor
92513158|NCT00005834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513159|NCT00005834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513160|NCT00005834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92513161|NCT00005834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92513162|NCT00005834|Growth Substances|growth substances|mesh-ancestor
92513163|NCT00005834|Growth Inhibitors|growth inhibitors|mesh-ancestor
92513164|NCT00001029|Zidovudine|zidovudine|mesh-list
92513165|NCT00001029|Didanosine|didanosine|mesh-list
92513166|NCT00001029|Zalcitabine|zalcitabine|mesh-list
92513167|NCT00001029|Antimetabolites|antimetabolites|mesh-ancestor
92513168|NCT00001029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513169|NCT00001029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513170|NCT00001029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513171|NCT00001029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513172|NCT00001029|Antiviral Agents|antiviral agents|mesh-ancestor
92513173|NCT00001029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513174|NCT00001029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513175|NCT00001029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513176|NCT00001032|Zidovudine|zidovudine|mesh-list
92513177|NCT00001032|Zalcitabine|zalcitabine|mesh-list
92513178|NCT00001032|Antimetabolites|antimetabolites|mesh-ancestor
92513179|NCT00001032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513180|NCT00001032|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513181|NCT00001032|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513182|NCT00001032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513183|NCT00001032|Antiviral Agents|antiviral agents|mesh-ancestor
92513184|NCT00001032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513185|NCT00001032|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513186|NCT00001032|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513187|NCT00005837|Oxaliplatin|oxaliplatin|mesh-list
92513188|NCT00005837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513189|NCT00001038|Valacyclovir|valacyclovir|mesh-list
92513190|NCT00001038|Acyclovir|acyclovir|mesh-list
92513191|NCT00001038|Antiviral Agents|antiviral agents|mesh-ancestor
92513192|NCT00001038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513193|NCT00005840|Paclitaxel|paclitaxel|mesh-list
92513194|NCT00005840|Cisplatin|cisplatin|mesh-list
92513195|NCT00005840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513196|NCT00005840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513197|NCT00005840|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513198|NCT00005840|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513199|NCT00005840|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513200|NCT00005840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513201|NCT00005843|Tipifarnib|tipifarnib|mesh-list
92513202|NCT00005843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513203|NCT00005849|Paclitaxel|paclitaxel|mesh-list
92513204|NCT00005849|Bryostatin 1|bryostatin 1|mesh-list
92513205|NCT00005849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513206|NCT00005849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513207|NCT00005849|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513208|NCT00005849|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513209|NCT00005849|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513210|NCT00005849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513211|NCT00005849|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92513212|NCT00005849|Immunologic Factors|immunologic factors|mesh-ancestor
92513213|NCT00005849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513214|NCT00001047|Clarithromycin|clarithromycin|mesh-list
92513215|NCT00001047|Ethambutol|ethambutol|mesh-list
92513216|NCT00001047|Rifabutin|rifabutin|mesh-list
92513217|NCT00001047|Clofazimine|clofazimine|mesh-list
92513218|NCT00001047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513219|NCT00001047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513220|NCT00001047|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92513221|NCT00001047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513222|NCT00001047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513223|NCT00001047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92513224|NCT00001047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513225|NCT00001047|Antitubercular Agents|antitubercular agents|mesh-ancestor
92513226|NCT00001047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92513227|NCT00001047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513228|NCT00001047|Leprostatic Agents|leprostatic agents|mesh-ancestor
92513229|NCT00005852|Cyclosporine|cyclosporine|mesh-list
92513230|NCT00005852|Methylprednisolone|methylprednisolone|mesh-list
92513231|NCT00005852|Cyclophosphamide|cyclophosphamide|mesh-list
92513232|NCT00005852|Cyclosporins|cyclosporins|mesh-list
92513233|NCT00005852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92513234|NCT00005852|Muromonab-CD3|muromonab-cd3|mesh-list
92513235|NCT00005852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513236|NCT00005852|Immunologic Factors|immunologic factors|mesh-ancestor
92513237|NCT00005852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513238|NCT00005852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513239|NCT00005852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513240|NCT00005852|Alkylating Agents|alkylating agents|mesh-ancestor
92513241|NCT00005852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513242|NCT00005852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513243|NCT00005852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513244|NCT00005852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351459|NCT03916068|Vitamins|vitamins|mesh-ancestor
92513245|NCT00005852|Antifungal Agents|antifungal agents|mesh-ancestor
92513246|NCT00005852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513247|NCT00005852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92513248|NCT00005852|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92513249|NCT00005852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513250|NCT00005852|Antiemetics|antiemetics|mesh-ancestor
92513251|NCT00005852|Autonomic Agents|autonomic agents|mesh-ancestor
92513252|NCT00005852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513253|NCT00005852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513254|NCT00005852|Glucocorticoids|glucocorticoids|mesh-ancestor
92513255|NCT00005852|Hormones|hormones|mesh-ancestor
92513256|NCT00005852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513257|NCT00005852|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92513258|NCT00005852|Protective Agents|protective agents|mesh-ancestor
92513259|NCT00001071|Lenograstim|lenograstim|mesh-list
92513260|NCT00001071|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92513261|NCT00001071|Immunologic Factors|immunologic factors|mesh-ancestor
92513262|NCT00001071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513263|NCT00005855|Carmustine|carmustine|mesh-list
92513264|NCT00005855|Efaproxiral|efaproxiral|mesh-list
92513265|NCT00005855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513266|NCT00005855|Alkylating Agents|alkylating agents|mesh-ancestor
92513267|NCT00005855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513268|NCT00005855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513269|NCT00005855|Antisickling Agents|antisickling agents|mesh-ancestor
92513270|NCT00001074|Didanosine|didanosine|mesh-list
92513271|NCT00001074|Hydroxyurea|hydroxyurea|mesh-list
92513272|NCT00001074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513273|NCT00001074|Antisickling Agents|antisickling agents|mesh-ancestor
92513274|NCT00001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513275|NCT00001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513276|NCT00001074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513277|NCT00001074|Antimetabolites|antimetabolites|mesh-ancestor
92513278|NCT00001074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513279|NCT00001074|Antiviral Agents|antiviral agents|mesh-ancestor
92513280|NCT00001074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513281|NCT00001074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513282|NCT00001074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513283|NCT00005858|Immunotoxins|immunotoxins|mesh-list
92513284|NCT00005858|Immunoconjugates|immunoconjugates|mesh-ancestor
92513285|NCT00005858|Immunologic Factors|immunologic factors|mesh-ancestor
92513286|NCT00005858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513288|NCT00005861|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92513289|NCT00005861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513290|NCT00005861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513291|NCT00005861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513292|NCT00005861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513293|NCT00005861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513294|NCT00005861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513296|NCT00001083|Indinavir|indinavir|mesh-list
92513297|NCT00001083|Lamivudine|lamivudine|mesh-list
92513298|NCT00001083|Zidovudine|zidovudine|mesh-list
92513299|NCT00001083|Nevirapine|nevirapine|mesh-list
92513300|NCT00001083|Stavudine|stavudine|mesh-list
92513301|NCT00001083|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92513302|NCT00001083|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92513303|NCT00001083|Protease Inhibitors|protease inhibitors|mesh-ancestor
92513304|NCT00001083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513305|NCT00001083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513306|NCT00001083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513307|NCT00001083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513308|NCT00001083|Antiviral Agents|antiviral agents|mesh-ancestor
92513309|NCT00001083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513310|NCT00001083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92513311|NCT00001083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513312|NCT00001083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513313|NCT00001083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513314|NCT00001083|Antimetabolites|antimetabolites|mesh-ancestor
92513315|NCT00001083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92513316|NCT00001083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92513317|NCT00005864|Sulfanilamides|sulfanilamides|mesh-list
92513318|NCT00005864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513319|NCT00001086|Efavirenz|efavirenz|mesh-list
92513320|NCT00001086|Abacavir|abacavir|mesh-list
92513321|NCT00001086|Indinavir|indinavir|mesh-list
92513322|NCT00001086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92351462|NCT03916068|Antioxidants|antioxidants|mesh-ancestor
92513323|NCT00001086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513324|NCT00001086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513325|NCT00001086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513326|NCT00001086|Antiviral Agents|antiviral agents|mesh-ancestor
92513327|NCT00001086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513328|NCT00001086|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92513329|NCT00001086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513330|NCT00001086|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92513331|NCT00001086|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92513332|NCT00001086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92513333|NCT00001086|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92513334|NCT00001086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513335|NCT00001086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513336|NCT00001086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92513337|NCT00001086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92513338|NCT00001086|Protease Inhibitors|protease inhibitors|mesh-ancestor
92513339|NCT00700258|Sirolimus|sirolimus|mesh-list
92513340|NCT00700258|Sunitinib|sunitinib|mesh-list
92513341|NCT00700258|Temsirolimus|temsirolimus|mesh-list
92513342|NCT00700258|Axitinib|axitinib|mesh-list
92513343|NCT00700258|MTOR Inhibitors|mtor inhibitors|mesh-list
92513344|NCT00700258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513345|NCT00700258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92513346|NCT00700258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92513347|NCT00700258|Growth Substances|growth substances|mesh-ancestor
92513348|NCT00700258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513349|NCT00700258|Growth Inhibitors|growth inhibitors|mesh-ancestor
92513350|NCT00700258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92513351|NCT00700258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513352|NCT00700258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513353|NCT00700258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513354|NCT00700258|Immunologic Factors|immunologic factors|mesh-ancestor
92513355|NCT00700258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513356|NCT00700258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513357|NCT00700258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513358|NCT00700258|Antifungal Agents|antifungal agents|mesh-ancestor
92513359|NCT00001113|Interferons|interferons|mesh-list
92513360|NCT00001113|Interferon-alpha|interferon-alpha|mesh-list
92513361|NCT00001113|Interferon alpha-2|interferon alpha-2|mesh-list
92513362|NCT00001113|Zidovudine|zidovudine|mesh-list
92513364|NCT00001113|Antiviral Agents|antiviral agents|mesh-ancestor
92513365|NCT00001113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513366|NCT00001113|Immunologic Factors|immunologic factors|mesh-ancestor
92513367|NCT00001113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513368|NCT00001113|Antimetabolites|antimetabolites|mesh-ancestor
92513369|NCT00001113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513370|NCT00001113|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513371|NCT00001113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513372|NCT00001113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513373|NCT00001113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513374|NCT00001113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513375|NCT00005867|Prednisolone|prednisolone|mesh-list
92513376|NCT00005867|Cyclophosphamide|cyclophosphamide|mesh-list
92513377|NCT00005867|Doxorubicin|doxorubicin|mesh-list
92513378|NCT00005867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92513379|NCT00005867|Etoposide|etoposide|mesh-list
92513380|NCT00005867|Vincristine|vincristine|mesh-list
92513381|NCT00005867|Mitoxantrone|mitoxantrone|mesh-list
92513382|NCT00005867|Bleomycin|bleomycin|mesh-list
92513383|NCT00005867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513384|NCT00005867|Immunologic Factors|immunologic factors|mesh-ancestor
92513385|NCT00005867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513386|NCT00005867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513387|NCT00005867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513388|NCT00005867|Alkylating Agents|alkylating agents|mesh-ancestor
92513389|NCT00005867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513390|NCT00005867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513391|NCT00005867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513392|NCT00005867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513393|NCT00005867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513394|NCT00005867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513395|NCT00005867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513396|NCT00005867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513397|NCT00005867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513398|NCT00005867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513399|NCT00005867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513400|NCT00005867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513401|NCT00005867|Glucocorticoids|glucocorticoids|mesh-ancestor
92513402|NCT00005867|Hormones|hormones|mesh-ancestor
92513403|NCT00005867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513404|NCT00005867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513405|NCT00005867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513406|NCT00005867|Analgesics|analgesics|mesh-ancestor
92513407|NCT00005867|Sensory System Agents|sensory system agents|mesh-ancestor
92513408|NCT00005870|Gemcitabine|gemcitabine|mesh-list
92513409|NCT00005870|Fluorouracil|fluorouracil|mesh-list
92513410|NCT00005870|Mitomycins|mitomycins|mesh-list
92513411|NCT00005870|Mitomycin|mitomycin|mesh-list
92513412|NCT00005870|Rubitecan|rubitecan|mesh-list
92513413|NCT00005870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513414|NCT00005870|Antimetabolites|antimetabolites|mesh-ancestor
92513415|NCT00005870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513416|NCT00005870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513417|NCT00005870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513418|NCT00005870|Immunologic Factors|immunologic factors|mesh-ancestor
92513419|NCT00005870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513420|NCT00005870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513421|NCT00005870|Alkylating Agents|alkylating agents|mesh-ancestor
92513422|NCT00005870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513423|NCT00005870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513424|NCT00005870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92513425|NCT00005870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513426|NCT00017407|Paclitaxel|paclitaxel|mesh-list
92513427|NCT00017407|Carboplatin|carboplatin|mesh-list
92513428|NCT00017407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513429|NCT00017407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513430|NCT00017407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513431|NCT00017407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513432|NCT00017407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513433|NCT00017407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513434|NCT00008866|Didanosine|didanosine|mesh-list
92513436|NCT00008866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513437|NCT00008866|Antisickling Agents|antisickling agents|mesh-ancestor
92513438|NCT00008866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513439|NCT00008866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513440|NCT00008866|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513441|NCT00008866|Antimetabolites|antimetabolites|mesh-ancestor
92513442|NCT00008866|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513443|NCT00008866|Antiviral Agents|antiviral agents|mesh-ancestor
92513444|NCT00008866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513445|NCT00008866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513446|NCT00008866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513447|NCT00001119|Ritonavir|ritonavir|mesh-list
92513448|NCT00001119|Indinavir|indinavir|mesh-list
92513450|NCT00001119|Lamivudine|lamivudine|mesh-list
92513451|NCT00001119|Zidovudine|zidovudine|mesh-list
92513452|NCT00001119|Abacavir|abacavir|mesh-list
92513453|NCT00001119|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92513454|NCT00001119|Efavirenz|efavirenz|mesh-list
92513455|NCT00001119|Vaccines|vaccines|mesh-list
92513456|NCT00001119|Immunologic Factors|immunologic factors|mesh-ancestor
92513457|NCT00001119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513458|NCT00001119|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92513459|NCT00001119|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92513460|NCT00001119|Protease Inhibitors|protease inhibitors|mesh-ancestor
92513461|NCT00001119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513462|NCT00001119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513463|NCT00001119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513464|NCT00001119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513465|NCT00001119|Antiviral Agents|antiviral agents|mesh-ancestor
92513466|NCT00001119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513467|NCT00001119|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92513468|NCT00001119|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513469|NCT00001119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513470|NCT00001119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513471|NCT00001119|Antimetabolites|antimetabolites|mesh-ancestor
92513472|NCT00001119|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92513473|NCT00001119|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92513474|NCT00001119|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92513475|NCT00001119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92513476|NCT00001119|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92513477|NCT00001119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92513478|NCT00001119|Antitubercular Agents|antitubercular agents|mesh-ancestor
92513479|NCT00001119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513480|NCT00009061|Ritonavir|ritonavir|mesh-list
92513481|NCT00009061|Nelfinavir|nelfinavir|mesh-list
92513482|NCT00009061|Fosamprenavir|fosamprenavir|mesh-list
92513483|NCT00009061|Lamivudine|lamivudine|mesh-list
92513484|NCT00009061|Abacavir|abacavir|mesh-list
92513485|NCT00009061|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92513486|NCT00009061|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92513487|NCT00009061|Protease Inhibitors|protease inhibitors|mesh-ancestor
92513488|NCT00009061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513489|NCT00009061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513490|NCT00009061|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513491|NCT00009061|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513492|NCT00009061|Antiviral Agents|antiviral agents|mesh-ancestor
92513493|NCT00009061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513494|NCT00009061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92513495|NCT00009061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513496|NCT00009061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513497|NCT00009061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513498|NCT00005873|Rubitecan|rubitecan|mesh-list
92513499|NCT00005873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513500|NCT00005873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92513501|NCT00005873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513502|NCT00005873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513503|NCT00005873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513504|NCT00009178|Fluoxetine|fluoxetine|mesh-list
92513505|NCT00009178|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92513506|NCT00009178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92351505|NCT03645408|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92513507|NCT00009178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92513508|NCT00009178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513509|NCT00009178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92513510|NCT00009178|Serotonin Agents|serotonin agents|mesh-ancestor
92513511|NCT00009178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513512|NCT00009178|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92513513|NCT00009178|Antidepressive Agents|antidepressive agents|mesh-ancestor
92513514|NCT00009178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92513515|NCT00009178|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92513516|NCT00009178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513517|NCT00009178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513518|NCT00009217|Haloperidol|haloperidol|mesh-list
92513519|NCT00009217|Haloperidol decanoate|haloperidol decanoate|mesh-list
92513520|NCT00009217|Antiemetics|antiemetics|mesh-ancestor
92513521|NCT00009217|Autonomic Agents|autonomic agents|mesh-ancestor
92513522|NCT00009217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513523|NCT00009217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513524|NCT00009217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513525|NCT00009217|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92513526|NCT00009217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92513527|NCT00009217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92513528|NCT00009217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92513529|NCT00009217|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92513530|NCT00009217|Dopamine Agents|dopamine agents|mesh-ancestor
92513531|NCT00009217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92513532|NCT00009217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513533|NCT00009217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92513534|NCT00005876|Rubitecan|rubitecan|mesh-list
92513535|NCT00005876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513536|NCT00005876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92513537|NCT00005876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513538|NCT00005876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513539|NCT00005876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513540|NCT00001146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92513541|NCT00001146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92513542|NCT00001146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92513543|NCT00009646|Indomethacin|indomethacin|mesh-list
92513544|NCT00009646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92513545|NCT00009646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92513546|NCT00009646|Analgesics|analgesics|mesh-ancestor
92513547|NCT00009646|Sensory System Agents|sensory system agents|mesh-ancestor
92513548|NCT00009646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513549|NCT00009646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513550|NCT00009646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513551|NCT00009646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513552|NCT00009646|Gout Suppressants|gout suppressants|mesh-ancestor
92513553|NCT00009646|Tocolytic Agents|tocolytic agents|mesh-ancestor
92513554|NCT00009646|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92513555|NCT00009646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92513556|NCT00009646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513557|NCT00009646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513558|NCT00009763|Cyclosporine|cyclosporine|mesh-list
92513559|NCT00009763|Paclitaxel|paclitaxel|mesh-list
92513560|NCT00009763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92513561|NCT00009763|Antibodies|antibodies|mesh-list
92513562|NCT00009763|Immunoglobulins|immunoglobulins|mesh-list
92513563|NCT00009763|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92513564|NCT00009763|Cyclosporins|cyclosporins|mesh-list
92513565|NCT00009763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513566|NCT00009763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513567|NCT00009763|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513568|NCT00009763|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513569|NCT00009763|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513570|NCT00009763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513571|NCT00009763|Immunologic Factors|immunologic factors|mesh-ancestor
92513572|NCT00009763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513573|NCT00009763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513574|NCT00009763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513575|NCT00009763|Antifungal Agents|antifungal agents|mesh-ancestor
92513576|NCT00009763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513577|NCT00009763|Dermatologic Agents|dermatologic agents|mesh-ancestor
92513578|NCT00009763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513579|NCT00009763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92513580|NCT00009802|Calcitriol|calcitriol|mesh-list
92513581|NCT00009802|Paclitaxel|paclitaxel|mesh-list
92513582|NCT00009802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513583|NCT00009802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513584|NCT00009802|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513585|NCT00009802|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513586|NCT00009802|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513587|NCT00009802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513588|NCT00009802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92513589|NCT00009802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513590|NCT00009802|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92513591|NCT00009802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92513592|NCT00009802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92513593|NCT00009802|Vitamins|vitamins|mesh-ancestor
92513594|NCT00009802|Micronutrients|micronutrients|mesh-ancestor
92513595|NCT00009802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92513596|NCT00009841|Mitogens|mitogens|mesh-list
92513597|NCT00009841|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513598|NCT00009841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513599|NCT00005891|Cyclophosphamide|cyclophosphamide|mesh-list
92513600|NCT00005891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513601|NCT00005891|Immunologic Factors|immunologic factors|mesh-ancestor
92513602|NCT00005891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513603|NCT00005891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513604|NCT00005891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513605|NCT00005891|Alkylating Agents|alkylating agents|mesh-ancestor
92513606|NCT00005891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513607|NCT00005891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513608|NCT00005891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513609|NCT00009880|Paclitaxel|paclitaxel|mesh-list
92513610|NCT00009880|Fluorouracil|fluorouracil|mesh-list
92513611|NCT00009880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513612|NCT00009880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513613|NCT00009880|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513614|NCT00009880|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513615|NCT00009880|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513616|NCT00009880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513617|NCT00009880|Antimetabolites|antimetabolites|mesh-ancestor
92513618|NCT00009880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513619|NCT00009880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513620|NCT00009880|Immunologic Factors|immunologic factors|mesh-ancestor
92513621|NCT00009880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513623|NCT00009919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92513624|NCT00009919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92513625|NCT00009919|Growth Substances|growth substances|mesh-ancestor
92513626|NCT00009919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513627|NCT00009919|Growth Inhibitors|growth inhibitors|mesh-ancestor
92513628|NCT00009919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513629|NCT00009919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92513630|NCT00009919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351514|NCT04141410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513631|NCT00009919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513632|NCT00009958|Metronidazole|metronidazole|mesh-list
92513633|NCT00009958|Vaccines|vaccines|mesh-list
92513634|NCT00009958|Sargramostim|sargramostim|mesh-list
92513635|NCT00009958|Immunologic Factors|immunologic factors|mesh-ancestor
92513636|NCT00009958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513637|NCT00009958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513638|NCT00009958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513639|NCT00009958|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92513640|NCT00009958|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92513641|NCT00009997|Tamoxifen|tamoxifen|mesh-list
92513642|NCT00009997|Paclitaxel|paclitaxel|mesh-list
92513643|NCT00009997|Cyclophosphamide|cyclophosphamide|mesh-list
92513644|NCT00009997|Doxorubicin|doxorubicin|mesh-list
92513645|NCT00009997|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92513646|NCT00009997|Trastuzumab|trastuzumab|mesh-list
92513647|NCT00009997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513648|NCT00009997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513649|NCT00009997|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513650|NCT00009997|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513651|NCT00009997|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513652|NCT00009997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513653|NCT00009997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513654|NCT00009997|Immunologic Factors|immunologic factors|mesh-ancestor
92513655|NCT00009997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513656|NCT00009997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513657|NCT00009997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513658|NCT00009997|Alkylating Agents|alkylating agents|mesh-ancestor
92513659|NCT00009997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513660|NCT00009997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513661|NCT00009997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513662|NCT00009997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513663|NCT00009997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513664|NCT00009997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92513665|NCT00009997|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92513666|NCT00009997|Hormone Antagonists|hormone antagonists|mesh-ancestor
92513667|NCT00009997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513668|NCT00009997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513669|NCT00009997|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92513670|NCT00009997|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92513671|NCT00009997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92513673|NCT00010036|Irinotecan|irinotecan|mesh-list
92513674|NCT00010036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513675|NCT00010036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92513676|NCT00010036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513677|NCT00010036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513678|NCT00010036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513679|NCT00010075|Leucovorin|leucovorin|mesh-list
92513680|NCT00010075|Fluorouracil|fluorouracil|mesh-list
92513681|NCT00010075|Mitoxantrone|mitoxantrone|mesh-list
92513682|NCT00010075|Calcium|calcium|mesh-list
92513683|NCT00010075|Levoleucovorin|levoleucovorin|mesh-list
92513684|NCT00010075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92513685|NCT00010075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513686|NCT00010075|Antimetabolites|antimetabolites|mesh-ancestor
92513687|NCT00010075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513688|NCT00010075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513689|NCT00010075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513690|NCT00010075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513691|NCT00010075|Immunologic Factors|immunologic factors|mesh-ancestor
92513692|NCT00010075|Antidotes|antidotes|mesh-ancestor
92513693|NCT00010075|Protective Agents|protective agents|mesh-ancestor
92513694|NCT00010075|Vitamin B Complex|vitamin b complex|mesh-ancestor
92513695|NCT00010075|Vitamins|vitamins|mesh-ancestor
92513696|NCT00010075|Micronutrients|micronutrients|mesh-ancestor
92513697|NCT00010075|Analgesics|analgesics|mesh-ancestor
92513698|NCT00010075|Sensory System Agents|sensory system agents|mesh-ancestor
92513699|NCT00010075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513700|NCT00010075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513701|NCT00010075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513702|NCT00010075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513703|NCT00010153|Fulvestrant|fulvestrant|mesh-list
92513704|NCT00010153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513705|NCT00010153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513706|NCT00010153|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92513707|NCT00010153|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92513708|NCT00010153|Hormone Antagonists|hormone antagonists|mesh-ancestor
92513709|NCT00010153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513710|NCT00010153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513711|NCT00010192|Aldesleukin|aldesleukin|mesh-list
92513712|NCT00010192|Rituximab|rituximab|mesh-list
92513713|NCT00010192|Interleukin-2|interleukin-2|mesh-list
92513714|NCT00010192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92513715|NCT00010192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513716|NCT00010192|Immunologic Factors|immunologic factors|mesh-ancestor
92513717|NCT00010192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513718|NCT00010192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513719|NCT00010192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92513720|NCT00010192|Analgesics|analgesics|mesh-ancestor
92513721|NCT00010192|Sensory System Agents|sensory system agents|mesh-ancestor
92513722|NCT00010192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513723|NCT00010192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513724|NCT00010192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513725|NCT00010192|Antiviral Agents|antiviral agents|mesh-ancestor
92513726|NCT00010192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513727|NCT00005912|Voriconazole|voriconazole|mesh-list
92513728|NCT00005912|Antifungal Agents|antifungal agents|mesh-ancestor
92513729|NCT00005912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513730|NCT00005912|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92513731|NCT00005912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92513732|NCT00005912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513733|NCT00005912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513734|NCT00005912|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92513735|NCT00005912|Hormone Antagonists|hormone antagonists|mesh-ancestor
92513736|NCT00005912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513737|NCT00005912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513738|NCT00005912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92513739|NCT00010231|Calcitriol|calcitriol|mesh-list
92513740|NCT00010231|Dexamethasone|dexamethasone|mesh-list
92513741|NCT00010231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513742|NCT00010231|Antiemetics|antiemetics|mesh-ancestor
92513743|NCT00010231|Autonomic Agents|autonomic agents|mesh-ancestor
92513744|NCT00010231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513745|NCT00010231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513746|NCT00010231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513747|NCT00010231|Glucocorticoids|glucocorticoids|mesh-ancestor
92513748|NCT00010231|Hormones|hormones|mesh-ancestor
92513749|NCT00010231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513750|NCT00010231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513751|NCT00010231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513752|NCT00010231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92513753|NCT00010231|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92513754|NCT00010231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92513755|NCT00010231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513756|NCT00010231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92513757|NCT00010231|Vitamins|vitamins|mesh-ancestor
92513758|NCT00010231|Micronutrients|micronutrients|mesh-ancestor
92513759|NCT00010231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92513760|NCT00010270|Immunotoxins|immunotoxins|mesh-list
92513761|NCT00010270|Immunoconjugates|immunoconjugates|mesh-ancestor
92513762|NCT00010270|Immunologic Factors|immunologic factors|mesh-ancestor
92513763|NCT00010270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513764|NCT00010387|Cyclophosphamide|cyclophosphamide|mesh-list
92513765|NCT00010387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513766|NCT00010387|Immunologic Factors|immunologic factors|mesh-ancestor
92513767|NCT00010387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513768|NCT00010387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513769|NCT00010387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513770|NCT00010387|Alkylating Agents|alkylating agents|mesh-ancestor
92513771|NCT00010387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513772|NCT00010387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513773|NCT00010387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513774|NCT00010426|Cysteamine|cysteamine|mesh-list
92513775|NCT00010426|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92513776|NCT00010426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513777|NCT00386516|Fluorouracil|fluorouracil|mesh-list
92513778|NCT00386516|Antimetabolites|antimetabolites|mesh-ancestor
92513779|NCT00386516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513780|NCT00386516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513781|NCT00386516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513782|NCT00386516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513783|NCT00386516|Immunologic Factors|immunologic factors|mesh-ancestor
92513784|NCT00386516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513785|NCT00010699|Vitamin E|vitamin e|mesh-list
92513786|NCT00010699|Vitamins|vitamins|mesh-ancestor
92513787|NCT00010699|Micronutrients|micronutrients|mesh-ancestor
92513788|NCT00010699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513789|NCT00010699|Antioxidants|antioxidants|mesh-ancestor
92513790|NCT00010699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513791|NCT00010699|Protective Agents|protective agents|mesh-ancestor
92513792|NCT00386555|Docetaxel|docetaxel|mesh-list
92513793|NCT00386555|Axitinib|axitinib|mesh-list
92513794|NCT00386555|Crenolanib|crenolanib|mesh-list
92513795|NCT00386555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513796|NCT00386555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513797|NCT00386555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513798|NCT00386555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513799|NCT00386555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513800|NCT00386555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92513801|NCT00386555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513802|NCT00010855|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92513803|NCT00010855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92513804|NCT00010855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513805|NCT00001191|Omeprazole|omeprazole|mesh-list
92513806|NCT00001191|Pantoprazole|pantoprazole|mesh-list
92513807|NCT00001191|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92513808|NCT00001191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513809|NCT00001191|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92513810|NCT00001191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513811|NCT00001191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513812|NCT00011089|Tenofovir|tenofovir|mesh-list
92513813|NCT00011089|Antiviral Agents|antiviral agents|mesh-ancestor
92513814|NCT00011089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513815|NCT00011089|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513816|NCT00011089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513817|NCT00011089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513818|NCT00011089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513819|NCT00011089|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513820|NCT00011089|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513821|NCT00011128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92513822|NCT00011128|Antiviral Agents|antiviral agents|mesh-ancestor
92513823|NCT00011128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513824|NCT00005921|Caspofungin|caspofungin|mesh-list
92513825|NCT00005921|Antifungal Agents|antifungal agents|mesh-ancestor
92513826|NCT00005921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513827|NCT00005921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513828|NCT00005921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513829|NCT00011362|Dexamethasone|dexamethasone|mesh-list
92513830|NCT00011362|Dexamethasone acetate|dexamethasone acetate|mesh-list
92513831|NCT00011362|BB 1101|bb 1101|mesh-list
92513832|NCT00011362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513833|NCT00011362|Antiemetics|antiemetics|mesh-ancestor
92513834|NCT00011362|Autonomic Agents|autonomic agents|mesh-ancestor
92513835|NCT00011362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513836|NCT00011362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513837|NCT00011362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513838|NCT00011362|Glucocorticoids|glucocorticoids|mesh-ancestor
92513839|NCT00011362|Hormones|hormones|mesh-ancestor
92513840|NCT00011362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513841|NCT00011362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513842|NCT00011362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513843|NCT00011362|Protease Inhibitors|protease inhibitors|mesh-ancestor
92513844|NCT00011362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513845|NCT00011362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513846|NCT00001212|Cyclosporine|cyclosporine|mesh-list
92513848|NCT00001212|Cyclophosphamide|cyclophosphamide|mesh-list
92513849|NCT00001212|Cyclosporins|cyclosporins|mesh-list
92513850|NCT00001212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513851|NCT00001212|Immunologic Factors|immunologic factors|mesh-ancestor
92513852|NCT00001212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513853|NCT00001212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513854|NCT00001212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513855|NCT00001212|Alkylating Agents|alkylating agents|mesh-ancestor
92513856|NCT00001212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513857|NCT00001212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513858|NCT00001212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513859|NCT00001212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513860|NCT00001212|Glucocorticoids|glucocorticoids|mesh-ancestor
92513861|NCT00001212|Hormones|hormones|mesh-ancestor
92513862|NCT00001212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513863|NCT00001212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513864|NCT00001212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513865|NCT00001212|Antifungal Agents|antifungal agents|mesh-ancestor
92513866|NCT00001212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513867|NCT00001212|Dermatologic Agents|dermatologic agents|mesh-ancestor
92513868|NCT00001212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92513869|NCT00011479|Abacavir|abacavir|mesh-list
92513870|NCT00011479|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92513871|NCT00011479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513872|NCT00011479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513873|NCT00011479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513874|NCT00011479|Antiviral Agents|antiviral agents|mesh-ancestor
92513875|NCT00011479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513876|NCT00011479|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92513877|NCT00011479|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92513878|NCT00011635|Silymarin|silymarin|mesh-list
92513879|NCT00011635|Antioxidants|antioxidants|mesh-ancestor
92513880|NCT00011635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513881|NCT00011635|Protective Agents|protective agents|mesh-ancestor
92513882|NCT00011635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513883|NCT00001221|Hormones|hormones|mesh-list
92513884|NCT00001221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513885|NCT00001221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513886|NCT00391417|Estradiol|estradiol|mesh-list
92513887|NCT00391417|Estrogens|estrogens|mesh-ancestor
92513888|NCT00391417|Hormones|hormones|mesh-ancestor
92513889|NCT00391417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513890|NCT00391417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513891|NCT00011908|Epratuzumab|epratuzumab|mesh-list
92513892|NCT00011908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92513893|NCT00011908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513894|NCT00012025|Fulvestrant|fulvestrant|mesh-list
92513895|NCT00012025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513896|NCT00012025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513897|NCT00012025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92513898|NCT00012025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92513899|NCT00012025|Hormone Antagonists|hormone antagonists|mesh-ancestor
92513900|NCT00012025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513901|NCT00012025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513903|NCT00005942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513904|NCT00005942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513905|NCT00005942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513906|NCT00005942|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92513907|NCT00005942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513908|NCT00005942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513909|NCT00012103|Dimercaprol|dimercaprol|mesh-list
92513910|NCT00012103|Chelating Agents|chelating agents|mesh-ancestor
92513911|NCT00012103|Sequestering Agents|sequestering agents|mesh-ancestor
92513912|NCT00012103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513913|NCT00001251|Mafosfamide|mafosfamide|mesh-list
92513914|NCT00001251|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92513915|NCT00001251|Immunologic Factors|immunologic factors|mesh-ancestor
92513916|NCT00001251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513917|NCT00001251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513918|NCT00012142|Sirolimus|sirolimus|mesh-list
92513919|NCT00012142|Temsirolimus|temsirolimus|mesh-list
92513920|NCT00012142|MTOR Inhibitors|mtor inhibitors|mesh-list
92513921|NCT00012142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92513922|NCT00012142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513923|NCT00012142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513924|NCT00012142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513925|NCT00012142|Immunologic Factors|immunologic factors|mesh-ancestor
92513926|NCT00012142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513927|NCT00012142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513928|NCT00012142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92513929|NCT00012142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513930|NCT00012142|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513931|NCT00012142|Antifungal Agents|antifungal agents|mesh-ancestor
92513932|NCT00012181|Alvocidib|alvocidib|mesh-list
92513933|NCT00012181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513934|NCT00012181|Growth Inhibitors|growth inhibitors|mesh-ancestor
92513935|NCT00012181|Growth Substances|growth substances|mesh-ancestor
92513936|NCT00012181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513937|NCT00012181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92513938|NCT00012181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513939|NCT00012181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513940|NCT00005945|Cytarabine|cytarabine|mesh-list
92513941|NCT00005945|Dexamethasone|dexamethasone|mesh-list
92513942|NCT00005945|Cyclophosphamide|cyclophosphamide|mesh-list
92513943|NCT00005945|Doxorubicin|doxorubicin|mesh-list
92513944|NCT00005945|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92513945|NCT00005945|Methotrexate|methotrexate|mesh-list
92513946|NCT00005945|Vincristine|vincristine|mesh-list
92513947|NCT00005945|Daunorubicin|daunorubicin|mesh-list
92513948|NCT00005945|Asparaginase|asparaginase|mesh-list
92513949|NCT00005945|Mercaptopurine|mercaptopurine|mesh-list
92513950|NCT00005945|Pegaspargase|pegaspargase|mesh-list
92513951|NCT00005945|Thioguanine|thioguanine|mesh-list
92513952|NCT00005945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92513953|NCT00005945|Immunologic Factors|immunologic factors|mesh-ancestor
92513954|NCT00005945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513955|NCT00005945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92513956|NCT00005945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92513957|NCT00005945|Alkylating Agents|alkylating agents|mesh-ancestor
92513958|NCT00005945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513959|NCT00005945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513960|NCT00005945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92513961|NCT00005945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92513962|NCT00005945|Antiemetics|antiemetics|mesh-ancestor
92513963|NCT00005945|Autonomic Agents|autonomic agents|mesh-ancestor
92513964|NCT00005945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92513965|NCT00005945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92513966|NCT00005945|Glucocorticoids|glucocorticoids|mesh-ancestor
92513967|NCT00005945|Hormones|hormones|mesh-ancestor
92513968|NCT00005945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92513969|NCT00005945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92513970|NCT00005945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513971|NCT00005945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92238916|NCT01094717|Tazarotene|tazarotene|mesh-list
92513972|NCT00005945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92513973|NCT00005945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92513974|NCT00005945|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92513975|NCT00005945|Abortifacient Agents|abortifacient agents|mesh-ancestor
92513976|NCT00005945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92513977|NCT00005945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92513978|NCT00005945|Antimetabolites|antimetabolites|mesh-ancestor
92513979|NCT00005945|Dermatologic Agents|dermatologic agents|mesh-ancestor
92513980|NCT00005945|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92513981|NCT00005945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92513982|NCT00005945|Antiviral Agents|antiviral agents|mesh-ancestor
92513983|NCT00005945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92513984|NCT00005945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92513985|NCT00005945|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513986|NCT00005945|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513987|NCT00005945|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513988|NCT01929811|Metformin|metformin|mesh-list
92513989|NCT01929811|Docetaxel|docetaxel|mesh-list
92513990|NCT01929811|Epirubicin|epirubicin|mesh-list
92513991|NCT01929811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92513992|NCT01929811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92513993|NCT01929811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92513994|NCT01929811|Tubulin Modulators|tubulin modulators|mesh-ancestor
92513995|NCT01929811|Antimitotic Agents|antimitotic agents|mesh-ancestor
92513996|NCT01929811|Mitosis Modulators|mitosis modulators|mesh-ancestor
92513997|NCT01929811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92513998|NCT01929811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92513999|NCT01929811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514000|NCT01929811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514001|NCT01929811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514002|NCT00012220|Gemcitabine|gemcitabine|mesh-list
92514003|NCT00012220|Docetaxel|docetaxel|mesh-list
92514004|NCT00012220|Irinotecan|irinotecan|mesh-list
92514005|NCT00012220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514006|NCT00012220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514007|NCT00012220|Antimetabolites|antimetabolites|mesh-ancestor
92514008|NCT00012220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514009|NCT00012220|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514010|NCT00012220|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514011|NCT00012220|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514012|NCT00012220|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514013|NCT00012220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514014|NCT00012220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514015|NCT00012259|Troxacitabine|troxacitabine|mesh-list
92514016|NCT00012259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514017|NCT00012259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514018|NCT00012259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514019|NCT00012259|Antiviral Agents|antiviral agents|mesh-ancestor
92514020|NCT00012259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514021|NCT00012337|Gefitinib|gefitinib|mesh-list
92514022|NCT00012337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514023|NCT00012337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92514024|NCT00012337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200572|NCT03434678|Anesthetics|anesthetics|mesh-ancestor
92514025|NCT00012337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514026|NCT00012376|Bryostatin 1|bryostatin 1|mesh-list
92514027|NCT00012376|Sargramostim|sargramostim|mesh-list
92514028|NCT00012376|Immunologic Factors|immunologic factors|mesh-ancestor
92514029|NCT00012376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514030|NCT00012376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514031|NCT00012376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92514032|NCT00001266|Suramin|suramin|mesh-list
92514033|NCT00001266|Antinematodal Agents|antinematodal agents|mesh-ancestor
92514034|NCT00001266|Anthelmintics|anthelmintics|mesh-ancestor
92514035|NCT00001266|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92514036|NCT00001266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514037|NCT00001266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514038|NCT00001266|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92514039|NCT00001266|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92514040|NCT00005948|Interferons|interferons|mesh-list
92514041|NCT00005948|Interferon-alpha|interferon-alpha|mesh-list
92514042|NCT00005948|Aldesleukin|aldesleukin|mesh-list
92514043|NCT00005948|Busulfan|busulfan|mesh-list
92514044|NCT00005948|Sargramostim|sargramostim|mesh-list
92514045|NCT00005948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238979|NCT01100723|Cinacalcet|cinacalcet|mesh-list
92514046|NCT00005948|Antiviral Agents|antiviral agents|mesh-ancestor
92514047|NCT00005948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514048|NCT00005948|Immunologic Factors|immunologic factors|mesh-ancestor
92514049|NCT00005948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514050|NCT00005948|Alkylating Agents|alkylating agents|mesh-ancestor
92514051|NCT00005948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514052|NCT00005948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514053|NCT00005948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514054|NCT00005948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514055|NCT00005948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514056|NCT00005948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514057|NCT00012688|Chlorhexidine|chlorhexidine|mesh-list
92514058|NCT00012688|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92514059|NCT00012688|Doxycycline|doxycycline|mesh-list
92514060|NCT00012688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92514061|NCT00012688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514062|NCT00012688|Disinfectants|disinfectants|mesh-ancestor
92514063|NCT00012688|Dermatologic Agents|dermatologic agents|mesh-ancestor
92514064|NCT00012688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92514065|NCT00012688|Antimalarials|antimalarials|mesh-ancestor
92514066|NCT00012688|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92514067|NCT00012688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92514068|NCT00005951|Irinotecan|irinotecan|mesh-list
92514069|NCT00005951|Temozolomide|temozolomide|mesh-list
92514070|NCT00005951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514071|NCT00005951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514072|NCT00005951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514073|NCT00005951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514074|NCT00005951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514075|NCT00005951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514076|NCT00005951|Alkylating Agents|alkylating agents|mesh-ancestor
92514077|NCT00001287|Immunoglobulins|immunoglobulins|mesh-list
92514078|NCT00001287|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92514079|NCT00001287|Antibodies|antibodies|mesh-list
92514080|NCT00001287|gamma-Globulins|gamma-globulins|mesh-list
92514081|NCT00001287|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92514082|NCT00001287|Immunologic Factors|immunologic factors|mesh-ancestor
92514083|NCT00001287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514084|NCT00005954|Temozolomide|temozolomide|mesh-list
92514085|NCT00005954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514086|NCT00005954|Alkylating Agents|alkylating agents|mesh-ancestor
92514087|NCT00005954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514088|NCT00005954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514089|NCT00005960|Cyclophosphamide|cyclophosphamide|mesh-list
92514090|NCT00005960|Docetaxel|docetaxel|mesh-list
92514091|NCT00005960|Doxorubicin|doxorubicin|mesh-list
92514092|NCT00005960|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92514093|NCT00005960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514094|NCT00005960|Immunologic Factors|immunologic factors|mesh-ancestor
92514095|NCT00005960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514096|NCT00005960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514097|NCT00005960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514098|NCT00005960|Alkylating Agents|alkylating agents|mesh-ancestor
92514099|NCT00005960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514100|NCT00005960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923050|NCT02149433|Prednisone|prednisone|mesh-list
92514101|NCT00005960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514102|NCT00005960|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514103|NCT00005960|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514104|NCT00005960|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514105|NCT00005960|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514106|NCT00005960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514107|NCT00005960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514108|NCT00005960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514109|NCT00005963|Carboplatin|carboplatin|mesh-list
92514110|NCT00005963|Docetaxel|docetaxel|mesh-list
92514111|NCT00005963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514112|NCT00005963|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514113|NCT00005963|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514114|NCT00005963|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514115|NCT00005963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514116|NCT00013585|Selegiline|selegiline|mesh-list
92514117|NCT00013585|Antidepressive Agents|antidepressive agents|mesh-ancestor
92514118|NCT00013585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92514119|NCT00013585|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92514120|NCT00013585|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92514121|NCT00013585|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92514122|NCT00013585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514123|NCT00013585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514124|NCT00013585|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92514125|NCT00013585|Protective Agents|protective agents|mesh-ancestor
92514126|NCT00013585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514127|NCT00013624|Levodopa|levodopa|mesh-list
92514128|NCT00013624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92514129|NCT00013624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92514130|NCT00013624|Dopamine Agents|dopamine agents|mesh-ancestor
92514131|NCT00013624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514132|NCT00013624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514133|NCT00013624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514134|NCT00013663|Aldesleukin|aldesleukin|mesh-list
92533215|NCT00058474|Fluorouracil|fluorouracil|mesh-list
92514135|NCT00013663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514136|NCT00013663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514137|NCT00013663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514138|NCT00013663|Antiviral Agents|antiviral agents|mesh-ancestor
92514139|NCT00013663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514140|NCT00013702|Adefovir|adefovir|mesh-list
92514141|NCT00013702|Antiviral Agents|antiviral agents|mesh-ancestor
92514142|NCT00013702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514143|NCT00013702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92514144|NCT00013702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92514145|NCT00013702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514146|NCT00013702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514147|NCT00005966|Interferons|interferons|mesh-list
92514148|NCT00005966|Interferon-alpha|interferon-alpha|mesh-list
92514149|NCT00005966|Thalidomide|thalidomide|mesh-list
92514150|NCT00005966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514151|NCT00005966|Antiviral Agents|antiviral agents|mesh-ancestor
92514152|NCT00005966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514153|NCT00005966|Immunologic Factors|immunologic factors|mesh-ancestor
92514154|NCT00005966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514155|NCT00005966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514156|NCT00005966|Leprostatic Agents|leprostatic agents|mesh-ancestor
92514157|NCT00005966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92514158|NCT00005966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92514159|NCT00005966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92514160|NCT00005966|Growth Substances|growth substances|mesh-ancestor
92514161|NCT00005966|Growth Inhibitors|growth inhibitors|mesh-ancestor
92514162|NCT00005969|Tretinoin|tretinoin|mesh-list
92514163|NCT00005969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514164|NCT00005969|Keratolytic Agents|keratolytic agents|mesh-ancestor
92514165|NCT00005969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92514166|NCT00014014|Lamivudine|lamivudine|mesh-list
92514167|NCT00014014|Zidovudine|zidovudine|mesh-list
92514168|NCT00014014|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92514169|NCT00014014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92514170|NCT00014014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92514171|NCT00014014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514172|NCT00014014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514173|NCT00014014|Antiviral Agents|antiviral agents|mesh-ancestor
92514174|NCT00014014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514175|NCT00014014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514176|NCT00014014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514177|NCT00014014|Antimetabolites|antimetabolites|mesh-ancestor
92514178|NCT00014092|Interferons|interferons|mesh-list
92514179|NCT00014092|Interferon-alpha|interferon-alpha|mesh-list
92514180|NCT00014092|Aldesleukin|aldesleukin|mesh-list
92514181|NCT00014092|Temozolomide|temozolomide|mesh-list
92514182|NCT00014092|Sargramostim|sargramostim|mesh-list
92514183|NCT00014092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514184|NCT00014092|Antiviral Agents|antiviral agents|mesh-ancestor
92514185|NCT00014092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152478|NCT03407703|Antiviral Agents|antiviral agents|mesh-ancestor
92514186|NCT00014092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514187|NCT00014092|Alkylating Agents|alkylating agents|mesh-ancestor
92514188|NCT00014092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514189|NCT00014092|Immunologic Factors|immunologic factors|mesh-ancestor
92514190|NCT00014092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514191|NCT00014092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514192|NCT00014092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514193|NCT00005972|Gemcitabine|gemcitabine|mesh-list
92514195|NCT00005972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514196|NCT00005972|Antimetabolites|antimetabolites|mesh-ancestor
92514197|NCT00005972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514198|NCT00005972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514199|NCT00005972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514200|NCT00005972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92239122|NCT04751318|Analgesics|analgesics|mesh-ancestor
92514201|NCT00005972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514202|NCT00014170|Gefitinib|gefitinib|mesh-list
92514203|NCT00014170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514204|NCT00014170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92514205|NCT00014170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514206|NCT00014170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514208|NCT00014209|Gemcitabine|gemcitabine|mesh-list
92514209|NCT00014209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514210|NCT00014209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92514212|NCT00014209|Autonomic Agents|autonomic agents|mesh-ancestor
92514213|NCT00014209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514214|NCT00014209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514215|NCT00014209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92514216|NCT00014209|Glucocorticoids|glucocorticoids|mesh-ancestor
92514217|NCT00014209|Hormones|hormones|mesh-ancestor
92514218|NCT00014209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514219|NCT00014209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514220|NCT00014209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514221|NCT00014209|Antimetabolites|antimetabolites|mesh-ancestor
92514222|NCT00014209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514223|NCT00014248|Adenosine|adenosine|mesh-list
92514224|NCT00014248|Analgesics|analgesics|mesh-ancestor
92514225|NCT00014248|Sensory System Agents|sensory system agents|mesh-ancestor
92514226|NCT00014248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514227|NCT00014248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514228|NCT00014248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92514229|NCT00014248|Vasodilator Agents|vasodilator agents|mesh-ancestor
92514230|NCT00014248|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92514231|NCT00014248|Purinergic Agonists|purinergic agonists|mesh-ancestor
92514232|NCT00014248|Purinergic Agents|purinergic agents|mesh-ancestor
92514233|NCT00014248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514234|NCT00014248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514235|NCT00005975|Megestrol|megestrol|mesh-list
92514236|NCT00005975|Megestrol Acetate|megestrol acetate|mesh-list
92514237|NCT00005975|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92514238|NCT00005975|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92514239|NCT00005975|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92514240|NCT00005975|Contraceptive Agents|contraceptive agents|mesh-ancestor
92514241|NCT00005975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92514242|NCT00005975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514243|NCT00005975|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92514244|NCT00005975|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92514245|NCT00005975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514246|NCT00005975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514247|NCT00005975|Appetite Stimulants|appetite stimulants|mesh-ancestor
92514248|NCT00005975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92514249|NCT00014287|Gemcitabine|gemcitabine|mesh-list
92514250|NCT00014287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514251|NCT00014287|Antimetabolites|antimetabolites|mesh-ancestor
92514252|NCT00014287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514253|NCT00014287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514254|NCT02971930|Factor VIII|factor viii|mesh-list
92514255|NCT02971930|Coagulants|coagulants|mesh-ancestor
92514256|NCT00005978|Carboplatin|carboplatin|mesh-list
92514258|NCT00005978|Melphalan|melphalan|mesh-list
92514259|NCT00005978|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92514260|NCT00005978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514261|NCT00005978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514262|NCT00005978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514263|NCT00005978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514264|NCT00005978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514265|NCT00005978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514266|NCT00005978|Immunologic Factors|immunologic factors|mesh-ancestor
92514267|NCT00005978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514268|NCT00005978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514269|NCT00005978|Alkylating Agents|alkylating agents|mesh-ancestor
92514270|NCT00005978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514271|NCT00005978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514272|NCT00005978|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92514273|NCT00014404|Celecoxib|celecoxib|mesh-list
92514274|NCT00014404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92514275|NCT00014404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92514276|NCT00014404|Analgesics|analgesics|mesh-ancestor
92514277|NCT00014404|Sensory System Agents|sensory system agents|mesh-ancestor
92514278|NCT00014404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514279|NCT00014404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514280|NCT00014404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92514281|NCT00014404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514282|NCT00014404|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92514283|NCT00014404|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92514284|NCT00014404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514285|NCT00014404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514287|NCT00001332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514288|NCT00014599|Paclitaxel|paclitaxel|mesh-list
92514289|NCT00014599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514290|NCT00014599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514291|NCT00014599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514292|NCT00014599|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514293|NCT00014599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514294|NCT00014599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514295|NCT00005981|Carmustine|carmustine|mesh-list
92514296|NCT00005981|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92514297|NCT00005981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514298|NCT00005981|Alkylating Agents|alkylating agents|mesh-ancestor
92514299|NCT00005981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514300|NCT00005981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514301|NCT00005981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514302|NCT00014638|Letrozole|letrozole|mesh-list
92514303|NCT00014638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514304|NCT00014638|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92514305|NCT00014638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92514306|NCT00014638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514307|NCT00014638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514308|NCT00014638|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92514309|NCT00014638|Hormone Antagonists|hormone antagonists|mesh-ancestor
92514310|NCT00014638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514311|NCT00014638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514312|NCT00001341|Raltitrexed|raltitrexed|mesh-list
92514313|NCT00001341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514314|NCT00001341|Antimetabolites|antimetabolites|mesh-ancestor
92514315|NCT00001341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514316|NCT00001341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514317|NCT00001341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92514318|NCT00001341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514319|NCT00014677|Interleukin-4|interleukin-4|mesh-list
92514320|NCT00014677|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92514321|NCT00014677|Immunologic Factors|immunologic factors|mesh-ancestor
92514322|NCT00014677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514323|NCT00014677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514324|NCT00014677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514325|NCT00391534|Oxcarbazepine|oxcarbazepine|mesh-list
92514326|NCT00391534|Anticonvulsants|anticonvulsants|mesh-ancestor
92514327|NCT00391534|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92514328|NCT00391534|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92514329|NCT00391534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514330|NCT00391534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514331|NCT00391534|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92514332|NCT00391534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92514333|NCT00005984|Interferons|interferons|mesh-list
92514334|NCT00005984|Interferon-alpha|interferon-alpha|mesh-list
92514335|NCT00005984|Cyclophosphamide|cyclophosphamide|mesh-list
92514336|NCT00005984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514337|NCT00005984|Immunologic Factors|immunologic factors|mesh-ancestor
92514338|NCT00005984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514339|NCT00005984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514340|NCT00005984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514341|NCT00005984|Alkylating Agents|alkylating agents|mesh-ancestor
92514342|NCT00005984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514343|NCT00005984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514344|NCT00005984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514345|NCT00005984|Antiviral Agents|antiviral agents|mesh-ancestor
92514346|NCT00005984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514347|NCT00391651|Nitrofurantoin|nitrofurantoin|mesh-list
92514348|NCT00391651|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92514349|NCT00391651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514350|NCT00391651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92514352|NCT00391690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92533225|NCT00392262|Amlodipine|amlodipine|mesh-list
92514353|NCT00391690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514354|NCT00005987|Interferons|interferons|mesh-list
92514355|NCT00005987|Interferon-alpha|interferon-alpha|mesh-list
92514356|NCT00005987|Dexamethasone|dexamethasone|mesh-list
92514357|NCT00005987|Cyclophosphamide|cyclophosphamide|mesh-list
92514359|NCT00005987|Etoposide|etoposide|mesh-list
92514360|NCT00005987|Mitoxantrone|mitoxantrone|mesh-list
92514361|NCT00005987|Sargramostim|sargramostim|mesh-list
92514362|NCT00005987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514363|NCT00005987|Immunologic Factors|immunologic factors|mesh-ancestor
92514364|NCT00005987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514365|NCT00005987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514366|NCT00005987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514367|NCT00005987|Alkylating Agents|alkylating agents|mesh-ancestor
92514368|NCT00005987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514369|NCT00005987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514370|NCT00005987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514371|NCT00005987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92514372|NCT00005987|Antiemetics|antiemetics|mesh-ancestor
92514373|NCT00005987|Autonomic Agents|autonomic agents|mesh-ancestor
92514374|NCT00005987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514375|NCT00005987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92514376|NCT00005987|Glucocorticoids|glucocorticoids|mesh-ancestor
92514377|NCT00005987|Hormones|hormones|mesh-ancestor
92514378|NCT00005987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514379|NCT00005987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514380|NCT00005987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514381|NCT00005987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514382|NCT00005987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514383|NCT00005987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514384|NCT00005987|Antiviral Agents|antiviral agents|mesh-ancestor
92514385|NCT00005987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514386|NCT00005987|Analgesics|analgesics|mesh-ancestor
92514387|NCT00005987|Sensory System Agents|sensory system agents|mesh-ancestor
92514388|NCT00014755|Prednisone|prednisone|mesh-list
92514389|NCT00014755|Cyclophosphamide|cyclophosphamide|mesh-list
92514390|NCT00014755|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92514391|NCT00014755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514392|NCT00014755|Immunologic Factors|immunologic factors|mesh-ancestor
92514393|NCT00014755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514394|NCT00014755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514395|NCT00014755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514396|NCT00014755|Alkylating Agents|alkylating agents|mesh-ancestor
92514397|NCT00014755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514398|NCT00014755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514399|NCT00014755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514400|NCT00014755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92514401|NCT00014755|Glucocorticoids|glucocorticoids|mesh-ancestor
92514402|NCT00014755|Hormones|hormones|mesh-ancestor
92514403|NCT00014755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514404|NCT00014755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514405|NCT00005990|Topotecan|topotecan|mesh-list
92514406|NCT00005990|Tipifarnib|tipifarnib|mesh-list
92514407|NCT00005990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514408|NCT00005990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514409|NCT00005990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514410|NCT00005990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514411|NCT00005990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514412|NCT00001344|Dextromethorphan|dextromethorphan|mesh-list
92514413|NCT00001344|Antitussive Agents|antitussive agents|mesh-ancestor
92514414|NCT00001344|Respiratory System Agents|respiratory system agents|mesh-ancestor
92514415|NCT00001344|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92514416|NCT00001344|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92514417|NCT00001344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514418|NCT00001344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514419|NCT00001344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514420|NCT00014989|Magnesium Sulfate|magnesium sulfate|mesh-list
92514421|NCT00014989|Analgesics|analgesics|mesh-ancestor
92514422|NCT00014989|Sensory System Agents|sensory system agents|mesh-ancestor
92514423|NCT00014989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514424|NCT00014989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514425|NCT00014989|Anesthetics|anesthetics|mesh-ancestor
92514426|NCT00014989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351718|NCT03580590|Coagulants|coagulants|mesh-ancestor
92514427|NCT00014989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92514428|NCT00014989|Anticonvulsants|anticonvulsants|mesh-ancestor
92514429|NCT00014989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92514430|NCT00014989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514431|NCT00014989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514432|NCT00014989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514433|NCT00014989|Tocolytic Agents|tocolytic agents|mesh-ancestor
92514434|NCT00014989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92514435|NCT00005993|Aldesleukin|aldesleukin|mesh-list
92514436|NCT00005993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514437|NCT00005993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514438|NCT00005993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514439|NCT00005993|Antiviral Agents|antiviral agents|mesh-ancestor
92514440|NCT00005993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514441|NCT00015028|Buprenorphine|buprenorphine|mesh-list
92514442|NCT00015028|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92514444|NCT00015028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92514445|NCT00015028|Narcotics|narcotics|mesh-ancestor
92514446|NCT00015028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92514447|NCT00015028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514448|NCT00015028|Analgesics|analgesics|mesh-ancestor
92514449|NCT00015028|Sensory System Agents|sensory system agents|mesh-ancestor
92514450|NCT00015028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514451|NCT00015028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92514452|NCT00015067|Methylphenidate|methylphenidate|mesh-list
92514453|NCT00015067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92514454|NCT00015067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514455|NCT00015067|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92514456|NCT00015067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92514457|NCT00015067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514458|NCT00015067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514459|NCT00015067|Dopamine Agents|dopamine agents|mesh-ancestor
92514460|NCT00015067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514461|NCT00015106|Lamotrigine|lamotrigine|mesh-list
92514462|NCT00015106|Anticonvulsants|anticonvulsants|mesh-ancestor
92514463|NCT00015106|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92514464|NCT00015106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514465|NCT00015106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514466|NCT00015106|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514467|NCT00015106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514468|NCT00015106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92514469|NCT00015106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92514470|NCT00015106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92514471|NCT00015106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92514472|NCT00015106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92514473|NCT00005996|Gemcitabine|gemcitabine|mesh-list
92514474|NCT00005996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514475|NCT00005996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514476|NCT00005996|Antimetabolites|antimetabolites|mesh-ancestor
92514477|NCT00005996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514478|NCT00001359|Penicillins|penicillins|mesh-list
92514479|NCT00001359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351731|NCT03586674|Fenofibrate|fenofibrate|mesh-list
92514480|NCT00001359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514481|NCT00015223|Methylphenidate|methylphenidate|mesh-list
92514482|NCT00015223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92514483|NCT00015223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514484|NCT00015223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92514485|NCT00015223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92514486|NCT00015223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514487|NCT00015223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514488|NCT00015223|Dopamine Agents|dopamine agents|mesh-ancestor
92514489|NCT00015223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514490|NCT00015301|Methylphenidate|methylphenidate|mesh-list
92514491|NCT00015301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92514492|NCT00015301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514493|NCT00015301|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92514494|NCT00015301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92514495|NCT00015301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514496|NCT00015301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514497|NCT00015301|Dopamine Agents|dopamine agents|mesh-ancestor
92514498|NCT00015301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514499|NCT00015340|Buprenorphine|buprenorphine|mesh-list
92514500|NCT00015340|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92514501|NCT00015340|Naloxone|naloxone|mesh-list
92514502|NCT00015340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92514503|NCT00015340|Narcotics|narcotics|mesh-ancestor
92514504|NCT00015340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92514505|NCT00015340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514506|NCT00015340|Analgesics|analgesics|mesh-ancestor
92514507|NCT00015340|Sensory System Agents|sensory system agents|mesh-ancestor
92514508|NCT00015340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514509|NCT00015340|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92514510|NCT00015652|Ribavirin|ribavirin|mesh-list
92514511|NCT00015652|Aldesleukin|aldesleukin|mesh-list
92514512|NCT00015652|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92514513|NCT00015652|Antimetabolites|antimetabolites|mesh-ancestor
92514514|NCT00015652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514515|NCT00015652|Antiviral Agents|antiviral agents|mesh-ancestor
92514516|NCT00015652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514517|NCT00015652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514518|NCT00015652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514519|NCT00015652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514520|NCT00005999|Arsenic Trioxide|arsenic trioxide|mesh-list
92514521|NCT00005999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514522|NCT00015691|Metformin|metformin|mesh-list
92514523|NCT00015691|Rosiglitazone|rosiglitazone|mesh-list
92514524|NCT00015691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92514525|NCT00015691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514526|NCT00015769|Levetiracetam|levetiracetam|mesh-list
92514527|NCT00015769|Anticonvulsants|anticonvulsants|mesh-ancestor
92514528|NCT00015769|Nootropic Agents|nootropic agents|mesh-ancestor
92514529|NCT00015808|Idebenone|idebenone|mesh-list
92514530|NCT00015808|Antioxidants|antioxidants|mesh-ancestor
92514531|NCT00015808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514532|NCT00015808|Protective Agents|protective agents|mesh-ancestor
92514533|NCT00015808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514534|NCT00015886|Docetaxel|docetaxel|mesh-list
92514535|NCT00015886|Fluorouracil|fluorouracil|mesh-list
92514536|NCT00015886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514537|NCT00015886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514538|NCT00015886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514539|NCT00015886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514540|NCT00015886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514541|NCT00015886|Antimetabolites|antimetabolites|mesh-ancestor
92514542|NCT00015886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514543|NCT00015886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514544|NCT00015886|Immunologic Factors|immunologic factors|mesh-ancestor
92514545|NCT00015886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514546|NCT00006002|Dexamethasone|dexamethasone|mesh-list
92514547|NCT00006002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92514548|NCT00006002|Antiemetics|antiemetics|mesh-ancestor
92514549|NCT00006002|Autonomic Agents|autonomic agents|mesh-ancestor
92514550|NCT00006002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514551|NCT00006002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152632|NCT03597035|Natriuretic Agents|natriuretic agents|mesh-ancestor
92514552|NCT00006002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92514553|NCT00006002|Glucocorticoids|glucocorticoids|mesh-ancestor
92514554|NCT00006002|Hormones|hormones|mesh-ancestor
92514555|NCT00006002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514556|NCT00006002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514557|NCT00006002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514558|NCT00001365|Dextromethorphan|dextromethorphan|mesh-list
92514559|NCT00001365|Antitussive Agents|antitussive agents|mesh-ancestor
92514560|NCT00001365|Respiratory System Agents|respiratory system agents|mesh-ancestor
92514561|NCT00001365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92514562|NCT00001365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92514563|NCT00001365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514564|NCT00001365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514565|NCT00001365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514566|NCT00015925|Entinostat|entinostat|mesh-list
92514567|NCT00015925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514568|NCT00015925|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92514569|NCT00015925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514570|NCT00015925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514571|NCT00006005|Thalidomide|thalidomide|mesh-list
92514572|NCT00006005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514573|NCT00006005|Immunologic Factors|immunologic factors|mesh-ancestor
92514574|NCT00006005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514575|NCT00006005|Leprostatic Agents|leprostatic agents|mesh-ancestor
92514576|NCT00006005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92514577|NCT00006005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514578|NCT00006005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92514579|NCT00006005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92514580|NCT00006005|Growth Substances|growth substances|mesh-ancestor
92514581|NCT00006005|Growth Inhibitors|growth inhibitors|mesh-ancestor
92514582|NCT00006005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514583|NCT00015964|Gefitinib|gefitinib|mesh-list
92514584|NCT00015964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514585|NCT00015964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92514586|NCT00015964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514587|NCT00015964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514588|NCT01630213|Vitamin D|vitamin d|mesh-list
92514589|NCT01630213|Ergocalciferols|ergocalciferols|mesh-list
92514590|NCT01630213|Cholecalciferol|cholecalciferol|mesh-list
92514591|NCT01630213|Vitamins|vitamins|mesh-list
92514592|NCT01630213|Micronutrients|micronutrients|mesh-ancestor
92514593|NCT01630213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514594|NCT01630213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92514595|NCT01630213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514596|NCT00006008|Arsenic Trioxide|arsenic trioxide|mesh-list
92514597|NCT00006008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514598|NCT00016042|Interferons|interferons|mesh-list
92514599|NCT00016042|Interferon-alpha|interferon-alpha|mesh-list
92514600|NCT00016042|Fluorouracil|fluorouracil|mesh-list
92514601|NCT00016042|Sargramostim|sargramostim|mesh-list
92514602|NCT00016042|Antimetabolites|antimetabolites|mesh-ancestor
92514603|NCT00016042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514604|NCT00016042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514605|NCT00016042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514606|NCT00016042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514607|NCT00016042|Immunologic Factors|immunologic factors|mesh-ancestor
92514608|NCT00016042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514609|NCT00016042|Antiviral Agents|antiviral agents|mesh-ancestor
92514610|NCT00016042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514611|NCT00016081|Ribavirin|ribavirin|mesh-list
92514612|NCT00016081|Antimetabolites|antimetabolites|mesh-ancestor
92514613|NCT00016081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514614|NCT00016081|Antiviral Agents|antiviral agents|mesh-ancestor
92351753|NCT03585738|Folic Acid|folic acid|mesh-list
92514615|NCT00016081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514616|NCT00016159|Idarubicin|idarubicin|mesh-list
92514617|NCT00016159|Arsenic Trioxide|arsenic trioxide|mesh-list
92514618|NCT00016159|Tretinoin|tretinoin|mesh-list
92514619|NCT00016159|Lintuzumab|lintuzumab|mesh-list
92514620|NCT00016159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514621|NCT00016159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514622|NCT00016159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514623|NCT00016159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514624|NCT00016159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514625|NCT00016159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514626|NCT00016159|Keratolytic Agents|keratolytic agents|mesh-ancestor
92514627|NCT00016159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92514628|NCT00016159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92514630|NCT00016198|Fluorouracil|fluorouracil|mesh-list
92514631|NCT00016198|Oxaliplatin|oxaliplatin|mesh-list
92514632|NCT00016198|Calcium|calcium|mesh-list
92514633|NCT00016198|Levoleucovorin|levoleucovorin|mesh-list
92514634|NCT00016198|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514635|NCT00016198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514636|NCT00016198|Antimetabolites|antimetabolites|mesh-ancestor
92514637|NCT00016198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514638|NCT00016198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514639|NCT00016198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514640|NCT00016198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514641|NCT00016198|Immunologic Factors|immunologic factors|mesh-ancestor
92514642|NCT00016198|Antidotes|antidotes|mesh-ancestor
92514643|NCT00016198|Protective Agents|protective agents|mesh-ancestor
92514644|NCT00016198|Vitamin B Complex|vitamin b complex|mesh-ancestor
92514646|NCT00016198|Micronutrients|micronutrients|mesh-ancestor
92514647|NCT00016276|Tamoxifen|tamoxifen|mesh-list
92514648|NCT00016276|Paclitaxel|paclitaxel|mesh-list
92514649|NCT00016276|Razoxane|razoxane|mesh-list
92514650|NCT00016276|Cyclophosphamide|cyclophosphamide|mesh-list
92514651|NCT00016276|Doxorubicin|doxorubicin|mesh-list
92514652|NCT00016276|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92514653|NCT00016276|Trastuzumab|trastuzumab|mesh-list
92514654|NCT00016276|Dexrazoxane|dexrazoxane|mesh-list
92514655|NCT00016276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514656|NCT00016276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514657|NCT00016276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514658|NCT00016276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514659|NCT00016276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514660|NCT00016276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514661|NCT00016276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514662|NCT00016276|Immunologic Factors|immunologic factors|mesh-ancestor
92514663|NCT00016276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514664|NCT00016276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514665|NCT00016276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514666|NCT00016276|Alkylating Agents|alkylating agents|mesh-ancestor
92514667|NCT00016276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514668|NCT00016276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514669|NCT00016276|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514670|NCT00016276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514671|NCT00016276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514672|NCT00016276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92514673|NCT00016276|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92514674|NCT00016276|Hormone Antagonists|hormone antagonists|mesh-ancestor
92514675|NCT00016276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514676|NCT00016276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514677|NCT00016276|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92514678|NCT00016276|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92514679|NCT00016276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92514680|NCT00016276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92514681|NCT00016276|Protective Agents|protective agents|mesh-ancestor
92514682|NCT00016315|Paclitaxel|paclitaxel|mesh-list
92514683|NCT00016315|Carboplatin|carboplatin|mesh-list
92514684|NCT00016315|Gemcitabine|gemcitabine|mesh-list
92514685|NCT00016315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514686|NCT00016315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514687|NCT00016315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514688|NCT00016315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514689|NCT00016315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514690|NCT00016315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514691|NCT00016315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514692|NCT00016315|Antimetabolites|antimetabolites|mesh-ancestor
92514693|NCT00006014|Semaxinib|semaxinib|mesh-list
92514694|NCT00006014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92514695|NCT00006014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92514696|NCT00006014|Growth Substances|growth substances|mesh-ancestor
92514697|NCT00006014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514698|NCT00006014|Growth Inhibitors|growth inhibitors|mesh-ancestor
92514699|NCT00006014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514700|NCT00006014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92514701|NCT00006014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514702|NCT00006014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514704|NCT00016432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514705|NCT00016432|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92514706|NCT00016432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92514707|NCT00016432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514708|NCT00016432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514709|NCT00016432|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92514710|NCT00016432|Hormone Antagonists|hormone antagonists|mesh-ancestor
92514711|NCT00016432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514712|NCT00016432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514713|NCT00389376|Silymarin|silymarin|mesh-list
92514714|NCT00389376|Antioxidants|antioxidants|mesh-ancestor
92514715|NCT00389376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514716|NCT00389376|Protective Agents|protective agents|mesh-ancestor
92514717|NCT00389376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514718|NCT00016549|Bevacizumab|bevacizumab|mesh-list
92514719|NCT00016549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92514720|NCT00016549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514721|NCT00016549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92514722|NCT00016549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92514723|NCT00016549|Growth Substances|growth substances|mesh-ancestor
92514724|NCT00016549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514725|NCT00016549|Growth Inhibitors|growth inhibitors|mesh-ancestor
92514726|NCT00006023|Capecitabine|capecitabine|mesh-list
92514727|NCT00006023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514728|NCT00006023|Antimetabolites|antimetabolites|mesh-ancestor
92514729|NCT00006023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514730|NCT00006023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514731|NCT00016588|Tenofovir|tenofovir|mesh-list
92514732|NCT00016588|Antiviral Agents|antiviral agents|mesh-ancestor
92514733|NCT00016588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92514734|NCT00016588|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92514735|NCT00016588|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92514736|NCT00016588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514737|NCT00016588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514738|NCT00016588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92514739|NCT00016588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92514740|NCT00006026|Rubitecan|rubitecan|mesh-list
92514741|NCT00006026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514742|NCT00006026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514743|NCT00006026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514744|NCT00006026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514745|NCT00006026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514746|NCT00016666|Propranolol|propranolol|mesh-list
92514747|NCT00016666|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92514748|NCT00016666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92514749|NCT00016666|Adrenergic Agents|adrenergic agents|mesh-ancestor
92514750|NCT00016666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514751|NCT00016666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514752|NCT00016666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514753|NCT00016666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92514754|NCT00016666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92514755|NCT00016666|Vasodilator Agents|vasodilator agents|mesh-ancestor
92514756|NCT00016744|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92514757|NCT00016744|Genistein|genistein|mesh-list
92514758|NCT00016744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514759|NCT00016744|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92514760|NCT00016744|Protective Agents|protective agents|mesh-ancestor
92514761|NCT00016744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514762|NCT00016744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92514763|NCT00016744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514764|NCT00016744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514765|NCT00016744|Phytoestrogens|phytoestrogens|mesh-ancestor
92514766|NCT00016744|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92514767|NCT00016744|Estrogens|estrogens|mesh-ancestor
92514768|NCT00016744|Hormones|hormones|mesh-ancestor
92514769|NCT00016744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514770|NCT00016861|Irinotecan|irinotecan|mesh-list
92514771|NCT00016861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514772|NCT00016861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514773|NCT00016861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514774|NCT00016861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514775|NCT00016861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514776|NCT00016900|Paclitaxel|paclitaxel|mesh-list
92514777|NCT00016900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514778|NCT00016900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514779|NCT00016900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514780|NCT00016900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514781|NCT00016900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514782|NCT00016900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514783|NCT00016939|Alvocidib|alvocidib|mesh-list
92514784|NCT00016939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514785|NCT00016939|Growth Inhibitors|growth inhibitors|mesh-ancestor
92514786|NCT00016939|Growth Substances|growth substances|mesh-ancestor
92514787|NCT00016939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514788|NCT00016939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92514789|NCT00016939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514790|NCT00016939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514791|NCT00386672|Calcium, Dietary|calcium, dietary|mesh-list
92514793|NCT00386672|Ergocalciferols|ergocalciferols|mesh-list
92514794|NCT00386672|Cholecalciferol|cholecalciferol|mesh-list
92514795|NCT00386672|Vitamins|vitamins|mesh-list
92514796|NCT00386672|Calcium|calcium|mesh-list
92514797|NCT00386672|Micronutrients|micronutrients|mesh-ancestor
92514798|NCT00386672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514799|NCT00386672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239716|NCT02101190|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92514800|NCT00386672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92514801|NCT00016978|Leucovorin|leucovorin|mesh-list
92514802|NCT00016978|Fluorouracil|fluorouracil|mesh-list
92514803|NCT00016978|Oxaliplatin|oxaliplatin|mesh-list
92514804|NCT00016978|Calcium|calcium|mesh-list
92514805|NCT00016978|Levoleucovorin|levoleucovorin|mesh-list
92514806|NCT00016978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514807|NCT00016978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514808|NCT00016978|Antimetabolites|antimetabolites|mesh-ancestor
92514809|NCT00016978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514810|NCT00016978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514811|NCT00016978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514812|NCT00016978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514813|NCT00016978|Immunologic Factors|immunologic factors|mesh-ancestor
92514814|NCT00016978|Antidotes|antidotes|mesh-ancestor
92514815|NCT00016978|Protective Agents|protective agents|mesh-ancestor
92514816|NCT00016978|Vitamin B Complex|vitamin b complex|mesh-ancestor
92514817|NCT00016978|Vitamins|vitamins|mesh-ancestor
92514818|NCT00016978|Micronutrients|micronutrients|mesh-ancestor
92514819|NCT00017017|Paclitaxel|paclitaxel|mesh-list
92514820|NCT00017017|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92514821|NCT00017017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514822|NCT00017017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514823|NCT00017017|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514824|NCT00017017|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514825|NCT00017017|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514826|NCT00017017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514827|NCT00017095|Cyclophosphamide|cyclophosphamide|mesh-list
92514828|NCT00017095|Docetaxel|docetaxel|mesh-list
92514829|NCT00017095|Fluorouracil|fluorouracil|mesh-list
92514830|NCT00017095|Epirubicin|epirubicin|mesh-list
92514831|NCT00017095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514832|NCT00017095|Immunologic Factors|immunologic factors|mesh-ancestor
92514833|NCT00017095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514834|NCT00017095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514835|NCT00017095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514836|NCT00017095|Alkylating Agents|alkylating agents|mesh-ancestor
92514837|NCT00017095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514838|NCT00017095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514839|NCT00017095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514840|NCT00017095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514841|NCT00017095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514842|NCT00017095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514843|NCT00017095|Antimetabolites|antimetabolites|mesh-ancestor
92514844|NCT00017095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514845|NCT00017095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514846|NCT00017095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514847|NCT00017095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514848|NCT00017095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514849|NCT00006029|Gemcitabine|gemcitabine|mesh-list
92514850|NCT00006029|Doxorubicin|doxorubicin|mesh-list
92514851|NCT00006029|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92514852|NCT00006029|Vinorelbine|vinorelbine|mesh-list
92514853|NCT00006029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514854|NCT00006029|Antimetabolites|antimetabolites|mesh-ancestor
92514855|NCT00006029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514856|NCT00006029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514857|NCT00006029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514858|NCT00006029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514859|NCT00006029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514860|NCT00006029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514861|NCT00006029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514862|NCT00006029|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514863|NCT00006029|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514864|NCT00006029|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514865|NCT00371059|Memantine|memantine|mesh-list
92514866|NCT00371059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92514867|NCT00371059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92514868|NCT00371059|Dopamine Agents|dopamine agents|mesh-ancestor
92514870|NCT00371059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514871|NCT00371059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514872|NCT00371059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92514873|NCT00371059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92514874|NCT00001482|Lamotrigine|lamotrigine|mesh-list
92514875|NCT00001482|Gabapentin|gabapentin|mesh-list
92514876|NCT00001482|Analgesics|analgesics|mesh-ancestor
92514877|NCT00001482|Sensory System Agents|sensory system agents|mesh-ancestor
92514878|NCT00001482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514879|NCT00001482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514880|NCT00001482|Anticonvulsants|anticonvulsants|mesh-ancestor
92514881|NCT00001482|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92514882|NCT00001482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92514883|NCT00001482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92514884|NCT00001482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92514885|NCT00001482|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92514886|NCT00001482|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92514887|NCT00001482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351797|NCT03589326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514888|NCT00001482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514889|NCT00001482|Antimanic Agents|antimanic agents|mesh-ancestor
92514890|NCT00001482|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92514891|NCT00001482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92514892|NCT00001482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514893|NCT00001482|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92514894|NCT00001482|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92514895|NCT00017134|Fenretinide|fenretinide|mesh-list
92514896|NCT00017134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514897|NCT00017134|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92514898|NCT00017134|Protective Agents|protective agents|mesh-ancestor
92514899|NCT00017134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514900|NCT04734418|Dexmedetomidine|dexmedetomidine|mesh-list
92514901|NCT04734418|Remifentanil|remifentanil|mesh-list
92514902|NCT04734418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92514903|NCT04734418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92514904|NCT04734418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514905|NCT04734418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92514906|NCT04734418|Analgesics|analgesics|mesh-ancestor
92514907|NCT04734418|Sensory System Agents|sensory system agents|mesh-ancestor
92514908|NCT04734418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92514909|NCT04734418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92514910|NCT04734418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92514911|NCT04734418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92514912|NCT04734418|Adrenergic Agents|adrenergic agents|mesh-ancestor
92514913|NCT04734418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92514914|NCT04734418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514915|NCT04734418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92514916|NCT04734418|Narcotics|narcotics|mesh-ancestor
92514917|NCT00006032|Etoposide|etoposide|mesh-list
92514918|NCT00006032|Topotecan|topotecan|mesh-list
92514919|NCT00006032|Ifosfamide|ifosfamide|mesh-list
92514920|NCT00006032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514921|NCT00006032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514922|NCT00006032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514923|NCT00006032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514924|NCT00006032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514925|NCT00006032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514926|NCT00006032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514927|NCT00006032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514928|NCT00006032|Alkylating Agents|alkylating agents|mesh-ancestor
92514929|NCT00017173|Cisplatin|cisplatin|mesh-list
92514930|NCT00017173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514931|NCT00001509|Tretinoin|tretinoin|mesh-list
92514932|NCT00001509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514933|NCT00001509|Keratolytic Agents|keratolytic agents|mesh-ancestor
92514934|NCT00001509|Dermatologic Agents|dermatologic agents|mesh-ancestor
92514935|NCT00006035|Bleomycin|bleomycin|mesh-list
92514936|NCT00006035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92514937|NCT00006035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514938|NCT00017212|Exatecan|exatecan|mesh-list
92514939|NCT00017212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92514940|NCT00017212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514941|NCT00017212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514942|NCT00017212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514943|NCT00017212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514944|NCT00017251|Carboplatin|carboplatin|mesh-list
92514945|NCT00017251|Etoposide|etoposide|mesh-list
92514946|NCT00017251|Etoposide phosphate|etoposide phosphate|mesh-list
92514947|NCT00017251|Oblimersen|oblimersen|mesh-list
92514948|NCT00017251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514949|NCT00017251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92514950|NCT00017251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92514951|NCT00017251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92514952|NCT00017251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92514953|NCT00017251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514955|NCT00006038|Docetaxel|docetaxel|mesh-list
92514956|NCT00006038|Fluorouracil|fluorouracil|mesh-list
92514957|NCT00006038|Floxuridine|floxuridine|mesh-list
92514958|NCT00006038|Calcium|calcium|mesh-list
92514959|NCT00006038|Levoleucovorin|levoleucovorin|mesh-list
92514960|NCT00006038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514961|NCT00006038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92514962|NCT00006038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92514963|NCT00006038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92514964|NCT00006038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514965|NCT00006038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92514966|NCT00006038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514967|NCT00006038|Antimetabolites|antimetabolites|mesh-ancestor
92514968|NCT00006038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92514969|NCT00006038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514970|NCT00006038|Immunologic Factors|immunologic factors|mesh-ancestor
92514971|NCT00006038|Antidotes|antidotes|mesh-ancestor
92514972|NCT00006038|Protective Agents|protective agents|mesh-ancestor
92514973|NCT00006038|Vitamin B Complex|vitamin b complex|mesh-ancestor
92514974|NCT00006038|Vitamins|vitamins|mesh-ancestor
92514975|NCT00006038|Micronutrients|micronutrients|mesh-ancestor
92514976|NCT00017290|Prednisone|prednisone|mesh-list
92514977|NCT00017290|Cyclophosphamide|cyclophosphamide|mesh-list
92514978|NCT00017290|Vincristine|vincristine|mesh-list
92514979|NCT00017290|Immunoglobulins|immunoglobulins|mesh-list
92514980|NCT00017290|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92514981|NCT00017290|Antibodies|antibodies|mesh-list
92514982|NCT00017290|Sargramostim|sargramostim|mesh-list
92514983|NCT00017290|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92514984|NCT00017290|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92514985|NCT00017290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92514986|NCT00017290|Immunologic Factors|immunologic factors|mesh-ancestor
92514987|NCT00017290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92514988|NCT00017290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92514989|NCT00017290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92514990|NCT00017290|Alkylating Agents|alkylating agents|mesh-ancestor
92514991|NCT00017290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92514992|NCT00017290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92514993|NCT00017290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92514994|NCT00017290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92514995|NCT00017290|Glucocorticoids|glucocorticoids|mesh-ancestor
92514996|NCT00017290|Hormones|hormones|mesh-ancestor
92514997|NCT00017290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92514998|NCT00017290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92514999|NCT00017290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92515000|NCT00017290|Tubulin Modulators|tubulin modulators|mesh-ancestor
92515001|NCT00017290|Antimitotic Agents|antimitotic agents|mesh-ancestor
92515002|NCT00017290|Mitosis Modulators|mitosis modulators|mesh-ancestor
92515003|NCT00017290|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92515004|NCT00017329|Bortezomib|bortezomib|mesh-list
92515005|NCT00017329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515006|NCT00017368|Cyclophosphamide|cyclophosphamide|mesh-list
92515007|NCT00017368|Melphalan|melphalan|mesh-list
92515008|NCT00017368|Ifosfamide|ifosfamide|mesh-list
92515010|NCT00017368|Carboplatin|carboplatin|mesh-list
92515011|NCT00017368|Doxorubicin|doxorubicin|mesh-list
92515012|NCT00017368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92515013|NCT00017368|Etoposide|etoposide|mesh-list
92515014|NCT00017368|Etoposide phosphate|etoposide phosphate|mesh-list
92515015|NCT00017368|Vincristine|vincristine|mesh-list
92515016|NCT00017368|Isotretinoin|isotretinoin|mesh-list
92515017|NCT00017368|Sargramostim|sargramostim|mesh-list
92515018|NCT00017368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515019|NCT00017368|Immunologic Factors|immunologic factors|mesh-ancestor
92515020|NCT00017368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515021|NCT00017368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515022|NCT00017368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92515023|NCT00017368|Alkylating Agents|alkylating agents|mesh-ancestor
92515024|NCT00017368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515025|NCT00017368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515026|NCT00017368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92515027|NCT00017368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92515028|NCT00017368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92515029|NCT00017368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92515030|NCT00017368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515031|NCT00017368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92515032|NCT00017368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92515033|NCT00017368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92515034|NCT00017368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92515035|NCT00017368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92515036|NCT00001524|Thalidomide|thalidomide|mesh-list
92515037|NCT00001524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515038|NCT00001524|Immunologic Factors|immunologic factors|mesh-ancestor
92515039|NCT00001524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515040|NCT00001524|Leprostatic Agents|leprostatic agents|mesh-ancestor
92515041|NCT00001524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515042|NCT00001524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515043|NCT00001524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92515044|NCT00001524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92515045|NCT00001524|Growth Substances|growth substances|mesh-ancestor
92515046|NCT00001524|Growth Inhibitors|growth inhibitors|mesh-ancestor
92515047|NCT00001524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515048|NCT00006041|Vaccines|vaccines|mesh-list
92515049|NCT00006041|Saponin QA-21V1|saponin qa-21v1|mesh-list
92515050|NCT00006041|Immunologic Factors|immunologic factors|mesh-ancestor
92515051|NCT00006041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515052|NCT00006041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92515053|NCT00017602|Dexamethasone|dexamethasone|mesh-list
92515054|NCT00017602|Oblimersen|oblimersen|mesh-list
92515055|NCT00017602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515056|NCT00017602|Antiemetics|antiemetics|mesh-ancestor
92515057|NCT00017602|Autonomic Agents|autonomic agents|mesh-ancestor
92515058|NCT00017602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515059|NCT00017602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515060|NCT00017602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515061|NCT00017602|Glucocorticoids|glucocorticoids|mesh-ancestor
92515062|NCT00017602|Hormones|hormones|mesh-ancestor
92515063|NCT00017602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515064|NCT00017602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92515065|NCT00017602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515066|NCT00001533|Cyclosporine|cyclosporine|mesh-list
92515067|NCT00001533|Cyclosporins|cyclosporins|mesh-list
92515068|NCT00001533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515069|NCT00001533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515070|NCT00001533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515071|NCT00001533|Immunologic Factors|immunologic factors|mesh-ancestor
92515072|NCT00001533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515073|NCT00001533|Antifungal Agents|antifungal agents|mesh-ancestor
92515074|NCT00001533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515075|NCT00001533|Dermatologic Agents|dermatologic agents|mesh-ancestor
92515076|NCT00001533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515077|NCT00001533|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92515078|NCT00017641|Cyclophosphamide|cyclophosphamide|mesh-list
92515079|NCT00017641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92515080|NCT00017641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515081|NCT00017641|Immunologic Factors|immunologic factors|mesh-ancestor
92515082|NCT00017641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515083|NCT00017641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515084|NCT00017641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92515085|NCT00017641|Alkylating Agents|alkylating agents|mesh-ancestor
92515086|NCT00017641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515087|NCT00017641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515088|NCT00017641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92515090|NCT00017680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92515091|NCT00017680|Alkylating Agents|alkylating agents|mesh-ancestor
92515092|NCT00017680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515093|NCT00017680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515094|NCT00017680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92515095|NCT00017680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515096|NCT00017680|Immunologic Factors|immunologic factors|mesh-ancestor
92515097|NCT00017680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515098|NCT00017719|Lamivudine|lamivudine|mesh-list
92515099|NCT00017719|Zidovudine|zidovudine|mesh-list
92515100|NCT00017719|Nevirapine|nevirapine|mesh-list
92515101|NCT00017719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92515102|NCT00017719|Nelfinavir|nelfinavir|mesh-list
92515103|NCT00017719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92515104|NCT00017719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92515105|NCT00017719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515106|NCT00017719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515107|NCT00017719|Antiviral Agents|antiviral agents|mesh-ancestor
92240008|NCT03954990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515109|NCT00017719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515110|NCT00017719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515111|NCT00017719|Antimetabolites|antimetabolites|mesh-ancestor
92515112|NCT00017719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92515113|NCT00017719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92515114|NCT00017719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92515115|NCT00017719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92515116|NCT00017719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515117|NCT00001542|Fluconazole|fluconazole|mesh-list
92515118|NCT00001542|Antifungal Agents|antifungal agents|mesh-ancestor
92515119|NCT00001542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515120|NCT00001542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92515121|NCT00001542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515122|NCT00001542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515123|NCT00001542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515124|NCT00001542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92515125|NCT00001542|Hormone Antagonists|hormone antagonists|mesh-ancestor
92515126|NCT00001542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515127|NCT00001542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515128|NCT00001542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92515129|NCT00001542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92515130|NCT00017758|Efavirenz|efavirenz|mesh-list
92515131|NCT00017758|Nelfinavir|nelfinavir|mesh-list
92515132|NCT00017758|Atorvastatin|atorvastatin|mesh-list
92515133|NCT00017758|Simvastatin|simvastatin|mesh-list
92515134|NCT00017758|Pravastatin|pravastatin|mesh-list
92515135|NCT00017758|Calcium|calcium|mesh-list
92515136|NCT00017758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92515137|NCT00017758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515138|NCT00017758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92515139|NCT00017758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92515140|NCT00017758|Antimetabolites|antimetabolites|mesh-ancestor
92515141|NCT00017758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515142|NCT00017758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92515143|NCT00017758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92515144|NCT00017758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515145|NCT00017758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92515146|NCT00017758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92515147|NCT00017758|Antiviral Agents|antiviral agents|mesh-ancestor
92515148|NCT00017758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351815|NCT03585426|Vancomycin|vancomycin|mesh-list
92515149|NCT00017758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92515150|NCT00017758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515151|NCT00017758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92515152|NCT00017758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92515153|NCT00017758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92515154|NCT00017758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92515155|NCT00017758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92533251|NCT02969473|Cisplatin|cisplatin|mesh-list
92515156|NCT00017758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92515157|NCT00017758|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515158|NCT00017758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515159|NCT00017758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515160|NCT00017992|Ritonavir|ritonavir|mesh-list
92515161|NCT00017992|Lopinavir|lopinavir|mesh-list
92515162|NCT00017992|Emtricitabine|emtricitabine|mesh-list
92515163|NCT00017992|Stavudine|stavudine|mesh-list
92515164|NCT00017992|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92515165|NCT00017992|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92515166|NCT00017992|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515167|NCT00017992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515168|NCT00017992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515169|NCT00017992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515170|NCT00017992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515171|NCT00017992|Antiviral Agents|antiviral agents|mesh-ancestor
92515172|NCT00017992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515173|NCT00017992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92515174|NCT00017992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515175|NCT00017992|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92515176|NCT00017992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92515177|NCT00017992|Antimetabolites|antimetabolites|mesh-ancestor
92515178|NCT04734067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92515179|NCT04734067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515180|NCT04734067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515181|NCT04734067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515183|NCT05680805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92515184|NCT05680805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515185|NCT00018148|Nortriptyline|nortriptyline|mesh-list
92515186|NCT00018148|Nicotine|nicotine|mesh-list
92515187|NCT00018148|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92515188|NCT00018148|Autonomic Agents|autonomic agents|mesh-ancestor
92515189|NCT00018148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515190|NCT00018148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515191|NCT00018148|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92515192|NCT00018148|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92515193|NCT00018148|Cholinergic Agents|cholinergic agents|mesh-ancestor
92515194|NCT00018148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515195|NCT00018148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515196|NCT00018148|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92515197|NCT00018148|Antidepressive Agents|antidepressive agents|mesh-ancestor
92515198|NCT00018148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92515199|NCT00018148|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92515200|NCT00018148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92515201|NCT00018148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515202|NCT00018148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92515203|NCT00001563|Rituximab|rituximab|mesh-list
92515204|NCT00001563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515205|NCT00001563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515206|NCT00001563|Immunologic Factors|immunologic factors|mesh-ancestor
92515207|NCT00001563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515208|NCT00001563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515209|NCT00018187|Mecamylamine|mecamylamine|mesh-list
92515210|NCT00018187|Bupropion|bupropion|mesh-list
92515211|NCT00018187|Nicotine|nicotine|mesh-list
92515212|NCT00018187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92515213|NCT00018187|Autonomic Agents|autonomic agents|mesh-ancestor
92515214|NCT00018187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515215|NCT00018187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515216|NCT00018187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92515217|NCT00018187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92515218|NCT00018187|Cholinergic Agents|cholinergic agents|mesh-ancestor
92515219|NCT00018187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515220|NCT00018187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515221|NCT00018187|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92515222|NCT00018187|Antidepressive Agents|antidepressive agents|mesh-ancestor
92515223|NCT00018187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92515224|NCT00018187|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92515225|NCT00018187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92515226|NCT00018187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515227|NCT00018187|Dopamine Agents|dopamine agents|mesh-ancestor
92515228|NCT00018187|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92515229|NCT00018187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515230|NCT00018187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515231|NCT00018187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92515232|NCT00018187|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92515233|NCT00018187|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92515234|NCT00018187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92515235|NCT00018343|Estrogens|estrogens|mesh-list
92515236|NCT00018343|Hormones|hormones|mesh-ancestor
92515237|NCT00018343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515238|NCT00018343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515239|NCT00001566|Indinavir|indinavir|mesh-list
92515240|NCT00001566|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92515241|NCT00001566|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92515242|NCT00001566|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515243|NCT00001566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515244|NCT00001566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515245|NCT00001566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515246|NCT00001566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515247|NCT00001566|Antiviral Agents|antiviral agents|mesh-ancestor
92515248|NCT00001566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515249|NCT00018382|Rosiglitazone|rosiglitazone|mesh-list
92515250|NCT00018382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92515251|NCT00018382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515252|NCT00018460|Vitamins|vitamins|mesh-list
92515253|NCT00018460|Vitamin B Complex|vitamin b complex|mesh-list
92515254|NCT00018460|Micronutrients|micronutrients|mesh-ancestor
92515255|NCT00018460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515257|NCT00386750|Artemether|artemether|mesh-list
92515258|NCT00386750|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92515259|NCT00386750|Antimalarials|antimalarials|mesh-ancestor
92515260|NCT00386750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92515261|NCT00386750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92515262|NCT00386750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515263|NCT00001575|Edetic Acid|edetic acid|mesh-list
92515264|NCT00001575|Calcium|calcium|mesh-list
92515265|NCT00001575|Pentetic Acid|pentetic acid|mesh-list
92515266|NCT00001575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92515267|NCT00001575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515268|NCT00001575|Antidotes|antidotes|mesh-ancestor
92515269|NCT00001575|Protective Agents|protective agents|mesh-ancestor
92515270|NCT00001575|Chelating Agents|chelating agents|mesh-ancestor
92515271|NCT00001575|Sequestering Agents|sequestering agents|mesh-ancestor
92515272|NCT00001575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515273|NCT00001575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92515274|NCT00001575|Anticoagulants|anticoagulants|mesh-ancestor
92515275|NCT00001575|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92515276|NCT00001596|Pirfenidone|pirfenidone|mesh-list
92515277|NCT00001596|Analgesics|analgesics|mesh-ancestor
92515278|NCT00001596|Sensory System Agents|sensory system agents|mesh-ancestor
92515279|NCT00001596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515280|NCT00001596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515281|NCT00001596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92515282|NCT00001596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92515283|NCT00001596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515284|NCT00001596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515285|NCT00001596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515286|NCT05576194|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92515287|NCT05576194|Taurolidine|taurolidine|mesh-list
92515288|NCT05576194|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92515289|NCT05576194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515290|NCT05576194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515291|NCT00391885|Anesthetics|anesthetics|mesh-list
92515292|NCT00391885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515293|NCT00391885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515294|NCT00391924|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92515295|NCT00391924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92515296|NCT00391924|Immunologic Factors|immunologic factors|mesh-ancestor
92515297|NCT00391924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515298|NCT00392002|Esomeprazole|esomeprazole|mesh-list
92515299|NCT00392002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92515300|NCT00392002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515301|NCT00392002|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92515302|NCT00392002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515303|NCT00392002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515305|NCT00392080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92515306|NCT00392080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92515307|NCT00392080|Analgesics|analgesics|mesh-ancestor
92533252|NCT02969473|Docetaxel|docetaxel|mesh-list
92515308|NCT00392080|Sensory System Agents|sensory system agents|mesh-ancestor
92515309|NCT00392080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515310|NCT00392080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515311|NCT00392080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515312|NCT00392080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515313|NCT00392080|Gout Suppressants|gout suppressants|mesh-ancestor
92515314|NCT00392080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92515315|NCT00392080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515316|NCT00392080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515317|NCT00001644|Lamivudine|lamivudine|mesh-list
92515318|NCT00001644|Zidovudine|zidovudine|mesh-list
92515319|NCT00001644|Nevirapine|nevirapine|mesh-list
92515320|NCT00001644|Indinavir|indinavir|mesh-list
92515321|NCT00001644|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92515322|NCT00001644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92515323|NCT00001644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515324|NCT00001644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515325|NCT00001644|Antiviral Agents|antiviral agents|mesh-ancestor
92515326|NCT00001644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515327|NCT00001644|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515328|NCT00001644|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515329|NCT00001644|Antimetabolites|antimetabolites|mesh-ancestor
92515330|NCT00001644|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92515331|NCT00001644|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92515332|NCT00001644|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92515333|NCT00001644|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92515334|NCT00001644|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515335|NCT05573386|Lenograstim|lenograstim|mesh-list
92515336|NCT05573386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92515337|NCT05573386|Immunologic Factors|immunologic factors|mesh-ancestor
92515338|NCT05573386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515339|NCT00001656|Olanzapine|olanzapine|mesh-list
92515340|NCT00001656|Clozapine|clozapine|mesh-list
92515341|NCT00001656|Antiemetics|antiemetics|mesh-ancestor
92515342|NCT00001656|Autonomic Agents|autonomic agents|mesh-ancestor
92515343|NCT00001656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515344|NCT00001656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515345|NCT00001656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515346|NCT00001656|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92515347|NCT00001656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92515348|NCT00001656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515349|NCT00001656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92515350|NCT00001656|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92515351|NCT00001656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92515352|NCT00001656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515353|NCT00001656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515354|NCT00001656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515355|NCT00001656|Serotonin Agents|serotonin agents|mesh-ancestor
92515356|NCT00001656|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92515357|NCT00001656|GABA Antagonists|gaba antagonists|mesh-ancestor
92515358|NCT00001656|GABA Agents|gaba agents|mesh-ancestor
92515359|NCT05573191|Lidocaine|lidocaine|mesh-list
92515360|NCT05573191|Anesthetics, Local|anesthetics, local|mesh-ancestor
92515361|NCT05573191|Anesthetics|anesthetics|mesh-ancestor
92515362|NCT05573191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515363|NCT05573191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515364|NCT05573191|Sensory System Agents|sensory system agents|mesh-ancestor
92515365|NCT05573191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515366|NCT05573191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92515367|NCT05573191|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92515368|NCT05573191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92515369|NCT05573191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515370|NCT05573191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515371|NCT05679830|Cannabidiol|cannabidiol|mesh-list
92515372|NCT05679830|Anticonvulsants|anticonvulsants|mesh-ancestor
92515373|NCT05572996|Treprostinil|treprostinil|mesh-list
92515374|NCT05572996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92515375|NCT05572723|Dexmedetomidine|dexmedetomidine|mesh-list
92515376|NCT05572723|Remifentanil|remifentanil|mesh-list
92515377|NCT05572723|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92515378|NCT05572723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515379|NCT05572723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515380|NCT05572723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92515381|NCT05572723|Analgesics|analgesics|mesh-ancestor
92515382|NCT05572723|Sensory System Agents|sensory system agents|mesh-ancestor
92515383|NCT05572723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515384|NCT05572723|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92515385|NCT05572723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92515386|NCT05572723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92515387|NCT05572723|Adrenergic Agents|adrenergic agents|mesh-ancestor
92515388|NCT05572723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515389|NCT05572723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515390|NCT05572723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92515391|NCT05572723|Narcotics|narcotics|mesh-ancestor
92515392|NCT05563753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92515393|NCT05563753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515394|NCT00389415|Vildagliptin|vildagliptin|mesh-list
92515395|NCT00389415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92515396|NCT00389415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515397|NCT00389415|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92515398|NCT00389415|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515399|NCT00389415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515400|NCT00389415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515402|NCT05419921|Anesthetics, Local|anesthetics, local|mesh-ancestor
92515403|NCT05419921|Anesthetics|anesthetics|mesh-ancestor
92515404|NCT05419921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515405|NCT05419921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515406|NCT05419921|Sensory System Agents|sensory system agents|mesh-ancestor
92515407|NCT05419921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515408|NCT05419921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92515409|NCT05419921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92515410|NCT05419921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92515411|NCT05419921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515412|NCT05419921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515413|NCT00386828|Bevacizumab|bevacizumab|mesh-list
92515414|NCT00386828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515415|NCT00386828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515416|NCT00386828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92515417|NCT00386828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92515418|NCT00386828|Growth Substances|growth substances|mesh-ancestor
92515419|NCT00386828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515420|NCT00386828|Growth Inhibitors|growth inhibitors|mesh-ancestor
92515421|NCT05367271|Dexamethasone|dexamethasone|mesh-list
92515422|NCT05367271|Cortisone|cortisone|mesh-list
92515423|NCT05367271|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92515424|NCT05367271|Botulinum Toxins|botulinum toxins|mesh-list
92515425|NCT05367271|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92515426|NCT05367271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515427|NCT05367271|Antiemetics|antiemetics|mesh-ancestor
92515428|NCT05367271|Autonomic Agents|autonomic agents|mesh-ancestor
92515429|NCT05367271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515430|NCT05367271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515431|NCT05367271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515432|NCT05367271|Glucocorticoids|glucocorticoids|mesh-ancestor
92515433|NCT05367271|Hormones|hormones|mesh-ancestor
92515434|NCT05367271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515435|NCT05367271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92515436|NCT05367271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515437|NCT05367271|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92515438|NCT05367271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515439|NCT05367271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515440|NCT05367271|Cholinergic Agents|cholinergic agents|mesh-ancestor
92515441|NCT05367271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515442|NCT05367271|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92515443|NCT00001725|Dextromethorphan|dextromethorphan|mesh-list
92515444|NCT00001725|Antitussive Agents|antitussive agents|mesh-ancestor
92515445|NCT00001725|Respiratory System Agents|respiratory system agents|mesh-ancestor
92515446|NCT00001725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92515447|NCT00001725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92515448|NCT00001725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515449|NCT00001725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515450|NCT00001725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515451|NCT05311618|Pembrolizumab|pembrolizumab|mesh-list
92515452|NCT05311618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515453|NCT05311618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515454|NCT05311618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92515455|NCT05311618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515456|NCT00001728|Alendronate|alendronate|mesh-list
92515457|NCT00001728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92515458|NCT00001728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515459|NCT05673629|Docetaxel|docetaxel|mesh-list
92515460|NCT05673629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515461|NCT05673629|Tubulin Modulators|tubulin modulators|mesh-ancestor
92515462|NCT05673629|Antimitotic Agents|antimitotic agents|mesh-ancestor
92515463|NCT05673629|Mitosis Modulators|mitosis modulators|mesh-ancestor
92515464|NCT05673629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515465|NCT00001731|Cyclosporine|cyclosporine|mesh-list
92515466|NCT00001731|Cyclosporins|cyclosporins|mesh-list
92515467|NCT00001731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515468|NCT00001731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515469|NCT00001731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515470|NCT00001731|Immunologic Factors|immunologic factors|mesh-ancestor
92515471|NCT00001731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515472|NCT00001731|Antifungal Agents|antifungal agents|mesh-ancestor
92515473|NCT00001731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515474|NCT00001731|Dermatologic Agents|dermatologic agents|mesh-ancestor
92515475|NCT00001731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515476|NCT00001731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92515477|NCT00392158|Anesthetics|anesthetics|mesh-list
92515478|NCT00392158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515479|NCT00392158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515480|NCT00392275|Ciprofloxacin|ciprofloxacin|mesh-list
92515481|NCT00392275|Levofloxacin|levofloxacin|mesh-list
92515482|NCT00392275|Ofloxacin|ofloxacin|mesh-list
92515483|NCT00392275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515484|NCT00392275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515485|NCT00392275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92515486|NCT00392275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92515487|NCT00392275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515488|NCT00392275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515489|NCT00392275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515490|NCT00392275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92515491|NCT00392275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515492|NCT00392275|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92515493|NCT00001749|Cyclosporine|cyclosporine|mesh-list
92515494|NCT00001749|Cyclosporins|cyclosporins|mesh-list
92515495|NCT00001749|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92515496|NCT00001749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515497|NCT00001749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515498|NCT00001749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515499|NCT00001749|Immunologic Factors|immunologic factors|mesh-ancestor
92515500|NCT00001749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515501|NCT00001749|Antifungal Agents|antifungal agents|mesh-ancestor
92515502|NCT00001749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515503|NCT00001749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92515504|NCT00001749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515505|NCT00001749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92515506|NCT00001752|Estrogens|estrogens|mesh-list
92515507|NCT00001752|Hormones|hormones|mesh-ancestor
92515508|NCT00001752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515509|NCT00001752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515510|NCT05171179|Lidocaine|lidocaine|mesh-list
92515511|NCT05171179|Bupivacaine|bupivacaine|mesh-list
92515512|NCT05171179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92515513|NCT05171179|Anesthetics|anesthetics|mesh-ancestor
92515514|NCT05171179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515515|NCT05171179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924467|NCT01610245|Oseltamivir|oseltamivir|mesh-list
92515516|NCT05171179|Sensory System Agents|sensory system agents|mesh-ancestor
92515517|NCT05171179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515518|NCT05171179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92515519|NCT05171179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92515520|NCT05171179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92515521|NCT05171179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515522|NCT05171179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515524|NCT05156905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515525|NCT05156905|Tubulin Modulators|tubulin modulators|mesh-ancestor
92515526|NCT05156905|Antimitotic Agents|antimitotic agents|mesh-ancestor
92515527|NCT05156905|Mitosis Modulators|mitosis modulators|mesh-ancestor
92515528|NCT05156905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515529|NCT00001758|Efavirenz|efavirenz|mesh-list
92515530|NCT00001758|Abacavir|abacavir|mesh-list
92515531|NCT00001758|Amprenavir|amprenavir|mesh-list
92515532|NCT00001758|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92515533|NCT00001758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92515534|NCT00001758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515535|NCT00001758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515536|NCT00001758|Antiviral Agents|antiviral agents|mesh-ancestor
92515537|NCT00001758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515538|NCT00001758|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92515539|NCT00001758|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515540|NCT00001758|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92515541|NCT00001758|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92515542|NCT00001758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92515543|NCT00001758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92515544|NCT00001758|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515545|NCT00001758|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515546|NCT00001758|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92515547|NCT00001758|Antitubercular Agents|antitubercular agents|mesh-ancestor
92515548|NCT00001758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515549|NCT00001758|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92515550|NCT00001758|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92515551|NCT00001758|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515552|NCT00001764|Mycophenolic Acid|mycophenolic acid|mesh-list
92515553|NCT00001764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92515554|NCT00001764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515555|NCT00001764|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92515556|NCT00001764|Antitubercular Agents|antitubercular agents|mesh-ancestor
92515557|NCT00001764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515558|NCT00001764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515559|NCT00001764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515560|NCT00001764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515561|NCT04983901|Vancomycin|vancomycin|mesh-list
92515562|NCT04983901|Meropenem|meropenem|mesh-list
92515563|NCT04983901|Linezolid|linezolid|mesh-list
92515564|NCT04983901|Tazobactam|tazobactam|mesh-list
92515565|NCT04983901|Piperacillin|piperacillin|mesh-list
92515566|NCT04983901|Daptomycin|daptomycin|mesh-list
92515567|NCT04983901|Imipenem|imipenem|mesh-list
92515568|NCT04983901|Cefepime|cefepime|mesh-list
92515569|NCT04983901|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92515570|NCT04983901|Relebactam|relebactam|mesh-list
92515571|NCT04983901|Cilastatin|cilastatin|mesh-list
92515572|NCT04983901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515573|NCT04983901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515574|NCT04983901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92515575|NCT04983901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515576|NCT04983901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515577|NCT04983901|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92515578|NCT04983901|Protease Inhibitors|protease inhibitors|mesh-ancestor
92515579|NCT04971343|Antibodies|antibodies|mesh-list
92515580|NCT04971343|Immunoglobulins|immunoglobulins|mesh-list
92515581|NCT04971343|Immunologic Factors|immunologic factors|mesh-ancestor
92515582|NCT04971343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515583|NCT04951804|Bupivacaine|bupivacaine|mesh-list
92515584|NCT04951804|Anesthetics, Local|anesthetics, local|mesh-ancestor
92515585|NCT04951804|Anesthetics|anesthetics|mesh-ancestor
92515586|NCT04951804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515587|NCT04951804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515588|NCT04951804|Sensory System Agents|sensory system agents|mesh-ancestor
92515589|NCT04951804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515590|NCT05620628|Durvalumab|durvalumab|mesh-list
92515591|NCT05620628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515592|NCT05620628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515593|NCT04905121|Psilocybin|psilocybin|mesh-list
92515594|NCT04905121|Hallucinogens|hallucinogens|mesh-ancestor
92515595|NCT04905121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515596|NCT04905121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92515597|NCT00001818|Hydroxyurea|hydroxyurea|mesh-list
92515598|NCT00001818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515599|NCT00001818|Antisickling Agents|antisickling agents|mesh-ancestor
92515600|NCT00001818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515601|NCT00001818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515602|NCT00001818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92515603|NCT04887805|Pembrolizumab|pembrolizumab|mesh-list
92515604|NCT04887805|Lenvatinib|lenvatinib|mesh-list
92515605|NCT04887805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515606|NCT04887805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515607|NCT04887805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92515608|NCT04887805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515609|NCT04887805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92515610|NCT04887805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515611|NCT00392314|Deoxyglucose|deoxyglucose|mesh-list
92515612|NCT00392314|Antimetabolites|antimetabolites|mesh-ancestor
92515613|NCT00392314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515614|NCT00392314|Antiviral Agents|antiviral agents|mesh-ancestor
92515615|NCT00392314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515616|NCT00000102|Nifedipine|nifedipine|mesh-list
92515617|NCT00000102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92515618|NCT00000102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515619|NCT00000102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515620|NCT00000102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92515621|NCT00000102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515622|NCT00000102|Vasodilator Agents|vasodilator agents|mesh-ancestor
92515623|NCT00000102|Tocolytic Agents|tocolytic agents|mesh-ancestor
92515624|NCT00000102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92515625|NCT05641623|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|3-(3-(methylsulfonyl)phenyl)-1-propylpiperidine|mesh-list
92515626|NCT05641623|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92515627|NCT05641623|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92515628|NCT05641623|Dopamine Agents|dopamine agents|mesh-ancestor
92515630|NCT05641623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515631|NCT05641623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515632|NCT05641506|Niraparib|niraparib|mesh-list
92515633|NCT05641506|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92515634|NCT05641506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515635|NCT05641506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515636|NCT05641506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515637|NCT04734730|Prednisone|prednisone|mesh-list
92515638|NCT04734730|Cortisone|cortisone|mesh-list
92515639|NCT04734730|Leuprolide|leuprolide|mesh-list
92515640|NCT04734730|Goserelin|goserelin|mesh-list
92515641|NCT04734730|Abiraterone Acetate|abiraterone acetate|mesh-list
92515642|NCT04734730|Bicalutamide|bicalutamide|mesh-list
92515643|NCT04734730|Talazoparib|talazoparib|mesh-list
92515644|NCT04734730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515645|NCT04734730|Glucocorticoids|glucocorticoids|mesh-ancestor
92515646|NCT04734730|Hormones|hormones|mesh-ancestor
92515647|NCT04734730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515648|NCT04734730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515649|NCT04734730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92515650|NCT04734730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515651|NCT04734730|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92515652|NCT04734730|Fertility Agents|fertility agents|mesh-ancestor
92515653|NCT04734730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92515654|NCT04734730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92515655|NCT04734730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515656|NCT04734730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515657|NCT04734730|Hormone Antagonists|hormone antagonists|mesh-ancestor
92515658|NCT04734730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515659|NCT04734730|Androgen Antagonists|androgen antagonists|mesh-ancestor
92515660|NCT04734730|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92515661|NCT05555888|Capecitabine|capecitabine|mesh-list
92515662|NCT05555888|Oxaliplatin|oxaliplatin|mesh-list
92515663|NCT05555888|Antibodies|antibodies|mesh-list
92515664|NCT05555888|Immunologic Factors|immunologic factors|mesh-ancestor
92515665|NCT05555888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515666|NCT05555888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92515667|NCT05555888|Antimetabolites|antimetabolites|mesh-ancestor
92515668|NCT05555888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515669|NCT05555888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515670|NCT04619680|Nintedanib|nintedanib|mesh-list
92515671|NCT04619680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515672|NCT04619680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92515673|NCT04619680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515674|NCT04619680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515675|NCT00386867|Misoprostol|misoprostol|mesh-list
92515676|NCT00386867|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92515677|NCT00386867|Abortifacient Agents|abortifacient agents|mesh-ancestor
92515678|NCT00386867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92515679|NCT00386867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515680|NCT00386867|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92515681|NCT00386867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515682|NCT00386867|Oxytocics|oxytocics|mesh-ancestor
92515683|NCT04526119|Z 338|z 338|mesh-list
92515684|NCT04526119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92515685|NCT04526119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515686|NCT04526119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515687|NCT04526119|Cholinergic Agents|cholinergic agents|mesh-ancestor
92515688|NCT04526119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515689|NCT04526119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515690|NCT04526119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515691|NCT04487236|Capecitabine|capecitabine|mesh-list
92515692|NCT04487236|Trastuzumab|trastuzumab|mesh-list
92515693|NCT04487236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92515694|NCT04487236|Antimetabolites|antimetabolites|mesh-ancestor
92515695|NCT04487236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515696|NCT04487236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515697|NCT04487236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515698|NCT00392431|Amiodarone|amiodarone|mesh-list
92515699|NCT00392431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92515700|NCT00392431|Vasodilator Agents|vasodilator agents|mesh-ancestor
92515701|NCT00392431|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92515702|NCT00392431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515703|NCT00392431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515704|NCT00392431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92515705|NCT00392431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92515706|NCT00392431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92515707|NCT00392431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515708|NCT00392431|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92515709|NCT00392431|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92515710|NCT00392431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92515711|NCT05495204|Ibalizumab|ibalizumab|mesh-list
92515712|NCT05495204|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92515713|NCT05495204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92515714|NCT05495204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92515715|NCT05495204|Antiviral Agents|antiviral agents|mesh-ancestor
92515716|NCT05495204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515717|NCT05495204|Immunologic Factors|immunologic factors|mesh-ancestor
92515718|NCT05495204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515719|NCT00392470|Irinotecan|irinotecan|mesh-list
92515720|NCT00392470|Cetuximab|cetuximab|mesh-list
92515721|NCT00392470|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92515722|NCT00392470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92515723|NCT00392470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515724|NCT00392470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515725|NCT00392470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515726|NCT00392470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515727|NCT05470517|Ceftriaxone|ceftriaxone|mesh-list
92515728|NCT05470517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515729|NCT05470517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515730|NCT03960151|Dexamethasone|dexamethasone|mesh-list
92515731|NCT03960151|Olanzapine|olanzapine|mesh-list
92515732|NCT03960151|Palonosetron|palonosetron|mesh-list
92515733|NCT03960151|Rolapitant|rolapitant|mesh-list
92515734|NCT03960151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515735|NCT03960151|Antiemetics|antiemetics|mesh-ancestor
92515736|NCT03960151|Autonomic Agents|autonomic agents|mesh-ancestor
92515737|NCT03960151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515738|NCT03960151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515739|NCT03960151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515740|NCT03960151|Glucocorticoids|glucocorticoids|mesh-ancestor
92515742|NCT03960151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515743|NCT03960151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92515744|NCT03960151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515745|NCT03960151|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92515746|NCT03960151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92533261|NCT02969473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515747|NCT03960151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515748|NCT03960151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92515749|NCT03960151|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92515750|NCT03960151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92515751|NCT03960151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515752|NCT03960151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515753|NCT03960151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515754|NCT03960151|Serotonin Agents|serotonin agents|mesh-ancestor
92515755|NCT03960151|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92515756|NCT03960151|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92515757|NCT03960151|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92515758|NCT04733326|Ketorolac|ketorolac|mesh-list
92515759|NCT04733326|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92515760|NCT04733326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92515761|NCT04733326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92515762|NCT04733326|Analgesics|analgesics|mesh-ancestor
92515763|NCT04733326|Sensory System Agents|sensory system agents|mesh-ancestor
92515764|NCT04733326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515765|NCT04733326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515766|NCT04733326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515767|NCT04733326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515768|NCT04733326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92515769|NCT04733326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515770|NCT04733326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515771|NCT00386984|Octreotide|octreotide|mesh-list
92515772|NCT00386984|Somatostatin|somatostatin|mesh-list
92515773|NCT00386984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515774|NCT00386984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92515775|NCT00386984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515776|NCT00386984|Hormones|hormones|mesh-ancestor
92515777|NCT00386984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515778|NCT00386984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515780|NCT03959761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515781|NCT03959761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515782|NCT03959761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92515783|NCT03959761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515784|NCT00387179|Melatonin|melatonin|mesh-list
92515785|NCT00387179|Antioxidants|antioxidants|mesh-ancestor
92515786|NCT00387179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515787|NCT00387179|Protective Agents|protective agents|mesh-ancestor
92515788|NCT00387179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515789|NCT00387179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515790|NCT03959332|Baloxavir|baloxavir|mesh-list
92515791|NCT03959332|Antiviral Agents|antiviral agents|mesh-ancestor
92515792|NCT03959332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515793|NCT03959332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533262|NCT02969473|Immunologic Factors|immunologic factors|mesh-ancestor
92515794|NCT03959332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515796|NCT04733521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515797|NCT05640726|Leucovorin|leucovorin|mesh-list
92515798|NCT05640726|Bevacizumab|bevacizumab|mesh-list
92515799|NCT05640726|Fluorouracil|fluorouracil|mesh-list
92515800|NCT05640726|Oxaliplatin|oxaliplatin|mesh-list
92515801|NCT05640726|Calcium|calcium|mesh-list
92515802|NCT05640726|Levoleucovorin|levoleucovorin|mesh-list
92515803|NCT05640726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515804|NCT05640726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515805|NCT05640726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92515806|NCT05640726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92515807|NCT05640726|Growth Substances|growth substances|mesh-ancestor
92515808|NCT05640726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515809|NCT05640726|Growth Inhibitors|growth inhibitors|mesh-ancestor
92515810|NCT05640726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92515811|NCT05640726|Antimetabolites|antimetabolites|mesh-ancestor
92515812|NCT05640726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515813|NCT05640726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92515814|NCT05640726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92515815|NCT05640726|Immunologic Factors|immunologic factors|mesh-ancestor
92515816|NCT05640726|Antidotes|antidotes|mesh-ancestor
92515817|NCT05640726|Protective Agents|protective agents|mesh-ancestor
92515818|NCT05640726|Vitamin B Complex|vitamin b complex|mesh-ancestor
92515819|NCT05640726|Vitamins|vitamins|mesh-ancestor
92515820|NCT05640726|Micronutrients|micronutrients|mesh-ancestor
92515821|NCT03959176|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92515822|NCT03959176|Phenylephrine|phenylephrine|mesh-list
92515823|NCT03959176|Oxymetazoline|oxymetazoline|mesh-list
92515824|NCT03959176|Tropicamide|tropicamide|mesh-list
92515825|NCT03959176|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92515826|NCT03959176|Mydriatics|mydriatics|mesh-ancestor
92515827|NCT03959176|Autonomic Agents|autonomic agents|mesh-ancestor
92515828|NCT03959176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515829|NCT03959176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515830|NCT03959176|Sympathomimetics|sympathomimetics|mesh-ancestor
92515831|NCT03959176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92515832|NCT03959176|Nasal Decongestants|nasal decongestants|mesh-ancestor
92515833|NCT03959176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92515834|NCT03959176|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92515835|NCT03959176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92515836|NCT03959176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92515837|NCT03959176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92515838|NCT03959176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515839|NCT03959176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515840|NCT03959176|Protective Agents|protective agents|mesh-ancestor
92515841|NCT03959176|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92515842|NCT03959176|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92515843|NCT03959176|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92515844|NCT03959176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92515845|NCT03959176|Cholinergic Agents|cholinergic agents|mesh-ancestor
92515846|NCT03958981|Castor Oil|castor oil|mesh-list
92515847|NCT03958981|Cathartics|cathartics|mesh-ancestor
92515848|NCT03958981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515849|NCT03958942|Bupivacaine|bupivacaine|mesh-list
92515850|NCT03958942|Anesthetics, Local|anesthetics, local|mesh-ancestor
92515851|NCT03958942|Anesthetics|anesthetics|mesh-ancestor
92515852|NCT03958942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515853|NCT03958942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515854|NCT03958942|Sensory System Agents|sensory system agents|mesh-ancestor
92515855|NCT03958942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515857|NCT03958708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515858|NCT03958708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515859|NCT03958708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92515860|NCT05640609|Bevacizumab|bevacizumab|mesh-list
92515861|NCT05640609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515862|NCT05640609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515863|NCT05640609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92515864|NCT05640609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92515865|NCT05640609|Growth Substances|growth substances|mesh-ancestor
92515866|NCT05640609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515867|NCT05640609|Growth Inhibitors|growth inhibitors|mesh-ancestor
92515868|NCT05411861|Analgesics|analgesics|mesh-list
92515869|NCT05411861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92515870|NCT05411861|Sensory System Agents|sensory system agents|mesh-ancestor
92515871|NCT05411861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515872|NCT05411861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515873|NCT03958513|Bupivacaine|bupivacaine|mesh-list
92515874|NCT03958513|Anesthetics, Local|anesthetics, local|mesh-ancestor
92515875|NCT03958513|Anesthetics|anesthetics|mesh-ancestor
92515876|NCT03958513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515877|NCT03958513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515878|NCT03958513|Sensory System Agents|sensory system agents|mesh-ancestor
92515879|NCT03958513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515880|NCT03958396|Remifentanil|remifentanil|mesh-list
92515881|NCT03958396|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92515882|NCT03958396|Narcotics|narcotics|mesh-ancestor
92515883|NCT03958396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515884|NCT03958396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515885|NCT03958396|Analgesics|analgesics|mesh-ancestor
92515886|NCT03958396|Sensory System Agents|sensory system agents|mesh-ancestor
92515887|NCT03958396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515888|NCT03958123|Moxifloxacin|moxifloxacin|mesh-list
92515889|NCT03958123|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92515890|NCT03958123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92515891|NCT03958123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92515892|NCT03958123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92515893|NCT03958123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92515894|NCT03958123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515895|NCT03958123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515896|NCT03958123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515897|NCT03958123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92515898|NCT03958123|Contraceptive Agents|contraceptive agents|mesh-ancestor
92515899|NCT03958123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92515900|NCT03958123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515901|NCT03958123|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92515902|NCT03958123|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92515903|NCT03958123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92515904|NCT03933865|Ketamine|ketamine|mesh-list
92515905|NCT03933865|Hydromorphone|hydromorphone|mesh-list
92515906|NCT03933865|Analgesics|analgesics|mesh-ancestor
92515907|NCT03933865|Sensory System Agents|sensory system agents|mesh-ancestor
92515908|NCT03933865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515909|NCT03933865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515910|NCT03933865|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92515911|NCT03933865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92515912|NCT03933865|Anesthetics, General|anesthetics, general|mesh-ancestor
92515913|NCT03933865|Anesthetics|anesthetics|mesh-ancestor
92515914|NCT03933865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515915|NCT03933865|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92515916|NCT03933865|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92515917|NCT03933865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515918|NCT03933865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515919|NCT03933865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92515920|NCT03933865|Narcotics|narcotics|mesh-ancestor
92515921|NCT03819322|Sofosbuvir|sofosbuvir|mesh-list
92515922|NCT03819322|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92515923|NCT03819322|Velpatasvir|velpatasvir|mesh-list
92515924|NCT03819322|Antiviral Agents|antiviral agents|mesh-ancestor
92515925|NCT03819322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240831|NCT00353522|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92515927|NCT05206175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92515928|NCT05206175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515929|NCT05206175|Sympathomimetics|sympathomimetics|mesh-ancestor
92515930|NCT05206175|Autonomic Agents|autonomic agents|mesh-ancestor
92515931|NCT05206175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515932|NCT05206175|Dopamine Agents|dopamine agents|mesh-ancestor
92515933|NCT05206175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92515934|NCT05206175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515935|NCT05206175|Adrenergic Agents|adrenergic agents|mesh-ancestor
92515936|NCT05206175|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92515937|NCT05206175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92515938|NCT05206175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92515939|NCT05206175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92515940|NCT00392899|Tegafur|tegafur|mesh-list
92515941|NCT00392899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92515942|NCT00392899|Antimetabolites|antimetabolites|mesh-ancestor
92515943|NCT00392899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515944|NCT00392899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515945|NCT05638893|Metformin|metformin|mesh-list
92515946|NCT05638893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92515947|NCT05638893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515948|NCT00392938|Docetaxel|docetaxel|mesh-list
92515949|NCT00392938|Androgen Antagonists|androgen antagonists|mesh-list
92515950|NCT00392938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515951|NCT00392938|Tubulin Modulators|tubulin modulators|mesh-ancestor
92515952|NCT00392938|Antimitotic Agents|antimitotic agents|mesh-ancestor
92515953|NCT00392938|Mitosis Modulators|mitosis modulators|mesh-ancestor
92515954|NCT00392938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515955|NCT00392938|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750751|NCT05936606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92515956|NCT00392938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92515957|NCT00392938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515958|NCT05637567|Aspirin|aspirin|mesh-list
92515959|NCT05637567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92515960|NCT05637567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92515961|NCT05637567|Analgesics|analgesics|mesh-ancestor
92515962|NCT05637567|Sensory System Agents|sensory system agents|mesh-ancestor
92515963|NCT05637567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92515964|NCT05637567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515965|NCT05637567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515966|NCT05637567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92515967|NCT05637567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92515968|NCT05637567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92515969|NCT05637567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515970|NCT05637567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92515971|NCT05637567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92515972|NCT05637567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92515973|NCT05637567|Antipyretics|antipyretics|mesh-ancestor
92515975|NCT03432091|Antioxidants|antioxidants|mesh-ancestor
92515976|NCT03432091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515977|NCT03432091|Protective Agents|protective agents|mesh-ancestor
92515978|NCT03432091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92515979|NCT03432091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92515980|NCT05634564|Paclitaxel|paclitaxel|mesh-list
92515981|NCT05634564|Gemcitabine|gemcitabine|mesh-list
92515982|NCT05634564|Tislelizumab|tislelizumab|mesh-list
92515983|NCT05634564|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92515984|NCT05634564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92515985|NCT05634564|Tubulin Modulators|tubulin modulators|mesh-ancestor
92515986|NCT05634564|Antimitotic Agents|antimitotic agents|mesh-ancestor
92515987|NCT05634564|Mitosis Modulators|mitosis modulators|mesh-ancestor
92515988|NCT05634564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92515989|NCT05634564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92515990|NCT05634564|Antimetabolites|antimetabolites|mesh-ancestor
92515991|NCT05634564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92515992|NCT03152149|Fluticasone|fluticasone|mesh-list
92515993|NCT03152149|Xhance|xhance|mesh-list
92515994|NCT03152149|Tiotropium Bromide|tiotropium bromide|mesh-list
92515995|NCT03152149|Olodaterol|olodaterol|mesh-list
92515996|NCT03152149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92515997|NCT03152149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92515998|NCT03152149|Autonomic Agents|autonomic agents|mesh-ancestor
92515999|NCT03152149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516000|NCT03152149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516001|NCT03152149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92516002|NCT03152149|Respiratory System Agents|respiratory system agents|mesh-ancestor
92516003|NCT03152149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516004|NCT03152149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92516005|NCT03152149|Parasympatholytics|parasympatholytics|mesh-ancestor
92516006|NCT03152149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92516007|NCT03152149|Cholinergic Agents|cholinergic agents|mesh-ancestor
92516008|NCT03152149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516009|NCT03152149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516010|NCT03151993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92516011|NCT03151993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92533293|NCT00059722|Gefitinib|gefitinib|mesh-list
92516012|NCT03151993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92516013|NCT03151993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516015|NCT05633472|Vitamins|vitamins|mesh-ancestor
92516016|NCT05633472|Micronutrients|micronutrients|mesh-ancestor
92516017|NCT05633472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516018|NCT05633472|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92516019|NCT03151876|Gemcitabine|gemcitabine|mesh-list
92516020|NCT03151876|Busulfan|busulfan|mesh-list
92516021|NCT03151876|Cladribine|cladribine|mesh-list
92516022|NCT03151876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92516023|NCT03151876|Antimetabolites|antimetabolites|mesh-ancestor
92516024|NCT03151876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516025|NCT03151876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516026|NCT03151876|Alkylating Agents|alkylating agents|mesh-ancestor
92516027|NCT03151876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516028|NCT03151876|Immunologic Factors|immunologic factors|mesh-ancestor
92516029|NCT03151876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516030|NCT03151876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92516031|NCT03151876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92516032|NCT03151720|Loratadine|loratadine|mesh-list
92516033|NCT03151720|Antipruritics|antipruritics|mesh-ancestor
92516034|NCT03151720|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516035|NCT03151720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92516036|NCT03151720|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92516037|NCT03151720|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92516038|NCT03151720|Histamine Antagonists|histamine antagonists|mesh-ancestor
92516040|NCT03151720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516041|NCT03151720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516042|NCT03151720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516043|NCT03151603|Fosfomycin|fosfomycin|mesh-list
92516044|NCT03151603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92516045|NCT03151603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516046|NCT03151525|Infliximab|infliximab|mesh-list
92516047|NCT03151525|Azathioprine|azathioprine|mesh-list
92516048|NCT03151525|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92516049|NCT03151525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516050|NCT03151525|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516051|NCT03151525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516052|NCT03151525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516053|NCT03151525|Antimetabolites|antimetabolites|mesh-ancestor
92516054|NCT03151525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516055|NCT03151525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92516056|NCT03151525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516057|NCT03151525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516058|NCT03151525|Immunologic Factors|immunologic factors|mesh-ancestor
92516059|NCT03151525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516060|NCT03151486|JNJ-55308942|jnj-55308942|mesh-list
92516061|NCT03151486|Purinergic P2X Receptor Antagonists|purinergic p2x receptor antagonists|mesh-ancestor
92516062|NCT03151486|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92516063|NCT03151486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92516064|NCT03151486|Purinergic Agents|purinergic agents|mesh-ancestor
92516065|NCT03151486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516066|NCT03151486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516067|NCT03151486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516068|NCT00387374|Paclitaxel|paclitaxel|mesh-list
92516069|NCT00387374|Bevacizumab|bevacizumab|mesh-list
92516070|NCT00387374|Carboplatin|carboplatin|mesh-list
92516071|NCT00387374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92516072|NCT00387374|Antibodies|antibodies|mesh-list
92516073|NCT00387374|Immunoglobulins|immunoglobulins|mesh-list
92516074|NCT00387374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92516075|NCT00387374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92516076|NCT00387374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516077|NCT00387374|Tubulin Modulators|tubulin modulators|mesh-ancestor
92516078|NCT00387374|Antimitotic Agents|antimitotic agents|mesh-ancestor
92516079|NCT00387374|Mitosis Modulators|mitosis modulators|mesh-ancestor
92516080|NCT00387374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516081|NCT00387374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92516082|NCT00387374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92516083|NCT00387374|Growth Substances|growth substances|mesh-ancestor
92516084|NCT00387374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516085|NCT00387374|Growth Inhibitors|growth inhibitors|mesh-ancestor
92516086|NCT00387374|Immunologic Factors|immunologic factors|mesh-ancestor
92516087|NCT03151369|Morphine|morphine|mesh-list
92516088|NCT03151369|Analgesics|analgesics|mesh-list
92516089|NCT03151369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92516090|NCT03151369|Narcotics|narcotics|mesh-ancestor
92516091|NCT03151369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516092|NCT03151369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516093|NCT03151369|Sensory System Agents|sensory system agents|mesh-ancestor
92516094|NCT03151369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516095|NCT04712266|Insulin|insulin|mesh-list
92516096|NCT04712266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92516097|NCT04712266|Glucagon|glucagon|mesh-list
92516098|NCT04712266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92516099|NCT04712266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516100|NCT04712266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516101|NCT04712266|Hormones|hormones|mesh-ancestor
92516102|NCT04712266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516103|NCT03912818|Carboplatin|carboplatin|mesh-list
92516104|NCT03912818|Gemcitabine|gemcitabine|mesh-list
92516105|NCT03912818|Doxorubicin|doxorubicin|mesh-list
92516106|NCT03912818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92516107|NCT03912818|Methotrexate|methotrexate|mesh-list
92516108|NCT03912818|Durvalumab|durvalumab|mesh-list
92516109|NCT03912818|Daunorubicin|daunorubicin|mesh-list
92516110|NCT03912818|Vinblastine|vinblastine|mesh-list
92516111|NCT03912818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516112|NCT03912818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92516113|NCT03912818|Antimetabolites|antimetabolites|mesh-ancestor
92516114|NCT03912818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516115|NCT03912818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92516116|NCT03912818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92516117|NCT03912818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92516118|NCT03912818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516119|NCT03912818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92516120|NCT03912818|Abortifacient Agents|abortifacient agents|mesh-ancestor
92516121|NCT03912818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92516122|NCT03912818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516123|NCT03912818|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516124|NCT03912818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92516125|NCT03912818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516126|NCT03912818|Immunologic Factors|immunologic factors|mesh-ancestor
92516127|NCT03912818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516128|NCT03912818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92516129|NCT03912818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516130|NCT03912818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92516131|NCT03912818|Tubulin Modulators|tubulin modulators|mesh-ancestor
92516132|NCT03912818|Antimitotic Agents|antimitotic agents|mesh-ancestor
92516133|NCT03912818|Mitosis Modulators|mitosis modulators|mesh-ancestor
92516135|NCT03151213|Analgesics|analgesics|mesh-ancestor
92516136|NCT03151213|Sensory System Agents|sensory system agents|mesh-ancestor
92516137|NCT03151213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516138|NCT03151213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516139|NCT03151213|Anticonvulsants|anticonvulsants|mesh-ancestor
92516140|NCT03151213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92516141|NCT03151213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516142|NCT03151213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516143|NCT03151213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92516144|NCT03151213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92516145|NCT03151213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92516146|NCT03151213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516147|NCT03151213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241061|NCT05334654|Bivalirudin|bivalirudin|mesh-list
92516148|NCT03151174|Vitamin D|vitamin d|mesh-list
92516149|NCT03151174|Ergocalciferols|ergocalciferols|mesh-list
92516150|NCT03151174|Cholecalciferol|cholecalciferol|mesh-list
92516151|NCT03151174|Vitamins|vitamins|mesh-list
92516152|NCT03151174|Micronutrients|micronutrients|mesh-ancestor
92516153|NCT03151174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516154|NCT03151174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92516155|NCT03151174|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92516156|NCT03151096|Riboflavin|riboflavin|mesh-list
92516157|NCT03151096|Vitamin B Complex|vitamin b complex|mesh-ancestor
92516158|NCT03151096|Vitamins|vitamins|mesh-ancestor
92516159|NCT03151096|Micronutrients|micronutrients|mesh-ancestor
92516160|NCT03151096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516161|NCT03151096|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92516162|NCT03151096|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516163|NCT03906539|Atorvastatin|atorvastatin|mesh-list
92516164|NCT03906539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92516165|NCT03906539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92516166|NCT03906539|Antimetabolites|antimetabolites|mesh-ancestor
92516167|NCT03906539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516168|NCT03906539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92516169|NCT03906539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92516170|NCT03906539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516171|NCT00389688|Pemetrexed|pemetrexed|mesh-list
92516172|NCT00389688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516173|NCT00389688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516174|NCT00389688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516175|NCT00389688|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92516176|NCT00389688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92516177|NCT05605665|Sirolimus|sirolimus|mesh-list
92516178|NCT05605665|Aldesleukin|aldesleukin|mesh-list
92516179|NCT05605665|Interleukin-2|interleukin-2|mesh-list
92516180|NCT05605665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92516181|NCT05605665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516182|NCT05605665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92516183|NCT05605665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516184|NCT05605665|Antifungal Agents|antifungal agents|mesh-ancestor
92516185|NCT05605665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516186|NCT05605665|Immunologic Factors|immunologic factors|mesh-ancestor
92516187|NCT05605665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516188|NCT05605665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516190|NCT05605665|Sensory System Agents|sensory system agents|mesh-ancestor
92516191|NCT05605665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516192|NCT05605665|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92516193|NCT05605665|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92516194|NCT05605665|Antiviral Agents|antiviral agents|mesh-ancestor
92516195|NCT03150706|Avelumab|avelumab|mesh-list
92516196|NCT03150706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516197|NCT03150706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516198|NCT03150667|Clopidogrel|clopidogrel|mesh-list
92516199|NCT03150667|Ticagrelor|ticagrelor|mesh-list
92516200|NCT03150667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516201|NCT03150667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92516202|NCT03150667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92516203|NCT03150667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92516204|NCT03150667|Purinergic Agents|purinergic agents|mesh-ancestor
92516205|NCT03150667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516206|NCT03150667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516207|NCT03150667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516208|NCT03150316|Dexamethasone|dexamethasone|mesh-list
92516209|NCT03150316|Lenalidomide|lenalidomide|mesh-list
92516210|NCT03150316|CKD-581|ckd-581|mesh-list
92516211|NCT03150316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516212|NCT03150316|Antiemetics|antiemetics|mesh-ancestor
92516213|NCT03150316|Autonomic Agents|autonomic agents|mesh-ancestor
92516214|NCT03150316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516215|NCT03150316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516216|NCT03150316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516217|NCT03150316|Glucocorticoids|glucocorticoids|mesh-ancestor
92516218|NCT03150316|Hormones|hormones|mesh-ancestor
92516219|NCT03150316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516220|NCT03150316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92516221|NCT03150316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516222|NCT03150316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516223|NCT03150316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516224|NCT03150316|Immunologic Factors|immunologic factors|mesh-ancestor
92516225|NCT03150316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92516226|NCT03150316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92516227|NCT03150316|Growth Substances|growth substances|mesh-ancestor
92516228|NCT03150316|Growth Inhibitors|growth inhibitors|mesh-ancestor
92516229|NCT03150316|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92516230|NCT02972125|Lacosamide|lacosamide|mesh-list
92516231|NCT02972125|Anticonvulsants|anticonvulsants|mesh-ancestor
92516232|NCT02972125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92516233|NCT02972125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92516234|NCT02972125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533298|NCT05359133|Tetrodotoxin|tetrodotoxin|mesh-list
92516235|NCT02972125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516237|NCT05597553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516238|NCT05597553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516239|NCT05597553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516240|NCT05597553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92516241|NCT05597553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92516242|NCT03086044|Sofosbuvir|sofosbuvir|mesh-list
92516243|NCT03086044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92516244|NCT03086044|Velpatasvir|velpatasvir|mesh-list
92516245|NCT03086044|Antiviral Agents|antiviral agents|mesh-ancestor
92516246|NCT03086044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516247|NCT03083665|Brivaracetam|brivaracetam|mesh-list
92516248|NCT03083665|Anticonvulsants|anticonvulsants|mesh-ancestor
92516249|NCT02866006|Topotecan|topotecan|mesh-list
92516250|NCT02866006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92516251|NCT02866006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92516252|NCT02866006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516253|NCT02866006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516254|NCT02866006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516255|NCT02719327|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92516256|NCT02719327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516257|NCT02719327|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92516258|NCT02633098|Artesunate|artesunate|mesh-list
92516259|NCT02633098|Antimalarials|antimalarials|mesh-ancestor
92516260|NCT02633098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92516261|NCT02633098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92516262|NCT02633098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200587|NCT05445921|Mepivacaine|mepivacaine|mesh-list
92516264|NCT02633098|Antiviral Agents|antiviral agents|mesh-ancestor
92516265|NCT02633098|Schistosomicides|schistosomicides|mesh-ancestor
92516266|NCT02633098|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92516267|NCT02633098|Anthelmintics|anthelmintics|mesh-ancestor
92516268|NCT00393289|Calcium|calcium|mesh-list
92516269|NCT00393289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750752|NCT05936606|Purinergic Agents|purinergic agents|mesh-ancestor
92516270|NCT00393289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516271|NCT02285179|Tamoxifen|tamoxifen|mesh-list
92516272|NCT02285179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92516273|NCT02285179|Hormone Antagonists|hormone antagonists|mesh-ancestor
92516274|NCT02285179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516275|NCT02285179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516276|NCT02285179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92516277|NCT02285179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516278|NCT02285179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92516279|NCT02285179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92516280|NCT02285179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92516281|NCT02250937|Fludarabine|fludarabine|mesh-list
92516282|NCT02250937|Fludarabine phosphate|fludarabine phosphate|mesh-list
92516283|NCT02250937|Busulfan|busulfan|mesh-list
92516284|NCT02250937|Venetoclax|venetoclax|mesh-list
92516285|NCT02250937|Cladribine|cladribine|mesh-list
92516286|NCT02250937|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92516287|NCT02250937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516288|NCT02250937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92516289|NCT02250937|Antimetabolites|antimetabolites|mesh-ancestor
92516290|NCT02250937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516291|NCT02250937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516292|NCT02250937|Immunologic Factors|immunologic factors|mesh-ancestor
92516293|NCT02250937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516294|NCT02250937|Alkylating Agents|alkylating agents|mesh-ancestor
92516295|NCT02250937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92516296|NCT02250937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92516297|NCT02122081|Cyclophosphamide|cyclophosphamide|mesh-list
92241211|NCT02528214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92516298|NCT02122081|Methotrexate|methotrexate|mesh-list
92516299|NCT02122081|Tacrolimus|tacrolimus|mesh-list
92516300|NCT02122081|Thymoglobulin|thymoglobulin|mesh-list
92516301|NCT02122081|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92516302|NCT02122081|Immunoglobulins|immunoglobulins|mesh-list
92516303|NCT02122081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516304|NCT02122081|Immunologic Factors|immunologic factors|mesh-ancestor
92516305|NCT02122081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516306|NCT02122081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516307|NCT02122081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92516308|NCT02122081|Alkylating Agents|alkylating agents|mesh-ancestor
92516309|NCT02122081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516310|NCT02122081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516311|NCT02122081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92516312|NCT02122081|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92516313|NCT02122081|Abortifacient Agents|abortifacient agents|mesh-ancestor
92516314|NCT02122081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92516315|NCT02122081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92516316|NCT02122081|Antimetabolites|antimetabolites|mesh-ancestor
92516317|NCT02122081|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516318|NCT02122081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516319|NCT02122081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92516320|NCT02122081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92516321|NCT02122081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92516322|NCT04708886|Alendronate|alendronate|mesh-list
92516323|NCT04708886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92516324|NCT04708886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516325|NCT00393328|Ritonavir|ritonavir|mesh-list
92516326|NCT00393328|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92516327|NCT00393328|Aripiprazole|aripiprazole|mesh-list
92516328|NCT00393328|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92516329|NCT00393328|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92516330|NCT00393328|Protease Inhibitors|protease inhibitors|mesh-ancestor
92352083|NCT05033808|Epirubicin|epirubicin|mesh-list
92516331|NCT00393328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516332|NCT00393328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516333|NCT00393328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92516334|NCT00393328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92516335|NCT00393328|Antiviral Agents|antiviral agents|mesh-ancestor
92516336|NCT00393328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516337|NCT00393328|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92516338|NCT00393328|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92516339|NCT00393328|Antidepressive Agents|antidepressive agents|mesh-ancestor
92516340|NCT00393328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92516341|NCT00393328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92516342|NCT00393328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92516343|NCT00393328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516344|NCT00393328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516345|NCT00393328|Dopamine Agonists|dopamine agonists|mesh-ancestor
92516346|NCT00393328|Dopamine Agents|dopamine agents|mesh-ancestor
92516347|NCT00393328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516348|NCT00393328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92516349|NCT00393328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92516350|NCT00393328|Serotonin Agents|serotonin agents|mesh-ancestor
92516351|NCT00393328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92516352|NCT00393328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92516353|NCT00393328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92516354|NCT00393328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92516355|NCT05530551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92516356|NCT05530551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516357|NCT01807429|Midazolam|midazolam|mesh-list
92516358|NCT01807429|Ketamine|ketamine|mesh-list
92516359|NCT01807429|Morphine|morphine|mesh-list
92516360|NCT01807429|Analgesics|analgesics|mesh-ancestor
92516361|NCT01807429|Sensory System Agents|sensory system agents|mesh-ancestor
92516362|NCT01807429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516363|NCT01807429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516364|NCT01807429|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92516365|NCT01807429|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92516366|NCT01807429|Anesthetics, General|anesthetics, general|mesh-ancestor
92516367|NCT01807429|Anesthetics|anesthetics|mesh-ancestor
92516368|NCT01807429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516369|NCT01807429|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92516370|NCT01807429|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92516371|NCT01807429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516372|NCT01807429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516373|NCT01807429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92241282|NCT05902078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516374|NCT01807429|Narcotics|narcotics|mesh-ancestor
92516375|NCT01807429|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92516376|NCT01807429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92516377|NCT01807429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92516378|NCT01807429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92516379|NCT01807429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92516380|NCT01807429|GABA Modulators|gaba modulators|mesh-ancestor
92516381|NCT01807429|GABA Agents|gaba agents|mesh-ancestor
92516382|NCT01807078|Ezetimibe|ezetimibe|mesh-list
92516383|NCT01807078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92516384|NCT01807078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92516385|NCT01807078|Antimetabolites|antimetabolites|mesh-ancestor
92516386|NCT01807078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516387|NCT01807078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92516388|NCT01349803|Formoterol Fumarate|formoterol fumarate|mesh-list
92516389|NCT01349803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92516390|NCT01349803|Autonomic Agents|autonomic agents|mesh-ancestor
92516391|NCT01349803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516392|NCT01349803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516393|NCT01349803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92516394|NCT01349803|Respiratory System Agents|respiratory system agents|mesh-ancestor
92516395|NCT01349803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92516396|NCT01349803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92516397|NCT01349803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92516398|NCT01349803|Adrenergic Agents|adrenergic agents|mesh-ancestor
92516399|NCT01349803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516400|NCT01349803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516401|NCT01807000|Prucalopride|prucalopride|mesh-list
92516402|NCT01807000|Laxatives|laxatives|mesh-ancestor
92516403|NCT01807000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516404|NCT01807000|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92516405|NCT01807000|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92516406|NCT01807000|Serotonin Agents|serotonin agents|mesh-ancestor
92516407|NCT01807000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516408|NCT01807000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516409|NCT01807000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516410|NCT01806805|Zonisamide|zonisamide|mesh-list
92516411|NCT01806805|Anticonvulsants|anticonvulsants|mesh-ancestor
92516412|NCT01806805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92516413|NCT01806805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516414|NCT01806805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516415|NCT01806805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92516416|NCT01806805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516417|NCT00387413|Niacinamide|niacinamide|mesh-list
92516418|NCT00387413|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92516419|NCT00387413|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92516420|NCT00387413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92516421|NCT00387413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516422|NCT00387413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516423|NCT00387413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516424|NCT00387413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516425|NCT00387413|Analgesics|analgesics|mesh-ancestor
92516426|NCT00387413|Sensory System Agents|sensory system agents|mesh-ancestor
92516427|NCT00387413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516428|NCT00387413|Antidepressive Agents|antidepressive agents|mesh-ancestor
92516429|NCT00387413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92516430|NCT00387413|Dopamine Agents|dopamine agents|mesh-ancestor
92516431|NCT00387413|Vitamin B Complex|vitamin b complex|mesh-ancestor
92516432|NCT00387413|Vitamins|vitamins|mesh-ancestor
92516433|NCT00387413|Micronutrients|micronutrients|mesh-ancestor
92516434|NCT01806610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92516435|NCT01806610|Immunologic Factors|immunologic factors|mesh-ancestor
92516436|NCT01806610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516437|NCT05517291|Paclitaxel|paclitaxel|mesh-list
92516438|NCT05517291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92516439|NCT05517291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516440|NCT05517291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92516441|NCT05517291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92516442|NCT05517291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92516443|NCT05517291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516444|NCT04590248|Adavosertib|adavosertib|mesh-list
92516445|NCT04590248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516446|NCT04590248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241362|NCT05901194|Lenvatinib|lenvatinib|mesh-list
92516447|NCT01806454|Calcium|calcium|mesh-list
92516448|NCT01806454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92516449|NCT01806454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516450|NCT01806415|Imidazole|imidazole|mesh-list
92516451|NCT01806415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516452|NCT01806415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516453|NCT01806376|Maleic acid|maleic acid|mesh-list
92516454|NCT01806376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516455|NCT01806376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516456|NCT01806337|Alemtuzumab|alemtuzumab|mesh-list
92516457|NCT01806337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516458|NCT01806337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516460|NCT01806259|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92516461|NCT01806259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92516462|NCT01806259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516463|NCT01806259|Analgesics|analgesics|mesh-ancestor
92516464|NCT01806259|Sensory System Agents|sensory system agents|mesh-ancestor
92516465|NCT01806259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516466|NCT01806259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516467|NCT01806259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516468|NCT01806259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516469|NCT01806259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92516470|NCT01806259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516471|NCT01806259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516472|NCT05482542|Cyclophosphamide|cyclophosphamide|mesh-list
92516473|NCT05482542|Rituximab|rituximab|mesh-list
92516474|NCT05482542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516475|NCT05482542|Immunologic Factors|immunologic factors|mesh-ancestor
92516476|NCT05482542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516477|NCT05482542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516478|NCT05482542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92516479|NCT05482542|Alkylating Agents|alkylating agents|mesh-ancestor
92516480|NCT05482542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516481|NCT05482542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516482|NCT05482542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92516483|NCT05482542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516484|NCT04579757|Tislelizumab|tislelizumab|mesh-list
92516485|NCT04579757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516486|NCT04579757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516487|NCT00393445|Glucagon|glucagon|mesh-list
92516488|NCT00393445|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92516489|NCT00393445|Incretins|incretins|mesh-ancestor
92516490|NCT00393445|Hormones|hormones|mesh-ancestor
92516491|NCT00393445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516492|NCT00393445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516493|NCT00393445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516494|NCT00393562|Methylphenidate|methylphenidate|mesh-list
92516495|NCT00393562|Modafinil|modafinil|mesh-list
92516496|NCT00393562|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92516497|NCT00393562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516498|NCT00393562|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92516499|NCT00393562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92516500|NCT00393562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516501|NCT00393562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516502|NCT00393562|Dopamine Agents|dopamine agents|mesh-ancestor
92516503|NCT00393562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516504|NCT00393562|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92516505|NCT00393562|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92516506|NCT00393562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92516507|NCT01806103|Anti-Infective Agents|anti-infective agents|mesh-list
92516508|NCT01806103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92516509|NCT01805908|Pertuzumab|pertuzumab|mesh-list
92352120|NCT01673724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516510|NCT01805908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516511|NCT01805908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516512|NCT04527107|Aflibercept|aflibercept|mesh-list
92516513|NCT04527107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92516514|NCT04527107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92516515|NCT04527107|Growth Substances|growth substances|mesh-ancestor
92516516|NCT04527107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516517|NCT04527107|Growth Inhibitors|growth inhibitors|mesh-ancestor
92516518|NCT04527107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241433|NCT05898854|FAPI-46|fapi-46|mesh-list
92516519|NCT05437887|Fucoidan|fucoidan|mesh-list
92516520|NCT05437887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92516521|NCT05437887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516522|NCT05437887|Anticoagulants|anticoagulants|mesh-ancestor
92516523|NCT05437887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516524|NCT01805596|Clopidogrel|clopidogrel|mesh-list
92516526|NCT01805596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516527|NCT01805596|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92516528|NCT01805596|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92516529|NCT01805596|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92516530|NCT01805596|Purinergic Agents|purinergic agents|mesh-ancestor
92516531|NCT01805596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516532|NCT01805596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516533|NCT01805596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516534|NCT04477343|Nivolumab|nivolumab|mesh-list
92516535|NCT04477343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516536|NCT04477343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516537|NCT04477343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92516538|NCT04477343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516539|NCT04474223|Dexamethasone|dexamethasone|mesh-list
92516540|NCT04474223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516541|NCT04474223|Antiemetics|antiemetics|mesh-ancestor
92516542|NCT04474223|Autonomic Agents|autonomic agents|mesh-ancestor
92516543|NCT04474223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516544|NCT04474223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516545|NCT04474223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516546|NCT04474223|Glucocorticoids|glucocorticoids|mesh-ancestor
92516547|NCT04474223|Hormones|hormones|mesh-ancestor
92516548|NCT04474223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516549|NCT04474223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92516550|NCT04474223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516551|NCT01466530|Misoprostol|misoprostol|mesh-list
92516552|NCT01466530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92516553|NCT01466530|Abortifacient Agents|abortifacient agents|mesh-ancestor
92516554|NCT01466530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92516555|NCT01466530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516556|NCT01466530|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92516557|NCT01466530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516558|NCT01466530|Oxytocics|oxytocics|mesh-ancestor
92516560|NCT01466452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92516561|NCT01466452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516562|NCT01466452|Analgesics|analgesics|mesh-ancestor
92516563|NCT01466452|Sensory System Agents|sensory system agents|mesh-ancestor
92516564|NCT01466452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516565|NCT01466452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516566|NCT01466452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516567|NCT01466452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516568|NCT01466452|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92516569|NCT01466452|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92516570|NCT01466452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516571|NCT01466452|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516572|NCT01466452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92516573|NCT01466452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516574|NCT01466452|Antipyretics|antipyretics|mesh-ancestor
92516575|NCT01466374|Antibodies|antibodies|mesh-list
92516576|NCT01466374|Immunoglobulins|immunoglobulins|mesh-list
92516577|NCT01466374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92516578|NCT01466374|Immunologic Factors|immunologic factors|mesh-ancestor
92516579|NCT01466374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516580|NCT01466257|Cetuximab|cetuximab|mesh-list
92516581|NCT01466257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516582|NCT01466257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516583|NCT01466101|Pregabalin|pregabalin|mesh-list
92516584|NCT01466101|Analgesics|analgesics|mesh-ancestor
92516585|NCT01466101|Sensory System Agents|sensory system agents|mesh-ancestor
92516586|NCT01466101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516587|NCT01466101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516588|NCT01466101|Anticonvulsants|anticonvulsants|mesh-ancestor
92516589|NCT01466101|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92516590|NCT01466101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516591|NCT01466101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516592|NCT01466101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92516593|NCT01466101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92516594|NCT01466101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92516595|NCT01466101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516596|NCT01466101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92516597|NCT01465984|Acetaminophen|acetaminophen|mesh-list
92516598|NCT01465984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516599|NCT01465984|Analgesics|analgesics|mesh-ancestor
92516600|NCT01465984|Sensory System Agents|sensory system agents|mesh-ancestor
92516601|NCT01465984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516602|NCT01465984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516603|NCT01465984|Antipyretics|antipyretics|mesh-ancestor
92516605|NCT01465906|Tiotropium Bromide|tiotropium bromide|mesh-list
92516606|NCT01465906|Tulobuterol|tulobuterol|mesh-list
92516607|NCT01465906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92516608|NCT01465906|Autonomic Agents|autonomic agents|mesh-ancestor
92516609|NCT01465906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516610|NCT01465906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516611|NCT01465906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92516612|NCT01465906|Respiratory System Agents|respiratory system agents|mesh-ancestor
92516613|NCT01465906|Parasympatholytics|parasympatholytics|mesh-ancestor
92516614|NCT01465906|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92516615|NCT01465906|Cholinergic Agents|cholinergic agents|mesh-ancestor
92516616|NCT01465906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516617|NCT01465906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516618|NCT01465906|Anticonvulsants|anticonvulsants|mesh-ancestor
92516619|NCT01465906|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92516620|NCT01465906|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92516621|NCT01465906|Adrenergic Agents|adrenergic agents|mesh-ancestor
92516622|NCT01465867|Selenium|selenium|mesh-list
92516623|NCT01465867|Antioxidants|antioxidants|mesh-ancestor
92516624|NCT01465867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516625|NCT01465867|Protective Agents|protective agents|mesh-ancestor
92516626|NCT01465867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516627|NCT01465867|Trace Elements|trace elements|mesh-ancestor
92516628|NCT01465867|Micronutrients|micronutrients|mesh-ancestor
92516629|NCT01465828|Clopidogrel|clopidogrel|mesh-list
92516630|NCT01465828|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92516631|NCT01465828|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516632|NCT01465828|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92516633|NCT01465828|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92516634|NCT01465828|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92516635|NCT01465828|Purinergic Agents|purinergic agents|mesh-ancestor
92516636|NCT01465828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516637|NCT01465828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516638|NCT01465828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516639|NCT01465438|Adalimumab|adalimumab|mesh-list
92516640|NCT01465438|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92516641|NCT01465438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352145|NCT03032328|Vitamin D|vitamin d|mesh-list
92516642|NCT01465438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516643|NCT01465399|Mitogens|mitogens|mesh-list
92516644|NCT01465399|Mitosis Modulators|mitosis modulators|mesh-ancestor
92516645|NCT01465399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516646|NCT05393505|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92516647|NCT05393505|Amoxicillin|amoxicillin|mesh-list
92516648|NCT05393505|Levofloxacin|levofloxacin|mesh-list
92516649|NCT05393505|Meropenem|meropenem|mesh-list
92516650|NCT05393505|Clavulanic Acid|clavulanic acid|mesh-list
92516651|NCT05393505|Clavulanic Acids|clavulanic acids|mesh-list
92516652|NCT05393505|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92516653|NCT05393505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516654|NCT05393505|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92516655|NCT05393505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92516656|NCT05393505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92516657|NCT05393505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516658|NCT05393505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516659|NCT05393505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516660|NCT05393505|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92516661|NCT05393505|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92516662|NCT05393505|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92516663|NCT04201457|Hydroxychloroquine|hydroxychloroquine|mesh-list
92516664|NCT04201457|Trametinib|trametinib|mesh-list
92516665|NCT04201457|Dabrafenib|dabrafenib|mesh-list
92516666|NCT04201457|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92516667|NCT04201457|Antimalarials|antimalarials|mesh-ancestor
92516668|NCT04201457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92516669|NCT04201457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92516670|NCT04201457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516671|NCT04201457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516672|NCT04201457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516673|NCT04201457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516674|NCT04201457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516675|NCT04201457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92516676|NCT04201457|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92516677|NCT04201457|Protective Agents|protective agents|mesh-ancestor
92516678|NCT04201457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516679|NCT04201457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92516681|NCT01465009|Aspirin|aspirin|mesh-list
92516682|NCT01465009|Acetaminophen|acetaminophen|mesh-list
92516683|NCT01465009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92516684|NCT01465009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516685|NCT01465009|Analgesics|analgesics|mesh-ancestor
92516686|NCT01465009|Sensory System Agents|sensory system agents|mesh-ancestor
92516687|NCT01465009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516688|NCT01465009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516689|NCT01465009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516690|NCT01465009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516691|NCT01465009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92516692|NCT01465009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92516693|NCT01465009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516694|NCT01465009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516695|NCT01465009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92516696|NCT01465009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516697|NCT01465009|Antipyretics|antipyretics|mesh-ancestor
92516698|NCT00389766|Topotecan|topotecan|mesh-list
92516699|NCT00389766|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92516700|NCT00389766|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92516701|NCT00389766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92516702|NCT00389766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516703|NCT00389766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516704|NCT00389766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516705|NCT00389766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92516706|NCT01464697|Progesterone|progesterone|mesh-list
92516707|NCT01464697|Progestins|progestins|mesh-ancestor
92516708|NCT01464697|Hormones|hormones|mesh-ancestor
92516709|NCT01464697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516710|NCT01464697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516711|NCT04083950|Aspirin|aspirin|mesh-list
92516712|NCT04083950|Vaccines|vaccines|mesh-list
92516713|NCT04083950|Immunologic Factors|immunologic factors|mesh-ancestor
92516714|NCT04083950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516715|NCT04083950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92516716|NCT04083950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516717|NCT04083950|Analgesics|analgesics|mesh-ancestor
92516718|NCT04083950|Sensory System Agents|sensory system agents|mesh-ancestor
92516719|NCT04083950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516720|NCT04083950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516721|NCT04083950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516722|NCT04083950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92516723|NCT04083950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92516724|NCT04083950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516725|NCT04083950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516726|NCT04083950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92516727|NCT04083950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516728|NCT04083950|Antipyretics|antipyretics|mesh-ancestor
92516729|NCT00393679|Artesunate|artesunate|mesh-list
92516730|NCT00393679|Lumefantrine|lumefantrine|mesh-list
92516731|NCT00393679|Artemether|artemether|mesh-list
92516732|NCT00393679|Piperaquine|piperaquine|mesh-list
92516733|NCT00393679|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92516734|NCT00393679|Amodiaquine|amodiaquine|mesh-list
92516735|NCT00393679|Artenimol|artenimol|mesh-list
92516736|NCT00393679|Dapsone|dapsone|mesh-list
92516737|NCT00393679|Chlorproguanil|chlorproguanil|mesh-list
92516738|NCT00393679|Antimalarials|antimalarials|mesh-ancestor
92516739|NCT00393679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92516740|NCT00393679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92516741|NCT00393679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516742|NCT00393679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516743|NCT00393679|Antiviral Agents|antiviral agents|mesh-ancestor
92516744|NCT00393679|Schistosomicides|schistosomicides|mesh-ancestor
92516745|NCT00393679|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92516746|NCT00393679|Anthelmintics|anthelmintics|mesh-ancestor
92516747|NCT00393679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92516748|NCT00393679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516749|NCT00393679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516750|NCT00393679|Leprostatic Agents|leprostatic agents|mesh-ancestor
92516751|NCT00393679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92516753|NCT00393835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92516754|NCT00393835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516755|NCT04078568|Aspirin|aspirin|mesh-list
92516756|NCT04078568|Prednisolone|prednisolone|mesh-list
92516757|NCT04078568|Immunoglobulins|immunoglobulins|mesh-list
92516758|NCT04078568|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92516759|NCT04078568|gamma-Globulins|gamma-globulins|mesh-list
92516760|NCT04078568|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92516761|NCT04078568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92516762|NCT04078568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92516763|NCT04078568|Analgesics|analgesics|mesh-ancestor
92516764|NCT04078568|Sensory System Agents|sensory system agents|mesh-ancestor
92516765|NCT04078568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516766|NCT04078568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516767|NCT04078568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516768|NCT04078568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516769|NCT04078568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92516770|NCT04078568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92516771|NCT04078568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516772|NCT04078568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516773|NCT04078568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92516774|NCT04078568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516775|NCT04078568|Antipyretics|antipyretics|mesh-ancestor
92516776|NCT04078568|Glucocorticoids|glucocorticoids|mesh-ancestor
92516777|NCT04078568|Hormones|hormones|mesh-ancestor
92516778|NCT04078568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516779|NCT04078568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92516780|NCT04078568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516781|NCT04078568|Immunologic Factors|immunologic factors|mesh-ancestor
92516782|NCT01057069|Paclitaxel|paclitaxel|mesh-list
92516783|NCT01057069|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92516784|NCT01057069|Cyclophosphamide|cyclophosphamide|mesh-list
92516785|NCT01057069|Carboplatin|carboplatin|mesh-list
92516786|NCT01057069|Doxorubicin|doxorubicin|mesh-list
92516787|NCT01057069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92516788|NCT01057069|Thiotepa|thiotepa|mesh-list
92516789|NCT01057069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92516790|NCT01057069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516791|NCT01057069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92516792|NCT01057069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92516793|NCT01057069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92516794|NCT01057069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516795|NCT01057069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516796|NCT01057069|Immunologic Factors|immunologic factors|mesh-ancestor
92516797|NCT01057069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516798|NCT01057069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516799|NCT01057069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92516800|NCT01057069|Alkylating Agents|alkylating agents|mesh-ancestor
92516801|NCT01057069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92516802|NCT01057069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92516803|NCT01057069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92516804|NCT01057069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92516805|NCT01057069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516806|NCT00847834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92516807|NCT00847834|Irbesartan|irbesartan|mesh-list
92516808|NCT00847834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92516809|NCT00847834|Diuretics|diuretics|mesh-ancestor
92516810|NCT00847834|Natriuretic Agents|natriuretic agents|mesh-ancestor
92516811|NCT00847834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516812|NCT00847834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92516813|NCT00847834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516814|NCT00847834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516815|NCT00847834|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92516816|NCT00847834|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92516817|NCT00847678|Amphotericin B|amphotericin b|mesh-list
92516818|NCT00847678|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92516819|NCT00847678|Flucytosine|flucytosine|mesh-list
92516820|NCT00847678|Efungumab|efungumab|mesh-list
92516821|NCT00847678|Amebicides|amebicides|mesh-ancestor
92516822|NCT00847678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92516824|NCT00847678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516825|NCT00847678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92516826|NCT00847678|Antifungal Agents|antifungal agents|mesh-ancestor
92516827|NCT00847678|Antimetabolites|antimetabolites|mesh-ancestor
92516828|NCT00847678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516829|NCT00847639|Lenalidomide|lenalidomide|mesh-list
92516830|NCT00847639|Immunologic Factors|immunologic factors|mesh-ancestor
92516831|NCT00847639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516832|NCT00847639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92516833|NCT00847639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92516834|NCT00847639|Growth Substances|growth substances|mesh-ancestor
92516835|NCT00847639|Growth Inhibitors|growth inhibitors|mesh-ancestor
92516836|NCT00847639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516837|NCT00847483|Bimatoprost|bimatoprost|mesh-list
92516838|NCT00847483|Travoprost|travoprost|mesh-list
92516839|NCT00847483|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92516840|NCT00847483|Latanoprost|latanoprost|mesh-list
92516841|NCT00847483|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92516842|NCT00847483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92516843|NCT04034927|Olaparib|olaparib|mesh-list
92516844|NCT04034927|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92516845|NCT04034927|Tremelimumab|tremelimumab|mesh-list
92516846|NCT04034927|Ipilimumab|ipilimumab|mesh-list
92516847|NCT04034927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92516848|NCT04034927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516849|NCT04034927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516850|NCT04034927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516851|NCT04034927|Immunologic Factors|immunologic factors|mesh-ancestor
92516852|NCT04034927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516853|NCT04034927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516854|NCT04034927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92516855|NCT00847366|Tamoxifen|tamoxifen|mesh-list
92516856|NCT00847366|Trastuzumab|trastuzumab|mesh-list
92516857|NCT00847366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516858|NCT00847366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516859|NCT00847366|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92516860|NCT00847366|Hormone Antagonists|hormone antagonists|mesh-ancestor
92516861|NCT00847366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516862|NCT00847366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516863|NCT00847366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92516864|NCT00847366|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92516865|NCT00847366|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92516866|NCT00847366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92516868|NCT05321160|Sevoflurane|sevoflurane|mesh-list
92516869|NCT05321160|Esketamine|esketamine|mesh-list
92516870|NCT05321160|Analgesics|analgesics|mesh-ancestor
92516871|NCT05321160|Sensory System Agents|sensory system agents|mesh-ancestor
92516872|NCT05321160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516873|NCT05321160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516874|NCT05321160|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92516875|NCT05321160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92516876|NCT05321160|Anesthetics, General|anesthetics, general|mesh-ancestor
92516877|NCT05321160|Anesthetics|anesthetics|mesh-ancestor
92516878|NCT05321160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516879|NCT05321160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92516880|NCT05321160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92516881|NCT05321160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516882|NCT05321160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516883|NCT05321160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92516884|NCT05321160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92516885|NCT05321160|Antidepressive Agents|antidepressive agents|mesh-ancestor
92516886|NCT05321160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92516887|NCT04009343|Lumefantrine|lumefantrine|mesh-list
92516888|NCT04009343|Artemether|artemether|mesh-list
92516889|NCT04009343|Piperaquine|piperaquine|mesh-list
92516890|NCT04009343|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92516891|NCT04009343|Artenimol|artenimol|mesh-list
92516892|NCT04009343|Antimalarials|antimalarials|mesh-ancestor
92516893|NCT04009343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92516894|NCT04009343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92516895|NCT04009343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516896|NCT03969641|Vaccines|vaccines|mesh-list
92516897|NCT03969641|Immunologic Factors|immunologic factors|mesh-ancestor
92241801|NCT05243290|Vitamins|vitamins|mesh-ancestor
92516899|NCT00847210|Dexlansoprazole|dexlansoprazole|mesh-list
92516900|NCT00847210|Lansoprazole|lansoprazole|mesh-list
92516901|NCT00847210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92516902|NCT00847210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516903|NCT00847210|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92516904|NCT00847210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516905|NCT00847210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516906|NCT00847171|Cyclophosphamide|cyclophosphamide|mesh-list
92516907|NCT00847171|Trastuzumab|trastuzumab|mesh-list
92516908|NCT00847171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516909|NCT00847171|Immunologic Factors|immunologic factors|mesh-ancestor
92516910|NCT00847171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516911|NCT00847171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516912|NCT00847171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92516913|NCT00847171|Alkylating Agents|alkylating agents|mesh-ancestor
92516914|NCT00847171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516915|NCT00847171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516916|NCT00847171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92516917|NCT00847171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92516918|NCT03940586|Letermovir|letermovir|mesh-list
92516919|NCT03940586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92516920|NCT03940586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516921|NCT03940586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516922|NCT03940586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516923|NCT03940586|Antiviral Agents|antiviral agents|mesh-ancestor
92516924|NCT03940586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92516925|NCT00847093|Lidocaine|lidocaine|mesh-list
92516926|NCT00847093|Anesthetics, Local|anesthetics, local|mesh-ancestor
92516927|NCT00847093|Anesthetics|anesthetics|mesh-ancestor
92516928|NCT00847093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92516929|NCT00847093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516930|NCT00847093|Sensory System Agents|sensory system agents|mesh-ancestor
92516931|NCT00847093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516932|NCT00847093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92516933|NCT00847093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92516934|NCT00847093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92516935|NCT00847093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92516936|NCT00847093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516937|NCT00847054|Antibodies|antibodies|mesh-list
92516938|NCT00847054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92516939|NCT00847054|Immunologic Factors|immunologic factors|mesh-ancestor
92516940|NCT00847054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516941|NCT00846976|Bicalutamide|bicalutamide|mesh-list
92516942|NCT00846976|Androgen Antagonists|androgen antagonists|mesh-ancestor
92516943|NCT00846976|Hormone Antagonists|hormone antagonists|mesh-ancestor
92516944|NCT00846976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516945|NCT00846976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516946|NCT00846976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516947|NCT00846859|Varenicline|varenicline|mesh-list
92516948|NCT00846859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92516949|NCT00846859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92516950|NCT00846859|Cholinergic Agents|cholinergic agents|mesh-ancestor
92516951|NCT00846859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92516952|NCT00846859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516953|NCT00846859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516954|NCT03885830|Imatinib Mesylate|imatinib mesylate|mesh-list
92516955|NCT03885830|Dasatinib|dasatinib|mesh-list
92516956|NCT03885830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516957|NCT03885830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92516958|NCT03885830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516959|NCT03885830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516960|NCT00846703|Dexamethasone|dexamethasone|mesh-list
92516961|NCT00846703|Methotrexate|methotrexate|mesh-list
92516962|NCT00846703|Vincristine|vincristine|mesh-list
92516963|NCT00846703|Mercaptopurine|mercaptopurine|mesh-list
92516964|NCT00846703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92516965|NCT00846703|Antiemetics|antiemetics|mesh-ancestor
92516966|NCT00846703|Autonomic Agents|autonomic agents|mesh-ancestor
92516967|NCT00846703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92516968|NCT00846703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516969|NCT00846703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92516970|NCT00846703|Glucocorticoids|glucocorticoids|mesh-ancestor
92516972|NCT00846703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92516973|NCT00846703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92516974|NCT00846703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92516975|NCT00846703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92516976|NCT00846703|Abortifacient Agents|abortifacient agents|mesh-ancestor
92516977|NCT00846703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92516978|NCT00846703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92516979|NCT00846703|Antimetabolites|antimetabolites|mesh-ancestor
92516980|NCT00846703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92516981|NCT00846703|Dermatologic Agents|dermatologic agents|mesh-ancestor
92516982|NCT00846703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92516983|NCT00846703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92516984|NCT00846703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92516985|NCT00846703|Immunologic Factors|immunologic factors|mesh-ancestor
92516986|NCT00846703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92516987|NCT00846703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92516988|NCT00846703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92516989|NCT00846703|Tubulin Modulators|tubulin modulators|mesh-ancestor
92516990|NCT00846703|Antimitotic Agents|antimitotic agents|mesh-ancestor
92516991|NCT00846703|Mitosis Modulators|mitosis modulators|mesh-ancestor
92516993|NCT03772964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92516994|NCT03772964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92516995|NCT00846625|Triamcinolone|triamcinolone|mesh-list
92516996|NCT00846625|Ranibizumab|ranibizumab|mesh-list
92516997|NCT00846625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92516998|NCT00846625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92516999|NCT00846625|Growth Substances|growth substances|mesh-ancestor
92517000|NCT00846625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517001|NCT00846625|Growth Inhibitors|growth inhibitors|mesh-ancestor
92517002|NCT00846625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517003|NCT00846625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517004|NCT00846625|Glucocorticoids|glucocorticoids|mesh-ancestor
92517005|NCT00846625|Hormones|hormones|mesh-ancestor
92517006|NCT00846625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517007|NCT00846508|Cisplatin|cisplatin|mesh-list
92517008|NCT00846508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517009|NCT03721172|Apremilast|apremilast|mesh-list
92517010|NCT03721172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92517011|NCT03721172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92517012|NCT03721172|Analgesics|analgesics|mesh-ancestor
92517013|NCT03721172|Sensory System Agents|sensory system agents|mesh-ancestor
92517014|NCT03721172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517015|NCT03721172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517016|NCT03721172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517017|NCT03721172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517018|NCT03721172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92517019|NCT03721172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92517020|NCT03721172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517021|NCT03721172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517022|NCT00846274|Antithrombins|antithrombins|mesh-list
92517023|NCT00846274|Antithrombin III|antithrombin iii|mesh-list
92517024|NCT00846274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92517025|NCT00846274|Protease Inhibitors|protease inhibitors|mesh-ancestor
92517026|NCT00846274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517027|NCT00846274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517028|NCT00846274|Anticoagulants|anticoagulants|mesh-ancestor
92517029|NCT00846235|Glycerol|glycerol|mesh-list
92517030|NCT00846235|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92517031|NCT00846235|Protective Agents|protective agents|mesh-ancestor
92517032|NCT00846235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517033|NCT00846196|Risedronic Acid|risedronic acid|mesh-list
92517034|NCT00846196|Etidronic Acid|etidronic acid|mesh-list
92517035|NCT00846196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92517036|NCT00846196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517037|NCT00846196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517038|NCT00846196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92517039|NCT00846196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533313|NCT02969239|Mydriatics|mydriatics|mesh-ancestor
92517040|NCT00846196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92517042|NCT00846118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92517043|NCT00846118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92517044|NCT00846118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92517045|NCT00846118|Antimetabolites|antimetabolites|mesh-ancestor
92517046|NCT00846118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517047|NCT00846118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517048|NCT00846118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92517049|NCT00846079|Regadenoson|regadenoson|mesh-list
92517050|NCT00846079|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92517051|NCT00846079|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92517052|NCT00846079|Purinergic Agonists|purinergic agonists|mesh-ancestor
92517053|NCT00846079|Purinergic Agents|purinergic agents|mesh-ancestor
92517054|NCT00846079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517055|NCT00846079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517056|NCT00846079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517057|NCT00845962|Bupivacaine|bupivacaine|mesh-list
92517058|NCT00845962|Chloroprocaine|chloroprocaine|mesh-list
92517059|NCT00845962|Anesthetics, Local|anesthetics, local|mesh-ancestor
92517060|NCT00845962|Anesthetics|anesthetics|mesh-ancestor
92517061|NCT00845962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517062|NCT00845962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517063|NCT00845962|Sensory System Agents|sensory system agents|mesh-ancestor
92517064|NCT00845962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517065|NCT03620942|Phenylephrine|phenylephrine|mesh-list
92517066|NCT03620942|Oxymetazoline|oxymetazoline|mesh-list
92517067|NCT03620942|Ephedrine|ephedrine|mesh-list
92517068|NCT03620942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92517069|NCT03620942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92517070|NCT03620942|Mydriatics|mydriatics|mesh-ancestor
92517071|NCT03620942|Autonomic Agents|autonomic agents|mesh-ancestor
92517072|NCT03620942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517073|NCT03620942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517074|NCT03620942|Sympathomimetics|sympathomimetics|mesh-ancestor
92517075|NCT03620942|Nasal Decongestants|nasal decongestants|mesh-ancestor
92517076|NCT03620942|Respiratory System Agents|respiratory system agents|mesh-ancestor
92517077|NCT03620942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92517078|NCT03620942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92517079|NCT03620942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92517080|NCT03620942|Adrenergic Agents|adrenergic agents|mesh-ancestor
92517081|NCT03620942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517082|NCT03620942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517083|NCT03620942|Protective Agents|protective agents|mesh-ancestor
92517084|NCT03620942|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92517085|NCT00277108|Escitalopram|escitalopram|mesh-list
92517086|NCT00277108|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92517087|NCT00277108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92517088|NCT00277108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517089|NCT00277108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517090|NCT00277108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517091|NCT00277108|Serotonin Agents|serotonin agents|mesh-ancestor
92517092|NCT00277108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517093|NCT00277069|Carboplatin|carboplatin|mesh-list
92517094|NCT00277069|Capecitabine|capecitabine|mesh-list
92517095|NCT00277069|Vinorelbine|vinorelbine|mesh-list
92517096|NCT00277069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517097|NCT00277069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517098|NCT00277069|Antimetabolites|antimetabolites|mesh-ancestor
92517099|NCT00277069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517100|NCT00277069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517101|NCT00277069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517102|NCT00277069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517103|NCT00277069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517104|NCT00277030|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92517105|NCT00277030|Respiratory System Agents|respiratory system agents|mesh-ancestor
92517106|NCT00276991|Immunomodulating Agents|immunomodulating agents|mesh-list
92517107|NCT00276991|Immunologic Factors|immunologic factors|mesh-ancestor
92517108|NCT00276991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517109|NCT00276874|Aripiprazole|aripiprazole|mesh-list
92517110|NCT00276874|Antidepressive Agents|antidepressive agents|mesh-ancestor
92517111|NCT00276874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92517112|NCT00276874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92517113|NCT00276874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92517114|NCT00276874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517115|NCT00276874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517116|NCT00276874|Dopamine Agonists|dopamine agonists|mesh-ancestor
92517117|NCT00276874|Dopamine Agents|dopamine agents|mesh-ancestor
92517118|NCT00276874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517119|NCT00276874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517120|NCT00276874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92517121|NCT00276874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92517122|NCT00276874|Serotonin Agents|serotonin agents|mesh-ancestor
92517123|NCT00276874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92517124|NCT00276874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92517125|NCT00276874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92517126|NCT00276874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92517127|NCT00276835|Aldesleukin|aldesleukin|mesh-list
92517128|NCT00276835|Interleukin-2|interleukin-2|mesh-list
92517129|NCT00276835|Genistein|genistein|mesh-list
92517130|NCT00276835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517131|NCT00276835|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92517132|NCT00276835|Analgesics|analgesics|mesh-ancestor
92517133|NCT00276835|Sensory System Agents|sensory system agents|mesh-ancestor
92517134|NCT00276835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517135|NCT00276835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517136|NCT00276835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92517137|NCT00276835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92517138|NCT00276835|Antiviral Agents|antiviral agents|mesh-ancestor
92517139|NCT00276835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517140|NCT00276835|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92517141|NCT00276835|Protective Agents|protective agents|mesh-ancestor
92517142|NCT00276835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92517143|NCT00276835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517144|NCT00276835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517145|NCT00276835|Phytoestrogens|phytoestrogens|mesh-ancestor
92517146|NCT00276835|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92517147|NCT00276835|Estrogens|estrogens|mesh-ancestor
92517148|NCT00276835|Hormones|hormones|mesh-ancestor
92517149|NCT00276835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517150|NCT00276796|Paclitaxel|paclitaxel|mesh-list
92517151|NCT00276796|Topotecan|topotecan|mesh-list
92517152|NCT00276796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517153|NCT00276796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517154|NCT00276796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517155|NCT00276796|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517156|NCT00276796|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517157|NCT00276796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517158|NCT00276796|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92517160|NCT00276796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517161|NCT00276757|Leucovorin|leucovorin|mesh-list
92517162|NCT00276757|Prednisolone|prednisolone|mesh-list
92517163|NCT00276757|Methotrexate|methotrexate|mesh-list
92517164|NCT00276757|Vinblastine|vinblastine|mesh-list
92517165|NCT00276757|Calcium|calcium|mesh-list
92517166|NCT00276757|Levoleucovorin|levoleucovorin|mesh-list
92517167|NCT00276757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92517168|NCT00276757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517169|NCT00276757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92517170|NCT00276757|Abortifacient Agents|abortifacient agents|mesh-ancestor
92517171|NCT00276757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92517172|NCT00276757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517173|NCT00276757|Antimetabolites|antimetabolites|mesh-ancestor
92517174|NCT00276757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517175|NCT00276757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517176|NCT00276757|Dermatologic Agents|dermatologic agents|mesh-ancestor
92517177|NCT00276757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517178|NCT00276757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92517179|NCT00276757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517180|NCT00276757|Immunologic Factors|immunologic factors|mesh-ancestor
92517181|NCT00276757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517182|NCT00276757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92517183|NCT00276757|Antidotes|antidotes|mesh-ancestor
92517184|NCT00276757|Protective Agents|protective agents|mesh-ancestor
92517185|NCT00276757|Vitamin B Complex|vitamin b complex|mesh-ancestor
92517186|NCT00276757|Vitamins|vitamins|mesh-ancestor
92517187|NCT00276757|Micronutrients|micronutrients|mesh-ancestor
92517188|NCT00276757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517189|NCT00276757|Glucocorticoids|glucocorticoids|mesh-ancestor
92517190|NCT00276757|Hormones|hormones|mesh-ancestor
92517191|NCT00276757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517192|NCT00276757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92517193|NCT00276757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517194|NCT00276757|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517195|NCT00276757|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517196|NCT00276757|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517197|NCT00276718|Carboplatin|carboplatin|mesh-list
92517198|NCT00276718|Etoposide|etoposide|mesh-list
92517199|NCT00276718|Bleomycin|bleomycin|mesh-list
92517200|NCT00276718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517201|NCT00276718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517202|NCT00276718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92517203|NCT00276718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517204|NCT00276718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517205|NCT00276718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517206|NCT00276718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92517207|NCT00276679|Temozolomide|temozolomide|mesh-list
92517208|NCT00276679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92517209|NCT00276679|Alkylating Agents|alkylating agents|mesh-ancestor
92517210|NCT00276679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517211|NCT00276679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517212|NCT00276601|Cytarabine|cytarabine|mesh-list
92517213|NCT00276601|Methotrexate|methotrexate|mesh-list
92517214|NCT00276601|Mercaptopurine|mercaptopurine|mesh-list
92517215|NCT00276601|Daunorubicin|daunorubicin|mesh-list
92517216|NCT00276601|Arsenic Trioxide|arsenic trioxide|mesh-list
92517217|NCT00276601|Tretinoin|tretinoin|mesh-list
92517218|NCT00276601|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92517219|NCT00276601|Abortifacient Agents|abortifacient agents|mesh-ancestor
92517220|NCT00276601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92517221|NCT00276601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517222|NCT00276601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517223|NCT00276601|Antimetabolites|antimetabolites|mesh-ancestor
92517224|NCT00276601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517225|NCT00276601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517226|NCT00276601|Dermatologic Agents|dermatologic agents|mesh-ancestor
92517227|NCT00276601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517228|NCT00276601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92517229|NCT00276601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517230|NCT00276601|Immunologic Factors|immunologic factors|mesh-ancestor
92517231|NCT00276601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517232|NCT00276601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92517233|NCT00276601|Antiviral Agents|antiviral agents|mesh-ancestor
92517234|NCT00276601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517236|NCT00276601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92517237|NCT00276601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517238|NCT00276601|Keratolytic Agents|keratolytic agents|mesh-ancestor
92517239|NCT00276523|Interferons|interferons|mesh-list
92517240|NCT00276523|Interferon-alpha|interferon-alpha|mesh-list
92517241|NCT00276523|Interferon alpha-2|interferon alpha-2|mesh-list
92517242|NCT00276523|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92517243|NCT00276523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517244|NCT00276523|Antiviral Agents|antiviral agents|mesh-ancestor
92517245|NCT00276523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517246|NCT00276523|Immunologic Factors|immunologic factors|mesh-ancestor
92517247|NCT00276523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517248|NCT00276445|Beta-1,3-glucan|beta-1,3-glucan|mesh-list
92517249|NCT00276445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92517250|NCT00276445|Immunologic Factors|immunologic factors|mesh-ancestor
92517251|NCT00276445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517252|NCT00276406|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92517253|NCT00276406|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92517254|NCT00276406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517255|NCT00276406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517256|NCT00276406|Cholinergic Agents|cholinergic agents|mesh-ancestor
92517257|NCT00276406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517258|NCT00276406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517259|NCT00389883|Anesthetics|anesthetics|mesh-list
92517260|NCT00389883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517261|NCT00389883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517262|NCT00389922|Vinorelbine|vinorelbine|mesh-list
92517263|NCT00389922|Lapatinib|lapatinib|mesh-list
92517264|NCT00389922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517265|NCT00389922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517266|NCT00389922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517267|NCT00389922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517268|NCT00389922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517269|NCT00389922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517270|NCT00389922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92517271|NCT00389922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517273|NCT00276289|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92517274|NCT00276289|Hormone Antagonists|hormone antagonists|mesh-ancestor
92517275|NCT00276289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517276|NCT00276289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517277|NCT00276289|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92517278|NCT00276289|Diuretics|diuretics|mesh-ancestor
92517279|NCT00276289|Natriuretic Agents|natriuretic agents|mesh-ancestor
92517280|NCT00276250|Abatacept|abatacept|mesh-list
92517281|NCT00276250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92517282|NCT00276250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517283|NCT00276250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517284|NCT00276250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517285|NCT00276250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517286|NCT00276250|Immunologic Factors|immunologic factors|mesh-ancestor
92517287|NCT00276250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517288|NCT00276250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517289|NCT00394186|Solabegron|solabegron|mesh-list
92517290|NCT00394186|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92517291|NCT00394186|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92517292|NCT00394186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92517293|NCT00394186|Adrenergic Agents|adrenergic agents|mesh-ancestor
92517294|NCT00394186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517295|NCT00394186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517296|NCT00394186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517297|NCT00276172|Natalizumab|natalizumab|mesh-list
92517298|NCT00276172|Immunologic Factors|immunologic factors|mesh-ancestor
92517299|NCT00276172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517300|NCT00276133|Atorvastatin|atorvastatin|mesh-list
92517301|NCT00276133|Probucol|probucol|mesh-list
92517302|NCT00276133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92517303|NCT00276133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92517304|NCT00276133|Antimetabolites|antimetabolites|mesh-ancestor
92517305|NCT00276133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517306|NCT00276133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92517307|NCT00276133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92517309|NCT00276133|Antioxidants|antioxidants|mesh-ancestor
92517310|NCT00276133|Protective Agents|protective agents|mesh-ancestor
92517311|NCT00276133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517312|NCT00276055|Bevacizumab|bevacizumab|mesh-list
92517313|NCT00276055|Gemcitabine|gemcitabine|mesh-list
92517314|NCT00276055|Docetaxel|docetaxel|mesh-list
92517315|NCT00276055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517316|NCT00276055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517317|NCT00276055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92517318|NCT00276055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92517319|NCT00276055|Growth Substances|growth substances|mesh-ancestor
92517320|NCT00276055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517321|NCT00276055|Growth Inhibitors|growth inhibitors|mesh-ancestor
92517322|NCT00276055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517323|NCT00276055|Antimetabolites|antimetabolites|mesh-ancestor
92517324|NCT00276055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517325|NCT00276055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517326|NCT00276055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517327|NCT00276055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517328|NCT00275938|Interferons|interferons|mesh-list
92517329|NCT00275938|Ribavirin|ribavirin|mesh-list
92517330|NCT00275938|Interferon-alpha|interferon-alpha|mesh-list
92517331|NCT00275938|Interferon alpha-2|interferon alpha-2|mesh-list
92517332|NCT00275938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517333|NCT00275938|Antiviral Agents|antiviral agents|mesh-ancestor
92517334|NCT00275938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517335|NCT00275938|Antimetabolites|antimetabolites|mesh-ancestor
92517336|NCT00275938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517337|NCT00275938|Immunologic Factors|immunologic factors|mesh-ancestor
92517338|NCT00275938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517339|NCT00275665|Valganciclovir|valganciclovir|mesh-list
92517340|NCT00275665|Antiviral Agents|antiviral agents|mesh-ancestor
92517341|NCT00275665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517342|NCT00276640|Carboplatin|carboplatin|mesh-list
92517343|NCT00276640|Etoposide|etoposide|mesh-list
92517344|NCT00276640|Vincristine|vincristine|mesh-list
92517345|NCT00276640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517346|NCT00276640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517347|NCT00276640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92517348|NCT00276640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517349|NCT00276640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517350|NCT00276640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517351|NCT00276640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517352|NCT00276640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517353|NCT00276640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517355|NCT00275548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92517356|NCT00275548|Antimetabolites|antimetabolites|mesh-ancestor
92517357|NCT00275548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517358|NCT00275548|Antiviral Agents|antiviral agents|mesh-ancestor
92517359|NCT00275548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517360|NCT00275431|Gossypol acetic acid|gossypol acetic acid|mesh-list
92517361|NCT00275431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517362|NCT00275431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517363|NCT00275431|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92517364|NCT00275431|Contraceptive Agents|contraceptive agents|mesh-ancestor
92517365|NCT00275431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92517366|NCT00275431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517367|NCT00275431|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92517368|NCT00275431|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92517369|NCT00275431|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92517370|NCT03152318|Cyclophosphamide|cyclophosphamide|mesh-list
92517371|NCT03152318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517372|NCT03152318|Immunologic Factors|immunologic factors|mesh-ancestor
92517373|NCT03152318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517374|NCT03152318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517375|NCT03152318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92517376|NCT03152318|Alkylating Agents|alkylating agents|mesh-ancestor
92517377|NCT03152318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517378|NCT03152318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352244|NCT03150576|Olaparib|olaparib|mesh-list
92517379|NCT03152318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92517380|NCT05566054|Azacitidine|azacitidine|mesh-list
92517381|NCT05566054|Venetoclax|venetoclax|mesh-list
92517382|NCT05566054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517383|NCT05566054|Antimetabolites|antimetabolites|mesh-ancestor
91926338|NCT02535416|Antipruritics|antipruritics|mesh-ancestor
92517384|NCT05566054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517385|NCT05566054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517386|NCT05566054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517387|NCT05565430|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92517388|NCT05565430|Cholinergic Agents|cholinergic agents|mesh-ancestor
92517389|NCT05565430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517390|NCT05565430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517391|NCT05565430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517392|NCT05140746|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92517393|NCT05140746|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92517394|NCT05140746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517395|NCT02979977|Cetuximab|cetuximab|mesh-list
92517396|NCT02979977|Afatinib|afatinib|mesh-list
92517397|NCT02979977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517398|NCT02979977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517399|NCT02979977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92517400|NCT02979977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517401|NCT02979977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517402|NCT05424757|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92517403|NCT05424757|Laxatives|laxatives|mesh-ancestor
92517404|NCT05424757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92517405|NCT02921555|Prednisone|prednisone|mesh-list
92517406|NCT02921555|Methylprednisolone|methylprednisolone|mesh-list
92517407|NCT02921555|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92517408|NCT02921555|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92517409|NCT02921555|Prednisolone|prednisolone|mesh-list
92517410|NCT02921555|Prednisolone acetate|prednisolone acetate|mesh-list
92517411|NCT02921555|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92517413|NCT02921555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517414|NCT02921555|Glucocorticoids|glucocorticoids|mesh-ancestor
92517415|NCT02921555|Hormones|hormones|mesh-ancestor
92517416|NCT02921555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517417|NCT02921555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517418|NCT02921555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92517419|NCT02921555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517420|NCT02921555|Antiemetics|antiemetics|mesh-ancestor
92517422|NCT02921555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517423|NCT02921555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92517424|NCT02921555|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92517425|NCT02921555|Protective Agents|protective agents|mesh-ancestor
92517426|NCT05070585|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
92517427|NCT05070585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517428|NCT05070585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517429|NCT05070585|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92517430|NCT05070585|Protective Agents|protective agents|mesh-ancestor
92517431|NCT05070585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517432|NCT05070585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517433|NCT00387530|Valganciclovir|valganciclovir|mesh-list
92517434|NCT00387530|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92517435|NCT00387530|Antiviral Agents|antiviral agents|mesh-ancestor
92517436|NCT00387530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517437|NCT00387530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517438|NCT02687906|Meropenem|meropenem|mesh-list
92517439|NCT02687906|Vaborbactam|vaborbactam|mesh-list
92517440|NCT02687906|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92517441|NCT02687906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92517442|NCT02687906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517443|NCT02687906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517444|NCT02687906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517445|NCT02680184|Pembrolizumab|pembrolizumab|mesh-list
92517446|NCT02680184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517447|NCT02680184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517448|NCT02680184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92517449|NCT02680184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517450|NCT00390000|Pemetrexed|pemetrexed|mesh-list
92517451|NCT00390000|Vatalanib|vatalanib|mesh-list
92517452|NCT00390000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517453|NCT00390000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517454|NCT00390000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517455|NCT00390000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92517456|NCT00390000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92517457|NCT00390000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92517458|NCT04856176|Paclitaxel|paclitaxel|mesh-list
92517459|NCT04856176|Carboplatin|carboplatin|mesh-list
92517460|NCT04856176|Pembrolizumab|pembrolizumab|mesh-list
92517461|NCT04856176|Pemetrexed|pemetrexed|mesh-list
92517462|NCT04856176|Molgramostim|molgramostim|mesh-list
92517463|NCT04856176|Sargramostim|sargramostim|mesh-list
92517464|NCT04856176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517465|NCT04856176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517466|NCT04856176|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517467|NCT04856176|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517468|NCT04856176|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517469|NCT04856176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517470|NCT04856176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517471|NCT04856176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92517472|NCT04856176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517473|NCT04856176|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92517474|NCT04856176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92517475|NCT04856176|Immunologic Factors|immunologic factors|mesh-ancestor
92517476|NCT04856176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517477|NCT02632760|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92517478|NCT02632760|Hematinics|hematinics|mesh-ancestor
92517479|NCT04732507|Lidocaine|lidocaine|mesh-list
92517480|NCT04732507|Bupivacaine|bupivacaine|mesh-list
92517481|NCT04732507|Anesthetics, Local|anesthetics, local|mesh-ancestor
92517482|NCT04732507|Anesthetics|anesthetics|mesh-ancestor
92517483|NCT04732507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517484|NCT04732507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517485|NCT04732507|Sensory System Agents|sensory system agents|mesh-ancestor
92517486|NCT04732507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517487|NCT04732507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92517489|NCT04732507|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92517490|NCT04732507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517491|NCT04732507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517492|NCT05047770|Vaccines|vaccines|mesh-list
92517493|NCT05047770|Immunologic Factors|immunologic factors|mesh-ancestor
92517494|NCT05047770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517495|NCT02453984|Atezolizumab|atezolizumab|mesh-list
92517496|NCT02453984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92517497|NCT02453984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517498|NCT02453984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517499|NCT02453984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517500|NCT04599478|Naltrexone|naltrexone|mesh-list
92517501|NCT04599478|Bupropion|bupropion|mesh-list
92517502|NCT04599478|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92517503|NCT04599478|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92517504|NCT04599478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517505|NCT04599478|Sensory System Agents|sensory system agents|mesh-ancestor
92517506|NCT04599478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517507|NCT04599478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92517508|NCT04599478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92517509|NCT04599478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92517510|NCT04599478|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92517511|NCT04599478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92517512|NCT04599478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517513|NCT04599478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517514|NCT04599478|Dopamine Agents|dopamine agents|mesh-ancestor
92517515|NCT04599478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517516|NCT04599478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92517517|NCT04599478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92517518|NCT04599478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517519|NCT04574245|Immunomodulating Agents|immunomodulating agents|mesh-list
92517520|NCT04574245|Immunologic Factors|immunologic factors|mesh-ancestor
92517521|NCT04574245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517522|NCT04556617|Prednisone|prednisone|mesh-list
92517523|NCT04556617|Olaparib|olaparib|mesh-list
92517524|NCT04556617|Abiraterone Acetate|abiraterone acetate|mesh-list
92517525|NCT04556617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517526|NCT04556617|Glucocorticoids|glucocorticoids|mesh-ancestor
92517527|NCT04556617|Hormones|hormones|mesh-ancestor
92517528|NCT04556617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517529|NCT04556617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517530|NCT04556617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92517531|NCT04556617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517532|NCT04556617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92517533|NCT04556617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517534|NCT04556617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517536|NCT04556617|Hormone Antagonists|hormone antagonists|mesh-ancestor
92517537|NCT04556617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92517538|NCT04554862|Ketorolac|ketorolac|mesh-list
92517539|NCT04554862|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92517540|NCT04554862|Magnesium Sulfate|magnesium sulfate|mesh-list
92517541|NCT04554862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92517542|NCT04554862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92517543|NCT04554862|Analgesics|analgesics|mesh-ancestor
92517544|NCT04554862|Sensory System Agents|sensory system agents|mesh-ancestor
92517545|NCT04554862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517546|NCT04554862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517547|NCT04554862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517548|NCT04554862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517549|NCT04554862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92517550|NCT04554862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517551|NCT04554862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517552|NCT04554862|Anesthetics|anesthetics|mesh-ancestor
92517553|NCT04554862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517554|NCT04554862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92517555|NCT04554862|Anticonvulsants|anticonvulsants|mesh-ancestor
92517556|NCT04554862|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92517557|NCT04554862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517558|NCT04554862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92517559|NCT04554862|Tocolytic Agents|tocolytic agents|mesh-ancestor
92517560|NCT04554862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92517561|NCT02337686|Pembrolizumab|pembrolizumab|mesh-list
92517562|NCT02337686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517563|NCT02337686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352280|NCT04747080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517564|NCT02337686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92517565|NCT02337686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517566|NCT03802097|Anti-Infective Agents|anti-infective agents|mesh-list
92517567|NCT03802097|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92517568|NCT04230499|Sirolimus|sirolimus|mesh-list
92517569|NCT04230499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92517570|NCT04230499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517571|NCT04230499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92517572|NCT04230499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517573|NCT04230499|Antifungal Agents|antifungal agents|mesh-ancestor
92517574|NCT04230499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517575|NCT04230499|Immunologic Factors|immunologic factors|mesh-ancestor
92517576|NCT04230499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517577|NCT04712435|Acetylcysteine|acetylcysteine|mesh-list
92517578|NCT04712435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92517579|NCT04712435|Antiviral Agents|antiviral agents|mesh-ancestor
92517580|NCT04712435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517581|NCT04712435|Expectorants|expectorants|mesh-ancestor
92517582|NCT04712435|Respiratory System Agents|respiratory system agents|mesh-ancestor
92517583|NCT04712435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92517584|NCT04712435|Antioxidants|antioxidants|mesh-ancestor
92517585|NCT04712435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517586|NCT04712435|Protective Agents|protective agents|mesh-ancestor
92517587|NCT04712435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517588|NCT04712435|Antidotes|antidotes|mesh-ancestor
92517589|NCT03977194|Paclitaxel|paclitaxel|mesh-list
92517590|NCT03977194|Carboplatin|carboplatin|mesh-list
92517591|NCT03977194|Atezolizumab|atezolizumab|mesh-list
92517592|NCT03977194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517593|NCT03977194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517594|NCT03977194|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517595|NCT03977194|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517596|NCT03977194|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517597|NCT03977194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517598|NCT03977194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92517599|NCT03977194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92517600|NCT04729465|Propofol|propofol|mesh-list
92517601|NCT04729465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92517602|NCT04729465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517603|NCT04729465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517604|NCT04729465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92517605|NCT04729465|Anesthetics, General|anesthetics, general|mesh-ancestor
92517606|NCT04729465|Anesthetics|anesthetics|mesh-ancestor
92517607|NCT04712357|Tenofovir|tenofovir|mesh-list
92517609|NCT04712357|Antiviral Agents|antiviral agents|mesh-ancestor
92517610|NCT04712357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517611|NCT04712357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92517612|NCT04712357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92517613|NCT04712357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517614|NCT04712357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517615|NCT04712357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92517616|NCT04712357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92517617|NCT00390039|Morphine|morphine|mesh-list
92517618|NCT00390039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92517619|NCT00390039|Narcotics|narcotics|mesh-ancestor
92517620|NCT00390039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517621|NCT00390039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517622|NCT00390039|Analgesics|analgesics|mesh-ancestor
92517623|NCT00390039|Sensory System Agents|sensory system agents|mesh-ancestor
92517624|NCT00390039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517625|NCT02966665|Vitamins|vitamins|mesh-list
92517626|NCT02966665|Vitamin E|vitamin e|mesh-list
92517627|NCT02966665|Thioctic Acid|thioctic acid|mesh-list
92517628|NCT02966665|Fexofenadine|fexofenadine|mesh-list
92517629|NCT02966665|Valsartan|valsartan|mesh-list
92517630|NCT02966665|Nitroprusside|nitroprusside|mesh-list
92517631|NCT02966665|Phentolamine|phentolamine|mesh-list
92517632|NCT02966665|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92517633|NCT02966665|Norepinephrine|norepinephrine|mesh-list
92517634|NCT02966665|Angiotensin II|angiotensin ii|mesh-list
92517635|NCT02966665|Giapreza|giapreza|mesh-list
92517636|NCT02966665|Acetylcholine|acetylcholine|mesh-list
92517637|NCT02966665|Ranitidine|ranitidine|mesh-list
92517638|NCT02966665|Angiotensinogen|angiotensinogen|mesh-list
92517639|NCT02966665|Micronutrients|micronutrients|mesh-ancestor
92517640|NCT02966665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517641|NCT02966665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92517642|NCT02966665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92517643|NCT02966665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92517644|NCT02966665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517645|NCT02966665|Antioxidants|antioxidants|mesh-ancestor
92517646|NCT02966665|Protective Agents|protective agents|mesh-ancestor
92517647|NCT02966665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92517648|NCT02966665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92517649|NCT02966665|Adrenergic Agents|adrenergic agents|mesh-ancestor
92517650|NCT02966665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517651|NCT02966665|Sympathomimetics|sympathomimetics|mesh-ancestor
92517652|NCT02966665|Autonomic Agents|autonomic agents|mesh-ancestor
92517653|NCT02966665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517654|NCT02966665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92517655|NCT02966665|Vitamin B Complex|vitamin b complex|mesh-ancestor
92517656|NCT02966665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92517657|NCT02966665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92517658|NCT02966665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92517659|NCT02966665|Histamine Antagonists|histamine antagonists|mesh-ancestor
92517660|NCT02966665|Histamine Agents|histamine agents|mesh-ancestor
92517661|NCT02966665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92517662|NCT02966665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92517663|NCT02966665|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92517664|NCT02966665|Vasodilator Agents|vasodilator agents|mesh-ancestor
92517665|NCT02966665|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92517666|NCT02966665|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92517667|NCT02966665|Protease Inhibitors|protease inhibitors|mesh-ancestor
92517668|NCT02966665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517669|NCT02966665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92517670|NCT02966665|Cholinergic Agents|cholinergic agents|mesh-ancestor
92517671|NCT02966665|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92517672|NCT02966665|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92517673|NCT02966665|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92517674|NCT02832544|Vitamin K|vitamin k|mesh-list
92517675|NCT02832544|Warfarin|warfarin|mesh-list
92517676|NCT02832544|Rivaroxaban|rivaroxaban|mesh-list
92517677|NCT02832544|Vitamins|vitamins|mesh-ancestor
92517678|NCT02832544|Micronutrients|micronutrients|mesh-ancestor
92517679|NCT02832544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517680|NCT02832544|Anticoagulants|anticoagulants|mesh-ancestor
92517681|NCT02832544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92517682|NCT02832544|Antithrombins|antithrombins|mesh-ancestor
92517683|NCT02832544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92517684|NCT02832544|Protease Inhibitors|protease inhibitors|mesh-ancestor
92517685|NCT02832544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517686|NCT02832544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517687|NCT02832544|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92517688|NCT02832544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92517689|NCT02832544|Hemostatics|hemostatics|mesh-ancestor
92517690|NCT02832544|Coagulants|coagulants|mesh-ancestor
92517691|NCT00006044|Testosterone|testosterone|mesh-list
92517692|NCT00006044|Androgens|androgens|mesh-ancestor
92517693|NCT00006044|Hormones|hormones|mesh-ancestor
92517694|NCT00006044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517695|NCT00006044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517696|NCT02490241|Lithium Carbonate|lithium carbonate|mesh-list
92517697|NCT02490241|Antidepressive Agents|antidepressive agents|mesh-ancestor
92517698|NCT02490241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92517699|NCT02490241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517700|NCT02490241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517701|NCT02490241|Antimanic Agents|antimanic agents|mesh-ancestor
92517702|NCT02490241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92517703|NCT02490241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92517704|NCT02490241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517705|NCT02395705|Paclitaxel|paclitaxel|mesh-list
92517706|NCT02395705|Cisplatin|cisplatin|mesh-list
92517707|NCT02395705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533327|NCT00059761|Irinotecan|irinotecan|mesh-list
92517708|NCT02395705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517709|NCT02395705|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517710|NCT02395705|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517711|NCT02395705|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517712|NCT02395705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517714|NCT00006047|Rubitecan|rubitecan|mesh-list
92517715|NCT00006047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
92517716|NCT00006047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517717|NCT00006047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517718|NCT00006047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92517719|NCT00006047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517720|NCT00006047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517721|NCT00006047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517722|NCT00083824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92517723|NCT00083824|Medroxyprogesterone|medroxyprogesterone|mesh-list
92517724|NCT00083824|Estrogens|estrogens|mesh-list
92517725|NCT00083824|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92517726|NCT00083824|Hormones|hormones|mesh-ancestor
92517727|NCT00083824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517728|NCT00083824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517729|NCT00083824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92517730|NCT00083824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92517731|NCT00083824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92517732|NCT00083824|Contraceptive Agents|contraceptive agents|mesh-ancestor
92517733|NCT00083824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92517734|NCT00083824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92517735|NCT00083824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92517736|NCT00083824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92517737|NCT00083824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92517738|NCT00083824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517739|NCT00083902|Thalidomide|thalidomide|mesh-list
92517740|NCT00083902|Dexamethasone|dexamethasone|mesh-list
92517741|NCT00083902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517742|NCT00083902|Antiemetics|antiemetics|mesh-ancestor
92517743|NCT00083902|Autonomic Agents|autonomic agents|mesh-ancestor
92517744|NCT00083902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517745|NCT00083902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517746|NCT00083902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92517747|NCT00083902|Glucocorticoids|glucocorticoids|mesh-ancestor
92517748|NCT00083902|Hormones|hormones|mesh-ancestor
92517749|NCT00083902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92517750|NCT00083902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92517751|NCT00083902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517752|NCT00083902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517753|NCT00083902|Immunologic Factors|immunologic factors|mesh-ancestor
92517754|NCT00083902|Leprostatic Agents|leprostatic agents|mesh-ancestor
92517755|NCT00083902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92517756|NCT00083902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517757|NCT00083902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92517758|NCT00083902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92517759|NCT00083902|Growth Substances|growth substances|mesh-ancestor
92517760|NCT00083902|Growth Inhibitors|growth inhibitors|mesh-ancestor
92517761|NCT00006050|Leucovorin|leucovorin|mesh-list
92517762|NCT00006050|Fluorouracil|fluorouracil|mesh-list
92517763|NCT00006050|Oxaliplatin|oxaliplatin|mesh-list
92517764|NCT00006050|Calcium|calcium|mesh-list
92517765|NCT00006050|Levoleucovorin|levoleucovorin|mesh-list
92517766|NCT00006050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92517767|NCT00006050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517768|NCT00006050|Antimetabolites|antimetabolites|mesh-ancestor
92517769|NCT00006050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517770|NCT00006050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517771|NCT00006050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517772|NCT00006050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517773|NCT00006050|Immunologic Factors|immunologic factors|mesh-ancestor
92517774|NCT00006050|Antidotes|antidotes|mesh-ancestor
92517775|NCT00006050|Protective Agents|protective agents|mesh-ancestor
92517776|NCT00006050|Vitamin B Complex|vitamin b complex|mesh-ancestor
92517777|NCT00006050|Vitamins|vitamins|mesh-ancestor
92517778|NCT00006050|Micronutrients|micronutrients|mesh-ancestor
92517779|NCT00083980|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92517780|NCT00083980|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92517781|NCT00083980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92517782|NCT00083980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92517783|NCT00083980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517784|NCT00083980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92517785|NCT00083980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517786|NCT00083980|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92517787|NCT00083980|Antidepressive Agents|antidepressive agents|mesh-ancestor
92517788|NCT00083980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92517789|NCT04893174|Hyaluronic Acid|hyaluronic acid|mesh-list
92517790|NCT04893174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92517791|NCT04893174|Immunologic Factors|immunologic factors|mesh-ancestor
92517792|NCT04893174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517793|NCT04893174|Viscosupplements|viscosupplements|mesh-ancestor
92517794|NCT04893174|Protective Agents|protective agents|mesh-ancestor
92517795|NCT00084019|Ritonavir|ritonavir|mesh-list
92517796|NCT00084019|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92517797|NCT00084019|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92517798|NCT00084019|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92517800|NCT00084019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517801|NCT00084019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517802|NCT00084019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92517803|NCT00084019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92517804|NCT00084019|Antiviral Agents|antiviral agents|mesh-ancestor
92517805|NCT00084019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517806|NCT00084019|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92517807|NCT00084019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92517808|NCT00084058|Ritonavir|ritonavir|mesh-list
92517809|NCT00084058|Lopinavir|lopinavir|mesh-list
92517810|NCT00084058|Saquinavir|saquinavir|mesh-list
92517811|NCT00084058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92517812|NCT00084058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92517813|NCT00084058|Protease Inhibitors|protease inhibitors|mesh-ancestor
92517814|NCT00084058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517815|NCT00084058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517816|NCT00084058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92517817|NCT00084058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92517818|NCT00084058|Antiviral Agents|antiviral agents|mesh-ancestor
92517819|NCT00084058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517820|NCT00084058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92517821|NCT00084058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92517822|NCT00006053|Imatinib Mesylate|imatinib mesylate|mesh-list
92517823|NCT00006053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517824|NCT00006053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92517825|NCT00006053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517826|NCT00006053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517827|NCT00084097|Omalizumab|omalizumab|mesh-list
92517828|NCT00084097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92517829|NCT00084097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92517830|NCT00084097|Respiratory System Agents|respiratory system agents|mesh-ancestor
92517831|NCT00084214|Paclitaxel|paclitaxel|mesh-list
92517832|NCT00084214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517833|NCT00084214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517834|NCT00084214|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517835|NCT00084214|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517836|NCT00084214|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517837|NCT00084214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517838|NCT00006056|Cyclosporine|cyclosporine|mesh-list
92517839|NCT00006056|Cyclophosphamide|cyclophosphamide|mesh-list
92517840|NCT00006056|Busulfan|busulfan|mesh-list
92517841|NCT00006056|Methotrexate|methotrexate|mesh-list
92517842|NCT00006056|Etoposide|etoposide|mesh-list
92517843|NCT00006056|Cyclosporins|cyclosporins|mesh-list
92517844|NCT00006056|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92517845|NCT00006056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517846|NCT00006056|Immunologic Factors|immunologic factors|mesh-ancestor
92517847|NCT00006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517848|NCT00006056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517849|NCT00006056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92517850|NCT00006056|Alkylating Agents|alkylating agents|mesh-ancestor
92517851|NCT00006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517852|NCT00006056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517853|NCT00006056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92517854|NCT00006056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92517855|NCT00006056|Abortifacient Agents|abortifacient agents|mesh-ancestor
92517856|NCT00006056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92517857|NCT00006056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517858|NCT00006056|Antimetabolites|antimetabolites|mesh-ancestor
92517859|NCT00006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92517860|NCT00006056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517861|NCT00006056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92517862|NCT00006056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92517863|NCT00006056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517864|NCT00006056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92517865|NCT00006056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517866|NCT00006056|Antifungal Agents|antifungal agents|mesh-ancestor
92517867|NCT00006056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517868|NCT00006056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92517869|NCT00084370|Celecoxib|celecoxib|mesh-list
92517870|NCT00084370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92517871|NCT00084370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92517872|NCT00084370|Analgesics|analgesics|mesh-ancestor
92517873|NCT00084370|Sensory System Agents|sensory system agents|mesh-ancestor
92517874|NCT00084370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517875|NCT00084370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517876|NCT00084370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517877|NCT00084370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517878|NCT00084370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92517879|NCT00084370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92517880|NCT00084370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517881|NCT00084370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517882|NCT00084448|Celecoxib|celecoxib|mesh-list
92517883|NCT00084448|Paclitaxel|paclitaxel|mesh-list
92517884|NCT00084448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517885|NCT00084448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517886|NCT00084448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517887|NCT00084448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517888|NCT00084448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517889|NCT00084448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517890|NCT00084448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92517891|NCT00084448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92517892|NCT00084448|Analgesics|analgesics|mesh-ancestor
92517893|NCT00084448|Sensory System Agents|sensory system agents|mesh-ancestor
92517894|NCT00084448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517895|NCT00084448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517896|NCT00084448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517897|NCT00084448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517898|NCT00084448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92517899|NCT00084448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92517900|NCT00084448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517901|NCT00084565|Paclitaxel|paclitaxel|mesh-list
92517902|NCT00084565|Topotecan|topotecan|mesh-list
92517903|NCT00084565|Estramustine|estramustine|mesh-list
92517904|NCT00084565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92517905|NCT00084565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517906|NCT00084565|Tubulin Modulators|tubulin modulators|mesh-ancestor
92517907|NCT00084565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92517908|NCT00084565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92517909|NCT00084565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517910|NCT00084565|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92517911|NCT00084565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517912|NCT00084565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517913|NCT00084565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92517914|NCT00084565|Alkylating Agents|alkylating agents|mesh-ancestor
92517915|NCT00084565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92517916|NCT00084604|Bevacizumab|bevacizumab|mesh-list
92517917|NCT00084604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92517918|NCT00084604|Irinotecan|irinotecan|mesh-list
92517919|NCT00084604|Antibodies|antibodies|mesh-list
92517920|NCT00084604|Immunoglobulins|immunoglobulins|mesh-list
92517921|NCT00084604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92517922|NCT00084604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517923|NCT00084604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92517924|NCT00084604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92517925|NCT00084604|Growth Substances|growth substances|mesh-ancestor
92517926|NCT00084604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517927|NCT00084604|Growth Inhibitors|growth inhibitors|mesh-ancestor
92517928|NCT00084604|Immunologic Factors|immunologic factors|mesh-ancestor
92517929|NCT00084604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92517930|NCT00084604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517931|NCT00084604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517932|NCT00084604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517933|NCT00084643|Capecitabine|capecitabine|mesh-list
92517934|NCT00084643|Oxaliplatin|oxaliplatin|mesh-list
92517935|NCT00084643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92517936|NCT00084643|Antimetabolites|antimetabolites|mesh-ancestor
92517937|NCT00084643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517938|NCT00084643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517939|NCT00006062|Oxaliplatin|oxaliplatin|mesh-list
92517940|NCT00006062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517941|NCT00084721|Celecoxib|celecoxib|mesh-list
92517942|NCT00084721|Irinotecan|irinotecan|mesh-list
92517943|NCT00084721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92517944|NCT00084721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517945|NCT00084721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517946|NCT00084721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517947|NCT00084721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517948|NCT00084721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92517949|NCT00084721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92517950|NCT00084721|Analgesics|analgesics|mesh-ancestor
92517951|NCT00084721|Sensory System Agents|sensory system agents|mesh-ancestor
92517952|NCT00084721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92517953|NCT00084721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517954|NCT00084721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92517955|NCT00084721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92517956|NCT00084721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92517957|NCT00084721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92517958|NCT00084877|Irinotecan|irinotecan|mesh-list
92517959|NCT00084877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92517960|NCT00084877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92517961|NCT00084877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517962|NCT00084877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517963|NCT00084877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517964|NCT00084916|Sirolimus|sirolimus|mesh-list
92517965|NCT00084916|Temsirolimus|temsirolimus|mesh-list
92517966|NCT00084916|MTOR Inhibitors|mtor inhibitors|mesh-list
92517967|NCT00084916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92517968|NCT00084916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92517969|NCT00084916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92517970|NCT00084916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517971|NCT00084916|Immunologic Factors|immunologic factors|mesh-ancestor
92517972|NCT00084916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517973|NCT00084916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517974|NCT00084916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92517975|NCT00084916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92517976|NCT00084916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92517977|NCT00084916|Antifungal Agents|antifungal agents|mesh-ancestor
92517978|NCT00085111|Bevacizumab|bevacizumab|mesh-list
92517979|NCT00085111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92517980|NCT00085111|Antibodies|antibodies|mesh-list
92517981|NCT00085111|Immunoglobulins|immunoglobulins|mesh-list
92517982|NCT00085111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92517983|NCT00085111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92517984|NCT00085111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92517985|NCT00085111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92517986|NCT00085111|Growth Substances|growth substances|mesh-ancestor
92517987|NCT00085111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517988|NCT00085111|Growth Inhibitors|growth inhibitors|mesh-ancestor
92517989|NCT00085111|Immunologic Factors|immunologic factors|mesh-ancestor
92517990|NCT00085150|Immunotoxins|immunotoxins|mesh-list
92517991|NCT00085150|Immunoconjugates|immunoconjugates|mesh-ancestor
92517992|NCT00085150|Immunologic Factors|immunologic factors|mesh-ancestor
92517993|NCT00085150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517994|NCT00400075|Cyclophosphamide|cyclophosphamide|mesh-list
92517995|NCT00400075|Azathioprine|azathioprine|mesh-list
92517996|NCT00400075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92517997|NCT00400075|Immunologic Factors|immunologic factors|mesh-ancestor
92517998|NCT00400075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92517999|NCT00400075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518000|NCT00400075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518001|NCT00400075|Alkylating Agents|alkylating agents|mesh-ancestor
92518002|NCT00400075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518003|NCT00400075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518004|NCT00400075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518005|NCT00400075|Antimetabolites|antimetabolites|mesh-ancestor
92518006|NCT00400075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518008|NCT00400114|Sunitinib|sunitinib|mesh-list
92518009|NCT00400114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518010|NCT00400114|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92518011|NCT00400114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518012|NCT00400114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518013|NCT00400114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518014|NCT00400114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92518015|NCT00400114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92518016|NCT00400114|Growth Substances|growth substances|mesh-ancestor
92518017|NCT00400114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518018|NCT00400114|Growth Inhibitors|growth inhibitors|mesh-ancestor
92518019|NCT00400114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518020|NCT00085189|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92518021|NCT00085189|Freund's Adjuvant|freund's adjuvant|mesh-list
92518022|NCT00085189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92518023|NCT00085189|Immunologic Factors|immunologic factors|mesh-ancestor
92518024|NCT00085189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518025|NCT00085228|Docetaxel|docetaxel|mesh-list
92518026|NCT00085228|Oblimersen|oblimersen|mesh-list
92518027|NCT00085228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518028|NCT00085228|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518029|NCT00085228|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518030|NCT00085228|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518031|NCT00085228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518032|NCT00085306|Interferons|interferons|mesh-list
92518033|NCT00085306|Interferon-beta|interferon-beta|mesh-list
92518034|NCT00085306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518035|NCT00085306|Antiviral Agents|antiviral agents|mesh-ancestor
92518036|NCT00085306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518037|NCT00085306|Immunologic Factors|immunologic factors|mesh-ancestor
92518038|NCT00085306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518039|NCT00006077|Levodopa|levodopa|mesh-list
92518040|NCT00006077|Domperidone|domperidone|mesh-list
92518041|NCT00006077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92518042|NCT00006077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92518043|NCT00006077|Dopamine Agents|dopamine agents|mesh-ancestor
92518044|NCT00006077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518045|NCT00006077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518046|NCT00006077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518047|NCT00006077|Antiemetics|antiemetics|mesh-ancestor
92518048|NCT00006077|Autonomic Agents|autonomic agents|mesh-ancestor
92518049|NCT00006077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518050|NCT00006077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92518051|NCT00006077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92518052|NCT04729348|Pembrolizumab|pembrolizumab|mesh-list
92518053|NCT04729348|Lenvatinib|lenvatinib|mesh-list
92518054|NCT04729348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518055|NCT04729348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518056|NCT04729348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92518057|NCT04729348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518058|NCT04729348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518059|NCT04729348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518060|NCT00085345|Ascorbic Acid|ascorbic acid|mesh-list
92518061|NCT00085345|Melphalan|melphalan|mesh-list
92518062|NCT00085345|Arsenic Trioxide|arsenic trioxide|mesh-list
91927018|NCT00717457|Exenatide|exenatide|mesh-list
92518063|NCT00085345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518064|NCT00085345|Alkylating Agents|alkylating agents|mesh-ancestor
92518065|NCT00085345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518066|NCT00085345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518067|NCT00085345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518068|NCT00085345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518069|NCT00085345|Immunologic Factors|immunologic factors|mesh-ancestor
92518070|NCT00085345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518071|NCT00085345|Antioxidants|antioxidants|mesh-ancestor
92518072|NCT00085345|Protective Agents|protective agents|mesh-ancestor
92518073|NCT00085345|Vitamins|vitamins|mesh-ancestor
92518074|NCT00085345|Micronutrients|micronutrients|mesh-ancestor
92518075|NCT00085384|Interferons|interferons|mesh-list
92518076|NCT00085384|Interferon-alpha|interferon-alpha|mesh-list
92518077|NCT00085384|Interferon alpha-2|interferon alpha-2|mesh-list
92518078|NCT00085384|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92518079|NCT00085384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518080|NCT00085384|Antiviral Agents|antiviral agents|mesh-ancestor
92518081|NCT00085384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518082|NCT00085384|Immunologic Factors|immunologic factors|mesh-ancestor
92518083|NCT00085384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518084|NCT00006080|Fenretinide|fenretinide|mesh-list
92518085|NCT00006080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518086|NCT00006080|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92518087|NCT00006080|Protective Agents|protective agents|mesh-ancestor
92518088|NCT00006080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518089|NCT00085462|Aldesleukin|aldesleukin|mesh-list
92518090|NCT00085462|Cyclophosphamide|cyclophosphamide|mesh-list
92518091|NCT00085462|Fludarabine|fludarabine|mesh-list
92518092|NCT00085462|Fludarabine phosphate|fludarabine phosphate|mesh-list
92518093|NCT00085462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518094|NCT00085462|Immunologic Factors|immunologic factors|mesh-ancestor
92518095|NCT00085462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518096|NCT00085462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518097|NCT00085462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518098|NCT00085462|Alkylating Agents|alkylating agents|mesh-ancestor
92518099|NCT00085462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518100|NCT00085462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518101|NCT00085462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518102|NCT00085462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518103|NCT00085462|Antimetabolites|antimetabolites|mesh-ancestor
92518104|NCT00085462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92518105|NCT00085462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92518106|NCT00085462|Antiviral Agents|antiviral agents|mesh-ancestor
92518107|NCT00085462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518108|NCT00085501|Paclitaxel|paclitaxel|mesh-list
92518109|NCT00085501|Carboplatin|carboplatin|mesh-list
92518110|NCT00085501|Cetuximab|cetuximab|mesh-list
92518111|NCT00085501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518112|NCT00085501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518113|NCT00085501|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518114|NCT00085501|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518115|NCT00085501|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518116|NCT00085501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518117|NCT00085501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518118|NCT00006083|Dalteparin|dalteparin|mesh-list
92518119|NCT00006083|Anticoagulants|anticoagulants|mesh-ancestor
92518120|NCT00006083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92518121|NCT00006083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92518122|NCT00006083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518123|NCT00085579|Aldesleukin|aldesleukin|mesh-list
92518124|NCT00085579|Sargramostim|sargramostim|mesh-list
92518125|NCT00085579|Immunologic Factors|immunologic factors|mesh-ancestor
92518126|NCT00085579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518127|NCT00085579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518128|NCT00085579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92518129|NCT00085579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92518130|NCT00085579|Antiviral Agents|antiviral agents|mesh-ancestor
92518131|NCT00085579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518132|NCT00085696|Rituximab|rituximab|mesh-list
92518133|NCT00085696|Bortezomib|bortezomib|mesh-list
92518134|NCT00085696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518135|NCT00085696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518136|NCT00085696|Immunologic Factors|immunologic factors|mesh-ancestor
92518137|NCT00085696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518138|NCT00085696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518139|NCT00006086|Carboplatin|carboplatin|mesh-list
92518140|NCT00006086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518141|NCT04798638|Osimertinib|osimertinib|mesh-list
92518142|NCT04798638|Complement Factor H|complement factor h|mesh-list
92518143|NCT04798638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518144|NCT04798638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518145|NCT04798638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518146|NCT04798638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518147|NCT04798638|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92518148|NCT04798638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518149|NCT04798638|Immunologic Factors|immunologic factors|mesh-ancestor
92518150|NCT04798638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518151|NCT00006089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92518152|NCT00006089|Trastuzumab|trastuzumab|mesh-list
92518153|NCT00006089|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92518154|NCT00006089|Antibodies|antibodies|mesh-list
92518155|NCT00006089|Immunoglobulins|immunoglobulins|mesh-list
92518156|NCT00006089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92518157|NCT00006089|Immunologic Factors|immunologic factors|mesh-ancestor
92518158|NCT00006089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518159|NCT00006089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518160|NCT00085891|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92518161|NCT00085891|Antidepressive Agents|antidepressive agents|mesh-ancestor
92518162|NCT00085891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352380|NCT03866772|Oxytocics|oxytocics|mesh-ancestor
92518163|NCT00085891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518164|NCT00085891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518165|NCT00085891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518166|NCT00085891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518167|NCT00085969|Exenatide|exenatide|mesh-list
92518168|NCT00085969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92518169|NCT00085969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518170|NCT00085969|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92518171|NCT00085969|Incretins|incretins|mesh-ancestor
92518172|NCT00085969|Hormones|hormones|mesh-ancestor
92518173|NCT00085969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92518174|NCT00086086|Darbepoetin alfa|darbepoetin alfa|mesh-list
92518175|NCT00086086|Hematinics|hematinics|mesh-ancestor
92518176|NCT00006092|Arsenic Trioxide|arsenic trioxide|mesh-list
92518177|NCT00006092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518178|NCT00086125|Sirolimus|sirolimus|mesh-list
92518179|NCT00086125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518180|NCT00086125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518181|NCT00086125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518182|NCT00086125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518183|NCT00086125|Antifungal Agents|antifungal agents|mesh-ancestor
92518184|NCT00086125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518185|NCT00086125|Immunologic Factors|immunologic factors|mesh-ancestor
92518186|NCT00086125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518187|NCT00086203|Rituximab|rituximab|mesh-list
92518188|NCT00086203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518189|NCT00086203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518190|NCT00086203|Immunologic Factors|immunologic factors|mesh-ancestor
92518191|NCT00086203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518192|NCT00086203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518193|NCT00006095|Irinotecan|irinotecan|mesh-list
92518194|NCT00006095|Vincristine|vincristine|mesh-list
92518195|NCT00006095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92518196|NCT00006095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518197|NCT00006095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518198|NCT00006095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518199|NCT00006095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518200|NCT00006095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518201|NCT00006095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518202|NCT00006095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518203|NCT00006095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518204|NCT00086320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92518205|NCT00086320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518206|NCT00086320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518207|NCT00086320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518208|NCT00086320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518209|NCT00086320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518210|NCT00086320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92518211|NCT00086320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92518212|NCT00086320|Serotonin Agents|serotonin agents|mesh-ancestor
92518213|NCT00086320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518214|NCT00086320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518215|NCT00086320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92518216|NCT00086320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92518217|NCT00086320|Dopamine Agents|dopamine agents|mesh-ancestor
92518219|NCT00086359|Lopinavir|lopinavir|mesh-list
92518220|NCT00086359|Lamivudine|lamivudine|mesh-list
92518221|NCT00086359|Zidovudine|zidovudine|mesh-list
92518222|NCT00086359|Abacavir|abacavir|mesh-list
92518223|NCT00086359|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92518224|NCT00086359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92518225|NCT00086359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92518226|NCT00086359|Protease Inhibitors|protease inhibitors|mesh-ancestor
92533341|NCT03216083|Hemostatics|hemostatics|mesh-ancestor
92518227|NCT00086359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518228|NCT00086359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518229|NCT00086359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92518230|NCT00086359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92518231|NCT00086359|Antiviral Agents|antiviral agents|mesh-ancestor
92518232|NCT00086359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518233|NCT00086359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92518234|NCT00086359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92518235|NCT00086359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92518236|NCT00086359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92518237|NCT00086359|Antimetabolites|antimetabolites|mesh-ancestor
92518238|NCT00006098|Bortezomib|bortezomib|mesh-list
92518239|NCT00006098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518240|NCT00086593|Lamotrigine|lamotrigine|mesh-list
92518241|NCT00086593|Anticonvulsants|anticonvulsants|mesh-ancestor
92518242|NCT00086593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92518243|NCT00086593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92518244|NCT00086593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518245|NCT00086593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92518246|NCT00086593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518247|NCT00086593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518248|NCT00086593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518249|NCT00086593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518250|NCT00086593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518251|NCT00086593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92518252|NCT00387569|Vaccines|vaccines|mesh-list
92518253|NCT00387569|Immunologic Factors|immunologic factors|mesh-ancestor
92518254|NCT00387569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518255|NCT04784637|Insulin|insulin|mesh-list
92243171|NCT01657266|Nepafenac|nepafenac|mesh-list
92518257|NCT04784637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518258|NCT00086632|Oregovomab|oregovomab|mesh-list
92518259|NCT00086632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518260|NCT00086632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518261|NCT00086710|Enfuvirtide|enfuvirtide|mesh-list
92518262|NCT00086710|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92518263|NCT00086710|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92518264|NCT00086710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518265|NCT00086710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92518266|NCT00086710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92518267|NCT00086710|Antiviral Agents|antiviral agents|mesh-ancestor
92518268|NCT00086710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518269|NCT00006104|Docetaxel|docetaxel|mesh-list
92518270|NCT00006104|Trastuzumab|trastuzumab|mesh-list
92518271|NCT00006104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518272|NCT00006104|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518273|NCT00006104|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518274|NCT00006104|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518275|NCT00006104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518276|NCT00006104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518277|NCT00086827|Romidepsin|romidepsin|mesh-list
92518278|NCT00086827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518279|NCT00086827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518280|NCT00086827|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92518281|NCT00086827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518282|NCT00086827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518283|NCT00086944|Rituximab|rituximab|mesh-list
92518284|NCT00086944|Carboplatin|carboplatin|mesh-list
92518285|NCT00086944|Etoposide|etoposide|mesh-list
92518286|NCT00086944|Etoposide phosphate|etoposide phosphate|mesh-list
92518287|NCT00086944|Ifosfamide|ifosfamide|mesh-list
92518288|NCT00086944|Oblimersen|oblimersen|mesh-list
92518289|NCT00086944|Lenograstim|lenograstim|mesh-list
92518290|NCT00086944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518291|NCT00086944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518292|NCT00086944|Immunologic Factors|immunologic factors|mesh-ancestor
92518293|NCT00086944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518294|NCT00086944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518295|NCT00086944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518296|NCT00086944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92518297|NCT00086944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518298|NCT00086944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518299|NCT00086944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518300|NCT00086944|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92518301|NCT00086944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518302|NCT00086944|Alkylating Agents|alkylating agents|mesh-ancestor
92518303|NCT00006107|Docetaxel|docetaxel|mesh-list
92518304|NCT00006107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518305|NCT00006107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518306|NCT00006107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518307|NCT00006107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518308|NCT00006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518309|NCT00086983|Oxaliplatin|oxaliplatin|mesh-list
92518310|NCT00086983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518311|NCT00087100|Pemetrexed|pemetrexed|mesh-list
92518312|NCT00087100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518313|NCT00087100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518314|NCT00087100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518315|NCT00087100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92518316|NCT00087100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92518317|NCT00006113|Interferons|interferons|mesh-list
92518318|NCT00006113|Aldesleukin|aldesleukin|mesh-list
92518319|NCT00006113|Interferon-gamma|interferon-gamma|mesh-list
92518320|NCT00006113|Interleukin-4|interleukin-4|mesh-list
92518321|NCT00006113|Sargramostim|sargramostim|mesh-list
92518322|NCT00006113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518323|NCT00006113|Antiviral Agents|antiviral agents|mesh-ancestor
92518324|NCT00006113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518325|NCT00006113|Immunologic Factors|immunologic factors|mesh-ancestor
92518326|NCT00006113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518327|NCT00006113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92518328|NCT00006113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92243306|NCT05299086|Xhance|xhance|mesh-list
92518329|NCT00006113|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92518330|NCT00006113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518331|NCT00087217|Paclitaxel|paclitaxel|mesh-list
92518332|NCT00087217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518333|NCT00087217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518334|NCT00087217|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518335|NCT00087217|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518336|NCT00087217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518337|NCT00087217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518338|NCT00087256|Celecoxib|celecoxib|mesh-list
92518339|NCT00087256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92518340|NCT00087256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92518341|NCT00087256|Analgesics|analgesics|mesh-ancestor
92518342|NCT00087256|Sensory System Agents|sensory system agents|mesh-ancestor
92518343|NCT00087256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518344|NCT00087256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518345|NCT00087256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92518346|NCT00087256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518347|NCT00087256|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92518348|NCT00087256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92518349|NCT00087256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518350|NCT00087256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518351|NCT00006116|Gemcitabine|gemcitabine|mesh-list
92518352|NCT00006116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518353|NCT00006116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518354|NCT00006116|Antimetabolites|antimetabolites|mesh-ancestor
92518355|NCT00006116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518356|NCT00087295|Romidepsin|romidepsin|mesh-list
92518357|NCT00087295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518358|NCT00087295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518359|NCT00087295|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92518360|NCT00087295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518361|NCT00087295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518362|NCT04762953|Leucovorin|leucovorin|mesh-list
92518363|NCT04762953|Paclitaxel|paclitaxel|mesh-list
92518364|NCT04762953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92518365|NCT04762953|Fluorouracil|fluorouracil|mesh-list
92518366|NCT04762953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518367|NCT04762953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518368|NCT04762953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518369|NCT04762953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518370|NCT04762953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533347|NCT00059878|Antiviral Agents|antiviral agents|mesh-ancestor
92518371|NCT04762953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518372|NCT04762953|Antimetabolites|antimetabolites|mesh-ancestor
92518373|NCT04762953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518374|NCT04762953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518375|NCT04762953|Immunologic Factors|immunologic factors|mesh-ancestor
92518376|NCT04762953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518377|NCT04762953|Antidotes|antidotes|mesh-ancestor
92518378|NCT04762953|Protective Agents|protective agents|mesh-ancestor
92518379|NCT04762953|Vitamin B Complex|vitamin b complex|mesh-ancestor
92518381|NCT04762953|Micronutrients|micronutrients|mesh-ancestor
92518382|NCT00087334|Capecitabine|capecitabine|mesh-list
92518383|NCT00087334|Oxaliplatin|oxaliplatin|mesh-list
92518385|NCT00087334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518386|NCT00087334|Antimetabolites|antimetabolites|mesh-ancestor
92518387|NCT00087334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518388|NCT00087334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518389|NCT00087334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518390|NCT00087334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518391|NCT00087373|Metronidazole|metronidazole|mesh-list
92518392|NCT00087373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518393|NCT00087373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518394|NCT00087373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92518395|NCT00087373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92518396|NCT00006119|Hydroxyurea|hydroxyurea|mesh-list
92518397|NCT00006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518398|NCT00006119|Antisickling Agents|antisickling agents|mesh-ancestor
92518399|NCT00006119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518400|NCT00006119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518401|NCT00006119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92518402|NCT00087412|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92518403|NCT00087412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518404|NCT00087412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518405|NCT00087412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518406|NCT00087412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518407|NCT00390078|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92518408|NCT00390078|Antiviral Agents|antiviral agents|mesh-ancestor
92518409|NCT00390078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518410|NCT00006122|Cytarabine|cytarabine|mesh-list
92518411|NCT00006122|Etoposide|etoposide|mesh-list
92518412|NCT00006122|Mitoxantrone|mitoxantrone|mesh-list
92518413|NCT00006122|Idarubicin|idarubicin|mesh-list
92518414|NCT00006122|Gemtuzumab|gemtuzumab|mesh-list
92518415|NCT00006122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518416|NCT00006122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518417|NCT00006122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92518418|NCT00006122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518419|NCT00006122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518420|NCT00006122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518421|NCT00006122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518422|NCT00006122|Antimetabolites|antimetabolites|mesh-ancestor
92518423|NCT00006122|Antiviral Agents|antiviral agents|mesh-ancestor
92518424|NCT00006122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518425|NCT00006122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518426|NCT00006122|Immunologic Factors|immunologic factors|mesh-ancestor
92518427|NCT00006122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518428|NCT00006122|Analgesics|analgesics|mesh-ancestor
92518429|NCT00006122|Sensory System Agents|sensory system agents|mesh-ancestor
92518430|NCT00006122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518431|NCT00006122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518432|NCT00006122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518433|NCT00006122|Immunotoxins|immunotoxins|mesh-ancestor
92518434|NCT00006122|Immunoconjugates|immunoconjugates|mesh-ancestor
92518435|NCT00087802|Paclitaxel|paclitaxel|mesh-list
92518436|NCT00087802|Carboplatin|carboplatin|mesh-list
92518437|NCT00087802|Gemcitabine|gemcitabine|mesh-list
92518438|NCT00087802|Oxaliplatin|oxaliplatin|mesh-list
92518439|NCT00087802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518440|NCT00087802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518441|NCT00087802|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518442|NCT00087802|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518443|NCT00087802|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518444|NCT00087802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518445|NCT00087802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518446|NCT00087802|Antimetabolites|antimetabolites|mesh-ancestor
92518447|NCT00006125|Doxorubicin|doxorubicin|mesh-list
92518448|NCT00006125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92518449|NCT00006125|Topotecan|topotecan|mesh-list
92518450|NCT00006125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518451|NCT00006125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518452|NCT00006125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92518453|NCT00006125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518454|NCT00006125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518455|NCT00006125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518456|NCT00006125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92518457|NCT00087841|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92518458|NCT00087841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518459|NCT00087841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518460|NCT00087880|Bupropion|bupropion|mesh-list
92518461|NCT00087880|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92518462|NCT00087880|Antidepressive Agents|antidepressive agents|mesh-ancestor
92518463|NCT00087880|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518464|NCT00087880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92518465|NCT00087880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92518466|NCT00087880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92518467|NCT00087880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518468|NCT00087880|Dopamine Agents|dopamine agents|mesh-ancestor
92518469|NCT00087880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518470|NCT00087880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518471|NCT00087880|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92518472|NCT00087880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92518473|NCT00087880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518474|NCT00088036|Olanzapine|olanzapine|mesh-list
92518475|NCT00088036|Antiemetics|antiemetics|mesh-ancestor
92518476|NCT00088036|Autonomic Agents|autonomic agents|mesh-ancestor
92518477|NCT00088036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518478|NCT00088036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518479|NCT00088036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92518480|NCT00088036|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518481|NCT00088036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518482|NCT00088036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518483|NCT00088036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518484|NCT00088036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92518485|NCT00088036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92518486|NCT00088036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92518487|NCT00088036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518488|NCT00088036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518489|NCT00088036|Serotonin Agents|serotonin agents|mesh-ancestor
92518490|NCT00088075|Risperidone|risperidone|mesh-list
92518491|NCT00088075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92518492|NCT00088075|Serotonin Agents|serotonin agents|mesh-ancestor
92518493|NCT00088075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518494|NCT00088075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518495|NCT00088075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518496|NCT00088075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518497|NCT00088075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518498|NCT00088075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518499|NCT00088075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518500|NCT00088075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92518501|NCT00088075|Dopamine Agents|dopamine agents|mesh-ancestor
92518502|NCT00088114|Paclitaxel|paclitaxel|mesh-list
92518503|NCT00088114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518504|NCT00088114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518505|NCT00088114|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518506|NCT00088114|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518507|NCT00088114|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518508|NCT00088114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518509|NCT00006131|Valacyclovir|valacyclovir|mesh-list
92518510|NCT00006131|Antiviral Agents|antiviral agents|mesh-ancestor
92518511|NCT00006131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518512|NCT00088231|Imatinib Mesylate|imatinib mesylate|mesh-list
92518513|NCT00088231|Vatalanib|vatalanib|mesh-list
92518514|NCT00088231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518515|NCT00088231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518516|NCT00088231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518517|NCT00088231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518520|NCT00088270|Antimetabolites|antimetabolites|mesh-ancestor
92518521|NCT00088270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518522|NCT00088270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518523|NCT00088270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518524|NCT00088270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518525|NCT00088270|Immunologic Factors|immunologic factors|mesh-ancestor
92518526|NCT00088270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518527|NCT00088270|Antidotes|antidotes|mesh-ancestor
92518528|NCT00088270|Protective Agents|protective agents|mesh-ancestor
92518529|NCT00088270|Vitamin B Complex|vitamin b complex|mesh-ancestor
92518530|NCT00088270|Vitamins|vitamins|mesh-ancestor
92518531|NCT00088270|Micronutrients|micronutrients|mesh-ancestor
92518532|NCT00088387|Valproic Acid|valproic acid|mesh-list
92518533|NCT00088387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518534|NCT00088387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518535|NCT00088387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518536|NCT00088387|Antimanic Agents|antimanic agents|mesh-ancestor
92518537|NCT00088387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518538|NCT00088387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518539|NCT00088387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518540|NCT00088387|Anticonvulsants|anticonvulsants|mesh-ancestor
92518541|NCT00088387|GABA Agents|gaba agents|mesh-ancestor
92518542|NCT00088387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518543|NCT00088504|Interferons|interferons|mesh-list
92518544|NCT00088504|Ribavirin|ribavirin|mesh-list
92518545|NCT00088504|Interferon-alpha|interferon-alpha|mesh-list
92518546|NCT00088504|Interferon alpha-2|interferon alpha-2|mesh-list
92518547|NCT00088504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92518548|NCT00088504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518549|NCT00088504|Antiviral Agents|antiviral agents|mesh-ancestor
92518550|NCT00088504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518551|NCT00088504|Antimetabolites|antimetabolites|mesh-ancestor
92518552|NCT00088504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518553|NCT00088504|Immunologic Factors|immunologic factors|mesh-ancestor
92518554|NCT00088504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518555|NCT00006137|Enalapril|enalapril|mesh-list
92518556|NCT00006137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92518557|NCT00006137|Protease Inhibitors|protease inhibitors|mesh-ancestor
92518558|NCT00006137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518559|NCT00006137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518560|NCT00006137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92518562|NCT00088543|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92518563|NCT00088543|Immunologic Factors|immunologic factors|mesh-ancestor
92518564|NCT00088543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518565|NCT00088543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518566|NCT00088582|Octreotide|octreotide|mesh-list
92518567|NCT00088582|Pasireotide|pasireotide|mesh-list
92518568|NCT00088582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92518569|NCT00088582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92518570|NCT00088582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518571|NCT00088582|Hormones|hormones|mesh-ancestor
92518572|NCT00088582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92518573|NCT00088582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518574|NCT00088816|Tegafur|tegafur|mesh-list
92518575|NCT00088816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352420|NCT03749070|Silymarin|silymarin|mesh-list
92518576|NCT00088816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518577|NCT00088816|Antimetabolites|antimetabolites|mesh-ancestor
92518578|NCT00088816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518579|NCT04688736|Chlorpheniramine|chlorpheniramine|mesh-list
92518580|NCT04688736|Antipruritics|antipruritics|mesh-ancestor
92518581|NCT04688736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92518582|NCT04688736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92518583|NCT04688736|Histamine Antagonists|histamine antagonists|mesh-ancestor
92518584|NCT04688736|Histamine Agents|histamine agents|mesh-ancestor
92518585|NCT04688736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518586|NCT04688736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518587|NCT04688736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518588|NCT04688736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92518589|NCT00088855|Doxorubicin|doxorubicin|mesh-list
92518590|NCT00088855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92518591|NCT00088855|Bortezomib|bortezomib|mesh-list
92518592|NCT00088855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518593|NCT00088855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518594|NCT00088855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92518595|NCT00088855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518596|NCT00088855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518597|NCT00088855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518599|NCT00088894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92518600|NCT00088894|Gemcitabine|gemcitabine|mesh-list
92518601|NCT00088894|Antibodies|antibodies|mesh-list
92518602|NCT00088894|Immunoglobulins|immunoglobulins|mesh-list
92518603|NCT00088894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92518604|NCT00088894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518605|NCT00088894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92518606|NCT00088894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92518607|NCT00088894|Growth Substances|growth substances|mesh-ancestor
92518608|NCT00088894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518609|NCT00088894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92518610|NCT00088894|Immunologic Factors|immunologic factors|mesh-ancestor
92518611|NCT00088894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518612|NCT00088894|Antimetabolites|antimetabolites|mesh-ancestor
92518613|NCT00088894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518614|NCT00006152|Ritonavir|ritonavir|mesh-list
92518615|NCT00006152|Amprenavir|amprenavir|mesh-list
92518616|NCT00006152|Abacavir|abacavir|mesh-list
92518617|NCT00006152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92518618|NCT00006152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92518619|NCT00006152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92518620|NCT00006152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518621|NCT00006152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518622|NCT00006152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92518623|NCT00006152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92518624|NCT00006152|Antiviral Agents|antiviral agents|mesh-ancestor
92518625|NCT00006152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518626|NCT00006152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92518627|NCT00006152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92518628|NCT00006152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92518629|NCT00006152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92518630|NCT00006152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92518631|NCT00006152|Antitubercular Agents|antitubercular agents|mesh-ancestor
92518632|NCT00006152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518633|NCT00088933|Metronidazole|metronidazole|mesh-list
92518634|NCT00088933|Docetaxel|docetaxel|mesh-list
92518635|NCT00088933|Vaccines|vaccines|mesh-list
92518636|NCT00088933|Sargramostim|sargramostim|mesh-list
92518637|NCT00088933|Immunologic Factors|immunologic factors|mesh-ancestor
92518638|NCT00088933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518639|NCT00088933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518640|NCT00088933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518641|NCT00088933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518642|NCT00088933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518643|NCT00088933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518644|NCT00088933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518645|NCT00088933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518646|NCT00088933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92518647|NCT00088933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92518648|NCT00089050|Cyclosporine|cyclosporine|mesh-list
92518649|NCT00089050|Gemtuzumab|gemtuzumab|mesh-list
92518650|NCT00089050|Cyclosporins|cyclosporins|mesh-list
92518651|NCT00089050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518652|NCT00089050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518653|NCT00089050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518654|NCT00089050|Immunologic Factors|immunologic factors|mesh-ancestor
92518655|NCT00089050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518656|NCT00089050|Antifungal Agents|antifungal agents|mesh-ancestor
92518657|NCT00089050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518658|NCT00089050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92518659|NCT00089050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518660|NCT00089050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92518661|NCT00089050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518662|NCT00089050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518663|NCT00089050|Immunotoxins|immunotoxins|mesh-ancestor
92518664|NCT00089050|Immunoconjugates|immunoconjugates|mesh-ancestor
92518665|NCT00006155|Carboplatin|carboplatin|mesh-list
92518666|NCT00006155|Semaxinib|semaxinib|mesh-list
92518667|NCT00006155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518668|NCT00006155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92518669|NCT00006155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92518670|NCT00006155|Growth Substances|growth substances|mesh-ancestor
92518671|NCT00006155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518672|NCT00006155|Growth Inhibitors|growth inhibitors|mesh-ancestor
92518673|NCT00006155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518674|NCT00006155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518675|NCT00006155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518676|NCT00089089|Decitabine|decitabine|mesh-list
92518677|NCT00089089|Azacitidine|azacitidine|mesh-list
92518678|NCT00089089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518679|NCT00089089|Antimetabolites|antimetabolites|mesh-ancestor
92518680|NCT00089089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518681|NCT00089089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518682|NCT00089089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518683|NCT00089167|Thalidomide|thalidomide|mesh-list
92518684|NCT00089167|Dexamethasone|dexamethasone|mesh-list
92518685|NCT00089167|Melphalan|melphalan|mesh-list
92518686|NCT00089167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92518687|NCT00089167|Antiemetics|antiemetics|mesh-ancestor
92518688|NCT00089167|Autonomic Agents|autonomic agents|mesh-ancestor
92518689|NCT00089167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518690|NCT00089167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518691|NCT00089167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92518692|NCT00089167|Glucocorticoids|glucocorticoids|mesh-ancestor
92518693|NCT00089167|Hormones|hormones|mesh-ancestor
92518694|NCT00089167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92518695|NCT00089167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92518696|NCT00089167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518697|NCT00089167|Immunologic Factors|immunologic factors|mesh-ancestor
92518698|NCT00089167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518699|NCT00089167|Alkylating Agents|alkylating agents|mesh-ancestor
92518700|NCT00089167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518701|NCT00089167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518702|NCT00089167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518703|NCT00089167|Leprostatic Agents|leprostatic agents|mesh-ancestor
92518704|NCT00089167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518705|NCT00089167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518706|NCT00089167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92518707|NCT00089167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92518708|NCT00089167|Growth Substances|growth substances|mesh-ancestor
92518709|NCT00089167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92518710|NCT00089206|Sargramostim|sargramostim|mesh-list
92518711|NCT00089206|Freund's Adjuvant|freund's adjuvant|mesh-list
92518712|NCT00089206|Immunologic Factors|immunologic factors|mesh-ancestor
92518713|NCT00089206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518714|NCT00089206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92518715|NCT00400231|Metformin|metformin|mesh-list
92518716|NCT00400231|Fenofibrate|fenofibrate|mesh-list
92518717|NCT00400231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92518718|NCT00400231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518719|NCT00400231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92518720|NCT00400231|Antimetabolites|antimetabolites|mesh-ancestor
92518721|NCT00400231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518722|NCT00400231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92518723|NCT00006158|Testosterone|testosterone|mesh-list
92518724|NCT00006158|Androgens|androgens|mesh-ancestor
92518725|NCT00006158|Hormones|hormones|mesh-ancestor
92518726|NCT00006158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92518727|NCT00006158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518728|NCT00423826|Cytarabine|cytarabine|mesh-list
92518729|NCT00423826|Mycophenolic Acid|mycophenolic acid|mesh-list
92518730|NCT00423826|Fludarabine|fludarabine|mesh-list
92518731|NCT00423826|Fludarabine phosphate|fludarabine phosphate|mesh-list
92518732|NCT00423826|Busulfan|busulfan|mesh-list
92518733|NCT00423826|Tacrolimus|tacrolimus|mesh-list
92518734|NCT00423826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518735|NCT00423826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518736|NCT00423826|Antimetabolites|antimetabolites|mesh-ancestor
92518737|NCT00423826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518738|NCT00423826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518739|NCT00423826|Immunologic Factors|immunologic factors|mesh-ancestor
92518740|NCT00423826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518741|NCT00423826|Antiviral Agents|antiviral agents|mesh-ancestor
92518742|NCT00423826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518743|NCT00423826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92518744|NCT00423826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200594|NCT03389750|Oxymorphone|oxymorphone|mesh-list
92518745|NCT00423826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518746|NCT00423826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92518747|NCT00423826|Antitubercular Agents|antitubercular agents|mesh-ancestor
92518748|NCT00423826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518749|NCT00423826|Alkylating Agents|alkylating agents|mesh-ancestor
92518750|NCT00423826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518751|NCT00423826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518752|NCT00423865|Everolimus|everolimus|mesh-list
92518753|NCT00423865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518754|NCT00423865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92518755|NCT00423865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518756|NCT00423865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518757|NCT00423865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518758|NCT00423865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518759|NCT00423865|Immunologic Factors|immunologic factors|mesh-ancestor
92518760|NCT00423865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518761|NCT00423982|Vancomycin|vancomycin|mesh-list
92518762|NCT00423982|Rifampin|rifampin|mesh-list
92518763|NCT00423982|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92518764|NCT00423982|Cloxacillin|cloxacillin|mesh-list
92518765|NCT00423982|Anti-Infective Agents|anti-infective agents|mesh-list
92518766|NCT00423982|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92518767|NCT00423982|Antitubercular Agents|antitubercular agents|mesh-ancestor
92518768|NCT00423982|Leprostatic Agents|leprostatic agents|mesh-ancestor
92518769|NCT00423982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92518770|NCT00423982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518771|NCT00423982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518772|NCT00423982|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92518773|NCT00423982|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92518774|NCT00423982|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92518775|NCT00423982|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92518776|NCT00423982|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92518777|NCT00423982|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92518778|NCT02965261|Fluoxetine|fluoxetine|mesh-list
92518779|NCT02965261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92518780|NCT02965261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92518781|NCT02965261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92518782|NCT02965261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518783|NCT02965261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518784|NCT02965261|Serotonin Agents|serotonin agents|mesh-ancestor
92518785|NCT02965261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518786|NCT02965261|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92518787|NCT02965261|Antidepressive Agents|antidepressive agents|mesh-ancestor
92518788|NCT02965261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518789|NCT02965261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92518790|NCT02965261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92518791|NCT02965261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518792|NCT00390156|Cyclophosphamide|cyclophosphamide|mesh-list
92518794|NCT00390156|Imatinib Mesylate|imatinib mesylate|mesh-list
92518795|NCT00390156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518796|NCT00390156|Immunologic Factors|immunologic factors|mesh-ancestor
92518797|NCT00390156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518798|NCT00390156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92518799|NCT00390156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518800|NCT00390156|Alkylating Agents|alkylating agents|mesh-ancestor
92518801|NCT00390156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518802|NCT00390156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518803|NCT00390156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518804|NCT00390156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518805|NCT00390156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92518806|NCT00390156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92518807|NCT00390156|Growth Substances|growth substances|mesh-ancestor
92518808|NCT00390156|Growth Inhibitors|growth inhibitors|mesh-ancestor
92518809|NCT00390156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518810|NCT00390156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518812|NCT00089401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92518813|NCT00089401|Alkylating Agents|alkylating agents|mesh-ancestor
92518814|NCT00089401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518815|NCT00089401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200595|NCT03389750|Morphine|morphine|mesh-list
92518816|NCT00089401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92518817|NCT00089401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518818|NCT00089401|Immunologic Factors|immunologic factors|mesh-ancestor
92518819|NCT00089401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518821|NCT00089440|Antidepressive Agents|antidepressive agents|mesh-ancestor
92518822|NCT00089440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518823|NCT00089440|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518824|NCT00089440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518825|NCT00089440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518826|NCT00089440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518827|NCT00089440|Dopamine Agonists|dopamine agonists|mesh-ancestor
92518828|NCT00089440|Dopamine Agents|dopamine agents|mesh-ancestor
92518829|NCT00089440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518830|NCT00089440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518831|NCT00089440|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92518832|NCT00089440|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92518833|NCT00089440|Serotonin Agents|serotonin agents|mesh-ancestor
92518834|NCT00089440|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92518835|NCT00089440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92518836|NCT00089440|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92518837|NCT00089440|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92518838|NCT00089518|Valsartan|valsartan|mesh-list
92518839|NCT00089518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92518840|NCT00089518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92518841|NCT00089518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92518842|NCT00089518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518843|NCT00089557|Capsaicin|capsaicin|mesh-list
92518844|NCT00089557|Antipruritics|antipruritics|mesh-ancestor
92518845|NCT00089557|Dermatologic Agents|dermatologic agents|mesh-ancestor
92518846|NCT00089557|Sensory System Agents|sensory system agents|mesh-ancestor
92518847|NCT00089557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518848|NCT00089557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518849|NCT00087451|Sirolimus|sirolimus|mesh-list
92518850|NCT00087451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518851|NCT00087451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518852|NCT00087451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518853|NCT00087451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518854|NCT00087451|Antifungal Agents|antifungal agents|mesh-ancestor
92518855|NCT00087451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518856|NCT00087451|Immunologic Factors|immunologic factors|mesh-ancestor
92518857|NCT00087451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518859|NCT00089830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518860|NCT00089830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518861|NCT00089830|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92518862|NCT00089830|Protective Agents|protective agents|mesh-ancestor
92518863|NCT00089830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518864|NCT00089830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518865|NCT00089830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92518866|NCT00089830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92518867|NCT00089830|Growth Substances|growth substances|mesh-ancestor
92518868|NCT00089830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92518869|NCT00089869|Olanzapine|olanzapine|mesh-list
92518870|NCT00089869|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92518871|NCT00089869|Antiemetics|antiemetics|mesh-ancestor
92518872|NCT00089869|Autonomic Agents|autonomic agents|mesh-ancestor
92518873|NCT00089869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518874|NCT00089869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518875|NCT00089869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92518876|NCT00089869|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92518877|NCT00089869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92518878|NCT00089869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92518879|NCT00089869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92518880|NCT00089869|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92518881|NCT00089869|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92518882|NCT00089869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92518883|NCT00089869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518884|NCT00089869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92518885|NCT00089869|Serotonin Agents|serotonin agents|mesh-ancestor
92518886|NCT00089869|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92518887|NCT00089869|Adrenergic Agents|adrenergic agents|mesh-ancestor
92518888|NCT00006167|Oxandrolone|oxandrolone|mesh-list
92518889|NCT00006167|Androgens|androgens|mesh-ancestor
92518890|NCT00006167|Hormones|hormones|mesh-ancestor
92518891|NCT00006167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92518892|NCT00006167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518894|NCT00089947|Thymoglobulin|thymoglobulin|mesh-list
92518895|NCT00089947|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92518896|NCT00089947|Immunologic Factors|immunologic factors|mesh-ancestor
92518897|NCT00089947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518898|NCT00089947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518899|NCT00090025|Leucovorin|leucovorin|mesh-list
92518900|NCT00090025|Fluorouracil|fluorouracil|mesh-list
92518901|NCT00090025|Antimetabolites|antimetabolites|mesh-ancestor
92518902|NCT00090025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518903|NCT00090025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518904|NCT00090025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518905|NCT00090025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518906|NCT00090025|Immunologic Factors|immunologic factors|mesh-ancestor
92518907|NCT00090025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518908|NCT00090025|Antidotes|antidotes|mesh-ancestor
92518909|NCT00090025|Protective Agents|protective agents|mesh-ancestor
92518910|NCT00090025|Vitamin B Complex|vitamin b complex|mesh-ancestor
92518911|NCT00090025|Vitamins|vitamins|mesh-ancestor
92518912|NCT00090025|Micronutrients|micronutrients|mesh-ancestor
92518913|NCT04633902|Pembrolizumab|pembrolizumab|mesh-list
92518914|NCT04633902|Olaparib|olaparib|mesh-list
92518915|NCT04633902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518916|NCT04633902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518917|NCT04633902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92518918|NCT04633902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518919|NCT04633902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92518920|NCT04633902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518922|NCT00090727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518923|NCT00006185|Rosiglitazone|rosiglitazone|mesh-list
92518924|NCT00006185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92518925|NCT00006185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518926|NCT00091039|Metronidazole|metronidazole|mesh-list
92518927|NCT00091039|Paclitaxel|paclitaxel|mesh-list
92518928|NCT00091039|Carboplatin|carboplatin|mesh-list
92518929|NCT00091039|Vaccines|vaccines|mesh-list
92518930|NCT00091039|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
92243844|NCT00457730|Analgesics|analgesics|mesh-ancestor
92518931|NCT00091039|Immunologic Factors|immunologic factors|mesh-ancestor
92518932|NCT00091039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518933|NCT00091039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92518934|NCT00091039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518935|NCT00091039|Tubulin Modulators|tubulin modulators|mesh-ancestor
92518936|NCT00091039|Antimitotic Agents|antimitotic agents|mesh-ancestor
92518937|NCT00091039|Mitosis Modulators|mitosis modulators|mesh-ancestor
92518938|NCT00091039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518939|NCT00091039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92518940|NCT00091039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92518941|NCT00091039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92518942|NCT00091039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92518943|NCT00091039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92518944|NCT00091078|Imatinib Mesylate|imatinib mesylate|mesh-list
92518945|NCT00091078|Oblimersen|oblimersen|mesh-list
92518946|NCT00091078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518947|NCT00091078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518949|NCT00091078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518950|NCT00091117|Bortezomib|bortezomib|mesh-list
92518951|NCT00091117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518952|NCT00091156|Gefitinib|gefitinib|mesh-list
92518953|NCT00091156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518954|NCT00091156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92518955|NCT00091156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518956|NCT00091156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518957|NCT00091195|Romidepsin|romidepsin|mesh-list
92518958|NCT00091195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92518959|NCT00091195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518960|NCT00091195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92518961|NCT00091195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518962|NCT00091195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518963|NCT00091234|Gemtuzumab|gemtuzumab|mesh-list
92518964|NCT00091234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92518965|NCT00091234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518966|NCT00091234|Immunotoxins|immunotoxins|mesh-ancestor
92518967|NCT00091234|Immunoconjugates|immunoconjugates|mesh-ancestor
92518968|NCT00091234|Immunologic Factors|immunologic factors|mesh-ancestor
92518969|NCT00091234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518970|NCT00091312|Leucovorin|leucovorin|mesh-list
92518971|NCT00091312|Fluorouracil|fluorouracil|mesh-list
92518972|NCT00091312|Irinotecan|irinotecan|mesh-list
92518973|NCT00091312|Calcium|calcium|mesh-list
92518974|NCT00091312|Levoleucovorin|levoleucovorin|mesh-list
92518975|NCT00091312|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92518976|NCT00091312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518977|NCT00091312|Antimetabolites|antimetabolites|mesh-ancestor
92518978|NCT00091312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92518979|NCT00091312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92518980|NCT00091312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92518981|NCT00091312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92518982|NCT00091312|Immunologic Factors|immunologic factors|mesh-ancestor
92518983|NCT00091312|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92518984|NCT00091312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92518985|NCT00091312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92518986|NCT00091312|Antidotes|antidotes|mesh-ancestor
92518987|NCT00091312|Protective Agents|protective agents|mesh-ancestor
92518988|NCT00091312|Vitamin B Complex|vitamin b complex|mesh-ancestor
92518989|NCT00091312|Vitamins|vitamins|mesh-ancestor
92518990|NCT00091312|Micronutrients|micronutrients|mesh-ancestor
92518991|NCT04619706|Palmidrol|palmidrol|mesh-list
92518992|NCT04619706|Analgesics|analgesics|mesh-ancestor
92518993|NCT04619706|Sensory System Agents|sensory system agents|mesh-ancestor
92518994|NCT04619706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92518995|NCT04619706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92518996|NCT04619706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92518997|NCT04619706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92518998|NCT04619706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92518999|NCT04619706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519000|NCT04619706|Antiviral Agents|antiviral agents|mesh-ancestor
92519001|NCT04619706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519002|NCT04619706|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92519003|NCT04619706|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92519004|NCT04619706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519005|NCT04619706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519006|NCT04619706|Hormones|hormones|mesh-ancestor
92519007|NCT04619706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92519008|NCT00091429|Ranolazine|ranolazine|mesh-list
92519009|NCT00091429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92519010|NCT00091429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519011|NCT00091429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519012|NCT00091468|Nicotine|nicotine|mesh-list
92519013|NCT00091468|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92519014|NCT00091468|Autonomic Agents|autonomic agents|mesh-ancestor
92519015|NCT00091468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519016|NCT00091468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519017|NCT00091468|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92519018|NCT00091468|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92519019|NCT00091468|Cholinergic Agents|cholinergic agents|mesh-ancestor
92533377|NCT02968927|Vitamin D|vitamin d|mesh-list
92519020|NCT00091468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519021|NCT00091468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519022|NCT00006200|Thalidomide|thalidomide|mesh-list
92519023|NCT00006200|Dacarbazine|dacarbazine|mesh-list
92519024|NCT00006200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519025|NCT00006200|Immunologic Factors|immunologic factors|mesh-ancestor
92519026|NCT00006200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519027|NCT00006200|Leprostatic Agents|leprostatic agents|mesh-ancestor
92519028|NCT00006200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519029|NCT00006200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519030|NCT00006200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519031|NCT00006200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519032|NCT00006200|Growth Substances|growth substances|mesh-ancestor
92519033|NCT00006200|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519034|NCT00006200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519035|NCT00006200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92519036|NCT00006200|Alkylating Agents|alkylating agents|mesh-ancestor
92519037|NCT00006200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519038|NCT00006203|Naltrexone|naltrexone|mesh-list
92519039|NCT00006203|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92519040|NCT00006203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92519041|NCT00006203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519042|NCT00006203|Sensory System Agents|sensory system agents|mesh-ancestor
92519043|NCT00006203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519045|NCT00091624|Immunologic Factors|immunologic factors|mesh-ancestor
92519046|NCT00091624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519047|NCT00091624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519048|NCT00091624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519049|NCT00091624|Growth Substances|growth substances|mesh-ancestor
92519050|NCT00091624|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519051|NCT00091624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519052|NCT00091663|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92519053|NCT00091663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519054|NCT00091663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519055|NCT00091663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519056|NCT00091663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519057|NCT00006206|Naltrexone|naltrexone|mesh-list
92519058|NCT00006206|Acamprosate|acamprosate|mesh-list
92519059|NCT00006206|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92519060|NCT00006206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92519061|NCT00006206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519062|NCT00006206|Sensory System Agents|sensory system agents|mesh-ancestor
92519063|NCT00006206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519064|NCT00091702|Vaccines|vaccines|mesh-list
92519065|NCT00091702|Immunologic Factors|immunologic factors|mesh-ancestor
92519066|NCT00091702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519067|NCT00091741|Etanercept|etanercept|mesh-list
92519068|NCT00091741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92519069|NCT00091741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92519070|NCT00091741|Analgesics|analgesics|mesh-ancestor
92519071|NCT00091741|Sensory System Agents|sensory system agents|mesh-ancestor
92519072|NCT00091741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519073|NCT00091741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519074|NCT00091741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92519075|NCT00091741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519076|NCT00091741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519077|NCT00091741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519078|NCT00091741|Immunologic Factors|immunologic factors|mesh-ancestor
92519079|NCT00091858|Darbepoetin alfa|darbepoetin alfa|mesh-list
92519080|NCT00091858|Hematinics|hematinics|mesh-ancestor
92519081|NCT00390195|Everolimus|everolimus|mesh-list
92519082|NCT00390195|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92519083|NCT00390195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519084|NCT00390195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519085|NCT00390195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519086|NCT00390195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519087|NCT00390195|Immunologic Factors|immunologic factors|mesh-ancestor
92519088|NCT00390195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519089|NCT00390195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519090|NCT00091897|Rituximab|rituximab|mesh-list
92519091|NCT00091897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92519092|NCT00091897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352522|NCT03834948|Pembrolizumab|pembrolizumab|mesh-list
92519093|NCT00091897|Immunologic Factors|immunologic factors|mesh-ancestor
92519094|NCT00091897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519095|NCT00091897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519096|NCT00006212|Vinblastine|vinblastine|mesh-list
92519097|NCT00006212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519098|NCT00006212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519099|NCT00006212|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519100|NCT00006212|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519101|NCT00006212|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519102|NCT00006212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519103|NCT00091936|Lamivudine|lamivudine|mesh-list
92519104|NCT00091936|Efavirenz|efavirenz|mesh-list
92519105|NCT00091936|Didanosine|didanosine|mesh-list
92519106|NCT00091936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92519107|NCT00091936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92519108|NCT00091936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519109|NCT00091936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519110|NCT00091936|Antiviral Agents|antiviral agents|mesh-ancestor
92519111|NCT00091936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519112|NCT00091936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92519113|NCT00091936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92519114|NCT00091936|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92519115|NCT00091936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92519116|NCT00091936|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92519117|NCT00091936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92519118|NCT00091936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92519119|NCT00091936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92519120|NCT00091936|Antimetabolites|antimetabolites|mesh-ancestor
92519121|NCT02972346|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92519122|NCT02972346|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92519123|NCT02972346|beta-Endorphin|beta-endorphin|mesh-list
92519124|NCT02972346|Hormones|hormones|mesh-ancestor
92519125|NCT02972346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92519126|NCT02972346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519127|NCT02972346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519128|NCT02972346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519129|NCT00092170|Clavulanic Acid|clavulanic acid|mesh-list
92519130|NCT00092170|Clavulanic Acids|clavulanic acids|mesh-list
92519131|NCT00092170|Ertapenem|ertapenem|mesh-list
92519132|NCT00092170|Ticarcillin|ticarcillin|mesh-list
92519133|NCT00092170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92519134|NCT00092170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519135|NCT00092170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519136|NCT00092170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519137|NCT00092170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519138|NCT00006215|Docetaxel|docetaxel|mesh-list
92519139|NCT00006215|Vinorelbine|vinorelbine|mesh-list
92519140|NCT00006215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519141|NCT00006215|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519142|NCT00006215|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519143|NCT00006215|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519144|NCT00006215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519145|NCT00006215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519146|NCT00092287|Lanreotide|lanreotide|mesh-list
92519147|NCT00092287|Octreotide|octreotide|mesh-list
92519148|NCT00092287|Somatostatin|somatostatin|mesh-list
92519149|NCT00092287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519150|NCT00092287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519151|NCT00092287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92519152|NCT00092287|Hormones|hormones|mesh-ancestor
92519153|NCT00092287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92519154|NCT00092287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519155|NCT00092326|Acetaminophen|acetaminophen|mesh-list
92519156|NCT00092326|Rofecoxib|rofecoxib|mesh-list
92519157|NCT00092326|Oxycodone|oxycodone|mesh-list
92519158|NCT00092326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92519159|NCT00092326|Analgesics|analgesics|mesh-ancestor
92519160|NCT00092326|Sensory System Agents|sensory system agents|mesh-ancestor
92519161|NCT00092326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519162|NCT00092326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519163|NCT00092326|Antipyretics|antipyretics|mesh-ancestor
92519164|NCT00092326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92519165|NCT00092326|Narcotics|narcotics|mesh-ancestor
92519166|NCT00092326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519167|NCT00092326|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92519168|NCT00092326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92519169|NCT00092326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519170|NCT00092326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519171|NCT00092326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92519172|NCT00092326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92519173|NCT00092326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519174|NCT00092365|Celecoxib|celecoxib|mesh-list
92519175|NCT00092365|Rofecoxib|rofecoxib|mesh-list
92519176|NCT00092365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92519177|NCT00092365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92519178|NCT00092365|Analgesics|analgesics|mesh-ancestor
92519179|NCT00092365|Sensory System Agents|sensory system agents|mesh-ancestor
92519180|NCT00092365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519181|NCT00092365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519182|NCT00092365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92519183|NCT00092365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519184|NCT00092365|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92519185|NCT00092365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92519186|NCT00092365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519187|NCT00092365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519188|NCT00092404|Vaccines|vaccines|mesh-list
92519189|NCT00092404|Immunologic Factors|immunologic factors|mesh-ancestor
92519190|NCT00092404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519191|NCT04728880|Remdesivir|remdesivir|mesh-list
92519192|NCT04728880|Antimetabolites|antimetabolites|mesh-ancestor
92519193|NCT04728880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519194|NCT04728880|Antiviral Agents|antiviral agents|mesh-ancestor
92519195|NCT04728880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519196|NCT00093028|Bortezomib|bortezomib|mesh-list
92519197|NCT00093028|Lenalidomide|lenalidomide|mesh-list
92519198|NCT00093028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519199|NCT00093028|Immunologic Factors|immunologic factors|mesh-ancestor
92519200|NCT00093028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519201|NCT00093028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519202|NCT00093028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519203|NCT00093028|Growth Substances|growth substances|mesh-ancestor
92519204|NCT00093028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519205|NCT00093067|Daptomycin|daptomycin|mesh-list
92519206|NCT00093067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519207|NCT00093067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519208|NCT00093184|Anticoagulants|anticoagulants|mesh-list
92519209|NCT00093184|Bivalirudin|bivalirudin|mesh-list
92519210|NCT00093184|Antithrombins|antithrombins|mesh-ancestor
92519211|NCT00093184|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92519212|NCT00093184|Protease Inhibitors|protease inhibitors|mesh-ancestor
92519213|NCT00093184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519214|NCT00093184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519215|NCT00006224|Gemcitabine|gemcitabine|mesh-list
92519216|NCT00006224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519217|NCT00006224|Antimetabolites|antimetabolites|mesh-ancestor
92519218|NCT00006224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519219|NCT00006224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519220|NCT00093223|Paclitaxel|paclitaxel|mesh-list
92519221|NCT00093223|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92519222|NCT00093223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519223|NCT00093223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519224|NCT00093223|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519225|NCT00093223|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519226|NCT00093223|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519227|NCT00093223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519228|NCT00093262|Clevidipine|clevidipine|mesh-list
92519229|NCT00093262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92519230|NCT00093262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519231|NCT00093262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519232|NCT00093262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92244137|NCT05168280|Analgesics|analgesics|mesh-ancestor
92519233|NCT00093262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519234|NCT00093301|Simendan|simendan|mesh-list
92519235|NCT00093301|Dobutamine|dobutamine|mesh-list
92352531|NCT01677468|Doxorubicin|doxorubicin|mesh-list
92519236|NCT00093301|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92519237|NCT00093301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92519238|NCT00093301|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92519240|NCT00093301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519241|NCT00093301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519242|NCT00093301|Protective Agents|protective agents|mesh-ancestor
92519243|NCT00093301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519244|NCT00093301|Sympathomimetics|sympathomimetics|mesh-ancestor
92519245|NCT00093301|Autonomic Agents|autonomic agents|mesh-ancestor
92519246|NCT00093301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519247|NCT00093301|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92519248|NCT00093301|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92519249|NCT00093301|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92519250|NCT00093301|Adrenergic Agents|adrenergic agents|mesh-ancestor
92519251|NCT00093301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519252|NCT00093418|Tipifarnib|tipifarnib|mesh-list
92519253|NCT00093418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519254|NCT00387608|Veliparib|veliparib|mesh-list
92519255|NCT00387608|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92519256|NCT00387608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519257|NCT00387608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519258|NCT00387608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519259|NCT00093457|Sorafenib|sorafenib|mesh-list
92519260|NCT00093457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519261|NCT00093457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519262|NCT00093457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519263|NCT00093457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519264|NCT00093613|Sorafenib|sorafenib|mesh-list
92519265|NCT00093613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519266|NCT00093613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519267|NCT00093613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519268|NCT00093613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519269|NCT00093652|Oxaliplatin|oxaliplatin|mesh-list
92519270|NCT00093652|Gefitinib|gefitinib|mesh-list
92519271|NCT00093652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519272|NCT00093652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519273|NCT00093652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519274|NCT00093652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519275|NCT00006230|Rubitecan|rubitecan|mesh-list
92519276|NCT00006230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519277|NCT00006230|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92519278|NCT00006230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92519279|NCT00006230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519280|NCT00006230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519281|NCT00093769|Rituximab|rituximab|mesh-list
92519282|NCT00093769|Bortezomib|bortezomib|mesh-list
92519283|NCT00093769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92519284|NCT00093769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519285|NCT00093769|Immunologic Factors|immunologic factors|mesh-ancestor
92519286|NCT00093769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519287|NCT00093769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519288|NCT00400348|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92519289|NCT00400348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519290|NCT00400348|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519291|NCT00400348|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519292|NCT00400348|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519293|NCT00400348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519294|NCT00006233|Cyclosporine|cyclosporine|mesh-list
92519295|NCT00006233|Mycophenolic Acid|mycophenolic acid|mesh-list
92519296|NCT00006233|Fludarabine|fludarabine|mesh-list
92519297|NCT00006233|Fludarabine phosphate|fludarabine phosphate|mesh-list
92519298|NCT00006233|Cyclosporins|cyclosporins|mesh-list
92519299|NCT00006233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519300|NCT00006233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519301|NCT00006233|Antimetabolites|antimetabolites|mesh-ancestor
92519302|NCT00006233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519303|NCT00006233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519304|NCT00006233|Immunologic Factors|immunologic factors|mesh-ancestor
92519305|NCT00006233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519306|NCT00006233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519307|NCT00006233|Antifungal Agents|antifungal agents|mesh-ancestor
92519308|NCT00006233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519309|NCT00006233|Dermatologic Agents|dermatologic agents|mesh-ancestor
92519310|NCT00006233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519311|NCT00006233|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92519312|NCT00006233|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92519313|NCT00006233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92519314|NCT00006233|Antitubercular Agents|antitubercular agents|mesh-ancestor
92519315|NCT00006233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519316|NCT02964715|Empagliflozin|empagliflozin|mesh-list
92519317|NCT02964715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92519318|NCT02964715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519319|NCT02964715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92519320|NCT02964715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519321|NCT00093886|Clevidipine|clevidipine|mesh-list
92519322|NCT00093886|Nitroglycerin|nitroglycerin|mesh-list
92519323|NCT00093886|Vasodilator Agents|vasodilator agents|mesh-ancestor
92519324|NCT00093886|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92519325|NCT00093886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519326|NCT00093886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519327|NCT00093886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92519328|NCT00093886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519329|NCT00093925|Nicardipine|nicardipine|mesh-list
92519330|NCT00093925|Clevidipine|clevidipine|mesh-list
92519331|NCT00093925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92519332|NCT00093925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519333|NCT00093925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519334|NCT00093925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92519335|NCT00093925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519336|NCT00093925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92519337|NCT00093925|Vasodilator Agents|vasodilator agents|mesh-ancestor
92519339|NCT00006239|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92519340|NCT00006239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519341|NCT00006239|Keratolytic Agents|keratolytic agents|mesh-ancestor
92519342|NCT00006239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92519343|NCT00094003|Poly I-C|poly i-c|mesh-list
92519344|NCT00094003|Antiviral Agents|antiviral agents|mesh-ancestor
92519345|NCT00094003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519346|NCT00094003|Interferon Inducers|interferon inducers|mesh-ancestor
92519347|NCT00094003|Immunologic Factors|immunologic factors|mesh-ancestor
92519348|NCT00094003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519349|NCT00094081|Tirapazamine|tirapazamine|mesh-list
92519350|NCT00094081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519351|NCT00094120|Squalamine|squalamine|mesh-list
92519352|NCT00094120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519353|NCT00094120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519354|NCT00094120|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92519355|NCT00094120|Protective Agents|protective agents|mesh-ancestor
92519356|NCT00094120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519357|NCT00094120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519358|NCT00094120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519359|NCT00094120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519360|NCT00094120|Growth Substances|growth substances|mesh-ancestor
92519361|NCT00094120|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519362|NCT00006245|Paclitaxel|paclitaxel|mesh-list
92519363|NCT00006245|Alvocidib|alvocidib|mesh-list
92519364|NCT00006245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519365|NCT00006245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519366|NCT00006245|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519367|NCT00006245|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519368|NCT00006245|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519369|NCT00006245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519370|NCT00006245|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519371|NCT00006245|Growth Substances|growth substances|mesh-ancestor
92519372|NCT00006245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519373|NCT00006245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519374|NCT00006245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519375|NCT00094315|Cocaine|cocaine|mesh-list
92519376|NCT00094315|Anesthetics, Local|anesthetics, local|mesh-ancestor
92519377|NCT00094315|Anesthetics|anesthetics|mesh-ancestor
92519378|NCT00094315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519379|NCT00094315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519380|NCT00094315|Sensory System Agents|sensory system agents|mesh-ancestor
92519381|NCT00094315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519382|NCT00094315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92519383|NCT00094315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92244281|NCT00471380|Timolol|timolol|mesh-list
92519384|NCT00094315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92519385|NCT00094315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519386|NCT00094315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519387|NCT00094315|Dopamine Agents|dopamine agents|mesh-ancestor
92519388|NCT00094315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519389|NCT00094432|Aripiprazole|aripiprazole|mesh-list
92519390|NCT00094432|Antidepressive Agents|antidepressive agents|mesh-ancestor
92519391|NCT00094432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519392|NCT00094432|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92519393|NCT00094432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519394|NCT00094432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519395|NCT00094432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519396|NCT00094432|Dopamine Agonists|dopamine agonists|mesh-ancestor
92519397|NCT00094432|Dopamine Agents|dopamine agents|mesh-ancestor
92519398|NCT00094432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519399|NCT00094432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519400|NCT00094432|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92519401|NCT00094432|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92519402|NCT00094432|Serotonin Agents|serotonin agents|mesh-ancestor
92519403|NCT00094432|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92519404|NCT00094432|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92519405|NCT00094432|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92519406|NCT00094432|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92519407|NCT00006248|Paclitaxel|paclitaxel|mesh-list
92519408|NCT00006248|Fluorouracil|fluorouracil|mesh-list
92519409|NCT00006248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519410|NCT00006248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519411|NCT00006248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519412|NCT00006248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519413|NCT00006248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519414|NCT00006248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519415|NCT00006248|Antimetabolites|antimetabolites|mesh-ancestor
92519416|NCT00006248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519417|NCT00006248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519418|NCT00006248|Immunologic Factors|immunologic factors|mesh-ancestor
92519419|NCT00006248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519420|NCT00094549|Valproic Acid|valproic acid|mesh-list
92519421|NCT00094549|Olanzapine|olanzapine|mesh-list
92519422|NCT00094549|Antiemetics|antiemetics|mesh-ancestor
92519423|NCT00094549|Autonomic Agents|autonomic agents|mesh-ancestor
92519424|NCT00094549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519425|NCT00094549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519426|NCT00094549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519427|NCT00094549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92519428|NCT00094549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519429|NCT00094549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519430|NCT00094549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519431|NCT00094549|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92519432|NCT00094549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92519433|NCT00094549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519434|NCT00094549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519435|NCT00094549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519436|NCT00094549|Serotonin Agents|serotonin agents|mesh-ancestor
92519437|NCT00094549|Anticonvulsants|anticonvulsants|mesh-ancestor
92519438|NCT00094549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519439|NCT00094549|GABA Agents|gaba agents|mesh-ancestor
92519440|NCT00094549|Antimanic Agents|antimanic agents|mesh-ancestor
92519441|NCT00094627|Gaboxadol|gaboxadol|mesh-list
92519442|NCT00094627|Analgesics|analgesics|mesh-ancestor
92519443|NCT00094627|Sensory System Agents|sensory system agents|mesh-ancestor
92519444|NCT00094627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519445|NCT00094627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519446|NCT00094627|Anticonvulsants|anticonvulsants|mesh-ancestor
92519447|NCT00094627|GABA Agonists|gaba agonists|mesh-ancestor
92519448|NCT00094627|GABA Agents|gaba agents|mesh-ancestor
92519449|NCT00094627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519450|NCT00094627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519451|NCT00094666|Gaboxadol|gaboxadol|mesh-list
92519452|NCT00094666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519453|NCT00094666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519454|NCT00094666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519455|NCT00094666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519456|NCT00094666|Analgesics|analgesics|mesh-ancestor
92244356|NCT00540722|Gossypol acetic acid|gossypol acetic acid|mesh-list
92519457|NCT00094666|Sensory System Agents|sensory system agents|mesh-ancestor
92519458|NCT00094666|Anticonvulsants|anticonvulsants|mesh-ancestor
92519459|NCT00094666|GABA Agonists|gaba agonists|mesh-ancestor
92519460|NCT00094666|GABA Agents|gaba agents|mesh-ancestor
92519461|NCT00006251|Cyclosporine|cyclosporine|mesh-list
92519462|NCT00006251|Mycophenolic Acid|mycophenolic acid|mesh-list
92519463|NCT00006251|Fludarabine|fludarabine|mesh-list
92519464|NCT00006251|Fludarabine phosphate|fludarabine phosphate|mesh-list
92519465|NCT00006251|Cyclosporins|cyclosporins|mesh-list
92519466|NCT00006251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519467|NCT00006251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519468|NCT00006251|Antimetabolites|antimetabolites|mesh-ancestor
92519469|NCT00006251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519470|NCT00006251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519471|NCT00006251|Immunologic Factors|immunologic factors|mesh-ancestor
92519472|NCT00006251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519473|NCT00006251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519474|NCT00006251|Antifungal Agents|antifungal agents|mesh-ancestor
92519475|NCT00006251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519476|NCT00006251|Dermatologic Agents|dermatologic agents|mesh-ancestor
92519477|NCT00006251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519478|NCT00006251|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92519479|NCT00006251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92519480|NCT00006251|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92519481|NCT00006251|Antitubercular Agents|antitubercular agents|mesh-ancestor
92519482|NCT00006251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519483|NCT00094978|Alvocidib|alvocidib|mesh-list
92519484|NCT00094978|Romidepsin|romidepsin|mesh-list
92519485|NCT00094978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519486|NCT00094978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519487|NCT00094978|Growth Substances|growth substances|mesh-ancestor
92519488|NCT00094978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519489|NCT00094978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519490|NCT00094978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519491|NCT00094978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519492|NCT00094978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92519493|NCT00094978|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92519494|NCT00095134|Risperidone|risperidone|mesh-list
92519495|NCT00095134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92519496|NCT00095134|Serotonin Agents|serotonin agents|mesh-ancestor
92519497|NCT00095134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519498|NCT00095134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519499|NCT00095134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519500|NCT00095134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92519501|NCT00095134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519502|NCT00095134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519503|NCT00095134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519504|NCT00095134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92519505|NCT00095134|Dopamine Agents|dopamine agents|mesh-ancestor
92519506|NCT00006257|Paclitaxel|paclitaxel|mesh-list
92519507|NCT00006257|Semaxinib|semaxinib|mesh-list
92519508|NCT00006257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519509|NCT00006257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519510|NCT00006257|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519511|NCT00006257|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519512|NCT00006257|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519513|NCT00006257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519514|NCT00006257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519515|NCT00006257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519516|NCT00006257|Growth Substances|growth substances|mesh-ancestor
92519517|NCT00006257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519518|NCT00006257|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519519|NCT00006257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92519520|NCT00006257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519521|NCT00095251|Dexmedetomidine|dexmedetomidine|mesh-list
92519522|NCT00095251|Lorazepam|lorazepam|mesh-list
92519523|NCT00095251|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92519524|NCT00095251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519525|NCT00095251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519526|NCT00095251|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92519527|NCT00095251|Analgesics|analgesics|mesh-ancestor
92519528|NCT00095251|Sensory System Agents|sensory system agents|mesh-ancestor
92519529|NCT00095251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519530|NCT00095251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92519531|NCT00095251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92519532|NCT00095251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92519533|NCT00095251|Adrenergic Agents|adrenergic agents|mesh-ancestor
92519534|NCT00095251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519535|NCT00095251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519536|NCT00095251|Anticonvulsants|anticonvulsants|mesh-ancestor
92519537|NCT00095251|Antiemetics|antiemetics|mesh-ancestor
92519538|NCT00095251|Autonomic Agents|autonomic agents|mesh-ancestor
92519539|NCT00095251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519540|NCT00095251|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92519541|NCT00095251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519542|NCT00095251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519543|NCT00095251|GABA Modulators|gaba modulators|mesh-ancestor
92519544|NCT00095251|GABA Agents|gaba agents|mesh-ancestor
92519545|NCT00006260|Etoposide|etoposide|mesh-list
92519546|NCT00006260|Ifosfamide|ifosfamide|mesh-list
92519547|NCT00006260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519548|NCT00006260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519549|NCT00006260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92519550|NCT00006260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92519551|NCT00006260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519552|NCT00006260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519553|NCT00006260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92519554|NCT00006260|Alkylating Agents|alkylating agents|mesh-ancestor
92519555|NCT00095329|Sirolimus|sirolimus|mesh-list
92519556|NCT00095329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519557|NCT00095329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519558|NCT00095329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92519559|NCT00095329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519560|NCT00095329|Antifungal Agents|antifungal agents|mesh-ancestor
92519561|NCT00095329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519562|NCT00095329|Immunologic Factors|immunologic factors|mesh-ancestor
92519563|NCT00095329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519564|NCT00095368|Amoxicillin|amoxicillin|mesh-list
92519565|NCT00095368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519566|NCT00095368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519567|NCT00095446|Insulin Aspart|insulin aspart|mesh-list
92519568|NCT00095446|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92519569|NCT00095446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519570|NCT00006263|Carboplatin|carboplatin|mesh-list
92519571|NCT00006263|Temozolomide|temozolomide|mesh-list
92519572|NCT00006263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519573|NCT00006263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92519574|NCT00006263|Alkylating Agents|alkylating agents|mesh-ancestor
92519575|NCT00006263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519576|NCT00095524|Aripiprazole|aripiprazole|mesh-list
92519577|NCT00095524|Antidepressive Agents|antidepressive agents|mesh-ancestor
92519578|NCT00095524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519579|NCT00095524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92519580|NCT00095524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519581|NCT00095524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519582|NCT00095524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519583|NCT00095524|Dopamine Agonists|dopamine agonists|mesh-ancestor
92519584|NCT00095524|Dopamine Agents|dopamine agents|mesh-ancestor
92519585|NCT00095524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519586|NCT00095524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519587|NCT00095524|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92519588|NCT00095524|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92519589|NCT00095524|Serotonin Agents|serotonin agents|mesh-ancestor
92519590|NCT00095524|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92519591|NCT00095524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92519592|NCT00095524|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92519593|NCT00095524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92519594|NCT04492566|Pancrelipase|pancrelipase|mesh-list
92519595|NCT04492566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519596|NCT00095641|Capecitabine|capecitabine|mesh-list
92519597|NCT00095641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519598|NCT00095641|Antimetabolites|antimetabolites|mesh-ancestor
92519599|NCT00095641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519600|NCT00095641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519601|NCT00006269|Irinotecan|irinotecan|mesh-list
92519602|NCT00006269|Octreotide|octreotide|mesh-list
92519603|NCT00006269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92519604|NCT00006269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92519605|NCT00006269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519606|NCT00006269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519607|NCT00006269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519608|NCT00006269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519609|NCT00006269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92519610|NCT04476030|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92519611|NCT04476030|Citalopram|citalopram|mesh-list
92519612|NCT04476030|Sertraline|sertraline|mesh-list
92519613|NCT04476030|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92519614|NCT04476030|Escitalopram|escitalopram|mesh-list
92519615|NCT04476030|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92519616|NCT04476030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92519617|NCT04476030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519618|NCT04476030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519619|NCT04476030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519620|NCT04476030|Serotonin Agents|serotonin agents|mesh-ancestor
92519621|NCT04476030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519622|NCT04476030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519623|NCT04476030|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92519624|NCT04476030|Antidepressive Agents|antidepressive agents|mesh-ancestor
92519625|NCT04476030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519626|NCT04476030|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92519627|NCT04476030|Analgesics|analgesics|mesh-ancestor
92519628|NCT04476030|Sensory System Agents|sensory system agents|mesh-ancestor
92519629|NCT04476030|Dopamine Agents|dopamine agents|mesh-ancestor
92519630|NCT00095680|Bortezomib|bortezomib|mesh-list
92519631|NCT00095680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519632|NCT00095719|Aripiprazole|aripiprazole|mesh-list
92519633|NCT00095719|Antidepressive Agents|antidepressive agents|mesh-ancestor
92519634|NCT00095719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519635|NCT00095719|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92519636|NCT00095719|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519637|NCT00095719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519638|NCT00095719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519639|NCT00095719|Dopamine Agonists|dopamine agonists|mesh-ancestor
92519640|NCT00095719|Dopamine Agents|dopamine agents|mesh-ancestor
92519641|NCT00095719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519642|NCT00095719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519643|NCT00095719|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92519644|NCT00095719|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92519645|NCT00095719|Serotonin Agents|serotonin agents|mesh-ancestor
92519646|NCT00095719|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92519647|NCT00095719|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92519648|NCT00095719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92519649|NCT00095719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92519650|NCT00095758|Aripiprazole|aripiprazole|mesh-list
92519651|NCT00095758|Antidepressive Agents|antidepressive agents|mesh-list
92519652|NCT00095758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92519653|NCT00095758|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92519654|NCT00095758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92519655|NCT00095758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519656|NCT00095758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519657|NCT00095758|Dopamine Agonists|dopamine agonists|mesh-ancestor
92519658|NCT00095758|Dopamine Agents|dopamine agents|mesh-ancestor
92519659|NCT00095758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519660|NCT00095758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519661|NCT00095758|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92519662|NCT00095758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92519663|NCT00095758|Serotonin Agents|serotonin agents|mesh-ancestor
92519664|NCT00095758|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92519665|NCT00095758|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92519666|NCT00095758|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92519667|NCT00095758|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92519668|NCT00095914|Paclitaxel|paclitaxel|mesh-list
92519669|NCT00095914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92519670|NCT00095914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519671|NCT00095914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519672|NCT00095914|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519673|NCT00095914|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519674|NCT00095914|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519675|NCT00095914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519676|NCT04432428|Sufentanil|sufentanil|mesh-list
92519677|NCT04432428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92519678|NCT04432428|Narcotics|narcotics|mesh-ancestor
92519679|NCT04432428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519680|NCT04432428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244581|NCT00490802|Oxytocin|oxytocin|mesh-list
92519681|NCT04432428|Analgesics|analgesics|mesh-ancestor
92519682|NCT04432428|Sensory System Agents|sensory system agents|mesh-ancestor
92519683|NCT04432428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519684|NCT04432428|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92519685|NCT04432428|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92519686|NCT04432428|Anesthetics, General|anesthetics, general|mesh-ancestor
92519687|NCT04432428|Anesthetics|anesthetics|mesh-ancestor
92519688|NCT00096070|Gemcitabine|gemcitabine|mesh-list
92519689|NCT00096070|Fluorouracil|fluorouracil|mesh-list
92519690|NCT00096070|Oxaliplatin|oxaliplatin|mesh-list
92519691|NCT00096070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519692|NCT00096070|Antimetabolites|antimetabolites|mesh-ancestor
92519693|NCT00096070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519694|NCT00096070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519695|NCT00096070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519696|NCT00096070|Immunologic Factors|immunologic factors|mesh-ancestor
92519697|NCT00096070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519698|NCT00006275|Calcitriol|calcitriol|mesh-list
92519699|NCT00006275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92519700|NCT00006275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519701|NCT00006275|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92519702|NCT00006275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92519703|NCT00006275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519704|NCT00006275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92519705|NCT00006275|Vitamins|vitamins|mesh-ancestor
92519706|NCT00006275|Micronutrients|micronutrients|mesh-ancestor
92519707|NCT00006275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92519708|NCT00096148|Cytarabine|cytarabine|mesh-list
92519709|NCT00096148|Bevacizumab|bevacizumab|mesh-list
92519710|NCT00096148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92519711|NCT00096148|Idarubicin|idarubicin|mesh-list
92519712|NCT00096148|Antibodies|antibodies|mesh-list
92519713|NCT00096148|Immunoglobulins|immunoglobulins|mesh-list
92519714|NCT00096148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92519715|NCT00096148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519716|NCT00096148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519717|NCT00096148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519718|NCT00096148|Growth Substances|growth substances|mesh-ancestor
92519719|NCT00096148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519720|NCT00096148|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519721|NCT00096148|Immunologic Factors|immunologic factors|mesh-ancestor
92519722|NCT00096148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92519723|NCT00096148|Antimetabolites|antimetabolites|mesh-ancestor
92519724|NCT00096148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519725|NCT00096148|Antiviral Agents|antiviral agents|mesh-ancestor
92519726|NCT00096148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519727|NCT00096148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92519728|NCT00096148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92519729|NCT00096148|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92519730|NCT00096148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92519731|NCT00096148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519732|NCT00096187|Pemetrexed|pemetrexed|mesh-list
92519733|NCT00096187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519734|NCT00096187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519735|NCT00096187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519736|NCT00096187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92519737|NCT00096187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92519738|NCT00096304|Docetaxel|docetaxel|mesh-list
92519739|NCT00096304|Epirubicin|epirubicin|mesh-list
92519740|NCT00096304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519741|NCT00096304|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519742|NCT00096304|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519743|NCT00096304|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519744|NCT00096304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519745|NCT00096304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92519746|NCT00096304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92519747|NCT00096304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92519748|NCT00096304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519749|NCT00096343|Paclitaxel|paclitaxel|mesh-list
92519750|NCT00096343|Carboplatin|carboplatin|mesh-list
92519751|NCT00096343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519752|NCT00096343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519753|NCT00096343|Tubulin Modulators|tubulin modulators|mesh-ancestor
92519754|NCT00096343|Antimitotic Agents|antimitotic agents|mesh-ancestor
92519755|NCT00096343|Mitosis Modulators|mitosis modulators|mesh-ancestor
92519756|NCT00096343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519757|NCT00096616|Albuterol|albuterol|mesh-list
92519758|NCT00096616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92519759|NCT00096616|Autonomic Agents|autonomic agents|mesh-ancestor
92519760|NCT00096616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519761|NCT00096616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519762|NCT00096616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92519763|NCT00096616|Respiratory System Agents|respiratory system agents|mesh-ancestor
92519764|NCT00096616|Tocolytic Agents|tocolytic agents|mesh-ancestor
92519765|NCT00096616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92519766|NCT00096616|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92519767|NCT00096616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92519768|NCT00096616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92519769|NCT00096616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92519770|NCT00096616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519771|NCT00096616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519772|NCT00096655|Infliximab|infliximab|mesh-list
92519773|NCT00096655|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92519774|NCT00096655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92519775|NCT00096655|Dermatologic Agents|dermatologic agents|mesh-ancestor
92519776|NCT00096655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519777|NCT00096655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519778|NCT00096694|Levonorgestrel|levonorgestrel|mesh-list
92519779|NCT00096694|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92519780|NCT00096694|Contraceptive Agents|contraceptive agents|mesh-ancestor
92519781|NCT00096694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92519782|NCT00096694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519783|NCT00096694|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92519784|NCT00096694|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92519785|NCT00096694|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92519786|NCT00006299|Celecoxib|celecoxib|mesh-list
92519787|NCT00006299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92519788|NCT00006299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92519789|NCT00006299|Analgesics|analgesics|mesh-ancestor
92519790|NCT00006299|Sensory System Agents|sensory system agents|mesh-ancestor
92519791|NCT00006299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519792|NCT00006299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519793|NCT00006299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92519794|NCT00006299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519795|NCT00006299|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92519796|NCT00006299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92519797|NCT00006299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519798|NCT00006299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519799|NCT00096811|Entecavir|entecavir|mesh-list
92519800|NCT00096811|Antiviral Agents|antiviral agents|mesh-ancestor
92519801|NCT00096811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519802|NCT00096850|Ritonavir|ritonavir|mesh-list
92519803|NCT00096850|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92519804|NCT00096850|Rifampin|rifampin|mesh-list
92519805|NCT00096850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92519806|NCT00096850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92519807|NCT00096850|Protease Inhibitors|protease inhibitors|mesh-ancestor
92519808|NCT00096850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519809|NCT00096850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519810|NCT00096850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92519811|NCT00096850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92519812|NCT00096850|Antiviral Agents|antiviral agents|mesh-ancestor
92519813|NCT00096850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519814|NCT00096850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92519815|NCT00096850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92519816|NCT00096850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92519817|NCT00096850|Antitubercular Agents|antitubercular agents|mesh-ancestor
92519818|NCT00096850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92519819|NCT00096850|Leprostatic Agents|leprostatic agents|mesh-ancestor
92519820|NCT00096850|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92352625|NCT03826992|Cytarabine|cytarabine|mesh-list
92519821|NCT00096850|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92519822|NCT00096850|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92519823|NCT00096850|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92519824|NCT00096850|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92519825|NCT00096850|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92519826|NCT00096850|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92519827|NCT00096967|Bevacizumab|bevacizumab|mesh-list
92519828|NCT00096967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92519829|NCT00096967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519830|NCT00096967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519831|NCT00096967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519832|NCT00096967|Growth Substances|growth substances|mesh-ancestor
92519833|NCT00096967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519834|NCT00096967|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519835|NCT04340076|Ixekizumab|ixekizumab|mesh-list
92519836|NCT04340076|Brodalumab|brodalumab|mesh-list
92519837|NCT04340076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92519838|NCT00097045|Interferons|interferons|mesh-list
92519839|NCT00097045|Ribavirin|ribavirin|mesh-list
92519840|NCT00097045|Interferon omega 1|interferon omega 1|mesh-list
92519841|NCT00097045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519842|NCT00097045|Antiviral Agents|antiviral agents|mesh-ancestor
92519843|NCT00097045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519844|NCT00097045|Antimetabolites|antimetabolites|mesh-ancestor
92519845|NCT00097045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519846|NCT00097084|Insulin|insulin|mesh-list
92519847|NCT00097084|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92519848|NCT00097084|Insulin Glargine|insulin glargine|mesh-list
92519849|NCT00097084|Insulin Aspart|insulin aspart|mesh-list
92519850|NCT00097084|Insulin Detemir|insulin detemir|mesh-list
92519851|NCT00097084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92519852|NCT00097084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519853|NCT04310709|Nivolumab|nivolumab|mesh-list
92519854|NCT04310709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92519855|NCT04310709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519856|NCT04310709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92519857|NCT04310709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519858|NCT00006320|Anti-HIV Agents|anti-hiv agents|mesh-list
92519859|NCT00006320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92519860|NCT00006320|Antiviral Agents|antiviral agents|mesh-ancestor
92519861|NCT00006320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519862|NCT00097123|Misoprostol|misoprostol|mesh-list
92519863|NCT00097123|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92519864|NCT00097123|Abortifacient Agents|abortifacient agents|mesh-ancestor
92519865|NCT00097123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92519866|NCT00097123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519867|NCT00097123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92519868|NCT00097123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519869|NCT00097123|Oxytocics|oxytocics|mesh-ancestor
92519870|NCT00097279|Metformin|metformin|mesh-list
92519871|NCT00097279|Pioglitazone|pioglitazone|mesh-list
92519872|NCT00097279|Insulin Aspart|insulin aspart|mesh-list
92519873|NCT00097279|Biphasic Insulins|biphasic insulins|mesh-list
92519874|NCT00097279|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92519875|NCT00097279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519876|NCT00390273|Metformin|metformin|mesh-list
92519877|NCT00390273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92352626|NCT03826992|Daunorubicin|daunorubicin|mesh-list
92519878|NCT00390273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519879|NCT00097318|Interferons|interferons|mesh-list
92519880|NCT00097318|Interferon-beta|interferon-beta|mesh-list
92519881|NCT00097318|Interferon beta-1a|interferon beta-1a|mesh-list
92519882|NCT00097318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519883|NCT00097318|Antiviral Agents|antiviral agents|mesh-ancestor
92519884|NCT00097318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519885|NCT00097318|Immunologic Factors|immunologic factors|mesh-ancestor
92519886|NCT00097318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519887|NCT00097318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92519888|NCT00097435|Ribavirin|ribavirin|mesh-list
92519889|NCT00097435|Antimetabolites|antimetabolites|mesh-ancestor
92519890|NCT00097435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519891|NCT00097435|Antiviral Agents|antiviral agents|mesh-ancestor
92519892|NCT00097435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519893|NCT00006326|Ritonavir|ritonavir|mesh-list
92519894|NCT00006326|Indinavir|indinavir|mesh-list
92519895|NCT00006326|Delavirdine|delavirdine|mesh-list
92519896|NCT00006326|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92519897|NCT00006326|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92519898|NCT00006326|Protease Inhibitors|protease inhibitors|mesh-ancestor
92519899|NCT00006326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519900|NCT00006326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519901|NCT00006326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92519902|NCT00006326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92519903|NCT00006326|Antiviral Agents|antiviral agents|mesh-ancestor
92519904|NCT00006326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92519905|NCT00006326|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92519906|NCT00006326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92519907|NCT00006326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92519908|NCT00006326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92519909|NCT00390312|Morphine|morphine|mesh-list
92519910|NCT00390312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92519911|NCT00390312|Narcotics|narcotics|mesh-ancestor
92519912|NCT00390312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92519913|NCT00390312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519914|NCT00390312|Analgesics|analgesics|mesh-ancestor
92519915|NCT00390312|Sensory System Agents|sensory system agents|mesh-ancestor
92519916|NCT00390312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519917|NCT00400387|Riboflavin|riboflavin|mesh-list
92519918|NCT00400387|Thiamine|thiamine|mesh-list
92519919|NCT00400387|Pyridoxine|pyridoxine|mesh-list
92519920|NCT00400387|Vitamin B 12|vitamin b 12|mesh-list
92519921|NCT00400387|Folic Acid|folic acid|mesh-list
92519922|NCT00400387|Vitamin B Complex|vitamin b complex|mesh-list
92519923|NCT00400387|Tocopherols|tocopherols|mesh-list
92519924|NCT00400387|Vitamin E|vitamin e|mesh-list
92519925|NCT00400387|Tocotrienols|tocotrienols|mesh-list
92519926|NCT00400387|alpha-Tocopherol|alpha-tocopherol|mesh-list
92519927|NCT00400387|Heparin|heparin|mesh-list
92519928|NCT00400387|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92519929|NCT00400387|Tinzaparin|tinzaparin|mesh-list
92519930|NCT00400387|Dalteparin|dalteparin|mesh-list
92519931|NCT00400387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519932|NCT00400387|Anticoagulants|anticoagulants|mesh-ancestor
92519933|NCT00400387|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92519934|NCT00400387|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92519935|NCT00400387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519936|NCT00400387|Vitamins|vitamins|mesh-ancestor
92519937|NCT00400387|Micronutrients|micronutrients|mesh-ancestor
92519938|NCT00400387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92519939|NCT00400387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92519940|NCT00400387|Antioxidants|antioxidants|mesh-ancestor
92519941|NCT00400387|Protective Agents|protective agents|mesh-ancestor
92519942|NCT00400387|Hematinics|hematinics|mesh-ancestor
92519943|NCT00006332|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92519944|NCT00006332|Chelating Agents|chelating agents|mesh-ancestor
92519945|NCT00006332|Sequestering Agents|sequestering agents|mesh-ancestor
92519946|NCT00006332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519947|NCT00006332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519948|NCT00006332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92519949|NCT00006332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92519950|NCT00006332|Growth Substances|growth substances|mesh-ancestor
92519951|NCT00006332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519952|NCT00006332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92519953|NCT00006332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519954|NCT00390390|Lansoprazole|lansoprazole|mesh-list
92519955|NCT00390390|Dexlansoprazole|dexlansoprazole|mesh-list
92519956|NCT00390390|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92519957|NCT00390390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92519958|NCT00390390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92519959|NCT00390390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519960|NCT00390390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519961|NCT00097825|Zoledronic Acid|zoledronic acid|mesh-list
92519962|NCT00097825|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92519963|NCT00097825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519964|NCT00097903|Camptothecin|camptothecin|mesh-list
92519965|NCT00097903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92519966|NCT00097903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519967|NCT00097903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92519968|NCT00097903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92519969|NCT00097903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519970|NCT00097903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519972|NCT00097942|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92519973|NCT00097942|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92519974|NCT00097942|Dopamine Agents|dopamine agents|mesh-ancestor
92519975|NCT00097942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92519976|NCT00097942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519977|NCT00097942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519978|NCT00097942|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92519979|NCT00097942|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92519980|NCT04294836|Curcumin|curcumin|mesh-list
92519981|NCT04294836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92519982|NCT04294836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92519983|NCT04294836|Analgesics|analgesics|mesh-ancestor
92519984|NCT04294836|Sensory System Agents|sensory system agents|mesh-ancestor
92519985|NCT04294836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92519986|NCT04294836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92519987|NCT04294836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92519988|NCT04294836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92519989|NCT04294836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92519990|NCT04294836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92519991|NCT04294836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519992|NCT00098137|Olmesartan|olmesartan|mesh-list
92519993|NCT00098137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92519994|NCT00098137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92519995|NCT00098137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92519996|NCT00098137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92519997|NCT00098488|Rituximab|rituximab|mesh-list
92519998|NCT00098488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92519999|NCT00098488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520000|NCT00098488|Immunologic Factors|immunologic factors|mesh-ancestor
92520001|NCT00098488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520002|NCT00098488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520003|NCT00098527|Romidepsin|romidepsin|mesh-list
92520004|NCT00098527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92520005|NCT00098527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520006|NCT00098527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92520007|NCT00098527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520008|NCT00098527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520009|NCT00006347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92520010|NCT00006347|Antibodies|antibodies|mesh-list
92520011|NCT00006347|Immunoglobulins|immunoglobulins|mesh-list
92520012|NCT00006347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92520013|NCT00006347|Immunologic Factors|immunologic factors|mesh-ancestor
92520014|NCT00006347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520015|NCT00006347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520016|NCT00098605|Lapatinib|lapatinib|mesh-list
92520017|NCT00098605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520018|NCT00098605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520019|NCT00098605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520020|NCT00098605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520021|NCT00098683|Amifostine|amifostine|mesh-list
92520022|NCT00098683|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92520023|NCT00098683|Protective Agents|protective agents|mesh-ancestor
92520024|NCT00098683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520025|NCT00098800|Fenretinide|fenretinide|mesh-list
92520026|NCT00098800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520027|NCT00098800|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92520028|NCT00098800|Protective Agents|protective agents|mesh-ancestor
92520029|NCT00098800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520030|NCT00098878|Carboplatin|carboplatin|mesh-list
92520031|NCT00098878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520032|NCT03633305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92520033|NCT03633305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92520034|NCT03633305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520035|NCT00098917|Vaccines|vaccines|mesh-list
92520036|NCT00098917|Immunologic Factors|immunologic factors|mesh-ancestor
92520037|NCT00098917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520038|NCT00098995|Tirapazamine|tirapazamine|mesh-list
92520039|NCT00098995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520040|NCT00099190|Beta-lapachone|beta-lapachone|mesh-list
92520041|NCT00099190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520042|NCT00099190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92520043|NCT00099190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92520044|NCT00099190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520045|NCT00099190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520046|NCT00099190|Antiviral Agents|antiviral agents|mesh-ancestor
92520047|NCT00099502|Interferons|interferons|mesh-list
92520048|NCT00099502|Interferon-beta|interferon-beta|mesh-list
92520049|NCT00099502|Glatiramer Acetate|glatiramer acetate|mesh-list
92520050|NCT00099502|Interferon beta-1b|interferon beta-1b|mesh-list
92520051|NCT00099502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520052|NCT00099502|Antiviral Agents|antiviral agents|mesh-ancestor
92520053|NCT00099502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520054|NCT00099502|Immunologic Factors|immunologic factors|mesh-ancestor
92520055|NCT00099502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520056|NCT00099502|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92520057|NCT00099502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520058|NCT00099502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520060|NCT00387920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244969|NCT01470859|Levodopa|levodopa|mesh-list
92520061|NCT00387920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92520062|NCT00387920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92520063|NCT00387920|Growth Substances|growth substances|mesh-ancestor
92520064|NCT00387920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520065|NCT00387920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92520066|NCT00387920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520067|NCT00387920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520068|NCT00387920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520069|NCT00099541|Zoledronic Acid|zoledronic acid|mesh-list
92520070|NCT00099541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92520071|NCT00099541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520073|NCT02888067|Rocuronium|rocuronium|mesh-list
92520074|NCT02888067|Anticonvulsants|anticonvulsants|mesh-ancestor
92520075|NCT02888067|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92520076|NCT02888067|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92520077|NCT02888067|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92520078|NCT02888067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520079|NCT02888067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520080|NCT00006350|Mycophenolic Acid|mycophenolic acid|mesh-list
92520081|NCT00006350|Tacrolimus|tacrolimus|mesh-list
92520082|NCT00006350|Daclizumab|daclizumab|mesh-list
92520083|NCT00006350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520084|NCT00006350|Immunologic Factors|immunologic factors|mesh-ancestor
92520085|NCT00006350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520086|NCT00006350|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92520087|NCT00006350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520088|NCT00006350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520089|NCT00006350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92520090|NCT00006350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520091|NCT00006350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92520092|NCT00006350|Antitubercular Agents|antitubercular agents|mesh-ancestor
92520093|NCT00006350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92520094|NCT00006350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520095|NCT00400582|Candesartan|candesartan|mesh-list
92520096|NCT00400582|Candesartan cilexetil|candesartan cilexetil|mesh-list
92520097|NCT00400582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92520098|NCT00400582|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92520099|NCT00400582|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92520100|NCT00400582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520101|NCT00400621|Acetaminophen|acetaminophen|mesh-list
92520102|NCT00400621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520103|NCT00400621|Analgesics|analgesics|mesh-ancestor
92520104|NCT00400621|Sensory System Agents|sensory system agents|mesh-ancestor
92520105|NCT00400621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520106|NCT00400621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520107|NCT00400621|Antipyretics|antipyretics|mesh-ancestor
92520108|NCT00006353|Temozolomide|temozolomide|mesh-list
92520109|NCT00006353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520110|NCT00006353|Alkylating Agents|alkylating agents|mesh-ancestor
92520111|NCT00006353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520112|NCT00006353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520113|NCT00400738|Ritonavir|ritonavir|mesh-list
92520114|NCT00400738|Lopinavir|lopinavir|mesh-list
92520115|NCT00400738|Saquinavir|saquinavir|mesh-list
92520116|NCT00400738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92520117|NCT00400738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92520118|NCT00400738|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520119|NCT00400738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520120|NCT00400738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520121|NCT00400738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520122|NCT00400738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520123|NCT00400738|Antiviral Agents|antiviral agents|mesh-ancestor
92520124|NCT00400738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520125|NCT00400738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92520126|NCT00400738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92520127|NCT00006356|Carboplatin|carboplatin|mesh-list
92520128|NCT00006356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520129|NCT00099619|Insulin|insulin|mesh-list
92520130|NCT00099619|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92520131|NCT00099619|Insulin Glargine|insulin glargine|mesh-list
92520132|NCT00099619|Exenatide|exenatide|mesh-list
92520133|NCT00099619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520134|NCT00099619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520135|NCT00099619|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92520136|NCT00099619|Incretins|incretins|mesh-ancestor
92520137|NCT00099619|Hormones|hormones|mesh-ancestor
92245029|NCT05140278|Antiviral Agents|antiviral agents|mesh-ancestor
92520138|NCT00099619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520139|NCT00006359|Androgen Antagonists|androgen antagonists|mesh-list
92520140|NCT00006359|Hormone Antagonists|hormone antagonists|mesh-ancestor
92520141|NCT00006359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520142|NCT00006359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520143|NCT00099736|Cyclosporine|cyclosporine|mesh-list
92520144|NCT00099736|Cyclosporins|cyclosporins|mesh-list
92520145|NCT00099736|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92520146|NCT00099736|Antifungal Agents|antifungal agents|mesh-ancestor
92520147|NCT00099736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520148|NCT00099736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520149|NCT00099736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520150|NCT00099736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520151|NCT00099736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520152|NCT00099736|Immunologic Factors|immunologic factors|mesh-ancestor
92520153|NCT00099736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520154|NCT00099736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520155|NCT00099736|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92520156|NCT00099736|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92520157|NCT04143711|Paclitaxel|paclitaxel|mesh-list
92520158|NCT04143711|Nivolumab|nivolumab|mesh-list
92520159|NCT04143711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520160|NCT04143711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520161|NCT04143711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520162|NCT04143711|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520163|NCT04143711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520164|NCT04143711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520165|NCT04143711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92520166|NCT04143711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92520167|NCT00099775|Caspofungin|caspofungin|mesh-list
92520168|NCT00099775|Antifungal Agents|antifungal agents|mesh-ancestor
92520169|NCT00099775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520170|NCT00099775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520171|NCT00099775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520172|NCT00006362|Bortezomib|bortezomib|mesh-list
92520173|NCT00006362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520174|NCT00099892|Vildagliptin|vildagliptin|mesh-list
92520175|NCT00099892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520176|NCT00099892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520177|NCT00099892|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92520178|NCT00099892|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520179|NCT00099892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520180|NCT00099892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520181|NCT00099931|Vildagliptin|vildagliptin|mesh-list
92520182|NCT00099931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520183|NCT00099931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520184|NCT00099931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92520185|NCT00099931|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520186|NCT00099931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533408|NCT00398515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92520187|NCT00099931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520189|NCT00099970|Volociximab|volociximab|mesh-list
92520190|NCT00099970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520191|NCT00099970|Alkylating Agents|alkylating agents|mesh-ancestor
92520192|NCT00099970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520193|NCT00099970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520194|NCT00099970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92520195|NCT00099970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92520196|NCT00099970|Growth Substances|growth substances|mesh-ancestor
92520197|NCT00099970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520198|NCT00099970|Growth Inhibitors|growth inhibitors|mesh-ancestor
92520199|NCT00100009|Triamcinolone|triamcinolone|mesh-list
92520200|NCT00100009|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92520201|NCT00100009|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92520202|NCT00100009|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92520203|NCT00100009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520204|NCT00100009|Glucocorticoids|glucocorticoids|mesh-ancestor
92520205|NCT00100009|Hormones|hormones|mesh-ancestor
92520206|NCT00100009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520207|NCT00100009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520208|NCT00100009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520209|NCT00100009|Immunologic Factors|immunologic factors|mesh-ancestor
92245109|NCT05077332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520210|NCT00100009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520211|NCT00100009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520212|NCT00100126|Amoxicillin|amoxicillin|mesh-list
92520213|NCT00100126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92520214|NCT00100126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520215|NCT00100243|Abarelix|abarelix|mesh-list
92520216|NCT00100243|Hormone Antagonists|hormone antagonists|mesh-ancestor
92520217|NCT00100243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520218|NCT00100243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520219|NCT04071756|Tazarotene|tazarotene|mesh-list
92520220|NCT04071756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520221|NCT04071756|Keratolytic Agents|keratolytic agents|mesh-ancestor
92520222|NCT00006368|Edotreotide|edotreotide|mesh-list
92520223|NCT00006368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92520224|NCT00006368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520225|NCT00100477|Etoposide|etoposide|mesh-list
92520226|NCT00100477|Mitoxantrone|mitoxantrone|mesh-list
92520227|NCT00100477|Topotecan|topotecan|mesh-list
92520228|NCT00100477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520229|NCT00100477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520230|NCT00100477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92520231|NCT00100477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92520232|NCT00100477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520233|NCT00100477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520234|NCT00100477|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92520235|NCT00100477|Analgesics|analgesics|mesh-ancestor
92520236|NCT00100477|Sensory System Agents|sensory system agents|mesh-ancestor
92520237|NCT00100477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520238|NCT00100477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520239|NCT00100555|Zoledronic Acid|zoledronic acid|mesh-list
92520240|NCT00100555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92520241|NCT00100555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520242|NCT00006371|Ketoconazole|ketoconazole|mesh-list
92520243|NCT00006371|Hydrocortisone|hydrocortisone|mesh-list
92520244|NCT00006371|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92520245|NCT00006371|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92520246|NCT00006371|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92520247|NCT00006371|Aminoglutethimide|aminoglutethimide|mesh-list
92520248|NCT00006371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520249|NCT00006371|Antifungal Agents|antifungal agents|mesh-ancestor
92520250|NCT00006371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520251|NCT00006371|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92520252|NCT00006371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92520253|NCT00006371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520254|NCT00006371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520255|NCT00006371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92520256|NCT00006371|Hormone Antagonists|hormone antagonists|mesh-ancestor
92520257|NCT00006371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520258|NCT00006371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520259|NCT00006371|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92520260|NCT00006371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92520261|NCT00006371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520263|NCT00006371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92520265|NCT04062708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92520266|NCT04062708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520267|NCT00100594|Lamivudine|lamivudine|mesh-list
92520268|NCT00100594|Zidovudine|zidovudine|mesh-list
92520269|NCT00100594|Efavirenz|efavirenz|mesh-list
92520270|NCT00100594|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92520271|NCT00100594|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92520272|NCT00100594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92520273|NCT00100594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520274|NCT00100594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520275|NCT00100594|Antiviral Agents|antiviral agents|mesh-ancestor
92520276|NCT00100594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520277|NCT00100594|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520278|NCT00100594|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520279|NCT00100594|Antimetabolites|antimetabolites|mesh-ancestor
92520280|NCT00100594|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92520281|NCT00100594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92520282|NCT00100594|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92152633|NCT03400683|Letrozole|letrozole|mesh-list
92520283|NCT00100594|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92520284|NCT00100594|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92520285|NCT00100594|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92520286|NCT00006374|Paclitaxel|paclitaxel|mesh-list
92520287|NCT00006374|Etoposide|etoposide|mesh-list
92520288|NCT00006374|Topotecan|topotecan|mesh-list
92520289|NCT00006374|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520290|NCT00006374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520291|NCT00006374|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520292|NCT00006374|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520293|NCT00006374|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520294|NCT00006374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520295|NCT00006374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92520296|NCT00006374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92520297|NCT00006374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520298|NCT00006374|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92520299|NCT00100750|Gemcitabine|gemcitabine|mesh-list
92520300|NCT00100750|Tipifarnib|tipifarnib|mesh-list
92520301|NCT00100750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520302|NCT00100750|Antimetabolites|antimetabolites|mesh-ancestor
92200608|NCT03837873|Cyclophosphamide|cyclophosphamide|mesh-list
92520303|NCT00100750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520304|NCT00100750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520305|NCT00006377|Paclitaxel|paclitaxel|mesh-list
92520306|NCT00006377|Carboplatin|carboplatin|mesh-list
92520307|NCT00006377|Doxorubicin|doxorubicin|mesh-list
92520308|NCT00006377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92520309|NCT00006377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520310|NCT00006377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520311|NCT00006377|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520312|NCT00006377|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520313|NCT00006377|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520314|NCT00006377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520315|NCT00006377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92520316|NCT00006377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92520317|NCT00006377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92520318|NCT00006377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520319|NCT01350102|Ascorbic Acid|ascorbic acid|mesh-list
92520320|NCT01350102|Bacitracin|bacitracin|mesh-list
92520321|NCT01350102|Vitamins|vitamins|mesh-ancestor
92520322|NCT01350102|Micronutrients|micronutrients|mesh-ancestor
92520323|NCT01350102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520324|NCT01350102|Antioxidants|antioxidants|mesh-ancestor
92520325|NCT01350102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520326|NCT01350102|Protective Agents|protective agents|mesh-ancestor
92520327|NCT01350102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92520328|NCT01350102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520329|NCT01350102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92520330|NCT00424060|Sagopilone|sagopilone|mesh-list
92520331|NCT00424060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520332|NCT00006380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92520333|NCT00006380|Antibodies|antibodies|mesh-list
92520334|NCT00006380|Immunoglobulins|immunoglobulins|mesh-list
92520335|NCT00006380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92520336|NCT00006380|Immunologic Factors|immunologic factors|mesh-ancestor
92520337|NCT00006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520338|NCT00006380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520339|NCT00100906|Aldesleukin|aldesleukin|mesh-list
92520340|NCT00100906|Interleukin-2|interleukin-2|mesh-list
92520341|NCT00100906|Tretinoin|tretinoin|mesh-list
92520342|NCT00100906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520343|NCT00100906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520344|NCT00100906|Analgesics|analgesics|mesh-ancestor
92520345|NCT00100906|Sensory System Agents|sensory system agents|mesh-ancestor
92520346|NCT00100906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520347|NCT00100906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520348|NCT00100906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520349|NCT00100906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520350|NCT00100906|Antiviral Agents|antiviral agents|mesh-ancestor
92520351|NCT00100906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520352|NCT00100906|Keratolytic Agents|keratolytic agents|mesh-ancestor
92520353|NCT00100906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520354|NCT00100945|Gefitinib|gefitinib|mesh-list
92520355|NCT00100945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520356|NCT00100945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520357|NCT00100945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520358|NCT00100945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520359|NCT00006383|Vincristine|vincristine|mesh-list
92520360|NCT00006383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520362|NCT00006383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520363|NCT00006383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520364|NCT00006383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520365|NCT00006383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520366|NCT00100984|Enfuvirtide|enfuvirtide|mesh-list
92520367|NCT00100984|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92520368|NCT00100984|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92520369|NCT00100984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520370|NCT00100984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520371|NCT00100984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520372|NCT00100984|Antiviral Agents|antiviral agents|mesh-ancestor
92520373|NCT00100984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520374|NCT00101062|Celecoxib|celecoxib|mesh-list
92520375|NCT00101062|Letrozole|letrozole|mesh-list
92520376|NCT00101062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520377|NCT00101062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92520378|NCT00101062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92520379|NCT00101062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520380|NCT00101062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520381|NCT00101062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92520382|NCT00101062|Hormone Antagonists|hormone antagonists|mesh-ancestor
92520383|NCT00101062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520384|NCT00101062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520385|NCT00101062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92520386|NCT00101062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520388|NCT00101062|Sensory System Agents|sensory system agents|mesh-ancestor
92520389|NCT00101062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520390|NCT00101062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520391|NCT00101062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520392|NCT00101062|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92520393|NCT00101062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92520394|NCT00006386|Carmustine|carmustine|mesh-list
92520395|NCT00006386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520396|NCT00006386|Alkylating Agents|alkylating agents|mesh-ancestor
92520397|NCT00006386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520398|NCT00006386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520399|NCT00101140|Fludarabine|fludarabine|mesh-list
92520400|NCT00101140|Fludarabine phosphate|fludarabine phosphate|mesh-list
92520401|NCT00101140|Thiotepa|thiotepa|mesh-list
92520402|NCT00101140|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92520403|NCT00101140|Immunomodulating Agents|immunomodulating agents|mesh-list
92520404|NCT00101140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520405|NCT00101140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520406|NCT00101140|Antimetabolites|antimetabolites|mesh-ancestor
92520407|NCT00101140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520408|NCT00101140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520409|NCT00101140|Immunologic Factors|immunologic factors|mesh-ancestor
92520410|NCT00101140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520411|NCT00101140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520412|NCT00101140|Alkylating Agents|alkylating agents|mesh-ancestor
92520413|NCT00101140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92520414|NCT00101179|Azacitidine|azacitidine|mesh-list
92520415|NCT00101179|Entinostat|entinostat|mesh-list
92520416|NCT00101179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92520417|NCT00101179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520418|NCT00101179|Antimetabolites|antimetabolites|mesh-ancestor
92520419|NCT00101179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520420|NCT00101179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520421|NCT00101179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520422|NCT00400777|Amlodipine|amlodipine|mesh-list
92520423|NCT00400777|Valsartan|valsartan|mesh-list
92520424|NCT00400777|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92520425|NCT00400777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92520426|NCT00400777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92520427|NCT00400777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92520428|NCT00400777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520429|NCT00400777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92520430|NCT00400777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520431|NCT00400777|Vasodilator Agents|vasodilator agents|mesh-ancestor
92520432|NCT00400777|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92245339|NCT01495819|Nicotine|nicotine|mesh-list
92520433|NCT00400777|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92520434|NCT00400777|Diuretics|diuretics|mesh-ancestor
92520435|NCT00400777|Natriuretic Agents|natriuretic agents|mesh-ancestor
92520436|NCT00400777|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92520437|NCT00400816|Temozolomide|temozolomide|mesh-list
92520438|NCT00400816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520439|NCT00400816|Alkylating Agents|alkylating agents|mesh-ancestor
92520440|NCT00400816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520441|NCT00400816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520442|NCT00400855|Fluticasone|fluticasone|mesh-list
92520443|NCT00400855|Xhance|xhance|mesh-list
92520444|NCT00400855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520445|NCT00400855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92520446|NCT00400855|Autonomic Agents|autonomic agents|mesh-ancestor
92520447|NCT00400855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520448|NCT00400855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520449|NCT00400855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92520450|NCT00400855|Respiratory System Agents|respiratory system agents|mesh-ancestor
92520451|NCT00400855|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520452|NCT00400855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92520453|NCT00101296|Tipifarnib|tipifarnib|mesh-list
92520454|NCT00101296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520455|NCT00006398|Timolol|timolol|mesh-list
92520456|NCT00006398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520457|NCT00006398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92520458|NCT00006398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92520459|NCT00006398|Adrenergic Agents|adrenergic agents|mesh-ancestor
92520460|NCT00006398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520461|NCT00006398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520462|NCT00006398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92520463|NCT00006398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92520464|NCT00101335|Celecoxib|celecoxib|mesh-list
92520465|NCT00101335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92520466|NCT00101335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520467|NCT00101335|Analgesics|analgesics|mesh-ancestor
92520468|NCT00101335|Sensory System Agents|sensory system agents|mesh-ancestor
92520469|NCT00101335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520470|NCT00101335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520471|NCT00101335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520472|NCT00101335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520473|NCT00101335|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92520474|NCT00101335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92520475|NCT00101335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520476|NCT00101335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520477|NCT00101374|Leflunomide|leflunomide|mesh-list
92520478|NCT00101374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520479|NCT00101374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520480|NCT00101374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520481|NCT00101374|Immunologic Factors|immunologic factors|mesh-ancestor
92520482|NCT00101374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520483|NCT00006401|Nitric Oxide|nitric oxide|mesh-list
92520484|NCT00006401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92520485|NCT00006401|Autonomic Agents|autonomic agents|mesh-ancestor
92520486|NCT00006401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520487|NCT00006401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520488|NCT00006401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92520489|NCT00006401|Respiratory System Agents|respiratory system agents|mesh-ancestor
92520490|NCT00006401|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92520491|NCT00006401|Antioxidants|antioxidants|mesh-ancestor
92520492|NCT00006401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520493|NCT00006401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520494|NCT00006401|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92520495|NCT00006401|Vasodilator Agents|vasodilator agents|mesh-ancestor
92520496|NCT00006401|Gasotransmitters|gasotransmitters|mesh-ancestor
92520497|NCT00006401|Protective Agents|protective agents|mesh-ancestor
92520498|NCT00101569|Aripiprazole|aripiprazole|mesh-list
92520499|NCT00101569|Antidepressive Agents|antidepressive agents|mesh-ancestor
92520500|NCT00101569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92520501|NCT00101569|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92520502|NCT00101569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92520503|NCT00101569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92520504|NCT00101569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245360|NCT00512876|Bevacizumab|bevacizumab|mesh-list
92520505|NCT00101569|Dopamine Agonists|dopamine agonists|mesh-ancestor
92520506|NCT00101569|Dopamine Agents|dopamine agents|mesh-ancestor
92520507|NCT00101569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520508|NCT00101569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520509|NCT00101569|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92520510|NCT00101569|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92520511|NCT00101569|Serotonin Agents|serotonin agents|mesh-ancestor
92520512|NCT00101569|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92520513|NCT00101569|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92520514|NCT00101569|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92520515|NCT00101569|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92520516|NCT00101764|Triamcinolone|triamcinolone|mesh-list
92520517|NCT00101764|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92520518|NCT00101764|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92520519|NCT00101764|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92520520|NCT00101764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520521|NCT00101764|Glucocorticoids|glucocorticoids|mesh-ancestor
92520522|NCT00101764|Hormones|hormones|mesh-ancestor
92520523|NCT00101764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520524|NCT00101764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520525|NCT00101764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520526|NCT00101764|Immunologic Factors|immunologic factors|mesh-ancestor
92520527|NCT00101764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520528|NCT00101764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520529|NCT00101803|Vildagliptin|vildagliptin|mesh-list
92520530|NCT00101803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520531|NCT00101803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520532|NCT00101803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92520533|NCT00101803|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520534|NCT00101803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520535|NCT00101803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520536|NCT00101842|Gemcitabine|gemcitabine|mesh-list
92520537|NCT00101842|Pemetrexed|pemetrexed|mesh-list
92520538|NCT00101842|Cisplatin|cisplatin|mesh-list
92520539|NCT00101842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520540|NCT00101842|Antimetabolites|antimetabolites|mesh-ancestor
92520541|NCT00101842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520542|NCT00101842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520543|NCT00101842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520544|NCT00101842|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92520545|NCT00101842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92520546|NCT00102115|Talaporfin|talaporfin|mesh-list
92520547|NCT00102115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520548|NCT00102115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92520549|NCT00102115|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520550|NCT00102154|Gaboxadol|gaboxadol|mesh-list
92520551|NCT00102154|Analgesics|analgesics|mesh-ancestor
92520552|NCT00102154|Sensory System Agents|sensory system agents|mesh-ancestor
92520553|NCT00102154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520554|NCT00102154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520555|NCT00102154|Anticonvulsants|anticonvulsants|mesh-ancestor
92520556|NCT00102154|GABA Agonists|gaba agonists|mesh-ancestor
92520557|NCT00102154|GABA Agents|gaba agents|mesh-ancestor
92520558|NCT00102154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520559|NCT00102154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520560|NCT00102271|Oxypurinol|oxypurinol|mesh-list
92520561|NCT00102271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520562|NCT00102271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520564|NCT00102310|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92520565|NCT00102310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520566|NCT00102310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520567|NCT00102310|Cholinergic Agents|cholinergic agents|mesh-ancestor
92520568|NCT00102310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520569|NCT00102310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520570|NCT00102310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92520571|NCT00102388|Vildagliptin|vildagliptin|mesh-list
92520572|NCT00102388|Gliclazide|gliclazide|mesh-list
92520573|NCT00102388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520574|NCT00102388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520575|NCT00102388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92520576|NCT00102388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520577|NCT00102388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520578|NCT00102388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520579|NCT00102505|Motexafin gadolinium|motexafin gadolinium|mesh-list
92520580|NCT00102505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520581|NCT00102505|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92520582|NCT00102505|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520583|NCT00102583|Cyclosporine|cyclosporine|mesh-list
92520584|NCT00102583|Cyclosporins|cyclosporins|mesh-list
92520585|NCT00102583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520586|NCT00102583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520587|NCT00102583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520588|NCT00102583|Immunologic Factors|immunologic factors|mesh-ancestor
92520589|NCT00102583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520590|NCT00102583|Antifungal Agents|antifungal agents|mesh-ancestor
92520591|NCT00102583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520592|NCT00102583|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520593|NCT00102583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520594|NCT00102583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92520595|NCT00102622|Paclitaxel|paclitaxel|mesh-list
92520596|NCT00102622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520597|NCT00102622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520598|NCT00102622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520600|NCT00102622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520601|NCT00102622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520602|NCT00006428|Amitriptyline|amitriptyline|mesh-list
92520603|NCT00006428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92520604|NCT00006428|Antidepressive Agents|antidepressive agents|mesh-ancestor
92520605|NCT00006428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92520606|NCT00006428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520607|NCT00006428|Analgesics|analgesics|mesh-ancestor
92520608|NCT00006428|Sensory System Agents|sensory system agents|mesh-ancestor
92520609|NCT00006428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520610|NCT00006428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520611|NCT00006428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92520612|NCT00006428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92520613|NCT00006428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92352728|NCT03598998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520614|NCT00006428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520615|NCT00006428|Adrenergic Agents|adrenergic agents|mesh-ancestor
92520616|NCT00006428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520617|NCT00102661|Alemtuzumab|alemtuzumab|mesh-list
92520618|NCT00102661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92520619|NCT00102661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520620|NCT00102700|Beta-lapachone|beta-lapachone|mesh-list
92520621|NCT00102700|Gemcitabine|gemcitabine|mesh-list
92520622|NCT00102700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520623|NCT00102700|Antimetabolites|antimetabolites|mesh-ancestor
92520624|NCT00102700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520625|NCT00102700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520626|NCT00102700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520627|NCT00102700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92520628|NCT00102700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92520629|NCT00102700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520630|NCT00102700|Antiviral Agents|antiviral agents|mesh-ancestor
92520631|NCT00102778|Ritonavir|ritonavir|mesh-list
92520632|NCT00102778|Lopinavir|lopinavir|mesh-list
92520633|NCT00102778|Aplaviroc|aplaviroc|mesh-list
92520634|NCT00102778|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92520635|NCT00102778|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92520636|NCT00102778|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520637|NCT00102778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520638|NCT00102778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520639|NCT00102778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520640|NCT00102778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520641|NCT00102778|Antiviral Agents|antiviral agents|mesh-ancestor
92520642|NCT00102778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520643|NCT00102778|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92520644|NCT00102778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92520645|NCT00102778|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92520646|NCT00102778|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92520647|NCT00101998|Alvimopan|alvimopan|mesh-list
92520648|NCT00101998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92520649|NCT00102856|Pramipexole|pramipexole|mesh-list
92520650|NCT00102856|Rivastigmine|rivastigmine|mesh-list
92520651|NCT00102856|Antioxidants|antioxidants|mesh-ancestor
92520652|NCT00102856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520653|NCT00102856|Protective Agents|protective agents|mesh-ancestor
92520654|NCT00102856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520655|NCT00102856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92520656|NCT00102856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92520657|NCT00102856|Dopamine Agonists|dopamine agonists|mesh-ancestor
92520658|NCT00102856|Dopamine Agents|dopamine agents|mesh-ancestor
92520659|NCT00102856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520660|NCT00102856|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92520661|NCT00102856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520662|NCT00102856|Cholinergic Agents|cholinergic agents|mesh-ancestor
92520663|NCT00102856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92520664|NCT00102934|Enfuvirtide|enfuvirtide|mesh-list
92520665|NCT00102934|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92520666|NCT00102934|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92520667|NCT00102934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520668|NCT00102934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520669|NCT00102934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520670|NCT00102934|Antiviral Agents|antiviral agents|mesh-ancestor
92520671|NCT00102934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520672|NCT00006443|Lamivudine|lamivudine|mesh-list
92520673|NCT00006443|Stavudine|stavudine|mesh-list
92520675|NCT00006443|Indinavir|indinavir|mesh-list
92520676|NCT00006443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92520677|NCT00006443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92520678|NCT00006443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520679|NCT00006443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520680|NCT00006443|Antiviral Agents|antiviral agents|mesh-ancestor
92520681|NCT00006443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520682|NCT00006443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92520683|NCT00006443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92520684|NCT00006443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92520685|NCT00006443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92520686|NCT00006443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92520687|NCT00006443|Antimetabolites|antimetabolites|mesh-ancestor
92520688|NCT00102973|Carboplatin|carboplatin|mesh-list
92520689|NCT00102973|Doxorubicin|doxorubicin|mesh-list
92520690|NCT00102973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92520691|NCT00102973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520692|NCT00102973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92520693|NCT00102973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92520694|NCT00102973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92520695|NCT00102973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533423|NCT05105685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520696|NCT00102973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520697|NCT00103051|Gemcitabine|gemcitabine|mesh-list
92520698|NCT00103051|Gefitinib|gefitinib|mesh-list
92520699|NCT00103051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520700|NCT00103051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520701|NCT00103051|Antimetabolites|antimetabolites|mesh-ancestor
92520702|NCT00103051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520703|NCT00103051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520704|NCT00103051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520705|NCT00103168|Imatinib Mesylate|imatinib mesylate|mesh-list
92520706|NCT00103168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520707|NCT00103168|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520708|NCT00103168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520709|NCT00103168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520710|NCT02697474|Vaccines|vaccines|mesh-list
92520711|NCT02697474|Immunologic Factors|immunologic factors|mesh-ancestor
92520712|NCT02697474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520713|NCT00103246|Silicon|silicon|mesh-list
92520714|NCT00103246|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
92520715|NCT00103246|Trace Elements|trace elements|mesh-ancestor
92520716|NCT00103246|Micronutrients|micronutrients|mesh-ancestor
92520717|NCT00103246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520718|NCT00103246|Antimalarials|antimalarials|mesh-ancestor
92520719|NCT00103246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92520720|NCT00103246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92520721|NCT00103246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520722|NCT00103246|Antiviral Agents|antiviral agents|mesh-ancestor
92520723|NCT00103246|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92520724|NCT00103246|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520725|NCT00103324|Lapatinib|lapatinib|mesh-list
92520726|NCT00103324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520727|NCT00103324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520728|NCT00103324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520729|NCT00103324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520730|NCT00103519|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
92520731|NCT00103519|Hormones|hormones|mesh-ancestor
92520732|NCT00103519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520733|NCT00103519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520734|NCT00103597|Fludrocortisone|fludrocortisone|mesh-list
92520735|NCT00103597|Domperidone|domperidone|mesh-list
92520736|NCT00103597|Antiemetics|antiemetics|mesh-ancestor
92520737|NCT00103597|Autonomic Agents|autonomic agents|mesh-ancestor
92520738|NCT00103597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520739|NCT00103597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520740|NCT00103597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92520741|NCT00103597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92520742|NCT00103597|Dopamine Agents|dopamine agents|mesh-ancestor
92520743|NCT00103597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520744|NCT00103597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520745|NCT00103597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520746|NCT00006449|Naltrexone|naltrexone|mesh-list
92520747|NCT00006449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92520748|NCT00006449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91929694|NCT02296840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520750|NCT00006449|Sensory System Agents|sensory system agents|mesh-ancestor
92520751|NCT00006449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520752|NCT00103753|Deferiprone|deferiprone|mesh-list
92520753|NCT00103753|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92520754|NCT00103753|Chelating Agents|chelating agents|mesh-ancestor
92520755|NCT00103753|Sequestering Agents|sequestering agents|mesh-ancestor
92520756|NCT00103753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520757|NCT00006452|Motexafin gadolinium|motexafin gadolinium|mesh-list
92520758|NCT00006452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520759|NCT00006452|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92520760|NCT00006452|Dermatologic Agents|dermatologic agents|mesh-ancestor
92520761|NCT00103792|Mycophenolic Acid|mycophenolic acid|mesh-list
92520762|NCT00103792|Cyclophosphamide|cyclophosphamide|mesh-list
92520763|NCT00103792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520764|NCT00103792|Immunologic Factors|immunologic factors|mesh-ancestor
92520765|NCT00103792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520766|NCT00103792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520767|NCT00103792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520768|NCT00103792|Alkylating Agents|alkylating agents|mesh-ancestor
92533424|NCT05325164|Morphine|morphine|mesh-list
92520769|NCT00103792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520770|NCT00103792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520771|NCT00103792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92520772|NCT00103792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92520773|NCT00103792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92520774|NCT00103792|Antitubercular Agents|antitubercular agents|mesh-ancestor
92520775|NCT00103792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92520776|NCT00103792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520777|NCT00103792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520779|NCT00103948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92520780|NCT00103948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520781|NCT00103948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520782|NCT00103948|Cholinergic Agents|cholinergic agents|mesh-ancestor
92520783|NCT00103948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520784|NCT00103948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520785|NCT00103948|Nootropic Agents|nootropic agents|mesh-ancestor
92520786|NCT00006458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92520787|NCT00006458|Antibodies|antibodies|mesh-list
92520788|NCT00006458|Immunoglobulins|immunoglobulins|mesh-list
92520789|NCT00006458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92520790|NCT00006458|Immunologic Factors|immunologic factors|mesh-ancestor
92520791|NCT00006458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520792|NCT00006458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520793|NCT03879408|Acetaminophen|acetaminophen|mesh-list
92520794|NCT03879408|Naproxen|naproxen|mesh-list
92520795|NCT03879408|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92520796|NCT03879408|Hydrocodone|hydrocodone|mesh-list
92520797|NCT03879408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520798|NCT03879408|Analgesics|analgesics|mesh-ancestor
92520799|NCT03879408|Sensory System Agents|sensory system agents|mesh-ancestor
92520800|NCT03879408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520801|NCT03879408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520802|NCT03879408|Antipyretics|antipyretics|mesh-ancestor
92520803|NCT03879408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92520804|NCT03879408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520805|NCT03879408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520806|NCT03879408|Gout Suppressants|gout suppressants|mesh-ancestor
92245656|NCT04946370|Hormones|hormones|mesh-ancestor
92520807|NCT03879408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92520808|NCT03879408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520809|NCT03879408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520810|NCT03879408|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92520811|NCT03879408|Narcotics|narcotics|mesh-ancestor
92520812|NCT03879408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92520813|NCT03879408|Antitussive Agents|antitussive agents|mesh-ancestor
92520814|NCT03879408|Respiratory System Agents|respiratory system agents|mesh-ancestor
92520816|NCT00104182|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92520817|NCT00104182|Insulin Detemir|insulin detemir|mesh-list
92520818|NCT00104182|Isophane Insulin, Human|isophane insulin, human|mesh-list
92520819|NCT00104182|Insulin, Isophane|insulin, isophane|mesh-list
92520820|NCT00104182|Isophane insulin, beef|isophane insulin, beef|mesh-list
92520821|NCT00104182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520822|NCT00104182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520823|NCT00104260|Verapamil|verapamil|mesh-list
92520825|NCT00104260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92520826|NCT00104260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92520827|NCT00104260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520828|NCT00104260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92520829|NCT00104260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520830|NCT00104260|Vasodilator Agents|vasodilator agents|mesh-ancestor
92520831|NCT00388076|Paclitaxel|paclitaxel|mesh-list
92520832|NCT00388076|Carboplatin|carboplatin|mesh-list
92520833|NCT00388076|Lapatinib|lapatinib|mesh-list
92520834|NCT00388076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520835|NCT00388076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520836|NCT00388076|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520837|NCT00388076|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520838|NCT00388076|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520839|NCT00388076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520840|NCT00388076|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520841|NCT00388076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520842|NCT00104689|Capecitabine|capecitabine|mesh-list
92520843|NCT00104689|Oxaliplatin|oxaliplatin|mesh-list
92520844|NCT00104689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520845|NCT00104689|Antimetabolites|antimetabolites|mesh-ancestor
92520846|NCT00104689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520847|NCT00104689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520848|NCT00006461|Cyclophosphamide|cyclophosphamide|mesh-list
92520849|NCT00006461|Etoposide|etoposide|mesh-list
92520850|NCT00006461|Vincristine|vincristine|mesh-list
92520851|NCT00006461|Etoposide phosphate|etoposide phosphate|mesh-list
92520852|NCT00006461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92520853|NCT00006461|Immunologic Factors|immunologic factors|mesh-ancestor
92520854|NCT00006461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520855|NCT00006461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520856|NCT00006461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92520857|NCT00006461|Alkylating Agents|alkylating agents|mesh-ancestor
92520858|NCT00006461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520859|NCT00006461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520860|NCT00006461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92520861|NCT00006461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92520862|NCT00006461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92520863|NCT00006461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92520864|NCT00006461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520865|NCT00006461|Tubulin Modulators|tubulin modulators|mesh-ancestor
92520866|NCT00006461|Antimitotic Agents|antimitotic agents|mesh-ancestor
92520867|NCT00006461|Mitosis Modulators|mitosis modulators|mesh-ancestor
92520868|NCT00104767|Celecoxib|celecoxib|mesh-list
92520869|NCT00104767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92352789|NCT03580356|Omalizumab|omalizumab|mesh-list
92520870|NCT00104767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520871|NCT00104767|Analgesics|analgesics|mesh-ancestor
92520872|NCT00104767|Sensory System Agents|sensory system agents|mesh-ancestor
92520873|NCT00104767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520874|NCT00104767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520875|NCT00104767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520876|NCT00104767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520877|NCT00104767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92520878|NCT00104767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92520879|NCT00104767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520880|NCT00104767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520881|NCT02972268|Tamsulosin|tamsulosin|mesh-list
92520882|NCT02972268|Solifenacin Succinate|solifenacin succinate|mesh-list
92520883|NCT02972268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92520884|NCT02972268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92520885|NCT02972268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92520886|NCT02972268|Adrenergic Agents|adrenergic agents|mesh-ancestor
92520887|NCT02972268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520888|NCT02972268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520889|NCT02972268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520890|NCT02972268|Urological Agents|urological agents|mesh-ancestor
92520891|NCT02972268|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92520892|NCT02972268|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92520893|NCT02972268|Cholinergic Agents|cholinergic agents|mesh-ancestor
92520894|NCT00104806|Cholecalciferol|cholecalciferol|mesh-list
92520895|NCT00104806|Vitamin D|vitamin d|mesh-list
92520896|NCT00104806|Arsenic Trioxide|arsenic trioxide|mesh-list
91929845|NCT02383563|Metformin|metformin|mesh-list
92520897|NCT00104806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92520898|NCT00104806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520899|NCT00104806|Vitamins|vitamins|mesh-ancestor
92520900|NCT00104806|Micronutrients|micronutrients|mesh-ancestor
92520901|NCT00104806|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92520902|NCT00104806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520903|NCT00401128|Gemcitabine|gemcitabine|mesh-list
92520904|NCT00401128|Irinotecan|irinotecan|mesh-list
92520905|NCT00401128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520906|NCT00401128|Antimetabolites|antimetabolites|mesh-ancestor
92520907|NCT00401128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520908|NCT00401128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520909|NCT00401128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92520910|NCT00401128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92520911|NCT00401128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520912|NCT00401167|Memantine|memantine|mesh-list
92520913|NCT00401167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92520914|NCT00401167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92520915|NCT00401167|Dopamine Agents|dopamine agents|mesh-ancestor
92520916|NCT00401167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92520917|NCT00401167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520918|NCT00401167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520919|NCT00401167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92520920|NCT00401167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92520921|NCT00006464|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92520922|NCT00006464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520923|NCT00006464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92520924|NCT00006464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520925|NCT00006464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520926|NCT00104845|Vaccines|vaccines|mesh-list
92520927|NCT00104845|Immunologic Factors|immunologic factors|mesh-ancestor
92520928|NCT00104845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520929|NCT00104923|Fenretinide|fenretinide|mesh-list
92520930|NCT00104923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520931|NCT00104923|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92520932|NCT00104923|Protective Agents|protective agents|mesh-ancestor
92520933|NCT00104923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520934|NCT00104962|Lenalidomide|lenalidomide|mesh-list
92520935|NCT00104962|Immunologic Factors|immunologic factors|mesh-ancestor
92520936|NCT00104962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520937|NCT00104962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92520938|NCT00104962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92520939|NCT00104962|Growth Substances|growth substances|mesh-ancestor
92520940|NCT00104962|Growth Inhibitors|growth inhibitors|mesh-ancestor
92520941|NCT00104962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520942|NCT00006467|Gemcitabine|gemcitabine|mesh-list
92520943|NCT00006467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92520944|NCT00006467|Antimetabolites|antimetabolites|mesh-ancestor
92520945|NCT00006467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520946|NCT00006467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520947|NCT00105040|Levetiracetam|levetiracetam|mesh-list
92520948|NCT00105040|Anticonvulsants|anticonvulsants|mesh-ancestor
92520949|NCT00105040|Nootropic Agents|nootropic agents|mesh-ancestor
92520950|NCT00006470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92520951|NCT00006470|Vaccines|vaccines|mesh-list
92520952|NCT00006470|Antibodies|antibodies|mesh-list
92520953|NCT00006470|Immunoglobulins|immunoglobulins|mesh-list
92520954|NCT00006470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92520955|NCT00006470|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92520956|NCT00006470|Immunologic Factors|immunologic factors|mesh-ancestor
92520957|NCT00006470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520958|NCT00006470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520959|NCT00105352|Glucagon|glucagon|mesh-list
92520960|NCT00105352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92520961|NCT00105352|Hormones|hormones|mesh-ancestor
92520962|NCT00105352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92520963|NCT00105352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520964|NCT03862950|Metformin|metformin|mesh-list
92520965|NCT03862950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92520966|NCT03862950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520967|NCT00105547|Flurbiprofen|flurbiprofen|mesh-list
92520968|NCT00105547|Tarenflurbil|tarenflurbil|mesh-list
92520969|NCT00105547|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92520970|NCT00105547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92520971|NCT00105547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92520972|NCT00105547|Analgesics|analgesics|mesh-ancestor
92520973|NCT00105547|Sensory System Agents|sensory system agents|mesh-ancestor
92520974|NCT00105547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520975|NCT00105547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520976|NCT00105547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92520977|NCT00105547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92520978|NCT00105547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92520979|NCT00105547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92520980|NCT00105547|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92520981|NCT00390624|Mannitol|mannitol|mesh-list
92520982|NCT00390624|Ularitide|ularitide|mesh-list
92520983|NCT00390624|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92520984|NCT00390624|Diuretics|diuretics|mesh-ancestor
92520985|NCT00390624|Natriuretic Agents|natriuretic agents|mesh-ancestor
92520986|NCT00390624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92520987|NCT00390624|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92520988|NCT00390624|Autonomic Agents|autonomic agents|mesh-ancestor
92520989|NCT00390624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92520990|NCT00390624|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92520991|NCT00390624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92520992|NCT00006473|Oxaliplatin|oxaliplatin|mesh-list
92520993|NCT00006473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92520994|NCT00006476|Suramin|suramin|mesh-list
92520995|NCT00006476|Antinematodal Agents|antinematodal agents|mesh-ancestor
92520996|NCT00006476|Anthelmintics|anthelmintics|mesh-ancestor
92520997|NCT00006476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92520998|NCT00006476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92520999|NCT00006476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521000|NCT00006476|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92521001|NCT00006476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92521002|NCT00105937|Fentanyl|fentanyl|mesh-list
92521003|NCT00105937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92521004|NCT00105937|Narcotics|narcotics|mesh-ancestor
92521005|NCT00105937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521006|NCT00105937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521007|NCT00105937|Analgesics|analgesics|mesh-ancestor
92521008|NCT00105937|Sensory System Agents|sensory system agents|mesh-ancestor
92521009|NCT00105937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521010|NCT00105937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92521011|NCT00105937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92521012|NCT00105937|Anesthetics, General|anesthetics, general|mesh-ancestor
92521013|NCT00105937|Anesthetics|anesthetics|mesh-ancestor
92521014|NCT00006479|Leucovorin|leucovorin|mesh-list
92521015|NCT00006479|Fluorouracil|fluorouracil|mesh-list
92521016|NCT00006479|Oxaliplatin|oxaliplatin|mesh-list
92521017|NCT00006479|Calcium|calcium|mesh-list
92521018|NCT00006479|Levoleucovorin|levoleucovorin|mesh-list
92521019|NCT00006479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92521020|NCT00006479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521021|NCT00006479|Antimetabolites|antimetabolites|mesh-ancestor
92521022|NCT00006479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521023|NCT00006479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521024|NCT00006479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521025|NCT00006479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521026|NCT00006479|Immunologic Factors|immunologic factors|mesh-ancestor
92521027|NCT00006479|Antidotes|antidotes|mesh-ancestor
92521028|NCT00006479|Protective Agents|protective agents|mesh-ancestor
92521029|NCT00006479|Vitamin B Complex|vitamin b complex|mesh-ancestor
92521030|NCT00006479|Vitamins|vitamins|mesh-ancestor
92521031|NCT00006479|Micronutrients|micronutrients|mesh-ancestor
92521032|NCT00106054|Leucovorin|leucovorin|mesh-list
92521033|NCT00106054|Bevacizumab|bevacizumab|mesh-list
92521034|NCT00106054|Irinotecan|irinotecan|mesh-list
92521035|NCT00106054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521036|NCT00106054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521037|NCT00106054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92521038|NCT00106054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92521039|NCT00106054|Growth Substances|growth substances|mesh-ancestor
92521040|NCT00106054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521041|NCT00106054|Growth Inhibitors|growth inhibitors|mesh-ancestor
92521042|NCT00106054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92521043|NCT00106054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521044|NCT00106054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521045|NCT00106054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521046|NCT00106054|Antidotes|antidotes|mesh-ancestor
92521047|NCT00106054|Protective Agents|protective agents|mesh-ancestor
92521048|NCT00106054|Vitamin B Complex|vitamin b complex|mesh-ancestor
92521049|NCT00106054|Vitamins|vitamins|mesh-ancestor
92521050|NCT00106054|Micronutrients|micronutrients|mesh-ancestor
92521052|NCT00106132|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92521053|NCT00106132|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92521054|NCT00106132|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92521055|NCT00106132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521056|NCT00106132|Glucocorticoids|glucocorticoids|mesh-ancestor
92521057|NCT00106132|Hormones|hormones|mesh-ancestor
92521058|NCT00106132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521059|NCT00106132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521060|NCT00106132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521061|NCT00106132|Immunologic Factors|immunologic factors|mesh-ancestor
92521062|NCT00106132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521063|NCT00106132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521064|NCT00106171|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92521065|NCT00106171|Antiviral Agents|antiviral agents|mesh-ancestor
92521066|NCT00106171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521067|NCT03815682|Pembrolizumab|pembrolizumab|mesh-list
92521068|NCT03815682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521069|NCT03815682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521070|NCT03815682|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92521071|NCT03815682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521072|NCT00106288|Amphotericin B|amphotericin b|mesh-list
92521073|NCT00106288|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92521075|NCT00106288|Amebicides|amebicides|mesh-ancestor
92521076|NCT00106288|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92521077|NCT00106288|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92521078|NCT00106288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521079|NCT00106288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521080|NCT00106288|Antifungal Agents|antifungal agents|mesh-ancestor
92521081|NCT00006482|Gemcitabine|gemcitabine|mesh-list
92521082|NCT00006482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521083|NCT00006482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521084|NCT00006482|Antimetabolites|antimetabolites|mesh-ancestor
92521085|NCT00006482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521086|NCT03809988|Letrozole|letrozole|mesh-list
92521087|NCT03809988|Fulvestrant|fulvestrant|mesh-list
92521088|NCT03809988|Palbociclib|palbociclib|mesh-list
92521089|NCT03809988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521090|NCT03809988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92521091|NCT03809988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92521092|NCT03809988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521093|NCT03809988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521094|NCT03809988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92521095|NCT03809988|Hormone Antagonists|hormone antagonists|mesh-ancestor
92521096|NCT03809988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521097|NCT03809988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521098|NCT03809988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92521099|NCT03809988|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92521100|NCT03809988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92521101|NCT00106366|Insulin|insulin|mesh-list
92521102|NCT00106366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92521103|NCT00106366|Insulin Glargine|insulin glargine|mesh-list
92521104|NCT00106366|Insulin Aspart|insulin aspart|mesh-list
92521105|NCT00106366|Insulin Detemir|insulin detemir|mesh-list
92521106|NCT00106366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521107|NCT00106366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521108|NCT00106405|Memantine|memantine|mesh-list
92521109|NCT00106405|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92521110|NCT00106405|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92521111|NCT00106405|Dopamine Agents|dopamine agents|mesh-ancestor
92521112|NCT00106405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521113|NCT00106405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521114|NCT00106405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521115|NCT00106405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92521116|NCT00106405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92521117|NCT00006485|Irinotecan|irinotecan|mesh-list
92521118|NCT00006485|Alvocidib|alvocidib|mesh-list
92521119|NCT00006485|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92521120|NCT00006485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521121|NCT00006485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521122|NCT00006485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521123|NCT00006485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521124|NCT00006485|Growth Inhibitors|growth inhibitors|mesh-ancestor
92521125|NCT00006485|Growth Substances|growth substances|mesh-ancestor
92521126|NCT00006485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521127|NCT00006485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92521128|NCT00106522|Methotrexate|methotrexate|mesh-list
92521129|NCT00106522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92521130|NCT00106522|Abortifacient Agents|abortifacient agents|mesh-ancestor
92521131|NCT00106522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92521132|NCT00106522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521133|NCT00106522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521134|NCT00106522|Antimetabolites|antimetabolites|mesh-ancestor
92521135|NCT00106522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521136|NCT00106522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521137|NCT00106522|Dermatologic Agents|dermatologic agents|mesh-ancestor
92521138|NCT00106522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521139|NCT00106522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92521140|NCT00106522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521141|NCT00106522|Immunologic Factors|immunologic factors|mesh-ancestor
92521142|NCT00106522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521143|NCT00106522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521144|NCT00106561|Irbesartan|irbesartan|mesh-list
92521145|NCT00106561|Spironolactone|spironolactone|mesh-list
92521146|NCT00106561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92521147|NCT00106561|Hormone Antagonists|hormone antagonists|mesh-ancestor
92521148|NCT00106561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521149|NCT00106561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521150|NCT00106561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92521151|NCT00106561|Diuretics|diuretics|mesh-ancestor
92521152|NCT00106561|Natriuretic Agents|natriuretic agents|mesh-ancestor
92521153|NCT00106561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92521154|NCT00106561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92521155|NCT00106561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92521156|NCT00106561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521157|NCT00106600|Pixantrone|pixantrone|mesh-list
92521158|NCT00106600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92521159|NCT00106600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521160|NCT00106600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521161|NCT00106600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521162|NCT00106600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521163|NCT00401206|Dexmedetomidine|dexmedetomidine|mesh-list
92521164|NCT00401206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92521165|NCT00401206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521166|NCT00401206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521167|NCT00401206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92521168|NCT00401206|Analgesics|analgesics|mesh-ancestor
92521169|NCT00401206|Sensory System Agents|sensory system agents|mesh-ancestor
92521170|NCT00401206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521171|NCT00401206|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92521172|NCT00401206|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92521173|NCT00401206|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92521174|NCT00401206|Adrenergic Agents|adrenergic agents|mesh-ancestor
92521175|NCT00401206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521176|NCT00401206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521177|NCT00401323|Docetaxel|docetaxel|mesh-list
92521178|NCT00401323|Fluorouracil|fluorouracil|mesh-list
92521179|NCT00401323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521180|NCT00401323|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521181|NCT00401323|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521182|NCT00401323|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521183|NCT00401323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521184|NCT00401323|Antimetabolites|antimetabolites|mesh-ancestor
92521185|NCT00401323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521186|NCT00401323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521187|NCT00401323|Immunologic Factors|immunologic factors|mesh-ancestor
92521188|NCT00401323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521189|NCT00401362|Naltrexone|naltrexone|mesh-list
92521190|NCT00401362|Methylnaltrexone|methylnaltrexone|mesh-list
92521191|NCT00401362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92521192|NCT00401362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521193|NCT00401362|Sensory System Agents|sensory system agents|mesh-ancestor
92521194|NCT00401362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521195|NCT00401362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92521196|NCT00106834|Infliximab|infliximab|mesh-list
92521197|NCT00106834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92521198|NCT00106834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521199|NCT00106834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92521200|NCT00106834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521201|NCT00106834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521202|NCT00107107|Pramlintide|pramlintide|mesh-list
92521203|NCT00107107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521204|NCT00107107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521205|NCT00107263|Zoledronic Acid|zoledronic acid|mesh-list
92521206|NCT00107263|Letrozole|letrozole|mesh-list
92521207|NCT00107263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521208|NCT00107263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92521209|NCT00107263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92521210|NCT00107263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521211|NCT00107263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521212|NCT00107263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92521213|NCT00107263|Hormone Antagonists|hormone antagonists|mesh-ancestor
92521214|NCT00107263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521215|NCT00107263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521216|NCT00107263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92521217|NCT02964949|Edoxaban|edoxaban|mesh-list
92521218|NCT02964949|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92521219|NCT02964949|Antithrombins|antithrombins|mesh-ancestor
92521220|NCT02964949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92521221|NCT02964949|Protease Inhibitors|protease inhibitors|mesh-ancestor
92521222|NCT02964949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521223|NCT02964949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521224|NCT02964949|Anticoagulants|anticoagulants|mesh-ancestor
92521225|NCT00107341|Paclitaxel|paclitaxel|mesh-list
92521226|NCT00107341|Carboplatin|carboplatin|mesh-list
92521227|NCT00107341|Bortezomib|bortezomib|mesh-list
92521228|NCT00107341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521229|NCT00107341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521230|NCT00107341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521231|NCT00107341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521232|NCT00107341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521233|NCT00107341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521234|NCT00107419|Pemetrexed|pemetrexed|mesh-list
92521235|NCT00107419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521236|NCT00107419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521237|NCT00107419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521238|NCT00107419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92521239|NCT00107419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521240|NCT03683667|Azithromycin|azithromycin|mesh-list
92521241|NCT03683667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521242|NCT03683667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521243|NCT00006578|Ritonavir|ritonavir|mesh-list
92521244|NCT00006578|Amprenavir|amprenavir|mesh-list
92521245|NCT00006578|Lamivudine|lamivudine|mesh-list
92521246|NCT00006578|Abacavir|abacavir|mesh-list
92521247|NCT00006578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92521248|NCT00006578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92521249|NCT00006578|Protease Inhibitors|protease inhibitors|mesh-ancestor
92521250|NCT00006578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521251|NCT00006578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521252|NCT00006578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521253|NCT00006578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521254|NCT00006578|Antiviral Agents|antiviral agents|mesh-ancestor
92521255|NCT00006578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521256|NCT00006578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92521257|NCT00006578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92521258|NCT00006578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521259|NCT00006578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521260|NCT00006578|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92521261|NCT00006578|Antitubercular Agents|antitubercular agents|mesh-ancestor
92521262|NCT00006578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521263|NCT00107458|Valproic Acid|valproic acid|mesh-list
92521264|NCT00107458|Anticonvulsants|anticonvulsants|mesh-ancestor
92521265|NCT00107458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521266|NCT00107458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521267|NCT00107458|GABA Agents|gaba agents|mesh-ancestor
92521268|NCT00107458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521269|NCT00107458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521270|NCT00107458|Antimanic Agents|antimanic agents|mesh-ancestor
92521271|NCT00107458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92521272|NCT00107458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521273|NCT00107458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92521274|NCT00006617|Lamivudine|lamivudine|mesh-list
92521275|NCT00006617|Zidovudine|zidovudine|mesh-list
92521276|NCT00006617|Abacavir|abacavir|mesh-list
92521277|NCT00006617|Amprenavir|amprenavir|mesh-list
92521278|NCT00006617|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521279|NCT00006617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521280|NCT00006617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521281|NCT00006617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521282|NCT00006617|Antiviral Agents|antiviral agents|mesh-ancestor
92521283|NCT00006617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521284|NCT00006617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521285|NCT00006617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521286|NCT00006617|Antimetabolites|antimetabolites|mesh-ancestor
92521287|NCT00006617|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92521288|NCT00006617|Antitubercular Agents|antitubercular agents|mesh-ancestor
92521289|NCT00006617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521290|NCT00006617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92521291|NCT00006617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92521292|NCT00006617|Protease Inhibitors|protease inhibitors|mesh-ancestor
92521293|NCT00107731|Valproic Acid|valproic acid|mesh-list
92521294|NCT00107731|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92521295|NCT00107731|Antidepressive Agents|antidepressive agents|mesh-ancestor
92521296|NCT00107731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92521297|NCT00107731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92521298|NCT00107731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92521299|NCT00107731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521300|NCT00107731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521301|NCT00107731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521302|NCT00107731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521303|NCT00107731|Antimanic Agents|antimanic agents|mesh-ancestor
92521304|NCT00107731|Anticonvulsants|anticonvulsants|mesh-ancestor
92521305|NCT00107731|GABA Agents|gaba agents|mesh-ancestor
92521306|NCT00107731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521307|NCT04712396|Itraconazole|itraconazole|mesh-list
92521308|NCT04712396|Antifungal Agents|antifungal agents|mesh-ancestor
92521309|NCT04712396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521310|NCT04712396|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92521311|NCT04712396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92521312|NCT04712396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521313|NCT04712396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521314|NCT04712396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92521315|NCT04712396|Hormone Antagonists|hormone antagonists|mesh-ancestor
92521316|NCT04712396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521317|NCT04712396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521318|NCT04712396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92521319|NCT00107770|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92521320|NCT00107770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521321|NCT00107809|Modafinil|modafinil|mesh-list
92521322|NCT00107809|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92521323|NCT00107809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521324|NCT00107809|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92521325|NCT00107809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92521326|NCT00107809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92521327|NCT00107809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521328|NCT00006656|Ethanol|ethanol|mesh-list
92521329|NCT00006656|Carmustine|carmustine|mesh-list
92521330|NCT00006656|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92521331|NCT00006656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521332|NCT00006656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521333|NCT00006656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521334|NCT00006656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92521335|NCT00006656|Alkylating Agents|alkylating agents|mesh-ancestor
92521336|NCT00006656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521337|NCT00006656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521338|NCT03667482|Cetuximab|cetuximab|mesh-list
92521339|NCT03667482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521340|NCT03667482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521341|NCT00107848|Modafinil|modafinil|mesh-list
92521342|NCT00107848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92521343|NCT00107848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521344|NCT00107848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92521345|NCT00107848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92521346|NCT00107848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92521347|NCT00107848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521348|NCT00006695|Iodine|iodine|mesh-list
92521349|NCT00006695|Cytarabine|cytarabine|mesh-list
92521350|NCT00006695|Etoposide|etoposide|mesh-list
92521351|NCT00006695|Melphalan|melphalan|mesh-list
92521352|NCT00006695|Carmustine|carmustine|mesh-list
92521353|NCT00006695|Tositumomab I-131|tositumomab i-131|mesh-list
92521354|NCT00006695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521355|NCT00006695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521356|NCT00006695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92521357|NCT00006695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521358|NCT00006695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521359|NCT00006695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521360|NCT00006695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521361|NCT00006695|Antimetabolites|antimetabolites|mesh-ancestor
92521362|NCT00006695|Antiviral Agents|antiviral agents|mesh-ancestor
92521363|NCT00006695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521364|NCT00006695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521365|NCT00006695|Immunologic Factors|immunologic factors|mesh-ancestor
92521366|NCT00006695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521367|NCT00006695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92521368|NCT00006695|Alkylating Agents|alkylating agents|mesh-ancestor
92521369|NCT00006695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92521370|NCT00006695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92521371|NCT00006695|Trace Elements|trace elements|mesh-ancestor
92521372|NCT00006695|Micronutrients|micronutrients|mesh-ancestor
92521373|NCT00108004|Pramlintide|pramlintide|mesh-list
92521374|NCT00108004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521375|NCT00108004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521376|NCT00006734|Cyclophosphamide|cyclophosphamide|mesh-list
92521377|NCT00006734|Ifosfamide|ifosfamide|mesh-list
92521378|NCT00006734|Doxorubicin|doxorubicin|mesh-list
92521379|NCT00006734|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92521380|NCT00006734|Etoposide|etoposide|mesh-list
92521381|NCT00006734|Vincristine|vincristine|mesh-list
92521382|NCT00006734|Lenograstim|lenograstim|mesh-list
92521383|NCT00006734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521384|NCT00006734|Immunologic Factors|immunologic factors|mesh-ancestor
92521385|NCT00006734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521386|NCT00006734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521387|NCT00006734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92521388|NCT00006734|Alkylating Agents|alkylating agents|mesh-ancestor
92521389|NCT00006734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521390|NCT00006734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521391|NCT00006734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92521392|NCT00006734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92521393|NCT00006734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92521394|NCT00006734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521395|NCT00006734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521396|NCT00006734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521397|NCT00006734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92521398|NCT00006734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521399|NCT00006734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521400|NCT00006734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521401|NCT00108238|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92521402|NCT00108238|Estradiol|estradiol|mesh-list
92521403|NCT00108238|Progesterone|progesterone|mesh-list
92521404|NCT00108238|Estrogens|estrogens|mesh-ancestor
92521405|NCT00108238|Hormones|hormones|mesh-ancestor
92521406|NCT00108238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521407|NCT00108238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521408|NCT00108238|Progestins|progestins|mesh-ancestor
92521409|NCT00108238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92521410|NCT00108238|Hormone Antagonists|hormone antagonists|mesh-ancestor
92521411|NCT00108238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92521412|NCT00108238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92521413|NCT00108238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92521415|NCT03625323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521416|NCT03625323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521417|NCT03625323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92521418|NCT03625323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521419|NCT00108316|Fluoxetine|fluoxetine|mesh-list
92521420|NCT00108316|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92521421|NCT00108316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92521422|NCT00108316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92521423|NCT00108316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521424|NCT00108316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521425|NCT00108316|Serotonin Agents|serotonin agents|mesh-ancestor
92521426|NCT00108316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521427|NCT00108316|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92521428|NCT00108316|Antidepressive Agents|antidepressive agents|mesh-ancestor
92521429|NCT00108316|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92521430|NCT00108316|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92521431|NCT00108316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92521432|NCT00108316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521433|NCT00108394|Pamidronate|pamidronate|mesh-list
92521434|NCT00108394|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92521435|NCT00108394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521436|NCT00108511|Gemfibrozil|gemfibrozil|mesh-list
92521437|NCT00108511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92521438|NCT00108511|Antimetabolites|antimetabolites|mesh-ancestor
92521439|NCT00108511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521440|NCT00108511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92521441|NCT00108511|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92521442|NCT00108511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92521444|NCT00401440|Misoprostol|misoprostol|mesh-list
92521445|NCT00401440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92521446|NCT00401440|Abortifacient Agents|abortifacient agents|mesh-ancestor
92521447|NCT00401440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92521448|NCT00401440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521449|NCT00401440|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92521450|NCT00401440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521451|NCT00401440|Oxytocics|oxytocics|mesh-ancestor
92521452|NCT00108667|Levodopa|levodopa|mesh-list
92521453|NCT00108667|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92521454|NCT00108667|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92521455|NCT00108667|Dopamine Agents|dopamine agents|mesh-ancestor
92521456|NCT00108667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521457|NCT00108667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521458|NCT00108667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521459|NCT00006773|Bortezomib|bortezomib|mesh-list
92521460|NCT00006773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521461|NCT00108706|Candesartan|candesartan|mesh-list
92521462|NCT00108706|Candesartan cilexetil|candesartan cilexetil|mesh-list
92521463|NCT00108706|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92521464|NCT00108706|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92521465|NCT00108706|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92521466|NCT00108706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521467|NCT03619551|Busulfan|busulfan|mesh-list
92521468|NCT03619551|Alkylating Agents|alkylating agents|mesh-ancestor
92521469|NCT03619551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521470|NCT03619551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521471|NCT03619551|Immunologic Factors|immunologic factors|mesh-ancestor
92521472|NCT03619551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521473|NCT03619551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92521474|NCT03619551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521475|NCT03619551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92521476|NCT00006812|Capecitabine|capecitabine|mesh-list
92521477|NCT00006812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521478|NCT00006812|Antimetabolites|antimetabolites|mesh-ancestor
92521479|NCT00006812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521480|NCT00006812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521481|NCT00006890|Thalidomide|thalidomide|mesh-list
92521482|NCT00006890|Prednisone|prednisone|mesh-list
92521483|NCT00006890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521484|NCT00006890|Glucocorticoids|glucocorticoids|mesh-ancestor
92521485|NCT00006890|Hormones|hormones|mesh-ancestor
92521486|NCT00006890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521487|NCT00006890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521488|NCT00006890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92521489|NCT00006890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521490|NCT00006890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521491|NCT00006890|Immunologic Factors|immunologic factors|mesh-ancestor
92521492|NCT00006890|Leprostatic Agents|leprostatic agents|mesh-ancestor
92521493|NCT00006890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521494|NCT00006890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521495|NCT00006890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92521496|NCT00006890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92521497|NCT00006890|Growth Substances|growth substances|mesh-ancestor
92521498|NCT00006890|Growth Inhibitors|growth inhibitors|mesh-ancestor
92521500|NCT00108979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92521501|NCT00108979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92521502|NCT00108979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92521503|NCT00108979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521504|NCT00108979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521505|NCT00108979|Serotonin Agents|serotonin agents|mesh-ancestor
92521506|NCT00108979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521507|NCT03608397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92521508|NCT03608397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92521509|NCT03608397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92521510|NCT03608397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533434|NCT05325164|Respiratory System Agents|respiratory system agents|mesh-ancestor
92521511|NCT03608397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521512|NCT03608397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92521513|NCT03608397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92521514|NCT03608397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521515|NCT03608397|Cholinergic Agents|cholinergic agents|mesh-ancestor
92521516|NCT03608397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521517|NCT00109057|Bevacizumab|bevacizumab|mesh-list
92521518|NCT00109057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521519|NCT00109057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521520|NCT00109057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92521521|NCT00109057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92521522|NCT00109057|Growth Substances|growth substances|mesh-ancestor
92521523|NCT00109057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521524|NCT00109057|Growth Inhibitors|growth inhibitors|mesh-ancestor
92521525|NCT00109096|Pemetrexed|pemetrexed|mesh-list
92521526|NCT00109096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521527|NCT00109096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521528|NCT00109096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521529|NCT00109096|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92521530|NCT00109096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521531|NCT00109135|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92521532|NCT00109135|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92521533|NCT00109135|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92521534|NCT00109135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521535|NCT00109135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521536|NCT00109135|Hormones|hormones|mesh-ancestor
92521537|NCT00109135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521538|NCT00109135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521539|NCT00006929|Suramin|suramin|mesh-list
92521540|NCT00006929|Paclitaxel|paclitaxel|mesh-list
92521541|NCT00006929|Carboplatin|carboplatin|mesh-list
92521542|NCT00006929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521543|NCT00006929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521544|NCT00006929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521545|NCT00006929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521546|NCT00006929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521547|NCT00006929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521548|NCT00006929|Antinematodal Agents|antinematodal agents|mesh-ancestor
92521549|NCT00006929|Anthelmintics|anthelmintics|mesh-ancestor
92521550|NCT00006929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92521551|NCT00006929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521552|NCT00006929|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92521553|NCT00006929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92521554|NCT00006968|Cyclosporine|cyclosporine|mesh-list
92521555|NCT00006968|Pentostatin|pentostatin|mesh-list
92521556|NCT00006968|Cyclosporins|cyclosporins|mesh-list
92521557|NCT00006968|Immunologic Factors|immunologic factors|mesh-ancestor
92521558|NCT00006968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521559|NCT00006968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521560|NCT00006968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521561|NCT00006968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521562|NCT00006968|Antifungal Agents|antifungal agents|mesh-ancestor
91930534|NCT02365155|Vitamin D|vitamin d|mesh-list
92521563|NCT00006968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521564|NCT00006968|Dermatologic Agents|dermatologic agents|mesh-ancestor
92521565|NCT00006968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521566|NCT00006968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92521567|NCT00006968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521568|NCT00006968|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92521570|NCT00109408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92521571|NCT00109408|Abortifacient Agents|abortifacient agents|mesh-ancestor
92521572|NCT00109408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92521573|NCT00109408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521574|NCT00109408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521576|NCT00109408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521577|NCT00109408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521578|NCT00109408|Dermatologic Agents|dermatologic agents|mesh-ancestor
92521579|NCT00109408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521580|NCT00109408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92521581|NCT00109408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521582|NCT00109408|Immunologic Factors|immunologic factors|mesh-ancestor
92521583|NCT00109408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521584|NCT00109408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521585|NCT00109564|Acetylcholine|acetylcholine|mesh-list
92521586|NCT00109564|Nicotinic Agonists|nicotinic agonists|mesh-list
92521587|NCT00109564|Vasodilator Agents|vasodilator agents|mesh-ancestor
92521588|NCT00109564|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92521589|NCT00109564|Cholinergic Agents|cholinergic agents|mesh-ancestor
92521590|NCT00109564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521591|NCT00109564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521592|NCT00109564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521593|NCT00109603|Tenofovir|tenofovir|mesh-list
92521594|NCT00109603|Antiviral Agents|antiviral agents|mesh-ancestor
92521595|NCT00109603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521596|NCT00109603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521597|NCT00109603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521598|NCT00109603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521599|NCT00109603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521600|NCT00109603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521601|NCT00109603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521602|NCT00109798|Temozolomide|temozolomide|mesh-list
92521603|NCT00109798|Topotecan|topotecan|mesh-list
92521604|NCT00109798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92521605|NCT00109798|Alkylating Agents|alkylating agents|mesh-ancestor
92521606|NCT00109798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521607|NCT00109798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521608|NCT00109798|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92521609|NCT00109798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521610|NCT00109798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521611|NCT00109954|Cisplatin|cisplatin|mesh-list
92521612|NCT00109954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521613|NCT00109993|Methylprednisolone|methylprednisolone|mesh-list
92521614|NCT00109993|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92521615|NCT00109993|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92521616|NCT00109993|Prednisolone|prednisolone|mesh-list
92521617|NCT00109993|Prednisolone acetate|prednisolone acetate|mesh-list
92521618|NCT00109993|Alemtuzumab|alemtuzumab|mesh-list
92521619|NCT00109993|Tacrolimus|tacrolimus|mesh-list
92521620|NCT00109993|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92521621|NCT00109993|Prednisolone phosphate|prednisolone phosphate|mesh-list
92521622|NCT00109993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521623|NCT00109993|Immunologic Factors|immunologic factors|mesh-ancestor
92521624|NCT00109993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521625|NCT00109993|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92521626|NCT00109993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521627|NCT00109993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521628|NCT00109993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521629|NCT00109993|Antiemetics|antiemetics|mesh-ancestor
92521630|NCT00109993|Autonomic Agents|autonomic agents|mesh-ancestor
92246477|NCT05092412|Durvalumab|durvalumab|mesh-list
92521632|NCT00109993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521633|NCT00109993|Glucocorticoids|glucocorticoids|mesh-ancestor
92521634|NCT00109993|Hormones|hormones|mesh-ancestor
92521635|NCT00109993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521636|NCT00109993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92521637|NCT00109993|Protective Agents|protective agents|mesh-ancestor
92521638|NCT00109993|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92521640|NCT00109993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521641|NCT00110032|Etanidazole|etanidazole|mesh-list
92521642|NCT00110032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521643|NCT00110071|Iodine|iodine|mesh-list
92521644|NCT00110071|Cadexomer iodine|cadexomer iodine|mesh-list
92521645|NCT00110071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92521646|NCT00110071|Fludarabine|fludarabine|mesh-list
92521647|NCT00110071|Fludarabine phosphate|fludarabine phosphate|mesh-list
92521648|NCT00110071|Tositumomab I-131|tositumomab i-131|mesh-list
92521649|NCT00110071|Antibodies|antibodies|mesh-list
92521650|NCT00110071|Immunoglobulins|immunoglobulins|mesh-list
92521651|NCT00110071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92521652|NCT00110071|Immunologic Factors|immunologic factors|mesh-ancestor
92521653|NCT00110071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521654|NCT00110071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521655|NCT00110071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521656|NCT00110071|Antimetabolites|antimetabolites|mesh-ancestor
92521657|NCT00110071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521658|NCT00110071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521659|NCT00110071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92521660|NCT00110071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521661|NCT00110071|Trace Elements|trace elements|mesh-ancestor
92521662|NCT00110071|Micronutrients|micronutrients|mesh-ancestor
92521664|NCT00110188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521665|NCT00110188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521666|NCT00110188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92521667|NCT00110188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521668|NCT00110188|Antifungal Agents|antifungal agents|mesh-ancestor
92521669|NCT00110188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521670|NCT00110188|Immunologic Factors|immunologic factors|mesh-ancestor
92521671|NCT00110188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521672|NCT00007202|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92521673|NCT00007202|Didanosine|didanosine|mesh-list
92521674|NCT00007202|Stavudine|stavudine|mesh-list
92521675|NCT00007202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92521676|NCT00007202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92521677|NCT00007202|Protease Inhibitors|protease inhibitors|mesh-ancestor
92521678|NCT00007202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521679|NCT00007202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521680|NCT00007202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521681|NCT00007202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521682|NCT00007202|Antiviral Agents|antiviral agents|mesh-ancestor
92521683|NCT00007202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521684|NCT00007202|Antimetabolites|antimetabolites|mesh-ancestor
92521685|NCT00007202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521686|NCT00007202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521687|NCT00110344|Sorafenib|sorafenib|mesh-list
92521688|NCT00110344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521689|NCT00110344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92521690|NCT00110344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521691|NCT00110344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521692|NCT00401479|Solabegron|solabegron|mesh-list
92521693|NCT00401479|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92521694|NCT00401479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92521695|NCT00401479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92521696|NCT00401479|Adrenergic Agents|adrenergic agents|mesh-ancestor
92521697|NCT00401479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521698|NCT00401479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521699|NCT00401479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521700|NCT00110578|Aldesleukin|aldesleukin|mesh-list
92521701|NCT00110578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521702|NCT00110578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521703|NCT00110578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521704|NCT00110578|Antiviral Agents|antiviral agents|mesh-ancestor
92521705|NCT00110578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521706|NCT00388193|Rituximab|rituximab|mesh-list
92521707|NCT00388193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521708|NCT00388193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521709|NCT00388193|Immunologic Factors|immunologic factors|mesh-ancestor
92521710|NCT00388193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521711|NCT00388193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521712|NCT00110695|Paclitaxel|paclitaxel|mesh-list
92521713|NCT00110695|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92521714|NCT00110695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521716|NCT00110695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521717|NCT00110695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521718|NCT00110695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521719|NCT00110695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521720|NCT00110734|Lidocaine|lidocaine|mesh-list
92521721|NCT00110734|Tetracaine|tetracaine|mesh-list
92521722|NCT00110734|Anesthetics, Local|anesthetics, local|mesh-ancestor
92521723|NCT00110734|Anesthetics|anesthetics|mesh-ancestor
92521724|NCT00110734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521725|NCT00110734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521726|NCT00110734|Sensory System Agents|sensory system agents|mesh-ancestor
92521727|NCT00110734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521728|NCT00110734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92521729|NCT00110734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92521730|NCT00110734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92521731|NCT00110734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92521732|NCT00110734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521734|NCT00110773|Tetracaine|tetracaine|mesh-list
92521735|NCT00110773|Anesthetics, Local|anesthetics, local|mesh-ancestor
92521736|NCT00110773|Anesthetics|anesthetics|mesh-ancestor
92521737|NCT00110773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521738|NCT00110773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521739|NCT00110773|Sensory System Agents|sensory system agents|mesh-ancestor
92521740|NCT00110773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521741|NCT00110773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92521742|NCT00110773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92521743|NCT00110773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92521744|NCT00110773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92521745|NCT00110773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521746|NCT00110851|Metformin|metformin|mesh-list
92521747|NCT00110851|Rosiglitazone|rosiglitazone|mesh-list
92521748|NCT00110851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521749|NCT00110851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521750|NCT00110929|Cinacalcet|cinacalcet|mesh-list
92521751|NCT00110929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92521752|NCT00110929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521753|NCT00110929|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92521754|NCT00110929|Hormone Antagonists|hormone antagonists|mesh-ancestor
92521755|NCT00110929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521756|NCT00111046|Ibuprofen|ibuprofen|mesh-list
92521757|NCT00111046|Tramadol|tramadol|mesh-list
92521758|NCT00111046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92521759|NCT00111046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92521760|NCT00111046|Analgesics|analgesics|mesh-ancestor
92521761|NCT00111046|Sensory System Agents|sensory system agents|mesh-ancestor
92521762|NCT00111046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521763|NCT00111046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521764|NCT00111046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521765|NCT00111046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521766|NCT00111046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92521767|NCT00111046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521768|NCT00111046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521769|NCT00111046|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92521770|NCT00111046|Narcotics|narcotics|mesh-ancestor
92521771|NCT00111046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521772|NCT00388271|Alfuzosin|alfuzosin|mesh-list
92521773|NCT00388271|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92521774|NCT00388271|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92521775|NCT00388271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92521776|NCT00388271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92521777|NCT00388271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521778|NCT00388271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521779|NCT00388271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521780|NCT00388271|Urological Agents|urological agents|mesh-ancestor
92521782|NCT00111124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92521783|NCT00111124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92521784|NCT00111124|Analgesics|analgesics|mesh-ancestor
92521785|NCT00111124|Sensory System Agents|sensory system agents|mesh-ancestor
92521786|NCT00111124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521787|NCT00111124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521788|NCT00111124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521789|NCT00111124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521790|NCT00111124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521791|NCT00111124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521792|NCT00111124|Immunologic Factors|immunologic factors|mesh-ancestor
92521794|NCT00111163|Pyrimethamine|pyrimethamine|mesh-list
92521795|NCT00111163|Sulfadoxine|sulfadoxine|mesh-list
92521796|NCT00111163|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92521797|NCT00111163|Amodiaquine|amodiaquine|mesh-list
92521798|NCT00111163|Dapsone|dapsone|mesh-list
92521799|NCT00111163|Chlorproguanil|chlorproguanil|mesh-list
92521800|NCT00111163|Antimalarials|antimalarials|mesh-ancestor
92521801|NCT00111163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92521802|NCT00111163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92521803|NCT00111163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521804|NCT00111163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521805|NCT00111163|Antiviral Agents|antiviral agents|mesh-ancestor
92521806|NCT00111163|Schistosomicides|schistosomicides|mesh-ancestor
92521807|NCT00111163|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92521808|NCT00111163|Anthelmintics|anthelmintics|mesh-ancestor
92521809|NCT00111163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92521810|NCT00111163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521811|NCT00111163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521812|NCT00111163|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92521813|NCT00111163|Leprostatic Agents|leprostatic agents|mesh-ancestor
92521814|NCT00111163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521815|NCT00111280|Etravirine|etravirine|mesh-list
92521816|NCT00111280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521817|NCT00111280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521818|NCT00111280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521819|NCT00111280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521820|NCT00111280|Antiviral Agents|antiviral agents|mesh-ancestor
92521821|NCT00111280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521822|NCT00111319|Bortezomib|bortezomib|mesh-list
92521823|NCT00111319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521824|NCT00111397|Interferons|interferons|mesh-list
92521825|NCT00111397|Interferon-gamma|interferon-gamma|mesh-list
92521826|NCT00111397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521827|NCT00111397|Antiviral Agents|antiviral agents|mesh-ancestor
92521828|NCT00111397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521829|NCT00111436|Etanercept|etanercept|mesh-list
92521830|NCT00111436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92521831|NCT00111436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92521832|NCT00111436|Analgesics|analgesics|mesh-ancestor
92521833|NCT00111436|Sensory System Agents|sensory system agents|mesh-ancestor
92521834|NCT00111436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521835|NCT00111436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521836|NCT00111436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521837|NCT00111436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92521838|NCT00111436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521839|NCT00111436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521840|NCT00111436|Immunologic Factors|immunologic factors|mesh-ancestor
92521841|NCT00111631|Metformin|metformin|mesh-list
92521842|NCT00111631|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92521843|NCT00111631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521844|NCT00111631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521845|NCT00111631|Protease Inhibitors|protease inhibitors|mesh-ancestor
92521846|NCT00111631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521847|NCT00111631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521848|NCT00111670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92521849|NCT00111670|Protease Inhibitors|protease inhibitors|mesh-ancestor
92521850|NCT00111670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521851|NCT00111670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521852|NCT00111670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521853|NCT00111670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521854|NCT00111748|Thalidomide|thalidomide|mesh-list
92521855|NCT00111748|Dexamethasone|dexamethasone|mesh-list
92521856|NCT00111748|Bortezomib|bortezomib|mesh-list
92521858|NCT00111748|Antiemetics|antiemetics|mesh-ancestor
92521859|NCT00111748|Autonomic Agents|autonomic agents|mesh-ancestor
92521860|NCT00111748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521861|NCT00111748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521862|NCT00111748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521863|NCT00111748|Glucocorticoids|glucocorticoids|mesh-ancestor
92521864|NCT00111748|Hormones|hormones|mesh-ancestor
92521865|NCT00111748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521867|NCT00111748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521868|NCT00111748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521869|NCT00111748|Immunologic Factors|immunologic factors|mesh-ancestor
92521870|NCT00111748|Leprostatic Agents|leprostatic agents|mesh-ancestor
92521871|NCT00111748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521872|NCT00111748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521873|NCT00111748|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92521874|NCT00111748|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92521875|NCT00111748|Growth Substances|growth substances|mesh-ancestor
92521876|NCT00111748|Growth Inhibitors|growth inhibitors|mesh-ancestor
92521877|NCT00111787|Paclitaxel|paclitaxel|mesh-list
92521878|NCT00111787|Lapatinib|lapatinib|mesh-list
92521879|NCT00111787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521880|NCT00111787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521881|NCT00111787|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521882|NCT00111787|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521883|NCT00111787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521884|NCT00111787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521885|NCT00111787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92521886|NCT00111787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521888|NCT00111904|genexol-PM|genexol-pm|mesh-list
92521889|NCT00111904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521890|NCT00111904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521891|NCT00111904|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521892|NCT00111904|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521893|NCT00111904|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521894|NCT00111904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521895|NCT00111943|Tenofovir|tenofovir|mesh-list
92521896|NCT00111943|Antiviral Agents|antiviral agents|mesh-ancestor
92521897|NCT00111943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521898|NCT00111943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521899|NCT00111943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521900|NCT00111943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521901|NCT00111943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521902|NCT00111943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521903|NCT00111943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521904|NCT00401596|Omalizumab|omalizumab|mesh-list
92521905|NCT00401596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92521906|NCT00401596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92521907|NCT00401596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92521908|NCT00401635|Carboplatin|carboplatin|mesh-list
92521909|NCT00401635|Doxorubicin|doxorubicin|mesh-list
92521910|NCT00401635|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92521911|NCT00401635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521912|NCT00401635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92521913|NCT00401635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92521914|NCT00401635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92521915|NCT00401635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521916|NCT00401635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521917|NCT00401674|Paclitaxel|paclitaxel|mesh-list
92521918|NCT00401674|Carboplatin|carboplatin|mesh-list
92521919|NCT00401674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92521920|NCT00401674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521921|NCT00401674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92521922|NCT00401674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92521923|NCT00401674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92521924|NCT00401674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521925|NCT00112021|Pramlintide|pramlintide|mesh-list
92521926|NCT00112021|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92521927|NCT00112021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92521928|NCT00112021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521929|NCT00112021|Appetite Depressants|appetite depressants|mesh-ancestor
92521930|NCT00112021|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92521931|NCT00112021|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92521932|NCT00112021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521933|NCT00007358|Dexamethasone|dexamethasone|mesh-list
92521934|NCT00007358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92521935|NCT00007358|Antiemetics|antiemetics|mesh-ancestor
92521936|NCT00007358|Autonomic Agents|autonomic agents|mesh-ancestor
92521937|NCT00007358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521938|NCT00007358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521939|NCT00007358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92521940|NCT00007358|Glucocorticoids|glucocorticoids|mesh-ancestor
92521942|NCT00007358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92521943|NCT00007358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92521944|NCT00007358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521945|NCT00112138|Gabapentin|gabapentin|mesh-list
92521946|NCT00112138|Analgesics|analgesics|mesh-ancestor
92521947|NCT00112138|Sensory System Agents|sensory system agents|mesh-ancestor
92521948|NCT00112138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521949|NCT00112138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521950|NCT00112138|Anticonvulsants|anticonvulsants|mesh-ancestor
92521951|NCT00112138|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92521952|NCT00112138|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92521953|NCT00112138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92521954|NCT00112138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92521955|NCT00112138|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92521956|NCT00112138|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92521957|NCT00112138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92521958|NCT00112138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521959|NCT00112138|Antimanic Agents|antimanic agents|mesh-ancestor
92521960|NCT03330639|Capsaicin|capsaicin|mesh-list
92521961|NCT03330639|Antipruritics|antipruritics|mesh-ancestor
92521962|NCT03330639|Dermatologic Agents|dermatologic agents|mesh-ancestor
92521963|NCT03330639|Sensory System Agents|sensory system agents|mesh-ancestor
92521964|NCT03330639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92521965|NCT03330639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521966|NCT00007436|Tenofovir|tenofovir|mesh-list
92521967|NCT00007436|Antiviral Agents|antiviral agents|mesh-ancestor
92521968|NCT00007436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521969|NCT00007436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92521970|NCT00007436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92521971|NCT00007436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92521972|NCT00007436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92521973|NCT00007436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92521974|NCT00007436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92521975|NCT00112216|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92521976|NCT00112216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92521977|NCT00112216|Immunologic Factors|immunologic factors|mesh-ancestor
92521978|NCT00112216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521979|NCT00112372|Sirolimus|sirolimus|mesh-list
92521980|NCT00112372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92521981|NCT00112372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92521982|NCT00112372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92521983|NCT00112372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521984|NCT00112372|Antifungal Agents|antifungal agents|mesh-ancestor
92521985|NCT00112372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92521986|NCT00112372|Immunologic Factors|immunologic factors|mesh-ancestor
92521987|NCT00112372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521988|NCT00112528|Bevacizumab|bevacizumab|mesh-list
92521989|NCT00112528|Gemcitabine|gemcitabine|mesh-list
92521990|NCT00112528|Oxaliplatin|oxaliplatin|mesh-list
92521991|NCT00112528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92521992|NCT00112528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92521993|NCT00112528|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92521994|NCT00112528|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92521995|NCT00112528|Growth Substances|growth substances|mesh-ancestor
92521996|NCT00112528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92521997|NCT00112528|Growth Inhibitors|growth inhibitors|mesh-ancestor
92521998|NCT00112528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92521999|NCT00112528|Antimetabolites|antimetabolites|mesh-ancestor
92522000|NCT00112528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522001|NCT00007592|Chlorthalidone|chlorthalidone|mesh-list
92522002|NCT00007592|Furosemide|furosemide|mesh-list
92522003|NCT00007592|Diuretics|diuretics|mesh-ancestor
92522004|NCT00007592|Natriuretic Agents|natriuretic agents|mesh-ancestor
92522005|NCT00007592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522006|NCT00007592|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92522007|NCT00007592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92522008|NCT00007592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522009|NCT00007592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92522010|NCT00007592|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92522012|NCT00007631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522013|NCT00007631|Keratolytic Agents|keratolytic agents|mesh-ancestor
92522014|NCT00007631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522015|NCT00112567|Fludarabine|fludarabine|mesh-list
92522017|NCT00112567|Thiotepa|thiotepa|mesh-list
92522018|NCT00112567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522019|NCT00112567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522020|NCT00112567|Antimetabolites|antimetabolites|mesh-ancestor
92522021|NCT00112567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522022|NCT00112567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522023|NCT00112567|Immunologic Factors|immunologic factors|mesh-ancestor
92522024|NCT00112567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522025|NCT00112567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522026|NCT00112567|Alkylating Agents|alkylating agents|mesh-ancestor
92522027|NCT00112567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92522028|NCT00112645|Cyclosporine|cyclosporine|mesh-list
92522029|NCT00112645|Methylprednisolone|methylprednisolone|mesh-list
92522030|NCT00112645|Methotrexate|methotrexate|mesh-list
92522031|NCT00112645|Melphalan|melphalan|mesh-list
92522032|NCT00112645|Busulfan|busulfan|mesh-list
92522033|NCT00112645|Cyclosporins|cyclosporins|mesh-list
92522034|NCT00112645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92522035|NCT00112645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92522036|NCT00112645|Abortifacient Agents|abortifacient agents|mesh-ancestor
92522037|NCT00112645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92522038|NCT00112645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522039|NCT00112645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522040|NCT00112645|Antimetabolites|antimetabolites|mesh-ancestor
92522041|NCT00112645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522042|NCT00112645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522043|NCT00112645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522044|NCT00112645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522045|NCT00112645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92522046|NCT00112645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522047|NCT00112645|Immunologic Factors|immunologic factors|mesh-ancestor
92522048|NCT00112645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522049|NCT00112645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92522050|NCT00112645|Antifungal Agents|antifungal agents|mesh-ancestor
92522051|NCT00112645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522052|NCT00112645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92522053|NCT00112645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522054|NCT00112645|Antiemetics|antiemetics|mesh-ancestor
92522055|NCT00112645|Autonomic Agents|autonomic agents|mesh-ancestor
92522056|NCT00112645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522057|NCT00112645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522058|NCT00112645|Glucocorticoids|glucocorticoids|mesh-ancestor
92522059|NCT00112645|Hormones|hormones|mesh-ancestor
92522060|NCT00112645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522061|NCT00112645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92522062|NCT00112645|Protective Agents|protective agents|mesh-ancestor
92522063|NCT00112645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522064|NCT00112645|Alkylating Agents|alkylating agents|mesh-ancestor
92522065|NCT00112645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92522066|NCT00112684|Alvocidib|alvocidib|mesh-list
92522067|NCT00112684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522068|NCT00112684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92522069|NCT00112684|Growth Substances|growth substances|mesh-ancestor
92522070|NCT00112684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522071|NCT00112684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92522072|NCT00112684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522073|NCT00112684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522074|NCT00007670|Lamotrigine|lamotrigine|mesh-list
92522075|NCT00007670|Carbamazepine|carbamazepine|mesh-list
92522076|NCT00007670|Gabapentin|gabapentin|mesh-list
92522077|NCT00007670|Analgesics|analgesics|mesh-ancestor
92522078|NCT00007670|Sensory System Agents|sensory system agents|mesh-ancestor
92522079|NCT00007670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522080|NCT00007670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522081|NCT00007670|Anticonvulsants|anticonvulsants|mesh-ancestor
92522082|NCT00007670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92522083|NCT00007670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92522084|NCT00007670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92522085|NCT00007670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92522086|NCT00007670|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92522087|NCT00007670|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92522088|NCT00007670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522089|NCT00007670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522091|NCT00007670|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92522093|NCT00007670|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92522094|NCT00007670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92352917|NCT03522168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92522095|NCT00007670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92522096|NCT00007670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92522097|NCT00007670|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92522098|NCT00007670|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92522099|NCT00112879|Ascorbic Acid|ascorbic acid|mesh-list
92522100|NCT00112879|Thalidomide|thalidomide|mesh-list
92522101|NCT00112879|Dexamethasone|dexamethasone|mesh-list
92522102|NCT00112879|Arsenic Trioxide|arsenic trioxide|mesh-list
92522103|NCT00112879|Mitogens|mitogens|mesh-list
92522104|NCT00112879|Immunomodulating Agents|immunomodulating agents|mesh-list
92522105|NCT00112879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522106|NCT00112879|Antiemetics|antiemetics|mesh-ancestor
92522107|NCT00112879|Autonomic Agents|autonomic agents|mesh-ancestor
92522108|NCT00112879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522109|NCT00112879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522110|NCT00112879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522111|NCT00112879|Glucocorticoids|glucocorticoids|mesh-ancestor
92522113|NCT00112879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522114|NCT00112879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92522115|NCT00112879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522116|NCT00112879|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522117|NCT00112879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522118|NCT00112879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522119|NCT00112879|Immunologic Factors|immunologic factors|mesh-ancestor
92522120|NCT00112879|Leprostatic Agents|leprostatic agents|mesh-ancestor
92522121|NCT00112879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92522122|NCT00112879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522123|NCT00112879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92522124|NCT00112879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92522125|NCT00112879|Growth Substances|growth substances|mesh-ancestor
92522126|NCT00112879|Growth Inhibitors|growth inhibitors|mesh-ancestor
92522127|NCT00112879|Antioxidants|antioxidants|mesh-ancestor
92522128|NCT00112879|Protective Agents|protective agents|mesh-ancestor
92522129|NCT00112879|Vitamins|vitamins|mesh-ancestor
92522130|NCT00112879|Micronutrients|micronutrients|mesh-ancestor
92522131|NCT00112996|Thioctic Acid|thioctic acid|mesh-list
92522132|NCT00112996|Antioxidants|antioxidants|mesh-ancestor
92522133|NCT00112996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522134|NCT00112996|Protective Agents|protective agents|mesh-ancestor
92522135|NCT00112996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522136|NCT00112996|Vitamin B Complex|vitamin b complex|mesh-ancestor
92522137|NCT00112996|Vitamins|vitamins|mesh-ancestor
92522138|NCT00112996|Micronutrients|micronutrients|mesh-ancestor
92522139|NCT00113074|Nicotine|nicotine|mesh-list
92522140|NCT00113074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92522141|NCT00113074|Autonomic Agents|autonomic agents|mesh-ancestor
92522142|NCT00113074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522143|NCT00113074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522144|NCT00113074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92522145|NCT00113074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92522146|NCT00113074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92522147|NCT00113074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522148|NCT00113074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522149|NCT00113113|Rubitecan|rubitecan|mesh-list
92522150|NCT00113113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522151|NCT00113113|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92522152|NCT00113113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522153|NCT00113113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522154|NCT00113113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522155|NCT00007787|Cyclosporine|cyclosporine|mesh-list
92522156|NCT00007787|Tacrolimus|tacrolimus|mesh-list
92522157|NCT00007787|Cyclosporins|cyclosporins|mesh-list
92522158|NCT00007787|Thymoglobulin|thymoglobulin|mesh-list
92522159|NCT00007787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522160|NCT00007787|Immunologic Factors|immunologic factors|mesh-ancestor
92522161|NCT00007787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522162|NCT00007787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92522163|NCT00007787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522164|NCT00007787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522165|NCT00007787|Antifungal Agents|antifungal agents|mesh-ancestor
92522166|NCT00007787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522167|NCT00007787|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522168|NCT00007787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522169|NCT00390897|Interferons|interferons|mesh-list
92522170|NCT00390897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522171|NCT00390897|Antiviral Agents|antiviral agents|mesh-ancestor
92522172|NCT00390897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522173|NCT00113347|Docetaxel|docetaxel|mesh-list
92522174|NCT00113347|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92522175|NCT00113347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522176|NCT00113347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522177|NCT00113347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522178|NCT00113347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522179|NCT00113347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522180|NCT00113347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92522181|NCT00113347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522182|NCT00113503|Azathioprine|azathioprine|mesh-list
92522183|NCT00113503|Antimetabolites|antimetabolites|mesh-ancestor
92522184|NCT00113503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522185|NCT00113503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522186|NCT00113503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522187|NCT00113503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522188|NCT00113503|Immunologic Factors|immunologic factors|mesh-ancestor
92522189|NCT00113503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522190|NCT00113503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522191|NCT00113542|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92522192|NCT00113542|Chelating Agents|chelating agents|mesh-ancestor
92522193|NCT00113542|Sequestering Agents|sequestering agents|mesh-ancestor
92522194|NCT00113542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522195|NCT00113542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522196|NCT00113542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92522197|NCT00113542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92522198|NCT00113542|Growth Substances|growth substances|mesh-ancestor
92522199|NCT00113542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522200|NCT00113542|Growth Inhibitors|growth inhibitors|mesh-ancestor
92522201|NCT00113542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522202|NCT00007826|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92522203|NCT00007826|Vaccines|vaccines|mesh-list
92522204|NCT00007826|Antibodies|antibodies|mesh-list
92522205|NCT00007826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92522206|NCT00007826|BCG Vaccine|bcg vaccine|mesh-list
92522207|NCT00007826|Aluminum sulfate|aluminum sulfate|mesh-list
92522208|NCT00007826|Immunologic Factors|immunologic factors|mesh-ancestor
92522209|NCT00007826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522210|NCT00007826|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92522211|NCT00007826|Antacids|antacids|mesh-ancestor
92522212|NCT00007826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522213|NCT00007826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522214|NCT00007865|Rituximab|rituximab|mesh-list
92522215|NCT00007865|Carboplatin|carboplatin|mesh-list
92522216|NCT00007865|Etoposide|etoposide|mesh-list
92522217|NCT00007865|Ifosfamide|ifosfamide|mesh-list
92522218|NCT00007865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522219|NCT00007865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522220|NCT00007865|Immunologic Factors|immunologic factors|mesh-ancestor
92522221|NCT00007865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522222|NCT00007865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522223|NCT00007865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522224|NCT00007865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92522225|NCT00007865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522226|NCT00007865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522227|NCT00007865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522228|NCT00007865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522229|NCT00007865|Alkylating Agents|alkylating agents|mesh-ancestor
92522230|NCT00113698|Enalapril|enalapril|mesh-list
92522231|NCT00113698|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92522232|NCT00113698|Protease Inhibitors|protease inhibitors|mesh-ancestor
92522233|NCT00113698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522234|NCT00113698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522235|NCT00113698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92522237|NCT00113737|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92522238|NCT00113737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92522239|NCT00113737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92522240|NCT00113737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522241|NCT00113737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522242|NCT00113737|Serotonin Agents|serotonin agents|mesh-ancestor
92522243|NCT00113737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522244|NCT00113737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92522245|NCT00113737|Antidepressive Agents|antidepressive agents|mesh-ancestor
92522246|NCT00113737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92522247|NCT00113737|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92522248|NCT00113737|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92522249|NCT00113737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522250|NCT03272295|Fenugreek seed meal|fenugreek seed meal|mesh-list
92522251|NCT03272295|Menthol|menthol|mesh-list
92522252|NCT03272295|Sorbitol|sorbitol|mesh-list
92522253|NCT03272295|Glycerol|glycerol|mesh-list
92533456|NCT00060385|Hormones|hormones|mesh-ancestor
92522254|NCT03272295|Antipruritics|antipruritics|mesh-ancestor
92522255|NCT03272295|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522256|NCT03272295|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92522257|NCT03272295|Protective Agents|protective agents|mesh-ancestor
92522258|NCT03272295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522259|NCT03272295|Cathartics|cathartics|mesh-ancestor
92522260|NCT03272295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522261|NCT03272295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92522262|NCT00007904|Tamoxifen|tamoxifen|mesh-list
92522263|NCT00007904|Paclitaxel|paclitaxel|mesh-list
92522264|NCT00007904|Cyclophosphamide|cyclophosphamide|mesh-list
92522265|NCT00007904|Doxorubicin|doxorubicin|mesh-list
92522266|NCT00007904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92522267|NCT00007904|Lenograstim|lenograstim|mesh-list
92522268|NCT00007904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522269|NCT00007904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522270|NCT00007904|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522271|NCT00007904|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522272|NCT00007904|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522273|NCT00007904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522274|NCT00007904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522275|NCT00007904|Immunologic Factors|immunologic factors|mesh-ancestor
92522276|NCT00007904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522277|NCT00007904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522278|NCT00007904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522279|NCT00007904|Alkylating Agents|alkylating agents|mesh-ancestor
92522280|NCT00007904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92522281|NCT00007904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92522282|NCT00007904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92522283|NCT00007904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522284|NCT00007904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522285|NCT00007904|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92522286|NCT00007904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92522287|NCT00007904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92522288|NCT00007904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522289|NCT00007904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92522290|NCT00007904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92522291|NCT00007904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92522292|NCT00007904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92522293|NCT00113815|Topiramate|topiramate|mesh-list
92522294|NCT00113815|Anticonvulsants|anticonvulsants|mesh-ancestor
92522295|NCT00113815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92522296|NCT00113815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522297|NCT00113854|Mannitol|mannitol|mesh-list
92522298|NCT00113854|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92522299|NCT00113854|Diuretics|diuretics|mesh-ancestor
92522300|NCT00113854|Natriuretic Agents|natriuretic agents|mesh-ancestor
92522301|NCT00113854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522302|NCT00007943|Gemcitabine|gemcitabine|mesh-list
92522303|NCT00007943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522304|NCT00007943|Antimetabolites|antimetabolites|mesh-ancestor
92522305|NCT00007943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522306|NCT00007943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522307|NCT00113971|Epratuzumab|epratuzumab|mesh-list
92522308|NCT00113971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522309|NCT00113971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522310|NCT00114010|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92353014|NCT00089544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522311|NCT00114010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92522312|NCT00114010|Immunologic Factors|immunologic factors|mesh-ancestor
92522313|NCT00114010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522314|NCT00114010|Antacids|antacids|mesh-ancestor
92522315|NCT00114010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522316|NCT00114010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522318|NCT00007982|Thiotepa|thiotepa|mesh-list
92522319|NCT00007982|Carmustine|carmustine|mesh-list
92522320|NCT00007982|Etoposide|etoposide|mesh-list
92522321|NCT00007982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522322|NCT00007982|Immunologic Factors|immunologic factors|mesh-ancestor
92522323|NCT00007982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522324|NCT00007982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522325|NCT00007982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522326|NCT00007982|Alkylating Agents|alkylating agents|mesh-ancestor
92522327|NCT00007982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522328|NCT00007982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522329|NCT00007982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92522330|NCT00007982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522331|NCT00007982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92522332|NCT00007982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522333|NCT00007982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522335|NCT00114205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522336|NCT00114205|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522337|NCT00114205|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522338|NCT00114205|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522339|NCT00114205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522340|NCT00114283|Lapatinib|lapatinib|mesh-list
92522341|NCT00114283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522342|NCT00114283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92522343|NCT00114283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522344|NCT00114283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522345|NCT00114361|Ribavirin|ribavirin|mesh-list
92522346|NCT00114361|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92522347|NCT00114361|Antimetabolites|antimetabolites|mesh-ancestor
92522348|NCT00114361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522349|NCT00114361|Antiviral Agents|antiviral agents|mesh-ancestor
92522350|NCT00114361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522351|NCT00114400|Vitamins|vitamins|mesh-list
92522352|NCT00114400|Folic Acid|folic acid|mesh-list
92522353|NCT00114400|Vitamin B 12|vitamin b 12|mesh-list
92522354|NCT00114400|Vitamin B 6|vitamin b 6|mesh-list
92522355|NCT00114400|Pyridoxal|pyridoxal|mesh-list
92522356|NCT00114400|Pyridoxine|pyridoxine|mesh-list
92522357|NCT00114400|Vitamin B Complex|vitamin b complex|mesh-list
92522358|NCT00114400|Micronutrients|micronutrients|mesh-ancestor
92522359|NCT00114400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522360|NCT00114400|Hematinics|hematinics|mesh-ancestor
92522361|NCT00114439|Lithium Carbonate|lithium carbonate|mesh-list
92522362|NCT00114439|Antidepressive Agents|antidepressive agents|mesh-ancestor
92522363|NCT00114439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92522364|NCT00114439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522365|NCT00114439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522366|NCT00114439|Antimanic Agents|antimanic agents|mesh-ancestor
92522367|NCT00114439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92522368|NCT00114439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92522369|NCT00114439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522370|NCT00114478|Epinephrine|epinephrine|mesh-list
92522371|NCT00114478|Albuterol|albuterol|mesh-list
92522372|NCT00114478|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92522373|NCT00114478|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92522374|NCT00114478|Adrenergic Agents|adrenergic agents|mesh-ancestor
92522375|NCT00114478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522376|NCT00114478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522377|NCT00114478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522378|NCT00114478|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92522379|NCT00114478|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92522380|NCT00114478|Autonomic Agents|autonomic agents|mesh-ancestor
92522381|NCT00114478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522382|NCT00114478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92522383|NCT00114478|Respiratory System Agents|respiratory system agents|mesh-ancestor
92522384|NCT00114478|Mydriatics|mydriatics|mesh-ancestor
92522385|NCT00114478|Sympathomimetics|sympathomimetics|mesh-ancestor
92522386|NCT00114478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92522387|NCT00114478|Tocolytic Agents|tocolytic agents|mesh-ancestor
92522388|NCT00114478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92522389|NCT00114478|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92522390|NCT00114556|Zoledronic Acid|zoledronic acid|mesh-list
92522391|NCT00114556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931337|NCT04910061|Niacinamide|niacinamide|mesh-list
92522392|NCT00114556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522393|NCT00008021|Cyclosporine|cyclosporine|mesh-list
92522394|NCT00008021|Paclitaxel|paclitaxel|mesh-list
92522395|NCT00008021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92522396|NCT00008021|Antibodies|antibodies|mesh-list
92522397|NCT00008021|Immunoglobulins|immunoglobulins|mesh-list
92522398|NCT00008021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92522399|NCT00008021|Cyclosporins|cyclosporins|mesh-list
92522400|NCT00008021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522401|NCT00008021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522402|NCT00008021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522403|NCT00008021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522404|NCT00008021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522405|NCT00008021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522406|NCT00008021|Immunologic Factors|immunologic factors|mesh-ancestor
92522407|NCT00008021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522408|NCT00008021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522409|NCT00008021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522410|NCT00008021|Antifungal Agents|antifungal agents|mesh-ancestor
92522411|NCT00008021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522412|NCT00008021|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522413|NCT00008021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522414|NCT00008021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92522415|NCT03079440|Capecitabine|capecitabine|mesh-list
92522416|NCT03079440|Temozolomide|temozolomide|mesh-list
92522417|NCT03079440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522418|NCT03079440|Antimetabolites|antimetabolites|mesh-ancestor
92522419|NCT03079440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522420|NCT03079440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522421|NCT03079440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522422|NCT03079440|Alkylating Agents|alkylating agents|mesh-ancestor
92522423|NCT04728178|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92522424|NCT00008060|Leucovorin|leucovorin|mesh-list
92522425|NCT00008060|Fluorouracil|fluorouracil|mesh-list
92522426|NCT00008060|Oxaliplatin|oxaliplatin|mesh-list
92522427|NCT00008060|Irinotecan|irinotecan|mesh-list
92522428|NCT00008060|Calcium|calcium|mesh-list
92522429|NCT00008060|Levoleucovorin|levoleucovorin|mesh-list
92522430|NCT00008060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92522431|NCT00008060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522432|NCT00008060|Antimetabolites|antimetabolites|mesh-ancestor
92522433|NCT00008060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522434|NCT00008060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522435|NCT00008060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522436|NCT00008060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522437|NCT00008060|Immunologic Factors|immunologic factors|mesh-ancestor
92522438|NCT00008060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92522439|NCT00008060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522440|NCT00008060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522441|NCT00008060|Antidotes|antidotes|mesh-ancestor
92522442|NCT00008060|Protective Agents|protective agents|mesh-ancestor
92522443|NCT00008060|Vitamin B Complex|vitamin b complex|mesh-ancestor
92522444|NCT00008060|Vitamins|vitamins|mesh-ancestor
92522445|NCT00008060|Micronutrients|micronutrients|mesh-ancestor
92522446|NCT00114868|Vitamins|vitamins|mesh-list
92522447|NCT00114868|Vitamin A|vitamin a|mesh-list
92522448|NCT00114868|Retinol palmitate|retinol palmitate|mesh-list
92522449|NCT00114868|Micronutrients|micronutrients|mesh-ancestor
92522450|NCT00114868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522451|NCT00114868|Antioxidants|antioxidants|mesh-ancestor
92522452|NCT00114868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522453|NCT00114868|Protective Agents|protective agents|mesh-ancestor
92522454|NCT00114868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92522455|NCT00114868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522456|NCT03034200|TIC10 compound|tic10 compound|mesh-list
92522457|NCT03034200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522458|NCT00114946|Bevacizumab|bevacizumab|mesh-list
92353030|NCT00089076|Ipilimumab|ipilimumab|mesh-list
92522459|NCT00114946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522460|NCT00114946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522461|NCT00114946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92522462|NCT00114946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92522463|NCT00114946|Growth Substances|growth substances|mesh-ancestor
92522464|NCT00114946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522465|NCT00114946|Growth Inhibitors|growth inhibitors|mesh-ancestor
92522467|NCT00115024|Estrogens|estrogens|mesh-ancestor
92522468|NCT00115024|Hormones|hormones|mesh-ancestor
92522469|NCT00115024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522470|NCT00115024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522473|NCT00008177|Mycophenolic Acid|mycophenolic acid|mesh-list
92522474|NCT00008177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92522475|NCT00008177|Fludarabine|fludarabine|mesh-list
92522476|NCT00008177|Fludarabine phosphate|fludarabine phosphate|mesh-list
92522477|NCT00008177|Antibodies|antibodies|mesh-list
92522478|NCT00008177|Immunoglobulins|immunoglobulins|mesh-list
92522479|NCT00008177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92522480|NCT00008177|Cyclosporins|cyclosporins|mesh-list
92522481|NCT00008177|Immunologic Factors|immunologic factors|mesh-ancestor
92522482|NCT00008177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522483|NCT00008177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522484|NCT00008177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522485|NCT00008177|Antimetabolites|antimetabolites|mesh-ancestor
92522486|NCT00008177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522487|NCT00008177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522488|NCT00008177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522489|NCT00008177|Antifungal Agents|antifungal agents|mesh-ancestor
92522490|NCT00008177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522491|NCT00008177|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522492|NCT00008177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522493|NCT00008177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92522494|NCT00008177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92522495|NCT00008177|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92522496|NCT00008177|Antitubercular Agents|antitubercular agents|mesh-ancestor
92522497|NCT00008177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92522498|NCT00008177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92522499|NCT00008177|Trace Elements|trace elements|mesh-ancestor
92522500|NCT00008177|Micronutrients|micronutrients|mesh-ancestor
92522501|NCT03007407|Durvalumab|durvalumab|mesh-list
92522502|NCT03007407|Tremelimumab|tremelimumab|mesh-list
92522503|NCT03007407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522504|NCT03007407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522505|NCT00115102|Fentanyl|fentanyl|mesh-list
92522506|NCT00115102|Ketamine|ketamine|mesh-list
92522507|NCT00115102|Esketamine|esketamine|mesh-list
92522508|NCT00115102|Analgesics|analgesics|mesh-ancestor
92522509|NCT00115102|Sensory System Agents|sensory system agents|mesh-ancestor
92522510|NCT00115102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522511|NCT00115102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522512|NCT00115102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92522513|NCT00115102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92522514|NCT00115102|Anesthetics, General|anesthetics, general|mesh-ancestor
92522515|NCT00115102|Anesthetics|anesthetics|mesh-ancestor
92522516|NCT00115102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92522517|NCT00115102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92522518|NCT00115102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92522519|NCT00115102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522520|NCT00115102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522521|NCT00115102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92522522|NCT00115102|Narcotics|narcotics|mesh-ancestor
92522523|NCT00115102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92522524|NCT00115102|Antidepressive Agents|antidepressive agents|mesh-ancestor
92522525|NCT00115102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92522526|NCT00115219|Etanercept|etanercept|mesh-list
92522527|NCT00115219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92522528|NCT00115219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92522529|NCT00115219|Analgesics|analgesics|mesh-ancestor
92522530|NCT00115219|Sensory System Agents|sensory system agents|mesh-ancestor
92522531|NCT00115219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522532|NCT00115219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522533|NCT00115219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522534|NCT00115219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522535|NCT00115219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522536|NCT00115219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522537|NCT00115219|Immunologic Factors|immunologic factors|mesh-ancestor
92522538|NCT00115375|Clopidogrel|clopidogrel|mesh-list
92522539|NCT00115375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92522540|NCT00115375|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92522541|NCT00115375|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92522542|NCT00115375|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92522543|NCT00115375|Purinergic Agents|purinergic agents|mesh-ancestor
92522544|NCT00115375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522545|NCT00115375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522546|NCT00115375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522547|NCT00115414|Cyclophosphamide|cyclophosphamide|mesh-list
92522548|NCT00115414|Docetaxel|docetaxel|mesh-list
92522549|NCT00115414|Doxorubicin|doxorubicin|mesh-list
92522550|NCT00115414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522551|NCT00115414|Immunologic Factors|immunologic factors|mesh-ancestor
92522552|NCT00115414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522553|NCT00115414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522554|NCT00115414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522555|NCT00115414|Alkylating Agents|alkylating agents|mesh-ancestor
92522556|NCT00115414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522557|NCT00115414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522558|NCT00115414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92522559|NCT00115414|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522560|NCT00115414|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522561|NCT00115414|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522562|NCT00115414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92522563|NCT00115414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92522564|NCT00115414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522565|NCT00115414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522566|NCT00115492|Fluticasone|fluticasone|mesh-list
92522567|NCT00115492|Xhance|xhance|mesh-list
92522568|NCT00115492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92522569|NCT00115492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92522570|NCT00115492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522571|NCT00115492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92522572|NCT00115492|Autonomic Agents|autonomic agents|mesh-ancestor
92522573|NCT00115492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522574|NCT00115492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522575|NCT00115492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92522576|NCT00115492|Respiratory System Agents|respiratory system agents|mesh-ancestor
92522577|NCT00115492|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522578|NCT00115492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92522579|NCT00115492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92522580|NCT00115492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92522581|NCT00115492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92522582|NCT00115492|Adrenergic Agents|adrenergic agents|mesh-ancestor
92522583|NCT00115492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522584|NCT00115492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522585|NCT00115492|Glucocorticoids|glucocorticoids|mesh-ancestor
92522586|NCT00115492|Hormones|hormones|mesh-ancestor
92522587|NCT00115492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522588|NCT00115492|Sympathomimetics|sympathomimetics|mesh-ancestor
92522589|NCT02993406|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92522590|NCT02993406|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92522591|NCT02993406|Antimetabolites|antimetabolites|mesh-ancestor
92522592|NCT02993406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522593|NCT02993406|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92522594|NCT02993406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522595|NCT02993406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92522596|NCT02993406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522597|NCT00115531|Vaccines|vaccines|mesh-list
92522598|NCT00115531|Immunologic Factors|immunologic factors|mesh-ancestor
92522599|NCT00115531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522600|NCT00115570|Insulin|insulin|mesh-list
92522601|NCT00115570|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92522602|NCT00115570|Insulin Glargine|insulin glargine|mesh-list
92522603|NCT00115570|Insulin Lispro|insulin lispro|mesh-list
92522604|NCT00115570|Insulin glulisine|insulin glulisine|mesh-list
92522605|NCT00115570|Insulin, Isophane|insulin, isophane|mesh-list
92522606|NCT00115570|Isophane Insulin, Human|isophane insulin, human|mesh-list
92522607|NCT00115570|Isophane insulin, beef|isophane insulin, beef|mesh-list
92522608|NCT00115570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92522609|NCT00115570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522610|NCT00115609|Tenofovir|tenofovir|mesh-list
92522611|NCT00115609|Emtricitabine|emtricitabine|mesh-list
92522612|NCT00115609|Efavirenz|efavirenz|mesh-list
92522613|NCT00115609|Antiviral Agents|antiviral agents|mesh-ancestor
92522614|NCT00115609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522615|NCT00115609|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92522616|NCT00115609|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92522617|NCT00115609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522618|NCT00115609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522619|NCT00115609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92522620|NCT00115609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92522621|NCT00115609|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92522623|NCT00115609|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92522624|NCT00115609|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92522625|NCT00115609|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92522626|NCT00115609|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92522627|NCT00115648|Zidovudine|zidovudine|mesh-list
92522628|NCT00115648|Nevirapine|nevirapine|mesh-list
92522629|NCT00115648|Antimetabolites|antimetabolites|mesh-ancestor
92522630|NCT00115648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522631|NCT00115648|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92522632|NCT00115648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92522633|NCT00115648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522634|NCT00115648|Antiviral Agents|antiviral agents|mesh-ancestor
92522635|NCT00115648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522636|NCT00115648|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92522637|NCT00115648|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92522638|NCT00115648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92522639|NCT00115648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92522640|NCT00008294|Leucovorin|leucovorin|mesh-list
92522641|NCT00008294|Dexamethasone|dexamethasone|mesh-list
92522642|NCT00008294|Fluorouracil|fluorouracil|mesh-list
92522643|NCT00008294|Oxaliplatin|oxaliplatin|mesh-list
92522644|NCT00008294|Floxuridine|floxuridine|mesh-list
92522645|NCT00008294|Calcium|calcium|mesh-list
92522646|NCT00008294|Levoleucovorin|levoleucovorin|mesh-list
92522647|NCT00008294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522648|NCT00008294|Antiemetics|antiemetics|mesh-ancestor
92522649|NCT00008294|Autonomic Agents|autonomic agents|mesh-ancestor
92522650|NCT00008294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522651|NCT00008294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522652|NCT00008294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522653|NCT00008294|Glucocorticoids|glucocorticoids|mesh-ancestor
92522654|NCT00008294|Hormones|hormones|mesh-ancestor
92522655|NCT00008294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522656|NCT00008294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92522657|NCT00008294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522658|NCT00008294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92522659|NCT00008294|Antimetabolites|antimetabolites|mesh-ancestor
92522660|NCT00008294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522661|NCT00008294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522662|NCT00008294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522663|NCT00008294|Immunologic Factors|immunologic factors|mesh-ancestor
92522664|NCT00008294|Antidotes|antidotes|mesh-ancestor
92522665|NCT00008294|Protective Agents|protective agents|mesh-ancestor
92522666|NCT00008294|Vitamin B Complex|vitamin b complex|mesh-ancestor
92522667|NCT00008294|Vitamins|vitamins|mesh-ancestor
92522668|NCT00008294|Micronutrients|micronutrients|mesh-ancestor
92522669|NCT00115687|Nicotine|nicotine|mesh-list
92522670|NCT00115687|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92522671|NCT00115687|Autonomic Agents|autonomic agents|mesh-ancestor
92522672|NCT00115687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522673|NCT00115687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522674|NCT00115687|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92522675|NCT00115687|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92522676|NCT00115687|Cholinergic Agents|cholinergic agents|mesh-ancestor
92522677|NCT00115687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522678|NCT00115687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522679|NCT00115726|Furosemide|furosemide|mesh-list
92522680|NCT00115726|Diuretics|diuretics|mesh-ancestor
92522681|NCT00115726|Natriuretic Agents|natriuretic agents|mesh-ancestor
92522682|NCT00115726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522683|NCT00115726|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92522684|NCT00115726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92522685|NCT00115726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522686|NCT00401869|Epoetin Alfa|epoetin alfa|mesh-list
92522687|NCT00401869|Hematinics|hematinics|mesh-ancestor
92522688|NCT00008333|Vinorelbine|vinorelbine|mesh-list
92522689|NCT00008333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522690|NCT00008333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247556|NCT03000127|Hormones|hormones|mesh-ancestor
92522691|NCT00008333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522692|NCT00008333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522693|NCT00008333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522694|NCT00008333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522695|NCT00008372|Sulfanilamides|sulfanilamides|mesh-list
92522696|NCT00008372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522697|NCT00115921|Antimalarials|antimalarials|mesh-list
92522698|NCT00115921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92522699|NCT00115921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92522700|NCT00115921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522701|NCT00008411|Docetaxel|docetaxel|mesh-list
92522702|NCT00008411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522703|NCT00008411|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522704|NCT00008411|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522705|NCT00008411|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522706|NCT00008411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522707|NCT04727671|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92522708|NCT04727671|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92522709|NCT04727671|Cetrorelix|cetrorelix|mesh-list
92522710|NCT04727671|Menotropins|menotropins|mesh-list
92522711|NCT04727671|Luteolytic Agents|luteolytic agents|mesh-ancestor
92522712|NCT04727671|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92522713|NCT04727671|Contraceptive Agents|contraceptive agents|mesh-ancestor
92522714|NCT04727671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92522715|NCT04727671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522716|NCT04727671|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92522717|NCT04727671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92522718|NCT04727671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522719|NCT04727671|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92522720|NCT04727671|Fertility Agents|fertility agents|mesh-ancestor
92522721|NCT04727671|Hormone Antagonists|hormone antagonists|mesh-ancestor
92522722|NCT04727671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522723|NCT00008450|Cyclosporine|cyclosporine|mesh-list
92522724|NCT00008450|Mycophenolic Acid|mycophenolic acid|mesh-list
92522725|NCT00008450|Cyclosporins|cyclosporins|mesh-list
92522726|NCT00008450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522727|NCT00008450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522728|NCT00008450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522729|NCT00008450|Immunologic Factors|immunologic factors|mesh-ancestor
92522730|NCT00008450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522731|NCT00008450|Antifungal Agents|antifungal agents|mesh-ancestor
92522732|NCT00008450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522733|NCT00008450|Dermatologic Agents|dermatologic agents|mesh-ancestor
92522734|NCT00008450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522735|NCT00008450|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92522736|NCT00008450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92522737|NCT00008450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522738|NCT00008450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92522739|NCT00008450|Antitubercular Agents|antitubercular agents|mesh-ancestor
92522740|NCT00008450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92522741|NCT00008489|Didanosine|didanosine|mesh-list
92522742|NCT00008489|Antimetabolites|antimetabolites|mesh-ancestor
92522743|NCT00008489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522744|NCT00008489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92522745|NCT00008489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92522746|NCT00008489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522747|NCT00008489|Antiviral Agents|antiviral agents|mesh-ancestor
92522748|NCT00008489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522749|NCT00008489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92522750|NCT00008489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92522751|NCT00116350|Misoprostol|misoprostol|mesh-list
92522752|NCT00116350|Oxytocin|oxytocin|mesh-list
92522753|NCT00116350|Oxytocics|oxytocics|mesh-ancestor
92522754|NCT00116350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92522755|NCT00116350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522756|NCT00116350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92522757|NCT00116350|Abortifacient Agents|abortifacient agents|mesh-ancestor
92522758|NCT00116350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92522759|NCT00116350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522760|NCT00116389|Gemcitabine|gemcitabine|mesh-list
92522761|NCT00116389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92522762|NCT00116389|Antimetabolites|antimetabolites|mesh-ancestor
92522763|NCT00116389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522764|NCT00116389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522765|NCT00116467|Vaccines|vaccines|mesh-list
92522766|NCT00116467|Immunologic Factors|immunologic factors|mesh-ancestor
92247616|NCT02248051|CXA-10|cxa-10|mesh-list
92522767|NCT00116467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522768|NCT00008528|Enfuvirtide|enfuvirtide|mesh-list
92522769|NCT00008528|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92522770|NCT00008528|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92522771|NCT00008528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522773|NCT00008528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92522774|NCT00008528|Antiviral Agents|antiviral agents|mesh-ancestor
92522775|NCT00008528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522776|NCT00116506|Bevacizumab|bevacizumab|mesh-list
92522777|NCT00116506|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92522778|NCT00116506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522779|NCT00116506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522780|NCT00116506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92353079|NCT00086346|Cyclosporine|cyclosporine|mesh-list
92522781|NCT00116506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92522782|NCT00116506|Growth Substances|growth substances|mesh-ancestor
92522783|NCT00116506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522784|NCT00116506|Growth Inhibitors|growth inhibitors|mesh-ancestor
92522785|NCT00116506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92522786|NCT00116506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522787|NCT00116506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522788|NCT00116545|Troglitazone|troglitazone|mesh-list
92522789|NCT00116545|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92522790|NCT00116545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522791|NCT00116623|Indomethacin|indomethacin|mesh-list
92522792|NCT00116623|Magnesium Sulfate|magnesium sulfate|mesh-list
92522793|NCT00116623|Analgesics|analgesics|mesh-ancestor
92522794|NCT00116623|Sensory System Agents|sensory system agents|mesh-ancestor
92522795|NCT00116623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522796|NCT00116623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522797|NCT00116623|Anesthetics|anesthetics|mesh-ancestor
92522798|NCT00116623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92522799|NCT00116623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92522800|NCT00116623|Anticonvulsants|anticonvulsants|mesh-ancestor
92522801|NCT00116623|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92522802|NCT00116623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92522803|NCT00116623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522804|NCT00116623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92522805|NCT00116623|Tocolytic Agents|tocolytic agents|mesh-ancestor
92522806|NCT00116623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92522807|NCT00116623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92522808|NCT00116623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92522809|NCT00116623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522810|NCT00116623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522811|NCT00116623|Gout Suppressants|gout suppressants|mesh-ancestor
92522812|NCT00116623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92522813|NCT00116623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522814|NCT02909322|Hydromorphone|hydromorphone|mesh-list
92522815|NCT02909322|Bupivacaine|bupivacaine|mesh-list
92522816|NCT02909322|Ropivacaine|ropivacaine|mesh-list
92522817|NCT02909322|Anesthetics, Local|anesthetics, local|mesh-ancestor
92522818|NCT02909322|Anesthetics|anesthetics|mesh-ancestor
92522819|NCT02909322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92522820|NCT02909322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522821|NCT02909322|Sensory System Agents|sensory system agents|mesh-ancestor
92522822|NCT02909322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522823|NCT02909322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92522824|NCT02909322|Narcotics|narcotics|mesh-ancestor
92522825|NCT02909322|Analgesics|analgesics|mesh-ancestor
92522826|NCT00116701|Darbepoetin alfa|darbepoetin alfa|mesh-list
92522827|NCT00116701|Hematinics|hematinics|mesh-ancestor
92522828|NCT00116896|Cisplatin|cisplatin|mesh-list
92522829|NCT00116896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522830|NCT02752815|Prednisone|prednisone|mesh-list
92522831|NCT02752815|Cyclophosphamide|cyclophosphamide|mesh-list
92522832|NCT02752815|Rituximab|rituximab|mesh-list
92522833|NCT02752815|Vincristine|vincristine|mesh-list
92522834|NCT02752815|Epirubicin|epirubicin|mesh-list
92522835|NCT02752815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92522836|NCT02752815|Immunologic Factors|immunologic factors|mesh-ancestor
92522837|NCT02752815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522838|NCT02752815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522839|NCT02752815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92522840|NCT02752815|Alkylating Agents|alkylating agents|mesh-ancestor
92522841|NCT02752815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522842|NCT02752815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522843|NCT02752815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92247678|NCT00651560|Ezetimibe|ezetimibe|mesh-list
92522844|NCT02752815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522845|NCT02752815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92522846|NCT02752815|Glucocorticoids|glucocorticoids|mesh-ancestor
92522847|NCT02752815|Hormones|hormones|mesh-ancestor
92522848|NCT02752815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522849|NCT02752815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92522850|NCT02752815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522851|NCT02752815|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522852|NCT02752815|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522853|NCT02752815|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522854|NCT02752815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92522855|NCT02752815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92522856|NCT02752815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522857|NCT02752815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522858|NCT00116935|Imatinib Mesylate|imatinib mesylate|mesh-list
92522859|NCT00116935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522860|NCT00116935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92522861|NCT00116935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522862|NCT00116935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522863|NCT00388388|Losartan|losartan|mesh-list
92522864|NCT00388388|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92522865|NCT00388388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92522866|NCT00388388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92522867|NCT00388388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92522868|NCT00388388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92522869|NCT00388388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522870|NCT00388388|Diuretics|diuretics|mesh-ancestor
92522871|NCT00388388|Natriuretic Agents|natriuretic agents|mesh-ancestor
92522872|NCT00388388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522873|NCT00388388|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92522874|NCT00388388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92522875|NCT00117013|Topotecan|topotecan|mesh-list
92522876|NCT00117013|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92522877|NCT00117013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92522878|NCT00117013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522879|NCT00117013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522880|NCT00117013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522881|NCT02743455|Vaccines|vaccines|mesh-list
92522882|NCT02743455|Immunologic Factors|immunologic factors|mesh-ancestor
92522883|NCT02743455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522884|NCT00117052|Cinacalcet|cinacalcet|mesh-list
92522885|NCT00117052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92522886|NCT00117052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522887|NCT00117052|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92522888|NCT00117052|Hormone Antagonists|hormone antagonists|mesh-ancestor
92522889|NCT00117052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92522890|NCT00117091|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92522891|NCT00117091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92522892|NCT02972450|Vedolizumab|vedolizumab|mesh-list
92522893|NCT02972450|Vaccines|vaccines|mesh-list
92522894|NCT02972450|Immunologic Factors|immunologic factors|mesh-ancestor
92522895|NCT02972450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522896|NCT02972450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92522897|NCT00117130|Darbepoetin alfa|darbepoetin alfa|mesh-list
92522898|NCT00117130|Hematinics|hematinics|mesh-ancestor
92522899|NCT00117208|Mannitol|mannitol|mesh-list
92522900|NCT00117208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92522901|NCT00117208|Diuretics|diuretics|mesh-ancestor
92522902|NCT00117208|Natriuretic Agents|natriuretic agents|mesh-ancestor
92522903|NCT00117208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522904|NCT00117247|Darbepoetin alfa|darbepoetin alfa|mesh-list
92522906|NCT00388427|Cetuximab|cetuximab|mesh-list
92522907|NCT00388427|Dasatinib|dasatinib|mesh-list
92522908|NCT00388427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92522909|NCT00388427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522910|NCT00388427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92522911|NCT00388427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522912|NCT00388427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522913|NCT00117364|Sacchachitin|sacchachitin|mesh-list
92522914|NCT00117364|Antioxidants|antioxidants|mesh-ancestor
92522915|NCT00117364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522916|NCT00117364|Protective Agents|protective agents|mesh-ancestor
92522917|NCT00117364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522918|NCT00117403|Vitamins|vitamins|mesh-list
92522919|NCT00117403|Vitamin E|vitamin e|mesh-list
92522920|NCT00117403|Thioctic Acid|thioctic acid|mesh-list
92522921|NCT00117403|Coenzyme Q10|coenzyme q10|mesh-list
92522922|NCT00117403|Ubiquinone|ubiquinone|mesh-list
92522923|NCT00117403|Micronutrients|micronutrients|mesh-ancestor
92522924|NCT00117403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522925|NCT00117403|Antioxidants|antioxidants|mesh-ancestor
92522926|NCT00117403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522927|NCT00117403|Protective Agents|protective agents|mesh-ancestor
92522928|NCT00117403|Vitamin B Complex|vitamin b complex|mesh-ancestor
92522929|NCT00117442|Paclitaxel|paclitaxel|mesh-list
92522930|NCT00117442|Carboplatin|carboplatin|mesh-list
92522931|NCT00117442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92522932|NCT00117442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92522933|NCT00117442|Tubulin Modulators|tubulin modulators|mesh-ancestor
92522934|NCT00117442|Antimitotic Agents|antimitotic agents|mesh-ancestor
92522935|NCT00117442|Mitosis Modulators|mitosis modulators|mesh-ancestor
92522936|NCT00117442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522937|NCT00117520|Caffeine|caffeine|mesh-list
92522938|NCT00117520|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92522939|NCT00117520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522940|NCT00117520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92522941|NCT00117520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522942|NCT00117520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522943|NCT00117520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92522944|NCT00117520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92522945|NCT00117520|Purinergic Agents|purinergic agents|mesh-ancestor
92522946|NCT00117520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522947|NCT04727515|Fentanyl|fentanyl|mesh-list
92522948|NCT04727515|Isoflurane|isoflurane|mesh-list
92522949|NCT04727515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92522950|NCT04727515|Narcotics|narcotics|mesh-ancestor
92522951|NCT04727515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92522952|NCT04727515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522953|NCT04727515|Analgesics|analgesics|mesh-ancestor
92522954|NCT04727515|Sensory System Agents|sensory system agents|mesh-ancestor
92522955|NCT04727515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522956|NCT04727515|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92522957|NCT04727515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92522958|NCT04727515|Anesthetics, General|anesthetics, general|mesh-ancestor
92522959|NCT04727515|Anesthetics|anesthetics|mesh-ancestor
92522960|NCT04727515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92522961|NCT00117754|Terbinafine|terbinafine|mesh-list
92522962|NCT00117754|Antifungal Agents|antifungal agents|mesh-ancestor
92522963|NCT00117754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522964|NCT00117754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522965|NCT00117754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522966|NCT00117832|Azelastine|azelastine|mesh-list
92522967|NCT00117832|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92522968|NCT00117832|Autonomic Agents|autonomic agents|mesh-ancestor
92522969|NCT00117832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92522970|NCT00117832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522971|NCT00117832|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92522972|NCT00117832|Respiratory System Agents|respiratory system agents|mesh-ancestor
92522973|NCT00117832|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92522974|NCT00117832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522975|NCT00117832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522976|NCT00117832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92522977|NCT00117832|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92522978|NCT00117832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92522979|NCT00117832|Histamine Antagonists|histamine antagonists|mesh-ancestor
92522980|NCT00117832|Histamine Agents|histamine agents|mesh-ancestor
92522981|NCT00117832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92522982|NCT00118027|Pyrimethamine|pyrimethamine|mesh-list
92522983|NCT00118027|Sulfadoxine|sulfadoxine|mesh-list
92522984|NCT00118027|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92522985|NCT00118027|Antimalarials|antimalarials|mesh-ancestor
92522986|NCT00118027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92522987|NCT00118027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92522988|NCT00118027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92522989|NCT00118027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92522990|NCT00118027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92522991|NCT00118027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522992|NCT00118027|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92522993|NCT00118066|Calcitriol|calcitriol|mesh-list
92522994|NCT00118066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92522995|NCT00118066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92522996|NCT00118066|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92522997|NCT00118066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92522998|NCT00118066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92522999|NCT00118066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92523001|NCT00118066|Micronutrients|micronutrients|mesh-ancestor
92523002|NCT00118066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92523003|NCT00118105|Bevacizumab|bevacizumab|mesh-list
92523004|NCT00118105|Capecitabine|capecitabine|mesh-list
92523005|NCT00118105|Oxaliplatin|oxaliplatin|mesh-list
92523006|NCT00118105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523007|NCT00118105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523008|NCT00118105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92523009|NCT00118105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92523010|NCT00118105|Growth Substances|growth substances|mesh-ancestor
92523011|NCT00118105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523012|NCT00118105|Growth Inhibitors|growth inhibitors|mesh-ancestor
92523013|NCT00118105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523014|NCT00118105|Antimetabolites|antimetabolites|mesh-ancestor
92523015|NCT00118105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523016|NCT00118183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92523017|NCT00118183|Cetuximab|cetuximab|mesh-list
92523018|NCT00118183|Docetaxel|docetaxel|mesh-list
92523019|NCT00118183|Bortezomib|bortezomib|mesh-list
92523020|NCT00118183|Antibodies|antibodies|mesh-list
92523021|NCT00118183|Immunoglobulins|immunoglobulins|mesh-list
92523022|NCT00118183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92523023|NCT00118183|Immunologic Factors|immunologic factors|mesh-ancestor
92523024|NCT00118183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523025|NCT00118183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523026|NCT00118183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92523027|NCT00118183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92523028|NCT00118183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92523029|NCT00118183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523030|NCT00390975|Tegaserod|tegaserod|mesh-list
92523031|NCT00390975|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92523032|NCT00390975|Serotonin Agents|serotonin agents|mesh-ancestor
92523033|NCT00390975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523034|NCT00390975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523035|NCT00390975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523036|NCT00118222|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92523037|NCT00118222|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92523038|NCT00118222|Ether|ether|mesh-list
92523039|NCT00118222|Trioxsalen|trioxsalen|mesh-list
92523040|NCT00118222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92523041|NCT00118222|Anesthetics, General|anesthetics, general|mesh-ancestor
92523042|NCT00118222|Anesthetics|anesthetics|mesh-ancestor
92523043|NCT00118222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523044|NCT00118222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353123|NCT00085098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523045|NCT00118222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523046|NCT00118222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523047|NCT00118222|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92523048|NCT00118261|Leucovorin|leucovorin|mesh-list
92523049|NCT00118261|Bevacizumab|bevacizumab|mesh-list
92523050|NCT00118261|Fluorouracil|fluorouracil|mesh-list
92523051|NCT00118261|Oxaliplatin|oxaliplatin|mesh-list
92523052|NCT00118261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92523053|NCT00118261|Calcium|calcium|mesh-list
92523054|NCT00118261|Levoleucovorin|levoleucovorin|mesh-list
92523055|NCT00118261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523056|NCT00118261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523057|NCT00118261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92523058|NCT00118261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92523059|NCT00118261|Growth Substances|growth substances|mesh-ancestor
92523060|NCT00118261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523061|NCT00118261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92523062|NCT00118261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92523063|NCT00118261|Antimetabolites|antimetabolites|mesh-ancestor
92523064|NCT00118261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523065|NCT00118261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523066|NCT00118261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523067|NCT00118261|Immunologic Factors|immunologic factors|mesh-ancestor
92523068|NCT00118261|Antidotes|antidotes|mesh-ancestor
92523069|NCT00118261|Protective Agents|protective agents|mesh-ancestor
92523070|NCT00118261|Vitamin B Complex|vitamin b complex|mesh-ancestor
92523071|NCT00118261|Vitamins|vitamins|mesh-ancestor
92523072|NCT00118261|Micronutrients|micronutrients|mesh-ancestor
91932016|NCT03525223|Dialysis Solutions|dialysis solutions|mesh-list
92523073|NCT00118261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92523074|NCT00118261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523075|NCT00118300|Capecitabine|capecitabine|mesh-list
92523076|NCT00118300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523077|NCT00118300|Antimetabolites|antimetabolites|mesh-ancestor
92523078|NCT00118300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523079|NCT00118300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523080|NCT02710734|Doxorubicin|doxorubicin|mesh-list
92523081|NCT02710734|Methotrexate|methotrexate|mesh-list
92523082|NCT02710734|Mitomycins|mitomycins|mesh-list
92523083|NCT02710734|Mitomycin|mitomycin|mesh-list
92523084|NCT02710734|Vinblastine|vinblastine|mesh-list
92523085|NCT02710734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523086|NCT02710734|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92523087|NCT02710734|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92523088|NCT02710734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92523089|NCT02710734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523090|NCT02710734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523091|NCT02710734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92523092|NCT02710734|Abortifacient Agents|abortifacient agents|mesh-ancestor
92523093|NCT02710734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92523094|NCT02710734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523095|NCT02710734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523096|NCT02710734|Antimetabolites|antimetabolites|mesh-ancestor
92523097|NCT02710734|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523098|NCT02710734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92523099|NCT02710734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523100|NCT02710734|Immunologic Factors|immunologic factors|mesh-ancestor
92523101|NCT02710734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92523102|NCT02710734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92523103|NCT02710734|Alkylating Agents|alkylating agents|mesh-ancestor
92523104|NCT02710734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92523105|NCT02710734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92523106|NCT02710734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92523107|NCT02710734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92523108|NCT00118690|Fluticasone|fluticasone|mesh-list
92523109|NCT00118690|Xhance|xhance|mesh-list
92523110|NCT00118690|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92523111|NCT00118690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92523112|NCT00118690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92523113|NCT00118690|Autonomic Agents|autonomic agents|mesh-ancestor
92523114|NCT00118690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523115|NCT00118690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523116|NCT00118690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92523117|NCT00118690|Respiratory System Agents|respiratory system agents|mesh-ancestor
92523118|NCT00118690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523119|NCT00118690|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92523120|NCT00118690|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92523121|NCT00118690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92523122|NCT00118690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92523123|NCT00118690|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523124|NCT00118690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523125|NCT00118690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523126|NCT00402142|Vaccines|vaccines|mesh-list
92523127|NCT00402142|Immunologic Factors|immunologic factors|mesh-ancestor
92523128|NCT00402142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523129|NCT00118768|Interferons|interferons|mesh-list
92523130|NCT00118768|Interferon-alpha|interferon-alpha|mesh-list
92523131|NCT00118768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523132|NCT00118768|Antiviral Agents|antiviral agents|mesh-ancestor
92523133|NCT00118768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523134|NCT00118768|Immunologic Factors|immunologic factors|mesh-ancestor
92523135|NCT00118768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523136|NCT00118807|Artesunate|artesunate|mesh-list
92523137|NCT00118807|Chloroquine|chloroquine|mesh-list
92523138|NCT00118807|Pyrimethamine|pyrimethamine|mesh-list
92523139|NCT00118807|Sulfadoxine|sulfadoxine|mesh-list
92523140|NCT00118807|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92523141|NCT00118807|Amodiaquine|amodiaquine|mesh-list
92523142|NCT00118807|Antimalarials|antimalarials|mesh-ancestor
92523143|NCT00118807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92523144|NCT00118807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92523145|NCT00118807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523146|NCT00118807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523147|NCT00118807|Antiviral Agents|antiviral agents|mesh-ancestor
92523148|NCT00118807|Schistosomicides|schistosomicides|mesh-ancestor
92523149|NCT00118807|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92523150|NCT00118807|Anthelmintics|anthelmintics|mesh-ancestor
92523151|NCT00118807|Amebicides|amebicides|mesh-ancestor
92523152|NCT00118807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92523153|NCT00118807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92523154|NCT00118807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523155|NCT00118807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523156|NCT00118807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92523157|NCT00118963|Metformin|metformin|mesh-list
92523158|NCT00118963|Insulin Aspart|insulin aspart|mesh-list
92523159|NCT00118963|Repaglinide|repaglinide|mesh-list
92523160|NCT00118963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92523161|NCT00118963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523162|NCT00119002|Dexamethasone|dexamethasone|mesh-list
92523163|NCT00119002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92523164|NCT00119002|Antiemetics|antiemetics|mesh-ancestor
92523165|NCT00119002|Autonomic Agents|autonomic agents|mesh-ancestor
92523166|NCT00119002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523167|NCT00119002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523168|NCT00119002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523169|NCT00119002|Glucocorticoids|glucocorticoids|mesh-ancestor
92523170|NCT00119002|Hormones|hormones|mesh-ancestor
92523171|NCT00119002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523172|NCT00119002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92523173|NCT00119002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523174|NCT00119119|Tocopherols|tocopherols|mesh-list
92523175|NCT00119119|Vitamin E|vitamin e|mesh-list
92523176|NCT00119119|Tocotrienols|tocotrienols|mesh-list
92523177|NCT00119119|alpha-Tocopherol|alpha-tocopherol|mesh-list
92523178|NCT00119119|Antioxidants|antioxidants|mesh-ancestor
92523179|NCT00119119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523180|NCT00119119|Protective Agents|protective agents|mesh-ancestor
92523181|NCT00119119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523182|NCT00119119|Vitamins|vitamins|mesh-ancestor
92523183|NCT00119119|Micronutrients|micronutrients|mesh-ancestor
92523184|NCT00119236|Irinotecan|irinotecan|mesh-list
92523185|NCT00119236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92523186|NCT00119236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92523187|NCT00119236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750753|NCT05936606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523188|NCT00119236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523189|NCT00119236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523190|NCT00119314|Gemcitabine|gemcitabine|mesh-list
92523191|NCT00119314|Capecitabine|capecitabine|mesh-list
92523192|NCT00119314|Docetaxel|docetaxel|mesh-list
92523193|NCT00119314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523194|NCT00119314|Antimetabolites|antimetabolites|mesh-ancestor
92523195|NCT00119314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523196|NCT00119314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523197|NCT00119314|Tubulin Modulators|tubulin modulators|mesh-ancestor
92523198|NCT00119314|Antimitotic Agents|antimitotic agents|mesh-ancestor
92523199|NCT00119314|Mitosis Modulators|mitosis modulators|mesh-ancestor
92523200|NCT00119431|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92523201|NCT00119431|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92523202|NCT00119431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523203|NCT00119431|Immunologic Factors|immunologic factors|mesh-ancestor
92523204|NCT00119431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523205|NCT00119587|Darbepoetin alfa|darbepoetin alfa|mesh-list
92523206|NCT00119587|Hematinics|hematinics|mesh-ancestor
92523207|NCT00119626|Disufenton sodium|disufenton sodium|mesh-list
92523208|NCT00119626|Antioxidants|antioxidants|mesh-ancestor
92523209|NCT00119626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523210|NCT00119626|Protective Agents|protective agents|mesh-ancestor
92523211|NCT00119626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523212|NCT00119704|Botulinum Toxins|botulinum toxins|mesh-list
92523213|NCT00119704|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92523214|NCT00119704|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92523215|NCT00119704|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92523216|NCT00119704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523217|NCT00119704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523218|NCT00119704|Cholinergic Agents|cholinergic agents|mesh-ancestor
92523219|NCT00119704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523220|NCT00119704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248040|NCT00594308|Mycophenolic Acid|mycophenolic acid|mesh-list
92523221|NCT00119704|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92523222|NCT00119704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523223|NCT02621151|Gemcitabine|gemcitabine|mesh-list
92523224|NCT02621151|Pembrolizumab|pembrolizumab|mesh-list
92523225|NCT02621151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523226|NCT02621151|Antimetabolites|antimetabolites|mesh-ancestor
92523227|NCT02621151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523228|NCT02621151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523229|NCT02621151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523230|NCT02621151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92523232|NCT00120055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92523233|NCT00120055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92523234|NCT00120055|Antimetabolites|antimetabolites|mesh-ancestor
92523235|NCT00120055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523236|NCT00120055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92523237|NCT00120055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92523238|NCT00120055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523239|NCT00120133|Atorvastatin|atorvastatin|mesh-list
92523240|NCT00120133|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92523241|NCT00120133|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92523242|NCT00120133|Antimetabolites|antimetabolites|mesh-ancestor
92523243|NCT00120133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523244|NCT00120133|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92523245|NCT00120133|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92523246|NCT00120133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523247|NCT00120172|Bevacizumab|bevacizumab|mesh-list
92523248|NCT00120172|Capecitabine|capecitabine|mesh-list
92523249|NCT00120172|Oxaliplatin|oxaliplatin|mesh-list
92523250|NCT00120172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523251|NCT00120172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523252|NCT00120172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92523253|NCT00120172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92523254|NCT00120172|Growth Substances|growth substances|mesh-ancestor
92523255|NCT00120172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523256|NCT00120172|Growth Inhibitors|growth inhibitors|mesh-ancestor
92523257|NCT00120172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523258|NCT00120172|Antimetabolites|antimetabolites|mesh-ancestor
92523259|NCT00120172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523260|NCT00402181|Dexamethasone|dexamethasone|mesh-list
92523261|NCT00402181|Siltuximab|siltuximab|mesh-list
92523262|NCT00402181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92523263|NCT00402181|Antiemetics|antiemetics|mesh-ancestor
92523264|NCT00402181|Autonomic Agents|autonomic agents|mesh-ancestor
92523265|NCT00402181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523266|NCT00402181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523267|NCT00402181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523268|NCT00402181|Glucocorticoids|glucocorticoids|mesh-ancestor
92523269|NCT00402181|Hormones|hormones|mesh-ancestor
92523270|NCT00402181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523271|NCT00402181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92523272|NCT00402181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523273|NCT04727437|Heparin|heparin|mesh-list
92523274|NCT04727437|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92523275|NCT04727437|Tinzaparin|tinzaparin|mesh-list
92523276|NCT04727437|Dalteparin|dalteparin|mesh-list
92523277|NCT04727437|Warfarin|warfarin|mesh-list
92523278|NCT04727437|Anticoagulants|anticoagulants|mesh-list
92523280|NCT04727437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92523281|NCT04727437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523282|NCT00120367|Tenofovir|tenofovir|mesh-list
92523283|NCT00120367|Emtricitabine|emtricitabine|mesh-list
92523284|NCT00120367|Enfuvirtide|enfuvirtide|mesh-list
92523285|NCT00120367|Antiviral Agents|antiviral agents|mesh-ancestor
92523286|NCT00120367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523287|NCT00120367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92523288|NCT00120367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92523289|NCT00120367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523290|NCT00120367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523291|NCT00120367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523292|NCT00120367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523293|NCT00120367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92523294|NCT00120367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92523295|NCT04727320|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92523296|NCT04727320|Antiviral Agents|antiviral agents|mesh-ancestor
92523297|NCT04727320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523298|NCT04727320|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92523299|NCT04727320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523300|NCT00120484|Vitamin B 12|vitamin b 12|mesh-list
92523301|NCT00120484|Hydroxocobalamin|hydroxocobalamin|mesh-list
92523303|NCT00120484|Micronutrients|micronutrients|mesh-ancestor
92523304|NCT00120484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523305|NCT00120484|Vitamin B Complex|vitamin b complex|mesh-ancestor
92523306|NCT00120484|Hematinics|hematinics|mesh-ancestor
92523307|NCT00391014|Amphotericin B|amphotericin b|mesh-list
92523308|NCT00391014|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92523309|NCT00391014|Amebicides|amebicides|mesh-ancestor
92523310|NCT00391014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92523311|NCT00391014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92523312|NCT00391014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523313|NCT00391014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92523314|NCT00391014|Antifungal Agents|antifungal agents|mesh-ancestor
92523315|NCT00120601|Naltrexone|naltrexone|mesh-list
92523316|NCT00120601|Acamprosate|acamprosate|mesh-list
92523317|NCT00120601|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92523318|NCT00120601|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92523319|NCT00120601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523320|NCT00120601|Sensory System Agents|sensory system agents|mesh-ancestor
92523321|NCT00120601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523322|NCT00120640|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92523323|NCT00120640|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92523324|NCT00120640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92523325|NCT00120640|Hormone Antagonists|hormone antagonists|mesh-ancestor
92523326|NCT00120640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523327|NCT00120640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523328|NCT00120640|Progestins|progestins|mesh-ancestor
92523329|NCT00120640|Hormones|hormones|mesh-ancestor
92523330|NCT00120679|Epoetin Alfa|epoetin alfa|mesh-list
92523331|NCT00120679|Darbepoetin alfa|darbepoetin alfa|mesh-list
92523332|NCT00120679|Hematinics|hematinics|mesh-ancestor
92523333|NCT00120718|Fasudil|fasudil|mesh-list
92523334|NCT00120718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92523335|NCT00120718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523336|NCT00120718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523337|NCT00120718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92523338|NCT00120718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523339|NCT00120718|Vasodilator Agents|vasodilator agents|mesh-ancestor
92523340|NCT00120718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92523341|NCT00120718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523342|NCT00120757|Alendronate|alendronate|mesh-list
92523343|NCT00120757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92523344|NCT00120757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523345|NCT00120796|Lamivudine|lamivudine|mesh-list
92523346|NCT00120796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92523347|NCT00120796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92523348|NCT00120796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523349|NCT00120796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523350|NCT00120796|Antiviral Agents|antiviral agents|mesh-ancestor
92523351|NCT00120796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523352|NCT00120796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523353|NCT00120796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523354|NCT00120835|Interferons|interferons|mesh-list
92523355|NCT00120835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523357|NCT00120835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523358|NCT00120913|Contraceptives, Oral|contraceptives, oral|mesh-list
92523359|NCT00120913|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92523360|NCT00120913|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92523361|NCT00120913|Contraceptive Agents|contraceptive agents|mesh-ancestor
92523362|NCT00120913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92523363|NCT00120913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523364|NCT00121030|Epoetin Alfa|epoetin alfa|mesh-list
92523365|NCT00121030|Darbepoetin alfa|darbepoetin alfa|mesh-list
92523366|NCT00121030|Hematinics|hematinics|mesh-ancestor
92523367|NCT00121069|Escitalopram|escitalopram|mesh-list
92523368|NCT00121069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92523369|NCT00121069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92523370|NCT00121069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523371|NCT00121069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523372|NCT00121069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523373|NCT00121069|Serotonin Agents|serotonin agents|mesh-ancestor
92523374|NCT00121069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523375|NCT00121147|Travoprost|travoprost|mesh-list
92523376|NCT00121147|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92523377|NCT00121147|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92523378|NCT00121147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92523379|NCT00121147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92523380|NCT00121147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92523381|NCT00121147|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523382|NCT00121147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523383|NCT00121147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523384|NCT00121147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523385|NCT00121264|Sorafenib|sorafenib|mesh-list
92523386|NCT00121264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523387|NCT00121264|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92523388|NCT00121264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523389|NCT00121264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523390|NCT00121303|Cytarabine|cytarabine|mesh-list
92523391|NCT00121303|Daunorubicin|daunorubicin|mesh-list
92523392|NCT00121303|Gemtuzumab|gemtuzumab|mesh-list
92523393|NCT00121303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92523394|NCT00121303|Antimetabolites|antimetabolites|mesh-ancestor
92523395|NCT00121303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523396|NCT00121303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523397|NCT00121303|Antiviral Agents|antiviral agents|mesh-ancestor
92523398|NCT00121303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523399|NCT00121303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523400|NCT00121303|Immunologic Factors|immunologic factors|mesh-ancestor
92523401|NCT00121303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523402|NCT00121303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92523403|NCT00121303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92523404|NCT00121303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92523405|NCT00121303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523406|NCT00121303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523407|NCT00121303|Immunotoxins|immunotoxins|mesh-ancestor
92523408|NCT00121303|Immunoconjugates|immunoconjugates|mesh-ancestor
92523409|NCT00121381|Pimecrolimus|pimecrolimus|mesh-list
92523410|NCT00121381|Tacrolimus|tacrolimus|mesh-list
92523411|NCT00121381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92523412|NCT00121381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92523413|NCT00121381|Analgesics|analgesics|mesh-ancestor
92523414|NCT00121381|Sensory System Agents|sensory system agents|mesh-ancestor
92523415|NCT00121381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523416|NCT00121381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523417|NCT00121381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92523418|NCT00121381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92523419|NCT00121381|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523420|NCT00121381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523421|NCT00121381|Immunologic Factors|immunologic factors|mesh-ancestor
92523422|NCT00121381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92523423|NCT00121381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523424|NCT00121381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523425|NCT00121420|Motexafin gadolinium|motexafin gadolinium|mesh-list
92523426|NCT00121420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523427|NCT00121420|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92523428|NCT00121420|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523430|NCT00121459|Calcium polycarbophil|calcium polycarbophil|mesh-list
92523431|NCT00121459|Cathartics|cathartics|mesh-ancestor
92523432|NCT00121459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523433|NCT00121459|Antidiarrheals|antidiarrheals|mesh-ancestor
92523434|NCT00121498|Lidocaine|lidocaine|mesh-list
92523435|NCT00121498|Anesthetics, Local|anesthetics, local|mesh-list
92523436|NCT00121498|Anesthetics|anesthetics|mesh-list
92523437|NCT00121498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523438|NCT00121498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523439|NCT00121498|Sensory System Agents|sensory system agents|mesh-ancestor
92523440|NCT00121498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523441|NCT00121498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92523442|NCT00121498|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92523443|NCT00121498|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92523444|NCT00121498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523445|NCT00121498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523446|NCT00121615|Etanercept|etanercept|mesh-list
92523447|NCT00121615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92523448|NCT00121615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92523449|NCT00121615|Analgesics|analgesics|mesh-ancestor
92523450|NCT00121615|Sensory System Agents|sensory system agents|mesh-ancestor
92523451|NCT00121615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523452|NCT00121615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523453|NCT00121615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92523454|NCT00121615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92523455|NCT00121615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523456|NCT00121615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523457|NCT00121615|Immunologic Factors|immunologic factors|mesh-ancestor
92523458|NCT00391248|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92523459|NCT00391248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353168|NCT00083226|Doxorubicin|doxorubicin|mesh-list
92523460|NCT00391248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92523461|NCT00391248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523462|NCT00391248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523463|NCT04711096|Bupivacaine|bupivacaine|mesh-list
92523464|NCT04711096|Anesthetics, Local|anesthetics, local|mesh-ancestor
92523465|NCT04711096|Anesthetics|anesthetics|mesh-ancestor
92523466|NCT04711096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523467|NCT04711096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523468|NCT04711096|Sensory System Agents|sensory system agents|mesh-ancestor
92523469|NCT04711096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523470|NCT04705948|Magnesium Sulfate|magnesium sulfate|mesh-list
92523471|NCT04705948|Ketamine|ketamine|mesh-list
92523472|NCT04705948|Analgesics|analgesics|mesh-ancestor
92523473|NCT04705948|Sensory System Agents|sensory system agents|mesh-ancestor
92523474|NCT04705948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523475|NCT04705948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523476|NCT04705948|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92523477|NCT04705948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92523478|NCT04705948|Anesthetics, General|anesthetics, general|mesh-ancestor
92523479|NCT04705948|Anesthetics|anesthetics|mesh-ancestor
92523480|NCT04705948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523481|NCT04705948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92523482|NCT04705948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92523483|NCT04705948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523484|NCT04705948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523485|NCT04705948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92523486|NCT04705948|Anticonvulsants|anticonvulsants|mesh-ancestor
92523487|NCT04705948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92523488|NCT04705948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523489|NCT04705948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92523490|NCT04705948|Tocolytic Agents|tocolytic agents|mesh-ancestor
92523491|NCT04705948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92523492|NCT00121888|Paroxetine|paroxetine|mesh-list
92523493|NCT00121888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92523494|NCT00121888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92523495|NCT00121888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523496|NCT00121888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523497|NCT00121888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523498|NCT00121888|Serotonin Agents|serotonin agents|mesh-ancestor
92523499|NCT00121888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523500|NCT00121888|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92523501|NCT00121888|Antidepressive Agents|antidepressive agents|mesh-ancestor
92523502|NCT00121888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92523503|NCT00121888|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92523504|NCT00121888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92523505|NCT00121888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523506|NCT00121966|Insulin|insulin|mesh-list
92523507|NCT00121966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92523508|NCT00121966|Metformin|metformin|mesh-list
92523509|NCT00121966|Insulin Aspart|insulin aspart|mesh-list
92523510|NCT00121966|Rosiglitazone|rosiglitazone|mesh-list
92523511|NCT00121966|Isophane Insulin, Human|isophane insulin, human|mesh-list
92523512|NCT00121966|Insulin, Isophane|insulin, isophane|mesh-list
92523513|NCT00121966|Isophane insulin, beef|isophane insulin, beef|mesh-list
92523514|NCT00121966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92523515|NCT00121966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523516|NCT00122044|Trihexyphenidyl|trihexyphenidyl|mesh-list
92523517|NCT00122044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92523518|NCT00122044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92523519|NCT00122044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92523520|NCT00122044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92523521|NCT00122044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92523522|NCT00122044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523523|NCT00122044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523524|NCT00122044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523525|NCT02013492|Propranolol|propranolol|mesh-list
92523526|NCT02013492|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92523527|NCT02013492|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92523528|NCT02013492|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523529|NCT02013492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523530|NCT02013492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523531|NCT02013492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523532|NCT02013492|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92523533|NCT02013492|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92523534|NCT02013492|Vasodilator Agents|vasodilator agents|mesh-ancestor
92523535|NCT00122356|Alendronate|alendronate|mesh-list
92523536|NCT00122356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92523537|NCT00122356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523538|NCT01931709|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92523539|NCT01931709|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92523540|NCT01931709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523541|NCT00122434|Tiotropium Bromide|tiotropium bromide|mesh-list
92523542|NCT00122434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92523543|NCT00122434|Autonomic Agents|autonomic agents|mesh-ancestor
92523544|NCT00122434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523545|NCT00122434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523546|NCT00122434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92523547|NCT00122434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92523548|NCT00122434|Parasympatholytics|parasympatholytics|mesh-ancestor
92523549|NCT00122434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92523550|NCT00122434|Cholinergic Agents|cholinergic agents|mesh-ancestor
92523551|NCT00122434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523552|NCT00122434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523553|NCT00122473|Imatinib Mesylate|imatinib mesylate|mesh-list
92523554|NCT00122473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523555|NCT00122473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92523556|NCT00122473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523557|NCT00122473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523558|NCT00122512|Tenofovir|tenofovir|mesh-list
92523559|NCT00122512|Antiviral Agents|antiviral agents|mesh-ancestor
92523560|NCT00122512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523561|NCT00122512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92523562|NCT00122512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92523563|NCT00122512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523564|NCT00122512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523565|NCT00122512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523566|NCT00122512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523567|NCT01720407|Imiquimod|imiquimod|mesh-list
92523568|NCT01720407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92523569|NCT01720407|Immunologic Factors|immunologic factors|mesh-ancestor
92523570|NCT01720407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523571|NCT01720407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523572|NCT01720407|Interferon Inducers|interferon inducers|mesh-ancestor
92523573|NCT00122551|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92523574|NCT00122551|Antiviral Agents|antiviral agents|mesh-ancestor
92523575|NCT00122551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523576|NCT00122590|Ritonavir|ritonavir|mesh-list
92523577|NCT00122590|Lopinavir|lopinavir|mesh-list
92523578|NCT00122590|Nelfinavir|nelfinavir|mesh-list
92523579|NCT00122590|Indinavir|indinavir|mesh-list
92523580|NCT00122590|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92523581|NCT00122590|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92523582|NCT00122590|Protease Inhibitors|protease inhibitors|mesh-ancestor
92523583|NCT00122590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523584|NCT00122590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523585|NCT00122590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523586|NCT00122590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523587|NCT00122590|Antiviral Agents|antiviral agents|mesh-ancestor
92523588|NCT00122590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523589|NCT00122590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92523590|NCT00122590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92523591|NCT00122629|Interferons|interferons|mesh-list
92523592|NCT00122629|Ribavirin|ribavirin|mesh-list
92523593|NCT00122629|Interferon-alpha|interferon-alpha|mesh-list
92523594|NCT00122629|Interferon alpha-2|interferon alpha-2|mesh-list
92523595|NCT00122629|Amantadine|amantadine|mesh-list
92523596|NCT00122629|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92523597|NCT00122629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523598|NCT00122629|Antiviral Agents|antiviral agents|mesh-ancestor
92523599|NCT00122629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523600|NCT00122629|Antimetabolites|antimetabolites|mesh-ancestor
92523601|NCT00122629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523602|NCT00122629|Immunologic Factors|immunologic factors|mesh-ancestor
92523603|NCT00122629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523604|NCT00122629|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92523605|NCT00122629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92523606|NCT00122629|Dopamine Agents|dopamine agents|mesh-ancestor
92523607|NCT00122629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523608|NCT00122629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92523609|NCT00122629|Analgesics|analgesics|mesh-ancestor
92523610|NCT00122629|Sensory System Agents|sensory system agents|mesh-ancestor
92523611|NCT00122629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523612|NCT00122668|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92523613|NCT00122668|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92523614|NCT00122668|Protease Inhibitors|protease inhibitors|mesh-list
92523615|NCT00122668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92523616|NCT00122668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523617|NCT00122668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523618|NCT00122668|Antiviral Agents|antiviral agents|mesh-ancestor
92523619|NCT00122668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523620|NCT00122668|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92523621|NCT00122668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523622|NCT00122668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523623|NCT05637164|Norepinephrine|norepinephrine|mesh-list
92523624|NCT05637164|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92523625|NCT05637164|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92523626|NCT05637164|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523627|NCT05637164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523628|NCT05637164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523629|NCT05637164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533512|NCT02968498|Lactulose|lactulose|mesh-list
92523630|NCT05637164|Sympathomimetics|sympathomimetics|mesh-ancestor
92523631|NCT05637164|Autonomic Agents|autonomic agents|mesh-ancestor
92523632|NCT05637164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523633|NCT05637164|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92523635|NCT00129337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523636|NCT00129337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523637|NCT00129298|Tiagabine|tiagabine|mesh-list
92523638|NCT00129298|Anticonvulsants|anticonvulsants|mesh-ancestor
92523639|NCT00129298|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92523640|NCT00129298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92523641|NCT00129298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523642|NCT00129298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523643|NCT00129298|GABA Agents|gaba agents|mesh-ancestor
92523644|NCT00129298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523645|NCT00129298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523646|NCT00129181|Levodopa|levodopa|mesh-list
92523647|NCT00129181|Carbidopa|carbidopa|mesh-list
92523648|NCT00129181|Cabergoline|cabergoline|mesh-list
92523649|NCT00129181|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92523650|NCT00129181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92523651|NCT00129181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92523652|NCT00129181|Dopamine Agents|dopamine agents|mesh-ancestor
92523653|NCT00129181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523654|NCT00129181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353205|NCT04402320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92523655|NCT00129181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523656|NCT00129181|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92523657|NCT00129181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523658|NCT00129181|Dopamine Agonists|dopamine agonists|mesh-ancestor
92523659|NCT00129181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92523660|NCT00129181|Immunologic Factors|immunologic factors|mesh-ancestor
92523661|NCT00129142|Toremifene|toremifene|mesh-list
92523662|NCT00129142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92523663|NCT00129142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523664|NCT00129142|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92523665|NCT00129142|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92523666|NCT00129142|Hormone Antagonists|hormone antagonists|mesh-ancestor
92523667|NCT00129142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523668|NCT00129142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523669|NCT00129142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92523670|NCT00128947|Mycophenolic Acid|mycophenolic acid|mesh-list
92523671|NCT00128947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92523672|NCT00128947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523673|NCT00128947|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92523674|NCT00128947|Antitubercular Agents|antitubercular agents|mesh-ancestor
92523675|NCT00128947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92248497|NCT00703664|Bortezomib|bortezomib|mesh-list
92523676|NCT00128947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523677|NCT00128947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523678|NCT00128947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523679|NCT00819780|Bevacizumab|bevacizumab|mesh-list
92523680|NCT00819780|Panitumumab|panitumumab|mesh-list
92523681|NCT00819780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523682|NCT00819780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523683|NCT00819780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92523684|NCT00819780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92523685|NCT00819780|Growth Substances|growth substances|mesh-ancestor
92523686|NCT00819780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523687|NCT00819780|Growth Inhibitors|growth inhibitors|mesh-ancestor
92523688|NCT00128908|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92523689|NCT00128908|Antiviral Agents|antiviral agents|mesh-ancestor
92523690|NCT00128908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523691|NCT00128791|Nitroprusside|nitroprusside|mesh-list
92523692|NCT00128791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92523693|NCT00128791|Vasodilator Agents|vasodilator agents|mesh-ancestor
92523694|NCT00128791|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92523695|NCT00128791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523696|NCT00128752|Beta Carotene|beta carotene|mesh-list
92523697|NCT00128752|Carotenoids|carotenoids|mesh-list
92523698|NCT00128752|Antioxidants|antioxidants|mesh-ancestor
92523699|NCT00128752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523700|NCT00128752|Protective Agents|protective agents|mesh-ancestor
92523701|NCT00128752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523702|NCT00128752|Provitamins|provitamins|mesh-ancestor
92523703|NCT00128752|Vitamins|vitamins|mesh-ancestor
92523704|NCT00128752|Micronutrients|micronutrients|mesh-ancestor
92523705|NCT05638295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92523706|NCT05638295|Panitumumab|panitumumab|mesh-list
92523707|NCT05638295|Sotorasib|sotorasib|mesh-list
92523708|NCT05638295|Antibodies|antibodies|mesh-list
92523709|NCT05638295|Immunoglobulins|immunoglobulins|mesh-list
92523710|NCT05638295|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92523711|NCT05638295|Immunologic Factors|immunologic factors|mesh-ancestor
92523712|NCT05638295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523713|NCT05638295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523714|NCT05638295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92523715|NCT05638295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523716|NCT00063414|Alicaforsen|alicaforsen|mesh-list
92523717|NCT00063414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523718|NCT00063414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523719|NCT00063414|Immunologic Factors|immunologic factors|mesh-ancestor
92523720|NCT00063414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523721|NCT05638451|Bevacizumab|bevacizumab|mesh-list
92523722|NCT05638451|Temozolomide|temozolomide|mesh-list
92523723|NCT05638451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92523724|NCT05638451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523725|NCT05638451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92523726|NCT05638451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92523727|NCT05638451|Growth Substances|growth substances|mesh-ancestor
92523728|NCT05638451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523729|NCT05638451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92523730|NCT05638451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92523731|NCT05638451|Alkylating Agents|alkylating agents|mesh-ancestor
92523732|NCT05638451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523733|NCT00009009|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92523734|NCT00009009|Complement System Proteins|complement system proteins|mesh-list
92523735|NCT00009009|Immunologic Factors|immunologic factors|mesh-ancestor
92523736|NCT00009009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523737|NCT05638763|Ketoconazole|ketoconazole|mesh-list
92523738|NCT05638763|Dasatinib|dasatinib|mesh-list
92523739|NCT05638763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523740|NCT05638763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92523741|NCT05638763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523742|NCT05638763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523743|NCT05638763|Antifungal Agents|antifungal agents|mesh-ancestor
92523744|NCT05638763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523745|NCT05638763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92523746|NCT05638763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92523747|NCT05638763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92523748|NCT05638763|Hormone Antagonists|hormone antagonists|mesh-ancestor
92523749|NCT05638763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523750|NCT05638763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523751|NCT05638763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92523752|NCT00128635|Antibodies|antibodies|mesh-list
92523753|NCT00128635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92523754|NCT00128635|Immunologic Factors|immunologic factors|mesh-ancestor
92523755|NCT00128635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523756|NCT00009048|Levodopa|levodopa|mesh-list
92523757|NCT00009048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92523758|NCT00009048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92523759|NCT00009048|Dopamine Agents|dopamine agents|mesh-ancestor
92523760|NCT00009048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523761|NCT00009048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523762|NCT00009048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523763|NCT00128596|Arsenic Trioxide|arsenic trioxide|mesh-list
92523764|NCT00128596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523765|NCT00128557|Vitamin A|vitamin a|mesh-list
92523766|NCT00128557|Vitamins|vitamins|mesh-ancestor
92523767|NCT00128557|Micronutrients|micronutrients|mesh-ancestor
92523768|NCT00128557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523769|NCT00128518|Perindopril|perindopril|mesh-list
92523770|NCT00128518|Indapamide|indapamide|mesh-list
92523771|NCT00128518|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92523772|NCT00128518|Protease Inhibitors|protease inhibitors|mesh-ancestor
92523773|NCT00128518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523774|NCT00128518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523775|NCT00128518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92523776|NCT00128518|Diuretics|diuretics|mesh-ancestor
92523777|NCT00128518|Natriuretic Agents|natriuretic agents|mesh-ancestor
92523778|NCT00128518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523779|NCT00128518|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92523780|NCT00128518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523781|NCT00009204|Perphenazine|perphenazine|mesh-list
92523782|NCT00009204|Citalopram|citalopram|mesh-list
92523783|NCT00009204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92523784|NCT00009204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92523785|NCT00009204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523786|NCT00009204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523787|NCT00009204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523788|NCT00009204|Serotonin Agents|serotonin agents|mesh-ancestor
92523789|NCT00009204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523790|NCT00009204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92523791|NCT00009204|Antidepressive Agents|antidepressive agents|mesh-ancestor
92523792|NCT00009204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92523793|NCT00009204|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92523794|NCT00009204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92523795|NCT00009204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523796|NCT00009204|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92523797|NCT00009204|Dopamine Agents|dopamine agents|mesh-ancestor
92523798|NCT00394459|Anesthetics|anesthetics|mesh-list
92523799|NCT00394459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523800|NCT00394459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523801|NCT00394498|Lenograstim|lenograstim|mesh-list
92523802|NCT00394498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92523803|NCT00394498|Immunologic Factors|immunologic factors|mesh-ancestor
92523804|NCT00394498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523805|NCT00394537|Labetalol|labetalol|mesh-list
92523806|NCT00394537|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92523807|NCT00394537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92523808|NCT00394537|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523809|NCT00394537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523810|NCT00394537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523811|NCT00394537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523812|NCT00394537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92523813|NCT00394537|Sympathomimetics|sympathomimetics|mesh-ancestor
92523814|NCT00394537|Autonomic Agents|autonomic agents|mesh-ancestor
92523815|NCT00394537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523816|NCT00394537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92523817|NCT00394537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92523818|NCT00009555|Testosterone|testosterone|mesh-list
92523819|NCT00009555|Androgens|androgens|mesh-ancestor
92523820|NCT00009555|Hormones|hormones|mesh-ancestor
92523821|NCT00009555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92523822|NCT00009555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523823|NCT00128479|Mifepristone|mifepristone|mesh-list
92523824|NCT00128479|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92523825|NCT00128479|Abortifacient Agents|abortifacient agents|mesh-ancestor
92523826|NCT00128479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92523827|NCT00128479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523828|NCT00128479|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92523829|NCT00128479|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92523830|NCT00128479|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92523831|NCT00128479|Contraceptive Agents|contraceptive agents|mesh-ancestor
92523832|NCT00128479|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92523833|NCT00128479|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92523834|NCT00128479|Hormone Antagonists|hormone antagonists|mesh-ancestor
92523835|NCT00128479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353243|NCT01678716|Micronutrients|micronutrients|mesh-list
92523836|NCT00128479|Luteolytic Agents|luteolytic agents|mesh-ancestor
92523837|NCT00128479|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92523838|NCT00128479|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92523839|NCT00128440|Tiotropium Bromide|tiotropium bromide|mesh-list
92523840|NCT00128440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92523841|NCT00128440|Autonomic Agents|autonomic agents|mesh-ancestor
92523842|NCT00128440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523843|NCT00128440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523844|NCT00128440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92523845|NCT00128440|Respiratory System Agents|respiratory system agents|mesh-ancestor
92523846|NCT00128440|Parasympatholytics|parasympatholytics|mesh-ancestor
92523847|NCT00128440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92523848|NCT00128440|Cholinergic Agents|cholinergic agents|mesh-ancestor
92523849|NCT00128440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523850|NCT00128440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523851|NCT00128401|Cycloserine|cycloserine|mesh-list
92523852|NCT00128401|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92523853|NCT00128401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523854|NCT00128401|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92523855|NCT00128401|Antitubercular Agents|antitubercular agents|mesh-ancestor
92523856|NCT00128401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92523857|NCT00128401|Antimetabolites|antimetabolites|mesh-ancestor
92523858|NCT00128401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523859|NCT00128323|Nystatin|nystatin|mesh-list
92523860|NCT00128323|Gentian Violet|gentian violet|mesh-list
92523861|NCT00128323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92523862|NCT00128323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92523863|NCT00128323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523864|NCT00128323|Antifungal Agents|antifungal agents|mesh-ancestor
92523865|NCT00128323|Ionophores|ionophores|mesh-ancestor
92523866|NCT00128323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523867|NCT00128323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523868|NCT00128323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92523869|NCT00009672|Morphine|morphine|mesh-list
92523870|NCT00009672|Nortriptyline|nortriptyline|mesh-list
92523871|NCT00009672|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92523872|NCT00009672|Narcotics|narcotics|mesh-ancestor
92523873|NCT00009672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523874|NCT00009672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523875|NCT00009672|Analgesics|analgesics|mesh-ancestor
92523876|NCT00009672|Sensory System Agents|sensory system agents|mesh-ancestor
92523877|NCT00009672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523878|NCT00009672|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92523879|NCT00009672|Antidepressive Agents|antidepressive agents|mesh-ancestor
92523880|NCT00009672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92523881|NCT00009672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92523882|NCT00009672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92523883|NCT00009672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523884|NCT00009672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523885|NCT00009672|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523886|NCT00009672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523887|NCT00018694|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92523888|NCT00018694|Cathartics|cathartics|mesh-ancestor
92523889|NCT00018694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523890|NCT00018733|Paroxetine|paroxetine|mesh-list
92523891|NCT00018733|Desipramine|desipramine|mesh-list
92523892|NCT00018733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92523893|NCT00018733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92523894|NCT00018733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92523895|NCT00018733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523896|NCT00018733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523897|NCT00018733|Serotonin Agents|serotonin agents|mesh-ancestor
92523898|NCT00018733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523899|NCT00018733|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92523900|NCT00018733|Antidepressive Agents|antidepressive agents|mesh-ancestor
92523901|NCT00018733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92523902|NCT00018733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92523903|NCT00018733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92523904|NCT00018733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523905|NCT00018733|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92523906|NCT00018733|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92523907|NCT00018733|Adrenergic Agents|adrenergic agents|mesh-ancestor
92523908|NCT00018850|Haloperidol|haloperidol|mesh-list
92523909|NCT00018850|Ondansetron|ondansetron|mesh-list
92523910|NCT00018850|Haloperidol decanoate|haloperidol decanoate|mesh-list
92523911|NCT00018850|Nicotine|nicotine|mesh-list
92523912|NCT00018850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92523913|NCT00018850|Autonomic Agents|autonomic agents|mesh-ancestor
92523914|NCT00018850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92523915|NCT00018850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523916|NCT00018850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92523917|NCT00018850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92523918|NCT00018850|Cholinergic Agents|cholinergic agents|mesh-ancestor
92523919|NCT00018850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92523920|NCT00018850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523921|NCT00018850|Antiemetics|antiemetics|mesh-ancestor
92523922|NCT00018850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92523923|NCT00018850|Antipruritics|antipruritics|mesh-ancestor
92523924|NCT00018850|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523925|NCT00018850|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92523926|NCT00018850|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92523927|NCT00018850|Serotonin Agents|serotonin agents|mesh-ancestor
92523928|NCT00018850|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92523929|NCT00018850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92523930|NCT00018850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92523931|NCT00018850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92523932|NCT00018850|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92523933|NCT00018850|Dopamine Agents|dopamine agents|mesh-ancestor
92523934|NCT00018850|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92523935|NCT00009750|Cyclosporine|cyclosporine|mesh-list
92523936|NCT00009750|Paclitaxel|paclitaxel|mesh-list
92523937|NCT00009750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92523938|NCT00009750|Antibodies|antibodies|mesh-list
92523939|NCT00009750|Immunoglobulins|immunoglobulins|mesh-list
92523940|NCT00009750|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92523941|NCT00009750|Cyclosporins|cyclosporins|mesh-list
92523942|NCT00009750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92523943|NCT00009750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523944|NCT00009750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92523945|NCT00009750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92523946|NCT00009750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92523947|NCT00009750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523948|NCT00009750|Immunologic Factors|immunologic factors|mesh-ancestor
92523949|NCT00009750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523950|NCT00009750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523951|NCT00009750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523952|NCT00009750|Antifungal Agents|antifungal agents|mesh-ancestor
92523953|NCT00009750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523954|NCT00009750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92523955|NCT00009750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92523956|NCT00009750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92523957|NCT00019006|Detox adjuvant|detox adjuvant|mesh-list
92523958|NCT00019006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92523959|NCT00019006|Immunologic Factors|immunologic factors|mesh-ancestor
92523960|NCT00019006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523961|NCT00019084|Aldesleukin|aldesleukin|mesh-list
92523962|NCT00019084|Vaccines|vaccines|mesh-list
92523963|NCT00019084|Sargramostim|sargramostim|mesh-list
92523964|NCT00019084|Immunologic Factors|immunologic factors|mesh-ancestor
92523965|NCT00019084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523966|NCT00019084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523967|NCT00019084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523968|NCT00019084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523969|NCT00019084|Antiviral Agents|antiviral agents|mesh-ancestor
92523970|NCT00019084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523971|NCT00019123|Thalidomide|thalidomide|mesh-list
92523972|NCT00019123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92523973|NCT00019123|Immunologic Factors|immunologic factors|mesh-ancestor
92523974|NCT00019123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523975|NCT00019123|Leprostatic Agents|leprostatic agents|mesh-ancestor
92523976|NCT00019123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92523977|NCT00019123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523978|NCT00019123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92523979|NCT00019123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92523980|NCT00019123|Growth Substances|growth substances|mesh-ancestor
92523981|NCT00019123|Growth Inhibitors|growth inhibitors|mesh-ancestor
92523982|NCT00019123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523983|NCT00019240|Cidofovir|cidofovir|mesh-list
92523984|NCT00019240|Antiviral Agents|antiviral agents|mesh-ancestor
92523985|NCT00019240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523986|NCT00019240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92523987|NCT00019240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92523988|NCT00019357|Aldesleukin|aldesleukin|mesh-list
92523989|NCT00019357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92523990|NCT00019357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92523991|NCT00019357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92523992|NCT00019357|Antiviral Agents|antiviral agents|mesh-ancestor
92523993|NCT00019357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92523995|NCT00019396|Flt3 ligand protein|flt3 ligand protein|mesh-list
92523996|NCT00019396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92523997|NCT00019396|Immunologic Factors|immunologic factors|mesh-ancestor
92523998|NCT00019396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92523999|NCT00019396|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92524000|NCT00019396|Protective Agents|protective agents|mesh-ancestor
92524001|NCT00009828|Leucovorin|leucovorin|mesh-list
92524002|NCT00009828|Paclitaxel|paclitaxel|mesh-list
92524003|NCT00009828|Tegafur|tegafur|mesh-list
92524004|NCT00009828|Calcium|calcium|mesh-list
92524005|NCT00009828|Levoleucovorin|levoleucovorin|mesh-list
92524006|NCT00009828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524007|NCT00009828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524008|NCT00009828|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524009|NCT00009828|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524010|NCT00009828|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524011|NCT00009828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524012|NCT00009828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524013|NCT00009828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524014|NCT00009828|Antidotes|antidotes|mesh-ancestor
92524015|NCT00009828|Protective Agents|protective agents|mesh-ancestor
92524016|NCT00009828|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524017|NCT00009828|Vitamins|vitamins|mesh-ancestor
92524018|NCT00009828|Micronutrients|micronutrients|mesh-ancestor
92524019|NCT00009828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524020|NCT00009828|Antimetabolites|antimetabolites|mesh-ancestor
92524021|NCT00019435|Immunotoxins|immunotoxins|mesh-list
92524022|NCT00019435|Immunoconjugates|immunoconjugates|mesh-ancestor
92524023|NCT00019435|Immunologic Factors|immunologic factors|mesh-ancestor
92524024|NCT00019435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524025|NCT00019474|Interferons|interferons|mesh-list
92524026|NCT00019474|Interferon-alpha|interferon-alpha|mesh-list
92524027|NCT00019474|Fluorouracil|fluorouracil|mesh-list
92524028|NCT00019474|Hydroxyurea|hydroxyurea|mesh-list
92524029|NCT00019474|Antimetabolites|antimetabolites|mesh-ancestor
92524030|NCT00019474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524031|NCT00019474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524032|NCT00019474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524033|NCT00019474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524034|NCT00019474|Immunologic Factors|immunologic factors|mesh-ancestor
92524035|NCT00019474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524036|NCT00019474|Antiviral Agents|antiviral agents|mesh-ancestor
92524037|NCT00019474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524038|NCT00019474|Antisickling Agents|antisickling agents|mesh-ancestor
92524039|NCT00019474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524040|NCT00019474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524041|NCT00019513|Leucovorin|leucovorin|mesh-list
92524042|NCT00019513|Gemcitabine|gemcitabine|mesh-list
92524043|NCT00019513|Fluorouracil|fluorouracil|mesh-list
92524044|NCT00019513|Calcium|calcium|mesh-list
92524045|NCT00019513|Levoleucovorin|levoleucovorin|mesh-list
92524046|NCT00019513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524047|NCT00019513|Antimetabolites|antimetabolites|mesh-ancestor
92524048|NCT00019513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524049|NCT00019513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524050|NCT00019513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524051|NCT00019513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524052|NCT00019513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524053|NCT00019513|Immunologic Factors|immunologic factors|mesh-ancestor
92524054|NCT00019513|Antidotes|antidotes|mesh-ancestor
92524055|NCT00019513|Protective Agents|protective agents|mesh-ancestor
92524057|NCT00019513|Vitamins|vitamins|mesh-ancestor
92524058|NCT00019513|Micronutrients|micronutrients|mesh-ancestor
92524059|NCT00019552|Irofulven|irofulven|mesh-list
92524060|NCT00019552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524061|NCT00019552|Alkylating Agents|alkylating agents|mesh-ancestor
92524062|NCT00019552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524063|NCT00019552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524064|NCT00009867|Arsenic Trioxide|arsenic trioxide|mesh-list
92524065|NCT00009867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524066|NCT00019591|Aldesleukin|aldesleukin|mesh-list
92524067|NCT00019591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524068|NCT00019591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92524069|NCT00019591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92524070|NCT00019591|Antiviral Agents|antiviral agents|mesh-ancestor
92524071|NCT00019591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524072|NCT00019630|Doxorubicin|doxorubicin|mesh-list
92524073|NCT00019630|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92524074|NCT00019630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524075|NCT00019630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524076|NCT00019630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524077|NCT00019630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524078|NCT00019630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524079|NCT00019630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524080|NCT00019669|Aldesleukin|aldesleukin|mesh-list
92524081|NCT00019669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524082|NCT00019669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92524083|NCT00019669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92524084|NCT00019669|Antiviral Agents|antiviral agents|mesh-ancestor
92524085|NCT00019669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524086|NCT00009906|Imatinib Mesylate|imatinib mesylate|mesh-list
92524087|NCT00009906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524088|NCT00009906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92524089|NCT00009906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524090|NCT00009906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524092|NCT00019786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524093|NCT00019786|Alkylating Agents|alkylating agents|mesh-ancestor
92524094|NCT00019786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524095|NCT00019786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524096|NCT00019786|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92524097|NCT00019786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524098|NCT00019786|Immunologic Factors|immunologic factors|mesh-ancestor
92524099|NCT00019786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524100|NCT00019825|Decitabine|decitabine|mesh-list
92524101|NCT00019825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524102|NCT00019825|Antimetabolites|antimetabolites|mesh-ancestor
92524103|NCT00019825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524104|NCT00019825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524105|NCT00019825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524106|NCT00019864|Leucovorin|leucovorin|mesh-list
92524107|NCT00019864|Doxorubicin|doxorubicin|mesh-list
92524108|NCT00019864|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92524109|NCT00019864|Methotrexate|methotrexate|mesh-list
92524110|NCT00019864|Dexrazoxane|dexrazoxane|mesh-list
92524111|NCT00019864|Razoxane|razoxane|mesh-list
92524112|NCT00019864|Calcium|calcium|mesh-list
92524113|NCT00019864|Levoleucovorin|levoleucovorin|mesh-list
92524114|NCT00019864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524115|NCT00019864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524116|NCT00019864|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524117|NCT00019864|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524118|NCT00019864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524119|NCT00019864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524120|NCT00019864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524121|NCT00019864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524122|NCT00019864|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92524123|NCT00019864|Abortifacient Agents|abortifacient agents|mesh-ancestor
92524124|NCT00019864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92524125|NCT00019864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524126|NCT00019864|Antimetabolites|antimetabolites|mesh-ancestor
92524127|NCT00019864|Dermatologic Agents|dermatologic agents|mesh-ancestor
92524128|NCT00019864|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92524129|NCT00019864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524130|NCT00019864|Immunologic Factors|immunologic factors|mesh-ancestor
92524131|NCT00019864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524132|NCT00019864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524133|NCT00019864|Antidotes|antidotes|mesh-ancestor
92524134|NCT00019864|Protective Agents|protective agents|mesh-ancestor
92524135|NCT00019864|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524136|NCT00019864|Vitamins|vitamins|mesh-ancestor
92524137|NCT00019864|Micronutrients|micronutrients|mesh-ancestor
92524138|NCT00019864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92524139|NCT00019864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524140|NCT00019864|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524141|NCT00020176|Cyclosporine|cyclosporine|mesh-list
92524142|NCT00020176|Cyclophosphamide|cyclophosphamide|mesh-list
92524143|NCT00020176|Fludarabine|fludarabine|mesh-list
92524144|NCT00020176|Fludarabine phosphate|fludarabine phosphate|mesh-list
92524145|NCT00020176|Cyclosporins|cyclosporins|mesh-list
92524146|NCT00020176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524147|NCT00020176|Immunologic Factors|immunologic factors|mesh-ancestor
92524148|NCT00020176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524149|NCT00020176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524150|NCT00020176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524151|NCT00020176|Alkylating Agents|alkylating agents|mesh-ancestor
92524152|NCT00020176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524153|NCT00020176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524154|NCT00020176|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92524155|NCT00020176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524156|NCT00020176|Antimetabolites|antimetabolites|mesh-ancestor
92524157|NCT00020176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524158|NCT00020176|Antifungal Agents|antifungal agents|mesh-ancestor
92524159|NCT00020176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524160|NCT00020176|Dermatologic Agents|dermatologic agents|mesh-ancestor
92524161|NCT00020176|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92524162|NCT00020254|Aldesleukin|aldesleukin|mesh-list
92524163|NCT00020254|Nilutamide|nilutamide|mesh-list
92524164|NCT00020254|Vaccines|vaccines|mesh-list
92524165|NCT00020254|Sargramostim|sargramostim|mesh-list
92524166|NCT00020254|Immunologic Factors|immunologic factors|mesh-ancestor
92524167|NCT00020254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524168|NCT00020254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524169|NCT00020254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92524170|NCT00020254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92524171|NCT00020254|Antiviral Agents|antiviral agents|mesh-ancestor
92524172|NCT00020254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524173|NCT00020254|Androgen Antagonists|androgen antagonists|mesh-ancestor
92524174|NCT00020254|Hormone Antagonists|hormone antagonists|mesh-ancestor
92524175|NCT00020254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524176|NCT00009984|Thalidomide|thalidomide|mesh-list
92524177|NCT00009984|Fludarabine|fludarabine|mesh-list
92524178|NCT00009984|Fludarabine phosphate|fludarabine phosphate|mesh-list
92524179|NCT00009984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524180|NCT00009984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524181|NCT00009984|Antimetabolites|antimetabolites|mesh-ancestor
92524182|NCT00009984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524183|NCT00009984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524184|NCT00009984|Immunologic Factors|immunologic factors|mesh-ancestor
92524185|NCT00009984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524186|NCT00009984|Leprostatic Agents|leprostatic agents|mesh-ancestor
92524187|NCT00009984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92524188|NCT00009984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524189|NCT00009984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92524190|NCT00009984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92524191|NCT00009984|Growth Substances|growth substances|mesh-ancestor
92524192|NCT00009984|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524193|NCT00020332|Docetaxel|docetaxel|mesh-list
92524194|NCT00020332|Alvocidib|alvocidib|mesh-list
92524195|NCT00020332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524196|NCT00020332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524197|NCT00020332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524198|NCT00020332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524199|NCT00020332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524200|NCT00020332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524201|NCT00020332|Growth Substances|growth substances|mesh-ancestor
92524202|NCT00020332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524203|NCT00020332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92524204|NCT00020332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524205|NCT00020371|Lenograstim|lenograstim|mesh-list
92524206|NCT00020371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92524207|NCT00020371|Immunologic Factors|immunologic factors|mesh-ancestor
92524208|NCT00020371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524209|NCT00020410|Antibodies|antibodies|mesh-list
92524210|NCT00020410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92524211|NCT00020410|Immunologic Factors|immunologic factors|mesh-ancestor
92524212|NCT00020410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524213|NCT00020449|Paclitaxel|paclitaxel|mesh-list
92524214|NCT00020449|Doxorubicin|doxorubicin|mesh-list
92524215|NCT00020449|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92524216|NCT00020449|Interleukin-12|interleukin-12|mesh-list
92524217|NCT00020449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524218|NCT00020449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524219|NCT00020449|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524220|NCT00020449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524221|NCT00020449|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524222|NCT00020449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524223|NCT00020449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524224|NCT00020449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524225|NCT00020449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524226|NCT00020449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524227|NCT00020449|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92524228|NCT00020449|Immunologic Factors|immunologic factors|mesh-ancestor
92524229|NCT00020449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524230|NCT00020449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92524231|NCT00020449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92524232|NCT00020449|Growth Substances|growth substances|mesh-ancestor
92524233|NCT00020449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524234|NCT00010023|Capecitabine|capecitabine|mesh-list
92524235|NCT00010023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524236|NCT00010023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524237|NCT00010023|Antimetabolites|antimetabolites|mesh-ancestor
92524238|NCT00010023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524239|NCT00020488|Leucovorin|leucovorin|mesh-list
92524240|NCT00020488|Fluorouracil|fluorouracil|mesh-list
92524241|NCT00020488|Irinotecan|irinotecan|mesh-list
92524242|NCT00020488|Calcium|calcium|mesh-list
92524243|NCT00020488|Levoleucovorin|levoleucovorin|mesh-list
92524244|NCT00020488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524245|NCT00020488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524246|NCT00020488|Antimetabolites|antimetabolites|mesh-ancestor
92524247|NCT00020488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524248|NCT00020488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524249|NCT00020488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524250|NCT00020488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524251|NCT00020488|Immunologic Factors|immunologic factors|mesh-ancestor
92524252|NCT00020488|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92524253|NCT00020488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524254|NCT00020488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524255|NCT00020488|Antidotes|antidotes|mesh-ancestor
92524256|NCT00020488|Protective Agents|protective agents|mesh-ancestor
92524257|NCT00020488|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524258|NCT00020488|Vitamins|vitamins|mesh-ancestor
92524259|NCT00020488|Micronutrients|micronutrients|mesh-ancestor
92524260|NCT00020527|Caspofungin|caspofungin|mesh-list
92524261|NCT00020527|Antifungal Agents|antifungal agents|mesh-ancestor
92524262|NCT00020527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524263|NCT00020527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524264|NCT00020527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524265|NCT00020566|Dactinomycin|dactinomycin|mesh-list
92524266|NCT00020566|Doxorubicin|doxorubicin|mesh-list
92524267|NCT00020566|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92524268|NCT00020566|Etoposide|etoposide|mesh-list
92524269|NCT00020566|Vincristine|vincristine|mesh-list
92524270|NCT00020566|Melphalan|melphalan|mesh-list
92524271|NCT00020566|Busulfan|busulfan|mesh-list
92524272|NCT00020566|Ifosfamide|ifosfamide|mesh-list
92524273|NCT00020566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524274|NCT00020566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524275|NCT00020566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524276|NCT00020566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524277|NCT00020566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524278|NCT00020566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524279|NCT00020566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524280|NCT00020566|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524281|NCT00020566|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524282|NCT00020566|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524283|NCT00020566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524284|NCT00020566|Alkylating Agents|alkylating agents|mesh-ancestor
92524285|NCT00020566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92524286|NCT00020566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524287|NCT00020566|Immunologic Factors|immunologic factors|mesh-ancestor
92524288|NCT00020566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524289|NCT00020566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92524290|NCT00020566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524291|NCT00020566|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92524292|NCT00020566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524294|NCT00010062|Antimetabolites|antimetabolites|mesh-ancestor
92524295|NCT00010062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524296|NCT00010062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524297|NCT00010062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524298|NCT00010062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524299|NCT00010062|Immunologic Factors|immunologic factors|mesh-ancestor
92524300|NCT00010062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524302|NCT00020605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92524303|NCT00020605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524304|NCT00020605|Sensory System Agents|sensory system agents|mesh-ancestor
92524305|NCT00020605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524306|NCT00020644|Gemcitabine|gemcitabine|mesh-list
92353314|NCT03473730|Daratumumab|daratumumab|mesh-list
92524307|NCT00020644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524308|NCT00020644|Antimetabolites|antimetabolites|mesh-ancestor
92524309|NCT00020644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524310|NCT00020644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524311|NCT00020761|Paclitaxel|paclitaxel|mesh-list
92524312|NCT00020761|Irinotecan|irinotecan|mesh-list
92524313|NCT00020761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524314|NCT00020761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524315|NCT00020761|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524316|NCT00020761|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524317|NCT00020761|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524318|NCT00020761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524319|NCT00020761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92524320|NCT00020761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524321|NCT00020761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524322|NCT00020800|Rituximab|rituximab|mesh-list
92524323|NCT00020800|Fludarabine|fludarabine|mesh-list
92524324|NCT00020800|Fludarabine phosphate|fludarabine phosphate|mesh-list
92524325|NCT00020800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92524326|NCT00020800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524327|NCT00020800|Immunologic Factors|immunologic factors|mesh-ancestor
92524328|NCT00020800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524329|NCT00020800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524330|NCT00020800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524331|NCT00020800|Antimetabolites|antimetabolites|mesh-ancestor
92524332|NCT00020800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524333|NCT00020800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524334|NCT00020839|Temozolomide|temozolomide|mesh-list
92524335|NCT00020839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524336|NCT00020839|Alkylating Agents|alkylating agents|mesh-ancestor
92524337|NCT00020839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524338|NCT00020839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524339|NCT00010140|Tamoxifen|tamoxifen|mesh-list
92524340|NCT00010140|Docetaxel|docetaxel|mesh-list
92524341|NCT00010140|Epirubicin|epirubicin|mesh-list
92524342|NCT00010140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524343|NCT00010140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524344|NCT00010140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524345|NCT00010140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524346|NCT00010140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524347|NCT00010140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524348|NCT00010140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524349|NCT00010140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524350|NCT00010140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524351|NCT00010140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92524352|NCT00010140|Hormone Antagonists|hormone antagonists|mesh-ancestor
92524353|NCT00010140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524354|NCT00010140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524355|NCT00010140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92524356|NCT00010140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92524357|NCT00010140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92524358|NCT00010140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92524359|NCT00020878|Celecoxib|celecoxib|mesh-list
92524360|NCT00020878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92524361|NCT00020878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92524362|NCT00020878|Analgesics|analgesics|mesh-ancestor
92524363|NCT00020878|Sensory System Agents|sensory system agents|mesh-ancestor
92524364|NCT00020878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524365|NCT00020878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524366|NCT00020878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524367|NCT00020878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524368|NCT00020878|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92524369|NCT00020878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92524370|NCT00020878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524371|NCT00020878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524372|NCT00020917|Leucovorin|leucovorin|mesh-list
92524373|NCT00020917|Fluorouracil|fluorouracil|mesh-list
92524374|NCT00020917|Irinotecan|irinotecan|mesh-list
92524375|NCT00020917|Cetuximab|cetuximab|mesh-list
92524376|NCT00020917|Calcium|calcium|mesh-list
92524377|NCT00020917|Levoleucovorin|levoleucovorin|mesh-list
92524378|NCT00020917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524379|NCT00020917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524380|NCT00020917|Antimetabolites|antimetabolites|mesh-ancestor
92524381|NCT00020917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524382|NCT00020917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524383|NCT00020917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524384|NCT00020917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524385|NCT00020917|Immunologic Factors|immunologic factors|mesh-ancestor
92524386|NCT00020917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92524387|NCT00020917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524388|NCT00020917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524389|NCT00020917|Antidotes|antidotes|mesh-ancestor
92524390|NCT00020917|Protective Agents|protective agents|mesh-ancestor
92524391|NCT00020917|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524392|NCT00020917|Vitamins|vitamins|mesh-ancestor
92524393|NCT00020917|Micronutrients|micronutrients|mesh-ancestor
92524394|NCT00020917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92524395|NCT00021034|Taurolidine|taurolidine|mesh-list
92524396|NCT00021034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524397|NCT00021034|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92524398|NCT00021034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524399|NCT00010179|Lurtotecan|lurtotecan|mesh-list
92524400|NCT00010179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524401|NCT00021073|Leucovorin|leucovorin|mesh-list
92524402|NCT00021073|Fluorouracil|fluorouracil|mesh-list
92524403|NCT00021073|Irinotecan|irinotecan|mesh-list
92524404|NCT00021073|Alvocidib|alvocidib|mesh-list
92524405|NCT00021073|Calcium|calcium|mesh-list
92524406|NCT00021073|Levoleucovorin|levoleucovorin|mesh-list
92524407|NCT00021073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524408|NCT00021073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524409|NCT00021073|Antimetabolites|antimetabolites|mesh-ancestor
92524410|NCT00021073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524411|NCT00021073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524412|NCT00021073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524413|NCT00021073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524414|NCT00021073|Immunologic Factors|immunologic factors|mesh-ancestor
92524415|NCT00021073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92524416|NCT00021073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524417|NCT00021073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524418|NCT00021073|Antidotes|antidotes|mesh-ancestor
92524419|NCT00021073|Protective Agents|protective agents|mesh-ancestor
92524420|NCT00021073|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524421|NCT00021073|Vitamins|vitamins|mesh-ancestor
92524422|NCT00021073|Micronutrients|micronutrients|mesh-ancestor
92524423|NCT00021073|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524424|NCT00021073|Growth Substances|growth substances|mesh-ancestor
92524425|NCT00021073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92524426|NCT00021112|Etoposide|etoposide|mesh-list
92524427|NCT00021112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524428|NCT00021112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524429|NCT00021112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524430|NCT00021112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524431|NCT00021112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524432|NCT00021112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524433|NCT00000122|Fluorouracil|fluorouracil|mesh-list
92524434|NCT00000122|Antimetabolites|antimetabolites|mesh-ancestor
92524435|NCT00000122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524436|NCT00000122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524437|NCT00000122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524438|NCT00000122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524439|NCT00000122|Immunologic Factors|immunologic factors|mesh-ancestor
92524440|NCT00000122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524442|NCT00021151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92524443|NCT00021151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524444|NCT00021268|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
92524445|NCT00021268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524446|NCT00021268|Immunologic Factors|immunologic factors|mesh-ancestor
92524447|NCT00021268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524448|NCT00021307|Carboplatin|carboplatin|mesh-list
92524449|NCT00021307|Temozolomide|temozolomide|mesh-list
92524450|NCT00021307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524451|NCT00021307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524452|NCT00021307|Alkylating Agents|alkylating agents|mesh-ancestor
92524453|NCT00021307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524454|NCT00021346|Carboplatin|carboplatin|mesh-list
92524455|NCT00021346|Gemcitabine|gemcitabine|mesh-list
92524456|NCT00021346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524457|NCT00021346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524458|NCT00021346|Antimetabolites|antimetabolites|mesh-ancestor
92524459|NCT00021346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524460|NCT00021385|Squalamine|squalamine|mesh-list
92524461|NCT00021385|Carboplatin|carboplatin|mesh-list
92524462|NCT00021385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524463|NCT00021385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92524464|NCT00021385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524465|NCT00021385|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92524466|NCT00021385|Protective Agents|protective agents|mesh-ancestor
92524467|NCT00021385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524468|NCT00021385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92524469|NCT00021385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92524470|NCT00021385|Growth Substances|growth substances|mesh-ancestor
92524471|NCT00021385|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524472|NCT00021463|Lamivudine|lamivudine|mesh-list
92524473|NCT00021463|Zidovudine|zidovudine|mesh-list
92524474|NCT00021463|Efavirenz|efavirenz|mesh-list
92524475|NCT00021463|Nevirapine|nevirapine|mesh-list
92524476|NCT00021463|Abacavir|abacavir|mesh-list
92524477|NCT00021463|Dideoxynucleosides|dideoxynucleosides|mesh-list
92524478|NCT00021463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92524479|NCT00021463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524480|NCT00021463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524481|NCT00021463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524482|NCT00021463|Antiviral Agents|antiviral agents|mesh-ancestor
92524483|NCT00021463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524484|NCT00021463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92524485|NCT00021463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92524486|NCT00021463|Antimetabolites|antimetabolites|mesh-ancestor
92524487|NCT00021463|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92524488|NCT00021463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92524489|NCT00021463|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92524490|NCT00021463|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92524491|NCT00021463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92524492|NCT00021463|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92524493|NCT00021502|Chrysarobin|chrysarobin|mesh-list
92524494|NCT00021502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92524495|NCT00021502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92524496|NCT00021502|Analgesics|analgesics|mesh-ancestor
92524497|NCT00021502|Sensory System Agents|sensory system agents|mesh-ancestor
92524498|NCT00021502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524499|NCT00021502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524500|NCT00021502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524501|NCT00021502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524502|NCT00000134|Ganciclovir|ganciclovir|mesh-list
92524503|NCT00000134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92524504|NCT00000134|Foscarnet|foscarnet|mesh-list
92524505|NCT00000134|Antiviral Agents|antiviral agents|mesh-ancestor
92524506|NCT00000134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524507|NCT00000134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524508|NCT00000134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524509|NCT00000134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524510|NCT00000134|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92524512|NCT00010413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524513|NCT00010413|Immunologic Factors|immunologic factors|mesh-ancestor
92524514|NCT00010413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524515|NCT00010413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524516|NCT00010413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524517|NCT00010413|Alkylating Agents|alkylating agents|mesh-ancestor
92524518|NCT00010413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524519|NCT00010413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524520|NCT00010413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92524521|NCT00010452|Picibanil|picibanil|mesh-list
92524522|NCT00010452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524523|NCT00394693|Interferons|interferons|mesh-list
92524524|NCT00394693|Interferon-gamma|interferon-gamma|mesh-list
92524525|NCT00394693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524526|NCT00394693|Antiviral Agents|antiviral agents|mesh-ancestor
92524527|NCT00394693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524528|NCT00394810|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92524529|NCT00394810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524530|NCT00394810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524531|NCT00394810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524532|NCT00394810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524533|NCT00394810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524534|NCT00021814|Doxazosin|doxazosin|mesh-list
92524535|NCT00021814|Finasteride|finasteride|mesh-list
92524536|NCT00021814|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92524537|NCT00021814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92524538|NCT00021814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524539|NCT00021814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524540|NCT00021814|Hormone Antagonists|hormone antagonists|mesh-ancestor
92353374|NCT03395184|PF-06700841|pf-06700841|mesh-list
92524541|NCT00021814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524542|NCT00021814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524543|NCT00021814|Urological Agents|urological agents|mesh-ancestor
92524544|NCT00021814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92524545|NCT00021814|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92524546|NCT00021814|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92524547|NCT00021814|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92524548|NCT00021814|Adrenergic Agents|adrenergic agents|mesh-ancestor
92524549|NCT00021814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92524550|NCT00019318|Romidepsin|romidepsin|mesh-list
92524551|NCT00019318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524552|NCT00019318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524553|NCT00019318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92524554|NCT00019318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524555|NCT00019318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524556|NCT00022009|Gemcitabine|gemcitabine|mesh-list
92524557|NCT00022009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524558|NCT00022009|Antimetabolites|antimetabolites|mesh-ancestor
92524559|NCT00022009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524560|NCT00022009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524561|NCT00388661|Melatonin|melatonin|mesh-list
92524562|NCT00388661|Antioxidants|antioxidants|mesh-ancestor
92524563|NCT00388661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524564|NCT00388661|Protective Agents|protective agents|mesh-ancestor
92524565|NCT00388661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524566|NCT00388661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92524567|NCT00022048|Bevacizumab|bevacizumab|mesh-list
92524568|NCT00022048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92524569|NCT00022048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524570|NCT00022048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92524571|NCT00022048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92524572|NCT00022048|Growth Substances|growth substances|mesh-ancestor
92524573|NCT00022048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524574|NCT00022048|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524575|NCT00022087|Vitamin D|vitamin d|mesh-list
92524577|NCT00022087|Zoledronic Acid|zoledronic acid|mesh-list
92524578|NCT00022087|Calcium|calcium|mesh-list
92524579|NCT00022087|Vitamins|vitamins|mesh-ancestor
92524580|NCT00022087|Micronutrients|micronutrients|mesh-ancestor
92524581|NCT00022087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933528|NCT03520543|Clonidine|clonidine|mesh-list
92524582|NCT00022087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92524583|NCT00022087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92524584|NCT00388700|Leucovorin|leucovorin|mesh-list
92524585|NCT00388700|Bevacizumab|bevacizumab|mesh-list
92524586|NCT00388700|Fluorouracil|fluorouracil|mesh-list
92524587|NCT00388700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92524588|NCT00388700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524589|NCT00388700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92524590|NCT00388700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92524591|NCT00388700|Growth Substances|growth substances|mesh-ancestor
92524592|NCT00388700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524593|NCT00388700|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524594|NCT00388700|Antimetabolites|antimetabolites|mesh-ancestor
92524595|NCT00388700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524596|NCT00388700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524597|NCT00388700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524598|NCT00388700|Immunologic Factors|immunologic factors|mesh-ancestor
92524599|NCT00388700|Antidotes|antidotes|mesh-ancestor
92524600|NCT00388700|Protective Agents|protective agents|mesh-ancestor
92524601|NCT00388700|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524602|NCT00388700|Vitamins|vitamins|mesh-ancestor
92524603|NCT00388700|Micronutrients|micronutrients|mesh-ancestor
92524604|NCT00022126|Cytarabine|cytarabine|mesh-list
92524605|NCT00022126|Cyclosporine|cyclosporine|mesh-list
92524606|NCT00022126|Dexamethasone|dexamethasone|mesh-list
92524607|NCT00022126|Methylprednisolone|methylprednisolone|mesh-list
92524608|NCT00022126|Cyclophosphamide|cyclophosphamide|mesh-list
92524609|NCT00022126|Doxorubicin|doxorubicin|mesh-list
92524610|NCT00022126|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92524611|NCT00022126|Methotrexate|methotrexate|mesh-list
92524612|NCT00022126|Vincristine|vincristine|mesh-list
92524613|NCT00022126|Daunorubicin|daunorubicin|mesh-list
92524614|NCT00022126|Asparaginase|asparaginase|mesh-list
92524615|NCT00022126|Mercaptopurine|mercaptopurine|mesh-list
92524616|NCT00022126|Pegaspargase|pegaspargase|mesh-list
92524617|NCT00022126|Thioguanine|thioguanine|mesh-list
92524618|NCT00022126|Cyclosporins|cyclosporins|mesh-list
92524619|NCT00022126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524620|NCT00022126|Immunologic Factors|immunologic factors|mesh-ancestor
92524621|NCT00022126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524622|NCT00022126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524623|NCT00022126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524624|NCT00022126|Alkylating Agents|alkylating agents|mesh-ancestor
92524625|NCT00022126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524626|NCT00022126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524627|NCT00022126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92524628|NCT00022126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524629|NCT00022126|Antiemetics|antiemetics|mesh-ancestor
92524630|NCT00022126|Autonomic Agents|autonomic agents|mesh-ancestor
92524631|NCT00022126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524632|NCT00022126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92524633|NCT00022126|Glucocorticoids|glucocorticoids|mesh-ancestor
92524634|NCT00022126|Hormones|hormones|mesh-ancestor
92524635|NCT00022126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524636|NCT00022126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92524637|NCT00022126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524638|NCT00022126|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524639|NCT00022126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524640|NCT00022126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524641|NCT00022126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92524642|NCT00022126|Abortifacient Agents|abortifacient agents|mesh-ancestor
92524643|NCT00022126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92524644|NCT00022126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524645|NCT00022126|Antimetabolites|antimetabolites|mesh-ancestor
92524646|NCT00022126|Dermatologic Agents|dermatologic agents|mesh-ancestor
92524647|NCT00022126|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92524648|NCT00022126|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524649|NCT00022126|Antiviral Agents|antiviral agents|mesh-ancestor
92524650|NCT00022126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524651|NCT00022126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524652|NCT00022126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524653|NCT00022126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524654|NCT00022126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524655|NCT00022126|Antifungal Agents|antifungal agents|mesh-ancestor
92524656|NCT00022126|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92524657|NCT00022126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92524658|NCT00022126|Protective Agents|protective agents|mesh-ancestor
92524660|NCT00022165|Antioxidants|antioxidants|mesh-ancestor
92524661|NCT00022165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524662|NCT00022165|Protective Agents|protective agents|mesh-ancestor
92524663|NCT00022165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524664|NCT00022165|Trace Elements|trace elements|mesh-ancestor
92524665|NCT00022165|Micronutrients|micronutrients|mesh-ancestor
92524666|NCT00022204|Vitamin E|vitamin e|mesh-list
92524667|NCT00022204|Pentoxifylline|pentoxifylline|mesh-list
92524668|NCT00022204|Vitamins|vitamins|mesh-ancestor
92524669|NCT00022204|Micronutrients|micronutrients|mesh-ancestor
92524670|NCT00022204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524671|NCT00022204|Antioxidants|antioxidants|mesh-ancestor
92524672|NCT00022204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524673|NCT00022204|Protective Agents|protective agents|mesh-ancestor
92524674|NCT00022204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92524675|NCT00022204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524676|NCT00022204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92524677|NCT00022204|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92524678|NCT00022204|Vasodilator Agents|vasodilator agents|mesh-ancestor
92524679|NCT00022204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92524680|NCT00388739|Prednisolone|prednisolone|mesh-list
92524681|NCT00388739|Budesonide|budesonide|mesh-list
92524682|NCT00388739|Albuterol|albuterol|mesh-list
92524683|NCT00388739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524684|NCT00388739|Glucocorticoids|glucocorticoids|mesh-ancestor
92524685|NCT00388739|Hormones|hormones|mesh-ancestor
92524686|NCT00388739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524687|NCT00388739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524688|NCT00388739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92524689|NCT00388739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524690|NCT00388739|Autonomic Agents|autonomic agents|mesh-ancestor
92524691|NCT00388739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524692|NCT00388739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92524693|NCT00388739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92524694|NCT00388739|Respiratory System Agents|respiratory system agents|mesh-ancestor
92524695|NCT00388739|Tocolytic Agents|tocolytic agents|mesh-ancestor
92524696|NCT00388739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92524697|NCT00388739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92524698|NCT00388739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92524699|NCT00388739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92524700|NCT00388739|Adrenergic Agents|adrenergic agents|mesh-ancestor
92524701|NCT00388739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92524702|NCT00388739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524703|NCT00022321|Gemtuzumab|gemtuzumab|mesh-list
92524704|NCT00022321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92524705|NCT00022321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524706|NCT00022321|Immunotoxins|immunotoxins|mesh-ancestor
92524707|NCT00022321|Immunoconjugates|immunoconjugates|mesh-ancestor
92524708|NCT00022321|Immunologic Factors|immunologic factors|mesh-ancestor
92524709|NCT00022321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524710|NCT00022360|Taurolidine|taurolidine|mesh-list
92524711|NCT00022360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524712|NCT00022360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92524713|NCT00022360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524714|NCT00022399|Celecoxib|celecoxib|mesh-list
92524715|NCT00022399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92524716|NCT00022399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92524717|NCT00022399|Analgesics|analgesics|mesh-ancestor
92524718|NCT00022399|Sensory System Agents|sensory system agents|mesh-ancestor
92524719|NCT00022399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524720|NCT00022399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524721|NCT00022399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524722|NCT00022399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524723|NCT00022399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92524724|NCT00022399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92524725|NCT00022399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524726|NCT00022399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524727|NCT00000143|Ganciclovir|ganciclovir|mesh-list
92524728|NCT00000143|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92524730|NCT00000143|Antiviral Agents|antiviral agents|mesh-ancestor
92524731|NCT00000143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524732|NCT00000143|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524733|NCT00000143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933673|NCT03133195|Calcium|calcium|mesh-list
92524734|NCT00000143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524735|NCT00022438|Aldesleukin|aldesleukin|mesh-list
92524736|NCT00022438|Freund's Adjuvant|freund's adjuvant|mesh-list
92524737|NCT00022438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524738|NCT00022438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92524739|NCT00022438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92524740|NCT00022438|Antiviral Agents|antiviral agents|mesh-ancestor
92524741|NCT00022438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524742|NCT00022438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92524743|NCT00022438|Immunologic Factors|immunologic factors|mesh-ancestor
92524744|NCT00022438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524745|NCT00010686|Phytoestrogens|phytoestrogens|mesh-list
92524746|NCT00010686|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92524747|NCT00010686|Estrogens|estrogens|mesh-ancestor
92524748|NCT00010686|Hormones|hormones|mesh-ancestor
92524749|NCT00010686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353399|NCT03088254|Vasodilator Agents|vasodilator agents|mesh-ancestor
92524750|NCT00010686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524751|NCT00022555|Vincristine|vincristine|mesh-list
92524752|NCT00022555|Bryostatin 1|bryostatin 1|mesh-list
92524753|NCT00022555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524754|NCT00022555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524755|NCT00022555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524756|NCT00022555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524757|NCT00022555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524758|NCT00022555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524759|NCT00022555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92524760|NCT00022555|Immunologic Factors|immunologic factors|mesh-ancestor
92524761|NCT00022555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524762|NCT00000146|Prednisone|prednisone|mesh-list
92524763|NCT00000146|Methylprednisolone|methylprednisolone|mesh-list
92524764|NCT00000146|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92524765|NCT00000146|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92524766|NCT00000146|Prednisolone|prednisolone|mesh-list
92524767|NCT00000146|Prednisolone acetate|prednisolone acetate|mesh-list
92524768|NCT00000146|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92524769|NCT00000146|Prednisolone phosphate|prednisolone phosphate|mesh-list
92524770|NCT00000146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524771|NCT00000146|Glucocorticoids|glucocorticoids|mesh-ancestor
92524772|NCT00000146|Hormones|hormones|mesh-ancestor
92524773|NCT00000146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524774|NCT00000146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524775|NCT00000146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92524776|NCT00000146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524777|NCT00000146|Antiemetics|antiemetics|mesh-ancestor
92524778|NCT00000146|Autonomic Agents|autonomic agents|mesh-ancestor
92524779|NCT00000146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524780|NCT00000146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92524781|NCT00000146|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92524782|NCT00000146|Protective Agents|protective agents|mesh-ancestor
92524783|NCT00010725|Vitamins|vitamins|mesh-list
92524784|NCT00010725|Micronutrients|micronutrients|mesh-ancestor
92524785|NCT00010725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524786|NCT00022594|Lurtotecan|lurtotecan|mesh-list
92524787|NCT00022594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524788|NCT00000149|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92524789|NCT00000149|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92524790|NCT00000149|Adrenergic Agents|adrenergic agents|mesh-ancestor
92524791|NCT00000149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92524792|NCT00000149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524793|NCT00000149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524794|NCT00022711|Temozolomide|temozolomide|mesh-list
92524795|NCT00022711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524796|NCT00022711|Alkylating Agents|alkylating agents|mesh-ancestor
92524797|NCT00022711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524798|NCT00022711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524799|NCT00010842|Vitamin E|vitamin e|mesh-list
92524800|NCT00010842|Thioctic Acid|thioctic acid|mesh-list
92524801|NCT00010842|Selenium|selenium|mesh-list
92524802|NCT00010842|Vitamins|vitamins|mesh-ancestor
92524803|NCT00010842|Micronutrients|micronutrients|mesh-ancestor
92524804|NCT00010842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524805|NCT00010842|Antioxidants|antioxidants|mesh-ancestor
92524806|NCT00010842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524807|NCT00010842|Protective Agents|protective agents|mesh-ancestor
92524808|NCT00010842|Trace Elements|trace elements|mesh-ancestor
92524809|NCT00010842|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524810|NCT00000152|Aspirin|aspirin|mesh-list
92524811|NCT00000152|Beta Carotene|beta carotene|mesh-list
92524812|NCT00000152|Carotenoids|carotenoids|mesh-list
92524813|NCT00000152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92524814|NCT00000152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92524815|NCT00000152|Analgesics|analgesics|mesh-ancestor
92524816|NCT00000152|Sensory System Agents|sensory system agents|mesh-ancestor
92524817|NCT00000152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524818|NCT00000152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524819|NCT00000152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524820|NCT00000152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524821|NCT00000152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92524822|NCT00000152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92524823|NCT00000152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524824|NCT00000152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92524825|NCT00000152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92524826|NCT00000152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524827|NCT00000152|Antipyretics|antipyretics|mesh-ancestor
92524828|NCT00000152|Antioxidants|antioxidants|mesh-ancestor
92524829|NCT00000152|Protective Agents|protective agents|mesh-ancestor
92524830|NCT00000152|Provitamins|provitamins|mesh-ancestor
92524831|NCT00000152|Vitamins|vitamins|mesh-ancestor
92524832|NCT00000152|Micronutrients|micronutrients|mesh-ancestor
92524833|NCT00010881|Antioxidants|antioxidants|mesh-list
92524834|NCT00010881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524835|NCT00010881|Protective Agents|protective agents|mesh-ancestor
92524836|NCT00010881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524837|NCT00022906|Tositumomab I-131|tositumomab i-131|mesh-list
92524838|NCT00022906|Antibodies|antibodies|mesh-list
92524839|NCT00022906|Immunologic Factors|immunologic factors|mesh-ancestor
92524840|NCT00022906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524841|NCT00022906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524842|NCT00022945|Prednisone|prednisone|mesh-list
92524843|NCT00022945|Cyclophosphamide|cyclophosphamide|mesh-list
92524844|NCT00022945|Doxorubicin|doxorubicin|mesh-list
92524845|NCT00022945|Vincristine|vincristine|mesh-list
92524846|NCT00022945|Tositumomab I-131|tositumomab i-131|mesh-list
92524847|NCT00022945|Antibodies|antibodies|mesh-list
92524848|NCT00022945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524849|NCT00022945|Immunologic Factors|immunologic factors|mesh-ancestor
92524850|NCT00022945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524851|NCT00022945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524852|NCT00022945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92524853|NCT00022945|Alkylating Agents|alkylating agents|mesh-ancestor
92524854|NCT00022945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524855|NCT00022945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92524856|NCT00022945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92524857|NCT00022945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92524858|NCT00022945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92524859|NCT00022945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524860|NCT00022945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524861|NCT00022945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524862|NCT00022945|Glucocorticoids|glucocorticoids|mesh-ancestor
92524863|NCT00022945|Hormones|hormones|mesh-ancestor
92524864|NCT00022945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92524865|NCT00022945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92524866|NCT00022945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92524867|NCT00022945|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524868|NCT00022945|Antimitotic Agents|antimitotic agents|mesh-ancestor
92524869|NCT00022945|Mitosis Modulators|mitosis modulators|mesh-ancestor
92524870|NCT00023218|Ritonavir|ritonavir|mesh-list
92524871|NCT00023218|Lopinavir|lopinavir|mesh-list
92524872|NCT00023218|Efavirenz|efavirenz|mesh-list
92524873|NCT00023218|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92524874|NCT00023218|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92524875|NCT00023218|Protease Inhibitors|protease inhibitors|mesh-ancestor
92524876|NCT00023218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524877|NCT00023218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524878|NCT00023218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92524879|NCT00023218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92524880|NCT00023218|Antiviral Agents|antiviral agents|mesh-ancestor
92524881|NCT00023218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524882|NCT00023218|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92524883|NCT00023218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92524884|NCT00023218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92524885|NCT00023218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524886|NCT00023218|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92524887|NCT00023218|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92524888|NCT00023218|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92524889|NCT00023218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92524890|NCT00023218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92524891|NCT00394966|Rolapitant|rolapitant|mesh-list
92200630|NCT03837873|Hormones|hormones|mesh-ancestor
92524892|NCT00394966|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92524893|NCT00394966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200920|NCT00618917|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92200995|NCT03396068|Serotonin Agents|serotonin agents|mesh-ancestor
92524894|NCT00394966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524895|NCT00394966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524897|NCT00000170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92201287|NCT00737737|Narcotics|narcotics|mesh-ancestor
92201438|NCT05096481|Alkylating Agents|alkylating agents|mesh-ancestor
92524898|NCT00000170|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92524899|NCT00000170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92524900|NCT00000170|Autonomic Agents|autonomic agents|mesh-ancestor
92524901|NCT00000170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524902|NCT00000170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524903|NCT00000170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92524904|NCT00000170|Respiratory System Agents|respiratory system agents|mesh-ancestor
92524905|NCT00000170|Mydriatics|mydriatics|mesh-ancestor
92524906|NCT00000170|Parasympatholytics|parasympatholytics|mesh-ancestor
92201950|NCT02143973|Narcotics|narcotics|mesh-ancestor
92524907|NCT00000170|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92524908|NCT00000170|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92524909|NCT00000170|Cholinergic Agents|cholinergic agents|mesh-ancestor
92202320|NCT00696293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92524910|NCT00000170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202391|NCT01959945|Agglutinins|agglutinins|mesh-ancestor
92524911|NCT00000170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524912|NCT02024607|Leucovorin|leucovorin|mesh-list
92524913|NCT02024607|Bevacizumab|bevacizumab|mesh-list
92524914|NCT02024607|Fluorouracil|fluorouracil|mesh-list
92524915|NCT02024607|Capecitabine|capecitabine|mesh-list
92524917|NCT02024607|Irinotecan|irinotecan|mesh-list
92524918|NCT02024607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202689|NCT03223376|Paclitaxel|paclitaxel|mesh-list
92524919|NCT02024607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202832|NCT00702299|Tubulin Modulators|tubulin modulators|mesh-ancestor
92524920|NCT02024607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92524921|NCT02024607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92524922|NCT02024607|Growth Substances|growth substances|mesh-ancestor
92524923|NCT02024607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202908|NCT00662675|Pancrelipase|pancrelipase|mesh-list
92524924|NCT02024607|Growth Inhibitors|growth inhibitors|mesh-ancestor
92524925|NCT02024607|Antimetabolites|antimetabolites|mesh-ancestor
92524926|NCT02024607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524927|NCT02024607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92524928|NCT02024607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92524929|NCT02024607|Immunologic Factors|immunologic factors|mesh-ancestor
92524930|NCT02024607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92524931|NCT02024607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92524932|NCT02024607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524933|NCT02024607|Antidotes|antidotes|mesh-ancestor
92524934|NCT02024607|Protective Agents|protective agents|mesh-ancestor
92524935|NCT02024607|Vitamin B Complex|vitamin b complex|mesh-ancestor
92524936|NCT02024607|Vitamins|vitamins|mesh-ancestor
92524937|NCT02024607|Micronutrients|micronutrients|mesh-ancestor
92524938|NCT00023296|Nitric Oxide|nitric oxide|mesh-list
92524939|NCT00023296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92524940|NCT00023296|Autonomic Agents|autonomic agents|mesh-ancestor
92524941|NCT00023296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92524942|NCT00023296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524943|NCT00023296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92524944|NCT00023296|Respiratory System Agents|respiratory system agents|mesh-ancestor
92524945|NCT00023296|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92524946|NCT00023296|Antioxidants|antioxidants|mesh-ancestor
92524947|NCT00023296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524948|NCT00023296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92524949|NCT00023296|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92524950|NCT00023296|Vasodilator Agents|vasodilator agents|mesh-ancestor
92524951|NCT00023296|Gasotransmitters|gasotransmitters|mesh-ancestor
92524952|NCT00023296|Protective Agents|protective agents|mesh-ancestor
92524953|NCT00023335|Isoniazid|isoniazid|mesh-list
92524954|NCT00023335|Rifapentine|rifapentine|mesh-list
92524955|NCT00023335|Antitubercular Agents|antitubercular agents|mesh-ancestor
92524956|NCT00023335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92524957|NCT00023335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524958|NCT00023335|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92524959|NCT00023335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92524960|NCT00023335|Antimetabolites|antimetabolites|mesh-ancestor
92524961|NCT00023335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524962|NCT00023335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92524963|NCT00023335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92524964|NCT00023335|Leprostatic Agents|leprostatic agents|mesh-ancestor
92524965|NCT00000173|Vitamin E|vitamin e|mesh-list
92524966|NCT00000173|Donepezil|donepezil|mesh-list
92524967|NCT00000173|Vitamins|vitamins|mesh-ancestor
92524968|NCT00000173|Micronutrients|micronutrients|mesh-ancestor
92524969|NCT00000173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92524970|NCT00000173|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92524971|NCT00000173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203384|NCT04183868|Empagliflozin|empagliflozin|mesh-list
92524972|NCT00000173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524973|NCT00000173|Cholinergic Agents|cholinergic agents|mesh-ancestor
92203600|NCT01276691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92524974|NCT00000173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92524975|NCT00000173|Nootropic Agents|nootropic agents|mesh-ancestor
92524976|NCT00000173|Antioxidants|antioxidants|mesh-ancestor
92524977|NCT00000173|Protective Agents|protective agents|mesh-ancestor
92524979|NCT00023374|Pyrazinamide|pyrazinamide|mesh-list
92524980|NCT00023374|Ethambutol|ethambutol|mesh-list
92524981|NCT00023374|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92203682|NCT01279681|Leucovorin|leucovorin|mesh-list
92524982|NCT00023374|Antitubercular Agents|antitubercular agents|mesh-ancestor
92524983|NCT00023374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92524984|NCT00023374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92524985|NCT00023374|Leprostatic Agents|leprostatic agents|mesh-ancestor
92524987|NCT00023374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92524988|NCT00023374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92524989|NCT00023374|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92524990|NCT00023374|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92524991|NCT00023374|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92204195|NCT02144675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92524992|NCT00023374|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92524993|NCT00023374|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92204336|NCT00735917|Saracatinib|saracatinib|mesh-list
92524994|NCT00023374|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92524996|NCT00023413|Rifabutin|rifabutin|mesh-list
92524997|NCT00023413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92524998|NCT00023413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92524999|NCT00023413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525000|NCT00023413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525001|NCT00023413|Antiviral Agents|antiviral agents|mesh-ancestor
92525002|NCT00023413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525003|NCT00023413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92525004|NCT00023413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92525005|NCT00023413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92525006|NCT00023413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92204850|NCT01272635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92525007|NCT00023413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92204926|NCT00750815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92525008|NCT00023413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92525009|NCT00023413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525010|NCT00023413|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92525011|NCT00023413|Antitubercular Agents|antitubercular agents|mesh-ancestor
92525013|NCT00023530|Fluconazole|fluconazole|mesh-list
92525015|NCT00023530|Dexamethasone|dexamethasone|mesh-list
92525016|NCT00023530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92525017|NCT00023530|Antiemetics|antiemetics|mesh-ancestor
92525018|NCT00023530|Autonomic Agents|autonomic agents|mesh-ancestor
92525019|NCT00023530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525020|NCT00023530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525021|NCT00023530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92525022|NCT00023530|Glucocorticoids|glucocorticoids|mesh-ancestor
92525023|NCT00023530|Hormones|hormones|mesh-ancestor
92525024|NCT00023530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525025|NCT00023530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92205221|NCT02149303|Dabigatran|dabigatran|mesh-list
92525026|NCT00023530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525027|NCT00023530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205368|NCT03801733|Analgesics|analgesics|mesh-ancestor
92525028|NCT00023530|Immunologic Factors|immunologic factors|mesh-ancestor
92525029|NCT00023530|Leprostatic Agents|leprostatic agents|mesh-ancestor
92525030|NCT00023530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525031|NCT00023530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525032|NCT00023530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525033|NCT00023530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525034|NCT00023530|Growth Substances|growth substances|mesh-ancestor
92525035|NCT00023530|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525036|NCT00023530|Antifungal Agents|antifungal agents|mesh-ancestor
92525037|NCT00023530|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92205443|NCT03800953|Avelumab|avelumab|mesh-list
92525038|NCT00023530|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92525039|NCT00023530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525040|NCT00023530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525041|NCT00023530|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92525042|NCT00023530|Hormone Antagonists|hormone antagonists|mesh-ancestor
92525043|NCT00023530|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92205502|NCT01993875|Lubiprostone|lubiprostone|mesh-list
92525044|NCT00023530|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92525045|NCT00023530|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92525048|NCT00000176|Progestins|progestins|mesh-ancestor
92525049|NCT00000176|Hormones|hormones|mesh-ancestor
92525050|NCT00000176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525051|NCT00000176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525052|NCT00000179|Haloperidol|haloperidol|mesh-list
92525053|NCT00000179|Haloperidol decanoate|haloperidol decanoate|mesh-list
92525054|NCT00000179|Trazodone|trazodone|mesh-list
92525055|NCT00000179|Antiemetics|antiemetics|mesh-ancestor
92525056|NCT00000179|Autonomic Agents|autonomic agents|mesh-ancestor
92525057|NCT00000179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525058|NCT00000179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525059|NCT00000179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92525060|NCT00000179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92525061|NCT00000179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92525062|NCT00000179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92525063|NCT00000179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92525064|NCT00000179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92525065|NCT00000179|Dopamine Agents|dopamine agents|mesh-ancestor
92525066|NCT00000179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205707|NCT04382443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525067|NCT00000179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525068|NCT00000179|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92205784|NCT00797797|Analgesics|analgesics|mesh-ancestor
92205869|NCT00799435|Exenatide|exenatide|mesh-list
92525069|NCT00000179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92205921|NCT03417921|Paclitaxel|paclitaxel|mesh-list
92525070|NCT00000179|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92525071|NCT00000179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92525072|NCT00000179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92525073|NCT00000179|Serotonin Agents|serotonin agents|mesh-ancestor
92525074|NCT00000179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92525075|NCT00000179|Antidepressive Agents|antidepressive agents|mesh-ancestor
92525076|NCT00023725|Semaxinib|semaxinib|mesh-list
92525077|NCT00023725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525078|NCT00023725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525079|NCT00023725|Growth Substances|growth substances|mesh-ancestor
92525080|NCT00023725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525081|NCT00023725|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525082|NCT00023725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525083|NCT00023725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525084|NCT00023725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525085|NCT00023725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525087|NCT00391404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92525088|NCT00391404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525089|NCT00000191|Carbamazepine|carbamazepine|mesh-list
92525090|NCT00000191|Anticonvulsants|anticonvulsants|mesh-ancestor
92525091|NCT00000191|Antimanic Agents|antimanic agents|mesh-ancestor
92525092|NCT00000191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92525093|NCT00000191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92525094|NCT00000191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525095|NCT00000191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92525096|NCT00000191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92525097|NCT00000191|Analgesics|analgesics|mesh-ancestor
92525098|NCT00000191|Sensory System Agents|sensory system agents|mesh-ancestor
92525099|NCT00000191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206260|NCT02065479|Ticagrelor|ticagrelor|mesh-list
92525100|NCT00000191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92206485|NCT02410707|Anesthetics|anesthetics|mesh-ancestor
92525101|NCT00000191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206633|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92525102|NCT00000191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525103|NCT00000191|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92525105|NCT00023842|Mitomycins|mitomycins|mesh-list
92525107|NCT00023842|BCG Vaccine|bcg vaccine|mesh-list
92525108|NCT00023842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92207079|NCT00354627|Etravirine|etravirine|mesh-list
92525109|NCT00023842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525110|NCT00023842|Alkylating Agents|alkylating agents|mesh-ancestor
92207160|NCT02379195|Analgesics|analgesics|mesh-ancestor
92525111|NCT00023842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525112|NCT00023842|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525113|NCT00023842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207303|NCT03801629|Morphine|morphine|mesh-list
92525114|NCT00023842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92525115|NCT00023842|Immunologic Factors|immunologic factors|mesh-ancestor
92525116|NCT00023842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525117|NCT00000221|Buprenorphine|buprenorphine|mesh-list
92249921|NCT00243932|Ubiquinone|ubiquinone|mesh-list
92525118|NCT00000221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92525119|NCT00000221|Narcotics|narcotics|mesh-ancestor
92525120|NCT00000221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92525121|NCT00000221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525123|NCT00000221|Sensory System Agents|sensory system agents|mesh-ancestor
92525124|NCT00000221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525125|NCT00000221|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92525126|NCT00023881|Bortezomib|bortezomib|mesh-list
92525127|NCT00023881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525128|NCT00023920|Cytarabine|cytarabine|mesh-list
92525129|NCT00023920|Bevacizumab|bevacizumab|mesh-list
92525130|NCT00023920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92525131|NCT00023920|Idarubicin|idarubicin|mesh-list
92525132|NCT00023920|Antibodies|antibodies|mesh-list
92525133|NCT00023920|Immunoglobulins|immunoglobulins|mesh-list
92525134|NCT00023920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92525135|NCT00023920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525136|NCT00023920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525137|NCT00023920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525138|NCT00023920|Growth Substances|growth substances|mesh-ancestor
92525139|NCT00023920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525140|NCT00023920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525141|NCT00023920|Immunologic Factors|immunologic factors|mesh-ancestor
92525142|NCT00023920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525143|NCT00023920|Antimetabolites|antimetabolites|mesh-ancestor
92525144|NCT00023920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525145|NCT00023920|Antiviral Agents|antiviral agents|mesh-ancestor
92525146|NCT00023920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525147|NCT00023920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525148|NCT00023920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525149|NCT00023920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525150|NCT00023920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525151|NCT00023920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525152|NCT00023959|Bevacizumab|bevacizumab|mesh-list
92207946|NCT00807209|Narcotics|narcotics|mesh-ancestor
92525153|NCT00023959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92525154|NCT00023959|Fluorouracil|fluorouracil|mesh-list
92525155|NCT00023959|Hydroxyurea|hydroxyurea|mesh-list
92525156|NCT00023959|Antibodies|antibodies|mesh-list
92525157|NCT00023959|Immunoglobulins|immunoglobulins|mesh-list
92525158|NCT00023959|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92525159|NCT00023959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525160|NCT00023959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525161|NCT00023959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92208463|NCT05236907|Anesthetics|anesthetics|mesh-ancestor
92208536|NCT00366418|Rituximab|rituximab|mesh-list
92525162|NCT00023959|Growth Substances|growth substances|mesh-ancestor
92525163|NCT00023959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525164|NCT00023959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525165|NCT00023959|Immunologic Factors|immunologic factors|mesh-ancestor
92525166|NCT00023959|Antimetabolites|antimetabolites|mesh-ancestor
92208752|NCT02630992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208825|NCT02633956|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92525167|NCT00023959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208973|NCT04339816|Hydroxychloroquine|hydroxychloroquine|mesh-list
92209047|NCT00866749|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525168|NCT00023959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525169|NCT00023959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525170|NCT00023959|Antisickling Agents|antisickling agents|mesh-ancestor
92525171|NCT00023959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209269|NCT02704702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92209344|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209420|NCT03376477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525172|NCT00023959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525173|NCT00023998|Leucovorin|leucovorin|mesh-list
92525174|NCT00023998|Doxorubicin|doxorubicin|mesh-list
92525175|NCT00023998|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92525177|NCT00023998|Trastuzumab|trastuzumab|mesh-list
92525178|NCT00023998|Etoposide|etoposide|mesh-list
92525179|NCT00023998|Etoposide phosphate|etoposide phosphate|mesh-list
92525180|NCT00023998|Ifosfamide|ifosfamide|mesh-list
92525181|NCT00023998|Levoleucovorin|levoleucovorin|mesh-list
92525182|NCT00023998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525183|NCT00023998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525184|NCT00023998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525185|NCT00023998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525186|NCT00023998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525187|NCT00023998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525188|NCT00023998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353466|NCT03086226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525189|NCT00023998|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92525190|NCT00023998|Abortifacient Agents|abortifacient agents|mesh-ancestor
92525191|NCT00023998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525192|NCT00023998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525193|NCT00023998|Antimetabolites|antimetabolites|mesh-ancestor
92525194|NCT00023998|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210159|NCT01954966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525195|NCT00023998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92525196|NCT00023998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525198|NCT00023998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525199|NCT00023998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525200|NCT00023998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92525201|NCT00023998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92210531|NCT02506660|Glucocorticoids|glucocorticoids|mesh-ancestor
92525203|NCT00023998|Protective Agents|protective agents|mesh-ancestor
92525204|NCT00023998|Vitamin B Complex|vitamin b complex|mesh-ancestor
92525205|NCT00023998|Vitamins|vitamins|mesh-ancestor
92525206|NCT00023998|Micronutrients|micronutrients|mesh-ancestor
92210751|NCT00864383|Moxifloxacin|moxifloxacin|mesh-list
92525207|NCT00023998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525208|NCT00023998|Alkylating Agents|alkylating agents|mesh-ancestor
92525209|NCT00024115|Antibodies|antibodies|mesh-list
92525210|NCT00024115|Immunotoxins|immunotoxins|mesh-list
92525211|NCT00024115|Immunologic Factors|immunologic factors|mesh-list
92525212|NCT00024115|Immunomodulating Agents|immunomodulating agents|mesh-list
92525213|NCT00024115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525214|NCT00024115|Immunoconjugates|immunoconjugates|mesh-ancestor
92525215|NCT00024154|Trastuzumab|trastuzumab|mesh-list
92525216|NCT00024154|Gefitinib|gefitinib|mesh-list
92211425|NCT05516862|Camphor|camphor|mesh-list
92211499|NCT00879359|Paclitaxel|paclitaxel|mesh-list
92525217|NCT00024154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92525218|NCT00024154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211652|NCT04659616|Cytarabine|cytarabine|mesh-list
92211796|NCT03384563|Analgesics|analgesics|mesh-ancestor
92525219|NCT00024154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525220|NCT00024154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525221|NCT00024154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525222|NCT00011076|Pirfenidone|pirfenidone|mesh-list
92212172|NCT01044433|Capecitabine|capecitabine|mesh-list
92525223|NCT00011076|Analgesics|analgesics|mesh-ancestor
92525224|NCT00011076|Sensory System Agents|sensory system agents|mesh-ancestor
92525225|NCT00011076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212388|NCT04751812|Narcotics|narcotics|mesh-ancestor
92525226|NCT00011076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212539|NCT00373282|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92212763|NCT03400267|Narcotics|narcotics|mesh-ancestor
92525227|NCT00011076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92212986|NCT02240173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92525228|NCT00011076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92525229|NCT00011076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92525230|NCT00011076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525231|NCT00011076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525233|NCT00000248|Dopamine Agonists|dopamine agonists|mesh-ancestor
92525234|NCT00000248|Dopamine Agents|dopamine agents|mesh-ancestor
92213279|NCT03216941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92213355|NCT00906503|Autonomic Agents|autonomic agents|mesh-ancestor
92525235|NCT00000248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213429|NCT00909155|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92213504|NCT03833947|Antiemetics|antiemetics|mesh-ancestor
92213577|NCT00926263|Moxifloxacin|moxifloxacin|mesh-list
92353468|NCT03086226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92525236|NCT00000248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525237|NCT00000248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525238|NCT00024193|Cyclophosphamide|cyclophosphamide|mesh-list
92525239|NCT00024193|Melphalan|melphalan|mesh-list
92525240|NCT00024193|Busulfan|busulfan|mesh-list
92525241|NCT00024193|Doxorubicin|doxorubicin|mesh-list
92213883|NCT01726829|Pancreatin|pancreatin|mesh-list
92525242|NCT00024193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92525243|NCT00024193|Etoposide|etoposide|mesh-list
92525244|NCT00024193|Vincristine|vincristine|mesh-list
92525245|NCT00024193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525246|NCT00024193|Immunologic Factors|immunologic factors|mesh-ancestor
92214166|NCT04379219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525247|NCT00024193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525248|NCT00024193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214390|NCT01729403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214463|NCT03834935|Immunologic Factors|immunologic factors|mesh-ancestor
92525249|NCT00024193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525250|NCT00024193|Alkylating Agents|alkylating agents|mesh-ancestor
92525251|NCT00024193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525252|NCT00024193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214758|NCT04363255|Cisplatin|cisplatin|mesh-list
92525253|NCT00024193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92525254|NCT00024193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92214908|NCT04361461|Azithromycin|azithromycin|mesh-list
92525256|NCT00024193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525257|NCT00024193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525258|NCT00024193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525259|NCT00024193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525260|NCT00024193|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525261|NCT00024193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525263|NCT00024232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92525264|NCT00024232|Immunologic Factors|immunologic factors|mesh-ancestor
92525265|NCT00024232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525266|NCT00024271|Interferons|interferons|mesh-list
92525267|NCT00024271|Interferon-gamma|interferon-gamma|mesh-list
92525268|NCT00024271|Gemcitabine|gemcitabine|mesh-list
92525269|NCT00024271|Doxorubicin|doxorubicin|mesh-list
92215792|NCT00358293|Tizanidine|tizanidine|mesh-list
92215870|NCT04364321|Anesthetics|anesthetics|mesh-ancestor
92525270|NCT00024271|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92525271|NCT00024271|Mitomycins|mitomycins|mesh-list
92250072|NCT00780026|Insulin|insulin|mesh-list
92525272|NCT00024271|Mitomycin|mitomycin|mesh-list
92525274|NCT00024271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525276|NCT00024271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525277|NCT00024271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92216113|NCT01008319|Clomiphene|clomiphene|mesh-list
92216165|NCT02245295|Anesthetics|anesthetics|mesh-list
92525278|NCT00024271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525279|NCT00024271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525280|NCT00024271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525281|NCT00024271|Antiviral Agents|antiviral agents|mesh-ancestor
92525282|NCT00024271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216460|NCT05168709|Vaccines|vaccines|mesh-list
92525283|NCT00024271|Alkylating Agents|alkylating agents|mesh-ancestor
92525284|NCT00024271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525285|NCT00024310|Folic Acid|folic acid|mesh-list
92525287|NCT00024310|Lometrexol|lometrexol|mesh-list
92216780|NCT00976183|Vorinostat|vorinostat|mesh-list
92525288|NCT00024310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525289|NCT00024310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525290|NCT00024310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525291|NCT00024310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217045|NCT04772547|Vigabatrin|vigabatrin|mesh-list
92525292|NCT00024310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217190|NCT00985543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525293|NCT00024310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525294|NCT00024310|Hematinics|hematinics|mesh-ancestor
92525295|NCT00024310|Vitamin B Complex|vitamin b complex|mesh-ancestor
92525296|NCT00024310|Vitamins|vitamins|mesh-ancestor
92525297|NCT00024310|Micronutrients|micronutrients|mesh-ancestor
92217564|NCT03161938|Antiemetics|antiemetics|mesh-ancestor
92217709|NCT00362505|Antiviral Agents|antiviral agents|mesh-ancestor
92525298|NCT00024310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525299|NCT00024310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525300|NCT00024310|Antimetabolites|antimetabolites|mesh-ancestor
92525301|NCT00024310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92525302|NCT00024310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525303|NCT00024349|Fluorouracil|fluorouracil|mesh-list
92525305|NCT00024349|Mitomycin|mitomycin|mesh-list
92218151|NCT00995761|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525307|NCT00024349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525308|NCT00024349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525309|NCT00024349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525310|NCT00024349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525311|NCT00024349|Immunologic Factors|immunologic factors|mesh-ancestor
92218397|NCT00634010|Morphine|morphine|mesh-list
92525312|NCT00024349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525313|NCT00024349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525315|NCT00024349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92218758|NCT03122444|Imipramine|imipramine|mesh-list
92218899|NCT03115424|Incretins|incretins|mesh-ancestor
92525316|NCT00024349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525317|NCT00000251|Isoflurane|isoflurane|mesh-list
92525318|NCT00000251|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92219121|NCT02226159|Lidocaine|lidocaine|mesh-list
92525319|NCT00000251|Anesthetics, General|anesthetics, general|mesh-ancestor
92525320|NCT00000251|Anesthetics|anesthetics|mesh-ancestor
92219269|NCT05136157|Insulin|insulin|mesh-list
92219339|NCT00376870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92525321|NCT00000251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219487|NCT03822013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525322|NCT00000251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525324|NCT00024388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525325|NCT00024388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525326|NCT00024388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525327|NCT00024388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525328|NCT00024388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525329|NCT00024388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525330|NCT00024427|Gemcitabine|gemcitabine|mesh-list
92525331|NCT00024427|Fluorouracil|fluorouracil|mesh-list
92525332|NCT00024427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525333|NCT00024427|Antimetabolites|antimetabolites|mesh-ancestor
92525334|NCT00024427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525335|NCT00024427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525336|NCT00024427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525337|NCT00024427|Immunologic Factors|immunologic factors|mesh-ancestor
92525338|NCT00024427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525339|NCT00000257|Nitrous Oxide|nitrous oxide|mesh-list
92525340|NCT00000257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92525341|NCT00000257|Anesthetics, General|anesthetics, general|mesh-ancestor
92525342|NCT00000257|Anesthetics|anesthetics|mesh-ancestor
92525343|NCT00000257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533571|NCT04711564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92525344|NCT00000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525345|NCT00000257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92525347|NCT00000257|Sensory System Agents|sensory system agents|mesh-ancestor
92525348|NCT00000257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219771|NCT04735042|Hormones|hormones|mesh-ancestor
92219838|NCT01110187|Lacosamide|lacosamide|mesh-list
92219986|NCT00947765|Prednisolone|prednisolone|mesh-list
92525352|NCT04733131|Abatacept|abatacept|mesh-list
92525353|NCT04733131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92220139|NCT03587428|Zinc|zinc|mesh-list
92220211|NCT03944681|Antiemetics|antiemetics|mesh-ancestor
92220284|NCT00362895|Glucocorticoids|glucocorticoids|mesh-ancestor
92220361|NCT03609047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525354|NCT04733131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220434|NCT01782989|Doxycycline|doxycycline|mesh-list
92525355|NCT04733131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92525356|NCT04733131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525357|NCT04733131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525358|NCT04733131|Immunologic Factors|immunologic factors|mesh-ancestor
92220958|NCT03960658|Ketamine|ketamine|mesh-list
92525359|NCT04733131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525360|NCT04733131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525361|NCT00024544|Antibodies|antibodies|mesh-list
92525362|NCT00024544|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92221252|NCT01104025|Methotrexate|methotrexate|mesh-list
92525363|NCT00024544|Immunologic Factors|immunologic factors|mesh-ancestor
92221327|NCT01106833|Antifungal Agents|antifungal agents|mesh-ancestor
92525364|NCT00024544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525365|NCT00395239|Budesonide|budesonide|mesh-list
92525366|NCT00395239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221546|NCT01048879|Dialysis Solutions|dialysis solutions|mesh-list
92525367|NCT00395239|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92221623|NCT01167829|Hormone Antagonists|hormone antagonists|mesh-ancestor
92525369|NCT00395239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525370|NCT00395239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525371|NCT00395239|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92525372|NCT00395239|Respiratory System Agents|respiratory system agents|mesh-ancestor
92525373|NCT00395239|Glucocorticoids|glucocorticoids|mesh-ancestor
92525374|NCT00395239|Hormones|hormones|mesh-ancestor
92221699|NCT01169467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221764|NCT01170715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92525375|NCT00395239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525376|NCT00025012|Isotretinoin|isotretinoin|mesh-list
92525377|NCT00025012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92525378|NCT00025051|Celecoxib|celecoxib|mesh-list
92525379|NCT00025051|Mitogens|mitogens|mesh-list
92222212|NCT03872947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92222286|NCT00987272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525380|NCT00025051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92222434|NCT04759742|Ropivacaine|ropivacaine|mesh-list
92525381|NCT00025051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92525383|NCT00025051|Sensory System Agents|sensory system agents|mesh-ancestor
92525384|NCT00025051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222744|NCT00972959|Bortezomib|bortezomib|mesh-list
92525385|NCT00025051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222959|NCT03827642|Naloxone|naloxone|mesh-list
92525386|NCT00025051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92525387|NCT00025051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223336|NCT00982553|Ribavirin|ribavirin|mesh-list
92525388|NCT00025051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92525389|NCT00025051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92223703|NCT05560542|Atropine|atropine|mesh-list
92525391|NCT00025051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525392|NCT00025051|Mitosis Modulators|mitosis modulators|mesh-ancestor
92223855|NCT03765502|Hormones|hormones|mesh-ancestor
92223937|NCT04081324|Lasmiditan|lasmiditan|mesh-list
92525393|NCT00025090|Fluorouracil|fluorouracil|mesh-list
92525394|NCT00025090|Mitomycins|mitomycins|mesh-list
92525395|NCT00025090|Mitomycin|mitomycin|mesh-list
92525396|NCT00025090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525397|NCT00025090|Antimetabolites|antimetabolites|mesh-ancestor
92224232|NCT05025488|Poly ICLC|poly iclc|mesh-list
92224301|NCT02559414|Aspirin|aspirin|mesh-list
92224377|NCT05495100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525398|NCT00025090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224527|NCT04272476|Antidepressive Agents|antidepressive agents|mesh-ancestor
92525399|NCT00025090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525400|NCT00025090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525401|NCT00025090|Immunologic Factors|immunologic factors|mesh-ancestor
92525402|NCT00025090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224746|NCT02773576|Serotonin Agents|serotonin agents|mesh-ancestor
92224820|NCT05493228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92525403|NCT00025090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525404|NCT00025090|Alkylating Agents|alkylating agents|mesh-ancestor
92224970|NCT05488860|Immunologic Factors|immunologic factors|mesh-ancestor
92525405|NCT00025090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525406|NCT00025090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525407|NCT00000368|Paroxetine|paroxetine|mesh-list
92525408|NCT00000368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92225193|NCT02317276|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92525409|NCT00000368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92525410|NCT00000368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92525411|NCT00000368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525412|NCT00000368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525413|NCT00000368|Serotonin Agents|serotonin agents|mesh-ancestor
92525414|NCT00000368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225634|NCT03428958|Growth Substances|growth substances|mesh-ancestor
92525415|NCT00000368|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92225704|NCT05292976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92525416|NCT00000368|Antidepressive Agents|antidepressive agents|mesh-ancestor
92525417|NCT00000368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92525418|NCT00000368|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92225924|NCT01530880|Antipyretics|antipyretics|mesh-ancestor
92525419|NCT00000368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92525421|NCT00025168|Gemcitabine|gemcitabine|mesh-list
92525422|NCT00025168|Irinotecan|irinotecan|mesh-list
92525423|NCT00025168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525424|NCT00025168|Antimetabolites|antimetabolites|mesh-ancestor
92525425|NCT00025168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525426|NCT00025168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525427|NCT00025168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92525428|NCT00025168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525429|NCT00025168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525430|NCT00025207|Gefitinib|gefitinib|mesh-list
92226294|NCT00268450|Growth Substances|growth substances|mesh-ancestor
92525432|NCT00025207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525433|NCT00025207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525434|NCT00025207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525435|NCT00025246|Imatinib Mesylate|imatinib mesylate|mesh-list
92525436|NCT00025246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525437|NCT00025246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525438|NCT00025246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226518|NCT02344472|Paclitaxel|paclitaxel|mesh-list
92525439|NCT00025246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525441|NCT00025285|Carboplatin|carboplatin|mesh-list
92525442|NCT00025285|Irinotecan|irinotecan|mesh-list
92226807|NCT00001906|Interleukin-12|interleukin-12|mesh-list
92226883|NCT00001930|Analgesics|analgesics|mesh-ancestor
92226960|NCT00000232|Narcotics|narcotics|mesh-ancestor
92525443|NCT00025285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525444|NCT00025285|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92525445|NCT00025285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525446|NCT00025285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525447|NCT00025285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227331|NCT02548650|Aspirin|aspirin|mesh-list
92525448|NCT00025285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525449|NCT00025285|Immunologic Factors|immunologic factors|mesh-ancestor
92525450|NCT00025285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525451|NCT00025285|Leprostatic Agents|leprostatic agents|mesh-ancestor
92525452|NCT00025285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227624|NCT00000334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92525453|NCT00025285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525454|NCT00025285|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92227772|NCT00001282|Analgesics|analgesics|mesh-ancestor
92525455|NCT00025285|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525456|NCT00025285|Growth Substances|growth substances|mesh-ancestor
92525458|NCT00025324|Cyclophosphamide|cyclophosphamide|mesh-list
92525460|NCT00025324|Carboplatin|carboplatin|mesh-list
92525461|NCT00025324|Etoposide|etoposide|mesh-list
92525462|NCT00025324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525463|NCT00025324|Immunologic Factors|immunologic factors|mesh-ancestor
92228450|NCT00000658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525464|NCT00025324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525465|NCT00025324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228601|NCT00000700|Zidovudine|zidovudine|mesh-list
92228675|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
92525466|NCT00025324|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525467|NCT00025324|Alkylating Agents|alkylating agents|mesh-ancestor
92228828|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92525468|NCT00025324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229053|NCT00002380|Nelfinavir|nelfinavir|mesh-list
92525470|NCT00025324|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92229205|NCT03009877|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92525471|NCT00025324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229352|NCT01243333|Antimetabolites|antimetabolites|mesh-ancestor
92525472|NCT00025324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525473|NCT00025324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525474|NCT00025324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525475|NCT00025363|Cyclophosphamide|cyclophosphamide|mesh-list
92525476|NCT00025363|Ifosfamide|ifosfamide|mesh-list
92525477|NCT00025363|Doxorubicin|doxorubicin|mesh-list
92525478|NCT00025363|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92525479|NCT00025363|Irinotecan|irinotecan|mesh-list
92525480|NCT00025363|Etoposide|etoposide|mesh-list
92525481|NCT00025363|Vincristine|vincristine|mesh-list
92525482|NCT00025363|Etoposide phosphate|etoposide phosphate|mesh-list
92525483|NCT00025363|Tirapazamine|tirapazamine|mesh-list
92525484|NCT00025363|Sargramostim|sargramostim|mesh-list
92525485|NCT00025363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525486|NCT00025363|Immunologic Factors|immunologic factors|mesh-ancestor
92525487|NCT00025363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230105|NCT01204255|Diphenhydramine|diphenhydramine|mesh-list
92230177|NCT01823198|Aldesleukin|aldesleukin|mesh-list
92525489|NCT00025363|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525490|NCT00025363|Alkylating Agents|alkylating agents|mesh-ancestor
92230254|NCT05749666|Tofacitinib|tofacitinib|mesh-list
92230326|NCT04094207|Pentoxifylline|pentoxifylline|mesh-list
92525491|NCT00025363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525492|NCT00025363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525493|NCT00025363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92525494|NCT00025363|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525495|NCT00025363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230557|NCT00002560|Antibodies|antibodies|mesh-list
92525496|NCT00025363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525497|NCT00025363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525498|NCT00025363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92525499|NCT00025363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525500|NCT00025363|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525501|NCT00025363|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525502|NCT00025363|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525503|NCT00025402|Interferons|interferons|mesh-list
92525504|NCT00025402|Cytarabine|cytarabine|mesh-list
92231183|NCT00002740|Cobalt|cobalt|mesh-list
92231229|NCT01049945|Hormones|hormones|mesh-ancestor
92525506|NCT00025402|Cyclophosphamide|cyclophosphamide|mesh-list
92525507|NCT00025402|Busulfan|busulfan|mesh-list
92525508|NCT00025402|Etoposide|etoposide|mesh-list
92525509|NCT00025402|Idarubicin|idarubicin|mesh-list
92525510|NCT00025402|Hydroxyurea|hydroxyurea|mesh-list
92525511|NCT00025402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525512|NCT00025402|Immunologic Factors|immunologic factors|mesh-ancestor
92525513|NCT00025402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525514|NCT00025402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525515|NCT00025402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525516|NCT00025402|Alkylating Agents|alkylating agents|mesh-ancestor
92525517|NCT00025402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525518|NCT00025402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231524|NCT01055171|Propranolol|propranolol|mesh-list
92525519|NCT00025402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92525520|NCT00025402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525521|NCT00025402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525522|NCT00025402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525523|NCT00025402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525524|NCT00025402|Antiviral Agents|antiviral agents|mesh-ancestor
92231656|NCT02169479|Dopamine Agents|dopamine agents|mesh-ancestor
92525525|NCT00025402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525526|NCT00025402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525528|NCT00025402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525529|NCT00025402|Antisickling Agents|antisickling agents|mesh-ancestor
92525530|NCT00025402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232071|NCT00002896|Cobalt|cobalt|mesh-list
92525532|NCT00025441|Cyclophosphamide|cyclophosphamide|mesh-list
92525534|NCT00025441|Carboplatin|carboplatin|mesh-list
92525535|NCT00025441|Doxorubicin|doxorubicin|mesh-list
92525536|NCT00025441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92525537|NCT00025441|Etoposide|etoposide|mesh-list
92525538|NCT00025441|Vincristine|vincristine|mesh-list
92525539|NCT00025441|Epirubicin|epirubicin|mesh-list
92232327|NCT01572662|Antimetabolites|antimetabolites|mesh-ancestor
92525540|NCT00025441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525541|NCT00025441|Immunologic Factors|immunologic factors|mesh-ancestor
92232550|NCT00002986|Alkylating Agents|alkylating agents|mesh-ancestor
92525542|NCT00025441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525543|NCT00025441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525544|NCT00025441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525545|NCT00025441|Alkylating Agents|alkylating agents|mesh-ancestor
92525546|NCT00025441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525547|NCT00025441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525548|NCT00025441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92525549|NCT00025441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525550|NCT00025441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525551|NCT00025441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525552|NCT00025441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525553|NCT00025441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525554|NCT00025441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525555|NCT00025441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525556|NCT00025441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525557|NCT00025441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525558|NCT00025441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525559|NCT00025441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92232844|NCT01269424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525560|NCT00025441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525561|NCT00000395|Folic Acid|folic acid|mesh-list
92525562|NCT00000395|Leucovorin|leucovorin|mesh-list
92525563|NCT00000395|Methotrexate|methotrexate|mesh-list
92525564|NCT00000395|Levoleucovorin|levoleucovorin|mesh-list
92525565|NCT00000395|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92525566|NCT00000395|Abortifacient Agents|abortifacient agents|mesh-ancestor
92525567|NCT00000395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525568|NCT00000395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525569|NCT00000395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525570|NCT00000395|Antimetabolites|antimetabolites|mesh-ancestor
92525571|NCT00000395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525572|NCT00000395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525573|NCT00000395|Dermatologic Agents|dermatologic agents|mesh-ancestor
92250364|NCT01216397|Hormones|hormones|mesh-ancestor
92525574|NCT00000395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525575|NCT00000395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92525576|NCT00000395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525577|NCT00000395|Immunologic Factors|immunologic factors|mesh-ancestor
92525578|NCT00000395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525579|NCT00000395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525580|NCT00000395|Hematinics|hematinics|mesh-ancestor
92233037|NCT00062738|Paroxetine|paroxetine|mesh-list
92525581|NCT00000395|Vitamin B Complex|vitamin b complex|mesh-ancestor
92525583|NCT00000395|Micronutrients|micronutrients|mesh-ancestor
92525584|NCT00000395|Antidotes|antidotes|mesh-ancestor
92525585|NCT00000395|Protective Agents|protective agents|mesh-ancestor
92525587|NCT00025480|Carboplatin|carboplatin|mesh-list
92233334|NCT01258855|Analgesics|analgesics|mesh-ancestor
92525589|NCT00025480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525590|NCT00025480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233483|NCT00003190|Cytarabine|cytarabine|mesh-list
92525592|NCT00025480|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525593|NCT00025480|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233554|NCT00003664|Interferons|interferons|mesh-list
92525594|NCT00025480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525595|NCT00025519|Mycophenolic Acid|mycophenolic acid|mesh-list
92525597|NCT00025519|Fludarabine|fludarabine|mesh-list
92525598|NCT00025519|Fludarabine phosphate|fludarabine phosphate|mesh-list
92525600|NCT00025519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525601|NCT00025519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525603|NCT00025519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525604|NCT00025519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525605|NCT00025519|Immunologic Factors|immunologic factors|mesh-ancestor
92233994|NCT00085436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92234086|NCT00003994|Amifostine|amifostine|mesh-list
92525606|NCT00025519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525607|NCT00025519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92525608|NCT00025519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525609|NCT00025519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525610|NCT00025519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92525611|NCT00025519|Antitubercular Agents|antitubercular agents|mesh-ancestor
92525612|NCT00025519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92234369|NCT00003784|Doxorubicin|doxorubicin|mesh-list
92525613|NCT00025519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525614|NCT00025519|Leprostatic Agents|leprostatic agents|mesh-ancestor
92525615|NCT00025519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525616|NCT00025519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525617|NCT00025519|Growth Substances|growth substances|mesh-ancestor
92525618|NCT00025519|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525619|NCT00025558|Carboplatin|carboplatin|mesh-list
92525620|NCT00025558|Temozolomide|temozolomide|mesh-list
92525622|NCT00025558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234826|NCT00004918|Sargramostim|sargramostim|mesh-list
92525623|NCT00025558|Immunologic Factors|immunologic factors|mesh-ancestor
92525624|NCT00025558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525625|NCT00025558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525626|NCT00025558|Alkylating Agents|alkylating agents|mesh-ancestor
92525627|NCT00025558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235033|NCT05775536|Antipyretics|antipyretics|mesh-ancestor
92525629|NCT00025558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235098|NCT05638594|Pertuzumab|pertuzumab|mesh-list
92525631|NCT00025597|Carboplatin|carboplatin|mesh-list
92525632|NCT00025597|Doxorubicin|doxorubicin|mesh-list
92525633|NCT00025597|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92525635|NCT00025597|Vincristine|vincristine|mesh-list
92525636|NCT00025597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235402|NCT04662710|Vitamins|vitamins|mesh-ancestor
92525637|NCT00025597|Immunologic Factors|immunologic factors|mesh-ancestor
92525638|NCT00025597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525639|NCT00025597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525640|NCT00025597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525641|NCT00025597|Alkylating Agents|alkylating agents|mesh-ancestor
92235616|NCT03297359|Anticoagulants|anticoagulants|mesh-ancestor
92525642|NCT00025597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525643|NCT00025597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525644|NCT00025597|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92525645|NCT00025597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92525646|NCT00025597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236071|NCT01216735|Fluticasone|fluticasone|mesh-list
92236145|NCT00004198|Vaccines|vaccines|mesh-list
92525647|NCT00025597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92525648|NCT00025597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525649|NCT00025597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92250439|NCT01252745|Anabolic Agents|anabolic agents|mesh-ancestor
92525650|NCT00025597|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525651|NCT00025597|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525652|NCT00025597|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525654|NCT00025636|Dexamethasone|dexamethasone|mesh-list
92525655|NCT00025636|Cyclophosphamide|cyclophosphamide|mesh-list
92525656|NCT00025636|Melphalan|melphalan|mesh-list
92525657|NCT00025636|Carmustine|carmustine|mesh-list
92525659|NCT00025636|Etoposide|etoposide|mesh-list
92525660|NCT00025636|Vincristine|vincristine|mesh-list
92525661|NCT00025636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525662|NCT00025636|Immunologic Factors|immunologic factors|mesh-ancestor
92525663|NCT00025636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525664|NCT00025636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525665|NCT00025636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525666|NCT00025636|Alkylating Agents|alkylating agents|mesh-ancestor
92525667|NCT00025636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525668|NCT00025636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237405|NCT01414153|Ranibizumab|ranibizumab|mesh-list
92525669|NCT00025636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92237635|NCT04780061|Vitamin K 2|vitamin k 2|mesh-list
92525671|NCT00025636|Antiemetics|antiemetics|mesh-ancestor
92237861|NCT01034111|Metformin|metformin|mesh-list
92525673|NCT00025636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238007|NCT01426867|Brinzolamide|brinzolamide|mesh-list
92525674|NCT00025636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92525675|NCT00025636|Glucocorticoids|glucocorticoids|mesh-ancestor
92525676|NCT00025636|Hormones|hormones|mesh-ancestor
92238232|NCT01323517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238396|NCT05448378|Inositol|inositol|mesh-list
92238454|NCT01118273|Autonomic Agents|autonomic agents|mesh-ancestor
92238529|NCT01086605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525677|NCT00025636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525678|NCT00025636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92525679|NCT00025636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92525680|NCT00025636|Abortifacient Agents|abortifacient agents|mesh-ancestor
92525681|NCT00025636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525682|NCT00025636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525683|NCT00025636|Antimetabolites|antimetabolites|mesh-ancestor
92525684|NCT00025636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92525685|NCT00025636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525686|NCT00025636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92239264|NCT00281918|Rituximab|rituximab|mesh-list
92525687|NCT00025636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92239342|NCT00210470|Gout Suppressants|gout suppressants|mesh-ancestor
92525688|NCT00025636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92239414|NCT01165541|Histamine Agents|histamine agents|mesh-ancestor
92525689|NCT00025636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92525690|NCT00025636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92239556|NCT01898624|Mirabegron|mirabegron|mesh-list
92525691|NCT00025636|Antiviral Agents|antiviral agents|mesh-ancestor
92239628|NCT00298610|Proguanil|proguanil|mesh-list
92525692|NCT00025636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525693|NCT00025636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92525694|NCT00025636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525695|NCT00025636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525696|NCT00025675|Gefitinib|gefitinib|mesh-list
92525697|NCT00025675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525698|NCT00025675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525699|NCT00025675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525700|NCT00025675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525701|NCT00025753|Rosiglitazone|rosiglitazone|mesh-list
92525702|NCT00025753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92525703|NCT00025753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525704|NCT00025792|Pramipexole|pramipexole|mesh-list
92525705|NCT00025792|Antioxidants|antioxidants|mesh-ancestor
92525706|NCT00025792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525707|NCT00025792|Protective Agents|protective agents|mesh-ancestor
92525708|NCT00025792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525709|NCT00025792|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92525710|NCT00025792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92525711|NCT00025792|Dopamine Agonists|dopamine agonists|mesh-ancestor
92525712|NCT00025792|Dopamine Agents|dopamine agents|mesh-ancestor
92240129|NCT00248534|Prednisolone|prednisolone|mesh-list
92240202|NCT02099006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92240275|NCT01480219|Antifungal Agents|antifungal agents|mesh-ancestor
92525713|NCT00025792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525714|NCT00000419|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92240388|NCT01791608|Zinc|zinc|mesh-list
92525715|NCT00000419|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92240503|NCT01183481|Serotonin Agents|serotonin agents|mesh-ancestor
92525716|NCT00000419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92525717|NCT00000419|Contraceptive Agents|contraceptive agents|mesh-ancestor
92525718|NCT00000419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525719|NCT00000419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525720|NCT00000419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92525721|NCT00000419|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92240644|NCT04352465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525722|NCT00000419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92525723|NCT00000419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525724|NCT00000419|Estrogens|estrogens|mesh-ancestor
92525725|NCT00000419|Hormones|hormones|mesh-ancestor
92240789|NCT00305942|Topotecan|topotecan|mesh-list
92525726|NCT00000419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525727|NCT00026104|Paclitaxel|paclitaxel|mesh-list
92525728|NCT00026104|Gemcitabine|gemcitabine|mesh-list
92240933|NCT02105324|Pancrelipase|pancrelipase|mesh-list
92525730|NCT00026104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92525732|NCT00026104|Tubulin Modulators|tubulin modulators|mesh-ancestor
92241155|NCT05329428|Vitamin D|vitamin d|mesh-list
92525733|NCT00026104|Antimitotic Agents|antimitotic agents|mesh-ancestor
92525734|NCT00026104|Mitosis Modulators|mitosis modulators|mesh-ancestor
92525735|NCT00026104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525736|NCT00026104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92241459|NCT05894603|Ritonavir|ritonavir|mesh-list
92525737|NCT00026104|Antimetabolites|antimetabolites|mesh-ancestor
92525738|NCT00026143|Interferons|interferons|mesh-list
92525739|NCT00026143|Interferon-alpha|interferon-alpha|mesh-list
92241759|NCT05376579|Siponimod|siponimod|mesh-list
92525741|NCT00026143|Interleukin-12|interleukin-12|mesh-list
92525742|NCT00026143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525743|NCT00026143|Antiviral Agents|antiviral agents|mesh-ancestor
92241889|NCT04999215|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92525744|NCT00026143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525745|NCT00026143|Immunologic Factors|immunologic factors|mesh-ancestor
92525746|NCT00026143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525747|NCT00026143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92525748|NCT00026143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525749|NCT00026143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525751|NCT00026143|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525753|NCT00026182|Interleukin-12|interleukin-12|mesh-list
92525754|NCT00026182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92525755|NCT00026182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242487|NCT03504397|Leucovorin|leucovorin|mesh-list
92525756|NCT00026182|Immunologic Factors|immunologic factors|mesh-ancestor
92525757|NCT00026182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525758|NCT00026182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525759|NCT00026182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92525760|NCT00026182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525761|NCT00026182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242936|NCT05514990|Dexamethasone|dexamethasone|mesh-list
92525762|NCT00026182|Growth Substances|growth substances|mesh-ancestor
92525763|NCT00026182|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525764|NCT00026260|Semaxinib|semaxinib|mesh-list
92525765|NCT00026260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525766|NCT00026260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92243225|NCT05263284|Venetoclax|venetoclax|mesh-list
92525767|NCT00026260|Growth Substances|growth substances|mesh-ancestor
92243326|NCT05258292|Insulin|insulin|mesh-list
92525768|NCT00026260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243375|NCT00379574|Hormones|hormones|mesh-ancestor
92525769|NCT00026260|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525770|NCT00026260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525771|NCT00026260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243521|NCT05292690|Caffeine|caffeine|mesh-list
92525772|NCT00026260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525773|NCT00026260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525774|NCT00026299|Oxaliplatin|oxaliplatin|mesh-list
92525776|NCT00026299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525777|NCT00026299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243888|NCT00462020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92243963|NCT00462644|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92244039|NCT01795664|Glucocorticoids|glucocorticoids|mesh-ancestor
92244111|NCT00533546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92525779|NCT00026299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244256|NCT05096832|Vaccines|vaccines|mesh-list
92525781|NCT00026338|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92525782|NCT00026338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92525783|NCT00026338|Antimetabolites|antimetabolites|mesh-ancestor
92525784|NCT00026338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525785|NCT00026338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525786|NCT00026338|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525787|NCT00026338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244549|NCT00489866|Serotonin Agents|serotonin agents|mesh-ancestor
92525788|NCT00026377|Leuprolide|leuprolide|mesh-list
92525789|NCT00026377|Goserelin|goserelin|mesh-list
92525790|NCT00026377|Flutamide|flutamide|mesh-list
92525791|NCT00026377|Bicalutamide|bicalutamide|mesh-list
92525792|NCT00026377|Semaxinib|semaxinib|mesh-list
92525793|NCT00026377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92525794|NCT00026377|Fertility Agents|fertility agents|mesh-ancestor
92525795|NCT00026377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525796|NCT00026377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525797|NCT00026377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92525798|NCT00026377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525799|NCT00026377|Androgen Antagonists|androgen antagonists|mesh-ancestor
92525800|NCT00026377|Hormone Antagonists|hormone antagonists|mesh-ancestor
92525801|NCT00026377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525802|NCT00026377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525803|NCT00026377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525804|NCT00026377|Growth Substances|growth substances|mesh-ancestor
92525805|NCT00026377|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525806|NCT00026377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525807|NCT00026377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525808|NCT00026377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525809|NCT00026416|Interferons|interferons|mesh-list
92525810|NCT00026416|Interferon-alpha|interferon-alpha|mesh-list
92525811|NCT00026416|Thalidomide|thalidomide|mesh-list
92525812|NCT00026416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525813|NCT00026416|Antiviral Agents|antiviral agents|mesh-ancestor
92525814|NCT00026416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525815|NCT00026416|Immunologic Factors|immunologic factors|mesh-ancestor
92525816|NCT00026416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525817|NCT00026416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525818|NCT00026416|Leprostatic Agents|leprostatic agents|mesh-ancestor
92245126|NCT04227678|Heparin|heparin|mesh-list
92525819|NCT00026416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525820|NCT00026416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525822|NCT00026416|Growth Substances|growth substances|mesh-ancestor
92525823|NCT00026416|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525824|NCT00026533|Thalidomide|thalidomide|mesh-list
92525825|NCT00026533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525826|NCT00026533|Immunologic Factors|immunologic factors|mesh-ancestor
92525827|NCT00026533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525828|NCT00026533|Leprostatic Agents|leprostatic agents|mesh-ancestor
92525829|NCT00026533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525830|NCT00026533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525831|NCT00026533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92525832|NCT00026533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92525833|NCT00026533|Growth Substances|growth substances|mesh-ancestor
92525834|NCT00026533|Growth Inhibitors|growth inhibitors|mesh-ancestor
92525835|NCT00026533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525836|NCT00026962|Estradiol|estradiol|mesh-list
92525837|NCT00026962|Progesterone|progesterone|mesh-list
92525838|NCT00026962|Estrogens|estrogens|mesh-ancestor
92525839|NCT00026962|Hormones|hormones|mesh-ancestor
92525840|NCT00026962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525841|NCT00026962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525842|NCT00026962|Progestins|progestins|mesh-ancestor
92525843|NCT00027040|Selegiline|selegiline|mesh-list
92525844|NCT00027040|Antidepressive Agents|antidepressive agents|mesh-ancestor
92525846|NCT00027040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92246097|NCT01563055|Ofatumumab|ofatumumab|mesh-list
92525847|NCT00027040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92525848|NCT00027040|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92246247|NCT02129426|Anesthetics|anesthetics|mesh-ancestor
92525849|NCT00027040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525850|NCT00027040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246463|NCT05085626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525851|NCT00027040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92525852|NCT00027040|Protective Agents|protective agents|mesh-ancestor
92525853|NCT00027040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246685|NCT01579513|Methylprednisolone|methylprednisolone|mesh-list
92525854|NCT00027079|Naltrexone|naltrexone|mesh-list
92525855|NCT00027079|Ondansetron|ondansetron|mesh-list
92525856|NCT00027079|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92525857|NCT00027079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92246766|NCT04257188|Anesthetics|anesthetics|mesh-list
92525858|NCT00027079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246899|NCT00587678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246981|NCT00610688|Vitamin D|vitamin d|mesh-list
92525859|NCT00027079|Sensory System Agents|sensory system agents|mesh-ancestor
92525860|NCT00027079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525861|NCT00027079|Antiemetics|antiemetics|mesh-ancestor
92525862|NCT00027079|Autonomic Agents|autonomic agents|mesh-ancestor
92247194|NCT01585207|Vigabatrin|vigabatrin|mesh-list
92247266|NCT00619190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525863|NCT00027079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92525864|NCT00027079|Antipruritics|antipruritics|mesh-ancestor
92247561|NCT02999815|Antibodies|antibodies|mesh-list
92525865|NCT00027079|Dermatologic Agents|dermatologic agents|mesh-ancestor
92525866|NCT00027079|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92247640|NCT02248129|Telmisartan|telmisartan|mesh-list
92525867|NCT00027079|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92525868|NCT00027079|Serotonin Agents|serotonin agents|mesh-ancestor
92247852|NCT00687674|Antiemetics|antiemetics|mesh-ancestor
92247926|NCT00588536|Thioguanine|thioguanine|mesh-list
92525869|NCT00027079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248150|NCT00639158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525870|NCT00027079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525871|NCT00011778|Bortezomib|bortezomib|mesh-list
92525872|NCT00011778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525874|NCT00000425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92525875|NCT00000425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92525876|NCT00000425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92525877|NCT00000425|Analgesics|analgesics|mesh-ancestor
92525878|NCT00000425|Sensory System Agents|sensory system agents|mesh-ancestor
92525879|NCT00000425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525880|NCT00000425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525881|NCT00000425|Antipyretics|antipyretics|mesh-ancestor
92525882|NCT00000425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525883|NCT00000428|Amitriptyline|amitriptyline|mesh-list
92525884|NCT00000428|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92525885|NCT00000428|Antidepressive Agents|antidepressive agents|mesh-ancestor
92525886|NCT00000428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92525887|NCT00000428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92525888|NCT00000428|Analgesics|analgesics|mesh-ancestor
92525889|NCT00000428|Sensory System Agents|sensory system agents|mesh-ancestor
92525890|NCT00000428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249099|NCT01211873|Chelating Agents|chelating agents|mesh-ancestor
92525891|NCT00000428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249244|NCT00731198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249317|NCT01278758|Vadimezan|vadimezan|mesh-list
92249391|NCT01275170|GABA Agents|gaba agents|mesh-ancestor
92525892|NCT00000428|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92525893|NCT00000428|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92525894|NCT00000428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249688|NCT01279616|Thymoglobulin|thymoglobulin|mesh-list
92525895|NCT00000428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525896|NCT00000428|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249925|NCT00243932|Vitamins|vitamins|mesh-ancestor
92525897|NCT00000428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525898|NCT00027391|Albuterol|albuterol|mesh-list
92525899|NCT00027391|Oxandrolone|oxandrolone|mesh-list
92525900|NCT00027391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92525902|NCT00027391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92525903|NCT00027391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525904|NCT00027391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92525905|NCT00027391|Respiratory System Agents|respiratory system agents|mesh-ancestor
92525906|NCT00027391|Tocolytic Agents|tocolytic agents|mesh-ancestor
92525907|NCT00027391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525908|NCT00027391|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92525909|NCT00027391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92525910|NCT00027391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92525911|NCT00027391|Adrenergic Agents|adrenergic agents|mesh-ancestor
92525912|NCT00027391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92525913|NCT00027391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525915|NCT00027391|Hormones|hormones|mesh-ancestor
92525916|NCT00027391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92525917|NCT00027391|Anabolic Agents|anabolic agents|mesh-ancestor
92525918|NCT00000461|Niacin|niacin|mesh-list
92525919|NCT00000461|Pravastatin|pravastatin|mesh-list
92525920|NCT00000461|Gemfibrozil|gemfibrozil|mesh-list
92525921|NCT00000461|Cholestyramine Resin|cholestyramine resin|mesh-list
92525922|NCT00000461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92525923|NCT00000461|Antimetabolites|antimetabolites|mesh-ancestor
92525924|NCT00000461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525925|NCT00000461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92525926|NCT00000461|Vasodilator Agents|vasodilator agents|mesh-ancestor
92525927|NCT00000461|Vitamin B Complex|vitamin b complex|mesh-ancestor
92525928|NCT00000461|Vitamins|vitamins|mesh-ancestor
92525929|NCT00000461|Micronutrients|micronutrients|mesh-ancestor
92525930|NCT00000461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525931|NCT00000461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92525932|NCT00000461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92525933|NCT00000461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353609|NCT03832452|Moxifloxacin|moxifloxacin|mesh-list
92525934|NCT00000461|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92525935|NCT00000461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92525936|NCT00027508|Trabectedin|trabectedin|mesh-list
92525937|NCT00027508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92525938|NCT00027508|Alkylating Agents|alkylating agents|mesh-ancestor
92525939|NCT00027508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533584|NCT00061360|Sirolimus|sirolimus|mesh-list
92525940|NCT00027508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525941|NCT00027547|Cytarabine|cytarabine|mesh-list
92525942|NCT00027547|Cyclosporine|cyclosporine|mesh-list
92525943|NCT00027547|Mycophenolic Acid|mycophenolic acid|mesh-list
92525944|NCT00027547|Methotrexate|methotrexate|mesh-list
92525945|NCT00027547|Fludarabine phosphate|fludarabine phosphate|mesh-list
92525946|NCT00027547|Fludarabine|fludarabine|mesh-list
92525947|NCT00027547|Cyclosporins|cyclosporins|mesh-list
92525948|NCT00027547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92525949|NCT00027547|Abortifacient Agents|abortifacient agents|mesh-ancestor
92525950|NCT00027547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92525951|NCT00027547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92525952|NCT00027547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250616|NCT05742698|Nabilone|nabilone|mesh-list
92525953|NCT00027547|Antimetabolites|antimetabolites|mesh-ancestor
92525954|NCT00027547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525955|NCT00027547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92525956|NCT00027547|Dermatologic Agents|dermatologic agents|mesh-ancestor
92525957|NCT00027547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525958|NCT00027547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92525959|NCT00027547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92525960|NCT00027547|Immunologic Factors|immunologic factors|mesh-ancestor
92525961|NCT00027547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92525962|NCT00027547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525963|NCT00027547|Antiviral Agents|antiviral agents|mesh-ancestor
92525964|NCT00027547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525965|NCT00027547|Antifungal Agents|antifungal agents|mesh-ancestor
92525966|NCT00027547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92525967|NCT00027547|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92250902|NCT01259063|Everolimus|everolimus|mesh-list
92525968|NCT00027547|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92525969|NCT00027547|Antitubercular Agents|antitubercular agents|mesh-ancestor
92525970|NCT00027547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92525971|NCT00011895|Lamivudine|lamivudine|mesh-list
92525972|NCT00011895|Zidovudine|zidovudine|mesh-list
92525973|NCT00011895|Efavirenz|efavirenz|mesh-list
92525974|NCT00011895|Abacavir|abacavir|mesh-list
92525975|NCT00011895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92525976|NCT00011895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92525977|NCT00011895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525978|NCT00011895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525979|NCT00011895|Antiviral Agents|antiviral agents|mesh-ancestor
92525980|NCT00011895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92525981|NCT00011895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92525982|NCT00011895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92525983|NCT00011895|Antimetabolites|antimetabolites|mesh-ancestor
92525984|NCT00011895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92525985|NCT00011895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92525986|NCT00011895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92525987|NCT00011895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92525988|NCT00011895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92525989|NCT00011895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92525990|NCT00027586|Imatinib Mesylate|imatinib mesylate|mesh-list
92525991|NCT00027586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251093|NCT01269047|Exenatide|exenatide|mesh-list
92525992|NCT00027586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92525993|NCT00027586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92525994|NCT00027586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92525995|NCT00000464|Quinidine|quinidine|mesh-list
92525996|NCT00000464|Amiodarone|amiodarone|mesh-list
92525997|NCT00000464|Sotalol|sotalol|mesh-list
92525998|NCT00000464|Propafenone|propafenone|mesh-list
92526000|NCT00000464|Procainamide|procainamide|mesh-list
92526001|NCT00000464|Imipramine|imipramine|mesh-list
92526002|NCT00000464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92526003|NCT00000464|Vasodilator Agents|vasodilator agents|mesh-ancestor
92251765|NCT01365611|Xhance|xhance|mesh-list
92526004|NCT00000464|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92251834|NCT01474109|Macitentan|macitentan|mesh-list
92526005|NCT00000464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526006|NCT00000464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526007|NCT00000464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92526008|NCT00000464|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92526009|NCT00000464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92526010|NCT00000464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252126|NCT01492673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92526011|NCT00000464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92526012|NCT00000464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92526013|NCT00000464|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92526014|NCT00000464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92526015|NCT00000464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92526016|NCT00000464|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526017|NCT00000464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252426|NCT01505933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92526018|NCT00000464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526020|NCT00000464|Autonomic Agents|autonomic agents|mesh-ancestor
92526021|NCT00000464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526022|NCT00000464|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92526023|NCT00000464|Antidepressive Agents|antidepressive agents|mesh-ancestor
92526024|NCT00000464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92526025|NCT00000464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92526026|NCT00000464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92526027|NCT00000464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92526028|NCT00000464|Antimalarials|antimalarials|mesh-ancestor
92526029|NCT00000464|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92253333|NCT05945368|Pertuzumab|pertuzumab|mesh-list
92526030|NCT00000464|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92526031|NCT00000464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526032|NCT00000464|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92253467|NCT05889468|Antipyretics|antipyretics|mesh-ancestor
92526033|NCT00000464|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92526034|NCT00000464|Cholinergic Agents|cholinergic agents|mesh-ancestor
92526035|NCT00000464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92253613|NCT05683392|Insulin|insulin|mesh-list
92526036|NCT00027625|Temozolomide|temozolomide|mesh-list
92526037|NCT00027625|Gefitinib|gefitinib|mesh-list
92526038|NCT00027625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526039|NCT00027625|Alkylating Agents|alkylating agents|mesh-ancestor
92526040|NCT00027625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526041|NCT00027625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526042|NCT00027625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254052|NCT04747496|Anticoagulants|anticoagulants|mesh-ancestor
92526043|NCT00027625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526044|NCT00027664|Interferons|interferons|mesh-list
92526045|NCT00027664|Interferon-alpha|interferon-alpha|mesh-list
92526046|NCT00027664|Thalidomide|thalidomide|mesh-list
92526047|NCT00027664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526048|NCT00027664|Antiviral Agents|antiviral agents|mesh-ancestor
92526049|NCT00027664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526050|NCT00027664|Immunologic Factors|immunologic factors|mesh-ancestor
92526051|NCT00027664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526052|NCT00027664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526053|NCT00027664|Leprostatic Agents|leprostatic agents|mesh-ancestor
92526054|NCT00027664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92526055|NCT00027664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526056|NCT00027664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92526057|NCT00027664|Growth Substances|growth substances|mesh-ancestor
92526058|NCT00027664|Growth Inhibitors|growth inhibitors|mesh-ancestor
92526059|NCT00027703|Bevacizumab|bevacizumab|mesh-list
92526060|NCT00027703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92526062|NCT00027703|Antibodies|antibodies|mesh-list
92526063|NCT00027703|Immunoglobulins|immunoglobulins|mesh-list
92526064|NCT00027703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92526065|NCT00027703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526066|NCT00027703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526067|NCT00027703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92526069|NCT00027703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526070|NCT00027703|Growth Inhibitors|growth inhibitors|mesh-ancestor
92526071|NCT00027703|Immunologic Factors|immunologic factors|mesh-ancestor
92526072|NCT00027703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526073|NCT00027703|Antimetabolites|antimetabolites|mesh-ancestor
92526074|NCT00027703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526075|NCT00011934|Interferons|interferons|mesh-list
92526076|NCT00011934|Interferon-alpha|interferon-alpha|mesh-list
92526077|NCT00011934|Sargramostim|sargramostim|mesh-list
92254714|NCT02654990|Dexamethasone|dexamethasone|mesh-list
92254773|NCT02340962|Immunologic Factors|immunologic factors|mesh-ancestor
92526078|NCT00011934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254982|NCT02210195|Aprepitant|aprepitant|mesh-list
92526081|NCT00011934|Immunologic Factors|immunologic factors|mesh-ancestor
92254993|NCT01437449|Cetuximab|cetuximab|mesh-list
92537682|NCT02825979|Sotalol|sotalol|mesh-list
92526082|NCT00011934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526084|NCT00027742|Interferon-alpha|interferon-alpha|mesh-list
92526085|NCT00027742|Temozolomide|temozolomide|mesh-list
92526086|NCT00027742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526088|NCT00027742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526089|NCT00027742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526090|NCT00027742|Alkylating Agents|alkylating agents|mesh-ancestor
92526091|NCT00027742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526092|NCT00027742|Immunologic Factors|immunologic factors|mesh-ancestor
92526093|NCT00027742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526094|NCT00027820|Cyclosporine|cyclosporine|mesh-list
92526095|NCT00027820|Mycophenolic Acid|mycophenolic acid|mesh-list
92526096|NCT00027820|Fludarabine|fludarabine|mesh-list
92526097|NCT00027820|Fludarabine phosphate|fludarabine phosphate|mesh-list
92526099|NCT00027820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526100|NCT00027820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526101|NCT00027820|Antimetabolites|antimetabolites|mesh-ancestor
92526102|NCT00027820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526103|NCT00027820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526104|NCT00027820|Immunologic Factors|immunologic factors|mesh-ancestor
92526105|NCT00027820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526106|NCT00027820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526107|NCT00027820|Antifungal Agents|antifungal agents|mesh-ancestor
92255876|NCT01457885|Busulfan|busulfan|mesh-list
92255940|NCT01462253|Alkylating Agents|alkylating agents|mesh-ancestor
92526109|NCT00027820|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526110|NCT00027820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526111|NCT00027820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92526112|NCT00027820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526113|NCT00027820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92256163|NCT03836222|Pentoxifylline|pentoxifylline|mesh-list
92526114|NCT00027820|Antitubercular Agents|antitubercular agents|mesh-ancestor
92526116|NCT00011973|Fenretinide|fenretinide|mesh-list
92256384|NCT01573169|Enoxaparin|enoxaparin|mesh-list
92526117|NCT00011973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256460|NCT03835286|Ascorbic Acid|ascorbic acid|mesh-list
92256534|NCT03406676|Methylene Blue|methylene blue|mesh-list
92526118|NCT00011973|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92256669|NCT03007121|Dsuvia|dsuvia|mesh-list
92526119|NCT00011973|Protective Agents|protective agents|mesh-ancestor
92256683|NCT01725152|Ganaxolone|ganaxolone|mesh-list
92526120|NCT00011973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526121|NCT00027898|Carboplatin|carboplatin|mesh-list
92526122|NCT00027898|Etoposide|etoposide|mesh-list
92526123|NCT00027898|Etoposide phosphate|etoposide phosphate|mesh-list
92526124|NCT00027898|Bortezomib|bortezomib|mesh-list
92256972|NCT01590875|Adenosine|adenosine|mesh-list
92353633|NCT05686356|Acetylcysteine|acetylcysteine|mesh-list
92526125|NCT00027898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257052|NCT01593215|Yohimbine|yohimbine|mesh-list
92526126|NCT00027898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92257119|NCT01041638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92526127|NCT00027898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92257202|NCT05014919|Serotonin Agents|serotonin agents|mesh-ancestor
92526128|NCT00027898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526129|NCT00027898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257338|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526130|NCT00027898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526132|NCT00027937|Paclitaxel|paclitaxel|mesh-list
92257561|NCT02461134|Ponesimod|ponesimod|mesh-list
92257645|NCT04372316|Vitamins|vitamins|mesh-ancestor
92526133|NCT00027937|Cyclophosphamide|cyclophosphamide|mesh-list
92526134|NCT00027937|Melphalan|melphalan|mesh-list
92526135|NCT00027937|Busulfan|busulfan|mesh-list
92526136|NCT00027937|Thiotepa|thiotepa|mesh-list
92526137|NCT00027937|Sargramostim|sargramostim|mesh-list
92526138|NCT00027937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526139|NCT00027937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526140|NCT00027937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92257999|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
92526141|NCT00027937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92526142|NCT00027937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92258146|NCT02459964|Narcotics|narcotics|mesh-ancestor
92258224|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526143|NCT00027937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526145|NCT00027937|Immunologic Factors|immunologic factors|mesh-ancestor
92526146|NCT00027937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526148|NCT00027937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526149|NCT00027937|Alkylating Agents|alkylating agents|mesh-ancestor
92526150|NCT00027937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526152|NCT00027937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92258829|NCT00943202|Vaccines|vaccines|mesh-list
92526153|NCT00027937|Antiviral Agents|antiviral agents|mesh-ancestor
92526154|NCT00027937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259041|NCT03032666|Velpatasvir|velpatasvir|mesh-list
92526155|NCT00012051|Cytarabine|cytarabine|mesh-list
92526156|NCT00012051|Dexamethasone|dexamethasone|mesh-list
92526157|NCT00012051|Rituximab|rituximab|mesh-list
92526158|NCT00012051|Methotrexate|methotrexate|mesh-list
92526159|NCT00012051|Etoposide|etoposide|mesh-list
92526160|NCT00012051|Melphalan|melphalan|mesh-list
92526161|NCT00012051|Ifosfamide|ifosfamide|mesh-list
92526162|NCT00012051|Carmustine|carmustine|mesh-list
92526163|NCT00012051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92526164|NCT00012051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526165|NCT00012051|Immunologic Factors|immunologic factors|mesh-ancestor
92259782|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92526166|NCT00012051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526167|NCT00012051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526168|NCT00012051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526169|NCT00012051|Antiemetics|antiemetics|mesh-ancestor
92526170|NCT00012051|Autonomic Agents|autonomic agents|mesh-ancestor
92526171|NCT00012051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526172|NCT00012051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92526173|NCT00012051|Glucocorticoids|glucocorticoids|mesh-ancestor
92260149|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526175|NCT00012051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526176|NCT00012051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260296|NCT01004354|Vitamin D|vitamin d|mesh-list
92526177|NCT00012051|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92526178|NCT00012051|Abortifacient Agents|abortifacient agents|mesh-ancestor
92526179|NCT00012051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526180|NCT00012051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526181|NCT00012051|Antimetabolites|antimetabolites|mesh-ancestor
92260587|NCT01072136|Azithromycin|azithromycin|mesh-list
92260663|NCT01077596|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92260734|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92526182|NCT00012051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526183|NCT00012051|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526184|NCT00012051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526186|NCT00012051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261103|NCT01116986|Nicotine|nicotine|mesh-list
92526187|NCT00012051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92261178|NCT02435901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353638|NCT05686356|Expectorants|expectorants|mesh-ancestor
92526188|NCT00012051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526189|NCT00012051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92261398|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526190|NCT00012051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526191|NCT00012051|Antiviral Agents|antiviral agents|mesh-ancestor
92526192|NCT00012051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261698|NCT01136798|Exenatide|exenatide|mesh-list
92526193|NCT00012051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526194|NCT00012051|Alkylating Agents|alkylating agents|mesh-ancestor
92526195|NCT00012051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526197|NCT00027976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92526198|NCT00027976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526199|NCT00027976|Analgesics|analgesics|mesh-ancestor
92526200|NCT00027976|Sensory System Agents|sensory system agents|mesh-ancestor
92526201|NCT00027976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262065|NCT02499081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526202|NCT00027976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262285|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526203|NCT00027976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526204|NCT00027976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262507|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92526205|NCT00027976|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92526206|NCT00027976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526207|NCT00027976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262726|NCT05857982|Glucocorticoids|glucocorticoids|mesh-ancestor
92526208|NCT00027976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526209|NCT00000479|Aspirin|aspirin|mesh-list
92526210|NCT00000479|Vitamin E|vitamin e|mesh-list
92526211|NCT00000479|Vitamins|vitamins|mesh-ancestor
92526212|NCT00000479|Micronutrients|micronutrients|mesh-ancestor
92526213|NCT00000479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263028|NCT05272605|Vaccines|vaccines|mesh-list
92263103|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
92263177|NCT04770532|Insulin|insulin|mesh-list
92263399|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
92526214|NCT00000479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92526215|NCT00000479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92263600|NCT02723500|Xenon|xenon|mesh-list
92526217|NCT00000479|Sensory System Agents|sensory system agents|mesh-ancestor
92526218|NCT00000479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526219|NCT00000479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526220|NCT00000479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526221|NCT00000479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92526222|NCT00000479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92264070|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92526223|NCT00000479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526224|NCT00000479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92526225|NCT00000479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526226|NCT00000479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526227|NCT00000479|Antipyretics|antipyretics|mesh-ancestor
92526228|NCT00000479|Antioxidants|antioxidants|mesh-ancestor
92526229|NCT00000479|Protective Agents|protective agents|mesh-ancestor
92526230|NCT00028132|Tenofovir|tenofovir|mesh-list
92264141|NCT05457647|Vitamins|vitamins|mesh-ancestor
92526231|NCT00028132|Antiviral Agents|antiviral agents|mesh-ancestor
92526232|NCT00028132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264208|NCT04838717|Doxycycline|doxycycline|mesh-list
92264281|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92526233|NCT00028132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92526234|NCT00028132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92526235|NCT00028132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526236|NCT00028132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526238|NCT00028132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92526239|NCT00028171|Tacrolimus|tacrolimus|mesh-list
92264733|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
92526240|NCT00028171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526241|NCT00028171|Immunologic Factors|immunologic factors|mesh-ancestor
92264880|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264957|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526242|NCT00028171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526243|NCT00028171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92526244|NCT00028171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526245|NCT00028171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526247|NCT00012090|Bicalutamide|bicalutamide|mesh-list
92265246|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265318|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92526248|NCT00012090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92526249|NCT00012090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526250|NCT00012090|Androgen Antagonists|androgen antagonists|mesh-ancestor
92265617|NCT01763645|Paclitaxel|paclitaxel|mesh-list
92265686|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
92265763|NCT04351724|Antimalarials|antimalarials|mesh-ancestor
92265839|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526252|NCT00012090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526253|NCT00012090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526254|NCT00395395|Calcitonin|calcitonin|mesh-list
92526255|NCT00395395|Salmon calcitonin|salmon calcitonin|mesh-list
92265985|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
92526256|NCT00395395|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92526257|NCT00395395|Katacalcin|katacalcin|mesh-list
92526258|NCT00395395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92526259|NCT00395395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526260|NCT00395395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92526261|NCT00395395|Vasodilator Agents|vasodilator agents|mesh-ancestor
92526262|NCT00395434|Bevacizumab|bevacizumab|mesh-list
92526263|NCT00395434|Combretastatin|combretastatin|mesh-list
92526264|NCT00395434|Fosbretabulin|fosbretabulin|mesh-list
92526265|NCT00395434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92526266|NCT00395434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266573|NCT01378520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92526267|NCT00395434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526268|NCT00395434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92266719|NCT05588037|Glucocorticoids|glucocorticoids|mesh-ancestor
92526269|NCT00395434|Growth Substances|growth substances|mesh-ancestor
92526270|NCT00395434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526271|NCT00395434|Growth Inhibitors|growth inhibitors|mesh-ancestor
92526272|NCT00395434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526273|NCT00395434|Tubulin Modulators|tubulin modulators|mesh-ancestor
92526274|NCT00395434|Antimitotic Agents|antimitotic agents|mesh-ancestor
92526275|NCT00395434|Mitosis Modulators|mitosis modulators|mesh-ancestor
92526276|NCT00395434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526278|NCT00395551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526279|NCT00395551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92526280|NCT00395551|Growth Substances|growth substances|mesh-ancestor
92526281|NCT00395551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267688|NCT05679479|Meplazumab|meplazumab|mesh-list
92526283|NCT00395551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267915|NCT00555425|Buprenorphine|buprenorphine|mesh-list
92526285|NCT00012129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526286|NCT00012129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526288|NCT00028288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526289|NCT00028288|Immunologic Factors|immunologic factors|mesh-ancestor
92526290|NCT00028288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268135|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92526291|NCT00012168|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92526292|NCT00012168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92526293|NCT00012168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526294|NCT00000482|Niacin|niacin|mesh-list
92526295|NCT00000482|Clofibrate|clofibrate|mesh-list
92526296|NCT00000482|Estrogens|estrogens|mesh-list
92526297|NCT00000482|Hormones|hormones|mesh-ancestor
92268357|NCT04766463|Morphine|morphine|mesh-list
92268430|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526298|NCT00000482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526299|NCT00000482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526300|NCT00000482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92268649|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526302|NCT00000482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526303|NCT00000482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92526304|NCT00000482|Vasodilator Agents|vasodilator agents|mesh-ancestor
92526305|NCT00000482|Vitamin B Complex|vitamin b complex|mesh-ancestor
92526306|NCT00000482|Vitamins|vitamins|mesh-ancestor
92526307|NCT00000482|Micronutrients|micronutrients|mesh-ancestor
92526308|NCT00000482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92526309|NCT00028327|Lamivudine|lamivudine|mesh-list
92526310|NCT00028327|Zidovudine|zidovudine|mesh-list
92526311|NCT00028327|Efavirenz|efavirenz|mesh-list
92269158|NCT05446779|Sympathomimetics|sympathomimetics|mesh-ancestor
92526312|NCT00028327|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92526313|NCT00028327|Nelfinavir|nelfinavir|mesh-list
92269315|NCT00371553|Sunitinib|sunitinib|mesh-list
92269377|NCT01509638|Bupivacaine|bupivacaine|mesh-list
92526314|NCT00028327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92269451|NCT02346240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92269526|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
92526315|NCT00028327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92526316|NCT00028327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269744|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
92269820|NCT02785185|Halobetasol|halobetasol|mesh-list
92526317|NCT00028327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526319|NCT00028327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526320|NCT00028327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92526321|NCT00028327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92526322|NCT00028327|Antimetabolites|antimetabolites|mesh-ancestor
92270122|NCT01578278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92270195|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526323|NCT00028327|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92270343|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526324|NCT00028327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92526325|NCT00028327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92526326|NCT00028327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92526327|NCT00028327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92526328|NCT00028327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92526329|NCT00028327|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92526330|NCT00028327|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92526331|NCT00028327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92526332|NCT00028366|Ritonavir|ritonavir|mesh-list
92526333|NCT00028366|Lopinavir|lopinavir|mesh-list
92526334|NCT00028366|Fosamprenavir|fosamprenavir|mesh-list
92251112|NCT03800264|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526336|NCT00028366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92271845|NCT01850108|Sirolimus|sirolimus|mesh-list
92271909|NCT05376722|Pamiparib|pamiparib|mesh-list
92526337|NCT00028366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92526338|NCT00028366|Protease Inhibitors|protease inhibitors|mesh-ancestor
92526339|NCT00028366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272135|NCT01691690|Acetaminophen|acetaminophen|mesh-list
92526340|NCT00028366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526341|NCT00028366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92526342|NCT00028366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92526343|NCT00028366|Antiviral Agents|antiviral agents|mesh-ancestor
92526345|NCT00028366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92526346|NCT00028366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92526347|NCT00028366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92272731|NCT04707027|Growth Substances|growth substances|mesh-ancestor
92526348|NCT00028366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92272804|NCT03140631|Protamines|protamines|mesh-list
92272954|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92526350|NCT00028405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273100|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
92526351|NCT00028405|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92526352|NCT00028405|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526353|NCT00012207|Aldesleukin|aldesleukin|mesh-list
92526354|NCT00012207|Prednisone|prednisone|mesh-list
92526356|NCT00012207|Vincristine|vincristine|mesh-list
92526357|NCT00012207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526358|NCT00012207|Immunologic Factors|immunologic factors|mesh-ancestor
92526359|NCT00012207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526361|NCT00012207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526363|NCT00012207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526364|NCT00012207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526365|NCT00012207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526366|NCT00012207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526367|NCT00012207|Glucocorticoids|glucocorticoids|mesh-ancestor
92526368|NCT00012207|Hormones|hormones|mesh-ancestor
92526369|NCT00012207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526370|NCT00012207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92526371|NCT00012207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526372|NCT00012207|Tubulin Modulators|tubulin modulators|mesh-ancestor
92526373|NCT00012207|Antimitotic Agents|antimitotic agents|mesh-ancestor
92526374|NCT00012207|Mitosis Modulators|mitosis modulators|mesh-ancestor
92526375|NCT00012207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92526376|NCT00012207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92526377|NCT00012207|Antiviral Agents|antiviral agents|mesh-ancestor
92526378|NCT00012207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526379|NCT00028483|Docetaxel|docetaxel|mesh-list
92526381|NCT00028483|Immunoconjugates|immunoconjugates|mesh-list
92526382|NCT00028483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273973|NCT01685684|Analgesics|analgesics|mesh-ancestor
92526383|NCT00028483|Tubulin Modulators|tubulin modulators|mesh-ancestor
92274203|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
92526385|NCT00028483|Mitosis Modulators|mitosis modulators|mesh-ancestor
92274344|NCT01688336|Protective Agents|protective agents|mesh-ancestor
92526386|NCT00028483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526387|NCT00028483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92274564|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92526388|NCT00028483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92526389|NCT00028483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526390|NCT00028483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274711|NCT02057939|Hormones|hormones|mesh-ancestor
92274790|NCT01981967|Vaccines|vaccines|mesh-list
92526392|NCT00028483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526393|NCT00000485|Antihypertensive Agents|antihypertensive agents|mesh-list
92526394|NCT00000485|Diuretics|diuretics|mesh-list
92526395|NCT00000485|Natriuretic Agents|natriuretic agents|mesh-ancestor
92526396|NCT00000485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274985|NCT02029703|Hylan|hylan|mesh-list
92526397|NCT00028561|Carboplatin|carboplatin|mesh-list
92526398|NCT00028561|Epothilone B|epothilone b|mesh-list
92526399|NCT00028561|Epothilones|epothilones|mesh-list
92275078|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275152|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92526400|NCT00028561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526401|NCT00028561|Tubulin Modulators|tubulin modulators|mesh-ancestor
92526402|NCT00028561|Antimitotic Agents|antimitotic agents|mesh-ancestor
92526403|NCT00028561|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533592|NCT00061360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526404|NCT00028561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526405|NCT00028600|Cyclophosphamide|cyclophosphamide|mesh-list
92526407|NCT00028600|Methotrexate|methotrexate|mesh-list
92526408|NCT00028600|Fludarabine|fludarabine|mesh-list
92526409|NCT00028600|Fludarabine phosphate|fludarabine phosphate|mesh-list
92526410|NCT00028600|Tacrolimus|tacrolimus|mesh-list
92526411|NCT00028600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526412|NCT00028600|Immunologic Factors|immunologic factors|mesh-ancestor
92526413|NCT00028600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526414|NCT00028600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275520|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526415|NCT00028600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92275587|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92275665|NCT02383043|Anesthetics|anesthetics|mesh-ancestor
92526417|NCT00028600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526418|NCT00028600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275805|NCT04873349|Vasodilator Agents|vasodilator agents|mesh-ancestor
92275877|NCT01783574|Testosterone|testosterone|mesh-list
92275955|NCT04259645|Bupivacaine|bupivacaine|mesh-list
92276176|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
92276257|NCT01815008|Aspirin|aspirin|mesh-list
92526421|NCT00028600|Abortifacient Agents|abortifacient agents|mesh-ancestor
92526422|NCT00028600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92276478|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526423|NCT00028600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92276567|NCT03368235|Hormones|hormones|mesh-ancestor
92526425|NCT00028600|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526426|NCT00028600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276774|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526427|NCT00028600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92526428|NCT00028600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92526429|NCT00028600|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92526430|NCT00388778|Doxycycline|doxycycline|mesh-list
92526431|NCT00388778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92526432|NCT00388778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526433|NCT00388778|Antimalarials|antimalarials|mesh-ancestor
92526434|NCT00388778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92526435|NCT00388778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92526436|NCT00012246|Sargramostim|sargramostim|mesh-list
92526437|NCT00012246|Freund's Adjuvant|freund's adjuvant|mesh-list
92526438|NCT00012246|Immunologic Factors|immunologic factors|mesh-ancestor
92526439|NCT00012246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526440|NCT00012246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92526441|NCT00028717|Prednisone|prednisone|mesh-list
92526442|NCT00028717|Cyclophosphamide|cyclophosphamide|mesh-list
92526443|NCT00028717|Rituximab|rituximab|mesh-list
92526444|NCT00028717|Doxorubicin|doxorubicin|mesh-list
92526445|NCT00028717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92526446|NCT00028717|Vincristine|vincristine|mesh-list
92526447|NCT00028717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526448|NCT00028717|Immunologic Factors|immunologic factors|mesh-ancestor
92277204|NCT04203225|Lidocaine|lidocaine|mesh-list
92526449|NCT00028717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526450|NCT00028717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526451|NCT00028717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526452|NCT00028717|Alkylating Agents|alkylating agents|mesh-ancestor
92526453|NCT00028717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526454|NCT00028717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526455|NCT00028717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526456|NCT00028717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92526457|NCT00028717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526458|NCT00028717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92526459|NCT00028717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526460|NCT00028717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526461|NCT00028717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526462|NCT00028717|Glucocorticoids|glucocorticoids|mesh-ancestor
92526463|NCT00028717|Hormones|hormones|mesh-ancestor
92526464|NCT00028717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526465|NCT00028717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92526466|NCT00028717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526467|NCT00028717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92526468|NCT00028717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92277634|NCT03852537|Hormones|hormones|mesh-ancestor
92526469|NCT00028717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92526470|NCT00028756|Gemcitabine|gemcitabine|mesh-list
92526472|NCT00028756|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92526473|NCT00028756|Methotrexate|methotrexate|mesh-list
92526475|NCT00028756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278020|NCT00378729|Metformin|metformin|mesh-list
92526476|NCT00028756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526478|NCT00028756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278311|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
92526479|NCT00028756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526480|NCT00028756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92526481|NCT00028756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526482|NCT00028756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526483|NCT00028756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92526484|NCT00028756|Abortifacient Agents|abortifacient agents|mesh-ancestor
92526485|NCT00028756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526486|NCT00028756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526487|NCT00028756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526488|NCT00028756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92251257|NCT00809276|Busulfan|busulfan|mesh-list
92526489|NCT00028756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526490|NCT00028756|Immunologic Factors|immunologic factors|mesh-ancestor
92526491|NCT00028756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526492|NCT00028756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92526493|NCT00028756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526494|NCT00028756|Tubulin Modulators|tubulin modulators|mesh-ancestor
92526495|NCT00028756|Antimitotic Agents|antimitotic agents|mesh-ancestor
92526496|NCT00028756|Mitosis Modulators|mitosis modulators|mesh-ancestor
92526497|NCT00012324|Doxorubicin|doxorubicin|mesh-list
92526498|NCT00012324|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92526499|NCT00012324|Nolatrexed|nolatrexed|mesh-list
92526500|NCT00012324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526501|NCT00012324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278957|NCT00684255|Fludarabine|fludarabine|mesh-list
92526503|NCT00012324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526504|NCT00012324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526505|NCT00012324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526506|NCT00012324|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526507|NCT00012324|Antimetabolites|antimetabolites|mesh-ancestor
92526508|NCT00012324|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92526509|NCT00028795|Temozolomide|temozolomide|mesh-list
92526510|NCT00028795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526511|NCT00028795|Alkylating Agents|alkylating agents|mesh-ancestor
92526512|NCT00028795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279101|NCT01673061|Lidocaine|lidocaine|mesh-list
92279168|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526513|NCT00028795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526514|NCT00012363|Gemcitabine|gemcitabine|mesh-list
92526515|NCT00012363|Irinotecan|irinotecan|mesh-list
92526516|NCT00012363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526517|NCT00012363|Antimetabolites|antimetabolites|mesh-ancestor
92750788|NCT05935059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526518|NCT00012363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279468|NCT05720273|Vitamins|vitamins|mesh-ancestor
92526519|NCT00012363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279613|NCT02959229|Lactoferrin|lactoferrin|mesh-list
92526521|NCT00012363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526522|NCT00012363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279767|NCT00000213|Fluoxetine|fluoxetine|mesh-list
92526523|NCT00388895|Imatinib Mesylate|imatinib mesylate|mesh-list
92526524|NCT00388895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526525|NCT00388895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92526526|NCT00388895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280135|NCT00000843|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92526527|NCT00388895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526528|NCT00028834|Bevacizumab|bevacizumab|mesh-list
92526529|NCT00028834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92526530|NCT00028834|Gemcitabine|gemcitabine|mesh-list
92526531|NCT00028834|Antibodies|antibodies|mesh-list
92280824|NCT05270057|Glucocorticoids|glucocorticoids|mesh-ancestor
92526533|NCT00028834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92526534|NCT00028834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526535|NCT00028834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526536|NCT00028834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92526537|NCT00028834|Growth Substances|growth substances|mesh-ancestor
92526538|NCT00028834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526539|NCT00028834|Growth Inhibitors|growth inhibitors|mesh-ancestor
92281412|NCT00002349|Stavudine|stavudine|mesh-list
92526540|NCT00028834|Immunologic Factors|immunologic factors|mesh-ancestor
92526541|NCT00028834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281713|NCT00002451|Indinavir|indinavir|mesh-list
92526543|NCT00028834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281866|NCT04862585|Diphenhydramine|diphenhydramine|mesh-list
92526544|NCT00028873|Paclitaxel|paclitaxel|mesh-list
92526545|NCT00028873|Docetaxel|docetaxel|mesh-list
92526546|NCT00028873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526547|NCT00028873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282259|NCT00002553|Cobalt|cobalt|mesh-list
92526548|NCT00028873|Tubulin Modulators|tubulin modulators|mesh-ancestor
91935183|NCT02301715|Oxytocin|oxytocin|mesh-list
92526549|NCT00028873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92526550|NCT00028873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92282546|NCT05806671|Fulvestrant|fulvestrant|mesh-list
92526551|NCT00028873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526553|NCT00028912|Bortezomib|bortezomib|mesh-list
92526554|NCT00028912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526555|NCT00028951|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92526558|NCT01803555|Budesonide|budesonide|mesh-list
92526559|NCT01803555|Formoterol Fumarate|formoterol fumarate|mesh-list
92526560|NCT01803555|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92526561|NCT01803555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526562|NCT01803555|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92526563|NCT01803555|Autonomic Agents|autonomic agents|mesh-ancestor
92282912|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526564|NCT01803555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526565|NCT01803555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526566|NCT01803555|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92283209|NCT03973268|Complement Factor H|complement factor h|mesh-list
92526567|NCT01803555|Respiratory System Agents|respiratory system agents|mesh-ancestor
92526569|NCT01803555|Hormones|hormones|mesh-ancestor
92283358|NCT02937818|Carboplatin|carboplatin|mesh-list
92283506|NCT01370811|Analgesics|analgesics|mesh-ancestor
92283577|NCT01322464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283652|NCT00005835|Antimetabolites|antimetabolites|mesh-ancestor
92283804|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
92283805|NCT00002691|Autonomic Agents|autonomic agents|mesh-ancestor
92526570|NCT01803555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526571|NCT01803555|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92526572|NCT01803555|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92526573|NCT01803555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92526574|NCT01803555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526575|NCT01803555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526576|NCT01803555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526577|NCT00000488|Cholestyramine Resin|cholestyramine resin|mesh-list
92526578|NCT00000488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92526579|NCT00000488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92526580|NCT00000488|Antimetabolites|antimetabolites|mesh-ancestor
92526581|NCT00000488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526582|NCT00000488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92526584|NCT00029224|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92526585|NCT00029224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526586|NCT00000491|Aspirin|aspirin|mesh-list
92526587|NCT00000491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92526588|NCT00000491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526589|NCT00000491|Analgesics|analgesics|mesh-ancestor
92526590|NCT00000491|Sensory System Agents|sensory system agents|mesh-ancestor
92284911|NCT01667029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526591|NCT00000491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526592|NCT00000491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526593|NCT00000491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526594|NCT00000491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526595|NCT00000491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92285204|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285280|NCT01952444|Ciprofloxacin|ciprofloxacin|mesh-list
92526596|NCT00000491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92285353|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
92526597|NCT00000491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285500|NCT00000669|Didanosine|didanosine|mesh-list
92526598|NCT00000491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92526599|NCT00000491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526600|NCT00000491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526602|NCT00029380|Cyclosporine|cyclosporine|mesh-list
92526603|NCT00029380|Mycophenolic Acid|mycophenolic acid|mesh-list
92526604|NCT00029380|Cyclophosphamide|cyclophosphamide|mesh-list
92526606|NCT00029380|Cyclosporins|cyclosporins|mesh-list
92286164|NCT04173507|Avelumab|avelumab|mesh-list
92526608|NCT00029380|Immunologic Factors|immunologic factors|mesh-ancestor
92526609|NCT00029380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526610|NCT00029380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526611|NCT00029380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526612|NCT00029380|Alkylating Agents|alkylating agents|mesh-ancestor
92526613|NCT00029380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526614|NCT00029380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526615|NCT00029380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526616|NCT00029380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526617|NCT00029380|Antifungal Agents|antifungal agents|mesh-ancestor
92526618|NCT00029380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526619|NCT00029380|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526620|NCT00029380|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92526621|NCT00029380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92286244|NCT00362531|Prednisone|prednisone|mesh-list
92526622|NCT00029380|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92526623|NCT00029380|Antitubercular Agents|antitubercular agents|mesh-ancestor
92526624|NCT00029380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92526625|NCT00029458|Clozapine|clozapine|mesh-list
92286832|NCT03083405|Opipramol|opipramol|mesh-list
92526628|NCT00029458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526629|NCT00029458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526630|NCT00029458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526631|NCT00029458|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92526633|NCT00029458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92526634|NCT00029458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92526635|NCT00029458|GABA Antagonists|gaba antagonists|mesh-ancestor
92526636|NCT00029458|GABA Agents|gaba agents|mesh-ancestor
92526637|NCT00029497|Amitriptyline|amitriptyline|mesh-list
92287564|NCT01760785|Valproic Acid|valproic acid|mesh-list
92287637|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
92287716|NCT01769365|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92526638|NCT00029497|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92526639|NCT00029497|Antidepressive Agents|antidepressive agents|mesh-ancestor
92526640|NCT00029497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92526641|NCT00029497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526642|NCT00029497|Analgesics|analgesics|mesh-ancestor
92288012|NCT01733953|Atorvastatin|atorvastatin|mesh-list
92526643|NCT00029497|Sensory System Agents|sensory system agents|mesh-ancestor
92526644|NCT00029497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526645|NCT00029497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526646|NCT00029497|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92526647|NCT00029497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92526648|NCT00029497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526649|NCT00029497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526651|NCT00029497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526652|NCT00000494|Indomethacin|indomethacin|mesh-list
92526653|NCT00000494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92526654|NCT00000494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526655|NCT00000494|Analgesics|analgesics|mesh-ancestor
92526656|NCT00000494|Sensory System Agents|sensory system agents|mesh-ancestor
92526657|NCT00000494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526658|NCT00000494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526659|NCT00000494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526660|NCT00000494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526661|NCT00000494|Gout Suppressants|gout suppressants|mesh-ancestor
92526662|NCT00000494|Tocolytic Agents|tocolytic agents|mesh-ancestor
92526663|NCT00000494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526664|NCT00000494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526665|NCT00000494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526666|NCT00000494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526667|NCT00012519|Ritonavir|ritonavir|mesh-list
92526668|NCT00012519|Indinavir|indinavir|mesh-list
92526669|NCT00012519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92526670|NCT00012519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92526671|NCT00012519|Protease Inhibitors|protease inhibitors|mesh-ancestor
92526672|NCT00012519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526673|NCT00012519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526675|NCT00012519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92526676|NCT00012519|Antiviral Agents|antiviral agents|mesh-ancestor
92526677|NCT00012519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526678|NCT00012519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92526679|NCT00012519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92288762|NCT05742763|Acetaminophen|acetaminophen|mesh-list
92288800|NCT02439281|Analgesics|analgesics|mesh-ancestor
92526680|NCT00029614|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92288877|NCT02508077|Antidotes|antidotes|mesh-ancestor
92526681|NCT00029614|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92289025|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
92526682|NCT00029614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92526683|NCT00029614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526684|NCT00029614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526685|NCT00029614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526686|NCT00029614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289251|NCT02274948|Metformin|metformin|mesh-list
92526687|NCT00029614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526688|NCT00029770|Acetaminophen|acetaminophen|mesh-list
92526689|NCT00029770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92526690|NCT00029770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92526691|NCT00029770|Codeine|codeine|mesh-list
92289390|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92526692|NCT00029770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526693|NCT00029770|Analgesics|analgesics|mesh-ancestor
92526694|NCT00029770|Sensory System Agents|sensory system agents|mesh-ancestor
92526695|NCT00029770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526696|NCT00029770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526697|NCT00029770|Antipyretics|antipyretics|mesh-ancestor
92526698|NCT00029770|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92526699|NCT00029770|Narcotics|narcotics|mesh-ancestor
92526700|NCT00029770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92526701|NCT00029770|Antitussive Agents|antitussive agents|mesh-ancestor
92526702|NCT00029770|Respiratory System Agents|respiratory system agents|mesh-ancestor
92526703|NCT00029770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526704|NCT00012558|Inositol|inositol|mesh-list
92526705|NCT00012558|Lamotrigine|lamotrigine|mesh-list
92526706|NCT00012558|Valproic Acid|valproic acid|mesh-list
92526707|NCT00012558|Risperidone|risperidone|mesh-list
92526708|NCT00012558|Tranylcypromine|tranylcypromine|mesh-list
92526709|NCT00012558|Bupropion|bupropion|mesh-list
92526710|NCT00012558|Paroxetine|paroxetine|mesh-list
92526711|NCT00012558|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92526712|NCT00012558|Serotonin Agents|serotonin agents|mesh-ancestor
92251483|NCT04493138|Antimetabolites|antimetabolites|mesh-ancestor
92526713|NCT00012558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526714|NCT00012558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526715|NCT00012558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526716|NCT00012558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92526717|NCT00012558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92526718|NCT00012558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92526719|NCT00012558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92526720|NCT00012558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92526721|NCT00012558|Dopamine Agents|dopamine agents|mesh-ancestor
92526722|NCT00012558|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92526723|NCT00012558|Antidepressive Agents|antidepressive agents|mesh-ancestor
92526724|NCT00012558|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92526725|NCT00012558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92526726|NCT00012558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526727|NCT00012558|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92526728|NCT00012558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92526729|NCT00012558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526730|NCT00012558|Antimanic Agents|antimanic agents|mesh-ancestor
92526731|NCT00012558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92526732|NCT00012558|Anticonvulsants|anticonvulsants|mesh-ancestor
92526733|NCT00012558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92526734|NCT00012558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92526735|NCT00012558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92526736|NCT00012558|GABA Agents|gaba agents|mesh-ancestor
92526737|NCT00012558|Vitamin B Complex|vitamin b complex|mesh-ancestor
92526738|NCT00012558|Vitamins|vitamins|mesh-ancestor
92526739|NCT00012558|Micronutrients|micronutrients|mesh-ancestor
92533605|NCT00061477|Antimetabolites|antimetabolites|mesh-ancestor
92526740|NCT00012558|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92526741|NCT00012558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92526742|NCT00395707|Ranibizumab|ranibizumab|mesh-list
92526743|NCT00395707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526744|NCT00395707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92526745|NCT00395707|Growth Substances|growth substances|mesh-ancestor
92526746|NCT00395707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526747|NCT00395707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92526748|NCT00395707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526749|NCT00000500|Aspirin|aspirin|mesh-list
92526750|NCT00000500|Carotenoids|carotenoids|mesh-list
92526751|NCT00000500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92526752|NCT00000500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526753|NCT00000500|Analgesics|analgesics|mesh-ancestor
92526754|NCT00000500|Sensory System Agents|sensory system agents|mesh-ancestor
92526755|NCT00000500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526756|NCT00000500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526757|NCT00000500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526758|NCT00000500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526759|NCT00000500|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92526760|NCT00000500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92526761|NCT00000500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526762|NCT00000500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92526763|NCT00000500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526764|NCT00000500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526765|NCT00000500|Antipyretics|antipyretics|mesh-ancestor
92526766|NCT00000500|Antioxidants|antioxidants|mesh-ancestor
92526767|NCT00000500|Protective Agents|protective agents|mesh-ancestor
92526768|NCT00395902|Cinacalcet|cinacalcet|mesh-list
92526769|NCT00395902|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92526770|NCT00395902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526771|NCT00395902|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92526772|NCT00395902|Hormone Antagonists|hormone antagonists|mesh-ancestor
92526773|NCT00395902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526774|NCT00029848|Rimonabant|rimonabant|mesh-list
92526775|NCT00029848|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92526776|NCT00029848|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92526777|NCT00029848|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92526778|NCT00029848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526779|NCT00029848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526780|NCT00029848|Hormones|hormones|mesh-ancestor
92526781|NCT00029848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92526782|NCT00029848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289784|NCT01852669|Furosemide|furosemide|mesh-list
92526783|NCT00000503|Streptokinase|streptokinase|mesh-list
92526784|NCT00000503|Nitroglycerin|nitroglycerin|mesh-list
92526785|NCT00000503|Vasodilator Agents|vasodilator agents|mesh-ancestor
92526786|NCT00000503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92526787|NCT00000503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92526788|NCT00000503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526789|NCT00030004|Midazolam|midazolam|mesh-list
92526790|NCT00030004|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92526791|NCT00030004|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92526792|NCT00030004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92526793|NCT00030004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526794|NCT00030004|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92526795|NCT00030004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92526796|NCT00030004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92526797|NCT00030004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92526798|NCT00030004|Anesthetics, General|anesthetics, general|mesh-ancestor
92526799|NCT00030004|Anesthetics|anesthetics|mesh-ancestor
92526800|NCT00030004|GABA Modulators|gaba modulators|mesh-ancestor
92526801|NCT00030004|GABA Agents|gaba agents|mesh-ancestor
92526802|NCT00030004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526803|NCT00030004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526804|NCT00030082|Melphalan|melphalan|mesh-list
92526805|NCT00030082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526806|NCT00030082|Alkylating Agents|alkylating agents|mesh-ancestor
92526807|NCT00030082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526808|NCT00030082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526809|NCT00030082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92526810|NCT00030082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526811|NCT00030082|Immunologic Factors|immunologic factors|mesh-ancestor
92526812|NCT00030082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526813|NCT00000518|Quinidine|quinidine|mesh-list
92526815|NCT00000518|Mexiletine|mexiletine|mesh-list
92526816|NCT00000518|Procainamide|procainamide|mesh-list
92526817|NCT00000518|Imipramine|imipramine|mesh-list
92526818|NCT00000518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92526819|NCT00000518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92526820|NCT00000518|Adrenergic Agents|adrenergic agents|mesh-ancestor
92526821|NCT00000518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526822|NCT00000518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526823|NCT00000518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526824|NCT00000518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92526825|NCT00000518|Sympatholytics|sympatholytics|mesh-ancestor
92526826|NCT00000518|Autonomic Agents|autonomic agents|mesh-ancestor
92526827|NCT00000518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526828|NCT00000518|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92526829|NCT00000518|Antidepressive Agents|antidepressive agents|mesh-ancestor
92526830|NCT00000518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92526831|NCT00000518|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92526832|NCT00000518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92526833|NCT00000518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526834|NCT00000518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92526835|NCT00000518|Antimalarials|antimalarials|mesh-ancestor
92526836|NCT00000518|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92526837|NCT00000518|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92526838|NCT00000518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526839|NCT00000518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526840|NCT00000518|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92526841|NCT00000518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92526842|NCT00000518|Cholinergic Agents|cholinergic agents|mesh-ancestor
92526843|NCT00000518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92526844|NCT00000518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92526845|NCT00000518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92526846|NCT00000518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92526847|NCT00030121|Cardiodilatin|cardiodilatin|mesh-list
92526848|NCT00030121|Vasodilator Agents|vasodilator agents|mesh-ancestor
92526849|NCT00030238|Calcium|calcium|mesh-list
92526850|NCT00030238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92526851|NCT00030238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526852|NCT00030355|Homoharringtonine|homoharringtonine|mesh-list
92526853|NCT00030355|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92526854|NCT00030355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526855|NCT00030355|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92526856|NCT00030355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526857|NCT00030355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526858|NCT00030394|Imatinib Mesylate|imatinib mesylate|mesh-list
92526859|NCT00030394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526860|NCT00030394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92526861|NCT00030394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251634|NCT01331213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92526862|NCT00030394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526863|NCT00395941|Pioglitazone|pioglitazone|mesh-list
92526864|NCT00395941|Acitretin|acitretin|mesh-list
92526865|NCT00395941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92526866|NCT00395941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526867|NCT00395941|Keratolytic Agents|keratolytic agents|mesh-ancestor
92526868|NCT00395941|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526869|NCT00030433|Gemcitabine|gemcitabine|mesh-list
92526870|NCT00030433|Irinotecan|irinotecan|mesh-list
92526871|NCT00030433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526872|NCT00030433|Antimetabolites|antimetabolites|mesh-ancestor
92526873|NCT00030433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526874|NCT00030433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526875|NCT00030433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92526876|NCT00030433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526877|NCT00030433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526878|NCT00030472|Doxorubicin|doxorubicin|mesh-list
92526879|NCT00030472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92526880|NCT00030472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526881|NCT00030472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526882|NCT00030472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92526883|NCT00030472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526884|NCT00030472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526885|NCT00030472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526886|NCT00000527|Aspirin|aspirin|mesh-list
92526887|NCT00000527|Dipyridamole|dipyridamole|mesh-list
92526888|NCT00000527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92526889|NCT00000527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92526890|NCT00000527|Analgesics|analgesics|mesh-ancestor
92526891|NCT00000527|Sensory System Agents|sensory system agents|mesh-ancestor
92526892|NCT00000527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92526893|NCT00000527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526894|NCT00000527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92526895|NCT00000527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92526896|NCT00000527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92526897|NCT00000527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92526898|NCT00000527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526899|NCT00000527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92526900|NCT00000527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92526901|NCT00000527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526902|NCT00000527|Antipyretics|antipyretics|mesh-ancestor
92526903|NCT00000527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92526904|NCT00000527|Vasodilator Agents|vasodilator agents|mesh-ancestor
92526906|NCT00030511|Antimetabolites|antimetabolites|mesh-ancestor
92526907|NCT00030511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526908|NCT00030511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526909|NCT00030511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526910|NCT00030511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526911|NCT00030511|Immunologic Factors|immunologic factors|mesh-ancestor
92526912|NCT00030511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526913|NCT00030550|Thalidomide|thalidomide|mesh-list
92526914|NCT00030550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92526915|NCT00030550|Immunologic Factors|immunologic factors|mesh-ancestor
92526916|NCT00030550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526917|NCT00030550|Leprostatic Agents|leprostatic agents|mesh-ancestor
92526918|NCT00030550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92526919|NCT00030550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92526920|NCT00030550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92526921|NCT00030550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92526922|NCT00030550|Growth Substances|growth substances|mesh-ancestor
92526923|NCT00030550|Growth Inhibitors|growth inhibitors|mesh-ancestor
92526924|NCT00030550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526925|NCT00030589|Bexarotene|bexarotene|mesh-list
92526926|NCT00030589|Methoxsalen|methoxsalen|mesh-list
92526927|NCT00030589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526928|NCT00030589|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92526929|NCT00030589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92526930|NCT00000530|Nifedipine|nifedipine|mesh-list
92526931|NCT00000530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92526932|NCT00000530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92526933|NCT00000530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526934|NCT00000530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92526935|NCT00000530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526936|NCT00000530|Vasodilator Agents|vasodilator agents|mesh-ancestor
92526937|NCT00000530|Tocolytic Agents|tocolytic agents|mesh-ancestor
92526938|NCT00000530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92526939|NCT00030667|Imatinib Mesylate|imatinib mesylate|mesh-list
92526940|NCT00030667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526941|NCT00030667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92526942|NCT00030667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526943|NCT00030667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526944|NCT00030745|Gemcitabine|gemcitabine|mesh-list
92526945|NCT00030745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526946|NCT00030745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92526947|NCT00030745|Antimetabolites|antimetabolites|mesh-ancestor
92526948|NCT00030745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526949|NCT00030784|Doxorubicin|doxorubicin|mesh-list
92526950|NCT00030784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92526951|NCT00030784|Ifosfamide|ifosfamide|mesh-list
92526952|NCT00030784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92526953|NCT00030784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526954|NCT00030784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92526955|NCT00030784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526956|NCT00030784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526957|NCT00030784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533611|NCT02968342|Progesterone|progesterone|mesh-list
92526958|NCT00030784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92526959|NCT00030784|Alkylating Agents|alkylating agents|mesh-ancestor
92526960|NCT00030862|Irinotecan|irinotecan|mesh-list
92526961|NCT00030862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92526962|NCT00030862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92526963|NCT00030862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92526964|NCT00030862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526965|NCT00030862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526967|NCT00000539|Vitamin E|vitamin e|mesh-list
92526968|NCT00000539|Beta Carotene|beta carotene|mesh-list
92526969|NCT00000539|Warfarin|warfarin|mesh-list
92526970|NCT00000539|Pravastatin|pravastatin|mesh-list
92526971|NCT00000539|Carotenoids|carotenoids|mesh-list
92526972|NCT00000539|Micronutrients|micronutrients|mesh-ancestor
92526973|NCT00000539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526974|NCT00000539|Anticoagulants|anticoagulants|mesh-ancestor
92526975|NCT00000539|Antioxidants|antioxidants|mesh-ancestor
92526976|NCT00000539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526977|NCT00000539|Protective Agents|protective agents|mesh-ancestor
92526978|NCT00000539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92526979|NCT00000539|Antimetabolites|antimetabolites|mesh-ancestor
92526980|NCT00000539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92526981|NCT00000539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92526982|NCT00000539|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92526983|NCT00000539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526984|NCT00000539|Provitamins|provitamins|mesh-ancestor
92526986|NCT00030979|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92526987|NCT00030979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526988|NCT00030979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526989|NCT00030979|Cholinergic Agents|cholinergic agents|mesh-ancestor
92526990|NCT00030979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92526991|NCT00030979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92526992|NCT00030979|Nootropic Agents|nootropic agents|mesh-ancestor
92526993|NCT00031018|Interferon alpha-2|interferon alpha-2|mesh-list
92526994|NCT00031018|Donepezil|donepezil|mesh-list
92526995|NCT00031018|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92526996|NCT00031018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92526997|NCT00031018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92526998|NCT00031018|Cholinergic Agents|cholinergic agents|mesh-ancestor
92526999|NCT00031018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527000|NCT00031018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527001|NCT00031018|Nootropic Agents|nootropic agents|mesh-ancestor
92527002|NCT00031018|Antiviral Agents|antiviral agents|mesh-ancestor
92527003|NCT00031018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527004|NCT00031018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527005|NCT00031057|Riboflavin|riboflavin|mesh-list
92527006|NCT00031057|Thiamine|thiamine|mesh-list
92527007|NCT00031057|Vitamin B Complex|vitamin b complex|mesh-ancestor
92527008|NCT00031057|Vitamins|vitamins|mesh-ancestor
92527009|NCT00031057|Micronutrients|micronutrients|mesh-ancestor
92527010|NCT00031057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527011|NCT00031057|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92527012|NCT00031057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92527013|NCT00000554|Dobutamine|dobutamine|mesh-list
92527014|NCT00000554|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92527016|NCT00000554|Autonomic Agents|autonomic agents|mesh-ancestor
92527017|NCT00000554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527018|NCT00000554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527019|NCT00000554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92527020|NCT00000554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92527021|NCT00000554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92527022|NCT00000554|Adrenergic Agents|adrenergic agents|mesh-ancestor
92527023|NCT00000554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527024|NCT00000554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527025|NCT00000554|Protective Agents|protective agents|mesh-ancestor
92527026|NCT00012909|Hormones|hormones|mesh-list
92527027|NCT00012909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527028|NCT00012909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527029|NCT00031096|Azelaic acid|azelaic acid|mesh-list
92527030|NCT00031096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527031|NCT00031096|Dermatologic Agents|dermatologic agents|mesh-ancestor
92527032|NCT00031135|Choline|choline|mesh-list
92527033|NCT00031135|Lipotropic Agents|lipotropic agents|mesh-ancestor
92527034|NCT00031135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92527035|NCT00031135|Antimetabolites|antimetabolites|mesh-ancestor
92527036|NCT00031135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527037|NCT00031135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527038|NCT00031135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92527039|NCT00031135|Nootropic Agents|nootropic agents|mesh-ancestor
92527040|NCT00031291|Immunoglobulins|immunoglobulins|mesh-list
92527041|NCT00031291|Antibodies|antibodies|mesh-list
92527042|NCT00031291|gamma-Globulins|gamma-globulins|mesh-list
92527043|NCT00031291|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92527044|NCT00031291|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92527045|NCT00031291|Immunologic Factors|immunologic factors|mesh-ancestor
92527046|NCT00031291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527047|NCT00000560|Adrenergic Agents|adrenergic agents|mesh-list
92527048|NCT00000560|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92527049|NCT00000560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527050|NCT00000560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527051|NCT00000560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527052|NCT00000560|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92527053|NCT00396058|Methylphenidate|methylphenidate|mesh-list
92527054|NCT00396058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92290676|NCT02682563|Dapagliflozin|dapagliflozin|mesh-list
92527056|NCT00396058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92527057|NCT00396058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92527058|NCT00396058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92527059|NCT00396058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527060|NCT00396058|Dopamine Agents|dopamine agents|mesh-ancestor
92527061|NCT00396058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527062|NCT00396214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92527063|NCT00396214|Antidepressive Agents|antidepressive agents|mesh-ancestor
92527064|NCT00396214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92527065|NCT00396214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92527066|NCT00396214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92527067|NCT00396214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527068|NCT00396214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527069|NCT00000563|Dexamethasone|dexamethasone|mesh-list
92527070|NCT00000563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527071|NCT00000563|Antiemetics|antiemetics|mesh-ancestor
92527072|NCT00000563|Autonomic Agents|autonomic agents|mesh-ancestor
92527073|NCT00000563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527074|NCT00000563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527075|NCT00000563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527076|NCT00000563|Glucocorticoids|glucocorticoids|mesh-ancestor
92527077|NCT00000563|Hormones|hormones|mesh-ancestor
92527078|NCT00000563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527079|NCT00000563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92527080|NCT00000563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527081|NCT00031564|Aldesleukin|aldesleukin|mesh-list
92527082|NCT00031564|Interleukin-2|interleukin-2|mesh-list
92527083|NCT00031564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527084|NCT00031564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527085|NCT00031564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527086|NCT00031564|Analgesics|analgesics|mesh-ancestor
92527087|NCT00031564|Sensory System Agents|sensory system agents|mesh-ancestor
92251856|NCT01368809|Fentanyl|fentanyl|mesh-list
92527088|NCT00031564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527090|NCT00031564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92527091|NCT00031564|Antiviral Agents|antiviral agents|mesh-ancestor
92527092|NCT00031564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527093|NCT00031642|Rituximab|rituximab|mesh-list
92527094|NCT00031642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92527095|NCT00031642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527096|NCT00031642|Immunologic Factors|immunologic factors|mesh-ancestor
92527097|NCT00031642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527098|NCT00031642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527099|NCT00031681|Irinotecan|irinotecan|mesh-list
92527100|NCT00031681|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92527101|NCT00031681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92527102|NCT00031681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92527103|NCT00031681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527104|NCT00031681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527105|NCT00031681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527106|NCT00031681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527107|NCT00031720|Tamoxifen|tamoxifen|mesh-list
92527108|NCT00031720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92527109|NCT00031720|Hormone Antagonists|hormone antagonists|mesh-ancestor
92527110|NCT00031720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527111|NCT00031720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527112|NCT00031720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92527113|NCT00031720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527114|NCT00031720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92527115|NCT00031720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92527116|NCT00031720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92527117|NCT00000569|Triamcinolone|triamcinolone|mesh-list
92527118|NCT00000569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527119|NCT00000569|Glucocorticoids|glucocorticoids|mesh-ancestor
92527120|NCT00000569|Hormones|hormones|mesh-ancestor
92527121|NCT00000569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527122|NCT00000569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527123|NCT00031759|Imiquimod|imiquimod|mesh-list
92527124|NCT00031759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92527125|NCT00031759|Immunologic Factors|immunologic factors|mesh-ancestor
92527126|NCT00031759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527127|NCT00031759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527128|NCT00031759|Interferon Inducers|interferon inducers|mesh-ancestor
92527129|NCT01791816|Phenylephrine|phenylephrine|mesh-list
92527130|NCT01791816|Oxymetazoline|oxymetazoline|mesh-list
92527131|NCT01791816|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92527132|NCT01791816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92527133|NCT01791816|Mydriatics|mydriatics|mesh-ancestor
92527134|NCT01791816|Autonomic Agents|autonomic agents|mesh-ancestor
92527135|NCT01791816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527136|NCT01791816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527137|NCT01791816|Sympathomimetics|sympathomimetics|mesh-ancestor
92527138|NCT01791816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92527139|NCT01791816|Nasal Decongestants|nasal decongestants|mesh-ancestor
92527140|NCT01791816|Respiratory System Agents|respiratory system agents|mesh-ancestor
92527141|NCT01791816|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92527142|NCT01791816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92527143|NCT01791816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92527144|NCT01791816|Adrenergic Agents|adrenergic agents|mesh-ancestor
92527145|NCT01791816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527146|NCT01791816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527147|NCT01791816|Protective Agents|protective agents|mesh-ancestor
92527148|NCT01791816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527149|NCT00031798|Methylphenidate|methylphenidate|mesh-list
92527150|NCT00031798|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92527151|NCT00031798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527152|NCT00031798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92527153|NCT00031798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92291180|NCT05446805|Corticosterone|corticosterone|mesh-list
92527154|NCT00031798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92527155|NCT00031798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527156|NCT00031798|Dopamine Agents|dopamine agents|mesh-ancestor
92527157|NCT00031798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527158|NCT00031837|Gemcitabine|gemcitabine|mesh-list
92527160|NCT00031837|Tinzaparin|tinzaparin|mesh-list
92527161|NCT00031837|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92527162|NCT00031837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527163|NCT00031837|Antimetabolites|antimetabolites|mesh-ancestor
92527164|NCT00031837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527165|NCT00031837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527166|NCT00031837|Anticoagulants|anticoagulants|mesh-ancestor
92527167|NCT00031837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92527168|NCT00031837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92527169|NCT00031876|Paclitaxel|paclitaxel|mesh-list
92527170|NCT00031876|Capecitabine|capecitabine|mesh-list
92527171|NCT00031876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533621|NCT00061516|Brinzolamide|brinzolamide|mesh-list
92527172|NCT00031876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527173|NCT00031876|Tubulin Modulators|tubulin modulators|mesh-ancestor
92527175|NCT00031876|Mitosis Modulators|mitosis modulators|mesh-ancestor
92527176|NCT00031876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527178|NCT00031876|Antimetabolites|antimetabolites|mesh-ancestor
92527179|NCT00031915|Imatinib Mesylate|imatinib mesylate|mesh-list
92527180|NCT00031915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527181|NCT00031915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527182|NCT00031915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527183|NCT00031915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527184|NCT00031954|Paclitaxel|paclitaxel|mesh-list
92527185|NCT00031954|Carboplatin|carboplatin|mesh-list
92527186|NCT00031954|Gemcitabine|gemcitabine|mesh-list
92527187|NCT00031954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92527188|NCT00031954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527189|NCT00031954|Tubulin Modulators|tubulin modulators|mesh-ancestor
92527190|NCT00031954|Antimitotic Agents|antimitotic agents|mesh-ancestor
92527191|NCT00031954|Mitosis Modulators|mitosis modulators|mesh-ancestor
92527192|NCT00031954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527193|NCT00031954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527194|NCT00031954|Antimetabolites|antimetabolites|mesh-ancestor
92291453|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
92527196|NCT00031993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527197|NCT00031993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527198|NCT00031993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527199|NCT00031993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527200|NCT00000575|Nedocromil|nedocromil|mesh-list
92527201|NCT00000575|Budesonide|budesonide|mesh-list
92527202|NCT00000575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527203|NCT00000575|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92527204|NCT00000575|Autonomic Agents|autonomic agents|mesh-ancestor
92527205|NCT00000575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527206|NCT00000575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527207|NCT00000575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92527208|NCT00000575|Respiratory System Agents|respiratory system agents|mesh-ancestor
92527209|NCT00000575|Glucocorticoids|glucocorticoids|mesh-ancestor
92527210|NCT00000575|Hormones|hormones|mesh-ancestor
92527211|NCT00000575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527212|NCT00000575|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92527213|NCT00000575|Immunologic Factors|immunologic factors|mesh-ancestor
92527214|NCT00000575|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92527215|NCT00032032|Paclitaxel|paclitaxel|mesh-list
92527216|NCT00032032|Carboplatin|carboplatin|mesh-list
92527217|NCT00032032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92527218|NCT00032032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527219|NCT00032032|Tubulin Modulators|tubulin modulators|mesh-ancestor
92527220|NCT00032032|Antimitotic Agents|antimitotic agents|mesh-ancestor
92527221|NCT00032032|Mitosis Modulators|mitosis modulators|mesh-ancestor
92527222|NCT00032032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527223|NCT00032110|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92527224|NCT00032110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527225|NCT00032110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353666|NCT05512962|Glucocorticoids|glucocorticoids|mesh-ancestor
92527226|NCT00032110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527227|NCT00032110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527228|NCT00032149|Prednisolone|prednisolone|mesh-list
92527229|NCT00032149|Cyclophosphamide|cyclophosphamide|mesh-list
92527230|NCT00032149|Etoposide|etoposide|mesh-list
92527231|NCT00032149|Vincristine|vincristine|mesh-list
92527232|NCT00032149|Mitoxantrone|mitoxantrone|mesh-list
92527233|NCT00032149|Bleomycin|bleomycin|mesh-list
92527234|NCT00032149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92527235|NCT00032149|Immunologic Factors|immunologic factors|mesh-ancestor
92527236|NCT00032149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291620|NCT05062577|Naloxone|naloxone|mesh-list
92527237|NCT00032149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527238|NCT00032149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92527239|NCT00032149|Alkylating Agents|alkylating agents|mesh-ancestor
92527240|NCT00032149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527241|NCT00032149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527242|NCT00032149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92527243|NCT00032149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92527244|NCT00032149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92527245|NCT00032149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92291753|NCT01907113|Empagliflozin|empagliflozin|mesh-list
92527247|NCT00032149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92527248|NCT00032149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92527249|NCT00032149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92527250|NCT00032149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527251|NCT00032149|Glucocorticoids|glucocorticoids|mesh-ancestor
92527252|NCT00032149|Hormones|hormones|mesh-ancestor
92527253|NCT00032149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527254|NCT00032149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92291970|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527255|NCT00032149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527256|NCT00032149|Analgesics|analgesics|mesh-ancestor
92292116|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
92527257|NCT00032149|Sensory System Agents|sensory system agents|mesh-ancestor
92527258|NCT00032149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92527259|NCT00032188|Aldesleukin|aldesleukin|mesh-list
92527260|NCT00032188|Interleukin-2|interleukin-2|mesh-list
92527261|NCT00032188|Bryostatin 1|bryostatin 1|mesh-list
92527262|NCT00032188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527263|NCT00032188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527264|NCT00032188|Analgesics|analgesics|mesh-ancestor
92527265|NCT00032188|Sensory System Agents|sensory system agents|mesh-ancestor
92527266|NCT00032188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527267|NCT00032188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527268|NCT00032188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92527269|NCT00032188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92527270|NCT00032188|Antiviral Agents|antiviral agents|mesh-ancestor
92527271|NCT00032188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527272|NCT00032188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92527273|NCT00032188|Immunologic Factors|immunologic factors|mesh-ancestor
92527274|NCT00032305|Visilizumab|visilizumab|mesh-list
92527275|NCT00032305|Immunologic Factors|immunologic factors|mesh-ancestor
92527276|NCT00032305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527277|NCT00000596|Dapsone|dapsone|mesh-list
92527278|NCT00000596|Prednisone|prednisone|mesh-list
92527279|NCT00000596|Cyclophosphamide|cyclophosphamide|mesh-list
92527280|NCT00000596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92527281|NCT00000596|Immunologic Factors|immunologic factors|mesh-ancestor
92527282|NCT00000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527283|NCT00000596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527284|NCT00000596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92527285|NCT00000596|Alkylating Agents|alkylating agents|mesh-ancestor
92527286|NCT00000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527287|NCT00000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527288|NCT00000596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92527289|NCT00000596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527290|NCT00000596|Glucocorticoids|glucocorticoids|mesh-ancestor
92527291|NCT00000596|Hormones|hormones|mesh-ancestor
92527292|NCT00000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527293|NCT00000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92527294|NCT00000596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527295|NCT00000596|Antimalarials|antimalarials|mesh-ancestor
92527296|NCT00000596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92527297|NCT00000596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92527298|NCT00000596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92527299|NCT00000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527300|NCT00000596|Leprostatic Agents|leprostatic agents|mesh-ancestor
92527301|NCT00000596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92527303|NCT00000599|Colestipol|colestipol|mesh-list
92527304|NCT00000599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92527305|NCT00000599|Antimetabolites|antimetabolites|mesh-ancestor
92527306|NCT00000599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527308|NCT00000599|Vasodilator Agents|vasodilator agents|mesh-ancestor
92527309|NCT00000599|Vitamin B Complex|vitamin b complex|mesh-ancestor
92527310|NCT00000599|Vitamins|vitamins|mesh-ancestor
92527311|NCT00000599|Micronutrients|micronutrients|mesh-ancestor
92527312|NCT00000599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527313|NCT00000599|Sequestering Agents|sequestering agents|mesh-ancestor
92527315|NCT00000602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293356|NCT01999400|Mesalamine|mesalamine|mesh-list
92527316|NCT00000602|Antisickling Agents|antisickling agents|mesh-ancestor
92527317|NCT00000602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527318|NCT00000602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293571|NCT02834663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92527319|NCT00000602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92293862|NCT01979276|Glucocorticoids|glucocorticoids|mesh-ancestor
92527321|NCT00032734|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92527322|NCT00032734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527323|NCT00032734|Natriuretic Agents|natriuretic agents|mesh-ancestor
92527324|NCT00032734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527326|NCT00032773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294162|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
92527327|NCT00032773|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92527328|NCT00032773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294232|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92527329|NCT00032773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527331|NCT00032812|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92294449|NCT02363270|Ketamine|ketamine|mesh-list
92294522|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294595|NCT02045264|Analgesics|analgesics|mesh-ancestor
92527333|NCT00032812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294826|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
92527334|NCT00032812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527335|NCT00032812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92527336|NCT00032812|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92527337|NCT00032812|Dopamine Agents|dopamine agents|mesh-ancestor
92527338|NCT00032812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295113|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92295186|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
92527339|NCT00032812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527340|NCT00032890|Celecoxib|celecoxib|mesh-list
92527341|NCT00032890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92527342|NCT00032890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527343|NCT00032890|Analgesics|analgesics|mesh-ancestor
92527344|NCT00032890|Sensory System Agents|sensory system agents|mesh-ancestor
92527345|NCT00032890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527346|NCT00032890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527347|NCT00032890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527348|NCT00032890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527349|NCT00032890|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92527350|NCT00032890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92527351|NCT00032890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295338|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527352|NCT00032890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527353|NCT00032929|Selegiline|selegiline|mesh-list
92527354|NCT00032929|Antidepressive Agents|antidepressive agents|mesh-ancestor
92527355|NCT00032929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92527356|NCT00032929|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92527357|NCT00032929|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92527359|NCT00032929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295853|NCT03198221|Antacids|antacids|mesh-ancestor
92527360|NCT00032929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527361|NCT00032929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92527362|NCT00032929|Protective Agents|protective agents|mesh-ancestor
92296017|NCT05721404|Icodextrin|icodextrin|mesh-list
92527363|NCT00032929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296155|NCT00354991|Losartan|losartan|mesh-list
92296258|NCT02376283|Ticagrelor|ticagrelor|mesh-list
92527365|NCT00000611|Calcium|calcium|mesh-list
92527366|NCT00000611|Hormones|hormones|mesh-list
92527367|NCT00000611|Estrogens|estrogens|mesh-list
92527368|NCT00000611|Progestins|progestins|mesh-list
92296441|NCT03226691|Plerixafor|plerixafor|mesh-list
92296516|NCT00376337|Clotrimazole|clotrimazole|mesh-list
92527370|NCT00000611|Micronutrients|micronutrients|mesh-ancestor
92527371|NCT00000611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527372|NCT00000611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92527373|NCT00000611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92527374|NCT00000611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527375|NCT00032968|Buprenorphine|buprenorphine|mesh-list
92527376|NCT00032968|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92527377|NCT00032968|Naloxone|naloxone|mesh-list
92527378|NCT00032968|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92527379|NCT00032968|Narcotics|narcotics|mesh-ancestor
92527380|NCT00032968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527381|NCT00032968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527382|NCT00032968|Analgesics|analgesics|mesh-ancestor
92527383|NCT00032968|Sensory System Agents|sensory system agents|mesh-ancestor
92527384|NCT00032968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527386|NCT00033046|Modafinil|modafinil|mesh-list
92527387|NCT00033046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92252161|NCT01495481|Adenosine|adenosine|mesh-list
92527388|NCT00033046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527389|NCT00033046|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92527390|NCT00033046|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92527391|NCT00033046|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92527392|NCT00033046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527393|NCT00033085|Ondansetron|ondansetron|mesh-list
92527394|NCT00033085|Antiemetics|antiemetics|mesh-ancestor
92527395|NCT00033085|Autonomic Agents|autonomic agents|mesh-ancestor
92527396|NCT00033085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527397|NCT00033085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527398|NCT00033085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296711|NCT00003213|Antiemetics|antiemetics|mesh-ancestor
92527399|NCT00033085|Antipruritics|antipruritics|mesh-ancestor
92527400|NCT00033085|Dermatologic Agents|dermatologic agents|mesh-ancestor
92527401|NCT00033085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92296944|NCT03256253|Pregabalin|pregabalin|mesh-list
92527402|NCT00033085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92527403|NCT00033085|Serotonin Agents|serotonin agents|mesh-ancestor
92297157|NCT04412863|Interferons|interferons|mesh-list
92527404|NCT00033085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297254|NCT05071352|Nefopam|nefopam|mesh-list
92527405|NCT00033085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527406|NCT00033163|Tenofovir|tenofovir|mesh-list
92527407|NCT00033163|Adefovir|adefovir|mesh-list
92527408|NCT00033163|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92297453|NCT05647278|Esomeprazole|esomeprazole|mesh-list
92527409|NCT00033163|Antiviral Agents|antiviral agents|mesh-ancestor
92297603|NCT05925140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527411|NCT00033163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92527412|NCT00033163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527413|NCT00033163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297823|NCT05922696|Vitamin D|vitamin d|mesh-list
92297898|NCT05922306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298046|NCT05920356|Sotorasib|sotorasib|mesh-list
92527414|NCT00033163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527416|NCT00033163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92298206|NCT05883852|Docetaxel|docetaxel|mesh-list
92527417|NCT00033241|Gemcitabine|gemcitabine|mesh-list
92527418|NCT00033241|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92527419|NCT00033241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92298343|NCT05823467|Trimethoprim|trimethoprim|mesh-list
92527420|NCT00033241|Antimetabolites|antimetabolites|mesh-ancestor
92298415|NCT05784844|Antifungal Agents|antifungal agents|mesh-ancestor
92527421|NCT00033241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527422|NCT00033241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527423|NCT00033241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527424|NCT00033241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527426|NCT00000620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92527427|NCT00000620|Metformin|metformin|mesh-list
92527428|NCT00000620|Insulin Glargine|insulin glargine|mesh-list
92527429|NCT00000620|Pioglitazone|pioglitazone|mesh-list
92527430|NCT00000620|Insulin Aspart|insulin aspart|mesh-list
92527431|NCT00000620|Glimepiride|glimepiride|mesh-list
92527432|NCT00000620|Rosiglitazone|rosiglitazone|mesh-list
92527433|NCT00000620|Insulin Detemir|insulin detemir|mesh-list
92527434|NCT00000620|Acarbose|acarbose|mesh-list
92527435|NCT00000620|Repaglinide|repaglinide|mesh-list
92527436|NCT00000620|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92527437|NCT00000620|Metoprolol|metoprolol|mesh-list
92298551|NCT05707208|Lidocaine|lidocaine|mesh-list
92527438|NCT00000620|Felodipine|felodipine|mesh-list
92527439|NCT00000620|Amlodipine|amlodipine|mesh-list
92527441|NCT00000620|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92298847|NCT05364944|Octreotide|octreotide|mesh-list
92527442|NCT00000620|Carvedilol|carvedilol|mesh-list
92527443|NCT00000620|Candesartan|candesartan|mesh-list
92527444|NCT00000620|Candesartan cilexetil|candesartan cilexetil|mesh-list
92527445|NCT00000620|Lisinopril|lisinopril|mesh-list
92527446|NCT00000620|Chlorthalidone|chlorthalidone|mesh-list
92527447|NCT00000620|Diltiazem|diltiazem|mesh-list
92527448|NCT00000620|Benazepril|benazepril|mesh-list
92527449|NCT00000620|Hydralazine|hydralazine|mesh-list
92527450|NCT00000620|Antihypertensive Agents|antihypertensive agents|mesh-list
92527451|NCT00000620|Reserpine|reserpine|mesh-list
92527452|NCT00000620|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
92299208|NCT05062889|Levoleucovorin|levoleucovorin|mesh-list
92527453|NCT00000620|Hydrochlorothiazide-triamterene|hydrochlorothiazide-triamterene|mesh-list
92527454|NCT00000620|Triamterene|triamterene|mesh-list
92527456|NCT00000620|Simvastatin|simvastatin|mesh-list
92527457|NCT00000620|Fenofibrate|fenofibrate|mesh-list
92527458|NCT00000620|Terazosin|terazosin|mesh-list
92299510|NCT04677504|Bevacizumab|bevacizumab|mesh-list
92299584|NCT04617938|Narcotics|narcotics|mesh-ancestor
92527459|NCT00000620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527460|NCT00000620|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92527461|NCT00000620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92252235|NCT00820664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92527462|NCT00000620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299729|NCT04439136|Afatinib|afatinib|mesh-list
92299795|NCT04360681|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92527463|NCT00000620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92527464|NCT00000620|Vasodilator Agents|vasodilator agents|mesh-ancestor
92527465|NCT00000620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92527466|NCT00000620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92527467|NCT00000620|Antimetabolites|antimetabolites|mesh-ancestor
92527468|NCT00000620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92527469|NCT00000620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92527470|NCT00000620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527471|NCT00000620|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92527472|NCT00000620|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92527473|NCT00000620|Diuretics|diuretics|mesh-ancestor
92527474|NCT00000620|Natriuretic Agents|natriuretic agents|mesh-ancestor
92527475|NCT00000620|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92299943|NCT04294459|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92300008|NCT04214288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527476|NCT00000620|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92527477|NCT00000620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92527479|NCT00000620|Immunologic Factors|immunologic factors|mesh-ancestor
92527480|NCT00000620|Sympatholytics|sympatholytics|mesh-ancestor
92527481|NCT00000620|Autonomic Agents|autonomic agents|mesh-ancestor
92527482|NCT00000620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300608|NCT03576885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92300683|NCT03456102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92527483|NCT00000620|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92300757|NCT03319901|Venetoclax|venetoclax|mesh-list
92300830|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527484|NCT00000620|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92527485|NCT00000620|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92527486|NCT00000620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92301060|NCT02626455|Hormones|hormones|mesh-ancestor
92527487|NCT00000620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92301125|NCT02579811|Axitinib|axitinib|mesh-list
92527489|NCT00000620|Protective Agents|protective agents|mesh-ancestor
92301270|NCT01964430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527490|NCT00000620|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92301363|NCT01216683|Rituximab|rituximab|mesh-list
92301417|NCT01145495|Lenalidomide|lenalidomide|mesh-list
92301494|NCT00783510|Abortifacient Agents|abortifacient agents|mesh-ancestor
92527491|NCT00000620|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92527492|NCT00000620|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92301570|NCT00316888|Cisplatin|cisplatin|mesh-list
92527494|NCT00000620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92527495|NCT00000620|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92527497|NCT00000620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92527498|NCT00000620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92302171|NCT03622619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92302248|NCT04486352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527499|NCT00000620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527500|NCT00000620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92302562|NCT03954314|Tranexamic Acid|tranexamic acid|mesh-list
92527501|NCT00000620|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92527502|NCT00000620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92527503|NCT00000620|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92527504|NCT00000620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92527505|NCT00000620|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92302923|NCT00361868|Metformin|metformin|mesh-list
92302988|NCT05346666|Anesthetics|anesthetics|mesh-ancestor
92527509|NCT00033280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527510|NCT00033280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527513|NCT00033319|Hematinics|hematinics|mesh-ancestor
92527514|NCT00033319|Vitamin B Complex|vitamin b complex|mesh-ancestor
92527515|NCT00033319|Vitamins|vitamins|mesh-ancestor
92527516|NCT00033319|Micronutrients|micronutrients|mesh-ancestor
92527517|NCT00033319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527518|NCT00033319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92527519|NCT00033319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527520|NCT00033319|Analgesics|analgesics|mesh-ancestor
92303670|NCT01920932|Prednisone|prednisone|mesh-list
92527521|NCT00033319|Sensory System Agents|sensory system agents|mesh-ancestor
92527522|NCT00033319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527523|NCT00033319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527524|NCT00033319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527525|NCT00033319|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92303867|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304013|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
92527526|NCT00033319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92304159|NCT05648916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92527527|NCT00033319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304236|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92527528|NCT00033319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92527529|NCT00033319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92527530|NCT00033319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527531|NCT00033319|Antipyretics|antipyretics|mesh-ancestor
92527532|NCT00033358|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92527533|NCT00033358|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92527534|NCT00033358|Medroxyprogesterone|medroxyprogesterone|mesh-list
92527535|NCT00033358|Norgestrel|norgestrel|mesh-list
92527536|NCT00033358|Estradiol|estradiol|mesh-list
92304454|NCT04730635|Donepezil|donepezil|mesh-list
92527537|NCT00033358|Estrogens|estrogens|mesh-ancestor
92527538|NCT00033358|Hormones|hormones|mesh-ancestor
92527539|NCT00033358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304676|NCT02065362|Alkylating Agents|alkylating agents|mesh-ancestor
92527540|NCT00033358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527541|NCT00033358|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92527542|NCT00033358|Contraceptive Agents|contraceptive agents|mesh-ancestor
92527543|NCT00033358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92527544|NCT00033358|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92527545|NCT00033358|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92527546|NCT00033358|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92527547|NCT00033358|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92527548|NCT00033358|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92527549|NCT00033358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92527550|NCT00033358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527551|NCT02971696|Sorafenib|sorafenib|mesh-list
92527552|NCT02971696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527553|NCT02971696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92527554|NCT02971696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527555|NCT02971696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305119|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
92527558|NCT00033436|Nicotinic Acids|nicotinic acids|mesh-list
92305273|NCT00002847|Interferons|interferons|mesh-list
92527559|NCT00033436|Vitamin B Complex|vitamin b complex|mesh-ancestor
92527560|NCT00033436|Vitamins|vitamins|mesh-ancestor
92527561|NCT00033436|Micronutrients|micronutrients|mesh-ancestor
92305430|NCT00003369|Tirapazamine|tirapazamine|mesh-list
92527562|NCT00033436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527563|NCT00033436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92527565|NCT00033436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527566|NCT00033436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92527567|NCT00033436|Vasodilator Agents|vasodilator agents|mesh-ancestor
92305868|NCT00004887|Paclitaxel|paclitaxel|mesh-list
92527568|NCT00000635|Trifluridine|trifluridine|mesh-list
92527569|NCT00000635|Polymyxins|polymyxins|mesh-list
92527570|NCT00000635|Bacitracin|bacitracin|mesh-list
92527571|NCT00000635|Polymyxin B|polymyxin b|mesh-list
92527572|NCT00000635|Antimetabolites|antimetabolites|mesh-ancestor
92306096|NCT00004071|Analgesics|analgesics|mesh-ancestor
92527573|NCT00000635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527574|NCT00000635|Antiviral Agents|antiviral agents|mesh-ancestor
92306243|NCT00384657|Trace Elements|trace elements|mesh-ancestor
92527575|NCT00000635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527576|NCT00000635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92527577|NCT00000635|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92527578|NCT00033553|Paclitaxel|paclitaxel|mesh-list
92527579|NCT00033553|Carboplatin|carboplatin|mesh-list
92527580|NCT00033553|Gemcitabine|gemcitabine|mesh-list
92527581|NCT00033553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92527582|NCT00033553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527583|NCT00033553|Tubulin Modulators|tubulin modulators|mesh-ancestor
92527584|NCT00033553|Antimitotic Agents|antimitotic agents|mesh-ancestor
92527585|NCT00033553|Mitosis Modulators|mitosis modulators|mesh-ancestor
92527586|NCT00033553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527587|NCT00033553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527588|NCT00033553|Antimetabolites|antimetabolites|mesh-ancestor
92527589|NCT00033592|Bupropion|bupropion|mesh-list
92527590|NCT00033592|Nicotine|nicotine|mesh-list
92306759|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
92527591|NCT00033592|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92527592|NCT00033592|Autonomic Agents|autonomic agents|mesh-ancestor
92527593|NCT00033592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527594|NCT00033592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306979|NCT00004257|Fluorouracil|fluorouracil|mesh-list
92527595|NCT00033592|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92527596|NCT00033592|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92527597|NCT00033592|Cholinergic Agents|cholinergic agents|mesh-ancestor
92527598|NCT00033592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307124|NCT00004785|Prednisolone|prednisolone|mesh-list
92527599|NCT00033592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527600|NCT00033592|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92527601|NCT00033592|Antidepressive Agents|antidepressive agents|mesh-ancestor
92527602|NCT00033592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92527603|NCT00033592|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92527604|NCT00033592|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92527605|NCT00033592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92527606|NCT00033592|Dopamine Agents|dopamine agents|mesh-ancestor
92307264|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307337|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307412|NCT02520518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92527607|NCT00033592|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92527608|NCT00033592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92527609|NCT00033592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307645|NCT00588523|Busulfan|busulfan|mesh-list
92527612|NCT00013689|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92527613|NCT00013689|Antimalarials|antimalarials|mesh-ancestor
92527614|NCT00013689|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92527615|NCT00013689|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92308005|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
92527616|NCT00013689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527617|NCT00013689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92527618|NCT00013689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308236|NCT02464657|Nivolumab|nivolumab|mesh-list
92308307|NCT02506634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527619|NCT00013689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527620|NCT00013689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92527621|NCT00033709|Thalidomide|thalidomide|mesh-list
92527622|NCT00033709|Temozolomide|temozolomide|mesh-list
92527623|NCT00033709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92527624|NCT00033709|Alkylating Agents|alkylating agents|mesh-ancestor
92527625|NCT00033709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527626|NCT00033709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527627|NCT00033709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92527628|NCT00033709|Immunologic Factors|immunologic factors|mesh-ancestor
92527629|NCT00033709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527630|NCT00033709|Leprostatic Agents|leprostatic agents|mesh-ancestor
92527631|NCT00033709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92527632|NCT00033709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527633|NCT00033709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92527634|NCT00033709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92527635|NCT00033709|Growth Substances|growth substances|mesh-ancestor
92527636|NCT00033709|Growth Inhibitors|growth inhibitors|mesh-ancestor
92527637|NCT00033748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92527638|NCT00033748|Antibodies|antibodies|mesh-list
92527639|NCT00033748|Immunoglobulins|immunoglobulins|mesh-list
92527641|NCT00033748|Immunologic Factors|immunologic factors|mesh-ancestor
92527642|NCT00033748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527643|NCT00033748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527645|NCT00000641|Ciprofloxacin|ciprofloxacin|mesh-list
92527647|NCT00000641|Amikacin|amikacin|mesh-list
92527648|NCT00000641|Ethambutol|ethambutol|mesh-list
92527649|NCT00000641|Clofazimine|clofazimine|mesh-list
92527650|NCT00000641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92308958|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
92309101|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
92527651|NCT00000641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527652|NCT00000641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92527653|NCT00000641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92527655|NCT00000641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527656|NCT00000641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527657|NCT00000641|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92309548|NCT03678428|Antidotes|antidotes|mesh-ancestor
92527658|NCT00000641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92527659|NCT00000641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92527660|NCT00000641|Antitubercular Agents|antitubercular agents|mesh-ancestor
92527661|NCT00000641|Leprostatic Agents|leprostatic agents|mesh-ancestor
92527662|NCT00000641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527663|NCT00000641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92527664|NCT00000641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92527665|NCT00000641|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92310142|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92527666|NCT00000641|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92527667|NCT00000641|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92527668|NCT00000641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92527669|NCT00000641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527670|NCT00000644|Clarithromycin|clarithromycin|mesh-list
92310442|NCT02625181|Hydrocodone|hydrocodone|mesh-list
92527671|NCT00000644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92527672|NCT00000644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527673|NCT00000644|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92527674|NCT00000644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527675|NCT00000644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527676|NCT00000644|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92527677|NCT00000644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92527679|NCT02971423|Sulbactam|sulbactam|mesh-list
92527680|NCT02971423|Durlobactam|durlobactam|mesh-list
92527681|NCT02971423|Cilastatin|cilastatin|mesh-list
92527682|NCT02971423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92527683|NCT02971423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527684|NCT02971423|Protease Inhibitors|protease inhibitors|mesh-ancestor
92527685|NCT02971423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527686|NCT02971423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527687|NCT02971423|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92527688|NCT00389051|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92527689|NCT00389051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92527690|NCT00389051|Alkylating Agents|alkylating agents|mesh-ancestor
92527691|NCT00389051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527693|NCT00389090|Temozolomide|temozolomide|mesh-list
92412863|NCT01236521|Analgesics|analgesics|mesh-list
92527694|NCT00389090|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92527695|NCT00389090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92527696|NCT00389090|Alkylating Agents|alkylating agents|mesh-ancestor
92527697|NCT00389090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527698|NCT00389090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527699|NCT00389090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527700|NCT00033982|Posaconazole|posaconazole|mesh-list
92527701|NCT00033982|Antifungal Agents|antifungal agents|mesh-ancestor
92310720|NCT04146571|Ensartinib|ensartinib|mesh-list
92527702|NCT00033982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527703|NCT00033982|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92527704|NCT00033982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92527705|NCT00033982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92310860|NCT03043807|Androgen Antagonists|androgen antagonists|mesh-ancestor
92527706|NCT00033982|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92527707|NCT00033982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92311011|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92527709|NCT00033982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527710|NCT00033982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92527711|NCT00033982|Hormone Antagonists|hormone antagonists|mesh-ancestor
92527712|NCT00033982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527713|NCT00033982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527714|NCT00034060|Etanercept|etanercept|mesh-list
92527715|NCT00034060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92527716|NCT00034060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527717|NCT00034060|Analgesics|analgesics|mesh-ancestor
92527718|NCT00034060|Sensory System Agents|sensory system agents|mesh-ancestor
92527719|NCT00034060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527720|NCT00034060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311899|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527721|NCT00034060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311975|NCT05243953|Cromakalim|cromakalim|mesh-list
92527722|NCT00034060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527723|NCT00034060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312049|NCT05172817|Adalimumab|adalimumab|mesh-list
92312133|NCT05061901|Lisinopril|lisinopril|mesh-list
92527724|NCT00034060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92527725|NCT00034060|Immunologic Factors|immunologic factors|mesh-ancestor
92527726|NCT00034138|Oregovomab|oregovomab|mesh-list
92527727|NCT00034138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92527728|NCT00034138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527730|NCT00034177|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92312708|NCT00371306|Glyburide|glyburide|mesh-list
92527731|NCT00034177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92527732|NCT00034177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527733|NCT00034177|Tubulin Modulators|tubulin modulators|mesh-ancestor
92527734|NCT00034177|Antimitotic Agents|antimitotic agents|mesh-ancestor
92527735|NCT00034177|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312997|NCT05057689|Fentanyl|fentanyl|mesh-list
92527736|NCT00034177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527737|NCT00389129|Aspirin|aspirin|mesh-list
92527738|NCT00389129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92527739|NCT00389129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527740|NCT00389129|Analgesics|analgesics|mesh-ancestor
92527741|NCT00389129|Sensory System Agents|sensory system agents|mesh-ancestor
92527742|NCT00389129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527743|NCT00389129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527744|NCT00389129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527745|NCT00389129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527746|NCT00389129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92313709|NCT04737655|Hormones|hormones|mesh-ancestor
92313740|NCT04209140|Antimanic Agents|antimanic agents|mesh-ancestor
92313816|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92527747|NCT00389129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92527748|NCT00389129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314035|NCT03002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527749|NCT00389129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92527750|NCT00389129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92527751|NCT00389129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314197|NCT02903407|Midazolam|midazolam|mesh-list
92527752|NCT00389129|Antipyretics|antipyretics|mesh-ancestor
92527753|NCT00013962|Vitamin D|vitamin d|mesh-list
92527754|NCT00013962|Vitamins|vitamins|mesh-ancestor
92527755|NCT00013962|Micronutrients|micronutrients|mesh-ancestor
92314335|NCT02937506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92527756|NCT00013962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314408|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527757|NCT00013962|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92527759|NCT00000665|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92527760|NCT00000665|Foscarnet|foscarnet|mesh-list
92314558|NCT02802241|Antiemetics|antiemetics|mesh-ancestor
92527761|NCT00000665|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92527762|NCT00000665|Antiviral Agents|antiviral agents|mesh-ancestor
92527763|NCT00000665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252538|NCT00877370|Ertapenem|ertapenem|mesh-list
92314778|NCT05828199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314849|NCT05825443|Paclitaxel|paclitaxel|mesh-list
92527764|NCT00000665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527765|NCT00000665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527766|NCT00000665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527767|NCT00000665|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92527768|NCT00034372|Oregovomab|oregovomab|mesh-list
92527769|NCT00034372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92527770|NCT00034372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527771|NCT00014001|Olanzapine|olanzapine|mesh-list
92527772|NCT00014001|Risperidone|risperidone|mesh-list
92527773|NCT00014001|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92527774|NCT00014001|Ziprasidone|ziprasidone|mesh-list
92527775|NCT00014001|Clozapine|clozapine|mesh-list
92527776|NCT00014001|Perphenazine|perphenazine|mesh-list
92527777|NCT00014001|Fluphenazine|fluphenazine|mesh-list
92527778|NCT00014001|Fluphenazine depot|fluphenazine depot|mesh-list
92527779|NCT00014001|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92527780|NCT00014001|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92527781|NCT00014001|Serotonin Agents|serotonin agents|mesh-ancestor
92315007|NCT05674487|Misoprostol|misoprostol|mesh-list
92527782|NCT00014001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315061|NCT05593939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527783|NCT00014001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527784|NCT00014001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527785|NCT00014001|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92527786|NCT00014001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92527787|NCT00014001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527788|NCT00014001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92527789|NCT00014001|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92527790|NCT00014001|Dopamine Agents|dopamine agents|mesh-ancestor
92527791|NCT00014001|Antiemetics|antiemetics|mesh-ancestor
92527792|NCT00014001|Autonomic Agents|autonomic agents|mesh-ancestor
92315428|NCT04724148|Narcotics|narcotics|mesh-ancestor
92527793|NCT00014001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527794|NCT00014001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527795|NCT00014001|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92527796|NCT00014001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92527797|NCT00014001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92527798|NCT00014001|Antidepressive Agents|antidepressive agents|mesh-ancestor
92527799|NCT00014001|GABA Antagonists|gaba antagonists|mesh-ancestor
92527800|NCT00014001|GABA Agents|gaba agents|mesh-ancestor
92527801|NCT00000671|Zidovudine|zidovudine|mesh-list
92527802|NCT00000671|Didanosine|didanosine|mesh-list
92315868|NCT03043430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315943|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527804|NCT00000671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353751|NCT03302910|Torsemide|torsemide|mesh-list
92316094|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
92316168|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
92527805|NCT00000671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92527806|NCT00000671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527807|NCT00000671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527808|NCT00000671|Antiviral Agents|antiviral agents|mesh-ancestor
92316312|NCT00374881|Autonomic Agents|autonomic agents|mesh-ancestor
92527809|NCT00000671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527810|NCT00000671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92527811|NCT00000671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92527812|NCT02971540|Dipyrone|dipyrone|mesh-list
92527813|NCT02971540|Tramadol|tramadol|mesh-list
92527814|NCT02971540|Bupivacaine|bupivacaine|mesh-list
92527816|NCT02971540|Anesthetics, Local|anesthetics, local|mesh-ancestor
92527817|NCT02971540|Anesthetics|anesthetics|mesh-ancestor
92527818|NCT02971540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527819|NCT02971540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527820|NCT02971540|Sensory System Agents|sensory system agents|mesh-ancestor
92527821|NCT02971540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527822|NCT02971540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92527823|NCT02971540|Narcotics|narcotics|mesh-ancestor
92527824|NCT02971540|Analgesics|analgesics|mesh-ancestor
92527825|NCT02971540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92527826|NCT02971540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92527827|NCT02971540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92527828|NCT02971540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92527829|NCT02971540|Antipyretics|antipyretics|mesh-ancestor
92527830|NCT00034489|Gemcitabine|gemcitabine|mesh-list
92527831|NCT00034489|Pemetrexed|pemetrexed|mesh-list
92527832|NCT00034489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527833|NCT00034489|Antimetabolites|antimetabolites|mesh-ancestor
92527834|NCT00034489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527835|NCT00034489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527836|NCT00034489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527837|NCT00034489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92252620|NCT02479230|Vaccines|vaccines|mesh-list
92527838|NCT00034489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527840|NCT00396487|Capecitabine|capecitabine|mesh-list
92527841|NCT00396487|Irinotecan|irinotecan|mesh-list
92527842|NCT00396487|Antimetabolites|antimetabolites|mesh-ancestor
92316808|NCT03100123|Aspirin|aspirin|mesh-list
92316884|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
92527843|NCT00396487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527844|NCT00396487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527845|NCT00396487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527846|NCT00396487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92527847|NCT00396487|Immunologic Factors|immunologic factors|mesh-ancestor
92527848|NCT00396487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527849|NCT00396487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92527850|NCT00396487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92527851|NCT00396487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527852|NCT00000674|Leucovorin|leucovorin|mesh-list
92527853|NCT00000674|Clindamycin|clindamycin|mesh-list
92527854|NCT00000674|Clindamycin palmitate|clindamycin palmitate|mesh-list
92527855|NCT00000674|Clindamycin phosphate|clindamycin phosphate|mesh-list
92527856|NCT00000674|Pyrimethamine|pyrimethamine|mesh-list
92527857|NCT00000674|Calcium|calcium|mesh-list
92527858|NCT00000674|Levoleucovorin|levoleucovorin|mesh-list
92527859|NCT00000674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92527860|NCT00000674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527861|NCT00000674|Antidotes|antidotes|mesh-ancestor
92527862|NCT00000674|Protective Agents|protective agents|mesh-ancestor
92527863|NCT00000674|Vitamin B Complex|vitamin b complex|mesh-ancestor
92527864|NCT00000674|Vitamins|vitamins|mesh-ancestor
92527865|NCT00000674|Micronutrients|micronutrients|mesh-ancestor
92527866|NCT00000674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92527867|NCT00000674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527868|NCT00000674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92527869|NCT00000674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317167|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527870|NCT00000674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527871|NCT00000674|Antimalarials|antimalarials|mesh-ancestor
92527872|NCT00000674|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92527873|NCT00000674|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92527874|NCT00000674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92527875|NCT00014040|Nitric Oxide|nitric oxide|mesh-list
92527876|NCT00014040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92527877|NCT00014040|Autonomic Agents|autonomic agents|mesh-ancestor
92527878|NCT00014040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527879|NCT00014040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527880|NCT00014040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92527881|NCT00014040|Respiratory System Agents|respiratory system agents|mesh-ancestor
92527882|NCT00014040|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92527883|NCT00014040|Antioxidants|antioxidants|mesh-ancestor
92527884|NCT00014040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527885|NCT00014040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527886|NCT00014040|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92527887|NCT00014040|Vasodilator Agents|vasodilator agents|mesh-ancestor
92527888|NCT00014040|Gasotransmitters|gasotransmitters|mesh-ancestor
92527889|NCT00014040|Protective Agents|protective agents|mesh-ancestor
92527890|NCT00034528|Prednisone|prednisone|mesh-list
92527891|NCT00034528|Fludarabine|fludarabine|mesh-list
92527892|NCT00034528|Busulfan|busulfan|mesh-list
92527893|NCT00034528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317920|NCT03424681|Modafinil|modafinil|mesh-list
92527895|NCT00034528|Hormones|hormones|mesh-ancestor
92318088|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
92318236|NCT02216214|Adrenergic Agents|adrenergic agents|mesh-ancestor
92527896|NCT00034528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527897|NCT00034528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527898|NCT00034528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92527899|NCT00034528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527900|NCT00034528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527901|NCT00034528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92527902|NCT00034528|Immunologic Factors|immunologic factors|mesh-ancestor
92527903|NCT00034528|Alkylating Agents|alkylating agents|mesh-ancestor
92527904|NCT00034528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92318685|NCT04390022|Ivermectin|ivermectin|mesh-list
92527905|NCT00034528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92527906|NCT00000677|Sch 39304|sch 39304|mesh-list
92527907|NCT00000677|Antifungal Agents|antifungal agents|mesh-ancestor
92527908|NCT00000677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527909|NCT04711642|Hyaluronic Acid|hyaluronic acid|mesh-list
92527910|NCT04711642|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92527911|NCT04711642|Immunologic Factors|immunologic factors|mesh-ancestor
92527912|NCT04711642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527913|NCT04711642|Viscosupplements|viscosupplements|mesh-ancestor
92527914|NCT04711642|Protective Agents|protective agents|mesh-ancestor
92527915|NCT00034606|Gemcitabine|gemcitabine|mesh-list
92527916|NCT00034606|Pemetrexed|pemetrexed|mesh-list
92527917|NCT00034606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92527918|NCT00034606|Antimetabolites|antimetabolites|mesh-ancestor
92319505|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92527919|NCT00034606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527920|NCT00034606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92527921|NCT00034606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319664|NCT03723980|Propolis|propolis|mesh-list
92527922|NCT00034606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92319731|NCT01200602|Megestrol|megestrol|mesh-list
92527923|NCT00034606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527924|NCT00034645|Posaconazole|posaconazole|mesh-list
92527926|NCT00034645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527927|NCT00034645|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92527928|NCT00034645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92527929|NCT00034645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92320094|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92320170|NCT05286554|Progestins|progestins|mesh-ancestor
92527930|NCT00034645|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92320481|NCT00624650|Mydriatics|mydriatics|mesh-ancestor
92320545|NCT00378716|Vitamin B Complex|vitamin b complex|mesh-ancestor
92320622|NCT00589550|Interferons|interferons|mesh-list
92320697|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527931|NCT00034645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92527932|NCT00034645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527933|NCT00034645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527934|NCT00034645|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92527935|NCT00034645|Hormone Antagonists|hormone antagonists|mesh-ancestor
92527936|NCT00034645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92527937|NCT00034645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527938|NCT00034762|Risperidone|risperidone|mesh-list
92527939|NCT00034762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92527940|NCT00034762|Serotonin Agents|serotonin agents|mesh-ancestor
92527941|NCT00034762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527942|NCT00034762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527943|NCT00034762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527944|NCT00034762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92527945|NCT00034762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92527946|NCT00034762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527947|NCT00034762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92527948|NCT00034762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92527949|NCT00034762|Dopamine Agents|dopamine agents|mesh-ancestor
92527950|NCT00000686|Stavudine|stavudine|mesh-list
92527951|NCT00000686|Antimetabolites|antimetabolites|mesh-ancestor
92527952|NCT00000686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320768|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527953|NCT00000686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92320981|NCT00000776|Hormones|hormones|mesh-ancestor
92321050|NCT03887299|Disinfectants|disinfectants|mesh-list
92527954|NCT00000686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92527955|NCT00000686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92527957|NCT00000686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92527959|NCT00000686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92527960|NCT00034801|Olanzapine|olanzapine|mesh-list
92527961|NCT00034801|Ziprasidone|ziprasidone|mesh-list
92527962|NCT00034801|Antiemetics|antiemetics|mesh-ancestor
92321420|NCT00000920|Ritonavir|ritonavir|mesh-list
92527964|NCT00034801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92527965|NCT00034801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527966|NCT00034801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92527967|NCT00034801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92527968|NCT00034801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92527969|NCT00034801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92527970|NCT00034801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92321789|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
92533651|NCT00061789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92527971|NCT00034801|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92527972|NCT00034801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92527973|NCT00034801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92527974|NCT00034801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92527975|NCT00034801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92527976|NCT00034801|Serotonin Agents|serotonin agents|mesh-ancestor
92527977|NCT00034801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92528019|NCT00000689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322597|NCT00002162|Antiviral Agents|antiviral agents|mesh-ancestor
92528020|NCT00000689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92322671|NCT00002168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528021|NCT00000689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92322750|NCT00002186|Acyclovir|acyclovir|mesh-list
92528022|NCT00000689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528023|NCT00000689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528024|NCT00000689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528025|NCT00000689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92528026|NCT00000689|Abortifacient Agents|abortifacient agents|mesh-ancestor
92528027|NCT00000689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92528028|NCT00000689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528029|NCT00000689|Antimetabolites|antimetabolites|mesh-ancestor
92528030|NCT00000689|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528031|NCT00000689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323106|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
92528032|NCT00000689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528033|NCT00000689|Antiviral Agents|antiviral agents|mesh-ancestor
92528034|NCT00000689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528035|NCT00000689|Antidotes|antidotes|mesh-ancestor
92528036|NCT00000689|Protective Agents|protective agents|mesh-ancestor
92528037|NCT00000689|Vitamin B Complex|vitamin b complex|mesh-ancestor
92528038|NCT00000689|Vitamins|vitamins|mesh-ancestor
92528039|NCT00000689|Micronutrients|micronutrients|mesh-ancestor
92323254|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528040|NCT00000689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92528041|NCT00000689|Tubulin Modulators|tubulin modulators|mesh-ancestor
92323675|NCT00002516|Cobalt|cobalt|mesh-list
92528042|NCT00000689|Antimitotic Agents|antimitotic agents|mesh-ancestor
92528043|NCT00000689|Mitosis Modulators|mitosis modulators|mesh-ancestor
92528045|NCT00034879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528046|NCT00034879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92528047|NCT00034879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323854|NCT00377923|Progesterone|progesterone|mesh-list
92323928|NCT00002582|Antimetabolites|antimetabolites|mesh-ancestor
92324022|NCT00002618|Cobalt|cobalt|mesh-list
92324151|NCT01434745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528048|NCT00034879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324298|NCT01303003|Hormones|hormones|mesh-ancestor
92528050|NCT00000707|Antifungal Agents|antifungal agents|mesh-ancestor
92528051|NCT00000707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528052|NCT00000707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92528053|NCT00000707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92528054|NCT00000707|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92528055|NCT00014235|Cyclosporine|cyclosporine|mesh-list
92528056|NCT00014235|Mycophenolic Acid|mycophenolic acid|mesh-list
92528057|NCT00014235|Fludarabine|fludarabine|mesh-list
92528058|NCT00014235|Fludarabine phosphate|fludarabine phosphate|mesh-list
92528059|NCT00014235|Cyclosporins|cyclosporins|mesh-list
92324829|NCT01583647|Vitamins|vitamins|mesh-ancestor
92528060|NCT00014235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324907|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
92324976|NCT04579640|Vitamin D|vitamin d|mesh-list
92528061|NCT00014235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528062|NCT00014235|Antimetabolites|antimetabolites|mesh-ancestor
92528063|NCT00014235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528064|NCT00014235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528065|NCT00014235|Immunologic Factors|immunologic factors|mesh-ancestor
92528066|NCT00014235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528067|NCT00014235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528068|NCT00014235|Antifungal Agents|antifungal agents|mesh-ancestor
92528069|NCT00014235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528070|NCT00014235|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528071|NCT00014235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325213|NCT00314353|Irinotecan|irinotecan|mesh-list
92528072|NCT00014235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92528073|NCT00014235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92325338|NCT00746239|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325414|NCT00728845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92528074|NCT00014235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92528075|NCT00014235|Antitubercular Agents|antitubercular agents|mesh-ancestor
92528076|NCT00014235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92325725|NCT00000301|Amantadine|amantadine|mesh-list
92528078|NCT00000710|Antimetabolites|antimetabolites|mesh-ancestor
92325787|NCT03521102|Antipyretics|antipyretics|mesh-ancestor
92325861|NCT00000805|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92528079|NCT00000710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528080|NCT00000710|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528081|NCT00000710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528082|NCT00000710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528083|NCT00000710|Antiviral Agents|antiviral agents|mesh-ancestor
92528084|NCT00000710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528085|NCT00000710|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528086|NCT00000710|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528087|NCT00000716|Zidovudine|zidovudine|mesh-list
92528088|NCT00000716|Antimetabolites|antimetabolites|mesh-ancestor
92528089|NCT00000716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528090|NCT00000716|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528091|NCT00000716|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528092|NCT00000716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528093|NCT00000716|Antiviral Agents|antiviral agents|mesh-ancestor
92528094|NCT00000716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528095|NCT00000716|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528096|NCT00000716|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528097|NCT00014274|Carboplatin|carboplatin|mesh-list
92528098|NCT00014274|Gemcitabine|gemcitabine|mesh-list
92528099|NCT00014274|Methotrexate|methotrexate|mesh-list
92528100|NCT00014274|Vinblastine|vinblastine|mesh-list
92528101|NCT00014274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326138|NCT00000505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92326214|NCT00000577|Gout Suppressants|gout suppressants|mesh-ancestor
92528102|NCT00014274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528103|NCT00014274|Antimetabolites|antimetabolites|mesh-ancestor
92326368|NCT00000979|Zidovudine|zidovudine|mesh-list
92528104|NCT00014274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528105|NCT00014274|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92528106|NCT00014274|Abortifacient Agents|abortifacient agents|mesh-ancestor
92528107|NCT00014274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92528108|NCT00014274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528109|NCT00014274|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528110|NCT00014274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528111|NCT00014274|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528112|NCT00014274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528113|NCT00014274|Immunologic Factors|immunologic factors|mesh-ancestor
92528114|NCT00014274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528115|NCT00014274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528116|NCT00014274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92528117|NCT00014274|Tubulin Modulators|tubulin modulators|mesh-ancestor
92528118|NCT00014274|Antimitotic Agents|antimitotic agents|mesh-ancestor
92528119|NCT00014274|Mitosis Modulators|mitosis modulators|mesh-ancestor
92528120|NCT00035035|Gemcitabine|gemcitabine|mesh-list
92528121|NCT00035035|Pemetrexed|pemetrexed|mesh-list
92326654|NCT00002305|Amebicides|amebicides|mesh-ancestor
92528122|NCT00035035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528123|NCT00035035|Antimetabolites|antimetabolites|mesh-ancestor
92326725|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
92326873|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
92528124|NCT00035035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327027|NCT00002407|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528125|NCT00035035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327116|NCT00002101|Ethambutol|ethambutol|mesh-list
92528126|NCT00035035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528127|NCT00035035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528128|NCT00035035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327402|NCT05752435|Bleomycin|bleomycin|mesh-list
92528131|NCT00000719|Antimetabolites|antimetabolites|mesh-ancestor
92327470|NCT00002185|Nelfinavir|nelfinavir|mesh-list
92528132|NCT00000719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327619|NCT00003092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92327771|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327841|NCT00383474|Bortezomib|bortezomib|mesh-list
92327916|NCT00002798|Daunorubicin|daunorubicin|mesh-list
92327991|NCT00002804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92528133|NCT00000719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92328149|NCT00002816|Antiviral Agents|antiviral agents|mesh-ancestor
92528134|NCT00000719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328221|NCT00002822|Cyclophosphamide|cyclophosphamide|mesh-list
92328301|NCT00002557|Leucovorin|leucovorin|mesh-list
92528135|NCT00000719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528136|NCT00000719|Antiviral Agents|antiviral agents|mesh-ancestor
92528137|NCT00000719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528138|NCT00000719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328543|NCT00002587|Paclitaxel|paclitaxel|mesh-list
92328588|NCT00003194|Etoposide|etoposide|mesh-list
92528139|NCT00000719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528140|NCT00014313|Etoposide|etoposide|mesh-list
92528141|NCT00014313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528142|NCT00014313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92528143|NCT00014313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528144|NCT00014313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528145|NCT00014313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528146|NCT00014313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528147|NCT00035074|Methotrexate|methotrexate|mesh-list
92528148|NCT00035074|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92528149|NCT00035074|Abortifacient Agents|abortifacient agents|mesh-ancestor
92528150|NCT00035074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92528151|NCT00035074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528152|NCT00035074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528153|NCT00035074|Antimetabolites|antimetabolites|mesh-ancestor
92528154|NCT00035074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528155|NCT00035074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528156|NCT00035074|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528157|NCT00035074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528158|NCT00035074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528159|NCT00035074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329641|NCT00003350|Paclitaxel|paclitaxel|mesh-list
92329719|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
92528160|NCT00035074|Immunologic Factors|immunologic factors|mesh-ancestor
92528161|NCT00035074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528162|NCT00035074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528166|NCT00035113|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330263|NCT00003728|Leucovorin|leucovorin|mesh-list
92528167|NCT00035113|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330404|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
92330477|NCT00004922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330553|NCT00003776|Antifungal Agents|antifungal agents|mesh-ancestor
92528168|NCT00035113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528169|NCT00035113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528170|NCT00000722|Pentamidine|pentamidine|mesh-list
92528171|NCT00000722|Antifungal Agents|antifungal agents|mesh-ancestor
92528172|NCT00000722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528173|NCT00000722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92528174|NCT00000722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92528175|NCT00000722|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92528176|NCT00035152|Paclitaxel|paclitaxel|mesh-list
92528177|NCT00035152|Carboplatin|carboplatin|mesh-list
92331087|NCT00004580|Ritonavir|ritonavir|mesh-list
92528178|NCT00035152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92528179|NCT00035152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528180|NCT00035152|Tubulin Modulators|tubulin modulators|mesh-ancestor
92528181|NCT00035152|Antimitotic Agents|antimitotic agents|mesh-ancestor
92528182|NCT00035152|Mitosis Modulators|mitosis modulators|mesh-ancestor
92528183|NCT00035152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528184|NCT00014352|Ketoconazole|ketoconazole|mesh-list
92528185|NCT00014352|Docetaxel|docetaxel|mesh-list
92528186|NCT00014352|Doxorubicin|doxorubicin|mesh-list
92528187|NCT00014352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92528188|NCT00014352|Estramustine|estramustine|mesh-list
92528189|NCT00014352|Warfarin|warfarin|mesh-list
92331677|NCT04569890|Prednisone|prednisone|mesh-list
92528190|NCT00014352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528191|NCT00014352|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331831|NCT02211482|Lamivudine|lamivudine|mesh-list
92331897|NCT04173403|Ezetimibe|ezetimibe|mesh-list
92528193|NCT00014352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331966|NCT04330027|Mitogens|mitogens|mesh-list
92528194|NCT00014352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332044|NCT00383695|Capecitabine|capecitabine|mesh-list
92528195|NCT00014352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92528196|NCT00014352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528197|NCT00014352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528198|NCT00014352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528199|NCT00014352|Anticoagulants|anticoagulants|mesh-ancestor
92528200|NCT00014352|Antifungal Agents|antifungal agents|mesh-ancestor
92528201|NCT00014352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528202|NCT00014352|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92528203|NCT00014352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528204|NCT00014352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92528205|NCT00014352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92332943|NCT00002881|Goserelin|goserelin|mesh-list
92537634|NCT00141583|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92333101|NCT00003955|Irinotecan|irinotecan|mesh-list
92333175|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
92333249|NCT00003679|Alkylating Agents|alkylating agents|mesh-ancestor
92333322|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333399|NCT00004039|Interferon-alpha|interferon-alpha|mesh-list
92333477|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537635|NCT00141583|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92528206|NCT00014352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92528207|NCT00014352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528208|NCT00014352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92528209|NCT00014352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92528210|NCT00014352|Alkylating Agents|alkylating agents|mesh-ancestor
92528211|NCT00014352|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92528213|NCT00035191|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92528214|NCT00035191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333998|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
92334070|NCT00003883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334144|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
92528215|NCT00035191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528216|NCT00035191|Cholinergic Agents|cholinergic agents|mesh-ancestor
92528217|NCT00035191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528218|NCT00035191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334376|NCT00004885|Antidotes|antidotes|mesh-ancestor
92528219|NCT00035191|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92528220|NCT00035191|Autonomic Agents|autonomic agents|mesh-ancestor
92334449|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
92334519|NCT00004999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528221|NCT00035191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528224|NCT00035230|Anticonvulsants|anticonvulsants|mesh-ancestor
92528225|NCT00035230|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92528226|NCT00035230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528227|NCT00035269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92528228|NCT00035269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528229|NCT00014391|Ribavirin|ribavirin|mesh-list
92528230|NCT00014391|Palivizumab|palivizumab|mesh-list
92528231|NCT00014391|Antimetabolites|antimetabolites|mesh-ancestor
92528232|NCT00014391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528233|NCT00014391|Antiviral Agents|antiviral agents|mesh-ancestor
92528234|NCT00014391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528235|NCT00035308|Abetimus|abetimus|mesh-list
92528236|NCT00035308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528237|NCT00035308|Immunologic Factors|immunologic factors|mesh-ancestor
92528238|NCT00035308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528239|NCT00035347|Azithromycin|azithromycin|mesh-list
92528240|NCT00035347|Levofloxacin|levofloxacin|mesh-list
92528241|NCT00035347|Ofloxacin|ofloxacin|mesh-list
92528242|NCT00035347|Ceftriaxone|ceftriaxone|mesh-list
92528243|NCT00035347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528244|NCT00035347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528245|NCT00035347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92528246|NCT00035347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334951|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
92528248|NCT00035347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528249|NCT00035347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335175|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
92528250|NCT00035347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528251|NCT00035347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92528252|NCT00035347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528254|NCT00014430|Vinorelbine|vinorelbine|mesh-list
92335344|NCT02122770|Paclitaxel|paclitaxel|mesh-list
92528255|NCT00014430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92528256|NCT00014430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335621|NCT04730856|Dalteparin|dalteparin|mesh-list
92528257|NCT00014430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92528258|NCT00014430|Tubulin Modulators|tubulin modulators|mesh-ancestor
92528259|NCT00014430|Antimitotic Agents|antimitotic agents|mesh-ancestor
92335700|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
92528260|NCT00014430|Mitosis Modulators|mitosis modulators|mesh-ancestor
92335918|NCT02062632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528261|NCT00014430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528263|NCT00035425|Linezolid|linezolid|mesh-list
92528264|NCT00035425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336285|NCT01363440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336367|NCT02029638|Glucocorticoids|glucocorticoids|mesh-ancestor
92528265|NCT00035425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336436|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528266|NCT00035425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92528267|NCT00035425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336506|NCT01998906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528268|NCT00035425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528269|NCT00000752|Cefuroxime|cefuroxime|mesh-list
92528270|NCT00000752|Cefuroxime axetil|cefuroxime axetil|mesh-list
92528271|NCT00000752|Beclomethasone|beclomethasone|mesh-list
92528272|NCT00000752|Phenylpropanolamine|phenylpropanolamine|mesh-list
92528273|NCT00000752|Pseudoephedrine|pseudoephedrine|mesh-list
92528274|NCT00000752|Ephedrine|ephedrine|mesh-list
92528276|NCT00000752|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92528277|NCT00000752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528278|NCT00000752|Glucocorticoids|glucocorticoids|mesh-ancestor
92337167|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528280|NCT00000752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337243|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528282|NCT00000752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92337384|NCT02634827|Staurosporine|staurosporine|mesh-list
92528283|NCT00000752|Respiratory System Agents|respiratory system agents|mesh-ancestor
92528284|NCT00000752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92528285|NCT00000752|Autonomic Agents|autonomic agents|mesh-ancestor
92337458|NCT02499887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92337529|NCT02351063|Angiotensin II|angiotensin ii|mesh-list
92528286|NCT00000752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528287|NCT00000752|Nasal Decongestants|nasal decongestants|mesh-ancestor
92528288|NCT00000752|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92528289|NCT00000752|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92528291|NCT00000752|Adrenergic Agents|adrenergic agents|mesh-ancestor
92528292|NCT00000752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528293|NCT00000752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528294|NCT00000752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528295|NCT00000752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528296|NCT00000752|Expectorants|expectorants|mesh-ancestor
92528297|NCT00000752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92528298|NCT00000752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92528299|NCT00000752|Appetite Depressants|appetite depressants|mesh-ancestor
92528300|NCT00000752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92528302|NCT00035464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92528303|NCT00035464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92528304|NCT00035464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92338420|NCT00521885|Enoxaparin|enoxaparin|mesh-list
92528305|NCT00035464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528306|NCT00035464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92528307|NCT00035464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528308|NCT00014469|Methotrexate|methotrexate|mesh-list
92528310|NCT00014469|Busulfan|busulfan|mesh-list
92528311|NCT00014469|Tacrolimus|tacrolimus|mesh-list
92338724|NCT00001049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338809|NCT00000293|Nefazodone|nefazodone|mesh-list
92528312|NCT00014469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92528313|NCT00014469|Abortifacient Agents|abortifacient agents|mesh-ancestor
92338873|NCT00000317|Risperidone|risperidone|mesh-list
92528314|NCT00014469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338943|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92528315|NCT00014469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528316|NCT00014469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528317|NCT00014469|Antimetabolites|antimetabolites|mesh-ancestor
92528318|NCT00014469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339161|NCT00000617|Azithromycin|azithromycin|mesh-list
92339233|NCT00000629|GABA Agents|gaba agents|mesh-ancestor
92528319|NCT00014469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528320|NCT00014469|Dermatologic Agents|dermatologic agents|mesh-ancestor
92339393|NCT00002045|Zidovudine|zidovudine|mesh-list
92528321|NCT00014469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528322|NCT00014469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528323|NCT00014469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528324|NCT00014469|Immunologic Factors|immunologic factors|mesh-ancestor
92528325|NCT00014469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528326|NCT00014469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528327|NCT00014469|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92339754|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92339826|NCT00002405|Antiviral Agents|antiviral agents|mesh-ancestor
92528328|NCT00014469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92528329|NCT00014469|Alkylating Agents|alkylating agents|mesh-ancestor
92528330|NCT00014469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92528331|NCT00000755|Zidovudine|zidovudine|mesh-list
92340055|NCT00002495|Vinblastine|vinblastine|mesh-list
92528332|NCT00000755|Antimetabolites|antimetabolites|mesh-ancestor
92528333|NCT00000755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528334|NCT00000755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528335|NCT00000755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528336|NCT00000755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528337|NCT00000755|Antiviral Agents|antiviral agents|mesh-ancestor
92528338|NCT00000755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528339|NCT00000755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528340|NCT00000755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528341|NCT00035581|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92528342|NCT00035581|Poly I-C|poly i-c|mesh-list
92528343|NCT00035581|Antiviral Agents|antiviral agents|mesh-ancestor
92528344|NCT00035581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528345|NCT00035581|Interferon Inducers|interferon inducers|mesh-ancestor
92340342|NCT00002531|Doxorubicin|doxorubicin|mesh-list
92528346|NCT00035581|Immunologic Factors|immunologic factors|mesh-ancestor
92340421|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528347|NCT00035581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528348|NCT00000758|Fluorouracil|fluorouracil|mesh-list
92528349|NCT00000758|Antimetabolites|antimetabolites|mesh-ancestor
92340743|NCT00002735|Cobalt|cobalt|mesh-list
92528350|NCT00000758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340814|NCT00002771|Cytarabine|cytarabine|mesh-list
92340874|NCT00002789|Cyclosporins|cyclosporins|mesh-list
92528351|NCT00000758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528352|NCT00000758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341096|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
92341181|NCT00382889|Hormones|hormones|mesh-ancestor
92528353|NCT00000758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341469|NCT00002993|Doxorubicin|doxorubicin|mesh-list
92528355|NCT00000758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528356|NCT00035620|Lenograstim|lenograstim|mesh-list
92528357|NCT00035620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92528358|NCT00035620|Immunologic Factors|immunologic factors|mesh-ancestor
92528359|NCT00035620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528360|NCT00014547|BBR 3464|bbr 3464|mesh-list
92341612|NCT00003089|Paclitaxel|paclitaxel|mesh-list
92528361|NCT00014547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528362|NCT02971306|Acetylcysteine|acetylcysteine|mesh-list
92528363|NCT02971306|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92528364|NCT02971306|Antiviral Agents|antiviral agents|mesh-ancestor
92528365|NCT02971306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528366|NCT02971306|Expectorants|expectorants|mesh-ancestor
92528367|NCT02971306|Respiratory System Agents|respiratory system agents|mesh-ancestor
92341925|NCT00003449|Hormones|hormones|mesh-ancestor
92341991|NCT00002831|Tacrolimus|tacrolimus|mesh-list
92528368|NCT02971306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92528369|NCT02971306|Antioxidants|antioxidants|mesh-ancestor
92342370|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
92528370|NCT02971306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342678|NCT00004139|Docetaxel|docetaxel|mesh-list
92528372|NCT02971306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528373|NCT02971306|Antidotes|antidotes|mesh-ancestor
92528374|NCT00000761|Interferons|interferons|mesh-list
92528375|NCT00000761|Interferon-gamma|interferon-gamma|mesh-list
92528376|NCT00000761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528377|NCT00000761|Antiviral Agents|antiviral agents|mesh-ancestor
92528378|NCT00000761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528379|NCT00014586|Goserelin|goserelin|mesh-list
92528380|NCT00014586|Bicalutamide|bicalutamide|mesh-list
92528381|NCT00014586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92528382|NCT00014586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528383|NCT00014586|Androgen Antagonists|androgen antagonists|mesh-ancestor
92528384|NCT00014586|Hormone Antagonists|hormone antagonists|mesh-ancestor
92342963|NCT00003335|Alkylating Agents|alkylating agents|mesh-ancestor
92528385|NCT00014586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343193|NCT00004985|Nelfinavir|nelfinavir|mesh-list
92343267|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528386|NCT00014586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528387|NCT04732390|Magnesium Sulfate|magnesium sulfate|mesh-list
92528388|NCT04732390|Bupivacaine|bupivacaine|mesh-list
92528390|NCT04732390|Anesthetics|anesthetics|mesh-ancestor
92528391|NCT04732390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343714|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92528392|NCT04732390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528393|NCT04732390|Sensory System Agents|sensory system agents|mesh-ancestor
92528394|NCT04732390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528395|NCT04732390|Analgesics|analgesics|mesh-ancestor
92344080|NCT05565560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92528396|NCT04732390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92528397|NCT04732390|Anticonvulsants|anticonvulsants|mesh-ancestor
92528398|NCT04732390|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92528399|NCT04732390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92344379|NCT04988035|Remdesivir|remdesivir|mesh-list
92528400|NCT04732390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528401|NCT04732390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92528402|NCT04732390|Tocolytic Agents|tocolytic agents|mesh-ancestor
92528403|NCT04732390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92528405|NCT00035854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528406|NCT00035854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528407|NCT00035854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92528408|NCT00035854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528409|NCT00035854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528410|NCT00000779|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92528411|NCT00000779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92528412|NCT00000779|Immunologic Factors|immunologic factors|mesh-ancestor
92528413|NCT00000779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528414|NCT00000779|Antacids|antacids|mesh-ancestor
92528415|NCT00000779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528416|NCT00000779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92528417|NCT00035893|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92528418|NCT00035893|Poly I-C|poly i-c|mesh-list
92344821|NCT03864042|Anesthetics|anesthetics|mesh-ancestor
92528419|NCT00035893|Antiviral Agents|antiviral agents|mesh-ancestor
92345038|NCT02971956|Pembrolizumab|pembrolizumab|mesh-list
92528421|NCT00035893|Interferon Inducers|interferon inducers|mesh-ancestor
92345334|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
92345409|NCT00003899|Melphalan|melphalan|mesh-list
92528422|NCT00035893|Immunologic Factors|immunologic factors|mesh-ancestor
92345559|NCT01948908|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92528423|NCT00035893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528424|NCT00035971|Alendronate|alendronate|mesh-list
92345707|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
92528425|NCT00035971|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92528426|NCT00035971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92528427|NCT00035971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528428|NCT00035971|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92528429|NCT00035971|Hormone Antagonists|hormone antagonists|mesh-ancestor
92345929|NCT01903434|Antimetabolites|antimetabolites|mesh-ancestor
92346001|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
92528430|NCT00035971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346088|NCT01856790|Hormones|hormones|mesh-ancestor
92528431|NCT00035971|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92528432|NCT00035971|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92528433|NCT00014625|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92528434|NCT00014625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528435|NCT00014625|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92528436|NCT00014625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528437|NCT00014625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528438|NCT02971345|Iodine|iodine|mesh-list
92528439|NCT02971345|Cadexomer iodine|cadexomer iodine|mesh-list
92528440|NCT02971345|Epirubicin|epirubicin|mesh-list
92528441|NCT02971345|Ethiodized Oil|ethiodized oil|mesh-list
92528442|NCT02971345|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92346452|NCT01844076|Quinacrine|quinacrine|mesh-list
92528443|NCT02971345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346592|NCT01794780|Glucocorticoids|glucocorticoids|mesh-ancestor
92528445|NCT02971345|Micronutrients|micronutrients|mesh-ancestor
92528446|NCT02971345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528447|NCT02971345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92528448|NCT02971345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346737|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92346807|NCT01789320|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92528449|NCT02971345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528450|NCT02971345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528451|NCT02971345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347033|NCT01809132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92347109|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
92528452|NCT02971345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347331|NCT01708902|Metformin|metformin|mesh-list
92347407|NCT01605396|Exemestane|exemestane|mesh-list
92528455|NCT00036088|Autonomic Agents|autonomic agents|mesh-ancestor
92528456|NCT00036088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528457|NCT00036088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528458|NCT00036088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92528459|NCT00036088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92528461|NCT00036088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347721|NCT01700946|Analgesics|analgesics|mesh-ancestor
92347776|NCT01746732|Moxifloxacin|moxifloxacin|mesh-list
92528462|NCT00036088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92348027|NCT01687296|Xhance|xhance|mesh-list
92348072|NCT01568112|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92528463|NCT00036088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92528464|NCT00036088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92528465|NCT00036088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348299|NCT04767828|Capecitabine|capecitabine|mesh-list
92348441|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92528466|NCT00036088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528467|NCT00036088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528468|NCT00036088|Serotonin Agents|serotonin agents|mesh-ancestor
92528469|NCT00036127|Aripiprazole|aripiprazole|mesh-list
92528470|NCT00036127|Antidepressive Agents|antidepressive agents|mesh-ancestor
92528471|NCT00036127|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92528472|NCT00036127|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92528473|NCT00036127|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92528474|NCT00036127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348955|NCT01518972|Prazosin|prazosin|mesh-list
92349033|NCT01462344|Hormones|hormones|mesh-ancestor
92349099|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
92353877|NCT04451772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528475|NCT00036127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528476|NCT00036127|Dopamine Agonists|dopamine agonists|mesh-ancestor
92528478|NCT00036127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528479|NCT00036127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528480|NCT00036127|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92528481|NCT00036127|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92528482|NCT00036127|Serotonin Agents|serotonin agents|mesh-ancestor
92349467|NCT01449630|Hormone Antagonists|hormone antagonists|mesh-ancestor
92528483|NCT00036127|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92528484|NCT00036127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92528485|NCT00036127|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92528486|NCT00036127|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92528488|NCT00000788|Methadone|methadone|mesh-list
92528489|NCT00000788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92528491|NCT00000788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92528492|NCT00000788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528493|NCT00000788|Analgesics|analgesics|mesh-ancestor
92528494|NCT00000788|Sensory System Agents|sensory system agents|mesh-ancestor
92528495|NCT00000788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528496|NCT00000788|Antitussive Agents|antitussive agents|mesh-ancestor
92528497|NCT00000788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92528499|NCT00000788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528500|NCT00000788|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92350353|NCT05365074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528501|NCT00000788|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528502|NCT00000788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528503|NCT00000788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528504|NCT00000788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92528505|NCT00000788|Hormone Antagonists|hormone antagonists|mesh-ancestor
92537636|NCT00141583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351023|NCT04194294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92528506|NCT00000788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351097|NCT04027530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92528507|NCT00000788|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92528508|NCT00000788|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92528509|NCT00036166|Micafungin|micafungin|mesh-list
92528510|NCT00036166|Antifungal Agents|antifungal agents|mesh-ancestor
92351325|NCT04020588|Celecoxib|celecoxib|mesh-list
92528511|NCT00036166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528512|NCT00000794|Leucovorin|leucovorin|mesh-list
92528513|NCT00000794|Clarithromycin|clarithromycin|mesh-list
92351471|NCT04143282|Metformin|metformin|mesh-list
92528514|NCT00000794|Sulfadiazine|sulfadiazine|mesh-list
92528515|NCT00000794|Pyrimethamine|pyrimethamine|mesh-list
92528516|NCT00000794|Atovaquone|atovaquone|mesh-list
92528518|NCT00000794|Levoleucovorin|levoleucovorin|mesh-list
92351688|NCT03587220|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92351762|NCT03583164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351838|NCT03159702|Fludarabine|fludarabine|mesh-list
92528519|NCT00000794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92528520|NCT00000794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253293|NCT05945745|Immunologic Factors|immunologic factors|mesh-ancestor
92528521|NCT00000794|Antidotes|antidotes|mesh-ancestor
92528522|NCT00000794|Protective Agents|protective agents|mesh-ancestor
92352139|NCT01674036|Venglustat|venglustat|mesh-list
92528525|NCT00000794|Micronutrients|micronutrients|mesh-ancestor
92352433|NCT03748134|Antimetabolites|antimetabolites|mesh-ancestor
92352508|NCT02082678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352583|NCT04763070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528526|NCT00000794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92352673|NCT03825198|Dexamethasone|dexamethasone|mesh-list
92352810|NCT01677546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92528527|NCT00000794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528528|NCT00000794|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92528529|NCT00000794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353110|NCT00085098|Lenograstim|lenograstim|mesh-list
92353182|NCT00082758|Sensory System Agents|sensory system agents|mesh-ancestor
92528530|NCT00000794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353339|NCT01679574|Fertility Agents|fertility agents|mesh-ancestor
92528531|NCT00000794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92353401|NCT03088254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92528532|NCT00000794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528533|NCT00000794|Antimalarials|antimalarials|mesh-ancestor
92528534|NCT00000794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92528536|NCT00000794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528537|NCT00000794|Coccidiostats|coccidiostats|mesh-ancestor
92528538|NCT00036244|Secretin|secretin|mesh-list
92528539|NCT00036244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92528540|NCT00036244|Hormones|hormones|mesh-ancestor
92528541|NCT00036244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92528542|NCT00036244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528543|NCT00036283|Celecoxib|celecoxib|mesh-list
92528544|NCT00036283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92528545|NCT00036283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92528546|NCT00036283|Analgesics|analgesics|mesh-ancestor
92528547|NCT00036283|Sensory System Agents|sensory system agents|mesh-ancestor
92528548|NCT00036283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528549|NCT00036283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528551|NCT00036283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528552|NCT00036283|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92528553|NCT00036283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92528554|NCT00036283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528555|NCT00036283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528556|NCT00391638|Interferons|interferons|mesh-list
92528557|NCT00391638|Tenofovir|tenofovir|mesh-list
92528558|NCT00391638|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92528559|NCT00391638|Emtricitabine|emtricitabine|mesh-list
92528560|NCT00391638|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92528561|NCT00391638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528562|NCT00391638|Antiviral Agents|antiviral agents|mesh-ancestor
92528563|NCT00391638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528564|NCT00391638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528565|NCT00391638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528566|NCT00391638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528567|NCT00391638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528568|NCT00391638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528569|NCT00391638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528570|NCT00036361|Aripiprazole|aripiprazole|mesh-list
92528571|NCT00036361|Antidepressive Agents|antidepressive agents|mesh-ancestor
92353912|NCT02084706|Hormones|hormones|mesh-ancestor
92528572|NCT00036361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92528573|NCT00036361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92528574|NCT00036361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92528575|NCT00036361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92528576|NCT00036361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528577|NCT00036361|Dopamine Agonists|dopamine agonists|mesh-ancestor
92528578|NCT00036361|Dopamine Agents|dopamine agents|mesh-ancestor
92528579|NCT00036361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528580|NCT00036361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528581|NCT00036361|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92528582|NCT00036361|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92528583|NCT00036361|Serotonin Agents|serotonin agents|mesh-ancestor
92528584|NCT00036361|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92528585|NCT00036361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92528586|NCT00036361|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92528587|NCT00036361|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92528588|NCT00036400|Epoetin Alfa|epoetin alfa|mesh-list
92528589|NCT00036400|Hematinics|hematinics|mesh-ancestor
92528590|NCT00036439|Infliximab|infliximab|mesh-list
92354032|NCT01812252|Decitabine|decitabine|mesh-list
92354090|NCT05158062|Growth Inhibitors|growth inhibitors|mesh-ancestor
92354246|NCT02984514|Deoxyglucose|deoxyglucose|mesh-list
92528591|NCT00036439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92528592|NCT00036439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528593|NCT00036439|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528594|NCT00036439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92528595|NCT00036439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528596|NCT00000821|Aldesleukin|aldesleukin|mesh-list
92528597|NCT00000821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528598|NCT00000821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528599|NCT00000821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528600|NCT00000821|Antiviral Agents|antiviral agents|mesh-ancestor
92528601|NCT00000821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528603|NCT00036556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528604|NCT00036556|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92528605|NCT00036556|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92528606|NCT00036556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354773|NCT00987402|Ethanol|ethanol|mesh-list
92528607|NCT00000827|Immune Sera|immune sera|mesh-list
92354835|NCT01925898|Ketamine|ketamine|mesh-list
92528609|NCT00000827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528610|NCT00036634|Tenofovir|tenofovir|mesh-list
92528611|NCT00036634|Antiviral Agents|antiviral agents|mesh-ancestor
92528612|NCT00036634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528613|NCT00036634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528614|NCT00036634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528615|NCT00036634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355204|NCT04760262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92528616|NCT00036634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528618|NCT00036634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528620|NCT00000851|Stavudine|stavudine|mesh-list
92528621|NCT00000851|Antimetabolites|antimetabolites|mesh-ancestor
92355495|NCT04394442|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92528622|NCT00000851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528623|NCT00000851|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528624|NCT00000851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528625|NCT00000851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528626|NCT00000851|Antiviral Agents|antiviral agents|mesh-ancestor
92528627|NCT00000851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528628|NCT00000851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528629|NCT00000851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528630|NCT00036751|Imatinib Mesylate|imatinib mesylate|mesh-list
92528632|NCT00036751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92528633|NCT00036751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528634|NCT00036751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528635|NCT00036790|Doxorubicin|doxorubicin|mesh-list
92528636|NCT00036790|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92356083|NCT01893060|Chlorhexidine|chlorhexidine|mesh-list
92356158|NCT01893450|Antioxidants|antioxidants|mesh-ancestor
92528637|NCT00036790|Motexafin gadolinium|motexafin gadolinium|mesh-list
92528639|NCT00036790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528640|NCT00036790|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528641|NCT00036790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528642|NCT00036790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356598|NCT01989780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92528643|NCT00036790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356824|NCT02442180|Hormones|hormones|mesh-ancestor
92528645|NCT00036790|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528646|NCT00000857|Interleukin-12|interleukin-12|mesh-list
92528647|NCT00000857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92528648|NCT00000857|Immunologic Factors|immunologic factors|mesh-ancestor
92528649|NCT00000857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357126|NCT01851642|Albuterol|albuterol|mesh-list
92528650|NCT00000857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92528651|NCT00000857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92528652|NCT00000857|Growth Substances|growth substances|mesh-ancestor
92528653|NCT00000857|Growth Inhibitors|growth inhibitors|mesh-ancestor
92528654|NCT00000857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528655|NCT00036868|Cyclophosphamide|cyclophosphamide|mesh-list
92528656|NCT00036868|Fluorouracil|fluorouracil|mesh-list
92528657|NCT00036868|Methotrexate|methotrexate|mesh-list
92528659|NCT00036868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528660|NCT00036868|Immunologic Factors|immunologic factors|mesh-ancestor
92528661|NCT00036868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528662|NCT00036868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528663|NCT00036868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92528664|NCT00036868|Alkylating Agents|alkylating agents|mesh-ancestor
92528665|NCT00036868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528666|NCT00036868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528667|NCT00036868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92528668|NCT00036868|Antimetabolites|antimetabolites|mesh-ancestor
92528669|NCT00036868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528670|NCT00036868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92528671|NCT00036868|Abortifacient Agents|abortifacient agents|mesh-ancestor
92528672|NCT00036868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92528673|NCT00036868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528674|NCT00036868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528675|NCT00036868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528676|NCT00036868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528677|NCT00036868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92528679|NCT00036946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358153|NCT00193596|Paclitaxel|paclitaxel|mesh-list
92528680|NCT00036946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92528681|NCT00036946|Growth Substances|growth substances|mesh-ancestor
92152634|NCT03400683|Misoprostol|misoprostol|mesh-list
92528682|NCT00036946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528683|NCT00036946|Growth Inhibitors|growth inhibitors|mesh-ancestor
92528684|NCT00036946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528685|NCT00036985|Cyclophosphamide|cyclophosphamide|mesh-list
92528687|NCT00036985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92528688|NCT00036985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528689|NCT00036985|Immunologic Factors|immunologic factors|mesh-ancestor
92528690|NCT00036985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528691|NCT00036985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528692|NCT00036985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92528693|NCT00036985|Alkylating Agents|alkylating agents|mesh-ancestor
92528694|NCT00036985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528695|NCT00036985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528696|NCT00036985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92528697|NCT00036985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359412|NCT03984240|Midazolam|midazolam|mesh-list
92528698|NCT00036985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528699|NCT00036985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528700|NCT00036985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528701|NCT00037063|Ascorbic Acid|ascorbic acid|mesh-list
92528702|NCT00037063|Vitamin E|vitamin e|mesh-list
92528703|NCT00037063|Riboflavin|riboflavin|mesh-list
92528704|NCT00037063|Thiamine|thiamine|mesh-list
92528705|NCT00037063|Vitamins|vitamins|mesh-ancestor
92528706|NCT00037063|Micronutrients|micronutrients|mesh-ancestor
92360012|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
92528707|NCT00037063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528708|NCT00037063|Antioxidants|antioxidants|mesh-ancestor
92528709|NCT00037063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360237|NCT00413166|Idarubicin|idarubicin|mesh-list
92528710|NCT00037063|Protective Agents|protective agents|mesh-ancestor
92528711|NCT00037063|Vitamin B Complex|vitamin b complex|mesh-ancestor
92528712|NCT00037063|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92528713|NCT00037063|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528715|NCT00000869|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528716|NCT00000869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528717|NCT00000869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360605|NCT00429702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360681|NCT00535938|Botulinum Toxins|botulinum toxins|mesh-list
92528718|NCT00000869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528719|NCT00000869|Antiviral Agents|antiviral agents|mesh-ancestor
92528720|NCT00000869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360836|NCT00439374|Hormones|hormones|mesh-ancestor
92528722|NCT00000869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528723|NCT00000869|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92528724|NCT00000869|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92528725|NCT00037102|Interferons|interferons|mesh-list
92528726|NCT00037102|Interferon-beta|interferon-beta|mesh-list
92361205|NCT00525876|Rituximab|rituximab|mesh-list
92528729|NCT00037102|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92528730|NCT00037102|Abortifacient Agents|abortifacient agents|mesh-ancestor
92361352|NCT03117972|Vitamins|vitamins|mesh-ancestor
92528731|NCT00037102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92528732|NCT00037102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528733|NCT00037102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528734|NCT00037102|Antimetabolites|antimetabolites|mesh-ancestor
92528735|NCT00037102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528736|NCT00037102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528737|NCT00037102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528738|NCT00037102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528739|NCT00037102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92528740|NCT00037102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528741|NCT00037102|Immunologic Factors|immunologic factors|mesh-ancestor
92528742|NCT00037102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528743|NCT00037102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528744|NCT00037102|Antiviral Agents|antiviral agents|mesh-ancestor
92528745|NCT00037102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528746|NCT00037102|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92528747|NCT00037141|Ethanol|ethanol|mesh-list
92528748|NCT00037141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92528749|NCT00037141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361577|NCT05362188|Vitamins|vitamins|mesh-ancestor
92361636|NCT04465734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361710|NCT03548454|Desipramine|desipramine|mesh-list
92353882|NCT03831984|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92528750|NCT00037141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92528751|NCT00037141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528752|NCT00037180|Leucovorin|leucovorin|mesh-list
92528753|NCT00037180|Celecoxib|celecoxib|mesh-list
92528754|NCT00037180|Fluorouracil|fluorouracil|mesh-list
92361934|NCT04405908|Antacids|antacids|mesh-ancestor
92528755|NCT00037180|Irinotecan|irinotecan|mesh-list
92528756|NCT00037180|Antimetabolites|antimetabolites|mesh-ancestor
92528757|NCT00037180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528758|NCT00037180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92528759|NCT00037180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528760|NCT00037180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528761|NCT00037180|Immunologic Factors|immunologic factors|mesh-ancestor
92362082|NCT00574236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92528763|NCT00037180|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92528765|NCT00037180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528766|NCT00037180|Antidotes|antidotes|mesh-ancestor
92528767|NCT00037180|Protective Agents|protective agents|mesh-ancestor
92362305|NCT05765617|Vitamins|vitamins|mesh-ancestor
92528768|NCT00037180|Vitamin B Complex|vitamin b complex|mesh-ancestor
92528769|NCT00037180|Vitamins|vitamins|mesh-ancestor
92528770|NCT00037180|Micronutrients|micronutrients|mesh-ancestor
92362455|NCT05581797|Psilocybin|psilocybin|mesh-list
92528771|NCT00037180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92528772|NCT00037180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92528773|NCT00037180|Analgesics|analgesics|mesh-ancestor
92362742|NCT04893109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92362818|NCT04760691|Contraceptive Agents|contraceptive agents|mesh-ancestor
92362876|NCT04560972|LB100|lb100|mesh-list
92362893|NCT04521335|Copper|copper|mesh-list
92363046|NCT04068610|Antidotes|antidotes|mesh-ancestor
92528774|NCT00037180|Sensory System Agents|sensory system agents|mesh-ancestor
92528775|NCT00037180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363119|NCT03775460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528776|NCT00037180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528777|NCT00037180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363191|NCT03282799|Contraceptive Agents|contraceptive agents|mesh-ancestor
92528778|NCT00037180|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92528779|NCT00037180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92528780|NCT00037219|Anidulafungin|anidulafungin|mesh-list
92528781|NCT00037219|Antifungal Agents|antifungal agents|mesh-ancestor
92528782|NCT00037219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528783|NCT00000893|Efavirenz|efavirenz|mesh-list
92528784|NCT00000893|Nelfinavir|nelfinavir|mesh-list
92528785|NCT00000893|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528786|NCT00000893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528787|NCT00000893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528788|NCT00000893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528789|NCT00000893|Antiviral Agents|antiviral agents|mesh-ancestor
92528790|NCT00000893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528791|NCT00000893|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92528792|NCT00000893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528793|NCT00000893|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92528794|NCT00000893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92528795|NCT00000893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92528796|NCT00000893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92528797|NCT00000893|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92528798|NCT00000893|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92528799|NCT00000893|Protease Inhibitors|protease inhibitors|mesh-ancestor
92528800|NCT00000893|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528801|NCT00000893|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528803|NCT00396526|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92528804|NCT00396526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528805|NCT00396526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528806|NCT00396526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92528807|NCT00396526|Antimalarials|antimalarials|mesh-ancestor
92363847|NCT04361370|Bevacizumab|bevacizumab|mesh-list
92528809|NCT00396526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92528810|NCT00037531|Sirolimus|sirolimus|mesh-list
92528811|NCT00037531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528812|NCT00037531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363914|NCT04358562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528813|NCT00037531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92528814|NCT00037531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528815|NCT00037531|Antifungal Agents|antifungal agents|mesh-ancestor
92528816|NCT00037531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528817|NCT00037531|Immunologic Factors|immunologic factors|mesh-ancestor
92364287|NCT04340778|Oxytocics|oxytocics|mesh-ancestor
92364427|NCT04332978|Xhance|xhance|mesh-list
92528819|NCT00037570|Pantoprazole|pantoprazole|mesh-list
92528820|NCT00037570|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92528821|NCT00037570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92253595|NCT05687123|Sunitinib|sunitinib|mesh-list
92528822|NCT00037570|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92528823|NCT00037570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364584|NCT03035214|Dexamethasone|dexamethasone|mesh-list
92528824|NCT00037570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528826|NCT00000899|Stavudine|stavudine|mesh-list
92364785|NCT03016806|Mesna|mesna|mesh-list
92528827|NCT00000899|Nelfinavir|nelfinavir|mesh-list
92528828|NCT00000899|Cyclophosphamide|cyclophosphamide|mesh-list
92528829|NCT00000899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92364963|NCT03005496|Trace Elements|trace elements|mesh-ancestor
92528830|NCT00000899|Immunologic Factors|immunologic factors|mesh-ancestor
92365033|NCT03002844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365105|NCT02989038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528831|NCT00000899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528832|NCT00000899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365329|NCT02641782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528833|NCT00000899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92528834|NCT00000899|Alkylating Agents|alkylating agents|mesh-ancestor
92365476|NCT05313828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92365549|NCT00582660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528835|NCT00000899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528836|NCT00000899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528837|NCT00000899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92528838|NCT00000899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528839|NCT00000899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92365842|NCT00628134|Calfactant|calfactant|mesh-list
92528841|NCT00000899|Antiviral Agents|antiviral agents|mesh-ancestor
92528842|NCT00000899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528843|NCT00000899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528844|NCT00000899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528845|NCT00000899|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92528846|NCT00000899|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92528847|NCT00000899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92528848|NCT00000899|Antimetabolites|antimetabolites|mesh-ancestor
92528849|NCT00037609|Sulindac sulfone|sulindac sulfone|mesh-list
92528850|NCT00037609|Capecitabine|capecitabine|mesh-list
92366436|NCT00726414|Sensory System Agents|sensory system agents|mesh-ancestor
92528851|NCT00037609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92366515|NCT00735306|Bevacizumab|bevacizumab|mesh-list
92528852|NCT00037609|Antimetabolites|antimetabolites|mesh-ancestor
92366585|NCT00741468|Antitussive Agents|antitussive agents|mesh-ancestor
92366661|NCT00753636|Vasodilator Agents|vasodilator agents|mesh-ancestor
92366733|NCT00760578|Pioglitazone|pioglitazone|mesh-list
92528853|NCT00037609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366883|NCT00785772|Antimanic Agents|antimanic agents|mesh-ancestor
92528854|NCT00037609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528855|NCT00037609|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92528856|NCT00037609|Protective Agents|protective agents|mesh-ancestor
92528857|NCT00037609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528858|NCT00037609|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92528859|NCT00037609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528860|NCT00037609|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92528861|NCT00037609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92528862|NCT00037609|Analgesics|analgesics|mesh-ancestor
92528863|NCT00037609|Sensory System Agents|sensory system agents|mesh-ancestor
92367479|NCT00834288|Tramadol|tramadol|mesh-list
92528864|NCT00037609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528865|NCT00037609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92528866|NCT00037609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92367623|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92367695|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
92528867|NCT00037648|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92528868|NCT00037648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92528869|NCT00037804|Irinotecan|irinotecan|mesh-list
92528870|NCT00037804|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92528871|NCT00037804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92528872|NCT00037804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368067|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
92528873|NCT00037804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528874|NCT00037804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528875|NCT00037882|Interferons|interferons|mesh-list
92528876|NCT00037882|Interferon-alpha|interferon-alpha|mesh-list
92528877|NCT00037882|Interferon alpha-2|interferon alpha-2|mesh-list
92528878|NCT00037882|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92528880|NCT00037882|Antiviral Agents|antiviral agents|mesh-ancestor
92528881|NCT00037882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528882|NCT00037882|Immunologic Factors|immunologic factors|mesh-ancestor
92528883|NCT00037882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528884|NCT00037999|Testosterone|testosterone|mesh-list
92528885|NCT00037999|Androgens|androgens|mesh-ancestor
92528886|NCT00037999|Hormones|hormones|mesh-ancestor
92528887|NCT00037999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92528888|NCT00037999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528889|NCT00038077|Metoprolol|metoprolol|mesh-list
92528890|NCT00038077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92528891|NCT00038077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92528892|NCT00038077|Sympatholytics|sympatholytics|mesh-ancestor
92528893|NCT00038077|Autonomic Agents|autonomic agents|mesh-ancestor
92528894|NCT00038077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528895|NCT00038077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368504|NCT01003938|Topotecan|topotecan|mesh-list
92528896|NCT00038077|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92528897|NCT00038077|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92528898|NCT00038077|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92528899|NCT00038077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92528900|NCT00038077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92528901|NCT00038077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528902|NCT00038116|Dopamine|dopamine|mesh-list
92528903|NCT00038116|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92528904|NCT00038116|Sympathomimetics|sympathomimetics|mesh-ancestor
92528905|NCT00038116|Autonomic Agents|autonomic agents|mesh-ancestor
92528906|NCT00038116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92528907|NCT00038116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528909|NCT00038116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369157|NCT05796570|Immunologic Factors|immunologic factors|mesh-ancestor
92528910|NCT00038116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528911|NCT00038116|Protective Agents|protective agents|mesh-ancestor
92528912|NCT00038194|Docetaxel|docetaxel|mesh-list
92528913|NCT00038194|Imatinib Mesylate|imatinib mesylate|mesh-list
92369303|NCT05398484|Vasodilator Agents|vasodilator agents|mesh-ancestor
92528914|NCT00038194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528915|NCT00038194|Tubulin Modulators|tubulin modulators|mesh-ancestor
92528916|NCT00038194|Antimitotic Agents|antimitotic agents|mesh-ancestor
92528917|NCT00038194|Mitosis Modulators|mitosis modulators|mesh-ancestor
92528918|NCT00038194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528919|NCT00038194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92528920|NCT00038194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528921|NCT00038233|Thalidomide|thalidomide|mesh-list
92528922|NCT00038233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92528923|NCT00038233|Immunologic Factors|immunologic factors|mesh-ancestor
92528924|NCT00038233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528925|NCT00038233|Leprostatic Agents|leprostatic agents|mesh-ancestor
92528926|NCT00038233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92369911|NCT03636451|Lidocaine|lidocaine|mesh-list
92528927|NCT00038233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528928|NCT00038233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92528929|NCT00038233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92370041|NCT01995344|Analgesics|analgesics|mesh-ancestor
92528931|NCT00038233|Growth Inhibitors|growth inhibitors|mesh-ancestor
92528932|NCT00038233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528933|NCT00000926|Nonoxynol|nonoxynol|mesh-list
92528934|NCT00000926|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92370335|NCT01102218|Antioxidants|antioxidants|mesh-ancestor
92528935|NCT00000926|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92528936|NCT00000926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370403|NCT01112358|Cetrorelix|cetrorelix|mesh-list
92370484|NCT01120704|Nicotine|nicotine|mesh-list
92370552|NCT03697356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528937|NCT00000926|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92528938|NCT00000926|Contraceptive Agents|contraceptive agents|mesh-ancestor
92370843|NCT01134510|Complement C1s|complement c1s|mesh-list
92528940|NCT00000926|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92528941|NCT00038272|Mycophenolic Acid|mycophenolic acid|mesh-list
92528942|NCT00038272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92528943|NCT00038272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92528944|NCT00038272|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92528945|NCT00038272|Antitubercular Agents|antitubercular agents|mesh-ancestor
92371138|NCT01224678|Vitamins|vitamins|mesh-ancestor
92528946|NCT00038272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92528947|NCT00038272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371211|NCT01236378|Sirolimus|sirolimus|mesh-list
92528948|NCT00038272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528949|NCT00038272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528950|NCT00000941|Ritonavir|ritonavir|mesh-list
92528951|NCT00000941|Nelfinavir|nelfinavir|mesh-list
92528952|NCT00000941|Saquinavir|saquinavir|mesh-list
92528953|NCT00000941|Atorvastatin|atorvastatin|mesh-list
92528954|NCT00000941|Simvastatin|simvastatin|mesh-list
92528955|NCT00000941|Pravastatin|pravastatin|mesh-list
92528956|NCT00000941|Calcium|calcium|mesh-list
92528957|NCT00000941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92371584|NCT01308294|Vaccines|vaccines|mesh-list
92528958|NCT00000941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92528959|NCT00000941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92528960|NCT00000941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92371870|NCT01337700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92528962|NCT00000941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528963|NCT00000941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92372019|NCT01363128|Dermatologic Agents|dermatologic agents|mesh-ancestor
92528964|NCT00000941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92528965|NCT00000941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92528966|NCT00000941|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92528967|NCT00000941|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92528968|NCT00000941|Protease Inhibitors|protease inhibitors|mesh-ancestor
92528969|NCT00000941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92533678|NCT00398554|Etoposide|etoposide|mesh-list
92372393|NCT01462812|Sumatriptan|sumatriptan|mesh-list
92528970|NCT00000941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528971|NCT00000941|Antiviral Agents|antiviral agents|mesh-ancestor
92528972|NCT00000941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372685|NCT01529502|Gasotransmitters|gasotransmitters|mesh-ancestor
92528973|NCT00000941|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92372831|NCT01559064|Lidocaine|lidocaine|mesh-list
92528974|NCT00000941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528976|NCT00014937|Lopinavir|lopinavir|mesh-list
92528978|NCT00014937|Zidovudine|zidovudine|mesh-list
92528979|NCT00014937|Didanosine|didanosine|mesh-list
92528980|NCT00014937|Stavudine|stavudine|mesh-list
92528981|NCT00014937|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92528983|NCT00014937|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92373264|NCT01600170|Atorvastatin|atorvastatin|mesh-list
92373352|NCT01619982|Vancomycin|vancomycin|mesh-list
92373419|NCT01635504|Botulinum Toxins|botulinum toxins|mesh-list
92528984|NCT00014937|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92528986|NCT00014937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373716|NCT01706952|Sensory System Agents|sensory system agents|mesh-ancestor
92373793|NCT05463354|Immunologic Factors|immunologic factors|mesh-ancestor
92528987|NCT00014937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92528988|NCT00014937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92528989|NCT00014937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92528990|NCT00014937|Antiviral Agents|antiviral agents|mesh-ancestor
92528991|NCT00014937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92528992|NCT00014937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92528993|NCT00014937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92528994|NCT00014937|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92528995|NCT00014937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92528996|NCT00014937|Antimetabolites|antimetabolites|mesh-ancestor
92528997|NCT00014937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92528998|NCT00014937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92528999|NCT00014937|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92529000|NCT00014937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92529001|NCT00014937|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92529002|NCT00000959|Pyridoxine|pyridoxine|mesh-list
92529003|NCT00000959|Vitamin B 6|vitamin b 6|mesh-list
92529004|NCT00000959|Isoniazid|isoniazid|mesh-list
92529005|NCT00000959|Antitubercular Agents|antitubercular agents|mesh-ancestor
92529006|NCT00000959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529007|NCT00000959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529008|NCT00000959|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92529009|NCT00000959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92529010|NCT00000959|Antimetabolites|antimetabolites|mesh-ancestor
92529011|NCT00000959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529012|NCT00000959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92374304|NCT01769586|Promethazine|promethazine|mesh-list
92529013|NCT00000959|Vitamin B Complex|vitamin b complex|mesh-ancestor
92529015|NCT00000959|Micronutrients|micronutrients|mesh-ancestor
92374455|NCT01794702|Cytarabine|cytarabine|mesh-list
92529016|NCT00000959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529017|NCT00000962|Nevirapine|nevirapine|mesh-list
92529018|NCT00000962|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92374597|NCT01825122|Sympatholytics|sympatholytics|mesh-ancestor
92529019|NCT00000962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529020|NCT00000962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529021|NCT00000962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529022|NCT00000962|Antiviral Agents|antiviral agents|mesh-ancestor
92374754|NCT01846728|Estrogens|estrogens|mesh-list
92374814|NCT01858428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92529023|NCT00000962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529025|NCT00000962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92374962|NCT05714670|Curcumin|curcumin|mesh-list
92529026|NCT00000962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92529027|NCT00000962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92529028|NCT00396682|Cyclophosphamide|cyclophosphamide|mesh-list
92375182|NCT01887132|Nootropic Agents|nootropic agents|mesh-ancestor
92375254|NCT01907334|Glucocorticoids|glucocorticoids|mesh-ancestor
92529029|NCT00396682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529030|NCT00396682|Immunologic Factors|immunologic factors|mesh-ancestor
92529031|NCT00396682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529032|NCT00396682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529033|NCT00396682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529034|NCT00396682|Alkylating Agents|alkylating agents|mesh-ancestor
92529035|NCT00396682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529036|NCT00396682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529037|NCT00396682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92529039|NCT00396721|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92529040|NCT00396721|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92529041|NCT00396721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529042|NCT00396721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529043|NCT00396721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92529044|NCT00396721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529045|NCT00396721|Antifungal Agents|antifungal agents|mesh-ancestor
92529046|NCT00396721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375459|NCT01957410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92529048|NCT00396721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529049|NCT00396721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375681|NCT05242692|Antidepressive Agents|antidepressive agents|mesh-ancestor
92529050|NCT00396721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529051|NCT00396721|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92529053|NCT00396721|Antimetabolites|antimetabolites|mesh-ancestor
92529054|NCT00396721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92376199|NCT02032758|Propranolol|propranolol|mesh-list
92529055|NCT00396721|Protease Inhibitors|protease inhibitors|mesh-ancestor
92529056|NCT00000965|Zidovudine|zidovudine|mesh-list
92529057|NCT00000965|Antimetabolites|antimetabolites|mesh-ancestor
92376346|NCT02062710|Protective Agents|protective agents|mesh-ancestor
92529058|NCT00000965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529059|NCT00000965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92529060|NCT00000965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529061|NCT00000965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529062|NCT00000965|Antiviral Agents|antiviral agents|mesh-ancestor
92529063|NCT00000965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376562|NCT02195232|Antioxidants|antioxidants|mesh-ancestor
92376719|NCT02239380|GABA Modulators|gaba modulators|mesh-ancestor
92529064|NCT00000965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529065|NCT00000965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529066|NCT00015054|Methylphenidate|methylphenidate|mesh-list
92529067|NCT00015054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92529068|NCT00015054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529069|NCT00015054|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92376933|NCT02284854|Analgesics|analgesics|mesh-ancestor
92377000|NCT02289222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529070|NCT00015054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92529071|NCT00015054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92529072|NCT00015054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529073|NCT00015054|Dopamine Agents|dopamine agents|mesh-ancestor
92529074|NCT00015054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529075|NCT00015132|Sertraline|sertraline|mesh-list
92377374|NCT05718492|Vitamins|vitamins|mesh-ancestor
92529076|NCT00015132|Antidepressive Agents|antidepressive agents|mesh-ancestor
92529077|NCT00015132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377516|NCT04481412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92529078|NCT00015132|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92529079|NCT00015132|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92377666|NCT05719506|Analgesics|analgesics|mesh-ancestor
92529080|NCT00015132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92529081|NCT00015132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529082|NCT00015132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529083|NCT00015132|Serotonin Agents|serotonin agents|mesh-ancestor
92377960|NCT04534218|Antipyretics|antipyretics|mesh-ancestor
92529084|NCT00015132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529085|NCT00000971|Zidovudine|zidovudine|mesh-list
92529086|NCT00000971|Didanosine|didanosine|mesh-list
92529087|NCT00000971|Clarithromycin|clarithromycin|mesh-list
92529088|NCT00000971|Antimetabolites|antimetabolites|mesh-ancestor
92378106|NCT03640728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529089|NCT00000971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529090|NCT00000971|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92529091|NCT00000971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529092|NCT00000971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529093|NCT00000971|Antiviral Agents|antiviral agents|mesh-ancestor
92529094|NCT00000971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529095|NCT00000971|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529096|NCT00000971|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529097|NCT00000971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529098|NCT00000971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92378769|NCT02525718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529099|NCT00000971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92529100|NCT00000971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92529101|NCT00015171|Buprenorphine|buprenorphine|mesh-list
92529102|NCT00015171|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92529103|NCT00015171|Naloxone|naloxone|mesh-list
92529104|NCT00015171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92529105|NCT00015171|Narcotics|narcotics|mesh-ancestor
92529106|NCT00015171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92529107|NCT00015171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529108|NCT00015171|Analgesics|analgesics|mesh-ancestor
92378992|NCT02577042|Raltegravir Potassium|raltegravir potassium|mesh-list
92529109|NCT00015171|Sensory System Agents|sensory system agents|mesh-ancestor
92529110|NCT00015171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529111|NCT00015171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92529112|NCT00015210|Nefazodone|nefazodone|mesh-list
92529113|NCT00015210|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92529115|NCT00015210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379732|NCT02655354|Fluoxetine|fluoxetine|mesh-list
92529116|NCT00015210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379806|NCT02658240|Autonomic Agents|autonomic agents|mesh-ancestor
92529117|NCT00015210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253900|NCT05111626|Nivolumab|nivolumab|mesh-list
92379878|NCT02701062|Warfarin|warfarin|mesh-list
92529118|NCT00015210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529119|NCT00015210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92529120|NCT00015210|Antidepressive Agents|antidepressive agents|mesh-ancestor
92380022|NCT05441046|Tislelizumab|tislelizumab|mesh-list
92529121|NCT00015210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92529122|NCT00015210|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92529123|NCT00015210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92380463|NCT02714634|Analgesics|analgesics|mesh-ancestor
92529126|NCT00000986|Aldesleukin|aldesleukin|mesh-list
92529127|NCT00000986|Antimetabolites|antimetabolites|mesh-ancestor
92380609|NCT02775240|Protective Agents|protective agents|mesh-ancestor
92529128|NCT00000986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529129|NCT00000986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92529130|NCT00000986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529132|NCT00000986|Antiviral Agents|antiviral agents|mesh-ancestor
92529133|NCT00000986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529134|NCT00000986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529135|NCT00000986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529136|NCT00000986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529137|NCT00015249|Amantadine|amantadine|mesh-list
92529138|NCT00015249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92529139|NCT00015249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92529141|NCT00015249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529142|NCT00015249|Dopamine Agents|dopamine agents|mesh-ancestor
92381496|NCT03107754|Lidocaine|lidocaine|mesh-list
92529143|NCT00015249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529144|NCT00015249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381644|NCT03883074|Immunologic Factors|immunologic factors|mesh-ancestor
92529145|NCT00015249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529146|NCT00015249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92529147|NCT00015249|Analgesics|analgesics|mesh-ancestor
92529148|NCT00015249|Sensory System Agents|sensory system agents|mesh-ancestor
92381789|NCT03257202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381862|NCT03336450|GABA Agents|gaba agents|mesh-ancestor
92529149|NCT00015249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529150|NCT05195242|Dexamethasone|dexamethasone|mesh-list
92382014|NCT03506724|Labetalol|labetalol|mesh-list
92529151|NCT05195242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529152|NCT05195242|Antiemetics|antiemetics|mesh-ancestor
92529153|NCT05195242|Autonomic Agents|autonomic agents|mesh-ancestor
92529154|NCT05195242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382311|NCT03933774|Tretinoin|tretinoin|mesh-list
92382383|NCT03796260|Entrectinib|entrectinib|mesh-list
92529155|NCT05195242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382460|NCT02974686|Everolimus|everolimus|mesh-list
92529156|NCT05195242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92529157|NCT05195242|Glucocorticoids|glucocorticoids|mesh-ancestor
92529158|NCT05195242|Hormones|hormones|mesh-ancestor
92529159|NCT05195242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529160|NCT05195242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92382897|NCT00907218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92529161|NCT05195242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529162|NCT00015288|Buprenorphine|buprenorphine|mesh-list
92529163|NCT00015288|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92529164|NCT00015288|Naloxone|naloxone|mesh-list
92529165|NCT00015288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92529166|NCT00015288|Narcotics|narcotics|mesh-ancestor
92529167|NCT00015288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92529169|NCT00015288|Analgesics|analgesics|mesh-ancestor
92529170|NCT00015288|Sensory System Agents|sensory system agents|mesh-ancestor
92529171|NCT00015288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529172|NCT00015288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92529173|NCT05083975|Anesthetics|anesthetics|mesh-list
92529174|NCT05083975|Anesthetics, Local|anesthetics, local|mesh-list
92383941|NCT00000918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92529175|NCT05083975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92529176|NCT05083975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529177|NCT05083975|Sensory System Agents|sensory system agents|mesh-ancestor
92529178|NCT05083975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529179|NCT00000998|Leucovorin|leucovorin|mesh-list
92529180|NCT00000998|Trimetrexate|trimetrexate|mesh-list
92529181|NCT00000998|Calcium|calcium|mesh-list
92529182|NCT00000998|Levoleucovorin|levoleucovorin|mesh-list
92384305|NCT00001968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384377|NCT00002052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529183|NCT00000998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92529184|NCT00000998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529185|NCT00000998|Antidotes|antidotes|mesh-ancestor
92529186|NCT00000998|Protective Agents|protective agents|mesh-ancestor
92529187|NCT00000998|Vitamin B Complex|vitamin b complex|mesh-ancestor
92529188|NCT00000998|Vitamins|vitamins|mesh-ancestor
92529189|NCT00000998|Micronutrients|micronutrients|mesh-ancestor
92529190|NCT00000998|Antifungal Agents|antifungal agents|mesh-ancestor
92529191|NCT00000998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529192|NCT00000998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92529193|NCT00000998|Antimetabolites|antimetabolites|mesh-ancestor
92529194|NCT00000998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529195|NCT00000998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529196|NCT00000998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92529197|NCT00000998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529198|NCT00001001|Zidovudine|zidovudine|mesh-list
92529199|NCT00001001|Antimetabolites|antimetabolites|mesh-ancestor
92385272|NCT00002580|Leuprolide|leuprolide|mesh-list
92385348|NCT00002598|Antimetabolites|antimetabolites|mesh-ancestor
92385415|NCT00002634|Cobalt|cobalt|mesh-list
92385424|NCT00002634|Immunologic Factors|immunologic factors|mesh-ancestor
92385593|NCT00002700|Leucovorin|leucovorin|mesh-list
92385659|NCT00002718|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92529200|NCT00001001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529201|NCT00001001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92529202|NCT00001001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529203|NCT00001001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529204|NCT00001001|Antiviral Agents|antiviral agents|mesh-ancestor
92529205|NCT00001001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529206|NCT00001001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529207|NCT00001001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529209|NCT05076877|Midazolam|midazolam|mesh-list
92529210|NCT05076877|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92386096|NCT03915366|Valganciclovir|valganciclovir|mesh-list
92529212|NCT05076877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92386166|NCT03652428|Paclitaxel|paclitaxel|mesh-list
92529213|NCT05076877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529214|NCT05076877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92529215|NCT05076877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92529216|NCT05076877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92529217|NCT05076877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92529218|NCT05076877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92529219|NCT05076877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92529220|NCT05076877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92529222|NCT05076877|Anesthetics|anesthetics|mesh-ancestor
92529223|NCT05076877|GABA Modulators|gaba modulators|mesh-ancestor
92386689|NCT00003090|Aldesleukin|aldesleukin|mesh-list
92529224|NCT05076877|GABA Agents|gaba agents|mesh-ancestor
92529225|NCT05076877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529226|NCT05076877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529227|NCT05076877|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92529228|NCT05076877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92529229|NCT05076877|Antimetabolites|antimetabolites|mesh-ancestor
92529230|NCT05076877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92387284|NCT00003678|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92529231|NCT05076877|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92529232|NCT05076877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529233|NCT05076877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92387592|NCT00003954|Melphalan|melphalan|mesh-list
92529235|NCT00001004|Interferon-gamma|interferon-gamma|mesh-list
92387674|NCT00003984|Lintuzumab|lintuzumab|mesh-list
92529236|NCT00001004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529237|NCT00001004|Antiviral Agents|antiviral agents|mesh-ancestor
92529238|NCT00001004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529239|NCT00396604|Maleic acid|maleic acid|mesh-list
92529240|NCT00396604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388110|NCT00004344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92388186|NCT00004446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92529241|NCT00396604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529242|NCT04896541|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92529243|NCT04896541|Antiviral Agents|antiviral agents|mesh-ancestor
92529244|NCT04896541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529245|NCT00396760|Tranexamic Acid|tranexamic acid|mesh-list
92529247|NCT00396760|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92529248|NCT00396760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92529249|NCT00396760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529250|NCT00396760|Hemostatics|hemostatics|mesh-ancestor
92388344|NCT00004734|Folic Acid|folic acid|mesh-list
92529251|NCT00396760|Coagulants|coagulants|mesh-ancestor
92388399|NCT00004770|Vitamins|vitamins|mesh-ancestor
92529252|NCT00396760|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92388697|NCT00005592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92529253|NCT00396760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92529257|NCT00001007|Antimetabolites|antimetabolites|mesh-ancestor
92529258|NCT00001007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529259|NCT00001007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92529260|NCT00001007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529261|NCT00001007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529262|NCT00001007|Antiviral Agents|antiviral agents|mesh-ancestor
92529263|NCT00001007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529264|NCT00001007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529265|NCT00001007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529266|NCT00396799|Bazedoxifene|bazedoxifene|mesh-list
92529267|NCT00396799|Estrogens|estrogens|mesh-list
92529268|NCT00396799|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92529269|NCT00396799|Hormones|hormones|mesh-ancestor
92529270|NCT00396799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529271|NCT00396799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529272|NCT00396799|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92529273|NCT00396799|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92529274|NCT00396799|Hormone Antagonists|hormone antagonists|mesh-ancestor
92529275|NCT00396799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92529276|NCT01786434|Fentanyl|fentanyl|mesh-list
92529277|NCT01786434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92529278|NCT01786434|Narcotics|narcotics|mesh-ancestor
92529279|NCT01786434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92529280|NCT01786434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529281|NCT01786434|Analgesics|analgesics|mesh-ancestor
92388975|NCT00357084|Antiemetics|antiemetics|mesh-ancestor
92389046|NCT00357864|Protective Agents|protective agents|mesh-ancestor
92529282|NCT01786434|Sensory System Agents|sensory system agents|mesh-ancestor
92529283|NCT01786434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529284|NCT01786434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92529285|NCT01786434|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92529286|NCT01786434|Anesthetics, General|anesthetics, general|mesh-ancestor
92529287|NCT01786434|Anesthetics|anesthetics|mesh-ancestor
92529288|NCT00001010|Zidovudine|zidovudine|mesh-list
92529289|NCT00001010|Acyclovir|acyclovir|mesh-list
92529290|NCT00001010|Antimetabolites|antimetabolites|mesh-ancestor
92389495|NCT00369018|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92389642|NCT00372294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529291|NCT00001010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529292|NCT00001010|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92389845|NCT00378456|Zinc|zinc|mesh-list
92529293|NCT00001010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529294|NCT00001010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529295|NCT00001010|Antiviral Agents|antiviral agents|mesh-ancestor
92529296|NCT00001010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529297|NCT00001010|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529298|NCT00001010|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529299|NCT00001013|Leucovorin|leucovorin|mesh-list
92529300|NCT00001013|Trimethoprim|trimethoprim|mesh-list
92390079|NCT00384618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390155|NCT00422526|Progestins|progestins|mesh-ancestor
92390235|NCT01799460|Cyclosporine|cyclosporine|mesh-list
92390305|NCT02996214|Tubulin Modulators|tubulin modulators|mesh-ancestor
92390532|NCT01271166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529301|NCT00001013|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92529302|NCT00001013|Sulfamethoxazole|sulfamethoxazole|mesh-list
92529303|NCT00001013|Pentamidine|pentamidine|mesh-list
92529304|NCT00001013|Trimetrexate|trimetrexate|mesh-list
92529305|NCT00001013|Calcium|calcium|mesh-list
92529306|NCT00001013|Levoleucovorin|levoleucovorin|mesh-list
92390977|NCT05742750|Apatinib|apatinib|mesh-list
92529307|NCT00001013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92529308|NCT00001013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529309|NCT00001013|Antidotes|antidotes|mesh-ancestor
92529311|NCT00001013|Vitamin B Complex|vitamin b complex|mesh-ancestor
92529312|NCT00001013|Vitamins|vitamins|mesh-ancestor
92529313|NCT00001013|Micronutrients|micronutrients|mesh-ancestor
92529314|NCT00001013|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92391267|NCT03211728|Anticonvulsants|anticonvulsants|mesh-ancestor
92391334|NCT03210324|Hormone Antagonists|hormone antagonists|mesh-ancestor
92529315|NCT00001013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529316|NCT00001013|Antimalarials|antimalarials|mesh-ancestor
92529317|NCT00001013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92529318|NCT00001013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92529319|NCT00001013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92529320|NCT00001013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529321|NCT00001013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529322|NCT00001013|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92529323|NCT00001013|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92391682|NCT01724268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529324|NCT00001013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92529325|NCT00001013|Antifungal Agents|antifungal agents|mesh-ancestor
92529326|NCT00001013|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92529327|NCT00001013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529328|NCT00001013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92529329|NCT00001013|Antimetabolites|antimetabolites|mesh-ancestor
92529330|NCT00001013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529331|NCT04680442|Trastuzumab|trastuzumab|mesh-list
92529332|NCT04680442|Pertuzumab|pertuzumab|mesh-list
92529333|NCT04680442|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92529335|NCT04680442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92392306|NCT02246244|Escitalopram|escitalopram|mesh-list
92529336|NCT04680442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529337|NCT04680442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92529338|NCT04680442|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529339|NCT04680442|Antimitotic Agents|antimitotic agents|mesh-ancestor
92392525|NCT00559962|Fenofibrate|fenofibrate|mesh-list
92529340|NCT04680442|Mitosis Modulators|mitosis modulators|mesh-ancestor
92392600|NCT00555438|PENTA|penta|mesh-list
92529341|NCT04680442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529342|NCT04680442|Immunotoxins|immunotoxins|mesh-ancestor
92529343|NCT04680442|Immunoconjugates|immunoconjugates|mesh-ancestor
92529344|NCT04680442|Immunologic Factors|immunologic factors|mesh-ancestor
92254113|NCT04512365|Hormones|hormones|mesh-ancestor
92529345|NCT04680442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529346|NCT00015834|Cytarabine|cytarabine|mesh-list
92392895|NCT05768230|Simendan|simendan|mesh-list
92529347|NCT00015834|Imatinib Mesylate|imatinib mesylate|mesh-list
92393037|NCT05767255|Hormones|hormones|mesh-ancestor
92529349|NCT00015834|Antimetabolites|antimetabolites|mesh-ancestor
92529350|NCT00015834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529351|NCT00015834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529352|NCT00015834|Antiviral Agents|antiviral agents|mesh-ancestor
92529353|NCT00015834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529354|NCT00015834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529356|NCT00015834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393337|NCT05078827|Fluorouracil|fluorouracil|mesh-list
92529357|NCT00015834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92529358|NCT00015834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529359|NCT00001040|Zidovudine|zidovudine|mesh-list
92529360|NCT00001040|Zalcitabine|zalcitabine|mesh-list
92529362|NCT00001040|Antimetabolites|antimetabolites|mesh-ancestor
92393624|NCT04469959|Dopamine Agents|dopamine agents|mesh-ancestor
92529363|NCT00001040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529364|NCT00001040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92393850|NCT03785587|Anticonvulsants|anticonvulsants|mesh-ancestor
92529365|NCT00001040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529366|NCT00001040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529367|NCT00001040|Antiviral Agents|antiviral agents|mesh-ancestor
92529368|NCT00001040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529370|NCT00001040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529371|NCT00001040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92529372|NCT00001040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92529373|NCT00001040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92529374|NCT00001040|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92529375|NCT00001040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92529376|NCT00015873|Cytarabine|cytarabine|mesh-list
92529377|NCT00015873|Prednisolone|prednisolone|mesh-list
92529378|NCT00015873|Methotrexate|methotrexate|mesh-list
92529379|NCT00015873|Mercaptopurine|mercaptopurine|mesh-list
92529380|NCT00015873|Vincristine|vincristine|mesh-list
92529381|NCT00015873|Asparaginase|asparaginase|mesh-list
92529382|NCT00015873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92529383|NCT00015873|Abortifacient Agents|abortifacient agents|mesh-ancestor
92529384|NCT00015873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92529385|NCT00015873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529386|NCT00015873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394435|NCT01384812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92529388|NCT00015873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529389|NCT00015873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394591|NCT01386229|Ketamine|ketamine|mesh-list
92529390|NCT00015873|Dermatologic Agents|dermatologic agents|mesh-ancestor
92529391|NCT00015873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529392|NCT00015873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92529393|NCT00015873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529394|NCT00015873|Immunologic Factors|immunologic factors|mesh-ancestor
92529395|NCT00015873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529396|NCT00015873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92394799|NCT01387048|Adapalene|adapalene|mesh-list
92529397|NCT00015873|Antiviral Agents|antiviral agents|mesh-ancestor
92394871|NCT01387620|Immunologic Factors|immunologic factors|mesh-ancestor
92529398|NCT00015873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529399|NCT00015873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92529400|NCT00015873|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529401|NCT00015873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92529402|NCT00015873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92529403|NCT00015873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529404|NCT00015873|Glucocorticoids|glucocorticoids|mesh-ancestor
92529405|NCT00015873|Hormones|hormones|mesh-ancestor
92537637|NCT00141583|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92529406|NCT00015873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537638|NCT00141583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92529407|NCT00015873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529408|NCT00015912|Interferons|interferons|mesh-list
92529409|NCT00015912|Interferon-alpha|interferon-alpha|mesh-list
92529410|NCT00015912|Interferon alpha-2|interferon alpha-2|mesh-list
92529411|NCT00015912|Thalidomide|thalidomide|mesh-list
92529412|NCT00015912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529414|NCT00015912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529415|NCT00015912|Immunologic Factors|immunologic factors|mesh-ancestor
92537639|NCT00141583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529416|NCT00015912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529417|NCT00015912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529418|NCT00015912|Leprostatic Agents|leprostatic agents|mesh-ancestor
92529419|NCT00015912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396269|NCT01395654|Isoniazid|isoniazid|mesh-list
92529420|NCT00015912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529421|NCT00015912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92529422|NCT00015912|Growth Substances|growth substances|mesh-ancestor
92529423|NCT00015912|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529424|NCT03668431|Trametinib|trametinib|mesh-list
92529425|NCT03668431|Dabrafenib|dabrafenib|mesh-list
92529426|NCT03668431|Spartalizumab|spartalizumab|mesh-list
92529427|NCT03668431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396786|NCT02564523|Antiviral Agents|antiviral agents|mesh-ancestor
92529428|NCT03668431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92529430|NCT03668431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397079|NCT05248724|Ketorolac|ketorolac|mesh-list
92397157|NCT05155917|Insulin Glargine|insulin glargine|mesh-list
92529431|NCT03668431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92529432|NCT03668431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92529433|NCT00001073|Isotretinoin|isotretinoin|mesh-list
92529434|NCT00001073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92529435|NCT02970721|Antipsychotic Agents|antipsychotic agents|mesh-list
92397380|NCT04760912|Bromides|bromides|mesh-list
92529436|NCT02970721|Antidepressive Agents|antidepressive agents|mesh-list
92529437|NCT02970721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92529438|NCT02970721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92529439|NCT02970721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92529440|NCT02970721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529441|NCT03636958|Anticonvulsants|anticonvulsants|mesh-list
92529442|NCT00015951|Cytarabine|cytarabine|mesh-list
92529444|NCT00015951|Mitoxantrone|mitoxantrone|mesh-list
92529445|NCT00015951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92529446|NCT00015951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529447|NCT00015951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529448|NCT00015951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92398130|NCT02619552|Hormones|hormones|mesh-ancestor
92529450|NCT00015951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529451|NCT00015951|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529452|NCT00015951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92529454|NCT00015951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529455|NCT00015951|Antiviral Agents|antiviral agents|mesh-ancestor
92398426|NCT00962988|Bupropion|bupropion|mesh-list
92529456|NCT00015951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398502|NCT00430040|Carvedilol|carvedilol|mesh-list
92529457|NCT00015951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529458|NCT00015951|Immunologic Factors|immunologic factors|mesh-ancestor
92529459|NCT00015951|Analgesics|analgesics|mesh-ancestor
92398580|NCT01397994|Vitamins|vitamins|mesh-ancestor
92398643|NCT01398189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92529460|NCT00015951|Sensory System Agents|sensory system agents|mesh-ancestor
92529461|NCT00015951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398722|NCT01398592|Hormones|hormones|mesh-ancestor
92529462|NCT00015951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92529463|NCT00015951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529464|NCT00015951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398868|NCT01400100|Octreotide|octreotide|mesh-list
92529466|NCT00001076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92529467|NCT00001076|Immunologic Factors|immunologic factors|mesh-ancestor
92529468|NCT00001076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529469|NCT00001076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92529470|NCT00001076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399082|NCT01401192|Antimetabolites|antimetabolites|mesh-ancestor
92529472|NCT00001076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529473|NCT00001076|Interferon Inducers|interferon inducers|mesh-ancestor
92529474|NCT00001076|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92529475|NCT00001076|Protective Agents|protective agents|mesh-ancestor
92529476|NCT00015990|Thalidomide|thalidomide|mesh-list
92529477|NCT00015990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399225|NCT01402336|Hormones|hormones|mesh-ancestor
92529478|NCT00015990|Immunologic Factors|immunologic factors|mesh-ancestor
92529479|NCT00015990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399376|NCT01403415|Hormones|hormones|mesh-ancestor
92529480|NCT00015990|Leprostatic Agents|leprostatic agents|mesh-ancestor
92529481|NCT00015990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529482|NCT00015990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529483|NCT00015990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529484|NCT00015990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92529485|NCT00015990|Growth Substances|growth substances|mesh-ancestor
92529486|NCT00015990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529487|NCT00015990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529488|NCT00001085|Lamivudine|lamivudine|mesh-list
92529489|NCT00001085|Zidovudine|zidovudine|mesh-list
92529490|NCT00001085|Amprenavir|amprenavir|mesh-list
92529491|NCT00001085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92529492|NCT00001085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529493|NCT00001085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400114|NCT01406639|Ranibizumab|ranibizumab|mesh-list
92529494|NCT00001085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529495|NCT00001085|Antiviral Agents|antiviral agents|mesh-ancestor
92529497|NCT00001085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529498|NCT00001085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529499|NCT00001085|Antimetabolites|antimetabolites|mesh-ancestor
92529500|NCT00001085|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92400564|NCT01409616|Purinergic Agents|purinergic agents|mesh-ancestor
92400640|NCT01410214|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529501|NCT00001085|Antitubercular Agents|antitubercular agents|mesh-ancestor
92529502|NCT00001085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529503|NCT00001085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92529504|NCT00001085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92529505|NCT00001085|Protease Inhibitors|protease inhibitors|mesh-ancestor
92529506|NCT02970916|Aflibercept|aflibercept|mesh-list
92529507|NCT02970916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529508|NCT02970916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92400931|NCT01412645|Antioxidants|antioxidants|mesh-ancestor
92529510|NCT02970916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401007|NCT01413230|Vitamin D|vitamin d|mesh-list
92529511|NCT02970916|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529512|NCT02970916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529513|NCT00016068|Valganciclovir|valganciclovir|mesh-list
92529514|NCT00016068|Ganciclovir|ganciclovir|mesh-list
92529515|NCT00016068|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92401303|NCT01415765|Pevonedistat|pevonedistat|mesh-list
92401381|NCT01416116|Narcotics|narcotics|mesh-ancestor
92529516|NCT00016068|Antiviral Agents|antiviral agents|mesh-ancestor
92529517|NCT00016068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401526|NCT01417065|Antifungal Agents|antifungal agents|mesh-ancestor
92529518|NCT00016068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529519|NCT00016068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401599|NCT01417494|Antidotes|antidotes|mesh-ancestor
92529520|NCT00016068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529521|NCT00016107|Bevacizumab|bevacizumab|mesh-list
92529522|NCT00016107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92529523|NCT00016107|Docetaxel|docetaxel|mesh-list
92529524|NCT00016107|Estramustine|estramustine|mesh-list
92529525|NCT00016107|Antibodies|antibodies|mesh-list
92529526|NCT00016107|Immunoglobulins|immunoglobulins|mesh-list
92529527|NCT00016107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92401890|NCT01419340|Donepezil|donepezil|mesh-list
92529528|NCT00016107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402038|NCT01420406|Micronutrients|micronutrients|mesh-ancestor
92529529|NCT00016107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92402118|NCT01420900|Autonomic Agents|autonomic agents|mesh-ancestor
92402185|NCT01421173|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92529530|NCT00016107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92529531|NCT00016107|Growth Substances|growth substances|mesh-ancestor
92529532|NCT00016107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529533|NCT00016107|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529534|NCT00016107|Immunologic Factors|immunologic factors|mesh-ancestor
92529535|NCT00016107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92402558|NCT01423370|Tadalafil|tadalafil|mesh-list
92529536|NCT00016107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92529537|NCT00016107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92529538|NCT00016107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529539|NCT00016107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529540|NCT00016107|Alkylating Agents|alkylating agents|mesh-ancestor
92529541|NCT00016107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529542|NCT00001118|Enfuvirtide|enfuvirtide|mesh-list
92402850|NCT01424891|Simvastatin|simvastatin|mesh-list
92402919|NCT01425320|Dapsone|dapsone|mesh-list
92402995|NCT01425619|Anesthetics, Local|anesthetics, local|mesh-ancestor
92529543|NCT00001118|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92529544|NCT00001118|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92529545|NCT00001118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529546|NCT00001118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92529547|NCT00001118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529548|NCT00001118|Antiviral Agents|antiviral agents|mesh-ancestor
92529549|NCT00001118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529550|NCT00016185|Docetaxel|docetaxel|mesh-list
92529551|NCT00016185|Alvocidib|alvocidib|mesh-list
92529552|NCT00016185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529553|NCT00016185|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529554|NCT00016185|Antimitotic Agents|antimitotic agents|mesh-ancestor
92529555|NCT00016185|Mitosis Modulators|mitosis modulators|mesh-ancestor
92529556|NCT00016185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529557|NCT00016185|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529558|NCT00016185|Growth Substances|growth substances|mesh-ancestor
92403739|NCT01426906|Rifampin|rifampin|mesh-list
92529559|NCT00016185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403810|NCT01427114|Glucocorticoids|glucocorticoids|mesh-ancestor
92403875|NCT01427400|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92529560|NCT00016185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92529561|NCT00016185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529562|NCT00001151|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92529563|NCT00001151|Calcitriol|calcitriol|mesh-list
92529564|NCT00001151|Vitamins|vitamins|mesh-ancestor
92404321|NCT01430065|Tacrolimus|tacrolimus|mesh-list
92529566|NCT00001151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529567|NCT00001151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92404557|NCT01431352|Letrozole|letrozole|mesh-list
92404626|NCT01431612|Sympathomimetics|sympathomimetics|mesh-ancestor
92537641|NCT00141700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92404847|NCT01432821|Dopamine Agents|dopamine agents|mesh-ancestor
92537642|NCT00141700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529568|NCT00001151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92529569|NCT00001151|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92529570|NCT00001151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537643|NCT00141700|Immunologic Factors|immunologic factors|mesh-ancestor
92099439|NCT03432780|Docetaxel|docetaxel|mesh-list
92529571|NCT00001151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529572|NCT00001151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92529573|NCT00016224|Thalidomide|thalidomide|mesh-list
92529574|NCT00016224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529575|NCT00016224|Immunologic Factors|immunologic factors|mesh-ancestor
92529576|NCT00016224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254330|NCT03914625|Leucovorin|leucovorin|mesh-list
92529577|NCT00016224|Leprostatic Agents|leprostatic agents|mesh-ancestor
92529578|NCT00016224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92529579|NCT00016224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099812|NCT01286818|Antidotes|antidotes|mesh-ancestor
92529580|NCT00016224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92100027|NCT01927263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529581|NCT00016224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92100176|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
92529582|NCT00016224|Growth Substances|growth substances|mesh-ancestor
92529583|NCT00016224|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529584|NCT00016224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529585|NCT00016263|Dacarbazine|dacarbazine|mesh-list
92529587|NCT00016263|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529588|NCT00016263|Alkylating Agents|alkylating agents|mesh-ancestor
92100393|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92100478|NCT04396977|Histamine|histamine|mesh-list
92529589|NCT00016263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100546|NCT03422640|Analgesics|analgesics|mesh-ancestor
92529590|NCT00016263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529591|NCT00016302|Leucovorin|leucovorin|mesh-list
92529593|NCT00016302|Dexamethasone|dexamethasone|mesh-list
92529594|NCT00016302|Prednisone|prednisone|mesh-list
92529595|NCT00016302|Cyclophosphamide|cyclophosphamide|mesh-list
92100770|NCT01352182|Pioglitazone|pioglitazone|mesh-list
92529597|NCT00016302|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92529598|NCT00016302|Methotrexate|methotrexate|mesh-list
92529599|NCT00016302|Vincristine|vincristine|mesh-list
92529600|NCT00016302|Daunorubicin|daunorubicin|mesh-list
92529601|NCT00016302|Asparaginase|asparaginase|mesh-list
92529602|NCT00016302|Mercaptopurine|mercaptopurine|mesh-list
92529603|NCT00016302|Pegaspargase|pegaspargase|mesh-list
92529604|NCT00016302|Thioguanine|thioguanine|mesh-list
92529605|NCT00016302|Levoleucovorin|levoleucovorin|mesh-list
92529606|NCT00016302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529607|NCT00016302|Immunologic Factors|immunologic factors|mesh-ancestor
92529608|NCT00016302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529609|NCT00016302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101286|NCT01307956|Vitamins|vitamins|mesh-ancestor
92529610|NCT00016302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529611|NCT00016302|Alkylating Agents|alkylating agents|mesh-ancestor
92101504|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
92529612|NCT00016302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529613|NCT00016302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529614|NCT00016302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92529615|NCT00016302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529616|NCT00016302|Antiemetics|antiemetics|mesh-ancestor
92529617|NCT00016302|Autonomic Agents|autonomic agents|mesh-ancestor
92101885|NCT03414450|Dasatinib|dasatinib|mesh-list
92529618|NCT00016302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529619|NCT00016302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92529620|NCT00016302|Glucocorticoids|glucocorticoids|mesh-ancestor
92529621|NCT00016302|Hormones|hormones|mesh-ancestor
92533692|NCT00398554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529622|NCT00016302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92102364|NCT03009058|Leucovorin|leucovorin|mesh-list
92102400|NCT01611857|Leucovorin|leucovorin|mesh-list
92529623|NCT00016302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529624|NCT00016302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92529625|NCT00016302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92529626|NCT00016302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529627|NCT00016302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529628|NCT00016302|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92529629|NCT00016302|Abortifacient Agents|abortifacient agents|mesh-ancestor
92529631|NCT00016302|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92529632|NCT00016302|Antimetabolites|antimetabolites|mesh-ancestor
92529633|NCT00016302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92529634|NCT00016302|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92529635|NCT00016302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529636|NCT00016302|Antiviral Agents|antiviral agents|mesh-ancestor
92529637|NCT00016302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529638|NCT00016302|Antidotes|antidotes|mesh-ancestor
92529639|NCT00016302|Protective Agents|protective agents|mesh-ancestor
92529640|NCT00016302|Vitamin B Complex|vitamin b complex|mesh-ancestor
92529642|NCT00016302|Micronutrients|micronutrients|mesh-ancestor
92103431|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
92529643|NCT00016302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92529644|NCT00016302|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529645|NCT00016302|Antimitotic Agents|antimitotic agents|mesh-ancestor
92103651|NCT05658120|Epinephrine|epinephrine|mesh-list
92529646|NCT00016302|Mitosis Modulators|mitosis modulators|mesh-ancestor
92529647|NCT00389285|Sorafenib|sorafenib|mesh-list
92529648|NCT00389285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529649|NCT00389285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92529650|NCT00389285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529651|NCT00389285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529652|NCT00016341|Tamoxifen|tamoxifen|mesh-list
92254413|NCT03914625|Hematinics|hematinics|mesh-ancestor
92529653|NCT00016341|Paclitaxel|paclitaxel|mesh-list
92104018|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
92529654|NCT00016341|Doxorubicin|doxorubicin|mesh-list
92529655|NCT00016341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92353917|NCT04704024|Tenofovir|tenofovir|mesh-list
92529657|NCT00016341|Megestrol Acetate|megestrol acetate|mesh-list
92529658|NCT00016341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92529659|NCT00016341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529660|NCT00016341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529661|NCT00016341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92529662|NCT00016341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92104457|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92529663|NCT00016341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529664|NCT00016341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92104684|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92529665|NCT00016341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92529666|NCT00016341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529667|NCT00016341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529668|NCT00016341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529669|NCT00016341|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92529670|NCT00016341|Hormone Antagonists|hormone antagonists|mesh-ancestor
92529671|NCT00016341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529672|NCT00016341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529673|NCT00016341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92529674|NCT00016341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92529675|NCT00016341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105051|NCT03361878|Metformin|metformin|mesh-list
92529676|NCT00016341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92529677|NCT00016341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92529678|NCT00016341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92529679|NCT00016341|Contraceptive Agents|contraceptive agents|mesh-ancestor
92105268|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92529680|NCT00016341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92529681|NCT00016341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92529682|NCT00016341|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92529683|NCT00016341|Appetite Stimulants|appetite stimulants|mesh-ancestor
92105487|NCT03365466|Aspirin|aspirin|mesh-list
92105562|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529684|NCT00016341|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92529686|NCT00001181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529687|NCT00001181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529688|NCT00016380|Dexamethasone|dexamethasone|mesh-list
92529689|NCT00016380|Ondansetron|ondansetron|mesh-list
92529690|NCT00016380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529691|NCT00016380|Antiemetics|antiemetics|mesh-ancestor
92529692|NCT00016380|Autonomic Agents|autonomic agents|mesh-ancestor
92529693|NCT00016380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529694|NCT00016380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529695|NCT00016380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92529697|NCT00016380|Hormones|hormones|mesh-ancestor
92106236|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
92537644|NCT00141700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529698|NCT00016380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529699|NCT00016380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529700|NCT00016380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529701|NCT00016380|Antipruritics|antipruritics|mesh-ancestor
92529702|NCT00016380|Dermatologic Agents|dermatologic agents|mesh-ancestor
92529703|NCT00016380|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92529704|NCT00016380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92529705|NCT00016380|Serotonin Agents|serotonin agents|mesh-ancestor
92537645|NCT00141700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537646|NCT03555149|Bevacizumab|bevacizumab|mesh-list
92529706|NCT00016380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106909|NCT02505282|Vitamin K|vitamin k|mesh-list
92537647|NCT03555149|Atezolizumab|atezolizumab|mesh-list
92107054|NCT02728206|Velpatasvir|velpatasvir|mesh-list
92537648|NCT03555149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92529707|NCT00016380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529708|NCT00001190|Deslorelin|deslorelin|mesh-list
92529709|NCT00001190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529710|NCT00001190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529711|NCT00001202|Testolactone|testolactone|mesh-list
92529712|NCT00001202|Spironolactone|spironolactone|mesh-list
92529713|NCT00001202|Deslorelin|deslorelin|mesh-list
92107501|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
92529714|NCT00001202|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92529715|NCT00001202|Hormone Antagonists|hormone antagonists|mesh-ancestor
92537649|NCT03555149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529716|NCT00001202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107796|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
92529717|NCT00001202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529718|NCT00001202|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92529719|NCT00001202|Diuretics|diuretics|mesh-ancestor
92529720|NCT00001202|Natriuretic Agents|natriuretic agents|mesh-ancestor
92529721|NCT00001202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108161|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92529722|NCT00001202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108235|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92529723|NCT00001202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529724|NCT00001202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529725|NCT00016419|Cyclosporine|cyclosporine|mesh-list
92108456|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
92529726|NCT00016419|Cyclosporins|cyclosporins|mesh-list
92529727|NCT00016419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92108533|NCT03109314|Donepezil|donepezil|mesh-list
92529728|NCT00016419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537650|NCT03555149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529729|NCT00016419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108685|NCT01808339|Xhance|xhance|mesh-list
92529730|NCT00016419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529731|NCT00016419|Immunologic Factors|immunologic factors|mesh-ancestor
92108821|NCT02483598|Buspirone|buspirone|mesh-list
92529732|NCT00016419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529733|NCT00016419|Antifungal Agents|antifungal agents|mesh-ancestor
92529734|NCT00016419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529735|NCT00016419|Dermatologic Agents|dermatologic agents|mesh-ancestor
92529736|NCT00016419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529737|NCT00016419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92529738|NCT00016458|Cyclophosphamide|cyclophosphamide|mesh-list
92529739|NCT00016458|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92529740|NCT00016458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529741|NCT00016458|Immunologic Factors|immunologic factors|mesh-ancestor
92529742|NCT00016458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529743|NCT00016458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529744|NCT00016458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529745|NCT00016458|Alkylating Agents|alkylating agents|mesh-ancestor
92529746|NCT00016458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529747|NCT00016458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529748|NCT00016458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92109113|NCT01807624|Tetracaine|tetracaine|mesh-list
92529750|NCT01156545|Simvastatin|simvastatin|mesh-list
92529751|NCT01156545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92529752|NCT01156545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92529753|NCT01156545|Antimetabolites|antimetabolites|mesh-ancestor
92529754|NCT01156545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109398|NCT02485080|Simeprevir|simeprevir|mesh-list
92529756|NCT01156545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92529757|NCT01156545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529758|NCT01156545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529759|NCT01156545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92529760|NCT01140516|Trimethoprim|trimethoprim|mesh-list
92529761|NCT01140516|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92109622|NCT02472054|Cyclosporins|cyclosporins|mesh-list
92529763|NCT01140516|Antimalarials|antimalarials|mesh-ancestor
92529764|NCT01140516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92529765|NCT01140516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92529766|NCT01140516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92109760|NCT01833988|Pancrelipase|pancrelipase|mesh-list
92109838|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
92529767|NCT01140516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109906|NCT01847638|Bromfenac|bromfenac|mesh-list
92529768|NCT01140516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529769|NCT01140516|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92529770|NCT01140516|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92529771|NCT01140516|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92529773|NCT02734771|Cyclophosphamide|cyclophosphamide|mesh-list
92529775|NCT02734771|Doxorubicin|doxorubicin|mesh-list
92529776|NCT02734771|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92529777|NCT02734771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529778|NCT02734771|Immunologic Factors|immunologic factors|mesh-ancestor
92110422|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529779|NCT02734771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110496|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
92529781|NCT02734771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529782|NCT02734771|Alkylating Agents|alkylating agents|mesh-ancestor
92537651|NCT03555149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92529783|NCT02734771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110941|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529784|NCT02734771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529785|NCT02734771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92529786|NCT02734771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92529787|NCT02734771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92529788|NCT02734771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92529789|NCT02734771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529790|NCT02734771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529791|NCT02734771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529792|NCT02734771|Glucocorticoids|glucocorticoids|mesh-ancestor
92529793|NCT02734771|Hormones|hormones|mesh-ancestor
92529794|NCT02734771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529795|NCT02734771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529796|NCT02734771|Immunotoxins|immunotoxins|mesh-ancestor
92529797|NCT02734771|Immunoconjugates|immunoconjugates|mesh-ancestor
92529798|NCT02347111|Sotalol|sotalol|mesh-list
92529799|NCT02347111|Flecainide|flecainide|mesh-list
92529800|NCT02347111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92529801|NCT02347111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92254568|NCT03356483|Niacin|niacin|mesh-list
92529802|NCT02347111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92529803|NCT02347111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529804|NCT02347111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529805|NCT02347111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529806|NCT02347111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92529807|NCT02347111|Sympatholytics|sympatholytics|mesh-ancestor
92529808|NCT02347111|Autonomic Agents|autonomic agents|mesh-ancestor
92529809|NCT02347111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529810|NCT02347111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92529811|NCT02347111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92529812|NCT02347111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92529813|NCT00001262|Copper|copper|mesh-list
92529814|NCT00001262|Trace Elements|trace elements|mesh-ancestor
92529815|NCT00001262|Micronutrients|micronutrients|mesh-ancestor
92529816|NCT00001262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529817|NCT00001280|Itraconazole|itraconazole|mesh-list
92529818|NCT00001280|Antifungal Agents|antifungal agents|mesh-ancestor
92529819|NCT00001280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529820|NCT00001280|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92529821|NCT00001280|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92529822|NCT00001280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529823|NCT00001280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529824|NCT00001280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92529825|NCT00001280|Hormone Antagonists|hormone antagonists|mesh-ancestor
92529826|NCT00001280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529827|NCT00001280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529828|NCT00001280|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92529829|NCT00016887|Interferons|interferons|mesh-list
92529830|NCT00016887|Cytarabine|cytarabine|mesh-list
92529831|NCT00016887|Interferon-alpha|interferon-alpha|mesh-list
92529832|NCT00016887|Dexamethasone|dexamethasone|mesh-list
92529833|NCT00016887|Cyclophosphamide|cyclophosphamide|mesh-list
92529834|NCT00016887|Melphalan|melphalan|mesh-list
92529835|NCT00016887|Carmustine|carmustine|mesh-list
92529836|NCT00016887|Etoposide|etoposide|mesh-list
92529837|NCT00016887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92529838|NCT00016887|Immunologic Factors|immunologic factors|mesh-ancestor
92529839|NCT00016887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529840|NCT00016887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529841|NCT00016887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92529842|NCT00016887|Alkylating Agents|alkylating agents|mesh-ancestor
92529843|NCT00016887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529844|NCT00016887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529845|NCT00016887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92529846|NCT00016887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92529847|NCT00016887|Antiemetics|antiemetics|mesh-ancestor
92529848|NCT00016887|Autonomic Agents|autonomic agents|mesh-ancestor
92529849|NCT00016887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529850|NCT00016887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92529851|NCT00016887|Glucocorticoids|glucocorticoids|mesh-ancestor
92529852|NCT00016887|Hormones|hormones|mesh-ancestor
92537653|NCT03555149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529853|NCT00016887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529854|NCT00016887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92529855|NCT00016887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92529856|NCT00016887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92529857|NCT00016887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529858|NCT00016887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529859|NCT00016887|Antiviral Agents|antiviral agents|mesh-ancestor
92529860|NCT00016887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529861|NCT00016887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92529862|NCT00016887|Antimetabolites|antimetabolites|mesh-ancestor
92529863|NCT00038389|Rofecoxib|rofecoxib|mesh-list
92529864|NCT00038389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92529865|NCT00038389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92529866|NCT00038389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537654|NCT03555149|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529867|NCT00038389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529868|NCT00038389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92529869|NCT00038389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92529870|NCT00038389|Analgesics|analgesics|mesh-ancestor
92529871|NCT00038389|Sensory System Agents|sensory system agents|mesh-ancestor
92111626|NCT04120311|Hormones|hormones|mesh-ancestor
92529872|NCT00038389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92529873|NCT00038389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529874|NCT00038389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254645|NCT03128359|Mycophenolic Acid|mycophenolic acid|mesh-list
92529875|NCT00038389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529877|NCT00038506|Lamivudine|lamivudine|mesh-list
92529880|NCT00038506|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92529882|NCT00038506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112548|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92529883|NCT00038506|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92112622|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92112697|NCT01730729|Cabergoline|cabergoline|mesh-list
92529884|NCT00038506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92529885|NCT00038506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537655|NCT03555149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92529886|NCT00038506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529887|NCT00038506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92113219|NCT05331664|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92113294|NCT05080322|Autonomic Agents|autonomic agents|mesh-ancestor
92529888|NCT00038506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92529889|NCT00038506|Antimetabolites|antimetabolites|mesh-ancestor
92529890|NCT00016926|Capecitabine|capecitabine|mesh-list
92529891|NCT00016926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92529892|NCT00016926|Antimetabolites|antimetabolites|mesh-ancestor
92113441|NCT04764162|Antimetabolites|antimetabolites|mesh-ancestor
92529893|NCT00016926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529894|NCT00016926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529895|NCT00038545|Paclitaxel|paclitaxel|mesh-list
92529896|NCT00038545|Topotecan|topotecan|mesh-list
92529897|NCT00038545|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113514|NCT04650074|Lidocaine|lidocaine|mesh-list
92529898|NCT00038545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529899|NCT00038545|Tubulin Modulators|tubulin modulators|mesh-ancestor
92529900|NCT00038545|Antimitotic Agents|antimitotic agents|mesh-ancestor
92529901|NCT00038545|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113654|NCT04256941|Letrozole|letrozole|mesh-list
92529902|NCT00038545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529903|NCT00038545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92529904|NCT00038545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529905|NCT00038545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529906|NCT00038584|Lonafarnib|lonafarnib|mesh-list
92529907|NCT00038584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92529908|NCT00038584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529909|NCT00038623|Rituximab|rituximab|mesh-list
92529910|NCT00038623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92529911|NCT00038623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529912|NCT00038623|Immunologic Factors|immunologic factors|mesh-ancestor
92529913|NCT00038623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529914|NCT00038623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529915|NCT00038662|Atrasentan|atrasentan|mesh-list
92114060|NCT01458015|Oxycodone|oxycodone|mesh-list
92529916|NCT00038662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114276|NCT05734612|Colchicine|colchicine|mesh-list
92529917|NCT00038662|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92529918|NCT00038662|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92114431|NCT01728623|Lenvatinib|lenvatinib|mesh-list
92529919|NCT00038662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114501|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92529920|NCT00038701|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
92529921|NCT00038701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92529922|NCT00038701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529923|NCT00038701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92529924|NCT00038701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92529926|NCT00038701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529927|NCT00038701|Growth Inhibitors|growth inhibitors|mesh-ancestor
92529928|NCT00038896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92529929|NCT00038896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92114579|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
92529930|NCT00038896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92114641|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529931|NCT00038896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92529932|NCT00038896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529933|NCT00038896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92529934|NCT00038896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529935|NCT00038896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92529936|NCT00038896|Antidepressive Agents|antidepressive agents|mesh-ancestor
92529937|NCT00038896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92529938|NCT00038935|Factor VIII|factor viii|mesh-list
92529939|NCT00038935|Coagulants|coagulants|mesh-ancestor
92529940|NCT00017004|Epoetin Alfa|epoetin alfa|mesh-list
92529941|NCT00017004|Hematinics|hematinics|mesh-ancestor
92529943|NCT00038974|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92529944|NCT00038974|Antimetabolites|antimetabolites|mesh-ancestor
92529945|NCT00038974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529946|NCT00038974|Antiviral Agents|antiviral agents|mesh-ancestor
92529947|NCT00038974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92529948|NCT00039013|Exenatide|exenatide|mesh-list
92529949|NCT00039013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92529950|NCT00039013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529951|NCT00039013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92529952|NCT00039013|Incretins|incretins|mesh-ancestor
92529953|NCT00039013|Hormones|hormones|mesh-ancestor
92529954|NCT00039013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529955|NCT00039052|Interleukin-4|interleukin-4|mesh-list
92529956|NCT00039052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92529957|NCT00039052|Immunologic Factors|immunologic factors|mesh-ancestor
92529958|NCT00039052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529959|NCT00039052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114857|NCT05402020|Olodaterol|olodaterol|mesh-list
92529960|NCT00039052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92529961|NCT00017082|Oxaliplatin|oxaliplatin|mesh-list
92529962|NCT00017082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529963|NCT00039091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92529965|NCT00039091|Antibodies|antibodies|mesh-list
92529966|NCT00039091|Immunoglobulins|immunoglobulins|mesh-list
92529967|NCT00039091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92529968|NCT00039091|Immunologic Factors|immunologic factors|mesh-ancestor
92529969|NCT00039091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529970|NCT00039091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529971|NCT00039091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92529972|NCT00039091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529973|NCT00039169|IDN 5109|idn 5109|mesh-list
92529974|NCT00039169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92529975|NCT00001304|Vitamin D|vitamin d|mesh-list
92529976|NCT00001304|Calcitriol|calcitriol|mesh-list
92529977|NCT00001304|Calcium|calcium|mesh-list
92529978|NCT00001304|Parathyroid Hormone|parathyroid hormone|mesh-list
92529979|NCT00001304|Hormones|hormones|mesh-list
92529980|NCT00001304|Vitamins|vitamins|mesh-ancestor
92529981|NCT00001304|Micronutrients|micronutrients|mesh-ancestor
92529982|NCT00001304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529983|NCT00001304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92115346|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
92529984|NCT00001304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92529985|NCT00001304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92529986|NCT00001304|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92529987|NCT00001304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92529988|NCT00001304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92529989|NCT00001304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92529990|NCT00039208|Leucovorin|leucovorin|mesh-list
92529991|NCT00039208|Fluorouracil|fluorouracil|mesh-list
92529992|NCT00039208|Oxaliplatin|oxaliplatin|mesh-list
92529993|NCT00039208|Irinotecan|irinotecan|mesh-list
92529994|NCT00039208|Calcium|calcium|mesh-list
92529995|NCT00039208|Levoleucovorin|levoleucovorin|mesh-list
92529996|NCT00039208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92529997|NCT00039208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92529998|NCT00039208|Antimetabolites|antimetabolites|mesh-ancestor
92115494|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
92529999|NCT00039208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530000|NCT00039208|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530001|NCT00039208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530002|NCT00039208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530003|NCT00039208|Immunologic Factors|immunologic factors|mesh-ancestor
92530004|NCT00039208|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92530005|NCT00039208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530006|NCT00039208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530007|NCT00039208|Antidotes|antidotes|mesh-ancestor
92530008|NCT00039208|Protective Agents|protective agents|mesh-ancestor
92530009|NCT00039208|Vitamin B Complex|vitamin b complex|mesh-ancestor
92530010|NCT00039208|Vitamins|vitamins|mesh-ancestor
92530011|NCT00039208|Micronutrients|micronutrients|mesh-ancestor
92530012|NCT00017121|Sargramostim|sargramostim|mesh-list
92530013|NCT00017121|Immunologic Factors|immunologic factors|mesh-ancestor
92115698|NCT01878669|Antidotes|antidotes|mesh-ancestor
92533703|NCT04917900|Paclitaxel|paclitaxel|mesh-list
92530014|NCT00017121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530016|NCT00039286|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92530017|NCT00039286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530018|NCT00039364|Imatinib Mesylate|imatinib mesylate|mesh-list
92530019|NCT00039364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530020|NCT00039364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530021|NCT00039364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116143|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
92116216|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
92530022|NCT00039364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530023|NCT00039403|Gemcitabine|gemcitabine|mesh-list
92530024|NCT00039403|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92116371|NCT02069704|Vitamins|vitamins|mesh-ancestor
92530025|NCT00039403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530026|NCT00039403|Antimetabolites|antimetabolites|mesh-ancestor
92116518|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530027|NCT00039403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530028|NCT00039403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116744|NCT02459574|Amiodarone|amiodarone|mesh-list
92530029|NCT00039403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530031|NCT00039442|Capecitabine|capecitabine|mesh-list
92116969|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
92530032|NCT00039442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530033|NCT00039442|Antimetabolites|antimetabolites|mesh-ancestor
92530034|NCT00039442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117187|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
92530035|NCT00039442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530037|NCT00039481|Doxorubicin|doxorubicin|mesh-list
92530038|NCT00039481|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92530040|NCT00039481|Razoxane|razoxane|mesh-list
92530041|NCT00039481|Oblimersen|oblimersen|mesh-list
92530042|NCT00039481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530043|NCT00039481|Immunologic Factors|immunologic factors|mesh-ancestor
92117782|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92530044|NCT00039481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530045|NCT00039481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117865|NCT03245424|Ivosidenib|ivosidenib|mesh-list
92530046|NCT00039481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92530047|NCT00039481|Alkylating Agents|alkylating agents|mesh-ancestor
92118078|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
92530048|NCT00039481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530049|NCT00039481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118225|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
92530050|NCT00039481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530051|NCT00039481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92118368|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
92530052|NCT00039481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530053|NCT00039481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530054|NCT00039481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530055|NCT00039481|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92530056|NCT00039481|Protective Agents|protective agents|mesh-ancestor
92118670|NCT03247218|Memantine|memantine|mesh-list
92530057|NCT00039481|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530058|NCT00039481|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530060|NCT00001322|Estradiol|estradiol|mesh-list
92530061|NCT00001322|Progesterone|progesterone|mesh-list
92530062|NCT00001322|Estrogens|estrogens|mesh-ancestor
92530063|NCT00001322|Hormones|hormones|mesh-ancestor
92119035|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
92119184|NCT00081861|Growth Substances|growth substances|mesh-ancestor
92119334|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
92537656|NCT03555149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530064|NCT00001322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119487|NCT00082329|Plerixafor|plerixafor|mesh-list
92530065|NCT00001322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530066|NCT00001322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92530067|NCT00001322|Progestins|progestins|mesh-ancestor
92530068|NCT00001322|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92530069|NCT00001322|Fertility Agents|fertility agents|mesh-ancestor
92530070|NCT00001322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530071|NCT00001322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530072|NCT00039520|Sulindac|sulindac|mesh-list
92530073|NCT00039520|Docetaxel|docetaxel|mesh-list
92530074|NCT00039520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530075|NCT00039520|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530076|NCT00039520|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530077|NCT00039520|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530078|NCT00039520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537657|NCT00141895|Misoprostol|misoprostol|mesh-list
92120470|NCT04943848|Iodine|iodine|mesh-list
92530079|NCT00039520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92530080|NCT00039520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92530081|NCT00039520|Analgesics|analgesics|mesh-ancestor
92530082|NCT00039520|Sensory System Agents|sensory system agents|mesh-ancestor
92530083|NCT00039520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530084|NCT00039520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530085|NCT00039520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92530086|NCT00039520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530087|NCT00039520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92530088|NCT00039520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530089|NCT04731961|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92530090|NCT04731961|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92530091|NCT04731961|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92530092|NCT04731961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120883|NCT05681260|Hormones|hormones|mesh-ancestor
92530093|NCT04731961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120953|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92530094|NCT04731961|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92530095|NCT04731961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537658|NCT00141895|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92537660|NCT00141895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537661|NCT00141895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537662|NCT00141895|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92530096|NCT04731961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530097|NCT04731961|Cholinergic Agents|cholinergic agents|mesh-ancestor
92530098|NCT04731961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530099|NCT00001328|Ganciclovir|ganciclovir|mesh-list
92530100|NCT00001328|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92530102|NCT00001328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530103|NCT00001328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92121920|NCT05716906|Melatonin|melatonin|mesh-list
92530104|NCT00001328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122215|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92537663|NCT00141895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122365|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
92537664|NCT00141895|Oxytocics|oxytocics|mesh-ancestor
92537665|NCT00142051|Nitric Oxide|nitric oxide|mesh-list
92750789|NCT05935059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530105|NCT00001328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530106|NCT00017160|Doxorubicin|doxorubicin|mesh-list
92530108|NCT00017160|Immunologic Factors|immunologic factors|mesh-list
92530109|NCT00017160|Immunomodulating Agents|immunomodulating agents|mesh-list
92530110|NCT00017160|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92122750|NCT00231309|Lenograstim|lenograstim|mesh-list
92530111|NCT00017160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530112|NCT00017160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530113|NCT00017160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530114|NCT00017160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122964|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
92123115|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530116|NCT00017160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530117|NCT00017160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92530118|NCT00017160|Alkylating Agents|alkylating agents|mesh-ancestor
92530119|NCT00039832|Reteplase|reteplase|mesh-list
92530120|NCT00039832|Abciximab|abciximab|mesh-list
92530121|NCT00039832|Anticoagulants|anticoagulants|mesh-ancestor
92123482|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530122|NCT00039832|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92530123|NCT00039832|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92530124|NCT00039832|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92537666|NCT00142051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92530125|NCT00039832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530126|NCT00039988|Glatiramer Acetate|glatiramer acetate|mesh-list
92530127|NCT00039988|Albuterol|albuterol|mesh-list
92530128|NCT00039988|(T,G)-A-L|(t,g)-a-l|mesh-list
92530129|NCT00039988|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92530130|NCT00039988|Autonomic Agents|autonomic agents|mesh-ancestor
92530131|NCT00039988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530132|NCT00039988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530133|NCT00039988|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92530134|NCT00039988|Respiratory System Agents|respiratory system agents|mesh-ancestor
92530135|NCT00039988|Tocolytic Agents|tocolytic agents|mesh-ancestor
92530136|NCT00039988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92530137|NCT00039988|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92530138|NCT00039988|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92124143|NCT02974426|Cisplatin|cisplatin|mesh-list
92530139|NCT00039988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92530140|NCT00039988|Adrenergic Agents|adrenergic agents|mesh-ancestor
92537667|NCT00142051|Autonomic Agents|autonomic agents|mesh-ancestor
92530141|NCT00039988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124365|NCT02412150|Narcotics|narcotics|mesh-ancestor
92530142|NCT00039988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124432|NCT02411994|Artemether|artemether|mesh-list
92124507|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92124587|NCT03174288|Diuretics|diuretics|mesh-ancestor
92124659|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
92530143|NCT00039988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92124742|NCT02405598|Albuterol|albuterol|mesh-list
92530144|NCT00039988|Immunologic Factors|immunologic factors|mesh-ancestor
92124957|NCT02558374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92530145|NCT00039988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530146|NCT00039988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530147|NCT00040027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92530148|NCT00040027|Interferon-alpha|interferon-alpha|mesh-list
92530150|NCT00040027|Antiviral Agents|antiviral agents|mesh-ancestor
92530151|NCT00040027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530152|NCT00040027|Immunologic Factors|immunologic factors|mesh-ancestor
92530153|NCT00040027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530154|NCT00040027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92530155|NCT00001343|Oxandrolone|oxandrolone|mesh-list
92530156|NCT00001343|Androgens|androgens|mesh-ancestor
92530157|NCT00001343|Hormones|hormones|mesh-ancestor
92530158|NCT00001343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530159|NCT00001343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530160|NCT00001343|Anabolic Agents|anabolic agents|mesh-ancestor
92530161|NCT00040066|Cocaine|cocaine|mesh-list
92530162|NCT00040066|Anesthetics, Local|anesthetics, local|mesh-ancestor
92530163|NCT00040066|Anesthetics|anesthetics|mesh-ancestor
92530164|NCT00040066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92530165|NCT00040066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530166|NCT00040066|Sensory System Agents|sensory system agents|mesh-ancestor
92530167|NCT00040066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530168|NCT00040066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92530169|NCT00040066|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92530170|NCT00040066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92530171|NCT00040066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530172|NCT00040066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530173|NCT00040066|Dopamine Agents|dopamine agents|mesh-ancestor
92530174|NCT00040066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530175|NCT00040105|Imatinib Mesylate|imatinib mesylate|mesh-list
92530176|NCT00040105|Tipifarnib|tipifarnib|mesh-list
92530177|NCT00040105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530178|NCT00040105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530179|NCT00040105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530180|NCT00040105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530181|NCT00040144|Dexelvucitabine|dexelvucitabine|mesh-list
92530182|NCT00040144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92530183|NCT00040144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530184|NCT00040144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530185|NCT00040144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530186|NCT00040144|Antiviral Agents|antiviral agents|mesh-ancestor
92530187|NCT00040144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530188|NCT00040144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92530189|NCT00040144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92530190|NCT00040183|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92530191|NCT00040183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530192|NCT00040183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530193|NCT00040183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537668|NCT00142051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530194|NCT00040183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530195|NCT00040261|Memantine|memantine|mesh-list
92530196|NCT00040261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92530197|NCT00040261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92530198|NCT00040261|Dopamine Agents|dopamine agents|mesh-ancestor
92530199|NCT00040261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530200|NCT00040261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530201|NCT00040261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530202|NCT00040261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92530203|NCT00040261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92530204|NCT00040300|Racivir|racivir|mesh-list
92530205|NCT00040300|Antiviral Agents|antiviral agents|mesh-ancestor
92530206|NCT00040300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530207|NCT00040378|Vitamins|vitamins|mesh-list
92530208|NCT00040378|Vitamin E|vitamin e|mesh-list
92530209|NCT00040378|Tocopherols|tocopherols|mesh-list
92530210|NCT00040378|Tocotrienols|tocotrienols|mesh-list
92530211|NCT00040378|alpha-Tocopherol|alpha-tocopherol|mesh-list
92530212|NCT00040378|Selenium|selenium|mesh-list
92530213|NCT00040378|Micronutrients|micronutrients|mesh-ancestor
92530214|NCT00040378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530215|NCT00040378|Antioxidants|antioxidants|mesh-ancestor
92530216|NCT00040378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530217|NCT00040378|Protective Agents|protective agents|mesh-ancestor
92530218|NCT00040378|Trace Elements|trace elements|mesh-ancestor
92530219|NCT00017199|Bortezomib|bortezomib|mesh-list
92125137|NCT00364000|Calcium|calcium|mesh-list
92530220|NCT00017199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530221|NCT00040417|Fludarabine|fludarabine|mesh-list
92530222|NCT00040417|Alemtuzumab|alemtuzumab|mesh-list
92530223|NCT00040417|Lenograstim|lenograstim|mesh-list
92530224|NCT00040417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530225|NCT00040417|Immunologic Factors|immunologic factors|mesh-ancestor
92530226|NCT00040417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530227|NCT00040417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92125185|NCT03169764|Micronutrients|micronutrients|mesh-ancestor
92530228|NCT00040417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92530229|NCT00040495|Pantoprazole|pantoprazole|mesh-list
92530230|NCT00040495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92530231|NCT00040495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530232|NCT00040495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92530233|NCT00040495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530234|NCT00040495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530235|NCT00040651|Cyclophosphamide|cyclophosphamide|mesh-list
92530236|NCT00040651|Fludarabine|fludarabine|mesh-list
92530237|NCT00040651|Thymoglobulin|thymoglobulin|mesh-list
92530238|NCT00040651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530239|NCT00040651|Immunologic Factors|immunologic factors|mesh-ancestor
92530240|NCT00040651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530241|NCT00040651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530242|NCT00040651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92530243|NCT00040651|Alkylating Agents|alkylating agents|mesh-ancestor
92530244|NCT00040651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530245|NCT00040651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530246|NCT00040651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530247|NCT00040690|Leucovorin|leucovorin|mesh-list
92530248|NCT00040690|Cytarabine|cytarabine|mesh-list
92530249|NCT00040690|Cyclophosphamide|cyclophosphamide|mesh-list
92530250|NCT00040690|Ifosfamide|ifosfamide|mesh-list
92530251|NCT00040690|Doxorubicin|doxorubicin|mesh-list
92255018|NCT00837200|Doxorubicin|doxorubicin|mesh-list
92530252|NCT00040690|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92530253|NCT00040690|Methotrexate|methotrexate|mesh-list
92530254|NCT00040690|Etoposide|etoposide|mesh-list
92530255|NCT00040690|Vincristine|vincristine|mesh-list
92530256|NCT00040690|Levoleucovorin|levoleucovorin|mesh-list
92530257|NCT00040690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530258|NCT00040690|Immunologic Factors|immunologic factors|mesh-ancestor
92530259|NCT00040690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530260|NCT00040690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530261|NCT00040690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92530262|NCT00040690|Alkylating Agents|alkylating agents|mesh-ancestor
92530263|NCT00040690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530264|NCT00040690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530265|NCT00040690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530266|NCT00040690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92530267|NCT00040690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530268|NCT00040690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530269|NCT00040690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530270|NCT00040690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92530271|NCT00040690|Abortifacient Agents|abortifacient agents|mesh-ancestor
92530272|NCT00040690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92530273|NCT00040690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530274|NCT00040690|Antimetabolites|antimetabolites|mesh-ancestor
92530275|NCT00040690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92530276|NCT00040690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92530277|NCT00040690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530278|NCT00040690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92530279|NCT00040690|Antiviral Agents|antiviral agents|mesh-ancestor
92530280|NCT00040690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530281|NCT00040690|Antidotes|antidotes|mesh-ancestor
92530282|NCT00040690|Protective Agents|protective agents|mesh-ancestor
92530283|NCT00040690|Vitamin B Complex|vitamin b complex|mesh-ancestor
92530284|NCT00040690|Vitamins|vitamins|mesh-ancestor
92530285|NCT00040690|Micronutrients|micronutrients|mesh-ancestor
92530286|NCT00040690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530287|NCT00040690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530288|NCT00040690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530289|NCT00040768|Bortezomib|bortezomib|mesh-list
92530290|NCT00040768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530291|NCT00017238|KRN 5500|krn 5500|mesh-list
92530292|NCT00017238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530294|NCT00017238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530295|NCT00017238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530296|NCT00040885|Infliximab|infliximab|mesh-list
92530297|NCT00040885|Docetaxel|docetaxel|mesh-list
92530298|NCT00040885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530299|NCT00040885|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530300|NCT00040885|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530301|NCT00040885|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537669|NCT00142051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530302|NCT00040885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530303|NCT00040885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92530304|NCT00040885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92530305|NCT00040885|Dermatologic Agents|dermatologic agents|mesh-ancestor
92530306|NCT00040885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530307|NCT00040885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530308|NCT00001421|Methimazole|methimazole|mesh-list
92530309|NCT00001421|Antithyroid Agents|antithyroid agents|mesh-ancestor
92530310|NCT00001421|Hormone Antagonists|hormone antagonists|mesh-ancestor
92530311|NCT00001421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530312|NCT00001421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530313|NCT00017277|Epoetin Alfa|epoetin alfa|mesh-list
92530314|NCT00017277|Hematinics|hematinics|mesh-ancestor
92530315|NCT00041041|Imatinib Mesylate|imatinib mesylate|mesh-list
92530316|NCT00041041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125784|NCT03189706|Irinotecan|irinotecan|mesh-list
92530317|NCT00041041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530318|NCT00041041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537670|NCT00142051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92530319|NCT00041041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530320|NCT00041197|Imatinib Mesylate|imatinib mesylate|mesh-list
92530321|NCT00041197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530322|NCT00041197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530323|NCT00041197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530324|NCT00041197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530325|NCT00001427|9-aminocamptothecin|9-aminocamptothecin|mesh-list
92530326|NCT00001427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530327|NCT00041236|Exatecan|exatecan|mesh-list
92530328|NCT00041236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92530329|NCT00041236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530330|NCT00041236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530331|NCT00041236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530332|NCT00041236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530333|NCT00017316|Thalidomide|thalidomide|mesh-list
92530334|NCT00017316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530335|NCT00017316|Immunologic Factors|immunologic factors|mesh-ancestor
92530336|NCT00017316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530337|NCT00017316|Leprostatic Agents|leprostatic agents|mesh-ancestor
92530338|NCT00017316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92530339|NCT00017316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530340|NCT00017316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92530341|NCT00017316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92530342|NCT00017316|Growth Substances|growth substances|mesh-ancestor
92530343|NCT00017316|Growth Inhibitors|growth inhibitors|mesh-ancestor
92530344|NCT00017316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530345|NCT00041275|Megestrol|megestrol|mesh-list
92530346|NCT00041275|Megestrol Acetate|megestrol acetate|mesh-list
92530347|NCT00041275|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92530348|NCT00041275|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92530349|NCT00041275|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92530350|NCT00041275|Contraceptive Agents|contraceptive agents|mesh-ancestor
92530351|NCT00041275|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92530352|NCT00041275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530353|NCT00041275|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92530354|NCT00041275|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92530355|NCT00041275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530356|NCT00041275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530357|NCT00041275|Appetite Stimulants|appetite stimulants|mesh-ancestor
92530358|NCT00041275|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92530359|NCT00017355|Lenograstim|lenograstim|mesh-list
92530360|NCT00017355|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92126264|NCT02664922|Narcotics|narcotics|mesh-ancestor
92530362|NCT00017355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530363|NCT00397072|Sagopilone|sagopilone|mesh-list
92530364|NCT00397072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530365|NCT00017394|Bevacizumab|bevacizumab|mesh-list
92530366|NCT00017394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92530367|NCT00017394|Vinorelbine|vinorelbine|mesh-list
92126481|NCT01567085|Eculizumab|eculizumab|mesh-list
92530368|NCT00017394|Antibodies|antibodies|mesh-list
92530369|NCT00017394|Immunoglobulins|immunoglobulins|mesh-list
92530370|NCT00017394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92530371|NCT00017394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530372|NCT00017394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92530373|NCT00017394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92530374|NCT00017394|Growth Substances|growth substances|mesh-ancestor
92530375|NCT00017394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530376|NCT00017394|Growth Inhibitors|growth inhibitors|mesh-ancestor
92530377|NCT00017394|Immunologic Factors|immunologic factors|mesh-ancestor
92530378|NCT00017394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92530379|NCT00017394|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530380|NCT00017394|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530381|NCT00017394|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530382|NCT00017394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530383|NCT00041431|Hormones|hormones|mesh-list
92530384|NCT00041431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126555|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92530385|NCT00041431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530387|NCT00001436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92530388|NCT00001436|Hormone Antagonists|hormone antagonists|mesh-ancestor
92530389|NCT00001436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530390|NCT00001436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530391|NCT00001436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530392|NCT00001436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530393|NCT00001436|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92530394|NCT00001436|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92530395|NCT00001436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92530396|NCT00041548|Nitric Oxide|nitric oxide|mesh-list
92126687|NCT01559675|Hormones|hormones|mesh-ancestor
92530397|NCT00041548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92530398|NCT00041548|Autonomic Agents|autonomic agents|mesh-ancestor
92530399|NCT00041548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530400|NCT00041548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530401|NCT00041548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92530402|NCT00041548|Respiratory System Agents|respiratory system agents|mesh-ancestor
92530403|NCT00041548|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92530404|NCT00041548|Antioxidants|antioxidants|mesh-ancestor
92530405|NCT00041548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530406|NCT00041548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530407|NCT00041548|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92530408|NCT00041548|Vasodilator Agents|vasodilator agents|mesh-ancestor
92530409|NCT00041548|Gasotransmitters|gasotransmitters|mesh-ancestor
92530410|NCT00041548|Protective Agents|protective agents|mesh-ancestor
92530411|NCT00041587|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92530412|NCT00041587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530413|NCT00017433|Arsenic Trioxide|arsenic trioxide|mesh-list
92530414|NCT00017433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530416|NCT00041665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92530417|NCT00041665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530418|NCT00041704|Anidulafungin|anidulafungin|mesh-list
92530419|NCT00041704|Antifungal Agents|antifungal agents|mesh-ancestor
92126811|NCT04775550|Dexamethasone|dexamethasone|mesh-list
92530420|NCT00041704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530421|NCT00017472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92530422|NCT00017472|Antibodies|antibodies|mesh-list
92530423|NCT00017472|Immunoglobulins|immunoglobulins|mesh-list
92530424|NCT00017472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92530425|NCT00017472|Immunologic Factors|immunologic factors|mesh-ancestor
92530426|NCT00017472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530427|NCT00017472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530428|NCT00041782|Dalteparin|dalteparin|mesh-list
92530429|NCT00041782|Tinzaparin|tinzaparin|mesh-list
92530430|NCT00041782|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92530431|NCT00041782|Anticoagulants|anticoagulants|mesh-ancestor
92530432|NCT00041782|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92530433|NCT00041782|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92530434|NCT00041782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530435|NCT00017511|Cevimeline|cevimeline|mesh-list
92530436|NCT00017511|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92530437|NCT00017511|Autonomic Agents|autonomic agents|mesh-ancestor
92530438|NCT00017511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530439|NCT00017511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530440|NCT00017511|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92530441|NCT00017511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92530442|NCT00017511|Cholinergic Agents|cholinergic agents|mesh-ancestor
92530443|NCT00017511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530444|NCT00017511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530445|NCT00041899|Ulipristal acetate|ulipristal acetate|mesh-list
92530446|NCT00041899|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92530447|NCT00041899|Contraceptive Agents|contraceptive agents|mesh-ancestor
92530448|NCT00041899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92530449|NCT00041899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126986|NCT01537081|Guaifenesin|guaifenesin|mesh-list
92533828|NCT00062296|Rituximab|rituximab|mesh-list
92530450|NCT00041899|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92127142|NCT01535443|Bromfenac|bromfenac|mesh-list
92530452|NCT00041977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92530453|NCT00041977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530454|NCT00041977|Antimalarials|antimalarials|mesh-ancestor
92530455|NCT00041977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92530456|NCT00041977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92530457|NCT00042016|Decitabine|decitabine|mesh-list
92530458|NCT00042016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530459|NCT00042016|Antimetabolites|antimetabolites|mesh-ancestor
92530460|NCT00042016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530461|NCT00042016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530462|NCT00042016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530463|NCT00017550|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92530464|NCT00017550|Immunologic Factors|immunologic factors|mesh-ancestor
92127428|NCT02689284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530465|NCT00017550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127496|NCT03163680|Omeprazole|omeprazole|mesh-list
92127648|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530466|NCT00017550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530467|NCT00001457|Lamivudine|lamivudine|mesh-list
92530468|NCT00001457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92530469|NCT00001457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530470|NCT00001457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530471|NCT00001457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530473|NCT00001457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530474|NCT00001457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92530475|NCT00001457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92530477|NCT00042172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92530478|NCT00042172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530479|NCT00042172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530480|NCT00042172|Cholinergic Agents|cholinergic agents|mesh-ancestor
92530481|NCT00042172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530482|NCT00042172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530483|NCT00042172|Nootropic Agents|nootropic agents|mesh-ancestor
92530484|NCT00017589|Gemtuzumab|gemtuzumab|mesh-list
92530485|NCT00017589|Oblimersen|oblimersen|mesh-list
92530486|NCT00017589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92530487|NCT00017589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530488|NCT00017589|Immunotoxins|immunotoxins|mesh-ancestor
92530489|NCT00017589|Immunoconjugates|immunoconjugates|mesh-ancestor
92530490|NCT00017589|Immunologic Factors|immunologic factors|mesh-ancestor
92530491|NCT00017589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530492|NCT00001475|Thalidomide|thalidomide|mesh-list
92530493|NCT00001475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530494|NCT00001475|Immunologic Factors|immunologic factors|mesh-ancestor
92530495|NCT00001475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530496|NCT00001475|Leprostatic Agents|leprostatic agents|mesh-ancestor
92530497|NCT00001475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92530498|NCT00001475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530499|NCT00001475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92530500|NCT00001475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92530501|NCT00001475|Growth Substances|growth substances|mesh-ancestor
92128021|NCT01578499|Bexarotene|bexarotene|mesh-list
92530502|NCT00001475|Growth Inhibitors|growth inhibitors|mesh-ancestor
92530503|NCT00001475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530504|NCT00042328|Valacyclovir|valacyclovir|mesh-list
92530505|NCT00042328|Antiviral Agents|antiviral agents|mesh-ancestor
92530506|NCT00042328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530507|NCT00042367|Mafosfamide|mafosfamide|mesh-list
92530508|NCT00042367|Cyclophosphamide|cyclophosphamide|mesh-list
92530509|NCT00042367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92530510|NCT00042367|Immunologic Factors|immunologic factors|mesh-ancestor
92530511|NCT00042367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530512|NCT00042367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530513|NCT00042367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530514|NCT00042367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530515|NCT00042367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92530516|NCT00042367|Alkylating Agents|alkylating agents|mesh-ancestor
92530517|NCT00042367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530518|NCT00042367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530520|NCT02970643|Palonosetron|palonosetron|mesh-list
92530521|NCT02970643|Antiemetics|antiemetics|mesh-ancestor
92530522|NCT02970643|Autonomic Agents|autonomic agents|mesh-ancestor
92530523|NCT02970643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128189|NCT04641507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92530524|NCT02970643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530525|NCT02970643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530527|NCT02970643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92530528|NCT02970643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92530529|NCT02970643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128337|NCT02391636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537671|NCT00142051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92128480|NCT01528345|Hormone Antagonists|hormone antagonists|mesh-ancestor
92530530|NCT02970643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92128560|NCT01510145|Travoprost|travoprost|mesh-list
92530531|NCT02970643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92530532|NCT02970643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530533|NCT02970643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530534|NCT02970643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530535|NCT02970643|Serotonin Agents|serotonin agents|mesh-ancestor
92530536|NCT02970643|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92530537|NCT02970643|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92128697|NCT02381730|Growth Substances|growth substances|mesh-ancestor
92530539|NCT00017628|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92530540|NCT00017628|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92530541|NCT00017628|Prednisolone|prednisolone|mesh-list
92530542|NCT00017628|Prednisolone acetate|prednisolone acetate|mesh-list
92128915|NCT02388750|Palonosetron|palonosetron|mesh-list
92530545|NCT00017628|Prednisolone phosphate|prednisolone phosphate|mesh-list
92530546|NCT00017628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530547|NCT00017628|Immunologic Factors|immunologic factors|mesh-ancestor
92530548|NCT00017628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530549|NCT00017628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530550|NCT00017628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92530551|NCT00017628|Alkylating Agents|alkylating agents|mesh-ancestor
92530552|NCT00017628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530553|NCT00017628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530554|NCT00017628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530555|NCT00017628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92530557|NCT00017628|Autonomic Agents|autonomic agents|mesh-ancestor
92530558|NCT00017628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530559|NCT00017628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530560|NCT00017628|Glucocorticoids|glucocorticoids|mesh-ancestor
92530561|NCT00017628|Hormones|hormones|mesh-ancestor
92129047|NCT00298155|Dutasteride|dutasteride|mesh-list
92530562|NCT00017628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530563|NCT00017628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92530564|NCT00017628|Protective Agents|protective agents|mesh-ancestor
92530565|NCT00017628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530566|NCT00042562|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92530567|NCT00042562|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92129335|NCT04039230|Immunoconjugates|immunoconjugates|mesh-ancestor
92530568|NCT00042562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92530569|NCT00042562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530570|NCT00042562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530571|NCT00042562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530572|NCT00042562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530573|NCT00042562|Analgesics|analgesics|mesh-ancestor
92530574|NCT00042562|Sensory System Agents|sensory system agents|mesh-ancestor
92129659|NCT05800015|Paclitaxel|paclitaxel|mesh-list
92129726|NCT05799300|Anesthetics|anesthetics|mesh-list
92530575|NCT00042562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92530576|NCT00042562|Antidepressive Agents|antidepressive agents|mesh-ancestor
92530577|NCT00042562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92530578|NCT00042562|Dopamine Agents|dopamine agents|mesh-ancestor
92530579|NCT00001487|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92530580|NCT00001487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92530581|NCT00001487|Immunologic Factors|immunologic factors|mesh-ancestor
92530582|NCT00001487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530583|NCT00042601|Pramlintide|pramlintide|mesh-list
92530584|NCT00042601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92530585|NCT00042601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530587|NCT00042679|Gemcitabine|gemcitabine|mesh-list
92530588|NCT00042679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530589|NCT00042679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530590|NCT00042679|Antimetabolites|antimetabolites|mesh-ancestor
92530591|NCT00042679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530592|NCT00042718|Amoxicillin|amoxicillin|mesh-list
92530593|NCT00042718|Azithromycin|azithromycin|mesh-list
92530594|NCT00042718|Levofloxacin|levofloxacin|mesh-list
92530595|NCT00042718|Clavulanic Acid|clavulanic acid|mesh-list
92530596|NCT00042718|Clavulanic Acids|clavulanic acids|mesh-list
92130242|NCT04436731|Mydriatics|mydriatics|mesh-ancestor
92530597|NCT00042718|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92530598|NCT00042718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92530599|NCT00042718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530600|NCT00042718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92530601|NCT00042718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530602|NCT00042718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530603|NCT00042718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530604|NCT00042718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530605|NCT00042718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530606|NCT00042718|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92530607|NCT00042718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92530608|NCT00042718|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92530609|NCT00042796|Decitabine|decitabine|mesh-list
92530610|NCT00042796|Azacitidine|azacitidine|mesh-list
92530611|NCT00042796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530612|NCT00042796|Antimetabolites|antimetabolites|mesh-ancestor
92530613|NCT00042796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530614|NCT00042796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130368|NCT03958877|Interferons|interferons|mesh-list
92530615|NCT00042796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530616|NCT00042835|Paclitaxel|paclitaxel|mesh-list
92530617|NCT00042835|Etoposide|etoposide|mesh-list
92530618|NCT00042835|Docetaxel|docetaxel|mesh-list
92530619|NCT00042835|Carboplatin|carboplatin|mesh-list
92530620|NCT00042835|Etoposide phosphate|etoposide phosphate|mesh-list
92530621|NCT00042835|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92530622|NCT00042835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92530623|NCT00042835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530624|NCT00042835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530625|NCT00042835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530626|NCT00042835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130809|NCT02374008|Ropivacaine|ropivacaine|mesh-list
92530627|NCT00042835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130920|NCT03922542|Riboflavin|riboflavin|mesh-list
92530628|NCT00042835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530629|NCT00042835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530630|NCT00042835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530632|NCT00017784|Valganciclovir|valganciclovir|mesh-list
92530633|NCT00017784|Antiviral Agents|antiviral agents|mesh-ancestor
92530634|NCT00017784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530635|NCT00042874|Leucovorin|leucovorin|mesh-list
92530636|NCT00042874|Fluorouracil|fluorouracil|mesh-list
92530637|NCT00042874|Irinotecan|irinotecan|mesh-list
92530638|NCT00042874|Alvocidib|alvocidib|mesh-list
92530639|NCT00042874|Calcium|calcium|mesh-list
92530640|NCT00042874|Levoleucovorin|levoleucovorin|mesh-list
92530641|NCT00042874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92530642|NCT00042874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530643|NCT00042874|Antimetabolites|antimetabolites|mesh-ancestor
92530644|NCT00042874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131397|NCT02360982|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92530645|NCT00042874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530646|NCT00042874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530647|NCT00042874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530648|NCT00042874|Immunologic Factors|immunologic factors|mesh-ancestor
92530649|NCT00042874|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92530650|NCT00042874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530651|NCT00042874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530652|NCT00042874|Antidotes|antidotes|mesh-ancestor
92530653|NCT00042874|Protective Agents|protective agents|mesh-ancestor
92530654|NCT00042874|Vitamin B Complex|vitamin b complex|mesh-ancestor
92530655|NCT00042874|Vitamins|vitamins|mesh-ancestor
92530656|NCT00042874|Micronutrients|micronutrients|mesh-ancestor
92530657|NCT00042874|Growth Inhibitors|growth inhibitors|mesh-ancestor
92530658|NCT00042874|Growth Substances|growth substances|mesh-ancestor
92530659|NCT00042874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530661|NCT00042913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92530662|NCT00042913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530663|NCT00042952|Imatinib Mesylate|imatinib mesylate|mesh-list
92530664|NCT00042952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132144|NCT02342574|Olorofim|olorofim|mesh-list
92530665|NCT00042952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530666|NCT00042952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530667|NCT00042952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530668|NCT00043069|Cholecalciferol|cholecalciferol|mesh-list
92530669|NCT00043069|Risedronic Acid|risedronic acid|mesh-list
92530670|NCT00043069|Calcium Carbonate|calcium carbonate|mesh-list
92530671|NCT00043069|Estrogens|estrogens|mesh-list
92530672|NCT00043069|Estrogen Antagonists|estrogen antagonists|mesh-list
92530673|NCT00043069|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
92132432|NCT02339142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132499|NCT00365391|Bevacizumab|bevacizumab|mesh-list
92537672|NCT00142051|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92530674|NCT00043069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92530675|NCT00043069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530676|NCT00043069|Vitamins|vitamins|mesh-ancestor
92530677|NCT00043069|Micronutrients|micronutrients|mesh-ancestor
92537673|NCT00142051|Antioxidants|antioxidants|mesh-ancestor
92530678|NCT00043069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92530680|NCT00043069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530682|NCT00043069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530683|NCT00043069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530684|NCT00043069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92530685|NCT00043069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530686|NCT00043069|Hormone Antagonists|hormone antagonists|mesh-ancestor
92530687|NCT00043147|Prednisone|prednisone|mesh-list
92530688|NCT00043147|Methylprednisolone|methylprednisolone|mesh-list
92530689|NCT00043147|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92530690|NCT00043147|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92530691|NCT00043147|Prednisolone|prednisolone|mesh-list
92530692|NCT00043147|Prednisolone acetate|prednisolone acetate|mesh-list
92530693|NCT00043147|Beclomethasone|beclomethasone|mesh-list
92530694|NCT00043147|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92530695|NCT00043147|Prednisolone phosphate|prednisolone phosphate|mesh-list
92530696|NCT00043147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92530697|NCT00043147|Glucocorticoids|glucocorticoids|mesh-ancestor
92530698|NCT00043147|Hormones|hormones|mesh-ancestor
92133234|NCT00420459|Aripiprazole|aripiprazole|mesh-list
92530699|NCT00043147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133301|NCT01491737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530700|NCT00043147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530701|NCT00043147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530702|NCT00043147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530703|NCT00043147|Antiemetics|antiemetics|mesh-ancestor
92530704|NCT00043147|Autonomic Agents|autonomic agents|mesh-ancestor
92530705|NCT00043147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255458|NCT01832558|Diuretics|diuretics|mesh-ancestor
92530706|NCT00043147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530707|NCT00043147|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92530708|NCT00043147|Protective Agents|protective agents|mesh-ancestor
92530709|NCT00043147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92530710|NCT00043147|Respiratory System Agents|respiratory system agents|mesh-ancestor
92530711|NCT00017862|Reslizumab|reslizumab|mesh-list
92530712|NCT00017862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92530713|NCT00017862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92530714|NCT00043264|Azithromycin|azithromycin|mesh-list
92530715|NCT00043264|Rifampin|rifampin|mesh-list
92530716|NCT00043264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92133730|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92530717|NCT00043264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530718|NCT00043264|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92530719|NCT00043264|Antitubercular Agents|antitubercular agents|mesh-ancestor
92134183|NCT00531453|Bortezomib|bortezomib|mesh-list
92530720|NCT00043264|Leprostatic Agents|leprostatic agents|mesh-ancestor
92134253|NCT01692626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530721|NCT00043264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530722|NCT00043264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530723|NCT00043264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530724|NCT00043264|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92530725|NCT00043264|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92530726|NCT00043264|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92530727|NCT00043264|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92134471|NCT00461331|Insulin|insulin|mesh-list
92134628|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530728|NCT00043264|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92530729|NCT00043264|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92134795|NCT01461551|Propofol|propofol|mesh-list
92530730|NCT00043303|Interferons|interferons|mesh-list
92530731|NCT00043303|Interferon-gamma|interferon-gamma|mesh-list
92134862|NCT00549393|Chlorhexidine|chlorhexidine|mesh-list
92530732|NCT00043303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530733|NCT00043303|Antiviral Agents|antiviral agents|mesh-ancestor
92135006|NCT00480987|Cytarabine|cytarabine|mesh-list
92530734|NCT00043303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530735|NCT00017940|Mitogens|mitogens|mesh-list
92530737|NCT00017940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530738|NCT02970604|Aspirin|aspirin|mesh-list
92530739|NCT02970604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92135293|NCT01453205|Rituximab|rituximab|mesh-list
92530740|NCT02970604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92530742|NCT02970604|Sensory System Agents|sensory system agents|mesh-ancestor
92530743|NCT02970604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135581|NCT01559012|Sympatholytics|sympatholytics|mesh-ancestor
92530744|NCT02970604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530745|NCT02970604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135817|NCT01556438|Dexamethasone|dexamethasone|mesh-list
92530747|NCT02970604|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92530748|NCT02970604|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92530749|NCT02970604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530750|NCT02970604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92530752|NCT02970604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530753|NCT02970604|Antipyretics|antipyretics|mesh-ancestor
92530754|NCT00043342|Interferons|interferons|mesh-list
92136271|NCT00502905|Busulfan|busulfan|mesh-list
92530755|NCT00043342|Interferon-gamma|interferon-gamma|mesh-list
92136380|NCT02130063|Iron|iron|mesh-list
92530756|NCT00043342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530757|NCT00043342|Antiviral Agents|antiviral agents|mesh-ancestor
92530758|NCT00043342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530760|NCT00043381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530761|NCT00043381|Antimetabolites|antimetabolites|mesh-ancestor
92530762|NCT00043381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136769|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92530763|NCT00043381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530765|NCT00001568|Deoxyglucose|deoxyglucose|mesh-list
92530766|NCT00001568|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92530767|NCT00001568|Antimetabolites|antimetabolites|mesh-ancestor
92136993|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137062|NCT00579813|Pioglitazone|pioglitazone|mesh-list
92530768|NCT00001568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137139|NCT00611325|Bevacizumab|bevacizumab|mesh-list
92530770|NCT00001568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530771|NCT00001568|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92530772|NCT00043537|Fluoxetine|fluoxetine|mesh-list
92137283|NCT01547390|Antipyretics|antipyretics|mesh-ancestor
92530773|NCT00043537|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92530774|NCT00043537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92530775|NCT00043537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137498|NCT01516970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92530776|NCT00043537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530777|NCT00043537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92530778|NCT00043537|Serotonin Agents|serotonin agents|mesh-ancestor
92530779|NCT00043537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530780|NCT00043537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92530781|NCT00043537|Antidepressive Agents|antidepressive agents|mesh-ancestor
92530782|NCT00043537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92137713|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530783|NCT00043537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92530784|NCT00043537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92530785|NCT00043537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530787|NCT00043576|Docetaxel|docetaxel|mesh-list
92530788|NCT00043576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530789|NCT00043576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138011|NCT01437995|Xhance|xhance|mesh-list
92530790|NCT00043576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92530791|NCT00043576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92138148|NCT00589563|Sirolimus|sirolimus|mesh-list
92533840|NCT05183984|Bevacizumab|bevacizumab|mesh-list
92530792|NCT00043576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138221|NCT00654069|Vasodilator Agents|vasodilator agents|mesh-ancestor
92530793|NCT00043576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92530794|NCT00043576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530795|NCT00043576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92530796|NCT00043576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530797|NCT00043576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92530798|NCT00043576|Vitamins|vitamins|mesh-ancestor
92530799|NCT00043576|Micronutrients|micronutrients|mesh-ancestor
92530800|NCT00043576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92530801|NCT00043654|Mifepristone|mifepristone|mesh-list
92530802|NCT00043654|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92353946|NCT05121246|Palivizumab|palivizumab|mesh-list
92530803|NCT00043654|Abortifacient Agents|abortifacient agents|mesh-ancestor
92530804|NCT00043654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138433|NCT01415401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92530805|NCT00043654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138510|NCT01514240|Mesalamine|mesalamine|mesh-list
92138580|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
92530806|NCT00043654|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92138652|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
92530807|NCT00043654|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92530809|NCT00043654|Contraceptive Agents|contraceptive agents|mesh-ancestor
92530810|NCT00043654|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92138871|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
92530811|NCT00043654|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92138973|NCT01430611|Vaccines|vaccines|mesh-list
92530813|NCT00043654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92530814|NCT00043654|Luteolytic Agents|luteolytic agents|mesh-ancestor
92530815|NCT00043654|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92530816|NCT00043654|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92530818|NCT00043771|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92530819|NCT00043771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530820|NCT00043771|Natriuretic Agents|natriuretic agents|mesh-ancestor
92530821|NCT00043771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530823|NCT00043810|Fludarabine phosphate|fludarabine phosphate|mesh-list
92530825|NCT00043810|GEL protein, Gelonium multiflorum|gel protein, gelonium multiflorum|mesh-list
92530826|NCT00043810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530827|NCT00043810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530828|NCT00043810|Antimetabolites|antimetabolites|mesh-ancestor
92139310|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92530829|NCT00043810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530830|NCT00043810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530831|NCT00043810|Immunologic Factors|immunologic factors|mesh-ancestor
92530832|NCT00043810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139534|NCT03140982|Propofol|propofol|mesh-list
92139678|NCT03359460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92530834|NCT00043810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139858|NCT05086848|Leucovorin|leucovorin|mesh-list
92139905|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92530835|NCT00043810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530836|NCT00043810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92530837|NCT00043810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92530838|NCT00043810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140052|NCT01421641|Lidocaine|lidocaine|mesh-list
92530839|NCT00043849|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92140213|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
92530840|NCT00043849|Antidepressive Agents|antidepressive agents|mesh-ancestor
92530841|NCT00043849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92140369|NCT05365165|Sevoflurane|sevoflurane|mesh-list
92530842|NCT00043849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92530843|NCT00043849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92530844|NCT00043849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92530845|NCT00043849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530846|NCT00001586|Rituximab|rituximab|mesh-list
92530848|NCT00001586|Fludarabine phosphate|fludarabine phosphate|mesh-list
92530849|NCT00001586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92530850|NCT00001586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530851|NCT00001586|Immunologic Factors|immunologic factors|mesh-ancestor
92530852|NCT00001586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255611|NCT03219710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92530853|NCT00001586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92530854|NCT00001586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92530856|NCT00001586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530857|NCT00001586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92530858|NCT00043888|Ritonavir|ritonavir|mesh-list
92530859|NCT00043888|Fosamprenavir|fosamprenavir|mesh-list
92141400|NCT03780127|Fenfluramine|fenfluramine|mesh-list
92141485|NCT03591991|Empagliflozin|empagliflozin|mesh-list
92530860|NCT00043888|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92530861|NCT00043888|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92141639|NCT03590431|Iodine|iodine|mesh-list
92141695|NCT04195867|Adrenergic Agents|adrenergic agents|mesh-ancestor
92530862|NCT00043888|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92530863|NCT00043888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92530864|NCT00043888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530865|NCT00043888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530866|NCT00043888|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92530867|NCT00043888|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92530868|NCT00043888|Antiviral Agents|antiviral agents|mesh-ancestor
92530869|NCT00043888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142144|NCT00722553|Aminopterin|aminopterin|mesh-list
92142228|NCT00752973|Malathion|malathion|mesh-list
92142293|NCT01273779|Talactoferrin alfa|talactoferrin alfa|mesh-list
92142387|NCT01508936|Reslizumab|reslizumab|mesh-list
92530870|NCT00043888|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92530872|NCT00043888|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92530873|NCT00043888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530874|NCT00018018|Zidovudine|zidovudine|mesh-list
92530875|NCT00018018|Antimetabolites|antimetabolites|mesh-ancestor
92142821|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
92530876|NCT00018018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530877|NCT00018018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92142971|NCT03661632|Nivolumab|nivolumab|mesh-list
92530878|NCT00018018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530879|NCT00018018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530880|NCT00018018|Antiviral Agents|antiviral agents|mesh-ancestor
92530881|NCT00018018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530882|NCT00018018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92530883|NCT00018018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92530884|NCT00043927|Cisplatin|cisplatin|mesh-list
92530886|NCT00043927|Topotecan|topotecan|mesh-list
92143485|NCT03583567|Antipruritics|antipruritics|mesh-ancestor
92530887|NCT00043927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530888|NCT00043927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92530889|NCT00043927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530890|NCT00043927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92143644|NCT03156361|Insulin|insulin|mesh-list
92530891|NCT00043927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143709|NCT05698771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92530892|NCT00043927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530893|NCT00043927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92530894|NCT00043966|Ritonavir|ritonavir|mesh-list
92530895|NCT00043966|Lopinavir|lopinavir|mesh-list
92530896|NCT00043966|Tenofovir|tenofovir|mesh-list
92530897|NCT00043966|Emtricitabine|emtricitabine|mesh-list
92530898|NCT00043966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92530899|NCT00043966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92530900|NCT00043966|Protease Inhibitors|protease inhibitors|mesh-ancestor
92530901|NCT00043966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530902|NCT00043966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530903|NCT00043966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92144013|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
92530904|NCT00043966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92530905|NCT00043966|Antiviral Agents|antiviral agents|mesh-ancestor
92144223|NCT01674127|Methyldopa|methyldopa|mesh-list
92530906|NCT00043966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530907|NCT00043966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92530908|NCT00043966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92530909|NCT00043966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92530910|NCT00043966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92530911|NCT00001598|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92530912|NCT00001598|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92530913|NCT00001598|Immunologic Factors|immunologic factors|mesh-ancestor
92530914|NCT00001598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530916|NCT04731727|Vitamin B Complex|vitamin b complex|mesh-ancestor
92530917|NCT04731727|Vitamins|vitamins|mesh-ancestor
92530918|NCT04731727|Micronutrients|micronutrients|mesh-ancestor
92530919|NCT04731727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530920|NCT04731727|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92530921|NCT04731727|Dermatologic Agents|dermatologic agents|mesh-ancestor
92530922|NCT00044278|Lamotrigine|lamotrigine|mesh-list
92530923|NCT00044278|Anticonvulsants|anticonvulsants|mesh-ancestor
92530924|NCT00044278|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92530925|NCT00044278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530926|NCT00044278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530927|NCT00044278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92144656|NCT03805399|Tubulin Modulators|tubulin modulators|mesh-ancestor
92353949|NCT04344678|Sildenafil Citrate|sildenafil citrate|mesh-list
92530928|NCT00044278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530929|NCT00044278|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92530930|NCT00044278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92530931|NCT00044278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92530932|NCT00044278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92530933|NCT00044278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92530934|NCT00044395|Ruboxistaurin|ruboxistaurin|mesh-list
92530935|NCT00044395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530936|NCT00044395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530938|NCT00044434|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92530939|NCT00044434|Antidepressive Agents|antidepressive agents|mesh-ancestor
92530940|NCT00044434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92530941|NCT00044434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92144730|NCT01279551|Anesthetics, Local|anesthetics, local|mesh-ancestor
92144791|NCT03630211|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92530942|NCT00044434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92530943|NCT00044434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92530944|NCT00044434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530945|NCT00044434|Dopamine Agents|dopamine agents|mesh-ancestor
92530947|NCT00044434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530948|NCT00044434|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92530949|NCT00044434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92530950|NCT00044434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530951|NCT00044473|Levofloxacin|levofloxacin|mesh-list
92530952|NCT00044473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92530953|NCT00044473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92530954|NCT00044473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92530955|NCT00044473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92530956|NCT00044473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92530957|NCT00044473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530958|NCT00044473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530959|NCT00044473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530960|NCT00044473|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92530961|NCT00044473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92530962|NCT00044551|Taxane|taxane|mesh-list
92530963|NCT00044551|IDN 5109|idn 5109|mesh-list
92530964|NCT00044551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530965|NCT00018135|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92530966|NCT00018135|Calcium|calcium|mesh-list
92530967|NCT00018135|Sevelamer|sevelamer|mesh-list
92530968|NCT00018135|Calcium acetate|calcium acetate|mesh-list
92530969|NCT00018135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92530970|NCT00018135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530971|NCT00018135|Chelating Agents|chelating agents|mesh-ancestor
92530972|NCT00018135|Sequestering Agents|sequestering agents|mesh-ancestor
92145151|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92530973|NCT00018135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530974|NCT00018135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92530975|NCT00018135|Immunologic Factors|immunologic factors|mesh-ancestor
92530977|NCT00018135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92530978|NCT00397384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92530979|NCT00397384|Cetuximab|cetuximab|mesh-list
92530980|NCT00397384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92530981|NCT00397384|Antibodies|antibodies|mesh-list
92530982|NCT00397384|Immunoglobulins|immunoglobulins|mesh-list
92530983|NCT00397384|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92530984|NCT00397384|Immunologic Factors|immunologic factors|mesh-ancestor
92530985|NCT00397384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530986|NCT00397384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258603|NCT02228681|Tamoxifen|tamoxifen|mesh-list
92530987|NCT00397384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92530988|NCT00397384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92530989|NCT00397384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92530990|NCT00397423|Lenograstim|lenograstim|mesh-list
92530991|NCT00397423|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92530992|NCT00397423|Immunologic Factors|immunologic factors|mesh-ancestor
92145643|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92145715|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
92530993|NCT00397423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92530994|NCT00397501|Sodium thiosulfate|sodium thiosulfate|mesh-list
92530995|NCT00397501|Carboplatin|carboplatin|mesh-list
92530996|NCT00397501|Methotrexate|methotrexate|mesh-list
92530997|NCT00397501|Trastuzumab|trastuzumab|mesh-list
92530998|NCT00397501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92530999|NCT00397501|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92531000|NCT00397501|Abortifacient Agents|abortifacient agents|mesh-ancestor
92531001|NCT00397501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92255762|NCT03217838|Venetoclax|venetoclax|mesh-list
92531002|NCT00397501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531003|NCT00397501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531004|NCT00397501|Antimetabolites|antimetabolites|mesh-ancestor
92531005|NCT00397501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531006|NCT00397501|Dermatologic Agents|dermatologic agents|mesh-ancestor
92531007|NCT00397501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531008|NCT00397501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92531009|NCT00397501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531010|NCT00397501|Immunologic Factors|immunologic factors|mesh-ancestor
92531011|NCT00397501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531012|NCT00397501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92531013|NCT00397501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531014|NCT00397501|Antidotes|antidotes|mesh-ancestor
92531015|NCT00397501|Protective Agents|protective agents|mesh-ancestor
92531016|NCT00397501|Antioxidants|antioxidants|mesh-ancestor
92531017|NCT00397501|Antitubercular Agents|antitubercular agents|mesh-ancestor
92531018|NCT00397501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531019|NCT00397501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531020|NCT00397501|Chelating Agents|chelating agents|mesh-ancestor
92531021|NCT00397501|Sequestering Agents|sequestering agents|mesh-ancestor
92146443|NCT00086281|Zolpidem|zolpidem|mesh-list
92146505|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531023|NCT00018174|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92531024|NCT00018174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531025|NCT00018174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146655|NCT01425281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531026|NCT00018174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531027|NCT00018174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146801|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92531029|NCT00018174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531030|NCT00018174|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92531031|NCT00018174|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531033|NCT00018174|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92531034|NCT00018174|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531035|NCT00018174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531036|NCT00044629|Zolpidem|zolpidem|mesh-list
92531037|NCT00044629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92531038|NCT00044629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92531039|NCT00044629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531040|NCT00044629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531041|NCT00044629|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92147316|NCT01499576|Acetic Acid|acetic acid|mesh-list
92531042|NCT00044629|GABA Agonists|gaba agonists|mesh-ancestor
92531043|NCT00044629|GABA Agents|gaba agents|mesh-ancestor
92531045|NCT00044629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531047|NCT00044668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531048|NCT00044668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531049|NCT00044668|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92531050|NCT00044668|Incretins|incretins|mesh-ancestor
92531052|NCT00044668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92531054|NCT00044707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531055|NCT00044707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531056|NCT00044746|Tazobactam|tazobactam|mesh-list
92531058|NCT00044746|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92531059|NCT00044746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531060|NCT00044746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531061|NCT00044746|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92531062|NCT00044746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531063|NCT00044746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531064|NCT00044785|Leucovorin|leucovorin|mesh-list
92148362|NCT03336073|Hormones|hormones|mesh-ancestor
92531066|NCT00044785|Irinotecan|irinotecan|mesh-list
92531067|NCT00044785|Antimetabolites|antimetabolites|mesh-ancestor
92531068|NCT00044785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531069|NCT00044785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531070|NCT00044785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531071|NCT00044785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531072|NCT00044785|Immunologic Factors|immunologic factors|mesh-ancestor
92531073|NCT00044785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531074|NCT00044785|Antidotes|antidotes|mesh-ancestor
92531075|NCT00044785|Protective Agents|protective agents|mesh-ancestor
92531076|NCT00044785|Vitamin B Complex|vitamin b complex|mesh-ancestor
92531078|NCT00044785|Micronutrients|micronutrients|mesh-ancestor
92148730|NCT04278469|Antineoplastic Agents|antineoplastic agents|mesh-list
92531079|NCT00044785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92531080|NCT00044785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92149023|NCT02647866|KHK4083|khk4083|mesh-list
92531082|NCT00044824|Fexofenadine|fexofenadine|mesh-list
92531083|NCT00044824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92531084|NCT00044824|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92531085|NCT00044824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92149243|NCT04398589|Analgesics|analgesics|mesh-ancestor
92531087|NCT00044824|Histamine Agents|histamine agents|mesh-ancestor
92531088|NCT00044824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531089|NCT00044824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531090|NCT00044824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531091|NCT00018213|Naltrexone|naltrexone|mesh-list
92531092|NCT00018213|Nicotine|nicotine|mesh-list
92531093|NCT00018213|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92531094|NCT00018213|Autonomic Agents|autonomic agents|mesh-ancestor
92531095|NCT00018213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531096|NCT00018213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531097|NCT00018213|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92531099|NCT00018213|Cholinergic Agents|cholinergic agents|mesh-ancestor
92531100|NCT00018213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531101|NCT00018213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531102|NCT00018213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92531103|NCT00018213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92531104|NCT00018213|Sensory System Agents|sensory system agents|mesh-ancestor
92531105|NCT00044863|Cetuximab|cetuximab|mesh-list
92531106|NCT00044863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531107|NCT00044863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531110|NCT00044902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531111|NCT00045136|Melphalan|melphalan|mesh-list
92150215|NCT01831011|Aspirin|aspirin|mesh-list
92531112|NCT00045136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92150436|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531114|NCT00045136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531115|NCT00045136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531116|NCT00045136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92150656|NCT05366777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92531117|NCT00045136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531118|NCT00045136|Immunologic Factors|immunologic factors|mesh-ancestor
92531119|NCT00045136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531120|NCT00001649|Valacyclovir|valacyclovir|mesh-list
92531122|NCT00001649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151247|NCT01929421|Gemcitabine|gemcitabine|mesh-list
92531123|NCT00018291|Gabapentin|gabapentin|mesh-list
92151336|NCT05061732|Antacids|antacids|mesh-ancestor
92531124|NCT00018291|Risperidone|risperidone|mesh-list
92531125|NCT00018291|Analgesics|analgesics|mesh-ancestor
92531126|NCT00018291|Sensory System Agents|sensory system agents|mesh-ancestor
92531127|NCT00018291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151481|NCT01835691|Vitamin D|vitamin d|mesh-list
92531128|NCT00018291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531129|NCT00018291|Anticonvulsants|anticonvulsants|mesh-ancestor
92151548|NCT01720563|Vitamins|vitamins|mesh-ancestor
92531130|NCT00018291|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92531131|NCT00018291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92531132|NCT00018291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531133|NCT00018291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92151772|NCT05054322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92531134|NCT00018291|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92151843|NCT01048671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531135|NCT00018291|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92531136|NCT00018291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531137|NCT00018291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531138|NCT00018291|Antimanic Agents|antimanic agents|mesh-ancestor
92531139|NCT00018291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92531141|NCT00018291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92531142|NCT00018291|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92531143|NCT00018291|Dopamine Agents|dopamine agents|mesh-ancestor
92531144|NCT00045175|Topotecan|topotecan|mesh-list
92531145|NCT00045175|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92531146|NCT00045175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92531147|NCT00045175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92152427|NCT01040871|Prednisone|prednisone|mesh-list
92531148|NCT00045175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531149|NCT00045175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152799|NCT03092544|Dermatologic Agents|dermatologic agents|mesh-ancestor
92255913|NCT01839500|Trastuzumab|trastuzumab|mesh-list
92531151|NCT00045175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531153|NCT00045292|Acyclovir|acyclovir|mesh-list
92531154|NCT00045292|Antiviral Agents|antiviral agents|mesh-ancestor
92531155|NCT00045292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531156|NCT00045370|Interferons|interferons|mesh-list
92531157|NCT00045370|Interferon-alpha|interferon-alpha|mesh-list
92531158|NCT00045370|Sirolimus|sirolimus|mesh-list
92531159|NCT00045370|Temsirolimus|temsirolimus|mesh-list
92153412|NCT05018988|Vitamin D|vitamin d|mesh-list
92531160|NCT00045370|MTOR Inhibitors|mtor inhibitors|mesh-list
92531161|NCT00045370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531162|NCT00045370|Antiviral Agents|antiviral agents|mesh-ancestor
92531163|NCT00045370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153579|NCT02242383|Telmisartan|telmisartan|mesh-list
92531164|NCT00045370|Immunologic Factors|immunologic factors|mesh-ancestor
92153715|NCT04365309|Antipyretics|antipyretics|mesh-ancestor
92531165|NCT00045370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531166|NCT00045370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531167|NCT00045370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531168|NCT00045370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531169|NCT00045370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531170|NCT00045370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531171|NCT00045370|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92531172|NCT00045370|Antifungal Agents|antifungal agents|mesh-ancestor
92531173|NCT02970682|Tamoxifen|tamoxifen|mesh-list
92531175|NCT02970682|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92154095|NCT04024865|Domperidone|domperidone|mesh-list
92531176|NCT02970682|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92531177|NCT02970682|Hormone Antagonists|hormone antagonists|mesh-ancestor
92154157|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531178|NCT02970682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92531179|NCT02970682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531180|NCT02970682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92531181|NCT02970682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405342|NCT01436123|Everolimus|everolimus|mesh-list
92405351|NCT01436188|Ibuprofen|ibuprofen|mesh-list
92531182|NCT02970682|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92531183|NCT02970682|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92531184|NCT02970682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92531185|NCT02970682|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92531186|NCT02970682|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92531187|NCT02970682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531188|NCT02970682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531189|NCT00045448|Docetaxel|docetaxel|mesh-list
92531190|NCT00045448|Alvocidib|alvocidib|mesh-list
92405782|NCT05164159|Propofol|propofol|mesh-list
92531191|NCT00045448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531194|NCT00045448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92531195|NCT00045448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406085|NCT03979365|Tacrolimus|tacrolimus|mesh-list
92531196|NCT00045448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531197|NCT00045448|Growth Substances|growth substances|mesh-ancestor
92531198|NCT00045448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531199|NCT00045448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531200|NCT00045448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531201|NCT00045526|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92531202|NCT00045526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406368|NCT01438515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92531203|NCT00045526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531204|NCT00045526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531205|NCT00045526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531207|NCT00045565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531208|NCT00045604|Irinotecan|irinotecan|mesh-list
92531209|NCT00045604|Imatinib Mesylate|imatinib mesylate|mesh-list
92531210|NCT00045604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531211|NCT00045604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92531212|NCT00045604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92406808|NCT01441284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92406881|NCT01441700|Anesthetics|anesthetics|mesh-list
92531214|NCT00045604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406957|NCT01442311|Interferon-alpha|interferon-alpha|mesh-list
92531215|NCT00045604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531216|NCT00045682|Paclitaxel|paclitaxel|mesh-list
92407035|NCT01442610|Rasagiline|rasagiline|mesh-list
92407196|NCT01443195|Iron|iron|mesh-list
92531217|NCT00045682|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92531218|NCT00045682|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92531219|NCT00045682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92407350|NCT01444248|Metformin|metformin|mesh-list
92407407|NCT01444677|Beta-lapachone|beta-lapachone|mesh-list
92531220|NCT00045682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531221|NCT00045682|Tubulin Modulators|tubulin modulators|mesh-ancestor
92531223|NCT00045682|Mitosis Modulators|mitosis modulators|mesh-ancestor
92531224|NCT00045682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407773|NCT01446523|Lactulose|lactulose|mesh-list
92531227|NCT00045721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92408074|NCT01448499|Dopamine Agents|dopamine agents|mesh-ancestor
92531229|NCT00045721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531230|NCT00045721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531232|NCT04731766|Listerine|listerine|mesh-list
92531233|NCT04731766|Fluorides|fluorides|mesh-list
92531234|NCT04731766|Sodium Fluoride|sodium fluoride|mesh-list
92531235|NCT04731766|Cariostatic Agents|cariostatic agents|mesh-ancestor
92408387|NCT01451489|Tacrolimus|tacrolimus|mesh-list
92408447|NCT01452607|Antioxidants|antioxidants|mesh-ancestor
92531236|NCT04731766|Protective Agents|protective agents|mesh-ancestor
92531237|NCT04731766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531238|NCT04731766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92531239|NCT04731766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531240|NCT00045760|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92531241|NCT00045760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531242|NCT00018447|Fluorides|fluorides|mesh-list
92531243|NCT00018447|Cariostatic Agents|cariostatic agents|mesh-ancestor
92531244|NCT00018447|Protective Agents|protective agents|mesh-ancestor
92531245|NCT00018447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531247|NCT00001688|Nevirapine|nevirapine|mesh-list
92531248|NCT00001688|Stavudine|stavudine|mesh-list
92531250|NCT00001688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92531251|NCT00001688|Protease Inhibitors|protease inhibitors|mesh-ancestor
92531253|NCT00001688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531254|NCT00001688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92531256|NCT00001688|Antiviral Agents|antiviral agents|mesh-ancestor
92531257|NCT00001688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531258|NCT00001688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92531259|NCT00001688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531260|NCT00001688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92531261|NCT00001688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92531262|NCT00001688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92531263|NCT00001688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92531264|NCT00001688|Antimetabolites|antimetabolites|mesh-ancestor
92531266|NCT00389402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92531267|NCT00389402|Saquinavir|saquinavir|mesh-list
92531268|NCT00389402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92531269|NCT00389402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92531270|NCT00389402|Protease Inhibitors|protease inhibitors|mesh-ancestor
92531271|NCT00389402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531272|NCT00389402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531274|NCT00389402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92531275|NCT00389402|Antiviral Agents|antiviral agents|mesh-ancestor
92531276|NCT00389402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531277|NCT00389402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92531278|NCT00389402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531279|NCT00001703|Freund's Adjuvant|freund's adjuvant|mesh-list
92531280|NCT00001703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92531281|NCT00001703|Immunologic Factors|immunologic factors|mesh-ancestor
92531282|NCT00001703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531283|NCT00045799|Omeprazole|omeprazole|mesh-list
92531284|NCT00045799|Cimetidine|cimetidine|mesh-list
92531285|NCT00045799|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92531286|NCT00045799|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92531287|NCT00045799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92531288|NCT00045799|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92531289|NCT00045799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531290|NCT00045799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531291|NCT00045799|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92531292|NCT00045799|Histamine Antagonists|histamine antagonists|mesh-ancestor
92531293|NCT00045799|Histamine Agents|histamine agents|mesh-ancestor
92531294|NCT00045799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531295|NCT00045799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531296|NCT00045799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92531297|NCT00045799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531298|NCT04394130|Ropivacaine|ropivacaine|mesh-list
92531299|NCT04394130|Anesthetics, Local|anesthetics, local|mesh-ancestor
92531300|NCT04394130|Anesthetics|anesthetics|mesh-ancestor
92531301|NCT04394130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531302|NCT04394130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531303|NCT04394130|Sensory System Agents|sensory system agents|mesh-ancestor
92531304|NCT04394130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531305|NCT00045877|Aldesleukin|aldesleukin|mesh-list
92531307|NCT00045877|Interleukin-2|interleukin-2|mesh-list
92531308|NCT00045877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531309|NCT00045877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531310|NCT00045877|Immunologic Factors|immunologic factors|mesh-ancestor
92531311|NCT00045877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531313|NCT00045877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92531314|NCT00045877|Analgesics|analgesics|mesh-ancestor
92531315|NCT00045877|Sensory System Agents|sensory system agents|mesh-ancestor
92531316|NCT00045877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531318|NCT00045877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92531319|NCT00045877|Antiviral Agents|antiviral agents|mesh-ancestor
92531320|NCT00045877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531321|NCT00045916|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92531322|NCT00045916|Nortriptyline|nortriptyline|mesh-list
92531323|NCT00045916|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531324|NCT00045916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531325|NCT00045916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531326|NCT00045916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531327|NCT00045916|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92531328|NCT00045916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531329|NCT00045916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531330|NCT00045916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531331|NCT00045916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92531332|NCT00045916|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92531333|NCT00045916|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92531334|NCT00045916|Adrenergic Agents|adrenergic agents|mesh-ancestor
92531336|NCT04380207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92531337|NCT04380207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531338|NCT04380207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531339|NCT04380207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531340|NCT04380207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531341|NCT00045955|Fexofenadine|fexofenadine|mesh-list
92531342|NCT00045955|Montelukast|montelukast|mesh-list
92531343|NCT00045955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92531344|NCT00045955|Respiratory System Agents|respiratory system agents|mesh-ancestor
92531345|NCT00045955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92531346|NCT00045955|Hormone Antagonists|hormone antagonists|mesh-ancestor
92531347|NCT00045955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92531348|NCT00045955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531349|NCT00045955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92531350|NCT00045955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92531351|NCT00045955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531352|NCT00045955|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92531353|NCT00045955|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92531354|NCT00045955|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92531355|NCT00045955|Histamine Antagonists|histamine antagonists|mesh-ancestor
92531356|NCT00045955|Histamine Agents|histamine agents|mesh-ancestor
92531357|NCT00045955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531359|NCT00046033|Lopinavir|lopinavir|mesh-list
92531360|NCT00046033|Saquinavir|saquinavir|mesh-list
92531362|NCT00046033|Tenofovir|tenofovir|mesh-list
92531363|NCT00046033|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92531364|NCT00046033|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92353962|NCT03249558|Analgesics|analgesics|mesh-ancestor
92531365|NCT00046033|Protease Inhibitors|protease inhibitors|mesh-ancestor
92531366|NCT00046033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531367|NCT00046033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531368|NCT00046033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92531369|NCT00046033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92531370|NCT00046033|Antiviral Agents|antiviral agents|mesh-ancestor
92531371|NCT00046033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531372|NCT00046033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92531373|NCT00046033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531374|NCT00046033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92531375|NCT00046033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92531376|NCT00046033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92531377|NCT00046033|Antitubercular Agents|antitubercular agents|mesh-ancestor
92531378|NCT00046033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531381|NCT04369560|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92531382|NCT04369560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92531383|NCT00046111|Topotecan|topotecan|mesh-list
92531384|NCT00046111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92531385|NCT00046111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92531386|NCT00046111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531387|NCT00046111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531388|NCT00046111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531389|NCT00001724|Flurbiprofen|flurbiprofen|mesh-list
92531390|NCT00001724|Analgesics|analgesics|mesh-ancestor
92531391|NCT00001724|Sensory System Agents|sensory system agents|mesh-ancestor
92531393|NCT00001724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531394|NCT00001724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92531395|NCT00001724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92531396|NCT00001724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92531397|NCT00001724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531398|NCT00001724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92531399|NCT00001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531400|NCT00001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531401|NCT00046150|Insulin glulisine|insulin glulisine|mesh-list
92531402|NCT00046150|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531403|NCT00046150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531404|NCT00046267|Niacin|niacin|mesh-list
92531405|NCT00046267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92531406|NCT00046267|Antimetabolites|antimetabolites|mesh-ancestor
92531407|NCT00046267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531408|NCT00046267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92531409|NCT00046267|Vasodilator Agents|vasodilator agents|mesh-ancestor
92531410|NCT00046267|Vitamin B Complex|vitamin b complex|mesh-ancestor
92531411|NCT00046267|Vitamins|vitamins|mesh-ancestor
92531412|NCT00046267|Micronutrients|micronutrients|mesh-ancestor
92531413|NCT00046267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531414|NCT00046306|Antioxidants|antioxidants|mesh-list
92531415|NCT00046306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531416|NCT00046306|Protective Agents|protective agents|mesh-ancestor
92531417|NCT00046306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531420|NCT00046345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92531421|NCT00046345|Protease Inhibitors|protease inhibitors|mesh-ancestor
92531422|NCT00046345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531423|NCT00046345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531424|NCT00046345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92531425|NCT00046345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92531426|NCT00046345|Antiviral Agents|antiviral agents|mesh-ancestor
92531427|NCT00046345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531428|NCT00397657|Niacin|niacin|mesh-list
92531429|NCT00397657|Ezetimibe|ezetimibe|mesh-list
92531430|NCT00397657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92531431|NCT00397657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92531432|NCT00397657|Antimetabolites|antimetabolites|mesh-ancestor
92531433|NCT00397657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531434|NCT00397657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92531435|NCT00397657|Vasodilator Agents|vasodilator agents|mesh-ancestor
92531436|NCT00397657|Vitamin B Complex|vitamin b complex|mesh-ancestor
92531437|NCT00397657|Vitamins|vitamins|mesh-ancestor
92531438|NCT00397657|Micronutrients|micronutrients|mesh-ancestor
92531439|NCT00397657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531440|NCT00001763|Interleukin-12|interleukin-12|mesh-list
92531441|NCT00001763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92531442|NCT00001763|Immunologic Factors|immunologic factors|mesh-ancestor
92531443|NCT00001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531444|NCT00001763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92531445|NCT00001763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92531446|NCT00001763|Growth Substances|growth substances|mesh-ancestor
92531447|NCT00001763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531448|NCT00001763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531449|NCT00397735|Acetylcysteine|acetylcysteine|mesh-list
92531451|NCT00397735|Antiviral Agents|antiviral agents|mesh-ancestor
92531452|NCT00397735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531453|NCT00397735|Expectorants|expectorants|mesh-ancestor
92531454|NCT00397735|Respiratory System Agents|respiratory system agents|mesh-ancestor
92531455|NCT00397735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92531456|NCT00397735|Antioxidants|antioxidants|mesh-ancestor
92531457|NCT00397735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531458|NCT00397735|Protective Agents|protective agents|mesh-ancestor
92531459|NCT00397735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531460|NCT00397735|Antidotes|antidotes|mesh-ancestor
92531461|NCT00046384|Aripiprazole|aripiprazole|mesh-list
92531462|NCT00046384|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531463|NCT00046384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531464|NCT00046384|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92531465|NCT00046384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92531466|NCT00046384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531467|NCT00046384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531469|NCT00046384|Dopamine Agents|dopamine agents|mesh-ancestor
92531470|NCT00046384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531471|NCT00046384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531472|NCT00046384|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92531473|NCT00046384|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92531474|NCT00046384|Serotonin Agents|serotonin agents|mesh-ancestor
92531475|NCT00046384|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92531476|NCT00046384|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92531477|NCT00046384|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92531478|NCT00046384|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92531479|NCT00046423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92531480|NCT00046423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531482|NCT04258410|Antioxidants|antioxidants|mesh-ancestor
92531483|NCT04258410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531484|NCT04258410|Protective Agents|protective agents|mesh-ancestor
92531485|NCT04258410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531487|NCT00046462|Insulin Glargine|insulin glargine|mesh-list
92531488|NCT00046462|Glyburide|glyburide|mesh-list
92531489|NCT00046462|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92531490|NCT00046462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531491|NCT00046462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531492|NCT00001766|Ritonavir|ritonavir|mesh-list
92531493|NCT00001766|Nelfinavir|nelfinavir|mesh-list
92531494|NCT00001766|Amprenavir|amprenavir|mesh-list
92531495|NCT00001766|Abacavir|abacavir|mesh-list
92531497|NCT00001766|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92531498|NCT00001766|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92531499|NCT00001766|Protease Inhibitors|protease inhibitors|mesh-ancestor
92531500|NCT00001766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531501|NCT00001766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531503|NCT00001766|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92531504|NCT00001766|Antiviral Agents|antiviral agents|mesh-ancestor
92531505|NCT00001766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531506|NCT00001766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92531507|NCT00001766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531508|NCT00001766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92531509|NCT00001766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92531510|NCT00001766|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92531511|NCT00001766|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92531512|NCT00001766|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92531513|NCT00001766|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92531514|NCT00001766|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92531515|NCT00001766|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92531516|NCT00001766|Antitubercular Agents|antitubercular agents|mesh-ancestor
92531517|NCT00001766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531518|NCT00046501|Insulin|insulin|mesh-list
92531519|NCT00046501|Insulin Glargine|insulin glargine|mesh-list
92531520|NCT00046501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92531521|NCT00046501|Insulin, Isophane|insulin, isophane|mesh-list
92531522|NCT00046501|Isophane Insulin, Human|isophane insulin, human|mesh-list
92531523|NCT00046501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531524|NCT00046501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531525|NCT00046735|Lenalidomide|lenalidomide|mesh-list
92256357|NCT01721798|Copper|copper|mesh-list
92531526|NCT00046735|Immunologic Factors|immunologic factors|mesh-ancestor
92531527|NCT00046735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531529|NCT00046735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92531530|NCT00046735|Growth Substances|growth substances|mesh-ancestor
92531531|NCT00046735|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531532|NCT00046735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531533|NCT00001784|Mexiletine|mexiletine|mesh-list
92531534|NCT00001784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92531535|NCT00001784|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92531536|NCT00001784|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92531537|NCT00001784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531538|NCT00001784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531539|NCT00046813|Nicotine|nicotine|mesh-list
92531540|NCT00046813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92531541|NCT00046813|Autonomic Agents|autonomic agents|mesh-ancestor
92531542|NCT00046813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531543|NCT00046813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531544|NCT00046813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92531545|NCT00046813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92531546|NCT00046813|Cholinergic Agents|cholinergic agents|mesh-ancestor
92531547|NCT00046813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531548|NCT00046813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531549|NCT00046852|Cyclophosphamide|cyclophosphamide|mesh-list
92531551|NCT00046852|Carmustine|carmustine|mesh-list
92531552|NCT00046852|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92531553|NCT00046852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531554|NCT00046852|Immunologic Factors|immunologic factors|mesh-ancestor
92531555|NCT00046852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531556|NCT00046852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531557|NCT00046852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92531559|NCT00046852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531560|NCT00046852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531561|NCT00046852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92531562|NCT00046969|Cisplatin|cisplatin|mesh-list
92531565|NCT00001805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531566|NCT00001805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531567|NCT00001805|Immunologic Factors|immunologic factors|mesh-ancestor
92531568|NCT00001805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531569|NCT00001805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531570|NCT00047047|Gemcitabine|gemcitabine|mesh-list
92531571|NCT00047047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531572|NCT00047047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531574|NCT00047047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531575|NCT04733781|Lidocaine|lidocaine|mesh-list
92531576|NCT04733781|Epinephrine|epinephrine|mesh-list
92531577|NCT04733781|Anesthetics, Local|anesthetics, local|mesh-ancestor
92533865|NCT00062686|Lapatinib|lapatinib|mesh-list
92531579|NCT04733781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531581|NCT04733781|Sensory System Agents|sensory system agents|mesh-ancestor
92531582|NCT04733781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531583|NCT04733781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92531584|NCT04733781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92531585|NCT04733781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92531586|NCT04733781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531587|NCT04733781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531588|NCT04733781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92531589|NCT04733781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92531590|NCT04733781|Adrenergic Agents|adrenergic agents|mesh-ancestor
92531591|NCT04733781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531592|NCT04733781|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92531593|NCT04733781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92531594|NCT04733781|Autonomic Agents|autonomic agents|mesh-ancestor
92531595|NCT04733781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92531596|NCT04733781|Respiratory System Agents|respiratory system agents|mesh-ancestor
92531597|NCT04733781|Mydriatics|mydriatics|mesh-ancestor
92531599|NCT04733781|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92531600|NCT00047164|Ipilimumab|ipilimumab|mesh-list
92531601|NCT00047164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531602|NCT00047164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531603|NCT00047164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92531604|NCT00047164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531605|NCT00047203|Alvocidib|alvocidib|mesh-list
92531606|NCT00047203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531607|NCT00047203|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531608|NCT00047203|Growth Substances|growth substances|mesh-ancestor
92531609|NCT00047203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531610|NCT00047203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531611|NCT00047203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531612|NCT00047203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531613|NCT04163874|Pramlintide|pramlintide|mesh-list
92531614|NCT04163874|Pancrelipase|pancrelipase|mesh-list
92531615|NCT04163874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92531616|NCT04163874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531617|NCT04163874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531619|NCT00047242|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92531620|NCT00047242|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92531621|NCT00047242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92531622|NCT00047242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531623|NCT00047242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531624|NCT00047242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531625|NCT00047242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531626|NCT00047281|Thalidomide|thalidomide|mesh-list
92531627|NCT00047281|Celecoxib|celecoxib|mesh-list
92531628|NCT00047281|Cyclophosphamide|cyclophosphamide|mesh-list
92531629|NCT00047281|Etoposide|etoposide|mesh-list
92531630|NCT00047281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531631|NCT00047281|Immunologic Factors|immunologic factors|mesh-ancestor
92531632|NCT00047281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531633|NCT00047281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531634|NCT00047281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92531635|NCT00047281|Alkylating Agents|alkylating agents|mesh-ancestor
92531636|NCT00047281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531637|NCT00047281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531638|NCT00047281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92531639|NCT00047281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92531640|NCT00047281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92531641|NCT00047281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92531642|NCT00047281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531643|NCT00047281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92531645|NCT00047281|Analgesics|analgesics|mesh-ancestor
92531646|NCT00047281|Sensory System Agents|sensory system agents|mesh-ancestor
92531647|NCT00047281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531648|NCT00047281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92531649|NCT00047281|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92531650|NCT00047281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92531651|NCT00047281|Leprostatic Agents|leprostatic agents|mesh-ancestor
92531652|NCT00047281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531653|NCT00047281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531654|NCT00047281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92531655|NCT00047281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92531656|NCT00047281|Growth Substances|growth substances|mesh-ancestor
92531657|NCT00047281|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531658|NCT00047476|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92531659|NCT00047476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92531660|NCT00047476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531661|NCT00047476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92531662|NCT00047476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531663|NCT00047476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531664|NCT00047476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531665|NCT00047476|Dopamine Agents|dopamine agents|mesh-ancestor
92531666|NCT00047476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531667|NCT00047554|Travoprost|travoprost|mesh-list
92531668|NCT00047554|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92531669|NCT00047554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92531670|NCT00047554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92531671|NCT00047632|Interferons|interferons|mesh-list
92531672|NCT00047632|Interferon-gamma|interferon-gamma|mesh-list
92531673|NCT00047632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256447|NCT01728272|Metoprolol|metoprolol|mesh-list
92531674|NCT00047632|Antiviral Agents|antiviral agents|mesh-ancestor
92531675|NCT00047632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531676|NCT00047671|Citalopram|citalopram|mesh-list
92531677|NCT00047671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92531678|NCT00047671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531679|NCT00047671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531680|NCT00047671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531681|NCT00047671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531682|NCT00047671|Serotonin Agents|serotonin agents|mesh-ancestor
92531683|NCT00047671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531684|NCT00047671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92531685|NCT00047671|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531686|NCT00047671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531687|NCT00047710|Bevacizumab|bevacizumab|mesh-list
92531688|NCT00047710|Capecitabine|capecitabine|mesh-list
92531689|NCT00047710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531690|NCT00047710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531692|NCT00047710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92531693|NCT00047710|Growth Substances|growth substances|mesh-ancestor
92531694|NCT00047710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531695|NCT00047710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92531696|NCT00047710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531698|NCT00047710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531699|NCT00047749|Ziconotide|ziconotide|mesh-list
92531700|NCT00047749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92531701|NCT00047749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531702|NCT00047749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531703|NCT00047749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92531704|NCT00047749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531705|NCT00047749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92531706|NCT00047749|Protective Agents|protective agents|mesh-ancestor
92531707|NCT00047749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92531708|NCT00047749|Analgesics|analgesics|mesh-ancestor
92531709|NCT00047749|Sensory System Agents|sensory system agents|mesh-ancestor
92531710|NCT00047749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531711|NCT00047827|Amphotericin B|amphotericin b|mesh-list
92531712|NCT00047827|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92531713|NCT00047827|Micafungin|micafungin|mesh-list
92531714|NCT00047827|Amebicides|amebicides|mesh-ancestor
92531715|NCT00047827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92531716|NCT00047827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92531718|NCT00047827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531719|NCT00047827|Antifungal Agents|antifungal agents|mesh-ancestor
92531720|NCT00048139|Capecitabine|capecitabine|mesh-list
92531721|NCT00048139|Irinotecan|irinotecan|mesh-list
92531722|NCT00048139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531723|NCT00048139|Antimetabolites|antimetabolites|mesh-ancestor
92531724|NCT00048139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531726|NCT00048139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92531728|NCT00048139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531730|NCT00048334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92531731|NCT00048334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531732|NCT00048334|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92531734|NCT00048334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531735|NCT00048373|Etanercept|etanercept|mesh-list
92531736|NCT00048373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92531737|NCT00048373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92531738|NCT00048373|Analgesics|analgesics|mesh-ancestor
92531739|NCT00048373|Sensory System Agents|sensory system agents|mesh-ancestor
92531740|NCT00048373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531741|NCT00048373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531742|NCT00048373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92531744|NCT00048373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92531745|NCT00048373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531746|NCT00048373|Immunologic Factors|immunologic factors|mesh-ancestor
92531747|NCT05641337|Insulin|insulin|mesh-list
92531748|NCT05641337|Metformin|metformin|mesh-list
92531750|NCT05641337|Linagliptin|linagliptin|mesh-list
92531751|NCT05641337|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92531752|NCT05641337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531753|NCT05641337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531755|NCT05641337|Hormones|hormones|mesh-ancestor
92531756|NCT05641337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92531757|NCT05641337|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92531758|NCT05641337|Protease Inhibitors|protease inhibitors|mesh-ancestor
92531759|NCT05641337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531760|NCT05641337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531761|NCT00048412|Fludarabine|fludarabine|mesh-list
92531762|NCT00048412|Alemtuzumab|alemtuzumab|mesh-list
92531763|NCT00048412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531764|NCT00048412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92531765|NCT02970526|Oxaliplatin|oxaliplatin|mesh-list
92531766|NCT02970526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531767|NCT00048607|Aprepitant|aprepitant|mesh-list
92531768|NCT00048607|Paroxetine|paroxetine|mesh-list
92531769|NCT00048607|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92531770|NCT00048607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531771|NCT00048607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531772|NCT00048607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531773|NCT00048607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531774|NCT00048607|Serotonin Agents|serotonin agents|mesh-ancestor
92531776|NCT00048607|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92531777|NCT00048607|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531778|NCT00048607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531779|NCT00048607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92531780|NCT00048607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531781|NCT00048607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531783|NCT00048607|Autonomic Agents|autonomic agents|mesh-ancestor
92531784|NCT00048607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531785|NCT00048607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92531786|NCT00048607|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92531787|NCT00048646|Progesterone|progesterone|mesh-list
92531788|NCT00048646|Progestins|progestins|mesh-ancestor
92531789|NCT00048646|Hormones|hormones|mesh-ancestor
92531790|NCT00048646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92531791|NCT00048646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531792|NCT00048763|Cilostazol|cilostazol|mesh-list
92531793|NCT00048763|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92531794|NCT00048763|Autonomic Agents|autonomic agents|mesh-ancestor
92531795|NCT00048763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531796|NCT00048763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531797|NCT00048763|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92531798|NCT00048763|Respiratory System Agents|respiratory system agents|mesh-ancestor
92531799|NCT00048763|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92531800|NCT00048763|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92531801|NCT00048763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531803|NCT00048763|Vasodilator Agents|vasodilator agents|mesh-ancestor
92531804|NCT00048763|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92531805|NCT00048763|Protective Agents|protective agents|mesh-ancestor
92531806|NCT00048763|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92531807|NCT00048763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92531808|NCT00048763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531810|NCT05576298|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92531811|NCT05576298|Insulin, Long-Acting|insulin, long-acting|mesh-list
92531812|NCT05576298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92531813|NCT05576298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531814|NCT00048802|Valproic Acid|valproic acid|mesh-list
92531815|NCT00048802|Olanzapine|olanzapine|mesh-list
92531816|NCT00048802|Risperidone|risperidone|mesh-list
92531817|NCT00048802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92531818|NCT00048802|Ziprasidone|ziprasidone|mesh-list
92531819|NCT00048802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92531820|NCT00048802|Serotonin Agents|serotonin agents|mesh-ancestor
92531821|NCT00048802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531822|NCT00048802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531823|NCT00048802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531824|NCT00048802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92531825|NCT00048802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92531826|NCT00048802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92531827|NCT00048802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531828|NCT00048802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92531829|NCT00048802|Dopamine Agents|dopamine agents|mesh-ancestor
92531830|NCT00048802|Antiemetics|antiemetics|mesh-ancestor
92531831|NCT00048802|Autonomic Agents|autonomic agents|mesh-ancestor
92531832|NCT00048802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92531833|NCT00048802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92531834|NCT00048802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92531835|NCT00048802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531837|NCT00048802|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531838|NCT00048802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531839|NCT00048802|Antimanic Agents|antimanic agents|mesh-ancestor
92531840|NCT00048802|Anticonvulsants|anticonvulsants|mesh-ancestor
92531841|NCT00048802|GABA Agents|gaba agents|mesh-ancestor
92531842|NCT00048841|Alendronate|alendronate|mesh-list
92531843|NCT00048841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92531844|NCT00048841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531845|NCT00048880|Antibodies|antibodies|mesh-list
92531846|NCT00048880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92531847|NCT00048880|Immunologic Factors|immunologic factors|mesh-ancestor
92531848|NCT00048880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531849|NCT00049075|Fludarabine|fludarabine|mesh-list
92531850|NCT00049075|Fludarabine phosphate|fludarabine phosphate|mesh-list
92531851|NCT00049075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531852|NCT00049075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531853|NCT00049075|Antimetabolites|antimetabolites|mesh-ancestor
92531854|NCT00049075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531855|NCT00049075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531856|NCT00049075|Immunologic Factors|immunologic factors|mesh-ancestor
92531857|NCT00049075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531858|NCT00049114|Cyclophosphamide|cyclophosphamide|mesh-list
92408862|NCT05960942|Anesthetics|anesthetics|mesh-ancestor
92531859|NCT00049114|Doxorubicin|doxorubicin|mesh-list
92531860|NCT00049114|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92531861|NCT00049114|Tipifarnib|tipifarnib|mesh-list
92531862|NCT00049114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531863|NCT00049114|Immunologic Factors|immunologic factors|mesh-ancestor
92409005|NCT05954442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531864|NCT00049114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409074|NCT05915702|Chelating Agents|chelating agents|mesh-ancestor
92531865|NCT00049114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531866|NCT00049114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92531867|NCT00049114|Alkylating Agents|alkylating agents|mesh-ancestor
92409219|NCT05887726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531868|NCT00049114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531869|NCT00049114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531870|NCT00049114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92531871|NCT00049114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92531872|NCT00049114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92531873|NCT00049114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92531874|NCT00049114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531875|NCT00049192|Imatinib Mesylate|imatinib mesylate|mesh-list
92531876|NCT00049192|Oblimersen|oblimersen|mesh-list
92531877|NCT00049192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531878|NCT00049192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92531879|NCT00049192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531880|NCT00049192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531881|NCT05576181|Cyclophosphamide|cyclophosphamide|mesh-list
92531882|NCT05576181|Fludarabine|fludarabine|mesh-list
92531883|NCT05576181|Etoposide|etoposide|mesh-list
92531884|NCT05576181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92531885|NCT05576181|Immunologic Factors|immunologic factors|mesh-ancestor
92531886|NCT05576181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531887|NCT05576181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531888|NCT05576181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92531889|NCT05576181|Alkylating Agents|alkylating agents|mesh-ancestor
92531890|NCT05576181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531891|NCT05576181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531892|NCT05576181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92531893|NCT05576181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92531894|NCT05576181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92531895|NCT05576181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92531896|NCT05576181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531897|NCT00049387|Temozolomide|temozolomide|mesh-list
92531898|NCT00049387|Tipifarnib|tipifarnib|mesh-list
92531899|NCT00049387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92531900|NCT00049387|Alkylating Agents|alkylating agents|mesh-ancestor
92531901|NCT00049387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531902|NCT00049387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531903|NCT05640791|Paclitaxel|paclitaxel|mesh-list
92531904|NCT05640791|Gemcitabine|gemcitabine|mesh-list
92531905|NCT05640791|Durvalumab|durvalumab|mesh-list
92531906|NCT05640791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92531907|NCT05640791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531908|NCT05640791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92531909|NCT05640791|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409738|NCT05620901|Prednisolone|prednisolone|mesh-list
92531910|NCT05640791|Mitosis Modulators|mitosis modulators|mesh-ancestor
92531911|NCT05640791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531912|NCT05640791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531914|NCT05640791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409919|NCT05577702|Tislelizumab|tislelizumab|mesh-list
92531915|NCT00391911|Acetylcysteine|acetylcysteine|mesh-list
92531916|NCT00391911|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92531917|NCT00391911|Antiviral Agents|antiviral agents|mesh-ancestor
92531918|NCT00391911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531919|NCT00391911|Expectorants|expectorants|mesh-ancestor
92531920|NCT00391911|Respiratory System Agents|respiratory system agents|mesh-ancestor
92531921|NCT00391911|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92531922|NCT00391911|Antioxidants|antioxidants|mesh-ancestor
92531923|NCT00391911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531924|NCT00391911|Protective Agents|protective agents|mesh-ancestor
92531925|NCT00391911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531926|NCT00391911|Antidotes|antidotes|mesh-ancestor
92531927|NCT02970409|Heparin|heparin|mesh-list
92531928|NCT02970409|Anticoagulants|anticoagulants|mesh-ancestor
92531929|NCT02970409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92410581|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
92531930|NCT02970409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92531931|NCT02970409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531932|NCT00049582|Decitabine|decitabine|mesh-list
92531933|NCT00049582|Azacitidine|azacitidine|mesh-list
92531934|NCT00049582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92531935|NCT00049582|Antimetabolites|antimetabolites|mesh-ancestor
92531936|NCT00049582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531937|NCT00049582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531938|NCT00049582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531939|NCT00049660|Capecitabine|capecitabine|mesh-list
92531940|NCT00049660|Vinorelbine|vinorelbine|mesh-list
92531941|NCT00049660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411315|NCT04518410|Immunologic Factors|immunologic factors|mesh-ancestor
92531943|NCT00049660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411396|NCT04370795|Sirolimus|sirolimus|mesh-list
92531944|NCT00049660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411460|NCT04279054|Analgesics|analgesics|mesh-ancestor
92531945|NCT00049660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92531946|NCT00049660|Tubulin Modulators|tubulin modulators|mesh-ancestor
92531948|NCT00049660|Mitosis Modulators|mitosis modulators|mesh-ancestor
92531949|NCT05640713|Cyclophosphamide|cyclophosphamide|mesh-list
92531950|NCT05640713|Fludarabine|fludarabine|mesh-list
92531952|NCT05640713|Immunologic Factors|immunologic factors|mesh-ancestor
92531953|NCT05640713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531954|NCT05640713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92531955|NCT05640713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92531956|NCT05640713|Alkylating Agents|alkylating agents|mesh-ancestor
92412043|NCT03605927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531957|NCT05640713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531958|NCT05640713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92531959|NCT05640713|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92531960|NCT00391950|Zoledronic Acid|zoledronic acid|mesh-list
92531961|NCT00391950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92531962|NCT00391950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531963|NCT00049777|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92531964|NCT00049777|Heparin|heparin|mesh-list
92531965|NCT00049777|Calcium heparin|calcium heparin|mesh-list
92412569|NCT02419495|Ipilimumab|ipilimumab|mesh-list
92531966|NCT00049777|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92531967|NCT00049777|Tinzaparin|tinzaparin|mesh-list
92531968|NCT00049777|Dalteparin|dalteparin|mesh-list
92531969|NCT00049777|Anticoagulants|anticoagulants|mesh-ancestor
92531970|NCT00049777|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92531971|NCT00049777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92412791|NCT01614197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92531972|NCT00049777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531974|NCT00392028|Ertapenem|ertapenem|mesh-list
92531975|NCT00392028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531976|NCT00392028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531977|NCT00392067|Calcipotriene|calcipotriene|mesh-list
92531978|NCT00392067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92531980|NCT00389558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92531981|NCT00389558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92531983|NCT00049972|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92531984|NCT00049972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92531985|NCT00049972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92531986|NCT00049972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92531987|NCT00049972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92531988|NCT00049972|Serotonin Agents|serotonin agents|mesh-ancestor
92531989|NCT00049972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92531990|NCT00049972|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92531991|NCT00049972|Antidepressive Agents|antidepressive agents|mesh-ancestor
92531992|NCT00049972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92531993|NCT00049972|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92531994|NCT00049972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92531995|NCT00049972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92531996|NCT00389636|Becaplermin|becaplermin|mesh-list
92531997|NCT00389636|Anticoagulants|anticoagulants|mesh-ancestor
92531998|NCT00389636|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92531999|NCT00389636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92532000|NCT00389636|Growth Substances|growth substances|mesh-ancestor
92532001|NCT00389636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532002|NCT00050206|Olanzapine|olanzapine|mesh-list
92532003|NCT00050206|Antiemetics|antiemetics|mesh-ancestor
92532004|NCT00050206|Autonomic Agents|autonomic agents|mesh-ancestor
92532005|NCT00050206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532006|NCT00050206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532007|NCT00050206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92532008|NCT00050206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92532009|NCT00050206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92532010|NCT00050206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532011|NCT00050206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92532012|NCT00050206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92532013|NCT00050206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92532014|NCT00050206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532015|NCT00050206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532016|NCT00050206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532017|NCT00050206|Serotonin Agents|serotonin agents|mesh-ancestor
92532018|NCT00050245|Rituximab|rituximab|mesh-list
92532019|NCT00050245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92532020|NCT00050245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532021|NCT00050245|Immunologic Factors|immunologic factors|mesh-ancestor
92532022|NCT00050245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532025|NCT00050362|Bupivacaine|bupivacaine|mesh-list
92532026|NCT00050362|Anesthetics, Local|anesthetics, local|mesh-ancestor
92532027|NCT00050362|Anesthetics|anesthetics|mesh-ancestor
92532028|NCT00050362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532029|NCT00050362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532031|NCT00050362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532032|NCT00050362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92532033|NCT00050362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92532034|NCT00050362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532035|NCT00050362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532036|NCT00050362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92532037|NCT00050362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92532038|NCT00050362|Analgesics|analgesics|mesh-ancestor
92532040|NCT00050362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532041|NCT00050401|Vancomycin|vancomycin|mesh-list
92532042|NCT00050401|Tobramycin|tobramycin|mesh-list
92532043|NCT00050401|Meropenem|meropenem|mesh-list
92532044|NCT00050401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92532045|NCT00050401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532046|NCT05640362|Benzydamine|benzydamine|mesh-list
92532047|NCT05640362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532048|NCT00050440|Dexamethasone|dexamethasone|mesh-list
92532049|NCT00050440|Trabectedin|trabectedin|mesh-list
92532050|NCT00050440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532051|NCT00050440|Antiemetics|antiemetics|mesh-ancestor
92532052|NCT00050440|Autonomic Agents|autonomic agents|mesh-ancestor
92532053|NCT00050440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532054|NCT00050440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532055|NCT00050440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92532056|NCT00050440|Glucocorticoids|glucocorticoids|mesh-ancestor
92532058|NCT00050440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532059|NCT00050440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92532060|NCT00050440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532061|NCT00050440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532062|NCT00050440|Alkylating Agents|alkylating agents|mesh-ancestor
92532063|NCT00050440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532064|NCT00050479|Celecoxib|celecoxib|mesh-list
92532065|NCT00050479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92532066|NCT00050479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92532068|NCT00050479|Sensory System Agents|sensory system agents|mesh-ancestor
92532069|NCT00050479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532070|NCT00050479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532071|NCT00050479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532072|NCT00050479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532073|NCT00050479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92532074|NCT00050479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92532075|NCT00050479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532076|NCT00050479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532077|NCT00050596|Docetaxel|docetaxel|mesh-list
92532078|NCT00050596|Ipilimumab|ipilimumab|mesh-list
92532079|NCT00050596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532080|NCT00050596|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532081|NCT00050596|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532082|NCT00050596|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532083|NCT00050596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533886|NCT00062881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532084|NCT00050596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92532085|NCT00050596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92532087|NCT00050635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92532088|NCT00050635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92532089|NCT00050635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532091|NCT00050674|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92532092|NCT00050674|Immunologic Factors|immunologic factors|mesh-ancestor
92532093|NCT00050674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532094|NCT00050713|Sirolimus|sirolimus|mesh-list
92532095|NCT00050713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92532096|NCT00050713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532097|NCT00050713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92532098|NCT00050713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532099|NCT00050713|Antifungal Agents|antifungal agents|mesh-ancestor
92532100|NCT00050713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532101|NCT00050713|Immunologic Factors|immunologic factors|mesh-ancestor
92532102|NCT00050713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532103|NCT00050830|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
92532104|NCT00050830|Anesthetics, Local|anesthetics, local|mesh-ancestor
92532105|NCT00050830|Anesthetics|anesthetics|mesh-ancestor
92532106|NCT00050830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532107|NCT00050830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532108|NCT00050830|Sensory System Agents|sensory system agents|mesh-ancestor
92532109|NCT00050830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532110|NCT00050830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532111|NCT00050830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92532112|NCT00050830|Protective Agents|protective agents|mesh-ancestor
92532113|NCT00050947|Oxcarbazepine|oxcarbazepine|mesh-list
92532115|NCT00050947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92532116|NCT00050947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92532117|NCT00050947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532118|NCT00050947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532119|NCT00050947|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92532120|NCT00050947|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92532121|NCT00051103|Antineoplastic Agents|antineoplastic agents|mesh-list
92532122|NCT00051142|Travoprost|travoprost|mesh-list
92532123|NCT00051142|Latanoprost|latanoprost|mesh-list
92532125|NCT00051142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92532126|NCT00051142|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92532127|NCT00051181|Travoprost|travoprost|mesh-list
92532128|NCT00051181|Latanoprost|latanoprost|mesh-list
92532129|NCT00051181|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92532130|NCT00051181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92532131|NCT00051181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92532132|NCT00051259|Bupropion|bupropion|mesh-list
92532133|NCT00051259|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92532134|NCT00051259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92532135|NCT00051259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92532136|NCT00051259|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92532137|NCT00051259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92532138|NCT00051259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532139|NCT00051259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532140|NCT00051259|Dopamine Agents|dopamine agents|mesh-ancestor
92532141|NCT00051259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532142|NCT00051259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532143|NCT00051259|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92532144|NCT00051259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532145|NCT00051259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532146|NCT05639777|Dexmedetomidine|dexmedetomidine|mesh-list
92532147|NCT05639777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92532148|NCT05639777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532149|NCT05639777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532150|NCT05639777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92532151|NCT05639777|Analgesics|analgesics|mesh-ancestor
92532152|NCT05639777|Sensory System Agents|sensory system agents|mesh-ancestor
92532153|NCT05639777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532154|NCT05639777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92532155|NCT05639777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92532156|NCT05639777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92532157|NCT05639777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92532158|NCT05639777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532159|NCT05639777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532160|NCT00051298|Olanzapine|olanzapine|mesh-list
92532161|NCT00051298|Antiemetics|antiemetics|mesh-ancestor
92532162|NCT00051298|Autonomic Agents|autonomic agents|mesh-ancestor
92532163|NCT00051298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532164|NCT00051298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532165|NCT00051298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92532166|NCT00051298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92532167|NCT00051298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92532168|NCT00051298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532169|NCT00051298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92532170|NCT00051298|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92532171|NCT00051298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92532172|NCT00051298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532173|NCT00051298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532174|NCT00051298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532175|NCT00051298|Serotonin Agents|serotonin agents|mesh-ancestor
92532176|NCT00398008|Naltrexone|naltrexone|mesh-list
92532177|NCT00398008|Buprenorphine|buprenorphine|mesh-list
92532178|NCT00398008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92532179|NCT00398008|Narcotics|narcotics|mesh-ancestor
92532180|NCT00398008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532181|NCT00398008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532182|NCT00398008|Analgesics|analgesics|mesh-ancestor
92532183|NCT00398008|Sensory System Agents|sensory system agents|mesh-ancestor
92532184|NCT00398008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532185|NCT00398008|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92532186|NCT00398008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92532187|NCT05636189|Anesthetics|anesthetics|mesh-list
92532188|NCT05636189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532189|NCT05636189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532190|NCT00051493|Carboplatin|carboplatin|mesh-list
92532191|NCT00051493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532192|NCT00051532|Seocalcitol|seocalcitol|mesh-list
92532193|NCT00051532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532194|NCT00051532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532195|NCT00051532|Immunologic Factors|immunologic factors|mesh-ancestor
92532196|NCT00051532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532197|NCT00051571|Docetaxel|docetaxel|mesh-list
92532198|NCT00051571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532199|NCT00051571|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532200|NCT00051571|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532201|NCT00051571|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532202|NCT00051571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532203|NCT05573958|Aspirin|aspirin|mesh-list
92532204|NCT05573958|Rivaroxaban|rivaroxaban|mesh-list
92532205|NCT05573958|Clopidogrel|clopidogrel|mesh-list
92532206|NCT05573958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92532207|NCT05573958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92532208|NCT05573958|Analgesics|analgesics|mesh-ancestor
92532209|NCT05573958|Sensory System Agents|sensory system agents|mesh-ancestor
92532210|NCT05573958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532211|NCT05573958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532212|NCT05573958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532213|NCT05573958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532214|NCT05573958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92532215|NCT05573958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92532216|NCT05573958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532217|NCT05573958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92532218|NCT05573958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92532219|NCT05573958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532220|NCT05573958|Antipyretics|antipyretics|mesh-ancestor
92532221|NCT05573958|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92532222|NCT05573958|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92532223|NCT05573958|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92532224|NCT05573958|Purinergic Agents|purinergic agents|mesh-ancestor
92532225|NCT05573958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532226|NCT05573958|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92532227|NCT05573958|Antithrombins|antithrombins|mesh-ancestor
92532228|NCT05573958|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92532229|NCT05573958|Protease Inhibitors|protease inhibitors|mesh-ancestor
92532230|NCT05573958|Anticoagulants|anticoagulants|mesh-ancestor
92532231|NCT00051688|Oxaliplatin|oxaliplatin|mesh-list
92532232|NCT00051688|Tezacitabine|tezacitabine|mesh-list
92532233|NCT00051688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532234|NCT00051688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532235|NCT00051688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532236|NCT00051844|Capravirine|capravirine|mesh-list
92532237|NCT00051844|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92532238|NCT00051844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92532239|NCT00051844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532240|NCT00051844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532241|NCT00051844|Antiviral Agents|antiviral agents|mesh-ancestor
92532242|NCT00051844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532243|NCT00051844|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92532244|NCT00051844|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92532245|NCT00052000|Antibodies|antibodies|mesh-list
92532246|NCT00052000|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92532247|NCT00052000|Immunologic Factors|immunologic factors|mesh-ancestor
92532248|NCT00052000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532249|NCT00052039|Interferons|interferons|mesh-list
92532250|NCT00052039|Interferon-gamma|interferon-gamma|mesh-list
92532251|NCT00052039|Azathioprine|azathioprine|mesh-list
92532252|NCT00052039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532253|NCT00052039|Antiviral Agents|antiviral agents|mesh-ancestor
92532254|NCT00052039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532255|NCT00052039|Antimetabolites|antimetabolites|mesh-ancestor
92354004|NCT02008656|Vitamins|vitamins|mesh-ancestor
92532256|NCT00052039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532257|NCT00052039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532258|NCT00052039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532259|NCT00052039|Immunologic Factors|immunologic factors|mesh-ancestor
92532260|NCT00052039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532261|NCT00052039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532262|NCT00052117|Capravirine|capravirine|mesh-list
92532263|NCT00052117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92532264|NCT00052117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92532265|NCT00052117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532266|NCT00052117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532267|NCT00052117|Antiviral Agents|antiviral agents|mesh-ancestor
92532268|NCT00052117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532269|NCT00052117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92532270|NCT00052117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92532271|NCT00052273|Capecitabine|capecitabine|mesh-list
92532272|NCT00052273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532273|NCT00052273|Antimetabolites|antimetabolites|mesh-ancestor
92532274|NCT00052273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532275|NCT00052273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532276|NCT00052312|Paclitaxel|paclitaxel|mesh-list
92532277|NCT00052312|Doxorubicin|doxorubicin|mesh-list
92532278|NCT00052312|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92532279|NCT00052312|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92532280|NCT00052312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532281|NCT00052312|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532282|NCT00052312|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532283|NCT00052312|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532284|NCT00052312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532285|NCT00052312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92532286|NCT00052312|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532287|NCT00052312|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532288|NCT00052312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532290|NCT00052351|Paclitaxel|paclitaxel|mesh-list
92532291|NCT00052351|Cyclophosphamide|cyclophosphamide|mesh-list
92532292|NCT00052351|Doxorubicin|doxorubicin|mesh-list
92532293|NCT00052351|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92532294|NCT00052351|Vaccines|vaccines|mesh-list
92532295|NCT00052351|Sargramostim|sargramostim|mesh-list
92532296|NCT00052351|Immunologic Factors|immunologic factors|mesh-ancestor
92532297|NCT00052351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532298|NCT00052351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92532299|NCT00052351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532300|NCT00052351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532301|NCT00052351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532302|NCT00052351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532303|NCT00052351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532304|NCT00052351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532305|NCT00052351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532306|NCT00052351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532307|NCT00052351|Alkylating Agents|alkylating agents|mesh-ancestor
92532308|NCT00052351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532309|NCT00052351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92532310|NCT00052351|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532311|NCT00052351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532312|NCT00052351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532313|NCT00052351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532314|NCT00052351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92532315|NCT00052351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92532316|NCT00052351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92532318|NCT00052390|Doxorubicin|doxorubicin|mesh-list
92532319|NCT00052390|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92532320|NCT00052390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92532321|NCT00052390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532322|NCT00052390|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92532323|NCT00052390|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92532324|NCT00052390|Growth Substances|growth substances|mesh-ancestor
92532325|NCT00052390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532326|NCT00052390|Growth Inhibitors|growth inhibitors|mesh-ancestor
92532327|NCT00052390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92532328|NCT00052390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532329|NCT00052390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532330|NCT00052390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532331|NCT00052390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532332|NCT00052468|Paclitaxel|paclitaxel|mesh-list
92532333|NCT00052468|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92532334|NCT00052468|Carboplatin|carboplatin|mesh-list
92532335|NCT00052468|Gemcitabine|gemcitabine|mesh-list
92532336|NCT00052468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92532337|NCT00052468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532338|NCT00052468|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532339|NCT00052468|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532340|NCT00052468|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532341|NCT00052468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532342|NCT00052468|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532343|NCT00052468|Antimetabolites|antimetabolites|mesh-ancestor
92532344|NCT00052507|Bortezomib|bortezomib|mesh-list
92532345|NCT00052507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532346|NCT00052585|Leucovorin|leucovorin|mesh-list
92532347|NCT00052585|Fluorouracil|fluorouracil|mesh-list
92532348|NCT00052585|Irinotecan|irinotecan|mesh-list
92532349|NCT00052585|Gefitinib|gefitinib|mesh-list
92532350|NCT00052585|Calcium|calcium|mesh-list
92532351|NCT00052585|Levoleucovorin|levoleucovorin|mesh-list
92532352|NCT00052585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92532353|NCT00052585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532354|NCT00052585|Antimetabolites|antimetabolites|mesh-ancestor
92532355|NCT00052585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532356|NCT00052585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532357|NCT00052585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532358|NCT00052585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532359|NCT00052585|Immunologic Factors|immunologic factors|mesh-ancestor
92532360|NCT00052585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92532361|NCT00052585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532362|NCT00052585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532363|NCT00052585|Antidotes|antidotes|mesh-ancestor
92532364|NCT00052585|Protective Agents|protective agents|mesh-ancestor
92532365|NCT00052585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92532367|NCT00052585|Micronutrients|micronutrients|mesh-ancestor
92532368|NCT00052585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92532369|NCT00052780|Temozolomide|temozolomide|mesh-list
92532370|NCT00052780|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92532371|NCT00052780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532372|NCT00052780|Alkylating Agents|alkylating agents|mesh-ancestor
92532373|NCT00052780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532374|NCT00052780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532375|NCT00052780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532376|NCT00052936|Prednisone|prednisone|mesh-list
92532377|NCT00052936|Cyclophosphamide|cyclophosphamide|mesh-list
92532378|NCT00052936|Rituximab|rituximab|mesh-list
92532379|NCT00052936|Doxorubicin|doxorubicin|mesh-list
92532380|NCT00052936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92532381|NCT00052936|Vincristine|vincristine|mesh-list
92532382|NCT00052936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532383|NCT00052936|Immunologic Factors|immunologic factors|mesh-ancestor
92532384|NCT00052936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532385|NCT00052936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532386|NCT00052936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532387|NCT00052936|Alkylating Agents|alkylating agents|mesh-ancestor
92532388|NCT00052936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532389|NCT00052936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532390|NCT00052936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532391|NCT00052936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92532392|NCT00052936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92532393|NCT00052936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532394|NCT00052936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532395|NCT00052936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532396|NCT00052936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532397|NCT00052936|Glucocorticoids|glucocorticoids|mesh-ancestor
92532398|NCT00052936|Hormones|hormones|mesh-ancestor
92532399|NCT00052936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532400|NCT00052936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92532401|NCT00052936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92354014|NCT03174132|Anesthetics|anesthetics|mesh-ancestor
92532402|NCT00052936|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532403|NCT00052936|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532404|NCT00052936|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532405|NCT00053092|Cyclophosphamide|cyclophosphamide|mesh-list
92532406|NCT00053092|Rituximab|rituximab|mesh-list
92532407|NCT00053092|Fludarabine|fludarabine|mesh-list
92532408|NCT00053092|Fludarabine phosphate|fludarabine phosphate|mesh-list
92532409|NCT00053092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532410|NCT00053092|Immunologic Factors|immunologic factors|mesh-ancestor
92532411|NCT00053092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532412|NCT00053092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532413|NCT00053092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532414|NCT00053092|Alkylating Agents|alkylating agents|mesh-ancestor
92532415|NCT00053092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532416|NCT00053092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532417|NCT00053092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532418|NCT00053092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92532419|NCT00053092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532420|NCT00053092|Antimetabolites|antimetabolites|mesh-ancestor
92532421|NCT00053131|Cytarabine|cytarabine|mesh-list
92532422|NCT00053131|Mitoxantrone|mitoxantrone|mesh-list
92532423|NCT00053131|Sargramostim|sargramostim|mesh-list
92532424|NCT00053131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532425|NCT00053131|Antimetabolites|antimetabolites|mesh-ancestor
92532426|NCT00053131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532427|NCT00053131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532428|NCT00053131|Antiviral Agents|antiviral agents|mesh-ancestor
92532429|NCT00053131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532430|NCT00053131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532431|NCT00053131|Immunologic Factors|immunologic factors|mesh-ancestor
92532432|NCT00053131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532433|NCT00053131|Analgesics|analgesics|mesh-ancestor
92532434|NCT00053131|Sensory System Agents|sensory system agents|mesh-ancestor
92532435|NCT00053131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532436|NCT00053131|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532437|NCT00053131|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532438|NCT00053131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532439|NCT00053248|Imatinib Mesylate|imatinib mesylate|mesh-list
92532440|NCT00053248|Arsenic Trioxide|arsenic trioxide|mesh-list
92532441|NCT00053248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532442|NCT00053248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92532443|NCT00053248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532444|NCT00053248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532445|NCT00053287|Thalidomide|thalidomide|mesh-list
92532446|NCT00053287|Carboplatin|carboplatin|mesh-list
92532447|NCT00053287|Fludarabine|fludarabine|mesh-list
92532448|NCT00053287|Fludarabine phosphate|fludarabine phosphate|mesh-list
92532449|NCT00053287|Topotecan|topotecan|mesh-list
92532450|NCT00053287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532451|NCT00053287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532452|NCT00053287|Antimetabolites|antimetabolites|mesh-ancestor
92532453|NCT00053287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532454|NCT00053287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532455|NCT00053287|Immunologic Factors|immunologic factors|mesh-ancestor
92532456|NCT00053287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532457|NCT00053287|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92532458|NCT00053287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532459|NCT00053287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532460|NCT00053287|Leprostatic Agents|leprostatic agents|mesh-ancestor
92532461|NCT00053287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92532462|NCT00053287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532463|NCT00053287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92532464|NCT00053287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92532465|NCT00053287|Growth Substances|growth substances|mesh-ancestor
92532466|NCT00053287|Growth Inhibitors|growth inhibitors|mesh-ancestor
92532467|NCT00053326|Fenretinide|fenretinide|mesh-list
92532468|NCT00053326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532469|NCT00053326|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92532470|NCT00053326|Protective Agents|protective agents|mesh-ancestor
92532471|NCT00053326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532472|NCT00053560|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92532473|NCT00053560|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92532474|NCT00053560|Immunologic Factors|immunologic factors|mesh-ancestor
92532475|NCT00053560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532476|NCT00053599|Simvastatin|simvastatin|mesh-list
92532477|NCT00053599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92532478|NCT00053599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92532479|NCT00053599|Antimetabolites|antimetabolites|mesh-ancestor
92532480|NCT00053599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532481|NCT00053599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92532482|NCT00053599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92532483|NCT00053599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532484|NCT00053638|Tenofovir|tenofovir|mesh-list
92532485|NCT00053638|Lamivudine|lamivudine|mesh-list
92532486|NCT00053638|Efavirenz|efavirenz|mesh-list
92532487|NCT00053638|Abacavir|abacavir|mesh-list
92532488|NCT00053638|Antiviral Agents|antiviral agents|mesh-ancestor
92532489|NCT00053638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532490|NCT00053638|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92532491|NCT00053638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92532492|NCT00053638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532493|NCT00053638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532494|NCT00053638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92532495|NCT00053638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92532496|NCT00053638|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92532497|NCT00053638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532498|NCT00053638|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92532499|NCT00053638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92532500|NCT00053638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92532501|NCT00053638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92532502|NCT00053716|Alprostadil|alprostadil|mesh-list
92532503|NCT00053716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92532504|NCT00053716|Vasodilator Agents|vasodilator agents|mesh-ancestor
92532505|NCT00053716|Urological Agents|urological agents|mesh-ancestor
92532506|NCT02970175|Terlipressin|terlipressin|mesh-list
92532507|NCT02970175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92532508|NCT02970175|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92532509|NCT00053833|Irinotecan|irinotecan|mesh-list
92532510|NCT00053833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92532511|NCT00053833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532512|NCT00053833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532513|NCT00053833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532514|NCT00053833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532515|NCT00053872|Vincristine|vincristine|mesh-list
92532516|NCT00053872|Lomustine|lomustine|mesh-list
92532517|NCT00053872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532518|NCT00053872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92532519|NCT00053872|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532520|NCT00053872|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532521|NCT00053872|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532522|NCT00053872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532523|NCT00053872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532524|NCT00053872|Alkylating Agents|alkylating agents|mesh-ancestor
92532525|NCT05624918|Paclitaxel|paclitaxel|mesh-list
92532526|NCT05624918|Gemcitabine|gemcitabine|mesh-list
92532527|NCT05624918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92532528|NCT05624918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532529|NCT05624918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532530|NCT05624918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532531|NCT05624918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532532|NCT05624918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532533|NCT05624918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532534|NCT05624918|Antimetabolites|antimetabolites|mesh-ancestor
92532535|NCT00053911|Tamoxifen|tamoxifen|mesh-list
92532536|NCT00053911|Cyclophosphamide|cyclophosphamide|mesh-list
92532537|NCT00053911|Docetaxel|docetaxel|mesh-list
92532538|NCT00053911|Fluorouracil|fluorouracil|mesh-list
92532539|NCT00053911|Epirubicin|epirubicin|mesh-list
92532540|NCT00053911|Anastrozole|anastrozole|mesh-list
92532541|NCT00053911|Goserelin|goserelin|mesh-list
92532542|NCT00053911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532543|NCT00053911|Immunologic Factors|immunologic factors|mesh-ancestor
92532544|NCT00053911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532545|NCT00053911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532546|NCT00053911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532547|NCT00053911|Alkylating Agents|alkylating agents|mesh-ancestor
92532548|NCT00053911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532549|NCT00053911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532550|NCT00053911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532551|NCT00053911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532552|NCT00053911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532553|NCT00053911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532554|NCT00053911|Antimetabolites|antimetabolites|mesh-ancestor
92532555|NCT00053911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532556|NCT00053911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92532557|NCT00053911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92532558|NCT00053911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532559|NCT00053911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532560|NCT00053911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92532561|NCT00053911|Hormone Antagonists|hormone antagonists|mesh-ancestor
92532562|NCT00053911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532563|NCT00053911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92532564|NCT00053911|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92532565|NCT00053911|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92532566|NCT00053911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92532567|NCT00053911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92532568|NCT00053911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92532569|NCT00053950|NSC 366140|nsc 366140|mesh-list
92532570|NCT00053950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532571|NCT00054067|Cisplatin|cisplatin|mesh-list
92532572|NCT00054067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532573|NCT00054106|Flutamide|flutamide|mesh-list
92532574|NCT00054106|Buserelin|buserelin|mesh-list
92257334|NCT04526951|Analgesics|analgesics|mesh-ancestor
92532575|NCT00054106|Androgen Antagonists|androgen antagonists|mesh-ancestor
92532576|NCT00054106|Hormone Antagonists|hormone antagonists|mesh-ancestor
92532577|NCT00054106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532578|NCT00054106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532579|NCT00054106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92532581|NCT00054106|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92532583|NCT00054106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92532584|NCT00054184|Paclitaxel|paclitaxel|mesh-list
92532585|NCT00054184|Docetaxel|docetaxel|mesh-list
92532586|NCT00054184|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92532587|NCT00054184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92532588|NCT00054184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532589|NCT00054184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532590|NCT00054184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532591|NCT00054184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532592|NCT00054184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532593|NCT00054340|Cyclosporine|cyclosporine|mesh-list
92532594|NCT00054340|Cyclophosphamide|cyclophosphamide|mesh-list
92532595|NCT00054340|Busulfan|busulfan|mesh-list
92532597|NCT00054340|Cyclosporins|cyclosporins|mesh-list
92532598|NCT00054340|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92532599|NCT00054340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532600|NCT00054340|Immunologic Factors|immunologic factors|mesh-ancestor
92532601|NCT00054340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532602|NCT00054340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532603|NCT00054340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532604|NCT00054340|Alkylating Agents|alkylating agents|mesh-ancestor
92532605|NCT00054340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532606|NCT00054340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532607|NCT00054340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532608|NCT00054340|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92532609|NCT00054340|Abortifacient Agents|abortifacient agents|mesh-ancestor
92532610|NCT00054340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92532611|NCT00054340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532612|NCT00054340|Antimetabolites|antimetabolites|mesh-ancestor
92532613|NCT00054340|Dermatologic Agents|dermatologic agents|mesh-ancestor
92532614|NCT00054340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532615|NCT00054340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92532616|NCT00054340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92532617|NCT00054340|Antifungal Agents|antifungal agents|mesh-ancestor
92532618|NCT00054340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532619|NCT00054340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92532621|NCT00054418|Risedronic Acid|risedronic acid|mesh-list
92532622|NCT00054418|Calcium Carbonate|calcium carbonate|mesh-list
92532623|NCT00054418|Calcium|calcium|mesh-list
92532624|NCT00054418|Vitamins|vitamins|mesh-ancestor
92532625|NCT00054418|Micronutrients|micronutrients|mesh-ancestor
92532626|NCT00054418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532627|NCT00054418|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92532628|NCT00054418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92532629|NCT00054418|Antacids|antacids|mesh-ancestor
92532630|NCT00054418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532631|NCT00054418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92532632|NCT00054418|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92532633|NCT00054418|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532634|NCT05560230|Clonidine|clonidine|mesh-list
92532635|NCT05560230|Analgesics|analgesics|mesh-ancestor
92532636|NCT05560230|Sensory System Agents|sensory system agents|mesh-ancestor
92532637|NCT05560230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532638|NCT05560230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532639|NCT05560230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92532640|NCT05560230|Sympatholytics|sympatholytics|mesh-ancestor
92532641|NCT05560230|Autonomic Agents|autonomic agents|mesh-ancestor
92532642|NCT05560230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92532643|NCT05560230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92532644|NCT05560230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92532645|NCT05560230|Adrenergic Agents|adrenergic agents|mesh-ancestor
92532646|NCT05560230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532647|NCT05560230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532648|NCT00054457|Docetaxel|docetaxel|mesh-list
92532649|NCT00054457|Capecitabine|capecitabine|mesh-list
92532650|NCT00054457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532651|NCT00054457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532652|NCT00054457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532653|NCT00054457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532654|NCT00054457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532655|NCT00054457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532656|NCT00054457|Antimetabolites|antimetabolites|mesh-ancestor
92532657|NCT00054496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92532658|NCT00054496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532659|NCT00054496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92532661|NCT00054496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532662|NCT00054535|Aldesleukin|aldesleukin|mesh-list
92532663|NCT00054535|Vaccines|vaccines|mesh-list
92532664|NCT00054535|Immunologic Factors|immunologic factors|mesh-ancestor
92532665|NCT00054535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532666|NCT00054535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532667|NCT00054535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92532668|NCT00054535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92532669|NCT00054535|Antiviral Agents|antiviral agents|mesh-ancestor
92532670|NCT00054535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532671|NCT00054574|Panitumumab|panitumumab|mesh-list
92532672|NCT00054574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92532673|NCT00054574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532674|NCT00054613|Methoxsalen|methoxsalen|mesh-list
92532675|NCT00054613|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92532676|NCT00054613|Dermatologic Agents|dermatologic agents|mesh-ancestor
92532677|NCT00054808|Gallium nitrate|gallium nitrate|mesh-list
92532678|NCT00054808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92532679|NCT00054808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532680|NCT00054808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532681|NCT00054886|Sunitinib|sunitinib|mesh-list
92532682|NCT00054886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532683|NCT00054886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92532684|NCT00054886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92532685|NCT00054886|Growth Substances|growth substances|mesh-ancestor
92532686|NCT00054886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532687|NCT00054886|Growth Inhibitors|growth inhibitors|mesh-ancestor
92532688|NCT00054886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92532689|NCT00054886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532690|NCT00054886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532692|NCT02970097|Midazolam|midazolam|mesh-list
92532693|NCT02970097|Ropivacaine|ropivacaine|mesh-list
92532694|NCT02970097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92532695|NCT02970097|Narcotics|narcotics|mesh-ancestor
92532696|NCT02970097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532697|NCT02970097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532698|NCT02970097|Analgesics|analgesics|mesh-ancestor
92532699|NCT02970097|Sensory System Agents|sensory system agents|mesh-ancestor
92532701|NCT02970097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92532702|NCT02970097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92532703|NCT02970097|Anesthetics, General|anesthetics, general|mesh-ancestor
92532704|NCT02970097|Anesthetics|anesthetics|mesh-ancestor
92532705|NCT02970097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92532706|NCT02970097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92532707|NCT02970097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92532708|NCT02970097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92532709|NCT02970097|GABA Modulators|gaba modulators|mesh-ancestor
92532710|NCT02970097|GABA Agents|gaba agents|mesh-ancestor
92532711|NCT02970097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532712|NCT02970097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532713|NCT02970097|Anesthetics, Local|anesthetics, local|mesh-ancestor
92532714|NCT00398281|Dutasteride|dutasteride|mesh-list
92532715|NCT00398281|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92532716|NCT00398281|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92532717|NCT00398281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532718|NCT00398281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532719|NCT00398281|Hormone Antagonists|hormone antagonists|mesh-ancestor
92532720|NCT00398281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532721|NCT00398281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532722|NCT00055042|Vitamin E|vitamin e|mesh-list
92532723|NCT00055042|Vitamins|vitamins|mesh-ancestor
92532724|NCT00055042|Micronutrients|micronutrients|mesh-ancestor
92532725|NCT00055042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532726|NCT00055042|Antioxidants|antioxidants|mesh-ancestor
92532727|NCT00055042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532728|NCT00055042|Protective Agents|protective agents|mesh-ancestor
92532731|NCT00055120|Tenofovir|tenofovir|mesh-list
92532732|NCT00055120|Emtricitabine|emtricitabine|mesh-list
92537674|NCT00142051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532733|NCT00055120|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92532734|NCT00055120|Stavudine|stavudine|mesh-list
92532735|NCT00055120|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92532736|NCT00055120|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92532737|NCT00055120|Protease Inhibitors|protease inhibitors|mesh-ancestor
92532738|NCT00055120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532739|NCT00055120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532740|NCT00055120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92532741|NCT00055120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92532742|NCT00055120|Antiviral Agents|antiviral agents|mesh-ancestor
92532743|NCT00055120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532744|NCT00055120|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92532745|NCT00055120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532746|NCT00055120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92532747|NCT00055120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92532748|NCT00055120|Antimetabolites|antimetabolites|mesh-ancestor
92532749|NCT05527704|Albuterol|albuterol|mesh-list
92532750|NCT05527704|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92532752|NCT05527704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532753|NCT05527704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532754|NCT05527704|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92532755|NCT05527704|Respiratory System Agents|respiratory system agents|mesh-ancestor
92532756|NCT05527704|Tocolytic Agents|tocolytic agents|mesh-ancestor
92532757|NCT05527704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92532758|NCT05527704|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92532759|NCT05527704|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92532760|NCT05527704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92532761|NCT05527704|Adrenergic Agents|adrenergic agents|mesh-ancestor
92532762|NCT05527704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532763|NCT05527704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532764|NCT00055159|Plasminogen|plasminogen|mesh-list
92532765|NCT00055159|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92532766|NCT00055159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92532767|NCT00055159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92532768|NCT00055159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532769|NCT00055198|Daptomycin|daptomycin|mesh-list
92532770|NCT00055198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92532771|NCT00055198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532773|NCT05525325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532774|NCT05525325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532775|NCT00055393|Bupropion|bupropion|mesh-list
92532776|NCT00055393|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92532777|NCT00055393|Antidepressive Agents|antidepressive agents|mesh-ancestor
92532778|NCT00055393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92532779|NCT00055393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92532780|NCT00055393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92532781|NCT00055393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532782|NCT00055393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532784|NCT00055393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532785|NCT00055393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532786|NCT00055393|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92532787|NCT00055393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532788|NCT00055393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532789|NCT00055432|Gemcitabine|gemcitabine|mesh-list
92532790|NCT00055432|Pemetrexed|pemetrexed|mesh-list
92532791|NCT00055432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532793|NCT00055432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532794|NCT00055432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532795|NCT00055432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532796|NCT00055432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92532797|NCT00055432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92532799|NCT00055549|Dextromethorphan|dextromethorphan|mesh-list
92532800|NCT00055549|Antitussive Agents|antitussive agents|mesh-ancestor
92532801|NCT00055549|Respiratory System Agents|respiratory system agents|mesh-ancestor
92532802|NCT00055549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92532804|NCT00055549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532805|NCT00055549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532807|NCT00055549|Anticonvulsants|anticonvulsants|mesh-ancestor
92532808|NCT00055549|Antiemetics|antiemetics|mesh-ancestor
92532809|NCT00055549|Autonomic Agents|autonomic agents|mesh-ancestor
92532810|NCT00055549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532811|NCT00055549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92532812|NCT00055549|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92532813|NCT00055549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92532814|NCT00055549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92532815|NCT00055549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92532816|NCT00055549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92532817|NCT00055549|GABA Modulators|gaba modulators|mesh-ancestor
92532818|NCT00055549|GABA Agents|gaba agents|mesh-ancestor
92532819|NCT00055666|Beclomethasone|beclomethasone|mesh-list
92532820|NCT00055666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532821|NCT00055666|Glucocorticoids|glucocorticoids|mesh-ancestor
92537675|NCT00142051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92532823|NCT00055666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532824|NCT00055666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532825|NCT00055666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92532826|NCT00055666|Respiratory System Agents|respiratory system agents|mesh-ancestor
92532827|NCT00055822|Leucovorin|leucovorin|mesh-list
92532828|NCT00055822|Fluorouracil|fluorouracil|mesh-list
92532829|NCT00055822|Oxaliplatin|oxaliplatin|mesh-list
92532830|NCT00055822|Oblimersen|oblimersen|mesh-list
92532831|NCT00055822|Calcium|calcium|mesh-list
92532832|NCT00055822|Levoleucovorin|levoleucovorin|mesh-list
92532833|NCT00055822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92532834|NCT00055822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532835|NCT00055822|Antimetabolites|antimetabolites|mesh-ancestor
92532836|NCT00055822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532837|NCT00055822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532838|NCT00055822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532839|NCT00055822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532840|NCT00055822|Immunologic Factors|immunologic factors|mesh-ancestor
92532841|NCT00055822|Antidotes|antidotes|mesh-ancestor
92532842|NCT00055822|Protective Agents|protective agents|mesh-ancestor
92532843|NCT00055822|Vitamin B Complex|vitamin b complex|mesh-ancestor
92532844|NCT00055822|Vitamins|vitamins|mesh-ancestor
92532845|NCT00055822|Micronutrients|micronutrients|mesh-ancestor
92532846|NCT00055861|Bevacizumab|bevacizumab|mesh-list
92532847|NCT00055861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92532849|NCT00055861|Antibodies|antibodies|mesh-list
92532850|NCT00055861|Immunoglobulins|immunoglobulins|mesh-list
92532851|NCT00055861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92532852|NCT00055861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532853|NCT00055861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92532854|NCT00055861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92532855|NCT00055861|Growth Substances|growth substances|mesh-ancestor
92354024|NCT03174132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92532856|NCT00055861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532857|NCT00055861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92532858|NCT00055861|Immunologic Factors|immunologic factors|mesh-ancestor
92532859|NCT00055861|Tubulin Modulators|tubulin modulators|mesh-ancestor
92532860|NCT00055861|Antimitotic Agents|antimitotic agents|mesh-ancestor
92532861|NCT00055861|Mitosis Modulators|mitosis modulators|mesh-ancestor
92532862|NCT00055861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532865|NCT00392106|Propafenone|propafenone|mesh-list
92532866|NCT00392106|Dofetilide|dofetilide|mesh-list
92532867|NCT00392106|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92532868|NCT00392106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92532869|NCT00392106|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92532870|NCT00392106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92532871|NCT00392106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532872|NCT00392106|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92532873|NCT00392106|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92532874|NCT00392106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532875|NCT00392106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532876|NCT00392106|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92532877|NCT00392106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92532878|NCT00392106|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92532879|NCT00392106|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92532881|NCT00055939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92532882|NCT00055939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92532883|NCT00055939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532884|NCT00055939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532885|NCT00055939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532886|NCT00055978|Celecoxib|celecoxib|mesh-list
92532887|NCT00055978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92532888|NCT00055978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92532889|NCT00055978|Analgesics|analgesics|mesh-ancestor
92532890|NCT00055978|Sensory System Agents|sensory system agents|mesh-ancestor
92532891|NCT00055978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532892|NCT00055978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532893|NCT00055978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92532894|NCT00055978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532895|NCT00055978|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92532896|NCT00055978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92532897|NCT00055978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532898|NCT00055978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532900|NCT00056056|Methoxsalen|methoxsalen|mesh-list
92532901|NCT00056056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532902|NCT00056056|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92532903|NCT00056056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92532904|NCT00056095|Cyclosporine|cyclosporine|mesh-list
92532905|NCT00056095|Cyclophosphamide|cyclophosphamide|mesh-list
92532906|NCT00056095|Fludarabine|fludarabine|mesh-list
92532907|NCT00056095|Fludarabine phosphate|fludarabine phosphate|mesh-list
92532908|NCT00056095|Cyclosporins|cyclosporins|mesh-list
92532909|NCT00056095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532910|NCT00056095|Immunologic Factors|immunologic factors|mesh-ancestor
92532911|NCT00056095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532912|NCT00056095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92532913|NCT00056095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532914|NCT00056095|Alkylating Agents|alkylating agents|mesh-ancestor
92532915|NCT00056095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532916|NCT00056095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532917|NCT00056095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532918|NCT00056095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92532919|NCT00056095|Antimetabolites|antimetabolites|mesh-ancestor
92532920|NCT00056095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532921|NCT00056095|Antifungal Agents|antifungal agents|mesh-ancestor
92532922|NCT00056095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532923|NCT00056095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92532924|NCT00056095|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92532925|NCT00056329|Vitamin E|vitamin e|mesh-list
92532926|NCT00056329|Tocopherols|tocopherols|mesh-list
92532928|NCT00056329|Micronutrients|micronutrients|mesh-ancestor
92532929|NCT00056329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532930|NCT00056329|Antioxidants|antioxidants|mesh-ancestor
92532931|NCT00056329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532932|NCT00056329|Protective Agents|protective agents|mesh-ancestor
92532933|NCT00056368|Fluconazole|fluconazole|mesh-list
92532934|NCT00056368|Anidulafungin|anidulafungin|mesh-list
92532935|NCT00056368|Antifungal Agents|antifungal agents|mesh-ancestor
92532936|NCT00056368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532937|NCT00056368|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92532938|NCT00056368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532939|NCT00056368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532940|NCT00056368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532941|NCT00056368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92532942|NCT00056368|Hormone Antagonists|hormone antagonists|mesh-ancestor
92532943|NCT00056368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92532944|NCT00056368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532945|NCT00056368|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92532946|NCT00056368|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92532948|NCT00056446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92532949|NCT00056446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532950|NCT00056446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532951|NCT00056641|Ritonavir|ritonavir|mesh-list
92532952|NCT00056641|Lopinavir|lopinavir|mesh-list
92532954|NCT00056641|Amprenavir|amprenavir|mesh-list
92532955|NCT00056641|Tipranavir|tipranavir|mesh-list
92532956|NCT00056641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92532957|NCT00056641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92532958|NCT00056641|Protease Inhibitors|protease inhibitors|mesh-ancestor
92532959|NCT00056641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92532960|NCT00056641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532962|NCT00056641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92532963|NCT00056641|Antiviral Agents|antiviral agents|mesh-ancestor
92532964|NCT00056641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92532965|NCT00056641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92532966|NCT00056641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92532967|NCT00056641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92532968|NCT00056641|Antitubercular Agents|antitubercular agents|mesh-ancestor
92532969|NCT00056641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92532970|NCT00398437|Trastuzumab|trastuzumab|mesh-list
92532972|NCT00398437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532973|NCT05433675|Macitentan|macitentan|mesh-list
92532974|NCT05433675|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92532975|NCT05433675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92532976|NCT05433675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532977|NCT05433675|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92532978|NCT00423709|Fludarabine|fludarabine|mesh-list
92532979|NCT00423709|Melphalan|melphalan|mesh-list
92532980|NCT00423709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532981|NCT00423709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92532982|NCT00423709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92532983|NCT00423709|Immunologic Factors|immunologic factors|mesh-ancestor
92532984|NCT00423709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532985|NCT00423709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92532986|NCT00423709|Alkylating Agents|alkylating agents|mesh-ancestor
92532987|NCT00423709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92532988|NCT00056797|Interleukin-2|interleukin-2|mesh-list
92532989|NCT00056797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92532990|NCT00056797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92532991|NCT00056797|Analgesics|analgesics|mesh-ancestor
92532992|NCT00056797|Sensory System Agents|sensory system agents|mesh-ancestor
92532993|NCT00056797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92532994|NCT00056797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92532995|NCT00056836|Ranibizumab|ranibizumab|mesh-list
92532996|NCT00056836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92532997|NCT00056836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92532998|NCT00056836|Growth Substances|growth substances|mesh-ancestor
92532999|NCT00056836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533000|NCT00056836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92533001|NCT00056836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533002|NCT05495321|Aldesleukin|aldesleukin|mesh-list
92533003|NCT05495321|Interleukin-2|interleukin-2|mesh-list
92533004|NCT05495321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533005|NCT05495321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533006|NCT05495321|Analgesics|analgesics|mesh-ancestor
92533007|NCT05495321|Sensory System Agents|sensory system agents|mesh-ancestor
92533008|NCT05495321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533009|NCT05495321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533010|NCT05495321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92533011|NCT05495321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92533012|NCT05495321|Antiviral Agents|antiviral agents|mesh-ancestor
92533013|NCT05495321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533014|NCT00056875|Mitogens|mitogens|mesh-list
92533015|NCT00056875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533016|NCT00056875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533017|NCT05410197|Gemcitabine|gemcitabine|mesh-list
92533018|NCT05410197|Lenvatinib|lenvatinib|mesh-list
92533019|NCT05410197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533020|NCT05410197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533021|NCT05410197|Antimetabolites|antimetabolites|mesh-ancestor
92533022|NCT05410197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533023|NCT05410197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533024|NCT05410197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533025|NCT03262454|Atezolizumab|atezolizumab|mesh-list
92533026|NCT03262454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92533027|NCT03262454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257789|NCT02242370|Telmisartan|telmisartan|mesh-list
92533029|NCT03262454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533030|NCT00057031|Calcitriol|calcitriol|mesh-list
92533031|NCT00057031|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533032|NCT00057031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533033|NCT00057031|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92533034|NCT00057031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533035|NCT00057031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533036|NCT00057031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92533037|NCT00057031|Vitamins|vitamins|mesh-ancestor
92533039|NCT00057031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92533040|NCT02969980|Cyclophosphamide|cyclophosphamide|mesh-list
92533041|NCT02969980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533042|NCT02969980|Immunologic Factors|immunologic factors|mesh-ancestor
92533043|NCT02969980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533044|NCT02969980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533045|NCT02969980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92533046|NCT02969980|Alkylating Agents|alkylating agents|mesh-ancestor
92533047|NCT02969980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533048|NCT02969980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533049|NCT02969980|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92533050|NCT00057265|Lamivudine|lamivudine|mesh-list
92533051|NCT00057265|Telbivudine|telbivudine|mesh-list
92533052|NCT00057265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92533053|NCT00057265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92533054|NCT00057265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533055|NCT00057265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533056|NCT00057265|Antiviral Agents|antiviral agents|mesh-ancestor
92533057|NCT00057265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533058|NCT00057265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92533059|NCT00057265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92533060|NCT00057343|Rituximab|rituximab|mesh-list
92533061|NCT00057343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533062|NCT00057343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533063|NCT00057343|Immunologic Factors|immunologic factors|mesh-ancestor
92533064|NCT00057343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533065|NCT00057343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533066|NCT00057382|Doxorubicin|doxorubicin|mesh-list
92533067|NCT00057382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533068|NCT00057382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533069|NCT00057382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533070|NCT00057382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533071|NCT00057382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533072|NCT00057382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533075|NCT00057421|Glucocorticoids|glucocorticoids|mesh-ancestor
92533076|NCT00057421|Hormones|hormones|mesh-ancestor
92533077|NCT00057421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533078|NCT00057421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533079|NCT00057421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92533080|NCT00057421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533081|NCT00057616|Lenalidomide|lenalidomide|mesh-list
92533083|NCT00057616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533084|NCT00057616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92533085|NCT00057616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92533086|NCT00057616|Growth Substances|growth substances|mesh-ancestor
92533087|NCT00057616|Growth Inhibitors|growth inhibitors|mesh-ancestor
92533088|NCT00057616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533089|NCT02969746|Charcoal|charcoal|mesh-list
92533090|NCT02969746|Antidotes|antidotes|mesh-ancestor
92533091|NCT02969746|Protective Agents|protective agents|mesh-ancestor
92533092|NCT02969746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533093|NCT00057850|Cisplatin|cisplatin|mesh-list
92533094|NCT00057850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533095|NCT00057889|Ipilimumab|ipilimumab|mesh-list
92533096|NCT00057889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533097|NCT00057889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533098|NCT00057889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92533099|NCT00057889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533101|NCT00057928|Gemcitabine|gemcitabine|mesh-list
92533102|NCT00057928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533103|NCT00057928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533104|NCT00057928|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533105|NCT00057928|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533106|NCT00057928|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533107|NCT00057928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533108|NCT00057928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533110|NCT05309304|Cefazolin|cefazolin|mesh-list
92533111|NCT05309304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92533112|NCT05309304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533113|NCT00057967|Alemtuzumab|alemtuzumab|mesh-list
92533114|NCT00057967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533115|NCT00057967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533116|NCT00058006|Celecoxib|celecoxib|mesh-list
92533117|NCT00058006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92533118|NCT00058006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533119|NCT00058006|Analgesics|analgesics|mesh-ancestor
92533120|NCT00058006|Sensory System Agents|sensory system agents|mesh-ancestor
92533121|NCT00058006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533122|NCT00058006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533123|NCT00058006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533124|NCT00058006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533125|NCT00058006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92533126|NCT00058006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92533127|NCT00058006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533128|NCT00058006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533129|NCT00058045|Aldesleukin|aldesleukin|mesh-list
92533130|NCT00058045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533131|NCT00058045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92533132|NCT00058045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92533134|NCT00058045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533135|NCT00058084|Prednisone|prednisone|mesh-list
92533136|NCT00058084|Mitoxantrone|mitoxantrone|mesh-list
92533137|NCT00058084|Epothilone B|epothilone b|mesh-list
92533138|NCT00058084|Epothilones|epothilones|mesh-list
92533139|NCT00058084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533140|NCT00058084|Glucocorticoids|glucocorticoids|mesh-ancestor
92533142|NCT00058084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533143|NCT00058084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533144|NCT00058084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92533145|NCT00058084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533147|NCT00058084|Sensory System Agents|sensory system agents|mesh-ancestor
92533148|NCT00058084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533149|NCT00058084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533150|NCT00058084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533151|NCT00058084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533152|NCT00058084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533153|NCT00058084|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533154|NCT00058084|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533155|NCT00058084|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533156|NCT02969629|Apomorphine|apomorphine|mesh-list
92533157|NCT02969629|Emetics|emetics|mesh-ancestor
92533158|NCT02969629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533159|NCT02969629|Autonomic Agents|autonomic agents|mesh-ancestor
92533160|NCT02969629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533161|NCT02969629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92533162|NCT02969629|Dopamine Agonists|dopamine agonists|mesh-ancestor
92533163|NCT02969629|Dopamine Agents|dopamine agents|mesh-ancestor
92533164|NCT02969629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533165|NCT02969629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533166|NCT00058201|Leucovorin|leucovorin|mesh-list
92533167|NCT00058201|Gemcitabine|gemcitabine|mesh-list
92533168|NCT00058201|Fluorouracil|fluorouracil|mesh-list
92533169|NCT00058201|Calcium|calcium|mesh-list
92533170|NCT00058201|Levoleucovorin|levoleucovorin|mesh-list
92533171|NCT00058201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533172|NCT00058201|Antimetabolites|antimetabolites|mesh-ancestor
92533173|NCT00058201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533174|NCT00058201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533175|NCT00058201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533176|NCT00058201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533177|NCT00058201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533178|NCT00058201|Immunologic Factors|immunologic factors|mesh-ancestor
92533180|NCT00058201|Protective Agents|protective agents|mesh-ancestor
92533181|NCT00058201|Vitamin B Complex|vitamin b complex|mesh-ancestor
92533183|NCT00058201|Micronutrients|micronutrients|mesh-ancestor
92533184|NCT00058279|Aldesleukin|aldesleukin|mesh-list
92533185|NCT00058279|Ipilimumab|ipilimumab|mesh-list
92533186|NCT00058279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533187|NCT00058279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533188|NCT00058279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92533189|NCT00058279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533190|NCT00058279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92533191|NCT00058279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92533192|NCT00058279|Antiviral Agents|antiviral agents|mesh-ancestor
92533193|NCT00058279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533194|NCT00058318|Gemcitabine|gemcitabine|mesh-list
92533195|NCT00058318|Capecitabine|capecitabine|mesh-list
92533196|NCT00058318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533197|NCT00058318|Antimetabolites|antimetabolites|mesh-ancestor
92533198|NCT00058318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533199|NCT00058318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533200|NCT00058357|Lidocaine|lidocaine|mesh-list
92533201|NCT00058357|Anesthetics, Local|anesthetics, local|mesh-ancestor
92533202|NCT00058357|Anesthetics|anesthetics|mesh-ancestor
92533203|NCT00058357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533204|NCT00058357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533205|NCT00058357|Sensory System Agents|sensory system agents|mesh-ancestor
92533206|NCT00058357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533207|NCT00058357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92533208|NCT00058357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92533209|NCT00058357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92533210|NCT00058357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533211|NCT00058357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533213|NCT00058435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533214|NCT00058435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533216|NCT00058474|Capecitabine|capecitabine|mesh-list
92533217|NCT00058474|Oxaliplatin|oxaliplatin|mesh-list
92533218|NCT00058474|Antimetabolites|antimetabolites|mesh-ancestor
92533219|NCT00058474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533220|NCT00058474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533221|NCT00058474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533222|NCT00058474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533223|NCT00058474|Immunologic Factors|immunologic factors|mesh-ancestor
92533224|NCT00058474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533226|NCT00392262|Valsartan|valsartan|mesh-list
92533227|NCT00392262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92533228|NCT00392262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92533229|NCT00392262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533230|NCT00392262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533231|NCT00392262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533232|NCT00392262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533233|NCT00392262|Vasodilator Agents|vasodilator agents|mesh-ancestor
92533234|NCT00392262|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92533235|NCT00392262|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92533236|NCT00058747|Imatinib Mesylate|imatinib mesylate|mesh-list
92533237|NCT00058747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533238|NCT00058747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533239|NCT00058747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152867|NCT05023122|Calcium|calcium|mesh-list
92533240|NCT00058747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533241|NCT00058903|Sertraline|sertraline|mesh-list
92533242|NCT00058903|Antidepressive Agents|antidepressive agents|mesh-ancestor
92533243|NCT00058903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92533244|NCT00058903|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92533245|NCT00058903|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92533246|NCT00058903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533247|NCT00058903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533248|NCT00058903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533249|NCT00058903|Serotonin Agents|serotonin agents|mesh-ancestor
92533250|NCT00058903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258007|NCT03060083|Nicotine|nicotine|mesh-list
92533253|NCT02969473|Fluorouracil|fluorouracil|mesh-list
92533254|NCT02969473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533255|NCT02969473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533256|NCT02969473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533257|NCT02969473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533258|NCT02969473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533259|NCT02969473|Antimetabolites|antimetabolites|mesh-ancestor
92533260|NCT02969473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533263|NCT02969473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533265|NCT00059254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533266|NCT00059254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533267|NCT01349907|Asenapine|asenapine|mesh-list
92533268|NCT01349907|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92533269|NCT01349907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92533270|NCT01349907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533271|NCT01349907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533272|NCT01349907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92533273|NCT02969278|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92533274|NCT02969278|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92533275|NCT02969278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533276|NCT05223582|Prednisone|prednisone|mesh-list
92533277|NCT05223582|Abiraterone Acetate|abiraterone acetate|mesh-list
92533278|NCT05223582|Fluzoparib|fluzoparib|mesh-list
92533279|NCT05223582|Androgens|androgens|mesh-list
92533280|NCT05223582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533281|NCT05223582|Glucocorticoids|glucocorticoids|mesh-ancestor
92533282|NCT05223582|Hormones|hormones|mesh-ancestor
92533283|NCT05223582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533284|NCT05223582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533285|NCT05223582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92533286|NCT05223582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533287|NCT05223582|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92533288|NCT05223582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533289|NCT05223582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533290|NCT05223582|Hormone Antagonists|hormone antagonists|mesh-ancestor
92533291|NCT05223582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92533292|NCT05223582|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92533294|NCT00059722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533295|NCT00059722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533296|NCT00059722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533297|NCT00059722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533299|NCT05359133|Anesthetics, Local|anesthetics, local|mesh-ancestor
92533300|NCT05359133|Anesthetics|anesthetics|mesh-ancestor
92533301|NCT05359133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533302|NCT05359133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533303|NCT05359133|Sensory System Agents|sensory system agents|mesh-ancestor
92533304|NCT05359133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533305|NCT05359133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92533306|NCT05359133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533307|NCT05359133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533308|NCT02969239|Phenylephrine|phenylephrine|mesh-list
92533309|NCT02969239|Oxymetazoline|oxymetazoline|mesh-list
92533310|NCT02969239|Norepinephrine|norepinephrine|mesh-list
92533311|NCT02969239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92533312|NCT02969239|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92533314|NCT02969239|Autonomic Agents|autonomic agents|mesh-ancestor
92533315|NCT02969239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533316|NCT02969239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354038|NCT03818802|Niacinamide|niacinamide|mesh-list
92533317|NCT02969239|Sympathomimetics|sympathomimetics|mesh-ancestor
92533318|NCT02969239|Nasal Decongestants|nasal decongestants|mesh-ancestor
92533319|NCT02969239|Respiratory System Agents|respiratory system agents|mesh-ancestor
92533320|NCT02969239|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92533321|NCT02969239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92533322|NCT02969239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92533323|NCT02969239|Adrenergic Agents|adrenergic agents|mesh-ancestor
92533324|NCT02969239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533325|NCT02969239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533326|NCT02969239|Protective Agents|protective agents|mesh-ancestor
92533328|NCT00059761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533329|NCT00059761|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92533330|NCT00059761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533331|NCT00059761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533332|NCT00059761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533334|NCT00059800|Trace Elements|trace elements|mesh-ancestor
92533335|NCT00059800|Micronutrients|micronutrients|mesh-ancestor
92533336|NCT00059800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533337|NCT03216083|Tranexamic Acid|tranexamic acid|mesh-list
92533338|NCT03216083|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92533339|NCT03216083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92533340|NCT03216083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533342|NCT03216083|Coagulants|coagulants|mesh-ancestor
92533343|NCT00059878|Interferons|interferons|mesh-list
92533344|NCT00059878|Interferon-gamma|interferon-gamma|mesh-list
92533345|NCT00059878|Voriconazole|voriconazole|mesh-list
92533346|NCT00059878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533348|NCT00059878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533349|NCT00059878|Antifungal Agents|antifungal agents|mesh-ancestor
92533350|NCT00059878|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92533351|NCT00059878|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92533352|NCT00059878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533353|NCT00059878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533354|NCT00059878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92533355|NCT00059878|Hormone Antagonists|hormone antagonists|mesh-ancestor
92533356|NCT00059878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533357|NCT00059878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533358|NCT00059878|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92533359|NCT00059917|Camptothecin|camptothecin|mesh-list
92533360|NCT00059917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533361|NCT00059917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533362|NCT00059917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92533363|NCT00059917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533364|NCT00059917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533365|NCT00059917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533366|NCT00060112|Gemcitabine|gemcitabine|mesh-list
92533368|NCT00060112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533369|NCT00060112|Antimetabolites|antimetabolites|mesh-ancestor
92533370|NCT00060112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533371|NCT00060112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533372|NCT00060307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92533373|NCT00060307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533374|NCT00060307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533375|NCT00060307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533376|NCT00060307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533378|NCT02968927|Cholecalciferol|cholecalciferol|mesh-list
92533379|NCT02968927|Rifabutin|rifabutin|mesh-list
92533380|NCT02968927|Everolimus|everolimus|mesh-list
92533381|NCT02968927|Auranofin|auranofin|mesh-list
92533382|NCT02968927|CC-11050|cc-11050|mesh-list
92533383|NCT02968927|Vitamins|vitamins|mesh-ancestor
92533384|NCT02968927|Micronutrients|micronutrients|mesh-ancestor
92533385|NCT02968927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533386|NCT02968927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92533387|NCT02968927|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92533388|NCT02968927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533389|NCT02968927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533390|NCT02968927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533391|NCT02968927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533392|NCT02968927|Immunologic Factors|immunologic factors|mesh-ancestor
92533393|NCT02968927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533936|NCT02967172|Ropivacaine|ropivacaine|mesh-list
92533394|NCT02968927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533395|NCT02968927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92533396|NCT02968927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533397|NCT02968927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92533398|NCT02968927|Antitubercular Agents|antitubercular agents|mesh-ancestor
92533399|NCT02968927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533400|NCT02968927|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92533401|NCT02968927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92533402|NCT00398515|Sirolimus|sirolimus|mesh-list
92533403|NCT00398515|Lenalidomide|lenalidomide|mesh-list
92533404|NCT00398515|Temsirolimus|temsirolimus|mesh-list
92533405|NCT00398515|MTOR Inhibitors|mtor inhibitors|mesh-list
92533406|NCT00398515|Immunologic Factors|immunologic factors|mesh-ancestor
92533407|NCT00398515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533409|NCT00398515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92533410|NCT00398515|Growth Substances|growth substances|mesh-ancestor
92533411|NCT00398515|Growth Inhibitors|growth inhibitors|mesh-ancestor
92533412|NCT00398515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533413|NCT00398515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533414|NCT00398515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533415|NCT00398515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533416|NCT00398515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533417|NCT00398515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92533418|NCT00398515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533419|NCT00398515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533420|NCT00398515|Antifungal Agents|antifungal agents|mesh-ancestor
92533421|NCT05105685|Hormones|hormones|mesh-list
92537676|NCT00142051|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92533422|NCT05105685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533425|NCT05325164|Methadone|methadone|mesh-list
92533426|NCT05325164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92533427|NCT05325164|Narcotics|narcotics|mesh-ancestor
92533428|NCT05325164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533429|NCT05325164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533430|NCT05325164|Analgesics|analgesics|mesh-ancestor
92533431|NCT05325164|Sensory System Agents|sensory system agents|mesh-ancestor
92533432|NCT05325164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533433|NCT05325164|Antitussive Agents|antitussive agents|mesh-ancestor
92533435|NCT00060385|Prednisone|prednisone|mesh-list
92533436|NCT00060385|Cyclophosphamide|cyclophosphamide|mesh-list
92533437|NCT00060385|Doxorubicin|doxorubicin|mesh-list
92533438|NCT00060385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92533439|NCT00060385|Etoposide|etoposide|mesh-list
92533440|NCT00060385|Vincristine|vincristine|mesh-list
92533441|NCT00060385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533442|NCT00060385|Immunologic Factors|immunologic factors|mesh-ancestor
92533443|NCT00060385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533444|NCT00060385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533445|NCT00060385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92533446|NCT00060385|Alkylating Agents|alkylating agents|mesh-ancestor
92533447|NCT00060385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533448|NCT00060385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533449|NCT00060385|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92533450|NCT00060385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533451|NCT00060385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533452|NCT00060385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533453|NCT00060385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533454|NCT00060385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533455|NCT00060385|Glucocorticoids|glucocorticoids|mesh-ancestor
92537677|NCT00142051|Vasodilator Agents|vasodilator agents|mesh-ancestor
92533457|NCT00060385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533458|NCT00060385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92533941|NCT02967172|Analgesics|analgesics|mesh-ancestor
92533459|NCT00060385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533460|NCT00060385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533461|NCT00060385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533462|NCT00060385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533463|NCT00060463|Contraceptive Agents|contraceptive agents|mesh-list
92533464|NCT00060463|Contraceptives, Postcoital|contraceptives, postcoital|mesh-list
92533465|NCT00060463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537678|NCT00142051|Gasotransmitters|gasotransmitters|mesh-ancestor
92533466|NCT00060463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533467|NCT00060463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92533468|NCT02968693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92533469|NCT02968693|Vancomycin|vancomycin|mesh-list
92533470|NCT02968693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92533471|NCT02968693|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92533472|NCT02968693|Calcium|calcium|mesh-list
92533473|NCT02968693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533474|NCT02968693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533475|NCT02968693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533476|NCT02968693|Antitubercular Agents|antitubercular agents|mesh-ancestor
92533477|NCT02968693|Vasodilator Agents|vasodilator agents|mesh-ancestor
92533478|NCT02968693|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92533479|NCT02968693|Protective Agents|protective agents|mesh-ancestor
92533480|NCT00060502|Infliximab|infliximab|mesh-list
92533481|NCT00060502|Gemcitabine|gemcitabine|mesh-list
92533482|NCT00060502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533483|NCT00060502|Antimetabolites|antimetabolites|mesh-ancestor
92533484|NCT00060502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533485|NCT00060502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533486|NCT00060502|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92537679|NCT00142051|Protective Agents|protective agents|mesh-ancestor
92533487|NCT00060502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533488|NCT00060502|Dermatologic Agents|dermatologic agents|mesh-ancestor
92533489|NCT00060502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92533490|NCT00060502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533491|NCT05312372|Paclitaxel|paclitaxel|mesh-list
92533492|NCT05312372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533493|NCT05312372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533494|NCT05312372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533495|NCT05312372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533496|NCT05312372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537680|NCT00142129|Bortezomib|bortezomib|mesh-list
92533497|NCT05312372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533498|NCT05038410|Wobenzym|wobenzym|mesh-list
92533499|NCT05038410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92533500|NCT05038410|Immunologic Factors|immunologic factors|mesh-ancestor
92533501|NCT05038410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533502|NCT05030493|Bevacizumab|bevacizumab|mesh-list
92533503|NCT05030493|Panitumumab|panitumumab|mesh-list
92533504|NCT05030493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533505|NCT05030493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533506|NCT05030493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92533507|NCT05030493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92533508|NCT05030493|Growth Substances|growth substances|mesh-ancestor
92533509|NCT05030493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533510|NCT05030493|Growth Inhibitors|growth inhibitors|mesh-ancestor
92533511|NCT02968498|Methamphetamine|methamphetamine|mesh-list
92533513|NCT02968498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92533514|NCT02968498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92533515|NCT02968498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533516|NCT02968498|Sympathomimetics|sympathomimetics|mesh-ancestor
92533517|NCT02968498|Autonomic Agents|autonomic agents|mesh-ancestor
92533518|NCT02968498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533519|NCT02968498|Dopamine Agents|dopamine agents|mesh-ancestor
92533520|NCT02968498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533521|NCT02968498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533522|NCT02968498|Adrenergic Agents|adrenergic agents|mesh-ancestor
92533523|NCT02968498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92533524|NCT02968498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92533525|NCT02968498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533526|NCT02968498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92533527|NCT00060931|Metoprolol|metoprolol|mesh-list
92533528|NCT00060931|Carvedilol|carvedilol|mesh-list
92533529|NCT00060931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92533530|NCT00060931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92533531|NCT00060931|Sympatholytics|sympatholytics|mesh-ancestor
92533532|NCT00060931|Autonomic Agents|autonomic agents|mesh-ancestor
92533533|NCT00060931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533534|NCT00060931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533535|NCT00060931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92533536|NCT00060931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92533537|NCT00060931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92533538|NCT00060931|Adrenergic Agents|adrenergic agents|mesh-ancestor
92533539|NCT00060931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533540|NCT00060931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533541|NCT00060931|Antioxidants|antioxidants|mesh-ancestor
92533542|NCT00060931|Protective Agents|protective agents|mesh-ancestor
92533543|NCT00060931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92533544|NCT00060931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533545|NCT00060931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533546|NCT00060931|Vasodilator Agents|vasodilator agents|mesh-ancestor
92533547|NCT00060931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92533548|NCT00060931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92533549|NCT00061087|Methylphenidate|methylphenidate|mesh-list
92258306|NCT04925076|Ethanol|ethanol|mesh-list
92533550|NCT00061087|Bupropion|bupropion|mesh-list
92533551|NCT00061087|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92533552|NCT00061087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533553|NCT00061087|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92533554|NCT00061087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92533555|NCT00061087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92533556|NCT00061087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533557|NCT00061087|Dopamine Agents|dopamine agents|mesh-ancestor
92533558|NCT00061087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533559|NCT00061087|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92533560|NCT00061087|Antidepressive Agents|antidepressive agents|mesh-ancestor
92533561|NCT00061087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92533562|NCT00061087|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92533563|NCT00061087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92533564|NCT00061087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533565|NCT00061243|Vaccines|vaccines|mesh-list
92533566|NCT00061243|Immunologic Factors|immunologic factors|mesh-ancestor
92533567|NCT00061243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533568|NCT04711564|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92533569|NCT04711564|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92533570|NCT04711564|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92533572|NCT00061321|Nevirapine|nevirapine|mesh-list
92533573|NCT00061321|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92533574|NCT00061321|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92533575|NCT00061321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533576|NCT00061321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533577|NCT00061321|Antiviral Agents|antiviral agents|mesh-ancestor
92533578|NCT00061321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533579|NCT00061321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92533580|NCT00061321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92533581|NCT00061321|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92533959|NCT00064090|Cytarabine|cytarabine|mesh-list
92533582|NCT00061321|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92533583|NCT00061360|Cyclosporine|cyclosporine|mesh-list
92533585|NCT00061360|Cyclosporins|cyclosporins|mesh-list
92533586|NCT00061360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537681|NCT00142129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533587|NCT00061360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533588|NCT00061360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533589|NCT00061360|Immunologic Factors|immunologic factors|mesh-ancestor
92533590|NCT00061360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533591|NCT00061360|Antifungal Agents|antifungal agents|mesh-ancestor
92533593|NCT00061360|Dermatologic Agents|dermatologic agents|mesh-ancestor
92533594|NCT00061360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537683|NCT02825979|Flecainide|flecainide|mesh-list
92533595|NCT00061360|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92533596|NCT00061360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92533597|NCT00061360|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533598|NCT00061360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533599|NCT00061438|Meropenem|meropenem|mesh-list
92533600|NCT00061438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92533601|NCT00061438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533602|NCT00061477|Gemcitabine|gemcitabine|mesh-list
92533603|NCT00061477|Pemetrexed|pemetrexed|mesh-list
92533604|NCT00061477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533606|NCT00061477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533607|NCT00061477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533608|NCT00061477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533609|NCT00061477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92533610|NCT00061477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92533612|NCT02968342|Progestins|progestins|mesh-ancestor
92533613|NCT02968342|Hormones|hormones|mesh-ancestor
92533614|NCT02968342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533615|NCT02968342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533616|NCT02968303|Vemurafenib|vemurafenib|mesh-list
92533617|NCT02968303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533618|NCT02968303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533619|NCT02968303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533620|NCT02968303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533622|NCT00061516|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92533623|NCT00061516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258380|NCT04356872|Doxorubicin|doxorubicin|mesh-list
92533624|NCT00061516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533625|NCT00061594|Ranibizumab|ranibizumab|mesh-list
92533626|NCT00061594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92533627|NCT00061594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92533628|NCT00061594|Growth Substances|growth substances|mesh-ancestor
92533629|NCT00061594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533630|NCT00061594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92533631|NCT00061594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533632|NCT00061711|Hormones|hormones|mesh-list
92533633|NCT00061711|Phytoestrogens|phytoestrogens|mesh-list
92533634|NCT00061711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92533635|NCT00061711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533636|NCT00061711|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92533637|NCT00061711|Estrogens|estrogens|mesh-ancestor
92533638|NCT00061750|Deferasirox|deferasirox|mesh-list
92533639|NCT00061750|Deferoxamine|deferoxamine|mesh-list
92533640|NCT00061750|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92533641|NCT00061750|Chelating Agents|chelating agents|mesh-ancestor
92533642|NCT00061750|Sequestering Agents|sequestering agents|mesh-ancestor
92533643|NCT00061750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533644|NCT00061750|Siderophores|siderophores|mesh-ancestor
92533645|NCT00061789|Acetylcholine|acetylcholine|mesh-list
92533646|NCT00061789|Vasodilator Agents|vasodilator agents|mesh-ancestor
92533647|NCT00061789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92533648|NCT00061789|Cholinergic Agents|cholinergic agents|mesh-ancestor
92533649|NCT00061789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533650|NCT00061789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533652|NCT00061867|Doxorubicin|doxorubicin|mesh-list
92533653|NCT00061867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92533654|NCT00061867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533655|NCT00061867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533656|NCT00061867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533657|NCT00061867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533658|NCT00061867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537684|NCT02825979|Dronedarone|dronedarone|mesh-list
92533659|NCT00061867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533660|NCT00061906|Celecoxib|celecoxib|mesh-list
92537685|NCT02825979|Propafenone|propafenone|mesh-list
92533661|NCT00061906|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92533662|NCT00061906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533663|NCT00061906|Analgesics|analgesics|mesh-ancestor
92533664|NCT00061906|Sensory System Agents|sensory system agents|mesh-ancestor
92533665|NCT00061906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533666|NCT00061906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533667|NCT00061906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533668|NCT00061906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537686|NCT02825979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92533669|NCT00061906|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92533670|NCT00061906|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92533671|NCT00061906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533672|NCT00061906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533673|NCT05219825|Psychotropic Drugs|psychotropic drugs|mesh-list
92533674|NCT00398554|Prednisone|prednisone|mesh-list
92533675|NCT00398554|Cyclophosphamide|cyclophosphamide|mesh-list
92533676|NCT00398554|Doxorubicin|doxorubicin|mesh-list
92533677|NCT00398554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92533679|NCT00398554|Vincristine|vincristine|mesh-list
92533680|NCT00398554|Vinblastine|vinblastine|mesh-list
92533681|NCT00398554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533682|NCT00398554|Immunologic Factors|immunologic factors|mesh-ancestor
92533683|NCT00398554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533684|NCT00398554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533685|NCT00398554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92533686|NCT00398554|Alkylating Agents|alkylating agents|mesh-ancestor
92533687|NCT00398554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533688|NCT00398554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533689|NCT00398554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92533690|NCT00398554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533691|NCT00398554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533693|NCT00398554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533694|NCT00398554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533695|NCT00398554|Glucocorticoids|glucocorticoids|mesh-ancestor
92533696|NCT00398554|Hormones|hormones|mesh-ancestor
92533697|NCT00398554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258456|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533698|NCT00398554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92533699|NCT00398554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533700|NCT00398554|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533701|NCT00398554|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533702|NCT00398554|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533704|NCT04917900|Trastuzumab|trastuzumab|mesh-list
92533705|NCT04917900|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92533706|NCT04917900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533707|NCT04917900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533708|NCT04917900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533709|NCT04917900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533710|NCT04917900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533711|NCT04917900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533712|NCT04917900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533713|NCT05219435|Nivolumab|nivolumab|mesh-list
92533714|NCT05219435|Ipilimumab|ipilimumab|mesh-list
92533715|NCT05219435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354093|NCT05158062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533716|NCT05219435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533717|NCT05219435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92533718|NCT05219435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533719|NCT00061984|Doxorubicin|doxorubicin|mesh-list
92533720|NCT00061984|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92533722|NCT00061984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533723|NCT00061984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533724|NCT00061984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533725|NCT00061984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533726|NCT00061984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533727|NCT00061984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533728|NCT00061984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92533729|NCT00061984|Alkylating Agents|alkylating agents|mesh-ancestor
92533730|NCT00062023|Aspirin|aspirin|mesh-list
92533731|NCT00062023|Sulindac|sulindac|mesh-list
92533732|NCT00062023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92533733|NCT00062023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92533734|NCT00062023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533735|NCT00062023|Analgesics|analgesics|mesh-ancestor
92533736|NCT00062023|Sensory System Agents|sensory system agents|mesh-ancestor
92533737|NCT00062023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533738|NCT00062023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533739|NCT00062023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533740|NCT00062023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533741|NCT00062023|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92533742|NCT00062023|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92533743|NCT00062023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533744|NCT00062023|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92533745|NCT00062023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92533746|NCT00062023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533747|NCT00062023|Antipyretics|antipyretics|mesh-ancestor
92533748|NCT00062023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92533749|NCT00062023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92533750|NCT00062023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533751|NCT00062062|Paclitaxel|paclitaxel|mesh-list
92533752|NCT00062062|Carboplatin|carboplatin|mesh-list
92533753|NCT00062062|Gefitinib|gefitinib|mesh-list
92533754|NCT00062062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533755|NCT00062062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533756|NCT00062062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533757|NCT00062062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533758|NCT00062062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533759|NCT00062062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533760|NCT00062062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533761|NCT00062062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533762|NCT00392340|Doxorubicin|doxorubicin|mesh-list
92533763|NCT00392340|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92533764|NCT00392340|Vincristine|vincristine|mesh-list
92533765|NCT00392340|Topotecan|topotecan|mesh-list
92533766|NCT00392340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533767|NCT00392340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533768|NCT00392340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533769|NCT00392340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533770|NCT00392340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533771|NCT00392340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533772|NCT00392340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533773|NCT00392340|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533774|NCT00392340|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533775|NCT00392340|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533776|NCT00392340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92533777|NCT00062101|Celecoxib|celecoxib|mesh-list
92533778|NCT00062101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92533779|NCT00062101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533780|NCT00062101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533781|NCT00062101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533782|NCT00062101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533783|NCT00062101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92533784|NCT00062101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533785|NCT00062101|Analgesics|analgesics|mesh-ancestor
92533786|NCT00062101|Sensory System Agents|sensory system agents|mesh-ancestor
92533787|NCT00062101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533788|NCT00062101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533789|NCT00062101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533790|NCT00062101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533791|NCT00062101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92533792|NCT00062101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92533794|NCT00062140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533795|NCT00062140|Immunologic Factors|immunologic factors|mesh-ancestor
92533796|NCT00062140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533797|NCT00062140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533798|NCT00062140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92533799|NCT00062140|Alkylating Agents|alkylating agents|mesh-ancestor
92537687|NCT02825979|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92533800|NCT00062140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533801|NCT00062140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533802|NCT00062140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92533803|NCT00062179|Celecoxib|celecoxib|mesh-list
92533804|NCT00062179|Paclitaxel|paclitaxel|mesh-list
92533805|NCT00062179|Carboplatin|carboplatin|mesh-list
92533806|NCT00062179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92533807|NCT00062179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533808|NCT00062179|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533809|NCT00062179|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533810|NCT00062179|Mitosis Modulators|mitosis modulators|mesh-ancestor
92533811|NCT00062179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533812|NCT00062179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92533813|NCT00062179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533814|NCT00062179|Analgesics|analgesics|mesh-ancestor
92533815|NCT00062179|Sensory System Agents|sensory system agents|mesh-ancestor
92533816|NCT00062179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533817|NCT00062179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533818|NCT00062179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533819|NCT00062179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533820|NCT00062179|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92533821|NCT00062179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92533822|NCT00062179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533823|NCT00062257|Irofulven|irofulven|mesh-list
92533824|NCT00062257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92533825|NCT00062257|Alkylating Agents|alkylating agents|mesh-ancestor
92533826|NCT00062257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533827|NCT00062257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533829|NCT00062296|Epirubicin|epirubicin|mesh-list
92533830|NCT00062296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533831|NCT00062296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533832|NCT00062296|Immunologic Factors|immunologic factors|mesh-ancestor
92533833|NCT00062296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533834|NCT00062296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533835|NCT00062296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533836|NCT00062296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92533837|NCT00062296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533838|NCT00062296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533839|NCT00062296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533841|NCT05183984|Niraparib|niraparib|mesh-list
92533842|NCT05183984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533843|NCT05183984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533844|NCT05183984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92533845|NCT05183984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92533846|NCT05183984|Growth Substances|growth substances|mesh-ancestor
92533847|NCT05183984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533848|NCT05183984|Growth Inhibitors|growth inhibitors|mesh-ancestor
92533849|NCT05183984|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92533850|NCT05183984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533851|NCT05183984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533852|NCT02967874|Hyaluronic Acid|hyaluronic acid|mesh-list
92533853|NCT02967874|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92533854|NCT02967874|Immunologic Factors|immunologic factors|mesh-ancestor
92533855|NCT02967874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533856|NCT02967874|Viscosupplements|viscosupplements|mesh-ancestor
92533857|NCT02967874|Protective Agents|protective agents|mesh-ancestor
92533858|NCT04733625|Vitamin D|vitamin d|mesh-list
92533859|NCT04733625|Cholecalciferol|cholecalciferol|mesh-list
92533860|NCT04733625|Vitamins|vitamins|mesh-ancestor
92533861|NCT04733625|Micronutrients|micronutrients|mesh-ancestor
92533862|NCT04733625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354101|NCT03193866|Rituximab|rituximab|mesh-list
92533863|NCT04733625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92533864|NCT04733625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92533866|NCT00062686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533867|NCT00062686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533868|NCT00062686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533869|NCT00062686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533870|NCT00062803|Heparin|heparin|mesh-list
92533871|NCT00062803|Warfarin|warfarin|mesh-list
92533872|NCT00062803|Acenocoumarol|acenocoumarol|mesh-list
92533873|NCT00062803|Anticoagulants|anticoagulants|mesh-ancestor
92533874|NCT00062803|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92533875|NCT00062803|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92537688|NCT02825979|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92533876|NCT00062803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533877|NCT00062842|Irinotecan|irinotecan|mesh-list
92533878|NCT00062842|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92533879|NCT00062842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92533880|NCT00062842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537689|NCT02825979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92533881|NCT00062842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533882|NCT00062842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533883|NCT00062881|Mafosfamide|mafosfamide|mesh-list
92533884|NCT00062881|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92533885|NCT00062881|Immunologic Factors|immunologic factors|mesh-ancestor
92533887|NCT00062881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533888|NCT00389909|Doxapram|doxapram|mesh-list
92533889|NCT00389909|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92533890|NCT00389909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533891|NCT00389909|Respiratory System Agents|respiratory system agents|mesh-ancestor
92533892|NCT00063076|Bexarotene|bexarotene|mesh-list
92533893|NCT00063076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533894|NCT00063193|Minocycline|minocycline|mesh-list
92533895|NCT00063193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92533896|NCT00063193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533897|NCT00063310|Leuprolide|leuprolide|mesh-list
92533898|NCT00063310|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92533899|NCT00063310|Fertility Agents|fertility agents|mesh-ancestor
92533900|NCT00063310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92533901|NCT00063310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533902|NCT00063310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92533903|NCT00063310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533904|NCT00063388|Cetuximab|cetuximab|mesh-list
92533905|NCT00063388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533906|NCT00063388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533907|NCT00063583|Pirfenidone|pirfenidone|mesh-list
92533908|NCT00063583|Analgesics|analgesics|mesh-ancestor
92533909|NCT00063583|Sensory System Agents|sensory system agents|mesh-ancestor
92533910|NCT00063583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533911|NCT00063583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533912|NCT00063583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92533913|NCT00063583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92533914|NCT00063583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92533915|NCT00063583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533916|NCT00063583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533917|NCT00063895|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92533918|NCT00063895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533919|NCT00063895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533920|NCT00063895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533921|NCT00063895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533922|NCT00064012|Docetaxel|docetaxel|mesh-list
92533923|NCT00064012|Bortezomib|bortezomib|mesh-list
92533924|NCT00064012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533925|NCT00064012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92533926|NCT00064012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92533928|NCT00064012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533929|NCT00064051|Gemcitabine|gemcitabine|mesh-list
92533930|NCT00064051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533931|NCT00064051|Antimetabolites|antimetabolites|mesh-ancestor
92533932|NCT00064051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533933|NCT00064051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533934|NCT02967172|Epinephrine|epinephrine|mesh-list
92533935|NCT02967172|Morphine|morphine|mesh-list
92533937|NCT02967172|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92533938|NCT02967172|Narcotics|narcotics|mesh-ancestor
92533939|NCT02967172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92533940|NCT02967172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533942|NCT02967172|Sensory System Agents|sensory system agents|mesh-ancestor
92533943|NCT02967172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92533944|NCT02967172|Anesthetics, Local|anesthetics, local|mesh-ancestor
92533945|NCT02967172|Anesthetics|anesthetics|mesh-ancestor
92533946|NCT02967172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92533947|NCT02967172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92533948|NCT02967172|Adrenergic Agents|adrenergic agents|mesh-ancestor
92533949|NCT02967172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92533950|NCT02967172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533951|NCT02967172|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92533952|NCT02967172|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92533953|NCT02967172|Autonomic Agents|autonomic agents|mesh-ancestor
92533954|NCT02967172|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92533955|NCT02967172|Respiratory System Agents|respiratory system agents|mesh-ancestor
92533956|NCT02967172|Mydriatics|mydriatics|mesh-ancestor
92533957|NCT02967172|Sympathomimetics|sympathomimetics|mesh-ancestor
92533958|NCT02967172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92533960|NCT00064090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533961|NCT00064090|Antimetabolites|antimetabolites|mesh-ancestor
92533962|NCT00064090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533963|NCT00064090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533964|NCT00064090|Antiviral Agents|antiviral agents|mesh-ancestor
92533965|NCT00064090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92533966|NCT00064090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92533967|NCT00064090|Immunologic Factors|immunologic factors|mesh-ancestor
92533968|NCT00064090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533969|NCT05141357|Pembrolizumab|pembrolizumab|mesh-list
92533970|NCT05141357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533971|NCT05141357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533972|NCT05141357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92536202|NCT00080743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536203|NCT00080743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92536204|NCT00080743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536205|NCT00080743|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92536206|NCT00080743|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92536207|NCT00080743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92536208|NCT00080743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536209|NCT00080743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536210|NCT04423367|Dexamethasone|dexamethasone|mesh-list
92536211|NCT04423367|Bortezomib|bortezomib|mesh-list
92536212|NCT04423367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536213|NCT04423367|Antiemetics|antiemetics|mesh-ancestor
92536214|NCT04423367|Autonomic Agents|autonomic agents|mesh-ancestor
92536215|NCT04423367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536216|NCT04423367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536217|NCT04423367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92536218|NCT04423367|Glucocorticoids|glucocorticoids|mesh-ancestor
92536219|NCT04423367|Hormones|hormones|mesh-ancestor
92536220|NCT04423367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536221|NCT04423367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92536222|NCT04423367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536223|NCT00080782|Celecoxib|celecoxib|mesh-list
92536224|NCT00080782|Doxorubicin|doxorubicin|mesh-list
92536225|NCT00080782|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92536226|NCT00080782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92533973|NCT05141357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533974|NCT00064129|Ipilimumab|ipilimumab|mesh-list
92533975|NCT00064129|Sargramostim|sargramostim|mesh-list
92536227|NCT00080782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536228|NCT00080782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536229|NCT00080782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92536230|NCT00080782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536231|NCT00080782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536232|NCT00080782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92536233|NCT00080782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92536234|NCT00080782|Analgesics|analgesics|mesh-ancestor
92536235|NCT00080782|Sensory System Agents|sensory system agents|mesh-ancestor
92536236|NCT00080782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942355|NCT05255653|Megestrol|megestrol|mesh-list
92536345|NCT03152175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92536346|NCT03152175|Vasodilator Agents|vasodilator agents|mesh-ancestor
92536347|NCT00399685|Efavirenz|efavirenz|mesh-list
92536348|NCT00399685|Moxifloxacin|moxifloxacin|mesh-list
92536349|NCT00399685|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92536350|NCT00399685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92536351|NCT00399685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92536352|NCT00399685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536353|NCT00399685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536354|NCT00399685|Antiviral Agents|antiviral agents|mesh-ancestor
92536355|NCT00399685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536356|NCT00399685|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92536357|NCT00399685|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92536358|NCT00399685|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92536359|NCT00399685|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92536360|NCT00399685|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91942777|NCT04414475|Glucocorticoids|glucocorticoids|mesh-ancestor
92536554|NCT00083785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536555|NCT00083785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92536556|NCT00083785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92536557|NCT03151707|Niacinamide|niacinamide|mesh-list
92536558|NCT03151707|Niacin|niacin|mesh-list
92536559|NCT03151707|Nicotinic Acids|nicotinic acids|mesh-list
92536560|NCT03151707|Vitamin B Complex|vitamin b complex|mesh-ancestor
92536561|NCT03151707|Vitamins|vitamins|mesh-ancestor
91943991|NCT02286635|Clarithromycin|clarithromycin|mesh-list
92538167|NCT01807455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538168|NCT01807455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92538169|NCT01807455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92538170|NCT01807455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92538171|NCT01807455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538172|NCT01807455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538173|NCT05594017|Scopolamine|scopolamine|mesh-list
92538174|NCT05594017|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92538175|NCT05594017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92538176|NCT05594017|Antiemetics|antiemetics|mesh-ancestor
92538177|NCT05594017|Autonomic Agents|autonomic agents|mesh-ancestor
92538178|NCT05594017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538179|NCT05594017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538180|NCT05594017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538181|NCT05594017|Mydriatics|mydriatics|mesh-ancestor
92538182|NCT05594017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92538183|NCT05594017|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538184|NCT05594017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538185|NCT05594017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538186|NCT05594017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92538187|NCT05594017|Parasympatholytics|parasympatholytics|mesh-ancestor
92538688|NCT04033276|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92538690|NCT04033276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538691|NCT04033276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538692|NCT04033276|Immunologic Factors|immunologic factors|mesh-ancestor
92538693|NCT04033276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539056|NCT00009815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539057|NCT00009815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539058|NCT00009815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539059|NCT00009815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539060|NCT00009815|Antidotes|antidotes|mesh-ancestor
92533976|NCT00064129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533977|NCT00064129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533978|NCT00064129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92533979|NCT00064129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533981|NCT00064129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533982|NCT00064207|Gemcitabine|gemcitabine|mesh-list
92533983|NCT00064207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92533984|NCT00064207|Antimetabolites|antimetabolites|mesh-ancestor
92533985|NCT00064207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533986|NCT00064207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533987|NCT00064246|Rituximab|rituximab|mesh-list
92533988|NCT00064246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92539061|NCT00009815|Protective Agents|protective agents|mesh-ancestor
92539062|NCT00009815|Vitamin B Complex|vitamin b complex|mesh-ancestor
92539063|NCT00009815|Vitamins|vitamins|mesh-ancestor
92539064|NCT00009815|Micronutrients|micronutrients|mesh-ancestor
92539065|NCT00009815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539066|NCT00009815|Antimetabolites|antimetabolites|mesh-ancestor
92539067|NCT01465815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92539068|NCT01465815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539069|NCT01465815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92539070|NCT01465815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539071|NCT01465815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539072|NCT00009854|Ethanol|ethanol|mesh-list
92539073|NCT00009854|Carmustine|carmustine|mesh-list
92539074|NCT00009854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92539075|NCT00009854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539076|NCT00009854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92539077|NCT00009854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539078|NCT00009854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539079|NCT00009854|Alkylating Agents|alkylating agents|mesh-ancestor
92539080|NCT00009854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539081|NCT00009854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539082|NCT00009893|Leucovorin|leucovorin|mesh-list
92539083|NCT00009893|Gemcitabine|gemcitabine|mesh-list
92539084|NCT00009893|Fluorouracil|fluorouracil|mesh-list
92539085|NCT00009893|Calcium|calcium|mesh-list
92539086|NCT00009893|Levoleucovorin|levoleucovorin|mesh-list
92539087|NCT00009893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539088|NCT00009893|Antimetabolites|antimetabolites|mesh-ancestor
92539089|NCT00009893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539090|NCT00009893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946635|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
92539105|NCT00010010|Exemestane|exemestane|mesh-list
92539106|NCT00010010|Goserelin|goserelin|mesh-list
92539107|NCT00010010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539108|NCT00010010|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92539109|NCT00010010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92539110|NCT00010010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539111|NCT00010010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539112|NCT00010010|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92539113|NCT00010010|Hormone Antagonists|hormone antagonists|mesh-ancestor
92539114|NCT00010010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539115|NCT00010010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539116|NCT00010010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92539117|NCT00010049|Imatinib Mesylate|imatinib mesylate|mesh-list
92539118|NCT00010049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539119|NCT00010049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92539120|NCT00010049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539121|NCT00010049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92533989|NCT00064246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92533990|NCT00064246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539122|NCT00010088|Leucovorin|leucovorin|mesh-list
92539123|NCT00010088|Gemcitabine|gemcitabine|mesh-list
92539124|NCT00010088|Fluorouracil|fluorouracil|mesh-list
92539125|NCT00010088|Calcium|calcium|mesh-list
92539126|NCT00010088|Levoleucovorin|levoleucovorin|mesh-list
92539127|NCT00010088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539128|NCT00010088|Antimetabolites|antimetabolites|mesh-ancestor
92539129|NCT00010088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539130|NCT00010088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539131|NCT00010088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92539132|NCT00010088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539133|NCT00010088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539134|NCT00010088|Immunologic Factors|immunologic factors|mesh-ancestor
92539135|NCT00010088|Antidotes|antidotes|mesh-ancestor
92539136|NCT00010088|Protective Agents|protective agents|mesh-ancestor
92539137|NCT00010088|Vitamin B Complex|vitamin b complex|mesh-ancestor
92539138|NCT00010088|Vitamins|vitamins|mesh-ancestor
92539139|NCT00010088|Micronutrients|micronutrients|mesh-ancestor
92539140|NCT01465503|Heparin|heparin|mesh-list
92539141|NCT01465503|Calcium heparin|calcium heparin|mesh-list
92539142|NCT01465503|Hirudins|hirudins|mesh-list
92539143|NCT01465503|Bivalirudin|bivalirudin|mesh-list
92539144|NCT01465503|Anticoagulants|anticoagulants|mesh-ancestor
92539145|NCT01465503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92539146|NCT01465503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92539147|NCT01465503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539148|NCT01465503|Antithrombins|antithrombins|mesh-ancestor
92539149|NCT01465503|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92539150|NCT01465503|Protease Inhibitors|protease inhibitors|mesh-ancestor
92539151|NCT01465503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539152|NCT00010166|Gemcitabine|gemcitabine|mesh-list
92539153|NCT00010166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539154|NCT00010166|Antimetabolites|antimetabolites|mesh-ancestor
92539176|NCT01465113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539178|NCT01465074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92539179|NCT01465074|Autonomic Agents|autonomic agents|mesh-ancestor
92539180|NCT01465074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539181|NCT01465074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539182|NCT01465074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92539183|NCT01465074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92539184|NCT01465074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92539185|NCT01465074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539186|NCT01465074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539187|NCT00010283|Beclomethasone|beclomethasone|mesh-list
92539188|NCT00010283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92539189|NCT00010283|Glucocorticoids|glucocorticoids|mesh-ancestor
92539190|NCT00010283|Hormones|hormones|mesh-ancestor
92539191|NCT00010283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539192|NCT00010283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539193|NCT00010283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92539194|NCT00010283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92539195|NCT00010322|Toremifene|toremifene|mesh-list
92539196|NCT00010322|Atamestane|atamestane|mesh-list
92539197|NCT00010322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92539198|NCT00010322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539199|NCT00010322|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92539200|NCT00010322|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92539201|NCT00010322|Hormone Antagonists|hormone antagonists|mesh-ancestor
92539202|NCT00010322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539203|NCT00010322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539204|NCT00010322|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92539205|NCT00010322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946752|NCT03962062|Moxidectin|moxidectin|mesh-list
92539217|NCT00010361|Antifungal Agents|antifungal agents|mesh-ancestor
92539218|NCT00010361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539219|NCT00010361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92539220|NCT00010361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539221|NCT00010361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92539222|NCT00010361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539223|NCT00010361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92539224|NCT00010361|Antitubercular Agents|antitubercular agents|mesh-ancestor
92539225|NCT00010361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539227|NCT00010400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539228|NCT00010400|Immunologic Factors|immunologic factors|mesh-ancestor
92539229|NCT00010400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539230|NCT00010400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539231|NCT00010400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539232|NCT00010400|Alkylating Agents|alkylating agents|mesh-ancestor
92539233|NCT00010400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539234|NCT00010400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539235|NCT00010400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92539236|NCT01464840|Azithromycin|azithromycin|mesh-list
92539237|NCT01464840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539238|NCT01464840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539239|NCT01464801|Resveratrol|resveratrol|mesh-list
92539240|NCT01464801|Antioxidants|antioxidants|mesh-ancestor
92539241|NCT01464801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539242|NCT01464801|Protective Agents|protective agents|mesh-ancestor
92539243|NCT01464801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539244|NCT01464801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539245|NCT01464801|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92539246|NCT01464762|Bedaquiline|bedaquiline|mesh-list
92539247|NCT01464762|Antitubercular Agents|antitubercular agents|mesh-ancestor
92539248|NCT01464762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539249|NCT01464762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539250|NCT02035358|Immunomodulating Agents|immunomodulating agents|mesh-list
92264001|NCT02379390|Prednisone|prednisone|mesh-list
92539251|NCT02035358|Immunologic Factors|immunologic factors|mesh-ancestor
92539252|NCT02035358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539253|NCT01464723|Ranibizumab|ranibizumab|mesh-list
92539254|NCT01464723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92539255|NCT01464723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92539256|NCT01464723|Growth Substances|growth substances|mesh-ancestor
92539257|NCT01464723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539258|NCT01464723|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539259|NCT01464723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539260|NCT01464606|Dactinomycin|dactinomycin|mesh-list
92539261|NCT01464606|Cyclophosphamide|cyclophosphamide|mesh-list
92539262|NCT01464606|Ifosfamide|ifosfamide|mesh-list
92539263|NCT01464606|Doxorubicin|doxorubicin|mesh-list
92539264|NCT01464606|Vincristine|vincristine|mesh-list
92539265|NCT01464606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539266|NCT01464606|Immunologic Factors|immunologic factors|mesh-ancestor
92539267|NCT01464606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539268|NCT01464606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539269|NCT01464606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539297|NCT00011297|Lorazepam|lorazepam|mesh-list
92539298|NCT00011297|Analgesics|analgesics|mesh-ancestor
92539299|NCT00011297|Sensory System Agents|sensory system agents|mesh-ancestor
92539300|NCT00011297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539301|NCT00011297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539302|NCT00011297|Anticonvulsants|anticonvulsants|mesh-ancestor
92539303|NCT00011297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92539304|NCT00011297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92539305|NCT00011297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92539306|NCT00011297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539307|NCT00011297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92539308|NCT00011297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92539309|NCT00011297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539310|NCT00011297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539311|NCT00011297|Antimanic Agents|antimanic agents|mesh-ancestor
92539312|NCT00011297|Antiemetics|antiemetics|mesh-ancestor
92539313|NCT00011297|Autonomic Agents|autonomic agents|mesh-ancestor
92539314|NCT00011297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92539315|NCT00011297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92539316|NCT00011297|GABA Modulators|gaba modulators|mesh-ancestor
92539317|NCT00011297|GABA Agents|gaba agents|mesh-ancestor
92539318|NCT00011375|Rolipram|rolipram|mesh-list
92539335|NCT00847899|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|1-(1-acetyl-piperidine-4-yl)-3-adamantan-1-yl-urea|mesh-list
92539336|NCT00847899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92539337|NCT00847899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539338|NCT00847899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539340|NCT00847860|Cilostazol|cilostazol|mesh-list
92539341|NCT00847860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92539342|NCT00847860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92539343|NCT00847860|Analgesics|analgesics|mesh-ancestor
92533991|NCT00064246|Immunologic Factors|immunologic factors|mesh-ancestor
92533992|NCT00064246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92533993|NCT00064246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92533994|NCT00064285|Imatinib Mesylate|imatinib mesylate|mesh-list
92258752|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92539344|NCT00847860|Sensory System Agents|sensory system agents|mesh-ancestor
92539345|NCT00847860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539346|NCT00847860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539347|NCT00847860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92539348|NCT00847860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539349|NCT00847860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92539350|NCT00847860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92539351|NCT00847860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539352|NCT00847860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92539353|NCT00847860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92539354|NCT00847860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539355|NCT00847860|Antipyretics|antipyretics|mesh-ancestor
92539356|NCT00847860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92539357|NCT00847860|Autonomic Agents|autonomic agents|mesh-ancestor
92539358|NCT00847860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92539359|NCT00847860|Respiratory System Agents|respiratory system agents|mesh-ancestor
92539360|NCT00847860|Vasodilator Agents|vasodilator agents|mesh-ancestor
92539361|NCT00847860|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92539362|NCT00847860|Protective Agents|protective agents|mesh-ancestor
92539363|NCT00847860|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92152868|NCT05023122|Vitamins|vitamins|mesh-ancestor
92539364|NCT00847860|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92539365|NCT00847821|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92539366|NCT00847821|Bazedoxifene|bazedoxifene|mesh-list
92539367|NCT00847821|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92539368|NCT00847821|Hormone Antagonists|hormone antagonists|mesh-ancestor
92539369|NCT00847821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539370|NCT00847821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539371|NCT00847821|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92539372|NCT00847821|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92539373|NCT00847821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92539391|NCT00847587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92539392|NCT00847587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92539394|NCT00847587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92539395|NCT00847587|Progestins|progestins|mesh-ancestor
92539396|NCT00847587|Hormones|hormones|mesh-ancestor
92539397|NCT00847587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539398|NCT00011765|Fluoxetine|fluoxetine|mesh-list
92539399|NCT00011765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92539400|NCT00011765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92539401|NCT00011765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92539402|NCT00011765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539403|NCT00011765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539404|NCT00011765|Serotonin Agents|serotonin agents|mesh-ancestor
92539405|NCT00011765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539406|NCT00011765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92539407|NCT00011765|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539408|NCT00011765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539409|NCT00011765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92539410|NCT00011765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92539411|NCT00011765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539412|NCT00011804|Topiramate|topiramate|mesh-list
92539413|NCT00011804|Anticonvulsants|anticonvulsants|mesh-ancestor
92539414|NCT00011804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92539415|NCT00011804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539416|NCT00011921|Paclitaxel|paclitaxel|mesh-list
92539417|NCT00011921|Etoposide|etoposide|mesh-list
92539418|NCT00011921|Carboplatin|carboplatin|mesh-list
92539419|NCT00011921|Etoposide phosphate|etoposide phosphate|mesh-list
92539420|NCT00011921|Epirubicin|epirubicin|mesh-list
92539421|NCT00011921|Ifosfamide|ifosfamide|mesh-list
92539422|NCT00011921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539423|NCT00011921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92533997|NCT00064285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92533998|NCT00064285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92533999|NCT00064285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534000|NCT00064285|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539424|NCT00011921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539425|NCT00011921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539426|NCT00011921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539427|NCT00011921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539428|NCT00011921|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539429|NCT00011921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539430|NCT00011921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539446|NCT00847314|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92539447|NCT00847314|Androgens|androgens|mesh-ancestor
92539448|NCT00847314|Hormones|hormones|mesh-ancestor
92539449|NCT00847314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539450|NCT00847314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354120|NCT04195776|Tenofovir|tenofovir|mesh-list
92539451|NCT00847314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92539452|NCT00847314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539453|NCT00847314|Anabolic Agents|anabolic agents|mesh-ancestor
92539454|NCT00011999|Paclitaxel|paclitaxel|mesh-list
92539455|NCT00011999|Cisplatin|cisplatin|mesh-list
92539456|NCT00011999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539457|NCT00011999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539458|NCT00011999|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539459|NCT00011999|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539460|NCT00011999|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539461|NCT00011999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539462|NCT00012038|Irofulven|irofulven|mesh-list
92539463|NCT00012038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539464|NCT00012038|Alkylating Agents|alkylating agents|mesh-ancestor
92539465|NCT00012038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539466|NCT00012038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539467|NCT00012116|Temozolomide|temozolomide|mesh-list
92539468|NCT00012116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539469|NCT00012116|Alkylating Agents|alkylating agents|mesh-ancestor
92539470|NCT00012116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539471|NCT00012116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539472|NCT00847119|Bevacizumab|bevacizumab|mesh-list
92539473|NCT00847119|Capecitabine|capecitabine|mesh-list
92539474|NCT00847119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92539475|NCT00847119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539477|NCT00847119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92539478|NCT00847119|Growth Substances|growth substances|mesh-ancestor
92539479|NCT00847119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539480|NCT00847119|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539481|NCT00847119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539482|NCT00847119|Antimetabolites|antimetabolites|mesh-ancestor
92539483|NCT00847119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539484|NCT00847080|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92539485|NCT00847080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92539486|NCT00847080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539487|NCT00847080|Incretins|incretins|mesh-ancestor
92539488|NCT00847080|Hormones|hormones|mesh-ancestor
92539489|NCT00847080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539490|NCT00847080|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92539518|NCT00012311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539519|NCT00012311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539520|NCT00012311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92539521|NCT00012311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539522|NCT00012311|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539523|NCT00012311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539524|NCT00012311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539525|NCT00012311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539526|NCT00012311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539527|NCT00012311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539528|NCT00012311|Antimetabolites|antimetabolites|mesh-ancestor
92534001|NCT00064285|Growth Substances|growth substances|mesh-ancestor
92534002|NCT00064285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539529|NCT00012311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539530|NCT00012311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92539531|NCT00012311|Abortifacient Agents|abortifacient agents|mesh-ancestor
92539532|NCT00012311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92539533|NCT00012311|Dermatologic Agents|dermatologic agents|mesh-ancestor
92539534|NCT00012311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92539535|NCT00012311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92539536|NCT00012311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539537|NCT00847002|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92539539|NCT00847002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92539565|NCT00012467|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92539566|NCT00012467|Flucytosine|flucytosine|mesh-list
92354138|NCT04130802|Dexamethasone|dexamethasone|mesh-list
92539567|NCT00012467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539568|NCT00012467|Antiviral Agents|antiviral agents|mesh-ancestor
92539569|NCT00012467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539570|NCT00012467|Antifungal Agents|antifungal agents|mesh-ancestor
92539571|NCT00012467|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92539572|NCT00012467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92539573|NCT00012467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539574|NCT00012467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539575|NCT00012467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92539576|NCT00012467|Hormone Antagonists|hormone antagonists|mesh-ancestor
92539577|NCT00012467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539578|NCT00012467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539579|NCT00012467|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92539580|NCT00012467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92539581|NCT00012467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92539582|NCT00012467|Amebicides|amebicides|mesh-ancestor
92539583|NCT00012467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92539584|NCT00012467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92539585|NCT00012467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539586|NCT00012467|Antimetabolites|antimetabolites|mesh-ancestor
92539587|NCT00012506|Etanercept|etanercept|mesh-list
92539588|NCT00012506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947143|NCT02293889|Vitamin D|vitamin d|mesh-list
92539606|NCT00012584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539608|NCT00012584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539609|NCT00012584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92539610|NCT00012584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92539611|NCT00012584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92539612|NCT00012584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539613|NCT00012584|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92539614|NCT00012584|Serotonin Agents|serotonin agents|mesh-ancestor
92539615|NCT00012584|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92539616|NCT00012584|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539617|NCT00012584|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92539618|NCT00012584|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92539619|NCT00012584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539620|NCT00012584|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92539621|NCT00846690|Lidocaine|lidocaine|mesh-list
92539622|NCT00846690|Phenylephrine|phenylephrine|mesh-list
92264380|NCT01215344|Bortezomib|bortezomib|mesh-list
92539624|NCT00846690|Tetracaine|tetracaine|mesh-list
92539625|NCT00846690|Anesthetics, Local|anesthetics, local|mesh-ancestor
92539626|NCT00846690|Anesthetics|anesthetics|mesh-ancestor
92539627|NCT00846690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92539628|NCT00846690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539629|NCT00846690|Sensory System Agents|sensory system agents|mesh-ancestor
92539630|NCT00846690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539631|NCT00846690|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92539632|NCT00846690|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92539633|NCT00846690|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92539634|NCT00846690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92539635|NCT00846690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539636|NCT00846690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92539637|NCT00846690|Mydriatics|mydriatics|mesh-ancestor
92539638|NCT00846690|Autonomic Agents|autonomic agents|mesh-ancestor
92539639|NCT00846690|Sympathomimetics|sympathomimetics|mesh-ancestor
92534003|NCT00392418|Micronutrients|micronutrients|mesh-list
92534004|NCT00392418|Trace Elements|trace elements|mesh-list
92539640|NCT00846690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92539641|NCT00846690|Nasal Decongestants|nasal decongestants|mesh-ancestor
92539642|NCT00846690|Respiratory System Agents|respiratory system agents|mesh-ancestor
92354140|NCT04130802|Antiemetics|antiemetics|mesh-ancestor
92539643|NCT00846690|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92539675|NCT00846612|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539676|NCT00846612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539677|NCT00846612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539678|NCT00846612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539679|NCT00846612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539680|NCT00846612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539682|NCT00012857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92539683|NCT00012857|Analgesics|analgesics|mesh-ancestor
92539684|NCT00012857|Sensory System Agents|sensory system agents|mesh-ancestor
92539685|NCT00012857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539686|NCT00012857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539706|NCT00846339|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539708|NCT00846339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92539709|NCT00846339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92539710|NCT00846339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92539711|NCT00846339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539712|NCT00846339|Dopamine Agents|dopamine agents|mesh-ancestor
92539713|NCT00846339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539714|NCT00846339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539715|NCT00846339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92539716|NCT00846339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92539717|NCT00846339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539718|NCT00846144|Copper|copper|mesh-list
92539719|NCT00846144|Copper Sulfate|copper sulfate|mesh-list
92539720|NCT00846144|Trace Elements|trace elements|mesh-ancestor
92539721|NCT00846144|Micronutrients|micronutrients|mesh-ancestor
92539722|NCT00846144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539723|NCT00846144|Antidotes|antidotes|mesh-ancestor
92539724|NCT00846144|Protective Agents|protective agents|mesh-ancestor
92539725|NCT00846144|Emetics|emetics|mesh-ancestor
92539726|NCT00846144|Autonomic Agents|autonomic agents|mesh-ancestor
92539727|NCT00846144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539728|NCT00846144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92539729|NCT00845988|Aripiprazole|aripiprazole|mesh-list
92539730|NCT00845988|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539731|NCT00845988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539732|NCT00845988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92539733|NCT00845988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92539734|NCT00845988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92539735|NCT00845988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539736|NCT00845988|Dopamine Agonists|dopamine agonists|mesh-ancestor
92539737|NCT00845988|Dopamine Agents|dopamine agents|mesh-ancestor
92539738|NCT00845988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947296|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92539755|NCT00845910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539756|NCT00845910|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539757|NCT00845910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539758|NCT00845910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539759|NCT00845910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539760|NCT00845910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539761|NCT00845910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539763|NCT00680628|Enoxaparin|enoxaparin|mesh-list
92539764|NCT00680628|Tenecteplase|tenecteplase|mesh-list
92539765|NCT00680628|Enoxaparin sodium|enoxaparin sodium|mesh-list
92539766|NCT00680628|Anticoagulants|anticoagulants|mesh-ancestor
92539767|NCT00680628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92539768|NCT00680628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92539769|NCT00680628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539770|NCT00013520|Lamivudine|lamivudine|mesh-list
92264520|NCT01337336|Xhance|xhance|mesh-list
92539772|NCT00013520|Efavirenz|efavirenz|mesh-list
92539773|NCT00013520|Nevirapine|nevirapine|mesh-list
92539774|NCT00013520|Abacavir|abacavir|mesh-list
92539775|NCT00013520|Dideoxynucleosides|dideoxynucleosides|mesh-list
92539776|NCT00013520|Didanosine|didanosine|mesh-list
92539777|NCT00013520|Stavudine|stavudine|mesh-list
92539778|NCT00013520|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92539779|NCT00013520|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92539780|NCT00013520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92539781|NCT00013520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92539783|NCT00013520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539784|NCT00013520|Antiviral Agents|antiviral agents|mesh-ancestor
92539785|NCT00013520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539786|NCT00013520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92539787|NCT00013520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92539788|NCT00013520|Antimetabolites|antimetabolites|mesh-ancestor
92539789|NCT00013520|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92539790|NCT00013520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92539791|NCT00013520|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92539792|NCT00013520|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92539793|NCT00013520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92539794|NCT00013520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92539795|NCT00013520|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92539796|NCT00013520|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92539811|NCT00277017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92539812|NCT00277017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92539813|NCT00277017|Growth Substances|growth substances|mesh-ancestor
92539814|NCT00277017|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539815|NCT00276978|Aripiprazole|aripiprazole|mesh-list
92539816|NCT00276978|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539817|NCT00276978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539818|NCT00276978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92539819|NCT00276978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92539820|NCT00276978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92539821|NCT00276978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539822|NCT00276978|Dopamine Agonists|dopamine agonists|mesh-ancestor
92539823|NCT00276978|Dopamine Agents|dopamine agents|mesh-ancestor
92539824|NCT00276978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539825|NCT00276978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539826|NCT00276978|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92539827|NCT00276978|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92539828|NCT00276978|Serotonin Agents|serotonin agents|mesh-ancestor
92539829|NCT00276978|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92539830|NCT00276978|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92539831|NCT00276978|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92539832|NCT00276978|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92539833|NCT00276900|Sertraline|sertraline|mesh-list
92539834|NCT00276900|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539835|NCT00276900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539836|NCT00276900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92539837|NCT00276900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92539838|NCT00276900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92539839|NCT00276900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539840|NCT00276900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539841|NCT00276900|Serotonin Agents|serotonin agents|mesh-ancestor
92539842|NCT00276900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539843|NCT00276861|Gemcitabine|gemcitabine|mesh-list
92539844|NCT00276861|Oxaliplatin|oxaliplatin|mesh-list
92539845|NCT00276861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539846|NCT00276861|Antimetabolites|antimetabolites|mesh-ancestor
92539847|NCT00276861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539848|NCT00276861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539849|NCT00013871|Vaccines|vaccines|mesh-list
92539850|NCT00013871|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92539851|NCT00013871|Immunologic Factors|immunologic factors|mesh-ancestor
92539852|NCT00013871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539853|NCT00276783|Pemetrexed|pemetrexed|mesh-list
92539854|NCT00276783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539855|NCT00276783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539856|NCT00276783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947412|NCT03510611|Ensartinib|ensartinib|mesh-list
92539881|NCT00276705|Growth Substances|growth substances|mesh-ancestor
92539882|NCT00276705|Growth Inhibitors|growth inhibitors|mesh-ancestor
92539883|NCT00276666|Vincristine|vincristine|mesh-list
92539884|NCT00276666|Lomustine|lomustine|mesh-list
92539885|NCT00276666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539886|NCT00276666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539887|NCT00276666|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539888|NCT00276666|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539889|NCT00276666|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534005|NCT00392418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534006|NCT05126147|Hydroxychloroquine|hydroxychloroquine|mesh-list
92354154|NCT03087162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92539890|NCT00276666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539891|NCT00276666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539892|NCT00276666|Alkylating Agents|alkylating agents|mesh-ancestor
92539893|NCT00014066|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92539894|NCT00014066|Hematoporphyrins|hematoporphyrins|mesh-list
92539895|NCT00014066|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92539896|NCT00014066|Dermatologic Agents|dermatologic agents|mesh-ancestor
92539897|NCT00014066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539898|NCT00014105|Carboplatin|carboplatin|mesh-list
92539899|NCT00014105|Temozolomide|temozolomide|mesh-list
92539900|NCT00014105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539901|NCT00014105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539902|NCT00014105|Alkylating Agents|alkylating agents|mesh-ancestor
92539903|NCT00014105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539904|NCT00014144|Gefitinib|gefitinib|mesh-list
92539905|NCT00014144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539906|NCT00014144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92539924|NCT00276549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539926|NCT00276549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539927|NCT00276549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539928|NCT00276549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539929|NCT00014183|Gefitinib|gefitinib|mesh-list
92539930|NCT00014183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539931|NCT00014183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92539932|NCT00014183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539933|NCT00014183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539934|NCT00014261|Interferons|interferons|mesh-list
92539935|NCT00014261|Interferon-alpha|interferon-alpha|mesh-list
92539936|NCT00014261|Interferon alpha-2|interferon alpha-2|mesh-list
92539937|NCT00014261|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92539938|NCT00014261|Temozolomide|temozolomide|mesh-list
92539939|NCT00014261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539940|NCT00014261|Antiviral Agents|antiviral agents|mesh-ancestor
92539941|NCT00014261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539942|NCT00014261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539943|NCT00014261|Alkylating Agents|alkylating agents|mesh-ancestor
92539944|NCT00014261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539945|NCT00014261|Immunologic Factors|immunologic factors|mesh-ancestor
92539946|NCT00014261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539947|NCT00014339|Prednisone|prednisone|mesh-list
92539948|NCT00014339|Melphalan|melphalan|mesh-list
92539949|NCT00014339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92539950|NCT00014339|Glucocorticoids|glucocorticoids|mesh-ancestor
92539951|NCT00014339|Hormones|hormones|mesh-ancestor
92539952|NCT00014339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92539953|NCT00014339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539954|NCT00014339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92539955|NCT00014339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539956|NCT00014339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539957|NCT00014339|Alkylating Agents|alkylating agents|mesh-ancestor
92539958|NCT00014339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539959|NCT00014339|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92539960|NCT00014339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539961|NCT00014339|Immunologic Factors|immunologic factors|mesh-ancestor
92539962|NCT00014456|Gemcitabine|gemcitabine|mesh-list
92539964|NCT00014456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539966|NCT00014456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539967|NCT00014456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539968|NCT00014456|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539969|NCT00014456|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539970|NCT00014456|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539971|NCT00276393|Insulin|insulin|mesh-list
92539972|NCT00276393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92539973|NCT00276393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539974|NCT00014534|Gemcitabine|gemcitabine|mesh-list
92539975|NCT00014534|Doxorubicin|doxorubicin|mesh-list
92539976|NCT00014534|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92539977|NCT00014534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539978|NCT00014534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539979|NCT00014534|Antimetabolites|antimetabolites|mesh-ancestor
92539980|NCT00014534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534007|NCT05126147|Antimalarials|antimalarials|mesh-ancestor
92534008|NCT05126147|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92534009|NCT05126147|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92534010|NCT05126147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534011|NCT05126147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539981|NCT00014534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539982|NCT00014534|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539983|NCT00014534|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539984|NCT00014534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539985|NCT00014573|Aldesleukin|aldesleukin|mesh-list
92539986|NCT00014573|Paclitaxel|paclitaxel|mesh-list
92539987|NCT00014573|Cyclophosphamide|cyclophosphamide|mesh-list
92539988|NCT00014573|Carmustine|carmustine|mesh-list
92539989|NCT00014573|Sargramostim|sargramostim|mesh-list
92539990|NCT00014573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539991|NCT00014573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539992|NCT00014573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539993|NCT00014573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92264749|NCT05732181|Lidocaine|lidocaine|mesh-list
92539994|NCT00014573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539995|NCT00014573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539996|NCT00014573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539997|NCT00014573|Immunologic Factors|immunologic factors|mesh-ancestor
92539998|NCT00014573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539999|NCT00014573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540000|NCT00014573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540001|NCT00014573|Alkylating Agents|alkylating agents|mesh-ancestor
92540002|NCT00014573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92540003|NCT00014573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92540004|NCT00014573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92540005|NCT00014573|Antiviral Agents|antiviral agents|mesh-ancestor
92540006|NCT00014573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540007|NCT00276315|Botulinum Toxins|botulinum toxins|mesh-list
92540008|NCT00276315|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92540009|NCT00276315|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92540010|NCT00276315|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92540011|NCT00276315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540012|NCT00276315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540013|NCT00276315|Cholinergic Agents|cholinergic agents|mesh-ancestor
92540014|NCT00276315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540015|NCT00276315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540016|NCT00276315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92540017|NCT00276315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540018|NCT00276276|Topotecan|topotecan|mesh-list
92540019|NCT00276276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92540020|NCT00276276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540021|NCT00276276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540022|NCT00276276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540023|NCT00276276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540024|NCT00014651|Vapreotide|vapreotide|mesh-list
92540025|NCT00014651|Analgesics|analgesics|mesh-ancestor
92540026|NCT00014651|Sensory System Agents|sensory system agents|mesh-ancestor
92540027|NCT00014651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540028|NCT00014651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540029|NCT00014651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540030|NCT00014690|Topotecan|topotecan|mesh-list
92540031|NCT00014690|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92540032|NCT00014690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540033|NCT00014690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540034|NCT00014690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540035|NCT00014690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540036|NCT00014729|Isotretinoin|isotretinoin|mesh-list
92540062|NCT00276003|Gemcitabine|gemcitabine|mesh-list
92540063|NCT00276003|Irinotecan|irinotecan|mesh-list
92540064|NCT00276003|Allopurinol|allopurinol|mesh-list
92540065|NCT00276003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540066|NCT00276003|Antimetabolites|antimetabolites|mesh-ancestor
92540067|NCT00276003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540068|NCT00276003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540069|NCT00276003|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92534012|NCT05126147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534013|NCT05126147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534014|NCT00064402|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92540070|NCT00276003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264821|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540071|NCT00276003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540072|NCT00276003|Gout Suppressants|gout suppressants|mesh-ancestor
92540073|NCT00276003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540074|NCT00276003|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92540075|NCT00276003|Antioxidants|antioxidants|mesh-ancestor
92540076|NCT00276003|Protective Agents|protective agents|mesh-ancestor
92540077|NCT00276003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540078|NCT00275925|Oxcarbazepine|oxcarbazepine|mesh-list
92540079|NCT00275925|Anticonvulsants|anticonvulsants|mesh-ancestor
92540080|NCT00275925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92540081|NCT00275925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92540082|NCT00275925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540083|NCT00275925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540084|NCT00275925|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92540085|NCT00275925|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91947649|NCT04406415|Nafamostat|nafamostat|mesh-list
92540132|NCT00275730|Sensory System Agents|sensory system agents|mesh-ancestor
92540133|NCT00275730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540134|NCT00275730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540135|NCT00275730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540136|NCT00275730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540137|NCT00275730|Gout Suppressants|gout suppressants|mesh-ancestor
92540138|NCT00275730|Tocolytic Agents|tocolytic agents|mesh-ancestor
92540139|NCT00275730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92540140|NCT00275730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92540141|NCT00275730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540142|NCT00275730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540143|NCT00275652|Lamivudine|lamivudine|mesh-list
92540144|NCT00275652|Telbivudine|telbivudine|mesh-list
92540145|NCT00275652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92540146|NCT00275652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92540148|NCT00275652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540149|NCT00275652|Antiviral Agents|antiviral agents|mesh-ancestor
92540150|NCT00275652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540151|NCT00275652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92540152|NCT00275652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92540153|NCT00275613|Rituximab|rituximab|mesh-list
92540154|NCT00275613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92540155|NCT00275613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540156|NCT00275613|Immunologic Factors|immunologic factors|mesh-ancestor
92540157|NCT00275613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540158|NCT00275613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540159|NCT00015548|Olanzapine|olanzapine|mesh-list
92540160|NCT00015548|Risperidone|risperidone|mesh-list
92540161|NCT00015548|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92540162|NCT00015548|Citalopram|citalopram|mesh-list
92540163|NCT00015548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92540164|NCT00015548|Serotonin Agents|serotonin agents|mesh-ancestor
92540165|NCT00015548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540166|NCT00015548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540167|NCT00015548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540168|NCT00015548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92540169|NCT00015548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92540170|NCT00015548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92540171|NCT00015548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92540172|NCT00015548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92540173|NCT00015548|Dopamine Agents|dopamine agents|mesh-ancestor
92540174|NCT00015548|Antiemetics|antiemetics|mesh-ancestor
92540175|NCT00015548|Autonomic Agents|autonomic agents|mesh-ancestor
92540176|NCT00015548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540177|NCT00015548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92540178|NCT00015548|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92540179|NCT00015548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92540214|NCT00015665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540215|NCT00015665|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92540216|NCT00015665|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92540217|NCT00015665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540218|NCT00015665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540219|NCT00015665|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92540220|NCT00015665|Hormone Antagonists|hormone antagonists|mesh-ancestor
92540235|NCT00015704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540236|NCT00015704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92540237|NCT00015704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92540238|NCT00015704|Antiviral Agents|antiviral agents|mesh-ancestor
92540239|NCT00015704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540241|NCT00275418|Carotenoids|carotenoids|mesh-list
92540242|NCT00275418|Antioxidants|antioxidants|mesh-ancestor
92540243|NCT00275418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540244|NCT00275418|Protective Agents|protective agents|mesh-ancestor
92540245|NCT00275418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540246|NCT00275418|Provitamins|provitamins|mesh-ancestor
92540247|NCT00275418|Vitamins|vitamins|mesh-ancestor
92540248|NCT00275418|Micronutrients|micronutrients|mesh-ancestor
92540249|NCT00015821|Thalidomide|thalidomide|mesh-list
92540250|NCT00015821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540251|NCT00015821|Immunologic Factors|immunologic factors|mesh-ancestor
92540252|NCT00015821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540253|NCT00015821|Leprostatic Agents|leprostatic agents|mesh-ancestor
92540254|NCT00015821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92540255|NCT00015821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540256|NCT00015821|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92540257|NCT00015821|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92540258|NCT00015821|Growth Substances|growth substances|mesh-ancestor
92540259|NCT00015821|Growth Inhibitors|growth inhibitors|mesh-ancestor
92540260|NCT00015821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540261|NCT00275184|Metoclopramide|metoclopramide|mesh-list
92540262|NCT00275184|Antiemetics|antiemetics|mesh-ancestor
92540263|NCT00275184|Autonomic Agents|autonomic agents|mesh-ancestor
92540264|NCT00275184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540265|NCT00275184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540266|NCT00275184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92540267|NCT00275184|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92540268|NCT00275184|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92540269|NCT00275184|Dopamine Agents|dopamine agents|mesh-ancestor
92540270|NCT00275184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540271|NCT00275184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540272|NCT00015860|Prednisone|prednisone|mesh-list
92540273|NCT00015860|Vincristine|vincristine|mesh-list
92540274|NCT00015860|Imatinib Mesylate|imatinib mesylate|mesh-list
92540275|NCT00015860|Daunorubicin|daunorubicin|mesh-list
92540276|NCT00015860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540277|NCT00015860|Glucocorticoids|glucocorticoids|mesh-ancestor
92540278|NCT00015860|Hormones|hormones|mesh-ancestor
92540279|NCT00015860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540280|NCT00015860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540281|NCT00015860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92540295|NCT00015899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265046|NCT05343429|Antipyretics|antipyretics|mesh-ancestor
92540296|NCT00275106|Leucovorin|leucovorin|mesh-list
92540297|NCT00275106|Cytarabine|cytarabine|mesh-list
92540298|NCT00275106|Dexamethasone|dexamethasone|mesh-list
92540299|NCT00275106|Prednisolone|prednisolone|mesh-list
92540300|NCT00275106|Cyclophosphamide|cyclophosphamide|mesh-list
92540301|NCT00275106|Doxorubicin|doxorubicin|mesh-list
92540302|NCT00275106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92540303|NCT00275106|Methotrexate|methotrexate|mesh-list
92540304|NCT00275106|Vincristine|vincristine|mesh-list
92540305|NCT00275106|Daunorubicin|daunorubicin|mesh-list
92540306|NCT00275106|Asparaginase|asparaginase|mesh-list
92540307|NCT00275106|Mercaptopurine|mercaptopurine|mesh-list
92540308|NCT00275106|Thioguanine|thioguanine|mesh-list
92540309|NCT00275106|Levoleucovorin|levoleucovorin|mesh-list
92540310|NCT00275106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540311|NCT00275106|Immunologic Factors|immunologic factors|mesh-ancestor
92540312|NCT00275106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540313|NCT00275106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540314|NCT00275106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540315|NCT00275106|Alkylating Agents|alkylating agents|mesh-ancestor
92540316|NCT00275106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540317|NCT00275106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540318|NCT00275106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92540319|NCT00275106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540320|NCT00275106|Antiemetics|antiemetics|mesh-ancestor
92534015|NCT00064402|Formoterol Fumarate|formoterol fumarate|mesh-list
92534016|NCT00064402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92534017|NCT00064402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92534018|NCT00064402|Autonomic Agents|autonomic agents|mesh-ancestor
92534019|NCT00064402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534020|NCT00064402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534021|NCT00064402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92540321|NCT00275106|Autonomic Agents|autonomic agents|mesh-ancestor
92540322|NCT00275106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540323|NCT00275106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92540324|NCT00275106|Glucocorticoids|glucocorticoids|mesh-ancestor
92540325|NCT00275106|Hormones|hormones|mesh-ancestor
92540326|NCT00275106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540327|NCT00275106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92540328|NCT00275106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540329|NCT00275106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540330|NCT00275106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540331|NCT00275106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540332|NCT00275106|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92540333|NCT00275106|Abortifacient Agents|abortifacient agents|mesh-ancestor
92540334|NCT00275106|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92540335|NCT00275106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540336|NCT00275106|Antimetabolites|antimetabolites|mesh-ancestor
92540337|NCT00275106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92540338|NCT00275106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92540339|NCT00275106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92540340|NCT00275106|Antiviral Agents|antiviral agents|mesh-ancestor
92540341|NCT00275106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540342|NCT00275106|Antidotes|antidotes|mesh-ancestor
92540343|NCT00275106|Protective Agents|protective agents|mesh-ancestor
91947886|NCT03512171|Amphetamine|amphetamine|mesh-list
92540377|NCT00015977|Immunologic Factors|immunologic factors|mesh-ancestor
92540378|NCT00015977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540379|NCT00015977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92540380|NCT00015977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92540381|NCT00015977|Growth Substances|growth substances|mesh-ancestor
92540382|NCT00015977|Growth Inhibitors|growth inhibitors|mesh-ancestor
92540383|NCT00015977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540384|NCT01678586|Diphenhydramine|diphenhydramine|mesh-list
92540385|NCT01678586|Gabapentin|gabapentin|mesh-list
92540386|NCT01678586|Analgesics|analgesics|mesh-ancestor
92540387|NCT01678586|Sensory System Agents|sensory system agents|mesh-ancestor
92540388|NCT01678586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540389|NCT01678586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540390|NCT01678586|Anticonvulsants|anticonvulsants|mesh-ancestor
92540391|NCT01678586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92540392|NCT01678586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92540393|NCT01678586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92540394|NCT01678586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92540395|NCT01678586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92540396|NCT01678586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92540397|NCT01678586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540398|NCT01678586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540399|NCT01678586|Antimanic Agents|antimanic agents|mesh-ancestor
92540400|NCT01678586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92540401|NCT01678586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92540402|NCT01678586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92540403|NCT01678586|Anesthetics|anesthetics|mesh-ancestor
92540404|NCT01678586|Antiemetics|antiemetics|mesh-ancestor
92540405|NCT01678586|Autonomic Agents|autonomic agents|mesh-ancestor
92540406|NCT01678586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92540407|NCT01678586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92540408|NCT01678586|Histamine Antagonists|histamine antagonists|mesh-ancestor
92540409|NCT01678586|Histamine Agents|histamine agents|mesh-ancestor
92540410|NCT01678586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92540411|NCT00274950|Carboplatin|carboplatin|mesh-list
92540412|NCT00274950|Etoposide|etoposide|mesh-list
92540465|NCT00016094|Immunoglobulins|immunoglobulins|mesh-list
92534022|NCT00064402|Respiratory System Agents|respiratory system agents|mesh-ancestor
92534023|NCT00064402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92534024|NCT00064402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92534025|NCT00064402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92540466|NCT00016094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92540467|NCT00016094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540468|NCT00016094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92540469|NCT00016094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92540470|NCT00016094|Growth Substances|growth substances|mesh-ancestor
92540471|NCT00016094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540472|NCT00016094|Growth Inhibitors|growth inhibitors|mesh-ancestor
92540473|NCT00016094|Immunologic Factors|immunologic factors|mesh-ancestor
92540474|NCT00130338|Rivastigmine|rivastigmine|mesh-list
92540475|NCT00130338|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92540476|NCT00130338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540477|NCT00130338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540478|NCT00130338|Cholinergic Agents|cholinergic agents|mesh-ancestor
92540479|NCT00130338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540480|NCT00130338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540481|NCT00130338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92540482|NCT00130338|Protective Agents|protective agents|mesh-ancestor
92540483|NCT00016133|Leucovorin|leucovorin|mesh-list
92540484|NCT00016133|Fluorouracil|fluorouracil|mesh-list
92540485|NCT00016133|Vaccines|vaccines|mesh-list
92540486|NCT00016133|BCG Vaccine|bcg vaccine|mesh-list
92540487|NCT00016133|Calcium|calcium|mesh-list
92540488|NCT00016133|Levoleucovorin|levoleucovorin|mesh-list
92540489|NCT00016133|Immunologic Factors|immunologic factors|mesh-ancestor
92540490|NCT00016133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540491|NCT00016133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92540492|NCT00016133|Antimetabolites|antimetabolites|mesh-ancestor
92540493|NCT00016133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540494|NCT00016133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540495|NCT00016133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540496|NCT00016133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540497|NCT00016133|Antidotes|antidotes|mesh-ancestor
91948045|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
92540516|NCT00394368|Fluticasone|fluticasone|mesh-list
92540517|NCT00394368|Xhance|xhance|mesh-list
92540518|NCT00394368|Beclomethasone|beclomethasone|mesh-list
92540519|NCT00394368|Formoterol Fumarate|formoterol fumarate|mesh-list
92540520|NCT00394368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92540521|NCT00394368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540522|NCT00394368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92540523|NCT00394368|Autonomic Agents|autonomic agents|mesh-ancestor
92540524|NCT00394368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540525|NCT00394368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540526|NCT00394368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92540527|NCT00394368|Respiratory System Agents|respiratory system agents|mesh-ancestor
92540528|NCT00394368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92540529|NCT00394368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92540530|NCT00394368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92540531|NCT00394368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92540532|NCT00394368|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92540533|NCT00394368|Adrenergic Agents|adrenergic agents|mesh-ancestor
92540534|NCT00394368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540535|NCT00394368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540536|NCT00394368|Glucocorticoids|glucocorticoids|mesh-ancestor
92540537|NCT00394368|Hormones|hormones|mesh-ancestor
92540538|NCT00394368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540539|NCT01441349|Simvastatin|simvastatin|mesh-list
92540540|NCT01441349|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92540541|NCT01441349|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92540542|NCT01441349|Antimetabolites|antimetabolites|mesh-ancestor
92540543|NCT01441349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540544|NCT01441349|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92540545|NCT01441349|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92540546|NCT01441349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540547|NCT00394407|Insulin|insulin|mesh-list
92540548|NCT00394407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92540549|NCT00394407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92540550|NCT00394407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534026|NCT00064402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92540551|NCT00130143|Amifostine|amifostine|mesh-list
92540552|NCT00130143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92540553|NCT00130143|Protective Agents|protective agents|mesh-ancestor
92540554|NCT00130143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540567|NCT00130065|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92540569|NCT00130065|Vitamin B Complex|vitamin b complex|mesh-ancestor
92540570|NCT00130065|Vitamins|vitamins|mesh-ancestor
92540571|NCT00130065|Micronutrients|micronutrients|mesh-ancestor
92540572|NCT00130065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540573|NCT00130065|Antimalarials|antimalarials|mesh-ancestor
92540574|NCT00130065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92540575|NCT00130065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92540576|NCT00130065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540577|NCT00130065|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92540578|NCT00130065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540579|NCT00130065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540580|NCT00130065|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92540581|NCT00016328|Sirolimus|sirolimus|mesh-list
92540582|NCT00016328|Temsirolimus|temsirolimus|mesh-list
92540583|NCT00016328|MTOR Inhibitors|mtor inhibitors|mesh-list
92540584|NCT00016328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92540585|NCT00016328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540586|NCT00016328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540587|NCT00016328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540588|NCT00016328|Immunologic Factors|immunologic factors|mesh-ancestor
92540589|NCT00016328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540590|NCT00016328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540591|NCT00016328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92540592|NCT00016328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540593|NCT00016328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540594|NCT00016328|Antifungal Agents|antifungal agents|mesh-ancestor
92540595|NCT00130026|Caffeine|caffeine|mesh-list
92540596|NCT00130026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92540597|NCT00130026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540598|NCT00130026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92540599|NCT00130026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540600|NCT00130026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540601|NCT00130026|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92540602|NCT00130026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92540603|NCT00130026|Purinergic Agents|purinergic agents|mesh-ancestor
92540604|NCT00130026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540605|NCT00016367|Cisplatin|cisplatin|mesh-list
92540606|NCT00016367|Gemcitabine|gemcitabine|mesh-list
92540607|NCT00016367|Trastuzumab|trastuzumab|mesh-list
92540608|NCT00016367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540609|NCT00016367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540610|NCT00016367|Antimetabolites|antimetabolites|mesh-ancestor
92540611|NCT00016367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540612|NCT00016367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92540613|NCT00129948|Troxacitabine|troxacitabine|mesh-list
92540614|NCT00129948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540615|NCT00129948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92540616|NCT00129948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92540617|NCT00129948|Antiviral Agents|antiviral agents|mesh-ancestor
92540618|NCT00129948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540649|NCT00016523|Autonomic Agents|autonomic agents|mesh-ancestor
92540650|NCT00016523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540651|NCT00016523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540652|NCT00016523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92540653|NCT00016523|Respiratory System Agents|respiratory system agents|mesh-ancestor
92540654|NCT00016523|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92540655|NCT00016523|Antioxidants|antioxidants|mesh-ancestor
92540656|NCT00016523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540657|NCT00016523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540658|NCT00016523|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92540659|NCT00016523|Vasodilator Agents|vasodilator agents|mesh-ancestor
92540660|NCT00016523|Gasotransmitters|gasotransmitters|mesh-ancestor
92540661|NCT00016523|Protective Agents|protective agents|mesh-ancestor
92540662|NCT00129597|Ketamine|ketamine|mesh-list
92540673|NCT00129597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92265420|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
92540675|NCT00129597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540676|NCT00016601|Ritonavir|ritonavir|mesh-list
92534027|NCT00064402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534028|NCT00064402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534029|NCT00423748|Ambrisentan|ambrisentan|mesh-list
92540678|NCT00016601|Indinavir|indinavir|mesh-list
92540679|NCT00016601|Nevirapine|nevirapine|mesh-list
92540680|NCT00016601|Efavirenz|efavirenz|mesh-list
92540681|NCT00016601|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92540682|NCT00016601|Medroxyprogesterone|medroxyprogesterone|mesh-list
92540683|NCT00016601|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92540684|NCT00016601|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92540685|NCT00016601|Protease Inhibitors|protease inhibitors|mesh-ancestor
92540686|NCT00016601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540687|NCT00016601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540688|NCT00016601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92540689|NCT00016601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92540690|NCT00016601|Antiviral Agents|antiviral agents|mesh-ancestor
92540691|NCT00016601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540692|NCT00016601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92540693|NCT00016601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92540694|NCT00016601|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92540695|NCT00016601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92540696|NCT00016601|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92540697|NCT00016601|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92540698|NCT00016601|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92540699|NCT00016601|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92540700|NCT00016601|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92540701|NCT00016601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92540702|NCT00016601|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92540703|NCT00016601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92540704|NCT00016601|Contraceptive Agents|contraceptive agents|mesh-ancestor
92540705|NCT00016601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92540706|NCT00016601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540707|NCT00016601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92540708|NCT00016601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92540709|NCT00016601|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92540710|NCT00016601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92540711|NCT00016601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540712|NCT00957086|Nimotuzumab|nimotuzumab|mesh-list
92540713|NCT00957086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92540714|NCT00957086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540715|NCT00129519|Imiquimod|imiquimod|mesh-list
92540716|NCT00129519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92540717|NCT00129519|Immunologic Factors|immunologic factors|mesh-ancestor
92540718|NCT00129519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540719|NCT00129519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540720|NCT00129519|Interferon Inducers|interferon inducers|mesh-ancestor
92540721|NCT00016835|Metronidazole|metronidazole|mesh-list
92540722|NCT00016835|Doxycycline|doxycycline|mesh-list
92540723|NCT00016835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948264|NCT02307305|Celecoxib|celecoxib|mesh-list
92540746|NCT00016952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540747|NCT00016952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540748|NCT00016952|Immunologic Factors|immunologic factors|mesh-ancestor
92540749|NCT00016952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92540750|NCT00016952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540751|NCT00016952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540752|NCT00016952|Antidotes|antidotes|mesh-ancestor
92540753|NCT00016952|Protective Agents|protective agents|mesh-ancestor
92540754|NCT00016952|Vitamin B Complex|vitamin b complex|mesh-ancestor
92540755|NCT00016952|Vitamins|vitamins|mesh-ancestor
92540756|NCT00016952|Micronutrients|micronutrients|mesh-ancestor
92540757|NCT00129363|Carvedilol|carvedilol|mesh-list
92540758|NCT00129363|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92540759|NCT00129363|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92540760|NCT00129363|Adrenergic Agents|adrenergic agents|mesh-ancestor
92540761|NCT00129363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540762|NCT00129363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540763|NCT00129363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540764|NCT00129363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92540765|NCT00129363|Antioxidants|antioxidants|mesh-ancestor
92540766|NCT00129363|Protective Agents|protective agents|mesh-ancestor
92540768|NCT00129363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540769|NCT00129363|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92540770|NCT00129363|Vasodilator Agents|vasodilator agents|mesh-ancestor
92540771|NCT00129363|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92540772|NCT00129363|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92540773|NCT00016991|Gefitinib|gefitinib|mesh-list
92540774|NCT00016991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540775|NCT00016991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92540776|NCT00016991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540777|NCT00016991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540778|NCT00017030|Trabectedin|trabectedin|mesh-list
92540798|NCT00129285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540799|NCT00129285|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92540800|NCT00129285|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92540801|NCT00129285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92540802|NCT00129285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540803|NCT00017108|Cyclophosphamide|cyclophosphamide|mesh-list
92540804|NCT00017108|Chlorambucil|chlorambucil|mesh-list
92540805|NCT00017108|Fludarabine|fludarabine|mesh-list
92540806|NCT00017108|Fludarabine phosphate|fludarabine phosphate|mesh-list
92540807|NCT00017108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540808|NCT00017108|Immunologic Factors|immunologic factors|mesh-ancestor
92540809|NCT00017108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540810|NCT00017108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540811|NCT00017108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540812|NCT00017108|Alkylating Agents|alkylating agents|mesh-ancestor
92540813|NCT00017108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540814|NCT00017108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540815|NCT00017108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92540816|NCT00017108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540817|NCT00017108|Antimetabolites|antimetabolites|mesh-ancestor
92540818|NCT00129246|Naltrexone|naltrexone|mesh-list
92540819|NCT00129246|Bupropion|bupropion|mesh-list
92540820|NCT00129246|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92540821|NCT00129246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92540822|NCT00129246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540823|NCT00129246|Sensory System Agents|sensory system agents|mesh-ancestor
92540824|NCT00129246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540825|NCT00129246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92540826|NCT00129246|Antidepressive Agents|antidepressive agents|mesh-ancestor
92540827|NCT00129246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92540828|NCT00129246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92540829|NCT00129246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92540830|NCT00129246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540831|NCT00129246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540852|NCT00129168|Antiviral Agents|antiviral agents|mesh-ancestor
92540853|NCT00129168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540854|NCT00129168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540855|NCT00129168|Immunologic Factors|immunologic factors|mesh-ancestor
92540856|NCT00129168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540857|NCT00129168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540858|NCT00129168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540859|NCT00129168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540860|NCT00129168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540861|NCT00017186|Gemcitabine|gemcitabine|mesh-list
92540862|NCT00017186|Epirubicin|epirubicin|mesh-list
92540863|NCT00017186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540864|NCT00017186|Antimetabolites|antimetabolites|mesh-ancestor
92540865|NCT00017186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540866|NCT00017186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540867|NCT00017186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540868|NCT00017186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540869|NCT00017186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540870|NCT00017186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540871|NCT00017225|Cyclophosphamide|cyclophosphamide|mesh-list
92540872|NCT00017225|Melphalan|melphalan|mesh-list
92540873|NCT00017225|Ifosfamide|ifosfamide|mesh-list
92540874|NCT00017225|Dacarbazine|dacarbazine|mesh-list
92540875|NCT00017225|Carboplatin|carboplatin|mesh-list
92540876|NCT00017225|Doxorubicin|doxorubicin|mesh-list
92540877|NCT00017225|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92540878|NCT00017225|Etoposide|etoposide|mesh-list
92354192|NCT03392376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534030|NCT00423748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92534032|NCT02967211|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92534033|NCT02967211|Insulin Glargine|insulin glargine|mesh-list
92534034|NCT02967211|Insulin Detemir|insulin detemir|mesh-list
92534035|NCT02967211|Insulin, Isophane|insulin, isophane|mesh-list
92534036|NCT02967211|Isophane Insulin, Human|isophane insulin, human|mesh-list
92534037|NCT02967211|Isophane insulin, beef|isophane insulin, beef|mesh-list
92534038|NCT02967211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92534039|NCT02967211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534040|NCT00064636|Bortezomib|bortezomib|mesh-list
92534041|NCT00064636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534042|NCT05113394|Immunomodulating Agents|immunomodulating agents|mesh-list
92534043|NCT05113394|Immunologic Factors|immunologic factors|mesh-list
92540879|NCT00017225|Vincristine|vincristine|mesh-list
92540880|NCT00017225|Tretinoin|tretinoin|mesh-list
92540881|NCT00017225|Vindesine|vindesine|mesh-list
92540882|NCT00017225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540883|NCT00017225|Immunologic Factors|immunologic factors|mesh-ancestor
92540884|NCT00017225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540885|NCT00017225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540886|NCT00017225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540887|NCT00017225|Alkylating Agents|alkylating agents|mesh-ancestor
91948435|NCT02312297|Minocycline|minocycline|mesh-list
92540913|NCT00128934|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92540914|NCT00128934|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92540916|NCT00017264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540917|NCT00017264|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92540918|NCT00017264|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92540919|NCT00017264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540920|NCT00128895|Azathioprine|azathioprine|mesh-list
92540921|NCT00128895|Antimetabolites|antimetabolites|mesh-ancestor
92540922|NCT00128895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540923|NCT00128895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540924|NCT00128895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540925|NCT00128895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540926|NCT00128895|Immunologic Factors|immunologic factors|mesh-ancestor
92540927|NCT00128895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540928|NCT00128895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540929|NCT00017303|Paclitaxel|paclitaxel|mesh-list
92540930|NCT00017303|Carboplatin|carboplatin|mesh-list
92540931|NCT00017303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540932|NCT00017303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540933|NCT00017303|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540934|NCT00017303|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540935|NCT00017303|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540936|NCT00017303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540954|NCT00128739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540955|NCT00128739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92540956|NCT00128739|Respiratory System Agents|respiratory system agents|mesh-ancestor
92540957|NCT00128739|Glucocorticoids|glucocorticoids|mesh-ancestor
92540958|NCT00128739|Hormones|hormones|mesh-ancestor
92540959|NCT00128739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540960|NCT00017381|Cyclophosphamide|cyclophosphamide|mesh-list
92540961|NCT00017381|Rituximab|rituximab|mesh-list
92540962|NCT00017381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92540963|NCT00017381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540964|NCT00017381|Immunologic Factors|immunologic factors|mesh-ancestor
92540965|NCT00017381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540966|NCT00017381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540967|NCT00017381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540968|NCT00017381|Alkylating Agents|alkylating agents|mesh-ancestor
92540969|NCT00017381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534044|NCT05113394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534045|NCT00065143|Clofarabine|clofarabine|mesh-list
92534046|NCT00065143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540970|NCT00017381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540971|NCT00017381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92540972|NCT00017381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92540973|NCT00128700|Temozolomide|temozolomide|mesh-list
92540974|NCT00128700|Vatalanib|vatalanib|mesh-list
92540975|NCT00128700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540976|NCT00128700|Alkylating Agents|alkylating agents|mesh-ancestor
92540977|NCT00128700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540978|NCT00128700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540979|NCT00128700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92540980|NCT00128700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540981|NCT00017459|Vinorelbine|vinorelbine|mesh-list
92540982|NCT00017459|Tirapazamine|tirapazamine|mesh-list
92540983|NCT00017459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540984|NCT00017459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540985|NCT00017459|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540986|NCT00017459|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540987|NCT00017459|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540988|NCT00017459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540989|NCT00128622|Denileukin diftitox|denileukin diftitox|mesh-list
92540990|NCT00128622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540991|NCT00017498|Gemcitabine|gemcitabine|mesh-list
92540992|NCT00017498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540993|NCT00017498|Antimetabolites|antimetabolites|mesh-ancestor
92682774|NCT04701320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541011|NCT00128505|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92541012|NCT00128505|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92541013|NCT00128505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92541014|NCT00128505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541015|NCT00128505|Luteolytic Agents|luteolytic agents|mesh-ancestor
92541016|NCT00128505|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92541017|NCT00128505|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92541019|NCT00017576|Carboplatin|carboplatin|mesh-list
92541020|NCT00017576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541021|NCT00017576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92541022|NCT00017576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541023|NCT00017576|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92541024|NCT00017576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92541025|NCT00017576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541026|NCT00017576|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92541027|NCT00017576|Vitamins|vitamins|mesh-ancestor
92541028|NCT00017576|Micronutrients|micronutrients|mesh-ancestor
92541029|NCT00017576|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92541030|NCT00017654|Cyclosporine|cyclosporine|mesh-list
92541031|NCT00017654|Methylprednisolone|methylprednisolone|mesh-list
92541032|NCT00017654|Cyclophosphamide|cyclophosphamide|mesh-list
92541033|NCT00017654|Cyclosporins|cyclosporins|mesh-list
92541034|NCT00017654|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92541035|NCT00017654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541036|NCT00017654|Immunologic Factors|immunologic factors|mesh-ancestor
92541037|NCT00017654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541038|NCT00017654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541039|NCT00017654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92541040|NCT00017654|Alkylating Agents|alkylating agents|mesh-ancestor
92541041|NCT00017654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541042|NCT00017654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541043|NCT00017654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92541044|NCT00017654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541045|NCT00017654|Antifungal Agents|antifungal agents|mesh-ancestor
92541046|NCT00017654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541047|NCT00017654|Dermatologic Agents|dermatologic agents|mesh-ancestor
91948605|NCT01680861|Hormones|hormones|mesh-ancestor
92541059|NCT00394485|Tiotropium Bromide|tiotropium bromide|mesh-list
92541060|NCT00394485|Procaterol|procaterol|mesh-list
92541061|NCT00394485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92541062|NCT00394485|Autonomic Agents|autonomic agents|mesh-ancestor
92541063|NCT00394485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541064|NCT00394485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534048|NCT00065143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534049|NCT00065143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534050|NCT00398749|Epoetin Alfa|epoetin alfa|mesh-list
92534051|NCT00398749|Hematinics|hematinics|mesh-ancestor
92534052|NCT00398788|Hydromorphone|hydromorphone|mesh-list
92534053|NCT00398788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92534054|NCT00398788|Narcotics|narcotics|mesh-ancestor
92534055|NCT00398788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534056|NCT00398788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541065|NCT00394485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92541066|NCT00394485|Respiratory System Agents|respiratory system agents|mesh-ancestor
92541067|NCT00394485|Parasympatholytics|parasympatholytics|mesh-ancestor
92541068|NCT00394485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92541069|NCT00394485|Cholinergic Agents|cholinergic agents|mesh-ancestor
92541070|NCT00394485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541071|NCT00394485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541072|NCT00394485|Sympathomimetics|sympathomimetics|mesh-ancestor
92541073|NCT00394485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92541074|NCT00394485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92541075|NCT00394485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92541076|NCT00394485|Adrenergic Agents|adrenergic agents|mesh-ancestor
92541077|NCT00017693|Interleukin-4|interleukin-4|mesh-list
92541078|NCT00017693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92541079|NCT00017693|Immunologic Factors|immunologic factors|mesh-ancestor
92541080|NCT00017693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541081|NCT00017693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541082|NCT00017693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541083|NCT00128466|Gentamicins|gentamicins|mesh-list
92541084|NCT00128466|Streptomycin|streptomycin|mesh-list
92541085|NCT00128466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541086|NCT00128466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541087|NCT00128466|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92541088|NCT00128466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541089|NCT00128466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541090|NCT00128427|Colchicine|colchicine|mesh-list
92541091|NCT00128427|Gout Suppressants|gout suppressants|mesh-ancestor
92541092|NCT00128427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541093|NCT00128427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541094|NCT00128427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541095|NCT00128427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541096|NCT00128427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541097|NCT00128427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541098|NCT00006099|Antibodies|antibodies|mesh-list
92541099|NCT00006099|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92541100|NCT00006099|Immunologic Factors|immunologic factors|mesh-ancestor
92541101|NCT00006099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541102|NCT00018603|Guanfacine|guanfacine|mesh-list
92541103|NCT00018603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92541104|NCT00018603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92541105|NCT00018603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92541106|NCT00018603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92541107|NCT00018603|Adrenergic Agents|adrenergic agents|mesh-ancestor
92541108|NCT00018603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541109|NCT00018603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541110|NCT00018603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541111|NCT00018642|Haloperidol|haloperidol|mesh-list
91948662|NCT02312609|Minocycline|minocycline|mesh-list
92541131|NCT00018083|Rifabutin|rifabutin|mesh-list
92541132|NCT00018083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92541133|NCT00018083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92541134|NCT00018083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541135|NCT00018083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541136|NCT00018083|Antiviral Agents|antiviral agents|mesh-ancestor
92541137|NCT00018083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541138|NCT00018083|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92541139|NCT00018083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92541140|NCT00018083|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92541141|NCT00018083|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92541142|NCT00018083|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92541143|NCT00018083|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92541144|NCT00018083|Antitubercular Agents|antitubercular agents|mesh-ancestor
92541145|NCT00018083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541146|NCT00018083|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92541147|NCT00018083|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92541148|NCT00018083|Antimetabolites|antimetabolites|mesh-ancestor
92541149|NCT00018083|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92541150|NCT00018083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92541151|NCT00018200|Benztropine|benztropine|mesh-list
92541152|NCT00018200|Fluoxetine|fluoxetine|mesh-list
92541153|NCT00018200|Desipramine|desipramine|mesh-list
92541154|NCT00018200|Clomipramine|clomipramine|mesh-list
92541155|NCT00018200|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92541156|NCT00018200|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92541157|NCT00018200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92541158|NCT00018200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541159|NCT00018200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541160|NCT00018200|Serotonin Agents|serotonin agents|mesh-ancestor
92541161|NCT00018200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541162|NCT00018200|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92541163|NCT00018200|Antidepressive Agents|antidepressive agents|mesh-ancestor
92541164|NCT00018200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92541165|NCT00018200|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92541166|NCT00018200|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92541167|NCT00018200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541185|NCT00018759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541186|NCT00018759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541187|NCT00018759|Serotonin Agents|serotonin agents|mesh-ancestor
92541188|NCT00018759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541189|NCT00018759|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92541190|NCT00018759|Antidepressive Agents|antidepressive agents|mesh-ancestor
92541191|NCT00018759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92541192|NCT00018759|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92541193|NCT00018759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92541194|NCT00018759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541195|NCT04734353|Ticagrelor|ticagrelor|mesh-list
92541196|NCT04734353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92541197|NCT04734353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92266018|NCT02251379|Xhance|xhance|mesh-list
92541198|NCT04734353|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92541199|NCT04734353|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92541200|NCT04734353|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92541201|NCT04734353|Purinergic Agents|purinergic agents|mesh-ancestor
92541202|NCT04734353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541203|NCT04734353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541204|NCT04734353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541205|NCT00018954|Cytarabine|cytarabine|mesh-list
92541206|NCT00018954|Prednisone|prednisone|mesh-list
92541207|NCT00018954|Cyclophosphamide|cyclophosphamide|mesh-list
92541208|NCT00018954|Ifosfamide|ifosfamide|mesh-list
92541209|NCT00018954|Doxorubicin|doxorubicin|mesh-list
92541210|NCT00018954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92541211|NCT00018954|Methotrexate|methotrexate|mesh-list
92541212|NCT00018954|Etoposide|etoposide|mesh-list
92541213|NCT00018954|Vincristine|vincristine|mesh-list
92541214|NCT00018954|Daunorubicin|daunorubicin|mesh-list
92541215|NCT00018954|Asparaginase|asparaginase|mesh-list
92541216|NCT00018954|Mercaptopurine|mercaptopurine|mesh-list
92541217|NCT00018954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541218|NCT00018954|Immunologic Factors|immunologic factors|mesh-ancestor
92541219|NCT00018954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541220|NCT00018954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541221|NCT00018954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92541222|NCT00018954|Alkylating Agents|alkylating agents|mesh-ancestor
92541223|NCT00018954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682775|NCT04701320|Sympathomimetics|sympathomimetics|mesh-ancestor
92541240|NCT00018954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92541241|NCT00018954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92541242|NCT00018954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92534058|NCT00398788|Sensory System Agents|sensory system agents|mesh-ancestor
92534059|NCT00398788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534060|NCT00398827|Dexmedetomidine|dexmedetomidine|mesh-list
92534061|NCT00398827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92534062|NCT00398827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534063|NCT00398827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534064|NCT00398827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92534065|NCT00398827|Analgesics|analgesics|mesh-ancestor
92534066|NCT00398827|Sensory System Agents|sensory system agents|mesh-ancestor
92534067|NCT00398827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534068|NCT00398827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92534069|NCT00398827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92534070|NCT00398827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92258827|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
92534071|NCT00398827|Adrenergic Agents|adrenergic agents|mesh-ancestor
92534072|NCT00398827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750790|NCT05935059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92534073|NCT00398827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534074|NCT00065455|Vitamin A|vitamin a|mesh-list
92541243|NCT00018954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541244|NCT00018954|Antiviral Agents|antiviral agents|mesh-ancestor
92541245|NCT00018954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541246|NCT00018954|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541247|NCT00018954|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541248|NCT00018954|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541249|NCT00018278|Donepezil|donepezil|mesh-list
92541250|NCT00018278|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92541251|NCT00018278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541252|NCT00018278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541253|NCT00018278|Cholinergic Agents|cholinergic agents|mesh-ancestor
92541254|NCT00018278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541255|NCT00018278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541256|NCT00018278|Nootropic Agents|nootropic agents|mesh-ancestor
92541257|NCT00019032|Antibodies|antibodies|mesh-list
92541258|NCT00019032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92541259|NCT00019032|Immunologic Factors|immunologic factors|mesh-ancestor
92541260|NCT00019032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541261|NCT00019071|Cladribine|cladribine|mesh-list
92541262|NCT00019071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541263|NCT00019071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541264|NCT00019071|Immunologic Factors|immunologic factors|mesh-ancestor
92541265|NCT00019071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541266|NCT04734119|Anesthetics|anesthetics|mesh-list
92541267|NCT04734119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541268|NCT04734119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541269|NCT00018356|Testosterone|testosterone|mesh-list
92541270|NCT00018356|Androgens|androgens|mesh-ancestor
92541271|NCT00018356|Hormones|hormones|mesh-ancestor
92541272|NCT00018356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541273|NCT00018356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541274|NCT00019188|Interleukin-12|interleukin-12|mesh-list
92541275|NCT00019188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92541276|NCT00019188|Immunologic Factors|immunologic factors|mesh-ancestor
92541277|NCT00019188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541278|NCT00019188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92541279|NCT00019188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92541280|NCT00019188|Growth Substances|growth substances|mesh-ancestor
92541281|NCT00019188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534076|NCT00065455|Micronutrients|micronutrients|mesh-ancestor
92534077|NCT00065455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534078|NCT04488081|Cyproheptadine|cyproheptadine|mesh-list
92534079|NCT04488081|Cyclosporine|cyclosporine|mesh-list
92534080|NCT04488081|Remdesivir|remdesivir|mesh-list
92541299|NCT00019344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92541300|NCT00019344|Growth Substances|growth substances|mesh-ancestor
92541301|NCT00019344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541302|NCT00019344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92541303|NCT00019344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541304|NCT00019344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541305|NCT00019383|Aldesleukin|aldesleukin|mesh-list
92541306|NCT00019383|Sargramostim|sargramostim|mesh-list
92541307|NCT00019383|Freund's Adjuvant|freund's adjuvant|mesh-list
92541308|NCT00019383|Immunologic Factors|immunologic factors|mesh-ancestor
92541309|NCT00019383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541310|NCT00019383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541311|NCT00019383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92541312|NCT00019383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92541313|NCT00019383|Antiviral Agents|antiviral agents|mesh-ancestor
92541314|NCT00019383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541315|NCT00019383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92541316|NCT00019422|Carboplatin|carboplatin|mesh-list
92541317|NCT00019422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541318|NCT00018551|Folic Acid|folic acid|mesh-list
92541319|NCT00018551|Hematinics|hematinics|mesh-ancestor
92541320|NCT00018551|Vitamin B Complex|vitamin b complex|mesh-ancestor
92541321|NCT00018551|Vitamins|vitamins|mesh-ancestor
92541322|NCT00018551|Micronutrients|micronutrients|mesh-ancestor
92541323|NCT00018551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541324|NCT00019461|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92354210|NCT05249478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92541325|NCT00019461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541326|NCT00019461|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92541327|NCT00019461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92541328|NCT00019461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541329|NCT00019461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92541330|NCT00019461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541331|NCT00019500|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92541332|NCT00019500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92541333|NCT00019500|Hormone Antagonists|hormone antagonists|mesh-ancestor
92541334|NCT00019500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541335|NCT00019500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541336|NCT00019500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92541337|NCT00019500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92541338|NCT00019500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92541339|NCT00019539|Thalidomide|thalidomide|mesh-list
92541340|NCT00019539|Bevacizumab|bevacizumab|mesh-list
92541358|NCT00019695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92541359|NCT00019695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541360|NCT00019695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541361|NCT00019695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92541362|NCT00019695|Hormone Antagonists|hormone antagonists|mesh-ancestor
92541363|NCT00019695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541364|NCT00019695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541365|NCT00019695|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92541366|NCT00019695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92541367|NCT00019734|Aldesleukin|aldesleukin|mesh-list
92541368|NCT00019734|Vaccines|vaccines|mesh-list
92541369|NCT00019734|Immunologic Factors|immunologic factors|mesh-ancestor
92541370|NCT00019734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541371|NCT00019734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541372|NCT00019734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92541373|NCT00019734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92541374|NCT00019734|Antiviral Agents|antiviral agents|mesh-ancestor
92541375|NCT00019734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541376|NCT04146935|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92541377|NCT04146935|Immunologic Factors|immunologic factors|mesh-ancestor
92541378|NCT04146935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541379|NCT00019773|Capecitabine|capecitabine|mesh-list
92541380|NCT00019773|Oxaliplatin|oxaliplatin|mesh-list
92534081|NCT04488081|Cenicriviroc|cenicriviroc|mesh-list
92534082|NCT04488081|Dexamethasone|dexamethasone|mesh-list
92534083|NCT04488081|Celecoxib|celecoxib|mesh-list
92541381|NCT00019773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92541382|NCT00019773|Antimetabolites|antimetabolites|mesh-ancestor
92541383|NCT00019773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541384|NCT00019773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541385|NCT00019812|Paclitaxel|paclitaxel|mesh-list
92541386|NCT00019812|Trastuzumab|trastuzumab|mesh-list
92541387|NCT00019812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541388|NCT00019812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541389|NCT00019812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541390|NCT00019812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541391|NCT00019812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541392|NCT00019812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541393|NCT00019812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92541394|NCT00019890|Sargramostim|sargramostim|mesh-list
92541395|NCT00019890|Immunologic Factors|immunologic factors|mesh-ancestor
92541411|NCT00020007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541412|NCT00020007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541413|NCT00142454|Imiquimod|imiquimod|mesh-list
92541414|NCT00142454|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92541415|NCT00142454|Immunologic Factors|immunologic factors|mesh-ancestor
92541416|NCT00142454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541417|NCT00142454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541418|NCT00142454|Interferon Inducers|interferon inducers|mesh-ancestor
92541419|NCT00020046|Thalidomide|thalidomide|mesh-list
92541420|NCT00020046|Docetaxel|docetaxel|mesh-list
92541421|NCT00020046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266171|NCT03362775|Anesthetics, General|anesthetics, general|mesh-ancestor
92541422|NCT00020046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541423|NCT00020046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541424|NCT00020046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354211|NCT05249478|Narcotics|narcotics|mesh-ancestor
92541425|NCT00020046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541426|NCT00020046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541427|NCT00020046|Immunologic Factors|immunologic factors|mesh-ancestor
92541428|NCT00020046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541429|NCT00020046|Leprostatic Agents|leprostatic agents|mesh-ancestor
92541430|NCT00020046|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541431|NCT00020046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541432|NCT00020046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92541433|NCT00020046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92541434|NCT00020046|Growth Substances|growth substances|mesh-ancestor
92541435|NCT00020046|Growth Inhibitors|growth inhibitors|mesh-ancestor
92541436|NCT00020124|Doxorubicin|doxorubicin|mesh-list
92541437|NCT00020124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92541438|NCT00020124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541439|NCT00020124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541440|NCT00020124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541441|NCT00020124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541442|NCT00020124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541443|NCT00020124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541444|NCT00020202|Romidepsin|romidepsin|mesh-list
92541445|NCT00020202|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541446|NCT00020202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541447|NCT00020202|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92541448|NCT00020202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541449|NCT00020202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541450|NCT05576675|Sufentanil|sufentanil|mesh-list
92541452|NCT05576675|Hydromorphone|hydromorphone|mesh-list
92541453|NCT05576675|Nalbuphine|nalbuphine|mesh-list
91949010|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
92541476|NCT00020397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541477|NCT00020397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92541478|NCT00020397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92541479|NCT00020397|Antiviral Agents|antiviral agents|mesh-ancestor
92541480|NCT00020397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541481|NCT00020475|Interleukin-2|interleukin-2|mesh-list
92541482|NCT00020475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92541483|NCT00020475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541484|NCT00020475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92541485|NCT00020475|Analgesics|analgesics|mesh-ancestor
92541486|NCT00020475|Sensory System Agents|sensory system agents|mesh-ancestor
92541487|NCT00020475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541488|NCT00020475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534085|NCT04488081|Icatibant|icatibant|mesh-list
92534086|NCT04488081|Imatinib Mesylate|imatinib mesylate|mesh-list
92534087|NCT04488081|Famotidine|famotidine|mesh-list
92541489|NCT00020475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92541490|NCT00020475|Immunologic Factors|immunologic factors|mesh-ancestor
92541491|NCT05576480|Capecitabine|capecitabine|mesh-list
92541492|NCT05576480|Oxaliplatin|oxaliplatin|mesh-list
92541493|NCT05576480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92541494|NCT05576480|Antimetabolites|antimetabolites|mesh-ancestor
92541495|NCT05576480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541496|NCT05576480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541497|NCT00020631|Pirfenidone|pirfenidone|mesh-list
92541498|NCT00020631|Analgesics|analgesics|mesh-ancestor
92541499|NCT00020631|Sensory System Agents|sensory system agents|mesh-ancestor
92541500|NCT00020631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541501|NCT00020631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541502|NCT00020631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92541503|NCT00020631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92541504|NCT00020631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541505|NCT00020631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541506|NCT00020631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541507|NCT05576324|Ivacaftor|ivacaftor|mesh-list
92541508|NCT05576324|Elexacaftor|elexacaftor|mesh-list
92541509|NCT05576324|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92541526|NCT00020748|Irinotecan|irinotecan|mesh-list
92541527|NCT00020748|Epirubicin|epirubicin|mesh-list
92541528|NCT00020748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92541529|NCT00020748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541530|NCT00020748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541531|NCT00020748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541532|NCT00020748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541533|NCT00020748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541534|NCT00020748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541535|NCT00020787|Cisplatin|cisplatin|mesh-list
92541536|NCT00020787|Fluorouracil|fluorouracil|mesh-list
92541537|NCT00020787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541538|NCT00020787|Antimetabolites|antimetabolites|mesh-ancestor
92541539|NCT00020787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541540|NCT00020787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92541541|NCT00020787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541542|NCT00020787|Immunologic Factors|immunologic factors|mesh-ancestor
92541543|NCT00020787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541544|NCT00020865|Levofloxacin|levofloxacin|mesh-list
92541545|NCT00020865|Cefepime|cefepime|mesh-list
92541546|NCT00020865|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92541547|NCT00020865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541548|NCT00020865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541549|NCT00020865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541550|NCT00020865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541551|NCT00020865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541552|NCT00020865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541553|NCT00020865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541554|NCT00020865|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92541555|NCT00020865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92541556|NCT00020943|Leucovorin|leucovorin|mesh-list
92541557|NCT00020943|Cytarabine|cytarabine|mesh-list
92541558|NCT00020943|Prednisone|prednisone|mesh-list
92541559|NCT00020943|Cyclophosphamide|cyclophosphamide|mesh-list
92541560|NCT00020943|Carmustine|carmustine|mesh-list
92541561|NCT00020943|Rituximab|rituximab|mesh-list
92541562|NCT00020943|Doxorubicin|doxorubicin|mesh-list
92541563|NCT00020943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92541564|NCT00020943|Methotrexate|methotrexate|mesh-list
92541565|NCT00020943|Etoposide|etoposide|mesh-list
92541566|NCT00020943|Vincristine|vincristine|mesh-list
92541567|NCT00020943|Levoleucovorin|levoleucovorin|mesh-list
92541568|NCT00020943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541569|NCT00020943|Immunologic Factors|immunologic factors|mesh-ancestor
92541570|NCT00020943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541631|NCT00021099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541632|NCT05574257|Propofol|propofol|mesh-list
92541633|NCT05574257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92541634|NCT05574257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541635|NCT05574257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541636|NCT05574257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92534088|NCT04488081|Cyclosporins|cyclosporins|mesh-list
92534089|NCT04488081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92534090|NCT04488081|Antiemetics|antiemetics|mesh-ancestor
92534091|NCT04488081|Autonomic Agents|autonomic agents|mesh-ancestor
92541637|NCT05574257|Anesthetics, General|anesthetics, general|mesh-ancestor
92541638|NCT05574257|Anesthetics|anesthetics|mesh-ancestor
92541639|NCT05574218|Glycine|glycine|mesh-list
92541640|NCT05574218|Glycine Agents|glycine agents|mesh-ancestor
92541641|NCT05574218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541642|NCT05574218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541643|NCT05574218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541644|NCT00021138|Nicotine|nicotine|mesh-list
92541645|NCT00021138|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92541646|NCT00021138|Autonomic Agents|autonomic agents|mesh-ancestor
92541647|NCT00021138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541648|NCT00021138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266402|NCT01332188|Cetirizine|cetirizine|mesh-list
92541649|NCT00021138|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92541650|NCT00021138|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92541651|NCT00021138|Cholinergic Agents|cholinergic agents|mesh-ancestor
92541652|NCT00021138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541653|NCT00021138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541655|NCT00020670|Immunologic Factors|immunologic factors|mesh-ancestor
92541656|NCT00020670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541657|NCT05574179|Midazolam|midazolam|mesh-list
92541658|NCT05574179|Dexmedetomidine|dexmedetomidine|mesh-list
92541659|NCT05574179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92541660|NCT05574179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541661|NCT05574179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541662|NCT05574179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92541663|NCT05574179|Analgesics|analgesics|mesh-ancestor
92541664|NCT05574179|Sensory System Agents|sensory system agents|mesh-ancestor
92541665|NCT05574179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541666|NCT05574179|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92541667|NCT05574179|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92541668|NCT05574179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92541669|NCT05574179|Adrenergic Agents|adrenergic agents|mesh-ancestor
92541670|NCT05574179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541671|NCT05574179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541672|NCT05574179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92541673|NCT05574179|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92541674|NCT05574179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92541675|NCT05574179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92541676|NCT05574179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92541677|NCT05574179|Anesthetics, General|anesthetics, general|mesh-ancestor
92541678|NCT05574179|Anesthetics|anesthetics|mesh-ancestor
92541679|NCT05574179|GABA Modulators|gaba modulators|mesh-ancestor
92541680|NCT05574179|GABA Agents|gaba agents|mesh-ancestor
92541681|NCT00021216|Bortezomib|bortezomib|mesh-list
92541682|NCT00021216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541683|NCT00021294|Eflornithine|eflornithine|mesh-list
92541684|NCT00021294|Triamcinolone|triamcinolone|mesh-list
92541685|NCT00021294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541686|NCT00021294|Glucocorticoids|glucocorticoids|mesh-ancestor
92541687|NCT00021294|Hormones|hormones|mesh-ancestor
92541688|NCT00021294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541689|NCT00021294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541690|NCT00021294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541691|NCT00021294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541692|NCT00021294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541693|NCT00021294|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92541694|NCT00021294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92541695|NCT00021294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92541696|NCT00021294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541697|NCT00021294|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92541698|NCT00021333|Paclitaxel|paclitaxel|mesh-list
92541699|NCT00021333|Cisplatin|cisplatin|mesh-list
92541700|NCT00021333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541701|NCT00021333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541702|NCT00021333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541703|NCT00021333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541704|NCT00021333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541705|NCT00021333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541706|NCT00021372|Paclitaxel|paclitaxel|mesh-list
92541707|NCT00021372|Estramustine|estramustine|mesh-list
92541708|NCT00021372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541709|NCT00021372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541710|NCT00021372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541711|NCT00021372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541712|NCT00021372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541713|NCT00021372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541714|NCT00021372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92541715|NCT00021372|Alkylating Agents|alkylating agents|mesh-ancestor
92541716|NCT00021372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92541717|NCT00392093|Estrogens|estrogens|mesh-list
92541718|NCT00392093|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92541719|NCT00392093|Hormones|hormones|mesh-ancestor
92541720|NCT00392093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541721|NCT00392093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541722|NCT00018161|Mecamylamine|mecamylamine|mesh-list
92541723|NCT00018161|Nicotine|nicotine|mesh-list
92541724|NCT00018161|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92541725|NCT00018161|Autonomic Agents|autonomic agents|mesh-ancestor
92541726|NCT00018161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541727|NCT00018161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541738|NCT00021450|Bicalutamide|bicalutamide|mesh-list
92541739|NCT00021450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92541740|NCT00021450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541741|NCT00021450|Androgen Antagonists|androgen antagonists|mesh-ancestor
92541742|NCT00021450|Hormone Antagonists|hormone antagonists|mesh-ancestor
92541743|NCT00021450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541744|NCT00021450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541745|NCT00021489|Mycophenolic Acid|mycophenolic acid|mesh-list
92541746|NCT00021489|Abacavir|abacavir|mesh-list
92541747|NCT00021489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541748|NCT00021489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541749|NCT00021489|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92541750|NCT00021489|Antitubercular Agents|antitubercular agents|mesh-ancestor
92541751|NCT00021489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541752|NCT00021489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541753|NCT00021489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541754|NCT00021489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541755|NCT00021489|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92541756|NCT00021489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92541757|NCT00021489|Antiviral Agents|antiviral agents|mesh-ancestor
92541758|NCT00021489|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92541759|NCT00021489|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92541760|NCT00021528|Mirtazapine|mirtazapine|mesh-list
92541761|NCT00021528|Buspirone|buspirone|mesh-list
92541762|NCT00021528|Tranylcypromine|tranylcypromine|mesh-list
92541763|NCT00021528|Sertraline|sertraline|mesh-list
92541764|NCT00021528|Citalopram|citalopram|mesh-list
92541765|NCT00021528|Nortriptyline|nortriptyline|mesh-list
92541766|NCT00021528|Antidepressive Agents|antidepressive agents|mesh-ancestor
92541767|NCT00021528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92541768|NCT00021528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92541769|NCT00021528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92541770|NCT00021528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92541771|NCT00021528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541772|NCT00021528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541773|NCT00021528|Serotonin Agents|serotonin agents|mesh-ancestor
92541774|NCT00021528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541775|NCT00021528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541776|NCT00021528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92541777|NCT00021528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541778|NCT00021528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92541779|NCT00021528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92541780|NCT00021528|Histamine Antagonists|histamine antagonists|mesh-ancestor
92541781|NCT00021528|Histamine Agents|histamine agents|mesh-ancestor
92541782|NCT00021528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92541783|NCT00021528|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92541784|NCT00021528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92541785|NCT00021528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92541786|NCT00021528|Adrenergic Agents|adrenergic agents|mesh-ancestor
92534092|NCT04488081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534093|NCT04488081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534094|NCT04488081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92534095|NCT04488081|Glucocorticoids|glucocorticoids|mesh-ancestor
92541787|NCT00021528|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92541788|NCT00021528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92541789|NCT00021528|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92541790|NCT00021528|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91949333|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
92541795|NCT00021567|Interferon-gamma|interferon-gamma|mesh-list
92541796|NCT00021567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541797|NCT00021567|Antiviral Agents|antiviral agents|mesh-ancestor
92541798|NCT00021567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541799|NCT00021645|Vitamin E|vitamin e|mesh-list
92541800|NCT00021645|Vitamins|vitamins|mesh-ancestor
92541801|NCT00021645|Micronutrients|micronutrients|mesh-ancestor
92541802|NCT00021645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541803|NCT00021645|Antioxidants|antioxidants|mesh-ancestor
92541804|NCT00021645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541805|NCT00021645|Protective Agents|protective agents|mesh-ancestor
92541806|NCT05573204|Vitamin E|vitamin e|mesh-list
92541807|NCT05573204|Vitamins|vitamins|mesh-ancestor
92541808|NCT05573204|Micronutrients|micronutrients|mesh-ancestor
92541809|NCT05573204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541810|NCT05573204|Antioxidants|antioxidants|mesh-ancestor
92541811|NCT05573204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541812|NCT05573204|Protective Agents|protective agents|mesh-ancestor
92541813|NCT00021996|Valdecoxib|valdecoxib|mesh-list
92541814|NCT00021996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92541815|NCT00021996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92541816|NCT00021996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541817|NCT00021996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541818|NCT00021996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92541819|NCT00021996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92541820|NCT00021996|Analgesics|analgesics|mesh-ancestor
92541821|NCT00021996|Sensory System Agents|sensory system agents|mesh-ancestor
92541822|NCT00021996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541823|NCT00021996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541824|NCT00021996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541825|NCT00021996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541826|NCT00022074|Gabapentin|gabapentin|mesh-list
92541827|NCT00022074|Analgesics|analgesics|mesh-ancestor
92541828|NCT00022074|Sensory System Agents|sensory system agents|mesh-ancestor
92541829|NCT00022074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541830|NCT00022074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541831|NCT00022074|Anticonvulsants|anticonvulsants|mesh-ancestor
92541832|NCT00022074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92541833|NCT00022074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92541834|NCT00022074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541835|NCT00022074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92541836|NCT00022074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92541837|NCT00022074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92541838|NCT00022074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541839|NCT00022074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541840|NCT00022074|Antimanic Agents|antimanic agents|mesh-ancestor
92541841|NCT00022152|Vinorelbine|vinorelbine|mesh-list
92541842|NCT00022152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541843|NCT00022152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541844|NCT00022152|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541845|NCT00022152|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541846|NCT00022152|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541847|NCT00022152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541848|NCT00022191|Paclitaxel|paclitaxel|mesh-list
92541849|NCT00022191|Gemcitabine|gemcitabine|mesh-list
92541850|NCT00022191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541851|NCT00022191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541852|NCT00022191|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541853|NCT00022191|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541854|NCT00022191|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541855|NCT00022191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541856|NCT00022191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92534096|NCT04488081|Hormones|hormones|mesh-ancestor
92534097|NCT04488081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541857|NCT00022191|Antimetabolites|antimetabolites|mesh-ancestor
92541858|NCT00022230|Aldesleukin|aldesleukin|mesh-list
92541859|NCT00022230|Paclitaxel|paclitaxel|mesh-list
92541860|NCT00022230|Cyclophosphamide|cyclophosphamide|mesh-list
92541861|NCT00022230|Doxorubicin|doxorubicin|mesh-list
92541862|NCT00022230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92541868|NCT00022230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541869|NCT00022230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541870|NCT00022230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541871|NCT00022230|Immunologic Factors|immunologic factors|mesh-ancestor
92541872|NCT00022230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541873|NCT00022230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541874|NCT00022230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92541875|NCT00022230|Alkylating Agents|alkylating agents|mesh-ancestor
92541876|NCT00022230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92541877|NCT00022230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541878|NCT00022230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541879|NCT00022230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541880|NCT00022230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541881|NCT00022230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92541882|NCT00022230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92541883|NCT00022230|Antiviral Agents|antiviral agents|mesh-ancestor
92541884|NCT00022230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541885|NCT00022308|Irinotecan|irinotecan|mesh-list
92541886|NCT00022308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541887|NCT00022308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92541888|NCT00022308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541889|NCT00022308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541890|NCT00022308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541891|NCT00022386|Epoetin Alfa|epoetin alfa|mesh-list
92541892|NCT00022386|Hematinics|hematinics|mesh-ancestor
92541893|NCT00022425|Perillyl alcohol|perillyl alcohol|mesh-list
92541894|NCT00022425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541895|NCT00022425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541896|NCT00022425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541897|NCT00022464|Sirolimus|sirolimus|mesh-list
92541898|NCT00022464|Temsirolimus|temsirolimus|mesh-list
92541899|NCT00022464|MTOR Inhibitors|mtor inhibitors|mesh-list
92541900|NCT00022464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92541901|NCT00022464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541902|NCT00022464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541903|NCT00022464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541904|NCT00022464|Immunologic Factors|immunologic factors|mesh-ancestor
92541905|NCT00022464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541906|NCT00022464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541907|NCT00022464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541908|NCT00022464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541909|NCT00022464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541910|NCT00022464|Antifungal Agents|antifungal agents|mesh-ancestor
92541911|NCT00022542|Epothilones|epothilones|mesh-list
92541912|NCT00022542|Epothilone B|epothilone b|mesh-list
92541913|NCT00022542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541914|NCT00022542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541915|NCT00022542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541916|NCT00022542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541917|NCT00022542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541918|NCT00022581|Thalidomide|thalidomide|mesh-list
92541919|NCT00022581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541920|NCT00022581|Immunologic Factors|immunologic factors|mesh-ancestor
92541921|NCT00022581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541922|NCT00022581|Leprostatic Agents|leprostatic agents|mesh-ancestor
92541923|NCT00022581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541924|NCT00022581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541925|NCT00022581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92541926|NCT00022581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92541927|NCT00022581|Growth Substances|growth substances|mesh-ancestor
92541928|NCT00022581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92541929|NCT00022581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541930|NCT05551871|Simvastatin|simvastatin|mesh-list
92541931|NCT05551871|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92541932|NCT05551871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92534098|NCT04488081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92534099|NCT04488081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534100|NCT04488081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534101|NCT04488081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541933|NCT05551871|Antimetabolites|antimetabolites|mesh-ancestor
92541935|NCT05551871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92541936|NCT05551871|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92541937|NCT05551871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541938|NCT00022620|Paclitaxel|paclitaxel|mesh-list
92541939|NCT00022620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541940|NCT00022620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541941|NCT00022620|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541942|NCT00022620|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541943|NCT00022620|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541944|NCT00022620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541945|NCT00022737|Leucovorin|leucovorin|mesh-list
92541946|NCT00022737|Cytarabine|cytarabine|mesh-list
92541947|NCT00022737|Cyclosporine|cyclosporine|mesh-list
92541948|NCT00022737|Dexamethasone|dexamethasone|mesh-list
92541949|NCT00022737|Cyclophosphamide|cyclophosphamide|mesh-list
92541950|NCT00022737|Ifosfamide|ifosfamide|mesh-list
92541951|NCT00022737|Methotrexate|methotrexate|mesh-list
92541952|NCT00022737|Etoposide|etoposide|mesh-list
92541953|NCT00022737|Vincristine|vincristine|mesh-list
92541954|NCT00022737|Etoposide phosphate|etoposide phosphate|mesh-list
92541955|NCT00022737|Imatinib Mesylate|imatinib mesylate|mesh-list
92541956|NCT00022737|Daunorubicin|daunorubicin|mesh-list
92541957|NCT00022737|Asparaginase|asparaginase|mesh-list
92541959|NCT00022737|Pegaspargase|pegaspargase|mesh-list
92541960|NCT00022737|Cyclosporins|cyclosporins|mesh-list
92541961|NCT00022737|Levoleucovorin|levoleucovorin|mesh-list
92541962|NCT00022737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541963|NCT00022737|Immunologic Factors|immunologic factors|mesh-ancestor
92541964|NCT00022737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541965|NCT00022737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541966|NCT00022737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92354231|NCT05244018|Vitamin D|vitamin d|mesh-list
92541967|NCT00022737|Alkylating Agents|alkylating agents|mesh-ancestor
92541968|NCT00022737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541969|NCT00022737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541970|NCT00022737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92541971|NCT00022737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541972|NCT00022737|Antiemetics|antiemetics|mesh-ancestor
92541973|NCT00022737|Autonomic Agents|autonomic agents|mesh-ancestor
92541974|NCT00022737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541975|NCT00022737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92541976|NCT00022737|Glucocorticoids|glucocorticoids|mesh-ancestor
92541977|NCT00022737|Hormones|hormones|mesh-ancestor
92541978|NCT00022737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541979|NCT00022737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92541980|NCT00022737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92541981|NCT00022737|Abortifacient Agents|abortifacient agents|mesh-ancestor
92541982|NCT00022737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92541983|NCT00022737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92541984|NCT00022737|Antimetabolites|antimetabolites|mesh-ancestor
92541985|NCT00022737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92541986|NCT00022737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541987|NCT00022737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92541988|NCT00022737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92541989|NCT00022737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541990|NCT00022737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541991|NCT00022737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541992|NCT00022737|Antiviral Agents|antiviral agents|mesh-ancestor
92541993|NCT00022737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541994|NCT00022737|Antidotes|antidotes|mesh-ancestor
92541995|NCT00022737|Protective Agents|protective agents|mesh-ancestor
92541996|NCT00022737|Vitamin B Complex|vitamin b complex|mesh-ancestor
92541997|NCT00022737|Vitamins|vitamins|mesh-ancestor
92541998|NCT00022737|Micronutrients|micronutrients|mesh-ancestor
92541999|NCT00022737|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542000|NCT00022737|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542001|NCT00022737|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542002|NCT00022737|Antifungal Agents|antifungal agents|mesh-ancestor
92542003|NCT00022737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92542004|NCT00022737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542005|NCT00022737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542006|NCT00022893|Tositumomab I-131|tositumomab i-131|mesh-list
92542007|NCT00022893|Antibodies|antibodies|mesh-list
92542008|NCT00022893|Immunologic Factors|immunologic factors|mesh-ancestor
92542009|NCT00022893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542010|NCT00022893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542011|NCT05514860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92542031|NCT05512754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542032|NCT05512754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92542033|NCT05512754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542034|NCT05512754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542036|NCT02971878|Acetylcarnitine|acetylcarnitine|mesh-list
92542037|NCT02971878|Acetylcysteine|acetylcysteine|mesh-list
92542038|NCT02971878|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92542039|NCT02971878|Antioxidants|antioxidants|mesh-ancestor
92542040|NCT02971878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542041|NCT02971878|Protective Agents|protective agents|mesh-ancestor
92542042|NCT02971878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542043|NCT02971878|Vitamin B Complex|vitamin b complex|mesh-ancestor
92542044|NCT02971878|Vitamins|vitamins|mesh-ancestor
92542045|NCT02971878|Micronutrients|micronutrients|mesh-ancestor
92542046|NCT02971878|Nootropic Agents|nootropic agents|mesh-ancestor
92542047|NCT02971878|Antiviral Agents|antiviral agents|mesh-ancestor
92542048|NCT02971878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542049|NCT02971878|Expectorants|expectorants|mesh-ancestor
92542050|NCT02971878|Respiratory System Agents|respiratory system agents|mesh-ancestor
92542051|NCT02971878|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92542052|NCT02971878|Antidotes|antidotes|mesh-ancestor
92542053|NCT00023166|Paclitaxel|paclitaxel|mesh-list
92542054|NCT00023166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542055|NCT00023166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542056|NCT00023166|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542057|NCT00023166|Antimitotic Agents|antimitotic agents|mesh-ancestor
92354234|NCT05244018|Vitamins|vitamins|mesh-list
92542058|NCT00023166|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542059|NCT00023166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542060|NCT00394992|Bevacizumab|bevacizumab|mesh-list
92542061|NCT00394992|Capecitabine|capecitabine|mesh-list
92542062|NCT00394992|Oxaliplatin|oxaliplatin|mesh-list
92542063|NCT00394992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542064|NCT00394992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542065|NCT00394992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92542066|NCT00394992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92542067|NCT00394992|Growth Substances|growth substances|mesh-ancestor
92542068|NCT00394992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542084|NCT00395031|Dopamine Agents|dopamine agents|mesh-ancestor
92542085|NCT00395070|Temozolomide|temozolomide|mesh-list
92542086|NCT00395070|Dacarbazine|dacarbazine|mesh-list
92542087|NCT00395070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542088|NCT00395070|Alkylating Agents|alkylating agents|mesh-ancestor
92542089|NCT00395070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542090|NCT00395070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542091|NCT00023244|Cyclosporine|cyclosporine|mesh-list
92542092|NCT00023244|Sirolimus|sirolimus|mesh-list
92542093|NCT00023244|Trimethoprim|trimethoprim|mesh-list
92542094|NCT00023244|Sulfamethoxazole|sulfamethoxazole|mesh-list
92542095|NCT00023244|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92542096|NCT00023244|Prednisone|prednisone|mesh-list
92542097|NCT00023244|Methylprednisolone|methylprednisolone|mesh-list
92542098|NCT00023244|Tacrolimus|tacrolimus|mesh-list
92542099|NCT00023244|Cyclosporins|cyclosporins|mesh-list
92542100|NCT00023244|Basiliximab|basiliximab|mesh-list
92542101|NCT00023244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542102|NCT00023244|Glucocorticoids|glucocorticoids|mesh-ancestor
92542103|NCT00023244|Hormones|hormones|mesh-ancestor
92542104|NCT00023244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92542105|NCT00023244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542106|NCT00023244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92542107|NCT00023244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542108|NCT00023244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266840|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542109|NCT00023244|Immunologic Factors|immunologic factors|mesh-ancestor
92542110|NCT00023244|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92542111|NCT00023244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542112|NCT00023244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542113|NCT00023244|Antifungal Agents|antifungal agents|mesh-ancestor
92534102|NCT04488081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534103|NCT04488081|Immunologic Factors|immunologic factors|mesh-ancestor
92534104|NCT04488081|Antifungal Agents|antifungal agents|mesh-ancestor
92542114|NCT00023244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542115|NCT00023244|Dermatologic Agents|dermatologic agents|mesh-ancestor
92542116|NCT00023244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542117|NCT00023244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542118|NCT00023244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542119|NCT00023244|Antiemetics|antiemetics|mesh-ancestor
92542120|NCT00023244|Autonomic Agents|autonomic agents|mesh-ancestor
92542121|NCT00023244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542122|NCT00023244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92542123|NCT00023244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92542124|NCT00023244|Protective Agents|protective agents|mesh-ancestor
92542125|NCT00023244|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92542126|NCT00023244|Antimalarials|antimalarials|mesh-ancestor
92542127|NCT00023244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92542151|NCT00023400|Protease Inhibitors|protease inhibitors|mesh-ancestor
92542152|NCT00023400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542153|NCT00023400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542154|NCT00023400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92542155|NCT00023400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92542156|NCT00023400|Antiviral Agents|antiviral agents|mesh-ancestor
92542157|NCT00023400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542158|NCT00023400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542159|NCT00023400|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92542160|NCT00023400|Antitubercular Agents|antitubercular agents|mesh-ancestor
92542161|NCT05359172|Tranexamic Acid|tranexamic acid|mesh-list
92542162|NCT05359172|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92542163|NCT05359172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92542164|NCT05359172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542165|NCT05359172|Hemostatics|hemostatics|mesh-ancestor
92542166|NCT05359172|Coagulants|coagulants|mesh-ancestor
92542167|NCT00023634|Sargramostim|sargramostim|mesh-list
92542168|NCT00023634|Immunologic Factors|immunologic factors|mesh-ancestor
92542169|NCT00023634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542170|NCT00023751|Leucovorin|leucovorin|mesh-list
92542171|NCT00023751|Fluorouracil|fluorouracil|mesh-list
92542172|NCT00023751|Calcium|calcium|mesh-list
92542173|NCT00023751|Levoleucovorin|levoleucovorin|mesh-list
92542174|NCT00023751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92542175|NCT00023751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542176|NCT00023751|Antimetabolites|antimetabolites|mesh-ancestor
92542177|NCT00023751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542178|NCT00023751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542179|NCT00023751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542180|NCT00023751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542198|NCT00023790|Dermatologic Agents|dermatologic agents|mesh-ancestor
92542199|NCT02971982|Dexamethasone|dexamethasone|mesh-list
92542200|NCT02971982|Dexamethasone acetate|dexamethasone acetate|mesh-list
92542201|NCT02971982|Cyclophosphamide|cyclophosphamide|mesh-list
92542202|NCT02971982|Rituximab|rituximab|mesh-list
92542203|NCT02971982|Bortezomib|bortezomib|mesh-list
92542204|NCT02971982|BB 1101|bb 1101|mesh-list
92542205|NCT02971982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542206|NCT02971982|Immunologic Factors|immunologic factors|mesh-ancestor
92542207|NCT02971982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542208|NCT02971982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542209|NCT02971982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542210|NCT02971982|Alkylating Agents|alkylating agents|mesh-ancestor
92542211|NCT02971982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542212|NCT02971982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542213|NCT02971982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542214|NCT02971982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542215|NCT02971982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542216|NCT02971982|Antiemetics|antiemetics|mesh-ancestor
92542217|NCT02971982|Autonomic Agents|autonomic agents|mesh-ancestor
92542218|NCT02971982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542219|NCT02971982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92542220|NCT02971982|Glucocorticoids|glucocorticoids|mesh-ancestor
92542221|NCT02971982|Hormones|hormones|mesh-ancestor
92542222|NCT02971982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92542223|NCT02971982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92542224|NCT02971982|Protease Inhibitors|protease inhibitors|mesh-ancestor
92534106|NCT04488081|Dermatologic Agents|dermatologic agents|mesh-ancestor
92534107|NCT04488081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534108|NCT04488081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92534109|NCT04488081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92534110|NCT04488081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92542225|NCT02971982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542226|NCT00023829|Bicalutamide|bicalutamide|mesh-list
92542227|NCT00023829|Flutamide|flutamide|mesh-list
92542228|NCT00023829|Hormones|hormones|mesh-list
92542229|NCT00023829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92542230|NCT00023829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542231|NCT00023829|Androgen Antagonists|androgen antagonists|mesh-ancestor
92542232|NCT00023829|Hormone Antagonists|hormone antagonists|mesh-ancestor
92542233|NCT00023829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542234|NCT00023829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92542235|NCT00023868|Leucovorin|leucovorin|mesh-list
92542236|NCT00023868|Doxorubicin|doxorubicin|mesh-list
92542237|NCT00023868|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92542238|NCT00023868|Fluorouracil|fluorouracil|mesh-list
92542239|NCT00023868|Irinotecan|irinotecan|mesh-list
92542240|NCT00023868|Mitomycins|mitomycins|mesh-list
92542241|NCT00023868|Mitomycin|mitomycin|mesh-list
92542242|NCT00023868|Levoleucovorin|levoleucovorin|mesh-list
92542243|NCT00023868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542244|NCT00023868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542267|NCT00023907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542268|NCT00023907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542269|NCT00023946|Epothilones|epothilones|mesh-list
92542270|NCT00023946|Epothilone B|epothilone b|mesh-list
92542271|NCT00023946|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542272|NCT00023946|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542273|NCT00023946|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542274|NCT00023946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542275|NCT00023946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542276|NCT05268185|Vaccines|vaccines|mesh-list
92542277|NCT05268185|Immunologic Factors|immunologic factors|mesh-ancestor
92542278|NCT05268185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542279|NCT00024063|Orantinib|orantinib|mesh-list
92542280|NCT00024063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542281|NCT00024063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542282|NCT00024063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542283|NCT00024141|Fluorouracil|fluorouracil|mesh-list
92542284|NCT00024141|Irinotecan|irinotecan|mesh-list
92542285|NCT00024141|Antimetabolites|antimetabolites|mesh-ancestor
92542286|NCT00024141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542287|NCT00024141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542288|NCT00024141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542289|NCT00024141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542290|NCT00024141|Immunologic Factors|immunologic factors|mesh-ancestor
92542291|NCT00024141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542292|NCT00024141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542293|NCT00024141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542294|NCT00024141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542295|NCT05239286|Anesthetics|anesthetics|mesh-list
92542296|NCT05239286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542297|NCT05239286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542310|NCT00024336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542311|NCT00024336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92542312|NCT00024336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542313|NCT00024336|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92542314|NCT00024336|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92542315|NCT00024336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92542316|NCT00024375|Paclitaxel|paclitaxel|mesh-list
92542317|NCT00024375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542318|NCT00024375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542319|NCT00024375|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542320|NCT00024375|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542321|NCT00024375|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542322|NCT00024375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534111|NCT04488081|Analgesics|analgesics|mesh-ancestor
92534112|NCT04488081|Sensory System Agents|sensory system agents|mesh-ancestor
92542323|NCT00024414|Paclitaxel|paclitaxel|mesh-list
92542324|NCT00024414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542325|NCT00024414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542326|NCT00024414|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542327|NCT00024414|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542328|NCT00024414|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542329|NCT00024414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542330|NCT00024453|Teicoplanin|teicoplanin|mesh-list
92542331|NCT00024453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542332|NCT00024453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542333|NCT00024492|Mitoxantrone|mitoxantrone|mesh-list
92542334|NCT00024492|Analgesics|analgesics|mesh-ancestor
92542335|NCT00024492|Sensory System Agents|sensory system agents|mesh-ancestor
92542336|NCT00024492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542337|NCT00024492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542338|NCT00024492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542339|NCT00024492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542340|NCT00024492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542341|NCT00024492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542342|NCT00024492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542343|NCT00024531|Atorvastatin|atorvastatin|mesh-list
92542344|NCT00024531|Calcium|calcium|mesh-list
92542345|NCT00024531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92542346|NCT00024531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542347|NCT00024531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92542348|NCT00024531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92542349|NCT00024531|Antimetabolites|antimetabolites|mesh-ancestor
92542350|NCT00024531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542351|NCT00024531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92542352|NCT00024531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92542353|NCT00024531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542354|NCT00024570|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92542355|NCT00024570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542356|NCT05080049|Epoetin Alfa|epoetin alfa|mesh-list
92542357|NCT05080049|Hematinics|hematinics|mesh-ancestor
92542358|NCT00024687|Immunotoxins|immunotoxins|mesh-list
91949873|NCT03491579|Cytarabine|cytarabine|mesh-list
92542378|NCT00025038|Immunologic Factors|immunologic factors|mesh-ancestor
92542379|NCT00025038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542380|NCT00025038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542381|NCT00025038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542382|NCT00025038|Alkylating Agents|alkylating agents|mesh-ancestor
92542383|NCT00025038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542384|NCT00025038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542385|NCT00025038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542386|NCT00025038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542387|NCT00025038|Antimetabolites|antimetabolites|mesh-ancestor
92542388|NCT00025038|Antiviral Agents|antiviral agents|mesh-ancestor
92542389|NCT00025038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542390|NCT00025038|Dermatologic Agents|dermatologic agents|mesh-ancestor
92542391|NCT05055830|Acetaminophen|acetaminophen|mesh-list
92542392|NCT05055830|Methadone|methadone|mesh-list
92542393|NCT05055830|Caffeine|caffeine|mesh-list
92542394|NCT05055830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92542395|NCT05055830|Analgesics|analgesics|mesh-ancestor
92542396|NCT05055830|Sensory System Agents|sensory system agents|mesh-ancestor
92542397|NCT05055830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542398|NCT05055830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542399|NCT05055830|Antipyretics|antipyretics|mesh-ancestor
92542400|NCT05055830|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92542401|NCT05055830|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92542402|NCT05055830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542403|NCT05055830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542404|NCT05055830|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92542405|NCT05055830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92542406|NCT05055830|Purinergic Agents|purinergic agents|mesh-ancestor
92542407|NCT05055830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542408|NCT05055830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92542409|NCT05055830|Narcotics|narcotics|mesh-ancestor
92542410|NCT05055830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534113|NCT04488081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92534114|NCT04488081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92534115|NCT04488081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92534116|NCT04488081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92534117|NCT04488081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92534119|NCT04488081|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92534120|NCT04488081|Histamine Antagonists|histamine antagonists|mesh-ancestor
92542411|NCT05055830|Antitussive Agents|antitussive agents|mesh-ancestor
92542412|NCT05055830|Respiratory System Agents|respiratory system agents|mesh-ancestor
92542413|NCT00025077|Cyclophosphamide|cyclophosphamide|mesh-list
92542414|NCT00025077|Thiotepa|thiotepa|mesh-list
92542415|NCT00025077|Carboplatin|carboplatin|mesh-list
92542416|NCT00025077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542417|NCT00025077|Immunologic Factors|immunologic factors|mesh-ancestor
91949939|NCT03779243|Melatonin|melatonin|mesh-list
92542433|NCT05051891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542434|NCT05051891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542435|NCT05051891|Alkylating Agents|alkylating agents|mesh-ancestor
92542436|NCT05051891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542437|NCT05051891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542438|NCT05051891|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542439|NCT05051891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542440|NCT05051891|Glucocorticoids|glucocorticoids|mesh-ancestor
92542442|NCT05051891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92542443|NCT05051891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92542444|NCT05051891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542445|NCT05051891|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542446|NCT05051891|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542447|NCT05051891|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542448|NCT05051891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542449|NCT05051891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542450|NCT05051891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542451|NCT05051891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542452|NCT05051891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542453|NCT00025194|Estramustine|estramustine|mesh-list
92542454|NCT00025194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542455|NCT00025194|Alkylating Agents|alkylating agents|mesh-ancestor
92542456|NCT00025194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542457|NCT00025194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542458|NCT00025194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92542459|NCT00025272|Carboplatin|carboplatin|mesh-list
92542460|NCT00025272|Etoposide|etoposide|mesh-list
92542461|NCT00025272|Topotecan|topotecan|mesh-list
92542462|NCT00025272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542463|NCT00025272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542464|NCT00025272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542465|NCT00025272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542466|NCT00025272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542467|NCT00025272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542468|NCT00025272|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542469|NCT05023382|Teduglutide|teduglutide|mesh-list
92542470|NCT05023382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92542471|NCT05023382|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92542472|NCT05023382|Protective Agents|protective agents|mesh-ancestor
92542473|NCT05023382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542474|NCT00025311|Topotecan|topotecan|mesh-list
92542475|NCT00025311|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542476|NCT00025311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542494|NCT00025389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542496|NCT00025389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542497|NCT00025389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542498|NCT00025389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542499|NCT00025389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542500|NCT00025389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92534121|NCT04488081|Histamine Agents|histamine agents|mesh-ancestor
92534122|NCT04488081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534123|NCT04488081|Antimetabolites|antimetabolites|mesh-ancestor
92534124|NCT04488081|Antiviral Agents|antiviral agents|mesh-ancestor
92534125|NCT04488081|Antipruritics|antipruritics|mesh-ancestor
92534126|NCT04488081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92534127|NCT04488081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92534128|NCT04488081|Serotonin Agents|serotonin agents|mesh-ancestor
92542501|NCT00025389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92542502|NCT00025389|Growth Substances|growth substances|mesh-ancestor
92542503|NCT00025389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542504|NCT00025389|Growth Inhibitors|growth inhibitors|mesh-ancestor
92542505|NCT00025428|Cyclophosphamide|cyclophosphamide|mesh-list
92542507|NCT00025428|Doxorubicin|doxorubicin|mesh-list
92542508|NCT00025428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92542509|NCT00025428|Etoposide|etoposide|mesh-list
92542510|NCT00025428|Vincristine|vincristine|mesh-list
92542511|NCT00025428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542512|NCT00025428|Immunologic Factors|immunologic factors|mesh-ancestor
92542513|NCT00025428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542514|NCT00025428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542515|NCT00025428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542516|NCT00025428|Alkylating Agents|alkylating agents|mesh-ancestor
92542517|NCT00025428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542518|NCT00025428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542519|NCT00025428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542520|NCT00025428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542521|NCT00025428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542522|NCT00025428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542523|NCT00025428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542524|NCT00025428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542525|NCT00025428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542526|NCT00025428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542527|NCT00025428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542528|NCT00025467|Thalidomide|thalidomide|mesh-list
92542529|NCT00025467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542530|NCT00025467|Immunologic Factors|immunologic factors|mesh-ancestor
92542531|NCT00025467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542532|NCT00025467|Leprostatic Agents|leprostatic agents|mesh-ancestor
92682776|NCT04701320|Autonomic Agents|autonomic agents|mesh-ancestor
92542552|NCT00025545|Methotrexate|methotrexate|mesh-list
92542553|NCT00025545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542554|NCT00025545|Immunologic Factors|immunologic factors|mesh-ancestor
92542555|NCT00025545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542556|NCT00025545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542557|NCT00025545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542558|NCT00025545|Alkylating Agents|alkylating agents|mesh-ancestor
92542559|NCT00025545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542560|NCT00025545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542561|NCT00025545|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542562|NCT00025545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92542563|NCT00025545|Abortifacient Agents|abortifacient agents|mesh-ancestor
92542564|NCT00025545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92542565|NCT00025545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542566|NCT00025545|Antimetabolites|antimetabolites|mesh-ancestor
92542567|NCT00025545|Dermatologic Agents|dermatologic agents|mesh-ancestor
92542568|NCT00025545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542569|NCT00025545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92542570|NCT00025545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92542571|NCT00025584|Bortezomib|bortezomib|mesh-list
92542572|NCT00025584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542573|NCT00025623|Cyclophosphamide|cyclophosphamide|mesh-list
92542574|NCT00025623|Carboplatin|carboplatin|mesh-list
92542575|NCT00025623|Doxorubicin|doxorubicin|mesh-list
92542576|NCT00025623|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92542577|NCT00025623|Etoposide|etoposide|mesh-list
92542578|NCT00025623|Vincristine|vincristine|mesh-list
92542579|NCT00025623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542580|NCT00025623|Immunologic Factors|immunologic factors|mesh-ancestor
92534129|NCT04488081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92542581|NCT00025623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542582|NCT00025623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542583|NCT00025623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542584|NCT00025623|Alkylating Agents|alkylating agents|mesh-ancestor
92542585|NCT00025623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542586|NCT00025623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542587|NCT00025623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542588|NCT00025623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542599|NCT00025740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92542601|NCT00025740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542602|NCT00025740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542603|NCT00025740|Serotonin Agents|serotonin agents|mesh-ancestor
92542604|NCT00025740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542605|NCT00025740|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92542606|NCT00025740|Antidepressive Agents|antidepressive agents|mesh-ancestor
92542607|NCT00025740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542608|NCT00025740|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92542609|NCT00025740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92542610|NCT00025740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542611|NCT00025740|Anticonvulsants|anticonvulsants|mesh-ancestor
92542612|NCT00025740|GABA Modulators|gaba modulators|mesh-ancestor
92542613|NCT00025740|GABA Agents|gaba agents|mesh-ancestor
92542614|NCT00025779|Guanfacine|guanfacine|mesh-list
92542615|NCT00025779|Methylphenidate|methylphenidate|mesh-list
92542616|NCT00025779|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92542617|NCT00025779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542618|NCT00025779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92542619|NCT00025779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92542620|NCT00025779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92542621|NCT00025779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542622|NCT00025779|Dopamine Agents|dopamine agents|mesh-ancestor
92542623|NCT00025779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542624|NCT00025779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92542625|NCT00025779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92542626|NCT00025779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92542627|NCT00025779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92542628|NCT00025779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92542629|NCT04876079|Insulin|insulin|mesh-list
92542630|NCT04876079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92542631|NCT04876079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542632|NCT00026052|Riluzole|riluzole|mesh-list
92542633|NCT00026052|Anticonvulsants|anticonvulsants|mesh-ancestor
92542634|NCT00026052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92542635|NCT00026052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92542636|NCT00026052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542637|NCT00026052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542638|NCT00026052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542639|NCT00026052|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92542640|NCT00026052|Protective Agents|protective agents|mesh-ancestor
92542641|NCT00026091|Fenretinide|fenretinide|mesh-list
92542642|NCT00026091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542643|NCT00026091|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92542644|NCT00026091|Protective Agents|protective agents|mesh-ancestor
92542645|NCT00026091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542646|NCT00026130|Gemcitabine|gemcitabine|mesh-list
92542647|NCT00026130|Fluorouracil|fluorouracil|mesh-list
92542648|NCT00026130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542649|NCT00026130|Antimetabolites|antimetabolites|mesh-ancestor
92542650|NCT00026130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542651|NCT00026130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542674|NCT00026364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542675|NCT00026364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542676|NCT00026364|Immunologic Factors|immunologic factors|mesh-ancestor
92542677|NCT00026364|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542678|NCT00026364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542679|NCT00026364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542680|NCT00026364|Antidotes|antidotes|mesh-ancestor
92542681|NCT00026364|Protective Agents|protective agents|mesh-ancestor
92542682|NCT00026364|Vitamin B Complex|vitamin b complex|mesh-ancestor
92542683|NCT00026364|Vitamins|vitamins|mesh-ancestor
92542684|NCT00026364|Micronutrients|micronutrients|mesh-ancestor
92542685|NCT00026364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542686|NCT00026403|Gemcitabine|gemcitabine|mesh-list
92542687|NCT00026403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542688|NCT00026403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542689|NCT00026403|Antimetabolites|antimetabolites|mesh-ancestor
92542690|NCT00026403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542691|NCT00026442|Capecitabine|capecitabine|mesh-list
92542692|NCT00026442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542693|NCT00026442|Antimetabolites|antimetabolites|mesh-ancestor
92542694|NCT00026442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542695|NCT00026442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542696|NCT04726280|Ropivacaine|ropivacaine|mesh-list
92542697|NCT04726280|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92542698|NCT04726280|Anesthetics, Local|anesthetics, local|mesh-ancestor
92542699|NCT04726280|Anesthetics|anesthetics|mesh-ancestor
92542700|NCT04726280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542701|NCT04726280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542702|NCT04726280|Sensory System Agents|sensory system agents|mesh-ancestor
92542703|NCT04726280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542704|NCT00026520|Interferons|interferons|mesh-list
92542705|NCT00026520|Interferon-alpha|interferon-alpha|mesh-list
92542706|NCT00026520|Thalidomide|thalidomide|mesh-list
92542727|NCT00026637|Serotonin Agents|serotonin agents|mesh-ancestor
92542728|NCT00026637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542729|NCT04657094|Acalabrutinib|acalabrutinib|mesh-list
92542730|NCT04657094|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92354277|NCT02395614|Disinfectants|disinfectants|mesh-ancestor
92542731|NCT04657094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542732|NCT04657094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542733|NCT04657094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542734|NCT04657094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542735|NCT04610684|Carboplatin|carboplatin|mesh-list
92542736|NCT04610684|Etoposide|etoposide|mesh-list
92542737|NCT04610684|Atezolizumab|atezolizumab|mesh-list
92542738|NCT04610684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542739|NCT04610684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542740|NCT04610684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542741|NCT04610684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542742|NCT04610684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542743|NCT04610684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542744|NCT04610684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92542745|NCT04610684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542746|NCT00027066|Aspirin|aspirin|mesh-list
92542747|NCT00027066|Warfarin|warfarin|mesh-list
92542748|NCT00027066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92542749|NCT00027066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92542750|NCT00027066|Analgesics|analgesics|mesh-ancestor
92542751|NCT00027066|Sensory System Agents|sensory system agents|mesh-ancestor
92542752|NCT00027066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542753|NCT00027066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542754|NCT00027066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542755|NCT00027066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542756|NCT00027066|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92542757|NCT00027066|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92542758|NCT00027066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542759|NCT00027066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92542760|NCT00027066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92542773|NCT04473482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542775|NCT00027300|Immunologic Factors|immunologic factors|mesh-ancestor
92542776|NCT00027300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542777|NCT00395382|Alendronate|alendronate|mesh-list
92542778|NCT00395382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92542779|NCT00395382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542780|NCT00027339|Ritonavir|ritonavir|mesh-list
92542781|NCT00027339|Lopinavir|lopinavir|mesh-list
92542782|NCT00027339|Indinavir|indinavir|mesh-list
92542783|NCT00027339|Fosamprenavir|fosamprenavir|mesh-list
92542784|NCT00027339|Tenofovir|tenofovir|mesh-list
92542785|NCT00027339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92542786|NCT00027339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92542787|NCT00027339|Protease Inhibitors|protease inhibitors|mesh-ancestor
92542788|NCT00027339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542789|NCT00027339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542790|NCT00027339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92542791|NCT00027339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92542792|NCT00027339|Antiviral Agents|antiviral agents|mesh-ancestor
92534130|NCT04488081|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92542793|NCT00027339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542794|NCT00027339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92542795|NCT00027339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92542796|NCT00027339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92542797|NCT00027339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92542799|NCT04206488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92542800|NCT04206488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92542801|NCT04206488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542802|NCT04206488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542803|NCT04206488|Protective Agents|protective agents|mesh-ancestor
92542804|NCT04206488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542806|NCT00027495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92542807|NCT00027495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92542808|NCT00027495|Analgesics|analgesics|mesh-ancestor
92542809|NCT00027495|Sensory System Agents|sensory system agents|mesh-ancestor
92542810|NCT00027495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542811|NCT00027495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542812|NCT00027495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542813|NCT00027495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542814|NCT00027495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542815|NCT00027495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542816|NCT00027495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542817|NCT00027534|Metronidazole|metronidazole|mesh-list
92542818|NCT00027534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542819|NCT00027534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542820|NCT00027534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92542821|NCT00027534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92542822|NCT00027573|Cyclophosphamide|cyclophosphamide|mesh-list
92542823|NCT00027573|Methotrexate|methotrexate|mesh-list
92542824|NCT00027573|Fludarabine|fludarabine|mesh-list
91950336|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
92542834|NCT00027573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542835|NCT00027573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542836|NCT00027573|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92542838|NCT00027573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92542839|NCT00027573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542840|NCT00027573|Antimetabolites|antimetabolites|mesh-ancestor
92542841|NCT00027573|Dermatologic Agents|dermatologic agents|mesh-ancestor
92542842|NCT00027573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542843|NCT00027573|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92542844|NCT00027573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92542845|NCT00027573|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92542846|NCT00027612|Irinotecan|irinotecan|mesh-list
92542847|NCT00027612|Carmustine|carmustine|mesh-list
92542848|NCT00027612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542849|NCT00027612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542850|NCT00027612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542851|NCT00027612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542852|NCT00027612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542853|NCT00027612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542854|NCT00027612|Alkylating Agents|alkylating agents|mesh-ancestor
92542855|NCT00027690|Gefitinib|gefitinib|mesh-list
92542856|NCT00027690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542857|NCT00027690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542858|NCT00027690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542859|NCT00027690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542860|NCT00027768|Ethiodized Oil|ethiodized oil|mesh-list
92542861|NCT00027768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542862|NCT00027807|Aldesleukin|aldesleukin|mesh-list
92542863|NCT00027807|Molgramostim|molgramostim|mesh-list
92542864|NCT00027807|Sargramostim|sargramostim|mesh-list
92542865|NCT00027807|Immunologic Factors|immunologic factors|mesh-ancestor
92542866|NCT00027807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542867|NCT00027807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267594|NCT04226495|Sufentanil|sufentanil|mesh-list
92542868|NCT00027807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92542869|NCT00027807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92542870|NCT00027807|Antiviral Agents|antiviral agents|mesh-ancestor
92542871|NCT00027807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542872|NCT00392522|Nitrous Oxide|nitrous oxide|mesh-list
92542873|NCT00392522|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92534131|NCT04488081|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92534132|NCT04488081|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92534133|NCT04488081|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92534134|NCT04488081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92542874|NCT00392522|Anesthetics, General|anesthetics, general|mesh-ancestor
92542875|NCT00392522|Anesthetics|anesthetics|mesh-ancestor
92542876|NCT00392522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542877|NCT00392522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542878|NCT00392522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92542879|NCT00392522|Analgesics|analgesics|mesh-ancestor
92542880|NCT00392522|Sensory System Agents|sensory system agents|mesh-ancestor
92542881|NCT00392522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542882|NCT00027885|Cyclophosphamide|cyclophosphamide|mesh-list
92542883|NCT00027885|Bevacizumab|bevacizumab|mesh-list
92542884|NCT00027885|Docetaxel|docetaxel|mesh-list
92542885|NCT00027885|Doxorubicin|doxorubicin|mesh-list
92542886|NCT00027885|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92542887|NCT00027885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542888|NCT00027885|Immunologic Factors|immunologic factors|mesh-ancestor
92542889|NCT00027885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542890|NCT00027885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542899|NCT00027885|Growth Substances|growth substances|mesh-ancestor
92542900|NCT00027885|Growth Inhibitors|growth inhibitors|mesh-ancestor
92542901|NCT00027885|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542902|NCT00027885|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542903|NCT00027885|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542904|NCT00027885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542905|NCT00027885|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542906|NCT00027885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542907|NCT00027885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542908|NCT00027924|Cyclosporine|cyclosporine|mesh-list
92542909|NCT00027924|Methotrexate|methotrexate|mesh-list
92542910|NCT00027924|Fludarabine phosphate|fludarabine phosphate|mesh-list
92542911|NCT00027924|Fludarabine|fludarabine|mesh-list
92542912|NCT00027924|Busulfan|busulfan|mesh-list
92542913|NCT00027924|Cyclosporins|cyclosporins|mesh-list
92542914|NCT00027924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92542915|NCT00027924|Abortifacient Agents|abortifacient agents|mesh-ancestor
92542916|NCT00027924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92542917|NCT00027924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542918|NCT00027924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542919|NCT00027924|Antimetabolites|antimetabolites|mesh-ancestor
92542920|NCT00027924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542921|NCT00027924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542922|NCT00027924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92542923|NCT00027924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542924|NCT00027924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92542925|NCT00027924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542926|NCT00027924|Immunologic Factors|immunologic factors|mesh-ancestor
92542927|NCT00027924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542928|NCT00027924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92542929|NCT00027924|Antifungal Agents|antifungal agents|mesh-ancestor
92542930|NCT00027924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542931|NCT00027924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92542932|NCT00027924|Alkylating Agents|alkylating agents|mesh-ancestor
92542933|NCT00027924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542934|NCT00027924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542935|NCT04022876|Carboplatin|carboplatin|mesh-list
92542936|NCT04022876|Pemetrexed|pemetrexed|mesh-list
92542937|NCT04022876|Topotecan|topotecan|mesh-list
92542938|NCT04022876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542939|NCT04022876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542940|NCT04022876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542941|NCT04022876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92542942|NCT04022876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92542943|NCT04022876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542944|NCT04022876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542946|NCT00027963|Analgesics|analgesics|mesh-ancestor
92542947|NCT00027963|Sensory System Agents|sensory system agents|mesh-ancestor
92542948|NCT00027963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542949|NCT00027963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542950|NCT00027963|Anticonvulsants|anticonvulsants|mesh-ancestor
92542951|NCT00027963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92534135|NCT04488081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92542952|NCT00027963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92542953|NCT00027963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542954|NCT00027963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542955|NCT00027963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92542956|NCT00027963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92542957|NCT00027963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542981|NCT03960125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92542982|NCT03960125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542983|NCT03960125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92542984|NCT03960125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542985|NCT03960125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542986|NCT00395655|Hydralazine|hydralazine|mesh-list
92542987|NCT00395655|Valproic Acid|valproic acid|mesh-list
92542988|NCT00395655|Anticonvulsants|anticonvulsants|mesh-ancestor
92542989|NCT00395655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542990|NCT00395655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542991|NCT00395655|GABA Agents|gaba agents|mesh-ancestor
92542992|NCT00395655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542993|NCT00395655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542994|NCT00395655|Antimanic Agents|antimanic agents|mesh-ancestor
92542995|NCT00395655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92542996|NCT00395655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542997|NCT00395655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542998|NCT00395655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92542999|NCT00395655|Vasodilator Agents|vasodilator agents|mesh-ancestor
92543000|NCT00392561|Vitamin E|vitamin e|mesh-list
92543001|NCT00392561|Selenium|selenium|mesh-list
92543002|NCT00392561|Vitamins|vitamins|mesh-ancestor
92543003|NCT00392561|Micronutrients|micronutrients|mesh-ancestor
92543004|NCT00392561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543005|NCT00392561|Antioxidants|antioxidants|mesh-ancestor
92543006|NCT00392561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543007|NCT00392561|Protective Agents|protective agents|mesh-ancestor
92543008|NCT00392561|Trace Elements|trace elements|mesh-ancestor
92543009|NCT00028275|Interferons|interferons|mesh-list
92543028|NCT03959969|Narcotics|narcotics|mesh-ancestor
92543029|NCT03959969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543031|NCT00028314|Lopinavir|lopinavir|mesh-list
92543032|NCT00028314|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92543033|NCT00028314|Nevirapine|nevirapine|mesh-list
92543034|NCT00028314|Abacavir|abacavir|mesh-list
92543035|NCT00028314|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92543036|NCT00028314|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92543037|NCT00028314|Protease Inhibitors|protease inhibitors|mesh-ancestor
92543038|NCT00028314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543039|NCT00028314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543040|NCT00028314|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92543041|NCT00028314|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92543042|NCT00028314|Antiviral Agents|antiviral agents|mesh-ancestor
92543043|NCT00028314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543044|NCT00028314|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92543045|NCT00028314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92543046|NCT00028314|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92543047|NCT00028314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92543048|NCT00028314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92543049|NCT00028314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92543050|NCT00028353|Toremifene|toremifene|mesh-list
92543051|NCT00028353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543052|NCT00028353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543053|NCT00028353|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92543054|NCT00028353|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92543055|NCT00028353|Hormone Antagonists|hormone antagonists|mesh-ancestor
92543056|NCT00028353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543057|NCT00028353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543058|NCT00028353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92543059|NCT03959852|Fentanyl|fentanyl|mesh-list
92543060|NCT03959852|Ketamine|ketamine|mesh-list
92543061|NCT03959852|Analgesics|analgesics|mesh-ancestor
92543062|NCT03959852|Sensory System Agents|sensory system agents|mesh-ancestor
92543063|NCT03959852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543064|NCT03959852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543065|NCT03959852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91950580|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
92534136|NCT00065767|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92534137|NCT00065767|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92534138|NCT00065767|Hormone Antagonists|hormone antagonists|mesh-ancestor
92543090|NCT00028587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543091|NCT00028587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543092|NCT00028587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543093|NCT00028587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543094|NCT04733196|Chlorhexidine|chlorhexidine|mesh-list
92543095|NCT04733196|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92543096|NCT04733196|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92543097|NCT04733196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92543098|NCT04733196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543099|NCT04733196|Disinfectants|disinfectants|mesh-ancestor
92543100|NCT04733196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92543101|NCT00028665|Cyclophosphamide|cyclophosphamide|mesh-list
92543102|NCT00028665|Carmustine|carmustine|mesh-list
92543103|NCT00028665|Rituximab|rituximab|mesh-list
92543104|NCT00028665|Etoposide|etoposide|mesh-list
92543105|NCT00028665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543106|NCT00028665|Immunologic Factors|immunologic factors|mesh-ancestor
92543107|NCT00028665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543108|NCT00028665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543109|NCT00028665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92543110|NCT00028665|Alkylating Agents|alkylating agents|mesh-ancestor
92543111|NCT00028665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543112|NCT00028665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543113|NCT00028665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92543114|NCT00028665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543115|NCT00028665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543116|NCT00028665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92543124|NCT03959540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543125|NCT03959540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543126|NCT03959540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543127|NCT03959540|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92543128|NCT03959540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543129|NCT00028743|Paclitaxel|paclitaxel|mesh-list
92543130|NCT00028743|Carboplatin|carboplatin|mesh-list
92543131|NCT00028743|Topotecan|topotecan|mesh-list
92543132|NCT00028743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543133|NCT00028743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543134|NCT00028743|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543135|NCT00028743|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543136|NCT00028743|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543137|NCT00028743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543138|NCT00028743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92543139|NCT00028743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92543140|NCT00028743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543141|NCT03959501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92543142|NCT03959501|Dapagliflozin|dapagliflozin|mesh-list
92543143|NCT03959501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92543144|NCT03959501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543145|NCT03959501|Incretins|incretins|mesh-ancestor
92543146|NCT03959501|Hormones|hormones|mesh-ancestor
92543147|NCT03959501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543148|NCT03959501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92543149|NCT03959501|Protease Inhibitors|protease inhibitors|mesh-ancestor
92543150|NCT03959501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543151|NCT03959501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543152|NCT03959501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92543153|NCT00028782|Etanidazole|etanidazole|mesh-list
92543154|NCT00028782|Imidazole|imidazole|mesh-list
92543155|NCT00028782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543156|NCT00028782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543157|NCT00028782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543158|NCT00028821|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92543159|NCT00028821|Estradiol|estradiol|mesh-list
92543160|NCT00028821|Estrogens|estrogens|mesh-ancestor
92543161|NCT00028821|Hormones|hormones|mesh-ancestor
92543162|NCT00028821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543163|NCT00028821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543164|NCT00028821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543165|NCT00028821|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534139|NCT00065767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354313|NCT02914158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534140|NCT00065767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534141|NCT00065767|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92534142|NCT00065767|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92543166|NCT00028821|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543167|NCT00028821|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543168|NCT00028821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543169|NCT03959384|Poractant alfa|poractant alfa|mesh-list
92267898|NCT05442411|Analgesics|analgesics|mesh-ancestor
92543170|NCT03959384|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92543171|NCT03959384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92543172|NCT00028860|Paclitaxel|paclitaxel|mesh-list
92543173|NCT00028860|Carboplatin|carboplatin|mesh-list
92543174|NCT00028860|Gemcitabine|gemcitabine|mesh-list
92543175|NCT00028860|Ifosfamide|ifosfamide|mesh-list
92543176|NCT00028860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543177|NCT00028860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543178|NCT00028860|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543179|NCT00028860|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543180|NCT00028860|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543181|NCT00028860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543182|NCT00028860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543183|NCT00028860|Antimetabolites|antimetabolites|mesh-ancestor
92543184|NCT00028860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92543185|NCT00028860|Alkylating Agents|alkylating agents|mesh-ancestor
92543224|NCT00029250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950758|NCT02455076|Hormones|hormones|mesh-ancestor
92543241|NCT00029328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543242|NCT00029328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543243|NCT00029328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543244|NCT00029328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543245|NCT00029328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92543246|NCT00029328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543247|NCT00029328|Immunologic Factors|immunologic factors|mesh-ancestor
92543248|NCT00029523|Cytarabine|cytarabine|mesh-list
92543249|NCT00029523|Methotrexate|methotrexate|mesh-list
92543250|NCT00029523|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92543251|NCT00029523|Abortifacient Agents|abortifacient agents|mesh-ancestor
92543252|NCT00029523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92543253|NCT00029523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543254|NCT00029523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543255|NCT00029523|Antimetabolites|antimetabolites|mesh-ancestor
92543256|NCT00029523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543257|NCT00029523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543258|NCT00029523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92543259|NCT00029523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543260|NCT00029523|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92543261|NCT00029523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543262|NCT00029523|Immunologic Factors|immunologic factors|mesh-ancestor
92543263|NCT00029523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543264|NCT00029523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92543265|NCT00029523|Antiviral Agents|antiviral agents|mesh-ancestor
92543266|NCT00029523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543267|NCT00392717|Atorvastatin|atorvastatin|mesh-list
92543268|NCT00392717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92543269|NCT00392717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92543270|NCT00392717|Antimetabolites|antimetabolites|mesh-ancestor
92543271|NCT00392717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543272|NCT00392717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92543273|NCT00392717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92543274|NCT00392717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543275|NCT00029679|Borage oil|borage oil|mesh-list
92543276|NCT00029679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543277|NCT03958799|Vaccines|vaccines|mesh-list
92543278|NCT03958799|Immunologic Factors|immunologic factors|mesh-ancestor
92543279|NCT03958799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543280|NCT00029757|Estrogens|estrogens|mesh-list
92543281|NCT00029757|Hormones|hormones|mesh-ancestor
92543282|NCT00029757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534143|NCT00065767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92534144|NCT00065884|Valproic Acid|valproic acid|mesh-list
92543283|NCT00029757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543296|NCT00029835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543298|NCT00395772|Vitamin K|vitamin k|mesh-list
92543299|NCT00395772|Heparin|heparin|mesh-list
92543300|NCT00395772|Rivaroxaban|rivaroxaban|mesh-list
92543301|NCT00395772|Vitamins|vitamins|mesh-ancestor
92543302|NCT00395772|Micronutrients|micronutrients|mesh-ancestor
92543303|NCT00395772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543304|NCT00395772|Anticoagulants|anticoagulants|mesh-ancestor
92543305|NCT00395772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92543306|NCT00395772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92543307|NCT00395772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543308|NCT00395772|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92543309|NCT00395772|Antithrombins|antithrombins|mesh-ancestor
92543310|NCT00395772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92543311|NCT00395772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92543312|NCT00395772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543313|NCT00395772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92543314|NCT00395772|Hemostatics|hemostatics|mesh-ancestor
92543315|NCT00395772|Coagulants|coagulants|mesh-ancestor
92543316|NCT00029874|Minocycline|minocycline|mesh-list
92543317|NCT00029874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92543318|NCT00029874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543319|NCT00030030|Silymarin|silymarin|mesh-list
92543320|NCT00030030|Antioxidants|antioxidants|mesh-ancestor
92543321|NCT00030030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543322|NCT00030030|Protective Agents|protective agents|mesh-ancestor
92543323|NCT00030030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543325|NCT00030069|Dexamethasone|dexamethasone|mesh-list
92543326|NCT00030069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543327|NCT00030069|Antiemetics|antiemetics|mesh-ancestor
92543328|NCT00030069|Autonomic Agents|autonomic agents|mesh-ancestor
92543329|NCT00030069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543330|NCT00030069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543331|NCT00030069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92543332|NCT00030069|Glucocorticoids|glucocorticoids|mesh-ancestor
92543333|NCT00030069|Hormones|hormones|mesh-ancestor
92543334|NCT00030069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543335|NCT00030069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543336|NCT00030069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543337|NCT00030069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92543338|NCT00030069|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92543339|NCT00030069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92543340|NCT00030069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543341|NCT00030069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92543342|NCT00030069|Vitamins|vitamins|mesh-ancestor
92543343|NCT00030069|Micronutrients|micronutrients|mesh-ancestor
92543344|NCT00030069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92543345|NCT03958097|Antibodies|antibodies|mesh-list
92543346|NCT03958097|Immunologic Factors|immunologic factors|mesh-ancestor
92543367|NCT00030420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543368|NCT00030420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543369|NCT00030420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543370|NCT00030420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543371|NCT00030420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92543372|NCT00030420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92543373|NCT00030420|Analgesics|analgesics|mesh-ancestor
92543374|NCT00030420|Sensory System Agents|sensory system agents|mesh-ancestor
92543375|NCT00030420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543376|NCT00030420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543377|NCT00030420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543378|NCT00030420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543379|NCT00030420|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92543380|NCT00030420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92543381|NCT00030420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543382|NCT00030459|Vinorelbine|vinorelbine|mesh-list
92543383|NCT00030459|Mitomycins|mitomycins|mesh-list
92543384|NCT00030459|Mitomycin|mitomycin|mesh-list
92543385|NCT00030459|Vinblastine|vinblastine|mesh-list
92543386|NCT00030459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543387|NCT00030459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543388|NCT00030459|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543389|NCT00030459|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534145|NCT00065884|Anticonvulsants|anticonvulsants|mesh-ancestor
92534146|NCT00065884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534147|NCT00065884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534148|NCT00065884|GABA Agents|gaba agents|mesh-ancestor
92534149|NCT00065884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534150|NCT00065884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543390|NCT00030459|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543391|NCT00030459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543392|NCT00030459|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92543393|NCT00030459|Alkylating Agents|alkylating agents|mesh-ancestor
92543394|NCT00030459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92543395|NCT00030459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543396|NCT00030498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92543397|NCT00030498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268128|NCT04338711|Tofacitinib|tofacitinib|mesh-list
92543399|NCT00030498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543400|NCT00030498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543401|NCT03873857|Venetoclax|venetoclax|mesh-list
92543402|NCT03873857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543403|NCT03866408|Pioglitazone|pioglitazone|mesh-list
92543413|NCT00030576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92543414|NCT00030576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543415|NCT00030576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543416|NCT00030615|Decitabine|decitabine|mesh-list
92543417|NCT00030615|Azacitidine|azacitidine|mesh-list
92543418|NCT00030615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543419|NCT00030615|Antimetabolites|antimetabolites|mesh-ancestor
92543420|NCT00030615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543421|NCT00030615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543422|NCT00030615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543423|NCT03857087|Edetic Acid|edetic acid|mesh-list
92543424|NCT03857087|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92543425|NCT03857087|Chelating Agents|chelating agents|mesh-ancestor
92543426|NCT03857087|Sequestering Agents|sequestering agents|mesh-ancestor
92543427|NCT03857087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543428|NCT03857087|Anticoagulants|anticoagulants|mesh-ancestor
92543429|NCT03857087|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92543430|NCT03857087|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92543431|NCT00030654|Ketoconazole|ketoconazole|mesh-list
92543432|NCT00030654|Vinblastine|vinblastine|mesh-list
92543433|NCT00030654|Docetaxel|docetaxel|mesh-list
92543434|NCT00030654|Doxorubicin|doxorubicin|mesh-list
92543435|NCT00030654|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92543436|NCT00030654|Bicalutamide|bicalutamide|mesh-list
92543437|NCT00030654|Flutamide|flutamide|mesh-list
92543438|NCT00030654|Estramustine|estramustine|mesh-list
92543439|NCT00030654|Hormones|hormones|mesh-list
92543440|NCT00030654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543441|NCT00030654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543442|NCT00030654|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543443|NCT00030654|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543444|NCT00030654|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543445|NCT00030654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543446|NCT00030654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92543447|NCT00030654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92543448|NCT00030654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92543449|NCT00030654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543450|NCT00030654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543451|NCT00030654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543452|NCT00030654|Antifungal Agents|antifungal agents|mesh-ancestor
92543453|NCT00030654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543454|NCT00030654|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92543455|NCT00030654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92543456|NCT00030654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92543457|NCT00030654|Hormone Antagonists|hormone antagonists|mesh-ancestor
92543458|NCT00030654|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92543459|NCT00030654|Androgen Antagonists|androgen antagonists|mesh-ancestor
92543460|NCT00030654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543461|NCT00030654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92534151|NCT00065884|Antimanic Agents|antimanic agents|mesh-ancestor
92534152|NCT00065884|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92534153|NCT00065884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534154|NCT00065884|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534156|NCT00065923|Anticonvulsants|anticonvulsants|mesh-ancestor
92534157|NCT00065923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92354324|NCT03136146|Ofatumumab|ofatumumab|mesh-list
92534158|NCT00065923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534159|NCT00065962|Secretin|secretin|mesh-list
92543462|NCT00030654|Alkylating Agents|alkylating agents|mesh-ancestor
92543463|NCT03852407|Cyclophosphamide|cyclophosphamide|mesh-list
92543464|NCT03852407|Melphalan|melphalan|mesh-list
92543465|NCT03852407|Fludarabine|fludarabine|mesh-list
92543466|NCT03852407|Thymoglobulin|thymoglobulin|mesh-list
92543467|NCT03852407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543468|NCT03852407|Immunologic Factors|immunologic factors|mesh-ancestor
92543469|NCT03852407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543489|NCT03823274|Sensory System Agents|sensory system agents|mesh-ancestor
92543490|NCT03823274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543491|NCT03823274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543492|NCT03823274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543493|NCT03823274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543494|NCT03823274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92543495|NCT03823274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92543496|NCT03823274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543497|NCT03823274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92543498|NCT03823274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92543499|NCT03823274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543500|NCT03823274|Antipyretics|antipyretics|mesh-ancestor
92543501|NCT03823274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92543502|NCT03823274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92543503|NCT03823274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92543504|NCT03823274|Purinergic Agents|purinergic agents|mesh-ancestor
92543505|NCT03823274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543506|NCT00030732|Gemcitabine|gemcitabine|mesh-list
92543507|NCT00030732|Capecitabine|capecitabine|mesh-list
92543508|NCT00030732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543509|NCT00030732|Antimetabolites|antimetabolites|mesh-ancestor
92543510|NCT00030732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543511|NCT00030732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543512|NCT00030810|Docetaxel|docetaxel|mesh-list
92543513|NCT00030810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543514|NCT00030810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543515|NCT00030810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543516|NCT00030810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543517|NCT00030810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543518|NCT00030849|Interferons|interferons|mesh-list
92543519|NCT00030849|Interferon-alpha|interferon-alpha|mesh-list
92543520|NCT00030849|Bexarotene|bexarotene|mesh-list
92543521|NCT00030849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543522|NCT00030849|Antiviral Agents|antiviral agents|mesh-ancestor
92543523|NCT00030849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543524|NCT00030849|Immunologic Factors|immunologic factors|mesh-ancestor
92543525|NCT00030849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543526|NCT00030888|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92543542|NCT00031044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543543|NCT00031044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92543544|NCT00031044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92543545|NCT00031044|Antiviral Agents|antiviral agents|mesh-ancestor
92268274|NCT00367965|Eszopiclone|eszopiclone|mesh-list
92543546|NCT00031044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543547|NCT03698006|Ropivacaine|ropivacaine|mesh-list
92543548|NCT03698006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92543549|NCT03698006|Anesthetics, Local|anesthetics, local|mesh-ancestor
92543550|NCT03698006|Anesthetics|anesthetics|mesh-ancestor
92543551|NCT03698006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543552|NCT03698006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543553|NCT03698006|Sensory System Agents|sensory system agents|mesh-ancestor
92543554|NCT03698006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543555|NCT00031083|Interferons|interferons|mesh-list
92534160|NCT00065962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92534161|NCT00065962|Hormones|hormones|mesh-ancestor
92534162|NCT00065962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534163|NCT00065962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534164|NCT05083754|Temozolomide|temozolomide|mesh-list
92534165|NCT05083754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92543556|NCT00031083|Interferon-beta|interferon-beta|mesh-list
92543557|NCT00031083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543558|NCT00031083|Antiviral Agents|antiviral agents|mesh-ancestor
92543559|NCT00031083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543560|NCT00031083|Immunologic Factors|immunologic factors|mesh-ancestor
92543561|NCT00031083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543562|NCT03559985|Acetaminophen|acetaminophen|mesh-list
92543563|NCT03559985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92543564|NCT03559985|Analgesics|analgesics|mesh-ancestor
92543565|NCT03559985|Sensory System Agents|sensory system agents|mesh-ancestor
92543566|NCT03559985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543567|NCT03559985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543568|NCT03559985|Antipyretics|antipyretics|mesh-ancestor
92543569|NCT04711863|Fluvoxamine|fluvoxamine|mesh-list
92543570|NCT04711863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92543571|NCT04711863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92543572|NCT04711863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543573|NCT04711863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543574|NCT04711863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92543575|NCT04711863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92543576|NCT04711863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92543577|NCT04711863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92543578|NCT04711863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543579|NCT04711863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543580|NCT04711863|Serotonin Agents|serotonin agents|mesh-ancestor
92543581|NCT04711863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92543582|NCT04711863|Antidepressive Agents|antidepressive agents|mesh-ancestor
92543583|NCT04711863|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92543601|NCT04712058|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92543602|NCT04712058|Antiviral Agents|antiviral agents|mesh-ancestor
92543603|NCT04712058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543604|NCT04712058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92543605|NCT04712058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92543606|NCT04712058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543607|NCT04712058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543608|NCT04712058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92543609|NCT04712058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92543610|NCT00393107|Cyclophosphamide|cyclophosphamide|mesh-list
92543611|NCT00393107|Rituximab|rituximab|mesh-list
92543612|NCT00393107|Fludarabine|fludarabine|mesh-list
92543613|NCT00393107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543614|NCT00393107|Immunologic Factors|immunologic factors|mesh-ancestor
92543615|NCT00393107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543616|NCT00393107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543617|NCT00393107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92543618|NCT00393107|Alkylating Agents|alkylating agents|mesh-ancestor
92543619|NCT00393107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543620|NCT00393107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543621|NCT00393107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92543622|NCT00393107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543623|NCT04711668|Lidocaine|lidocaine|mesh-list
92543624|NCT04711668|Ketamine|ketamine|mesh-list
92543625|NCT04711668|Anesthetics, Local|anesthetics, local|mesh-ancestor
92543626|NCT04711668|Anesthetics|anesthetics|mesh-ancestor
92543627|NCT04711668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543628|NCT04711668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543629|NCT04711668|Sensory System Agents|sensory system agents|mesh-ancestor
92543630|NCT04711668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543631|NCT04711668|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92543632|NCT04711668|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92543633|NCT04711668|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92534166|NCT05083754|Alkylating Agents|alkylating agents|mesh-ancestor
92534167|NCT05083754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543634|NCT04711668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92543635|NCT04711668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543636|NCT04711668|Analgesics|analgesics|mesh-ancestor
92543637|NCT04711668|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92543638|NCT04711668|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92543639|NCT04711668|Anesthetics, General|anesthetics, general|mesh-ancestor
92543640|NCT04711668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92543641|NCT04711668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92543662|NCT00031317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92354330|NCT03136146|Lenograstim|lenograstim|mesh-list
92543664|NCT00031317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92543665|NCT00031317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92543666|NCT00031317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92543667|NCT00031317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543668|NCT00031317|GABA Antagonists|gaba antagonists|mesh-ancestor
92543669|NCT00031317|GABA Agents|gaba agents|mesh-ancestor
92543670|NCT00396045|Lenalidomide|lenalidomide|mesh-list
92543671|NCT00396045|Immunologic Factors|immunologic factors|mesh-ancestor
92543672|NCT00396045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543673|NCT00396045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92543674|NCT00396045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92543675|NCT00396045|Growth Substances|growth substances|mesh-ancestor
92543676|NCT00396045|Growth Inhibitors|growth inhibitors|mesh-ancestor
92543677|NCT00396045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543678|NCT00396240|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92543679|NCT00396240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92543680|NCT00396240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92543681|NCT00396240|Antimetabolites|antimetabolites|mesh-ancestor
92543682|NCT00396240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543683|NCT00396240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92543684|NCT00396240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92543685|NCT00396240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543686|NCT00031395|Clonidine|clonidine|mesh-list
92543687|NCT00031395|Methylphenidate|methylphenidate|mesh-list
92543688|NCT00031395|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92543689|NCT00031395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543690|NCT00031395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92543691|NCT00031395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92543692|NCT00031395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92543716|NCT03152123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543717|NCT03152123|Appetite Depressants|appetite depressants|mesh-ancestor
92543718|NCT03152123|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92543719|NCT03152123|Sympathomimetics|sympathomimetics|mesh-ancestor
92543720|NCT03152123|Autonomic Agents|autonomic agents|mesh-ancestor
92543721|NCT03152123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543722|NCT03152123|Adrenergic Agents|adrenergic agents|mesh-ancestor
92543723|NCT03152123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543724|NCT03152123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543725|NCT00031473|Ribavirin|ribavirin|mesh-list
92543726|NCT00031473|Antimetabolites|antimetabolites|mesh-ancestor
92543727|NCT00031473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543728|NCT00031473|Antiviral Agents|antiviral agents|mesh-ancestor
92543729|NCT00031473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543730|NCT00031629|Gemcitabine|gemcitabine|mesh-list
92543731|NCT00031629|Docetaxel|docetaxel|mesh-list
92543732|NCT00031629|Lenograstim|lenograstim|mesh-list
92543733|NCT00031629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543734|NCT00031629|Antimetabolites|antimetabolites|mesh-ancestor
92543735|NCT00031629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543736|NCT00031629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543737|NCT00031629|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543738|NCT00031629|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543739|NCT00031629|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543740|NCT00031629|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92543741|NCT00031629|Immunologic Factors|immunologic factors|mesh-ancestor
92543742|NCT00031629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543776|NCT00031785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543777|NCT00031785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543778|NCT00031785|Appetite Stimulants|appetite stimulants|mesh-ancestor
92543779|NCT00031785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92534168|NCT05083754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534169|NCT00066001|Metronidazole|metronidazole|mesh-list
92534170|NCT00066001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534171|NCT00066001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92534172|NCT00066001|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92543780|NCT03151772|Metformin|metformin|mesh-list
92543781|NCT03151772|Disulfiram|disulfiram|mesh-list
92543801|NCT00031824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543802|NCT00031824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543803|NCT00031824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543804|NCT00031824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543805|NCT00031824|Immunologic Factors|immunologic factors|mesh-ancestor
92543806|NCT00031824|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92543807|NCT00031824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543808|NCT00031824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543809|NCT00031824|Antifungal Agents|antifungal agents|mesh-ancestor
92543810|NCT00031824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543811|NCT00031824|Dermatologic Agents|dermatologic agents|mesh-ancestor
92543812|NCT00031824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543814|NCT00031824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92543815|NCT00031824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92543816|NCT00031863|Rofecoxib|rofecoxib|mesh-list
92543817|NCT00031863|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92543818|NCT00031863|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92543819|NCT00031863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543820|NCT00031863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543821|NCT00031863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92543822|NCT00031863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92543823|NCT00031863|Analgesics|analgesics|mesh-ancestor
92543824|NCT00031863|Sensory System Agents|sensory system agents|mesh-ancestor
92543825|NCT00031863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543826|NCT00031863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543827|NCT00031863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543828|NCT00031863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543829|NCT03151616|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92543830|NCT03151616|Cholinergic Agents|cholinergic agents|mesh-ancestor
92543831|NCT03151616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543832|NCT03151616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543833|NCT03151616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543834|NCT00031902|Prednisolone|prednisolone|mesh-list
92543835|NCT00031902|Rituximab|rituximab|mesh-list
92543836|NCT00031902|Vincristine|vincristine|mesh-list
92543837|NCT00031902|Bleomycin|bleomycin|mesh-list
91951352|NCT03668639|Hormones|hormones|mesh-ancestor
92543852|NCT00031902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543853|NCT00031902|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92543854|NCT00031941|Lenalidomide|lenalidomide|mesh-list
92543855|NCT00031941|Immunologic Factors|immunologic factors|mesh-ancestor
92543856|NCT00031941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543857|NCT00031941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92543858|NCT00031941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92543859|NCT00031941|Growth Substances|growth substances|mesh-ancestor
92543860|NCT00031941|Growth Inhibitors|growth inhibitors|mesh-ancestor
92543861|NCT00031941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543862|NCT00031980|Cyclosporine|cyclosporine|mesh-list
92543863|NCT00031980|Cyclosporins|cyclosporins|mesh-list
92543864|NCT00031980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543865|NCT00031980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543866|NCT00031980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543867|NCT00031980|Immunologic Factors|immunologic factors|mesh-ancestor
92543868|NCT00031980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543869|NCT00031980|Antifungal Agents|antifungal agents|mesh-ancestor
92543870|NCT00031980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543871|NCT00031980|Dermatologic Agents|dermatologic agents|mesh-ancestor
92543872|NCT00031980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543873|NCT00031980|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92543874|NCT03151499|Rifampin|rifampin|mesh-list
92543875|NCT03151499|BI 409306|bi 409306|mesh-list
92543876|NCT03151499|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92543877|NCT03151499|Antitubercular Agents|antitubercular agents|mesh-ancestor
92543878|NCT03151499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92543879|NCT03151499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534173|NCT00066001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92534174|NCT00066157|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92543880|NCT03151499|Leprostatic Agents|leprostatic agents|mesh-ancestor
92543881|NCT03151499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92543882|NCT03151499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543883|NCT03151499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543884|NCT03151499|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92543885|NCT03151499|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92543886|NCT03151499|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92543887|NCT03151499|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92543888|NCT03151499|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92543889|NCT03151499|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92543890|NCT03151499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92543891|NCT00032019|Prednisone|prednisone|mesh-list
92543892|NCT00032019|Cyclophosphamide|cyclophosphamide|mesh-list
92543893|NCT00032019|Rituximab|rituximab|mesh-list
92543894|NCT00032019|Doxorubicin|doxorubicin|mesh-list
92543895|NCT00032019|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92543913|NCT00032019|Glucocorticoids|glucocorticoids|mesh-ancestor
92543914|NCT00032019|Hormones|hormones|mesh-ancestor
92268644|NCT04685499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543915|NCT00032019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543916|NCT00032019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543917|NCT00032019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543918|NCT00032019|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543919|NCT00032019|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543920|NCT00032019|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543921|NCT03151460|Dopamine|dopamine|mesh-list
92543922|NCT03151460|Dopamine Agents|dopamine agents|mesh-list
92543923|NCT03151460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92543924|NCT03151460|Sympathomimetics|sympathomimetics|mesh-ancestor
92543925|NCT03151460|Autonomic Agents|autonomic agents|mesh-ancestor
92543926|NCT03151460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543927|NCT03151460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543928|NCT03151460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543929|NCT03151460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543930|NCT03151460|Protective Agents|protective agents|mesh-ancestor
92543931|NCT00032097|Motexafin gadolinium|motexafin gadolinium|mesh-list
92543932|NCT00032097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543933|NCT00032097|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92543934|NCT00032097|Dermatologic Agents|dermatologic agents|mesh-ancestor
92543935|NCT03151382|Tandospirone|tandospirone|mesh-list
92543936|NCT03151382|Donepezil|donepezil|mesh-list
92543937|NCT03151382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543938|NCT03151382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92543939|NCT03151382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543940|NCT03151382|Cholinergic Agents|cholinergic agents|mesh-ancestor
92543941|NCT03151382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543942|NCT03151382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543943|NCT03151382|Nootropic Agents|nootropic agents|mesh-ancestor
92543944|NCT03151382|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92543945|NCT03151382|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92543946|NCT03151382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543947|NCT03151382|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92543948|NCT03151382|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92543949|NCT03151382|Serotonin Agents|serotonin agents|mesh-ancestor
92543950|NCT00032136|Tamoxifen|tamoxifen|mesh-list
92543951|NCT00032136|Exemestane|exemestane|mesh-list
91951450|NCT05162417|Methylene Blue|methylene blue|mesh-list
92543965|NCT03151343|Empagliflozin|empagliflozin|mesh-list
92543966|NCT03151343|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92543967|NCT03151343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543968|NCT03151343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92543969|NCT03151343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543970|NCT00032175|Gemcitabine|gemcitabine|mesh-list
92543971|NCT00032175|Capecitabine|capecitabine|mesh-list
92543972|NCT00032175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543973|NCT00032175|Antimetabolites|antimetabolites|mesh-ancestor
92543974|NCT00032175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543975|NCT00032175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543976|NCT04712279|Hydroxychloroquine|hydroxychloroquine|mesh-list
92543977|NCT04712279|Ivermectin|ivermectin|mesh-list
92534175|NCT00066157|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92534176|NCT00066157|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92543978|NCT04712279|Antimalarials|antimalarials|mesh-ancestor
92543979|NCT04712279|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92543980|NCT04712279|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92543981|NCT04712279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543982|NCT04712279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543983|NCT04712279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543984|NCT04712279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543985|NCT00032292|Visilizumab|visilizumab|mesh-list
92543986|NCT00032292|Immunologic Factors|immunologic factors|mesh-ancestor
92543987|NCT00032292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543988|NCT03150914|Sirolimus|sirolimus|mesh-list
92543989|NCT03150914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92543990|NCT03150914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543991|NCT03150914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92543992|NCT03150914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543993|NCT03150914|Antifungal Agents|antifungal agents|mesh-ancestor
92543994|NCT03150914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543995|NCT03150914|Immunologic Factors|immunologic factors|mesh-ancestor
92543996|NCT03150914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543997|NCT00032799|Natalizumab|natalizumab|mesh-list
92543998|NCT00032799|Immunologic Factors|immunologic factors|mesh-ancestor
92543999|NCT00032799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544000|NCT03150836|Durvalumab|durvalumab|mesh-list
92544001|NCT03150836|Tremelimumab|tremelimumab|mesh-list
92544002|NCT03150836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92544003|NCT03150836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544004|NCT00032838|Yohimbine|yohimbine|mesh-list
92544005|NCT00032838|Mydriatics|mydriatics|mesh-ancestor
92544006|NCT00032838|Autonomic Agents|autonomic agents|mesh-ancestor
92544007|NCT00032838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544008|NCT00032838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544009|NCT00032838|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92544010|NCT00032838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92544022|NCT03150680|Clopidogrel|clopidogrel|mesh-list
92544023|NCT03150680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92544024|NCT03150680|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92544025|NCT03150680|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92544026|NCT03150680|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92544027|NCT03150680|Purinergic Agents|purinergic agents|mesh-ancestor
92544028|NCT03150680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544029|NCT03150680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544030|NCT03150680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544031|NCT00396396|Acetylcysteine|acetylcysteine|mesh-list
92544032|NCT00396396|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92544033|NCT00396396|Antiviral Agents|antiviral agents|mesh-ancestor
92544034|NCT00396396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544035|NCT00396396|Expectorants|expectorants|mesh-ancestor
92544036|NCT00396396|Respiratory System Agents|respiratory system agents|mesh-ancestor
92544037|NCT00396396|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92544038|NCT00396396|Antioxidants|antioxidants|mesh-ancestor
92544039|NCT00396396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544040|NCT00396396|Protective Agents|protective agents|mesh-ancestor
92544041|NCT00396396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544042|NCT00396396|Antidotes|antidotes|mesh-ancestor
92544043|NCT00032955|Buprenorphine|buprenorphine|mesh-list
92544044|NCT00032955|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92544045|NCT00032955|Naloxone|naloxone|mesh-list
92544046|NCT00032955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92544047|NCT00032955|Narcotics|narcotics|mesh-ancestor
92544048|NCT00032955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544049|NCT00032955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544050|NCT00032955|Analgesics|analgesics|mesh-ancestor
92544051|NCT00032955|Sensory System Agents|sensory system agents|mesh-ancestor
92544052|NCT00032955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544053|NCT00032955|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92544054|NCT03150524|Verapamil|verapamil|mesh-list
92544055|NCT03150524|Nimodipine|nimodipine|mesh-list
92544056|NCT03150524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92544057|NCT03150524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92544058|NCT03150524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544059|NCT03150524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544060|NCT03150524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534178|NCT00066157|Estradiol|estradiol|mesh-list
92534179|NCT00066157|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92544061|NCT03150524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544062|NCT03150524|Vasodilator Agents|vasodilator agents|mesh-ancestor
92544063|NCT03150524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92544064|NCT00033033|Reserpine|reserpine|mesh-list
92544065|NCT00033033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92544066|NCT00033033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92544067|NCT00033033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92544068|NCT00033033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544069|NCT00033033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544070|NCT00033033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544071|NCT00033033|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92544072|NCT00033033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92544087|NCT00033072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92544088|NCT00033072|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92544089|NCT00033072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544090|NCT00033072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544091|NCT00033072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92544092|NCT00033072|Protective Agents|protective agents|mesh-ancestor
92544093|NCT00033072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544094|NCT03150290|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92544095|NCT03150290|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92544096|NCT03150290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544098|NCT00033111|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92544099|NCT00033111|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92544100|NCT00033111|Dopamine Agonists|dopamine agonists|mesh-ancestor
92544101|NCT00033111|Dopamine Agents|dopamine agents|mesh-ancestor
92544102|NCT00033111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544103|NCT00033111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544104|NCT00033111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544105|NCT00033189|Ubiquinone|ubiquinone|mesh-list
92544106|NCT00033189|Coenzyme Q10|coenzyme q10|mesh-list
92544107|NCT00033189|Micronutrients|micronutrients|mesh-ancestor
92544108|NCT00033189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544109|NCT00033189|Vitamins|vitamins|mesh-ancestor
92544110|NCT00033267|Sirolimus|sirolimus|mesh-list
92544111|NCT00033267|Temsirolimus|temsirolimus|mesh-list
92544112|NCT00033267|MTOR Inhibitors|mtor inhibitors|mesh-list
92544113|NCT00033267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92544114|NCT00033267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544115|NCT00033267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544116|NCT00033267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544117|NCT00033267|Immunologic Factors|immunologic factors|mesh-ancestor
92544118|NCT00033267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544119|NCT00033267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544120|NCT00033267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92544121|NCT00033267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544122|NCT00033267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92544123|NCT00033267|Antifungal Agents|antifungal agents|mesh-ancestor
92544124|NCT00033306|Irinotecan|irinotecan|mesh-list
92544125|NCT00033306|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92544126|NCT00033306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92544127|NCT00033306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544128|NCT00033306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544129|NCT00033306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544130|NCT02984384|Aspirin|aspirin|mesh-list
92544131|NCT02984384|Heparin|heparin|mesh-list
92544132|NCT02984384|Enoxaparin|enoxaparin|mesh-list
92544133|NCT02984384|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92544146|NCT02984384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544148|NCT02984384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92544149|NCT02984384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544150|NCT02984384|Antipyretics|antipyretics|mesh-ancestor
92544151|NCT02984384|Anticoagulants|anticoagulants|mesh-ancestor
92544152|NCT00033345|Indole-3-carbinol|indole-3-carbinol|mesh-list
92544153|NCT00033345|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92544154|NCT00033345|Protective Agents|protective agents|mesh-ancestor
92544155|NCT00033345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544156|NCT00033345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544157|NCT00033423|Rituximab|rituximab|mesh-list
92544158|NCT00033423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534180|NCT00066157|Estrogens|estrogens|mesh-list
92534181|NCT00066157|Progesterone|progesterone|mesh-list
92534182|NCT00066157|Hormones|hormones|mesh-ancestor
92534183|NCT00066157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534184|NCT00066157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544159|NCT00033423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544160|NCT00033423|Immunologic Factors|immunologic factors|mesh-ancestor
92544161|NCT00033423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544162|NCT00033423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544163|NCT00033462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92544164|NCT00033462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544165|NCT00033462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92544166|NCT00033462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544167|NCT00033462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544168|NCT00393263|Clobetasol|clobetasol|mesh-list
92544169|NCT00393263|Pimecrolimus|pimecrolimus|mesh-list
92544170|NCT00393263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544171|NCT00393263|Glucocorticoids|glucocorticoids|mesh-ancestor
92544172|NCT00393263|Hormones|hormones|mesh-ancestor
92544173|NCT00393263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544174|NCT00393263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544175|NCT00393263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92544176|NCT00393263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544177|NCT00393263|Analgesics|analgesics|mesh-ancestor
92544178|NCT00393263|Sensory System Agents|sensory system agents|mesh-ancestor
92544179|NCT00393263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544180|NCT00393263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544181|NCT00393263|Dermatologic Agents|dermatologic agents|mesh-ancestor
92544182|NCT00393263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544183|NCT00393263|Immunologic Factors|immunologic factors|mesh-ancestor
92544184|NCT00393263|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92544185|NCT00393263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544186|NCT00393263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544187|NCT00033618|Epothilones|epothilones|mesh-list
92544188|NCT00033618|Epothilone B|epothilone b|mesh-list
92544189|NCT00033618|Tubulin Modulators|tubulin modulators|mesh-ancestor
92544190|NCT00033618|Antimitotic Agents|antimitotic agents|mesh-ancestor
92544191|NCT00033618|Mitosis Modulators|mitosis modulators|mesh-ancestor
92544192|NCT00033618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544193|NCT00033618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544194|NCT00033696|Paclitaxel|paclitaxel|mesh-list
92544195|NCT00033696|Etoposide|etoposide|mesh-list
92544196|NCT00033696|Carboplatin|carboplatin|mesh-list
92544207|NCT00033696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92544209|NCT02548559|Anticonvulsants|anticonvulsants|mesh-ancestor
92544210|NCT00033735|Fluorouracil|fluorouracil|mesh-list
92544211|NCT00033735|Irofulven|irofulven|mesh-list
92544212|NCT00033735|Antimetabolites|antimetabolites|mesh-ancestor
92544213|NCT00033735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544214|NCT00033735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92544215|NCT00033735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268940|NCT03996057|Hormones|hormones|mesh-ancestor
92544216|NCT00033735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544217|NCT00033735|Immunologic Factors|immunologic factors|mesh-ancestor
92544218|NCT00033735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544219|NCT00033735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92544220|NCT00033735|Alkylating Agents|alkylating agents|mesh-ancestor
92544221|NCT00033813|Oxatomide|oxatomide|mesh-list
92544222|NCT00033813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92544223|NCT00033813|Histamine Antagonists|histamine antagonists|mesh-ancestor
92544224|NCT00033813|Histamine Agents|histamine agents|mesh-ancestor
92544225|NCT00033813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544226|NCT00033813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544227|NCT00033813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544228|NCT00033813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92354363|NCT05241132|Paclitaxel|paclitaxel|mesh-list
92544229|NCT00033813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92544230|NCT00033813|Respiratory System Agents|respiratory system agents|mesh-ancestor
92544231|NCT00033891|Infliximab|infliximab|mesh-list
92544232|NCT00033891|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92544233|NCT00033891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544234|NCT00033891|Dermatologic Agents|dermatologic agents|mesh-ancestor
92534185|NCT00066157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92534186|NCT00066157|Contraceptive Agents|contraceptive agents|mesh-ancestor
92534187|NCT00066157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92544235|NCT00033891|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544236|NCT00033891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544237|NCT02271893|Dextromethorphan|dextromethorphan|mesh-list
92544238|NCT02271893|Antitussive Agents|antitussive agents|mesh-ancestor
92544239|NCT02271893|Respiratory System Agents|respiratory system agents|mesh-ancestor
92544240|NCT02271893|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92544241|NCT02271893|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92544242|NCT02271893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544243|NCT02271893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544244|NCT02271893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544245|NCT02149823|Oxytocin|oxytocin|mesh-list
92544246|NCT02149823|Oxytocics|oxytocics|mesh-ancestor
92544247|NCT02149823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92544248|NCT02149823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544249|NCT02971410|Simvastatin|simvastatin|mesh-list
92544250|NCT02971410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92544251|NCT02971410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92544252|NCT02971410|Antimetabolites|antimetabolites|mesh-ancestor
92544253|NCT02971410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544254|NCT02971410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92544255|NCT02971410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92544256|NCT02971410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544257|NCT02035397|Botulinum Toxins|botulinum toxins|mesh-list
92544258|NCT02035397|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92544259|NCT02035397|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92544276|NCT00034086|Lamivudine|lamivudine|mesh-list
92544277|NCT00034086|Zidovudine|zidovudine|mesh-list
92544278|NCT00034086|Didanosine|didanosine|mesh-list
92544279|NCT00034086|Stavudine|stavudine|mesh-list
92544280|NCT00034086|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92544281|NCT00034086|Vaccines|vaccines|mesh-list
92544282|NCT00034086|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92544283|NCT00034086|Immunologic Factors|immunologic factors|mesh-ancestor
92544284|NCT00034086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544285|NCT00034086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92544286|NCT00034086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92544287|NCT00034086|Protease Inhibitors|protease inhibitors|mesh-ancestor
92544288|NCT00034086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544289|NCT00034086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544290|NCT00034086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92544291|NCT00034086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92544292|NCT00034086|Antiviral Agents|antiviral agents|mesh-ancestor
92544293|NCT00034086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544294|NCT00034086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92544295|NCT00034086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92544296|NCT00034086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92544297|NCT00034086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92544298|NCT00034086|Antimetabolites|antimetabolites|mesh-ancestor
92544300|NCT00034125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92544301|NCT00034125|Hormone Antagonists|hormone antagonists|mesh-ancestor
92544302|NCT00034125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544303|NCT00034125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544304|NCT00034125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92544305|NCT00034125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544306|NCT00034125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92544307|NCT00034125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92544308|NCT00034125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92544309|NCT00034164|Paclitaxel|paclitaxel|mesh-list
92544310|NCT00034164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92544311|NCT00034164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544312|NCT00034164|Tubulin Modulators|tubulin modulators|mesh-ancestor
92544313|NCT00034164|Antimitotic Agents|antimitotic agents|mesh-ancestor
92544314|NCT00034164|Mitosis Modulators|mitosis modulators|mesh-ancestor
92544315|NCT00034164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544316|NCT00034242|Immunoglobulins|immunoglobulins|mesh-list
92544317|NCT00034242|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92544318|NCT00034242|Antibodies|antibodies|mesh-list
92534188|NCT00066157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92534190|NCT00066157|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92544368|NCT00034632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92544369|NCT00034632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92544370|NCT00034632|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92544371|NCT00034632|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92544372|NCT00034632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544373|NCT00034632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544374|NCT00034632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92544375|NCT00034632|Hormone Antagonists|hormone antagonists|mesh-ancestor
92544376|NCT00034632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544377|NCT00034632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544378|NCT00034671|Posaconazole|posaconazole|mesh-list
92544379|NCT00034671|Antifungal Agents|antifungal agents|mesh-ancestor
92544380|NCT00034671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544381|NCT00034671|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92544382|NCT00034671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92544383|NCT00034671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92544384|NCT00034671|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92544385|NCT00034671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92544386|NCT00034671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544387|NCT00034671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544388|NCT00034671|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92544389|NCT00034671|Hormone Antagonists|hormone antagonists|mesh-ancestor
92544390|NCT00034671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544391|NCT00034671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544392|NCT01806857|Quinidine|quinidine|mesh-list
92544393|NCT01806857|Dextromethorphan|dextromethorphan|mesh-list
92544394|NCT01806857|Antitussive Agents|antitussive agents|mesh-ancestor
92544395|NCT01806857|Respiratory System Agents|respiratory system agents|mesh-ancestor
92544396|NCT01806857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92544397|NCT01806857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92544398|NCT01806857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544399|NCT01806857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544400|NCT01806857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544401|NCT01806857|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92544402|NCT01806857|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92544403|NCT01806857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544404|NCT01806857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92544405|NCT01806857|Antimalarials|antimalarials|mesh-ancestor
92544406|NCT01806857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92544407|NCT01806857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92544408|NCT01806857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544409|NCT01806857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544410|NCT01806857|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92544411|NCT01806857|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92544412|NCT01806857|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682777|NCT04701320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544439|NCT00034788|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92544440|NCT00034788|Growth Substances|growth substances|mesh-ancestor
92544441|NCT00034788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544442|NCT00034866|Tipranavir|tipranavir|mesh-list
92544443|NCT00034866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92544444|NCT00034866|Protease Inhibitors|protease inhibitors|mesh-list
92544445|NCT00034866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92544446|NCT00034866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92544447|NCT00034866|Antiviral Agents|antiviral agents|mesh-ancestor
92544448|NCT00034866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544449|NCT00034866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544450|NCT00034866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544451|NCT00034866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92544452|NCT00034905|Risperidone|risperidone|mesh-list
92544453|NCT00034905|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92544454|NCT00034905|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92544455|NCT00034905|Serotonin Agents|serotonin agents|mesh-ancestor
92544456|NCT00034905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544457|NCT00034905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544458|NCT00034905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544459|NCT00034905|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92534191|NCT00066157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92534192|NCT00066157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92534193|NCT00066157|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92534194|NCT00066157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91951973|NCT05313659|Anesthetics|anesthetics|mesh-ancestor
92544477|NCT01806311|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92544478|NCT00034944|Aprepitant|aprepitant|mesh-list
92544479|NCT00034944|Antiemetics|antiemetics|mesh-ancestor
92544480|NCT00034944|Autonomic Agents|autonomic agents|mesh-ancestor
92544481|NCT00034944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544482|NCT00034944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544483|NCT00034944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544484|NCT00034944|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92544485|NCT00034944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544486|NCT00034944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544487|NCT01806272|Vitamin B 12|vitamin b 12|mesh-list
92544488|NCT01806272|Hydroxocobalamin|hydroxocobalamin|mesh-list
92544489|NCT01806272|Vitamins|vitamins|mesh-ancestor
92544490|NCT01806272|Micronutrients|micronutrients|mesh-ancestor
92544491|NCT01806272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544492|NCT01806272|Vitamin B Complex|vitamin b complex|mesh-ancestor
92544493|NCT01806272|Hematinics|hematinics|mesh-ancestor
92544494|NCT00034983|Aprepitant|aprepitant|mesh-list
92544495|NCT00034983|Paroxetine|paroxetine|mesh-list
92544496|NCT00034983|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92544497|NCT00034983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92544498|NCT00034983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544499|NCT00034983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544500|NCT00034983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544501|NCT00034983|Serotonin Agents|serotonin agents|mesh-ancestor
92544502|NCT00034983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544503|NCT00034983|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92544504|NCT00034983|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544505|NCT00034983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544506|NCT00034983|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92544507|NCT00034983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92544508|NCT00034983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544509|NCT00034983|Antiemetics|antiemetics|mesh-ancestor
92544510|NCT00034983|Autonomic Agents|autonomic agents|mesh-ancestor
92544511|NCT00034983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269237|NCT01557452|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92544512|NCT00034983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544513|NCT00034983|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92544515|NCT00035061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544538|NCT00035139|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92544539|NCT00035139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92544540|NCT00035139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544541|NCT00035139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544542|NCT00035139|Dopamine Agents|dopamine agents|mesh-ancestor
92544543|NCT00035139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544544|NCT00035178|Argatroban|argatroban|mesh-list
92544545|NCT00035178|Antithrombins|antithrombins|mesh-ancestor
92544546|NCT00035178|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92544547|NCT00035178|Protease Inhibitors|protease inhibitors|mesh-ancestor
92544548|NCT00035178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544549|NCT00035178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544550|NCT00035178|Anticoagulants|anticoagulants|mesh-ancestor
92544551|NCT00035178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92544552|NCT00393614|Levetiracetam|levetiracetam|mesh-list
92544553|NCT00393614|Anticonvulsants|anticonvulsants|mesh-ancestor
92544554|NCT00393614|Nootropic Agents|nootropic agents|mesh-ancestor
92544555|NCT00035256|Teriparatide|teriparatide|mesh-list
92544556|NCT00035256|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92544557|NCT00035256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92544558|NCT00035256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544559|NCT00035256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92544560|NCT00035256|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92544561|NCT00035256|Hormone Antagonists|hormone antagonists|mesh-ancestor
92534195|NCT00066157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534196|NCT00066196|Dacarbazine|dacarbazine|mesh-list
92544562|NCT00035256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544563|NCT00035256|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92544564|NCT00035256|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92544565|NCT00035295|Aprepitant|aprepitant|mesh-list
92544595|NCT01805999|Psyllium|psyllium|mesh-list
92544596|NCT01805999|Calcium polycarbophil|calcium polycarbophil|mesh-list
92544597|NCT01805999|Cathartics|cathartics|mesh-ancestor
92544598|NCT01805999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544599|NCT01805999|Antidiarrheals|antidiarrheals|mesh-ancestor
92544600|NCT00035490|Azimilide|azimilide|mesh-list
92544601|NCT00035490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92544602|NCT00035490|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92544603|NCT00035490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544604|NCT00035490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544605|NCT00035490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92544606|NCT00035490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544607|NCT00035607|Darbepoetin alfa|darbepoetin alfa|mesh-list
92544608|NCT00035607|Hematinics|hematinics|mesh-ancestor
92544609|NCT02971254|Sevoflurane|sevoflurane|mesh-list
92544629|NCT04732377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544630|NCT04732377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544631|NCT04732377|Sensory System Agents|sensory system agents|mesh-ancestor
92544632|NCT04732377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544633|NCT04732377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92544634|NCT04732377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544635|NCT04732377|Analgesics|analgesics|mesh-ancestor
92544636|NCT04732377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92544637|NCT04732377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92544638|NCT04732377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92544639|NCT04732377|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544640|NCT04732377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544641|NCT04732377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544642|NCT01805726|Dexmedetomidine|dexmedetomidine|mesh-list
92544643|NCT01805726|Alfentanil|alfentanil|mesh-list
92544644|NCT01805726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92544645|NCT01805726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544646|NCT01805726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544647|NCT01805726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544648|NCT01805726|Analgesics|analgesics|mesh-ancestor
92544649|NCT01805726|Sensory System Agents|sensory system agents|mesh-ancestor
92544650|NCT01805726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544651|NCT01805726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92544652|NCT01805726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92544653|NCT01805726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92544654|NCT01805726|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544655|NCT01805726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544656|NCT01805726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544657|NCT01805726|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92544658|NCT01805726|Narcotics|narcotics|mesh-ancestor
92544659|NCT01805726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92544660|NCT01805726|Anesthetics, General|anesthetics, general|mesh-ancestor
92544662|NCT00035958|Prednisone|prednisone|mesh-list
92544663|NCT00035958|Etanercept|etanercept|mesh-list
92544664|NCT00035958|Methotrexate|methotrexate|mesh-list
92544665|NCT00035958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544666|NCT00035958|Glucocorticoids|glucocorticoids|mesh-ancestor
92544667|NCT00035958|Hormones|hormones|mesh-ancestor
92544668|NCT00035958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544669|NCT00035958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544719|NCT01805531|Rivaroxaban|rivaroxaban|mesh-list
92544720|NCT01805531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92544721|NCT01805531|Antithrombins|antithrombins|mesh-ancestor
92544722|NCT01805531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92544723|NCT01805531|Protease Inhibitors|protease inhibitors|mesh-ancestor
92544724|NCT01805531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544725|NCT01805531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544726|NCT01805531|Anticoagulants|anticoagulants|mesh-ancestor
92544727|NCT00036114|Aripiprazole|aripiprazole|mesh-list
92544728|NCT00036114|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544729|NCT00036114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544730|NCT00036114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92544731|NCT00036114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92534197|NCT00066196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92534198|NCT00066196|Alkylating Agents|alkylating agents|mesh-ancestor
92544732|NCT00036114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544733|NCT00036114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544734|NCT00036114|Dopamine Agonists|dopamine agonists|mesh-ancestor
92544735|NCT00036114|Dopamine Agents|dopamine agents|mesh-ancestor
92544736|NCT00036114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544737|NCT00036114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544738|NCT00036114|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92544739|NCT00036114|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92544740|NCT00036114|Serotonin Agents|serotonin agents|mesh-ancestor
92544741|NCT00036114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92544742|NCT00036114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92544743|NCT00036114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92544744|NCT00036114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92544746|NCT01805453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92544747|NCT01805453|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92544748|NCT01805453|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92544749|NCT01805453|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92544750|NCT01805453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544751|NCT00036153|Methotrexate|methotrexate|mesh-list
92544752|NCT00036153|Tacrolimus|tacrolimus|mesh-list
92544753|NCT00036153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92544754|NCT00036153|Abortifacient Agents|abortifacient agents|mesh-ancestor
92544755|NCT00036153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92544756|NCT00036153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544757|NCT00036153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92544758|NCT00036153|Antimetabolites|antimetabolites|mesh-ancestor
92544759|NCT00036153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544760|NCT00036153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544784|NCT00036309|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544785|NCT00036309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544786|NCT00036309|Dopamine Agents|dopamine agents|mesh-ancestor
92544787|NCT00036348|Aripiprazole|aripiprazole|mesh-list
92544788|NCT00036348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544789|NCT00036348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544790|NCT00036348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92544791|NCT00036348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92544792|NCT00036348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544793|NCT00036348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544794|NCT00036348|Dopamine Agonists|dopamine agonists|mesh-ancestor
92544795|NCT00036348|Dopamine Agents|dopamine agents|mesh-ancestor
92544796|NCT00036348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544797|NCT00036348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544798|NCT00036348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92544799|NCT00036348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92544800|NCT00036348|Serotonin Agents|serotonin agents|mesh-ancestor
92544801|NCT00036348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92544802|NCT00036348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92544803|NCT00036348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92544804|NCT00036348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92544805|NCT00036387|Infliximab|infliximab|mesh-list
92544806|NCT00036387|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92544807|NCT00036387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544808|NCT00036387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92544829|NCT00036543|Atrasentan|atrasentan|mesh-list
92544830|NCT00036543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544831|NCT00036543|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92544832|NCT00036543|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92544833|NCT00036543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544834|NCT01466231|Everolimus|everolimus|mesh-list
92544835|NCT01466231|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92544836|NCT01466231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92544837|NCT01466231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544838|NCT01466231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544839|NCT01466231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544840|NCT01466231|Immunologic Factors|immunologic factors|mesh-ancestor
92544841|NCT01466231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534199|NCT00066196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534200|NCT00066196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534201|NCT00066274|Leucovorin|leucovorin|mesh-list
92534202|NCT00066274|Fluorouracil|fluorouracil|mesh-list
92544842|NCT01466231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544843|NCT00036582|Clozapine|clozapine|mesh-list
92544844|NCT00036582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92544845|NCT00036582|Serotonin Agents|serotonin agents|mesh-ancestor
92544846|NCT00036582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544847|NCT00036582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544848|NCT00036582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544849|NCT00036582|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92544850|NCT00036582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92544851|NCT00036582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544852|NCT00036582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544853|NCT00036582|GABA Antagonists|gaba antagonists|mesh-ancestor
92544854|NCT00036582|GABA Agents|gaba agents|mesh-ancestor
92544855|NCT01466114|Norethindrone|norethindrone|mesh-list
92544856|NCT01466114|Norethindrone Acetate|norethindrone acetate|mesh-list
92544857|NCT01466114|Progestins|progestins|mesh-list
92544858|NCT01466114|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92544859|NCT01466114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92544860|NCT01466114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92544861|NCT01466114|Contraceptive Agents|contraceptive agents|mesh-ancestor
92544862|NCT01466114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91952381|NCT03237611|Hormones|hormones|mesh-ancestor
92544894|NCT00396513|Metformin|metformin|mesh-list
92544895|NCT00396513|Simvastatin|simvastatin|mesh-list
92544896|NCT00396513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92544897|NCT00396513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544898|NCT00396513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92544899|NCT00396513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92544900|NCT00396513|Antimetabolites|antimetabolites|mesh-ancestor
92544901|NCT00396513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544902|NCT00396513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92544903|NCT00396513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92544916|NCT00036894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92544917|NCT00036894|Growth Substances|growth substances|mesh-ancestor
92544918|NCT00036894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92544919|NCT00036894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544920|NCT01465685|Methylphenidate|methylphenidate|mesh-list
92544921|NCT01465685|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92544922|NCT01465685|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92544923|NCT01465685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544924|NCT01465685|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92544925|NCT01465685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92544926|NCT01465685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544927|NCT01465685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544928|NCT01465685|Dopamine Agents|dopamine agents|mesh-ancestor
92544929|NCT01465685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544930|NCT01465685|Hallucinogens|hallucinogens|mesh-ancestor
92544931|NCT01465685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544932|NCT01465685|Serotonin Agents|serotonin agents|mesh-ancestor
92544933|NCT01465685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92544934|NCT01465685|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544935|NCT00037011|Antibodies|antibodies|mesh-list
92544936|NCT00037011|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92544937|NCT00037011|Immunologic Factors|immunologic factors|mesh-ancestor
92544938|NCT00037011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544939|NCT00037050|Vancomycin|vancomycin|mesh-list
92544940|NCT00037050|Linezolid|linezolid|mesh-list
92544941|NCT00037050|Oxacillin|oxacillin|mesh-list
92544942|NCT00037050|Dicloxacillin|dicloxacillin|mesh-list
92544943|NCT00037050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92544944|NCT00037050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544945|NCT00037050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92544946|NCT00037050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544947|NCT00037050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544948|NCT00037089|Tegafur|tegafur|mesh-list
92544949|NCT00037089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92544950|NCT00037089|Antimetabolites|antimetabolites|mesh-ancestor
92544951|NCT00037089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534204|NCT00066274|Irinotecan|irinotecan|mesh-list
92534205|NCT00066274|Calcium|calcium|mesh-list
92534206|NCT00066274|Levoleucovorin|levoleucovorin|mesh-list
92534207|NCT00066274|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534208|NCT00066274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534209|NCT00066274|Antimetabolites|antimetabolites|mesh-ancestor
92544952|NCT00037089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544953|NCT01465568|Denosumab|denosumab|mesh-list
92544954|NCT01465568|Diphosphonates|diphosphonates|mesh-list
92544955|NCT01465568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92544956|NCT01465568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544957|NCT00037206|Anidulafungin|anidulafungin|mesh-list
92544958|NCT00037206|Antifungal Agents|antifungal agents|mesh-ancestor
92544959|NCT00037206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544960|NCT01465412|Adenosine|adenosine|mesh-list
92544961|NCT01465412|Analgesics|analgesics|mesh-ancestor
92544962|NCT01465412|Sensory System Agents|sensory system agents|mesh-ancestor
92544963|NCT01465412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544964|NCT01465412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544965|NCT01465412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92544966|NCT01465412|Vasodilator Agents|vasodilator agents|mesh-ancestor
92544967|NCT01465412|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92544984|NCT01465256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544985|NCT01465256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544986|NCT01465256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92544987|NCT01465256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92544988|NCT01465256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544989|NCT01465256|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92544990|NCT01465256|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92544991|NCT01465256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544992|NCT01465256|Antipyretics|antipyretics|mesh-ancestor
92544993|NCT00037479|Ceftriaxone|ceftriaxone|mesh-list
92544994|NCT00037479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92544995|NCT00037479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544996|NCT01464983|Aspirin|aspirin|mesh-list
92544997|NCT01464983|Ibuprofen|ibuprofen|mesh-list
92544998|NCT01464983|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92544999|NCT01464983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92545000|NCT01464983|Analgesics|analgesics|mesh-ancestor
92545001|NCT01464983|Sensory System Agents|sensory system agents|mesh-ancestor
92545002|NCT01464983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545003|NCT01464983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545004|NCT01464983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545005|NCT01464983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545006|NCT01464983|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92545007|NCT01464983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92545008|NCT01464983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545009|NCT01464983|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92545010|NCT01464983|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92545011|NCT01464983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545012|NCT01464983|Antipyretics|antipyretics|mesh-ancestor
92545013|NCT00037518|Cinacalcet|cinacalcet|mesh-list
92545014|NCT00037518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92545015|NCT00037518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545016|NCT00037518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92545017|NCT00037518|Hormone Antagonists|hormone antagonists|mesh-ancestor
92545018|NCT00037518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545019|NCT01464944|Aspirin|aspirin|mesh-list
92545020|NCT01464944|Acetaminophen|acetaminophen|mesh-list
92545021|NCT01464944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92545022|NCT01464944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92545023|NCT01464944|Analgesics|analgesics|mesh-ancestor
92545024|NCT01464944|Sensory System Agents|sensory system agents|mesh-ancestor
92545025|NCT01464944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545052|NCT00037635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545053|NCT00037635|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92545054|NCT00037635|Hormone Antagonists|hormone antagonists|mesh-ancestor
92534210|NCT00066274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534211|NCT00066274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92534212|NCT00066274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534213|NCT00066274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545055|NCT00037635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545056|NCT00037674|Topiramate|topiramate|mesh-list
92545057|NCT00037674|Anticonvulsants|anticonvulsants|mesh-ancestor
92545058|NCT00037674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92545059|NCT00037674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545060|NCT00037752|Sibutramine|sibutramine|mesh-list
92545061|NCT00037752|Antidepressive Agents|antidepressive agents|mesh-ancestor
92545062|NCT00037752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545063|NCT00037752|Appetite Depressants|appetite depressants|mesh-ancestor
92545064|NCT00037752|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92545065|NCT01464671|Heparin|heparin|mesh-list
92545066|NCT01464671|Bivalirudin|bivalirudin|mesh-list
92545067|NCT01464671|Anticoagulants|anticoagulants|mesh-ancestor
92545068|NCT01464671|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92545069|NCT01464671|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92545070|NCT01464671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545071|NCT01464671|Antithrombins|antithrombins|mesh-ancestor
92545072|NCT01464671|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92545087|NCT00393731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92545088|NCT00393731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545089|NCT00038025|Pentostatin|pentostatin|mesh-list
92545090|NCT00038025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545091|NCT00038025|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92545092|NCT00038025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545093|NCT00038025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545094|NCT00393770|Acetylcarnitine|acetylcarnitine|mesh-list
92545095|NCT00393770|Vitamin B Complex|vitamin b complex|mesh-ancestor
92545097|NCT00393770|Micronutrients|micronutrients|mesh-ancestor
92545098|NCT00393770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545099|NCT00393770|Nootropic Agents|nootropic agents|mesh-ancestor
92545100|NCT00038064|Darbepoetin alfa|darbepoetin alfa|mesh-list
92545101|NCT00038064|Hematinics|hematinics|mesh-ancestor
92545102|NCT00038181|Thalidomide|thalidomide|mesh-list
92545103|NCT00038181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545104|NCT00038181|Immunologic Factors|immunologic factors|mesh-ancestor
92545105|NCT00038181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545106|NCT00038181|Leprostatic Agents|leprostatic agents|mesh-ancestor
92545107|NCT00038181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545108|NCT00038181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545109|NCT00038181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92545110|NCT00038181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92545111|NCT00038181|Growth Substances|growth substances|mesh-ancestor
92545112|NCT00038181|Growth Inhibitors|growth inhibitors|mesh-ancestor
92545113|NCT00038181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545114|NCT00038220|Ritonavir|ritonavir|mesh-list
92545115|NCT00038220|Lopinavir|lopinavir|mesh-list
92545116|NCT00038220|Tenofovir|tenofovir|mesh-list
92545117|NCT00038220|Lamivudine|lamivudine|mesh-list
92545118|NCT00038220|Efavirenz|efavirenz|mesh-list
92545119|NCT00038220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92545120|NCT00038220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92545121|NCT00038220|Protease Inhibitors|protease inhibitors|mesh-ancestor
92545122|NCT00038220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545123|NCT00038220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545124|NCT00038220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92545125|NCT00038220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92545126|NCT00038220|Antiviral Agents|antiviral agents|mesh-ancestor
92545127|NCT00038220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545128|NCT00038220|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92545129|NCT00038220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92545130|NCT00038220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92545131|NCT00038220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92545132|NCT00038220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92545133|NCT00038220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92545134|NCT00038220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92545148|NCT00847262|Amlodipine|amlodipine|mesh-list
92545149|NCT00847262|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92545150|NCT00847262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92534214|NCT00066274|Immunologic Factors|immunologic factors|mesh-ancestor
92534215|NCT00066274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92534216|NCT00066274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92534217|NCT00066274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534218|NCT00066274|Antidotes|antidotes|mesh-ancestor
92534219|NCT00066274|Protective Agents|protective agents|mesh-ancestor
92534220|NCT00066274|Vitamin B Complex|vitamin b complex|mesh-ancestor
92534221|NCT00066274|Vitamins|vitamins|mesh-ancestor
92534222|NCT00066274|Micronutrients|micronutrients|mesh-ancestor
92258983|NCT01661621|Doxazosin|doxazosin|mesh-list
92534223|NCT04401150|Ascorbic Acid|ascorbic acid|mesh-list
92534224|NCT04401150|Vitamins|vitamins|mesh-ancestor
92534225|NCT04401150|Micronutrients|micronutrients|mesh-ancestor
92534226|NCT04401150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545151|NCT00847262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545152|NCT00847262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545153|NCT00847262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92545154|NCT00847262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545155|NCT00847262|Vasodilator Agents|vasodilator agents|mesh-ancestor
92545156|NCT00847223|Tipifarnib|tipifarnib|mesh-list
92545157|NCT00847223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545158|NCT05433207|Eldecalcitol|eldecalcitol|mesh-list
92545159|NCT05433207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92545160|NCT05433207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545161|NCT00847106|Daclizumab|daclizumab|mesh-list
92545162|NCT00847106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545163|NCT00847106|Immunologic Factors|immunologic factors|mesh-ancestor
92545164|NCT00847106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545165|NCT00396669|Bupropion|bupropion|mesh-list
92545166|NCT00396669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92545167|NCT00396669|Antidepressive Agents|antidepressive agents|mesh-ancestor
92545168|NCT00396669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545169|NCT00396669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92545170|NCT00396669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92545171|NCT00396669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545172|NCT00396669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545173|NCT00396669|Dopamine Agents|dopamine agents|mesh-ancestor
92545174|NCT00396669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545175|NCT00396669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545176|NCT00396669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92545177|NCT00396669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92545178|NCT00396669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545179|NCT00846989|Latanoprost|latanoprost|mesh-list
92545180|NCT00846989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92545181|NCT00846989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92545182|NCT00396747|Methylprednisolone|methylprednisolone|mesh-list
92545183|NCT00396747|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92545184|NCT00396747|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92545185|NCT00396747|Prednisolone|prednisolone|mesh-list
92545186|NCT00396747|Prednisolone acetate|prednisolone acetate|mesh-list
92545187|NCT00396747|Infliximab|infliximab|mesh-list
92545188|NCT00396747|Methotrexate|methotrexate|mesh-list
92545189|NCT00396747|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92545190|NCT00396747|Prednisolone phosphate|prednisolone phosphate|mesh-list
92545191|NCT00396747|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92545192|NCT00396747|Abortifacient Agents|abortifacient agents|mesh-ancestor
92545193|NCT00396747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92545194|NCT00396747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545195|NCT00396747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92545196|NCT00396747|Antimetabolites|antimetabolites|mesh-ancestor
92682778|NCT04701320|Dopamine Agents|dopamine agents|mesh-ancestor
92545212|NCT00396747|Hormones|hormones|mesh-ancestor
92545213|NCT00396747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534227|NCT04401150|Antioxidants|antioxidants|mesh-ancestor
92534228|NCT04401150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545214|NCT00396747|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92545215|NCT00396747|Protective Agents|protective agents|mesh-ancestor
92545216|NCT00396747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92545217|NCT00396747|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92545218|NCT00846950|Lorazepam|lorazepam|mesh-list
92545219|NCT00846950|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92545220|NCT00846950|Anticonvulsants|anticonvulsants|mesh-ancestor
92545221|NCT00846950|Antiemetics|antiemetics|mesh-ancestor
92545222|NCT00846950|Autonomic Agents|autonomic agents|mesh-ancestor
92545223|NCT00846950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545224|NCT00846950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545225|NCT00846950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545226|NCT00846950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92545227|NCT00846950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92545228|NCT00846950|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92545229|NCT00846950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92545230|NCT00846950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545231|NCT00846950|GABA Modulators|gaba modulators|mesh-ancestor
92545232|NCT00846950|GABA Agents|gaba agents|mesh-ancestor
92545233|NCT00846950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545234|NCT00846950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545235|NCT00846950|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92545236|NCT00846950|Histamine Antagonists|histamine antagonists|mesh-ancestor
92545237|NCT00846950|Histamine Agents|histamine agents|mesh-ancestor
92545238|NCT05432934|Dexamethasone|dexamethasone|mesh-list
92545239|NCT05432934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545240|NCT05432934|Antiemetics|antiemetics|mesh-ancestor
92545241|NCT05432934|Autonomic Agents|autonomic agents|mesh-ancestor
92545242|NCT05432934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545243|NCT05432934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545244|NCT05432934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545245|NCT05432934|Glucocorticoids|glucocorticoids|mesh-ancestor
92545246|NCT05432934|Hormones|hormones|mesh-ancestor
92545247|NCT05432934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545248|NCT05432934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92545249|NCT05432934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545250|NCT00846911|Moxifloxacin|moxifloxacin|mesh-list
92545251|NCT00846911|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92545252|NCT00846911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545253|NCT00846911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545254|NCT00846911|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92545255|NCT00846911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545256|NCT00846911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545273|NCT00846872|Natriuretic Agents|natriuretic agents|mesh-ancestor
92545274|NCT05432778|Letermovir|letermovir|mesh-list
92545275|NCT05432778|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92545276|NCT05432778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545277|NCT05432778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545278|NCT05432778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545279|NCT05432778|Antiviral Agents|antiviral agents|mesh-ancestor
92545280|NCT05432778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545281|NCT00846755|Propylthiouracil|propylthiouracil|mesh-list
92545282|NCT00846755|Antimetabolites|antimetabolites|mesh-ancestor
92545283|NCT00846755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545284|NCT00846755|Antithyroid Agents|antithyroid agents|mesh-ancestor
92545285|NCT00846755|Hormone Antagonists|hormone antagonists|mesh-ancestor
92545286|NCT00846755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545287|NCT00846755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545288|NCT00846716|Pioglitazone|pioglitazone|mesh-list
92545289|NCT00846716|Biguanides|biguanides|mesh-list
92545290|NCT00846716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92545291|NCT00846716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545292|NCT05432427|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92545293|NCT05432427|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92545294|NCT05432427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545295|NCT00846677|Vitamin D|vitamin d|mesh-list
92545296|NCT00846677|Ergocalciferols|ergocalciferols|mesh-list
92545297|NCT00846677|Cholecalciferol|cholecalciferol|mesh-list
92545298|NCT00846677|Vitamins|vitamins|mesh-list
92545299|NCT00846677|Micronutrients|micronutrients|mesh-ancestor
92534229|NCT04401150|Protective Agents|protective agents|mesh-ancestor
92534230|NCT05077280|Immunomodulating Agents|immunomodulating agents|mesh-list
92534231|NCT05077280|Immunologic Factors|immunologic factors|mesh-ancestor
92545300|NCT00846677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545301|NCT00846677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92545302|NCT00846677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92545303|NCT00846482|Oxaliplatin|oxaliplatin|mesh-list
92545304|NCT00846482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545305|NCT05428683|Moxifloxacin|moxifloxacin|mesh-list
92545306|NCT05428683|Triamcinolone|triamcinolone|mesh-list
92545307|NCT05428683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545308|NCT05428683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545309|NCT05428683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92545310|NCT05428683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545311|NCT05428683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545312|NCT05428683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545313|NCT05428683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952805|NCT02522039|Timolol|timolol|mesh-list
92545330|NCT00846326|Phenylephrine|phenylephrine|mesh-list
92545331|NCT00846326|Oxymetazoline|oxymetazoline|mesh-list
92270066|NCT01576952|Analgesics|analgesics|mesh-ancestor
92545332|NCT00846326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545333|NCT00846326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92545334|NCT00846326|Autonomic Agents|autonomic agents|mesh-ancestor
92545335|NCT00846326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545336|NCT00846326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545337|NCT00846326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92545338|NCT00846326|Respiratory System Agents|respiratory system agents|mesh-ancestor
92545339|NCT00846326|Dermatologic Agents|dermatologic agents|mesh-ancestor
92545340|NCT00846326|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92545341|NCT00846326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92545342|NCT00846326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92545343|NCT00846326|Adrenergic Agents|adrenergic agents|mesh-ancestor
92545344|NCT00846326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545345|NCT00846326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545346|NCT00846326|Sympathomimetics|sympathomimetics|mesh-ancestor
92545347|NCT00846326|Nasal Decongestants|nasal decongestants|mesh-ancestor
92545348|NCT00846326|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92545349|NCT00846326|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92545350|NCT00846326|Mydriatics|mydriatics|mesh-ancestor
92545351|NCT00846326|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92545352|NCT00846326|Protective Agents|protective agents|mesh-ancestor
92545353|NCT05330013|Dapagliflozin|dapagliflozin|mesh-list
92545354|NCT05330013|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92545355|NCT05330013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545356|NCT05330013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92545357|NCT05330013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545358|NCT00846248|Chromium|chromium|mesh-list
92545359|NCT00846248|Trace Elements|trace elements|mesh-ancestor
92545360|NCT00846248|Micronutrients|micronutrients|mesh-ancestor
92545361|NCT00846248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545362|NCT00846131|Sorafenib|sorafenib|mesh-list
92545363|NCT00846131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545364|NCT00846131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92545365|NCT00846131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545366|NCT00846131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545367|NCT05116059|Amphotericin B|amphotericin b|mesh-list
92545368|NCT05116059|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92545369|NCT05116059|Amebicides|amebicides|mesh-ancestor
92545370|NCT05116059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92545371|NCT05116059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92545372|NCT05116059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545391|NCT04888377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545392|NCT04888377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545393|NCT04888377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545394|NCT04888377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92545395|NCT04888377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92545396|NCT04888377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545397|NCT04888377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92545398|NCT04888377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92545399|NCT04888377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545401|NCT00277043|Paclitaxel|paclitaxel|mesh-list
92545402|NCT00277043|Docetaxel|docetaxel|mesh-list
92545403|NCT00277043|Taxane|taxane|mesh-list
92534232|NCT05077280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534233|NCT00066352|Bortezomib|bortezomib|mesh-list
92534234|NCT00066352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545404|NCT00277043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92545405|NCT00277043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545406|NCT00277043|Tubulin Modulators|tubulin modulators|mesh-ancestor
92270140|NCT00372879|Vitamin E|vitamin e|mesh-list
92545407|NCT00277043|Antimitotic Agents|antimitotic agents|mesh-ancestor
92545408|NCT00277043|Mitosis Modulators|mitosis modulators|mesh-ancestor
92545409|NCT00277043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545410|NCT00276965|Lithium Carbonate|lithium carbonate|mesh-list
92545411|NCT00276965|Sertraline|sertraline|mesh-list
92545412|NCT00276965|Antidepressive Agents|antidepressive agents|mesh-ancestor
92545413|NCT00276965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545414|NCT00276965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92545415|NCT00276965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92545416|NCT00276965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545417|NCT00276965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545418|NCT00276965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545419|NCT00276965|Serotonin Agents|serotonin agents|mesh-ancestor
92545420|NCT00276965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545421|NCT00276965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545422|NCT00276965|Antimanic Agents|antimanic agents|mesh-ancestor
92545423|NCT00276965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92545424|NCT00276965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92545425|NCT00276926|Imatinib Mesylate|imatinib mesylate|mesh-list
92545426|NCT00276926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545427|NCT00276926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92545444|NCT00276848|Fludarabine phosphate|fludarabine phosphate|mesh-list
92545445|NCT00276848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545446|NCT00276848|Immunologic Factors|immunologic factors|mesh-ancestor
92545447|NCT00276848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545448|NCT00276848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545449|NCT00276848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92545450|NCT00276848|Alkylating Agents|alkylating agents|mesh-ancestor
92545451|NCT00276848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545452|NCT00276848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545453|NCT00276848|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92545454|NCT00276848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92545455|NCT00276848|Antimetabolites|antimetabolites|mesh-ancestor
92545456|NCT00276848|Antiviral Agents|antiviral agents|mesh-ancestor
92545457|NCT00276848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545458|NCT00276809|Cytarabine|cytarabine|mesh-list
92545459|NCT00276809|Dexamethasone|dexamethasone|mesh-list
92545460|NCT00276809|Cyclophosphamide|cyclophosphamide|mesh-list
92545461|NCT00276809|Melphalan|melphalan|mesh-list
92545462|NCT00276809|Carmustine|carmustine|mesh-list
92545463|NCT00276809|Fludarabine|fludarabine|mesh-list
92545464|NCT00276809|Fludarabine phosphate|fludarabine phosphate|mesh-list
92545465|NCT00276809|Etoposide|etoposide|mesh-list
92545466|NCT00276809|Alemtuzumab|alemtuzumab|mesh-list
92545467|NCT00276809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545468|NCT00276809|Immunologic Factors|immunologic factors|mesh-ancestor
92545469|NCT00276809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545470|NCT00276809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545471|NCT00276809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92545472|NCT00276809|Alkylating Agents|alkylating agents|mesh-ancestor
92545473|NCT00276809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545474|NCT00276809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545475|NCT00276809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92545476|NCT00276809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545477|NCT00276809|Antiemetics|antiemetics|mesh-ancestor
92545478|NCT00276809|Autonomic Agents|autonomic agents|mesh-ancestor
92545479|NCT00276809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545480|NCT00276809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545481|NCT00276809|Glucocorticoids|glucocorticoids|mesh-ancestor
92545482|NCT00276809|Hormones|hormones|mesh-ancestor
92704600|NCT02203643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545483|NCT00276809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545484|NCT00276809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92545485|NCT00276809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92545486|NCT00276809|Antimetabolites|antimetabolites|mesh-ancestor
92534236|NCT00066391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534237|NCT00066391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92545487|NCT00276809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92545501|NCT00276731|Vincristine|vincristine|mesh-list
92545502|NCT00276731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545503|NCT00276731|Immunologic Factors|immunologic factors|mesh-ancestor
92545504|NCT00276731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545505|NCT00276731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545506|NCT00276731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92545507|NCT00276731|Alkylating Agents|alkylating agents|mesh-ancestor
92545508|NCT00276731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545509|NCT00276731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545510|NCT00276731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92545511|NCT00276731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92545512|NCT00276731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92545513|NCT00276731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545514|NCT00276731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545515|NCT00276731|Tubulin Modulators|tubulin modulators|mesh-ancestor
92545516|NCT00276731|Antimitotic Agents|antimitotic agents|mesh-ancestor
92545517|NCT00276731|Mitosis Modulators|mitosis modulators|mesh-ancestor
92545518|NCT00276692|Irinotecan|irinotecan|mesh-list
92545519|NCT00276692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92545520|NCT00276692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545521|NCT00276692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545522|NCT00276692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545523|NCT00276692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545524|NCT00276575|Bevacizumab|bevacizumab|mesh-list
92545525|NCT00276575|Everolimus|everolimus|mesh-list
92545526|NCT00276575|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92545527|NCT00276575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545528|NCT00276575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545529|NCT00276575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92545530|NCT00276575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92545531|NCT00276575|Growth Substances|growth substances|mesh-ancestor
92545532|NCT00276575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545533|NCT00276575|Growth Inhibitors|growth inhibitors|mesh-ancestor
92545534|NCT00276575|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92545535|NCT00276575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92545536|NCT00276575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545537|NCT00276575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545538|NCT00276575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545539|NCT00276575|Immunologic Factors|immunologic factors|mesh-ancestor
92545540|NCT00276536|Interferons|interferons|mesh-list
92545541|NCT00276536|Interferon-alpha|interferon-alpha|mesh-list
92545542|NCT00276536|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92545543|NCT00276536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545544|NCT00276536|Antiviral Agents|antiviral agents|mesh-ancestor
92545545|NCT00276536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545546|NCT00276536|Immunologic Factors|immunologic factors|mesh-ancestor
92545547|NCT00276536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545548|NCT00276497|Pioglitazone|pioglitazone|mesh-list
92545549|NCT00276497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92545550|NCT00276497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545551|NCT04430790|Doxapram|doxapram|mesh-list
92545552|NCT04430790|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92545593|NCT00276068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545594|NCT00276068|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92545595|NCT00276068|Antidepressive Agents|antidepressive agents|mesh-ancestor
92545596|NCT00276068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545597|NCT00276068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545598|NCT00276068|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92545599|NCT00276068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92545600|NCT00276068|Adrenergic Agents|adrenergic agents|mesh-ancestor
92545601|NCT00276068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545602|NCT00276029|Etanercept|etanercept|mesh-list
92545603|NCT00276029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92545604|NCT00276029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92545605|NCT00276029|Analgesics|analgesics|mesh-ancestor
92545606|NCT00276029|Sensory System Agents|sensory system agents|mesh-ancestor
92545607|NCT00276029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545608|NCT00276029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534238|NCT00066391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92534239|NCT00066391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534240|NCT00066391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534241|NCT04388475|Temozolomide|temozolomide|mesh-list
92545609|NCT00276029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545610|NCT00276029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545611|NCT00276029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545612|NCT00276029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545613|NCT00276029|Immunologic Factors|immunologic factors|mesh-ancestor
92545614|NCT00397059|Escitalopram|escitalopram|mesh-list
92545615|NCT00397059|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92545616|NCT00397059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92545617|NCT00397059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545618|NCT00397059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545619|NCT00397059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545620|NCT00397059|Serotonin Agents|serotonin agents|mesh-ancestor
92545621|NCT00397059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545622|NCT04149210|Fluorometholone|fluorometholone|mesh-list
92545623|NCT04149210|Lubricant Eye Drops|lubricant eye drops|mesh-list
92545624|NCT04149210|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92545625|NCT04149210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92545626|NCT04149210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545627|NCT04149210|Glucocorticoids|glucocorticoids|mesh-ancestor
92545628|NCT04149210|Hormones|hormones|mesh-ancestor
92270372|NCT00373893|Lidocaine|lidocaine|mesh-list
92545642|NCT00275912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92545643|NCT00397098|Amibegron|amibegron|mesh-list
92545644|NCT00397098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92545645|NCT00397098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92545646|NCT00397098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92545647|NCT00397098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92545648|NCT00397098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545649|NCT00397098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545650|NCT00397098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545651|NCT00397098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92545652|NCT00275834|Zonisamide|zonisamide|mesh-list
92545653|NCT00275834|Anticonvulsants|anticonvulsants|mesh-ancestor
92545654|NCT00275834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92545655|NCT00275834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545656|NCT00275834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545657|NCT00275834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92545658|NCT00275834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545659|NCT00397176|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92545660|NCT00397176|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92545661|NCT00397176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92545662|NCT00397176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545663|NCT00397176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545664|NCT00397176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545665|NCT00397176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545666|NCT00397176|Antidepressive Agents|antidepressive agents|mesh-ancestor
92545667|NCT00397176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545668|NCT00275756|Timolol|timolol|mesh-list
92545669|NCT00275756|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92545670|NCT00275756|Dorzolamide|dorzolamide|mesh-list
92545671|NCT00275756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92545672|NCT00275756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92545673|NCT00275756|Adrenergic Agents|adrenergic agents|mesh-ancestor
92545674|NCT00275756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545675|NCT00275756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545676|NCT00275756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545677|NCT00275756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92545678|NCT00275756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92545679|NCT00275756|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92545680|NCT00275756|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92545681|NCT00275756|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92545682|NCT00275756|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92545683|NCT00275756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545684|NCT00275639|Losartan|losartan|mesh-list
92545685|NCT00275639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92534242|NCT04388475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92545704|NCT00275522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545705|NCT00275522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545706|NCT00275522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92545707|NCT00275522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545708|NCT00275522|Antifungal Agents|antifungal agents|mesh-ancestor
92545709|NCT00275522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545710|NCT00275522|Immunologic Factors|immunologic factors|mesh-ancestor
92545711|NCT00275522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545712|NCT00275444|Tipranavir|tipranavir|mesh-list
92545713|NCT00275444|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92545714|NCT00275444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92545715|NCT00275444|Antiviral Agents|antiviral agents|mesh-ancestor
92545716|NCT00275444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545717|NCT00275405|Allyl sulfide|allyl sulfide|mesh-list
92545718|NCT00275405|Antioxidants|antioxidants|mesh-ancestor
92545719|NCT00275405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545720|NCT00275405|Protective Agents|protective agents|mesh-ancestor
92545721|NCT00275405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545722|NCT00275405|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92545723|NCT00275405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545724|NCT00275405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92545725|NCT00275405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545726|NCT00275249|Levorphanol|levorphanol|mesh-list
92545727|NCT00275249|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92545728|NCT00275249|Narcotics|narcotics|mesh-ancestor
92545729|NCT00275249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92545730|NCT00275249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545731|NCT00275249|Analgesics|analgesics|mesh-ancestor
92545732|NCT00275249|Sensory System Agents|sensory system agents|mesh-ancestor
92545733|NCT00275249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545734|NCT00275210|Oxaliplatin|oxaliplatin|mesh-list
92545735|NCT00275210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545736|NCT00041535|Miglustat|miglustat|mesh-list
92545737|NCT00041535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545738|NCT00041535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545739|NCT00041535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92545740|NCT00041535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92545741|NCT00041535|Antiviral Agents|antiviral agents|mesh-ancestor
92545742|NCT00041535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545743|NCT00041535|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92545744|NCT00041535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92545745|NCT00041535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545746|NCT00041574|Nitric Oxide|nitric oxide|mesh-list
92545747|NCT00041574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92545762|NCT00275132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545763|NCT00275132|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92545764|NCT00275132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545765|NCT00275132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545766|NCT00275093|Sirolimus|sirolimus|mesh-list
92545767|NCT00275093|Temsirolimus|temsirolimus|mesh-list
92545768|NCT00275093|MTOR Inhibitors|mtor inhibitors|mesh-list
92545769|NCT00275093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92545770|NCT00275093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545771|NCT00275093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545772|NCT00275093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545773|NCT00275093|Immunologic Factors|immunologic factors|mesh-ancestor
92545774|NCT00275093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545775|NCT00275093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545776|NCT00275093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545777|NCT00275093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545778|NCT00275093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92545779|NCT00275093|Antifungal Agents|antifungal agents|mesh-ancestor
92545780|NCT00041652|Labetuzumab|labetuzumab|mesh-list
92545781|NCT00041652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545782|NCT00041652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545783|NCT03430596|Pramipexole|pramipexole|mesh-list
92545784|NCT03430596|Trihexyphenidyl|trihexyphenidyl|mesh-list
92545785|NCT03430596|Antioxidants|antioxidants|mesh-ancestor
92545786|NCT03430596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545787|NCT03430596|Protective Agents|protective agents|mesh-ancestor
92545788|NCT03430596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545789|NCT03430596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92545790|NCT03430596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92545791|NCT03430596|Dopamine Agonists|dopamine agonists|mesh-ancestor
92534243|NCT04388475|Alkylating Agents|alkylating agents|mesh-ancestor
92534244|NCT04388475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534245|NCT04388475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545792|NCT03430596|Dopamine Agents|dopamine agents|mesh-ancestor
92545793|NCT03430596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545794|NCT03430596|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92545795|NCT03430596|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92545796|NCT03430596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92545797|NCT00275054|Cyclophosphamide|cyclophosphamide|mesh-list
92545798|NCT00275054|Rituximab|rituximab|mesh-list
92545799|NCT00275054|Fludarabine|fludarabine|mesh-list
92545800|NCT00275054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545801|NCT00275054|Immunologic Factors|immunologic factors|mesh-ancestor
92545802|NCT00275054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545803|NCT00275054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545804|NCT00275054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92545805|NCT00275054|Alkylating Agents|alkylating agents|mesh-ancestor
92750791|NCT05935059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545806|NCT00275054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545807|NCT00275054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545818|NCT03208179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545819|NCT03208179|Antimalarials|antimalarials|mesh-ancestor
92545820|NCT03208179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92545821|NCT03208179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92545822|NCT03208179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92545823|NCT03208179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545824|NCT03208179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545825|NCT03208179|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92545826|NCT00275015|Cytarabine|cytarabine|mesh-list
92545827|NCT00275015|Dexamethasone|dexamethasone|mesh-list
92545828|NCT00275015|Cyclophosphamide|cyclophosphamide|mesh-list
92545829|NCT00275015|Melphalan|melphalan|mesh-list
92545830|NCT00275015|Carmustine|carmustine|mesh-list
92545831|NCT00275015|Fludarabine|fludarabine|mesh-list
92545832|NCT00275015|Fludarabine phosphate|fludarabine phosphate|mesh-list
92545833|NCT00275015|Etoposide|etoposide|mesh-list
92545834|NCT00275015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545835|NCT00275015|Immunologic Factors|immunologic factors|mesh-ancestor
92545836|NCT00275015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545837|NCT00275015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545838|NCT00275015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92545839|NCT00275015|Alkylating Agents|alkylating agents|mesh-ancestor
92545840|NCT00275015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545841|NCT00275015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545842|NCT00275015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92545843|NCT00275015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545844|NCT00275015|Antiemetics|antiemetics|mesh-ancestor
92545845|NCT00275015|Autonomic Agents|autonomic agents|mesh-ancestor
92545846|NCT00275015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545847|NCT00275015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545848|NCT00275015|Glucocorticoids|glucocorticoids|mesh-ancestor
92545849|NCT00275015|Hormones|hormones|mesh-ancestor
92545850|NCT00275015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545851|NCT00275015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92545852|NCT00275015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92545853|NCT00275015|Antimetabolites|antimetabolites|mesh-ancestor
92545854|NCT00275015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92545855|NCT00275015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92545856|NCT00275015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545857|NCT00275015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545858|NCT00275015|Antiviral Agents|antiviral agents|mesh-ancestor
92545859|NCT00275015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545860|NCT00274976|Alemtuzumab|alemtuzumab|mesh-list
92545861|NCT00274976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545862|NCT00274976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545863|NCT00130403|Risedronic Acid|risedronic acid|mesh-list
92545864|NCT00130403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92545865|NCT00130403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545866|NCT00130403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545867|NCT00130403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92545868|NCT00130403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534246|NCT00389987|Tazobactam|tazobactam|mesh-list
92534247|NCT00389987|Piperacillin|piperacillin|mesh-list
92534248|NCT00389987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534249|NCT00389987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92534250|NCT00389987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545869|NCT00130403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92545870|NCT03062826|Aspirin|aspirin|mesh-list
92545871|NCT03062826|Clopidogrel|clopidogrel|mesh-list
92545872|NCT03062826|Ticagrelor|ticagrelor|mesh-list
92545873|NCT03062826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92545874|NCT03062826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92545893|NCT00130364|Pimecrolimus|pimecrolimus|mesh-list
92545894|NCT00130364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92545895|NCT00130364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92545896|NCT00130364|Analgesics|analgesics|mesh-ancestor
92545897|NCT00130364|Sensory System Agents|sensory system agents|mesh-ancestor
92545898|NCT00130364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545899|NCT00130364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545900|NCT00130364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545901|NCT00130364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545902|NCT00130364|Dermatologic Agents|dermatologic agents|mesh-ancestor
92545903|NCT00130364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545904|NCT00130364|Immunologic Factors|immunologic factors|mesh-ancestor
92545905|NCT00130364|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92545906|NCT00130364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545907|NCT00130364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545908|NCT00130325|Isoniazid|isoniazid|mesh-list
92545909|NCT00130325|Antitubercular Agents|antitubercular agents|mesh-ancestor
92545910|NCT00130325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545911|NCT00130325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545912|NCT00130325|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92545913|NCT00130325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92545914|NCT00130325|Antimetabolites|antimetabolites|mesh-ancestor
92545915|NCT00130325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545916|NCT00130325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92545917|NCT00041691|Labetuzumab|labetuzumab|mesh-list
92545918|NCT00041691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545919|NCT00041691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545920|NCT00394394|Enalapril|enalapril|mesh-list
92545921|NCT00394394|Amiloride|amiloride|mesh-list
92545922|NCT00394394|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92545923|NCT00394394|Protease Inhibitors|protease inhibitors|mesh-ancestor
92545924|NCT00394394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545925|NCT00394394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545926|NCT00394394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92545927|NCT00394394|Diuretics|diuretics|mesh-ancestor
92545929|NCT00394394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953424|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
92545947|NCT00130091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545948|NCT00130091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545949|NCT00130013|Amoxicillin|amoxicillin|mesh-list
92545950|NCT00130013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545951|NCT00130013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545952|NCT00129857|HU 211|hu 211|mesh-list
92545953|NCT00129857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92545954|NCT00129857|Antiemetics|antiemetics|mesh-ancestor
92545955|NCT00129857|Autonomic Agents|autonomic agents|mesh-ancestor
92545956|NCT00129857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545957|NCT00129857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545958|NCT00129857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545959|NCT00129857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92545960|NCT00129857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92545961|NCT00129857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545962|NCT00129857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545963|NCT00129857|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92545964|NCT00129857|Protective Agents|protective agents|mesh-ancestor
92545965|NCT00129818|Famciclovir|famciclovir|mesh-list
92545966|NCT00129818|Antiviral Agents|antiviral agents|mesh-ancestor
92545967|NCT00129818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545968|NCT00129818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92534251|NCT00389987|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92534252|NCT00389987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534254|NCT00066508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534255|NCT00066547|Antibodies|antibodies|mesh-list
92534256|NCT00066547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92534257|NCT00066547|Immunologic Factors|immunologic factors|mesh-ancestor
92534258|NCT00066547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534259|NCT00066586|Exemestane|exemestane|mesh-list
92545969|NCT00129818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545970|NCT00129818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545971|NCT00129506|Methotrexate|methotrexate|mesh-list
92545972|NCT00129506|Misoprostol|misoprostol|mesh-list
92545973|NCT00129506|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92545974|NCT00129506|Abortifacient Agents|abortifacient agents|mesh-ancestor
92545975|NCT00129506|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92545976|NCT00129506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545977|NCT00129506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92545978|NCT00129506|Antimetabolites|antimetabolites|mesh-ancestor
92545979|NCT00129506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545980|NCT00129506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545981|NCT00129506|Dermatologic Agents|dermatologic agents|mesh-ancestor
92545982|NCT00129506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545983|NCT00129506|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92545984|NCT00129506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545985|NCT00129506|Immunologic Factors|immunologic factors|mesh-ancestor
92545998|NCT00129233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545999|NCT00129233|Vasodilator Agents|vasodilator agents|mesh-ancestor
92546000|NCT00129233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92546001|NCT00129233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92546002|NCT00129155|Treosulfan|treosulfan|mesh-list
92546003|NCT00129155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546004|NCT00129155|Alkylating Agents|alkylating agents|mesh-ancestor
92546005|NCT00129155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546006|NCT00129155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546007|NCT00712881|Cyclophosphamide|cyclophosphamide|mesh-list
92546008|NCT00712881|Docetaxel|docetaxel|mesh-list
92546009|NCT00712881|Doxorubicin|doxorubicin|mesh-list
92546010|NCT00712881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92546011|NCT00712881|Trastuzumab|trastuzumab|mesh-list
92546012|NCT00712881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546013|NCT00712881|Immunologic Factors|immunologic factors|mesh-ancestor
92546014|NCT00712881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546015|NCT00712881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546016|NCT00712881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546017|NCT00712881|Alkylating Agents|alkylating agents|mesh-ancestor
92546018|NCT00712881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546019|NCT00712881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546020|NCT00712881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92546021|NCT00712881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546022|NCT00712881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546023|NCT00712881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546024|NCT00712881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92546025|NCT00712881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92546026|NCT00712881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92546027|NCT00712881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546028|NCT00712881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546029|NCT00042003|Decitabine|decitabine|mesh-list
92546030|NCT00042003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546031|NCT00042003|Antimetabolites|antimetabolites|mesh-ancestor
92546032|NCT00042003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546033|NCT00042003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546034|NCT00042003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546035|NCT00129038|Aspirin|aspirin|mesh-list
92546036|NCT00129038|Dipyridamole|dipyridamole|mesh-list
92546037|NCT00129038|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92534261|NCT00066586|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92546038|NCT00129038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546039|NCT00129038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546040|NCT00129038|Analgesics|analgesics|mesh-ancestor
92546041|NCT00129038|Sensory System Agents|sensory system agents|mesh-ancestor
92546042|NCT00129038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546043|NCT00129038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546044|NCT00129038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546045|NCT00129038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546046|NCT00129038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91953536|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
92546062|NCT00470223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92546063|NCT00470223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92546064|NCT00470223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92546065|NCT00470223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546066|NCT00470223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546067|NCT00470223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92546068|NCT00470223|Abortifacient Agents|abortifacient agents|mesh-ancestor
92546069|NCT00470223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92546070|NCT00470223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546071|NCT00470223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546072|NCT00470223|Antimetabolites|antimetabolites|mesh-ancestor
92546073|NCT00470223|Dermatologic Agents|dermatologic agents|mesh-ancestor
92546074|NCT00470223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92546075|NCT00470223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546076|NCT00470223|Immunologic Factors|immunologic factors|mesh-ancestor
92546077|NCT00470223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546078|NCT00470223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546079|NCT00470223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92546080|NCT00470223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546081|NCT00470223|Alkylating Agents|alkylating agents|mesh-ancestor
92546082|NCT00470223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92546083|NCT00103389|Docetaxel|docetaxel|mesh-list
92546084|NCT00103389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546085|NCT00103389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546086|NCT00103389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546087|NCT00103389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546088|NCT00103389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546089|NCT00128921|Bortezomib|bortezomib|mesh-list
92546090|NCT00128921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546091|NCT00128804|Beta Carotene|beta carotene|mesh-list
92546092|NCT00128804|Carotenoids|carotenoids|mesh-list
92546093|NCT00128804|Antioxidants|antioxidants|mesh-ancestor
92546094|NCT00128804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546095|NCT00128804|Protective Agents|protective agents|mesh-ancestor
92546096|NCT00128804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546097|NCT00128804|Provitamins|provitamins|mesh-ancestor
92546098|NCT00128804|Vitamins|vitamins|mesh-ancestor
92546099|NCT00128804|Micronutrients|micronutrients|mesh-ancestor
92546100|NCT00097851|Docetaxel|docetaxel|mesh-list
92546101|NCT00097851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546102|NCT00097851|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546103|NCT00097851|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546104|NCT00097851|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546105|NCT00097851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546106|NCT00038376|Interferons|interferons|mesh-list
92546107|NCT00038376|Interferon-alpha|interferon-alpha|mesh-list
92546108|NCT00038376|Interferon alpha-2|interferon alpha-2|mesh-list
92546124|NCT00038454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546125|NCT00038454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546126|NCT00038454|Analgesics|analgesics|mesh-ancestor
92546127|NCT00038454|Sensory System Agents|sensory system agents|mesh-ancestor
92546128|NCT00038454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546129|NCT00038454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546130|NCT00038454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546131|NCT00038454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546132|NCT00128453|Colchicine|colchicine|mesh-list
92546133|NCT00128453|Gout Suppressants|gout suppressants|mesh-ancestor
92546134|NCT00128453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546135|NCT00128453|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546136|NCT00128453|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546137|NCT00128453|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534262|NCT00066586|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92534263|NCT00066586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534264|NCT00066586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546138|NCT00128453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546139|NCT00128453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546140|NCT00128414|Colchicine|colchicine|mesh-list
92546141|NCT00128414|Gout Suppressants|gout suppressants|mesh-ancestor
92546142|NCT00128414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546143|NCT00128414|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546144|NCT00128414|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546145|NCT00128414|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546146|NCT00128414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546147|NCT00128414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546148|NCT00038493|Temozolomide|temozolomide|mesh-list
92546149|NCT00038493|Lonafarnib|lonafarnib|mesh-list
92546150|NCT00038493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546151|NCT00038493|Alkylating Agents|alkylating agents|mesh-ancestor
92546152|NCT00038493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546153|NCT00038493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546154|NCT00038493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546155|NCT00038532|Ritonavir|ritonavir|mesh-list
92546156|NCT00038532|Saquinavir|saquinavir|mesh-list
92546157|NCT00038532|Amprenavir|amprenavir|mesh-list
92546158|NCT00038532|Efavirenz|efavirenz|mesh-list
92546159|NCT00038532|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92546160|NCT00038532|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92546161|NCT00038532|Protease Inhibitors|protease inhibitors|mesh-ancestor
92546162|NCT00038532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546163|NCT00038532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546164|NCT00038532|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92546165|NCT00038532|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92546166|NCT00038532|Antiviral Agents|antiviral agents|mesh-ancestor
92546167|NCT00038532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546168|NCT00038532|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92546169|NCT00038532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92546170|NCT00038532|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92546187|NCT05770687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546188|NCT05770687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92546189|NCT05770687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546190|NCT05770323|Uric Acid|uric acid|mesh-list
92546191|NCT05770323|Antioxidants|antioxidants|mesh-ancestor
92546192|NCT05770323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546193|NCT05770323|Protective Agents|protective agents|mesh-ancestor
92546194|NCT05770323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546195|NCT05769881|Anesthetics|anesthetics|mesh-list
92546196|NCT05769881|Anesthetics, Local|anesthetics, local|mesh-list
92546197|NCT05769881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546198|NCT05769881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546199|NCT05769881|Sensory System Agents|sensory system agents|mesh-ancestor
92546200|NCT05769881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546201|NCT05769855|Ropivacaine|ropivacaine|mesh-list
92546202|NCT05769855|Anesthetics, Local|anesthetics, local|mesh-ancestor
92546203|NCT05769855|Anesthetics|anesthetics|mesh-ancestor
92546204|NCT05769855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546205|NCT05769855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546206|NCT05769855|Sensory System Agents|sensory system agents|mesh-ancestor
92546207|NCT05769855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546208|NCT05769738|Furosemide|furosemide|mesh-list
92546209|NCT05769738|Diuretics|diuretics|mesh-list
92546210|NCT05769738|Natriuretic Agents|natriuretic agents|mesh-ancestor
92546211|NCT05769738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546212|NCT05769738|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92546213|NCT05769738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92546214|NCT05769738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546215|NCT05769725|Docetaxel|docetaxel|mesh-list
92546216|NCT05769725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546217|NCT05769725|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546218|NCT05769725|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546219|NCT05769725|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546220|NCT05769725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546221|NCT05769660|Temozolomide|temozolomide|mesh-list
92534265|NCT00066586|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92534266|NCT00066586|Hormone Antagonists|hormone antagonists|mesh-ancestor
92546222|NCT05769660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546223|NCT05769660|Alkylating Agents|alkylating agents|mesh-ancestor
92546224|NCT05769660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546225|NCT05769660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546226|NCT05769569|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92546227|NCT05769569|Antiviral Agents|antiviral agents|mesh-ancestor
92546238|NCT05768945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92546239|NCT05768945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546241|NCT05765305|Letrozole|letrozole|mesh-list
92546242|NCT05765305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546243|NCT05765305|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92546244|NCT05765305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92546245|NCT05765305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546246|NCT05765305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546247|NCT05765305|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92546248|NCT05765305|Hormone Antagonists|hormone antagonists|mesh-ancestor
92546249|NCT05765305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92546250|NCT05765305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546251|NCT05765305|Trace Elements|trace elements|mesh-ancestor
92546252|NCT05765305|Micronutrients|micronutrients|mesh-ancestor
92546253|NCT05762146|Perphenazine|perphenazine|mesh-list
92546254|NCT05762146|Riociguat|riociguat|mesh-list
92546255|NCT05762146|Propylthiouracil|propylthiouracil|mesh-list
92546256|NCT05762146|Enzyme Activators|enzyme activators|mesh-ancestor
92546257|NCT05762146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546258|NCT05762146|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92546259|NCT05762146|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92546260|NCT05762146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546261|NCT05762146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546262|NCT05762146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92546263|NCT05762146|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92546264|NCT05762146|Dopamine Agents|dopamine agents|mesh-ancestor
92546265|NCT05762146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546266|NCT05762146|Antimetabolites|antimetabolites|mesh-ancestor
92546267|NCT05762146|Antithyroid Agents|antithyroid agents|mesh-ancestor
92546268|NCT05762146|Hormone Antagonists|hormone antagonists|mesh-ancestor
92546269|NCT05762146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92546270|NCT05760612|Trastuzumab|trastuzumab|mesh-list
92546271|NCT05760612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546272|NCT05760612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546273|NCT05760144|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92546274|NCT05760144|Etonogestrel|etonogestrel|mesh-list
92546275|NCT05760144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92546276|NCT05760144|Contraceptive Agents|contraceptive agents|mesh-ancestor
92546277|NCT05760144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92546278|NCT05760144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546279|NCT05760144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92546280|NCT05760144|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92546281|NCT05760144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92546282|NCT05760144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546283|NCT05744674|Ropivacaine|ropivacaine|mesh-list
92546284|NCT05744674|Anesthetics, Local|anesthetics, local|mesh-ancestor
92546285|NCT05744674|Anesthetics|anesthetics|mesh-ancestor
92546286|NCT05744674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546287|NCT05744674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546288|NCT05744674|Sensory System Agents|sensory system agents|mesh-ancestor
92546289|NCT05744674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546290|NCT05736978|Azacitidine|azacitidine|mesh-list
92546291|NCT05736978|Venetoclax|venetoclax|mesh-list
91953781|NCT05112471|Erythritol|erythritol|mesh-list
92546309|NCT05706727|Autonomic Agents|autonomic agents|mesh-ancestor
92546310|NCT05706727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546311|NCT05706727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546312|NCT05706727|Sympathomimetics|sympathomimetics|mesh-ancestor
92546313|NCT05706727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92546314|NCT05706727|Nasal Decongestants|nasal decongestants|mesh-ancestor
92546315|NCT05706727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92546316|NCT05706727|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92546317|NCT05706727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92537690|NCT02825979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546318|NCT05706727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92546319|NCT05706727|Adrenergic Agents|adrenergic agents|mesh-ancestor
92546320|NCT05706727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546321|NCT05706727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546322|NCT05706727|Protective Agents|protective agents|mesh-ancestor
92546323|NCT05697783|Fentanyl|fentanyl|mesh-list
92546324|NCT05697783|Methadone|methadone|mesh-list
92546325|NCT05697783|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92546326|NCT05697783|Narcotics|narcotics|mesh-ancestor
92546327|NCT05697783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546328|NCT05697783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546329|NCT05697783|Analgesics|analgesics|mesh-ancestor
92546330|NCT05697783|Sensory System Agents|sensory system agents|mesh-ancestor
92546331|NCT05697783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546332|NCT05697783|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92546333|NCT05697783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92546334|NCT05697783|Anesthetics, General|anesthetics, general|mesh-ancestor
92546335|NCT05697783|Anesthetics|anesthetics|mesh-ancestor
92546336|NCT05697783|Antitussive Agents|antitussive agents|mesh-ancestor
92546337|NCT05697783|Respiratory System Agents|respiratory system agents|mesh-ancestor
92546338|NCT05672225|Dexmedetomidine|dexmedetomidine|mesh-list
92546339|NCT05672225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92546340|NCT05672225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354437|NCT00637728|Megestrol|megestrol|mesh-list
92546341|NCT05672225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546342|NCT05672225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546343|NCT05672225|Analgesics|analgesics|mesh-ancestor
92546344|NCT05672225|Sensory System Agents|sensory system agents|mesh-ancestor
92546345|NCT05672225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546346|NCT05672225|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92546347|NCT05672225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92546348|NCT05672225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92546349|NCT05672225|Adrenergic Agents|adrenergic agents|mesh-ancestor
92546350|NCT05672225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546371|NCT05657860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546372|NCT05657860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546373|NCT05619627|Dexmedetomidine|dexmedetomidine|mesh-list
92546374|NCT05619627|Anesthetics|anesthetics|mesh-list
92546375|NCT05619627|Anesthetics, General|anesthetics, general|mesh-list
92546376|NCT05619627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92546377|NCT05619627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546378|NCT05619627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546379|NCT05619627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546380|NCT05619627|Analgesics|analgesics|mesh-ancestor
92546381|NCT05619627|Sensory System Agents|sensory system agents|mesh-ancestor
92546382|NCT05619627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546383|NCT05619627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92546384|NCT05619627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92546385|NCT05619627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92546386|NCT05619627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92546387|NCT05619627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546388|NCT05619627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546389|NCT05615818|Gemcitabine|gemcitabine|mesh-list
92546390|NCT05615818|Trastuzumab|trastuzumab|mesh-list
92546391|NCT05615818|Niraparib|niraparib|mesh-list
92546392|NCT05615818|Ivosidenib|ivosidenib|mesh-list
92546393|NCT05615818|Futibatinib|futibatinib|mesh-list
92546394|NCT05615818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546395|NCT05615818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546396|NCT05615818|Antimetabolites|antimetabolites|mesh-ancestor
92546397|NCT05615818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546398|NCT05615818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546399|NCT05615818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92546400|NCT05615818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546401|NCT05595603|Gentamicins|gentamicins|mesh-list
92546402|NCT05595603|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92546403|NCT05595603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92546404|NCT05595603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546430|NCT05543785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546431|NCT05543785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546432|NCT05543785|Analgesics|analgesics|mesh-ancestor
92546433|NCT05543785|Sensory System Agents|sensory system agents|mesh-ancestor
92546434|NCT05543785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546435|NCT05543785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546436|NCT05543785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546437|NCT05543785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546438|NCT05543785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92546439|NCT05543785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546440|NCT05543785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546441|NCT05457465|Cannabidiol|cannabidiol|mesh-list
92546442|NCT05457465|Anticonvulsants|anticonvulsants|mesh-ancestor
92546443|NCT05453955|Propofol|propofol|mesh-list
92546444|NCT05453955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92546445|NCT05453955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546446|NCT05453955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546447|NCT05453955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92546448|NCT05453955|Anesthetics, General|anesthetics, general|mesh-ancestor
92546449|NCT05453955|Anesthetics|anesthetics|mesh-ancestor
92546450|NCT05427786|Nicorandil|nicorandil|mesh-list
92546451|NCT05427786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92546452|NCT05427786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92546453|NCT05427786|Vasodilator Agents|vasodilator agents|mesh-ancestor
92546454|NCT05427786|Vitamin B Complex|vitamin b complex|mesh-ancestor
92546491|NCT05379322|Analgesics|analgesics|mesh-ancestor
92546503|NCT05301023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546504|NCT05301023|Antitubercular Agents|antitubercular agents|mesh-ancestor
92546505|NCT05298696|Cilostazol|cilostazol|mesh-list
92546506|NCT05298696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92546507|NCT05298696|Autonomic Agents|autonomic agents|mesh-ancestor
92546508|NCT05298696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546509|NCT05298696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546510|NCT05298696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92546511|NCT05298696|Respiratory System Agents|respiratory system agents|mesh-ancestor
92546512|NCT05298696|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92546513|NCT05298696|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92546514|NCT05298696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546515|NCT05298696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92546516|NCT05298696|Vasodilator Agents|vasodilator agents|mesh-ancestor
92546517|NCT05298696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92546518|NCT05298696|Protective Agents|protective agents|mesh-ancestor
92546519|NCT05298696|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92546520|NCT05298696|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92546521|NCT05298696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546522|NCT05287425|Ciprofloxacin|ciprofloxacin|mesh-list
92546523|NCT05287425|Gentamicins|gentamicins|mesh-list
92546524|NCT05287425|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92546525|NCT05287425|Povidone|povidone|mesh-list
92546526|NCT05287425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92546527|NCT05287425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271277|NCT01887587|Hormones|hormones|mesh-ancestor
92546528|NCT05287425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92546529|NCT05287425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92546530|NCT05287425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546531|NCT05287425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546532|NCT05287425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546533|NCT05287425|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92546534|NCT05287425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92546535|NCT05287425|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92546536|NCT05287425|Plasma Substitutes|plasma substitutes|mesh-ancestor
92546537|NCT05287425|Blood Substitutes|blood substitutes|mesh-ancestor
92546538|NCT05287425|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92546539|NCT05276492|Prednisone|prednisone|mesh-list
92546540|NCT05276492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546541|NCT05276492|Glucocorticoids|glucocorticoids|mesh-ancestor
92546542|NCT05276492|Hormones|hormones|mesh-ancestor
92546543|NCT05276492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92546544|NCT05276492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546545|NCT05276492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92546546|NCT05276492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546547|NCT05258721|Fluorides|fluorides|mesh-list
92546548|NCT05258721|Cariostatic Agents|cariostatic agents|mesh-ancestor
92546549|NCT05258721|Protective Agents|protective agents|mesh-ancestor
92546550|NCT05258721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546551|NCT05232032|Nociceptin|nociceptin|mesh-list
92546552|NCT05232032|Vasodilator Agents|vasodilator agents|mesh-ancestor
92546553|NCT05222516|Broncho-Vaxom|broncho-vaxom|mesh-list
92546568|NCT05111717|Desflurane|desflurane|mesh-list
92546569|NCT05111717|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92546570|NCT05111717|Anesthetics, General|anesthetics, general|mesh-ancestor
92546571|NCT05111717|Anesthetics|anesthetics|mesh-ancestor
92534267|NCT00066586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534268|NCT00066586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534269|NCT00066625|Oxaliplatin|oxaliplatin|mesh-list
92534270|NCT00066625|Bortezomib|bortezomib|mesh-list
92534271|NCT00066625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534272|NCT00066859|Sertraline|sertraline|mesh-list
92534273|NCT00066859|Antidepressive Agents|antidepressive agents|mesh-ancestor
92534274|NCT00066859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534275|NCT00066859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92534276|NCT00066859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92534277|NCT00066859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534278|NCT00066859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546572|NCT05111717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546573|NCT05111717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546574|NCT05105919|Aspirin|aspirin|mesh-list
92546575|NCT05105919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546576|NCT05105919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546577|NCT05105919|Analgesics|analgesics|mesh-ancestor
92546578|NCT05105919|Sensory System Agents|sensory system agents|mesh-ancestor
92546579|NCT05105919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546580|NCT05105919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546581|NCT05105919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546582|NCT05105919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546583|NCT05105919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92546584|NCT05105919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92546585|NCT05105919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546586|NCT05105919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92546587|NCT05105919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92546588|NCT05105919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546589|NCT05105919|Antipyretics|antipyretics|mesh-ancestor
92546590|NCT05077527|Cyclophosphamide|cyclophosphamide|mesh-list
92546591|NCT05077527|Fludarabine|fludarabine|mesh-list
92546592|NCT05077527|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92546593|NCT05077527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546594|NCT05077527|Immunologic Factors|immunologic factors|mesh-ancestor
92546595|NCT05077527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546596|NCT05077527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546597|NCT05077527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546598|NCT05077527|Alkylating Agents|alkylating agents|mesh-ancestor
92546599|NCT05077527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546600|NCT05077527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546601|NCT05077527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92546602|NCT05077527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546603|NCT05070364|Interferons|interferons|mesh-list
92546604|NCT05070364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546605|NCT05070364|Antiviral Agents|antiviral agents|mesh-ancestor
92546606|NCT05070364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546607|NCT05054439|Paclitaxel|paclitaxel|mesh-list
92546608|NCT05054439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92546609|NCT05054439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546610|NCT05054439|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546611|NCT05054439|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546612|NCT05054439|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546613|NCT05054439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546614|NCT05049603|Atorvastatin|atorvastatin|mesh-list
91954102|NCT02412878|Hormones|hormones|mesh-ancestor
92546625|NCT05037162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546626|NCT05037162|Hemostatics|hemostatics|mesh-ancestor
92546627|NCT05037162|Coagulants|coagulants|mesh-ancestor
92546628|NCT05024318|Pembrolizumab|pembrolizumab|mesh-list
92546629|NCT05024318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534279|NCT00066859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546630|NCT05024318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546631|NCT05024318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92546632|NCT05024318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546633|NCT05022654|Irinotecan|irinotecan|mesh-list
92546634|NCT05022654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92546635|NCT05022654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92546636|NCT05022654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546637|NCT05022654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546638|NCT05022654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546639|NCT05020457|Paclitaxel|paclitaxel|mesh-list
92546640|NCT05020457|Docetaxel|docetaxel|mesh-list
92546641|NCT05020457|Cisplatin|cisplatin|mesh-list
92546642|NCT05020457|Pemetrexed|pemetrexed|mesh-list
92546643|NCT05020457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92546644|NCT05020457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546645|NCT05020457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546646|NCT05020457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546647|NCT05020457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546648|NCT05020457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546649|NCT05020457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546650|NCT05020457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92546651|NCT05020457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546652|NCT05020444|Cyclophosphamide|cyclophosphamide|mesh-list
92546653|NCT05020444|Fludarabine|fludarabine|mesh-list
92546654|NCT05020444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92354451|NCT01922466|Loxoprofen|loxoprofen|mesh-list
92546655|NCT05020444|Immunologic Factors|immunologic factors|mesh-ancestor
92546656|NCT05020444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546657|NCT05020444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546658|NCT05020444|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546659|NCT05020444|Alkylating Agents|alkylating agents|mesh-ancestor
92546660|NCT05020444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546661|NCT05020444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546662|NCT05020444|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92546663|NCT05012189|Oseltamivir|oseltamivir|mesh-list
92546664|NCT05012189|Baloxavir|baloxavir|mesh-list
92546665|NCT05012189|Antiviral Agents|antiviral agents|mesh-ancestor
92546666|NCT05012189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546667|NCT05012189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546668|NCT05012189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546669|NCT05006573|Benralizumab|benralizumab|mesh-list
92546670|NCT05006573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92546671|NCT05006573|Respiratory System Agents|respiratory system agents|mesh-ancestor
92546672|NCT04985721|Tislelizumab|tislelizumab|mesh-list
92546673|NCT04985721|Pamiparib|pamiparib|mesh-list
92546674|NCT04985721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546675|NCT04985721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546676|NCT04985721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92271418|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
92546677|NCT04985721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546693|NCT04921189|Micronutrients|micronutrients|mesh-ancestor
92546694|NCT04921189|Vitamin B Complex|vitamin b complex|mesh-ancestor
92546695|NCT04921189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546696|NCT04902911|Antibodies|antibodies|mesh-list
92546697|NCT04902911|Immunoglobulin M|immunoglobulin m|mesh-list
92546698|NCT04902911|Immunologic Factors|immunologic factors|mesh-ancestor
92546699|NCT04902911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546700|NCT04864366|Tenofovir|tenofovir|mesh-list
92546701|NCT04864366|Antiviral Agents|antiviral agents|mesh-ancestor
92546702|NCT04864366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546703|NCT04864366|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92546704|NCT04864366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546705|NCT04864366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546706|NCT04864366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546707|NCT04864366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92546708|NCT04864366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92546709|NCT04859296|Dronabinol|dronabinol|mesh-list
92546710|NCT04859296|Hallucinogens|hallucinogens|mesh-ancestor
92546711|NCT04859296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546712|NCT04859296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92546713|NCT04859296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546714|NCT04859296|Analgesics|analgesics|mesh-ancestor
92534281|NCT00066859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534282|NCT04235673|Melatonin|melatonin|mesh-list
92534283|NCT04235673|Antioxidants|antioxidants|mesh-ancestor
92546715|NCT04859296|Sensory System Agents|sensory system agents|mesh-ancestor
92546716|NCT04859296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546717|NCT04859296|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92546718|NCT04859296|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92546719|NCT04859296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546720|NCT04859296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546721|NCT04859296|Hormones|hormones|mesh-ancestor
92546722|NCT04859296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92546723|NCT04857684|Bevacizumab|bevacizumab|mesh-list
92546724|NCT04857684|Atezolizumab|atezolizumab|mesh-list
92546725|NCT04857684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546726|NCT04857684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546727|NCT04857684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92546728|NCT04857684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92546729|NCT04857684|Growth Substances|growth substances|mesh-ancestor
92546730|NCT04857684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546731|NCT04857684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92546732|NCT04857684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92546733|NCT04857684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546734|NCT04854811|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
92546735|NCT04854811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92546755|NCT04846348|Histamine Antagonists|histamine antagonists|mesh-ancestor
92546756|NCT04846348|Histamine Agents|histamine agents|mesh-ancestor
92546757|NCT04846348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546758|NCT04846348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546759|NCT04846348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92546760|NCT04846348|Antipruritics|antipruritics|mesh-ancestor
92546761|NCT04846348|Dermatologic Agents|dermatologic agents|mesh-ancestor
92546762|NCT04846348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546763|NCT04846348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546764|NCT04846348|Analgesics|analgesics|mesh-ancestor
92546765|NCT04846348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546766|NCT04846348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546767|NCT04846348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92546768|NCT04846348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546769|NCT04846348|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92546770|NCT04846348|Immunologic Factors|immunologic factors|mesh-ancestor
92546771|NCT04846348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92546772|NCT04846348|Respiratory System Agents|respiratory system agents|mesh-ancestor
92546773|NCT04844918|Tirzepatide|tirzepatide|mesh-list
92546774|NCT04844918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92546775|NCT04844918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546776|NCT04844918|Incretins|incretins|mesh-ancestor
92546777|NCT04844918|Hormones|hormones|mesh-ancestor
92546778|NCT04844918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92546779|NCT04771520|Piperazine|piperazine|mesh-list
92546780|NCT04771520|Mebendazole|mebendazole|mesh-list
92546781|NCT04771520|Piperazine citrate|piperazine citrate|mesh-list
92546782|NCT04771520|DMP 777|dmp 777|mesh-list
92546783|NCT04771520|Antinematodal Agents|antinematodal agents|mesh-ancestor
92546784|NCT04771520|Anthelmintics|anthelmintics|mesh-ancestor
92546785|NCT04771520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92546786|NCT04771520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546787|NCT04771520|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546788|NCT04771520|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546789|NCT04771520|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546790|NCT04771520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546791|NCT04771520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546792|NCT04771520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546793|NCT04769453|Hyaluronic Acid|hyaluronic acid|mesh-list
91954289|NCT02692339|Hormones|hormones|mesh-ancestor
92546813|NCT04765709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546814|NCT04765709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546815|NCT04765709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546817|NCT04742699|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92546818|NCT04742699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546819|NCT04742699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534284|NCT04235673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534285|NCT04235673|Protective Agents|protective agents|mesh-ancestor
92546820|NCT04742699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92546821|NCT04742699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92546822|NCT04742699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546823|NCT04742699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546825|NCT04654689|Resveratrol|resveratrol|mesh-list
92546826|NCT04654689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546827|NCT04654689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546828|NCT04654689|Analgesics|analgesics|mesh-ancestor
92546829|NCT04654689|Sensory System Agents|sensory system agents|mesh-ancestor
92546830|NCT04654689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546831|NCT04654689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546832|NCT04654689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546833|NCT04654689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546834|NCT04654689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546835|NCT04654689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546836|NCT04654689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546837|NCT04654689|Antioxidants|antioxidants|mesh-ancestor
92546838|NCT04654689|Protective Agents|protective agents|mesh-ancestor
92546839|NCT04654689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92546840|NCT04634838|Copper|copper|mesh-list
92546841|NCT04634838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92546842|NCT04634838|Trace Elements|trace elements|mesh-ancestor
92546843|NCT04634838|Micronutrients|micronutrients|mesh-ancestor
92546844|NCT04634838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546845|NCT04634838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546846|NCT04629534|Cholecalciferol|cholecalciferol|mesh-list
92546847|NCT04629534|Vitamin D|vitamin d|mesh-list
92546848|NCT04629534|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91954343|NCT03437785|Ethanol|ethanol|mesh-list
92546860|NCT04616183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546862|NCT04602065|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92546863|NCT04602065|Immunologic Factors|immunologic factors|mesh-ancestor
92546864|NCT04602065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546865|NCT04598815|Sirolimus|sirolimus|mesh-list
92546866|NCT04598815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92546867|NCT04598815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546868|NCT04598815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92546869|NCT04598815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546870|NCT04598815|Antifungal Agents|antifungal agents|mesh-ancestor
92546871|NCT04598815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546872|NCT04598815|Immunologic Factors|immunologic factors|mesh-ancestor
92546873|NCT04598815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546874|NCT04584112|Paclitaxel|paclitaxel|mesh-list
92546875|NCT04584112|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92546876|NCT04584112|Cyclophosphamide|cyclophosphamide|mesh-list
92546877|NCT04584112|Carboplatin|carboplatin|mesh-list
92546878|NCT04584112|Doxorubicin|doxorubicin|mesh-list
92546879|NCT04584112|Atezolizumab|atezolizumab|mesh-list
92546880|NCT04584112|Molgramostim|molgramostim|mesh-list
92546881|NCT04584112|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92546882|NCT04584112|Lenograstim|lenograstim|mesh-list
92546883|NCT04584112|Sargramostim|sargramostim|mesh-list
92546884|NCT04584112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92546885|NCT04584112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546886|NCT04584112|Tubulin Modulators|tubulin modulators|mesh-ancestor
92546887|NCT04584112|Antimitotic Agents|antimitotic agents|mesh-ancestor
92546888|NCT04584112|Mitosis Modulators|mitosis modulators|mesh-ancestor
92546889|NCT04584112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546890|NCT04584112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546891|NCT04584112|Immunologic Factors|immunologic factors|mesh-ancestor
92546892|NCT04584112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546893|NCT04584112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546894|NCT04584112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92546895|NCT04584112|Alkylating Agents|alkylating agents|mesh-ancestor
92546896|NCT04584112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92546897|NCT04584112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92546898|NCT04584112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92546899|NCT04584112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92546900|NCT04584112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546901|NCT04584112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92546902|NCT04584112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534286|NCT04235673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534287|NCT04235673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534289|NCT00067015|Bicalutamide|bicalutamide|mesh-list
92534290|NCT00067015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92546903|NCT04584112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92546904|NCT04573777|Evolocumab|evolocumab|mesh-list
92546905|NCT04573777|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92546906|NCT04573777|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92546907|NCT04573777|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92546908|NCT04573777|Antimetabolites|antimetabolites|mesh-ancestor
92546909|NCT04573777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546910|NCT04573777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92546911|NCT04573777|Protease Inhibitors|protease inhibitors|mesh-ancestor
92546912|NCT04573777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546913|NCT04573777|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92546914|NCT04507711|Palonosetron|palonosetron|mesh-list
92546915|NCT04507711|Antiemetics|antiemetics|mesh-ancestor
92546934|NCT04499274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92546936|NCT04499274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546937|NCT04499274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546938|NCT04488159|Leucovorin|leucovorin|mesh-list
92546939|NCT04488159|Fluorouracil|fluorouracil|mesh-list
92546940|NCT04488159|Capecitabine|capecitabine|mesh-list
92546941|NCT04488159|Oxaliplatin|oxaliplatin|mesh-list
92546942|NCT04488159|Antimetabolites|antimetabolites|mesh-ancestor
92546943|NCT04488159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546944|NCT04488159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546945|NCT04488159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546946|NCT04488159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546947|NCT04488159|Immunologic Factors|immunologic factors|mesh-ancestor
92546948|NCT04488159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546949|NCT04488159|Antidotes|antidotes|mesh-ancestor
92546950|NCT04488159|Protective Agents|protective agents|mesh-ancestor
92546951|NCT04488159|Vitamin B Complex|vitamin b complex|mesh-ancestor
92546952|NCT04488159|Vitamins|vitamins|mesh-ancestor
92546953|NCT04488159|Micronutrients|micronutrients|mesh-ancestor
92546954|NCT04435691|Azacitidine|azacitidine|mesh-list
92546955|NCT04435691|Venetoclax|venetoclax|mesh-list
92546956|NCT04435691|Magrolimab|magrolimab|mesh-list
92546957|NCT04435691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546958|NCT04435691|Antimetabolites|antimetabolites|mesh-ancestor
92546959|NCT04435691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546960|NCT04435691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546961|NCT04435691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546962|NCT04435691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546963|NCT04376827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92546964|NCT04376827|Immunologic Factors|immunologic factors|mesh-ancestor
92546965|NCT04376827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546966|NCT04351555|Carboplatin|carboplatin|mesh-list
92546967|NCT04351555|Pemetrexed|pemetrexed|mesh-list
92546968|NCT04351555|Osimertinib|osimertinib|mesh-list
92546969|NCT04351555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546970|NCT04351555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546971|NCT04351555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546972|NCT04351555|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92546994|NCT04315948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92546995|NCT04315948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92546996|NCT04315948|Protease Inhibitors|protease inhibitors|mesh-ancestor
92546997|NCT04315948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546998|NCT04315948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546999|NCT04315948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92547000|NCT04315948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92547001|NCT04315948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92547002|NCT04315948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92547003|NCT04315948|Antimalarials|antimalarials|mesh-ancestor
92547004|NCT04315948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92547005|NCT04315948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92547006|NCT04315948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547007|NCT04315948|Immunologic Factors|immunologic factors|mesh-ancestor
92547008|NCT04315948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547009|NCT04315948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92534291|NCT00067015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534292|NCT00067015|Androgen Antagonists|androgen antagonists|mesh-ancestor
92534293|NCT00067015|Hormone Antagonists|hormone antagonists|mesh-ancestor
92547010|NCT04315948|Antimetabolites|antimetabolites|mesh-ancestor
92547011|NCT04300127|Pioglitazone|pioglitazone|mesh-list
92547012|NCT04300127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92547013|NCT04300127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547014|NCT04296305|Hydromorphone|hydromorphone|mesh-list
92547015|NCT04296305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92547016|NCT04296305|Narcotics|narcotics|mesh-ancestor
92547017|NCT04296305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547018|NCT04296305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547019|NCT04296305|Analgesics|analgesics|mesh-ancestor
92547020|NCT04296305|Sensory System Agents|sensory system agents|mesh-ancestor
92547021|NCT04296305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547022|NCT04266236|Ropivacaine|ropivacaine|mesh-list
92547023|NCT04266236|Anesthetics|anesthetics|mesh-ancestor
92547024|NCT04266236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547025|NCT04266236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547026|NCT04266236|Anesthetics, Local|anesthetics, local|mesh-ancestor
92547027|NCT04266236|Sensory System Agents|sensory system agents|mesh-ancestor
92547028|NCT04266236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547065|NCT04199026|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92547066|NCT04199026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547067|NCT04199026|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92547068|NCT04199026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92547069|NCT04199026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547070|NCT04199026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547071|NCT04199026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92547094|NCT04182997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547095|NCT04182997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547096|NCT04182997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547097|NCT04171219|Pembrolizumab|pembrolizumab|mesh-list
92547098|NCT04171219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547099|NCT04171219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547100|NCT04171219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547101|NCT04171219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547102|NCT04167163|Abaloparatide|abaloparatide|mesh-list
92547103|NCT04167163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92547104|NCT04167163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547105|NCT04134936|Lenalidomide|lenalidomide|mesh-list
92547106|NCT04134936|Immunologic Factors|immunologic factors|mesh-ancestor
92547107|NCT04134936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547108|NCT04134936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92547109|NCT04134936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92547110|NCT04134936|Growth Substances|growth substances|mesh-ancestor
92547111|NCT04134936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92547112|NCT04134936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547113|NCT04115111|Durvalumab|durvalumab|mesh-list
92547114|NCT04115111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547115|NCT04115111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547116|NCT04113109|Icatibant|icatibant|mesh-list
92547117|NCT04113109|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92547118|NCT04113109|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92547119|NCT04113109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547120|NCT04113109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92547121|NCT04113109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92547122|NCT04113109|Analgesics|analgesics|mesh-ancestor
92547123|NCT04113109|Sensory System Agents|sensory system agents|mesh-ancestor
92547141|NCT03982693|Anticoagulants|anticoagulants|mesh-ancestor
92547142|NCT03982693|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92547143|NCT03982693|Chelating Agents|chelating agents|mesh-ancestor
92547144|NCT03982693|Sequestering Agents|sequestering agents|mesh-ancestor
92547145|NCT03982693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547146|NCT03982693|Antidotes|antidotes|mesh-ancestor
92547147|NCT03982693|Protective Agents|protective agents|mesh-ancestor
92547148|NCT03982693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547149|NCT03982693|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92534294|NCT00067015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534295|NCT00067015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547151|NCT03965195|Immunologic Factors|immunologic factors|mesh-ancestor
92547152|NCT03965195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547153|NCT03942653|Pembrolizumab|pembrolizumab|mesh-list
92547154|NCT03942653|Goserelin|goserelin|mesh-list
92547155|NCT03942653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547156|NCT03942653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547157|NCT03942653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547158|NCT03942653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547159|NCT03942653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547160|NCT03928314|Paclitaxel|paclitaxel|mesh-list
92547161|NCT03928314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92547162|NCT03928314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547163|NCT03928314|Tubulin Modulators|tubulin modulators|mesh-ancestor
92547164|NCT03928314|Antimitotic Agents|antimitotic agents|mesh-ancestor
92547165|NCT03928314|Mitosis Modulators|mitosis modulators|mesh-ancestor
92547166|NCT03928314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547167|NCT03878082|Acetaminophen|acetaminophen|mesh-list
92547168|NCT03878082|Propacetamol|propacetamol|mesh-list
92547169|NCT03878082|Analgesics|analgesics|mesh-ancestor
92547170|NCT03878082|Sensory System Agents|sensory system agents|mesh-ancestor
92547171|NCT03878082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547172|NCT03878082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547173|NCT03878082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92547174|NCT03878082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92547175|NCT03878082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547176|NCT03878082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547177|NCT03878082|Antipyretics|antipyretics|mesh-ancestor
92547178|NCT03862859|Warfarin|warfarin|mesh-list
92547179|NCT03862859|Anticoagulants|anticoagulants|mesh-ancestor
92547180|NCT03848689|Fluoroquinolones|fluoroquinolones|mesh-list
92547181|NCT03848689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92547206|NCT03737240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92547207|NCT03737240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547209|NCT03737240|Hormones|hormones|mesh-ancestor
92547210|NCT03737240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547211|NCT03732950|Pembrolizumab|pembrolizumab|mesh-list
92547212|NCT03732950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547213|NCT03732950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547214|NCT03732950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547215|NCT03732950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547216|NCT03658447|Pembrolizumab|pembrolizumab|mesh-list
92547217|NCT03658447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547218|NCT03658447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547219|NCT03658447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547220|NCT03658447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547221|NCT03596164|Teduglutide|teduglutide|mesh-list
92547222|NCT03596164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547223|NCT03596164|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92547224|NCT03596164|Protective Agents|protective agents|mesh-ancestor
92547225|NCT03596164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547226|NCT03547908|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92547227|NCT03547908|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92547228|NCT03547908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92547229|NCT03547908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547230|NCT03547908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547231|NCT03547908|Antiviral Agents|antiviral agents|mesh-ancestor
92547232|NCT03547908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547243|NCT03525873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547244|NCT03492125|Rituximab|rituximab|mesh-list
92547245|NCT03492125|Obinutuzumab|obinutuzumab|mesh-list
92547246|NCT03492125|Venetoclax|venetoclax|mesh-list
92547247|NCT03492125|Acalabrutinib|acalabrutinib|mesh-list
92547248|NCT03492125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547249|NCT03492125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547250|NCT03492125|Immunologic Factors|immunologic factors|mesh-ancestor
92547251|NCT03492125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547252|NCT03492125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547253|NCT03427463|Morphine|morphine|mesh-list
92534296|NCT00067093|Vitamin K|vitamin k|mesh-list
92534297|NCT00067093|Heparin|heparin|mesh-list
92534298|NCT00067093|Calcium heparin|calcium heparin|mesh-list
92534299|NCT00067093|Idraparinux|idraparinux|mesh-list
92534300|NCT00067093|Vitamins|vitamins|mesh-ancestor
92547254|NCT03427463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92547255|NCT03427463|Narcotics|narcotics|mesh-ancestor
92547256|NCT03427463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547257|NCT03427463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547258|NCT03427463|Analgesics|analgesics|mesh-ancestor
92547259|NCT03427463|Sensory System Agents|sensory system agents|mesh-ancestor
92547260|NCT03427463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547261|NCT03363867|Bevacizumab|bevacizumab|mesh-list
92547262|NCT03363867|Atezolizumab|atezolizumab|mesh-list
92547263|NCT03363867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547264|NCT03363867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547265|NCT03363867|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92547266|NCT03363867|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92547267|NCT03363867|Growth Substances|growth substances|mesh-ancestor
92547268|NCT03363867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547269|NCT03363867|Growth Inhibitors|growth inhibitors|mesh-ancestor
92547270|NCT03363867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547271|NCT03363867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547272|NCT03356873|Vitamin D|vitamin d|mesh-list
92547273|NCT03356873|Ergocalciferols|ergocalciferols|mesh-list
92547274|NCT03356873|Cholecalciferol|cholecalciferol|mesh-list
92547275|NCT03356873|Vitamins|vitamins|mesh-list
92547276|NCT03356873|Micronutrients|micronutrients|mesh-ancestor
92547277|NCT03356873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547278|NCT03356873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92547279|NCT03356873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92547280|NCT03308578|Atorvastatin|atorvastatin|mesh-list
92547281|NCT03308578|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92547282|NCT03308578|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92547283|NCT03308578|Antimetabolites|antimetabolites|mesh-ancestor
92547284|NCT03308578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547285|NCT03308578|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92116534|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92547286|NCT03308578|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92272026|NCT01915823|Fluticasone|fluticasone|mesh-list
92547287|NCT03308578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547288|NCT03305341|Molgramostim|molgramostim|mesh-list
92547289|NCT03305341|Sargramostim|sargramostim|mesh-list
92547290|NCT03305341|Immunologic Factors|immunologic factors|mesh-ancestor
92547291|NCT03305341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547292|NCT03305341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547293|NCT03255473|Dexamethasone|dexamethasone|mesh-list
92547294|NCT03255473|Dexamethasone acetate|dexamethasone acetate|mesh-list
92547295|NCT03255473|Prednisone|prednisone|mesh-list
92547296|NCT03255473|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92547313|NCT03176277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547315|NCT03173560|Lenvatinib|lenvatinib|mesh-list
92547316|NCT03173560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92547317|NCT03173560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92547318|NCT03173560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547319|NCT03173560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547320|NCT03173560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547321|NCT03173560|Immunologic Factors|immunologic factors|mesh-ancestor
92547322|NCT03173560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547323|NCT03173560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547324|NCT03098225|Methylprednisolone|methylprednisolone|mesh-list
92547325|NCT03098225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92547326|NCT03098225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92547327|NCT03098225|Prednisolone|prednisolone|mesh-list
92547328|NCT03098225|Prednisolone acetate|prednisolone acetate|mesh-list
92547329|NCT03098225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92547330|NCT03098225|Prednisolone phosphate|prednisolone phosphate|mesh-list
92547331|NCT03098225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547332|NCT03098225|Antiemetics|antiemetics|mesh-ancestor
92547333|NCT03098225|Autonomic Agents|autonomic agents|mesh-ancestor
92547334|NCT03098225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547335|NCT03098225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547336|NCT03098225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547337|NCT03098225|Glucocorticoids|glucocorticoids|mesh-ancestor
92547338|NCT03098225|Hormones|hormones|mesh-ancestor
92534301|NCT00067093|Micronutrients|micronutrients|mesh-ancestor
92534302|NCT00067093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534303|NCT00067093|Anticoagulants|anticoagulants|mesh-ancestor
92534304|NCT00067093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92547339|NCT03098225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547340|NCT03098225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92547341|NCT03098225|Protective Agents|protective agents|mesh-ancestor
92547342|NCT03098225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547343|NCT03098225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547344|NCT03017131|Aldesleukin|aldesleukin|mesh-list
92547345|NCT03017131|Cyclophosphamide|cyclophosphamide|mesh-list
92547346|NCT03017131|Decitabine|decitabine|mesh-list
92547347|NCT03017131|Interleukin-2|interleukin-2|mesh-list
92547348|NCT03017131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547349|NCT03017131|Immunologic Factors|immunologic factors|mesh-ancestor
92547350|NCT03017131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547351|NCT03017131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547352|NCT03017131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92547353|NCT03017131|Alkylating Agents|alkylating agents|mesh-ancestor
92547354|NCT03017131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547355|NCT03017131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547372|NCT02940301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547373|NCT02940301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547374|NCT02940301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547375|NCT02882100|Vaccines|vaccines|mesh-list
92547376|NCT02882100|Immunologic Factors|immunologic factors|mesh-ancestor
92547377|NCT02882100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547378|NCT02855944|Paclitaxel|paclitaxel|mesh-list
92547379|NCT02855944|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92547380|NCT02855944|Cisplatin|cisplatin|mesh-list
92547381|NCT02855944|Carboplatin|carboplatin|mesh-list
92547382|NCT02855944|Gemcitabine|gemcitabine|mesh-list
92547383|NCT02855944|Rucaparib|rucaparib|mesh-list
92547384|NCT02855944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92547385|NCT02855944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547386|NCT02855944|Tubulin Modulators|tubulin modulators|mesh-ancestor
92547387|NCT02855944|Antimitotic Agents|antimitotic agents|mesh-ancestor
92547388|NCT02855944|Mitosis Modulators|mitosis modulators|mesh-ancestor
92547389|NCT02855944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547390|NCT02855944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547391|NCT02855944|Antimetabolites|antimetabolites|mesh-ancestor
92547392|NCT02855944|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92547393|NCT02855944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547394|NCT02733185|Vitamins|vitamins|mesh-list
92547395|NCT02733185|Edetic Acid|edetic acid|mesh-list
92547396|NCT02733185|Pentetic Acid|pentetic acid|mesh-list
92547397|NCT02733185|Micronutrients|micronutrients|mesh-ancestor
92547398|NCT02733185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547399|NCT02733185|Anticoagulants|anticoagulants|mesh-ancestor
92547400|NCT02733185|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92547401|NCT02733185|Chelating Agents|chelating agents|mesh-ancestor
92547402|NCT02733185|Sequestering Agents|sequestering agents|mesh-ancestor
92547403|NCT02733185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547404|NCT02733185|Antidotes|antidotes|mesh-ancestor
92547405|NCT02733185|Protective Agents|protective agents|mesh-ancestor
92547406|NCT02733185|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92547407|NCT02603848|Ibuprofen|ibuprofen|mesh-list
92547408|NCT02603848|Morphine|morphine|mesh-list
92547409|NCT02603848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92547410|NCT02603848|Narcotics|narcotics|mesh-ancestor
92547411|NCT02603848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547412|NCT02603848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547413|NCT02603848|Analgesics|analgesics|mesh-ancestor
92547414|NCT02603848|Sensory System Agents|sensory system agents|mesh-ancestor
92547415|NCT02603848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547416|NCT02603848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954882|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
92547446|NCT02471430|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92547447|NCT02471430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547448|NCT02471430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547450|NCT02451943|Olaratumab|olaratumab|mesh-list
92534305|NCT00067093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92547451|NCT02451943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92547452|NCT02451943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547453|NCT02451943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92547454|NCT02451943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92547455|NCT02451943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547456|NCT02451943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547457|NCT02438007|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
92547458|NCT02438007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547459|NCT02438007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547460|NCT02409342|Carboplatin|carboplatin|mesh-list
92547491|NCT02213757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547492|NCT02213757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547494|NCT02120404|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92547495|NCT02120404|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92547496|NCT02120404|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92547497|NCT02120404|Adrenergic Agents|adrenergic agents|mesh-ancestor
92547498|NCT02120404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547499|NCT02120404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547500|NCT02120404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547501|NCT02102243|Insulin|insulin|mesh-list
92547502|NCT02102243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92547503|NCT02102243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92547504|NCT02102243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547505|NCT01969227|Ketamine|ketamine|mesh-list
92547520|NCT01885949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92547521|NCT01885949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547522|NCT01885949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547523|NCT01709734|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
92547524|NCT01709734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547525|NCT01709734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547526|NCT01604135|Riboflavin|riboflavin|mesh-list
92547527|NCT01604135|Dextrans|dextrans|mesh-list
92547528|NCT01604135|Vitamin B Complex|vitamin b complex|mesh-ancestor
92547529|NCT01604135|Vitamins|vitamins|mesh-ancestor
92547530|NCT01604135|Micronutrients|micronutrients|mesh-ancestor
92547531|NCT01604135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547532|NCT01604135|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92547533|NCT01604135|Dermatologic Agents|dermatologic agents|mesh-ancestor
92547534|NCT01604135|Anticoagulants|anticoagulants|mesh-ancestor
92547535|NCT01604135|Plasma Substitutes|plasma substitutes|mesh-ancestor
92547536|NCT01604135|Blood Substitutes|blood substitutes|mesh-ancestor
92547537|NCT00644189|Clofarabine|clofarabine|mesh-list
92547538|NCT00644189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547539|NCT00644189|Antimetabolites|antimetabolites|mesh-ancestor
92547540|NCT00644189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547541|NCT00644189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547542|NCT00630032|Cyclophosphamide|cyclophosphamide|mesh-list
92547543|NCT00630032|Docetaxel|docetaxel|mesh-list
92547544|NCT00630032|Fluorouracil|fluorouracil|mesh-list
92547545|NCT00630032|Epirubicin|epirubicin|mesh-list
92547546|NCT00630032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547547|NCT00630032|Immunologic Factors|immunologic factors|mesh-ancestor
92547548|NCT00630032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547549|NCT00630032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547550|NCT00630032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92547551|NCT00630032|Alkylating Agents|alkylating agents|mesh-ancestor
92547552|NCT00630032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547553|NCT00630032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547554|NCT00630032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92547555|NCT00630032|Tubulin Modulators|tubulin modulators|mesh-ancestor
92547556|NCT00630032|Antimitotic Agents|antimitotic agents|mesh-ancestor
92547557|NCT00630032|Mitosis Modulators|mitosis modulators|mesh-ancestor
92547558|NCT00630032|Antimetabolites|antimetabolites|mesh-ancestor
92547559|NCT00630032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547560|NCT00630032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92547561|NCT00630032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92547562|NCT00630032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92547563|NCT00630032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547564|NCT00465517|Ganaxolone|ganaxolone|mesh-list
92547565|NCT00465517|Neurosteroids|neurosteroids|mesh-ancestor
92547580|NCT00289952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547581|NCT00289952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92547583|NCT05772871|Prednisone|prednisone|mesh-list
92547584|NCT05772871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547585|NCT05772871|Glucocorticoids|glucocorticoids|mesh-ancestor
92547586|NCT05772871|Hormones|hormones|mesh-ancestor
92547587|NCT05772871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547588|NCT05772871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547589|NCT05772871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547590|NCT05772871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547591|NCT05772871|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92547592|NCT05772871|Immunologic Factors|immunologic factors|mesh-ancestor
92547593|NCT05772871|Antinematodal Agents|antinematodal agents|mesh-ancestor
92547594|NCT05772871|Anthelmintics|anthelmintics|mesh-ancestor
92547595|NCT05772871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92547596|NCT05772871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547597|NCT05772871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547598|NCT05772832|Dexmedetomidine|dexmedetomidine|mesh-list
92547600|NCT05772832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92547601|NCT05772832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547602|NCT05772832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547603|NCT05772832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92547604|NCT05772832|Analgesics|analgesics|mesh-ancestor
92547605|NCT05772832|Sensory System Agents|sensory system agents|mesh-ancestor
92547606|NCT05772832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547607|NCT05772832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92547608|NCT05772832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92547609|NCT05772832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92547610|NCT05772832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92547611|NCT05772832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547612|NCT05772832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547613|NCT05772832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92547614|NCT05772832|Narcotics|narcotics|mesh-ancestor
92547615|NCT05772728|Azacitidine|azacitidine|mesh-list
92547616|NCT05772728|Mitoxantrone|mitoxantrone|mesh-list
92547617|NCT05772728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547618|NCT05772728|Antimetabolites|antimetabolites|mesh-ancestor
92547619|NCT05772728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547620|NCT05772728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547621|NCT05772728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547622|NCT05772728|Analgesics|analgesics|mesh-ancestor
92547623|NCT05772728|Sensory System Agents|sensory system agents|mesh-ancestor
92547624|NCT05772728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547625|NCT05772728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116535|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547626|NCT05772728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92547627|NCT05772728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92547644|NCT05772546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547645|NCT05772377|Carboplatin|carboplatin|mesh-list
92547646|NCT05772377|Cisplatin|cisplatin|mesh-list
92547647|NCT05772377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547648|NCT05772208|Nimotuzumab|nimotuzumab|mesh-list
92547649|NCT05772208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547650|NCT05772208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547651|NCT05772039|Listerine|listerine|mesh-list
92547652|NCT05772039|Fluorides|fluorides|mesh-list
92547653|NCT05772039|Sodium Fluoride|sodium fluoride|mesh-list
92547654|NCT05772039|Cariostatic Agents|cariostatic agents|mesh-ancestor
92547655|NCT05772039|Protective Agents|protective agents|mesh-ancestor
92547656|NCT05772039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547657|NCT05772039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92547658|NCT05772039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547659|NCT05772013|Azithromycin|azithromycin|mesh-list
92547660|NCT05772013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92547661|NCT05772013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547662|NCT05771779|Vaccines|vaccines|mesh-list
92547663|NCT05771779|Immunologic Factors|immunologic factors|mesh-ancestor
92547664|NCT05771779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547665|NCT05771675|Simvastatin|simvastatin|mesh-list
92547666|NCT05771675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92547667|NCT05771675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92547668|NCT05771675|Antimetabolites|antimetabolites|mesh-ancestor
92547669|NCT05771675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547670|NCT05771675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92534306|NCT00067093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534307|NCT00067093|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92534309|NCT00067093|Coagulants|coagulants|mesh-ancestor
92547671|NCT05771675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92547672|NCT05771675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547673|NCT05771194|Lubricant Eye Drops|lubricant eye drops|mesh-list
92547674|NCT05771194|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92547675|NCT05771194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92547676|NCT05771181|Vitamin E|vitamin e|mesh-list
92547677|NCT05771181|Tislelizumab|tislelizumab|mesh-list
92547678|NCT05771181|Vitamins|vitamins|mesh-ancestor
92547679|NCT05771181|Micronutrients|micronutrients|mesh-ancestor
92547680|NCT05771181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547681|NCT05771181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547682|NCT05771181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547683|NCT05771181|Antioxidants|antioxidants|mesh-ancestor
92547684|NCT05771181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547685|NCT05771181|Protective Agents|protective agents|mesh-ancestor
92547686|NCT05771038|Alendronate|alendronate|mesh-list
92547708|NCT05770960|Sensory System Agents|sensory system agents|mesh-ancestor
92547709|NCT05770960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547710|NCT05770960|Antitussive Agents|antitussive agents|mesh-ancestor
92547711|NCT05770960|Respiratory System Agents|respiratory system agents|mesh-ancestor
92547712|NCT05770960|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92547713|NCT05769946|Hemay005|hemay005|mesh-list
92547714|NCT05769946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92547715|NCT05769946|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92547716|NCT05769946|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92547717|NCT05769946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547718|NCT05769946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547719|NCT05768282|Prednisolone|prednisolone|mesh-list
92547720|NCT05768282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547721|NCT05768282|Glucocorticoids|glucocorticoids|mesh-ancestor
92547722|NCT05768282|Hormones|hormones|mesh-ancestor
92547723|NCT05768282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547724|NCT05768282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547725|NCT05768282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547726|NCT05768282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547727|NCT05766800|Paclitaxel|paclitaxel|mesh-list
92547728|NCT05766800|Carboplatin|carboplatin|mesh-list
92547729|NCT05766800|Pemetrexed|pemetrexed|mesh-list
92547730|NCT05766800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92547731|NCT05766800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547732|NCT05766800|Tubulin Modulators|tubulin modulators|mesh-ancestor
92547733|NCT05766800|Antimitotic Agents|antimitotic agents|mesh-ancestor
92547734|NCT05766800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92547735|NCT05766800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547736|NCT05766800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547737|NCT05766800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92547738|NCT05766800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92547739|NCT05766410|Letrozole|letrozole|mesh-list
92547740|NCT05766410|Palbociclib|palbociclib|mesh-list
92547741|NCT05766410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547760|NCT05750875|Analgesics|analgesics|mesh-ancestor
92547761|NCT05750875|Sensory System Agents|sensory system agents|mesh-ancestor
92547762|NCT05750875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547763|NCT05750875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547764|NCT05750875|Anticonvulsants|anticonvulsants|mesh-ancestor
92547765|NCT05750875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92547766|NCT05750875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92547767|NCT05750875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547768|NCT05750875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92547769|NCT05750875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92547770|NCT05750875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92547771|NCT05750875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547772|NCT05750875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547773|NCT05750875|Antimanic Agents|antimanic agents|mesh-ancestor
92547774|NCT05750875|Antipruritics|antipruritics|mesh-ancestor
92547775|NCT05750875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92547776|NCT05750875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92534310|NCT00067093|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92534311|NCT00067093|Antithrombins|antithrombins|mesh-ancestor
92534312|NCT00067093|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92534313|NCT00067093|Protease Inhibitors|protease inhibitors|mesh-ancestor
92547777|NCT05750875|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92547778|NCT05750875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92547779|NCT05750875|Histamine Antagonists|histamine antagonists|mesh-ancestor
92547780|NCT05750875|Histamine Agents|histamine agents|mesh-ancestor
92547781|NCT05734794|Rituximab|rituximab|mesh-list
92547782|NCT05734794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547783|NCT05734794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547784|NCT05734794|Immunologic Factors|immunologic factors|mesh-ancestor
92547785|NCT05734794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547786|NCT05734794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547787|NCT05715073|Caffeine|caffeine|mesh-list
92547788|NCT05715073|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92547789|NCT05715073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547790|NCT05715073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92547791|NCT05715073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547792|NCT05715073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547793|NCT05715073|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92547794|NCT05715073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92547795|NCT05715073|Purinergic Agents|purinergic agents|mesh-ancestor
91955261|NCT03415763|Vitamins|vitamins|mesh-ancestor
92547818|NCT05680584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547819|NCT05680584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547821|NCT05680584|Dermatologic Agents|dermatologic agents|mesh-ancestor
92547822|NCT05680584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92547823|NCT05680584|Histamine Antagonists|histamine antagonists|mesh-ancestor
92547824|NCT05680584|Histamine Agents|histamine agents|mesh-ancestor
92547825|NCT05680584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547826|NCT05646992|Azathioprine|azathioprine|mesh-list
92547827|NCT05646992|Tacrolimus|tacrolimus|mesh-list
92547828|NCT05646992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547829|NCT05646992|Immunologic Factors|immunologic factors|mesh-ancestor
92547830|NCT05646992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547831|NCT05646992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92547832|NCT05646992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547833|NCT05646992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547834|NCT05646992|Antimetabolites|antimetabolites|mesh-ancestor
92547835|NCT05646992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547836|NCT05646992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547837|NCT05646992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547838|NCT05637606|Etilefrine|etilefrine|mesh-list
92547839|NCT05637606|Norepinephrine|norepinephrine|mesh-list
92547840|NCT05637606|Ephedrine|ephedrine|mesh-list
92547841|NCT05637606|Pseudoephedrine|pseudoephedrine|mesh-list
92547842|NCT05637606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92547843|NCT05637606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92547844|NCT05637606|Adrenergic Agents|adrenergic agents|mesh-ancestor
92547845|NCT05637606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547846|NCT05637606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547847|NCT05637606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547858|NCT05637606|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92547860|NCT05637606|Protective Agents|protective agents|mesh-ancestor
92547861|NCT05549206|Vaccines|vaccines|mesh-list
92547862|NCT05549206|Immunologic Factors|immunologic factors|mesh-ancestor
92547863|NCT05549206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547864|NCT05533684|Gabapentin|gabapentin|mesh-list
92547865|NCT05533684|Analgesics|analgesics|mesh-ancestor
92547866|NCT05533684|Sensory System Agents|sensory system agents|mesh-ancestor
92547867|NCT05533684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547868|NCT05533684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547869|NCT05533684|Anticonvulsants|anticonvulsants|mesh-ancestor
92547870|NCT05533684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92547871|NCT05533684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92547872|NCT05533684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547873|NCT05533684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92547874|NCT05533684|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92547875|NCT05533684|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92547876|NCT05533684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534314|NCT00067093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534315|NCT00398905|Enoxaparin|enoxaparin|mesh-list
92547877|NCT05533684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547878|NCT05533684|Antimanic Agents|antimanic agents|mesh-ancestor
92547879|NCT05458479|Fluoxetine|fluoxetine|mesh-list
92547880|NCT05458479|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92547881|NCT05458479|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92547882|NCT05458479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92547883|NCT05458479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547884|NCT05458479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547885|NCT05458479|Serotonin Agents|serotonin agents|mesh-ancestor
92547886|NCT05458479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547887|NCT05458479|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92547888|NCT05458479|Antidepressive Agents|antidepressive agents|mesh-ancestor
92547889|NCT05458479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92547890|NCT05458479|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92547891|NCT05458479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92547892|NCT05458479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547893|NCT05423769|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92547894|NCT05423769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92547895|NCT05423769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547896|NCT05423769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547897|NCT05423769|Immunologic Factors|immunologic factors|mesh-ancestor
92547898|NCT05423769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547899|NCT05408247|Acetylcysteine|acetylcysteine|mesh-list
92547900|NCT05408247|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92547901|NCT05408247|Antiviral Agents|antiviral agents|mesh-ancestor
92547902|NCT05408247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547903|NCT05408247|Expectorants|expectorants|mesh-ancestor
92547904|NCT05408247|Respiratory System Agents|respiratory system agents|mesh-ancestor
92547905|NCT05408247|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92547906|NCT05408247|Antioxidants|antioxidants|mesh-ancestor
92547907|NCT05408247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547908|NCT05408247|Protective Agents|protective agents|mesh-ancestor
92547909|NCT05408247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547920|NCT05375942|Dermatologic Agents|dermatologic agents|mesh-ancestor
92547921|NCT05375942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547922|NCT05375942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547924|NCT05209308|Venetoclax|venetoclax|mesh-list
92547925|NCT05209308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547926|NCT05209308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547927|NCT05209308|Immunologic Factors|immunologic factors|mesh-ancestor
92547928|NCT05209308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547929|NCT05209308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547930|NCT05153317|Ivacaftor|ivacaftor|mesh-list
92547931|NCT05153317|Elexacaftor|elexacaftor|mesh-list
92547932|NCT05153317|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92547933|NCT05153317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92547934|NCT05153317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547935|NCT05150015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92547936|NCT05150015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547937|NCT05112848|Vaccines|vaccines|mesh-list
92547938|NCT05112848|Immunologic Factors|immunologic factors|mesh-ancestor
92547939|NCT05112848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547940|NCT05029622|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92547941|NCT05029622|Luteolytic Agents|luteolytic agents|mesh-ancestor
92547942|NCT05029622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92547943|NCT05029622|Contraceptive Agents|contraceptive agents|mesh-ancestor
92547944|NCT05029622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92547945|NCT05029622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547946|NCT05029622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92547947|NCT05029622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547948|NCT05029622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547949|NCT05010122|Decitabine|decitabine|mesh-list
92547950|NCT05010122|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92547951|NCT05010122|Venetoclax|venetoclax|mesh-list
92547952|NCT05010122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547953|NCT05010122|Antimetabolites|antimetabolites|mesh-ancestor
92547954|NCT05010122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547955|NCT05010122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547956|NCT05010122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547957|NCT04916418|Ropivacaine|ropivacaine|mesh-list
92534316|NCT00398905|Rivaroxaban|rivaroxaban|mesh-list
92534317|NCT00398905|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92534318|NCT00398905|Antithrombins|antithrombins|mesh-ancestor
92534319|NCT00398905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92534320|NCT00398905|Protease Inhibitors|protease inhibitors|mesh-ancestor
92547958|NCT04916418|Anesthetics, Local|anesthetics, local|mesh-ancestor
92547959|NCT04916418|Anesthetics|anesthetics|mesh-ancestor
92547960|NCT04916418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547961|NCT04916418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547962|NCT04916418|Sensory System Agents|sensory system agents|mesh-ancestor
92547963|NCT04916418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547964|NCT04899518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92547965|NCT04899518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92547966|NCT04893096|Felzartamab|felzartamab|mesh-list
92547967|NCT04893096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547968|NCT04893096|Immunologic Factors|immunologic factors|mesh-ancestor
92547969|NCT04893096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547970|NCT04892511|Nitroprusside|nitroprusside|mesh-list
92547986|NCT04892511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92547987|NCT04892511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547988|NCT04892511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547989|NCT04892511|Protective Agents|protective agents|mesh-ancestor
92547990|NCT04892511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92547991|NCT04892511|Vasodilator Agents|vasodilator agents|mesh-ancestor
92547992|NCT04892511|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92547993|NCT04892511|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92547994|NCT04892511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92547995|NCT04892511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92547996|NCT04892511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92547997|NCT04892511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92547998|NCT04892511|Serotonin Agents|serotonin agents|mesh-ancestor
92547999|NCT04857333|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92548000|NCT04857333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548001|NCT04855695|Venetoclax|venetoclax|mesh-list
92548002|NCT04855695|Obinutuzumab|obinutuzumab|mesh-list
92548003|NCT04855695|Acalabrutinib|acalabrutinib|mesh-list
92548004|NCT04855695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548005|NCT04855695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548006|NCT04785118|Scopolamine|scopolamine|mesh-list
92548007|NCT04785118|Ondansetron|ondansetron|mesh-list
92548008|NCT04785118|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92548009|NCT04785118|Antiemetics|antiemetics|mesh-ancestor
92548010|NCT04785118|Autonomic Agents|autonomic agents|mesh-ancestor
92548011|NCT04785118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548012|NCT04785118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548013|NCT04785118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548014|NCT04785118|Antipruritics|antipruritics|mesh-ancestor
92548015|NCT04785118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92548016|NCT04785118|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92548017|NCT04785118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92548018|NCT04785118|Serotonin Agents|serotonin agents|mesh-ancestor
92548019|NCT04785118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548020|NCT04785118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548021|NCT04785118|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92548022|NCT04785118|Mydriatics|mydriatics|mesh-ancestor
92548023|NCT04785118|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92548024|NCT04785118|Cholinergic Agents|cholinergic agents|mesh-ancestor
92548025|NCT04785118|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92548026|NCT04785118|Parasympatholytics|parasympatholytics|mesh-ancestor
92548027|NCT04752163|Leucovorin|leucovorin|mesh-list
92548028|NCT04752163|Cytarabine|cytarabine|mesh-list
92548029|NCT04752163|Voriconazole|voriconazole|mesh-list
92548030|NCT04752163|Posaconazole|posaconazole|mesh-list
92548031|NCT04752163|Dexamethasone|dexamethasone|mesh-list
92548032|NCT04752163|Dexamethasone acetate|dexamethasone acetate|mesh-list
92548033|NCT04752163|Prednisone|prednisone|mesh-list
92548034|NCT04752163|Cortisone|cortisone|mesh-list
92548035|NCT04752163|Cyclophosphamide|cyclophosphamide|mesh-list
92548036|NCT04752163|Rituximab|rituximab|mesh-list
92548070|NCT04752163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92548071|NCT04752163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548072|NCT04752163|Antimetabolites|antimetabolites|mesh-ancestor
92548073|NCT04752163|Dermatologic Agents|dermatologic agents|mesh-ancestor
92548074|NCT04752163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92534321|NCT00398905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534322|NCT00398905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534323|NCT00398905|Anticoagulants|anticoagulants|mesh-ancestor
92534324|NCT00398905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92548075|NCT04752163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92548076|NCT04752163|Antiviral Agents|antiviral agents|mesh-ancestor
92548077|NCT04752163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548079|NCT04752163|Protective Agents|protective agents|mesh-ancestor
92548080|NCT04752163|Vitamin B Complex|vitamin b complex|mesh-ancestor
92548095|NCT04752163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92548096|NCT04752163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92548097|NCT04735926|Calcifediol|calcifediol|mesh-list
92548099|NCT04735926|Micronutrients|micronutrients|mesh-ancestor
92548100|NCT04735926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548101|NCT04735926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92548102|NCT04720768|Palbociclib|palbociclib|mesh-list
92548103|NCT04720768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548104|NCT04720768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92548105|NCT04720768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548106|NCT04720768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548107|NCT04702256|Mycophenolic Acid|mycophenolic acid|mesh-list
92548108|NCT04702256|Prednisone|prednisone|mesh-list
92548109|NCT04702256|Methylprednisolone|methylprednisolone|mesh-list
92548110|NCT04702256|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92548111|NCT04702256|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92548112|NCT04702256|Prednisolone|prednisolone|mesh-list
92548113|NCT04702256|Prednisolone acetate|prednisolone acetate|mesh-list
92548114|NCT04702256|Obinutuzumab|obinutuzumab|mesh-list
92548115|NCT04702256|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92548116|NCT04702256|Prednisolone phosphate|prednisolone phosphate|mesh-list
92548117|NCT04702256|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92548118|NCT04702256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92548119|NCT04702256|Glucocorticoids|glucocorticoids|mesh-ancestor
92548120|NCT04702256|Hormones|hormones|mesh-ancestor
92548121|NCT04702256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548122|NCT04702256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548123|NCT04702256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92548124|NCT04702256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548125|NCT04702256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92548126|NCT04702256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92548127|NCT04702256|Antitubercular Agents|antitubercular agents|mesh-ancestor
92548128|NCT04702256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92548129|NCT04702256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548131|NCT04702256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548132|NCT04702256|Antiemetics|antiemetics|mesh-ancestor
92548133|NCT04702256|Autonomic Agents|autonomic agents|mesh-ancestor
92548134|NCT04702256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548135|NCT04702256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548136|NCT04702256|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92548137|NCT04702256|Protective Agents|protective agents|mesh-ancestor
92548138|NCT04702256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548139|NCT04702256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92548140|NCT04702256|Histamine Antagonists|histamine antagonists|mesh-ancestor
92548141|NCT04702256|Histamine Agents|histamine agents|mesh-ancestor
92548142|NCT04702256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548162|NCT04641702|Mydriatics|mydriatics|mesh-ancestor
92548163|NCT04641702|Parasympatholytics|parasympatholytics|mesh-ancestor
92548164|NCT04641702|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92548165|NCT04641702|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92548166|NCT04641702|Cholinergic Agents|cholinergic agents|mesh-ancestor
92548167|NCT04641702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548168|NCT04641702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548169|NCT04624750|Mexiletine|mexiletine|mesh-list
92548170|NCT04624750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92548171|NCT04624750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92548172|NCT04624750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92548173|NCT04624750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548174|NCT04624750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548175|NCT04622553|Mexiletine|mexiletine|mesh-list
92548176|NCT04622553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92548177|NCT04622553|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92534325|NCT00398905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92534326|NCT00067405|Micronutrients|micronutrients|mesh-list
92534327|NCT00067405|Trace Elements|trace elements|mesh-list
92548178|NCT04622553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92548179|NCT04622553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548180|NCT04622553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548182|NCT04616807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92548183|NCT04616807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92548184|NCT04616807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92548185|NCT04616807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548186|NCT04616807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548187|NCT04608630|Zoledronic Acid|zoledronic acid|mesh-list
92548188|NCT04608630|Denosumab|denosumab|mesh-list
92548189|NCT04608630|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92548190|NCT04608630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548191|NCT04603183|Paclitaxel|paclitaxel|mesh-list
92548192|NCT04603183|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92548193|NCT04603183|Letrozole|letrozole|mesh-list
92548194|NCT04603183|Fulvestrant|fulvestrant|mesh-list
92272927|NCT05400993|Epirubicin|epirubicin|mesh-list
92548195|NCT04603183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548196|NCT04603183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548197|NCT04603183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548214|NCT04580134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548215|NCT04580134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548216|NCT04580134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548217|NCT04580134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92548218|NCT04580134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92548219|NCT04580134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548220|NCT04580134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548221|NCT04580134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92548222|NCT04580134|Dopamine Agents|dopamine agents|mesh-ancestor
92548223|NCT04580134|GABA Antagonists|gaba antagonists|mesh-ancestor
92548225|NCT04541108|Pembrolizumab|pembrolizumab|mesh-list
92548226|NCT04541108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548227|NCT04541108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548228|NCT04541108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92548229|NCT04541108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548230|NCT04529954|Valproic Acid|valproic acid|mesh-list
92548231|NCT04529954|Anticonvulsants|anticonvulsants|mesh-ancestor
92548232|NCT04529954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548233|NCT04529954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548234|NCT04529954|GABA Agents|gaba agents|mesh-ancestor
92548235|NCT04529954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548236|NCT04529954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548237|NCT04529954|Antimanic Agents|antimanic agents|mesh-ancestor
92548238|NCT04529954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92548239|NCT04529954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548240|NCT04529954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548241|NCT04525755|Nicotine|nicotine|mesh-list
92548242|NCT04525755|Varenicline|varenicline|mesh-list
92548243|NCT04525755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92548244|NCT04525755|Autonomic Agents|autonomic agents|mesh-ancestor
92548245|NCT04525755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548246|NCT04525755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548247|NCT04525755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92548248|NCT04525755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92548249|NCT04525755|Cholinergic Agents|cholinergic agents|mesh-ancestor
92548250|NCT04525755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548251|NCT04525755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548252|NCT04512079|Enoxaparin|enoxaparin|mesh-list
92548253|NCT04512079|Apixaban|apixaban|mesh-list
92548254|NCT04512079|Anticoagulants|anticoagulants|mesh-ancestor
92548255|NCT04512079|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92548269|NCT04508725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548270|NCT04508725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92548271|NCT04508725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548272|NCT04468165|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92548273|NCT04468165|Dermatologic Agents|dermatologic agents|mesh-ancestor
92548274|NCT04468165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548275|NCT04468165|Immunologic Factors|immunologic factors|mesh-ancestor
92548276|NCT04468165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548277|NCT04437485|Norepinephrine|norepinephrine|mesh-list
92534328|NCT00067405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548278|NCT04437485|Bupropion|bupropion|mesh-list
92548279|NCT04437485|Antidepressive Agents|antidepressive agents|mesh-list
92548280|NCT04437485|Serotonin|serotonin|mesh-list
92548281|NCT04437485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92548282|NCT04437485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92548283|NCT04437485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548284|NCT04437485|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92548285|NCT04437485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92548286|NCT04437485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548287|NCT04437485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548288|NCT04437485|Dopamine Agents|dopamine agents|mesh-ancestor
92548289|NCT04437485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548290|NCT04437485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548291|NCT04437485|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92548292|NCT04437485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92548293|NCT04437485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548294|NCT04437485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92548295|NCT04437485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92548296|NCT04437485|Adrenergic Agents|adrenergic agents|mesh-ancestor
92548297|NCT04437485|Sympathomimetics|sympathomimetics|mesh-ancestor
92548298|NCT04437485|Autonomic Agents|autonomic agents|mesh-ancestor
92548299|NCT04437485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548300|NCT04437485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92548301|NCT04437485|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92548302|NCT04437485|Serotonin Agents|serotonin agents|mesh-ancestor
92548303|NCT04421560|Rituximab|rituximab|mesh-list
92548304|NCT04421560|Pembrolizumab|pembrolizumab|mesh-list
92548305|NCT04421560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548306|NCT04421560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548307|NCT04421560|Immunologic Factors|immunologic factors|mesh-ancestor
92548308|NCT04421560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548309|NCT04421560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92548310|NCT04421560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92548311|NCT04421560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548312|NCT04332341|Niacinamide|niacinamide|mesh-list
92548313|NCT04332341|Niacin|niacin|mesh-list
92548314|NCT04332341|Nicotinic Acids|nicotinic acids|mesh-list
92548315|NCT04332341|Vitamin B Complex|vitamin b complex|mesh-ancestor
92548316|NCT04332341|Vitamins|vitamins|mesh-ancestor
91955773|NCT03412721|Analgesics|analgesics|mesh-list
92548333|NCT04323657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548334|NCT04323657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92548335|NCT04318691|Dimercaprol|dimercaprol|mesh-list
92548336|NCT04318691|Chelating Agents|chelating agents|mesh-ancestor
92548337|NCT04318691|Sequestering Agents|sequestering agents|mesh-ancestor
92548338|NCT04318691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548339|NCT04278092|Paclitaxel|paclitaxel|mesh-list
92548340|NCT04278092|Cetuximab|cetuximab|mesh-list
92548341|NCT04278092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548342|NCT04278092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548343|NCT04278092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548344|NCT04278092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548345|NCT04278092|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548346|NCT04278092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548347|NCT04278092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548349|NCT04240106|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92548350|NCT04240106|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92548351|NCT04240106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548352|NCT04240106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548353|NCT04240106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548354|NCT04240106|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92548355|NCT04240106|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92548356|NCT04240106|Hormone Antagonists|hormone antagonists|mesh-ancestor
92548357|NCT04240106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548358|NCT04240106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548359|NCT04220489|Ketamine|ketamine|mesh-list
92548360|NCT04220489|Analgesics|analgesics|mesh-ancestor
92548361|NCT04220489|Sensory System Agents|sensory system agents|mesh-ancestor
92548362|NCT04220489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548363|NCT04220489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548364|NCT04220489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92534330|NCT00067444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92548365|NCT04220489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92548366|NCT04220489|Anesthetics, General|anesthetics, general|mesh-ancestor
92548367|NCT04220489|Anesthetics|anesthetics|mesh-ancestor
92548368|NCT04220489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548369|NCT04220489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92548370|NCT04220489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92548371|NCT04220489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548372|NCT04220489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548373|NCT04201262|Ravulizumab|ravulizumab|mesh-list
92548392|NCT04189107|Protease Inhibitors|protease inhibitors|mesh-ancestor
92548393|NCT04189107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548394|NCT04189107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548395|NCT04124991|Durvalumab|durvalumab|mesh-list
92548396|NCT04124991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548397|NCT04124991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548398|NCT04123314|Psilocybin|psilocybin|mesh-list
92548399|NCT04123314|Hallucinogens|hallucinogens|mesh-ancestor
92548400|NCT04123314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548401|NCT04123314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548402|NCT04115267|Antineoplastic Agents|antineoplastic agents|mesh-list
92548403|NCT04004221|Tislelizumab|tislelizumab|mesh-list
92548404|NCT04004221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548405|NCT04004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548406|NCT03934567|Abexinostat|abexinostat|mesh-list
92548407|NCT03934567|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92548408|NCT03934567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548409|NCT03934567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548410|NCT03872388|Capecitabine|capecitabine|mesh-list
92548411|NCT03872388|Atorvastatin|atorvastatin|mesh-list
92548412|NCT03872388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548413|NCT03872388|Antimetabolites|antimetabolites|mesh-ancestor
92548414|NCT03872388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548415|NCT03872388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548416|NCT03872388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92548417|NCT03872388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92273154|NCT05736419|Alkylating Agents|alkylating agents|mesh-ancestor
92548418|NCT03872388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92548419|NCT03872388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92548421|NCT03865940|Lidocaine|lidocaine|mesh-list
92548422|NCT03865940|Guanfacine|guanfacine|mesh-list
92548423|NCT03865940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92548424|NCT03865940|Anesthetics|anesthetics|mesh-ancestor
92548425|NCT03865940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548426|NCT03865940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548427|NCT03865940|Sensory System Agents|sensory system agents|mesh-ancestor
92548428|NCT03865940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548429|NCT03865940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91955902|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
92548438|NCT03865940|Adrenergic Agents|adrenergic agents|mesh-ancestor
92548439|NCT03865940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548440|NCT03844997|Palbociclib|palbociclib|mesh-list
92548441|NCT03844997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548442|NCT03844997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92548443|NCT03844997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548444|NCT03844997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548445|NCT03826199|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92548446|NCT03826199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92548447|NCT03826199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92548448|NCT03826199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548449|NCT03826199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548450|NCT03826199|Antiviral Agents|antiviral agents|mesh-ancestor
92548451|NCT03826199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548452|NCT03826199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92548453|NCT03826199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92548454|NCT03776071|Temozolomide|temozolomide|mesh-list
92548455|NCT03776071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92548456|NCT03776071|Alkylating Agents|alkylating agents|mesh-ancestor
92548457|NCT03776071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548458|NCT03776071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534331|NCT00067444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92534332|NCT00067444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548460|NCT03671811|Megestrol Acetate|megestrol acetate|mesh-list
92548461|NCT03671811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92548462|NCT03671811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92548463|NCT03671811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92548464|NCT03671811|Contraceptive Agents|contraceptive agents|mesh-ancestor
92548465|NCT03671811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92548466|NCT03671811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548467|NCT03671811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92548468|NCT03671811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92548469|NCT03671811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92548470|NCT03671811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548471|NCT03671811|Appetite Stimulants|appetite stimulants|mesh-ancestor
92548472|NCT03671811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92548473|NCT03625388|Dasatinib|dasatinib|mesh-list
92548474|NCT03625388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548475|NCT03625388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92548476|NCT03625388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548477|NCT03625388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548478|NCT03589729|Cytarabine|cytarabine|mesh-list
92548479|NCT03589729|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92548480|NCT03589729|Idarubicin|idarubicin|mesh-list
92548481|NCT03589729|Cladribine|cladribine|mesh-list
92548482|NCT03589729|Gemtuzumab|gemtuzumab|mesh-list
92548483|NCT03589729|Dexrazoxane|dexrazoxane|mesh-list
92548484|NCT03589729|Razoxane|razoxane|mesh-list
92548485|NCT03589729|Calicheamicins|calicheamicins|mesh-list
92548486|NCT03589729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548487|NCT03589729|Antimetabolites|antimetabolites|mesh-ancestor
92548488|NCT03589729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548489|NCT03589729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548490|NCT03589729|Antiviral Agents|antiviral agents|mesh-ancestor
92548492|NCT03589729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548493|NCT03589729|Immunologic Factors|immunologic factors|mesh-ancestor
92548494|NCT03589729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548504|NCT03589729|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548505|NCT03589729|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548506|NCT03585686|Cytarabine|cytarabine|mesh-list
92548507|NCT03585686|Vemurafenib|vemurafenib|mesh-list
92548508|NCT03585686|Cladribine|cladribine|mesh-list
92548509|NCT03585686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548510|NCT03585686|Antimetabolites|antimetabolites|mesh-ancestor
92548511|NCT03585686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548512|NCT03585686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548513|NCT03585686|Antiviral Agents|antiviral agents|mesh-ancestor
92548514|NCT03585686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548515|NCT03585686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548516|NCT03585686|Immunologic Factors|immunologic factors|mesh-ancestor
92548517|NCT03585686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548518|NCT03585686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92548519|NCT03585686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548520|NCT03479307|Ketotifen|ketotifen|mesh-list
92548521|NCT03479307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92548522|NCT03479307|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92548523|NCT03479307|Antipruritics|antipruritics|mesh-ancestor
92548524|NCT03479307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92548525|NCT03479307|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92548526|NCT03479307|Histamine Antagonists|histamine antagonists|mesh-ancestor
92548527|NCT03479307|Histamine Agents|histamine agents|mesh-ancestor
92548528|NCT03479307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548529|NCT03479307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548530|NCT03479307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548531|NCT03479307|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92548532|NCT03467867|Rituximab|rituximab|mesh-list
92548533|NCT03467867|Venetoclax|venetoclax|mesh-list
92548534|NCT03467867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548535|NCT03467867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548536|NCT03467867|Immunologic Factors|immunologic factors|mesh-ancestor
92548537|NCT03467867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548538|NCT03467867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92548539|NCT03452111|ST 1435|st 1435|mesh-list
92548540|NCT03452111|Testosterone|testosterone|mesh-list
92548541|NCT03452111|Androgens|androgens|mesh-ancestor
92548542|NCT03452111|Hormones|hormones|mesh-ancestor
92534333|NCT00067444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548543|NCT03452111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548544|NCT03452111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548545|NCT03452111|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92548546|NCT03452111|Contraceptive Agents|contraceptive agents|mesh-ancestor
92548547|NCT03452111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92548548|NCT03452111|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92548549|NCT03390933|Fluoxetine|fluoxetine|mesh-list
92548550|NCT03390933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92548551|NCT03390933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92548552|NCT03390933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548553|NCT03390933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548554|NCT03390933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548555|NCT03390933|Serotonin Agents|serotonin agents|mesh-ancestor
92548556|NCT03390933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548557|NCT03390933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92548558|NCT03390933|Antidepressive Agents|antidepressive agents|mesh-ancestor
92548559|NCT03390933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548560|NCT03390933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91956025|NCT05168137|Colchicine|colchicine|mesh-list
92548586|NCT03338790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548587|NCT03338790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92548588|NCT03338790|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92548589|NCT03338790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548590|NCT03315897|Epoetin Alfa|epoetin alfa|mesh-list
92548591|NCT03315897|Hematinics|hematinics|mesh-ancestor
92548592|NCT03299660|Fluorouracil|fluorouracil|mesh-list
92548593|NCT03299660|Capecitabine|capecitabine|mesh-list
92548595|NCT03299660|Antimetabolites|antimetabolites|mesh-ancestor
92548596|NCT03299660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548597|NCT03299660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548598|NCT03299660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548599|NCT03299660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548600|NCT03299660|Immunologic Factors|immunologic factors|mesh-ancestor
92548601|NCT03299660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548602|NCT03299660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548603|NCT03292458|Sodium Oxybate|sodium oxybate|mesh-list
92548604|NCT03292458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92548605|NCT03292458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92548606|NCT03292458|Anesthetics, General|anesthetics, general|mesh-ancestor
92548607|NCT03292458|Anesthetics|anesthetics|mesh-ancestor
92548608|NCT03292458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548609|NCT03292458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548624|NCT03140358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548625|NCT03140358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548626|NCT02954536|Pembrolizumab|pembrolizumab|mesh-list
92548627|NCT02954536|Fluorouracil|fluorouracil|mesh-list
92548628|NCT02954536|Capecitabine|capecitabine|mesh-list
92548629|NCT02954536|Oxaliplatin|oxaliplatin|mesh-list
92548630|NCT02954536|Trastuzumab|trastuzumab|mesh-list
92548631|NCT02954536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548632|NCT02954536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548633|NCT02954536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92548634|NCT02954536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548635|NCT02954536|Antimetabolites|antimetabolites|mesh-ancestor
92548636|NCT02954536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273374|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548637|NCT02954536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548638|NCT02954536|Immunologic Factors|immunologic factors|mesh-ancestor
92548639|NCT02954536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548640|NCT02899611|Valproic Acid|valproic acid|mesh-list
92548641|NCT02899611|Anticonvulsants|anticonvulsants|mesh-ancestor
92548642|NCT02899611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548643|NCT02899611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548644|NCT02899611|GABA Agents|gaba agents|mesh-ancestor
92548645|NCT02899611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548646|NCT02899611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548647|NCT02899611|Antimanic Agents|antimanic agents|mesh-ancestor
92548648|NCT02899611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92548649|NCT02899611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548650|NCT02899611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534334|NCT00067444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534336|NCT00067444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548651|NCT02750202|Vaccines|vaccines|mesh-list
92548652|NCT02750202|Immunologic Factors|immunologic factors|mesh-ancestor
92548653|NCT02750202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548654|NCT02645266|Aflibercept|aflibercept|mesh-list
92548655|NCT02645266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92548656|NCT02645266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92548657|NCT02645266|Growth Substances|growth substances|mesh-ancestor
92548658|NCT02645266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548659|NCT02645266|Growth Inhibitors|growth inhibitors|mesh-ancestor
92548660|NCT02645266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548661|NCT02634294|Interferons|interferons|mesh-list
92548662|NCT02634294|Interferon-alpha|interferon-alpha|mesh-list
92548663|NCT02634294|Interferon alpha-2|interferon alpha-2|mesh-list
92548664|NCT02634294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92548665|NCT02634294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548666|NCT02634294|Antiviral Agents|antiviral agents|mesh-ancestor
92548667|NCT02634294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548668|NCT02634294|Immunologic Factors|immunologic factors|mesh-ancestor
92548669|NCT02634294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548670|NCT02575677|Oxycodone|oxycodone|mesh-list
92548671|NCT02575677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92548688|NCT02571881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92548689|NCT02571881|Narcotics|narcotics|mesh-ancestor
92548690|NCT02571881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548691|NCT02571881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548692|NCT02571881|Analgesics|analgesics|mesh-ancestor
92548693|NCT02571881|Sensory System Agents|sensory system agents|mesh-ancestor
92548694|NCT02571881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548695|NCT02571881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92548696|NCT02571179|Fentanyl|fentanyl|mesh-list
92548697|NCT02571179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92548698|NCT02571179|Narcotics|narcotics|mesh-ancestor
92548699|NCT02571179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548700|NCT02571179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548701|NCT02571179|Analgesics|analgesics|mesh-ancestor
92548702|NCT02571179|Sensory System Agents|sensory system agents|mesh-ancestor
92548703|NCT02571179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548704|NCT02571179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92548705|NCT02571179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92548706|NCT02571179|Anesthetics, General|anesthetics, general|mesh-ancestor
92548707|NCT02571179|Anesthetics|anesthetics|mesh-ancestor
92548708|NCT02511418|Simvastatin|simvastatin|mesh-list
92548709|NCT02511418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92548710|NCT02511418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92548711|NCT02511418|Antimetabolites|antimetabolites|mesh-ancestor
92548712|NCT02511418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548713|NCT02511418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92273449|NCT03000309|Analgesics|analgesics|mesh-ancestor
92548714|NCT02511418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92548715|NCT02511418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548716|NCT02278250|Carboplatin|carboplatin|mesh-list
92548717|NCT02278250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548718|NCT02250326|Paclitaxel|paclitaxel|mesh-list
92548719|NCT02250326|Azacitidine|azacitidine|mesh-list
92548720|NCT02250326|Cc-486|cc-486|mesh-list
92548721|NCT02250326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548722|NCT02250326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548723|NCT02250326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548724|NCT02250326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548725|NCT02250326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548726|NCT02250326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548727|NCT02250326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548728|NCT02250326|Antimetabolites|antimetabolites|mesh-ancestor
92548729|NCT02250326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548730|NCT02225600|Oxytocin|oxytocin|mesh-list
92548731|NCT02225600|Oxytocics|oxytocics|mesh-ancestor
92548732|NCT02225600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92548759|NCT01526603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92548760|NCT01526603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548761|NCT01526603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548762|NCT01526603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92548763|NCT01526603|Alkylating Agents|alkylating agents|mesh-ancestor
92548764|NCT01526603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92548765|NCT01526603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548766|NCT01526603|Immunologic Factors|immunologic factors|mesh-ancestor
92548767|NCT01526603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548768|NCT01526603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92548769|NCT01526603|Keratolytic Agents|keratolytic agents|mesh-ancestor
92548770|NCT01526603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92548772|NCT00038766|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92548773|NCT00038766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92548774|NCT00038766|Analgesics|analgesics|mesh-ancestor
92548775|NCT00038766|Sensory System Agents|sensory system agents|mesh-ancestor
92548776|NCT00038766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548777|NCT00038766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548778|NCT00038766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92548779|NCT00038766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92548780|NCT00038766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548800|NCT00042315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548801|NCT00042315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548802|NCT00018668|Olanzapine|olanzapine|mesh-list
92548803|NCT00018668|Risperidone|risperidone|mesh-list
92548804|NCT00018668|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92548805|NCT00018668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92548806|NCT00018668|Serotonin Agents|serotonin agents|mesh-ancestor
92548807|NCT00018668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548808|NCT00018668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548809|NCT00018668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548810|NCT00018668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92548811|NCT00018668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92548812|NCT00018668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548813|NCT00018668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548814|NCT00018668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92548815|NCT00018668|Dopamine Agents|dopamine agents|mesh-ancestor
92548816|NCT00018668|Antiemetics|antiemetics|mesh-ancestor
92548817|NCT00018668|Autonomic Agents|autonomic agents|mesh-ancestor
92548818|NCT00018668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548819|NCT00018668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548820|NCT00018668|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92548821|NCT00018668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92548822|NCT00018668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548823|NCT00018668|Antidepressive Agents|antidepressive agents|mesh-ancestor
92548824|NCT00042354|Clofarabine|clofarabine|mesh-list
92548825|NCT00042354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548826|NCT00042354|Antimetabolites|antimetabolites|mesh-ancestor
92548827|NCT00042354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548828|NCT00042354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548829|NCT00042393|Adefovir|adefovir|mesh-list
92548830|NCT00042393|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92548831|NCT00042393|Antiviral Agents|antiviral agents|mesh-ancestor
92548832|NCT00042393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548833|NCT00042393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92548834|NCT00042393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92548835|NCT00042393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354500|NCT00636636|Anticonvulsants|anticonvulsants|mesh-ancestor
92548836|NCT00042393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548837|NCT00042471|Pramlintide|pramlintide|mesh-list
92548849|NCT00042588|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92548850|NCT00042588|Immunologic Factors|immunologic factors|mesh-ancestor
92548851|NCT00042588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548852|NCT00038805|Gemtuzumab|gemtuzumab|mesh-list
92548853|NCT00038805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548854|NCT00038805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548855|NCT00038805|Immunotoxins|immunotoxins|mesh-ancestor
92548856|NCT00038805|Immunoconjugates|immunoconjugates|mesh-ancestor
92548857|NCT00038805|Immunologic Factors|immunologic factors|mesh-ancestor
92548858|NCT00038805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548859|NCT00018824|Naltrexone|naltrexone|mesh-list
92548860|NCT00018824|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92548861|NCT00018824|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92548862|NCT00018824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548863|NCT00018824|Sensory System Agents|sensory system agents|mesh-ancestor
92548864|NCT00018824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548865|NCT00038844|Cyclophosphamide|cyclophosphamide|mesh-list
92548866|NCT00038844|Rituximab|rituximab|mesh-list
92548867|NCT00038844|Fludarabine|fludarabine|mesh-list
92548868|NCT00038844|Fludarabine phosphate|fludarabine phosphate|mesh-list
92548869|NCT00038844|Alemtuzumab|alemtuzumab|mesh-list
92548870|NCT00038844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534337|NCT00067444|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92534338|NCT00067444|Antidepressive Agents|antidepressive agents|mesh-ancestor
92534339|NCT00067444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548871|NCT00038844|Immunologic Factors|immunologic factors|mesh-ancestor
92548872|NCT00038844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548873|NCT00038844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92548874|NCT00038844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92548875|NCT00038844|Alkylating Agents|alkylating agents|mesh-ancestor
92548876|NCT00038844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548877|NCT00038844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548878|NCT00038844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92548879|NCT00038844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548880|NCT00038844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548881|NCT00038844|Antimetabolites|antimetabolites|mesh-ancestor
92548882|NCT00018863|Methylphenidate|methylphenidate|mesh-list
92548883|NCT00018863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92548884|NCT00018863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548885|NCT00018863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92548886|NCT00018863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92548887|NCT00018863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548888|NCT00018863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548889|NCT00018863|Dopamine Agents|dopamine agents|mesh-ancestor
92548890|NCT00018863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548891|NCT00038883|Alemtuzumab|alemtuzumab|mesh-list
92548892|NCT00038883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548893|NCT00038883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548894|NCT00018902|Fluoxetine|fluoxetine|mesh-list
92548895|NCT00018902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92548896|NCT00018902|Citalopram|citalopram|mesh-list
92548897|NCT00018902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92548898|NCT00018902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92548899|NCT00018902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548900|NCT00018902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548921|NCT00038961|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92548922|NCT00038961|Antithrombins|antithrombins|mesh-ancestor
92548923|NCT00038961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92548924|NCT00038961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92548925|NCT00038961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548926|NCT00038961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548927|NCT00038961|Anticoagulants|anticoagulants|mesh-ancestor
92548928|NCT00038961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92548929|NCT00038961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92548930|NCT00019019|Paclitaxel|paclitaxel|mesh-list
92548931|NCT00019019|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92548932|NCT00019019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548933|NCT00019019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548934|NCT00019019|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548935|NCT00019019|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548936|NCT00019019|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548937|NCT00019019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548938|NCT00019019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92548939|NCT00019019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548940|NCT00019019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92548941|NCT00019019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548942|NCT00019058|Hydroxyurea|hydroxyurea|mesh-list
92548943|NCT00019058|Pentoxifylline|pentoxifylline|mesh-list
92548944|NCT00019058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548945|NCT00019058|Antisickling Agents|antisickling agents|mesh-ancestor
92548946|NCT00019058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548947|NCT00019058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548948|NCT00019058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92548949|NCT00019058|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92548950|NCT00019058|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92548951|NCT00019058|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92548952|NCT00019058|Protective Agents|protective agents|mesh-ancestor
92548953|NCT00019058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548954|NCT00019058|Vasodilator Agents|vasodilator agents|mesh-ancestor
92548965|NCT00019097|Melphalan|melphalan|mesh-list
92548966|NCT00019097|Sargramostim|sargramostim|mesh-list
92534340|NCT00067444|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92548967|NCT00019097|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92548968|NCT00019097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92548969|NCT00019097|Alkylating Agents|alkylating agents|mesh-ancestor
92548970|NCT00019097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548971|NCT00019097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548972|NCT00019097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92548973|NCT00019097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548974|NCT00019097|Immunologic Factors|immunologic factors|mesh-ancestor
92548975|NCT00019097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548976|NCT00019097|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92548977|NCT00019136|Aldesleukin|aldesleukin|mesh-list
92548978|NCT00019136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548979|NCT00019136|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92548980|NCT00019136|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92548981|NCT00019136|Antiviral Agents|antiviral agents|mesh-ancestor
92548982|NCT00019136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548983|NCT00039117|Cytarabine|cytarabine|mesh-list
92548984|NCT00039117|Daunorubicin|daunorubicin|mesh-list
92548985|NCT00039117|Oblimersen|oblimersen|mesh-list
92548986|NCT00039117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92548987|NCT00039117|Antimetabolites|antimetabolites|mesh-ancestor
92548988|NCT00039117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548989|NCT00039117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548990|NCT00039117|Antiviral Agents|antiviral agents|mesh-ancestor
92548991|NCT00039117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548992|NCT00039117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548993|NCT00039117|Immunologic Factors|immunologic factors|mesh-ancestor
92548994|NCT00039117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548995|NCT00039117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92548996|NCT00039117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92548997|NCT00039117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92548998|NCT00039117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548999|NCT00019175|Aldesleukin|aldesleukin|mesh-list
92549000|NCT00019175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549001|NCT00019175|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549002|NCT00019175|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549003|NCT00019175|Antiviral Agents|antiviral agents|mesh-ancestor
92549004|NCT00019175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549005|NCT00039156|IDN 5109|idn 5109|mesh-list
92549006|NCT00039156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549007|NCT00019214|Aldesleukin|aldesleukin|mesh-list
92549008|NCT00019214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549009|NCT00019214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549010|NCT00019214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549011|NCT00019214|Antiviral Agents|antiviral agents|mesh-ancestor
92549012|NCT00019214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549013|NCT00039234|Aldesleukin|aldesleukin|mesh-list
92549014|NCT00039234|Histamine|histamine|mesh-list
92549015|NCT00039234|Histamine phosphate|histamine phosphate|mesh-list
92549016|NCT00039234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549017|NCT00039234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549018|NCT00039234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549019|NCT00039234|Antiviral Agents|antiviral agents|mesh-ancestor
92549020|NCT00039234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549021|NCT00039234|Histamine Agonists|histamine agonists|mesh-ancestor
92549022|NCT00039234|Histamine Agents|histamine agents|mesh-ancestor
92549023|NCT00039234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92549035|NCT00039273|Panitumumab|panitumumab|mesh-list
92549036|NCT00039273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92549037|NCT00039273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549038|NCT00019409|Cytarabine|cytarabine|mesh-list
92549039|NCT00019409|Prednisone|prednisone|mesh-list
92549040|NCT00019409|Hydrocortisone|hydrocortisone|mesh-list
92549041|NCT00019409|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92549042|NCT00019409|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92549043|NCT00019409|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92549044|NCT00019409|Cyclophosphamide|cyclophosphamide|mesh-list
92549045|NCT00019409|Methotrexate|methotrexate|mesh-list
92549046|NCT00019409|Vincristine|vincristine|mesh-list
92549047|NCT00019409|Daunorubicin|daunorubicin|mesh-list
92549048|NCT00019409|Asparaginase|asparaginase|mesh-list
92549049|NCT00019409|Mercaptopurine|mercaptopurine|mesh-list
92549050|NCT00019409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549051|NCT00019409|Immunologic Factors|immunologic factors|mesh-ancestor
92549052|NCT00019409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549053|NCT00019409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549054|NCT00019409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92534341|NCT00067444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92534342|NCT00067444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549055|NCT00019409|Alkylating Agents|alkylating agents|mesh-ancestor
92549056|NCT00019409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549057|NCT00019409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549058|NCT00019409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549059|NCT00019409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92549060|NCT00019409|Glucocorticoids|glucocorticoids|mesh-ancestor
92549061|NCT00019409|Hormones|hormones|mesh-ancestor
92549062|NCT00019409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549063|NCT00019409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549064|NCT00019409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92549065|NCT00019409|Abortifacient Agents|abortifacient agents|mesh-ancestor
92549066|NCT00019409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92549067|NCT00019409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549068|NCT00019409|Antimetabolites|antimetabolites|mesh-ancestor
92549069|NCT00019409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549070|NCT00019409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549071|NCT00019409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92549072|NCT00019409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92549073|NCT00019409|Antiviral Agents|antiviral agents|mesh-ancestor
92549074|NCT00019409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549075|NCT00019409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549076|NCT00019409|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549077|NCT00019409|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549078|NCT00019409|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549079|NCT00019409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549080|NCT00019409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549081|NCT00019409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549082|NCT00019448|Interleukin-2|interleukin-2|mesh-list
92549083|NCT00019448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549084|NCT00019448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92549085|NCT00019448|Analgesics|analgesics|mesh-ancestor
92549086|NCT00019448|Sensory System Agents|sensory system agents|mesh-ancestor
92549087|NCT00019448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549088|NCT00019448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549108|NCT00039351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549110|NCT00039351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549111|NCT00039351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92549112|NCT00039351|Glucocorticoids|glucocorticoids|mesh-ancestor
92549113|NCT00039351|Hormones|hormones|mesh-ancestor
92549114|NCT00039351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549115|NCT00039351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549116|NCT00039351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549117|NCT00039351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549118|NCT00039351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549119|NCT00039351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549120|NCT00019565|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92549121|NCT00019565|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92549122|NCT00019565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549123|NCT00039390|Capecitabine|capecitabine|mesh-list
92549124|NCT00039390|Gefitinib|gefitinib|mesh-list
92549125|NCT00039390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549126|NCT00039390|Antimetabolites|antimetabolites|mesh-ancestor
92549127|NCT00039390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549128|NCT00039390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549129|NCT00039390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549130|NCT00039390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549131|NCT00019721|Aldesleukin|aldesleukin|mesh-list
92549132|NCT00019721|Freund's Adjuvant|freund's adjuvant|mesh-list
92549133|NCT00019721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549134|NCT00019721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549135|NCT00019721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549136|NCT00019721|Antiviral Agents|antiviral agents|mesh-ancestor
92549137|NCT00019721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549138|NCT00019721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92549139|NCT00019721|Immunologic Factors|immunologic factors|mesh-ancestor
92549140|NCT00019721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549141|NCT00019760|Leucovorin|leucovorin|mesh-list
92549142|NCT00019760|Melphalan|melphalan|mesh-list
92549143|NCT00019760|Floxuridine|floxuridine|mesh-list
92534343|NCT00399022|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92549145|NCT00019760|Levoleucovorin|levoleucovorin|mesh-list
92549146|NCT00019760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549147|NCT00019760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549177|NCT00039468|Growth Substances|growth substances|mesh-ancestor
92549178|NCT00039468|Growth Inhibitors|growth inhibitors|mesh-ancestor
92549179|NCT00019838|Fludarabine|fludarabine|mesh-list
92549180|NCT00019838|Fludarabine phosphate|fludarabine phosphate|mesh-list
92549181|NCT00019838|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92549182|NCT00019838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549183|NCT00019838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549184|NCT00019838|Antimetabolites|antimetabolites|mesh-ancestor
92549185|NCT00019838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549186|NCT00019838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549187|NCT00019838|Immunologic Factors|immunologic factors|mesh-ancestor
92549188|NCT00019838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549189|NCT00019838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549190|NCT00019838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549191|NCT00019916|Aldesleukin|aldesleukin|mesh-list
92549192|NCT00019916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549193|NCT00019916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549210|NCT00039546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549211|NCT00039546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549212|NCT00039546|Alkylating Agents|alkylating agents|mesh-ancestor
92549213|NCT00039546|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549214|NCT00039546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549215|NCT00039546|Antimetabolites|antimetabolites|mesh-ancestor
92549216|NCT00039546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549217|NCT00039546|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549218|NCT00039546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549219|NCT00039546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549220|NCT00039585|Imatinib Mesylate|imatinib mesylate|mesh-list
92549221|NCT00039585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549222|NCT00039585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549223|NCT00039585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549224|NCT00039585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549225|NCT00019994|Aldesleukin|aldesleukin|mesh-list
92549226|NCT00019994|Freund's Adjuvant|freund's adjuvant|mesh-list
92549227|NCT00019994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549228|NCT00019994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549229|NCT00019994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549230|NCT00019994|Antiviral Agents|antiviral agents|mesh-ancestor
92549231|NCT00019994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549232|NCT00019994|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92549233|NCT00019994|Immunologic Factors|immunologic factors|mesh-ancestor
92549234|NCT00019994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549235|NCT00039663|Rosiglitazone|rosiglitazone|mesh-list
92549236|NCT00039663|Pravastatin|pravastatin|mesh-list
92549237|NCT00039663|Gemfibrozil|gemfibrozil|mesh-list
92549238|NCT00039663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92549239|NCT00039663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549240|NCT00039663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92549241|NCT00039663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92549242|NCT00039663|Antimetabolites|antimetabolites|mesh-ancestor
92549243|NCT00039663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549244|NCT00039663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92549245|NCT00039663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92549246|NCT00039663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549247|NCT00039663|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92549248|NCT00039663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92273970|NCT01685684|Narcotics|narcotics|mesh-ancestor
92549249|NCT00020111|Arsenic Trioxide|arsenic trioxide|mesh-list
92549250|NCT00020111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549251|NCT00020150|Temozolomide|temozolomide|mesh-list
91956713|NCT03391609|Analgesics|analgesics|mesh-ancestor
92549283|NCT00020189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549284|NCT00020189|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92549285|NCT00020189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92549286|NCT00020189|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92549287|NCT00020189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549288|NCT00020189|Antipyretics|antipyretics|mesh-ancestor
92549289|NCT00020189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549290|NCT00020189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534344|NCT00399022|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92534345|NCT00399022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92549292|NCT00020189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549293|NCT00039975|Ritonavir|ritonavir|mesh-list
92549311|NCT00039975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549312|NCT00039975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549314|NCT00020267|Interleukin-2|interleukin-2|mesh-list
92549315|NCT00020267|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92549316|NCT00020267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549317|NCT00020267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92549318|NCT00020267|Analgesics|analgesics|mesh-ancestor
92549319|NCT00020267|Sensory System Agents|sensory system agents|mesh-ancestor
92549320|NCT00020267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549321|NCT00020267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549322|NCT00020267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92549323|NCT00020267|Immunologic Factors|immunologic factors|mesh-ancestor
92549324|NCT00040014|Exemestane|exemestane|mesh-list
92549325|NCT00040014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549326|NCT00040014|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92549327|NCT00040014|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92549328|NCT00040014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549329|NCT00040014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549330|NCT00040014|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92549331|NCT00040014|Hormone Antagonists|hormone antagonists|mesh-ancestor
92549332|NCT00040014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549333|NCT00040014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549334|NCT00020345|Gemcitabine|gemcitabine|mesh-list
92549335|NCT00020345|Fluorouracil|fluorouracil|mesh-list
92549336|NCT00020345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549337|NCT00020345|Antimetabolites|antimetabolites|mesh-ancestor
92549338|NCT00020345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549339|NCT00020345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549340|NCT00020345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549341|NCT00020345|Immunologic Factors|immunologic factors|mesh-ancestor
92549342|NCT00020345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549343|NCT00040053|Ondansetron|ondansetron|mesh-list
92549344|NCT00040053|Antiemetics|antiemetics|mesh-ancestor
92549345|NCT00040053|Autonomic Agents|autonomic agents|mesh-ancestor
92549346|NCT00040053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549347|NCT00040053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549348|NCT00040053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549349|NCT00040053|Antipruritics|antipruritics|mesh-ancestor
92549350|NCT00040053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549365|NCT00020501|Irinotecan|irinotecan|mesh-list
92549366|NCT00020501|Melphalan|melphalan|mesh-list
92549367|NCT00020501|Calcium|calcium|mesh-list
92549368|NCT00020501|Levoleucovorin|levoleucovorin|mesh-list
92549369|NCT00020501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549370|NCT00020501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549371|NCT00020501|Antimetabolites|antimetabolites|mesh-ancestor
92549372|NCT00020501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549373|NCT00020501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549374|NCT00020501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549375|NCT00020501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549376|NCT00020501|Immunologic Factors|immunologic factors|mesh-ancestor
92549377|NCT00020501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92549378|NCT00020501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549379|NCT00020501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549380|NCT00020501|Antidotes|antidotes|mesh-ancestor
92549381|NCT00020501|Protective Agents|protective agents|mesh-ancestor
92549382|NCT00020501|Vitamin B Complex|vitamin b complex|mesh-ancestor
92549383|NCT00020501|Vitamins|vitamins|mesh-ancestor
92549384|NCT00020501|Micronutrients|micronutrients|mesh-ancestor
92549385|NCT00020501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549386|NCT00020501|Alkylating Agents|alkylating agents|mesh-ancestor
92549387|NCT00020501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549388|NCT00020540|Flt3 ligand protein|flt3 ligand protein|mesh-list
92549389|NCT00020540|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92549390|NCT00020540|Immunologic Factors|immunologic factors|mesh-ancestor
92549391|NCT00020540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534346|NCT00399022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534347|NCT00399022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549392|NCT00020540|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92549393|NCT00020540|Protective Agents|protective agents|mesh-ancestor
92549394|NCT00020579|Entinostat|entinostat|mesh-list
92549395|NCT00020579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549396|NCT00020579|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92549397|NCT00020579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549398|NCT00020579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549399|NCT00040209|Levodopa|levodopa|mesh-list
92549400|NCT00040209|Apomorphine|apomorphine|mesh-list
92549401|NCT00040209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92549402|NCT00040209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92549403|NCT00040209|Dopamine Agents|dopamine agents|mesh-ancestor
92549404|NCT00040209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92549405|NCT00040209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549406|NCT00040209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549407|NCT00040209|Emetics|emetics|mesh-ancestor
92549408|NCT00040209|Autonomic Agents|autonomic agents|mesh-ancestor
92549409|NCT00040209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549410|NCT00040209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549411|NCT00040209|Dopamine Agonists|dopamine agonists|mesh-ancestor
92549412|NCT00040248|Daclizumab|daclizumab|mesh-list
92549413|NCT00040248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91956868|NCT00540839|Xhance|xhance|mesh-list
92549431|NCT00020657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549433|NCT00020657|Antipruritics|antipruritics|mesh-ancestor
92549434|NCT00020657|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549435|NCT00020657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92549436|NCT00020657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92549437|NCT00020657|Serotonin Agents|serotonin agents|mesh-ancestor
92549438|NCT00020657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92549439|NCT00020657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549440|NCT00020657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92549441|NCT00020657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92549442|NCT00020657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92549443|NCT00020657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92549444|NCT00020657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92549445|NCT00020657|Dopamine Agents|dopamine agents|mesh-ancestor
92549446|NCT00040326|Anticonvulsants|anticonvulsants|mesh-list
92549447|NCT00020696|Tirapazamine|tirapazamine|mesh-list
92549448|NCT00020696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549449|NCT02970630|Everolimus|everolimus|mesh-list
92549450|NCT02970630|Tacrolimus|tacrolimus|mesh-list
92549451|NCT02970630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549452|NCT02970630|Immunologic Factors|immunologic factors|mesh-ancestor
92549453|NCT02970630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549454|NCT02970630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92549455|NCT02970630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549456|NCT02970630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549457|NCT02970630|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92549458|NCT02970630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549459|NCT02970630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549460|NCT00020735|Toremifene|toremifene|mesh-list
92549461|NCT00020735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549462|NCT00020735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549463|NCT00020735|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92549464|NCT00020735|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92549465|NCT00020735|Hormone Antagonists|hormone antagonists|mesh-ancestor
92549466|NCT00020735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549467|NCT00020735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549468|NCT00020735|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92549469|NCT00040482|Cyclophosphamide|cyclophosphamide|mesh-list
92549470|NCT00040482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549471|NCT00040482|Immunologic Factors|immunologic factors|mesh-ancestor
92549472|NCT00040482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549491|NCT00020930|Cetuximab|cetuximab|mesh-list
92549492|NCT00020930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92549493|NCT00020930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549494|NCT00020969|Arsenic Trioxide|arsenic trioxide|mesh-list
92549495|NCT00020969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549496|NCT00040794|Paclitaxel|paclitaxel|mesh-list
92549497|NCT00040794|Carboplatin|carboplatin|mesh-list
92534348|NCT00399022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534349|NCT00399022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549498|NCT00040794|Gefitinib|gefitinib|mesh-list
92549499|NCT00040794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549500|NCT00040794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549501|NCT00040794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549502|NCT00040794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549503|NCT00040794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549504|NCT00040794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549505|NCT00040794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549506|NCT00040794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549507|NCT00021047|Carboplatin|carboplatin|mesh-list
92549508|NCT00021047|Capecitabine|capecitabine|mesh-list
92549509|NCT00021047|Epirubicin|epirubicin|mesh-list
92549510|NCT00021047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549511|NCT00021047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549512|NCT00021047|Antimetabolites|antimetabolites|mesh-ancestor
92549513|NCT00021047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549514|NCT00021047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549515|NCT00021047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549516|NCT00021047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549517|NCT00021047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549518|NCT00021164|Aldesleukin|aldesleukin|mesh-list
92549519|NCT00021164|Freund's Adjuvant|freund's adjuvant|mesh-list
92549520|NCT00021164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549521|NCT00021164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549522|NCT00021164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549523|NCT00021164|Antiviral Agents|antiviral agents|mesh-ancestor
92549524|NCT00021164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549525|NCT00021164|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92549526|NCT00021164|Immunologic Factors|immunologic factors|mesh-ancestor
92549527|NCT00021164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549528|NCT00040872|Cyclophosphamide|cyclophosphamide|mesh-list
92549529|NCT00040872|Thiotepa|thiotepa|mesh-list
92549530|NCT00040872|Carboplatin|carboplatin|mesh-list
92549531|NCT00040872|Doxorubicin|doxorubicin|mesh-list
92549552|NCT00040872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549553|NCT00040872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92274269|NCT03440229|Laxatives|laxatives|mesh-ancestor
92549554|NCT00040872|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549555|NCT00040872|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549556|NCT00040872|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549557|NCT00040872|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92549558|NCT00040872|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549559|NCT00021242|Docetaxel|docetaxel|mesh-list
92549560|NCT00021242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549561|NCT00021242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549562|NCT00021242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549563|NCT00021242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549564|NCT00021242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549565|NCT00040950|Rituximab|rituximab|mesh-list
92549566|NCT00040950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92549567|NCT00040950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549568|NCT00040950|Immunologic Factors|immunologic factors|mesh-ancestor
92549569|NCT00040950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549570|NCT00040950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549571|NCT00040989|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92549572|NCT00040989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549573|NCT00021281|Leucovorin|leucovorin|mesh-list
92549574|NCT00021281|Fluorouracil|fluorouracil|mesh-list
92549575|NCT00021281|Irinotecan|irinotecan|mesh-list
92549576|NCT00021281|Calcium|calcium|mesh-list
92549577|NCT00021281|Levoleucovorin|levoleucovorin|mesh-list
92549578|NCT00021281|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549579|NCT00021281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549580|NCT00021281|Antimetabolites|antimetabolites|mesh-ancestor
92549581|NCT00021281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549582|NCT00021281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549583|NCT00021281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549584|NCT00021281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549585|NCT00021281|Immunologic Factors|immunologic factors|mesh-ancestor
92549586|NCT00021281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91957040|NCT03388151|Anesthetics|anesthetics|mesh-ancestor
92549599|NCT00041106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549600|NCT00041106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92534350|NCT00399022|Analgesics|analgesics|mesh-ancestor
92534351|NCT00399022|Sensory System Agents|sensory system agents|mesh-ancestor
92534352|NCT00399022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534353|NCT00399022|Antidepressive Agents|antidepressive agents|mesh-ancestor
92549601|NCT00041106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549602|NCT00021320|Paclitaxel|paclitaxel|mesh-list
92549603|NCT00021320|Fluorouracil|fluorouracil|mesh-list
92549604|NCT00021320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549605|NCT00021320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549606|NCT00021320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549607|NCT00021320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549608|NCT00021320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549609|NCT00021320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549610|NCT00021320|Antimetabolites|antimetabolites|mesh-ancestor
92549611|NCT00021320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549612|NCT00021320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549613|NCT00021320|Immunologic Factors|immunologic factors|mesh-ancestor
92549614|NCT00021320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549615|NCT00041223|Proanthocyanidin|proanthocyanidin|mesh-list
92549616|NCT00041223|Procyanidin|procyanidin|mesh-list
92549617|NCT00041223|Antioxidants|antioxidants|mesh-ancestor
92549618|NCT00041223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549619|NCT00041223|Protective Agents|protective agents|mesh-ancestor
92549620|NCT00041223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549621|NCT00041223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92549622|NCT00041223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92549623|NCT00041223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549624|NCT00021359|Dexamethasone|dexamethasone|mesh-list
92549625|NCT00021359|Isotretinoin|isotretinoin|mesh-list
92549626|NCT00021359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92549627|NCT00021359|Antiemetics|antiemetics|mesh-ancestor
92549628|NCT00021359|Autonomic Agents|autonomic agents|mesh-ancestor
92549629|NCT00021359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549630|NCT00021359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549631|NCT00021359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549632|NCT00021359|Glucocorticoids|glucocorticoids|mesh-ancestor
92549633|NCT00021359|Hormones|hormones|mesh-ancestor
92549634|NCT00021359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549635|NCT00021359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549636|NCT00021359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549637|NCT00021359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549638|NCT00041262|Fluorouracil|fluorouracil|mesh-list
92549639|NCT00041262|Epirubicin|epirubicin|mesh-list
92549640|NCT00041262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549641|NCT00041262|Antimetabolites|antimetabolites|mesh-ancestor
92549642|NCT00041262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549643|NCT00041262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549644|NCT00041262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549645|NCT00041262|Immunologic Factors|immunologic factors|mesh-ancestor
92549646|NCT00041262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549647|NCT00041262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549648|NCT00041262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549649|NCT00041262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549650|NCT00041262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549651|NCT00021398|Leucovorin|leucovorin|mesh-list
92549652|NCT00021398|Fluorouracil|fluorouracil|mesh-list
92549669|NCT00048945|Antiviral Agents|antiviral agents|mesh-ancestor
92549670|NCT00048945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549671|NCT00021554|Enfuvirtide|enfuvirtide|mesh-list
92549672|NCT00021554|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92549673|NCT00021554|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92549674|NCT00021554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549675|NCT00021554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549676|NCT00021554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549677|NCT00021554|Antiviral Agents|antiviral agents|mesh-ancestor
92549678|NCT00021554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549679|NCT00049023|Octreotide|octreotide|mesh-list
92549680|NCT00049023|Edotreotide|edotreotide|mesh-list
92549681|NCT00049023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549682|NCT00049023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549683|NCT00049023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534354|NCT00399022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534355|NCT00399022|Dopamine Agents|dopamine agents|mesh-ancestor
92534356|NCT00065533|Pemetrexed|pemetrexed|mesh-list
92534357|NCT00065533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549684|NCT00049023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92549685|NCT00049023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549686|NCT00021671|Metronidazole|metronidazole|mesh-list
92549687|NCT00021671|Nevirapine|nevirapine|mesh-list
92549688|NCT00021671|Erythromycin|erythromycin|mesh-list
92549689|NCT00021671|Erythromycin Estolate|erythromycin estolate|mesh-list
92549690|NCT00021671|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92549691|NCT00021671|Erythromycin stearate|erythromycin stearate|mesh-list
92549692|NCT00021671|Ampicillin|ampicillin|mesh-list
92549693|NCT00021671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549694|NCT00021671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92549695|NCT00021671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92549696|NCT00021671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92549697|NCT00021671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92549698|NCT00021671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92549699|NCT00021671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549700|NCT00021671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549701|NCT00021671|Antiviral Agents|antiviral agents|mesh-ancestor
92549702|NCT00021671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549703|NCT00021671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549704|NCT00021671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92549705|NCT00021671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92549706|NCT00021671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549707|NCT00021671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92549708|NCT00049062|Gefitinib|gefitinib|mesh-list
92549709|NCT00049062|Anastrozole|anastrozole|mesh-list
92549710|NCT00049062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549711|NCT00049062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549712|NCT00049062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957162|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
92549730|NCT00049101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549731|NCT00049101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549732|NCT00049101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549733|NCT00049101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549734|NCT00049101|Immunologic Factors|immunologic factors|mesh-ancestor
92549736|NCT00049101|Protective Agents|protective agents|mesh-ancestor
92549737|NCT00049101|Vitamin B Complex|vitamin b complex|mesh-ancestor
92549738|NCT00049101|Vitamins|vitamins|mesh-ancestor
92549739|NCT00049101|Micronutrients|micronutrients|mesh-ancestor
92549740|NCT00049101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549741|NCT00049101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549742|NCT00394628|Temozolomide|temozolomide|mesh-list
92549743|NCT00394628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549744|NCT00394628|Alkylating Agents|alkylating agents|mesh-ancestor
92549745|NCT00394628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549746|NCT00394628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549747|NCT00049179|Cytarabine|cytarabine|mesh-list
92549748|NCT00049179|Gemtuzumab|gemtuzumab|mesh-list
92549749|NCT00049179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549750|NCT00049179|Antimetabolites|antimetabolites|mesh-ancestor
92549751|NCT00049179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549752|NCT00049179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549753|NCT00049179|Antiviral Agents|antiviral agents|mesh-ancestor
92549754|NCT00049179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549755|NCT00049179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549756|NCT00049179|Immunologic Factors|immunologic factors|mesh-ancestor
92549757|NCT00049179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549758|NCT00049179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92549759|NCT00049179|Immunotoxins|immunotoxins|mesh-ancestor
92549760|NCT00049179|Immunoconjugates|immunoconjugates|mesh-ancestor
92549761|NCT00394745|Valsartan|valsartan|mesh-list
92549762|NCT00394745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92549763|NCT00394745|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92549764|NCT00394745|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92549765|NCT00394745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549766|NCT00049218|Carboplatin|carboplatin|mesh-list
92549767|NCT00049218|Etoposide|etoposide|mesh-list
92549768|NCT00049218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957220|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92549780|NCT00049296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549782|NCT00049296|Immunologic Factors|immunologic factors|mesh-ancestor
92549783|NCT00049296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549784|NCT00049296|Leprostatic Agents|leprostatic agents|mesh-ancestor
92549785|NCT00049296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92549786|NCT00049296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549787|NCT00049296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92549788|NCT00049296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92549790|NCT00049296|Growth Inhibitors|growth inhibitors|mesh-ancestor
92549792|NCT00021827|Parathyroid Hormone|parathyroid hormone|mesh-list
92549793|NCT00021827|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92549794|NCT00021827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549795|NCT00021827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549796|NCT00021827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549797|NCT00049335|Capecitabine|capecitabine|mesh-list
92549798|NCT00049335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549799|NCT00049335|Antimetabolites|antimetabolites|mesh-ancestor
92549800|NCT00049335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549801|NCT00049335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549802|NCT00049374|Thalidomide|thalidomide|mesh-list
92549803|NCT00049374|Dexamethasone|dexamethasone|mesh-list
92549804|NCT00049374|Oblimersen|oblimersen|mesh-list
92549805|NCT00049374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92549806|NCT00049374|Antiemetics|antiemetics|mesh-ancestor
92549807|NCT00049374|Autonomic Agents|autonomic agents|mesh-ancestor
92549808|NCT00049374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549809|NCT00049374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549810|NCT00049374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549811|NCT00049374|Glucocorticoids|glucocorticoids|mesh-ancestor
92549812|NCT00049374|Hormones|hormones|mesh-ancestor
92549813|NCT00049374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549814|NCT00049374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549815|NCT00049374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549816|NCT00049374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549817|NCT00049374|Immunologic Factors|immunologic factors|mesh-ancestor
92549818|NCT00049374|Leprostatic Agents|leprostatic agents|mesh-ancestor
92549819|NCT00049374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92549820|NCT00049374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549821|NCT00049374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92549822|NCT00049374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92549823|NCT00049374|Growth Substances|growth substances|mesh-ancestor
92549824|NCT00049374|Growth Inhibitors|growth inhibitors|mesh-ancestor
92549825|NCT00021983|Immunotoxins|immunotoxins|mesh-list
92549826|NCT00021983|Immunoconjugates|immunoconjugates|mesh-ancestor
92549827|NCT00021983|Immunologic Factors|immunologic factors|mesh-ancestor
92549828|NCT00021983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549829|NCT00049413|Cyclophosphamide|cyclophosphamide|mesh-list
92549830|NCT00049413|Rituximab|rituximab|mesh-list
92549831|NCT00049413|Pentostatin|pentostatin|mesh-list
92549832|NCT00049413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549845|NCT00022022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549846|NCT00022022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549847|NCT00022022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549848|NCT00022022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549849|NCT00022022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549850|NCT00049452|Zoledronic Acid|zoledronic acid|mesh-list
92549851|NCT00049452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92549852|NCT00049452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549854|NCT00022139|Carboplatin|carboplatin|mesh-list
92549855|NCT00022139|Fluorouracil|fluorouracil|mesh-list
92549856|NCT00022139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549857|NCT00022139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549858|NCT00022139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549859|NCT00022139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549860|NCT00022139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549861|NCT00022139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549863|NCT00022139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549864|NCT00022139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549865|NCT00022139|Immunologic Factors|immunologic factors|mesh-ancestor
92549866|NCT00022139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534359|NCT00065533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534360|NCT00065533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92549867|NCT00049569|Leucovorin|leucovorin|mesh-list
92549868|NCT00049569|Cytarabine|cytarabine|mesh-list
92549869|NCT00049569|Prednisone|prednisone|mesh-list
92549870|NCT00049569|Hydrocortisone|hydrocortisone|mesh-list
92549871|NCT00049569|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92549872|NCT00049569|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92549873|NCT00049569|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92549874|NCT00049569|Cyclophosphamide|cyclophosphamide|mesh-list
92549875|NCT00049569|Doxorubicin|doxorubicin|mesh-list
92549876|NCT00049569|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92549877|NCT00049569|Methotrexate|methotrexate|mesh-list
92549878|NCT00049569|Etoposide|etoposide|mesh-list
92549879|NCT00049569|Vincristine|vincristine|mesh-list
92549880|NCT00049569|Imatinib Mesylate|imatinib mesylate|mesh-list
92549881|NCT00049569|Asparaginase|asparaginase|mesh-list
92549882|NCT00049569|Pegaspargase|pegaspargase|mesh-list
92549883|NCT00049569|Levoleucovorin|levoleucovorin|mesh-list
92549884|NCT00049569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549885|NCT00049569|Immunologic Factors|immunologic factors|mesh-ancestor
92549886|NCT00049569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549887|NCT00049569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549888|NCT00049569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549889|NCT00049569|Alkylating Agents|alkylating agents|mesh-ancestor
92549890|NCT00049569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549891|NCT00049569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549892|NCT00049569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549893|NCT00049569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549894|NCT00049569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549895|NCT00049569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549896|NCT00049569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549912|NCT00049569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549913|NCT00049569|Antidotes|antidotes|mesh-ancestor
92549914|NCT00049569|Protective Agents|protective agents|mesh-ancestor
92549915|NCT00049569|Vitamin B Complex|vitamin b complex|mesh-ancestor
92549916|NCT00049569|Vitamins|vitamins|mesh-ancestor
92549917|NCT00049569|Micronutrients|micronutrients|mesh-ancestor
92549918|NCT00049569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549919|NCT00049569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549920|NCT00049569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549921|NCT00049569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92549922|NCT00022178|Cyclophosphamide|cyclophosphamide|mesh-list
92549923|NCT00022178|Doxorubicin|doxorubicin|mesh-list
92549924|NCT00022178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92549925|NCT00022178|Fluorouracil|fluorouracil|mesh-list
92549926|NCT00022178|Vincristine|vincristine|mesh-list
92549927|NCT00022178|Epirubicin|epirubicin|mesh-list
92549928|NCT00022178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549929|NCT00022178|Immunologic Factors|immunologic factors|mesh-ancestor
92549930|NCT00022178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549931|NCT00022178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549932|NCT00022178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549933|NCT00022178|Alkylating Agents|alkylating agents|mesh-ancestor
92549934|NCT00022178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549935|NCT00022178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549936|NCT00022178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549937|NCT00022178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549938|NCT00022178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549939|NCT00022178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549940|NCT00022178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549941|NCT00022178|Antimetabolites|antimetabolites|mesh-ancestor
92549942|NCT00022178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549943|NCT00022178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549944|NCT00022178|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549945|NCT00022178|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549946|NCT00022178|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549947|NCT00049608|Gemcitabine|gemcitabine|mesh-list
92549948|NCT00049608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549949|NCT00049608|Antimetabolites|antimetabolites|mesh-ancestor
92549950|NCT00049608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549951|NCT00049608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549952|NCT00022217|Paclitaxel|paclitaxel|mesh-list
92549953|NCT00022217|Carboplatin|carboplatin|mesh-list
92534361|NCT00065533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92549954|NCT00022217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549955|NCT00022217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957411|NCT03394729|Propolis|propolis|mesh-list
92549972|NCT00049803|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92549973|NCT00049803|Anesthetics, General|anesthetics, general|mesh-ancestor
92549974|NCT00049803|Anesthetics|anesthetics|mesh-ancestor
92549975|NCT00049803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92549976|NCT00049803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549977|NCT00397761|Paclitaxel|paclitaxel|mesh-list
92549978|NCT00397761|Capecitabine|capecitabine|mesh-list
92549979|NCT00397761|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92549980|NCT00397761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549981|NCT00397761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549982|NCT00397761|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549983|NCT00397761|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549984|NCT00397761|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549985|NCT00397761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549986|NCT00397761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549987|NCT00397761|Antimetabolites|antimetabolites|mesh-ancestor
92549988|NCT00022412|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92549989|NCT00022412|Vitamins|vitamins|mesh-ancestor
92549990|NCT00022412|Micronutrients|micronutrients|mesh-ancestor
92354572|NCT01923012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92549991|NCT00022412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549992|NCT00022412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92549993|NCT00397800|Cyclophosphamide|cyclophosphamide|mesh-list
92549994|NCT00397800|Rituximab|rituximab|mesh-list
92549995|NCT00397800|Fludarabine|fludarabine|mesh-list
92549996|NCT00397800|Fludarabine phosphate|fludarabine phosphate|mesh-list
92549997|NCT00397800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549998|NCT00397800|Immunologic Factors|immunologic factors|mesh-ancestor
92549999|NCT00397800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550000|NCT00397800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550001|NCT00397800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550002|NCT00397800|Alkylating Agents|alkylating agents|mesh-ancestor
92550003|NCT00397800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550004|NCT00397800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550005|NCT00397800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550006|NCT00397800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550007|NCT00397800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550008|NCT00397800|Antimetabolites|antimetabolites|mesh-ancestor
92550009|NCT00022451|Tipifarnib|tipifarnib|mesh-list
92550010|NCT00022451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550011|NCT00022529|Trastuzumab|trastuzumab|mesh-list
92550012|NCT00022529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274722|NCT00482690|Nicotine|nicotine|mesh-list
92550013|NCT00022529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550014|NCT00022607|Thalidomide|thalidomide|mesh-list
92550032|NCT00049998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550034|NCT00022646|Gemcitabine|gemcitabine|mesh-list
92550035|NCT00022646|Pemetrexed|pemetrexed|mesh-list
92550036|NCT00022646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550037|NCT00022646|Antimetabolites|antimetabolites|mesh-ancestor
92550038|NCT00022646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550039|NCT00022646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550040|NCT00022646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550041|NCT00022646|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92550042|NCT00022646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550043|NCT00022685|Epratuzumab|epratuzumab|mesh-list
92550044|NCT00022685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550045|NCT00022685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550046|NCT00022724|Sirolimus|sirolimus|mesh-list
92550047|NCT00022724|Temsirolimus|temsirolimus|mesh-list
92550048|NCT00022724|MTOR Inhibitors|mtor inhibitors|mesh-list
92550049|NCT00022724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550050|NCT00022724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550051|NCT00022724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550052|NCT00022724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550053|NCT00022724|Immunologic Factors|immunologic factors|mesh-ancestor
92550054|NCT00022724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550055|NCT00022724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550056|NCT00022724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550057|NCT00022724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550058|NCT00022724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550060|NCT00050154|Tipifarnib|tipifarnib|mesh-list
92550061|NCT00050154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550062|NCT00022841|Pamidronate|pamidronate|mesh-list
92550063|NCT00022841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92550064|NCT00022841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550065|NCT00022880|Tositumomab I-131|tositumomab i-131|mesh-list
92550066|NCT00022880|Antibodies|antibodies|mesh-list
92550067|NCT00022880|Immunologic Factors|immunologic factors|mesh-ancestor
92550068|NCT00022880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550069|NCT00022880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550070|NCT00050271|Acetylcarnitine|acetylcarnitine|mesh-list
92550071|NCT00050271|Vitamin B Complex|vitamin b complex|mesh-ancestor
92550072|NCT00050271|Vitamins|vitamins|mesh-ancestor
92550092|NCT00050427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550093|NCT00023153|Adefovir|adefovir|mesh-list
92550094|NCT00023153|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92550095|NCT00023153|Antiviral Agents|antiviral agents|mesh-ancestor
92550096|NCT00023153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550097|NCT00023153|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92550098|NCT00023153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550099|NCT00023153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550100|NCT00023153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550101|NCT00050505|Vaccines|vaccines|mesh-list
92550102|NCT00050505|Immunologic Factors|immunologic factors|mesh-ancestor
92550103|NCT00050505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550104|NCT00050661|Daclizumab|daclizumab|mesh-list
92550105|NCT00050661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550106|NCT00050661|Immunologic Factors|immunologic factors|mesh-ancestor
92550107|NCT00050661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550108|NCT00050817|Clopidogrel|clopidogrel|mesh-list
92550109|NCT00050817|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92550110|NCT00050817|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92550111|NCT00050817|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92550112|NCT00050817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92550113|NCT00050817|Purinergic Agents|purinergic agents|mesh-ancestor
92550114|NCT00050817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92550115|NCT00050817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550116|NCT00050817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550117|NCT00023231|Mycophenolic Acid|mycophenolic acid|mesh-list
92550118|NCT00023231|Sirolimus|sirolimus|mesh-list
92550119|NCT00023231|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92550120|NCT00023231|Ganciclovir|ganciclovir|mesh-list
92550121|NCT00023231|Prednisone|prednisone|mesh-list
92550122|NCT00023231|Methylprednisolone|methylprednisolone|mesh-list
92550123|NCT00023231|Atorvastatin|atorvastatin|mesh-list
92550124|NCT00023231|Daclizumab|daclizumab|mesh-list
92550125|NCT00023231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550126|NCT00023231|Glucocorticoids|glucocorticoids|mesh-ancestor
92550127|NCT00023231|Hormones|hormones|mesh-ancestor
92550128|NCT00023231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957577|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92550143|NCT00023231|Autonomic Agents|autonomic agents|mesh-ancestor
92550144|NCT00023231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550145|NCT00023231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92550146|NCT00023231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92550147|NCT00023231|Protective Agents|protective agents|mesh-ancestor
92550148|NCT00023231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92550149|NCT00023231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92550150|NCT00023231|Antimetabolites|antimetabolites|mesh-ancestor
92550151|NCT00023231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92550152|NCT00023231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92550153|NCT00023231|Antiviral Agents|antiviral agents|mesh-ancestor
92550154|NCT00023231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92550155|NCT00023231|Antimalarials|antimalarials|mesh-ancestor
92550156|NCT00023231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92550157|NCT00023231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92550158|NCT00050856|Enfuvirtide|enfuvirtide|mesh-list
92550159|NCT00050856|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92550160|NCT00050856|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92550161|NCT00050856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550162|NCT00050856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92550163|NCT00050856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92550164|NCT00050856|Antiviral Agents|antiviral agents|mesh-ancestor
92550165|NCT00050856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550166|NCT00023348|Isoniazid|isoniazid|mesh-list
92550167|NCT00023348|Rifabutin|rifabutin|mesh-list
92534362|NCT02967094|Expectorants|expectorants|mesh-list
92534363|NCT02967094|Respiratory System Agents|respiratory system agents|mesh-ancestor
92534364|NCT00067561|Alosetron|alosetron|mesh-list
92534365|NCT00067561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92534366|NCT00067561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92550168|NCT00023348|Antitubercular Agents|antitubercular agents|mesh-ancestor
92550169|NCT00023348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550170|NCT00023348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550171|NCT00023348|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92550172|NCT00023348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92550173|NCT00023348|Antimetabolites|antimetabolites|mesh-ancestor
92550174|NCT00023348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550175|NCT00023348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92550176|NCT00023348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92550177|NCT00050895|Ritonavir|ritonavir|mesh-list
92550178|NCT00050895|Lopinavir|lopinavir|mesh-list
92550179|NCT00050895|Tenofovir|tenofovir|mesh-list
92550180|NCT00050895|Lamivudine|lamivudine|mesh-list
92550181|NCT00050895|Zidovudine|zidovudine|mesh-list
92550182|NCT00050895|Stavudine|stavudine|mesh-list
92550183|NCT00050895|Efavirenz|efavirenz|mesh-list
92550184|NCT00050895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92550185|NCT00050895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92550186|NCT00050895|Protease Inhibitors|protease inhibitors|mesh-ancestor
92550187|NCT00050895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550188|NCT00050895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550189|NCT00050895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92550190|NCT00050895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92550202|NCT00050895|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92550203|NCT00023387|Isoniazid|isoniazid|mesh-list
92550204|NCT00023387|Rifapentine|rifapentine|mesh-list
92550205|NCT00023387|Rifampin|rifampin|mesh-list
92550206|NCT00023387|Antitubercular Agents|antitubercular agents|mesh-ancestor
92550207|NCT00023387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550208|NCT00023387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550209|NCT00023387|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92550210|NCT00023387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92550211|NCT00023387|Antimetabolites|antimetabolites|mesh-ancestor
92550212|NCT00023387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550213|NCT00023387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92550214|NCT00023387|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92550215|NCT00023387|Leprostatic Agents|leprostatic agents|mesh-ancestor
92550216|NCT00023387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550217|NCT00023387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550218|NCT00023387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92550219|NCT00023387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92550220|NCT00023387|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92550221|NCT00023387|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92550222|NCT00023387|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92550223|NCT00023387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92550224|NCT00050934|Oxcarbazepine|oxcarbazepine|mesh-list
92550225|NCT00050934|Anticonvulsants|anticonvulsants|mesh-ancestor
92550226|NCT00050934|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92550227|NCT00050934|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92550228|NCT00050934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92550229|NCT00050934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550230|NCT00050934|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92550231|NCT00050934|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92550232|NCT00023426|Rifapentine|rifapentine|mesh-list
92550233|NCT00023426|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92550234|NCT00023426|Antitubercular Agents|antitubercular agents|mesh-ancestor
92550235|NCT00023426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550236|NCT00023426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550237|NCT00023426|Leprostatic Agents|leprostatic agents|mesh-ancestor
92274944|NCT02400437|Rituximab|rituximab|mesh-list
92550238|NCT00050973|Bexarotene|bexarotene|mesh-list
92550239|NCT00050973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550240|NCT00023504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92550241|NCT00023504|Immunologic Factors|immunologic factors|mesh-ancestor
92550242|NCT00023504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534368|NCT00067561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534369|NCT00067561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550243|NCT00051051|Canertinib dihydrochloride|canertinib dihydrochloride|mesh-list
92550244|NCT00051051|Anesthetics, Local|anesthetics, local|mesh-ancestor
92550245|NCT00051051|Anesthetics|anesthetics|mesh-ancestor
92550246|NCT00051051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92550247|NCT00051051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550248|NCT00051051|Sensory System Agents|sensory system agents|mesh-ancestor
92550249|NCT00051051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550269|NCT00051090|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92550270|NCT00051090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92550271|NCT00051090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92550272|NCT00051090|Antimetabolites|antimetabolites|mesh-ancestor
92550273|NCT00023621|Celecoxib|celecoxib|mesh-list
92550274|NCT00023621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92550275|NCT00023621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92550276|NCT00023621|Analgesics|analgesics|mesh-ancestor
92550277|NCT00023621|Sensory System Agents|sensory system agents|mesh-ancestor
92550278|NCT00023621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550279|NCT00023621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550280|NCT00023621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550281|NCT00023621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550282|NCT00023621|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92550283|NCT00023621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92550284|NCT00023621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550285|NCT00023621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550286|NCT00023660|Celecoxib|celecoxib|mesh-list
92550287|NCT00023660|Fluorouracil|fluorouracil|mesh-list
92550288|NCT00023660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550289|NCT00023660|Antimetabolites|antimetabolites|mesh-ancestor
92550290|NCT00023660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550291|NCT00023660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550292|NCT00023660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550293|NCT00023660|Immunologic Factors|immunologic factors|mesh-ancestor
92550294|NCT00023660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550295|NCT00023660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92550296|NCT00023660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92550297|NCT00023660|Analgesics|analgesics|mesh-ancestor
92550298|NCT00023660|Sensory System Agents|sensory system agents|mesh-ancestor
92550299|NCT00023660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550300|NCT00023660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550301|NCT00023660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550302|NCT00023660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92550303|NCT00023660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92550304|NCT00023660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550305|NCT00051285|Enoximone|enoximone|mesh-list
92550325|NCT00023738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550326|NCT00023738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550327|NCT00023738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550328|NCT00023738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550329|NCT00023738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550330|NCT00023738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550331|NCT00023738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550332|NCT00023738|Alkylating Agents|alkylating agents|mesh-ancestor
92550334|NCT00397917|Hematinics|hematinics|mesh-ancestor
92550335|NCT00397917|Vitamin B Complex|vitamin b complex|mesh-ancestor
92550336|NCT00397917|Vitamins|vitamins|mesh-ancestor
92550337|NCT00397917|Micronutrients|micronutrients|mesh-ancestor
92550338|NCT00397917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550339|NCT00397956|Ertapenem|ertapenem|mesh-list
92550340|NCT00397956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550341|NCT00397956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550342|NCT00023777|Cytarabine|cytarabine|mesh-list
92550343|NCT00023777|Daunorubicin|daunorubicin|mesh-list
92550344|NCT00023777|Sargramostim|sargramostim|mesh-list
92550345|NCT00023777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550346|NCT00023777|Antimetabolites|antimetabolites|mesh-ancestor
92550347|NCT00023777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550348|NCT00023777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550349|NCT00023777|Antiviral Agents|antiviral agents|mesh-ancestor
92534370|NCT00067561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534371|NCT00067600|Calcium|calcium|mesh-list
92550350|NCT00023777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550351|NCT00023777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550352|NCT00023777|Immunologic Factors|immunologic factors|mesh-ancestor
92550353|NCT00023777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550354|NCT00023777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550355|NCT00023777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550356|NCT00023777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550357|NCT00023777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550358|NCT00023816|Carbendazim|carbendazim|mesh-list
92550359|NCT00023816|Antinematodal Agents|antinematodal agents|mesh-ancestor
92550360|NCT00023816|Anthelmintics|anthelmintics|mesh-ancestor
92550361|NCT00023816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92550362|NCT00023816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550381|NCT00023894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550382|NCT00023894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550384|NCT00023894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550385|NCT00023933|Antibodies|antibodies|mesh-list
92550386|NCT00023933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92550387|NCT00023933|Immunologic Factors|immunologic factors|mesh-ancestor
92550388|NCT00023933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275094|NCT02037893|Antipyrine|antipyrine|mesh-list
92550389|NCT00051597|Antibodies|antibodies|mesh-list
92550390|NCT00051597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92550391|NCT00051597|Immunologic Factors|immunologic factors|mesh-ancestor
92550392|NCT00051597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550393|NCT00023972|Gemcitabine|gemcitabine|mesh-list
92550394|NCT00023972|Exatecan|exatecan|mesh-list
92550395|NCT00023972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550396|NCT00023972|Antimetabolites|antimetabolites|mesh-ancestor
92550397|NCT00023972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550398|NCT00023972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550399|NCT00023972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92550400|NCT00023972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550401|NCT00023972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550402|NCT00024011|Bortezomib|bortezomib|mesh-list
92550403|NCT00024011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550404|NCT00051753|Amoxicillin|amoxicillin|mesh-list
92550405|NCT00051753|Levofloxacin|levofloxacin|mesh-list
92550406|NCT00051753|Clavulanic Acid|clavulanic acid|mesh-list
92550407|NCT00051753|Clavulanic Acids|clavulanic acids|mesh-list
92550408|NCT00051753|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92550409|NCT00051753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550410|NCT00051753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550411|NCT00051753|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92550412|NCT00051753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550413|NCT00051753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550414|NCT00051753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550415|NCT00051753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550416|NCT00051753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550417|NCT00051753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92550418|NCT00051753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92550431|NCT00024050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550433|NCT00024050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550434|NCT00024050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92550435|NCT00024050|Abortifacient Agents|abortifacient agents|mesh-ancestor
92550436|NCT00024050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92550437|NCT00024050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550438|NCT00024050|Antimetabolites|antimetabolites|mesh-ancestor
92550439|NCT00024050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92550440|NCT00024050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550441|NCT00024050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92550442|NCT00024050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550443|NCT00024050|Antifungal Agents|antifungal agents|mesh-ancestor
92550444|NCT00024050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550445|NCT00024050|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92550446|NCT00024089|Gefitinib|gefitinib|mesh-list
92550447|NCT00024089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550448|NCT00024089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550449|NCT00024089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550450|NCT00024089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550451|NCT00051831|Ritonavir|ritonavir|mesh-list
92550452|NCT00051831|Saquinavir|saquinavir|mesh-list
92534372|NCT00067600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534373|NCT00067600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534374|NCT05010707|Spironolactone|spironolactone|mesh-list
92550453|NCT00051831|Tenofovir|tenofovir|mesh-list
92550454|NCT00051831|Emtricitabine|emtricitabine|mesh-list
92550455|NCT00051831|Enfuvirtide|enfuvirtide|mesh-list
92550456|NCT00051831|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92550457|NCT00051831|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92550458|NCT00051831|Protease Inhibitors|protease inhibitors|mesh-ancestor
92550459|NCT00051831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550460|NCT00051831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550461|NCT00051831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92550462|NCT00051831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92550463|NCT00051831|Antiviral Agents|antiviral agents|mesh-ancestor
92275171|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92550464|NCT00051831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550465|NCT00051831|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92550466|NCT00051831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92550467|NCT00051831|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92550468|NCT00051831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550469|NCT00051831|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92550470|NCT00051831|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92550471|NCT00024128|Cyclosporine|cyclosporine|mesh-list
92550472|NCT00024128|Cyclophosphamide|cyclophosphamide|mesh-list
92550473|NCT00024128|Cyclosporins|cyclosporins|mesh-list
92550474|NCT00024128|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92550475|NCT00024128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550476|NCT00024128|Immunologic Factors|immunologic factors|mesh-ancestor
92550477|NCT00024128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550478|NCT00024128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550479|NCT00024128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550480|NCT00024128|Alkylating Agents|alkylating agents|mesh-ancestor
92682779|NCT04701320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92550500|NCT00024284|Irinotecan|irinotecan|mesh-list
92550501|NCT00024284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550502|NCT00024284|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92550503|NCT00024284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550504|NCT00024284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550505|NCT00024284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550506|NCT00052026|Carvedilol|carvedilol|mesh-list
92550507|NCT00052026|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92550508|NCT00052026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92550509|NCT00052026|Adrenergic Agents|adrenergic agents|mesh-ancestor
92550510|NCT00052026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92550511|NCT00052026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550512|NCT00052026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550513|NCT00052026|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92550514|NCT00052026|Antioxidants|antioxidants|mesh-ancestor
92550515|NCT00052026|Protective Agents|protective agents|mesh-ancestor
92550516|NCT00052026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92550517|NCT00052026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92550518|NCT00052026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92550519|NCT00052026|Vasodilator Agents|vasodilator agents|mesh-ancestor
92550520|NCT00052026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92550521|NCT00052026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92550522|NCT00024323|Cisplatin|cisplatin|mesh-list
92550523|NCT00024323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550524|NCT00024362|BBR 3464|bbr 3464|mesh-list
92550525|NCT00024362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550526|NCT00024401|Paclitaxel|paclitaxel|mesh-list
92550527|NCT00024401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550528|NCT00024401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550529|NCT00024401|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550530|NCT00024401|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550531|NCT00024401|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550532|NCT00024401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550533|NCT00024440|Cyclophosphamide|cyclophosphamide|mesh-list
92550534|NCT00024440|Fludarabine|fludarabine|mesh-list
92550535|NCT00024440|Fludarabine phosphate|fludarabine phosphate|mesh-list
92550536|NCT00024440|Oblimersen|oblimersen|mesh-list
92550537|NCT00024440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550553|NCT00024518|Immunologic Factors|immunologic factors|mesh-ancestor
92550554|NCT00024518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550555|NCT00052221|Epoetin Alfa|epoetin alfa|mesh-list
92550556|NCT00052221|Hematinics|hematinics|mesh-ancestor
92550557|NCT00024557|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92550558|NCT00024557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550559|NCT00052299|Cytarabine|cytarabine|mesh-list
92550560|NCT00052299|Etoposide|etoposide|mesh-list
92550561|NCT00052299|Mitoxantrone|mitoxantrone|mesh-list
92550562|NCT00052299|Idarubicin|idarubicin|mesh-list
92550563|NCT00052299|Gemtuzumab|gemtuzumab|mesh-list
92550564|NCT00052299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550565|NCT00052299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550566|NCT00052299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550567|NCT00052299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550568|NCT00052299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550569|NCT00052299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550570|NCT00052299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550571|NCT00052299|Antimetabolites|antimetabolites|mesh-ancestor
92550572|NCT00052299|Antiviral Agents|antiviral agents|mesh-ancestor
92550573|NCT00052299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550574|NCT00052299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550575|NCT00052299|Immunologic Factors|immunologic factors|mesh-ancestor
92550576|NCT00052299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550577|NCT00052299|Analgesics|analgesics|mesh-ancestor
92550578|NCT00052299|Sensory System Agents|sensory system agents|mesh-ancestor
92550579|NCT00052299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550580|NCT00052299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550581|NCT00052299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550582|NCT00052299|Immunotoxins|immunotoxins|mesh-ancestor
92550583|NCT00052299|Immunoconjugates|immunoconjugates|mesh-ancestor
92550584|NCT00052338|Carboplatin|carboplatin|mesh-list
92550585|NCT00052338|Gemcitabine|gemcitabine|mesh-list
92550586|NCT00052338|Bortezomib|bortezomib|mesh-list
92550587|NCT00052338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550588|NCT00052338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550589|NCT00052338|Antimetabolites|antimetabolites|mesh-ancestor
92550590|NCT00052338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550591|NCT04733066|Teduglutide|teduglutide|mesh-list
92550592|NCT04733066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92550593|NCT04733066|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92550594|NCT04733066|Protective Agents|protective agents|mesh-ancestor
92550595|NCT04733066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550596|NCT00052377|Aldesleukin|aldesleukin|mesh-list
92550597|NCT00052377|Interleukin-2|interleukin-2|mesh-list
92550598|NCT00052377|Interleukin-12|interleukin-12|mesh-list
92550599|NCT00052377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550611|NCT00052377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550612|NCT00052377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550613|NCT00052377|Growth Substances|growth substances|mesh-ancestor
92550614|NCT00052377|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550616|NCT00052416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550617|NCT00052416|Immunologic Factors|immunologic factors|mesh-ancestor
92550618|NCT00052416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550619|NCT00052416|Leprostatic Agents|leprostatic agents|mesh-ancestor
92550620|NCT00052416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550621|NCT00052416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550622|NCT00052416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550623|NCT00052416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550624|NCT00052416|Growth Substances|growth substances|mesh-ancestor
92550625|NCT00052416|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550626|NCT00052416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550627|NCT00052455|Vincristine|vincristine|mesh-list
92550628|NCT00052455|Temozolomide|temozolomide|mesh-list
92550629|NCT00052455|Lomustine|lomustine|mesh-list
92550630|NCT00052455|Procarbazine|procarbazine|mesh-list
92550631|NCT00052455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550632|NCT00052455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550633|NCT00052455|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550634|NCT00052455|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550635|NCT00052455|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550636|NCT00052455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550637|NCT00052455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550638|NCT00052455|Alkylating Agents|alkylating agents|mesh-ancestor
92550639|NCT00052494|Irinotecan|irinotecan|mesh-list
92550640|NCT00052494|Imatinib Mesylate|imatinib mesylate|mesh-list
92550641|NCT00052494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550642|NCT00052494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92550643|NCT00052494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550644|NCT00052494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550645|NCT00052494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550646|NCT00052494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550647|NCT00395174|Hemagglutinins|hemagglutinins|mesh-list
92550648|NCT00395174|Agglutinins|agglutinins|mesh-ancestor
92550649|NCT00395174|Immunologic Factors|immunologic factors|mesh-ancestor
92550650|NCT00395174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550651|NCT00395174|Coagulants|coagulants|mesh-ancestor
92550652|NCT00395213|Norepinephrine|norepinephrine|mesh-list
92550653|NCT00395213|Serotonin|serotonin|mesh-list
92550654|NCT00395213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92550655|NCT00395213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92550656|NCT00395213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92550657|NCT00395213|Adrenergic Agents|adrenergic agents|mesh-ancestor
92550658|NCT00395213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92550659|NCT00395213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550660|NCT00395213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550661|NCT00395213|Sympathomimetics|sympathomimetics|mesh-ancestor
92550662|NCT00395213|Autonomic Agents|autonomic agents|mesh-ancestor
92550663|NCT00395213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550664|NCT00395213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92550683|NCT00395252|Cetuximab|cetuximab|mesh-list
92550684|NCT00395252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550685|NCT00395252|Antimetabolites|antimetabolites|mesh-ancestor
92550686|NCT00395252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550687|NCT00395252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550688|NCT00395252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550689|NCT00052689|Gemcitabine|gemcitabine|mesh-list
92550690|NCT00052689|Bortezomib|bortezomib|mesh-list
92550691|NCT00052689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550692|NCT00052689|Antimetabolites|antimetabolites|mesh-ancestor
92550693|NCT00052689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550694|NCT00052689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550695|NCT00052728|Tamoxifen|tamoxifen|mesh-list
92550696|NCT00052728|Tipifarnib|tipifarnib|mesh-list
92550697|NCT00052728|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92550698|NCT00052728|Hormone Antagonists|hormone antagonists|mesh-ancestor
92550699|NCT00052728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92550700|NCT00052728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550701|NCT00052728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92550702|NCT00052728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550703|NCT00052728|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92550704|NCT00052728|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92550705|NCT00052728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92550706|NCT00395369|Aprotinin|aprotinin|mesh-list
92550707|NCT00395369|Hemostatics|hemostatics|mesh-ancestor
92550708|NCT00395369|Coagulants|coagulants|mesh-ancestor
92550709|NCT00395369|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92550710|NCT00395369|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92550711|NCT00395369|Protease Inhibitors|protease inhibitors|mesh-ancestor
92550712|NCT00395369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550713|NCT00395369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550714|NCT00052845|Sulindac sulfone|sulindac sulfone|mesh-list
92550715|NCT00052845|Docetaxel|docetaxel|mesh-list
92550716|NCT00052845|Estramustine|estramustine|mesh-list
92550717|NCT00052845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550718|NCT00052845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550719|NCT00052845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550720|NCT00052845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550731|NCT00052845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92550733|NCT00052845|Sensory System Agents|sensory system agents|mesh-ancestor
92550734|NCT00052845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550735|NCT00052845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550736|NCT00052845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550737|NCT00024986|Tenofovir|tenofovir|mesh-list
92550738|NCT00024986|Antiviral Agents|antiviral agents|mesh-ancestor
92550739|NCT00024986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550740|NCT00024986|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92550741|NCT00024986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550742|NCT00024986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534376|NCT05010707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92550743|NCT00024986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550745|NCT00024986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92550746|NCT00052923|Cyclophosphamide|cyclophosphamide|mesh-list
92550747|NCT00052923|Carmustine|carmustine|mesh-list
92550748|NCT00052923|Rituximab|rituximab|mesh-list
92550749|NCT00052923|Etoposide|etoposide|mesh-list
92550750|NCT00052923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550751|NCT00052923|Immunologic Factors|immunologic factors|mesh-ancestor
92550752|NCT00052923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550753|NCT00052923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550754|NCT00052923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550755|NCT00052923|Alkylating Agents|alkylating agents|mesh-ancestor
92550756|NCT00052923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550757|NCT00052923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550758|NCT00052923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550759|NCT00052923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550760|NCT00052923|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550761|NCT00052923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550762|NCT00052923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550763|NCT00052923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550764|NCT00025064|Prednisolone|prednisolone|mesh-list
92550765|NCT00025064|Doxorubicin|doxorubicin|mesh-list
92550766|NCT00025064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92550767|NCT00025064|Etoposide|etoposide|mesh-list
92550768|NCT00025064|Vincristine|vincristine|mesh-list
92550769|NCT00025064|Melphalan|melphalan|mesh-list
92550771|NCT00025064|Dacarbazine|dacarbazine|mesh-list
92550772|NCT00025064|Bleomycin|bleomycin|mesh-list
92550773|NCT00025064|Vinblastine|vinblastine|mesh-list
92550774|NCT00025064|Procarbazine|procarbazine|mesh-list
92550775|NCT00025064|Chlorambucil|chlorambucil|mesh-list
92550776|NCT00025064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550777|NCT00025064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550778|NCT00025064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550779|NCT00025064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550780|NCT00025064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550781|NCT00025064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550782|NCT00025064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550783|NCT00025064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550784|NCT00025064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550785|NCT00025064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550800|NCT00053001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550801|NCT00053001|Immunologic Factors|immunologic factors|mesh-ancestor
92550802|NCT00053001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550803|NCT00053001|Leprostatic Agents|leprostatic agents|mesh-ancestor
92550804|NCT00053001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550805|NCT00053001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550806|NCT00053001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550807|NCT00053001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550808|NCT00053001|Growth Substances|growth substances|mesh-ancestor
92550809|NCT00053001|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550810|NCT00053001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550811|NCT00025103|Dactinomycin|dactinomycin|mesh-list
92550812|NCT00025103|Cyclophosphamide|cyclophosphamide|mesh-list
92550813|NCT00025103|Melphalan|melphalan|mesh-list
92550814|NCT00025103|Carboplatin|carboplatin|mesh-list
92550815|NCT00025103|Doxorubicin|doxorubicin|mesh-list
92550816|NCT00025103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92550817|NCT00025103|Etoposide|etoposide|mesh-list
92550818|NCT00025103|Vincristine|vincristine|mesh-list
92550819|NCT00025103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550820|NCT00025103|Immunologic Factors|immunologic factors|mesh-ancestor
92550821|NCT00025103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550822|NCT00025103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550823|NCT00025103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550824|NCT00025103|Alkylating Agents|alkylating agents|mesh-ancestor
92550825|NCT00025103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550826|NCT00025103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550827|NCT00025103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550828|NCT00025103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550829|NCT00025103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550830|NCT00025103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550831|NCT00025103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550832|NCT00025103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550833|NCT00025103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550834|NCT00025103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550835|NCT00025103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550836|NCT00025103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550837|NCT00025103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550838|NCT00025103|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92550839|NCT00025103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550840|NCT00053040|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92550841|NCT00053040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550842|NCT00025142|Leucovorin|leucovorin|mesh-list
92550843|NCT00025142|Fluorouracil|fluorouracil|mesh-list
92550844|NCT00025142|Oxaliplatin|oxaliplatin|mesh-list
92550845|NCT00025142|Gefitinib|gefitinib|mesh-list
92550846|NCT00025142|Calcium|calcium|mesh-list
92550847|NCT00025142|Levoleucovorin|levoleucovorin|mesh-list
92550848|NCT00025142|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92550856|NCT00025142|Antidotes|antidotes|mesh-ancestor
92550857|NCT00025142|Protective Agents|protective agents|mesh-ancestor
92550858|NCT00025142|Vitamin B Complex|vitamin b complex|mesh-ancestor
92550860|NCT00025142|Micronutrients|micronutrients|mesh-ancestor
92550861|NCT00025142|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550862|NCT00025142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550863|NCT00053118|Carboplatin|carboplatin|mesh-list
92550864|NCT00053118|Etoposide|etoposide|mesh-list
92550865|NCT00053118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550866|NCT00053118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550867|NCT00053118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550868|NCT00053118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550869|NCT00053118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550870|NCT00053118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550871|NCT00025181|Ipilimumab|ipilimumab|mesh-list
92550872|NCT00025181|Freund's Adjuvant|freund's adjuvant|mesh-list
92550873|NCT00025181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550874|NCT00025181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550875|NCT00025181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92550876|NCT00025181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550877|NCT00025181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92550878|NCT00025181|Immunologic Factors|immunologic factors|mesh-ancestor
92550879|NCT00025181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550880|NCT00025220|Thalidomide|thalidomide|mesh-list
92550881|NCT00025220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550882|NCT00025220|Immunologic Factors|immunologic factors|mesh-ancestor
92550883|NCT00025220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550884|NCT00025220|Leprostatic Agents|leprostatic agents|mesh-ancestor
92550885|NCT00025220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550886|NCT00025220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550887|NCT00025220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550888|NCT00025220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550889|NCT00025220|Growth Substances|growth substances|mesh-ancestor
92550890|NCT00025220|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550891|NCT00025220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550892|NCT00053157|Sargramostim|sargramostim|mesh-list
92550893|NCT00053157|Immunologic Factors|immunologic factors|mesh-ancestor
92550894|NCT00053157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550895|NCT00025298|Paclitaxel|paclitaxel|mesh-list
92550896|NCT00025298|Carboplatin|carboplatin|mesh-list
92550897|NCT00025298|Amifostine|amifostine|mesh-list
92550898|NCT00025298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92550899|NCT00025298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550900|NCT00025298|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550901|NCT00025298|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550902|NCT00025298|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550903|NCT00025298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550904|NCT00025298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92550905|NCT00025298|Protective Agents|protective agents|mesh-ancestor
92550906|NCT00025298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550907|NCT00053196|Mycophenolic Acid|mycophenolic acid|mesh-list
92550908|NCT00053196|Methotrexate|methotrexate|mesh-list
92550909|NCT00053196|Fludarabine phosphate|fludarabine phosphate|mesh-list
92550910|NCT00053196|Fludarabine|fludarabine|mesh-list
92550911|NCT00053196|Busulfan|busulfan|mesh-list
92550912|NCT00053196|Allopurinol|allopurinol|mesh-list
92550913|NCT00053196|Tacrolimus|tacrolimus|mesh-list
92550914|NCT00053196|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92550915|NCT00053196|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92534378|NCT05010707|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92534379|NCT05010707|Hormone Antagonists|hormone antagonists|mesh-ancestor
92534380|NCT05010707|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92550916|NCT00053196|Abortifacient Agents|abortifacient agents|mesh-ancestor
91958348|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
92550930|NCT00053196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92550931|NCT00053196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550932|NCT00053196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92550933|NCT00053196|Antitubercular Agents|antitubercular agents|mesh-ancestor
92550934|NCT00053196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550935|NCT00053196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550936|NCT00053196|Alkylating Agents|alkylating agents|mesh-ancestor
92550937|NCT00053196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550938|NCT00053196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550939|NCT00053196|Gout Suppressants|gout suppressants|mesh-ancestor
92550940|NCT00053196|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92550941|NCT00053196|Antioxidants|antioxidants|mesh-ancestor
92550942|NCT00053196|Protective Agents|protective agents|mesh-ancestor
92550944|NCT00025337|Bevacizumab|bevacizumab|mesh-list
92550945|NCT00025337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92550946|NCT00025337|Fluorouracil|fluorouracil|mesh-list
92550947|NCT00025337|Oxaliplatin|oxaliplatin|mesh-list
92550948|NCT00025337|Antibodies|antibodies|mesh-list
92550949|NCT00025337|Immunoglobulins|immunoglobulins|mesh-list
92550950|NCT00025337|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92550951|NCT00025337|Levoleucovorin|levoleucovorin|mesh-list
92550952|NCT00025337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550953|NCT00025337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550954|NCT00025337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550955|NCT00025337|Growth Substances|growth substances|mesh-ancestor
92550956|NCT00025337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550957|NCT00025337|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550958|NCT00025337|Immunologic Factors|immunologic factors|mesh-ancestor
92550959|NCT00025337|Antimetabolites|antimetabolites|mesh-ancestor
92550960|NCT00025337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550961|NCT00025337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550962|NCT00025337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550963|NCT00025337|Antidotes|antidotes|mesh-ancestor
92550964|NCT00025337|Protective Agents|protective agents|mesh-ancestor
92550965|NCT00025337|Vitamin B Complex|vitamin b complex|mesh-ancestor
92550966|NCT00025337|Vitamins|vitamins|mesh-ancestor
92550967|NCT00025337|Micronutrients|micronutrients|mesh-ancestor
92550968|NCT00025376|Bortezomib|bortezomib|mesh-list
92550969|NCT00025376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550970|NCT00025415|Imatinib Mesylate|imatinib mesylate|mesh-list
92550971|NCT00025415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550972|NCT00025415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550973|NCT00025415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550974|NCT00025415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550975|NCT00025454|Tipifarnib|tipifarnib|mesh-list
92550976|NCT00025454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550977|NCT00025493|Docetaxel|docetaxel|mesh-list
92550991|NCT00053430|Leprostatic Agents|leprostatic agents|mesh-ancestor
92550992|NCT00053430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550993|NCT00053430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550994|NCT00053430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550995|NCT00053430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550996|NCT00053430|Growth Substances|growth substances|mesh-ancestor
92550997|NCT00053430|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550998|NCT00053430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550999|NCT00025610|Cyclophosphamide|cyclophosphamide|mesh-list
92551000|NCT00025610|Carboplatin|carboplatin|mesh-list
92551001|NCT00025610|Doxorubicin|doxorubicin|mesh-list
92551002|NCT00025610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92551003|NCT00025610|Etoposide|etoposide|mesh-list
92551004|NCT00025610|Vincristine|vincristine|mesh-list
92551005|NCT00025610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551006|NCT00025610|Immunologic Factors|immunologic factors|mesh-ancestor
92551007|NCT00025610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551008|NCT00025610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551009|NCT00025610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551010|NCT00025610|Alkylating Agents|alkylating agents|mesh-ancestor
92551011|NCT00025610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534382|NCT05010707|Natriuretic Agents|natriuretic agents|mesh-ancestor
92534383|NCT00067756|Butyric Acid|butyric acid|mesh-list
92551012|NCT00025610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551013|NCT00025610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92551014|NCT00025610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551015|NCT00025610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92551016|NCT00025610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551017|NCT00025610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551018|NCT00025610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551019|NCT00025610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551020|NCT00025610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551021|NCT00025610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551022|NCT00025649|Cyclophosphamide|cyclophosphamide|mesh-list
92551023|NCT00025649|Melphalan|melphalan|mesh-list
92551024|NCT00025649|Busulfan|busulfan|mesh-list
92551025|NCT00025649|Carboplatin|carboplatin|mesh-list
92551026|NCT00025649|Doxorubicin|doxorubicin|mesh-list
92551027|NCT00025649|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92551028|NCT00025649|Etoposide|etoposide|mesh-list
92551029|NCT00025649|Vincristine|vincristine|mesh-list
92551030|NCT00025649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551031|NCT00025649|Immunologic Factors|immunologic factors|mesh-ancestor
92551032|NCT00025649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551033|NCT00025649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551034|NCT00025649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551035|NCT00025649|Alkylating Agents|alkylating agents|mesh-ancestor
92551036|NCT00025649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551037|NCT00025649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551038|NCT00025649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92551039|NCT00025649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551040|NCT00025649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92551041|NCT00025649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551060|NCT00025727|Protease Inhibitors|protease inhibitors|mesh-ancestor
92551061|NCT00025727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551062|NCT00025727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551063|NCT00025727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92551064|NCT00025727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92551065|NCT00025727|Antiviral Agents|antiviral agents|mesh-ancestor
92551066|NCT00025727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551067|NCT00025727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92551068|NCT00025727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92551069|NCT00053820|Interferons|interferons|mesh-list
92551070|NCT00053820|Interferon-alpha|interferon-alpha|mesh-list
92551071|NCT00053820|Aldesleukin|aldesleukin|mesh-list
92551072|NCT00053820|Fluorouracil|fluorouracil|mesh-list
92551073|NCT00053820|Antimetabolites|antimetabolites|mesh-ancestor
92551074|NCT00053820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551075|NCT00053820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551076|NCT00053820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551077|NCT00053820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551078|NCT00053820|Immunologic Factors|immunologic factors|mesh-ancestor
92551079|NCT00053820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551080|NCT00053820|Antiviral Agents|antiviral agents|mesh-ancestor
92551081|NCT00053820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551082|NCT00053820|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92551083|NCT00053820|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92551084|NCT04731090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92551085|NCT04731090|Fluoroquinolones|fluoroquinolones|mesh-list
92551086|NCT04731090|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92551087|NCT04731090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551088|NCT04731090|Antitubercular Agents|antitubercular agents|mesh-ancestor
92551089|NCT04731090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92551090|NCT04731090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551091|NCT04731090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551092|NCT00053937|Pirfenidone|pirfenidone|mesh-list
92551093|NCT00053937|Analgesics|analgesics|mesh-ancestor
92551094|NCT00053937|Sensory System Agents|sensory system agents|mesh-ancestor
92551095|NCT00053937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551096|NCT00053937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551097|NCT00053937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92551098|NCT00053937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551099|NCT00053937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551119|NCT00053976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92551120|NCT00053976|Protective Agents|protective agents|mesh-ancestor
92551121|NCT00053976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92551122|NCT00053976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551123|NCT00053976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551124|NCT00053976|Immunologic Factors|immunologic factors|mesh-ancestor
92551125|NCT04733573|Salicylic Acid|salicylic acid|mesh-list
92551126|NCT04733573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551127|NCT04733573|Antifungal Agents|antifungal agents|mesh-ancestor
92551128|NCT04733573|Keratolytic Agents|keratolytic agents|mesh-ancestor
92551129|NCT04733573|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551130|NCT00054054|Docetaxel|docetaxel|mesh-list
92551131|NCT00054054|Fluorouracil|fluorouracil|mesh-list
92551132|NCT00054054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551133|NCT00054054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551134|NCT00054054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551135|NCT00054054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551136|NCT00054054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551137|NCT00054054|Antimetabolites|antimetabolites|mesh-ancestor
92551138|NCT00054054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551139|NCT00054054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551140|NCT00054054|Immunologic Factors|immunologic factors|mesh-ancestor
92551141|NCT00054054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551142|NCT00026078|Docetaxel|docetaxel|mesh-list
92551143|NCT00026078|Ifosfamide|ifosfamide|mesh-list
92551144|NCT00026078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551145|NCT00026078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551146|NCT00026078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551147|NCT00026078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551148|NCT00026078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551149|NCT00026078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551150|NCT00026078|Alkylating Agents|alkylating agents|mesh-ancestor
92551151|NCT00398229|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92551152|NCT00398229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92551153|NCT00398229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551154|NCT00026156|Docetaxel|docetaxel|mesh-list
92551155|NCT00026156|Vinorelbine|vinorelbine|mesh-list
92551156|NCT00026156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551157|NCT00026156|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551170|NCT00026195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551171|NCT00054210|Paclitaxel|paclitaxel|mesh-list
92551172|NCT00054210|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92551173|NCT00054210|Carboplatin|carboplatin|mesh-list
92551174|NCT00054210|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92551175|NCT00054210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551176|NCT00054210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551177|NCT00054210|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551178|NCT00054210|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551179|NCT00054210|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551180|NCT00054210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551181|NCT00026234|Dexamethasone|dexamethasone|mesh-list
92551182|NCT00026234|Capecitabine|capecitabine|mesh-list
92551183|NCT00026234|Oxaliplatin|oxaliplatin|mesh-list
92551184|NCT00026234|Floxuridine|floxuridine|mesh-list
92551185|NCT00026234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551186|NCT00026234|Antiemetics|antiemetics|mesh-ancestor
92551187|NCT00026234|Autonomic Agents|autonomic agents|mesh-ancestor
92551188|NCT00026234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551189|NCT00026234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551190|NCT00026234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92551191|NCT00026234|Glucocorticoids|glucocorticoids|mesh-ancestor
92551192|NCT00026234|Hormones|hormones|mesh-ancestor
92551193|NCT00026234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551194|NCT00026234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92551195|NCT00026234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551196|NCT00026234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551197|NCT00026234|Antimetabolites|antimetabolites|mesh-ancestor
92551198|NCT00026234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551199|NCT00054288|Gemcitabine|gemcitabine|mesh-list
92551200|NCT00054288|Irinotecan|irinotecan|mesh-list
92551201|NCT00054288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551202|NCT00054288|Antimetabolites|antimetabolites|mesh-ancestor
92551203|NCT00054288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551204|NCT00054288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551205|NCT00054288|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551206|NCT00054288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551207|NCT00054288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551208|NCT00026273|Leucovorin|leucovorin|mesh-list
92551209|NCT00026273|Fluorouracil|fluorouracil|mesh-list
92551210|NCT00026273|Irinotecan|irinotecan|mesh-list
92551212|NCT00026273|Levoleucovorin|levoleucovorin|mesh-list
92551213|NCT00026273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92551214|NCT00026273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551215|NCT00026273|Antimetabolites|antimetabolites|mesh-ancestor
92551216|NCT00026273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551217|NCT00026273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551218|NCT00026273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551219|NCT00026273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551220|NCT00026273|Immunologic Factors|immunologic factors|mesh-ancestor
92551236|NCT00054405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551237|NCT00054405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551238|NCT00054405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92551239|NCT00054405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92551240|NCT00054405|Antiviral Agents|antiviral agents|mesh-ancestor
92551241|NCT00054405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551242|NCT00054405|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92551243|NCT00054405|Immunologic Factors|immunologic factors|mesh-ancestor
92551244|NCT00054405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551245|NCT00054405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551246|NCT00054405|Growth Substances|growth substances|mesh-ancestor
92551247|NCT00054405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551248|NCT00026351|Rituximab|rituximab|mesh-list
92551249|NCT00026351|Pentostatin|pentostatin|mesh-list
92551250|NCT00026351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551251|NCT00026351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551252|NCT00026351|Immunologic Factors|immunologic factors|mesh-ancestor
92551253|NCT00026351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551254|NCT00026351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551255|NCT00026351|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92551256|NCT00026351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551257|NCT00026351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551258|NCT00054444|Topotecan|topotecan|mesh-list
92551259|NCT00054444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551260|NCT00054444|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551261|NCT00054444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551262|NCT00054444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354667|NCT01922076|Adavosertib|adavosertib|mesh-list
92551263|NCT00054444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551264|NCT00026429|Denileukin diftitox|denileukin diftitox|mesh-list
92551265|NCT00026429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551266|NCT00054483|Bortezomib|bortezomib|mesh-list
92551267|NCT00054483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551268|NCT00026468|Sulindac sulfone|sulindac sulfone|mesh-list
92551269|NCT00026468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551270|NCT00026468|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92551271|NCT00026468|Protective Agents|protective agents|mesh-ancestor
92551272|NCT00026468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551273|NCT00026468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92551274|NCT00026468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551275|NCT00026468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551276|NCT00026468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92551277|NCT00026468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551278|NCT00026468|Analgesics|analgesics|mesh-ancestor
92551279|NCT00026468|Sensory System Agents|sensory system agents|mesh-ancestor
92551280|NCT00026468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551281|NCT00026468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551282|NCT00026468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551294|NCT00054522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92551295|NCT00054522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551296|NCT00054522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92551297|NCT00054522|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92551298|NCT00054522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92551299|NCT00054522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551300|NCT00054522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92551302|NCT00054522|Micronutrients|micronutrients|mesh-ancestor
92551303|NCT00054522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92551304|NCT00026585|Tamoxifen|tamoxifen|mesh-list
92551305|NCT00026585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92276003|NCT02261948|Simendan|simendan|mesh-list
92551306|NCT00026585|Hormone Antagonists|hormone antagonists|mesh-ancestor
92551307|NCT00026585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551308|NCT00026585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534384|NCT00067756|Histamine Antagonists|histamine antagonists|mesh-ancestor
92534385|NCT00067756|Histamine Agents|histamine agents|mesh-ancestor
92551309|NCT00026585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92551310|NCT00026585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551311|NCT00026585|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92551312|NCT00026585|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92551313|NCT00026585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92551314|NCT00026624|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92551315|NCT00026624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92551316|NCT00026624|Immunologic Factors|immunologic factors|mesh-ancestor
92551317|NCT00026624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551318|NCT00054600|Methoxsalen|methoxsalen|mesh-list
92551319|NCT00054600|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92551320|NCT00054600|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551321|NCT00054795|Motexafin gadolinium|motexafin gadolinium|mesh-list
92551322|NCT00054795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551323|NCT00054795|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92551324|NCT00054795|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551325|NCT00026819|Rofecoxib|rofecoxib|mesh-list
92551326|NCT00026819|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92551327|NCT00026819|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92551328|NCT00026819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551329|NCT00026819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551330|NCT00026819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92551331|NCT00026819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551332|NCT00026819|Analgesics|analgesics|mesh-ancestor
92551333|NCT00026819|Sensory System Agents|sensory system agents|mesh-ancestor
92551334|NCT00026819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551335|NCT00026819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551336|NCT00026819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551337|NCT00026819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551338|NCT00054834|Epratuzumab|epratuzumab|mesh-list
92551339|NCT00054834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551340|NCT00054834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551341|NCT00054873|Fluorouracil|fluorouracil|mesh-list
92551342|NCT00054873|Tezacitabine|tezacitabine|mesh-list
92551343|NCT00054873|Antimetabolites|antimetabolites|mesh-ancestor
92551344|NCT00054873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551362|NCT00027014|Analgesics|analgesics|mesh-ancestor
92551363|NCT00027014|Sensory System Agents|sensory system agents|mesh-ancestor
92551364|NCT00027014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551365|NCT00027014|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92551366|NCT00027014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92551367|NCT00027014|Anesthetics, General|anesthetics, general|mesh-ancestor
92551368|NCT00027014|Anesthetics|anesthetics|mesh-ancestor
92551369|NCT00398424|Cisplatin|cisplatin|mesh-list
92551370|NCT00398424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551371|NCT00027053|Trazodone|trazodone|mesh-list
92551372|NCT00027053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92551373|NCT00027053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92551374|NCT00027053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92551375|NCT00027053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551376|NCT00027053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92551377|NCT00027053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92551378|NCT00027053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92551379|NCT00027053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92551380|NCT00027053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551381|NCT00027053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92551382|NCT00027053|Serotonin Agents|serotonin agents|mesh-ancestor
92551383|NCT00027053|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92551384|NCT00027053|Antidepressive Agents|antidepressive agents|mesh-ancestor
92551385|NCT00055107|Nitazoxanide|nitazoxanide|mesh-list
92551386|NCT00055107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92551387|NCT00055107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551388|NCT00055185|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92551389|NCT00055185|Immunologic Factors|immunologic factors|mesh-ancestor
92551390|NCT00055185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551391|NCT00055302|Anastrozole|anastrozole|mesh-list
92551392|NCT00055302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92551393|NCT00055302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551394|NCT00055302|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92551395|NCT00055302|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92551396|NCT00055302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534386|NCT00067756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92551397|NCT00055302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551398|NCT00055302|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92551399|NCT00055302|Hormone Antagonists|hormone antagonists|mesh-ancestor
92551400|NCT00055302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958836|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551423|NCT00027443|Cyclosporine|cyclosporine|mesh-list
92551424|NCT00027443|Cyclosporins|cyclosporins|mesh-list
92551425|NCT00027443|Muromonab-CD3|muromonab-cd3|mesh-list
92551426|NCT00027443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551427|NCT00027443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551428|NCT00027443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551429|NCT00027443|Immunologic Factors|immunologic factors|mesh-ancestor
92551430|NCT00027443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551431|NCT00027443|Antifungal Agents|antifungal agents|mesh-ancestor
92551432|NCT00027443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551433|NCT00027443|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551434|NCT00027443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551435|NCT00027443|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92551436|NCT00055614|Topotecan|topotecan|mesh-list
92551437|NCT00055614|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551438|NCT00055614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551439|NCT00055614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551440|NCT00055614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551441|NCT00055614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551442|NCT00027521|Bleomycin|bleomycin|mesh-list
92551443|NCT00027521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551444|NCT00027521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551445|NCT00027599|Bevacizumab|bevacizumab|mesh-list
92551446|NCT00027599|Sargramostim|sargramostim|mesh-list
92551447|NCT00027599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551448|NCT00027599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551449|NCT00027599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551450|NCT00027599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551451|NCT00027599|Growth Substances|growth substances|mesh-ancestor
92354671|NCT00633750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551452|NCT00027599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551453|NCT00027599|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551454|NCT00027599|Immunologic Factors|immunologic factors|mesh-ancestor
92551470|NCT00055653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551472|NCT00055653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92551473|NCT00055653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551474|NCT00055653|Antimetabolites|antimetabolites|mesh-ancestor
92551475|NCT00055653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551476|NCT00055653|Antifungal Agents|antifungal agents|mesh-ancestor
92551477|NCT00055653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551478|NCT00055653|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551479|NCT00055653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92551480|NCT00055653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551481|NCT00055653|Antiemetics|antiemetics|mesh-ancestor
92551482|NCT00055653|Autonomic Agents|autonomic agents|mesh-ancestor
92551483|NCT00055653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551484|NCT00055653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92551485|NCT00055653|Glucocorticoids|glucocorticoids|mesh-ancestor
92551486|NCT00055653|Hormones|hormones|mesh-ancestor
92551487|NCT00055653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551488|NCT00055653|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92551489|NCT00055653|Protective Agents|protective agents|mesh-ancestor
92551490|NCT00055770|Docetaxel|docetaxel|mesh-list
92551491|NCT00055770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92551492|NCT00055770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551493|NCT00055770|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551494|NCT00055770|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551495|NCT00055770|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551496|NCT00055770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551497|NCT00055770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92551498|NCT00055770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551499|NCT00027638|Thalidomide|thalidomide|mesh-list
92551500|NCT00027638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551501|NCT00027638|Immunologic Factors|immunologic factors|mesh-ancestor
92551502|NCT00027638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551503|NCT00027638|Leprostatic Agents|leprostatic agents|mesh-ancestor
92534387|NCT00067756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551505|NCT00027638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551506|NCT00027638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551507|NCT00027638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551508|NCT00027638|Growth Substances|growth substances|mesh-ancestor
92551509|NCT00027638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551510|NCT00027638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551511|NCT00055809|Interferons|interferons|mesh-list
92551512|NCT00055809|Interferon-alpha|interferon-alpha|mesh-list
92551513|NCT00055809|Interferon alpha-2|interferon alpha-2|mesh-list
92551514|NCT00055809|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92551515|NCT00055809|Bevacizumab|bevacizumab|mesh-list
92551516|NCT00055809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92551517|NCT00055809|Antibodies|antibodies|mesh-list
92551518|NCT00055809|Immunoglobulins|immunoglobulins|mesh-list
92551519|NCT00055809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92551538|NCT00027677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551539|NCT00027677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551540|NCT00027677|Growth Substances|growth substances|mesh-ancestor
92551541|NCT00027677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551542|NCT00027677|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551543|NCT00027716|Bortezomib|bortezomib|mesh-list
92551544|NCT00027716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551545|NCT00055887|Paclitaxel|paclitaxel|mesh-list
92551546|NCT00055887|Vinorelbine|vinorelbine|mesh-list
92551547|NCT00055887|Carboplatin|carboplatin|mesh-list
92551548|NCT00055887|Gemcitabine|gemcitabine|mesh-list
92551549|NCT00055887|Efaproxiral|efaproxiral|mesh-list
92551550|NCT00055887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551551|NCT00055887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551552|NCT00055887|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551553|NCT00055887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551554|NCT00055887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551555|NCT00055887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551556|NCT00055887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551557|NCT00055887|Antimetabolites|antimetabolites|mesh-ancestor
92551558|NCT00055887|Antisickling Agents|antisickling agents|mesh-ancestor
92551559|NCT00026039|Estrogens|estrogens|mesh-list
92551560|NCT00026039|Hormones|hormones|mesh-ancestor
92551561|NCT00026039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551562|NCT00026039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551563|NCT00027404|Fluoxetine|fluoxetine|mesh-list
92551564|NCT00027404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92551565|NCT00027404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92551566|NCT00027404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92551567|NCT00027404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551568|NCT00027404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92551569|NCT00027404|Serotonin Agents|serotonin agents|mesh-ancestor
92551570|NCT00027404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551571|NCT00027404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92551572|NCT00027404|Antidepressive Agents|antidepressive agents|mesh-ancestor
92551573|NCT00027404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92551574|NCT00027404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92551575|NCT00027404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92551600|NCT00027833|Protective Agents|protective agents|mesh-ancestor
92551601|NCT00027833|Vitamin B Complex|vitamin b complex|mesh-ancestor
92551602|NCT00027833|Vitamins|vitamins|mesh-ancestor
92551603|NCT00027833|Micronutrients|micronutrients|mesh-ancestor
92551604|NCT00027872|Tipifarnib|tipifarnib|mesh-list
92551605|NCT00027872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551606|NCT00027911|Sargramostim|sargramostim|mesh-list
92551607|NCT00027911|Immunologic Factors|immunologic factors|mesh-ancestor
92551608|NCT00027911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551609|NCT00027989|Gemcitabine|gemcitabine|mesh-list
92551610|NCT00027989|Doxorubicin|doxorubicin|mesh-list
92551611|NCT00027989|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92551612|NCT00027989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551613|NCT00027989|Antimetabolites|antimetabolites|mesh-ancestor
92551614|NCT00027989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551615|NCT00027989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551616|NCT00027989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551617|NCT00027989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92534388|NCT00067756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534389|NCT04091880|Vaccines|vaccines|mesh-list
92534390|NCT04091880|Immunologic Factors|immunologic factors|mesh-ancestor
92534391|NCT04091880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551618|NCT00027989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551619|NCT00027989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551620|NCT00056004|Zileuton|zileuton|mesh-list
92551621|NCT00056004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92551622|NCT00056004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551623|NCT00056004|Analgesics|analgesics|mesh-ancestor
92551624|NCT00056004|Sensory System Agents|sensory system agents|mesh-ancestor
92551625|NCT00056004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551626|NCT00056004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551627|NCT00056004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551628|NCT00056004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551652|NCT00028106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551654|NCT00056082|Celecoxib|celecoxib|mesh-list
92551655|NCT00056082|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92551656|NCT00056082|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551657|NCT00056082|Analgesics|analgesics|mesh-ancestor
92551658|NCT00056082|Sensory System Agents|sensory system agents|mesh-ancestor
92551659|NCT00056082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551660|NCT00056082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551661|NCT00056082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551662|NCT00056082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551663|NCT00056082|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92551664|NCT00056082|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92551665|NCT00056082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551666|NCT00056082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551667|NCT04730973|Evolocumab|evolocumab|mesh-list
92551668|NCT04730973|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92551669|NCT04730973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92551670|NCT04730973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92551671|NCT04730973|Antimetabolites|antimetabolites|mesh-ancestor
92551672|NCT04730973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551673|NCT04730973|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92551674|NCT04730973|Protease Inhibitors|protease inhibitors|mesh-ancestor
92551675|NCT04730973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551676|NCT04730973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92551677|NCT00028418|Clofarabine|clofarabine|mesh-list
92551692|NCT00028496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92551693|NCT00028496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92551694|NCT00028496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92551695|NCT00028535|Paclitaxel|paclitaxel|mesh-list
92551696|NCT00028535|Trastuzumab|trastuzumab|mesh-list
92551697|NCT00028535|Interleukin-12|interleukin-12|mesh-list
92551698|NCT00028535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551699|NCT00028535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551700|NCT00028535|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551701|NCT00028535|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551702|NCT00028535|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551703|NCT00028535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551704|NCT00028535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551705|NCT00028535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92551706|NCT00028535|Immunologic Factors|immunologic factors|mesh-ancestor
92551707|NCT00028535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551708|NCT00028535|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551709|NCT00028535|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551710|NCT00028535|Growth Substances|growth substances|mesh-ancestor
92551711|NCT00028535|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551712|NCT00056277|Lamotrigine|lamotrigine|mesh-list
92551713|NCT00056277|Anticonvulsants|anticonvulsants|mesh-ancestor
92551714|NCT00056277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92551715|NCT00056277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92551716|NCT00056277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551717|NCT00056277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92551718|NCT00056277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551719|NCT00056277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92551720|NCT00056277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92551721|NCT00056277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534392|NCT00067912|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92534393|NCT00067912|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92534394|NCT00067912|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92551722|NCT00056277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92551723|NCT00056277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92551725|NCT00028574|Analgesics|analgesics|mesh-ancestor
92551726|NCT00028574|Sensory System Agents|sensory system agents|mesh-ancestor
92551727|NCT00028574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551728|NCT00028574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551729|NCT00028574|Anticonvulsants|anticonvulsants|mesh-ancestor
92551730|NCT00028574|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92551731|NCT00028574|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92551732|NCT00028574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92551733|NCT00028574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92551734|NCT00028574|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92551735|NCT00028574|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92551736|NCT00028574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92551737|NCT00028574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551738|NCT00028574|Antimanic Agents|antimanic agents|mesh-ancestor
92551739|NCT00056433|Hydroxyurea|hydroxyurea|mesh-list
92551740|NCT00056433|Sildenafil Citrate|sildenafil citrate|mesh-list
92551774|NCT00028730|Immunologic Factors|immunologic factors|mesh-ancestor
92551775|NCT00028730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551776|NCT00028730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551777|NCT00028730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551778|NCT00028730|Alkylating Agents|alkylating agents|mesh-ancestor
92551779|NCT00028730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551780|NCT00028730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959231|NCT04038489|Aspirin|aspirin|mesh-list
92551851|NCT00398463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551852|NCT00398463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92551854|NCT00398463|Immunologic Factors|immunologic factors|mesh-ancestor
92551855|NCT00398463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551856|NCT00398463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551857|NCT00398463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551858|NCT00398463|Antiviral Agents|antiviral agents|mesh-ancestor
92551859|NCT00398463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551868|NCT00028964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551870|NCT00028964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551871|NCT00028964|Alkylating Agents|alkylating agents|mesh-ancestor
92551872|NCT00028964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551873|NCT00028964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551874|NCT00028964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92551875|NCT00028964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551876|NCT00028964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92551877|NCT00028964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551878|NCT00028964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551879|NCT00423501|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92551880|NCT00423501|Incretins|incretins|mesh-ancestor
92551881|NCT00423501|Hormones|hormones|mesh-ancestor
92551882|NCT00423501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551883|NCT00423501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551884|NCT00029003|Gefitinib|gefitinib|mesh-list
92551885|NCT00029003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551886|NCT00029003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92551887|NCT00029003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551888|NCT00029003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551889|NCT00029042|Infliximab|infliximab|mesh-list
92551890|NCT00029042|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92551891|NCT00029042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551892|NCT00029042|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551893|NCT00029042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92551894|NCT00029042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551895|NCT00423540|Magnesium Sulfate|magnesium sulfate|mesh-list
92551896|NCT00423540|Analgesics|analgesics|mesh-ancestor
92551897|NCT00423540|Sensory System Agents|sensory system agents|mesh-ancestor
92551898|NCT00423540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551899|NCT00423540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551900|NCT00423540|Anesthetics|anesthetics|mesh-ancestor
92534395|NCT00067912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92551901|NCT00423540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92551902|NCT00423540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92551904|NCT00423540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92551905|NCT00423540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92551906|NCT00423540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276592|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
92551907|NCT00423540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92551908|NCT00423540|Tocolytic Agents|tocolytic agents|mesh-ancestor
92551909|NCT00423540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92551910|NCT00029159|Estrogens|estrogens|mesh-list
92551911|NCT00029159|Androgens|androgens|mesh-list
92551912|NCT00029159|Hormones|hormones|mesh-ancestor
92551913|NCT00029159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551914|NCT00029159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551915|NCT00423696|Leucovorin|leucovorin|mesh-list
92551916|NCT00423696|Bevacizumab|bevacizumab|mesh-list
92551917|NCT00423696|Fluorouracil|fluorouracil|mesh-list
92551918|NCT00423696|Capecitabine|capecitabine|mesh-list
92551919|NCT00423696|Irinotecan|irinotecan|mesh-list
92551920|NCT00423696|Calcium|calcium|mesh-list
92551921|NCT00423696|Levoleucovorin|levoleucovorin|mesh-list
92551922|NCT00423696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551923|NCT00423696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551924|NCT00423696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551925|NCT00423696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551926|NCT00423696|Growth Substances|growth substances|mesh-ancestor
92551958|NCT00029627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551959|NCT00029627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551960|NCT00029627|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92551961|NCT00029627|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92551962|NCT00029627|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92551963|NCT00029627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92551964|NCT00029627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92551965|NCT00029627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551966|NCT00029627|Urological Agents|urological agents|mesh-ancestor
92551967|NCT02970084|Vitamin K|vitamin k|mesh-list
92551968|NCT02970084|Vitamin K 2|vitamin k 2|mesh-list
92551969|NCT02970084|Vitamins|vitamins|mesh-ancestor
92551970|NCT02970084|Micronutrients|micronutrients|mesh-ancestor
92551986|NCT00029822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92551987|NCT00029822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551988|NCT00029822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551989|NCT00029822|Urological Agents|urological agents|mesh-ancestor
92551990|NCT00395681|Propofol|propofol|mesh-list
92551991|NCT00395681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92551992|NCT00395681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92551993|NCT00395681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551994|NCT00395681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92551995|NCT00395681|Anesthetics, General|anesthetics, general|mesh-ancestor
92551996|NCT00395681|Anesthetics|anesthetics|mesh-ancestor
92551997|NCT00395720|Vaccines|vaccines|mesh-list
92551998|NCT00395720|Immunologic Factors|immunologic factors|mesh-ancestor
92551999|NCT00395720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552000|NCT00395759|Lubricant Eye Drops|lubricant eye drops|mesh-list
92552001|NCT00395759|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92552002|NCT00395759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92552003|NCT00395915|Aripiprazole|aripiprazole|mesh-list
92552004|NCT00395915|Antidepressive Agents|antidepressive agents|mesh-ancestor
92552005|NCT00395915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552006|NCT00395915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92552007|NCT00395915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92552008|NCT00395915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552009|NCT00395915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552010|NCT00395915|Dopamine Agonists|dopamine agonists|mesh-ancestor
92552011|NCT00395915|Dopamine Agents|dopamine agents|mesh-ancestor
92552012|NCT00395915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552013|NCT00395915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552014|NCT00395915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92552015|NCT00395915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92552016|NCT00395915|Serotonin Agents|serotonin agents|mesh-ancestor
92552017|NCT00395915|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92534396|NCT00067912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534397|NCT00067912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534398|NCT00067912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552018|NCT00395915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92552019|NCT00395915|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92552020|NCT00395915|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92552021|NCT00029861|Rimonabant|rimonabant|mesh-list
92552022|NCT00029861|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92552023|NCT00029861|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92552024|NCT00029861|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92552025|NCT00029861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552026|NCT00029861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552027|NCT00029861|Hormones|hormones|mesh-ancestor
92552028|NCT00029861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552029|NCT00029861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552030|NCT00057369|Dalbavancin|dalbavancin|mesh-list
91959463|NCT03122665|Nefopam|nefopam|mesh-list
92552051|NCT00030056|Immunologic Factors|immunologic factors|mesh-ancestor
92552052|NCT00030056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552053|NCT00030056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552054|NCT00057447|Interferons|interferons|mesh-list
92552055|NCT00057447|Interferon-gamma|interferon-gamma|mesh-list
92552056|NCT00057447|Rituximab|rituximab|mesh-list
92276755|NCT05748236|Analgesics|analgesics|mesh-ancestor
92552057|NCT00057447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354704|NCT01923870|Enclomiphene|enclomiphene|mesh-list
92552058|NCT00057447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552059|NCT00057447|Immunologic Factors|immunologic factors|mesh-ancestor
92552060|NCT00057447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552061|NCT00057447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552062|NCT00057447|Antiviral Agents|antiviral agents|mesh-ancestor
92552063|NCT00057447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552064|NCT00030095|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92552065|NCT00030095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552066|NCT00030095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552067|NCT00030095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552068|NCT00030095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552069|NCT00030095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552070|NCT00030173|Epothilones|epothilones|mesh-list
92552071|NCT00030173|Desoxyepothilone B|desoxyepothilone b|mesh-list
92552072|NCT00030173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552073|NCT00030173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552074|NCT00030173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552075|NCT00030173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552076|NCT00030173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552077|NCT00057564|Thalidomide|thalidomide|mesh-list
92552078|NCT00057564|Dexamethasone|dexamethasone|mesh-list
92552079|NCT00057564|Dexamethasone acetate|dexamethasone acetate|mesh-list
92552080|NCT00057564|BB 1101|bb 1101|mesh-list
92552081|NCT00057564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92552082|NCT00057564|Antiemetics|antiemetics|mesh-ancestor
92552083|NCT00057564|Autonomic Agents|autonomic agents|mesh-ancestor
92552084|NCT00057564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552085|NCT00057564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552097|NCT00057564|Leprostatic Agents|leprostatic agents|mesh-ancestor
92552098|NCT00057564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552099|NCT00057564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552100|NCT00057564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92552101|NCT00057564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92552102|NCT00057564|Growth Substances|growth substances|mesh-ancestor
92552103|NCT00057564|Growth Inhibitors|growth inhibitors|mesh-ancestor
92552104|NCT00030368|Paclitaxel|paclitaxel|mesh-list
92552105|NCT00030368|Bortezomib|bortezomib|mesh-list
92552106|NCT00030368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552107|NCT00030368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552108|NCT00030368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552109|NCT00030368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552110|NCT00030368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552111|NCT00030368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552112|NCT00030407|Celecoxib|celecoxib|mesh-list
92552113|NCT00030407|Docetaxel|docetaxel|mesh-list
92552114|NCT00030407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552115|NCT00030407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552116|NCT00030407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534399|NCT00067912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534400|NCT00067912|Analgesics|analgesics|mesh-ancestor
92534401|NCT00067912|Sensory System Agents|sensory system agents|mesh-ancestor
92552117|NCT00030407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552118|NCT00030407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552119|NCT00030407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92552120|NCT00030407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92552121|NCT00030407|Analgesics|analgesics|mesh-ancestor
92552122|NCT00030407|Sensory System Agents|sensory system agents|mesh-ancestor
92552123|NCT00030407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552124|NCT00030407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552125|NCT00030407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92552126|NCT00030407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552127|NCT00030407|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92552128|NCT00030407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92552129|NCT00030407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552130|NCT00057642|Sertraline|sertraline|mesh-list
92552131|NCT00057642|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92552132|NCT00057642|Antidepressive Agents|antidepressive agents|mesh-ancestor
92552133|NCT00057642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552134|NCT00057642|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92552135|NCT00057642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92552136|NCT00057642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552137|NCT00057642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552138|NCT00057642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552139|NCT00057642|Serotonin Agents|serotonin agents|mesh-ancestor
92552140|NCT00057642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552141|NCT00057642|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92552142|NCT00057642|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92552143|NCT00030446|Carboplatin|carboplatin|mesh-list
92552144|NCT00030446|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92552145|NCT00030446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552146|NCT00030446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92552147|NCT00030446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552150|NCT00030485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552151|NCT00030485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92552152|NCT00030485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552153|NCT00030485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552154|NCT00057720|Doxorubicin|doxorubicin|mesh-list
92552155|NCT00057720|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92552156|NCT00057720|Topotecan|topotecan|mesh-list
92552157|NCT00057720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92552158|NCT00057720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552159|NCT00057720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552160|NCT00057720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552161|NCT00057720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552162|NCT00057720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552163|NCT00057720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92552164|NCT00030524|Gefitinib|gefitinib|mesh-list
92552165|NCT00030524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552166|NCT00030524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92552167|NCT00030524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552168|NCT00030524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552169|NCT00030563|Irinotecan|irinotecan|mesh-list
92552170|NCT00030563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92552171|NCT00030563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552172|NCT00030563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552173|NCT00030563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552174|NCT00030563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552175|NCT00030602|Freund's Adjuvant|freund's adjuvant|mesh-list
92552176|NCT00030602|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92552177|NCT00030602|Immunologic Factors|immunologic factors|mesh-ancestor
92552178|NCT00030602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552179|NCT00057759|Sildenafil Citrate|sildenafil citrate|mesh-list
92552180|NCT00057759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552181|NCT00057759|Vasodilator Agents|vasodilator agents|mesh-ancestor
92552182|NCT00057759|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92552183|NCT00057759|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92552184|NCT00057759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534402|NCT00067912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534403|NCT00067912|Antidepressive Agents|antidepressive agents|mesh-ancestor
92534404|NCT00067912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534405|NCT00067912|Dopamine Agents|dopamine agents|mesh-ancestor
92552185|NCT00057759|Urological Agents|urological agents|mesh-ancestor
92552186|NCT00030641|Docetaxel|docetaxel|mesh-list
92552187|NCT00030641|Oblimersen|oblimersen|mesh-list
92552188|NCT00030641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552189|NCT00030641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552190|NCT00030641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552191|NCT00030641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552192|NCT00030641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552193|NCT00057798|Gemcitabine|gemcitabine|mesh-list
92552194|NCT00057798|Vinorelbine|vinorelbine|mesh-list
92552195|NCT00057798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552196|NCT00057798|Antimetabolites|antimetabolites|mesh-ancestor
92552197|NCT00057798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552198|NCT00057798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552199|NCT00057798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552200|NCT00057798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552201|NCT00057798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552202|NCT00057798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552203|NCT02969733|Lidocaine|lidocaine|mesh-list
92552204|NCT02969733|Ketamine|ketamine|mesh-list
92276897|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552205|NCT02969733|Analgesics|analgesics|mesh-ancestor
92552206|NCT02969733|Sensory System Agents|sensory system agents|mesh-ancestor
92552207|NCT02969733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552208|NCT02969733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552209|NCT02969733|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92552210|NCT02969733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92552211|NCT02969733|Anesthetics, General|anesthetics, general|mesh-ancestor
92552212|NCT02969733|Anesthetics|anesthetics|mesh-ancestor
92552213|NCT02969733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552214|NCT02969733|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92552215|NCT02969733|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92552216|NCT02969733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552217|NCT02969733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959649|NCT05302713|Calcium|calcium|mesh-list
92552226|NCT00030719|Carboplatin|carboplatin|mesh-list
92552227|NCT00030719|Etoposide|etoposide|mesh-list
92552228|NCT00030719|Vincristine|vincristine|mesh-list
92552229|NCT00030719|Dinutuximab|dinutuximab|mesh-list
92552230|NCT00030719|Isotretinoin|isotretinoin|mesh-list
92552231|NCT00030719|Antibodies|antibodies|mesh-list
92552232|NCT00030719|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92552233|NCT00030719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552234|NCT00030719|Immunologic Factors|immunologic factors|mesh-ancestor
92552235|NCT00030719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552236|NCT00030719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552237|NCT00030719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92552238|NCT00030719|Alkylating Agents|alkylating agents|mesh-ancestor
92552239|NCT00030719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552240|NCT00030719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552241|NCT00030719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92552242|NCT00030719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552243|NCT00030719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552244|NCT00030719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552245|NCT00030719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552246|NCT00030719|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552247|NCT00030719|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552248|NCT00030719|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552249|NCT00030719|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552250|NCT00030758|Lenograstim|lenograstim|mesh-list
92552251|NCT00030758|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92552252|NCT00030758|Immunologic Factors|immunologic factors|mesh-ancestor
92552253|NCT00030758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552254|NCT04730895|Tretinoin|tretinoin|mesh-list
92552255|NCT04730895|Isotretinoin|isotretinoin|mesh-list
92552256|NCT04730895|Vaccines|vaccines|mesh-list
92552257|NCT04730895|Myeloma Proteins|myeloma proteins|mesh-list
92552258|NCT04730895|Paraproteins|paraproteins|mesh-list
92552259|NCT04730895|Immunologic Factors|immunologic factors|mesh-ancestor
92552260|NCT04730895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534406|NCT00067912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92552261|NCT04730895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552262|NCT04730895|Keratolytic Agents|keratolytic agents|mesh-ancestor
92552263|NCT04730895|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552264|NCT00030797|Irinotecan|irinotecan|mesh-list
92552265|NCT00030797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92552266|NCT00030797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552267|NCT00030797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552268|NCT00030797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552269|NCT00030797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552270|NCT00030875|Bortezomib|bortezomib|mesh-list
92552271|NCT00030875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552272|NCT00058071|Amifostine|amifostine|mesh-list
92552273|NCT00058071|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92552274|NCT00058071|Protective Agents|protective agents|mesh-ancestor
92552275|NCT00058071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552276|NCT00030914|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92552277|NCT00030914|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92552278|NCT00030914|Medroxyprogesterone|medroxyprogesterone|mesh-list
92552279|NCT00030914|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92552280|NCT00030914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92552281|NCT00030914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552282|NCT00030914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552283|NCT00030914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552284|NCT00030914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552285|NCT00030914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92552286|NCT00030914|Antidepressive Agents|antidepressive agents|mesh-ancestor
92552289|NCT00030914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92552290|NCT00030914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92552291|NCT00030914|Contraceptive Agents|contraceptive agents|mesh-ancestor
92552292|NCT00030914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92552293|NCT00030914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92552294|NCT00030914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92552295|NCT00030914|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92552296|NCT00030914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92552297|NCT00030914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552298|NCT00058149|Gemcitabine|gemcitabine|mesh-list
92552299|NCT00058149|Oxaliplatin|oxaliplatin|mesh-list
92552300|NCT00058149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552301|NCT00058149|Antimetabolites|antimetabolites|mesh-ancestor
92552302|NCT00058149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552303|NCT00058149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552304|NCT00058227|Rituximab|rituximab|mesh-list
92552305|NCT00058227|Fludarabine|fludarabine|mesh-list
92552306|NCT00058227|Fludarabine phosphate|fludarabine phosphate|mesh-list
92552307|NCT00058227|Alvocidib|alvocidib|mesh-list
92552308|NCT00058227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92552309|NCT00058227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552310|NCT00058227|Immunologic Factors|immunologic factors|mesh-ancestor
92552311|NCT00058227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552312|NCT00058227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552313|NCT00058227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552314|NCT00058227|Antimetabolites|antimetabolites|mesh-ancestor
92552315|NCT00058227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552316|NCT00058227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552317|NCT00058227|Growth Inhibitors|growth inhibitors|mesh-ancestor
92552318|NCT00058227|Growth Substances|growth substances|mesh-ancestor
92552319|NCT00058227|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92552320|NCT00058227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552321|NCT00031070|Cyclosporine|cyclosporine|mesh-list
92552322|NCT00031070|Lamivudine|lamivudine|mesh-list
92552323|NCT00031070|Zidovudine|zidovudine|mesh-list
92552324|NCT00031070|Efavirenz|efavirenz|mesh-list
92552325|NCT00031070|Abacavir|abacavir|mesh-list
92552326|NCT00031070|Vaccines|vaccines|mesh-list
92552327|NCT00031070|Cyclosporins|cyclosporins|mesh-list
92552328|NCT00031070|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92552329|NCT00031070|Immunologic Factors|immunologic factors|mesh-ancestor
92552330|NCT00031070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552331|NCT00031070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552332|NCT00031070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552333|NCT00031070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552334|NCT00031070|Antifungal Agents|antifungal agents|mesh-ancestor
92534407|NCT04074096|Pembrolizumab|pembrolizumab|mesh-list
92534408|NCT04074096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534409|NCT04074096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534410|NCT04074096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92534411|NCT04074096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534412|NCT00067951|Metformin|metformin|mesh-list
92534413|NCT00067951|Rosiglitazone|rosiglitazone|mesh-list
92534414|NCT00067951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92534415|NCT00067951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534416|NCT00392457|Ketoconazole|ketoconazole|mesh-list
92534417|NCT00392457|Hormones|hormones|mesh-list
92534418|NCT00392457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534419|NCT00392457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534420|NCT00392457|Antifungal Agents|antifungal agents|mesh-ancestor
92534421|NCT00392457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534422|NCT00392457|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92534423|NCT00392457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92354724|NCT01923948|Pregabalin|pregabalin|mesh-list
92552335|NCT00031070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552336|NCT00031070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552337|NCT00031070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552338|NCT00031070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92552339|NCT00031070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92552340|NCT00031070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92552341|NCT00031070|Antiviral Agents|antiviral agents|mesh-ancestor
92552342|NCT00031070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92552343|NCT00031070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92552344|NCT00031070|Antimetabolites|antimetabolites|mesh-ancestor
92552345|NCT00031070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92552346|NCT00031070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92552347|NCT00031070|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92552348|NCT00031070|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92552349|NCT00031070|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92552350|NCT00031070|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92552351|NCT00058305|Vincristine|vincristine|mesh-list
92552352|NCT00058305|Bryostatin 1|bryostatin 1|mesh-list
92552353|NCT00058305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552354|NCT00058305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552355|NCT00058305|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552356|NCT00058305|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552357|NCT00058305|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552358|NCT00058305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959769|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92552371|NCT00058461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552373|NCT00058461|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92552374|NCT00058461|Abortifacient Agents|abortifacient agents|mesh-ancestor
92552375|NCT00058461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92552376|NCT00058461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552377|NCT00058461|Antimetabolites|antimetabolites|mesh-ancestor
92552378|NCT00058461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552379|NCT00058461|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552380|NCT00058461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552381|NCT00058461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92552382|NCT00058461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552383|NCT00058461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92534424|NCT00392457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534425|NCT00392457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552384|NCT00058461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552385|NCT00058461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552386|NCT00058461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552387|NCT00058461|Antiviral Agents|antiviral agents|mesh-ancestor
92552388|NCT00058461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552389|NCT00058461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92552390|NCT00058461|Alkylating Agents|alkylating agents|mesh-ancestor
92552391|NCT00058578|Cyclophosphamide|cyclophosphamide|mesh-list
92552392|NCT00058578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552393|NCT00058578|Immunologic Factors|immunologic factors|mesh-ancestor
92552394|NCT00058578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552395|NCT00058578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552396|NCT00058578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92552397|NCT00058578|Alkylating Agents|alkylating agents|mesh-ancestor
92552398|NCT00058578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552399|NCT00058578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552400|NCT00058578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92552401|NCT04711889|Urinastatin|urinastatin|mesh-list
92552402|NCT04711889|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92552403|NCT04711889|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92552404|NCT04711889|Protease Inhibitors|protease inhibitors|mesh-ancestor
92552405|NCT04711889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552406|NCT04711889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552407|NCT00031109|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92552408|NCT00031109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92552409|NCT00031109|Immunologic Factors|immunologic factors|mesh-ancestor
92552410|NCT00031109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552412|NCT00031109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552413|NCT00031109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92552414|NCT00031148|Mitogens|mitogens|mesh-list
92552415|NCT00031148|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552416|NCT00031148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552417|NCT00031187|Docetaxel|docetaxel|mesh-list
92552418|NCT00031187|Doxorubicin|doxorubicin|mesh-list
92552419|NCT00031187|Immunoconjugates|immunoconjugates|mesh-list
92552420|NCT00031187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552421|NCT00031187|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552422|NCT00031187|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552432|NCT00031343|Antiviral Agents|antiviral agents|mesh-ancestor
92552433|NCT00031343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552434|NCT00058890|Gabapentin|gabapentin|mesh-list
92552435|NCT00058890|Analgesics|analgesics|mesh-ancestor
92552436|NCT00058890|Sensory System Agents|sensory system agents|mesh-ancestor
92552437|NCT00058890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552438|NCT00058890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552439|NCT00058890|Anticonvulsants|anticonvulsants|mesh-ancestor
92552440|NCT00058890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92552441|NCT00058890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92552442|NCT00058890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552443|NCT00058890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552444|NCT00058890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92552445|NCT00058890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92552446|NCT00058890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552447|NCT00058890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552448|NCT00058890|Antimanic Agents|antimanic agents|mesh-ancestor
92552449|NCT00058929|Treprostinil|treprostinil|mesh-list
92552450|NCT00058929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92552451|NCT00396071|Vildagliptin|vildagliptin|mesh-list
92552452|NCT00396071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92552453|NCT00396071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552454|NCT00396071|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92552455|NCT00396071|Protease Inhibitors|protease inhibitors|mesh-ancestor
92552456|NCT00396071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552457|NCT00396071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552458|NCT00058968|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92552459|NCT00058968|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92552460|NCT00058968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92552461|NCT00058968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534426|NCT00392457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92534427|NCT00392457|Hormone Antagonists|hormone antagonists|mesh-ancestor
92552462|NCT00058968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552463|NCT00058968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552464|NCT00058968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552466|NCT00058968|Sensory System Agents|sensory system agents|mesh-ancestor
92552467|NCT00058968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552468|NCT00058968|Antidepressive Agents|antidepressive agents|mesh-ancestor
92552469|NCT00058968|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552470|NCT00058968|Dopamine Agents|dopamine agents|mesh-ancestor
92552471|NCT00396227|Pioglitazone|pioglitazone|mesh-list
92552472|NCT00396227|Rosiglitazone|rosiglitazone|mesh-list
92552473|NCT00396227|Vildagliptin|vildagliptin|mesh-list
92552474|NCT00396227|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92552475|NCT00396227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92552476|NCT00396227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552477|NCT00396227|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92552478|NCT00396227|Protease Inhibitors|protease inhibitors|mesh-ancestor
92552479|NCT00396227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552480|NCT00396227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552481|NCT00396344|Hydrocortisone|hydrocortisone|mesh-list
92552482|NCT00396344|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92552483|NCT00396344|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92552484|NCT00396344|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92552485|NCT00396344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92552486|NCT00031499|Azithromycin|azithromycin|mesh-list
92552506|NCT00059358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552507|NCT00059358|Immunologic Factors|immunologic factors|mesh-ancestor
92552508|NCT00059358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552509|NCT00031577|Paclitaxel|paclitaxel|mesh-list
92552510|NCT00031577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552511|NCT00031577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552512|NCT00031577|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552513|NCT00031577|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552514|NCT00031577|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552515|NCT00031577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552516|NCT00031616|Brivudine|brivudine|mesh-list
92552517|NCT00031616|Phosphoramidic acid|phosphoramidic acid|mesh-list
92552518|NCT00031616|Antiviral Agents|antiviral agents|mesh-ancestor
92552519|NCT00031616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552520|NCT00031616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552521|NCT00031616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552522|NCT02969304|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92552523|NCT02969304|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552524|NCT02969304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552525|NCT02969304|Immunologic Factors|immunologic factors|mesh-ancestor
92552526|NCT02969304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552527|NCT00031655|Cyclosporine|cyclosporine|mesh-list
92552528|NCT00031655|Mycophenolic Acid|mycophenolic acid|mesh-list
92552529|NCT00031655|Fludarabine|fludarabine|mesh-list
92552530|NCT00031655|Fludarabine phosphate|fludarabine phosphate|mesh-list
92552531|NCT00031655|Cyclosporins|cyclosporins|mesh-list
92552532|NCT00031655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552533|NCT00031655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552534|NCT00031655|Antimetabolites|antimetabolites|mesh-ancestor
92552535|NCT00031655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552536|NCT00031655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552537|NCT00031655|Immunologic Factors|immunologic factors|mesh-ancestor
92552538|NCT00031655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552539|NCT00031655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552540|NCT00031655|Antifungal Agents|antifungal agents|mesh-ancestor
92552541|NCT00031655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552542|NCT00031655|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552543|NCT00031655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552544|NCT00031655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92552545|NCT00031655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92552546|NCT00031655|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92552550|NCT00059592|Antiviral Agents|antiviral agents|mesh-ancestor
92552551|NCT00059592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552552|NCT00031733|Interleukin-12|interleukin-12|mesh-list
92552553|NCT00031733|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92552554|NCT00031733|Sargramostim|sargramostim|mesh-list
92552555|NCT00031733|Freund's Adjuvant|freund's adjuvant|mesh-list
92534428|NCT00392457|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92552556|NCT00031733|Aluminum sulfate|aluminum sulfate|mesh-list
92552557|NCT00031733|Immunologic Factors|immunologic factors|mesh-ancestor
92552558|NCT00031733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552559|NCT00031733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552560|NCT00031733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92552561|NCT00031733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92552562|NCT00031733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92552563|NCT00031733|Growth Substances|growth substances|mesh-ancestor
92552564|NCT00031733|Growth Inhibitors|growth inhibitors|mesh-ancestor
92552565|NCT00031733|Antacids|antacids|mesh-ancestor
92552566|NCT00031733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552567|NCT00031733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92552568|NCT02969265|Amlodipine|amlodipine|mesh-list
92552569|NCT02969265|Candesartan cilexetil|candesartan cilexetil|mesh-list
92552570|NCT02969265|Candesartan|candesartan|mesh-list
92552571|NCT02969265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92552572|NCT02969265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92552573|NCT02969265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552574|NCT02969265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552575|NCT02969265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92552576|NCT02969265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552577|NCT02969265|Vasodilator Agents|vasodilator agents|mesh-ancestor
92552578|NCT02969265|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92354739|NCT00989196|Coagulants|coagulants|mesh-ancestor
92552579|NCT02969265|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92552580|NCT00031811|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92552581|NCT00031811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92552582|NCT00031811|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704601|NCT02203643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552583|NCT00031811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552584|NCT00031811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552585|NCT00031811|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92552586|NCT00031811|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92552587|NCT00031811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92552588|NCT00031850|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92552589|NCT00031850|Goserelin|goserelin|mesh-list
92552590|NCT00031850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92552591|NCT00031850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552592|NCT00031850|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92552593|NCT00031850|Hormone Antagonists|hormone antagonists|mesh-ancestor
92552594|NCT00031850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552595|NCT00031850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552596|NCT00031850|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92552597|NCT00031850|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92552598|NCT00031850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92552599|NCT00059631|Bortezomib|bortezomib|mesh-list
92552600|NCT00059631|Mitoxantrone|mitoxantrone|mesh-list
92552601|NCT00059631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552602|NCT00059631|Analgesics|analgesics|mesh-ancestor
92552603|NCT00059631|Sensory System Agents|sensory system agents|mesh-ancestor
92552604|NCT00059631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552605|NCT00059631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552606|NCT00059631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552607|NCT00059631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552608|NCT00059631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552609|NCT00059631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552610|NCT00031889|Exemestane|exemestane|mesh-list
92552611|NCT00031889|Bicalutamide|bicalutamide|mesh-list
92552612|NCT00031889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552613|NCT00031889|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92552614|NCT00031889|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92552615|NCT00031889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960028|NCT03161223|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92552627|NCT00031967|Melatonin|melatonin|mesh-list
92552628|NCT00031967|Antioxidants|antioxidants|mesh-ancestor
92552629|NCT00031967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552630|NCT00031967|Protective Agents|protective agents|mesh-ancestor
92552631|NCT00031967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552632|NCT00031967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552633|NCT00059826|Interferons|interferons|mesh-list
92552634|NCT00059826|Interferon-alpha|interferon-alpha|mesh-list
92552635|NCT00059826|Interferon alpha-2|interferon alpha-2|mesh-list
92552636|NCT00059826|Fluorouracil|fluorouracil|mesh-list
92552637|NCT00059826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552638|NCT00059826|Antimetabolites|antimetabolites|mesh-ancestor
92552639|NCT00059826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552640|NCT00059826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552641|NCT00059826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552642|NCT00059826|Immunologic Factors|immunologic factors|mesh-ancestor
92552643|NCT00059826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552644|NCT00059826|Antiviral Agents|antiviral agents|mesh-ancestor
92552645|NCT00059826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552646|NCT00032045|Ipilimumab|ipilimumab|mesh-list
92552647|NCT00032045|Freund's Adjuvant|freund's adjuvant|mesh-list
92552648|NCT00032045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92552649|NCT00032045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552650|NCT00032045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92552651|NCT00032045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552652|NCT00032045|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92552653|NCT00032045|Immunologic Factors|immunologic factors|mesh-ancestor
92552654|NCT00032045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552655|NCT00059865|Gemcitabine|gemcitabine|mesh-list
92552656|NCT00059865|Pemetrexed|pemetrexed|mesh-list
92552657|NCT00059865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552658|NCT00059865|Antimetabolites|antimetabolites|mesh-ancestor
92552659|NCT00059865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552660|NCT00059865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552661|NCT00059865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552662|NCT00059865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92552663|NCT00059865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92552664|NCT00032084|Bupropion|bupropion|mesh-list
92552665|NCT00032084|Nicotine|nicotine|mesh-list
92552666|NCT00032084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92552667|NCT00032084|Autonomic Agents|autonomic agents|mesh-ancestor
92552668|NCT00032084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552669|NCT00032084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552670|NCT00032084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92552671|NCT00032084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92552672|NCT00032084|Cholinergic Agents|cholinergic agents|mesh-ancestor
92552673|NCT00032084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552674|NCT00032084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552675|NCT00032084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92552676|NCT00032084|Antidepressive Agents|antidepressive agents|mesh-ancestor
92552677|NCT00032084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552679|NCT00032084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92552680|NCT00032084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552681|NCT00032084|Dopamine Agents|dopamine agents|mesh-ancestor
92552682|NCT00032084|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92552683|NCT00032084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92552684|NCT00032084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552685|NCT00059904|Aldesleukin|aldesleukin|mesh-list
92552686|NCT00059904|Rituximab|rituximab|mesh-list
92552687|NCT00059904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92552688|NCT00059904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552689|NCT00059904|Immunologic Factors|immunologic factors|mesh-ancestor
92552690|NCT00059904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552691|NCT00059904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552692|NCT00059904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92552693|NCT00059904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92552694|NCT00059904|Antiviral Agents|antiviral agents|mesh-ancestor
92552695|NCT00059904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552696|NCT00032123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92552697|NCT00032123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552698|NCT00032123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92552699|NCT00032123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552700|NCT00032123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552701|NCT00059943|Docetaxel|docetaxel|mesh-list
92552702|NCT00059943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552703|NCT00059943|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552704|NCT00059943|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552705|NCT00059943|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552706|NCT00059943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552707|NCT00032162|Carboplatin|carboplatin|mesh-list
92534430|NCT00068029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92534431|NCT00068029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92534432|NCT00068029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534433|NCT00068068|Talaporfin|talaporfin|mesh-list
92552708|NCT00032162|Doxorubicin|doxorubicin|mesh-list
92552709|NCT00032162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92552710|NCT00032162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552711|NCT00032162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92552712|NCT00032162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552713|NCT00032162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552714|NCT00032162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552715|NCT00032162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552716|NCT00032279|Visilizumab|visilizumab|mesh-list
92552717|NCT00032279|Immunologic Factors|immunologic factors|mesh-ancestor
92552718|NCT00032279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552719|NCT00060138|Zoledronic Acid|zoledronic acid|mesh-list
92552720|NCT00060138|Antibodies|antibodies|mesh-list
92552721|NCT00060138|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92552722|NCT00060138|Immunologic Factors|immunologic factors|mesh-ancestor
92552723|NCT00060138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552724|NCT00060138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92552725|NCT00032396|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92552726|NCT00032396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92552727|NCT00032396|Glucocorticoids|glucocorticoids|mesh-ancestor
92552728|NCT00032396|Hormones|hormones|mesh-ancestor
92552729|NCT00032396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277420|NCT00554840|Varenicline|varenicline|mesh-list
92552730|NCT00032396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552732|NCT00060255|Melphalan|melphalan|mesh-list
92552733|NCT00060255|Busulfan|busulfan|mesh-list
92552734|NCT00060255|Thiotepa|thiotepa|mesh-list
92552735|NCT00060255|Carmustine|carmustine|mesh-list
92552736|NCT00060255|Carboplatin|carboplatin|mesh-list
92552737|NCT00060255|Etoposide|etoposide|mesh-list
92552738|NCT00060255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552739|NCT00060255|Immunologic Factors|immunologic factors|mesh-ancestor
92552740|NCT00060255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552741|NCT00060255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552742|NCT00060255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92552743|NCT00060255|Alkylating Agents|alkylating agents|mesh-ancestor
92552744|NCT00060255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552745|NCT00060255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552746|NCT00060255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92552747|NCT00060255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92552748|NCT00060255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552749|NCT00060255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552750|NCT00060255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552751|NCT00060294|Rituximab|rituximab|mesh-list
91960162|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552753|NCT00060294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552754|NCT00060294|Immunologic Factors|immunologic factors|mesh-ancestor
92552755|NCT00060294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552756|NCT00060294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552757|NCT00060372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92552758|NCT00060372|Ipilimumab|ipilimumab|mesh-list
92552759|NCT00060372|Antibodies|antibodies|mesh-list
92552760|NCT00060372|Immunoglobulins|immunoglobulins|mesh-list
92552761|NCT00060372|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92552762|NCT00060372|Immunologic Factors|immunologic factors|mesh-ancestor
92552763|NCT00060372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552764|NCT00060372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552765|NCT00060372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92552766|NCT00060372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552767|NCT00060411|Leucovorin|leucovorin|mesh-list
92552768|NCT00060411|Bevacizumab|bevacizumab|mesh-list
92552769|NCT00060411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92552770|NCT00060411|Fluorouracil|fluorouracil|mesh-list
92552771|NCT00060411|Oxaliplatin|oxaliplatin|mesh-list
92552772|NCT00060411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92552773|NCT00060411|Antibodies|antibodies|mesh-list
92552774|NCT00060411|Immunoglobulins|immunoglobulins|mesh-list
92552775|NCT00060411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92552776|NCT00060411|Levoleucovorin|levoleucovorin|mesh-list
92534434|NCT00068068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534435|NCT00068068|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92552777|NCT00060411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552778|NCT00060411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92552779|NCT00060411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92552780|NCT00060411|Growth Substances|growth substances|mesh-ancestor
92552781|NCT00060411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552782|NCT00060411|Growth Inhibitors|growth inhibitors|mesh-ancestor
92552783|NCT00060411|Immunologic Factors|immunologic factors|mesh-ancestor
92552784|NCT00060411|Antimetabolites|antimetabolites|mesh-ancestor
92552785|NCT00060411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552786|NCT00060411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92552787|NCT00060411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552788|NCT00060411|Antidotes|antidotes|mesh-ancestor
92552789|NCT00060411|Protective Agents|protective agents|mesh-ancestor
92552790|NCT00060411|Vitamin B Complex|vitamin b complex|mesh-ancestor
92552791|NCT00060411|Vitamins|vitamins|mesh-ancestor
92552792|NCT00060411|Micronutrients|micronutrients|mesh-ancestor
92552793|NCT00060411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92552794|NCT00060411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552795|NCT00060450|Nitric Oxide|nitric oxide|mesh-list
92552796|NCT00060450|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92552797|NCT00060450|Autonomic Agents|autonomic agents|mesh-ancestor
92552798|NCT00060450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552799|NCT00060450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552800|NCT00060450|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92552801|NCT00060450|Respiratory System Agents|respiratory system agents|mesh-ancestor
92354751|NCT01924104|Aspirin|aspirin|mesh-list
92552802|NCT00060450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92552803|NCT00060450|Antioxidants|antioxidants|mesh-ancestor
92552804|NCT00060450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552805|NCT00060450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552806|NCT00060450|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92552807|NCT00060450|Vasodilator Agents|vasodilator agents|mesh-ancestor
92552808|NCT00060450|Gasotransmitters|gasotransmitters|mesh-ancestor
92552809|NCT00060450|Protective Agents|protective agents|mesh-ancestor
92552810|NCT00032747|Vasopressins|vasopressins|mesh-list
92552811|NCT00032747|Arginine Vasopressin|arginine vasopressin|mesh-list
92552812|NCT00032747|Hemostatics|hemostatics|mesh-ancestor
92552813|NCT00032747|Coagulants|coagulants|mesh-ancestor
92552814|NCT00032747|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92552815|NCT00032747|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92552816|NCT00032747|Natriuretic Agents|natriuretic agents|mesh-ancestor
92552817|NCT00032747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552818|NCT00032786|Natalizumab|natalizumab|mesh-list
92552819|NCT00032786|Immunologic Factors|immunologic factors|mesh-ancestor
92552820|NCT00032786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552821|NCT02968719|Donepezil|donepezil|mesh-list
92552822|NCT02968719|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92552823|NCT02968719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552824|NCT02968719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552825|NCT02968719|Cholinergic Agents|cholinergic agents|mesh-ancestor
92552826|NCT02968719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552827|NCT02968719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552831|NCT00060489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552832|NCT00060489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92552833|NCT00060489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92552834|NCT00060489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552835|NCT00060489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552837|NCT00032825|Docetaxel|docetaxel|mesh-list
92552838|NCT00032825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552839|NCT00032825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92552840|NCT00032825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92552841|NCT00032825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552842|NCT00032825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552843|NCT00032825|Antifungal Agents|antifungal agents|mesh-ancestor
92552844|NCT00032825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552845|NCT00032825|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92552846|NCT00032825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92552847|NCT00032825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552848|NCT00032825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92552849|NCT00032825|Hormone Antagonists|hormone antagonists|mesh-ancestor
92620220|NCT00150020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534436|NCT00068068|Dermatologic Agents|dermatologic agents|mesh-ancestor
92552850|NCT00032825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552851|NCT00032825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552852|NCT00032825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92552854|NCT00060645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552855|NCT00060645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552856|NCT00060645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92552857|NCT00060645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552858|NCT00060645|Antifungal Agents|antifungal agents|mesh-ancestor
92552859|NCT00060645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552860|NCT00060645|Immunologic Factors|immunologic factors|mesh-ancestor
92552861|NCT00060645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552862|NCT00060684|Dexamethasone|dexamethasone|mesh-list
92552863|NCT00060684|Rituximab|rituximab|mesh-list
92552864|NCT00060684|Fludarabine|fludarabine|mesh-list
92552865|NCT00060684|Pixantrone|pixantrone|mesh-list
92552866|NCT00060684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92552867|NCT00060684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552868|NCT00060684|Immunologic Factors|immunologic factors|mesh-ancestor
92552869|NCT00060684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552870|NCT00060684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552871|NCT00060684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92552872|NCT00060684|Antiemetics|antiemetics|mesh-ancestor
92552873|NCT00060684|Autonomic Agents|autonomic agents|mesh-ancestor
92552874|NCT00060684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552875|NCT00060684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92552876|NCT00060684|Glucocorticoids|glucocorticoids|mesh-ancestor
92552877|NCT00060684|Hormones|hormones|mesh-ancestor
92552878|NCT00060684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552879|NCT00060684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92552880|NCT00060684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552881|NCT00060684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552882|NCT00060684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552884|NCT02971475|Analgesics|analgesics|mesh-list
92552885|NCT02971475|Sensory System Agents|sensory system agents|mesh-ancestor
92552886|NCT02971475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552887|NCT02971475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552888|NCT00032942|Lofexidine|lofexidine|mesh-list
92552889|NCT00032942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92552890|NCT00032942|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92552891|NCT00032942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552892|NCT00032942|Sensory System Agents|sensory system agents|mesh-ancestor
92552893|NCT00032942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552894|NCT00032942|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92552895|NCT00032942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92552896|NCT00032942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92552897|NCT00032942|Adrenergic Agents|adrenergic agents|mesh-ancestor
92552898|NCT00032942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552899|NCT00032942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552903|NCT00033059|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92552905|NCT00033059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552906|NCT00060918|Metoprolol|metoprolol|mesh-list
92552907|NCT00060918|Carvedilol|carvedilol|mesh-list
92552908|NCT00060918|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92552909|NCT00060918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92552910|NCT00060918|Sympatholytics|sympatholytics|mesh-ancestor
92552911|NCT00060918|Autonomic Agents|autonomic agents|mesh-ancestor
92552912|NCT00060918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552913|NCT00060918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552914|NCT00060918|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92552915|NCT00060918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92552916|NCT00060918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92552917|NCT00060918|Adrenergic Agents|adrenergic agents|mesh-ancestor
92552918|NCT00060918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552919|NCT00060918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552920|NCT00060918|Antioxidants|antioxidants|mesh-ancestor
92552921|NCT00060918|Protective Agents|protective agents|mesh-ancestor
92552922|NCT00060918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92552923|NCT00060918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552924|NCT00060918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92552925|NCT00060918|Vasodilator Agents|vasodilator agents|mesh-ancestor
92534437|NCT00068302|Sirolimus|sirolimus|mesh-list
92534438|NCT00068302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552926|NCT00060918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92552927|NCT00060918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92552928|NCT00033098|Metyrapone|metyrapone|mesh-list
92552929|NCT00033098|Antimetabolites|antimetabolites|mesh-ancestor
92552930|NCT00033098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552931|NCT00033098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552932|NCT02968641|Ritonavir|ritonavir|mesh-list
92552933|NCT02968641|Lonafarnib|lonafarnib|mesh-list
92552934|NCT02968641|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92552935|NCT02968641|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92552936|NCT02968641|Protease Inhibitors|protease inhibitors|mesh-ancestor
92552937|NCT02968641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552938|NCT02968641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552939|NCT02968641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92552940|NCT02968641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92552941|NCT02968641|Antiviral Agents|antiviral agents|mesh-ancestor
92552942|NCT02968641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552943|NCT02968641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92552944|NCT02968641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92552945|NCT00033176|Thioctic Acid|thioctic acid|mesh-list
92552946|NCT00033176|Antioxidants|antioxidants|mesh-ancestor
92552947|NCT00033176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552948|NCT00033176|Protective Agents|protective agents|mesh-ancestor
92552949|NCT00033176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552950|NCT00033176|Vitamin B Complex|vitamin b complex|mesh-ancestor
92552951|NCT00033176|Vitamins|vitamins|mesh-ancestor
92552952|NCT00033176|Micronutrients|micronutrients|mesh-ancestor
92552953|NCT00033215|S 3304|s 3304|mesh-list
92552954|NCT00033215|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
92552955|NCT00033215|Protease Inhibitors|protease inhibitors|mesh-ancestor
92552956|NCT00033215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552957|NCT00033215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552958|NCT00060957|Botulinum Toxins|botulinum toxins|mesh-list
92552959|NCT00060957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92552960|NCT00060957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92552961|NCT00060957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92552962|NCT00060957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552963|NCT00060957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552964|NCT00060957|Cholinergic Agents|cholinergic agents|mesh-ancestor
92552965|NCT00060957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552966|NCT00060957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552967|NCT00060957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92552968|NCT00060957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552969|NCT00060996|Treprostinil|treprostinil|mesh-list
91960387|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
92552979|NCT00033254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92552980|NCT00033254|Growth Substances|growth substances|mesh-ancestor
92552981|NCT00033254|Growth Inhibitors|growth inhibitors|mesh-ancestor
92552982|NCT00033254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552984|NCT00061074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92552985|NCT00061074|Autonomic Agents|autonomic agents|mesh-ancestor
92552986|NCT00061074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552987|NCT00061074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552988|NCT00061074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92552989|NCT00061074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92552990|NCT00061074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92552991|NCT00061074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552992|NCT00061074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552993|NCT00033332|Zoledronic Acid|zoledronic acid|mesh-list
92552994|NCT00033332|Pamidronate|pamidronate|mesh-list
92552995|NCT00033332|Thalidomide|thalidomide|mesh-list
92552996|NCT00033332|Dexamethasone|dexamethasone|mesh-list
92552997|NCT00033332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92552998|NCT00033332|Antiemetics|antiemetics|mesh-ancestor
92552999|NCT00033332|Autonomic Agents|autonomic agents|mesh-ancestor
92553000|NCT00033332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553001|NCT00033332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553002|NCT00033332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553003|NCT00033332|Glucocorticoids|glucocorticoids|mesh-ancestor
92553004|NCT00033332|Hormones|hormones|mesh-ancestor
92620221|NCT02914015|Morphine|morphine|mesh-list
92620222|NCT02914015|Ropivacaine|ropivacaine|mesh-list
92534439|NCT00068302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534440|NCT00068302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534441|NCT00068302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534442|NCT00068302|Antifungal Agents|antifungal agents|mesh-ancestor
92553005|NCT00033332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553006|NCT00033332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92553007|NCT00033332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553008|NCT00033332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553009|NCT00033332|Immunologic Factors|immunologic factors|mesh-ancestor
92553010|NCT00033332|Leprostatic Agents|leprostatic agents|mesh-ancestor
92553011|NCT00033332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92553012|NCT00033332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553013|NCT00033332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92553014|NCT00033332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92553015|NCT00033332|Growth Substances|growth substances|mesh-ancestor
92553016|NCT00033332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92553017|NCT00033332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92553018|NCT00033410|Paclitaxel|paclitaxel|mesh-list
92553019|NCT00033410|Carboplatin|carboplatin|mesh-list
92553020|NCT00033410|Tirapazamine|tirapazamine|mesh-list
92553021|NCT00033410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92553022|NCT00033410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553023|NCT00033410|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553024|NCT00033410|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553025|NCT00033410|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553026|NCT00033410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553027|NCT00061113|Fluoxetine|fluoxetine|mesh-list
92553028|NCT00061113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92354756|NCT01924104|Dalteparin|dalteparin|mesh-list
92553029|NCT00061113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553030|NCT00061113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277722|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92553031|NCT00061113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553032|NCT00061113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553033|NCT00061113|Serotonin Agents|serotonin agents|mesh-ancestor
92553034|NCT00061113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553049|NCT00061152|Sensory System Agents|sensory system agents|mesh-ancestor
92553050|NCT00061152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553051|NCT00061152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553052|NCT00033566|S 3304|s 3304|mesh-list
92553053|NCT00033566|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
92553054|NCT00033566|Protease Inhibitors|protease inhibitors|mesh-ancestor
92553055|NCT00033566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553056|NCT00033566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553057|NCT00033605|Octreotide|octreotide|mesh-list
92553058|NCT00033605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553059|NCT00033605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92553060|NCT00033605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553061|NCT00033644|Doxorubicin|doxorubicin|mesh-list
92553062|NCT00033644|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92553063|NCT00033644|Mitomycins|mitomycins|mesh-list
92553064|NCT00033644|Mitomycin|mitomycin|mesh-list
92553065|NCT00033644|Dacarbazine|dacarbazine|mesh-list
92553066|NCT00033644|Sargramostim|sargramostim|mesh-list
92553067|NCT00033644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553068|NCT00033644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92553069|NCT00033644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92553070|NCT00033644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553071|NCT00033644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553072|NCT00033644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553073|NCT00033644|Immunologic Factors|immunologic factors|mesh-ancestor
92553074|NCT00033644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553075|NCT00033644|Alkylating Agents|alkylating agents|mesh-ancestor
92553076|NCT00033644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553077|NCT00033644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92553078|NCT00033683|Tamoxifen|tamoxifen|mesh-list
92553079|NCT00033683|Cyclophosphamide|cyclophosphamide|mesh-list
92553080|NCT00033683|Docetaxel|docetaxel|mesh-list
92553081|NCT00033683|Fluorouracil|fluorouracil|mesh-list
92553082|NCT00033683|Methotrexate|methotrexate|mesh-list
92553083|NCT00033683|Epirubicin|epirubicin|mesh-list
92553084|NCT00033683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553085|NCT00033683|Immunologic Factors|immunologic factors|mesh-ancestor
92534443|NCT00068302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534444|NCT00068302|Immunologic Factors|immunologic factors|mesh-ancestor
92553086|NCT00033683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553087|NCT00033683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553088|NCT00033683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92553089|NCT00033683|Alkylating Agents|alkylating agents|mesh-ancestor
92553090|NCT00033683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553091|NCT00033683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553092|NCT00033683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92553093|NCT00033683|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553094|NCT00033683|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553095|NCT00033683|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553096|NCT00033683|Antimetabolites|antimetabolites|mesh-ancestor
92553097|NCT00033683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553108|NCT00033683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92553109|NCT00033683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92553110|NCT00033683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553111|NCT00033683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92553112|NCT00033683|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92553113|NCT00033683|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92553114|NCT00033683|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92553115|NCT00061308|Gemcitabine|gemcitabine|mesh-list
92553116|NCT00061308|Topotecan|topotecan|mesh-list
92553117|NCT00061308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553118|NCT00061308|Antimetabolites|antimetabolites|mesh-ancestor
92553119|NCT00061308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553120|NCT00061308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553121|NCT00061308|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553122|NCT00061308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553123|NCT00061308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553124|NCT00033722|Folic Acid|folic acid|mesh-list
92553125|NCT00033722|Lometrexol|lometrexol|mesh-list
92553126|NCT00033722|Hematinics|hematinics|mesh-ancestor
92553127|NCT00033722|Vitamin B Complex|vitamin b complex|mesh-ancestor
92553128|NCT00033722|Vitamins|vitamins|mesh-ancestor
92553129|NCT00033722|Micronutrients|micronutrients|mesh-ancestor
92553130|NCT00033722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553131|NCT00033722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553132|NCT00033722|Antimetabolites|antimetabolites|mesh-ancestor
92553133|NCT00033722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553134|NCT00033722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553135|NCT00033722|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92553136|NCT00033722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553137|NCT00061425|Epratuzumab|epratuzumab|mesh-list
92553138|NCT00061425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553139|NCT00061425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553140|NCT00061464|Gemcitabine|gemcitabine|mesh-list
92553141|NCT00061464|Pemetrexed|pemetrexed|mesh-list
92553142|NCT00061464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553143|NCT00061464|Antimetabolites|antimetabolites|mesh-ancestor
92553144|NCT00061464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553145|NCT00061464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553146|NCT00061464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553147|NCT00061464|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92553148|NCT00061464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553149|NCT00061503|Travoprost|travoprost|mesh-list
92553150|NCT00061503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92553151|NCT00061542|Timolol|timolol|mesh-list
92553152|NCT00061542|Betaxolol|betaxolol|mesh-list
92553153|NCT00061542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92553154|NCT00061542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92553155|NCT00061542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92553156|NCT00061542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553157|NCT00061542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553158|NCT00061542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553159|NCT00061542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92553160|NCT00061542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92553161|NCT00061542|Sympatholytics|sympatholytics|mesh-ancestor
92553175|NCT00034151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553177|NCT00034190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92553178|NCT00034190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553179|NCT00034190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92277874|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
92553180|NCT00034190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553181|NCT00034190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553182|NCT00034190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553184|NCT00034229|Anticonvulsants|anticonvulsants|mesh-ancestor
92553185|NCT00034229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92553186|NCT00034229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92553187|NCT00034229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553188|NCT00034229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553189|NCT00034229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553190|NCT00034307|Sitaxsentan|sitaxsentan|mesh-list
92553191|NCT00034307|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92553192|NCT00034307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553193|NCT00061776|Capsaicin|capsaicin|mesh-list
92553194|NCT00061776|Antipruritics|antipruritics|mesh-ancestor
92553195|NCT00061776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553196|NCT00061776|Sensory System Agents|sensory system agents|mesh-ancestor
92553197|NCT00061776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553198|NCT00061776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553199|NCT00034346|Paclitaxel|paclitaxel|mesh-list
92553200|NCT00034346|Carboplatin|carboplatin|mesh-list
92553201|NCT00034346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92553202|NCT00034346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553203|NCT00034346|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553204|NCT00034346|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553205|NCT00034346|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553206|NCT00034346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553207|NCT00034385|Valganciclovir|valganciclovir|mesh-list
92553208|NCT00034385|Antiviral Agents|antiviral agents|mesh-ancestor
92553209|NCT00034385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553210|NCT00034463|Folic Acid|folic acid|mesh-list
92553211|NCT00034463|Vitamins|vitamins|mesh-ancestor
92553212|NCT00034463|Micronutrients|micronutrients|mesh-ancestor
92553213|NCT00034463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553214|NCT00034463|Hematinics|hematinics|mesh-ancestor
92553215|NCT00034463|Vitamin B Complex|vitamin b complex|mesh-ancestor
92553216|NCT02971397|Cytarabine|cytarabine|mesh-list
92553217|NCT02971397|Daunorubicin|daunorubicin|mesh-list
92553218|NCT02971397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553219|NCT02971397|Antimetabolites|antimetabolites|mesh-ancestor
92553220|NCT02971397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553221|NCT02971397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553222|NCT02971397|Antiviral Agents|antiviral agents|mesh-ancestor
92553226|NCT02971397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553227|NCT02971397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92553228|NCT02971397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92553229|NCT02971397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553230|NCT02971397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553232|NCT00396500|Albendazole|albendazole|mesh-list
92553233|NCT00396500|Vitamins|vitamins|mesh-ancestor
92553234|NCT00396500|Micronutrients|micronutrients|mesh-ancestor
92553235|NCT00396500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553236|NCT00396500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553237|NCT00396500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553238|NCT00396500|Anthelmintics|anthelmintics|mesh-ancestor
92553239|NCT00396500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92553240|NCT00396500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553241|NCT00396500|Anticestodal Agents|anticestodal agents|mesh-ancestor
92553242|NCT00396500|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92553243|NCT00396500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92553244|NCT00396500|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553245|NCT00396500|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553246|NCT00396500|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553247|NCT00034502|Irinotecan|irinotecan|mesh-list
92553248|NCT00034502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553249|NCT00034502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553250|NCT00034502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553251|NCT00034502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553252|NCT00034502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277950|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92553253|NCT00034541|Paclitaxel|paclitaxel|mesh-list
92553254|NCT00034541|Carboplatin|carboplatin|mesh-list
92553255|NCT00034541|Cetuximab|cetuximab|mesh-list
92553256|NCT00034541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92553257|NCT00034541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553258|NCT00034541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553259|NCT00034541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534445|NCT00068302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534446|NCT00068458|Calcium, Dietary|calcium, dietary|mesh-list
92534447|NCT00068458|Calcium|calcium|mesh-list
92534448|NCT00068458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92553260|NCT00034541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553261|NCT00034541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553262|NCT00034541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553264|NCT00034580|Risperidone|risperidone|mesh-list
92553265|NCT00034580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92553266|NCT00034580|Serotonin Agents|serotonin agents|mesh-ancestor
92553267|NCT00034580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553268|NCT00034580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553269|NCT00034580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553270|NCT00034580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92553271|NCT00034580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92553272|NCT00034580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92553273|NCT00034580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553274|NCT00034580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92553275|NCT00034580|Dopamine Agents|dopamine agents|mesh-ancestor
92553276|NCT00034580|Antiemetics|antiemetics|mesh-ancestor
92553277|NCT00034580|Autonomic Agents|autonomic agents|mesh-ancestor
92553278|NCT00034580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553279|NCT00034580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553280|NCT00034580|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92553281|NCT00034580|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553282|NCT00034580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553283|NCT00034619|Oxaliplatin|oxaliplatin|mesh-list
92553284|NCT00034619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553285|NCT00061815|Leucovorin|leucovorin|mesh-list
92553286|NCT00061815|Fluorouracil|fluorouracil|mesh-list
92553287|NCT00061815|Oxaliplatin|oxaliplatin|mesh-list
92553288|NCT00061815|Cetuximab|cetuximab|mesh-list
92553289|NCT00061815|Antimetabolites|antimetabolites|mesh-ancestor
92553290|NCT00061815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553291|NCT00061815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553292|NCT00061815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553293|NCT00061815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553294|NCT00061815|Immunologic Factors|immunologic factors|mesh-ancestor
91960714|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92553297|NCT00061815|Protective Agents|protective agents|mesh-ancestor
92553298|NCT00061815|Vitamin B Complex|vitamin b complex|mesh-ancestor
92553300|NCT00061815|Micronutrients|micronutrients|mesh-ancestor
92553301|NCT00061815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553302|NCT00061854|Soblidotin|soblidotin|mesh-list
92553303|NCT00061854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553304|NCT00034658|Posaconazole|posaconazole|mesh-list
92553305|NCT00034658|Antifungal Agents|antifungal agents|mesh-ancestor
92553306|NCT00034658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553307|NCT00034658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92553308|NCT00034658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92553309|NCT00034658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92553310|NCT00034658|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92553311|NCT00034658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553312|NCT00034658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553313|NCT00034658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553314|NCT00034658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92553315|NCT00034658|Hormone Antagonists|hormone antagonists|mesh-ancestor
92553316|NCT00034658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553317|NCT00034658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553318|NCT00398580|Methyltestosterone|methyltestosterone|mesh-list
92553319|NCT00398580|Testosterone|testosterone|mesh-list
92553320|NCT00398580|Testosterone undecanoate|testosterone undecanoate|mesh-list
92553321|NCT00398580|Testosterone enanthate|testosterone enanthate|mesh-list
92553322|NCT00398580|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92553323|NCT00398580|Dutasteride|dutasteride|mesh-list
92553324|NCT00398580|Androgens|androgens|mesh-ancestor
92553325|NCT00398580|Hormones|hormones|mesh-ancestor
92553326|NCT00398580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553327|NCT00398580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553328|NCT00398580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92553329|NCT00398580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534449|NCT00068458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534450|NCT00068458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92534452|NCT00068497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534453|NCT00068497|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92534454|NCT00068497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534455|NCT00068497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534456|NCT00068653|Celecoxib|celecoxib|mesh-list
92534457|NCT00068653|Gefitinib|gefitinib|mesh-list
92534458|NCT00068653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92534459|NCT00068653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92534460|NCT00068653|Analgesics|analgesics|mesh-ancestor
92534461|NCT00068653|Sensory System Agents|sensory system agents|mesh-ancestor
92553330|NCT00398580|Anabolic Agents|anabolic agents|mesh-ancestor
92553331|NCT00398580|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92553332|NCT00398580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92553333|NCT00398580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553334|NCT00398580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553335|NCT00398580|Hormone Antagonists|hormone antagonists|mesh-ancestor
92553337|NCT00034697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92553338|NCT00034697|Alkylating Agents|alkylating agents|mesh-ancestor
92553339|NCT00034697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553340|NCT00034697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553341|NCT00034736|Levofloxacin|levofloxacin|mesh-list
92553342|NCT00034736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92553343|NCT00034736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553344|NCT00034736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92553345|NCT00034736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92553346|NCT00034736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553347|NCT00034736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553348|NCT00034736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553349|NCT00034736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553350|NCT00034736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92553351|NCT00034736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553352|NCT02967939|Tenofovir|tenofovir|mesh-list
92553353|NCT02967939|Antiviral Agents|antiviral agents|mesh-ancestor
92553354|NCT02967939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553355|NCT02967939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92553356|NCT02967939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553357|NCT02967939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553358|NCT02967939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553359|NCT02967939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92553360|NCT02967939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92553361|NCT00034775|Risperidone|risperidone|mesh-list
92553362|NCT00034775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92553363|NCT00034775|Serotonin Agents|serotonin agents|mesh-ancestor
92553364|NCT00034775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553365|NCT00034775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960787|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
92553379|NCT00062127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553380|NCT00062127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553381|NCT00062127|Immunologic Factors|immunologic factors|mesh-ancestor
92553382|NCT00062127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553383|NCT00062127|Leprostatic Agents|leprostatic agents|mesh-ancestor
92553384|NCT00062127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92553385|NCT00062127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553386|NCT00062127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92553387|NCT00062127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92553388|NCT00062127|Growth Substances|growth substances|mesh-ancestor
92553389|NCT00062127|Growth Inhibitors|growth inhibitors|mesh-ancestor
92553390|NCT00034853|Naproxen|naproxen|mesh-list
92534462|NCT00068653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534463|NCT00068653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553391|NCT00034853|Meloxicam|meloxicam|mesh-list
92553392|NCT00034853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92553393|NCT00034853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92553394|NCT00034853|Analgesics|analgesics|mesh-ancestor
92553395|NCT00034853|Sensory System Agents|sensory system agents|mesh-ancestor
92553396|NCT00034853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553397|NCT00034853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553398|NCT00034853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553399|NCT00034853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553400|NCT00034853|Gout Suppressants|gout suppressants|mesh-ancestor
92553401|NCT00034853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92553402|NCT00034853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553403|NCT00034853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553404|NCT00034853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92553405|NCT00034892|Olanzapine|olanzapine|mesh-list
92553406|NCT00034892|Risperidone|risperidone|mesh-list
92553407|NCT00034892|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92553408|NCT00034892|Serotonin Agents|serotonin agents|mesh-ancestor
92553409|NCT00034892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553410|NCT00034892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553411|NCT00034892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553412|NCT00034892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92553413|NCT00034892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92553414|NCT00034892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92553415|NCT00034892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553416|NCT00034892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92553417|NCT00034892|Dopamine Agents|dopamine agents|mesh-ancestor
92553418|NCT00034892|Antiemetics|antiemetics|mesh-ancestor
92553419|NCT00034892|Autonomic Agents|autonomic agents|mesh-ancestor
92553420|NCT00034892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553421|NCT00034892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553422|NCT00034892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92553423|NCT00034892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553424|NCT00034892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553425|NCT00062205|Imatinib Mesylate|imatinib mesylate|mesh-list
92553426|NCT00062205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553427|NCT00062205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92553441|NCT00035009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92553443|NCT00035009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553444|NCT00035009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92553445|NCT00035009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553446|NCT00035009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553447|NCT00035009|Antiemetics|antiemetics|mesh-ancestor
92553448|NCT00035009|Autonomic Agents|autonomic agents|mesh-ancestor
92553449|NCT00035009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553450|NCT00035009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553451|NCT00035009|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92553452|NCT00062283|Alanosine|alanosine|mesh-list
92553453|NCT00062283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92553454|NCT00062283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553455|NCT00062283|Chelating Agents|chelating agents|mesh-ancestor
92553456|NCT00062283|Sequestering Agents|sequestering agents|mesh-ancestor
92553457|NCT00062283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553458|NCT00035048|Aprepitant|aprepitant|mesh-list
92553459|NCT00035048|Antiemetics|antiemetics|mesh-ancestor
92553460|NCT00035048|Autonomic Agents|autonomic agents|mesh-ancestor
92553461|NCT00035048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553462|NCT00035048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553463|NCT00035048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553464|NCT00035048|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92553465|NCT00035048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553466|NCT00035048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553467|NCT00035087|Epothilones|epothilones|mesh-list
92553468|NCT00035087|Epothilone B|epothilone b|mesh-list
92553469|NCT00035087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553470|NCT00035087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553471|NCT00035087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553472|NCT00035087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534464|NCT00068653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92534465|NCT00068653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534466|NCT00068653|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92534467|NCT00068653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92534468|NCT00068653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553473|NCT00035087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553475|NCT00062322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553476|NCT00062322|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553477|NCT00062322|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553478|NCT00062322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553479|NCT00062322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553480|NCT00035126|Epothilones|epothilones|mesh-list
92553481|NCT00035126|Epothilone B|epothilone b|mesh-list
92553482|NCT00035126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553483|NCT00035126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553484|NCT00035126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553485|NCT00035126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553486|NCT00035126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553496|NCT00035204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553497|NCT00035204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553498|NCT00035204|Cholinergic Agents|cholinergic agents|mesh-ancestor
92553499|NCT00035204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553500|NCT00035204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553501|NCT00035204|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92553502|NCT00035204|Autonomic Agents|autonomic agents|mesh-ancestor
92553503|NCT00035204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553504|NCT00035204|Nootropic Agents|nootropic agents|mesh-ancestor
92553505|NCT00062478|Camptothecin|camptothecin|mesh-list
92553506|NCT00062478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92553507|NCT00062478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553508|NCT00062478|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553509|NCT00062478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92354779|NCT00630786|Conatumumab|conatumumab|mesh-list
92553510|NCT00062478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553511|NCT00062478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553512|NCT00035243|Epothilones|epothilones|mesh-list
92553513|NCT00035243|Epothilone B|epothilone b|mesh-list
92553514|NCT00035243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553515|NCT00035243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553516|NCT00035243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553517|NCT00035243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553518|NCT00035243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553519|NCT00035282|Aprepitant|aprepitant|mesh-list
92553520|NCT00035282|Antiemetics|antiemetics|mesh-ancestor
92553521|NCT00035282|Autonomic Agents|autonomic agents|mesh-ancestor
92553522|NCT00035282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553523|NCT00035282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553524|NCT00035282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553525|NCT00035282|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92553526|NCT00035282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553527|NCT00035282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553529|NCT00062556|Lovastatin|lovastatin|mesh-list
92553530|NCT00062556|L 647318|l 647318|mesh-list
92553531|NCT00062556|Dihydromevinolin|dihydromevinolin|mesh-list
92553532|NCT00062556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92553533|NCT00062556|Antimetabolites|antimetabolites|mesh-ancestor
92553534|NCT00062556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553535|NCT00062556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92553536|NCT00062556|Vasodilator Agents|vasodilator agents|mesh-ancestor
92553537|NCT00062556|Vitamin B Complex|vitamin b complex|mesh-ancestor
92553538|NCT00062556|Vitamins|vitamins|mesh-ancestor
92553539|NCT00062556|Micronutrients|micronutrients|mesh-ancestor
92553540|NCT00062556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553541|NCT00062556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92553542|NCT00062556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92553543|NCT00062556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553544|NCT00035321|Olanzapine|olanzapine|mesh-list
92553545|NCT00035321|Fluoxetine|fluoxetine|mesh-list
92553546|NCT00035321|Antiemetics|antiemetics|mesh-ancestor
92553547|NCT00035321|Autonomic Agents|autonomic agents|mesh-ancestor
92534469|NCT00068653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534470|NCT00068653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553548|NCT00035321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553549|NCT00035321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553550|NCT00035321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553551|NCT00035321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92553552|NCT00035321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92553553|NCT00035321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92553554|NCT00035321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553557|NCT00035321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553558|NCT00035321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553559|NCT00035321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553560|NCT00035321|Serotonin Agents|serotonin agents|mesh-ancestor
92553561|NCT00035321|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92553562|NCT00035321|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553563|NCT00035321|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92553564|NCT00035321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553565|NCT00035321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553567|NCT00062595|Vitamin K|vitamin k|mesh-list
92553568|NCT00062595|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92553569|NCT00062595|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92553570|NCT00062595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553571|NCT00062595|Hemostatics|hemostatics|mesh-ancestor
92553572|NCT00062595|Coagulants|coagulants|mesh-ancestor
92553573|NCT00062595|Vitamins|vitamins|mesh-ancestor
92553574|NCT00062595|Micronutrients|micronutrients|mesh-ancestor
92553575|NCT00062595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553576|NCT00035360|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92553577|NCT00035360|Antiviral Agents|antiviral agents|mesh-ancestor
92553578|NCT00035360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553579|NCT00062673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92553580|NCT00062673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92553581|NCT00062673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553582|NCT00062673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553583|NCT00062673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553584|NCT00062673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553585|NCT00062673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553586|NCT00062673|Analgesics|analgesics|mesh-ancestor
92553587|NCT00062673|Sensory System Agents|sensory system agents|mesh-ancestor
92553588|NCT00062673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553589|NCT00062673|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553590|NCT00062673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553591|NCT00062673|Dopamine Agents|dopamine agents|mesh-ancestor
92553592|NCT00035477|Azimilide|azimilide|mesh-list
92553593|NCT00035477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92553594|NCT00035477|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92553595|NCT00035477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553596|NCT00035477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553597|NCT00035477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92553598|NCT00035477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553599|NCT00062712|Sirolimus|sirolimus|mesh-list
92553600|NCT00062712|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92553601|NCT00062712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92553602|NCT00062712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553603|NCT00062712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92553604|NCT00062712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553605|NCT00062712|Antifungal Agents|antifungal agents|mesh-ancestor
92553606|NCT00062712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553607|NCT00062712|Immunologic Factors|immunologic factors|mesh-ancestor
92553608|NCT00062712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553609|NCT00062790|Dutasteride|dutasteride|mesh-list
92553610|NCT00062790|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92553611|NCT00062790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92553612|NCT00062790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553613|NCT00062790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553614|NCT00062790|Hormone Antagonists|hormone antagonists|mesh-ancestor
92553615|NCT00062790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620223|NCT02914015|Anesthetics, Local|anesthetics, local|mesh-list
92534471|NCT00068653|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92534472|NCT00068731|Lycopene|lycopene|mesh-list
92534473|NCT00068731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553616|NCT00062790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553617|NCT00035516|Epothilones|epothilones|mesh-list
92553618|NCT00035516|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553619|NCT00035516|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553620|NCT00035516|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553621|NCT00035516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553622|NCT00035516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553623|NCT00062946|Fallypride|fallypride|mesh-list
92553624|NCT00062946|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91961049|NCT03335059|Mitomycins|mitomycins|mesh-list
92553629|NCT00062946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553630|NCT00063024|Calcium|calcium|mesh-list
92553631|NCT00063024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92553632|NCT00063024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553633|NCT00035984|Exenatide|exenatide|mesh-list
92553634|NCT00035984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92553635|NCT00035984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553636|NCT00035984|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92553637|NCT00035984|Incretins|incretins|mesh-ancestor
92553638|NCT00035984|Hormones|hormones|mesh-ancestor
92553639|NCT00035984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553640|NCT00063141|Irinotecan|irinotecan|mesh-list
92553641|NCT00063141|Cetuximab|cetuximab|mesh-list
92553642|NCT00063141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553643|NCT00063141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553644|NCT00063141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553645|NCT00063141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553646|NCT00063141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553647|NCT00063141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553648|NCT00036023|Darbepoetin alfa|darbepoetin alfa|mesh-list
92553649|NCT00036023|Hematinics|hematinics|mesh-ancestor
92553650|NCT00036062|Sivelestat|sivelestat|mesh-list
92553651|NCT00036062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92553652|NCT00036062|Protease Inhibitors|protease inhibitors|mesh-ancestor
92553653|NCT00036062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553654|NCT00036062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553655|NCT00036101|Aripiprazole|aripiprazole|mesh-list
92553656|NCT00036101|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553657|NCT00036101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553658|NCT00036101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92553659|NCT00036101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92553660|NCT00036101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92553661|NCT00036101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553662|NCT00036101|Dopamine Agonists|dopamine agonists|mesh-ancestor
92553663|NCT00036101|Dopamine Agents|dopamine agents|mesh-ancestor
92553664|NCT00036101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553665|NCT00036101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553666|NCT00036101|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92553667|NCT00036101|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92553668|NCT00036101|Serotonin Agents|serotonin agents|mesh-ancestor
92553669|NCT00036101|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92553670|NCT00036101|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92553671|NCT00036101|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92553672|NCT00036101|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92553673|NCT00036179|Micafungin|micafungin|mesh-list
92553674|NCT00036179|Antifungal Agents|antifungal agents|mesh-ancestor
92553675|NCT00036179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553676|NCT00036218|Ropinirole|ropinirole|mesh-list
92553677|NCT00036218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92553678|NCT00036218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92553679|NCT00036218|Dopamine Agonists|dopamine agonists|mesh-ancestor
92553680|NCT00036218|Dopamine Agents|dopamine agents|mesh-ancestor
92553681|NCT00036218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553682|NCT00036218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553683|NCT00036218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553684|NCT00063453|Vitamins|vitamins|mesh-list
92553685|NCT00063453|Vitamin E|vitamin e|mesh-list
92553686|NCT00063453|Tocopherols|tocopherols|mesh-list
92553687|NCT00063453|Tocotrienols|tocotrienols|mesh-list
92553688|NCT00063453|alpha-Tocopherol|alpha-tocopherol|mesh-list
92553689|NCT00063453|Selenium|selenium|mesh-list
92534474|NCT00068731|Antioxidants|antioxidants|mesh-ancestor
92553690|NCT00063453|Micronutrients|micronutrients|mesh-ancestor
92553691|NCT00063453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553692|NCT00063453|Antioxidants|antioxidants|mesh-ancestor
92553693|NCT00063453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553694|NCT00063453|Protective Agents|protective agents|mesh-ancestor
92553695|NCT00063453|Trace Elements|trace elements|mesh-ancestor
92553696|NCT00036335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92553722|NCT00036452|Protease Inhibitors|protease inhibitors|mesh-ancestor
92553723|NCT00036452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553724|NCT00036452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553726|NCT00036452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92553727|NCT00036452|Antiviral Agents|antiviral agents|mesh-ancestor
92553728|NCT00036452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553729|NCT00036452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92553730|NCT00036452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553731|NCT00036452|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92553732|NCT00036452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553733|NCT00036452|Antimetabolites|antimetabolites|mesh-ancestor
92553735|NCT02967276|Dexamethasone|dexamethasone|mesh-list
92553736|NCT02967276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553737|NCT02967276|Antiemetics|antiemetics|mesh-ancestor
92553738|NCT02967276|Autonomic Agents|autonomic agents|mesh-ancestor
92553739|NCT02967276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553740|NCT02967276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553741|NCT02967276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553742|NCT02967276|Glucocorticoids|glucocorticoids|mesh-ancestor
92553743|NCT02967276|Hormones|hormones|mesh-ancestor
92553744|NCT02967276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553745|NCT02967276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92553746|NCT02967276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553747|NCT02967276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92553749|NCT00036491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553750|NCT00036491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553751|NCT00036491|Immunologic Factors|immunologic factors|mesh-ancestor
92553752|NCT00036491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553753|NCT00036491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553754|NCT00063609|Zoledronic Acid|zoledronic acid|mesh-list
92553755|NCT00063609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92553756|NCT00063609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553757|NCT02971319|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
92553758|NCT02971319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92553759|NCT02971319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553760|NCT00036647|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92553761|NCT00036647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553762|NCT00036647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92553763|NCT00036647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553764|NCT00036647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553765|NCT00063687|Oxypurinol|oxypurinol|mesh-list
92553766|NCT00063687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553767|NCT00063687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553768|NCT00036764|Epothilones|epothilones|mesh-list
92553769|NCT00036764|Epothilone B|epothilone b|mesh-list
92553770|NCT00036764|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553771|NCT00036764|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553772|NCT00036764|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553773|NCT00036764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553774|NCT00036764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553775|NCT00063726|Bortezomib|bortezomib|mesh-list
92278478|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
92553776|NCT00063726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553777|NCT00036842|Arsenic Trioxide|arsenic trioxide|mesh-list
92553778|NCT00036842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553779|NCT00036881|Zinc Sulfate|zinc sulfate|mesh-list
92553780|NCT00036881|Astringents|astringents|mesh-ancestor
92553781|NCT00036881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553782|NCT00036881|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553783|NCT00063804|Ritonavir|ritonavir|mesh-list
92553784|NCT00063804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92553785|NCT00063804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92553786|NCT00063804|Protease Inhibitors|protease inhibitors|mesh-ancestor
92534475|NCT00068731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553787|NCT00063804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553788|NCT00063804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553789|NCT00063804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92553790|NCT00063804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92553791|NCT00063804|Antiviral Agents|antiviral agents|mesh-ancestor
92553792|NCT00063804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553793|NCT00063804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92553794|NCT00063804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553795|NCT02967432|Mupirocin|mupirocin|mesh-list
92553796|NCT02967432|Petrolatum|petrolatum|mesh-list
92553797|NCT02967432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92553798|NCT02967432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553799|NCT02967432|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92553800|NCT02967432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553801|NCT02967432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553802|NCT02967432|Emollients|emollients|mesh-ancestor
92553803|NCT02967432|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553804|NCT00063960|Irinotecan|irinotecan|mesh-list
92553805|NCT00063960|Floxuridine|floxuridine|mesh-list
92553806|NCT00063960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553807|NCT00063960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553808|NCT00063960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553809|NCT00063960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553810|NCT00063960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553811|NCT00063960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553812|NCT00063960|Antimetabolites|antimetabolites|mesh-ancestor
92553813|NCT00064116|Rituximab|rituximab|mesh-list
92553814|NCT00064116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553815|NCT00064116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553816|NCT00064116|Immunologic Factors|immunologic factors|mesh-ancestor
92553817|NCT00064116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553818|NCT00064116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553819|NCT00037037|Sargramostim|sargramostim|mesh-list
92553820|NCT00037037|Immunologic Factors|immunologic factors|mesh-ancestor
92553821|NCT00037037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553825|NCT00064194|Micronutrients|micronutrients|mesh-ancestor
92553826|NCT00064194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553827|NCT00064194|Antioxidants|antioxidants|mesh-ancestor
92553828|NCT00064194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553829|NCT00064194|Protective Agents|protective agents|mesh-ancestor
92553830|NCT00064194|Trace Elements|trace elements|mesh-ancestor
92553831|NCT00064233|Dasatinib|dasatinib|mesh-list
92553832|NCT00064233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553833|NCT00064233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92553834|NCT00064233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553835|NCT00064233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553836|NCT02967237|Insulin Glargine|insulin glargine|mesh-list
92553837|NCT02967237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92553838|NCT02967237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553839|NCT00037115|Interferons|interferons|mesh-list
92553840|NCT00037115|Interferon-beta|interferon-beta|mesh-list
92553841|NCT00037115|Interferon beta-1a|interferon beta-1a|mesh-list
92553842|NCT00037115|Methylprednisolone|methylprednisolone|mesh-list
92553843|NCT00037115|Methotrexate|methotrexate|mesh-list
92553844|NCT00037115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92553845|NCT00037115|Abortifacient Agents|abortifacient agents|mesh-ancestor
92553846|NCT00037115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92553847|NCT00037115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553848|NCT00037115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553849|NCT00037115|Antimetabolites|antimetabolites|mesh-ancestor
92553850|NCT00037115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553851|NCT00037115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553852|NCT00037115|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553853|NCT00037115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553854|NCT00037115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92553855|NCT00037115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553856|NCT00037115|Immunologic Factors|immunologic factors|mesh-ancestor
92553857|NCT00037115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553858|NCT00037115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553859|NCT00037115|Antiviral Agents|antiviral agents|mesh-ancestor
92553860|NCT00037115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553861|NCT00037115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553862|NCT00037115|Antiemetics|antiemetics|mesh-ancestor
92534476|NCT00068731|Protective Agents|protective agents|mesh-ancestor
92534477|NCT00068731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553863|NCT00037115|Autonomic Agents|autonomic agents|mesh-ancestor
92553864|NCT00037115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553865|NCT00037115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553866|NCT00037115|Glucocorticoids|glucocorticoids|mesh-ancestor
92553867|NCT00037115|Hormones|hormones|mesh-ancestor
92553868|NCT00037115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92553869|NCT00037115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92553870|NCT00037115|Protective Agents|protective agents|mesh-ancestor
92553871|NCT00037115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92553872|NCT00037154|Saw palmetto extract|saw palmetto extract|mesh-list
92553873|NCT00037154|Urological Agents|urological agents|mesh-ancestor
92553874|NCT00064389|Albuterol|albuterol|mesh-list
92553875|NCT00064389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92553876|NCT00064389|Autonomic Agents|autonomic agents|mesh-ancestor
92553877|NCT00064389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553878|NCT00064389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553879|NCT00064389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92553880|NCT00064389|Respiratory System Agents|respiratory system agents|mesh-ancestor
92553881|NCT00064389|Tocolytic Agents|tocolytic agents|mesh-ancestor
92553882|NCT00064389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92553883|NCT00064389|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92553884|NCT00064389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92553885|NCT00064389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92553886|NCT00064389|Adrenergic Agents|adrenergic agents|mesh-ancestor
92553887|NCT00064389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553888|NCT00064389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553890|NCT00064428|Fondaparinux|fondaparinux|mesh-list
92553891|NCT00064428|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92553892|NCT00064428|Antithrombins|antithrombins|mesh-ancestor
92553893|NCT00064428|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92553894|NCT00064428|Protease Inhibitors|protease inhibitors|mesh-ancestor
92553895|NCT00064428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961322|NCT05430087|Vitamin D|vitamin d|mesh-list
92354798|NCT03095352|Pembrolizumab|pembrolizumab|mesh-list
92553899|NCT00064428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92553901|NCT00064467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92553902|NCT00064467|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553903|NCT00064467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553904|NCT00064467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92553905|NCT00064467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553906|NCT00064467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553907|NCT00064467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553908|NCT00064467|Dopamine Agents|dopamine agents|mesh-ancestor
92553909|NCT00064467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553910|NCT00064467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553911|NCT00064467|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92553912|NCT00064467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553913|NCT00064467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553914|NCT00064623|Capsaicin|capsaicin|mesh-list
92553915|NCT00064623|Antipruritics|antipruritics|mesh-ancestor
92553916|NCT00064623|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553917|NCT00064623|Sensory System Agents|sensory system agents|mesh-ancestor
92553918|NCT00064623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553919|NCT00064623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553920|NCT00064779|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92553921|NCT00064779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553922|NCT00037544|Factor VIII|factor viii|mesh-list
92553923|NCT00037544|Coagulants|coagulants|mesh-ancestor
92553924|NCT00037583|Gemtuzumab|gemtuzumab|mesh-list
92553925|NCT00037583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92553926|NCT00037583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553927|NCT00037583|Immunotoxins|immunotoxins|mesh-ancestor
92553928|NCT00037583|Immunoconjugates|immunoconjugates|mesh-ancestor
92553929|NCT00037583|Immunologic Factors|immunologic factors|mesh-ancestor
92553930|NCT00037583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553931|NCT00064857|Pycnogenols|pycnogenols|mesh-list
92553932|NCT00064857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92553933|NCT00064857|Immunologic Factors|immunologic factors|mesh-ancestor
92553934|NCT00064857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553935|NCT00064857|Antioxidants|antioxidants|mesh-ancestor
92553936|NCT00064857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553937|NCT00064857|Protective Agents|protective agents|mesh-ancestor
92534478|NCT00068731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92534479|NCT00068731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92553938|NCT00064857|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92553939|NCT00037622|Dexelvucitabine|dexelvucitabine|mesh-list
92553940|NCT00037622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92553941|NCT00037622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553942|NCT00037622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553943|NCT00037622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553944|NCT00037622|Antiviral Agents|antiviral agents|mesh-ancestor
92553945|NCT00037622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92553946|NCT00037622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92553947|NCT00037622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92553948|NCT00037661|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92553949|NCT00037661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92553951|NCT04730622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553952|NCT04730622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553953|NCT00037700|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92553954|NCT00037700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553955|NCT00064974|Lenalidomide|lenalidomide|mesh-list
92553956|NCT00064974|Immunologic Factors|immunologic factors|mesh-ancestor
92553957|NCT00064974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553958|NCT00064974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92553959|NCT00064974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92553960|NCT00064974|Growth Substances|growth substances|mesh-ancestor
92553961|NCT00064974|Growth Inhibitors|growth inhibitors|mesh-ancestor
92354804|NCT03092856|Axitinib|axitinib|mesh-list
92553962|NCT00064974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553963|NCT00037817|Celecoxib|celecoxib|mesh-list
92553964|NCT00037817|Decitabine|decitabine|mesh-list
92553965|NCT00037817|Romidepsin|romidepsin|mesh-list
92553966|NCT00037817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92553970|NCT00037817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553971|NCT00037817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553972|NCT00037817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553973|NCT00037817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553974|NCT00037817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92553975|NCT00037817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92553976|NCT00037817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553977|NCT00037817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553978|NCT00037817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92553979|NCT00037817|Antimetabolites|antimetabolites|mesh-ancestor
92553980|NCT00037817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553981|NCT00037817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92553982|NCT00037817|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92553983|NCT00065130|Insulin|insulin|mesh-list
92553984|NCT00065130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92553985|NCT00065130|Insulin Aspart|insulin aspart|mesh-list
92553986|NCT00065130|Isophane Insulin, Human|isophane insulin, human|mesh-list
92553987|NCT00065130|Insulin, Isophane|insulin, isophane|mesh-list
92553988|NCT00065130|Isophane insulin, beef|isophane insulin, beef|mesh-list
92553989|NCT00065130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92553990|NCT00065130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553991|NCT00065169|Celecoxib|celecoxib|mesh-list
92553992|NCT00065169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92553993|NCT00065169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92553994|NCT00065169|Analgesics|analgesics|mesh-ancestor
92553995|NCT00065169|Sensory System Agents|sensory system agents|mesh-ancestor
92553996|NCT00065169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553997|NCT00065169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553998|NCT00065169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553999|NCT00065169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554000|NCT00065169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92554001|NCT00065169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92554002|NCT00065169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554003|NCT00065169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554005|NCT00038012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554006|NCT00038051|Lintuzumab|lintuzumab|mesh-list
92554007|NCT00038051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554008|NCT00038051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554009|NCT00038090|Thalidomide|thalidomide|mesh-list
92554010|NCT00038090|Dexamethasone|dexamethasone|mesh-list
92554011|NCT00038090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92554012|NCT00038090|Antiemetics|antiemetics|mesh-ancestor
92534480|NCT00068731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534481|NCT00068809|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92534483|NCT00068809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554013|NCT00038090|Autonomic Agents|autonomic agents|mesh-ancestor
92554014|NCT00038090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554015|NCT00038090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554016|NCT00038090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92554017|NCT00038090|Glucocorticoids|glucocorticoids|mesh-ancestor
92554018|NCT00038090|Hormones|hormones|mesh-ancestor
92554019|NCT00038090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554020|NCT00038090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554021|NCT00038090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554022|NCT00038090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554023|NCT00038090|Immunologic Factors|immunologic factors|mesh-ancestor
92554024|NCT00038090|Leprostatic Agents|leprostatic agents|mesh-ancestor
92554025|NCT00038090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554026|NCT00038090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554027|NCT00038090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92554028|NCT00038090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92554029|NCT00038090|Growth Substances|growth substances|mesh-ancestor
92554030|NCT00038090|Growth Inhibitors|growth inhibitors|mesh-ancestor
92554031|NCT00065325|Fulvestrant|fulvestrant|mesh-list
92554032|NCT00065325|Exemestane|exemestane|mesh-list
92554033|NCT00065325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554034|NCT00065325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554035|NCT00065325|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92554036|NCT00065325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92554037|NCT00065325|Hormone Antagonists|hormone antagonists|mesh-ancestor
92554038|NCT00065325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554052|NCT00038168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554053|NCT00038168|Alkylating Agents|alkylating agents|mesh-ancestor
92554054|NCT00038168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554055|NCT00398658|Clindamycin|clindamycin|mesh-list
92554056|NCT00398658|Clindamycin palmitate|clindamycin palmitate|mesh-list
92554057|NCT00398658|Clindamycin phosphate|clindamycin phosphate|mesh-list
92554058|NCT00398658|Gentamicins|gentamicins|mesh-list
92554059|NCT00398658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554060|NCT00398658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554061|NCT00398658|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92554062|NCT00398658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554063|NCT00398658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554064|NCT00038207|Vincristine|vincristine|mesh-list
92554065|NCT00038207|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554066|NCT00038207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554067|NCT00038207|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554068|NCT00038207|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554069|NCT00038207|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554070|NCT00038207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554071|NCT00398697|Gemcitabine|gemcitabine|mesh-list
92554072|NCT00398697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554073|NCT00398697|Antimetabolites|antimetabolites|mesh-ancestor
92554074|NCT00398697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554075|NCT00398697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554076|NCT00038246|Thalidomide|thalidomide|mesh-list
92554078|NCT00038246|Estramustine|estramustine|mesh-list
92554079|NCT00038246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554080|NCT00038246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554081|NCT00038246|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554082|NCT00038246|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554083|NCT00038246|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554084|NCT00038246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554085|NCT00038246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554086|NCT00038246|Immunologic Factors|immunologic factors|mesh-ancestor
92554087|NCT00038246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554088|NCT00038246|Leprostatic Agents|leprostatic agents|mesh-ancestor
92554089|NCT00038246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554090|NCT00038246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554091|NCT00038246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92620224|NCT02914015|Anesthetics|anesthetics|mesh-list
92554092|NCT00038246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92554093|NCT00038246|Growth Substances|growth substances|mesh-ancestor
92554094|NCT00038246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92554095|NCT00038246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554096|NCT00038246|Alkylating Agents|alkylating agents|mesh-ancestor
92554097|NCT00038246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554098|NCT00398775|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92554103|NCT00398814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554104|NCT00398814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554106|NCT00065559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92554107|NCT00065559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92554108|NCT00065559|Analgesics|analgesics|mesh-ancestor
92554109|NCT00065559|Sensory System Agents|sensory system agents|mesh-ancestor
92554110|NCT00065559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554111|NCT00065559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554112|NCT00065559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92554113|NCT00065559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554114|NCT00065559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92554115|NCT00065559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92554116|NCT00065559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554117|NCT00065559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554118|NCT00065637|Teriparatide|teriparatide|mesh-list
92554119|NCT00065637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92354817|NCT04275258|Analgesics, Opioid|analgesics, opioid|mesh-list
92554120|NCT00065637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554121|NCT00065637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92554122|NCT00396578|Vancomycin|vancomycin|mesh-list
92554123|NCT00396578|Gentamicins|gentamicins|mesh-list
92554124|NCT00396578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554125|NCT00396578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554126|NCT00396578|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92554127|NCT00396578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554128|NCT00396578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554129|NCT00398853|Chromium|chromium|mesh-list
92554130|NCT00398853|Picolinic acid|picolinic acid|mesh-list
92554131|NCT00398853|Trace Elements|trace elements|mesh-ancestor
92554132|NCT00398853|Micronutrients|micronutrients|mesh-ancestor
92554133|NCT00398853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554134|NCT00398853|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92554135|NCT00398853|Chelating Agents|chelating agents|mesh-ancestor
92554136|NCT00398853|Sequestering Agents|sequestering agents|mesh-ancestor
92554137|NCT00398853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554138|NCT05433896|Dasatinib|dasatinib|mesh-list
92554139|NCT05433896|Omeprazole|omeprazole|mesh-list
92554140|NCT05433896|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92554141|NCT05433896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92554142|NCT05433896|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92554143|NCT05433896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554144|NCT05433896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554145|NCT05433896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554146|NCT05433896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554147|NCT00069888|Docetaxel|docetaxel|mesh-list
92554148|NCT00069888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554149|NCT00069888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554150|NCT00069888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554151|NCT00069888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554152|NCT00069888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554153|NCT05433428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92554154|NCT05433428|Lubricant Eye Drops|lubricant eye drops|mesh-list
92554155|NCT05433428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92554156|NCT00069927|Methylphenidate|methylphenidate|mesh-list
92554157|NCT00069927|Amphetamine|amphetamine|mesh-list
92554158|NCT00069927|Adderall|adderall|mesh-list
92554159|NCT00069927|Dextroamphetamine|dextroamphetamine|mesh-list
92554160|NCT00069927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92554161|NCT00069927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554162|NCT00069927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92554163|NCT00069927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92554164|NCT00069927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554165|NCT00069927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554166|NCT00069927|Dopamine Agents|dopamine agents|mesh-ancestor
92554167|NCT00069927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534485|NCT00068848|Contraceptives, Oral|contraceptives, oral|mesh-list
92554168|NCT00069927|Sympathomimetics|sympathomimetics|mesh-ancestor
92554169|NCT00069927|Autonomic Agents|autonomic agents|mesh-ancestor
92554170|NCT00069927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554177|NCT00069966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554178|NCT00069966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554179|NCT00069966|Immunologic Factors|immunologic factors|mesh-ancestor
92554180|NCT00069966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554181|NCT00069966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554182|NCT00069966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554183|NCT00069966|Antimetabolites|antimetabolites|mesh-ancestor
92554184|NCT00069966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554185|NCT00069966|Antiviral Agents|antiviral agents|mesh-ancestor
92554186|NCT00069966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554187|NCT00069966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554188|NCT00069966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92554189|NCT00069966|Antiemetics|antiemetics|mesh-ancestor
92554190|NCT00069966|Autonomic Agents|autonomic agents|mesh-ancestor
92554191|NCT00069966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554192|NCT00069966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92554193|NCT00069966|Glucocorticoids|glucocorticoids|mesh-ancestor
92554194|NCT00069966|Hormones|hormones|mesh-ancestor
92554195|NCT00069966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554196|NCT00069966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92554197|NCT00069966|Protective Agents|protective agents|mesh-ancestor
92554198|NCT00069966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554199|NCT00069966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554200|NCT00069966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554201|NCT00065871|Contraceptive Agents|contraceptive agents|mesh-list
92554202|NCT00065871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92554203|NCT00065871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554204|NCT00065949|Magnesium Sulfate|magnesium sulfate|mesh-list
92554205|NCT00065949|Analgesics|analgesics|mesh-ancestor
92554206|NCT00065949|Sensory System Agents|sensory system agents|mesh-ancestor
92554207|NCT00065949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554208|NCT00065949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554209|NCT00065949|Anesthetics|anesthetics|mesh-ancestor
92554210|NCT00065949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554211|NCT00065949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92554212|NCT00065949|Anticonvulsants|anticonvulsants|mesh-ancestor
92554213|NCT00065949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92554214|NCT00065949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554215|NCT00065949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554216|NCT00065949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92554217|NCT00065949|Tocolytic Agents|tocolytic agents|mesh-ancestor
92554218|NCT00065949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92554219|NCT00066027|Doxycycline|doxycycline|mesh-list
92554220|NCT00066027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554221|NCT00066027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554222|NCT00066027|Antimalarials|antimalarials|mesh-ancestor
92554223|NCT00066027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92554224|NCT00066027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92278938|NCT01901679|Celecoxib|celecoxib|mesh-list
92554225|NCT00396734|Topiramate|topiramate|mesh-list
92554226|NCT00396734|Modafinil|modafinil|mesh-list
92554227|NCT00396734|Anticonvulsants|anticonvulsants|mesh-ancestor
92554228|NCT00396734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92554229|NCT00396734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554230|NCT00396734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92554231|NCT00396734|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92554232|NCT00396734|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92554233|NCT00396734|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92554234|NCT00396734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554235|NCT00070083|Prednisone|prednisone|mesh-list
92554236|NCT00070083|Cyclophosphamide|cyclophosphamide|mesh-list
92554237|NCT00070083|Rituximab|rituximab|mesh-list
92554238|NCT00070083|Doxorubicin|doxorubicin|mesh-list
92554239|NCT00070083|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92554240|NCT00070083|Vincristine|vincristine|mesh-list
92554241|NCT00070083|Oblimersen|oblimersen|mesh-list
92554257|NCT00070083|Glucocorticoids|glucocorticoids|mesh-ancestor
92554258|NCT00070083|Hormones|hormones|mesh-ancestor
92554259|NCT00070083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620225|NCT02914015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92554260|NCT00070083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554261|NCT00070083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554262|NCT00070083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554263|NCT00070083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554264|NCT00070083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554266|NCT00070122|Bevacizumab|bevacizumab|mesh-list
92554267|NCT00070122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92554268|NCT00070122|Fluorouracil|fluorouracil|mesh-list
92554269|NCT00070122|Capecitabine|capecitabine|mesh-list
92554270|NCT00070122|Oxaliplatin|oxaliplatin|mesh-list
92554271|NCT00070122|Antibodies|antibodies|mesh-list
92554272|NCT00070122|Immunoglobulins|immunoglobulins|mesh-list
92554273|NCT00070122|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92554274|NCT00070122|Levoleucovorin|levoleucovorin|mesh-list
92554275|NCT00070122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554276|NCT00070122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92354834|NCT01925898|Midazolam|midazolam|mesh-list
92554277|NCT00070122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92554278|NCT00070122|Growth Substances|growth substances|mesh-ancestor
92554279|NCT00070122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554280|NCT00070122|Growth Inhibitors|growth inhibitors|mesh-ancestor
92554281|NCT00070122|Immunologic Factors|immunologic factors|mesh-ancestor
92554282|NCT00070122|Antimetabolites|antimetabolites|mesh-ancestor
92554283|NCT00070122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554284|NCT00070122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554285|NCT00070122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554286|NCT00070122|Antidotes|antidotes|mesh-ancestor
92554287|NCT00070122|Protective Agents|protective agents|mesh-ancestor
92554288|NCT00070122|Vitamin B Complex|vitamin b complex|mesh-ancestor
92554289|NCT00070122|Vitamins|vitamins|mesh-ancestor
92554290|NCT00070122|Micronutrients|micronutrients|mesh-ancestor
92554291|NCT00070161|Donepezil|donepezil|mesh-list
92554292|NCT00070161|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92554293|NCT00070161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554294|NCT00070161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554295|NCT00070161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92554296|NCT00070161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92554297|NCT00070161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554298|NCT00070161|Nootropic Agents|nootropic agents|mesh-ancestor
92554299|NCT00070200|Cyclophosphamide|cyclophosphamide|mesh-list
92554300|NCT00070200|Melphalan|melphalan|mesh-list
92554301|NCT00070200|Doxorubicin|doxorubicin|mesh-list
92554304|NCT00070200|Vincristine|vincristine|mesh-list
92554305|NCT00070200|Topotecan|topotecan|mesh-list
92554306|NCT00070200|Isotretinoin|isotretinoin|mesh-list
92554307|NCT00070200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554308|NCT00070200|Immunologic Factors|immunologic factors|mesh-ancestor
92554309|NCT00070200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554310|NCT00070200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554311|NCT00070200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554312|NCT00070200|Alkylating Agents|alkylating agents|mesh-ancestor
92554313|NCT00070200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554314|NCT00070200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554315|NCT00070200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92554316|NCT00070200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92554317|NCT00070200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554318|NCT00070200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554319|NCT00070200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554320|NCT00070200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554321|NCT00070200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554322|NCT00070200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554323|NCT00070200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554324|NCT00070200|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92554325|NCT00070200|Dermatologic Agents|dermatologic agents|mesh-ancestor
92554326|NCT00066339|Gefitinib|gefitinib|mesh-list
92554327|NCT00066339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554328|NCT00066339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554329|NCT00066339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554330|NCT00066339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554331|NCT00070239|Alvocidib|alvocidib|mesh-list
92554332|NCT00070239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92554333|NCT00070239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92554334|NCT00070239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554335|NCT00070239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554336|NCT00070239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554337|NCT00070239|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534486|NCT00068848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92534487|NCT00068848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554338|NCT00070239|Growth Substances|growth substances|mesh-ancestor
92554339|NCT00070239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554340|NCT00070239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554341|NCT00070278|Paclitaxel|paclitaxel|mesh-list
92554342|NCT00070278|Cyclophosphamide|cyclophosphamide|mesh-list
92554343|NCT00070278|Gemcitabine|gemcitabine|mesh-list
92554344|NCT00070278|Epirubicin|epirubicin|mesh-list
92554345|NCT00070278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554346|NCT00070278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554347|NCT00070278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554348|NCT00070278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554349|NCT00070278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554350|NCT00070278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554351|NCT00070278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554352|NCT00070278|Immunologic Factors|immunologic factors|mesh-ancestor
92554353|NCT00070278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554354|NCT00070278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554355|NCT00070278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554356|NCT00070278|Alkylating Agents|alkylating agents|mesh-ancestor
92554357|NCT00070278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92554358|NCT00070278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554359|NCT00070278|Antimetabolites|antimetabolites|mesh-ancestor
92554360|NCT00070278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92554361|NCT00070278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554362|NCT00070278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554363|NCT00070278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554364|NCT00066378|Gefitinib|gefitinib|mesh-list
92554365|NCT00066378|Anastrozole|anastrozole|mesh-list
92554366|NCT00066378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554367|NCT00066378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554368|NCT00066378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554369|NCT00066378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554370|NCT00066378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554371|NCT00066378|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92554372|NCT00066378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92554373|NCT00066378|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92554374|NCT00066378|Hormone Antagonists|hormone antagonists|mesh-ancestor
91961797|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
92554392|NCT00066417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554393|NCT00066417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92554394|NCT00066417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554395|NCT00066417|Antimetabolites|antimetabolites|mesh-ancestor
92554396|NCT00066417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554397|NCT00066417|Antifungal Agents|antifungal agents|mesh-ancestor
92554398|NCT00066417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554399|NCT00066417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92554400|NCT00066417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92554401|NCT00066417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92554403|NCT00066417|Autonomic Agents|autonomic agents|mesh-ancestor
92554404|NCT00066417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554405|NCT00066417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92554406|NCT00066417|Glucocorticoids|glucocorticoids|mesh-ancestor
92554407|NCT00066417|Hormones|hormones|mesh-ancestor
92554408|NCT00066417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554409|NCT00066417|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92554410|NCT00066417|Protective Agents|protective agents|mesh-ancestor
92554411|NCT00066456|Docetaxel|docetaxel|mesh-list
92554412|NCT00066456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554413|NCT00066456|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554414|NCT00066456|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554415|NCT00066456|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554416|NCT00066456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554417|NCT00070434|Leucovorin|leucovorin|mesh-list
92554418|NCT00070434|Pyridoxine|pyridoxine|mesh-list
92554419|NCT00070434|Fluorouracil|fluorouracil|mesh-list
92554420|NCT00070434|Capecitabine|capecitabine|mesh-list
92554421|NCT00070434|Oxaliplatin|oxaliplatin|mesh-list
92554422|NCT00070434|Irinotecan|irinotecan|mesh-list
92554423|NCT00070434|Levoleucovorin|levoleucovorin|mesh-list
92554424|NCT00070434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554425|NCT00070434|Antimetabolites|antimetabolites|mesh-ancestor
92534488|NCT00068848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92554426|NCT00070434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554427|NCT00070434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554428|NCT00070434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554429|NCT00070434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554430|NCT00070434|Immunologic Factors|immunologic factors|mesh-ancestor
92152869|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
92554431|NCT00070434|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92554432|NCT00070434|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554433|NCT00070434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554436|NCT00070434|Vitamin B Complex|vitamin b complex|mesh-ancestor
92554437|NCT00070434|Vitamins|vitamins|mesh-ancestor
92554438|NCT00070434|Micronutrients|micronutrients|mesh-ancestor
92554439|NCT05402891|Lithium Carbonate|lithium carbonate|mesh-list
92554440|NCT05402891|Antidepressive Agents|antidepressive agents|mesh-ancestor
92554441|NCT05402891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92554442|NCT05402891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554443|NCT05402891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554444|NCT05402891|Antimanic Agents|antimanic agents|mesh-ancestor
92554445|NCT05402891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92554446|NCT05402891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554447|NCT05402891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554448|NCT00070473|Pemetrexed|pemetrexed|mesh-list
92554449|NCT00070473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554450|NCT00070473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554451|NCT00070473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554452|NCT00070473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92554453|NCT00070473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92554454|NCT00066612|Irinotecan|irinotecan|mesh-list
92554455|NCT00066612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92554456|NCT00066612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554457|NCT00066612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554458|NCT00066612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554459|NCT00066612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554460|NCT00070551|Cytarabine|cytarabine|mesh-list
92554461|NCT00070551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554462|NCT00070551|Antimetabolites|antimetabolites|mesh-ancestor
92554463|NCT00070551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554464|NCT00070551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554465|NCT00070551|Antiviral Agents|antiviral agents|mesh-ancestor
92554466|NCT00070551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554467|NCT00070551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554468|NCT00070551|Immunologic Factors|immunologic factors|mesh-ancestor
92554469|NCT00070551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554470|NCT00070629|Paclitaxel|paclitaxel|mesh-list
92554471|NCT00070629|Docetaxel|docetaxel|mesh-list
92554472|NCT00070629|Cisplatin|cisplatin|mesh-list
92554473|NCT00070629|Carboplatin|carboplatin|mesh-list
92554474|NCT00070629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554475|NCT00070629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554476|NCT00070629|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554477|NCT00070629|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554478|NCT00070629|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554479|NCT00070629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554480|NCT01349595|Bortezomib|bortezomib|mesh-list
92554481|NCT01349595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554482|NCT05184920|Nicotine|nicotine|mesh-list
92554483|NCT05184920|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92554484|NCT05184920|Autonomic Agents|autonomic agents|mesh-ancestor
92554485|NCT05184920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554486|NCT05184920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554487|NCT05184920|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92554488|NCT05184920|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92554489|NCT05184920|Cholinergic Agents|cholinergic agents|mesh-ancestor
92554490|NCT05184920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92554491|NCT05184920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554492|NCT02958501|Cholecalciferol|cholecalciferol|mesh-list
92554493|NCT02958501|Vitamin D|vitamin d|mesh-list
92554494|NCT02958501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92554495|NCT02958501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554496|NCT02958501|Vitamins|vitamins|mesh-ancestor
92554497|NCT02958501|Micronutrients|micronutrients|mesh-ancestor
92554498|NCT02958501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92554499|NCT00066651|Immunotoxins|immunotoxins|mesh-list
92534490|NCT00399061|Cyclosporins|cyclosporins|mesh-list
92534491|NCT00399061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554500|NCT00066651|Immunoconjugates|immunoconjugates|mesh-ancestor
92554501|NCT00066651|Immunologic Factors|immunologic factors|mesh-ancestor
92554502|NCT00066651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554503|NCT00398892|Thioctic Acid|thioctic acid|mesh-list
92554504|NCT00398892|Antioxidants|antioxidants|mesh-ancestor
92554505|NCT00398892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554506|NCT00398892|Protective Agents|protective agents|mesh-ancestor
92554507|NCT00398892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554508|NCT00398892|Vitamin B Complex|vitamin b complex|mesh-ancestor
92554514|NCT00066768|Gemcitabine|gemcitabine|mesh-list
92554515|NCT00066768|Docetaxel|docetaxel|mesh-list
92554516|NCT00066768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554517|NCT00066768|Antimetabolites|antimetabolites|mesh-ancestor
92554518|NCT00066768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554519|NCT00066768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554520|NCT00066768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554521|NCT00066768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554522|NCT00066768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554523|NCT00066768|Antinematodal Agents|antinematodal agents|mesh-ancestor
92554524|NCT00066768|Anthelmintics|anthelmintics|mesh-ancestor
92554525|NCT00066768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92554526|NCT00066768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554527|NCT00066768|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92554528|NCT00066768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92554529|NCT00066846|Leucovorin|leucovorin|mesh-list
92554530|NCT00066846|Bevacizumab|bevacizumab|mesh-list
92554531|NCT00066846|Fluorouracil|fluorouracil|mesh-list
92554532|NCT00066846|Calcium|calcium|mesh-list
92554533|NCT00066846|Levoleucovorin|levoleucovorin|mesh-list
92554534|NCT00066846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554535|NCT00066846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554536|NCT00066846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92554537|NCT00066846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92554538|NCT00066846|Growth Substances|growth substances|mesh-ancestor
92554539|NCT00066846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554540|NCT00066846|Growth Inhibitors|growth inhibitors|mesh-ancestor
92554541|NCT00066846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92554542|NCT00066846|Antimetabolites|antimetabolites|mesh-ancestor
92554543|NCT00066846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554544|NCT00066846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554545|NCT00066846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554546|NCT00066846|Immunologic Factors|immunologic factors|mesh-ancestor
92554547|NCT00066846|Antidotes|antidotes|mesh-ancestor
92554548|NCT00066846|Protective Agents|protective agents|mesh-ancestor
92554549|NCT00066846|Vitamin B Complex|vitamin b complex|mesh-ancestor
92554550|NCT00066846|Vitamins|vitamins|mesh-ancestor
92554551|NCT00066846|Micronutrients|micronutrients|mesh-ancestor
92554552|NCT00066885|Calcitriol|calcitriol|mesh-list
92554553|NCT00066885|Docetaxel|docetaxel|mesh-list
92554554|NCT00066885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554555|NCT00066885|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554556|NCT00066885|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554557|NCT00066885|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554558|NCT00066885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554559|NCT00066885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92554560|NCT00066885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554561|NCT00066885|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92554562|NCT00066885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554563|NCT00066885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92554564|NCT00066885|Vitamins|vitamins|mesh-ancestor
92554565|NCT00066885|Micronutrients|micronutrients|mesh-ancestor
92554566|NCT00066885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92554567|NCT04941521|Exenatide|exenatide|mesh-list
92554568|NCT04941521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92554569|NCT04941521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554570|NCT04941521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92554571|NCT04941521|Incretins|incretins|mesh-ancestor
92554572|NCT04941521|Hormones|hormones|mesh-ancestor
92554573|NCT04941521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554574|NCT02966457|Colistin|colistin|mesh-list
92554575|NCT02966457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554576|NCT02966457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554577|NCT00067041|Treprostinil|treprostinil|mesh-list
92554578|NCT00067041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92554579|NCT04732364|Bupivacaine|bupivacaine|mesh-list
92534492|NCT00399061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534493|NCT00399061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534494|NCT00399061|Immunologic Factors|immunologic factors|mesh-ancestor
92554580|NCT04732364|Anesthetics, Local|anesthetics, local|mesh-ancestor
92554581|NCT04732364|Anesthetics|anesthetics|mesh-ancestor
92554582|NCT04732364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554583|NCT04732364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554596|NCT04732598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554597|NCT04732598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92554598|NCT04732598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92554599|NCT04732598|Growth Substances|growth substances|mesh-ancestor
92554600|NCT04732598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554601|NCT04732598|Growth Inhibitors|growth inhibitors|mesh-ancestor
92554602|NCT04732598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92554603|NCT00067080|Deferasirox|deferasirox|mesh-list
92554604|NCT00067080|Deferoxamine|deferoxamine|mesh-list
92554605|NCT00067080|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92554606|NCT00067080|Chelating Agents|chelating agents|mesh-ancestor
92554607|NCT00067080|Sequestering Agents|sequestering agents|mesh-ancestor
92554608|NCT00067080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554609|NCT00067080|Siderophores|siderophores|mesh-ancestor
92554610|NCT00396851|Metformin|metformin|mesh-list
92554611|NCT00396851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92554612|NCT00396851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554613|NCT00067119|Dipyridamole|dipyridamole|mesh-list
92554614|NCT00067119|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92554615|NCT00067119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554616|NCT00067119|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92554617|NCT00067119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554618|NCT00067119|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92554619|NCT00067119|Vasodilator Agents|vasodilator agents|mesh-ancestor
92554621|NCT00396929|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554622|NCT00396929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554623|NCT00396929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554624|NCT00396929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554625|NCT00396929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554626|NCT00396929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554627|NCT04750772|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92554628|NCT04750772|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92554629|NCT04750772|Chelating Agents|chelating agents|mesh-ancestor
92554630|NCT04750772|Sequestering Agents|sequestering agents|mesh-ancestor
92554631|NCT04750772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554632|NCT04750772|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92554633|NCT00399165|Methyltestosterone|methyltestosterone|mesh-list
92554634|NCT00399165|Testosterone|testosterone|mesh-list
92554635|NCT00399165|Testosterone undecanoate|testosterone undecanoate|mesh-list
92554636|NCT00399165|Testosterone enanthate|testosterone enanthate|mesh-list
92554637|NCT00399165|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92554638|NCT00399165|Dutasteride|dutasteride|mesh-list
92554639|NCT00399165|Androgens|androgens|mesh-ancestor
92554640|NCT00399165|Hormones|hormones|mesh-ancestor
92554641|NCT00399165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554642|NCT00399165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554643|NCT00399165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92554644|NCT00399165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554645|NCT00399165|Anabolic Agents|anabolic agents|mesh-ancestor
92554646|NCT00399165|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92554660|NCT00067158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554662|NCT00071097|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92554663|NCT00071097|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92554664|NCT00071097|Protease Inhibitors|protease inhibitors|mesh-ancestor
92554665|NCT00071097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554666|NCT00071097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554667|NCT00071097|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92554668|NCT00071097|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92554669|NCT00071097|Antiviral Agents|antiviral agents|mesh-ancestor
92554670|NCT00071097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554671|NCT00067353|Fluorides|fluorides|mesh-list
92554672|NCT00067353|Fluorides, Topical|fluorides, topical|mesh-list
92554673|NCT00067353|Cariostatic Agents|cariostatic agents|mesh-ancestor
92534495|NCT00399061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534496|NCT00399061|Antifungal Agents|antifungal agents|mesh-ancestor
92534497|NCT00399061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534498|NCT00399061|Dermatologic Agents|dermatologic agents|mesh-ancestor
92554674|NCT00067353|Protective Agents|protective agents|mesh-ancestor
92554675|NCT00067353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554676|NCT00071136|Gemcitabine|gemcitabine|mesh-list
92554677|NCT00071136|Pemetrexed|pemetrexed|mesh-list
92554678|NCT00071136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554679|NCT00071136|Antimetabolites|antimetabolites|mesh-ancestor
92554680|NCT00071136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554681|NCT00071136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554682|NCT00071136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554683|NCT00071136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92554684|NCT00071136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92554685|NCT02970773|Rivaroxaban|rivaroxaban|mesh-list
92554686|NCT02970773|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92279370|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554687|NCT02970773|Antithrombins|antithrombins|mesh-ancestor
92554688|NCT02970773|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92554689|NCT02970773|Protease Inhibitors|protease inhibitors|mesh-ancestor
92554690|NCT02970773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554691|NCT02970773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554692|NCT02970773|Anticoagulants|anticoagulants|mesh-ancestor
92554694|NCT00067431|Anticonvulsants|anticonvulsants|mesh-ancestor
92554695|NCT00067431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554696|NCT00067431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554697|NCT00067431|GABA Agents|gaba agents|mesh-ancestor
92554698|NCT00067431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92554699|NCT00067431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554700|NCT00067431|Antimanic Agents|antimanic agents|mesh-ancestor
92554701|NCT00067431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92554702|NCT00067431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554703|NCT00067431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92554704|NCT00067509|Progesterone|progesterone|mesh-list
92554705|NCT00067509|Estrogens|estrogens|mesh-list
92554706|NCT00067509|Progestins|progestins|mesh-ancestor
92554707|NCT00067509|Hormones|hormones|mesh-ancestor
92554708|NCT00067509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554726|NCT00071253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554727|NCT00071253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92554728|NCT00071253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92554729|NCT00071253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92554730|NCT00071253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554731|NCT00071253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92354891|NCT00982488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554732|NCT00071253|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92554733|NCT00071253|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92554734|NCT00071253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554735|NCT00071253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554736|NCT00071253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92554737|NCT00071253|Serotonin Agents|serotonin agents|mesh-ancestor
92554738|NCT00071253|Anticonvulsants|anticonvulsants|mesh-ancestor
92554739|NCT00071253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554740|NCT00071253|GABA Agents|gaba agents|mesh-ancestor
92554741|NCT00071253|Antimanic Agents|antimanic agents|mesh-ancestor
92554743|NCT00067548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554744|NCT00067548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554745|NCT00067548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554746|NCT00067548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554747|NCT03338621|Moxifloxacin|moxifloxacin|mesh-list
92554748|NCT03338621|Rifampin|rifampin|mesh-list
92554749|NCT03338621|Isoniazid|isoniazid|mesh-list
92554750|NCT03338621|Pyrazinamide|pyrazinamide|mesh-list
92554751|NCT03338621|Ethambutol|ethambutol|mesh-list
92554752|NCT03338621|Bedaquiline|bedaquiline|mesh-list
92554753|NCT03338621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554754|NCT03338621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554755|NCT03338621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554756|NCT03338621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554757|NCT03338621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554758|NCT03338621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554759|NCT03338621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534499|NCT00399061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534500|NCT00399061|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92534501|NCT00069355|Propranolol|propranolol|mesh-list
92534502|NCT00069355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92554760|NCT03338621|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92279445|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554761|NCT03338621|Antitubercular Agents|antitubercular agents|mesh-ancestor
92554762|NCT03338621|Leprostatic Agents|leprostatic agents|mesh-ancestor
92554763|NCT03338621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92554764|NCT03338621|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92554765|NCT03338621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92554784|NCT00067743|Immunologic Factors|immunologic factors|mesh-ancestor
92554785|NCT00067743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554786|NCT00067743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92554787|NCT00067743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92554788|NCT00067743|Growth Substances|growth substances|mesh-ancestor
92554789|NCT00067743|Growth Inhibitors|growth inhibitors|mesh-ancestor
92554790|NCT00067743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554791|NCT00396968|Plerixafor|plerixafor|mesh-list
92554792|NCT00396968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92554793|NCT00396968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92554794|NCT00396968|Antiviral Agents|antiviral agents|mesh-ancestor
92554795|NCT00396968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554796|NCT00067860|Hormones|hormones|mesh-list
92554797|NCT00067860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554798|NCT00067860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554799|NCT00071448|Insulin|insulin|mesh-list
92554800|NCT00071448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92554801|NCT00071448|Insulin Aspart|insulin aspart|mesh-list
92554802|NCT00071448|Insulin Lispro|insulin lispro|mesh-list
92554803|NCT00071448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92554804|NCT00071448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554805|NCT02599324|Paclitaxel|paclitaxel|mesh-list
92554806|NCT02599324|Docetaxel|docetaxel|mesh-list
92554807|NCT02599324|Pembrolizumab|pembrolizumab|mesh-list
92554808|NCT02599324|Cetuximab|cetuximab|mesh-list
92554809|NCT02599324|Everolimus|everolimus|mesh-list
92554810|NCT02599324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554811|NCT02599324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554812|NCT02599324|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554813|NCT02599324|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554814|NCT02599324|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554815|NCT02599324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554816|NCT02599324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554817|NCT02599324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92554818|NCT02599324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92554819|NCT02599324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554820|NCT02599324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554821|NCT02599324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554822|NCT02599324|Immunologic Factors|immunologic factors|mesh-ancestor
92554842|NCT00067938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92554843|NCT02358187|Poly ICLC|poly iclc|mesh-list
92554844|NCT02358187|Interferon Inducers|interferon inducers|mesh-ancestor
92554845|NCT02358187|Immunologic Factors|immunologic factors|mesh-ancestor
92554846|NCT02358187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554847|NCT01809808|Hormones|hormones|mesh-list
92554848|NCT01809808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554849|NCT01809808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554850|NCT00068055|gamma-Globulins|gamma-globulins|mesh-list
92554851|NCT00068055|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92554852|NCT00068055|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92554853|NCT00068055|Immunologic Factors|immunologic factors|mesh-ancestor
92554854|NCT00068055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554855|NCT01406197|Progesterone|progesterone|mesh-list
92554856|NCT01406197|Progestins|progestins|mesh-ancestor
92554857|NCT01406197|Hormones|hormones|mesh-ancestor
92554858|NCT01406197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554859|NCT01406197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554860|NCT00038402|Paclitaxel|paclitaxel|mesh-list
92554861|NCT00038402|Cyclophosphamide|cyclophosphamide|mesh-list
92554862|NCT00038402|Fluorouracil|fluorouracil|mesh-list
92554863|NCT00038402|Trastuzumab|trastuzumab|mesh-list
92554864|NCT00038402|Epirubicin|epirubicin|mesh-list
92620226|NCT02914015|Narcotics|narcotics|mesh-ancestor
92534503|NCT00069355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92534504|NCT00069355|Adrenergic Agents|adrenergic agents|mesh-ancestor
92534505|NCT00069355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534506|NCT00069355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534507|NCT00069355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554865|NCT00038402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554866|NCT00038402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554867|NCT00038402|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554868|NCT00038402|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554869|NCT00038402|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554870|NCT00038402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554871|NCT00038402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554872|NCT00038402|Immunologic Factors|immunologic factors|mesh-ancestor
92554873|NCT00038402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554874|NCT00038402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962320|NCT03646617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554884|NCT00038402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554886|NCT00144703|Tacrolimus|tacrolimus|mesh-list
92554887|NCT00144703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554888|NCT00144703|Immunologic Factors|immunologic factors|mesh-ancestor
92554889|NCT00144703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554890|NCT00144703|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92554891|NCT00144703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554892|NCT00144703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554893|NCT00144703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554894|NCT00144703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554895|NCT00144703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92554896|NCT00144703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554897|NCT00144703|Antifungal Agents|antifungal agents|mesh-ancestor
92554898|NCT00144820|Hyaluronic Acid|hyaluronic acid|mesh-list
92554899|NCT00144820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92554900|NCT00144820|Immunologic Factors|immunologic factors|mesh-ancestor
92554901|NCT00144820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554902|NCT00144820|Viscosupplements|viscosupplements|mesh-ancestor
92554903|NCT00144820|Protective Agents|protective agents|mesh-ancestor
92554904|NCT00071643|Escitalopram|escitalopram|mesh-list
92554905|NCT00071643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92554906|NCT00071643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92554907|NCT00071643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554908|NCT00071643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554909|NCT00071643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92554910|NCT00071643|Serotonin Agents|serotonin agents|mesh-ancestor
92279595|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
92554911|NCT00071643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554912|NCT00144976|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92554913|NCT00144976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554914|NCT00144976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554915|NCT00144976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554916|NCT00144976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554917|NCT00038480|Ritonavir|ritonavir|mesh-list
92554918|NCT00038480|Lopinavir|lopinavir|mesh-list
92554919|NCT00038480|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92554920|NCT00038480|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92554921|NCT00038480|Protease Inhibitors|protease inhibitors|mesh-ancestor
92554922|NCT00038480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554923|NCT00038480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554924|NCT00038480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92554925|NCT00038480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92554926|NCT00038480|Antiviral Agents|antiviral agents|mesh-ancestor
92554927|NCT00038480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554928|NCT00038480|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92554929|NCT00038480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92554930|NCT00202306|Lithium Carbonate|lithium carbonate|mesh-list
92554931|NCT00202306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92554932|NCT00202306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92554933|NCT00202306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554934|NCT00202306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534508|NCT00069355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92534509|NCT00069355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92534510|NCT00069355|Vasodilator Agents|vasodilator agents|mesh-ancestor
92534511|NCT00069550|Dextromethorphan|dextromethorphan|mesh-list
92534512|NCT00069550|Donepezil|donepezil|mesh-list
92534513|NCT00069550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92534514|NCT00069550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554935|NCT00202306|Antimanic Agents|antimanic agents|mesh-ancestor
92554936|NCT00202306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92554937|NCT00202306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554939|NCT00038519|Ritonavir|ritonavir|mesh-list
92554940|NCT00038519|Saquinavir|saquinavir|mesh-list
92554941|NCT00038519|Amprenavir|amprenavir|mesh-list
92554942|NCT00038519|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92554943|NCT00038519|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92554944|NCT00038519|Protease Inhibitors|protease inhibitors|mesh-ancestor
92554945|NCT00038519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554946|NCT00038519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554947|NCT00038519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92554948|NCT00038519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92554949|NCT00038519|Antiviral Agents|antiviral agents|mesh-ancestor
92554950|NCT00038519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554951|NCT00038519|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92554952|NCT00038519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92554953|NCT00038519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92554954|NCT00038519|Antitubercular Agents|antitubercular agents|mesh-ancestor
92554955|NCT00038519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92554956|NCT00202345|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92554957|NCT00202345|Hematinics|hematinics|mesh-ancestor
92554958|NCT00202423|Nabiximols|nabiximols|mesh-list
92554959|NCT00202423|Analgesics|analgesics|mesh-ancestor
92554960|NCT00202423|Sensory System Agents|sensory system agents|mesh-ancestor
92554961|NCT00202423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354917|NCT01926210|Letrozole|letrozole|mesh-list
92554962|NCT00202423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554963|NCT00202462|Testosterone|testosterone|mesh-list
92554964|NCT00202462|Androgens|androgens|mesh-ancestor
92554965|NCT00202462|Hormones|hormones|mesh-ancestor
92554966|NCT00202462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554967|NCT00202462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554968|NCT00038558|Doxorubicin|doxorubicin|mesh-list
92554969|NCT00038558|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92554970|NCT00038558|Bleomycin|bleomycin|mesh-list
92554971|NCT00038558|Dacarbazine|dacarbazine|mesh-list
92554972|NCT00038558|Vinblastine|vinblastine|mesh-list
92554973|NCT00038558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92554974|NCT00038558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554975|NCT00038558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554976|NCT00038558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554977|NCT00038558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554978|NCT00038558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554979|NCT00038558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554980|NCT00038558|Alkylating Agents|alkylating agents|mesh-ancestor
92554981|NCT00038558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554982|NCT00038558|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554983|NCT00038558|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554984|NCT00038558|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554985|NCT00038597|Lonafarnib|lonafarnib|mesh-list
92279671|NCT00000201|Selegiline|selegiline|mesh-list
92554986|NCT00038597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554987|NCT00038597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554988|NCT00202618|Amlodipine|amlodipine|mesh-list
92554989|NCT00202618|Valsartan|valsartan|mesh-list
92554990|NCT00202618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92554991|NCT00202618|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92554992|NCT00202618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554993|NCT00202618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554994|NCT00202618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92554995|NCT00202618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554996|NCT00202618|Vasodilator Agents|vasodilator agents|mesh-ancestor
92554997|NCT00202618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92554998|NCT00202618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92554999|NCT00202696|Nalmefene|nalmefene|mesh-list
92555000|NCT00202696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92555001|NCT00202696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555002|NCT00202696|Sensory System Agents|sensory system agents|mesh-ancestor
92555003|NCT00202696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555004|NCT00038636|Ritonavir|ritonavir|mesh-list
92555005|NCT00038636|Lopinavir|lopinavir|mesh-list
92555006|NCT00038636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92555007|NCT00038636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92555008|NCT00038636|Protease Inhibitors|protease inhibitors|mesh-ancestor
92555009|NCT00038636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555010|NCT00038636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555011|NCT00038636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92555027|NCT00202891|Sisomicin|sisomicin|mesh-list
92555028|NCT00202891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92555029|NCT00202891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555030|NCT00202891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92555031|NCT00202891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555032|NCT00202891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555033|NCT00202969|Cisplatin|cisplatin|mesh-list
92555034|NCT00202969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555035|NCT00203125|Rasagiline|rasagiline|mesh-list
92555036|NCT00203125|Tyramine|tyramine|mesh-list
92555037|NCT00203125|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92555038|NCT00203125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555039|NCT00203125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555040|NCT00203125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92555041|NCT00203125|Protective Agents|protective agents|mesh-ancestor
92555042|NCT00203125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555043|NCT00203125|Sympathomimetics|sympathomimetics|mesh-ancestor
92555044|NCT00203125|Autonomic Agents|autonomic agents|mesh-ancestor
92555045|NCT00203125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555046|NCT00203125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92555047|NCT00203125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92555048|NCT00203125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92555049|NCT00203125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92555050|NCT00203125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555051|NCT00203164|Rasagiline|rasagiline|mesh-list
92555052|NCT00203164|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92555053|NCT00203164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555054|NCT00203164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555055|NCT00203164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92555056|NCT00203164|Protective Agents|protective agents|mesh-ancestor
92555057|NCT00203164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555058|NCT00203281|Mycophenolic Acid|mycophenolic acid|mesh-list
92555059|NCT00203281|Tacrolimus|tacrolimus|mesh-list
92555060|NCT00203281|Daclizumab|daclizumab|mesh-list
92555061|NCT00203281|Immunoglobulins|immunoglobulins|mesh-list
92555062|NCT00203281|Antibodies|antibodies|mesh-list
92555063|NCT00203281|gamma-Globulins|gamma-globulins|mesh-list
92555064|NCT00203281|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92555065|NCT00203281|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92555066|NCT00203281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555067|NCT00203281|Immunologic Factors|immunologic factors|mesh-ancestor
92555068|NCT00203281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555069|NCT00203281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92555070|NCT00203281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555071|NCT00203281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555072|NCT00203281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92555078|NCT00203320|Etanercept|etanercept|mesh-list
92555079|NCT00203320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555080|NCT00203320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555081|NCT00203320|Analgesics|analgesics|mesh-ancestor
92555082|NCT00203320|Sensory System Agents|sensory system agents|mesh-ancestor
92555083|NCT00203320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555084|NCT00203320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555085|NCT00203320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555086|NCT00203320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555087|NCT00203320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555088|NCT00203320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555089|NCT00203320|Immunologic Factors|immunologic factors|mesh-ancestor
92555090|NCT00038792|Mitogens|mitogens|mesh-list
92555091|NCT00038792|Mitosis Modulators|mitosis modulators|mesh-ancestor
92555092|NCT00038792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534515|NCT00069550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555093|NCT00203359|Etanercept|etanercept|mesh-list
92555094|NCT00203359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555095|NCT00203359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555096|NCT00203359|Analgesics|analgesics|mesh-ancestor
92555097|NCT00203359|Sensory System Agents|sensory system agents|mesh-ancestor
92555098|NCT00203359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555099|NCT00203359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555100|NCT00203359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555101|NCT00203359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555102|NCT00203359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555103|NCT00203359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555104|NCT00203359|Immunologic Factors|immunologic factors|mesh-ancestor
92555105|NCT00410644|Hydromorphone|hydromorphone|mesh-list
92555106|NCT00410644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92555107|NCT00410644|Narcotics|narcotics|mesh-ancestor
92555108|NCT00410644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354936|NCT00981084|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92555109|NCT00410644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555110|NCT00410644|Analgesics|analgesics|mesh-ancestor
92555111|NCT00410644|Sensory System Agents|sensory system agents|mesh-ancestor
92555112|NCT00410644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555113|NCT00038831|Fludarabine|fludarabine|mesh-list
92555114|NCT00038831|Fludarabine phosphate|fludarabine phosphate|mesh-list
92555115|NCT00038831|Melphalan|melphalan|mesh-list
92555116|NCT00038831|Gemtuzumab|gemtuzumab|mesh-list
92555117|NCT00038831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92555118|NCT00038831|Thymoglobulin|thymoglobulin|mesh-list
92555119|NCT00038831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555120|NCT00038831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555121|NCT00038831|Antimetabolites|antimetabolites|mesh-ancestor
92555122|NCT00038831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555123|NCT00038831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555124|NCT00038831|Immunologic Factors|immunologic factors|mesh-ancestor
92555125|NCT00038831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555126|NCT00038831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92555127|NCT00038831|Alkylating Agents|alkylating agents|mesh-ancestor
92555128|NCT00038831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92555129|NCT00038831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92555130|NCT00038831|Immunotoxins|immunotoxins|mesh-ancestor
92555131|NCT00038831|Immunoconjugates|immunoconjugates|mesh-ancestor
92555132|NCT00071955|Immunoglobulins|immunoglobulins|mesh-list
92555133|NCT00071955|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92555134|NCT00071955|Antibodies|antibodies|mesh-list
92555135|NCT00071955|Sargramostim|sargramostim|mesh-list
92555136|NCT00071955|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92279823|NCT03465735|Heparin|heparin|mesh-list
92555137|NCT00071955|Immunologic Factors|immunologic factors|mesh-ancestor
92555138|NCT00071955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555139|NCT00203554|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92555140|NCT00203554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92555141|NCT00203554|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92555142|NCT00203554|Protective Agents|protective agents|mesh-ancestor
92555143|NCT00203554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555163|NCT00203788|Dopamine Agents|dopamine agents|mesh-ancestor
92555164|NCT00072033|Docetaxel|docetaxel|mesh-list
92555165|NCT00072033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555166|NCT00072033|Tubulin Modulators|tubulin modulators|mesh-ancestor
92555167|NCT00072033|Antimitotic Agents|antimitotic agents|mesh-ancestor
92555168|NCT00072033|Mitosis Modulators|mitosis modulators|mesh-ancestor
92555169|NCT00072033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555170|NCT00203905|Bevacizumab|bevacizumab|mesh-list
92555171|NCT00203905|Fluorouracil|fluorouracil|mesh-list
92555172|NCT00203905|Hydroxyurea|hydroxyurea|mesh-list
92555173|NCT00203905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92555174|NCT00203905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555175|NCT00203905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92555176|NCT00203905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92555177|NCT00203905|Growth Substances|growth substances|mesh-ancestor
92555178|NCT00203905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555179|NCT00203905|Growth Inhibitors|growth inhibitors|mesh-ancestor
92555180|NCT00203905|Antimetabolites|antimetabolites|mesh-ancestor
92555181|NCT00203905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555182|NCT00203905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555183|NCT00203905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534516|NCT00069550|Cholinergic Agents|cholinergic agents|mesh-ancestor
92534517|NCT00069550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555184|NCT00203905|Immunologic Factors|immunologic factors|mesh-ancestor
92555185|NCT00203905|Antisickling Agents|antisickling agents|mesh-ancestor
92555186|NCT00203905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555187|NCT00203905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92555188|NCT00072072|Celecoxib|celecoxib|mesh-list
92555189|NCT00072072|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92555190|NCT00072072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555191|NCT00072072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555192|NCT00072072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555193|NCT00072072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555194|NCT00072072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555195|NCT00072072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555196|NCT00072072|Analgesics|analgesics|mesh-ancestor
92555197|NCT00072072|Sensory System Agents|sensory system agents|mesh-ancestor
92555198|NCT00072072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555212|NCT00204022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555213|NCT00204022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555214|NCT00204022|Antimetabolites|antimetabolites|mesh-ancestor
92555215|NCT00204022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555216|NCT00204022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555217|NCT00204022|Immunologic Factors|immunologic factors|mesh-ancestor
92555218|NCT00204022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555219|NCT00204022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555220|NCT00204061|Amisulpride|amisulpride|mesh-list
92555221|NCT00204061|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92555222|NCT00204061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555223|NCT00204061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555224|NCT00204061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555225|NCT00204061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555226|NCT00204061|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92555227|NCT00204061|Dopamine Agents|dopamine agents|mesh-ancestor
92555228|NCT00204061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555229|NCT00204061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555230|NCT00204061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92555231|NCT00204061|Antidepressive Agents|antidepressive agents|mesh-ancestor
92555232|NCT02966652|Methyltestosterone|methyltestosterone|mesh-list
92555233|NCT02966652|Testosterone|testosterone|mesh-list
92555234|NCT02966652|Testosterone undecanoate|testosterone undecanoate|mesh-list
92555235|NCT02966652|Testosterone enanthate|testosterone enanthate|mesh-list
92555236|NCT02966652|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92555237|NCT02966652|Androgens|androgens|mesh-ancestor
92555238|NCT02966652|Hormones|hormones|mesh-ancestor
92555239|NCT02966652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555240|NCT02966652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555241|NCT02966652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92555242|NCT02966652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555243|NCT02966652|Anabolic Agents|anabolic agents|mesh-ancestor
92555244|NCT00039026|Exenatide|exenatide|mesh-list
92555245|NCT00039026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555246|NCT00039026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555247|NCT00039026|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92555248|NCT00039026|Incretins|incretins|mesh-ancestor
92555249|NCT00039026|Hormones|hormones|mesh-ancestor
92555250|NCT00039026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555251|NCT00204256|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92555252|NCT00204256|Hematinics|hematinics|mesh-ancestor
92555253|NCT00072111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92555254|NCT00072111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555255|NCT00204451|Levonorgestrel|levonorgestrel|mesh-list
92555256|NCT00204451|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92555257|NCT00204451|Estradiol|estradiol|mesh-list
92555258|NCT00204451|Estrogens|estrogens|mesh-ancestor
92555259|NCT00204451|Hormones|hormones|mesh-ancestor
92555260|NCT00204451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555264|NCT00204451|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92555265|NCT00204451|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92555266|NCT00204451|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92555267|NCT00204451|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92555268|NCT00204451|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92555269|NCT00204529|Interferons|interferons|mesh-list
92534518|NCT00069550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534519|NCT00069550|Nootropic Agents|nootropic agents|mesh-ancestor
92534520|NCT00069550|Antitussive Agents|antitussive agents|mesh-ancestor
92534521|NCT00069550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92555270|NCT00204529|Interferon-alpha|interferon-alpha|mesh-list
92555271|NCT00204529|Interferon alpha-2|interferon alpha-2|mesh-list
92555272|NCT00204529|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92555273|NCT00204529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555274|NCT00204529|Antiviral Agents|antiviral agents|mesh-ancestor
92555275|NCT00204529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555276|NCT00204529|Immunologic Factors|immunologic factors|mesh-ancestor
92555277|NCT00204529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555278|NCT00039104|Zoledronic Acid|zoledronic acid|mesh-list
92555279|NCT00039104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92555280|NCT00039104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555281|NCT00204568|Doxorubicin|doxorubicin|mesh-list
92555282|NCT00204568|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92555283|NCT00204568|Trofosfamide|trofosfamide|mesh-list
92555284|NCT00204568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92555285|NCT00204568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555286|NCT00204568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92555287|NCT00204568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555288|NCT00204568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555289|NCT00204568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555290|NCT00204568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555291|NCT00204568|Immunologic Factors|immunologic factors|mesh-ancestor
92555292|NCT00204568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555293|NCT00204568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92555294|NCT00204568|Alkylating Agents|alkylating agents|mesh-ancestor
92555295|NCT00072150|Bortezomib|bortezomib|mesh-list
92555296|NCT00072150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555297|NCT00204646|Carboplatin|carboplatin|mesh-list
92555298|NCT00204646|Etoposide|etoposide|mesh-list
92555299|NCT00204646|Doxorubicin|doxorubicin|mesh-list
92555300|NCT00204646|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92555301|NCT00204646|Ifosfamide|ifosfamide|mesh-list
92555302|NCT00204646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555303|NCT00204646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92555304|NCT00204646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92555305|NCT00204646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555306|NCT00204646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555307|NCT00204646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555308|NCT00204646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92555309|NCT00204646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92555310|NCT00204646|Alkylating Agents|alkylating agents|mesh-ancestor
92555311|NCT00039182|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92555312|NCT00039182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555313|NCT00039182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555314|NCT00039182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555315|NCT00039182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555316|NCT00410878|Hydromorphone|hydromorphone|mesh-list
92555317|NCT00410878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92555318|NCT00410878|Narcotics|narcotics|mesh-ancestor
92555319|NCT00410878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555320|NCT00410878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555321|NCT00410878|Analgesics|analgesics|mesh-ancestor
92555322|NCT00410878|Sensory System Agents|sensory system agents|mesh-ancestor
92555323|NCT00410878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555324|NCT00410995|Naproxen|naproxen|mesh-list
92555325|NCT00410995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555326|NCT00410995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555327|NCT00410995|Analgesics|analgesics|mesh-ancestor
92555328|NCT00410995|Sensory System Agents|sensory system agents|mesh-ancestor
92555329|NCT00410995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555330|NCT00410995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555331|NCT00410995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555332|NCT00410995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555373|NCT00072345|Immunologic Factors|immunologic factors|mesh-ancestor
92555374|NCT00072345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555375|NCT00072345|Leprostatic Agents|leprostatic agents|mesh-ancestor
92534522|NCT00069550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92534523|NCT00069550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92555376|NCT00072345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92555377|NCT00072345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555378|NCT00072345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92555379|NCT00072345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92555380|NCT00072345|Growth Substances|growth substances|mesh-ancestor
92354965|NCT00983814|Carbidopa|carbidopa|mesh-list
92555381|NCT00072345|Growth Inhibitors|growth inhibitors|mesh-ancestor
92555382|NCT00039455|Trastuzumab|trastuzumab|mesh-list
92555383|NCT00039455|Alvocidib|alvocidib|mesh-list
92555384|NCT00039455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92555385|NCT00039455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555386|NCT00039455|Growth Inhibitors|growth inhibitors|mesh-ancestor
92555387|NCT00039455|Growth Substances|growth substances|mesh-ancestor
92555388|NCT00039455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555389|NCT00039455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555390|NCT00039455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555391|NCT00039455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555392|NCT00205231|Etanercept|etanercept|mesh-list
92555393|NCT00205231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555394|NCT00205231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555395|NCT00205231|Analgesics|analgesics|mesh-ancestor
92555396|NCT00205231|Sensory System Agents|sensory system agents|mesh-ancestor
92555397|NCT00205231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555398|NCT00205231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555399|NCT00205231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555400|NCT00205231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555401|NCT00205231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555402|NCT00205231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555403|NCT00205231|Immunologic Factors|immunologic factors|mesh-ancestor
92555404|NCT00072462|Tamoxifen|tamoxifen|mesh-list
92555405|NCT00072462|Anastrozole|anastrozole|mesh-list
92555406|NCT00072462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555407|NCT00072462|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92555408|NCT00072462|Hormone Antagonists|hormone antagonists|mesh-ancestor
92555409|NCT00072462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555410|NCT00072462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555411|NCT00072462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92555412|NCT00072462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555413|NCT00072462|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92555414|NCT00072462|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92555415|NCT00072462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92555416|NCT00072462|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92555417|NCT00072462|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92555418|NCT00072462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555419|NCT00205426|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92555420|NCT00205426|Natriuretic Agents|natriuretic agents|mesh-ancestor
92555421|NCT00205426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555422|NCT00039494|Temozolomide|temozolomide|mesh-list
92555423|NCT00039494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92555424|NCT00039494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92555425|NCT00039494|Alkylating Agents|alkylating agents|mesh-ancestor
92555426|NCT00039494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555427|NCT00039494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555428|NCT00039494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555429|NCT00039494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555430|NCT00205738|Olanzapine|olanzapine|mesh-list
92555431|NCT00205738|Risperidone|risperidone|mesh-list
92555432|NCT00205738|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92555433|NCT00205738|Serotonin Agents|serotonin agents|mesh-ancestor
92555434|NCT00205738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555435|NCT00205738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280122|NCT00001737|Cyclosporine|cyclosporine|mesh-list
92555436|NCT00205738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555441|NCT00205738|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92555442|NCT00205738|Dopamine Agents|dopamine agents|mesh-ancestor
92555443|NCT00205738|Antiemetics|antiemetics|mesh-ancestor
92555444|NCT00205738|Autonomic Agents|autonomic agents|mesh-ancestor
92555445|NCT00205738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555446|NCT00205738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555447|NCT00205738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92534525|NCT02966587|Immunoglobulins|immunoglobulins|mesh-list
92534526|NCT02966587|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92534527|NCT02966587|Immunoglobulin G|immunoglobulin g|mesh-list
92555448|NCT00205738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92555449|NCT00205738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92555450|NCT00205816|Tigecycline|tigecycline|mesh-list
92555451|NCT00205816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92555452|NCT00205816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555453|NCT00205816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92555454|NCT00205816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555455|NCT00205816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555456|NCT00072540|Celecoxib|celecoxib|mesh-list
92555457|NCT00072540|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92555458|NCT00072540|Mitogens|mitogens|mesh-list
92555459|NCT00072540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555460|NCT00072540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555461|NCT00072540|Analgesics|analgesics|mesh-ancestor
92555462|NCT00072540|Sensory System Agents|sensory system agents|mesh-ancestor
92555463|NCT00072540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555464|NCT00072540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555465|NCT00072540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555466|NCT00072540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555467|NCT00072540|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92555468|NCT00072540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92555469|NCT00072540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555470|NCT00072540|Mitosis Modulators|mitosis modulators|mesh-ancestor
92555471|NCT00206050|Esomeprazole|esomeprazole|mesh-list
92555472|NCT00206050|Pantoprazole|pantoprazole|mesh-list
92555473|NCT00206050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92555474|NCT00206050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555475|NCT00206050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92555476|NCT00206050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555477|NCT00206050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555478|NCT00206089|Ximelagatran|ximelagatran|mesh-list
92555479|NCT00206089|Melagatran|melagatran|mesh-list
92555480|NCT00206089|Antithrombins|antithrombins|mesh-ancestor
92555481|NCT00206089|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92555482|NCT00206089|Protease Inhibitors|protease inhibitors|mesh-ancestor
92555483|NCT00206089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555484|NCT00206089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555485|NCT00206089|Anticoagulants|anticoagulants|mesh-ancestor
92555486|NCT00072579|Sargramostim|sargramostim|mesh-list
92555487|NCT00072579|Immunologic Factors|immunologic factors|mesh-ancestor
92555488|NCT00072579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555489|NCT04732247|Oxytocin|oxytocin|mesh-list
92555490|NCT04732247|Oxytocics|oxytocics|mesh-ancestor
92555491|NCT04732247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92555492|NCT04732247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354989|NCT04395768|Vitamin D|vitamin d|mesh-list
92555493|NCT00206128|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92555494|NCT00206128|Antidepressive Agents|antidepressive agents|mesh-ancestor
92555495|NCT00206128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555496|NCT00206128|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92555497|NCT00206128|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555498|NCT00206128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555499|NCT00206128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555500|NCT00206167|Budesonide|budesonide|mesh-list
92555501|NCT00206167|Formoterol Fumarate|formoterol fumarate|mesh-list
92555502|NCT00206167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555503|NCT00206167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92555504|NCT00206167|Autonomic Agents|autonomic agents|mesh-ancestor
92555505|NCT00206167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555506|NCT00206167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555507|NCT00206167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92555508|NCT00206167|Respiratory System Agents|respiratory system agents|mesh-ancestor
92555511|NCT00206167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555512|NCT00206167|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92555513|NCT00206167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92555515|NCT00206167|Adrenergic Agents|adrenergic agents|mesh-ancestor
92555516|NCT00206167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555517|NCT00206167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555518|NCT00039611|Leucovorin|leucovorin|mesh-list
92555519|NCT00039611|Fluorouracil|fluorouracil|mesh-list
92555520|NCT00039611|Oxaliplatin|oxaliplatin|mesh-list
92534528|NCT02966587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534529|NCT02966587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534530|NCT02966587|Immunologic Factors|immunologic factors|mesh-ancestor
92534531|NCT02966587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555521|NCT00039611|Calcium|calcium|mesh-list
92555522|NCT00039611|Levoleucovorin|levoleucovorin|mesh-list
92555523|NCT00039611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92555524|NCT00039611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555525|NCT00039611|Antimetabolites|antimetabolites|mesh-ancestor
92555526|NCT00039611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555527|NCT00039611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555528|NCT00039611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555529|NCT00039611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555530|NCT00039611|Immunologic Factors|immunologic factors|mesh-ancestor
92555531|NCT00039611|Antidotes|antidotes|mesh-ancestor
92555532|NCT00039611|Protective Agents|protective agents|mesh-ancestor
92555533|NCT00039611|Vitamin B Complex|vitamin b complex|mesh-ancestor
92555534|NCT00039611|Vitamins|vitamins|mesh-ancestor
92555535|NCT00039611|Micronutrients|micronutrients|mesh-ancestor
92555536|NCT00068289|Bortezomib|bortezomib|mesh-list
92555537|NCT00068289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555538|NCT00039767|Lepirudin|lepirudin|mesh-list
92555539|NCT00039767|Antithrombins|antithrombins|mesh-ancestor
92555540|NCT00039767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92555541|NCT00039767|Protease Inhibitors|protease inhibitors|mesh-ancestor
92555542|NCT00039767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555543|NCT00039767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555544|NCT00039767|Anticoagulants|anticoagulants|mesh-ancestor
92555545|NCT00039767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92555546|NCT00039767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92555547|NCT00072618|Sulindac sulfone|sulindac sulfone|mesh-list
92555548|NCT00072618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555549|NCT00072618|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92555550|NCT00072618|Protective Agents|protective agents|mesh-ancestor
92555551|NCT00072618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555552|NCT00072618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92555553|NCT00072618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555554|NCT00072618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555555|NCT00072618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555556|NCT00072618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555557|NCT00072618|Analgesics|analgesics|mesh-ancestor
92555558|NCT00072618|Sensory System Agents|sensory system agents|mesh-ancestor
92555559|NCT00072618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555560|NCT00072618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555561|NCT00072618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555562|NCT00039884|Darbepoetin alfa|darbepoetin alfa|mesh-list
92555563|NCT00039884|Hematinics|hematinics|mesh-ancestor
92555564|NCT00206401|Insulin Glargine|insulin glargine|mesh-list
92555565|NCT00206401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555566|NCT00206401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555567|NCT00399204|Metformin|metformin|mesh-list
92555568|NCT00399204|Pioglitazone|pioglitazone|mesh-list
92555569|NCT00399204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555570|NCT00399204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555571|NCT00411034|Hydromorphone|hydromorphone|mesh-list
92555572|NCT00411034|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92555573|NCT00411034|Narcotics|narcotics|mesh-ancestor
92555574|NCT00411034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555575|NCT00411034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555576|NCT00411034|Analgesics|analgesics|mesh-ancestor
92555577|NCT00411034|Sensory System Agents|sensory system agents|mesh-ancestor
92555578|NCT00411034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555579|NCT00411073|Darapladib|darapladib|mesh-list
92555580|NCT00411073|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92555581|NCT00411073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555584|NCT00411190|Ibuprofen|ibuprofen|mesh-list
92555585|NCT00411190|Atorvastatin|atorvastatin|mesh-list
92555586|NCT00411190|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92555587|NCT00411190|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92555589|NCT00411190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555590|NCT00411190|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92534532|NCT04958720|Immunomodulating Agents|immunomodulating agents|mesh-list
92534533|NCT04958720|Immunologic Factors|immunologic factors|mesh-ancestor
92555591|NCT00411190|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92555592|NCT00411190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555593|NCT00411190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555594|NCT00411190|Analgesics|analgesics|mesh-ancestor
92555595|NCT00411190|Sensory System Agents|sensory system agents|mesh-ancestor
92555596|NCT00411190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555597|NCT00411190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555598|NCT00411190|Antipyretics|antipyretics|mesh-ancestor
92555599|NCT00411190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92555600|NCT00411190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555601|NCT00411190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555602|NCT00411190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92555603|NCT00411229|Capecitabine|capecitabine|mesh-list
92555604|NCT00411229|Oxaliplatin|oxaliplatin|mesh-list
92555605|NCT00411229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555606|NCT00411229|Antimetabolites|antimetabolites|mesh-ancestor
92555607|NCT00411229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555608|NCT00411229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555609|NCT00411268|Hydromorphone|hydromorphone|mesh-list
92555610|NCT00411268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92555611|NCT00411268|Narcotics|narcotics|mesh-ancestor
92555612|NCT00411268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555613|NCT00411268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555614|NCT00411268|Analgesics|analgesics|mesh-ancestor
92555615|NCT00411268|Sensory System Agents|sensory system agents|mesh-ancestor
92555616|NCT00411268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555617|NCT00039962|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92555618|NCT00039962|Thymalfasin|thymalfasin|mesh-list
92555619|NCT00039962|Antiviral Agents|antiviral agents|mesh-ancestor
92555620|NCT00039962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555621|NCT00039962|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92555622|NCT00039962|Immunologic Factors|immunologic factors|mesh-ancestor
92555623|NCT00039962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555624|NCT00424333|Insulin|insulin|mesh-list
92555625|NCT00424333|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92555626|NCT00424333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555627|NCT00424333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555628|NCT00206557|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92555629|NCT00206557|Estradiol|estradiol|mesh-list
92555630|NCT00206557|Estrogens|estrogens|mesh-ancestor
92555631|NCT00206557|Hormones|hormones|mesh-ancestor
92555632|NCT00206557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555633|NCT00206557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555634|NCT00206557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92555635|NCT00206557|Hormone Antagonists|hormone antagonists|mesh-ancestor
92555636|NCT00206557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92555637|NCT00206557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92555638|NCT00206557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92555639|NCT00068484|Bortezomib|bortezomib|mesh-list
92555640|NCT00068484|Topotecan|topotecan|mesh-list
92555641|NCT00068484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555642|NCT00068484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92555643|NCT00068484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555644|NCT00068484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555645|NCT00068484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555646|NCT00206596|Sargramostim|sargramostim|mesh-list
92555647|NCT00206596|Immunologic Factors|immunologic factors|mesh-ancestor
92555648|NCT00206596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555649|NCT00206635|Interferons|interferons|mesh-list
92555650|NCT00206635|Interferon-beta|interferon-beta|mesh-list
92555651|NCT00206635|Interferon beta-1b|interferon beta-1b|mesh-list
92555652|NCT00206635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555653|NCT00206635|Antiviral Agents|antiviral agents|mesh-ancestor
92555654|NCT00206635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555655|NCT00206635|Immunologic Factors|immunologic factors|mesh-ancestor
92555656|NCT00206635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555667|NCT00040040|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555668|NCT00040040|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92555669|NCT00040040|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92555670|NCT00040040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92534534|NCT04958720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555671|NCT00040040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555672|NCT00040040|Dopamine Agents|dopamine agents|mesh-ancestor
92555673|NCT00040040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555674|NCT00040040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555675|NCT00040040|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92555676|NCT00040040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92555677|NCT00040040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555678|NCT00068523|Cyclosporine|cyclosporine|mesh-list
92555679|NCT00068523|Methylprednisolone|methylprednisolone|mesh-list
92555680|NCT00068523|Cyclophosphamide|cyclophosphamide|mesh-list
92555681|NCT00068523|Fludarabine|fludarabine|mesh-list
92555682|NCT00068523|Fludarabine phosphate|fludarabine phosphate|mesh-list
92555683|NCT00068523|Cyclosporins|cyclosporins|mesh-list
92555684|NCT00068523|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92555685|NCT00068523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555686|NCT00068523|Immunologic Factors|immunologic factors|mesh-ancestor
92555687|NCT00068523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555688|NCT00068523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555689|NCT00068523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92555690|NCT00068523|Alkylating Agents|alkylating agents|mesh-ancestor
92555691|NCT00068523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555692|NCT00068523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555693|NCT00068523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92555694|NCT00068523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555695|NCT00068523|Antimetabolites|antimetabolites|mesh-ancestor
92555696|NCT00068523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555697|NCT00068523|Antifungal Agents|antifungal agents|mesh-ancestor
92555698|NCT00068523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555699|NCT00068523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92555700|NCT00068523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92555701|NCT00068523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555702|NCT00068523|Antiemetics|antiemetics|mesh-ancestor
92555703|NCT00068523|Autonomic Agents|autonomic agents|mesh-ancestor
92555704|NCT00068523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555705|NCT00068523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555706|NCT00068523|Glucocorticoids|glucocorticoids|mesh-ancestor
92555708|NCT00068523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555709|NCT00068523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92555710|NCT00068523|Protective Agents|protective agents|mesh-ancestor
92555711|NCT00040157|Dexelvucitabine|dexelvucitabine|mesh-list
92555712|NCT00040157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92555713|NCT00040157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92555714|NCT00040157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555715|NCT00040157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555716|NCT00040157|Antiviral Agents|antiviral agents|mesh-ancestor
92555717|NCT00040157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555718|NCT00040157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92555719|NCT00040157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92555720|NCT00206947|Ziprasidone|ziprasidone|mesh-list
92555721|NCT00206947|Donepezil|donepezil|mesh-list
92555723|NCT00206947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555724|NCT00206947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555725|NCT00206947|Cholinergic Agents|cholinergic agents|mesh-ancestor
92555726|NCT00206947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555727|NCT00206947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555728|NCT00206947|Nootropic Agents|nootropic agents|mesh-ancestor
92555729|NCT00206947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92555730|NCT00206947|Serotonin Agents|serotonin agents|mesh-ancestor
92555731|NCT00206947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92555732|NCT00206947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555733|NCT00206947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555734|NCT00206947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555735|NCT00206947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92555736|NCT00206947|Dopamine Agents|dopamine agents|mesh-ancestor
92555737|NCT00068757|Paclitaxel|paclitaxel|mesh-list
92555738|NCT00068757|Trastuzumab|trastuzumab|mesh-list
92555739|NCT00068757|Lonafarnib|lonafarnib|mesh-list
92555740|NCT00068757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92555741|NCT00068757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555742|NCT00068757|Tubulin Modulators|tubulin modulators|mesh-ancestor
92555743|NCT00068757|Antimitotic Agents|antimitotic agents|mesh-ancestor
92555744|NCT00068757|Mitosis Modulators|mitosis modulators|mesh-ancestor
92555745|NCT00068757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534535|NCT00069706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92534536|NCT00069706|Latanoprost|latanoprost|mesh-list
92555746|NCT00068757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92555747|NCT00068757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555748|NCT00206986|Clonidine|clonidine|mesh-list
92555749|NCT00206986|Analgesics|analgesics|mesh-ancestor
92555750|NCT00206986|Sensory System Agents|sensory system agents|mesh-ancestor
92555751|NCT00206986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555752|NCT00206986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555753|NCT00206986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92555754|NCT00206986|Sympatholytics|sympatholytics|mesh-ancestor
92555755|NCT00206986|Autonomic Agents|autonomic agents|mesh-ancestor
92555756|NCT00206986|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92555757|NCT00206986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92555758|NCT00206986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92555759|NCT00206986|Adrenergic Agents|adrenergic agents|mesh-ancestor
92555760|NCT00206986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555761|NCT00206986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555762|NCT00207064|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92555763|NCT00207064|Antidepressive Agents|antidepressive agents|mesh-ancestor
92555764|NCT00207064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555765|NCT00207064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92555766|NCT00207064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555767|NCT00207064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555768|NCT00207064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555769|NCT00040274|Dexelvucitabine|dexelvucitabine|mesh-list
92555770|NCT00040274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92555771|NCT00040274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92555772|NCT00040274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555773|NCT00040274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555774|NCT00040274|Antiviral Agents|antiviral agents|mesh-ancestor
92555775|NCT00040274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555776|NCT00040274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92555777|NCT00040274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92555778|NCT00072852|Irinotecan|irinotecan|mesh-list
92555779|NCT00072852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92555780|NCT00072852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555781|NCT00072852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555782|NCT00072852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555783|NCT00072852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555784|NCT00207532|Folic Acid|folic acid|mesh-list
92555785|NCT00207532|Hematinics|hematinics|mesh-ancestor
92555786|NCT00207532|Vitamin B Complex|vitamin b complex|mesh-ancestor
92555787|NCT00207532|Vitamins|vitamins|mesh-ancestor
92555788|NCT00207532|Micronutrients|micronutrients|mesh-ancestor
92555789|NCT00207532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555790|NCT00040391|Leucovorin|leucovorin|mesh-list
92555791|NCT00040391|Fluorouracil|fluorouracil|mesh-list
92555792|NCT00040391|Irinotecan|irinotecan|mesh-list
92555793|NCT00040391|Antimetabolites|antimetabolites|mesh-ancestor
92555794|NCT00040391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555795|NCT00040391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555796|NCT00040391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555804|NCT00040391|Protective Agents|protective agents|mesh-ancestor
92555805|NCT00040391|Vitamin B Complex|vitamin b complex|mesh-ancestor
92555806|NCT00040391|Vitamins|vitamins|mesh-ancestor
92555807|NCT00040391|Micronutrients|micronutrients|mesh-ancestor
92555808|NCT00207688|Infliximab|infliximab|mesh-list
92555809|NCT00207688|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92555810|NCT00207688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555811|NCT00207688|Dermatologic Agents|dermatologic agents|mesh-ancestor
92555812|NCT00207688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555813|NCT00207688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555814|NCT00207766|Infliximab|infliximab|mesh-list
92555815|NCT00207766|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92555816|NCT00207766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555817|NCT00207766|Dermatologic Agents|dermatologic agents|mesh-ancestor
92555818|NCT00207766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555819|NCT00207766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555820|NCT00040469|Cyclophosphamide|cyclophosphamide|mesh-list
92555821|NCT00040469|Busulfan|busulfan|mesh-list
92555822|NCT00040469|Alemtuzumab|alemtuzumab|mesh-list
92555823|NCT00040469|Phenytoin|phenytoin|mesh-list
92555824|NCT00040469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555825|NCT00040469|Immunologic Factors|immunologic factors|mesh-ancestor
92555826|NCT00040469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534537|NCT00069706|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92534538|NCT00069901|Paclitaxel|paclitaxel|mesh-list
92534539|NCT00069901|Carboplatin|carboplatin|mesh-list
92555827|NCT00040469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555828|NCT00040469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92555829|NCT00040469|Alkylating Agents|alkylating agents|mesh-ancestor
92555830|NCT00040469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555831|NCT00040469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555832|NCT00040469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92555833|NCT00040469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92555834|NCT00040469|Anticonvulsants|anticonvulsants|mesh-ancestor
92555835|NCT00040469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92555836|NCT00040469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92555837|NCT00040469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92555838|NCT00040469|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92555839|NCT00040469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92555840|NCT00207844|Selenium|selenium|mesh-list
92555841|NCT00207844|Selenious Acid|selenious acid|mesh-list
92555842|NCT00207844|Sodium Selenite|sodium selenite|mesh-list
92555843|NCT00207844|Antioxidants|antioxidants|mesh-ancestor
92555844|NCT00207844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555845|NCT00207844|Protective Agents|protective agents|mesh-ancestor
92555846|NCT00207844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555847|NCT00207844|Trace Elements|trace elements|mesh-ancestor
92555848|NCT00207844|Micronutrients|micronutrients|mesh-ancestor
92555849|NCT00072930|Zoledronic Acid|zoledronic acid|mesh-list
92555850|NCT00072930|Prednisone|prednisone|mesh-list
92555851|NCT00072930|Docetaxel|docetaxel|mesh-list
92555852|NCT00072930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555853|NCT00072930|Tubulin Modulators|tubulin modulators|mesh-ancestor
92555854|NCT00072930|Antimitotic Agents|antimitotic agents|mesh-ancestor
92555855|NCT00072930|Mitosis Modulators|mitosis modulators|mesh-ancestor
92555856|NCT00072930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555857|NCT00072930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555858|NCT00072930|Glucocorticoids|glucocorticoids|mesh-ancestor
92555859|NCT00072930|Hormones|hormones|mesh-ancestor
92555860|NCT00072930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555861|NCT00072930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555862|NCT00072930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92555863|NCT00072930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92555864|NCT00411307|Hydromorphone|hydromorphone|mesh-list
92555865|NCT00411307|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92555866|NCT00411307|Narcotics|narcotics|mesh-ancestor
92555870|NCT00411307|Sensory System Agents|sensory system agents|mesh-ancestor
92555871|NCT00411307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555873|NCT00040508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92555874|NCT00040508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555875|NCT00040508|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92555876|NCT00040508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555877|NCT00040508|Antifungal Agents|antifungal agents|mesh-ancestor
92555878|NCT00040508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555879|NCT00040508|Immunologic Factors|immunologic factors|mesh-ancestor
92555880|NCT00040508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555881|NCT00424411|Insulin|insulin|mesh-list
92555882|NCT00424411|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92555883|NCT00424411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555884|NCT00424411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555885|NCT00072969|Daclizumab|daclizumab|mesh-list
92555886|NCT00072969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555887|NCT00072969|Immunologic Factors|immunologic factors|mesh-ancestor
92555888|NCT00072969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555889|NCT00424606|Docetaxel|docetaxel|mesh-list
92280573|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
92555890|NCT00424606|Epirubicin|epirubicin|mesh-list
92555891|NCT00424606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555892|NCT00424606|Tubulin Modulators|tubulin modulators|mesh-ancestor
92555893|NCT00424606|Antimitotic Agents|antimitotic agents|mesh-ancestor
92555894|NCT00424606|Mitosis Modulators|mitosis modulators|mesh-ancestor
92555895|NCT00424606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555896|NCT00424606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92555897|NCT00424606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92555898|NCT00424606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555899|NCT00424606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555901|NCT00208039|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92534540|NCT00069901|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92555902|NCT00208039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92555903|NCT02962921|Insulin|insulin|mesh-list
92555904|NCT02962921|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92555905|NCT02962921|Insulin Lispro|insulin lispro|mesh-list
92555906|NCT02962921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555907|NCT02962921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555908|NCT00040586|Interleukin-2|interleukin-2|mesh-list
92555909|NCT00040586|Antibodies|antibodies|mesh-list
92555910|NCT00040586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92555911|NCT00040586|Immunologic Factors|immunologic factors|mesh-ancestor
92555912|NCT00040586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555913|NCT00040586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555914|NCT00040586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92555915|NCT00040586|Analgesics|analgesics|mesh-ancestor
92555916|NCT00040586|Sensory System Agents|sensory system agents|mesh-ancestor
92555917|NCT00040586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555918|NCT00208117|Sertraline|sertraline|mesh-list
92555919|NCT00208117|Simvastatin|simvastatin|mesh-list
92555920|NCT00208117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92555921|NCT00208117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92555922|NCT00208117|Antimetabolites|antimetabolites|mesh-ancestor
92555923|NCT00208117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555924|NCT00208117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92555925|NCT00208117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92555926|NCT00208117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555927|NCT00208117|Antidepressive Agents|antidepressive agents|mesh-ancestor
92555928|NCT00208117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555929|NCT00208117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92555930|NCT00208117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92555931|NCT00208117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92555932|NCT00208117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555933|NCT00208117|Serotonin Agents|serotonin agents|mesh-ancestor
92555934|NCT00208117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555935|NCT00208156|Mifepristone|mifepristone|mesh-list
92555936|NCT00208156|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92555937|NCT00208156|Abortifacient Agents|abortifacient agents|mesh-ancestor
92355029|NCT03059940|Nicotine|nicotine|mesh-list
92555938|NCT00208156|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91963411|NCT05727163|Leucovorin|leucovorin|mesh-list
92555942|NCT00208156|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92555943|NCT00208156|Contraceptive Agents|contraceptive agents|mesh-ancestor
92555944|NCT00208156|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92555945|NCT00208156|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92555946|NCT00208156|Hormone Antagonists|hormone antagonists|mesh-ancestor
92555947|NCT00208156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555948|NCT00208156|Luteolytic Agents|luteolytic agents|mesh-ancestor
92555949|NCT00208156|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92555950|NCT00208156|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92555951|NCT00040625|Pemetrexed|pemetrexed|mesh-list
92555952|NCT00040625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555953|NCT00040625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555954|NCT00040625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555955|NCT00040625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92555956|NCT00040625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92555957|NCT00208195|Valproic Acid|valproic acid|mesh-list
92555958|NCT00208195|Anticonvulsants|anticonvulsants|mesh-ancestor
92555959|NCT00208195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555960|NCT00208195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555961|NCT00208195|GABA Agents|gaba agents|mesh-ancestor
92555962|NCT00208195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555963|NCT00208195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280656|NCT00002001|Zidovudine|zidovudine|mesh-list
92555964|NCT00208195|Antimanic Agents|antimanic agents|mesh-ancestor
92555965|NCT00208195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555966|NCT00208195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555967|NCT00208195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555968|NCT00208234|Omalizumab|omalizumab|mesh-list
92555969|NCT00208234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92555970|NCT00208234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92555971|NCT00208234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92555972|NCT00208234|Respiratory System Agents|respiratory system agents|mesh-ancestor
92555973|NCT00208234|Immunologic Factors|immunologic factors|mesh-ancestor
92534541|NCT00069901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92555974|NCT00208234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555975|NCT00208273|Letrozole|letrozole|mesh-list
92555976|NCT00208273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555977|NCT00208273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92555978|NCT00208273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92555979|NCT00208273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555980|NCT00208273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555981|NCT00208273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92555982|NCT00208273|Hormone Antagonists|hormone antagonists|mesh-ancestor
92555983|NCT00208273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92555984|NCT00208273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555985|NCT00208312|Adenosine|adenosine|mesh-list
92555986|NCT00208312|Regadenoson|regadenoson|mesh-list
92555987|NCT00208312|Analgesics|analgesics|mesh-ancestor
92555988|NCT00208312|Sensory System Agents|sensory system agents|mesh-ancestor
92555989|NCT00208312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92555990|NCT00208312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555991|NCT00208312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92555992|NCT00208312|Vasodilator Agents|vasodilator agents|mesh-ancestor
92555993|NCT00208312|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92555994|NCT00208312|Purinergic Agonists|purinergic agonists|mesh-ancestor
92555995|NCT00208312|Purinergic Agents|purinergic agents|mesh-ancestor
92555996|NCT00208312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555997|NCT00208312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555998|NCT00208312|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92555999|NCT00040781|Gefitinib|gefitinib|mesh-list
92556000|NCT00040781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556001|NCT00040781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92556002|NCT00040781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556003|NCT00040781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556004|NCT00068952|Temozolomide|temozolomide|mesh-list
92556005|NCT00068952|Carmustine|carmustine|mesh-list
92556006|NCT00068952|Lomustine|lomustine|mesh-list
92556007|NCT00068952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92556008|NCT00068952|Alkylating Agents|alkylating agents|mesh-ancestor
92556009|NCT00068952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556011|NCT00040820|Oxaliplatin|oxaliplatin|mesh-list
92556012|NCT00040820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556013|NCT00208546|Bevacizumab|bevacizumab|mesh-list
92556014|NCT00208546|Cetuximab|cetuximab|mesh-list
92556015|NCT00208546|Capecitabine|capecitabine|mesh-list
92556016|NCT00208546|Oxaliplatin|oxaliplatin|mesh-list
92556017|NCT00208546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92556018|NCT00208546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556019|NCT00208546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556020|NCT00208546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92556021|NCT00208546|Growth Substances|growth substances|mesh-ancestor
92556022|NCT00208546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556023|NCT00208546|Growth Inhibitors|growth inhibitors|mesh-ancestor
92556024|NCT00208546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556025|NCT00208546|Antimetabolites|antimetabolites|mesh-ancestor
92556026|NCT00208546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556027|NCT00208585|Sertraline|sertraline|mesh-list
92556028|NCT00208585|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556029|NCT00208585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556030|NCT00208585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92556031|NCT00208585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556032|NCT00208585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556033|NCT00208585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556034|NCT00208585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556035|NCT00208585|Serotonin Agents|serotonin agents|mesh-ancestor
92556036|NCT00208585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556037|NCT00040859|Capecitabine|capecitabine|mesh-list
92556038|NCT00040859|Oxaliplatin|oxaliplatin|mesh-list
92556039|NCT00040859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556041|NCT00040859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556042|NCT00040859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556043|NCT00208702|Sertraline|sertraline|mesh-list
92556044|NCT00208702|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556045|NCT00208702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556046|NCT00208702|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92534542|NCT00069901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534543|NCT00069901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534544|NCT00069901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534545|NCT00069901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534546|NCT00069901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534547|NCT00069940|Sargramostim|sargramostim|mesh-list
92556047|NCT00208702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556048|NCT00208702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556049|NCT00208702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556050|NCT00208702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556051|NCT00208702|Serotonin Agents|serotonin agents|mesh-ancestor
92556052|NCT00208702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556053|NCT00208741|Tiagabine|tiagabine|mesh-list
92556054|NCT00208741|Anticonvulsants|anticonvulsants|mesh-ancestor
92556055|NCT00208741|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92556056|NCT00208741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556057|NCT00208741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556058|NCT00208741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556059|NCT00208741|GABA Agents|gaba agents|mesh-ancestor
92556060|NCT00208741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556061|NCT00208741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556062|NCT00399048|Hydromorphone|hydromorphone|mesh-list
92556063|NCT00399048|Oxycodone|oxycodone|mesh-list
92556064|NCT00399048|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92556065|NCT00399048|Narcotics|narcotics|mesh-ancestor
92556066|NCT00399048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556067|NCT00399048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556068|NCT00399048|Analgesics|analgesics|mesh-ancestor
92556069|NCT00399048|Sensory System Agents|sensory system agents|mesh-ancestor
92556070|NCT00399048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556071|NCT00208819|Valproic Acid|valproic acid|mesh-list
92556072|NCT00208819|Olanzapine|olanzapine|mesh-list
92556073|NCT00208819|Risperidone|risperidone|mesh-list
92556074|NCT00208819|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92556075|NCT00208819|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92556076|NCT00208819|Serotonin Agents|serotonin agents|mesh-ancestor
92556077|NCT00208819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556078|NCT00208819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556079|NCT00208819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556080|NCT00208819|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92556081|NCT00208819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92556082|NCT00208819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556086|NCT00208819|Antiemetics|antiemetics|mesh-ancestor
92556087|NCT00208819|Autonomic Agents|autonomic agents|mesh-ancestor
92556088|NCT00208819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556089|NCT00208819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92556090|NCT00208819|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92556091|NCT00208819|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556092|NCT00208819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556093|NCT00208819|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556094|NCT00208819|Anticonvulsants|anticonvulsants|mesh-ancestor
92556095|NCT00208819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556096|NCT00208819|GABA Agents|gaba agents|mesh-ancestor
92556097|NCT00208819|Antimanic Agents|antimanic agents|mesh-ancestor
92556098|NCT00208858|Topiramate|topiramate|mesh-list
92556099|NCT00208858|Anticonvulsants|anticonvulsants|mesh-ancestor
92556100|NCT00208858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556101|NCT00208858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556102|NCT00041015|Etoposide|etoposide|mesh-list
92556103|NCT00041015|Topotecan|topotecan|mesh-list
92556104|NCT00041015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556105|NCT00041015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556106|NCT00041015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92556107|NCT00041015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556108|NCT00041015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556109|NCT00041015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556110|NCT00041015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92556111|NCT00073047|Daclizumab|daclizumab|mesh-list
92556112|NCT00073047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556113|NCT00073047|Immunologic Factors|immunologic factors|mesh-ancestor
92534548|NCT00069940|Immunologic Factors|immunologic factors|mesh-ancestor
92556114|NCT00073047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556116|NCT00208897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92556117|NCT00208897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556118|NCT00208897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556119|NCT00208897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556120|NCT00208897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556121|NCT00208897|Serotonin Agents|serotonin agents|mesh-ancestor
92556122|NCT00208897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556123|NCT00208897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92556124|NCT00208897|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556125|NCT00208897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556126|NCT00208897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92556127|NCT00208897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92556128|NCT00208897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556129|NCT00208936|Fluorouracil|fluorouracil|mesh-list
92556130|NCT00208936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556131|NCT00208936|Antimetabolites|antimetabolites|mesh-ancestor
92556132|NCT00208936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556133|NCT00208936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556134|NCT00208936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556135|NCT00208936|Immunologic Factors|immunologic factors|mesh-ancestor
92556136|NCT00208936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556137|NCT00209014|Thalidomide|thalidomide|mesh-list
92556138|NCT00209014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556139|NCT00209014|Immunologic Factors|immunologic factors|mesh-ancestor
92556140|NCT00209014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556141|NCT00209014|Leprostatic Agents|leprostatic agents|mesh-ancestor
92556142|NCT00209014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92556143|NCT00209014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556144|NCT00209014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556145|NCT00209014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92556146|NCT00209014|Growth Substances|growth substances|mesh-ancestor
92556147|NCT00209014|Growth Inhibitors|growth inhibitors|mesh-ancestor
92556148|NCT00209014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556149|NCT00041054|Sulindac sulfone|sulindac sulfone|mesh-list
92556150|NCT00041054|Carboplatin|carboplatin|mesh-list
92556151|NCT00041054|Etoposide|etoposide|mesh-list
92556152|NCT00041054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556153|NCT00041054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556154|NCT00041054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91963593|NCT02465749|Vitamins|vitamins|mesh-list
92355035|NCT03059940|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92556158|NCT00041054|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92556159|NCT00041054|Protective Agents|protective agents|mesh-ancestor
92556160|NCT00041054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556161|NCT00041054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92556162|NCT00041054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92556163|NCT00041054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92556165|NCT00041054|Sensory System Agents|sensory system agents|mesh-ancestor
92556166|NCT00041054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556167|NCT00041054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556168|NCT00041054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556169|NCT00209209|Interferons|interferons|mesh-list
92556170|NCT00209209|Interferon-alpha|interferon-alpha|mesh-list
92556171|NCT00209209|Interferon alpha-2|interferon alpha-2|mesh-list
92556172|NCT00209209|Prednisone|prednisone|mesh-list
92556173|NCT00209209|Cyclophosphamide|cyclophosphamide|mesh-list
92556174|NCT00209209|Rituximab|rituximab|mesh-list
92556175|NCT00209209|Doxorubicin|doxorubicin|mesh-list
92556176|NCT00209209|Fludarabine|fludarabine|mesh-list
92556177|NCT00209209|Vincristine|vincristine|mesh-list
92556178|NCT00209209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556179|NCT00209209|Immunologic Factors|immunologic factors|mesh-ancestor
92556180|NCT00209209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556181|NCT00209209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556182|NCT00209209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92556183|NCT00209209|Alkylating Agents|alkylating agents|mesh-ancestor
92556184|NCT00209209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556185|NCT00209209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556186|NCT00209209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92556187|NCT00209209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92556188|NCT00209209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534549|NCT00069940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534550|NCT00390026|Bevacizumab|bevacizumab|mesh-list
92534551|NCT00390026|Verteporfin|verteporfin|mesh-list
92556189|NCT00209209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92556190|NCT00209209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556191|NCT00209209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556192|NCT00209209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556193|NCT00209209|Glucocorticoids|glucocorticoids|mesh-ancestor
92556194|NCT00209209|Hormones|hormones|mesh-ancestor
92556195|NCT00209209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556196|NCT00209209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556197|NCT00209209|Antiviral Agents|antiviral agents|mesh-ancestor
92556198|NCT00209209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556199|NCT00209209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556200|NCT00209209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556201|NCT00209209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556202|NCT00209209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556203|NCT00041093|Docetaxel|docetaxel|mesh-list
92556204|NCT00041093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556205|NCT00041093|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556206|NCT00041093|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556207|NCT00041093|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556208|NCT00041093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556209|NCT00399087|Prednisone|prednisone|mesh-list
92556210|NCT00399087|Docetaxel|docetaxel|mesh-list
92556211|NCT00399087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556212|NCT00399087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556213|NCT00399087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556214|NCT00399087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556215|NCT00399087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556216|NCT00399087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556217|NCT00399087|Glucocorticoids|glucocorticoids|mesh-ancestor
92556218|NCT00399087|Hormones|hormones|mesh-ancestor
92556219|NCT00399087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556220|NCT00399087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556221|NCT00399087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556222|NCT00209482|Metformin|metformin|mesh-list
92556223|NCT00209482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556224|NCT00209482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556225|NCT00041171|Docetaxel|docetaxel|mesh-list
92556226|NCT00041171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556229|NCT00041171|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556230|NCT00041171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556231|NCT00209521|Propofol|propofol|mesh-list
92556232|NCT00209521|Fospropofol|fospropofol|mesh-list
92556233|NCT00209521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92556234|NCT00209521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556235|NCT00209521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556236|NCT00209521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92556237|NCT00209521|Anesthetics, General|anesthetics, general|mesh-ancestor
92556238|NCT00209521|Anesthetics|anesthetics|mesh-ancestor
92556239|NCT00209638|Irinotecan|irinotecan|mesh-list
92556240|NCT00209638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92556241|NCT00209638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556242|NCT00209638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556243|NCT00209638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556244|NCT00209638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556245|NCT00399126|Paclitaxel|paclitaxel|mesh-list
92556246|NCT00399126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556247|NCT00399126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556248|NCT00399126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556249|NCT00399126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556250|NCT00399126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556251|NCT00399126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556252|NCT00209677|Gemcitabine|gemcitabine|mesh-list
92556253|NCT00209677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556254|NCT00209677|Antimetabolites|antimetabolites|mesh-ancestor
92556255|NCT00209677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556256|NCT00209677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556257|NCT00209716|Cisplatin|cisplatin|mesh-list
92556258|NCT00209716|Docetaxel|docetaxel|mesh-list
92556259|NCT00209716|Fluorouracil|fluorouracil|mesh-list
92556260|NCT00209716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556261|NCT00209716|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534552|NCT00390026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92556262|NCT00209716|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556263|NCT00209716|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556264|NCT00209716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556266|NCT00209716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556267|NCT00209716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556268|NCT00209716|Immunologic Factors|immunologic factors|mesh-ancestor
92556269|NCT00209716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556270|NCT00209755|Ribavirin|ribavirin|mesh-list
92556271|NCT00209755|Antimetabolites|antimetabolites|mesh-ancestor
92556272|NCT00209755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556273|NCT00209755|Antiviral Agents|antiviral agents|mesh-ancestor
92556274|NCT00209755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556275|NCT00209794|Pyrimethamine|pyrimethamine|mesh-list
92556276|NCT00209794|Sulfadoxine|sulfadoxine|mesh-list
92556277|NCT00209794|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92556278|NCT00209794|Antimalarials|antimalarials|mesh-ancestor
92556279|NCT00209794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92556280|NCT00209794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92556281|NCT00209794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556282|NCT00209794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92556283|NCT00209794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556284|NCT00209794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556285|NCT00209794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92556286|NCT00209833|Cytarabine|cytarabine|mesh-list
92556287|NCT00209833|Fludarabine|fludarabine|mesh-list
92556288|NCT00209833|Etoposide|etoposide|mesh-list
92556289|NCT00209833|Idarubicin|idarubicin|mesh-list
92556290|NCT00209833|Daunorubicin|daunorubicin|mesh-list
92556291|NCT00209833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556292|NCT00209833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556293|NCT00209833|Antimetabolites|antimetabolites|mesh-ancestor
92556294|NCT00209833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556295|NCT00209833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556296|NCT00209833|Immunologic Factors|immunologic factors|mesh-ancestor
92556297|NCT00209833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556298|NCT00209833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556299|NCT00209833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92556300|NCT00209833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556301|NCT00209833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556305|NCT00041210|Prednisone|prednisone|mesh-list
92556306|NCT00041210|Doxorubicin|doxorubicin|mesh-list
92355042|NCT03423342|Niacinamide|niacinamide|mesh-list
92556307|NCT00041210|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92556308|NCT00041210|Bleomycin|bleomycin|mesh-list
92556309|NCT00041210|Etoposide|etoposide|mesh-list
92556310|NCT00041210|Vincristine|vincristine|mesh-list
92556311|NCT00041210|Dacarbazine|dacarbazine|mesh-list
92556312|NCT00041210|Vinblastine|vinblastine|mesh-list
92556313|NCT00041210|Mechlorethamine|mechlorethamine|mesh-list
92556314|NCT00041210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92556315|NCT00041210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556316|NCT00041210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92556317|NCT00041210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556318|NCT00041210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556319|NCT00041210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556320|NCT00041210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556321|NCT00041210|Glucocorticoids|glucocorticoids|mesh-ancestor
92556322|NCT00041210|Hormones|hormones|mesh-ancestor
92556323|NCT00041210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556324|NCT00041210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556325|NCT00041210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556326|NCT00041210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556327|NCT00041210|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556328|NCT00041210|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556329|NCT00041210|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556330|NCT00041210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92556331|NCT00041210|Alkylating Agents|alkylating agents|mesh-ancestor
92556332|NCT00209872|Lidocaine|lidocaine|mesh-list
92556333|NCT00209872|Ketamine|ketamine|mesh-list
92556334|NCT00209872|Gabapentin|gabapentin|mesh-list
92556335|NCT00209872|Esketamine|esketamine|mesh-list
92556336|NCT00209872|Anesthetics, Local|anesthetics, local|mesh-ancestor
92556337|NCT00209872|Anesthetics|anesthetics|mesh-ancestor
92556338|NCT00209872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556339|NCT00209872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556340|NCT00209872|Sensory System Agents|sensory system agents|mesh-ancestor
92534553|NCT00390026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534554|NCT00390026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556341|NCT00209872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556342|NCT00209872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92556343|NCT00209872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92556344|NCT00209872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92556345|NCT00209872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556346|NCT00209872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556347|NCT00209872|Analgesics|analgesics|mesh-ancestor
92556348|NCT00209872|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92556349|NCT00209872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92556350|NCT00209872|Anesthetics, General|anesthetics, general|mesh-ancestor
92556351|NCT00209872|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92556352|NCT00209872|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92556353|NCT00209872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556354|NCT00209872|Anticonvulsants|anticonvulsants|mesh-ancestor
92556355|NCT00209872|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92556356|NCT00209872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92556357|NCT00209872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556358|NCT00209872|Antimanic Agents|antimanic agents|mesh-ancestor
92556359|NCT00209872|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556360|NCT00209950|Gaboxadol|gaboxadol|mesh-list
92556361|NCT00209950|Analgesics|analgesics|mesh-ancestor
92556362|NCT00209950|Sensory System Agents|sensory system agents|mesh-ancestor
92556363|NCT00209950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556364|NCT00209950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556365|NCT00209950|Anticonvulsants|anticonvulsants|mesh-ancestor
92556366|NCT00209950|GABA Agonists|gaba agonists|mesh-ancestor
92556367|NCT00209950|GABA Agents|gaba agents|mesh-ancestor
92556368|NCT00209950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556369|NCT00209950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556370|NCT00209989|Tipifarnib|tipifarnib|mesh-list
92556371|NCT00209989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556372|NCT00210028|Tamoxifen|tamoxifen|mesh-list
92556373|NCT00210028|Tipifarnib|tipifarnib|mesh-list
92556374|NCT00210028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92556375|NCT00210028|Hormone Antagonists|hormone antagonists|mesh-ancestor
91963810|NCT03289819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92556378|NCT00210028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556380|NCT00210028|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92556381|NCT00210028|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92556382|NCT00210028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92556383|NCT00041288|Cyclosporine|cyclosporine|mesh-list
92556384|NCT00041288|Mycophenolic Acid|mycophenolic acid|mesh-list
92556385|NCT00041288|Cyclophosphamide|cyclophosphamide|mesh-list
92556386|NCT00041288|Methotrexate|methotrexate|mesh-list
92556387|NCT00041288|Fludarabine|fludarabine|mesh-list
92556388|NCT00041288|Fludarabine phosphate|fludarabine phosphate|mesh-list
92556389|NCT00041288|Tacrolimus|tacrolimus|mesh-list
92556390|NCT00041288|Cyclosporins|cyclosporins|mesh-list
92556391|NCT00041288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556392|NCT00041288|Immunologic Factors|immunologic factors|mesh-ancestor
92556393|NCT00041288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556394|NCT00041288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556395|NCT00041288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92556396|NCT00041288|Alkylating Agents|alkylating agents|mesh-ancestor
92556397|NCT00041288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556398|NCT00041288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556399|NCT00041288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92556400|NCT00041288|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92556401|NCT00041288|Abortifacient Agents|abortifacient agents|mesh-ancestor
92556402|NCT00041288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92556403|NCT00041288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556404|NCT00041288|Antimetabolites|antimetabolites|mesh-ancestor
92556405|NCT00041288|Dermatologic Agents|dermatologic agents|mesh-ancestor
92556406|NCT00041288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556407|NCT00041288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92556408|NCT00041288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92556409|NCT00041288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92556410|NCT00041288|Antifungal Agents|antifungal agents|mesh-ancestor
92556411|NCT00041288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556412|NCT00041288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92556413|NCT00041288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92556414|NCT00041288|Antitubercular Agents|antitubercular agents|mesh-ancestor
92534555|NCT00390026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92534556|NCT00390026|Growth Substances|growth substances|mesh-ancestor
92534557|NCT00390026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556415|NCT00041288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92556416|NCT00073164|Valproic Acid|valproic acid|mesh-list
92556417|NCT00073164|Olanzapine|olanzapine|mesh-list
92556418|NCT00073164|Risperidone|risperidone|mesh-list
92556419|NCT00073164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92556420|NCT00073164|Serotonin Agents|serotonin agents|mesh-ancestor
92556421|NCT00073164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556422|NCT00073164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556423|NCT00073164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556424|NCT00073164|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92556425|NCT00073164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92556426|NCT00073164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556427|NCT00073164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556428|NCT00073164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92556429|NCT00073164|Dopamine Agents|dopamine agents|mesh-ancestor
92556430|NCT00073164|Antiemetics|antiemetics|mesh-ancestor
92556431|NCT00073164|Autonomic Agents|autonomic agents|mesh-ancestor
92556432|NCT00073164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556433|NCT00073164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92556434|NCT00073164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92556435|NCT00073164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556436|NCT00073164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556437|NCT00073164|Anticonvulsants|anticonvulsants|mesh-ancestor
92556438|NCT00073164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556439|NCT00073164|GABA Agents|gaba agents|mesh-ancestor
92556440|NCT00073164|Antimanic Agents|antimanic agents|mesh-ancestor
92556441|NCT00210301|Modafinil|modafinil|mesh-list
92556442|NCT00210301|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92556443|NCT00210301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556444|NCT00210301|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92556445|NCT00210301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92556446|NCT00210301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92556447|NCT00210301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556449|NCT00210340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92556450|NCT00210340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556451|NCT00210340|Immunologic Factors|immunologic factors|mesh-ancestor
92556452|NCT00210340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556453|NCT00210340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556454|NCT00411541|Dexamethasone|dexamethasone|mesh-list
92556455|NCT00411541|Vincristine|vincristine|mesh-list
92556456|NCT00411541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556457|NCT00411541|Antiemetics|antiemetics|mesh-ancestor
92556458|NCT00411541|Autonomic Agents|autonomic agents|mesh-ancestor
92556459|NCT00411541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556460|NCT00411541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556461|NCT00411541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92556462|NCT00411541|Glucocorticoids|glucocorticoids|mesh-ancestor
92556463|NCT00411541|Hormones|hormones|mesh-ancestor
92556464|NCT00411541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556465|NCT00411541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556466|NCT00411541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556467|NCT00411541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556468|NCT00411541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556469|NCT00411541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556470|NCT00411541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556471|NCT00411541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556472|NCT00210379|Rituximab|rituximab|mesh-list
92556473|NCT00210379|Methotrexate|methotrexate|mesh-list
92556474|NCT00210379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92556475|NCT00210379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556476|NCT00210379|Immunologic Factors|immunologic factors|mesh-ancestor
92556477|NCT00210379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556478|NCT00210379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556479|NCT00210379|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92556480|NCT00210379|Abortifacient Agents|abortifacient agents|mesh-ancestor
92556481|NCT00210379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92556482|NCT00210379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556483|NCT00210379|Antimetabolites|antimetabolites|mesh-ancestor
92534558|NCT00390026|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534559|NCT00390026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92534560|NCT00390026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92556484|NCT00210379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556485|NCT00210379|Dermatologic Agents|dermatologic agents|mesh-ancestor
92556486|NCT00210379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556487|NCT00210379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92556488|NCT00210379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556489|NCT00210379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92556490|NCT00041327|Interferons|interferons|mesh-list
92556491|NCT00041327|Interferon-alpha|interferon-alpha|mesh-list
92556492|NCT00041327|Lamivudine|lamivudine|mesh-list
92556493|NCT00041327|Zidovudine|zidovudine|mesh-list
92556494|NCT00041327|Prednisone|prednisone|mesh-list
92556495|NCT00041327|Cyclophosphamide|cyclophosphamide|mesh-list
92556496|NCT00041327|Doxorubicin|doxorubicin|mesh-list
92556497|NCT00041327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92556498|NCT00041327|Etoposide|etoposide|mesh-list
92556499|NCT00041327|Vincristine|vincristine|mesh-list
92556500|NCT00041327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556501|NCT00041327|Immunologic Factors|immunologic factors|mesh-ancestor
92556502|NCT00041327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556503|NCT00041327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556504|NCT00041327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92556505|NCT00041327|Alkylating Agents|alkylating agents|mesh-ancestor
92556506|NCT00041327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556507|NCT00041327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556508|NCT00041327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92556509|NCT00041327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92556510|NCT00041327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92556511|NCT00041327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556512|NCT00041327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556513|NCT00041327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556514|NCT00041327|Glucocorticoids|glucocorticoids|mesh-ancestor
92556515|NCT00041327|Hormones|hormones|mesh-ancestor
92556516|NCT00041327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556517|NCT00041327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556518|NCT00041327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92556519|NCT00041327|Antiviral Agents|antiviral agents|mesh-ancestor
92556520|NCT00041327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556521|NCT00041327|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556524|NCT00041327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92556525|NCT00041327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92556526|NCT00041327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92556527|NCT00041327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92556528|NCT00041327|Antimetabolites|antimetabolites|mesh-ancestor
92556529|NCT00210457|Lanreotide|lanreotide|mesh-list
92556530|NCT00210457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556531|NCT00210496|Topiramate|topiramate|mesh-list
92556532|NCT00210496|Almotriptan|almotriptan|mesh-list
92556533|NCT00210496|Anticonvulsants|anticonvulsants|mesh-ancestor
92556534|NCT00210496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556535|NCT00210496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556536|NCT00210496|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92556537|NCT00210496|Serotonin Agents|serotonin agents|mesh-ancestor
92556538|NCT00210496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556539|NCT00210496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556540|NCT00210535|Topiramate|topiramate|mesh-list
92556541|NCT00210535|Anticonvulsants|anticonvulsants|mesh-ancestor
92556542|NCT00210535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556543|NCT00210535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556544|NCT00210574|Topiramate|topiramate|mesh-list
92556545|NCT00210574|Anticonvulsants|anticonvulsants|mesh-ancestor
92556546|NCT00210574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556547|NCT00210574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556548|NCT00210691|Risperidone|risperidone|mesh-list
92556549|NCT00210691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92556550|NCT00210691|Serotonin Agents|serotonin agents|mesh-ancestor
92556551|NCT00210691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556552|NCT00210691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556553|NCT00210691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556554|NCT00210691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92556555|NCT00210691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92556556|NCT00210691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534561|NCT00070057|Celecoxib|celecoxib|mesh-list
92534562|NCT00070057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92556557|NCT00210691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556558|NCT00210691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92556559|NCT00210691|Dopamine Agents|dopamine agents|mesh-ancestor
92556560|NCT00210730|Epoetin Alfa|epoetin alfa|mesh-list
92556561|NCT00210730|Hematinics|hematinics|mesh-ancestor
92556562|NCT00210769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92556563|NCT00210769|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92556564|NCT00210769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92556565|NCT00210769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556566|NCT00210769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556567|NCT00210769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556568|NCT00210769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92556569|NCT00210769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92556570|NCT00210769|Serotonin Agents|serotonin agents|mesh-ancestor
92556571|NCT00210769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556572|NCT00210769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556573|NCT00210769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92556574|NCT00210769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92556575|NCT00210769|Dopamine Agents|dopamine agents|mesh-ancestor
92556576|NCT00210808|Topiramate|topiramate|mesh-list
92556577|NCT00210808|Anticonvulsants|anticonvulsants|mesh-ancestor
92556578|NCT00210808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556579|NCT00210808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556580|NCT00210847|Acetaminophen|acetaminophen|mesh-list
92556581|NCT00210847|Tramadol|tramadol|mesh-list
92556582|NCT00210847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92556583|NCT00210847|Analgesics|analgesics|mesh-ancestor
92556584|NCT00210847|Sensory System Agents|sensory system agents|mesh-ancestor
92556585|NCT00210847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556586|NCT00210847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556587|NCT00210847|Antipyretics|antipyretics|mesh-ancestor
92556588|NCT00210847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92556589|NCT00210847|Narcotics|narcotics|mesh-ancestor
92556590|NCT00210847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556591|NCT00210886|Levofloxacin|levofloxacin|mesh-list
92556592|NCT00210886|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92556593|NCT00210886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556594|NCT00210886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92556595|NCT00210886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92556596|NCT00210886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556597|NCT00210886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556600|NCT00210886|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92556601|NCT00210886|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92556602|NCT00210925|Topiramate|topiramate|mesh-list
92556603|NCT00210925|Anticonvulsants|anticonvulsants|mesh-ancestor
92556604|NCT00210925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556605|NCT00210925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556606|NCT00211003|Doripenem|doripenem|mesh-list
92556607|NCT00211003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92556608|NCT00211003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556609|NCT00211120|Epoetin Alfa|epoetin alfa|mesh-list
92556610|NCT00211120|Hematinics|hematinics|mesh-ancestor
92556611|NCT00211198|Denileukin diftitox|denileukin diftitox|mesh-list
92556612|NCT00211198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556613|NCT00211276|Denileukin diftitox|denileukin diftitox|mesh-list
92556614|NCT00211276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556615|NCT00211315|Anecortave|anecortave|mesh-list
92556616|NCT00211315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556617|NCT00211315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92556618|NCT00211315|Growth Substances|growth substances|mesh-ancestor
92556619|NCT00211315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556620|NCT00211315|Growth Inhibitors|growth inhibitors|mesh-ancestor
92556621|NCT00211315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556622|NCT00211354|Anecortave|anecortave|mesh-list
92556623|NCT00211354|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556624|NCT00211354|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92556625|NCT00211354|Growth Substances|growth substances|mesh-ancestor
92556626|NCT00211354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556627|NCT00211354|Growth Inhibitors|growth inhibitors|mesh-ancestor
92556628|NCT00211354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556629|NCT00211393|Ketoconazole|ketoconazole|mesh-list
92556630|NCT00211393|Antifungal Agents|antifungal agents|mesh-ancestor
92556631|NCT00211393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556632|NCT00211393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92534563|NCT00070057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92534564|NCT00070057|Analgesics|analgesics|mesh-ancestor
92556633|NCT00211393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92556634|NCT00211393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556635|NCT00211393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556636|NCT00211393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92556637|NCT00211393|Hormone Antagonists|hormone antagonists|mesh-ancestor
92556638|NCT00211393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556639|NCT00211393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556640|NCT00211393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92556641|NCT00211432|Anecortave|anecortave|mesh-list
92556642|NCT00211432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556643|NCT00211432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92281336|NCT00002331|Clarithromycin|clarithromycin|mesh-list
92556644|NCT00211432|Growth Substances|growth substances|mesh-ancestor
92556645|NCT00211432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556646|NCT00211432|Growth Inhibitors|growth inhibitors|mesh-ancestor
92556647|NCT00211432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556648|NCT00211471|Anecortave|anecortave|mesh-list
92556649|NCT00211471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92556650|NCT00211471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92556651|NCT00211471|Growth Substances|growth substances|mesh-ancestor
92556652|NCT00211471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556653|NCT00211471|Growth Inhibitors|growth inhibitors|mesh-ancestor
92556654|NCT00211471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556655|NCT00211588|Galantamine|galantamine|mesh-list
92556656|NCT00211588|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92556657|NCT00211588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556658|NCT00211588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556659|NCT00211588|Cholinergic Agents|cholinergic agents|mesh-ancestor
92556660|NCT00211588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556661|NCT00211588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556662|NCT00211588|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92556663|NCT00211588|Autonomic Agents|autonomic agents|mesh-ancestor
92556664|NCT00211588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556665|NCT00211588|Nootropic Agents|nootropic agents|mesh-ancestor
92556666|NCT00211705|Pravastatin|pravastatin|mesh-list
92556667|NCT00211705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92556668|NCT00211705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92556669|NCT00211705|Antimetabolites|antimetabolites|mesh-ancestor
92556672|NCT00211705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92556674|NCT00211744|Topiramate|topiramate|mesh-list
92556675|NCT00211744|Anticonvulsants|anticonvulsants|mesh-ancestor
92556676|NCT00211744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556677|NCT00211744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556678|NCT00211939|Atorvastatin|atorvastatin|mesh-list
92556679|NCT00211939|Calcium|calcium|mesh-list
92556680|NCT00211939|Sevelamer|sevelamer|mesh-list
92556681|NCT00211939|Calcium acetate|calcium acetate|mesh-list
92556682|NCT00211939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92556683|NCT00211939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556684|NCT00211939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92556685|NCT00211939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92556686|NCT00211939|Antimetabolites|antimetabolites|mesh-ancestor
92556687|NCT00211939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556688|NCT00211939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92556689|NCT00211939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92556690|NCT00211939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556691|NCT00211939|Chelating Agents|chelating agents|mesh-ancestor
92556692|NCT00211939|Sequestering Agents|sequestering agents|mesh-ancestor
92556693|NCT00211978|Calcium|calcium|mesh-list
92556694|NCT00211978|Calcium acetate|calcium acetate|mesh-list
92556695|NCT00211978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92556696|NCT00211978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556697|NCT00211978|Chelating Agents|chelating agents|mesh-ancestor
92556698|NCT00211978|Sequestering Agents|sequestering agents|mesh-ancestor
92556699|NCT00211978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556700|NCT00212017|Voglibose|voglibose|mesh-list
92556701|NCT00212017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556702|NCT00212017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556703|NCT00212017|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92556704|NCT00212017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556705|NCT00212017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556706|NCT00212095|Ketoconazole|ketoconazole|mesh-list
92556707|NCT00212095|Docetaxel|docetaxel|mesh-list
92556708|NCT00212095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556709|NCT00212095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556710|NCT00212095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556711|NCT00212095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556712|NCT00212095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556713|NCT00212095|Antifungal Agents|antifungal agents|mesh-ancestor
92556714|NCT00212095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556715|NCT00212095|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92556716|NCT00212095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92556717|NCT00212095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281406|NCT05168735|Anesthetics|anesthetics|mesh-ancestor
92556718|NCT00212095|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92556719|NCT00212095|Hormone Antagonists|hormone antagonists|mesh-ancestor
92556720|NCT00212095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556721|NCT00212095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556722|NCT00212095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92556723|NCT00212173|Sibutramine|sibutramine|mesh-list
92556724|NCT00212173|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556725|NCT00212173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556726|NCT00212173|Appetite Depressants|appetite depressants|mesh-ancestor
92556727|NCT00212173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92556728|NCT00212212|Selenium|selenium|mesh-list
92556729|NCT00212212|Antioxidants|antioxidants|mesh-ancestor
92556730|NCT00212212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556731|NCT00212212|Protective Agents|protective agents|mesh-ancestor
92556732|NCT00212212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556733|NCT00212212|Trace Elements|trace elements|mesh-ancestor
92556734|NCT00212212|Micronutrients|micronutrients|mesh-ancestor
92556735|NCT00212290|Pioglitazone|pioglitazone|mesh-list
92556736|NCT00212290|Nateglinide|nateglinide|mesh-list
92556737|NCT00212290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556738|NCT00212290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556739|NCT00073203|Paroxetine|paroxetine|mesh-list
91964172|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
92556743|NCT00073203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556744|NCT00073203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556745|NCT00073203|Serotonin Agents|serotonin agents|mesh-ancestor
92556746|NCT00073203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556747|NCT00073203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92556748|NCT00073203|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556749|NCT00073203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556750|NCT00073203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92556751|NCT00073203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92556752|NCT00073203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556754|NCT00411736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92556755|NCT00411736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556756|NCT00212602|Aprepitant|aprepitant|mesh-list
92556757|NCT00212602|Fosaprepitant|fosaprepitant|mesh-list
92556758|NCT00212602|Antiemetics|antiemetics|mesh-ancestor
92556759|NCT00212602|Autonomic Agents|autonomic agents|mesh-ancestor
92556760|NCT00212602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556761|NCT00212602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556762|NCT00212602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92556763|NCT00212602|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92556764|NCT00212602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556765|NCT00212602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556766|NCT00212680|Landiolol|landiolol|mesh-list
92556767|NCT00212680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92556768|NCT00212680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92556769|NCT00212680|Adrenergic Agents|adrenergic agents|mesh-ancestor
92556770|NCT00212680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556771|NCT00212680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556772|NCT00212680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556773|NCT00212680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92556774|NCT00212875|Epoetin Alfa|epoetin alfa|mesh-list
92556775|NCT00212875|Hematinics|hematinics|mesh-ancestor
92556776|NCT00213070|Miglitol|miglitol|mesh-list
92556777|NCT00213070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556778|NCT00213070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556779|NCT00213070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92534565|NCT00070057|Sensory System Agents|sensory system agents|mesh-ancestor
92556780|NCT00213070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556781|NCT00213070|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92556783|NCT00213109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556784|NCT00213109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556785|NCT00213109|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92556786|NCT00213109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556787|NCT00213109|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92556788|NCT00213226|Dexamethasone|dexamethasone|mesh-list
92556789|NCT00213226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556790|NCT00213226|Antiemetics|antiemetics|mesh-ancestor
92281481|NCT00002373|Maribavir|maribavir|mesh-list
92556791|NCT00213226|Autonomic Agents|autonomic agents|mesh-ancestor
92556792|NCT00213226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556793|NCT00213226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556794|NCT00213226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92556795|NCT00213226|Glucocorticoids|glucocorticoids|mesh-ancestor
92556796|NCT00213226|Hormones|hormones|mesh-ancestor
92556797|NCT00213226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556798|NCT00213226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92556799|NCT00213226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556800|NCT00213265|Vaccines|vaccines|mesh-list
92556801|NCT00213265|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92556802|NCT00213265|Immunologic Factors|immunologic factors|mesh-ancestor
92556803|NCT00213265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556804|NCT00213538|Methotrexate|methotrexate|mesh-list
92556805|NCT00213538|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92556806|NCT00213538|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92556807|NCT00213538|Abortifacient Agents|abortifacient agents|mesh-ancestor
92556810|NCT00213538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556811|NCT00213538|Antimetabolites|antimetabolites|mesh-ancestor
92556812|NCT00213538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556813|NCT00213538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556814|NCT00213538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92556815|NCT00213538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556816|NCT00213538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92556817|NCT00213538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92556818|NCT00213538|Immunologic Factors|immunologic factors|mesh-ancestor
92556819|NCT00213538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556820|NCT00213538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92556821|NCT00213577|Botulinum Toxins|botulinum toxins|mesh-list
92556822|NCT00213577|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92556823|NCT00213577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556824|NCT00213577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556825|NCT00213577|Cholinergic Agents|cholinergic agents|mesh-ancestor
92556826|NCT00213577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556827|NCT00213577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556828|NCT00213694|Celecoxib|celecoxib|mesh-list
92556829|NCT00213694|Docetaxel|docetaxel|mesh-list
92556830|NCT00213694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556831|NCT00213694|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556832|NCT00213694|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556833|NCT00213694|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556834|NCT00213694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556835|NCT00213694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92556836|NCT00213694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92556837|NCT00213694|Analgesics|analgesics|mesh-ancestor
92556838|NCT00213694|Sensory System Agents|sensory system agents|mesh-ancestor
92556839|NCT00213694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556840|NCT00213694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556841|NCT00213694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556842|NCT00213694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556843|NCT00213694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92556844|NCT00213694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92556845|NCT00213694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556846|NCT00214084|Allopurinol|allopurinol|mesh-list
92556847|NCT00214084|Antimetabolites|antimetabolites|mesh-ancestor
92556848|NCT00214084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556849|NCT00214084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556850|NCT00214084|Gout Suppressants|gout suppressants|mesh-ancestor
92534566|NCT00070057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534567|NCT00070057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534568|NCT00070057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92534569|NCT00070057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534570|NCT00070057|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92556851|NCT00214084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556852|NCT00214084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92556853|NCT00214084|Antioxidants|antioxidants|mesh-ancestor
92556854|NCT00214084|Protective Agents|protective agents|mesh-ancestor
92556855|NCT00214084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556856|NCT00214240|Immunoglobulins|immunoglobulins|mesh-list
92556857|NCT00214240|Antibodies|antibodies|mesh-list
92556858|NCT00214240|gamma-Globulins|gamma-globulins|mesh-list
92556859|NCT00214240|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92556860|NCT00214240|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92556861|NCT00214240|Immunologic Factors|immunologic factors|mesh-ancestor
92556862|NCT00214240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556863|NCT00214318|Metoprolol|metoprolol|mesh-list
92556864|NCT00214318|Carvedilol|carvedilol|mesh-list
92556865|NCT00214318|Terbutaline|terbutaline|mesh-list
92556867|NCT00214318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92556868|NCT00214318|Sympatholytics|sympatholytics|mesh-ancestor
92556869|NCT00214318|Autonomic Agents|autonomic agents|mesh-ancestor
92556870|NCT00214318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556871|NCT00214318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556872|NCT00214318|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92556873|NCT00214318|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92556874|NCT00214318|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92556875|NCT00214318|Adrenergic Agents|adrenergic agents|mesh-ancestor
92556876|NCT00214318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556877|NCT00214318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556878|NCT00214318|Antioxidants|antioxidants|mesh-ancestor
92556879|NCT00214318|Protective Agents|protective agents|mesh-ancestor
92556880|NCT00214318|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92556881|NCT00214318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556887|NCT00214318|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92556888|NCT00214318|Respiratory System Agents|respiratory system agents|mesh-ancestor
92556889|NCT00214318|Sympathomimetics|sympathomimetics|mesh-ancestor
92556890|NCT00214318|Tocolytic Agents|tocolytic agents|mesh-ancestor
92556891|NCT00214318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92556892|NCT00214318|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92556893|NCT00214318|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92556894|NCT00214318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92556895|NCT00214435|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92556896|NCT00214435|Antiviral Agents|antiviral agents|mesh-ancestor
92556897|NCT00214435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556898|NCT00214552|Rabeprazole|rabeprazole|mesh-list
92556899|NCT00214552|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92556900|NCT00214552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92556901|NCT00214552|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92556902|NCT00214552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556903|NCT00214552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556905|NCT00069459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92556906|NCT00069459|Antidepressive Agents|antidepressive agents|mesh-ancestor
92556907|NCT00069459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556908|NCT00069459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92556909|NCT00069459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556910|NCT00069459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556911|NCT00069459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556912|NCT00069459|Dopamine Agents|dopamine agents|mesh-ancestor
92556913|NCT00069459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556914|NCT00069459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556915|NCT00069459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92556916|NCT00069459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92556917|NCT00069459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556918|NCT00214630|Atorvastatin|atorvastatin|mesh-list
92556919|NCT00214630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92556920|NCT00214630|Calcium|calcium|mesh-list
92556922|NCT00214630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556923|NCT00214630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92556924|NCT00214630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92556925|NCT00214630|Antimetabolites|antimetabolites|mesh-ancestor
92556926|NCT00214630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556927|NCT00214630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92556928|NCT00214630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92556929|NCT00214630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556930|NCT00214825|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92556931|NCT00214825|Eplerenone|eplerenone|mesh-list
92556932|NCT00214825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92556933|NCT00214825|Diuretics|diuretics|mesh-ancestor
92556934|NCT00214825|Natriuretic Agents|natriuretic agents|mesh-ancestor
92556935|NCT00214825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556936|NCT00214825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92556937|NCT00214825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556938|NCT00214825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556939|NCT00214825|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92556941|NCT00214825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556942|NCT00214825|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92556943|NCT00214864|Docetaxel|docetaxel|mesh-list
92556944|NCT00214864|Capecitabine|capecitabine|mesh-list
92556945|NCT00214864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556946|NCT00214864|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556947|NCT00214864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556948|NCT00214864|Mitosis Modulators|mitosis modulators|mesh-ancestor
91964406|NCT04527055|Bismuth|bismuth|mesh-list
92556949|NCT00214864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556950|NCT00214864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92556951|NCT00214864|Antimetabolites|antimetabolites|mesh-ancestor
92556953|NCT00214942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92556954|NCT00214942|Narcotics|narcotics|mesh-ancestor
92556955|NCT00214942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92556956|NCT00214942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556957|NCT00214942|Analgesics|analgesics|mesh-ancestor
92556958|NCT00214942|Sensory System Agents|sensory system agents|mesh-ancestor
92556959|NCT00214942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556960|NCT00214942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92556961|NCT00214942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92556962|NCT00214942|Anesthetics, General|anesthetics, general|mesh-ancestor
92556963|NCT00214942|Anesthetics|anesthetics|mesh-ancestor
92556964|NCT00069498|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92556965|NCT00069498|Mesalamine|mesalamine|mesh-list
92556966|NCT00069498|Antitubercular Agents|antitubercular agents|mesh-ancestor
92556967|NCT00069498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92556968|NCT00069498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556969|NCT00069498|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92556970|NCT00069498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92556971|NCT00069498|Analgesics|analgesics|mesh-ancestor
92556972|NCT00069498|Sensory System Agents|sensory system agents|mesh-ancestor
92556973|NCT00069498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92556974|NCT00069498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556975|NCT00069498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92556976|NCT00069498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92556977|NCT00214981|Modafinil|modafinil|mesh-list
92556978|NCT00214981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92556979|NCT00214981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556980|NCT00214981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92556981|NCT00214981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92556982|NCT00214981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92556983|NCT00214981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556984|NCT00397241|Timolol|timolol|mesh-list
92556985|NCT00397241|Dorzolamide|dorzolamide|mesh-list
92556986|NCT00397241|Latanoprost|latanoprost|mesh-list
92556987|NCT00397241|Lubricant Eye Drops|lubricant eye drops|mesh-list
92556988|NCT00397241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92556989|NCT00397241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92556990|NCT00397241|Adrenergic Agents|adrenergic agents|mesh-ancestor
92556991|NCT00397241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92556992|NCT00397241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556993|NCT00397241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534571|NCT00070057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92556994|NCT00397241|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92556995|NCT00397241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92556996|NCT00397241|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92556997|NCT00397241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92556998|NCT00397241|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92556999|NCT00397241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557000|NCT00073320|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92557001|NCT00073320|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92557002|NCT00073320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557003|NCT00073320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557004|NCT00073320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557005|NCT00073320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557006|NCT00073320|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92557007|NCT00073320|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92557008|NCT00073320|Serotonin Agents|serotonin agents|mesh-ancestor
92557009|NCT00073320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557010|NCT00073320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557011|NCT00073320|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92557012|NCT00073320|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92557013|NCT00073320|Dopamine Agents|dopamine agents|mesh-ancestor
92557014|NCT00215176|Modafinil|modafinil|mesh-list
92557015|NCT00215176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92557016|NCT00215176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557017|NCT00215176|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92557018|NCT00215176|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92557019|NCT00215176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92557020|NCT00215176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557021|NCT00215254|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92557026|NCT00215254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557027|NCT00215254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557028|NCT00041483|Anecortave|anecortave|mesh-list
92557029|NCT00041483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92557030|NCT00041483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92557031|NCT00041483|Growth Substances|growth substances|mesh-ancestor
92557032|NCT00041483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557033|NCT00041483|Growth Inhibitors|growth inhibitors|mesh-ancestor
92557034|NCT00041483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557035|NCT00215371|Formoterol Fumarate|formoterol fumarate|mesh-list
92557036|NCT00215371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92557037|NCT00215371|Autonomic Agents|autonomic agents|mesh-ancestor
92557038|NCT00215371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557039|NCT00215371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557040|NCT00215371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92557041|NCT00215371|Respiratory System Agents|respiratory system agents|mesh-ancestor
92557042|NCT00215371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92557043|NCT00215371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92557044|NCT00215371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92557045|NCT00215371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557046|NCT00215371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557047|NCT00215371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557048|NCT00215410|Formoterol Fumarate|formoterol fumarate|mesh-list
92557049|NCT00215410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92557050|NCT00215410|Autonomic Agents|autonomic agents|mesh-ancestor
92557051|NCT00215410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557052|NCT00215410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557053|NCT00215410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92557054|NCT00215410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92557055|NCT00215410|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92557056|NCT00215410|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92557057|NCT00215410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92557058|NCT00215410|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557059|NCT00215410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557060|NCT00215410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557061|NCT00215449|Formoterol Fumarate|formoterol fumarate|mesh-list
92557062|NCT00215449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92557063|NCT00215449|Autonomic Agents|autonomic agents|mesh-ancestor
92557064|NCT00215449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557065|NCT00215449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557066|NCT00215449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92557067|NCT00215449|Respiratory System Agents|respiratory system agents|mesh-ancestor
92534572|NCT00070057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534573|NCT00070057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534574|NCT00070174|Cytarabine|cytarabine|mesh-list
92534575|NCT00070174|Cyclosporine|cyclosporine|mesh-list
92534576|NCT00070174|Cyclophosphamide|cyclophosphamide|mesh-list
92557068|NCT00215449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92557069|NCT00215449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92557070|NCT00215449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92557071|NCT00215449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557072|NCT00215449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557073|NCT00215449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557074|NCT00215722|Cetuximab|cetuximab|mesh-list
92557075|NCT00215722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92557076|NCT00215722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557077|NCT00215800|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92557078|NCT00215800|Antiviral Agents|antiviral agents|mesh-ancestor
92557079|NCT00215800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557080|NCT00215839|Ribavirin|ribavirin|mesh-list
92557081|NCT00215839|Antimetabolites|antimetabolites|mesh-ancestor
92557082|NCT00215839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557083|NCT00215839|Antiviral Agents|antiviral agents|mesh-ancestor
92557084|NCT00215839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557085|NCT00215956|Topotecan|topotecan|mesh-list
92557086|NCT00215956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92557087|NCT00215956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557088|NCT00215956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557089|NCT00215956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355084|NCT01928628|Valsartan|valsartan|mesh-list
92557090|NCT00215956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557091|NCT00215995|Cisplatin|cisplatin|mesh-list
92557093|NCT00215995|Gefitinib|gefitinib|mesh-list
92557094|NCT00215995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557095|NCT00215995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92557096|NCT00215995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557097|NCT00215995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557098|NCT00215995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557099|NCT00215995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92557100|NCT00216034|polysaccharide-K|polysaccharide-k|mesh-list
92557101|NCT00216034|Tegafur|tegafur|mesh-list
92557102|NCT00216034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557103|NCT00216034|Antimetabolites|antimetabolites|mesh-ancestor
92557104|NCT00216034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557105|NCT00216034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557106|NCT00216034|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92557107|NCT00216034|Immunologic Factors|immunologic factors|mesh-ancestor
92557108|NCT00216034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557109|NCT00216034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92557110|NCT00216034|Antiviral Agents|antiviral agents|mesh-ancestor
92557111|NCT00216034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557112|NCT00216034|Interferon Inducers|interferon inducers|mesh-ancestor
92557113|NCT00216034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92557114|NCT00216034|Protective Agents|protective agents|mesh-ancestor
92557115|NCT00216073|Capecitabine|capecitabine|mesh-list
92557116|NCT00216073|Oxaliplatin|oxaliplatin|mesh-list
92557117|NCT00216073|Trastuzumab|trastuzumab|mesh-list
92557118|NCT00216073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557119|NCT00216073|Antimetabolites|antimetabolites|mesh-ancestor
92557120|NCT00216073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557121|NCT00216073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557122|NCT00216073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92557123|NCT00216112|Docetaxel|docetaxel|mesh-list
92557124|NCT00216112|Imatinib Mesylate|imatinib mesylate|mesh-list
92557125|NCT00216112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557126|NCT00216112|Tubulin Modulators|tubulin modulators|mesh-ancestor
92557127|NCT00216112|Antimitotic Agents|antimitotic agents|mesh-ancestor
92557128|NCT00216112|Mitosis Modulators|mitosis modulators|mesh-ancestor
92557129|NCT00216112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557130|NCT00216112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92557131|NCT00216112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557132|NCT00216151|Zoledronic Acid|zoledronic acid|mesh-list
92557133|NCT00216151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92557134|NCT00216151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534577|NCT00070174|Busulfan|busulfan|mesh-list
92534578|NCT00070174|Methotrexate|methotrexate|mesh-list
92557135|NCT00216190|Midazolam|midazolam|mesh-list
92557136|NCT00216190|Dexmedetomidine|dexmedetomidine|mesh-list
92557137|NCT00216190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92557138|NCT00216190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557139|NCT00216190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557140|NCT00216190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92557141|NCT00216190|Analgesics|analgesics|mesh-ancestor
92557142|NCT00216190|Sensory System Agents|sensory system agents|mesh-ancestor
92557143|NCT00216190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557144|NCT00216190|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92557145|NCT00216190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92557146|NCT00216190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92557147|NCT00216190|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557148|NCT00216190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557149|NCT00216190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557150|NCT00216190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92557151|NCT00216190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92557152|NCT00216190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557153|NCT00216190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557154|NCT00216190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92557155|NCT00216190|Anesthetics, General|anesthetics, general|mesh-ancestor
92557156|NCT00216190|Anesthetics|anesthetics|mesh-ancestor
92557157|NCT00216190|GABA Modulators|gaba modulators|mesh-ancestor
92557158|NCT00216190|GABA Agents|gaba agents|mesh-ancestor
92281862|NCT00002253|Octreotide|octreotide|mesh-list
92557159|NCT00216268|Ribavirin|ribavirin|mesh-list
92557160|NCT00216268|Antimetabolites|antimetabolites|mesh-ancestor
92557161|NCT00216268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557162|NCT00216268|Antiviral Agents|antiviral agents|mesh-ancestor
92557163|NCT00216268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557164|NCT00216346|Amphotericin B|amphotericin b|mesh-list
92557165|NCT00216346|Paromomycin|paromomycin|mesh-list
92557166|NCT00216346|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92557169|NCT00216346|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92557170|NCT00216346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557171|NCT00216346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92557172|NCT00216346|Antifungal Agents|antifungal agents|mesh-ancestor
92557173|NCT00216385|Gatifloxacin|gatifloxacin|mesh-list
92557174|NCT00216385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92557175|NCT00216385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557176|NCT00216385|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92557177|NCT00216385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92557178|NCT00216385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92557179|NCT00216385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557180|NCT00216385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557181|NCT00216385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557182|NCT00216385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557183|NCT00216424|Capecitabine|capecitabine|mesh-list
92557184|NCT00216424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557185|NCT00216424|Antimetabolites|antimetabolites|mesh-ancestor
92557186|NCT00216424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557187|NCT00216424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557188|NCT00216463|Mipomersen|mipomersen|mesh-list
92557189|NCT00216463|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92557190|NCT00216463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92557191|NCT00216463|Antimetabolites|antimetabolites|mesh-ancestor
92557192|NCT00216463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557193|NCT00216463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92557194|NCT00216502|Galantamine|galantamine|mesh-list
92557195|NCT00216502|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92557196|NCT00216502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557197|NCT00216502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557198|NCT00216502|Cholinergic Agents|cholinergic agents|mesh-ancestor
92557199|NCT00216502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557200|NCT00216502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557201|NCT00216502|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92557202|NCT00216502|Autonomic Agents|autonomic agents|mesh-ancestor
92557203|NCT00216502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557204|NCT00216502|Nootropic Agents|nootropic agents|mesh-ancestor
92557205|NCT00216541|Epoetin Alfa|epoetin alfa|mesh-list
92557206|NCT00216541|Hematinics|hematinics|mesh-ancestor
92557207|NCT00216580|Risperidone|risperidone|mesh-list
92557208|NCT00216580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92557209|NCT00216580|Serotonin Agents|serotonin agents|mesh-ancestor
92534579|NCT00070174|Etoposide|etoposide|mesh-list
92534580|NCT00070174|Daunorubicin|daunorubicin|mesh-list
92534581|NCT00070174|Asparaginase|asparaginase|mesh-list
92534582|NCT00070174|Mitoxantrone|mitoxantrone|mesh-list
92534583|NCT00070174|Gemtuzumab|gemtuzumab|mesh-list
92534584|NCT00070174|Cyclosporins|cyclosporins|mesh-list
92557210|NCT00216580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557211|NCT00216580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557212|NCT00216580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557213|NCT00216580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92557214|NCT00216580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557215|NCT00216580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557216|NCT00216580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557217|NCT00216580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92557218|NCT00216580|Dopamine Agents|dopamine agents|mesh-ancestor
92557219|NCT00041561|Nitric Oxide|nitric oxide|mesh-list
92557220|NCT00041561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92557221|NCT00041561|Autonomic Agents|autonomic agents|mesh-ancestor
92557222|NCT00041561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557223|NCT00041561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557224|NCT00041561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92557225|NCT00041561|Respiratory System Agents|respiratory system agents|mesh-ancestor
92557226|NCT00041561|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92557227|NCT00041561|Antioxidants|antioxidants|mesh-ancestor
92557228|NCT00041561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557229|NCT00041561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355088|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92557230|NCT00041561|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92557231|NCT00041561|Vasodilator Agents|vasodilator agents|mesh-ancestor
92557232|NCT00041561|Gasotransmitters|gasotransmitters|mesh-ancestor
92557233|NCT00041561|Protective Agents|protective agents|mesh-ancestor
92557234|NCT00216619|Topiramate|topiramate|mesh-list
92557235|NCT00216619|Anticonvulsants|anticonvulsants|mesh-ancestor
92557236|NCT00216619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92557237|NCT00216619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557238|NCT00216658|Fentanyl|fentanyl|mesh-list
92557239|NCT00216658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92557240|NCT00216658|Narcotics|narcotics|mesh-ancestor
91964685|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92557242|NCT00216658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557243|NCT00216658|Analgesics|analgesics|mesh-ancestor
92557244|NCT00216658|Sensory System Agents|sensory system agents|mesh-ancestor
92557245|NCT00216658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557246|NCT00216658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92557247|NCT00216658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92557248|NCT00216658|Anesthetics, General|anesthetics, general|mesh-ancestor
92557249|NCT00216658|Anesthetics|anesthetics|mesh-ancestor
92557251|NCT00216697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557252|NCT00216775|Interferons|interferons|mesh-list
92557253|NCT00216775|Ribavirin|ribavirin|mesh-list
92557254|NCT00216775|Interferon-alpha|interferon-alpha|mesh-list
92557255|NCT00216775|Interferon alpha-2|interferon alpha-2|mesh-list
92557256|NCT00216775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557257|NCT00216775|Antiviral Agents|antiviral agents|mesh-ancestor
92557258|NCT00216775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557259|NCT00216775|Antimetabolites|antimetabolites|mesh-ancestor
92557260|NCT00216775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557261|NCT00216775|Immunologic Factors|immunologic factors|mesh-ancestor
92557262|NCT00216775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557263|NCT00041639|Labetuzumab|labetuzumab|mesh-list
92557264|NCT00041639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92557265|NCT00041639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557266|NCT00216892|Betamethasone|betamethasone|mesh-list
92557267|NCT00216892|Calcipotriene|calcipotriene|mesh-list
92557268|NCT00216892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557269|NCT00216892|Glucocorticoids|glucocorticoids|mesh-ancestor
92557270|NCT00216892|Hormones|hormones|mesh-ancestor
92557271|NCT00216892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557272|NCT00216892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557273|NCT00216892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92557274|NCT00216892|Respiratory System Agents|respiratory system agents|mesh-ancestor
92557275|NCT00216892|Dermatologic Agents|dermatologic agents|mesh-ancestor
92557276|NCT00216931|Iloprost|iloprost|mesh-list
92557277|NCT00216931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92557278|NCT00216931|Vasodilator Agents|vasodilator agents|mesh-ancestor
92534585|NCT00070174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92557279|NCT00217009|Furocoumarins|furocoumarins|mesh-list
92557280|NCT00217009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92557281|NCT00217009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92557282|NCT00217048|Yohimbine|yohimbine|mesh-list
92557283|NCT00217048|Mydriatics|mydriatics|mesh-ancestor
92557284|NCT00217048|Autonomic Agents|autonomic agents|mesh-ancestor
92557285|NCT00217048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557286|NCT00217048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557287|NCT00217048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92557288|NCT00217048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92557289|NCT00217048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92557290|NCT00217048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557291|NCT00217048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557292|NCT00217048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557293|NCT00217048|Urological Agents|urological agents|mesh-ancestor
92557294|NCT00217204|Pancrelipase|pancrelipase|mesh-list
92557295|NCT00217204|Pancreatin|pancreatin|mesh-list
92557296|NCT00217204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92557297|NCT00412126|Insulin|insulin|mesh-list
92557298|NCT00412126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92557299|NCT00412126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557300|NCT00412204|Bromides|bromides|mesh-list
92557301|NCT00412204|Tiotropium Bromide|tiotropium bromide|mesh-list
92557302|NCT00412204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92557303|NCT00412204|Autonomic Agents|autonomic agents|mesh-ancestor
92557304|NCT00412204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557305|NCT00412204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557306|NCT00412204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92557307|NCT00412204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92557308|NCT00412204|Parasympatholytics|parasympatholytics|mesh-ancestor
92557309|NCT00412204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92557310|NCT00412204|Cholinergic Agents|cholinergic agents|mesh-ancestor
92557311|NCT00412204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557312|NCT00412204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557313|NCT00412204|Anticonvulsants|anticonvulsants|mesh-ancestor
92557314|NCT00041678|Aripiprazole|aripiprazole|mesh-list
92557315|NCT00041678|Antidepressive Agents|antidepressive agents|mesh-ancestor
92557316|NCT00041678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557328|NCT00041678|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92557329|NCT00041678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92557330|NCT00041678|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92557331|NCT00041678|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92557333|NCT00217243|Anesthetics, Local|anesthetics, local|mesh-ancestor
92557334|NCT00217243|Anesthetics|anesthetics|mesh-ancestor
92557335|NCT00217243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557336|NCT00217243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557337|NCT00217243|Sensory System Agents|sensory system agents|mesh-ancestor
92557338|NCT00217243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557339|NCT00217243|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92557340|NCT00217243|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92557341|NCT00217243|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92557342|NCT00217243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557343|NCT00217243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557344|NCT00217282|Bevacizumab|bevacizumab|mesh-list
92557345|NCT00217282|Gemcitabine|gemcitabine|mesh-list
92557346|NCT00217282|Oxaliplatin|oxaliplatin|mesh-list
92557347|NCT00217282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92557348|NCT00217282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557349|NCT00217282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92557350|NCT00217282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92557351|NCT00217282|Growth Substances|growth substances|mesh-ancestor
92557352|NCT00217282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557353|NCT00217282|Growth Inhibitors|growth inhibitors|mesh-ancestor
92557354|NCT00217282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557355|NCT00217282|Antimetabolites|antimetabolites|mesh-ancestor
92557356|NCT00217282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557357|NCT00217477|Gemcitabine|gemcitabine|mesh-list
92557358|NCT00217477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557359|NCT00217477|Antimetabolites|antimetabolites|mesh-ancestor
92557360|NCT00217477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557361|NCT00217477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557362|NCT00217516|Selenium|selenium|mesh-list
92557363|NCT00217516|Antioxidants|antioxidants|mesh-ancestor
92534586|NCT00070174|Immunologic Factors|immunologic factors|mesh-ancestor
92534587|NCT00070174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534588|NCT00070174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92557364|NCT00217516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557365|NCT00217516|Protective Agents|protective agents|mesh-ancestor
92557366|NCT00217516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557367|NCT00217516|Trace Elements|trace elements|mesh-ancestor
92557368|NCT00217516|Micronutrients|micronutrients|mesh-ancestor
92557369|NCT00217555|Gemcitabine|gemcitabine|mesh-list
92557370|NCT00217555|Topotecan|topotecan|mesh-list
92557371|NCT00217555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557372|NCT00217555|Antimetabolites|antimetabolites|mesh-ancestor
92557373|NCT00217555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557374|NCT00217555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557375|NCT00217555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92557376|NCT00217555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557377|NCT00217555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557391|NCT00217789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557392|NCT00217828|Citalopram|citalopram|mesh-list
92557393|NCT00217828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92557394|NCT00217828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92557395|NCT00217828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557396|NCT00217828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557397|NCT00217828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557398|NCT00217828|Serotonin Agents|serotonin agents|mesh-ancestor
92557399|NCT00217828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557400|NCT00217828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92557401|NCT00217828|Antidepressive Agents|antidepressive agents|mesh-ancestor
92557402|NCT00217828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557403|NCT00041990|Decitabine|decitabine|mesh-list
92557404|NCT00041990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557405|NCT00041990|Antimetabolites|antimetabolites|mesh-ancestor
92557406|NCT00041990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557407|NCT00041990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557408|NCT00041990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557409|NCT00073437|Infliximab|infliximab|mesh-list
92557410|NCT00073437|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92557411|NCT00073437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557412|NCT00073437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92557413|NCT00073437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92557414|NCT00073437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92557415|NCT00218101|Buprenorphine|buprenorphine|mesh-list
92557416|NCT00218101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92557417|NCT00218101|Narcotics|narcotics|mesh-ancestor
92557418|NCT00218101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557419|NCT00218101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557420|NCT00218101|Analgesics|analgesics|mesh-ancestor
92557421|NCT00218101|Sensory System Agents|sensory system agents|mesh-ancestor
92557422|NCT00218101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557423|NCT00218101|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92557424|NCT00218140|Nicotine|nicotine|mesh-list
92557425|NCT00218140|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92557426|NCT00218140|Autonomic Agents|autonomic agents|mesh-ancestor
92557427|NCT00218140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557428|NCT00218140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557429|NCT00218140|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92557430|NCT00218140|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92557431|NCT00218140|Cholinergic Agents|cholinergic agents|mesh-ancestor
92557432|NCT00218140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557433|NCT00218140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557434|NCT00042029|Aprepitant|aprepitant|mesh-list
92557435|NCT00042029|Antiemetics|antiemetics|mesh-ancestor
92557436|NCT00042029|Autonomic Agents|autonomic agents|mesh-ancestor
92557437|NCT00042029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557438|NCT00042029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557439|NCT00042029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964893|NCT03280849|Coagulants|coagulants|mesh-ancestor
92557454|NCT00218374|Analgesics|analgesics|mesh-ancestor
92557455|NCT00218374|Sensory System Agents|sensory system agents|mesh-ancestor
92557456|NCT00218374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557457|NCT00218374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557458|NCT00218374|Anticonvulsants|anticonvulsants|mesh-ancestor
92534589|NCT00070174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92557459|NCT00218374|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92557460|NCT00218374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557461|NCT00218374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557462|NCT00218374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557463|NCT00218374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92557464|NCT00218374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92557466|NCT00218374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557467|NCT00218374|Antimanic Agents|antimanic agents|mesh-ancestor
92557468|NCT00218413|Vaccines|vaccines|mesh-list
92557469|NCT00218413|Immunologic Factors|immunologic factors|mesh-ancestor
92557470|NCT00218413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557471|NCT00042068|Meloxicam|meloxicam|mesh-list
92557472|NCT00042068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92557473|NCT00042068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92557474|NCT00042068|Analgesics|analgesics|mesh-ancestor
92557475|NCT00042068|Sensory System Agents|sensory system agents|mesh-ancestor
92557476|NCT00042068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557477|NCT00042068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557478|NCT00042068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557479|NCT00042068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92557480|NCT00042068|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92557481|NCT00042068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92557482|NCT00042068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355098|NCT01929096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92557483|NCT00042068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557484|NCT00218530|Lofexidine|lofexidine|mesh-list
92557485|NCT00218530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92557486|NCT00218530|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92557487|NCT00218530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557488|NCT00218530|Sensory System Agents|sensory system agents|mesh-ancestor
92557489|NCT00218530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557490|NCT00218530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92557491|NCT00218530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92557492|NCT00218530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92557493|NCT00218530|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557494|NCT00218530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557495|NCT00218530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557496|NCT00218569|Naltrexone|naltrexone|mesh-list
92557497|NCT00218569|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92557498|NCT00218569|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91964962|NCT03268525|Bupivacaine|bupivacaine|mesh-list
92557506|NCT00218608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557507|NCT00042146|Zolpidem|zolpidem|mesh-list
92557508|NCT00042146|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92557509|NCT00042146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92557510|NCT00042146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557511|NCT00042146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557512|NCT00042146|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92557513|NCT00042146|GABA Agonists|gaba agonists|mesh-ancestor
92557514|NCT00042146|GABA Agents|gaba agents|mesh-ancestor
92557515|NCT00042146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557516|NCT00042146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557517|NCT00412321|Siltuximab|siltuximab|mesh-list
92557518|NCT00412321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557519|NCT00219232|Rivastigmine|rivastigmine|mesh-list
92557520|NCT00219232|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92557521|NCT00219232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557522|NCT00219232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557523|NCT00219232|Cholinergic Agents|cholinergic agents|mesh-ancestor
92557524|NCT00219232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557525|NCT00219232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557526|NCT00219232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92557527|NCT00219232|Protective Agents|protective agents|mesh-ancestor
92557528|NCT00219271|Zoledronic Acid|zoledronic acid|mesh-list
92557529|NCT00219271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92557530|NCT00219271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557531|NCT00219310|Famciclovir|famciclovir|mesh-list
92557532|NCT00219310|Antiviral Agents|antiviral agents|mesh-ancestor
92557533|NCT00219310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557534|NCT00219310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92557535|NCT00219310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557536|NCT00219310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534590|NCT00070174|Alkylating Agents|alkylating agents|mesh-ancestor
92557538|NCT00219388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92557539|NCT00219388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92557540|NCT00219388|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92557541|NCT00219388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92557542|NCT00219388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557543|NCT00219388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557544|NCT00219388|Protective Agents|protective agents|mesh-ancestor
92557545|NCT00219388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557546|NCT00219466|Zinc|zinc|mesh-list
92557547|NCT00219466|Tocopherols|tocopherols|mesh-list
92557548|NCT00219466|Vitamin E|vitamin e|mesh-list
92557549|NCT00219466|Tocotrienols|tocotrienols|mesh-list
92557550|NCT00219466|alpha-Tocopherol|alpha-tocopherol|mesh-list
92557551|NCT00219466|Zinc Oxide|zinc oxide|mesh-list
92557552|NCT00219466|Trace Elements|trace elements|mesh-ancestor
92557553|NCT00219466|Micronutrients|micronutrients|mesh-ancestor
92557554|NCT00219466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557555|NCT00219466|Antioxidants|antioxidants|mesh-ancestor
92557556|NCT00219466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355102|NCT03059004|Antioxidants|antioxidants|mesh-ancestor
92557557|NCT00219466|Protective Agents|protective agents|mesh-ancestor
92557558|NCT00219466|Vitamins|vitamins|mesh-ancestor
92557559|NCT00219466|Dermatologic Agents|dermatologic agents|mesh-ancestor
92557560|NCT00219466|Sunscreening Agents|sunscreening agents|mesh-ancestor
92557561|NCT00219466|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92557562|NCT00042302|Paclitaxel|paclitaxel|mesh-list
92557563|NCT00042302|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92557564|NCT00042302|Carboplatin|carboplatin|mesh-list
92557565|NCT00042302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92557566|NCT00042302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557567|NCT00042302|Tubulin Modulators|tubulin modulators|mesh-ancestor
91965015|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
92557570|NCT00042302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557571|NCT00219700|Ibuprofen|ibuprofen|mesh-list
92557572|NCT00219700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92557573|NCT00219700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92557574|NCT00219700|Analgesics|analgesics|mesh-ancestor
92557575|NCT00219700|Sensory System Agents|sensory system agents|mesh-ancestor
92557576|NCT00219700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557577|NCT00219700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557578|NCT00219700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557579|NCT00219700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92557580|NCT00219700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92557581|NCT00219700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557582|NCT00219700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557583|NCT00219739|Interferons|interferons|mesh-list
92557584|NCT00219739|Cytarabine|cytarabine|mesh-list
92557585|NCT00219739|Imatinib Mesylate|imatinib mesylate|mesh-list
92557586|NCT00219739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557587|NCT00219739|Antiviral Agents|antiviral agents|mesh-ancestor
92557588|NCT00219739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557589|NCT00219739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557590|NCT00219739|Antimetabolites|antimetabolites|mesh-ancestor
92557591|NCT00219739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557592|NCT00219739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92557593|NCT00219739|Immunologic Factors|immunologic factors|mesh-ancestor
92557594|NCT00219739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557595|NCT00219739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92557596|NCT00219739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557597|NCT00219778|Mifepristone|mifepristone|mesh-list
92557598|NCT00219778|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92557599|NCT00219778|Abortifacient Agents|abortifacient agents|mesh-ancestor
92557600|NCT00219778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92557601|NCT00219778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557602|NCT00219778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92557603|NCT00219778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92557604|NCT00219778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92557605|NCT00219778|Contraceptive Agents|contraceptive agents|mesh-ancestor
92557606|NCT00219778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92557607|NCT00219778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92557608|NCT00219778|Hormone Antagonists|hormone antagonists|mesh-ancestor
92557609|NCT00219778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557610|NCT00219778|Luteolytic Agents|luteolytic agents|mesh-ancestor
92534591|NCT00070174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534592|NCT00070174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557611|NCT00219778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92557612|NCT00219778|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92557613|NCT00219856|Propofol|propofol|mesh-list
92557614|NCT00219856|Desflurane|desflurane|mesh-list
92557615|NCT00219856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92557616|NCT00219856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557617|NCT00219856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557618|NCT00219856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92557619|NCT00219856|Anesthetics, General|anesthetics, general|mesh-ancestor
92557620|NCT00219856|Anesthetics|anesthetics|mesh-ancestor
92152949|NCT00010257|Paclitaxel|paclitaxel|mesh-list
92557621|NCT00219856|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92557622|NCT00042458|Pramlintide|pramlintide|mesh-list
92557623|NCT00042458|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92557624|NCT00042458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557625|NCT00219895|Ibuprofen|ibuprofen|mesh-list
92557626|NCT00219895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92557627|NCT00219895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92557628|NCT00219895|Analgesics|analgesics|mesh-ancestor
92557629|NCT00219895|Sensory System Agents|sensory system agents|mesh-ancestor
92557630|NCT00219895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557631|NCT00219895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557632|NCT00219895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557633|NCT00219895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92557634|NCT00219895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92557635|NCT00219895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557636|NCT00219895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557637|NCT00077337|Romidepsin|romidepsin|mesh-list
92557638|NCT00077337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92557639|NCT00077337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557642|NCT00077337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557643|NCT00219934|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92557644|NCT00219934|Antiviral Agents|antiviral agents|mesh-ancestor
92557645|NCT00219934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557646|NCT00219973|Bemiparin|bemiparin|mesh-list
92557647|NCT00219973|Anticoagulants|anticoagulants|mesh-ancestor
92557648|NCT00220051|Capecitabine|capecitabine|mesh-list
92557649|NCT00220051|Oxaliplatin|oxaliplatin|mesh-list
92557650|NCT00220051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557651|NCT00220051|Antimetabolites|antimetabolites|mesh-ancestor
92557652|NCT00220051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557653|NCT00220051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557654|NCT00077415|Gemcitabine|gemcitabine|mesh-list
92557655|NCT00077415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557656|NCT00077415|Antimetabolites|antimetabolites|mesh-ancestor
92557657|NCT00077415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557658|NCT00077415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557659|NCT00042536|Naltrexone|naltrexone|mesh-list
92557660|NCT00042536|Yohimbine|yohimbine|mesh-list
92557661|NCT00042536|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92557662|NCT00042536|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92557663|NCT00042536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557664|NCT00042536|Sensory System Agents|sensory system agents|mesh-ancestor
92557665|NCT00042536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557666|NCT00042536|Mydriatics|mydriatics|mesh-ancestor
92557667|NCT00042536|Autonomic Agents|autonomic agents|mesh-ancestor
92557668|NCT00042536|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92557669|NCT00042536|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92557670|NCT00042536|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92557671|NCT00042536|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557672|NCT00042536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557673|NCT00042536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557674|NCT00042536|Urological Agents|urological agents|mesh-ancestor
92557675|NCT00220129|Capecitabine|capecitabine|mesh-list
92557676|NCT00220129|Epirubicin|epirubicin|mesh-list
92557677|NCT00220129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557678|NCT00220129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557679|NCT00220129|Antimetabolites|antimetabolites|mesh-ancestor
92557680|NCT00220129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557681|NCT00220129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92557682|NCT00220129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92534593|NCT00070174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92557683|NCT00220129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557684|NCT00220129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557685|NCT00220168|Capecitabine|capecitabine|mesh-list
92282408|NCT02223871|Artemether|artemether|mesh-list
92557686|NCT00220168|Irinotecan|irinotecan|mesh-list
92557687|NCT00220168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557688|NCT00220168|Antimetabolites|antimetabolites|mesh-ancestor
92557689|NCT00220168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557690|NCT00220168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557691|NCT00220168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92557692|NCT00220168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557693|NCT00220168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557694|NCT00042575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92557695|NCT00042575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92557696|NCT00042575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92557697|NCT00042575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557698|NCT00042575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557699|NCT00042575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557700|NCT00042575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557701|NCT00042575|Analgesics|analgesics|mesh-ancestor
92557702|NCT00042575|Sensory System Agents|sensory system agents|mesh-ancestor
92557703|NCT00042575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557704|NCT00042575|Antidepressive Agents|antidepressive agents|mesh-ancestor
92557705|NCT00042575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557706|NCT00042575|Dopamine Agents|dopamine agents|mesh-ancestor
92557707|NCT00220285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92557708|NCT00220285|Immunologic Factors|immunologic factors|mesh-ancestor
92557709|NCT00220285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557710|NCT00077454|Temozolomide|temozolomide|mesh-list
92557711|NCT00077454|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92557727|NCT00220324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92557728|NCT00220324|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92557729|NCT00220324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92557730|NCT00220324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92557731|NCT00412555|Oseltamivir|oseltamivir|mesh-list
92557732|NCT00412555|Antiviral Agents|antiviral agents|mesh-ancestor
92557733|NCT00412555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557734|NCT00412555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557735|NCT00412555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557736|NCT00412633|Sulfamethazine|sulfamethazine|mesh-list
92557737|NCT00412633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92557738|NCT00042653|Cinacalcet|cinacalcet|mesh-list
92557739|NCT00042653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92557740|NCT00042653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557741|NCT00042653|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92557742|NCT00042653|Hormone Antagonists|hormone antagonists|mesh-ancestor
92557743|NCT00042653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557744|NCT00073593|Heparin|heparin|mesh-list
92557745|NCT00073593|Bivalirudin|bivalirudin|mesh-list
92557746|NCT00073593|Protamines|protamines|mesh-list
92557747|NCT00073593|Anticoagulants|anticoagulants|mesh-ancestor
92557748|NCT00073593|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92557749|NCT00073593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92557750|NCT00073593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557751|NCT00073593|Antithrombins|antithrombins|mesh-ancestor
92557752|NCT00073593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92557753|NCT00073593|Protease Inhibitors|protease inhibitors|mesh-ancestor
92557754|NCT00073593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557755|NCT00073593|Heparin Antagonists|heparin antagonists|mesh-ancestor
92557756|NCT00073593|Coagulants|coagulants|mesh-ancestor
92557757|NCT00220480|Escitalopram|escitalopram|mesh-list
92282475|NCT05752305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557758|NCT00220480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92557759|NCT00220480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92557760|NCT00220480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557761|NCT00220480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557762|NCT00220480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557763|NCT00220480|Serotonin Agents|serotonin agents|mesh-ancestor
92557764|NCT00220480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557765|NCT00220675|Epoetin Alfa|epoetin alfa|mesh-list
92534594|NCT00070174|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92534595|NCT00070174|Abortifacient Agents|abortifacient agents|mesh-ancestor
92557766|NCT00220675|Hematinics|hematinics|mesh-ancestor
92557777|NCT00220714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557778|NCT00220714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557779|NCT00220714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557780|NCT00220714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557781|NCT00077493|Antibodies|antibodies|mesh-list
92557782|NCT00077493|Immunoglobulins|immunoglobulins|mesh-list
92557783|NCT00077493|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92557784|NCT00077493|Immunotoxins|immunotoxins|mesh-list
92557785|NCT00077493|Immunoconjugates|immunoconjugates|mesh-list
92557786|NCT00077493|Immunologic Factors|immunologic factors|mesh-ancestor
92557787|NCT00077493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557788|NCT00220831|Vitamin E|vitamin e|mesh-list
92557789|NCT00220831|Vitamins|vitamins|mesh-ancestor
92557790|NCT00220831|Micronutrients|micronutrients|mesh-ancestor
92557791|NCT00220831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557792|NCT00220831|Antioxidants|antioxidants|mesh-ancestor
92557793|NCT00220831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557794|NCT00220831|Protective Agents|protective agents|mesh-ancestor
92557795|NCT00220909|Lansoprazole|lansoprazole|mesh-list
92557796|NCT00220909|Dexlansoprazole|dexlansoprazole|mesh-list
92557797|NCT00220909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92557798|NCT00220909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92557799|NCT00220909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92557800|NCT00220909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557801|NCT00220909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557802|NCT00220987|Insulin|insulin|mesh-list
92557803|NCT00220987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92557804|NCT00220987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92557805|NCT00220987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557806|NCT02966067|Anesthetics|anesthetics|mesh-list
92557807|NCT02966067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92557808|NCT02966067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557809|NCT02966067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557810|NCT00221026|Methoxsalen|methoxsalen|mesh-list
92557811|NCT00221026|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92557812|NCT00221026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92557813|NCT00042809|Paclitaxel|paclitaxel|mesh-list
92557814|NCT00042809|Trastuzumab|trastuzumab|mesh-list
92557815|NCT00042809|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92557816|NCT00042809|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92557817|NCT00042809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557818|NCT00042809|Tubulin Modulators|tubulin modulators|mesh-ancestor
92557819|NCT00042809|Antimitotic Agents|antimitotic agents|mesh-ancestor
92557820|NCT00042809|Mitosis Modulators|mitosis modulators|mesh-ancestor
92557821|NCT00042809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557822|NCT00042809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92557823|NCT00042809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92557824|NCT00042809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557825|NCT00073710|Calcitriol|calcitriol|mesh-list
92557826|NCT00073710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92557827|NCT00073710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557828|NCT00073710|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92557829|NCT00073710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557830|NCT00073710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557831|NCT00073710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91965293|NCT03252457|Hormones|hormones|mesh-ancestor
92557839|NCT00042848|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92557840|NCT00042848|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92557841|NCT00042848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557842|NCT00221260|Anesthetics|anesthetics|mesh-list
92557843|NCT00221260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557844|NCT00221260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557845|NCT00402259|Esomeprazole|esomeprazole|mesh-list
92557846|NCT00402259|Omeprazole|omeprazole|mesh-list
92557847|NCT00402259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92557848|NCT00402259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92557849|NCT00402259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92557850|NCT00402259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557851|NCT00402259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534596|NCT00070174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92534597|NCT00070174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92534598|NCT00070174|Antimetabolites|antimetabolites|mesh-ancestor
92557852|NCT02965677|Paclitaxel|paclitaxel|mesh-list
92557853|NCT02965677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92557854|NCT02965677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557855|NCT02965677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92557856|NCT02965677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92557857|NCT02965677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92557858|NCT02965677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557859|NCT00402376|Carvedilol|carvedilol|mesh-list
92557860|NCT00402376|Perindopril|perindopril|mesh-list
92557861|NCT00402376|Pravastatin|pravastatin|mesh-list
92557862|NCT00402376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92557863|NCT00402376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92557864|NCT00402376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92557865|NCT00402376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557866|NCT00402376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557867|NCT00402376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557868|NCT00402376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92557869|NCT00402376|Antioxidants|antioxidants|mesh-ancestor
92557870|NCT00402376|Protective Agents|protective agents|mesh-ancestor
92557871|NCT00402376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92557872|NCT00402376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557873|NCT00402376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92557874|NCT00402376|Vasodilator Agents|vasodilator agents|mesh-ancestor
92557875|NCT00402376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92557876|NCT00402376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92557877|NCT00402376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92557878|NCT00402376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92557879|NCT00402376|Antimetabolites|antimetabolites|mesh-ancestor
92557880|NCT00402376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92557881|NCT00402376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92557882|NCT00402376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557883|NCT00402376|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92557884|NCT00402376|Protease Inhibitors|protease inhibitors|mesh-ancestor
92557885|NCT00042887|Mitomycins|mitomycins|mesh-list
92557886|NCT00042887|Mitomycin|mitomycin|mesh-list
92557887|NCT00042887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92557888|NCT00042887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557889|NCT00042887|Alkylating Agents|alkylating agents|mesh-ancestor
92557890|NCT00042887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557891|NCT00042887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92557892|NCT00042887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557893|NCT00122746|Cisplatin|cisplatin|mesh-list
92557894|NCT00122746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557895|NCT00122785|Dexamethasone|dexamethasone|mesh-list
92557896|NCT00122785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557897|NCT00122785|Antiemetics|antiemetics|mesh-ancestor
92557918|NCT00122824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557919|NCT00122824|Dopamine Agents|dopamine agents|mesh-ancestor
92557921|NCT00077532|Freund's Adjuvant|freund's adjuvant|mesh-list
92557922|NCT00077532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92557923|NCT00077532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557924|NCT00077532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92557925|NCT00077532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557926|NCT00077532|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92557927|NCT00077532|Immunologic Factors|immunologic factors|mesh-ancestor
92557928|NCT00077532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557929|NCT00122863|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92557930|NCT00122863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92557931|NCT00122863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92557932|NCT00122863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557933|NCT00122863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557934|NCT00122863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557935|NCT00122863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557936|NCT00122863|Analgesics|analgesics|mesh-ancestor
92557937|NCT00122863|Sensory System Agents|sensory system agents|mesh-ancestor
92557938|NCT00122863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557939|NCT00122863|Antidepressive Agents|antidepressive agents|mesh-ancestor
92534599|NCT00070174|Dermatologic Agents|dermatologic agents|mesh-ancestor
92534600|NCT00070174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557940|NCT00122863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557941|NCT00122863|Dopamine Agents|dopamine agents|mesh-ancestor
92557942|NCT00042926|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92557943|NCT00042926|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92557944|NCT00042926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557945|NCT00122941|Micronutrients|micronutrients|mesh-list
92557946|NCT00122941|Trace Elements|trace elements|mesh-list
92557947|NCT00122941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557950|NCT00077688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557951|NCT00077688|Tubulin Modulators|tubulin modulators|mesh-ancestor
92557952|NCT00077688|Antimitotic Agents|antimitotic agents|mesh-ancestor
92557953|NCT00077688|Mitosis Modulators|mitosis modulators|mesh-ancestor
92557954|NCT00077688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557955|NCT00397319|Hormones|hormones|mesh-list
92557956|NCT00397319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557957|NCT00397319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557958|NCT02965443|Dapagliflozin|dapagliflozin|mesh-list
92557959|NCT02965443|Saxagliptin|saxagliptin|mesh-list
92557960|NCT02965443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92557961|NCT02965443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557962|NCT02965443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92557963|NCT02965443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557964|NCT02965443|Incretins|incretins|mesh-ancestor
92557965|NCT02965443|Hormones|hormones|mesh-ancestor
92557966|NCT02965443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557967|NCT02965443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92557968|NCT02965443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92557969|NCT02965443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557970|NCT00042965|Gemcitabine|gemcitabine|mesh-list
92557971|NCT00042965|Capecitabine|capecitabine|mesh-list
92557972|NCT00042965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557973|NCT00042965|Antimetabolites|antimetabolites|mesh-ancestor
92557974|NCT00042965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557975|NCT00042965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557976|NCT00123175|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92282719|NCT05751044|Cytarabine|cytarabine|mesh-list
92557977|NCT00123175|Medroxyprogesterone|medroxyprogesterone|mesh-list
92557978|NCT00123175|Progestins|progestins|mesh-list
92557979|NCT00123175|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92557980|NCT00123175|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92557981|NCT00123175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92557982|NCT00123175|Contraceptive Agents|contraceptive agents|mesh-ancestor
92557983|NCT00123175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92557984|NCT00123175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557985|NCT00123175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92557986|NCT00123175|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92557987|NCT00123175|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92557988|NCT00123175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92557989|NCT00123175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557990|NCT00123175|Hormones|hormones|mesh-ancestor
92557991|NCT00123175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557992|NCT00077727|Galantamine|galantamine|mesh-list
92557993|NCT00077727|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92557994|NCT00077727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557995|NCT00077727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557996|NCT00077727|Cholinergic Agents|cholinergic agents|mesh-ancestor
92557997|NCT00077727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557998|NCT00077727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557999|NCT00077727|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92558000|NCT00077727|Autonomic Agents|autonomic agents|mesh-ancestor
92558001|NCT00077727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558002|NCT00077727|Nootropic Agents|nootropic agents|mesh-ancestor
92558003|NCT00123292|Plasminogen|plasminogen|mesh-list
92558004|NCT00123292|Fibrinolysin|fibrinolysin|mesh-list
92558005|NCT00123292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92558006|NCT00123292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92558007|NCT00123292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558008|NCT00043004|Leucovorin|leucovorin|mesh-list
92558009|NCT00043004|Bevacizumab|bevacizumab|mesh-list
92558010|NCT00043004|Fluorouracil|fluorouracil|mesh-list
92558011|NCT00043004|Oxaliplatin|oxaliplatin|mesh-list
92534601|NCT00070174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92534602|NCT00070174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92534603|NCT00070174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92534604|NCT00070174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92558013|NCT00043004|Levoleucovorin|levoleucovorin|mesh-list
92558014|NCT00043004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558015|NCT00043004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558016|NCT00043004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92558017|NCT00043004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92558018|NCT00043004|Growth Substances|growth substances|mesh-ancestor
91965470|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92558041|NCT00123331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558043|NCT00123331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558044|NCT00123331|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92558045|NCT00123331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92558046|NCT00123331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558047|NCT00123331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558048|NCT00123370|Modafinil|modafinil|mesh-list
92558049|NCT00123370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92558050|NCT00123370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558051|NCT00123370|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92558052|NCT00123370|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92558053|NCT00123370|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92558054|NCT00123370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558055|NCT00043043|Celecoxib|celecoxib|mesh-list
92558056|NCT00043043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92558057|NCT00043043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558058|NCT00043043|Analgesics|analgesics|mesh-ancestor
92558059|NCT00043043|Sensory System Agents|sensory system agents|mesh-ancestor
92558060|NCT00043043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558061|NCT00043043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558062|NCT00043043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558063|NCT00043043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558064|NCT00043043|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92558065|NCT00043043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92558066|NCT00043043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558067|NCT00043043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558068|NCT00077805|Enoxaparin|enoxaparin|mesh-list
92558069|NCT00077805|Enoxaparin sodium|enoxaparin sodium|mesh-list
92558070|NCT00077805|Anticoagulants|anticoagulants|mesh-ancestor
92558075|NCT00043082|Doxorubicin|doxorubicin|mesh-list
92558076|NCT00043082|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92558077|NCT00043082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558078|NCT00043082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558079|NCT00043082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92558080|NCT00043082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92558081|NCT00043082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558082|NCT00043082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558083|NCT00123877|Esorubicin|esorubicin|mesh-list
92558084|NCT00123877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558085|NCT00123877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558086|NCT00123916|Benzonidazole|benzonidazole|mesh-list
92558087|NCT00123916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558088|NCT00123916|Immunologic Factors|immunologic factors|mesh-ancestor
92558089|NCT00123916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558090|NCT00123916|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92558091|NCT00123916|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92558092|NCT00123916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92558093|NCT00123916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558094|NCT00073827|Albuterol|albuterol|mesh-list
92558095|NCT00073827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92558096|NCT00073827|Autonomic Agents|autonomic agents|mesh-ancestor
92558097|NCT00073827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558098|NCT00073827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558099|NCT00073827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92558100|NCT00073827|Respiratory System Agents|respiratory system agents|mesh-ancestor
92558101|NCT00073827|Tocolytic Agents|tocolytic agents|mesh-ancestor
92558102|NCT00073827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92558103|NCT00073827|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92534605|NCT00070174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92534607|NCT00070174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534608|NCT00070174|Antifungal Agents|antifungal agents|mesh-ancestor
92558104|NCT00073827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92558105|NCT00073827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92558106|NCT00073827|Adrenergic Agents|adrenergic agents|mesh-ancestor
92558107|NCT00073827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558108|NCT00073827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558109|NCT02970539|Paclitaxel|paclitaxel|mesh-list
92558110|NCT02970539|Ramucirumab|ramucirumab|mesh-list
92558111|NCT02970539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92558112|NCT02970539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558113|NCT02970539|Tubulin Modulators|tubulin modulators|mesh-ancestor
92558114|NCT02970539|Antimitotic Agents|antimitotic agents|mesh-ancestor
92558115|NCT02970539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92558116|NCT02970539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558117|NCT00124111|Cyclophosphamide|cyclophosphamide|mesh-list
92558118|NCT00124111|Fluorouracil|fluorouracil|mesh-list
92558119|NCT00124111|Methotrexate|methotrexate|mesh-list
92558120|NCT00124111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558121|NCT00124111|Immunologic Factors|immunologic factors|mesh-ancestor
92558122|NCT00124111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558123|NCT00124111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558124|NCT00124111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92558125|NCT00124111|Alkylating Agents|alkylating agents|mesh-ancestor
92558126|NCT00124111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282851|NCT05486104|Hemay005|hemay005|mesh-list
92558127|NCT00124111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558128|NCT00124111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92558129|NCT00124111|Antimetabolites|antimetabolites|mesh-ancestor
92558130|NCT00124111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558131|NCT00124111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92558132|NCT00124111|Abortifacient Agents|abortifacient agents|mesh-ancestor
92558133|NCT00124111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92558134|NCT00124111|Dermatologic Agents|dermatologic agents|mesh-ancestor
92558135|NCT00124111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558136|NCT00124111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92558137|NCT00124111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558138|NCT00124150|Magnesium Sulfate|magnesium sulfate|mesh-list
92558139|NCT00124150|Analgesics|analgesics|mesh-ancestor
92558140|NCT00124150|Sensory System Agents|sensory system agents|mesh-ancestor
92558153|NCT02958046|Domperidone|domperidone|mesh-list
92558154|NCT02958046|Lansoprazole|lansoprazole|mesh-list
92558155|NCT02958046|Dexlansoprazole|dexlansoprazole|mesh-list
92558156|NCT02958046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92558157|NCT02958046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558158|NCT02958046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92558159|NCT02958046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558160|NCT02958046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558161|NCT02958046|Antiemetics|antiemetics|mesh-ancestor
92558162|NCT02958046|Autonomic Agents|autonomic agents|mesh-ancestor
92558163|NCT02958046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558164|NCT02958046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558165|NCT02958046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92558166|NCT02958046|Dopamine Agents|dopamine agents|mesh-ancestor
92558167|NCT02958046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558168|NCT00073905|Gemcitabine|gemcitabine|mesh-list
92558169|NCT00073905|Capecitabine|capecitabine|mesh-list
92558170|NCT00073905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558171|NCT00073905|Antimetabolites|antimetabolites|mesh-ancestor
92558172|NCT00073905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558173|NCT00073905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558174|NCT00124267|Quinine|quinine|mesh-list
92558175|NCT00124267|Antimalarials|antimalarials|mesh-ancestor
92558176|NCT00124267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92558177|NCT00124267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92558178|NCT00124267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558179|NCT00124267|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92558180|NCT00124267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558181|NCT00124267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92558182|NCT00124267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558183|NCT00124267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558185|NCT00124267|Sensory System Agents|sensory system agents|mesh-ancestor
92558187|NCT00077844|Enoxaparin sodium|enoxaparin sodium|mesh-list
92558188|NCT00077844|Anticoagulants|anticoagulants|mesh-ancestor
92558189|NCT00077844|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92558190|NCT00077844|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92558191|NCT00077844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558192|NCT00043121|Leucovorin|leucovorin|mesh-list
92558193|NCT00043121|Fluorouracil|fluorouracil|mesh-list
92558194|NCT00043121|Capecitabine|capecitabine|mesh-list
92558195|NCT00043121|Oxaliplatin|oxaliplatin|mesh-list
92558196|NCT00043121|Calcium|calcium|mesh-list
92558197|NCT00043121|Levoleucovorin|levoleucovorin|mesh-list
92558198|NCT00043121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92558199|NCT00043121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558200|NCT00043121|Antimetabolites|antimetabolites|mesh-ancestor
92558201|NCT00043121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558202|NCT00043121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965670|NCT04487743|Hormones|hormones|mesh-ancestor
92558206|NCT00043121|Antidotes|antidotes|mesh-ancestor
92558207|NCT00043121|Protective Agents|protective agents|mesh-ancestor
92558208|NCT00043121|Vitamin B Complex|vitamin b complex|mesh-ancestor
92558210|NCT00043121|Micronutrients|micronutrients|mesh-ancestor
92558211|NCT00402415|Sirolimus|sirolimus|mesh-list
92558212|NCT00402415|Sunitinib|sunitinib|mesh-list
92558213|NCT00402415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92558214|NCT00402415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558215|NCT00402415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558216|NCT00402415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558217|NCT00402415|Antifungal Agents|antifungal agents|mesh-ancestor
92558218|NCT00402415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558219|NCT00402415|Immunologic Factors|immunologic factors|mesh-ancestor
92558220|NCT00402415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558221|NCT00402415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92558222|NCT00402415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558223|NCT00402415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558224|NCT00402415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92558225|NCT00402415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92558226|NCT00402415|Growth Substances|growth substances|mesh-ancestor
92558227|NCT00402415|Growth Inhibitors|growth inhibitors|mesh-ancestor
92558228|NCT04727476|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92558229|NCT04727476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92558230|NCT04727476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558231|NCT04727476|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92558232|NCT04727476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92558233|NCT04727476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558234|NCT04727476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558235|NCT04727476|Dopamine Agents|dopamine agents|mesh-ancestor
92558236|NCT04727476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558237|NCT00124306|Amitriptyline|amitriptyline|mesh-list
92558238|NCT00124306|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92558239|NCT00124306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92558240|NCT00124306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92558241|NCT00124306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558242|NCT00124306|Analgesics|analgesics|mesh-ancestor
92558243|NCT00124306|Sensory System Agents|sensory system agents|mesh-ancestor
92558244|NCT00124306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558245|NCT00124306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558246|NCT00124306|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92558247|NCT00124306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92558248|NCT00124306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558249|NCT00124306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558250|NCT00124306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92558251|NCT00124306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558252|NCT00043199|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
92558253|NCT00043199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558254|NCT00124384|Modafinil|modafinil|mesh-list
92558255|NCT00124384|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92558256|NCT00124384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558257|NCT00124384|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92558258|NCT00124384|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92558259|NCT00124384|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92534610|NCT00070174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558260|NCT00124384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558261|NCT00077883|Cisplatin|cisplatin|mesh-list
92558262|NCT00077883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558263|NCT00124540|Misoprostol|misoprostol|mesh-list
92558264|NCT00124540|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92558265|NCT00124540|Abortifacient Agents|abortifacient agents|mesh-ancestor
92558266|NCT00124540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92558267|NCT00124540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558268|NCT00124540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92558269|NCT00124540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558270|NCT00124540|Oxytocics|oxytocics|mesh-ancestor
92558271|NCT00124696|Cocaethylene|cocaethylene|mesh-list
92558272|NCT00124696|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91965728|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558278|NCT00124696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558280|NCT00043277|Antithrombins|antithrombins|mesh-ancestor
92558281|NCT00043277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92558282|NCT00043277|Protease Inhibitors|protease inhibitors|mesh-ancestor
92558283|NCT00043277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558284|NCT00043277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558285|NCT00043277|Anticoagulants|anticoagulants|mesh-ancestor
92558286|NCT00074022|Docetaxel|docetaxel|mesh-list
92558287|NCT00074022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558288|NCT00074022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92558289|NCT00074022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92558290|NCT00074022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92558291|NCT00074022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558292|NCT00124813|Thalidomide|thalidomide|mesh-list
92558293|NCT00124813|Idarubicin|idarubicin|mesh-list
92558294|NCT00124813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558295|NCT00124813|Immunologic Factors|immunologic factors|mesh-ancestor
92558296|NCT00124813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558297|NCT00124813|Leprostatic Agents|leprostatic agents|mesh-ancestor
92558298|NCT00124813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92558299|NCT00124813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558300|NCT00124813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92558301|NCT00124813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92558302|NCT00124813|Growth Substances|growth substances|mesh-ancestor
92558303|NCT00124813|Growth Inhibitors|growth inhibitors|mesh-ancestor
92558304|NCT00124813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558305|NCT00124813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558306|NCT00124813|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92558307|NCT00124813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92558308|NCT00124813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558309|NCT00124813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558310|NCT00124930|Olanzapine|olanzapine|mesh-list
92558311|NCT00124930|Antiemetics|antiemetics|mesh-ancestor
92558312|NCT00124930|Autonomic Agents|autonomic agents|mesh-ancestor
92558313|NCT00124930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558314|NCT00124930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558315|NCT00124930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558316|NCT00124930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92558317|NCT00124930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92558318|NCT00124930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558319|NCT00124930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92558320|NCT00124930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92558321|NCT00124930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92558322|NCT00124930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558323|NCT00124930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558324|NCT00124930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558325|NCT00124930|Serotonin Agents|serotonin agents|mesh-ancestor
92558326|NCT00124969|Amlodipine|amlodipine|mesh-list
92558327|NCT00124969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92558328|NCT00124969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92558329|NCT00124969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558330|NCT00124969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558331|NCT00124969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92558332|NCT00124969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558333|NCT00124969|Vasodilator Agents|vasodilator agents|mesh-ancestor
92558334|NCT00043316|Interferons|interferons|mesh-list
92534611|NCT00070174|Analgesics|analgesics|mesh-ancestor
92534612|NCT00070174|Sensory System Agents|sensory system agents|mesh-ancestor
92558335|NCT00043316|Interferon-gamma|interferon-gamma|mesh-list
92558336|NCT00043316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558337|NCT00043316|Antiviral Agents|antiviral agents|mesh-ancestor
92558338|NCT00043316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558345|NCT00125047|Vaccines|vaccines|mesh-list
92558346|NCT00125047|Immunologic Factors|immunologic factors|mesh-ancestor
92558347|NCT00125047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558348|NCT00078000|Sunitinib|sunitinib|mesh-list
92558349|NCT00078000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558350|NCT00078000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92558351|NCT00078000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92558352|NCT00078000|Growth Substances|growth substances|mesh-ancestor
92558353|NCT00078000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558354|NCT00078000|Growth Inhibitors|growth inhibitors|mesh-ancestor
92558355|NCT00078000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92558356|NCT00078000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558357|NCT00078000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558358|NCT00125203|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92558359|NCT00125203|Botulinum Toxins|botulinum toxins|mesh-list
92558360|NCT00125203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92558361|NCT00125203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92558362|NCT00125203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92558363|NCT00125203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558364|NCT00125203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558365|NCT00125203|Cholinergic Agents|cholinergic agents|mesh-ancestor
92558366|NCT00125203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558367|NCT00125203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558368|NCT00125203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92558369|NCT00125203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558370|NCT00125203|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92558371|NCT00043355|Interferons|interferons|mesh-list
92558372|NCT00043355|Interferon-gamma|interferon-gamma|mesh-list
92558373|NCT00043355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558374|NCT00043355|Antiviral Agents|antiviral agents|mesh-ancestor
92558375|NCT00043355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558376|NCT00125398|Fospropofol|fospropofol|mesh-list
92558377|NCT00125398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92558378|NCT00125398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558379|NCT00125398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558380|NCT04729998|Rivaroxaban|rivaroxaban|mesh-list
92558381|NCT04729998|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92558382|NCT04729998|Antithrombins|antithrombins|mesh-ancestor
92558383|NCT04729998|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92558384|NCT04729998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92558385|NCT04729998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558386|NCT04729998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558387|NCT04729998|Anticoagulants|anticoagulants|mesh-ancestor
92558388|NCT00125437|Spironolactone|spironolactone|mesh-list
92558389|NCT00125437|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92558390|NCT00125437|Hormone Antagonists|hormone antagonists|mesh-ancestor
92558391|NCT00125437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92558392|NCT00125437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558393|NCT00125437|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92558394|NCT00125437|Diuretics|diuretics|mesh-ancestor
92558395|NCT00125437|Natriuretic Agents|natriuretic agents|mesh-ancestor
92558396|NCT00125554|Metyrapone|metyrapone|mesh-list
92558397|NCT00125554|Antimetabolites|antimetabolites|mesh-ancestor
92558398|NCT00125554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558399|NCT00125554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558400|NCT00043394|Trastuzumab|trastuzumab|mesh-list
92558401|NCT00043394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558402|NCT00043394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558403|NCT00125671|Warfarin|warfarin|mesh-list
92558404|NCT00125671|Anticoagulants|anticoagulants|mesh-ancestor
92558405|NCT00125827|Clofarabine|clofarabine|mesh-list
92558406|NCT00125827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558407|NCT00125827|Antimetabolites|antimetabolites|mesh-ancestor
91965865|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92558412|NCT00078039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92558413|NCT00078039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558414|NCT00078039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558415|NCT00078039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92558416|NCT00078039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92558417|NCT00078039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92558419|NCT00078039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558420|NCT00078039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558421|NCT00078039|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92558423|NCT00078039|Dopamine Agents|dopamine agents|mesh-ancestor
92558425|NCT00125905|Nicotine|nicotine|mesh-list
92558426|NCT00125905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92558427|NCT00125905|Autonomic Agents|autonomic agents|mesh-ancestor
92558428|NCT00125905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558429|NCT00125905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558430|NCT00125905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92558431|NCT00125905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92558432|NCT00125905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92558433|NCT00125905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558434|NCT00125905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558435|NCT00125905|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92558436|NCT00125905|Antidepressive Agents|antidepressive agents|mesh-ancestor
92558437|NCT00125905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92558438|NCT00125905|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92558439|NCT00125905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92558440|NCT00125905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558441|NCT00125905|Dopamine Agents|dopamine agents|mesh-ancestor
92558442|NCT00125905|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92558443|NCT00125905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92558444|NCT00125905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558445|NCT00078117|Buprenorphine|buprenorphine|mesh-list
92558446|NCT00078117|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92558447|NCT00078117|Narcotics|narcotics|mesh-ancestor
92558448|NCT00078117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558449|NCT00078117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558450|NCT00078117|Analgesics|analgesics|mesh-ancestor
92558451|NCT00078117|Sensory System Agents|sensory system agents|mesh-ancestor
92558452|NCT00078117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558453|NCT00078117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92558454|NCT00125983|Ritonavir|ritonavir|mesh-list
92558455|NCT00125983|Lopinavir|lopinavir|mesh-list
92558456|NCT00125983|Norinyl|norinyl|mesh-list
92558457|NCT00125983|Ortho Evra|ortho evra|mesh-list
92558458|NCT00125983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92558459|NCT00125983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92558460|NCT00125983|Protease Inhibitors|protease inhibitors|mesh-ancestor
92558461|NCT00125983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558462|NCT00125983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558463|NCT00125983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92558464|NCT00125983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92558465|NCT00125983|Antiviral Agents|antiviral agents|mesh-ancestor
92558466|NCT00125983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558467|NCT00125983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92558468|NCT00125983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92558469|NCT00125983|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92558470|NCT00125983|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92558471|NCT00125983|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92558472|NCT00125983|Contraceptive Agents|contraceptive agents|mesh-ancestor
92558473|NCT00125983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92558474|NCT00125983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558475|NCT00125983|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92558476|NCT00125983|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92558477|NCT00126022|Tedisamil|tedisamil|mesh-list
92558480|NCT00126022|Protective Agents|protective agents|mesh-ancestor
92558481|NCT00126022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558482|NCT00402454|Rifampin|rifampin|mesh-list
92558483|NCT00402454|Isoniazid|isoniazid|mesh-list
92558484|NCT00402454|Pyrazinamide|pyrazinamide|mesh-list
92558485|NCT00402454|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92558486|NCT00402454|Antitubercular Agents|antitubercular agents|mesh-ancestor
92558487|NCT00402454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92558488|NCT00402454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558489|NCT00402454|Leprostatic Agents|leprostatic agents|mesh-ancestor
92558490|NCT00402454|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558491|NCT00402454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558492|NCT00402454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534613|NCT00070174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558493|NCT00402454|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92558494|NCT00402454|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92558495|NCT00402454|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92558496|NCT00402454|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92558497|NCT00402454|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92558498|NCT00402454|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92558499|NCT00402454|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92558500|NCT00402454|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92558501|NCT00402454|Antimetabolites|antimetabolites|mesh-ancestor
92558502|NCT00402454|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92558503|NCT00402493|Ibuprofen|ibuprofen|mesh-list
92558504|NCT00402493|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92558505|NCT00402493|Latanoprost|latanoprost|mesh-list
92558506|NCT00402493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92558507|NCT00402493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558508|NCT00402493|Analgesics|analgesics|mesh-ancestor
92558509|NCT00402493|Sensory System Agents|sensory system agents|mesh-ancestor
92558510|NCT00402493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558511|NCT00402493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152950|NCT00010257|Carboplatin|carboplatin|mesh-list
92558512|NCT00402493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558513|NCT00402493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558514|NCT00402493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92558515|NCT00402493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558516|NCT00402493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558517|NCT00402493|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92558518|NCT00402493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92558519|NCT00402493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92558520|NCT00402493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92558521|NCT00402493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92558522|NCT00402493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92558523|NCT00402493|Adrenergic Agents|adrenergic agents|mesh-ancestor
92558524|NCT00402493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558525|NCT00402532|Everolimus|everolimus|mesh-list
92558526|NCT00402532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92558527|NCT00402532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92558528|NCT00402532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558529|NCT00402532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558530|NCT00402532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558531|NCT00402532|Immunologic Factors|immunologic factors|mesh-ancestor
92558532|NCT00402532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558533|NCT00402532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558534|NCT00126061|Tedisamil|tedisamil|mesh-list
92558535|NCT00126061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92558536|NCT00126061|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92558537|NCT00126061|Protective Agents|protective agents|mesh-ancestor
92558538|NCT00126061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558539|NCT00043589|Donepezil|donepezil|mesh-list
92558540|NCT00043589|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92558541|NCT00043589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558542|NCT00043589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558543|NCT00043589|Cholinergic Agents|cholinergic agents|mesh-ancestor
92558544|NCT00043589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558545|NCT00043589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558546|NCT00043589|Nootropic Agents|nootropic agents|mesh-ancestor
92558547|NCT00399399|Cyclophosphamide|cyclophosphamide|mesh-list
92558548|NCT00399399|Azathioprine|azathioprine|mesh-list
92558549|NCT00399399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558550|NCT00399399|Immunologic Factors|immunologic factors|mesh-ancestor
92558569|NCT00126139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92558570|NCT00074100|Amonafide|amonafide|mesh-list
92558571|NCT00074100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558572|NCT00074100|Antiviral Agents|antiviral agents|mesh-ancestor
92283306|NCT03555916|Cholinergic Agents|cholinergic agents|mesh-ancestor
92558573|NCT00074100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558574|NCT00074100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558575|NCT00074100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558576|NCT00126256|Leucovorin|leucovorin|mesh-list
92558577|NCT00126256|Fluorouracil|fluorouracil|mesh-list
92558578|NCT00126256|Oxaliplatin|oxaliplatin|mesh-list
92558579|NCT00126256|Irinotecan|irinotecan|mesh-list
92558580|NCT00126256|Antimetabolites|antimetabolites|mesh-ancestor
92558581|NCT00126256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534614|NCT00070174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534615|NCT00070174|Immunotoxins|immunotoxins|mesh-ancestor
92534616|NCT00070174|Immunoconjugates|immunoconjugates|mesh-ancestor
92534617|NCT00070213|Leucovorin|leucovorin|mesh-list
92534618|NCT00070213|Fluorouracil|fluorouracil|mesh-list
92534619|NCT00070213|Capecitabine|capecitabine|mesh-list
92355146|NCT04124094|Xhance|xhance|mesh-list
92534620|NCT00070213|Oxaliplatin|oxaliplatin|mesh-list
92534621|NCT00070213|Calcium|calcium|mesh-list
92534622|NCT00070213|Levoleucovorin|levoleucovorin|mesh-list
92534623|NCT00070213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534624|NCT00070213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534625|NCT00070213|Antimetabolites|antimetabolites|mesh-ancestor
92534626|NCT00070213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558582|NCT00126256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558583|NCT00126256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558584|NCT00126256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558585|NCT00126256|Immunologic Factors|immunologic factors|mesh-ancestor
92558586|NCT00126256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558587|NCT00126256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92558588|NCT00126256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92558589|NCT00126256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558590|NCT00126256|Antidotes|antidotes|mesh-ancestor
92558591|NCT00126256|Protective Agents|protective agents|mesh-ancestor
92558592|NCT00126256|Vitamin B Complex|vitamin b complex|mesh-ancestor
92558593|NCT00126256|Vitamins|vitamins|mesh-ancestor
92558594|NCT00126256|Micronutrients|micronutrients|mesh-ancestor
92558595|NCT00043667|Daclizumab|daclizumab|mesh-list
92558596|NCT00043667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558597|NCT00043667|Immunologic Factors|immunologic factors|mesh-ancestor
92558598|NCT00043667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558599|NCT00074139|Cyclophosphamide|cyclophosphamide|mesh-list
92558600|NCT00074139|Docetaxel|docetaxel|mesh-list
92558601|NCT00074139|Doxorubicin|doxorubicin|mesh-list
92558602|NCT00074139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92558603|NCT00074139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558604|NCT00074139|Immunologic Factors|immunologic factors|mesh-ancestor
92558605|NCT00074139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558606|NCT00074139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558607|NCT00074139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92558608|NCT00074139|Alkylating Agents|alkylating agents|mesh-ancestor
92558610|NCT00074139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558611|NCT00074139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92558612|NCT00074139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92558613|NCT00074139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92558614|NCT00074139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92558615|NCT00074139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92558616|NCT00074139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92558617|NCT00074139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92558618|NCT00074139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558619|NCT00126373|Bupropion|bupropion|mesh-list
92558620|NCT00126373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92558621|NCT00126373|Antidepressive Agents|antidepressive agents|mesh-ancestor
92558622|NCT00126373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92558623|NCT00126373|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92558624|NCT00126373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92558625|NCT00126373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558626|NCT00126373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558627|NCT00126373|Dopamine Agents|dopamine agents|mesh-ancestor
92558628|NCT00126373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558629|NCT00126373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558630|NCT00126373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92558631|NCT00126373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92558632|NCT00126373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558633|NCT00126412|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92534627|NCT00070213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558634|NCT00126412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558635|NCT00126412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558636|NCT00126412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558637|NCT00126412|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92558638|NCT00043706|Antibodies|antibodies|mesh-list
92558639|NCT00043706|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92558640|NCT00043706|Mitogens|mitogens|mesh-list
92558641|NCT00043706|Immunologic Factors|immunologic factors|mesh-ancestor
92558642|NCT00043706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558643|NCT00043706|Mitosis Modulators|mitosis modulators|mesh-ancestor
92558644|NCT00043706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558645|NCT00126451|Vorinostat|vorinostat|mesh-list
92558646|NCT00126451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558647|NCT00126451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92558648|NCT00126451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558649|NCT00126451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558650|NCT00126607|Trastuzumab|trastuzumab|mesh-list
92558651|NCT00126607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558652|NCT00126607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558653|NCT00074178|Cytarabine|cytarabine|mesh-list
92558654|NCT00074178|Dexamethasone|dexamethasone|mesh-list
92558655|NCT00074178|Cyclophosphamide|cyclophosphamide|mesh-list
92558656|NCT00074178|Methotrexate|methotrexate|mesh-list
92558657|NCT00074178|Etoposide|etoposide|mesh-list
92558658|NCT00074178|Etoposide phosphate|etoposide phosphate|mesh-list
92558659|NCT00074178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558660|NCT00074178|Immunologic Factors|immunologic factors|mesh-ancestor
92558661|NCT00074178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558662|NCT00074178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558663|NCT00074178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92558664|NCT00074178|Alkylating Agents|alkylating agents|mesh-ancestor
92558665|NCT00074178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558666|NCT00074178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558667|NCT00074178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92558668|NCT00074178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558669|NCT00074178|Antiemetics|antiemetics|mesh-ancestor
92558670|NCT00074178|Autonomic Agents|autonomic agents|mesh-ancestor
92558671|NCT00074178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558672|NCT00074178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558673|NCT00074178|Glucocorticoids|glucocorticoids|mesh-ancestor
92558674|NCT00074178|Hormones|hormones|mesh-ancestor
92558675|NCT00074178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92558676|NCT00074178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92558677|NCT00074178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92558678|NCT00074178|Abortifacient Agents|abortifacient agents|mesh-ancestor
92558679|NCT00074178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92558680|NCT00074178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558708|NCT00402571|Acetaminophen|acetaminophen|mesh-list
92558709|NCT00402571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558710|NCT00402571|Analgesics|analgesics|mesh-ancestor
92558711|NCT00402571|Sensory System Agents|sensory system agents|mesh-ancestor
92558712|NCT00402571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558713|NCT00402571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558714|NCT00402571|Antipyretics|antipyretics|mesh-ancestor
92558716|NCT00126880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92558717|NCT00126880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558718|NCT00126880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558719|NCT00126880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558720|NCT00126880|Antiviral Agents|antiviral agents|mesh-ancestor
92558721|NCT00126880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558722|NCT00126880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92558723|NCT00126880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92558724|NCT02965911|Fenofibrate|fenofibrate|mesh-list
92558725|NCT02965911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92558726|NCT02965911|Antimetabolites|antimetabolites|mesh-ancestor
92558727|NCT02965911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558728|NCT02965911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92558729|NCT00127075|Estradiol|estradiol|mesh-list
91966220|NCT03243643|Apatinib|apatinib|mesh-list
92558735|NCT00127114|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92558736|NCT00127114|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92558737|NCT00127114|Antiviral Agents|antiviral agents|mesh-ancestor
92558738|NCT00127114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558739|NCT00127114|Dopamine Agents|dopamine agents|mesh-ancestor
92534628|NCT00070213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534629|NCT00070213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534630|NCT00070213|Immunologic Factors|immunologic factors|mesh-ancestor
92534631|NCT00070213|Antidotes|antidotes|mesh-ancestor
92558740|NCT00127114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558741|NCT00127114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558742|NCT00127114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558743|NCT00127114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558744|NCT00127114|Analgesics|analgesics|mesh-ancestor
92558745|NCT00127114|Sensory System Agents|sensory system agents|mesh-ancestor
92558746|NCT00127114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558747|NCT00043784|Enoxaparin|enoxaparin|mesh-list
92558748|NCT00043784|Anticoagulants|anticoagulants|mesh-ancestor
92558749|NCT00043784|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92558750|NCT00043784|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92558751|NCT00043784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704603|NCT02203643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704604|NCT02203643|Antiemetics|antiemetics|mesh-ancestor
92704605|NCT02203643|Autonomic Agents|autonomic agents|mesh-ancestor
92704606|NCT02203643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704607|NCT02203643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704608|NCT02203643|Glucocorticoids|glucocorticoids|mesh-ancestor
92704609|NCT02203643|Hormones|hormones|mesh-ancestor
92704610|NCT02203643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704611|NCT02203643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92704612|NCT02203643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92704613|NCT02203643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92704614|NCT02203643|Growth Substances|growth substances|mesh-ancestor
92704615|NCT02203643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92704616|NCT01252186|Levonorgestrel|levonorgestrel|mesh-list
92704617|NCT01252186|Desogestrel|desogestrel|mesh-list
92704618|NCT01252186|Contraceptive Agents|contraceptive agents|mesh-list
92704619|NCT01252186|Contraceptives, Oral|contraceptives, oral|mesh-list
92704620|NCT01252186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92704621|NCT01252186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92704622|NCT01252186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704623|NCT01252186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92704624|NCT01252186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92704625|NCT01252186|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92704626|NCT01252186|Progestins|progestins|mesh-ancestor
92704627|NCT01252186|Hormones|hormones|mesh-ancestor
92704628|NCT01252186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704629|NCT01731782|Bupivacaine|bupivacaine|mesh-list
92704630|NCT01731782|Anesthetics, Local|anesthetics, local|mesh-ancestor
92704631|NCT01731782|Anesthetics|anesthetics|mesh-ancestor
92704632|NCT01731782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704633|NCT01731782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704634|NCT01731782|Sensory System Agents|sensory system agents|mesh-ancestor
92704635|NCT01731782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704636|NCT01251952|Denileukin diftitox|denileukin diftitox|mesh-list
92704637|NCT01251952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704638|NCT04356430|Prednisone|prednisone|mesh-list
92704639|NCT04356430|Goserelin|goserelin|mesh-list
92704640|NCT04356430|Abiraterone Acetate|abiraterone acetate|mesh-list
92704641|NCT04356430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704642|NCT04356430|Glucocorticoids|glucocorticoids|mesh-ancestor
92704643|NCT04356430|Hormones|hormones|mesh-ancestor
92704644|NCT04356430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704645|NCT04356430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704646|NCT04356430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92704647|NCT04356430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704648|NCT04356430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92704649|NCT04356430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704650|NCT04356430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558753|NCT00127153|Immunologic Factors|immunologic factors|mesh-ancestor
92558754|NCT00127153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558756|NCT00399477|Pramipexole|pramipexole|mesh-list
92558757|NCT00399477|Rasagiline|rasagiline|mesh-list
92558758|NCT00399477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92558759|NCT00399477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92558760|NCT00399477|Dopamine Agents|dopamine agents|mesh-ancestor
92558761|NCT00399477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534632|NCT00070213|Protective Agents|protective agents|mesh-ancestor
92534633|NCT00070213|Vitamin B Complex|vitamin b complex|mesh-ancestor
92534634|NCT00070213|Vitamins|vitamins|mesh-ancestor
92534635|NCT00070213|Micronutrients|micronutrients|mesh-ancestor
92558762|NCT00399477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558763|NCT00399477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558764|NCT00399477|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92558765|NCT00399477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558766|NCT00399477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92558767|NCT00399477|Protective Agents|protective agents|mesh-ancestor
92558768|NCT00399477|Antioxidants|antioxidants|mesh-ancestor
92558769|NCT00399477|Dopamine Agonists|dopamine agonists|mesh-ancestor
92558770|NCT00127270|Darifenacin|darifenacin|mesh-list
92558771|NCT00127270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92558772|NCT00127270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92558773|NCT00127270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92558774|NCT00127270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558775|NCT00127270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558776|NCT00127270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558777|NCT00127270|Urological Agents|urological agents|mesh-ancestor
92558778|NCT00043823|Bevacizumab|bevacizumab|mesh-list
92558779|NCT00043823|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92558780|NCT00043823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558781|NCT00043823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558782|NCT00043823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92558783|NCT00043823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92558784|NCT00043823|Growth Substances|growth substances|mesh-ancestor
92558785|NCT00043823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558786|NCT00043823|Growth Inhibitors|growth inhibitors|mesh-ancestor
92558787|NCT00043823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92558788|NCT00043823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558789|NCT00043823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558790|NCT00074334|Immunotoxins|immunotoxins|mesh-list
92558791|NCT00074334|Immunoconjugates|immunoconjugates|mesh-ancestor
92558792|NCT00074334|Immunologic Factors|immunologic factors|mesh-ancestor
92558793|NCT00074334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558794|NCT00127387|Etanercept|etanercept|mesh-list
92558795|NCT00127387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92558796|NCT00127387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558797|NCT00127387|Analgesics|analgesics|mesh-ancestor
92558798|NCT00127387|Sensory System Agents|sensory system agents|mesh-ancestor
92558799|NCT00127387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558800|NCT00127387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558801|NCT00127387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558802|NCT00127387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558803|NCT00127387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558804|NCT00127387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558805|NCT00127387|Immunologic Factors|immunologic factors|mesh-ancestor
92558806|NCT00043862|Topotecan|topotecan|mesh-list
92558807|NCT00043862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92558808|NCT00043862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92558809|NCT00043862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558810|NCT00043862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558811|NCT00043862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558812|NCT00127504|Azithromycin|azithromycin|mesh-list
92558813|NCT00127504|Rifampin|rifampin|mesh-list
92558814|NCT00127504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92558815|NCT00127504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558816|NCT00127504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92558817|NCT00127504|Antitubercular Agents|antitubercular agents|mesh-ancestor
92558818|NCT00127504|Leprostatic Agents|leprostatic agents|mesh-ancestor
92558819|NCT00127504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558820|NCT00127504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558821|NCT00127504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558822|NCT00127504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92558823|NCT00127504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92558826|NCT00127504|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92558827|NCT00127504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92558828|NCT00043901|Lamotrigine|lamotrigine|mesh-list
92558829|NCT00043901|Anticonvulsants|anticonvulsants|mesh-ancestor
92558830|NCT00043901|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92534636|NCT00070252|Docetaxel|docetaxel|mesh-list
92534637|NCT00070252|Capecitabine|capecitabine|mesh-list
92534638|NCT00070252|Tipifarnib|tipifarnib|mesh-list
92534639|NCT00070252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558831|NCT00043901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558832|NCT00043901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558833|NCT00043901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92558834|NCT00043901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558835|NCT00043901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92558836|NCT00043901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92558837|NCT00043901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558838|NCT00043901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92558839|NCT00043901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92558840|NCT00127777|Amantadine|amantadine|mesh-list
92558841|NCT00127777|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92558842|NCT00127777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92558843|NCT00127777|Antiviral Agents|antiviral agents|mesh-ancestor
92558844|NCT00127777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558845|NCT00127777|Dopamine Agents|dopamine agents|mesh-ancestor
92558846|NCT00127777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558847|NCT00127777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558848|NCT00127777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558849|NCT00127777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558850|NCT00127777|Analgesics|analgesics|mesh-ancestor
92558851|NCT00127777|Sensory System Agents|sensory system agents|mesh-ancestor
92558852|NCT00127777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558853|NCT00399633|Sumatriptan|sumatriptan|mesh-list
92558854|NCT00399633|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92558855|NCT00399633|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92558856|NCT00399633|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92558857|NCT00399633|Serotonin Agents|serotonin agents|mesh-ancestor
92558858|NCT00399633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558859|NCT00399633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558860|NCT00399633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558861|NCT04727008|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
92558862|NCT04727008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558863|NCT04727008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558864|NCT04726657|Insulin|insulin|mesh-list
92558865|NCT04726657|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92558866|NCT04726657|Insulin, Isophane|insulin, isophane|mesh-list
92558867|NCT04726657|Isophane Insulin, Human|isophane insulin, human|mesh-list
92558868|NCT04726657|Isophane insulin, beef|isophane insulin, beef|mesh-list
92558869|NCT04726657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92558870|NCT04726657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558871|NCT00402610|Rifampin|rifampin|mesh-list
92558872|NCT00402610|Isoniazid|isoniazid|mesh-list
92558873|NCT00402610|Pyrazinamide|pyrazinamide|mesh-list
92558874|NCT00402610|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92558875|NCT00402610|Antitubercular Agents|antitubercular agents|mesh-ancestor
92558876|NCT00402610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92558877|NCT00402610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558878|NCT00402610|Leprostatic Agents|leprostatic agents|mesh-ancestor
92558879|NCT00402610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558880|NCT00402610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558881|NCT00402610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558882|NCT00402610|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92558883|NCT00402610|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92558884|NCT00402610|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92558885|NCT00402610|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92558886|NCT00402610|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92558887|NCT00402610|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92558888|NCT00402610|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92558889|NCT00402610|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92558890|NCT00402610|Antimetabolites|antimetabolites|mesh-ancestor
92558891|NCT00402610|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92558892|NCT00402766|Dexamethasone|dexamethasone|mesh-list
92558893|NCT00402766|Cisplatin|cisplatin|mesh-list
92558894|NCT00402766|Pemetrexed|pemetrexed|mesh-list
92558895|NCT00402766|Imatinib Mesylate|imatinib mesylate|mesh-list
92558906|NCT00402766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92534640|NCT00070252|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534641|NCT00070252|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534642|NCT00070252|Mitosis Modulators|mitosis modulators|mesh-ancestor
92558908|NCT00402766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558909|NCT00402766|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92558910|NCT00402766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558911|NCT00402766|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92558913|NCT00127972|Efavirenz|efavirenz|mesh-list
92558914|NCT00127972|Nevirapine|nevirapine|mesh-list
92558915|NCT00127972|Stavudine|stavudine|mesh-list
92558916|NCT00127972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92558917|NCT00127972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558918|NCT00127972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558919|NCT00127972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558920|NCT00127972|Antiviral Agents|antiviral agents|mesh-ancestor
92558921|NCT00127972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558922|NCT00127972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92558923|NCT00127972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92558924|NCT00127972|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92355166|NCT04124094|Hormones|hormones|mesh-ancestor
92558925|NCT00127972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92558926|NCT00127972|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92558927|NCT00127972|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92558928|NCT00127972|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92558929|NCT00127972|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92558930|NCT00127972|Antimetabolites|antimetabolites|mesh-ancestor
92558931|NCT00043940|Bivalirudin|bivalirudin|mesh-list
92558932|NCT00043940|Antithrombins|antithrombins|mesh-ancestor
92558933|NCT00043940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92558934|NCT00043940|Protease Inhibitors|protease inhibitors|mesh-ancestor
92558935|NCT00043940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558936|NCT00043940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558937|NCT00043940|Anticoagulants|anticoagulants|mesh-ancestor
92558938|NCT04711434|Antibodies|antibodies|mesh-list
92558939|NCT04711434|Immunologic Factors|immunologic factors|mesh-ancestor
92558940|NCT04711434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558941|NCT00128245|Pimecrolimus|pimecrolimus|mesh-list
92558942|NCT00128245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92558943|NCT00128245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92558944|NCT00128245|Analgesics|analgesics|mesh-ancestor
92558945|NCT00128245|Sensory System Agents|sensory system agents|mesh-ancestor
92558946|NCT00128245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558947|NCT00128245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558948|NCT00128245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558949|NCT00128245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558950|NCT00128245|Dermatologic Agents|dermatologic agents|mesh-ancestor
92558951|NCT00128245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558952|NCT00128245|Immunologic Factors|immunologic factors|mesh-ancestor
92558953|NCT00128245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92558954|NCT00128245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558955|NCT00128245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558956|NCT00044057|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92558957|NCT00044057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92558958|NCT00044057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92558961|NCT00044135|Antiviral Agents|antiviral agents|mesh-ancestor
92558962|NCT00044135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558963|NCT05561725|Dexamethasone|dexamethasone|mesh-list
92558964|NCT05561725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558965|NCT05561725|Antiemetics|antiemetics|mesh-ancestor
92558966|NCT05561725|Autonomic Agents|autonomic agents|mesh-ancestor
92558967|NCT05561725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558968|NCT05561725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558969|NCT05561725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558970|NCT05561725|Glucocorticoids|glucocorticoids|mesh-ancestor
92558971|NCT05561725|Hormones|hormones|mesh-ancestor
92558972|NCT05561725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92558973|NCT05561725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92558974|NCT05561725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558976|NCT00078195|Immunoglobulins|immunoglobulins|mesh-list
92558977|NCT00078195|Immunologic Factors|immunologic factors|mesh-list
92558978|NCT00078195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92558979|NCT00078195|Immunomodulating Agents|immunomodulating agents|mesh-list
92534643|NCT00070252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534644|NCT00070252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92534646|NCT00070447|Prednisone|prednisone|mesh-list
92558980|NCT00078195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558981|NCT00078195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92558982|NCT00078195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92558983|NCT00078195|Respiratory System Agents|respiratory system agents|mesh-ancestor
92558984|NCT00044291|Toremifene|toremifene|mesh-list
92558985|NCT00044291|Letrozole|letrozole|mesh-list
92558986|NCT00044291|Hormones|hormones|mesh-list
92558987|NCT00044291|Atamestane|atamestane|mesh-list
92558988|NCT00044291|Estrogen Antagonists|estrogen antagonists|mesh-list
92558989|NCT00044291|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
92558990|NCT00044291|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
92558991|NCT00044291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92558992|NCT00044291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558993|NCT00044291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558994|NCT00044291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92558995|NCT00044291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92558996|NCT00044291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558997|NCT00044291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558998|NCT00044291|Hormone Antagonists|hormone antagonists|mesh-ancestor
92558999|NCT00044291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559000|NCT00044291|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92559001|NCT00044291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92559002|NCT00078234|Rituximab|rituximab|mesh-list
92559003|NCT00078234|Fludarabine|fludarabine|mesh-list
92559004|NCT00078234|Oblimersen|oblimersen|mesh-list
92559005|NCT00078234|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559006|NCT00078234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559007|NCT00078234|Immunologic Factors|immunologic factors|mesh-ancestor
92559008|NCT00078234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559009|NCT00078234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559010|NCT00044408|Ruboxistaurin|ruboxistaurin|mesh-list
92559011|NCT00044408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559012|NCT00044408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559014|NCT00078351|Viscosupplements|viscosupplements|mesh-ancestor
92559015|NCT00078351|Protective Agents|protective agents|mesh-ancestor
92559016|NCT00078351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559017|NCT00044447|Glimepiride|glimepiride|mesh-list
92559018|NCT00044447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92559019|NCT00044447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92559020|NCT00044447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559021|NCT00044447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559022|NCT00044447|Immunologic Factors|immunologic factors|mesh-ancestor
92559023|NCT00397358|Icodextrin|icodextrin|mesh-list
92559024|NCT00397358|Dialysis Solutions|dialysis solutions|mesh-list
92559025|NCT00397358|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92559026|NCT05519917|Afatinib|afatinib|mesh-list
92559027|NCT05519917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559028|NCT05519917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559029|NCT05519917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559030|NCT05519917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559031|NCT00078390|S 3304|s 3304|mesh-list
92559032|NCT00078390|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
92559033|NCT00078390|Protease Inhibitors|protease inhibitors|mesh-ancestor
92559037|NCT00044486|Antifungal Agents|antifungal agents|mesh-ancestor
92559038|NCT00044486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559039|NCT00044486|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92559040|NCT00044486|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92559041|NCT00044486|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92559042|NCT00044486|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92559043|NCT00044486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92559044|NCT00044486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559045|NCT00044486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559046|NCT00044486|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92559047|NCT00044486|Hormone Antagonists|hormone antagonists|mesh-ancestor
92559048|NCT00044486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283828|NCT00002691|Vitamin B Complex|vitamin b complex|mesh-ancestor
92534647|NCT00070447|Cyclophosphamide|cyclophosphamide|mesh-list
92534648|NCT00070447|Rituximab|rituximab|mesh-list
92534649|NCT00070447|Doxorubicin|doxorubicin|mesh-list
92559049|NCT00044486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559050|NCT05497336|Cetuximab|cetuximab|mesh-list
92559051|NCT05497336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559052|NCT05497336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559054|NCT00044525|IDN 5109|idn 5109|mesh-list
92559055|NCT00044525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559056|NCT00074607|Gemcitabine|gemcitabine|mesh-list
92559057|NCT00074607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559058|NCT00074607|Antimetabolites|antimetabolites|mesh-ancestor
92559059|NCT00074607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559060|NCT00074607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559061|NCT05305885|Pemetrexed|pemetrexed|mesh-list
92559062|NCT05305885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559063|NCT05305885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559064|NCT05305885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559065|NCT05305885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92559066|NCT05305885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92559067|NCT00044564|IDN 5109|idn 5109|mesh-list
92559068|NCT00044564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559069|NCT00078546|Antibodies|antibodies|mesh-list
92559070|NCT00078546|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92559071|NCT00078546|Immunologic Factors|immunologic factors|mesh-ancestor
92559072|NCT00078546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559073|NCT00044642|Lorazepam|lorazepam|mesh-list
92559074|NCT00044642|Anticonvulsants|anticonvulsants|mesh-ancestor
92559075|NCT00044642|Antiemetics|antiemetics|mesh-ancestor
92559076|NCT00044642|Autonomic Agents|autonomic agents|mesh-ancestor
92559077|NCT00044642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559078|NCT00044642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559079|NCT00044642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92559080|NCT00044642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92559081|NCT00044642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92559082|NCT00044642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92559083|NCT00044642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92559084|NCT00044642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559085|NCT00044642|GABA Modulators|gaba modulators|mesh-ancestor
92559086|NCT00044642|GABA Agents|gaba agents|mesh-ancestor
92559087|NCT00044642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559088|NCT00044642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559089|NCT00044681|Risperidone|risperidone|mesh-list
92559090|NCT00044681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92559091|NCT00044681|Serotonin Agents|serotonin agents|mesh-ancestor
92559092|NCT00044681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559093|NCT00044681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559094|NCT00044681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559095|NCT00044681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92559096|NCT00044681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92559097|NCT00044681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92559098|NCT00044681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559099|NCT00044681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92559100|NCT00044681|Dopamine Agents|dopamine agents|mesh-ancestor
92559101|NCT00044720|Sirolimus|sirolimus|mesh-list
92559102|NCT00044720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559103|NCT00044720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559104|NCT00044720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559106|NCT00044720|Antifungal Agents|antifungal agents|mesh-ancestor
92559107|NCT00044720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559108|NCT00044720|Immunologic Factors|immunologic factors|mesh-ancestor
92559109|NCT00044720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559111|NCT00403000|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92559112|NCT00403000|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92559113|NCT00403000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559114|NCT00403000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559115|NCT00403000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92559116|NCT00403000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559117|NCT00403000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559118|NCT00397553|Insulin glulisine|insulin glulisine|mesh-list
92559119|NCT00397553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92559120|NCT00397553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559121|NCT00403039|Ranibizumab|ranibizumab|mesh-list
92534650|NCT00070447|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92559122|NCT00403039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92559123|NCT00403039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92559124|NCT00403039|Growth Substances|growth substances|mesh-ancestor
92559125|NCT00403039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559126|NCT00403039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92559127|NCT00403039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559128|NCT00078858|Cyclosporine|cyclosporine|mesh-list
92559129|NCT00078858|Mycophenolic Acid|mycophenolic acid|mesh-list
92559130|NCT00078858|Fludarabine|fludarabine|mesh-list
92559131|NCT00078858|Fludarabine phosphate|fludarabine phosphate|mesh-list
92559132|NCT00078858|Cyclosporins|cyclosporins|mesh-list
92559133|NCT00078858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559134|NCT00078858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559135|NCT00078858|Antimetabolites|antimetabolites|mesh-ancestor
92559136|NCT00078858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559137|NCT00078858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559138|NCT00078858|Immunologic Factors|immunologic factors|mesh-ancestor
92559139|NCT00078858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559140|NCT00078858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559141|NCT00078858|Antifungal Agents|antifungal agents|mesh-ancestor
92559142|NCT00078858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559143|NCT00078858|Dermatologic Agents|dermatologic agents|mesh-ancestor
92559144|NCT00078858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559145|NCT00078858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92559146|NCT00078858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559147|NCT00078858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92559148|NCT00078858|Antitubercular Agents|antitubercular agents|mesh-ancestor
92559149|NCT00078858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559150|NCT00044759|Tazobactam|tazobactam|mesh-list
92559151|NCT00044759|Piperacillin|piperacillin|mesh-list
92559152|NCT00044759|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92559153|NCT00044759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559154|NCT00044759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559155|NCT00044759|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92559156|NCT00044759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559157|NCT00044759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559158|NCT00044798|Citalopram|citalopram|mesh-list
92559159|NCT00044798|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92559160|NCT00044798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92559161|NCT00044798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92559162|NCT00044798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559163|NCT00044798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559164|NCT00044798|Serotonin Agents|serotonin agents|mesh-ancestor
92559165|NCT00044798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559166|NCT00044798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92559167|NCT00044798|Antidepressive Agents|antidepressive agents|mesh-ancestor
92559168|NCT00044798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559169|NCT00074841|Azithromycin|azithromycin|mesh-list
92559170|NCT00074841|Chloroquine|chloroquine|mesh-list
92559171|NCT00074841|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92559172|NCT00074841|Pyrimethamine|pyrimethamine|mesh-list
92559173|NCT00074841|Sulfadoxine|sulfadoxine|mesh-list
92559174|NCT00074841|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92559175|NCT00074841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559176|NCT00074841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559177|NCT00074841|Amebicides|amebicides|mesh-ancestor
92559182|NCT00074841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92559183|NCT00074841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92559184|NCT00074841|Analgesics|analgesics|mesh-ancestor
92559185|NCT00074841|Sensory System Agents|sensory system agents|mesh-ancestor
92559186|NCT00074841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559187|NCT00074841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559188|NCT00074841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92559189|NCT00074841|Filaricides|filaricides|mesh-ancestor
92559190|NCT00074841|Antinematodal Agents|antinematodal agents|mesh-ancestor
92559191|NCT00074841|Anthelmintics|anthelmintics|mesh-ancestor
92559192|NCT00074841|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92559193|NCT00074841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559194|NCT00074841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559195|NCT00074841|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92559196|NCT00078975|Gemcitabine|gemcitabine|mesh-list
92559197|NCT00078975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559198|NCT00078975|Antimetabolites|antimetabolites|mesh-ancestor
92534651|NCT00070447|Vincristine|vincristine|mesh-list
92559199|NCT00078975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559200|NCT00078975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559201|NCT00044837|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92559202|NCT00044837|Medroxyprogesterone|medroxyprogesterone|mesh-list
92559203|NCT00044837|Estradiol|estradiol|mesh-list
92559204|NCT00044837|Estrogens|estrogens|mesh-ancestor
92559205|NCT00044837|Hormones|hormones|mesh-ancestor
92559206|NCT00044837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559207|NCT00044837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559208|NCT00044837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92559209|NCT00044837|Contraceptive Agents|contraceptive agents|mesh-ancestor
92559210|NCT00044837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92559211|NCT00044837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92559212|NCT00044837|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92559213|NCT00044837|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92559214|NCT00044837|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92559215|NCT00044837|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92559216|NCT00044837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559217|NCT00044837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559218|NCT04457557|Ropivacaine|ropivacaine|mesh-list
92559219|NCT04457557|Anesthetics, Local|anesthetics, local|mesh-list
92559220|NCT04457557|Anesthetics|anesthetics|mesh-list
92559221|NCT04457557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92559222|NCT04457557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559223|NCT04457557|Sensory System Agents|sensory system agents|mesh-ancestor
92559224|NCT04457557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559225|NCT00044876|Ulipristal acetate|ulipristal acetate|mesh-list
92559226|NCT00044876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92559227|NCT00044876|Contraceptive Agents|contraceptive agents|mesh-ancestor
92559228|NCT00044876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92559229|NCT00044876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559230|NCT00044876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92559231|NCT00079014|Doxorubicin|doxorubicin|mesh-list
92559232|NCT00079014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92559233|NCT00079014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559234|NCT00079014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559235|NCT00079014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92559236|NCT00079014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92559237|NCT00079014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559238|NCT00079014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559239|NCT00397475|Cholecalciferol|cholecalciferol|mesh-list
92559240|NCT00397475|Vitamin D|vitamin d|mesh-list
92559241|NCT00397475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92559242|NCT00397475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559243|NCT00397475|Vitamins|vitamins|mesh-ancestor
92559244|NCT00397475|Micronutrients|micronutrients|mesh-ancestor
92559245|NCT00397475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92559246|NCT04731740|Pembrolizumab|pembrolizumab|mesh-list
92559247|NCT04731740|Lenvatinib|lenvatinib|mesh-list
91966755|NCT03344393|Analgesics|analgesics|mesh-ancestor
92559250|NCT04731740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92559251|NCT04731740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559252|NCT04731740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559253|NCT04731740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559254|NCT00044915|Repinotan hydrochloride|repinotan hydrochloride|mesh-list
92559255|NCT00044915|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92559256|NCT00044915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92559258|NCT00044915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559259|NCT00044915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559260|NCT00044915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559261|NCT04321408|Ziconotide|ziconotide|mesh-list
92559262|NCT04321408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92559263|NCT04321408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92559264|NCT04321408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559265|NCT04321408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92559266|NCT04321408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559267|NCT04321408|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92559268|NCT04321408|Protective Agents|protective agents|mesh-ancestor
92559269|NCT04321408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92559270|NCT04321408|Analgesics|analgesics|mesh-ancestor
92284055|NCT00002763|Interferon-alpha|interferon-alpha|mesh-list
92559272|NCT04321408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559273|NCT00079053|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92559274|NCT00079053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559275|NCT00079053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559276|NCT00079053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559277|NCT00079053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559278|NCT04263298|Capecitabine|capecitabine|mesh-list
92559279|NCT04263298|Fulvestrant|fulvestrant|mesh-list
92559280|NCT04263298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559281|NCT04263298|Antimetabolites|antimetabolites|mesh-ancestor
92559282|NCT04263298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559283|NCT04263298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559284|NCT04263298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559285|NCT04263298|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92559286|NCT04263298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92559287|NCT04263298|Hormone Antagonists|hormone antagonists|mesh-ancestor
92559288|NCT04263298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559289|NCT04263298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559290|NCT00044954|Cyclosporine|cyclosporine|mesh-list
92559291|NCT00044954|Mycophenolic Acid|mycophenolic acid|mesh-list
92559292|NCT00044954|Fludarabine|fludarabine|mesh-list
92559293|NCT00044954|Fludarabine phosphate|fludarabine phosphate|mesh-list
92355180|NCT04123392|Busulfan|busulfan|mesh-list
92559294|NCT00044954|Cyclosporins|cyclosporins|mesh-list
92559295|NCT00044954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559296|NCT00044954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559297|NCT00044954|Antimetabolites|antimetabolites|mesh-ancestor
92559298|NCT00044954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559299|NCT00044954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559300|NCT00044954|Immunologic Factors|immunologic factors|mesh-ancestor
92559301|NCT00044954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559302|NCT00044954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559303|NCT00044954|Antifungal Agents|antifungal agents|mesh-ancestor
92559304|NCT00044954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559305|NCT00044954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92559306|NCT00044954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559307|NCT00044954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92559308|NCT00044954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559309|NCT00044954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92559310|NCT00044954|Antitubercular Agents|antitubercular agents|mesh-ancestor
92559311|NCT00044954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559312|NCT00079092|Thalidomide|thalidomide|mesh-list
92559313|NCT00079092|Procarbazine|procarbazine|mesh-list
92559314|NCT00079092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559315|NCT00079092|Immunologic Factors|immunologic factors|mesh-ancestor
92559316|NCT00079092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559319|NCT00079092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559320|NCT00079092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92559321|NCT00079092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92559322|NCT00079092|Growth Substances|growth substances|mesh-ancestor
92559323|NCT00079092|Growth Inhibitors|growth inhibitors|mesh-ancestor
92559324|NCT00079092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559325|NCT00044993|Docetaxel|docetaxel|mesh-list
92559326|NCT00044993|Doxorubicin|doxorubicin|mesh-list
92559327|NCT00044993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92559328|NCT00044993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559329|NCT00044993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559330|NCT00044993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559331|NCT00044993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559332|NCT00044993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559333|NCT00044993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559334|NCT00044993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92559335|NCT00044993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92559336|NCT00044993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559337|NCT04162210|Dexamethasone|dexamethasone|mesh-list
92559338|NCT04162210|Pomalidomide|pomalidomide|mesh-list
92559339|NCT04162210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92559340|NCT04162210|Antiemetics|antiemetics|mesh-ancestor
92559341|NCT04162210|Autonomic Agents|autonomic agents|mesh-ancestor
92559342|NCT04162210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559343|NCT04162210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559344|NCT04162210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92559345|NCT04162210|Glucocorticoids|glucocorticoids|mesh-ancestor
92534652|NCT00070447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534653|NCT00070447|Immunologic Factors|immunologic factors|mesh-ancestor
92534654|NCT00070447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559346|NCT04162210|Hormones|hormones|mesh-ancestor
92704652|NCT04356430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92559347|NCT04162210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559348|NCT04162210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559349|NCT04162210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559350|NCT04162210|Immunologic Factors|immunologic factors|mesh-ancestor
92559351|NCT04162210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92559352|NCT04162210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92559353|NCT04162210|Growth Substances|growth substances|mesh-ancestor
92559354|NCT04162210|Growth Inhibitors|growth inhibitors|mesh-ancestor
92559355|NCT00079131|Oblimersen|oblimersen|mesh-list
92559356|NCT00079131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559357|NCT00045149|Aldesleukin|aldesleukin|mesh-list
92559358|NCT00045149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559359|NCT00045149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92559360|NCT00045149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92559361|NCT00045149|Antiviral Agents|antiviral agents|mesh-ancestor
92559362|NCT00045149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559363|NCT00045188|Imatinib Mesylate|imatinib mesylate|mesh-list
92559364|NCT00045188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559365|NCT00045188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559366|NCT00045188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559367|NCT00045188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559368|NCT00403156|Ranibizumab|ranibizumab|mesh-list
92559369|NCT00403156|Imatinib Mesylate|imatinib mesylate|mesh-list
92559370|NCT00403156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92559371|NCT00403156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92559372|NCT00403156|Growth Substances|growth substances|mesh-ancestor
92559373|NCT00403156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559374|NCT00403156|Growth Inhibitors|growth inhibitors|mesh-ancestor
92559375|NCT00403156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559376|NCT00403156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559377|NCT00403156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559378|NCT00403156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559379|NCT00045227|Docetaxel|docetaxel|mesh-list
92559380|NCT00045227|Vaccines|vaccines|mesh-list
92559381|NCT00045227|Sargramostim|sargramostim|mesh-list
92559382|NCT00045227|Immunologic Factors|immunologic factors|mesh-ancestor
92559383|NCT00045227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559384|NCT00045227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559385|NCT00045227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559386|NCT00045227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559387|NCT00045227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559388|NCT00045227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559389|NCT00075075|Infliximab|infliximab|mesh-list
91966918|NCT02494895|Aspirin|aspirin|mesh-list
92559392|NCT00075075|Dermatologic Agents|dermatologic agents|mesh-ancestor
92559393|NCT00075075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92559394|NCT00075075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559395|NCT04065451|Epinephrine|epinephrine|mesh-list
92559396|NCT04065451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92559397|NCT04065451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92559398|NCT04065451|Adrenergic Agents|adrenergic agents|mesh-ancestor
92559399|NCT04065451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559400|NCT04065451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559401|NCT04065451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559402|NCT04065451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92559403|NCT04065451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92559404|NCT04065451|Autonomic Agents|autonomic agents|mesh-ancestor
92559405|NCT04065451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559406|NCT04065451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92559407|NCT04065451|Respiratory System Agents|respiratory system agents|mesh-ancestor
92559408|NCT04065451|Mydriatics|mydriatics|mesh-ancestor
92559409|NCT04065451|Sympathomimetics|sympathomimetics|mesh-ancestor
92559410|NCT04065451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92559411|NCT00045266|Aflibercept|aflibercept|mesh-list
92559412|NCT00045266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92559413|NCT00045266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92559414|NCT00045266|Growth Substances|growth substances|mesh-ancestor
92559415|NCT00045266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534655|NCT00070447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534656|NCT00070447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92559416|NCT00045266|Growth Inhibitors|growth inhibitors|mesh-ancestor
92559417|NCT00045266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559418|NCT03953131|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92559419|NCT03953131|Chelating Agents|chelating agents|mesh-ancestor
92559420|NCT03953131|Sequestering Agents|sequestering agents|mesh-ancestor
92559421|NCT03953131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559422|NCT03948568|Tamoxifen|tamoxifen|mesh-list
92559423|NCT03948568|Letrozole|letrozole|mesh-list
92559424|NCT03948568|Anastrozole|anastrozole|mesh-list
92559425|NCT03948568|Exemestane|exemestane|mesh-list
92559426|NCT03948568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559427|NCT03948568|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92559428|NCT03948568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92559429|NCT03948568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559430|NCT03948568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559431|NCT03948568|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92559432|NCT03948568|Hormone Antagonists|hormone antagonists|mesh-ancestor
92559433|NCT03948568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559434|NCT03948568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559435|NCT03948568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559436|NCT03948568|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92559437|NCT03948568|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92559438|NCT03948568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92559439|NCT03928366|Remifentanil|remifentanil|mesh-list
92559440|NCT03928366|Propofol|propofol|mesh-list
92559441|NCT03928366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92559442|NCT03928366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92559443|NCT03928366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559444|NCT03928366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92559445|NCT03928366|Anesthetics, General|anesthetics, general|mesh-ancestor
92559446|NCT03928366|Anesthetics|anesthetics|mesh-ancestor
92559447|NCT03928366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92559448|NCT03928366|Narcotics|narcotics|mesh-ancestor
92559449|NCT03928366|Analgesics|analgesics|mesh-ancestor
92559450|NCT03928366|Sensory System Agents|sensory system agents|mesh-ancestor
92559451|NCT03928366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559452|NCT00045422|Interferons|interferons|mesh-list
92559453|NCT00045422|Interferon-alpha|interferon-alpha|mesh-list
92559454|NCT00045422|Imatinib Mesylate|imatinib mesylate|mesh-list
92559455|NCT00045422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559456|NCT00045422|Antiviral Agents|antiviral agents|mesh-ancestor
92559457|NCT00045422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559458|NCT00045422|Immunologic Factors|immunologic factors|mesh-ancestor
92559459|NCT00045422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559460|NCT00045422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559461|NCT00045422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966975|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92559476|NCT03739411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92559478|NCT03739411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559479|NCT03739411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559480|NCT00045461|Carboplatin|carboplatin|mesh-list
92559481|NCT00045461|Ifosfamide|ifosfamide|mesh-list
92559482|NCT00045461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559483|NCT00045461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92559484|NCT00045461|Alkylating Agents|alkylating agents|mesh-ancestor
92559485|NCT00045461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559486|NCT00075231|Ritonavir|ritonavir|mesh-list
92559487|NCT00075231|Lopinavir|lopinavir|mesh-list
92559488|NCT00075231|Lamivudine|lamivudine|mesh-list
92559489|NCT00075231|Zidovudine|zidovudine|mesh-list
92559490|NCT00075231|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92559491|NCT00075231|Efavirenz|efavirenz|mesh-list
92559492|NCT00075231|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92559493|NCT00075231|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92559494|NCT00075231|Protease Inhibitors|protease inhibitors|mesh-ancestor
92559495|NCT00075231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559496|NCT00075231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559497|NCT00075231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92559498|NCT00075231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92559499|NCT00075231|Antiviral Agents|antiviral agents|mesh-ancestor
92534657|NCT00070447|Alkylating Agents|alkylating agents|mesh-ancestor
92534658|NCT00070447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534659|NCT00070447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559500|NCT00075231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559501|NCT00075231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92559502|NCT00075231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92559503|NCT00075231|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92559504|NCT00075231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92559505|NCT00075231|Antimetabolites|antimetabolites|mesh-ancestor
92559506|NCT00075231|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92559507|NCT00075231|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92559508|NCT00075231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92559509|NCT00075231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92559510|NCT00075231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92559511|NCT00403312|Nicotine|nicotine|mesh-list
92559512|NCT00403312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92559513|NCT00403312|Autonomic Agents|autonomic agents|mesh-ancestor
92559514|NCT00403312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559515|NCT00403312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559516|NCT00403312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92559517|NCT00403312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92559518|NCT00403312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92559519|NCT00403312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967050|NCT05035485|Protective Agents|protective agents|mesh-ancestor
92559522|NCT00079170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559523|NCT00079170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559524|NCT00079170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559525|NCT00079170|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559526|NCT00079170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559527|NCT00045500|Prednisone|prednisone|mesh-list
92559528|NCT00045500|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92559529|NCT00045500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92559530|NCT00045500|Glucocorticoids|glucocorticoids|mesh-ancestor
92559531|NCT00045500|Hormones|hormones|mesh-ancestor
92559532|NCT00045500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559533|NCT00045500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559534|NCT00045500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559535|NCT00045500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559536|NCT00045500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559537|NCT00045500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559538|NCT00045500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559539|NCT00045539|Leucovorin|leucovorin|mesh-list
92559540|NCT00045539|Methotrexate|methotrexate|mesh-list
92559541|NCT00045539|Thiotepa|thiotepa|mesh-list
92559542|NCT00045539|Calcium|calcium|mesh-list
92559543|NCT00045539|Levoleucovorin|levoleucovorin|mesh-list
92559544|NCT00045539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92559545|NCT00045539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559546|NCT00045539|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92559547|NCT00045539|Abortifacient Agents|abortifacient agents|mesh-ancestor
92559548|NCT00045539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92559549|NCT00045539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559550|NCT00045539|Antimetabolites|antimetabolites|mesh-ancestor
92559551|NCT00045539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559552|NCT00045539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559553|NCT00045539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92559554|NCT00045539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559555|NCT00045539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92559556|NCT00045539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559557|NCT00045539|Immunologic Factors|immunologic factors|mesh-ancestor
92559558|NCT00045539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559559|NCT00045539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92559560|NCT00045539|Antidotes|antidotes|mesh-ancestor
92559561|NCT00045539|Protective Agents|protective agents|mesh-ancestor
92559562|NCT00045539|Vitamin B Complex|vitamin b complex|mesh-ancestor
92559563|NCT00045539|Vitamins|vitamins|mesh-ancestor
92559564|NCT00045539|Micronutrients|micronutrients|mesh-ancestor
92559565|NCT00045539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92559566|NCT00045539|Alkylating Agents|alkylating agents|mesh-ancestor
92559567|NCT00045539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92559568|NCT00079248|Progesterone|progesterone|mesh-list
92534660|NCT00070447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92559569|NCT00079248|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92559570|NCT00079248|Estrogens|estrogens|mesh-list
92559571|NCT00079248|Progestins|progestins|mesh-ancestor
92284357|NCT00382239|Hormones|hormones|mesh-ancestor
92559572|NCT00079248|Hormones|hormones|mesh-ancestor
92559573|NCT00079248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559574|NCT00079248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559575|NCT00045617|Etoposide|etoposide|mesh-list
92559576|NCT00045617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92559577|NCT00045617|Vaccines|vaccines|mesh-list
92559578|NCT00045617|Antibodies|antibodies|mesh-list
92559579|NCT00045617|Immunoglobulins|immunoglobulins|mesh-list
92559580|NCT00045617|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92559581|NCT00045617|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92559582|NCT00045617|Immunologic Factors|immunologic factors|mesh-ancestor
92559583|NCT00045617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559584|NCT00045617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559585|NCT00045617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92559586|NCT00045617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92559587|NCT00045617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92559588|NCT00045617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559589|NCT00045617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559590|NCT03442309|Fluorides|fluorides|mesh-list
92559591|NCT03442309|Fluorides, Topical|fluorides, topical|mesh-list
92559592|NCT03442309|Cariostatic Agents|cariostatic agents|mesh-ancestor
92559599|NCT03399838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559600|NCT03399838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92559601|NCT03399838|Analgesics|analgesics|mesh-ancestor
92559602|NCT03399838|Sensory System Agents|sensory system agents|mesh-ancestor
92559603|NCT03399838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559604|NCT03399838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92559605|NCT03399838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92559606|NCT03399838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92559607|NCT03399838|Adrenergic Agents|adrenergic agents|mesh-ancestor
92559608|NCT03399838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559609|NCT03399838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559610|NCT03399838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92559611|NCT03399838|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92559612|NCT03399838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92559613|NCT03399838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559614|NCT03399838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92559615|NCT03399838|Anesthetics, General|anesthetics, general|mesh-ancestor
92559616|NCT03399838|Anesthetics|anesthetics|mesh-ancestor
92559617|NCT03399838|GABA Modulators|gaba modulators|mesh-ancestor
92559618|NCT03399838|GABA Agents|gaba agents|mesh-ancestor
92559619|NCT00079287|Paclitaxel|paclitaxel|mesh-list
92559620|NCT00079287|Vinorelbine|vinorelbine|mesh-list
92559621|NCT00079287|Docetaxel|docetaxel|mesh-list
92559622|NCT00079287|Carboplatin|carboplatin|mesh-list
92559623|NCT00079287|Gemcitabine|gemcitabine|mesh-list
92559624|NCT00079287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92559625|NCT00079287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559626|NCT00079287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559627|NCT00079287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559628|NCT00079287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559629|NCT00079287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559630|NCT00079287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559631|NCT00079287|Antimetabolites|antimetabolites|mesh-ancestor
92559632|NCT00045695|Bortezomib|bortezomib|mesh-list
92559633|NCT00045695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559634|NCT00079365|Gemcitabine|gemcitabine|mesh-list
92559635|NCT00079365|Fluorouracil|fluorouracil|mesh-list
92559636|NCT00079365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559637|NCT00079365|Antimetabolites|antimetabolites|mesh-ancestor
92559638|NCT00079365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559639|NCT00079365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559640|NCT00079365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559641|NCT00079365|Immunologic Factors|immunologic factors|mesh-ancestor
92559642|NCT00079365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559643|NCT00045773|Sertraline|sertraline|mesh-list
92559644|NCT00045773|Antidepressive Agents|antidepressive agents|mesh-ancestor
92559645|NCT00045773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559646|NCT00045773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92559647|NCT00045773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92704653|NCT03974139|Metformin|metformin|mesh-list
92534661|NCT00070447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559648|NCT00045773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92355208|NCT04760262|Sensory System Agents|sensory system agents|mesh-ancestor
92559649|NCT00045773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559650|NCT00045773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559651|NCT00045773|Serotonin Agents|serotonin agents|mesh-ancestor
92559652|NCT00045773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559653|NCT02839915|Leucovorin|leucovorin|mesh-list
92559654|NCT02839915|Folic Acid|folic acid|mesh-list
92559655|NCT02839915|Levoleucovorin|levoleucovorin|mesh-list
92559656|NCT02839915|Antidotes|antidotes|mesh-ancestor
92559657|NCT02839915|Protective Agents|protective agents|mesh-ancestor
92559658|NCT02839915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559659|NCT02839915|Vitamin B Complex|vitamin b complex|mesh-ancestor
92559660|NCT02839915|Vitamins|vitamins|mesh-ancestor
92559661|NCT02839915|Micronutrients|micronutrients|mesh-ancestor
92559662|NCT02839915|Hematinics|hematinics|mesh-ancestor
92559663|NCT00045812|Ezetimibe|ezetimibe|mesh-list
92559674|NCT00079443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559675|NCT00079443|Immunologic Factors|immunologic factors|mesh-ancestor
92559676|NCT00079443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559677|NCT00079443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559678|NCT00079443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559679|NCT00079443|Antimetabolites|antimetabolites|mesh-ancestor
92559680|NCT00079443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559681|NCT00079443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559682|NCT00079443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559683|NCT00079443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92559684|NCT00079443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559685|NCT02599363|Paclitaxel|paclitaxel|mesh-list
92559686|NCT02599363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92559687|NCT02599363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559688|NCT02599363|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559689|NCT02599363|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559690|NCT02599363|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559691|NCT02599363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559692|NCT02580838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92559693|NCT02580838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92559694|NCT02580838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92559695|NCT02580838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559696|NCT02580838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559697|NCT02580838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92559698|NCT02580838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92559699|NCT02580838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559700|NCT02580838|Cholinergic Agents|cholinergic agents|mesh-ancestor
92559701|NCT02580838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559702|NCT00403429|Capecitabine|capecitabine|mesh-list
92559703|NCT00403429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559704|NCT00403429|Antimetabolites|antimetabolites|mesh-ancestor
92559705|NCT00403429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559706|NCT00403429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559707|NCT00403624|Oxaliplatin|oxaliplatin|mesh-list
92559708|NCT00403624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559709|NCT00079560|Dronabinol|dronabinol|mesh-list
92559710|NCT00079560|Hallucinogens|hallucinogens|mesh-ancestor
92559711|NCT00079560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559712|NCT00079560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559713|NCT00079560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92559714|NCT00079560|Analgesics|analgesics|mesh-ancestor
92559715|NCT00079560|Sensory System Agents|sensory system agents|mesh-ancestor
92559716|NCT00079560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559717|NCT00079560|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92559718|NCT00079560|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92559719|NCT00079560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559720|NCT00079560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559721|NCT00079560|Hormones|hormones|mesh-ancestor
92559722|NCT00079560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559723|NCT00046163|Midodrine|midodrine|mesh-list
92559724|NCT00046163|Sympathomimetics|sympathomimetics|mesh-ancestor
92559725|NCT00046163|Autonomic Agents|autonomic agents|mesh-ancestor
92559726|NCT00046163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559727|NCT00046163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559737|NCT01409161|Tretinoin|tretinoin|mesh-list
92534662|NCT00070447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534663|NCT00070447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92559738|NCT01409161|Retinol palmitate|retinol palmitate|mesh-list
92559739|NCT01409161|Arsenic Trioxide|arsenic trioxide|mesh-list
92559740|NCT01409161|Gemtuzumab|gemtuzumab|mesh-list
92559741|NCT01409161|Calicheamicins|calicheamicins|mesh-list
92559742|NCT01409161|Micronutrients|micronutrients|mesh-ancestor
92559743|NCT01409161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559744|NCT01409161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559745|NCT01409161|Keratolytic Agents|keratolytic agents|mesh-ancestor
92559746|NCT01409161|Dermatologic Agents|dermatologic agents|mesh-ancestor
92559747|NCT01409161|Antioxidants|antioxidants|mesh-ancestor
92559748|NCT01409161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559749|NCT01409161|Protective Agents|protective agents|mesh-ancestor
92559750|NCT01409161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92559751|NCT01409161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559752|NCT01409161|Immunotoxins|immunotoxins|mesh-ancestor
92559753|NCT01409161|Immunoconjugates|immunoconjugates|mesh-ancestor
92559754|NCT01409161|Immunologic Factors|immunologic factors|mesh-ancestor
92559755|NCT01409161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559756|NCT00079638|Niacin|niacin|mesh-list
92559757|NCT00079638|Atorvastatin|atorvastatin|mesh-list
92559758|NCT00079638|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92559759|NCT00079638|Simvastatin|simvastatin|mesh-list
92559760|NCT00079638|Ezetimibe|ezetimibe|mesh-list
92559761|NCT00079638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92559762|NCT00079638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92559763|NCT00079638|Antimetabolites|antimetabolites|mesh-ancestor
92559764|NCT00079638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559765|NCT00079638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92559766|NCT00079638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92559767|NCT00079638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559768|NCT00079638|Vasodilator Agents|vasodilator agents|mesh-ancestor
92559769|NCT00079638|Vitamin B Complex|vitamin b complex|mesh-ancestor
92559770|NCT00079638|Vitamins|vitamins|mesh-ancestor
92559771|NCT00079638|Micronutrients|micronutrients|mesh-ancestor
92559772|NCT00079638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559773|NCT00046241|Bupropion|bupropion|mesh-list
92559774|NCT00046241|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92559775|NCT00046241|Antidepressive Agents|antidepressive agents|mesh-ancestor
92559776|NCT00046241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92559777|NCT00046241|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92559778|NCT00046241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92559779|NCT00046241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92559780|NCT00046241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559781|NCT00046241|Dopamine Agents|dopamine agents|mesh-ancestor
92559782|NCT00046241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559783|NCT00046241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559784|NCT00046241|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92559785|NCT00046241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92559786|NCT00046241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559787|NCT00079716|Dacetuzumab|dacetuzumab|mesh-list
92559788|NCT00079716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559789|NCT00079716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559790|NCT00130468|Hyaluronic Acid|hyaluronic acid|mesh-list
92559791|NCT00130468|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92559792|NCT00130468|Immunologic Factors|immunologic factors|mesh-ancestor
92559793|NCT00130468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559794|NCT00130468|Viscosupplements|viscosupplements|mesh-ancestor
92559807|NCT00130507|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559809|NCT00130546|Paclitaxel|paclitaxel|mesh-list
92559810|NCT00130546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92559811|NCT00130546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559812|NCT00130546|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559813|NCT00130546|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559814|NCT00130546|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559815|NCT00130546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559816|NCT00130546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559817|NCT00130546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559818|NCT00130546|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92559819|NCT00130546|Antifungal Agents|antifungal agents|mesh-ancestor
92559820|NCT00130546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559821|NCT00130546|Immunologic Factors|immunologic factors|mesh-ancestor
92559822|NCT00130546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559823|NCT00130585|Folic Acid|folic acid|mesh-list
92559824|NCT00130585|Vitamin B Complex|vitamin b complex|mesh-list
92559825|NCT00130585|Hematinics|hematinics|mesh-ancestor
92559826|NCT00130585|Vitamins|vitamins|mesh-ancestor
92559827|NCT00130585|Micronutrients|micronutrients|mesh-ancestor
92559828|NCT00130585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559829|NCT00079755|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92559830|NCT00079755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559831|NCT00079755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559832|NCT00079755|Immunotoxins|immunotoxins|mesh-ancestor
92559833|NCT00079755|Immunoconjugates|immunoconjugates|mesh-ancestor
92559834|NCT00079755|Immunologic Factors|immunologic factors|mesh-ancestor
92559835|NCT00079755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559836|NCT00130702|Gefitinib|gefitinib|mesh-list
92559837|NCT00130702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559838|NCT00130702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559839|NCT00130702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559840|NCT00130702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559841|NCT00130819|Buprenorphine|buprenorphine|mesh-list
92559842|NCT00130819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92559843|NCT00130819|Narcotics|narcotics|mesh-ancestor
92559844|NCT00130819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92559845|NCT00130819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559846|NCT00130819|Analgesics|analgesics|mesh-ancestor
92559847|NCT00130819|Sensory System Agents|sensory system agents|mesh-ancestor
92559848|NCT00130819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559849|NCT00130819|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92559850|NCT00130858|Carboplatin|carboplatin|mesh-list
92559851|NCT00130858|Topotecan|topotecan|mesh-list
92559852|NCT00130858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559853|NCT00130858|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92559854|NCT00130858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92559855|NCT00130858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559856|NCT00130858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559857|NCT00130897|Sunitinib|sunitinib|mesh-list
92559858|NCT00130897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559860|NCT00130897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92559861|NCT00130897|Growth Substances|growth substances|mesh-ancestor
92559862|NCT00130897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559863|NCT00130897|Growth Inhibitors|growth inhibitors|mesh-ancestor
92559864|NCT00130897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92559865|NCT00130897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559866|NCT00130897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559868|NCT00046319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92559869|NCT00079833|Esomeprazole|esomeprazole|mesh-list
92559870|NCT00079833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92559871|NCT00079833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92559872|NCT00079833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92559873|NCT00079833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559874|NCT00079833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559875|NCT00079872|Pemetrexed|pemetrexed|mesh-list
92559876|NCT00079872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559877|NCT00079872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559878|NCT00079872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559879|NCT00079872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92559880|NCT00079872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92559881|NCT00046358|Ibuprofen|ibuprofen|mesh-list
92559882|NCT00046358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92559883|NCT00046358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92559884|NCT00046358|Analgesics|analgesics|mesh-ancestor
92559885|NCT00046358|Sensory System Agents|sensory system agents|mesh-ancestor
92559886|NCT00046358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559887|NCT00046358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559888|NCT00046358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92559889|NCT00046358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559890|NCT00046358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92559891|NCT00046358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559892|NCT00046358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559893|NCT00130936|Carboplatin|carboplatin|mesh-list
92559894|NCT00130936|Capecitabine|capecitabine|mesh-list
92559895|NCT00130936|Epirubicin|epirubicin|mesh-list
92559896|NCT00130936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559897|NCT00130936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559898|NCT00130936|Antimetabolites|antimetabolites|mesh-ancestor
92559899|NCT00130936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559900|NCT00130936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534664|NCT00070447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92534665|NCT00070447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559901|NCT00130936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92559902|NCT00130936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92559903|NCT00130936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559904|NCT00130975|Candesartan|candesartan|mesh-list
92559905|NCT00130975|Candesartan cilexetil|candesartan cilexetil|mesh-list
92559906|NCT00130975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92559907|NCT00130975|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92559908|NCT00130975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92559909|NCT00130975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559910|NCT00131053|Cytarabine|cytarabine|mesh-list
92559911|NCT00131053|Dexamethasone|dexamethasone|mesh-list
92559912|NCT00131053|Prednisolone|prednisolone|mesh-list
92559913|NCT00131053|Hydrocortisone|hydrocortisone|mesh-list
92559914|NCT00131053|Cyclophosphamide|cyclophosphamide|mesh-list
92559915|NCT00131053|Methotrexate|methotrexate|mesh-list
92559916|NCT00131053|Vincristine|vincristine|mesh-list
92559917|NCT00131053|Asparaginase|asparaginase|mesh-list
92559918|NCT00131053|Mercaptopurine|mercaptopurine|mesh-list
92559919|NCT00131053|Pirarubicin|pirarubicin|mesh-list
92559920|NCT00131053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92559921|NCT00131053|Immunologic Factors|immunologic factors|mesh-ancestor
92559922|NCT00131053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559923|NCT00131053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559924|NCT00131053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92559925|NCT00131053|Alkylating Agents|alkylating agents|mesh-ancestor
92559926|NCT00131053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559927|NCT00131053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559928|NCT00131053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92559929|NCT00131053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92559930|NCT00131053|Antiemetics|antiemetics|mesh-ancestor
92559931|NCT00131053|Autonomic Agents|autonomic agents|mesh-ancestor
92559932|NCT00131053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92559953|NCT00079911|Valacyclovir|valacyclovir|mesh-list
92559954|NCT00079911|Antiviral Agents|antiviral agents|mesh-ancestor
92559955|NCT00079911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559956|NCT00397592|Hormones|hormones|mesh-list
92559957|NCT00397592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559958|NCT00397592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559959|NCT00131326|Hylan|hylan|mesh-list
92559960|NCT00131326|Viscosupplements|viscosupplements|mesh-ancestor
92559961|NCT00131326|Protective Agents|protective agents|mesh-ancestor
92559962|NCT00131326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559963|NCT00131404|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92559964|NCT00131404|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92559965|NCT00131404|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92559966|NCT00131404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559967|NCT00131404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559968|NCT00131404|Hormones|hormones|mesh-ancestor
92559969|NCT00131404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559970|NCT00131404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559971|NCT00131443|Topiramate|topiramate|mesh-list
92559972|NCT00131443|Anticonvulsants|anticonvulsants|mesh-ancestor
92559973|NCT00131443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92559974|NCT00131443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559975|NCT00079989|Tigecycline|tigecycline|mesh-list
92559976|NCT00079989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559977|NCT00079989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559978|NCT00079989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92559979|NCT00079989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559980|NCT00079989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559981|NCT00131482|Thrombin|thrombin|mesh-list
92559982|NCT00131482|Hemostatics|hemostatics|mesh-ancestor
92559983|NCT00131482|Coagulants|coagulants|mesh-ancestor
92559984|NCT00397709|Rifampin|rifampin|mesh-list
92560008|NCT00131521|Respiratory System Agents|respiratory system agents|mesh-ancestor
92560009|NCT00131521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92560011|NCT00131521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560012|NCT00131521|Protective Agents|protective agents|mesh-ancestor
92560013|NCT00131521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560014|NCT00080028|Motexafin gadolinium|motexafin gadolinium|mesh-list
92560015|NCT00080028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534666|NCT00070447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92534668|NCT00070447|Hormones|hormones|mesh-ancestor
92534669|NCT00070447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560016|NCT00080028|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92560017|NCT00080028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92560018|NCT00131716|Pyrimethamine|pyrimethamine|mesh-list
92560019|NCT00131716|Sulfadoxine|sulfadoxine|mesh-list
92560020|NCT00131716|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92560021|NCT00131716|Antimalarials|antimalarials|mesh-ancestor
92284807|NCT01940276|Abiraterone Acetate|abiraterone acetate|mesh-list
92560022|NCT00131716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92560023|NCT00131716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92560024|NCT00131716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560025|NCT00131716|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92560026|NCT00131716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560027|NCT00131716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560028|NCT00131716|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92560029|NCT00080145|Risperidone|risperidone|mesh-list
92560030|NCT00080145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92560031|NCT00080145|Serotonin Agents|serotonin agents|mesh-ancestor
92560032|NCT00080145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967568|NCT03334487|Antiemetics|antiemetics|mesh-ancestor
92560034|NCT00080145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560035|NCT00080145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92560036|NCT00080145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92560037|NCT00080145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560038|NCT00080145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92560039|NCT00080145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92560040|NCT00080145|Dopamine Agents|dopamine agents|mesh-ancestor
92560042|NCT00403663|Morphine|morphine|mesh-list
92560043|NCT00403663|Bupivacaine|bupivacaine|mesh-list
92560044|NCT00403663|Anesthetics, Local|anesthetics, local|mesh-ancestor
92560045|NCT00403663|Anesthetics|anesthetics|mesh-ancestor
92560046|NCT00403663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560047|NCT00403663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560048|NCT00403663|Sensory System Agents|sensory system agents|mesh-ancestor
92560049|NCT00403663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560050|NCT00403663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92560051|NCT00403663|Narcotics|narcotics|mesh-ancestor
92560052|NCT00403663|Analgesics|analgesics|mesh-ancestor
92560053|NCT00403663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92560054|NCT00403663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92560055|NCT00403663|Anesthetics, General|anesthetics, general|mesh-ancestor
92560056|NCT00403780|Pregabalin|pregabalin|mesh-list
92560057|NCT00403780|Analgesics|analgesics|mesh-ancestor
92560058|NCT00403780|Sensory System Agents|sensory system agents|mesh-ancestor
92560059|NCT00403780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560060|NCT00403780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560061|NCT00403780|Anticonvulsants|anticonvulsants|mesh-ancestor
92560062|NCT00403780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92560063|NCT00403780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560064|NCT00403780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560065|NCT00403780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92560066|NCT00403780|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92560067|NCT00403780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92560068|NCT00403780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560069|NCT00403780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92560070|NCT00046514|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92560071|NCT00046514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560072|NCT00403819|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92560073|NCT00403819|Laxatives|laxatives|mesh-ancestor
92560074|NCT00403819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560075|NCT00403858|Lactulose|lactulose|mesh-list
92560076|NCT00403858|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92560077|NCT00403858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560078|NCT00403858|Laxatives|laxatives|mesh-ancestor
92560079|NCT00046553|Mifepristone|mifepristone|mesh-list
92560080|NCT00046553|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92560081|NCT00046553|Abortifacient Agents|abortifacient agents|mesh-ancestor
92560082|NCT00046553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92560083|NCT00046553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534670|NCT00070447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92534671|NCT00070447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92534672|NCT00070447|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560084|NCT00046553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92560085|NCT00046553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92560086|NCT00046553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92560087|NCT00046553|Contraceptive Agents|contraceptive agents|mesh-ancestor
92560088|NCT00046553|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92560089|NCT00046553|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92560090|NCT00046553|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560091|NCT00046553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560092|NCT00046553|Luteolytic Agents|luteolytic agents|mesh-ancestor
92560093|NCT00046553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92560094|NCT00046553|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92560096|NCT00131989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560097|NCT00131989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92560098|NCT00131989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560099|NCT00131989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560100|NCT00132067|Vorinostat|vorinostat|mesh-list
92560101|NCT00132067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560102|NCT00132067|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92560103|NCT00132067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560104|NCT00132067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560105|NCT00132106|Phentolamine|phentolamine|mesh-list
92560108|NCT00132106|Adrenergic Agents|adrenergic agents|mesh-ancestor
92560109|NCT00132106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560110|NCT00132106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560111|NCT00132106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560112|NCT00132106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92560113|NCT00080340|Gefitinib|gefitinib|mesh-list
92560114|NCT00080340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560115|NCT00080340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92560116|NCT00080340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560117|NCT00080340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560118|NCT00132184|Vitamin D|vitamin d|mesh-list
92560119|NCT00132184|Vitamins|vitamins|mesh-ancestor
92560120|NCT00132184|Micronutrients|micronutrients|mesh-ancestor
92560121|NCT00132184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560122|NCT00132184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92560123|NCT00132379|Docetaxel|docetaxel|mesh-list
92560124|NCT00132379|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
92560125|NCT00132379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560126|NCT00132379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560127|NCT00132379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560128|NCT00132379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560129|NCT00132379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560130|NCT00132379|Immunoconjugates|immunoconjugates|mesh-ancestor
92560131|NCT00132379|Immunologic Factors|immunologic factors|mesh-ancestor
92560132|NCT00132379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560133|NCT00132418|Etanercept|etanercept|mesh-list
92560134|NCT00132418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92560135|NCT00132418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92560136|NCT00132418|Analgesics|analgesics|mesh-ancestor
92560137|NCT00132418|Sensory System Agents|sensory system agents|mesh-ancestor
92560138|NCT00132418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560139|NCT00132418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560140|NCT00132418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560141|NCT00132418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560142|NCT00132418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560143|NCT00132418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560144|NCT00132418|Immunologic Factors|immunologic factors|mesh-ancestor
92560145|NCT00132535|Chloroquine|chloroquine|mesh-list
92560146|NCT00132535|Pyrimethamine|pyrimethamine|mesh-list
92560147|NCT00132535|Sulfadoxine|sulfadoxine|mesh-list
92560148|NCT00132535|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92560149|NCT00132535|Amebicides|amebicides|mesh-ancestor
92560150|NCT00132535|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92560151|NCT00132535|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92560152|NCT00132535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534673|NCT00070447|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534674|NCT00070447|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534675|NCT03959865|Glucagon|glucagon|mesh-list
92534676|NCT03959865|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92534677|NCT03959865|Incretins|incretins|mesh-ancestor
92534678|NCT03959865|Hormones|hormones|mesh-ancestor
92560153|NCT00132535|Antimalarials|antimalarials|mesh-ancestor
92560154|NCT00132535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560155|NCT00132535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92560156|NCT00132535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560157|NCT00132535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560158|NCT00132535|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92560159|NCT00132613|Bleomycin|bleomycin|mesh-list
92560160|NCT00132613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560161|NCT00132613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560162|NCT00132652|Lamivudine|lamivudine|mesh-list
92560163|NCT00132652|Telbivudine|telbivudine|mesh-list
92560164|NCT00132652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92560165|NCT00132652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92560166|NCT00132652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560167|NCT00132652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560168|NCT00132652|Antiviral Agents|antiviral agents|mesh-ancestor
92560169|NCT00132652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560170|NCT00132652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92560171|NCT00132652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92560172|NCT00046748|Omalizumab|omalizumab|mesh-list
92560173|NCT00046748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92560174|NCT00046748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92560175|NCT00046748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92560176|NCT00132886|Tolvaptan|tolvaptan|mesh-list
92560177|NCT00132886|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92560178|NCT00132886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560179|NCT00132886|Natriuretic Agents|natriuretic agents|mesh-ancestor
92560196|NCT00133003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92560197|NCT00046787|Lurtotecan|lurtotecan|mesh-list
92560198|NCT00046787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560199|NCT00133042|Omalizumab|omalizumab|mesh-list
92560200|NCT00133042|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92560201|NCT00133042|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92560202|NCT00133042|Respiratory System Agents|respiratory system agents|mesh-ancestor
92560203|NCT00080457|Sitaxsentan|sitaxsentan|mesh-list
92560204|NCT00080457|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92560205|NCT00080457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560206|NCT00133081|Anticonvulsants|anticonvulsants|mesh-list
92560207|NCT00133198|Pramipexole|pramipexole|mesh-list
92560208|NCT00133198|Antioxidants|antioxidants|mesh-ancestor
92560209|NCT00133198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560210|NCT00133198|Protective Agents|protective agents|mesh-ancestor
92560211|NCT00133198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560212|NCT00133198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92560213|NCT00133198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92560214|NCT00133198|Dopamine Agonists|dopamine agonists|mesh-ancestor
92560215|NCT00133198|Dopamine Agents|dopamine agents|mesh-ancestor
92560216|NCT00133198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560217|NCT00046826|Thalidomide|thalidomide|mesh-list
92560218|NCT00046826|Docetaxel|docetaxel|mesh-list
92560219|NCT00046826|Estramustine|estramustine|mesh-list
92560220|NCT00046826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560221|NCT00046826|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560222|NCT00046826|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560223|NCT00046826|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560224|NCT00046826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560225|NCT00046826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560226|NCT00046826|Immunologic Factors|immunologic factors|mesh-ancestor
92560227|NCT00046826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560228|NCT00046826|Leprostatic Agents|leprostatic agents|mesh-ancestor
92560229|NCT00046826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92560230|NCT00046826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560231|NCT00046826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92560232|NCT00046826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92560233|NCT00046826|Growth Substances|growth substances|mesh-ancestor
92560234|NCT00046826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534679|NCT03959865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534680|NCT03959865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560235|NCT00046826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560236|NCT00046826|Alkylating Agents|alkylating agents|mesh-ancestor
92560237|NCT00046826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560238|NCT00133237|Sirolimus|sirolimus|mesh-list
92560239|NCT00133237|Paclitaxel|paclitaxel|mesh-list
92560241|NCT00133237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560242|NCT00133237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560243|NCT00133237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560244|NCT00133237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560245|NCT00133237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560246|NCT00133237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92560247|NCT00133237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560248|NCT00133237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560249|NCT00133237|Antifungal Agents|antifungal agents|mesh-ancestor
92560250|NCT00133237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560251|NCT00133237|Immunologic Factors|immunologic factors|mesh-ancestor
92560252|NCT00133237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560253|NCT00399672|Interferons|interferons|mesh-list
92560255|NCT00399672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560256|NCT00399672|Antiviral Agents|antiviral agents|mesh-ancestor
92560257|NCT00399672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560258|NCT00399672|Antimetabolites|antimetabolites|mesh-ancestor
92560259|NCT00399672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560260|NCT00133276|Escitalopram|escitalopram|mesh-list
92560261|NCT00133276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92560262|NCT00133276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92560263|NCT00133276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560264|NCT00133276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560265|NCT00133276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560266|NCT00133276|Serotonin Agents|serotonin agents|mesh-ancestor
92560267|NCT00133276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560268|NCT00131755|Diazoxide|diazoxide|mesh-list
92560269|NCT00131755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92560270|NCT00131755|Vasodilator Agents|vasodilator agents|mesh-ancestor
92560271|NCT00133315|Adalimumab|adalimumab|mesh-list
92560272|NCT00133315|Infliximab|infliximab|mesh-list
92560273|NCT00133315|Etanercept|etanercept|mesh-list
92560274|NCT00133315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92560275|NCT00133315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560276|NCT00133315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560277|NCT00133315|Dermatologic Agents|dermatologic agents|mesh-ancestor
92560278|NCT00133315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560279|NCT00133315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92560280|NCT00133315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92560281|NCT00133315|Analgesics|analgesics|mesh-ancestor
92560282|NCT00133315|Sensory System Agents|sensory system agents|mesh-ancestor
92560283|NCT00133315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560284|NCT00133315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560285|NCT00133315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560286|NCT00133315|Immunologic Factors|immunologic factors|mesh-ancestor
92560287|NCT00080496|Imipenem|imipenem|mesh-list
92560288|NCT00080496|Tigecycline|tigecycline|mesh-list
92560289|NCT00080496|Cilastatin|cilastatin|mesh-list
92560290|NCT00080496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92560291|NCT00080496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560292|NCT00080496|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92560293|NCT00080496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560294|NCT00080496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560295|NCT00080496|Protease Inhibitors|protease inhibitors|mesh-ancestor
92560296|NCT00133354|Anastrozole|anastrozole|mesh-list
92560297|NCT00133354|Hormones|hormones|mesh-list
92560298|NCT00133354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560299|NCT00133354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560300|NCT00133354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560301|NCT00133354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560302|NCT00133354|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92560303|NCT00133354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92560304|NCT00133354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560305|NCT00133354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560306|NCT00133354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92534681|NCT03959865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92534682|NCT00070486|Celecoxib|celecoxib|mesh-list
92534683|NCT00070486|Zileuton|zileuton|mesh-list
92560307|NCT00133354|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560308|NCT00133393|Pentoxifylline|pentoxifylline|mesh-list
92560309|NCT00133393|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92560310|NCT00133393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560311|NCT00133393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560312|NCT00133393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92560316|NCT00133393|Vasodilator Agents|vasodilator agents|mesh-ancestor
92560317|NCT00133393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92560318|NCT00133393|Antioxidants|antioxidants|mesh-ancestor
92560320|NCT00046904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92560321|NCT00046904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92560322|NCT00046904|Analgesics|analgesics|mesh-ancestor
92560323|NCT00046904|Sensory System Agents|sensory system agents|mesh-ancestor
92560324|NCT00046904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560325|NCT00046904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560326|NCT00046904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560327|NCT00046904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560328|NCT00046904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560329|NCT00046904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560330|NCT00046904|Immunologic Factors|immunologic factors|mesh-ancestor
92560331|NCT00403897|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92560332|NCT00403897|Laxatives|laxatives|mesh-ancestor
92560333|NCT00403897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560334|NCT00403975|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92560335|NCT00403975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92560336|NCT00046943|Atrasentan|atrasentan|mesh-list
92560337|NCT00046943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560338|NCT00046943|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92560339|NCT00046943|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92560340|NCT00046943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560341|NCT00133549|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92560342|NCT00133549|Immunologic Factors|immunologic factors|mesh-ancestor
92560343|NCT00133549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560344|NCT00080613|Exemestane|exemestane|mesh-list
92560345|NCT00080613|Hormones|hormones|mesh-list
92560346|NCT00080613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560347|NCT00080613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560348|NCT00080613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560349|NCT00080613|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92560350|NCT00080613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92560351|NCT00080613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560352|NCT00080613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560353|NCT00080613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92560354|NCT00080613|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560355|NCT00047021|Cytarabine|cytarabine|mesh-list
92560356|NCT00047021|Mitoxantrone|mitoxantrone|mesh-list
92560357|NCT00047021|Sargramostim|sargramostim|mesh-list
92560358|NCT00047021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560359|NCT00047021|Antimetabolites|antimetabolites|mesh-ancestor
92560360|NCT00047021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560361|NCT00047021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560362|NCT00047021|Antiviral Agents|antiviral agents|mesh-ancestor
92560363|NCT00047021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560364|NCT00047021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560365|NCT00047021|Immunologic Factors|immunologic factors|mesh-ancestor
92560366|NCT00047021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560367|NCT00047021|Analgesics|analgesics|mesh-ancestor
92560368|NCT00047021|Sensory System Agents|sensory system agents|mesh-ancestor
92560369|NCT00047021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560370|NCT00047021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560371|NCT00047021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560372|NCT00047021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560373|NCT00133627|Ketotifen|ketotifen|mesh-list
92560374|NCT00133627|Antipruritics|antipruritics|mesh-ancestor
92560375|NCT00133627|Dermatologic Agents|dermatologic agents|mesh-ancestor
92560376|NCT00133627|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92560377|NCT00133627|Histamine Antagonists|histamine antagonists|mesh-ancestor
92560378|NCT00133627|Histamine Agents|histamine agents|mesh-ancestor
92560379|NCT00133627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560380|NCT00133627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560381|NCT00133627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560382|NCT00133627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92560383|NCT00133744|Folic Acid|folic acid|mesh-list
91967898|NCT03331523|Calcipotriene|calcipotriene|mesh-list
92560399|NCT00080808|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92285177|NCT01675297|Micronutrients|micronutrients|mesh-ancestor
92560400|NCT00080808|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92560401|NCT00080808|Adrenergic Agents|adrenergic agents|mesh-ancestor
92704654|NCT03974139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92560402|NCT00080808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560403|NCT00080808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560404|NCT00080808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92560405|NCT00080808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92560407|NCT00047099|Cyclophosphamide|cyclophosphamide|mesh-list
92560408|NCT00047099|Docetaxel|docetaxel|mesh-list
92560409|NCT00047099|Fluorouracil|fluorouracil|mesh-list
92560410|NCT00047099|Epirubicin|epirubicin|mesh-list
92560411|NCT00047099|Goserelin|goserelin|mesh-list
92560412|NCT00047099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560413|NCT00047099|Immunologic Factors|immunologic factors|mesh-ancestor
92560414|NCT00047099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560415|NCT00047099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560416|NCT00047099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560417|NCT00047099|Alkylating Agents|alkylating agents|mesh-ancestor
92560418|NCT00047099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560419|NCT00047099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560420|NCT00047099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92560421|NCT00047099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560422|NCT00047099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560423|NCT00047099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560424|NCT00047099|Antimetabolites|antimetabolites|mesh-ancestor
92560425|NCT00047099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560426|NCT00047099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560427|NCT00047099|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560428|NCT00047099|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560429|NCT00047099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560430|NCT00047099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92560431|NCT00047099|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560432|NCT00047099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560433|NCT00047099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560434|NCT00047099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92560435|NCT00047099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92560436|NCT00047099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92560437|NCT00133822|Risperidone|risperidone|mesh-list
92560438|NCT00133822|Sertraline|sertraline|mesh-list
92560439|NCT00133822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92560440|NCT00133822|Serotonin Agents|serotonin agents|mesh-ancestor
92560441|NCT00133822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560442|NCT00133822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560443|NCT00133822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560444|NCT00133822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92560463|NCT00134095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92560464|NCT00134095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560465|NCT00134095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560466|NCT00134095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560467|NCT00134095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560468|NCT00134095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560469|NCT00134095|Antimetabolites|antimetabolites|mesh-ancestor
92560470|NCT00047138|Dactinomycin|dactinomycin|mesh-list
92560471|NCT00047138|Cyclophosphamide|cyclophosphamide|mesh-list
92560472|NCT00047138|Carboplatin|carboplatin|mesh-list
92560473|NCT00047138|Doxorubicin|doxorubicin|mesh-list
92560474|NCT00047138|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92560475|NCT00047138|Etoposide|etoposide|mesh-list
92560476|NCT00047138|Vincristine|vincristine|mesh-list
92560477|NCT00047138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560478|NCT00047138|Immunologic Factors|immunologic factors|mesh-ancestor
92560479|NCT00047138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560480|NCT00047138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560481|NCT00047138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560482|NCT00047138|Alkylating Agents|alkylating agents|mesh-ancestor
92560483|NCT00047138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560484|NCT00047138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560485|NCT00047138|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92534684|NCT00070486|Carboplatin|carboplatin|mesh-list
92534685|NCT00070486|Gemcitabine|gemcitabine|mesh-list
92534686|NCT00070486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91911985|NCT02145715|Immunologic Factors|immunologic factors|mesh-ancestor
92355446|NCT03829566|Methylprednisolone|methylprednisolone|mesh-list
92560486|NCT00047138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560487|NCT00047138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560488|NCT00047138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560489|NCT00047138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560490|NCT00047138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560491|NCT00047138|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560492|NCT00047138|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560493|NCT00047138|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560494|NCT00047138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92560495|NCT00047138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560496|NCT00047138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92560497|NCT00047138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92560498|NCT00080847|Prednisone|prednisone|mesh-list
92560499|NCT00080847|Cyclophosphamide|cyclophosphamide|mesh-list
92560500|NCT00080847|Rituximab|rituximab|mesh-list
92560505|NCT00080847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560506|NCT00080847|Immunologic Factors|immunologic factors|mesh-ancestor
92560507|NCT00080847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560508|NCT00080847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560509|NCT00080847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560510|NCT00080847|Alkylating Agents|alkylating agents|mesh-ancestor
92560511|NCT00080847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560512|NCT00080847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560513|NCT00080847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92560514|NCT00080847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92560515|NCT00080847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560516|NCT00080847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560517|NCT00080847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560518|NCT00080847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560519|NCT00080847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560520|NCT00080847|Glucocorticoids|glucocorticoids|mesh-ancestor
92560521|NCT00080847|Hormones|hormones|mesh-ancestor
92560522|NCT00080847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560523|NCT00080847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560524|NCT00080847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560525|NCT00080847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560526|NCT00080847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560527|NCT00080847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560528|NCT00134173|Atorvastatin|atorvastatin|mesh-list
92560529|NCT00134173|Torcetrapib|torcetrapib|mesh-list
92560530|NCT00134173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92560531|NCT00134173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92560532|NCT00134173|Antimetabolites|antimetabolites|mesh-ancestor
92560533|NCT00134173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560534|NCT00134173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92560535|NCT00134173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92560536|NCT00134173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560537|NCT00047177|Oxaliplatin|oxaliplatin|mesh-list
92560538|NCT00047177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560539|NCT00080886|Cytarabine|cytarabine|mesh-list
92560540|NCT00080886|Rituximab|rituximab|mesh-list
92560541|NCT00080886|Etoposide|etoposide|mesh-list
92560542|NCT00080886|Melphalan|melphalan|mesh-list
92560543|NCT00080886|Carmustine|carmustine|mesh-list
92560544|NCT00080886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92560545|NCT00080886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560546|NCT00080886|Immunologic Factors|immunologic factors|mesh-ancestor
92560547|NCT00080886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560548|NCT00080886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560549|NCT00080886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560550|NCT00080886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560551|NCT00080886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560552|NCT00080886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560553|NCT00080886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560554|NCT00080886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560555|NCT00080886|Antimetabolites|antimetabolites|mesh-ancestor
92560556|NCT00080886|Antiviral Agents|antiviral agents|mesh-ancestor
92560557|NCT00080886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534687|NCT00070486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560558|NCT00080886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560559|NCT00080886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560560|NCT00080886|Alkylating Agents|alkylating agents|mesh-ancestor
92560561|NCT00080886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92560563|NCT00134212|Norepinephrine|norepinephrine|mesh-list
92560564|NCT00134212|Dopexamine|dopexamine|mesh-list
92560565|NCT00134212|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92560566|NCT00134212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92560567|NCT00134212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92560568|NCT00134212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560569|NCT00134212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560570|NCT00134212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560571|NCT00134212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92560572|NCT00134212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92560573|NCT00134212|Autonomic Agents|autonomic agents|mesh-ancestor
92560580|NCT00134212|Vasodilator Agents|vasodilator agents|mesh-ancestor
92560581|NCT00134212|Dopamine Agonists|dopamine agonists|mesh-ancestor
92560582|NCT00134212|Dopamine Agents|dopamine agents|mesh-ancestor
92560583|NCT00134290|Metformin|metformin|mesh-list
92560584|NCT00134290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92560585|NCT00134290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560586|NCT00047216|Tipifarnib|tipifarnib|mesh-list
92560587|NCT00047216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560588|NCT00080925|Cytarabine|cytarabine|mesh-list
92560589|NCT00080925|Cyclosporine|cyclosporine|mesh-list
92560590|NCT00080925|Prednisone|prednisone|mesh-list
92560591|NCT00080925|Cyclophosphamide|cyclophosphamide|mesh-list
92560592|NCT00080925|Rituximab|rituximab|mesh-list
92560593|NCT00080925|Doxorubicin|doxorubicin|mesh-list
92560594|NCT00080925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92560595|NCT00080925|Fludarabine|fludarabine|mesh-list
92560596|NCT00080925|Fludarabine phosphate|fludarabine phosphate|mesh-list
92560597|NCT00080925|Etoposide|etoposide|mesh-list
92560598|NCT00080925|Vincristine|vincristine|mesh-list
92560599|NCT00080925|Cyclosporins|cyclosporins|mesh-list
92560600|NCT00080925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560601|NCT00080925|Immunologic Factors|immunologic factors|mesh-ancestor
92560602|NCT00080925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560603|NCT00080925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560604|NCT00080925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560605|NCT00080925|Alkylating Agents|alkylating agents|mesh-ancestor
92560606|NCT00080925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560607|NCT00080925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560608|NCT00080925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92560609|NCT00080925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92560610|NCT00080925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560611|NCT00080925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560612|NCT00080925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560613|NCT00080925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560614|NCT00080925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560615|NCT00080925|Glucocorticoids|glucocorticoids|mesh-ancestor
92560616|NCT00080925|Hormones|hormones|mesh-ancestor
92560617|NCT00080925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560618|NCT00080925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560619|NCT00080925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560620|NCT00080925|Antimetabolites|antimetabolites|mesh-ancestor
92560621|NCT00080925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560622|NCT00080925|Antiviral Agents|antiviral agents|mesh-ancestor
92560623|NCT00080925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560624|NCT00080925|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560625|NCT00080925|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560626|NCT00080925|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560627|NCT00080925|Antifungal Agents|antifungal agents|mesh-ancestor
92560628|NCT00080925|Dermatologic Agents|dermatologic agents|mesh-ancestor
92560629|NCT00080925|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92560630|NCT04705831|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92560631|NCT04705831|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92560632|NCT04705831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560633|NCT04705831|Immunologic Factors|immunologic factors|mesh-ancestor
92560634|NCT04705831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560635|NCT00047255|Carboplatin|carboplatin|mesh-list
92560636|NCT00047255|Docetaxel|docetaxel|mesh-list
92560637|NCT00047255|Trastuzumab|trastuzumab|mesh-list
92560638|NCT00047255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560639|NCT00047255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534688|NCT00070486|Antimetabolites|antimetabolites|mesh-ancestor
92534689|NCT00070486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534690|NCT00070486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91912127|NCT02769247|Naproxen|naproxen|mesh-list
92560640|NCT00047255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560641|NCT00047255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560642|NCT00047255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560643|NCT00047255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92560644|NCT00134368|Etanercept|etanercept|mesh-list
92560645|NCT00134368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92560648|NCT00134368|Sensory System Agents|sensory system agents|mesh-ancestor
92560649|NCT00134368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560650|NCT00134368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560651|NCT00134368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560652|NCT00134368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560653|NCT00134368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560654|NCT00134368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560655|NCT00134368|Immunologic Factors|immunologic factors|mesh-ancestor
92560656|NCT00134485|Atorvastatin|atorvastatin|mesh-list
92560657|NCT00134485|Torcetrapib|torcetrapib|mesh-list
92560658|NCT00134485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92560659|NCT00134485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92560660|NCT00134485|Antimetabolites|antimetabolites|mesh-ancestor
92560661|NCT00134485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560662|NCT00134485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92560663|NCT00134485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92560664|NCT00134485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560665|NCT00047294|Thalidomide|thalidomide|mesh-list
92560667|NCT00047294|Temozolomide|temozolomide|mesh-list
92560668|NCT00047294|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560669|NCT00047294|Alkylating Agents|alkylating agents|mesh-ancestor
92560670|NCT00047294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560671|NCT00047294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560672|NCT00047294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92560673|NCT00047294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92560674|NCT00047294|Analgesics|analgesics|mesh-ancestor
92560675|NCT00047294|Sensory System Agents|sensory system agents|mesh-ancestor
92560676|NCT00047294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560677|NCT00047294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560678|NCT00047294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560679|NCT00047294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560680|NCT00047294|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92560681|NCT00047294|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92560682|NCT00047294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560683|NCT00047294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560684|NCT00047294|Immunologic Factors|immunologic factors|mesh-ancestor
92560685|NCT00047294|Leprostatic Agents|leprostatic agents|mesh-ancestor
92560686|NCT00047294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92560687|NCT00047294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560688|NCT00047294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92560689|NCT00047294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92560690|NCT00047294|Growth Substances|growth substances|mesh-ancestor
92560691|NCT00047294|Growth Inhibitors|growth inhibitors|mesh-ancestor
92560692|NCT00042822|Romidepsin|romidepsin|mesh-list
92560693|NCT00042822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92560694|NCT00042822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560695|NCT00042822|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92560696|NCT00042822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560697|NCT00042822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560698|NCT00134641|Gemcitabine|gemcitabine|mesh-list
92560699|NCT00134641|Vinorelbine|vinorelbine|mesh-list
92560700|NCT00134641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560701|NCT00134641|Antimetabolites|antimetabolites|mesh-ancestor
92560702|NCT00134641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560703|NCT00134641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560704|NCT00134641|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92285476|NCT01701505|Tetracaine|tetracaine|mesh-list
92560705|NCT00134641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560706|NCT00134641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534691|NCT00070486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92534692|NCT00070486|Analgesics|analgesics|mesh-ancestor
92534693|NCT00070486|Sensory System Agents|sensory system agents|mesh-ancestor
92560707|NCT00134641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560708|NCT00134680|Trastuzumab|trastuzumab|mesh-list
92560709|NCT00134680|Letrozole|letrozole|mesh-list
92560710|NCT00134680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92560711|NCT00134680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560712|NCT00134680|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92560713|NCT00134680|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92560714|NCT00134680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560715|NCT00134680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560716|NCT00134680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92560717|NCT00134680|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560722|NCT00134758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560724|NCT00081042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92560725|NCT00081042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560726|NCT00081042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560727|NCT00081042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560728|NCT00081042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560729|NCT00081042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92560730|NCT00081042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560731|NCT00047333|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92560732|NCT00047333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560733|NCT00047333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92560734|NCT00047333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560735|NCT00047333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560736|NCT00134875|Buprenorphine|buprenorphine|mesh-list
92560737|NCT00134875|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92560738|NCT00134875|Naloxone|naloxone|mesh-list
92560739|NCT00134875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92560740|NCT00134875|Narcotics|narcotics|mesh-ancestor
92560741|NCT00134875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560742|NCT00134875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560743|NCT00134875|Analgesics|analgesics|mesh-ancestor
92560744|NCT00134875|Sensory System Agents|sensory system agents|mesh-ancestor
92560745|NCT00134875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560746|NCT00134875|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92560747|NCT00134914|Buprenorphine|buprenorphine|mesh-list
92560748|NCT00134914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92560749|NCT00134914|Narcotics|narcotics|mesh-ancestor
92560750|NCT00134914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560751|NCT00134914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560752|NCT00134914|Analgesics|analgesics|mesh-ancestor
92560753|NCT00134914|Sensory System Agents|sensory system agents|mesh-ancestor
92560754|NCT00134914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560755|NCT00134914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92560756|NCT00134953|Rivastigmine|rivastigmine|mesh-list
92560757|NCT00134953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92560758|NCT00134953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560759|NCT00134953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560760|NCT00134953|Cholinergic Agents|cholinergic agents|mesh-ancestor
92560761|NCT00134953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560762|NCT00134953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560763|NCT00134953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92560764|NCT00134953|Protective Agents|protective agents|mesh-ancestor
92560765|NCT00042861|Leucovorin|leucovorin|mesh-list
92560766|NCT00042861|Fluorouracil|fluorouracil|mesh-list
92560767|NCT00042861|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92560768|NCT00042861|Calcium|calcium|mesh-list
92560769|NCT00042861|Levoleucovorin|levoleucovorin|mesh-list
92355548|NCT03828084|Antimetabolites|antimetabolites|mesh-ancestor
92560770|NCT00042861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92560771|NCT00042861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560772|NCT00042861|Antimetabolites|antimetabolites|mesh-ancestor
92560773|NCT00042861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560774|NCT00042861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92560775|NCT00042861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560776|NCT00042861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92560777|NCT00042861|Immunologic Factors|immunologic factors|mesh-ancestor
92560778|NCT00042861|Antidotes|antidotes|mesh-ancestor
92560779|NCT00042861|Protective Agents|protective agents|mesh-ancestor
92560781|NCT00042861|Vitamins|vitamins|mesh-ancestor
92560782|NCT00042861|Micronutrients|micronutrients|mesh-ancestor
92534694|NCT00070486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534695|NCT00070486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534696|NCT00070486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92534697|NCT00070486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92560783|NCT00042861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92560784|NCT00042861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560785|NCT00134992|Prednisolone|prednisolone|mesh-list
92560786|NCT00134992|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92560787|NCT00134992|Methylprednisolone|methylprednisolone|mesh-list
92560788|NCT00134992|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92560793|NCT00134992|Glucocorticoids|glucocorticoids|mesh-ancestor
92560794|NCT00134992|Hormones|hormones|mesh-ancestor
92560795|NCT00134992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560796|NCT00134992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560797|NCT00134992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560798|NCT00134992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560799|NCT00134992|Antiemetics|antiemetics|mesh-ancestor
92560800|NCT00134992|Autonomic Agents|autonomic agents|mesh-ancestor
92560801|NCT00134992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560802|NCT00134992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560803|NCT00134992|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92560804|NCT00134992|Protective Agents|protective agents|mesh-ancestor
92560805|NCT00135070|Insulin Detemir|insulin detemir|mesh-list
92560806|NCT00135070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92560807|NCT00135070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560808|NCT00135187|Dexamethasone|dexamethasone|mesh-list
92560809|NCT00135187|Bortezomib|bortezomib|mesh-list
92560810|NCT00135187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560811|NCT00135187|Antiemetics|antiemetics|mesh-ancestor
92560812|NCT00135187|Autonomic Agents|autonomic agents|mesh-ancestor
92560813|NCT00135187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560814|NCT00135187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560815|NCT00135187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560816|NCT00135187|Glucocorticoids|glucocorticoids|mesh-ancestor
92560817|NCT00135187|Hormones|hormones|mesh-ancestor
92560818|NCT00135187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560819|NCT00135187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560820|NCT00135187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560821|NCT00145093|Chromium|chromium|mesh-list
92560822|NCT00145093|Trace Elements|trace elements|mesh-ancestor
92560823|NCT00145093|Micronutrients|micronutrients|mesh-ancestor
92560824|NCT00145093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560825|NCT00047450|Citalopram|citalopram|mesh-list
92560826|NCT00047450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92560827|NCT00047450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92560828|NCT00047450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560829|NCT00047450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560830|NCT00047450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560831|NCT00047450|Serotonin Agents|serotonin agents|mesh-ancestor
92560832|NCT00047450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560833|NCT00047450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92560834|NCT00047450|Antidepressive Agents|antidepressive agents|mesh-ancestor
92560835|NCT00047450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92560836|NCT00081237|Oxaliplatin|oxaliplatin|mesh-list
92560837|NCT00081237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560838|NCT00145171|Apomorphine|apomorphine|mesh-list
92560839|NCT00145171|Emetics|emetics|mesh-ancestor
92560840|NCT00145171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560841|NCT00145171|Autonomic Agents|autonomic agents|mesh-ancestor
92560842|NCT00145171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560843|NCT00145171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560844|NCT00145171|Dopamine Agonists|dopamine agonists|mesh-ancestor
92560845|NCT00145171|Dopamine Agents|dopamine agents|mesh-ancestor
92560846|NCT00145171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560847|NCT00145171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560848|NCT00145210|Atenolol|atenolol|mesh-list
92560849|NCT00145210|Nebivolol|nebivolol|mesh-list
92560850|NCT00145210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92560851|NCT00145210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92560852|NCT00145210|Sympatholytics|sympatholytics|mesh-ancestor
92560853|NCT00145210|Autonomic Agents|autonomic agents|mesh-ancestor
92560854|NCT00145210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534698|NCT00070486|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91912357|NCT02086019|Bisoprolol|bisoprolol|mesh-list
92560855|NCT00145210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560856|NCT00145210|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92560857|NCT00145210|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92560858|NCT00145210|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92560859|NCT00145210|Adrenergic Agents|adrenergic agents|mesh-ancestor
92560860|NCT00145210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560862|NCT00145210|Vasodilator Agents|vasodilator agents|mesh-ancestor
92560863|NCT00145210|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92560864|NCT00145210|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92560865|NCT00145210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92560867|NCT00081276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560868|NCT00145405|Octreotide|octreotide|mesh-list
92560869|NCT00145405|Lanreotide|lanreotide|mesh-list
92560870|NCT00145405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560871|NCT00145405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560872|NCT00145405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560873|NCT00145444|Olanzapine|olanzapine|mesh-list
92560874|NCT00145444|Ziprasidone|ziprasidone|mesh-list
92560875|NCT00145444|Antiemetics|antiemetics|mesh-ancestor
92560876|NCT00145444|Autonomic Agents|autonomic agents|mesh-ancestor
92560877|NCT00145444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560878|NCT00145444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560879|NCT00145444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92560880|NCT00145444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92560881|NCT00145444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92560882|NCT00145444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560883|NCT00145444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92560884|NCT00145444|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92560885|NCT00145444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92560886|NCT00145444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560887|NCT00145444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560888|NCT00145444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560889|NCT00145444|Serotonin Agents|serotonin agents|mesh-ancestor
92560890|NCT00145444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92560891|NCT00145444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92560892|NCT00145444|Dopamine Agents|dopamine agents|mesh-ancestor
92560893|NCT00145483|Sildenafil Citrate|sildenafil citrate|mesh-list
92560894|NCT00145483|Vasodilator Agents|vasodilator agents|mesh-ancestor
92560895|NCT00145483|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92560896|NCT00145483|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92560897|NCT00145483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560898|NCT00145483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560899|NCT00145483|Urological Agents|urological agents|mesh-ancestor
92560900|NCT00145522|Tibolone|tibolone|mesh-list
92560901|NCT00145522|Estradiol|estradiol|mesh-list
92560902|NCT00145522|Dydrogesterone|dydrogesterone|mesh-list
92560903|NCT00145522|Estrogens|estrogens|mesh-ancestor
92560904|NCT00145522|Hormones|hormones|mesh-ancestor
92560905|NCT00145522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560906|NCT00145522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560907|NCT00145522|Progestins|progestins|mesh-ancestor
92560908|NCT00145522|Androgen Antagonists|androgen antagonists|mesh-ancestor
92560909|NCT00145522|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560910|NCT00145522|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92560911|NCT00145522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560912|NCT00145522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560913|NCT00145522|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92560914|NCT00145522|Anabolic Agents|anabolic agents|mesh-ancestor
92560915|NCT00081315|Amifostine|amifostine|mesh-list
92560916|NCT00081315|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92560917|NCT00081315|Protective Agents|protective agents|mesh-ancestor
92560918|NCT00081315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560919|NCT00145561|Ritonavir|ritonavir|mesh-list
92560920|NCT00145561|Saquinavir|saquinavir|mesh-list
92560921|NCT00145561|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92560922|NCT00145561|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92560923|NCT00145561|Protease Inhibitors|protease inhibitors|mesh-ancestor
92560924|NCT00145561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560925|NCT00145561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560926|NCT00145561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92560927|NCT00145561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92560928|NCT00145561|Antiviral Agents|antiviral agents|mesh-ancestor
92560929|NCT00145561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534699|NCT00070486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92534700|NCT00070486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560930|NCT00145561|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92560931|NCT00145561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92560932|NCT00145639|Carboplatin|carboplatin|mesh-list
92560933|NCT00145639|Doxorubicin|doxorubicin|mesh-list
92560934|NCT00145639|Ifosfamide|ifosfamide|mesh-list
92560935|NCT00145639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560946|NCT00047567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560947|NCT00047567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560948|NCT00047567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92560949|NCT00047567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560950|NCT00145873|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92560951|NCT00145873|Natriuretic Agents|natriuretic agents|mesh-ancestor
92560952|NCT00145873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560953|NCT00145990|Methacholine Chloride|methacholine chloride|mesh-list
92560954|NCT00145990|Miotics|miotics|mesh-ancestor
92560955|NCT00145990|Autonomic Agents|autonomic agents|mesh-ancestor
92560956|NCT00145990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560957|NCT00145990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560958|NCT00145990|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92560959|NCT00145990|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92560960|NCT00145990|Respiratory System Agents|respiratory system agents|mesh-ancestor
92560961|NCT00145990|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92560962|NCT00145990|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92560963|NCT00145990|Cholinergic Agents|cholinergic agents|mesh-ancestor
92560964|NCT00145990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560965|NCT00145990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560966|NCT00146068|Interferon beta-1a|interferon beta-1a|mesh-list
92560967|NCT00146068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92560968|NCT00146068|Immunologic Factors|immunologic factors|mesh-ancestor
92560969|NCT00146068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560970|NCT00146068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560971|NCT00146068|Antiviral Agents|antiviral agents|mesh-ancestor
92560972|NCT00146068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560973|NCT00081471|Darbepoetin alfa|darbepoetin alfa|mesh-list
92560974|NCT00081471|Hematinics|hematinics|mesh-ancestor
92560975|NCT00047645|Interferons|interferons|mesh-list
92560976|NCT00047645|Interferon-gamma|interferon-gamma|mesh-list
92560977|NCT00047645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560978|NCT00047645|Antiviral Agents|antiviral agents|mesh-ancestor
92560979|NCT00047645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560980|NCT00146146|Letrozole|letrozole|mesh-list
92560981|NCT00146146|Methyltestosterone|methyltestosterone|mesh-list
92560982|NCT00146146|Dutasteride|dutasteride|mesh-list
92560983|NCT00146146|Testosterone|testosterone|mesh-list
92560984|NCT00146146|Testosterone undecanoate|testosterone undecanoate|mesh-list
92560985|NCT00146146|Testosterone enanthate|testosterone enanthate|mesh-list
92560986|NCT00146146|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92560987|NCT00146146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560988|NCT00146146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92560989|NCT00146146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92560990|NCT00146146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560991|NCT00146146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560992|NCT00146146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92560993|NCT00146146|Hormone Antagonists|hormone antagonists|mesh-ancestor
92560994|NCT00146146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560995|NCT00146146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560996|NCT00146146|Androgens|androgens|mesh-ancestor
92560997|NCT00146146|Hormones|hormones|mesh-ancestor
92560998|NCT00146146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92560999|NCT00146146|Anabolic Agents|anabolic agents|mesh-ancestor
91968524|NCT03319043|Hormones|hormones|mesh-ancestor
92561015|NCT00146380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92561016|NCT00146380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561017|NCT00146380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561018|NCT00146380|Antiviral Agents|antiviral agents|mesh-ancestor
92561019|NCT00146380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561020|NCT00146380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92561021|NCT00146380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92561022|NCT00146380|Antimetabolites|antimetabolites|mesh-ancestor
92561023|NCT00146380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92561024|NCT00146380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92561025|NCT00146380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92534701|NCT00070486|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92534702|NCT00070486|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92534703|NCT00070486|Hormone Antagonists|hormone antagonists|mesh-ancestor
92534704|NCT00070486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534705|NCT00070525|Tipifarnib|tipifarnib|mesh-list
92561026|NCT00146380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92561027|NCT00146380|Protease Inhibitors|protease inhibitors|mesh-ancestor
92561029|NCT00081588|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92561030|NCT00081588|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92561031|NCT00081588|Protease Inhibitors|protease inhibitors|mesh-ancestor
92561032|NCT00081588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561033|NCT00081588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561034|NCT00081588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92561035|NCT00081588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92561036|NCT00081588|Antiviral Agents|antiviral agents|mesh-ancestor
92561037|NCT00081588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561038|NCT00146458|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92561039|NCT00146458|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92561040|NCT00146458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561041|NCT00047723|Minocycline|minocycline|mesh-list
92561042|NCT00047723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561043|NCT00047723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561044|NCT00146497|Budesonide|budesonide|mesh-list
92561045|NCT00146497|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92561046|NCT00146497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561047|NCT00146497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92561048|NCT00146497|Autonomic Agents|autonomic agents|mesh-ancestor
92561049|NCT00146497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561050|NCT00146497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561051|NCT00146497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92561052|NCT00146497|Respiratory System Agents|respiratory system agents|mesh-ancestor
92561053|NCT00146497|Glucocorticoids|glucocorticoids|mesh-ancestor
92561054|NCT00146497|Hormones|hormones|mesh-ancestor
92561055|NCT00146497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561056|NCT02957890|Vaccines|vaccines|mesh-list
92561057|NCT02957890|Immunologic Factors|immunologic factors|mesh-ancestor
92561058|NCT02957890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561059|NCT00146575|Sirolimus|sirolimus|mesh-list
92561069|NCT00146575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561071|NCT00146575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561072|NCT00146575|Immunologic Factors|immunologic factors|mesh-ancestor
92561073|NCT00146575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561074|NCT00146614|Sirolimus|sirolimus|mesh-list
92561075|NCT00146614|Methotrexate|methotrexate|mesh-list
92561076|NCT00146614|Tacrolimus|tacrolimus|mesh-list
92561077|NCT00146614|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92561078|NCT00146614|Abortifacient Agents|abortifacient agents|mesh-ancestor
92561079|NCT00146614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92561080|NCT00146614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561081|NCT00146614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561082|NCT00146614|Antimetabolites|antimetabolites|mesh-ancestor
92561083|NCT00146614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561084|NCT00146614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561085|NCT00146614|Dermatologic Agents|dermatologic agents|mesh-ancestor
92561086|NCT00146614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561087|NCT00146614|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92561088|NCT00146614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561089|NCT00146614|Immunologic Factors|immunologic factors|mesh-ancestor
92561090|NCT00146614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561091|NCT00146614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92561092|NCT00146614|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92561093|NCT00146614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561094|NCT00146614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561095|NCT00146614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561096|NCT00146614|Antifungal Agents|antifungal agents|mesh-ancestor
92561097|NCT00047762|Bevacizumab|bevacizumab|mesh-list
92561098|NCT00047762|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92561099|NCT00047762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92561100|NCT00047762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561101|NCT00047762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92534706|NCT00070525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534707|NCT00070642|Dacarbazine|dacarbazine|mesh-list
92561102|NCT00047762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92561103|NCT00047762|Growth Substances|growth substances|mesh-ancestor
92561104|NCT00047762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561105|NCT00047762|Growth Inhibitors|growth inhibitors|mesh-ancestor
92561106|NCT00047762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92561107|NCT00047762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561108|NCT00047762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561109|NCT00042978|Carboplatin|carboplatin|mesh-list
92561110|NCT00042978|Etoposide|etoposide|mesh-list
92561111|NCT00042978|Etoposide phosphate|etoposide phosphate|mesh-list
92561112|NCT00042978|Oblimersen|oblimersen|mesh-list
92561113|NCT00042978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561114|NCT00042978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561115|NCT00042978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92561116|NCT00042978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92561117|NCT00042978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561118|NCT00042978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561119|NCT00405730|Ketorolac|ketorolac|mesh-list
92561120|NCT00405730|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92561121|NCT00405730|Nepafenac|nepafenac|mesh-list
92561122|NCT00405730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92561123|NCT00405730|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92561124|NCT00405730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92561136|NCT00405769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92561137|NCT00405769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92561139|NCT00405769|Antimetabolites|antimetabolites|mesh-ancestor
92561140|NCT00405769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561141|NCT00405769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561142|NCT00405769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92561143|NCT00047801|Docetaxel|docetaxel|mesh-list
92561144|NCT00047801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561145|NCT00047801|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561146|NCT00047801|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561147|NCT00047801|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561148|NCT00047801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561149|NCT00146731|Artesunate|artesunate|mesh-list
92561150|NCT00146731|Amodiaquine|amodiaquine|mesh-list
92561151|NCT00146731|Dapsone|dapsone|mesh-list
92561152|NCT00146731|Chlorproguanil|chlorproguanil|mesh-list
92561153|NCT00146731|Antimalarials|antimalarials|mesh-ancestor
92561154|NCT00146731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92561155|NCT00146731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92561156|NCT00146731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561157|NCT00146731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561158|NCT00146731|Antiviral Agents|antiviral agents|mesh-ancestor
92561159|NCT00146731|Schistosomicides|schistosomicides|mesh-ancestor
92561160|NCT00146731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92561161|NCT00146731|Anthelmintics|anthelmintics|mesh-ancestor
92561162|NCT00146731|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92561163|NCT00146731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561164|NCT00146731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561165|NCT00146731|Leprostatic Agents|leprostatic agents|mesh-ancestor
92561166|NCT00146731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561167|NCT00047840|Docetaxel|docetaxel|mesh-list
92561168|NCT00047840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561169|NCT00047840|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561170|NCT00047840|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561171|NCT00047840|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561172|NCT00047840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561173|NCT00146926|Lidocaine|lidocaine|mesh-list
92561174|NCT00146926|Ephedrine|ephedrine|mesh-list
92561175|NCT00146926|Ketamine|ketamine|mesh-list
92561176|NCT00146926|Anesthetics, Local|anesthetics, local|mesh-ancestor
92561177|NCT00146926|Anesthetics|anesthetics|mesh-ancestor
92561178|NCT00146926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561179|NCT00146926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561180|NCT00146926|Sensory System Agents|sensory system agents|mesh-ancestor
92561181|NCT00146926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561182|NCT00146926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92561183|NCT00146926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92561184|NCT00146926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92561185|NCT00146926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620227|NCT02914015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534708|NCT00070642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92534710|NCT00070642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534711|NCT00070642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534712|NCT00070759|Daclizumab|daclizumab|mesh-list
92534713|NCT00070759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534714|NCT00070759|Immunologic Factors|immunologic factors|mesh-ancestor
92561186|NCT00146926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561187|NCT00146926|Analgesics|analgesics|mesh-ancestor
91968707|NCT03225781|Bleomycin|bleomycin|mesh-list
92561221|NCT04732104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561222|NCT04732104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561223|NCT04732104|Sensory System Agents|sensory system agents|mesh-ancestor
92561224|NCT04732104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561225|NCT04732104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92561226|NCT04732104|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92561227|NCT04732104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92561228|NCT04732104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561247|NCT00147355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561248|NCT00147355|Antipyretics|antipyretics|mesh-ancestor
92561249|NCT00147355|Antiemetics|antiemetics|mesh-ancestor
92561250|NCT00147355|Autonomic Agents|autonomic agents|mesh-ancestor
92561251|NCT00147355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92561252|NCT00147355|Antipruritics|antipruritics|mesh-ancestor
92561253|NCT00147355|Dermatologic Agents|dermatologic agents|mesh-ancestor
92561254|NCT00147355|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92561255|NCT00147355|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92561256|NCT00147355|Serotonin Agents|serotonin agents|mesh-ancestor
92561257|NCT00147355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561258|NCT00147355|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92561259|NCT00147355|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92561260|NCT00147355|Dopamine Agents|dopamine agents|mesh-ancestor
92561261|NCT00147355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92561262|NCT00147355|Narcotics|narcotics|mesh-ancestor
92561263|NCT00147355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561264|NCT00147355|Antitussive Agents|antitussive agents|mesh-ancestor
92561265|NCT00147355|Respiratory System Agents|respiratory system agents|mesh-ancestor
92561266|NCT00048152|Mycophenolic Acid|mycophenolic acid|mesh-list
92561267|NCT00048152|Cyclosporine|cyclosporine|mesh-list
92561268|NCT00048152|Cyclosporins|cyclosporins|mesh-list
92561269|NCT00048152|Daclizumab|daclizumab|mesh-list
92561270|NCT00048152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561271|NCT00048152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561272|NCT00048152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92561273|NCT00048152|Antitubercular Agents|antitubercular agents|mesh-ancestor
92561274|NCT00048152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561275|NCT00048152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561276|NCT00048152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561277|NCT00048152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561278|NCT00048152|Antifungal Agents|antifungal agents|mesh-ancestor
92561279|NCT00048152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92561280|NCT00048152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561281|NCT00048152|Immunologic Factors|immunologic factors|mesh-ancestor
92561282|NCT00048152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561283|NCT00048152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561284|NCT00048152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92561285|NCT00147394|Risperidone|risperidone|mesh-list
92561286|NCT00147394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91968817|NCT05004519|Narcotics|narcotics|mesh-ancestor
92561289|NCT00147394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561290|NCT00147394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561291|NCT00147394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92561292|NCT00147394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92561293|NCT00147394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561294|NCT00147394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92561295|NCT00147394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92561296|NCT00147394|Dopamine Agents|dopamine agents|mesh-ancestor
92561297|NCT04725682|Tacrolimus|tacrolimus|mesh-list
92561298|NCT04725682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561299|NCT04725682|Immunologic Factors|immunologic factors|mesh-ancestor
92561300|NCT04725682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561301|NCT04725682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92561302|NCT04725682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561303|NCT04725682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561304|NCT00147511|Linezolid|linezolid|mesh-list
92561305|NCT00147511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561306|NCT00147511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561307|NCT00147511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92561308|NCT00147511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561309|NCT00147511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561310|NCT00043095|Gemcitabine|gemcitabine|mesh-list
92561311|NCT00043095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561312|NCT00043095|Antimetabolites|antimetabolites|mesh-ancestor
92561313|NCT00043095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561314|NCT00043095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561315|NCT00048230|Bortezomib|bortezomib|mesh-list
92561316|NCT00048230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561317|NCT00147589|Eplerenone|eplerenone|mesh-list
92561318|NCT00147589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92561319|NCT00147589|Hormone Antagonists|hormone antagonists|mesh-ancestor
92561320|NCT00147589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561321|NCT00147589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561322|NCT00147589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92561323|NCT00147589|Diuretics|diuretics|mesh-ancestor
92561324|NCT00147589|Natriuretic Agents|natriuretic agents|mesh-ancestor
92561325|NCT00147589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92561326|NCT00397332|Alefacept|alefacept|mesh-list
92561327|NCT00397332|Dermatologic Agents|dermatologic agents|mesh-ancestor
92561328|NCT00397332|Immunologic Factors|immunologic factors|mesh-ancestor
92561329|NCT00397332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561330|NCT00147628|Sildenafil Citrate|sildenafil citrate|mesh-list
92561331|NCT00147628|Citric Acid|citric acid|mesh-list
92561332|NCT00147628|Sodium Citrate|sodium citrate|mesh-list
92561333|NCT00147628|Anticoagulants|anticoagulants|mesh-ancestor
92561334|NCT00147628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92561335|NCT00147628|Chelating Agents|chelating agents|mesh-ancestor
92561336|NCT00147628|Sequestering Agents|sequestering agents|mesh-ancestor
92561337|NCT00147628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561338|NCT00147628|Vasodilator Agents|vasodilator agents|mesh-ancestor
92561339|NCT00147628|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92561340|NCT00147628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92561341|NCT00147628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561342|NCT00147628|Urological Agents|urological agents|mesh-ancestor
92561343|NCT00147667|Erythromycin|erythromycin|mesh-list
92561344|NCT00147667|Erythromycin Estolate|erythromycin estolate|mesh-list
92561345|NCT00147667|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92561346|NCT00147667|Erythromycin stearate|erythromycin stearate|mesh-list
92561347|NCT00147667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561348|NCT00147667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561349|NCT00147667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92561350|NCT00147667|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92561351|NCT00147667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561352|NCT00147667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561353|NCT00147784|Interferons|interferons|mesh-list
92561354|NCT00147784|Ribavirin|ribavirin|mesh-list
92561355|NCT00147784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561356|NCT00147784|Antiviral Agents|antiviral agents|mesh-ancestor
92561357|NCT00147784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561358|NCT00147784|Antimetabolites|antimetabolites|mesh-ancestor
92561359|NCT00147784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561360|NCT00081744|Tigecycline|tigecycline|mesh-list
92561363|NCT00081744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92561365|NCT00081744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561366|NCT00147862|Tranexamic Acid|tranexamic acid|mesh-list
92561367|NCT00147862|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92561368|NCT00147862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92561369|NCT00147862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561370|NCT00147862|Hemostatics|hemostatics|mesh-ancestor
92561371|NCT00147862|Coagulants|coagulants|mesh-ancestor
92561372|NCT00147901|Cyclophosphamide|cyclophosphamide|mesh-list
92561373|NCT00147901|Fludarabine|fludarabine|mesh-list
92561374|NCT00147901|Alemtuzumab|alemtuzumab|mesh-list
92534715|NCT00070759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534716|NCT00070837|Antibodies|antibodies|mesh-list
92534717|NCT00070837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92534718|NCT00070837|Immunologic Factors|immunologic factors|mesh-ancestor
92561375|NCT00147901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561376|NCT00147901|Immunologic Factors|immunologic factors|mesh-ancestor
92561377|NCT00147901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561378|NCT00147901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561379|NCT00147901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92561380|NCT00147901|Alkylating Agents|alkylating agents|mesh-ancestor
92561381|NCT00147901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561382|NCT00147901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561383|NCT00147901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92561384|NCT00147901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286147|NCT03300947|Anticonvulsants|anticonvulsants|mesh-ancestor
92561385|NCT02957851|Nitrous Oxide|nitrous oxide|mesh-list
92561386|NCT02957851|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92561387|NCT02957851|Anesthetics, General|anesthetics, general|mesh-ancestor
92561388|NCT02957851|Anesthetics|anesthetics|mesh-ancestor
92561389|NCT02957851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561390|NCT02957851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561391|NCT02957851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92561392|NCT02957851|Analgesics|analgesics|mesh-ancestor
92561393|NCT02957851|Sensory System Agents|sensory system agents|mesh-ancestor
92561394|NCT02957851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561395|NCT00147979|Heparin|heparin|mesh-list
92561396|NCT00147979|Calcium heparin|calcium heparin|mesh-list
92561397|NCT00147979|Anticoagulants|anticoagulants|mesh-ancestor
92561398|NCT00147979|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92561399|NCT00147979|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92561400|NCT00147979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561401|NCT00148018|Dexamethasone|dexamethasone|mesh-list
92561402|NCT00148018|Bortezomib|bortezomib|mesh-list
92561403|NCT00148018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561404|NCT00148018|Antiemetics|antiemetics|mesh-ancestor
92561405|NCT00148018|Autonomic Agents|autonomic agents|mesh-ancestor
92561406|NCT00148018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561407|NCT00148018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561408|NCT00148018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92561409|NCT00148018|Glucocorticoids|glucocorticoids|mesh-ancestor
92561410|NCT00148018|Hormones|hormones|mesh-ancestor
92561411|NCT00148018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561412|NCT00148018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92561413|NCT00148018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561414|NCT00081822|Cytarabine|cytarabine|mesh-list
92561415|NCT00081822|Clofarabine|clofarabine|mesh-list
92561416|NCT00081822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561417|NCT00081822|Antimetabolites|antimetabolites|mesh-ancestor
92561418|NCT00081822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561419|NCT00081822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561420|NCT00081822|Antiviral Agents|antiviral agents|mesh-ancestor
92561421|NCT00081822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561422|NCT00081822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561423|NCT00081822|Immunologic Factors|immunologic factors|mesh-ancestor
92561424|NCT00081822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561425|NCT00048425|Simendan|simendan|mesh-list
92561426|NCT00048425|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92561427|NCT00048425|Vasodilator Agents|vasodilator agents|mesh-ancestor
92561428|NCT00048425|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92561429|NCT00048425|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92561430|NCT00048425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561431|NCT00048425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561432|NCT00048425|Protective Agents|protective agents|mesh-ancestor
92561436|NCT00148135|Capecitabine|capecitabine|mesh-list
92561437|NCT00148135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561438|NCT00148135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561439|NCT00148135|Antimetabolites|antimetabolites|mesh-ancestor
92561440|NCT00148135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561441|NCT00399711|Metformin|metformin|mesh-list
92561442|NCT00399711|Rosiglitazone|rosiglitazone|mesh-list
92561443|NCT00399711|Repaglinide|repaglinide|mesh-list
92561444|NCT00399711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92561445|NCT00399711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561446|NCT00148252|Mycophenolic Acid|mycophenolic acid|mesh-list
92561447|NCT00148252|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561448|NCT00148252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561449|NCT00148252|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92561450|NCT00148252|Antitubercular Agents|antitubercular agents|mesh-ancestor
92561451|NCT00148252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561452|NCT00148252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561453|NCT00148252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561454|NCT00148252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561455|NCT00148291|Docetaxel|docetaxel|mesh-list
92561456|NCT00148291|Vinorelbine|vinorelbine|mesh-list
92561457|NCT00148291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561458|NCT00148291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561459|NCT00148291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561460|NCT00148291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561461|NCT00148291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561462|NCT00148291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561464|NCT00148330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561465|NCT00148330|Glucocorticoids|glucocorticoids|mesh-ancestor
92561466|NCT00148330|Hormones|hormones|mesh-ancestor
92561467|NCT00148330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561468|NCT00148330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561469|NCT00405808|Rimonabant|rimonabant|mesh-list
92561470|NCT00405808|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92561471|NCT00405808|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92561472|NCT00405808|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92561473|NCT00405808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561474|NCT00405808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561475|NCT00405808|Hormones|hormones|mesh-ancestor
92561476|NCT00405808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561477|NCT00405808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561478|NCT00081900|N(1),N(11)-diethylnorspermine|n(1),n(11)-diethylnorspermine|mesh-list
92561479|NCT00081900|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92561480|NCT00081900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561481|NCT00405847|Dexmedetomidine|dexmedetomidine|mesh-list
92561482|NCT00405847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92561483|NCT00405847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561484|NCT00405847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561485|NCT00405847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92561486|NCT00405847|Analgesics|analgesics|mesh-ancestor
92561487|NCT00405847|Sensory System Agents|sensory system agents|mesh-ancestor
92561488|NCT00405847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561489|NCT00405847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92561490|NCT00405847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92561491|NCT00405847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92561492|NCT00405847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92561493|NCT00405847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561494|NCT00405847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561495|NCT00148408|Montelukast|montelukast|mesh-list
92561496|NCT00148408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92561497|NCT00148408|Respiratory System Agents|respiratory system agents|mesh-ancestor
92561498|NCT00148408|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92561499|NCT00148408|Hormone Antagonists|hormone antagonists|mesh-ancestor
92561500|NCT00148408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561501|NCT00148408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561502|NCT00148408|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92561503|NCT00148408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92561525|NCT00148564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561526|NCT00148564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561528|NCT00148564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92561529|NCT00148564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92561530|NCT00148564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561531|NCT00148564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92561532|NCT00148564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92561533|NCT00148564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92561535|NCT00148564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561536|NCT00148564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561537|NCT00148564|Serotonin Agents|serotonin agents|mesh-ancestor
92561538|NCT00148564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92561539|NCT00148564|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91912929|NCT02090543|Antithrombins|antithrombins|mesh-ancestor
92561540|NCT00148564|Dopamine Agents|dopamine agents|mesh-ancestor
92561541|NCT00148603|Montelukast|montelukast|mesh-list
92561542|NCT00148603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92561543|NCT00148603|Respiratory System Agents|respiratory system agents|mesh-ancestor
92561544|NCT00148603|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92561545|NCT00148603|Hormone Antagonists|hormone antagonists|mesh-ancestor
92561546|NCT00148603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92561547|NCT00148603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561548|NCT00148603|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92561549|NCT00148603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92561550|NCT00148603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561551|NCT00048659|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
92561552|NCT00048659|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91969086|NCT03204097|Alendronate|alendronate|mesh-list
92561555|NCT00148681|Vinorelbine|vinorelbine|mesh-list
92561556|NCT00148681|Cyclophosphamide|cyclophosphamide|mesh-list
92561557|NCT00148681|Doxorubicin|doxorubicin|mesh-list
92561558|NCT00148681|Trastuzumab|trastuzumab|mesh-list
92561559|NCT00148681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561560|NCT00148681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561561|NCT00148681|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561562|NCT00148681|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561563|NCT00148681|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561564|NCT00148681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561565|NCT00148681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561566|NCT00148681|Immunologic Factors|immunologic factors|mesh-ancestor
92561567|NCT00148681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561568|NCT00148681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561569|NCT00148681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92561570|NCT00148681|Alkylating Agents|alkylating agents|mesh-ancestor
92561571|NCT00148681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92561572|NCT00148681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561573|NCT00148681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92561574|NCT00148681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92561575|NCT00148681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561576|NCT00148681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92561577|NCT00148720|Capecitabine|capecitabine|mesh-list
92561578|NCT00148720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561579|NCT00148720|Antimetabolites|antimetabolites|mesh-ancestor
92561580|NCT00148720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561581|NCT00148720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561582|NCT00148837|Interferons|interferons|mesh-list
92561583|NCT00148837|Ribavirin|ribavirin|mesh-list
92561584|NCT00148837|Interferon-alpha|interferon-alpha|mesh-list
92561585|NCT00148837|Interferon alpha-2|interferon alpha-2|mesh-list
92561586|NCT00148837|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92561587|NCT00148837|Prazosin|prazosin|mesh-list
92561588|NCT00148837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561589|NCT00148837|Antiviral Agents|antiviral agents|mesh-ancestor
92561590|NCT00148837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561591|NCT00148837|Antimetabolites|antimetabolites|mesh-ancestor
92561592|NCT00148837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561593|NCT00148837|Immunologic Factors|immunologic factors|mesh-ancestor
92561594|NCT00148837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561595|NCT00148837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92561596|NCT00148837|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92561597|NCT00148837|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92561598|NCT00148837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92561599|NCT00148837|Adrenergic Agents|adrenergic agents|mesh-ancestor
92561600|NCT00148837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561601|NCT00148876|Capecitabine|capecitabine|mesh-list
92561602|NCT00148876|Trastuzumab|trastuzumab|mesh-list
92561603|NCT00148876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561604|NCT00148876|Antimetabolites|antimetabolites|mesh-ancestor
92561605|NCT00148876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561606|NCT00148876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561607|NCT00148876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92561608|NCT00148915|Ibandronic Acid|ibandronic acid|mesh-list
92561609|NCT00148915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92561610|NCT00148915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561611|NCT00149110|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92561612|NCT00149110|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92561613|NCT00149110|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92561614|NCT00149110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561615|NCT00149110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355646|NCT01453920|Growth Substances|growth substances|mesh-ancestor
92561616|NCT00149110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561617|NCT00149110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561618|NCT00149110|Analgesics|analgesics|mesh-ancestor
92561619|NCT00149110|Sensory System Agents|sensory system agents|mesh-ancestor
92561620|NCT00149110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561621|NCT00149110|Antidepressive Agents|antidepressive agents|mesh-ancestor
92561622|NCT00149110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92561623|NCT00149110|Dopamine Agents|dopamine agents|mesh-ancestor
92561624|NCT00149149|Polaprezinc|polaprezinc|mesh-list
92561630|NCT00043212|Immunologic Factors|immunologic factors|mesh-ancestor
92561631|NCT00043212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561632|NCT00048776|Cilostazol|cilostazol|mesh-list
92561633|NCT00048776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92561634|NCT00048776|Autonomic Agents|autonomic agents|mesh-ancestor
92561635|NCT00048776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561636|NCT00048776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561637|NCT00048776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92561638|NCT00048776|Respiratory System Agents|respiratory system agents|mesh-ancestor
92561639|NCT00048776|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92561640|NCT00048776|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92561641|NCT00048776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561642|NCT00048776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92561643|NCT00048776|Vasodilator Agents|vasodilator agents|mesh-ancestor
92561644|NCT00048776|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92561645|NCT00048776|Protective Agents|protective agents|mesh-ancestor
92561646|NCT00048776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92561647|NCT00048776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92561648|NCT00048776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561649|NCT00149383|Rosiglitazone|rosiglitazone|mesh-list
92561650|NCT00149383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92561651|NCT00149383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561652|NCT00048854|Sertraline|sertraline|mesh-list
92561653|NCT00048854|Antidepressive Agents|antidepressive agents|mesh-ancestor
92561654|NCT00048854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92561655|NCT00048854|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92561656|NCT00048854|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92561657|NCT00048854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561658|NCT00048854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561659|NCT00048854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561660|NCT00048854|Serotonin Agents|serotonin agents|mesh-ancestor
92561661|NCT00048854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561662|NCT00081978|Etravirine|etravirine|mesh-list
92561663|NCT00081978|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92561664|NCT00081978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92561665|NCT00081978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561666|NCT00081978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561667|NCT00081978|Antiviral Agents|antiviral agents|mesh-ancestor
92561668|NCT00081978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561669|NCT00149539|Buprenorphine|buprenorphine|mesh-list
92561670|NCT00149539|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92561671|NCT00149539|Naloxone|naloxone|mesh-list
92561672|NCT00149539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92561673|NCT00149539|Narcotics|narcotics|mesh-ancestor
92561674|NCT00149539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561675|NCT00149539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561676|NCT00149539|Analgesics|analgesics|mesh-ancestor
92561677|NCT00149539|Sensory System Agents|sensory system agents|mesh-ancestor
92561678|NCT00149539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561679|NCT00149539|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92561680|NCT00149578|Leucovorin|leucovorin|mesh-list
92561681|NCT00149578|Gemcitabine|gemcitabine|mesh-list
92561682|NCT00149578|Oxaliplatin|oxaliplatin|mesh-list
92561683|NCT00149578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561684|NCT00149578|Antimetabolites|antimetabolites|mesh-ancestor
92561685|NCT00149578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561686|NCT00149578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561687|NCT00149578|Antidotes|antidotes|mesh-ancestor
92561688|NCT00149578|Protective Agents|protective agents|mesh-ancestor
92561689|NCT00149578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561690|NCT00149578|Vitamin B Complex|vitamin b complex|mesh-ancestor
92534719|NCT00070837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534720|NCT00071188|Paclitaxel|paclitaxel|mesh-list
92561691|NCT00149578|Vitamins|vitamins|mesh-ancestor
92561692|NCT00149578|Micronutrients|micronutrients|mesh-ancestor
92561693|NCT00149617|Buspirone|buspirone|mesh-list
92561694|NCT00149617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92561695|NCT00149617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92561715|NCT00082095|Capecitabine|capecitabine|mesh-list
92561716|NCT00082095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561717|NCT00082095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561718|NCT00082095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92561719|NCT00082095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92561720|NCT00082095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561721|NCT00082095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561722|NCT00082095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561723|NCT00082095|Antimetabolites|antimetabolites|mesh-ancestor
92561724|NCT00149851|Tegaserod|tegaserod|mesh-list
92561725|NCT00149851|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92561726|NCT00149851|Serotonin Agents|serotonin agents|mesh-ancestor
92561727|NCT00149851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561728|NCT00149851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561729|NCT00149851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561730|NCT00149929|Mycophenolic Acid|mycophenolic acid|mesh-list
92561731|NCT00149929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561732|NCT00149929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561733|NCT00149929|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92561734|NCT00149929|Antitubercular Agents|antitubercular agents|mesh-ancestor
92561735|NCT00149929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561736|NCT00149929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561737|NCT00149929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561738|NCT00149929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561739|NCT00049088|Bevacizumab|bevacizumab|mesh-list
92561740|NCT00049088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92561741|NCT00049088|Docetaxel|docetaxel|mesh-list
92561742|NCT00049088|Antibodies|antibodies|mesh-list
92561743|NCT00049088|Immunoglobulins|immunoglobulins|mesh-list
92561744|NCT00049088|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92561745|NCT00049088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561746|NCT00049088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92561747|NCT00049088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92561748|NCT00049088|Growth Substances|growth substances|mesh-ancestor
92561749|NCT00049088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561750|NCT00049088|Growth Inhibitors|growth inhibitors|mesh-ancestor
92561751|NCT00049088|Immunologic Factors|immunologic factors|mesh-ancestor
92561774|NCT04725448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561775|NCT04725448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92561776|NCT04725448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92561777|NCT04725448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92561778|NCT04725448|Growth Substances|growth substances|mesh-ancestor
92561779|NCT04725448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561780|NCT04725448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92561782|NCT00405925|Zidovudine|zidovudine|mesh-list
92561783|NCT00405925|Abacavir|abacavir|mesh-list
92561784|NCT00405925|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92561785|NCT00405925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92561786|NCT00405925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561787|NCT00405925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561788|NCT00405925|Antiviral Agents|antiviral agents|mesh-ancestor
92561789|NCT00405925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561790|NCT00405925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92561791|NCT00405925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92561792|NCT00405925|Antimetabolites|antimetabolites|mesh-ancestor
92561793|NCT00049166|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92561794|NCT00049166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561795|NCT00049166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92561796|NCT00049166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561797|NCT00049166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561798|NCT00082212|Cetuximab|cetuximab|mesh-list
92561799|NCT00082212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92561800|NCT00082212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561801|NCT00150007|Mycophenolic Acid|mycophenolic acid|mesh-list
92561802|NCT00150007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91969341|NCT03202459|Anticonvulsants|anticonvulsants|mesh-ancestor
92562042|NCT00151138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534721|NCT00071188|Carboplatin|carboplatin|mesh-list
92534722|NCT00071188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92562043|NCT00151138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562044|NCT00151138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92562045|NCT00151138|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92562046|NCT00151138|Protective Agents|protective agents|mesh-ancestor
92562047|NCT00151138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562048|NCT00151138|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92562049|NCT00151138|Sympatholytics|sympatholytics|mesh-ancestor
92563521|NCT05568147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92563522|NCT05568147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92563524|NCT05568147|Sensory System Agents|sensory system agents|mesh-ancestor
92563525|NCT05568147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563526|NCT05568147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563527|NCT05568147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563528|NCT05568147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563529|NCT05568147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92563530|NCT05568147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92563531|NCT05568147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563532|NCT05568147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92563533|NCT05568147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92563534|NCT05568147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563535|NCT05568147|Antipyretics|antipyretics|mesh-ancestor
92563536|NCT00051896|Vanoxerine|vanoxerine|mesh-list
92563537|NCT00051896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92563538|NCT00051896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92563539|NCT00051896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970835|NCT03303053|Glucocorticoids|glucocorticoids|mesh-ancestor
92563564|NCT00159133|Lorazepam|lorazepam|mesh-list
92563565|NCT00159133|Antipsychotic Agents|antipsychotic agents|mesh-list
92563566|NCT00159133|Anticonvulsants|anticonvulsants|mesh-ancestor
92563567|NCT00159133|Antiemetics|antiemetics|mesh-ancestor
92563568|NCT00159133|Autonomic Agents|autonomic agents|mesh-ancestor
92563569|NCT00159133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563570|NCT00159133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563571|NCT00159133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563572|NCT00159133|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92563573|NCT00159133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563574|NCT00159133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92563575|NCT00159133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92563576|NCT00159133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563577|NCT00159133|GABA Modulators|gaba modulators|mesh-ancestor
92563578|NCT00159133|GABA Agents|gaba agents|mesh-ancestor
92563579|NCT00159133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563580|NCT00159133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563581|NCT00051974|Bortezomib|bortezomib|mesh-list
92563582|NCT00051974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563583|NCT00159211|Pioglitazone|pioglitazone|mesh-list
92563584|NCT00159211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563585|NCT00159211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563586|NCT05567718|Anesthetics|anesthetics|mesh-list
92563587|NCT05567718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563588|NCT05567718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563589|NCT00052013|Vatalanib|vatalanib|mesh-list
92563590|NCT00052013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563591|NCT00052013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563605|NCT00159484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92563606|NCT00159484|Analgesics|analgesics|mesh-ancestor
92563607|NCT00159484|Sensory System Agents|sensory system agents|mesh-ancestor
92563608|NCT00159484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563609|NCT00159484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563610|NCT00159484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563611|NCT00159484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563612|NCT00159484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92563613|NCT00159484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92563614|NCT00159484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563615|NCT00159484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563616|NCT00159484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563617|NCT00159484|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563618|NCT00159484|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563619|NCT00159484|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563620|NCT00052052|Interferons|interferons|mesh-list
92563621|NCT00052052|Interferon-gamma|interferon-gamma|mesh-list
92534723|NCT00071188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534724|NCT00071188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563622|NCT00052052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563623|NCT00052052|Antiviral Agents|antiviral agents|mesh-ancestor
92563624|NCT00052052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563625|NCT00159679|Pregabalin|pregabalin|mesh-list
92563626|NCT00159679|Analgesics|analgesics|mesh-ancestor
92563627|NCT00159679|Sensory System Agents|sensory system agents|mesh-ancestor
92563628|NCT00159679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563629|NCT00159679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563630|NCT00159679|Anticonvulsants|anticonvulsants|mesh-ancestor
92563631|NCT00159679|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92563632|NCT00159679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563633|NCT00159679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563634|NCT00159679|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92563635|NCT00159679|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92563636|NCT00159679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92563637|NCT00159679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563638|NCT00159679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563639|NCT00159718|Amlodipine|amlodipine|mesh-list
92563640|NCT00159718|Atorvastatin|atorvastatin|mesh-list
92563641|NCT00159718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92563642|NCT00159718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92563643|NCT00159718|Antimetabolites|antimetabolites|mesh-ancestor
92563644|NCT00159718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563645|NCT00159718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92563646|NCT00159718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92563647|NCT00159718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563648|NCT00159718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92563649|NCT00159718|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92563650|NCT00159718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563651|NCT00159718|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92563652|NCT00159718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563656|NCT00159757|Serotonin Agents|serotonin agents|mesh-ancestor
92563657|NCT00159757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563658|NCT00159757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563659|NCT00159757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563660|NCT00159757|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92563661|NCT00159757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92563662|NCT00159757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563663|NCT00159757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563664|NCT00159757|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92563665|NCT00159757|Dopamine Agents|dopamine agents|mesh-ancestor
92563666|NCT00159835|Atorvastatin|atorvastatin|mesh-list
92563667|NCT00159835|Simvastatin|simvastatin|mesh-list
92563668|NCT00159835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92563669|NCT00159835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92563670|NCT00159835|Antimetabolites|antimetabolites|mesh-ancestor
92563671|NCT00159835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563672|NCT00159835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92563673|NCT00159835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92563674|NCT00159835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563675|NCT00052169|Docetaxel|docetaxel|mesh-list
92563676|NCT00052169|Gefitinib|gefitinib|mesh-list
92563677|NCT00052169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563678|NCT00052169|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563679|NCT00052169|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563680|NCT00052169|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563681|NCT00052169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563682|NCT00052169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563683|NCT00052169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563684|NCT00159952|Insulin|insulin|mesh-list
92563685|NCT00159952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563686|NCT00159952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563687|NCT00052208|Gefitinib|gefitinib|mesh-list
92563688|NCT00052208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563689|NCT00052208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563690|NCT00052208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563691|NCT00052208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563692|NCT00407017|Moxifloxacin|moxifloxacin|mesh-list
92563693|NCT00407017|Gatifloxacin|gatifloxacin|mesh-list
92563694|NCT00407017|Ketorolac|ketorolac|mesh-list
92563695|NCT00407017|Nepafenac|nepafenac|mesh-list
92534725|NCT00071188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534726|NCT00071188|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913297|NCT02106845|Digoxin|digoxin|mesh-list
92563696|NCT00407017|Prednisolone acetate|prednisolone acetate|mesh-list
92563697|NCT00407017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563698|NCT00407017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563699|NCT00407017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92288489|NCT05747521|Doxorubicin|doxorubicin|mesh-list
92563700|NCT00407017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92563701|NCT00407017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563702|NCT00407017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563703|NCT00407017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563704|NCT00407017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563705|NCT00407017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92563706|NCT00407017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92563707|NCT00407017|Analgesics|analgesics|mesh-ancestor
92563708|NCT00407017|Sensory System Agents|sensory system agents|mesh-ancestor
92563709|NCT00407017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563710|NCT00407017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563711|NCT00407017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563712|NCT00407017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92563713|NCT00407017|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92563714|NCT00407017|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92563715|NCT00160030|Cisplatin|cisplatin|mesh-list
92563716|NCT00160030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563717|NCT00160069|Sagopilone|sagopilone|mesh-list
92563718|NCT00160069|Epothilones|epothilones|mesh-list
92563719|NCT00160069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563720|NCT00160069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563721|NCT00160069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563722|NCT00160069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563723|NCT00160069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563724|NCT00052286|Modafinil|modafinil|mesh-list
92563725|NCT00052286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92563730|NCT00052286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563732|NCT00160186|Pancrelipase|pancrelipase|mesh-list
92563733|NCT00160186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563734|NCT05567484|Itraconazole|itraconazole|mesh-list
92563735|NCT05567484|Antifungal Agents|antifungal agents|mesh-ancestor
92563736|NCT05567484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563737|NCT05567484|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92563738|NCT05567484|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92563739|NCT05567484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563740|NCT05567484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563741|NCT05567484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92563742|NCT05567484|Hormone Antagonists|hormone antagonists|mesh-ancestor
92563743|NCT05567484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92563744|NCT05567484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563745|NCT05567484|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92563746|NCT00160264|Vitamin D|vitamin d|mesh-list
92563747|NCT00160264|Lactulose|lactulose|mesh-list
92563748|NCT00160264|Calcium|calcium|mesh-list
92563749|NCT00160264|Vitamins|vitamins|mesh-ancestor
92563750|NCT00160264|Micronutrients|micronutrients|mesh-ancestor
92563751|NCT00160264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563752|NCT00160264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92563753|NCT00160264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92563754|NCT00160264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563755|NCT00160342|Methyltestosterone|methyltestosterone|mesh-list
92563756|NCT00160342|Estrogens|estrogens|mesh-list
92563757|NCT00160342|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
92563758|NCT00160342|Estrone|estrone|mesh-list
92563759|NCT00160342|Testosterone|testosterone|mesh-list
92563760|NCT00160342|Testosterone undecanoate|testosterone undecanoate|mesh-list
92563761|NCT00160342|Testosterone enanthate|testosterone enanthate|mesh-list
92563762|NCT00160342|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92563763|NCT00160342|Hormones|hormones|mesh-ancestor
92563764|NCT00160342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92563765|NCT00160342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563766|NCT00160342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92563767|NCT00160342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563768|NCT00160342|Anabolic Agents|anabolic agents|mesh-ancestor
92563769|NCT00160342|Androgens|androgens|mesh-ancestor
92534727|NCT00071188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534728|NCT00071227|Triamcinolone|triamcinolone|mesh-list
92534729|NCT00071227|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91913370|NCT02102321|Albendazole|albendazole|mesh-list
92563770|NCT00052364|Oxaliplatin|oxaliplatin|mesh-list
92563771|NCT00052364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563772|NCT00052403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92563773|NCT00052403|Antibodies|antibodies|mesh-list
92563774|NCT00052403|Immunoglobulins|immunoglobulins|mesh-list
92563775|NCT00052403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92563776|NCT00052403|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
92563777|NCT00052403|Immunologic Factors|immunologic factors|mesh-list
92563778|NCT00052403|Mitogens|mitogens|mesh-list
91937336|NCT01022801|Entecavir|entecavir|mesh-list
92563779|NCT00052403|Immunomodulating Agents|immunomodulating agents|mesh-list
92563780|NCT00052403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563781|NCT00052403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563782|NCT00052403|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563783|NCT00052403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563784|NCT00160498|Lercanidipine|lercanidipine|mesh-list
92563785|NCT00160498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92563786|NCT00160498|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92563787|NCT00160498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563788|NCT00160498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563789|NCT00160498|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92563790|NCT00160498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563791|NCT00160537|Levocetirizine|levocetirizine|mesh-list
92563792|NCT00160537|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92563793|NCT00160537|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92563794|NCT00160537|Histamine Antagonists|histamine antagonists|mesh-ancestor
92563803|NCT00160849|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92563804|NCT00160849|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92563805|NCT00160849|Protease Inhibitors|protease inhibitors|mesh-ancestor
92563806|NCT00160849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563807|NCT00160849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563808|NCT00160849|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92563809|NCT00160849|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92563810|NCT00160849|Antiviral Agents|antiviral agents|mesh-ancestor
92563811|NCT00160849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563812|NCT00160849|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92563813|NCT00160849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92563814|NCT00160888|Nitroprusside|nitroprusside|mesh-list
92563815|NCT00160888|Acetylcholine|acetylcholine|mesh-list
92563816|NCT00160888|Bradykinin|bradykinin|mesh-list
92563817|NCT00160888|Kininogens|kininogens|mesh-list
92563818|NCT00160888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92563819|NCT00160888|Vasodilator Agents|vasodilator agents|mesh-ancestor
92563820|NCT00160888|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92563821|NCT00160888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563822|NCT00160888|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92563823|NCT00160888|Cholinergic Agents|cholinergic agents|mesh-ancestor
92563824|NCT00160888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563825|NCT00160888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563826|NCT00160888|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92563827|NCT00160888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92563828|NCT00160888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563829|NCT00160927|Nitroprusside|nitroprusside|mesh-list
92563830|NCT00160927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92563831|NCT00160927|Vasodilator Agents|vasodilator agents|mesh-ancestor
92563832|NCT00160927|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92563833|NCT00160927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563834|NCT00160966|Cyclosporine|cyclosporine|mesh-list
92563835|NCT00160966|Mycophenolic Acid|mycophenolic acid|mesh-list
92563836|NCT00160966|Everolimus|everolimus|mesh-list
92563837|NCT00160966|Tacrolimus|tacrolimus|mesh-list
92563838|NCT00160966|Cyclosporins|cyclosporins|mesh-list
92563839|NCT00160966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563840|NCT00160966|Immunologic Factors|immunologic factors|mesh-ancestor
92563841|NCT00160966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563842|NCT00160966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92563843|NCT00160966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563844|NCT00160966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563845|NCT00160966|Antifungal Agents|antifungal agents|mesh-ancestor
92563846|NCT00160966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563847|NCT00160966|Dermatologic Agents|dermatologic agents|mesh-ancestor
92563848|NCT00160966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563849|NCT00160966|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92563850|NCT00160966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563851|NCT00160966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563852|NCT00160966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92563853|NCT00160966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92563854|NCT00160966|Antitubercular Agents|antitubercular agents|mesh-ancestor
92563855|NCT00160966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563857|NCT00052559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92563858|NCT00052559|Fluorouracil|fluorouracil|mesh-list
92563859|NCT00052559|Antibodies|antibodies|mesh-list
92563860|NCT00052559|Immunoglobulins|immunoglobulins|mesh-list
92563861|NCT00052559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92563862|NCT00052559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563863|NCT00052559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563864|NCT00052559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563890|NCT00161122|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92563892|NCT00161122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563893|NCT00161200|Pantoprazole|pantoprazole|mesh-list
92563894|NCT00161200|Ranitidine|ranitidine|mesh-list
92563895|NCT00161200|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92563896|NCT00161200|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92563897|NCT00161200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563898|NCT00161200|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92563899|NCT00161200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563900|NCT00161200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563901|NCT00161200|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92563902|NCT00161200|Histamine Antagonists|histamine antagonists|mesh-ancestor
92563903|NCT00161200|Histamine Agents|histamine agents|mesh-ancestor
92563904|NCT00161200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563905|NCT00161200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563906|NCT00161239|Prednisone|prednisone|mesh-list
92563907|NCT00161239|Methotrexate|methotrexate|mesh-list
92563908|NCT00161239|Asparaginase|asparaginase|mesh-list
92563909|NCT00161239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563910|NCT00161239|Glucocorticoids|glucocorticoids|mesh-ancestor
92563911|NCT00161239|Hormones|hormones|mesh-ancestor
92563912|NCT00161239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92563913|NCT00161239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563914|NCT00161239|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92563923|NCT00161239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563924|NCT00161239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92563925|NCT00161239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288707|NCT01827475|Analgesics|analgesics|mesh-ancestor
92563926|NCT00161239|Immunologic Factors|immunologic factors|mesh-ancestor
92563927|NCT00161239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563928|NCT00161239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563929|NCT00161278|Paclitaxel|paclitaxel|mesh-list
92563930|NCT00161278|Carboplatin|carboplatin|mesh-list
92563931|NCT00161278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92563932|NCT00161278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563933|NCT00161278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563934|NCT00161278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563935|NCT00161278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563936|NCT00161278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563937|NCT00044616|Fluoxetine|fluoxetine|mesh-list
92563938|NCT00044616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92563939|NCT00044616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92563940|NCT00044616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563941|NCT00044616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563942|NCT00044616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563943|NCT00044616|Serotonin Agents|serotonin agents|mesh-ancestor
92563944|NCT00044616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563945|NCT00044616|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92563946|NCT00044616|Antidepressive Agents|antidepressive agents|mesh-ancestor
92563947|NCT00044616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563948|NCT00044616|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92563949|NCT00044616|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92563950|NCT00044616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563951|NCT00161356|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92563952|NCT00161356|Antifungal Agents|antifungal agents|mesh-ancestor
92563953|NCT00161356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563954|NCT00161356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91913539|NCT03554915|Midazolam|midazolam|mesh-list
92563955|NCT00161356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92563956|NCT00052676|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92563957|NCT00052676|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92563958|NCT00052676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563959|NCT00161434|Valacyclovir|valacyclovir|mesh-list
92563960|NCT00161434|Antiviral Agents|antiviral agents|mesh-ancestor
92563961|NCT00161434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563962|NCT00044694|Exenatide|exenatide|mesh-list
92563963|NCT00044694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563964|NCT00044694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563965|NCT00044694|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92563966|NCT00044694|Incretins|incretins|mesh-ancestor
92563967|NCT00044694|Hormones|hormones|mesh-ancestor
92563968|NCT00044694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92563969|NCT00052754|Gefitinib|gefitinib|mesh-list
92563970|NCT00052754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563971|NCT00052754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563972|NCT00052754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563973|NCT00052754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563974|NCT00161590|Alemtuzumab|alemtuzumab|mesh-list
92563975|NCT00161590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92563976|NCT00161590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563977|NCT00161668|Gemtuzumab|gemtuzumab|mesh-list
92563978|NCT00161668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92563984|NCT00052832|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92563986|NCT00052832|Micronutrients|micronutrients|mesh-ancestor
92563987|NCT00052832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563988|NCT00052832|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92563989|NCT00161707|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92563990|NCT00161707|Protein C Inhibitor|protein c inhibitor|mesh-list
92563991|NCT00161707|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92563992|NCT00161707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92563993|NCT00161707|Protease Inhibitors|protease inhibitors|mesh-ancestor
92563994|NCT00161707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563995|NCT00161707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563996|NCT00044538|Taxane|taxane|mesh-list
92563997|NCT00044538|IDN 5109|idn 5109|mesh-list
92563998|NCT00044538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563999|NCT00044733|Gemtuzumab|gemtuzumab|mesh-list
92564000|NCT00044733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564001|NCT00044733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564002|NCT00044733|Immunotoxins|immunotoxins|mesh-ancestor
92564003|NCT00044733|Immunoconjugates|immunoconjugates|mesh-ancestor
92564004|NCT00044733|Immunologic Factors|immunologic factors|mesh-ancestor
92564005|NCT00044733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564006|NCT00052949|Imatinib Mesylate|imatinib mesylate|mesh-list
92564007|NCT00052949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564008|NCT00052949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92564009|NCT00052949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564010|NCT00052949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564011|NCT00161902|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92564012|NCT00161902|Hemostatics|hemostatics|mesh-ancestor
92564013|NCT00161902|Coagulants|coagulants|mesh-ancestor
92564014|NCT00053027|Rituximab|rituximab|mesh-list
92564015|NCT00053027|Cladribine|cladribine|mesh-list
92564016|NCT00053027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564017|NCT00053027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564018|NCT00053027|Immunologic Factors|immunologic factors|mesh-ancestor
92564019|NCT00053027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564020|NCT00053027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564021|NCT00053027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564022|NCT00161980|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92564023|NCT00161980|Hemostatics|hemostatics|mesh-ancestor
92564024|NCT00161980|Coagulants|coagulants|mesh-ancestor
92564025|NCT00162019|Factor VIII|factor viii|mesh-list
92564026|NCT00162019|Coagulants|coagulants|mesh-ancestor
92564027|NCT00162214|Ketoconazole|ketoconazole|mesh-list
92564028|NCT00162214|Dasatinib|dasatinib|mesh-list
92564029|NCT00162214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564030|NCT00162214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92564031|NCT00162214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564032|NCT00162214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564033|NCT00162214|Antifungal Agents|antifungal agents|mesh-ancestor
92564034|NCT00162214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564035|NCT00162214|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92564036|NCT00162214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92534730|NCT00071227|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92534731|NCT00071227|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92564037|NCT00162214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92564038|NCT00162214|Hormone Antagonists|hormone antagonists|mesh-ancestor
92564039|NCT00162214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564040|NCT00162214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564041|NCT00162214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92564042|NCT04731116|Cannabidiol|cannabidiol|mesh-list
92564043|NCT04731116|Anticonvulsants|anticonvulsants|mesh-ancestor
92564044|NCT00407056|Difluprednate|difluprednate|mesh-list
92564045|NCT00407056|Glucocorticoids|glucocorticoids|mesh-ancestor
92564046|NCT00407056|Hormones|hormones|mesh-ancestor
92564047|NCT00407056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564048|NCT00407056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564049|NCT00405457|Cyclosporine|cyclosporine|mesh-list
92564050|NCT00405457|Cyclosporins|cyclosporins|mesh-list
92564055|NCT00405457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564056|NCT00405457|Antifungal Agents|antifungal agents|mesh-ancestor
92564057|NCT00405457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564058|NCT00405457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92564059|NCT00405457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564060|NCT00405457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92564061|NCT00053105|Cytarabine|cytarabine|mesh-list
92564062|NCT00053105|Methylprednisolone|methylprednisolone|mesh-list
92564063|NCT00053105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92355875|NCT02861898|Mannitol|mannitol|mesh-list
92564064|NCT00053105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92564065|NCT00053105|Prednisolone|prednisolone|mesh-list
92564066|NCT00053105|Prednisolone acetate|prednisolone acetate|mesh-list
92564067|NCT00053105|Pixantrone|pixantrone|mesh-list
92564068|NCT00053105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92564069|NCT00053105|Prednisolone phosphate|prednisolone phosphate|mesh-list
92564070|NCT00053105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564071|NCT00053105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564072|NCT00053105|Antimetabolites|antimetabolites|mesh-ancestor
92564073|NCT00053105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564074|NCT00053105|Antiviral Agents|antiviral agents|mesh-ancestor
92564075|NCT00053105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564076|NCT00053105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564077|NCT00053105|Immunologic Factors|immunologic factors|mesh-ancestor
92564078|NCT00053105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564079|NCT00053105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564080|NCT00053105|Antiemetics|antiemetics|mesh-ancestor
92564081|NCT00053105|Autonomic Agents|autonomic agents|mesh-ancestor
92564082|NCT00053105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564083|NCT00053105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564084|NCT00053105|Glucocorticoids|glucocorticoids|mesh-ancestor
92564085|NCT00053105|Hormones|hormones|mesh-ancestor
92564086|NCT00053105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564087|NCT00053105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92564088|NCT00053105|Protective Agents|protective agents|mesh-ancestor
92564089|NCT00053105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92564090|NCT00053105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564091|NCT00053105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564092|NCT00053105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564093|NCT00162331|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92564094|NCT00162331|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92564095|NCT00162331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564096|NCT00162409|Folic Acid|folic acid|mesh-list
92564097|NCT00162409|Hematinics|hematinics|mesh-ancestor
92564098|NCT00162409|Vitamin B Complex|vitamin b complex|mesh-ancestor
92564099|NCT00162409|Vitamins|vitamins|mesh-ancestor
92564100|NCT00162409|Micronutrients|micronutrients|mesh-ancestor
92564101|NCT00162409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564102|NCT00053144|Cytarabine|cytarabine|mesh-list
92564103|NCT00053144|Irinotecan|irinotecan|mesh-list
92564104|NCT00053144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92564105|NCT00053144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564106|NCT00053144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564107|NCT00053144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564108|NCT00053144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564109|NCT00053144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564110|NCT00053144|Antimetabolites|antimetabolites|mesh-ancestor
92564111|NCT00053144|Antiviral Agents|antiviral agents|mesh-ancestor
92564112|NCT00053144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534732|NCT00071227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564113|NCT00053144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564114|NCT00053144|Immunologic Factors|immunologic factors|mesh-ancestor
92564115|NCT00053144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564116|NCT00162487|Albuterol|albuterol|mesh-list
92564117|NCT00162487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92564118|NCT00162487|Autonomic Agents|autonomic agents|mesh-ancestor
92564119|NCT00162487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564120|NCT00162487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564121|NCT00162487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92564122|NCT00162487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92564130|NCT00162487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564132|NCT00162526|Vitamin E|vitamin e|mesh-list
92564133|NCT00162526|Tocotrienols|tocotrienols|mesh-list
92564134|NCT00162526|alpha-Tocopherol|alpha-tocopherol|mesh-list
92564135|NCT00162526|Antioxidants|antioxidants|mesh-ancestor
92564136|NCT00162526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564137|NCT00162526|Protective Agents|protective agents|mesh-ancestor
92564138|NCT00162526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564139|NCT00162526|Vitamins|vitamins|mesh-ancestor
92564140|NCT00162526|Micronutrients|micronutrients|mesh-ancestor
92564141|NCT00162565|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92564142|NCT00162565|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92564143|NCT00162565|Adrenergic Agents|adrenergic agents|mesh-ancestor
92564144|NCT00162565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564145|NCT00162565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564146|NCT00162565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564147|NCT00162604|Cefuroxime|cefuroxime|mesh-list
92564148|NCT00162604|Cefuroxime axetil|cefuroxime axetil|mesh-list
92564149|NCT00162604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564150|NCT00162604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564151|NCT00162643|Ritonavir|ritonavir|mesh-list
92564152|NCT00162643|Lopinavir|lopinavir|mesh-list
92564153|NCT00162643|Lamivudine|lamivudine|mesh-list
92564154|NCT00162643|Zidovudine|zidovudine|mesh-list
92564155|NCT00162643|Efavirenz|efavirenz|mesh-list
92564156|NCT00162643|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92564157|NCT00162643|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92564158|NCT00162643|Protease Inhibitors|protease inhibitors|mesh-ancestor
92564159|NCT00162643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564160|NCT00162643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564161|NCT00162643|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92564162|NCT00162643|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92564163|NCT00162643|Antiviral Agents|antiviral agents|mesh-ancestor
92564164|NCT00162643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564165|NCT00162643|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92564166|NCT00162643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92564167|NCT00162643|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92564168|NCT00162643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92564169|NCT00162643|Antimetabolites|antimetabolites|mesh-ancestor
92564170|NCT00162643|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92564171|NCT00162643|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92564172|NCT00162643|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92564173|NCT00162643|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92564174|NCT00162643|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92564175|NCT00162682|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92564176|NCT00162682|Antiviral Agents|antiviral agents|mesh-ancestor
92564177|NCT00162682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564178|NCT00044772|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92564179|NCT00044772|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92564180|NCT00044772|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92564181|NCT00044772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92564182|NCT00044772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564183|NCT00044772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564184|NCT00044772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564185|NCT00044772|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92564186|NCT00044772|Antidepressive Agents|antidepressive agents|mesh-ancestor
92564187|NCT00044772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92564188|NCT00162721|Doxorubicin|doxorubicin|mesh-list
92564208|NCT00162760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92564209|NCT00162760|Growth Substances|growth substances|mesh-ancestor
92564210|NCT00162760|Growth Inhibitors|growth inhibitors|mesh-ancestor
92564211|NCT00162760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564213|NCT00162799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92564214|NCT00044811|Fexofenadine|fexofenadine|mesh-list
92564215|NCT00044811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92564216|NCT00044811|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92564217|NCT00044811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92564218|NCT00044811|Histamine Antagonists|histamine antagonists|mesh-ancestor
92564219|NCT00044811|Histamine Agents|histamine agents|mesh-ancestor
92564220|NCT00044811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564221|NCT00044811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564222|NCT00044811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564223|NCT00162877|Esomeprazole|esomeprazole|mesh-list
92564224|NCT00162877|Rabeprazole|rabeprazole|mesh-list
92564225|NCT00162877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92564226|NCT00162877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564227|NCT00162877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92564228|NCT00162877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704655|NCT03974139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289009|NCT04477733|Analgesics|analgesics|mesh-ancestor
92564229|NCT00162877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564230|NCT00162916|Citalopram|citalopram|mesh-list
92564231|NCT00162916|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92564232|NCT00162916|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92564233|NCT00162916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92564234|NCT00162916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564235|NCT00162916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564236|NCT00162916|Serotonin Agents|serotonin agents|mesh-ancestor
92564237|NCT00162916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564238|NCT00162916|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92564239|NCT00162916|Antidepressive Agents|antidepressive agents|mesh-ancestor
92564240|NCT00162916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92564253|NCT00163111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564254|NCT00163111|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564255|NCT00163111|Antifungal Agents|antifungal agents|mesh-ancestor
92564256|NCT00163111|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92564257|NCT00163111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92564258|NCT00163111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564259|NCT00163111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564260|NCT00163111|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92564261|NCT00163111|Hormone Antagonists|hormone antagonists|mesh-ancestor
92564262|NCT00163111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564263|NCT00163111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564264|NCT00163111|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92564265|NCT00163111|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92564266|NCT00163150|Atorvastatin|atorvastatin|mesh-list
92564267|NCT00163150|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92564268|NCT00163150|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92564269|NCT00163150|Antimetabolites|antimetabolites|mesh-ancestor
92564270|NCT00163150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564271|NCT00163150|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92564272|NCT00163150|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92564273|NCT00163150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564274|NCT00163267|Clopidogrel|clopidogrel|mesh-list
92564275|NCT00163267|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92564276|NCT00163267|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92564277|NCT00163267|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92564278|NCT00163267|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92564279|NCT00163267|Purinergic Agents|purinergic agents|mesh-ancestor
92564280|NCT00163267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564281|NCT00163267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564282|NCT00163267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564283|NCT00163306|Pantoprazole|pantoprazole|mesh-list
92564284|NCT00163306|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92564285|NCT00163306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564286|NCT00163306|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92564287|NCT00163306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564288|NCT00163306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564289|NCT00044889|Clofarabine|clofarabine|mesh-list
92564290|NCT00044889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92534735|NCT00071227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534736|NCT00071227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564291|NCT00044889|Antimetabolites|antimetabolites|mesh-ancestor
92564292|NCT00044889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564293|NCT00044889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564294|NCT00163345|Ciclesonide|ciclesonide|mesh-list
92564295|NCT00163345|Glucocorticoids|glucocorticoids|mesh-ancestor
92564296|NCT00163345|Hormones|hormones|mesh-ancestor
92564297|NCT00163345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564298|NCT00163345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289089|NCT04743011|Heparin|heparin|mesh-list
92564299|NCT00163345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92564300|NCT00163384|Ciclesonide|ciclesonide|mesh-list
92564310|NCT00163423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564312|NCT04731038|Paclitaxel|paclitaxel|mesh-list
92564313|NCT04731038|Carboplatin|carboplatin|mesh-list
92564314|NCT04731038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564315|NCT04731038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564316|NCT04731038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564317|NCT04731038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564318|NCT04731038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564319|NCT04731038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564320|NCT00163462|Ciclesonide|ciclesonide|mesh-list
92564321|NCT00163462|Glucocorticoids|glucocorticoids|mesh-ancestor
92564322|NCT00163462|Hormones|hormones|mesh-ancestor
92564323|NCT00163462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564324|NCT00163462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564325|NCT00163462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92564326|NCT00053300|Thalidomide|thalidomide|mesh-list
92564327|NCT00053300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564328|NCT00053300|Immunologic Factors|immunologic factors|mesh-ancestor
92564329|NCT00053300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564330|NCT00053300|Leprostatic Agents|leprostatic agents|mesh-ancestor
92564331|NCT00053300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564332|NCT00053300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564333|NCT00053300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92564334|NCT00053300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92564335|NCT00053300|Growth Substances|growth substances|mesh-ancestor
92564336|NCT00053300|Growth Inhibitors|growth inhibitors|mesh-ancestor
92564337|NCT00053300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564338|NCT00163501|Ciclesonide|ciclesonide|mesh-list
92564339|NCT00163501|Glucocorticoids|glucocorticoids|mesh-ancestor
92564340|NCT00163501|Hormones|hormones|mesh-ancestor
92564341|NCT00163501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564342|NCT00163501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564343|NCT00163501|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92564344|NCT00163540|Formaldehyde|formaldehyde|mesh-list
92564345|NCT00163540|Disinfectants|disinfectants|mesh-ancestor
92564346|NCT00163540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564347|NCT00053339|Tamoxifen|tamoxifen|mesh-list
92564348|NCT00053339|Trastuzumab|trastuzumab|mesh-list
92564349|NCT00053339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564350|NCT00053339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564351|NCT00053339|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92564352|NCT00053339|Hormone Antagonists|hormone antagonists|mesh-ancestor
92564353|NCT00053339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564354|NCT00053339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564355|NCT00053339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92564356|NCT00053339|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92564357|NCT00053339|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92564358|NCT00053339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92564359|NCT00163618|Formaldehyde|formaldehyde|mesh-list
92564360|NCT00163618|Disinfectants|disinfectants|mesh-ancestor
92564361|NCT00163618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564362|NCT00053378|Calcium|calcium|mesh-list
92564363|NCT00053378|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92564364|NCT00053378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564365|NCT02970383|Narcotics|narcotics|mesh-list
92564366|NCT02970383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92564367|NCT02970383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534737|NCT00071227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534738|NCT00071227|Immunologic Factors|immunologic factors|mesh-ancestor
92534739|NCT00071227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913892|NCT04854044|TIC10 compound|tic10 compound|mesh-list
92564368|NCT02970383|Analgesics|analgesics|mesh-ancestor
92564369|NCT02970383|Sensory System Agents|sensory system agents|mesh-ancestor
92564370|NCT02970383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564371|NCT05502900|Melatonin|melatonin|mesh-list
92564372|NCT05502900|Antioxidants|antioxidants|mesh-ancestor
92704656|NCT04320238|Interferons|interferons|mesh-list
92289166|NCT02585843|Spironolactone|spironolactone|mesh-list
92564373|NCT05502900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564374|NCT05502900|Protective Agents|protective agents|mesh-ancestor
92564375|NCT05502900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564376|NCT05502900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92564377|NCT00163969|Ketamine|ketamine|mesh-list
92564378|NCT00163969|Analgesics|analgesics|mesh-ancestor
92564379|NCT00163969|Sensory System Agents|sensory system agents|mesh-ancestor
92564380|NCT00163969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564381|NCT00163969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564382|NCT00163969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92564383|NCT00163969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92564384|NCT00163969|Anesthetics, General|anesthetics, general|mesh-ancestor
92564385|NCT00163969|Anesthetics|anesthetics|mesh-ancestor
92564386|NCT00163969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92564387|NCT00163969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92564388|NCT00163969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92564389|NCT00163969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564390|NCT00163969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564391|NCT00164008|Zoledronic Acid|zoledronic acid|mesh-list
92564392|NCT00164008|Pamidronate|pamidronate|mesh-list
92564393|NCT00164008|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92564394|NCT00164008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564395|NCT00164047|Nitrous Oxide|nitrous oxide|mesh-list
92564396|NCT00164047|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92564397|NCT00164047|Anesthetics, General|anesthetics, general|mesh-ancestor
92564398|NCT00164047|Anesthetics|anesthetics|mesh-ancestor
92564399|NCT00164047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92564400|NCT00164047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564401|NCT00164047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92564402|NCT00164047|Analgesics|analgesics|mesh-ancestor
92564403|NCT00164047|Sensory System Agents|sensory system agents|mesh-ancestor
92564404|NCT00164047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564405|NCT00164086|Atorvastatin|atorvastatin|mesh-list
92564406|NCT00164086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92564407|NCT00164086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92564408|NCT00164086|Antimetabolites|antimetabolites|mesh-ancestor
92564409|NCT00164086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564410|NCT00164086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92564411|NCT00164086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92564412|NCT00164086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564413|NCT00164125|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92564414|NCT00164125|Laxatives|laxatives|mesh-ancestor
92564415|NCT00164125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564416|NCT00164164|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92564417|NCT00164164|Laxatives|laxatives|mesh-ancestor
92564418|NCT00164164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564419|NCT00164242|Galantamine|galantamine|mesh-list
92564420|NCT00164242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92564421|NCT00164242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564422|NCT00164242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564423|NCT00164242|Cholinergic Agents|cholinergic agents|mesh-ancestor
92564424|NCT00164242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564425|NCT00164242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564426|NCT00164242|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92564427|NCT00164242|Autonomic Agents|autonomic agents|mesh-ancestor
92564428|NCT00164242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564429|NCT00164242|Nootropic Agents|nootropic agents|mesh-ancestor
92564430|NCT00162955|Valsartan|valsartan|mesh-list
92564431|NCT00162955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92564432|NCT00162955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92564433|NCT00162955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92534740|NCT00071227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534741|NCT00071266|Niacin|niacin|mesh-list
92564434|NCT00162955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564435|NCT00164281|Isoniazid|isoniazid|mesh-list
92564436|NCT00164281|Antitubercular Agents|antitubercular agents|mesh-ancestor
92564437|NCT00164281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564438|NCT00164281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564454|NCT00164359|Dapsone|dapsone|mesh-list
92564455|NCT00164359|Chlorproguanil|chlorproguanil|mesh-list
92564456|NCT00164359|Antimalarials|antimalarials|mesh-ancestor
92564457|NCT00164359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92564458|NCT00164359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92564459|NCT00164359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564460|NCT00164359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564461|NCT00164359|Antiviral Agents|antiviral agents|mesh-ancestor
92564462|NCT00164359|Schistosomicides|schistosomicides|mesh-ancestor
92564463|NCT00164359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92564464|NCT00164359|Anthelmintics|anthelmintics|mesh-ancestor
92564465|NCT00164359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92564466|NCT00164359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564467|NCT00164359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564468|NCT00164359|Leprostatic Agents|leprostatic agents|mesh-ancestor
92564469|NCT00164359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564470|NCT00053612|Vitamin A|vitamin a|mesh-list
92564471|NCT00053612|Vitamins|vitamins|mesh-ancestor
92564472|NCT00053612|Micronutrients|micronutrients|mesh-ancestor
92564473|NCT00053612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564474|NCT00045006|Vorinostat|vorinostat|mesh-list
92564475|NCT00045006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564476|NCT00045006|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92564477|NCT00045006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564478|NCT00045006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564479|NCT00164710|Artesunate|artesunate|mesh-list
92564480|NCT00164710|Lumefantrine|lumefantrine|mesh-list
92564481|NCT00164710|Artemether|artemether|mesh-list
92564482|NCT00164710|Pyrimethamine|pyrimethamine|mesh-list
92564483|NCT00164710|Sulfadoxine|sulfadoxine|mesh-list
92564484|NCT00164710|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92564485|NCT00164710|Amodiaquine|amodiaquine|mesh-list
92564486|NCT00164710|Dapsone|dapsone|mesh-list
92564487|NCT00164710|Chlorproguanil|chlorproguanil|mesh-list
92564488|NCT00164710|Antimalarials|antimalarials|mesh-ancestor
92564489|NCT00164710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92564490|NCT00164710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92564491|NCT00164710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564492|NCT00164710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564493|NCT00164710|Antiviral Agents|antiviral agents|mesh-ancestor
92564494|NCT00164710|Schistosomicides|schistosomicides|mesh-ancestor
92564495|NCT00164710|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92564496|NCT00164710|Anthelmintics|anthelmintics|mesh-ancestor
92564497|NCT00164710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92564498|NCT00164710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564499|NCT00164710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564500|NCT00164710|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92564501|NCT00164710|Leprostatic Agents|leprostatic agents|mesh-ancestor
92564507|NCT00164749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92564508|NCT00164749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92564509|NCT00164749|Analgesics|analgesics|mesh-ancestor
92564510|NCT00164749|Sensory System Agents|sensory system agents|mesh-ancestor
92564511|NCT00164749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564512|NCT00164749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564513|NCT00164749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564514|NCT00164749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564515|NCT00164749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564516|NCT00164749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564517|NCT00164749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564518|NCT00164788|Esomeprazole|esomeprazole|mesh-list
92564519|NCT00164788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92564520|NCT00164788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564521|NCT00164788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92289309|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564522|NCT00164788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564523|NCT00164788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564524|NCT00053768|Prednisone|prednisone|mesh-list
92564525|NCT00053768|Cyclophosphamide|cyclophosphamide|mesh-list
92564526|NCT00053768|Doxorubicin|doxorubicin|mesh-list
92534742|NCT00071266|Lovastatin|lovastatin|mesh-list
92534743|NCT00071266|L 647318|l 647318|mesh-list
92564527|NCT00053768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92564528|NCT00053768|Etoposide|etoposide|mesh-list
92564529|NCT00053768|Vincristine|vincristine|mesh-list
92564530|NCT00053768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564531|NCT00053768|Immunologic Factors|immunologic factors|mesh-ancestor
92564532|NCT00053768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564533|NCT00053768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564534|NCT00053768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92564535|NCT00053768|Alkylating Agents|alkylating agents|mesh-ancestor
92564536|NCT00053768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564537|NCT00053768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564538|NCT00053768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92564539|NCT00053768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564540|NCT00053768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564541|NCT00053768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564542|NCT00053768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564543|NCT00053768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564544|NCT00053768|Glucocorticoids|glucocorticoids|mesh-ancestor
92564545|NCT00053768|Hormones|hormones|mesh-ancestor
92564546|NCT00053768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564547|NCT00053768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92564548|NCT00053768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564549|NCT00053768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564550|NCT00053768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564551|NCT00053768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564552|NCT00045123|Tarenflurbil|tarenflurbil|mesh-list
92564553|NCT00045123|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92564554|NCT00045123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564555|NCT00045123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564556|NCT00164866|Omeprazole|omeprazole|mesh-list
92564557|NCT00164866|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92564558|NCT00164866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564559|NCT00164866|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92564560|NCT00164866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564561|NCT00164866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564562|NCT00407212|Maleic acid|maleic acid|mesh-list
92564563|NCT00407212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564564|NCT00407212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564565|NCT00165139|Cyclophosphamide|cyclophosphamide|mesh-list
92564566|NCT00165139|Melphalan|melphalan|mesh-list
92564567|NCT00165139|Ifosfamide|ifosfamide|mesh-list
92564568|NCT00165139|Carboplatin|carboplatin|mesh-list
92564569|NCT00165139|Etoposide|etoposide|mesh-list
92564570|NCT00165139|Vincristine|vincristine|mesh-list
92564571|NCT00165139|Doxorubicin|doxorubicin|mesh-list
92564575|NCT00165139|Immunologic Factors|immunologic factors|mesh-ancestor
92564576|NCT00165139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564577|NCT00165139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564578|NCT00165139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92564579|NCT00165139|Alkylating Agents|alkylating agents|mesh-ancestor
92564580|NCT00165139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564581|NCT00165139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564582|NCT00165139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92564583|NCT00165139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564584|NCT00165139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564585|NCT00165139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564586|NCT00165139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564587|NCT00165139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564588|NCT00165139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564589|NCT00165139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564590|NCT00165139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564591|NCT00165139|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92564592|NCT00053807|Interferons|interferons|mesh-list
92564593|NCT00053807|Interferon-alpha|interferon-alpha|mesh-list
92564594|NCT00053807|Aldesleukin|aldesleukin|mesh-list
92564595|NCT00053807|Fluorouracil|fluorouracil|mesh-list
92564596|NCT00053807|Antimetabolites|antimetabolites|mesh-ancestor
92564597|NCT00053807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564598|NCT00053807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564599|NCT00053807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704657|NCT04320238|Interferon-alpha|interferon-alpha|mesh-list
92564600|NCT00053807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564601|NCT00053807|Immunologic Factors|immunologic factors|mesh-ancestor
92534744|NCT00071266|Dihydromevinolin|dihydromevinolin|mesh-list
92534745|NCT00071266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92534746|NCT00071266|Antimetabolites|antimetabolites|mesh-ancestor
92564602|NCT00053807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564603|NCT00053807|Antiviral Agents|antiviral agents|mesh-ancestor
92564604|NCT00053807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564605|NCT00053807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92564606|NCT00053807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92564608|NCT00165178|Cytarabine|cytarabine|mesh-list
92564609|NCT00165178|Dexamethasone|dexamethasone|mesh-list
92564610|NCT00165178|Prednisone|prednisone|mesh-list
92564611|NCT00165178|Hydrocortisone|hydrocortisone|mesh-list
92564612|NCT00165178|Doxorubicin|doxorubicin|mesh-list
92564613|NCT00165178|Methotrexate|methotrexate|mesh-list
92564614|NCT00165178|Vincristine|vincristine|mesh-list
92564615|NCT00165178|Asparaginase|asparaginase|mesh-list
92564616|NCT00165178|Dexrazoxane|dexrazoxane|mesh-list
92564617|NCT00165178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564618|NCT00165178|Antiemetics|antiemetics|mesh-ancestor
92564619|NCT00165178|Autonomic Agents|autonomic agents|mesh-ancestor
92564620|NCT00165178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564621|NCT00165178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564622|NCT00165178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564623|NCT00165178|Glucocorticoids|glucocorticoids|mesh-ancestor
92564624|NCT00165178|Hormones|hormones|mesh-ancestor
92564625|NCT00165178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564626|NCT00165178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92564627|NCT00165178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564628|NCT00165178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564629|NCT00165178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564630|NCT00165178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564631|NCT00165178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564632|NCT00165178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564633|NCT00165178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92564634|NCT00165178|Abortifacient Agents|abortifacient agents|mesh-ancestor
92564635|NCT00165178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92564636|NCT00165178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564637|NCT00165178|Antimetabolites|antimetabolites|mesh-ancestor
92564638|NCT00165178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92564639|NCT00165178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92564640|NCT00165178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564641|NCT00165178|Immunologic Factors|immunologic factors|mesh-ancestor
92564642|NCT00165178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564643|NCT00165178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92564644|NCT00165178|Antiviral Agents|antiviral agents|mesh-ancestor
92564663|NCT00165217|Immunologic Factors|immunologic factors|mesh-ancestor
92564664|NCT00165217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564665|NCT00165217|Leprostatic Agents|leprostatic agents|mesh-ancestor
92564666|NCT00165217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564667|NCT00165217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564668|NCT00165217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92564669|NCT00165217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92564670|NCT00165217|Growth Substances|growth substances|mesh-ancestor
92564671|NCT00165217|Growth Inhibitors|growth inhibitors|mesh-ancestor
91937343|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
92564673|NCT00165295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564674|NCT00165295|Vasodilator Agents|vasodilator agents|mesh-ancestor
92564675|NCT00165295|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92564676|NCT00165295|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92564677|NCT00165295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564678|NCT00165295|Urological Agents|urological agents|mesh-ancestor
92564680|NCT00053885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92564681|NCT00053885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564682|NCT00053885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564683|NCT00165334|Cetuximab|cetuximab|mesh-list
92564684|NCT00165334|Vinorelbine|vinorelbine|mesh-list
92564685|NCT00165334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564686|NCT00165334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564687|NCT00165334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564688|NCT00165334|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564689|NCT00165334|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564690|NCT00165334|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564691|NCT00165334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564692|NCT00165373|Endostatins|endostatins|mesh-list
92564693|NCT00165373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534747|NCT00071266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534748|NCT00071266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92564694|NCT00165373|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92564695|NCT00165373|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92564696|NCT00165373|Growth Substances|growth substances|mesh-ancestor
92564697|NCT00165373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564698|NCT00165373|Growth Inhibitors|growth inhibitors|mesh-ancestor
92564699|NCT00165451|Thalidomide|thalidomide|mesh-list
92564700|NCT00165451|Celecoxib|celecoxib|mesh-list
92564701|NCT00165451|Cyclophosphamide|cyclophosphamide|mesh-list
92564702|NCT00165451|Etoposide|etoposide|mesh-list
92564703|NCT00165451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564711|NCT00165451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92564712|NCT00165451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564713|NCT00165451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564714|NCT00165451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564715|NCT00165451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564716|NCT00165451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92564717|NCT00165451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92564718|NCT00165451|Analgesics|analgesics|mesh-ancestor
92564719|NCT00165451|Sensory System Agents|sensory system agents|mesh-ancestor
92564720|NCT00165451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564721|NCT00165451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564722|NCT00165451|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92564723|NCT00165451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92564724|NCT00165451|Leprostatic Agents|leprostatic agents|mesh-ancestor
92564725|NCT00165451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564726|NCT00165451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564727|NCT00165451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92564728|NCT00165451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92564729|NCT00165451|Growth Substances|growth substances|mesh-ancestor
92564730|NCT00165451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92564731|NCT00165490|Irinotecan|irinotecan|mesh-list
92564732|NCT00165490|Cetuximab|cetuximab|mesh-list
92564733|NCT00165490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564734|NCT00165490|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92564735|NCT00165490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564736|NCT00165490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564737|NCT00165490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564738|NCT00165490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564739|NCT00165568|Bevacizumab|bevacizumab|mesh-list
92564740|NCT00165568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564741|NCT00165568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564742|NCT00165568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92564743|NCT00165568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92564744|NCT00165568|Growth Substances|growth substances|mesh-ancestor
92564745|NCT00165568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564746|NCT00165568|Growth Inhibitors|growth inhibitors|mesh-ancestor
92564747|NCT00165685|Sibutramine|sibutramine|mesh-list
92564748|NCT00165685|Antidepressive Agents|antidepressive agents|mesh-ancestor
92564749|NCT00165685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92564750|NCT00165685|Appetite Depressants|appetite depressants|mesh-ancestor
92564751|NCT00165685|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92564752|NCT00045279|Interferons|interferons|mesh-list
92564753|NCT00045279|Interferon-alpha|interferon-alpha|mesh-list
92564754|NCT00045279|Interferon alpha-2|interferon alpha-2|mesh-list
92564755|NCT00045279|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92564756|NCT00045279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564757|NCT00045279|Antiviral Agents|antiviral agents|mesh-ancestor
92564758|NCT00045279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564759|NCT00045279|Immunologic Factors|immunologic factors|mesh-ancestor
92564760|NCT00045279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564761|NCT00053963|Romidepsin|romidepsin|mesh-list
92564762|NCT00053963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564763|NCT00053963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564764|NCT00053963|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92564765|NCT00053963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564766|NCT00053963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564767|NCT00165763|Donepezil|donepezil|mesh-list
92564768|NCT00165763|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92564769|NCT00165763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564770|NCT00165763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564774|NCT00165763|Nootropic Agents|nootropic agents|mesh-ancestor
91914286|NCT03036644|Nicotine|nicotine|mesh-list
92564775|NCT00165880|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92564776|NCT00165880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564777|NCT00165880|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92564778|NCT00165880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564779|NCT00165880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564780|NCT00045318|Exatecan|exatecan|mesh-list
92564781|NCT00045318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92564782|NCT00045318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564783|NCT00045318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564784|NCT00045318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564785|NCT00045318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564786|NCT00054002|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92564787|NCT00054002|Trioxsalen|trioxsalen|mesh-list
92564788|NCT00054002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564789|NCT00054002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92564790|NCT00054002|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92564791|NCT00054041|Vaccines|vaccines|mesh-list
92564792|NCT00054041|Immunologic Factors|immunologic factors|mesh-ancestor
92564793|NCT00054041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564794|NCT00166153|Mycophenolic Acid|mycophenolic acid|mesh-list
92564795|NCT00166153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564796|NCT00166153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564797|NCT00166153|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92564798|NCT00166153|Antitubercular Agents|antitubercular agents|mesh-ancestor
92564799|NCT00166153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564800|NCT00166153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564801|NCT00166153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564802|NCT00166153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564803|NCT00054197|Paclitaxel|paclitaxel|mesh-list
92564804|NCT00054197|Vinorelbine|vinorelbine|mesh-list
92564805|NCT00054197|Gemcitabine|gemcitabine|mesh-list
92564806|NCT00054197|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92564807|NCT00054197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564808|NCT00054197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564809|NCT00054197|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564810|NCT00054197|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564811|NCT00054197|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564812|NCT00054197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564813|NCT00054197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564814|NCT00054197|Antimetabolites|antimetabolites|mesh-ancestor
92564815|NCT00045396|Tipifarnib|tipifarnib|mesh-list
92564816|NCT00045396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564817|NCT00166426|Sulindac sulfone|sulindac sulfone|mesh-list
92564818|NCT00166426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564819|NCT00166426|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92564820|NCT00166426|Protective Agents|protective agents|mesh-ancestor
92564821|NCT00166426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564822|NCT00166426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92564823|NCT00166426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564824|NCT00166426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564825|NCT00166426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92289604|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
92704658|NCT04320238|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92564826|NCT00166426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92564827|NCT00166426|Analgesics|analgesics|mesh-ancestor
92564828|NCT00166426|Sensory System Agents|sensory system agents|mesh-ancestor
92564829|NCT00166426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564830|NCT00166426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564831|NCT00166426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564832|NCT00166465|Leucovorin|leucovorin|mesh-list
92564833|NCT00166465|Fluorouracil|fluorouracil|mesh-list
92564834|NCT00166465|Oxaliplatin|oxaliplatin|mesh-list
92564835|NCT00166465|Antimetabolites|antimetabolites|mesh-ancestor
92564836|NCT00166465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564837|NCT00166465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564838|NCT00166465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564839|NCT00166465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564840|NCT00166465|Immunologic Factors|immunologic factors|mesh-ancestor
92564848|NCT00166621|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92564849|NCT00166621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92564850|NCT00166621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92564851|NCT00166621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564852|NCT00166621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534749|NCT00071266|Vasodilator Agents|vasodilator agents|mesh-ancestor
92564853|NCT00166621|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92564854|NCT00166621|Serotonin Agents|serotonin agents|mesh-ancestor
92564855|NCT00166621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564856|NCT00166621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564857|NCT00054236|Methylprednisolone|methylprednisolone|mesh-list
92564858|NCT00054236|Cyclophosphamide|cyclophosphamide|mesh-list
92564859|NCT00054236|Fludarabine|fludarabine|mesh-list
92564860|NCT00054236|Fludarabine phosphate|fludarabine phosphate|mesh-list
92564861|NCT00054236|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92564862|NCT00054236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564863|NCT00054236|Immunologic Factors|immunologic factors|mesh-ancestor
92564864|NCT00054236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564865|NCT00054236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564866|NCT00054236|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92564867|NCT00054236|Alkylating Agents|alkylating agents|mesh-ancestor
92564868|NCT00054236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564869|NCT00054236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564870|NCT00054236|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92564871|NCT00054236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564872|NCT00054236|Antimetabolites|antimetabolites|mesh-ancestor
92564873|NCT00054236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564874|NCT00054236|Antiemetics|antiemetics|mesh-ancestor
92564875|NCT00054236|Autonomic Agents|autonomic agents|mesh-ancestor
92564876|NCT00054236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92564877|NCT00054236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92564878|NCT00054236|Glucocorticoids|glucocorticoids|mesh-ancestor
92564879|NCT00054236|Hormones|hormones|mesh-ancestor
92564880|NCT00054236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564881|NCT00054236|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92564882|NCT00054236|Protective Agents|protective agents|mesh-ancestor
92564883|NCT00054392|Paclitaxel|paclitaxel|mesh-list
92564884|NCT00054392|Carboplatin|carboplatin|mesh-list
92564885|NCT00054392|Gemcitabine|gemcitabine|mesh-list
92564886|NCT00054392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564887|NCT00054392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564888|NCT00054392|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564889|NCT00054392|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564890|NCT00054392|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564891|NCT00054392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564892|NCT00054392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564893|NCT00054392|Antimetabolites|antimetabolites|mesh-ancestor
92564894|NCT00166816|Cyclosporine|cyclosporine|mesh-list
92564895|NCT00166816|Sirolimus|sirolimus|mesh-list
92564896|NCT00166816|Tacrolimus|tacrolimus|mesh-list
92564897|NCT00166816|Cyclosporins|cyclosporins|mesh-list
92564898|NCT00166816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564899|NCT00166816|Immunologic Factors|immunologic factors|mesh-ancestor
92564900|NCT00166816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289682|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
92564901|NCT00166816|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92564902|NCT00166816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564903|NCT00166816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564904|NCT00166816|Antifungal Agents|antifungal agents|mesh-ancestor
92356164|NCT01893450|Dopamine Agents|dopamine agents|mesh-ancestor
92564905|NCT00166816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564906|NCT00166816|Dermatologic Agents|dermatologic agents|mesh-ancestor
92564907|NCT00166816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564908|NCT00166816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564909|NCT00166816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564910|NCT00166816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564915|NCT04723732|Disinfectants|disinfectants|mesh-ancestor
92564916|NCT04723732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92564917|NCT00054431|Imatinib Mesylate|imatinib mesylate|mesh-list
92564918|NCT00054431|Decitabine|decitabine|mesh-list
92564919|NCT00054431|Azacitidine|azacitidine|mesh-list
92564920|NCT00054431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564921|NCT00054431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92564922|NCT00054431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564923|NCT00054431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564924|NCT00054431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564925|NCT00054431|Antimetabolites|antimetabolites|mesh-ancestor
92564926|NCT00054470|Trastuzumab|trastuzumab|mesh-list
92564927|NCT00054470|Tipifarnib|tipifarnib|mesh-list
92564928|NCT00054470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564929|NCT00054470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534750|NCT00071266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92534751|NCT00071266|Vitamins|vitamins|mesh-ancestor
92534752|NCT00071266|Micronutrients|micronutrients|mesh-ancestor
92534753|NCT00071266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534754|NCT00071266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92534755|NCT00071266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92534756|NCT00071266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564930|NCT00054548|Paclitaxel|paclitaxel|mesh-list
92564931|NCT00054548|Oblimersen|oblimersen|mesh-list
92564932|NCT00054548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564933|NCT00054548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564934|NCT00054548|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564935|NCT00054548|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564936|NCT00054548|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564937|NCT00054548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564938|NCT00045513|Fludarabine|fludarabine|mesh-list
92564939|NCT00045513|Fludarabine phosphate|fludarabine phosphate|mesh-list
92564940|NCT00045513|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92564941|NCT00045513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564942|NCT00045513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564943|NCT00045513|Antimetabolites|antimetabolites|mesh-ancestor
92564944|NCT00045513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564945|NCT00045513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564946|NCT00045513|Immunologic Factors|immunologic factors|mesh-ancestor
92564947|NCT00045513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564948|NCT00045513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92564949|NCT00045513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564950|NCT00167401|Docetaxel|docetaxel|mesh-list
92564951|NCT00167401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564952|NCT00167401|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564953|NCT00167401|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564954|NCT00167401|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564955|NCT00167401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564956|NCT00167479|Risperidone|risperidone|mesh-list
92564957|NCT00167479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92564958|NCT00167479|Serotonin Agents|serotonin agents|mesh-ancestor
92564959|NCT00167479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564960|NCT00167479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564961|NCT00167479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564962|NCT00167479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92564963|NCT00167479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92564964|NCT00167479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92564965|NCT00167479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92564966|NCT00167479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92564967|NCT00167479|Dopamine Agents|dopamine agents|mesh-ancestor
92564968|NCT00054587|Cyclophosphamide|cyclophosphamide|mesh-list
92564969|NCT00054587|Docetaxel|docetaxel|mesh-list
92564970|NCT00054587|Fluorouracil|fluorouracil|mesh-list
92564971|NCT00054587|Trastuzumab|trastuzumab|mesh-list
92564972|NCT00054587|Epirubicin|epirubicin|mesh-list
92564973|NCT00054587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564974|NCT00054587|Immunologic Factors|immunologic factors|mesh-ancestor
92564975|NCT00054587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564976|NCT00054587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564977|NCT00054587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92564978|NCT00054587|Alkylating Agents|alkylating agents|mesh-ancestor
92704659|NCT04320238|Thymalfasin|thymalfasin|mesh-list
92564979|NCT00054587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564980|NCT00054587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564981|NCT00054587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92564982|NCT00054587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564984|NCT00054587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564986|NCT00054587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564987|NCT00054587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92564988|NCT00054587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564989|NCT00054587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564990|NCT00054587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564991|NCT00054587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564992|NCT00167518|Triamcinolone|triamcinolone|mesh-list
92534757|NCT02966743|Midazolam|midazolam|mesh-list
92534758|NCT02966743|Dexmedetomidine|dexmedetomidine|mesh-list
91914485|NCT03180957|Adalimumab|adalimumab|mesh-list
92564993|NCT00167518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92564994|NCT00167518|Glucocorticoids|glucocorticoids|mesh-ancestor
92564996|NCT00167518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564997|NCT00167518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564998|NCT00167557|Interferons|interferons|mesh-list
92564999|NCT00167557|Ribavirin|ribavirin|mesh-list
92565000|NCT00167557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565001|NCT00167557|Antiviral Agents|antiviral agents|mesh-ancestor
92565002|NCT00167557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565003|NCT00167557|Antimetabolites|antimetabolites|mesh-ancestor
92565004|NCT00167557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565005|NCT00167674|Zidovudine|zidovudine|mesh-list
92565006|NCT00167674|Nevirapine|nevirapine|mesh-list
92565007|NCT00167674|Antimetabolites|antimetabolites|mesh-ancestor
92565008|NCT00167674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565009|NCT00167674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92565010|NCT00167674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92565011|NCT00167674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565012|NCT00167674|Antiviral Agents|antiviral agents|mesh-ancestor
92565013|NCT00167674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565014|NCT00167674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92565015|NCT00167674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92565016|NCT00167674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92565017|NCT00167674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92565018|NCT00054626|Gemcitabine|gemcitabine|mesh-list
92565019|NCT00054626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565020|NCT00054626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565021|NCT00054626|Antimetabolites|antimetabolites|mesh-ancestor
92565022|NCT00054626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565023|NCT00167713|Ibuprofen|ibuprofen|mesh-list
92565024|NCT00167713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92565025|NCT00167713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565026|NCT00167713|Analgesics|analgesics|mesh-ancestor
92565027|NCT00167713|Sensory System Agents|sensory system agents|mesh-ancestor
92565028|NCT00167713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565029|NCT00167713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565030|NCT00167713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565031|NCT00167713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565032|NCT00167713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92565033|NCT00167713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565034|NCT00167713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565035|NCT00167791|Rituximab|rituximab|mesh-list
92565036|NCT00167791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565037|NCT00167791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565038|NCT00167791|Immunologic Factors|immunologic factors|mesh-ancestor
92565039|NCT00167791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565040|NCT00167791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565041|NCT00045591|Celecoxib|celecoxib|mesh-list
92565042|NCT00045591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92565043|NCT00045591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565044|NCT00045591|Analgesics|analgesics|mesh-ancestor
92565045|NCT00045591|Sensory System Agents|sensory system agents|mesh-ancestor
92565046|NCT00045591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565047|NCT00045591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565048|NCT00045591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565049|NCT00045591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565050|NCT00045591|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92565051|NCT00045591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92565052|NCT00045591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565053|NCT00045591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565054|NCT00167908|Amifostine|amifostine|mesh-list
92565055|NCT00167908|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91972328|NCT03294551|Vaccines|vaccines|mesh-list
92565061|NCT00167947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565062|NCT00167947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565063|NCT00167947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565064|NCT00167947|Immunologic Factors|immunologic factors|mesh-ancestor
92565065|NCT00167947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565066|NCT00167947|Antifungal Agents|antifungal agents|mesh-ancestor
92534759|NCT02966743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91914550|NCT03183843|Antithrombins|antithrombins|mesh-ancestor
92565067|NCT00167947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565068|NCT00167947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92565069|NCT00167947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565070|NCT00167947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92565071|NCT00167947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565072|NCT00167947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92565073|NCT00167947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565075|NCT00167986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565076|NCT00167986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565077|NCT00168025|Immunoglobulins|immunoglobulins|mesh-list
92565078|NCT00168025|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92565080|NCT00168025|Immunologic Factors|immunologic factors|mesh-ancestor
92565081|NCT00168025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565082|NCT00168181|Pilocarpine|pilocarpine|mesh-list
92565083|NCT00168181|Miotics|miotics|mesh-ancestor
92565084|NCT00168181|Autonomic Agents|autonomic agents|mesh-ancestor
92565085|NCT00168181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565086|NCT00168181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565087|NCT00168181|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92565088|NCT00168181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92565089|NCT00168181|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565090|NCT00168181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565091|NCT00168181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565092|NCT00407251|Epothilone B|epothilone b|mesh-list
92565093|NCT00407251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565094|NCT00407251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565095|NCT00407251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565096|NCT00407251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565097|NCT00407251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565098|NCT00045669|Imatinib Mesylate|imatinib mesylate|mesh-list
92565099|NCT00045669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565100|NCT00045669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565101|NCT00045669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565102|NCT00045669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565103|NCT00407290|Neostigmine|neostigmine|mesh-list
92565104|NCT00407290|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92565105|NCT00407290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565106|NCT00407290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565107|NCT00407290|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565108|NCT00407290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565109|NCT00407290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565110|NCT00407290|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92565111|NCT00407290|Autonomic Agents|autonomic agents|mesh-ancestor
92565112|NCT00407290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565113|NCT00407407|Carboplatin|carboplatin|mesh-list
92565114|NCT00407407|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92565115|NCT00407407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565116|NCT00407446|Sildenafil Citrate|sildenafil citrate|mesh-list
92565117|NCT00407446|Vasodilator Agents|vasodilator agents|mesh-ancestor
92565118|NCT00407446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92565119|NCT00407446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92565120|NCT00407446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565121|NCT00407446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565122|NCT00407446|Urological Agents|urological agents|mesh-ancestor
92565123|NCT00168415|Botulinum Toxins|botulinum toxins|mesh-list
92565124|NCT00168415|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92565125|NCT00168415|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92565126|NCT00168415|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92565131|NCT00168415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565132|NCT00168415|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92565133|NCT00168415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565134|NCT00168493|Antidepressive Agents|antidepressive agents|mesh-list
92565136|NCT00168493|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92565137|NCT00168493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92565138|NCT00168493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92565139|NCT00168493|Serotonin Agents|serotonin agents|mesh-ancestor
92565140|NCT00168493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565141|NCT00168493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565142|NCT00168493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534760|NCT02966743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534761|NCT02966743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565143|NCT00168493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92565144|NCT00168493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565145|NCT00168532|Trimethoprim|trimethoprim|mesh-list
92565146|NCT00168532|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92565147|NCT00168532|Sulfamethoxazole|sulfamethoxazole|mesh-list
92565148|NCT00168532|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92565149|NCT00168532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565150|NCT00168532|Antimalarials|antimalarials|mesh-ancestor
92565151|NCT00168532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92565152|NCT00168532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92565153|NCT00168532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92565154|NCT00168532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565155|NCT00168532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565156|NCT00168532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92565157|NCT00168532|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92565158|NCT00168532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92565159|NCT00168532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565160|NCT00168610|Vitamin A|vitamin a|mesh-list
92565161|NCT00168610|Vitamins|vitamins|mesh-ancestor
92565162|NCT00168610|Micronutrients|micronutrients|mesh-ancestor
92565163|NCT00168610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565164|NCT04731948|Vitamins|vitamins|mesh-list
92565165|NCT04731948|Folic Acid|folic acid|mesh-list
92565166|NCT04731948|Hydroxocobalamin|hydroxocobalamin|mesh-list
92565167|NCT04731948|Vitamin B 12|vitamin b 12|mesh-list
92565168|NCT04731948|Vitamin B Complex|vitamin b complex|mesh-list
92565169|NCT04731948|Micronutrients|micronutrients|mesh-ancestor
92565170|NCT04731948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565171|NCT04731948|Hematinics|hematinics|mesh-ancestor
92565172|NCT00168649|Vitamin A|vitamin a|mesh-list
92565173|NCT00168649|Vitamins|vitamins|mesh-ancestor
92565174|NCT00168649|Micronutrients|micronutrients|mesh-ancestor
92356272|NCT02716974|Fertility Agents|fertility agents|mesh-ancestor
92565175|NCT00168649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565176|NCT00168688|Micronutrients|micronutrients|mesh-list
92565177|NCT00168688|Trace Elements|trace elements|mesh-list
92565178|NCT00168688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565179|NCT00168766|Interferons|interferons|mesh-list
92565180|NCT00168766|Interferon-beta|interferon-beta|mesh-list
92565181|NCT00168766|Interferon beta-1a|interferon beta-1a|mesh-list
92565182|NCT00168766|Methylprednisolone|methylprednisolone|mesh-list
92565183|NCT00168766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565184|NCT00168766|Antiviral Agents|antiviral agents|mesh-ancestor
92565185|NCT00168766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565186|NCT00168766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565187|NCT00168766|Antiemetics|antiemetics|mesh-ancestor
92565188|NCT00168766|Autonomic Agents|autonomic agents|mesh-ancestor
92565189|NCT00168766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565190|NCT00168766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565191|NCT00168766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92565192|NCT00168766|Glucocorticoids|glucocorticoids|mesh-ancestor
92565193|NCT00168766|Hormones|hormones|mesh-ancestor
92565194|NCT00168766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92565195|NCT00168766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92565196|NCT00168766|Protective Agents|protective agents|mesh-ancestor
92565197|NCT00168766|Immunologic Factors|immunologic factors|mesh-ancestor
92565198|NCT00168766|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92565199|NCT00168883|Paclitaxel|paclitaxel|mesh-list
92565200|NCT00168883|Vinorelbine|vinorelbine|mesh-list
92565201|NCT00168883|Carboplatin|carboplatin|mesh-list
92289979|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565202|NCT00168883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92565203|NCT00168883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565204|NCT00168883|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565205|NCT00168883|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565206|NCT00168883|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565207|NCT00168883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565209|NCT04731909|Carboplatin|carboplatin|mesh-list
92565210|NCT04731909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565211|NCT00168922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92565212|NCT00168922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92565213|NCT00168922|Alkylating Agents|alkylating agents|mesh-ancestor
92565214|NCT00168922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565215|NCT00168922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534762|NCT02966743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914704|NCT01648348|Antibodies|antibodies|mesh-list
92565216|NCT00054938|Aspirin|aspirin|mesh-list
92565217|NCT00054938|Ramipril|ramipril|mesh-list
92565218|NCT00054938|Pravastatin|pravastatin|mesh-list
92565219|NCT00054938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565220|NCT00054938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92565221|NCT00054938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565222|NCT00054938|Analgesics|analgesics|mesh-ancestor
92565223|NCT00054938|Sensory System Agents|sensory system agents|mesh-ancestor
92565224|NCT00054938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565225|NCT00054938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565226|NCT00054938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565227|NCT00054938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92565228|NCT00054938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92565229|NCT00054938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565230|NCT00054938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92565231|NCT00054938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92565232|NCT00054938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565233|NCT00054938|Antipyretics|antipyretics|mesh-ancestor
92565234|NCT00054938|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92565235|NCT00054938|Protease Inhibitors|protease inhibitors|mesh-ancestor
92565236|NCT00054938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565237|NCT00054938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92565238|NCT00054938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92565239|NCT00054938|Antimetabolites|antimetabolites|mesh-ancestor
92565240|NCT00054938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92565241|NCT00054938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92565242|NCT00169000|Docetaxel|docetaxel|mesh-list
92565243|NCT00169000|Capecitabine|capecitabine|mesh-list
92565244|NCT00169000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565245|NCT00169000|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565246|NCT00169000|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565247|NCT00169000|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565248|NCT00169000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565249|NCT00169000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565250|NCT00169000|Antimetabolites|antimetabolites|mesh-ancestor
92565251|NCT00045747|Fluorouracil|fluorouracil|mesh-list
92565252|NCT00045747|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92565253|NCT00045747|Antimetabolites|antimetabolites|mesh-ancestor
92565254|NCT00045747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565255|NCT00045747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565256|NCT00045747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565257|NCT00045747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565258|NCT00045747|Immunologic Factors|immunologic factors|mesh-ancestor
92565259|NCT00045747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565260|NCT00045747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565261|NCT00045747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565262|NCT00169039|Chlorpromazine|chlorpromazine|mesh-list
92565263|NCT00169039|Clozapine|clozapine|mesh-list
92565264|NCT00169039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92565265|NCT00169039|Serotonin Agents|serotonin agents|mesh-ancestor
92565266|NCT00169039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565267|NCT00169039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565268|NCT00169039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565269|NCT00169039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92356328|NCT02706678|Tacrolimus|tacrolimus|mesh-list
92565270|NCT00169039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92565271|NCT00169039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92565272|NCT00169039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92565298|NCT00169156|Rituximab|rituximab|mesh-list
92565299|NCT00169156|Doxorubicin|doxorubicin|mesh-list
92565300|NCT00169156|Vincristine|vincristine|mesh-list
92565301|NCT00169156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565302|NCT00169156|Immunologic Factors|immunologic factors|mesh-ancestor
92565303|NCT00169156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565304|NCT00169156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565305|NCT00169156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92565306|NCT00169156|Alkylating Agents|alkylating agents|mesh-ancestor
92565307|NCT00169156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565308|NCT00169156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565309|NCT00169156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92565310|NCT00169156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565311|NCT00169156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534763|NCT02966743|Analgesics|analgesics|mesh-ancestor
92534764|NCT02966743|Sensory System Agents|sensory system agents|mesh-ancestor
92534765|NCT02966743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565312|NCT00169156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92565313|NCT00169156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92565314|NCT00169156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565315|NCT00169156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565316|NCT00169156|Glucocorticoids|glucocorticoids|mesh-ancestor
92565317|NCT00169156|Hormones|hormones|mesh-ancestor
92565318|NCT00169156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92565319|NCT00169156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92565320|NCT00169156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92565321|NCT00169156|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565322|NCT00169156|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565323|NCT00169156|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565324|NCT00169195|Rituximab|rituximab|mesh-list
92565325|NCT00169195|Gemcitabine|gemcitabine|mesh-list
92565326|NCT00169195|Oxaliplatin|oxaliplatin|mesh-list
91972619|NCT03291821|Ganirelix|ganirelix|mesh-list
92565328|NCT00169195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565330|NCT00169195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565331|NCT00169195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565332|NCT00169195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565333|NCT00169195|Antimetabolites|antimetabolites|mesh-ancestor
92565334|NCT00169195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565335|NCT00169234|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92565336|NCT00169234|Immunologic Factors|immunologic factors|mesh-ancestor
92565337|NCT00169234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565338|NCT00169468|Rituximab|rituximab|mesh-list
92565339|NCT00169468|Bortezomib|bortezomib|mesh-list
92565340|NCT00169468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565341|NCT00169468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565342|NCT00169468|Immunologic Factors|immunologic factors|mesh-ancestor
92565343|NCT00169468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565344|NCT00169468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565345|NCT00169546|Fluticasone|fluticasone|mesh-list
92565346|NCT00169546|Xhance|xhance|mesh-list
92565347|NCT00169546|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92565348|NCT00169546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565349|NCT00169546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92565350|NCT00169546|Autonomic Agents|autonomic agents|mesh-ancestor
92565351|NCT00169546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565352|NCT00169546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565353|NCT00169546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92565354|NCT00169546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92565356|NCT00169546|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92565357|NCT00169546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92565358|NCT00169546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92565359|NCT00169546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92565360|NCT00169546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92565361|NCT00169546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565362|NCT00169546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565363|NCT00398372|Rituximab|rituximab|mesh-list
92565364|NCT00398372|Epratuzumab|epratuzumab|mesh-list
92565365|NCT00398372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565366|NCT00398372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565367|NCT00398372|Immunologic Factors|immunologic factors|mesh-ancestor
92565368|NCT00398372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565369|NCT00398372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565370|NCT00169585|Levofloxacin|levofloxacin|mesh-list
92565371|NCT00169585|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92565372|NCT00169585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565373|NCT00169585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565374|NCT00169585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92565375|NCT00169585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92565376|NCT00169585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565377|NCT00169585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565378|NCT00169585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565379|NCT00169585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92565380|NCT00169585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92565381|NCT00169624|Metformin|metformin|mesh-list
92565382|NCT00169624|Gliclazide|gliclazide|mesh-list
92565383|NCT00169624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92534766|NCT02966743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92534767|NCT02966743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92565384|NCT00169624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565385|NCT00407641|Heparin|heparin|mesh-list
92565386|NCT00407641|Tinzaparin|tinzaparin|mesh-list
92565387|NCT00407641|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92565388|NCT00407641|Dalteparin|dalteparin|mesh-list
92565389|NCT00407641|Anticoagulants|anticoagulants|mesh-ancestor
92565390|NCT00407641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92565391|NCT00407641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92565392|NCT00407641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565393|NCT00407680|Valsartan|valsartan|mesh-list
92565394|NCT00407680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565395|NCT00407680|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565396|NCT00407680|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565397|NCT00407680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565398|NCT00169819|Abciximab|abciximab|mesh-list
92565399|NCT00169819|Anticoagulants|anticoagulants|mesh-ancestor
92565400|NCT00169819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92565408|NCT00170053|Sirolimus|sirolimus|mesh-list
92565409|NCT00170053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565410|NCT00170053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565411|NCT00170053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92565412|NCT00170053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565413|NCT00170053|Antifungal Agents|antifungal agents|mesh-ancestor
92565414|NCT00170053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565415|NCT00170053|Immunologic Factors|immunologic factors|mesh-ancestor
92565416|NCT00170053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565417|NCT00055250|Gemcitabine|gemcitabine|mesh-list
92565418|NCT00055250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565419|NCT00055250|Antimetabolites|antimetabolites|mesh-ancestor
92565420|NCT00055250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565421|NCT00055250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565422|NCT00170209|Rifampin|rifampin|mesh-list
92565423|NCT00170209|Isoniazid|isoniazid|mesh-list
92565424|NCT00170209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92565425|NCT00170209|Antitubercular Agents|antitubercular agents|mesh-ancestor
92565426|NCT00170209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565427|NCT00170209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565428|NCT00170209|Leprostatic Agents|leprostatic agents|mesh-ancestor
92290203|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
92565429|NCT00170209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92565431|NCT00170209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565432|NCT00170209|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92565433|NCT00170209|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92565434|NCT00170209|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92565435|NCT00170209|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92565436|NCT00170209|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92565437|NCT00170209|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92565438|NCT00170209|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92565439|NCT00170209|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92565440|NCT00170209|Antimetabolites|antimetabolites|mesh-ancestor
92565441|NCT00170209|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92565442|NCT02964091|Sofosbuvir|sofosbuvir|mesh-list
92565443|NCT02964091|Ledipasvir|ledipasvir|mesh-list
92565444|NCT02964091|Antiviral Agents|antiviral agents|mesh-ancestor
92565445|NCT02964091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565446|NCT00170404|Vitamins|vitamins|mesh-list
92565447|NCT00170404|Folic Acid|folic acid|mesh-list
92565448|NCT00170404|Vitamin A|vitamin a|mesh-list
92565449|NCT00170404|Thiamine|thiamine|mesh-list
92565450|NCT00170404|Selenium|selenium|mesh-list
92565451|NCT00170404|Micronutrients|micronutrients|mesh-list
92565452|NCT00170404|Trace Elements|trace elements|mesh-list
92565453|NCT00170404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565454|NCT00170404|Hematinics|hematinics|mesh-ancestor
92565455|NCT00170404|Vitamin B Complex|vitamin b complex|mesh-ancestor
92565456|NCT00170404|Antioxidants|antioxidants|mesh-ancestor
92565457|NCT00170404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565458|NCT00170404|Protective Agents|protective agents|mesh-ancestor
92565459|NCT00055367|Natalizumab|natalizumab|mesh-list
92565460|NCT00055367|Immunologic Factors|immunologic factors|mesh-ancestor
92565461|NCT00055367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565462|NCT00170677|Topotecan|topotecan|mesh-list
92565463|NCT00170677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92534768|NCT02966743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92534769|NCT02966743|Adrenergic Agents|adrenergic agents|mesh-ancestor
92534770|NCT02966743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534771|NCT02966743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534772|NCT02966743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92565464|NCT00170677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92565465|NCT00170677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565466|NCT00170677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565467|NCT00170677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565468|NCT00170755|Darifenacin|darifenacin|mesh-list
92565469|NCT00170755|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91972748|NCT03284645|Tenofovir|tenofovir|mesh-list
92356380|NCT02666742|Antipyretics|antipyretics|mesh-ancestor
92565474|NCT00170755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565475|NCT00170755|Urological Agents|urological agents|mesh-ancestor
92565476|NCT00170794|Everolimus|everolimus|mesh-list
92565477|NCT00170794|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92565478|NCT00170794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565479|NCT00170794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565480|NCT00170794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565481|NCT00170794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565482|NCT00170794|Immunologic Factors|immunologic factors|mesh-ancestor
92565483|NCT00170794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565484|NCT00170794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565485|NCT00170833|Everolimus|everolimus|mesh-list
92565486|NCT00170833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92565487|NCT00170833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565488|NCT00170833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565489|NCT00170833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565490|NCT00170833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565491|NCT00170833|Immunologic Factors|immunologic factors|mesh-ancestor
92565492|NCT00170833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565493|NCT00170833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565494|NCT00170872|Lumiracoxib|lumiracoxib|mesh-list
92565495|NCT00170872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92565496|NCT00170872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92565497|NCT00170872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565498|NCT00170872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565499|NCT00170872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92565500|NCT00170872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565501|NCT00170872|Analgesics|analgesics|mesh-ancestor
92565502|NCT00170872|Sensory System Agents|sensory system agents|mesh-ancestor
92565503|NCT00170872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565504|NCT00170872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565505|NCT00170872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565506|NCT00170872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565507|NCT00170989|Valsartan|valsartan|mesh-list
92565508|NCT00170989|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92565509|NCT00170989|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565510|NCT00170989|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565511|NCT00170989|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565512|NCT00170989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565513|NCT00170989|Diuretics|diuretics|mesh-ancestor
92565514|NCT00170989|Natriuretic Agents|natriuretic agents|mesh-ancestor
92565515|NCT00170989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356392|NCT02684292|Immunoconjugates|immunoconjugates|mesh-ancestor
92565516|NCT00170989|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92565517|NCT00170989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565518|NCT00171028|Valsartan|valsartan|mesh-list
92565519|NCT00171028|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565520|NCT00171028|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565521|NCT00171028|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565522|NCT00171028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565523|NCT00055484|Zonisamide|zonisamide|mesh-list
92565524|NCT00055484|Anticonvulsants|anticonvulsants|mesh-ancestor
92565525|NCT00055484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92565526|NCT00055484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565527|NCT00055484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565528|NCT00055484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534774|NCT02966743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92534775|NCT02966743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914993|NCT04826822|Glucocorticoids|glucocorticoids|mesh-ancestor
92565529|NCT00055484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565530|NCT00171067|Valsartan|valsartan|mesh-list
92565531|NCT00171067|Lisinopril|lisinopril|mesh-list
92565532|NCT00171067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565533|NCT00171067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565534|NCT00171067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565535|NCT00171067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565536|NCT00171067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92565543|NCT00171106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565544|NCT00171106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565545|NCT00171106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565546|NCT00171106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565547|NCT00171145|Darifenacin|darifenacin|mesh-list
92565548|NCT00171145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92565549|NCT00171145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92565550|NCT00171145|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565551|NCT00171145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565552|NCT00171145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565553|NCT00171145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565554|NCT00171145|Urological Agents|urological agents|mesh-ancestor
92565555|NCT00171184|Darifenacin|darifenacin|mesh-list
92565556|NCT00171184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92565557|NCT00171184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92565558|NCT00171184|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565559|NCT00171184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565560|NCT00171184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565561|NCT00171184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565562|NCT00171184|Urological Agents|urological agents|mesh-ancestor
92565564|NCT00055523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92565565|NCT00055523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565566|NCT00055523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565567|NCT00171379|Mycophenolic Acid|mycophenolic acid|mesh-list
92565568|NCT00171379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92565569|NCT00171379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565570|NCT00171379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92565571|NCT00171379|Antitubercular Agents|antitubercular agents|mesh-ancestor
92565572|NCT00171379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92565573|NCT00171379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565574|NCT00171379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565575|NCT00171379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565576|NCT00171418|Tegaserod|tegaserod|mesh-list
92565577|NCT00171418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92565578|NCT00171418|Serotonin Agents|serotonin agents|mesh-ancestor
92565579|NCT00171418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565580|NCT00171418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565581|NCT00171418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565582|NCT00171457|Tegaserod|tegaserod|mesh-list
92565583|NCT00171457|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92565584|NCT00171457|Serotonin Agents|serotonin agents|mesh-ancestor
92565585|NCT00171457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565586|NCT00171457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565587|NCT00171457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565588|NCT00055562|Lenalidomide|lenalidomide|mesh-list
92565589|NCT00055562|Immunologic Factors|immunologic factors|mesh-ancestor
92565590|NCT00055562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565591|NCT00055562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92565592|NCT00055562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92565593|NCT00055562|Growth Substances|growth substances|mesh-ancestor
92565594|NCT00055562|Growth Inhibitors|growth inhibitors|mesh-ancestor
92565595|NCT00055562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565596|NCT00171496|Cyclosporine|cyclosporine|mesh-list
92565597|NCT00171496|Tacrolimus|tacrolimus|mesh-list
92565598|NCT00171496|Cyclosporins|cyclosporins|mesh-list
92565599|NCT00171496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565600|NCT00171496|Immunologic Factors|immunologic factors|mesh-ancestor
92565601|NCT00171496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534776|NCT02966743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92534777|NCT02966743|Anesthetics, General|anesthetics, general|mesh-ancestor
92534778|NCT02966743|Anesthetics|anesthetics|mesh-ancestor
92565602|NCT00171496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92565603|NCT00171496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565604|NCT00171496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565607|NCT00171496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92565608|NCT00171496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565609|NCT00171535|Amlodipine|amlodipine|mesh-list
92565610|NCT00171535|Valsartan|valsartan|mesh-list
92565611|NCT00171535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565612|NCT00171535|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92565613|NCT00171535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565614|NCT00171535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565615|NCT00171535|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92565616|NCT00171535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565617|NCT00171535|Vasodilator Agents|vasodilator agents|mesh-ancestor
92565618|NCT00171535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565619|NCT00171535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565620|NCT00171574|Valsartan|valsartan|mesh-list
92565621|NCT00171574|Lisinopril|lisinopril|mesh-list
92565622|NCT00171574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92565623|NCT00171574|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92565624|NCT00171574|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92565625|NCT00171574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565626|NCT00171574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92565627|NCT00171574|Protease Inhibitors|protease inhibitors|mesh-ancestor
92565628|NCT00171574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565629|NCT00171574|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92565630|NCT00171574|Protective Agents|protective agents|mesh-ancestor
92565631|NCT00171574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565632|NCT00171613|Octreotide|octreotide|mesh-list
92565633|NCT00171613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92565634|NCT00171613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92565635|NCT00171613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565636|NCT04920981|Atezolizumab|atezolizumab|mesh-list
92565637|NCT04920981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92565638|NCT04920981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565639|NCT04920981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565640|NCT04920981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565641|NCT00055640|Prednisone|prednisone|mesh-list
92565642|NCT00055640|Cyclophosphamide|cyclophosphamide|mesh-list
92565643|NCT00055640|Rituximab|rituximab|mesh-list
92565644|NCT00055640|Doxorubicin|doxorubicin|mesh-list
92565645|NCT00055640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92565646|NCT00055640|Vincristine|vincristine|mesh-list
92565647|NCT00055640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565648|NCT00055640|Immunologic Factors|immunologic factors|mesh-ancestor
92565649|NCT00055640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565650|NCT00055640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565651|NCT00055640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92565652|NCT00055640|Alkylating Agents|alkylating agents|mesh-ancestor
92565653|NCT00055640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565654|NCT00055640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565655|NCT00055640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92565656|NCT00055640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565657|NCT00055640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92565658|NCT00055640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92565659|NCT00055640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92565660|NCT00055640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565661|NCT00055640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565662|NCT00055640|Glucocorticoids|glucocorticoids|mesh-ancestor
92565663|NCT00055640|Hormones|hormones|mesh-ancestor
92565664|NCT00055640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92565665|NCT00055640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92565666|NCT00055640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92565667|NCT00055640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565668|NCT00055640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565669|NCT00055640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565670|NCT00171652|Diclofenac|diclofenac|mesh-list
92565671|NCT00171652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92534779|NCT02966743|GABA Modulators|gaba modulators|mesh-ancestor
92565672|NCT00171652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565673|NCT00171652|Analgesics|analgesics|mesh-ancestor
92565674|NCT00171652|Sensory System Agents|sensory system agents|mesh-ancestor
92565675|NCT00171652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565676|NCT00171652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565686|NCT00171691|Sensory System Agents|sensory system agents|mesh-ancestor
92565687|NCT00171691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565688|NCT00171691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565689|NCT00171691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565690|NCT00171691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565691|NCT00171691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92565692|NCT00171691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565693|NCT00171691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565694|NCT00171769|Certoparin|certoparin|mesh-list
92565695|NCT00171769|Anticoagulants|anticoagulants|mesh-ancestor
92565696|NCT00171808|Letrozole|letrozole|mesh-list
92565697|NCT00171808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565698|NCT00171808|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92565699|NCT00171808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92565700|NCT00171808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565701|NCT00171808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565702|NCT00171808|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92565703|NCT00171808|Hormone Antagonists|hormone antagonists|mesh-ancestor
92565704|NCT00171808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92565705|NCT00171808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565706|NCT00171847|Trastuzumab|trastuzumab|mesh-list
92565707|NCT00171847|Letrozole|letrozole|mesh-list
92565708|NCT00171847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565709|NCT00171847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565710|NCT00171847|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92565711|NCT00171847|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92565712|NCT00171847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565713|NCT00171847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565714|NCT00171847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92565715|NCT00171847|Hormone Antagonists|hormone antagonists|mesh-ancestor
92565716|NCT00171847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92565717|NCT00171847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565718|NCT00055679|Cyclophosphamide|cyclophosphamide|mesh-list
92565719|NCT00055679|Fluorouracil|fluorouracil|mesh-list
92565720|NCT00055679|Epirubicin|epirubicin|mesh-list
92565721|NCT00055679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565722|NCT00055679|Immunologic Factors|immunologic factors|mesh-ancestor
92565723|NCT00055679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565724|NCT00055679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565725|NCT00055679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92565726|NCT00055679|Alkylating Agents|alkylating agents|mesh-ancestor
92565727|NCT00055679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565728|NCT00055679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565729|NCT00055679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92565730|NCT00055679|Antimetabolites|antimetabolites|mesh-ancestor
92565731|NCT00055679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565732|NCT00055679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92565733|NCT00055679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92565734|NCT00055679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92565735|NCT00055679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565736|NCT00171886|Octreotide|octreotide|mesh-list
92565737|NCT00171886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92565738|NCT00171886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92565739|NCT00171886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565740|NCT00171964|Zoledronic Acid|zoledronic acid|mesh-list
92565744|NCT00172003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92565745|NCT00172003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565746|NCT00055718|Silymarin|silymarin|mesh-list
92565747|NCT00055718|Antioxidants|antioxidants|mesh-ancestor
92565748|NCT00055718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565749|NCT00055718|Protective Agents|protective agents|mesh-ancestor
92565750|NCT00055718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565751|NCT00055757|Gemcitabine|gemcitabine|mesh-list
92565752|NCT00055757|Tipifarnib|tipifarnib|mesh-list
92565753|NCT00055757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565754|NCT00055757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565755|NCT00055757|Antimetabolites|antimetabolites|mesh-ancestor
92534781|NCT00071539|Immunotoxins|immunotoxins|mesh-list
92534782|NCT00071539|Immunoconjugates|immunoconjugates|mesh-ancestor
91915219|NCT02115659|Triptolide|triptolide|mesh-list
92565756|NCT00055757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565757|NCT00399867|Simvastatin|simvastatin|mesh-list
92565758|NCT00399867|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92565759|NCT00399867|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92565760|NCT00399867|Antimetabolites|antimetabolites|mesh-ancestor
92565761|NCT00399867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565762|NCT00399867|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92565763|NCT00399867|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92565764|NCT00399867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565765|NCT00055835|Paclitaxel|paclitaxel|mesh-list
92565766|NCT00055835|Carboplatin|carboplatin|mesh-list
92565767|NCT00055835|Gemcitabine|gemcitabine|mesh-list
92565768|NCT00055835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92565769|NCT00055835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565770|NCT00055835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565771|NCT00055835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565772|NCT00055835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565773|NCT00055835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565774|NCT00055835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565775|NCT00055835|Antimetabolites|antimetabolites|mesh-ancestor
92565776|NCT00172354|Hydrocortisone|hydrocortisone|mesh-list
92565777|NCT00172354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92565778|NCT00055874|Interferons|interferons|mesh-list
92565779|NCT00055874|Cytarabine|cytarabine|mesh-list
92565780|NCT00055874|Interferon-alpha|interferon-alpha|mesh-list
92565781|NCT00055874|Imatinib Mesylate|imatinib mesylate|mesh-list
92565782|NCT00055874|Hydroxyurea|hydroxyurea|mesh-list
92565783|NCT00055874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565784|NCT00055874|Antiviral Agents|antiviral agents|mesh-ancestor
92565785|NCT00055874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565786|NCT00055874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565787|NCT00055874|Antimetabolites|antimetabolites|mesh-ancestor
92565788|NCT00055874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565789|NCT00055874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565790|NCT00055874|Immunologic Factors|immunologic factors|mesh-ancestor
92565791|NCT00055874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565792|NCT00055874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565793|NCT00055874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565794|NCT00055874|Antisickling Agents|antisickling agents|mesh-ancestor
92356489|NCT02589600|Vitamin D|vitamin d|mesh-list
92565795|NCT00055874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92565796|NCT00407719|Bevacizumab|bevacizumab|mesh-list
92565797|NCT00407719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565798|NCT00407719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565799|NCT00407719|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92565800|NCT00407719|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92565801|NCT00407719|Growth Substances|growth substances|mesh-ancestor
92565802|NCT00407719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565803|NCT00407719|Growth Inhibitors|growth inhibitors|mesh-ancestor
92565805|NCT04732845|Fludarabine|fludarabine|mesh-list
92565806|NCT04732845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565807|NCT04732845|Immunologic Factors|immunologic factors|mesh-ancestor
92565808|NCT04732845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565809|NCT04732845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565810|NCT04732845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92565811|NCT04732845|Alkylating Agents|alkylating agents|mesh-ancestor
92565812|NCT04732845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565813|NCT04732845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565818|NCT00055913|Antibodies|antibodies|mesh-list
92565819|NCT00055913|Immunoglobulins|immunoglobulins|mesh-list
92565820|NCT00055913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92565821|NCT00055913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565822|NCT00055913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92565823|NCT00055913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92565824|NCT00055913|Growth Substances|growth substances|mesh-ancestor
92565825|NCT00055913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565826|NCT00055913|Growth Inhibitors|growth inhibitors|mesh-ancestor
92565827|NCT00055913|Immunologic Factors|immunologic factors|mesh-ancestor
92565828|NCT00055913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565829|NCT00055913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565830|NCT00055913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565831|NCT00045864|Aldesleukin|aldesleukin|mesh-list
92565832|NCT00045864|Rituximab|rituximab|mesh-list
92565833|NCT00045864|Interleukin-2|interleukin-2|mesh-list
92565834|NCT00045864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565835|NCT00045864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565836|NCT00045864|Immunologic Factors|immunologic factors|mesh-ancestor
92565837|NCT00045864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565838|NCT00045864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565839|NCT00045864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565840|NCT00045864|Analgesics|analgesics|mesh-ancestor
92565841|NCT00045864|Sensory System Agents|sensory system agents|mesh-ancestor
92565842|NCT00045864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565843|NCT00045864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92565844|NCT00045864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92565845|NCT00045864|Antiviral Agents|antiviral agents|mesh-ancestor
92565846|NCT00045864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565847|NCT00055952|Exatecan|exatecan|mesh-list
92565848|NCT00055952|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92565849|NCT00055952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92565850|NCT00055952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565851|NCT00055952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565852|NCT00055952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565853|NCT00055991|Bexarotene|bexarotene|mesh-list
92565854|NCT00055991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565855|NCT04631484|Riboflavin|riboflavin|mesh-list
92565856|NCT04631484|Niacinamide|niacinamide|mesh-list
92565857|NCT04631484|Niacin|niacin|mesh-list
92565858|NCT04631484|Nicotinic Acids|nicotinic acids|mesh-list
92565859|NCT04631484|Vitamin B Complex|vitamin b complex|mesh-ancestor
92565860|NCT04631484|Vitamins|vitamins|mesh-ancestor
92565861|NCT04631484|Micronutrients|micronutrients|mesh-ancestor
92565862|NCT04631484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565863|NCT04631484|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92565864|NCT04631484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92565865|NCT04631484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92565866|NCT04631484|Antimetabolites|antimetabolites|mesh-ancestor
92565867|NCT04631484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565868|NCT04631484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92565869|NCT04631484|Vasodilator Agents|vasodilator agents|mesh-ancestor
92565870|NCT00056030|Leucovorin|leucovorin|mesh-list
92565871|NCT00056030|Fluorouracil|fluorouracil|mesh-list
92565872|NCT00056030|Oxaliplatin|oxaliplatin|mesh-list
92565873|NCT00056030|Cetuximab|cetuximab|mesh-list
92565874|NCT00056030|Calcium|calcium|mesh-list
92565875|NCT00056030|Levoleucovorin|levoleucovorin|mesh-list
92565876|NCT00056030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92565877|NCT00056030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565879|NCT00056030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565880|NCT00056030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565881|NCT00056030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565882|NCT00056030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565883|NCT00056030|Immunologic Factors|immunologic factors|mesh-ancestor
92565884|NCT00056030|Antidotes|antidotes|mesh-ancestor
92565885|NCT00056030|Protective Agents|protective agents|mesh-ancestor
92565886|NCT00056030|Vitamin B Complex|vitamin b complex|mesh-ancestor
92565887|NCT00056030|Vitamins|vitamins|mesh-ancestor
92565888|NCT00056030|Micronutrients|micronutrients|mesh-ancestor
92565889|NCT00056030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565894|NCT00046020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565895|NCT00046020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565896|NCT00046020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565897|NCT00046020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92565898|NCT00046020|Antidepressive Agents|antidepressive agents|mesh-ancestor
92565899|NCT00046020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92565900|NCT00173875|Gefitinib|gefitinib|mesh-list
92565901|NCT00173875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565902|NCT00173875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92565903|NCT00173875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565904|NCT00173875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565905|NCT04605081|Naltrexone|naltrexone|mesh-list
92565906|NCT04605081|Bupropion|bupropion|mesh-list
92565907|NCT04605081|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92565908|NCT04605081|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92565909|NCT04605081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565910|NCT04605081|Sensory System Agents|sensory system agents|mesh-ancestor
92565911|NCT04605081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620228|NCT02914015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534783|NCT00071539|Immunologic Factors|immunologic factors|mesh-ancestor
92534784|NCT00071539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534785|NCT00071695|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92534786|NCT00071695|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92565912|NCT04605081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92565913|NCT04605081|Antidepressive Agents|antidepressive agents|mesh-ancestor
92565914|NCT04605081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92565915|NCT04605081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92565916|NCT04605081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92565917|NCT04605081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565918|NCT04605081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565919|NCT04605081|Dopamine Agents|dopamine agents|mesh-ancestor
92565920|NCT04605081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565921|NCT04605081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92565922|NCT04605081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92565923|NCT04605081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565924|NCT04599504|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92565925|NCT04599504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92565926|NCT04599504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565927|NCT04599504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92565928|NCT04599504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92565929|NCT04599504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565930|NCT04599504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565931|NCT04599504|Dopamine Agents|dopamine agents|mesh-ancestor
92565932|NCT04599504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565933|NCT00174226|Buspirone|buspirone|mesh-list
92565934|NCT00174226|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92565935|NCT00174226|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92565936|NCT00174226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92565937|NCT00174226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565938|NCT00174226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565939|NCT00174226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92565940|NCT00174226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565941|NCT00174226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565942|NCT00174226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92565943|NCT00174226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92565944|NCT00174226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92565945|NCT00174226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92290726|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
92565946|NCT00174226|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92565947|NCT00174226|Serotonin Agents|serotonin agents|mesh-ancestor
92565948|NCT00174304|Amlodipine|amlodipine|mesh-list
92565949|NCT00174304|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92565950|NCT00174304|Atorvastatin|atorvastatin|mesh-list
92565951|NCT00174304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92565952|NCT00174304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92565953|NCT00174304|Antimetabolites|antimetabolites|mesh-ancestor
92565954|NCT00174304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565959|NCT00174304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92565960|NCT00174304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565961|NCT00174304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92565962|NCT00174304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565963|NCT00174304|Vasodilator Agents|vasodilator agents|mesh-ancestor
92565964|NCT00174343|Exemestane|exemestane|mesh-list
92565965|NCT00174343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565966|NCT00174343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92565967|NCT00174343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92565968|NCT00174343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565969|NCT00174343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565970|NCT00174343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92565971|NCT00174343|Hormone Antagonists|hormone antagonists|mesh-ancestor
92565972|NCT00174343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92565973|NCT00174343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565974|NCT00174499|Nicotine|nicotine|mesh-list
92565975|NCT00174499|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92565976|NCT00174499|Autonomic Agents|autonomic agents|mesh-ancestor
92565977|NCT00174499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565978|NCT00174499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565979|NCT00174499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92565980|NCT00174499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92565981|NCT00174499|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565982|NCT00174499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565983|NCT00174499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565984|NCT00174538|Codeine|codeine|mesh-list
92565985|NCT00174538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92565986|NCT00174538|Narcotics|narcotics|mesh-ancestor
92565987|NCT00174538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92565988|NCT00174538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565989|NCT00174538|Analgesics|analgesics|mesh-ancestor
92565990|NCT00174538|Sensory System Agents|sensory system agents|mesh-ancestor
92565991|NCT00174538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565992|NCT00174538|Antitussive Agents|antitussive agents|mesh-ancestor
92565993|NCT00174538|Respiratory System Agents|respiratory system agents|mesh-ancestor
92565994|NCT00174577|Risperidone|risperidone|mesh-list
92565995|NCT00174577|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92565996|NCT00174577|Serotonin Agents|serotonin agents|mesh-ancestor
92565997|NCT00174577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565998|NCT00174577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565999|NCT00174577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566000|NCT00174577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92566001|NCT00174577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92566002|NCT00174577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566003|NCT00174577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566004|NCT00174577|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92566005|NCT00174577|Dopamine Agents|dopamine agents|mesh-ancestor
92566006|NCT00046137|Teriparatide|teriparatide|mesh-list
92566007|NCT00046137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92566008|NCT00046137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92566009|NCT00046137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566010|NCT00046137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92566011|NCT00046137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92566012|NCT00046137|Hormone Antagonists|hormone antagonists|mesh-ancestor
92566013|NCT00046137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566014|NCT00046137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92566015|NCT00046137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92566016|NCT00056225|Vitamins|vitamins|mesh-list
92566017|NCT00056225|Vitamin B 12|vitamin b 12|mesh-list
92566018|NCT00056225|Vitamin B 6|vitamin b 6|mesh-list
92566019|NCT00056225|Pyridoxal|pyridoxal|mesh-list
92566020|NCT00056225|Pyridoxine|pyridoxine|mesh-list
92566021|NCT00056225|Vitamin B Complex|vitamin b complex|mesh-list
92566022|NCT00056225|Micronutrients|micronutrients|mesh-ancestor
92566023|NCT00056225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566024|NCT00174616|Capecitabine|capecitabine|mesh-list
92566028|NCT00174616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566029|NCT00174616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566030|NCT00174655|Cyclophosphamide|cyclophosphamide|mesh-list
92566031|NCT00174655|Docetaxel|docetaxel|mesh-list
92566032|NCT00174655|Doxorubicin|doxorubicin|mesh-list
92566033|NCT00174655|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92566034|NCT00174655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566035|NCT00174655|Immunologic Factors|immunologic factors|mesh-ancestor
92566036|NCT00174655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566037|NCT00174655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566038|NCT00174655|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92566039|NCT00174655|Alkylating Agents|alkylating agents|mesh-ancestor
92566040|NCT00174655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566041|NCT00174655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566042|NCT00174655|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92566043|NCT00174655|Tubulin Modulators|tubulin modulators|mesh-ancestor
92566044|NCT00174655|Antimitotic Agents|antimitotic agents|mesh-ancestor
92566045|NCT00174655|Mitosis Modulators|mitosis modulators|mesh-ancestor
92566046|NCT00174655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92566047|NCT00174655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92566048|NCT00174655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92566049|NCT00174655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566050|NCT00174694|Telithromycin|telithromycin|mesh-list
92566051|NCT00174694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566052|NCT00174694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566053|NCT00174733|Ciclesonide|ciclesonide|mesh-list
92566054|NCT00174733|Glucocorticoids|glucocorticoids|mesh-ancestor
92566055|NCT00174733|Hormones|hormones|mesh-ancestor
92566056|NCT00174733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534787|NCT00071695|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92534788|NCT00071695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566057|NCT00174733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566058|NCT00174733|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92566059|NCT00056264|Infliximab|infliximab|mesh-list
92566060|NCT00056264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92566061|NCT00056264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566062|NCT00056264|Dermatologic Agents|dermatologic agents|mesh-ancestor
92356611|NCT01989780|Fertility Agents|fertility agents|mesh-ancestor
92566063|NCT00056264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92566064|NCT00056264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566065|NCT00174772|Cisplatin|cisplatin|mesh-list
92566066|NCT00174772|Docetaxel|docetaxel|mesh-list
92566067|NCT00174772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566068|NCT00174772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92566069|NCT00174772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92566070|NCT00174772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92566071|NCT00174772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566072|NCT00174811|Telithromycin|telithromycin|mesh-list
92566073|NCT00174811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566074|NCT00174811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566075|NCT02963779|Apremilast|apremilast|mesh-list
92566076|NCT02963779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92566077|NCT02963779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92566078|NCT02963779|Analgesics|analgesics|mesh-ancestor
92566079|NCT02963779|Sensory System Agents|sensory system agents|mesh-ancestor
92566080|NCT02963779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566081|NCT02963779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566082|NCT02963779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566083|NCT02963779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566084|NCT02963779|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92566085|NCT02963779|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92566086|NCT02963779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566087|NCT02963779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566088|NCT00046176|Lamivudine|lamivudine|mesh-list
92566089|NCT00046176|Abacavir|abacavir|mesh-list
92566090|NCT00046176|Dideoxynucleosides|dideoxynucleosides|mesh-list
92566091|NCT00046176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92566092|NCT00046176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92566093|NCT00046176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566094|NCT00046176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566095|NCT00046176|Antiviral Agents|antiviral agents|mesh-ancestor
92566096|NCT00046176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973364|NCT04975971|Dexamethasone|dexamethasone|mesh-list
92566100|NCT00174928|Lansoprazole|lansoprazole|mesh-list
92566101|NCT00174928|Dexlansoprazole|dexlansoprazole|mesh-list
92566102|NCT00174928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92566103|NCT00174928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92566104|NCT00174928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92566105|NCT00174928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566106|NCT00174928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566107|NCT00175045|Lansoprazole|lansoprazole|mesh-list
92566108|NCT00175045|Dexlansoprazole|dexlansoprazole|mesh-list
92566109|NCT00175045|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92566110|NCT00175045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92566111|NCT00175045|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92566112|NCT00175045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566113|NCT00175045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566114|NCT00056381|Anidulafungin|anidulafungin|mesh-list
92566115|NCT00056381|Antifungal Agents|antifungal agents|mesh-ancestor
92566116|NCT00056381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566117|NCT00175123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92566118|NCT00175123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92566119|NCT00175123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92566120|NCT00175123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566121|NCT00175123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566122|NCT00175123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92566123|NCT00175123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566124|NCT00175123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566125|NCT00175123|Cholinergic Agents|cholinergic agents|mesh-ancestor
92566126|NCT00175123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566128|NCT00175357|Heroin|heroin|mesh-list
92566129|NCT00175357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92566130|NCT00175357|Narcotics|narcotics|mesh-ancestor
92534789|NCT00071695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566131|NCT00175357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566132|NCT00175357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566133|NCT00175357|Analgesics|analgesics|mesh-ancestor
92566134|NCT00175357|Sensory System Agents|sensory system agents|mesh-ancestor
92566135|NCT00175357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566136|NCT00175357|Antitussive Agents|antitussive agents|mesh-ancestor
92566137|NCT00175357|Respiratory System Agents|respiratory system agents|mesh-ancestor
92566138|NCT00046254|Zoledronic Acid|zoledronic acid|mesh-list
92566139|NCT00046254|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92566140|NCT00046254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566141|NCT00175396|Ascorbic Acid|ascorbic acid|mesh-list
92566142|NCT00175396|Leuprolide|leuprolide|mesh-list
92566143|NCT00175396|Methyltestosterone|methyltestosterone|mesh-list
92566144|NCT00175396|Flutamide|flutamide|mesh-list
92566145|NCT00175396|Bicalutamide|bicalutamide|mesh-list
92566146|NCT00175396|Nilutamide|nilutamide|mesh-list
92566147|NCT00175396|Buserelin|buserelin|mesh-list
92566148|NCT00175396|Androgens|androgens|mesh-list
92566149|NCT00175396|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92566150|NCT00175396|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92566151|NCT00175396|Fertility Agents|fertility agents|mesh-ancestor
92566152|NCT00175396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92566153|NCT00175396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566154|NCT00175396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92566155|NCT00175396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566156|NCT00175396|Hormones|hormones|mesh-ancestor
92566157|NCT00175396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566158|NCT00175396|Antioxidants|antioxidants|mesh-ancestor
92566159|NCT00175396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566160|NCT00175396|Protective Agents|protective agents|mesh-ancestor
92566161|NCT00175396|Vitamins|vitamins|mesh-ancestor
92566162|NCT00175396|Micronutrients|micronutrients|mesh-ancestor
92566163|NCT00175396|Estrogens|estrogens|mesh-ancestor
92566164|NCT00175396|Anabolic Agents|anabolic agents|mesh-ancestor
92566165|NCT00175396|Androgen Antagonists|androgen antagonists|mesh-ancestor
92566166|NCT00175396|Hormone Antagonists|hormone antagonists|mesh-ancestor
92566167|NCT00056459|Vatalanib|vatalanib|mesh-list
92566168|NCT00056459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92566169|NCT00056459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566170|NCT00056459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566171|NCT00175435|Vaccines|vaccines|mesh-list
92566172|NCT00175435|Immunologic Factors|immunologic factors|mesh-ancestor
92566187|NCT00175630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566188|NCT00175630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566189|NCT00175630|Sensory System Agents|sensory system agents|mesh-ancestor
92566190|NCT00175630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566191|NCT00056537|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
92566192|NCT00056537|Immunoconjugates|immunoconjugates|mesh-ancestor
92566193|NCT00056537|Immunologic Factors|immunologic factors|mesh-ancestor
92566194|NCT00056537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566195|NCT00408031|Cycloserine|cycloserine|mesh-list
92566196|NCT00408031|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92566197|NCT00408031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566198|NCT00408031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92566199|NCT00408031|Antitubercular Agents|antitubercular agents|mesh-ancestor
92566200|NCT00408031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566201|NCT00408031|Antimetabolites|antimetabolites|mesh-ancestor
92566202|NCT00408031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566204|NCT00175747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566205|NCT00175747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92566206|NCT00175747|Autonomic Agents|autonomic agents|mesh-ancestor
92566207|NCT00175747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566208|NCT00175747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566209|NCT00175747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92566210|NCT00175747|Respiratory System Agents|respiratory system agents|mesh-ancestor
92566211|NCT00175747|Glucocorticoids|glucocorticoids|mesh-ancestor
92566212|NCT00175747|Hormones|hormones|mesh-ancestor
92750754|NCT05936606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566213|NCT00175747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566214|NCT04493619|Carboplatin|carboplatin|mesh-list
92566215|NCT04493619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566216|NCT00056576|Zonisamide|zonisamide|mesh-list
92566217|NCT00056576|Anticonvulsants|anticonvulsants|mesh-ancestor
92566218|NCT00056576|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92566219|NCT00056576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915654|NCT02122055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92566220|NCT00056576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566221|NCT00056576|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92566222|NCT00056576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566223|NCT00175903|Carbamazepine|carbamazepine|mesh-list
92566224|NCT00175903|Levetiracetam|levetiracetam|mesh-list
92566225|NCT00175903|Valproic Acid|valproic acid|mesh-list
92566226|NCT00175903|Anticonvulsants|anticonvulsants|mesh-ancestor
92566227|NCT00175903|Nootropic Agents|nootropic agents|mesh-ancestor
92566228|NCT00175903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566229|NCT00175903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566230|NCT00175903|GABA Agents|gaba agents|mesh-ancestor
92566231|NCT00175903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566232|NCT00175903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566233|NCT00175903|Antimanic Agents|antimanic agents|mesh-ancestor
92566234|NCT00175903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973512|NCT04967469|Calcitriol|calcitriol|mesh-list
92566243|NCT00175903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92566244|NCT00175903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92566245|NCT00056654|Leuprolide|leuprolide|mesh-list
92566246|NCT00056654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92566247|NCT00056654|Fertility Agents|fertility agents|mesh-ancestor
92566248|NCT00056654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92291026|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566249|NCT00056654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566250|NCT00056654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92566251|NCT00056654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566252|NCT00175981|Sildenafil Citrate|sildenafil citrate|mesh-list
92566253|NCT00175981|Fluvoxamine|fluvoxamine|mesh-list
92566254|NCT00175981|Vasodilator Agents|vasodilator agents|mesh-ancestor
92566255|NCT00175981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92566256|NCT00175981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92566257|NCT00175981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566258|NCT00175981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566259|NCT00175981|Urological Agents|urological agents|mesh-ancestor
92566260|NCT00175981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92566261|NCT00175981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92566262|NCT00175981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566263|NCT00175981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566264|NCT00175981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566265|NCT00175981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566266|NCT00175981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566267|NCT00175981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566268|NCT00175981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566269|NCT00175981|Serotonin Agents|serotonin agents|mesh-ancestor
92566270|NCT00175981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92566271|NCT00175981|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566272|NCT00175981|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92566273|NCT00175981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92566274|NCT00175981|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92566275|NCT04420533|Mirabegron|mirabegron|mesh-list
92566276|NCT04420533|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92566277|NCT04420533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92566278|NCT04420533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92566279|NCT04420533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92566280|NCT04420533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566281|NCT04420533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566282|NCT04420533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566283|NCT04420533|Urological Agents|urological agents|mesh-ancestor
92566284|NCT00176020|Nicotinic Acids|nicotinic acids|mesh-list
92566285|NCT00176020|Niacin|niacin|mesh-list
92566286|NCT00176020|Niacinamide|niacinamide|mesh-list
92566287|NCT00176020|Vitamin B Complex|vitamin b complex|mesh-ancestor
92566288|NCT00176020|Vitamins|vitamins|mesh-ancestor
92566289|NCT00176020|Micronutrients|micronutrients|mesh-ancestor
92566290|NCT00176020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566291|NCT00176020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92566292|NCT00176020|Antimetabolites|antimetabolites|mesh-ancestor
92566293|NCT00176020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566294|NCT00176020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92566295|NCT00176020|Vasodilator Agents|vasodilator agents|mesh-ancestor
92566296|NCT00176059|Immunoglobulins|immunoglobulins|mesh-list
92566297|NCT00176059|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92534790|NCT00071695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534791|NCT00071695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566298|NCT00176059|Antibodies|antibodies|mesh-list
92566299|NCT00176059|gamma-Globulins|gamma-globulins|mesh-list
92566308|NCT00176293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566309|NCT00176293|Antiemetics|antiemetics|mesh-ancestor
92566310|NCT00176293|Autonomic Agents|autonomic agents|mesh-ancestor
92566311|NCT00176293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566312|NCT00176293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566313|NCT00176293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92566314|NCT00176293|Glucocorticoids|glucocorticoids|mesh-ancestor
92566315|NCT00176293|Hormones|hormones|mesh-ancestor
92566316|NCT00176293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566317|NCT00176293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92566318|NCT00176293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566319|NCT00176293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92566320|NCT00176293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92566321|NCT00176293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92566322|NCT00176293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566323|NCT00176293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566324|NCT00056693|Sunitinib|sunitinib|mesh-list
92566325|NCT00056693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566326|NCT00056693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92566327|NCT00056693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92566328|NCT00056693|Growth Substances|growth substances|mesh-ancestor
92566329|NCT00056693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566330|NCT00056693|Growth Inhibitors|growth inhibitors|mesh-ancestor
92566331|NCT00056693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92566332|NCT00056693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566333|NCT00056693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566334|NCT00176332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92566335|NCT00176332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92566336|NCT00176332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92566337|NCT00176332|Antimetabolites|antimetabolites|mesh-ancestor
92566338|NCT00176332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566339|NCT00176332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92566340|NCT00176332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92566341|NCT00176332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566342|NCT00176449|Bupropion|bupropion|mesh-list
92566343|NCT00176449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92566344|NCT00176449|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566345|NCT00176449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566346|NCT00176449|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92566347|NCT00176449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566348|NCT00176449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566349|NCT00176449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566350|NCT00176449|Dopamine Agents|dopamine agents|mesh-ancestor
92566351|NCT00176449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566352|NCT00176449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566353|NCT00176449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92566354|NCT00176449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92566355|NCT00176449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566356|NCT00398450|Interferons|interferons|mesh-list
92566357|NCT00398450|Interferon-alpha|interferon-alpha|mesh-list
92566358|NCT00398450|Interferon alpha-2|interferon alpha-2|mesh-list
92566359|NCT00398450|Azacitidine|azacitidine|mesh-list
92566360|NCT00398450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566361|NCT00398450|Antiviral Agents|antiviral agents|mesh-ancestor
92566362|NCT00398450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566363|NCT00398450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92566364|NCT00398450|Antimetabolites|antimetabolites|mesh-ancestor
92566376|NCT00176527|Estramustine|estramustine|mesh-list
92566377|NCT00176527|Isotretinoin|isotretinoin|mesh-list
92566378|NCT00176527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566379|NCT00176527|Tubulin Modulators|tubulin modulators|mesh-ancestor
92566380|NCT00176527|Antimitotic Agents|antimitotic agents|mesh-ancestor
92566381|NCT00176527|Mitosis Modulators|mitosis modulators|mesh-ancestor
92566382|NCT00176527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566383|NCT00176527|Antiviral Agents|antiviral agents|mesh-ancestor
92566384|NCT00176527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566385|NCT00176527|Immunologic Factors|immunologic factors|mesh-ancestor
92534792|NCT00071695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566386|NCT00176527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566387|NCT00176527|Dermatologic Agents|dermatologic agents|mesh-ancestor
92566388|NCT00176527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92566389|NCT00176527|Alkylating Agents|alkylating agents|mesh-ancestor
92566390|NCT00176527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92566391|NCT00398489|Tamoxifen|tamoxifen|mesh-list
92566392|NCT00398489|Cyclophosphamide|cyclophosphamide|mesh-list
92566393|NCT00398489|Docetaxel|docetaxel|mesh-list
92566394|NCT00398489|Trastuzumab|trastuzumab|mesh-list
92566395|NCT00398489|Epirubicin|epirubicin|mesh-list
92566396|NCT00398489|Anastrozole|anastrozole|mesh-list
92566397|NCT00398489|Goserelin|goserelin|mesh-list
92566398|NCT00398489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566399|NCT00398489|Immunologic Factors|immunologic factors|mesh-ancestor
92566400|NCT00398489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566401|NCT00398489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566402|NCT00398489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92566403|NCT00398489|Alkylating Agents|alkylating agents|mesh-ancestor
92566404|NCT00398489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566405|NCT00398489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566406|NCT00398489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92566407|NCT00398489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92566408|NCT00398489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92566409|NCT00398489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92566410|NCT00398489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92566411|NCT00398489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92566412|NCT00398489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92566413|NCT00398489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92566414|NCT00398489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566415|NCT00398489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92566416|NCT00398489|Hormone Antagonists|hormone antagonists|mesh-ancestor
92566417|NCT00398489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566418|NCT00398489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92566419|NCT00398489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92566420|NCT00398489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92566421|NCT00398489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92566422|NCT00398489|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92566423|NCT00398489|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92566424|NCT00176761|Interleukin-2|interleukin-2|mesh-list
92566425|NCT00176761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566426|NCT00176761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92566427|NCT00176761|Analgesics|analgesics|mesh-ancestor
92566428|NCT00176761|Sensory System Agents|sensory system agents|mesh-ancestor
92566429|NCT00176761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973704|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
92566437|NCT00176995|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92566438|NCT00176995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566439|NCT00176995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566440|NCT00423527|Levetiracetam|levetiracetam|mesh-list
92566441|NCT00423527|Anticonvulsants|anticonvulsants|mesh-ancestor
92566442|NCT00423527|Nootropic Agents|nootropic agents|mesh-ancestor
92566443|NCT00408148|Rimonabant|rimonabant|mesh-list
92566444|NCT00408148|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92566445|NCT00408148|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92566446|NCT00408148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92566447|NCT00408148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566448|NCT00408148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566449|NCT00408148|Hormones|hormones|mesh-ancestor
92566450|NCT00408148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566451|NCT00408148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566452|NCT00397566|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
92566453|NCT00397566|BMS-707035|bms-707035|mesh-list
92566454|NCT00397566|Integrase Inhibitors|integrase inhibitors|mesh-list
92566455|NCT00397566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566456|NCT00397566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566457|NCT00397566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92566458|NCT00397566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92566459|NCT00397566|Antiviral Agents|antiviral agents|mesh-ancestor
92566460|NCT00397566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566461|NCT00177424|Sertraline|sertraline|mesh-list
92566462|NCT00177424|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566463|NCT00177424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620229|NCT02914015|Analgesics|analgesics|mesh-ancestor
92534794|NCT00071695|Sensory System Agents|sensory system agents|mesh-ancestor
92534795|NCT00071695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566464|NCT00177424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566465|NCT00177424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566466|NCT00177424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566467|NCT00177424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566468|NCT00177424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566469|NCT00177424|Serotonin Agents|serotonin agents|mesh-ancestor
92566470|NCT00177424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566471|NCT00177580|Pravastatin|pravastatin|mesh-list
92566472|NCT00177580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92566473|NCT00177580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92566474|NCT00177580|Antimetabolites|antimetabolites|mesh-ancestor
92566475|NCT00177580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566476|NCT00177580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92566477|NCT00177580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92566478|NCT00177580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566479|NCT04723342|Blinatumomab|blinatumomab|mesh-list
92566480|NCT04723342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566481|NCT00177619|Alendronate|alendronate|mesh-list
92566482|NCT00177619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92566483|NCT00177619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566484|NCT00056810|4-Aminopyridine|4-aminopyridine|mesh-list
92566485|NCT00056810|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92566486|NCT00056810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566487|NCT00056810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566488|NCT00177853|Celecoxib|celecoxib|mesh-list
92566489|NCT00177853|Irinotecan|irinotecan|mesh-list
92566490|NCT00177853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92566491|NCT00177853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92566492|NCT00177853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566493|NCT00177853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566494|NCT00177853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566495|NCT00177853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92566501|NCT00177853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566502|NCT00177853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566503|NCT00177853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92566504|NCT00177853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92566505|NCT00178048|Paroxetine|paroxetine|mesh-list
92566506|NCT00178048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566507|NCT00178048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566508|NCT00178048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566509|NCT00178048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566510|NCT00178048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566511|NCT00178048|Serotonin Agents|serotonin agents|mesh-ancestor
92566512|NCT00178048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566513|NCT00178048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92566514|NCT00178048|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566515|NCT00178048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566516|NCT00178048|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92566517|NCT00178048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92566518|NCT00178048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566519|NCT00056966|Fludarabine|fludarabine|mesh-list
92566520|NCT00056966|Alemtuzumab|alemtuzumab|mesh-list
92566521|NCT00056966|Tacrolimus|tacrolimus|mesh-list
92566522|NCT00056966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566523|NCT00056966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566524|NCT00056966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566525|NCT00056966|Immunologic Factors|immunologic factors|mesh-ancestor
92566526|NCT00056966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566527|NCT00056966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92566528|NCT00056966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566529|NCT00056966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92566530|NCT00178828|Bupropion|bupropion|mesh-list
92566531|NCT00178828|Sertraline|sertraline|mesh-list
92566532|NCT00178828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92566533|NCT00178828|Antidepressive Agents|antidepressive agents|mesh-ancestor
91915950|NCT02252627|Ephedrine|ephedrine|mesh-list
92566534|NCT00178828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566535|NCT00178828|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92566536|NCT00178828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566537|NCT00178828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566538|NCT00178828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566539|NCT00178828|Dopamine Agents|dopamine agents|mesh-ancestor
92566540|NCT00178828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566541|NCT00178828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566542|NCT00178828|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92566543|NCT00178828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92566544|NCT00178828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566545|NCT00178828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566546|NCT00178828|Serotonin Agents|serotonin agents|mesh-ancestor
92566547|NCT00408187|Cyclosporine|cyclosporine|mesh-list
92566548|NCT00408187|Cyclosporins|cyclosporins|mesh-list
92566549|NCT00408187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566550|NCT00408187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566551|NCT00408187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566552|NCT00408187|Immunologic Factors|immunologic factors|mesh-ancestor
92566553|NCT00408187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566554|NCT00408187|Antifungal Agents|antifungal agents|mesh-ancestor
92566555|NCT00408187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566556|NCT00408187|Dermatologic Agents|dermatologic agents|mesh-ancestor
92566557|NCT00408187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566558|NCT00408187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92566559|NCT00408226|Pemetrexed|pemetrexed|mesh-list
92566560|NCT00408226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566561|NCT00408226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566562|NCT00408226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973835|NCT00700817|Metformin|metformin|mesh-list
92566565|NCT02963896|Gentamicins|gentamicins|mesh-list
92566566|NCT02963896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566567|NCT02963896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566568|NCT02963896|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92566569|NCT02963896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566570|NCT02963896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566571|NCT00178945|Botulinum Toxins|botulinum toxins|mesh-list
92566572|NCT00178945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92566573|NCT00178945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92566574|NCT00178945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92566575|NCT00178945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566576|NCT00178945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566577|NCT00178945|Cholinergic Agents|cholinergic agents|mesh-ancestor
92566578|NCT00178945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566579|NCT00178945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566580|NCT00178945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92566581|NCT00178945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566582|NCT00397722|Paroxetine|paroxetine|mesh-list
92566583|NCT00397722|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566584|NCT00397722|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566585|NCT00397722|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566586|NCT00397722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566587|NCT00397722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566588|NCT00397722|Serotonin Agents|serotonin agents|mesh-ancestor
92566589|NCT00397722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566590|NCT00397722|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92566591|NCT00397722|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566592|NCT00397722|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566593|NCT00397722|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92566594|NCT00397722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92566595|NCT00397722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566596|NCT00179023|Trimethaphan|trimethaphan|mesh-list
92566597|NCT00179023|Pseudoephedrine|pseudoephedrine|mesh-list
92566598|NCT00179023|Ephedrine|ephedrine|mesh-list
92566599|NCT00179023|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
92566600|NCT00179023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92566601|NCT00179023|Autonomic Agents|autonomic agents|mesh-ancestor
92566602|NCT00179023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566603|NCT00179023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534797|NCT00071695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92534798|NCT00071695|Dopamine Agents|dopamine agents|mesh-ancestor
91916020|NCT02129231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92566604|NCT00179023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92566605|NCT00179023|Respiratory System Agents|respiratory system agents|mesh-ancestor
92566606|NCT00179023|Nasal Decongestants|nasal decongestants|mesh-ancestor
92566607|NCT00179023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92566608|NCT00179023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92566609|NCT00179023|Sympathomimetics|sympathomimetics|mesh-ancestor
92566610|NCT00179023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92566611|NCT00179023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566612|NCT00179023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566613|NCT00179023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92566614|NCT00179023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92566615|NCT00179023|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92566616|NCT00179023|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92566617|NCT00179023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92566618|NCT00179023|Cholinergic Agents|cholinergic agents|mesh-ancestor
92566619|NCT00179023|Vasodilator Agents|vasodilator agents|mesh-ancestor
92566620|NCT00057005|Cyclophosphamide|cyclophosphamide|mesh-list
92566621|NCT00057005|Alemtuzumab|alemtuzumab|mesh-list
92566622|NCT00057005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566623|NCT00057005|Immunologic Factors|immunologic factors|mesh-ancestor
92566624|NCT00057005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566625|NCT00057005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566626|NCT00057005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92566627|NCT00057005|Alkylating Agents|alkylating agents|mesh-ancestor
92356845|NCT02086500|Hemostatics|hemostatics|mesh-ancestor
92566628|NCT00057005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566629|NCT00057005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566630|NCT00057005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92566631|NCT00057005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92566633|NCT00179062|Risperidone|risperidone|mesh-list
92566634|NCT00179062|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92566637|NCT00179062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566638|NCT00179062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566639|NCT00179062|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92566640|NCT00179062|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92566641|NCT00179062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566642|NCT00179062|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566643|NCT00179062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92566644|NCT00179062|Dopamine Agents|dopamine agents|mesh-ancestor
92566645|NCT00179062|Antiemetics|antiemetics|mesh-ancestor
92566646|NCT00179062|Autonomic Agents|autonomic agents|mesh-ancestor
92566647|NCT00179062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566648|NCT00179062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92566649|NCT00179062|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566650|NCT00179062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566651|NCT00179062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566652|NCT04723459|Ivermectin|ivermectin|mesh-list
92566653|NCT04723459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92566654|NCT04723459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566655|NCT00179257|Sertraline|sertraline|mesh-list
92566656|NCT00179257|Antidepressive Agents|antidepressive agents|mesh-ancestor
92566657|NCT00179257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566658|NCT00179257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92566659|NCT00179257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566660|NCT00179257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566661|NCT00179257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566662|NCT00179257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566663|NCT00179257|Serotonin Agents|serotonin agents|mesh-ancestor
92566664|NCT00179257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566665|NCT00408382|Atorvastatin|atorvastatin|mesh-list
92566666|NCT00408382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92566667|NCT00408382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92566668|NCT00408382|Antimetabolites|antimetabolites|mesh-ancestor
92566669|NCT00408382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566670|NCT00408382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92566671|NCT00408382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92566672|NCT00408382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566673|NCT00057122|Rifampin|rifampin|mesh-list
92566674|NCT00057122|Rifapentine|rifapentine|mesh-list
92534799|NCT00071695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92566675|NCT00057122|Isoniazid|isoniazid|mesh-list
92566676|NCT00057122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92566677|NCT00057122|Antitubercular Agents|antitubercular agents|mesh-ancestor
92566678|NCT00057122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566679|NCT00057122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566680|NCT00057122|Leprostatic Agents|leprostatic agents|mesh-ancestor
92566681|NCT00057122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92566682|NCT00057122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566683|NCT00057122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566684|NCT00057122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92566685|NCT00057122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92566686|NCT00057122|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92566687|NCT00057122|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92566688|NCT00057122|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92566689|NCT00057122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92566690|NCT00057122|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92566691|NCT00057122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92566692|NCT00057122|Antimetabolites|antimetabolites|mesh-ancestor
92566693|NCT00057122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92566694|NCT00179608|Lenalidomide|lenalidomide|mesh-list
92566695|NCT00179608|Immunologic Factors|immunologic factors|mesh-ancestor
92566696|NCT00179608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566697|NCT00179608|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92566698|NCT00179608|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92566699|NCT00179608|Growth Substances|growth substances|mesh-ancestor
92566700|NCT00179608|Growth Inhibitors|growth inhibitors|mesh-ancestor
92566701|NCT00179608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566702|NCT00179686|Lenalidomide|lenalidomide|mesh-list
92566703|NCT00179686|Immunologic Factors|immunologic factors|mesh-ancestor
92566704|NCT00179686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566705|NCT00179686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91973984|NCT04947189|Glucocorticoids|glucocorticoids|mesh-ancestor
92566719|NCT00179725|Immunologic Factors|immunologic factors|mesh-ancestor
92566720|NCT00179725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566721|NCT00179725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92566722|NCT00179725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92566723|NCT00179725|Growth Substances|growth substances|mesh-ancestor
92566724|NCT00179725|Growth Inhibitors|growth inhibitors|mesh-ancestor
92566726|NCT00179764|Alkylating Agents|alkylating agents|mesh-ancestor
92566727|NCT00179764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566728|NCT00179764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566729|NCT00179764|Immunologic Factors|immunologic factors|mesh-ancestor
92566730|NCT00179764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566731|NCT00179764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92566732|NCT00179764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566733|NCT00179764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92566734|NCT00179881|Thalidomide|thalidomide|mesh-list
92566735|NCT00179881|Carboplatin|carboplatin|mesh-list
92566736|NCT00179881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566737|NCT00179881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566738|NCT00179881|Immunologic Factors|immunologic factors|mesh-ancestor
92566739|NCT00179881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566740|NCT00179881|Leprostatic Agents|leprostatic agents|mesh-ancestor
92566741|NCT00179881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566742|NCT00179881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566743|NCT00179881|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92566744|NCT00179881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92566745|NCT00179881|Growth Substances|growth substances|mesh-ancestor
92566746|NCT00179881|Growth Inhibitors|growth inhibitors|mesh-ancestor
92566747|NCT00179920|Carboplatin|carboplatin|mesh-list
92566748|NCT00179920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566749|NCT00180037|Ubiquinone|ubiquinone|mesh-list
92566750|NCT00180037|Coenzyme Q10|coenzyme q10|mesh-list
92566751|NCT00180037|Micronutrients|micronutrients|mesh-ancestor
92566752|NCT00180037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566753|NCT00180037|Vitamins|vitamins|mesh-ancestor
92566754|NCT00180076|Budesonide|budesonide|mesh-list
92566755|NCT00180076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566756|NCT00180076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92566757|NCT00180076|Autonomic Agents|autonomic agents|mesh-ancestor
92153181|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
92566758|NCT00180076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534801|NCT00071929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534802|NCT00071968|Sirolimus|sirolimus|mesh-list
92534803|NCT00071968|Temsirolimus|temsirolimus|mesh-list
92566759|NCT00180076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566760|NCT00180076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92566761|NCT00180076|Respiratory System Agents|respiratory system agents|mesh-ancestor
92566762|NCT00180076|Glucocorticoids|glucocorticoids|mesh-ancestor
92566763|NCT00180076|Hormones|hormones|mesh-ancestor
92566764|NCT00180076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566765|NCT00180115|Cytarabine|cytarabine|mesh-list
92566766|NCT00180115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92566768|NCT00180115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566776|NCT00046527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566777|NCT00180310|Paclitaxel|paclitaxel|mesh-list
92566778|NCT00180310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92566779|NCT00180310|Everolimus|everolimus|mesh-list
92566780|NCT00180310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92566781|NCT00180310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566782|NCT00180310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92566783|NCT00180310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92566784|NCT00180310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92566785|NCT00180310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566786|NCT00180310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92566787|NCT00180310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92566788|NCT00180310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566789|NCT00180310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566790|NCT00180310|Immunologic Factors|immunologic factors|mesh-ancestor
92566791|NCT00180310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566792|NCT00057278|Gabapentin|gabapentin|mesh-list
92566793|NCT00057278|Analgesics|analgesics|mesh-ancestor
92566794|NCT00057278|Sensory System Agents|sensory system agents|mesh-ancestor
92566795|NCT00057278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566796|NCT00057278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566797|NCT00057278|Anticonvulsants|anticonvulsants|mesh-ancestor
92566798|NCT00057278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92566799|NCT00057278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92566800|NCT00057278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566801|NCT00057278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566802|NCT00057278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92566803|NCT00057278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92566804|NCT00057278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566805|NCT00057278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566806|NCT00057278|Antimanic Agents|antimanic agents|mesh-ancestor
92566807|NCT00180622|Nitric Oxide|nitric oxide|mesh-list
92566808|NCT00180622|Carbon Monoxide|carbon monoxide|mesh-list
92566809|NCT00180622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92566810|NCT00180622|Autonomic Agents|autonomic agents|mesh-ancestor
92566811|NCT00180622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566812|NCT00180622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566813|NCT00180622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92566814|NCT00180622|Respiratory System Agents|respiratory system agents|mesh-ancestor
92566815|NCT00180622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92566816|NCT00180622|Antioxidants|antioxidants|mesh-ancestor
92566817|NCT00180622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566818|NCT00180622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566819|NCT00180622|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92566820|NCT00180622|Vasodilator Agents|vasodilator agents|mesh-ancestor
92566821|NCT00180622|Gasotransmitters|gasotransmitters|mesh-ancestor
92566822|NCT00180622|Protective Agents|protective agents|mesh-ancestor
92566823|NCT00180622|Antimetabolites|antimetabolites|mesh-ancestor
92566824|NCT00180895|Rituximab|rituximab|mesh-list
92566825|NCT00180895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92566826|NCT00180895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566827|NCT00180895|Immunologic Factors|immunologic factors|mesh-ancestor
92566828|NCT00180895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566829|NCT00180895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92566830|NCT00180973|Hydroxyurea|hydroxyurea|mesh-list
92566831|NCT00180973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566832|NCT00180973|Antisickling Agents|antisickling agents|mesh-ancestor
92566833|NCT00180973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356904|NCT04757532|Natriuretic Agents|natriuretic agents|mesh-ancestor
92566834|NCT00180973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566835|NCT00180973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92566836|NCT04729491|Azithromycin|azithromycin|mesh-list
92566856|NCT00181012|Anesthetics|anesthetics|mesh-ancestor
92566857|NCT00181012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566858|NCT00181012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566859|NCT00181012|Sensory System Agents|sensory system agents|mesh-ancestor
92566860|NCT00181012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566861|NCT00181012|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92566862|NCT00181012|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92566863|NCT00181012|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92566864|NCT00181012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566865|NCT00181012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566866|NCT00181246|Fentanyl|fentanyl|mesh-list
92566867|NCT00181246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92566868|NCT00181246|Narcotics|narcotics|mesh-ancestor
92566869|NCT00181246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566870|NCT00181246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566871|NCT00181246|Analgesics|analgesics|mesh-ancestor
92566872|NCT00181246|Sensory System Agents|sensory system agents|mesh-ancestor
92566873|NCT00181246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566874|NCT00181246|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92566875|NCT00181246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92566876|NCT00181246|Anesthetics, General|anesthetics, general|mesh-ancestor
92566877|NCT00181246|Anesthetics|anesthetics|mesh-ancestor
92566878|NCT00181558|Zoledronic Acid|zoledronic acid|mesh-list
92566879|NCT00181558|Atrasentan|atrasentan|mesh-list
92566880|NCT00181558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92566881|NCT00181558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566882|NCT00181558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566883|NCT00181558|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92566884|NCT00181558|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92566885|NCT00181558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566886|NCT00181597|Hydrocortisone|hydrocortisone|mesh-list
92566887|NCT00181597|Trilostane|trilostane|mesh-list
92566888|NCT00181597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92566889|NCT00181597|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92566893|NCT00181597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566894|NCT00181597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566895|NCT00181597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566896|NCT00181636|Galantamine|galantamine|mesh-list
92566897|NCT00181636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92566898|NCT00181636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566899|NCT00181636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566900|NCT00181636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92566901|NCT00181636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566902|NCT00181636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566903|NCT00181636|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92566904|NCT00181636|Autonomic Agents|autonomic agents|mesh-ancestor
92566905|NCT00181636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566906|NCT00181636|Nootropic Agents|nootropic agents|mesh-ancestor
92566907|NCT00181675|Galantamine|galantamine|mesh-list
92566908|NCT00181675|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92566909|NCT00181675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566910|NCT00181675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566911|NCT00181675|Cholinergic Agents|cholinergic agents|mesh-ancestor
92566912|NCT00181675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566913|NCT00181675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566914|NCT00181675|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92566915|NCT00181675|Autonomic Agents|autonomic agents|mesh-ancestor
92566916|NCT00181675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566917|NCT00181675|Nootropic Agents|nootropic agents|mesh-ancestor
92566919|NCT00181870|Anticonvulsants|anticonvulsants|mesh-ancestor
92566920|NCT00181870|Antimanic Agents|antimanic agents|mesh-ancestor
92566921|NCT00181870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92566922|NCT00181870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566923|NCT00181870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566924|NCT00181870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566925|NCT00181870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92566926|NCT00181870|Analgesics|analgesics|mesh-ancestor
92009432|NCT03490903|GABA Modulators|gaba modulators|mesh-ancestor
92566927|NCT00181870|Sensory System Agents|sensory system agents|mesh-ancestor
92566928|NCT00181870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566929|NCT00181870|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92566930|NCT00181870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566931|NCT00181870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566932|NCT00181870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92534804|NCT00071968|MTOR Inhibitors|mtor inhibitors|mesh-list
92534805|NCT00071968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92534806|NCT00071968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534807|NCT00071968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566933|NCT00181870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92566934|NCT00181948|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92566935|NCT00181948|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92566936|NCT00181948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566937|NCT00181948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566938|NCT00181948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566939|NCT00181948|Adrenergic Agents|adrenergic agents|mesh-ancestor
92566940|NCT00181948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566941|NCT00181948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566942|NCT00181987|Methylphenidate|methylphenidate|mesh-list
92566943|NCT00181987|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92566944|NCT00181987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566945|NCT00181987|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92566946|NCT00181987|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92566947|NCT00181987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566948|NCT00181987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566949|NCT00181987|Dopamine Agents|dopamine agents|mesh-ancestor
92566950|NCT00181987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566951|NCT00182104|Warfarin|warfarin|mesh-list
92566952|NCT00182104|Anticoagulants|anticoagulants|mesh-ancestor
92566953|NCT00182143|Heparin|heparin|mesh-list
92566954|NCT00182143|Calcium heparin|calcium heparin|mesh-list
92566955|NCT00182143|Dalteparin|dalteparin|mesh-list
92566956|NCT00182143|Tinzaparin|tinzaparin|mesh-list
92566957|NCT00182143|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92566958|NCT00182143|Anticoagulants|anticoagulants|mesh-ancestor
92566959|NCT00182143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92566960|NCT00182143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92566964|NCT00182221|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92566965|NCT00182221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566967|NCT00182221|Coagulants|coagulants|mesh-ancestor
92566968|NCT00182260|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92566969|NCT00182260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566970|NCT00182260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566971|NCT00408538|UC-781|uc-781|mesh-list
92566972|NCT00408538|Anti-Infective Agents|anti-infective agents|mesh-list
92566973|NCT00408538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92566974|NCT00408538|Antiviral Agents|antiviral agents|mesh-ancestor
92566975|NCT00408655|Sirolimus|sirolimus|mesh-list
92566976|NCT00408655|Paclitaxel|paclitaxel|mesh-list
92566977|NCT00408655|Carboplatin|carboplatin|mesh-list
92566978|NCT00408655|Temsirolimus|temsirolimus|mesh-list
92566979|NCT00408655|MTOR Inhibitors|mtor inhibitors|mesh-list
92566980|NCT00408655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92566981|NCT00408655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566982|NCT00408655|Tubulin Modulators|tubulin modulators|mesh-ancestor
92566983|NCT00408655|Antimitotic Agents|antimitotic agents|mesh-ancestor
92566984|NCT00408655|Mitosis Modulators|mitosis modulators|mesh-ancestor
92566985|NCT00408655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566986|NCT00408655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92566987|NCT00408655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566988|NCT00408655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566989|NCT00408655|Immunologic Factors|immunologic factors|mesh-ancestor
92566990|NCT00408655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566991|NCT00408655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566992|NCT00408655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566993|NCT00408655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92566994|NCT00408655|Antifungal Agents|antifungal agents|mesh-ancestor
92566995|NCT00182377|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92566996|NCT00182377|Plasma Substitutes|plasma substitutes|mesh-ancestor
92566997|NCT00182377|Blood Substitutes|blood substitutes|mesh-ancestor
92566998|NCT00182455|Topiramate|topiramate|mesh-list
92566999|NCT00182455|Anticonvulsants|anticonvulsants|mesh-ancestor
92567000|NCT00182455|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92567001|NCT00182455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567002|NCT00182494|Metformin|metformin|mesh-list
92567003|NCT00182494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92567004|NCT00182494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567005|NCT00182533|Sertraline|sertraline|mesh-list
92567006|NCT00182533|Antidepressive Agents|antidepressive agents|mesh-ancestor
92567007|NCT00182533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92567008|NCT00182533|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92567009|NCT00182533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92567010|NCT00182533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92567011|NCT00182533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567012|NCT00182533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567013|NCT00182533|Serotonin Agents|serotonin agents|mesh-ancestor
92567014|NCT00182533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567015|NCT00182572|Naltrexone|naltrexone|mesh-list
92567016|NCT00182572|Buprenorphine|buprenorphine|mesh-list
92567017|NCT00182572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92567018|NCT00182572|Narcotics|narcotics|mesh-ancestor
92567019|NCT00182572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92567020|NCT00182572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567021|NCT00182572|Analgesics|analgesics|mesh-ancestor
92567022|NCT00182572|Sensory System Agents|sensory system agents|mesh-ancestor
92567023|NCT00182572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567024|NCT00182572|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92567025|NCT00182572|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92567026|NCT00182611|Tegafur|tegafur|mesh-list
92567027|NCT00182611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567028|NCT00182611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567029|NCT00182611|Antimetabolites|antimetabolites|mesh-ancestor
92567030|NCT00182611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567031|NCT00182650|Aldesleukin|aldesleukin|mesh-list
92567032|NCT00182650|Rituximab|rituximab|mesh-list
92567033|NCT00182650|Fludarabine|fludarabine|mesh-list
92567040|NCT00182650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567041|NCT00182650|Antimetabolites|antimetabolites|mesh-ancestor
92567042|NCT00182650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567043|NCT00182650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567044|NCT00182650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92567045|NCT00182650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92567046|NCT00182650|Antiviral Agents|antiviral agents|mesh-ancestor
92567047|NCT00182650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567048|NCT00182806|Gemcitabine|gemcitabine|mesh-list
92567050|NCT00182806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567051|NCT00182806|Antimetabolites|antimetabolites|mesh-ancestor
92567052|NCT00182806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567053|NCT00182806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567054|NCT00182806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92567055|NCT00182806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567056|NCT00182806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567057|NCT00182845|Donepezil|donepezil|mesh-list
92567058|NCT00182845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92567059|NCT00182845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567060|NCT00182845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567061|NCT00182845|Cholinergic Agents|cholinergic agents|mesh-ancestor
92291850|NCT04403711|Anesthetics|anesthetics|mesh-list
92567062|NCT00182845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567063|NCT00182845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567064|NCT00182845|Nootropic Agents|nootropic agents|mesh-ancestor
92567066|NCT00182884|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92567067|NCT00182884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567068|NCT00182884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567069|NCT00182884|Cholinergic Agents|cholinergic agents|mesh-ancestor
92567070|NCT00182884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567071|NCT00182884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567072|NCT00182884|Nootropic Agents|nootropic agents|mesh-ancestor
92567073|NCT00183001|Vitamin K|vitamin k|mesh-list
92567074|NCT00183001|Vitamins|vitamins|mesh-ancestor
92567075|NCT00183001|Micronutrients|micronutrients|mesh-ancestor
92567076|NCT00183001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567077|NCT00183001|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92567078|NCT00183001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92567079|NCT00183001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567080|NCT00183001|Hemostatics|hemostatics|mesh-ancestor
92567081|NCT00183001|Coagulants|coagulants|mesh-ancestor
92567082|NCT00183040|Hormones|hormones|mesh-list
92567083|NCT00183040|Testosterone|testosterone|mesh-list
92567084|NCT00183040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92567085|NCT00183040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567086|NCT00183040|Androgens|androgens|mesh-ancestor
92534808|NCT00071968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534809|NCT00071968|Immunologic Factors|immunologic factors|mesh-ancestor
92534810|NCT00071968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567087|NCT00057395|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
92567088|NCT00057395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567089|NCT00183235|Aripiprazole|aripiprazole|mesh-list
92567090|NCT00183235|Antidepressive Agents|antidepressive agents|mesh-ancestor
92567091|NCT00183235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92567092|NCT00183235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92567093|NCT00183235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92567094|NCT00183235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92567095|NCT00183235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567096|NCT00183235|Dopamine Agonists|dopamine agonists|mesh-ancestor
92567097|NCT00183235|Dopamine Agents|dopamine agents|mesh-ancestor
92567098|NCT00183235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567099|NCT00183235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567100|NCT00183235|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91974387|NCT02453087|Rituximab|rituximab|mesh-list
92567104|NCT00183235|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92567105|NCT00183235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92567106|NCT00183235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92567107|NCT00057512|Masoprocol|masoprocol|mesh-list
92567108|NCT00057512|Antioxidants|antioxidants|mesh-ancestor
92567109|NCT00057512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567110|NCT00057512|Protective Agents|protective agents|mesh-ancestor
92567111|NCT00057512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567112|NCT00057512|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92567113|NCT00057512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567114|NCT00057512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92567115|NCT00057512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92567116|NCT00057512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567117|NCT00057512|Analgesics|analgesics|mesh-ancestor
92567118|NCT00057512|Sensory System Agents|sensory system agents|mesh-ancestor
92567119|NCT00057512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567120|NCT00057512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567121|NCT00057512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567122|NCT00183742|Docetaxel|docetaxel|mesh-list
92567123|NCT00183742|Doxorubicin|doxorubicin|mesh-list
92567124|NCT00183742|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92567125|NCT00183742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567126|NCT00183742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567127|NCT00183742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567128|NCT00183742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567129|NCT00183742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567130|NCT00183742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92567131|NCT00183742|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92567132|NCT00183742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567133|NCT00183742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567134|NCT02965248|Calcium, Dietary|calcium, dietary|mesh-list
92567135|NCT02965248|Leucovorin|leucovorin|mesh-list
92567136|NCT02965248|Capecitabine|capecitabine|mesh-list
92567137|NCT02965248|Raltitrexed|raltitrexed|mesh-list
92567138|NCT02965248|Oxaliplatin|oxaliplatin|mesh-list
92567139|NCT02965248|Calcium|calcium|mesh-list
92567140|NCT02965248|Levoleucovorin|levoleucovorin|mesh-list
92567141|NCT02965248|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92567142|NCT02965248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567143|NCT02965248|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92567144|NCT02965248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567145|NCT02965248|Antimetabolites|antimetabolites|mesh-ancestor
92567146|NCT02965248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567147|NCT02965248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567148|NCT02965248|Antidotes|antidotes|mesh-ancestor
92567149|NCT02965248|Protective Agents|protective agents|mesh-ancestor
92567150|NCT02965248|Vitamin B Complex|vitamin b complex|mesh-ancestor
92567151|NCT02965248|Vitamins|vitamins|mesh-ancestor
92567152|NCT02965248|Micronutrients|micronutrients|mesh-ancestor
92567153|NCT02965248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92567154|NCT02965248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567155|NCT00183820|Paclitaxel|paclitaxel|mesh-list
92567156|NCT00183820|Gemcitabine|gemcitabine|mesh-list
92567157|NCT00183820|Oxaliplatin|oxaliplatin|mesh-list
92567158|NCT00183820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92534811|NCT00071968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534812|NCT00071968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567159|NCT00183820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567160|NCT00183820|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567161|NCT00183820|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567162|NCT00183820|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567163|NCT00183820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567164|NCT00183820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567165|NCT00183820|Antimetabolites|antimetabolites|mesh-ancestor
92567166|NCT02969720|Titanium dioxide|titanium dioxide|mesh-list
92567167|NCT02969720|Sunscreening Agents|sunscreening agents|mesh-ancestor
92567168|NCT02969720|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92567169|NCT02969720|Protective Agents|protective agents|mesh-ancestor
92567170|NCT02969720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567171|NCT02969720|Dermatologic Agents|dermatologic agents|mesh-ancestor
92567172|NCT02969720|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92567173|NCT00183859|Irinotecan|irinotecan|mesh-list
92567174|NCT00183859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92567180|NCT00183898|Oxaliplatin|oxaliplatin|mesh-list
92567181|NCT00183898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567182|NCT00183898|Antimetabolites|antimetabolites|mesh-ancestor
92567183|NCT00183898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567184|NCT00183898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567185|NCT04730765|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92567186|NCT04730765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567187|NCT00183937|Docetaxel|docetaxel|mesh-list
92567188|NCT00183937|Bortezomib|bortezomib|mesh-list
92567189|NCT00183937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567190|NCT00183937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567191|NCT00183937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567192|NCT00183937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567193|NCT00183937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567194|NCT00408772|Bevacizumab|bevacizumab|mesh-list
92567195|NCT00408772|Capecitabine|capecitabine|mesh-list
92567196|NCT00408772|Oxaliplatin|oxaliplatin|mesh-list
92567197|NCT00408772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92567198|NCT00408772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567199|NCT00408772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92567200|NCT00408772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92567201|NCT00408772|Growth Substances|growth substances|mesh-ancestor
92567202|NCT00408772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567203|NCT00408772|Growth Inhibitors|growth inhibitors|mesh-ancestor
92567204|NCT00408772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567205|NCT00408772|Antimetabolites|antimetabolites|mesh-ancestor
92567206|NCT00408772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567207|NCT00408850|Pioglitazone|pioglitazone|mesh-list
92567208|NCT00408850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92567209|NCT00408850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567210|NCT00183976|Rituximab|rituximab|mesh-list
92567211|NCT00183976|Doxorubicin|doxorubicin|mesh-list
92292007|NCT02284555|Mupirocin|mupirocin|mesh-list
92567212|NCT00183976|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92567213|NCT00183976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92567214|NCT00183976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567215|NCT00183976|Immunologic Factors|immunologic factors|mesh-ancestor
92567216|NCT00183976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567217|NCT00183976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567218|NCT00183976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92567219|NCT00183976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92567220|NCT00183976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567221|NCT00183976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567222|NCT00183976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567223|NCT00046683|Alemtuzumab|alemtuzumab|mesh-list
92567224|NCT00046683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92567225|NCT00046683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567226|NCT00184015|Bevacizumab|bevacizumab|mesh-list
92567227|NCT00184015|Bortezomib|bortezomib|mesh-list
92567228|NCT00184015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92567229|NCT00184015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567230|NCT00184015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92567231|NCT00184015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92567232|NCT00184015|Growth Substances|growth substances|mesh-ancestor
92567233|NCT00184015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567234|NCT00184015|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534813|NCT00071968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534814|NCT00071968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534815|NCT00071968|Antifungal Agents|antifungal agents|mesh-ancestor
92567235|NCT00184171|Budesonide|budesonide|mesh-list
92567236|NCT00184171|Bismuth|bismuth|mesh-list
92567237|NCT00184171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567238|NCT00184171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92567239|NCT00184171|Autonomic Agents|autonomic agents|mesh-ancestor
92567240|NCT00184171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567241|NCT00184171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567242|NCT00184171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92567243|NCT00184171|Respiratory System Agents|respiratory system agents|mesh-ancestor
92567244|NCT00184171|Glucocorticoids|glucocorticoids|mesh-ancestor
92567248|NCT00184171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567250|NCT00057707|Modafinil|modafinil|mesh-list
92567251|NCT00057707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92567252|NCT00057707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567253|NCT00057707|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92567254|NCT00057707|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92567255|NCT00057707|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92567256|NCT00057707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567257|NCT00184522|Esomeprazole|esomeprazole|mesh-list
92567258|NCT00184522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92567259|NCT00184522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92567260|NCT00184522|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92567261|NCT00184522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567262|NCT00184522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567263|NCT00184561|Insulin Aspart|insulin aspart|mesh-list
92567264|NCT00184561|Biphasic Insulins|biphasic insulins|mesh-list
92567265|NCT00184561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92567266|NCT00184561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567267|NCT00184639|Insulin Detemir|insulin detemir|mesh-list
92567268|NCT00184639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92567269|NCT00184639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567270|NCT00058097|Tipifarnib|tipifarnib|mesh-list
92567271|NCT00058097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567272|NCT00184795|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92567273|NCT00184795|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92567274|NCT00184795|Norethindrone|norethindrone|mesh-list
92567275|NCT00184795|Norethindrone Acetate|norethindrone acetate|mesh-list
92567276|NCT00184795|Estradiol|estradiol|mesh-list
92567277|NCT00184795|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92567278|NCT00184795|Estrogens|estrogens|mesh-ancestor
92567279|NCT00184795|Hormones|hormones|mesh-ancestor
92567280|NCT00184795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92567281|NCT00184795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567282|NCT00184795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92567283|NCT00184795|Contraceptive Agents|contraceptive agents|mesh-ancestor
92567284|NCT00184795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567285|NCT00184795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92567286|NCT00184795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92567287|NCT00184795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92567288|NCT00184795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92567289|NCT00058253|Docetaxel|docetaxel|mesh-list
92567290|NCT00058253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567291|NCT00058253|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567292|NCT00058253|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567293|NCT00058253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567294|NCT00058253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567295|NCT00046800|Lurtotecan|lurtotecan|mesh-list
92567296|NCT00046800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567297|NCT00058292|Cytarabine|cytarabine|mesh-list
92567298|NCT00058292|Rituximab|rituximab|mesh-list
92567299|NCT00058292|Etoposide|etoposide|mesh-list
92567300|NCT00058292|Etoposide phosphate|etoposide phosphate|mesh-list
92567301|NCT00058292|Melphalan|melphalan|mesh-list
92567302|NCT00058292|Carmustine|carmustine|mesh-list
92567303|NCT00058292|Lenograstim|lenograstim|mesh-list
92567304|NCT00058292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356993|NCT02087748|Analgesics|analgesics|mesh-ancestor
92567305|NCT00058292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567306|NCT00058292|Immunologic Factors|immunologic factors|mesh-ancestor
92567307|NCT00058292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567308|NCT00058292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567309|NCT00058292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92567310|NCT00058292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92567311|NCT00058292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567312|NCT00058292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567313|NCT00058292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567314|NCT00058292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567315|NCT00058292|Antimetabolites|antimetabolites|mesh-ancestor
92567316|NCT00058292|Antiviral Agents|antiviral agents|mesh-ancestor
92567335|NCT00184912|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92567336|NCT00184912|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92567337|NCT00184912|Purinergic Agents|purinergic agents|mesh-ancestor
92567338|NCT00184912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567339|NCT00184951|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92567340|NCT00184951|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92567341|NCT00184951|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92567342|NCT00184951|Antimetabolites|antimetabolites|mesh-ancestor
92567343|NCT00184951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567344|NCT00184951|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92567345|NCT00184951|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92567346|NCT00184951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567347|NCT00184990|Pimagedine|pimagedine|mesh-list
92567348|NCT00184990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567349|NCT00184990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567350|NCT00058331|Epoetin Alfa|epoetin alfa|mesh-list
92567351|NCT00058331|Hematinics|hematinics|mesh-ancestor
92567352|NCT00185068|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92567353|NCT00185068|Olmesartan|olmesartan|mesh-list
92567354|NCT00185068|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92567355|NCT00185068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92567356|NCT00185068|Diuretics|diuretics|mesh-ancestor
92567357|NCT00185068|Natriuretic Agents|natriuretic agents|mesh-ancestor
92567358|NCT00185068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567359|NCT00185068|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92567360|NCT00185068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92567361|NCT00185068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567362|NCT00185068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92567363|NCT00185068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92567364|NCT00185107|Simvastatin|simvastatin|mesh-list
92567365|NCT00185107|Ezetimibe|ezetimibe|mesh-list
92567366|NCT00185107|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92567367|NCT00185107|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92567368|NCT00185107|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92567369|NCT00185107|Antimetabolites|antimetabolites|mesh-ancestor
92567370|NCT00185107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567371|NCT00185107|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91974671|NCT04918953|Hormones|hormones|mesh-ancestor
92567376|NCT00058448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567377|NCT00058448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567378|NCT00058448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567379|NCT00058448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567380|NCT00185185|Atenolol|atenolol|mesh-list
92567381|NCT00185185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92567382|NCT00185185|Olmesartan|olmesartan|mesh-list
92567383|NCT00185185|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92567384|NCT00185185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92567385|NCT00185185|Diuretics|diuretics|mesh-ancestor
92567386|NCT00185185|Natriuretic Agents|natriuretic agents|mesh-ancestor
92567387|NCT00185185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567388|NCT00185185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92567389|NCT00185185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92567390|NCT00185185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567391|NCT00185185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92567392|NCT00185185|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92567393|NCT00185185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92567394|NCT00185185|Sympatholytics|sympatholytics|mesh-ancestor
92567395|NCT00185185|Autonomic Agents|autonomic agents|mesh-ancestor
92567396|NCT00185185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567397|NCT00185185|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92567398|NCT00185185|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92567399|NCT00185185|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92567400|NCT00185185|Adrenergic Agents|adrenergic agents|mesh-ancestor
92567401|NCT00185185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567402|NCT00185224|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92534816|NCT00390065|Nitric Oxide|nitric oxide|mesh-list
92534817|NCT00390065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92567403|NCT00185224|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92567404|NCT00185224|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92567405|NCT00185224|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92567406|NCT00185224|Contraceptive Agents|contraceptive agents|mesh-ancestor
92567407|NCT00185224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567408|NCT00185224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567409|NCT00185224|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92567410|NCT00185224|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92567411|NCT00185224|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92567412|NCT00185224|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92567413|NCT00185224|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92567414|NCT00185224|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92567415|NCT00185302|Entinostat|entinostat|mesh-list
92567416|NCT00185302|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92567417|NCT00185302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567418|NCT00185302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567419|NCT00185302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567420|NCT03784014|Durvalumab|durvalumab|mesh-list
92567421|NCT03784014|Olaparib|olaparib|mesh-list
92567422|NCT03784014|Palbociclib|palbociclib|mesh-list
92567423|NCT03784014|Lapatinib|lapatinib|mesh-list
92567424|NCT03784014|Trametinib|trametinib|mesh-list
92567425|NCT03784014|Dabrafenib|dabrafenib|mesh-list
92567426|NCT03784014|Ceritinib|ceritinib|mesh-list
92567427|NCT03784014|Futibatinib|futibatinib|mesh-list
92567428|NCT03784014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92567429|NCT03784014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567430|NCT03784014|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92567431|NCT03784014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567432|NCT03784014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567433|NCT03784014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92567434|NCT00058487|Thalidomide|thalidomide|mesh-list
92567435|NCT00058487|Epirubicin|epirubicin|mesh-list
92567436|NCT00058487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92567437|NCT00058487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567438|NCT00058487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92567439|NCT00058487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567440|NCT00058487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567441|NCT00058487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567443|NCT00058487|Immunologic Factors|immunologic factors|mesh-ancestor
92567444|NCT00058487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567445|NCT00058487|Leprostatic Agents|leprostatic agents|mesh-ancestor
92567446|NCT00058487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567447|NCT00058487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567448|NCT00058487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92567449|NCT00058487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92567450|NCT00058487|Growth Substances|growth substances|mesh-ancestor
92567451|NCT00058487|Growth Inhibitors|growth inhibitors|mesh-ancestor
92567452|NCT00185419|Desogestrel|desogestrel|mesh-list
92567453|NCT00185419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567454|NCT00185419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567455|NCT00185419|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92567456|NCT00185419|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92567457|NCT00185419|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92567458|NCT00185419|Contraceptive Agents|contraceptive agents|mesh-ancestor
92567459|NCT00185419|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92567460|NCT00185419|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92567461|NCT00185419|Progestins|progestins|mesh-ancestor
92567462|NCT00185419|Hormones|hormones|mesh-ancestor
92567463|NCT00185419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357002|NCT01490502|Vitamin D|vitamin d|mesh-list
92567464|NCT00185575|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92567465|NCT00185575|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92567466|NCT00185575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92567467|NCT00185575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92567468|NCT00185575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567469|NCT00185575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567470|NCT00185575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567471|NCT00185575|Analgesics|analgesics|mesh-ancestor
92567472|NCT00185575|Sensory System Agents|sensory system agents|mesh-ancestor
92534818|NCT00390065|Autonomic Agents|autonomic agents|mesh-ancestor
92534819|NCT00390065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534820|NCT00390065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567473|NCT00185575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567474|NCT00185575|Antidepressive Agents|antidepressive agents|mesh-ancestor
92567475|NCT00185575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92567476|NCT00185575|Dopamine Agents|dopamine agents|mesh-ancestor
92567477|NCT03731832|Dexamethasone|dexamethasone|mesh-list
92567478|NCT03731832|Cyclophosphamide|cyclophosphamide|mesh-list
92567479|NCT03731832|Pomalidomide|pomalidomide|mesh-list
92567481|NCT03731832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567482|NCT03731832|Immunologic Factors|immunologic factors|mesh-ancestor
92567483|NCT03731832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567484|NCT03731832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567485|NCT03731832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92567486|NCT03731832|Alkylating Agents|alkylating agents|mesh-ancestor
92567487|NCT03731832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567488|NCT03731832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567489|NCT03731832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92567490|NCT03731832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567491|NCT03731832|Antiemetics|antiemetics|mesh-ancestor
92567492|NCT03731832|Autonomic Agents|autonomic agents|mesh-ancestor
92567493|NCT03731832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567494|NCT03731832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92567495|NCT03731832|Glucocorticoids|glucocorticoids|mesh-ancestor
92567496|NCT03731832|Hormones|hormones|mesh-ancestor
92567497|NCT03731832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92567498|NCT03731832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92567499|NCT03731832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92567500|NCT03731832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92567501|NCT03731832|Growth Substances|growth substances|mesh-ancestor
92567502|NCT03731832|Growth Inhibitors|growth inhibitors|mesh-ancestor
92567503|NCT03731832|Protease Inhibitors|protease inhibitors|mesh-ancestor
92567504|NCT03731832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567505|NCT00185887|Terbutaline|terbutaline|mesh-list
92567506|NCT00185887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92567507|NCT00185887|Autonomic Agents|autonomic agents|mesh-ancestor
92567508|NCT00185887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567509|NCT00185887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567510|NCT00185887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92567511|NCT00185887|Respiratory System Agents|respiratory system agents|mesh-ancestor
92567512|NCT00185887|Sympathomimetics|sympathomimetics|mesh-ancestor
92567513|NCT00185887|Tocolytic Agents|tocolytic agents|mesh-ancestor
91974791|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92567520|NCT00185887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567522|NCT00186082|Cefotetan|cefotetan|mesh-list
92567523|NCT00186082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567524|NCT00186082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567525|NCT00186277|Docetaxel|docetaxel|mesh-list
92567526|NCT00186277|Oxaliplatin|oxaliplatin|mesh-list
92567527|NCT00186277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567528|NCT00186277|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567529|NCT00186277|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567530|NCT00186277|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567531|NCT00186277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567532|NCT00186316|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92567533|NCT00186316|Immunologic Factors|immunologic factors|mesh-ancestor
92567534|NCT00186316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567535|NCT00058682|Anidulafungin|anidulafungin|mesh-list
92567536|NCT00058682|Antifungal Agents|antifungal agents|mesh-ancestor
92567537|NCT00058682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567538|NCT00186589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92567539|NCT00186589|Immunologic Factors|immunologic factors|mesh-ancestor
92153337|NCT03402087|Methotrexate|methotrexate|mesh-list
92567540|NCT00186589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567541|NCT00186706|Selenium|selenium|mesh-list
92567542|NCT00186706|Antioxidants|antioxidants|mesh-ancestor
92567543|NCT00186706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567544|NCT00186706|Protective Agents|protective agents|mesh-ancestor
92567545|NCT00186706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567546|NCT00186706|Trace Elements|trace elements|mesh-ancestor
92567547|NCT00186706|Micronutrients|micronutrients|mesh-ancestor
92567548|NCT00409201|Reboxetine|reboxetine|mesh-list
92567549|NCT00409201|Antidepressive Agents|antidepressive agents|mesh-ancestor
92534821|NCT00390065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92534822|NCT00390065|Respiratory System Agents|respiratory system agents|mesh-ancestor
92567550|NCT00409201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92567551|NCT00409201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92567552|NCT00409201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92567553|NCT00409201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92567554|NCT00409201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567555|NCT00409201|Adrenergic Agents|adrenergic agents|mesh-ancestor
92567556|NCT00409201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567557|NCT00409201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567558|NCT00046878|Carmustine|carmustine|mesh-list
92567559|NCT00046878|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92567560|NCT00046878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92567561|NCT00046878|Alkylating Agents|alkylating agents|mesh-ancestor
92567562|NCT00046878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567563|NCT00046878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567564|NCT00046878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567565|NCT00186745|Tinzaparin|tinzaparin|mesh-list
92567566|NCT00186745|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92567567|NCT00186745|Dalteparin|dalteparin|mesh-list
92567568|NCT00186745|Anticoagulants|anticoagulants|mesh-ancestor
92567569|NCT00186745|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92567570|NCT00186745|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92567571|NCT00186745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567572|NCT00186823|Antibodies|antibodies|mesh-list
92567573|NCT00186823|Immunologic Factors|immunologic factors|mesh-ancestor
92567574|NCT00186823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567575|NCT00186862|Interleukin-2|interleukin-2|mesh-list
92567576|NCT00186862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567577|NCT00186862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567578|NCT00186862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567579|NCT00186862|Analgesics|analgesics|mesh-ancestor
92567580|NCT00186862|Sensory System Agents|sensory system agents|mesh-ancestor
92567581|NCT00186862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567582|NCT03551964|Ticagrelor|ticagrelor|mesh-list
92567585|NCT03551964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92567586|NCT03551964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92567588|NCT03551964|Purinergic Agents|purinergic agents|mesh-ancestor
92567589|NCT03551964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567590|NCT03551964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567591|NCT03551964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567592|NCT00186940|Rasburicase|rasburicase|mesh-list
92567593|NCT00186940|Gout Suppressants|gout suppressants|mesh-ancestor
92567594|NCT00186940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567595|NCT00186979|Cefixime|cefixime|mesh-list
92567596|NCT00186979|Cefpodoxime|cefpodoxime|mesh-list
92567597|NCT00186979|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
92567598|NCT00186979|Irinotecan|irinotecan|mesh-list
92567599|NCT00186979|Vincristine|vincristine|mesh-list
92567600|NCT00186979|Gefitinib|gefitinib|mesh-list
92567601|NCT00186979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92567602|NCT00186979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567603|NCT00186979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567604|NCT00186979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567605|NCT00186979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567606|NCT00186979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92567607|NCT00186979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567608|NCT00186979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567609|NCT00186979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567610|NCT00186979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92567611|NCT00186979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567612|NCT00186979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567613|NCT00187057|Cytarabine|cytarabine|mesh-list
92567614|NCT00187057|Dexamethasone|dexamethasone|mesh-list
92567615|NCT00187057|Prednisone|prednisone|mesh-list
92567616|NCT00187057|Cyclophosphamide|cyclophosphamide|mesh-list
92567617|NCT00187057|Doxorubicin|doxorubicin|mesh-list
92567618|NCT00187057|Methotrexate|methotrexate|mesh-list
92567619|NCT00187057|Etoposide|etoposide|mesh-list
92567620|NCT00187057|Vincristine|vincristine|mesh-list
92567621|NCT00187057|Daunorubicin|daunorubicin|mesh-list
92567622|NCT00187057|Asparaginase|asparaginase|mesh-list
92567623|NCT00187057|Mercaptopurine|mercaptopurine|mesh-list
92567624|NCT00187057|Vinblastine|vinblastine|mesh-list
92567625|NCT00187057|Procarbazine|procarbazine|mesh-list
92567626|NCT00187057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534823|NCT00390065|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92567627|NCT00187057|Immunologic Factors|immunologic factors|mesh-ancestor
92567628|NCT00187057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567629|NCT00187057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567630|NCT00187057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92567631|NCT00187057|Alkylating Agents|alkylating agents|mesh-ancestor
92567632|NCT00187057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567633|NCT00187057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567634|NCT00187057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92567635|NCT00187057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567636|NCT00187057|Antiemetics|antiemetics|mesh-ancestor
92567637|NCT00187057|Autonomic Agents|autonomic agents|mesh-ancestor
92567638|NCT00187057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567639|NCT00187057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92567640|NCT00187057|Glucocorticoids|glucocorticoids|mesh-ancestor
92567641|NCT00187057|Hormones|hormones|mesh-ancestor
92567642|NCT00187057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92567643|NCT00187057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92567644|NCT00187057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92567645|NCT00187057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92567646|NCT00187057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567647|NCT00187057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567648|NCT00187057|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92567649|NCT00187057|Abortifacient Agents|abortifacient agents|mesh-ancestor
92567650|NCT00187057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567651|NCT00187057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567652|NCT00187057|Antimetabolites|antimetabolites|mesh-ancestor
92567653|NCT00187057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92567654|NCT00187057|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92567655|NCT00187057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92567656|NCT00187057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92567657|NCT00187057|Antiviral Agents|antiviral agents|mesh-ancestor
92567664|NCT00046917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567665|NCT00046917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92567666|NCT00046917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567667|NCT00046917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567668|NCT00046917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567669|NCT00046917|Growth Inhibitors|growth inhibitors|mesh-ancestor
92567670|NCT00046917|Growth Substances|growth substances|mesh-ancestor
92567671|NCT00046917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567672|NCT00046917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92567674|NCT00187174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92567675|NCT00187174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92567676|NCT00187174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567677|NCT00187174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567678|NCT00187174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567679|NCT00187174|Immunologic Factors|immunologic factors|mesh-ancestor
92567680|NCT00187174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567681|NCT00187174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567682|NCT00187330|Acetylcysteine|acetylcysteine|mesh-list
92567683|NCT00187330|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92567684|NCT00187330|Antiviral Agents|antiviral agents|mesh-ancestor
92567685|NCT00187330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567686|NCT00187330|Expectorants|expectorants|mesh-ancestor
92567687|NCT00187330|Respiratory System Agents|respiratory system agents|mesh-ancestor
92567688|NCT00187330|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92567689|NCT00187330|Antioxidants|antioxidants|mesh-ancestor
92567690|NCT00187330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567691|NCT00187330|Protective Agents|protective agents|mesh-ancestor
92567692|NCT00187330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567693|NCT00187330|Antidotes|antidotes|mesh-ancestor
92567694|NCT00187408|Heparin|heparin|mesh-list
92567695|NCT00187408|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92567696|NCT00187408|Tinzaparin|tinzaparin|mesh-list
92567697|NCT00187408|Dalteparin|dalteparin|mesh-list
92567698|NCT00187408|Anticoagulants|anticoagulants|mesh-ancestor
92567699|NCT00187408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92567700|NCT00187408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92567701|NCT00187408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567702|NCT00187447|Indomethacin|indomethacin|mesh-list
92567703|NCT00187447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92567704|NCT00187447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567705|NCT00187447|Analgesics|analgesics|mesh-ancestor
91917053|NCT05557604|Contraceptive Agents|contraceptive agents|mesh-ancestor
92567706|NCT00187447|Sensory System Agents|sensory system agents|mesh-ancestor
92567707|NCT00187447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567708|NCT00187447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567709|NCT00187447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567710|NCT00187447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567711|NCT00187447|Gout Suppressants|gout suppressants|mesh-ancestor
92567712|NCT00187447|Tocolytic Agents|tocolytic agents|mesh-ancestor
92567713|NCT00187447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567714|NCT00187447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92567715|NCT00187447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567716|NCT00187447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567717|NCT02969564|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92567718|NCT02969564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92567719|NCT02969564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567720|NCT00187525|Memantine|memantine|mesh-list
92567721|NCT00187525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92567722|NCT00187525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92567723|NCT00187525|Dopamine Agents|dopamine agents|mesh-ancestor
92567724|NCT00187525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567725|NCT00187525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567726|NCT00187525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567727|NCT00187525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92567728|NCT00187525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92567735|NCT00187564|Vitamins|vitamins|mesh-ancestor
92567736|NCT00187564|Micronutrients|micronutrients|mesh-ancestor
92567737|NCT00046995|Leucovorin|leucovorin|mesh-list
92567738|NCT00046995|Carboplatin|carboplatin|mesh-list
92567739|NCT00046995|Fluorouracil|fluorouracil|mesh-list
92567740|NCT00046995|Calcium|calcium|mesh-list
92567741|NCT00046995|Levoleucovorin|levoleucovorin|mesh-list
92567742|NCT00046995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567743|NCT00046995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92567744|NCT00046995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567745|NCT00046995|Antimetabolites|antimetabolites|mesh-ancestor
92567746|NCT00046995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567747|NCT00046995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567748|NCT00046995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567749|NCT00046995|Immunologic Factors|immunologic factors|mesh-ancestor
92567750|NCT00046995|Antidotes|antidotes|mesh-ancestor
92567751|NCT00046995|Protective Agents|protective agents|mesh-ancestor
92567752|NCT00046995|Vitamin B Complex|vitamin b complex|mesh-ancestor
92567753|NCT00046995|Vitamins|vitamins|mesh-ancestor
92567754|NCT00046995|Micronutrients|micronutrients|mesh-ancestor
92567755|NCT00058955|Sodium Oxybate|sodium oxybate|mesh-list
92567756|NCT00058955|Triazolam|triazolam|mesh-list
92567757|NCT00058955|Pentobarbital|pentobarbital|mesh-list
92567758|NCT00058955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92567759|NCT00058955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92567760|NCT00058955|Anesthetics, General|anesthetics, general|mesh-ancestor
92567761|NCT00058955|Anesthetics|anesthetics|mesh-ancestor
92567762|NCT00058955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92567763|NCT00058955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567764|NCT00058955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92567765|NCT00058955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92567766|NCT00058955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92567767|NCT00058955|GABA Modulators|gaba modulators|mesh-ancestor
92567768|NCT00058955|GABA Agents|gaba agents|mesh-ancestor
92567769|NCT00058955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750755|NCT05936606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567770|NCT00058955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567771|NCT00058955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92567772|NCT00187759|Cephalexin|cephalexin|mesh-list
92567773|NCT00187759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567774|NCT00187759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567775|NCT00187798|Metformin|metformin|mesh-list
92567776|NCT00187798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92567777|NCT00187798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567778|NCT00058994|Anecortave|anecortave|mesh-list
92567779|NCT00058994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92567780|NCT00058994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92567781|NCT00058994|Growth Substances|growth substances|mesh-ancestor
92567782|NCT00058994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567783|NCT00058994|Growth Inhibitors|growth inhibitors|mesh-ancestor
92567784|NCT00058994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567785|NCT00187915|Cyclosporine|cyclosporine|mesh-list
92534825|NCT00390065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567786|NCT00187915|Mycophenolic Acid|mycophenolic acid|mesh-list
92567787|NCT00187915|Tacrolimus|tacrolimus|mesh-list
92567788|NCT00187915|Cyclosporins|cyclosporins|mesh-list
92567789|NCT00187915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567790|NCT00187915|Immunologic Factors|immunologic factors|mesh-ancestor
92567791|NCT00187915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567792|NCT00187915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92567793|NCT00187915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567794|NCT00187915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567795|NCT00187915|Antifungal Agents|antifungal agents|mesh-ancestor
92567796|NCT00187915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567797|NCT00187915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92567798|NCT00187915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567799|NCT00187915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92567800|NCT00187915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975079|NCT04430361|Dexamethasone|dexamethasone|mesh-list
92567815|NCT00188071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92567816|NCT00188071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567817|NCT00188071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567818|NCT00188071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92292606|NCT04332497|Narcotics|narcotics|mesh-ancestor
92567819|NCT00188071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567820|NCT00188071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567821|NCT00188227|Midazolam|midazolam|mesh-list
92567822|NCT00188227|Pirinitramide|pirinitramide|mesh-list
92567823|NCT00188227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92567824|NCT00188227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92567825|NCT00188227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92567826|NCT00188227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567827|NCT00188227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92567828|NCT00188227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92567829|NCT00188227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92567830|NCT00188227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92567831|NCT00188227|Anesthetics, General|anesthetics, general|mesh-ancestor
92567832|NCT00188227|Anesthetics|anesthetics|mesh-ancestor
92567833|NCT00188227|GABA Modulators|gaba modulators|mesh-ancestor
92567834|NCT00188227|GABA Agents|gaba agents|mesh-ancestor
92567835|NCT00188227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567836|NCT00188227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567837|NCT00188227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92567838|NCT00188227|Narcotics|narcotics|mesh-ancestor
92567839|NCT00188227|Analgesics|analgesics|mesh-ancestor
92567840|NCT00188227|Sensory System Agents|sensory system agents|mesh-ancestor
92567841|NCT00188227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567842|NCT00188266|Fluorouracil|fluorouracil|mesh-list
92567843|NCT00188266|Cisplatin|cisplatin|mesh-list
92567844|NCT00188266|Antimetabolites|antimetabolites|mesh-ancestor
92750756|NCT05936489|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92567845|NCT00188266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567846|NCT00188266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567847|NCT00188266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567848|NCT00188266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567849|NCT00188266|Immunologic Factors|immunologic factors|mesh-ancestor
92567850|NCT00188266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567851|NCT00047073|Sirolimus|sirolimus|mesh-list
92567852|NCT00047073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567853|NCT00047073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567854|NCT00047073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92567855|NCT00047073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567856|NCT00047073|Antifungal Agents|antifungal agents|mesh-ancestor
92567857|NCT00047073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567858|NCT00047073|Immunologic Factors|immunologic factors|mesh-ancestor
92567859|NCT00047073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567860|NCT00188383|Amantadine|amantadine|mesh-list
92567861|NCT00188383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92567866|NCT00188383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567867|NCT00188383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567868|NCT00188383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567869|NCT00188383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567870|NCT00188383|Analgesics|analgesics|mesh-ancestor
92567871|NCT00188383|Sensory System Agents|sensory system agents|mesh-ancestor
92567872|NCT00188383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567873|NCT02969447|Oxytocin|oxytocin|mesh-list
92567874|NCT02969447|Oxytocics|oxytocics|mesh-ancestor
92567875|NCT02969447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92259573|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534826|NCT00390065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92534827|NCT00390065|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92534828|NCT00390065|Vasodilator Agents|vasodilator agents|mesh-ancestor
92534829|NCT00390065|Gasotransmitters|gasotransmitters|mesh-ancestor
92567876|NCT02969447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567877|NCT00188617|Gefitinib|gefitinib|mesh-list
92567878|NCT00188617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567879|NCT00188617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92567880|NCT00188617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567881|NCT00188617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567882|NCT00047112|Fluorouracil|fluorouracil|mesh-list
92567883|NCT00047112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567884|NCT00047112|Antimetabolites|antimetabolites|mesh-ancestor
92567885|NCT00047112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567886|NCT00047112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92567887|NCT00047112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567888|NCT00047112|Immunologic Factors|immunologic factors|mesh-ancestor
92567889|NCT00047112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567890|NCT00409318|Etanercept|etanercept|mesh-list
92567891|NCT00409318|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92567892|NCT00409318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567893|NCT00409318|Analgesics|analgesics|mesh-ancestor
92567894|NCT00409318|Sensory System Agents|sensory system agents|mesh-ancestor
92567895|NCT00409318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567896|NCT00409318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567897|NCT00409318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567898|NCT00409318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567899|NCT00409318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92567900|NCT00409318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567901|NCT00409318|Immunologic Factors|immunologic factors|mesh-ancestor
92567902|NCT00409357|Alfuzosin|alfuzosin|mesh-list
92567903|NCT00409357|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92567904|NCT00409357|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92567905|NCT00409357|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92567906|NCT00409357|Adrenergic Agents|adrenergic agents|mesh-ancestor
92567907|NCT00409357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750757|NCT05936489|Aceclidine|aceclidine|mesh-list
92567908|NCT00409357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567909|NCT00409357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567910|NCT00409357|Urological Agents|urological agents|mesh-ancestor
92567911|NCT00059267|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92567912|NCT00059267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92567913|NCT00059267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92567914|NCT00059267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567915|NCT00059267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567916|NCT00059267|Antiviral Agents|antiviral agents|mesh-ancestor
92567917|NCT00059267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567918|NCT00188773|Acetylcysteine|acetylcysteine|mesh-list
92567919|NCT00188773|Heparin|heparin|mesh-list
92567920|NCT00188773|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92567921|NCT00188773|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92567922|NCT00188773|Anticoagulants|anticoagulants|mesh-ancestor
92567923|NCT00188773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92567924|NCT00188773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92567925|NCT00188773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567926|NCT00188773|Antiviral Agents|antiviral agents|mesh-ancestor
92567927|NCT00188773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567928|NCT00188773|Expectorants|expectorants|mesh-ancestor
92567929|NCT00188773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92567930|NCT00188773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92567931|NCT00188773|Antioxidants|antioxidants|mesh-ancestor
92567932|NCT00188773|Protective Agents|protective agents|mesh-ancestor
92567939|NCT00188812|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92567940|NCT00188812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567941|NCT00188812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567942|NCT00188812|Cholinergic Agents|cholinergic agents|mesh-ancestor
92567943|NCT00188812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567944|NCT00188812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567945|NCT00188812|Nootropic Agents|nootropic agents|mesh-ancestor
92534830|NCT00390065|Protective Agents|protective agents|mesh-ancestor
92534831|NCT00072007|Prednisone|prednisone|mesh-list
92534832|NCT00072007|Cyclophosphamide|cyclophosphamide|mesh-list
92534833|NCT00072007|Rituximab|rituximab|mesh-list
92567946|NCT02963194|Oxytocin|oxytocin|mesh-list
92567947|NCT02963194|Oxytocics|oxytocics|mesh-ancestor
92567948|NCT02963194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567949|NCT02963194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567950|NCT00059306|Aspirin|aspirin|mesh-list
92567951|NCT00059306|Clopidogrel|clopidogrel|mesh-list
92567952|NCT00059306|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92567953|NCT00059306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567954|NCT00059306|Analgesics|analgesics|mesh-ancestor
92567955|NCT00059306|Sensory System Agents|sensory system agents|mesh-ancestor
92567956|NCT00059306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567957|NCT00059306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567958|NCT00059306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92567959|NCT00059306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567960|NCT00059306|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92567961|NCT00059306|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92567962|NCT00059306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567963|NCT00059306|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92567964|NCT00059306|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92567965|NCT00059306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567966|NCT00059306|Antipyretics|antipyretics|mesh-ancestor
92567967|NCT00059306|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92567968|NCT00059306|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92567969|NCT00059306|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92567970|NCT00059306|Purinergic Agents|purinergic agents|mesh-ancestor
92567971|NCT00059306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567972|NCT00188929|Deoxyglucose|deoxyglucose|mesh-list
92567973|NCT00188929|Antimetabolites|antimetabolites|mesh-ancestor
92567974|NCT00188929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567975|NCT00188929|Antiviral Agents|antiviral agents|mesh-ancestor
92567976|NCT00188929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567977|NCT03428373|Rivaroxaban|rivaroxaban|mesh-list
92567978|NCT03428373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567979|NCT03428373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567980|NCT03428373|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92567981|NCT03428373|Antithrombins|antithrombins|mesh-ancestor
92567982|NCT03428373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92567983|NCT03428373|Protease Inhibitors|protease inhibitors|mesh-ancestor
92567984|NCT03428373|Anticoagulants|anticoagulants|mesh-ancestor
92567985|NCT00189007|Allopurinol|allopurinol|mesh-list
92567986|NCT00189007|Mannitol|mannitol|mesh-list
92567987|NCT00189007|Antimetabolites|antimetabolites|mesh-ancestor
92567988|NCT00189007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567989|NCT00189007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567990|NCT00189007|Gout Suppressants|gout suppressants|mesh-ancestor
92567991|NCT00189007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567992|NCT00189007|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92567993|NCT00189007|Antioxidants|antioxidants|mesh-ancestor
92567994|NCT00189007|Protective Agents|protective agents|mesh-ancestor
92567995|NCT00189007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567996|NCT00189007|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92567997|NCT00189007|Diuretics|diuretics|mesh-ancestor
92567998|NCT00189007|Natriuretic Agents|natriuretic agents|mesh-ancestor
92567999|NCT00399945|Tobramycin|tobramycin|mesh-list
92568000|NCT00399945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568001|NCT00399945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568002|NCT00189085|Simvastatin|simvastatin|mesh-list
92568003|NCT00189085|Ezetimibe|ezetimibe|mesh-list
92568011|NCT00189085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568012|NCT00189124|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92568013|NCT00189124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92568014|NCT00189124|Immunologic Factors|immunologic factors|mesh-ancestor
92568015|NCT00189124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568016|NCT00189163|Pioglitazone|pioglitazone|mesh-list
92568017|NCT00189163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92568018|NCT00189163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568019|NCT00189358|Tamoxifen|tamoxifen|mesh-list
92568020|NCT00189358|Gefitinib|gefitinib|mesh-list
92568021|NCT00189358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92568022|NCT00189358|Hormone Antagonists|hormone antagonists|mesh-ancestor
92568023|NCT00189358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92534834|NCT00072007|Doxorubicin|doxorubicin|mesh-list
92534835|NCT00072007|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92568024|NCT00189358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568025|NCT00189358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92568026|NCT00189358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568027|NCT00189358|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92568028|NCT00189358|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92568029|NCT00189358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92568030|NCT00189358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568031|NCT00189358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568032|NCT00189358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568033|NCT00189397|Azathioprine|azathioprine|mesh-list
92568034|NCT00189397|Antimetabolites|antimetabolites|mesh-ancestor
92568035|NCT00189397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568036|NCT00189397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568037|NCT00189397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568038|NCT00189397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568039|NCT00189397|Immunologic Factors|immunologic factors|mesh-ancestor
92568040|NCT00189397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568041|NCT00189397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568042|NCT00189514|Pramlintide|pramlintide|mesh-list
92568043|NCT00189514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92357210|NCT01026012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568044|NCT00189514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568045|NCT00189553|Paclitaxel|paclitaxel|mesh-list
92568046|NCT00189553|Carboplatin|carboplatin|mesh-list
92568047|NCT00189553|Doxorubicin|doxorubicin|mesh-list
92568048|NCT00189553|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92568049|NCT00189553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568050|NCT00189553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568051|NCT00189553|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568052|NCT00189553|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568053|NCT00189553|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568054|NCT00189553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568055|NCT00189553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92568056|NCT00189553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92568057|NCT00189553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568058|NCT00189553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568059|NCT00189709|Fluconazole|fluconazole|mesh-list
92568060|NCT00189709|Micafungin|micafungin|mesh-list
92568061|NCT00189709|Antifungal Agents|antifungal agents|mesh-ancestor
92568062|NCT00189709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568063|NCT00189709|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92568064|NCT00189709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92568065|NCT00189709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568066|NCT00189709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568067|NCT00189709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91975362|NCT05257395|Anastrozole|anastrozole|mesh-list
92568071|NCT00189709|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92568072|NCT00189709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92568073|NCT04722796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92568075|NCT00189748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568076|NCT00189748|Immunologic Factors|immunologic factors|mesh-ancestor
92568077|NCT00189748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568078|NCT00189748|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92568079|NCT00189748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568080|NCT00189748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568081|NCT00189787|Tacrolimus|tacrolimus|mesh-list
92568082|NCT00189787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568083|NCT00189787|Immunologic Factors|immunologic factors|mesh-ancestor
92568084|NCT00189787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568085|NCT00189787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92568086|NCT00189787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568087|NCT00189787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568088|NCT00059462|Interleukin-2|interleukin-2|mesh-list
92568089|NCT00059462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568090|NCT00059462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92568091|NCT00059462|Analgesics|analgesics|mesh-ancestor
92568092|NCT00059462|Sensory System Agents|sensory system agents|mesh-ancestor
92568093|NCT00059462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568094|NCT00059462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568095|NCT00189826|Tacrolimus|tacrolimus|mesh-list
92568096|NCT00189826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534836|NCT00072007|Vincristine|vincristine|mesh-list
92534837|NCT00072007|Cladribine|cladribine|mesh-list
92534838|NCT00072007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568097|NCT00189826|Immunologic Factors|immunologic factors|mesh-ancestor
92568098|NCT00189826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568099|NCT00189826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92568100|NCT00189826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568101|NCT00189826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568102|NCT00047190|Tipifarnib|tipifarnib|mesh-list
92568103|NCT00047190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568104|NCT00189904|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92568105|NCT00189904|Antiviral Agents|antiviral agents|mesh-ancestor
92568106|NCT00189904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568107|NCT00189943|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92568108|NCT00189943|Antiviral Agents|antiviral agents|mesh-ancestor
92568109|NCT00189943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568110|NCT00189982|Factor VIII|factor viii|mesh-list
92568111|NCT00189982|Coagulants|coagulants|mesh-ancestor
92568112|NCT00190021|Donepezil|donepezil|mesh-list
92568113|NCT00190021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92568114|NCT00190021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568115|NCT00190021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568116|NCT00190021|Cholinergic Agents|cholinergic agents|mesh-ancestor
92568117|NCT00190021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568118|NCT00190021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568119|NCT00190021|Nootropic Agents|nootropic agents|mesh-ancestor
92568120|NCT00190060|Testosterone|testosterone|mesh-list
92568121|NCT00190060|Androgens|androgens|mesh-ancestor
92568122|NCT00190060|Hormones|hormones|mesh-ancestor
92568123|NCT00190060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568124|NCT00190060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568125|NCT00047229|Doxorubicin|doxorubicin|mesh-list
92568126|NCT00047229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92568128|NCT00047229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92568129|NCT00047229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568130|NCT00047229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92568131|NCT00047229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568132|NCT00047229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568133|NCT00047229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568134|NCT00190099|Dexamethasone|dexamethasone|mesh-list
92568135|NCT00190099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568136|NCT00190099|Antiemetics|antiemetics|mesh-ancestor
92568137|NCT00190099|Autonomic Agents|autonomic agents|mesh-ancestor
92568157|NCT00047268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568158|NCT00047268|Antiviral Agents|antiviral agents|mesh-ancestor
92568159|NCT00047268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568160|NCT00047268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568161|NCT00047268|Immunologic Factors|immunologic factors|mesh-ancestor
92568162|NCT00047268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568163|NCT00047268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568164|NCT00047268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568166|NCT00190294|Mifepristone|mifepristone|mesh-list
92568167|NCT00190294|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92568168|NCT00190294|Abortifacient Agents|abortifacient agents|mesh-ancestor
92568169|NCT00190294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92568170|NCT00190294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568171|NCT00190294|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92568172|NCT00190294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92568173|NCT00190294|Oxytocics|oxytocics|mesh-ancestor
92568174|NCT00190294|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92568175|NCT00190294|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92568176|NCT00190294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92568177|NCT00190294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92568178|NCT00190294|Contraceptive Agents|contraceptive agents|mesh-ancestor
92568179|NCT00190294|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92568180|NCT00190294|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92568181|NCT00190294|Hormone Antagonists|hormone antagonists|mesh-ancestor
92568182|NCT00190294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568183|NCT00190294|Luteolytic Agents|luteolytic agents|mesh-ancestor
92568184|NCT00190294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92568185|NCT00190294|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92568187|NCT03238365|Tadalafil|tadalafil|mesh-list
92568188|NCT03238365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92568189|NCT03238365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568190|NCT03238365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92568198|NCT00059618|Bortezomib|bortezomib|mesh-list
92568199|NCT00059618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568200|NCT00190333|Escitalopram|escitalopram|mesh-list
92568201|NCT00190333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92568202|NCT00190333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568203|NCT00190333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568204|NCT00190333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568205|NCT00190333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568206|NCT00190333|Serotonin Agents|serotonin agents|mesh-ancestor
92568207|NCT00190333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568208|NCT00190372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92568209|NCT00190372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92568210|NCT00190372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568211|NCT00190411|Celiprolol|celiprolol|mesh-list
92568212|NCT00190411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92568213|NCT00190411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92568214|NCT00190411|Sympathomimetics|sympathomimetics|mesh-ancestor
92568215|NCT00190411|Autonomic Agents|autonomic agents|mesh-ancestor
92568216|NCT00190411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568217|NCT00190411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568218|NCT00190411|Vasodilator Agents|vasodilator agents|mesh-ancestor
92568219|NCT00190411|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92568220|NCT00190411|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92568221|NCT00190411|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92568222|NCT00190411|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568223|NCT00190411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568224|NCT00190411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568225|NCT00047307|Gemcitabine|gemcitabine|mesh-list
92568226|NCT00047307|Alvocidib|alvocidib|mesh-list
92568227|NCT00047307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568228|NCT00047307|Antimetabolites|antimetabolites|mesh-ancestor
92568229|NCT00047307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568230|NCT00047307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568231|NCT00047307|Growth Inhibitors|growth inhibitors|mesh-ancestor
92568232|NCT00047307|Growth Substances|growth substances|mesh-ancestor
92568233|NCT00047307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568234|NCT00047307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568235|NCT00047307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568236|NCT00190489|Docetaxel|docetaxel|mesh-list
92568237|NCT00190489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568238|NCT00190489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568239|NCT00190489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568240|NCT00190489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568241|NCT00190489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568242|NCT00190567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92568243|NCT00190567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92568244|NCT00190567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568245|NCT00190567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568246|NCT00190567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568247|NCT00190567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568248|NCT00190567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568249|NCT00190567|Analgesics|analgesics|mesh-ancestor
92568250|NCT00190567|Sensory System Agents|sensory system agents|mesh-ancestor
92568251|NCT00190567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568252|NCT00190567|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568253|NCT00190567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568254|NCT00190567|Dopamine Agents|dopamine agents|mesh-ancestor
92568255|NCT02969252|Rifamycins|rifamycins|mesh-list
91975540|NCT03046173|Mitogens|mitogens|mesh-list
92568261|NCT00190606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92568262|NCT00190606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568263|NCT00190606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568264|NCT00190606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568265|NCT00190606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568266|NCT00190606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568267|NCT00190606|Analgesics|analgesics|mesh-ancestor
92568268|NCT00190606|Sensory System Agents|sensory system agents|mesh-ancestor
92534839|NCT00072007|Immunologic Factors|immunologic factors|mesh-ancestor
92534840|NCT00072007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534841|NCT00072007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568269|NCT00190606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568270|NCT00190606|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357449|NCT05605158|Pioglitazone|pioglitazone|mesh-list
92568271|NCT00190606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568272|NCT00190606|Dopamine Agents|dopamine agents|mesh-ancestor
92568273|NCT00190645|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92568274|NCT00190645|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92568275|NCT00190645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568276|NCT00190645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568277|NCT00190645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568278|NCT00190645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568279|NCT00190645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568280|NCT00190645|Analgesics|analgesics|mesh-ancestor
92568281|NCT00190645|Sensory System Agents|sensory system agents|mesh-ancestor
92568282|NCT00190645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568283|NCT00190645|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568284|NCT00190645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568285|NCT00190645|Dopamine Agents|dopamine agents|mesh-ancestor
92568286|NCT00190762|Pemetrexed|pemetrexed|mesh-list
92568287|NCT00190762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568288|NCT00190762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568289|NCT00190762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568290|NCT00190762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568291|NCT00190762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568292|NCT00190801|Pemetrexed|pemetrexed|mesh-list
92568293|NCT00190801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568294|NCT00190801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568295|NCT00190801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568296|NCT00190801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568297|NCT00190801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568298|NCT00047346|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92568299|NCT00047346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568300|NCT00047346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568301|NCT00047346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568302|NCT00047346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568303|NCT00190840|Pemetrexed|pemetrexed|mesh-list
92568304|NCT00190840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568305|NCT00190840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568306|NCT00190840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568307|NCT00190840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568308|NCT00190840|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568309|NCT00190879|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92568310|NCT00190879|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92568311|NCT00190879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568312|NCT00190879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568313|NCT00190879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568314|NCT00190879|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568315|NCT00190879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568316|NCT00190879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568317|NCT00190918|Pemetrexed|pemetrexed|mesh-list
92568318|NCT00190918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568319|NCT00190918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568320|NCT00190918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568321|NCT00190918|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568335|NCT00190996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568336|NCT00190996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568337|NCT00190996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568338|NCT00190996|Analgesics|analgesics|mesh-ancestor
92568339|NCT00190996|Sensory System Agents|sensory system agents|mesh-ancestor
92568340|NCT00190996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568341|NCT00190996|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568342|NCT00190996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568343|NCT00190996|Dopamine Agents|dopamine agents|mesh-ancestor
92568344|NCT00191035|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92568345|NCT00191035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92568346|NCT00191035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92534842|NCT00072007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92534843|NCT00072007|Alkylating Agents|alkylating agents|mesh-ancestor
92568347|NCT00191035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568348|NCT00191035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568349|NCT00191035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568350|NCT00191035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568351|NCT00191035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568353|NCT02922894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92568354|NCT02922894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92568355|NCT02922894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92568356|NCT02922894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568357|NCT02922894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568358|NCT02922894|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92568359|NCT02922894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568360|NCT02922894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568361|NCT02922894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568362|NCT02922894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568363|NCT02922894|Serotonin Agents|serotonin agents|mesh-ancestor
92568364|NCT02922894|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92568365|NCT02922894|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568366|NCT00191230|Carboplatin|carboplatin|mesh-list
92568367|NCT00191230|Gemcitabine|gemcitabine|mesh-list
92568368|NCT00191230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568369|NCT00191230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568370|NCT00191230|Antimetabolites|antimetabolites|mesh-ancestor
92568371|NCT00191230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568372|NCT00191347|Gemcitabine|gemcitabine|mesh-list
92568374|NCT00191347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568375|NCT00191347|Antimetabolites|antimetabolites|mesh-ancestor
92568376|NCT00191347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568385|NCT00191425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92568386|NCT00191425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92568387|NCT00191425|Hormone Antagonists|hormone antagonists|mesh-ancestor
92568388|NCT00191425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568389|NCT00191425|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92568390|NCT00191425|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92568391|NCT00191464|Insulin|insulin|mesh-list
92568392|NCT00191464|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92568393|NCT00191464|Metformin|metformin|mesh-list
92568394|NCT00191464|Insulin Glargine|insulin glargine|mesh-list
92568395|NCT00191464|Insulin Lispro|insulin lispro|mesh-list
92568396|NCT00191464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92568397|NCT00191464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568398|NCT04723030|Paclitaxel|paclitaxel|mesh-list
92568399|NCT04723030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568400|NCT04723030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568401|NCT04723030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568402|NCT04723030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568403|NCT04723030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568404|NCT04723030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568405|NCT00191503|Gemcitabine|gemcitabine|mesh-list
92568406|NCT00191503|Pemetrexed|pemetrexed|mesh-list
92568407|NCT00191503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568408|NCT00191503|Antimetabolites|antimetabolites|mesh-ancestor
92568409|NCT00191503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568410|NCT00191503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568411|NCT00191503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568412|NCT00191503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568413|NCT00191503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568414|NCT00191542|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92568415|NCT00191542|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92568416|NCT00191542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568417|NCT00191542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568418|NCT00191542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568419|NCT00191542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568420|NCT00191542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568421|NCT00191542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568422|NCT00059735|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92534844|NCT00072007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568423|NCT00059735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568424|NCT00059735|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92568425|NCT00059735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568426|NCT00059735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568427|NCT00191581|Insulin|insulin|mesh-list
92568428|NCT00191581|Insulin Lispro|insulin lispro|mesh-list
92568429|NCT00191581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92568430|NCT00191581|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
92568431|NCT00191581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92568432|NCT00191581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568433|NCT00191620|Gemcitabine|gemcitabine|mesh-list
92568434|NCT00191620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568435|NCT00191620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568436|NCT00191620|Antimetabolites|antimetabolites|mesh-ancestor
92568437|NCT00191620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568438|NCT00191659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92568439|NCT00191659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91975740|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92568457|NCT02470299|Analgesics|analgesics|mesh-ancestor
92568458|NCT02470299|Sensory System Agents|sensory system agents|mesh-ancestor
92568459|NCT02470299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568460|NCT02470299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568461|NCT02470299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568462|NCT02470299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568463|NCT02470299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92568464|NCT02470299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568465|NCT02470299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568466|NCT00191737|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92568467|NCT00191737|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92568468|NCT00191737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568469|NCT00191737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568470|NCT00191737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568471|NCT00191737|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568472|NCT00191737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568473|NCT00191737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568474|NCT00191893|Teriparatide|teriparatide|mesh-list
92568475|NCT00191893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92568476|NCT00191893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568477|NCT00191893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92568478|NCT00191932|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92293291|NCT00374621|Isosorbide|isosorbide|mesh-list
92568479|NCT00191932|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92568480|NCT00191932|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568481|NCT00191932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568482|NCT00191932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568483|NCT00191932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568484|NCT00191932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568485|NCT00191932|Analgesics|analgesics|mesh-ancestor
92568486|NCT00191932|Sensory System Agents|sensory system agents|mesh-ancestor
92568487|NCT00191932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568488|NCT00191932|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568489|NCT00191932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568499|NCT00059813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568500|NCT00191971|Gemcitabine|gemcitabine|mesh-list
92568501|NCT00191971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568502|NCT00191971|Antimetabolites|antimetabolites|mesh-ancestor
92568503|NCT00191971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568504|NCT00191971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568505|NCT00047502|Imatinib Mesylate|imatinib mesylate|mesh-list
92568506|NCT00047502|Lonafarnib|lonafarnib|mesh-list
92568507|NCT00047502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357480|NCT03012984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568508|NCT00047502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568509|NCT00047502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568510|NCT00047502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568511|NCT00192049|Gemcitabine|gemcitabine|mesh-list
92568512|NCT00192049|Mitomycins|mitomycins|mesh-list
92568513|NCT00192049|Mitomycin|mitomycin|mesh-list
92568514|NCT00192049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568515|NCT00192049|Antimetabolites|antimetabolites|mesh-ancestor
92534845|NCT00072007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534846|NCT00072007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92568516|NCT00192049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568517|NCT00192049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568518|NCT00192049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92568519|NCT00192049|Alkylating Agents|alkylating agents|mesh-ancestor
92568520|NCT00192049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568521|NCT00192049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568522|NCT00192088|Oxaliplatin|oxaliplatin|mesh-list
92568523|NCT00192088|Pemetrexed|pemetrexed|mesh-list
92568524|NCT00192088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568525|NCT00192088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568526|NCT00192088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568527|NCT00192088|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568528|NCT00192088|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568529|NCT00059852|Gemcitabine|gemcitabine|mesh-list
92568530|NCT00059852|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92568531|NCT00059852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568532|NCT00059852|Antimetabolites|antimetabolites|mesh-ancestor
92568533|NCT00059852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568534|NCT00059852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568535|NCT00059852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568536|NCT00059852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568537|NCT00047580|Tizanidine|tizanidine|mesh-list
92568538|NCT00047580|Analgesics|analgesics|mesh-ancestor
92568539|NCT00047580|Sensory System Agents|sensory system agents|mesh-ancestor
92568540|NCT00047580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568541|NCT00047580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568542|NCT00047580|Anticonvulsants|anticonvulsants|mesh-ancestor
92568543|NCT00047580|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92568544|NCT00047580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92568545|NCT00047580|Parasympatholytics|parasympatholytics|mesh-ancestor
92568546|NCT00047580|Autonomic Agents|autonomic agents|mesh-ancestor
92568547|NCT00047580|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92568548|NCT00047580|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92568549|NCT00047580|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92568550|NCT00047580|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568551|NCT00047580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568552|NCT00047580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568553|NCT02968901|Tadalafil|tadalafil|mesh-list
92568554|NCT02968901|Macitentan|macitentan|mesh-list
92568555|NCT02968901|Vasodilator Agents|vasodilator agents|mesh-ancestor
92568556|NCT02968901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92568557|NCT02968901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91975869|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
92568560|NCT02968901|Urological Agents|urological agents|mesh-ancestor
92568561|NCT02968901|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92568562|NCT02968901|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92568563|NCT02968901|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92568564|NCT00192595|Tenofovir|tenofovir|mesh-list
92568565|NCT00192595|Lamivudine|lamivudine|mesh-list
92568566|NCT00192595|Zidovudine|zidovudine|mesh-list
92568567|NCT00192595|Efavirenz|efavirenz|mesh-list
92568568|NCT00192595|Antiviral Agents|antiviral agents|mesh-ancestor
92568569|NCT00192595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568570|NCT00192595|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92568571|NCT00192595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568572|NCT00192595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568573|NCT00192595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568574|NCT00192595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92568575|NCT00192595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92568576|NCT00192595|Antimetabolites|antimetabolites|mesh-ancestor
92568577|NCT00192595|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92568578|NCT00192595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92568579|NCT00192595|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92568580|NCT00192595|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92568581|NCT00192595|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92568582|NCT00192595|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92568583|NCT00192634|Tenofovir|tenofovir|mesh-list
92568584|NCT00192634|Lamivudine|lamivudine|mesh-list
92568585|NCT00192634|Emtricitabine|emtricitabine|mesh-list
92568586|NCT00192634|Abacavir|abacavir|mesh-list
92568587|NCT00192634|Antiviral Agents|antiviral agents|mesh-ancestor
92534847|NCT00072007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92534848|NCT00072007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92568588|NCT00192634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568589|NCT00192634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92568590|NCT00192634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568591|NCT00192634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568592|NCT00192634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568593|NCT00192634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92568594|NCT00192634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92568595|NCT00192673|Asparaginase|asparaginase|mesh-list
92568596|NCT00192673|Pegaspargase|pegaspargase|mesh-list
92568597|NCT00192673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568598|NCT00192712|Gemcitabine|gemcitabine|mesh-list
92568599|NCT00192712|Irinotecan|irinotecan|mesh-list
92568600|NCT00192712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568601|NCT00192712|Antimetabolites|antimetabolites|mesh-ancestor
92568602|NCT00192712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568603|NCT00192712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568604|NCT00192712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92568605|NCT00192712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568606|NCT00192712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568607|NCT00047658|Interferons|interferons|mesh-list
92568608|NCT00047658|Interferon-gamma|interferon-gamma|mesh-list
92568609|NCT00047658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568610|NCT00047658|Antiviral Agents|antiviral agents|mesh-ancestor
92568611|NCT00047658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568612|NCT00193024|Docetaxel|docetaxel|mesh-list
92568613|NCT00193024|Epirubicin|epirubicin|mesh-list
92568614|NCT00193024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568615|NCT00193024|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568616|NCT00193024|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568617|NCT00193024|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568618|NCT00193024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568619|NCT00193024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92568620|NCT00193024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92568621|NCT00193024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568622|NCT00193024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568623|NCT00193102|Thalidomide|thalidomide|mesh-list
92568624|NCT00193102|Capecitabine|capecitabine|mesh-list
92568625|NCT00193102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568626|NCT00193102|Antimetabolites|antimetabolites|mesh-ancestor
92568627|NCT00193102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568628|NCT00193102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568629|NCT00193102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568630|NCT00193102|Immunologic Factors|immunologic factors|mesh-ancestor
91975928|NCT04873479|Analgesics|analgesics|mesh-ancestor
92568636|NCT00193102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92568638|NCT00193102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92568639|NCT00193141|Paclitaxel|paclitaxel|mesh-list
92568640|NCT00193141|Carboplatin|carboplatin|mesh-list
92568641|NCT00193141|Fluorouracil|fluorouracil|mesh-list
92568642|NCT00193141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568643|NCT00193141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568644|NCT00193141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568645|NCT00193141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568646|NCT00193141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568647|NCT00193141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568648|NCT00193141|Antimetabolites|antimetabolites|mesh-ancestor
92568649|NCT00193141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568650|NCT00193141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568651|NCT00193141|Immunologic Factors|immunologic factors|mesh-ancestor
92568652|NCT00193141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568653|NCT00193297|Paclitaxel|paclitaxel|mesh-list
92568654|NCT00193297|Carboplatin|carboplatin|mesh-list
92568655|NCT00193297|Topotecan|topotecan|mesh-list
92568656|NCT00193297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568657|NCT00193297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568658|NCT00193297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568659|NCT00193297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568660|NCT00193297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568661|NCT00193297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568662|NCT00193297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92568663|NCT00193297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568664|NCT00193297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534849|NCT00072007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92534850|NCT00072007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568665|NCT00193336|Gefitinib|gefitinib|mesh-list
92568666|NCT00193336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568667|NCT00193336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568668|NCT00193336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568669|NCT00193336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568670|NCT00193531|Paclitaxel|paclitaxel|mesh-list
92568671|NCT00193531|Etoposide|etoposide|mesh-list
92568672|NCT00193531|Carboplatin|carboplatin|mesh-list
92568673|NCT00193531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568674|NCT00193531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568675|NCT00193531|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568676|NCT00193531|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568677|NCT00193531|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568678|NCT00193531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568679|NCT00193531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92568680|NCT00193531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568681|NCT00193531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568682|NCT00193570|Docetaxel|docetaxel|mesh-list
92568683|NCT00193570|Topotecan|topotecan|mesh-list
92568684|NCT00193570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568685|NCT00193570|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568686|NCT00193570|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568687|NCT00193570|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568688|NCT00193570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568689|NCT00193570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92568690|NCT00193570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568691|NCT00193570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568692|NCT00047736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92568693|NCT00047736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568694|NCT00047736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92568695|NCT00047736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568696|NCT00047736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568697|NCT00409591|Ritonavir|ritonavir|mesh-list
92568698|NCT00409591|Lopinavir|lopinavir|mesh-list
92568699|NCT00409591|Zidovudine|zidovudine|mesh-list
92568700|NCT00409591|Nevirapine|nevirapine|mesh-list
92568701|NCT00409591|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92568714|NCT00409591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568715|NCT00409591|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92568716|NCT00409591|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92568717|NCT00409630|Fluticasone|fluticasone|mesh-list
92568718|NCT00409630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568719|NCT00409630|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92568720|NCT00409630|Autonomic Agents|autonomic agents|mesh-ancestor
92357499|NCT01896960|Anesthetics, Local|anesthetics, local|mesh-ancestor
92568721|NCT00409630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568722|NCT00409630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568723|NCT00409630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92568724|NCT00409630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92568725|NCT00409630|Dermatologic Agents|dermatologic agents|mesh-ancestor
92568726|NCT00409630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92568727|NCT00060125|Tipifarnib|tipifarnib|mesh-list
92568728|NCT00060125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568729|NCT00193648|Rosiglitazone|rosiglitazone|mesh-list
92568730|NCT00193648|Adalimumab|adalimumab|mesh-list
92568731|NCT00193648|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92568732|NCT00193648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568733|NCT00193648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568734|NCT00193648|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92568735|NCT00193648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568736|NCT00193726|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92568737|NCT00193726|Estradiol|estradiol|mesh-list
92568738|NCT00193726|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92568739|NCT00193726|Estrogens|estrogens|mesh-ancestor
92568740|NCT00193726|Hormones|hormones|mesh-ancestor
92568741|NCT00193726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568742|NCT00193726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568743|NCT00193726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92568744|NCT00193726|Contraceptive Agents|contraceptive agents|mesh-ancestor
92568745|NCT00193726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92568746|NCT00193726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92568747|NCT00193726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92534851|NCT00072007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534852|NCT00072007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357523|NCT04772352|Febuxostat|febuxostat|mesh-list
92568748|NCT00193726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92568749|NCT00193882|Cisplatin|cisplatin|mesh-list
92568750|NCT00193882|Fluorouracil|fluorouracil|mesh-list
92568751|NCT00193882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568752|NCT00193882|Antimetabolites|antimetabolites|mesh-ancestor
92568753|NCT00193882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568754|NCT00193882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568755|NCT00193882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568756|NCT00193882|Immunologic Factors|immunologic factors|mesh-ancestor
92568757|NCT00193882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568758|NCT00060242|Fosbretabulin|fosbretabulin|mesh-list
92568759|NCT00060242|Combretastatin|combretastatin|mesh-list
92568760|NCT00060242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568761|NCT00060242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568762|NCT00060242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568769|NCT00193921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568770|NCT00193921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568772|NCT00193921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568773|NCT00193921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568774|NCT00193921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568775|NCT00193921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568776|NCT00193921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568777|NCT00194038|Aripiprazole|aripiprazole|mesh-list
92568778|NCT00194038|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568779|NCT00194038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568780|NCT00194038|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92568781|NCT00194038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92568782|NCT00194038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92568783|NCT00194038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568784|NCT00194038|Dopamine Agonists|dopamine agonists|mesh-ancestor
92568785|NCT00194038|Dopamine Agents|dopamine agents|mesh-ancestor
92568786|NCT00194038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568787|NCT00194038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568788|NCT00194038|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92568789|NCT00194038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92568790|NCT00194038|Serotonin Agents|serotonin agents|mesh-ancestor
92568791|NCT00194038|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92568792|NCT00194038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92568793|NCT00194038|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92568794|NCT00194038|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92568795|NCT00060359|Paclitaxel|paclitaxel|mesh-list
92568796|NCT00060359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92568797|NCT00060359|Carboplatin|carboplatin|mesh-list
92568798|NCT00060359|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92568799|NCT00060359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568800|NCT00060359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568801|NCT00060359|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568802|NCT00060359|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568803|NCT00060359|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568804|NCT00060359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568805|NCT00194272|Methotrexate|methotrexate|mesh-list
92568806|NCT00194272|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92568807|NCT00194272|Abortifacient Agents|abortifacient agents|mesh-ancestor
92568808|NCT00194272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92568809|NCT00194272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568810|NCT00194272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568811|NCT00194272|Antimetabolites|antimetabolites|mesh-ancestor
92568812|NCT00194272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568813|NCT00194272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568814|NCT00194272|Dermatologic Agents|dermatologic agents|mesh-ancestor
92568815|NCT00194272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568816|NCT00194272|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568817|NCT00194272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568818|NCT00194272|Immunologic Factors|immunologic factors|mesh-ancestor
92568819|NCT00194272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568820|NCT00194272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568821|NCT00398528|Glatiramer Acetate|glatiramer acetate|mesh-list
92568822|NCT00398528|(T,G)-A-L|(t,g)-a-l|mesh-list
92568823|NCT00398528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92568824|NCT00398528|Immunologic Factors|immunologic factors|mesh-ancestor
92534853|NCT00072007|Glucocorticoids|glucocorticoids|mesh-ancestor
92534854|NCT00072007|Hormones|hormones|mesh-ancestor
91918096|NCT02409537|Resveratrol|resveratrol|mesh-list
92568825|NCT00398528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568826|NCT00398528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568827|NCT00398528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568828|NCT00194467|Valganciclovir|valganciclovir|mesh-list
92568829|NCT00194467|Antiviral Agents|antiviral agents|mesh-ancestor
92568830|NCT00194467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568831|NCT00194623|Botulinum Toxins|botulinum toxins|mesh-list
92568832|NCT00194623|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92568833|NCT00194623|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92568834|NCT00194623|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92568835|NCT00194623|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568836|NCT00194623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568837|NCT00194623|Cholinergic Agents|cholinergic agents|mesh-ancestor
92568838|NCT00194623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568839|NCT00194623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568840|NCT00194623|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92568841|NCT00194623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568842|NCT00194740|Docetaxel|docetaxel|mesh-list
92568843|NCT00194740|Vinorelbine|vinorelbine|mesh-list
92568844|NCT00194740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568845|NCT00194740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92568846|NCT00194740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568847|NCT00194740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568848|NCT00194740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568849|NCT00194740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92568850|NCT00194818|Mesalamine|mesalamine|mesh-list
92568851|NCT00194818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92568852|NCT00194818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92568853|NCT00194818|Analgesics|analgesics|mesh-ancestor
92568854|NCT00194818|Sensory System Agents|sensory system agents|mesh-ancestor
92568855|NCT00194818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568856|NCT00194818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568857|NCT00194818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568858|NCT00194818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568859|NCT00194857|Epoetin Alfa|epoetin alfa|mesh-list
92568860|NCT00194857|Hematinics|hematinics|mesh-ancestor
92568861|NCT00194935|Topotecan|topotecan|mesh-list
92568862|NCT00194935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92568863|NCT00194935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92568864|NCT00194935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568865|NCT00194935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568866|NCT00194935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568867|NCT00194974|Clonidine|clonidine|mesh-list
92568868|NCT00194974|Labetalol|labetalol|mesh-list
92568869|NCT00194974|Methyldopa|methyldopa|mesh-list
92568870|NCT00194974|Nifedipine|nifedipine|mesh-list
92568871|NCT00194974|Analgesics|analgesics|mesh-ancestor
92568872|NCT00194974|Sensory System Agents|sensory system agents|mesh-ancestor
92568873|NCT00194974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568874|NCT00194974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568875|NCT00194974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92568876|NCT00194974|Sympatholytics|sympatholytics|mesh-ancestor
92568877|NCT00194974|Autonomic Agents|autonomic agents|mesh-ancestor
92568878|NCT00194974|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92568879|NCT00194974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92568880|NCT00194974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92568881|NCT00194974|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568882|NCT00194974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568883|NCT00194974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568884|NCT00194974|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92568885|NCT00194974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568886|NCT00194974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92568887|NCT00194974|Vasodilator Agents|vasodilator agents|mesh-ancestor
92568888|NCT00194974|Tocolytic Agents|tocolytic agents|mesh-ancestor
92568889|NCT00194974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92568890|NCT00194974|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92568891|NCT00194974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92568892|NCT00194974|Sympathomimetics|sympathomimetics|mesh-ancestor
92568893|NCT00194974|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92568894|NCT00194974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92568895|NCT00195208|Pantoprazole|pantoprazole|mesh-list
92537691|NCT02825979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568896|NCT00195208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92568897|NCT00195208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92568898|NCT00195208|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92568899|NCT00195208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568900|NCT00195208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568901|NCT02963116|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92568902|NCT02963116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92568903|NCT02963116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92568904|NCT02963116|Antimetabolites|antimetabolites|mesh-ancestor
92568905|NCT02963116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568906|NCT02963116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92568909|NCT00195286|Tazobactam|tazobactam|mesh-list
92568910|NCT00195286|Piperacillin|piperacillin|mesh-list
92568911|NCT00195286|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92568912|NCT00195286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568913|NCT00195286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568914|NCT00195286|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92568915|NCT00195286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568916|NCT00195286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568917|NCT00084201|Amoxicillin|amoxicillin|mesh-list
92568918|NCT00084201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568919|NCT00084201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568920|NCT00195364|Etanercept|etanercept|mesh-list
92568921|NCT00195364|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92568922|NCT00195364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92568923|NCT00195364|Analgesics|analgesics|mesh-ancestor
92568924|NCT00195364|Sensory System Agents|sensory system agents|mesh-ancestor
92568925|NCT00195364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568926|NCT00195364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568927|NCT00195364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568928|NCT00195364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568929|NCT00195364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92568930|NCT00195364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568931|NCT00195364|Immunologic Factors|immunologic factors|mesh-ancestor
92568932|NCT00195481|Sirolimus|sirolimus|mesh-list
92568933|NCT00195481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568934|NCT00195481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568935|NCT00195481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92568936|NCT00195481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568937|NCT00195481|Antifungal Agents|antifungal agents|mesh-ancestor
92568938|NCT00195481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92568939|NCT00195481|Immunologic Factors|immunologic factors|mesh-ancestor
92568940|NCT00195481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568941|NCT00195559|Levonorgestrel|levonorgestrel|mesh-list
92568942|NCT00195559|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92568943|NCT00195559|Estradiol|estradiol|mesh-list
92568944|NCT00195559|Estrogens|estrogens|mesh-ancestor
92568945|NCT00195559|Hormones|hormones|mesh-ancestor
92568946|NCT00195559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568947|NCT00195559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568948|NCT00195559|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92568949|NCT00195559|Contraceptive Agents|contraceptive agents|mesh-ancestor
92568950|NCT00195559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92568951|NCT00195559|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92568952|NCT00195559|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92568953|NCT00195559|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92568954|NCT00195559|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92568955|NCT00084240|Azithromycin|azithromycin|mesh-list
92568956|NCT00084240|Chloroquine|chloroquine|mesh-list
92568957|NCT00084240|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92568958|NCT00084240|Pyrimethamine|pyrimethamine|mesh-list
92568959|NCT00084240|Sulfadoxine|sulfadoxine|mesh-list
92568960|NCT00084240|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92568961|NCT00084240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568962|NCT00084240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568963|NCT00084240|Amebicides|amebicides|mesh-ancestor
92568964|NCT00084240|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92568965|NCT00084240|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92568966|NCT00084240|Antimalarials|antimalarials|mesh-ancestor
92568967|NCT00084240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568968|NCT00084240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92568969|NCT00084240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92568970|NCT00084240|Analgesics|analgesics|mesh-ancestor
92534855|NCT00072007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918252|NCT02414529|Vitamin D|vitamin d|mesh-list
92568971|NCT00084240|Sensory System Agents|sensory system agents|mesh-ancestor
92568972|NCT00084240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568973|NCT00084240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568974|NCT00084240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92568975|NCT00084240|Filaricides|filaricides|mesh-ancestor
92568976|NCT00084240|Antinematodal Agents|antinematodal agents|mesh-ancestor
92568977|NCT00084240|Anthelmintics|anthelmintics|mesh-ancestor
92568978|NCT00084240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568979|NCT00084240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976281|NCT03209219|Interferons|interferons|mesh-list
92568985|NCT00195598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568986|NCT00195598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568987|NCT00195598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568988|NCT00195598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568989|NCT00195598|Serotonin Agents|serotonin agents|mesh-ancestor
92568990|NCT00195598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568991|NCT00195598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92568992|NCT00195598|Antidepressive Agents|antidepressive agents|mesh-ancestor
92568993|NCT00195598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92568994|NCT00195598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92568995|NCT00195598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92568996|NCT00195598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568997|NCT00195598|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92568998|NCT00195637|Immunoglobulins|immunoglobulins|mesh-list
92568999|NCT00195637|Antibodies|antibodies|mesh-list
92569000|NCT00195637|gamma-Globulins|gamma-globulins|mesh-list
92569001|NCT00195637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92569002|NCT00195637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92569003|NCT00195637|Immunologic Factors|immunologic factors|mesh-ancestor
92293818|NCT02869451|Bupropion|bupropion|mesh-list
92569004|NCT00195637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569006|NCT00195754|Anticonvulsants|anticonvulsants|mesh-ancestor
92569007|NCT00195754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569008|NCT00195754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569009|NCT00195754|GABA Agents|gaba agents|mesh-ancestor
92569010|NCT00195754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569011|NCT00195754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569012|NCT00195754|Antimanic Agents|antimanic agents|mesh-ancestor
92569013|NCT00195754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569014|NCT00195754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569015|NCT00195754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569016|NCT00195793|Atorvastatin|atorvastatin|mesh-list
92569017|NCT00195793|Ezetimibe|ezetimibe|mesh-list
92569018|NCT00195793|Fenofibrate|fenofibrate|mesh-list
92569019|NCT00195793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92569020|NCT00195793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92569021|NCT00195793|Antimetabolites|antimetabolites|mesh-ancestor
92569022|NCT00195793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569023|NCT00195793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92569024|NCT00195793|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92569025|NCT00195793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569026|NCT00195871|Cytarabine|cytarabine|mesh-list
92569027|NCT00195871|Prednisone|prednisone|mesh-list
92569028|NCT00195871|Cyclophosphamide|cyclophosphamide|mesh-list
92569029|NCT00195871|Methotrexate|methotrexate|mesh-list
92569030|NCT00195871|Etoposide|etoposide|mesh-list
92569031|NCT00195871|Vincristine|vincristine|mesh-list
92569032|NCT00195871|Daunorubicin|daunorubicin|mesh-list
92569033|NCT00195871|Asparaginase|asparaginase|mesh-list
92569034|NCT00195871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569035|NCT00195871|Immunologic Factors|immunologic factors|mesh-ancestor
92569036|NCT00195871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569037|NCT00195871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569038|NCT00195871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92569039|NCT00195871|Alkylating Agents|alkylating agents|mesh-ancestor
92569040|NCT00195871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569041|NCT00195871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569042|NCT00195871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92569043|NCT00195871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569044|NCT00195871|Glucocorticoids|glucocorticoids|mesh-ancestor
92569045|NCT00195871|Hormones|hormones|mesh-ancestor
92620230|NCT02914015|Sensory System Agents|sensory system agents|mesh-ancestor
92569046|NCT00195871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92569047|NCT00195871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92569051|NCT00195871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569053|NCT00195871|Dermatologic Agents|dermatologic agents|mesh-ancestor
92569054|NCT00195871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569055|NCT00195871|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92569056|NCT00195871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92569057|NCT00195871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92569058|NCT00195871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92569059|NCT00195871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569060|NCT00195871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569061|NCT00195871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569062|NCT00195871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569063|NCT00195871|Antiviral Agents|antiviral agents|mesh-ancestor
92569064|NCT00195871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569065|NCT00195871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569066|NCT00195910|Morphine|morphine|mesh-list
92569067|NCT00195910|Hydromorphone|hydromorphone|mesh-list
92569068|NCT00195910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92569069|NCT00195910|Narcotics|narcotics|mesh-ancestor
92569070|NCT00195910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569071|NCT00195910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569072|NCT00195910|Analgesics|analgesics|mesh-ancestor
92569073|NCT00195910|Sensory System Agents|sensory system agents|mesh-ancestor
92569074|NCT00195910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569075|NCT00195988|Mycophenolic Acid|mycophenolic acid|mesh-list
92569076|NCT00195988|Tacrolimus|tacrolimus|mesh-list
92569077|NCT00195988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569078|NCT00195988|Immunologic Factors|immunologic factors|mesh-ancestor
92293884|NCT02871011|Antioxidants|antioxidants|mesh-ancestor
92569079|NCT00195988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569080|NCT00195988|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92569081|NCT00195988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569082|NCT00195988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569083|NCT00195988|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569084|NCT00195988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569085|NCT00195988|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92569086|NCT00195988|Antitubercular Agents|antitubercular agents|mesh-ancestor
92569087|NCT00195988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569088|NCT00195988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569089|NCT00060476|Rofecoxib|rofecoxib|mesh-list
92569090|NCT00060476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92569091|NCT00060476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92569092|NCT00060476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569093|NCT00060476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569094|NCT00060476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92569095|NCT00060476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92569096|NCT00060476|Analgesics|analgesics|mesh-ancestor
92569097|NCT00060476|Sensory System Agents|sensory system agents|mesh-ancestor
92569098|NCT00060476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569099|NCT00060476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569100|NCT00060476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569101|NCT00060476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569102|NCT00084279|Interferons|interferons|mesh-list
92569103|NCT00084279|Ribavirin|ribavirin|mesh-list
92569104|NCT00084279|Interferon-alpha|interferon-alpha|mesh-list
92569105|NCT00084279|Interferon-gamma|interferon-gamma|mesh-list
92569106|NCT00084279|Interferon alfacon-1|interferon alfacon-1|mesh-list
92569107|NCT00084279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569108|NCT00084279|Antiviral Agents|antiviral agents|mesh-ancestor
92569109|NCT00084279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569110|NCT00084279|Antimetabolites|antimetabolites|mesh-ancestor
92569111|NCT00084279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569112|NCT00084279|Immunologic Factors|immunologic factors|mesh-ancestor
92569113|NCT00084279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569114|NCT00196378|Estrogens|estrogens|mesh-list
92569115|NCT00196378|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92569116|NCT00196378|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
92569117|NCT00196378|Estrogens, conjugated synthetic B|estrogens, conjugated synthetic b|mesh-list
92569118|NCT00196378|Hormones|hormones|mesh-ancestor
92569120|NCT00196378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569121|NCT00196417|Heparin|heparin|mesh-list
92569122|NCT00196417|Certoparin|certoparin|mesh-list
92569123|NCT00196417|Anticoagulants|anticoagulants|mesh-ancestor
92569124|NCT00196417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92534856|NCT00072007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92534857|NCT00072007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92534858|NCT00072007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534859|NCT00072007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534860|NCT00072007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569125|NCT00196417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92569126|NCT00196417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569127|NCT00060554|Heparin|heparin|mesh-list
92569128|NCT00060554|PENTA|penta|mesh-list
92569129|NCT00060554|Fondaparinux|fondaparinux|mesh-list
92569130|NCT00060554|Anticoagulants|anticoagulants|mesh-ancestor
92569131|NCT00060554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92569132|NCT00060554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92569133|NCT00060554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569134|NCT00060554|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92569135|NCT00060554|Antithrombins|antithrombins|mesh-ancestor
92569136|NCT00060554|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92569137|NCT00060554|Protease Inhibitors|protease inhibitors|mesh-ancestor
92569138|NCT00060554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569139|NCT00048087|Docetaxel|docetaxel|mesh-list
92569140|NCT00048087|Gefitinib|gefitinib|mesh-list
92569141|NCT00048087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569142|NCT00048087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569143|NCT00048087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569144|NCT00048087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569145|NCT00048087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569146|NCT00048087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569147|NCT00048087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569148|NCT00196534|Thrombin|thrombin|mesh-list
92569149|NCT00196534|Hemostatics|hemostatics|mesh-ancestor
92569150|NCT00196534|Coagulants|coagulants|mesh-ancestor
92569151|NCT00048126|Capecitabine|capecitabine|mesh-list
92569152|NCT00048126|Irinotecan|irinotecan|mesh-list
92569153|NCT00048126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569154|NCT00048126|Antimetabolites|antimetabolites|mesh-ancestor
92569155|NCT00048126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569156|NCT00048126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569157|NCT00048126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92357684|NCT01897428|Analgesics|analgesics|mesh-ancestor
92569158|NCT00048126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569159|NCT00048126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569160|NCT00196612|Emtricitabine|emtricitabine|mesh-list
92569161|NCT00196612|Efavirenz|efavirenz|mesh-list
92569162|NCT00196612|Didanosine|didanosine|mesh-list
92569163|NCT00196612|Antiviral Agents|antiviral agents|mesh-ancestor
92569164|NCT00196612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569165|NCT00196612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92569166|NCT00196612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92569167|NCT00196612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569168|NCT00196612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569169|NCT00196612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92569170|NCT00196612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92569171|NCT00196612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92569172|NCT00196612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92569173|NCT00196612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92569174|NCT00196612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92569175|NCT00196612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92569176|NCT00196612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92569177|NCT00196612|Antimetabolites|antimetabolites|mesh-ancestor
92569178|NCT00196690|Donepezil|donepezil|mesh-list
92569179|NCT00196690|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92569180|NCT00196690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569181|NCT00196690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569182|NCT00196690|Cholinergic Agents|cholinergic agents|mesh-ancestor
92569183|NCT00196690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569184|NCT00196690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569185|NCT00196690|Nootropic Agents|nootropic agents|mesh-ancestor
92569186|NCT00196768|Arsenic Trioxide|arsenic trioxide|mesh-list
92569187|NCT00196768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569188|NCT00084396|Letrozole|letrozole|mesh-list
92569189|NCT00084396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569190|NCT00084396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92534861|NCT00072046|Interferons|interferons|mesh-list
92534862|NCT00072046|Interferon-alpha|interferon-alpha|mesh-list
92534863|NCT00072046|Bevacizumab|bevacizumab|mesh-list
92534864|NCT00072046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569191|NCT00084396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92569192|NCT00084396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569193|NCT00084396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569197|NCT00084396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569199|NCT00196846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92569200|NCT00196846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569201|NCT00060632|Sirolimus|sirolimus|mesh-list
92569202|NCT00060632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569203|NCT00060632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569204|NCT00060632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569205|NCT00060632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569206|NCT00060632|Antifungal Agents|antifungal agents|mesh-ancestor
92569207|NCT00060632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569208|NCT00060632|Immunologic Factors|immunologic factors|mesh-ancestor
92569209|NCT00060632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569210|NCT00196885|Acetylcysteine|acetylcysteine|mesh-list
92569211|NCT00196885|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92569212|NCT00196885|Antiviral Agents|antiviral agents|mesh-ancestor
92569213|NCT00196885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569214|NCT00196885|Expectorants|expectorants|mesh-ancestor
92569215|NCT00196885|Respiratory System Agents|respiratory system agents|mesh-ancestor
92569216|NCT00196885|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92569217|NCT00196885|Antioxidants|antioxidants|mesh-ancestor
92569218|NCT00196885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569219|NCT00196885|Protective Agents|protective agents|mesh-ancestor
92569220|NCT00196885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569221|NCT00196885|Antidotes|antidotes|mesh-ancestor
92569222|NCT00048204|Paroxetine|paroxetine|mesh-list
92569223|NCT00048204|Vestipitant|vestipitant|mesh-list
92569224|NCT00048204|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92569225|NCT00048204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92569226|NCT00048204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569227|NCT00048204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569228|NCT00048204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569229|NCT00048204|Serotonin Agents|serotonin agents|mesh-ancestor
92569230|NCT00048204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569231|NCT00048204|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92569232|NCT00048204|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569234|NCT00048204|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92569235|NCT00048204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92569236|NCT00048204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569237|NCT00048204|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92569238|NCT00197080|Ropinirole|ropinirole|mesh-list
92569239|NCT00197080|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92569240|NCT00197080|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92569241|NCT00197080|Dopamine Agonists|dopamine agonists|mesh-ancestor
92569242|NCT00197080|Dopamine Agents|dopamine agents|mesh-ancestor
92569243|NCT00197080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569244|NCT00197080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569245|NCT00197080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569246|NCT00060671|Rituximab|rituximab|mesh-list
92569247|NCT00060671|Pixantrone|pixantrone|mesh-list
92569248|NCT00060671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569249|NCT00060671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569250|NCT00060671|Immunologic Factors|immunologic factors|mesh-ancestor
92569251|NCT00060671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569252|NCT00060671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569253|NCT00060671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92569254|NCT00060671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569255|NCT00060671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569256|NCT00060671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569257|NCT00197197|Aplaviroc|aplaviroc|mesh-list
92569258|NCT00197197|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92569259|NCT00197197|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92569260|NCT00197197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569261|NCT00197197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92569262|NCT00197197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92569263|NCT00197197|Antiviral Agents|antiviral agents|mesh-ancestor
92569264|NCT00197197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569269|NCT00409903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569270|NCT00084435|Docetaxel|docetaxel|mesh-list
92569271|NCT00084435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569272|NCT00084435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569273|NCT00084435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569274|NCT00084435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569275|NCT00084435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569276|NCT00197353|Bupivacaine|bupivacaine|mesh-list
92569277|NCT00197353|Anesthetics, Local|anesthetics, local|mesh-ancestor
92569278|NCT00197353|Anesthetics|anesthetics|mesh-ancestor
92569279|NCT00197353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569280|NCT00197353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569281|NCT00197353|Sensory System Agents|sensory system agents|mesh-ancestor
92569282|NCT00197353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569283|NCT02962999|Ketamine|ketamine|mesh-list
92569284|NCT02962999|Analgesics|analgesics|mesh-ancestor
92569285|NCT02962999|Sensory System Agents|sensory system agents|mesh-ancestor
92569286|NCT02962999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569287|NCT02962999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569288|NCT02962999|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92569289|NCT02962999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92569290|NCT02962999|Anesthetics, General|anesthetics, general|mesh-ancestor
92569291|NCT02962999|Anesthetics|anesthetics|mesh-ancestor
92569292|NCT02962999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569293|NCT02962999|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92569294|NCT02962999|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92569295|NCT02962999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569296|NCT02962999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569297|NCT00084513|Trastuzumab|trastuzumab|mesh-list
92569298|NCT00084513|Imatinib Mesylate|imatinib mesylate|mesh-list
92569299|NCT00084513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569300|NCT00084513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569301|NCT00084513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569302|NCT00084513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569303|NCT00084513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569304|NCT00084591|Capecitabine|capecitabine|mesh-list
92569305|NCT00084591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569306|NCT00084591|Antimetabolites|antimetabolites|mesh-ancestor
92569307|NCT00084591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569308|NCT00084591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569309|NCT00197548|Folic Acid|folic acid|mesh-list
92569310|NCT00197548|Vitamin B Complex|vitamin b complex|mesh-list
92569311|NCT00197548|Vitamins|vitamins|mesh-ancestor
92569312|NCT00197548|Micronutrients|micronutrients|mesh-ancestor
92569313|NCT00197548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569314|NCT00197548|Hematinics|hematinics|mesh-ancestor
92569315|NCT00197587|Nevirapine|nevirapine|mesh-list
92569316|NCT00197587|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92569317|NCT00197587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92569318|NCT00197587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569319|NCT00197587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569320|NCT00197587|Antiviral Agents|antiviral agents|mesh-ancestor
92569321|NCT00197587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569322|NCT00197587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92569323|NCT00197587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92569324|NCT00197587|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92569325|NCT00197587|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92569326|NCT00197743|Vitamin A|vitamin a|mesh-list
92569327|NCT00197743|Beta Carotene|beta carotene|mesh-list
92569328|NCT00197743|Carotenoids|carotenoids|mesh-list
92569329|NCT00197743|Vitamins|vitamins|mesh-ancestor
92569330|NCT00197743|Micronutrients|micronutrients|mesh-ancestor
92569331|NCT00197743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569332|NCT00197743|Antioxidants|antioxidants|mesh-ancestor
92569333|NCT00197743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569334|NCT00197743|Protective Agents|protective agents|mesh-ancestor
92569335|NCT00197743|Provitamins|provitamins|mesh-ancestor
92569343|NCT00197821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569344|NCT00084669|Zolpidem|zolpidem|mesh-list
92569345|NCT00084669|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92569346|NCT00084669|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92534865|NCT00072046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534866|NCT00072046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92569347|NCT00084669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92569348|NCT00084669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569349|NCT00084669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569350|NCT00084669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569351|NCT00084669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569352|NCT00084669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92569353|NCT00084669|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569355|NCT00084669|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92569356|NCT00084669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92569357|NCT00084669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569358|NCT00084669|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92569359|NCT00084669|GABA Agonists|gaba agonists|mesh-ancestor
92569360|NCT00084669|GABA Agents|gaba agents|mesh-ancestor
92569361|NCT00060866|Propranolol|propranolol|mesh-list
92569362|NCT00060866|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92569363|NCT00060866|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92569364|NCT00060866|Adrenergic Agents|adrenergic agents|mesh-ancestor
92569365|NCT00060866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569366|NCT00060866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569367|NCT00060866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569368|NCT00060866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92569369|NCT00060866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92569370|NCT00060866|Vasodilator Agents|vasodilator agents|mesh-ancestor
92569371|NCT00048360|Bupropion|bupropion|mesh-list
92569372|NCT00048360|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92569373|NCT00048360|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569374|NCT00048360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569375|NCT00048360|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92569376|NCT00048360|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92569377|NCT00048360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704660|NCT04320238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569378|NCT00048360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569379|NCT00048360|Dopamine Agents|dopamine agents|mesh-ancestor
92569380|NCT00048360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569381|NCT00048360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569382|NCT00048360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92569383|NCT00048360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92569384|NCT00048360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569385|NCT00198055|Aripiprazole|aripiprazole|mesh-list
92569386|NCT00198055|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569387|NCT00198055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569388|NCT00198055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92569389|NCT00198055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569390|NCT00198055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569391|NCT00198055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569392|NCT00198055|Dopamine Agonists|dopamine agonists|mesh-ancestor
92569393|NCT00198055|Dopamine Agents|dopamine agents|mesh-ancestor
92569394|NCT00198055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569395|NCT00198055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569396|NCT00198055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92569397|NCT00198055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92569398|NCT00198055|Serotonin Agents|serotonin agents|mesh-ancestor
92569415|NCT00198094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569416|NCT00198094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92569417|NCT00198094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569418|NCT00198094|GABA Modulators|gaba modulators|mesh-ancestor
92569419|NCT00198094|GABA Agents|gaba agents|mesh-ancestor
92569420|NCT00198172|Epirubicin|epirubicin|mesh-list
92569421|NCT00198172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569422|NCT00198172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569423|NCT00198172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92569424|NCT00198172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569425|NCT00198172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569426|NCT00198172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569427|NCT00198250|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92569428|NCT00198250|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92569429|NCT00198250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92534867|NCT00072046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92534868|NCT00072046|Growth Substances|growth substances|mesh-ancestor
91918693|NCT02171455|Protease Inhibitors|protease inhibitors|mesh-ancestor
92569430|NCT00198250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569431|NCT00198250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569432|NCT00198250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569433|NCT00198250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569434|NCT00198250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92569435|NCT00198250|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569436|NCT00198250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569437|NCT00084708|Calcitriol|calcitriol|mesh-list
92569438|NCT00084708|Dexamethasone|dexamethasone|mesh-list
92569439|NCT00084708|Gefitinib|gefitinib|mesh-list
92569440|NCT00084708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569441|NCT00084708|Antiemetics|antiemetics|mesh-ancestor
92569442|NCT00084708|Autonomic Agents|autonomic agents|mesh-ancestor
92569443|NCT00084708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569444|NCT00084708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569445|NCT00084708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569446|NCT00084708|Glucocorticoids|glucocorticoids|mesh-ancestor
92569447|NCT00084708|Hormones|hormones|mesh-ancestor
92569448|NCT00084708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704661|NCT04320238|Antiviral Agents|antiviral agents|mesh-ancestor
92294264|NCT02062177|Midazolam|midazolam|mesh-list
92569449|NCT00084708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92569450|NCT00084708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569451|NCT00084708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569452|NCT00084708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976782|NCT03037593|Vitamin D|vitamin d|mesh-list
92569487|NCT00060905|GABA Agents|gaba agents|mesh-ancestor
92569488|NCT00060905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569489|NCT00060905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569490|NCT00060905|Antimanic Agents|antimanic agents|mesh-ancestor
92569491|NCT00060905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569492|NCT00060905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569493|NCT00060905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569495|NCT00198523|Prednisolone|prednisolone|mesh-list
92569496|NCT00198523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92569497|NCT00198523|Methylprednisolone|methylprednisolone|mesh-list
92569498|NCT00198523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92569499|NCT00198523|Prednisolone acetate|prednisolone acetate|mesh-list
92569500|NCT00198523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92569501|NCT00198523|Prednisolone phosphate|prednisolone phosphate|mesh-list
92569502|NCT00198523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569503|NCT00198523|Glucocorticoids|glucocorticoids|mesh-ancestor
92569504|NCT00198523|Hormones|hormones|mesh-ancestor
92569505|NCT00198523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92569506|NCT00198523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569507|NCT00198523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92569508|NCT00198523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569509|NCT00198523|Antiemetics|antiemetics|mesh-ancestor
92569510|NCT00198523|Autonomic Agents|autonomic agents|mesh-ancestor
92569511|NCT00198523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569512|NCT00198523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569513|NCT00198523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92569514|NCT00198523|Protective Agents|protective agents|mesh-ancestor
92569515|NCT00198523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569516|NCT00198523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569517|NCT00198562|Losartan|losartan|mesh-list
92569518|NCT00198562|Amlodipine|amlodipine|mesh-list
92569519|NCT00198562|Antihypertensive Agents|antihypertensive agents|mesh-list
92569520|NCT00198562|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92569521|NCT00198562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569522|NCT00198562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294331|NCT02877485|Triamcinolone|triamcinolone|mesh-list
92569523|NCT00198562|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92569524|NCT00198562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569525|NCT00198562|Vasodilator Agents|vasodilator agents|mesh-ancestor
92569526|NCT00198562|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92569527|NCT00198562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92569528|NCT00198562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92569529|NCT00409942|Torsemide|torsemide|mesh-list
92569530|NCT00409942|Furosemide|furosemide|mesh-list
92534869|NCT00072046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534870|NCT00072046|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534871|NCT00072046|Antiviral Agents|antiviral agents|mesh-ancestor
92534872|NCT00072046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534873|NCT00072046|Immunologic Factors|immunologic factors|mesh-ancestor
92534874|NCT03959514|Insulin Aspart|insulin aspart|mesh-list
92569531|NCT00409942|Diuretics|diuretics|mesh-ancestor
92569532|NCT00409942|Natriuretic Agents|natriuretic agents|mesh-ancestor
92569533|NCT00409942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569534|NCT00409942|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92569535|NCT00409942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569536|NCT00409942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569537|NCT00409942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92569538|NCT00084786|Docetaxel|docetaxel|mesh-list
92569539|NCT00084786|Gefitinib|gefitinib|mesh-list
92569540|NCT00084786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569541|NCT00084786|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569542|NCT00084786|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569543|NCT00084786|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569544|NCT00084786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569545|NCT00084786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569546|NCT00084786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569547|NCT00409981|Paclitaxel|paclitaxel|mesh-list
91976862|NCT04428879|Topotecan|topotecan|mesh-list
92569551|NCT00409981|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569552|NCT00409981|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569553|NCT00409981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569554|NCT00198601|Gentamicins|gentamicins|mesh-list
92569555|NCT00198601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569556|NCT00198601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569557|NCT00198601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92569558|NCT00198601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569559|NCT00198601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569560|NCT00198640|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92569561|NCT00198640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569562|NCT00198679|Chlorhexidine|chlorhexidine|mesh-list
92569563|NCT00198679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92569564|NCT00198679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569565|NCT00198679|Disinfectants|disinfectants|mesh-ancestor
92569566|NCT00084825|Docetaxel|docetaxel|mesh-list
92569567|NCT00084825|Imatinib Mesylate|imatinib mesylate|mesh-list
92569568|NCT00084825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569569|NCT00084825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569570|NCT00084825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569571|NCT00084825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569572|NCT00084825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153338|NCT03402087|Deucravacitinib|deucravacitinib|mesh-list
92569573|NCT00084825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569574|NCT00084825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569575|NCT00048477|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92569576|NCT00048477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569577|NCT00048477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569578|NCT00199147|Cytarabine|cytarabine|mesh-list
92569579|NCT00199147|Fludarabine|fludarabine|mesh-list
92569580|NCT00199147|Etoposide|etoposide|mesh-list
92569581|NCT00199147|Idarubicin|idarubicin|mesh-list
92569582|NCT00199147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569583|NCT00199147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569584|NCT00199147|Antimetabolites|antimetabolites|mesh-ancestor
92569585|NCT00199147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569586|NCT00199147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569587|NCT00199147|Immunologic Factors|immunologic factors|mesh-ancestor
92569588|NCT00199147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569589|NCT00199147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92569590|NCT00199147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92569591|NCT00199147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569592|NCT00199147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569593|NCT00199147|Antiviral Agents|antiviral agents|mesh-ancestor
92569594|NCT00199147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569595|NCT00199147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569596|NCT00199186|Cytarabine|cytarabine|mesh-list
92569597|NCT00199186|Dexamethasone|dexamethasone|mesh-list
92534875|NCT03959514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92534876|NCT03959514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569598|NCT00199186|Dexamethasone acetate|dexamethasone acetate|mesh-list
92569599|NCT00199186|Cyclophosphamide|cyclophosphamide|mesh-list
92569600|NCT00199186|Methotrexate|methotrexate|mesh-list
92569601|NCT00199186|Vincristine|vincristine|mesh-list
92569602|NCT00199186|Imatinib Mesylate|imatinib mesylate|mesh-list
92569603|NCT00199186|Idarubicin|idarubicin|mesh-list
92569604|NCT00199186|BB 1101|bb 1101|mesh-list
92569605|NCT00199186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569606|NCT00199186|Immunologic Factors|immunologic factors|mesh-ancestor
92569607|NCT00199186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569608|NCT00199186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569609|NCT00199186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92569610|NCT00199186|Alkylating Agents|alkylating agents|mesh-ancestor
92569611|NCT00199186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569612|NCT00199186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569613|NCT00199186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92569614|NCT00199186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569615|NCT00199186|Antiemetics|antiemetics|mesh-ancestor
92569616|NCT00199186|Autonomic Agents|autonomic agents|mesh-ancestor
92569617|NCT00199186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569618|NCT00199186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569619|NCT00199186|Glucocorticoids|glucocorticoids|mesh-ancestor
92569620|NCT00199186|Hormones|hormones|mesh-ancestor
91976927|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92569625|NCT00199186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92569626|NCT00199186|Abortifacient Agents|abortifacient agents|mesh-ancestor
92569627|NCT00199186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92569628|NCT00199186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569629|NCT00199186|Antimetabolites|antimetabolites|mesh-ancestor
92569630|NCT00199186|Dermatologic Agents|dermatologic agents|mesh-ancestor
92569631|NCT00199186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92569632|NCT00199186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92569633|NCT00199186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92569634|NCT00199186|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569635|NCT00199186|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569636|NCT00199186|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569637|NCT00199186|Antiviral Agents|antiviral agents|mesh-ancestor
92569638|NCT00199186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569639|NCT00199186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569640|NCT00199186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569641|NCT00199186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92569642|NCT00199186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569643|NCT00199225|Moxifloxacin|moxifloxacin|mesh-list
92569644|NCT00199225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569645|NCT00199225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569646|NCT00199225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92569647|NCT00199225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92569648|NCT00199225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569649|NCT00199225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569650|NCT00199225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569651|NCT00061022|Disufenton sodium|disufenton sodium|mesh-list
92569652|NCT00061022|Antioxidants|antioxidants|mesh-ancestor
92569653|NCT00061022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569654|NCT00061022|Protective Agents|protective agents|mesh-ancestor
92569655|NCT00061022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569656|NCT00199264|Albaconazole|albaconazole|mesh-list
92569657|NCT00199264|Antifungal Agents|antifungal agents|mesh-ancestor
92569658|NCT00199264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569659|NCT00199342|Ecromeximab|ecromeximab|mesh-list
92569660|NCT00199342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569661|NCT00199342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569662|NCT00199420|Istradefylline|istradefylline|mesh-list
92569663|NCT00199420|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92569664|NCT00199420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92569665|NCT00199420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92569666|NCT00199420|Purinergic Agents|purinergic agents|mesh-ancestor
92569667|NCT00199420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569668|NCT00199420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569669|NCT00199420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569670|NCT00199576|Methylprednisolone|methylprednisolone|mesh-list
92569671|NCT00199576|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92534877|NCT04730596|Dexmedetomidine|dexmedetomidine|mesh-list
92534878|NCT04730596|Ketamine|ketamine|mesh-list
92534879|NCT04730596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91918911|NCT00701883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92569672|NCT00199576|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92569673|NCT00199576|Prednisolone|prednisolone|mesh-list
92294478|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
92569674|NCT00199576|Prednisolone acetate|prednisolone acetate|mesh-list
92569675|NCT00199576|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92569676|NCT00199576|Prednisolone phosphate|prednisolone phosphate|mesh-list
92569677|NCT00199576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569678|NCT00199576|Antiemetics|antiemetics|mesh-ancestor
92569679|NCT00199576|Autonomic Agents|autonomic agents|mesh-ancestor
92569680|NCT00199576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569681|NCT00199576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569682|NCT00199576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569683|NCT00199576|Glucocorticoids|glucocorticoids|mesh-ancestor
92569684|NCT00199576|Hormones|hormones|mesh-ancestor
92569685|NCT00199576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92569686|NCT00199576|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92569687|NCT00199576|Protective Agents|protective agents|mesh-ancestor
92569688|NCT00199576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92569694|NCT00084942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569696|NCT02968394|Omalizumab|omalizumab|mesh-list
92569697|NCT02968394|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92569698|NCT02968394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92569699|NCT02968394|Respiratory System Agents|respiratory system agents|mesh-ancestor
92569700|NCT00199771|Dextrans|dextrans|mesh-list
92569701|NCT00199771|Anticoagulants|anticoagulants|mesh-ancestor
92569702|NCT00199771|Plasma Substitutes|plasma substitutes|mesh-ancestor
92569703|NCT00199771|Blood Substitutes|blood substitutes|mesh-ancestor
92569704|NCT00084981|Decitabine|decitabine|mesh-list
92569705|NCT00084981|Azacitidine|azacitidine|mesh-list
92569706|NCT00084981|Valproic Acid|valproic acid|mesh-list
92569707|NCT00084981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569708|NCT00084981|Antimetabolites|antimetabolites|mesh-ancestor
92569709|NCT00084981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569710|NCT00084981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569711|NCT00084981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569712|NCT00084981|Anticonvulsants|anticonvulsants|mesh-ancestor
92569713|NCT00084981|GABA Agents|gaba agents|mesh-ancestor
92569714|NCT00084981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569715|NCT00084981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569716|NCT00084981|Antimanic Agents|antimanic agents|mesh-ancestor
92569717|NCT00084981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569718|NCT00084981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569719|NCT00084981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569720|NCT00199966|Valproic Acid|valproic acid|mesh-list
92569721|NCT00199966|Anticonvulsants|anticonvulsants|mesh-ancestor
92569722|NCT00199966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569723|NCT00199966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569724|NCT00199966|GABA Agents|gaba agents|mesh-ancestor
92569725|NCT00199966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569726|NCT00199966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569727|NCT00199966|Antimanic Agents|antimanic agents|mesh-ancestor
92569728|NCT00199966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569729|NCT00199966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569730|NCT00199966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569731|NCT00085020|Trastuzumab|trastuzumab|mesh-list
92569732|NCT00085020|Lapatinib|lapatinib|mesh-list
92569733|NCT00085020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569734|NCT00085020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569735|NCT00085020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569736|NCT00085020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569737|NCT00085020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569738|NCT00410215|Bisacodyl|bisacodyl|mesh-list
92569739|NCT00410215|Cathartics|cathartics|mesh-ancestor
92569740|NCT00410215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569741|NCT00410215|Laxatives|laxatives|mesh-ancestor
92569742|NCT00410254|Midazolam|midazolam|mesh-list
92569743|NCT00410254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92569744|NCT00410254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92569745|NCT00410254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569746|NCT00410254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534880|NCT04730596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569747|NCT00410254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92569748|NCT00410254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569749|NCT00410254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569750|NCT00410254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92569751|NCT00410254|Anesthetics, General|anesthetics, general|mesh-ancestor
92569753|NCT00410254|GABA Modulators|gaba modulators|mesh-ancestor
92569754|NCT00410254|GABA Agents|gaba agents|mesh-ancestor
92569755|NCT00410254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569756|NCT00410254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569757|NCT00061178|Bevacizumab|bevacizumab|mesh-list
92569758|NCT00061178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569759|NCT00061178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569760|NCT00061178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92569761|NCT00061178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92569775|NCT00200434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92569776|NCT00200434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92569777|NCT00200434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569778|NCT00200434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569779|NCT00200434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569780|NCT00200473|Nebivolol|nebivolol|mesh-list
92569781|NCT00200473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92569782|NCT00200473|Vasodilator Agents|vasodilator agents|mesh-ancestor
92569783|NCT00200473|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92569784|NCT00200473|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92569785|NCT00200473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92569786|NCT00200473|Adrenergic Agents|adrenergic agents|mesh-ancestor
92569787|NCT00200473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569788|NCT00200473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569789|NCT00200473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569790|NCT02962804|Nivolumab|nivolumab|mesh-list
92569791|NCT02962804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569792|NCT02962804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569793|NCT02962804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92569794|NCT02962804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569795|NCT00048555|Galiximab|galiximab|mesh-list
92569796|NCT00048555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569797|NCT00048555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569798|NCT00200512|Apomorphine|apomorphine|mesh-list
92569799|NCT00200512|Emetics|emetics|mesh-ancestor
92569800|NCT00200512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569801|NCT00200512|Autonomic Agents|autonomic agents|mesh-ancestor
92569802|NCT00200512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569803|NCT00200512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569804|NCT00200512|Dopamine Agonists|dopamine agonists|mesh-ancestor
92569805|NCT00200512|Dopamine Agents|dopamine agents|mesh-ancestor
92569806|NCT00200512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569807|NCT00200512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569808|NCT00200551|Cyclosporine|cyclosporine|mesh-list
92569809|NCT00200551|Mycophenolic Acid|mycophenolic acid|mesh-list
92569810|NCT00200551|Cyclosporins|cyclosporins|mesh-list
92569811|NCT00200551|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92569812|NCT00200551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569813|NCT00200551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569814|NCT00200551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569815|NCT00200551|Immunologic Factors|immunologic factors|mesh-ancestor
92569816|NCT00200551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569817|NCT00200551|Antifungal Agents|antifungal agents|mesh-ancestor
92569818|NCT00200551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569819|NCT00200551|Dermatologic Agents|dermatologic agents|mesh-ancestor
92569820|NCT00200551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569821|NCT00200551|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92569822|NCT00200551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92569830|NCT00061256|Calcium|calcium|mesh-list
92569831|NCT00061256|Vitamins|vitamins|mesh-ancestor
92569832|NCT00061256|Micronutrients|micronutrients|mesh-ancestor
92569833|NCT00061256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569834|NCT00061256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92569835|NCT00061256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92569836|NCT00061256|Antacids|antacids|mesh-ancestor
92569837|NCT00061256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569838|NCT00061256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569839|NCT00200590|Acetaminophen|acetaminophen|mesh-list
92569840|NCT00200590|Morphine|morphine|mesh-list
92534881|NCT04730596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534882|NCT04730596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92569841|NCT00200590|Nalbuphine|nalbuphine|mesh-list
92569842|NCT00200590|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92569843|NCT00200590|Narcotics|narcotics|mesh-ancestor
92569844|NCT00200590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569845|NCT00200590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569846|NCT00200590|Analgesics|analgesics|mesh-ancestor
92569847|NCT00200590|Sensory System Agents|sensory system agents|mesh-ancestor
92569848|NCT00200590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569849|NCT00200590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92569850|NCT00200590|Antipyretics|antipyretics|mesh-ancestor
92569851|NCT00200629|Adenosine|adenosine|mesh-list
92569852|NCT00200629|Analgesics|analgesics|mesh-ancestor
92569853|NCT00200629|Sensory System Agents|sensory system agents|mesh-ancestor
92569854|NCT00200629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569855|NCT00200629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569856|NCT00200629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92569857|NCT00200629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92569858|NCT00200629|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92569859|NCT00200629|Purinergic Agonists|purinergic agonists|mesh-ancestor
92569860|NCT00200629|Purinergic Agents|purinergic agents|mesh-ancestor
92569861|NCT00200629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569862|NCT00200629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569863|NCT00200668|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92569864|NCT00200668|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92569865|NCT00200668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569866|NCT00048594|Aprepitant|aprepitant|mesh-list
92569867|NCT00048594|Antiemetics|antiemetics|mesh-ancestor
92569868|NCT00048594|Autonomic Agents|autonomic agents|mesh-ancestor
92569869|NCT00048594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569870|NCT00048594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569871|NCT00048594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569872|NCT00048594|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92569873|NCT00048594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569874|NCT00048594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569875|NCT00200941|Topiramate|topiramate|mesh-list
92569876|NCT00200941|Anticonvulsants|anticonvulsants|mesh-ancestor
92569877|NCT00200941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92569878|NCT00200941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569879|NCT00201253|Dimercaprol|dimercaprol|mesh-list
92569880|NCT00201253|Chelating Agents|chelating agents|mesh-ancestor
92569881|NCT00201253|Sequestering Agents|sequestering agents|mesh-ancestor
92569882|NCT00201253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569883|NCT00201331|Leucovorin|leucovorin|mesh-list
92569884|NCT00201331|Antidotes|antidotes|mesh-ancestor
92569885|NCT00201331|Protective Agents|protective agents|mesh-ancestor
92569886|NCT00201331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569887|NCT00201331|Vitamin B Complex|vitamin b complex|mesh-ancestor
92569888|NCT00201331|Vitamins|vitamins|mesh-ancestor
92569889|NCT00201331|Micronutrients|micronutrients|mesh-ancestor
92569890|NCT00048672|Imatinib Mesylate|imatinib mesylate|mesh-list
92569891|NCT00048672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569892|NCT00048672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569893|NCT00048672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569894|NCT00048672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569914|NCT00410371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569915|NCT00410371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92569916|NCT00410371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569917|NCT00410371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92569918|NCT00410371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92569919|NCT00410371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569920|NCT00410371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569921|NCT00410371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92569922|NCT00410449|Tocopherols|tocopherols|mesh-list
92569923|NCT00410449|Vitamin E|vitamin e|mesh-list
92569924|NCT00410449|Tocotrienols|tocotrienols|mesh-list
92569925|NCT00410449|alpha-Tocopherol|alpha-tocopherol|mesh-list
92569926|NCT00410449|Antioxidants|antioxidants|mesh-ancestor
92569927|NCT00410449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569928|NCT00410449|Protective Agents|protective agents|mesh-ancestor
92569929|NCT00410449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534884|NCT04730596|Sensory System Agents|sensory system agents|mesh-ancestor
92569931|NCT00410449|Micronutrients|micronutrients|mesh-ancestor
92569932|NCT00061451|Gemcitabine|gemcitabine|mesh-list
92569933|NCT00061451|Pemetrexed|pemetrexed|mesh-list
92569934|NCT00061451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569935|NCT00061451|Antimetabolites|antimetabolites|mesh-ancestor
92569936|NCT00061451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569937|NCT00061451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569938|NCT00061451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569939|NCT00061451|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92569940|NCT00061451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92569941|NCT00410527|Meropenem|meropenem|mesh-list
92569942|NCT00410527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569943|NCT00410527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569944|NCT00048750|Micafungin|micafungin|mesh-list
92569945|NCT00048750|Antifungal Agents|antifungal agents|mesh-ancestor
92569946|NCT00048750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569947|NCT00221416|Aripiprazole|aripiprazole|mesh-list
92569948|NCT00221416|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569949|NCT00221416|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569950|NCT00221416|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92569951|NCT00221416|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91977266|NCT02601573|Ribavirin|ribavirin|mesh-list
92569970|NCT00221494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569972|NCT00221494|Serotonin Agents|serotonin agents|mesh-ancestor
92569973|NCT00221494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569974|NCT00221494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92569975|NCT00221494|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569976|NCT00221494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569977|NCT00221494|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92569978|NCT00221494|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92569979|NCT00221494|Adrenergic Agents|adrenergic agents|mesh-ancestor
92569980|NCT00221494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92569981|NCT00221494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92569982|NCT00221494|Vasodilator Agents|vasodilator agents|mesh-ancestor
92569983|NCT00221611|Baclofen|baclofen|mesh-list
92569984|NCT00221611|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92569985|NCT00221611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569986|NCT00221611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92569987|NCT00221611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569988|NCT00221611|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92569989|NCT00221611|GABA Agonists|gaba agonists|mesh-ancestor
92569990|NCT00221611|GABA Agents|gaba agents|mesh-ancestor
92569991|NCT00221611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569992|NCT00221611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569993|NCT00221650|Ribavirin|ribavirin|mesh-list
92569994|NCT00221650|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92569995|NCT00221650|Antimetabolites|antimetabolites|mesh-ancestor
92569996|NCT00221650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569997|NCT00221650|Antiviral Agents|antiviral agents|mesh-ancestor
92569998|NCT00221650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92569999|NCT00221689|Baclofen|baclofen|mesh-list
92570000|NCT00221689|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92570001|NCT00221689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570002|NCT00221689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92570003|NCT00221689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570004|NCT00221689|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92570018|NCT00412789|Tubulin Modulators|tubulin modulators|mesh-ancestor
92570019|NCT00412789|Antimitotic Agents|antimitotic agents|mesh-ancestor
92570020|NCT00412789|Mitosis Modulators|mitosis modulators|mesh-ancestor
92570021|NCT00412789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570022|NCT00048828|Olanzapine|olanzapine|mesh-list
92570023|NCT00048828|Clozapine|clozapine|mesh-list
92570024|NCT00048828|Antiemetics|antiemetics|mesh-ancestor
92570025|NCT00048828|Autonomic Agents|autonomic agents|mesh-ancestor
92570026|NCT00048828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570027|NCT00048828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570028|NCT00048828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570029|NCT00048828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570030|NCT00048828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570031|NCT00048828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570032|NCT00048828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570033|NCT00048828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92570034|NCT00048828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92534885|NCT04730596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534886|NCT04730596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92534887|NCT04730596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92534888|NCT04730596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92534889|NCT04730596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92570035|NCT00048828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570036|NCT00048828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570037|NCT00048828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570038|NCT00048828|Serotonin Agents|serotonin agents|mesh-ancestor
92570039|NCT00048828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92570040|NCT00048828|GABA Antagonists|gaba antagonists|mesh-ancestor
92570041|NCT00048828|GABA Agents|gaba agents|mesh-ancestor
92570042|NCT00061529|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92570043|NCT00061529|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92570044|NCT00061529|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92570045|NCT00061529|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570046|NCT00061529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92570047|NCT00061529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92570048|NCT00061529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92570049|NCT00061529|Adrenergic Agents|adrenergic agents|mesh-ancestor
92570050|NCT00061529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570051|NCT00061529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570052|NCT00061529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570053|NCT00221845|Telmisartan|telmisartan|mesh-list
92570054|NCT00221845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570055|NCT00221845|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92570056|NCT00221845|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92570057|NCT00221845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570058|NCT00085761|Capsaicin|capsaicin|mesh-list
92570059|NCT00085761|Antipruritics|antipruritics|mesh-ancestor
92570060|NCT00085761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92570061|NCT00085761|Sensory System Agents|sensory system agents|mesh-ancestor
92570062|NCT00085761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570063|NCT00085761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570064|NCT00221962|Aripiprazole|aripiprazole|mesh-list
92570065|NCT00221962|Antidepressive Agents|antidepressive agents|mesh-ancestor
92570069|NCT00221962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570070|NCT00221962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570072|NCT00221962|Dopamine Agents|dopamine agents|mesh-ancestor
92570073|NCT00221962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570074|NCT00221962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570075|NCT00221962|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92570076|NCT00221962|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92570077|NCT00221962|Serotonin Agents|serotonin agents|mesh-ancestor
92570078|NCT00221962|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92570079|NCT00221962|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92570080|NCT00221962|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92570081|NCT00221962|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92570082|NCT02968160|Telmisartan|telmisartan|mesh-list
92570083|NCT02968160|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92570084|NCT02968160|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92570085|NCT02968160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92570086|NCT02968160|Antimetabolites|antimetabolites|mesh-ancestor
92570087|NCT02968160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570088|NCT02968160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92570089|NCT02968160|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92570090|NCT02968160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570091|NCT02968160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570092|NCT02968160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92570093|NCT02968160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92570094|NCT00222079|Esomeprazole|esomeprazole|mesh-list
92570095|NCT00222079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92570096|NCT00222079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570097|NCT00222079|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92570098|NCT00222079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570099|NCT00222079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570100|NCT00222235|Cycloserine|cycloserine|mesh-list
92570101|NCT00222235|Glycine|glycine|mesh-list
92570102|NCT00222235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92570103|NCT00222235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570104|NCT00222235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92570105|NCT00222235|Antitubercular Agents|antitubercular agents|mesh-ancestor
92570106|NCT00222235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92570107|NCT00222235|Antimetabolites|antimetabolites|mesh-ancestor
92570108|NCT00222235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570109|NCT00222235|Glycine Agents|glycine agents|mesh-ancestor
92570110|NCT00222235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570111|NCT00222235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570112|NCT00061646|Carboplatin|carboplatin|mesh-list
92570113|NCT00061646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570114|NCT00222469|Bevacizumab|bevacizumab|mesh-list
92570115|NCT00222469|Gemcitabine|gemcitabine|mesh-list
92570116|NCT00222469|Oxaliplatin|oxaliplatin|mesh-list
92570117|NCT00222469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92570118|NCT00222469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570119|NCT00222469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92570120|NCT00222469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92570121|NCT00222469|Growth Substances|growth substances|mesh-ancestor
92570122|NCT00222469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570123|NCT00222469|Growth Inhibitors|growth inhibitors|mesh-ancestor
92570124|NCT00222469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92570125|NCT00222469|Antimetabolites|antimetabolites|mesh-ancestor
92704662|NCT04320238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570126|NCT00222469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570127|NCT00222547|Vitamin A|vitamin a|mesh-list
92570128|NCT00222547|Albendazole|albendazole|mesh-list
92570129|NCT00222547|Vitamins|vitamins|mesh-ancestor
92570130|NCT00222547|Micronutrients|micronutrients|mesh-ancestor
92570131|NCT00222547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570132|NCT00222547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570133|NCT00222547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570134|NCT00222547|Anthelmintics|anthelmintics|mesh-ancestor
91977437|NCT04352439|Aspirin|aspirin|mesh-list
92570155|NCT02968082|Mydriatics|mydriatics|mesh-ancestor
92570156|NCT02968082|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92570157|NCT02968082|Cholinergic Agents|cholinergic agents|mesh-ancestor
92570158|NCT02968082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570159|NCT02968082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570160|NCT02968082|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92570161|NCT02968082|Parasympatholytics|parasympatholytics|mesh-ancestor
92570162|NCT00222820|Escitalopram|escitalopram|mesh-list
92570163|NCT00222820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92570164|NCT00222820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357717|NCT02505750|Capecitabine|capecitabine|mesh-list
92570165|NCT00222820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570166|NCT00222820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570167|NCT00222820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570168|NCT00222820|Serotonin Agents|serotonin agents|mesh-ancestor
92570169|NCT00222820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570170|NCT00085332|Docetaxel|docetaxel|mesh-list
92570171|NCT00085332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570172|NCT00085332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92570173|NCT00085332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92570174|NCT00085332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92570175|NCT00085332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570176|NCT00222976|Naproxen|naproxen|mesh-list
92570177|NCT00222976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92570178|NCT00222976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570179|NCT00222976|Analgesics|analgesics|mesh-ancestor
92570180|NCT00222976|Sensory System Agents|sensory system agents|mesh-ancestor
92570181|NCT00222976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570182|NCT00222976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570183|NCT00222976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570184|NCT00222976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570185|NCT00222976|Gout Suppressants|gout suppressants|mesh-ancestor
92570186|NCT00222976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92570187|NCT00222976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570188|NCT00222976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570189|NCT00223015|Tacrolimus|tacrolimus|mesh-list
92570202|NCT00223054|Sirolimus|sirolimus|mesh-list
92570203|NCT00223054|Everolimus|everolimus|mesh-list
92570204|NCT00223054|Tacrolimus|tacrolimus|mesh-list
92534891|NCT04730596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534892|NCT04730596|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92570205|NCT00223054|Cyclosporins|cyclosporins|mesh-list
92570206|NCT00223054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570207|NCT00223054|Immunologic Factors|immunologic factors|mesh-ancestor
92570208|NCT00223054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570209|NCT00223054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92570210|NCT00223054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570211|NCT00223054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570212|NCT00223054|Antifungal Agents|antifungal agents|mesh-ancestor
92570213|NCT00223054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570214|NCT00223054|Dermatologic Agents|dermatologic agents|mesh-ancestor
92570215|NCT00223054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570216|NCT00223054|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92570217|NCT00223054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92570218|NCT00223054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570219|NCT00223054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92570220|NCT00223054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92570221|NCT00223210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92570222|NCT00223210|Antidepressive Agents|antidepressive agents|mesh-ancestor
92570223|NCT00223210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570224|NCT00223210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570225|NCT00223210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570226|NCT00223210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570227|NCT00223210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570228|NCT00061802|Risperidone|risperidone|mesh-list
92570229|NCT00061802|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92570230|NCT00061802|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92570231|NCT00061802|Serotonin Agents|serotonin agents|mesh-ancestor
92570232|NCT00061802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570233|NCT00061802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570234|NCT00061802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570235|NCT00061802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570236|NCT00061802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570237|NCT00061802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570238|NCT00061802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570239|NCT00061802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92570240|NCT00061802|Dopamine Agents|dopamine agents|mesh-ancestor
92570241|NCT00061802|Antidepressive Agents|antidepressive agents|mesh-ancestor
92570242|NCT00223249|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92570243|NCT00223249|Antidepressive Agents|antidepressive agents|mesh-ancestor
92570244|NCT00223249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570245|NCT00223249|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570246|NCT00223249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570247|NCT00223249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570248|NCT00223249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570249|NCT00223288|Escitalopram|escitalopram|mesh-list
92570250|NCT00223288|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92570251|NCT00223288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91977559|NCT03206411|Hormones|hormones|mesh-list
92570254|NCT00223288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570255|NCT00223288|Serotonin Agents|serotonin agents|mesh-ancestor
92570256|NCT00223288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570257|NCT00085449|Cyclosporine|cyclosporine|mesh-list
92570258|NCT00085449|Mycophenolic Acid|mycophenolic acid|mesh-list
92570259|NCT00085449|Fludarabine|fludarabine|mesh-list
92570260|NCT00085449|Fludarabine phosphate|fludarabine phosphate|mesh-list
92570261|NCT00085449|Melphalan|melphalan|mesh-list
92570262|NCT00085449|Alemtuzumab|alemtuzumab|mesh-list
92570263|NCT00085449|Cyclosporins|cyclosporins|mesh-list
92570264|NCT00085449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570265|NCT00085449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92570266|NCT00085449|Antimetabolites|antimetabolites|mesh-ancestor
92570267|NCT00085449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570268|NCT00085449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570269|NCT00085449|Immunologic Factors|immunologic factors|mesh-ancestor
92570270|NCT00085449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570271|NCT00085449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570272|NCT00085449|Antifungal Agents|antifungal agents|mesh-ancestor
92570273|NCT00085449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570274|NCT00085449|Dermatologic Agents|dermatologic agents|mesh-ancestor
92570275|NCT00085449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534893|NCT04730596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92534894|NCT04730596|Anesthetics, General|anesthetics, general|mesh-ancestor
92534895|NCT04730596|Anesthetics|anesthetics|mesh-ancestor
92534896|NCT04730596|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92570276|NCT00085449|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92704663|NCT04320238|Immunologic Factors|immunologic factors|mesh-ancestor
92570277|NCT00085449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92570278|NCT00085449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92570279|NCT00085449|Antitubercular Agents|antitubercular agents|mesh-ancestor
92570280|NCT00085449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92570281|NCT00085449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92570282|NCT00085449|Alkylating Agents|alkylating agents|mesh-ancestor
92570283|NCT00085449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92570284|NCT00085449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92570285|NCT00223561|Methylphenidate|methylphenidate|mesh-list
92570286|NCT00223561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92570287|NCT00223561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570288|NCT00223561|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92570289|NCT00223561|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92570290|NCT00223561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570291|NCT00223561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570292|NCT00223561|Dopamine Agents|dopamine agents|mesh-ancestor
92570293|NCT00223561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570294|NCT00223639|Topiramate|topiramate|mesh-list
92570295|NCT00223639|Anticonvulsants|anticonvulsants|mesh-ancestor
92570296|NCT00223639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92570297|NCT00223639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570298|NCT00223717|Aspirin|aspirin|mesh-list
92570299|NCT00223717|Losartan|losartan|mesh-list
92570300|NCT00223717|Metoprolol|metoprolol|mesh-list
92570301|NCT00223717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92570302|NCT00223717|Clonidine|clonidine|mesh-list
92570303|NCT00223717|Eplerenone|eplerenone|mesh-list
92570304|NCT00223717|Nebivolol|nebivolol|mesh-list
92570305|NCT00223717|Bosentan|bosentan|mesh-list
92570306|NCT00223717|Diltiazem|diltiazem|mesh-list
92570307|NCT00223717|Guanfacine|guanfacine|mesh-list
92570308|NCT00223717|Prazosin|prazosin|mesh-list
92570309|NCT00223717|Hydralazine|hydralazine|mesh-list
92570310|NCT00223717|Captopril|captopril|mesh-list
92570311|NCT00223717|Nifedipine|nifedipine|mesh-list
92570312|NCT00223717|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92570313|NCT00223717|Sildenafil Citrate|sildenafil citrate|mesh-list
92570314|NCT00223717|Nitroglycerin|nitroglycerin|mesh-list
92570315|NCT00223717|Dipyridamole|dipyridamole|mesh-list
92570316|NCT00223717|Carbidopa|carbidopa|mesh-list
92570317|NCT00223717|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92570318|NCT00223717|Tamsulosin|tamsulosin|mesh-list
92570319|NCT00223717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92570320|NCT00223717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570321|NCT00223717|Analgesics|analgesics|mesh-ancestor
92570322|NCT00223717|Sensory System Agents|sensory system agents|mesh-ancestor
92570323|NCT00223717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570324|NCT00223717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570325|NCT00223717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570326|NCT00223717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570327|NCT00223717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92570338|NCT00223717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92570339|NCT00223717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570340|NCT00223717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92570341|NCT00223717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92570342|NCT00223717|Diuretics|diuretics|mesh-ancestor
92570343|NCT00223717|Natriuretic Agents|natriuretic agents|mesh-ancestor
92570344|NCT00223717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92570345|NCT00223717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570346|NCT00223717|Sympatholytics|sympatholytics|mesh-ancestor
92570347|NCT00223717|Autonomic Agents|autonomic agents|mesh-ancestor
92570348|NCT00223717|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92570349|NCT00223717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92570350|NCT00223717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92570351|NCT00223717|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295147|NCT02389088|Letrozole|letrozole|mesh-list
92570352|NCT00223717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570353|NCT00223717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92534897|NCT04730596|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92534898|NCT00072085|Aldesleukin|aldesleukin|mesh-list
92570354|NCT00223717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92570355|NCT00223717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92570356|NCT00223717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92570357|NCT00223717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92570358|NCT00223717|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92570359|NCT00223717|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92570360|NCT00223717|Dopamine Agents|dopamine agents|mesh-ancestor
92570361|NCT00223717|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92570362|NCT00223717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92570363|NCT00223717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92570364|NCT00223717|Tocolytic Agents|tocolytic agents|mesh-ancestor
92570365|NCT00223717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92570366|NCT00223717|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92570367|NCT00223717|Hormone Antagonists|hormone antagonists|mesh-ancestor
92570368|NCT00223717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92570369|NCT00223717|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92570370|NCT00223717|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92570371|NCT00223717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92570372|NCT00223717|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92570373|NCT00223717|Hemostatics|hemostatics|mesh-ancestor
92570374|NCT00223717|Coagulants|coagulants|mesh-ancestor
92570375|NCT00223717|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92570376|NCT00223717|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92570377|NCT00223717|Protease Inhibitors|protease inhibitors|mesh-ancestor
92570378|NCT00061919|Thalidomide|thalidomide|mesh-list
92570379|NCT00061919|Carboplatin|carboplatin|mesh-list
92570380|NCT00061919|Etoposide|etoposide|mesh-list
92570381|NCT00061919|Etoposide phosphate|etoposide phosphate|mesh-list
92570382|NCT00061919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570383|NCT00061919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92570384|NCT00061919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92570385|NCT00061919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92570386|NCT00061919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570387|NCT00061919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570388|NCT00061919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570390|NCT00061919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570391|NCT00061919|Leprostatic Agents|leprostatic agents|mesh-ancestor
92570392|NCT00061919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92570393|NCT00061919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570394|NCT00061919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92570395|NCT00061919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92570396|NCT00061919|Growth Substances|growth substances|mesh-ancestor
92570397|NCT00061919|Growth Inhibitors|growth inhibitors|mesh-ancestor
92570398|NCT00085527|Romidepsin|romidepsin|mesh-list
92570399|NCT00085527|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92570400|NCT00085527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570401|NCT00085527|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92570402|NCT00085527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570403|NCT00085527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570404|NCT00061958|Arsenic Trioxide|arsenic trioxide|mesh-list
92570405|NCT00061958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570406|NCT00224068|Ferric gluconate|ferric gluconate|mesh-list
92570407|NCT00224068|Hematinics|hematinics|mesh-ancestor
92570408|NCT00224146|Oxybutynin|oxybutynin|mesh-list
92570409|NCT00224146|Parasympatholytics|parasympatholytics|mesh-ancestor
92570410|NCT00224146|Autonomic Agents|autonomic agents|mesh-ancestor
92570411|NCT00224146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570412|NCT00224146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570413|NCT00224146|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92570414|NCT00224146|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92570415|NCT00224146|Cholinergic Agents|cholinergic agents|mesh-ancestor
92570416|NCT00224146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570417|NCT00224146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570418|NCT00224146|Urological Agents|urological agents|mesh-ancestor
92570419|NCT00061997|Inositol|inositol|mesh-list
92570420|NCT00061997|Vitamin B Complex|vitamin b complex|mesh-ancestor
92570421|NCT00061997|Vitamins|vitamins|mesh-ancestor
92570422|NCT00061997|Micronutrients|micronutrients|mesh-ancestor
92570423|NCT00061997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570424|NCT00224185|Dimercaprol|dimercaprol|mesh-list
92570425|NCT00224185|Chelating Agents|chelating agents|mesh-ancestor
92534900|NCT00072085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919569|NCT03538327|Silybin|silybin|mesh-list
92570426|NCT00224185|Sequestering Agents|sequestering agents|mesh-ancestor
92570427|NCT00224185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570428|NCT00062036|Aldesleukin|aldesleukin|mesh-list
92570430|NCT00062036|Fludarabine|fludarabine|mesh-list
92570431|NCT00062036|Fludarabine phosphate|fludarabine phosphate|mesh-list
92570432|NCT00062036|Interleukin-2|interleukin-2|mesh-list
92570433|NCT00062036|Freund's Adjuvant|freund's adjuvant|mesh-list
92570434|NCT00062036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570435|NCT00062036|Immunologic Factors|immunologic factors|mesh-ancestor
92570436|NCT00062036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570437|NCT00062036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570438|NCT00062036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92570439|NCT00062036|Alkylating Agents|alkylating agents|mesh-ancestor
92570440|NCT00062036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570441|NCT00062036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570442|NCT00062036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92570443|NCT00062036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92570444|NCT00062036|Antimetabolites|antimetabolites|mesh-ancestor
92570445|NCT00062036|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92570446|NCT00062036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570447|NCT00062036|Analgesics|analgesics|mesh-ancestor
92570448|NCT00062036|Sensory System Agents|sensory system agents|mesh-ancestor
92570449|NCT00062036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570450|NCT00062036|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92570451|NCT00062036|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92570452|NCT00062036|Antiviral Agents|antiviral agents|mesh-ancestor
92570453|NCT00062036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570454|NCT00224302|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92570455|NCT00224302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92570456|NCT00224302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92570457|NCT00224302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570458|NCT00224302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570459|NCT00224302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570460|NCT00224302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570461|NCT00224302|Analgesics|analgesics|mesh-ancestor
92570462|NCT00224302|Sensory System Agents|sensory system agents|mesh-ancestor
92570463|NCT00224302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977769|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
92570467|NCT00062075|Romidepsin|romidepsin|mesh-list
92570468|NCT00062075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92570469|NCT00062075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570470|NCT00062075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92570471|NCT00062075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570472|NCT00062075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570473|NCT00224419|Nicotine|nicotine|mesh-list
92570474|NCT00224419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92570475|NCT00224419|Autonomic Agents|autonomic agents|mesh-ancestor
92570476|NCT00224419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570477|NCT00224419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570478|NCT00224419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92570479|NCT00224419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92570480|NCT00224419|Cholinergic Agents|cholinergic agents|mesh-ancestor
92570481|NCT00224419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570482|NCT00224419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570483|NCT00224458|Efavirenz|efavirenz|mesh-list
92570484|NCT00224458|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92570485|NCT00224458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92570486|NCT00224458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92570487|NCT00224458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570488|NCT00224458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570489|NCT00224458|Antiviral Agents|antiviral agents|mesh-ancestor
92570490|NCT00224458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570491|NCT00224458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92570492|NCT00224458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92570493|NCT00224458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92570494|NCT00224458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92570495|NCT00224458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92259660|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
92570496|NCT00224458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92570497|NCT00224458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92570498|NCT00224458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92570499|NCT00062114|Rituximab|rituximab|mesh-list
92570500|NCT00062114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92570501|NCT00062114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570502|NCT00062114|Immunologic Factors|immunologic factors|mesh-ancestor
92570503|NCT00062114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570504|NCT00062114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570505|NCT00095043|Gaboxadol|gaboxadol|mesh-list
92570506|NCT00095043|Analgesics|analgesics|mesh-ancestor
92570507|NCT00095043|Sensory System Agents|sensory system agents|mesh-ancestor
92570508|NCT00095043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570509|NCT00095043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570510|NCT00095043|Anticonvulsants|anticonvulsants|mesh-ancestor
92570511|NCT00095043|GABA Agonists|gaba agonists|mesh-ancestor
92570512|NCT00095043|GABA Agents|gaba agents|mesh-ancestor
92570513|NCT00095043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570514|NCT00095043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570515|NCT00095082|Insulin|insulin|mesh-list
92570516|NCT00095082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92570517|NCT00095082|Insulin Glargine|insulin glargine|mesh-list
92570518|NCT00095082|Insulin Aspart|insulin aspart|mesh-list
92570519|NCT00095082|Insulin Detemir|insulin detemir|mesh-list
92570520|NCT00095082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92570521|NCT00095082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570522|NCT00062231|Amoxicillin|amoxicillin|mesh-list
92570523|NCT00062231|Moxifloxacin|moxifloxacin|mesh-list
92570524|NCT00062231|Ciprofloxacin|ciprofloxacin|mesh-list
92570525|NCT00062231|Clavulanic Acid|clavulanic acid|mesh-list
92570526|NCT00062231|Clavulanic Acids|clavulanic acids|mesh-list
92570527|NCT00062231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92570528|NCT00062231|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92570529|NCT00062231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92570530|NCT00062231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570531|NCT00062231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92570532|NCT00062231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92570533|NCT00062231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570534|NCT00062231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570537|NCT00062231|Contraceptive Agents|contraceptive agents|mesh-ancestor
92570538|NCT00062231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92570539|NCT00062231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570540|NCT00062231|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92570541|NCT00062231|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92570542|NCT00062231|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92570543|NCT00062231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92570544|NCT00062231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92570545|NCT00062231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92570546|NCT00224692|Ketamine|ketamine|mesh-list
92570547|NCT00224692|Analgesics|analgesics|mesh-ancestor
92570548|NCT00224692|Sensory System Agents|sensory system agents|mesh-ancestor
92570549|NCT00224692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570550|NCT00224692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570551|NCT00224692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92570552|NCT00224692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92570553|NCT00224692|Anesthetics, General|anesthetics, general|mesh-ancestor
92570554|NCT00224692|Anesthetics|anesthetics|mesh-ancestor
92570555|NCT00224692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570556|NCT00224692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92570557|NCT00224692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92570558|NCT00224692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570559|NCT00224692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570560|NCT00224809|Aspirin|aspirin|mesh-list
92570561|NCT00224809|Spironolactone|spironolactone|mesh-list
92570562|NCT00224809|Clopidogrel|clopidogrel|mesh-list
92570563|NCT00224809|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92570564|NCT00224809|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92570565|NCT00224809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92570566|NCT00224809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92570567|NCT00224809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570568|NCT00224809|Analgesics|analgesics|mesh-ancestor
92570569|NCT00224809|Sensory System Agents|sensory system agents|mesh-ancestor
92570570|NCT00224809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92534901|NCT00072085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92534902|NCT00072085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92534903|NCT00072085|Antiviral Agents|antiviral agents|mesh-ancestor
92534904|NCT00072085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534905|NCT00072085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92534906|NCT00072085|Immunologic Factors|immunologic factors|mesh-ancestor
92570571|NCT00224809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570572|NCT00224809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570573|NCT00224809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570574|NCT00224809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92295381|NCT02049307|Losartan|losartan|mesh-list
92570576|NCT00224809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570577|NCT00224809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92570578|NCT00224809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92570579|NCT00224809|Antipyretics|antipyretics|mesh-ancestor
92570580|NCT00224809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92570581|NCT00224809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92570582|NCT00224809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92570583|NCT00224809|Purinergic Agents|purinergic agents|mesh-ancestor
92570584|NCT00224809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570585|NCT00224809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92570586|NCT00224809|Hormone Antagonists|hormone antagonists|mesh-ancestor
92570587|NCT00224809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92570588|NCT00224809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92570589|NCT00224809|Diuretics|diuretics|mesh-ancestor
92570590|NCT00224809|Natriuretic Agents|natriuretic agents|mesh-ancestor
92570591|NCT00224809|Protease Inhibitors|protease inhibitors|mesh-ancestor
92570592|NCT00062270|Gemcitabine|gemcitabine|mesh-list
92570593|NCT00062270|Docetaxel|docetaxel|mesh-list
92570594|NCT00062270|Gefitinib|gefitinib|mesh-list
92570595|NCT00062270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570596|NCT00062270|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92570597|NCT00062270|Antimetabolites|antimetabolites|mesh-ancestor
92570598|NCT00062270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570599|NCT00062270|Tubulin Modulators|tubulin modulators|mesh-ancestor
92570600|NCT00062270|Antimitotic Agents|antimitotic agents|mesh-ancestor
92570601|NCT00062270|Mitosis Modulators|mitosis modulators|mesh-ancestor
92570602|NCT00062270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92570603|NCT00062270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570604|NCT00413023|Casopitant|casopitant|mesh-list
92570605|NCT00413023|Antiemetics|antiemetics|mesh-ancestor
91977925|NCT03195257|Glucagon|glucagon|mesh-list
92570611|NCT00413023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570612|NCT00413023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570613|NCT00095277|Darbepoetin alfa|darbepoetin alfa|mesh-list
92570614|NCT00095277|Hematinics|hematinics|mesh-ancestor
92570615|NCT00413101|Epoetin Alfa|epoetin alfa|mesh-list
92570616|NCT00413101|Hematinics|hematinics|mesh-ancestor
92570617|NCT00413179|Metformin|metformin|mesh-list
92570618|NCT00413179|Clomiphene|clomiphene|mesh-list
92570619|NCT00413179|Enclomiphene|enclomiphene|mesh-list
92570620|NCT00413179|Zuclomiphene|zuclomiphene|mesh-list
92570621|NCT00413179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92570622|NCT00413179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570623|NCT00413179|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92570624|NCT00413179|Hormone Antagonists|hormone antagonists|mesh-ancestor
92570625|NCT00413179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92570626|NCT00413179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92570627|NCT00413179|Fertility Agents|fertility agents|mesh-ancestor
92570628|NCT00413179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92570629|NCT00413179|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92570630|NCT00413179|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92570631|NCT00413257|Nefopam|nefopam|mesh-list
92570632|NCT00413257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570633|NCT00413257|Analgesics|analgesics|mesh-ancestor
92570634|NCT00413257|Sensory System Agents|sensory system agents|mesh-ancestor
92570635|NCT00413257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570636|NCT00413257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570637|NCT00095316|Caspofungin|caspofungin|mesh-list
92570638|NCT00095316|Antifungal Agents|antifungal agents|mesh-ancestor
92570639|NCT00095316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570640|NCT00095316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570641|NCT00095316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570642|NCT00225043|Phenylephrine|phenylephrine|mesh-list
92570643|NCT00225043|Epinephrine|epinephrine|mesh-list
92570644|NCT00225043|Oxymetazoline|oxymetazoline|mesh-list
92570645|NCT00225043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92570646|NCT00225043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92570647|NCT00225043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92570648|NCT00225043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570649|NCT00225043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570650|NCT00225043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570651|NCT00225043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92570652|NCT00225043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92570653|NCT00225043|Autonomic Agents|autonomic agents|mesh-ancestor
92570654|NCT00225043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570655|NCT00225043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92570656|NCT00225043|Respiratory System Agents|respiratory system agents|mesh-ancestor
92570657|NCT00225043|Mydriatics|mydriatics|mesh-ancestor
92570658|NCT00225043|Sympathomimetics|sympathomimetics|mesh-ancestor
92570659|NCT00225043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92570660|NCT00225043|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92570661|NCT00225043|Nasal Decongestants|nasal decongestants|mesh-ancestor
92570662|NCT00225043|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92570663|NCT00225043|Protective Agents|protective agents|mesh-ancestor
92570664|NCT00095355|Valproic Acid|valproic acid|mesh-list
92570665|NCT00095355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570666|NCT00095355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570667|NCT00095355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570668|NCT00095355|Antimanic Agents|antimanic agents|mesh-ancestor
92570669|NCT00095355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570670|NCT00095355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570671|NCT00095355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570672|NCT00095355|Anticonvulsants|anticonvulsants|mesh-ancestor
92570673|NCT00095355|GABA Agents|gaba agents|mesh-ancestor
92570674|NCT00095355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570675|NCT00225160|Acetylcarnitine|acetylcarnitine|mesh-list
92570676|NCT00225160|Vitamin B Complex|vitamin b complex|mesh-ancestor
92570682|NCT00225238|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92570683|NCT00225238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570684|NCT00225238|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92570685|NCT00225238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570686|NCT00225238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570688|NCT00062426|Bevacizumab|bevacizumab|mesh-list
92570689|NCT00062426|Fluorouracil|fluorouracil|mesh-list
92570690|NCT00062426|Capecitabine|capecitabine|mesh-list
92570691|NCT00062426|Oxaliplatin|oxaliplatin|mesh-list
92570692|NCT00062426|Calcium|calcium|mesh-list
92570693|NCT00062426|Levoleucovorin|levoleucovorin|mesh-list
92570694|NCT00062426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92570695|NCT00062426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570696|NCT00062426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92570697|NCT00062426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92570698|NCT00062426|Growth Substances|growth substances|mesh-ancestor
92570699|NCT00062426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570700|NCT00062426|Growth Inhibitors|growth inhibitors|mesh-ancestor
92570701|NCT00062426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92570702|NCT00062426|Antimetabolites|antimetabolites|mesh-ancestor
92570703|NCT00062426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570704|NCT00062426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92570705|NCT00062426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570706|NCT00062426|Immunologic Factors|immunologic factors|mesh-ancestor
92570707|NCT00062426|Antidotes|antidotes|mesh-ancestor
92570708|NCT00062426|Protective Agents|protective agents|mesh-ancestor
92570709|NCT00062426|Vitamin B Complex|vitamin b complex|mesh-ancestor
92570710|NCT00062426|Vitamins|vitamins|mesh-ancestor
92570711|NCT00062426|Micronutrients|micronutrients|mesh-ancestor
92570712|NCT00095433|Ranibizumab|ranibizumab|mesh-list
92570713|NCT00095433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92570714|NCT00095433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92570715|NCT00095433|Growth Substances|growth substances|mesh-ancestor
92570716|NCT00095433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570717|NCT00095433|Growth Inhibitors|growth inhibitors|mesh-ancestor
92570718|NCT00095433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570719|NCT00225355|Rosiglitazone|rosiglitazone|mesh-list
92570720|NCT00225355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92534909|NCT04730674|Lidocaine|lidocaine|mesh-list
92534910|NCT04730674|Anesthetics, Local|anesthetics, local|mesh-ancestor
92534911|NCT04730674|Anesthetics|anesthetics|mesh-ancestor
92534912|NCT04730674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570721|NCT00225355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570722|NCT00225433|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92570723|NCT00225433|Ganirelix|ganirelix|mesh-list
92570724|NCT00225433|Hormones|hormones|mesh-ancestor
92570725|NCT00225433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92570726|NCT00225433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570727|NCT00225433|Hormone Antagonists|hormone antagonists|mesh-ancestor
92570728|NCT00095472|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92570729|NCT00095472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570730|NCT00095472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570731|NCT02962258|Amlodipine|amlodipine|mesh-list
92570732|NCT02962258|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92570733|NCT02962258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570734|NCT02962258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92570735|NCT02962258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570736|NCT02962258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570737|NCT02962258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92570738|NCT02962258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570739|NCT02962258|Vasodilator Agents|vasodilator agents|mesh-ancestor
92570740|NCT02962258|Diuretics|diuretics|mesh-ancestor
92570741|NCT02962258|Natriuretic Agents|natriuretic agents|mesh-ancestor
92570742|NCT02962258|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92570743|NCT00225511|Milnacipran|milnacipran|mesh-list
92570744|NCT00225511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92570745|NCT00225511|Levomilnacipran|levomilnacipran|mesh-list
92570746|NCT00225511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92570747|NCT00225511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92570753|NCT00225511|Antidepressive Agents|antidepressive agents|mesh-ancestor
92570754|NCT00225511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570755|NCT00225511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570757|NCT00225511|Sensory System Agents|sensory system agents|mesh-ancestor
92570758|NCT00225511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570759|NCT00095511|Aripiprazole|aripiprazole|mesh-list
92570760|NCT00095511|Antidepressive Agents|antidepressive agents|mesh-ancestor
92570761|NCT00095511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570762|NCT00095511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570763|NCT00095511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570764|NCT00095511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570765|NCT00095511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570766|NCT00095511|Dopamine Agonists|dopamine agonists|mesh-ancestor
92570767|NCT00095511|Dopamine Agents|dopamine agents|mesh-ancestor
92570768|NCT00095511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570769|NCT00095511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570770|NCT00095511|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92570771|NCT00095511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92570772|NCT00095511|Serotonin Agents|serotonin agents|mesh-ancestor
92570773|NCT00095511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92570774|NCT00095511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92570775|NCT00095511|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92570776|NCT00095511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92570777|NCT00225589|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92570778|NCT00225589|Calcium|calcium|mesh-list
92570779|NCT00225589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92570780|NCT00225589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570781|NCT00225589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92570782|NCT00225589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92570783|NCT00225589|Antimetabolites|antimetabolites|mesh-ancestor
92570784|NCT00225589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570785|NCT00225589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92570786|NCT00225589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92570787|NCT00225589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570788|NCT02967887|Fluorouracil|fluorouracil|mesh-list
92570789|NCT02967887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570790|NCT02967887|Antimetabolites|antimetabolites|mesh-ancestor
92534913|NCT04730674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534914|NCT04730674|Sensory System Agents|sensory system agents|mesh-ancestor
92534915|NCT04730674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570791|NCT02967887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570792|NCT02967887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92570793|NCT02967887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570794|NCT02967887|Immunologic Factors|immunologic factors|mesh-ancestor
92570795|NCT02967887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570796|NCT00225667|Irbesartan|irbesartan|mesh-list
92570797|NCT00225667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570798|NCT00225667|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92295604|NCT04652414|Prednisone|prednisone|mesh-list
92570799|NCT00225667|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92570800|NCT00225667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570801|NCT00225706|Ibuprofen|ibuprofen|mesh-list
92570802|NCT00225706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92570803|NCT00225706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570804|NCT00225706|Analgesics|analgesics|mesh-ancestor
92570805|NCT00225706|Sensory System Agents|sensory system agents|mesh-ancestor
92570806|NCT00225706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570807|NCT00225706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570808|NCT00225706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570809|NCT00225706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570810|NCT00225706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92570811|NCT00225706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978135|NCT04790331|Verapamil|verapamil|mesh-list
92570831|NCT00095706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92570832|NCT00095706|Growth Substances|growth substances|mesh-ancestor
92570833|NCT00095706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570834|NCT00095706|Growth Inhibitors|growth inhibitors|mesh-ancestor
92570835|NCT00225901|Mitogens|mitogens|mesh-list
92570836|NCT00225901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92570837|NCT00225901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570838|NCT00225979|Octreotide|octreotide|mesh-list
92570839|NCT00225979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570840|NCT00225979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92570841|NCT00225979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570842|NCT02967731|Mometasone Furoate|mometasone furoate|mesh-list
92570843|NCT02967731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570844|NCT02967731|Dermatologic Agents|dermatologic agents|mesh-ancestor
92570845|NCT02967731|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92570846|NCT00095745|Aripiprazole|aripiprazole|mesh-list
92570847|NCT00095745|Antidepressive Agents|antidepressive agents|mesh-list
92570848|NCT00095745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570849|NCT00095745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570850|NCT00095745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570851|NCT00095745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570852|NCT00095745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570853|NCT00095745|Dopamine Agonists|dopamine agonists|mesh-ancestor
92570854|NCT00095745|Dopamine Agents|dopamine agents|mesh-ancestor
92570855|NCT00095745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570856|NCT00095745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570857|NCT00095745|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92570858|NCT00095745|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92570859|NCT00095745|Serotonin Agents|serotonin agents|mesh-ancestor
92570860|NCT00095745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92570861|NCT00095745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92570862|NCT00095745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92570863|NCT00095745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92570864|NCT00226096|Metoprolol|metoprolol|mesh-list
92570865|NCT00226096|Clonidine|clonidine|mesh-list
92570866|NCT00226096|Nitroprusside|nitroprusside|mesh-list
92570882|NCT00226096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92570883|NCT00226096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92570884|NCT00226096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92570885|NCT00226096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92570886|NCT00226096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570887|NCT00226096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570888|NCT00226096|Analgesics|analgesics|mesh-ancestor
92570889|NCT00226096|Sensory System Agents|sensory system agents|mesh-ancestor
92570890|NCT00226096|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92534916|NCT04730674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92534917|NCT04730674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92534918|NCT04730674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92570891|NCT00226096|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92570892|NCT00226096|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92570893|NCT00226096|Vasodilator Agents|vasodilator agents|mesh-ancestor
92570894|NCT00226096|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92570895|NCT00226096|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92570896|NCT00226096|Protective Agents|protective agents|mesh-ancestor
92570897|NCT00226096|Sympathomimetics|sympathomimetics|mesh-ancestor
92570898|NCT00226096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92570899|NCT00226096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92570900|NCT00226096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92570901|NCT00226096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570902|NCT00226096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92570903|NCT00226096|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92570904|NCT00226096|Serotonin Agents|serotonin agents|mesh-ancestor
92570905|NCT00226096|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92570906|NCT00226096|Protease Inhibitors|protease inhibitors|mesh-ancestor
92570907|NCT00226096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570908|NCT00226135|Lamotrigine|lamotrigine|mesh-list
92570909|NCT00226135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570910|NCT00226135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570911|NCT00226135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570912|NCT00226135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570913|NCT00226135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570914|NCT00226135|Anticonvulsants|anticonvulsants|mesh-ancestor
92570915|NCT00226135|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92570916|NCT00226135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570917|NCT00226135|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92570918|NCT00226135|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570919|NCT00226135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92570920|NCT00400374|Celecoxib|celecoxib|mesh-list
92570921|NCT00400374|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92570922|NCT00400374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570923|NCT00400374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92570924|NCT00400374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570925|NCT00400374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570926|NCT00400374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92570927|NCT00400374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570940|NCT00075426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570941|NCT00226408|Interferons|interferons|mesh-list
92570942|NCT00226408|Interferon-alpha|interferon-alpha|mesh-list
92570943|NCT00226408|Interferon alpha-2|interferon alpha-2|mesh-list
92570944|NCT00226408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570945|NCT00226408|Antiviral Agents|antiviral agents|mesh-ancestor
92570946|NCT00226408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570947|NCT00226408|Immunologic Factors|immunologic factors|mesh-ancestor
92570948|NCT00226408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570949|NCT00226447|Interferons|interferons|mesh-list
92570950|NCT00226447|Lamivudine|lamivudine|mesh-list
92570951|NCT00226447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570952|NCT00226447|Antiviral Agents|antiviral agents|mesh-ancestor
92570953|NCT00226447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570954|NCT00226447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92570955|NCT00226447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92570956|NCT00226447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570957|NCT00226447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570958|NCT00226447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92570959|NCT00226447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92570960|NCT00062660|Tipranavir|tipranavir|mesh-list
92570961|NCT00062660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92570962|NCT00062660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92570963|NCT00062660|Antiviral Agents|antiviral agents|mesh-ancestor
92570964|NCT00062660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570965|NCT00413296|Levetiracetam|levetiracetam|mesh-list
92570966|NCT00413296|Anticonvulsants|anticonvulsants|mesh-ancestor
92570967|NCT00413296|Nootropic Agents|nootropic agents|mesh-ancestor
92570968|NCT00413452|Etanercept|etanercept|mesh-list
92570969|NCT00413452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92570970|NCT00413452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92570971|NCT00413452|Analgesics|analgesics|mesh-ancestor
92357780|NCT00038610|Dexamethasone|dexamethasone|mesh-list
92534919|NCT04730674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570972|NCT00413452|Sensory System Agents|sensory system agents|mesh-ancestor
92570973|NCT00413452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570974|NCT00413452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570975|NCT00413452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570976|NCT00413452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570977|NCT00413452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570978|NCT00413452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570979|NCT00413452|Immunologic Factors|immunologic factors|mesh-ancestor
92570981|NCT00095823|Antidepressive Agents|antidepressive agents|mesh-list
92570982|NCT00095823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570983|NCT00095823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570984|NCT00095823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570985|NCT00095823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92570986|NCT00095823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570987|NCT00095823|Dopamine Agonists|dopamine agonists|mesh-ancestor
92570988|NCT00095823|Dopamine Agents|dopamine agents|mesh-ancestor
92570989|NCT00095823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570990|NCT00095823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570991|NCT00095823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92570992|NCT00095823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92570995|NCT00095823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92570996|NCT00095823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92570997|NCT00095823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92570998|NCT00226564|Alfentanil|alfentanil|mesh-list
92570999|NCT00226564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92571000|NCT00226564|Narcotics|narcotics|mesh-ancestor
92571001|NCT00226564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571002|NCT00226564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571003|NCT00226564|Analgesics|analgesics|mesh-ancestor
92571004|NCT00226564|Sensory System Agents|sensory system agents|mesh-ancestor
92571005|NCT00226564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571006|NCT00226564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92571007|NCT00226564|Anesthetics, General|anesthetics, general|mesh-ancestor
92571008|NCT00226564|Anesthetics|anesthetics|mesh-ancestor
92571009|NCT00062699|Calcitriol|calcitriol|mesh-list
92571010|NCT00062699|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92571011|NCT00062699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571012|NCT00062699|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92571013|NCT00062699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571014|NCT00062699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571015|NCT00062699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92571016|NCT00062699|Vitamins|vitamins|mesh-ancestor
92571017|NCT00062699|Micronutrients|micronutrients|mesh-ancestor
92571018|NCT00062699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92571019|NCT00226798|Capecitabine|capecitabine|mesh-list
92571020|NCT00226798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92571021|NCT00226798|Antimetabolites|antimetabolites|mesh-ancestor
92571022|NCT00226798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571023|NCT00226798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295831|NCT02397265|Insulin|insulin|mesh-list
92571024|NCT00399243|Sumatriptan|sumatriptan|mesh-list
92571025|NCT00399243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92571026|NCT00399243|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92571027|NCT00399243|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92571028|NCT00399243|Serotonin Agents|serotonin agents|mesh-ancestor
92571029|NCT00399243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571030|NCT00399243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571031|NCT00399243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571032|NCT00226837|Nitrous Oxide|nitrous oxide|mesh-list
92571033|NCT00226837|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92571034|NCT00226837|Anesthetics, General|anesthetics, general|mesh-ancestor
92571035|NCT00226837|Anesthetics|anesthetics|mesh-ancestor
92571036|NCT00226837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571037|NCT00226837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571038|NCT00226837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92571039|NCT00226837|Analgesics|analgesics|mesh-ancestor
92571040|NCT00226837|Sensory System Agents|sensory system agents|mesh-ancestor
92571041|NCT00226837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571042|NCT00226915|Paclitaxel|paclitaxel|mesh-list
92571043|NCT00226915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92571044|NCT00226915|Carboplatin|carboplatin|mesh-list
92571045|NCT00226915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92571046|NCT00226915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571047|NCT00226915|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571048|NCT00226915|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571049|NCT00226915|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571050|NCT00226915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571051|NCT00095862|Interferons|interferons|mesh-list
92571052|NCT00095862|Interferon-alpha|interferon-alpha|mesh-list
92571053|NCT00095862|Cyclophosphamide|cyclophosphamide|mesh-list
92571054|NCT00095862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571055|NCT00095862|Immunologic Factors|immunologic factors|mesh-ancestor
92571056|NCT00095862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571057|NCT00095862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571058|NCT00095862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92571059|NCT00095862|Alkylating Agents|alkylating agents|mesh-ancestor
92571060|NCT00095862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571061|NCT00095862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571062|NCT00095862|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92571063|NCT00095862|Antiviral Agents|antiviral agents|mesh-ancestor
92571064|NCT00095862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571082|NCT00062894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571083|NCT00227188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92571084|NCT00227188|Immunologic Factors|immunologic factors|mesh-ancestor
92571085|NCT00227188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571087|NCT00096057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92571088|NCT00096057|Immunologic Factors|immunologic factors|mesh-ancestor
92571089|NCT00096057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571090|NCT00227461|Levetiracetam|levetiracetam|mesh-list
92571091|NCT00227461|Anticonvulsants|anticonvulsants|mesh-ancestor
92571092|NCT00227461|Nootropic Agents|nootropic agents|mesh-ancestor
92571093|NCT00227500|Pravastatin|pravastatin|mesh-list
92571094|NCT00227500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92571095|NCT00227500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92571096|NCT00227500|Antimetabolites|antimetabolites|mesh-ancestor
92571097|NCT00227500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571098|NCT00227500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92571099|NCT00227500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92571100|NCT00227500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571101|NCT00096096|Mycophenolic Acid|mycophenolic acid|mesh-list
92571102|NCT00096096|Tacrolimus|tacrolimus|mesh-list
92571103|NCT00096096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571104|NCT00096096|Immunologic Factors|immunologic factors|mesh-ancestor
92571105|NCT00096096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571106|NCT00096096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92571107|NCT00096096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571108|NCT00096096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571109|NCT00096096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571110|NCT00096096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571111|NCT00096096|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92571112|NCT00096096|Antitubercular Agents|antitubercular agents|mesh-ancestor
92571113|NCT00096096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571114|NCT00096096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571115|NCT04721899|Vitamin D|vitamin d|mesh-list
92571116|NCT04721899|Vitamins|vitamins|mesh-ancestor
92571117|NCT04721899|Micronutrients|micronutrients|mesh-ancestor
92571118|NCT04721899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571119|NCT04721899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92571120|NCT00062972|Donepezil|donepezil|mesh-list
91978472|NCT05612451|Calcium|calcium|mesh-list
92571126|NCT00062972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571127|NCT00062972|Nootropic Agents|nootropic agents|mesh-ancestor
92571128|NCT00227656|Interferons|interferons|mesh-list
92571129|NCT00227656|Interferon-alpha|interferon-alpha|mesh-list
92571130|NCT00227656|Interferon alpha-2|interferon alpha-2|mesh-list
92571131|NCT00227656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92571132|NCT00227656|Capecitabine|capecitabine|mesh-list
92571133|NCT00227656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92571134|NCT00227656|Antimetabolites|antimetabolites|mesh-ancestor
92571135|NCT00227656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571136|NCT00227656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571137|NCT00227656|Antiviral Agents|antiviral agents|mesh-ancestor
92571138|NCT00227656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571139|NCT00227656|Immunologic Factors|immunologic factors|mesh-ancestor
92571140|NCT00227656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534920|NCT04730674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571141|NCT00227695|Rituximab|rituximab|mesh-list
92571142|NCT00227695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92571143|NCT00227695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571144|NCT00227695|Immunologic Factors|immunologic factors|mesh-ancestor
92571145|NCT00227695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571146|NCT00227695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571147|NCT00227734|Capecitabine|capecitabine|mesh-list
92571148|NCT00227734|Oxaliplatin|oxaliplatin|mesh-list
92571149|NCT00227734|Cetuximab|cetuximab|mesh-list
92571150|NCT00227734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92571151|NCT00227734|Antimetabolites|antimetabolites|mesh-ancestor
92571152|NCT00227734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571153|NCT00227734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571154|NCT00227734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92571155|NCT00063011|Calcium|calcium|mesh-list
92571156|NCT00063011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92571157|NCT00063011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571158|NCT00227773|Octreotide|octreotide|mesh-list
92571159|NCT00227773|Hormones|hormones|mesh-list
92571160|NCT00227773|Somatostatin|somatostatin|mesh-list
92571161|NCT00227773|Mitogens|mitogens|mesh-list
92571162|NCT00227773|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92571163|NCT00227773|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92571164|NCT00227773|Vatalanib|vatalanib|mesh-list
92571165|NCT00227773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571166|NCT00227773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571167|NCT00227773|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571168|NCT00227773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571169|NCT00227773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92571170|NCT00227773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92571171|NCT00227773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571172|NCT00227773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92571173|NCT00227812|Bupropion|bupropion|mesh-list
92571174|NCT00227812|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92571175|NCT00227812|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571177|NCT00227812|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92571178|NCT00227812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92571179|NCT00227812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571180|NCT00227812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571181|NCT00227812|Dopamine Agents|dopamine agents|mesh-ancestor
92571182|NCT00227812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571183|NCT00227812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571184|NCT00227812|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92571185|NCT00227812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92571186|NCT00227812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571187|NCT00096291|Paclitaxel|paclitaxel|mesh-list
92571188|NCT00096291|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92571189|NCT00096291|Doxorubicin|doxorubicin|mesh-list
92571190|NCT00096291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92571196|NCT00096291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571197|NCT00096291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571198|NCT00096291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92571199|NCT00096291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92571200|NCT00096291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571201|NCT02967302|Triamcinolone|triamcinolone|mesh-list
92571202|NCT02967302|Morphine|morphine|mesh-list
92571203|NCT02967302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92571204|NCT02967302|Narcotics|narcotics|mesh-ancestor
92571205|NCT02967302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571206|NCT02967302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571207|NCT02967302|Analgesics|analgesics|mesh-ancestor
92571208|NCT02967302|Sensory System Agents|sensory system agents|mesh-ancestor
92357843|NCT02187354|Blinatumomab|blinatumomab|mesh-list
92571209|NCT02967302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571210|NCT02967302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571211|NCT02967302|Glucocorticoids|glucocorticoids|mesh-ancestor
92571212|NCT02967302|Hormones|hormones|mesh-ancestor
92571213|NCT02967302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571214|NCT00096330|Folic Acid|folic acid|mesh-list
92571215|NCT00096330|Hematinics|hematinics|mesh-ancestor
92571216|NCT00096330|Vitamin B Complex|vitamin b complex|mesh-ancestor
92571217|NCT00096330|Vitamins|vitamins|mesh-ancestor
92571218|NCT00096330|Micronutrients|micronutrients|mesh-ancestor
92534922|NCT04730674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571219|NCT00096330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571220|NCT02962492|Dapagliflozin|dapagliflozin|mesh-list
92571221|NCT02962492|Exenatide|exenatide|mesh-list
92571222|NCT02962492|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92571223|NCT02962492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571224|NCT02962492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571225|NCT02962492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571226|NCT02962492|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92571227|NCT02962492|Incretins|incretins|mesh-ancestor
92571228|NCT02962492|Hormones|hormones|mesh-ancestor
92571229|NCT02962492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571230|NCT00096369|Tamoxifen|tamoxifen|mesh-list
92571231|NCT00096369|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92571232|NCT00096369|Hormone Antagonists|hormone antagonists|mesh-ancestor
92571233|NCT00096369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571234|NCT00096369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571235|NCT00096369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92571236|NCT00096369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571237|NCT00096369|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92571238|NCT00096369|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92571239|NCT00096369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92571240|NCT00228007|Antidepressive Agents|antidepressive agents|mesh-list
92571241|NCT00228007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571242|NCT00228046|Valproic Acid|valproic acid|mesh-list
92571243|NCT00228046|Methylphenidate|methylphenidate|mesh-list
92571244|NCT00228046|Amphetamine|amphetamine|mesh-list
92571245|NCT00228046|Dextroamphetamine|dextroamphetamine|mesh-list
92571246|NCT00228046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92571247|NCT00228046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571248|NCT00228046|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92571249|NCT00228046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92571250|NCT00228046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571251|NCT00228046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571252|NCT00228046|Dopamine Agents|dopamine agents|mesh-ancestor
92571253|NCT00228046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571254|NCT00228046|Sympathomimetics|sympathomimetics|mesh-ancestor
92571255|NCT00228046|Autonomic Agents|autonomic agents|mesh-ancestor
92571256|NCT00228046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571257|NCT00228046|Adrenergic Agents|adrenergic agents|mesh-ancestor
92571258|NCT00228046|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92571259|NCT00228046|Anticonvulsants|anticonvulsants|mesh-ancestor
92571260|NCT00228046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571265|NCT00228046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571266|NCT00063089|Immunoglobulins|immunoglobulins|mesh-list
92571267|NCT00063089|Antibodies|antibodies|mesh-list
92571268|NCT00063089|gamma-Globulins|gamma-globulins|mesh-list
92571269|NCT00063089|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92571270|NCT00063089|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92571271|NCT00063089|Immunologic Factors|immunologic factors|mesh-ancestor
92571272|NCT00063089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571273|NCT00228163|Teriflunomide|teriflunomide|mesh-list
92571274|NCT00228163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92571275|NCT00228163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92571276|NCT00228163|Analgesics|analgesics|mesh-ancestor
92571277|NCT00228163|Sensory System Agents|sensory system agents|mesh-ancestor
92571278|NCT00228163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571279|NCT00228163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571280|NCT00228163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571281|NCT00228163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571282|NCT00228163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571283|NCT00228163|Immunologic Factors|immunologic factors|mesh-ancestor
92571284|NCT00063128|Insulin|insulin|mesh-list
92571285|NCT00063128|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92571286|NCT00063128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571287|NCT00063128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571288|NCT00075465|Docetaxel|docetaxel|mesh-list
92571289|NCT00075465|Epirubicin|epirubicin|mesh-list
92571290|NCT00075465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571291|NCT00075465|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571292|NCT00075465|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571293|NCT00075465|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534923|NCT04730674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92534924|NCT04730674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534925|NCT03959436|Carbetocin|carbetocin|mesh-list
92571294|NCT00075465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571295|NCT00075465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571296|NCT00075465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92571297|NCT00075465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92571298|NCT00075465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571299|NCT00228319|Vitamins|vitamins|mesh-list
92571300|NCT00228319|Ascorbic Acid|ascorbic acid|mesh-list
92571301|NCT00228319|Vitamin E|vitamin e|mesh-list
92571302|NCT00228319|Vitamin A|vitamin a|mesh-list
92571303|NCT00228319|Carboplatin|carboplatin|mesh-list
92571304|NCT00228319|Carotenoids|carotenoids|mesh-list
92571305|NCT00228319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571306|NCT00228319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571307|NCT00228319|Micronutrients|micronutrients|mesh-ancestor
92357935|NCT00254592|Paclitaxel|paclitaxel|mesh-list
92571308|NCT00228319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571309|NCT00228319|Antioxidants|antioxidants|mesh-ancestor
92571310|NCT00228319|Protective Agents|protective agents|mesh-ancestor
92571311|NCT00096525|Lenalidomide|lenalidomide|mesh-list
92571312|NCT00096525|Immunologic Factors|immunologic factors|mesh-ancestor
92571313|NCT00096525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571314|NCT00096525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92571315|NCT00096525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92571316|NCT00096525|Growth Substances|growth substances|mesh-ancestor
92571317|NCT00096525|Growth Inhibitors|growth inhibitors|mesh-ancestor
92571318|NCT00096525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571319|NCT00228358|Cyclophosphamide|cyclophosphamide|mesh-list
92571320|NCT00228358|Interleukin-2|interleukin-2|mesh-list
92571321|NCT00228358|Denileukin diftitox|denileukin diftitox|mesh-list
92296151|NCT02362321|Hormones|hormones|mesh-ancestor
92571322|NCT00228358|Immunotoxins|immunotoxins|mesh-list
92571323|NCT00228358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571324|NCT00228358|Immunologic Factors|immunologic factors|mesh-ancestor
92571325|NCT00228358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571326|NCT00228358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571327|NCT00228358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92571328|NCT00228358|Alkylating Agents|alkylating agents|mesh-ancestor
92571329|NCT00228358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571330|NCT00228358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571331|NCT00228358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92571332|NCT00228358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92571333|NCT00228358|Analgesics|analgesics|mesh-ancestor
91978668|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571337|NCT00228397|Temsirolimus|temsirolimus|mesh-list
92571338|NCT00228397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92571339|NCT00228397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92571340|NCT00228397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571341|NCT00228397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571342|NCT00228397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571343|NCT00228397|Immunologic Factors|immunologic factors|mesh-ancestor
92571344|NCT00228397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571345|NCT00228397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571347|NCT00075543|Oxaliplatin|oxaliplatin|mesh-list
92571348|NCT00075543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571349|NCT00075543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571350|NCT00075543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571351|NCT00075543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571352|NCT00075543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571353|NCT00228475|Budesonide|budesonide|mesh-list
92571354|NCT00228475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571355|NCT00228475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92571356|NCT00228475|Autonomic Agents|autonomic agents|mesh-ancestor
92571357|NCT00228475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571358|NCT00228475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571359|NCT00228475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92571360|NCT00228475|Respiratory System Agents|respiratory system agents|mesh-ancestor
92571361|NCT00228475|Glucocorticoids|glucocorticoids|mesh-ancestor
92571362|NCT00228475|Hormones|hormones|mesh-ancestor
92571363|NCT00228475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571364|NCT00228514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92571365|NCT00228514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92571366|NCT00228514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92571367|NCT00228514|Antimetabolites|antimetabolites|mesh-ancestor
92534926|NCT03959436|Oxytocics|oxytocics|mesh-ancestor
92534927|NCT03959436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537693|NCT02825979|Sympatholytics|sympatholytics|mesh-ancestor
92571368|NCT00228514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571369|NCT00228514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92571370|NCT00228514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92571371|NCT00228514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571372|NCT00228592|Immunoglobulins|immunoglobulins|mesh-list
92571373|NCT00228592|Antibodies|antibodies|mesh-list
92571374|NCT00228592|gamma-Globulins|gamma-globulins|mesh-list
92571375|NCT00228592|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92571376|NCT00228592|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92571377|NCT00228592|Immunologic Factors|immunologic factors|mesh-ancestor
92571378|NCT00228592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571379|NCT00075621|Melphalan|melphalan|mesh-list
92571380|NCT00075621|Immunologic Factors|immunologic factors|mesh-ancestor
92571381|NCT00075621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571382|NCT00075621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92571383|NCT00075621|Alkylating Agents|alkylating agents|mesh-ancestor
92571384|NCT00075621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571385|NCT00075621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571386|NCT00075621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92571387|NCT00075621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571388|NCT00228865|Insulin|insulin|mesh-list
92571389|NCT00228865|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92571390|NCT00228865|Insulin, Isophane|insulin, isophane|mesh-list
92571391|NCT00228865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571392|NCT00228865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571393|NCT00228904|Insulin|insulin|mesh-list
92571394|NCT00228904|Insulin Lispro|insulin lispro|mesh-list
92571395|NCT00228904|Insulin Aspart|insulin aspart|mesh-list
92571396|NCT00228904|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92571397|NCT00228904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571398|NCT00228904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571399|NCT00228982|Vancomycin|vancomycin|mesh-list
92571400|NCT00228982|Ceftobiprole|ceftobiprole|mesh-list
92571401|NCT00228982|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92571402|NCT00228982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571403|NCT00228982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571404|NCT00229060|Doripenem|doripenem|mesh-list
92571405|NCT00229060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571406|NCT00229060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571407|NCT00229138|Tacrolimus|tacrolimus|mesh-list
92571408|NCT00229138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571422|NCT00063323|Dopamine Agents|dopamine agents|mesh-ancestor
92571423|NCT00063323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571424|NCT00063323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571425|NCT00063323|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92571426|NCT00063323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92571427|NCT00063323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571429|NCT00229216|Alkylating Agents|alkylating agents|mesh-ancestor
92571430|NCT00229216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571431|NCT00229216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571432|NCT00229216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571433|NCT00229216|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92571434|NCT00229216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92571435|NCT00229216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92571436|NCT02967653|Atorvastatin|atorvastatin|mesh-list
92571437|NCT02967653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92571438|NCT02967653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92571439|NCT02967653|Antimetabolites|antimetabolites|mesh-ancestor
92571440|NCT02967653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571441|NCT02967653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92571442|NCT02967653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92571443|NCT02967653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571444|NCT00229333|Escitalopram|escitalopram|mesh-list
92571445|NCT00229333|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92571446|NCT00229333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92571447|NCT00229333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571448|NCT00229333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571449|NCT00229333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571450|NCT00229333|Serotonin Agents|serotonin agents|mesh-ancestor
92357965|NCT00255684|Cyclosporine|cyclosporine|mesh-list
92571451|NCT00229333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534928|NCT03959436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534929|NCT00072124|Dacarbazine|dacarbazine|mesh-list
92537694|NCT02825979|Autonomic Agents|autonomic agents|mesh-ancestor
92571452|NCT00229450|Estrogens|estrogens|mesh-list
92571453|NCT00229450|Hormones|hormones|mesh-ancestor
92571454|NCT00229450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571455|NCT00229450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571456|NCT00229528|Paroxetine|paroxetine|mesh-list
92571457|NCT00229528|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92571458|NCT00229528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92571459|NCT00229528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571460|NCT00229528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571461|NCT00229528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571462|NCT00229528|Serotonin Agents|serotonin agents|mesh-ancestor
92571463|NCT00229528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571464|NCT00229528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92571467|NCT00229528|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92571468|NCT00229528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92571469|NCT00229528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571470|NCT00075699|Vincristine|vincristine|mesh-list
92571471|NCT00075699|Vinorelbine|vinorelbine|mesh-list
92571472|NCT00075699|Mitomycins|mitomycins|mesh-list
92571473|NCT00075699|Mitomycin|mitomycin|mesh-list
92571474|NCT00075699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296349|NCT03224351|VX-659|vx-659|mesh-list
92571475|NCT00075699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92571476|NCT00075699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571477|NCT00075699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571478|NCT00075699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571479|NCT00075699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571480|NCT00075699|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571481|NCT00075699|Alkylating Agents|alkylating agents|mesh-ancestor
92571482|NCT00075699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92571483|NCT00075699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571485|NCT00229567|Ketamine|ketamine|mesh-list
92571486|NCT00229567|Anesthetics, Local|anesthetics, local|mesh-ancestor
92571487|NCT00229567|Anesthetics|anesthetics|mesh-ancestor
92571488|NCT00229567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571489|NCT00229567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571490|NCT00229567|Sensory System Agents|sensory system agents|mesh-ancestor
92571491|NCT00229567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571492|NCT00229567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92571493|NCT00229567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92571494|NCT00229567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92571495|NCT00229567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571496|NCT00229567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571497|NCT00229567|Analgesics|analgesics|mesh-ancestor
92571498|NCT00229567|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92357993|NCT00256776|Bortezomib|bortezomib|mesh-list
92571499|NCT00229567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92571500|NCT00229567|Anesthetics, General|anesthetics, general|mesh-ancestor
92571501|NCT00229567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92571502|NCT00229567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92571503|NCT00229567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571504|NCT00229645|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92571505|NCT00229645|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571506|NCT00229645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571507|NCT00229645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92571508|NCT00229645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571509|NCT00229645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571510|NCT00229645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571511|NCT02967341|Ciprofloxacin|ciprofloxacin|mesh-list
92571512|NCT02967341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571513|NCT02967341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571514|NCT02967341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92571515|NCT02967341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92571516|NCT02967341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571517|NCT02967341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571518|NCT02967341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571519|NCT02967341|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92571520|NCT02967341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92534930|NCT00072124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534931|NCT00072124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92534932|NCT00072124|Alkylating Agents|alkylating agents|mesh-ancestor
92571521|NCT00229684|Pioglitazone|pioglitazone|mesh-list
92571522|NCT00229684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571523|NCT00229684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571525|NCT00096720|Pramipexole|pramipexole|mesh-list
92571526|NCT00096720|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92571527|NCT00096720|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92571528|NCT00096720|Dopamine Agents|dopamine agents|mesh-ancestor
92571529|NCT00096720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571530|NCT00096720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571531|NCT00096720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571532|NCT00096720|Antioxidants|antioxidants|mesh-ancestor
92571533|NCT00096720|Protective Agents|protective agents|mesh-ancestor
92571534|NCT00096720|Dopamine Agonists|dopamine agonists|mesh-ancestor
92571535|NCT00413608|Clopidogrel|clopidogrel|mesh-list
92571536|NCT00413608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91978871|NCT02112448|Ketorolac|ketorolac|mesh-list
92571543|NCT00413608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571544|NCT00229918|Triamcinolone|triamcinolone|mesh-list
92571545|NCT00229918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92571546|NCT00229918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92571547|NCT00229918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92571548|NCT00229918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571549|NCT00229918|Glucocorticoids|glucocorticoids|mesh-ancestor
92571551|NCT00229918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571552|NCT00229918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571553|NCT00229918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571554|NCT00229918|Immunologic Factors|immunologic factors|mesh-ancestor
92571555|NCT00229918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571556|NCT00229918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571557|NCT00096798|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92571558|NCT00096798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92571559|NCT00096798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92571560|NCT00229996|Leuprolide|leuprolide|mesh-list
92571561|NCT00229996|Norethindrone|norethindrone|mesh-list
92571562|NCT00229996|Norethindrone Acetate|norethindrone acetate|mesh-list
92571563|NCT00229996|Contraceptive Agents|contraceptive agents|mesh-list
92571564|NCT00229996|Contraceptives, Oral|contraceptives, oral|mesh-list
92571565|NCT00229996|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92571566|NCT00229996|Fertility Agents|fertility agents|mesh-ancestor
92571567|NCT00229996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92571568|NCT00229996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571569|NCT00229996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92571570|NCT00229996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571571|NCT00229996|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92571572|NCT00229996|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92571573|NCT00229996|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92571574|NCT00229996|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92571575|NCT00230035|Mycophenolic Acid|mycophenolic acid|mesh-list
92571576|NCT00230035|Methylprednisolone|methylprednisolone|mesh-list
92571577|NCT00230035|Rituximab|rituximab|mesh-list
92571578|NCT00230035|Methotrexate|methotrexate|mesh-list
92571579|NCT00230035|Azathioprine|azathioprine|mesh-list
92571580|NCT00230035|Immunoglobulins|immunoglobulins|mesh-list
92571581|NCT00230035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92571582|NCT00230035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92571583|NCT00230035|gamma-Globulins|gamma-globulins|mesh-list
92571584|NCT00230035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92571585|NCT00230035|Leflunomide|leflunomide|mesh-list
92571586|NCT00230035|Thymoglobulin|thymoglobulin|mesh-list
92571587|NCT00230035|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92571588|NCT00230035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92571589|NCT00230035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571590|NCT00230035|Immunologic Factors|immunologic factors|mesh-ancestor
92571591|NCT00230035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571592|NCT00230035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571593|NCT00230035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92571594|NCT00230035|Abortifacient Agents|abortifacient agents|mesh-ancestor
92571595|NCT00230035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92571596|NCT00230035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92534933|NCT00072124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534934|NCT00072163|Thalidomide|thalidomide|mesh-list
92571597|NCT00230035|Antimetabolites|antimetabolites|mesh-ancestor
92571598|NCT00230035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571599|NCT00230035|Dermatologic Agents|dermatologic agents|mesh-ancestor
92571600|NCT00230035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571601|NCT00230035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92571602|NCT00230035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92571603|NCT00230035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571621|NCT00063401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92571623|NCT00063401|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571624|NCT00063401|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571625|NCT00063401|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571626|NCT00063401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571627|NCT00063401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92571628|NCT00096837|Motexafin gadolinium|motexafin gadolinium|mesh-list
92571629|NCT00096837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571630|NCT00096837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92571631|NCT00096837|Dermatologic Agents|dermatologic agents|mesh-ancestor
92571632|NCT00230464|Vildagliptin|vildagliptin|mesh-list
92571633|NCT00230464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571634|NCT00230464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571635|NCT00230464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92571636|NCT00230464|Protease Inhibitors|protease inhibitors|mesh-ancestor
92571637|NCT00230464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571638|NCT00230464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571639|NCT00096915|Darbepoetin alfa|darbepoetin alfa|mesh-list
92571640|NCT00096915|Hematinics|hematinics|mesh-ancestor
92571643|NCT00230503|Antiviral Agents|antiviral agents|mesh-ancestor
92358070|NCT00179478|Interferons|interferons|mesh-list
92571644|NCT00230503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571645|NCT00230503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92571646|NCT00230503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92571647|NCT00230503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571648|NCT00230503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571649|NCT00230503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92571650|NCT00424723|Pemetrexed|pemetrexed|mesh-list
92571651|NCT00424723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571652|NCT00424723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571653|NCT00424723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571654|NCT00424723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92571655|NCT00424723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92571656|NCT00230542|Carboplatin|carboplatin|mesh-list
92571657|NCT00230542|Pemetrexed|pemetrexed|mesh-list
92571658|NCT00230542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571659|NCT00230542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571660|NCT00230542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571661|NCT00230542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91979016|NCT02141620|Antidotes|antidotes|mesh-ancestor
92571680|NCT02962336|Amlodipine|amlodipine|mesh-list
92571681|NCT02962336|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92571682|NCT02962336|Olmesartan|olmesartan|mesh-list
92571683|NCT02962336|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92571684|NCT02962336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92571685|NCT02962336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92571686|NCT02962336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571687|NCT02962336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571688|NCT02962336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92571689|NCT02962336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571690|NCT02962336|Vasodilator Agents|vasodilator agents|mesh-ancestor
92571691|NCT02962336|Diuretics|diuretics|mesh-ancestor
92571692|NCT02962336|Natriuretic Agents|natriuretic agents|mesh-ancestor
92571693|NCT02962336|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92571694|NCT02962336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92571695|NCT02962336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92571696|NCT00075738|Leucovorin|leucovorin|mesh-list
92296503|NCT00356005|Artesunate|artesunate|mesh-list
92571697|NCT00075738|Fluorouracil|fluorouracil|mesh-list
92571699|NCT00075738|Calcium|calcium|mesh-list
92571700|NCT00075738|Levoleucovorin|levoleucovorin|mesh-list
92571701|NCT00075738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571702|NCT00075738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534935|NCT00072163|Temozolomide|temozolomide|mesh-list
92571703|NCT00075738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571704|NCT00075738|Antimetabolites|antimetabolites|mesh-ancestor
92358100|NCT00087672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92571705|NCT00075738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571706|NCT00075738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92571707|NCT00075738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571708|NCT00075738|Immunologic Factors|immunologic factors|mesh-ancestor
92571709|NCT00075738|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92571710|NCT00075738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92571711|NCT00075738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571712|NCT00075738|Antidotes|antidotes|mesh-ancestor
92571713|NCT00075738|Protective Agents|protective agents|mesh-ancestor
92571714|NCT00075738|Vitamin B Complex|vitamin b complex|mesh-ancestor
92571716|NCT00075738|Micronutrients|micronutrients|mesh-ancestor
92571717|NCT00230698|Topiramate|topiramate|mesh-list
92571718|NCT00230698|Anticonvulsants|anticonvulsants|mesh-ancestor
92571723|NCT00230776|Sensory System Agents|sensory system agents|mesh-ancestor
92571724|NCT00230776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571725|NCT00230776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571726|NCT00230776|Anticonvulsants|anticonvulsants|mesh-ancestor
92571727|NCT00230776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92571728|NCT00230776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571729|NCT00230776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571730|NCT00230776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92571731|NCT00230776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92571732|NCT00230776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571733|NCT00230776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571734|NCT00230776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571735|NCT00075777|Valproic Acid|valproic acid|mesh-list
92571736|NCT00075777|Anticonvulsants|anticonvulsants|mesh-ancestor
92571737|NCT00075777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571738|NCT00075777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571739|NCT00075777|GABA Agents|gaba agents|mesh-ancestor
92571740|NCT00075777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571741|NCT00075777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571742|NCT00075777|Antimanic Agents|antimanic agents|mesh-ancestor
92571743|NCT00075777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571744|NCT00075777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571745|NCT00075777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571746|NCT02967614|Timolol|timolol|mesh-list
92571747|NCT02967614|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92571748|NCT02967614|Dorzolamide|dorzolamide|mesh-list
92571749|NCT02967614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92571750|NCT02967614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92571751|NCT02967614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92571752|NCT02967614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571753|NCT02967614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571754|NCT02967614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571755|NCT02967614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92571756|NCT02967614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92571757|NCT02967614|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92571758|NCT02967614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92571759|NCT02967614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92571760|NCT02967614|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92571761|NCT02967614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571762|NCT00230815|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92571763|NCT00230815|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92571764|NCT00230815|Hormones|hormones|mesh-ancestor
92571765|NCT00230815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571766|NCT00230815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571767|NCT00230815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92571768|NCT00097071|Insulin|insulin|mesh-list
92571769|NCT00097071|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92571770|NCT00097071|Insulin Aspart|insulin aspart|mesh-list
92571771|NCT00097071|Insulin Lispro|insulin lispro|mesh-list
92571772|NCT00097071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571773|NCT00097071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571774|NCT02967380|Pentetic Acid|pentetic acid|mesh-list
92571775|NCT02967380|Antidotes|antidotes|mesh-ancestor
92571776|NCT02967380|Protective Agents|protective agents|mesh-ancestor
92571777|NCT02967380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571778|NCT02967380|Chelating Agents|chelating agents|mesh-ancestor
92571779|NCT02967380|Sequestering Agents|sequestering agents|mesh-ancestor
92571780|NCT02967380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534936|NCT00072163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92571781|NCT02967380|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92571782|NCT00075855|Testosterone|testosterone|mesh-list
92571783|NCT00075855|Androgens|androgens|mesh-ancestor
92571784|NCT00075855|Hormones|hormones|mesh-ancestor
92571785|NCT00075855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571786|NCT00075855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571787|NCT00063596|Vitamin A|vitamin a|mesh-list
92571788|NCT00063596|Vitamins|vitamins|mesh-ancestor
92571789|NCT00063596|Micronutrients|micronutrients|mesh-ancestor
91979127|NCT05547789|Analgesics|analgesics|mesh-ancestor
92571796|NCT00231244|Antifungal Agents|antifungal agents|mesh-ancestor
92571797|NCT00231244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571798|NCT00231244|Immunologic Factors|immunologic factors|mesh-ancestor
92571799|NCT00231244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571800|NCT00231322|Praziquantel|praziquantel|mesh-list
92571801|NCT00231322|Anthelmintics|anthelmintics|mesh-ancestor
92571802|NCT00231322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92571803|NCT00231322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571804|NCT00231517|Morphine|morphine|mesh-list
92571805|NCT00231517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92571806|NCT00231517|Narcotics|narcotics|mesh-ancestor
92571807|NCT00231517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571808|NCT00231517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571809|NCT00231517|Analgesics|analgesics|mesh-ancestor
92571810|NCT00231517|Sensory System Agents|sensory system agents|mesh-ancestor
92571811|NCT00231517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571812|NCT00075894|Alanosine|alanosine|mesh-list
92571813|NCT00075894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571814|NCT00075894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571815|NCT00075894|Chelating Agents|chelating agents|mesh-ancestor
92571816|NCT00075894|Sequestering Agents|sequestering agents|mesh-ancestor
92571817|NCT00075894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571818|NCT00231556|Topiramate|topiramate|mesh-list
92571819|NCT00231556|Anticonvulsants|anticonvulsants|mesh-ancestor
92571820|NCT00231556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571821|NCT00231556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571822|NCT00231595|Topiramate|topiramate|mesh-list
92571823|NCT00231595|Anticonvulsants|anticonvulsants|mesh-ancestor
92571824|NCT00231595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571825|NCT00231595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571826|NCT00231634|Topiramate|topiramate|mesh-list
92571827|NCT00231634|Anticonvulsants|anticonvulsants|mesh-ancestor
92571828|NCT00231634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571829|NCT00231634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571830|NCT00231673|Topiramate|topiramate|mesh-list
92571831|NCT00231673|Anticonvulsants|anticonvulsants|mesh-ancestor
92571832|NCT00231673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571833|NCT00231673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571834|NCT00097188|Rituximab|rituximab|mesh-list
92571835|NCT00097188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92571836|NCT00097188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571837|NCT00097188|Immunologic Factors|immunologic factors|mesh-ancestor
92571838|NCT00097188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571839|NCT00097188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571840|NCT00231829|Celecoxib|celecoxib|mesh-list
92571841|NCT00231829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92571842|NCT00231829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92571843|NCT00231829|Analgesics|analgesics|mesh-ancestor
92571844|NCT00231829|Sensory System Agents|sensory system agents|mesh-ancestor
92571845|NCT00231829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571846|NCT00231829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571847|NCT00231829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571848|NCT00231829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571849|NCT00231829|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92571850|NCT00231829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92571851|NCT00231829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571852|NCT00231829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571854|NCT00075933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571855|NCT00075933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92571856|NCT00075933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92571857|NCT00075933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571858|NCT00075933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571859|NCT00075933|Antiviral Agents|antiviral agents|mesh-ancestor
92571860|NCT00063713|Bortezomib|bortezomib|mesh-list
92571861|NCT00063713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534937|NCT00072163|Alkylating Agents|alkylating agents|mesh-ancestor
91920881|NCT02184247|Vasodilator Agents|vasodilator agents|mesh-ancestor
92571876|NCT00232063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571877|NCT00232063|Dermatologic Agents|dermatologic agents|mesh-ancestor
92571878|NCT00232063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571879|NCT00232063|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92571880|NCT00232102|Tegaserod|tegaserod|mesh-list
92571881|NCT00232102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92571882|NCT00232102|Serotonin Agents|serotonin agents|mesh-ancestor
92571883|NCT00232102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571884|NCT00232102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571885|NCT00232102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571886|NCT00097227|Paclitaxel|paclitaxel|mesh-list
92571887|NCT00097227|Carboplatin|carboplatin|mesh-list
92571888|NCT00097227|Cetuximab|cetuximab|mesh-list
92571889|NCT00097227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92571890|NCT00097227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571891|NCT00097227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571892|NCT00097227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571893|NCT00097227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571894|NCT00097227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571895|NCT00097227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92571896|NCT00232336|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92571897|NCT00232336|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571898|NCT00232336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571899|NCT00232336|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92571900|NCT00232336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571901|NCT00232336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571902|NCT00232336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571903|NCT00232375|Insulin|insulin|mesh-list
92571904|NCT00232375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571905|NCT00232375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571906|NCT00063791|Bortezomib|bortezomib|mesh-list
92571907|NCT00063791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571908|NCT00232414|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92571909|NCT00232414|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571910|NCT00232414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571911|NCT00232414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92571912|NCT00232414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571913|NCT00232414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571914|NCT00232414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571915|NCT00232492|Ketamine|ketamine|mesh-list
92571916|NCT00232492|Analgesics|analgesics|mesh-ancestor
92571917|NCT00232492|Sensory System Agents|sensory system agents|mesh-ancestor
92571918|NCT00232492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571919|NCT00232492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571920|NCT00232492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92571921|NCT00232492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92571922|NCT00232492|Anesthetics, General|anesthetics, general|mesh-ancestor
92571941|NCT00063869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92571943|NCT00063869|Sensory System Agents|sensory system agents|mesh-ancestor
92571944|NCT00063869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571945|NCT00063869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571946|NCT00063869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571947|NCT00063869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92571948|NCT00063869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92571949|NCT00063869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571950|NCT00063869|Immunologic Factors|immunologic factors|mesh-ancestor
92571951|NCT00232531|Niacin|niacin|mesh-list
92571952|NCT00232531|Nicotinic Acids|nicotinic acids|mesh-list
92571953|NCT00232531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92571954|NCT00232531|Antimetabolites|antimetabolites|mesh-ancestor
92571955|NCT00232531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571956|NCT00232531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92571957|NCT00232531|Vasodilator Agents|vasodilator agents|mesh-ancestor
92571958|NCT00232531|Vitamin B Complex|vitamin b complex|mesh-ancestor
92571959|NCT00232531|Vitamins|vitamins|mesh-ancestor
92571960|NCT00232531|Micronutrients|micronutrients|mesh-ancestor
92571961|NCT00232531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571962|NCT00232570|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92571963|NCT00232570|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571964|NCT00232570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571965|NCT00232570|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92571966|NCT00232570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571967|NCT00232570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92534938|NCT00072163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920962|NCT04870424|Colchicine|colchicine|mesh-list
92571968|NCT00232570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571969|NCT00097266|Haloperidol|haloperidol|mesh-list
92571970|NCT00097266|Aripiprazole|aripiprazole|mesh-list
92571971|NCT00097266|Haloperidol decanoate|haloperidol decanoate|mesh-list
92571972|NCT00097266|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571973|NCT00097266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571974|NCT00097266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92571975|NCT00097266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571976|NCT00097266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572002|NCT00232648|Budesonide|budesonide|mesh-list
92572003|NCT00232648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572004|NCT00232648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92572005|NCT00232648|Autonomic Agents|autonomic agents|mesh-ancestor
92572006|NCT00232648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572007|NCT00232648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572008|NCT00232648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92572009|NCT00232648|Respiratory System Agents|respiratory system agents|mesh-ancestor
92572010|NCT00232648|Glucocorticoids|glucocorticoids|mesh-ancestor
92572011|NCT00232648|Hormones|hormones|mesh-ancestor
92572012|NCT00232648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572013|NCT00232687|Aripiprazole|aripiprazole|mesh-list
92572014|NCT00232687|Antidepressive Agents|antidepressive agents|mesh-ancestor
92572015|NCT00232687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572016|NCT00232687|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572017|NCT00232687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572018|NCT00232687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572019|NCT00232687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572020|NCT00232687|Dopamine Agonists|dopamine agonists|mesh-ancestor
92572021|NCT00232687|Dopamine Agents|dopamine agents|mesh-ancestor
92572022|NCT00232687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572033|NCT00232765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572034|NCT00232765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92572035|NCT00232765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572036|NCT00232765|Antifungal Agents|antifungal agents|mesh-ancestor
92572037|NCT00232765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572038|NCT00232765|Immunologic Factors|immunologic factors|mesh-ancestor
92572039|NCT00232765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572040|NCT02958566|Acetaminophen|acetaminophen|mesh-list
92572041|NCT02958566|Ketorolac|ketorolac|mesh-list
92572042|NCT02958566|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92572043|NCT02958566|Lidocaine|lidocaine|mesh-list
92572044|NCT02958566|Fentanyl|fentanyl|mesh-list
92572045|NCT02958566|Ketamine|ketamine|mesh-list
92572046|NCT02958566|Morphine|morphine|mesh-list
92572047|NCT02958566|Gabapentin|gabapentin|mesh-list
92572048|NCT02958566|Tramadol|tramadol|mesh-list
92572049|NCT02958566|Methadone|methadone|mesh-list
92572050|NCT02958566|Hydrocodone|hydrocodone|mesh-list
92572051|NCT02958566|Hydromorphone|hydromorphone|mesh-list
92572052|NCT02958566|Orphenadrine|orphenadrine|mesh-list
92572053|NCT02958566|Bupivacaine|bupivacaine|mesh-list
92572054|NCT02958566|Anesthetics, Local|anesthetics, local|mesh-ancestor
92572055|NCT02958566|Anesthetics|anesthetics|mesh-ancestor
92572056|NCT02958566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572057|NCT02958566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572058|NCT02958566|Sensory System Agents|sensory system agents|mesh-ancestor
92572059|NCT02958566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572060|NCT02958566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92572061|NCT02958566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92572062|NCT02958566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92572063|NCT02958566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572064|NCT02958566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572065|NCT02958566|Analgesics|analgesics|mesh-ancestor
92572066|NCT02958566|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92572067|NCT02958566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92572068|NCT02958566|Anesthetics, General|anesthetics, general|mesh-ancestor
92572069|NCT02958566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92572070|NCT02958566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92572071|NCT02958566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572072|NCT02958566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92296879|NCT02265510|Gemcitabine|gemcitabine|mesh-list
92572073|NCT02958566|Narcotics|narcotics|mesh-ancestor
92572074|NCT02958566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92572075|NCT02958566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92534939|NCT00072163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534940|NCT00072163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534941|NCT00072163|Immunologic Factors|immunologic factors|mesh-ancestor
91921036|NCT02186275|Micronutrients|micronutrients|mesh-ancestor
92572077|NCT02958566|Anticonvulsants|anticonvulsants|mesh-ancestor
92572078|NCT02958566|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92572079|NCT02958566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572080|NCT02958566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572081|NCT02958566|Antimanic Agents|antimanic agents|mesh-ancestor
92572082|NCT02958566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92572083|NCT02958566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572084|NCT02958566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92572085|NCT02958566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92572086|NCT02958566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572087|NCT02958566|Antitussive Agents|antitussive agents|mesh-ancestor
91979424|NCT04062201|Isoniazid|isoniazid|mesh-list
92572089|NCT02958566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92572090|NCT02958566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92572091|NCT02958566|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92572092|NCT02958566|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92572093|NCT02958566|Parasympatholytics|parasympatholytics|mesh-ancestor
92572094|NCT02958566|Autonomic Agents|autonomic agents|mesh-ancestor
92572095|NCT02958566|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92572096|NCT02958566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92572097|NCT02958566|Cholinergic Agents|cholinergic agents|mesh-ancestor
92572098|NCT02958566|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
92572099|NCT02958566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92572100|NCT00097344|Toremifene|toremifene|mesh-list
92572101|NCT00097344|Letrozole|letrozole|mesh-list
92572102|NCT00097344|Hormones|hormones|mesh-list
92572103|NCT00097344|Atamestane|atamestane|mesh-list
92572104|NCT00097344|Estrogen Antagonists|estrogen antagonists|mesh-list
92572105|NCT00097344|Estrogens|estrogens|mesh-list
92572106|NCT00097344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-list
92572107|NCT00097344|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-list
92572108|NCT00097344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572109|NCT00097344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572110|NCT00097344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572111|NCT00097344|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92572112|NCT00097344|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92572113|NCT00097344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572114|NCT00097344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572115|NCT00097344|Hormone Antagonists|hormone antagonists|mesh-ancestor
92572116|NCT00097344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92572117|NCT00097344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92572118|NCT00097344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92572119|NCT00232882|Atenolol|atenolol|mesh-list
92572120|NCT00232882|Candesartan|candesartan|mesh-list
92572121|NCT00232882|Candesartan cilexetil|candesartan cilexetil|mesh-list
92572122|NCT00232882|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92572123|NCT00232882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92572124|NCT00232882|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92572125|NCT00232882|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92572126|NCT00232882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572127|NCT00232882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92572128|NCT00232882|Sympatholytics|sympatholytics|mesh-ancestor
92572129|NCT00232882|Autonomic Agents|autonomic agents|mesh-ancestor
92572130|NCT00232882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572131|NCT00232882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572132|NCT00232882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92572133|NCT00232882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92572134|NCT00232882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92572135|NCT00232882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92572136|NCT00232882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572137|NCT00232882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572138|NCT00232882|Diuretics|diuretics|mesh-ancestor
92572139|NCT00232882|Natriuretic Agents|natriuretic agents|mesh-ancestor
92572140|NCT00064064|Gemcitabine|gemcitabine|mesh-list
92572141|NCT00064064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92572142|NCT00064064|Antimetabolites|antimetabolites|mesh-ancestor
92534942|NCT00072163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534943|NCT00072163|Leprostatic Agents|leprostatic agents|mesh-ancestor
92534944|NCT00072163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92534945|NCT00072163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92534946|NCT00072163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92534947|NCT00072163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92534948|NCT00072163|Growth Substances|growth substances|mesh-ancestor
92534949|NCT00072163|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534950|NCT00072319|Paclitaxel|paclitaxel|mesh-list
92534951|NCT00072319|Cyclophosphamide|cyclophosphamide|mesh-list
92534952|NCT00072319|Epirubicin|epirubicin|mesh-list
92534953|NCT00072319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92534954|NCT00072319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534955|NCT00072319|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534956|NCT00072319|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534957|NCT00072319|Mitosis Modulators|mitosis modulators|mesh-ancestor
92534958|NCT00072319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534959|NCT00072319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92534960|NCT00072319|Immunologic Factors|immunologic factors|mesh-ancestor
91921119|NCT02752633|Febuxostat|febuxostat|mesh-list
92572143|NCT00064064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572144|NCT00064064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572145|NCT00413686|Gemcitabine|gemcitabine|mesh-list
92572146|NCT00413686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92572147|NCT00413686|Antimetabolites|antimetabolites|mesh-ancestor
92572148|NCT00413686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572149|NCT00413686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572150|NCT00233038|Ethanol|ethanol|mesh-list
92572151|NCT00233038|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92572152|NCT00233038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572153|NCT00233038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572154|NCT00233038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572155|NCT00097383|Epirubicin|epirubicin|mesh-list
92572156|NCT00097383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92572157|NCT00097383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572158|NCT00097383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92572159|NCT00097383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92572160|NCT00097383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572191|NCT00064181|Antimetabolites|antimetabolites|mesh-ancestor
92572192|NCT00064181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572193|NCT00064181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92572194|NCT00064181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572195|NCT00064181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572196|NCT00064181|Immunologic Factors|immunologic factors|mesh-ancestor
92572197|NCT00064181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92572198|NCT00064181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92572199|NCT00064181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572200|NCT00064181|Antidotes|antidotes|mesh-ancestor
92572201|NCT00064181|Protective Agents|protective agents|mesh-ancestor
92572202|NCT00064181|Vitamin B Complex|vitamin b complex|mesh-ancestor
92572203|NCT00064181|Vitamins|vitamins|mesh-ancestor
92572204|NCT00064181|Micronutrients|micronutrients|mesh-ancestor
92572205|NCT00064181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92572206|NCT00064181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92572207|NCT00064181|Analgesics|analgesics|mesh-ancestor
92572213|NCT00064181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92534961|NCT00072319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534962|NCT00072319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534963|NCT00072319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92572215|NCT00233545|Antifungal Agents|antifungal agents|mesh-ancestor
92572216|NCT00233545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572217|NCT00233545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572218|NCT00233545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572219|NCT00233545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572221|NCT00233584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572222|NCT00233584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92572223|NCT00233584|Autonomic Agents|autonomic agents|mesh-ancestor
92572224|NCT00233584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572225|NCT00233584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572226|NCT00233584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92572227|NCT00233584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92572228|NCT00233584|Glucocorticoids|glucocorticoids|mesh-ancestor
92572229|NCT00233584|Hormones|hormones|mesh-ancestor
92572230|NCT00233584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572231|NCT00233623|Leucovorin|leucovorin|mesh-list
92572232|NCT00233623|Fluorouracil|fluorouracil|mesh-list
92572233|NCT00233623|Irinotecan|irinotecan|mesh-list
92572234|NCT00233623|Gefitinib|gefitinib|mesh-list
92572235|NCT00233623|Antimetabolites|antimetabolites|mesh-ancestor
92572236|NCT00233623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358347|NCT00211692|Immunologic Factors|immunologic factors|mesh-ancestor
92572237|NCT00233623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92572238|NCT00233623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572239|NCT00233623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572240|NCT00233623|Immunologic Factors|immunologic factors|mesh-ancestor
92572241|NCT00233623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572242|NCT00233623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92572243|NCT00233623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92572244|NCT00233623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572245|NCT00233623|Antidotes|antidotes|mesh-ancestor
92572246|NCT00233623|Protective Agents|protective agents|mesh-ancestor
92572247|NCT00233623|Vitamin B Complex|vitamin b complex|mesh-ancestor
92572248|NCT00233623|Vitamins|vitamins|mesh-ancestor
92572249|NCT00233623|Micronutrients|micronutrients|mesh-ancestor
92572250|NCT00233623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572251|NCT00233662|Alefacept|alefacept|mesh-list
92572252|NCT00233662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92572253|NCT00233662|Immunologic Factors|immunologic factors|mesh-ancestor
92572254|NCT00233662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572255|NCT00064220|Soblidotin|soblidotin|mesh-list
92572256|NCT00064220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572257|NCT00233779|Sirolimus|sirolimus|mesh-list
92572258|NCT00233779|Heparin|heparin|mesh-list
92572259|NCT00233779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572260|NCT00233779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572261|NCT00233779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92572262|NCT00233779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572263|NCT00233779|Antifungal Agents|antifungal agents|mesh-ancestor
92572264|NCT00233779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572265|NCT00233779|Immunologic Factors|immunologic factors|mesh-ancestor
92572266|NCT00233779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572267|NCT00233779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572268|NCT00233779|Anticoagulants|anticoagulants|mesh-ancestor
92572269|NCT00233779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92572270|NCT00233779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92572271|NCT00233818|Sirolimus|sirolimus|mesh-list
92572272|NCT00233818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572273|NCT00233818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572274|NCT00233818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92572275|NCT00233818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572276|NCT00233818|Antifungal Agents|antifungal agents|mesh-ancestor
92572277|NCT00233818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572278|NCT00233818|Immunologic Factors|immunologic factors|mesh-ancestor
92572279|NCT00233818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572291|NCT00233896|Glucocorticoids|glucocorticoids|mesh-ancestor
92572293|NCT00233896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572294|NCT00233896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572295|NCT00233896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92572296|NCT00233896|Respiratory System Agents|respiratory system agents|mesh-ancestor
92534964|NCT00072319|Alkylating Agents|alkylating agents|mesh-ancestor
92534965|NCT00072319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92572297|NCT00233935|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92572298|NCT00233935|Antioxidants|antioxidants|mesh-ancestor
92572299|NCT00233935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572300|NCT00233935|Protective Agents|protective agents|mesh-ancestor
92572301|NCT00233935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572302|NCT00233935|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92572303|NCT00233935|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92572304|NCT00233935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572305|NCT00233935|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92572306|NCT00234091|Ritonavir|ritonavir|mesh-list
92572307|NCT00234091|Lopinavir|lopinavir|mesh-list
92572308|NCT00234091|Nelfinavir|nelfinavir|mesh-list
92572309|NCT00234091|Lamivudine|lamivudine|mesh-list
92572310|NCT00234091|Zidovudine|zidovudine|mesh-list
92572311|NCT00234091|Nevirapine|nevirapine|mesh-list
92572312|NCT00234091|Abacavir|abacavir|mesh-list
92572313|NCT00234091|Efavirenz|efavirenz|mesh-list
92572314|NCT00234091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92572315|NCT00234091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92572316|NCT00234091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92572317|NCT00234091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572318|NCT00234091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572319|NCT00234091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92572320|NCT00234091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92572321|NCT00234091|Antiviral Agents|antiviral agents|mesh-ancestor
92572322|NCT00234091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572323|NCT00234091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92572324|NCT00234091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92572325|NCT00234091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92572326|NCT00234091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92572327|NCT00234091|Antimetabolites|antimetabolites|mesh-ancestor
92572328|NCT00234091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92572329|NCT00234091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92572330|NCT00234091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92572331|NCT00234091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92572332|NCT00234091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92572333|NCT04721704|Amoxicillin|amoxicillin|mesh-list
92572334|NCT04721704|Metronidazole|metronidazole|mesh-list
92572335|NCT04721704|Clarithromycin|clarithromycin|mesh-list
92572336|NCT04721704|Omeprazole|omeprazole|mesh-list
92572337|NCT04721704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572338|NCT04721704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572339|NCT04721704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572340|NCT04721704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572341|NCT04721704|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92572342|NCT04721704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572343|NCT04721704|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92572344|NCT04721704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572356|NCT00076284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572357|NCT00234403|Fulvestrant|fulvestrant|mesh-list
92572358|NCT00234403|Gefitinib|gefitinib|mesh-list
92572359|NCT00234403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92572360|NCT00234403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572361|NCT00234403|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92572362|NCT00234403|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92572363|NCT00234403|Hormone Antagonists|hormone antagonists|mesh-ancestor
92572364|NCT00234403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572365|NCT00234403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572366|NCT00234403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572367|NCT00234403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572368|NCT00234403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572369|NCT00064415|Formoterol Fumarate|formoterol fumarate|mesh-list
92572370|NCT00064415|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92572371|NCT00064415|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92572372|NCT00064415|Autonomic Agents|autonomic agents|mesh-ancestor
92572373|NCT00064415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572374|NCT00064415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572375|NCT00064415|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92572376|NCT00064415|Respiratory System Agents|respiratory system agents|mesh-ancestor
92572377|NCT00064415|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92572378|NCT00064415|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92572379|NCT00064415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92534966|NCT00072319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92534967|NCT00072319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92534968|NCT00072319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91921314|NCT02191657|Deferiprone|deferiprone|mesh-list
92572380|NCT00064415|Adrenergic Agents|adrenergic agents|mesh-ancestor
92572381|NCT00064415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572382|NCT00064415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572383|NCT00234442|Gefitinib|gefitinib|mesh-list
92572384|NCT00234442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572385|NCT00234442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572386|NCT00234442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572387|NCT00234442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572388|NCT00076323|Primaquine|primaquine|mesh-list
92572389|NCT00076323|Antimalarials|antimalarials|mesh-ancestor
92572390|NCT00076323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572391|NCT00076323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572392|NCT00076323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572393|NCT00234598|Chlorhexidine|chlorhexidine|mesh-list
92572394|NCT00234598|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92572395|NCT00234598|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92572396|NCT00234598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572397|NCT00234598|Disinfectants|disinfectants|mesh-ancestor
92572398|NCT00234598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92572399|NCT00234637|Memantine|memantine|mesh-list
92572400|NCT00234637|Rivastigmine|rivastigmine|mesh-list
92572401|NCT00234637|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92572402|NCT00234637|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92572403|NCT00234637|Dopamine Agents|dopamine agents|mesh-ancestor
92572404|NCT00234637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572405|NCT00234637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979739|NCT02709785|Chlorhexidine|chlorhexidine|mesh-list
92572417|NCT00234676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572418|NCT00234676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572420|NCT00076362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572421|NCT00076362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92572422|NCT00076362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572423|NCT00234871|Verapamil|verapamil|mesh-list
92572424|NCT00234871|Amlodipine|amlodipine|mesh-list
92572425|NCT00234871|Benazepril|benazepril|mesh-list
92572426|NCT00234871|Trandolapril|trandolapril|mesh-list
92572427|NCT00234871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92572428|NCT00234871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92572429|NCT00234871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572430|NCT00234871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572431|NCT00234871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92572432|NCT00234871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572433|NCT00234871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92572434|NCT00234871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92572435|NCT00234871|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92572436|NCT00234871|Protease Inhibitors|protease inhibitors|mesh-ancestor
92572437|NCT00234871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572438|NCT00234910|Ritonavir|ritonavir|mesh-list
92572439|NCT00234910|Lopinavir|lopinavir|mesh-list
92572440|NCT00234910|Tenofovir|tenofovir|mesh-list
92572441|NCT00234910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92572442|NCT00234910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92572443|NCT00234910|Protease Inhibitors|protease inhibitors|mesh-ancestor
92572444|NCT00234910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572445|NCT00234910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572446|NCT00234910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92572447|NCT00234910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92572448|NCT00234910|Antiviral Agents|antiviral agents|mesh-ancestor
92572449|NCT00234910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572450|NCT00234910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92572451|NCT00234910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92572452|NCT00234910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92572453|NCT00234910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92572454|NCT00234949|Cephalexin|cephalexin|mesh-list
92572455|NCT00234949|Cefdinir|cefdinir|mesh-list
92572456|NCT00234949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572457|NCT00234949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572458|NCT00234988|Sibutramine|sibutramine|mesh-list
92534970|NCT03959397|Paclitaxel|paclitaxel|mesh-list
92534971|NCT03959397|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92572459|NCT00234988|Antidepressive Agents|antidepressive agents|mesh-ancestor
92572460|NCT00234988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572461|NCT00234988|Appetite Depressants|appetite depressants|mesh-ancestor
92572462|NCT00234988|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92572463|NCT00400491|Vitamin D|vitamin d|mesh-list
92572464|NCT00400491|Ergocalciferols|ergocalciferols|mesh-list
92572465|NCT00400491|Cholecalciferol|cholecalciferol|mesh-list
92572466|NCT00400491|Vitamins|vitamins|mesh-list
92572467|NCT00400491|Micronutrients|micronutrients|mesh-ancestor
92572468|NCT00400491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572469|NCT00400491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91979800|NCT02204085|Decitabine|decitabine|mesh-list
92572473|NCT00235105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572474|NCT00235105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92572475|NCT00235144|Sirolimus|sirolimus|mesh-list
92572476|NCT00235144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572477|NCT00235144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572478|NCT00235144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92572479|NCT00235144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572480|NCT00235144|Antifungal Agents|antifungal agents|mesh-ancestor
92572481|NCT00235144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572482|NCT00235144|Immunologic Factors|immunologic factors|mesh-ancestor
92572483|NCT00235144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572484|NCT00400530|Alendronate|alendronate|mesh-list
92572485|NCT00400530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572486|NCT00400530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92572487|NCT00064610|Bortezomib|bortezomib|mesh-list
92358660|NCT00118404|Fluoxetine|fluoxetine|mesh-list
92572488|NCT00064610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572489|NCT00235222|Stavudine|stavudine|mesh-list
92572490|NCT00235222|Antimetabolites|antimetabolites|mesh-ancestor
92572491|NCT00235222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572492|NCT00235222|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92572493|NCT00235222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92572494|NCT00235222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572495|NCT00235222|Antiviral Agents|antiviral agents|mesh-ancestor
92572496|NCT00235222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572497|NCT00235222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92572498|NCT00235222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92572499|NCT00235261|Dexamethasone|dexamethasone|mesh-list
92572500|NCT00235261|Pregabalin|pregabalin|mesh-list
92572501|NCT00235261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572502|NCT00235261|Antiemetics|antiemetics|mesh-ancestor
92572503|NCT00235261|Autonomic Agents|autonomic agents|mesh-ancestor
92572504|NCT00235261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572505|NCT00235261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572506|NCT00235261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572507|NCT00235261|Glucocorticoids|glucocorticoids|mesh-ancestor
92572508|NCT00235261|Hormones|hormones|mesh-ancestor
92572509|NCT00235261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572510|NCT00235261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92572511|NCT00235261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572512|NCT00235261|Analgesics|analgesics|mesh-ancestor
92572513|NCT00235261|Sensory System Agents|sensory system agents|mesh-ancestor
92572514|NCT00235261|Anticonvulsants|anticonvulsants|mesh-ancestor
92572515|NCT00235261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92572516|NCT00235261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572517|NCT00235261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572518|NCT00235261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92572519|NCT00235261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92572520|NCT00235261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572521|NCT00235261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572522|NCT00235261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572523|NCT00235300|Thymoglobulin|thymoglobulin|mesh-list
92572524|NCT00235300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92572525|NCT00235300|Basiliximab|basiliximab|mesh-list
92572526|NCT00235300|Immunologic Factors|immunologic factors|mesh-ancestor
92572527|NCT00235300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572528|NCT00235300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572529|NCT00064649|Finasteride|finasteride|mesh-list
92572530|NCT00064649|Alfuzosin|alfuzosin|mesh-list
92297332|NCT00356395|Candesartan|candesartan|mesh-list
92572531|NCT00064649|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92534972|NCT03959397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92572532|NCT00064649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92572533|NCT00064649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572534|NCT00064649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572535|NCT00064649|Hormone Antagonists|hormone antagonists|mesh-ancestor
92572536|NCT00064649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572537|NCT00064649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572538|NCT00064649|Urological Agents|urological agents|mesh-ancestor
92572539|NCT00064649|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92572540|NCT00064649|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92572545|NCT00097734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572546|NCT00097734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572547|NCT00064727|Rosiglitazone|rosiglitazone|mesh-list
92572548|NCT00064727|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572549|NCT00064727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572550|NCT00235651|Amphotericin B|amphotericin b|mesh-list
92572551|NCT00235651|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92572552|NCT00235651|Amebicides|amebicides|mesh-ancestor
92572553|NCT00235651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572554|NCT00235651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572555|NCT00235651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572556|NCT00235651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572557|NCT00235651|Antifungal Agents|antifungal agents|mesh-ancestor
92572558|NCT00097812|Zoledronic Acid|zoledronic acid|mesh-list
92572559|NCT00097812|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92572560|NCT00097812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572561|NCT00064766|Doxycycline|doxycycline|mesh-list
92572562|NCT00064766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572563|NCT00064766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572564|NCT00064766|Antimalarials|antimalarials|mesh-ancestor
92572565|NCT00064766|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572566|NCT00064766|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572567|NCT00235729|Lofexidine|lofexidine|mesh-list
92572568|NCT00235729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92572569|NCT00235729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92572570|NCT00235729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572571|NCT00235729|Sensory System Agents|sensory system agents|mesh-ancestor
92572572|NCT00235729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572573|NCT00235729|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92572574|NCT00235729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92572575|NCT00235729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92572576|NCT00235729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92572577|NCT00235729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572578|NCT00235729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572579|NCT00235885|Adalimumab|adalimumab|mesh-list
92572580|NCT00235885|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92572581|NCT00235885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572582|NCT00235885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92572583|NCT04728750|Pancrelipase|pancrelipase|mesh-list
92572584|NCT04728750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572585|NCT00235963|Simvastatin|simvastatin|mesh-list
92572586|NCT00235963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92572587|NCT00235963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92572588|NCT00235963|Antimetabolites|antimetabolites|mesh-ancestor
92572589|NCT00235963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572590|NCT00235963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92572591|NCT00235963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92572592|NCT00235963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572593|NCT00236002|Alendronate|alendronate|mesh-list
92572594|NCT00236002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92572595|NCT00236002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572596|NCT00414037|Eszopiclone|eszopiclone|mesh-list
92572597|NCT00414037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92572598|NCT00414037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572599|NCT00414037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572600|NCT00236275|Telbivudine|telbivudine|mesh-list
92572601|NCT00236275|Antiviral Agents|antiviral agents|mesh-ancestor
92572602|NCT00236275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572603|NCT00236275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92572604|NCT00236275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572605|NCT00236275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534974|NCT03959397|Tubulin Modulators|tubulin modulators|mesh-ancestor
92534975|NCT03959397|Antimitotic Agents|antimitotic agents|mesh-ancestor
92534976|NCT03959397|Mitosis Modulators|mitosis modulators|mesh-ancestor
92572606|NCT00236353|Risperidone|risperidone|mesh-list
92572607|NCT00236353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572608|NCT00236353|Serotonin Agents|serotonin agents|mesh-ancestor
92572609|NCT00236353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572610|NCT00236353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572611|NCT00236353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572612|NCT00236353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572625|NCT00236431|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92572626|NCT00236431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572627|NCT00236431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572628|NCT00236431|Cholinergic Agents|cholinergic agents|mesh-ancestor
92572629|NCT00236431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572630|NCT00236431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572631|NCT00236431|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92572633|NCT00236431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572634|NCT00236431|Nootropic Agents|nootropic agents|mesh-ancestor
92572635|NCT00097929|Vorinostat|vorinostat|mesh-list
92572636|NCT00097929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572637|NCT00097929|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92572638|NCT00097929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572639|NCT00097929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358740|NCT00240162|Vatalanib|vatalanib|mesh-list
92572640|NCT00236470|Risperidone|risperidone|mesh-list
92572641|NCT00236470|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572642|NCT00236470|Serotonin Agents|serotonin agents|mesh-ancestor
92572643|NCT00236470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572644|NCT00236470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572645|NCT00236470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572646|NCT00236470|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572647|NCT00236470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572648|NCT00236470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572649|NCT00236470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572650|NCT00236470|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572651|NCT00236470|Dopamine Agents|dopamine agents|mesh-ancestor
92572652|NCT00236509|Topiramate|topiramate|mesh-list
92572653|NCT00236509|Anticonvulsants|anticonvulsants|mesh-ancestor
92572654|NCT00236509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572655|NCT00236509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572656|NCT02962141|Paclitaxel|paclitaxel|mesh-list
92572657|NCT02962141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92572658|NCT02962141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572659|NCT02962141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92572660|NCT02962141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92572661|NCT02962141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92572662|NCT02962141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572663|NCT00076401|Motexafin gadolinium|motexafin gadolinium|mesh-list
92572664|NCT00076401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572665|NCT00076401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92572666|NCT00076401|Dermatologic Agents|dermatologic agents|mesh-ancestor
92572667|NCT00236548|Risperidone|risperidone|mesh-list
92572668|NCT00236548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572669|NCT00236548|Serotonin Agents|serotonin agents|mesh-ancestor
92572670|NCT00236548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572671|NCT00236548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572672|NCT00236548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572673|NCT00236548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572674|NCT00236548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358762|NCT00300456|Antimetabolites|antimetabolites|mesh-ancestor
92572675|NCT00236548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572676|NCT00236548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572719|NCT00236782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572721|NCT00236782|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92572722|NCT00236782|Contraceptive Agents|contraceptive agents|mesh-ancestor
92572723|NCT00236782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92572724|NCT00236782|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92572725|NCT00236782|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92572726|NCT00236782|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92572727|NCT00097968|Everolimus|everolimus|mesh-list
92572728|NCT00097968|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92572729|NCT00097968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92534977|NCT03959397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534978|NCT00072436|Gemcitabine|gemcitabine|mesh-list
92534979|NCT00072436|Alvocidib|alvocidib|mesh-list
92572730|NCT00097968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572731|NCT00097968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572732|NCT00097968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572733|NCT00097968|Immunologic Factors|immunologic factors|mesh-ancestor
92572734|NCT00097968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572735|NCT00097968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572736|NCT00236821|Levofloxacin|levofloxacin|mesh-list
92572737|NCT00236821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92572738|NCT00236821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572739|NCT00236821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572740|NCT00236821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92572741|NCT00236821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92572742|NCT00236821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572743|NCT00236821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572744|NCT00236821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572745|NCT00236821|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92572746|NCT00236821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92572747|NCT00236860|Topiramate|topiramate|mesh-list
92572748|NCT00236860|Anticonvulsants|anticonvulsants|mesh-ancestor
92572749|NCT00236860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572750|NCT00236860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572751|NCT00065117|Leucovorin|leucovorin|mesh-list
92572752|NCT00065117|Fluorouracil|fluorouracil|mesh-list
92572753|NCT00065117|Oxaliplatin|oxaliplatin|mesh-list
92572754|NCT00065117|Antimetabolites|antimetabolites|mesh-ancestor
92572755|NCT00065117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572756|NCT00065117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92572757|NCT00065117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572758|NCT00065117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572759|NCT00065117|Immunologic Factors|immunologic factors|mesh-ancestor
92572760|NCT00065117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572761|NCT00065117|Antidotes|antidotes|mesh-ancestor
92572762|NCT00065117|Protective Agents|protective agents|mesh-ancestor
92572763|NCT00065117|Vitamin B Complex|vitamin b complex|mesh-ancestor
92572764|NCT00065117|Vitamins|vitamins|mesh-ancestor
92572765|NCT00065117|Micronutrients|micronutrients|mesh-ancestor
92572766|NCT00237016|Doxycycline|doxycycline|mesh-list
92572767|NCT00237016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572768|NCT00237016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572769|NCT00237016|Antimalarials|antimalarials|mesh-ancestor
92572770|NCT00237016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572771|NCT00237016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572772|NCT00237133|Letrozole|letrozole|mesh-list
92572773|NCT00237133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572774|NCT00237133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92572775|NCT00237133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92572776|NCT00237133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572777|NCT00237133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572778|NCT00237133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92572779|NCT00237133|Hormone Antagonists|hormone antagonists|mesh-ancestor
92572780|NCT00237133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572781|NCT00237133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572782|NCT00237172|Imatinib Mesylate|imatinib mesylate|mesh-list
92572783|NCT00237172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572784|NCT00237172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572785|NCT00237172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572786|NCT00237172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572787|NCT00237211|Letrozole|letrozole|mesh-list
92572790|NCT00237211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92572791|NCT00237211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572792|NCT00237211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572793|NCT00237211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92572794|NCT00237211|Hormone Antagonists|hormone antagonists|mesh-ancestor
92572795|NCT00237211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92572796|NCT00237211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572798|NCT00098007|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92572799|NCT00098007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572800|NCT00098007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534980|NCT00072436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92572801|NCT00098007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572802|NCT00098007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358834|NCT04389060|Antioxidants|antioxidants|mesh-ancestor
92572803|NCT00098007|Immunologic Factors|immunologic factors|mesh-ancestor
92572804|NCT00098007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572805|NCT00098007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572806|NCT00237250|Vildagliptin|vildagliptin|mesh-list
92572807|NCT00237250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572808|NCT00237250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572809|NCT00237250|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92572810|NCT00237250|Protease Inhibitors|protease inhibitors|mesh-ancestor
92572811|NCT00237250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572812|NCT00237250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572813|NCT00237289|Topiramate|topiramate|mesh-list
92572814|NCT00237289|Anticonvulsants|anticonvulsants|mesh-ancestor
92572815|NCT00237289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572816|NCT00237289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572817|NCT00237328|Heparin|heparin|mesh-list
92572818|NCT00237328|Anticoagulants|anticoagulants|mesh-ancestor
92572819|NCT00237328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92572820|NCT00237328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92572821|NCT00237328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572822|NCT00237367|Rabeprazole|rabeprazole|mesh-list
92572823|NCT00237367|Pantoprazole|pantoprazole|mesh-list
92572824|NCT00237367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92572825|NCT00237367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572826|NCT00237367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92572827|NCT00237367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572828|NCT00237367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572829|NCT00098046|Famciclovir|famciclovir|mesh-list
92572830|NCT00098046|Antiviral Agents|antiviral agents|mesh-ancestor
92572831|NCT00098046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572832|NCT00098046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92572833|NCT00098046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572834|NCT00098046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572835|NCT00065273|Olanzapine|olanzapine|mesh-list
92572836|NCT00065273|Risperidone|risperidone|mesh-list
92572837|NCT00065273|Clozapine|clozapine|mesh-list
92572838|NCT00065273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572839|NCT00065273|Serotonin Agents|serotonin agents|mesh-ancestor
92572840|NCT00065273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572841|NCT00065273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572842|NCT00065273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572843|NCT00065273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572844|NCT00065273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572845|NCT00065273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572846|NCT00065273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572847|NCT00065273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572848|NCT00065273|Dopamine Agents|dopamine agents|mesh-ancestor
92572849|NCT00065273|Antiemetics|antiemetics|mesh-ancestor
92572850|NCT00065273|Autonomic Agents|autonomic agents|mesh-ancestor
92572851|NCT00065273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572852|NCT00065273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572853|NCT00065273|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92572854|NCT00065273|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92572855|NCT00065273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572856|NCT00065273|GABA Antagonists|gaba antagonists|mesh-ancestor
92572857|NCT00065273|GABA Agents|gaba agents|mesh-ancestor
92572858|NCT00237445|Azithromycin|azithromycin|mesh-list
92572859|NCT00237445|Telithromycin|telithromycin|mesh-list
91980192|NCT02435459|Calcium|calcium|mesh-list
92572866|NCT00237484|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92572867|NCT00237484|Infliximab|infliximab|mesh-list
92572868|NCT00237484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572869|NCT00237484|Antiviral Agents|antiviral agents|mesh-ancestor
92572870|NCT00237484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572871|NCT00237484|Antimetabolites|antimetabolites|mesh-ancestor
92572872|NCT00237484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572873|NCT00237484|Immunologic Factors|immunologic factors|mesh-ancestor
92572874|NCT00237484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572875|NCT00237484|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92572876|NCT00237484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572877|NCT00237484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92572878|NCT00237484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572879|NCT00237484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92534981|NCT00072436|Antimetabolites|antimetabolites|mesh-ancestor
92534982|NCT00072436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572881|NCT00237523|Cadexomer iodine|cadexomer iodine|mesh-list
92572882|NCT00237523|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92572883|NCT00237523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572884|NCT00237523|Trace Elements|trace elements|mesh-ancestor
92572885|NCT00237523|Micronutrients|micronutrients|mesh-ancestor
92572886|NCT00237523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572887|NCT00098124|Milnacipran|milnacipran|mesh-list
92572888|NCT00098124|Levomilnacipran|levomilnacipran|mesh-list
92572889|NCT00098124|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92572890|NCT00098124|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92572891|NCT00098124|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572892|NCT00098124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572893|NCT00098124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572894|NCT00098124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572895|NCT00098124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92572896|NCT00098124|Analgesics|analgesics|mesh-ancestor
92572897|NCT00098124|Sensory System Agents|sensory system agents|mesh-ancestor
92572898|NCT00098124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572899|NCT00098124|Antidepressive Agents|antidepressive agents|mesh-ancestor
92572900|NCT00098124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572901|NCT04710160|Calcium|calcium|mesh-list
92572902|NCT04710160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92572903|NCT04710160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572904|NCT00065351|Lenalidomide|lenalidomide|mesh-list
92572905|NCT00065351|Immunologic Factors|immunologic factors|mesh-ancestor
92572906|NCT00065351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572907|NCT00065351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92572908|NCT00065351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92297708|NCT05923996|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92572909|NCT00065351|Growth Substances|growth substances|mesh-ancestor
92572910|NCT00065351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92572911|NCT00065351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572912|NCT04709770|Simethicone|simethicone|mesh-list
92572913|NCT04709770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572914|NCT04709770|Antifoaming Agents|antifoaming agents|mesh-ancestor
92572915|NCT04709770|Emollients|emollients|mesh-ancestor
92572916|NCT04709770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92572918|NCT04709731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572919|NCT04709731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572920|NCT04709731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572921|NCT04709731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572922|NCT00398684|Nevirapine|nevirapine|mesh-list
92572923|NCT00398684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92572924|NCT00398684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92572925|NCT00398684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572926|NCT00398684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572927|NCT00398684|Antiviral Agents|antiviral agents|mesh-ancestor
92572928|NCT00398684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572929|NCT00398684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92572936|NCT00076440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92572937|NCT00076440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358932|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92572938|NCT00076440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92572939|NCT00076440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572940|NCT00237874|Aripiprazole|aripiprazole|mesh-list
92572941|NCT00237874|Antidepressive Agents|antidepressive agents|mesh-ancestor
92572942|NCT00237874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572943|NCT00237874|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572944|NCT00237874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572945|NCT00237874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572946|NCT00237874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572947|NCT00237874|Dopamine Agonists|dopamine agonists|mesh-ancestor
92572948|NCT00237874|Dopamine Agents|dopamine agents|mesh-ancestor
92572949|NCT00237874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572950|NCT00237874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572951|NCT00237874|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92572952|NCT00237874|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92572953|NCT00237874|Serotonin Agents|serotonin agents|mesh-ancestor
92572954|NCT00237874|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92572955|NCT00237874|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572956|NCT00237874|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92572957|NCT00237874|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572958|NCT00237913|Olanzapine|olanzapine|mesh-list
92572959|NCT00237913|Risperidone|risperidone|mesh-list
92572960|NCT00237913|Aripiprazole|aripiprazole|mesh-list
92572961|NCT00237913|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92572962|NCT00237913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572963|NCT00237913|Serotonin Agents|serotonin agents|mesh-ancestor
92572964|NCT00237913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572965|NCT00237913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572966|NCT00237913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572967|NCT00237913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572968|NCT00237913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572969|NCT00237913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572970|NCT00237913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572971|NCT00237913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572972|NCT00237913|Dopamine Agents|dopamine agents|mesh-ancestor
92572973|NCT00237913|Antiemetics|antiemetics|mesh-ancestor
92572974|NCT00237913|Autonomic Agents|autonomic agents|mesh-ancestor
92572975|NCT00237913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572976|NCT00237913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572977|NCT00237913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92572978|NCT00237913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92572979|NCT00237913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92572980|NCT00237913|Antidepressive Agents|antidepressive agents|mesh-ancestor
92572981|NCT00237913|Dopamine Agonists|dopamine agonists|mesh-ancestor
92572982|NCT00237913|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92572983|NCT00237913|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92297782|NCT05922839|Zanubrutinib|zanubrutinib|mesh-list
92572984|NCT00237913|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92572985|NCT00237913|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92572986|NCT00237952|Chelating Agents|chelating agents|mesh-list
92572987|NCT00237952|Sequestering Agents|sequestering agents|mesh-ancestor
92572988|NCT00237952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572989|NCT00098241|Everolimus|everolimus|mesh-list
92572990|NCT00098241|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92572991|NCT00098241|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572992|NCT00098241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572993|NCT00098241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572994|NCT00098241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572995|NCT00098241|Immunologic Factors|immunologic factors|mesh-ancestor
92572996|NCT00098241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573017|NCT00065390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573018|NCT00065390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573019|NCT00238225|Calcitriol|calcitriol|mesh-list
92573020|NCT00238225|Ketoconazole|ketoconazole|mesh-list
92573021|NCT00238225|Dexamethasone|dexamethasone|mesh-list
92573022|NCT00238225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573023|NCT00238225|Antiemetics|antiemetics|mesh-ancestor
92573024|NCT00238225|Autonomic Agents|autonomic agents|mesh-ancestor
92573025|NCT00238225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573026|NCT00238225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573027|NCT00238225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573028|NCT00238225|Glucocorticoids|glucocorticoids|mesh-ancestor
92573029|NCT00238225|Hormones|hormones|mesh-ancestor
92573030|NCT00238225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573031|NCT00238225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92573032|NCT00238225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573033|NCT00238225|Antifungal Agents|antifungal agents|mesh-ancestor
92573034|NCT00238225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573035|NCT00238225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92573036|NCT00238225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92573037|NCT00238225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573038|NCT00238225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573039|NCT00238225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92573040|NCT00238225|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573041|NCT00238225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92573042|NCT00238225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92573043|NCT00238225|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92573044|NCT00238225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92573045|NCT00238225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92573046|NCT00238225|Vitamins|vitamins|mesh-ancestor
92573047|NCT00238225|Micronutrients|micronutrients|mesh-ancestor
92573048|NCT00238225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92534983|NCT00072436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92534984|NCT00072436|Growth Inhibitors|growth inhibitors|mesh-ancestor
92534985|NCT00072436|Growth Substances|growth substances|mesh-ancestor
92534986|NCT00072436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534987|NCT00072436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573049|NCT00076518|Fenofibrate|fenofibrate|mesh-list
92573050|NCT00076518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92573051|NCT00076518|Antimetabolites|antimetabolites|mesh-ancestor
91980393|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
92573068|NCT00098280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573069|NCT00098280|Immunologic Factors|immunologic factors|mesh-ancestor
92573070|NCT00098280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573071|NCT00238459|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92573072|NCT00238459|Vaccines|vaccines|mesh-list
92573073|NCT00238459|Immunologic Factors|immunologic factors|mesh-ancestor
92573074|NCT00238459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573075|NCT00238459|Antiviral Agents|antiviral agents|mesh-ancestor
92573076|NCT00238459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573077|NCT00238498|Vildagliptin|vildagliptin|mesh-list
92573078|NCT00238498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92573079|NCT00238498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573080|NCT00238498|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92573081|NCT00238498|Protease Inhibitors|protease inhibitors|mesh-ancestor
92573082|NCT00238498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573083|NCT00238498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573084|NCT00238537|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92573085|NCT00238537|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92573086|NCT00238537|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92573087|NCT00238537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573088|NCT00098319|Folic Acid|folic acid|mesh-list
92573089|NCT00098319|Hematinics|hematinics|mesh-ancestor
92573090|NCT00098319|Vitamin B Complex|vitamin b complex|mesh-ancestor
92573091|NCT00098319|Vitamins|vitamins|mesh-ancestor
92573092|NCT00098319|Micronutrients|micronutrients|mesh-ancestor
92573093|NCT00098319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573094|NCT00238732|Bazedoxifene|bazedoxifene|mesh-list
92573095|NCT00238732|Estrogens|estrogens|mesh-list
92573096|NCT00238732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92573097|NCT00238732|Hormones|hormones|mesh-ancestor
92573098|NCT00238732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573099|NCT00238732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573100|NCT00238732|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92573101|NCT00238732|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92573102|NCT00238732|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573103|NCT00238732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573104|NCT00238849|Oxaliplatin|oxaliplatin|mesh-list
92573105|NCT00238849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573106|NCT00238927|Fluticasone|fluticasone|mesh-list
92573107|NCT00238927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573108|NCT00238927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92573109|NCT00238927|Autonomic Agents|autonomic agents|mesh-ancestor
92573112|NCT00238927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92573113|NCT00238927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92573114|NCT00238927|Dermatologic Agents|dermatologic agents|mesh-ancestor
92573115|NCT00238927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92573117|NCT00065624|Antioxidants|antioxidants|mesh-ancestor
92573118|NCT00065624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573119|NCT00065624|Protective Agents|protective agents|mesh-ancestor
92573120|NCT00065624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573121|NCT00065624|Vitamin B Complex|vitamin b complex|mesh-ancestor
92573122|NCT00065624|Vitamins|vitamins|mesh-ancestor
92573123|NCT00065624|Micronutrients|micronutrients|mesh-ancestor
92573124|NCT00238966|Mycophenolic Acid|mycophenolic acid|mesh-list
92573125|NCT00238966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573126|NCT00238966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573127|NCT00238966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92573128|NCT00238966|Antitubercular Agents|antitubercular agents|mesh-ancestor
92573129|NCT00238966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573130|NCT00238966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573131|NCT00238966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573132|NCT00238966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534988|NCT00072436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534989|NCT00072553|Leucovorin|leucovorin|mesh-list
92534990|NCT00072553|Celecoxib|celecoxib|mesh-list
92534991|NCT00072553|Fluorouracil|fluorouracil|mesh-list
92573133|NCT00239044|Mycophenolic Acid|mycophenolic acid|mesh-list
92573134|NCT00239044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573135|NCT00239044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573136|NCT00239044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92573137|NCT00239044|Antitubercular Agents|antitubercular agents|mesh-ancestor
92573138|NCT00239044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573139|NCT00239044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573140|NCT00239044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573141|NCT00239044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573142|NCT00098358|Zileuton|zileuton|mesh-list
92573143|NCT00098358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92573144|NCT00098358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92573145|NCT00098358|Analgesics|analgesics|mesh-ancestor
92573146|NCT00098358|Sensory System Agents|sensory system agents|mesh-ancestor
92573147|NCT00098358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573148|NCT00098358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573149|NCT00098358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573150|NCT00098358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573151|NCT00098358|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92573152|NCT00098358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573153|NCT00098358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573154|NCT00098358|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92573155|NCT00098358|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573156|NCT00098358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573157|NCT00239083|Mycophenolic Acid|mycophenolic acid|mesh-list
92573158|NCT00239083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573159|NCT00239083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573160|NCT00239083|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92573161|NCT00239083|Antitubercular Agents|antitubercular agents|mesh-ancestor
92573162|NCT00239083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573163|NCT00239083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573164|NCT00239083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573165|NCT00239083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573166|NCT00239161|Levofloxacin|levofloxacin|mesh-list
92573167|NCT00239161|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92573168|NCT00239161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573169|NCT00239161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573170|NCT00239161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92573171|NCT00239161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92573172|NCT00239161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573173|NCT00239161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573174|NCT00239161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573175|NCT00239161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92573176|NCT00239161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92573177|NCT00239200|Lapatinib|lapatinib|mesh-list
92573178|NCT00239200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573179|NCT00239200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573207|NCT00414349|Analgesics|analgesics|mesh-list
92573208|NCT00414349|Sensory System Agents|sensory system agents|mesh-ancestor
92573209|NCT00414349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573210|NCT00414349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573211|NCT00065741|Silymarin|silymarin|mesh-list
92573212|NCT00065741|Antioxidants|antioxidants|mesh-ancestor
92573213|NCT00065741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573214|NCT00065741|Protective Agents|protective agents|mesh-ancestor
92573215|NCT00065741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573216|NCT00098397|Romidepsin|romidepsin|mesh-list
92573217|NCT00098397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573218|NCT00098397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573219|NCT00098397|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92573220|NCT00098397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573221|NCT00098397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573222|NCT00239278|Prednisolone|prednisolone|mesh-list
92573223|NCT00239278|Budesonide|budesonide|mesh-list
92573224|NCT00239278|Formoterol Fumarate|formoterol fumarate|mesh-list
92573225|NCT00239278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573226|NCT00239278|Glucocorticoids|glucocorticoids|mesh-ancestor
92534992|NCT00072553|Oxaliplatin|oxaliplatin|mesh-list
92534993|NCT00072553|Calcium|calcium|mesh-list
92534994|NCT00072553|Levoleucovorin|levoleucovorin|mesh-list
92573227|NCT00239278|Hormones|hormones|mesh-ancestor
92573228|NCT00239278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573229|NCT00239278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980577|NCT02429219|Ethanol|ethanol|mesh-list
92573236|NCT00239278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92573237|NCT00239278|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92573238|NCT00239278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92573239|NCT00239278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92573240|NCT00239278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92573241|NCT00239278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573242|NCT00239278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573244|NCT00239395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92573245|NCT00239395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92573246|NCT00239395|Analgesics|analgesics|mesh-ancestor
92573247|NCT00239395|Sensory System Agents|sensory system agents|mesh-ancestor
92573248|NCT00239395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573249|NCT00239395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573250|NCT00239395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573251|NCT00239395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573252|NCT00239395|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92573253|NCT00239395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92573254|NCT00239395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573255|NCT00239395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573256|NCT00076635|Interferons|interferons|mesh-list
92573257|NCT00076635|Interferon-gamma|interferon-gamma|mesh-list
92573258|NCT00076635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573259|NCT00076635|Antiviral Agents|antiviral agents|mesh-ancestor
92573260|NCT00076635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573261|NCT00239434|Bromides|bromides|mesh-list
92573262|NCT00239434|Tiotropium Bromide|tiotropium bromide|mesh-list
92573263|NCT00239434|Ipratropium|ipratropium|mesh-list
92573264|NCT00239434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92573265|NCT00239434|Autonomic Agents|autonomic agents|mesh-ancestor
92573266|NCT00239434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573267|NCT00239434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573268|NCT00239434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92573269|NCT00239434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92573270|NCT00239434|Parasympatholytics|parasympatholytics|mesh-ancestor
92573271|NCT00239434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92573272|NCT00239434|Cholinergic Agents|cholinergic agents|mesh-ancestor
92573273|NCT00239434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573274|NCT00239434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573275|NCT00239434|Anticonvulsants|anticonvulsants|mesh-ancestor
92573276|NCT00239473|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92573277|NCT00239473|Tiotropium Bromide|tiotropium bromide|mesh-list
92573278|NCT00239473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92573279|NCT00239473|Autonomic Agents|autonomic agents|mesh-ancestor
92573280|NCT00239473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573281|NCT00239473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573282|NCT00239473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92298086|NCT05919992|Metyrapone|metyrapone|mesh-list
92573283|NCT00239473|Respiratory System Agents|respiratory system agents|mesh-ancestor
92573284|NCT00239473|Parasympatholytics|parasympatholytics|mesh-ancestor
92573285|NCT00239473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92573286|NCT00239473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92573287|NCT00239473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573288|NCT00239473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573289|NCT00239512|Ibuprofen|ibuprofen|mesh-list
92573290|NCT00239512|Indomethacin|indomethacin|mesh-list
92573291|NCT00239512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92573292|NCT00239512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92573293|NCT00239512|Analgesics|analgesics|mesh-ancestor
92573294|NCT00239512|Sensory System Agents|sensory system agents|mesh-ancestor
92573295|NCT00239512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573296|NCT00239512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573312|NCT00239551|Lansoprazole|lansoprazole|mesh-list
92573313|NCT00239551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92573314|NCT00239551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92359163|NCT00334074|Cytarabine|cytarabine|mesh-list
92573315|NCT00239551|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92573316|NCT00239551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92534995|NCT00072553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92534996|NCT00072553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534997|NCT00072553|Antimetabolites|antimetabolites|mesh-ancestor
92537695|NCT02825979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573317|NCT00239551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573318|NCT00239629|Teriparatide|teriparatide|mesh-list
92573319|NCT00239629|Strontium ranelate|strontium ranelate|mesh-list
92573320|NCT00239629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92573321|NCT00239629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573322|NCT00239629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573323|NCT00098436|Temozolomide|temozolomide|mesh-list
92573324|NCT00098436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92573325|NCT00098436|Alkylating Agents|alkylating agents|mesh-ancestor
92573326|NCT00098436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573327|NCT00098436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573328|NCT00239707|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92573329|NCT00239707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573330|NCT00239707|Incretins|incretins|mesh-ancestor
92573331|NCT00239707|Hormones|hormones|mesh-ancestor
92573332|NCT00239707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573333|NCT00239707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573334|NCT00239746|Ibuprofen|ibuprofen|mesh-list
92573335|NCT00239746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92573336|NCT00239746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92573337|NCT00239746|Analgesics|analgesics|mesh-ancestor
92573338|NCT00239746|Sensory System Agents|sensory system agents|mesh-ancestor
92573339|NCT00239746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573340|NCT00239746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573341|NCT00239746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573342|NCT00239746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573343|NCT00239746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92573344|NCT00239746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573345|NCT00239746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573346|NCT00239785|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92573347|NCT00239785|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92573348|NCT00239785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573349|NCT00239785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573350|NCT00239785|Immunologic Factors|immunologic factors|mesh-ancestor
92573351|NCT00239785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573352|NCT00239863|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91980696|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
92573358|NCT00239902|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92573359|NCT00239902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92573360|NCT00239902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573361|NCT00239902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573362|NCT00239902|Immunologic Factors|immunologic factors|mesh-ancestor
92573363|NCT00239902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573366|NCT00239980|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92573367|NCT00239980|Anticoagulants|anticoagulants|mesh-ancestor
92573368|NCT00239980|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92573369|NCT00239980|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92573370|NCT00239980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573371|NCT00240019|Furosemide|furosemide|mesh-list
92573372|NCT00240019|Diuretics|diuretics|mesh-ancestor
92573373|NCT00240019|Natriuretic Agents|natriuretic agents|mesh-ancestor
92573374|NCT00240019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573375|NCT00240019|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92573376|NCT00240019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92573377|NCT00240019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573378|NCT00240058|Phenylephrine|phenylephrine|mesh-list
92573379|NCT00240058|Oxymetazoline|oxymetazoline|mesh-list
92573380|NCT00240058|Nitric Oxide|nitric oxide|mesh-list
92573381|NCT00240058|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92573382|NCT00240058|Mydriatics|mydriatics|mesh-ancestor
92573383|NCT00240058|Autonomic Agents|autonomic agents|mesh-ancestor
92573384|NCT00240058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573385|NCT00240058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92534998|NCT00072553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92534999|NCT00072553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535000|NCT00072553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573386|NCT00240058|Sympathomimetics|sympathomimetics|mesh-ancestor
92573387|NCT00240058|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92573388|NCT00240058|Nasal Decongestants|nasal decongestants|mesh-ancestor
92573389|NCT00240058|Respiratory System Agents|respiratory system agents|mesh-ancestor
92573390|NCT00240058|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92573391|NCT00240058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92573392|NCT00240058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92573393|NCT00240058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92573394|NCT00240058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573395|NCT00240058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573396|NCT00240058|Protective Agents|protective agents|mesh-ancestor
92573397|NCT00240058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92573398|NCT00240058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92573399|NCT00240058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92573400|NCT00240058|Antioxidants|antioxidants|mesh-ancestor
92573401|NCT00240058|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92573402|NCT00240058|Vasodilator Agents|vasodilator agents|mesh-ancestor
92573403|NCT00240058|Gasotransmitters|gasotransmitters|mesh-ancestor
92573404|NCT00098553|Everolimus|everolimus|mesh-list
92573405|NCT00098553|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92573406|NCT00098553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573407|NCT00098553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573408|NCT00098553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573409|NCT00098553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573410|NCT00098553|Immunologic Factors|immunologic factors|mesh-ancestor
92573411|NCT00098553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573412|NCT00098553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573413|NCT00240214|Sirolimus|sirolimus|mesh-list
92573414|NCT00240214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573415|NCT00240214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573416|NCT00240214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573417|NCT00240214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573418|NCT00240214|Antifungal Agents|antifungal agents|mesh-ancestor
92359220|NCT00344682|Memantine|memantine|mesh-list
92573419|NCT00240214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573420|NCT00240214|Immunologic Factors|immunologic factors|mesh-ancestor
92573441|NCT00240409|Antioxidants|antioxidants|mesh-ancestor
92573442|NCT00240409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573443|NCT00240409|Protective Agents|protective agents|mesh-ancestor
92573444|NCT00240409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573445|NCT00240409|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92573446|NCT00240409|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92573447|NCT00240409|Dopamine Agonists|dopamine agonists|mesh-ancestor
92573448|NCT00240409|Dopamine Agents|dopamine agents|mesh-ancestor
92573449|NCT00240409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573450|NCT00240409|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573451|NCT00240409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573453|NCT00240448|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92573454|NCT00240448|Telmisartan|telmisartan|mesh-list
92573455|NCT00240448|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92573456|NCT00240448|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92573457|NCT00240448|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92573458|NCT00240448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573459|NCT00240448|Diuretics|diuretics|mesh-ancestor
92573460|NCT00240448|Natriuretic Agents|natriuretic agents|mesh-ancestor
92573461|NCT00240448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573462|NCT00240448|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92573463|NCT00240448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92573464|NCT00098631|Lapatinib|lapatinib|mesh-list
92573465|NCT00098631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573466|NCT00098631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573467|NCT00098631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573468|NCT00098631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573469|NCT00240604|Rosiglitazone|rosiglitazone|mesh-list
92573470|NCT00240604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92573471|NCT00240604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573472|NCT00076791|Tenofovir|tenofovir|mesh-list
92573480|NCT00076791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535001|NCT00072553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535002|NCT00072553|Immunologic Factors|immunologic factors|mesh-ancestor
92535003|NCT00072553|Antidotes|antidotes|mesh-ancestor
92535004|NCT00072553|Protective Agents|protective agents|mesh-ancestor
92573482|NCT00076791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92573483|NCT00240682|Cetuximab|cetuximab|mesh-list
92573484|NCT00240682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92573485|NCT00240682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573486|NCT00240721|Topiramate|topiramate|mesh-list
92573487|NCT00240721|Anticonvulsants|anticonvulsants|mesh-ancestor
92573488|NCT00240721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92573489|NCT00240721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573490|NCT00240760|Memantine|memantine|mesh-list
92573491|NCT00240760|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92573492|NCT00240760|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92573493|NCT00240760|Dopamine Agents|dopamine agents|mesh-ancestor
92573494|NCT00240760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573495|NCT00240760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573496|NCT00240760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573497|NCT00240760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92573498|NCT00240760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92573499|NCT00066092|Lenograstim|lenograstim|mesh-list
92573500|NCT00066092|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92573501|NCT00066092|Immunologic Factors|immunologic factors|mesh-ancestor
92573502|NCT00066092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573504|NCT04720807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573505|NCT04720807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92573506|NCT04720807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92573507|NCT04720807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573508|NCT04720807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573509|NCT04720807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92573510|NCT04720807|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573511|NCT04720807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573512|NCT04720807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573513|NCT00240799|Acetaminophen|acetaminophen|mesh-list
92573514|NCT00240799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92573515|NCT00240799|Analgesics|analgesics|mesh-ancestor
92573516|NCT00240799|Sensory System Agents|sensory system agents|mesh-ancestor
92573517|NCT00240799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573518|NCT00240799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573519|NCT00240799|Antipyretics|antipyretics|mesh-ancestor
92573520|NCT00240838|Acetaminophen|acetaminophen|mesh-list
92573521|NCT00240838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92573522|NCT00240838|Analgesics|analgesics|mesh-ancestor
92573523|NCT00240838|Sensory System Agents|sensory system agents|mesh-ancestor
92573524|NCT00240838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573525|NCT00240838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573526|NCT00240838|Antipyretics|antipyretics|mesh-ancestor
92573527|NCT02965404|Vaccines|vaccines|mesh-list
92573528|NCT02965404|Immunologic Factors|immunologic factors|mesh-ancestor
92573529|NCT02965404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573530|NCT00240955|Mycophenolic Acid|mycophenolic acid|mesh-list
92573531|NCT00240955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573532|NCT00240955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573533|NCT00240955|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92573534|NCT00240955|Antitubercular Agents|antitubercular agents|mesh-ancestor
92573535|NCT00240955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573536|NCT00240955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573537|NCT00240955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573538|NCT00240955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573539|NCT00241072|Valsartan|valsartan|mesh-list
92573542|NCT00241072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92573543|NCT00241072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573545|NCT00241111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573546|NCT00241111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573547|NCT00241150|Valsartan|valsartan|mesh-list
92573548|NCT00241150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92573549|NCT00241150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92573550|NCT00241150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92573551|NCT00241150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573552|NCT00076869|Amphotericin B|amphotericin b|mesh-list
92535005|NCT00072553|Vitamin B Complex|vitamin b complex|mesh-ancestor
92535006|NCT00072553|Vitamins|vitamins|mesh-ancestor
92535007|NCT00072553|Micronutrients|micronutrients|mesh-ancestor
92573553|NCT00076869|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92573554|NCT00076869|Caspofungin|caspofungin|mesh-list
92573555|NCT00076869|Amebicides|amebicides|mesh-ancestor
92573556|NCT00076869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92573557|NCT00076869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92573558|NCT00076869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573559|NCT00076869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573560|NCT00076869|Antifungal Agents|antifungal agents|mesh-ancestor
92573561|NCT00076869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573562|NCT00076869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573563|NCT00066248|Cyproheptadine|cyproheptadine|mesh-list
92573564|NCT00066248|Megestrol|megestrol|mesh-list
92573565|NCT00066248|Megestrol Acetate|megestrol acetate|mesh-list
92573566|NCT00066248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92573567|NCT00066248|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92573568|NCT00066248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92573569|NCT00066248|Contraceptive Agents|contraceptive agents|mesh-ancestor
92573570|NCT00066248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92573571|NCT00066248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573572|NCT00066248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92573573|NCT00066248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92573574|NCT00066248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92573575|NCT00066248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573576|NCT00066248|Appetite Stimulants|appetite stimulants|mesh-ancestor
92573577|NCT00066248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92573578|NCT00066248|Antipruritics|antipruritics|mesh-ancestor
92573579|NCT00066248|Dermatologic Agents|dermatologic agents|mesh-ancestor
92573580|NCT00066248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573581|NCT00066248|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92573582|NCT00066248|Histamine Antagonists|histamine antagonists|mesh-ancestor
92573583|NCT00066248|Histamine Agents|histamine agents|mesh-ancestor
92573584|NCT00066248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573585|NCT00066248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573586|NCT00066248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92573587|NCT00066248|Serotonin Agents|serotonin agents|mesh-ancestor
92573588|NCT00066248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92573589|NCT00241189|Sirolimus|sirolimus|mesh-list
92573590|NCT00241189|Methotrexate|methotrexate|mesh-list
92573591|NCT00241189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92573592|NCT00241189|Abortifacient Agents|abortifacient agents|mesh-ancestor
92573593|NCT00241189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92573594|NCT00241189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573595|NCT00241189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573596|NCT00241189|Antimetabolites|antimetabolites|mesh-ancestor
92573597|NCT00241189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573598|NCT00241189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573599|NCT00241189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92573600|NCT00241189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573601|NCT00241189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92573602|NCT00241189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573603|NCT00241189|Immunologic Factors|immunologic factors|mesh-ancestor
92573604|NCT00241189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573605|NCT00241189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92573606|NCT00241189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92573607|NCT00241189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573608|NCT00241189|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573609|NCT00241189|Antifungal Agents|antifungal agents|mesh-ancestor
92573610|NCT00066326|Imatinib Mesylate|imatinib mesylate|mesh-list
92573613|NCT00066326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573614|NCT00066326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573615|NCT00241345|Valganciclovir|valganciclovir|mesh-list
92573616|NCT00241345|Ganciclovir|ganciclovir|mesh-list
92573617|NCT00241345|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92573618|NCT00241345|Antiviral Agents|antiviral agents|mesh-ancestor
92573619|NCT00241345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573620|NCT00241345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92573621|NCT00241345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573622|NCT00241345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573623|NCT00241423|Exenatide|exenatide|mesh-list
92573624|NCT00241423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92535008|NCT00072553|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92535009|NCT00072553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92535010|NCT00072553|Analgesics|analgesics|mesh-ancestor
92573625|NCT00241423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573626|NCT00241423|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92573627|NCT00241423|Incretins|incretins|mesh-ancestor
92573628|NCT00241423|Hormones|hormones|mesh-ancestor
92573629|NCT00241423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573630|NCT00241501|Esomeprazole|esomeprazole|mesh-list
92573631|NCT00241501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92573632|NCT00241501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573633|NCT00241501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92573634|NCT00241501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573635|NCT00241501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573636|NCT00076986|Carmustine|carmustine|mesh-list
92573637|NCT00076986|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92573638|NCT00076986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92573639|NCT00076986|Alkylating Agents|alkylating agents|mesh-ancestor
92573640|NCT00076986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573641|NCT00076986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573642|NCT00241540|Esomeprazole|esomeprazole|mesh-list
92573643|NCT00241540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92573644|NCT00241540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573645|NCT00241540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92573646|NCT00241540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573647|NCT00241540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573648|NCT00066443|Docetaxel|docetaxel|mesh-list
92573649|NCT00066443|Epirubicin|epirubicin|mesh-list
92573650|NCT00066443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573651|NCT00066443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92573652|NCT00066443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92573653|NCT00066443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92573654|NCT00066443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573655|NCT00066443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573656|NCT00066443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92573657|NCT00066443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92573658|NCT00066443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573659|NCT00098982|Leucovorin|leucovorin|mesh-list
92573660|NCT00098982|Fluorouracil|fluorouracil|mesh-list
92573661|NCT00098982|Oxaliplatin|oxaliplatin|mesh-list
92573662|NCT00098982|Bortezomib|bortezomib|mesh-list
92573663|NCT00098982|Calcium|calcium|mesh-list
92573664|NCT00098982|Levoleucovorin|levoleucovorin|mesh-list
92573665|NCT00098982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92573666|NCT00098982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573667|NCT00098982|Antimetabolites|antimetabolites|mesh-ancestor
92573668|NCT00098982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573669|NCT00098982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573670|NCT00098982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573671|NCT00098982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573672|NCT00098982|Immunologic Factors|immunologic factors|mesh-ancestor
92573673|NCT00098982|Antidotes|antidotes|mesh-ancestor
92573674|NCT00098982|Protective Agents|protective agents|mesh-ancestor
92573675|NCT00098982|Vitamin B Complex|vitamin b complex|mesh-ancestor
92573676|NCT00098982|Vitamins|vitamins|mesh-ancestor
92573677|NCT00098982|Micronutrients|micronutrients|mesh-ancestor
92573678|NCT00241618|Interferons|interferons|mesh-list
92573679|NCT00241618|Ribavirin|ribavirin|mesh-list
92573680|NCT00241618|Interferon-alpha|interferon-alpha|mesh-list
92573681|NCT00241618|Interferon alpha-2|interferon alpha-2|mesh-list
92573682|NCT00241618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573683|NCT00241618|Antiviral Agents|antiviral agents|mesh-ancestor
92573684|NCT00241618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573685|NCT00241618|Antimetabolites|antimetabolites|mesh-ancestor
92573690|NCT00066482|Cisplatin|cisplatin|mesh-list
92573691|NCT00066482|Etoposide|etoposide|mesh-list
92573692|NCT00066482|Bleomycin|bleomycin|mesh-list
92573693|NCT00066482|Lenograstim|lenograstim|mesh-list
92573695|NCT00066482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573696|NCT00066482|Immunologic Factors|immunologic factors|mesh-ancestor
92573697|NCT00066482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573698|NCT00066482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573699|NCT00066482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92573700|NCT00066482|Alkylating Agents|alkylating agents|mesh-ancestor
92573701|NCT00066482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535011|NCT00072553|Sensory System Agents|sensory system agents|mesh-ancestor
92535012|NCT00072553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573702|NCT00066482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573703|NCT00066482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92573704|NCT00066482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92573705|NCT00066482|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92573706|NCT00066482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92573707|NCT00066482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573708|NCT00066482|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92573709|NCT00066482|Protective Agents|protective agents|mesh-ancestor
92573710|NCT00066482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573711|NCT00099060|Lapatinib|lapatinib|mesh-list
92573712|NCT00099060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573713|NCT00099060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573714|NCT00099060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573715|NCT00099060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573716|NCT00066599|Voriconazole|voriconazole|mesh-list
92573717|NCT00066599|Antifungal Agents|antifungal agents|mesh-ancestor
92573718|NCT00066599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573719|NCT00066599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92573720|NCT00066599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92573721|NCT00066599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573722|NCT00066599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573723|NCT00066599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92573724|NCT00066599|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573725|NCT00066599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573726|NCT00066599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573727|NCT00066599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92573728|NCT00242008|Rotigotine|rotigotine|mesh-list
92573729|NCT00242008|Dopamine Agonists|dopamine agonists|mesh-ancestor
92573730|NCT00242008|Dopamine Agents|dopamine agents|mesh-ancestor
92573731|NCT00242008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573732|NCT00242008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573733|NCT00242008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573734|NCT00242164|Dialysis Solutions|dialysis solutions|mesh-list
92573735|NCT00242164|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92573736|NCT00099177|Zoledronic Acid|zoledronic acid|mesh-list
92573737|NCT00099177|Ibandronic Acid|ibandronic acid|mesh-list
92573738|NCT00099177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573739|NCT00099177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573740|NCT02962024|Morphine|morphine|mesh-list
92573741|NCT02962024|Bupivacaine|bupivacaine|mesh-list
92573742|NCT02962024|Anesthetics, Local|anesthetics, local|mesh-ancestor
92573743|NCT02962024|Anesthetics|anesthetics|mesh-ancestor
92573744|NCT02962024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92573745|NCT02962024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573746|NCT02962024|Sensory System Agents|sensory system agents|mesh-ancestor
92573747|NCT02962024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573748|NCT02962024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92573749|NCT02962024|Narcotics|narcotics|mesh-ancestor
92573750|NCT02962024|Analgesics|analgesics|mesh-ancestor
92573751|NCT00066638|Romidepsin|romidepsin|mesh-list
92573752|NCT00066638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573753|NCT00066638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573754|NCT00066638|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92573755|NCT00066638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573756|NCT00066638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573764|NCT00242203|Mitosis Modulators|mitosis modulators|mesh-ancestor
92573765|NCT00242203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573766|NCT00242203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92573767|NCT00242203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573768|NCT00242203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92573769|NCT00242203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92573770|NCT00242203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573771|NCT00242203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573772|NCT00242203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573773|NCT00077025|Gefitinib|gefitinib|mesh-list
92573774|NCT00077025|Anastrozole|anastrozole|mesh-list
92573775|NCT00077025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573776|NCT00077025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535013|NCT00072553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535014|NCT00072553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573777|NCT00077025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573778|NCT00077025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573779|NCT00077025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92573780|NCT00077025|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92573781|NCT00077025|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92573782|NCT00077025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92573783|NCT00077025|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573784|NCT00077025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573785|NCT00077025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573787|NCT00242359|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92573788|NCT00242359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92573789|NCT00242359|Respiratory System Agents|respiratory system agents|mesh-ancestor
92573790|NCT00066716|Celecoxib|celecoxib|mesh-list
92573791|NCT00066716|Paclitaxel|paclitaxel|mesh-list
92573792|NCT00066716|Carboplatin|carboplatin|mesh-list
92573793|NCT00066716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92573794|NCT00066716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573795|NCT00066716|Tubulin Modulators|tubulin modulators|mesh-ancestor
92573796|NCT00066716|Antimitotic Agents|antimitotic agents|mesh-ancestor
92573797|NCT00066716|Mitosis Modulators|mitosis modulators|mesh-ancestor
92573798|NCT00066716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573799|NCT00066716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92573800|NCT00066716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298611|NCT05672108|Mitomycins|mitomycins|mesh-list
92573801|NCT00066716|Analgesics|analgesics|mesh-ancestor
92573802|NCT00066716|Sensory System Agents|sensory system agents|mesh-ancestor
92573803|NCT00066716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573804|NCT00066716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573805|NCT00066716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573806|NCT00066716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573807|NCT00066716|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92573808|NCT00066716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92573809|NCT00066716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573810|NCT00077103|Doxorubicin|doxorubicin|mesh-list
92573811|NCT00077103|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92573812|NCT00077103|Fosbretabulin|fosbretabulin|mesh-list
92573813|NCT00077103|Combretastatin|combretastatin|mesh-list
92573814|NCT00077103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573815|NCT00077103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573816|NCT00077103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92573817|NCT00077103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92573818|NCT00077103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573819|NCT00077103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573820|NCT00077103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92573821|NCT00077103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92573822|NCT00077103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92573823|NCT00077103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92573825|NCT00242437|Hemostatics|hemostatics|mesh-list
92573826|NCT00242437|Coagulants|coagulants|mesh-ancestor
92573833|NCT00066794|Antimetabolites|antimetabolites|mesh-ancestor
92573834|NCT00066794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573835|NCT00066794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573836|NCT00066794|Antiviral Agents|antiviral agents|mesh-ancestor
92573837|NCT00066794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573838|NCT00066794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573839|NCT00066794|Immunologic Factors|immunologic factors|mesh-ancestor
92573840|NCT00066794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573841|NCT00066794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573842|NCT00066794|Antifungal Agents|antifungal agents|mesh-ancestor
92573843|NCT00066794|Dermatologic Agents|dermatologic agents|mesh-ancestor
92573844|NCT00066794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573845|NCT00066794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92573846|NCT00066794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92573847|NCT00066794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92573848|NCT00066794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92573849|NCT00242554|Zoledronic Acid|zoledronic acid|mesh-list
92573850|NCT00242554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573851|NCT00242554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573852|NCT00242593|Rosiglitazone|rosiglitazone|mesh-list
92573853|NCT00242593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92573854|NCT00242593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573856|NCT00242749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573857|NCT00242749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573858|NCT00242749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573859|NCT00242749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573860|NCT00242788|Capecitabine|capecitabine|mesh-list
92573861|NCT00242788|Gefitinib|gefitinib|mesh-list
92573862|NCT00242788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573863|NCT00242788|Antimetabolites|antimetabolites|mesh-ancestor
92573864|NCT00242788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573865|NCT00242788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573866|NCT00242788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573867|NCT00242788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573868|NCT00066872|Imiquimod|imiquimod|mesh-list
92573869|NCT00066872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92573870|NCT00066872|Immunologic Factors|immunologic factors|mesh-ancestor
92573871|NCT00066872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573872|NCT00066872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573873|NCT00066872|Interferon Inducers|interferon inducers|mesh-ancestor
92573874|NCT00242944|Atorvastatin|atorvastatin|mesh-list
92573875|NCT00242944|Pitavastatin|pitavastatin|mesh-list
92573876|NCT00242944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92573877|NCT00242944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92573878|NCT00242944|Antimetabolites|antimetabolites|mesh-ancestor
92573879|NCT00242944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573880|NCT00242944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92573881|NCT00242944|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92573882|NCT00242944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573883|NCT00243100|Gemcitabine|gemcitabine|mesh-list
92573884|NCT00243100|Vorinostat|vorinostat|mesh-list
92573885|NCT00243100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573886|NCT00243100|Antimetabolites|antimetabolites|mesh-ancestor
92573887|NCT00243100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573888|NCT00243100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573889|NCT00243100|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92573890|NCT00243100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573891|NCT00099216|Rivastigmine|rivastigmine|mesh-list
92573892|NCT00099216|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92573893|NCT00099216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573894|NCT00099216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573895|NCT00099216|Cholinergic Agents|cholinergic agents|mesh-ancestor
92573896|NCT00099216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981226|NCT03178721|Calcium|calcium|mesh-list
92573901|NCT00066989|Antibodies|antibodies|mesh-list
92573902|NCT00066989|gamma-Globulins|gamma-globulins|mesh-list
92573903|NCT00066989|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92573904|NCT00066989|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92573905|NCT00066989|Immunologic Factors|immunologic factors|mesh-ancestor
92573906|NCT00066989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573907|NCT00243178|Clopidogrel|clopidogrel|mesh-list
92573908|NCT00243178|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92573909|NCT00243178|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92573910|NCT00243178|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92573911|NCT00243178|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92573912|NCT00243178|Purinergic Agents|purinergic agents|mesh-ancestor
92573913|NCT00243178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573914|NCT00243178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573915|NCT00243178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573916|NCT00243256|Cholecalciferol|cholecalciferol|mesh-list
92573917|NCT00243256|Vitamin D|vitamin d|mesh-list
92573918|NCT00243256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92573919|NCT00243256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573920|NCT00243256|Vitamins|vitamins|mesh-ancestor
92573921|NCT00243256|Micronutrients|micronutrients|mesh-ancestor
92573922|NCT00243256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92573923|NCT00243646|Bicalutamide|bicalutamide|mesh-list
92573924|NCT00243646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573925|NCT00243646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573926|NCT00243646|Androgen Antagonists|androgen antagonists|mesh-ancestor
92573927|NCT00243646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92573928|NCT00243646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573929|NCT00099333|Exenatide|exenatide|mesh-list
92573930|NCT00099333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92535015|NCT00072553|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91922712|NCT02221999|Paclitaxel|paclitaxel|mesh-list
92573931|NCT00099333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573932|NCT00099333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92573933|NCT00099333|Incretins|incretins|mesh-ancestor
92573934|NCT00099333|Hormones|hormones|mesh-ancestor
92573935|NCT00099333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573936|NCT00243724|Esomeprazole|esomeprazole|mesh-list
92573937|NCT00243724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92573938|NCT00243724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573939|NCT00243724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92573940|NCT00243724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573941|NCT00243724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573942|NCT00243880|Lovastatin|lovastatin|mesh-list
92573943|NCT00243880|L 647318|l 647318|mesh-list
92573944|NCT00243880|Dihydromevinolin|dihydromevinolin|mesh-list
92573945|NCT00243880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92573946|NCT00243880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92573947|NCT00243880|Antimetabolites|antimetabolites|mesh-ancestor
92573948|NCT00243880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573949|NCT00243880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92573950|NCT00243880|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92573951|NCT00243880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573952|NCT00244075|Hormones|hormones|mesh-list
92573953|NCT00244075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573954|NCT00244075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573955|NCT00244153|Dexamethasone|dexamethasone|mesh-list
92573956|NCT00244153|Morphine|morphine|mesh-list
92573957|NCT00244153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573958|NCT00244153|Antiemetics|antiemetics|mesh-ancestor
92573959|NCT00244153|Autonomic Agents|autonomic agents|mesh-ancestor
92573960|NCT00244153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573961|NCT00244153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573962|NCT00244153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573963|NCT00244153|Glucocorticoids|glucocorticoids|mesh-ancestor
92573964|NCT00244153|Hormones|hormones|mesh-ancestor
92573965|NCT00244153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92573966|NCT00244153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92573967|NCT00244153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573974|NCT02967029|Esmolol|esmolol|mesh-list
92573975|NCT02967029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92573976|NCT02967029|Narcotics|narcotics|mesh-ancestor
92573977|NCT02967029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92573978|NCT02967029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573979|NCT02967029|Analgesics|analgesics|mesh-ancestor
92573980|NCT02967029|Sensory System Agents|sensory system agents|mesh-ancestor
92359307|NCT00351936|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92573981|NCT02967029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573982|NCT02967029|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92573983|NCT02967029|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92573984|NCT02967029|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92573985|NCT02967029|Adrenergic Agents|adrenergic agents|mesh-ancestor
92573986|NCT02967029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573987|NCT02967029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573988|NCT00244192|Infliximab|infliximab|mesh-list
92573989|NCT00244192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92573990|NCT00244192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573991|NCT00244192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92573992|NCT00244192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573993|NCT00244192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573994|NCT00077181|Cytarabine|cytarabine|mesh-list
92573995|NCT00077181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573996|NCT00077181|Antimetabolites|antimetabolites|mesh-ancestor
92573997|NCT00077181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573998|NCT00077181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573999|NCT00077181|Antiviral Agents|antiviral agents|mesh-ancestor
92574000|NCT00077181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574001|NCT00077181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574002|NCT00077181|Immunologic Factors|immunologic factors|mesh-ancestor
92574003|NCT00077181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574004|NCT00244309|Tamsulosin|tamsulosin|mesh-list
92574005|NCT00244309|Dutasteride|dutasteride|mesh-list
92574006|NCT00244309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92574007|NCT00244309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92535016|NCT00072553|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92535017|NCT00072553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535018|NCT00072592|Rituximab|rituximab|mesh-list
92574008|NCT00244309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92574009|NCT00244309|Adrenergic Agents|adrenergic agents|mesh-ancestor
92574010|NCT00244309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574011|NCT00244309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574012|NCT00244309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574013|NCT00244309|Urological Agents|urological agents|mesh-ancestor
92574014|NCT00244309|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92574015|NCT00244309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92574016|NCT00244309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574017|NCT00244309|Hormone Antagonists|hormone antagonists|mesh-ancestor
92574018|NCT00244309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574019|NCT00244348|Fluorouracil|fluorouracil|mesh-list
92574020|NCT00244348|Oxaliplatin|oxaliplatin|mesh-list
92574021|NCT00244348|Antimetabolites|antimetabolites|mesh-ancestor
92574022|NCT00244348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574023|NCT00244348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92574024|NCT00244348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574025|NCT00244348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574026|NCT00244348|Immunologic Factors|immunologic factors|mesh-ancestor
92574027|NCT00244348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574028|NCT00077220|Paclitaxel|paclitaxel|mesh-list
92574029|NCT00077220|Carboplatin|carboplatin|mesh-list
92574030|NCT00077220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574031|NCT00077220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574032|NCT00077220|Tubulin Modulators|tubulin modulators|mesh-ancestor
92574033|NCT00077220|Antimitotic Agents|antimitotic agents|mesh-ancestor
92574034|NCT00077220|Mitosis Modulators|mitosis modulators|mesh-ancestor
92574035|NCT00077220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574036|NCT00244426|Aspirin|aspirin|mesh-list
92574043|NCT00244426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574044|NCT00244426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574045|NCT00244426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574046|NCT00244426|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92574047|NCT00244426|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92574048|NCT00244426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574049|NCT00244426|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92574050|NCT00244426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92574051|NCT00244426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574052|NCT00244426|Antipyretics|antipyretics|mesh-ancestor
92574054|NCT00398957|Hydromorphone|hydromorphone|mesh-list
92574055|NCT00398957|Narcotic Antagonists|narcotic antagonists|mesh-list
92574056|NCT00398957|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92574057|NCT00398957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574058|NCT00398957|Sensory System Agents|sensory system agents|mesh-ancestor
92574059|NCT00398957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574060|NCT00398957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92574061|NCT00398957|Narcotics|narcotics|mesh-ancestor
92574062|NCT00398957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574063|NCT00398957|Analgesics|analgesics|mesh-ancestor
92574064|NCT00099450|INS 50589|ins 50589|mesh-list
92574065|NCT00099450|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92574066|NCT00099450|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92574067|NCT00099450|Purinergic Agents|purinergic agents|mesh-ancestor
92574068|NCT00099450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574069|NCT00099450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574070|NCT00099450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574071|NCT00244504|Moxonidine|moxonidine|mesh-list
92574072|NCT00244504|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92574073|NCT00099489|Interferons|interferons|mesh-list
92574074|NCT00099489|Interferon-beta|interferon-beta|mesh-list
92574075|NCT00099489|Interferon beta-1a|interferon beta-1a|mesh-list
92574076|NCT00099489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574077|NCT00099489|Antiviral Agents|antiviral agents|mesh-ancestor
92574078|NCT00099489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574079|NCT00099489|Immunologic Factors|immunologic factors|mesh-ancestor
92574080|NCT00099489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574081|NCT00099489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92574082|NCT00067262|Valproic Acid|valproic acid|mesh-list
92574083|NCT00067262|Anticonvulsants|anticonvulsants|mesh-ancestor
92535019|NCT00072592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92535020|NCT00072592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535021|NCT00072592|Immunologic Factors|immunologic factors|mesh-ancestor
91922856|NCT02145065|Paclitaxel|paclitaxel|mesh-list
92574084|NCT00067262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574085|NCT00067262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574086|NCT00067262|GABA Agents|gaba agents|mesh-ancestor
92574087|NCT00067262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574088|NCT00067262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574089|NCT00067262|Antimanic Agents|antimanic agents|mesh-ancestor
92574090|NCT00067262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574091|NCT00067262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574092|NCT00067262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574093|NCT00244738|Castor Oil|castor oil|mesh-list
92574094|NCT00244738|Cathartics|cathartics|mesh-ancestor
92574095|NCT00244738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574096|NCT00077259|Epothilones|epothilones|mesh-list
92574097|NCT00077259|Desoxyepothilone B|desoxyepothilone b|mesh-list
92574098|NCT00077259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92574099|NCT00077259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92574100|NCT00077259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92574101|NCT00077259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574102|NCT00077259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574103|NCT00067301|Citalopram|citalopram|mesh-list
92574104|NCT00067301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92574105|NCT00067301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574106|NCT00067301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574122|NCT00245089|Vincristine|vincristine|mesh-list
92574123|NCT00245089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574124|NCT00245089|Immunologic Factors|immunologic factors|mesh-ancestor
92574125|NCT00245089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574126|NCT00245089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574127|NCT00245089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92574128|NCT00245089|Alkylating Agents|alkylating agents|mesh-ancestor
92574129|NCT00245089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574130|NCT00245089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574131|NCT00245089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92574132|NCT00245089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574133|NCT00245089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92574134|NCT00245089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92574135|NCT00245089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92574136|NCT00245089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574137|NCT00245089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574138|NCT00245089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92574139|NCT00245089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92574140|NCT00245089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574141|NCT00245089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92574142|NCT00067340|Chlorhexidine|chlorhexidine|mesh-list
92574143|NCT00067340|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92574144|NCT00067340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574145|NCT00067340|Disinfectants|disinfectants|mesh-ancestor
92574146|NCT00245206|Olanzapine|olanzapine|mesh-list
92574147|NCT00245206|Risperidone|risperidone|mesh-list
92574148|NCT00245206|Aripiprazole|aripiprazole|mesh-list
92574149|NCT00245206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92574150|NCT00245206|Serotonin Agents|serotonin agents|mesh-ancestor
92574151|NCT00245206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574152|NCT00245206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574153|NCT00245206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574154|NCT00245206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92574155|NCT00245206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574156|NCT00245206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574157|NCT00245206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574158|NCT00245206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92574159|NCT00245206|Dopamine Agents|dopamine agents|mesh-ancestor
92574160|NCT00245206|Antiemetics|antiemetics|mesh-ancestor
92574161|NCT00245206|Autonomic Agents|autonomic agents|mesh-ancestor
92574162|NCT00245206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574163|NCT00245206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574164|NCT00245206|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92574165|NCT00245206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92535022|NCT00072592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535023|NCT00072592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535024|NCT00072631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92535025|NCT00072631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574169|NCT00245206|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92574170|NCT00245206|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92574171|NCT00245206|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92574172|NCT00245206|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92574173|NCT00245245|Factor VIII|factor viii|mesh-list
92574174|NCT00245245|Coagulants|coagulants|mesh-ancestor
92574175|NCT00077298|Bevacizumab|bevacizumab|mesh-list
92574176|NCT00077298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92574177|NCT00077298|Cetuximab|cetuximab|mesh-list
92574178|NCT00077298|Irinotecan|irinotecan|mesh-list
92574179|NCT00077298|Antibodies|antibodies|mesh-list
92574180|NCT00077298|Immunoglobulins|immunoglobulins|mesh-list
92574181|NCT00077298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92574182|NCT00077298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574183|NCT00077298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92574184|NCT00077298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92574185|NCT00077298|Growth Substances|growth substances|mesh-ancestor
92574186|NCT00077298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574187|NCT00077298|Growth Inhibitors|growth inhibitors|mesh-ancestor
92574188|NCT00077298|Immunologic Factors|immunologic factors|mesh-ancestor
92574189|NCT00077298|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92574190|NCT00077298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92574191|NCT00077298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574192|NCT00077298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574193|NCT00245401|Sirolimus|sirolimus|mesh-list
92574194|NCT00245401|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574195|NCT00245401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574196|NCT00245401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92574197|NCT00245401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574198|NCT00245401|Antifungal Agents|antifungal agents|mesh-ancestor
92574199|NCT00245401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574200|NCT00245401|Immunologic Factors|immunologic factors|mesh-ancestor
92574201|NCT00245401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574202|NCT00245440|Azithromycin|azithromycin|mesh-list
92574203|NCT00245440|Telithromycin|telithromycin|mesh-list
92574204|NCT00245440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574205|NCT00245440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574206|NCT00400608|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92574207|NCT00400608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92574208|NCT00400608|Autonomic Agents|autonomic agents|mesh-ancestor
92574209|NCT00400608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574210|NCT00400608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574211|NCT00400608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92574212|NCT00400608|Respiratory System Agents|respiratory system agents|mesh-ancestor
92574213|NCT00400608|Glucocorticoids|glucocorticoids|mesh-ancestor
92574214|NCT00400608|Hormones|hormones|mesh-ancestor
92574215|NCT00400608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574216|NCT00400608|Sympathomimetics|sympathomimetics|mesh-ancestor
92574217|NCT00245596|Sildenafil Citrate|sildenafil citrate|mesh-list
92574218|NCT00245596|Vasodilator Agents|vasodilator agents|mesh-ancestor
92574219|NCT00245596|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92574220|NCT00245596|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92574221|NCT00245596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574222|NCT00245596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574223|NCT00245596|Urological Agents|urological agents|mesh-ancestor
92574224|NCT00245674|Amisulpride|amisulpride|mesh-list
92574225|NCT00245674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92574226|NCT00245674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574227|NCT00245674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574228|NCT00245674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574229|NCT00245674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574230|NCT00245674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92574231|NCT00245674|Dopamine Agents|dopamine agents|mesh-ancestor
92574232|NCT00245674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574233|NCT00245674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574234|NCT00245674|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92574235|NCT00245674|Antidepressive Agents|antidepressive agents|mesh-ancestor
91922991|NCT02145689|Botulinum Toxins|botulinum toxins|mesh-list
92574237|NCT00245713|Anticonvulsants|anticonvulsants|mesh-ancestor
92574253|NCT00102843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574254|NCT00102843|Lipotropic Agents|lipotropic agents|mesh-ancestor
92574255|NCT00102843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92574257|NCT00102843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574258|NCT00102843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92574260|NCT00245791|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92574261|NCT00245791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574262|NCT00245791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574263|NCT00245791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92574264|NCT00245791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92574265|NCT00245791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574266|NCT00245791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574267|NCT00245791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574268|NCT00245791|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92574269|NCT00245791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92574270|NCT00400647|Mycophenolic Acid|mycophenolic acid|mesh-list
92574271|NCT00400647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92574272|NCT00400647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574273|NCT00400647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92574274|NCT00400647|Antitubercular Agents|antitubercular agents|mesh-ancestor
92574275|NCT00400647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574276|NCT00400647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574277|NCT00400647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574278|NCT00400647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574279|NCT00245908|Azithromycin|azithromycin|mesh-list
92574280|NCT00245908|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574281|NCT00245908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574282|NCT00067496|Modafinil|modafinil|mesh-list
92574283|NCT00067496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92574284|NCT00067496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574285|NCT00067496|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92574286|NCT00067496|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92574287|NCT00067496|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92574288|NCT00067496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574289|NCT00246064|Infliximab|infliximab|mesh-list
92574290|NCT00246064|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92574291|NCT00246064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574292|NCT00246064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92574293|NCT00246064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574294|NCT00246064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574295|NCT00246103|Cyclophosphamide|cyclophosphamide|mesh-list
92574296|NCT00246103|Fluorouracil|fluorouracil|mesh-list
92574297|NCT00246103|Epirubicin|epirubicin|mesh-list
92574298|NCT00246103|Valproic Acid|valproic acid|mesh-list
91981639|NCT02419859|Insulin|insulin|mesh-list
92574305|NCT00246103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574307|NCT00246103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92574308|NCT00246103|Antimetabolites|antimetabolites|mesh-ancestor
92574309|NCT00246103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92574310|NCT00246103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92574311|NCT00246103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92574312|NCT00246103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92574313|NCT00246103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574314|NCT00246103|Anticonvulsants|anticonvulsants|mesh-ancestor
92574315|NCT00246103|GABA Agents|gaba agents|mesh-ancestor
92574316|NCT00246103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574317|NCT00246103|Antimanic Agents|antimanic agents|mesh-ancestor
92574318|NCT00246103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574319|NCT00246103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574320|NCT00246103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574321|NCT00246142|Botulinum Toxins|botulinum toxins|mesh-list
92574322|NCT00246142|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92574323|NCT00246142|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92574324|NCT00246142|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92574325|NCT00246142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574326|NCT00246142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574327|NCT00246142|Cholinergic Agents|cholinergic agents|mesh-ancestor
92574328|NCT00246142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574329|NCT00246142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574330|NCT00246142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92535026|NCT00072631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91923065|NCT02228005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574331|NCT00246142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574332|NCT00067535|Cocaine|cocaine|mesh-list
92574333|NCT00067535|Anesthetics, Local|anesthetics, local|mesh-ancestor
92574334|NCT00067535|Anesthetics|anesthetics|mesh-ancestor
92574335|NCT00067535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574336|NCT00067535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574337|NCT00067535|Sensory System Agents|sensory system agents|mesh-ancestor
92574338|NCT00067535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574339|NCT00067535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92574340|NCT00067535|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92574341|NCT00067535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574342|NCT00067535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574343|NCT00067535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574344|NCT00067535|Dopamine Agents|dopamine agents|mesh-ancestor
92574345|NCT00067535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574346|NCT00102882|Fluticasone|fluticasone|mesh-list
92574348|NCT00102882|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92574349|NCT00102882|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92574350|NCT00102882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574351|NCT00102882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92574352|NCT00102882|Autonomic Agents|autonomic agents|mesh-ancestor
92574353|NCT00102882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574354|NCT00102882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574355|NCT00102882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92574356|NCT00102882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92574357|NCT00102882|Dermatologic Agents|dermatologic agents|mesh-ancestor
92574358|NCT00102882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92574359|NCT00102882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92574360|NCT00102882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92574361|NCT00102882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92574362|NCT00102882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92574363|NCT00102882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574364|NCT00102882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574365|NCT00102882|Glucocorticoids|glucocorticoids|mesh-ancestor
92574368|NCT00102882|Sympathomimetics|sympathomimetics|mesh-ancestor
92574369|NCT00246220|Methylphenidate|methylphenidate|mesh-list
92574370|NCT00246220|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92574371|NCT00246220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574372|NCT00246220|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92574373|NCT00246220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574374|NCT00246220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574375|NCT00246220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574376|NCT00246220|Dopamine Agents|dopamine agents|mesh-ancestor
92574377|NCT00246220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574378|NCT00424801|Nicorandil|nicorandil|mesh-list
92574379|NCT00424801|Valsartan|valsartan|mesh-list
92574380|NCT00424801|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92574381|NCT00424801|Doxazosin|doxazosin|mesh-list
92574382|NCT00424801|Lercanidipine|lercanidipine|mesh-list
92574383|NCT00424801|Pindolol|pindolol|mesh-list
92574384|NCT00424801|Moxonidine|moxonidine|mesh-list
92574385|NCT00424801|Amiloride|amiloride|mesh-list
92574386|NCT00424801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92574387|NCT00424801|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92574388|NCT00424801|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92574389|NCT00424801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574390|NCT00424801|Diuretics|diuretics|mesh-ancestor
92574391|NCT00424801|Natriuretic Agents|natriuretic agents|mesh-ancestor
92574392|NCT00424801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574393|NCT00424801|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92574394|NCT00424801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574395|NCT00424801|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92574396|NCT00424801|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92574397|NCT00424801|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92574398|NCT00424801|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92574399|NCT00424801|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92574400|NCT00424801|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92535028|NCT00072631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923136|NCT02142569|Vitamins|vitamins|mesh-ancestor
92574401|NCT00424801|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92574402|NCT00424801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92574403|NCT00424801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574404|NCT00424801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92574405|NCT00424801|Vasodilator Agents|vasodilator agents|mesh-ancestor
92574406|NCT00424801|Vitamin B Complex|vitamin b complex|mesh-ancestor
92574407|NCT00424801|Vitamins|vitamins|mesh-ancestor
92574408|NCT00424801|Micronutrients|micronutrients|mesh-ancestor
92574409|NCT00424801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92574410|NCT00424801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92574411|NCT00424801|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92574412|NCT00424801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92574413|NCT00424801|Serotonin Agents|serotonin agents|mesh-ancestor
92574414|NCT00246298|Epoetin Alfa|epoetin alfa|mesh-list
92574415|NCT00246298|Hematinics|hematinics|mesh-ancestor
92574416|NCT00246415|Memantine|memantine|mesh-list
92574417|NCT00246415|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92574418|NCT00246415|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92574419|NCT00246415|Dopamine Agents|dopamine agents|mesh-ancestor
92574420|NCT00246415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574421|NCT00246415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574422|NCT00246415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574423|NCT00246415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92574424|NCT00246415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92574425|NCT00246532|Morphine|morphine|mesh-list
92574426|NCT00246532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92574427|NCT00246532|Narcotics|narcotics|mesh-ancestor
92574428|NCT00246532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574429|NCT00246532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574430|NCT00246532|Analgesics|analgesics|mesh-ancestor
92574431|NCT00246532|Sensory System Agents|sensory system agents|mesh-ancestor
92574432|NCT00246532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574433|NCT00246610|Nelfinavir|nelfinavir|mesh-list
92574434|NCT00246610|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92574435|NCT00246610|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92574436|NCT00246610|Protease Inhibitors|protease inhibitors|mesh-ancestor
92574437|NCT00246610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981766|NCT04482881|Isosorbide|isosorbide|mesh-list
92574443|NCT00246688|Sagopilone|sagopilone|mesh-list
92574444|NCT00246688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574445|NCT04728516|Amoxicillin|amoxicillin|mesh-list
92574446|NCT04728516|Pantoprazole|pantoprazole|mesh-list
92574447|NCT04728516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574448|NCT04728516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574449|NCT04728516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92574450|NCT04728516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574451|NCT04728516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92574452|NCT04728516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574453|NCT04728516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574454|NCT00400998|Fluticasone|fluticasone|mesh-list
92574456|NCT00400998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574457|NCT00400998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92574458|NCT00400998|Autonomic Agents|autonomic agents|mesh-ancestor
92574459|NCT00400998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574460|NCT00400998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574461|NCT00400998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92574462|NCT00400998|Respiratory System Agents|respiratory system agents|mesh-ancestor
92574463|NCT00400998|Dermatologic Agents|dermatologic agents|mesh-ancestor
92574464|NCT00400998|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92574465|NCT00247078|Antivenins|antivenins|mesh-list
92574466|NCT00247078|Immunologic Factors|immunologic factors|mesh-ancestor
92574467|NCT00247078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574468|NCT00247117|Metformin|metformin|mesh-list
92574469|NCT00247117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92574470|NCT00247117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574471|NCT00099606|Dasatinib|dasatinib|mesh-list
92574472|NCT00099606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574473|NCT00099606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92574474|NCT00099606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574475|NCT00099606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574476|NCT00247507|Acetylcysteine|acetylcysteine|mesh-list
92574477|NCT00247507|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92535030|NCT00072670|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92574478|NCT00247507|Antiviral Agents|antiviral agents|mesh-ancestor
92574479|NCT00247507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574480|NCT00247507|Expectorants|expectorants|mesh-ancestor
92574481|NCT00247507|Respiratory System Agents|respiratory system agents|mesh-ancestor
92574482|NCT00247507|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92574483|NCT00247507|Antioxidants|antioxidants|mesh-ancestor
92574484|NCT00247507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574485|NCT00247507|Protective Agents|protective agents|mesh-ancestor
92574486|NCT00247507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574487|NCT00247507|Antidotes|antidotes|mesh-ancestor
92574488|NCT00247585|Ethanol|ethanol|mesh-list
92574489|NCT00247585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92574490|NCT00247585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574491|NCT00247585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574492|NCT00247585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574493|NCT00099645|Mifepristone|mifepristone|mesh-list
92574494|NCT00099645|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92574495|NCT00099645|Abortifacient Agents|abortifacient agents|mesh-ancestor
92574496|NCT00099645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92574497|NCT00099645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574498|NCT00099645|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92574499|NCT00099645|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92574500|NCT00099645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92574501|NCT00099645|Contraceptive Agents|contraceptive agents|mesh-ancestor
92574502|NCT00099645|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92574503|NCT00099645|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92574504|NCT00099645|Hormone Antagonists|hormone antagonists|mesh-ancestor
92574505|NCT00099645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574506|NCT00099645|Luteolytic Agents|luteolytic agents|mesh-ancestor
92574507|NCT00099645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92574516|NCT00247663|Hormone Antagonists|hormone antagonists|mesh-ancestor
92574517|NCT00247663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574518|NCT00247663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574519|NCT00247702|Warfarin|warfarin|mesh-list
92574520|NCT00247702|Anticoagulants|anticoagulants|mesh-ancestor
92574521|NCT01349660|Bevacizumab|bevacizumab|mesh-list
92574522|NCT01349660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574523|NCT01349660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574524|NCT01349660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92574525|NCT01349660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92574526|NCT01349660|Growth Substances|growth substances|mesh-ancestor
92574527|NCT01349660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574528|NCT01349660|Growth Inhibitors|growth inhibitors|mesh-ancestor
92574529|NCT00247741|Lidocaine|lidocaine|mesh-list
92574530|NCT00247741|Carticaine|carticaine|mesh-list
92574531|NCT00247741|Anesthetics, Local|anesthetics, local|mesh-ancestor
92574532|NCT00247741|Anesthetics|anesthetics|mesh-ancestor
92574533|NCT00247741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574534|NCT00247741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574535|NCT00247741|Sensory System Agents|sensory system agents|mesh-ancestor
92574536|NCT00247741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574537|NCT00247741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92574538|NCT00247741|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92574539|NCT00247741|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92574540|NCT00247741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574541|NCT00247741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574542|NCT00099684|Ezetimibe|ezetimibe|mesh-list
92574543|NCT00099684|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92574544|NCT00099684|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92574545|NCT00099684|Antimetabolites|antimetabolites|mesh-ancestor
92574546|NCT00099684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574547|NCT00099684|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92574548|NCT00067730|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92574549|NCT00067730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574550|NCT00248053|Curcumin|curcumin|mesh-list
92574551|NCT00248053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92574552|NCT00248053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92574553|NCT00248053|Analgesics|analgesics|mesh-ancestor
92574554|NCT00248053|Sensory System Agents|sensory system agents|mesh-ancestor
92574555|NCT00248053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574556|NCT00248053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535031|NCT00072670|Alkylating Agents|alkylating agents|mesh-ancestor
91923281|NCT02149901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574557|NCT00248053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574558|NCT00248053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574559|NCT00248053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574560|NCT00248053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574561|NCT00248053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574562|NCT00248092|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92574563|NCT00248092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92574564|NCT00248092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574565|NCT00248092|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92574566|NCT00248092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574567|NCT00248092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574568|NCT00248092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574569|NCT00248092|Dopamine Agents|dopamine agents|mesh-ancestor
92574570|NCT00248092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574571|NCT00248131|Octreotide|octreotide|mesh-list
92574572|NCT00248131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574578|NCT00248209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574579|NCT00248209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92574580|NCT00248209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574581|NCT00248209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574582|NCT00248209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574584|NCT00248209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574585|NCT00248209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574586|NCT00248209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92574587|NCT00248209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92574588|NCT00248209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574589|NCT00248248|Doxorubicin|doxorubicin|mesh-list
92574590|NCT00248248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92574591|NCT00248248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92574592|NCT00248248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574593|NCT00248248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92574594|NCT00248248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92574595|NCT00248248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574596|NCT00248248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574597|NCT00248443|Dimercaprol|dimercaprol|mesh-list
92574598|NCT00248443|Chelating Agents|chelating agents|mesh-ancestor
92574599|NCT00248443|Sequestering Agents|sequestering agents|mesh-ancestor
92574600|NCT00248443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574601|NCT00248482|Cisplatin|cisplatin|mesh-list
92574602|NCT00248482|Irinotecan|irinotecan|mesh-list
92574603|NCT00248482|Imatinib Mesylate|imatinib mesylate|mesh-list
92574604|NCT00248482|Camptothecin|camptothecin|mesh-list
92574605|NCT00248482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574606|NCT00248482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92574607|NCT00248482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92574608|NCT00248482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574609|NCT00248482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574610|NCT00248482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92574611|NCT00248482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574612|NCT00103233|Trastuzumab|trastuzumab|mesh-list
92574613|NCT00103233|Vinorelbine|vinorelbine|mesh-list
92574614|NCT00103233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574615|NCT00103233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574616|NCT00103233|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574617|NCT00103233|Tubulin Modulators|tubulin modulators|mesh-ancestor
92574618|NCT00103233|Antimitotic Agents|antimitotic agents|mesh-ancestor
92574619|NCT00103233|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359393|NCT00354978|Immunologic Factors|immunologic factors|mesh-ancestor
92574620|NCT00103233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574621|NCT00248716|Ferrous gluconate|ferrous gluconate|mesh-list
92574622|NCT00248716|Hematinics|hematinics|mesh-ancestor
92574623|NCT00067925|Calcium|calcium|mesh-list
92574624|NCT00067925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92574625|NCT00067925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574626|NCT00103272|Bortezomib|bortezomib|mesh-list
92574627|NCT00103272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574628|NCT00248989|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92574629|NCT00248989|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92574630|NCT00248989|Immunologic Factors|immunologic factors|mesh-ancestor
92574631|NCT00248989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535032|NCT00072670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923359|NCT02147015|Methylprednisolone|methylprednisolone|mesh-list
92574632|NCT00249106|Vaccines|vaccines|mesh-list
92574633|NCT00249106|Immunologic Factors|immunologic factors|mesh-ancestor
92574634|NCT00249106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574635|NCT00068042|Octreotide|octreotide|mesh-list
92574636|NCT00068042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574637|NCT00068042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92574638|NCT00068042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574639|NCT00249145|Risperidone|risperidone|mesh-list
92574640|NCT00249145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92574641|NCT00249145|Serotonin Agents|serotonin agents|mesh-ancestor
92574646|NCT00249145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574647|NCT00249145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574648|NCT00249145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574649|NCT00249145|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92574650|NCT00249145|Dopamine Agents|dopamine agents|mesh-ancestor
92574651|NCT00099801|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92574652|NCT00099801|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92574653|NCT00099801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574654|NCT00099801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574655|NCT00099801|Immunologic Factors|immunologic factors|mesh-ancestor
92574656|NCT00099801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574657|NCT00414739|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92574658|NCT00414739|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92574659|NCT00414739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574660|NCT00068081|Capsaicin|capsaicin|mesh-list
92574661|NCT00068081|Antipruritics|antipruritics|mesh-ancestor
92574662|NCT00068081|Dermatologic Agents|dermatologic agents|mesh-ancestor
92574663|NCT00068081|Sensory System Agents|sensory system agents|mesh-ancestor
92574664|NCT00068081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574665|NCT00068081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574666|NCT00249223|Risperidone|risperidone|mesh-list
92574667|NCT00249223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92574668|NCT00249223|Serotonin Agents|serotonin agents|mesh-ancestor
92574669|NCT00249223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574670|NCT00249223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574671|NCT00249223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574672|NCT00249223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92574673|NCT00249223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574674|NCT00249223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574675|NCT00249223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574676|NCT00249223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92574677|NCT00249223|Dopamine Agents|dopamine agents|mesh-ancestor
92574678|NCT00099840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92574679|NCT00099840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574680|NCT02967224|Insulin|insulin|mesh-list
92574681|NCT02967224|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92574682|NCT02967224|Insulin Glargine|insulin glargine|mesh-list
92574683|NCT02967224|Insulin Detemir|insulin detemir|mesh-list
92574684|NCT02967224|Insulin, Isophane|insulin, isophane|mesh-list
92574685|NCT02967224|Isophane Insulin, Human|isophane insulin, human|mesh-list
92574686|NCT02967224|Isophane insulin, beef|isophane insulin, beef|mesh-list
92574687|NCT02967224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92574688|NCT02967224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359400|NCT00354978|Vitamins|vitamins|mesh-ancestor
92574689|NCT00099918|Vildagliptin|vildagliptin|mesh-list
92574690|NCT00099918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92574691|NCT00099918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574692|NCT00099918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92574693|NCT00099918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92574694|NCT00099918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574695|NCT00099918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574696|NCT00249574|Buprenorphine|buprenorphine|mesh-list
92574697|NCT00249574|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92574698|NCT00249574|Naloxone|naloxone|mesh-list
92574699|NCT00249574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92574700|NCT00249574|Narcotics|narcotics|mesh-ancestor
92574701|NCT00249574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574702|NCT00249574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574703|NCT00249574|Analgesics|analgesics|mesh-ancestor
92574704|NCT00249574|Sensory System Agents|sensory system agents|mesh-ancestor
92574705|NCT00249574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574706|NCT00249574|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92574707|NCT00249691|Topiramate|topiramate|mesh-list
92535033|NCT00072670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535034|NCT02966704|Caseins|caseins|mesh-list
92535035|NCT02966704|Chelating Agents|chelating agents|mesh-ancestor
92535036|NCT02966704|Sequestering Agents|sequestering agents|mesh-ancestor
91923428|NCT04093765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574708|NCT00249691|Anticonvulsants|anticonvulsants|mesh-ancestor
92574709|NCT00249691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92574710|NCT00249691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574711|NCT00249730|Sildenafil Citrate|sildenafil citrate|mesh-list
92574712|NCT00249730|Vasodilator Agents|vasodilator agents|mesh-ancestor
92574716|NCT00249730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574717|NCT00249730|Urological Agents|urological agents|mesh-ancestor
92574718|NCT00249847|Paroxetine|paroxetine|mesh-list
92574719|NCT00249847|Estrogens|estrogens|mesh-list
92574720|NCT00249847|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92574721|NCT00249847|Hormones|hormones|mesh-ancestor
92574722|NCT00249847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574723|NCT00249847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574724|NCT00249847|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92574725|NCT00249847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574726|NCT00249847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574727|NCT00249847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574728|NCT00249847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574729|NCT00249847|Serotonin Agents|serotonin agents|mesh-ancestor
92574730|NCT00249847|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92574731|NCT00249847|Antidepressive Agents|antidepressive agents|mesh-ancestor
92574732|NCT00249847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574733|NCT00249847|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92574734|NCT00249847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92574735|NCT00249847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574736|NCT00249886|Citalopram|citalopram|mesh-list
92574737|NCT00249886|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92574738|NCT00249886|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92574739|NCT00249886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574740|NCT00249886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574741|NCT00249886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574742|NCT00249886|Serotonin Agents|serotonin agents|mesh-ancestor
92574743|NCT00249886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574744|NCT00249886|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92574745|NCT00249886|Antidepressive Agents|antidepressive agents|mesh-ancestor
92574746|NCT00249886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574747|NCT00249964|Paclitaxel|paclitaxel|mesh-list
92574748|NCT00249964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92574749|NCT00249964|Carboplatin|carboplatin|mesh-list
92574750|NCT00249964|Temozolomide|temozolomide|mesh-list
92574751|NCT00249964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574752|NCT00249964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574753|NCT00249964|Tubulin Modulators|tubulin modulators|mesh-ancestor
92574754|NCT00249964|Antimitotic Agents|antimitotic agents|mesh-ancestor
92574755|NCT00249964|Mitosis Modulators|mitosis modulators|mesh-ancestor
92574756|NCT00249964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574757|NCT00249964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92574758|NCT00249964|Alkylating Agents|alkylating agents|mesh-ancestor
92574759|NCT00068276|Cholecalciferol|cholecalciferol|mesh-list
92574760|NCT00068276|Vitamin D|vitamin d|mesh-list
92574761|NCT00068276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92574762|NCT00068276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574763|NCT00068276|Vitamins|vitamins|mesh-ancestor
92574764|NCT00068276|Micronutrients|micronutrients|mesh-ancestor
92574765|NCT00068276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92574766|NCT00250042|Imatinib Mesylate|imatinib mesylate|mesh-list
92574767|NCT00250042|Arsenic Trioxide|arsenic trioxide|mesh-list
92574768|NCT00250042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574769|NCT00250042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92574770|NCT00250042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574771|NCT00250042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574772|NCT00068315|Rituximab|rituximab|mesh-list
92574773|NCT00068315|Fludarabine|fludarabine|mesh-list
92574774|NCT00068315|Fludarabine phosphate|fludarabine phosphate|mesh-list
92574775|NCT00068315|Bortezomib|bortezomib|mesh-list
92535037|NCT02966704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535038|NCT00072748|EKB 569|ekb 569|mesh-list
92535039|NCT00072748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923504|NCT02255045|Meloxicam|meloxicam|mesh-list
92574776|NCT00068315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574778|NCT00068315|Immunologic Factors|immunologic factors|mesh-ancestor
92574779|NCT00068315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574780|NCT00068315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574781|NCT00068315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92574782|NCT00068315|Antimetabolites|antimetabolites|mesh-ancestor
91982123|NCT03175679|Sensory System Agents|sensory system agents|mesh-ancestor
92574785|NCT00250081|Botulinum Toxins|botulinum toxins|mesh-list
92574786|NCT00250081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92574787|NCT00250081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574788|NCT00250081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574789|NCT00250081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92574790|NCT00250081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574791|NCT00250081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574792|NCT00250120|Camptothecin|camptothecin|mesh-list
92574793|NCT00250120|Rubitecan|rubitecan|mesh-list
92574794|NCT00250120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574795|NCT00250120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574796|NCT00250120|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92574797|NCT00250120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92574798|NCT00250120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574799|NCT00250120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574800|NCT04720573|Neostigmine|neostigmine|mesh-list
92574801|NCT04720573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92574802|NCT04720573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574803|NCT04720573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574804|NCT04720573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92574805|NCT04720573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574806|NCT04720573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574807|NCT04720573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92574808|NCT04720573|Autonomic Agents|autonomic agents|mesh-ancestor
92574809|NCT04720573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574810|NCT00103545|Abagovomab|abagovomab|mesh-list
92574811|NCT00103545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574812|NCT00103545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574813|NCT00068432|Celecoxib|celecoxib|mesh-list
92574814|NCT00068432|Gemcitabine|gemcitabine|mesh-list
92574815|NCT00068432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92574816|NCT00068432|Antimetabolites|antimetabolites|mesh-ancestor
92574817|NCT00068432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574818|NCT00068432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574819|NCT00068432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92574820|NCT00068432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92574821|NCT00068432|Analgesics|analgesics|mesh-ancestor
92574822|NCT00068432|Sensory System Agents|sensory system agents|mesh-ancestor
92574823|NCT00068432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574824|NCT00068432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574825|NCT00068432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574826|NCT00068432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574827|NCT00068432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92574828|NCT00068432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92574829|NCT00068432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574830|NCT00250237|Haloperidol|haloperidol|mesh-list
92574831|NCT00250237|Haloperidol decanoate|haloperidol decanoate|mesh-list
92574832|NCT00250237|Antiemetics|antiemetics|mesh-ancestor
92574833|NCT00250237|Autonomic Agents|autonomic agents|mesh-ancestor
92574834|NCT00250237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574835|NCT00250237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574836|NCT00250237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574837|NCT00250237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92574838|NCT00250237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574839|NCT00250237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574840|NCT00250237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574841|NCT00250237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92574842|NCT00250237|Dopamine Agents|dopamine agents|mesh-ancestor
92574843|NCT00250237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535040|NCT00072748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535041|NCT00072748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574844|NCT00250237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574845|NCT00250237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92574847|NCT00099957|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92574848|NCT00099957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574849|NCT00099957|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92574850|NCT00099957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92574851|NCT00099957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574852|NCT00099957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574854|NCT00250315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92574858|NCT00250315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574859|NCT00250315|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92574860|NCT00250315|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92574861|NCT00250315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92574862|NCT00250315|Adrenergic Agents|adrenergic agents|mesh-ancestor
92574863|NCT00250315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574864|NCT00250315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574865|NCT00250315|Protective Agents|protective agents|mesh-ancestor
92574866|NCT00068471|Anidulafungin|anidulafungin|mesh-list
92574867|NCT00068471|Antifungal Agents|antifungal agents|mesh-ancestor
92574868|NCT00068471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574869|NCT00250354|Risperidone|risperidone|mesh-list
92574870|NCT00250354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92574871|NCT00250354|Serotonin Agents|serotonin agents|mesh-ancestor
92574872|NCT00250354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574873|NCT00250354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574874|NCT00250354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574875|NCT00250354|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92574876|NCT00250354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574877|NCT00250354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574878|NCT00250354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574879|NCT00250354|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92574880|NCT00250354|Dopamine Agents|dopamine agents|mesh-ancestor
92574881|NCT00250393|Istradefylline|istradefylline|mesh-list
92574882|NCT00250393|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92574883|NCT00250393|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92574884|NCT00250393|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92574885|NCT00250393|Purinergic Agents|purinergic agents|mesh-ancestor
92574886|NCT00250393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359425|NCT03984240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574887|NCT00250393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574888|NCT00250393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574889|NCT02961634|Ciclopirox|ciclopirox|mesh-list
92574890|NCT02961634|Antifungal Agents|antifungal agents|mesh-ancestor
92574891|NCT02961634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574892|NCT02966717|Rituximab|rituximab|mesh-list
92574893|NCT02966717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574894|NCT02966717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574895|NCT02966717|Immunologic Factors|immunologic factors|mesh-ancestor
92574896|NCT02966717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574897|NCT02966717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574898|NCT00099996|Ezetimibe|ezetimibe|mesh-list
92574899|NCT00099996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92574900|NCT00099996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92574901|NCT00099996|Antimetabolites|antimetabolites|mesh-ancestor
92574902|NCT00099996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574903|NCT00099996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92574904|NCT00250744|Gabapentin|gabapentin|mesh-list
92574905|NCT00250744|Aprepitant|aprepitant|mesh-list
92574906|NCT00250744|Fosaprepitant|fosaprepitant|mesh-list
92574907|NCT00250744|Analgesics|analgesics|mesh-ancestor
92574908|NCT00250744|Sensory System Agents|sensory system agents|mesh-ancestor
92574909|NCT00250744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574910|NCT00250744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574911|NCT00250744|Anticonvulsants|anticonvulsants|mesh-ancestor
92574912|NCT00250744|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92574913|NCT00250744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92574914|NCT00250744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92574915|NCT00250744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574916|NCT00250744|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92574917|NCT00250744|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92535042|NCT00072748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535043|NCT00072787|Cisplatin|cisplatin|mesh-list
91923653|NCT02224105|Hormones|hormones|mesh-ancestor
92574918|NCT00250744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574919|NCT00250744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574920|NCT00250744|Antimanic Agents|antimanic agents|mesh-ancestor
92574921|NCT00250744|Antiemetics|antiemetics|mesh-ancestor
92574922|NCT00250744|Autonomic Agents|autonomic agents|mesh-ancestor
92574923|NCT00250744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574924|NCT00250744|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92574926|NCT00103623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92682780|NCT04701320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574928|NCT00103623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574929|NCT00250861|Aldesleukin|aldesleukin|mesh-list
92574931|NCT00250861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574932|NCT00250861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574933|NCT00250861|Immunologic Factors|immunologic factors|mesh-ancestor
92574934|NCT00250861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574935|NCT00250861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574936|NCT00250861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92574937|NCT00250861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92574938|NCT00250861|Antiviral Agents|antiviral agents|mesh-ancestor
92574939|NCT00250861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574940|NCT00068549|Gemcitabine|gemcitabine|mesh-list
92574941|NCT00068549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574942|NCT00068549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92574943|NCT00068549|Antimetabolites|antimetabolites|mesh-ancestor
92574944|NCT00068549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574945|NCT04720183|Sulfasalazine|sulfasalazine|mesh-list
92574946|NCT04720183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574947|NCT04720183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92574948|NCT04720183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92574949|NCT04720183|Analgesics|analgesics|mesh-ancestor
92574950|NCT04720183|Sensory System Agents|sensory system agents|mesh-ancestor
92574951|NCT04720183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359435|NCT03984240|GABA Agents|gaba agents|mesh-ancestor
92574952|NCT04720183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574953|NCT04720183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92574954|NCT04720183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574955|NCT04720183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574956|NCT00250978|Bevacizumab|bevacizumab|mesh-list
92574957|NCT00250978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92574958|NCT00250978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574959|NCT00250978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92574960|NCT00250978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92574961|NCT00250978|Growth Substances|growth substances|mesh-ancestor
92574962|NCT00250978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574963|NCT00250978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92574964|NCT00068666|Temozolomide|temozolomide|mesh-list
92574965|NCT00068666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92574966|NCT00068666|Alkylating Agents|alkylating agents|mesh-ancestor
92574967|NCT00068666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574968|NCT00068666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574969|NCT00103701|Dasatinib|dasatinib|mesh-list
92574970|NCT00103701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574971|NCT00103701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92574972|NCT00103701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574973|NCT00103701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574974|NCT00251017|Vancomycin|vancomycin|mesh-list
92574975|NCT00251017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92574976|NCT00251017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574977|NCT00251056|Mannitol|mannitol|mesh-list
92574978|NCT00251056|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92574979|NCT00251056|Diuretics|diuretics|mesh-ancestor
92574980|NCT00251056|Natriuretic Agents|natriuretic agents|mesh-ancestor
92574981|NCT00251056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574982|NCT00251095|Paclitaxel|paclitaxel|mesh-list
92574983|NCT00251095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92574984|NCT00251095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574985|NCT00251095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92574986|NCT00251095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92574987|NCT00251095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92574988|NCT00251095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574990|NCT00100074|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92574991|NCT00100074|Autonomic Agents|autonomic agents|mesh-ancestor
92574992|NCT00100074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574993|NCT00100074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574994|NCT00100074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92574995|NCT00100074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92574996|NCT00100074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92574997|NCT00100074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299804|NCT04334759|Cisplatin|cisplatin|mesh-list
92574998|NCT00100074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575007|NCT00068744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575008|NCT00068744|Immunologic Factors|immunologic factors|mesh-ancestor
92575009|NCT00068744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575010|NCT00068744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92575011|NCT00068744|Alkylating Agents|alkylating agents|mesh-ancestor
92575012|NCT00068744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92575013|NCT00068744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575014|NCT00100113|Vanoxerine|vanoxerine|mesh-list
92575015|NCT00100113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92575016|NCT00100113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92575017|NCT00100113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575018|NCT00100113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575019|NCT00100113|Dopamine Agents|dopamine agents|mesh-ancestor
92575020|NCT00100113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575021|NCT00100113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575022|NCT00068783|Imatinib Mesylate|imatinib mesylate|mesh-list
92575023|NCT00068783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575024|NCT00068783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575025|NCT00068783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750758|NCT05936489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92575026|NCT00068783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575027|NCT00251368|9-aminocamptothecin|9-aminocamptothecin|mesh-list
92575028|NCT00251368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575029|NCT00103779|Dacetuzumab|dacetuzumab|mesh-list
92575030|NCT00103779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92575031|NCT00103779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575032|NCT00251407|Docetaxel|docetaxel|mesh-list
92575033|NCT00251407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575034|NCT00251407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575035|NCT00251407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575036|NCT00251407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575037|NCT00251407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575038|NCT02966522|Thalidomide|thalidomide|mesh-list
92575039|NCT02966522|Dexamethasone|dexamethasone|mesh-list
92575040|NCT02966522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92575041|NCT02966522|Antiemetics|antiemetics|mesh-ancestor
92575042|NCT02966522|Autonomic Agents|autonomic agents|mesh-ancestor
92575043|NCT02966522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575044|NCT02966522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575045|NCT02966522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575046|NCT02966522|Glucocorticoids|glucocorticoids|mesh-ancestor
92575047|NCT02966522|Hormones|hormones|mesh-ancestor
92575048|NCT02966522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575049|NCT02966522|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575050|NCT02966522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575051|NCT02966522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575052|NCT02966522|Immunologic Factors|immunologic factors|mesh-ancestor
92575053|NCT02966522|Leprostatic Agents|leprostatic agents|mesh-ancestor
92575054|NCT02966522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575055|NCT02966522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575056|NCT02966522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92575057|NCT02966522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92575058|NCT02966522|Growth Substances|growth substances|mesh-ancestor
92575059|NCT02966522|Growth Inhibitors|growth inhibitors|mesh-ancestor
92575060|NCT00251485|Cetuximab|cetuximab|mesh-list
92575061|NCT00251485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92575062|NCT00251485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575063|NCT00100152|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92575064|NCT00100152|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92575065|NCT00100152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575071|NCT00251524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575072|NCT00251524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92575073|NCT00251524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92535044|NCT00072787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535045|NCT00072826|Acetylcholine|acetylcholine|mesh-list
92535046|NCT00072826|Oxypurinol|oxypurinol|mesh-list
92535047|NCT00072826|Vasodilator Agents|vasodilator agents|mesh-ancestor
92535048|NCT00072826|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92535049|NCT00072826|Cholinergic Agents|cholinergic agents|mesh-ancestor
92575074|NCT00251524|Growth Substances|growth substances|mesh-ancestor
92575075|NCT00251524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575076|NCT00251524|Growth Inhibitors|growth inhibitors|mesh-ancestor
92575077|NCT00251524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575078|NCT00251524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575079|NCT00251524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92575080|NCT00251524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92575082|NCT00068861|Clomiphene|clomiphene|mesh-list
92575083|NCT00068861|Enclomiphene|enclomiphene|mesh-list
92575084|NCT00068861|Zuclomiphene|zuclomiphene|mesh-list
92575085|NCT00068861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575086|NCT00068861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575087|NCT00068861|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92575088|NCT00068861|Hormone Antagonists|hormone antagonists|mesh-ancestor
92575089|NCT00068861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575090|NCT00068861|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92575091|NCT00068861|Fertility Agents|fertility agents|mesh-ancestor
92575092|NCT00068861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92575093|NCT00068861|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92575094|NCT00068861|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92575095|NCT00251602|Propranolol|propranolol|mesh-list
92575096|NCT00251602|Atropine|atropine|mesh-list
92575097|NCT00251602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92575098|NCT00251602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92575099|NCT00251602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92575100|NCT00251602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575101|NCT00251602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575102|NCT00251602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575103|NCT00251602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92575104|NCT00251602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92575105|NCT00251602|Vasodilator Agents|vasodilator agents|mesh-ancestor
92575106|NCT00251602|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92575107|NCT00251602|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92575108|NCT00251602|Autonomic Agents|autonomic agents|mesh-ancestor
92575109|NCT00251602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575110|NCT00251602|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92575111|NCT00251602|Respiratory System Agents|respiratory system agents|mesh-ancestor
92575112|NCT00251602|Mydriatics|mydriatics|mesh-ancestor
92575113|NCT00251602|Parasympatholytics|parasympatholytics|mesh-ancestor
92575114|NCT00251602|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92575115|NCT00251602|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92575116|NCT00251602|Cholinergic Agents|cholinergic agents|mesh-ancestor
92575117|NCT02961166|Immunoglobulins|immunoglobulins|mesh-list
92575118|NCT02961166|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92575119|NCT02961166|Antibodies|antibodies|mesh-list
92575120|NCT02961166|Immunologic Factors|immunologic factors|mesh-ancestor
92575121|NCT02961166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575122|NCT00103818|Gaboxadol|gaboxadol|mesh-list
92575123|NCT00103818|Analgesics|analgesics|mesh-ancestor
92575124|NCT00103818|Sensory System Agents|sensory system agents|mesh-ancestor
92575125|NCT00103818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575126|NCT00103818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575127|NCT00103818|Anticonvulsants|anticonvulsants|mesh-ancestor
92575128|NCT00103818|GABA Agonists|gaba agonists|mesh-ancestor
92575129|NCT00103818|GABA Agents|gaba agents|mesh-ancestor
92575130|NCT00103818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575131|NCT00103818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575132|NCT00251680|Atorvastatin|atorvastatin|mesh-list
92575133|NCT00251680|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92575134|NCT00251680|Simvastatin|simvastatin|mesh-list
92575135|NCT00251680|Fenofibrate|fenofibrate|mesh-list
92575136|NCT00251680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92575137|NCT00251680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92575146|NCT00251797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575148|NCT00251797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535050|NCT00072826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535051|NCT00072826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535052|NCT00072826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575149|NCT00251797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575150|NCT00251797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575151|NCT00251797|Immunologic Factors|immunologic factors|mesh-ancestor
92575152|NCT00251797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575153|NCT00251797|Leprostatic Agents|leprostatic agents|mesh-ancestor
92575154|NCT00251797|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575155|NCT00251797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575156|NCT00251797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92575157|NCT00251797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92575158|NCT00251797|Growth Substances|growth substances|mesh-ancestor
92575159|NCT00251797|Growth Inhibitors|growth inhibitors|mesh-ancestor
92575161|NCT00251914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92575162|NCT00251914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575163|NCT00251914|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92575164|NCT00251914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575165|NCT00251914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575166|NCT00100269|Antioxidants|antioxidants|mesh-list
92575167|NCT00100269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575168|NCT00100269|Protective Agents|protective agents|mesh-ancestor
92575169|NCT00100269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575170|NCT00399074|Pyrimethamine|pyrimethamine|mesh-list
92575171|NCT00399074|Sulfadoxine|sulfadoxine|mesh-list
92575172|NCT00399074|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92575173|NCT00399074|Antimalarials|antimalarials|mesh-ancestor
92575174|NCT00399074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92575175|NCT00399074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92575176|NCT00399074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575177|NCT00399074|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92575178|NCT00399074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575179|NCT00399074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575180|NCT00399074|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92575181|NCT00100308|Heparin|heparin|mesh-list
92575182|NCT00100308|Anticoagulants|anticoagulants|mesh-ancestor
92575183|NCT00100308|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92575184|NCT00100308|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92575185|NCT00100308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575186|NCT00251953|Metformin|metformin|mesh-list
92575187|NCT00251953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575188|NCT00251953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575189|NCT00251992|Esomeprazole|esomeprazole|mesh-list
92575190|NCT00251992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92575191|NCT00251992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575192|NCT00251992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92575193|NCT00251992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575194|NCT00251992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575195|NCT00103935|Exenatide|exenatide|mesh-list
92575196|NCT00103935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575197|NCT00103935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575198|NCT00103935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92575199|NCT00103935|Incretins|incretins|mesh-ancestor
92575200|NCT00103935|Hormones|hormones|mesh-ancestor
92575201|NCT00103935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575202|NCT00399152|Sunitinib|sunitinib|mesh-list
92575221|NCT04719715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575223|NCT00252226|Antidepressive Agents|antidepressive agents|mesh-ancestor
92575224|NCT00252226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575225|NCT00252226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92575226|NCT00252226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92575227|NCT00252226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92575228|NCT00252226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575229|NCT00252304|Zinc Sulfate|zinc sulfate|mesh-list
92575230|NCT00252304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575231|NCT00252304|Astringents|astringents|mesh-ancestor
92575232|NCT00252304|Dermatologic Agents|dermatologic agents|mesh-ancestor
92575233|NCT00252343|Amibegron|amibegron|mesh-list
92575234|NCT00252343|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92575235|NCT00252343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92575236|NCT00252343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92575237|NCT00252343|Adrenergic Agents|adrenergic agents|mesh-ancestor
92535053|NCT00072826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535054|NCT00072865|Carboplatin|carboplatin|mesh-list
92535055|NCT00072865|Pemetrexed|pemetrexed|mesh-list
92535056|NCT00072865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575238|NCT00252343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575239|NCT00252343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575240|NCT00252343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575241|NCT00252343|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92575242|NCT00252421|Nitroglycerin|nitroglycerin|mesh-list
92575243|NCT00252421|Vasodilator Agents|vasodilator agents|mesh-ancestor
92575244|NCT00252655|Sirolimus|sirolimus|mesh-list
92575245|NCT00252655|Tacrolimus|tacrolimus|mesh-list
92575246|NCT00252655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575247|NCT00252655|Immunologic Factors|immunologic factors|mesh-ancestor
92575248|NCT00252655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575249|NCT00252655|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92575250|NCT00252655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575251|NCT00252655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575252|NCT00252655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575253|NCT00252655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575254|NCT00252655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92575255|NCT00252655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575256|NCT00252655|Antifungal Agents|antifungal agents|mesh-ancestor
92575257|NCT00252811|Gefitinib|gefitinib|mesh-list
92575265|NCT00069251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575266|NCT00069251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92575267|NCT00069251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92575268|NCT00069251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575269|NCT00069251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575270|NCT00069251|Dopamine Agents|dopamine agents|mesh-ancestor
92575271|NCT00069251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575272|NCT00069251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575273|NCT00069251|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92575274|NCT00069251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575275|NCT00069251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575276|NCT00252889|Doxorubicin|doxorubicin|mesh-list
92575278|NCT00252889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
92575279|NCT00252889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92575280|NCT00252889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575281|NCT00252889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92575282|NCT00252889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575283|NCT00252889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575284|NCT00252889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575285|NCT00252928|Troclosene|troclosene|mesh-list
92575286|NCT00252928|Antifungal Agents|antifungal agents|mesh-ancestor
92575287|NCT00252928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575288|NCT00252928|Antiviral Agents|antiviral agents|mesh-ancestor
92575289|NCT00252928|Disinfectants|disinfectants|mesh-ancestor
92575290|NCT00253123|Risperidone|risperidone|mesh-list
92575291|NCT00253123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92575292|NCT00253123|Serotonin Agents|serotonin agents|mesh-ancestor
92575293|NCT00253123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575294|NCT00253123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575295|NCT00253123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575296|NCT00253123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92575297|NCT00253123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92575298|NCT00253123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92575299|NCT00253123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575300|NCT00253123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92575301|NCT00253123|Dopamine Agents|dopamine agents|mesh-ancestor
92575302|NCT00253162|Risperidone|risperidone|mesh-list
92575303|NCT00253162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92575304|NCT00253162|Serotonin Agents|serotonin agents|mesh-ancestor
92575305|NCT00253162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575306|NCT00253162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575307|NCT00253162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575308|NCT00253162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92575309|NCT00253162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92575310|NCT00253162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92575311|NCT00253162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575312|NCT00253162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92535057|NCT00072865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924011|NCT02262637|Telmisartan|telmisartan|mesh-list
92575313|NCT00253162|Dopamine Agents|dopamine agents|mesh-ancestor
92575314|NCT00253201|Galantamine|galantamine|mesh-list
92575315|NCT00253201|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92575316|NCT00253201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575317|NCT00253201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575318|NCT00253201|Cholinergic Agents|cholinergic agents|mesh-ancestor
92575319|NCT00253201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575320|NCT00253201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575321|NCT00253201|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92575322|NCT00253201|Autonomic Agents|autonomic agents|mesh-ancestor
92575323|NCT00253201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575351|NCT00100464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575352|NCT00100464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575353|NCT00100464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575354|NCT00100464|Serotonin Agents|serotonin agents|mesh-ancestor
92575355|NCT00100464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575356|NCT00100464|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92575357|NCT00100464|Antidepressive Agents|antidepressive agents|mesh-ancestor
92575358|NCT00100464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575359|NCT00100464|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92575360|NCT00100464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575361|NCT00100464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575362|NCT00253396|Heparin|heparin|mesh-list
92575363|NCT00253396|Enoxaparin|enoxaparin|mesh-list
92575364|NCT00253396|Calcium heparin|calcium heparin|mesh-list
92575365|NCT00253396|Anticoagulants|anticoagulants|mesh-ancestor
92575366|NCT00253396|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92575367|NCT00253396|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92575368|NCT00253396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300182|NCT04037527|Docetaxel|docetaxel|mesh-list
92575370|NCT00253474|Interferon-alpha|interferon-alpha|mesh-list
91982730|NCT05504967|Anesthetics|anesthetics|mesh-ancestor
92575375|NCT00253474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575376|NCT00253474|Immunologic Factors|immunologic factors|mesh-ancestor
92575377|NCT00253474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575378|NCT00253552|Cyclosporine|cyclosporine|mesh-list
92575379|NCT00253552|Cyclophosphamide|cyclophosphamide|mesh-list
92575380|NCT00253552|Busulfan|busulfan|mesh-list
92575381|NCT00253552|Methotrexate|methotrexate|mesh-list
92575382|NCT00253552|Etoposide|etoposide|mesh-list
92575383|NCT00253552|Cyclosporins|cyclosporins|mesh-list
92575384|NCT00253552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575385|NCT00253552|Immunologic Factors|immunologic factors|mesh-ancestor
92575386|NCT00253552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575387|NCT00253552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92575388|NCT00253552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92575389|NCT00253552|Alkylating Agents|alkylating agents|mesh-ancestor
92575390|NCT00253552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575391|NCT00253552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575392|NCT00253552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92575393|NCT00253552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92575394|NCT00253552|Abortifacient Agents|abortifacient agents|mesh-ancestor
92575395|NCT00253552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92575396|NCT00253552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575397|NCT00253552|Antimetabolites|antimetabolites|mesh-ancestor
92575398|NCT00253552|Dermatologic Agents|dermatologic agents|mesh-ancestor
92575399|NCT00253552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575400|NCT00253552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92575401|NCT00253552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92575402|NCT00253552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92575403|NCT00253552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92575404|NCT00253552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575405|NCT00253552|Antifungal Agents|antifungal agents|mesh-ancestor
92575406|NCT00253552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575407|NCT00253552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92575408|NCT00253591|Vinorelbine|vinorelbine|mesh-list
92575409|NCT00253591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575410|NCT00253591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92575411|NCT00253591|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575412|NCT00253591|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575413|NCT00253591|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575414|NCT00253591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575415|NCT04719481|Pravastatin|pravastatin|mesh-list
92575416|NCT04719481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92575417|NCT04719481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92575418|NCT04719481|Antimetabolites|antimetabolites|mesh-ancestor
92575419|NCT04719481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575420|NCT04719481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92575421|NCT04719481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92575422|NCT04719481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575423|NCT00253903|SR 46349B|sr 46349b|mesh-list
92575424|NCT00253903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92575425|NCT00253903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92575426|NCT00253903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575427|NCT00253903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92575428|NCT00253903|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92575429|NCT00253903|Serotonin Agents|serotonin agents|mesh-ancestor
92575430|NCT00253903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575431|NCT00253903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575432|NCT00104130|Desoxyepothilone B|desoxyepothilone b|mesh-list
92575433|NCT00104130|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575434|NCT00104130|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575435|NCT00104130|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575436|NCT00104130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575437|NCT00104130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575438|NCT00254020|Citalopram|citalopram|mesh-list
92575439|NCT00254020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92575440|NCT00254020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92682781|NCT04701320|Adrenergic Agents|adrenergic agents|mesh-ancestor
92575445|NCT00254020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575446|NCT00254020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92575447|NCT00254020|Antidepressive Agents|antidepressive agents|mesh-ancestor
92575448|NCT00254020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575450|NCT00254137|Oxaliplatin|oxaliplatin|mesh-list
92575451|NCT00254137|Irinotecan|irinotecan|mesh-list
92575452|NCT00254137|Cetuximab|cetuximab|mesh-list
92575453|NCT00254137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575454|NCT00254137|Antimetabolites|antimetabolites|mesh-ancestor
92575455|NCT00254137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575456|NCT00254137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575457|NCT00254137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92575458|NCT00254137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575459|NCT00254137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575460|NCT00254137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92575461|NCT00104169|Epoetin Alfa|epoetin alfa|mesh-list
92575462|NCT00104169|Hematinics|hematinics|mesh-ancestor
92575463|NCT00415090|Nevirapine|nevirapine|mesh-list
92575464|NCT00415090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92575465|NCT00415090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92575466|NCT00415090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575467|NCT00415090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575468|NCT00415090|Antiviral Agents|antiviral agents|mesh-ancestor
92575469|NCT00415090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575470|NCT00415090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92575471|NCT00415090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92575472|NCT00415090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92575473|NCT00415090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92575474|NCT00254176|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
92575475|NCT00254176|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92575476|NCT00254176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92575477|NCT00254254|Exenatide|exenatide|mesh-list
92575478|NCT00254254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575479|NCT00254254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575480|NCT00254254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92575481|NCT00254254|Incretins|incretins|mesh-ancestor
92575482|NCT00254254|Hormones|hormones|mesh-ancestor
92575483|NCT00254254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575484|NCT00254371|Androgens|androgens|mesh-list
92575485|NCT00254371|Hormones|hormones|mesh-ancestor
92575486|NCT00254371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575487|NCT00254371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575488|NCT00254449|Capsaicin|capsaicin|mesh-list
92575489|NCT00254449|Antipruritics|antipruritics|mesh-ancestor
92575490|NCT00254449|Dermatologic Agents|dermatologic agents|mesh-ancestor
92575491|NCT00254449|Sensory System Agents|sensory system agents|mesh-ancestor
92575492|NCT00254449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535058|NCT00072865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535059|NCT00072865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92535060|NCT00072865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92535061|NCT00072904|Repaglinide|repaglinide|mesh-list
92575493|NCT00254449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575494|NCT00104286|Troxacitabine|troxacitabine|mesh-list
92575495|NCT00104286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575496|NCT00104286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92575497|NCT00104286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92575498|NCT00104286|Antiviral Agents|antiviral agents|mesh-ancestor
92575499|NCT00104286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575500|NCT00254800|Exenatide|exenatide|mesh-list
92575501|NCT00254800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92575502|NCT00254800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92575503|NCT00254800|Levonorgestrel|levonorgestrel|mesh-list
92575504|NCT00254800|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92575505|NCT00254800|Estradiol|estradiol|mesh-list
92575506|NCT00254800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92575507|NCT00254800|Estrogens|estrogens|mesh-ancestor
92575508|NCT00254800|Hormones|hormones|mesh-ancestor
92575509|NCT00254800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575510|NCT00254800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575511|NCT00254800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92575512|NCT00254800|Contraceptive Agents|contraceptive agents|mesh-ancestor
92575517|NCT00254800|Incretins|incretins|mesh-ancestor
92575518|NCT00254800|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92575519|NCT00254800|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92575520|NCT00254800|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92575521|NCT00104403|Dexamethasone|dexamethasone|mesh-list
92575522|NCT00104403|Dexamethasone acetate|dexamethasone acetate|mesh-list
92575523|NCT00104403|Ondansetron|ondansetron|mesh-list
92575524|NCT00104403|Casopitant|casopitant|mesh-list
92575525|NCT00104403|BB 1101|bb 1101|mesh-list
92575526|NCT00104403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92575527|NCT00104403|Antiemetics|antiemetics|mesh-ancestor
92575528|NCT00104403|Autonomic Agents|autonomic agents|mesh-ancestor
92575529|NCT00104403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575530|NCT00104403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575531|NCT00104403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575532|NCT00104403|Glucocorticoids|glucocorticoids|mesh-ancestor
92575533|NCT00104403|Hormones|hormones|mesh-ancestor
92575534|NCT00104403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575535|NCT00104403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575536|NCT00104403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575537|NCT00104403|Protease Inhibitors|protease inhibitors|mesh-ancestor
92575538|NCT00104403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575539|NCT00104403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575540|NCT00104403|Antipruritics|antipruritics|mesh-ancestor
92575541|NCT00104403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92575542|NCT00104403|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92575543|NCT00104403|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92575544|NCT00104403|Serotonin Agents|serotonin agents|mesh-ancestor
92575545|NCT00104403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575546|NCT00104403|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92575547|NCT00069836|Metformin|metformin|mesh-list
92575548|NCT00069836|Rosiglitazone|rosiglitazone|mesh-list
92575549|NCT00069836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575550|NCT00069836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575551|NCT00254878|Methylphenidate|methylphenidate|mesh-list
92575552|NCT00254878|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92575553|NCT00254878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575554|NCT00254878|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92575555|NCT00254878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92575556|NCT00254878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575557|NCT00254878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575558|NCT00254878|Dopamine Agents|dopamine agents|mesh-ancestor
92575559|NCT00254878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575560|NCT00254917|Vaccines|vaccines|mesh-list
92575561|NCT00254917|Immunologic Factors|immunologic factors|mesh-ancestor
92575562|NCT00254917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575563|NCT00254956|Ciclesonide|ciclesonide|mesh-list
92575564|NCT00254956|Glucocorticoids|glucocorticoids|mesh-ancestor
92535062|NCT00072904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575565|NCT00254956|Hormones|hormones|mesh-ancestor
92575566|NCT00254956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575567|NCT00254956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575568|NCT00254956|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92575569|NCT00255073|Baclofen|baclofen|mesh-list
92575570|NCT00255073|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92575571|NCT00255073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575572|NCT00255073|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92575573|NCT00255073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575574|NCT00255073|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92575575|NCT00255073|GABA Agonists|gaba agonists|mesh-ancestor
92575576|NCT00255073|GABA Agents|gaba agents|mesh-ancestor
92575577|NCT00255073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575578|NCT00255073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575579|NCT00069875|Gemcitabine|gemcitabine|mesh-list
92575580|NCT00069875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575581|NCT00069875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575582|NCT00069875|Antimetabolites|antimetabolites|mesh-ancestor
92575583|NCT00069875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575590|NCT00255268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575591|NCT00255268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575592|NCT00104442|Rivastigmine|rivastigmine|mesh-list
92575593|NCT00104442|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92575594|NCT00104442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575595|NCT00104442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575596|NCT00104442|Cholinergic Agents|cholinergic agents|mesh-ancestor
92575597|NCT00104442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575598|NCT00104442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575599|NCT00104442|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92575600|NCT00104442|Protective Agents|protective agents|mesh-ancestor
92575601|NCT00255385|Micronutrients|micronutrients|mesh-list
92575602|NCT00255385|Trace Elements|trace elements|mesh-list
92575603|NCT00255385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575604|NCT00255424|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92575605|NCT00255424|Hematinics|hematinics|mesh-ancestor
92575606|NCT00255424|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92575607|NCT00255424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92575608|NCT00069992|Fludarabine|fludarabine|mesh-list
92575609|NCT00069992|Alemtuzumab|alemtuzumab|mesh-list
92575610|NCT00069992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575611|NCT00069992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92575613|NCT00255463|Anastrozole|anastrozole|mesh-list
92575614|NCT00255463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575615|NCT00255463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575616|NCT00255463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575617|NCT00255463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575618|NCT00255463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575619|NCT00255463|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92575620|NCT00255463|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92575621|NCT00255463|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92575622|NCT00255463|Hormone Antagonists|hormone antagonists|mesh-ancestor
92575623|NCT00255463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575624|NCT00255463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575625|NCT00255502|Metoprolol|metoprolol|mesh-list
92575626|NCT00255502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92575627|NCT00255502|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92575628|NCT00255502|Sympatholytics|sympatholytics|mesh-ancestor
92575629|NCT00255502|Autonomic Agents|autonomic agents|mesh-ancestor
92575630|NCT00255502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575631|NCT00255502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575632|NCT00255502|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92575633|NCT00255502|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92575634|NCT00255502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92575635|NCT00255502|Adrenergic Agents|adrenergic agents|mesh-ancestor
92575636|NCT00255502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575637|NCT00255502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575638|NCT00255541|Glyburide|glyburide|mesh-list
92575639|NCT00255541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575640|NCT00255541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575641|NCT00255658|Sirolimus|sirolimus|mesh-list
92575642|NCT00255658|Sorafenib|sorafenib|mesh-list
92575643|NCT00255658|Temsirolimus|temsirolimus|mesh-list
92535063|NCT00072904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535064|NCT00072943|Interferons|interferons|mesh-list
92535065|NCT00072943|Interferon-gamma|interferon-gamma|mesh-list
92535066|NCT00072943|Antibodies|antibodies|mesh-list
92575644|NCT00255658|MTOR Inhibitors|mtor inhibitors|mesh-list
92575645|NCT00255658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575646|NCT00255658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575647|NCT00255658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575648|NCT00255658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575649|NCT00255658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575650|NCT00255658|Immunologic Factors|immunologic factors|mesh-ancestor
92575651|NCT00255658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575652|NCT00255658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575655|NCT00255658|Antifungal Agents|antifungal agents|mesh-ancestor
92575656|NCT00070148|Megestrol|megestrol|mesh-list
92575657|NCT00070148|Megestrol Acetate|megestrol acetate|mesh-list
92575658|NCT00070148|Oxandrolone|oxandrolone|mesh-list
92575659|NCT00070148|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92575660|NCT00070148|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92575661|NCT00070148|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92575662|NCT00070148|Contraceptive Agents|contraceptive agents|mesh-ancestor
92575663|NCT00070148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92575664|NCT00070148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575665|NCT00070148|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92575666|NCT00070148|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92575667|NCT00070148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575668|NCT00070148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575669|NCT00070148|Appetite Stimulants|appetite stimulants|mesh-ancestor
92575670|NCT00070148|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92575671|NCT00070148|Androgens|androgens|mesh-ancestor
92575672|NCT00070148|Hormones|hormones|mesh-ancestor
92575673|NCT00070148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575674|NCT00070148|Anabolic Agents|anabolic agents|mesh-ancestor
92575675|NCT00100581|Interferons|interferons|mesh-list
92575676|NCT00100581|Ritonavir|ritonavir|mesh-list
92575677|NCT00100581|Tenofovir|tenofovir|mesh-list
92575678|NCT00100581|Ribavirin|ribavirin|mesh-list
92575679|NCT00100581|Interferon-alpha|interferon-alpha|mesh-list
92575680|NCT00100581|Lamivudine|lamivudine|mesh-list
92575681|NCT00100581|Interferon alpha-2|interferon alpha-2|mesh-list
92575682|NCT00100581|Efavirenz|efavirenz|mesh-list
92575683|NCT00100581|Lopinavir|lopinavir|mesh-list
92575684|NCT00100581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92575685|NCT00100581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575686|NCT00100581|Antiviral Agents|antiviral agents|mesh-ancestor
92575687|NCT00100581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575688|NCT00100581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92575689|NCT00100581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92575690|NCT00100581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92575691|NCT00100581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575692|NCT00100581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575693|NCT00100581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92575694|NCT00100581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92575695|NCT00100581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92575696|NCT00100581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575697|NCT00100581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92575698|NCT00100581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92575699|NCT00100581|Antimetabolites|antimetabolites|mesh-ancestor
92575700|NCT00100581|Immunologic Factors|immunologic factors|mesh-ancestor
92575701|NCT00100581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575702|NCT00100581|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92575703|NCT00100581|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92575704|NCT00100581|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92575705|NCT00100581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92575706|NCT00100581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92575707|NCT00070187|Interferons|interferons|mesh-list
92575708|NCT00070187|Cytarabine|cytarabine|mesh-list
92575709|NCT00070187|Aldesleukin|aldesleukin|mesh-list
92575710|NCT00070187|Interferon-gamma|interferon-gamma|mesh-list
92575711|NCT00070187|Cyclosporine|cyclosporine|mesh-list
92575712|NCT00070187|Etoposide|etoposide|mesh-list
92575713|NCT00070187|Melphalan|melphalan|mesh-list
92575714|NCT00070187|Interleukin-2|interleukin-2|mesh-list
92575715|NCT00070187|Carmustine|carmustine|mesh-list
92575716|NCT00070187|Cyclosporins|cyclosporins|mesh-list
92535068|NCT00072943|Immunologic Factors|immunologic factors|mesh-ancestor
91924376|NCT02558894|Immunologic Factors|immunologic factors|mesh-ancestor
92575717|NCT00070187|Lenograstim|lenograstim|mesh-list
92575718|NCT00070187|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92575719|NCT00070187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575720|NCT00070187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92575721|NCT00070187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575722|NCT00070187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575723|NCT00070187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575724|NCT00070187|Antiviral Agents|antiviral agents|mesh-ancestor
92575725|NCT00070187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575726|NCT00070187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575727|NCT00070187|Antimetabolites|antimetabolites|mesh-ancestor
92575728|NCT00070187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575732|NCT00070187|Antifungal Agents|antifungal agents|mesh-ancestor
92575733|NCT00070187|Dermatologic Agents|dermatologic agents|mesh-ancestor
92575734|NCT00070187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92575735|NCT00070187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92575736|NCT00070187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92575737|NCT00070187|Alkylating Agents|alkylating agents|mesh-ancestor
92575738|NCT00070187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92575739|NCT00070187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92575741|NCT00070187|Sensory System Agents|sensory system agents|mesh-ancestor
92300563|NCT03635489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92575742|NCT00070187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575743|NCT00070187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92575744|NCT00070187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92575745|NCT00415246|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92575746|NCT00415246|Luteolytic Agents|luteolytic agents|mesh-ancestor
92575747|NCT00415246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92575748|NCT00415246|Contraceptive Agents|contraceptive agents|mesh-ancestor
92575749|NCT00415246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92575750|NCT00415246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575751|NCT00415246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92575752|NCT00415246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575753|NCT00415246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575755|NCT00415285|Capecitabine|capecitabine|mesh-list
92575756|NCT00415285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575757|NCT00415285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575758|NCT00415285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575759|NCT00415285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575760|NCT00415285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575761|NCT00415285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575762|NCT00415285|Antimetabolites|antimetabolites|mesh-ancestor
92575763|NCT00256009|Misoprostol|misoprostol|mesh-list
92575764|NCT00256009|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92575765|NCT00256009|Abortifacient Agents|abortifacient agents|mesh-ancestor
92575766|NCT00256009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92575767|NCT00256009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575768|NCT00256009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92575769|NCT00256009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575770|NCT00256009|Oxytocics|oxytocics|mesh-ancestor
92575771|NCT00100620|Zoledronic Acid|zoledronic acid|mesh-list
92575772|NCT00100620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92575773|NCT00100620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575774|NCT00070265|Capecitabine|capecitabine|mesh-list
92575775|NCT00070265|Oxaliplatin|oxaliplatin|mesh-list
92575776|NCT00070265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575777|NCT00070265|Antimetabolites|antimetabolites|mesh-ancestor
92575778|NCT00070265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575779|NCT00070265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575780|NCT00104598|Bupropion|bupropion|mesh-list
92575781|NCT00104598|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92575782|NCT00104598|Antidepressive Agents|antidepressive agents|mesh-ancestor
92575783|NCT00104598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575784|NCT00104598|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92575785|NCT00104598|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92575786|NCT00104598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575787|NCT00104598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575788|NCT00104598|Dopamine Agents|dopamine agents|mesh-ancestor
92535069|NCT00072943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924460|NCT04046887|Antimetabolites|antimetabolites|mesh-ancestor
92575789|NCT00104598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575790|NCT00104598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575791|NCT00104598|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92575792|NCT00104598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575793|NCT00104598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575794|NCT00256321|Celecoxib|celecoxib|mesh-list
92575795|NCT00256321|Capecitabine|capecitabine|mesh-list
92575796|NCT00256321|Oxaliplatin|oxaliplatin|mesh-list
92575797|NCT00256321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575798|NCT00256321|Antimetabolites|antimetabolites|mesh-ancestor
91983134|NCT03169751|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92575823|NCT00070304|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575824|NCT00070304|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575825|NCT00070304|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575826|NCT00100737|Rituximab|rituximab|mesh-list
92575827|NCT00100737|Interleukin-2|interleukin-2|mesh-list
92575828|NCT00100737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92575829|NCT00100737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575830|NCT00100737|Immunologic Factors|immunologic factors|mesh-ancestor
92575831|NCT00100737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575832|NCT00100737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92575833|NCT00100737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92575834|NCT00100737|Analgesics|analgesics|mesh-ancestor
92575835|NCT00100737|Sensory System Agents|sensory system agents|mesh-ancestor
92575836|NCT00100737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575837|NCT00070343|Dacarbazine|dacarbazine|mesh-list
92575838|NCT00070343|Oblimersen|oblimersen|mesh-list
92575839|NCT00070343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92575840|NCT00070343|Alkylating Agents|alkylating agents|mesh-ancestor
92575841|NCT00070343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575842|NCT00070343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575843|NCT00104715|Docetaxel|docetaxel|mesh-list
92575844|NCT00104715|Goserelin|goserelin|mesh-list
92575845|NCT00104715|Androgen Antagonists|androgen antagonists|mesh-list
92575846|NCT00104715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575862|NCT00256711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575864|NCT00256711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575865|NCT00070382|Epoetin Alfa|epoetin alfa|mesh-list
92575866|NCT00070382|Darbepoetin alfa|darbepoetin alfa|mesh-list
92575867|NCT00070382|Hematinics|hematinics|mesh-ancestor
92575868|NCT04709380|Sorafenib|sorafenib|mesh-list
92575869|NCT04709380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575870|NCT04709380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575871|NCT04709380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575872|NCT04709380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575873|NCT00256828|Lamivudine|lamivudine|mesh-list
92575874|NCT00256828|Efavirenz|efavirenz|mesh-list
92575875|NCT00256828|Didanosine|didanosine|mesh-list
92575876|NCT00256828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92575877|NCT00256828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92575878|NCT00256828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575879|NCT00256828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575880|NCT00256828|Antiviral Agents|antiviral agents|mesh-ancestor
92575881|NCT00256828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575882|NCT00256828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92575883|NCT00256828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92575884|NCT00256828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92575885|NCT00256828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575886|NCT00256828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92575887|NCT00256828|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92575888|NCT00256828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92575889|NCT00256828|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92575890|NCT00256828|Antimetabolites|antimetabolites|mesh-ancestor
92575891|NCT00100776|Olanzapine|olanzapine|mesh-list
92575892|NCT00100776|Antiemetics|antiemetics|mesh-ancestor
92575893|NCT00100776|Autonomic Agents|autonomic agents|mesh-ancestor
92575894|NCT00100776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575895|NCT00100776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575896|NCT00100776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575897|NCT00100776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92575898|NCT00100776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92575899|NCT00100776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924530|NCT03859687|Vitamins|vitamins|mesh-list
92575900|NCT00100776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575901|NCT00100776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92575902|NCT00100776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92575903|NCT00100776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575912|NCT00070538|Antiviral Agents|antiviral agents|mesh-ancestor
92575913|NCT00070538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575914|NCT00070538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575915|NCT00070538|Immunologic Factors|immunologic factors|mesh-ancestor
92575916|NCT00070538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575917|NCT00257023|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92575918|NCT00257023|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92575919|NCT00257023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92575920|NCT00257023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92575921|NCT00257023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575922|NCT00257023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92575923|NCT00257023|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92575924|NCT00257023|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92575925|NCT00257023|Serotonin Agents|serotonin agents|mesh-ancestor
92575926|NCT00257023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575927|NCT00257023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575928|NCT00257023|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92575929|NCT00257023|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92575930|NCT00257023|Dopamine Agents|dopamine agents|mesh-ancestor
92575931|NCT00257062|Levofloxacin|levofloxacin|mesh-list
92575932|NCT00257062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92575933|NCT00257062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575934|NCT00257062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575935|NCT00257062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92575936|NCT00257062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575937|NCT00257062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575938|NCT00257062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575939|NCT00257062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575940|NCT00257062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92575941|NCT00257062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575942|NCT00100854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92575943|NCT00100854|Fulvestrant|fulvestrant|mesh-list
92575944|NCT00100854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575945|NCT00100854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575946|NCT00100854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575947|NCT00100854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575948|NCT00100854|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575949|NCT00100854|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92575950|NCT00100854|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92575951|NCT00100854|Hormone Antagonists|hormone antagonists|mesh-ancestor
92575952|NCT00100854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575953|NCT00100854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575954|NCT00257140|Levofloxacin|levofloxacin|mesh-list
92575955|NCT00257140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92575956|NCT00257140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575957|NCT00257140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575958|NCT00257140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92575959|NCT00257140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575960|NCT00257140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575961|NCT00257140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575962|NCT00257140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575963|NCT00257140|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92575964|NCT00257140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92575965|NCT00257257|Rimonabant|rimonabant|mesh-list
91983313|NCT03169127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92575983|NCT00257452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575984|NCT00257452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92575985|NCT00257452|Autonomic Agents|autonomic agents|mesh-ancestor
92575986|NCT00257452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575987|NCT00257452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92575988|NCT00257452|Respiratory System Agents|respiratory system agents|mesh-ancestor
92575989|NCT00257452|Parasympatholytics|parasympatholytics|mesh-ancestor
92575990|NCT00257452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92575991|NCT00257452|Cholinergic Agents|cholinergic agents|mesh-ancestor
92575992|NCT00257452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575994|NCT00257491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92535070|NCT00072943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575995|NCT00257491|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92575996|NCT00257491|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92575997|NCT00257491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575998|NCT00104793|Carboplatin|carboplatin|mesh-list
92575999|NCT00104793|Irinotecan|irinotecan|mesh-list
92576000|NCT00104793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576001|NCT00104793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92576002|NCT00104793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92576003|NCT00104793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576004|NCT00104793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576005|NCT00070655|Vitamin K|vitamin k|mesh-list
92576006|NCT00070655|Warfarin|warfarin|mesh-list
92576007|NCT00070655|Acenocoumarol|acenocoumarol|mesh-list
92576008|NCT00070655|Idraparinux|idraparinux|mesh-list
92576009|NCT00070655|Vitamins|vitamins|mesh-ancestor
92576010|NCT00070655|Micronutrients|micronutrients|mesh-ancestor
92576011|NCT00070655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576012|NCT00070655|Anticoagulants|anticoagulants|mesh-ancestor
92576013|NCT00070655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92576014|NCT00070655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92576015|NCT00070655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576016|NCT00070655|Hemostatics|hemostatics|mesh-ancestor
92576017|NCT00070655|Coagulants|coagulants|mesh-ancestor
92576018|NCT00070655|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92576019|NCT00070655|Antithrombins|antithrombins|mesh-ancestor
92576020|NCT00070655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92576021|NCT00070655|Protease Inhibitors|protease inhibitors|mesh-ancestor
92576022|NCT00070655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576023|NCT00257530|Imiquimod|imiquimod|mesh-list
92576037|NCT00257569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576039|NCT00100893|Procyanidin|procyanidin|mesh-list
92576040|NCT00100893|Antioxidants|antioxidants|mesh-ancestor
92576041|NCT00100893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576042|NCT00100893|Protective Agents|protective agents|mesh-ancestor
92359470|NCT00360360|Growth Inhibitors|growth inhibitors|mesh-ancestor
92576043|NCT00100893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576044|NCT00100893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92576045|NCT00100893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92576046|NCT00100893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576047|NCT00257803|Oxytocin|oxytocin|mesh-list
92576048|NCT00257803|Oxytocics|oxytocics|mesh-ancestor
92576049|NCT00257803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92576050|NCT00257803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576051|NCT00401115|Sirolimus|sirolimus|mesh-list
92576052|NCT00401115|Temsirolimus|temsirolimus|mesh-list
92576053|NCT00401115|MTOR Inhibitors|mtor inhibitors|mesh-list
92576054|NCT00401115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576055|NCT00401115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576056|NCT00401115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92576057|NCT00401115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576058|NCT00401115|Antifungal Agents|antifungal agents|mesh-ancestor
92576059|NCT00401115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576060|NCT00401115|Immunologic Factors|immunologic factors|mesh-ancestor
92576061|NCT00401115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576062|NCT00401115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92576063|NCT00401115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576064|NCT00401115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576065|NCT00257959|Amiodarone|amiodarone|mesh-list
92576066|NCT00257959|Sotalol|sotalol|mesh-list
92576067|NCT00257959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92576068|NCT00257959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92576069|NCT00257959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92576070|NCT00257959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576071|NCT00257959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576072|NCT00257959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576073|NCT00257959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92576074|NCT00257959|Vasodilator Agents|vasodilator agents|mesh-ancestor
92576075|NCT00257959|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92576076|NCT00257959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576077|NCT00257959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92576078|NCT00257959|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92576079|NCT00257959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92576080|NCT00257959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576081|NCT00257959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92576082|NCT00257959|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92535071|NCT00072943|Antiviral Agents|antiviral agents|mesh-ancestor
91924694|NCT02233777|Analgesics|analgesics|mesh-ancestor
92576083|NCT00257959|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92576101|NCT00258076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576102|NCT00258115|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92576103|NCT00258115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92576104|NCT00258115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92576106|NCT00258115|Sensory System Agents|sensory system agents|mesh-ancestor
92576107|NCT00258115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576108|NCT00258115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576109|NCT00258115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576110|NCT00258115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576111|NCT00258193|Linaclotide|linaclotide|mesh-list
92576112|NCT00258193|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92576113|NCT00258193|Enzyme Activators|enzyme activators|mesh-ancestor
92576114|NCT00258193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576115|NCT00258193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576117|NCT00100971|Immunologic Factors|immunologic factors|mesh-ancestor
92576118|NCT00100971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576119|NCT00258232|Celecoxib|celecoxib|mesh-list
92576120|NCT00258232|Capecitabine|capecitabine|mesh-list
92576121|NCT00258232|Irinotecan|irinotecan|mesh-list
92576122|NCT00258232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576123|NCT00258232|Antimetabolites|antimetabolites|mesh-ancestor
92576124|NCT00258232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576125|NCT00258232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576126|NCT00258232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92576127|NCT00258232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92576128|NCT00258232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576129|NCT00258232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92576130|NCT00258232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92576131|NCT00258232|Analgesics|analgesics|mesh-ancestor
92576132|NCT00258232|Sensory System Agents|sensory system agents|mesh-ancestor
92576133|NCT00258232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576134|NCT00258232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576135|NCT00258232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576136|NCT00258232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576137|NCT00258232|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92576138|NCT00258232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92576139|NCT00258271|Cytarabine|cytarabine|mesh-list
92576140|NCT00258271|Imatinib Mesylate|imatinib mesylate|mesh-list
92576141|NCT00258271|Cladribine|cladribine|mesh-list
92576144|NCT00258271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576145|NCT00258271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576146|NCT00258271|Antiviral Agents|antiviral agents|mesh-ancestor
92576147|NCT00258271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576148|NCT00258271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576149|NCT00258271|Immunologic Factors|immunologic factors|mesh-ancestor
92576150|NCT00258271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576151|NCT00258271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92576152|NCT00258271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576153|NCT00258388|Prednisone|prednisone|mesh-list
92576154|NCT00258388|Docetaxel|docetaxel|mesh-list
92576155|NCT00258388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576156|NCT00258388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576157|NCT00258388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576158|NCT00258388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576159|NCT00258388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576160|NCT00258388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576161|NCT00258388|Glucocorticoids|glucocorticoids|mesh-ancestor
92576162|NCT00258388|Hormones|hormones|mesh-ancestor
92576163|NCT00258388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576164|NCT00258388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576165|NCT00258388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576166|NCT00101088|Sirolimus|sirolimus|mesh-list
92576167|NCT00101088|Imatinib Mesylate|imatinib mesylate|mesh-list
92576168|NCT00101088|Temsirolimus|temsirolimus|mesh-list
92576169|NCT00101088|MTOR Inhibitors|mtor inhibitors|mesh-list
92576170|NCT00101088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576171|NCT00101088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92576172|NCT00101088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576173|NCT00101088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576174|NCT00101088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535072|NCT00072943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535073|NCT04834349|Pembrolizumab|pembrolizumab|mesh-list
92535074|NCT04834349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92576175|NCT00101088|Immunologic Factors|immunologic factors|mesh-ancestor
92576176|NCT00101088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576177|NCT00101088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576178|NCT00101088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576179|NCT00101088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92576180|NCT00101088|Antifungal Agents|antifungal agents|mesh-ancestor
92576181|NCT00258622|Lidocaine|lidocaine|mesh-list
92576182|NCT00258622|Anesthetics, Local|anesthetics, local|mesh-ancestor
92576183|NCT00258622|Anesthetics|anesthetics|mesh-ancestor
92576184|NCT00258622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576185|NCT00258622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576186|NCT00258622|Sensory System Agents|sensory system agents|mesh-ancestor
92576187|NCT00258622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576188|NCT00258622|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92576189|NCT00258622|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92576190|NCT00258622|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92576191|NCT00258622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576192|NCT00258622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576193|NCT00423761|Midazolam|midazolam|mesh-list
92576194|NCT00423761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92576195|NCT00423761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92576196|NCT00423761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576197|NCT00423761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576198|NCT00423761|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92576199|NCT00423761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92576200|NCT00423761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576201|NCT00423761|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92576202|NCT00423761|Anesthetics, General|anesthetics, general|mesh-ancestor
92576203|NCT00423761|Anesthetics|anesthetics|mesh-ancestor
92576204|NCT00423761|GABA Modulators|gaba modulators|mesh-ancestor
92576205|NCT00423761|GABA Agents|gaba agents|mesh-ancestor
92576206|NCT00423761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576207|NCT00423761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576208|NCT00104910|Cetuximab|cetuximab|mesh-list
92576209|NCT00104910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576210|NCT00104910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92576211|NCT00415324|Cisplatin|cisplatin|mesh-list
92576212|NCT00415324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576213|NCT00258739|Carboplatin|carboplatin|mesh-list
92576214|NCT00258739|Gemcitabine|gemcitabine|mesh-list
92576215|NCT00258739|Docetaxel|docetaxel|mesh-list
92576221|NCT00258739|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576222|NCT00258739|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576224|NCT00104949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92576225|NCT00104949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576226|NCT00101127|Gemcitabine|gemcitabine|mesh-list
92576227|NCT00101127|Docetaxel|docetaxel|mesh-list
92576228|NCT00101127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576229|NCT00101127|Antimetabolites|antimetabolites|mesh-ancestor
92576230|NCT00101127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576231|NCT00101127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576232|NCT00101127|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576233|NCT00101127|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576234|NCT00101127|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576235|NCT00259051|Omeprazole|omeprazole|mesh-list
92576236|NCT00259051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92576237|NCT00259051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576238|NCT00259051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92576239|NCT00259051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576240|NCT00259051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576241|NCT00259129|Sorafenib|sorafenib|mesh-list
92576242|NCT00259129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576243|NCT00259129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92576244|NCT00259129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576245|NCT00259129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576246|NCT00259168|Nateglinide|nateglinide|mesh-list
92576247|NCT00259168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576248|NCT00259168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576249|NCT00259363|Oxaliplatin|oxaliplatin|mesh-list
92576250|NCT00259363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535075|NCT04834349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924826|NCT05491694|Paclitaxel|paclitaxel|mesh-list
92576251|NCT00104988|Thalidomide|thalidomide|mesh-list
92576252|NCT00104988|Temozolomide|temozolomide|mesh-list
92576253|NCT00104988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92576254|NCT00104988|Alkylating Agents|alkylating agents|mesh-ancestor
92576255|NCT00104988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576256|NCT00104988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576257|NCT00104988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576258|NCT00104988|Immunologic Factors|immunologic factors|mesh-ancestor
92576259|NCT00104988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576260|NCT00104988|Leprostatic Agents|leprostatic agents|mesh-ancestor
92576261|NCT00104988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576262|NCT00104988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576263|NCT00104988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92576264|NCT00104988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92576265|NCT00104988|Growth Substances|growth substances|mesh-ancestor
92576266|NCT00104988|Growth Inhibitors|growth inhibitors|mesh-ancestor
92576267|NCT00415402|Vitamin D|vitamin d|mesh-list
92576268|NCT00415402|Cholecalciferol|cholecalciferol|mesh-list
92576269|NCT00415402|Vitamins|vitamins|mesh-ancestor
92576270|NCT00415402|Micronutrients|micronutrients|mesh-ancestor
92576271|NCT00415402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576272|NCT00415402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576273|NCT00415402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92576274|NCT00259402|Fluorouracil|fluorouracil|mesh-list
92576275|NCT00259402|Oxaliplatin|oxaliplatin|mesh-list
92576276|NCT00259402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576277|NCT00259402|Antimetabolites|antimetabolites|mesh-ancestor
92576278|NCT00259402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359481|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
92576279|NCT00259402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576280|NCT00259402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576281|NCT00259402|Immunologic Factors|immunologic factors|mesh-ancestor
92576282|NCT00259402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576283|NCT00259441|Simvastatin|simvastatin|mesh-list
92576284|NCT00259441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92576285|NCT00259441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92576291|NCT00071201|Adefovir|adefovir|mesh-list
92576292|NCT00071201|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92576293|NCT00071201|Antiviral Agents|antiviral agents|mesh-ancestor
92576294|NCT00071201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576295|NCT00071201|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92576296|NCT00071201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92576297|NCT00071201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576298|NCT00071201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576299|NCT00259636|Zonisamide|zonisamide|mesh-list
92576300|NCT00259636|Anticonvulsants|anticonvulsants|mesh-ancestor
92576301|NCT00259636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92576302|NCT00259636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576303|NCT00259636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576304|NCT00259636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92576305|NCT00259636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576306|NCT00259675|Carboplatin|carboplatin|mesh-list
92576307|NCT00259675|Gemcitabine|gemcitabine|mesh-list
92576308|NCT00259675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576309|NCT00259675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576310|NCT00259675|Antimetabolites|antimetabolites|mesh-ancestor
92576311|NCT00259675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576312|NCT00105105|Mifepristone|mifepristone|mesh-list
92576313|NCT00105105|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92576314|NCT00105105|Abortifacient Agents|abortifacient agents|mesh-ancestor
92576315|NCT00105105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92576316|NCT00105105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576317|NCT00105105|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92576318|NCT00105105|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92576319|NCT00105105|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92576320|NCT00105105|Contraceptive Agents|contraceptive agents|mesh-ancestor
92576321|NCT00105105|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92576322|NCT00105105|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92576323|NCT00105105|Hormone Antagonists|hormone antagonists|mesh-ancestor
92576324|NCT00105105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576325|NCT00105105|Luteolytic Agents|luteolytic agents|mesh-ancestor
91924900|NCT01435369|Pidilizumab|pidilizumab|mesh-list
92576326|NCT00105105|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92576327|NCT00105105|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92576328|NCT00259714|Dialysis Solutions|dialysis solutions|mesh-list
92576329|NCT00259714|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92576330|NCT00071240|Hormones|hormones|mesh-list
92576331|NCT00071240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576332|NCT00071240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576333|NCT00259792|Budesonide|budesonide|mesh-list
92576334|NCT00259792|Formoterol Fumarate|formoterol fumarate|mesh-list
92576335|NCT00259792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576336|NCT00259792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92576337|NCT00259792|Autonomic Agents|autonomic agents|mesh-ancestor
92576338|NCT00259792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576339|NCT00259792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576340|NCT00259792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92576341|NCT00259792|Respiratory System Agents|respiratory system agents|mesh-ancestor
92576342|NCT00259792|Glucocorticoids|glucocorticoids|mesh-ancestor
92576343|NCT00259792|Hormones|hormones|mesh-ancestor
92576344|NCT00259792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576345|NCT00259792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92576346|NCT00259792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92576347|NCT00259792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92576348|NCT00259792|Adrenergic Agents|adrenergic agents|mesh-ancestor
92576349|NCT00259792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576350|NCT00259792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576351|NCT00105144|Caspofungin|caspofungin|mesh-list
92576358|NCT00259870|Antiemetics|antiemetics|mesh-ancestor
92576359|NCT00259870|Autonomic Agents|autonomic agents|mesh-ancestor
92576360|NCT00259870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576361|NCT00259870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576362|NCT00259870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576363|NCT00259870|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92576364|NCT00259870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92576365|NCT00259870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576366|NCT00259870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576367|NCT00259870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92576368|NCT00259870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92576369|NCT00259870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576370|NCT00259870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576371|NCT00259870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576372|NCT00259870|Serotonin Agents|serotonin agents|mesh-ancestor
92576373|NCT00071279|Idraparinux|idraparinux|mesh-list
92576374|NCT00071279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92576375|NCT00071279|Antithrombins|antithrombins|mesh-ancestor
92576376|NCT00071279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92576377|NCT00071279|Protease Inhibitors|protease inhibitors|mesh-ancestor
92576378|NCT00071279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576379|NCT00071279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576380|NCT00071279|Anticoagulants|anticoagulants|mesh-ancestor
92576381|NCT00259987|Lapatinib|lapatinib|mesh-list
92576382|NCT00259987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576383|NCT00259987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92576384|NCT00259987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576385|NCT00259987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576386|NCT00260026|Docetaxel|docetaxel|mesh-list
92576387|NCT00260026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576388|NCT00260026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576389|NCT00260026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576390|NCT00260026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576391|NCT00260026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576392|NCT00260143|Methyltestosterone|methyltestosterone|mesh-list
92576393|NCT00260143|Testosterone|testosterone|mesh-list
92576394|NCT00260143|Testosterone undecanoate|testosterone undecanoate|mesh-list
92576395|NCT00260143|Testosterone enanthate|testosterone enanthate|mesh-list
92576396|NCT00260143|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92576397|NCT00260143|Androgens|androgens|mesh-ancestor
92576398|NCT00260143|Hormones|hormones|mesh-ancestor
92576399|NCT00260143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576400|NCT00260143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576401|NCT00260143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535077|NCT04834349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576402|NCT00260143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576403|NCT00260143|Anabolic Agents|anabolic agents|mesh-ancestor
92576404|NCT00260260|Oxycodone|oxycodone|mesh-list
92576405|NCT00260260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92576406|NCT00260260|Narcotics|narcotics|mesh-ancestor
92576407|NCT00260260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576408|NCT00260260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576409|NCT00260260|Analgesics|analgesics|mesh-ancestor
92576410|NCT00260260|Sensory System Agents|sensory system agents|mesh-ancestor
92576411|NCT00260260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576412|NCT00105300|Adalimumab|adalimumab|mesh-list
92301235|NCT02020707|Paclitaxel|paclitaxel|mesh-list
92576413|NCT00105300|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92576414|NCT00105300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576415|NCT00105300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576416|NCT00260416|Abciximab|abciximab|mesh-list
92576417|NCT00260416|Anticoagulants|anticoagulants|mesh-ancestor
92576418|NCT00260416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92576419|NCT00260611|Docetaxel|docetaxel|mesh-list
92576420|NCT00260611|Oxaliplatin|oxaliplatin|mesh-list
92576421|NCT00260611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576428|NCT00424086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576429|NCT00101205|Oxaliplatin|oxaliplatin|mesh-list
92576430|NCT00101205|Etoposide|etoposide|mesh-list
92576431|NCT00101205|Etoposide phosphate|etoposide phosphate|mesh-list
92576432|NCT00101205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576433|NCT00101205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92576434|NCT00101205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92576435|NCT00101205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92576436|NCT00101205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576437|NCT00101205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576438|NCT00261079|Fexofenadine|fexofenadine|mesh-list
92576439|NCT00261079|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92576440|NCT00261079|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92576441|NCT00261079|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92576442|NCT00261079|Histamine Antagonists|histamine antagonists|mesh-ancestor
92576443|NCT00261079|Histamine Agents|histamine agents|mesh-ancestor
92576444|NCT00261079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576445|NCT00261079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576446|NCT00261079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576447|NCT00261118|Rituximab|rituximab|mesh-list
92576448|NCT00261118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92576449|NCT00261118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576450|NCT00261118|Immunologic Factors|immunologic factors|mesh-ancestor
92576451|NCT00261118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576452|NCT00261118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576453|NCT00071747|Lamotrigine|lamotrigine|mesh-list
92576454|NCT00071747|Anticonvulsants|anticonvulsants|mesh-ancestor
92576455|NCT00071747|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92576456|NCT00071747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576457|NCT00071747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576458|NCT00071747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92576459|NCT00071747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576460|NCT00071747|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92576461|NCT00071747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92576462|NCT00071747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576463|NCT00071747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576464|NCT00071747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92576465|NCT00261313|Darbepoetin alfa|darbepoetin alfa|mesh-list
92576466|NCT00261313|Hematinics|hematinics|mesh-ancestor
92576467|NCT00261352|Metformin|metformin|mesh-list
92576468|NCT00261352|Fenofibrate|fenofibrate|mesh-list
92576469|NCT00261352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576470|NCT00261352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576471|NCT00261352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92576472|NCT00261352|Antimetabolites|antimetabolites|mesh-ancestor
92576473|NCT00261352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576474|NCT00261352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92576475|NCT00261391|Marimastat|marimastat|mesh-list
92576476|NCT00261391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576477|NCT00261391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576478|NCT00071942|Metronidazole|metronidazole|mesh-list
92576479|NCT00071942|Vaccines|vaccines|mesh-list
92576480|NCT00071942|Immunologic Factors|immunologic factors|mesh-ancestor
92535078|NCT00072982|Borage oil|borage oil|mesh-list
92535079|NCT00072982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576481|NCT00071942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576482|NCT00071942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576483|NCT00071942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576484|NCT00071942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92576485|NCT00071942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92576486|NCT00261469|Topiramate|topiramate|mesh-list
92576487|NCT00261469|Anticonvulsants|anticonvulsants|mesh-ancestor
92576488|NCT00261469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576489|NCT00261469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301308|NCT01566240|Paclitaxel|paclitaxel|mesh-list
92576490|NCT00261508|Risperidone|risperidone|mesh-list
92576509|NCT00261586|Acetaminophen|acetaminophen|mesh-list
92576510|NCT00261586|Ibuprofen|ibuprofen|mesh-list
92576511|NCT00261586|Celecoxib|celecoxib|mesh-list
92576512|NCT00261586|Naproxen|naproxen|mesh-list
92576513|NCT00261586|Rofecoxib|rofecoxib|mesh-list
92576514|NCT00261586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92576515|NCT00261586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92576516|NCT00261586|Analgesics|analgesics|mesh-ancestor
92576517|NCT00261586|Sensory System Agents|sensory system agents|mesh-ancestor
92576518|NCT00261586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576519|NCT00261586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576520|NCT00261586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576521|NCT00261586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576522|NCT00261586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92576523|NCT00261586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92576524|NCT00261586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576525|NCT00261586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92576526|NCT00261586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92576527|NCT00261586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576528|NCT00261586|Antipyretics|antipyretics|mesh-ancestor
92576529|NCT00261586|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92576530|NCT00261586|Gout Suppressants|gout suppressants|mesh-ancestor
92576531|NCT00072020|Zoledronic Acid|zoledronic acid|mesh-list
92576532|NCT00072020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576533|NCT00072020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576534|NCT00261625|Alendronate|alendronate|mesh-list
92576535|NCT00261625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576536|NCT00261625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576537|NCT00261703|Cisplatin|cisplatin|mesh-list
92576538|NCT00261703|Docetaxel|docetaxel|mesh-list
92576539|NCT00261703|Fluorouracil|fluorouracil|mesh-list
92576540|NCT00261703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576541|NCT00261703|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576542|NCT00261703|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576543|NCT00261703|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576544|NCT00261703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576545|NCT00261703|Antimetabolites|antimetabolites|mesh-ancestor
92576546|NCT00261703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576547|NCT00261703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91983918|NCT05487963|Tofacitinib|tofacitinib|mesh-list
92576553|NCT00072059|Epoetin Alfa|epoetin alfa|mesh-list
92576554|NCT00072059|Hematinics|hematinics|mesh-ancestor
92576555|NCT00261820|Mycophenolic Acid|mycophenolic acid|mesh-list
92576556|NCT00261820|Sirolimus|sirolimus|mesh-list
92576557|NCT00261820|Methylprednisolone|methylprednisolone|mesh-list
92576558|NCT00261820|Prednisolone|prednisolone|mesh-list
92576559|NCT00261820|Tacrolimus|tacrolimus|mesh-list
92576560|NCT00261820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576561|NCT00261820|Immunologic Factors|immunologic factors|mesh-ancestor
92576562|NCT00261820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576563|NCT00261820|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92576564|NCT00261820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576565|NCT00261820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576566|NCT00261820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92576567|NCT00261820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576568|NCT00261820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92576569|NCT00261820|Antitubercular Agents|antitubercular agents|mesh-ancestor
92576570|NCT00261820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576571|NCT00261820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576572|NCT00261820|Antifungal Agents|antifungal agents|mesh-ancestor
92576573|NCT00261820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576574|NCT00261820|Antiemetics|antiemetics|mesh-ancestor
92576575|NCT00261820|Autonomic Agents|autonomic agents|mesh-ancestor
92576576|NCT00261820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535081|NCT03959124|Rivastigmine|rivastigmine|mesh-list
92535082|NCT03959124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92576577|NCT00261820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576578|NCT00261820|Glucocorticoids|glucocorticoids|mesh-ancestor
92576579|NCT00261820|Hormones|hormones|mesh-ancestor
92576580|NCT00261820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576581|NCT00261820|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92576582|NCT00261820|Protective Agents|protective agents|mesh-ancestor
92576583|NCT00261820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576584|NCT00072098|Interleukin-12|interleukin-12|mesh-list
92576585|NCT00072098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92576586|NCT00072098|Immunologic Factors|immunologic factors|mesh-ancestor
92576587|NCT00072098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576588|NCT00072098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359506|NCT03983226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576589|NCT00072098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92576590|NCT00072098|Growth Substances|growth substances|mesh-ancestor
92576591|NCT00072098|Growth Inhibitors|growth inhibitors|mesh-ancestor
92576592|NCT00072098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576593|NCT00261937|Furosemide|furosemide|mesh-list
92576594|NCT00261937|Diuretics|diuretics|mesh-ancestor
92576595|NCT00261937|Natriuretic Agents|natriuretic agents|mesh-ancestor
92576596|NCT00261937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576597|NCT00261937|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92576598|NCT00261937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576599|NCT00261937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576600|NCT00105495|Deferiprone|deferiprone|mesh-list
92576601|NCT00105495|Deferoxamine|deferoxamine|mesh-list
92576602|NCT00105495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92576603|NCT00105495|Chelating Agents|chelating agents|mesh-ancestor
92576604|NCT00105495|Sequestering Agents|sequestering agents|mesh-ancestor
92576605|NCT00105495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576606|NCT00105495|Siderophores|siderophores|mesh-ancestor
92576607|NCT00261976|Infliximab|infliximab|mesh-list
92576608|NCT00261976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92576609|NCT00261976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576610|NCT00261976|Dermatologic Agents|dermatologic agents|mesh-ancestor
92576611|NCT00261976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576612|NCT00261976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576613|NCT00072137|Metronidazole|metronidazole|mesh-list
92576614|NCT00072137|Molgramostim|molgramostim|mesh-list
92576615|NCT00072137|Vaccines|vaccines|mesh-list
92576616|NCT00072137|Sargramostim|sargramostim|mesh-list
92576617|NCT00072137|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
92576618|NCT00072137|Immunologic Factors|immunologic factors|mesh-ancestor
92576619|NCT00072137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983966|NCT05476731|Hormone Antagonists|hormone antagonists|mesh-ancestor
92576624|NCT00072137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92576625|NCT00072137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92576626|NCT00262015|Vaccines|vaccines|mesh-list
92576627|NCT00262015|Immunologic Factors|immunologic factors|mesh-ancestor
92576628|NCT00262015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576629|NCT00262054|Heparin|heparin|mesh-list
92576630|NCT00262054|Calcium heparin|calcium heparin|mesh-list
92576631|NCT00262054|Bivalirudin|bivalirudin|mesh-list
92576632|NCT00262054|Anticoagulants|anticoagulants|mesh-ancestor
92576633|NCT00262054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92576634|NCT00262054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92576635|NCT00262054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576636|NCT00262054|Antithrombins|antithrombins|mesh-ancestor
92576637|NCT00262054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92576638|NCT00262054|Protease Inhibitors|protease inhibitors|mesh-ancestor
92576639|NCT00262054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576640|NCT00262132|Mycophenolic Acid|mycophenolic acid|mesh-list
92576641|NCT00262132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301458|NCT01063179|Prednisone|prednisone|mesh-list
92576642|NCT00262132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576643|NCT00262132|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92576644|NCT00262132|Antitubercular Agents|antitubercular agents|mesh-ancestor
92576645|NCT00262132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576646|NCT00262132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576647|NCT00262132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576648|NCT00262132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576649|NCT00262210|Prednisolone|prednisolone|mesh-list
92576650|NCT00262210|Cyclophosphamide|cyclophosphamide|mesh-list
92576651|NCT00262210|Etoposide|etoposide|mesh-list
92576652|NCT00262210|Epirubicin|epirubicin|mesh-list
92576653|NCT00262210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576654|NCT00262210|Immunologic Factors|immunologic factors|mesh-ancestor
92576655|NCT00262210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576656|NCT00262210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576657|NCT00262210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92576658|NCT00262210|Alkylating Agents|alkylating agents|mesh-ancestor
92576659|NCT00262210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576660|NCT00262210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576661|NCT00262210|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92576662|NCT00262210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92576663|NCT00262210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92576664|NCT00262210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92576665|NCT00262210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576666|NCT00262210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576667|NCT00262210|Glucocorticoids|glucocorticoids|mesh-ancestor
92576668|NCT00262210|Hormones|hormones|mesh-ancestor
92576669|NCT00262210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576670|NCT00262210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576671|NCT00262210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92576672|NCT00262288|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92576673|NCT00262288|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92576674|NCT00262288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576675|NCT00262288|Immunologic Factors|immunologic factors|mesh-ancestor
92576676|NCT00262288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576677|NCT00262327|Endostatins|endostatins|mesh-list
92576678|NCT00262327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576679|NCT00262327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92576680|NCT00262327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92576681|NCT00262327|Growth Substances|growth substances|mesh-ancestor
92576682|NCT00262327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576683|NCT00262327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92576684|NCT02966288|Ibuprofen|ibuprofen|mesh-list
92576685|NCT02966288|Ketorolac|ketorolac|mesh-list
92576686|NCT02966288|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92576687|NCT02966288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92576688|NCT02966288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92576689|NCT02966288|Analgesics|analgesics|mesh-ancestor
91984030|NCT03434769|Cyclophosphamide|cyclophosphamide|mesh-list
92576715|NCT00262405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92576716|NCT00262405|Analgesics|analgesics|mesh-ancestor
92576717|NCT00262405|Sensory System Agents|sensory system agents|mesh-ancestor
92301533|NCT00665600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576718|NCT00262405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576719|NCT00262405|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92576720|NCT00262405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576721|NCT00262405|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92576722|NCT00262405|Hormone Antagonists|hormone antagonists|mesh-ancestor
92576723|NCT00262483|Ribavirin|ribavirin|mesh-list
92576724|NCT00262483|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92576725|NCT00262483|Antimetabolites|antimetabolites|mesh-ancestor
92576726|NCT00262483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576727|NCT00262483|Antiviral Agents|antiviral agents|mesh-ancestor
92576728|NCT00262483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576729|NCT00262561|Aspirin|aspirin|mesh-list
92576730|NCT00262561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92576731|NCT00262561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92576732|NCT00262561|Analgesics|analgesics|mesh-ancestor
92576733|NCT00262561|Sensory System Agents|sensory system agents|mesh-ancestor
92576734|NCT00262561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576735|NCT00262561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576736|NCT00262561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576746|NCT00072215|Vinblastine|vinblastine|mesh-list
92576747|NCT00072215|Ifosfamide|ifosfamide|mesh-list
92576748|NCT00072215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92576749|NCT00072215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576750|NCT00072215|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576751|NCT00072215|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576752|NCT00072215|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576753|NCT00072215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576754|NCT00072215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92576755|NCT00072215|Alkylating Agents|alkylating agents|mesh-ancestor
92576756|NCT00262795|Fludarabine|fludarabine|mesh-list
92576757|NCT00262795|Chlorambucil|chlorambucil|mesh-list
92535083|NCT03959124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92535084|NCT03959124|Dopamine Agents|dopamine agents|mesh-ancestor
92576758|NCT00262795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576759|NCT00262795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576760|NCT00262795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92576761|NCT00262795|Alkylating Agents|alkylating agents|mesh-ancestor
92576762|NCT00072332|Cisplatin|cisplatin|mesh-list
92576763|NCT00072332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576764|NCT00263029|Capecitabine|capecitabine|mesh-list
92576765|NCT00263029|Oxaliplatin|oxaliplatin|mesh-list
92576766|NCT00263029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576767|NCT00263029|Antimetabolites|antimetabolites|mesh-ancestor
92576768|NCT00263029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576769|NCT00263029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576770|NCT00263068|Rotigotine|rotigotine|mesh-list
92576771|NCT00263068|Dopamine Agonists|dopamine agonists|mesh-ancestor
92576772|NCT00263068|Dopamine Agents|dopamine agents|mesh-ancestor
92576773|NCT00263068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576774|NCT00263068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576775|NCT00263068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576776|NCT00101634|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92576777|NCT00101634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92576778|NCT00101634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92576779|NCT00101634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576780|NCT00101634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576781|NCT00101634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576782|NCT00101634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92576783|NCT00101634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92576784|NCT00101634|Serotonin Agents|serotonin agents|mesh-ancestor
92576785|NCT00101634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576786|NCT00101634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576787|NCT00101634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92576788|NCT00101634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92576789|NCT00101634|Dopamine Agents|dopamine agents|mesh-ancestor
92576790|NCT00263185|Vitamin D|vitamin d|mesh-list
92576791|NCT00263185|Ergocalciferols|ergocalciferols|mesh-list
92576792|NCT00263185|Cholecalciferol|cholecalciferol|mesh-list
92576793|NCT00263185|Vitamins|vitamins|mesh-list
92576794|NCT00263185|Calcium Carbonate|calcium carbonate|mesh-list
92576795|NCT00263185|Micronutrients|micronutrients|mesh-ancestor
92576796|NCT00263185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576797|NCT00263185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92576798|NCT00263185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576799|NCT00263185|Antacids|antacids|mesh-ancestor
92576800|NCT00263185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576801|NCT00263185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576802|NCT00263263|Sirolimus|sirolimus|mesh-list
92576807|NCT00263263|Antifungal Agents|antifungal agents|mesh-ancestor
92576808|NCT00263263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576809|NCT00263263|Immunologic Factors|immunologic factors|mesh-ancestor
92576810|NCT00263263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576811|NCT00101673|Vildagliptin|vildagliptin|mesh-list
92576812|NCT00101673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576813|NCT00101673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576814|NCT00101673|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92576815|NCT00101673|Protease Inhibitors|protease inhibitors|mesh-ancestor
92576816|NCT00101673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576817|NCT00101673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576818|NCT00263302|Dexamethasone|dexamethasone|mesh-list
92576819|NCT00263302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576820|NCT00263302|Antiemetics|antiemetics|mesh-ancestor
92576821|NCT00263302|Autonomic Agents|autonomic agents|mesh-ancestor
92576822|NCT00263302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576823|NCT00263302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576824|NCT00263302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576825|NCT00263302|Glucocorticoids|glucocorticoids|mesh-ancestor
92576826|NCT00263302|Hormones|hormones|mesh-ancestor
92576827|NCT00263302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576828|NCT00263302|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576829|NCT00263302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576830|NCT00263458|Buprenorphine|buprenorphine|mesh-list
92576831|NCT00263458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92576832|NCT00263458|Narcotics|narcotics|mesh-ancestor
92535085|NCT03959124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535086|NCT03959124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535087|NCT03959124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535088|NCT03959124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92576833|NCT00263458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576834|NCT00263458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576835|NCT00263458|Analgesics|analgesics|mesh-ancestor
92576836|NCT00263458|Sensory System Agents|sensory system agents|mesh-ancestor
92576837|NCT00263458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576838|NCT00263458|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92576839|NCT00101712|Vildagliptin|vildagliptin|mesh-list
92576840|NCT00101712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576841|NCT00101712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576842|NCT00101712|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92576843|NCT00101712|Protease Inhibitors|protease inhibitors|mesh-ancestor
92576844|NCT00101712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576845|NCT00101712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576846|NCT00072527|Carboplatin|carboplatin|mesh-list
92576847|NCT00072527|Irinotecan|irinotecan|mesh-list
92576848|NCT00072527|Etoposide|etoposide|mesh-list
92576849|NCT00072527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576850|NCT00072527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92576851|NCT00072527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92576852|NCT00072527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576853|NCT00072527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576854|NCT00072527|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92576855|NCT00072527|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92576856|NCT00101751|Insulin Aspart|insulin aspart|mesh-list
92576857|NCT00101751|Biphasic Insulins|biphasic insulins|mesh-list
92576858|NCT00101751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576859|NCT00101751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576860|NCT00263965|Metformin|metformin|mesh-list
92576861|NCT00263965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576862|NCT00263965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576863|NCT00264082|Zoledronic Acid|zoledronic acid|mesh-list
92576864|NCT00264082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576865|NCT00264082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576866|NCT00072683|Tolvaptan|tolvaptan|mesh-list
92576867|NCT00072683|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92301683|NCT00078949|Gemcitabine|gemcitabine|mesh-list
92576868|NCT00072683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576869|NCT00072683|Natriuretic Agents|natriuretic agents|mesh-ancestor
92576870|NCT00072683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576871|NCT00101790|Pamidronate|pamidronate|mesh-list
92576872|NCT00101790|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576902|NCT04709029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576904|NCT00072722|Immunologic Factors|immunologic factors|mesh-ancestor
92576905|NCT00072722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576906|NCT00072722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92576907|NCT00072722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92576908|NCT00072722|Growth Substances|growth substances|mesh-ancestor
92576909|NCT00072722|Growth Inhibitors|growth inhibitors|mesh-ancestor
92576910|NCT00072722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576911|NCT00264355|Cyclosporine|cyclosporine|mesh-list
92576912|NCT00264355|Cyclosporins|cyclosporins|mesh-list
92576913|NCT00264355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576914|NCT00264355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576915|NCT00264355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576916|NCT00264355|Immunologic Factors|immunologic factors|mesh-ancestor
92576917|NCT00264355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576918|NCT00264355|Antifungal Agents|antifungal agents|mesh-ancestor
91984293|NCT02723955|Paclitaxel|paclitaxel|mesh-list
92576975|NCT00106197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576976|NCT00106197|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92576977|NCT00106197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92576978|NCT00106197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576980|NCT00265252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92576981|NCT00265252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535089|NCT03959124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92535090|NCT03959124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92576982|NCT00265291|Fluoxetine|fluoxetine|mesh-list
92576983|NCT00265291|Desipramine|desipramine|mesh-list
92576984|NCT00265291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92576985|NCT00265291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92576986|NCT00265291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92578085|NCT00273013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578086|NCT00273013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92578087|NCT00273013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92578088|NCT00273013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578089|NCT00107835|Lidocaine|lidocaine|mesh-list
92578090|NCT00107835|Tetracaine|tetracaine|mesh-list
92578091|NCT00107835|Anesthetics, Local|anesthetics, local|mesh-ancestor
92578092|NCT00107835|Anesthetics|anesthetics|mesh-ancestor
92578093|NCT00107835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578094|NCT00107835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578095|NCT00107835|Sensory System Agents|sensory system agents|mesh-ancestor
92578096|NCT00107835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578097|NCT00107835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92578098|NCT00107835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92578099|NCT00107835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92578100|NCT00107835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92578101|NCT00107835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578102|NCT00107874|Misoprostol|misoprostol|mesh-list
92578103|NCT00107874|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92578104|NCT00107874|Abortifacient Agents|abortifacient agents|mesh-ancestor
92578105|NCT00107874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92578106|NCT00107874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578107|NCT00107874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92578108|NCT00107874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578109|NCT00107874|Oxytocics|oxytocics|mesh-ancestor
92578110|NCT00074828|Enoxaparin|enoxaparin|mesh-list
92578111|NCT00074828|Anticoagulants|anticoagulants|mesh-ancestor
92578112|NCT00074828|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92578113|NCT00074828|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92578114|NCT00074828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578115|NCT00273247|Interferons|interferons|mesh-list
92578116|NCT00273247|Interferon-alpha|interferon-alpha|mesh-list
92578117|NCT00273247|Interferon alpha-2|interferon alpha-2|mesh-list
92578118|NCT00273247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578119|NCT00273247|Antiviral Agents|antiviral agents|mesh-ancestor
92578120|NCT00273247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578121|NCT00273247|Immunologic Factors|immunologic factors|mesh-ancestor
92578122|NCT00273247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578123|NCT00273442|Timolol|timolol|mesh-list
92578124|NCT00273442|Dorzolamide|dorzolamide|mesh-list
92578125|NCT00273442|Maleic acid|maleic acid|mesh-list
92578126|NCT00273442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578127|NCT00273442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578128|NCT00273442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92578129|NCT00273442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92578130|NCT00273442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578131|NCT00273442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578132|NCT00273442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578133|NCT00273442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92578134|NCT00273442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578135|NCT00273442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92578136|NCT00401427|Trastuzumab|trastuzumab|mesh-list
92578137|NCT00401427|Vinorelbine|vinorelbine|mesh-list
92578138|NCT00401427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578139|NCT00401427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578140|NCT00401427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92578141|NCT00401427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92578142|NCT00401427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92578143|NCT00401427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92578144|NCT00401427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578145|NCT00273481|Timolol|timolol|mesh-list
92578146|NCT00273481|Dorzolamide|dorzolamide|mesh-list
92578147|NCT00273481|Latanoprost|latanoprost|mesh-list
92578148|NCT00273481|Maleic acid|maleic acid|mesh-list
92578149|NCT00273481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682794|NCT00438113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92535091|NCT03959124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578151|NCT00273481|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92578152|NCT00273481|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92578153|NCT00273481|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578154|NCT00273481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578155|NCT00273481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578156|NCT00273481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92578157|NCT00273481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578158|NCT00273481|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92578159|NCT00273481|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92578160|NCT00273481|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92578161|NCT00273520|Telithromycin|telithromycin|mesh-list
92578162|NCT00273520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92578163|NCT00273520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578164|NCT00273559|Prednisone|prednisone|mesh-list
92578165|NCT00273559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92578166|NCT00273559|Glucocorticoids|glucocorticoids|mesh-ancestor
92578167|NCT00273559|Hormones|hormones|mesh-ancestor
92578168|NCT00273559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578169|NCT00273559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578170|NCT00273559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92578171|NCT00273559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578172|NCT00273676|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92578173|NCT00273676|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92578174|NCT00273676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578175|NCT00273676|Antitubercular Agents|antitubercular agents|mesh-ancestor
92578176|NCT00273871|Cyclosporine|cyclosporine|mesh-list
92578177|NCT00273871|Tacrolimus|tacrolimus|mesh-list
92578178|NCT00273871|Cyclosporins|cyclosporins|mesh-list
92578179|NCT00273871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578180|NCT00273871|Immunologic Factors|immunologic factors|mesh-ancestor
92578181|NCT00273871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578182|NCT00273871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92578183|NCT00273871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578184|NCT00273871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578185|NCT00273871|Antifungal Agents|antifungal agents|mesh-ancestor
92578186|NCT00273871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578187|NCT00273871|Dermatologic Agents|dermatologic agents|mesh-ancestor
92578188|NCT00273871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92578189|NCT00273949|Lactulose|lactulose|mesh-list
92578190|NCT00273949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578191|NCT00273988|Nevirapine|nevirapine|mesh-list
92578192|NCT00273988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92578193|NCT00273988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92578194|NCT00273988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578195|NCT00273988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578196|NCT00273988|Antiviral Agents|antiviral agents|mesh-ancestor
92578197|NCT00273988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578198|NCT00273988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92578199|NCT00273988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92578200|NCT00273988|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92578201|NCT00273988|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92578202|NCT00274027|Bromides|bromides|mesh-list
92578203|NCT00274027|Tiotropium Bromide|tiotropium bromide|mesh-list
92578204|NCT00274027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578205|NCT00274027|Autonomic Agents|autonomic agents|mesh-ancestor
92578206|NCT00274027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578207|NCT00274027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578208|NCT00274027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578209|NCT00274027|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578210|NCT00274027|Parasympatholytics|parasympatholytics|mesh-ancestor
92578211|NCT00274027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92578212|NCT00274027|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578213|NCT00274027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578214|NCT00274027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578215|NCT00274027|Anticonvulsants|anticonvulsants|mesh-ancestor
92578216|NCT00075101|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92578217|NCT00075101|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92578218|NCT00075101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578219|NCT00075101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578220|NCT00075101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578221|NCT00075101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578222|NCT00075101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578227|NCT00274066|Autonomic Agents|autonomic agents|mesh-ancestor
92535092|NCT03959124|Cholinergic Agents|cholinergic agents|mesh-ancestor
92535093|NCT03959124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92578228|NCT00274066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578229|NCT00274066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578230|NCT00274066|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578231|NCT00274066|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578232|NCT00274066|Parasympatholytics|parasympatholytics|mesh-ancestor
92578233|NCT00274066|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92578234|NCT00274066|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578235|NCT00274066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578236|NCT00274066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578237|NCT00274066|Sympathomimetics|sympathomimetics|mesh-ancestor
92578238|NCT00274066|Tocolytic Agents|tocolytic agents|mesh-ancestor
92578239|NCT00274066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92578240|NCT00274066|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92578241|NCT00274066|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92578242|NCT00274066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92578243|NCT00274066|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578244|NCT00274105|Telmisartan|telmisartan|mesh-list
92578245|NCT00274105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578246|NCT00274105|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92578247|NCT00274105|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92578248|NCT00274105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578249|NCT00274144|Telmisartan|telmisartan|mesh-list
92578250|NCT00274144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578251|NCT00274144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92578252|NCT00274144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92578253|NCT00274144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578254|NCT00108186|Celecoxib|celecoxib|mesh-list
92578255|NCT00108186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92578256|NCT00108186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92578257|NCT00108186|Analgesics|analgesics|mesh-ancestor
92578258|NCT00108186|Sensory System Agents|sensory system agents|mesh-ancestor
92578259|NCT00108186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578260|NCT00108186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578261|NCT00108186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92578262|NCT00108186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92578263|NCT00108186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92578264|NCT00108186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92578265|NCT00108186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578266|NCT00108186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578267|NCT00274339|Lansoprazole|lansoprazole|mesh-list
92578268|NCT00274339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92578269|NCT00274339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578270|NCT00274339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92578271|NCT00274339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578272|NCT00274339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578273|NCT00075179|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92578274|NCT00075179|Natriuretic Agents|natriuretic agents|mesh-ancestor
92578275|NCT00075179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578276|NCT00416650|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92578277|NCT00416650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578278|NCT00416650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92578279|NCT00416650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578280|NCT00416650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578281|NCT00274417|Dutasteride|dutasteride|mesh-list
92578282|NCT00274417|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92578283|NCT00274417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92578284|NCT00274417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578285|NCT00274417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578286|NCT00274417|Hormone Antagonists|hormone antagonists|mesh-ancestor
92578287|NCT00274417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578288|NCT00274417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578289|NCT00274495|Rosiglitazone|rosiglitazone|mesh-list
92578290|NCT00274495|Ribavirin|ribavirin|mesh-list
92578291|NCT00274495|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92578294|NCT00274495|Antiviral Agents|antiviral agents|mesh-ancestor
92578295|NCT00274495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303119|NCT02974712|Narcotics|narcotics|mesh-ancestor
92578297|NCT00274495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535094|NCT03959124|Protective Agents|protective agents|mesh-ancestor
92535095|NCT02966236|Tranexamic Acid|tranexamic acid|mesh-list
92535096|NCT02966236|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92535097|NCT02966236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92578298|NCT00274534|Tiotropium Bromide|tiotropium bromide|mesh-list
92578299|NCT00274534|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92578300|NCT00274534|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578301|NCT00274534|Autonomic Agents|autonomic agents|mesh-ancestor
92578302|NCT00274534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578303|NCT00274534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578304|NCT00274534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578305|NCT00274534|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578306|NCT00274534|Parasympatholytics|parasympatholytics|mesh-ancestor
92578307|NCT00274534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92578308|NCT00274534|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578309|NCT00274534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578310|NCT00274534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578311|NCT00274534|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92578312|NCT00274534|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92578313|NCT00274534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92578314|NCT00274534|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578315|NCT00274573|Bromides|bromides|mesh-list
92578316|NCT00274573|Tiotropium Bromide|tiotropium bromide|mesh-list
92578317|NCT00274573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578318|NCT00274573|Autonomic Agents|autonomic agents|mesh-ancestor
92578319|NCT00274573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578320|NCT00274573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578321|NCT00274573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578322|NCT00274573|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578323|NCT00274573|Parasympatholytics|parasympatholytics|mesh-ancestor
92578324|NCT00274573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92578325|NCT00274573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578326|NCT00274573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578327|NCT00274573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578328|NCT00274573|Anticonvulsants|anticonvulsants|mesh-ancestor
92578329|NCT00274612|Telmisartan|telmisartan|mesh-list
92578330|NCT00274612|Ramipril|ramipril|mesh-list
92578331|NCT00274612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578332|NCT00274612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92578333|NCT00274612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92578334|NCT00274612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578335|NCT00274612|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92578336|NCT00274612|Protease Inhibitors|protease inhibitors|mesh-ancestor
92578337|NCT00274612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578338|NCT00075374|Docetaxel|docetaxel|mesh-list
92578339|NCT00075374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578340|NCT00075374|Tubulin Modulators|tubulin modulators|mesh-ancestor
92578341|NCT00075374|Antimitotic Agents|antimitotic agents|mesh-ancestor
92578342|NCT00075374|Mitosis Modulators|mitosis modulators|mesh-ancestor
92578343|NCT00075374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578344|NCT00274690|Casopitant|casopitant|mesh-list
92578345|NCT00274690|Antiemetics|antiemetics|mesh-ancestor
92578346|NCT00274690|Autonomic Agents|autonomic agents|mesh-ancestor
92578347|NCT00274690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578348|NCT00274690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578349|NCT00274690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578350|NCT00274690|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92578351|NCT00274690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578352|NCT00274690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578353|NCT00274807|Cytarabine|cytarabine|mesh-list
92578354|NCT00274807|Etoposide|etoposide|mesh-list
92578355|NCT00274807|Mitoxantrone|mitoxantrone|mesh-list
92578356|NCT00274807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92578357|NCT00274807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578358|NCT00274807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92578359|NCT00274807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92578360|NCT00274807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578361|NCT00274807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578362|NCT00274807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92578363|NCT00274807|Antimetabolites|antimetabolites|mesh-ancestor
92578370|NCT00274807|Sensory System Agents|sensory system agents|mesh-ancestor
92535098|NCT02966236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578371|NCT00274807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578372|NCT00274885|Oxaliplatin|oxaliplatin|mesh-list
92578373|NCT00274885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578374|NCT00277225|Abatacept|abatacept|mesh-list
92578375|NCT00277225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92578376|NCT00277225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578377|NCT00277225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578378|NCT00277225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578379|NCT00277225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578380|NCT00277225|Immunologic Factors|immunologic factors|mesh-ancestor
92578381|NCT00277225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578382|NCT00277225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92578383|NCT00277264|Tiotropium Bromide|tiotropium bromide|mesh-list
92578384|NCT00277264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578385|NCT00277264|Autonomic Agents|autonomic agents|mesh-ancestor
92578386|NCT00277264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578387|NCT00277264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578388|NCT00277264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578389|NCT00277264|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578390|NCT00277264|Parasympatholytics|parasympatholytics|mesh-ancestor
92578391|NCT00277264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92578392|NCT00277264|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578393|NCT00277264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578394|NCT00277264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578395|NCT00108420|Prazosin|prazosin|mesh-list
92578396|NCT00108420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578397|NCT00108420|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92578398|NCT00108420|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92578399|NCT00108420|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92578400|NCT00108420|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578401|NCT00108420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578402|NCT00108420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578403|NCT00108420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578404|NCT00075413|Arsenic Trioxide|arsenic trioxide|mesh-list
92578405|NCT00075413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578406|NCT00277342|Insulin|insulin|mesh-list
92578407|NCT00277342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92578408|NCT00277342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578409|NCT00277498|Timolol|timolol|mesh-list
92578410|NCT00277498|Latanoprost|latanoprost|mesh-list
92578411|NCT00277498|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92578412|NCT00277498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92578413|NCT00277498|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578414|NCT00277498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578415|NCT00277498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578416|NCT00277498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578417|NCT00277498|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92578418|NCT00277498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578419|NCT00277498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92578420|NCT00277498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92578421|NCT00108498|Mirtazapine|mirtazapine|mesh-list
92578422|NCT00108498|Antidepressive Agents|antidepressive agents|mesh-ancestor
92578423|NCT00108498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578424|NCT00108498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92578425|NCT00108498|Histamine Antagonists|histamine antagonists|mesh-ancestor
92578426|NCT00108498|Histamine Agents|histamine agents|mesh-ancestor
92578427|NCT00108498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578428|NCT00108498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578429|NCT00108498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578430|NCT00108498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92578431|NCT00108498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91985594|NCT02383823|Estradiol|estradiol|mesh-list
92578436|NCT00108498|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578437|NCT00108498|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92578438|NCT00108498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92578439|NCT00108498|Serotonin Agents|serotonin agents|mesh-ancestor
92578440|NCT00108498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92578441|NCT00277537|Mannitol|mannitol|mesh-list
92578442|NCT00277537|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92578443|NCT00277537|Diuretics|diuretics|mesh-ancestor
92578444|NCT00277537|Natriuretic Agents|natriuretic agents|mesh-ancestor
92578445|NCT00277537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535099|NCT02966236|Hemostatics|hemostatics|mesh-ancestor
92535100|NCT02966236|Coagulants|coagulants|mesh-ancestor
92535101|NCT04711291|Tacrolimus|tacrolimus|mesh-list
92535102|NCT04711291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535103|NCT04711291|Immunologic Factors|immunologic factors|mesh-ancestor
92578446|NCT00075452|Gemcitabine|gemcitabine|mesh-list
92578447|NCT00075452|Oxaliplatin|oxaliplatin|mesh-list
92578448|NCT00075452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92578449|NCT00075452|Antimetabolites|antimetabolites|mesh-ancestor
92578450|NCT00075452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578451|NCT00075452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578452|NCT00108537|Bupropion|bupropion|mesh-list
92578453|NCT00108537|Nicotine|nicotine|mesh-list
92578454|NCT00108537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92578455|NCT00108537|Autonomic Agents|autonomic agents|mesh-ancestor
92578456|NCT00108537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578457|NCT00108537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578458|NCT00108537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92578459|NCT00108537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92578460|NCT00108537|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578461|NCT00108537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578462|NCT00108537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578463|NCT00108537|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92578464|NCT00108537|Antidepressive Agents|antidepressive agents|mesh-ancestor
92578465|NCT00108537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578466|NCT00108537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92578467|NCT00108537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92578468|NCT00108537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92578469|NCT00108537|Dopamine Agents|dopamine agents|mesh-ancestor
92578470|NCT00108537|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92578471|NCT00108537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92578472|NCT00108537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578473|NCT00277654|Risperidone|risperidone|mesh-list
92578474|NCT00277654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92578475|NCT00277654|Serotonin Agents|serotonin agents|mesh-ancestor
92578476|NCT00277654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578477|NCT00277654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578478|NCT00277654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578479|NCT00277654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92578480|NCT00277654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578481|NCT00277654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578482|NCT00277654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578483|NCT00277654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92578484|NCT00277654|Dopamine Agents|dopamine agents|mesh-ancestor
92578485|NCT00277693|Spironolactone|spironolactone|mesh-list
92578486|NCT00277693|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92578487|NCT00277693|Hormone Antagonists|hormone antagonists|mesh-ancestor
92578488|NCT00277693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578489|NCT00277693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578490|NCT00277693|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92578491|NCT00277693|Diuretics|diuretics|mesh-ancestor
92578492|NCT00277693|Natriuretic Agents|natriuretic agents|mesh-ancestor
92578493|NCT00108576|Valproic Acid|valproic acid|mesh-list
92578494|NCT00108576|Anticonvulsants|anticonvulsants|mesh-ancestor
92578495|NCT00108576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578496|NCT00108576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578497|NCT00108576|GABA Agents|gaba agents|mesh-ancestor
92578498|NCT00108576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578499|NCT00108576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578500|NCT00108576|Antimanic Agents|antimanic agents|mesh-ancestor
92578502|NCT00108576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578503|NCT00108576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578505|NCT00075491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578506|NCT00075491|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92578507|NCT00075491|Protective Agents|protective agents|mesh-ancestor
92578508|NCT00075491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578509|NCT00108615|Metformin|metformin|mesh-list
92578510|NCT00108615|Pioglitazone|pioglitazone|mesh-list
92578511|NCT00108615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92578512|NCT00108615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578513|NCT00278083|Nitric Oxide|nitric oxide|mesh-list
92535104|NCT04711291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578514|NCT00278083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578515|NCT00278083|Autonomic Agents|autonomic agents|mesh-ancestor
92578516|NCT00278083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578517|NCT00278083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303347|NCT04023695|Autonomic Agents|autonomic agents|mesh-ancestor
92578518|NCT00278083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578519|NCT00278083|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578520|NCT00278083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92578521|NCT00278083|Antioxidants|antioxidants|mesh-ancestor
92578522|NCT00278083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578523|NCT00278083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578524|NCT00278083|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92578525|NCT00278083|Vasodilator Agents|vasodilator agents|mesh-ancestor
92578526|NCT00278083|Gasotransmitters|gasotransmitters|mesh-ancestor
92578527|NCT00278083|Protective Agents|protective agents|mesh-ancestor
92578528|NCT00278122|Paclitaxel|paclitaxel|mesh-list
92578529|NCT00278122|Sargramostim|sargramostim|mesh-list
92578530|NCT00278122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92578531|NCT00278122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578532|NCT00278122|Tubulin Modulators|tubulin modulators|mesh-ancestor
92578533|NCT00278122|Antimitotic Agents|antimitotic agents|mesh-ancestor
92578534|NCT00278122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92578535|NCT00278122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578536|NCT00278122|Immunologic Factors|immunologic factors|mesh-ancestor
92578537|NCT00278122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578538|NCT00075647|Sirolimus|sirolimus|mesh-list
92578539|NCT00075647|Temsirolimus|temsirolimus|mesh-list
92578540|NCT00075647|MTOR Inhibitors|mtor inhibitors|mesh-list
92578541|NCT00075647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92578542|NCT00075647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578543|NCT00075647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578544|NCT00075647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578545|NCT00075647|Immunologic Factors|immunologic factors|mesh-ancestor
92578546|NCT00075647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578547|NCT00075647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578548|NCT00075647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92578549|NCT00075647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578550|NCT00075647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92578551|NCT00075647|Antifungal Agents|antifungal agents|mesh-ancestor
92578552|NCT00278278|Prednisone|prednisone|mesh-list
92578553|NCT00278278|Methotrexate|methotrexate|mesh-list
92578554|NCT00278278|Etoposide|etoposide|mesh-list
92578555|NCT00278278|Vincristine|vincristine|mesh-list
92578556|NCT00278278|Ifosfamide|ifosfamide|mesh-list
92578557|NCT00278278|Lomustine|lomustine|mesh-list
92578558|NCT00278278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578559|NCT00278278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92578560|NCT00278278|Glucocorticoids|glucocorticoids|mesh-ancestor
92578561|NCT00278278|Hormones|hormones|mesh-ancestor
92578562|NCT00278278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578563|NCT00278278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578564|NCT00278278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92578565|NCT00278278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92578566|NCT00278278|Abortifacient Agents|abortifacient agents|mesh-ancestor
92578567|NCT00278278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92578568|NCT00278278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92578569|NCT00278278|Antimetabolites|antimetabolites|mesh-ancestor
92578570|NCT00278278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578571|NCT00278278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92578572|NCT00278278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578573|NCT00278278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92578574|NCT00278278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578578|NCT00278278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92578579|NCT00278278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92578580|NCT00278278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92578581|NCT00278278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92578582|NCT00278278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92578583|NCT00278278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92578584|NCT00278278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92578585|NCT00278278|Alkylating Agents|alkylating agents|mesh-ancestor
92578586|NCT00108771|Fentanyl|fentanyl|mesh-list
92578587|NCT00108771|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92578588|NCT00108771|Narcotics|narcotics|mesh-ancestor
92578589|NCT00108771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535105|NCT04711291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91925922|NCT02153879|Antimetabolites|antimetabolites|mesh-ancestor
92578590|NCT00108771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578591|NCT00108771|Analgesics|analgesics|mesh-ancestor
92578592|NCT00108771|Sensory System Agents|sensory system agents|mesh-ancestor
92578593|NCT00108771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578594|NCT00108771|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92578595|NCT00108771|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92578597|NCT00108771|Anesthetics|anesthetics|mesh-ancestor
92578598|NCT00278434|Zoledronic Acid|zoledronic acid|mesh-list
92578599|NCT00278434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92578600|NCT00278434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578601|NCT00075686|Gemcitabine|gemcitabine|mesh-list
92578602|NCT00075686|Cetuximab|cetuximab|mesh-list
92578603|NCT00075686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92578604|NCT00075686|Antimetabolites|antimetabolites|mesh-ancestor
92578605|NCT00075686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578606|NCT00075686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578607|NCT00075686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578608|NCT00278824|Fentanyl|fentanyl|mesh-list
92578609|NCT00278824|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92578610|NCT00278824|Narcotics|narcotics|mesh-ancestor
92578611|NCT00278824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578612|NCT00278824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578613|NCT00278824|Analgesics|analgesics|mesh-ancestor
92578614|NCT00278824|Sensory System Agents|sensory system agents|mesh-ancestor
92578615|NCT00278824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578616|NCT00278824|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92578617|NCT00278824|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92578618|NCT00278824|Anesthetics, General|anesthetics, general|mesh-ancestor
92578619|NCT00278824|Anesthetics|anesthetics|mesh-ancestor
92578620|NCT00278941|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92578621|NCT00278941|Antidepressive Agents|antidepressive agents|mesh-ancestor
92578622|NCT00278941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578623|NCT00278941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92578624|NCT00278941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578625|NCT00278941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578626|NCT00278941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578627|NCT00279019|Tiotropium Bromide|tiotropium bromide|mesh-list
92578628|NCT00279019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578629|NCT00279019|Autonomic Agents|autonomic agents|mesh-ancestor
92578630|NCT00279019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578631|NCT00279019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578632|NCT00279019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578633|NCT00279019|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578634|NCT00279019|Parasympatholytics|parasympatholytics|mesh-ancestor
92578635|NCT00279019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92578636|NCT00279019|Cholinergic Agents|cholinergic agents|mesh-ancestor
92578637|NCT00279019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578638|NCT00279019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578639|NCT00108849|Estradiol|estradiol|mesh-list
92578640|NCT00108849|Estrogens|estrogens|mesh-ancestor
92578641|NCT00108849|Hormones|hormones|mesh-ancestor
92578642|NCT00108849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578643|NCT00108849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578644|NCT00279058|Immunomodulating Agents|immunomodulating agents|mesh-list
92578645|NCT00279058|Immunologic Factors|immunologic factors|mesh-ancestor
92578646|NCT00279058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578647|NCT00279253|Clonidine|clonidine|mesh-list
92578648|NCT00279253|Analgesics|analgesics|mesh-ancestor
92578713|NCT00279565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578714|NCT00279565|Antimetabolites|antimetabolites|mesh-ancestor
92578715|NCT00279565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578716|NCT00279565|Immunologic Factors|immunologic factors|mesh-ancestor
91985918|NCT03959891|Letrozole|letrozole|mesh-list
92578718|NCT00279565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92578719|NCT00279565|Narcotics|narcotics|mesh-ancestor
92578720|NCT00279565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578721|NCT00279565|Analgesics|analgesics|mesh-ancestor
92578722|NCT00279565|Sensory System Agents|sensory system agents|mesh-ancestor
92578723|NCT00279565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578724|NCT00279565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91925995|NCT03541265|Sensory System Agents|sensory system agents|mesh-ancestor
92578725|NCT00279565|Antitussive Agents|antitussive agents|mesh-ancestor
92578726|NCT00279565|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578727|NCT00075998|Interferons|interferons|mesh-list
92578728|NCT00075998|Interferon-gamma|interferon-gamma|mesh-list
92578729|NCT00075998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578730|NCT00075998|Antiviral Agents|antiviral agents|mesh-ancestor
92578731|NCT00075998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578732|NCT00109161|Antibodies|antibodies|mesh-list
92578733|NCT00109161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92578734|NCT00109161|Daclizumab|daclizumab|mesh-list
92578735|NCT00109161|Immunologic Factors|immunologic factors|mesh-ancestor
92578736|NCT00109161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578737|NCT00109161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578738|NCT00279760|Abatacept|abatacept|mesh-list
92578739|NCT00279760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92578740|NCT00279760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578741|NCT00279760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578742|NCT00279760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578743|NCT00279760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578744|NCT00279760|Immunologic Factors|immunologic factors|mesh-ancestor
92578745|NCT00279760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578746|NCT00279760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92578747|NCT00109200|Omalizumab|omalizumab|mesh-list
92578748|NCT00109200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92578749|NCT00109200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92578750|NCT00109200|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578751|NCT00416728|Valsartan|valsartan|mesh-list
92578752|NCT00416728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578753|NCT00416728|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92578754|NCT00416728|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92578755|NCT00416728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578756|NCT00416767|Leucovorin|leucovorin|mesh-list
92578757|NCT00416767|Fluorouracil|fluorouracil|mesh-list
92578758|NCT00416767|Irinotecan|irinotecan|mesh-list
92578759|NCT00416767|Calcium|calcium|mesh-list
92578760|NCT00416767|Levoleucovorin|levoleucovorin|mesh-list
92578761|NCT00416767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92578762|NCT00416767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578763|NCT00416767|Antimetabolites|antimetabolites|mesh-ancestor
92578764|NCT00416767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578765|NCT00416767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92578766|NCT00416767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578767|NCT00416767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578768|NCT00416767|Immunologic Factors|immunologic factors|mesh-ancestor
92578769|NCT00416767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92578770|NCT00416767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92578771|NCT00416767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578772|NCT00416767|Antidotes|antidotes|mesh-ancestor
92578773|NCT00416767|Protective Agents|protective agents|mesh-ancestor
92578774|NCT00416767|Vitamin B Complex|vitamin b complex|mesh-ancestor
92578775|NCT00416767|Vitamins|vitamins|mesh-ancestor
92578776|NCT00416767|Micronutrients|micronutrients|mesh-ancestor
92578777|NCT00076115|Risperidone|risperidone|mesh-list
92578778|NCT00076115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92578779|NCT00076115|Serotonin Agents|serotonin agents|mesh-ancestor
92578780|NCT00076115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578781|NCT00076115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578782|NCT00076115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578783|NCT00076115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92578784|NCT00076115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578785|NCT00076115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578786|NCT00076115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578787|NCT00076115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92578788|NCT00076115|Dopamine Agents|dopamine agents|mesh-ancestor
92578789|NCT00109239|Bevacizumab|bevacizumab|mesh-list
92578790|NCT00109239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578791|NCT00109239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578792|NCT00109239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92578794|NCT00109239|Growth Substances|growth substances|mesh-ancestor
92578795|NCT00109239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578796|NCT00109239|Growth Inhibitors|growth inhibitors|mesh-ancestor
92578797|NCT00280033|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92578798|NCT00280033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92578799|NCT00280033|Immunologic Factors|immunologic factors|mesh-ancestor
92578800|NCT00280033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535107|NCT04711291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535108|NCT00073372|Abciximab|abciximab|mesh-list
92535109|NCT00073372|Anticoagulants|anticoagulants|mesh-ancestor
92535110|NCT00073372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92578801|NCT00280033|Antacids|antacids|mesh-ancestor
92578802|NCT00280033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578803|NCT00280033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578804|NCT00109278|Vaccines|vaccines|mesh-list
92578805|NCT00109278|Immunologic Factors|immunologic factors|mesh-ancestor
92578806|NCT00109278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578807|NCT00280267|Testosterone|testosterone|mesh-list
92578808|NCT00280267|Androgens|androgens|mesh-ancestor
92578809|NCT00280267|Hormones|hormones|mesh-ancestor
92578810|NCT00280267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578811|NCT00280267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578812|NCT00076232|Acyclovir|acyclovir|mesh-list
92578813|NCT00076232|Antiviral Agents|antiviral agents|mesh-ancestor
92578814|NCT00076232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578815|NCT00280423|Casopitant|casopitant|mesh-list
92578816|NCT00280423|Antiemetics|antiemetics|mesh-ancestor
92578817|NCT00280423|Autonomic Agents|autonomic agents|mesh-ancestor
92578818|NCT00280423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578819|NCT00280423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578820|NCT00280423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578821|NCT00280423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92578822|NCT00280423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578823|NCT00280423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578825|NCT00109356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578826|NCT00280462|Nifedipine|nifedipine|mesh-list
92578827|NCT00280462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92578828|NCT00280462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92578829|NCT00280462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578830|NCT00280462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92578831|NCT00280462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578832|NCT00280462|Vasodilator Agents|vasodilator agents|mesh-ancestor
92578833|NCT00280462|Tocolytic Agents|tocolytic agents|mesh-ancestor
92578834|NCT00280462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92578835|NCT00280501|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92578836|NCT00280501|Sulpiride|sulpiride|mesh-list
92578837|NCT00280501|Antidepressive Agents|antidepressive agents|mesh-ancestor
92578838|NCT00280501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578839|NCT00280501|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92578840|NCT00280501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578841|NCT00280501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578842|NCT00280501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578843|NCT00280501|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92578844|NCT00280501|Dopamine Agents|dopamine agents|mesh-ancestor
92578845|NCT00280501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578846|NCT00280501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578847|NCT00280501|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92578848|NCT00280540|Valsartan|valsartan|mesh-list
92578849|NCT00280540|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92578850|NCT00280540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578851|NCT00280540|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92578852|NCT00280540|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92578853|NCT00280540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578854|NCT00280540|Diuretics|diuretics|mesh-ancestor
92578855|NCT00280540|Natriuretic Agents|natriuretic agents|mesh-ancestor
92578856|NCT00280540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578857|NCT00280540|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92578858|NCT00280540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92578859|NCT00076349|Rituximab|rituximab|mesh-list
92578860|NCT00076349|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92578861|NCT00076349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578862|NCT00076349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578863|NCT00076349|Immunologic Factors|immunologic factors|mesh-ancestor
92578864|NCT00076349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578865|NCT00076349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986021|NCT02369549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578869|NCT00280618|Oxaliplatin|oxaliplatin|mesh-list
92535111|NCT04821830|Levodopa|levodopa|mesh-list
92535112|NCT04821830|Carbidopa|carbidopa|mesh-list
92535113|NCT04821830|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92535114|NCT04821830|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91926146|NCT04475107|Antiviral Agents|antiviral agents|mesh-ancestor
92578870|NCT00280618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578871|NCT00416845|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92578872|NCT00416845|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92578873|NCT00416845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578874|NCT00416845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578875|NCT00416845|Immunologic Factors|immunologic factors|mesh-ancestor
92578876|NCT00416845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578877|NCT00280696|Levetiracetam|levetiracetam|mesh-list
92578878|NCT00280696|Anticonvulsants|anticonvulsants|mesh-ancestor
92578879|NCT00280696|Nootropic Agents|nootropic agents|mesh-ancestor
92578880|NCT00076388|Docetaxel|docetaxel|mesh-list
92578881|NCT00076388|Gefitinib|gefitinib|mesh-list
92578882|NCT00076388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578883|NCT00076388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92578884|NCT00076388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92578885|NCT00076388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92578886|NCT00076388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578887|NCT00076388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92578888|NCT00076388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578889|NCT00280774|Memantine|memantine|mesh-list
92578890|NCT00280774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92578891|NCT00280774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92578892|NCT00280774|Dopamine Agents|dopamine agents|mesh-ancestor
92578893|NCT00280774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578894|NCT00280774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578895|NCT00280774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578896|NCT00280774|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92578897|NCT00280774|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92578898|NCT00109551|Folic Acid|folic acid|mesh-list
92578899|NCT00109551|Zinc Sulfate|zinc sulfate|mesh-list
92578900|NCT00109551|Hematinics|hematinics|mesh-ancestor
92578901|NCT00109551|Vitamin B Complex|vitamin b complex|mesh-ancestor
92578902|NCT00109551|Vitamins|vitamins|mesh-ancestor
92578903|NCT00109551|Micronutrients|micronutrients|mesh-ancestor
92578904|NCT00109551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578905|NCT00109551|Astringents|astringents|mesh-ancestor
92578906|NCT00109551|Dermatologic Agents|dermatologic agents|mesh-ancestor
92578907|NCT00280930|Letrozole|letrozole|mesh-list
92578908|NCT00280930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578909|NCT00280930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92578910|NCT00280930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92578911|NCT00280930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578912|NCT00280930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578913|NCT00280930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92578914|NCT00280930|Hormone Antagonists|hormone antagonists|mesh-ancestor
92578915|NCT00280930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578916|NCT00280930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578917|NCT00280969|Efavirenz|efavirenz|mesh-list
92578918|NCT00280969|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92578919|NCT00280969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92578920|NCT00280969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92578921|NCT00280969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578922|NCT00280969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578923|NCT00280969|Antiviral Agents|antiviral agents|mesh-ancestor
92578924|NCT00280969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578925|NCT00280969|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92578926|NCT00280969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92578927|NCT00280969|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92578928|NCT00280969|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92578929|NCT00280969|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92578930|NCT00280969|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92578931|NCT00280969|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92578932|NCT00280969|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92578933|NCT00280969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92578934|NCT00280969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92535115|NCT04821830|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92535116|NCT04821830|Dopamine Agents|dopamine agents|mesh-ancestor
92535117|NCT04821830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578935|NCT00280969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92578936|NCT00281008|Mipomersen|mipomersen|mesh-list
92578949|NCT00281125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92578951|NCT00109746|Picolinic acid|picolinic acid|mesh-list
92578952|NCT00109746|Trace Elements|trace elements|mesh-ancestor
92578953|NCT00109746|Micronutrients|micronutrients|mesh-ancestor
92578954|NCT00109746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578955|NCT00109746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92578956|NCT00109746|Chelating Agents|chelating agents|mesh-ancestor
92578957|NCT00109746|Sequestering Agents|sequestering agents|mesh-ancestor
92578958|NCT00109746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578959|NCT04730297|Acetaminophen|acetaminophen|mesh-list
92578960|NCT04730297|Ibuprofen|ibuprofen|mesh-list
92578961|NCT04730297|Codeine|codeine|mesh-list
92578962|NCT04730297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92578963|NCT04730297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92578964|NCT04730297|Analgesics|analgesics|mesh-ancestor
92578965|NCT04730297|Sensory System Agents|sensory system agents|mesh-ancestor
92578966|NCT04730297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578967|NCT04730297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303794|NCT05723341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92578968|NCT04730297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92578969|NCT04730297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92578970|NCT04730297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92578971|NCT04730297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578972|NCT04730297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578973|NCT04730297|Antipyretics|antipyretics|mesh-ancestor
92578974|NCT04730297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92578975|NCT04730297|Narcotics|narcotics|mesh-ancestor
92578976|NCT04730297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578977|NCT04730297|Antitussive Agents|antitussive agents|mesh-ancestor
92578978|NCT04730297|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578979|NCT00399269|Epoetin Alfa|epoetin alfa|mesh-list
92578980|NCT00399269|Hematinics|hematinics|mesh-ancestor
92578981|NCT00281281|Vancomycin|vancomycin|mesh-list
92578982|NCT00281281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92578983|NCT00281281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578984|NCT00109785|Idoxuridine|idoxuridine|mesh-list
92578985|NCT00109785|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92578986|NCT00109785|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92578987|NCT00109785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578988|NCT00109785|Antiviral Agents|antiviral agents|mesh-ancestor
92578989|NCT00109785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578990|NCT00109785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92578991|NCT00109785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578992|NCT00281476|Simvastatin|simvastatin|mesh-list
92578993|NCT00281476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92578994|NCT00281476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92578995|NCT00281476|Antimetabolites|antimetabolites|mesh-ancestor
92578996|NCT00281476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578997|NCT00281476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92578998|NCT00281476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92579014|NCT00416962|Dopamine Agents|dopamine agents|mesh-ancestor
92579015|NCT00416962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579016|NCT00416962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579017|NCT00416962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92579018|NCT00416962|Analgesics|analgesics|mesh-ancestor
92579019|NCT00416962|Sensory System Agents|sensory system agents|mesh-ancestor
92579020|NCT00416962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579021|NCT00109824|Decitabine|decitabine|mesh-list
92579022|NCT00109824|Azacitidine|azacitidine|mesh-list
92579023|NCT00109824|Valproic Acid|valproic acid|mesh-list
92579024|NCT00109824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579025|NCT00109824|Antimetabolites|antimetabolites|mesh-ancestor
92579026|NCT00109824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579027|NCT00109824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579028|NCT00109824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579029|NCT00109824|Anticonvulsants|anticonvulsants|mesh-ancestor
92579030|NCT00109824|GABA Agents|gaba agents|mesh-ancestor
92579031|NCT00109824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579032|NCT00109824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579033|NCT00109824|Antimanic Agents|antimanic agents|mesh-ancestor
92579034|NCT00109824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579035|NCT00109824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579036|NCT00109824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579037|NCT00281515|Lonafarnib|lonafarnib|mesh-list
92579038|NCT00281515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579039|NCT00281515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579040|NCT00109941|Analgesics, Opioid|analgesics, opioid|mesh-list
92579041|NCT00109941|Mitogens|mitogens|mesh-list
92579042|NCT00109941|Enkephalin, Methionine|enkephalin, methionine|mesh-list
92579043|NCT00109941|Narcotics|narcotics|mesh-ancestor
92579044|NCT00109941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579045|NCT00109941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579047|NCT00109941|Sensory System Agents|sensory system agents|mesh-ancestor
92579048|NCT00109941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579049|NCT00109941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579050|NCT00109941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579051|NCT00109941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579052|NCT00281593|Telmisartan|telmisartan|mesh-list
92579053|NCT00281593|Ramipril|ramipril|mesh-list
92579054|NCT00281593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92579055|NCT00281593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92579056|NCT00281593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92579057|NCT00281593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579058|NCT00281593|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92579059|NCT00281593|Protease Inhibitors|protease inhibitors|mesh-ancestor
92579060|NCT00281593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579075|NCT00281710|Hormones|hormones|mesh-ancestor
92359613|NCT00365274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579076|NCT00281710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579077|NCT00281710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92579078|NCT00281710|Protective Agents|protective agents|mesh-ancestor
92579079|NCT00281710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579080|NCT00281710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579081|NCT00076544|Ziconotide|ziconotide|mesh-list
92579082|NCT00076544|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92579083|NCT00076544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579084|NCT00076544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579085|NCT00076544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92579086|NCT00076544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579087|NCT00076544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92579088|NCT00076544|Protective Agents|protective agents|mesh-ancestor
92579089|NCT00076544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92579090|NCT00076544|Analgesics|analgesics|mesh-ancestor
92579091|NCT00076544|Sensory System Agents|sensory system agents|mesh-ancestor
92579092|NCT00076544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579093|NCT00281788|Paclitaxel|paclitaxel|mesh-list
92579094|NCT00281788|Carboplatin|carboplatin|mesh-list
92579095|NCT00281788|Capecitabine|capecitabine|mesh-list
92579096|NCT00281788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92579097|NCT00281788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579098|NCT00281788|Tubulin Modulators|tubulin modulators|mesh-ancestor
92579099|NCT00281788|Antimitotic Agents|antimitotic agents|mesh-ancestor
92579100|NCT00281788|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579101|NCT00281788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579102|NCT00281788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579103|NCT00281788|Antimetabolites|antimetabolites|mesh-ancestor
92579104|NCT00281866|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92579105|NCT00281866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579106|NCT00281866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92579107|NCT00281866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579108|NCT00281866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579109|NCT00281905|Cyclophosphamide|cyclophosphamide|mesh-list
92579110|NCT00281905|Carboplatin|carboplatin|mesh-list
92579111|NCT00281905|Methotrexate|methotrexate|mesh-list
92579112|NCT00281905|Vincristine|vincristine|mesh-list
92579113|NCT00281905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579114|NCT00281905|Immunologic Factors|immunologic factors|mesh-ancestor
92579115|NCT00281905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579116|NCT00281905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579117|NCT00281905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92579118|NCT00281905|Alkylating Agents|alkylating agents|mesh-ancestor
92579119|NCT00281905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579120|NCT00281905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579121|NCT00281905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535118|NCT04821830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579133|NCT00281905|Antimitotic Agents|antimitotic agents|mesh-ancestor
92579134|NCT00281905|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579136|NCT00110058|Interferon-alpha|interferon-alpha|mesh-list
92579137|NCT00110058|Cyclosporine|cyclosporine|mesh-list
92579138|NCT00110058|Mycophenolic Acid|mycophenolic acid|mesh-list
92579139|NCT00110058|Fludarabine|fludarabine|mesh-list
92579140|NCT00110058|Fludarabine phosphate|fludarabine phosphate|mesh-list
92579141|NCT00110058|Imatinib Mesylate|imatinib mesylate|mesh-list
92579142|NCT00110058|Cyclosporins|cyclosporins|mesh-list
92579143|NCT00110058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579144|NCT00110058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579145|NCT00110058|Antimetabolites|antimetabolites|mesh-ancestor
92579146|NCT00110058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579147|NCT00110058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579148|NCT00110058|Immunologic Factors|immunologic factors|mesh-ancestor
92579149|NCT00110058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579150|NCT00110058|Antiviral Agents|antiviral agents|mesh-ancestor
92579151|NCT00110058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579152|NCT00110058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579153|NCT00110058|Antifungal Agents|antifungal agents|mesh-ancestor
92579154|NCT00110058|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579155|NCT00110058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579156|NCT00110058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92579157|NCT00110058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92579158|NCT00110058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92579159|NCT00110058|Antitubercular Agents|antitubercular agents|mesh-ancestor
92579160|NCT00110058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92579161|NCT00110058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92579163|NCT00281944|Fluorouracil|fluorouracil|mesh-list
92579164|NCT00281944|Oxaliplatin|oxaliplatin|mesh-list
92579165|NCT00281944|Calcium|calcium|mesh-list
92579166|NCT00281944|Levoleucovorin|levoleucovorin|mesh-list
92579167|NCT00281944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92579168|NCT00281944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579169|NCT00281944|Antimetabolites|antimetabolites|mesh-ancestor
92579170|NCT00281944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579171|NCT00281944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579172|NCT00281944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579173|NCT00281944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579174|NCT00281944|Immunologic Factors|immunologic factors|mesh-ancestor
92579175|NCT00281944|Antidotes|antidotes|mesh-ancestor
92579176|NCT00281944|Protective Agents|protective agents|mesh-ancestor
92579177|NCT00281944|Vitamin B Complex|vitamin b complex|mesh-ancestor
92579178|NCT00281944|Vitamins|vitamins|mesh-ancestor
92579179|NCT00281944|Micronutrients|micronutrients|mesh-ancestor
92579180|NCT00281983|Cyclosporine|cyclosporine|mesh-list
92579181|NCT00281983|Mycophenolic Acid|mycophenolic acid|mesh-list
92579182|NCT00281983|Cyclophosphamide|cyclophosphamide|mesh-list
92579183|NCT00281983|Busulfan|busulfan|mesh-list
92579184|NCT00281983|Rituximab|rituximab|mesh-list
92579185|NCT00281983|Methotrexate|methotrexate|mesh-list
92579186|NCT00281983|Fludarabine|fludarabine|mesh-list
92579187|NCT00281983|Fludarabine phosphate|fludarabine phosphate|mesh-list
92579188|NCT00281983|Alemtuzumab|alemtuzumab|mesh-list
92579192|NCT00281983|Immunologic Factors|immunologic factors|mesh-ancestor
92579193|NCT00281983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579194|NCT00281983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579195|NCT00281983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92579196|NCT00281983|Alkylating Agents|alkylating agents|mesh-ancestor
92704664|NCT04320238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579197|NCT00281983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579198|NCT00281983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579199|NCT00281983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92579200|NCT00281983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92579201|NCT00281983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92579202|NCT00281983|Abortifacient Agents|abortifacient agents|mesh-ancestor
92579203|NCT00281983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92579204|NCT00281983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579205|NCT00281983|Antimetabolites|antimetabolites|mesh-ancestor
92579206|NCT00281983|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579207|NCT00281983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579208|NCT00281983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92579209|NCT00281983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92579210|NCT00281983|Antifungal Agents|antifungal agents|mesh-ancestor
92535119|NCT04821830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579211|NCT00281983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579212|NCT00281983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92579213|NCT00281983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92579214|NCT00281983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92579215|NCT00281983|Antitubercular Agents|antitubercular agents|mesh-ancestor
92579216|NCT00281983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92579218|NCT00282061|Antioxidants|antioxidants|mesh-ancestor
92579219|NCT00282061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579220|NCT00282061|Protective Agents|protective agents|mesh-ancestor
92579221|NCT00282061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579222|NCT00282061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579223|NCT00282100|Gefitinib|gefitinib|mesh-list
92579224|NCT00282100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579225|NCT00282100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92579226|NCT00282100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579227|NCT00282100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579228|NCT00282139|Aripiprazole|aripiprazole|mesh-list
92579229|NCT00282139|Antidepressive Agents|antidepressive agents|mesh-ancestor
92579230|NCT00282139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579231|NCT00282139|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92579232|NCT00282139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579233|NCT00282139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579234|NCT00282139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579235|NCT00282139|Dopamine Agonists|dopamine agonists|mesh-ancestor
92579236|NCT00282139|Dopamine Agents|dopamine agents|mesh-ancestor
92579237|NCT00282139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579238|NCT00282139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579239|NCT00282139|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92579240|NCT00282139|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92579241|NCT00282139|Serotonin Agents|serotonin agents|mesh-ancestor
92579242|NCT00282139|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92579243|NCT00282139|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92579244|NCT00282139|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92579245|NCT00282139|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92579246|NCT00110253|Lidocaine|lidocaine|mesh-list
92579247|NCT00110253|Tetracaine|tetracaine|mesh-list
92579248|NCT00110253|Anesthetics, Local|anesthetics, local|mesh-ancestor
92579249|NCT00110253|Anesthetics|anesthetics|mesh-ancestor
92579250|NCT00110253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579251|NCT00110253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579252|NCT00110253|Sensory System Agents|sensory system agents|mesh-ancestor
92579253|NCT00110253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579254|NCT00110253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92579255|NCT00110253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92579256|NCT00110253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92579257|NCT00110253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579258|NCT00110253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579261|NCT00282178|Candesartan cilexetil|candesartan cilexetil|mesh-list
92579262|NCT00282178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92579264|NCT00282178|Natriuretic Agents|natriuretic agents|mesh-ancestor
92579265|NCT00282178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579266|NCT00282178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92579267|NCT00282178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579268|NCT00282178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579269|NCT00282178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92579270|NCT00282178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92579271|NCT00282217|Sirolimus|sirolimus|mesh-list
92579272|NCT00282217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92579273|NCT00282217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579274|NCT00282217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92579275|NCT00282217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579276|NCT00282217|Antifungal Agents|antifungal agents|mesh-ancestor
92579277|NCT00282217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579278|NCT00282217|Immunologic Factors|immunologic factors|mesh-ancestor
92579279|NCT00282217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579280|NCT00282451|Insulin|insulin|mesh-list
92579281|NCT00282451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92579282|NCT00282451|Insulin Aspart|insulin aspart|mesh-list
92579283|NCT00282451|Insulin, Long-Acting|insulin, long-acting|mesh-list
92579284|NCT00282451|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92579285|NCT00282451|Biphasic Insulins|biphasic insulins|mesh-list
92579286|NCT00282451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92579287|NCT00282451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579288|NCT00282607|Udenafil|udenafil|mesh-list
92579289|NCT00282607|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92579290|NCT00282607|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92579291|NCT00282607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579292|NCT00282607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579293|NCT00282724|Liarozole|liarozole|mesh-list
92579294|NCT00282724|Androgen Antagonists|androgen antagonists|mesh-ancestor
92579295|NCT00282724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92579296|NCT00282724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579297|NCT00282724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579298|NCT00282724|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579299|NCT00282724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579300|NCT00282724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579301|NCT00282724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579302|NCT00282724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579303|NCT00282958|Botulinum Toxins|botulinum toxins|mesh-list
92579304|NCT00282958|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92579305|NCT00282958|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92579306|NCT00282958|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92579307|NCT00282958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579308|NCT00282958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579309|NCT00282958|Cholinergic Agents|cholinergic agents|mesh-ancestor
92579310|NCT00282958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579311|NCT00282958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579312|NCT00282958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92579313|NCT00282958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579314|NCT00282997|Pregabalin|pregabalin|mesh-list
92579315|NCT00282997|Analgesics|analgesics|mesh-ancestor
92579316|NCT00282997|Sensory System Agents|sensory system agents|mesh-ancestor
92579317|NCT00282997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579318|NCT00282997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579319|NCT00282997|Anticonvulsants|anticonvulsants|mesh-ancestor
92579320|NCT00282997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92579321|NCT00282997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579322|NCT00282997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579323|NCT00282997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92579324|NCT00282997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92579325|NCT00282997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579326|NCT00282997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579327|NCT00282997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579328|NCT00283036|Irbesartan|irbesartan|mesh-list
92579329|NCT00283036|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92579332|NCT00283036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579333|NCT00110370|Insulin Glargine|insulin glargine|mesh-list
92579334|NCT00110370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92579335|NCT00110370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579336|NCT00283114|Lintuzumab|lintuzumab|mesh-list
92579337|NCT00283114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92579338|NCT00283114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579339|NCT00076856|Temozolomide|temozolomide|mesh-list
92579340|NCT00076856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92579341|NCT00076856|Alkylating Agents|alkylating agents|mesh-ancestor
92579342|NCT00076856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579343|NCT00076856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579344|NCT00283192|Sertraline|sertraline|mesh-list
92579345|NCT00283192|Antidepressive Agents|antidepressive agents|mesh-ancestor
92579346|NCT00283192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579347|NCT00283192|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92579348|NCT00283192|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92579349|NCT00283192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579350|NCT00283192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579351|NCT00283192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579352|NCT00283192|Serotonin Agents|serotonin agents|mesh-ancestor
92579353|NCT00283192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579354|NCT00283309|Riluzole|riluzole|mesh-list
92579355|NCT00283309|Memantine|memantine|mesh-list
92579356|NCT00283309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92579357|NCT00283309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92535120|NCT04821830|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92535121|NCT04821830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579358|NCT00283309|Dopamine Agents|dopamine agents|mesh-ancestor
92579359|NCT00283309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579360|NCT00283309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579361|NCT00283309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579362|NCT00283309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92579363|NCT00283309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92579364|NCT00283309|Anticonvulsants|anticonvulsants|mesh-ancestor
92579365|NCT00283309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92579366|NCT00283309|Protective Agents|protective agents|mesh-ancestor
92579367|NCT00417157|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92359633|NCT00365274|Immunotoxins|immunotoxins|mesh-ancestor
92579369|NCT00417157|Hormone Antagonists|hormone antagonists|mesh-ancestor
92579370|NCT00417157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579371|NCT00417157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579372|NCT00417157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92579373|NCT00283465|Epoetin Alfa|epoetin alfa|mesh-list
92579374|NCT00283465|Hematinics|hematinics|mesh-ancestor
92579375|NCT00283543|Temozolomide|temozolomide|mesh-list
92579376|NCT00283543|Carmustine|carmustine|mesh-list
92579377|NCT00283543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92579378|NCT00283543|Alkylating Agents|alkylating agents|mesh-ancestor
92579379|NCT00283543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579380|NCT00283543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579381|NCT00283621|Doxorubicin|doxorubicin|mesh-list
92579382|NCT00283621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92579383|NCT00283621|Ifosfamide|ifosfamide|mesh-list
92579384|NCT00283621|Darbepoetin alfa|darbepoetin alfa|mesh-list
92579385|NCT00283621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92579386|NCT00283621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579387|NCT00283621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92579388|NCT00283621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92579389|NCT00283621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579390|NCT00283621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579391|NCT00283621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92579392|NCT00283621|Alkylating Agents|alkylating agents|mesh-ancestor
92579393|NCT00283621|Hematinics|hematinics|mesh-ancestor
92579394|NCT00283660|Zinc Oxide|zinc oxide|mesh-list
92579395|NCT00283660|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579396|NCT00283660|Sunscreening Agents|sunscreening agents|mesh-ancestor
92579397|NCT00283660|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92579398|NCT00283660|Protective Agents|protective agents|mesh-ancestor
92579399|NCT00283660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579400|NCT00077051|Tetrahydrouridine|tetrahydrouridine|mesh-list
92579401|NCT00077051|Antimetabolites|antimetabolites|mesh-ancestor
92579402|NCT00077051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579403|NCT00283699|Albendazole|albendazole|mesh-list
92579404|NCT00283699|Anthelmintics|anthelmintics|mesh-ancestor
92579405|NCT00283699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92579406|NCT00283699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579407|NCT00283699|Anticestodal Agents|anticestodal agents|mesh-ancestor
92579408|NCT00283699|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92579409|NCT00283699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92579410|NCT00283699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92579411|NCT00283699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92579412|NCT00283699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579413|NCT00283699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579414|NCT00283699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579415|NCT00283777|Chromium|chromium|mesh-list
92579416|NCT00283777|Picolinic acid|picolinic acid|mesh-list
92579417|NCT00283777|Trace Elements|trace elements|mesh-ancestor
92579418|NCT00283777|Micronutrients|micronutrients|mesh-ancestor
92579419|NCT00283777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579420|NCT00283777|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92579421|NCT00283777|Chelating Agents|chelating agents|mesh-ancestor
92579422|NCT00283777|Sequestering Agents|sequestering agents|mesh-ancestor
92579423|NCT00283777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579424|NCT00110448|Aspirin|aspirin|mesh-list
92579425|NCT00110448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92579426|NCT00110448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92579427|NCT00110448|Analgesics|analgesics|mesh-ancestor
92579428|NCT00110448|Sensory System Agents|sensory system agents|mesh-ancestor
92579429|NCT00110448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579430|NCT00110448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579431|NCT00110448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92579432|NCT00110448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579433|NCT00110448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92579434|NCT00110448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92579435|NCT00110448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579436|NCT00110448|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92579437|NCT00110448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92579438|NCT00110448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579439|NCT00110448|Antipyretics|antipyretics|mesh-ancestor
92579440|NCT00284206|Risperidone|risperidone|mesh-list
92579441|NCT00284206|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92579442|NCT00284206|Serotonin Agents|serotonin agents|mesh-ancestor
92579443|NCT00284206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579444|NCT00284206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579445|NCT00284206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579446|NCT00284206|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92579447|NCT00284206|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579448|NCT00284206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579449|NCT00284206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579450|NCT00284206|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92579451|NCT00284206|Dopamine Agents|dopamine agents|mesh-ancestor
92579452|NCT00284323|Adenosine|adenosine|mesh-list
92579453|NCT00284323|Analgesics|analgesics|mesh-ancestor
92579454|NCT00284323|Sensory System Agents|sensory system agents|mesh-ancestor
92579455|NCT00284323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579456|NCT00284323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579457|NCT00284323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92579458|NCT00284323|Vasodilator Agents|vasodilator agents|mesh-ancestor
92579459|NCT00284323|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92579460|NCT00284323|Purinergic Agonists|purinergic agonists|mesh-ancestor
92579461|NCT00284323|Purinergic Agents|purinergic agents|mesh-ancestor
92579462|NCT00284323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579463|NCT00284323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579464|NCT04718701|Paclitaxel|paclitaxel|mesh-list
92579465|NCT04718701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92579466|NCT04718701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579467|NCT04718701|Tubulin Modulators|tubulin modulators|mesh-ancestor
92579468|NCT04718701|Antimitotic Agents|antimitotic agents|mesh-ancestor
92579469|NCT04718701|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579470|NCT04718701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579471|NCT00077168|Tamoxifen|tamoxifen|mesh-list
92579472|NCT00077168|Anastrozole|anastrozole|mesh-list
92579473|NCT00077168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579474|NCT00077168|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92579475|NCT00077168|Hormone Antagonists|hormone antagonists|mesh-ancestor
92682795|NCT00438113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579477|NCT00077168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579478|NCT00077168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579479|NCT00077168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579480|NCT00077168|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92579481|NCT00077168|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92579482|NCT00077168|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92579483|NCT00077168|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92579484|NCT00077168|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92579485|NCT00077168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579487|NCT00110604|Hematinics|hematinics|mesh-ancestor
92579488|NCT00110604|Vitamin B Complex|vitamin b complex|mesh-ancestor
92579489|NCT00110604|Vitamins|vitamins|mesh-ancestor
92579490|NCT00110604|Micronutrients|micronutrients|mesh-ancestor
92579491|NCT00110604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579492|NCT00284752|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92579493|NCT00284752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579494|NCT00284791|Lamotrigine|lamotrigine|mesh-list
92579495|NCT00284791|Sertraline|sertraline|mesh-list
92579496|NCT00284791|Fluoxetine|fluoxetine|mesh-list
92579497|NCT00284791|Antidepressive Agents|antidepressive agents|mesh-ancestor
92579498|NCT00284791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579499|NCT00284791|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92579500|NCT00284791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92579501|NCT00284791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579502|NCT00284791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579503|NCT00284791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535122|NCT04821830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92579504|NCT00284791|Serotonin Agents|serotonin agents|mesh-ancestor
92579505|NCT00284791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579506|NCT00284791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92579507|NCT00284791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92579508|NCT00284791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92579509|NCT00284791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579510|NCT00284791|Anticonvulsants|anticonvulsants|mesh-ancestor
92579511|NCT00284791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92154045|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579512|NCT00284791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92579513|NCT00284791|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92579514|NCT00284791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579515|NCT00284791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579516|NCT00284791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92579518|NCT00284947|Prednisolone|prednisolone|mesh-list
92579519|NCT00284947|Methylprednisolone|methylprednisolone|mesh-list
92579520|NCT00284947|Basiliximab|basiliximab|mesh-list
92579521|NCT00284947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92579522|NCT00284947|Glucocorticoids|glucocorticoids|mesh-ancestor
92579523|NCT00284947|Hormones|hormones|mesh-ancestor
92579524|NCT00284947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579525|NCT00284947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579526|NCT00284947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579527|NCT00284947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579528|NCT00284947|Antiemetics|antiemetics|mesh-ancestor
92579529|NCT00284947|Autonomic Agents|autonomic agents|mesh-ancestor
92579530|NCT00284947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579531|NCT00284947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92579532|NCT00284947|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92579533|NCT00284947|Protective Agents|protective agents|mesh-ancestor
92579534|NCT00284947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579535|NCT00284947|Immunologic Factors|immunologic factors|mesh-ancestor
92579536|NCT00110682|Imiquimod|imiquimod|mesh-list
92579537|NCT00110682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92579538|NCT00110682|Immunologic Factors|immunologic factors|mesh-ancestor
92579539|NCT00110682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579540|NCT00110682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579541|NCT00110682|Interferon Inducers|interferon inducers|mesh-ancestor
92579542|NCT00077246|Paclitaxel|paclitaxel|mesh-list
92579543|NCT00077246|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92579544|NCT00077246|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92579545|NCT00077246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579546|NCT00077246|Tubulin Modulators|tubulin modulators|mesh-ancestor
92579547|NCT00077246|Antimitotic Agents|antimitotic agents|mesh-ancestor
92579548|NCT00077246|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579550|NCT00110721|Fluorouracil|fluorouracil|mesh-list
92579551|NCT00110721|Antimetabolites|antimetabolites|mesh-ancestor
92579552|NCT00110721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579553|NCT00110721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579554|NCT00110721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579555|NCT00110721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579556|NCT00110721|Immunologic Factors|immunologic factors|mesh-ancestor
92579557|NCT00110721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579558|NCT00417235|Chlorhexidine|chlorhexidine|mesh-list
92579559|NCT00417235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92579560|NCT00417235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579561|NCT00417235|Disinfectants|disinfectants|mesh-ancestor
92579562|NCT00425035|Panitumumab|panitumumab|mesh-list
92579563|NCT00425035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92579564|NCT00425035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579565|NCT00110760|Lidocaine|lidocaine|mesh-list
92579566|NCT00110760|Tetracaine|tetracaine|mesh-list
92579567|NCT00110760|Anesthetics, Local|anesthetics, local|mesh-ancestor
92579568|NCT00110760|Anesthetics|anesthetics|mesh-ancestor
92579569|NCT00110760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579570|NCT00110760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579571|NCT00110760|Sensory System Agents|sensory system agents|mesh-ancestor
92579572|NCT00110760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579573|NCT00110760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92579574|NCT00110760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92579575|NCT00110760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92579576|NCT00110760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579577|NCT00110760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535123|NCT04821830|Immunologic Factors|immunologic factors|mesh-ancestor
92535124|NCT04821830|Dopamine Agonists|dopamine agonists|mesh-ancestor
92535125|NCT00073411|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92535126|NCT00073411|Escitalopram|escitalopram|mesh-list
91926815|NCT00782431|Immunologic Factors|immunologic factors|mesh-ancestor
92579578|NCT00285142|Rosiglitazone|rosiglitazone|mesh-list
92579579|NCT00285142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92579580|NCT00285142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579581|NCT00285181|Simvastatin|simvastatin|mesh-list
92579582|NCT00285181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92579583|NCT00285181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92579584|NCT00285181|Antimetabolites|antimetabolites|mesh-ancestor
92579585|NCT00285181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579586|NCT00285181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92579587|NCT00285181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92579588|NCT00285181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579589|NCT00285298|Pentoxifylline|pentoxifylline|mesh-list
92579590|NCT00285298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92579591|NCT00285298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579592|NCT00285298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579593|NCT00285298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92579594|NCT00285298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92579595|NCT00285298|Protective Agents|protective agents|mesh-ancestor
92579596|NCT00285298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579597|NCT00285298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92579598|NCT00285298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92579599|NCT00285298|Antioxidants|antioxidants|mesh-ancestor
92579600|NCT00285376|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92579601|NCT00285376|Antidepressive Agents|antidepressive agents|mesh-ancestor
92579602|NCT00285376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579603|NCT00285376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92579604|NCT00285376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92579605|NCT00285376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579606|NCT00285376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579607|NCT00285376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579608|NCT00285376|Serotonin Agents|serotonin agents|mesh-ancestor
92579609|NCT00285376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579610|NCT00285376|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92579611|NCT00285376|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92579612|NCT00077363|Capecitabine|capecitabine|mesh-list
92579613|NCT00077363|Tipifarnib|tipifarnib|mesh-list
92579614|NCT00077363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579615|NCT00077363|Antimetabolites|antimetabolites|mesh-ancestor
92579616|NCT00077363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579617|NCT00077363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579618|NCT00285415|Carboplatin|carboplatin|mesh-list
92579619|NCT00285415|Docetaxel|docetaxel|mesh-list
91986780|NCT03159845|Levofloxacin|levofloxacin|mesh-list
92579626|NCT00285493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579628|NCT00285727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92579629|NCT00285727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92579630|NCT00285727|Dopamine Agonists|dopamine agonists|mesh-ancestor
92579631|NCT00285727|Dopamine Agents|dopamine agents|mesh-ancestor
92579632|NCT00285727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579633|NCT00285727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579634|NCT00285727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579635|NCT00077402|Fenretinide|fenretinide|mesh-list
92579636|NCT00077402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579637|NCT00077402|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92579638|NCT00077402|Protective Agents|protective agents|mesh-ancestor
92579639|NCT00077402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579640|NCT00285766|Selegiline|selegiline|mesh-list
92579641|NCT00285766|Antidepressive Agents|antidepressive agents|mesh-ancestor
92579642|NCT00285766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579643|NCT00285766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92579644|NCT00285766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92579645|NCT00285766|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92579646|NCT00285766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579647|NCT00285766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579648|NCT00285766|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92535127|NCT00073411|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92535128|NCT00073411|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92579649|NCT00285766|Protective Agents|protective agents|mesh-ancestor
92579650|NCT00285766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579651|NCT00285805|Rosiglitazone|rosiglitazone|mesh-list
92579652|NCT00285805|Amiloride|amiloride|mesh-list
92579653|NCT00285805|Furosemide|furosemide|mesh-list
92579654|NCT00285805|Diuretics|diuretics|mesh-ancestor
92579655|NCT00285805|Natriuretic Agents|natriuretic agents|mesh-ancestor
92579656|NCT00285805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579657|NCT00285805|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92579658|NCT00285805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579659|NCT00285805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579660|NCT00285805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92579661|NCT00285805|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92579662|NCT00285805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92579663|NCT00285805|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92579664|NCT00285805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92579665|NCT00285844|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92579666|NCT00285844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92579667|NCT00285844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579668|NCT00077441|Bortezomib|bortezomib|mesh-list
92579669|NCT00077441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579670|NCT00285883|Saquinavir|saquinavir|mesh-list
92579671|NCT00285883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92579672|NCT00285883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92579673|NCT00285883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92579674|NCT00285883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579675|NCT00285883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579676|NCT00285883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92579677|NCT00285883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92579678|NCT00285883|Antiviral Agents|antiviral agents|mesh-ancestor
92579679|NCT00285883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579680|NCT00285883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92579681|NCT00285883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92579682|NCT00110877|Darunavir|darunavir|mesh-list
92579683|NCT00110877|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92579684|NCT00110877|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92579685|NCT00110877|Protease Inhibitors|protease inhibitors|mesh-ancestor
92579686|NCT00110877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579687|NCT00110877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579691|NCT00110877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579692|NCT00077519|Tipifarnib|tipifarnib|mesh-list
92579693|NCT00077519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579694|NCT00286117|Tamoxifen|tamoxifen|mesh-list
92579695|NCT00286117|Anastrozole|anastrozole|mesh-list
92579696|NCT00286117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92579697|NCT00286117|Hormone Antagonists|hormone antagonists|mesh-ancestor
92579698|NCT00286117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579699|NCT00286117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579700|NCT00286117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579701|NCT00286117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579702|NCT00286117|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92579703|NCT00286117|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92579704|NCT00286117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92579705|NCT00286117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92579706|NCT00286117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92579707|NCT00286117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579708|NCT00286117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579709|NCT00110916|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92579710|NCT00110916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579711|NCT00077558|Fludarabine|fludarabine|mesh-list
92579712|NCT00077558|Fludarabine phosphate|fludarabine phosphate|mesh-list
92579713|NCT00077558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579714|NCT00077558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579715|NCT00077558|Antimetabolites|antimetabolites|mesh-ancestor
92579716|NCT00077558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579717|NCT00077558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579718|NCT00077558|Immunologic Factors|immunologic factors|mesh-ancestor
92579719|NCT00077558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579720|NCT00286273|Heparin|heparin|mesh-list
92535129|NCT00073411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92535130|NCT00073411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579721|NCT00286273|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92579723|NCT00286273|Dalteparin|dalteparin|mesh-list
92579724|NCT00286273|Nadroparin|nadroparin|mesh-list
92579725|NCT00286273|Citric Acid|citric acid|mesh-list
92579726|NCT00286273|Sodium Citrate|sodium citrate|mesh-list
92579727|NCT00286273|Anticoagulants|anticoagulants|mesh-ancestor
92579728|NCT00286273|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92579729|NCT00286273|Chelating Agents|chelating agents|mesh-ancestor
92579730|NCT00286273|Sequestering Agents|sequestering agents|mesh-ancestor
92579731|NCT00286273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579732|NCT00286273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92579733|NCT00286273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92579734|NCT00286312|Atorvastatin|atorvastatin|mesh-list
92579735|NCT00286312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92579736|NCT00286312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92579737|NCT00286312|Antimetabolites|antimetabolites|mesh-ancestor
92579738|NCT00286312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579739|NCT00286312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92579740|NCT00286312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92579741|NCT00286312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579742|NCT00286351|Goserelin|goserelin|mesh-list
92579743|NCT00286351|Anastrozole|anastrozole|mesh-list
92579744|NCT00286351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579745|NCT00286351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579746|NCT00286351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92579747|NCT00286351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92579748|NCT00286351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579749|NCT00286351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579750|NCT00286351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92579751|NCT00286351|Hormone Antagonists|hormone antagonists|mesh-ancestor
92579752|NCT00286351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579753|NCT00286351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579754|NCT00110955|Darbepoetin alfa|darbepoetin alfa|mesh-list
92579755|NCT00110955|Hematinics|hematinics|mesh-ancestor
92579756|NCT00286585|Propofol|propofol|mesh-list
92579757|NCT00286585|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92579758|NCT00286585|Anesthetics|anesthetics|mesh-list
92579759|NCT00286585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92579760|NCT00286585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579761|NCT00286585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579763|NCT00111072|Dexamethasone|dexamethasone|mesh-list
92579764|NCT00111072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92579765|NCT00111072|Antiemetics|antiemetics|mesh-ancestor
92579766|NCT00111072|Autonomic Agents|autonomic agents|mesh-ancestor
92579767|NCT00111072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579768|NCT00111072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579769|NCT00111072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92579770|NCT00111072|Glucocorticoids|glucocorticoids|mesh-ancestor
92579771|NCT00111072|Hormones|hormones|mesh-ancestor
92579772|NCT00111072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579773|NCT00111072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579774|NCT00111072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579775|NCT00286624|Cyclosporine|cyclosporine|mesh-list
92579776|NCT00286624|Everolimus|everolimus|mesh-list
92579777|NCT00286624|Cyclosporins|cyclosporins|mesh-list
92579778|NCT00286624|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92579779|NCT00286624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579780|NCT00286624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579781|NCT00286624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579782|NCT00286624|Immunologic Factors|immunologic factors|mesh-ancestor
92579783|NCT00286624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579784|NCT00286624|Antifungal Agents|antifungal agents|mesh-ancestor
92579785|NCT00286624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579786|NCT00286624|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579787|NCT00286624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579788|NCT00286624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92579789|NCT00286624|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92579790|NCT00286624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92579791|NCT00286624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579792|NCT00077597|Epoetin Alfa|epoetin alfa|mesh-list
92579793|NCT00077597|Hematinics|hematinics|mesh-ancestor
92535131|NCT00073411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535132|NCT00073411|Serotonin Agents|serotonin agents|mesh-ancestor
92535133|NCT00073411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579794|NCT00286780|Gossypol acetic acid|gossypol acetic acid|mesh-list
92359655|NCT00314106|Aldesleukin|aldesleukin|mesh-list
92579795|NCT00286780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92579796|NCT00286780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579797|NCT00286780|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92579798|NCT00286780|Contraceptive Agents|contraceptive agents|mesh-ancestor
92579799|NCT00286780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92579800|NCT00286780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579801|NCT00286780|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92579802|NCT00286780|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92579803|NCT00286780|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92579804|NCT00111111|Etanercept|etanercept|mesh-list
92579805|NCT00111111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92579806|NCT00111111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92579807|NCT00111111|Analgesics|analgesics|mesh-ancestor
92579808|NCT00111111|Sensory System Agents|sensory system agents|mesh-ancestor
92579809|NCT00111111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579810|NCT00111111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579811|NCT00111111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92579812|NCT00111111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579813|NCT00111111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92579814|NCT00111111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579815|NCT00111111|Immunologic Factors|immunologic factors|mesh-ancestor
92579816|NCT00077714|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92579817|NCT00077714|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92579818|NCT00077714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579819|NCT00077714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579820|NCT00077714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579821|NCT00077714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579822|NCT00077714|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92579823|NCT00077714|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92579824|NCT00077714|Serotonin Agents|serotonin agents|mesh-ancestor
92579825|NCT00077714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579826|NCT00077714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579827|NCT00077714|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92579828|NCT00077714|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92579829|NCT00077714|Dopamine Agents|dopamine agents|mesh-ancestor
92579830|NCT00111150|Tenofovir|tenofovir|mesh-list
92579831|NCT00111150|Antiviral Agents|antiviral agents|mesh-ancestor
92579832|NCT00111150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579833|NCT00111150|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92579834|NCT00111150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92579835|NCT00111150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579841|NCT00417430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579842|NCT00417430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92579843|NCT00417430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92579844|NCT00417430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92579845|NCT00417430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579846|NCT00417430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579847|NCT00077753|Enoxaparin|enoxaparin|mesh-list
92579848|NCT00077753|Enoxaparin sodium|enoxaparin sodium|mesh-list
92579849|NCT00077753|Anticoagulants|anticoagulants|mesh-ancestor
92579850|NCT00077753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92579851|NCT00077753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92579852|NCT00077753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579853|NCT00111189|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92579854|NCT00111189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92579855|NCT00111189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92579856|NCT00111189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579857|NCT00111189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579858|NCT00111189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359657|NCT00314106|Fludarabine|fludarabine|mesh-list
92579859|NCT00111189|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92579860|NCT00111189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92579861|NCT00111189|Serotonin Agents|serotonin agents|mesh-ancestor
92579862|NCT00111189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579863|NCT00111189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579864|NCT00111189|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92579865|NCT00111189|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92579867|NCT00077792|Enoxaparin|enoxaparin|mesh-list
92535134|NCT00073411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927108|NCT00835705|Clavulanic Acids|clavulanic acids|mesh-list
92579868|NCT00077792|Enoxaparin sodium|enoxaparin sodium|mesh-list
92579869|NCT00077792|Anticoagulants|anticoagulants|mesh-ancestor
92579870|NCT00077792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92579871|NCT00077792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92579872|NCT00077792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579873|NCT00111267|Vitamins|vitamins|mesh-list
92579874|NCT00111267|Folic Acid|folic acid|mesh-list
92579875|NCT00111267|Hydroxocobalamin|hydroxocobalamin|mesh-list
92579876|NCT00111267|Vitamin B 12|vitamin b 12|mesh-list
92579877|NCT00111267|Vitamin B Complex|vitamin b complex|mesh-list
92579878|NCT00111267|Micronutrients|micronutrients|mesh-ancestor
92579879|NCT00111267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579880|NCT00111267|Hematinics|hematinics|mesh-ancestor
92579881|NCT00286936|Zolpidem|zolpidem|mesh-list
92579882|NCT00286936|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92579883|NCT00286936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92579884|NCT00286936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579885|NCT00286936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579886|NCT00286936|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92579887|NCT00286936|GABA Agonists|gaba agonists|mesh-ancestor
92579888|NCT00286936|GABA Agents|gaba agents|mesh-ancestor
92579889|NCT00286936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579890|NCT00286936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579891|NCT00111306|Epratuzumab|epratuzumab|mesh-list
92579892|NCT00111306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92579893|NCT00111306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579894|NCT00077870|Ocrelizumab|ocrelizumab|mesh-list
92579895|NCT00077870|Immunologic Factors|immunologic factors|mesh-ancestor
92579896|NCT00077870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579897|NCT00287170|Calcitriol|calcitriol|mesh-list
92579898|NCT00287170|Mercaptopurine|mercaptopurine|mesh-list
92579899|NCT00287170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92579900|NCT00287170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579901|NCT00287170|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92579902|NCT00287170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579903|NCT00287170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579904|NCT00287170|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92579905|NCT00287170|Vitamins|vitamins|mesh-ancestor
92579906|NCT00287170|Micronutrients|micronutrients|mesh-ancestor
92579923|NCT00287209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92579924|NCT00287209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579925|NCT00287209|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92579926|NCT00287209|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92579927|NCT00287209|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92579929|NCT00077948|Enoximone|enoximone|mesh-list
92579930|NCT00077948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92579931|NCT00077948|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92579932|NCT00077948|Sympatholytics|sympatholytics|mesh-ancestor
92579933|NCT00077948|Autonomic Agents|autonomic agents|mesh-ancestor
92579934|NCT00077948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579935|NCT00077948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579936|NCT00077948|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92579937|NCT00077948|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92579938|NCT00077948|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92579939|NCT00077948|Adrenergic Agents|adrenergic agents|mesh-ancestor
92579940|NCT00077948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579941|NCT00077948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579942|NCT00077948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92579943|NCT00077948|Vasodilator Agents|vasodilator agents|mesh-ancestor
92579944|NCT00077948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92579945|NCT00077948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92579946|NCT00077948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579947|NCT00077948|Protective Agents|protective agents|mesh-ancestor
92579948|NCT00111345|Daunorubicin|daunorubicin|mesh-list
92579949|NCT00111345|Idarubicin|idarubicin|mesh-list
92579950|NCT00111345|Cladribine|cladribine|mesh-list
92579951|NCT00111345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92579952|NCT00111345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579953|NCT00111345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92579954|NCT00111345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92579955|NCT00111345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620231|NCT02914015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535135|NCT00073411|Antidepressive Agents|antidepressive agents|mesh-ancestor
92535136|NCT00073411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92579956|NCT00111345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579957|NCT00111345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579958|NCT00111345|Immunologic Factors|immunologic factors|mesh-ancestor
92579959|NCT00111345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579961|NCT00287326|Morphine|morphine|mesh-list
92579962|NCT00287326|Bupivacaine|bupivacaine|mesh-list
92579963|NCT00287326|Anesthetics, Local|anesthetics, local|mesh-ancestor
92579973|NCT00287326|Sympatholytics|sympatholytics|mesh-ancestor
92579974|NCT00287326|Autonomic Agents|autonomic agents|mesh-ancestor
92579975|NCT00287326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92579976|NCT00287326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92579977|NCT00287326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92579978|NCT00287326|Adrenergic Agents|adrenergic agents|mesh-ancestor
92579979|NCT00287326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92579980|NCT00287326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579981|NCT00287443|Hormones|hormones|mesh-list
92579982|NCT00287443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579983|NCT00287443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579984|NCT00077987|Sunitinib|sunitinib|mesh-list
92579985|NCT00077987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579986|NCT00077987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92579987|NCT00077987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92579988|NCT00077987|Growth Substances|growth substances|mesh-ancestor
92579989|NCT00077987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579990|NCT00077987|Growth Inhibitors|growth inhibitors|mesh-ancestor
92579991|NCT00077987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92579992|NCT00077987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579993|NCT00077987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579994|NCT00287521|Timolol|timolol|mesh-list
92579995|NCT00287521|Latanoprost|latanoprost|mesh-list
92579996|NCT00287521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579997|NCT00287521|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92579998|NCT00287521|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92579999|NCT00287521|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580000|NCT00287521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580001|NCT00287521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580002|NCT00287521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92580003|NCT00287521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92580004|NCT00287521|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92580005|NCT00287521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92580006|NCT00287560|Propofol|propofol|mesh-list
92580007|NCT00287560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92580008|NCT00287560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580009|NCT00287560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580010|NCT00287560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92580011|NCT00287560|Anesthetics, General|anesthetics, general|mesh-ancestor
92580012|NCT00287560|Anesthetics|anesthetics|mesh-ancestor
92580013|NCT00111462|Darbepoetin alfa|darbepoetin alfa|mesh-list
92580014|NCT00111462|Hematinics|hematinics|mesh-ancestor
92580015|NCT00287677|Hormones|hormones|mesh-list
92304851|NCT00003417|Carmustine|carmustine|mesh-list
92580016|NCT00287677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580017|NCT00287677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580018|NCT00287794|Diazepam|diazepam|mesh-list
92580019|NCT00287794|Melatonin|melatonin|mesh-list
92580020|NCT00287794|Antioxidants|antioxidants|mesh-ancestor
92580021|NCT00287794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580022|NCT00287794|Protective Agents|protective agents|mesh-ancestor
92580023|NCT00287794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359674|NCT00318708|Fluticasone|fluticasone|mesh-list
92580024|NCT00287794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580025|NCT00287794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92580026|NCT00287794|Anticonvulsants|anticonvulsants|mesh-ancestor
92580027|NCT00287794|Antiemetics|antiemetics|mesh-ancestor
92580028|NCT00287794|Autonomic Agents|autonomic agents|mesh-ancestor
92580030|NCT00287794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92580031|NCT00287794|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92580032|NCT00287794|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92580033|NCT00287794|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92580034|NCT00287794|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92580035|NCT00287794|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92580036|NCT00287794|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92535137|NCT00073411|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92580037|NCT00287794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92580038|NCT00287794|Anesthetics, General|anesthetics, general|mesh-ancestor
92580039|NCT00287794|Anesthetics|anesthetics|mesh-ancestor
92580040|NCT00287794|GABA Modulators|gaba modulators|mesh-ancestor
92580041|NCT00287794|GABA Agents|gaba agents|mesh-ancestor
92580042|NCT00287794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580043|NCT00287911|Topotecan|topotecan|mesh-list
92580044|NCT00287911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580045|NCT00287911|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92580046|NCT00287911|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580047|NCT00287911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580048|NCT00287911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580049|NCT00287950|Cyclophosphamide|cyclophosphamide|mesh-list
92580050|NCT00287950|Carboplatin|carboplatin|mesh-list
92580051|NCT00287950|Etoposide|etoposide|mesh-list
92580052|NCT00287950|Vincristine|vincristine|mesh-list
92580053|NCT00287950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580054|NCT00287950|Immunologic Factors|immunologic factors|mesh-ancestor
92580055|NCT00287950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580056|NCT00287950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580057|NCT00287950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92580058|NCT00287950|Alkylating Agents|alkylating agents|mesh-ancestor
92580059|NCT00287950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580060|NCT00287950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580061|NCT00287950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92580062|NCT00287950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580063|NCT00287950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92580064|NCT00287950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580065|NCT00287950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580066|NCT00287950|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580067|NCT00287950|Antimitotic Agents|antimitotic agents|mesh-ancestor
92580068|NCT00287950|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580069|NCT00288028|Bortezomib|bortezomib|mesh-list
92580070|NCT00288028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580071|NCT00111540|Exenatide|exenatide|mesh-list
92580072|NCT00111540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92580073|NCT00111540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580074|NCT00111540|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92580075|NCT00111540|Incretins|incretins|mesh-ancestor
92580076|NCT00111540|Hormones|hormones|mesh-ancestor
92580077|NCT00111540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580078|NCT00288184|Allopurinol|allopurinol|mesh-list
92580079|NCT00288184|Antimetabolites|antimetabolites|mesh-ancestor
92580080|NCT00288184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580081|NCT00288184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580082|NCT00288184|Gout Suppressants|gout suppressants|mesh-ancestor
92580083|NCT00288184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580084|NCT00288184|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92580085|NCT00288184|Antioxidants|antioxidants|mesh-ancestor
92580086|NCT00288184|Protective Agents|protective agents|mesh-ancestor
92580087|NCT00288184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580088|NCT00288223|Telithromycin|telithromycin|mesh-list
92580089|NCT00288223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580090|NCT00288223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304925|NCT00003273|Abortifacient Agents|abortifacient agents|mesh-ancestor
92580091|NCT00288262|Melatonin|melatonin|mesh-list
92580092|NCT00288262|Antioxidants|antioxidants|mesh-ancestor
92580093|NCT00288262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580094|NCT00288262|Protective Agents|protective agents|mesh-ancestor
92580095|NCT00288262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580096|NCT00288262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580097|NCT00288379|Budesonide|budesonide|mesh-list
92580098|NCT00288379|Formoterol Fumarate|formoterol fumarate|mesh-list
92580099|NCT00288379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580100|NCT00288379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92580101|NCT00288379|Autonomic Agents|autonomic agents|mesh-ancestor
92580102|NCT00288379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580103|NCT00288379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580105|NCT00288379|Respiratory System Agents|respiratory system agents|mesh-ancestor
92580107|NCT00288379|Hormones|hormones|mesh-ancestor
92580108|NCT00288379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580109|NCT00288379|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92580110|NCT00288379|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92580111|NCT00288379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92535138|NCT00073411|Analgesics|analgesics|mesh-ancestor
92535139|NCT00073411|Sensory System Agents|sensory system agents|mesh-ancestor
92535140|NCT00073411|Dopamine Agents|dopamine agents|mesh-ancestor
92535141|NCT02966041|Ondansetron|ondansetron|mesh-list
92580112|NCT00288379|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580113|NCT00288379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580114|NCT00288379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580115|NCT00078182|Tenofovir|tenofovir|mesh-list
92580116|NCT00078182|Antiviral Agents|antiviral agents|mesh-ancestor
92580117|NCT00078182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580118|NCT00078182|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92580119|NCT00078182|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92580120|NCT00078182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580121|NCT00078182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580122|NCT00078182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92580123|NCT00078182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92580124|NCT00111618|Vadimezan|vadimezan|mesh-list
92580125|NCT00111618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580126|NCT00399425|Heparin|heparin|mesh-list
92580127|NCT00399425|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92580128|NCT00399425|Tinzaparin|tinzaparin|mesh-list
92580129|NCT00399425|Dalteparin|dalteparin|mesh-list
92580130|NCT00399425|Bemiparin|bemiparin|mesh-list
92580131|NCT00399425|Anticoagulants|anticoagulants|mesh-ancestor
92580132|NCT00399425|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92580133|NCT00399425|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92580134|NCT00399425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580135|NCT00288535|Sirolimus|sirolimus|mesh-list
92580136|NCT00288535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580137|NCT00288535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580138|NCT00288535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580139|NCT00288535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580140|NCT00288535|Antifungal Agents|antifungal agents|mesh-ancestor
92580141|NCT00288535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580142|NCT00288535|Immunologic Factors|immunologic factors|mesh-ancestor
92580143|NCT00288535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580144|NCT00399464|Alfuzosin|alfuzosin|mesh-list
92580145|NCT00399464|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92580146|NCT00399464|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92580147|NCT00399464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92580148|NCT00399464|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580149|NCT00399464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580150|NCT00399464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580151|NCT00399464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580152|NCT00399464|Urological Agents|urological agents|mesh-ancestor
92580153|NCT00288652|Reboxetine|reboxetine|mesh-list
92580154|NCT00288652|Antidepressive Agents|antidepressive agents|mesh-ancestor
92580155|NCT00288652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580156|NCT00288652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92580157|NCT00288652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92580158|NCT00288652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92580159|NCT00288652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580160|NCT00288652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580161|NCT00288652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580162|NCT00288652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580163|NCT00288730|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92580164|NCT00288730|Natriuretic Agents|natriuretic agents|mesh-ancestor
92580165|NCT00288730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580166|NCT00288769|Vitamin B 12|vitamin b 12|mesh-list
92580167|NCT00288769|Hydroxocobalamin|hydroxocobalamin|mesh-list
92580168|NCT00288769|Vitamins|vitamins|mesh-ancestor
92580169|NCT00288769|Micronutrients|micronutrients|mesh-ancestor
92580170|NCT00288769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580171|NCT00288769|Vitamin B Complex|vitamin b complex|mesh-ancestor
92580172|NCT00288769|Hematinics|hematinics|mesh-ancestor
92580173|NCT00111852|Salivary plasminogen activator alpha 1, Desmodus rotundus|salivary plasminogen activator alpha 1, desmodus rotundus|mesh-list
92580174|NCT00111852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92580175|NCT00111852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92580176|NCT00111852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580177|NCT00289042|Enoxaparin|enoxaparin|mesh-list
92580178|NCT00289042|Anticoagulants|anticoagulants|mesh-ancestor
92580179|NCT00289042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92580180|NCT00289042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92535143|NCT02966041|Autonomic Agents|autonomic agents|mesh-ancestor
91927400|NCT02169167|Octenidine|octenidine|mesh-list
92580181|NCT00289042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580182|NCT00111891|Niacin|niacin|mesh-list
92580183|NCT00111891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92580184|NCT00111891|Antimetabolites|antimetabolites|mesh-ancestor
92580185|NCT00111891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580186|NCT00111891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92580187|NCT00111891|Vasodilator Agents|vasodilator agents|mesh-ancestor
92580188|NCT00111891|Vitamin B Complex|vitamin b complex|mesh-ancestor
92580189|NCT00111891|Vitamins|vitamins|mesh-ancestor
92580190|NCT00111891|Micronutrients|micronutrients|mesh-ancestor
92580191|NCT00111891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580192|NCT00289354|Chromium|chromium|mesh-list
92580193|NCT00289354|Biotin|biotin|mesh-list
92580194|NCT00289354|Picolinic acid|picolinic acid|mesh-list
92580195|NCT00289354|Trace Elements|trace elements|mesh-ancestor
92580196|NCT00289354|Micronutrients|micronutrients|mesh-ancestor
92580197|NCT00289354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580198|NCT00289354|Vitamin B Complex|vitamin b complex|mesh-ancestor
92580199|NCT00289354|Vitamins|vitamins|mesh-ancestor
92580200|NCT00289354|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92580201|NCT00289354|Chelating Agents|chelating agents|mesh-ancestor
92580202|NCT00289354|Sequestering Agents|sequestering agents|mesh-ancestor
92580203|NCT00289354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580204|NCT00289510|Vaccines|vaccines|mesh-list
92580205|NCT00289510|Immunologic Factors|immunologic factors|mesh-ancestor
92580206|NCT00289510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580207|NCT00289588|Mupirocin|mupirocin|mesh-list
92580208|NCT00289588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580209|NCT00289588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580210|NCT00289588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92580211|NCT00289588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580212|NCT00289588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580213|NCT00289627|Ipilimumab|ipilimumab|mesh-list
92580214|NCT00289627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92580215|NCT00289627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580216|NCT00289627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92580217|NCT00289627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580218|NCT00401661|Alfuzosin|alfuzosin|mesh-list
92580219|NCT00401661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92580220|NCT00401661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92580221|NCT00401661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92580222|NCT00401661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580223|NCT00401661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580224|NCT00401661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580225|NCT00401661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580226|NCT00401661|Urological Agents|urological agents|mesh-ancestor
92580227|NCT00289861|Risperidone|risperidone|mesh-list
92580228|NCT00289861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92580229|NCT00289861|Serotonin Agents|serotonin agents|mesh-ancestor
92580230|NCT00289861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580231|NCT00289861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580232|NCT00289861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580233|NCT00289861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92580234|NCT00289861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92580235|NCT00289861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580236|NCT00289861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580237|NCT00289861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92580238|NCT00289861|Dopamine Agents|dopamine agents|mesh-ancestor
92580239|NCT00290017|Pemetrexed|pemetrexed|mesh-list
92580240|NCT00290017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580241|NCT00290017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580242|NCT00290017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580243|NCT00290017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92580244|NCT00290017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92580245|NCT00112008|Darbepoetin alfa|darbepoetin alfa|mesh-list
92580247|NCT00112086|Paclitaxel|paclitaxel|mesh-list
92580248|NCT00112086|Carboplatin|carboplatin|mesh-list
92580249|NCT00112086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580250|NCT00112086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580251|NCT00112086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580252|NCT00112086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535144|NCT02966041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927474|NCT00833521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580253|NCT00112086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580265|NCT00290173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580266|NCT00290173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580267|NCT00290173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580268|NCT00290485|Imatinib Mesylate|imatinib mesylate|mesh-list
92580269|NCT00290485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580270|NCT00290485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580271|NCT00290485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580272|NCT00290485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580273|NCT00112164|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92580274|NCT00112164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580275|NCT00078260|Pemetrexed|pemetrexed|mesh-list
92580276|NCT00078260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580277|NCT00078260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580278|NCT00078260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580279|NCT00078260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92580280|NCT00078260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92580281|NCT00290602|Methylprednisolone|methylprednisolone|mesh-list
92580282|NCT00290602|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92580283|NCT00290602|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92580284|NCT00290602|Prednisolone|prednisolone|mesh-list
92580285|NCT00290602|Prednisolone acetate|prednisolone acetate|mesh-list
92580286|NCT00290602|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92580287|NCT00290602|Prednisolone phosphate|prednisolone phosphate|mesh-list
92580288|NCT00290602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580289|NCT00290602|Antiemetics|antiemetics|mesh-ancestor
92580290|NCT00290602|Autonomic Agents|autonomic agents|mesh-ancestor
92580291|NCT00290602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580292|NCT00290602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580293|NCT00290602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92580294|NCT00290602|Glucocorticoids|glucocorticoids|mesh-ancestor
92580295|NCT00290602|Hormones|hormones|mesh-ancestor
92580296|NCT00290602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580297|NCT00290602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92580298|NCT00290602|Protective Agents|protective agents|mesh-ancestor
92580299|NCT00290602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92580300|NCT00290602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580301|NCT00290641|Cyclosporine|cyclosporine|mesh-list
92580302|NCT00290641|Mycophenolic Acid|mycophenolic acid|mesh-list
92580303|NCT00290641|Cyclophosphamide|cyclophosphamide|mesh-list
92580304|NCT00290641|Fludarabine|fludarabine|mesh-list
92580305|NCT00290641|Fludarabine phosphate|fludarabine phosphate|mesh-list
92580306|NCT00290641|Cyclosporins|cyclosporins|mesh-list
92580307|NCT00290641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580308|NCT00290641|Immunologic Factors|immunologic factors|mesh-ancestor
92580309|NCT00290641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580310|NCT00290641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580311|NCT00290641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92580312|NCT00290641|Alkylating Agents|alkylating agents|mesh-ancestor
92580313|NCT00290641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580314|NCT00290641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580315|NCT00290641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92580316|NCT00290641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580319|NCT00290641|Antifungal Agents|antifungal agents|mesh-ancestor
92580320|NCT00290641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580321|NCT00290641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580322|NCT00290641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92580323|NCT00290641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580324|NCT00290641|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92580325|NCT00290641|Antitubercular Agents|antitubercular agents|mesh-ancestor
92580326|NCT00290641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580327|NCT00290680|Celecoxib|celecoxib|mesh-list
92580328|NCT00290680|Bortezomib|bortezomib|mesh-list
92580329|NCT00290680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580330|NCT00290680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92580331|NCT00290680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92580332|NCT00290680|Analgesics|analgesics|mesh-ancestor
92580333|NCT00290680|Sensory System Agents|sensory system agents|mesh-ancestor
92580334|NCT00290680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580335|NCT00290680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535145|NCT02966041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535146|NCT02966041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535148|NCT02966041|Dermatologic Agents|dermatologic agents|mesh-ancestor
92535149|NCT02966041|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92580336|NCT00290680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580337|NCT00290680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580338|NCT00290680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92580339|NCT00290680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92580340|NCT00290680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580341|NCT00290680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580342|NCT02960815|Imiquimod|imiquimod|mesh-list
92580343|NCT02960815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92580344|NCT02960815|Immunologic Factors|immunologic factors|mesh-ancestor
92580345|NCT02960815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580346|NCT02960815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580347|NCT02960815|Interferon Inducers|interferon inducers|mesh-ancestor
92580348|NCT00112281|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92580349|NCT00112281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580350|NCT00112281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580351|NCT00290719|Irinotecan|irinotecan|mesh-list
92580352|NCT00290719|Gefitinib|gefitinib|mesh-list
92580353|NCT00290719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580354|NCT00290719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92580355|NCT00290719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580356|NCT00290719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580357|NCT00290719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580358|NCT00290719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580359|NCT00290836|Thrombin|thrombin|mesh-list
92580360|NCT00290836|Aprotinin|aprotinin|mesh-list
92580361|NCT00290836|Hemostatics|hemostatics|mesh-ancestor
92580362|NCT00290836|Coagulants|coagulants|mesh-ancestor
92580363|NCT00290836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92580364|NCT00290836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92580365|NCT00290836|Protease Inhibitors|protease inhibitors|mesh-ancestor
92580366|NCT00290836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580367|NCT00290836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580368|NCT04729556|Chitosan|chitosan|mesh-list
92580369|NCT04729556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92580370|NCT04729556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92580371|NCT04729556|Antimetabolites|antimetabolites|mesh-ancestor
92580372|NCT04729556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580373|NCT04729556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92580374|NCT04729556|Chelating Agents|chelating agents|mesh-ancestor
92580375|NCT04729556|Sequestering Agents|sequestering agents|mesh-ancestor
92580376|NCT04729556|Hemostatics|hemostatics|mesh-ancestor
92580377|NCT04729556|Coagulants|coagulants|mesh-ancestor
92580378|NCT00290914|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92580379|NCT00290914|Antidepressive Agents|antidepressive agents|mesh-ancestor
92580380|NCT00290914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580381|NCT00290914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92580382|NCT00290914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92580383|NCT00290914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92580384|NCT00290914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580385|NCT00290914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580386|NCT00290914|Serotonin Agents|serotonin agents|mesh-ancestor
92580387|NCT00290914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580388|NCT00290914|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92580389|NCT00290914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92580390|NCT00290992|Rasburicase|rasburicase|mesh-list
92580394|NCT00291109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580396|NCT00291109|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92580397|NCT00291109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580398|NCT00291109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580399|NCT00291109|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92580400|NCT00291109|Hormone Antagonists|hormone antagonists|mesh-ancestor
92580401|NCT00291109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580402|NCT00291109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580403|NCT00291148|Pregabalin|pregabalin|mesh-list
92535150|NCT02966041|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92535151|NCT02966041|Serotonin Agents|serotonin agents|mesh-ancestor
92535152|NCT02966041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535153|NCT02966041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580404|NCT00291148|Paroxetine|paroxetine|mesh-list
92580405|NCT00291148|Analgesics|analgesics|mesh-ancestor
92580406|NCT00291148|Sensory System Agents|sensory system agents|mesh-ancestor
92580407|NCT00291148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580408|NCT00291148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580409|NCT00291148|Anticonvulsants|anticonvulsants|mesh-ancestor
92580410|NCT00291148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92580411|NCT00291148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92580412|NCT00291148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580413|NCT00291148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92580414|NCT00291148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92580415|NCT00291148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92580416|NCT00291148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580417|NCT00291148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580418|NCT00291148|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92580419|NCT00291148|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92580420|NCT00291148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580421|NCT00291148|Serotonin Agents|serotonin agents|mesh-ancestor
92580422|NCT00291148|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92580423|NCT00291148|Antidepressive Agents|antidepressive agents|mesh-ancestor
92580424|NCT00291148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92580425|NCT00291148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92580426|NCT00291148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580427|NCT00291382|Fluticasone|fluticasone|mesh-list
92580428|NCT00291382|Xhance|xhance|mesh-list
92580429|NCT00291382|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92580430|NCT00291382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580431|NCT00291382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92580432|NCT00291382|Autonomic Agents|autonomic agents|mesh-ancestor
92580433|NCT00291382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580434|NCT00291382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580435|NCT00291382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92580436|NCT00291382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92580437|NCT00291382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580438|NCT00291382|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92580439|NCT00291382|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92580440|NCT00291382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92580441|NCT00291382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92580442|NCT00291382|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580443|NCT00291382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580444|NCT00291382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580445|NCT00112476|Sirolimus|sirolimus|mesh-list
92580446|NCT00112476|Temsirolimus|temsirolimus|mesh-list
92580447|NCT00112476|MTOR Inhibitors|mtor inhibitors|mesh-list
92580448|NCT00112476|Bryostatin 1|bryostatin 1|mesh-list
92580449|NCT00112476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580450|NCT00112476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580451|NCT00112476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580452|NCT00112476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580453|NCT00112476|Immunologic Factors|immunologic factors|mesh-ancestor
92580454|NCT00112476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580455|NCT00112476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580456|NCT00112476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580457|NCT00112476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580458|NCT00112476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580459|NCT00112476|Antifungal Agents|antifungal agents|mesh-ancestor
92580460|NCT00112476|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92580461|NCT00291538|Bortezomib|bortezomib|mesh-list
92580462|NCT00291538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580463|NCT00291616|Interferons|interferons|mesh-list
92580470|NCT00291616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580471|NCT00291616|Immunologic Factors|immunologic factors|mesh-ancestor
92580472|NCT00291616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580473|NCT00291616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92580474|NCT00078572|Capecitabine|capecitabine|mesh-list
92580475|NCT00078572|Lapatinib|lapatinib|mesh-list
92580476|NCT00078572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580477|NCT00078572|Antimetabolites|antimetabolites|mesh-ancestor
92580478|NCT00078572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580479|NCT00078572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580480|NCT00078572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580481|NCT00078572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580482|NCT00291733|Levetiracetam|levetiracetam|mesh-list
92580483|NCT00291733|Anticonvulsants|anticonvulsants|mesh-ancestor
92580484|NCT00291733|Nootropic Agents|nootropic agents|mesh-ancestor
92580486|NCT00112515|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92580487|NCT00112515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580488|NCT00112515|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92580489|NCT00112515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92580490|NCT00112515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92580491|NCT00112515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580492|NCT00291772|Pramlintide|pramlintide|mesh-list
92580493|NCT00291772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92580494|NCT00291772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580495|NCT00078611|Natalizumab|natalizumab|mesh-list
92580496|NCT00078611|Immunologic Factors|immunologic factors|mesh-ancestor
92580497|NCT00078611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580498|NCT00291811|Plerixafor|plerixafor|mesh-list
92580499|NCT00291811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92580500|NCT00291811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92580501|NCT00291811|Antiviral Agents|antiviral agents|mesh-ancestor
92580502|NCT00291811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580503|NCT00291850|Paclitaxel|paclitaxel|mesh-list
92580504|NCT00291850|Cisplatin|cisplatin|mesh-list
92580505|NCT00291850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580506|NCT00291850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580507|NCT00291850|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580508|NCT00291850|Antimitotic Agents|antimitotic agents|mesh-ancestor
92580509|NCT00291850|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580510|NCT00291850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580511|NCT00112554|Cytarabine|cytarabine|mesh-list
92580512|NCT00112554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580513|NCT00112554|Antimetabolites|antimetabolites|mesh-ancestor
92580514|NCT00112554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580515|NCT00112554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580516|NCT00112554|Antiviral Agents|antiviral agents|mesh-ancestor
92580517|NCT00112554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580518|NCT00112554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580519|NCT00112554|Immunologic Factors|immunologic factors|mesh-ancestor
92580520|NCT00112554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580521|NCT04718311|Tacrolimus|tacrolimus|mesh-list
92580522|NCT04718311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580523|NCT04718311|Immunologic Factors|immunologic factors|mesh-ancestor
92580524|NCT04718311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580525|NCT04718311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92580526|NCT04718311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580527|NCT04718311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580528|NCT00078689|Daclizumab|daclizumab|mesh-list
92580529|NCT00078689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580530|NCT00078689|Immunologic Factors|immunologic factors|mesh-ancestor
92580531|NCT00078689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580532|NCT00112632|Imatinib Mesylate|imatinib mesylate|mesh-list
92580533|NCT00112632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580534|NCT00112632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580535|NCT00112632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580536|NCT00112632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580541|NCT00275314|Valganciclovir|valganciclovir|mesh-list
92580542|NCT00275314|Antiviral Agents|antiviral agents|mesh-ancestor
92305387|NCT04530487|Etoposide|etoposide|mesh-list
92580543|NCT00275314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580544|NCT00275275|Pramipexole|pramipexole|mesh-list
92580545|NCT00275275|Ropinirole|ropinirole|mesh-list
92580546|NCT00275275|Antioxidants|antioxidants|mesh-ancestor
92580547|NCT00275275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580548|NCT00275275|Protective Agents|protective agents|mesh-ancestor
92580549|NCT00275275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580550|NCT00275275|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92580551|NCT00275275|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92580552|NCT00275275|Dopamine Agonists|dopamine agonists|mesh-ancestor
92580553|NCT00275275|Dopamine Agents|dopamine agents|mesh-ancestor
92580554|NCT00275275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535154|NCT00073723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92580555|NCT00112710|Carboplatin|carboplatin|mesh-list
92580556|NCT00112710|Gemcitabine|gemcitabine|mesh-list
92580557|NCT00112710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580558|NCT00112710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580559|NCT00112710|Antimetabolites|antimetabolites|mesh-ancestor
92580560|NCT00112710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580561|NCT00275236|Rotigotine|rotigotine|mesh-list
92580562|NCT00275236|Dopamine Agonists|dopamine agonists|mesh-ancestor
92580563|NCT00275236|Dopamine Agents|dopamine agents|mesh-ancestor
92580564|NCT00275236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580565|NCT00275236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580566|NCT00275236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580567|NCT00275197|Sertraline|sertraline|mesh-list
92580568|NCT00275197|Antidepressive Agents|antidepressive agents|mesh-ancestor
92580569|NCT00275197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580570|NCT00275197|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92580571|NCT00275197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92580572|NCT00275197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92580573|NCT00275197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580574|NCT00275197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580575|NCT00275197|Serotonin Agents|serotonin agents|mesh-ancestor
92580576|NCT00275197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580577|NCT00275119|Gemcitabine|gemcitabine|mesh-list
92580578|NCT00275119|Fluorouracil|fluorouracil|mesh-list
92580579|NCT00275119|Oxaliplatin|oxaliplatin|mesh-list
92580580|NCT00275119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580581|NCT00275119|Antimetabolites|antimetabolites|mesh-ancestor
92580582|NCT00275119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580583|NCT00275119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580584|NCT00275119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580585|NCT00275119|Immunologic Factors|immunologic factors|mesh-ancestor
92580586|NCT00275119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580587|NCT00275080|Decitabine|decitabine|mesh-list
92580588|NCT00275080|Azacitidine|azacitidine|mesh-list
92580589|NCT00275080|Vorinostat|vorinostat|mesh-list
92580590|NCT00275080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580591|NCT00275080|Antimetabolites|antimetabolites|mesh-ancestor
92580592|NCT00275080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580593|NCT00275080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580594|NCT00275080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580595|NCT00275080|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92580596|NCT00078962|Gemcitabine|gemcitabine|mesh-list
92580597|NCT00078962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580598|NCT00078962|Antimetabolites|antimetabolites|mesh-ancestor
92580599|NCT00078962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580600|NCT00078962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580601|NCT00275041|Irinotecan|irinotecan|mesh-list
92580602|NCT00275041|Cetuximab|cetuximab|mesh-list
92580603|NCT00275041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92580604|NCT00275041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580605|NCT00275041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580606|NCT00275041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580607|NCT00275041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580627|NCT00102765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92580628|NCT00102765|Autonomic Agents|autonomic agents|mesh-ancestor
92580629|NCT00102765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580630|NCT00102765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580631|NCT00102765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92580632|NCT00102765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92580633|NCT00102765|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580634|NCT00102765|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92580635|NCT00102765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92580636|NCT00102765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92580637|NCT00102765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92580638|NCT00102765|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580639|NCT00102765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580640|NCT00102765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580641|NCT00102765|Glucocorticoids|glucocorticoids|mesh-ancestor
92580642|NCT00102765|Hormones|hormones|mesh-ancestor
92580643|NCT00102765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580644|NCT00102765|Sympathomimetics|sympathomimetics|mesh-ancestor
91927840|NCT02274259|Ranibizumab|ranibizumab|mesh-list
92580645|NCT00130390|Nitazoxanide|nitazoxanide|mesh-list
92580646|NCT00130390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92580647|NCT00130390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580648|NCT00079079|Carboplatin|carboplatin|mesh-list
92580649|NCT00079079|Gemcitabine|gemcitabine|mesh-list
92580650|NCT00079079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580651|NCT00079079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580652|NCT00079079|Antimetabolites|antimetabolites|mesh-ancestor
92580653|NCT00079079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580654|NCT00130312|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92580655|NCT00130312|Anticoagulants|anticoagulants|mesh-ancestor
92580656|NCT00130312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92580657|NCT00130312|Antimetabolites|antimetabolites|mesh-ancestor
92580658|NCT00130312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580659|NCT00130312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92580675|NCT00119301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92580677|NCT00119301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92580678|NCT00119301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580679|NCT00119301|Antimetabolites|antimetabolites|mesh-ancestor
92580680|NCT00119301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580681|NCT00119301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580682|NCT00119301|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580683|NCT00119301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580684|NCT00119301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92580685|NCT00119301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580686|NCT00119301|Immunologic Factors|immunologic factors|mesh-ancestor
92580687|NCT00119301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580688|NCT00119301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92580689|NCT00119301|Antidotes|antidotes|mesh-ancestor
92580690|NCT00119301|Protective Agents|protective agents|mesh-ancestor
92580691|NCT00119301|Vitamin B Complex|vitamin b complex|mesh-ancestor
92580692|NCT00119301|Vitamins|vitamins|mesh-ancestor
92580693|NCT00119301|Micronutrients|micronutrients|mesh-ancestor
92580694|NCT00119301|Antifungal Agents|antifungal agents|mesh-ancestor
92580695|NCT00119301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580696|NCT00079118|Docetaxel|docetaxel|mesh-list
92580697|NCT00079118|Irinotecan|irinotecan|mesh-list
92580698|NCT00079118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580699|NCT00079118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580700|NCT00079118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92580701|NCT00079118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580702|NCT00079118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580703|NCT00079118|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92580704|NCT00079118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580705|NCT00079118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580706|NCT00130195|Cytarabine|cytarabine|mesh-list
92580707|NCT00130195|Dexamethasone|dexamethasone|mesh-list
92580708|NCT00130195|Prednisolone|prednisolone|mesh-list
92580709|NCT00130195|Cyclophosphamide|cyclophosphamide|mesh-list
92580710|NCT00130195|Methotrexate|methotrexate|mesh-list
92580711|NCT00130195|Vincristine|vincristine|mesh-list
92580712|NCT00130195|Imatinib Mesylate|imatinib mesylate|mesh-list
92580713|NCT00130195|Daunorubicin|daunorubicin|mesh-list
92580714|NCT00130195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580715|NCT00130195|Immunologic Factors|immunologic factors|mesh-ancestor
92580716|NCT00130195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580717|NCT00130195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580718|NCT00130195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92580719|NCT00130195|Alkylating Agents|alkylating agents|mesh-ancestor
92580720|NCT00130195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580721|NCT00130195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580722|NCT00130195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92580724|NCT00130195|Antiemetics|antiemetics|mesh-ancestor
92580725|NCT00130195|Autonomic Agents|autonomic agents|mesh-ancestor
92580726|NCT00130195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580727|NCT00130195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92580728|NCT00130195|Glucocorticoids|glucocorticoids|mesh-ancestor
92580729|NCT00130195|Hormones|hormones|mesh-ancestor
92580730|NCT00130195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580731|NCT00130195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92580732|NCT00130195|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92580733|NCT00130195|Abortifacient Agents|abortifacient agents|mesh-ancestor
92580734|NCT00130195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92580735|NCT00130195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580736|NCT00130195|Antimetabolites|antimetabolites|mesh-ancestor
92535155|NCT00073723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580738|NCT00130195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580739|NCT00130195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92580740|NCT00130195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92580741|NCT00130195|Antiviral Agents|antiviral agents|mesh-ancestor
92580742|NCT00130195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580743|NCT00130195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580744|NCT00130195|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580745|NCT00130195|Antimitotic Agents|antimitotic agents|mesh-ancestor
92580746|NCT00130195|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580747|NCT00130195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580748|NCT00130195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580749|NCT00130195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92580750|NCT00130195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580751|NCT00394303|Insulin|insulin|mesh-list
92580752|NCT00394303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92580753|NCT00394303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580754|NCT00119340|Cyclosporine|cyclosporine|mesh-list
92580755|NCT00119340|Mycophenolic Acid|mycophenolic acid|mesh-list
92580756|NCT00119340|Fludarabine|fludarabine|mesh-list
92580757|NCT00119340|Fludarabine phosphate|fludarabine phosphate|mesh-list
92580758|NCT00119340|Cyclosporins|cyclosporins|mesh-list
92580759|NCT00119340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580760|NCT00119340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580761|NCT00119340|Antimetabolites|antimetabolites|mesh-ancestor
92580762|NCT00119340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580763|NCT00119340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580764|NCT00119340|Immunologic Factors|immunologic factors|mesh-ancestor
92580765|NCT00119340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580766|NCT00119340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305632|NCT00004833|Antibodies|antibodies|mesh-list
92580767|NCT00119340|Antifungal Agents|antifungal agents|mesh-ancestor
92580768|NCT00119340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580769|NCT00119340|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580770|NCT00119340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580771|NCT00119340|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92580772|NCT00119340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580773|NCT00119340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92580774|NCT00119340|Antitubercular Agents|antitubercular agents|mesh-ancestor
92580775|NCT00119340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580776|NCT00130156|Doxazosin|doxazosin|mesh-list
92580777|NCT00130156|Bunazosin|bunazosin|mesh-list
92580778|NCT00130156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92580779|NCT00130156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92580780|NCT00130156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92580781|NCT00130156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92580782|NCT00130156|Adrenergic Agents|adrenergic agents|mesh-ancestor
92580783|NCT00130156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580784|NCT00130156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580785|NCT00130156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580786|NCT00130117|Contraceptive Agents|contraceptive agents|mesh-list
92580787|NCT00130117|Contraceptives, Oral|contraceptives, oral|mesh-list
92580788|NCT00130117|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92580789|NCT00130117|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92580790|NCT00130117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580791|NCT00130117|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92580792|NCT00079157|Sargramostim|sargramostim|mesh-list
92580793|NCT00079157|Freund's Adjuvant|freund's adjuvant|mesh-list
92580794|NCT00079157|Immunologic Factors|immunologic factors|mesh-ancestor
92580795|NCT00079157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580806|NCT00079235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580807|NCT00079235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580808|NCT00079235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580809|NCT00079235|Immunologic Factors|immunologic factors|mesh-ancestor
92580810|NCT00079235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580811|NCT00079235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580812|NCT00079235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580813|NCT00079235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580814|NCT00079235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580815|NCT00079235|Antifungal Agents|antifungal agents|mesh-ancestor
92580816|NCT00129844|Motexafin gadolinium|motexafin gadolinium|mesh-list
92580817|NCT00129844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580818|NCT00129844|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92535157|NCT00073840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92535158|NCT00073840|Autonomic Agents|autonomic agents|mesh-ancestor
92535159|NCT00073840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580819|NCT00129844|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580820|NCT00129805|Aspirin|aspirin|mesh-list
92580821|NCT00129805|Sarpogrelate|sarpogrelate|mesh-list
92580822|NCT00129805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92580823|NCT00129805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92580824|NCT00129805|Analgesics|analgesics|mesh-ancestor
92580825|NCT00129805|Sensory System Agents|sensory system agents|mesh-ancestor
92580826|NCT00129805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580827|NCT00129805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580828|NCT00129805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580829|NCT00129805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580830|NCT00129805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92580831|NCT00129805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92580832|NCT00129805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580833|NCT00129805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92580834|NCT00129805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92580835|NCT00129805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580836|NCT00129805|Antipyretics|antipyretics|mesh-ancestor
92580837|NCT00129805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92580838|NCT00129805|Serotonin Agents|serotonin agents|mesh-ancestor
92580839|NCT00129805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580840|NCT00129727|Paclitaxel|paclitaxel|mesh-list
92580841|NCT00129727|Bevacizumab|bevacizumab|mesh-list
92580842|NCT00129727|Carboplatin|carboplatin|mesh-list
92580843|NCT00129727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580844|NCT00129727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580845|NCT00129727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580846|NCT00129727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92580847|NCT00129727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580848|NCT00129727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580849|NCT00129727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92580850|NCT00129727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92580851|NCT00129727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92580852|NCT00129727|Growth Substances|growth substances|mesh-ancestor
92580853|NCT00129727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580854|NCT00129727|Growth Inhibitors|growth inhibitors|mesh-ancestor
92580855|NCT00129688|Amikacin|amikacin|mesh-list
92580856|NCT00129688|Cloxacillin|cloxacillin|mesh-list
92580857|NCT00129688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580858|NCT00129688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580859|NCT00079352|Gemcitabine|gemcitabine|mesh-list
92580860|NCT00079352|Irinotecan|irinotecan|mesh-list
92580861|NCT00079352|Alvocidib|alvocidib|mesh-list
92580862|NCT00079352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92580874|NCT00119496|Beclomethasone|beclomethasone|mesh-list
92580875|NCT00119496|Theophylline|theophylline|mesh-list
92580876|NCT00119496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580877|NCT00119496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580878|NCT00119496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92580879|NCT00119496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580880|NCT00119496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580881|NCT00119496|Glucocorticoids|glucocorticoids|mesh-ancestor
92580883|NCT00119496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580884|NCT00119496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92580885|NCT00119496|Respiratory System Agents|respiratory system agents|mesh-ancestor
92580886|NCT00119496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92580887|NCT00119496|Autonomic Agents|autonomic agents|mesh-ancestor
92580888|NCT00119496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580889|NCT00119496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92580890|NCT00119496|Vasodilator Agents|vasodilator agents|mesh-ancestor
92580891|NCT00119496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92580892|NCT00119496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92580893|NCT00119496|Purinergic Agents|purinergic agents|mesh-ancestor
92580894|NCT00119496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580895|NCT00298285|Enoxaparin|enoxaparin|mesh-list
92580896|NCT00298285|Anticoagulants|anticoagulants|mesh-ancestor
92580897|NCT00298285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92580898|NCT00298285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92580899|NCT00298285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580900|NCT00298324|Cyclosporine|cyclosporine|mesh-list
92535160|NCT00073840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580901|NCT00298324|Mycophenolic Acid|mycophenolic acid|mesh-list
92580902|NCT00298324|Prednisone|prednisone|mesh-list
92580903|NCT00298324|Cyclosporins|cyclosporins|mesh-list
92580904|NCT00298324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580905|NCT00298324|Glucocorticoids|glucocorticoids|mesh-ancestor
92580906|NCT00298324|Hormones|hormones|mesh-ancestor
92580907|NCT00298324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92580908|NCT00298324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580909|NCT00298324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92580910|NCT00298324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580911|NCT00298324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580912|NCT00298324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580913|NCT00298324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580914|NCT00298324|Immunologic Factors|immunologic factors|mesh-ancestor
92580915|NCT00298324|Antifungal Agents|antifungal agents|mesh-ancestor
92580916|NCT00298324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92580917|NCT00298324|Dermatologic Agents|dermatologic agents|mesh-ancestor
92580918|NCT00298324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580919|NCT00298324|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92305759|NCT03468985|Ipilimumab|ipilimumab|mesh-list
92580920|NCT00298324|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92580921|NCT00298324|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92580923|NCT00298324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92580924|NCT00079430|Paclitaxel|paclitaxel|mesh-list
92580925|NCT00079430|Bevacizumab|bevacizumab|mesh-list
92580926|NCT00079430|Carboplatin|carboplatin|mesh-list
92580946|NCT00298636|Analgesics|analgesics|mesh-ancestor
92580947|NCT00298636|Sensory System Agents|sensory system agents|mesh-ancestor
92580948|NCT00298636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580949|NCT00298636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580950|NCT00298636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92580951|NCT00298636|Vasodilator Agents|vasodilator agents|mesh-ancestor
92580952|NCT00298636|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92580953|NCT00298636|Purinergic Agonists|purinergic agonists|mesh-ancestor
92580954|NCT00298636|Purinergic Agents|purinergic agents|mesh-ancestor
92580955|NCT00298636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580956|NCT00298636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580957|NCT00086112|Risperidone|risperidone|mesh-list
92580958|NCT00086112|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92580959|NCT00086112|Serotonin Agents|serotonin agents|mesh-ancestor
92580960|NCT00086112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580961|NCT00086112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580962|NCT00086112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580963|NCT00086112|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92580964|NCT00086112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92580965|NCT00086112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92580966|NCT00086112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580967|NCT00086112|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92580968|NCT00086112|Dopamine Agents|dopamine agents|mesh-ancestor
92580969|NCT00079469|Bupropion|bupropion|mesh-list
92580970|NCT00079469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92580971|NCT00079469|Antidepressive Agents|antidepressive agents|mesh-ancestor
92580972|NCT00079469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92580973|NCT00079469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92580974|NCT00079469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92580975|NCT00079469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92580976|NCT00079469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580977|NCT00079469|Dopamine Agents|dopamine agents|mesh-ancestor
92580978|NCT00079469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92580979|NCT00079469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580980|NCT00079469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91988146|NCT03144245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92580981|NCT00079469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92580983|NCT00298675|Irinotecan|irinotecan|mesh-list
92580984|NCT00298675|Iniparib|iniparib|mesh-list
92580985|NCT00298675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92580986|NCT00298675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359699|NCT02448420|Palbociclib|palbociclib|mesh-list
92580987|NCT00298675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580988|NCT00298675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580989|NCT00298675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580990|NCT00298675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92580991|NCT00298714|Losartan|losartan|mesh-list
92535161|NCT00073840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92535162|NCT00073840|Respiratory System Agents|respiratory system agents|mesh-ancestor
92580992|NCT00298714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92580993|NCT00298714|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92580994|NCT00298714|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92580995|NCT00298714|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92580996|NCT00298714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580997|NCT00079508|Bivalirudin|bivalirudin|mesh-list
92580998|NCT00079508|Antithrombins|antithrombins|mesh-ancestor
92580999|NCT00079508|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92581000|NCT00079508|Protease Inhibitors|protease inhibitors|mesh-ancestor
92581001|NCT00079508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581002|NCT00079508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581003|NCT00079508|Anticoagulants|anticoagulants|mesh-ancestor
92581004|NCT00298870|Isoniazid|isoniazid|mesh-list
92581005|NCT00298870|Antitubercular Agents|antitubercular agents|mesh-ancestor
92581006|NCT00298870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581007|NCT00298870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581008|NCT00298870|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92581009|NCT00298870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92581010|NCT00298870|Antimetabolites|antimetabolites|mesh-ancestor
92581011|NCT00298870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581012|NCT00298870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92581013|NCT00298909|Niacin|niacin|mesh-list
92581014|NCT00298909|Niacinamide|niacinamide|mesh-list
92581015|NCT00298909|Nicotinic Acids|nicotinic acids|mesh-list
92581016|NCT00298909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92581017|NCT00298909|Antimetabolites|antimetabolites|mesh-ancestor
92581018|NCT00298909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581019|NCT00298909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92581020|NCT00298909|Vasodilator Agents|vasodilator agents|mesh-ancestor
92581021|NCT00298909|Vitamin B Complex|vitamin b complex|mesh-ancestor
92581022|NCT00298909|Vitamins|vitamins|mesh-ancestor
92581023|NCT00298909|Micronutrients|micronutrients|mesh-ancestor
92581024|NCT00298909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581025|NCT00299026|Paclitaxel|paclitaxel|mesh-list
92581026|NCT00299026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92581027|NCT00299026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581028|NCT00299026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581029|NCT00299026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581030|NCT00299026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581031|NCT00299026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581032|NCT00299065|Zileuton|zileuton|mesh-list
92581033|NCT00299065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92581034|NCT00299065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92581035|NCT00299065|Analgesics|analgesics|mesh-ancestor
92581036|NCT00299065|Sensory System Agents|sensory system agents|mesh-ancestor
92581037|NCT00299065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581038|NCT00299065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581039|NCT00299065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581040|NCT00299065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581041|NCT00299065|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92581042|NCT00299065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581043|NCT00299065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581044|NCT00299065|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92581045|NCT00299065|Hormone Antagonists|hormone antagonists|mesh-ancestor
92581046|NCT00299065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581047|NCT00079586|Heparin|heparin|mesh-list
92581048|NCT00079586|Bivalirudin|bivalirudin|mesh-list
92581049|NCT00079586|Anticoagulants|anticoagulants|mesh-ancestor
92581050|NCT00079586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92581051|NCT00079586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92581052|NCT00079586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581053|NCT00079586|Antithrombins|antithrombins|mesh-ancestor
92581054|NCT00079586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92581068|NCT00418132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581069|NCT00119613|Darbepoetin alfa|darbepoetin alfa|mesh-list
92581070|NCT00119613|Hematinics|hematinics|mesh-ancestor
92581071|NCT00299377|Abciximab|abciximab|mesh-list
92581072|NCT00299377|Anticoagulants|anticoagulants|mesh-ancestor
92581073|NCT00299377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92581074|NCT00299455|Amoxicillin|amoxicillin|mesh-list
92581075|NCT00299455|Clavulanic Acid|clavulanic acid|mesh-list
92581076|NCT00299455|Clavulanic Acids|clavulanic acids|mesh-list
92535163|NCT00073840|Tocolytic Agents|tocolytic agents|mesh-ancestor
92535164|NCT00073840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92535165|NCT00073840|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92535166|NCT00073840|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92581077|NCT00299455|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92581078|NCT00299455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581079|NCT00299455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581080|NCT00299455|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92581081|NCT00299455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581082|NCT00299455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581083|NCT00299572|Alendronate|alendronate|mesh-list
92581084|NCT00299572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92581085|NCT00299572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581086|NCT00299611|Levetiracetam|levetiracetam|mesh-list
92581087|NCT00299611|Sertraline|sertraline|mesh-list
92581088|NCT00299611|Antidepressive Agents|antidepressive agents|mesh-ancestor
92581089|NCT00299611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92581090|NCT00299611|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92581091|NCT00299611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92581092|NCT00299611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92581093|NCT00299611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581094|NCT00299611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581095|NCT00299611|Serotonin Agents|serotonin agents|mesh-ancestor
92581096|NCT00299611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581097|NCT00299611|Anticonvulsants|anticonvulsants|mesh-ancestor
92581098|NCT00299611|Nootropic Agents|nootropic agents|mesh-ancestor
92581099|NCT00299650|Cisatracurium|cisatracurium|mesh-list
92581100|NCT00299650|Atracurium|atracurium|mesh-list
92581101|NCT00299650|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92581102|NCT00299650|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92581103|NCT00299650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581104|NCT00299650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581105|NCT00299650|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92581106|NCT00299650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92581107|NCT00299650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92581108|NCT00299650|Cholinergic Agents|cholinergic agents|mesh-ancestor
92581109|NCT00299650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581110|NCT00299650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581111|NCT04727853|Irinotecan|irinotecan|mesh-list
92581112|NCT04727853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92581113|NCT04727853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581114|NCT04727853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581115|NCT04727853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581116|NCT04727853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581119|NCT00299845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92581120|NCT00299845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581121|NCT00299845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92581122|NCT00299845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581123|NCT00299845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581125|NCT00299884|Ezetimibe|ezetimibe|mesh-list
92581126|NCT00299884|Fenofibrate|fenofibrate|mesh-list
92581127|NCT00299884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92581128|NCT00299884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92581129|NCT00299884|Antimetabolites|antimetabolites|mesh-ancestor
92581130|NCT00299884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581131|NCT00299884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92581132|NCT00299884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92581133|NCT00299884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581134|NCT00119652|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92581135|NCT00119652|Paroxetine|paroxetine|mesh-list
92581136|NCT00119652|Antidepressive Agents|antidepressive agents|mesh-ancestor
92581137|NCT00119652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92581138|NCT00119652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92581139|NCT00119652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92581140|NCT00119652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92581141|NCT00119652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581142|NCT00119652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92581143|NCT00119652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92535167|NCT00073840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92535168|NCT00073840|Adrenergic Agents|adrenergic agents|mesh-ancestor
92581144|NCT00119652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92581145|NCT00119652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581146|NCT00119652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581147|NCT00119652|Serotonin Agents|serotonin agents|mesh-ancestor
92581148|NCT00119652|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92581149|NCT00119652|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92581150|NCT00119652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92581151|NCT00119652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581152|NCT00299923|Ribavirin|ribavirin|mesh-list
92581153|NCT00299923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92581154|NCT00299923|Amantadine|amantadine|mesh-list
92581155|NCT00299923|Antimetabolites|antimetabolites|mesh-ancestor
92581156|NCT00299923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581157|NCT00299923|Antiviral Agents|antiviral agents|mesh-ancestor
92581158|NCT00299923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581159|NCT00299923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92581160|NCT00299923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92581161|NCT00299923|Dopamine Agents|dopamine agents|mesh-ancestor
92581162|NCT00299923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581163|NCT00299923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581164|NCT00299923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92581165|NCT00299923|Analgesics|analgesics|mesh-ancestor
92581166|NCT00299923|Sensory System Agents|sensory system agents|mesh-ancestor
92581167|NCT00299923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581168|NCT00299962|Interferons|interferons|mesh-list
92581169|NCT00299962|Interferon-beta|interferon-beta|mesh-list
92581170|NCT00299962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581171|NCT00299962|Antiviral Agents|antiviral agents|mesh-ancestor
92581172|NCT00299962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581173|NCT00299962|Immunologic Factors|immunologic factors|mesh-ancestor
92581174|NCT00299962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581175|NCT00418171|Olanzapine|olanzapine|mesh-list
92581176|NCT00418171|Ziprasidone|ziprasidone|mesh-list
92581177|NCT00418171|Antiemetics|antiemetics|mesh-ancestor
92581178|NCT00418171|Autonomic Agents|autonomic agents|mesh-ancestor
92581179|NCT00418171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581180|NCT00418171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581181|NCT00418171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581182|NCT00418171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92581183|NCT00418171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92581184|NCT00418171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92581185|NCT00418171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92581186|NCT00418171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92581187|NCT00418171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92581188|NCT00418171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988340|NCT02428777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92581205|NCT00300040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581206|NCT00300040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581207|NCT00300040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581208|NCT00300040|Blood Substitutes|blood substitutes|mesh-ancestor
92581209|NCT00079820|Vaccines|vaccines|mesh-list
92581210|NCT00079820|Immunologic Factors|immunologic factors|mesh-ancestor
92581211|NCT00079820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581212|NCT00300079|Brinzolamide|brinzolamide|mesh-list
92581213|NCT00300079|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92581214|NCT00300079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581215|NCT00300079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581216|NCT00300118|Budesonide|budesonide|mesh-list
92581217|NCT00300118|Mesalamine|mesalamine|mesh-list
92581218|NCT00300118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581219|NCT00300118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92581220|NCT00300118|Autonomic Agents|autonomic agents|mesh-ancestor
92581221|NCT00300118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581222|NCT00300118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581223|NCT00300118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92581224|NCT00300118|Respiratory System Agents|respiratory system agents|mesh-ancestor
92581225|NCT00300118|Glucocorticoids|glucocorticoids|mesh-ancestor
92581226|NCT00300118|Hormones|hormones|mesh-ancestor
92581227|NCT00300118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581228|NCT00300118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92581229|NCT00300118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92535169|NCT00073840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535170|NCT00073840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581231|NCT00300118|Sensory System Agents|sensory system agents|mesh-ancestor
92581232|NCT00300118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581233|NCT00119730|Rituximab|rituximab|mesh-list
92581234|NCT00119730|Fludarabine|fludarabine|mesh-list
92581235|NCT00119730|Mitoxantrone|mitoxantrone|mesh-list
92581236|NCT00119730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581237|NCT00119730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581238|NCT00119730|Immunologic Factors|immunologic factors|mesh-ancestor
92581239|NCT00119730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581240|NCT00119730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581241|NCT00119730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581242|NCT00119730|Analgesics|analgesics|mesh-ancestor
92581243|NCT00119730|Sensory System Agents|sensory system agents|mesh-ancestor
92581244|NCT00119730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581245|NCT00119730|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92581246|NCT00119730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581247|NCT00119730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581248|NCT00300196|Ancrod|ancrod|mesh-list
92581254|NCT00119769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581255|NCT00119769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581256|NCT00300313|Escitalopram|escitalopram|mesh-list
92581257|NCT00300313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92581258|NCT00300313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92581259|NCT00300313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92581260|NCT00300313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581261|NCT00300313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581262|NCT00300313|Serotonin Agents|serotonin agents|mesh-ancestor
92581263|NCT00300313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581264|NCT00399659|Tegaserod|tegaserod|mesh-list
92581265|NCT00399659|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92581266|NCT00399659|Serotonin Agents|serotonin agents|mesh-ancestor
92581267|NCT00399659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581268|NCT00399659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581269|NCT00399659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581270|NCT00300352|Folic Acid|folic acid|mesh-list
92581271|NCT00300352|Hematinics|hematinics|mesh-ancestor
92581272|NCT00300352|Vitamin B Complex|vitamin b complex|mesh-ancestor
92581273|NCT00300352|Vitamins|vitamins|mesh-ancestor
92581274|NCT00300352|Micronutrients|micronutrients|mesh-ancestor
92581275|NCT00300352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581276|NCT00300508|Anastrozole|anastrozole|mesh-list
92581277|NCT00300508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92581278|NCT00300508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581279|NCT00300508|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92581280|NCT00300508|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92581281|NCT00300508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581282|NCT00300508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581283|NCT00300508|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92581284|NCT00300508|Hormone Antagonists|hormone antagonists|mesh-ancestor
92581285|NCT00300508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581286|NCT00300508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581287|NCT00086463|Iloprost|iloprost|mesh-list
92581288|NCT00086463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92581289|NCT00086463|Vasodilator Agents|vasodilator agents|mesh-ancestor
92581290|NCT00079976|Tigecycline|tigecycline|mesh-list
92581291|NCT00079976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581292|NCT00079976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581293|NCT00079976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92581294|NCT00079976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581295|NCT00079976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581296|NCT00079313|Imatinib Mesylate|imatinib mesylate|mesh-list
92581297|NCT00079313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581298|NCT00079313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92581299|NCT00079313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581300|NCT00079313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581301|NCT00086268|Zoledronic Acid|zoledronic acid|mesh-list
92581303|NCT00086268|Docetaxel|docetaxel|mesh-list
92581304|NCT00086268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535171|NCT00073879|Cyclophosphamide|cyclophosphamide|mesh-list
92535172|NCT00073879|Fludarabine|fludarabine|mesh-list
92535173|NCT00073879|Fludarabine phosphate|fludarabine phosphate|mesh-list
92535174|NCT00073879|Alemtuzumab|alemtuzumab|mesh-list
92535175|NCT00073879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581305|NCT00086268|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581306|NCT00086268|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581307|NCT00086268|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581308|NCT00086268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581309|NCT00086268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92581310|NCT00086268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581311|NCT00300586|Gemcitabine|gemcitabine|mesh-list
92581312|NCT00300586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92581313|NCT00300586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581314|NCT00300586|Antimetabolites|antimetabolites|mesh-ancestor
92581315|NCT00300586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581316|NCT00300586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581317|NCT00300586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92581322|NCT00086541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581323|NCT00086541|Antiviral Agents|antiviral agents|mesh-ancestor
92581324|NCT00086541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581325|NCT00086541|Antimetabolites|antimetabolites|mesh-ancestor
92581326|NCT00086541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581327|NCT00300664|Hormones|hormones|mesh-list
92581328|NCT00300664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581329|NCT00300664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581330|NCT04718038|Cetuximab|cetuximab|mesh-list
92581331|NCT04718038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581332|NCT04718038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581333|NCT00080054|Motexafin gadolinium|motexafin gadolinium|mesh-list
92581334|NCT00080054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581335|NCT00080054|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92581336|NCT00080054|Dermatologic Agents|dermatologic agents|mesh-ancestor
92581337|NCT04718233|Sildenafil Citrate|sildenafil citrate|mesh-list
92581338|NCT04718233|Vasodilator Agents|vasodilator agents|mesh-ancestor
92581339|NCT04718233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92581340|NCT04718233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92581341|NCT04718233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581342|NCT04718233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581343|NCT04718233|Urological Agents|urological agents|mesh-ancestor
92581344|NCT00119886|Botulinum Toxins|botulinum toxins|mesh-list
92581345|NCT00119886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92581346|NCT00119886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92581347|NCT00119886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581348|NCT00119886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92581349|NCT00119886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581350|NCT00119886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581351|NCT00300937|Ubiquinone|ubiquinone|mesh-list
92581352|NCT00300937|Coenzyme Q10|coenzyme q10|mesh-list
92581353|NCT00300937|Micronutrients|micronutrients|mesh-ancestor
92581354|NCT00300937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581355|NCT00300937|Vitamins|vitamins|mesh-ancestor
92581356|NCT00418249|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92581357|NCT00418249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92581358|NCT00418249|Immunologic Factors|immunologic factors|mesh-ancestor
92581359|NCT00418249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581360|NCT00418249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581361|NCT00418249|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92581362|NCT00418249|Protective Agents|protective agents|mesh-ancestor
92581363|NCT00418249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92581364|NCT00418249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92581365|NCT00418249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359715|NCT02422446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92581366|NCT00418249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581367|NCT00418249|Antiviral Agents|antiviral agents|mesh-ancestor
92581368|NCT00418249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581369|NCT00301054|Pyrimethamine|pyrimethamine|mesh-list
92581370|NCT00301054|Sulfadoxine|sulfadoxine|mesh-list
92581371|NCT00301054|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92581372|NCT00301054|Antimalarials|antimalarials|mesh-ancestor
92535176|NCT00073879|Immunologic Factors|immunologic factors|mesh-ancestor
92535177|NCT00073879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535178|NCT00073879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581373|NCT00301054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92581374|NCT00301054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92581375|NCT00301054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581376|NCT00301054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92581377|NCT00301054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581378|NCT00301054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581379|NCT00301054|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92581380|NCT00301093|Imatinib Mesylate|imatinib mesylate|mesh-list
92581381|NCT00301093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581382|NCT00301093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92581383|NCT00301093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581384|NCT00301093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581385|NCT00301171|Fluticasone|fluticasone|mesh-list
92581386|NCT00301171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581387|NCT00301171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92581388|NCT00301171|Autonomic Agents|autonomic agents|mesh-ancestor
92581393|NCT00301171|Dermatologic Agents|dermatologic agents|mesh-ancestor
92581394|NCT00301171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92581396|NCT00301210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92581397|NCT00301210|Narcotics|narcotics|mesh-ancestor
92581398|NCT00301210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92581399|NCT00301210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581400|NCT00301210|Analgesics|analgesics|mesh-ancestor
92581401|NCT00301210|Sensory System Agents|sensory system agents|mesh-ancestor
92581402|NCT00301210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581403|NCT00080327|Aripiprazole|aripiprazole|mesh-list
92581404|NCT00080327|Antidepressive Agents|antidepressive agents|mesh-ancestor
92581405|NCT00080327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92581406|NCT00080327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92581407|NCT00080327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92581408|NCT00080327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92581409|NCT00080327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581410|NCT00080327|Dopamine Agonists|dopamine agonists|mesh-ancestor
92581411|NCT00080327|Dopamine Agents|dopamine agents|mesh-ancestor
92581412|NCT00080327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581413|NCT00080327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581414|NCT00080327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92581415|NCT00080327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92581416|NCT00080327|Serotonin Agents|serotonin agents|mesh-ancestor
92581417|NCT00080327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92581418|NCT00080327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92581419|NCT00080327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92581420|NCT00080327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92581421|NCT00301405|Thalidomide|thalidomide|mesh-list
92581422|NCT00301405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581423|NCT00301405|Immunologic Factors|immunologic factors|mesh-ancestor
92581424|NCT00301405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581425|NCT00301405|Leprostatic Agents|leprostatic agents|mesh-ancestor
92581426|NCT00301405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581427|NCT00301405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581428|NCT00301405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92581429|NCT00301405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92581430|NCT00301405|Growth Substances|growth substances|mesh-ancestor
92581431|NCT00301405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92581432|NCT00301405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581433|NCT00301483|Chrysarobin|chrysarobin|mesh-list
92581434|NCT00301483|HBOC 201|hboc 201|mesh-list
92581435|NCT00301483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92581436|NCT00301483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92581437|NCT00301483|Analgesics|analgesics|mesh-ancestor
92581438|NCT00301483|Sensory System Agents|sensory system agents|mesh-ancestor
92581439|NCT00301483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581440|NCT00301483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581441|NCT00301483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306296|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581442|NCT00301483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581443|NCT00301483|Blood Substitutes|blood substitutes|mesh-ancestor
92581444|NCT00301522|Paclitaxel|paclitaxel|mesh-list
92581445|NCT00301522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92535179|NCT00073879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535180|NCT00073879|Alkylating Agents|alkylating agents|mesh-ancestor
92535181|NCT00073879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535182|NCT00073879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581446|NCT00301522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581447|NCT00301522|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581448|NCT00301522|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581449|NCT00301522|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581450|NCT00301522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581451|NCT00080405|Bortezomib|bortezomib|mesh-list
92581452|NCT00080405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581453|NCT00292123|Methadone|methadone|mesh-list
92581454|NCT00292123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92581455|NCT00292123|Narcotics|narcotics|mesh-ancestor
92581456|NCT00292123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92581457|NCT00292123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581458|NCT00292123|Analgesics|analgesics|mesh-ancestor
92581461|NCT00292123|Antitussive Agents|antitussive agents|mesh-ancestor
92581462|NCT00292123|Respiratory System Agents|respiratory system agents|mesh-ancestor
92581463|NCT00080444|Dexamethasone|dexamethasone|mesh-list
92581464|NCT00080444|Dexamethasone acetate|dexamethasone acetate|mesh-list
92581465|NCT00080444|Ondansetron|ondansetron|mesh-list
92581466|NCT00080444|Aprepitant|aprepitant|mesh-list
92581467|NCT00080444|Fosaprepitant|fosaprepitant|mesh-list
92581468|NCT00080444|BB 1101|bb 1101|mesh-list
92581469|NCT00080444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581470|NCT00080444|Antiemetics|antiemetics|mesh-ancestor
92581471|NCT00080444|Autonomic Agents|autonomic agents|mesh-ancestor
92581472|NCT00080444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581473|NCT00080444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581474|NCT00080444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581475|NCT00080444|Glucocorticoids|glucocorticoids|mesh-ancestor
92581476|NCT00080444|Hormones|hormones|mesh-ancestor
92581477|NCT00080444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581478|NCT00080444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92581479|NCT00080444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581480|NCT00080444|Protease Inhibitors|protease inhibitors|mesh-ancestor
92581481|NCT00080444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581482|NCT00080444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581483|NCT00080444|Antipruritics|antipruritics|mesh-ancestor
92581484|NCT00080444|Dermatologic Agents|dermatologic agents|mesh-ancestor
92581485|NCT00080444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92581486|NCT00080444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92581487|NCT00080444|Serotonin Agents|serotonin agents|mesh-ancestor
92581488|NCT00080444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581489|NCT00080444|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92581490|NCT00086736|Eflornithine|eflornithine|mesh-list
92581491|NCT00086736|Bicalutamide|bicalutamide|mesh-list
92581492|NCT00086736|Androgen Antagonists|androgen antagonists|mesh-ancestor
92581493|NCT00086736|Hormone Antagonists|hormone antagonists|mesh-ancestor
92581494|NCT00086736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581495|NCT00086736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581496|NCT00086736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581497|NCT00086736|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92581498|NCT00086736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92581499|NCT00086736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92581500|NCT00086736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581501|NCT00086736|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92581502|NCT00086736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581503|NCT00086736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581504|NCT00292201|Atorvastatin|atorvastatin|mesh-list
92581505|NCT00292201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92581506|NCT00292201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92581507|NCT00292201|Antimetabolites|antimetabolites|mesh-ancestor
92581508|NCT00292201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581509|NCT00292201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92581510|NCT00292201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92581511|NCT00292201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581512|NCT00292279|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92581513|NCT00292279|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92581514|NCT00292279|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92581515|NCT00292279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92581517|NCT00080522|Lopinavir|lopinavir|mesh-list
92581518|NCT00080522|Lamivudine|lamivudine|mesh-list
92581519|NCT00080522|Zidovudine|zidovudine|mesh-list
92581520|NCT00080522|Didanosine|didanosine|mesh-list
92581521|NCT00080522|Stavudine|stavudine|mesh-list
92581522|NCT00080522|Efavirenz|efavirenz|mesh-list
92581523|NCT00080522|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92581524|NCT00080522|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92581525|NCT00080522|Protease Inhibitors|protease inhibitors|mesh-ancestor
92581526|NCT00080522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581527|NCT00080522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581528|NCT00080522|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92581529|NCT00080522|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92581530|NCT00080522|Antiviral Agents|antiviral agents|mesh-ancestor
92581531|NCT00080522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581532|NCT00080522|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92581545|NCT00086775|Fludarabine phosphate|fludarabine phosphate|mesh-list
92581546|NCT00086775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581547|NCT00086775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581548|NCT00086775|Immunologic Factors|immunologic factors|mesh-ancestor
92581549|NCT00086775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581550|NCT00086775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581551|NCT00086775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581552|NCT00086775|Antimetabolites|antimetabolites|mesh-ancestor
92581553|NCT00086775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581554|NCT00086775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581555|NCT00086892|Carboplatin|carboplatin|mesh-list
92581556|NCT00086892|Cetuximab|cetuximab|mesh-list
92581557|NCT00086892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581558|NCT00086892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581559|NCT00292708|Cefmetazole|cefmetazole|mesh-list
92581560|NCT00292708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581561|NCT00292708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581562|NCT00086931|Capecitabine|capecitabine|mesh-list
92581563|NCT00086931|Oxaliplatin|oxaliplatin|mesh-list
92581564|NCT00086931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581565|NCT00086931|Antimetabolites|antimetabolites|mesh-ancestor
92581566|NCT00086931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581567|NCT00086931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581568|NCT00292747|Ibuprofen|ibuprofen|mesh-list
92581569|NCT00292747|Drotaverin|drotaverin|mesh-list
92581570|NCT00292747|Papaverine|papaverine|mesh-list
92581571|NCT00292747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92581572|NCT00292747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92581573|NCT00292747|Analgesics|analgesics|mesh-ancestor
92581574|NCT00292747|Sensory System Agents|sensory system agents|mesh-ancestor
92581575|NCT00292747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581576|NCT00292747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581577|NCT00292747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581578|NCT00292747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581579|NCT00292747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92581580|NCT00292747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581581|NCT00292747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581582|NCT00292747|Parasympatholytics|parasympatholytics|mesh-ancestor
92581583|NCT00292747|Autonomic Agents|autonomic agents|mesh-ancestor
92581584|NCT00292747|Vasodilator Agents|vasodilator agents|mesh-ancestor
92581585|NCT00292747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92581586|NCT00292747|Urological Agents|urological agents|mesh-ancestor
92581587|NCT00120003|Candesartan|candesartan|mesh-list
92581588|NCT00120003|Candesartan cilexetil|candesartan cilexetil|mesh-list
92581589|NCT00120003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92581590|NCT00120003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92581591|NCT00120003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92581592|NCT00120003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581593|NCT00201721|Cyclophosphamide|cyclophosphamide|mesh-list
92581594|NCT00201721|Rituximab|rituximab|mesh-list
92581597|NCT00201721|Immunologic Factors|immunologic factors|mesh-ancestor
92581598|NCT00201721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581599|NCT00201721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581600|NCT00201721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92581601|NCT00201721|Alkylating Agents|alkylating agents|mesh-ancestor
92581602|NCT00201721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581603|NCT00201721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535183|NCT00073879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535184|NCT00073879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581604|NCT00201721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92581605|NCT00201721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581606|NCT00201721|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92581607|NCT00201721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581608|NCT00201799|Infliximab|infliximab|mesh-list
92581609|NCT00201799|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92581610|NCT00201799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581611|NCT00201799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92581612|NCT00201799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581613|NCT00201799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581614|NCT00080678|Docetaxel|docetaxel|mesh-list
92581615|NCT00080678|Imatinib Mesylate|imatinib mesylate|mesh-list
92581616|NCT00080678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581617|NCT00080678|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581618|NCT00080678|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581619|NCT00080678|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581620|NCT00080678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581621|NCT00080678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92581622|NCT00080678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581623|NCT00086970|Ifosfamide|ifosfamide|mesh-list
92581624|NCT00086970|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92581625|NCT00086970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92581626|NCT00086970|Alkylating Agents|alkylating agents|mesh-ancestor
92581627|NCT00086970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581628|NCT00086970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581629|NCT00086970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581630|NCT00201955|Rebamipide|rebamipide|mesh-list
92581631|NCT00201955|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92581632|NCT00201955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581633|NCT00201955|Antioxidants|antioxidants|mesh-ancestor
92581634|NCT00201955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581635|NCT00201955|Protective Agents|protective agents|mesh-ancestor
92581636|NCT00201955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581637|NCT00201955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581638|NCT00080795|Gemcitabine|gemcitabine|mesh-list
92581639|NCT00080795|Doxorubicin|doxorubicin|mesh-list
92581640|NCT00080795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92581641|NCT00080795|Ifosfamide|ifosfamide|mesh-list
92581642|NCT00080795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581643|NCT00080795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581644|NCT00080795|Antimetabolites|antimetabolites|mesh-ancestor
92581645|NCT00080795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581646|NCT00080795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92581647|NCT00080795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92581648|NCT00080795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581649|NCT00080795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581650|NCT00080795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92581651|NCT00080795|Alkylating Agents|alkylating agents|mesh-ancestor
92581652|NCT00120081|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92581653|NCT00120081|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92581654|NCT00120081|Immunologic Factors|immunologic factors|mesh-ancestor
92581655|NCT00120081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581656|NCT00120081|Antacids|antacids|mesh-ancestor
92581657|NCT00120081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581658|NCT00120081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581659|NCT00201994|Tolvaptan|tolvaptan|mesh-list
92581660|NCT00201994|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92581661|NCT00201994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581662|NCT00201994|Natriuretic Agents|natriuretic agents|mesh-ancestor
92581663|NCT00201994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581664|NCT00120120|Lenalidomide|lenalidomide|mesh-list
92581665|NCT00120120|Immunologic Factors|immunologic factors|mesh-ancestor
92581666|NCT00120120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581667|NCT00120120|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92581679|NCT00202189|Respiratory System Agents|respiratory system agents|mesh-ancestor
92581680|NCT00202189|Glucocorticoids|glucocorticoids|mesh-ancestor
92581681|NCT00202189|Hormones|hormones|mesh-ancestor
92581682|NCT00202189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581683|NCT00202228|Riboflavin|riboflavin|mesh-list
92581684|NCT00202228|Thiamine|thiamine|mesh-list
92581685|NCT00202228|Vitamin B Complex|vitamin b complex|mesh-ancestor
92581686|NCT00202228|Vitamins|vitamins|mesh-ancestor
92535185|NCT00073879|Antimetabolites|antimetabolites|mesh-ancestor
92535186|NCT00073879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581687|NCT00202228|Micronutrients|micronutrients|mesh-ancestor
92581688|NCT00202228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581689|NCT00202228|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92581690|NCT00202228|Dermatologic Agents|dermatologic agents|mesh-ancestor
92581691|NCT00087009|Rituximab|rituximab|mesh-list
92581692|NCT00087009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581693|NCT00087009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581694|NCT00087009|Immunologic Factors|immunologic factors|mesh-ancestor
92581695|NCT00087009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581696|NCT00087009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581697|NCT00306319|Moxifloxacin|moxifloxacin|mesh-list
92581698|NCT00306319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581699|NCT00306319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581700|NCT00306319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92581701|NCT00306319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581702|NCT00306319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581703|NCT00306319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581704|NCT00306319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581705|NCT00306358|Vitamin B 12|vitamin b 12|mesh-list
92581706|NCT00306358|Hydroxocobalamin|hydroxocobalamin|mesh-list
92581707|NCT00306358|Vitamins|vitamins|mesh-ancestor
92581708|NCT00306358|Micronutrients|micronutrients|mesh-ancestor
92581709|NCT00306358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581710|NCT00306358|Vitamin B Complex|vitamin b complex|mesh-ancestor
92581711|NCT00306358|Hematinics|hematinics|mesh-ancestor
92581712|NCT00306397|Sirolimus|sirolimus|mesh-list
92581713|NCT00306397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581714|NCT00306397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581715|NCT00306397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92581716|NCT00306397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581717|NCT00306397|Antifungal Agents|antifungal agents|mesh-ancestor
92581718|NCT00306397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581719|NCT00306397|Immunologic Factors|immunologic factors|mesh-ancestor
92581720|NCT00306397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581721|NCT00418600|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92581722|NCT00418600|Ergocalciferols|ergocalciferols|mesh-list
92581723|NCT00418600|Vitamins|vitamins|mesh-ancestor
92581724|NCT00418600|Micronutrients|micronutrients|mesh-ancestor
92581725|NCT00418600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581726|NCT00418600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92581727|NCT00418600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92581728|NCT00087048|Topotecan|topotecan|mesh-list
92581729|NCT00087048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92581730|NCT00087048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581731|NCT00087048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581732|NCT00087048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988886|NCT03194165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92581739|NCT00080951|Levoleucovorin|levoleucovorin|mesh-list
92581740|NCT00080951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92581741|NCT00080951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581742|NCT00080951|Antimetabolites|antimetabolites|mesh-ancestor
92581743|NCT00080951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581744|NCT00080951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581745|NCT00080951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581746|NCT00080951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581747|NCT00080951|Immunologic Factors|immunologic factors|mesh-ancestor
92581748|NCT00080951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92581749|NCT00080951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581750|NCT00080951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581751|NCT00080951|Antidotes|antidotes|mesh-ancestor
92581752|NCT00080951|Protective Agents|protective agents|mesh-ancestor
92581753|NCT00080951|Vitamin B Complex|vitamin b complex|mesh-ancestor
92581754|NCT00080951|Vitamins|vitamins|mesh-ancestor
92581755|NCT00080951|Micronutrients|micronutrients|mesh-ancestor
92581756|NCT00301600|Mycophenolic Acid|mycophenolic acid|mesh-list
92581757|NCT00301600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92581758|NCT00301600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581759|NCT00301600|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92581760|NCT00301600|Antitubercular Agents|antitubercular agents|mesh-ancestor
92581761|NCT00301600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581762|NCT00301600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581763|NCT00301600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535187|NCT00074074|Infliximab|infliximab|mesh-list
92535188|NCT00074074|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92581764|NCT00301600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581765|NCT00301639|Methylphenidate|methylphenidate|mesh-list
92581766|NCT00301639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92581767|NCT00301639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581768|NCT00301639|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92581769|NCT00301639|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92581770|NCT00301639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92581771|NCT00301639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581772|NCT00301639|Dopamine Agents|dopamine agents|mesh-ancestor
92581773|NCT00301639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581774|NCT00087087|Pemetrexed|pemetrexed|mesh-list
92581775|NCT00087087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581776|NCT00087087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581777|NCT00087087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581778|NCT00087087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92581779|NCT00087087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92581780|NCT00301795|Rituximab|rituximab|mesh-list
92581781|NCT00301795|Oblimersen|oblimersen|mesh-list
92581782|NCT00301795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581783|NCT00301795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581784|NCT00301795|Immunologic Factors|immunologic factors|mesh-ancestor
92581785|NCT00301795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581786|NCT00301795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581787|NCT00080990|Leucovorin|leucovorin|mesh-list
92581788|NCT00080990|Fluorouracil|fluorouracil|mesh-list
92581789|NCT00080990|Oxaliplatin|oxaliplatin|mesh-list
92581790|NCT00080990|Alvocidib|alvocidib|mesh-list
92581791|NCT00080990|Calcium|calcium|mesh-list
92581792|NCT00080990|Levoleucovorin|levoleucovorin|mesh-list
92581793|NCT00080990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92581794|NCT00080990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581795|NCT00080990|Antimetabolites|antimetabolites|mesh-ancestor
92581796|NCT00080990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581797|NCT00080990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581798|NCT00080990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581799|NCT00080990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581800|NCT00080990|Immunologic Factors|immunologic factors|mesh-ancestor
92581801|NCT00080990|Antidotes|antidotes|mesh-ancestor
92581802|NCT00080990|Protective Agents|protective agents|mesh-ancestor
92581803|NCT00080990|Vitamin B Complex|vitamin b complex|mesh-ancestor
92581804|NCT00080990|Vitamins|vitamins|mesh-ancestor
92581809|NCT00080990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581810|NCT00301912|Methotrexate|methotrexate|mesh-list
92581811|NCT00301912|Fludarabine phosphate|fludarabine phosphate|mesh-list
92581812|NCT00301912|Fludarabine|fludarabine|mesh-list
92581813|NCT00301912|Busulfan|busulfan|mesh-list
92581814|NCT00301912|Tacrolimus|tacrolimus|mesh-list
92581815|NCT00301912|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92581816|NCT00301912|Abortifacient Agents|abortifacient agents|mesh-ancestor
92581817|NCT00301912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92581818|NCT00301912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581819|NCT00301912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581820|NCT00301912|Antimetabolites|antimetabolites|mesh-ancestor
92581821|NCT00301912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581822|NCT00301912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581823|NCT00301912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92581824|NCT00301912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581825|NCT00301912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92581826|NCT00301912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581827|NCT00301912|Immunologic Factors|immunologic factors|mesh-ancestor
92581828|NCT00301912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581829|NCT00301912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92581830|NCT00301912|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92581831|NCT00301912|Alkylating Agents|alkylating agents|mesh-ancestor
92581832|NCT00301912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92581833|NCT00301912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92581834|NCT00301951|Mycophenolic Acid|mycophenolic acid|mesh-list
92581835|NCT00301951|Fludarabine|fludarabine|mesh-list
92581836|NCT00301951|Fludarabine phosphate|fludarabine phosphate|mesh-list
92581837|NCT00301951|Busulfan|busulfan|mesh-list
92581838|NCT00301951|Tacrolimus|tacrolimus|mesh-list
92581839|NCT00301951|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92581840|NCT00301951|Sargramostim|sargramostim|mesh-list
92581841|NCT00301951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581842|NCT00301951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581843|NCT00301951|Antimetabolites|antimetabolites|mesh-ancestor
92581844|NCT00301951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581845|NCT00301951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581846|NCT00301951|Immunologic Factors|immunologic factors|mesh-ancestor
92581847|NCT00301951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581848|NCT00301951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92581849|NCT00301951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581850|NCT00301951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92581851|NCT00301951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92581852|NCT00301951|Antitubercular Agents|antitubercular agents|mesh-ancestor
92581853|NCT00301951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581854|NCT00301951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581855|NCT00301951|Alkylating Agents|alkylating agents|mesh-ancestor
92581856|NCT00301951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92581857|NCT00301951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92581858|NCT00301990|Aldesleukin|aldesleukin|mesh-list
92581859|NCT00301990|Bevacizumab|bevacizumab|mesh-list
92581860|NCT00301990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581861|NCT00301990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581862|NCT00301990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92581863|NCT00301990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92581864|NCT00301990|Growth Substances|growth substances|mesh-ancestor
92581865|NCT00301990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581866|NCT00301990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92581867|NCT00301990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92581868|NCT00301990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92581869|NCT00301990|Antiviral Agents|antiviral agents|mesh-ancestor
92581870|NCT00301990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581871|NCT00120198|Rituximab|rituximab|mesh-list
92581872|NCT00120198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581873|NCT00120198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581874|NCT00120198|Immunologic Factors|immunologic factors|mesh-ancestor
92581875|NCT00120198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581876|NCT00120198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581877|NCT00302224|Ketoconazole|ketoconazole|mesh-list
92581899|NCT00087165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581900|NCT00087165|Glucocorticoids|glucocorticoids|mesh-ancestor
92581901|NCT00087165|Hormones|hormones|mesh-ancestor
92581902|NCT00087165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581903|NCT00087165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581904|NCT00087165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92581905|NCT00302341|Trimethoprim|trimethoprim|mesh-list
92581906|NCT00302341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92581907|NCT00302341|Sulfamethoxazole|sulfamethoxazole|mesh-list
92581908|NCT00302341|Pafuramidine|pafuramidine|mesh-list
92581909|NCT00302341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581910|NCT00302341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581911|NCT00302341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92581912|NCT00302341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581913|NCT00302341|Antimalarials|antimalarials|mesh-ancestor
92581914|NCT00302341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92581915|NCT00302341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92581916|NCT00302341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92581917|NCT00302341|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92581918|NCT00302341|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92581919|NCT00302341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92581920|NCT00302341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581921|NCT00302341|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92581922|NCT00302419|Streptokinase|streptokinase|mesh-list
92581923|NCT00302419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92581924|NCT00302419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92581925|NCT00302419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581926|NCT00302497|Basiliximab|basiliximab|mesh-list
91989094|NCT02420509|Antimetabolites|antimetabolites|mesh-ancestor
92581964|NCT00120237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92581965|NCT00120237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581966|NCT00120237|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92581967|NCT00120237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581968|NCT00120237|Oxytocics|oxytocics|mesh-ancestor
92581969|NCT00081302|Paclitaxel|paclitaxel|mesh-list
92581970|NCT00081302|Carboplatin|carboplatin|mesh-list
92581971|NCT00081302|Cetuximab|cetuximab|mesh-list
92581972|NCT00081302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92535190|NCT00074074|Dermatologic Agents|dermatologic agents|mesh-ancestor
92535191|NCT00074074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535192|NCT00074074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581973|NCT00081302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581974|NCT00081302|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581975|NCT00081302|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581976|NCT00081302|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581977|NCT00081302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581978|NCT00081302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581979|NCT00302653|Rasburicase|rasburicase|mesh-list
92581980|NCT00302653|Gout Suppressants|gout suppressants|mesh-ancestor
92581981|NCT00302653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581982|NCT00418288|Glucagon|glucagon|mesh-list
92581983|NCT00418288|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92581984|NCT00418288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92581985|NCT00418288|Hormones|hormones|mesh-ancestor
92581986|NCT00418288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581987|NCT00418288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581988|NCT00418288|Incretins|incretins|mesh-ancestor
92581989|NCT00418327|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92581990|NCT00418327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581991|NCT00418327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92581992|NCT00418327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581993|NCT00418327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581994|NCT00087282|Irinotecan|irinotecan|mesh-list
92581995|NCT00087282|Alvocidib|alvocidib|mesh-list
92581996|NCT00087282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92581997|NCT00087282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92581998|NCT00087282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581999|NCT00087282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582000|NCT00087282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582001|NCT00087282|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582002|NCT00087282|Growth Substances|growth substances|mesh-ancestor
92582003|NCT00087282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582004|NCT00087282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92582005|NCT00418366|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92582006|NCT00418366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92582007|NCT00418366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582008|NCT00418366|Incretins|incretins|mesh-ancestor
92582009|NCT00418366|Hormones|hormones|mesh-ancestor
92582010|NCT00418366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582011|NCT00418366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92582012|NCT00418366|Protease Inhibitors|protease inhibitors|mesh-ancestor
92582013|NCT00418366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582014|NCT00418366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582015|NCT00120315|Esomeprazole|esomeprazole|mesh-list
92582016|NCT00120315|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92582017|NCT00120315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582018|NCT00120315|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92582019|NCT00120315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582020|NCT00120315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582021|NCT00081380|Valproic Acid|valproic acid|mesh-list
92582022|NCT00081380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92582023|NCT00081380|Antipsychotic Agents|antipsychotic agents|mesh-list
92582024|NCT00081380|Antidepressive Agents|antidepressive agents|mesh-ancestor
92582025|NCT00081380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582026|NCT00081380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582027|NCT00081380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582028|NCT00081380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582029|NCT00081380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582030|NCT00081380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582031|NCT00081380|Antimanic Agents|antimanic agents|mesh-ancestor
92582032|NCT00081380|Anticonvulsants|anticonvulsants|mesh-ancestor
92582033|NCT00081380|GABA Agents|gaba agents|mesh-ancestor
92582034|NCT00081380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582036|NCT00418483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92582037|NCT00418483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92582038|NCT00418483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582039|NCT00302692|Metoprolol|metoprolol|mesh-list
92582040|NCT00302692|Esmolol|esmolol|mesh-list
92535193|NCT00392652|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92582041|NCT00302692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92582042|NCT00302692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92582043|NCT00302692|Sympatholytics|sympatholytics|mesh-ancestor
92582044|NCT00302692|Autonomic Agents|autonomic agents|mesh-ancestor
92582045|NCT00302692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582046|NCT00302692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306912|NCT00004551|Nicotine|nicotine|mesh-list
92582047|NCT00302692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92582048|NCT00302692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92582050|NCT00302692|Adrenergic Agents|adrenergic agents|mesh-ancestor
92582051|NCT00302692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582052|NCT00302692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582053|NCT00302770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92582054|NCT00302770|Antidepressive Agents|antidepressive agents|mesh-ancestor
92582055|NCT00302770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582056|NCT00302770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92582057|NCT00302770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582058|NCT00302770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582059|NCT00302770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582060|NCT00081536|Capecitabine|capecitabine|mesh-list
92582061|NCT00081536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582062|NCT00081536|Antimetabolites|antimetabolites|mesh-ancestor
92582063|NCT00081536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582064|NCT00081536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582065|NCT00303004|Bosentan|bosentan|mesh-list
92582066|NCT00303004|Sildenafil Citrate|sildenafil citrate|mesh-list
92582067|NCT00303004|Vasodilator Agents|vasodilator agents|mesh-ancestor
92582068|NCT00303004|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92582069|NCT00303004|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92582070|NCT00303004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582071|NCT00303004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582072|NCT00303004|Urological Agents|urological agents|mesh-ancestor
92582073|NCT00303004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92582074|NCT00303004|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92582075|NCT00081575|Levofloxacin|levofloxacin|mesh-list
92582076|NCT00081575|Tigecycline|tigecycline|mesh-list
92582077|NCT00081575|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92582078|NCT00081575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582079|NCT00081575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582080|NCT00081575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92582081|NCT00081575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92582082|NCT00081575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582083|NCT00081575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582084|NCT00081575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582085|NCT00081575|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92582086|NCT00081575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92359758|NCT00321594|Belinostat|belinostat|mesh-list
92582087|NCT00081575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92582088|NCT00087399|Gabapentin|gabapentin|mesh-list
92582089|NCT00087399|Antidepressive Agents|antidepressive agents|mesh-list
92582090|NCT00087399|Analgesics|analgesics|mesh-ancestor
92582091|NCT00087399|Sensory System Agents|sensory system agents|mesh-ancestor
92582092|NCT00087399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582093|NCT00087399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582094|NCT00087399|Anticonvulsants|anticonvulsants|mesh-ancestor
92582095|NCT00087399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92582096|NCT00087399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582097|NCT00087399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582098|NCT00087399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582099|NCT00087399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92582100|NCT00087399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92582101|NCT00087399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582102|NCT00087399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582103|NCT00087399|Antimanic Agents|antimanic agents|mesh-ancestor
92582104|NCT00081614|Bevacizumab|bevacizumab|mesh-list
92582105|NCT00081614|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92582106|NCT00081614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92582107|NCT00081614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582110|NCT00081614|Growth Substances|growth substances|mesh-ancestor
92582111|NCT00081614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582112|NCT00081614|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582113|NCT00081614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929141|NCT02287129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582114|NCT00081614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582115|NCT00081614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582116|NCT00303277|Simvastatin|simvastatin|mesh-list
92582117|NCT00303277|Pravastatin|pravastatin|mesh-list
92582118|NCT00303277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92582119|NCT00303277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92582120|NCT00303277|Antimetabolites|antimetabolites|mesh-ancestor
92582121|NCT00303277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582122|NCT00303277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92582123|NCT00303277|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92582124|NCT00303277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582125|NCT00303394|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92582126|NCT00303394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92582128|NCT00303433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92582129|NCT00303433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92582130|NCT00303433|Dopamine Agents|dopamine agents|mesh-ancestor
92582131|NCT00303433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582132|NCT00303433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582133|NCT00303433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582134|NCT00303433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92582135|NCT00303433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92582136|NCT00303550|Linezolid|linezolid|mesh-list
92582137|NCT00303550|Iclaprim|iclaprim|mesh-list
92582138|NCT00303550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582139|NCT00303550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582140|NCT00303550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92582141|NCT00303550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582142|NCT00303550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582143|NCT00303550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92582144|NCT00120354|Lamivudine|lamivudine|mesh-list
92582145|NCT00120354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92582146|NCT00120354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582147|NCT00120354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582148|NCT00120354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582149|NCT00120354|Antiviral Agents|antiviral agents|mesh-ancestor
92582150|NCT00120354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582151|NCT00120354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582152|NCT00120354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582153|NCT00399698|Risperidone|risperidone|mesh-list
92582154|NCT00399698|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92582155|NCT00399698|Serotonin Agents|serotonin agents|mesh-ancestor
92582156|NCT00399698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582157|NCT00399698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582158|NCT00399698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582159|NCT00399698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92582160|NCT00399698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582161|NCT00399698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582162|NCT00399698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582163|NCT00399698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92582164|NCT00399698|Dopamine Agents|dopamine agents|mesh-ancestor
92582165|NCT00303589|Lactams|lactams|mesh-list
92582166|NCT00303589|beta-Lactams|beta-lactams|mesh-list
92582167|NCT00303589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582168|NCT00303589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582169|NCT00081848|Metronidazole|metronidazole|mesh-list
92582170|NCT00081848|Celecoxib|celecoxib|mesh-list
92582171|NCT00081848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92582172|NCT00081848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92582173|NCT00081848|Analgesics|analgesics|mesh-ancestor
92582174|NCT00081848|Sensory System Agents|sensory system agents|mesh-ancestor
92582175|NCT00081848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582176|NCT00081848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582177|NCT00081848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582178|NCT00081848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92582179|NCT00081848|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92582182|NCT00081848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582183|NCT00081848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582184|NCT00081848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582185|NCT00081848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92582186|NCT00081848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92582187|NCT00120432|Phenylephrine|phenylephrine|mesh-list
92582188|NCT00120432|Oxymetazoline|oxymetazoline|mesh-list
92582189|NCT00120432|Tropicamide|tropicamide|mesh-list
92535194|NCT00392652|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92535195|NCT00392652|Protective Agents|protective agents|mesh-ancestor
92582190|NCT00120432|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92582192|NCT00120432|Autonomic Agents|autonomic agents|mesh-ancestor
92582193|NCT00120432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582194|NCT00120432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582195|NCT00120432|Sympathomimetics|sympathomimetics|mesh-ancestor
92582196|NCT00120432|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92582197|NCT00120432|Nasal Decongestants|nasal decongestants|mesh-ancestor
92582198|NCT00120432|Respiratory System Agents|respiratory system agents|mesh-ancestor
92582199|NCT00120432|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92582200|NCT00120432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92582201|NCT00120432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92582202|NCT00120432|Adrenergic Agents|adrenergic agents|mesh-ancestor
92582203|NCT00120432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582204|NCT00120432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582205|NCT00120432|Protective Agents|protective agents|mesh-ancestor
92582206|NCT00120432|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92582207|NCT00120432|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92582208|NCT00120432|Cholinergic Agents|cholinergic agents|mesh-ancestor
92582209|NCT00303745|Capecitabine|capecitabine|mesh-list
92582211|NCT00303745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582212|NCT00303745|Antimetabolites|antimetabolites|mesh-ancestor
92582213|NCT00303745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582214|NCT00303745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582215|NCT00303745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92582216|NCT00303745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92582217|NCT00303745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582218|NCT00303784|Goserelin|goserelin|mesh-list
92582219|NCT00303784|Estradiol|estradiol|mesh-list
92582220|NCT00303784|Estrogens|estrogens|mesh-ancestor
92582221|NCT00303784|Hormones|hormones|mesh-ancestor
92582222|NCT00303784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582223|NCT00303784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582224|NCT00303784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582225|NCT00303784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582226|NCT00081887|Clofarabine|clofarabine|mesh-list
92582227|NCT00081887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582228|NCT00081887|Antimetabolites|antimetabolites|mesh-ancestor
92582229|NCT00081887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582230|NCT00081887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582231|NCT00303940|Carboplatin|carboplatin|mesh-list
92582232|NCT00303940|Temozolomide|temozolomide|mesh-list
92582233|NCT00303940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582234|NCT00303940|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92582235|NCT00303940|Alkylating Agents|alkylating agents|mesh-ancestor
92582236|NCT00303940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582237|NCT00304018|Prednisone|prednisone|mesh-list
92582238|NCT00304018|Fludarabine|fludarabine|mesh-list
92582239|NCT00304018|Fludarabine phosphate|fludarabine phosphate|mesh-list
92582240|NCT00304018|Etoposide|etoposide|mesh-list
92582241|NCT00304018|Busulfan|busulfan|mesh-list
92582242|NCT00304018|Tacrolimus|tacrolimus|mesh-list
92582243|NCT00304018|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92582244|NCT00304018|Sargramostim|sargramostim|mesh-list
92582245|NCT00304018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582246|NCT00304018|Glucocorticoids|glucocorticoids|mesh-ancestor
92582247|NCT00304018|Hormones|hormones|mesh-ancestor
92582248|NCT00304018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582249|NCT00304018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582250|NCT00304018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582251|NCT00304018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582252|NCT00304018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582253|NCT00304018|Antimetabolites|antimetabolites|mesh-ancestor
92582254|NCT00304018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582256|NCT00304018|Immunologic Factors|immunologic factors|mesh-ancestor
92582257|NCT00304018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92582258|NCT00304018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92582259|NCT00304018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92582260|NCT00304018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582261|NCT00304018|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92582262|NCT00304018|Alkylating Agents|alkylating agents|mesh-ancestor
92620232|NCT00171093|Valsartan|valsartan|mesh-list
92535196|NCT00392652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535197|NCT00392652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582263|NCT00304018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92582264|NCT00304018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92582265|NCT00081926|Imatinib Mesylate|imatinib mesylate|mesh-list
92582266|NCT00081926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582267|NCT00081926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92582268|NCT00081926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582269|NCT00081926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582270|NCT00304135|Gemcitabine|gemcitabine|mesh-list
92582271|NCT00304135|Oxaliplatin|oxaliplatin|mesh-list
92582272|NCT00304135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582273|NCT00304135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582274|NCT00304135|Antimetabolites|antimetabolites|mesh-ancestor
92582275|NCT00304135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582276|NCT00304213|Testosterone|testosterone|mesh-list
92582277|NCT00304213|Androgens|androgens|mesh-ancestor
92582278|NCT00304213|Hormones|hormones|mesh-ancestor
92582279|NCT00304213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582280|NCT00304213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582281|NCT00304252|Interferons|interferons|mesh-list
92582282|NCT00304252|Interferon-beta|interferon-beta|mesh-list
92582283|NCT00304252|Interferon beta-1a|interferon beta-1a|mesh-list
92582284|NCT00304252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582285|NCT00304252|Antiviral Agents|antiviral agents|mesh-ancestor
92582286|NCT00304252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582287|NCT00304252|Immunologic Factors|immunologic factors|mesh-ancestor
92359778|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
92582288|NCT00304252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582289|NCT00304252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92582290|NCT00120471|Tenofovir|tenofovir|mesh-list
92582291|NCT00120471|Antiviral Agents|antiviral agents|mesh-ancestor
92582292|NCT00120471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582293|NCT00120471|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92582294|NCT00120471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582295|NCT00120471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582296|NCT00120471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582297|NCT00120471|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582298|NCT00120471|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582299|NCT00082043|Dutasteride|dutasteride|mesh-list
92582300|NCT00082043|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92582301|NCT00082043|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92582302|NCT00082043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582303|NCT00082043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582304|NCT00082043|Hormone Antagonists|hormone antagonists|mesh-ancestor
92582305|NCT00082043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582306|NCT00082043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582307|NCT00304291|Mitoxantrone|mitoxantrone|mesh-list
92582308|NCT00304291|Analgesics|analgesics|mesh-ancestor
92582309|NCT00304291|Sensory System Agents|sensory system agents|mesh-ancestor
92582310|NCT00304291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582311|NCT00304291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582312|NCT00304291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582313|NCT00304291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92582314|NCT00304291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92582315|NCT00304291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582316|NCT00304291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582317|NCT00304369|Metronidazole|metronidazole|mesh-list
92582318|NCT00304369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582319|NCT00304369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582320|NCT00304369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92582321|NCT00304369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92582322|NCT00082082|Thymalfasin|thymalfasin|mesh-list
92582323|NCT00082082|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92582324|NCT00082082|Immunologic Factors|immunologic factors|mesh-ancestor
92582325|NCT00082082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582326|NCT00304447|Gemtuzumab|gemtuzumab|mesh-list
92582331|NCT00304447|Immunologic Factors|immunologic factors|mesh-ancestor
92582332|NCT00304447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582333|NCT00087711|Gemcitabine|gemcitabine|mesh-list
92582334|NCT00087711|Pemetrexed|pemetrexed|mesh-list
92582335|NCT00087711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535198|NCT00074191|Cytarabine|cytarabine|mesh-list
92535199|NCT00074191|Dexamethasone|dexamethasone|mesh-list
92535200|NCT00074191|Methotrexate|methotrexate|mesh-list
92535201|NCT00074191|Lomustine|lomustine|mesh-list
92535202|NCT00074191|Procarbazine|procarbazine|mesh-list
92582336|NCT00087711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582337|NCT00087711|Antimetabolites|antimetabolites|mesh-ancestor
92582338|NCT00087711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582339|NCT00087711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582340|NCT00087711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92582341|NCT00087711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582342|NCT00304642|Dapivirine|dapivirine|mesh-list
92582343|NCT00304642|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582344|NCT00304642|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582345|NCT00304642|Antiviral Agents|antiviral agents|mesh-ancestor
92582346|NCT00304642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582347|NCT00304681|Methylphenidate|methylphenidate|mesh-list
92582348|NCT00304681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92582349|NCT00304681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582350|NCT00304681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92582351|NCT00304681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92582352|NCT00304681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92582353|NCT00304681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582354|NCT00304681|Dopamine Agents|dopamine agents|mesh-ancestor
92582355|NCT00304681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582356|NCT00304720|Tacrolimus|tacrolimus|mesh-list
92582357|NCT00304720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582358|NCT00304720|Immunologic Factors|immunologic factors|mesh-ancestor
92582359|NCT00304720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582360|NCT00304720|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92582361|NCT00304720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582362|NCT00304720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582363|NCT00082199|Aripiprazole|aripiprazole|mesh-list
92582364|NCT00082199|Antidepressive Agents|antidepressive agents|mesh-ancestor
92582365|NCT00082199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582366|NCT00082199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92582367|NCT00082199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582368|NCT00082199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582369|NCT00082199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582370|NCT00082199|Dopamine Agonists|dopamine agonists|mesh-ancestor
92582371|NCT00082199|Dopamine Agents|dopamine agents|mesh-ancestor
92582372|NCT00082199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582373|NCT00082199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582374|NCT00082199|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92582375|NCT00082199|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92582376|NCT00082199|Serotonin Agents|serotonin agents|mesh-ancestor
92582377|NCT00082199|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92582378|NCT00082199|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92582379|NCT00082199|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92582380|NCT00082199|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92582381|NCT00120510|Lamivudine|lamivudine|mesh-list
92582382|NCT00120510|Zidovudine|zidovudine|mesh-list
92582383|NCT00120510|Efavirenz|efavirenz|mesh-list
92582384|NCT00120510|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92582385|NCT00120510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92582386|NCT00120510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582387|NCT00120510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582388|NCT00120510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582389|NCT00120510|Antiviral Agents|antiviral agents|mesh-ancestor
92582390|NCT00120510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582391|NCT00120510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582392|NCT00120510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582393|NCT00120510|Antimetabolites|antimetabolites|mesh-ancestor
92582394|NCT00120510|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92582395|NCT00120510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92582396|NCT00120510|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92582400|NCT00087750|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92582401|NCT00087750|Antidepressive Agents|antidepressive agents|mesh-ancestor
92582402|NCT00087750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582403|NCT00087750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92582404|NCT00087750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92535203|NCT00074191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535205|NCT00074191|Autonomic Agents|autonomic agents|mesh-ancestor
92535206|NCT00074191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535207|NCT00074191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582405|NCT00087750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582406|NCT00087750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582408|NCT00304993|Rosiglitazone|rosiglitazone|mesh-list
92582409|NCT00304993|Fenofibrate|fenofibrate|mesh-list
92582410|NCT00304993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92582411|NCT00304993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582412|NCT00304993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92582413|NCT00304993|Antimetabolites|antimetabolites|mesh-ancestor
92582414|NCT00304993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582415|NCT00304993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92582416|NCT00304993|Vasodilator Agents|vasodilator agents|mesh-ancestor
92582417|NCT00304993|Vitamin B Complex|vitamin b complex|mesh-ancestor
92582418|NCT00304993|Vitamins|vitamins|mesh-ancestor
92582419|NCT00304993|Micronutrients|micronutrients|mesh-ancestor
92582420|NCT00082277|Risedronic Acid|risedronic acid|mesh-list
92582422|NCT00082277|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582423|NCT00082277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582424|NCT00082277|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92582425|NCT00082277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92582426|NCT00082277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582427|NCT00082277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582428|NCT00082277|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92582429|NCT00082277|Hormone Antagonists|hormone antagonists|mesh-ancestor
92582430|NCT00082277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582431|NCT00082277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582432|NCT00082277|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92582433|NCT00082277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92582434|NCT00082277|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92582435|NCT00082277|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92582436|NCT00305266|gamma-Globulins|gamma-globulins|mesh-list
92582437|NCT00305266|Immunologic Factors|immunologic factors|mesh-ancestor
92582438|NCT00305266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582439|NCT00082316|Capsaicin|capsaicin|mesh-list
92582440|NCT00082316|Antipruritics|antipruritics|mesh-ancestor
92582441|NCT00082316|Dermatologic Agents|dermatologic agents|mesh-ancestor
92582442|NCT00082316|Sensory System Agents|sensory system agents|mesh-ancestor
92582443|NCT00082316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582444|NCT00082316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582445|NCT00305383|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92582446|NCT00305383|Taribavirin|taribavirin|mesh-list
92582447|NCT00305383|Antiviral Agents|antiviral agents|mesh-ancestor
92582448|NCT00305383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582449|NCT00305422|Risperidone|risperidone|mesh-list
92582450|NCT00305422|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92582451|NCT00305422|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92582452|NCT00305422|Serotonin Agents|serotonin agents|mesh-ancestor
92582453|NCT00305422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582454|NCT00305422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582455|NCT00305422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582456|NCT00305422|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92582457|NCT00305422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582458|NCT00305422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582459|NCT00305422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582460|NCT00305422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92582461|NCT00305422|Dopamine Agents|dopamine agents|mesh-ancestor
92582462|NCT00305422|Antidepressive Agents|antidepressive agents|mesh-ancestor
92582463|NCT00305461|Ciclesonide|ciclesonide|mesh-list
92582464|NCT00305461|Glucocorticoids|glucocorticoids|mesh-ancestor
92582465|NCT00305461|Hormones|hormones|mesh-ancestor
92582466|NCT00305461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582467|NCT00305461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582468|NCT00305461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92582490|NCT00305539|Adalimumab|adalimumab|mesh-list
92582491|NCT00305539|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92582492|NCT00305539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582493|NCT00305539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92582494|NCT00305617|Antineoplastic Agents|antineoplastic agents|mesh-list
92582495|NCT00305734|Gemcitabine|gemcitabine|mesh-list
92582496|NCT00305734|Bortezomib|bortezomib|mesh-list
92582497|NCT00305734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582498|NCT00305734|Antimetabolites|antimetabolites|mesh-ancestor
92582499|NCT00305734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582500|NCT00305734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582501|NCT00082472|Docetaxel|docetaxel|mesh-list
92582502|NCT00082472|Doxorubicin|doxorubicin|mesh-list
92582503|NCT00082472|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92582504|NCT00082472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582505|NCT00082472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92582506|NCT00082472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92582507|NCT00082472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92582508|NCT00082472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582509|NCT00082472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92582510|NCT00082472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92582511|NCT00082472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92582512|NCT00082472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582513|NCT00087867|Bortezomib|bortezomib|mesh-list
92582514|NCT00087867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582515|NCT00305812|Dexamethasone|dexamethasone|mesh-list
92582516|NCT00305812|Lenalidomide|lenalidomide|mesh-list
92582517|NCT00305812|Melphalan|melphalan|mesh-list
92582518|NCT00305812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582519|NCT00305812|Antiemetics|antiemetics|mesh-ancestor
92582520|NCT00305812|Autonomic Agents|autonomic agents|mesh-ancestor
92582525|NCT00305812|Hormones|hormones|mesh-ancestor
92582526|NCT00305812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582527|NCT00305812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582528|NCT00305812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582529|NCT00305812|Immunologic Factors|immunologic factors|mesh-ancestor
92582530|NCT00305812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92582531|NCT00305812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92582532|NCT00305812|Growth Substances|growth substances|mesh-ancestor
92582533|NCT00305812|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582534|NCT00305812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92582535|NCT00305812|Alkylating Agents|alkylating agents|mesh-ancestor
92582536|NCT00305812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582537|NCT00305812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92582538|NCT00305812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582539|NCT00082511|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92582540|NCT00082511|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92582541|NCT00082511|Immunologic Factors|immunologic factors|mesh-ancestor
92582542|NCT00082511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582543|NCT00306046|Diphosphonates|diphosphonates|mesh-list
92582544|NCT00306046|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92582545|NCT00306046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582546|NCT00306124|Levodopa|levodopa|mesh-list
92582547|NCT00306124|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92582548|NCT00306124|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92582549|NCT00306124|Dopamine Agents|dopamine agents|mesh-ancestor
92582550|NCT00306124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582551|NCT00306124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582552|NCT00306124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582553|NCT00082589|Eplerenone|eplerenone|mesh-list
92582554|NCT00082589|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92582555|NCT00082589|Hormone Antagonists|hormone antagonists|mesh-ancestor
92582556|NCT00082589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582557|NCT00082589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582558|NCT00082589|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92582559|NCT00082589|Diuretics|diuretics|mesh-ancestor
92582560|NCT00082589|Natriuretic Agents|natriuretic agents|mesh-ancestor
92582561|NCT00082589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92582562|NCT00313924|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92582563|NCT00313924|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92582564|NCT00313924|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92582565|NCT00313924|Cholinergic Agents|cholinergic agents|mesh-ancestor
92582566|NCT00313924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582567|NCT00313924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582568|NCT00313924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582569|NCT00313924|Urological Agents|urological agents|mesh-ancestor
92582570|NCT00306475|Valproic Acid|valproic acid|mesh-list
92582571|NCT00306475|Anticonvulsants|anticonvulsants|mesh-ancestor
92582572|NCT00306475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582573|NCT00306475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929575|NCT00355849|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92582574|NCT00306475|GABA Agents|gaba agents|mesh-ancestor
92582575|NCT00306475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582576|NCT00306475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582577|NCT00306475|Antimanic Agents|antimanic agents|mesh-ancestor
92582578|NCT00306475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582579|NCT00306475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582580|NCT00306475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582581|NCT00082667|Gefitinib|gefitinib|mesh-list
92582582|NCT00082667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582583|NCT00082667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92582584|NCT00082667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582585|NCT00082667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582586|NCT00306748|Linaclotide|linaclotide|mesh-list
92582587|NCT00306748|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92582588|NCT00306748|Enzyme Activators|enzyme activators|mesh-ancestor
92582589|NCT00306748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582604|NCT00306826|Antimetabolites|antimetabolites|mesh-ancestor
92582605|NCT00306826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582606|NCT00306826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92582607|NCT00306826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92582608|NCT00306826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582609|NCT00306826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92582610|NCT00306826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582611|NCT00082823|Aflibercept|aflibercept|mesh-list
92582612|NCT00082823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92582613|NCT00082823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92582614|NCT00082823|Growth Substances|growth substances|mesh-ancestor
92582615|NCT00082823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582616|NCT00082823|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582617|NCT00082823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582618|NCT00087945|Lamivudine|lamivudine|mesh-list
92582619|NCT00087945|Zidovudine|zidovudine|mesh-list
92582620|NCT00087945|Abacavir|abacavir|mesh-list
92582621|NCT00087945|Dideoxynucleosides|dideoxynucleosides|mesh-list
92582622|NCT00087945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92582623|NCT00087945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582624|NCT00087945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582625|NCT00087945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582626|NCT00087945|Antiviral Agents|antiviral agents|mesh-ancestor
92582627|NCT00087945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582628|NCT00087945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582629|NCT00087945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582630|NCT00087945|Antimetabolites|antimetabolites|mesh-ancestor
92582631|NCT00082862|Interferons|interferons|mesh-list
92582632|NCT00082862|Interferon-alpha|interferon-alpha|mesh-list
92582633|NCT00082862|Gemcitabine|gemcitabine|mesh-list
92582634|NCT00082862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582635|NCT00082862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582636|NCT00082862|Antimetabolites|antimetabolites|mesh-ancestor
92582637|NCT00082862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582638|NCT00082862|Antiviral Agents|antiviral agents|mesh-ancestor
92582639|NCT00082862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582640|NCT00082862|Immunologic Factors|immunologic factors|mesh-ancestor
92582641|NCT00082862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582642|NCT00307099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92582643|NCT00307099|Meropenem|meropenem|mesh-list
92582644|NCT00307099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582646|NCT00082940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582647|NCT00307138|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92582648|NCT00307138|Plasma Substitutes|plasma substitutes|mesh-ancestor
92582649|NCT00307138|Blood Substitutes|blood substitutes|mesh-ancestor
92582650|NCT00307177|Vaccines|vaccines|mesh-list
92582651|NCT00307177|Immunologic Factors|immunologic factors|mesh-ancestor
92582652|NCT00307177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582653|NCT00120705|Darbepoetin alfa|darbepoetin alfa|mesh-list
92582658|NCT00307255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92582659|NCT00307255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582660|NCT00307255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92582661|NCT00307255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92582662|NCT00307255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92582663|NCT00307255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582664|NCT00307255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582665|NCT00307255|Antimetabolites|antimetabolites|mesh-ancestor
92582666|NCT00307411|Hormones|hormones|mesh-list
91929652|NCT00099853|Pioglitazone|pioglitazone|mesh-list
92582667|NCT00307411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582668|NCT00307411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582669|NCT00307450|Levetiracetam|levetiracetam|mesh-list
92582670|NCT00307450|Anticonvulsants|anticonvulsants|mesh-ancestor
92582671|NCT00307450|Nootropic Agents|nootropic agents|mesh-ancestor
92582672|NCT00307528|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92582673|NCT00307528|Immunologic Factors|immunologic factors|mesh-ancestor
92582674|NCT00307528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582675|NCT00120744|Ondansetron|ondansetron|mesh-list
92582676|NCT00120744|Antiemetics|antiemetics|mesh-ancestor
92582677|NCT00120744|Autonomic Agents|autonomic agents|mesh-ancestor
92582678|NCT00120744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582679|NCT00120744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582680|NCT00120744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582681|NCT00120744|Antipruritics|antipruritics|mesh-ancestor
92582682|NCT00120744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92582683|NCT00120744|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92582684|NCT00120744|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92582685|NCT00120744|Serotonin Agents|serotonin agents|mesh-ancestor
92582686|NCT00120744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582687|NCT00120744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582688|NCT00083057|Paclitaxel|paclitaxel|mesh-list
92582689|NCT00083057|Gefitinib|gefitinib|mesh-list
92582690|NCT00083057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92582691|NCT00083057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582692|NCT00083057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92582693|NCT00083057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92582694|NCT00083057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92582695|NCT00083057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582696|NCT00083057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92582697|NCT00083057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582698|NCT00307606|Methylprednisolone|methylprednisolone|mesh-list
92582699|NCT00307606|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92582700|NCT00307606|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92582701|NCT00307606|Prednisolone|prednisolone|mesh-list
92582702|NCT00307606|Prednisolone acetate|prednisolone acetate|mesh-list
92582703|NCT00307606|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92582704|NCT00307606|Prednisolone phosphate|prednisolone phosphate|mesh-list
92582705|NCT00307606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582706|NCT00307606|Antiemetics|antiemetics|mesh-ancestor
92582707|NCT00307606|Autonomic Agents|autonomic agents|mesh-ancestor
92582708|NCT00307606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582709|NCT00307606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582710|NCT00307606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582711|NCT00307606|Glucocorticoids|glucocorticoids|mesh-ancestor
92582712|NCT00307606|Hormones|hormones|mesh-ancestor
92582713|NCT00307606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582714|NCT00307606|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92582715|NCT00307606|Protective Agents|protective agents|mesh-ancestor
92582716|NCT00307606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582717|NCT00307606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582718|NCT00083096|Temozolomide|temozolomide|mesh-list
92582719|NCT00083096|Lonafarnib|lonafarnib|mesh-list
92582720|NCT00083096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92582721|NCT00083096|Alkylating Agents|alkylating agents|mesh-ancestor
92582722|NCT00083096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582723|NCT00083096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582724|NCT00083096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582725|NCT00307645|Mycophenolic Acid|mycophenolic acid|mesh-list
92582726|NCT00307645|Prednisone|prednisone|mesh-list
92582731|NCT00307645|Immunologic Factors|immunologic factors|mesh-ancestor
92582732|NCT00307645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582733|NCT00307645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92582734|NCT00307645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92582735|NCT00307645|Alkylating Agents|alkylating agents|mesh-ancestor
92582736|NCT00307645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582737|NCT00307645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582738|NCT00307645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92582739|NCT00307645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582740|NCT00307645|Glucocorticoids|glucocorticoids|mesh-ancestor
92582741|NCT00307645|Hormones|hormones|mesh-ancestor
92582742|NCT00307645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582743|NCT00307645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582744|NCT00307645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92582745|NCT00307645|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92582746|NCT00307645|Antitubercular Agents|antitubercular agents|mesh-ancestor
92582747|NCT00307645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582748|NCT00307645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582749|NCT00307645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582750|NCT00307645|Antiemetics|antiemetics|mesh-ancestor
92582751|NCT00307645|Autonomic Agents|autonomic agents|mesh-ancestor
92582752|NCT00307645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582753|NCT00307645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582754|NCT00307645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92582755|NCT00307645|Protective Agents|protective agents|mesh-ancestor
92582756|NCT00307645|Antimetabolites|antimetabolites|mesh-ancestor
92582757|NCT00307645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582758|NCT00120783|Ritonavir|ritonavir|mesh-list
92582759|NCT00120783|Indinavir|indinavir|mesh-list
92582760|NCT00120783|Lamivudine|lamivudine|mesh-list
92582761|NCT00120783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92582762|NCT00120783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92582763|NCT00120783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92582764|NCT00120783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582765|NCT00120783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582766|NCT00120783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582767|NCT00120783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582768|NCT00120783|Antiviral Agents|antiviral agents|mesh-ancestor
92582769|NCT00120783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582770|NCT00120783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92582771|NCT00120783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92582772|NCT00120783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92582773|NCT00120783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582774|NCT00307723|Bevacizumab|bevacizumab|mesh-list
92582775|NCT00307723|Gemcitabine|gemcitabine|mesh-list
92582776|NCT00307723|Fluorouracil|fluorouracil|mesh-list
92582777|NCT00307723|Oxaliplatin|oxaliplatin|mesh-list
92582778|NCT00307723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92582779|NCT00307723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582780|NCT00307723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92582781|NCT00307723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92582782|NCT00307723|Growth Substances|growth substances|mesh-ancestor
92582783|NCT00307723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582784|NCT00307723|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582785|NCT00307723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582786|NCT00307723|Antimetabolites|antimetabolites|mesh-ancestor
92582787|NCT00307723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582788|NCT00307723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582789|NCT00307723|Immunologic Factors|immunologic factors|mesh-ancestor
92582790|NCT00083135|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92582791|NCT00083135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582792|NCT00083135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582793|NCT00083135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582794|NCT00083135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92582796|NCT00120822|Hematinics|hematinics|mesh-ancestor
92582797|NCT00120822|Vitamin B Complex|vitamin b complex|mesh-ancestor
92582798|NCT00120822|Vitamins|vitamins|mesh-ancestor
92582799|NCT00120822|Micronutrients|micronutrients|mesh-ancestor
92582803|NCT00083213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92582804|NCT00083213|Growth Substances|growth substances|mesh-ancestor
92582805|NCT00083213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582806|NCT00083213|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582807|NCT00083213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582808|NCT00307996|Ubiquinone|ubiquinone|mesh-list
92582809|NCT00307996|Coenzyme Q10|coenzyme q10|mesh-list
92582810|NCT00307996|Micronutrients|micronutrients|mesh-ancestor
92582811|NCT00307996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582812|NCT00307996|Vitamins|vitamins|mesh-ancestor
92582813|NCT00083252|Cisplatin|cisplatin|mesh-list
92582814|NCT00083252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582815|NCT00418639|Nitazoxanide|nitazoxanide|mesh-list
92582816|NCT00418639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92582817|NCT00418639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582818|NCT00418678|Nabilone|nabilone|mesh-list
92582819|NCT00418678|Antiemetics|antiemetics|mesh-ancestor
92582820|NCT00418678|Autonomic Agents|autonomic agents|mesh-ancestor
92582821|NCT00418678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582822|NCT00418678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582823|NCT00418678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535209|NCT00074191|Glucocorticoids|glucocorticoids|mesh-ancestor
92535210|NCT00074191|Hormones|hormones|mesh-ancestor
91929799|NCT02192723|Ziprasidone|ziprasidone|mesh-list
92582824|NCT00418678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92582825|NCT00418678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92582826|NCT00418678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92582827|NCT00418678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582828|NCT00120861|Interferons|interferons|mesh-list
92582829|NCT00120861|Ribavirin|ribavirin|mesh-list
92582830|NCT00120861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582831|NCT00120861|Antiviral Agents|antiviral agents|mesh-ancestor
92582832|NCT00120861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582833|NCT00120861|Antimetabolites|antimetabolites|mesh-ancestor
92582834|NCT00120861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582835|NCT05446142|Rabeprazole|rabeprazole|mesh-list
92582836|NCT05446142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92582837|NCT05446142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582838|NCT05446142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92582839|NCT05446142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582840|NCT05446142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582841|NCT00308191|Bromides|bromides|mesh-list
92582842|NCT00308191|Formoterol Fumarate|formoterol fumarate|mesh-list
92582843|NCT00308191|Tiotropium Bromide|tiotropium bromide|mesh-list
92582844|NCT00308191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92582845|NCT00308191|Autonomic Agents|autonomic agents|mesh-ancestor
92582846|NCT00308191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582847|NCT00308191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582848|NCT00308191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92582849|NCT00308191|Respiratory System Agents|respiratory system agents|mesh-ancestor
92582850|NCT00308191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92582851|NCT00308191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92582852|NCT00308191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92582853|NCT00308191|Adrenergic Agents|adrenergic agents|mesh-ancestor
92582854|NCT00308191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582855|NCT00308191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582856|NCT00308191|Parasympatholytics|parasympatholytics|mesh-ancestor
92582857|NCT00308191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92582858|NCT00308191|Cholinergic Agents|cholinergic agents|mesh-ancestor
92582859|NCT00308191|Anticonvulsants|anticonvulsants|mesh-ancestor
92582860|NCT00308269|Folic Acid|folic acid|mesh-list
92582861|NCT00308269|Vinca Alkaloids|vinca alkaloids|mesh-list
92582862|NCT00308269|Hematinics|hematinics|mesh-ancestor
92582863|NCT00308269|Vitamin B Complex|vitamin b complex|mesh-ancestor
92582864|NCT00308269|Vitamins|vitamins|mesh-ancestor
92582865|NCT00308269|Micronutrients|micronutrients|mesh-ancestor
92582866|NCT00308269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582867|NCT00308269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582868|NCT00308269|Tubulin Modulators|tubulin modulators|mesh-ancestor
92582869|NCT00308269|Antimitotic Agents|antimitotic agents|mesh-ancestor
92582870|NCT00308269|Mitosis Modulators|mitosis modulators|mesh-ancestor
92582871|NCT00308269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582872|NCT00308425|Mycophenolic Acid|mycophenolic acid|mesh-list
92582873|NCT00308425|Valsartan|valsartan|mesh-list
92582874|NCT00308425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91990020|NCT02416765|Hormones|hormones|mesh-ancestor
92582878|NCT00308425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582879|NCT00308425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582880|NCT00308425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582881|NCT00308425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582882|NCT00308425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92582883|NCT00308425|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92582884|NCT00308425|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92582886|NCT00308503|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92582887|NCT00308503|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92582888|NCT00308503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582889|NCT00308503|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92582890|NCT00308503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92582891|NCT00308503|Serotonin Agents|serotonin agents|mesh-ancestor
92582892|NCT00308503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582893|NCT00308503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582894|NCT00308542|Dexamethasone|dexamethasone|mesh-list
92582895|NCT00308542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582896|NCT00308542|Antiemetics|antiemetics|mesh-ancestor
92582897|NCT00308542|Autonomic Agents|autonomic agents|mesh-ancestor
92620233|NCT00171093|Simvastatin|simvastatin|mesh-list
92535211|NCT00074191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535212|NCT00074191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582898|NCT00308542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582899|NCT00308542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582900|NCT00308542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582901|NCT00308542|Glucocorticoids|glucocorticoids|mesh-ancestor
92582902|NCT00308542|Hormones|hormones|mesh-ancestor
92582903|NCT00308542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582904|NCT00308542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92582905|NCT00308542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582906|NCT00308776|Cholecystokinin|cholecystokinin|mesh-list
92582907|NCT00308776|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92582908|NCT00308776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582909|NCT00083408|Pamidronate|pamidronate|mesh-list
92582910|NCT00083408|Thalidomide|thalidomide|mesh-list
92582911|NCT00083408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582912|NCT00083408|Immunologic Factors|immunologic factors|mesh-ancestor
92582913|NCT00083408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582914|NCT00083408|Leprostatic Agents|leprostatic agents|mesh-ancestor
92582915|NCT00083408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92582916|NCT00083408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582917|NCT00083408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92582918|NCT00083408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92582919|NCT00083408|Growth Substances|growth substances|mesh-ancestor
92582920|NCT00083408|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582921|NCT00083408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582922|NCT00083408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92582923|NCT00308971|Vitamin E|vitamin e|mesh-list
92582924|NCT00308971|Tocopherols|tocopherols|mesh-list
92582925|NCT00308971|Tocotrienols|tocotrienols|mesh-list
92582926|NCT00308971|alpha-Tocopherol|alpha-tocopherol|mesh-list
92582927|NCT00308971|Thioctic Acid|thioctic acid|mesh-list
92582928|NCT00308971|Vitamins|vitamins|mesh-ancestor
92582929|NCT00308971|Micronutrients|micronutrients|mesh-ancestor
92582930|NCT00308971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582931|NCT00308971|Antioxidants|antioxidants|mesh-ancestor
92582932|NCT00308971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582933|NCT00308971|Protective Agents|protective agents|mesh-ancestor
92582934|NCT00308971|Vitamin B Complex|vitamin b complex|mesh-ancestor
92582935|NCT00120939|Motexafin gadolinium|motexafin gadolinium|mesh-list
92582936|NCT00120939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582937|NCT00120939|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92582938|NCT00120939|Dermatologic Agents|dermatologic agents|mesh-ancestor
92582939|NCT00309049|Epothilones|epothilones|mesh-list
92582940|NCT00309049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92582941|NCT00309049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92582942|NCT00309049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92582943|NCT00309049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582944|NCT00309049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582945|NCT00309088|Tacrolimus|tacrolimus|mesh-list
92582946|NCT00309088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582947|NCT00309088|Immunologic Factors|immunologic factors|mesh-ancestor
92307804|NCT02424799|GSK2646264|gsk2646264|mesh-list
92582949|NCT00309088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92582950|NCT00309088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582951|NCT00309088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582952|NCT00083486|Epoetin Alfa|epoetin alfa|mesh-list
92582953|NCT00083486|Hematinics|hematinics|mesh-ancestor
92582954|NCT00120978|Fluticasone|fluticasone|mesh-list
92582955|NCT00120978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92582956|NCT00120978|Autonomic Agents|autonomic agents|mesh-ancestor
92582957|NCT00120978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582958|NCT00120978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582959|NCT00120978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92582960|NCT00120978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92582961|NCT00120978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92582962|NCT00120978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92582963|NCT00120978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92582964|NCT00309205|Dapivirine|dapivirine|mesh-list
92582965|NCT00309205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582966|NCT00309205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582967|NCT00309205|Antiviral Agents|antiviral agents|mesh-ancestor
92582968|NCT00309205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582969|NCT00309283|Somatostatin|somatostatin|mesh-list
92582970|NCT00309283|Hormones|hormones|mesh-ancestor
92535213|NCT00074191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535214|NCT00074191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92535215|NCT00074191|Abortifacient Agents|abortifacient agents|mesh-ancestor
92582971|NCT00309283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92582972|NCT00309283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582973|NCT00083525|Capecitabine|capecitabine|mesh-list
92582974|NCT00083525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92582975|NCT00083525|Antimetabolites|antimetabolites|mesh-ancestor
92582976|NCT00083525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582977|NCT00083525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582978|NCT00309322|Phentolamine|phentolamine|mesh-list
92582979|NCT00309322|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92582980|NCT00309322|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92582981|NCT00309322|Adrenergic Agents|adrenergic agents|mesh-ancestor
92582982|NCT00309322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582983|NCT00309322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582984|NCT00309322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582985|NCT00309322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92582986|NCT04727502|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92582987|NCT04727502|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92582988|NCT04727502|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92582989|NCT04727502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92582990|NCT04727502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582991|NCT04727502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582992|NCT04727502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582993|NCT04727502|Analgesics|analgesics|mesh-ancestor
92582994|NCT04727502|Sensory System Agents|sensory system agents|mesh-ancestor
92582995|NCT04727502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582996|NCT04727502|Antidepressive Agents|antidepressive agents|mesh-ancestor
92582997|NCT04727502|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92582998|NCT04727502|Dopamine Agents|dopamine agents|mesh-ancestor
92582999|NCT00309361|Phentolamine|phentolamine|mesh-list
92583000|NCT00309361|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92583001|NCT00309361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92583002|NCT00309361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583003|NCT00309361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583004|NCT00309361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583005|NCT00309361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583006|NCT00309361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583007|NCT00088491|Olanzapine|olanzapine|mesh-list
92583008|NCT00088491|Antiemetics|antiemetics|mesh-ancestor
92583009|NCT00088491|Autonomic Agents|autonomic agents|mesh-ancestor
92583010|NCT00088491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583011|NCT00088491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583012|NCT00088491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583013|NCT00088491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92583014|NCT00088491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92583015|NCT00088491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583016|NCT00088491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92583017|NCT00088491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92583018|NCT00088491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92583019|NCT00088491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307876|NCT02428478|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583021|NCT00088491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583023|NCT00309517|Leucovorin|leucovorin|mesh-list
92583024|NCT00309517|Edrecolomab|edrecolomab|mesh-list
92583025|NCT00309517|Antidotes|antidotes|mesh-ancestor
92583026|NCT00309517|Protective Agents|protective agents|mesh-ancestor
92583027|NCT00309517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583028|NCT00309517|Vitamin B Complex|vitamin b complex|mesh-ancestor
92583029|NCT00309517|Vitamins|vitamins|mesh-ancestor
92583030|NCT00309517|Micronutrients|micronutrients|mesh-ancestor
92583031|NCT00309517|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92583032|NCT00309517|Immunologic Factors|immunologic factors|mesh-ancestor
92583033|NCT00121017|Ritonavir|ritonavir|mesh-list
92583034|NCT00121017|Lopinavir|lopinavir|mesh-list
92583035|NCT00121017|Tenofovir|tenofovir|mesh-list
92583036|NCT00121017|Emtricitabine|emtricitabine|mesh-list
92583037|NCT00121017|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92583038|NCT00121017|Efavirenz|efavirenz|mesh-list
92583039|NCT00121017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92535216|NCT00074191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91930019|NCT03535415|Hormones|hormones|mesh-list
92583040|NCT00121017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92583041|NCT00121017|Protease Inhibitors|protease inhibitors|mesh-ancestor
92583042|NCT00121017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583043|NCT00121017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583044|NCT00121017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92583045|NCT00121017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92583046|NCT00121017|Antiviral Agents|antiviral agents|mesh-ancestor
92583047|NCT00121017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583048|NCT00121017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92583049|NCT00121017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92583050|NCT00121017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92583051|NCT00121017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92583052|NCT00121017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92583053|NCT00121017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92583054|NCT00121017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92583055|NCT00121017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92583056|NCT00121017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92583057|NCT00309556|Docetaxel|docetaxel|mesh-list
92583058|NCT00309556|Capecitabine|capecitabine|mesh-list
92583059|NCT00309556|Trastuzumab|trastuzumab|mesh-list
92583060|NCT00309556|Epirubicin|epirubicin|mesh-list
92583061|NCT00309556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583062|NCT00309556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583063|NCT00309556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583064|NCT00309556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583065|NCT00309556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583066|NCT00309556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583067|NCT00309556|Antimetabolites|antimetabolites|mesh-ancestor
92583068|NCT00309556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583069|NCT00309556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92583070|NCT00309556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92583071|NCT00309556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92583072|NCT00309556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583073|NCT00402207|Fluticasone|fluticasone|mesh-list
92583074|NCT00402207|Beclomethasone|beclomethasone|mesh-list
92583075|NCT00402207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583076|NCT00402207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92583077|NCT00402207|Autonomic Agents|autonomic agents|mesh-ancestor
92583078|NCT00402207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583079|NCT00402207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583080|NCT00402207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92583081|NCT00402207|Respiratory System Agents|respiratory system agents|mesh-ancestor
92583082|NCT00402207|Dermatologic Agents|dermatologic agents|mesh-ancestor
92583083|NCT00402207|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92583084|NCT00402207|Glucocorticoids|glucocorticoids|mesh-ancestor
92583085|NCT00402207|Hormones|hormones|mesh-ancestor
92583086|NCT00402207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583087|NCT00399737|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92583088|NCT00399737|Protease Inhibitors|protease inhibitors|mesh-ancestor
92583089|NCT00399737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583090|NCT00399737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583091|NCT00309634|Vaccines|vaccines|mesh-list
92583092|NCT00309634|Immunologic Factors|immunologic factors|mesh-ancestor
92583093|NCT00309634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307949|NCT02437669|Analgesics|analgesics|mesh-ancestor
92583096|NCT00309712|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92583097|NCT00309712|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92583098|NCT00309712|Antimetabolites|antimetabolites|mesh-ancestor
92583099|NCT00309712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583100|NCT00309712|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92583101|NCT00309712|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92583102|NCT00309712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583103|NCT00121056|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92583104|NCT00121056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583105|NCT00309790|Sildenafil Citrate|sildenafil citrate|mesh-list
92583106|NCT00309790|Vasodilator Agents|vasodilator agents|mesh-ancestor
92583107|NCT00309790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92583108|NCT00309790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92583109|NCT00309790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535217|NCT00074191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583110|NCT00309790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583111|NCT00309790|Urological Agents|urological agents|mesh-ancestor
92583112|NCT00418873|Risperidone|risperidone|mesh-list
92583113|NCT00418873|Zotepine|zotepine|mesh-list
92583114|NCT00418873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92583115|NCT00418873|Serotonin Agents|serotonin agents|mesh-ancestor
92583116|NCT00418873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583117|NCT00418873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583118|NCT00418873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583119|NCT00418873|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92583120|NCT00418873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92583121|NCT00418873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583122|NCT00418873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92583123|NCT00418873|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92583124|NCT00418873|Dopamine Agents|dopamine agents|mesh-ancestor
92583125|NCT00088608|Pasireotide|pasireotide|mesh-list
92583126|NCT00088608|Hormones|hormones|mesh-ancestor
92583127|NCT00088608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583128|NCT00088608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583129|NCT00310024|Bortezomib|bortezomib|mesh-list
92583130|NCT00310024|Vorinostat|vorinostat|mesh-list
92583131|NCT00310024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583132|NCT00310024|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92583133|NCT00310024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583134|NCT00310024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583135|NCT00310141|Nicotine|nicotine|mesh-list
92583136|NCT00310141|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92583137|NCT00310141|Autonomic Agents|autonomic agents|mesh-ancestor
92583138|NCT00310141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583139|NCT00310141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583140|NCT00310141|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92583141|NCT00310141|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92583142|NCT00310141|Cholinergic Agents|cholinergic agents|mesh-ancestor
92583143|NCT00310141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583144|NCT00310141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583145|NCT00088686|Capsaicin|capsaicin|mesh-list
92583146|NCT00088686|Antipruritics|antipruritics|mesh-ancestor
92583147|NCT00088686|Dermatologic Agents|dermatologic agents|mesh-ancestor
92583148|NCT00088686|Sensory System Agents|sensory system agents|mesh-ancestor
92583149|NCT00088686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583150|NCT00088686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583151|NCT00083681|Thalidomide|thalidomide|mesh-list
92583152|NCT00083681|Dexamethasone|dexamethasone|mesh-list
92583153|NCT00083681|Etoposide|etoposide|mesh-list
92583154|NCT00083681|Cyclophosphamide|cyclophosphamide|mesh-list
92583155|NCT00083681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583156|NCT00083681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583157|NCT00083681|Antiemetics|antiemetics|mesh-ancestor
92583158|NCT00083681|Autonomic Agents|autonomic agents|mesh-ancestor
92583159|NCT00083681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583160|NCT00083681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583161|NCT00083681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583162|NCT00083681|Glucocorticoids|glucocorticoids|mesh-ancestor
92583163|NCT00083681|Hormones|hormones|mesh-ancestor
92583164|NCT00083681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583165|NCT00083681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92583166|NCT00083681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92583168|NCT00083681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92308024|NCT02523235|Sensory System Agents|sensory system agents|mesh-ancestor
92583169|NCT00083681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583170|NCT00083681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583171|NCT00083681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583172|NCT00083681|Immunologic Factors|immunologic factors|mesh-ancestor
92583173|NCT00083681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583174|NCT00083681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92583175|NCT00083681|Alkylating Agents|alkylating agents|mesh-ancestor
92583176|NCT00083681|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92583177|NCT00083681|Leprostatic Agents|leprostatic agents|mesh-ancestor
92583178|NCT00083681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92583179|NCT00083681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583180|NCT00083681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92583181|NCT00083681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92583182|NCT00083681|Growth Substances|growth substances|mesh-ancestor
91930175|NCT00004165|Melphalan|melphalan|mesh-list
92583183|NCT00083681|Growth Inhibitors|growth inhibitors|mesh-ancestor
92583184|NCT00121095|Docetaxel|docetaxel|mesh-list
92583185|NCT00121095|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92583186|NCT00121095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583187|NCT00121095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583188|NCT00121095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583189|NCT00121095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583190|NCT00121095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583191|NCT00121095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92583192|NCT00121095|Analgesics|analgesics|mesh-ancestor
92583193|NCT00121095|Sensory System Agents|sensory system agents|mesh-ancestor
92583194|NCT00121095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583195|NCT00121095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583196|NCT00310297|Insulin glulisine|insulin glulisine|mesh-list
92583197|NCT00310297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92583198|NCT00310297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583199|NCT00310336|Interferons|interferons|mesh-list
92583200|NCT00310336|Ribavirin|ribavirin|mesh-list
92583201|NCT00310336|Interferon-alpha|interferon-alpha|mesh-list
92583202|NCT00310336|Interferon alpha-2|interferon alpha-2|mesh-list
92583203|NCT00310336|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92583204|NCT00310336|Betaine|betaine|mesh-list
92583205|NCT00310336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583206|NCT00310336|Antiviral Agents|antiviral agents|mesh-ancestor
92583207|NCT00310336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583208|NCT00310336|Antimetabolites|antimetabolites|mesh-ancestor
92583209|NCT00310336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583210|NCT00310336|Immunologic Factors|immunologic factors|mesh-ancestor
92583211|NCT00310336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583212|NCT00310336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583213|NCT00310336|Lipotropic Agents|lipotropic agents|mesh-ancestor
92583214|NCT00310336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92583215|NCT00310336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92583216|NCT05568602|Dexamethasone|dexamethasone|mesh-list
92583217|NCT05568602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583218|NCT05568602|Antiemetics|antiemetics|mesh-ancestor
92583219|NCT05568602|Autonomic Agents|autonomic agents|mesh-ancestor
92583220|NCT05568602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583221|NCT05568602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583222|NCT05568602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583223|NCT05568602|Glucocorticoids|glucocorticoids|mesh-ancestor
92583224|NCT05568602|Hormones|hormones|mesh-ancestor
92583225|NCT05568602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583226|NCT05568602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92583227|NCT05568602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583228|NCT00310492|Immunomodulating Agents|immunomodulating agents|mesh-list
92583229|NCT00310492|Immunologic Factors|immunologic factors|mesh-ancestor
92583230|NCT00310492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583231|NCT00310531|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92583232|NCT00310531|Estradiol|estradiol|mesh-list
92583233|NCT00310531|Estrogens|estrogens|mesh-ancestor
92583234|NCT00310531|Hormones|hormones|mesh-ancestor
92583235|NCT00310531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583236|NCT00310531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583237|NCT00310531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92583238|NCT00310531|Hormone Antagonists|hormone antagonists|mesh-ancestor
92583239|NCT00310531|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92583240|NCT00310531|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92583243|NCT00309673|Prilocaine|prilocaine|mesh-list
92583244|NCT00309673|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92583245|NCT00309673|Anesthetics, Local|anesthetics, local|mesh-ancestor
92583247|NCT00309673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583248|NCT00309673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583249|NCT00309673|Sensory System Agents|sensory system agents|mesh-ancestor
92583250|NCT00309673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583251|NCT00309673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92583252|NCT00309673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92583253|NCT00309673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92583254|NCT00309673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583255|NCT00309673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583256|NCT00309673|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92583257|NCT00310765|Pregabalin|pregabalin|mesh-list
92583258|NCT00310765|Gabapentin|gabapentin|mesh-list
92583259|NCT00310765|Analgesics|analgesics|mesh-ancestor
92535218|NCT00074191|Antimetabolites|antimetabolites|mesh-ancestor
92535219|NCT00074191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583260|NCT00310765|Sensory System Agents|sensory system agents|mesh-ancestor
92583261|NCT00310765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583262|NCT00310765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583263|NCT00310765|Anticonvulsants|anticonvulsants|mesh-ancestor
92583264|NCT00310765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92583265|NCT00310765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583266|NCT00310765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583267|NCT00310765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92583268|NCT00310765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92583269|NCT00310765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92583270|NCT00310765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583271|NCT00310765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92583272|NCT00310765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92583273|NCT00310765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92359816|NCT00638898|Topotecan|topotecan|mesh-list
92583274|NCT00310765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583275|NCT00310765|Antimanic Agents|antimanic agents|mesh-ancestor
92583276|NCT00310843|Nevirapine|nevirapine|mesh-list
92583277|NCT00310843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92583278|NCT00310843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92583279|NCT00310843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583280|NCT00310843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583281|NCT00310843|Antiviral Agents|antiviral agents|mesh-ancestor
92583282|NCT00310843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583283|NCT00310843|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92583284|NCT00310843|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92583285|NCT00310843|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92583286|NCT00310843|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92583287|NCT00310921|Misoprostol|misoprostol|mesh-list
92583288|NCT00310921|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92583289|NCT00310921|Abortifacient Agents|abortifacient agents|mesh-ancestor
92583290|NCT00310921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92583291|NCT00310921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583292|NCT00310921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92583293|NCT00310921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583294|NCT00310921|Oxytocics|oxytocics|mesh-ancestor
92583295|NCT05568212|Durvalumab|durvalumab|mesh-list
92583296|NCT05568212|Olaparib|olaparib|mesh-list
92583297|NCT05568212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583298|NCT05568212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583299|NCT05568212|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92583300|NCT05568212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583301|NCT05568212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583302|NCT00121329|Lidocaine|lidocaine|mesh-list
92583303|NCT00121329|Anesthetics, Local|anesthetics, local|mesh-ancestor
92583304|NCT00121329|Anesthetics|anesthetics|mesh-ancestor
92583305|NCT00121329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583306|NCT00121329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583307|NCT00121329|Sensory System Agents|sensory system agents|mesh-ancestor
92583308|NCT00121329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583309|NCT00121329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92583310|NCT00121329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92583311|NCT00121329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92583312|NCT00121329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583316|NCT00311038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92308178|NCT02464033|Analgesics|analgesics|mesh-ancestor
92583317|NCT00311038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583318|NCT00311038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583319|NCT00311038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583320|NCT00311038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583321|NCT00311038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92583322|NCT00311077|Insulin glulisine|insulin glulisine|mesh-list
92583323|NCT00311077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92583324|NCT00311077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583325|NCT00311116|Vitamin E|vitamin e|mesh-list
92583326|NCT00311116|Vitamins|vitamins|mesh-ancestor
92583327|NCT00311116|Micronutrients|micronutrients|mesh-ancestor
92583328|NCT00311116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583329|NCT00311116|Antioxidants|antioxidants|mesh-ancestor
92620234|NCT00171093|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92535220|NCT00074191|Dermatologic Agents|dermatologic agents|mesh-ancestor
92535221|NCT00074191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583330|NCT00311116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583331|NCT00311116|Protective Agents|protective agents|mesh-ancestor
92583332|NCT00088959|Celecoxib|celecoxib|mesh-list
92583333|NCT00088959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92583334|NCT00088959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583335|NCT00088959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92583336|NCT00088959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583337|NCT00088959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583338|NCT00088959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92583339|NCT00088959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92583340|NCT00088959|Analgesics|analgesics|mesh-ancestor
92583341|NCT00088959|Sensory System Agents|sensory system agents|mesh-ancestor
92583342|NCT00088959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583343|NCT00088959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583344|NCT00088959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583345|NCT00088959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583346|NCT00088959|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92583347|NCT00088959|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92583348|NCT05568017|Edotreotide|edotreotide|mesh-list
92583349|NCT05568017|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92583350|NCT05568017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583351|NCT00311389|Timolol|timolol|mesh-list
92583352|NCT00311389|Travoprost|travoprost|mesh-list
92583353|NCT00311389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92583354|NCT00311389|Latanoprost|latanoprost|mesh-list
92583355|NCT00311389|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92583356|NCT00311389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583357|NCT00311389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92583358|NCT00311389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92583359|NCT00311389|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583360|NCT00311389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583361|NCT00311389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583362|NCT00311389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92583363|NCT00311389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583364|NCT00088998|Bevacizumab|bevacizumab|mesh-list
92583365|NCT00088998|Docetaxel|docetaxel|mesh-list
92583366|NCT00088998|Capecitabine|capecitabine|mesh-list
92583367|NCT00088998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583368|NCT00088998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583369|NCT00088998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92583370|NCT00088998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92583371|NCT00088998|Growth Substances|growth substances|mesh-ancestor
92583372|NCT00088998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583373|NCT00088998|Growth Inhibitors|growth inhibitors|mesh-ancestor
92583374|NCT00088998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583375|NCT00088998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583376|NCT00088998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583377|NCT00088998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583378|NCT00088998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583379|NCT00088998|Antimetabolites|antimetabolites|mesh-ancestor
92583380|NCT00311467|Interferons|interferons|mesh-list
92583381|NCT00311467|Capecitabine|capecitabine|mesh-list
92583382|NCT00311467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583383|NCT00311467|Antimetabolites|antimetabolites|mesh-ancestor
92583396|NCT00089037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583397|NCT00089037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583399|NCT00089037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583400|NCT00089037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583401|NCT00089037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92583402|NCT00089037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583403|NCT00089037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92583404|NCT00089037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583405|NCT00089037|Immunologic Factors|immunologic factors|mesh-ancestor
92583406|NCT00089037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583407|NCT00089037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92583408|NCT00089037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92583409|NCT00089037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92583410|NCT00089037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583411|NCT00089037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92583412|NCT00089037|Antifungal Agents|antifungal agents|mesh-ancestor
92583413|NCT00311740|Valsartan|valsartan|mesh-list
92535222|NCT00074191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92535223|NCT00074191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930394|NCT02288923|Antipyretics|antipyretics|mesh-ancestor
92583414|NCT00311740|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92583415|NCT00311740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583416|NCT00311740|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92583417|NCT00311740|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92583418|NCT00311740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583419|NCT00311740|Diuretics|diuretics|mesh-ancestor
92583420|NCT00311740|Natriuretic Agents|natriuretic agents|mesh-ancestor
92583421|NCT00311740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583422|NCT00311740|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92583423|NCT00311740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583424|NCT00311818|Insulin Glargine|insulin glargine|mesh-list
92583425|NCT00311818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92583426|NCT00311818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583427|NCT00121407|Verteporfin|verteporfin|mesh-list
92583428|NCT00121407|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92583429|NCT00121407|Dermatologic Agents|dermatologic agents|mesh-ancestor
92583430|NCT00311857|Cetuximab|cetuximab|mesh-list
92583431|NCT00311857|Temozolomide|temozolomide|mesh-list
92583432|NCT00311857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583433|NCT00311857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583434|NCT00311857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92583435|NCT00311857|Alkylating Agents|alkylating agents|mesh-ancestor
92583436|NCT00311857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583437|NCT00311896|Bemiparin|bemiparin|mesh-list
92583438|NCT00311896|Anticoagulants|anticoagulants|mesh-ancestor
92583439|NCT00121446|Enoxaparin|enoxaparin|mesh-list
92583440|NCT00121446|Tenecteplase|tenecteplase|mesh-list
92583441|NCT00121446|Clopidogrel|clopidogrel|mesh-list
92583442|NCT00121446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92583443|NCT00121446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92583444|NCT00121446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92583445|NCT00121446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92583446|NCT00121446|Purinergic Agents|purinergic agents|mesh-ancestor
92583468|NCT00121524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583469|NCT00121524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92583470|NCT00121524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92583471|NCT00121524|Autonomic Agents|autonomic agents|mesh-ancestor
92583472|NCT00121524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583473|NCT00121524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92583474|NCT00121524|Respiratory System Agents|respiratory system agents|mesh-ancestor
92583475|NCT00121524|Mydriatics|mydriatics|mesh-ancestor
92583476|NCT00121524|Sympathomimetics|sympathomimetics|mesh-ancestor
92583477|NCT00121524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92583478|NCT00121524|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92583479|NCT00121524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92583480|NCT00121524|Parasympatholytics|parasympatholytics|mesh-ancestor
92583481|NCT00121524|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92583482|NCT00121524|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92583483|NCT00121524|Cholinergic Agents|cholinergic agents|mesh-ancestor
92583484|NCT00121524|Vasodilator Agents|vasodilator agents|mesh-ancestor
92583485|NCT00121524|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92583486|NCT00121524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583487|NCT00121524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92583488|NCT00121524|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92583489|NCT00121524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92583490|NCT00121524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583491|NCT00121524|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92583492|NCT00121524|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92583493|NCT00121524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92583494|NCT00312130|Vildagliptin|vildagliptin|mesh-list
92583495|NCT00312130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92583496|NCT00312130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359830|NCT00393978|Topiramate|topiramate|mesh-list
92583497|NCT00312130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92583499|NCT00312130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583500|NCT00312130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583502|NCT00089115|Immunoglobulins|immunoglobulins|mesh-list
92583503|NCT00089115|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92583505|NCT00089115|Sargramostim|sargramostim|mesh-list
92535224|NCT00074191|Immunologic Factors|immunologic factors|mesh-ancestor
92535225|NCT00074191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930460|NCT02257463|Vasodilator Agents|vasodilator agents|mesh-ancestor
92583506|NCT00089115|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92583507|NCT00089115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583508|NCT00089115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583509|NCT00089115|Immunologic Factors|immunologic factors|mesh-ancestor
92583510|NCT00089115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583511|NCT00089115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583512|NCT00312325|Prednisolone|prednisolone|mesh-list
92583513|NCT00312325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583514|NCT00312325|Glucocorticoids|glucocorticoids|mesh-ancestor
92583515|NCT00312325|Hormones|hormones|mesh-ancestor
92583516|NCT00312325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583517|NCT00312325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583518|NCT00312325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92583519|NCT00312325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583520|NCT05567471|Vaccines|vaccines|mesh-list
92583521|NCT05567471|Immunologic Factors|immunologic factors|mesh-ancestor
92583522|NCT05567471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583523|NCT00089154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92583524|NCT00089154|Antibodies|antibodies|mesh-list
92583525|NCT00089154|Immunoglobulins|immunoglobulins|mesh-list
92583526|NCT00089154|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92583527|NCT00089154|Immunologic Factors|immunologic factors|mesh-ancestor
92583528|NCT00089154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583529|NCT00089154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583530|NCT00312481|Ascorbic Acid|ascorbic acid|mesh-list
92583531|NCT00312481|Magnesium citrate|magnesium citrate|mesh-list
92583532|NCT00312481|Picosulfate sodium|picosulfate sodium|mesh-list
92583533|NCT00312481|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92583534|NCT00312481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583535|NCT00312481|Antioxidants|antioxidants|mesh-ancestor
92583536|NCT00312481|Protective Agents|protective agents|mesh-ancestor
92583537|NCT00312481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583538|NCT00312481|Vitamins|vitamins|mesh-ancestor
92583539|NCT00312481|Micronutrients|micronutrients|mesh-ancestor
92583540|NCT00312481|Cathartics|cathartics|mesh-ancestor
92583541|NCT00312481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583542|NCT00312481|Laxatives|laxatives|mesh-ancestor
92583543|NCT00312520|Methylprednisolone|methylprednisolone|mesh-list
92583544|NCT00312520|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92583545|NCT00312520|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92583546|NCT00312520|Prednisolone|prednisolone|mesh-list
92583547|NCT00312520|Prednisolone acetate|prednisolone acetate|mesh-list
92583548|NCT00312520|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92583549|NCT00312520|Prednisolone phosphate|prednisolone phosphate|mesh-list
92583550|NCT00312520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583551|NCT00312520|Antiemetics|antiemetics|mesh-ancestor
92583552|NCT00312520|Autonomic Agents|autonomic agents|mesh-ancestor
92583553|NCT00312520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583554|NCT00312520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583555|NCT00312520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583556|NCT00312520|Glucocorticoids|glucocorticoids|mesh-ancestor
92583557|NCT00312520|Hormones|hormones|mesh-ancestor
92583558|NCT00312520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583559|NCT00312520|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92583560|NCT00312520|Protective Agents|protective agents|mesh-ancestor
92583561|NCT00312520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92583562|NCT00312520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583563|NCT00089193|Sargramostim|sargramostim|mesh-list
92583564|NCT00089193|Freund's Adjuvant|freund's adjuvant|mesh-list
92583565|NCT00089193|Immunologic Factors|immunologic factors|mesh-ancestor
92583566|NCT00089193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583567|NCT00089193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92583568|NCT00293098|Deferiprone|deferiprone|mesh-list
92583569|NCT00293098|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92583570|NCT00293098|Chelating Agents|chelating agents|mesh-ancestor
92583571|NCT00293098|Sequestering Agents|sequestering agents|mesh-ancestor
92583572|NCT00293098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583573|NCT00293176|Donepezil|donepezil|mesh-list
92583574|NCT00293176|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92583577|NCT00293176|Cholinergic Agents|cholinergic agents|mesh-ancestor
92583578|NCT00293176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620235|NCT00171093|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92535226|NCT00074191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92535227|NCT00074191|Antiviral Agents|antiviral agents|mesh-ancestor
92535228|NCT00074191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535229|NCT00074191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92583579|NCT00293176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583580|NCT00293176|Nootropic Agents|nootropic agents|mesh-ancestor
92583581|NCT00121563|Thalidomide|thalidomide|mesh-list
92583583|NCT00121563|Diazepam|diazepam|mesh-list
92583584|NCT00121563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92583585|NCT00121563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92583586|NCT00121563|Analgesics|analgesics|mesh-ancestor
92583587|NCT00121563|Sensory System Agents|sensory system agents|mesh-ancestor
92583588|NCT00121563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583589|NCT00121563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583590|NCT00121563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583591|NCT00121563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583592|NCT00121563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92583593|NCT00121563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583594|NCT00121563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583595|NCT00121563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583596|NCT00121563|Immunologic Factors|immunologic factors|mesh-ancestor
92583597|NCT00121563|Leprostatic Agents|leprostatic agents|mesh-ancestor
92583598|NCT00121563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92583599|NCT00121563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583600|NCT00121563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92583601|NCT00121563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92583602|NCT00121563|Growth Substances|growth substances|mesh-ancestor
92583603|NCT00121563|Growth Inhibitors|growth inhibitors|mesh-ancestor
92583604|NCT00121563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583605|NCT00121563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92583606|NCT00121563|Anticonvulsants|anticonvulsants|mesh-ancestor
92583607|NCT00121563|Antiemetics|antiemetics|mesh-ancestor
92583608|NCT00121563|Autonomic Agents|autonomic agents|mesh-ancestor
92583609|NCT00121563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583610|NCT00121563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92583611|NCT00121563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583612|NCT00121563|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92583613|NCT00121563|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92583614|NCT00121563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92583615|NCT00121563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92583616|NCT00121563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92583617|NCT00121563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92583618|NCT00121563|Anesthetics, General|anesthetics, general|mesh-ancestor
92583619|NCT00121563|Anesthetics|anesthetics|mesh-ancestor
92583620|NCT00121563|GABA Modulators|gaba modulators|mesh-ancestor
92583621|NCT00121563|GABA Agents|gaba agents|mesh-ancestor
92583622|NCT00121563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583623|NCT00293332|Bevacizumab|bevacizumab|mesh-list
92583624|NCT00293332|Carboplatin|carboplatin|mesh-list
92583626|NCT00293332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583627|NCT00293332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583628|NCT00293332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92583629|NCT00293332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92583630|NCT00293332|Growth Substances|growth substances|mesh-ancestor
92583631|NCT00293332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583632|NCT00293332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92583633|NCT00293332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583634|NCT00293332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583635|NCT00293332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583636|NCT00293332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583637|NCT00293371|Prednisone|prednisone|mesh-list
92583638|NCT00293371|Docetaxel|docetaxel|mesh-list
92583639|NCT00293371|Vatalanib|vatalanib|mesh-list
92583640|NCT00293371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583641|NCT00293371|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583642|NCT00293371|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583643|NCT00293371|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583644|NCT00293371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583645|NCT00293371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583646|NCT00293371|Glucocorticoids|glucocorticoids|mesh-ancestor
92583647|NCT00293371|Hormones|hormones|mesh-ancestor
92620236|NCT00171093|Antimetabolites|antimetabolites|mesh-ancestor
92535230|NCT00074191|Alkylating Agents|alkylating agents|mesh-ancestor
92535231|NCT00074230|BIRC5 protein, human|birc5 protein, human|mesh-list
92535232|NCT00074230|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92583648|NCT00293371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583649|NCT00293371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583669|NCT00293527|Interferon-alpha|interferon-alpha|mesh-list
92583670|NCT00293527|Interferon alpha-2|interferon alpha-2|mesh-list
92583671|NCT00293527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583672|NCT00293527|Antiviral Agents|antiviral agents|mesh-ancestor
92583673|NCT00293527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583674|NCT00293527|Immunologic Factors|immunologic factors|mesh-ancestor
92583675|NCT00293527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583676|NCT04711161|Paclitaxel|paclitaxel|mesh-list
92583677|NCT04711161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92583678|NCT04711161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583679|NCT04711161|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583680|NCT04711161|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583681|NCT04711161|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583682|NCT04711161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583683|NCT00293644|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
92583684|NCT00293644|Antiemetics|antiemetics|mesh-ancestor
92583685|NCT00293644|Autonomic Agents|autonomic agents|mesh-ancestor
92583686|NCT00293644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583687|NCT00293644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583688|NCT00293644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92583689|NCT00293644|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92583690|NCT00293644|Histamine Antagonists|histamine antagonists|mesh-ancestor
92583691|NCT00293644|Histamine Agents|histamine agents|mesh-ancestor
92583692|NCT00293644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583693|NCT00293644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583694|NCT00293761|Travoprost|travoprost|mesh-list
92583695|NCT00293761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583696|NCT00293800|Timolol|timolol|mesh-list
92583697|NCT00293800|Travoprost|travoprost|mesh-list
92583698|NCT00293800|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92583699|NCT00293800|Latanoprost|latanoprost|mesh-list
92583700|NCT00293800|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92583701|NCT00293800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92583702|NCT00293800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92583703|NCT00293800|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583704|NCT00293800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583705|NCT00293800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583716|NCT00423969|Serotonin Agents|serotonin agents|mesh-ancestor
92583717|NCT00423969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583718|NCT00423969|Autonomic Agents|autonomic agents|mesh-ancestor
92583719|NCT00423969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583720|NCT00423969|Cholinergic Agents|cholinergic agents|mesh-ancestor
92583721|NCT00423969|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92583722|NCT00423969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583723|NCT00423969|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92583724|NCT00423969|Nootropic Agents|nootropic agents|mesh-ancestor
92583725|NCT00293839|Oxybutynin|oxybutynin|mesh-list
92583726|NCT00293839|Parasympatholytics|parasympatholytics|mesh-ancestor
92583727|NCT00293839|Autonomic Agents|autonomic agents|mesh-ancestor
92583728|NCT00293839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583729|NCT00293839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583730|NCT00293839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92583731|NCT00293839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92583732|NCT00293839|Cholinergic Agents|cholinergic agents|mesh-ancestor
92583733|NCT00293839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583734|NCT00293839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583735|NCT00293839|Urological Agents|urological agents|mesh-ancestor
92583736|NCT00293917|Tacrolimus|tacrolimus|mesh-list
92583737|NCT00293917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583738|NCT00293917|Immunologic Factors|immunologic factors|mesh-ancestor
92583739|NCT00293917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583740|NCT00293917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92583741|NCT00293917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583742|NCT00293917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583743|NCT05567081|Triamcinolone|triamcinolone|mesh-list
92583744|NCT05567081|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92583745|NCT05567081|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92535233|NCT00074230|Protease Inhibitors|protease inhibitors|mesh-ancestor
92583746|NCT05567081|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92583747|NCT05567081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583748|NCT05567081|Glucocorticoids|glucocorticoids|mesh-ancestor
92583749|NCT05567081|Hormones|hormones|mesh-ancestor
92583750|NCT05567081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583751|NCT05567081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583752|NCT05567081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583753|NCT05567081|Immunologic Factors|immunologic factors|mesh-ancestor
92583754|NCT05567081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583755|NCT05567081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583756|NCT00294112|Remestemcel-l|remestemcel-l|mesh-list
92583757|NCT00294112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583758|NCT00294112|Antiviral Agents|antiviral agents|mesh-ancestor
92583759|NCT00294112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583760|NCT00417898|Aspirin|aspirin|mesh-list
92583761|NCT00417898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92583762|NCT00417898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92583763|NCT00417898|Analgesics|analgesics|mesh-ancestor
92583764|NCT00417898|Sensory System Agents|sensory system agents|mesh-ancestor
92583765|NCT00417898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583766|NCT00417898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583767|NCT00417898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92583768|NCT00417898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583773|NCT00417898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92583774|NCT00417898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583775|NCT00417898|Antipyretics|antipyretics|mesh-ancestor
92583776|NCT00294190|Topotecan|topotecan|mesh-list
92583777|NCT00294190|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92583778|NCT00294190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92583779|NCT00294190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583780|NCT00294190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583781|NCT00294190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583782|NCT02960503|Azithromycin|azithromycin|mesh-list
92583783|NCT02960503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92583784|NCT02960503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583785|NCT04706091|Suvorexant|suvorexant|mesh-list
92583786|NCT04706091|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92583787|NCT04706091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92583788|NCT04706091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583789|NCT04706091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583790|NCT04706091|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92583791|NCT04706091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583792|NCT04706091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583793|NCT00294385|Gemcitabine|gemcitabine|mesh-list
92583794|NCT00294385|Docetaxel|docetaxel|mesh-list
92583795|NCT00294385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583796|NCT00294385|Antimetabolites|antimetabolites|mesh-ancestor
92583797|NCT00294385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583798|NCT00294385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583799|NCT00294385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583800|NCT00294385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583801|NCT00294385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583802|NCT00294463|Tibolone|tibolone|mesh-list
92583803|NCT00294463|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92583804|NCT00294463|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92583805|NCT00294463|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92583806|NCT00294463|Medroxyprogesterone|medroxyprogesterone|mesh-list
92583807|NCT00294463|Estradiol|estradiol|mesh-list
92583808|NCT00294463|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92583809|NCT00294463|Progesterone|progesterone|mesh-list
92583810|NCT00294463|Estrogens|estrogens|mesh-ancestor
92583811|NCT00294463|Hormones|hormones|mesh-ancestor
92583812|NCT00294463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583813|NCT00294463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583814|NCT00294463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92583815|NCT00294463|Contraceptive Agents|contraceptive agents|mesh-ancestor
92583816|NCT00294463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92583817|NCT00294463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92583818|NCT00294463|Progestins|progestins|mesh-ancestor
92583819|NCT00294463|Androgen Antagonists|androgen antagonists|mesh-ancestor
92583820|NCT00294463|Hormone Antagonists|hormone antagonists|mesh-ancestor
92583821|NCT00294463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583822|NCT00294463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92583823|NCT00294463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535234|NCT00074230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535235|NCT00074230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583824|NCT00294463|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92583825|NCT00294463|Anabolic Agents|anabolic agents|mesh-ancestor
92583826|NCT00294463|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92583827|NCT00294463|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92583828|NCT00294463|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92583829|NCT00294463|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92583830|NCT00294502|Minocycline|minocycline|mesh-list
92583831|NCT00294502|Gentamicins|gentamicins|mesh-list
92583832|NCT00294502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583833|NCT00294502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92583834|NCT00294502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583835|NCT00294502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92583836|NCT00294502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583837|NCT00089349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92583838|NCT00089349|Alemtuzumab|alemtuzumab|mesh-list
92583841|NCT00089349|Antibodies|antibodies|mesh-list
92583842|NCT00089349|Immunoglobulins|immunoglobulins|mesh-list
92583843|NCT00089349|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92583844|NCT00089349|Immunologic Factors|immunologic factors|mesh-ancestor
92583845|NCT00089349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583846|NCT00089349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583847|NCT00089349|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92583848|NCT00089349|Abortifacient Agents|abortifacient agents|mesh-ancestor
92583849|NCT00089349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92583850|NCT00089349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583851|NCT00089349|Antimetabolites|antimetabolites|mesh-ancestor
92583852|NCT00089349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583853|NCT00089349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92583854|NCT00089349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583855|NCT00089349|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92583856|NCT00089349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583857|NCT00089349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583858|NCT00089349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92583860|NCT00294580|Antimalarials|antimalarials|mesh-ancestor
92583861|NCT00294580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92583862|NCT00294580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92583863|NCT00294580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583864|NCT00294619|Hormones|hormones|mesh-list
92583865|NCT00294619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583866|NCT00294619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583867|NCT00294736|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92583868|NCT00294736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583869|NCT00294736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92583870|NCT00294736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583871|NCT00294736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583872|NCT00294775|Candesartan|candesartan|mesh-list
92583873|NCT00294775|Candesartan cilexetil|candesartan cilexetil|mesh-list
92583874|NCT00294775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583875|NCT00294775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92583876|NCT00294775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92583877|NCT00294775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583878|NCT00121680|Lenvatinib|lenvatinib|mesh-list
92583879|NCT00121680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583880|NCT00121680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92583881|NCT00121680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583882|NCT00121680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583883|NCT00294853|Calcium|calcium|mesh-list
92583884|NCT00294853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92583885|NCT00294853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583886|NCT00294892|Nevirapine|nevirapine|mesh-list
92583887|NCT00294892|Carbamazepine|carbamazepine|mesh-list
92583888|NCT00294892|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92583889|NCT00294892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92583890|NCT00294892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583891|NCT00294892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583892|NCT00294892|Antiviral Agents|antiviral agents|mesh-ancestor
92583893|NCT00294892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583894|NCT00294892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92583895|NCT00294892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92535236|NCT00392691|Rituximab|rituximab|mesh-list
92535237|NCT00392691|Melphalan|melphalan|mesh-list
92535238|NCT00392691|Vinorelbine|vinorelbine|mesh-list
92535239|NCT00392691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583896|NCT00294892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92583897|NCT00294892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92583898|NCT00294892|Anticonvulsants|anticonvulsants|mesh-ancestor
92583899|NCT00294892|Antimanic Agents|antimanic agents|mesh-ancestor
92583900|NCT00294892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92583901|NCT00294892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92583902|NCT00294892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583903|NCT00294892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92583904|NCT00294892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92583905|NCT00294892|Analgesics|analgesics|mesh-ancestor
92583906|NCT00294892|Sensory System Agents|sensory system agents|mesh-ancestor
92583907|NCT00294892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92583908|NCT00294892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92583909|NCT00294892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583910|NCT00089427|Temozolomide|temozolomide|mesh-list
92583911|NCT00089427|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92583913|NCT00089427|Alkylating Agents|alkylating agents|mesh-ancestor
92583914|NCT00089427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583915|NCT00089427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583916|NCT00294931|Bevacizumab|bevacizumab|mesh-list
92583917|NCT00294931|Carboplatin|carboplatin|mesh-list
92583918|NCT00294931|Irinotecan|irinotecan|mesh-list
92583919|NCT00294931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92583920|NCT00294931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583921|NCT00294931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92583922|NCT00294931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92583923|NCT00294931|Growth Substances|growth substances|mesh-ancestor
92583924|NCT00294931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583925|NCT00294931|Growth Inhibitors|growth inhibitors|mesh-ancestor
92583926|NCT00294931|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92583927|NCT00294931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92583928|NCT00294931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583929|NCT00294931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583930|NCT02958423|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
92583931|NCT02958423|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92583932|NCT02958423|Serotonin Agents|serotonin agents|mesh-ancestor
92583933|NCT02958423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583934|NCT02958423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583935|NCT02958423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583937|NCT00295165|Immunologic Factors|immunologic factors|mesh-ancestor
92583938|NCT00295165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583939|NCT00295243|Topotecan|topotecan|mesh-list
92583940|NCT00295243|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92583941|NCT00295243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92583942|NCT00295243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583943|NCT00295243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583944|NCT00295243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583945|NCT00295282|Antibodies|antibodies|mesh-list
92583946|NCT00295282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92583947|NCT00295282|Immunologic Factors|immunologic factors|mesh-ancestor
92583948|NCT00295282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583949|NCT00121797|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92583950|NCT00121797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583951|NCT00089622|Levodopa|levodopa|mesh-list
92583952|NCT00089622|Lisuride|lisuride|mesh-list
92583953|NCT00089622|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92583954|NCT00089622|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92583955|NCT00089622|Dopamine Agents|dopamine agents|mesh-ancestor
92583956|NCT00089622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583957|NCT00089622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583958|NCT00089622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583959|NCT00089622|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92583960|NCT00089622|Serotonin Agents|serotonin agents|mesh-ancestor
92583961|NCT00089622|Dopamine Agonists|dopamine agonists|mesh-ancestor
92583962|NCT00295555|Doxazosin|doxazosin|mesh-list
92583963|NCT00295555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583964|NCT00295555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92535240|NCT00392691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535241|NCT00392691|Immunologic Factors|immunologic factors|mesh-ancestor
92535242|NCT00392691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583965|NCT00295555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92583966|NCT00295555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92583967|NCT00295555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583968|NCT00295555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583969|NCT00295555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583970|NCT00295555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583971|NCT00295594|Tacrolimus|tacrolimus|mesh-list
92583972|NCT00295594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583973|NCT00295594|Immunologic Factors|immunologic factors|mesh-ancestor
92583974|NCT00295594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583975|NCT00295594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92583976|NCT00295594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583977|NCT00295594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583978|NCT00121875|Hormones|hormones|mesh-list
92583979|NCT00121875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92583980|NCT00121875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583981|NCT00295672|Vinorelbine|vinorelbine|mesh-list
92583982|NCT00295672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92583983|NCT00295672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583984|NCT00295672|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583986|NCT00295672|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583987|NCT00295672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583988|NCT00295789|Paclitaxel|paclitaxel|mesh-list
92583989|NCT00295789|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92583990|NCT00295789|Carboplatin|carboplatin|mesh-list
92359908|NCT00377832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92583991|NCT00295789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92583992|NCT00295789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583993|NCT00295789|Tubulin Modulators|tubulin modulators|mesh-ancestor
92583994|NCT00295789|Antimitotic Agents|antimitotic agents|mesh-ancestor
92583995|NCT00295789|Mitosis Modulators|mitosis modulators|mesh-ancestor
92583996|NCT00295789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583997|NCT00089700|Ibalizumab|ibalizumab|mesh-list
92583998|NCT00089700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92583999|NCT00089700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584000|NCT00089700|Antiviral Agents|antiviral agents|mesh-ancestor
92584001|NCT00089700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584002|NCT04718584|Antibodies|antibodies|mesh-list
92584003|NCT04718584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92584004|NCT04718584|Immunologic Factors|immunologic factors|mesh-ancestor
92584005|NCT04718584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584006|NCT00417937|Azelaic acid|azelaic acid|mesh-list
92584007|NCT00417937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584008|NCT00417937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584009|NCT00418054|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92584010|NCT00418054|Interferon-alpha|interferon-alpha|mesh-list
92584011|NCT00418054|Nitazoxanide|nitazoxanide|mesh-list
92584012|NCT00418054|Antiviral Agents|antiviral agents|mesh-ancestor
92584013|NCT00418054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584014|NCT00418054|Immunologic Factors|immunologic factors|mesh-ancestor
92584015|NCT00418054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584016|NCT00418054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92584017|NCT00295945|Fentanyl|fentanyl|mesh-list
92584018|NCT00295945|Hydromorphone|hydromorphone|mesh-list
92584019|NCT00295945|Ropivacaine|ropivacaine|mesh-list
92584020|NCT00295945|Anesthetics, Local|anesthetics, local|mesh-ancestor
92584021|NCT00295945|Anesthetics|anesthetics|mesh-ancestor
92584022|NCT00295945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584023|NCT00295945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584024|NCT00295945|Sensory System Agents|sensory system agents|mesh-ancestor
92584025|NCT00295945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584026|NCT00295945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92584027|NCT00295945|Narcotics|narcotics|mesh-ancestor
92584028|NCT00295945|Analgesics|analgesics|mesh-ancestor
92584029|NCT00295945|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92584030|NCT00295945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92584031|NCT00295945|Anesthetics, General|anesthetics, general|mesh-ancestor
92584032|NCT00121914|Ethanol|ethanol|mesh-list
92584033|NCT00121914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92584034|NCT00121914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584035|NCT00121914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535243|NCT00392691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535244|NCT00392691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535245|NCT00392691|Alkylating Agents|alkylating agents|mesh-ancestor
92584036|NCT00121914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584037|NCT00295984|Nicotine|nicotine|mesh-list
92584038|NCT00295984|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92584039|NCT00295984|Autonomic Agents|autonomic agents|mesh-ancestor
92584040|NCT00295984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584041|NCT00295984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584042|NCT00295984|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92584043|NCT00295984|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92584044|NCT00295984|Cholinergic Agents|cholinergic agents|mesh-ancestor
92584045|NCT00295984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584046|NCT00295984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584047|NCT00296023|Methotrexate|methotrexate|mesh-list
92584048|NCT00296023|Fludarabine phosphate|fludarabine phosphate|mesh-list
92584049|NCT00296023|Fludarabine|fludarabine|mesh-list
92584050|NCT00296023|Busulfan|busulfan|mesh-list
92584051|NCT00296023|Tacrolimus|tacrolimus|mesh-list
92584052|NCT00296023|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92584053|NCT00296023|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92584054|NCT00296023|Abortifacient Agents|abortifacient agents|mesh-ancestor
92584055|NCT00296023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92584056|NCT00296023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584057|NCT00296023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584058|NCT00296023|Antimetabolites|antimetabolites|mesh-ancestor
92584059|NCT00296023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584060|NCT00296023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584061|NCT00296023|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584064|NCT00296023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584065|NCT00296023|Immunologic Factors|immunologic factors|mesh-ancestor
92584066|NCT00296023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584067|NCT00296023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584068|NCT00296023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92584069|NCT00296023|Alkylating Agents|alkylating agents|mesh-ancestor
92584070|NCT00296023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92584071|NCT00296023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92584072|NCT00121953|Rosiglitazone|rosiglitazone|mesh-list
92584073|NCT00121953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584074|NCT00121953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584075|NCT00296062|Bevacizumab|bevacizumab|mesh-list
92584076|NCT00296062|Capecitabine|capecitabine|mesh-list
92584077|NCT00296062|Oxaliplatin|oxaliplatin|mesh-list
92584078|NCT00296062|Irinotecan|irinotecan|mesh-list
92584079|NCT00296062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92584080|NCT00296062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584081|NCT00296062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92584082|NCT00296062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92584083|NCT00296062|Growth Substances|growth substances|mesh-ancestor
92584084|NCT00296062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584085|NCT00296062|Growth Inhibitors|growth inhibitors|mesh-ancestor
92584086|NCT00296062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584087|NCT00296062|Antimetabolites|antimetabolites|mesh-ancestor
92584088|NCT00296062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584089|NCT00296062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92584090|NCT00296062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92584091|NCT00296062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584092|NCT00296179|Zolpidem|zolpidem|mesh-list
92584093|NCT00296179|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92584094|NCT00296179|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92584095|NCT00296179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584096|NCT00296179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584097|NCT00296179|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92584098|NCT00296179|GABA Agonists|gaba agonists|mesh-ancestor
92584099|NCT00296179|GABA Agents|gaba agents|mesh-ancestor
92584100|NCT00296179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584101|NCT00296179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584102|NCT00296218|Irbesartan|irbesartan|mesh-list
92584103|NCT00296218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92584104|NCT00296218|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92584105|NCT00296218|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91931048|NCT05790902|Urological Agents|urological agents|mesh-ancestor
92584106|NCT00296218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584107|NCT00089856|Prednisone|prednisone|mesh-list
92584108|NCT00089856|Docetaxel|docetaxel|mesh-list
92584109|NCT00089856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584110|NCT00089856|Glucocorticoids|glucocorticoids|mesh-ancestor
92584111|NCT00089856|Hormones|hormones|mesh-ancestor
92584112|NCT00089856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584113|NCT00089856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584114|NCT00089856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92584115|NCT00089856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584116|NCT00089856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584117|NCT00089856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584118|NCT00089856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584119|NCT00089856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584120|NCT00296257|Rimacalib|rimacalib|mesh-list
92584121|NCT00296257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92584122|NCT00296257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584123|NCT00296257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584124|NCT00296530|Fluticasone|fluticasone|mesh-list
92584126|NCT00296530|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92584127|NCT00296530|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92584128|NCT00296530|Montelukast|montelukast|mesh-list
92584129|NCT00296530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584130|NCT00296530|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92584131|NCT00296530|Autonomic Agents|autonomic agents|mesh-ancestor
92584132|NCT00296530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584133|NCT00296530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584134|NCT00296530|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91991294|NCT03701711|Lenalidomide|lenalidomide|mesh-list
92584136|NCT00296530|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584137|NCT00296530|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92584138|NCT00296530|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92584139|NCT00296530|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92584140|NCT00296530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92584141|NCT00296530|Adrenergic Agents|adrenergic agents|mesh-ancestor
92584142|NCT00296530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584143|NCT00296530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584144|NCT00296530|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92584145|NCT00296530|Hormone Antagonists|hormone antagonists|mesh-ancestor
92584146|NCT00296530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584147|NCT00296530|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92584148|NCT00296530|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92584149|NCT00296530|Glucocorticoids|glucocorticoids|mesh-ancestor
92584151|NCT00296530|Sympathomimetics|sympathomimetics|mesh-ancestor
92584152|NCT00090012|Olanzapine|olanzapine|mesh-list
92584153|NCT00090012|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92584154|NCT00090012|Antiemetics|antiemetics|mesh-ancestor
92584155|NCT00090012|Autonomic Agents|autonomic agents|mesh-ancestor
92584156|NCT00090012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584157|NCT00090012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584158|NCT00090012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92584159|NCT00090012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92584160|NCT00090012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584161|NCT00090012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584162|NCT00090012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584163|NCT00090012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92584164|NCT00090012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92584165|NCT00090012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92584166|NCT00090012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584167|NCT00090012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584168|NCT00090012|Serotonin Agents|serotonin agents|mesh-ancestor
92584169|NCT00090012|Antidepressive Agents|antidepressive agents|mesh-ancestor
92584170|NCT00296608|Leucovorin|leucovorin|mesh-list
92584171|NCT00296608|Fluorouracil|fluorouracil|mesh-list
92584172|NCT00296608|Calcium|calcium|mesh-list
92584173|NCT00296608|Levoleucovorin|levoleucovorin|mesh-list
92584174|NCT00296608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92584175|NCT00296608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584176|NCT00296608|Antimetabolites|antimetabolites|mesh-ancestor
92584177|NCT00296608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584178|NCT00296608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584179|NCT00296608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535246|NCT00392691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535247|NCT00392691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92584180|NCT00296608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584181|NCT00296608|Immunologic Factors|immunologic factors|mesh-ancestor
92584182|NCT00296608|Antidotes|antidotes|mesh-ancestor
92584183|NCT00296608|Protective Agents|protective agents|mesh-ancestor
92584184|NCT00296608|Vitamin B Complex|vitamin b complex|mesh-ancestor
92584185|NCT00296608|Vitamins|vitamins|mesh-ancestor
92584186|NCT00296608|Micronutrients|micronutrients|mesh-ancestor
92584187|NCT00296686|Tranylcypromine|tranylcypromine|mesh-list
92584188|NCT00296686|Dextroamphetamine|dextroamphetamine|mesh-list
92584189|NCT00296686|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92584190|NCT00296686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584191|NCT00296686|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92584192|NCT00296686|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92584193|NCT00296686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92584194|NCT00296686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584195|NCT00296686|Dopamine Agents|dopamine agents|mesh-ancestor
92584196|NCT00296686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584197|NCT00296686|Antidepressive Agents|antidepressive agents|mesh-ancestor
92584198|NCT00296686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584199|NCT00296686|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92584200|NCT00296686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584201|NCT00296686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92584202|NCT00296686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584203|NCT00296686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584204|NCT00122070|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92584205|NCT00122070|Antidepressive Agents|antidepressive agents|mesh-ancestor
92584206|NCT00122070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584207|NCT00122070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92584208|NCT00122070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584211|NCT00296803|Clopidogrel|clopidogrel|mesh-list
92584212|NCT00296803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92584213|NCT00296803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92584214|NCT00296803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92584215|NCT00296803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92584216|NCT00296803|Purinergic Agents|purinergic agents|mesh-ancestor
92584217|NCT00296803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584218|NCT00296803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584219|NCT00296803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584220|NCT00090090|Elsamicin A|elsamicin a|mesh-list
92584221|NCT00090090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92584222|NCT00090090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584224|NCT00296959|Anticonvulsants|anticonvulsants|mesh-ancestor
92584225|NCT00296959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584226|NCT00296959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584227|NCT00297076|Aplaviroc|aplaviroc|mesh-list
92584228|NCT00297076|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92584229|NCT00297076|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92584230|NCT00297076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584231|NCT00297076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584232|NCT00297076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584233|NCT00297076|Antiviral Agents|antiviral agents|mesh-ancestor
92584234|NCT00297076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584235|NCT00297349|Topiramate|topiramate|mesh-list
92584236|NCT00297349|Anticonvulsants|anticonvulsants|mesh-ancestor
92584237|NCT00297349|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584238|NCT00297349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584239|NCT00297388|Risperidone|risperidone|mesh-list
92584240|NCT00297388|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92584241|NCT00297388|Serotonin Agents|serotonin agents|mesh-ancestor
92584242|NCT00297388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584243|NCT00297388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584244|NCT00297388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584245|NCT00297388|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92584246|NCT00297388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584247|NCT00297388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584248|NCT00297388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584249|NCT00297388|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92584250|NCT00297388|Dopamine Agents|dopamine agents|mesh-ancestor
92584251|NCT00297466|Nicotine|nicotine|mesh-list
92584252|NCT00297466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92584253|NCT00297466|Autonomic Agents|autonomic agents|mesh-ancestor
92535248|NCT00392691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535249|NCT00392691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92584254|NCT00297466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584255|NCT00297466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584256|NCT00297466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92584257|NCT00297466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92584258|NCT00297466|Cholinergic Agents|cholinergic agents|mesh-ancestor
92584259|NCT00297466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584260|NCT00297466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584261|NCT00297505|Citalopram|citalopram|mesh-list
92584262|NCT00297505|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92584263|NCT00297505|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92584264|NCT00297505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92584265|NCT00297505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584266|NCT00297505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584267|NCT00297505|Serotonin Agents|serotonin agents|mesh-ancestor
92584268|NCT00297505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584269|NCT00297505|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92584270|NCT00297505|Antidepressive Agents|antidepressive agents|mesh-ancestor
92584271|NCT00297505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584272|NCT00297544|Sildenafil Citrate|sildenafil citrate|mesh-list
92584273|NCT00297544|Vasodilator Agents|vasodilator agents|mesh-ancestor
92584274|NCT00297544|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92584275|NCT00297544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92584276|NCT00297544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584277|NCT00297544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584278|NCT00297544|Urological Agents|urological agents|mesh-ancestor
92584279|NCT00297583|Insulin glulisine|insulin glulisine|mesh-list
92584280|NCT00297583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584292|NCT00297661|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92584293|NCT00297661|Antifungal Agents|antifungal agents|mesh-ancestor
92584294|NCT00297661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584295|NCT00297661|Immunologic Factors|immunologic factors|mesh-ancestor
92584296|NCT00297661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584297|NCT00090207|Ondansetron|ondansetron|mesh-list
92584298|NCT00090207|Aprepitant|aprepitant|mesh-list
92584299|NCT00090207|Antiemetics|antiemetics|mesh-ancestor
92584300|NCT00090207|Autonomic Agents|autonomic agents|mesh-ancestor
92584301|NCT00090207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584302|NCT00090207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584303|NCT00090207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92584304|NCT00090207|Antipruritics|antipruritics|mesh-ancestor
92584305|NCT00090207|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584306|NCT00090207|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92584307|NCT00090207|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92584308|NCT00090207|Serotonin Agents|serotonin agents|mesh-ancestor
92584309|NCT00090207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584310|NCT00090207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584311|NCT00090207|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92584312|NCT00297739|Risperidone|risperidone|mesh-list
92584313|NCT00297739|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92584314|NCT00297739|Serotonin Agents|serotonin agents|mesh-ancestor
92584315|NCT00297739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584316|NCT00297739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584317|NCT00297739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584318|NCT00297739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92584319|NCT00297739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584320|NCT00297739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584321|NCT00297739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584322|NCT00297739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92584323|NCT00297739|Dopamine Agents|dopamine agents|mesh-ancestor
92584324|NCT00090246|Ondansetron|ondansetron|mesh-list
92584325|NCT00090246|Aprepitant|aprepitant|mesh-list
92584326|NCT00090246|Antiemetics|antiemetics|mesh-ancestor
92584327|NCT00090246|Autonomic Agents|autonomic agents|mesh-ancestor
92584328|NCT00090246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584329|NCT00090246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584330|NCT00090246|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92584331|NCT00090246|Antipruritics|antipruritics|mesh-ancestor
92584332|NCT00090246|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584333|NCT00090246|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92584334|NCT00090246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92535250|NCT00392691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584335|NCT00090246|Serotonin Agents|serotonin agents|mesh-ancestor
92584336|NCT00090246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584337|NCT00090246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584338|NCT00090246|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92584339|NCT00297817|Vaccines|vaccines|mesh-list
92584340|NCT00297817|Immunologic Factors|immunologic factors|mesh-ancestor
92584341|NCT00297817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584342|NCT00090324|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92584343|NCT00090324|Antidepressive Agents|antidepressive agents|mesh-ancestor
92584344|NCT00090324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584358|NCT00122226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584360|NCT00122226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584361|NCT00122226|Antiviral Agents|antiviral agents|mesh-ancestor
92584362|NCT00122226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584363|NCT00122226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92309230|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584364|NCT00122226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92584365|NCT00122226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92584366|NCT00122226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584367|NCT00122226|Antimetabolites|antimetabolites|mesh-ancestor
92584368|NCT00122226|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92584369|NCT00122226|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92584370|NCT05200559|Pembrolizumab|pembrolizumab|mesh-list
92584371|NCT05200559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92584372|NCT05200559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584373|NCT05200559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92584374|NCT05200559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584375|NCT00298012|Methotrexate|methotrexate|mesh-list
92584376|NCT00298012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92584377|NCT00298012|Abortifacient Agents|abortifacient agents|mesh-ancestor
92584378|NCT00298012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92584379|NCT00298012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584380|NCT00298012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584381|NCT00298012|Antimetabolites|antimetabolites|mesh-ancestor
92584382|NCT00298012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584383|NCT00298012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584384|NCT00298012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584385|NCT00298012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584386|NCT00298012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92584387|NCT00298012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584388|NCT00298012|Immunologic Factors|immunologic factors|mesh-ancestor
92584389|NCT00298012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584390|NCT00298012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584391|NCT00298168|polysaccharide-K|polysaccharide-k|mesh-list
92584392|NCT00298168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92584393|NCT00298168|Immunologic Factors|immunologic factors|mesh-ancestor
92584394|NCT00298168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584395|NCT00298168|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92584396|NCT00298168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584397|NCT00298168|Antiviral Agents|antiviral agents|mesh-ancestor
92584398|NCT00298168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584399|NCT00298168|Interferon Inducers|interferon inducers|mesh-ancestor
92584400|NCT00298168|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92584401|NCT00298168|Protective Agents|protective agents|mesh-ancestor
92584402|NCT00122304|Eculizumab|eculizumab|mesh-list
92584403|NCT00122304|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92584404|NCT00122304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991574|NCT04367909|Carboplatin|carboplatin|mesh-list
92584434|NCT00313963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92584435|NCT00313963|Tocolytic Agents|tocolytic agents|mesh-ancestor
92584436|NCT00313963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92584437|NCT00122343|Sirolimus|sirolimus|mesh-list
92584438|NCT00122343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92584439|NCT00122343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309307|NCT04235036|Rituximab|rituximab|mesh-list
92584440|NCT00122343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92584441|NCT00122343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584442|NCT00122343|Antifungal Agents|antifungal agents|mesh-ancestor
92584443|NCT00122343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584444|NCT00122343|Immunologic Factors|immunologic factors|mesh-ancestor
92584445|NCT00122343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584446|NCT00314080|Antitoxins|antitoxins|mesh-list
92535251|NCT00392691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535252|NCT00392691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535253|NCT02966080|Heparin|heparin|mesh-list
92535254|NCT02966080|Anticoagulants|anticoagulants|mesh-ancestor
91931349|NCT04892264|Dexamethasone|dexamethasone|mesh-list
92584447|NCT00314080|Botulinum Antitoxin|botulinum antitoxin|mesh-list
92584451|NCT00314158|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92584453|NCT00314158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92584454|NCT00314158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92359947|NCT00381810|Rituximab|rituximab|mesh-list
92584455|NCT00314158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92584456|NCT00314158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92584457|NCT00314158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584458|NCT00314158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584459|NCT00314158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584460|NCT00314158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92584461|NCT00314158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92584462|NCT00314158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92584463|NCT00314158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584464|NCT00090480|Vaccines|vaccines|mesh-list
92584465|NCT00090480|Immunologic Factors|immunologic factors|mesh-ancestor
92584466|NCT00090480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584467|NCT00322660|Epinephrine|epinephrine|mesh-list
92584468|NCT00322660|Racepinephrine|racepinephrine|mesh-list
92584469|NCT00322660|Epinephryl borate|epinephryl borate|mesh-list
92584470|NCT00322660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92584471|NCT00322660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92584472|NCT00322660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92584473|NCT00322660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584474|NCT00322660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584475|NCT00322660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584476|NCT00322660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92584477|NCT00322660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92584478|NCT00322660|Autonomic Agents|autonomic agents|mesh-ancestor
92584479|NCT00322660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584480|NCT00322660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92584481|NCT00322660|Respiratory System Agents|respiratory system agents|mesh-ancestor
92584482|NCT00322660|Mydriatics|mydriatics|mesh-ancestor
92584483|NCT00322660|Sympathomimetics|sympathomimetics|mesh-ancestor
92584484|NCT00322660|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92584485|NCT00322699|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92584486|NCT00322699|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92584487|NCT00322699|Trioxsalen|trioxsalen|mesh-list
92584488|NCT00322699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584489|NCT00322699|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584490|NCT00322699|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92584491|NCT00322972|Azithromycin|azithromycin|mesh-list
92584492|NCT00322972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92584493|NCT00322972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584494|NCT00090558|Nitroglycerin|nitroglycerin|mesh-list
92584495|NCT00090558|Vasodilator Agents|vasodilator agents|mesh-ancestor
92584496|NCT00323011|Leucovorin|leucovorin|mesh-list
92584497|NCT00323011|Folic Acid|folic acid|mesh-list
92584498|NCT00323011|Bevacizumab|bevacizumab|mesh-list
92584499|NCT00323011|Fluorouracil|fluorouracil|mesh-list
92584500|NCT00323011|Irinotecan|irinotecan|mesh-list
92584501|NCT00323011|Dalteparin|dalteparin|mesh-list
92584502|NCT00323011|Levoleucovorin|levoleucovorin|mesh-list
92584503|NCT00323011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92584504|NCT00323011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584505|NCT00323011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92584506|NCT00323011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92584507|NCT00323011|Growth Substances|growth substances|mesh-ancestor
92584508|NCT00323011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584509|NCT00323011|Growth Inhibitors|growth inhibitors|mesh-ancestor
92584510|NCT00323011|Antimetabolites|antimetabolites|mesh-ancestor
92584511|NCT00323011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584512|NCT00323011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584513|NCT00323011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584514|NCT00323011|Immunologic Factors|immunologic factors|mesh-ancestor
92584515|NCT00323011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92584516|NCT00323011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309376|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584517|NCT00323011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584518|NCT00323011|Antidotes|antidotes|mesh-ancestor
92535255|NCT02966080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92535256|NCT02966080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92584519|NCT00323011|Protective Agents|protective agents|mesh-ancestor
92584520|NCT00323011|Vitamin B Complex|vitamin b complex|mesh-ancestor
92584522|NCT00323011|Micronutrients|micronutrients|mesh-ancestor
92584542|NCT04717531|Immunologic Factors|immunologic factors|mesh-ancestor
92584543|NCT04717531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584544|NCT04717531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359949|NCT00381810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584545|NCT04717531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92584546|NCT04717531|Alkylating Agents|alkylating agents|mesh-ancestor
92584547|NCT04717531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584548|NCT04717531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584549|NCT04717531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92584550|NCT04717531|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584551|NCT04717531|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584552|NCT04717531|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584553|NCT04717531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92584554|NCT04717531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92584555|NCT04717531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92584556|NCT04717531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92584557|NCT04717531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584558|NCT00323323|Prednisone|prednisone|mesh-list
92584559|NCT00323323|Cyclophosphamide|cyclophosphamide|mesh-list
92584560|NCT00323323|Doxorubicin|doxorubicin|mesh-list
92584561|NCT00323323|Vincristine|vincristine|mesh-list
92584562|NCT00323323|Alemtuzumab|alemtuzumab|mesh-list
92584563|NCT00323323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584564|NCT00323323|Immunologic Factors|immunologic factors|mesh-ancestor
92584565|NCT00323323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584566|NCT00323323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584567|NCT00323323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92584568|NCT00323323|Alkylating Agents|alkylating agents|mesh-ancestor
92584569|NCT00323323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584570|NCT00323323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584571|NCT00323323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92584572|NCT00323323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92584573|NCT00323323|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92584574|NCT00323323|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92584575|NCT00323323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584576|NCT00323323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584577|NCT00323323|Glucocorticoids|glucocorticoids|mesh-ancestor
92584578|NCT00323323|Hormones|hormones|mesh-ancestor
92584579|NCT00323323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584580|NCT00323323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92584581|NCT00323323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92584595|NCT00312598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92584596|NCT00312598|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92584597|NCT00312598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584598|NCT00312598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584599|NCT00312598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584600|NCT00312598|Dopamine Agonists|dopamine agonists|mesh-ancestor
92584602|NCT00312598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584603|NCT00312598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584604|NCT00312598|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92584605|NCT00312598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92584606|NCT00312598|Serotonin Agents|serotonin agents|mesh-ancestor
92584607|NCT00312598|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92584608|NCT00312598|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92584609|NCT00312598|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92584610|NCT00312598|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92584611|NCT00312754|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92584612|NCT00312754|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92584613|NCT00312754|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92584614|NCT00312754|Protease Inhibitors|protease inhibitors|mesh-ancestor
92584615|NCT00312754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584616|NCT00312754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584617|NCT00312754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584618|NCT00312754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584619|NCT00312754|Antiviral Agents|antiviral agents|mesh-ancestor
92584620|NCT00312754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584622|NCT00312871|Hematinics|hematinics|mesh-ancestor
92584623|NCT00090675|Gefitinib|gefitinib|mesh-list
91931499|NCT04276363|Nicotine|nicotine|mesh-list
92584624|NCT00090675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584625|NCT00090675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92584626|NCT00090675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584627|NCT00090675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584628|NCT00312988|Gemcitabine|gemcitabine|mesh-list
92584629|NCT00312988|Topotecan|topotecan|mesh-list
92584630|NCT00312988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584631|NCT00312988|Antimetabolites|antimetabolites|mesh-ancestor
92584632|NCT00312988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584633|NCT00312988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584634|NCT00312988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92584635|NCT00312988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92584636|NCT00312988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584637|NCT00122538|Lamivudine|lamivudine|mesh-list
92584638|NCT00122538|Efavirenz|efavirenz|mesh-list
92584639|NCT00122538|Didanosine|didanosine|mesh-list
92584640|NCT00122538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92584641|NCT00122538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584642|NCT00122538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584643|NCT00122538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584646|NCT00122538|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584647|NCT00122538|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584648|NCT00122538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92584649|NCT00122538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92584650|NCT00122538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92584651|NCT00122538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92584652|NCT00122538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92584653|NCT00122538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92584654|NCT00122538|Antimetabolites|antimetabolites|mesh-ancestor
92584655|NCT00313105|Lobeline|lobeline|mesh-list
92584656|NCT00313105|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92584657|NCT00313105|Autonomic Agents|autonomic agents|mesh-ancestor
92584658|NCT00313105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584659|NCT00313105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584660|NCT00313105|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92584661|NCT00313105|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92584662|NCT00313105|Cholinergic Agents|cholinergic agents|mesh-ancestor
92584663|NCT00313105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584664|NCT00313105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584665|NCT00313105|Respiratory System Agents|respiratory system agents|mesh-ancestor
92584666|NCT00313183|Pramlintide|pramlintide|mesh-list
92584667|NCT00313183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584668|NCT00313183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584670|NCT00122577|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92584671|NCT00122577|Tenofovir|tenofovir|mesh-list
92584672|NCT00122577|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92584673|NCT00122577|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92584674|NCT00122577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92584675|NCT00122577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584676|NCT00122577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584677|NCT00122577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584678|NCT00122577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584679|NCT00122577|Antiviral Agents|antiviral agents|mesh-ancestor
92584680|NCT00122577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584681|NCT00122577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92584682|NCT00122577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92584683|NCT00122577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92584684|NCT00122577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584685|NCT00313261|Clevudine|clevudine|mesh-list
92584686|NCT00313261|Antiviral Agents|antiviral agents|mesh-ancestor
92584687|NCT00313261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584688|NCT00425074|Aspirin|aspirin|mesh-list
92584689|NCT00425074|Salicylic Acid|salicylic acid|mesh-list
92584690|NCT00425074|Salicylates|salicylates|mesh-list
92584691|NCT00425074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584692|NCT00425074|Antifungal Agents|antifungal agents|mesh-ancestor
92584693|NCT00425074|Keratolytic Agents|keratolytic agents|mesh-ancestor
92584694|NCT00425074|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584695|NCT00425074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92584696|NCT00425074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92584697|NCT00425074|Analgesics|analgesics|mesh-ancestor
92584698|NCT00425074|Sensory System Agents|sensory system agents|mesh-ancestor
92584699|NCT00425074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535257|NCT02966080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535258|NCT04767776|Rivaroxaban|rivaroxaban|mesh-list
92535259|NCT04767776|Charcoal|charcoal|mesh-list
92584700|NCT00425074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584701|NCT00425074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584702|NCT00425074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584703|NCT00425074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92584704|NCT00425074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584705|NCT00425074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584706|NCT00425074|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92584707|NCT00425074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92584708|NCT00425074|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92584709|NCT00425074|Antipyretics|antipyretics|mesh-ancestor
92584710|NCT00425152|Leucovorin|leucovorin|mesh-list
92584711|NCT00425152|Levamisole|levamisole|mesh-list
92584712|NCT00425152|Fluorouracil|fluorouracil|mesh-list
92584713|NCT00425152|Calcium|calcium|mesh-list
92584714|NCT00425152|Levoleucovorin|levoleucovorin|mesh-list
92584715|NCT00425152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92584716|NCT00425152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584717|NCT00425152|Antimetabolites|antimetabolites|mesh-ancestor
92584721|NCT00425152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584722|NCT00425152|Immunologic Factors|immunologic factors|mesh-ancestor
92584723|NCT00425152|Antidotes|antidotes|mesh-ancestor
92584724|NCT00425152|Protective Agents|protective agents|mesh-ancestor
92584725|NCT00425152|Vitamin B Complex|vitamin b complex|mesh-ancestor
92584726|NCT00425152|Vitamins|vitamins|mesh-ancestor
92584727|NCT00425152|Micronutrients|micronutrients|mesh-ancestor
92584728|NCT00425152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92584729|NCT00425152|Antinematodal Agents|antinematodal agents|mesh-ancestor
92584730|NCT00425152|Anthelmintics|anthelmintics|mesh-ancestor
92584731|NCT00425152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92584732|NCT00425152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584733|NCT00425152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584734|NCT00314314|Insulin|insulin|mesh-list
92584735|NCT00314314|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584736|NCT00314314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584737|NCT00122616|Ribavirin|ribavirin|mesh-list
92584738|NCT00122616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92584739|NCT00122616|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92584740|NCT00122616|Antimetabolites|antimetabolites|mesh-ancestor
92584741|NCT00122616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584742|NCT00122616|Antiviral Agents|antiviral agents|mesh-ancestor
92584743|NCT00122616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584744|NCT04984070|Metformin|metformin|mesh-list
92584745|NCT04984070|Drospirenone|drospirenone|mesh-list
92584746|NCT04984070|Contraceptive Agents|contraceptive agents|mesh-list
92584747|NCT04984070|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92584748|NCT04984070|Contraceptives, Oral|contraceptives, oral|mesh-list
92584749|NCT04984070|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92584750|NCT04984070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92584751|NCT04984070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92584752|NCT04984070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584753|NCT04984070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92584754|NCT04984070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92584755|NCT04984070|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92584756|NCT04984070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92584757|NCT04984070|Estrogens|estrogens|mesh-ancestor
92584758|NCT04984070|Hormones|hormones|mesh-ancestor
92584759|NCT04984070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584760|NCT04984070|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92584761|NCT04984070|Hormone Antagonists|hormone antagonists|mesh-ancestor
92584762|NCT04984070|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92584763|NCT04984070|Diuretics|diuretics|mesh-ancestor
92584764|NCT04984070|Natriuretic Agents|natriuretic agents|mesh-ancestor
92584765|NCT00314509|Ciclesonide|ciclesonide|mesh-list
92584766|NCT00314509|Formoterol Fumarate|formoterol fumarate|mesh-list
92584767|NCT00314509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92584768|NCT00314509|Autonomic Agents|autonomic agents|mesh-ancestor
92584769|NCT00314509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584770|NCT00314509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584771|NCT00314509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92584772|NCT00314509|Respiratory System Agents|respiratory system agents|mesh-ancestor
92584773|NCT00314509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92535260|NCT04767776|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92535261|NCT04767776|Antithrombins|antithrombins|mesh-ancestor
92535262|NCT04767776|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92584774|NCT00314509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92584775|NCT00314509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92584776|NCT00314509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92584777|NCT00314509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584778|NCT00314509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584779|NCT00314509|Glucocorticoids|glucocorticoids|mesh-ancestor
92584780|NCT00314509|Hormones|hormones|mesh-ancestor
92584781|NCT00314509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584782|NCT00314509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92584783|NCT00314548|Epoprostenol|epoprostenol|mesh-list
92584784|NCT00314548|Alprostadil|alprostadil|mesh-list
92584785|NCT00314548|Tezosentan|tezosentan|mesh-list
92584786|NCT00314548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92584787|NCT00314548|Vasodilator Agents|vasodilator agents|mesh-ancestor
92584788|NCT00314548|Urological Agents|urological agents|mesh-ancestor
92584789|NCT00314548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92584790|NCT00314626|Lamivudine|lamivudine|mesh-list
92584804|NCT00314626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92584805|NCT00314626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92584806|NCT00314626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92584807|NCT00314665|Thalidomide|thalidomide|mesh-list
92584808|NCT00314665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584809|NCT00314665|Immunologic Factors|immunologic factors|mesh-ancestor
92584810|NCT00314665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584811|NCT00314665|Leprostatic Agents|leprostatic agents|mesh-ancestor
92584812|NCT00314665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92584813|NCT00314665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584814|NCT00314665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92584815|NCT00314665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92584816|NCT00314665|Growth Substances|growth substances|mesh-ancestor
92584817|NCT00314665|Growth Inhibitors|growth inhibitors|mesh-ancestor
92584818|NCT00314665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309683|NCT02489227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584820|NCT00314704|Norepinephrine|norepinephrine|mesh-list
92584821|NCT00314704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92584822|NCT00314704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92584823|NCT00314704|Adrenergic Agents|adrenergic agents|mesh-ancestor
92584824|NCT00314704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584825|NCT00314704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584826|NCT00314704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584827|NCT00314704|Sympathomimetics|sympathomimetics|mesh-ancestor
92584828|NCT00314704|Autonomic Agents|autonomic agents|mesh-ancestor
92584829|NCT00314704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584830|NCT00314704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92584831|NCT00314704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92584832|NCT00314704|Dopamine Agents|dopamine agents|mesh-ancestor
92584833|NCT00314704|Protective Agents|protective agents|mesh-ancestor
92584834|NCT00090909|Dexamethasone|dexamethasone|mesh-list
92584835|NCT00090909|Gemcitabine|gemcitabine|mesh-list
92584836|NCT00090909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584837|NCT00090909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584838|NCT00090909|Antiemetics|antiemetics|mesh-ancestor
92584839|NCT00090909|Autonomic Agents|autonomic agents|mesh-ancestor
92584840|NCT00090909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584841|NCT00090909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584842|NCT00090909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92584843|NCT00090909|Glucocorticoids|glucocorticoids|mesh-ancestor
92584844|NCT00090909|Hormones|hormones|mesh-ancestor
92584845|NCT00090909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584846|NCT00090909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92584847|NCT00090909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584848|NCT00090909|Antimetabolites|antimetabolites|mesh-ancestor
92584849|NCT00090909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584850|NCT04943627|Gemcitabine|gemcitabine|mesh-list
92584851|NCT04943627|Irinotecan|irinotecan|mesh-list
92584871|NCT00314743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584873|NCT00314743|Autonomic Agents|autonomic agents|mesh-ancestor
92584874|NCT00314743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584875|NCT00314743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584876|NCT00314743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535263|NCT04767776|Protease Inhibitors|protease inhibitors|mesh-ancestor
92535264|NCT04767776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931718|NCT02959944|Prednisone|prednisone|mesh-list
92584877|NCT00314743|Glucocorticoids|glucocorticoids|mesh-ancestor
92584878|NCT00314743|Hormones|hormones|mesh-ancestor
92584879|NCT00314743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92584880|NCT00314743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92584881|NCT00314743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584882|NCT00314743|Antipruritics|antipruritics|mesh-ancestor
92584883|NCT00314743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584884|NCT00314743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92584885|NCT00314743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92584886|NCT00314743|Serotonin Agents|serotonin agents|mesh-ancestor
92584887|NCT00314743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584888|NCT00314743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584889|NCT00314743|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92584890|NCT00314782|Docetaxel|docetaxel|mesh-list
92584891|NCT00314782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584892|NCT00314782|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584893|NCT00314782|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584894|NCT00314782|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584895|NCT00314782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584896|NCT00122655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92584897|NCT00122655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92584898|NCT00122655|Protease Inhibitors|protease inhibitors|mesh-list
92584899|NCT00122655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584900|NCT00122655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584901|NCT00122655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584902|NCT00122655|Antiviral Agents|antiviral agents|mesh-ancestor
92584903|NCT00122655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584904|NCT00122655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92584905|NCT00122655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584906|NCT00122655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584907|NCT00314821|Ropinirole|ropinirole|mesh-list
92584914|NCT00314821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584915|NCT00314860|Ropinirole|ropinirole|mesh-list
92584916|NCT00314860|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92584917|NCT00314860|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92584918|NCT00314860|Dopamine Agonists|dopamine agonists|mesh-ancestor
92584919|NCT00314860|Dopamine Agents|dopamine agents|mesh-ancestor
92584920|NCT00314860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584921|NCT00314860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584922|NCT00314860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584923|NCT04928339|Bupivacaine|bupivacaine|mesh-list
92584924|NCT04928339|Anesthetics, Local|anesthetics, local|mesh-ancestor
92584925|NCT04928339|Anesthetics|anesthetics|mesh-ancestor
92584926|NCT04928339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584927|NCT04928339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584928|NCT04928339|Sensory System Agents|sensory system agents|mesh-ancestor
92584929|NCT04928339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584930|NCT00091104|Aldesleukin|aldesleukin|mesh-list
92584931|NCT00091104|Cyclophosphamide|cyclophosphamide|mesh-list
92584932|NCT00091104|Fludarabine|fludarabine|mesh-list
92584933|NCT00091104|Fludarabine phosphate|fludarabine phosphate|mesh-list
92584934|NCT00091104|Freund's Adjuvant|freund's adjuvant|mesh-list
92584935|NCT00091104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584936|NCT00091104|Immunologic Factors|immunologic factors|mesh-ancestor
92584937|NCT00091104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584938|NCT00091104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584939|NCT00091104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92584940|NCT00091104|Alkylating Agents|alkylating agents|mesh-ancestor
92584941|NCT00091104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584942|NCT00091104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584943|NCT00091104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92584944|NCT00091104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584945|NCT00091104|Antimetabolites|antimetabolites|mesh-ancestor
92584946|NCT00091104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92584947|NCT00091104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584948|NCT00091104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584949|NCT00091104|Antiviral Agents|antiviral agents|mesh-ancestor
92584950|NCT00091104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584951|NCT00122694|Carbon Monoxide|carbon monoxide|mesh-list
92584952|NCT00122694|Antimetabolites|antimetabolites|mesh-ancestor
92535265|NCT04767776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535266|NCT04767776|Anticoagulants|anticoagulants|mesh-ancestor
92535267|NCT04767776|Antidotes|antidotes|mesh-ancestor
92535268|NCT04767776|Protective Agents|protective agents|mesh-ancestor
92535269|NCT04767776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535270|NCT04754321|Pembrolizumab|pembrolizumab|mesh-list
92535271|NCT04754321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92535272|NCT04754321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535273|NCT04754321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92535274|NCT04754321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535275|NCT04730245|Rifaximin|rifaximin|mesh-list
92260026|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
92535276|NCT04730245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92535277|NCT04730245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584953|NCT00122694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584954|NCT00122694|Gasotransmitters|gasotransmitters|mesh-ancestor
92584955|NCT00122694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584956|NCT00122694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584957|NCT00313456|Satraplatin|satraplatin|mesh-list
92584958|NCT00313456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584959|NCT00313534|Masoprocol|masoprocol|mesh-list
92584960|NCT00313534|Antioxidants|antioxidants|mesh-ancestor
92584961|NCT00313534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584962|NCT00313534|Protective Agents|protective agents|mesh-ancestor
92584963|NCT00313534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584964|NCT00313534|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92584965|NCT00313534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584966|NCT00313534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92584967|NCT00313534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92584968|NCT00313534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92584969|NCT00313534|Analgesics|analgesics|mesh-ancestor
92584970|NCT00313534|Sensory System Agents|sensory system agents|mesh-ancestor
92584971|NCT00313534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584972|NCT00313534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584973|NCT00313534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584974|NCT00313690|Docetaxel|docetaxel|mesh-list
92584975|NCT00313690|Bortezomib|bortezomib|mesh-list
92584976|NCT00313690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584977|NCT00313690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584978|NCT00313690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584979|NCT00313690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584980|NCT00313690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584981|NCT00313885|SR 46349B|sr 46349b|mesh-list
92584982|NCT00313885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92584983|NCT00313885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92584984|NCT00313885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584989|NCT00313885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584991|NCT00091143|Fludarabine phosphate|fludarabine phosphate|mesh-list
92584992|NCT00091143|Freund's Adjuvant|freund's adjuvant|mesh-list
92584993|NCT00091143|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92584994|NCT00091143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584995|NCT00091143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584996|NCT00091143|Antimetabolites|antimetabolites|mesh-ancestor
92584997|NCT00091143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584998|NCT00091143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584999|NCT00091143|Immunologic Factors|immunologic factors|mesh-ancestor
92585000|NCT00091143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585001|NCT00091143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92585002|NCT00091182|Oxaliplatin|oxaliplatin|mesh-list
92585003|NCT00091182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535278|NCT04730245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535280|NCT00074620|Antithrombins|antithrombins|mesh-ancestor
92585004|NCT04635280|Pancrelipase|pancrelipase|mesh-list
92585005|NCT04635280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585006|NCT00122733|Loxapine|loxapine|mesh-list
92585007|NCT00122733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92585008|NCT00122733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92585009|NCT00122733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585010|NCT00122733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585011|NCT00122733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585012|NCT00122733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92585013|NCT00122733|Dopamine Agents|dopamine agents|mesh-ancestor
92585014|NCT00122733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585015|NCT00122733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585016|NCT04432012|Dexamethasone|dexamethasone|mesh-list
92585017|NCT04432012|Dexamethasone acetate|dexamethasone acetate|mesh-list
92585018|NCT04432012|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92585019|NCT04432012|BB 1101|bb 1101|mesh-list
92585020|NCT04432012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585021|NCT04432012|Antiemetics|antiemetics|mesh-ancestor
92585022|NCT04432012|Autonomic Agents|autonomic agents|mesh-ancestor
92585023|NCT04432012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585024|NCT04432012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585025|NCT04432012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585026|NCT04432012|Glucocorticoids|glucocorticoids|mesh-ancestor
92585027|NCT04432012|Hormones|hormones|mesh-ancestor
92585028|NCT04432012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585029|NCT04432012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585030|NCT04432012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585031|NCT04432012|Protease Inhibitors|protease inhibitors|mesh-ancestor
92585032|NCT04432012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585033|NCT04432012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585034|NCT00091299|Warfarin|warfarin|mesh-list
92585035|NCT00091299|Anticoagulants|anticoagulants|mesh-ancestor
92585036|NCT04607603|Cannabidiol|cannabidiol|mesh-list
92585037|NCT04607603|Anticonvulsants|anticonvulsants|mesh-ancestor
92585038|NCT00122772|Cisplatin|cisplatin|mesh-list
92585039|NCT00122772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585040|NCT00091338|Freund's Adjuvant|freund's adjuvant|mesh-list
92585041|NCT00091338|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92585042|NCT00091338|Immunologic Factors|immunologic factors|mesh-ancestor
92585043|NCT00091338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585044|NCT00122811|Perindopril|perindopril|mesh-list
92585045|NCT00122811|Indapamide|indapamide|mesh-list
92585046|NCT00122811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92585047|NCT00122811|Protease Inhibitors|protease inhibitors|mesh-ancestor
92585048|NCT00122811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585049|NCT00122811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585050|NCT00122811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92585051|NCT00122811|Diuretics|diuretics|mesh-ancestor
92585052|NCT00122811|Natriuretic Agents|natriuretic agents|mesh-ancestor
92585053|NCT00122811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585054|NCT00122811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92585055|NCT00122811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92585056|NCT04551170|Theophylline|theophylline|mesh-list
92585059|NCT04551170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585060|NCT04551170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585061|NCT04551170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92585062|NCT04551170|Respiratory System Agents|respiratory system agents|mesh-ancestor
92585063|NCT04551170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92585065|NCT04551170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585066|NCT04551170|Vasodilator Agents|vasodilator agents|mesh-ancestor
92585067|NCT04551170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92585068|NCT04551170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92585069|NCT04551170|Purinergic Agents|purinergic agents|mesh-ancestor
92585070|NCT04551170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585071|NCT00122850|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92585072|NCT00122850|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92585073|NCT00122850|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92585074|NCT00122850|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92585075|NCT00122850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92585076|NCT00122850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585077|NCT00122850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585078|NCT00122850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585079|NCT00122850|Analgesics|analgesics|mesh-ancestor
92585080|NCT00122850|Sensory System Agents|sensory system agents|mesh-ancestor
92585081|NCT00122850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585082|NCT00122850|Antidepressive Agents|antidepressive agents|mesh-ancestor
92585083|NCT00122850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585084|NCT00122850|Dopamine Agents|dopamine agents|mesh-ancestor
92585085|NCT00122850|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92585086|NCT04542278|Prednisone|prednisone|mesh-list
92585087|NCT04542278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585088|NCT04542278|Glucocorticoids|glucocorticoids|mesh-ancestor
92585089|NCT04542278|Hormones|hormones|mesh-ancestor
92585090|NCT04542278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585091|NCT04542278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585092|NCT04542278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585093|NCT04542278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585094|NCT03975439|Chrysarobin|chrysarobin|mesh-list
92585095|NCT03975439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585096|NCT03975439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585097|NCT03975439|Analgesics|analgesics|mesh-ancestor
92585098|NCT03975439|Sensory System Agents|sensory system agents|mesh-ancestor
92585099|NCT03975439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585100|NCT03975439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585101|NCT03975439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585102|NCT03975439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585103|NCT00091377|Paclitaxel|paclitaxel|mesh-list
92585104|NCT00091377|Cisplatin|cisplatin|mesh-list
92585105|NCT00091377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92585106|NCT00091377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585107|NCT00091377|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585108|NCT00091377|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585109|NCT00091377|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585110|NCT00091377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585111|NCT03897868|Losartan|losartan|mesh-list
92585112|NCT03897868|Amlodipine|amlodipine|mesh-list
92585113|NCT03897868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92585114|NCT03897868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92585115|NCT03897868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92585116|NCT03897868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585117|NCT03897868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92585118|NCT03897868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585120|NCT03897868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92585121|NCT03897868|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92585122|NCT03897868|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92585123|NCT00122889|Allicin|allicin|mesh-list
92585124|NCT00122889|Allyl sulfide|allyl sulfide|mesh-list
92585125|NCT00122889|Antioxidants|antioxidants|mesh-ancestor
92585126|NCT00122889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585127|NCT00122889|Protective Agents|protective agents|mesh-ancestor
92585131|NCT00122889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92585133|NCT00122889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585134|NCT00122889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92585135|NCT00122889|Antimetabolites|antimetabolites|mesh-ancestor
92585136|NCT00122889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92585137|NCT00122889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92585138|NCT00122889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92585139|NCT04729868|Dexmedetomidine|dexmedetomidine|mesh-list
92585140|NCT04729868|Bupivacaine|bupivacaine|mesh-list
92585141|NCT04729868|Levobupivacaine|levobupivacaine|mesh-list
92585142|NCT04729868|Anesthetics, Local|anesthetics, local|mesh-ancestor
92585143|NCT04729868|Anesthetics|anesthetics|mesh-ancestor
92585144|NCT04729868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585145|NCT04729868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585146|NCT04729868|Sensory System Agents|sensory system agents|mesh-ancestor
92585147|NCT04729868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585148|NCT04729868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92585149|NCT04729868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585150|NCT04729868|Analgesics|analgesics|mesh-ancestor
92585151|NCT04729868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92585152|NCT04729868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92585153|NCT04729868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92535282|NCT00074620|Protease Inhibitors|protease inhibitors|mesh-ancestor
92535283|NCT00074620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535284|NCT00074620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535285|NCT00074620|Anticoagulants|anticoagulants|mesh-ancestor
92535286|NCT00074620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92535287|NCT00074620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92535288|NCT02972333|Osimertinib|osimertinib|mesh-list
92535289|NCT02972333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585154|NCT04729868|Adrenergic Agents|adrenergic agents|mesh-ancestor
92585155|NCT04729868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585156|NCT04729868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585157|NCT00419887|Vildagliptin|vildagliptin|mesh-list
92585158|NCT00419887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92585159|NCT00419887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585160|NCT00419887|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92585161|NCT00419887|Protease Inhibitors|protease inhibitors|mesh-ancestor
92585162|NCT00419887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585163|NCT00419887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585164|NCT03690544|Apremilast|apremilast|mesh-list
92585165|NCT03690544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585166|NCT03690544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585167|NCT03690544|Analgesics|analgesics|mesh-ancestor
92585168|NCT03690544|Sensory System Agents|sensory system agents|mesh-ancestor
92585169|NCT03690544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585170|NCT03690544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585171|NCT03690544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585172|NCT03690544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585173|NCT03690544|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92585174|NCT03690544|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92585175|NCT03690544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585176|NCT03690544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585177|NCT00314977|Cyclophosphamide|cyclophosphamide|mesh-list
92585178|NCT00314977|Docetaxel|docetaxel|mesh-list
92585179|NCT00314977|Doxorubicin|doxorubicin|mesh-list
92585180|NCT00314977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92585181|NCT00314977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585182|NCT00314977|Immunologic Factors|immunologic factors|mesh-ancestor
92585183|NCT00314977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585184|NCT00314977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585185|NCT00314977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92585186|NCT00314977|Alkylating Agents|alkylating agents|mesh-ancestor
92585187|NCT00314977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585188|NCT00314977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585189|NCT00314977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92585190|NCT00314977|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585191|NCT00314977|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585192|NCT00314977|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585193|NCT00314977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92585194|NCT00314977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92585195|NCT00314977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92585196|NCT00314977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585197|NCT00315016|Eplerenone|eplerenone|mesh-list
92585198|NCT00315016|Fosinopril|fosinopril|mesh-list
92585200|NCT00315016|Hormone Antagonists|hormone antagonists|mesh-ancestor
92585201|NCT00315016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585202|NCT00315016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585203|NCT00315016|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92585204|NCT00315016|Diuretics|diuretics|mesh-ancestor
92585205|NCT00315016|Natriuretic Agents|natriuretic agents|mesh-ancestor
92585206|NCT00315016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92585207|NCT00315016|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92585208|NCT00315016|Protease Inhibitors|protease inhibitors|mesh-ancestor
92585209|NCT00315016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585210|NCT00315016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535290|NCT02972333|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535291|NCT02972333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535292|NCT02972333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585212|NCT00419068|Vitamin D|vitamin d|mesh-list
92585213|NCT00419068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92585214|NCT00419068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585215|NCT00419068|Vitamins|vitamins|mesh-ancestor
92585216|NCT00419068|Micronutrients|micronutrients|mesh-ancestor
92585217|NCT00419068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92585218|NCT00419146|Vitamins|vitamins|mesh-list
92585219|NCT00419146|Vitamin E|vitamin e|mesh-list
92585220|NCT00419146|Tocopherols|tocopherols|mesh-list
92585221|NCT00419146|Tocotrienols|tocotrienols|mesh-list
92585222|NCT00419146|alpha-Tocopherol|alpha-tocopherol|mesh-list
92585223|NCT00419146|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92585224|NCT00419146|Micronutrients|micronutrients|mesh-ancestor
92585225|NCT00419146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585226|NCT00419146|Antioxidants|antioxidants|mesh-ancestor
92585227|NCT00419146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585228|NCT00419146|Protective Agents|protective agents|mesh-ancestor
92585229|NCT00419146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92585230|NCT00419146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92585231|NCT02965196|Dexamethasone|dexamethasone|mesh-list
92585232|NCT02965196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585233|NCT02965196|Antiemetics|antiemetics|mesh-ancestor
92585234|NCT02965196|Autonomic Agents|autonomic agents|mesh-ancestor
92585235|NCT02965196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585236|NCT02965196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585237|NCT02965196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585238|NCT02965196|Glucocorticoids|glucocorticoids|mesh-ancestor
92585239|NCT02965196|Hormones|hormones|mesh-ancestor
92585240|NCT02965196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585241|NCT02965196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585242|NCT02965196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585243|NCT00091611|Cyclophosphamide|cyclophosphamide|mesh-list
92585244|NCT00091611|Fludarabine|fludarabine|mesh-list
92585245|NCT00091611|Interleukin-2|interleukin-2|mesh-list
92585246|NCT00091611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585247|NCT00091611|Immunologic Factors|immunologic factors|mesh-ancestor
92585248|NCT00091611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585249|NCT00091611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585250|NCT00091611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92585251|NCT00091611|Alkylating Agents|alkylating agents|mesh-ancestor
92585252|NCT00091611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585253|NCT00091611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585254|NCT00091611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92585255|NCT00091611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585256|NCT00091611|Analgesics|analgesics|mesh-ancestor
92585257|NCT00091611|Sensory System Agents|sensory system agents|mesh-ancestor
92585258|NCT00091611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585259|NCT00123201|Dronabinol|dronabinol|mesh-list
92585260|NCT00123201|Hallucinogens|hallucinogens|mesh-ancestor
92585261|NCT00123201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585262|NCT00123201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585263|NCT00123201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585264|NCT00123201|Analgesics|analgesics|mesh-ancestor
92585265|NCT00123201|Sensory System Agents|sensory system agents|mesh-ancestor
92585266|NCT00123201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585267|NCT00123201|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92585268|NCT00123201|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92585269|NCT00123201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585270|NCT00123201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585271|NCT00123201|Hormones|hormones|mesh-ancestor
92682796|NCT00438113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92585275|NCT03031483|Immunologic Factors|immunologic factors|mesh-ancestor
92585276|NCT03031483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585277|NCT03031483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92585278|NCT03031483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92585279|NCT03031483|Growth Substances|growth substances|mesh-ancestor
92585280|NCT03031483|Growth Inhibitors|growth inhibitors|mesh-ancestor
92585281|NCT03031483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535293|NCT00074737|Cytarabine|cytarabine|mesh-list
92535294|NCT00074737|Idarubicin|idarubicin|mesh-list
92585282|NCT03031483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92585283|NCT03031483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585284|NCT03031483|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92585285|NCT03031483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585286|NCT03031483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585287|NCT03031483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92585288|NCT03031483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92585289|NCT00091650|Olanzapine|olanzapine|mesh-list
92585290|NCT00091650|Antiemetics|antiemetics|mesh-ancestor
92585291|NCT00091650|Autonomic Agents|autonomic agents|mesh-ancestor
92585292|NCT00091650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585293|NCT00091650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585294|NCT00091650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585295|NCT00091650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92585296|NCT00091650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92585297|NCT00091650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585298|NCT00091650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585299|NCT00091650|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92585300|NCT00091650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92585301|NCT00091650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92585302|NCT00091650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585303|NCT00091650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585304|NCT00091650|Serotonin Agents|serotonin agents|mesh-ancestor
92585305|NCT02645149|Trametinib|trametinib|mesh-list
92585306|NCT02645149|Ceritinib|ceritinib|mesh-list
92585307|NCT02645149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585308|NCT02645149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585309|NCT02645149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585310|NCT02645149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585311|NCT01691833|Vitamin D|vitamin d|mesh-list
92585312|NCT01691833|Vitamins|vitamins|mesh-ancestor
92585313|NCT01691833|Micronutrients|micronutrients|mesh-ancestor
92585314|NCT01691833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585315|NCT01691833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92585316|NCT00091728|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92585317|NCT00091728|Contraceptive Agents|contraceptive agents|mesh-list
92585318|NCT00091728|Medroxyprogesterone|medroxyprogesterone|mesh-list
92585319|NCT00091728|Contraceptives, Oral|contraceptives, oral|mesh-list
92585320|NCT00091728|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92585321|NCT00091728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92585322|NCT00091728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585323|NCT00091728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92585324|NCT00091728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92585325|NCT00091728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92585326|NCT00091728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92585327|NCT00091728|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92585328|NCT00091728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585329|NCT00091728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585330|NCT00123279|Plasminogen|plasminogen|mesh-list
92585331|NCT00123279|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92585332|NCT00123279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92585333|NCT00123279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585334|NCT00091806|Panitumumab|panitumumab|mesh-list
92585335|NCT00091806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92585336|NCT00091806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585337|NCT01589302|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92585338|NCT01589302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585339|NCT01589302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585340|NCT01589302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585346|NCT00123318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585348|NCT00123318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585349|NCT00123318|Immunologic Factors|immunologic factors|mesh-ancestor
92585350|NCT00123318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585351|NCT00123318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92585352|NCT00123318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92585353|NCT00123318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92585354|NCT00123318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585355|NCT00327535|Epoetin Alfa|epoetin alfa|mesh-list
92585356|NCT00327535|Darbepoetin alfa|darbepoetin alfa|mesh-list
92585357|NCT00327535|Hematinics|hematinics|mesh-ancestor
91932208|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92585358|NCT00327691|Atorvastatin|atorvastatin|mesh-list
92585359|NCT00327691|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92585360|NCT00327691|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92585361|NCT00327691|Antimetabolites|antimetabolites|mesh-ancestor
92585362|NCT00327691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585363|NCT00327691|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92585364|NCT00327691|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92585365|NCT00327691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585366|NCT03913832|Sirolimus|sirolimus|mesh-list
92585367|NCT03913832|Paclitaxel|paclitaxel|mesh-list
92585368|NCT03913832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92585369|NCT03913832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585370|NCT03913832|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585371|NCT03913832|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585372|NCT03913832|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585373|NCT03913832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585374|NCT03913832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92585375|NCT03913832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585376|NCT03913832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92585377|NCT03913832|Antifungal Agents|antifungal agents|mesh-ancestor
92585378|NCT03913832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585379|NCT03913832|Immunologic Factors|immunologic factors|mesh-ancestor
92585380|NCT03913832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585381|NCT00327730|Eperisone|eperisone|mesh-list
92585382|NCT00327730|Anticonvulsants|anticonvulsants|mesh-ancestor
92585383|NCT00327730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92585384|NCT00327730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92585385|NCT00327730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585386|NCT00327730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92585387|NCT00327730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585388|NCT00327730|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92585389|NCT00327730|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92585390|NCT00327730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585391|NCT00327730|Parasympatholytics|parasympatholytics|mesh-ancestor
92585392|NCT00327730|Autonomic Agents|autonomic agents|mesh-ancestor
92585393|NCT00327730|Vasodilator Agents|vasodilator agents|mesh-ancestor
92585394|NCT04716868|Levan|levan|mesh-list
92585395|NCT04716868|Psyllium|psyllium|mesh-list
92585396|NCT04716868|Cathartics|cathartics|mesh-ancestor
92585397|NCT04716868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585398|NCT04716868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585399|NCT00327769|Fulvestrant|fulvestrant|mesh-list
92585400|NCT00327769|Anastrozole|anastrozole|mesh-list
92585401|NCT00327769|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585402|NCT00327769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585403|NCT00327769|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92585404|NCT00327769|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92585405|NCT00327769|Hormone Antagonists|hormone antagonists|mesh-ancestor
92585406|NCT00327769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585407|NCT00327769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585408|NCT00327769|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92585409|NCT00327769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92585410|NCT00327769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585411|NCT00327769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585412|NCT00092001|Sunitinib|sunitinib|mesh-list
92585457|NCT00092079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585459|NCT00092079|Micronutrients|micronutrients|mesh-ancestor
92585460|NCT00092079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92585461|NCT00327847|Vitamin D|vitamin d|mesh-list
92585462|NCT00327847|Vitamins|vitamins|mesh-ancestor
92585463|NCT00327847|Micronutrients|micronutrients|mesh-ancestor
92585464|NCT00327847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585465|NCT00327847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92585466|NCT00327925|Antibodies|antibodies|mesh-list
92585467|NCT00327925|Immunologic Factors|immunologic factors|mesh-ancestor
92585468|NCT00327925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585469|NCT03709550|Decitabine|decitabine|mesh-list
92585470|NCT03709550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92585471|NCT03709550|Antimetabolites|antimetabolites|mesh-ancestor
92585472|NCT03709550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585473|NCT03709550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585474|NCT03709550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585475|NCT00315211|Docetaxel|docetaxel|mesh-list
92585476|NCT00315211|Topotecan|topotecan|mesh-list
92535295|NCT00074737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535296|NCT00074737|Antimetabolites|antimetabolites|mesh-ancestor
92535297|NCT00074737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535298|NCT00074737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535299|NCT00074737|Antiviral Agents|antiviral agents|mesh-ancestor
92535300|NCT00074737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535301|NCT00074737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535302|NCT00074737|Immunologic Factors|immunologic factors|mesh-ancestor
92585477|NCT00315211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585478|NCT00315211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585479|NCT00315211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585480|NCT00315211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585481|NCT00315211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585482|NCT00315211|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92585483|NCT00315211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92585484|NCT00315211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585486|NCT00315367|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92585487|NCT00315367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585488|NCT00315367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585489|NCT00315367|Cholinergic Agents|cholinergic agents|mesh-ancestor
92585490|NCT00315367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585491|NCT00315367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585492|NCT00315367|Nootropic Agents|nootropic agents|mesh-ancestor
92585493|NCT00315484|Epoetin Alfa|epoetin alfa|mesh-list
92585494|NCT00315484|Darbepoetin alfa|darbepoetin alfa|mesh-list
92585495|NCT00315484|Hematinics|hematinics|mesh-ancestor
92585496|NCT00315523|Levocetirizine|levocetirizine|mesh-list
92585497|NCT00315523|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92585498|NCT00315523|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92585499|NCT00315523|Histamine Antagonists|histamine antagonists|mesh-ancestor
92585500|NCT00315523|Histamine Agents|histamine agents|mesh-ancestor
92585501|NCT00315523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585502|NCT00315523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585503|NCT00315523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585505|NCT00092196|Antiemetics|antiemetics|mesh-ancestor
92585506|NCT00092196|Autonomic Agents|autonomic agents|mesh-ancestor
92585507|NCT00092196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585508|NCT00092196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585509|NCT00092196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585510|NCT00092196|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92585511|NCT00092196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585512|NCT00092196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585513|NCT00315601|Azithromycin|azithromycin|mesh-list
92585514|NCT00315601|Telithromycin|telithromycin|mesh-list
92585515|NCT00315601|Dimercaprol|dimercaprol|mesh-list
92585516|NCT00315601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92585517|NCT00315601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585518|NCT00315601|Chelating Agents|chelating agents|mesh-ancestor
92585519|NCT00315601|Sequestering Agents|sequestering agents|mesh-ancestor
92585520|NCT00315601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585521|NCT00315679|Pentoxifylline|pentoxifylline|mesh-list
92585522|NCT00315679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92585525|NCT00315679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92585526|NCT00315679|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92585527|NCT00315679|Protective Agents|protective agents|mesh-ancestor
92585528|NCT00315679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585529|NCT00315679|Vasodilator Agents|vasodilator agents|mesh-ancestor
92585530|NCT00315679|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92585531|NCT00315679|Antioxidants|antioxidants|mesh-ancestor
92585532|NCT00092274|Ofatumumab|ofatumumab|mesh-list
92585533|NCT00092274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585534|NCT00315835|Buprenorphine|buprenorphine|mesh-list
92585535|NCT00315835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92585536|NCT00315835|Narcotics|narcotics|mesh-ancestor
92585537|NCT00315835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585538|NCT00315835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535303|NCT00074737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535304|NCT00074737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92585539|NCT00315835|Analgesics|analgesics|mesh-ancestor
92585540|NCT00315835|Sensory System Agents|sensory system agents|mesh-ancestor
92585541|NCT00315835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585542|NCT00315835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92585543|NCT00315874|Buprenorphine|buprenorphine|mesh-list
92585544|NCT00315874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92585545|NCT00315874|Narcotics|narcotics|mesh-ancestor
92585546|NCT00315874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585547|NCT00315874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585548|NCT00315874|Analgesics|analgesics|mesh-ancestor
92585549|NCT00315874|Sensory System Agents|sensory system agents|mesh-ancestor
92585550|NCT00315874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585551|NCT00315874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92585552|NCT00315913|Propranolol|propranolol|mesh-list
92585553|NCT00315913|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92585554|NCT00315913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92585555|NCT00315913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92585556|NCT00315913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750759|NCT05936489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92585557|NCT00315913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585558|NCT00315913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585559|NCT00315913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92585560|NCT00315913|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92585561|NCT00315913|Vasodilator Agents|vasodilator agents|mesh-ancestor
92585562|NCT00092313|Acetaminophen|acetaminophen|mesh-list
92585563|NCT00092313|Rofecoxib|rofecoxib|mesh-list
92585564|NCT00092313|Oxycodone|oxycodone|mesh-list
92585565|NCT00092313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585566|NCT00092313|Analgesics|analgesics|mesh-ancestor
92585567|NCT00092313|Sensory System Agents|sensory system agents|mesh-ancestor
92585568|NCT00092313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585569|NCT00092313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585570|NCT00092313|Antipyretics|antipyretics|mesh-ancestor
92585571|NCT00092313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92585572|NCT00092313|Narcotics|narcotics|mesh-ancestor
92585573|NCT00092313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585574|NCT00092313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92585575|NCT00092313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92585576|NCT00092313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585577|NCT00092313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585578|NCT00092313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585579|NCT00092313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585580|NCT00092313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585581|NCT00399971|Immunomodulating Agents|immunomodulating agents|mesh-list
92585582|NCT00399971|Immunologic Factors|immunologic factors|mesh-list
92585583|NCT00399971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585585|NCT00316030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585586|NCT00123552|Artesunate|artesunate|mesh-list
92585587|NCT00123552|Lumefantrine|lumefantrine|mesh-list
92585588|NCT00123552|Artemether|artemether|mesh-list
92585589|NCT00123552|Pyrimethamine|pyrimethamine|mesh-list
92585590|NCT00123552|Sulfadoxine|sulfadoxine|mesh-list
92585591|NCT00123552|Amodiaquine|amodiaquine|mesh-list
92585592|NCT00123552|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92585593|NCT00123552|Antimalarials|antimalarials|mesh-ancestor
92585594|NCT00123552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92585595|NCT00123552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92585596|NCT00123552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585597|NCT00123552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585598|NCT00123552|Antiviral Agents|antiviral agents|mesh-ancestor
92585601|NCT00123552|Anthelmintics|anthelmintics|mesh-ancestor
92585602|NCT00123552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92585603|NCT00123552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585604|NCT00123552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585605|NCT00123552|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92585607|NCT03352427|Dasatinib|dasatinib|mesh-list
92585608|NCT03352427|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92585609|NCT03352427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585610|NCT03352427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585611|NCT03352427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585612|NCT03352427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585613|NCT03352427|Immunologic Factors|immunologic factors|mesh-ancestor
92585614|NCT03352427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535305|NCT00074737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91932445|NCT02322892|Thiamine|thiamine|mesh-list
92585615|NCT03352427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585616|NCT00316420|Gemcitabine|gemcitabine|mesh-list
92585617|NCT00316420|Capecitabine|capecitabine|mesh-list
92585618|NCT00316420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92585619|NCT00316420|Antimetabolites|antimetabolites|mesh-ancestor
92585620|NCT00316420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585621|NCT00316420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585622|NCT00092352|Celecoxib|celecoxib|mesh-list
92585623|NCT00092352|Rofecoxib|rofecoxib|mesh-list
92585624|NCT00092352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585625|NCT00092352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585626|NCT00092352|Analgesics|analgesics|mesh-ancestor
92585627|NCT00092352|Sensory System Agents|sensory system agents|mesh-ancestor
92585628|NCT00092352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585629|NCT00092352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585630|NCT00092352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585631|NCT00092352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585632|NCT00092352|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92585633|NCT00092352|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92585634|NCT00092352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585635|NCT00092352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585636|NCT00316498|Miglustat|miglustat|mesh-list
92585637|NCT00316498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585638|NCT00316498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585639|NCT00316498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92585640|NCT00316498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92585641|NCT00316498|Antiviral Agents|antiviral agents|mesh-ancestor
92585642|NCT00316498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585643|NCT00316498|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92585644|NCT00316498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92585645|NCT00316498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585646|NCT00316810|Alemtuzumab|alemtuzumab|mesh-list
92585647|NCT00316810|Thymoglobulin|thymoglobulin|mesh-list
92585648|NCT00316810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92585649|NCT00316810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585650|NCT00316810|Immunologic Factors|immunologic factors|mesh-ancestor
92585651|NCT00316810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585652|NCT00316810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585653|NCT00092391|Vaccines|vaccines|mesh-list
92585654|NCT00092391|Immunologic Factors|immunologic factors|mesh-ancestor
92585655|NCT00092391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585656|NCT00316849|Sirolimus|sirolimus|mesh-list
92585657|NCT00316849|Temozolomide|temozolomide|mesh-list
92585658|NCT00316849|Temsirolimus|temsirolimus|mesh-list
92585659|NCT00316849|MTOR Inhibitors|mtor inhibitors|mesh-list
92585660|NCT00316849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92585661|NCT00316849|Alkylating Agents|alkylating agents|mesh-ancestor
92585662|NCT00316849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585663|NCT00316849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585664|NCT00316849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585665|NCT00316849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585666|NCT00316849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585667|NCT00316849|Immunologic Factors|immunologic factors|mesh-ancestor
92585668|NCT00316849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585669|NCT00316849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92585670|NCT00316849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585671|NCT00316849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92585677|NCT03272477|Trastuzumab|trastuzumab|mesh-list
92585678|NCT03272477|Letrozole|letrozole|mesh-list
92585679|NCT03272477|Epirubicin|epirubicin|mesh-list
92585680|NCT03272477|Pertuzumab|pertuzumab|mesh-list
92585681|NCT03272477|Anastrozole|anastrozole|mesh-list
92585682|NCT03272477|Exemestane|exemestane|mesh-list
92585683|NCT03272477|Goserelin|goserelin|mesh-list
92585684|NCT03272477|Leuprolide|leuprolide|mesh-list
92585685|NCT03272477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92585686|NCT03272477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585687|NCT03272477|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585688|NCT03272477|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585689|NCT03272477|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585690|NCT03272477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585691|NCT03272477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585692|NCT03272477|Immunologic Factors|immunologic factors|mesh-ancestor
92585693|NCT03272477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535306|NCT00074737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932512|NCT04467931|Isradipine|isradipine|mesh-list
92585694|NCT03272477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585695|NCT03272477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92585696|NCT03272477|Alkylating Agents|alkylating agents|mesh-ancestor
92585697|NCT03272477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92585698|NCT03272477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92585699|NCT03272477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92585700|NCT03272477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92585701|NCT03272477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585702|NCT03272477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92585703|NCT03272477|Hormone Antagonists|hormone antagonists|mesh-ancestor
92585704|NCT03272477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585705|NCT03272477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92585706|NCT03272477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92585707|NCT03272477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92585708|NCT03272477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585709|NCT03272477|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92585710|NCT03272477|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92585711|NCT03272477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92585712|NCT03272477|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92585713|NCT03272477|Fertility Agents|fertility agents|mesh-ancestor
92585714|NCT03272477|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92585715|NCT02959957|Cefotaxime|cefotaxime|mesh-list
92585716|NCT02959957|Cefoxitin|cefoxitin|mesh-list
92585717|NCT02959957|Temocillin|temocillin|mesh-list
92585718|NCT02959957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92585719|NCT02959957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585720|NCT00316927|Aspirin|aspirin|mesh-list
92585721|NCT00316927|Dexamethasone|dexamethasone|mesh-list
92585722|NCT00316927|Fosfestrol|fosfestrol|mesh-list
92585723|NCT00316927|Diethylstilbestrol|diethylstilbestrol|mesh-list
92585724|NCT00316927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585725|NCT00316927|Antiemetics|antiemetics|mesh-ancestor
92585726|NCT00316927|Autonomic Agents|autonomic agents|mesh-ancestor
92585727|NCT00316927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585728|NCT00316927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585729|NCT00316927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585730|NCT00316927|Glucocorticoids|glucocorticoids|mesh-ancestor
92585731|NCT00316927|Hormones|hormones|mesh-ancestor
92585732|NCT00316927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585733|NCT00316927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585734|NCT00316927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585735|NCT00316927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585736|NCT00316927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585737|NCT00316927|Analgesics|analgesics|mesh-ancestor
92585738|NCT00316927|Sensory System Agents|sensory system agents|mesh-ancestor
92585739|NCT00316927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585740|NCT00316927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92585741|NCT00316927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92585742|NCT00316927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585743|NCT00316927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92585744|NCT00316927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92585749|NCT00123669|Progesterone|progesterone|mesh-list
92585750|NCT00123669|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92585751|NCT00123669|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92585752|NCT00123669|Progestins|progestins|mesh-ancestor
92585753|NCT00123669|Hormones|hormones|mesh-ancestor
92585754|NCT00123669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585755|NCT00123669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585756|NCT00123669|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92585757|NCT00123669|Hormone Antagonists|hormone antagonists|mesh-ancestor
92585758|NCT00317200|Paclitaxel|paclitaxel|mesh-list
92585759|NCT00317200|Bevacizumab|bevacizumab|mesh-list
92585760|NCT00317200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92585761|NCT00317200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585762|NCT00317200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585763|NCT00317200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585764|NCT00317200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585765|NCT00317200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585766|NCT00317200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92585767|NCT00317200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92585768|NCT00317200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92535307|NCT00074737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535308|NCT00074776|Lamotrigine|lamotrigine|mesh-list
92535309|NCT00074776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585769|NCT00317200|Growth Substances|growth substances|mesh-ancestor
92585770|NCT00317200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585771|NCT00317200|Growth Inhibitors|growth inhibitors|mesh-ancestor
92585772|NCT02960035|Etanercept|etanercept|mesh-list
92585773|NCT02960035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585774|NCT02960035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585775|NCT02960035|Analgesics|analgesics|mesh-ancestor
92585776|NCT02960035|Sensory System Agents|sensory system agents|mesh-ancestor
92585777|NCT02960035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585778|NCT02960035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585779|NCT02960035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585780|NCT02960035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585781|NCT02960035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92585782|NCT02960035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585783|NCT02960035|Immunologic Factors|immunologic factors|mesh-ancestor
92585784|NCT00317434|Lapatinib|lapatinib|mesh-list
92585785|NCT00317434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585786|NCT00317434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585787|NCT00317434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585788|NCT00317434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585789|NCT00328120|Fulvestrant|fulvestrant|mesh-list
92585790|NCT00328120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92585791|NCT00328120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585792|NCT00328120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92585793|NCT00328120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92585794|NCT00328120|Hormone Antagonists|hormone antagonists|mesh-ancestor
92585795|NCT00328120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585796|NCT00328120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585797|NCT00328393|Pioglitazone|pioglitazone|mesh-list
92585798|NCT00328393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92585799|NCT00328393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585800|NCT00328432|Celecoxib|celecoxib|mesh-list
92585801|NCT00328432|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585802|NCT00328432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585803|NCT00328432|Analgesics|analgesics|mesh-ancestor
92585804|NCT00328432|Sensory System Agents|sensory system agents|mesh-ancestor
92585805|NCT00328432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585806|NCT00328432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585807|NCT00328432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585808|NCT00328432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585809|NCT00328432|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92585810|NCT00328432|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92585811|NCT00328432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585812|NCT00328432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585813|NCT02571725|Olaparib|olaparib|mesh-list
92585814|NCT02571725|Tremelimumab|tremelimumab|mesh-list
92585815|NCT02571725|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92585817|NCT02571725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585818|NCT02571725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585819|NCT00328549|Interferons|interferons|mesh-list
92585820|NCT00328549|Ribavirin|ribavirin|mesh-list
92585821|NCT00328549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585822|NCT00328549|Antiviral Agents|antiviral agents|mesh-ancestor
92585823|NCT00328549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585824|NCT00328549|Antimetabolites|antimetabolites|mesh-ancestor
92585825|NCT00328549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585826|NCT00092508|Mesalamine|mesalamine|mesh-list
92585827|NCT00092508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92585828|NCT00092508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585829|NCT00092508|Analgesics|analgesics|mesh-ancestor
92585830|NCT00092508|Sensory System Agents|sensory system agents|mesh-ancestor
92585831|NCT00092508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585832|NCT00092508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585833|NCT00092508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585834|NCT00092508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92585835|NCT00328822|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92585836|NCT00328822|Antidepressive Agents|antidepressive agents|mesh-ancestor
92585837|NCT00328822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585838|NCT00328822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92535310|NCT00074776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535311|NCT00074776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92585839|NCT00328822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92585840|NCT00328822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585841|NCT00328822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585842|NCT00420043|Imatinib Mesylate|imatinib mesylate|mesh-list
92585843|NCT00420043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585844|NCT00420043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585845|NCT00420043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585846|NCT00420043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585847|NCT00420082|Cetirizine|cetirizine|mesh-list
92585848|NCT00420082|Fexofenadine|fexofenadine|mesh-list
92585849|NCT00420082|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92585850|NCT00420082|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92585851|NCT00420082|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92585852|NCT00420082|Histamine Antagonists|histamine antagonists|mesh-ancestor
92585853|NCT00420082|Histamine Agents|histamine agents|mesh-ancestor
92585854|NCT00420082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585855|NCT00420082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585856|NCT00420082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585857|NCT01821833|Paclitaxel|paclitaxel|mesh-list
92585858|NCT01821833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92585859|NCT01821833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585860|NCT01821833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585861|NCT01821833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585862|NCT01821833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585863|NCT01821833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585864|NCT00328900|Atropine|atropine|mesh-list
92585865|NCT00328900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92585866|NCT00328900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92585867|NCT00328900|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92585868|NCT00328900|Autonomic Agents|autonomic agents|mesh-ancestor
92585869|NCT00328900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585870|NCT00328900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585871|NCT00328900|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92310745|NCT02237196|Immunomodulating Agents|immunomodulating agents|mesh-list
92585872|NCT00328900|Respiratory System Agents|respiratory system agents|mesh-ancestor
92585873|NCT00328900|Mydriatics|mydriatics|mesh-ancestor
92585874|NCT00328900|Parasympatholytics|parasympatholytics|mesh-ancestor
92585875|NCT00328900|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92585876|NCT00328900|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92585877|NCT00328900|Cholinergic Agents|cholinergic agents|mesh-ancestor
92585878|NCT00328900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585879|NCT00328900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585880|NCT00328939|Enoxaparin|enoxaparin|mesh-list
92585881|NCT00328939|PENTA|penta|mesh-list
92585882|NCT00328939|Fondaparinux|fondaparinux|mesh-list
92585883|NCT00328939|Anticoagulants|anticoagulants|mesh-ancestor
92585884|NCT00328939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92585885|NCT00328939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92585886|NCT00328939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585887|NCT00328939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92585888|NCT00328939|Antithrombins|antithrombins|mesh-ancestor
92682797|NCT00438113|Sympatholytics|sympatholytics|mesh-ancestor
92585890|NCT00328939|Protease Inhibitors|protease inhibitors|mesh-ancestor
92585891|NCT00328939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585892|NCT00328978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92585893|NCT00328978|Antidepressive Agents|antidepressive agents|mesh-ancestor
92585894|NCT00328978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585895|NCT00328978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92585896|NCT00328978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92585897|NCT00328978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585898|NCT00328978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585899|NCT00329095|Bimatoprost|bimatoprost|mesh-list
92585900|NCT00329095|Travoprost|travoprost|mesh-list
92585901|NCT00329095|Antihypertensive Agents|antihypertensive agents|mesh-list
92585902|NCT00329095|Latanoprost|latanoprost|mesh-list
92585903|NCT00329095|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92585904|NCT00329095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92585905|NCT00329134|Quinine|quinine|mesh-list
92585906|NCT00329134|Antimalarials|antimalarials|mesh-ancestor
92585907|NCT00329134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92585908|NCT00329134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92585909|NCT00329134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932736|NCT02365935|Cisplatin|cisplatin|mesh-list
92585910|NCT00329134|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92585911|NCT00329134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585912|NCT00329134|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92585913|NCT00329134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585914|NCT00329134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585915|NCT00329134|Analgesics|analgesics|mesh-ancestor
92585916|NCT00329134|Sensory System Agents|sensory system agents|mesh-ancestor
92585917|NCT00329173|Atorvastatin|atorvastatin|mesh-list
92585918|NCT00329173|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92585919|NCT00329173|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92585920|NCT00329173|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92585921|NCT00329173|Antimetabolites|antimetabolites|mesh-ancestor
92585922|NCT00329173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585923|NCT00329173|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92585924|NCT00329173|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92585925|NCT00329173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585926|NCT00123825|Gemcitabine|gemcitabine|mesh-list
92585927|NCT00123825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585928|NCT00123825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92585929|NCT00123825|Antimetabolites|antimetabolites|mesh-ancestor
92585930|NCT00123825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585931|NCT00329329|Capecitabine|capecitabine|mesh-list
92585932|NCT00329329|Satraplatin|satraplatin|mesh-list
92585933|NCT00329329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92585934|NCT00329329|Antimetabolites|antimetabolites|mesh-ancestor
92585935|NCT00329329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585936|NCT00329329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585937|NCT00329368|Folic Acid|folic acid|mesh-list
92585938|NCT00329368|Vitamin B Complex|vitamin b complex|mesh-list
92585939|NCT00329368|Interferons|interferons|mesh-list
92585940|NCT00329368|Interferon-alpha|interferon-alpha|mesh-list
92585941|NCT00329368|Interleukin-2|interleukin-2|mesh-list
92585942|NCT00329368|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92585943|NCT00329368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585944|NCT00329368|Antiviral Agents|antiviral agents|mesh-ancestor
92585945|NCT00329368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92585946|NCT00329368|Immunologic Factors|immunologic factors|mesh-ancestor
92585947|NCT00329368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585948|NCT00329368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92585949|NCT00329368|Analgesics|analgesics|mesh-ancestor
92585950|NCT00329368|Sensory System Agents|sensory system agents|mesh-ancestor
92585951|NCT00329368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585952|NCT00329368|Hematinics|hematinics|mesh-ancestor
92585953|NCT00329368|Vitamins|vitamins|mesh-ancestor
92585954|NCT00329368|Micronutrients|micronutrients|mesh-ancestor
92585955|NCT00329368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92585956|NCT00329446|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92585957|NCT00329446|Escitalopram|escitalopram|mesh-list
92585958|NCT00329446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92585959|NCT00329446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92585960|NCT00329446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92585961|NCT00329446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585962|NCT00329446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92585963|NCT00329446|Serotonin Agents|serotonin agents|mesh-ancestor
92585964|NCT00329446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585966|NCT00329446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92585967|NCT00329446|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92585968|NCT00329446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92585969|NCT00329446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92585970|NCT00092937|Busulfan|busulfan|mesh-list
92585971|NCT00092937|Alkylating Agents|alkylating agents|mesh-ancestor
92585972|NCT00092937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585973|NCT00092937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585974|NCT00092937|Immunologic Factors|immunologic factors|mesh-ancestor
92585975|NCT00092937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585976|NCT00092937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92585977|NCT00092937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585978|NCT00092937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92585979|NCT00420277|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92585980|NCT00420277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92585981|NCT00420277|Plasma Substitutes|plasma substitutes|mesh-ancestor
92585982|NCT00420277|Blood Substitutes|blood substitutes|mesh-ancestor
92585983|NCT04716751|Paclitaxel|paclitaxel|mesh-list
92585984|NCT04716751|Carboplatin|carboplatin|mesh-list
92535312|NCT00074776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535313|NCT00074776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585985|NCT04716751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92585986|NCT04716751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585987|NCT04716751|Tubulin Modulators|tubulin modulators|mesh-ancestor
92585988|NCT04716751|Antimitotic Agents|antimitotic agents|mesh-ancestor
92585989|NCT04716751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92585990|NCT04716751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585992|NCT00123903|Carvedilol|carvedilol|mesh-list
92585993|NCT00123903|Lisinopril|lisinopril|mesh-list
92585994|NCT00123903|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92585995|NCT00123903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92585996|NCT00123903|Sympatholytics|sympatholytics|mesh-ancestor
92585997|NCT00123903|Autonomic Agents|autonomic agents|mesh-ancestor
92585998|NCT00123903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585999|NCT00123903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586000|NCT00123903|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92586001|NCT00123903|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92586002|NCT00123903|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92586003|NCT00123903|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586004|NCT00123903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586005|NCT00123903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586006|NCT00123903|Antioxidants|antioxidants|mesh-ancestor
92586007|NCT00123903|Protective Agents|protective agents|mesh-ancestor
92586008|NCT00123903|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92586009|NCT00123903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586010|NCT00123903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586011|NCT00123903|Vasodilator Agents|vasodilator agents|mesh-ancestor
92586012|NCT00123903|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92586013|NCT00123903|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92586014|NCT00123903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92586015|NCT00123903|Protease Inhibitors|protease inhibitors|mesh-ancestor
92586016|NCT00123903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586017|NCT00123903|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92586018|NCT00329680|Evening primrose oil|evening primrose oil|mesh-list
92586019|NCT00329680|Antioxidants|antioxidants|mesh-list
92586020|NCT00329680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586021|NCT00329680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586022|NCT00329680|Protective Agents|protective agents|mesh-ancestor
92586023|NCT00329680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586024|NCT00329680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586025|NCT00329680|Analgesics|analgesics|mesh-ancestor
92586026|NCT00329680|Sensory System Agents|sensory system agents|mesh-ancestor
92586027|NCT00329680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586028|NCT00329680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586029|NCT00329680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586030|NCT00329680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92586031|NCT00329680|Antimetabolites|antimetabolites|mesh-ancestor
92586032|NCT00329680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92586033|NCT00329680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92586034|NCT00329758|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92586035|NCT00329758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92586036|NCT00329758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92586037|NCT00329758|Antimetabolites|antimetabolites|mesh-ancestor
92682798|NCT00438113|Autonomic Agents|autonomic agents|mesh-ancestor
92586040|NCT00329758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92586041|NCT00329758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586042|NCT00329914|Progesterone|progesterone|mesh-list
92586043|NCT00329914|Progestins|progestins|mesh-ancestor
92586044|NCT00329914|Hormones|hormones|mesh-ancestor
92586045|NCT00329914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586046|NCT00329914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586047|NCT00092976|Factor VIII|factor viii|mesh-list
92586048|NCT00092976|Coagulants|coagulants|mesh-ancestor
92586049|NCT00083876|Thalidomide|thalidomide|mesh-list
92586050|NCT00083876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586051|NCT00083876|Immunologic Factors|immunologic factors|mesh-ancestor
92586052|NCT00083876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586053|NCT00083876|Leprostatic Agents|leprostatic agents|mesh-ancestor
92586054|NCT00083876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586055|NCT00083876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535315|NCT00074776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92535316|NCT00074776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586056|NCT00083876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92586057|NCT00083876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92586058|NCT00083876|Growth Substances|growth substances|mesh-ancestor
92586059|NCT00083876|Growth Inhibitors|growth inhibitors|mesh-ancestor
92586060|NCT00083876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586061|NCT00330148|Eflornithine|eflornithine|mesh-list
92586062|NCT00330148|Nifurtimox|nifurtimox|mesh-list
92586063|NCT00330148|Melarsoprol|melarsoprol|mesh-list
92586064|NCT00330148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586065|NCT00330148|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92586066|NCT00330148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92586067|NCT00330148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92586068|NCT00330148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586069|NCT00330148|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92586070|NCT00330148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586071|NCT00330148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586072|NCT00093093|Interferons|interferons|mesh-list
92586073|NCT00093093|Ribavirin|ribavirin|mesh-list
92586074|NCT00093093|Interferon-alpha|interferon-alpha|mesh-list
92586075|NCT00093093|Interferon alpha-2|interferon alpha-2|mesh-list
92586076|NCT00093093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92586077|NCT00093093|Taribavirin|taribavirin|mesh-list
92586078|NCT00093093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586079|NCT00093093|Antiviral Agents|antiviral agents|mesh-ancestor
92586080|NCT00093093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586081|NCT00093093|Antimetabolites|antimetabolites|mesh-ancestor
92586082|NCT00093093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586083|NCT00093093|Immunologic Factors|immunologic factors|mesh-ancestor
92586084|NCT00093093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586085|NCT00330304|Isoniazid|isoniazid|mesh-list
92586086|NCT00330304|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92586087|NCT00330304|Antitubercular Agents|antitubercular agents|mesh-ancestor
92586088|NCT00330304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586089|NCT00330304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586090|NCT00330304|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92586091|NCT00330304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92586092|NCT00330304|Antimetabolites|antimetabolites|mesh-ancestor
92586093|NCT00330304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586094|NCT00330304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92586095|NCT00330304|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92586096|NCT00330304|Antimalarials|antimalarials|mesh-ancestor
92586097|NCT00330304|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92586098|NCT00330304|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92310972|NCT00367562|Protease Inhibitors|protease inhibitors|mesh-ancestor
92586099|NCT00330499|Cisplatin|cisplatin|mesh-list
92586100|NCT00330499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586101|NCT00083954|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92586102|NCT00083954|Antidepressive Agents|antidepressive agents|mesh-ancestor
92586103|NCT00083954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586104|NCT00083954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92586105|NCT00083954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92586106|NCT00083954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586107|NCT00083954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586109|NCT00330577|Latanoprost|latanoprost|mesh-list
92586110|NCT00330577|Lubricant Eye Drops|lubricant eye drops|mesh-list
91993255|NCT05422027|Bortezomib|bortezomib|mesh-list
92586112|NCT00330577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92586113|NCT00330577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92586114|NCT00330577|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586115|NCT00330577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586116|NCT00330577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586117|NCT00330577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92586118|NCT00330577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92586119|NCT00330577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92586120|NCT00330577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92586122|NCT00083993|Letrozole|letrozole|mesh-list
92586123|NCT00083993|Temsirolimus|temsirolimus|mesh-list
92586124|NCT00083993|MTOR Inhibitors|mtor inhibitors|mesh-list
92586125|NCT00083993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586126|NCT00083993|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92586127|NCT00083993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92586128|NCT00083993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932958|NCT05092841|Sorbitol|sorbitol|mesh-list
92586129|NCT00083993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586130|NCT00083993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92586131|NCT00083993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92586132|NCT00083993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586133|NCT00083993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586134|NCT00083993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586135|NCT00083993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586136|NCT00083993|Immunologic Factors|immunologic factors|mesh-ancestor
92586137|NCT00083993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586138|NCT00083993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586139|NCT00083993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586140|NCT00083993|Antifungal Agents|antifungal agents|mesh-ancestor
92586141|NCT00323791|Gemcitabine|gemcitabine|mesh-list
92586142|NCT00323791|Imatinib Mesylate|imatinib mesylate|mesh-list
92586143|NCT00323791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586144|NCT00323791|Antimetabolites|antimetabolites|mesh-ancestor
92586145|NCT00323791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586146|NCT00323791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586147|NCT00323791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586148|NCT00323791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586149|NCT00323830|Capecitabine|capecitabine|mesh-list
92586150|NCT00323830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586151|NCT00323830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586152|NCT00323830|Antimetabolites|antimetabolites|mesh-ancestor
92586153|NCT00323830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586154|NCT00317512|Chrysarobin|chrysarobin|mesh-list
92586155|NCT00317512|HBOC 201|hboc 201|mesh-list
92586156|NCT00317512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586157|NCT00317512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586158|NCT00317512|Analgesics|analgesics|mesh-ancestor
92586159|NCT00317512|Sensory System Agents|sensory system agents|mesh-ancestor
92586160|NCT00317512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586161|NCT00317512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586162|NCT00317512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586163|NCT00317512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586164|NCT00317512|Blood Substitutes|blood substitutes|mesh-ancestor
92586165|NCT00124059|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92586166|NCT00124059|Antidepressive Agents|antidepressive agents|mesh-ancestor
92586167|NCT00124059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586168|NCT00124059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92586169|NCT00124059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92586170|NCT00124059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586171|NCT00124059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586172|NCT00084032|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92586173|NCT00084032|Antiviral Agents|antiviral agents|mesh-ancestor
92311046|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586174|NCT00084032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586175|NCT00323947|Methylphenidate|methylphenidate|mesh-list
92586176|NCT00323947|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92586177|NCT00323947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586178|NCT00323947|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92586179|NCT00323947|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92586180|NCT00323947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586181|NCT00323947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586186|NCT00323986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586188|NCT00324025|Antifungal Agents|antifungal agents|mesh-ancestor
92586189|NCT00324025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586190|NCT00317629|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92586191|NCT00317629|Nitric Oxide|nitric oxide|mesh-list
92586192|NCT00317629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92586193|NCT00317629|Autonomic Agents|autonomic agents|mesh-ancestor
92586194|NCT00317629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586195|NCT00317629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586196|NCT00317629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92586197|NCT00317629|Respiratory System Agents|respiratory system agents|mesh-ancestor
92586198|NCT00317629|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92586199|NCT00317629|Antioxidants|antioxidants|mesh-ancestor
92586200|NCT00317629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586201|NCT00317629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586202|NCT00317629|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92535317|NCT00074776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92535318|NCT00074776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92535319|NCT00074776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92586203|NCT00317629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92586204|NCT00317629|Gasotransmitters|gasotransmitters|mesh-ancestor
92586205|NCT00317629|Protective Agents|protective agents|mesh-ancestor
92586206|NCT00317629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92586207|NCT00317629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92586208|NCT00317629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586209|NCT00093249|Clevidipine|clevidipine|mesh-list
92586210|NCT00093249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92586211|NCT00093249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586212|NCT00093249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586213|NCT00093249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586214|NCT00093249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586215|NCT00124098|Darbepoetin alfa|darbepoetin alfa|mesh-list
92586216|NCT00124098|Hematinics|hematinics|mesh-ancestor
92586217|NCT00324142|Tinidazole|tinidazole|mesh-list
92586218|NCT00324142|Alkylating Agents|alkylating agents|mesh-ancestor
92586219|NCT00324142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586220|NCT00324142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586221|NCT00324142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586222|NCT00324142|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92586223|NCT00324142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92586224|NCT00324142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92586225|NCT00324298|Etoposide|etoposide|mesh-list
92586226|NCT00324298|Bleomycin|bleomycin|mesh-list
92586227|NCT00324298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586228|NCT00324298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92586229|NCT00324298|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92586230|NCT00324298|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92586231|NCT00324298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586232|NCT00324298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586233|NCT00324298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586234|NCT00124137|Diuretics|diuretics|mesh-list
92586235|NCT00124137|Natriuretic Agents|natriuretic agents|mesh-ancestor
92586236|NCT00124137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586237|NCT00324376|Sevelamer|sevelamer|mesh-list
92586238|NCT00324376|Chelating Agents|chelating agents|mesh-ancestor
92586239|NCT00324376|Sequestering Agents|sequestering agents|mesh-ancestor
92586240|NCT00324376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586241|NCT00084227|Azithromycin|azithromycin|mesh-list
92586242|NCT00084227|Chloroquine|chloroquine|mesh-list
92586243|NCT00084227|Atovaquone|atovaquone|mesh-list
92586244|NCT00084227|Proguanil|proguanil|mesh-list
92586245|NCT00084227|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92586246|NCT00084227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586247|NCT00084227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311125|NCT00367315|Analgesics|analgesics|mesh-ancestor
92586248|NCT00084227|Amebicides|amebicides|mesh-ancestor
92586250|NCT00084227|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92586251|NCT00084227|Antimalarials|antimalarials|mesh-ancestor
92586252|NCT00084227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586253|NCT00084227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993397|NCT04439929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586256|NCT00317746|Citalopram|citalopram|mesh-list
92586257|NCT00317746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92586258|NCT00317746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92586259|NCT00317746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586260|NCT00317746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586261|NCT00317746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586262|NCT00317746|Serotonin Agents|serotonin agents|mesh-ancestor
92586263|NCT00317746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586264|NCT00317746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92586265|NCT00317746|Antidepressive Agents|antidepressive agents|mesh-ancestor
92586266|NCT00317746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586267|NCT00317785|Cyclosporine|cyclosporine|mesh-list
92586268|NCT00317785|Sirolimus|sirolimus|mesh-list
92586269|NCT00317785|Mycophenolic Acid|mycophenolic acid|mesh-list
92586270|NCT00317785|Cyclophosphamide|cyclophosphamide|mesh-list
92586271|NCT00317785|Methotrexate|methotrexate|mesh-list
92586272|NCT00317785|Tacrolimus|tacrolimus|mesh-list
92586273|NCT00317785|Cyclosporins|cyclosporins|mesh-list
92535322|NCT00075010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535323|NCT00075010|Antimetabolites|antimetabolites|mesh-ancestor
92535324|NCT00075010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586274|NCT00317785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586275|NCT00317785|Immunologic Factors|immunologic factors|mesh-ancestor
92586276|NCT00317785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586277|NCT00317785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586278|NCT00317785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92586279|NCT00317785|Alkylating Agents|alkylating agents|mesh-ancestor
92586280|NCT00317785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586281|NCT00317785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586282|NCT00317785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92586283|NCT00317785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92586284|NCT00317785|Abortifacient Agents|abortifacient agents|mesh-ancestor
92586285|NCT00317785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92586286|NCT00317785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586287|NCT00317785|Antimetabolites|antimetabolites|mesh-ancestor
92586288|NCT00317785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92586289|NCT00317785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586290|NCT00317785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92586291|NCT00317785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92586292|NCT00317785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92586293|NCT00317785|Antifungal Agents|antifungal agents|mesh-ancestor
92586294|NCT00317785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586295|NCT00317785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586296|NCT00317785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92586297|NCT00317785|Antitubercular Agents|antitubercular agents|mesh-ancestor
92586298|NCT00317785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586299|NCT00093288|Bupropion|bupropion|mesh-list
92586300|NCT00093288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92586301|NCT00093288|Antidepressive Agents|antidepressive agents|mesh-ancestor
92586302|NCT00093288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586303|NCT00093288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92586304|NCT00093288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92586305|NCT00093288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586306|NCT00093288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586307|NCT00093288|Dopamine Agents|dopamine agents|mesh-ancestor
92586308|NCT00093288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586309|NCT00093288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586310|NCT00093288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92586311|NCT00093288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92586312|NCT00093288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586313|NCT00324454|Levetiracetam|levetiracetam|mesh-list
92586314|NCT00324454|Anticonvulsants|anticonvulsants|mesh-ancestor
92586315|NCT00324454|Nootropic Agents|nootropic agents|mesh-ancestor
92586316|NCT00317902|Epoetin Alfa|epoetin alfa|mesh-list
92586317|NCT00317902|Hematinics|hematinics|mesh-ancestor
92586318|NCT00317980|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92586319|NCT00317980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92586320|NCT00317980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92586321|NCT00317980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586322|NCT00324571|Calcium|calcium|mesh-list
92586323|NCT00324571|Sevelamer|sevelamer|mesh-list
92586324|NCT00324571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586325|NCT00324571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586328|NCT00324571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586329|NCT00084461|Romidepsin|romidepsin|mesh-list
92586330|NCT00084461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586331|NCT00084461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586332|NCT00084461|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92586333|NCT00084461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586334|NCT00084461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586335|NCT00324610|Capecitabine|capecitabine|mesh-list
92586336|NCT00324610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586337|NCT00324610|Antimetabolites|antimetabolites|mesh-ancestor
92586338|NCT00324610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586339|NCT00324610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586340|NCT00093366|Etanercept|etanercept|mesh-list
92535325|NCT00075010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535326|NCT00075010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586341|NCT00093366|Arsenic Trioxide|arsenic trioxide|mesh-list
92586342|NCT00093366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586343|NCT00093366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586344|NCT00093366|Analgesics|analgesics|mesh-ancestor
92586345|NCT00093366|Sensory System Agents|sensory system agents|mesh-ancestor
92586346|NCT00093366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586347|NCT00093366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586348|NCT00093366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586349|NCT00093366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586350|NCT00093366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92586351|NCT00093366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586352|NCT00093366|Immunologic Factors|immunologic factors|mesh-ancestor
92586353|NCT00093366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586354|NCT00324688|Tenofovir|tenofovir|mesh-list
92586355|NCT00324688|Antiviral Agents|antiviral agents|mesh-ancestor
92586356|NCT00324688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586357|NCT00324688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92586358|NCT00324688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92586359|NCT00324688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586360|NCT00324688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586361|NCT00324688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92586362|NCT00324688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92586363|NCT00324727|Melphalan|melphalan|mesh-list
92586364|NCT00324727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92586365|NCT00324727|Alkylating Agents|alkylating agents|mesh-ancestor
92586366|NCT00324727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586367|NCT00324727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586368|NCT00324727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92586369|NCT00324727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586370|NCT00324727|Immunologic Factors|immunologic factors|mesh-ancestor
92586371|NCT00324727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586372|NCT00324766|Simendan|simendan|mesh-list
92586373|NCT00324766|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92586374|NCT00324766|Vasodilator Agents|vasodilator agents|mesh-ancestor
92586375|NCT00324766|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92586376|NCT00324766|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92586377|NCT00324766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586378|NCT00324766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586379|NCT00324766|Protective Agents|protective agents|mesh-ancestor
92586380|NCT00324766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586381|NCT00084578|Rosiglitazone|rosiglitazone|mesh-list
92586382|NCT00084578|Celecoxib|celecoxib|mesh-list
92586383|NCT00084578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586384|NCT00084578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586385|NCT00084578|Analgesics|analgesics|mesh-ancestor
92586386|NCT00084578|Sensory System Agents|sensory system agents|mesh-ancestor
92586387|NCT00084578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586388|NCT00084578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586389|NCT00084578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586390|NCT00084578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586391|NCT00084578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92586392|NCT00084578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92586393|NCT00084578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586394|NCT00084578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586395|NCT00084578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311270|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92586396|NCT00318175|Bosentan|bosentan|mesh-list
92586399|NCT00318175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586400|NCT00093444|Doxorubicin|doxorubicin|mesh-list
92586401|NCT00093444|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92586402|NCT00093444|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586403|NCT00093444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586404|NCT00093444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92586405|NCT00093444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92586406|NCT00093444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586407|NCT00093444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586408|NCT00325000|Amitriptyline|amitriptyline|mesh-list
92586410|NCT00325000|Antidepressive Agents|antidepressive agents|mesh-ancestor
92586411|NCT00325000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586412|NCT00325000|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92535327|NCT00075010|Anticonvulsants|anticonvulsants|mesh-ancestor
92535328|NCT00075010|GABA Agents|gaba agents|mesh-ancestor
92535329|NCT00075010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535330|NCT00075010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535331|NCT00075010|Antimanic Agents|antimanic agents|mesh-ancestor
91933276|NCT02226341|Hormones|hormones|mesh-ancestor
92586413|NCT00325000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92586414|NCT00325000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586415|NCT00325000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586416|NCT00325000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586417|NCT00325000|Serotonin Agents|serotonin agents|mesh-ancestor
92586418|NCT00325000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586419|NCT00325000|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92586420|NCT00325000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586421|NCT00325000|Analgesics|analgesics|mesh-ancestor
92586422|NCT00325000|Sensory System Agents|sensory system agents|mesh-ancestor
92586423|NCT00325000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586424|NCT00325000|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92586425|NCT00325000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586426|NCT00318448|Zolpidem|zolpidem|mesh-list
92586427|NCT00318448|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92586428|NCT00318448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92586429|NCT00318448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586430|NCT00318448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586431|NCT00318448|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92586432|NCT00318448|GABA Agonists|gaba agonists|mesh-ancestor
92586433|NCT00318448|GABA Agents|gaba agents|mesh-ancestor
92586434|NCT00318448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586435|NCT00318448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586436|NCT00325117|Vildagliptin|vildagliptin|mesh-list
92586437|NCT00325117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92586438|NCT00325117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586439|NCT00325117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92586440|NCT00325117|Protease Inhibitors|protease inhibitors|mesh-ancestor
92586441|NCT00325117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586442|NCT00325117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586443|NCT00084695|Methylprednisolone|methylprednisolone|mesh-list
92586444|NCT00084695|Cyclophosphamide|cyclophosphamide|mesh-list
92586445|NCT00084695|Melphalan|melphalan|mesh-list
92586446|NCT00084695|Busulfan|busulfan|mesh-list
92586447|NCT00084695|Fludarabine|fludarabine|mesh-list
92586448|NCT00084695|Fludarabine phosphate|fludarabine phosphate|mesh-list
92586449|NCT00084695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92586450|NCT00084695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586451|NCT00084695|Immunologic Factors|immunologic factors|mesh-ancestor
92586452|NCT00084695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586453|NCT00084695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586454|NCT00084695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92586455|NCT00084695|Alkylating Agents|alkylating agents|mesh-ancestor
92586456|NCT00084695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586457|NCT00084695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586458|NCT00084695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92586459|NCT00084695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586460|NCT00084695|Antimetabolites|antimetabolites|mesh-ancestor
92586461|NCT00084695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586462|NCT00084695|Antiemetics|antiemetics|mesh-ancestor
92586463|NCT00084695|Autonomic Agents|autonomic agents|mesh-ancestor
92586464|NCT00084695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586465|NCT00084695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92586466|NCT00084695|Glucocorticoids|glucocorticoids|mesh-ancestor
92586467|NCT00084695|Hormones|hormones|mesh-ancestor
91993616|NCT02388373|Dermatologic Agents|dermatologic agents|mesh-ancestor
92311342|NCT04708106|Menthol|menthol|mesh-list
92586470|NCT00084695|Protective Agents|protective agents|mesh-ancestor
92586471|NCT00325351|Carboplatin|carboplatin|mesh-list
92586472|NCT00325351|Sagopilone|sagopilone|mesh-list
92586473|NCT00325351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586474|NCT00093483|Cytarabine|cytarabine|mesh-list
92586475|NCT00093483|Idarubicin|idarubicin|mesh-list
92586476|NCT00093483|Arsenic Trioxide|arsenic trioxide|mesh-list
92586477|NCT00093483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586478|NCT00093483|Antimetabolites|antimetabolites|mesh-ancestor
92535332|NCT00075010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92535333|NCT00075010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535334|NCT00075010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92535335|NCT04729595|Tempol|tempol|mesh-list
92535336|NCT04729595|Antioxidants|antioxidants|mesh-ancestor
92535337|NCT04729595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535338|NCT04729595|Protective Agents|protective agents|mesh-ancestor
92535339|NCT04729595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535340|NCT04729595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92586479|NCT00093483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586480|NCT00093483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586481|NCT00093483|Antiviral Agents|antiviral agents|mesh-ancestor
92586482|NCT00093483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586483|NCT00093483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586484|NCT00093483|Immunologic Factors|immunologic factors|mesh-ancestor
92586485|NCT00093483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586486|NCT00093483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586487|NCT00093483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92586488|NCT00093483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92586489|NCT00093483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586490|NCT00084734|Docetaxel|docetaxel|mesh-list
92586491|NCT00084734|Capecitabine|capecitabine|mesh-list
92586492|NCT00084734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586493|NCT00084734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92586494|NCT00084734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92586495|NCT00084734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360029|NCT00382590|Cytarabine|cytarabine|mesh-list
92586496|NCT00084734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586497|NCT00084734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586498|NCT00084734|Antimetabolites|antimetabolites|mesh-ancestor
92586499|NCT00325390|Clopidogrel|clopidogrel|mesh-list
92586500|NCT00325390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92586501|NCT00325390|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92586502|NCT00325390|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92586503|NCT00325390|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92586504|NCT00325390|Purinergic Agents|purinergic agents|mesh-ancestor
92586505|NCT00325390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586506|NCT00325390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586507|NCT00325390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586508|NCT00325429|Vildagliptin|vildagliptin|mesh-list
92586509|NCT00325429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92586510|NCT00325429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586511|NCT00325429|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92586512|NCT00325429|Protease Inhibitors|protease inhibitors|mesh-ancestor
92586513|NCT00325429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586514|NCT00325429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586515|NCT00093522|Fludarabine|fludarabine|mesh-list
92586516|NCT00093522|Fludarabine phosphate|fludarabine phosphate|mesh-list
92586517|NCT00093522|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92586518|NCT00093522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586519|NCT00093522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586520|NCT00093522|Antimetabolites|antimetabolites|mesh-ancestor
92586521|NCT00093522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586522|NCT00093522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586523|NCT00093522|Immunologic Factors|immunologic factors|mesh-ancestor
92586524|NCT00093522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586525|NCT00093522|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92586526|NCT00084773|Fluorouracil|fluorouracil|mesh-list
92586527|NCT00084773|Cetuximab|cetuximab|mesh-list
92586528|NCT00084773|Antimetabolites|antimetabolites|mesh-ancestor
92586529|NCT00084773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586530|NCT00084773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586531|NCT00084773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586532|NCT00084773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586533|NCT00084773|Immunologic Factors|immunologic factors|mesh-ancestor
92535341|NCT04729595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535342|NCT04729595|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92535343|NCT04729595|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92535344|NCT00075205|Rimonabant|rimonabant|mesh-list
92535345|NCT00075205|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92535346|NCT00075205|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92535347|NCT00075205|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92535348|NCT00075205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535349|NCT00075205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535350|NCT00075205|Hormones|hormones|mesh-ancestor
92535351|NCT00075205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535352|NCT00075205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535354|NCT00075439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535355|NCT00075439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535356|NCT00075439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535357|NCT00075439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535358|NCT00075517|Gemcitabine|gemcitabine|mesh-list
92535359|NCT00075517|Docetaxel|docetaxel|mesh-list
92535360|NCT00075517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535361|NCT00075517|Antimetabolites|antimetabolites|mesh-ancestor
92586534|NCT00084773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586535|NCT00084773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92586536|NCT00325546|Rimonabant|rimonabant|mesh-list
92586537|NCT00325546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91993687|NCT04556357|Nasal Decongestants|nasal decongestants|mesh-ancestor
92586539|NCT00325546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92586540|NCT00325546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586541|NCT00325546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586542|NCT00325546|Hormones|hormones|mesh-ancestor
92586543|NCT00325546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360033|NCT00382590|Antimetabolites|antimetabolites|mesh-ancestor
92586544|NCT00325546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586545|NCT00084812|Safingol|safingol|mesh-list
92586546|NCT00084812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586547|NCT00084812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586548|NCT02959879|Folfirinox|folfirinox|mesh-list
92586549|NCT02959879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586550|NCT04717609|Ropivacaine|ropivacaine|mesh-list
92586551|NCT04717609|Anesthetics, Local|anesthetics, local|mesh-ancestor
92586552|NCT04717609|Anesthetics|anesthetics|mesh-ancestor
92586553|NCT04717609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586554|NCT04717609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586555|NCT04717609|Sensory System Agents|sensory system agents|mesh-ancestor
92586556|NCT04717609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586557|NCT00318760|Clonidine|clonidine|mesh-list
92586558|NCT00318760|Analgesics|analgesics|mesh-ancestor
92586559|NCT00318760|Sensory System Agents|sensory system agents|mesh-ancestor
92586560|NCT00318760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586561|NCT00318760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586562|NCT00318760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92586563|NCT00318760|Sympatholytics|sympatholytics|mesh-ancestor
92586564|NCT00318760|Autonomic Agents|autonomic agents|mesh-ancestor
92586565|NCT00318760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92586566|NCT00318760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92535362|NCT00075517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535363|NCT00075517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535364|NCT00075517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92535365|NCT00075517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535366|NCT00075517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535367|NCT00075556|Capecitabine|capecitabine|mesh-list
92535368|NCT00075556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535369|NCT00075556|Antimetabolites|antimetabolites|mesh-ancestor
92586567|NCT00318760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92586568|NCT00318760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586569|NCT00318760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586570|NCT00318760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586571|NCT00093561|Lycopene|lycopene|mesh-list
92586572|NCT00093561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586573|NCT00093561|Antioxidants|antioxidants|mesh-ancestor
92586574|NCT00093561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586575|NCT00093561|Protective Agents|protective agents|mesh-ancestor
92586576|NCT00093561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586577|NCT00093561|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92586578|NCT00093561|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92586579|NCT00093561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586580|NCT00084890|Carboplatin|carboplatin|mesh-list
92586581|NCT00084890|Docetaxel|docetaxel|mesh-list
92586582|NCT00084890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586583|NCT00084890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92586584|NCT00084890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92586585|NCT00084890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92586586|NCT00084890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586587|NCT00318838|Azimilide|azimilide|mesh-list
92586588|NCT00318838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92586589|NCT00318838|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92586590|NCT00318838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586591|NCT00318838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586592|NCT00318838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586593|NCT00318838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586594|NCT00085124|Cytarabine|cytarabine|mesh-list
92586595|NCT00085124|Daunorubicin|daunorubicin|mesh-list
92586596|NCT00085124|Oblimersen|oblimersen|mesh-list
92586597|NCT00085124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586598|NCT00085124|Antimetabolites|antimetabolites|mesh-ancestor
92586599|NCT00085124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586600|NCT00085124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586601|NCT00085124|Antiviral Agents|antiviral agents|mesh-ancestor
92586602|NCT00085124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586603|NCT00085124|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586604|NCT00085124|Immunologic Factors|immunologic factors|mesh-ancestor
92586605|NCT00085124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586606|NCT00085124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586607|NCT00085124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92586608|NCT00085124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92586609|NCT00085124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586610|NCT00402441|Risedronic Acid|risedronic acid|mesh-list
92586612|NCT00402441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586613|NCT00402441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586614|NCT00402441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586615|NCT00402441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586616|NCT00402441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92311491|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
92586617|NCT00325858|Tramadol|tramadol|mesh-list
92586618|NCT00325858|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92586619|NCT00325858|Narcotics|narcotics|mesh-ancestor
92586620|NCT00325858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586621|NCT00325858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586622|NCT00325858|Analgesics|analgesics|mesh-ancestor
92586623|NCT00325858|Sensory System Agents|sensory system agents|mesh-ancestor
92586624|NCT00325858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535370|NCT00075556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535371|NCT00075556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535372|NCT00075595|Leucovorin|leucovorin|mesh-list
92535373|NCT00075595|Fluorouracil|fluorouracil|mesh-list
92535374|NCT00075595|Irinotecan|irinotecan|mesh-list
92535375|NCT00075595|Calcium|calcium|mesh-list
92535376|NCT00075595|Levoleucovorin|levoleucovorin|mesh-list
92535377|NCT00075595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92535378|NCT00075595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535379|NCT00075595|Antimetabolites|antimetabolites|mesh-ancestor
92535380|NCT00075595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933499|NCT02231333|Protective Agents|protective agents|mesh-ancestor
92586625|NCT00318955|Dexmedetomidine|dexmedetomidine|mesh-list
92586626|NCT00318955|Propofol|propofol|mesh-list
92586627|NCT00318955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92586628|NCT00318955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586629|NCT00318955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586630|NCT00318955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586631|NCT00318955|Analgesics|analgesics|mesh-ancestor
92586632|NCT00318955|Sensory System Agents|sensory system agents|mesh-ancestor
92586633|NCT00318955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586634|NCT00318955|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92586635|NCT00318955|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92586636|NCT00318955|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92586637|NCT00318955|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586638|NCT00318955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586639|NCT00318955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586640|NCT00318955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92586641|NCT00318955|Anesthetics, General|anesthetics, general|mesh-ancestor
92586642|NCT00318955|Anesthetics|anesthetics|mesh-ancestor
92586643|NCT00325936|Cilnidipine|cilnidipine|mesh-list
92586644|NCT00325936|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92586645|NCT00325936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586646|NCT00325936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586647|NCT00325936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586648|NCT00325936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586649|NCT00318994|Meropenem|meropenem|mesh-list
92586650|NCT00318994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586651|NCT00318994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586652|NCT00093600|Cytarabine|cytarabine|mesh-list
92586653|NCT00093600|Daunorubicin|daunorubicin|mesh-list
92586654|NCT00093600|Midostaurin|midostaurin|mesh-list
92586655|NCT00093600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586656|NCT00093600|Antimetabolites|antimetabolites|mesh-ancestor
92586657|NCT00093600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586658|NCT00093600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586659|NCT00093600|Antiviral Agents|antiviral agents|mesh-ancestor
92586660|NCT00093600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92586661|NCT00093600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586662|NCT00093600|Immunologic Factors|immunologic factors|mesh-ancestor
92586663|NCT00093600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586664|NCT00093600|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92586665|NCT00093600|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92586666|NCT00093600|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92586667|NCT00093600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586668|NCT00093600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586669|NCT00319033|Bosentan|bosentan|mesh-list
92586670|NCT00319033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92360035|NCT00382590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586671|NCT00319033|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92586672|NCT00319033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586673|NCT00085163|Leucovorin|leucovorin|mesh-list
92586674|NCT00085163|Celecoxib|celecoxib|mesh-list
92586675|NCT00085163|Fluorouracil|fluorouracil|mesh-list
92586676|NCT00085163|Calcium|calcium|mesh-list
92535382|NCT00075595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535383|NCT00075595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535384|NCT00075595|Immunologic Factors|immunologic factors|mesh-ancestor
92535385|NCT00075595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92535386|NCT00075595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535387|NCT00075595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535388|NCT00075595|Antidotes|antidotes|mesh-ancestor
92586677|NCT00085163|Levoleucovorin|levoleucovorin|mesh-list
92586678|NCT00085163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586679|NCT00085163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586680|NCT00085163|Antimetabolites|antimetabolites|mesh-ancestor
92586681|NCT00085163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586682|NCT00085163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92586684|NCT00085163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586685|NCT00085163|Immunologic Factors|immunologic factors|mesh-ancestor
92586686|NCT00085163|Antidotes|antidotes|mesh-ancestor
92586687|NCT00085163|Protective Agents|protective agents|mesh-ancestor
92586688|NCT00085163|Vitamin B Complex|vitamin b complex|mesh-ancestor
92586689|NCT00085163|Vitamins|vitamins|mesh-ancestor
92586690|NCT00085163|Micronutrients|micronutrients|mesh-ancestor
92586691|NCT00085163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586692|NCT00085163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586693|NCT00085163|Analgesics|analgesics|mesh-ancestor
92586694|NCT00085163|Sensory System Agents|sensory system agents|mesh-ancestor
92586695|NCT00085163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586696|NCT00085163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586697|NCT00085163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586698|NCT00085163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92586699|NCT00085163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92586700|NCT00085163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586701|NCT00319072|Hormones|hormones|mesh-list
92586702|NCT00319072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586703|NCT00319072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586704|NCT00093639|Everolimus|everolimus|mesh-list
92586705|NCT00093639|Imatinib Mesylate|imatinib mesylate|mesh-list
92586706|NCT00093639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92586707|NCT00093639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586708|NCT00093639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586709|NCT00093639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586710|NCT00093639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92586711|NCT00093639|Immunologic Factors|immunologic factors|mesh-ancestor
92586712|NCT00093639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586713|NCT00093639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586714|NCT00319150|Epoetin Alfa|epoetin alfa|mesh-list
92586715|NCT00319150|Hematinics|hematinics|mesh-ancestor
92586716|NCT00326053|Budesonide|budesonide|mesh-list
92586717|NCT00326053|Formoterol Fumarate|formoterol fumarate|mesh-list
92586718|NCT00326053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586719|NCT00326053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92586720|NCT00326053|Autonomic Agents|autonomic agents|mesh-ancestor
92586721|NCT00326053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586722|NCT00326053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586723|NCT00326053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92586724|NCT00326053|Respiratory System Agents|respiratory system agents|mesh-ancestor
92586725|NCT00326053|Glucocorticoids|glucocorticoids|mesh-ancestor
92586726|NCT00326053|Hormones|hormones|mesh-ancestor
92586727|NCT00326053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586728|NCT00326053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92586729|NCT00326053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92586730|NCT00326053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92586731|NCT00326053|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586732|NCT00326053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586733|NCT00326053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586734|NCT00400088|Lithium Carbonate|lithium carbonate|mesh-list
92586735|NCT00400088|Paroxetine|paroxetine|mesh-list
92586736|NCT00400088|Antidepressive Agents|antidepressive agents|mesh-ancestor
92586737|NCT00400088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92535389|NCT00075595|Protective Agents|protective agents|mesh-ancestor
92535390|NCT00075595|Vitamin B Complex|vitamin b complex|mesh-ancestor
92535391|NCT00075595|Vitamins|vitamins|mesh-ancestor
92535392|NCT00075595|Micronutrients|micronutrients|mesh-ancestor
91933629|NCT02355093|Ropivacaine|ropivacaine|mesh-list
92586738|NCT00400088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586739|NCT00400088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586740|NCT00400088|Antimanic Agents|antimanic agents|mesh-ancestor
92586741|NCT00400088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92586742|NCT00400088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586743|NCT00400088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586744|NCT00400088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92586745|NCT00400088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92586746|NCT00400088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92586747|NCT00400088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586748|NCT00400088|Serotonin Agents|serotonin agents|mesh-ancestor
92586749|NCT00400088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92586750|NCT00400088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92586751|NCT00400088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92586752|NCT00326092|Timolol|timolol|mesh-list
92586753|NCT00326092|Brinzolamide|brinzolamide|mesh-list
92586754|NCT00326092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92586755|NCT00326092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92586756|NCT00326092|Adrenergic Agents|adrenergic agents|mesh-ancestor
92586758|NCT00326092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586759|NCT00326092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586761|NCT00326092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92586762|NCT00326092|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92586763|NCT00326092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586764|NCT00326131|Taxane|taxane|mesh-list
92586765|NCT00326131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586766|NCT00319189|Nateglinide|nateglinide|mesh-list
92586767|NCT00319189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92586768|NCT00319189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586769|NCT00319267|Bosentan|bosentan|mesh-list
92586770|NCT00319267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92586771|NCT00319267|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92586772|NCT00319267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586773|NCT00085280|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92586774|NCT00085280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586775|NCT00085280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586776|NCT00085280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586777|NCT00085280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586778|NCT00326248|Casopitant|casopitant|mesh-list
92586779|NCT00326248|Antiemetics|antiemetics|mesh-ancestor
92586780|NCT00326248|Autonomic Agents|autonomic agents|mesh-ancestor
92586781|NCT00326248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586782|NCT00326248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586783|NCT00326248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92586784|NCT00326248|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92586785|NCT00326248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586786|NCT00326248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586787|NCT00319306|Budesonide|budesonide|mesh-list
92586788|NCT00319306|Formoterol Fumarate|formoterol fumarate|mesh-list
92586789|NCT00319306|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92586790|NCT00319306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586791|NCT00319306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92586792|NCT00319306|Autonomic Agents|autonomic agents|mesh-ancestor
92586793|NCT00319306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586794|NCT00319306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586795|NCT00319306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92586796|NCT00319306|Respiratory System Agents|respiratory system agents|mesh-ancestor
92586797|NCT00319306|Glucocorticoids|glucocorticoids|mesh-ancestor
92586798|NCT00319306|Hormones|hormones|mesh-ancestor
92586799|NCT00319306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586800|NCT00319306|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92586801|NCT00319306|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92586802|NCT00319306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92586803|NCT00319306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92535394|NCT00075634|Doxorubicin|doxorubicin|mesh-list
92586804|NCT00319306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586805|NCT00319306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586806|NCT00085358|Paclitaxel|paclitaxel|mesh-list
92586807|NCT00085358|Docetaxel|docetaxel|mesh-list
92586808|NCT00085358|Bevacizumab|bevacizumab|mesh-list
92586809|NCT00085358|Carboplatin|carboplatin|mesh-list
92586810|NCT00085358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92586811|NCT00085358|Antibodies|antibodies|mesh-list
92586812|NCT00085358|Immunoglobulins|immunoglobulins|mesh-list
92586813|NCT00085358|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92586814|NCT00085358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92586815|NCT00085358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586816|NCT00085358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92586817|NCT00085358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92586818|NCT00085358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92586819|NCT00085358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586820|NCT00085358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92586821|NCT00085358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92586822|NCT00085358|Growth Substances|growth substances|mesh-ancestor
92586823|NCT00085358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586824|NCT00085358|Growth Inhibitors|growth inhibitors|mesh-ancestor
92586825|NCT00085358|Immunologic Factors|immunologic factors|mesh-ancestor
92586826|NCT00093678|Celecoxib|celecoxib|mesh-list
92586827|NCT00093678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586828|NCT00093678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586832|NCT00093678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586834|NCT00093678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92586835|NCT00093678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92586836|NCT00093678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92586837|NCT00093678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586838|NCT00093678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586839|NCT00319345|Mannitol|mannitol|mesh-list
92311716|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92586840|NCT00319345|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92586841|NCT00319345|Diuretics|diuretics|mesh-ancestor
92586842|NCT00319345|Natriuretic Agents|natriuretic agents|mesh-ancestor
92586843|NCT00319345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586844|NCT00419536|Panobinostat|panobinostat|mesh-list
92586845|NCT00419536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586846|NCT00419536|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92586847|NCT00419536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586848|NCT00419536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586849|NCT00326404|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92586850|NCT00326404|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92586851|NCT00326404|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92586852|NCT00326404|Desogestrel|desogestrel|mesh-list
92586853|NCT00326404|Estradiol|estradiol|mesh-list
92586854|NCT00326404|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92586855|NCT00326404|Estrogens|estrogens|mesh-ancestor
92586856|NCT00326404|Hormones|hormones|mesh-ancestor
92586857|NCT00326404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586858|NCT00326404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586859|NCT00326404|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92586860|NCT00326404|Contraceptive Agents|contraceptive agents|mesh-ancestor
92586861|NCT00326404|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92586862|NCT00326404|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92586863|NCT00326404|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92586864|NCT00326404|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92586865|NCT00326404|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92586866|NCT00326404|Progestins|progestins|mesh-ancestor
92586867|NCT00085475|Imatinib Mesylate|imatinib mesylate|mesh-list
92586868|NCT00085475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586869|NCT00085475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586870|NCT00085475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586871|NCT00085475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586872|NCT00319618|Docetaxel|docetaxel|mesh-list
92586873|NCT00319618|Gefitinib|gefitinib|mesh-list
92586874|NCT00319618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586875|NCT00319618|Tubulin Modulators|tubulin modulators|mesh-ancestor
92586876|NCT00319618|Antimitotic Agents|antimitotic agents|mesh-ancestor
92586877|NCT00319618|Mitosis Modulators|mitosis modulators|mesh-ancestor
92586878|NCT00319618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535395|NCT00075634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92535396|NCT00075634|Decitabine|decitabine|mesh-list
92535397|NCT00075634|Azacitidine|azacitidine|mesh-list
92586879|NCT00319618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586880|NCT00319618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586881|NCT00124332|Rimonabant|rimonabant|mesh-list
92586882|NCT00124332|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92586883|NCT00124332|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92586884|NCT00124332|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92586885|NCT00124332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586886|NCT00124332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586887|NCT00124332|Hormones|hormones|mesh-ancestor
92586888|NCT00124332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586889|NCT00124332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586890|NCT00085553|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92586891|NCT00085553|Tipifarnib|tipifarnib|mesh-list
92586892|NCT00085553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586893|NCT00085553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586894|NCT00085553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586895|NCT00085553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586896|NCT00400335|Methyltestosterone|methyltestosterone|mesh-list
92586897|NCT00400335|Testosterone|testosterone|mesh-list
92586898|NCT00400335|Testosterone undecanoate|testosterone undecanoate|mesh-list
92586904|NCT00400335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586905|NCT00400335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586906|NCT00400335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92586907|NCT00400335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586908|NCT00400335|Anabolic Agents|anabolic agents|mesh-ancestor
92586909|NCT00400335|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92586910|NCT00400335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92586911|NCT00400335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586912|NCT00400335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586913|NCT00400335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92311794|NCT04947085|Ketamine|ketamine|mesh-list
92586914|NCT00319852|Vaccines|vaccines|mesh-list
92586915|NCT00319852|Immunologic Factors|immunologic factors|mesh-ancestor
92586916|NCT00319852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586917|NCT00326833|Vitamin B 12|vitamin b 12|mesh-list
92586918|NCT00326833|Hydroxocobalamin|hydroxocobalamin|mesh-list
92586919|NCT00326833|Vitamins|vitamins|mesh-ancestor
92586920|NCT00326833|Micronutrients|micronutrients|mesh-ancestor
92586921|NCT00326833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586922|NCT00326833|Vitamin B Complex|vitamin b complex|mesh-ancestor
92586923|NCT00326833|Hematinics|hematinics|mesh-ancestor
92586924|NCT00085748|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92586925|NCT00085748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92586926|NCT00085748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92586927|NCT00085748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586928|NCT00085748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586929|NCT00085748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92586930|NCT00085748|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92586931|NCT00085748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92586932|NCT00085748|Serotonin Agents|serotonin agents|mesh-ancestor
92586933|NCT00085748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586934|NCT00085748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586935|NCT00085748|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92586936|NCT00085748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92586937|NCT00085748|Dopamine Agents|dopamine agents|mesh-ancestor
92586938|NCT04717102|Desflurane|desflurane|mesh-list
92586939|NCT04717102|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92586940|NCT04717102|Anesthetics, General|anesthetics, general|mesh-ancestor
92586941|NCT04717102|Anesthetics|anesthetics|mesh-ancestor
92586942|NCT04717102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92586943|NCT04717102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586944|NCT00320047|Baclofen|baclofen|mesh-list
92586945|NCT00320047|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92586946|NCT00320047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586947|NCT00320047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92586948|NCT00320047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586949|NCT00320047|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92586950|NCT00320047|GABA Agonists|gaba agonists|mesh-ancestor
92586951|NCT00320047|GABA Agents|gaba agents|mesh-ancestor
92586952|NCT00320047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586953|NCT00320047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586954|NCT00085826|Sulindac sulfone|sulindac sulfone|mesh-list
92586955|NCT00085826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586956|NCT00085826|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92586957|NCT00085826|Protective Agents|protective agents|mesh-ancestor
92586958|NCT00085826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586959|NCT00085826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92586960|NCT00085826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586961|NCT00085826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586962|NCT00085826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92586963|NCT00085826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92586964|NCT00085826|Analgesics|analgesics|mesh-ancestor
92586965|NCT00085826|Sensory System Agents|sensory system agents|mesh-ancestor
92586966|NCT00085826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586967|NCT00085826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994133|NCT05888896|Methyldopa|methyldopa|mesh-list
92586979|NCT00320320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586980|NCT00320320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586981|NCT00320320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586982|NCT00327106|Tranexamic Acid|tranexamic acid|mesh-list
92586983|NCT00327106|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92586984|NCT00327106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92586985|NCT00327106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586986|NCT00327106|Hemostatics|hemostatics|mesh-ancestor
92586987|NCT00327106|Coagulants|coagulants|mesh-ancestor
92586988|NCT00320359|Cisplatin|cisplatin|mesh-list
92586989|NCT00320359|Etoposide|etoposide|mesh-list
92586991|NCT00320359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586992|NCT00320359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92586993|NCT00320359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92586994|NCT00320359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92586995|NCT00320359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586996|NCT00320359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586997|NCT00320359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92586998|NCT00093912|Nitroprusside|nitroprusside|mesh-list
92586999|NCT00093912|Clevidipine|clevidipine|mesh-list
92587000|NCT00093912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92587001|NCT00093912|Vasodilator Agents|vasodilator agents|mesh-ancestor
92587002|NCT00093912|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92587003|NCT00093912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587004|NCT00093912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92587005|NCT00093912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587006|NCT00093912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92587007|NCT00093912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587008|NCT00327145|Amlodipine|amlodipine|mesh-list
92587009|NCT00327145|Valsartan|valsartan|mesh-list
92587010|NCT00327145|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92587011|NCT00327145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92587012|NCT00327145|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92587013|NCT00327145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587014|NCT00327145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587015|NCT00327145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92587016|NCT00327145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587017|NCT00327145|Vasodilator Agents|vasodilator agents|mesh-ancestor
92587018|NCT00327145|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92587019|NCT00327145|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92587020|NCT00327145|Diuretics|diuretics|mesh-ancestor
92587021|NCT00327145|Natriuretic Agents|natriuretic agents|mesh-ancestor
92587022|NCT00327145|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92587023|NCT00085943|Ritonavir|ritonavir|mesh-list
92587024|NCT00085943|Fosamprenavir|fosamprenavir|mesh-list
92587025|NCT00085943|Lamivudine|lamivudine|mesh-list
92587026|NCT00085943|Abacavir|abacavir|mesh-list
92587027|NCT00085943|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92587028|NCT00085943|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92587029|NCT00085943|Protease Inhibitors|protease inhibitors|mesh-ancestor
92587030|NCT00085943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994200|NCT05783219|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92587033|NCT00085943|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92587034|NCT00085943|Antiviral Agents|antiviral agents|mesh-ancestor
92587035|NCT00085943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587036|NCT00085943|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92535399|NCT00075634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535400|NCT00075634|Immunologic Factors|immunologic factors|mesh-ancestor
92535401|NCT00075634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587037|NCT00085943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92587038|NCT00085943|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92587039|NCT00085943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92587041|NCT00327184|Anticoagulants|anticoagulants|mesh-ancestor
92587042|NCT00327184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92587043|NCT00327184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92587044|NCT00327184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587045|NCT00419302|Insulin|insulin|mesh-list
92587046|NCT00419302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92587047|NCT00419302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587048|NCT00093951|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
92587049|NCT00093951|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92587050|NCT00093951|Protective Agents|protective agents|mesh-ancestor
92587051|NCT00093951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587052|NCT00093951|GABA Antagonists|gaba antagonists|mesh-ancestor
92587053|NCT00093951|GABA Agents|gaba agents|mesh-ancestor
92587054|NCT00093951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587055|NCT00093951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587056|NCT00419419|Nitroglycerin|nitroglycerin|mesh-list
92587057|NCT00419419|Vasodilator Agents|vasodilator agents|mesh-ancestor
92587058|NCT00320476|Bortezomib|bortezomib|mesh-list
92587059|NCT00320476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587060|NCT00327262|Imatinib Mesylate|imatinib mesylate|mesh-list
92587061|NCT00327262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587062|NCT00327262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92311942|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92587063|NCT00327262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587064|NCT00327262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587065|NCT00093990|Tipifarnib|tipifarnib|mesh-list
92587066|NCT00093990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587067|NCT00327379|Aprotinin|aprotinin|mesh-list
92587068|NCT00327379|Hemostatics|hemostatics|mesh-ancestor
92587069|NCT00327379|Coagulants|coagulants|mesh-ancestor
92587070|NCT00327379|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92587071|NCT00327379|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92587072|NCT00327379|Protease Inhibitors|protease inhibitors|mesh-ancestor
92587073|NCT00327379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587074|NCT00327379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587075|NCT00327418|Atorvastatin|atorvastatin|mesh-list
92587076|NCT00327418|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92587077|NCT00327418|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92587078|NCT00327418|Antimetabolites|antimetabolites|mesh-ancestor
92587079|NCT00327418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587080|NCT00327418|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92587081|NCT00327418|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92587082|NCT00327418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587083|NCT00094029|Sunitinib|sunitinib|mesh-list
92587084|NCT00094029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587085|NCT00094029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92587086|NCT00094029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92587087|NCT00094029|Growth Substances|growth substances|mesh-ancestor
92587088|NCT00094029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587089|NCT00094029|Growth Inhibitors|growth inhibitors|mesh-ancestor
92587090|NCT00094029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587091|NCT00094029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587092|NCT00094029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587093|NCT00086099|Amifostine|amifostine|mesh-list
92587094|NCT00086099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92587095|NCT00086099|Protective Agents|protective agents|mesh-ancestor
92587096|NCT00086099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587097|NCT00320632|Desipramine|desipramine|mesh-list
92587098|NCT00320632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92587099|NCT00320632|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587100|NCT00320632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587101|NCT00320632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587104|NCT00320632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587105|NCT00320632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587106|NCT00320632|Adrenergic Agents|adrenergic agents|mesh-ancestor
92535402|NCT00075634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535403|NCT00075634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535404|NCT00075634|Alkylating Agents|alkylating agents|mesh-ancestor
92535405|NCT00075634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587107|NCT00320632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587108|NCT00320632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587110|NCT00320827|Immunologic Factors|immunologic factors|mesh-ancestor
92587111|NCT00320827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587112|NCT00320983|Topotecan|topotecan|mesh-list
92587113|NCT00320983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587114|NCT00320983|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92587115|NCT00320983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587116|NCT00320983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587117|NCT00320983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587118|NCT00086177|Progesterone|progesterone|mesh-list
92587119|NCT00086177|Progestins|progestins|mesh-ancestor
92587120|NCT00086177|Hormones|hormones|mesh-ancestor
92587121|NCT00086177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92587122|NCT00086177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587123|NCT05458765|Tenofovir|tenofovir|mesh-list
92587124|NCT05458765|Emtricitabine|emtricitabine|mesh-list
92587125|NCT05458765|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92587126|NCT05458765|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92587127|NCT05458765|Antiviral Agents|antiviral agents|mesh-ancestor
92587128|NCT05458765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587129|NCT05458765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92587130|NCT05458765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92587131|NCT05458765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587132|NCT05458765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587133|NCT05458765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92587134|NCT05458765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92587135|NCT00094146|Octreotide|octreotide|mesh-list
92312018|NCT04700761|Analgesics, Opioid|analgesics, opioid|mesh-list
92587136|NCT00094146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92587137|NCT00094146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92587138|NCT00094146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587140|NCT00086255|Anticonvulsants|anticonvulsants|mesh-ancestor
92587141|NCT00086255|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92587142|NCT00086255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587143|NCT00086255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587144|NCT00086255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587145|NCT00086255|GABA Agents|gaba agents|mesh-ancestor
92587146|NCT00086255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587147|NCT00086255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587148|NCT00321178|Clarithromycin|clarithromycin|mesh-list
92587149|NCT00321178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587150|NCT00321178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587151|NCT00321178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92587152|NCT00321178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587153|NCT00321178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587154|NCT00321178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92587155|NCT00321178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92587156|NCT00124527|Capecitabine|capecitabine|mesh-list
92587157|NCT00124527|Irofulven|irofulven|mesh-list
92587158|NCT00124527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587159|NCT00124527|Antimetabolites|antimetabolites|mesh-ancestor
92587160|NCT00124527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587161|NCT00124527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587162|NCT00124527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92587163|NCT00124527|Alkylating Agents|alkylating agents|mesh-ancestor
92587164|NCT00086294|Levodopa|levodopa|mesh-list
92587165|NCT00086294|Pimavanserin|pimavanserin|mesh-list
92587166|NCT00086294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92587167|NCT00086294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92587168|NCT00086294|Dopamine Agents|dopamine agents|mesh-ancestor
92587169|NCT00086294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587170|NCT00086294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535406|NCT00075634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535407|NCT00075634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535408|NCT00075634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587171|NCT00086294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587174|NCT00086294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587175|NCT00086294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587176|NCT00086294|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92587177|NCT00086294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92587179|NCT05458492|Sirolimus|sirolimus|mesh-list
92587180|NCT05458492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587181|NCT05458492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587182|NCT05458492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587183|NCT05458492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587184|NCT05458492|Antifungal Agents|antifungal agents|mesh-ancestor
92587185|NCT05458492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587186|NCT05458492|Immunologic Factors|immunologic factors|mesh-ancestor
92587187|NCT05458492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587188|NCT00086333|Docetaxel|docetaxel|mesh-list
92587189|NCT00086333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587190|NCT00086333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92587191|NCT00086333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92587192|NCT00086333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92587193|NCT00086333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587194|NCT05458180|Prednisone|prednisone|mesh-list
92587195|NCT05458180|Cyclophosphamide|cyclophosphamide|mesh-list
92587196|NCT05458180|Etoposide|etoposide|mesh-list
92587197|NCT05458180|Vincristine|vincristine|mesh-list
92587198|NCT05458180|Mitoxantrone|mitoxantrone|mesh-list
92587199|NCT05458180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587200|NCT05458180|Immunologic Factors|immunologic factors|mesh-ancestor
92587201|NCT05458180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587202|NCT05458180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587203|NCT05458180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92587204|NCT05458180|Alkylating Agents|alkylating agents|mesh-ancestor
92587205|NCT05458180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587206|NCT05458180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587207|NCT05458180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92587208|NCT05458180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587209|NCT05458180|Glucocorticoids|glucocorticoids|mesh-ancestor
92587210|NCT05458180|Hormones|hormones|mesh-ancestor
92587211|NCT05458180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92587212|NCT05458180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92587213|NCT05458180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587214|NCT05458180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587215|NCT05458180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587216|NCT05458180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587217|NCT05458180|Tubulin Modulators|tubulin modulators|mesh-ancestor
92587218|NCT05458180|Antimitotic Agents|antimitotic agents|mesh-ancestor
92587219|NCT05458180|Mitosis Modulators|mitosis modulators|mesh-ancestor
92587220|NCT05458180|Analgesics|analgesics|mesh-ancestor
92587221|NCT05458180|Sensory System Agents|sensory system agents|mesh-ancestor
92587222|NCT05458180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587223|NCT00419653|Haloperidol|haloperidol|mesh-list
92587225|NCT00419653|Haloperidol decanoate|haloperidol decanoate|mesh-list
92587226|NCT00419653|Amisulpride|amisulpride|mesh-list
92587227|NCT00419653|Antiemetics|antiemetics|mesh-ancestor
92587228|NCT00419653|Autonomic Agents|autonomic agents|mesh-ancestor
92587229|NCT00419653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587230|NCT00419653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587231|NCT00419653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92587232|NCT00419653|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587233|NCT00419653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587234|NCT00419653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587235|NCT00419653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587236|NCT00419653|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92587237|NCT00419653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587238|NCT00419653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587239|NCT00419653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587240|NCT00419653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587241|NCT00419653|Serotonin Agents|serotonin agents|mesh-ancestor
92587242|NCT00419653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92587243|NCT00419653|Dopamine Agents|dopamine agents|mesh-ancestor
92535409|NCT00075634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92535410|NCT00075634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535411|NCT00075634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587244|NCT00419653|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92587245|NCT00419653|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92587249|NCT00094341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92587250|NCT00094341|Analgesics|analgesics|mesh-ancestor
92587251|NCT00094341|Sensory System Agents|sensory system agents|mesh-ancestor
92587252|NCT00094341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587253|NCT00094341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587254|NCT00094341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587255|NCT00094341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587256|NCT00094341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92587257|NCT00094341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587258|NCT00094341|Immunologic Factors|immunologic factors|mesh-ancestor
92587259|NCT00086489|Tremelimumab|tremelimumab|mesh-list
92587260|NCT00086489|Ipilimumab|ipilimumab|mesh-list
92587261|NCT00086489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587262|NCT00086489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92587263|NCT00086489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92587264|NCT00086489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587265|NCT00094380|Cyclophosphamide|cyclophosphamide|mesh-list
92587266|NCT00094380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587267|NCT00094380|Immunologic Factors|immunologic factors|mesh-ancestor
92587268|NCT00094380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587269|NCT00094380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587270|NCT00094380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92587271|NCT00094380|Alkylating Agents|alkylating agents|mesh-ancestor
92587272|NCT00094380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587273|NCT00094380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587274|NCT00094380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92587275|NCT00321490|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92587276|NCT00321490|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92587277|NCT00321490|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587278|NCT00321490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587279|NCT00321490|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587280|NCT00321490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587281|NCT00321490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587282|NCT00321490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587283|NCT00321490|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92587284|NCT00321490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587285|NCT00321490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587286|NCT00321490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587287|NCT00321490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587288|NCT00321490|Analgesics|analgesics|mesh-ancestor
92587289|NCT00321490|Sensory System Agents|sensory system agents|mesh-ancestor
92587290|NCT00321490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587291|NCT00321490|Dopamine Agents|dopamine agents|mesh-ancestor
92587292|NCT00086528|XL647|xl647|mesh-list
92587293|NCT00086528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587294|NCT00086528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587295|NCT00086528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587296|NCT00086528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587297|NCT05457829|Doxorubicin|doxorubicin|mesh-list
92587298|NCT05457829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92587299|NCT05457829|Irinotecan|irinotecan|mesh-list
92587300|NCT05457829|Vincristine|vincristine|mesh-list
92587301|NCT05457829|Temozolomide|temozolomide|mesh-list
92587302|NCT05457829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587303|NCT05457829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587304|NCT05457829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587305|NCT05457829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587306|NCT05457829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587307|NCT05457829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587308|NCT05457829|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92587309|NCT05457829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587310|NCT05457829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92587311|NCT05457829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92587312|NCT05457829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92587313|NCT05457829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535412|NCT00075634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92535413|NCT00075634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535414|NCT00075634|Antimetabolites|antimetabolites|mesh-ancestor
92535415|NCT00075673|Celecoxib|celecoxib|mesh-list
92587314|NCT05457829|Alkylating Agents|alkylating agents|mesh-ancestor
92587315|NCT05457751|Rocuronium|rocuronium|mesh-list
92587316|NCT05457751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92587320|NCT05457751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587321|NCT00086606|Omalizumab|omalizumab|mesh-list
92587322|NCT00086606|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92587323|NCT00086606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92587324|NCT00086606|Respiratory System Agents|respiratory system agents|mesh-ancestor
92587325|NCT00124566|Prednisone|prednisone|mesh-list
92587326|NCT00124566|Capecitabine|capecitabine|mesh-list
92587327|NCT00124566|Mitoxantrone|mitoxantrone|mesh-list
92587328|NCT00124566|Irofulven|irofulven|mesh-list
92587329|NCT00124566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587330|NCT00124566|Glucocorticoids|glucocorticoids|mesh-ancestor
92587331|NCT00124566|Hormones|hormones|mesh-ancestor
92587332|NCT00124566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92587333|NCT00124566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587334|NCT00124566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92587335|NCT00124566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587336|NCT00124566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587337|NCT00124566|Antimetabolites|antimetabolites|mesh-ancestor
92587338|NCT00124566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587339|NCT00124566|Analgesics|analgesics|mesh-ancestor
92587340|NCT00124566|Sensory System Agents|sensory system agents|mesh-ancestor
92587341|NCT00124566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587342|NCT00124566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587343|NCT00124566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587344|NCT00124566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587345|NCT00124566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92587346|NCT00124566|Alkylating Agents|alkylating agents|mesh-ancestor
92587347|NCT00321724|Cediranib|cediranib|mesh-list
92587348|NCT00321724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587349|NCT00321724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587350|NCT00321724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587351|NCT00321724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587352|NCT00086645|Dexetimide|dexetimide|mesh-list
92587353|NCT00086645|Citalopram|citalopram|mesh-list
92587354|NCT00086645|Escitalopram|escitalopram|mesh-list
92587355|NCT00086645|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92312244|NCT05451121|Analgesics|analgesics|mesh-ancestor
92587356|NCT00086645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587357|NCT00086645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587358|NCT00086645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587359|NCT00086645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587360|NCT00086645|Serotonin Agents|serotonin agents|mesh-ancestor
92587361|NCT00086645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587362|NCT00086645|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92587363|NCT00086645|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587364|NCT00086645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587365|NCT00086645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92587366|NCT00086645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92587367|NCT00086645|Parasympatholytics|parasympatholytics|mesh-ancestor
92587368|NCT00086645|Autonomic Agents|autonomic agents|mesh-ancestor
92587369|NCT00086645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587370|NCT00086645|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92587371|NCT00086645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92587372|NCT00086645|Cholinergic Agents|cholinergic agents|mesh-ancestor
92587373|NCT00321802|Simvastatin|simvastatin|mesh-list
92587374|NCT00321802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92587375|NCT00321802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92587376|NCT00321802|Antimetabolites|antimetabolites|mesh-ancestor
92587377|NCT00321802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587378|NCT00321802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92587379|NCT00321802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92587380|NCT00321802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587381|NCT00124605|Pamidronate|pamidronate|mesh-list
92587382|NCT00124605|Arsenic Trioxide|arsenic trioxide|mesh-list
92587383|NCT00124605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535416|NCT00075673|Vinorelbine|vinorelbine|mesh-list
92360069|NCT00408564|Gemcitabine|gemcitabine|mesh-list
92535417|NCT00075673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92587384|NCT00124605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92587385|NCT00124605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587386|NCT05457361|Azacitidine|azacitidine|mesh-list
92587387|NCT05457361|Homoharringtonine|homoharringtonine|mesh-list
92587393|NCT05457361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587394|NCT05457361|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92587395|NCT00086801|Gemcitabine|gemcitabine|mesh-list
92587396|NCT00086801|Doxorubicin|doxorubicin|mesh-list
92587397|NCT00086801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92587398|NCT00086801|Vinblastine|vinblastine|mesh-list
92587399|NCT00086801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92587400|NCT00086801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587401|NCT00086801|Antimetabolites|antimetabolites|mesh-ancestor
92587402|NCT00086801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587403|NCT00086801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587404|NCT00086801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587405|NCT00086801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587406|NCT00086801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587407|NCT00086801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587408|NCT00086801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92587409|NCT00086801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587410|NCT00086801|Tubulin Modulators|tubulin modulators|mesh-ancestor
92587411|NCT00086801|Antimitotic Agents|antimitotic agents|mesh-ancestor
92587412|NCT00086801|Mitosis Modulators|mitosis modulators|mesh-ancestor
92587413|NCT05456113|Cannabidiol|cannabidiol|mesh-list
92587414|NCT05456113|Anticonvulsants|anticonvulsants|mesh-ancestor
92587415|NCT00124644|Cytarabine|cytarabine|mesh-list
92587416|NCT00124644|Etoposide|etoposide|mesh-list
92587417|NCT00124644|Daunorubicin|daunorubicin|mesh-list
92587418|NCT00124644|Tipifarnib|tipifarnib|mesh-list
92587419|NCT00124644|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92587420|NCT00124644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587421|NCT00124644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587422|NCT00124644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587423|NCT00124644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587424|NCT00124644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587425|NCT00124644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587426|NCT00124644|Antimetabolites|antimetabolites|mesh-ancestor
92587427|NCT00124644|Antiviral Agents|antiviral agents|mesh-ancestor
92587428|NCT00124644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587429|NCT00124644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587430|NCT00124644|Immunologic Factors|immunologic factors|mesh-ancestor
92587431|NCT00124644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587432|NCT00124644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587433|NCT00086840|Sirolimus|sirolimus|mesh-list
92587435|NCT00086840|MTOR Inhibitors|mtor inhibitors|mesh-list
92587436|NCT00086840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587437|NCT00086840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587438|NCT00086840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587439|NCT00086840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587440|NCT00086840|Immunologic Factors|immunologic factors|mesh-ancestor
92587441|NCT00086840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587442|NCT00086840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587443|NCT00086840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587444|NCT00086840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587445|NCT00086840|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587446|NCT00086840|Antifungal Agents|antifungal agents|mesh-ancestor
92587447|NCT00124683|Bupropion|bupropion|mesh-list
92587448|NCT00124683|Nicotine|nicotine|mesh-list
92587449|NCT00124683|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92587450|NCT00124683|Autonomic Agents|autonomic agents|mesh-ancestor
92587451|NCT00124683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587452|NCT00124683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587453|NCT00124683|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92587454|NCT00124683|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92587455|NCT00124683|Cholinergic Agents|cholinergic agents|mesh-ancestor
92587456|NCT00124683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587457|NCT00124683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587458|NCT00124683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92587463|NCT00124683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92535418|NCT00075673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92535419|NCT00075673|Analgesics|analgesics|mesh-ancestor
92535420|NCT00075673|Sensory System Agents|sensory system agents|mesh-ancestor
92587464|NCT00124683|Dopamine Agents|dopamine agents|mesh-ancestor
92360072|NCT00408564|Cetuximab|cetuximab|mesh-list
92587465|NCT00124683|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92587466|NCT00124683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92587467|NCT00124683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587468|NCT04717063|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92587469|NCT04717063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92587470|NCT04717063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587471|NCT00086879|Temozolomide|temozolomide|mesh-list
92587472|NCT00086879|Carmustine|carmustine|mesh-list
92587473|NCT00086879|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92587474|NCT00086879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92587475|NCT00086879|Alkylating Agents|alkylating agents|mesh-ancestor
92587476|NCT00086879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587477|NCT00086879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587478|NCT00086879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587479|NCT00086879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587480|NCT00124722|Bromides|bromides|mesh-list
92587481|NCT00124722|Rocuronium|rocuronium|mesh-list
92587482|NCT00124722|Anticonvulsants|anticonvulsants|mesh-ancestor
92587483|NCT00124722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92587484|NCT00124722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92587485|NCT00124722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92587486|NCT00124722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587487|NCT00124722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587488|NCT00322036|Flurbiprofen|flurbiprofen|mesh-list
92587489|NCT00322036|Tarenflurbil|tarenflurbil|mesh-list
92587490|NCT00322036|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92587491|NCT00322036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587492|NCT00322036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587493|NCT00322036|Analgesics|analgesics|mesh-ancestor
92587494|NCT00322036|Sensory System Agents|sensory system agents|mesh-ancestor
92587495|NCT00322036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587496|NCT00322036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587497|NCT00322036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92587498|NCT00322036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92587499|NCT00322036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587500|NCT00322036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587501|NCT00322036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92587502|NCT00094614|Atropine|atropine|mesh-list
92587503|NCT00094614|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92587504|NCT00094614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92587505|NCT00094614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92587506|NCT00094614|Autonomic Agents|autonomic agents|mesh-ancestor
92312385|NCT05448781|Pemetrexed|pemetrexed|mesh-list
92587507|NCT00094614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587508|NCT00094614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587509|NCT00094614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92587510|NCT00094614|Respiratory System Agents|respiratory system agents|mesh-ancestor
92587511|NCT00094614|Mydriatics|mydriatics|mesh-ancestor
92587512|NCT00094614|Parasympatholytics|parasympatholytics|mesh-ancestor
92587513|NCT00094614|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92587514|NCT00094614|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92587515|NCT00094614|Cholinergic Agents|cholinergic agents|mesh-ancestor
92587516|NCT00094614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587517|NCT00094614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587518|NCT00087035|Docetaxel|docetaxel|mesh-list
92587519|NCT00087035|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92587520|NCT00087035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587521|NCT00087035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92587522|NCT00087035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92587523|NCT00087035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92587524|NCT00087035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587525|NCT00087035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587526|NCT00087035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587527|NCT00322075|Insulin Glargine|insulin glargine|mesh-list
92587531|NCT00322114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587533|NCT00322114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587534|NCT00322114|Protective Agents|protective agents|mesh-ancestor
92587535|NCT00322114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535421|NCT00075673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535422|NCT00075673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535423|NCT00075673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587536|NCT00322114|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92587537|NCT00322114|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92587538|NCT00322114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587539|NCT00087074|Sirolimus|sirolimus|mesh-list
92587540|NCT00087074|Temsirolimus|temsirolimus|mesh-list
92587541|NCT00087074|MTOR Inhibitors|mtor inhibitors|mesh-list
92587542|NCT00087074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587543|NCT00087074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587544|NCT00087074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587545|NCT00087074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587546|NCT00087074|Immunologic Factors|immunologic factors|mesh-ancestor
92587547|NCT00087074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587548|NCT00087074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587549|NCT00087074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587550|NCT00087074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587551|NCT00087074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587552|NCT00087074|Antifungal Agents|antifungal agents|mesh-ancestor
92587553|NCT00332176|Ribavirin|ribavirin|mesh-list
92587554|NCT00332176|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92587555|NCT00332176|Antimetabolites|antimetabolites|mesh-ancestor
92587556|NCT00332176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587557|NCT00332176|Antiviral Agents|antiviral agents|mesh-ancestor
92587558|NCT00332176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587559|NCT00087113|Pemetrexed|pemetrexed|mesh-list
92587560|NCT00087113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587561|NCT00087113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587562|NCT00087113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587563|NCT00087113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92587564|NCT00087113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92587565|NCT00332254|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92587566|NCT00332254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587567|NCT00332293|Moxifloxacin|moxifloxacin|mesh-list
92587568|NCT00332293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92587569|NCT00332293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92587570|NCT00332293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92587571|NCT00332293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587572|NCT00332293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587573|NCT00332293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587574|NCT00332293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587575|NCT00332293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587576|NCT00332293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587577|NCT00332293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587578|NCT00332293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92587579|NCT00332293|Contraceptive Agents|contraceptive agents|mesh-ancestor
92587580|NCT00332293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92587581|NCT00332293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587582|NCT00332293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92587583|NCT00332293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92587584|NCT00332293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92587585|NCT00087191|Motexafin lutetium|motexafin lutetium|mesh-list
92587586|NCT00087191|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92587587|NCT00087191|Dermatologic Agents|dermatologic agents|mesh-ancestor
92587588|NCT05222152|Hydrocortisone|hydrocortisone|mesh-list
92587589|NCT05222152|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92587590|NCT05222152|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92587591|NCT05222152|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92587592|NCT05222152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587593|NCT00094692|Atropine|atropine|mesh-list
92587594|NCT00094692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92587595|NCT00094692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92587596|NCT00094692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92587597|NCT00094692|Autonomic Agents|autonomic agents|mesh-ancestor
92587598|NCT00094692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587601|NCT00094692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92587602|NCT00094692|Mydriatics|mydriatics|mesh-ancestor
92587603|NCT00094692|Parasympatholytics|parasympatholytics|mesh-ancestor
92587604|NCT00094692|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92587605|NCT00094692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92360078|NCT00383448|Cyclosporine|cyclosporine|mesh-list
92535424|NCT00075673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535425|NCT00075673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92535426|NCT00075673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91934418|NCT02294071|Analgesics|analgesics|mesh-ancestor
92587606|NCT00094692|Cholinergic Agents|cholinergic agents|mesh-ancestor
92587607|NCT00094692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587608|NCT00094692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587609|NCT05181007|Valproic Acid|valproic acid|mesh-list
92587610|NCT05181007|Anticonvulsants|anticonvulsants|mesh-ancestor
92587611|NCT05181007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587612|NCT05181007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587613|NCT05181007|GABA Agents|gaba agents|mesh-ancestor
92587614|NCT05181007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587615|NCT05181007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587616|NCT05181007|Antimanic Agents|antimanic agents|mesh-ancestor
92587617|NCT05181007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587618|NCT05181007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587619|NCT05181007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587620|NCT00124839|Naltrexone|naltrexone|mesh-list
92587621|NCT00124839|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92587622|NCT00124839|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92587623|NCT00124839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587624|NCT00124839|Sensory System Agents|sensory system agents|mesh-ancestor
92587625|NCT00124839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587626|NCT00087269|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92587627|NCT00087269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587628|NCT00087269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92587629|NCT00087269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587630|NCT00087269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587631|NCT00087347|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92587632|NCT00087347|Hematinics|hematinics|mesh-ancestor
92587633|NCT00087347|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92587634|NCT00087347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92587635|NCT04960930|Minocycline|minocycline|mesh-list
92587636|NCT04960930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587637|NCT04960930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587638|NCT00419692|Ropinirole|ropinirole|mesh-list
92587639|NCT00419692|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92587640|NCT00419692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92587641|NCT00419692|Dopamine Agonists|dopamine agonists|mesh-ancestor
92587642|NCT00419692|Dopamine Agents|dopamine agents|mesh-ancestor
92587643|NCT00419692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587644|NCT00419692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587645|NCT00419692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587646|NCT00419731|Naltrexone|naltrexone|mesh-list
92587647|NCT00419731|Bupropion|bupropion|mesh-list
92587648|NCT00419731|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92587649|NCT00419731|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92587650|NCT00419731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587651|NCT00419731|Sensory System Agents|sensory system agents|mesh-ancestor
92587652|NCT00419731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587653|NCT00419731|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92312535|NCT02197416|Anticoagulants|anticoagulants|mesh-ancestor
92587654|NCT00419731|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587655|NCT00419731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587656|NCT00419731|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92587657|NCT00419731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587658|NCT00419731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587659|NCT00419731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587660|NCT00419731|Dopamine Agents|dopamine agents|mesh-ancestor
92587661|NCT00419731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587662|NCT00419731|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92587663|NCT00419731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92587664|NCT00419731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587666|NCT00419848|Doxycycline|doxycycline|mesh-list
92587667|NCT00419848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587668|NCT00419848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587669|NCT00419848|Antimalarials|antimalarials|mesh-ancestor
92587670|NCT00419848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92587671|NCT00419848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92587676|NCT00087425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360083|NCT00383448|Cyclosporins|cyclosporins|mesh-list
92535428|NCT00075673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535429|NCT00075673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587677|NCT00087425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587678|NCT00087425|Immunologic Factors|immunologic factors|mesh-ancestor
92587679|NCT00087425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587680|NCT00087425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587681|NCT00087425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92587683|NCT00330655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92587684|NCT00330655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92587685|NCT00330655|Dopamine Agents|dopamine agents|mesh-ancestor
92587686|NCT00330655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587687|NCT00330655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587688|NCT00330655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587689|NCT00330655|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92587690|NCT00330655|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92587691|NCT00330772|Aspirin|aspirin|mesh-list
92587692|NCT00330772|Clopidogrel|clopidogrel|mesh-list
92587693|NCT00330772|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92587694|NCT00330772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92587695|NCT00330772|Analgesics|analgesics|mesh-ancestor
92587696|NCT00330772|Sensory System Agents|sensory system agents|mesh-ancestor
92587697|NCT00330772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587698|NCT00330772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587699|NCT00330772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587700|NCT00330772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587701|NCT00330772|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92587702|NCT00330772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92587703|NCT00330772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587704|NCT00330772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92587705|NCT00330772|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92587706|NCT00330772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587707|NCT00330772|Antipyretics|antipyretics|mesh-ancestor
92587708|NCT00330772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92587709|NCT00330772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92587710|NCT00330772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92587711|NCT00330772|Purinergic Agents|purinergic agents|mesh-ancestor
92587712|NCT00330772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587713|NCT00094926|Risperidone|risperidone|mesh-list
92587714|NCT00094926|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92587715|NCT00094926|Serotonin Agents|serotonin agents|mesh-ancestor
92587716|NCT00094926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587717|NCT00094926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587718|NCT00094926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587719|NCT00094926|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587720|NCT00094926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587721|NCT00094926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587722|NCT00094926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587723|NCT00094926|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92587724|NCT00094926|Dopamine Agents|dopamine agents|mesh-ancestor
92587725|NCT00087464|Tenofovir|tenofovir|mesh-list
92587726|NCT00087464|Emtricitabine|emtricitabine|mesh-list
92587727|NCT00087464|Nevirapine|nevirapine|mesh-list
92587728|NCT00087464|Antiviral Agents|antiviral agents|mesh-ancestor
92587729|NCT00087464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587730|NCT00087464|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92587731|NCT00087464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92587732|NCT00087464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587733|NCT00087464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587734|NCT00087464|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92587735|NCT00087464|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92587736|NCT00087464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92587737|NCT00087464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92587738|NCT00331045|Alvimopan|alvimopan|mesh-list
92587739|NCT00331045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92587740|NCT00331084|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92587741|NCT00331084|Moxifloxacin|moxifloxacin|mesh-list
92587742|NCT00331084|Dexamethasone|dexamethasone|mesh-list
92587743|NCT00331084|Dexamethasone acetate|dexamethasone acetate|mesh-list
92587748|NCT00331084|Autonomic Agents|autonomic agents|mesh-ancestor
92587749|NCT00331084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587750|NCT00331084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587751|NCT00331084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535430|NCT00075673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535431|NCT00075673|Tubulin Modulators|tubulin modulators|mesh-ancestor
92535432|NCT00075673|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535433|NCT00075673|Mitosis Modulators|mitosis modulators|mesh-ancestor
92587752|NCT00331084|Glucocorticoids|glucocorticoids|mesh-ancestor
92587754|NCT00331084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92587755|NCT00331084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92587756|NCT00331084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587757|NCT00331084|Protease Inhibitors|protease inhibitors|mesh-ancestor
92587758|NCT00331084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587759|NCT00331084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587760|NCT00331084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587761|NCT00331084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587762|NCT00331084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587763|NCT00331084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92587764|NCT00331084|Contraceptive Agents|contraceptive agents|mesh-ancestor
92587765|NCT00331084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92587766|NCT00331084|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92587767|NCT00331084|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92587768|NCT00331084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92587769|NCT00420355|Ritonavir|ritonavir|mesh-list
92587770|NCT00420355|Lopinavir|lopinavir|mesh-list
92587771|NCT00420355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92587772|NCT00420355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92587773|NCT00420355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92587774|NCT00420355|Protease Inhibitors|protease inhibitors|mesh-ancestor
92587775|NCT00420355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587776|NCT00420355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587777|NCT00420355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92587778|NCT00420355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92587779|NCT00420355|Antiviral Agents|antiviral agents|mesh-ancestor
92587780|NCT00420355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587781|NCT00420355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92587782|NCT00420355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92587783|NCT00331123|Testosterone|testosterone|mesh-list
92587784|NCT00331123|Androgens|androgens|mesh-ancestor
92587785|NCT00331123|Hormones|hormones|mesh-ancestor
92587786|NCT00331123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92587787|NCT00331123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587788|NCT00087542|Pimavanserin|pimavanserin|mesh-list
92587789|NCT00087542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92587790|NCT00087542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92587791|NCT00087542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587792|NCT00087542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587793|NCT00087542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587794|NCT00087542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587795|NCT00087542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587796|NCT00087542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92587797|NCT00087542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92587798|NCT00087542|Serotonin Agents|serotonin agents|mesh-ancestor
92587799|NCT00087542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587800|NCT00087542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587801|NCT00331240|Timolol|timolol|mesh-list
92587802|NCT00331240|Travoprost|travoprost|mesh-list
92587803|NCT00331240|Lubricant Eye Drops|lubricant eye drops|mesh-list
92587804|NCT00331240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92587805|NCT00331240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92587806|NCT00331240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92587807|NCT00331240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587808|NCT00331240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587809|NCT00331240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587810|NCT00331240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92587811|NCT00331240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92587812|NCT00331240|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92587813|NCT00331240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92587818|NCT00124956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587819|NCT00124956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587820|NCT00124956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587821|NCT00087581|Cyclosporine|cyclosporine|mesh-list
92587822|NCT00087581|Mycophenolic Acid|mycophenolic acid|mesh-list
92535434|NCT00075712|Paclitaxel|paclitaxel|mesh-list
92535435|NCT00075712|Carboplatin|carboplatin|mesh-list
92587824|NCT00087581|Cyclosporins|cyclosporins|mesh-list
92587825|NCT00087581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587826|NCT00087581|Immunologic Factors|immunologic factors|mesh-ancestor
92587827|NCT00087581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587828|NCT00087581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92587829|NCT00087581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587830|NCT00087581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587831|NCT00087581|Antifungal Agents|antifungal agents|mesh-ancestor
92587832|NCT00087581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587833|NCT00087581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92587834|NCT00087581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587835|NCT00087581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587836|NCT00087581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587837|NCT00087581|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92587838|NCT00087581|Antitubercular Agents|antitubercular agents|mesh-ancestor
92587839|NCT00087581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92587840|NCT00094965|Oxaliplatin|oxaliplatin|mesh-list
92587841|NCT00094965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587842|NCT00331435|Verteporfin|verteporfin|mesh-list
92587843|NCT00331435|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92587844|NCT00331435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92587845|NCT00331513|Vorinostat|vorinostat|mesh-list
92587846|NCT00331513|Idarubicin|idarubicin|mesh-list
92587847|NCT00331513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587848|NCT00331513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92587849|NCT00331513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587850|NCT00331513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587851|NCT00331513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587852|NCT00331513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587853|NCT00331513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587854|NCT00087620|Capecitabine|capecitabine|mesh-list
92587855|NCT00087620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587856|NCT00087620|Antimetabolites|antimetabolites|mesh-ancestor
92587857|NCT00087620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587858|NCT00087620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587859|NCT00124995|Terbutaline|terbutaline|mesh-list
92587860|NCT00124995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92587861|NCT00124995|Autonomic Agents|autonomic agents|mesh-ancestor
92587862|NCT00124995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587863|NCT00124995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587864|NCT00124995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92587865|NCT00124995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92587866|NCT00124995|Sympathomimetics|sympathomimetics|mesh-ancestor
92587867|NCT00124995|Tocolytic Agents|tocolytic agents|mesh-ancestor
92587868|NCT00124995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92587869|NCT00124995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92587870|NCT00124995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92587871|NCT00124995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92587872|NCT00124995|Adrenergic Agents|adrenergic agents|mesh-ancestor
92587873|NCT00124995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587874|NCT00124995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587875|NCT00331708|Artesunate|artesunate|mesh-list
92587876|NCT00331708|Pyrimethamine|pyrimethamine|mesh-list
92587877|NCT00331708|Sulfadoxine|sulfadoxine|mesh-list
92587878|NCT00331708|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92587879|NCT00331708|Antimalarials|antimalarials|mesh-ancestor
92587880|NCT00331708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92587881|NCT00331708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92587882|NCT00331708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587883|NCT00331708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587884|NCT00331708|Antiviral Agents|antiviral agents|mesh-ancestor
92587885|NCT00331708|Schistosomicides|schistosomicides|mesh-ancestor
92587886|NCT00331708|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92587887|NCT00331708|Anthelmintics|anthelmintics|mesh-ancestor
92587888|NCT00331708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92587889|NCT00331708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587890|NCT00331708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587891|NCT00331708|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92587892|NCT00331747|Glatiramer Acetate|glatiramer acetate|mesh-list
92587893|NCT00331747|(T,G)-A-L|(t,g)-a-l|mesh-list
92587894|NCT00331747|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92587895|NCT00331747|Immunologic Factors|immunologic factors|mesh-ancestor
92587896|NCT00331747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535436|NCT00075712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92587897|NCT00331747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92587898|NCT00331747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587899|NCT00087659|Zoledronic Acid|zoledronic acid|mesh-list
92587900|NCT00087659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92587901|NCT00087659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587902|NCT00331786|Aspirin|aspirin|mesh-list
92587903|NCT00331786|Nitroaspirin|nitroaspirin|mesh-list
92587904|NCT00331786|Nitric Oxide|nitric oxide|mesh-list
92587905|NCT00331786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92587906|NCT00331786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92587907|NCT00331786|Analgesics|analgesics|mesh-ancestor
92587908|NCT00331786|Sensory System Agents|sensory system agents|mesh-ancestor
92587909|NCT00331786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587910|NCT00331786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587911|NCT00331786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587912|NCT00331786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92587913|NCT00331786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92587914|NCT00331786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92587915|NCT00331786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587916|NCT00331786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92587917|NCT00331786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92587918|NCT00331786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587919|NCT00331786|Antipyretics|antipyretics|mesh-ancestor
92587920|NCT00331786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92587921|NCT00331786|Autonomic Agents|autonomic agents|mesh-ancestor
92587922|NCT00331786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92587923|NCT00331786|Respiratory System Agents|respiratory system agents|mesh-ancestor
92587924|NCT00331786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92587925|NCT00331786|Antioxidants|antioxidants|mesh-ancestor
92587926|NCT00331786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587927|NCT00331786|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92587928|NCT00331786|Vasodilator Agents|vasodilator agents|mesh-ancestor
92587929|NCT00331786|Gasotransmitters|gasotransmitters|mesh-ancestor
92587930|NCT00331786|Protective Agents|protective agents|mesh-ancestor
92587931|NCT00331786|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92587932|NCT00331786|Protease Inhibitors|protease inhibitors|mesh-ancestor
92587933|NCT00331825|Olanzapine|olanzapine|mesh-list
92587934|NCT00331825|Risperidone|risperidone|mesh-list
92587935|NCT00331825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92587936|NCT00331825|Serotonin Agents|serotonin agents|mesh-ancestor
92587937|NCT00331825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587938|NCT00331825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587939|NCT00331825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587940|NCT00331825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587941|NCT00331825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587942|NCT00331825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587943|NCT00331825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587944|NCT00331825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92587945|NCT00331825|Dopamine Agents|dopamine agents|mesh-ancestor
92587946|NCT00331825|Antiemetics|antiemetics|mesh-ancestor
92587947|NCT00331825|Autonomic Agents|autonomic agents|mesh-ancestor
92587948|NCT00331825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587949|NCT00331825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92587950|NCT00331825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92587951|NCT00331825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587952|NCT00331825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587953|NCT00420472|Mycophenolic Acid|mycophenolic acid|mesh-list
92587954|NCT00420472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587955|NCT00420472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587956|NCT00420472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92587957|NCT00420472|Antitubercular Agents|antitubercular agents|mesh-ancestor
92587959|NCT00420472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92587960|NCT00420472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587961|NCT00420472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360091|NCT00383448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92587963|NCT00087737|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92587964|NCT00087737|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587965|NCT00087737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92587966|NCT00087737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587967|NCT00087737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587968|NCT00087737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587969|NCT00087737|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92535437|NCT00075712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535438|NCT00075712|Tubulin Modulators|tubulin modulators|mesh-ancestor
92535439|NCT00075712|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535440|NCT00075712|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535441|NCT00075712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587970|NCT00087737|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587971|NCT00087737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587972|NCT00331981|Amisulpride|amisulpride|mesh-list
92587973|NCT00331981|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587974|NCT00331981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587975|NCT00331981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92587976|NCT00331981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587977|NCT00331981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587978|NCT00331981|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92587979|NCT00331981|Dopamine Agents|dopamine agents|mesh-ancestor
92587980|NCT00331981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92587981|NCT00331981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587982|NCT00331981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92587983|NCT00331981|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587984|NCT00126633|Bevacizumab|bevacizumab|mesh-list
92587985|NCT00126633|Gemcitabine|gemcitabine|mesh-list
92587986|NCT00126633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92587987|NCT00126633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587988|NCT00126633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92587989|NCT00126633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92587990|NCT00126633|Growth Substances|growth substances|mesh-ancestor
92587991|NCT00126633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587992|NCT00126633|Growth Inhibitors|growth inhibitors|mesh-ancestor
92587993|NCT00126633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587994|NCT00126633|Antimetabolites|antimetabolites|mesh-ancestor
92587995|NCT00126633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587996|NCT00332020|Enoxaparin|enoxaparin|mesh-list
92587997|NCT00332020|Rivaroxaban|rivaroxaban|mesh-list
92587998|NCT00332020|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92587999|NCT00332020|Antithrombins|antithrombins|mesh-ancestor
92588000|NCT00332020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92588001|NCT00332020|Protease Inhibitors|protease inhibitors|mesh-ancestor
92588002|NCT00332020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588003|NCT00332020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588004|NCT00332020|Anticoagulants|anticoagulants|mesh-ancestor
92588005|NCT00332020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92588006|NCT00332020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92588007|NCT02965274|Fluoxetine|fluoxetine|mesh-list
92588008|NCT02965274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92588009|NCT02965274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92588010|NCT02965274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588011|NCT02965274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588012|NCT02965274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588013|NCT02965274|Serotonin Agents|serotonin agents|mesh-ancestor
92588014|NCT02965274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588015|NCT02965274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92588016|NCT02965274|Antidepressive Agents|antidepressive agents|mesh-ancestor
92588017|NCT02965274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92588018|NCT02965274|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92588019|NCT02965274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92588020|NCT02965274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588021|NCT00332059|Timolol|timolol|mesh-list
92588022|NCT00332059|Bimatoprost|bimatoprost|mesh-list
92588023|NCT00332059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92588024|NCT00332059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92588025|NCT00332059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92588026|NCT00332059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588027|NCT00332059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312910|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92588028|NCT00332059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588029|NCT00332059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92588030|NCT00332059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92588031|NCT00332137|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92535442|NCT03958500|Methylene Blue|methylene blue|mesh-list
92535443|NCT03958500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588035|NCT00332137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588036|NCT00332137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588037|NCT00332137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588038|NCT00332137|Urological Agents|urological agents|mesh-ancestor
92588039|NCT00126789|Fentanyl|fentanyl|mesh-list
92588040|NCT00126789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92588041|NCT00126789|Narcotics|narcotics|mesh-ancestor
92588042|NCT00126789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588043|NCT00126789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588044|NCT00126789|Analgesics|analgesics|mesh-ancestor
92588045|NCT00126789|Sensory System Agents|sensory system agents|mesh-ancestor
92588046|NCT00126789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588047|NCT00126789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92588048|NCT00126789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92588049|NCT00126789|Anesthetics, General|anesthetics, general|mesh-ancestor
92588050|NCT00126789|Anesthetics|anesthetics|mesh-ancestor
92588051|NCT05831969|Lenalidomide|lenalidomide|mesh-list
92588052|NCT05831969|Immunologic Factors|immunologic factors|mesh-ancestor
92588053|NCT05831969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588054|NCT05831969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92588055|NCT05831969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92588056|NCT05831969|Growth Substances|growth substances|mesh-ancestor
92588057|NCT05831969|Growth Inhibitors|growth inhibitors|mesh-ancestor
92588058|NCT05831969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588059|NCT05831761|Lidocaine|lidocaine|mesh-list
92588060|NCT05831761|Analgesics|analgesics|mesh-list
92588061|NCT05831761|Anesthetics, Local|anesthetics, local|mesh-ancestor
92588062|NCT05831761|Anesthetics|anesthetics|mesh-ancestor
92588063|NCT05831761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588064|NCT05831761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588065|NCT05831761|Sensory System Agents|sensory system agents|mesh-ancestor
92588066|NCT05831761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588067|NCT05831761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92588068|NCT05831761|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92588069|NCT05831761|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92588070|NCT05831761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588071|NCT05831761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588072|NCT05831566|Budesonide|budesonide|mesh-list
92588073|NCT05831566|Formoterol Fumarate|formoterol fumarate|mesh-list
92588074|NCT05831566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588075|NCT05831566|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92588076|NCT05831566|Autonomic Agents|autonomic agents|mesh-ancestor
92588077|NCT05831566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588078|NCT05831566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588079|NCT05831566|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92588080|NCT05831566|Respiratory System Agents|respiratory system agents|mesh-ancestor
92588081|NCT05831566|Glucocorticoids|glucocorticoids|mesh-ancestor
92588082|NCT05831566|Hormones|hormones|mesh-ancestor
92588083|NCT05831566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588084|NCT05831566|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92588085|NCT05831566|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92588086|NCT05831566|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92588087|NCT05831566|Adrenergic Agents|adrenergic agents|mesh-ancestor
92588088|NCT05831566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588089|NCT05831566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588090|NCT05831462|Ticagrelor|ticagrelor|mesh-list
92588091|NCT05831462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92588092|NCT05831462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92588093|NCT05831462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92588094|NCT05831462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92588095|NCT05831462|Purinergic Agents|purinergic agents|mesh-ancestor
92588096|NCT05831462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588097|NCT05831462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588098|NCT05831462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588099|NCT05831449|Ropivacaine|ropivacaine|mesh-list
92588100|NCT05831449|Anesthetics, Local|anesthetics, local|mesh-list
92588101|NCT05831449|Anesthetics|anesthetics|mesh-list
92588102|NCT05831449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588103|NCT05831449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588104|NCT05831449|Sensory System Agents|sensory system agents|mesh-ancestor
92535444|NCT03958500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535445|NCT00075751|Carboplatin|carboplatin|mesh-list
92535446|NCT00075751|Gemcitabine|gemcitabine|mesh-list
92535447|NCT00075751|Bortezomib|bortezomib|mesh-list
92535448|NCT00075751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535449|NCT00075751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588105|NCT05831449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588106|NCT05831345|Sufentanil|sufentanil|mesh-list
92588108|NCT05831345|Methadone|methadone|mesh-list
92588109|NCT05831345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92588110|NCT05831345|Narcotics|narcotics|mesh-ancestor
92588111|NCT05831345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588112|NCT05831345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588113|NCT05831345|Analgesics|analgesics|mesh-ancestor
92588114|NCT05831345|Sensory System Agents|sensory system agents|mesh-ancestor
92588115|NCT05831345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588116|NCT05831345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92588117|NCT05831345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92588118|NCT05831345|Anesthetics, General|anesthetics, general|mesh-ancestor
92588119|NCT05831345|Anesthetics|anesthetics|mesh-ancestor
92588120|NCT05831345|Antitussive Agents|antitussive agents|mesh-ancestor
92588121|NCT05831345|Respiratory System Agents|respiratory system agents|mesh-ancestor
92588122|NCT05831267|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92588123|NCT05831267|Hemostatics|hemostatics|mesh-ancestor
92588124|NCT05831267|Coagulants|coagulants|mesh-ancestor
92588125|NCT05831098|Antibodies|antibodies|mesh-list
92588126|NCT05831098|Immunologic Factors|immunologic factors|mesh-ancestor
92588127|NCT05831098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588128|NCT05830916|Antibodies|antibodies|mesh-list
92588129|NCT05830916|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
92588130|NCT05830916|Immunologic Factors|immunologic factors|mesh-ancestor
92588131|NCT05830916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588132|NCT05830864|Isoflurane|isoflurane|mesh-list
92588133|NCT05830864|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92588134|NCT05830864|Anesthetics, General|anesthetics, general|mesh-ancestor
92588135|NCT05830864|Anesthetics|anesthetics|mesh-ancestor
92588136|NCT05830864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588137|NCT05830864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588138|NCT05830747|Prednisone|prednisone|mesh-list
92588139|NCT05830747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588140|NCT05830747|Glucocorticoids|glucocorticoids|mesh-ancestor
92588141|NCT05830747|Hormones|hormones|mesh-ancestor
92588142|NCT05830747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588143|NCT05830747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588144|NCT05830747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92588145|NCT05830747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588146|NCT05830604|Salicylic Acid|salicylic acid|mesh-list
92588147|NCT05830604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588148|NCT05830604|Antifungal Agents|antifungal agents|mesh-ancestor
92588149|NCT05830604|Keratolytic Agents|keratolytic agents|mesh-ancestor
92588150|NCT05830604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92588151|NCT05830136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92588152|NCT05830071|Moxifloxacin|moxifloxacin|mesh-list
92588153|NCT05830071|Beclomethasone|beclomethasone|mesh-list
92588154|NCT05830071|Glycopyrrolate|glycopyrrolate|mesh-list
92588155|NCT05830071|Bromides|bromides|mesh-list
92588156|NCT05830071|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92588157|NCT05830071|Formoterol Fumarate|formoterol fumarate|mesh-list
92588158|NCT05830071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92588159|NCT05830071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588160|NCT05830071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92588161|NCT05830071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588162|NCT05830071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588163|NCT05830071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588164|NCT05830071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588165|NCT05830071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92588166|NCT05830071|Contraceptive Agents|contraceptive agents|mesh-ancestor
92588167|NCT05830071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92588168|NCT05830071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588169|NCT05830071|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92588170|NCT05830071|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92535450|NCT00075751|Antimetabolites|antimetabolites|mesh-ancestor
92535451|NCT00075751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535452|NCT00075868|Octreotide|octreotide|mesh-list
92535453|NCT00075868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535454|NCT00075868|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535455|NCT00075868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535456|NCT00075907|Ritonavir|ritonavir|mesh-list
92535457|NCT00075907|Lopinavir|lopinavir|mesh-list
92535458|NCT00075907|Efavirenz|efavirenz|mesh-list
92535459|NCT00075907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92535460|NCT00075907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92535461|NCT00075907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92588171|NCT05830071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92588172|NCT05830071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92588173|NCT05830071|Autonomic Agents|autonomic agents|mesh-ancestor
92588174|NCT05830071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588175|NCT05830071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92588176|NCT05830071|Respiratory System Agents|respiratory system agents|mesh-ancestor
92588177|NCT05830071|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92588178|NCT05830071|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91995363|NCT04121507|Thiotepa|thiotepa|mesh-list
92588183|NCT05830071|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92588184|NCT05830071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92588185|NCT05830071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92588186|NCT05830071|Cholinergic Agents|cholinergic agents|mesh-ancestor
92588187|NCT05830071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588188|NCT05830071|Glucocorticoids|glucocorticoids|mesh-ancestor
92588190|NCT05830071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588191|NCT05828758|Amoxicillin|amoxicillin|mesh-list
92588192|NCT05828758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92588193|NCT05828758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588194|NCT05821725|Hyaluronic Acid|hyaluronic acid|mesh-list
92588195|NCT05821725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92588196|NCT05821725|Immunologic Factors|immunologic factors|mesh-ancestor
92588197|NCT05821725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588198|NCT05821725|Viscosupplements|viscosupplements|mesh-ancestor
92588199|NCT05821725|Protective Agents|protective agents|mesh-ancestor
92588200|NCT05820997|Ropivacaine|ropivacaine|mesh-list
92588201|NCT05820997|Anesthetics, Local|anesthetics, local|mesh-ancestor
92588202|NCT05820997|Anesthetics|anesthetics|mesh-ancestor
92588203|NCT05820997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588204|NCT05820997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588205|NCT05820997|Sensory System Agents|sensory system agents|mesh-ancestor
92588206|NCT05820997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588207|NCT05814523|Ganaxolone|ganaxolone|mesh-list
92588208|NCT05814523|Neurosteroids|neurosteroids|mesh-ancestor
92588209|NCT05814523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588210|NCT05814523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588211|NCT05814523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588212|NCT05814523|GABA Modulators|gaba modulators|mesh-ancestor
92588213|NCT05814523|GABA Agents|gaba agents|mesh-ancestor
92588214|NCT05793905|Lidocaine|lidocaine|mesh-list
92588215|NCT05793905|Anesthetics, Local|anesthetics, local|mesh-ancestor
92588216|NCT05793905|Anesthetics|anesthetics|mesh-ancestor
92588217|NCT05793905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588218|NCT05793905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588219|NCT05793905|Sensory System Agents|sensory system agents|mesh-ancestor
92588220|NCT05793905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588221|NCT05793905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92588222|NCT05793905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92588223|NCT05793905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92588224|NCT05793905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588225|NCT05793905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588226|NCT05776017|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92535462|NCT00075907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535463|NCT00075907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535464|NCT00075907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92535465|NCT00075907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92535466|NCT00075907|Antiviral Agents|antiviral agents|mesh-ancestor
92535467|NCT00075907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535468|NCT00075907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92535469|NCT00075907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92535470|NCT00075907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92535471|NCT00075907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92588227|NCT05776017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92588228|NCT05776017|Immunologic Factors|immunologic factors|mesh-ancestor
92588229|NCT05776017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588230|NCT05776017|Antacids|antacids|mesh-ancestor
92588231|NCT05776017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588232|NCT05776017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92588233|NCT05744648|Titanium dioxide|titanium dioxide|mesh-list
92588234|NCT05744648|Sunscreening Agents|sunscreening agents|mesh-ancestor
92588235|NCT05744648|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92588236|NCT05744648|Protective Agents|protective agents|mesh-ancestor
92588237|NCT05744648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588238|NCT05744648|Dermatologic Agents|dermatologic agents|mesh-ancestor
92588239|NCT05744648|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92588240|NCT05735353|Methamphetamine|methamphetamine|mesh-list
92588241|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92588242|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588243|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
92588244|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
92588245|NCT05735353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588246|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
92588247|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588248|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588249|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92588252|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588254|NCT05691517|Exatecan|exatecan|mesh-list
92588255|NCT05691517|Camptothecin|camptothecin|mesh-list
92588256|NCT05691517|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588257|NCT05691517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588258|NCT05691517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588259|NCT05691517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588260|NCT05691517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588261|NCT05691517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92588262|NCT05680818|Vitamin D|vitamin d|mesh-list
92588263|NCT05680818|Calcitriol|calcitriol|mesh-list
92588264|NCT05680818|Alfacalcidol|alfacalcidol|mesh-list
92588265|NCT05680818|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92588266|NCT05680818|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3|mesh-list
92588267|NCT05680818|Calcium|calcium|mesh-list
92588268|NCT05680818|Vitamins|vitamins|mesh-ancestor
92588269|NCT05680818|Micronutrients|micronutrients|mesh-ancestor
92588270|NCT05680818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588271|NCT05680818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92588272|NCT05680818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92588273|NCT05680818|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92588274|NCT05680818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588275|NCT05680818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588276|NCT05680818|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92588277|NCT05680818|Dermatologic Agents|dermatologic agents|mesh-ancestor
92588278|NCT05670379|Exenatide|exenatide|mesh-list
92588279|NCT05670379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92588280|NCT05670379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588281|NCT05670379|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92588282|NCT05670379|Incretins|incretins|mesh-ancestor
92535472|NCT00075907|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92535473|NCT00075907|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92535474|NCT00075907|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92535475|NCT00075907|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92535476|NCT00075907|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92535477|NCT03958383|Nivolumab|nivolumab|mesh-list
92535478|NCT03958383|Ipilimumab|ipilimumab|mesh-list
92535479|NCT03958383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92535480|NCT03958383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535481|NCT03958383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92535482|NCT03958383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535483|NCT00076414|Acetylcholine|acetylcholine|mesh-list
92535484|NCT00076414|Vasodilator Agents|vasodilator agents|mesh-ancestor
92588283|NCT05670379|Hormones|hormones|mesh-ancestor
92588284|NCT05670379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588285|NCT05665270|Prednisolone|prednisolone|mesh-list
92588286|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92588287|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
92588288|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92588289|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
92588290|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92588291|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
92588292|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588293|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
92588294|NCT05665270|Hormones|hormones|mesh-ancestor
92588295|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588296|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588297|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92588298|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588299|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
92588300|NCT05665270|Autonomic Agents|autonomic agents|mesh-ancestor
92588301|NCT05665270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588302|NCT05665270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92588303|NCT05665270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92588304|NCT05665270|Protective Agents|protective agents|mesh-ancestor
92588305|NCT05660447|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92588306|NCT05660447|Lubricant Eye Drops|lubricant eye drops|mesh-list
92588307|NCT05660447|Glycerol|glycerol|mesh-list
92588308|NCT05660447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92588309|NCT05660447|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92588310|NCT05660447|Protective Agents|protective agents|mesh-ancestor
92588311|NCT05660447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588312|NCT05653973|Acetylcholine|acetylcholine|mesh-list
92588313|NCT05653973|Vasodilator Agents|vasodilator agents|mesh-ancestor
92588314|NCT05653973|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92588315|NCT05653973|Cholinergic Agents|cholinergic agents|mesh-ancestor
92588316|NCT05653973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588317|NCT05653973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588318|NCT05653973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588319|NCT05628363|Androgens|androgens|mesh-list
92588320|NCT05628363|Hormones|hormones|mesh-ancestor
92588321|NCT05628363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588327|NCT05574400|Anticoagulants|anticoagulants|mesh-ancestor
92588328|NCT05574400|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92313211|NCT01190306|Riboflavin|riboflavin|mesh-list
92588329|NCT05574400|Chelating Agents|chelating agents|mesh-ancestor
92588330|NCT05574400|Sequestering Agents|sequestering agents|mesh-ancestor
92588331|NCT05574400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588332|NCT05574400|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92588333|NCT05574400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588334|NCT05574400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92535485|NCT00076414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92535486|NCT00076414|Cholinergic Agents|cholinergic agents|mesh-ancestor
92535487|NCT00076414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535488|NCT00076414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535489|NCT00076414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535490|NCT00399256|Acetylcysteine|acetylcysteine|mesh-list
92535491|NCT00399256|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92535492|NCT00399256|Antiviral Agents|antiviral agents|mesh-ancestor
91935089|NCT02309281|Growth Inhibitors|growth inhibitors|mesh-ancestor
92588335|NCT05574400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588336|NCT05574400|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92588337|NCT05574400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92588338|NCT05574400|Purinergic Agents|purinergic agents|mesh-ancestor
92588339|NCT05574400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588340|NCT05555862|Artesunate|artesunate|mesh-list
92588341|NCT05555862|Artenimol|artenimol|mesh-list
92588342|NCT05555862|Artemisinins|artemisinins|mesh-list
92588343|NCT05555862|Artemisinin|artemisinin|mesh-list
92588344|NCT05555862|Antimalarials|antimalarials|mesh-ancestor
92588345|NCT05555862|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92588346|NCT05555862|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92588347|NCT05555862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588348|NCT05555862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588349|NCT05555862|Antiviral Agents|antiviral agents|mesh-ancestor
92588350|NCT05555862|Schistosomicides|schistosomicides|mesh-ancestor
92588351|NCT05555862|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92588352|NCT05555862|Anthelmintics|anthelmintics|mesh-ancestor
92588353|NCT05546359|Dexamethasone|dexamethasone|mesh-list
92588354|NCT05546359|Amisulpride|amisulpride|mesh-list
92588355|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588356|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
92588357|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
92588358|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588359|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588360|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92588361|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
92588362|NCT05546359|Hormones|hormones|mesh-ancestor
92588363|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588364|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92588365|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588366|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92588367|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92588368|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588369|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92588370|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92588371|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
92588372|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588373|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588374|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92588375|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
92588376|NCT05510115|Empagliflozin|empagliflozin|mesh-list
92588377|NCT05510115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92588378|NCT05510115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588379|NCT05510115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92588380|NCT05510115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588381|NCT05413330|Triamcinolone|triamcinolone|mesh-list
92588382|NCT05413330|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92588383|NCT05413330|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92588384|NCT05413330|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92588385|NCT05413330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588386|NCT05413330|Glucocorticoids|glucocorticoids|mesh-ancestor
92588387|NCT05413330|Hormones|hormones|mesh-ancestor
92588388|NCT05413330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588389|NCT05413330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588390|NCT05413330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588391|NCT05413330|Immunologic Factors|immunologic factors|mesh-ancestor
92588392|NCT05413330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535493|NCT00399256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535494|NCT00399256|Expectorants|expectorants|mesh-ancestor
92535495|NCT00399256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92535496|NCT00399256|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92535497|NCT00399256|Antioxidants|antioxidants|mesh-ancestor
92535498|NCT00399256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535499|NCT00399256|Protective Agents|protective agents|mesh-ancestor
92260250|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
92535500|NCT00399256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535501|NCT00399256|Antidotes|antidotes|mesh-ancestor
92535502|NCT00399295|Naltrexone|naltrexone|mesh-list
92535503|NCT00399295|Hydromorphone|hydromorphone|mesh-list
92535504|NCT00399295|Narcotic Antagonists|narcotic antagonists|mesh-list
92535505|NCT00399295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92535506|NCT00399295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588400|NCT05271630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588401|NCT05254639|Donepezil|donepezil|mesh-list
92588402|NCT05254639|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92588403|NCT05254639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313284|NCT02192970|Bevacizumab|bevacizumab|mesh-list
92588404|NCT05254639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588405|NCT05254639|Cholinergic Agents|cholinergic agents|mesh-ancestor
92588406|NCT05254639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588407|NCT05254639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588408|NCT05254639|Nootropic Agents|nootropic agents|mesh-ancestor
92588409|NCT05243940|Lidocaine|lidocaine|mesh-list
92588410|NCT05243940|Dexmedetomidine|dexmedetomidine|mesh-list
92588411|NCT05243940|Ketamine|ketamine|mesh-list
92588412|NCT05243940|Remifentanil|remifentanil|mesh-list
92588413|NCT05243940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92588414|NCT05243940|Anesthetics|anesthetics|mesh-ancestor
92588415|NCT05243940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588416|NCT05243940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588417|NCT05243940|Sensory System Agents|sensory system agents|mesh-ancestor
92588418|NCT05243940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588419|NCT05243940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92588420|NCT05243940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92360115|NCT00464646|Bevacizumab|bevacizumab|mesh-list
92588421|NCT05243940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92588422|NCT05243940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588423|NCT05243940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588424|NCT05243940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92588425|NCT05243940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92588426|NCT05243940|Analgesics|analgesics|mesh-ancestor
92588427|NCT05243940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92588428|NCT05243940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92588429|NCT05243940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92588430|NCT05243940|Adrenergic Agents|adrenergic agents|mesh-ancestor
92588431|NCT05243940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588432|NCT05243940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92588433|NCT05243940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92588434|NCT05243940|Anesthetics, General|anesthetics, general|mesh-ancestor
92588435|NCT05243940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92588436|NCT05243940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92588437|NCT05243940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92588438|NCT05243940|Narcotics|narcotics|mesh-ancestor
92588439|NCT05209347|Carbon Fiber|carbon fiber|mesh-list
92588440|NCT05209347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92588441|NCT05209347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588442|NCT05198544|Hyaluronic Acid|hyaluronic acid|mesh-list
92588443|NCT05198544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92588444|NCT05198544|Immunologic Factors|immunologic factors|mesh-ancestor
92588445|NCT05198544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535507|NCT00399295|Sensory System Agents|sensory system agents|mesh-ancestor
92535508|NCT00399295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535509|NCT00399295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92535510|NCT00399295|Narcotics|narcotics|mesh-ancestor
92535511|NCT00399295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535512|NCT00399295|Analgesics|analgesics|mesh-ancestor
92535513|NCT00399334|Antipsychotic Agents|antipsychotic agents|mesh-list
92535514|NCT00399334|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92535515|NCT00399334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535516|NCT00399334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535517|NCT00399334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92535518|NCT00076492|Coenzyme Q10|coenzyme q10|mesh-list
92535519|NCT00076492|Vitamins|vitamins|mesh-ancestor
92535520|NCT00076492|Micronutrients|micronutrients|mesh-ancestor
92535521|NCT00076492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535522|NCT00076531|Leuprolide|leuprolide|mesh-list
92535523|NCT00076531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92535524|NCT00076531|Fertility Agents|fertility agents|mesh-ancestor
92535525|NCT00076531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92535526|NCT00076531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935187|NCT03509545|Torsemide|torsemide|mesh-list
92588446|NCT05198544|Viscosupplements|viscosupplements|mesh-ancestor
92588447|NCT05198544|Protective Agents|protective agents|mesh-ancestor
92588448|NCT05167734|Dextrans|dextrans|mesh-list
92588449|NCT05167734|Epoetin Alfa|epoetin alfa|mesh-list
92588450|NCT05167734|Iron-Dextran Complex|iron-dextran complex|mesh-list
92588451|NCT05167734|Hematinics|hematinics|mesh-ancestor
92588452|NCT05167734|Anticoagulants|anticoagulants|mesh-ancestor
92588453|NCT05167734|Plasma Substitutes|plasma substitutes|mesh-ancestor
92588454|NCT05167734|Blood Substitutes|blood substitutes|mesh-ancestor
92588455|NCT05145309|Magnesium citrate|magnesium citrate|mesh-list
92588456|NCT05145309|Cathartics|cathartics|mesh-ancestor
92588457|NCT05145309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92588458|NCT05142241|Temozolomide|temozolomide|mesh-list
92588459|NCT05142241|Talazoparib|talazoparib|mesh-list
91995649|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588464|NCT05142241|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92588465|NCT05142241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588467|NCT05141474|Cyclophosphamide|cyclophosphamide|mesh-list
92588468|NCT05141474|Fludarabine|fludarabine|mesh-list
92588469|NCT05141474|Interleukin-2|interleukin-2|mesh-list
92588470|NCT05141474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588471|NCT05141474|Immunologic Factors|immunologic factors|mesh-ancestor
92588472|NCT05141474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588473|NCT05141474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92588474|NCT05141474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92588475|NCT05141474|Alkylating Agents|alkylating agents|mesh-ancestor
92588476|NCT05141474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588477|NCT05141474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588478|NCT05141474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92588479|NCT05141474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92588480|NCT05141474|Analgesics|analgesics|mesh-ancestor
92588481|NCT05141474|Sensory System Agents|sensory system agents|mesh-ancestor
92588482|NCT05141474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588483|NCT05141474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92588484|NCT05141474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92588485|NCT05141474|Antiviral Agents|antiviral agents|mesh-ancestor
92588486|NCT05141474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588487|NCT05126719|Docetaxel|docetaxel|mesh-list
92535527|NCT00076531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535528|NCT00076531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535530|NCT00076609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535531|NCT00076609|Antimetabolites|antimetabolites|mesh-ancestor
92535532|NCT00076609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535533|NCT00076609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535534|NCT00076726|Infliximab|infliximab|mesh-list
92535535|NCT00076726|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92535536|NCT00076726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535537|NCT00076726|Dermatologic Agents|dermatologic agents|mesh-ancestor
92588488|NCT05126719|Capecitabine|capecitabine|mesh-list
92588489|NCT05126719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588490|NCT05126719|Tubulin Modulators|tubulin modulators|mesh-ancestor
92588491|NCT05126719|Antimitotic Agents|antimitotic agents|mesh-ancestor
92588492|NCT05126719|Mitosis Modulators|mitosis modulators|mesh-ancestor
92588493|NCT05126719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588494|NCT05126719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588495|NCT05126719|Antimetabolites|antimetabolites|mesh-ancestor
92588496|NCT05119140|Hydroxychloroquine|hydroxychloroquine|mesh-list
92588497|NCT05119140|Mesalamine|mesalamine|mesh-list
92588498|NCT05119140|Antimalarials|antimalarials|mesh-ancestor
92588499|NCT05119140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92588500|NCT05119140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92588501|NCT05119140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588502|NCT05119140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588503|NCT05119140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588504|NCT05119140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92588505|NCT05119140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92588506|NCT05119140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92588507|NCT05119140|Analgesics|analgesics|mesh-ancestor
92588508|NCT05119140|Sensory System Agents|sensory system agents|mesh-ancestor
92588509|NCT05119140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588510|NCT05119140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588511|NCT05119140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588512|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
92588513|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92588514|NCT05097261|Ketamine|ketamine|mesh-list
92588515|NCT05097261|Analgesics|analgesics|mesh-ancestor
92588516|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
92588517|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588518|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588519|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92588520|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92588521|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
92588522|NCT05097261|Anesthetics|anesthetics|mesh-ancestor
92588523|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588524|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92588525|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92588526|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588527|NCT05097261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588528|NCT05037032|Naltrexone|naltrexone|mesh-list
92588529|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92588532|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
92588533|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588535|NCT04981509|Bevacizumab|bevacizumab|mesh-list
92588536|NCT04981509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92588537|NCT04981509|Atezolizumab|atezolizumab|mesh-list
92588538|NCT04981509|Endothelial Growth Factors|endothelial growth factors|mesh-list
92588539|NCT04981509|Antibodies|antibodies|mesh-list
92588540|NCT04981509|Immunoglobulins|immunoglobulins|mesh-list
92588541|NCT04981509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92588542|NCT04981509|Immunoglobulin G|immunoglobulin g|mesh-list
92588543|NCT04981509|Fluorides|fluorides|mesh-list
92588544|NCT04981509|Sodium Fluoride|sodium fluoride|mesh-list
92535539|NCT00076726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535540|NCT00076960|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92535541|NCT00076960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535542|NCT00076960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535543|NCT00077077|Capecitabine|capecitabine|mesh-list
92535544|NCT00077077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535545|NCT00077077|Antimetabolites|antimetabolites|mesh-ancestor
92535546|NCT00077077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535547|NCT00077077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535548|NCT00077116|Cytarabine|cytarabine|mesh-list
92535549|NCT00077116|Cyclophosphamide|cyclophosphamide|mesh-list
92588545|NCT04981509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588546|NCT04981509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92588547|NCT04981509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92588548|NCT04981509|Growth Substances|growth substances|mesh-ancestor
92588549|NCT04981509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588550|NCT04981509|Growth Inhibitors|growth inhibitors|mesh-ancestor
92588551|NCT04981509|Immunologic Factors|immunologic factors|mesh-ancestor
92588552|NCT04981509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588553|NCT04981509|Cariostatic Agents|cariostatic agents|mesh-ancestor
92588554|NCT04981509|Protective Agents|protective agents|mesh-ancestor
92313438|NCT02748889|Carboplatin|carboplatin|mesh-list
92588555|NCT04981509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92588556|NCT04981509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92588557|NCT04981509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588558|NCT04970901|Obinutuzumab|obinutuzumab|mesh-list
92588559|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92588560|NCT04970901|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92588561|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588562|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588563|NCT04970901|Immunoconjugates|immunoconjugates|mesh-ancestor
92588564|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
92588565|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588566|NCT04904588|Mycophenolic Acid|mycophenolic acid|mesh-list
92588567|NCT04904588|Cyclophosphamide|cyclophosphamide|mesh-list
92588568|NCT04904588|Melphalan|melphalan|mesh-list
92588569|NCT04904588|Busulfan|busulfan|mesh-list
92588570|NCT04904588|Fludarabine|fludarabine|mesh-list
92588571|NCT04904588|Tacrolimus|tacrolimus|mesh-list
92588572|NCT04904588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588573|NCT04904588|Immunologic Factors|immunologic factors|mesh-ancestor
92588574|NCT04904588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588575|NCT04904588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92588576|NCT04904588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92588577|NCT04904588|Alkylating Agents|alkylating agents|mesh-ancestor
92588578|NCT04904588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588579|NCT04904588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588580|NCT04904588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92588581|NCT04904588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92588582|NCT04904588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588583|NCT04904588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92588584|NCT04904588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92588585|NCT04904588|Antitubercular Agents|antitubercular agents|mesh-ancestor
92588586|NCT04904588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92588587|NCT04904588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588588|NCT04857931|Colchicine|colchicine|mesh-list
92588589|NCT04857931|Gout Suppressants|gout suppressants|mesh-ancestor
92588590|NCT04857931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92588591|NCT04857931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92588592|NCT04857931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92588593|NCT04857931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92588594|NCT04857931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588595|NCT04857931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535550|NCT00077116|Busulfan|busulfan|mesh-list
92535551|NCT00077116|Idarubicin|idarubicin|mesh-list
92535552|NCT00077116|Gemtuzumab|gemtuzumab|mesh-list
92535553|NCT00077116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535554|NCT00077116|Immunologic Factors|immunologic factors|mesh-ancestor
92535555|NCT00077116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535556|NCT00077116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535557|NCT00077116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535558|NCT00077116|Alkylating Agents|alkylating agents|mesh-ancestor
92360124|NCT00464646|Alkylating Agents|alkylating agents|mesh-ancestor
92535559|NCT00077116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535560|NCT00077116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535561|NCT00077116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535562|NCT00077116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535563|NCT00077116|Antimetabolites|antimetabolites|mesh-ancestor
92535564|NCT00077116|Antiviral Agents|antiviral agents|mesh-ancestor
92535565|NCT00077116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535566|NCT00077116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92588596|NCT04840199|Letermovir|letermovir|mesh-list
92588597|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92588598|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588599|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588600|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588601|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
92588602|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588603|NCT04800393|Propofol|propofol|mesh-list
92588607|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588608|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92588609|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
92588610|NCT04800393|Anesthetics|anesthetics|mesh-ancestor
92588611|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92588612|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92588613|NCT04718220|Antibodies|antibodies|mesh-list
92588614|NCT04718220|Immunologic Factors|immunologic factors|mesh-ancestor
92588615|NCT04718220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588616|NCT04668300|Durvalumab|durvalumab|mesh-list
92588617|NCT04668300|Immunoglobulins|immunoglobulins|mesh-list
92588618|NCT04668300|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92588619|NCT04668300|Immunoglobulin G|immunoglobulin g|mesh-list
92588620|NCT04668300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588621|NCT04668300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588622|NCT04668300|Immunologic Factors|immunologic factors|mesh-ancestor
92588623|NCT04668300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588624|NCT04521868|Sulforaphane|sulforaphane|mesh-list
92588625|NCT04521868|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92588626|NCT04521868|Protective Agents|protective agents|mesh-ancestor
92588627|NCT04521868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588628|NCT04521868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588629|NCT04514497|Irinotecan|irinotecan|mesh-list
92313506|NCT04507022|Estrogens|estrogens|mesh-ancestor
92588630|NCT04514497|Topotecan|topotecan|mesh-list
92588631|NCT04514497|Camptothecin|camptothecin|mesh-list
92588632|NCT04514497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588633|NCT04514497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588634|NCT04514497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588635|NCT04514497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588636|NCT04514497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588637|NCT04514497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92588638|NCT04514484|Nivolumab|nivolumab|mesh-list
92588639|NCT04514484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588640|NCT04514484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535567|NCT00077116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92535568|NCT00077116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535569|NCT00077116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535570|NCT00077116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92535572|NCT00077116|Immunoconjugates|immunoconjugates|mesh-ancestor
92535573|NCT03951207|Amlodipine|amlodipine|mesh-list
92535574|NCT03951207|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92535575|NCT03951207|Atorvastatin|atorvastatin|mesh-list
92535576|NCT03951207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92535577|NCT03951207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92535579|NCT03951207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535580|NCT03951207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92535581|NCT03951207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92535582|NCT03951207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535583|NCT03951207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92535584|NCT03951207|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92535585|NCT03951207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92535586|NCT03951207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92535587|NCT03951207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535588|NCT03951207|Vasodilator Agents|vasodilator agents|mesh-ancestor
92535589|NCT00077194|Romidepsin|romidepsin|mesh-list
92588641|NCT04514484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92588642|NCT04514484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588643|NCT04481204|Leucovorin|leucovorin|mesh-list
92588644|NCT04481204|Paclitaxel|paclitaxel|mesh-list
92588645|NCT04481204|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92588646|NCT04481204|Cisplatin|cisplatin|mesh-list
92588647|NCT04481204|Gemcitabine|gemcitabine|mesh-list
92588648|NCT04481204|Fluorouracil|fluorouracil|mesh-list
92588649|NCT04481204|Oxaliplatin|oxaliplatin|mesh-list
92588650|NCT04481204|Irinotecan|irinotecan|mesh-list
92588651|NCT04481204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92588652|NCT04481204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588653|NCT04481204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92588654|NCT04481204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92588655|NCT04481204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92588656|NCT04481204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588657|NCT04481204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588658|NCT04481204|Antimetabolites|antimetabolites|mesh-ancestor
92588659|NCT04481204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588660|NCT04481204|Immunologic Factors|immunologic factors|mesh-ancestor
92588661|NCT04481204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588662|NCT04481204|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588663|NCT04481204|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588664|NCT04481204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588665|NCT04481204|Antidotes|antidotes|mesh-ancestor
92588666|NCT04481204|Protective Agents|protective agents|mesh-ancestor
92588667|NCT04481204|Vitamin B Complex|vitamin b complex|mesh-ancestor
92588668|NCT04481204|Vitamins|vitamins|mesh-ancestor
92588669|NCT04481204|Micronutrients|micronutrients|mesh-ancestor
92588670|NCT04440735|Atezolizumab|atezolizumab|mesh-list
92588671|NCT04440735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92535590|NCT00077194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92535591|NCT00077194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535592|NCT00077194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92535593|NCT00077194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535594|NCT00077194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535595|NCT00077233|Leucovorin|leucovorin|mesh-list
92588672|NCT04440735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588673|NCT04440735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588674|NCT04440735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588675|NCT04419493|Heparin|heparin|mesh-list
92588676|NCT04419493|Calcium heparin|calcium heparin|mesh-list
92588677|NCT04419493|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92588680|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92588681|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588683|NCT04401748|Venetoclax|venetoclax|mesh-list
92588684|NCT04401748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588685|NCT04401748|Antimetabolites|antimetabolites|mesh-ancestor
92588686|NCT04401748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588687|NCT04401748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588688|NCT04401748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588689|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92588690|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92588691|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
92588692|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92588693|NCT04394975|Sunitinib|sunitinib|mesh-list
92588694|NCT04394975|Axitinib|axitinib|mesh-list
92588695|NCT04394975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588696|NCT04394975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92588697|NCT04394975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92588698|NCT04394975|Growth Substances|growth substances|mesh-ancestor
92588699|NCT04394975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588700|NCT04394975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92588701|NCT04394975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92588702|NCT04394975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588703|NCT04394975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588704|NCT04381910|Irinotecan|irinotecan|mesh-list
92588705|NCT04381910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588706|NCT04381910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588707|NCT04381910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588708|NCT04381910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588709|NCT04381910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588710|NCT04340843|Decitabine|decitabine|mesh-list
92588711|NCT04340843|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92588712|NCT04340843|Azacitidine|azacitidine|mesh-list
92588713|NCT04340843|Belinostat|belinostat|mesh-list
92588714|NCT04340843|Guadecitabine|guadecitabine|mesh-list
92588715|NCT04340843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588716|NCT04340843|Antimetabolites|antimetabolites|mesh-ancestor
92588717|NCT04340843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588718|NCT04340843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588719|NCT04340843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588720|NCT04340843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92588721|NCT04334876|Antibodies|antibodies|mesh-list
92588722|NCT04334876|Immunoglobulin G|immunoglobulin g|mesh-list
92588723|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
92588724|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588725|NCT04302870|Amantadine|amantadine|mesh-list
92588726|NCT04302870|Memantine|memantine|mesh-list
92588727|NCT04302870|Trazodone|trazodone|mesh-list
92588728|NCT04302870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92588729|NCT04302870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92588730|NCT04302870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92588731|NCT04302870|Dopamine Agents|dopamine agents|mesh-ancestor
92588732|NCT04302870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588733|NCT04302870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588734|NCT04302870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588735|NCT04302870|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92535597|NCT00077233|Oxaliplatin|oxaliplatin|mesh-list
92535598|NCT00077233|Irinotecan|irinotecan|mesh-list
92535599|NCT00077233|Cetuximab|cetuximab|mesh-list
92535600|NCT00077233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535601|NCT00077233|Antimetabolites|antimetabolites|mesh-ancestor
92535602|NCT00077233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535603|NCT00077233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588736|NCT04302870|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92588737|NCT04302870|Antiviral Agents|antiviral agents|mesh-ancestor
92588738|NCT04302870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588739|NCT04302870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92588740|NCT04302870|Analgesics|analgesics|mesh-ancestor
92588741|NCT04302870|Sensory System Agents|sensory system agents|mesh-ancestor
92588742|NCT04302870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588743|NCT04302870|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92588744|NCT04302870|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92588745|NCT04302870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588746|NCT04302870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92588747|NCT04302870|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92588748|NCT04302870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92588749|NCT04302870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92588750|NCT04302870|Serotonin Agents|serotonin agents|mesh-ancestor
92588755|NCT04294628|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92588756|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
92588757|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588758|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588759|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
92588760|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588761|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92588762|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588763|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588764|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588765|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588766|NCT04231214|Tiotropium Bromide|tiotropium bromide|mesh-list
92588767|NCT04231214|Olodaterol|olodaterol|mesh-list
92588768|NCT04231214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92588769|NCT04231214|Autonomic Agents|autonomic agents|mesh-ancestor
92588770|NCT04231214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588771|NCT04231214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588772|NCT04231214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92588773|NCT04231214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92588774|NCT04231214|Parasympatholytics|parasympatholytics|mesh-ancestor
92588775|NCT04231214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92588776|NCT04231214|Cholinergic Agents|cholinergic agents|mesh-ancestor
92588777|NCT04231214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588778|NCT04231214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588779|NCT04229095|Suvorexant|suvorexant|mesh-list
92588780|NCT04229095|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92588781|NCT04229095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92588782|NCT04229095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588783|NCT04229095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588784|NCT04229095|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92588785|NCT04229095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588786|NCT04229095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588787|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
92588788|NCT04164069|Leucovorin|leucovorin|mesh-list
92588789|NCT04164069|Folic Acid|folic acid|mesh-list
92588790|NCT04164069|Bevacizumab|bevacizumab|mesh-list
92588791|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92588792|NCT04164069|Fluorouracil|fluorouracil|mesh-list
92588793|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
92588794|NCT04164069|Dasatinib|dasatinib|mesh-list
92588795|NCT04164069|Endothelial Growth Factors|endothelial growth factors|mesh-list
92588796|NCT04164069|Antibodies|antibodies|mesh-list
92588797|NCT04164069|Immunoglobulins|immunoglobulins|mesh-list
92588798|NCT04164069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92588799|NCT04164069|Immunoglobulin G|immunoglobulin g|mesh-list
92588800|NCT04164069|Calcium|calcium|mesh-list
92535604|NCT00077233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535605|NCT00077233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535606|NCT00077233|Immunologic Factors|immunologic factors|mesh-ancestor
92535607|NCT00077233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92535608|NCT00077233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588801|NCT04164069|Levoleucovorin|levoleucovorin|mesh-list
92588802|NCT04164069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588803|NCT04164069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92588804|NCT04164069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92588805|NCT04164069|Growth Substances|growth substances|mesh-ancestor
92588806|NCT04164069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588807|NCT04164069|Growth Inhibitors|growth inhibitors|mesh-ancestor
92588808|NCT04164069|Immunologic Factors|immunologic factors|mesh-ancestor
92588809|NCT04164069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92588810|NCT04164069|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92588811|NCT04164069|Antimetabolites|antimetabolites|mesh-ancestor
92588812|NCT04164069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588813|NCT04164069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588814|NCT04164069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588815|NCT04164069|Antidotes|antidotes|mesh-ancestor
92588816|NCT04164069|Protective Agents|protective agents|mesh-ancestor
92588817|NCT04164069|Vitamin B Complex|vitamin b complex|mesh-ancestor
92588818|NCT04164069|Vitamins|vitamins|mesh-ancestor
92588819|NCT04164069|Micronutrients|micronutrients|mesh-ancestor
92588820|NCT04164069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92588821|NCT04164069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588822|NCT04164069|Hematinics|hematinics|mesh-ancestor
92588823|NCT04098744|Artesunate|artesunate|mesh-list
92588828|NCT04098744|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92588829|NCT04098744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588830|NCT04098744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588831|NCT04098744|Antiviral Agents|antiviral agents|mesh-ancestor
92588832|NCT04098744|Schistosomicides|schistosomicides|mesh-ancestor
92588833|NCT04098744|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92588834|NCT04098744|Anthelmintics|anthelmintics|mesh-ancestor
92588835|NCT04088604|Fluorouracil|fluorouracil|mesh-list
92588836|NCT04088604|Irinotecan|irinotecan|mesh-list
92588837|NCT04088604|Antimetabolites|antimetabolites|mesh-ancestor
92588838|NCT04088604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588839|NCT04088604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92588840|NCT04088604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588841|NCT04088604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588842|NCT04088604|Immunologic Factors|immunologic factors|mesh-ancestor
92588843|NCT04088604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588844|NCT04088604|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588845|NCT04088604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588846|NCT04088604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588847|NCT04078152|Durvalumab|durvalumab|mesh-list
92588848|NCT04078152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588849|NCT04078152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588850|NCT04036435|Deucravacitinib|deucravacitinib|mesh-list
92588851|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92588852|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92588853|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750760|NCT05936489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92588854|NCT04036435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588855|NCT04006288|Aspirin|aspirin|mesh-list
92588856|NCT04006288|Rivaroxaban|rivaroxaban|mesh-list
92588857|NCT04006288|Clopidogrel|clopidogrel|mesh-list
92588858|NCT04006288|Ticagrelor|ticagrelor|mesh-list
92588859|NCT04006288|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92588860|NCT04006288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92588861|NCT04006288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313733|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588862|NCT04006288|Analgesics|analgesics|mesh-ancestor
92588863|NCT04006288|Sensory System Agents|sensory system agents|mesh-ancestor
92588864|NCT04006288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588865|NCT04006288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588866|NCT04006288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588867|NCT04006288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92588868|NCT04006288|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92588869|NCT04006288|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92535609|NCT00077233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588870|NCT04006288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588871|NCT04006288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92588872|NCT04006288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92588873|NCT04006288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588874|NCT04006288|Antipyretics|antipyretics|mesh-ancestor
92588875|NCT04006288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92588876|NCT04006288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92588877|NCT04006288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92588878|NCT04006288|Purinergic Agents|purinergic agents|mesh-ancestor
92588879|NCT04006288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588880|NCT04006288|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92588881|NCT04006288|Antithrombins|antithrombins|mesh-ancestor
92588882|NCT04006288|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92588883|NCT04006288|Protease Inhibitors|protease inhibitors|mesh-ancestor
92588884|NCT04006288|Anticoagulants|anticoagulants|mesh-ancestor
92588885|NCT03979131|Avelumab|avelumab|mesh-list
92588886|NCT03979131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588887|NCT03979131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588888|NCT03958045|Nivolumab|nivolumab|mesh-list
92588889|NCT03958045|Rucaparib|rucaparib|mesh-list
92588890|NCT03958045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588891|NCT03958045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588892|NCT03958045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92588893|NCT03958045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588894|NCT03958045|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92588895|NCT03958045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588898|NCT03956680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588899|NCT03956680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588900|NCT03956680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92588901|NCT03956680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588903|NCT03952273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92588904|NCT03952273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588905|NCT03952273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92588906|NCT03952273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588907|NCT03952273|Antifungal Agents|antifungal agents|mesh-ancestor
92588908|NCT03952273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92588909|NCT03952273|Immunologic Factors|immunologic factors|mesh-ancestor
92588910|NCT03952273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588911|NCT03947827|Minocycline|minocycline|mesh-list
92588912|NCT03947827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92588913|NCT03947827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588914|NCT03927989|Nicotine|nicotine|mesh-list
92588915|NCT03927989|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92588916|NCT03927989|Autonomic Agents|autonomic agents|mesh-ancestor
92588917|NCT03927989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588918|NCT03927989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588919|NCT03927989|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92588920|NCT03927989|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92588921|NCT03927989|Cholinergic Agents|cholinergic agents|mesh-ancestor
92588922|NCT03927989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588923|NCT03927989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588924|NCT03914300|Nivolumab|nivolumab|mesh-list
92588925|NCT03914300|Ipilimumab|ipilimumab|mesh-list
92588926|NCT03914300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92588927|NCT03914300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588928|NCT03914300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92588929|NCT03914300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588930|NCT03896503|Topotecan|topotecan|mesh-list
92588931|NCT03896503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92588932|NCT03896503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92588933|NCT03896503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588934|NCT03896503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588935|NCT03896503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588936|NCT03880019|Temozolomide|temozolomide|mesh-list
92588937|NCT03880019|Olaparib|olaparib|mesh-list
92588938|NCT03880019|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92588939|NCT03880019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92588940|NCT03880019|Alkylating Agents|alkylating agents|mesh-ancestor
92588941|NCT03880019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588942|NCT03880019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588943|NCT03880019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588944|NCT03843645|Anesthetics|anesthetics|mesh-list
92535610|NCT00077233|Antidotes|antidotes|mesh-ancestor
92535611|NCT00077233|Protective Agents|protective agents|mesh-ancestor
92535612|NCT00077233|Vitamin B Complex|vitamin b complex|mesh-ancestor
92535613|NCT00077233|Vitamins|vitamins|mesh-ancestor
92588945|NCT03843645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588946|NCT03843645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588947|NCT03803787|Budesonide|budesonide|mesh-list
92588948|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588949|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92588950|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
92588951|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588952|NCT03803787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588953|NCT03803787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92588954|NCT03803787|Respiratory System Agents|respiratory system agents|mesh-ancestor
92588955|NCT03803787|Glucocorticoids|glucocorticoids|mesh-ancestor
92588956|NCT03803787|Hormones|hormones|mesh-ancestor
92588957|NCT03803787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588958|NCT03765788|Prednisolone|prednisolone|mesh-list
92588959|NCT03765788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588960|NCT03765788|Glucocorticoids|glucocorticoids|mesh-ancestor
92588961|NCT03765788|Hormones|hormones|mesh-ancestor
92588962|NCT03765788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588963|NCT03765788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588964|NCT03765788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92588965|NCT03765788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588966|NCT03728881|Vaccines|vaccines|mesh-list
92588967|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
91996148|NCT02371603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92588972|NCT03711253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92588973|NCT03711253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92588974|NCT03711253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92588975|NCT03711253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588976|NCT03711253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588977|NCT03711253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92588978|NCT03711253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92588980|NCT03643822|Dexamethasone acetate|dexamethasone acetate|mesh-list
92588981|NCT03643822|Dexmedetomidine|dexmedetomidine|mesh-list
92588982|NCT03643822|BB 1101|bb 1101|mesh-list
92588983|NCT03643822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92588984|NCT03643822|Antiemetics|antiemetics|mesh-ancestor
92588985|NCT03643822|Autonomic Agents|autonomic agents|mesh-ancestor
92588986|NCT03643822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92588987|NCT03643822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588988|NCT03643822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92588989|NCT03643822|Glucocorticoids|glucocorticoids|mesh-ancestor
92588990|NCT03643822|Hormones|hormones|mesh-ancestor
92588991|NCT03643822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92588992|NCT03643822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92588993|NCT03643822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588994|NCT03643822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92588995|NCT03643822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588996|NCT03643822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588997|NCT03643822|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92588998|NCT03643822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588999|NCT03643822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589000|NCT03643822|Analgesics|analgesics|mesh-ancestor
92589001|NCT03643822|Sensory System Agents|sensory system agents|mesh-ancestor
92589002|NCT03643822|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92589003|NCT03643822|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92589004|NCT03643822|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92589005|NCT03643822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589006|NCT03643822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589007|NCT03606967|Poly I-C|poly i-c|mesh-list
92589008|NCT03606967|Paclitaxel|paclitaxel|mesh-list
92589009|NCT03606967|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92589010|NCT03606967|Carboplatin|carboplatin|mesh-list
92313879|NCT02902172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589011|NCT03606967|Gemcitabine|gemcitabine|mesh-list
92589012|NCT03606967|Durvalumab|durvalumab|mesh-list
92589013|NCT03606967|Tremelimumab|tremelimumab|mesh-list
92589014|NCT03606967|Ipilimumab|ipilimumab|mesh-list
92589015|NCT03606967|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92589016|NCT03606967|Vaccines|vaccines|mesh-list
92589017|NCT03606967|Immunoglobulins|immunoglobulins|mesh-list
92535614|NCT00077233|Micronutrients|micronutrients|mesh-ancestor
92535615|NCT00077233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92535616|NCT02958631|Losartan|losartan|mesh-list
92535617|NCT02958631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92589018|NCT03606967|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92589019|NCT03606967|Immunoglobulin G|immunoglobulin g|mesh-list
92589020|NCT03606967|Poly ICLC|poly iclc|mesh-list
92589021|NCT03606967|Immunologic Factors|immunologic factors|mesh-ancestor
92589022|NCT03606967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589023|NCT03606967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589024|NCT03606967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589025|NCT03606967|Tubulin Modulators|tubulin modulators|mesh-ancestor
92589026|NCT03606967|Antimitotic Agents|antimitotic agents|mesh-ancestor
92589027|NCT03606967|Mitosis Modulators|mitosis modulators|mesh-ancestor
92589028|NCT03606967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589029|NCT03606967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92589030|NCT03606967|Antimetabolites|antimetabolites|mesh-ancestor
92589031|NCT03606967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589032|NCT03606967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589033|NCT03606967|Interferon Inducers|interferon inducers|mesh-ancestor
92589034|NCT03606967|Laxatives|laxatives|mesh-ancestor
92589035|NCT03606967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92589036|NCT03606967|Antiviral Agents|antiviral agents|mesh-ancestor
92589037|NCT03606967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589038|NCT03603964|Guadecitabine|guadecitabine|mesh-list
92589039|NCT03603964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589040|NCT03575000|Bromocriptine|bromocriptine|mesh-list
92589044|NCT03575000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589045|NCT03575000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589046|NCT03575000|Dopamine Agonists|dopamine agonists|mesh-ancestor
92589047|NCT03575000|Dopamine Agents|dopamine agents|mesh-ancestor
92589048|NCT03575000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589049|NCT03575000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589050|NCT03513952|Atezolizumab|atezolizumab|mesh-list
92589051|NCT03513952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92589052|NCT03513952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589053|NCT03513952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589054|NCT03513952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589055|NCT03513952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589056|NCT03513952|Immunologic Factors|immunologic factors|mesh-ancestor
92589057|NCT03513952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589058|NCT03498261|Gabapentin|gabapentin|mesh-list
92589059|NCT03498261|Analgesics|analgesics|mesh-ancestor
92589060|NCT03498261|Sensory System Agents|sensory system agents|mesh-ancestor
92589061|NCT03498261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589062|NCT03498261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589063|NCT03498261|Anticonvulsants|anticonvulsants|mesh-ancestor
92589064|NCT03498261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92589065|NCT03498261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92589066|NCT03498261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589067|NCT03498261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589068|NCT03498261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92589069|NCT03498261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92589070|NCT03498261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589071|NCT03498261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589072|NCT03498261|Antimanic Agents|antimanic agents|mesh-ancestor
92589073|NCT03495921|Irinotecan|irinotecan|mesh-list
92589074|NCT03495921|Camptothecin|camptothecin|mesh-list
92589075|NCT03495921|Temozolomide|temozolomide|mesh-list
92589076|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92589077|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92589078|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589079|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589080|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589081|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92589082|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
92589083|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589084|NCT03475186|Ramipril|ramipril|mesh-list
92589085|NCT03475186|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92589086|NCT03475186|Protease Inhibitors|protease inhibitors|mesh-ancestor
92589087|NCT03475186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535618|NCT02958631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92535619|NCT02958631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92535620|NCT02958631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91935868|NCT02440009|Itraconazole|itraconazole|mesh-list
92704665|NCT04320238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92589088|NCT03475186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589089|NCT03475186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92589090|NCT03278925|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92589091|NCT03278925|Antioxidants|antioxidants|mesh-ancestor
92589092|NCT03278925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589093|NCT03278925|Protective Agents|protective agents|mesh-ancestor
92589094|NCT03278925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589095|NCT03278925|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92589096|NCT03278925|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92589097|NCT03278925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589098|NCT03278925|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92589099|NCT03212274|Olaparib|olaparib|mesh-list
92589100|NCT03212274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92589101|NCT03212274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589102|NCT03212274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589103|NCT03212274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589104|NCT03191864|Fluticasone|fluticasone|mesh-list
92589106|NCT03191864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92589107|NCT03191864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92589108|NCT03191864|Autonomic Agents|autonomic agents|mesh-ancestor
92589109|NCT03191864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589110|NCT03191864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589113|NCT03191864|Dermatologic Agents|dermatologic agents|mesh-ancestor
92589114|NCT03191864|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92589115|NCT03141684|Bevacizumab|bevacizumab|mesh-list
92589116|NCT03141684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92589117|NCT03141684|Atezolizumab|atezolizumab|mesh-list
92589118|NCT03141684|Endothelial Growth Factors|endothelial growth factors|mesh-list
92589119|NCT03141684|Antibodies|antibodies|mesh-list
92589120|NCT03141684|Immunoglobulins|immunoglobulins|mesh-list
92589121|NCT03141684|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92589122|NCT03141684|Immunoglobulin G|immunoglobulin g|mesh-list
92589123|NCT03141684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589124|NCT03141684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92589125|NCT03141684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92589126|NCT03141684|Growth Substances|growth substances|mesh-ancestor
92589127|NCT03141684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589128|NCT03141684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92589129|NCT03141684|Immunologic Factors|immunologic factors|mesh-ancestor
92589130|NCT03141684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589131|NCT03141684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589132|NCT03123978|Niclosamide|niclosamide|mesh-list
92589133|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
92589134|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92589135|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
92589136|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92589137|NCT03123978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589138|NCT03123978|Antinematodal Agents|antinematodal agents|mesh-ancestor
92589139|NCT03114072|Methamphetamine|methamphetamine|mesh-list
92589140|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92589141|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589142|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
92589143|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
92589144|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589145|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
92589146|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589147|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589148|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589149|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92589150|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92589151|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92589152|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92589153|NCT03063619|Tamoxifen|tamoxifen|mesh-list
92589154|NCT03063619|Afimoxifene|afimoxifene|mesh-list
92589155|NCT03063619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92589156|NCT03063619|Hormone Antagonists|hormone antagonists|mesh-ancestor
92535621|NCT02958631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535622|NCT00077311|Docetaxel|docetaxel|mesh-list
92535623|NCT00077311|Darbepoetin alfa|darbepoetin alfa|mesh-list
92535624|NCT00077311|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
92535625|NCT00077311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535626|NCT00077311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92535627|NCT00077311|Antimitotic Agents|antimitotic agents|mesh-ancestor
91935982|NCT02319343|Hormones|hormones|mesh-ancestor
92589157|NCT03063619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589158|NCT03063619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589159|NCT03063619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92589160|NCT03063619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589161|NCT03063619|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92589162|NCT03063619|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92589163|NCT03063619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92589165|NCT03002103|Gemcitabine|gemcitabine|mesh-list
92589166|NCT03002103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589167|NCT03002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589168|NCT03002103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92589169|NCT03002103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92589170|NCT03002103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92589171|NCT03002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589172|NCT03002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92589173|NCT03002103|Antimetabolites|antimetabolites|mesh-ancestor
92589174|NCT02975882|Sirolimus|sirolimus|mesh-list
92589175|NCT02975882|Irinotecan|irinotecan|mesh-list
92589176|NCT02975882|Camptothecin|camptothecin|mesh-list
92589177|NCT02975882|Temozolomide|temozolomide|mesh-list
92589178|NCT02975882|Temsirolimus|temsirolimus|mesh-list
92589179|NCT02975882|MTOR Inhibitors|mtor inhibitors|mesh-list
92589180|NCT02975882|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92589181|NCT02975882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92589182|NCT02975882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589183|NCT02975882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589184|NCT02975882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589189|NCT02975882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92589190|NCT02975882|Antifungal Agents|antifungal agents|mesh-ancestor
92589191|NCT02975882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92589192|NCT02975882|Immunologic Factors|immunologic factors|mesh-ancestor
92589193|NCT02975882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589194|NCT02975882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92589195|NCT02975882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589196|NCT02968810|Simvastatin|simvastatin|mesh-list
92589197|NCT02968810|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92589198|NCT02968810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92589199|NCT02968810|Antimetabolites|antimetabolites|mesh-ancestor
92589200|NCT02968810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589201|NCT02968810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92589202|NCT02968810|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92589203|NCT02968810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589204|NCT02935205|Indomethacin|indomethacin|mesh-list
92589205|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92589206|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589207|NCT02935205|Analgesics|analgesics|mesh-ancestor
92589208|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
92589209|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589210|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589211|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92589212|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92589213|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
92589214|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
92589215|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92589216|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92589217|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589218|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589219|NCT02898207|Olaparib|olaparib|mesh-list
92535628|NCT00077311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535629|NCT00077311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589220|NCT02898207|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92589221|NCT02898207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589222|NCT02898207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589223|NCT02898207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589224|NCT02862275|Atezolizumab|atezolizumab|mesh-list
92589225|NCT02862275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92589226|NCT02862275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589227|NCT02862275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589228|NCT02862275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589229|NCT02862275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589230|NCT02862275|Immunologic Factors|immunologic factors|mesh-ancestor
92589231|NCT02862275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589232|NCT02849496|Atezolizumab|atezolizumab|mesh-list
92589233|NCT02849496|Olaparib|olaparib|mesh-list
92589234|NCT02849496|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92589235|NCT02849496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92589236|NCT02849496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589237|NCT02849496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589238|NCT02849496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589239|NCT02849496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589240|NCT02849496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589241|NCT02849496|Immunologic Factors|immunologic factors|mesh-ancestor
92589242|NCT02849496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589243|NCT02807805|Niclosamide|niclosamide|mesh-list
92589244|NCT02807805|Prednisone|prednisone|mesh-list
92589245|NCT02807805|Cortisone|cortisone|mesh-list
92589246|NCT02807805|Abiraterone Acetate|abiraterone acetate|mesh-list
92589247|NCT02807805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92589248|NCT02807805|Glucocorticoids|glucocorticoids|mesh-ancestor
92589249|NCT02807805|Hormones|hormones|mesh-ancestor
92589250|NCT02807805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589251|NCT02807805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589252|NCT02807805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92589253|NCT02807805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589256|NCT02807805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589258|NCT02807805|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92589259|NCT02807805|Anticestodal Agents|anticestodal agents|mesh-ancestor
92589260|NCT02807805|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92589261|NCT02807805|Anthelmintics|anthelmintics|mesh-ancestor
92589262|NCT02807805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92589263|NCT02807805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589264|NCT02807805|Antinematodal Agents|antinematodal agents|mesh-ancestor
92589265|NCT02737046|Interferons|interferons|mesh-list
92589266|NCT02737046|Interferon-alpha|interferon-alpha|mesh-list
92589267|NCT02737046|Interferon alpha-2|interferon alpha-2|mesh-list
92589268|NCT02737046|Zidovudine|zidovudine|mesh-list
92589269|NCT02737046|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92589270|NCT02737046|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92589271|NCT02737046|Belinostat|belinostat|mesh-list
92589272|NCT02737046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589273|NCT02737046|Antiviral Agents|antiviral agents|mesh-ancestor
92589274|NCT02737046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589275|NCT02737046|Immunologic Factors|immunologic factors|mesh-ancestor
92589276|NCT02737046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589277|NCT02737046|Antimetabolites|antimetabolites|mesh-ancestor
92589278|NCT02737046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589279|NCT02737046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92589280|NCT02737046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92589281|NCT02737046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589282|NCT02737046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92589283|NCT02737046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92589284|NCT02737046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92589285|NCT02707926|Anti-HIV Agents|anti-hiv agents|mesh-list
92589286|NCT02707926|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92589287|NCT02707926|Antiviral Agents|antiviral agents|mesh-ancestor
92589288|NCT02707926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589289|NCT02682485|Metronidazole|metronidazole|mesh-list
92589290|NCT02682485|Ciprofloxacin|ciprofloxacin|mesh-list
92589291|NCT02682485|Neomycin|neomycin|mesh-list
92535631|NCT00077311|Protective Agents|protective agents|mesh-ancestor
92535632|NCT00077311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589292|NCT02682485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589293|NCT02682485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92589294|NCT02682485|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92589295|NCT02682485|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92589296|NCT02682485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92589297|NCT02682485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92589298|NCT02682485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589299|NCT02682485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589300|NCT02682485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589301|NCT02682485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92589302|NCT02682485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92589303|NCT02682485|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92589305|NCT02649790|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92589306|NCT02649790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92589307|NCT02649790|Antiemetics|antiemetics|mesh-ancestor
92589308|NCT02649790|Autonomic Agents|autonomic agents|mesh-ancestor
92589309|NCT02649790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589310|NCT02649790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314234|NCT02812238|Niacin|niacin|mesh-list
92589311|NCT02649790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92589312|NCT02649790|Glucocorticoids|glucocorticoids|mesh-ancestor
92589314|NCT02649790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589315|NCT02649790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92589316|NCT02649790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589317|NCT02649790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92589318|NCT02649790|Antimetabolites|antimetabolites|mesh-ancestor
92589319|NCT02649790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589320|NCT02636725|Pembrolizumab|pembrolizumab|mesh-list
92589321|NCT02636725|Axitinib|axitinib|mesh-list
92589322|NCT02636725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589323|NCT02636725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589324|NCT02636725|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589325|NCT02636725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589330|NCT02595866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589332|NCT02595866|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589333|NCT02595866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589334|NCT02595866|Antiviral Agents|antiviral agents|mesh-ancestor
92589335|NCT02595866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589336|NCT02573493|Paclitaxel|paclitaxel|mesh-list
92589337|NCT02573493|Cisplatin|cisplatin|mesh-list
92589338|NCT02573493|Cetuximab|cetuximab|mesh-list
92589339|NCT02573493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589340|NCT02573493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589341|NCT02573493|Tubulin Modulators|tubulin modulators|mesh-ancestor
92589342|NCT02573493|Antimitotic Agents|antimitotic agents|mesh-ancestor
92589343|NCT02573493|Mitosis Modulators|mitosis modulators|mesh-ancestor
92589344|NCT02573493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589345|NCT02573493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589346|NCT02521493|Cytarabine|cytarabine|mesh-list
92589347|NCT02521493|Etoposide|etoposide|mesh-list
92589348|NCT02521493|Podophyllotoxin|podophyllotoxin|mesh-list
92589349|NCT02521493|Daunorubicin|daunorubicin|mesh-list
92589350|NCT02521493|Mitoxantrone|mitoxantrone|mesh-list
92589351|NCT02521493|Etoposide phosphate|etoposide phosphate|mesh-list
92589352|NCT02521493|Asparaginase|asparaginase|mesh-list
92589353|NCT02521493|Mercaptopurine|mercaptopurine|mesh-list
92589354|NCT02521493|Thioguanine|thioguanine|mesh-list
92589355|NCT02521493|2-Aminopurine|2-aminopurine|mesh-list
92589356|NCT02521493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589357|NCT02521493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589358|NCT02521493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92589359|NCT02521493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92589360|NCT02521493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589361|NCT02521493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589362|NCT02521493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92589363|NCT02521493|Antimetabolites|antimetabolites|mesh-ancestor
92589364|NCT02521493|Antiviral Agents|antiviral agents|mesh-ancestor
92589365|NCT02521493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589366|NCT02521493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92589367|NCT02521493|Immunologic Factors|immunologic factors|mesh-ancestor
92535633|NCT00077350|Gemcitabine|gemcitabine|mesh-list
92535634|NCT00077350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92589368|NCT02521493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589369|NCT02521493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92589370|NCT02521493|Analgesics|analgesics|mesh-ancestor
92589371|NCT02521493|Sensory System Agents|sensory system agents|mesh-ancestor
92589372|NCT02521493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589373|NCT02521493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92589374|NCT02521493|Keratolytic Agents|keratolytic agents|mesh-ancestor
92589375|NCT02521493|Dermatologic Agents|dermatologic agents|mesh-ancestor
92589376|NCT02521493|Tubulin Modulators|tubulin modulators|mesh-ancestor
92589377|NCT02521493|Antimitotic Agents|antimitotic agents|mesh-ancestor
92589378|NCT02521493|Mitosis Modulators|mitosis modulators|mesh-ancestor
92589379|NCT02498613|Misonidazole|misonidazole|mesh-list
92589380|NCT02498613|Olaparib|olaparib|mesh-list
92589381|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92589382|NCT02498613|Cediranib|cediranib|mesh-list
92589383|NCT02498613|Maleic acid|maleic acid|mesh-list
92589384|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589385|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589386|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589387|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92589388|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92589389|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92589390|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589392|NCT02496208|Ipilimumab|ipilimumab|mesh-list
92589393|NCT02496208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589394|NCT02496208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589395|NCT02496208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589396|NCT02496208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589397|NCT02465268|Molgramostim|molgramostim|mesh-list
92589398|NCT02465268|Sargramostim|sargramostim|mesh-list
92589399|NCT02465268|Immunologic Factors|immunologic factors|mesh-ancestor
92589403|NCT02408861|Ipilimumab|ipilimumab|mesh-list
92589404|NCT02408861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589405|NCT02408861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589406|NCT02408861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589407|NCT02408861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589408|NCT02394834|Calcium, Dietary|calcium, dietary|mesh-list
92589409|NCT02394834|Leucovorin|leucovorin|mesh-list
92589410|NCT02394834|Bevacizumab|bevacizumab|mesh-list
92589411|NCT02394834|Panitumumab|panitumumab|mesh-list
92589412|NCT02394834|Oxaliplatin|oxaliplatin|mesh-list
92589413|NCT02394834|Fluorouracil|fluorouracil|mesh-list
92589414|NCT02394834|Calcium|calcium|mesh-list
92589415|NCT02394834|Levoleucovorin|levoleucovorin|mesh-list
92589416|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589417|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589418|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92589419|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92589420|NCT02394834|Growth Substances|growth substances|mesh-ancestor
92589421|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589422|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
92589423|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92589424|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92589425|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
92589426|NCT02394834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589427|NCT02394834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92589428|NCT02394834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92589429|NCT02394834|Immunologic Factors|immunologic factors|mesh-ancestor
92589430|NCT02394834|Antidotes|antidotes|mesh-ancestor
92589431|NCT02394834|Protective Agents|protective agents|mesh-ancestor
92589432|NCT02394834|Vitamin B Complex|vitamin b complex|mesh-ancestor
92589433|NCT02394834|Vitamins|vitamins|mesh-ancestor
92589434|NCT02394834|Micronutrients|micronutrients|mesh-ancestor
92589435|NCT02381561|Ropidoxuridine|ropidoxuridine|mesh-list
92589436|NCT02381561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589437|NCT02381535|Cisplatin|cisplatin|mesh-list
92589438|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589439|NCT02327078|Nivolumab|nivolumab|mesh-list
92589440|NCT02327078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589441|NCT02327078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589442|NCT02327078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589443|NCT02327078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589444|NCT02314169|Nivolumab|nivolumab|mesh-list
92589445|NCT02314169|Ipilimumab|ipilimumab|mesh-list
92535635|NCT00077350|Antimetabolites|antimetabolites|mesh-ancestor
92535636|NCT00077350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535637|NCT00077350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535638|NCT00077389|Carboplatin|carboplatin|mesh-list
92535639|NCT00077389|Doxorubicin|doxorubicin|mesh-list
92535640|NCT00077389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92535641|NCT00077389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589446|NCT02314169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589447|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589448|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589449|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589450|NCT02304458|Nivolumab|nivolumab|mesh-list
92589451|NCT02304458|Ipilimumab|ipilimumab|mesh-list
92589452|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589453|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589454|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589455|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589456|NCT02298959|Pembrolizumab|pembrolizumab|mesh-list
92589457|NCT02298959|Aflibercept|aflibercept|mesh-list
92589458|NCT02298959|Endothelial Growth Factors|endothelial growth factors|mesh-list
92589459|NCT02298959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589460|NCT02298959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589461|NCT02298959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589462|NCT02298959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589463|NCT02298959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92589464|NCT02298959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92589465|NCT02298959|Growth Substances|growth substances|mesh-ancestor
92589466|NCT02298959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589467|NCT02298959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92589469|NCT02219373|Gabapentin|gabapentin|mesh-list
92589470|NCT02219373|Analgesics|analgesics|mesh-ancestor
92589471|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
92589472|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589473|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589479|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92589480|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92589481|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589482|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589483|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
92589484|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92589485|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92589486|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92589487|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92589488|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92589489|NCT02187224|Progesterone|progesterone|mesh-list
92589490|NCT02187224|Progestins|progestins|mesh-ancestor
92589491|NCT02187224|Hormones|hormones|mesh-ancestor
92589492|NCT02187224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589493|NCT02187224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589494|NCT02159066|Infigratinib|infigratinib|mesh-list
92589495|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589496|NCT02099825|Cycloserine|cycloserine|mesh-list
92589497|NCT02099825|Mifepristone|mifepristone|mesh-list
92589498|NCT02099825|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92589499|NCT02099825|Abortifacient Agents|abortifacient agents|mesh-ancestor
92589500|NCT02099825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92589501|NCT02099825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589502|NCT02099825|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92589503|NCT02099825|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92589504|NCT02099825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92589505|NCT02099825|Contraceptive Agents|contraceptive agents|mesh-ancestor
92589506|NCT02099825|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92589507|NCT02099825|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92589508|NCT02099825|Hormone Antagonists|hormone antagonists|mesh-ancestor
92589509|NCT02099825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535642|NCT00077389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92535643|NCT00077389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92589510|NCT02099825|Luteolytic Agents|luteolytic agents|mesh-ancestor
92589511|NCT02099825|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92589512|NCT02099825|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92589513|NCT02099825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92589514|NCT02099825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589515|NCT02099825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92589516|NCT02099825|Antitubercular Agents|antitubercular agents|mesh-ancestor
92589517|NCT02099825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92589518|NCT02099825|Antimetabolites|antimetabolites|mesh-ancestor
92589519|NCT02099825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589521|NCT02057978|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92589522|NCT02057978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92589523|NCT02057978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589524|NCT02057978|Disinfectants|disinfectants|mesh-ancestor
92589525|NCT02057978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92589526|NCT02032823|Olaparib|olaparib|mesh-list
92589527|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92589528|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589529|NCT02032823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589530|NCT02032823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589531|NCT01958021|Letrozole|letrozole|mesh-list
92589532|NCT01958021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589533|NCT01958021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92589534|NCT01958021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92589535|NCT01958021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589536|NCT01958021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589537|NCT01958021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92589538|NCT01958021|Hormone Antagonists|hormone antagonists|mesh-ancestor
92589539|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589540|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589547|NCT01946477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589548|NCT01946477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589549|NCT01946477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92589550|NCT01946477|Glucocorticoids|glucocorticoids|mesh-ancestor
92589551|NCT01946477|Hormones|hormones|mesh-ancestor
92589552|NCT01946477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589553|NCT01946477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92589554|NCT01946477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589555|NCT01946477|Immunologic Factors|immunologic factors|mesh-ancestor
92589556|NCT01946477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92589557|NCT01946477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92589558|NCT01946477|Growth Substances|growth substances|mesh-ancestor
92589559|NCT01946477|Growth Inhibitors|growth inhibitors|mesh-ancestor
92589560|NCT01742299|Imatinib Mesylate|imatinib mesylate|mesh-list
92589561|NCT01742299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589562|NCT01742299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92589563|NCT01742299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589564|NCT01742299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589565|NCT05953168|Trastuzumab|trastuzumab|mesh-list
92589566|NCT05953168|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92589567|NCT05953168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589568|NCT05953168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589569|NCT05953168|Immunoconjugates|immunoconjugates|mesh-ancestor
92589570|NCT05953168|Immunologic Factors|immunologic factors|mesh-ancestor
92589571|NCT05953168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589572|NCT05953142|Dobutamine|dobutamine|mesh-list
92589573|NCT05953142|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92589574|NCT05953142|Sympathomimetics|sympathomimetics|mesh-ancestor
92589575|NCT05953142|Autonomic Agents|autonomic agents|mesh-ancestor
92589576|NCT05953142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589577|NCT05953142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589578|NCT05953142|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92589579|NCT05953142|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92589580|NCT05953142|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92589581|NCT05953142|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589582|NCT05953142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589583|NCT05953142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589584|NCT05953142|Protective Agents|protective agents|mesh-ancestor
92535644|NCT00077389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535645|NCT00077389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535646|NCT00077389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750761|NCT05936489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92589585|NCT05953038|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92589586|NCT05953038|Hallucinogens|hallucinogens|mesh-ancestor
92589587|NCT05953038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589588|NCT05953038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589589|NCT05953038|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92589590|NCT05953038|Serotonin Agents|serotonin agents|mesh-ancestor
92589591|NCT05953038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589592|NCT05953038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589593|NCT05953038|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92589594|NCT05952947|Cyclophosphamide|cyclophosphamide|mesh-list
92589595|NCT05952947|Fludarabine|fludarabine|mesh-list
92589596|NCT05952947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92589597|NCT05952947|Immunologic Factors|immunologic factors|mesh-ancestor
92589598|NCT05952947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589599|NCT05952947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92589600|NCT05952947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92589601|NCT05952947|Alkylating Agents|alkylating agents|mesh-ancestor
92589602|NCT05952947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589603|NCT05952947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589604|NCT05952947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92589605|NCT05952921|Chlorhexidine|chlorhexidine|mesh-list
92589606|NCT05952921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92589607|NCT05952921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589608|NCT05952921|Disinfectants|disinfectants|mesh-ancestor
92589609|NCT05952882|Metformin|metformin|mesh-list
92589610|NCT05952882|Liraglutide|liraglutide|mesh-list
92589611|NCT05952882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92589615|NCT05952882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589616|NCT05952713|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92589617|NCT05952713|Amitriptyline|amitriptyline|mesh-list
92589618|NCT05952713|Vortioxetine|vortioxetine|mesh-list
92589619|NCT05952713|Mirtazapine|mirtazapine|mesh-list
92589620|NCT05952713|Agomelatine|agomelatine|mesh-list
92589621|NCT05952713|Citalopram|citalopram|mesh-list
92589622|NCT05952713|Fluoxetine|fluoxetine|mesh-list
92589623|NCT05952713|Paroxetine|paroxetine|mesh-list
92589624|NCT05952713|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92589625|NCT05952713|Sertraline|sertraline|mesh-list
92589626|NCT05952713|Antidepressive Agents|antidepressive agents|mesh-list
92589627|NCT05952713|Reboxetine|reboxetine|mesh-list
92589628|NCT05952713|Imipramine|imipramine|mesh-list
92589629|NCT05952713|Escitalopram|escitalopram|mesh-list
92589630|NCT05952713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92589631|NCT05952713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92589632|NCT05952713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92589633|NCT05952713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589634|NCT05952713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589635|NCT05952713|Serotonin Agents|serotonin agents|mesh-ancestor
92589636|NCT05952713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589637|NCT05952713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589638|NCT05952713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92589639|NCT05952713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589640|NCT05952713|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92589641|NCT05952713|Analgesics|analgesics|mesh-ancestor
92589642|NCT05952713|Sensory System Agents|sensory system agents|mesh-ancestor
92589643|NCT05952713|Dopamine Agents|dopamine agents|mesh-ancestor
92589644|NCT05952713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92589645|NCT05952713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92589646|NCT05952713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589647|NCT05952713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92589648|NCT05952713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92589649|NCT05952713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589650|NCT05952713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92589651|NCT05952713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92589652|NCT05952713|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92589653|NCT05952713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92589654|NCT05952713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92589655|NCT05952713|Histamine Antagonists|histamine antagonists|mesh-ancestor
92589656|NCT05952713|Histamine Agents|histamine agents|mesh-ancestor
92535647|NCT00077428|Doxorubicin|doxorubicin|mesh-list
92535648|NCT00077428|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92589657|NCT05952713|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92589658|NCT05952713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92589659|NCT05952713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92589660|NCT05952713|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589661|NCT05952713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92589662|NCT05952713|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92589663|NCT05952713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589664|NCT05952713|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92589665|NCT05952713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589666|NCT05952596|Vaccines|vaccines|mesh-list
92589667|NCT05952596|Immunologic Factors|immunologic factors|mesh-ancestor
92589668|NCT05952596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589669|NCT05952557|Tamoxifen|tamoxifen|mesh-list
92589670|NCT05952557|Letrozole|letrozole|mesh-list
92589671|NCT05952557|Anastrozole|anastrozole|mesh-list
92589672|NCT05952557|Exemestane|exemestane|mesh-list
92589673|NCT05952557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589674|NCT05952557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92589675|NCT05952557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92589676|NCT05952557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589677|NCT05952557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589678|NCT05952557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92589679|NCT05952557|Hormone Antagonists|hormone antagonists|mesh-ancestor
92589680|NCT05952557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589681|NCT05952557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589682|NCT05952557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92682799|NCT00438113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589687|NCT05952505|Immunologic Factors|immunologic factors|mesh-ancestor
92589688|NCT05952505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589689|NCT05952453|Carboplatin|carboplatin|mesh-list
92589690|NCT05952453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589691|NCT05952206|Sirolimus|sirolimus|mesh-list
92589692|NCT05952206|Temsirolimus|temsirolimus|mesh-list
92589693|NCT05952206|MTOR Inhibitors|mtor inhibitors|mesh-list
92589694|NCT05952206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92589695|NCT05952206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589696|NCT05952206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92589697|NCT05952206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589698|NCT05952206|Antifungal Agents|antifungal agents|mesh-ancestor
92589699|NCT05952206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92589700|NCT05952206|Immunologic Factors|immunologic factors|mesh-ancestor
92589701|NCT05952206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589702|NCT05952206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92589703|NCT05952206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589704|NCT05952206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589705|NCT05952128|Fluzoparib|fluzoparib|mesh-list
92589706|NCT05952128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92589707|NCT05952128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589708|NCT05952128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589709|NCT05952128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589710|NCT05952089|Midazolam|midazolam|mesh-list
92589711|NCT05952089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92589712|NCT05952089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589713|NCT05952089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589714|NCT05952089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589715|NCT05952089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92589716|NCT05952089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92589717|NCT05952089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589718|NCT05952089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92589719|NCT05952089|Anesthetics, General|anesthetics, general|mesh-ancestor
92589720|NCT05952089|Anesthetics|anesthetics|mesh-ancestor
92589721|NCT05952089|GABA Modulators|gaba modulators|mesh-ancestor
92589722|NCT05952089|GABA Agents|gaba agents|mesh-ancestor
92589723|NCT05952089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589724|NCT05952089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589725|NCT05952050|Dexmedetomidine|dexmedetomidine|mesh-list
92589726|NCT05952050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589727|NCT05952050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589728|NCT05952050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589729|NCT05952050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589730|NCT05952050|Analgesics|analgesics|mesh-ancestor
92535649|NCT00077428|Bortezomib|bortezomib|mesh-list
92535650|NCT00077428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92260406|NCT02170376|Levodopa|levodopa|mesh-list
92535651|NCT00077428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589731|NCT05952050|Sensory System Agents|sensory system agents|mesh-ancestor
92589732|NCT05952050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589733|NCT05952050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92589734|NCT05952050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92589735|NCT05952050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92589736|NCT05952050|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589737|NCT05952050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589738|NCT05952050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589739|NCT05952024|Rituximab|rituximab|mesh-list
92589740|NCT05952024|Acalabrutinib|acalabrutinib|mesh-list
92589741|NCT05952024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589742|NCT05952024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589743|NCT05952024|Immunologic Factors|immunologic factors|mesh-ancestor
92589744|NCT05952024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589745|NCT05952024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92589746|NCT05951959|Rituximab|rituximab|mesh-list
92589747|NCT05951959|Venetoclax|venetoclax|mesh-list
92589748|NCT05951959|Acalabrutinib|acalabrutinib|mesh-list
92589749|NCT05951959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589750|NCT05951959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589751|NCT05951959|Immunologic Factors|immunologic factors|mesh-ancestor
92589752|NCT05951959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589753|NCT05951959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92589755|NCT05951842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589756|NCT05951842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589757|NCT05951816|Technetium Tc 99m Pyrophosphate|technetium tc 99m pyrophosphate|mesh-list
92589759|NCT05951816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589760|NCT05951725|Vaccines|vaccines|mesh-list
92589761|NCT05951725|Immunologic Factors|immunologic factors|mesh-ancestor
92589762|NCT05951725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589763|NCT05951686|Remifentanil|remifentanil|mesh-list
92589764|NCT05951686|Propofol|propofol|mesh-list
92589765|NCT05951686|Desflurane|desflurane|mesh-list
92589766|NCT05951686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589767|NCT05951686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589768|NCT05951686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589769|NCT05951686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92589770|NCT05951686|Anesthetics, General|anesthetics, general|mesh-ancestor
92589771|NCT05951686|Anesthetics|anesthetics|mesh-ancestor
92589772|NCT05951686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92589773|NCT05951686|Narcotics|narcotics|mesh-ancestor
92589774|NCT05951686|Analgesics|analgesics|mesh-ancestor
92589775|NCT05951686|Sensory System Agents|sensory system agents|mesh-ancestor
92589776|NCT05951686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589777|NCT05951686|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92589778|NCT05951569|Insulin|insulin|mesh-list
92589779|NCT05951569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92589780|NCT05951569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589781|NCT05951465|Propofol|propofol|mesh-list
92589782|NCT05951465|Esketamine|esketamine|mesh-list
92589783|NCT05951465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589784|NCT05951465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589785|NCT05951465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589786|NCT05951465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92589787|NCT05951465|Anesthetics, General|anesthetics, general|mesh-ancestor
92589788|NCT05951465|Anesthetics|anesthetics|mesh-ancestor
92589789|NCT05951465|Antidepressive Agents|antidepressive agents|mesh-ancestor
92589790|NCT05951465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589791|NCT05951452|Oxytocin|oxytocin|mesh-list
92589792|NCT05951452|Testosterone|testosterone|mesh-list
92589793|NCT05951452|Oxytocics|oxytocics|mesh-ancestor
92589794|NCT05951452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92589795|NCT05951452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589796|NCT05951452|Androgens|androgens|mesh-ancestor
92589797|NCT05951452|Hormones|hormones|mesh-ancestor
92589798|NCT05951452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589799|NCT05951413|Sildenafil Citrate|sildenafil citrate|mesh-list
92589800|NCT05951413|Estradiol|estradiol|mesh-list
92589801|NCT05951413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589802|NCT05951413|Estrogens|estrogens|mesh-ancestor
92535653|NCT00077428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535654|NCT00077428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589803|NCT05951413|Hormones|hormones|mesh-ancestor
92589804|NCT05951413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589805|NCT05951413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589806|NCT05951413|Vasodilator Agents|vasodilator agents|mesh-ancestor
92589807|NCT05951413|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92589808|NCT05951413|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92589809|NCT05951413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589810|NCT05951413|Urological Agents|urological agents|mesh-ancestor
92589811|NCT05951400|Cetrorelix|cetrorelix|mesh-list
92589812|NCT05951400|Dydrogesterone|dydrogesterone|mesh-list
92589813|NCT05951400|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92589814|NCT05951400|Fertility Agents|fertility agents|mesh-ancestor
92589815|NCT05951400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92589816|NCT05951400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589817|NCT05951400|Hormone Antagonists|hormone antagonists|mesh-ancestor
92589818|NCT05951400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589819|NCT05951400|Progestins|progestins|mesh-ancestor
92589820|NCT05951400|Hormones|hormones|mesh-ancestor
92589821|NCT05951387|Dexmedetomidine|dexmedetomidine|mesh-list
92589822|NCT05951387|Ketamine|ketamine|mesh-list
92589823|NCT05951387|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589824|NCT05951387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589825|NCT05951387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589826|NCT05951387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589827|NCT05951387|Analgesics|analgesics|mesh-ancestor
92589828|NCT05951387|Sensory System Agents|sensory system agents|mesh-ancestor
92589829|NCT05951387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589832|NCT05951387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92589833|NCT05951387|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589834|NCT05951387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589835|NCT05951387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589836|NCT05951387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92589837|NCT05951387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92589838|NCT05951387|Anesthetics, General|anesthetics, general|mesh-ancestor
92589839|NCT05951387|Anesthetics|anesthetics|mesh-ancestor
92589840|NCT05951387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92589841|NCT05951387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92589842|NCT05951361|Triamcinolone|triamcinolone|mesh-list
92589843|NCT05951361|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92589844|NCT05951361|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92589846|NCT05951361|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92589847|NCT05951361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92589848|NCT05951361|Glucocorticoids|glucocorticoids|mesh-ancestor
92589849|NCT05951361|Hormones|hormones|mesh-ancestor
92589850|NCT05951361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589851|NCT05951361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589852|NCT05951361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92589853|NCT05951361|Immunologic Factors|immunologic factors|mesh-ancestor
92589854|NCT05951361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589855|NCT05951361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589856|NCT05951361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92589857|NCT05951361|Anesthetics|anesthetics|mesh-ancestor
92589858|NCT05951361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589859|NCT05951361|Sensory System Agents|sensory system agents|mesh-ancestor
92589860|NCT05951361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589861|NCT05951309|Metformin|metformin|mesh-list
92589862|NCT05951309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92589863|NCT05951309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589864|NCT05951283|Insulin|insulin|mesh-list
92589865|NCT05951283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92589866|NCT05951283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589867|NCT05950646|Dexmedetomidine|dexmedetomidine|mesh-list
92589868|NCT05950646|Esketamine|esketamine|mesh-list
92589869|NCT05950646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92589870|NCT05950646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589871|NCT05950646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589872|NCT05950646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92589873|NCT05950646|Analgesics|analgesics|mesh-ancestor
92589874|NCT05950646|Sensory System Agents|sensory system agents|mesh-ancestor
92535655|NCT00077428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535656|NCT00077467|Bortezomib|bortezomib|mesh-list
92535657|NCT00077467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535658|NCT03832569|Pembrolizumab|pembrolizumab|mesh-list
92589875|NCT05950646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589876|NCT05950646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92589877|NCT05950646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92589878|NCT05950646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92589879|NCT05950646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92589880|NCT05950646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589881|NCT05950646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589882|NCT05950646|Antidepressive Agents|antidepressive agents|mesh-ancestor
92589883|NCT05950646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589884|NCT05949632|Axitinib|axitinib|mesh-list
92589885|NCT05949632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589886|NCT05949632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92589887|NCT05949632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589888|NCT05949632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589889|NCT05949008|Metformin|metformin|mesh-list
92589890|NCT05949008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92589891|NCT05949008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589892|NCT05947435|Tranexamic Acid|tranexamic acid|mesh-list
92589893|NCT05947435|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92589894|NCT05947435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92589895|NCT05947435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589896|NCT05947435|Hemostatics|hemostatics|mesh-ancestor
92589897|NCT05947435|Coagulants|coagulants|mesh-ancestor
92589898|NCT05938699|Bimatoprost|bimatoprost|mesh-list
92589899|NCT05938699|Nitric Oxide|nitric oxide|mesh-list
92589900|NCT05938699|Lubricant Eye Drops|lubricant eye drops|mesh-list
92589901|NCT05938699|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92589902|NCT05938699|Autonomic Agents|autonomic agents|mesh-ancestor
91997103|NCT05058677|Lidocaine|lidocaine|mesh-list
92589907|NCT05938699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92589908|NCT05938699|Antioxidants|antioxidants|mesh-ancestor
92589909|NCT05938699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589910|NCT05938699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92589911|NCT05938699|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92589912|NCT05938699|Vasodilator Agents|vasodilator agents|mesh-ancestor
92589913|NCT05938699|Gasotransmitters|gasotransmitters|mesh-ancestor
92589914|NCT05938699|Protective Agents|protective agents|mesh-ancestor
92589915|NCT05938699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92589916|NCT05938699|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92589917|NCT05938699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92589918|NCT05936671|Remifentanil|remifentanil|mesh-list
92589919|NCT05936671|Anesthetics|anesthetics|mesh-list
92589920|NCT05936671|Sevoflurane|sevoflurane|mesh-list
92589921|NCT05936671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589922|NCT05936671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589923|NCT05936671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92589924|NCT05936671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92589925|NCT05936671|Anesthetics, General|anesthetics, general|mesh-ancestor
92589926|NCT05936671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92589927|NCT05936671|Narcotics|narcotics|mesh-ancestor
92589928|NCT05936671|Analgesics|analgesics|mesh-ancestor
92589929|NCT05936671|Sensory System Agents|sensory system agents|mesh-ancestor
92589930|NCT05936671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589931|NCT05933499|Vitamin D|vitamin d|mesh-list
92589932|NCT05933499|Calcium|calcium|mesh-list
92589933|NCT05933499|Vitamins|vitamins|mesh-ancestor
92589934|NCT05933499|Micronutrients|micronutrients|mesh-ancestor
92589935|NCT05933499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589936|NCT05933499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92589937|NCT05933499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92589938|NCT05928806|Nivolumab|nivolumab|mesh-list
92589939|NCT05928806|Ipilimumab|ipilimumab|mesh-list
92589940|NCT05928806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589941|NCT05928806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589942|NCT05928806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92589943|NCT05928806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589944|NCT05925179|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92589945|NCT05925179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92535659|NCT03832569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589946|NCT05925179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589947|NCT05925179|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92589948|NCT05925179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589949|NCT05925179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589950|NCT05921968|Iron|iron|mesh-list
92589951|NCT05921968|Lactoferrin|lactoferrin|mesh-list
92589952|NCT05921968|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92589953|NCT05921968|Trace Elements|trace elements|mesh-ancestor
92589954|NCT05921968|Micronutrients|micronutrients|mesh-ancestor
92589955|NCT05921968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589956|NCT05921968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589957|NCT05921968|Hematinics|hematinics|mesh-ancestor
92589958|NCT05912062|Paclitaxel|paclitaxel|mesh-list
92589959|NCT05912062|Trastuzumab|trastuzumab|mesh-list
92589960|NCT05912062|Pertuzumab|pertuzumab|mesh-list
92589961|NCT05912062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589962|NCT05912062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589963|NCT05912062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92589964|NCT05912062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92589965|NCT05912062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92589966|NCT05912062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589967|NCT05912062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589968|NCT05904379|Paclitaxel|paclitaxel|mesh-list
92589969|NCT05904379|Docetaxel|docetaxel|mesh-list
92589970|NCT05904379|Pemetrexed|pemetrexed|mesh-list
92589971|NCT05904379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589972|NCT05904379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589973|NCT05904379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92589974|NCT05904379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92589979|NCT05904379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92589980|NCT05903092|Carboplatin|carboplatin|mesh-list
92589981|NCT05903092|Etoposide|etoposide|mesh-list
92589982|NCT05903092|Durvalumab|durvalumab|mesh-list
92589983|NCT05903092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589984|NCT05903092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92589985|NCT05903092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92589986|NCT05903092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92589987|NCT05903092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589988|NCT05903092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589989|NCT05903092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92589990|NCT05901974|Venetoclax|venetoclax|mesh-list
92589991|NCT05901974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589992|NCT05901467|Hormones|hormones|mesh-list
92589993|NCT05901467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92589994|NCT05901467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589995|NCT05898724|Zinc Oxide|zinc oxide|mesh-list
92589996|NCT05898724|Dermatologic Agents|dermatologic agents|mesh-ancestor
92589997|NCT05898724|Sunscreening Agents|sunscreening agents|mesh-ancestor
92589998|NCT05898724|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92589999|NCT05898724|Protective Agents|protective agents|mesh-ancestor
92590000|NCT05898724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590001|NCT05890898|Nitrous Oxide|nitrous oxide|mesh-list
92590002|NCT05890898|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92590003|NCT05890898|Anesthetics, General|anesthetics, general|mesh-ancestor
92590004|NCT05890898|Anesthetics|anesthetics|mesh-ancestor
92590005|NCT05890898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590006|NCT05890898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590007|NCT05890898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92590008|NCT05890898|Analgesics|analgesics|mesh-ancestor
92590009|NCT05890898|Sensory System Agents|sensory system agents|mesh-ancestor
92590010|NCT05890898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590011|NCT05878717|Belimumab|belimumab|mesh-list
92590012|NCT05878717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590013|NCT05878717|Immunologic Factors|immunologic factors|mesh-ancestor
92590014|NCT05878717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590015|NCT05878522|Moxifloxacin|moxifloxacin|mesh-list
92590016|NCT05878522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92590017|NCT05878522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590018|NCT05878522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590019|NCT05878522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590020|NCT05878522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590021|NCT05878522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590022|NCT05878522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535660|NCT03832569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535661|NCT03832569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92535662|NCT03832569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590023|NCT05871333|Losartan|losartan|mesh-list
92590024|NCT05871333|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92590025|NCT05871333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92590026|NCT05871333|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92590027|NCT05871333|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92590028|NCT05871333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590029|NCT05860933|Itraconazole|itraconazole|mesh-list
92590030|NCT05860933|Carbamazepine|carbamazepine|mesh-list
92590031|NCT05860933|Antifungal Agents|antifungal agents|mesh-ancestor
92590032|NCT05860933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590033|NCT05860933|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92590034|NCT05860933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92590035|NCT05860933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590036|NCT05860933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590037|NCT05860933|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92590038|NCT05860933|Hormone Antagonists|hormone antagonists|mesh-ancestor
92590039|NCT05860933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590040|NCT05860933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590041|NCT05860933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92590042|NCT05860933|Anticonvulsants|anticonvulsants|mesh-ancestor
92590043|NCT05860933|Antimanic Agents|antimanic agents|mesh-ancestor
92590045|NCT05860933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590046|NCT05860933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92590047|NCT05860933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92590049|NCT05860933|Sensory System Agents|sensory system agents|mesh-ancestor
92590050|NCT05860933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590051|NCT05860933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92590052|NCT05860933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92590053|NCT05860933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92590054|NCT05860933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92590055|NCT05846750|Lenalidomide|lenalidomide|mesh-list
92590056|NCT05846750|Obinutuzumab|obinutuzumab|mesh-list
92590057|NCT05846750|Immunologic Factors|immunologic factors|mesh-ancestor
92590058|NCT05846750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590059|NCT05846750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92590060|NCT05846750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92590061|NCT05846750|Growth Substances|growth substances|mesh-ancestor
92590062|NCT05846750|Growth Inhibitors|growth inhibitors|mesh-ancestor
92590063|NCT05846750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314940|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
92590064|NCT05846750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590065|NCT05845814|Pembrolizumab|pembrolizumab|mesh-list
92590066|NCT05845814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590067|NCT05845814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590068|NCT05845814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590069|NCT05845814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590070|NCT05819892|Paclitaxel|paclitaxel|mesh-list
92590071|NCT05819892|Cisplatin|cisplatin|mesh-list
92590072|NCT05819892|Carboplatin|carboplatin|mesh-list
92590073|NCT05819892|Dostarlimab|dostarlimab|mesh-list
92590074|NCT05819892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590075|NCT05819892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590076|NCT05819892|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590077|NCT05819892|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590078|NCT05819892|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590079|NCT05819892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590080|NCT05811390|Erythritol|erythritol|mesh-list
92590081|NCT05811390|Vasodilator Agents|vasodilator agents|mesh-ancestor
92590082|NCT05794997|Propranolol|propranolol|mesh-list
92590083|NCT05794997|Atenolol|atenolol|mesh-list
92590084|NCT05794997|Sotalol|sotalol|mesh-list
92590085|NCT05794997|Carvedilol|carvedilol|mesh-list
92590086|NCT05794997|Bisoprolol|bisoprolol|mesh-list
92590087|NCT05794997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92590088|NCT05794997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92590089|NCT05794997|Adrenergic Agents|adrenergic agents|mesh-ancestor
92590090|NCT05794997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535663|NCT04551482|Oxytocin|oxytocin|mesh-list
92590091|NCT05794997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590092|NCT05794997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590093|NCT05794997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92590094|NCT05794997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92590095|NCT05794997|Vasodilator Agents|vasodilator agents|mesh-ancestor
92590096|NCT05794997|Antioxidants|antioxidants|mesh-ancestor
92590097|NCT05794997|Protective Agents|protective agents|mesh-ancestor
92360172|NCT00385788|Melphalan|melphalan|mesh-list
92590098|NCT05794997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92590099|NCT05794997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92590100|NCT05794997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92590101|NCT05794997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92590102|NCT05794997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92590103|NCT05794997|Sympatholytics|sympatholytics|mesh-ancestor
92590104|NCT05794997|Autonomic Agents|autonomic agents|mesh-ancestor
92590105|NCT05794997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590106|NCT05794997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92590107|NCT05794828|Bupivacaine|bupivacaine|mesh-list
92590108|NCT05794828|Anesthetics, Local|anesthetics, local|mesh-ancestor
92590109|NCT05794828|Anesthetics|anesthetics|mesh-ancestor
92590110|NCT05794828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590111|NCT05794828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590112|NCT05794828|Sensory System Agents|sensory system agents|mesh-ancestor
92590113|NCT05794828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590114|NCT05789524|Protein C|protein c|mesh-list
92590115|NCT05789524|Anticoagulants|anticoagulants|mesh-ancestor
92590116|NCT05789524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91997323|NCT02366299|Anesthetics|anesthetics|mesh-ancestor
92590119|NCT05788328|Dabigatran|dabigatran|mesh-list
92590120|NCT05788328|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92590121|NCT05788328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92590122|NCT05788328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92590123|NCT05788328|Antimetabolites|antimetabolites|mesh-ancestor
92590124|NCT05788328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590125|NCT05788328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92590126|NCT05788328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92590127|NCT05788328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590128|NCT05788328|Antithrombins|antithrombins|mesh-ancestor
92590129|NCT05788328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92590130|NCT05788328|Protease Inhibitors|protease inhibitors|mesh-ancestor
92590131|NCT05788328|Anticoagulants|anticoagulants|mesh-ancestor
92590132|NCT05784363|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92590133|NCT05784363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92590134|NCT05784363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590135|NCT05784363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590136|NCT05784363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92590137|NCT05784363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92590138|NCT05784363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590139|NCT05784363|Cholinergic Agents|cholinergic agents|mesh-ancestor
92590140|NCT05784363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590141|NCT05768854|Diphosphonates|diphosphonates|mesh-list
92590142|NCT05768854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92590143|NCT05768854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590144|NCT05752526|Diclofenac|diclofenac|mesh-list
92590145|NCT05752526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92590146|NCT05752526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92590147|NCT05752526|Analgesics|analgesics|mesh-ancestor
92590148|NCT05752526|Sensory System Agents|sensory system agents|mesh-ancestor
92590149|NCT05752526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590150|NCT05752526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590151|NCT05752526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590152|NCT05752526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590153|NCT05752526|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92590154|NCT05752526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590155|NCT05752526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590156|NCT05748834|Doxorubicin|doxorubicin|mesh-list
92590157|NCT05748834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92590158|NCT05748834|Tucatinib|tucatinib|mesh-list
92590159|NCT05748834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92590160|NCT05748834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590161|NCT05748834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590162|NCT05748834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590163|NCT05748834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535665|NCT04551482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91936905|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
92590164|NCT05748834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590165|NCT05748834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92590166|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
92590167|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92590168|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
92590169|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590170|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
92590171|NCT05742399|Protective Agents|protective agents|mesh-ancestor
92590172|NCT05734560|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
92590173|NCT05734560|Immunoconjugates|immunoconjugates|mesh-ancestor
92590174|NCT05734560|Immunologic Factors|immunologic factors|mesh-ancestor
92590175|NCT05734560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590176|NCT05726110|Cytarabine|cytarabine|mesh-list
92590177|NCT05726110|Daunorubicin|daunorubicin|mesh-list
92590178|NCT05726110|Homoharringtonine|homoharringtonine|mesh-list
92590179|NCT05726110|Aclacinomycins|aclacinomycins|mesh-list
92590180|NCT05726110|Lenograstim|lenograstim|mesh-list
92590181|NCT05726110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590182|NCT05726110|Antimetabolites|antimetabolites|mesh-ancestor
92590183|NCT05726110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590184|NCT05726110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590185|NCT05726110|Antiviral Agents|antiviral agents|mesh-ancestor
92590186|NCT05726110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590187|NCT05726110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590188|NCT05726110|Immunologic Factors|immunologic factors|mesh-ancestor
92590189|NCT05726110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590190|NCT05726110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92590191|NCT05726110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590192|NCT05726110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590194|NCT05726110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92590195|NCT05726110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590196|NCT05726110|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92590197|NCT05716516|Estradiol|estradiol|mesh-list
92590198|NCT05716516|Estrogens|estrogens|mesh-ancestor
92590199|NCT05716516|Hormones|hormones|mesh-ancestor
92590200|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590201|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590202|NCT05694286|Hyaluronic Acid|hyaluronic acid|mesh-list
92590203|NCT05694286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92590204|NCT05694286|Immunologic Factors|immunologic factors|mesh-ancestor
92590205|NCT05694286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590206|NCT05694286|Viscosupplements|viscosupplements|mesh-ancestor
92590207|NCT05694286|Protective Agents|protective agents|mesh-ancestor
92590208|NCT05692180|Benralizumab|benralizumab|mesh-list
92590209|NCT05692180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92590210|NCT05692180|Respiratory System Agents|respiratory system agents|mesh-ancestor
92590211|NCT05679024|Apixaban|apixaban|mesh-list
92590212|NCT05679024|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92590213|NCT05679024|Antithrombins|antithrombins|mesh-ancestor
92590214|NCT05679024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92590215|NCT05679024|Protease Inhibitors|protease inhibitors|mesh-ancestor
92590216|NCT05679024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590217|NCT05679024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590218|NCT05679024|Anticoagulants|anticoagulants|mesh-ancestor
92590219|NCT05661955|Tislelizumab|tislelizumab|mesh-list
92590220|NCT05661955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590221|NCT05661955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590222|NCT05645718|Cytarabine|cytarabine|mesh-list
92590223|NCT05645718|Dexamethasone|dexamethasone|mesh-list
92590224|NCT05645718|Prednisone|prednisone|mesh-list
92590225|NCT05645718|Cyclophosphamide|cyclophosphamide|mesh-list
92590226|NCT05645718|Rituximab|rituximab|mesh-list
92590227|NCT05645718|Methotrexate|methotrexate|mesh-list
92590228|NCT05645718|Vincristine|vincristine|mesh-list
92590229|NCT05645718|Mercaptopurine|mercaptopurine|mesh-list
92590230|NCT05645718|Blinatumomab|blinatumomab|mesh-list
92590231|NCT05645718|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92590232|NCT05645718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590233|NCT05645718|Immunologic Factors|immunologic factors|mesh-ancestor
92590234|NCT05645718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590235|NCT05645718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590236|NCT05645718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92590237|NCT05645718|Alkylating Agents|alkylating agents|mesh-ancestor
92535666|NCT04551482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535667|NCT00077545|Cisplatin|cisplatin|mesh-list
92535668|NCT00077545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590238|NCT05645718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590239|NCT05645718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590240|NCT05645718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92590241|NCT05645718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590242|NCT05645718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590243|NCT05645718|Antiemetics|antiemetics|mesh-ancestor
92590244|NCT05645718|Autonomic Agents|autonomic agents|mesh-ancestor
92590245|NCT05645718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590246|NCT05645718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92590247|NCT05645718|Glucocorticoids|glucocorticoids|mesh-ancestor
92590248|NCT05645718|Hormones|hormones|mesh-ancestor
92590249|NCT05645718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590250|NCT05645718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590251|NCT05645718|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92590252|NCT05645718|Abortifacient Agents|abortifacient agents|mesh-ancestor
92590253|NCT05645718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92590254|NCT05645718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590255|NCT05645718|Antimetabolites|antimetabolites|mesh-ancestor
92590256|NCT05645718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92590257|NCT05645718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590258|NCT05645718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92590259|NCT05645718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92590260|NCT05645718|Antiviral Agents|antiviral agents|mesh-ancestor
92590261|NCT05645718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590262|NCT05645718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590263|NCT05645718|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590264|NCT05645718|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590269|NCT05641298|Fusidic Acid|fusidic acid|mesh-list
92590270|NCT05641298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92590271|NCT05641298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590272|NCT05641298|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92590273|NCT05641298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590274|NCT05641298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590275|NCT05635708|Paclitaxel|paclitaxel|mesh-list
92590276|NCT05635708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92590277|NCT05635708|Carboplatin|carboplatin|mesh-list
92590278|NCT05635708|Pemetrexed|pemetrexed|mesh-list
92590279|NCT05635708|Tislelizumab|tislelizumab|mesh-list
92590280|NCT05635708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590281|NCT05635708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590282|NCT05635708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590283|NCT05635708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590284|NCT05635708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590285|NCT05635708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590286|NCT05635708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590287|NCT05635708|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92590288|NCT05635708|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92590289|NCT05635708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590290|NCT05635370|Cilostazol|cilostazol|mesh-list
92590291|NCT05635370|Pentoxifylline|pentoxifylline|mesh-list
92590292|NCT05635370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92590293|NCT05635370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590294|NCT05635370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590295|NCT05635370|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92590296|NCT05635370|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92590297|NCT05635370|Protective Agents|protective agents|mesh-ancestor
92590298|NCT05635370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590299|NCT05635370|Vasodilator Agents|vasodilator agents|mesh-ancestor
92590300|NCT05635370|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92590301|NCT05635370|Antioxidants|antioxidants|mesh-ancestor
92590302|NCT05635370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92590303|NCT05635370|Autonomic Agents|autonomic agents|mesh-ancestor
92590304|NCT05635370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590305|NCT05635370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92590306|NCT05635370|Respiratory System Agents|respiratory system agents|mesh-ancestor
92590307|NCT05635370|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92590308|NCT05635370|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92590309|NCT05635370|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92535669|NCT00077584|Bosentan|bosentan|mesh-list
92535670|NCT00077584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92535671|NCT00077584|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92590310|NCT05635370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92590311|NCT05635357|Letrozole|letrozole|mesh-list
92590312|NCT05635357|Anastrozole|anastrozole|mesh-list
92590313|NCT05635357|Exemestane|exemestane|mesh-list
92590314|NCT05635357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590315|NCT05635357|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92590316|NCT05635357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92590317|NCT05635357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590318|NCT05635357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590319|NCT05635357|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92590320|NCT05635357|Hormone Antagonists|hormone antagonists|mesh-ancestor
92590321|NCT05635357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590322|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590323|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590324|NCT05633966|Hormones|hormones|mesh-list
92590325|NCT05633966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590326|NCT05633966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590327|NCT05614089|Insulin|insulin|mesh-list
92590328|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92590329|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
92590330|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92590331|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590332|NCT05592418|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92590333|NCT05592418|Poly I-C|poly i-c|mesh-list
92590334|NCT05592418|Antiviral Agents|antiviral agents|mesh-ancestor
92590335|NCT05592418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997542|NCT02362165|Bortezomib|bortezomib|mesh-list
92590340|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
92590341|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
92590342|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
92590343|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590344|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92590345|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590346|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590347|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92590348|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
92590349|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590350|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92590351|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92590352|NCT05559931|Serotonin Agents|serotonin agents|mesh-ancestor
92590353|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590354|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590355|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92590356|NCT05559879|Dostarlimab|dostarlimab|mesh-list
92590357|NCT05559879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590358|NCT05548296|Gemcitabine|gemcitabine|mesh-list
92590359|NCT05548296|Prexasertib|prexasertib|mesh-list
92590360|NCT05548296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590361|NCT05548296|Antimetabolites|antimetabolites|mesh-ancestor
92590362|NCT05548296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590363|NCT05548296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590364|NCT05548296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92590365|NCT05548296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590366|NCT05543629|Paclitaxel|paclitaxel|mesh-list
92590367|NCT05543629|Docetaxel|docetaxel|mesh-list
92590368|NCT05543629|Carboplatin|carboplatin|mesh-list
92590370|NCT05543629|Taxane|taxane|mesh-list
92590371|NCT05543629|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590372|NCT05543629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590373|NCT05543629|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590374|NCT05543629|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590375|NCT05543629|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590376|NCT05543629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590377|NCT05543629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590378|NCT05543629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590379|NCT05516498|Dapagliflozin|dapagliflozin|mesh-list
92590380|NCT05516498|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92590381|NCT05516498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590382|NCT05516498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92535672|NCT00077584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535673|NCT00077779|Adalimumab|adalimumab|mesh-list
92535674|NCT00077779|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91937095|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590383|NCT05516498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590384|NCT05491083|Pembrolizumab|pembrolizumab|mesh-list
92590385|NCT05491083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590386|NCT05491083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590387|NCT05491083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590388|NCT05491083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590389|NCT05481112|Buprenorphine|buprenorphine|mesh-list
92590390|NCT05481112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92590391|NCT05481112|Narcotics|narcotics|mesh-ancestor
92590392|NCT05481112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590393|NCT05481112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590394|NCT05481112|Analgesics|analgesics|mesh-ancestor
92590395|NCT05481112|Sensory System Agents|sensory system agents|mesh-ancestor
92590396|NCT05481112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590397|NCT05481112|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92590398|NCT05473585|Nicotine|nicotine|mesh-list
92590399|NCT05473585|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92590400|NCT05473585|Autonomic Agents|autonomic agents|mesh-ancestor
92590401|NCT05473585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590402|NCT05473585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590403|NCT05473585|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92590404|NCT05473585|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92590405|NCT05473585|Cholinergic Agents|cholinergic agents|mesh-ancestor
92590406|NCT05473585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590407|NCT05473585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590411|NCT05457855|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92590412|NCT05457855|Autonomic Agents|autonomic agents|mesh-ancestor
92590413|NCT05457855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590414|NCT05457855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590415|NCT05457855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92590416|NCT05457855|Respiratory System Agents|respiratory system agents|mesh-ancestor
92590417|NCT05457855|Dermatologic Agents|dermatologic agents|mesh-ancestor
92590418|NCT05457855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92590419|NCT05457855|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92590420|NCT05457855|Hormone Antagonists|hormone antagonists|mesh-ancestor
92590421|NCT05457855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590422|NCT05457855|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92590423|NCT05457855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92590424|NCT05457855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590425|NCT05445778|Bevacizumab|bevacizumab|mesh-list
92590426|NCT05445778|Maytansine|maytansine|mesh-list
92590427|NCT05445778|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92590428|NCT05445778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590429|NCT05445778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590430|NCT05445778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92590431|NCT05445778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92590432|NCT05445778|Growth Substances|growth substances|mesh-ancestor
92590433|NCT05445778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590434|NCT05445778|Growth Inhibitors|growth inhibitors|mesh-ancestor
92590435|NCT05445778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590436|NCT05445778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590437|NCT05445778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590438|NCT05445778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590439|NCT05445778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590440|NCT05445778|Immunoconjugates|immunoconjugates|mesh-ancestor
92315318|NCT05001724|Docetaxel|docetaxel|mesh-list
92590441|NCT05445778|Immunologic Factors|immunologic factors|mesh-ancestor
92590442|NCT05432804|Temozolomide|temozolomide|mesh-list
92590443|NCT05432804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92590444|NCT05432804|Alkylating Agents|alkylating agents|mesh-ancestor
92590445|NCT05432804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590446|NCT05432804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590447|NCT05411081|Atezolizumab|atezolizumab|mesh-list
92590448|NCT05411081|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92590449|NCT05411081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590450|NCT05411081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590451|NCT05411081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590452|NCT05411081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590453|NCT05411081|Immunologic Factors|immunologic factors|mesh-ancestor
92590454|NCT05411081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590456|NCT05408429|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92590457|NCT05408429|Immunologic Factors|immunologic factors|mesh-ancestor
92590458|NCT05408429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590459|NCT05383352|Leucovorin|leucovorin|mesh-list
92590460|NCT05383352|Folic Acid|folic acid|mesh-list
92590461|NCT05383352|Fluorouracil|fluorouracil|mesh-list
92590462|NCT05383352|Irinotecan|irinotecan|mesh-list
92590463|NCT05383352|Camptothecin|camptothecin|mesh-list
92590464|NCT05383352|Levoleucovorin|levoleucovorin|mesh-list
92590465|NCT05383352|Antimetabolites|antimetabolites|mesh-ancestor
92590466|NCT05383352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590467|NCT05383352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590468|NCT05383352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590469|NCT05383352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590470|NCT05383352|Immunologic Factors|immunologic factors|mesh-ancestor
92590471|NCT05383352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590472|NCT05383352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92590473|NCT05383352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590474|NCT05383352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590475|NCT05383352|Antidotes|antidotes|mesh-ancestor
92590476|NCT05383352|Protective Agents|protective agents|mesh-ancestor
92590477|NCT05383352|Vitamin B Complex|vitamin b complex|mesh-ancestor
92590478|NCT05383352|Vitamins|vitamins|mesh-ancestor
92590479|NCT05383352|Micronutrients|micronutrients|mesh-ancestor
92590480|NCT05383352|Hematinics|hematinics|mesh-ancestor
92590483|NCT05382559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590485|NCT05382286|Paclitaxel|paclitaxel|mesh-list
92590486|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92590487|NCT05382286|Carboplatin|carboplatin|mesh-list
92590488|NCT05382286|Gemcitabine|gemcitabine|mesh-list
92590489|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
92590490|NCT05382286|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92590491|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590492|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590493|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590494|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590495|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590496|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590497|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590498|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
92590499|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590500|NCT05382286|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590501|NCT05382286|Immunoconjugates|immunoconjugates|mesh-ancestor
92590502|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
92590503|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590504|NCT05381948|Aflibercept|aflibercept|mesh-list
92590505|NCT05381948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92590506|NCT05381948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92590507|NCT05381948|Growth Substances|growth substances|mesh-ancestor
92590508|NCT05381948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590509|NCT05381948|Growth Inhibitors|growth inhibitors|mesh-ancestor
92590510|NCT05381948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590511|NCT05381909|Paclitaxel|paclitaxel|mesh-list
92590512|NCT05381909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590513|NCT05381909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590514|NCT05381909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590515|NCT05381909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590516|NCT05381909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92704666|NCT01229072|Heparin|heparin|mesh-list
92590517|NCT05381909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590518|NCT05379491|Linaclotide|linaclotide|mesh-list
92590519|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92590520|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
92590521|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590522|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92590523|NCT05376111|Azacitidine|azacitidine|mesh-list
92590525|NCT05376111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590526|NCT05376111|Antimetabolites|antimetabolites|mesh-ancestor
92590527|NCT05376111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590528|NCT05376111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590529|NCT05376111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535676|NCT00077779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590530|NCT05363670|Albuterol|albuterol|mesh-list
92590531|NCT05363670|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92590532|NCT05363670|Autonomic Agents|autonomic agents|mesh-ancestor
92590533|NCT05363670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590534|NCT05363670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590535|NCT05363670|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92590536|NCT05363670|Respiratory System Agents|respiratory system agents|mesh-ancestor
92590537|NCT05363670|Tocolytic Agents|tocolytic agents|mesh-ancestor
92590538|NCT05363670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92590539|NCT05363670|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92590540|NCT05363670|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92590541|NCT05363670|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92590542|NCT05363670|Adrenergic Agents|adrenergic agents|mesh-ancestor
92590543|NCT05363670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590544|NCT05363670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590545|NCT05350371|Pirfenidone|pirfenidone|mesh-list
92590546|NCT05350371|Analgesics|analgesics|mesh-ancestor
92590547|NCT05350371|Sensory System Agents|sensory system agents|mesh-ancestor
92590548|NCT05350371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590549|NCT05350371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590550|NCT05350371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92590551|NCT05350371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92590552|NCT05350371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590556|NCT05343312|Antimalarials|antimalarials|mesh-ancestor
92590557|NCT05343312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92590558|NCT05343312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92590559|NCT05343312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590560|NCT05342636|Paclitaxel|paclitaxel|mesh-list
92590561|NCT05342636|Pembrolizumab|pembrolizumab|mesh-list
92590562|NCT05342636|Irinotecan|irinotecan|mesh-list
92590563|NCT05342636|Lenvatinib|lenvatinib|mesh-list
92590564|NCT05342636|Immunoglobulins|immunoglobulins|mesh-list
92590565|NCT05342636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590566|NCT05342636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590567|NCT05342636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590568|NCT05342636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590569|NCT05342636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590570|NCT05342636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590571|NCT05342636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590572|NCT05342636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590573|NCT05342636|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92590574|NCT05342636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590575|NCT05342636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590576|NCT05342636|Immunologic Factors|immunologic factors|mesh-ancestor
92590577|NCT05342636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590578|NCT05342636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92590579|NCT05338970|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92590580|NCT05338970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590581|NCT05338970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590582|NCT05322902|Propofol|propofol|mesh-list
92590583|NCT05322902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92590584|NCT05322902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590585|NCT05322902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590586|NCT05322902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92590587|NCT05322902|Anesthetics, General|anesthetics, general|mesh-ancestor
92590588|NCT05322902|Anesthetics|anesthetics|mesh-ancestor
92590589|NCT05317416|Lenalidomide|lenalidomide|mesh-list
92590590|NCT05317416|Immunologic Factors|immunologic factors|mesh-ancestor
92315480|NCT04639180|Apatinib|apatinib|mesh-list
92590591|NCT05317416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590592|NCT05317416|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92590593|NCT05317416|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92590594|NCT05317416|Growth Substances|growth substances|mesh-ancestor
92590595|NCT05317416|Growth Inhibitors|growth inhibitors|mesh-ancestor
92590596|NCT05317416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590597|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92590598|NCT05287906|Cardiac Glycosides|cardiac glycosides|mesh-list
92590599|NCT05287906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92590600|NCT05287906|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92590601|NCT05287906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590602|NCT05287906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590603|NCT05287906|Protective Agents|protective agents|mesh-ancestor
92535678|NCT00077818|Enoxaparin sodium|enoxaparin sodium|mesh-list
92535679|NCT00077818|Anticoagulants|anticoagulants|mesh-ancestor
92535680|NCT00077818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92535681|NCT00077818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91937266|NCT01173497|Iniparib|iniparib|mesh-list
92590604|NCT05287906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590605|NCT05286060|Pembrolizumab|pembrolizumab|mesh-list
92590606|NCT05286060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590607|NCT05286060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590608|NCT05286060|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590609|NCT05286060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590610|NCT05253833|Allopurinol|allopurinol|mesh-list
92590611|NCT05253833|Antimetabolites|antimetabolites|mesh-ancestor
92590612|NCT05253833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590613|NCT05253833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590614|NCT05253833|Gout Suppressants|gout suppressants|mesh-ancestor
92590615|NCT05253833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590616|NCT05253833|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92590617|NCT05253833|Antioxidants|antioxidants|mesh-ancestor
92590618|NCT05253833|Protective Agents|protective agents|mesh-ancestor
92590619|NCT05253833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590620|NCT05242458|Ustekinumab|ustekinumab|mesh-list
92590621|NCT05242458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92590623|NCT05222971|Olaparib|olaparib|mesh-list
92590624|NCT05222971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590625|NCT05222971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590628|NCT05222971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590630|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590631|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590632|NCT05183035|Cytarabine|cytarabine|mesh-list
92590633|NCT05183035|Fludarabine|fludarabine|mesh-list
92590634|NCT05183035|Azacitidine|azacitidine|mesh-list
92590635|NCT05183035|Venetoclax|venetoclax|mesh-list
92590636|NCT05183035|Gemtuzumab|gemtuzumab|mesh-list
92590637|NCT05183035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590638|NCT05183035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590639|NCT05183035|Antimetabolites|antimetabolites|mesh-ancestor
92590640|NCT05183035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590641|NCT05183035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590642|NCT05183035|Immunologic Factors|immunologic factors|mesh-ancestor
92590643|NCT05183035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590644|NCT05183035|Antiviral Agents|antiviral agents|mesh-ancestor
92590645|NCT05183035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590646|NCT05183035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590647|NCT05183035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590648|NCT05183035|Immunotoxins|immunotoxins|mesh-ancestor
92590649|NCT05183035|Immunoconjugates|immunoconjugates|mesh-ancestor
92590650|NCT05170893|Ubiquinone|ubiquinone|mesh-list
92590651|NCT05170893|Coenzyme Q10|coenzyme q10|mesh-list
92590652|NCT05170893|Micronutrients|micronutrients|mesh-ancestor
92590653|NCT05170893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590654|NCT05170893|Vitamins|vitamins|mesh-ancestor
92590655|NCT05167864|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92590656|NCT05167864|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92590657|NCT05167864|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92590658|NCT05167864|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92590659|NCT05167864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590660|NCT05167864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590661|NCT05167864|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92590662|NCT05167864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92590663|NCT05167864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590664|NCT05167864|Cholinergic Agents|cholinergic agents|mesh-ancestor
92590665|NCT05167864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590666|NCT05125276|Aspirin|aspirin|mesh-list
92590667|NCT05125276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92750762|NCT05936489|Adrenergic Agents|adrenergic agents|mesh-ancestor
92590668|NCT05125276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92590669|NCT05125276|Analgesics|analgesics|mesh-ancestor
92590670|NCT05125276|Sensory System Agents|sensory system agents|mesh-ancestor
92590671|NCT05125276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590672|NCT05125276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590673|NCT05125276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535682|NCT00077818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535683|NCT00078130|Buprenorphine|buprenorphine|mesh-list
92535684|NCT00078130|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92590674|NCT05125276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590675|NCT05125276|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92590676|NCT05125276|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92590677|NCT05125276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590678|NCT05125276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92590679|NCT05125276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92590680|NCT05125276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590681|NCT05125276|Antipyretics|antipyretics|mesh-ancestor
92590682|NCT05086627|Capecitabine|capecitabine|mesh-list
92590683|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
92590684|NCT05086627|Tislelizumab|tislelizumab|mesh-list
92590685|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590686|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
92590687|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590688|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590689|NCT05086627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590690|NCT05083780|Hydroxychloroquine|hydroxychloroquine|mesh-list
92590691|NCT05083780|Chlorphenesin|chlorphenesin|mesh-list
92590692|NCT05083780|Antimalarials|antimalarials|mesh-ancestor
92590693|NCT05083780|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92590694|NCT05083780|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92590695|NCT05083780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590696|NCT05083780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590697|NCT05083780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590698|NCT05083780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590702|NCT05083780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590703|NCT05074823|Ketamine|ketamine|mesh-list
92590704|NCT05074823|Analgesics|analgesics|mesh-ancestor
92590705|NCT05074823|Sensory System Agents|sensory system agents|mesh-ancestor
92590706|NCT05074823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590707|NCT05074823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590708|NCT05074823|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92590709|NCT05074823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92590710|NCT05074823|Anesthetics, General|anesthetics, general|mesh-ancestor
92590711|NCT05074823|Anesthetics|anesthetics|mesh-ancestor
92590712|NCT05074823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590713|NCT05074823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92590714|NCT05074823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92590715|NCT05074823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590716|NCT05074823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590717|NCT05059600|Pregnanolone|pregnanolone|mesh-list
92590718|NCT05059600|Brexanolone|brexanolone|mesh-list
92590719|NCT05059600|Anesthetics|anesthetics|mesh-ancestor
92590720|NCT05059600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590721|NCT05059600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590722|NCT05059600|Neurosteroids|neurosteroids|mesh-ancestor
92590723|NCT05059600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92590724|NCT05059600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590725|NCT05059600|GABA Modulators|gaba modulators|mesh-ancestor
92590726|NCT05059600|GABA Agents|gaba agents|mesh-ancestor
92590727|NCT05049902|Amoxicillin|amoxicillin|mesh-list
92590728|NCT05049902|Metronidazole|metronidazole|mesh-list
92590729|NCT05049902|Clarithromycin|clarithromycin|mesh-list
92590730|NCT05049902|Tetracycline|tetracycline|mesh-list
92590731|NCT05049902|Potassium Citrate|potassium citrate|mesh-list
92590732|NCT05049902|Bismuth|bismuth|mesh-list
92590733|NCT05049902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590734|NCT05049902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92590735|NCT05049902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590736|NCT05049902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92590737|NCT05049902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92590738|NCT05049902|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92590739|NCT05049902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590740|NCT05049902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92590741|NCT05049902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92590743|NCT05049902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92590744|NCT05049902|Diuretics|diuretics|mesh-ancestor
92590745|NCT05049902|Natriuretic Agents|natriuretic agents|mesh-ancestor
92590746|NCT05049902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535686|NCT00078130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92535687|NCT00078130|Narcotics|narcotics|mesh-ancestor
92535688|NCT00078130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535689|NCT00078130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590747|NCT05049902|Expectorants|expectorants|mesh-ancestor
92590748|NCT05049902|Respiratory System Agents|respiratory system agents|mesh-ancestor
92590749|NCT05048797|Carboplatin|carboplatin|mesh-list
92590750|NCT05048797|Pembrolizumab|pembrolizumab|mesh-list
92590751|NCT05048797|Trastuzumab|trastuzumab|mesh-list
92590752|NCT05048797|Pemetrexed|pemetrexed|mesh-list
92590753|NCT05048797|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92590754|NCT05048797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590755|NCT05048797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590756|NCT05048797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590757|NCT05048797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590758|NCT05048797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590759|NCT05048797|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92590760|NCT05048797|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92590761|NCT05048797|Immunoconjugates|immunoconjugates|mesh-ancestor
92590762|NCT05048797|Immunologic Factors|immunologic factors|mesh-ancestor
92590763|NCT05048797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590764|NCT05026593|Carboplatin|carboplatin|mesh-list
92590765|NCT05026593|Etoposide|etoposide|mesh-list
92590766|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590767|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590768|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590769|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590770|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590771|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590772|NCT05020236|Dexamethasone|dexamethasone|mesh-list
92590778|NCT05020236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590779|NCT05020236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590780|NCT05020236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92590781|NCT05020236|Glucocorticoids|glucocorticoids|mesh-ancestor
92590783|NCT05020236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590784|NCT05020236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590785|NCT05020236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590786|NCT05020236|Immunologic Factors|immunologic factors|mesh-ancestor
92590787|NCT05020236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92590788|NCT05020236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92590789|NCT05020236|Growth Substances|growth substances|mesh-ancestor
92590790|NCT05020236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92590791|NCT04980222|Prednisone|prednisone|mesh-list
92590792|NCT04980222|Cyclophosphamide|cyclophosphamide|mesh-list
92590793|NCT04980222|Rituximab|rituximab|mesh-list
92590794|NCT04980222|Doxorubicin|doxorubicin|mesh-list
92590795|NCT04980222|Vincristine|vincristine|mesh-list
92590796|NCT04980222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590797|NCT04980222|Immunologic Factors|immunologic factors|mesh-ancestor
92590798|NCT04980222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590799|NCT04980222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590800|NCT04980222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92590801|NCT04980222|Alkylating Agents|alkylating agents|mesh-ancestor
92590802|NCT04980222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590803|NCT04980222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590804|NCT04980222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92590805|NCT04980222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590806|NCT04980222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92590807|NCT04980222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590808|NCT04980222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590809|NCT04980222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590810|NCT04980222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590811|NCT04980222|Glucocorticoids|glucocorticoids|mesh-ancestor
92590812|NCT04980222|Hormones|hormones|mesh-ancestor
92590813|NCT04980222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590814|NCT04980222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590815|NCT04980222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360217|NCT00412464|Anticoagulants|anticoagulants|mesh-ancestor
92590816|NCT04980222|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590817|NCT04980222|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535690|NCT00078130|Analgesics|analgesics|mesh-ancestor
92535691|NCT00078130|Sensory System Agents|sensory system agents|mesh-ancestor
92535692|NCT00078130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535693|NCT00078130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92590818|NCT04980222|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590819|NCT04977986|Cannabidiol|cannabidiol|mesh-list
92590820|NCT04977986|Anticonvulsants|anticonvulsants|mesh-ancestor
92590821|NCT04976855|Buprenorphine|buprenorphine|mesh-list
92590822|NCT04976855|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92590823|NCT04976855|Naloxone|naloxone|mesh-list
92590824|NCT04976855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92590825|NCT04976855|Narcotics|narcotics|mesh-ancestor
92590826|NCT04976855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92590827|NCT04976855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590828|NCT04976855|Analgesics|analgesics|mesh-ancestor
92590829|NCT04976855|Sensory System Agents|sensory system agents|mesh-ancestor
92590830|NCT04976855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92590831|NCT04976855|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92590832|NCT04974398|Cisplatin|cisplatin|mesh-list
92590833|NCT04974398|Gemcitabine|gemcitabine|mesh-list
92590834|NCT04974398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590835|NCT04974398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590836|NCT04974398|Antimetabolites|antimetabolites|mesh-ancestor
92590837|NCT04974398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590838|NCT04971785|Firsocostat|firsocostat|mesh-list
92590839|NCT04971785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590840|NCT04971785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590841|NCT04971109|Tecovirimat|tecovirimat|mesh-list
92590842|NCT04971109|Antiviral Agents|antiviral agents|mesh-ancestor
92590843|NCT04971109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590844|NCT04963153|Immunoconjugates|immunoconjugates|mesh-list
92590846|NCT04963153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590847|NCT04958785|Paclitaxel|paclitaxel|mesh-list
92590848|NCT04958785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92590849|NCT04958785|Magrolimab|magrolimab|mesh-list
92590850|NCT04958785|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92590851|NCT04958785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590852|NCT04958785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590853|NCT04958785|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590854|NCT04958785|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590855|NCT04958785|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590856|NCT04958785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590857|NCT04958785|Immunoconjugates|immunoconjugates|mesh-ancestor
92590858|NCT04958785|Immunologic Factors|immunologic factors|mesh-ancestor
92590859|NCT04958785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590860|NCT04958785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590861|NCT04957485|Tecovirimat|tecovirimat|mesh-list
92590862|NCT04957485|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92590863|NCT04957485|Antiviral Agents|antiviral agents|mesh-ancestor
92590864|NCT04957485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92590865|NCT04943900|Nivolumab|nivolumab|mesh-list
92590866|NCT04943900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590867|NCT04943900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590868|NCT04943900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590869|NCT04943900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590870|NCT04921358|Docetaxel|docetaxel|mesh-list
92590871|NCT04921358|Tislelizumab|tislelizumab|mesh-list
92590872|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590873|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590874|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590875|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590876|NCT04921358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590877|NCT04921358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590878|NCT04893798|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92590879|NCT04893798|Medroxyprogesterone|medroxyprogesterone|mesh-list
92590880|NCT04893798|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92590881|NCT04893798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92590882|NCT04893798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92590883|NCT04893798|Contraceptive Agents|contraceptive agents|mesh-ancestor
92590884|NCT04893798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92590885|NCT04893798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535694|NCT00399451|Polidocanol|polidocanol|mesh-list
92535695|NCT00399451|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92535696|NCT00399451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92535697|NCT04711213|Dexamethasone|dexamethasone|mesh-list
92535698|NCT04711213|Dexamethasone acetate|dexamethasone acetate|mesh-list
92590886|NCT04893798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92590887|NCT04893798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92590888|NCT04893798|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92590889|NCT04893798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590890|NCT04893798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590891|NCT04885998|AMG 757|amg 757|mesh-list
92590892|NCT04885998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590893|NCT04857138|Atezolizumab|atezolizumab|mesh-list
92590894|NCT04857138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590895|NCT04857138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590896|NCT04857138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590897|NCT04857138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590898|NCT04833959|Panitumumab|panitumumab|mesh-list
92590899|NCT04833959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590900|NCT04833959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590901|NCT04799275|Prednisone|prednisone|mesh-list
92590902|NCT04799275|Cortisone|cortisone|mesh-list
92590903|NCT04799275|Cyclophosphamide|cyclophosphamide|mesh-list
92590904|NCT04799275|Rituximab|rituximab|mesh-list
92590905|NCT04799275|Doxorubicin|doxorubicin|mesh-list
92590906|NCT04799275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92590907|NCT04799275|Vincristine|vincristine|mesh-list
92590908|NCT04799275|Azacitidine|azacitidine|mesh-list
92590909|NCT04799275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92590910|NCT04799275|Antibodies|antibodies|mesh-list
92590911|NCT04799275|Immunoglobulins|immunoglobulins|mesh-list
92590912|NCT04799275|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92590913|NCT04799275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590914|NCT04799275|Immunologic Factors|immunologic factors|mesh-ancestor
92590915|NCT04799275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590916|NCT04799275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590917|NCT04799275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92590918|NCT04799275|Alkylating Agents|alkylating agents|mesh-ancestor
92590923|NCT04799275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590924|NCT04799275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590925|NCT04799275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590926|NCT04799275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590927|NCT04799275|Glucocorticoids|glucocorticoids|mesh-ancestor
92590928|NCT04799275|Hormones|hormones|mesh-ancestor
92590929|NCT04799275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590930|NCT04799275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590931|NCT04799275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590932|NCT04799275|Tubulin Modulators|tubulin modulators|mesh-ancestor
92590933|NCT04799275|Antimitotic Agents|antimitotic agents|mesh-ancestor
92590934|NCT04799275|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590935|NCT04799275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92590936|NCT04799275|Antimetabolites|antimetabolites|mesh-ancestor
92590937|NCT04795661|Pembrolizumab|pembrolizumab|mesh-list
92590938|NCT04795661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590939|NCT04795661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590940|NCT04795661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92590941|NCT04795661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590942|NCT04793906|Iron|iron|mesh-list
92590943|NCT04793906|Trace Elements|trace elements|mesh-ancestor
92590944|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
92590945|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590946|NCT04784715|Trastuzumab|trastuzumab|mesh-list
92590947|NCT04784715|Pertuzumab|pertuzumab|mesh-list
92590948|NCT04784715|Taxane|taxane|mesh-list
92590949|NCT04784715|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92590950|NCT04784715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92590951|NCT04784715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590952|NCT04784715|Immunoconjugates|immunoconjugates|mesh-ancestor
92590953|NCT04784715|Immunologic Factors|immunologic factors|mesh-ancestor
92590954|NCT04784715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590955|NCT04759586|Prednisone|prednisone|mesh-list
92590956|NCT04759586|Prednisolone|prednisolone|mesh-list
92590957|NCT04759586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92590958|NCT04759586|Methylprednisolone|methylprednisolone|mesh-list
92590959|NCT04759586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92590960|NCT04759586|Prednisolone acetate|prednisolone acetate|mesh-list
92590961|NCT04759586|Hydrocortisone|hydrocortisone|mesh-list
92590962|NCT04759586|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92590963|NCT04759586|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92590964|NCT04759586|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92590965|NCT04759586|Cortisone|cortisone|mesh-list
92590966|NCT04759586|Cyclophosphamide|cyclophosphamide|mesh-list
92590967|NCT04759586|Rituximab|rituximab|mesh-list
92590968|NCT04759586|Doxorubicin|doxorubicin|mesh-list
92590969|NCT04759586|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92590970|NCT04759586|Nivolumab|nivolumab|mesh-list
92590971|NCT04759586|Etoposide|etoposide|mesh-list
92590972|NCT04759586|Vincristine|vincristine|mesh-list
92590973|NCT04759586|Etoposide phosphate|etoposide phosphate|mesh-list
92590974|NCT04759586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92590975|NCT04759586|Antibodies|antibodies|mesh-list
92590976|NCT04759586|Immunoglobulins|immunoglobulins|mesh-list
92590977|NCT04759586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92590978|NCT04759586|Lenograstim|lenograstim|mesh-list
92590979|NCT04759586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92590980|NCT04759586|Prednisolone phosphate|prednisolone phosphate|mesh-list
92590981|NCT04759586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92590982|NCT04759586|Immunologic Factors|immunologic factors|mesh-ancestor
92590983|NCT04759586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590984|NCT04759586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590985|NCT04759586|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92590986|NCT04759586|Alkylating Agents|alkylating agents|mesh-ancestor
92590987|NCT04759586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590988|NCT04759586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590989|NCT04759586|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92590990|NCT04759586|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92590991|NCT04759586|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92590997|NCT04759586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92590998|NCT04759586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92590999|NCT04759586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591000|NCT04759586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591001|NCT04759586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92591002|NCT04759586|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591003|NCT04759586|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591004|NCT04759586|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591005|NCT04759586|Antiemetics|antiemetics|mesh-ancestor
92591006|NCT04759586|Autonomic Agents|autonomic agents|mesh-ancestor
92591007|NCT04759586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591008|NCT04759586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591009|NCT04759586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92591010|NCT04759586|Protective Agents|protective agents|mesh-ancestor
92591011|NCT04750954|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92591012|NCT04750954|Peposertib|peposertib|mesh-list
92591013|NCT04750954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591014|NCT04750954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92591015|NCT04750954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591016|NCT04750954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591017|NCT04746924|Pembrolizumab|pembrolizumab|mesh-list
92591018|NCT04746924|Tislelizumab|tislelizumab|mesh-list
92591019|NCT04746924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591020|NCT04746924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591021|NCT04746924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591022|NCT04746924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591023|NCT04716413|Dsuvia|dsuvia|mesh-list
92591024|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92591025|NCT04716413|Narcotics|narcotics|mesh-ancestor
92591026|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92591027|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591028|NCT04716413|Analgesics|analgesics|mesh-ancestor
92591029|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
92591030|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591031|NCT04711252|Palbociclib|palbociclib|mesh-list
92591032|NCT04711252|Anastrozole|anastrozole|mesh-list
92591033|NCT04711252|Hormones|hormones|mesh-list
92591034|NCT04711252|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92591035|NCT04711252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591036|NCT04711252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591037|NCT04711252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591038|NCT04711252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535700|NCT04711213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535701|NCT04711213|Antiemetics|antiemetics|mesh-ancestor
92535702|NCT04711213|Autonomic Agents|autonomic agents|mesh-ancestor
92535703|NCT04711213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591039|NCT04711252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591040|NCT04711252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591041|NCT04711252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591042|NCT04711252|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92591043|NCT04711252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92591044|NCT04711252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92591045|NCT04711252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92591047|NCT04696042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591049|NCT04684212|Rivaroxaban|rivaroxaban|mesh-list
92591050|NCT04684212|Dabigatran|dabigatran|mesh-list
92591051|NCT04684212|Edoxaban|edoxaban|mesh-list
92591052|NCT04684212|Apixaban|apixaban|mesh-list
92591053|NCT04684212|Betrixaban|betrixaban|mesh-list
92591054|NCT04684212|Anticoagulants|anticoagulants|mesh-ancestor
92591055|NCT04684212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92591056|NCT04684212|Antithrombins|antithrombins|mesh-ancestor
92591057|NCT04684212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92591058|NCT04684212|Protease Inhibitors|protease inhibitors|mesh-ancestor
92591059|NCT04684212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591060|NCT04684212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591061|NCT04649385|Tislelizumab|tislelizumab|mesh-list
92591062|NCT04649385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591063|NCT04649385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591064|NCT04635189|Dexamethasone|dexamethasone|mesh-list
92591068|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
92591069|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
92591070|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591071|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591072|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591073|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
92591074|NCT04635189|Hormones|hormones|mesh-ancestor
92591075|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591076|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591077|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591078|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
92591079|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92591080|NCT04635189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92591081|NCT04635189|Growth Substances|growth substances|mesh-ancestor
92591082|NCT04635189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92591083|NCT04608448|Sirolimus|sirolimus|mesh-list
92591084|NCT04608448|Petrolatum|petrolatum|mesh-list
92591085|NCT04608448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92591086|NCT04608448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591087|NCT04608448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591088|NCT04608448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591089|NCT04608448|Antifungal Agents|antifungal agents|mesh-ancestor
92591090|NCT04608448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591091|NCT04608448|Immunologic Factors|immunologic factors|mesh-ancestor
92591092|NCT04608448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591093|NCT04608448|Emollients|emollients|mesh-ancestor
92591094|NCT04608448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591095|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
92591096|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591097|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591098|NCT04592653|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591099|NCT04592653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591100|NCT04562285|Antibodies|antibodies|mesh-list
92591101|NCT04562285|Immunologic Factors|immunologic factors|mesh-ancestor
92591102|NCT04562285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591103|NCT04562246|Antibodies|antibodies|mesh-list
92591104|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
92591105|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591106|NCT04558112|Levodopa|levodopa|mesh-list
92591107|NCT04558112|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92591108|NCT04558112|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92591109|NCT04558112|Dopamine Agents|dopamine agents|mesh-ancestor
92591110|NCT04558112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535704|NCT04711213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535705|NCT04711213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92535706|NCT04711213|Glucocorticoids|glucocorticoids|mesh-ancestor
92535707|NCT04711213|Hormones|hormones|mesh-ancestor
92591111|NCT04558112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591112|NCT04558112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591113|NCT04528004|Niacinamide|niacinamide|mesh-list
92591114|NCT04528004|Niacin|niacin|mesh-list
92591115|NCT04528004|Nicotinic Acids|nicotinic acids|mesh-list
92591116|NCT04528004|Vitamin B Complex|vitamin b complex|mesh-ancestor
92591117|NCT04528004|Vitamins|vitamins|mesh-ancestor
92591118|NCT04528004|Micronutrients|micronutrients|mesh-ancestor
92591119|NCT04528004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591120|NCT04528004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92591121|NCT04528004|Antimetabolites|antimetabolites|mesh-ancestor
92591122|NCT04528004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591123|NCT04528004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92591124|NCT04528004|Vasodilator Agents|vasodilator agents|mesh-ancestor
92591125|NCT04500899|Phenylephrine|phenylephrine|mesh-list
92591126|NCT04500899|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92591127|NCT04500899|Mydriatics|mydriatics|mesh-ancestor
92591128|NCT04500899|Autonomic Agents|autonomic agents|mesh-ancestor
92591129|NCT04500899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591130|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591131|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
92591132|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92591133|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
92591134|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
92591135|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92591136|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92591137|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92591138|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92591139|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591145|NCT04485039|Chelating Agents|chelating agents|mesh-ancestor
92591146|NCT04485039|Sequestering Agents|sequestering agents|mesh-ancestor
92591147|NCT04485039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591148|NCT04485039|Antiviral Agents|antiviral agents|mesh-ancestor
92591149|NCT04485039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591150|NCT04428671|Cemiplimab|cemiplimab|mesh-list
92591151|NCT04428671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591152|NCT04428671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591153|NCT04413890|Dinoprostone|dinoprostone|mesh-list
92591154|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
92591155|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92591156|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591158|NCT04318405|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92591159|NCT04318405|Trace Elements|trace elements|mesh-ancestor
92591160|NCT04318405|Micronutrients|micronutrients|mesh-ancestor
92591161|NCT04318405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591162|NCT04318405|Hematinics|hematinics|mesh-ancestor
92591163|NCT04313790|Heparin|heparin|mesh-list
92591164|NCT04313790|Calcium heparin|calcium heparin|mesh-list
92591165|NCT04313790|Anticoagulants|anticoagulants|mesh-ancestor
92591166|NCT04313790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92591167|NCT04313790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92591168|NCT04313790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591169|NCT04293393|Paclitaxel|paclitaxel|mesh-list
92591170|NCT04293393|Docetaxel|docetaxel|mesh-list
92591171|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
92591172|NCT04293393|Doxorubicin|doxorubicin|mesh-list
92591173|NCT04293393|Letrozole|letrozole|mesh-list
92591174|NCT04293393|Leuprolide|leuprolide|mesh-list
92591175|NCT04293393|Goserelin|goserelin|mesh-list
92591176|NCT04293393|Taxane|taxane|mesh-list
92591177|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591178|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591179|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591180|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591181|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591182|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591183|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591184|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
92591185|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591186|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591187|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535708|NCT04711213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535709|NCT04711213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535710|NCT04711213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535711|NCT04711213|Protease Inhibitors|protease inhibitors|mesh-ancestor
92535712|NCT04711213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591188|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
92591189|NCT04293393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92591190|NCT04293393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591191|NCT04293393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591192|NCT04293393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591193|NCT04293393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591194|NCT04293393|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92591195|NCT04293393|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92591196|NCT04293393|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92591197|NCT04293393|Hormone Antagonists|hormone antagonists|mesh-ancestor
92591198|NCT04293393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316085|NCT02970032|Heparin|heparin|mesh-list
92591199|NCT04293393|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92591200|NCT04293393|Fertility Agents|fertility agents|mesh-ancestor
92591201|NCT04293393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92591202|NCT04293393|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591203|NCT04285567|Cyclophosphamide|cyclophosphamide|mesh-list
92591204|NCT04285567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92591205|NCT04285567|Rituximab|rituximab|mesh-list
92591206|NCT04285567|Fludarabine|fludarabine|mesh-list
92591207|NCT04285567|Venetoclax|venetoclax|mesh-list
92591208|NCT04285567|Obinutuzumab|obinutuzumab|mesh-list
92591209|NCT04285567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591210|NCT04285567|Immunologic Factors|immunologic factors|mesh-ancestor
92591211|NCT04285567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591212|NCT04285567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591213|NCT04285567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591218|NCT04285567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591219|NCT04276480|Tazobactam|tazobactam|mesh-list
92591220|NCT04276480|Piperacillin|piperacillin|mesh-list
92591221|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92591222|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92591223|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591224|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92591225|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591226|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591227|NCT04269902|Venetoclax|venetoclax|mesh-list
92591228|NCT04269902|Obinutuzumab|obinutuzumab|mesh-list
92591229|NCT04269902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591230|NCT04269902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591231|NCT04263896|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92591232|NCT04263896|Laxatives|laxatives|mesh-ancestor
92591233|NCT04263896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591234|NCT04240002|Cytarabine|cytarabine|mesh-list
92591235|NCT04240002|Fludarabine|fludarabine|mesh-list
92591236|NCT04240002|Lenograstim|lenograstim|mesh-list
92591237|NCT04240002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591238|NCT04240002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591239|NCT04240002|Antimetabolites|antimetabolites|mesh-ancestor
92591240|NCT04240002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591241|NCT04240002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591242|NCT04240002|Immunologic Factors|immunologic factors|mesh-ancestor
92591243|NCT04240002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591244|NCT04240002|Antiviral Agents|antiviral agents|mesh-ancestor
92591245|NCT04240002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591246|NCT04240002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92591247|NCT04224493|Rituximab|rituximab|mesh-list
92591248|NCT04224493|Lenalidomide|lenalidomide|mesh-list
92591249|NCT04224493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591250|NCT04224493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591251|NCT04224493|Immunologic Factors|immunologic factors|mesh-ancestor
92591252|NCT04224493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591253|NCT04224493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591254|NCT04224493|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92535713|NCT04711213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535714|NCT00078247|Lamivudine|lamivudine|mesh-list
92591255|NCT04224493|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92591256|NCT04224493|Growth Substances|growth substances|mesh-ancestor
92591257|NCT04224493|Growth Inhibitors|growth inhibitors|mesh-ancestor
92591258|NCT04223856|Carboplatin|carboplatin|mesh-list
92591259|NCT04223856|Gemcitabine|gemcitabine|mesh-list
92591260|NCT04223856|Pembrolizumab|pembrolizumab|mesh-list
92591261|NCT04223856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591262|NCT04223856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591263|NCT04223856|Antimetabolites|antimetabolites|mesh-ancestor
92591264|NCT04223856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591265|NCT04223856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591266|NCT04223856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591267|NCT04182373|Antithrombins|antithrombins|mesh-list
92591268|NCT04182373|Antithrombin III|antithrombin iii|mesh-list
92591269|NCT04182373|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92591270|NCT04182373|Protease Inhibitors|protease inhibitors|mesh-ancestor
92591271|NCT04182373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591272|NCT04182373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591273|NCT04182373|Anticoagulants|anticoagulants|mesh-ancestor
92591274|NCT04161898|Prednisolone|prednisolone|mesh-list
92591275|NCT04161898|Upadacitinib|upadacitinib|mesh-list
92591276|NCT04161898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591277|NCT04161898|Glucocorticoids|glucocorticoids|mesh-ancestor
92591278|NCT04161898|Hormones|hormones|mesh-ancestor
92591279|NCT04161898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591280|NCT04161898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591281|NCT04161898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591282|NCT04161898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591283|NCT04161898|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92591284|NCT04161898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591287|NCT04161898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591288|NCT04153487|Ascorbic Acid|ascorbic acid|mesh-list
92591290|NCT04153487|Micronutrients|micronutrients|mesh-ancestor
92591291|NCT04153487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591292|NCT04153487|Antioxidants|antioxidants|mesh-ancestor
92591293|NCT04153487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591294|NCT04153487|Protective Agents|protective agents|mesh-ancestor
92591295|NCT04153032|Diltiazem|diltiazem|mesh-list
92591296|NCT04153032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92591297|NCT04153032|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92591298|NCT04153032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92591299|NCT04153032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591300|NCT04153032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92591301|NCT04153032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591302|NCT04153032|Vasodilator Agents|vasodilator agents|mesh-ancestor
92591303|NCT04116437|Zanubrutinib|zanubrutinib|mesh-list
92591304|NCT04116437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591305|NCT04116437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591306|NCT04116437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591307|NCT04116437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591308|NCT04092179|Venetoclax|venetoclax|mesh-list
92591309|NCT04092179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591310|NCT04085445|Paclitaxel|paclitaxel|mesh-list
92591311|NCT04085445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591312|NCT04085445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591313|NCT04085445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591314|NCT04085445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591315|NCT04085445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591316|NCT04085445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591317|NCT04065841|Licogliflozin|licogliflozin|mesh-list
92591318|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92591319|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591320|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92591321|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591322|NCT03924869|Pembrolizumab|pembrolizumab|mesh-list
92591323|NCT03924869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591324|NCT03924869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591325|NCT03924869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591326|NCT03924869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535715|NCT00078247|Zidovudine|zidovudine|mesh-list
92535716|NCT00078247|Abacavir|abacavir|mesh-list
92591327|NCT03895567|Ceftriaxone|ceftriaxone|mesh-list
92591328|NCT03895567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92591329|NCT03895567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591330|NCT03885089|Infliximab|infliximab|mesh-list
92591331|NCT03885089|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92591332|NCT03885089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591333|NCT03885089|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591334|NCT03885089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591335|NCT03885089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591336|NCT03833167|Pembrolizumab|pembrolizumab|mesh-list
92591337|NCT03833167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591338|NCT03833167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591339|NCT03833167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591340|NCT03833167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591341|NCT03811002|Cisplatin|cisplatin|mesh-list
92591342|NCT03811002|Carboplatin|carboplatin|mesh-list
92591343|NCT03811002|Etoposide|etoposide|mesh-list
92591344|NCT03811002|Etoposide phosphate|etoposide phosphate|mesh-list
92591345|NCT03811002|Atezolizumab|atezolizumab|mesh-list
92591346|NCT03811002|Podophyllotoxin|podophyllotoxin|mesh-list
92591347|NCT03811002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92591348|NCT03811002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591349|NCT03811002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591350|NCT03811002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591351|NCT03811002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591352|NCT03811002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591353|NCT03811002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591354|NCT03811002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591355|NCT03811002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591360|NCT03811002|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591361|NCT03811002|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591362|NCT03811002|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591363|NCT03800134|Paclitaxel|paclitaxel|mesh-list
92591364|NCT03800134|Cisplatin|cisplatin|mesh-list
92591365|NCT03800134|Carboplatin|carboplatin|mesh-list
92591366|NCT03800134|Gemcitabine|gemcitabine|mesh-list
92591367|NCT03800134|Pemetrexed|pemetrexed|mesh-list
92591368|NCT03800134|Durvalumab|durvalumab|mesh-list
92591369|NCT03800134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591370|NCT03800134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591371|NCT03800134|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591372|NCT03800134|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591373|NCT03800134|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591374|NCT03800134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591375|NCT03800134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591376|NCT03800134|Antimetabolites|antimetabolites|mesh-ancestor
92591377|NCT03800134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591378|NCT03800134|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92591379|NCT03800134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92591380|NCT03800134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591381|NCT03774810|Zolpidem|zolpidem|mesh-list
92591382|NCT03774810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92591383|NCT03774810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92591384|NCT03774810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92591385|NCT03774810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591386|NCT03774810|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92591387|NCT03774810|GABA Agonists|gaba agonists|mesh-ancestor
92591388|NCT03774810|GABA Agents|gaba agents|mesh-ancestor
92591389|NCT03774810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591390|NCT03774810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591391|NCT03726268|Fentanyl|fentanyl|mesh-list
92591392|NCT03726268|Sufentanil|sufentanil|mesh-list
92591393|NCT03726268|Morphine|morphine|mesh-list
92591394|NCT03726268|Methadone|methadone|mesh-list
92591395|NCT03726268|Hydromorphone|hydromorphone|mesh-list
92591396|NCT03726268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92591397|NCT03726268|Narcotics|narcotics|mesh-ancestor
92591398|NCT03726268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92591399|NCT03726268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591400|NCT03726268|Analgesics|analgesics|mesh-ancestor
92591401|NCT03726268|Sensory System Agents|sensory system agents|mesh-ancestor
92591402|NCT03726268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591403|NCT03726268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92591404|NCT03726268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92591405|NCT03726268|Anesthetics, General|anesthetics, general|mesh-ancestor
92535717|NCT00078247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92535718|NCT00078247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92591406|NCT03726268|Anesthetics|anesthetics|mesh-ancestor
92591407|NCT03726268|Antitussive Agents|antitussive agents|mesh-ancestor
92591408|NCT03726268|Respiratory System Agents|respiratory system agents|mesh-ancestor
92591409|NCT03688178|Temozolomide|temozolomide|mesh-list
92591410|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591411|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
92591412|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591413|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591414|NCT03678883|Paclitaxel|paclitaxel|mesh-list
92591415|NCT03678883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92591416|NCT03678883|Carboplatin|carboplatin|mesh-list
92591417|NCT03678883|Gemcitabine|gemcitabine|mesh-list
92591418|NCT03678883|Doxorubicin|doxorubicin|mesh-list
92591419|NCT03678883|Irinotecan|irinotecan|mesh-list
92591420|NCT03678883|Lomustine|lomustine|mesh-list
92591421|NCT03678883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591422|NCT03678883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591423|NCT03678883|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591424|NCT03678883|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591425|NCT03678883|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591426|NCT03678883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591427|NCT03678883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591428|NCT03678883|Antimetabolites|antimetabolites|mesh-ancestor
92591429|NCT03678883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91998610|NCT02342509|Isoflurane|isoflurane|mesh-list
92591431|NCT03678883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591432|NCT03678883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591433|NCT03678883|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92591434|NCT03678883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591435|NCT03678883|Alkylating Agents|alkylating agents|mesh-ancestor
92591437|NCT03671109|Artenimol|artenimol|mesh-list
92591438|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
92591439|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92591440|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92591441|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591442|NCT03616587|Everolimus|everolimus|mesh-list
92591443|NCT03616587|Palbociclib|palbociclib|mesh-list
92591444|NCT03616587|Anastrozole|anastrozole|mesh-list
92591445|NCT03616587|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92591446|NCT03616587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591447|NCT03616587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591448|NCT03616587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591449|NCT03616587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591450|NCT03616587|Immunologic Factors|immunologic factors|mesh-ancestor
92591451|NCT03616587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591452|NCT03616587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591453|NCT03616587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591454|NCT03616587|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92591455|NCT03616587|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92591456|NCT03616587|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92591457|NCT03616587|Hormone Antagonists|hormone antagonists|mesh-ancestor
92591458|NCT03616587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591459|NCT03610971|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92591460|NCT03610971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591461|NCT03610971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591462|NCT03610971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591463|NCT03600701|Atezolizumab|atezolizumab|mesh-list
92591464|NCT03600701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92591465|NCT03600701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591466|NCT03600701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591467|NCT03600701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591468|NCT03600701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591469|NCT03600701|Immunologic Factors|immunologic factors|mesh-ancestor
92591470|NCT03600701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591471|NCT03582774|Edetic Acid|edetic acid|mesh-list
92591472|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92591473|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
92591474|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
92591475|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591476|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
92591477|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92591478|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92591479|NCT03532399|Bivalirudin|bivalirudin|mesh-list
92591480|NCT03532399|Antithrombins|antithrombins|mesh-ancestor
92591481|NCT03532399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92591482|NCT03532399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92591483|NCT03532399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591484|NCT03532399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591485|NCT03532399|Anticoagulants|anticoagulants|mesh-ancestor
92591486|NCT03504956|Metoprolol|metoprolol|mesh-list
92591487|NCT03504956|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92591488|NCT03504956|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92591489|NCT03504956|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92591490|NCT03504956|Sympatholytics|sympatholytics|mesh-ancestor
92591491|NCT03504956|Autonomic Agents|autonomic agents|mesh-ancestor
92591492|NCT03504956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591493|NCT03504956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591494|NCT03504956|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92591495|NCT03504956|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92591496|NCT03504956|Adrenergic Agents|adrenergic agents|mesh-ancestor
92591497|NCT03504956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591498|NCT03504956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591499|NCT03486873|Pembrolizumab|pembrolizumab|mesh-list
92591500|NCT03486873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591501|NCT03486873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591502|NCT03486873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92704667|NCT01229072|Calcium heparin|calcium heparin|mesh-list
92591505|NCT03464942|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591506|NCT03464942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591507|NCT03464942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591508|NCT03464942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591509|NCT03431831|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
92591510|NCT03431831|Naltrexone|naltrexone|mesh-list
92591511|NCT03431831|Bupropion|bupropion|mesh-list
92591512|NCT03431831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92591513|NCT03431831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92591514|NCT03431831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92591515|NCT03431831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591516|NCT03431831|Sensory System Agents|sensory system agents|mesh-ancestor
92591517|NCT03431831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591518|NCT03431831|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92591519|NCT03431831|Antidepressive Agents|antidepressive agents|mesh-ancestor
92591520|NCT03431831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92591521|NCT03431831|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92591522|NCT03431831|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92591523|NCT03431831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92591524|NCT03431831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591525|NCT03431831|Dopamine Agents|dopamine agents|mesh-ancestor
92591526|NCT03431831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591527|NCT03431831|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92591528|NCT03431831|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92591529|NCT03431831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591530|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
92591531|NCT03426891|Temozolomide|temozolomide|mesh-list
92591532|NCT03426891|Vorinostat|vorinostat|mesh-list
92591533|NCT03426891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92591534|NCT03426891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591535|NCT03426891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591536|NCT03426891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591537|NCT03426891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591538|NCT03426891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591539|NCT03426891|Alkylating Agents|alkylating agents|mesh-ancestor
92591540|NCT03426891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591541|NCT03422822|Abrocitinib|abrocitinib|mesh-list
92591542|NCT03422822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591543|NCT03422822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591544|NCT03422822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591545|NCT03422536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92591546|NCT03422536|Cetuximab|cetuximab|mesh-list
92591547|NCT03422536|Antibodies|antibodies|mesh-list
92591548|NCT03422536|Immunoglobulins|immunoglobulins|mesh-list
92591549|NCT03422536|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92535720|NCT00078247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535721|NCT00078247|Antiviral Agents|antiviral agents|mesh-ancestor
91938087|NCT05297396|Narcotics|narcotics|mesh-ancestor
92591550|NCT03422536|Immunologic Factors|immunologic factors|mesh-ancestor
92591551|NCT03422536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591552|NCT03422536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591553|NCT03407144|Prednisone|prednisone|mesh-list
92591554|NCT03407144|Prednisolone|prednisolone|mesh-list
92591555|NCT03407144|Cyclophosphamide|cyclophosphamide|mesh-list
92591556|NCT03407144|Dacarbazine|dacarbazine|mesh-list
92591557|NCT03407144|Doxorubicin|doxorubicin|mesh-list
92591558|NCT03407144|Pembrolizumab|pembrolizumab|mesh-list
92591559|NCT03407144|Etoposide|etoposide|mesh-list
92591560|NCT03407144|Etoposide phosphate|etoposide phosphate|mesh-list
92591561|NCT03407144|Vincristine|vincristine|mesh-list
92591562|NCT03407144|Bleomycin|bleomycin|mesh-list
92591563|NCT03407144|Vinblastine|vinblastine|mesh-list
92591564|NCT03407144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591565|NCT03407144|Immunologic Factors|immunologic factors|mesh-ancestor
92591566|NCT03407144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591567|NCT03407144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591568|NCT03407144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591569|NCT03407144|Alkylating Agents|alkylating agents|mesh-ancestor
92591570|NCT03407144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591571|NCT03407144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591572|NCT03407144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92591575|NCT03407144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591576|NCT03407144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591577|NCT03407144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591578|NCT03407144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591579|NCT03407144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591580|NCT03407144|Glucocorticoids|glucocorticoids|mesh-ancestor
92591581|NCT03407144|Hormones|hormones|mesh-ancestor
92591582|NCT03407144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591583|NCT03407144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591584|NCT03407144|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591585|NCT03407144|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591586|NCT03407144|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591587|NCT03407144|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591588|NCT03397966|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92591589|NCT03397966|Natriuretic Agents|natriuretic agents|mesh-ancestor
92591590|NCT03397966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591591|NCT03382977|Carmustine|carmustine|mesh-list
92591592|NCT03382977|Lomustine|lomustine|mesh-list
92591593|NCT03382977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591594|NCT03382977|Alkylating Agents|alkylating agents|mesh-ancestor
92591595|NCT03382977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591596|NCT03382977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591597|NCT03358693|Infliximab|infliximab|mesh-list
92591598|NCT03358693|Upadacitinib|upadacitinib|mesh-list
92591599|NCT03358693|Ustekinumab|ustekinumab|mesh-list
92591600|NCT03358693|Ixekizumab|ixekizumab|mesh-list
92591601|NCT03358693|Brodalumab|brodalumab|mesh-list
92591602|NCT03358693|Abrocitinib|abrocitinib|mesh-list
92591603|NCT03358693|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92591604|NCT03358693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591605|NCT03358693|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591606|NCT03358693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591607|NCT03358693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591608|NCT03358693|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92591609|NCT03358693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591610|NCT03358693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591611|NCT03358693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591612|NCT03311126|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92591613|NCT03311126|Obinutuzumab|obinutuzumab|mesh-list
92591614|NCT03311126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591615|NCT03311126|Alkylating Agents|alkylating agents|mesh-ancestor
92591616|NCT03311126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591617|NCT03311126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591618|NCT03311126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591619|NCT03273023|Chromium|chromium|mesh-list
92591620|NCT03273023|Everolimus|everolimus|mesh-list
92591621|NCT03273023|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92591622|NCT03273023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535722|NCT00078247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535723|NCT00078247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92360254|NCT00413400|Etanercept|etanercept|mesh-list
92535724|NCT00078247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92535725|NCT00078247|Antimetabolites|antimetabolites|mesh-ancestor
92535726|NCT00078442|Interferons|interferons|mesh-list
92535727|NCT00078442|Interferon-alpha|interferon-alpha|mesh-list
92591623|NCT03273023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591624|NCT03273023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591625|NCT03273023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591626|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
92591627|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591628|NCT03273023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591629|NCT03273023|Trace Elements|trace elements|mesh-ancestor
92591630|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
92591631|NCT03269669|Prednisone|prednisone|mesh-list
92591632|NCT03269669|Cortisone|cortisone|mesh-list
92591633|NCT03269669|Cyclophosphamide|cyclophosphamide|mesh-list
92591634|NCT03269669|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92591635|NCT03269669|Doxorubicin|doxorubicin|mesh-list
92591636|NCT03269669|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92591637|NCT03269669|Vincristine|vincristine|mesh-list
92591638|NCT03269669|Lenalidomide|lenalidomide|mesh-list
92591639|NCT03269669|Obinutuzumab|obinutuzumab|mesh-list
92591640|NCT03269669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591641|NCT03269669|Immunologic Factors|immunologic factors|mesh-ancestor
92591642|NCT03269669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591643|NCT03269669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591644|NCT03269669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591645|NCT03269669|Alkylating Agents|alkylating agents|mesh-ancestor
91998831|NCT05916742|Analgesics|analgesics|mesh-ancestor
92591651|NCT03269669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591652|NCT03269669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591653|NCT03269669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316527|NCT05405270|Imiquimod|imiquimod|mesh-list
92591654|NCT03269669|Glucocorticoids|glucocorticoids|mesh-ancestor
92591655|NCT03269669|Hormones|hormones|mesh-ancestor
92591656|NCT03269669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591657|NCT03269669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591658|NCT03269669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591659|NCT03269669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591660|NCT03269669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591661|NCT03269669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591662|NCT03269669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92591663|NCT03269669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92591664|NCT03269669|Growth Substances|growth substances|mesh-ancestor
92591665|NCT03269669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92591666|NCT03269669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591667|NCT03228394|Ganaxolone|ganaxolone|mesh-list
92591668|NCT03228394|Neurosteroids|neurosteroids|mesh-ancestor
92591669|NCT03228394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591670|NCT03228394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591671|NCT03228394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591672|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
92591673|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
92591674|NCT03213977|Prednisone|prednisone|mesh-list
92591675|NCT03213977|Cyclophosphamide|cyclophosphamide|mesh-list
92591676|NCT03213977|Doxorubicin|doxorubicin|mesh-list
92591677|NCT03213977|Etoposide|etoposide|mesh-list
92591678|NCT03213977|Vincristine|vincristine|mesh-list
92591679|NCT03213977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591680|NCT03213977|Immunologic Factors|immunologic factors|mesh-ancestor
92591681|NCT03213977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591682|NCT03213977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591683|NCT03213977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92591684|NCT03213977|Alkylating Agents|alkylating agents|mesh-ancestor
92591685|NCT03213977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591686|NCT03213977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591687|NCT03213977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92591688|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591689|NCT03213977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591690|NCT03213977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535728|NCT00078442|Interferon alpha-2|interferon alpha-2|mesh-list
92535729|NCT00078442|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92535730|NCT00078442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535731|NCT00078442|Antiviral Agents|antiviral agents|mesh-ancestor
92591691|NCT03213977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591692|NCT03213977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591693|NCT03213977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591694|NCT03213977|Glucocorticoids|glucocorticoids|mesh-ancestor
92591695|NCT03213977|Hormones|hormones|mesh-ancestor
92591696|NCT03213977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591697|NCT03213977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591698|NCT03213977|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591699|NCT03213977|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591700|NCT03213977|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591701|NCT03043872|Carboplatin|carboplatin|mesh-list
92591702|NCT03043872|Etoposide|etoposide|mesh-list
92591703|NCT03043872|Durvalumab|durvalumab|mesh-list
92591704|NCT03043872|Tremelimumab|tremelimumab|mesh-list
92591705|NCT03043872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591706|NCT03043872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591707|NCT03043872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591708|NCT03043872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591709|NCT03043872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591710|NCT03043872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591711|NCT03043872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591712|NCT03012529|Riboflavin|riboflavin|mesh-list
92591713|NCT03012529|Rifampin|rifampin|mesh-list
91998898|NCT05916352|Caffeine|caffeine|mesh-list
92591724|NCT03012529|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92591725|NCT03012529|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92591726|NCT03012529|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92591727|NCT03012529|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92591729|NCT03012529|Vitamins|vitamins|mesh-ancestor
92591730|NCT03012529|Micronutrients|micronutrients|mesh-ancestor
92591731|NCT03012529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591732|NCT03012529|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92591733|NCT03012529|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591734|NCT02978625|Nivolumab|nivolumab|mesh-list
92591735|NCT02978625|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92591736|NCT02978625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591737|NCT02978625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591738|NCT02978625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591739|NCT02978625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591740|NCT02956447|Hormones|hormones|mesh-list
92591741|NCT02956447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591742|NCT02956447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591743|NCT02953834|Insulin|insulin|mesh-list
92591744|NCT02953834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92591745|NCT02953834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591746|NCT02944071|Paclitaxel|paclitaxel|mesh-list
92591747|NCT02944071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591748|NCT02944071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591749|NCT02944071|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591750|NCT02944071|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591751|NCT02944071|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591752|NCT02944071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591753|NCT02912559|Calcium, Dietary|calcium, dietary|mesh-list
92591754|NCT02912559|Leucovorin|leucovorin|mesh-list
92591755|NCT02912559|Folic Acid|folic acid|mesh-list
92591756|NCT02912559|Fluorouracil|fluorouracil|mesh-list
92591757|NCT02912559|Oxaliplatin|oxaliplatin|mesh-list
92591758|NCT02912559|Atezolizumab|atezolizumab|mesh-list
92591759|NCT02912559|Calcium|calcium|mesh-list
92591760|NCT02912559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92591761|NCT02912559|Levoleucovorin|levoleucovorin|mesh-list
92591762|NCT02912559|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92591763|NCT02912559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591764|NCT02912559|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92591765|NCT02912559|Antimetabolites|antimetabolites|mesh-ancestor
92591766|NCT02912559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591767|NCT02912559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591768|NCT02912559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535732|NCT00078442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535733|NCT00078442|Immunologic Factors|immunologic factors|mesh-ancestor
92535734|NCT00078442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535735|NCT00078481|Idebenone|idebenone|mesh-list
92535736|NCT00078481|Antioxidants|antioxidants|mesh-ancestor
92591769|NCT02912559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591770|NCT02912559|Immunologic Factors|immunologic factors|mesh-ancestor
92591771|NCT02912559|Antidotes|antidotes|mesh-ancestor
92591772|NCT02912559|Protective Agents|protective agents|mesh-ancestor
92591773|NCT02912559|Vitamin B Complex|vitamin b complex|mesh-ancestor
92591774|NCT02912559|Vitamins|vitamins|mesh-ancestor
92591775|NCT02912559|Micronutrients|micronutrients|mesh-ancestor
92591776|NCT02912559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591780|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92591781|NCT02849639|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92591782|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
92591783|NCT02849639|Autonomic Agents|autonomic agents|mesh-ancestor
92591784|NCT02849639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591785|NCT02849639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591786|NCT02849639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591787|NCT02849639|Mydriatics|mydriatics|mesh-ancestor
92591788|NCT02849639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92591789|NCT02849639|Cholinergic Agents|cholinergic agents|mesh-ancestor
92591790|NCT02849639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591791|NCT02849639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591792|NCT02849639|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92591793|NCT02849639|Parasympatholytics|parasympatholytics|mesh-ancestor
92591794|NCT02773030|Dexamethasone|dexamethasone|mesh-list
92591795|NCT02773030|Bortezomib|bortezomib|mesh-list
92591796|NCT02773030|Daratumumab|daratumumab|mesh-list
92591797|NCT02773030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591798|NCT02773030|Antiemetics|antiemetics|mesh-ancestor
92591799|NCT02773030|Autonomic Agents|autonomic agents|mesh-ancestor
92591800|NCT02773030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591801|NCT02773030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591802|NCT02773030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591803|NCT02773030|Glucocorticoids|glucocorticoids|mesh-ancestor
92591804|NCT02773030|Hormones|hormones|mesh-ancestor
92591805|NCT02773030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591806|NCT02773030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591807|NCT02773030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591808|NCT02728388|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92591809|NCT02728388|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92591810|NCT02728388|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591811|NCT02633397|Riociguat|riociguat|mesh-list
92591812|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
92591813|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591814|NCT02594384|Rituximab|rituximab|mesh-list
92591815|NCT02594384|Atezolizumab|atezolizumab|mesh-list
92591816|NCT02594384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591817|NCT02594384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591818|NCT02594384|Immunologic Factors|immunologic factors|mesh-ancestor
92591819|NCT02594384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591820|NCT02594384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591821|NCT02594384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591822|NCT02594384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591823|NCT02592707|Dexamethasone|dexamethasone|mesh-list
92591824|NCT02592707|Ondansetron|ondansetron|mesh-list
92591825|NCT02592707|Antiemetics|antiemetics|mesh-list
92591826|NCT02592707|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92591827|NCT02592707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591828|NCT02592707|Autonomic Agents|autonomic agents|mesh-ancestor
92591829|NCT02592707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591830|NCT02592707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591831|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92591832|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
92591833|NCT02592707|Hormones|hormones|mesh-ancestor
92591834|NCT02592707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591835|NCT02592707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591836|NCT02592707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591837|NCT02592707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535737|NCT00078481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535738|NCT00078481|Protective Agents|protective agents|mesh-ancestor
92535739|NCT00078481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535740|NCT00078598|Rituximab|rituximab|mesh-list
92591838|NCT02592707|Antipruritics|antipruritics|mesh-ancestor
92591839|NCT02592707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591840|NCT02592707|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92591841|NCT02592707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92591842|NCT02592707|Serotonin Agents|serotonin agents|mesh-ancestor
92591843|NCT02592707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92591844|NCT02592707|Chelating Agents|chelating agents|mesh-ancestor
92591845|NCT02592707|Sequestering Agents|sequestering agents|mesh-ancestor
92591846|NCT02421939|Cytarabine|cytarabine|mesh-list
92591847|NCT02421939|Fludarabine|fludarabine|mesh-list
92591848|NCT02421939|Etoposide|etoposide|mesh-list
92591849|NCT02421939|Azacitidine|azacitidine|mesh-list
92591850|NCT02421939|Mitoxantrone|mitoxantrone|mesh-list
92591855|NCT02421939|Antimetabolites|antimetabolites|mesh-ancestor
92591856|NCT02421939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591857|NCT02421939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591858|NCT02421939|Immunologic Factors|immunologic factors|mesh-ancestor
92591859|NCT02421939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591860|NCT02421939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92591861|NCT02421939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591862|NCT02421939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591863|NCT02421939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591864|NCT02421939|Antiviral Agents|antiviral agents|mesh-ancestor
92591865|NCT02421939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591866|NCT02421939|Analgesics|analgesics|mesh-ancestor
92591867|NCT02421939|Sensory System Agents|sensory system agents|mesh-ancestor
92591868|NCT02421939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591869|NCT02421939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92591870|NCT02421939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591871|NCT02326805|Metronidazole|metronidazole|mesh-list
92591872|NCT02326805|Vaccines|vaccines|mesh-list
92591873|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
92591874|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591875|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591876|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92591877|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92591878|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92591879|NCT02310321|Cytarabine|cytarabine|mesh-list
92591880|NCT02310321|Idarubicin|idarubicin|mesh-list
92591881|NCT02310321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591882|NCT02310321|Antimetabolites|antimetabolites|mesh-ancestor
92704668|NCT01229072|Anticoagulants|anticoagulants|mesh-ancestor
92591883|NCT02310321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591884|NCT02310321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591885|NCT02310321|Antiviral Agents|antiviral agents|mesh-ancestor
92591886|NCT02310321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591887|NCT02310321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591888|NCT02310321|Immunologic Factors|immunologic factors|mesh-ancestor
92591889|NCT02310321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591890|NCT02310321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591891|NCT02310321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591892|NCT02310321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92591893|NCT02310321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591894|NCT02288247|Prednisolone|prednisolone|mesh-list
92591895|NCT02288247|Docetaxel|docetaxel|mesh-list
92591896|NCT02288247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591897|NCT02288247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591898|NCT02288247|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591899|NCT02288247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591900|NCT02288247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591901|NCT02288247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591902|NCT02288247|Glucocorticoids|glucocorticoids|mesh-ancestor
92591903|NCT02288247|Hormones|hormones|mesh-ancestor
92591904|NCT02288247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92591905|NCT02288247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591906|NCT02288247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92591907|NCT02275533|Nivolumab|nivolumab|mesh-list
92591908|NCT02275533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591909|NCT02275533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535741|NCT00078598|Tositumomab I-131|tositumomab i-131|mesh-list
92535742|NCT00078598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92535743|NCT00078598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591910|NCT02275533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591911|NCT02275533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591912|NCT02169310|Raclopride|raclopride|mesh-list
92591913|NCT02169310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92591914|NCT02169310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92591915|NCT02169310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92591916|NCT02169310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591917|NCT02169310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92591918|NCT02169310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92591919|NCT02169310|Dopamine Agents|dopamine agents|mesh-ancestor
92591920|NCT02169310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999110|NCT05914662|Zanubrutinib|zanubrutinib|mesh-list
92591923|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591925|NCT01952782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591926|NCT01952782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92591927|NCT01952782|Sensory System Agents|sensory system agents|mesh-ancestor
92591928|NCT01952782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92591929|NCT01896999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92591930|NCT01896999|Nivolumab|nivolumab|mesh-list
92591931|NCT01896999|Ipilimumab|ipilimumab|mesh-list
92591932|NCT01896999|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92591933|NCT01896999|Antibodies|antibodies|mesh-list
92591934|NCT01896999|Immunoglobulins|immunoglobulins|mesh-list
92591935|NCT01896999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92591936|NCT01896999|Immunoconjugates|immunoconjugates|mesh-list
92591937|NCT01896999|Immunologic Factors|immunologic factors|mesh-ancestor
92591938|NCT01896999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591939|NCT01896999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591940|NCT01896999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591941|NCT01896999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591942|NCT01896999|Immunotoxins|immunotoxins|mesh-ancestor
92591943|NCT01810913|Cisplatin|cisplatin|mesh-list
92591944|NCT01810913|Docetaxel|docetaxel|mesh-list
92591945|NCT01810913|Cetuximab|cetuximab|mesh-list
92591946|NCT01810913|Atezolizumab|atezolizumab|mesh-list
92591947|NCT01810913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92591948|NCT01810913|Antibodies|antibodies|mesh-list
92591949|NCT01810913|Immunoglobulins|immunoglobulins|mesh-list
92591950|NCT01810913|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92591951|NCT01810913|Immunologic Factors|immunologic factors|mesh-ancestor
92591952|NCT01810913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591953|NCT01810913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591954|NCT01810913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92591955|NCT01810913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92591956|NCT01810913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92591957|NCT01810913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591958|NCT01810913|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92591959|NCT01423812|Ritonavir|ritonavir|mesh-list
92591960|NCT01423812|Darunavir|darunavir|mesh-list
92591961|NCT01423812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92591962|NCT01423812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92591963|NCT01423812|Protease Inhibitors|protease inhibitors|mesh-ancestor
92591964|NCT01423812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591965|NCT01423812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591966|NCT01423812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92591967|NCT01423812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92591968|NCT01423812|Antiviral Agents|antiviral agents|mesh-ancestor
92591969|NCT01423812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591970|NCT01423812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92591971|NCT01423812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92591972|NCT01291719|Insulin|insulin|mesh-list
92591973|NCT01291719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92591974|NCT01291719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591975|NCT01176474|Nivolumab|nivolumab|mesh-list
92591976|NCT01176474|Ipilimumab|ipilimumab|mesh-list
92591977|NCT01176474|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92591978|NCT01176474|Immunologic Factors|immunologic factors|mesh-ancestor
92591979|NCT01176474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591980|NCT01176474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591981|NCT01176474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591982|NCT01176474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92535745|NCT00078598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535746|NCT00078598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92591983|NCT01176474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591984|NCT01176474|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92591985|NCT01141309|Everolimus|everolimus|mesh-list
92591986|NCT01141309|Sorafenib|sorafenib|mesh-list
92591987|NCT01141309|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92591988|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92591989|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591990|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591991|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92591992|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
92591993|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591994|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591995|NCT00914823|Hormones|hormones|mesh-list
92591997|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591999|NCT00859781|Hydrocortisone|hydrocortisone|mesh-list
92592000|NCT00859781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592001|NCT00859781|Antifungal Agents|antifungal agents|mesh-ancestor
92592002|NCT00859781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592003|NCT00859781|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92592004|NCT00859781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92592005|NCT00859781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592006|NCT00859781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592007|NCT00859781|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92592008|NCT00859781|Hormone Antagonists|hormone antagonists|mesh-ancestor
92592009|NCT00859781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592010|NCT00859781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592011|NCT00859781|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92592012|NCT00792740|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92592013|NCT00792740|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92592014|NCT00792740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592015|NCT00792740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592016|NCT00729300|Disulfiram|disulfiram|mesh-list
92592017|NCT00729300|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92592018|NCT00729300|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92592019|NCT00729300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592020|NCT00729300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592021|NCT00099086|Docetaxel|docetaxel|mesh-list
92592022|NCT00099086|Leuprolide|leuprolide|mesh-list
92592023|NCT00099086|Goserelin|goserelin|mesh-list
92592024|NCT00099086|Bicalutamide|bicalutamide|mesh-list
92592025|NCT00099086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592026|NCT00099086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592027|NCT00099086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92592028|NCT00099086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592029|NCT00099086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592030|NCT00099086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92592031|NCT00099086|Fertility Agents|fertility agents|mesh-ancestor
92592032|NCT00099086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92592033|NCT00099086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592034|NCT00099086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592035|NCT00099086|Androgen Antagonists|androgen antagonists|mesh-ancestor
92592036|NCT00099086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92592037|NCT00099086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592038|NCT00856947|Vitamin D|vitamin d|mesh-list
92592039|NCT00856947|Cholecalciferol|cholecalciferol|mesh-list
92592040|NCT00856947|Vitamins|vitamins|mesh-ancestor
92592041|NCT00856947|Micronutrients|micronutrients|mesh-ancestor
92592042|NCT00856947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592043|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92592044|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92592045|NCT00655993|Simvastatin|simvastatin|mesh-list
92592046|NCT00655993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92592047|NCT00655993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92592048|NCT00655993|Antimetabolites|antimetabolites|mesh-ancestor
92592049|NCT00655993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592050|NCT00655993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92592051|NCT00655993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92535747|NCT00078793|Etanercept|etanercept|mesh-list
92535748|NCT00078793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92535749|NCT00078793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92535750|NCT00078793|Analgesics|analgesics|mesh-ancestor
92535751|NCT00078793|Sensory System Agents|sensory system agents|mesh-ancestor
92592052|NCT00655993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592053|NCT00567580|Leuprolide|leuprolide|mesh-list
92592054|NCT00567580|Goserelin|goserelin|mesh-list
92592055|NCT00567580|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92592056|NCT00567580|Flutamide|flutamide|mesh-list
92592057|NCT00567580|Bicalutamide|bicalutamide|mesh-list
92592058|NCT00567580|Buserelin|buserelin|mesh-list
92592059|NCT00567580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92592060|NCT00567580|Fertility Agents|fertility agents|mesh-ancestor
92592061|NCT00567580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92592062|NCT00567580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592063|NCT00567580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592064|NCT00567580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592065|NCT00567580|Androgen Antagonists|androgen antagonists|mesh-ancestor
92592066|NCT00567580|Hormone Antagonists|hormone antagonists|mesh-ancestor
91999255|NCT05913427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592067|NCT00567580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592069|NCT00567580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92592070|NCT00567580|Contraceptive Agents|contraceptive agents|mesh-ancestor
92592071|NCT00567580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92592072|NCT00268385|Temozolomide|temozolomide|mesh-list
92592073|NCT00268385|Vorinostat|vorinostat|mesh-list
92592074|NCT00268385|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592075|NCT00268385|Alkylating Agents|alkylating agents|mesh-ancestor
92592076|NCT00268385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592077|NCT00268385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592078|NCT00268385|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92592079|NCT00268385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592080|NCT00125151|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92592081|NCT00125151|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92592082|NCT00125151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592083|NCT00125151|Immunologic Factors|immunologic factors|mesh-ancestor
92592084|NCT00125151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592085|NCT00087815|Dexamethasone|dexamethasone|mesh-list
92592086|NCT00087815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592087|NCT00087815|Antiemetics|antiemetics|mesh-ancestor
92592088|NCT00087815|Autonomic Agents|autonomic agents|mesh-ancestor
92592089|NCT00087815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592090|NCT00087815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592091|NCT00087815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592092|NCT00087815|Glucocorticoids|glucocorticoids|mesh-ancestor
92592093|NCT00087815|Hormones|hormones|mesh-ancestor
92592094|NCT00087815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592095|NCT00087815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592096|NCT00087815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592097|NCT00087854|Amonafide|amonafide|mesh-list
92592098|NCT00087854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592099|NCT00087854|Antiviral Agents|antiviral agents|mesh-ancestor
92592100|NCT00087854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592101|NCT00087854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592102|NCT00087854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592103|NCT04715620|Niraparib|niraparib|mesh-list
92592104|NCT04715620|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92592105|NCT04715620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316972|NCT03115801|Immunomodulating Agents|immunomodulating agents|mesh-list
92704669|NCT01229072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92592106|NCT04715620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592107|NCT04715620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592109|NCT00125229|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92592110|NCT00125229|Diuretics|diuretics|mesh-ancestor
92592111|NCT00125229|Natriuretic Agents|natriuretic agents|mesh-ancestor
92592112|NCT00125229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592113|NCT00126906|Pyrimethamine|pyrimethamine|mesh-list
92592114|NCT00126906|Sulfadoxine|sulfadoxine|mesh-list
92592115|NCT00126906|Antimalarials|antimalarials|mesh-ancestor
92592116|NCT00126906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92592117|NCT00126906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92535752|NCT00078793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535753|NCT00078793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535754|NCT00078793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592118|NCT00126906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592119|NCT00126906|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92592120|NCT00126906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592121|NCT00126906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592122|NCT00126906|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92592123|NCT00088049|Olanzapine|olanzapine|mesh-list
92592124|NCT00088049|Aripiprazole|aripiprazole|mesh-list
92592125|NCT00088049|Antiemetics|antiemetics|mesh-ancestor
92592126|NCT00088049|Autonomic Agents|autonomic agents|mesh-ancestor
92592127|NCT00088049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592128|NCT00088049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592129|NCT00088049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592130|NCT00088049|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92592131|NCT00088049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592132|NCT00088049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592133|NCT00088049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592134|NCT00088049|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92592135|NCT00088049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92592136|NCT00088049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92592137|NCT00088049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592138|NCT00088049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592156|NCT00088088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592157|NCT00125307|Tacrolimus|tacrolimus|mesh-list
92592158|NCT00125307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592159|NCT00125307|Immunologic Factors|immunologic factors|mesh-ancestor
92592160|NCT00125307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592161|NCT00125307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92592162|NCT00125307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592163|NCT00125307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592164|NCT00127023|Vaccines|vaccines|mesh-list
92592165|NCT00127023|Immunologic Factors|immunologic factors|mesh-ancestor
92592166|NCT00127023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592167|NCT00332761|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92592168|NCT00332761|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92592169|NCT00332761|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92592170|NCT00332761|Antimetabolites|antimetabolites|mesh-ancestor
92592171|NCT00332761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592172|NCT00332761|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92592173|NCT00332761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92592174|NCT00332761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92592175|NCT00332761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92592176|NCT00332761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92592177|NCT00332761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592178|NCT00332761|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92592179|NCT00332761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592180|NCT00332995|Dapivirine|dapivirine|mesh-list
92592181|NCT00332995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92592182|NCT00332995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92592183|NCT00332995|Antiviral Agents|antiviral agents|mesh-ancestor
92592184|NCT00332995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592185|NCT00333034|Etanercept|etanercept|mesh-list
92592186|NCT00333034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92592187|NCT00333034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92592188|NCT00333034|Analgesics|analgesics|mesh-ancestor
92592189|NCT00333034|Sensory System Agents|sensory system agents|mesh-ancestor
92592190|NCT00333034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592191|NCT00333034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592192|NCT00333034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592193|NCT00333034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592194|NCT00333034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592195|NCT00333034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592204|NCT00088478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592205|NCT00088478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592206|NCT00088478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592207|NCT00088478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92592208|NCT00088478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92592209|NCT00088478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92592210|NCT00088478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592211|NCT00088478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592213|NCT00125346|Tobramycin|tobramycin|mesh-list
92592214|NCT00125346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92592215|NCT00125346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592216|NCT00333112|Tamsulosin|tamsulosin|mesh-list
92592217|NCT00333112|Solifenacin Succinate|solifenacin succinate|mesh-list
92592218|NCT00333112|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92592219|NCT00333112|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92592220|NCT00333112|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92592221|NCT00333112|Adrenergic Agents|adrenergic agents|mesh-ancestor
92592222|NCT00333112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592223|NCT00333112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592224|NCT00333112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592225|NCT00333112|Urological Agents|urological agents|mesh-ancestor
92592226|NCT00333112|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92592227|NCT00333112|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92592228|NCT00333112|Cholinergic Agents|cholinergic agents|mesh-ancestor
92592229|NCT00333151|Metformin|metformin|mesh-list
92592230|NCT00333151|Liraglutide|liraglutide|mesh-list
92592231|NCT00333151|Rosiglitazone|rosiglitazone|mesh-list
92592232|NCT00333151|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92592233|NCT00333151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592234|NCT00333151|Incretins|incretins|mesh-ancestor
92592235|NCT00333151|Hormones|hormones|mesh-ancestor
92592236|NCT00333151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592237|NCT00125385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92592238|NCT00125385|Immunologic Factors|immunologic factors|mesh-ancestor
92592239|NCT00125385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592240|NCT00088556|Paclitaxel|paclitaxel|mesh-list
92592241|NCT00088556|Carboplatin|carboplatin|mesh-list
92592242|NCT00088556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592243|NCT00088556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592244|NCT00088556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592245|NCT00088556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92592246|NCT00088556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592247|NCT00088556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592248|NCT00127140|Vorinostat|vorinostat|mesh-list
92592249|NCT00127140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592250|NCT00127140|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92592251|NCT00127140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592252|NCT00127140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592253|NCT00333307|Methocarbamol|methocarbamol|mesh-list
92592254|NCT00333307|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92592255|NCT00333307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592256|NCT00333307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92592257|NCT00333307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592258|NCT00125424|Midazolam|midazolam|mesh-list
92592259|NCT00125424|Fospropofol|fospropofol|mesh-list
92592260|NCT00125424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92592261|NCT00125424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92592262|NCT00125424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592272|NCT00125424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592273|NCT00125424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592274|NCT00333346|Tramadol|tramadol|mesh-list
92592275|NCT00333346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92592276|NCT00333346|Narcotics|narcotics|mesh-ancestor
92592277|NCT00333346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592278|NCT00333346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592279|NCT00333346|Analgesics|analgesics|mesh-ancestor
92592280|NCT00333346|Sensory System Agents|sensory system agents|mesh-ancestor
92592281|NCT00333346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592282|NCT00333385|Ceftazidime|ceftazidime|mesh-list
92592283|NCT00333385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92592284|NCT00333385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592285|NCT00127257|Diazepam|diazepam|mesh-list
92592286|NCT00127257|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92592287|NCT00127257|Anticonvulsants|anticonvulsants|mesh-ancestor
92592288|NCT00127257|Antiemetics|antiemetics|mesh-ancestor
92592289|NCT00127257|Autonomic Agents|autonomic agents|mesh-ancestor
92592290|NCT00127257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592291|NCT00127257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592292|NCT00127257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592293|NCT00127257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92535755|NCT00078793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535756|NCT00078793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592294|NCT00127257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592295|NCT00127257|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92592296|NCT00127257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92592297|NCT00127257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92592298|NCT00127257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592299|NCT00127257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592300|NCT00127257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92592301|NCT00127257|Anesthetics, General|anesthetics, general|mesh-ancestor
92592302|NCT00127257|Anesthetics|anesthetics|mesh-ancestor
92592303|NCT00127257|GABA Modulators|gaba modulators|mesh-ancestor
92592304|NCT00127257|GABA Agents|gaba agents|mesh-ancestor
92592305|NCT00127257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592306|NCT00127257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592308|NCT00333424|Immunologic Factors|immunologic factors|mesh-ancestor
92592309|NCT00333424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592310|NCT00125463|Candesartan|candesartan|mesh-list
92592311|NCT00125463|Candesartan cilexetil|candesartan cilexetil|mesh-list
92592312|NCT00125463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92592313|NCT00125463|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92592314|NCT00125463|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92592315|NCT00125463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592316|NCT00088946|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92592317|NCT00088946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592318|NCT00088946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92592319|NCT00088946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592320|NCT00088946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592321|NCT00421018|Montelukast|montelukast|mesh-list
92592322|NCT00421018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92592323|NCT00421018|Respiratory System Agents|respiratory system agents|mesh-ancestor
92592324|NCT00421018|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92592325|NCT00421018|Hormone Antagonists|hormone antagonists|mesh-ancestor
92592326|NCT00421018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592327|NCT00421018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592328|NCT00421018|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91999550|NCT05906303|Sensory System Agents|sensory system agents|mesh-ancestor
92592333|NCT00421096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592334|NCT00421096|Antimetabolites|antimetabolites|mesh-ancestor
92592335|NCT00421096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592336|NCT00089063|Sargramostim|sargramostim|mesh-list
92592337|NCT00089063|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92592338|NCT00089063|Freund's Adjuvant|freund's adjuvant|mesh-list
92592339|NCT00089063|Immunologic Factors|immunologic factors|mesh-ancestor
92592340|NCT00089063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592341|NCT00089063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92592342|NCT00333931|Phenytoin|phenytoin|mesh-list
92592343|NCT00333931|Anticonvulsants|anticonvulsants|mesh-ancestor
92592344|NCT00333931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92592345|NCT00333931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92592346|NCT00333931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92592347|NCT00333931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592348|NCT00333931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92592349|NCT00333931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92592350|NCT00334048|Ropinirole|ropinirole|mesh-list
92592351|NCT00334048|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92592352|NCT00334048|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92592353|NCT00334048|Dopamine Agonists|dopamine agonists|mesh-ancestor
92592354|NCT00334048|Dopamine Agents|dopamine agents|mesh-ancestor
92592355|NCT00334048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592356|NCT00334048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592357|NCT00334048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592358|NCT00334126|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92592359|NCT00334126|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92592360|NCT00334126|Antidepressive Agents|antidepressive agents|mesh-ancestor
92592361|NCT00334126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592362|NCT00334126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92592363|NCT00334126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592364|NCT00334126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592365|NCT00334126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535757|NCT00078793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535758|NCT00078793|Immunologic Factors|immunologic factors|mesh-ancestor
92535759|NCT00078832|Anastrozole|anastrozole|mesh-list
91938811|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
92592366|NCT00334126|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92592367|NCT00334126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92592368|NCT00334126|Serotonin Agents|serotonin agents|mesh-ancestor
92592369|NCT00334126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592370|NCT00334126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592371|NCT00334126|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92592372|NCT00334126|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92592373|NCT00334126|Dopamine Agents|dopamine agents|mesh-ancestor
92592374|NCT00089219|Sargramostim|sargramostim|mesh-list
92592375|NCT00089219|Freund's Adjuvant|freund's adjuvant|mesh-list
92592376|NCT00089219|Immunologic Factors|immunologic factors|mesh-ancestor
92592377|NCT00089219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592378|NCT00089219|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92592379|NCT00334321|Paclitaxel|paclitaxel|mesh-list
92592380|NCT00334321|Carboplatin|carboplatin|mesh-list
92592381|NCT00334321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592382|NCT00334321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592383|NCT00334321|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592384|NCT00334321|Antimitotic Agents|antimitotic agents|mesh-ancestor
92592385|NCT00334321|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592386|NCT00334321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592387|NCT00334360|Dexmedetomidine|dexmedetomidine|mesh-list
92592388|NCT00334360|Buspirone|buspirone|mesh-list
92592389|NCT00334360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92592390|NCT00334360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592391|NCT00334360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592392|NCT00334360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92592393|NCT00334360|Analgesics|analgesics|mesh-ancestor
92592394|NCT00334360|Sensory System Agents|sensory system agents|mesh-ancestor
92592395|NCT00334360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592396|NCT00334360|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92592397|NCT00334360|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92592401|NCT00334360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592402|NCT00334360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92592403|NCT00334360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592404|NCT00334360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592405|NCT00334360|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92592406|NCT00334360|Serotonin Agents|serotonin agents|mesh-ancestor
92592407|NCT00334399|Miglitol|miglitol|mesh-list
92592408|NCT00334399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592409|NCT00334399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592410|NCT00334399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92592411|NCT00334399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592412|NCT00334399|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92592413|NCT00334438|Rituximab|rituximab|mesh-list
92592414|NCT00334438|Bortezomib|bortezomib|mesh-list
92592415|NCT00334438|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92592416|NCT00334438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592417|NCT00334438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592418|NCT00334438|Immunologic Factors|immunologic factors|mesh-ancestor
92592419|NCT00334438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592420|NCT00334438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592421|NCT00334477|Tadalafil|tadalafil|mesh-list
92592422|NCT00334477|Vasodilator Agents|vasodilator agents|mesh-ancestor
92592423|NCT00334477|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92592424|NCT00334477|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92592425|NCT00334477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592426|NCT00334477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592427|NCT00334477|Urological Agents|urological agents|mesh-ancestor
92592428|NCT04715269|Alprazolam|alprazolam|mesh-list
92592429|NCT04715269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92592430|NCT04715269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592431|NCT04715269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592432|NCT04715269|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92592433|NCT04715269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592434|NCT04715269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592435|NCT04715269|GABA Modulators|gaba modulators|mesh-ancestor
92592436|NCT04715269|GABA Agents|gaba agents|mesh-ancestor
92535760|NCT00078832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535761|NCT00078832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535762|NCT00078832|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91938870|NCT00871481|Aldesleukin|aldesleukin|mesh-list
92592437|NCT04715269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592438|NCT04715269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592439|NCT00125541|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92592440|NCT00125541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92592441|NCT00125541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592442|NCT00125541|Immunologic Factors|immunologic factors|mesh-ancestor
92592443|NCT00125541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592444|NCT00089258|Isotretinoin|isotretinoin|mesh-list
92592445|NCT00089258|Antibodies|antibodies|mesh-list
92592446|NCT00089258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92592447|NCT00089258|Sargramostim|sargramostim|mesh-list
92592448|NCT00089258|Immunologic Factors|immunologic factors|mesh-ancestor
92592449|NCT00089258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592450|NCT00089258|Dermatologic Agents|dermatologic agents|mesh-ancestor
92592451|NCT00127569|Rituximab|rituximab|mesh-list
92592452|NCT00127569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592453|NCT00127569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592454|NCT00127569|Immunologic Factors|immunologic factors|mesh-ancestor
92592455|NCT00127569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592456|NCT00127569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592457|NCT00334594|Pemetrexed|pemetrexed|mesh-list
92592458|NCT00334594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592459|NCT00334594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592460|NCT00334594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592461|NCT00334594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92592462|NCT00334594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92592463|NCT00334672|Cyclosporine|cyclosporine|mesh-list
92592464|NCT00334672|Mycophenolic Acid|mycophenolic acid|mesh-list
92592465|NCT00334672|Dexamethasone|dexamethasone|mesh-list
92592466|NCT00334672|Hydrocortisone|hydrocortisone|mesh-list
92592467|NCT00334672|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92592468|NCT00334672|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92592469|NCT00334672|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91999696|NCT05848375|Ropivacaine|ropivacaine|mesh-list
92592475|NCT00334672|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92592476|NCT00334672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592477|NCT00334672|Immunologic Factors|immunologic factors|mesh-ancestor
92592478|NCT00334672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592479|NCT00334672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592480|NCT00334672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592481|NCT00334672|Alkylating Agents|alkylating agents|mesh-ancestor
92592482|NCT00334672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592483|NCT00334672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592484|NCT00334672|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592485|NCT00334672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592486|NCT00334672|Antiemetics|antiemetics|mesh-ancestor
92592487|NCT00334672|Autonomic Agents|autonomic agents|mesh-ancestor
92592488|NCT00334672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592489|NCT00334672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592490|NCT00334672|Glucocorticoids|glucocorticoids|mesh-ancestor
92592491|NCT00334672|Hormones|hormones|mesh-ancestor
92592492|NCT00334672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592493|NCT00334672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592494|NCT00334672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92592495|NCT00334672|Abortifacient Agents|abortifacient agents|mesh-ancestor
92592496|NCT00334672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92592497|NCT00334672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592498|NCT00334672|Antimetabolites|antimetabolites|mesh-ancestor
92592499|NCT00334672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92592500|NCT00334672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592501|NCT00334672|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92592502|NCT00334672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92592503|NCT00334672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592504|NCT00334672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92592505|NCT00334672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92592506|NCT00334672|Antifungal Agents|antifungal agents|mesh-ancestor
92592507|NCT00334672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535763|NCT00078832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92535764|NCT00078832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535765|NCT00078832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592508|NCT00334672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92592509|NCT00334672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592510|NCT00334672|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92592511|NCT00334672|Antitubercular Agents|antitubercular agents|mesh-ancestor
92592512|NCT00334672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92592514|NCT00089453|Cyclophosphamide|cyclophosphamide|mesh-list
92592515|NCT00089453|Melphalan|melphalan|mesh-list
92592516|NCT00089453|Fludarabine|fludarabine|mesh-list
92592517|NCT00089453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592518|NCT00089453|Immunologic Factors|immunologic factors|mesh-ancestor
92592519|NCT00089453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592520|NCT00089453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592521|NCT00089453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592522|NCT00089453|Alkylating Agents|alkylating agents|mesh-ancestor
92592523|NCT00089453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592524|NCT00089453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592525|NCT00089453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592526|NCT00089453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592527|NCT00089453|Antiemetics|antiemetics|mesh-ancestor
92592528|NCT00089453|Autonomic Agents|autonomic agents|mesh-ancestor
92592529|NCT00089453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592530|NCT00089453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592531|NCT00089453|Glucocorticoids|glucocorticoids|mesh-ancestor
92592532|NCT00089453|Hormones|hormones|mesh-ancestor
92592533|NCT00089453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592534|NCT00089453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592535|NCT00089492|Enfuvirtide|enfuvirtide|mesh-list
92592536|NCT00089492|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92592537|NCT00089492|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92592538|NCT00089492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592539|NCT00089492|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92592540|NCT00089492|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92592554|NCT00334789|Isotretinoin|isotretinoin|mesh-list
92592555|NCT00334789|Vitamins|vitamins|mesh-ancestor
92592556|NCT00334789|Micronutrients|micronutrients|mesh-ancestor
92592557|NCT00334789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592558|NCT00334789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592559|NCT00334789|Keratolytic Agents|keratolytic agents|mesh-ancestor
92592560|NCT00334789|Dermatologic Agents|dermatologic agents|mesh-ancestor
92592561|NCT00334789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592562|NCT00334789|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92592563|NCT00334789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592564|NCT00334867|Cyclophosphamide|cyclophosphamide|mesh-list
92592565|NCT00334867|Ifosfamide|ifosfamide|mesh-list
92592566|NCT00334867|Doxorubicin|doxorubicin|mesh-list
92592567|NCT00334867|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92592568|NCT00334867|Etoposide|etoposide|mesh-list
92592569|NCT00334867|Vincristine|vincristine|mesh-list
92592570|NCT00334867|Topotecan|topotecan|mesh-list
92592571|NCT00334867|Dexrazoxane|dexrazoxane|mesh-list
92592572|NCT00334867|Razoxane|razoxane|mesh-list
92592573|NCT00334867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592574|NCT00334867|Immunologic Factors|immunologic factors|mesh-ancestor
92592575|NCT00334867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592576|NCT00334867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592577|NCT00334867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592578|NCT00334867|Alkylating Agents|alkylating agents|mesh-ancestor
92592579|NCT00334867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592580|NCT00334867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592581|NCT00334867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592582|NCT00334867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592583|NCT00334867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92592584|NCT00334867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92592585|NCT00334867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592586|NCT00334867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592587|NCT00334867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592588|NCT00334867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92592589|NCT00334867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592590|NCT00334867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92535766|NCT00078832|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92535767|NCT00078832|Hormone Antagonists|hormone antagonists|mesh-ancestor
91939029|NCT05088057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592591|NCT00334867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92592592|NCT00334867|Protective Agents|protective agents|mesh-ancestor
92592594|NCT04715152|Dexamethasone acetate|dexamethasone acetate|mesh-list
92592595|NCT04715152|Levobupivacaine|levobupivacaine|mesh-list
92592596|NCT04715152|BB 1101|bb 1101|mesh-list
92592597|NCT04715152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592598|NCT04715152|Antiemetics|antiemetics|mesh-ancestor
92592599|NCT04715152|Autonomic Agents|autonomic agents|mesh-ancestor
92592600|NCT04715152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592601|NCT04715152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592602|NCT04715152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592603|NCT04715152|Glucocorticoids|glucocorticoids|mesh-ancestor
92592604|NCT04715152|Hormones|hormones|mesh-ancestor
92592605|NCT04715152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592609|NCT04715152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592610|NCT04715152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592611|NCT04715152|Anesthetics, Local|anesthetics, local|mesh-ancestor
92592612|NCT04715152|Anesthetics|anesthetics|mesh-ancestor
92592613|NCT04715152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592614|NCT04715152|Sensory System Agents|sensory system agents|mesh-ancestor
92592615|NCT00334906|Memantine|memantine|mesh-list
92592616|NCT00334906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92592617|NCT00334906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92592618|NCT00334906|Dopamine Agents|dopamine agents|mesh-ancestor
92592619|NCT00334906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592620|NCT00334906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592621|NCT00334906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592622|NCT00334906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92592623|NCT00334906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92592624|NCT00089570|Terlipressin|terlipressin|mesh-list
92592625|NCT00089570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92592626|NCT00089570|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92592627|NCT00342862|Alefacept|alefacept|mesh-list
92592628|NCT00342862|Dermatologic Agents|dermatologic agents|mesh-ancestor
92592629|NCT00342862|Immunologic Factors|immunologic factors|mesh-ancestor
92592630|NCT00342862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592631|NCT00089687|Vanoxerine|vanoxerine|mesh-list
92592632|NCT00089687|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92592633|NCT00089687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92592634|NCT00089687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92592635|NCT00089687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592636|NCT00089687|Dopamine Agents|dopamine agents|mesh-ancestor
92592637|NCT00089687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592638|NCT00089687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592639|NCT00127764|Dexamethasone|dexamethasone|mesh-list
92592640|NCT00127764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592641|NCT00127764|Antiemetics|antiemetics|mesh-ancestor
92592642|NCT00127764|Autonomic Agents|autonomic agents|mesh-ancestor
92592643|NCT00127764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592644|NCT00127764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592645|NCT00127764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592646|NCT00127764|Glucocorticoids|glucocorticoids|mesh-ancestor
92592647|NCT00127764|Hormones|hormones|mesh-ancestor
92592648|NCT00127764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592649|NCT00127764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592650|NCT00127764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592651|NCT00089726|Cyclophosphamide|cyclophosphamide|mesh-list
92592652|NCT00089726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592653|NCT00089726|Immunologic Factors|immunologic factors|mesh-ancestor
92592654|NCT00089726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592655|NCT00089726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592656|NCT00089726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592657|NCT00089726|Alkylating Agents|alkylating agents|mesh-ancestor
92592658|NCT00089726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592659|NCT00089726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592660|NCT00089726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592661|NCT00343096|Lorazepam|lorazepam|mesh-list
92592662|NCT00343096|Anticonvulsants|anticonvulsants|mesh-ancestor
92592663|NCT00343096|Antiemetics|antiemetics|mesh-ancestor
92535768|NCT00078832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535769|NCT00078832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535771|NCT01350128|Ipratropium|ipratropium|mesh-list
92535772|NCT01350128|Anticonvulsants|anticonvulsants|mesh-ancestor
91939109|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
92592664|NCT00343096|Autonomic Agents|autonomic agents|mesh-ancestor
92592665|NCT00343096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592666|NCT00343096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592667|NCT00343096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592668|NCT00343096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92592669|NCT00343096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592670|NCT00343096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92592671|NCT00343096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592672|NCT00343096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592673|NCT00343096|GABA Modulators|gaba modulators|mesh-ancestor
92592674|NCT00343096|GABA Agents|gaba agents|mesh-ancestor
92592675|NCT00343096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592676|NCT00343096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592680|NCT00335179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592681|NCT00335179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592682|NCT00335179|Interferon Inducers|interferon inducers|mesh-ancestor
92592683|NCT00089765|Ranibizumab|ranibizumab|mesh-list
92592684|NCT00089765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92592685|NCT00089765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92592686|NCT00089765|Growth Substances|growth substances|mesh-ancestor
92592687|NCT00089765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592688|NCT00089765|Growth Inhibitors|growth inhibitors|mesh-ancestor
92592689|NCT00089765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592690|NCT00343135|Amoxicillin|amoxicillin|mesh-list
92592691|NCT00343135|Clavulanic Acid|clavulanic acid|mesh-list
92592692|NCT00343135|Clavulanic Acids|clavulanic acids|mesh-list
92592693|NCT00343135|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92592694|NCT00343135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92592695|NCT00343135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592696|NCT00343135|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92592697|NCT00343135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592698|NCT00343135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592699|NCT00343174|Ancrod|ancrod|mesh-list
92592700|NCT00343174|Anticoagulants|anticoagulants|mesh-ancestor
92592701|NCT00343174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92592702|NCT00343174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92592703|NCT00343174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592704|NCT00343369|Cytarabine|cytarabine|mesh-list
92592705|NCT00343369|Dexamethasone|dexamethasone|mesh-list
92592706|NCT00343369|Prednisolone|prednisolone|mesh-list
92592707|NCT00343369|Cyclophosphamide|cyclophosphamide|mesh-list
92592708|NCT00343369|Doxorubicin|doxorubicin|mesh-list
92592709|NCT00343369|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92592710|NCT00343369|Methotrexate|methotrexate|mesh-list
92592711|NCT00343369|Vincristine|vincristine|mesh-list
92592712|NCT00343369|Daunorubicin|daunorubicin|mesh-list
92592713|NCT00343369|Asparaginase|asparaginase|mesh-list
92592714|NCT00343369|Mercaptopurine|mercaptopurine|mesh-list
92592715|NCT00343369|Pegaspargase|pegaspargase|mesh-list
92592716|NCT00343369|Thioguanine|thioguanine|mesh-list
92592717|NCT00343369|Teniposide|teniposide|mesh-list
92592718|NCT00343369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592719|NCT00343369|Immunologic Factors|immunologic factors|mesh-ancestor
92592720|NCT00343369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592721|NCT00343369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592722|NCT00343369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592723|NCT00343369|Alkylating Agents|alkylating agents|mesh-ancestor
92592724|NCT00343369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592725|NCT00343369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592726|NCT00343369|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592727|NCT00343369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592728|NCT00343369|Antiemetics|antiemetics|mesh-ancestor
92592729|NCT00343369|Autonomic Agents|autonomic agents|mesh-ancestor
92592730|NCT00343369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592731|NCT00343369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592732|NCT00343369|Glucocorticoids|glucocorticoids|mesh-ancestor
92535773|NCT01350128|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92535774|NCT01350128|Autonomic Agents|autonomic agents|mesh-ancestor
92535775|NCT01350128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535776|NCT01350128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592733|NCT00343369|Hormones|hormones|mesh-ancestor
92592734|NCT00343369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592735|NCT00343369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592736|NCT00343369|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592737|NCT00343369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92592738|NCT00343369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92592739|NCT00343369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592740|NCT00343369|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92592741|NCT00343369|Abortifacient Agents|abortifacient agents|mesh-ancestor
92592742|NCT00343369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92592743|NCT00343369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592744|NCT00343369|Antimetabolites|antimetabolites|mesh-ancestor
92592745|NCT00343369|Dermatologic Agents|dermatologic agents|mesh-ancestor
92592746|NCT00343369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92592747|NCT00343369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92592748|NCT00343369|Antiviral Agents|antiviral agents|mesh-ancestor
92592749|NCT00343369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592750|NCT00343369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592751|NCT00343369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592757|NCT00343408|Oxaliplatin|oxaliplatin|mesh-list
92592759|NCT00343408|Calcium|calcium|mesh-list
92592760|NCT00343408|Levoleucovorin|levoleucovorin|mesh-list
92592761|NCT00343408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592762|NCT00343408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592763|NCT00343408|Antimetabolites|antimetabolites|mesh-ancestor
92592764|NCT00343408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592765|NCT00343408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92592766|NCT00343408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592767|NCT00343408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592768|NCT00343408|Immunologic Factors|immunologic factors|mesh-ancestor
92592769|NCT00343408|Antidotes|antidotes|mesh-ancestor
92592770|NCT00343408|Protective Agents|protective agents|mesh-ancestor
92592771|NCT00343408|Vitamin B Complex|vitamin b complex|mesh-ancestor
92592772|NCT00343408|Vitamins|vitamins|mesh-ancestor
92592773|NCT00343408|Micronutrients|micronutrients|mesh-ancestor
92592774|NCT00343408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592775|NCT00343408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92592776|NCT02958111|Capecitabine|capecitabine|mesh-list
92592777|NCT02958111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592778|NCT02958111|Antimetabolites|antimetabolites|mesh-ancestor
92592779|NCT02958111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592780|NCT02958111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592781|NCT00343447|Cyclophosphamide|cyclophosphamide|mesh-list
92592782|NCT00343447|Rituximab|rituximab|mesh-list
92592783|NCT00343447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592784|NCT00343447|Immunologic Factors|immunologic factors|mesh-ancestor
92592785|NCT00343447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592786|NCT00343447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592787|NCT00343447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592788|NCT00343447|Alkylating Agents|alkylating agents|mesh-ancestor
92592789|NCT00343447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592790|NCT00343447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592791|NCT00343447|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592792|NCT00343447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592793|NCT00343486|Solabegron|solabegron|mesh-list
92592794|NCT00343486|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92592795|NCT00343486|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92592796|NCT00343486|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92592797|NCT00343486|Adrenergic Agents|adrenergic agents|mesh-ancestor
92592798|NCT00343486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592799|NCT00343486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592800|NCT00343486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592801|NCT00089804|Abetimus|abetimus|mesh-list
92592802|NCT00089804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592803|NCT00089804|Immunologic Factors|immunologic factors|mesh-ancestor
92592804|NCT00089804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535777|NCT01350128|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92535778|NCT01350128|Respiratory System Agents|respiratory system agents|mesh-ancestor
92535779|NCT01350128|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92535780|NCT01350128|Cholinergic Agents|cholinergic agents|mesh-ancestor
92535781|NCT01350128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535782|NCT01350128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592805|NCT00343525|Bavituximab|bavituximab|mesh-list
92592806|NCT00343525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592807|NCT00343525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592808|NCT00127881|Zanolimumab|zanolimumab|mesh-list
92592809|NCT00127881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592810|NCT00127881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592811|NCT00343720|Bortezomib|bortezomib|mesh-list
92592812|NCT00343720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592813|NCT00343759|Lapatinib|lapatinib|mesh-list
92592814|NCT00343759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592815|NCT00343759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92592816|NCT00343759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592817|NCT00343759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592818|NCT00127920|Bevacizumab|bevacizumab|mesh-list
92592819|NCT00127920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592820|NCT00127920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592821|NCT00127920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92592822|NCT00127920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92592823|NCT00127920|Growth Substances|growth substances|mesh-ancestor
92592827|NCT00343798|Mycophenolic Acid|mycophenolic acid|mesh-list
92592828|NCT00343798|Cyclophosphamide|cyclophosphamide|mesh-list
92592829|NCT00343798|Fludarabine|fludarabine|mesh-list
92592830|NCT00343798|Fludarabine phosphate|fludarabine phosphate|mesh-list
92592831|NCT00343798|Cyclosporins|cyclosporins|mesh-list
92592832|NCT00343798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592833|NCT00343798|Immunologic Factors|immunologic factors|mesh-ancestor
92592834|NCT00343798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592835|NCT00343798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592836|NCT00343798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92592837|NCT00343798|Alkylating Agents|alkylating agents|mesh-ancestor
92592838|NCT00343798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592839|NCT00343798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592840|NCT00343798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92592841|NCT00343798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92592842|NCT00343798|Antimetabolites|antimetabolites|mesh-ancestor
92592843|NCT00343798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592844|NCT00343798|Antifungal Agents|antifungal agents|mesh-ancestor
92592845|NCT00343798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592846|NCT00343798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92592847|NCT00343798|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92592848|NCT00343798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592849|NCT00343798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92592850|NCT00343798|Antitubercular Agents|antitubercular agents|mesh-ancestor
92592851|NCT00343798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92592853|NCT00343876|Clopidogrel|clopidogrel|mesh-list
92592854|NCT00343876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92592855|NCT00343876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92592856|NCT00343876|Analgesics|analgesics|mesh-ancestor
92592857|NCT00343876|Sensory System Agents|sensory system agents|mesh-ancestor
92592858|NCT00343876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592859|NCT00343876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592860|NCT00343876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592861|NCT00343876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592862|NCT00343876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92592863|NCT00343876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92592864|NCT00343876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592865|NCT00343876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92592866|NCT00343876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92592867|NCT00343876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592869|NCT00343876|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92592870|NCT00343876|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92592871|NCT00343876|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92535783|NCT00078910|Sulindac sulfone|sulindac sulfone|mesh-list
92535784|NCT00078910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535785|NCT00078910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92592872|NCT00343876|Purinergic Agents|purinergic agents|mesh-ancestor
92592873|NCT00343876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592874|NCT00402636|Sirolimus|sirolimus|mesh-list
92592875|NCT00402636|Temsirolimus|temsirolimus|mesh-list
92592876|NCT00402636|MTOR Inhibitors|mtor inhibitors|mesh-list
92592877|NCT00402636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92592878|NCT00402636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592879|NCT00402636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592880|NCT00402636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592881|NCT00402636|Antifungal Agents|antifungal agents|mesh-ancestor
92592882|NCT00402636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92592883|NCT00402636|Immunologic Factors|immunologic factors|mesh-ancestor
92592884|NCT00402636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592885|NCT00402636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92592886|NCT00402636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592887|NCT00402636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592888|NCT00344149|Rituximab|rituximab|mesh-list
92592889|NCT00344149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592890|NCT00344149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592891|NCT00344149|Immunologic Factors|immunologic factors|mesh-ancestor
92592892|NCT00344149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592893|NCT00344149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592894|NCT00089960|Motesanib diphosphate|motesanib diphosphate|mesh-list
92592895|NCT00089960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92592896|NCT00089960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592897|NCT00089960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592898|NCT00344227|Ranibizumab|ranibizumab|mesh-list
92592899|NCT00344227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92592900|NCT00344227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92592901|NCT00344227|Growth Substances|growth substances|mesh-ancestor
92592902|NCT00344227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592903|NCT00344227|Growth Inhibitors|growth inhibitors|mesh-ancestor
92592904|NCT00344227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592905|NCT00344383|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92592906|NCT00344383|Norgestimate|norgestimate|mesh-list
92592907|NCT00344383|Estradiol|estradiol|mesh-list
92592908|NCT00344383|Estrogens|estrogens|mesh-ancestor
92592909|NCT00344383|Hormones|hormones|mesh-ancestor
92592910|NCT00344383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592911|NCT00344383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592912|NCT00344383|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92592913|NCT00344383|Contraceptive Agents|contraceptive agents|mesh-ancestor
92592914|NCT00344383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92592915|NCT00344383|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92592916|NCT00344383|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92592917|NCT00344383|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92592918|NCT00344383|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92592919|NCT00344422|Dexamethasone|dexamethasone|mesh-list
92592920|NCT00344422|Dexamethasone acetate|dexamethasone acetate|mesh-list
92592921|NCT00344422|Doxorubicin|doxorubicin|mesh-list
92592922|NCT00344422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92592923|NCT00344422|Vincristine|vincristine|mesh-list
92592924|NCT00344422|BB 1101|bb 1101|mesh-list
92592925|NCT00344422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592926|NCT00344422|Antiemetics|antiemetics|mesh-ancestor
92592927|NCT00344422|Autonomic Agents|autonomic agents|mesh-ancestor
92592928|NCT00344422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592929|NCT00344422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592930|NCT00344422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592931|NCT00344422|Glucocorticoids|glucocorticoids|mesh-ancestor
92592932|NCT00344422|Hormones|hormones|mesh-ancestor
92592933|NCT00344422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592934|NCT00344422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592935|NCT00344422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592936|NCT00344422|Protease Inhibitors|protease inhibitors|mesh-ancestor
92592937|NCT00344422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592938|NCT00344422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592939|NCT00344422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92592940|NCT00344422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92592941|NCT00344422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535786|NCT00078910|Protective Agents|protective agents|mesh-ancestor
92535787|NCT00078910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535788|NCT00078910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92535789|NCT00078910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92592942|NCT00344422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592943|NCT00344422|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592944|NCT00344422|Antimitotic Agents|antimitotic agents|mesh-ancestor
92592945|NCT00344422|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592946|NCT00090038|Rituximab|rituximab|mesh-list
92592947|NCT00090038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92592948|NCT00090038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592949|NCT00090038|Immunologic Factors|immunologic factors|mesh-ancestor
92592950|NCT00090038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592951|NCT00090038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592952|NCT00402792|Acetaminophen|acetaminophen|mesh-list
92592953|NCT00402792|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92592954|NCT00402792|Hydrocodone|hydrocodone|mesh-list
92592955|NCT00402792|Oxycodone|oxycodone|mesh-list
92592956|NCT00402792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92592957|NCT00402792|Analgesics|analgesics|mesh-ancestor
92592958|NCT00402792|Sensory System Agents|sensory system agents|mesh-ancestor
92592959|NCT00402792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592960|NCT00402792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592961|NCT00402792|Antipyretics|antipyretics|mesh-ancestor
92592962|NCT00402792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92592963|NCT00402792|Narcotics|narcotics|mesh-ancestor
92592964|NCT00402792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92592965|NCT00402792|Antitussive Agents|antitussive agents|mesh-ancestor
92592966|NCT00402792|Respiratory System Agents|respiratory system agents|mesh-ancestor
92592967|NCT00402792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92592968|NCT00402792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92592969|NCT00402792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92592970|NCT00127959|Tenofovir|tenofovir|mesh-list
92592971|NCT00127959|Emtricitabine|emtricitabine|mesh-list
92592972|NCT00127959|Zidovudine|zidovudine|mesh-list
92592973|NCT00127959|Efavirenz|efavirenz|mesh-list
92592976|NCT00127959|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92592977|NCT00127959|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92592979|NCT00127959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592980|NCT00127959|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92592981|NCT00127959|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92592982|NCT00127959|Antimetabolites|antimetabolites|mesh-ancestor
92592983|NCT00127959|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92592984|NCT00127959|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92592985|NCT00127959|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92592986|NCT00127959|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92592987|NCT00127959|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92592988|NCT00127959|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92592989|NCT00344539|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92592990|NCT00344539|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92592991|NCT00344539|Immunologic Factors|immunologic factors|mesh-ancestor
92592992|NCT00344539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592993|NCT00344539|Antacids|antacids|mesh-ancestor
92592994|NCT00344539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592995|NCT00344539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592996|NCT04715503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92592997|NCT04715503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92592998|NCT04715503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592999|NCT00344617|Bevacizumab|bevacizumab|mesh-list
92593000|NCT00344617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593001|NCT00344617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593002|NCT00344617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92593003|NCT00344617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92593004|NCT00344617|Growth Substances|growth substances|mesh-ancestor
92593005|NCT00344617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593006|NCT00344617|Growth Inhibitors|growth inhibitors|mesh-ancestor
92593007|NCT00127998|Artesunate|artesunate|mesh-list
92593008|NCT00127998|Lumefantrine|lumefantrine|mesh-list
92593009|NCT00127998|Chloroquine|chloroquine|mesh-list
92593010|NCT00127998|Artemether|artemether|mesh-list
92593011|NCT00127998|Pyrimethamine|pyrimethamine|mesh-list
92317887|NCT02157948|Denosumab|denosumab|mesh-list
92535790|NCT00078910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535791|NCT00078910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92535792|NCT00078910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92535793|NCT00078910|Analgesics|analgesics|mesh-ancestor
92535794|NCT00078910|Sensory System Agents|sensory system agents|mesh-ancestor
91939420|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
92593012|NCT00127998|Sulfadoxine|sulfadoxine|mesh-list
92593013|NCT00127998|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92593014|NCT00127998|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92593015|NCT00127998|Amodiaquine|amodiaquine|mesh-list
92593016|NCT00127998|Mefloquine|mefloquine|mesh-list
92593017|NCT00127998|Antimalarials|antimalarials|mesh-ancestor
92593018|NCT00127998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92593019|NCT00127998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92593020|NCT00127998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593021|NCT00127998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593022|NCT00127998|Antiviral Agents|antiviral agents|mesh-ancestor
92593023|NCT00127998|Schistosomicides|schistosomicides|mesh-ancestor
92593024|NCT00127998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92593025|NCT00127998|Anthelmintics|anthelmintics|mesh-ancestor
92593026|NCT00127998|Amebicides|amebicides|mesh-ancestor
92593027|NCT00127998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593028|NCT00127998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92593029|NCT00127998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593030|NCT00127998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593031|NCT00127998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92593032|NCT00420589|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92593033|NCT00420589|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92593034|NCT00420589|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92593035|NCT00420589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593036|NCT00420589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593037|NCT00420589|Hormones|hormones|mesh-ancestor
92593038|NCT00420589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92593039|NCT00420589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593040|NCT00344695|Bupropion|bupropion|mesh-list
92593041|NCT00344695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92593042|NCT00344695|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593047|NCT00344695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593048|NCT00344695|Dopamine Agents|dopamine agents|mesh-ancestor
92593049|NCT00344695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593050|NCT00344695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593051|NCT00344695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92593052|NCT00344695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92593053|NCT00344695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593054|NCT00128037|Mitomycins|mitomycins|mesh-list
92593055|NCT00128037|Mitomycin|mitomycin|mesh-list
92593056|NCT00128037|Vindesine|vindesine|mesh-list
92360358|NCT03531918|Immunologic Factors|immunologic factors|mesh-ancestor
92593057|NCT00128037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593058|NCT00128037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92593059|NCT00128037|Alkylating Agents|alkylating agents|mesh-ancestor
92593060|NCT00128037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593061|NCT00128037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593062|NCT00128037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593063|NCT00128037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92593064|NCT00128037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92593065|NCT00128037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92593066|NCT00128037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92593067|NCT00344734|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92593068|NCT00344734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593069|NCT00344734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593070|NCT00344812|Buprenorphine|buprenorphine|mesh-list
92593071|NCT00344812|Methadone|methadone|mesh-list
92593072|NCT00344812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92593073|NCT00344812|Narcotics|narcotics|mesh-ancestor
92593074|NCT00344812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535795|NCT00078910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939486|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
92593075|NCT00344812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593076|NCT00344812|Analgesics|analgesics|mesh-ancestor
92593077|NCT00344812|Sensory System Agents|sensory system agents|mesh-ancestor
92593078|NCT00344812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593079|NCT00344812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92593080|NCT00344812|Antitussive Agents|antitussive agents|mesh-ancestor
92593081|NCT00344812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92593082|NCT00344851|Metformin|metformin|mesh-list
92317948|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593083|NCT00344851|Exenatide|exenatide|mesh-list
92593084|NCT00344851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92593085|NCT00344851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593086|NCT00344851|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92593087|NCT00344851|Incretins|incretins|mesh-ancestor
92593089|NCT00344851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92593090|NCT00090155|Ondansetron|ondansetron|mesh-list
92593091|NCT00090155|Aprepitant|aprepitant|mesh-list
92593092|NCT00090155|Antiemetics|antiemetics|mesh-ancestor
92593093|NCT00090155|Autonomic Agents|autonomic agents|mesh-ancestor
92593094|NCT00090155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593095|NCT00090155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593096|NCT00090155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593097|NCT00090155|Antipruritics|antipruritics|mesh-ancestor
92593098|NCT00090155|Dermatologic Agents|dermatologic agents|mesh-ancestor
92593099|NCT00090155|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92593100|NCT00090155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92593101|NCT00090155|Serotonin Agents|serotonin agents|mesh-ancestor
92593102|NCT00090155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593103|NCT00090155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593104|NCT00090155|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92593105|NCT00335413|Spironolactone|spironolactone|mesh-list
92593106|NCT00335413|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92593107|NCT00335413|Hormone Antagonists|hormone antagonists|mesh-ancestor
92593108|NCT00335413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92593109|NCT00335413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593110|NCT00335413|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92593111|NCT00335413|Diuretics|diuretics|mesh-ancestor
92593112|NCT00335413|Natriuretic Agents|natriuretic agents|mesh-ancestor
92593116|NCT00090194|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92593117|NCT00090194|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92593118|NCT00090194|Immunologic Factors|immunologic factors|mesh-ancestor
92593119|NCT00090194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593120|NCT00345163|Bevacizumab|bevacizumab|mesh-list
92593122|NCT00345163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593123|NCT00345163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593124|NCT00345163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92593125|NCT00345163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92593126|NCT00345163|Growth Substances|growth substances|mesh-ancestor
92593127|NCT00345163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593128|NCT00345163|Growth Inhibitors|growth inhibitors|mesh-ancestor
92593129|NCT00345163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92593130|NCT00345163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92593131|NCT00345163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360360|NCT03531918|Analgesics|analgesics|mesh-ancestor
92593132|NCT00345163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593133|NCT00345202|Atorvastatin|atorvastatin|mesh-list
92593134|NCT00345202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92593135|NCT00345202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92593136|NCT00345202|Antimetabolites|antimetabolites|mesh-ancestor
92593137|NCT00345202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593138|NCT00345202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92593139|NCT00345202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92593140|NCT00345202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593141|NCT00335647|Fluphenazine|fluphenazine|mesh-list
92593142|NCT00335647|Fluphenazine depot|fluphenazine depot|mesh-list
92593143|NCT00335647|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92593144|NCT00335647|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92593145|NCT00335647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593146|NCT00335647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593147|NCT00335647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593148|NCT00335647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92535796|NCT00078910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535797|NCT00078910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535798|NCT00078988|Carboplatin|carboplatin|mesh-list
92535799|NCT00078988|Etoposide|etoposide|mesh-list
92593149|NCT00335647|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92593150|NCT00335647|Dopamine Agents|dopamine agents|mesh-ancestor
92593151|NCT00335647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593152|NCT00335647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593153|NCT00128154|Chromium|chromium|mesh-list
92593154|NCT00128154|Picolinic acid|picolinic acid|mesh-list
92593155|NCT00128154|Trace Elements|trace elements|mesh-ancestor
92593156|NCT00128154|Micronutrients|micronutrients|mesh-ancestor
92593157|NCT00128154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593158|NCT00128154|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92593159|NCT00128154|Chelating Agents|chelating agents|mesh-ancestor
92593160|NCT00128154|Sequestering Agents|sequestering agents|mesh-ancestor
92593161|NCT00128154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593162|NCT00335686|Lopinavir|lopinavir|mesh-list
92593163|NCT00335686|Nevirapine|nevirapine|mesh-list
92593164|NCT00335686|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92593165|NCT00335686|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92593166|NCT00335686|Protease Inhibitors|protease inhibitors|mesh-ancestor
92593167|NCT00335686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593168|NCT00335686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593169|NCT00335686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92593170|NCT00335686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92593171|NCT00335686|Antiviral Agents|antiviral agents|mesh-ancestor
92593172|NCT00335686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593173|NCT00335686|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92593174|NCT00335686|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92593175|NCT00335686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92593176|NCT00335686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593177|NCT00335686|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92593178|NCT00335686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92593179|NCT00128232|Octreotide|octreotide|mesh-list
92593180|NCT00128232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593181|NCT00128232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92593182|NCT00128232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593183|NCT04708249|Inositol|inositol|mesh-list
92593184|NCT04708249|Vitamin B Complex|vitamin b complex|mesh-ancestor
92593185|NCT04708249|Vitamins|vitamins|mesh-ancestor
92593188|NCT00090272|Ertapenem|ertapenem|mesh-list
92593189|NCT00090272|Cefotetan|cefotetan|mesh-list
92593190|NCT00090272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593191|NCT00090272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593192|NCT00345787|Buprenorphine|buprenorphine|mesh-list
92593193|NCT00345787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92593194|NCT00345787|Narcotics|narcotics|mesh-ancestor
92593195|NCT00345787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593196|NCT00345787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593197|NCT00345787|Analgesics|analgesics|mesh-ancestor
92593198|NCT00345787|Sensory System Agents|sensory system agents|mesh-ancestor
92593199|NCT00345787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593200|NCT00345787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92593201|NCT00128271|Bavituximab|bavituximab|mesh-list
92593202|NCT00128271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593203|NCT00128271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593204|NCT00090311|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92593205|NCT00090311|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593206|NCT00090311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593207|NCT00090311|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92593208|NCT00090311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593209|NCT00090311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593210|NCT00090311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593211|NCT02959762|Vitamins|vitamins|mesh-list
92593212|NCT02959762|Vitamin K|vitamin k|mesh-list
92593213|NCT02959762|Vitamin K 2|vitamin k 2|mesh-list
92593214|NCT02959762|Menaquinone 7|menaquinone 7|mesh-list
92593215|NCT02959762|Micronutrients|micronutrients|mesh-ancestor
92593216|NCT02959762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593217|NCT02959762|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92593218|NCT02959762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92593219|NCT02959762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593220|NCT02959762|Hemostatics|hemostatics|mesh-ancestor
92593221|NCT02959762|Coagulants|coagulants|mesh-ancestor
92535800|NCT00078988|Thiotepa|thiotepa|mesh-list
92535801|NCT00078988|Isotretinoin|isotretinoin|mesh-list
92535802|NCT00078988|Lenograstim|lenograstim|mesh-list
92535803|NCT00078988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535804|NCT00078988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92535805|NCT00078988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92593222|NCT00345826|Dasatinib|dasatinib|mesh-list
92593223|NCT00345826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593224|NCT00345826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92593225|NCT00345826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593226|NCT00345826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593227|NCT00345982|Sertindole|sertindole|mesh-list
92593228|NCT00345982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92593229|NCT00345982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593230|NCT00345982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593231|NCT00345982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593232|NCT00345982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593233|NCT00346099|Capecitabine|capecitabine|mesh-list
92593234|NCT00346099|Oxaliplatin|oxaliplatin|mesh-list
92593235|NCT00346099|Panitumumab|panitumumab|mesh-list
92593236|NCT00346099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92593237|NCT00346099|Antimetabolites|antimetabolites|mesh-ancestor
92593238|NCT00346099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593239|NCT00346099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593240|NCT00346099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593242|NCT00125736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92593243|NCT00125736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593244|NCT00125736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92593245|NCT00125736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593246|NCT00125736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593247|NCT00090428|Caseins|caseins|mesh-list
92593248|NCT00090428|Chelating Agents|chelating agents|mesh-ancestor
92593249|NCT00090428|Sequestering Agents|sequestering agents|mesh-ancestor
92593250|NCT00090428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593251|NCT00346255|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
92593252|NCT00346255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593253|NCT00346255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593254|NCT00346255|Immunotoxins|immunotoxins|mesh-ancestor
92593255|NCT00346255|Immunoconjugates|immunoconjugates|mesh-ancestor
92593256|NCT00346255|Immunologic Factors|immunologic factors|mesh-ancestor
92593257|NCT00346255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593258|NCT00346255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92593259|NCT00346294|Etanercept|etanercept|mesh-list
92593260|NCT00346294|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92593261|NCT00346294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593273|NCT00346489|Mitomycin|mitomycin|mesh-list
92593274|NCT00346489|Antimetabolites|antimetabolites|mesh-ancestor
92593275|NCT00346489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593276|NCT00346489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92593277|NCT00346489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593278|NCT00346489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593279|NCT00346489|Immunologic Factors|immunologic factors|mesh-ancestor
92593280|NCT00346489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593281|NCT00346489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92593282|NCT00346489|Alkylating Agents|alkylating agents|mesh-ancestor
92593283|NCT00346489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593284|NCT00346489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593285|NCT00125814|Interferons|interferons|mesh-list
92593286|NCT00125814|Interferon-alpha|interferon-alpha|mesh-list
92593287|NCT00125814|Interferon alpha-2|interferon alpha-2|mesh-list
92593288|NCT00125814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593289|NCT00125814|Antiviral Agents|antiviral agents|mesh-ancestor
92593290|NCT00125814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593291|NCT00125814|Immunologic Factors|immunologic factors|mesh-ancestor
92593292|NCT00125814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593293|NCT00346567|Tenofovir|tenofovir|mesh-list
92593294|NCT00346567|Lamivudine|lamivudine|mesh-list
92593295|NCT00346567|Emtricitabine|emtricitabine|mesh-list
92593296|NCT00346567|Zidovudine|zidovudine|mesh-list
92593297|NCT00346567|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92535806|NCT00078988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535807|NCT00078988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535808|NCT00078988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535809|NCT00078988|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92535810|NCT00078988|Immunologic Factors|immunologic factors|mesh-ancestor
92593298|NCT00346567|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92593299|NCT00346567|Antiviral Agents|antiviral agents|mesh-ancestor
92593300|NCT00346567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593301|NCT00346567|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92593302|NCT00346567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593303|NCT00346567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593304|NCT00346567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593305|NCT00346567|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92593306|NCT00346567|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92593307|NCT00346567|Antimetabolites|antimetabolites|mesh-ancestor
92593308|NCT00090623|Ranibizumab|ranibizumab|mesh-list
92593309|NCT00090623|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92593310|NCT00090623|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92593311|NCT00090623|Growth Substances|growth substances|mesh-ancestor
92593312|NCT00090623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593313|NCT00090623|Growth Inhibitors|growth inhibitors|mesh-ancestor
92593314|NCT00090623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593315|NCT02957994|Tenofovir|tenofovir|mesh-list
92593316|NCT02957994|Antiviral Agents|antiviral agents|mesh-ancestor
92593317|NCT02957994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593318|NCT02957994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92593319|NCT02957994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593320|NCT02957994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593321|NCT02957994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593322|NCT02957994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92593323|NCT02957994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92593324|NCT00346645|Bortezomib|bortezomib|mesh-list
92593325|NCT00346645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593326|NCT00346684|Rituximab|rituximab|mesh-list
92000561|NCT05342844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92593328|NCT00346684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593329|NCT00346684|Immunologic Factors|immunologic factors|mesh-ancestor
92593330|NCT00346684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593331|NCT00346684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593333|NCT04728932|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92593334|NCT04728932|Vasodilator Agents|vasodilator agents|mesh-ancestor
92593335|NCT04728932|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92593336|NCT04728932|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92593337|NCT04728932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593338|NCT04728932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593339|NCT04728932|Protective Agents|protective agents|mesh-ancestor
92593340|NCT04728932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593341|NCT00125892|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92593342|NCT00125892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92593343|NCT00125892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92593344|NCT00125892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92593345|NCT00125892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593346|NCT00125892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593347|NCT00125892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593348|NCT00125892|Analgesics|analgesics|mesh-ancestor
92593349|NCT00125892|Sensory System Agents|sensory system agents|mesh-ancestor
92593350|NCT00125892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593351|NCT00125892|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593352|NCT00125892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593353|NCT00125892|Dopamine Agents|dopamine agents|mesh-ancestor
92593354|NCT00346801|Celecoxib|celecoxib|mesh-list
92593355|NCT00346801|Cisplatin|cisplatin|mesh-list
92593356|NCT00346801|Irinotecan|irinotecan|mesh-list
92593357|NCT00346801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593358|NCT00346801|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92593359|NCT00346801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92593360|NCT00346801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593361|NCT00346801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535811|NCT00078988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535812|NCT00078988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92593362|NCT00346801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92593363|NCT00346801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593364|NCT00346801|Analgesics|analgesics|mesh-ancestor
92593365|NCT00346801|Sensory System Agents|sensory system agents|mesh-ancestor
92593366|NCT00346801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593367|NCT00346801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593368|NCT00346801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92593369|NCT00346801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593370|NCT00346801|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92593371|NCT00346801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92593372|NCT00346840|Misoprostol|misoprostol|mesh-list
92593373|NCT00346840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92593374|NCT00346840|Abortifacient Agents|abortifacient agents|mesh-ancestor
92593375|NCT00346840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92593376|NCT00346840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593377|NCT00346840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92593378|NCT00346840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593379|NCT00346840|Oxytocics|oxytocics|mesh-ancestor
92593380|NCT00346879|PENTA|penta|mesh-list
92593381|NCT00346879|Fondaparinux|fondaparinux|mesh-list
92593382|NCT00346879|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92593383|NCT00346879|Antithrombins|antithrombins|mesh-ancestor
92593384|NCT00346879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92593385|NCT00346879|Protease Inhibitors|protease inhibitors|mesh-ancestor
92593386|NCT00346879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593387|NCT00346879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593388|NCT00346879|Anticoagulants|anticoagulants|mesh-ancestor
92593389|NCT00346879|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92593390|NCT00346879|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92593391|NCT00126009|Amisulpride|amisulpride|mesh-list
92593392|NCT00126009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92593393|NCT00126009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593394|NCT00126009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593395|NCT00126009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593396|NCT00126009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593397|NCT00126009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92593398|NCT00126009|Dopamine Agents|dopamine agents|mesh-ancestor
92593399|NCT00126009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593410|NCT00346918|Immunologic Factors|immunologic factors|mesh-ancestor
92593411|NCT00346918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593412|NCT00346957|Hydrocortisone|hydrocortisone|mesh-list
92593413|NCT00346957|Anecortave|anecortave|mesh-list
92593414|NCT00346957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92593415|NCT00346957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92593416|NCT00346957|Growth Substances|growth substances|mesh-ancestor
92593417|NCT00346957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593418|NCT00346957|Growth Inhibitors|growth inhibitors|mesh-ancestor
92593419|NCT00346957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593420|NCT00346957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92593421|NCT00346996|Insulin|insulin|mesh-list
92593422|NCT00346996|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92593423|NCT00346996|Insulin Detemir|insulin detemir|mesh-list
92593424|NCT00346996|Isophane Insulin, Human|isophane insulin, human|mesh-list
92593425|NCT00346996|Insulin, Isophane|insulin, isophane|mesh-list
92593426|NCT00346996|Isophane insulin, beef|isophane insulin, beef|mesh-list
92593427|NCT00346996|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92593428|NCT00346996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593429|NCT00402480|Hydroxyurea|hydroxyurea|mesh-list
92593430|NCT00402480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593431|NCT00402480|Antisickling Agents|antisickling agents|mesh-ancestor
92593432|NCT00402480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360368|NCT03531918|Immunotoxins|immunotoxins|mesh-ancestor
92593433|NCT00402480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593434|NCT00402480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593435|NCT00347035|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92593436|NCT00347035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92593437|NCT00347035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92593438|NCT00347035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92593439|NCT00347035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92593440|NCT00347035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92593441|NCT00347035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535814|NCT00078988|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535815|NCT00078988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535816|NCT00078988|Dermatologic Agents|dermatologic agents|mesh-ancestor
92535817|NCT00079027|Doxorubicin|doxorubicin|mesh-list
92535818|NCT00079027|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92593442|NCT00347035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593443|NCT00347035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593444|NCT00347113|Albendazole|albendazole|mesh-list
92593445|NCT00347113|Praziquantel|praziquantel|mesh-list
92593446|NCT00347113|Anthelmintics|anthelmintics|mesh-ancestor
92593447|NCT00347113|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92593448|NCT00347113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593449|NCT00347113|Anticestodal Agents|anticestodal agents|mesh-ancestor
92593450|NCT00347113|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92593451|NCT00347113|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92593452|NCT00347113|Tubulin Modulators|tubulin modulators|mesh-ancestor
92593453|NCT00347113|Antimitotic Agents|antimitotic agents|mesh-ancestor
92593454|NCT00347113|Mitosis Modulators|mitosis modulators|mesh-ancestor
92593455|NCT00347113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593456|NCT00347113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593457|NCT00347152|Valproic Acid|valproic acid|mesh-list
92593458|NCT00347152|Anticonvulsants|anticonvulsants|mesh-ancestor
92593459|NCT00347152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593460|NCT00347152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593461|NCT00347152|GABA Agents|gaba agents|mesh-ancestor
92318310|NCT03581084|Acetylcysteine|acetylcysteine|mesh-list
92593463|NCT00347152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593464|NCT00347152|Antimanic Agents|antimanic agents|mesh-ancestor
92593476|NCT00090896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593477|NCT00402558|Aldesleukin|aldesleukin|mesh-list
92593478|NCT00402558|Methotrexate|methotrexate|mesh-list
92593479|NCT00402558|Fludarabine phosphate|fludarabine phosphate|mesh-list
92593480|NCT00402558|Fludarabine|fludarabine|mesh-list
92593481|NCT00402558|Busulfan|busulfan|mesh-list
92593482|NCT00402558|Interleukin-2|interleukin-2|mesh-list
92593483|NCT00402558|Tacrolimus|tacrolimus|mesh-list
92593484|NCT00402558|Thymoglobulin|thymoglobulin|mesh-list
92593485|NCT00402558|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92593486|NCT00402558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92593487|NCT00402558|Abortifacient Agents|abortifacient agents|mesh-ancestor
92593488|NCT00402558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92593489|NCT00402558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593490|NCT00402558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92593491|NCT00402558|Antimetabolites|antimetabolites|mesh-ancestor
92593492|NCT00402558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593493|NCT00402558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593494|NCT00402558|Dermatologic Agents|dermatologic agents|mesh-ancestor
92593495|NCT00402558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593496|NCT00402558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92593497|NCT00402558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593498|NCT00402558|Immunologic Factors|immunologic factors|mesh-ancestor
92593499|NCT00402558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593500|NCT00402558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92593501|NCT00402558|Antiviral Agents|antiviral agents|mesh-ancestor
92593502|NCT00402558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593503|NCT00402558|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92593504|NCT00402558|Alkylating Agents|alkylating agents|mesh-ancestor
92593505|NCT00402558|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92593506|NCT00402558|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92593507|NCT00402558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593508|NCT00402558|Analgesics|analgesics|mesh-ancestor
92593509|NCT00402558|Sensory System Agents|sensory system agents|mesh-ancestor
92593510|NCT00402558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593511|NCT00402558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92593512|NCT00402558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92593513|NCT00347386|Zinc Sulfate|zinc sulfate|mesh-list
92593514|NCT00347386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593515|NCT00347386|Astringents|astringents|mesh-ancestor
92593516|NCT00347386|Dermatologic Agents|dermatologic agents|mesh-ancestor
92593517|NCT00347425|Olanzapine|olanzapine|mesh-list
92593518|NCT00347425|Risperidone|risperidone|mesh-list
92593519|NCT00347425|Aripiprazole|aripiprazole|mesh-list
92593520|NCT00347425|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92593521|NCT00347425|Ziprasidone|ziprasidone|mesh-list
92535819|NCT00079027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92535820|NCT00079027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535821|NCT00079027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91939862|NCT04215848|Budesonide|budesonide|mesh-list
92593522|NCT00347425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92593523|NCT00347425|Serotonin Agents|serotonin agents|mesh-ancestor
92593524|NCT00347425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593525|NCT00347425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593526|NCT00347425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593527|NCT00347425|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92593528|NCT00347425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593529|NCT00347425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593530|NCT00347425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593533|NCT00347425|Antiemetics|antiemetics|mesh-ancestor
92593534|NCT00347425|Autonomic Agents|autonomic agents|mesh-ancestor
92593535|NCT00347425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593536|NCT00347425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593537|NCT00347425|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92593538|NCT00347425|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92593539|NCT00347425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92593540|NCT00347425|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593541|NCT00347425|Dopamine Agonists|dopamine agonists|mesh-ancestor
92593542|NCT00347425|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92593543|NCT00347425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92593544|NCT00347425|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92593545|NCT00347425|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92593546|NCT00126048|Atorvastatin|atorvastatin|mesh-list
92593547|NCT00126048|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92593548|NCT00126048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92593549|NCT00126048|Antimetabolites|antimetabolites|mesh-ancestor
92593550|NCT00126048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593551|NCT00126048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92593552|NCT00126048|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92593553|NCT00126048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593554|NCT00126087|Dopamine|dopamine|mesh-list
92593555|NCT00126087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92593556|NCT00126087|Sympathomimetics|sympathomimetics|mesh-ancestor
92593557|NCT00126087|Autonomic Agents|autonomic agents|mesh-ancestor
92593558|NCT00126087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593559|NCT00126087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593560|NCT00126087|Dopamine Agents|dopamine agents|mesh-ancestor
92593561|NCT00126087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593562|NCT00126087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593563|NCT00126087|Protective Agents|protective agents|mesh-ancestor
92593564|NCT00347503|Ketorolac|ketorolac|mesh-list
92593565|NCT00347503|Bromfenac|bromfenac|mesh-list
92593566|NCT00347503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92593567|NCT00347503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593568|NCT00347503|Analgesics|analgesics|mesh-ancestor
92593569|NCT00347503|Sensory System Agents|sensory system agents|mesh-ancestor
92593570|NCT00347503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593571|NCT00347503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593572|NCT00347503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92593573|NCT00347503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593574|NCT00347503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92593575|NCT00347503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593576|NCT00347503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593577|NCT00347542|Vitamin D|vitamin d|mesh-list
92593578|NCT00347542|Vitamins|vitamins|mesh-ancestor
92593579|NCT00347542|Micronutrients|micronutrients|mesh-ancestor
92593580|NCT00347542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593581|NCT00347542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92593582|NCT00091052|Sargramostim|sargramostim|mesh-list
92593583|NCT00091052|Immunologic Factors|immunologic factors|mesh-ancestor
92360374|NCT03520686|Paclitaxel|paclitaxel|mesh-list
92593584|NCT00091052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593585|NCT00347581|Methamphetamine|methamphetamine|mesh-list
92593586|NCT00347581|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92593587|NCT00347581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593588|NCT00347581|Sympathomimetics|sympathomimetics|mesh-ancestor
92593589|NCT00347581|Autonomic Agents|autonomic agents|mesh-ancestor
92593591|NCT00347581|Dopamine Agents|dopamine agents|mesh-ancestor
92593592|NCT00347581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593593|NCT00347581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593594|NCT00347581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92593595|NCT00347581|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92593596|NCT00347581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92593597|NCT00347581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92593598|NCT00347581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92593599|NCT00421252|Clopidogrel|clopidogrel|mesh-list
92593600|NCT00421252|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92593601|NCT00421252|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92593606|NCT00421252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593607|NCT00421252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593609|NCT00126204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593610|NCT00126204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593611|NCT00126204|Antimalarials|antimalarials|mesh-ancestor
92593612|NCT00126204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92593613|NCT00126204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92593614|NCT04705402|Mannitol|mannitol|mesh-list
92593615|NCT04705402|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92593616|NCT04705402|Diuretics|diuretics|mesh-ancestor
92593617|NCT04705402|Natriuretic Agents|natriuretic agents|mesh-ancestor
92593618|NCT04705402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593619|NCT00091130|Vaccines|vaccines|mesh-list
92593620|NCT00091130|Immunologic Factors|immunologic factors|mesh-ancestor
92593621|NCT00091130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593622|NCT00126243|Rituximab|rituximab|mesh-list
92593623|NCT00126243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593624|NCT00126243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593625|NCT00126243|Immunologic Factors|immunologic factors|mesh-ancestor
92593626|NCT00126243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593627|NCT00126243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593628|NCT00426439|Lumefantrine|lumefantrine|mesh-list
92593629|NCT00426439|Chloroquine|chloroquine|mesh-list
92593630|NCT00426439|Artemether|artemether|mesh-list
92593631|NCT00426439|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92593632|NCT00426439|Antimalarials|antimalarials|mesh-ancestor
92593633|NCT00426439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92593634|NCT00426439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92593635|NCT00426439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593636|NCT00426439|Amebicides|amebicides|mesh-ancestor
92593637|NCT00426439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593638|NCT00426478|Amlodipine|amlodipine|mesh-list
92593639|NCT00426478|Valsartan|valsartan|mesh-list
92593640|NCT00426478|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92593641|NCT00426478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92593642|NCT00426478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92593643|NCT00426478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92593644|NCT00426478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593645|NCT00426478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92593646|NCT00426478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593647|NCT00426478|Vasodilator Agents|vasodilator agents|mesh-ancestor
92593648|NCT00426478|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92593649|NCT00426478|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92593650|NCT00426478|Diuretics|diuretics|mesh-ancestor
92593651|NCT00426478|Natriuretic Agents|natriuretic agents|mesh-ancestor
92593652|NCT00426478|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92593653|NCT04705519|Paclitaxel|paclitaxel|mesh-list
92593654|NCT04705519|Bevacizumab|bevacizumab|mesh-list
92593655|NCT04705519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92593656|NCT04705519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593657|NCT04705519|Tubulin Modulators|tubulin modulators|mesh-ancestor
92593658|NCT04705519|Antimitotic Agents|antimitotic agents|mesh-ancestor
92593659|NCT04705519|Mitosis Modulators|mitosis modulators|mesh-ancestor
92593660|NCT04705519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593661|NCT04705519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593662|NCT04705519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92593663|NCT04705519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92593664|NCT04705519|Growth Substances|growth substances|mesh-ancestor
92593665|NCT04705519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593666|NCT04705519|Growth Inhibitors|growth inhibitors|mesh-ancestor
92593667|NCT00126282|Cycloserine|cycloserine|mesh-list
92535822|NCT00079027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91939974|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593668|NCT00126282|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92593669|NCT00126282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593670|NCT00126282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92593671|NCT00126282|Antitubercular Agents|antitubercular agents|mesh-ancestor
92593672|NCT00126282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593677|NCT04705129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593679|NCT04705129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92593680|NCT04705129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593681|NCT04705129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593682|NCT00126321|Cladribine|cladribine|mesh-list
92593683|NCT00126321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593684|NCT00126321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593685|NCT00126321|Immunologic Factors|immunologic factors|mesh-ancestor
92593686|NCT00126321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593687|NCT00426595|Omeprazole|omeprazole|mesh-list
92593688|NCT00426595|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92593689|NCT00426595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593690|NCT00426595|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92593691|NCT00426595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593692|NCT00426595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593693|NCT00426673|Brivaracetam|brivaracetam|mesh-list
92593694|NCT00426673|Anticonvulsants|anticonvulsants|mesh-ancestor
92593695|NCT00426712|1018 oligonucleotide|1018 oligonucleotide|mesh-list
92593696|NCT00426712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92593697|NCT00426712|Immunologic Factors|immunologic factors|mesh-ancestor
92593698|NCT00426712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593699|NCT00091247|Tetracycline|tetracycline|mesh-list
92593700|NCT00091247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593701|NCT00091247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593702|NCT00091247|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92593703|NCT00091247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593704|NCT00091247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593705|NCT00126360|Anastrozole|anastrozole|mesh-list
92593706|NCT00126360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92593707|NCT00126360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593708|NCT00126360|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92593709|NCT00126360|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92593710|NCT00126360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593711|NCT00126360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593712|NCT00126360|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92593713|NCT00126360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92593714|NCT00126360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92593715|NCT00126360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593716|NCT01058863|Albuterol|albuterol|mesh-list
92593717|NCT01058863|Procaterol|procaterol|mesh-list
92593718|NCT01058863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92593719|NCT01058863|Autonomic Agents|autonomic agents|mesh-ancestor
92593720|NCT01058863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593721|NCT01058863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593722|NCT01058863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92593723|NCT01058863|Respiratory System Agents|respiratory system agents|mesh-ancestor
92593724|NCT01058863|Tocolytic Agents|tocolytic agents|mesh-ancestor
92593725|NCT01058863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92593726|NCT01058863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92593727|NCT01058863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92593728|NCT01058863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92593729|NCT01058863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92593730|NCT01058863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593731|NCT01058863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593732|NCT01058863|Sympathomimetics|sympathomimetics|mesh-ancestor
92593733|NCT00091286|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92593734|NCT00091286|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92593735|NCT00091286|Immunologic Factors|immunologic factors|mesh-ancestor
92593736|NCT00091286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593737|NCT00126399|Doxycycline|doxycycline|mesh-list
92593738|NCT00126399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593739|NCT00126399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593740|NCT00126399|Antimalarials|antimalarials|mesh-ancestor
92535824|NCT00079027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593741|NCT00126399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92001003|NCT05050084|Fertility Agents|fertility agents|mesh-ancestor
92593760|NCT00126516|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92593761|NCT00126516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593763|NCT00126516|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92593764|NCT00126516|Protease Inhibitors|protease inhibitors|mesh-ancestor
92593765|NCT00091520|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92593766|NCT00091520|Natriuretic Agents|natriuretic agents|mesh-ancestor
92593767|NCT00091520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593768|NCT04050462|Nivolumab|nivolumab|mesh-list
92593769|NCT04050462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593770|NCT04050462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593771|NCT04050462|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92593772|NCT04050462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593773|NCT04710888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92593774|NCT01058005|Interferons|interferons|mesh-list
92593775|NCT01058005|Interferon-beta|interferon-beta|mesh-list
92593776|NCT01058005|Interferon beta-1a|interferon beta-1a|mesh-list
92593777|NCT01058005|Glatiramer Acetate|glatiramer acetate|mesh-list
92593778|NCT01058005|Natalizumab|natalizumab|mesh-list
92593779|NCT01058005|(T,G)-A-L|(t,g)-a-l|mesh-list
92593780|NCT01058005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593781|NCT01058005|Antiviral Agents|antiviral agents|mesh-ancestor
92593782|NCT01058005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593783|NCT01058005|Immunologic Factors|immunologic factors|mesh-ancestor
92593784|NCT01058005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593785|NCT01058005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92593786|NCT01058005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593787|NCT01058005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593788|NCT00091559|Vorinostat|vorinostat|mesh-list
92593789|NCT00091559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593790|NCT00091559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92593791|NCT00091559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593792|NCT00091559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593793|NCT00426829|Bevacizumab|bevacizumab|mesh-list
92593794|NCT00426829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593795|NCT00426829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593796|NCT00426829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92593797|NCT00426829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92593798|NCT00426829|Growth Substances|growth substances|mesh-ancestor
92593801|NCT00426946|Reboxetine|reboxetine|mesh-list
92593802|NCT00426946|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593803|NCT00426946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593804|NCT00426946|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92593805|NCT00426946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92593806|NCT00426946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92593807|NCT00426946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593808|NCT00426946|Adrenergic Agents|adrenergic agents|mesh-ancestor
92593809|NCT00426946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593810|NCT00426946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593811|NCT00091598|Ambrisentan|ambrisentan|mesh-list
92593812|NCT00091598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92593813|NCT00426985|Ketoprofen|ketoprofen|mesh-list
92593814|NCT00426985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92593815|NCT00426985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593816|NCT00426985|Analgesics|analgesics|mesh-ancestor
92593817|NCT00426985|Sensory System Agents|sensory system agents|mesh-ancestor
92593818|NCT00426985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593819|NCT00426985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593820|NCT00426985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92593821|NCT00426985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593822|NCT00426985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92593823|NCT00426985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593824|NCT00426985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593825|NCT00427102|Cisplatin|cisplatin|mesh-list
92593826|NCT00427102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593827|NCT00427414|Daunorubicin|daunorubicin|mesh-list
92750763|NCT05936489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593828|NCT00427414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593829|NCT00427414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92593830|NCT00427414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593831|NCT00427414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92593832|NCT00427414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535825|NCT00079105|Prednisolone|prednisolone|mesh-list
92535826|NCT00079105|Cyclophosphamide|cyclophosphamide|mesh-list
92535827|NCT00079105|Etoposide|etoposide|mesh-list
92535828|NCT00079105|Vincristine|vincristine|mesh-list
92535829|NCT00079105|Mitoxantrone|mitoxantrone|mesh-list
92593833|NCT00427414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593834|NCT03929718|Spironolactone|spironolactone|mesh-list
92593835|NCT03929718|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92593836|NCT03929718|Hormone Antagonists|hormone antagonists|mesh-ancestor
92593837|NCT03929718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92593838|NCT03929718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593839|NCT03929718|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92593840|NCT03929718|Diuretics|diuretics|mesh-ancestor
92593841|NCT03929718|Natriuretic Agents|natriuretic agents|mesh-ancestor
92593842|NCT01056523|Cytarabine|cytarabine|mesh-list
92593843|NCT01056523|Ribavirin|ribavirin|mesh-list
92593844|NCT01056523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92593845|NCT01056523|Antimetabolites|antimetabolites|mesh-ancestor
92593846|NCT01056523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593847|NCT01056523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593848|NCT01056523|Antiviral Agents|antiviral agents|mesh-ancestor
92593849|NCT01056523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593850|NCT01056523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593851|NCT01056523|Immunologic Factors|immunologic factors|mesh-ancestor
92593852|NCT01056523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593853|NCT00091715|Bosentan|bosentan|mesh-list
92593854|NCT00091715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92593855|NCT00091715|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92593856|NCT00091715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593857|NCT00427492|Magnesium Oxide|magnesium oxide|mesh-list
92593858|NCT00427492|Antacids|antacids|mesh-ancestor
92593859|NCT00427492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593860|NCT00427492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593861|NCT00427570|Fluorouracil|fluorouracil|mesh-list
92593862|NCT00427570|Vincristine|vincristine|mesh-list
92593863|NCT00427570|Semustine|semustine|mesh-list
92593864|NCT00427570|BCG Vaccine|bcg vaccine|mesh-list
92593865|NCT00427570|Antimetabolites|antimetabolites|mesh-ancestor
92593866|NCT00427570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593867|NCT00427570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92593868|NCT00427570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593869|NCT00427570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593870|NCT00427570|Immunologic Factors|immunologic factors|mesh-ancestor
92593872|NCT00427570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92593874|NCT00427570|Antimitotic Agents|antimitotic agents|mesh-ancestor
92593875|NCT00427570|Mitosis Modulators|mitosis modulators|mesh-ancestor
92593876|NCT00427570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92593877|NCT00427570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92593878|NCT00427570|Alkylating Agents|alkylating agents|mesh-ancestor
92593879|NCT00427609|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92593880|NCT00427609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593881|NCT00427609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593882|NCT00091910|Epoetin Alfa|epoetin alfa|mesh-list
92593883|NCT00091910|Hematinics|hematinics|mesh-ancestor
92593884|NCT00427882|Alfuzosin|alfuzosin|mesh-list
92593885|NCT00427882|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92593886|NCT00427882|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92593887|NCT00427882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92593888|NCT00427882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92593889|NCT00427882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593890|NCT00427882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593891|NCT00427882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593892|NCT00427882|Urological Agents|urological agents|mesh-ancestor
92593893|NCT04704622|Midazolam|midazolam|mesh-list
92593894|NCT04704622|Dexmedetomidine|dexmedetomidine|mesh-list
92593895|NCT04704622|Ketamine|ketamine|mesh-list
92593896|NCT04704622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92593897|NCT04704622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593898|NCT04704622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593899|NCT04704622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593900|NCT04704622|Analgesics|analgesics|mesh-ancestor
92593901|NCT04704622|Sensory System Agents|sensory system agents|mesh-ancestor
92593902|NCT04704622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535830|NCT00079105|Bleomycin|bleomycin|mesh-list
92535831|NCT00079105|Vinblastine|vinblastine|mesh-list
92535832|NCT00079105|Procarbazine|procarbazine|mesh-list
92593903|NCT04704622|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92593904|NCT04704622|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92593905|NCT04704622|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92593906|NCT04704622|Adrenergic Agents|adrenergic agents|mesh-ancestor
92593907|NCT04704622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593908|NCT04704622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593909|NCT04704622|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92593910|NCT04704622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92593911|NCT04704622|Anesthetics, General|anesthetics, general|mesh-ancestor
92593913|NCT04704622|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92593914|NCT04704622|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92593915|NCT04704622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92593916|NCT04704622|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92593917|NCT04704622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593918|NCT04704622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593919|NCT04704622|GABA Modulators|gaba modulators|mesh-ancestor
92593920|NCT04704622|GABA Agents|gaba agents|mesh-ancestor
92593921|NCT00428194|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92593922|NCT00428194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593923|NCT00428194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92593924|NCT00428194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593925|NCT00428194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593926|NCT03769467|Pembrolizumab|pembrolizumab|mesh-list
92593927|NCT03769467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593928|NCT03769467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593929|NCT03769467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92593930|NCT03769467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593931|NCT00092183|Ondansetron|ondansetron|mesh-list
92593932|NCT00092183|Aprepitant|aprepitant|mesh-list
92593933|NCT00092183|Antiemetics|antiemetics|mesh-ancestor
92593934|NCT00092183|Autonomic Agents|autonomic agents|mesh-ancestor
92593935|NCT00092183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593936|NCT00092183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593937|NCT00092183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593938|NCT00092183|Antipruritics|antipruritics|mesh-ancestor
92593939|NCT00092183|Dermatologic Agents|dermatologic agents|mesh-ancestor
92593940|NCT00092183|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92360414|NCT00477204|Antimetabolites|antimetabolites|mesh-ancestor
92593941|NCT00092183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92593942|NCT00092183|Serotonin Agents|serotonin agents|mesh-ancestor
92593943|NCT00092183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001222|NCT04887259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593946|NCT00428272|Interferons|interferons|mesh-list
92593947|NCT00428272|Interferon-gamma|interferon-gamma|mesh-list
92593948|NCT00428272|Lexatumumab|lexatumumab|mesh-list
92593949|NCT00428272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92593950|NCT00428272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593951|NCT00428272|Antiviral Agents|antiviral agents|mesh-ancestor
92593952|NCT00428272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593953|NCT00428272|Immunologic Factors|immunologic factors|mesh-ancestor
92593954|NCT00428272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593955|NCT01580254|Latanoprost|latanoprost|mesh-list
92593956|NCT01580254|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92593957|NCT01580254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92593958|NCT00428311|Metformin|metformin|mesh-list
92593959|NCT00428311|Cyproterone Acetate|cyproterone acetate|mesh-list
92593960|NCT00428311|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92593961|NCT00428311|Estradiol|estradiol|mesh-list
92593962|NCT00428311|Cyproterone|cyproterone|mesh-list
92593963|NCT00428311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92593964|NCT00428311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593965|NCT00428311|Estrogens|estrogens|mesh-ancestor
92593966|NCT00428311|Hormones|hormones|mesh-ancestor
92593967|NCT00428311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92593968|NCT00428311|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92593969|NCT00428311|Contraceptive Agents|contraceptive agents|mesh-ancestor
92593970|NCT00428311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92593971|NCT00428311|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92593972|NCT00428311|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92593973|NCT00428311|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92593974|NCT00428311|Androgen Antagonists|androgen antagonists|mesh-ancestor
92593975|NCT00428311|Hormone Antagonists|hormone antagonists|mesh-ancestor
92593976|NCT00428311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535833|NCT00079105|Prednisolone phosphate|prednisolone phosphate|mesh-list
92535834|NCT00079105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535835|NCT00079105|Immunologic Factors|immunologic factors|mesh-ancestor
92535836|NCT00079105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535837|NCT00079105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535838|NCT00079105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535839|NCT00079105|Alkylating Agents|alkylating agents|mesh-ancestor
92535840|NCT00079105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535841|NCT00079105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535842|NCT00079105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535843|NCT00079105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92535844|NCT00079105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92535845|NCT00079105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535846|NCT00079105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535847|NCT00079105|Tubulin Modulators|tubulin modulators|mesh-ancestor
92535848|NCT00079105|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535849|NCT00079105|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535850|NCT00079105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940263|NCT03420521|Nivolumab|nivolumab|mesh-list
92593977|NCT00428311|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92593978|NCT00092300|Valdecoxib|valdecoxib|mesh-list
92593979|NCT00092300|Rofecoxib|rofecoxib|mesh-list
92593980|NCT00092300|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92593981|NCT00092300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92593982|NCT00092300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593983|NCT00092300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593984|NCT00092300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92593985|NCT00092300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92593986|NCT00092300|Analgesics|analgesics|mesh-ancestor
92593987|NCT00092300|Sensory System Agents|sensory system agents|mesh-ancestor
92593988|NCT00092300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593989|NCT00092300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593990|NCT00092300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92593991|NCT00092300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593992|NCT00428350|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92593993|NCT00428350|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593994|NCT00428350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593995|NCT00428350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92593996|NCT00428350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593997|NCT00428350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593998|NCT00428350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593999|NCT00428428|Isoproterenol|isoproterenol|mesh-list
92594000|NCT00428428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92594001|NCT00428428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92594002|NCT00428428|Adrenergic Agents|adrenergic agents|mesh-ancestor
92594003|NCT00428428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594004|NCT00428428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594005|NCT00428428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594006|NCT00428428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92594007|NCT00428428|Autonomic Agents|autonomic agents|mesh-ancestor
92594008|NCT00428428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594009|NCT00428428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92594010|NCT00428428|Respiratory System Agents|respiratory system agents|mesh-ancestor
92594011|NCT00428428|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92594012|NCT00428428|Sympathomimetics|sympathomimetics|mesh-ancestor
92535851|NCT00079105|Glucocorticoids|glucocorticoids|mesh-ancestor
92535852|NCT00079105|Hormones|hormones|mesh-ancestor
92535853|NCT00079105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535854|NCT00079105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535855|NCT00079105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535856|NCT00079105|Analgesics|analgesics|mesh-ancestor
92535857|NCT00079105|Sensory System Agents|sensory system agents|mesh-ancestor
92535858|NCT00079105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92535859|NCT03647124|Lenalidomide|lenalidomide|mesh-list
92535860|NCT03647124|Immunologic Factors|immunologic factors|mesh-ancestor
92535861|NCT03647124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535862|NCT03647124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92535863|NCT03647124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594013|NCT00428428|Protective Agents|protective agents|mesh-ancestor
92594014|NCT00092339|Valdecoxib|valdecoxib|mesh-list
92594015|NCT00092339|Rofecoxib|rofecoxib|mesh-list
92594016|NCT00092339|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92594017|NCT00092339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92594021|NCT00092339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92594022|NCT00092339|Analgesics|analgesics|mesh-ancestor
92594023|NCT00092339|Sensory System Agents|sensory system agents|mesh-ancestor
92594024|NCT00092339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594025|NCT00092339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594026|NCT00092339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92594027|NCT00092339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594028|NCT00428545|Bevacizumab|bevacizumab|mesh-list
92594029|NCT00428545|Bortezomib|bortezomib|mesh-list
92594030|NCT00428545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92594031|NCT00428545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594032|NCT00428545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92594033|NCT00428545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594034|NCT00428545|Growth Substances|growth substances|mesh-ancestor
92594035|NCT00428545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594036|NCT00428545|Growth Inhibitors|growth inhibitors|mesh-ancestor
92594037|NCT00092378|Diclofenac|diclofenac|mesh-list
92594038|NCT00092378|Rofecoxib|rofecoxib|mesh-list
92594039|NCT00092378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92594040|NCT00092378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92594041|NCT00092378|Analgesics|analgesics|mesh-ancestor
92594042|NCT00092378|Sensory System Agents|sensory system agents|mesh-ancestor
92594043|NCT00092378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594044|NCT00092378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594045|NCT00092378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92594046|NCT00092378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594047|NCT00092378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92594048|NCT00092378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594049|NCT00092378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594050|NCT00092378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92594051|NCT00092846|Lovastatin|lovastatin|mesh-list
92594052|NCT00092846|L 647318|l 647318|mesh-list
92594053|NCT00092846|Dihydromevinolin|dihydromevinolin|mesh-list
92594054|NCT00092846|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92594055|NCT00092846|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92594056|NCT00092846|Antimetabolites|antimetabolites|mesh-ancestor
92594057|NCT00092846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594058|NCT00092846|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92594059|NCT00092846|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92594060|NCT00092846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594061|NCT00092924|Mapatumumab|mapatumumab|mesh-list
92594062|NCT00092924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594063|NCT00093002|Fulvestrant|fulvestrant|mesh-list
92594064|NCT00093002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535864|NCT03647124|Growth Substances|growth substances|mesh-ancestor
92535865|NCT03647124|Growth Inhibitors|growth inhibitors|mesh-ancestor
92535866|NCT03647124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535867|NCT00079144|Aldesleukin|aldesleukin|mesh-list
92535868|NCT00079144|Cyclophosphamide|cyclophosphamide|mesh-list
92535869|NCT00079144|Fludarabine|fludarabine|mesh-list
92535870|NCT00079144|Fludarabine phosphate|fludarabine phosphate|mesh-list
92535871|NCT00079144|Freund's Adjuvant|freund's adjuvant|mesh-list
92535872|NCT00079144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535873|NCT00079144|Immunologic Factors|immunologic factors|mesh-ancestor
92535874|NCT00079144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535875|NCT00079144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535876|NCT00079144|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535877|NCT00079144|Alkylating Agents|alkylating agents|mesh-ancestor
92535878|NCT00079144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535879|NCT00079144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594065|NCT00093002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594066|NCT00093002|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92594067|NCT00093002|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92594068|NCT00093002|Hormone Antagonists|hormone antagonists|mesh-ancestor
92594069|NCT00093002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594070|NCT00093002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594071|NCT00093119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92594072|NCT00093119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594073|NCT00093158|Anticoagulants|anticoagulants|mesh-list
92594074|NCT00093158|Bivalirudin|bivalirudin|mesh-list
92594075|NCT00093158|Antithrombins|antithrombins|mesh-ancestor
92594076|NCT00093158|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92594077|NCT00093158|Protease Inhibitors|protease inhibitors|mesh-ancestor
92594078|NCT00093158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594079|NCT00093158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594081|NCT03501498|Antidiarrheals|antidiarrheals|mesh-list
92594082|NCT03501498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594083|NCT05561049|Thalidomide|thalidomide|mesh-list
92594084|NCT05561049|Dexamethasone|dexamethasone|mesh-list
92594085|NCT05561049|Bortezomib|bortezomib|mesh-list
92594086|NCT05561049|Daratumumab|daratumumab|mesh-list
92594087|NCT05561049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92594088|NCT05561049|Antiemetics|antiemetics|mesh-ancestor
92594089|NCT05561049|Autonomic Agents|autonomic agents|mesh-ancestor
92594090|NCT05561049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594092|NCT05561049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594093|NCT05561049|Glucocorticoids|glucocorticoids|mesh-ancestor
92594094|NCT05561049|Hormones|hormones|mesh-ancestor
92594095|NCT05561049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594096|NCT05561049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92594097|NCT05561049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594098|NCT05561049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594099|NCT05561049|Immunologic Factors|immunologic factors|mesh-ancestor
92594100|NCT05561049|Leprostatic Agents|leprostatic agents|mesh-ancestor
92594101|NCT05561049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594102|NCT05561049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594103|NCT05561049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92594104|NCT05561049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594105|NCT05561049|Growth Substances|growth substances|mesh-ancestor
92594106|NCT05561049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92594107|NCT00424034|Ambrisentan|ambrisentan|mesh-list
92594108|NCT00424034|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92594109|NCT05561010|Bupivacaine|bupivacaine|mesh-list
92594110|NCT05561010|Anesthetics, Local|anesthetics, local|mesh-ancestor
92594111|NCT05561010|Anesthetics|anesthetics|mesh-ancestor
92535880|NCT00079144|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92535881|NCT00079144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535882|NCT00079144|Antimetabolites|antimetabolites|mesh-ancestor
92535883|NCT00079144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92535884|NCT00079144|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92535885|NCT00079144|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92535886|NCT00079144|Antiviral Agents|antiviral agents|mesh-ancestor
92535887|NCT00079144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535888|NCT00079222|Itraconazole|itraconazole|mesh-list
92535889|NCT00079222|Voriconazole|voriconazole|mesh-list
92535890|NCT00079222|Antifungal Agents|antifungal agents|mesh-ancestor
92535891|NCT00079222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535892|NCT00079222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92535893|NCT00079222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92535894|NCT00079222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940412|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
92594112|NCT05561010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594113|NCT05561010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594114|NCT05561010|Sensory System Agents|sensory system agents|mesh-ancestor
92594115|NCT05561010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594116|NCT03448107|Fluorides|fluorides|mesh-list
92594117|NCT03448107|Fluorides, Topical|fluorides, topical|mesh-list
92594118|NCT03448107|Cariostatic Agents|cariostatic agents|mesh-ancestor
92594119|NCT03448107|Protective Agents|protective agents|mesh-ancestor
92594120|NCT03448107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594121|NCT00093314|Ofatumumab|ofatumumab|mesh-list
92594122|NCT00093314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594123|NCT00093353|Cefixime|cefixime|mesh-list
92594124|NCT00093353|Irinotecan|irinotecan|mesh-list
92594125|NCT00093353|Temozolomide|temozolomide|mesh-list
92594126|NCT00093353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92594127|NCT00093353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594128|NCT00093353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594129|NCT00093353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594130|NCT00093353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594131|NCT00093353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594132|NCT00093353|Alkylating Agents|alkylating agents|mesh-ancestor
92594133|NCT00093353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594134|NCT00093353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594135|NCT00093509|Doxorubicin|doxorubicin|mesh-list
92594136|NCT00093509|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92594137|NCT00093509|Ifosfamide|ifosfamide|mesh-list
92594138|NCT00093509|Isophosphamide mustard|isophosphamide mustard|mesh-list
92594139|NCT00093509|Mesna|mesna|mesh-list
92594140|NCT00093509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594142|NCT00093509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92594143|NCT00093509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594144|NCT00093509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594145|NCT00093509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594146|NCT00093509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594147|NCT00093509|Alkylating Agents|alkylating agents|mesh-ancestor
92594148|NCT00093509|Protective Agents|protective agents|mesh-ancestor
92594149|NCT00093509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594150|NCT00093548|Vaccines|vaccines|mesh-list
92594151|NCT00093548|Sargramostim|sargramostim|mesh-list
92594152|NCT00093548|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
92594153|NCT00093548|Immunologic Factors|immunologic factors|mesh-ancestor
92594154|NCT00093548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594155|NCT00093548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92594156|NCT05549895|Dexamethasone|dexamethasone|mesh-list
92594157|NCT05549895|Bupivacaine|bupivacaine|mesh-list
92594158|NCT05549895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92594159|NCT05549895|Antiemetics|antiemetics|mesh-ancestor
92535895|NCT00079222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535896|NCT00079222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92535897|NCT00079222|Hormone Antagonists|hormone antagonists|mesh-ancestor
92535898|NCT00079222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940469|NCT03484195|Fluorouracil|fluorouracil|mesh-list
92594160|NCT05549895|Autonomic Agents|autonomic agents|mesh-ancestor
92594161|NCT05549895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594162|NCT05549895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594163|NCT05549895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594164|NCT05549895|Glucocorticoids|glucocorticoids|mesh-ancestor
92594165|NCT05549895|Hormones|hormones|mesh-ancestor
92594166|NCT05549895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001438|NCT04630886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92594169|NCT05549895|Anesthetics, Local|anesthetics, local|mesh-ancestor
92594170|NCT05549895|Anesthetics|anesthetics|mesh-ancestor
92594171|NCT05549895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594172|NCT05549895|Sensory System Agents|sensory system agents|mesh-ancestor
92594173|NCT00093587|Cyclosporine|cyclosporine|mesh-list
92594174|NCT00093587|Cyclophosphamide|cyclophosphamide|mesh-list
92594175|NCT00093587|Busulfan|busulfan|mesh-list
92594176|NCT00093587|Cyclosporins|cyclosporins|mesh-list
92594177|NCT00093587|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92594178|NCT00093587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594179|NCT00093587|Immunologic Factors|immunologic factors|mesh-ancestor
92594180|NCT00093587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594181|NCT00093587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594182|NCT00093587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594183|NCT00093587|Alkylating Agents|alkylating agents|mesh-ancestor
92594184|NCT00093587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594185|NCT00093587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594186|NCT00093587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92594187|NCT00093587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594188|NCT00093587|Antifungal Agents|antifungal agents|mesh-ancestor
92594189|NCT00093587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594190|NCT00093587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92594191|NCT00093587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92594192|NCT00093626|Sorafenib|sorafenib|mesh-list
92594193|NCT00093626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594194|NCT00093626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594195|NCT00093626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594196|NCT00093626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594197|NCT05543109|Fentanyl|fentanyl|mesh-list
92594198|NCT05543109|Narcotics|narcotics|mesh-list
92594199|NCT05543109|Propofol|propofol|mesh-list
92594200|NCT05543109|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92594201|NCT05543109|Ropivacaine|ropivacaine|mesh-list
92594202|NCT05543109|Anesthetics|anesthetics|mesh-list
92594203|NCT05543109|Sevoflurane|sevoflurane|mesh-list
92594204|NCT05543109|Anesthetics, Local|anesthetics, local|mesh-list
92594205|NCT05543109|Rocuronium|rocuronium|mesh-list
92594206|NCT05543109|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92594207|NCT05543109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594208|NCT05543109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594209|NCT05543109|Anesthetics, General|anesthetics, general|mesh-ancestor
92594210|NCT05543109|Sensory System Agents|sensory system agents|mesh-ancestor
92594211|NCT05543109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594212|NCT05543109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92594213|NCT05543109|Analgesics|analgesics|mesh-ancestor
92319066|NCT03378973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92594214|NCT05543109|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92594215|NCT05543109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92594216|NCT05543109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92594217|NCT05543109|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92594218|NCT05543109|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92594219|NCT05543109|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92594221|NCT00093665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594222|NCT00093665|Antimetabolites|antimetabolites|mesh-ancestor
92594223|NCT00093665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594224|NCT00093665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594225|NCT00093665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535899|NCT00079222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940539|NCT00873275|Bevacizumab|bevacizumab|mesh-list
92594226|NCT00093665|Immunologic Factors|immunologic factors|mesh-ancestor
92594227|NCT00093665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594228|NCT00093704|Ganciclovir|ganciclovir|mesh-list
92594229|NCT00093704|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92594230|NCT00093704|Bortezomib|bortezomib|mesh-list
92594231|NCT00093704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594232|NCT00093704|Antiviral Agents|antiviral agents|mesh-ancestor
92594233|NCT00093704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594234|NCT00093704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92594235|NCT00093704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594236|NCT00093704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594237|NCT01055314|Dactinomycin|dactinomycin|mesh-list
92594238|NCT01055314|Cyclophosphamide|cyclophosphamide|mesh-list
92594239|NCT01055314|Temozolomide|temozolomide|mesh-list
92594240|NCT01055314|Ifosfamide|ifosfamide|mesh-list
92594241|NCT01055314|Isophosphamide mustard|isophosphamide mustard|mesh-list
92594242|NCT01055314|Doxorubicin|doxorubicin|mesh-list
92594248|NCT01055314|Podophyllotoxin|podophyllotoxin|mesh-list
92594249|NCT01055314|Camptothecin|camptothecin|mesh-list
92594250|NCT01055314|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92594251|NCT01055314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594252|NCT01055314|Immunologic Factors|immunologic factors|mesh-ancestor
92594253|NCT01055314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594254|NCT01055314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594255|NCT01055314|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594256|NCT01055314|Alkylating Agents|alkylating agents|mesh-ancestor
92594257|NCT01055314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594258|NCT01055314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594259|NCT01055314|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92594260|NCT01055314|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594261|NCT01055314|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92594262|NCT01055314|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594263|NCT01055314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594264|NCT01055314|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92594265|NCT01055314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92594266|NCT01055314|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594267|NCT01055314|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594268|NCT01055314|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594269|NCT01055314|Keratolytic Agents|keratolytic agents|mesh-ancestor
92594270|NCT01055314|Dermatologic Agents|dermatologic agents|mesh-ancestor
92594271|NCT01055314|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594272|NCT01055314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594273|NCT01055314|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92594274|NCT01055314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92594275|NCT00093743|Cyclosporine|cyclosporine|mesh-list
92594276|NCT00093743|Mycophenolic Acid|mycophenolic acid|mesh-list
92594277|NCT00093743|Fludarabine|fludarabine|mesh-list
92594278|NCT00093743|Fludarabine phosphate|fludarabine phosphate|mesh-list
92594279|NCT00093743|Cyclosporins|cyclosporins|mesh-list
92594280|NCT00093743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594281|NCT00093743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594282|NCT00093743|Antimetabolites|antimetabolites|mesh-ancestor
92594283|NCT00093743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594284|NCT00093743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594285|NCT00093743|Immunologic Factors|immunologic factors|mesh-ancestor
92594286|NCT00093743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594287|NCT00093743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594288|NCT00093743|Antifungal Agents|antifungal agents|mesh-ancestor
92594289|NCT00093743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594290|NCT00093743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92594291|NCT00093743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92319150|NCT03840278|Pancreatin|pancreatin|mesh-list
92594292|NCT00093743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92594293|NCT00093743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594294|NCT00093743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92594295|NCT00093743|Antitubercular Agents|antitubercular agents|mesh-ancestor
92594296|NCT00093743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594297|NCT00400322|Valganciclovir|valganciclovir|mesh-list
92594298|NCT00400322|Antiviral Agents|antiviral agents|mesh-ancestor
92594299|NCT00400322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594300|NCT00093860|Propranolol|propranolol|mesh-list
92594301|NCT00093860|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92594302|NCT00093860|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92535900|NCT00079222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92535901|NCT00079261|Prednisone|prednisone|mesh-list
92535902|NCT00079261|Cyclophosphamide|cyclophosphamide|mesh-list
92535903|NCT00079261|Gemcitabine|gemcitabine|mesh-list
92535904|NCT00079261|Doxorubicin|doxorubicin|mesh-list
92535905|NCT00079261|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92594303|NCT00093860|Adrenergic Agents|adrenergic agents|mesh-ancestor
92594304|NCT00093860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594305|NCT00093860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594306|NCT00093860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594307|NCT00093860|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92594308|NCT00093860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92594309|NCT00093860|Vasodilator Agents|vasodilator agents|mesh-ancestor
92594310|NCT00402909|Nateglinide|nateglinide|mesh-list
92594311|NCT00402909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92594312|NCT00402909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594313|NCT02823366|Fenofibrate|fenofibrate|mesh-list
92594314|NCT02823366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92594316|NCT02823366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594318|NCT00093977|Darbepoetin alfa|darbepoetin alfa|mesh-list
92594319|NCT00093977|Hematinics|hematinics|mesh-ancestor
92594320|NCT00094289|Disulfiram|disulfiram|mesh-list
92594321|NCT00094289|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92594322|NCT00094289|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92594323|NCT00094289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594324|NCT00094289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594325|NCT00094367|Lamivudine|lamivudine|mesh-list
92594326|NCT00094367|Abacavir|abacavir|mesh-list
92594327|NCT00094367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92594328|NCT00094367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92594329|NCT00094367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594330|NCT00094367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594331|NCT00094367|Antiviral Agents|antiviral agents|mesh-ancestor
92594332|NCT00094367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594333|NCT00094367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92594334|NCT00094367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92594335|NCT00094406|Dimercaprol|dimercaprol|mesh-list
92594336|NCT00094406|Carbon Monoxide|carbon monoxide|mesh-list
92594337|NCT00094406|Chelating Agents|chelating agents|mesh-ancestor
92594338|NCT00094406|Sequestering Agents|sequestering agents|mesh-ancestor
92594339|NCT00094406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594340|NCT00094406|Antimetabolites|antimetabolites|mesh-ancestor
92594341|NCT00094406|Gasotransmitters|gasotransmitters|mesh-ancestor
92594342|NCT00094406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594343|NCT00094406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594344|NCT00094484|Cinacalcet|cinacalcet|mesh-list
92594345|NCT00094484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92594346|NCT00094484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594347|NCT00094484|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92594348|NCT00094484|Hormone Antagonists|hormone antagonists|mesh-ancestor
92594349|NCT00094484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594350|NCT00094523|Fosamprenavir|fosamprenavir|mesh-list
92594351|NCT00094523|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92594352|NCT00094523|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92594353|NCT00094523|Protease Inhibitors|protease inhibitors|mesh-ancestor
92594354|NCT00094523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594355|NCT00094523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594356|NCT00094523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92594357|NCT00094523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92594358|NCT00094523|Antiviral Agents|antiviral agents|mesh-ancestor
92594359|NCT00094523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594360|NCT00428701|Esomeprazole|esomeprazole|mesh-list
92594361|NCT00428701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92594362|NCT00428701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594363|NCT00428701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92594364|NCT00428701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594365|NCT00428701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594366|NCT00428818|Doxycycline|doxycycline|mesh-list
92594367|NCT00428818|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92594368|NCT00428818|Trimethoprim|trimethoprim|mesh-list
92535906|NCT00079261|Vincristine|vincristine|mesh-list
92535907|NCT00079261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535908|NCT00079261|Immunologic Factors|immunologic factors|mesh-ancestor
92594369|NCT00428818|Sulfamethoxazole|sulfamethoxazole|mesh-list
92594370|NCT00428818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594371|NCT00428818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594372|NCT00428818|Antimalarials|antimalarials|mesh-ancestor
92594373|NCT00428818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92594374|NCT00428818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92594375|NCT00428818|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92594376|NCT00428818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92594377|NCT00428818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594378|NCT00428818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594379|NCT00428818|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92594380|NCT00428818|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92594381|NCT00428818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92594382|NCT00094640|Olanzapine|olanzapine|mesh-list
92594383|NCT00094640|Antiemetics|antiemetics|mesh-ancestor
92594384|NCT00094640|Autonomic Agents|autonomic agents|mesh-ancestor
92594385|NCT00094640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594386|NCT00094640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594387|NCT00094640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594389|NCT00094640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92594390|NCT00094640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594391|NCT00094640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92594392|NCT00094640|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92594393|NCT00094640|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92594394|NCT00094640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92594395|NCT00094640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594396|NCT00094640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594397|NCT00094640|Serotonin Agents|serotonin agents|mesh-ancestor
92594398|NCT02415309|Melatonin|melatonin|mesh-list
92594399|NCT02415309|Antioxidants|antioxidants|mesh-ancestor
92594400|NCT02415309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594401|NCT02415309|Protective Agents|protective agents|mesh-ancestor
92594402|NCT02415309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594403|NCT02415309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594404|NCT05393817|Caffeine|caffeine|mesh-list
92594405|NCT05393817|Caffeine citrate|caffeine citrate|mesh-list
92594406|NCT05393817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594407|NCT05393817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92594408|NCT05393817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594409|NCT05393817|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92594410|NCT05393817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594411|NCT05393817|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92594412|NCT05393817|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92594413|NCT05393817|Purinergic Agents|purinergic agents|mesh-ancestor
92594414|NCT05393817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594415|NCT00403338|Sirolimus|sirolimus|mesh-list
92594416|NCT00403338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594417|NCT00403338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594418|NCT00403338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594419|NCT00403338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594420|NCT00403338|Antifungal Agents|antifungal agents|mesh-ancestor
92594421|NCT00403338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594422|NCT00403338|Immunologic Factors|immunologic factors|mesh-ancestor
92594423|NCT00403338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594424|NCT00095069|Gaboxadol|gaboxadol|mesh-list
92594425|NCT00095069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594426|NCT00095069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594427|NCT00095069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594428|NCT00095069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594429|NCT00095069|Analgesics|analgesics|mesh-ancestor
92594430|NCT00095069|Sensory System Agents|sensory system agents|mesh-ancestor
92594431|NCT00095069|Anticonvulsants|anticonvulsants|mesh-ancestor
92594432|NCT00095069|GABA Agonists|gaba agonists|mesh-ancestor
92594433|NCT00095069|GABA Agents|gaba agents|mesh-ancestor
92594434|NCT00403533|Atorvastatin|atorvastatin|mesh-list
92594435|NCT00403533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92594436|NCT00403533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92594437|NCT00403533|Antimetabolites|antimetabolites|mesh-ancestor
92535909|NCT00079261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535910|NCT00079261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92535911|NCT00079261|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92535912|NCT00079261|Alkylating Agents|alkylating agents|mesh-ancestor
92594438|NCT00403533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594439|NCT00403533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92594440|NCT00403533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92319289|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594441|NCT00403533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594442|NCT00095225|Bevacizumab|bevacizumab|mesh-list
92594443|NCT00095225|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92594444|NCT00095225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92594445|NCT00095225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594446|NCT00095225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92594447|NCT00095225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594448|NCT00095225|Growth Substances|growth substances|mesh-ancestor
92594449|NCT00095225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594450|NCT00095225|Growth Inhibitors|growth inhibitors|mesh-ancestor
92594451|NCT00095225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594452|NCT00095225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594453|NCT00095225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594454|NCT00095264|Darbepoetin alfa|darbepoetin alfa|mesh-list
92594455|NCT00095264|Hematinics|hematinics|mesh-ancestor
92594456|NCT01054729|Sofosbuvir|sofosbuvir|mesh-list
92594457|NCT01054729|Antiviral Agents|antiviral agents|mesh-ancestor
92594458|NCT01054729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594459|NCT00403611|Praziquantel|praziquantel|mesh-list
92594464|NCT00428896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594465|NCT00428896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594466|NCT00428896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594467|NCT00428896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594468|NCT01990911|Diuretics|diuretics|mesh-list
92594469|NCT01990911|Natriuretic Agents|natriuretic agents|mesh-ancestor
92594470|NCT01990911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594471|NCT00429091|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92594472|NCT00429091|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92594473|NCT00429091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92594474|NCT00429091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92594475|NCT00429091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594476|NCT00429091|Adrenergic Agents|adrenergic agents|mesh-ancestor
92594477|NCT00429091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594478|NCT00429091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594479|NCT00095459|Bevacizumab|bevacizumab|mesh-list
92594480|NCT00095459|Sorafenib|sorafenib|mesh-list
92594481|NCT00095459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92594482|NCT00095459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594483|NCT00095459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92594484|NCT00095459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594485|NCT00095459|Growth Substances|growth substances|mesh-ancestor
92594486|NCT00095459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594487|NCT00095459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92594488|NCT00095459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594489|NCT00095459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594490|NCT00095459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594491|NCT00429208|Nicotine|nicotine|mesh-list
92594492|NCT00429208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92594493|NCT00429208|Autonomic Agents|autonomic agents|mesh-ancestor
92594494|NCT00429208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594495|NCT00429208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594496|NCT00429208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92594497|NCT00429208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92594498|NCT00429208|Cholinergic Agents|cholinergic agents|mesh-ancestor
92594499|NCT00429208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594500|NCT00429208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594501|NCT00429247|Trastuzumab|trastuzumab|mesh-list
92594502|NCT00429247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92594503|NCT00429247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594504|NCT00095654|Rosiglitazone|rosiglitazone|mesh-list
92594505|NCT00095654|Ramipril|ramipril|mesh-list
92535913|NCT00079261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535914|NCT00079261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535915|NCT00079261|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92594507|NCT00095654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594508|NCT00095654|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92594509|NCT00095654|Protease Inhibitors|protease inhibitors|mesh-ancestor
92594510|NCT00095654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594511|NCT00095654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594512|NCT00095654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92594513|NCT00095693|Sorafenib|sorafenib|mesh-list
92594514|NCT00095693|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92594515|NCT00095693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594516|NCT00095693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594517|NCT00095693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594518|NCT00095693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594519|NCT00095693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92594520|NCT01054573|Interferons|interferons|mesh-list
92594521|NCT01054573|Ribavirin|ribavirin|mesh-list
92594522|NCT01054573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594523|NCT01054573|Antiviral Agents|antiviral agents|mesh-ancestor
92594524|NCT01054573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594525|NCT01054573|Antimetabolites|antimetabolites|mesh-ancestor
92594526|NCT01054573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594527|NCT00095771|Arsenic Trioxide|arsenic trioxide|mesh-list
92594528|NCT00095771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594529|NCT00429442|Simvastatin|simvastatin|mesh-list
92594530|NCT00429442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92594532|NCT00429442|Antimetabolites|antimetabolites|mesh-ancestor
92594533|NCT00429442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594534|NCT00429442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92594535|NCT00429442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92594536|NCT00429442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594537|NCT00429520|Hyaluronic Acid|hyaluronic acid|mesh-list
92594538|NCT00429520|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92594539|NCT00429520|Immunologic Factors|immunologic factors|mesh-ancestor
92360430|NCT00478218|Dexamethasone|dexamethasone|mesh-list
92594540|NCT00429520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594541|NCT00429520|Viscosupplements|viscosupplements|mesh-ancestor
92594542|NCT00429520|Protective Agents|protective agents|mesh-ancestor
92594543|NCT00429559|Gemcitabine|gemcitabine|mesh-list
92594545|NCT00429559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594546|NCT00429559|Antimetabolites|antimetabolites|mesh-ancestor
92594547|NCT00429559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594548|NCT00429559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594549|NCT00429559|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92594550|NCT00429559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594551|NCT00429559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594552|NCT00095810|Aripiprazole|aripiprazole|mesh-list
92594553|NCT00095810|Antidepressive Agents|antidepressive agents|mesh-ancestor
92594554|NCT00095810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92594555|NCT00095810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92594556|NCT00095810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92594557|NCT00095810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594558|NCT00095810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594559|NCT00095810|Dopamine Agonists|dopamine agonists|mesh-ancestor
92594560|NCT00095810|Dopamine Agents|dopamine agents|mesh-ancestor
92594561|NCT00095810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594562|NCT00095810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594563|NCT00095810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92594564|NCT00095810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92594565|NCT00095810|Serotonin Agents|serotonin agents|mesh-ancestor
92594566|NCT00095810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92594567|NCT00095810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92594568|NCT00095810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92594569|NCT00095810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92594570|NCT05234112|Acetic Acid|acetic acid|mesh-list
92594571|NCT05234112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594572|NCT05234112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594573|NCT01054300|Ertugliflozin|ertugliflozin|mesh-list
92594574|NCT01054300|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92535916|NCT00079261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535917|NCT00079261|Antimetabolites|antimetabolites|mesh-ancestor
92535918|NCT00079261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92535919|NCT00079261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92535920|NCT00079261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92535921|NCT00079261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594575|NCT01054300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594576|NCT01054300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92594577|NCT01054300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594578|NCT00095888|Gemcitabine|gemcitabine|mesh-list
92594579|NCT00095888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594580|NCT00095888|Antimetabolites|antimetabolites|mesh-ancestor
92594581|NCT00095888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594582|NCT00095888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594583|NCT00429676|Haloperidol|haloperidol|mesh-list
92594584|NCT00429676|Haloperidol decanoate|haloperidol decanoate|mesh-list
92594585|NCT00429676|Antiemetics|antiemetics|mesh-ancestor
92594586|NCT00429676|Autonomic Agents|autonomic agents|mesh-ancestor
92594587|NCT00429676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594588|NCT00429676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594589|NCT00429676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319439|NCT03031340|Pregabalin|pregabalin|mesh-list
92594590|NCT00429676|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92594591|NCT00429676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92594592|NCT00429676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594593|NCT00429676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92594594|NCT00429676|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92594595|NCT00429676|Dopamine Agents|dopamine agents|mesh-ancestor
92594596|NCT00429676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594597|NCT00429676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594598|NCT00429676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92594599|NCT00429715|Aluminum sulfate|aluminum sulfate|mesh-list
92594600|NCT00429715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92594601|NCT00429715|Immunologic Factors|immunologic factors|mesh-ancestor
92594602|NCT00429715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594604|NCT00095927|Carboplatin|carboplatin|mesh-list
92594605|NCT00095927|Amifostine|amifostine|mesh-list
92594606|NCT00095927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92594607|NCT00095927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594608|NCT00095927|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594609|NCT00095927|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594610|NCT00095927|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594611|NCT00095927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594612|NCT00095927|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92594613|NCT00095927|Protective Agents|protective agents|mesh-ancestor
92594614|NCT00095927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594615|NCT00429754|Aprepitant|aprepitant|mesh-list
92594616|NCT00429754|Antiemetics|antiemetics|mesh-ancestor
92594617|NCT00429754|Autonomic Agents|autonomic agents|mesh-ancestor
92594618|NCT00429754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594619|NCT00429754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594620|NCT00429754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594621|NCT00429754|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92594622|NCT00429754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594623|NCT00429754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594624|NCT00429832|Promethazine|promethazine|mesh-list
92594625|NCT00429832|Diphenhydramine|diphenhydramine|mesh-list
92594626|NCT00429832|Ondansetron|ondansetron|mesh-list
92594627|NCT00429832|Antiemetics|antiemetics|mesh-ancestor
92594628|NCT00429832|Autonomic Agents|autonomic agents|mesh-ancestor
92594629|NCT00429832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594630|NCT00429832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594631|NCT00429832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594632|NCT00429832|Antipruritics|antipruritics|mesh-ancestor
92594633|NCT00429832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92594634|NCT00429832|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92594635|NCT00429832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92594636|NCT00429832|Serotonin Agents|serotonin agents|mesh-ancestor
92594637|NCT00429832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535922|NCT00079261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92535923|NCT00079261|Glucocorticoids|glucocorticoids|mesh-ancestor
92535925|NCT00079261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535926|NCT00079261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92535927|NCT00079261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92535928|NCT00079261|Tubulin Modulators|tubulin modulators|mesh-ancestor
91940971|NCT05647642|Analgesics|analgesics|mesh-ancestor
92594638|NCT00429832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594639|NCT00429832|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92594640|NCT00429832|Histamine Antagonists|histamine antagonists|mesh-ancestor
92594641|NCT00429832|Histamine Agents|histamine agents|mesh-ancestor
92594642|NCT00429832|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92594643|NCT00429832|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92594644|NCT00429832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92594645|NCT00429832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594646|NCT00429832|Anesthetics, Local|anesthetics, local|mesh-ancestor
92594647|NCT00429832|Anesthetics|anesthetics|mesh-ancestor
92594648|NCT00429832|Sensory System Agents|sensory system agents|mesh-ancestor
92594649|NCT00429871|Docetaxel|docetaxel|mesh-list
92594650|NCT00429871|Capecitabine|capecitabine|mesh-list
92594651|NCT00429871|Epirubicin|epirubicin|mesh-list
92594652|NCT00429871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594653|NCT00429871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594654|NCT00429871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594655|NCT00429871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594656|NCT00429871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594657|NCT00429871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594658|NCT00429871|Antimetabolites|antimetabolites|mesh-ancestor
92594659|NCT00429871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594660|NCT00429871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92594661|NCT00429871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594662|NCT00429871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594663|NCT00095966|Gemcitabine|gemcitabine|mesh-list
92594664|NCT00095966|Sorafenib|sorafenib|mesh-list
92319584|NCT02892500|Hormones|hormones|mesh-ancestor
92594665|NCT00095966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594666|NCT00095966|Antimetabolites|antimetabolites|mesh-ancestor
92594667|NCT00095966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594668|NCT00095966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594669|NCT00095966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594670|NCT00095966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594671|NCT01803594|Nicotinic Acids|nicotinic acids|mesh-list
92594673|NCT01803594|Niacinamide|niacinamide|mesh-list
92594674|NCT01803594|Vitamin B Complex|vitamin b complex|mesh-ancestor
92594675|NCT01803594|Vitamins|vitamins|mesh-ancestor
92594676|NCT01803594|Micronutrients|micronutrients|mesh-ancestor
92594677|NCT01803594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594678|NCT01803594|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92594679|NCT01803594|Antimetabolites|antimetabolites|mesh-ancestor
92594685|NCT00430066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594687|NCT00430066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594688|NCT00096005|Bortezomib|bortezomib|mesh-list
92594689|NCT00096005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594690|NCT00430105|Cyclophosphamide|cyclophosphamide|mesh-list
92594691|NCT00430105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594692|NCT00430105|Immunologic Factors|immunologic factors|mesh-ancestor
92594693|NCT00430105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594694|NCT00430105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594695|NCT00430105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594696|NCT00430105|Alkylating Agents|alkylating agents|mesh-ancestor
92594697|NCT00430105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594698|NCT00430105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594699|NCT00430105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92594700|NCT00430144|Belotecan|belotecan|mesh-list
92594701|NCT00430144|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92594702|NCT00430144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594703|NCT00430144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535929|NCT00079261|Antimitotic Agents|antimitotic agents|mesh-ancestor
92535930|NCT00079261|Mitosis Modulators|mitosis modulators|mesh-ancestor
92535931|NCT00079300|Imiquimod|imiquimod|mesh-list
92535932|NCT00079300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92535933|NCT00079300|Immunologic Factors|immunologic factors|mesh-ancestor
92535934|NCT00079300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535935|NCT00079300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535936|NCT00079300|Interferon Inducers|interferon inducers|mesh-ancestor
92535937|NCT00079378|Decitabine|decitabine|mesh-list
92535938|NCT00079378|Azacitidine|azacitidine|mesh-list
92594704|NCT00430144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594705|NCT00430144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594706|NCT00430261|Sunitinib|sunitinib|mesh-list
92594707|NCT00430261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594708|NCT00430261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92594709|NCT00430261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594710|NCT00430261|Growth Substances|growth substances|mesh-ancestor
92594711|NCT00430261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594712|NCT00430261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92594713|NCT00430261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594714|NCT00430261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594715|NCT00430261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594716|NCT00096083|Melphalan|melphalan|mesh-list
92594717|NCT00096083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594718|NCT00096083|Alkylating Agents|alkylating agents|mesh-ancestor
92594719|NCT00096083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594720|NCT00096083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594721|NCT00096083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92594722|NCT00096083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594723|NCT00096083|Immunologic Factors|immunologic factors|mesh-ancestor
92594724|NCT00096083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594725|NCT01726452|Leucovorin|leucovorin|mesh-list
92594726|NCT01726452|Paclitaxel|paclitaxel|mesh-list
92594727|NCT01726452|Docetaxel|docetaxel|mesh-list
92594728|NCT01726452|Carboplatin|carboplatin|mesh-list
92594729|NCT01726452|Fluorouracil|fluorouracil|mesh-list
92594730|NCT01726452|Capecitabine|capecitabine|mesh-list
92594731|NCT01726452|Oxaliplatin|oxaliplatin|mesh-list
92594732|NCT01726452|Epirubicin|epirubicin|mesh-list
92594733|NCT01726452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92594734|NCT01726452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594735|NCT01726452|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594736|NCT01726452|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594737|NCT01726452|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594738|NCT01726452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594739|NCT01726452|Antimetabolites|antimetabolites|mesh-ancestor
92594740|NCT01726452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319590|NCT00378872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92594741|NCT01726452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594742|NCT01726452|Immunologic Factors|immunologic factors|mesh-ancestor
92594743|NCT01726452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594744|NCT01726452|Antidotes|antidotes|mesh-ancestor
92594745|NCT01726452|Protective Agents|protective agents|mesh-ancestor
92594746|NCT01726452|Vitamin B Complex|vitamin b complex|mesh-ancestor
92594747|NCT01726452|Vitamins|vitamins|mesh-ancestor
92594748|NCT01726452|Micronutrients|micronutrients|mesh-ancestor
92594752|NCT01726452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594753|NCT00096317|Ketoconazole|ketoconazole|mesh-list
92594754|NCT00096317|Antifungal Agents|antifungal agents|mesh-ancestor
92594755|NCT00096317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594756|NCT00096317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92594757|NCT00096317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92594758|NCT00096317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594759|NCT00096317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594760|NCT00096317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92594761|NCT00096317|Hormone Antagonists|hormone antagonists|mesh-ancestor
92594762|NCT00096317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92535940|NCT00079378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92535941|NCT00079378|Antimetabolites|antimetabolites|mesh-ancestor
92535942|NCT00079378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535943|NCT00079378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535944|NCT00079378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535945|NCT00079378|Anticonvulsants|anticonvulsants|mesh-ancestor
92535946|NCT00079378|GABA Agents|gaba agents|mesh-ancestor
92535947|NCT00079378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535948|NCT00079378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941171|NCT02260492|Xhance|xhance|mesh-list
92594763|NCT00096317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594764|NCT00096317|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92594765|NCT00096395|Gemcitabine|gemcitabine|mesh-list
92594766|NCT00096395|Sorafenib|sorafenib|mesh-list
92594767|NCT00096395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594768|NCT00096395|Antimetabolites|antimetabolites|mesh-ancestor
92594769|NCT00096395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594770|NCT00096395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594771|NCT00096395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594772|NCT00096395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594773|NCT00096434|Sorafenib|sorafenib|mesh-list
92594774|NCT00096434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594775|NCT00096434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594776|NCT00096434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594777|NCT00096434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594778|NCT00096473|Donepezil|donepezil|mesh-list
92594779|NCT00096473|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92594780|NCT00096473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594781|NCT00096473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594782|NCT00096473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92594783|NCT00096473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594784|NCT00096473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594785|NCT00096473|Nootropic Agents|nootropic agents|mesh-ancestor
92594786|NCT00130494|Zoledronic Acid|zoledronic acid|mesh-list
92594787|NCT00130494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92594788|NCT00130494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594789|NCT00096512|Sorafenib|sorafenib|mesh-list
92594790|NCT00096512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594791|NCT00096512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92594792|NCT00096512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594793|NCT00096512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594794|NCT00096551|Metronidazole|metronidazole|mesh-list
92594795|NCT00096551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594796|NCT00096551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594797|NCT00096551|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92594798|NCT00096551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92594799|NCT00095186|Lactoferrin|lactoferrin|mesh-list
92594800|NCT00095186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594801|NCT00130572|Pimecrolimus|pimecrolimus|mesh-list
92594802|NCT00130572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92594803|NCT00130572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92594804|NCT00130572|Analgesics|analgesics|mesh-ancestor
92594805|NCT00130572|Sensory System Agents|sensory system agents|mesh-ancestor
92594806|NCT00130572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594807|NCT00130572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594808|NCT00130572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92594809|NCT00130572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594810|NCT00130572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92594811|NCT00130572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594812|NCT00130572|Immunologic Factors|immunologic factors|mesh-ancestor
92594813|NCT00130572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92594814|NCT00130572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319669|NCT01240304|Gemcitabine|gemcitabine|mesh-list
92594815|NCT00130572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535949|NCT00079378|Antimanic Agents|antimanic agents|mesh-ancestor
92535950|NCT00079378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92535951|NCT00079378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92535952|NCT00079378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92535953|NCT00079456|Sirolimus|sirolimus|mesh-list
92535954|NCT00079456|Temsirolimus|temsirolimus|mesh-list
92535955|NCT00079456|MTOR Inhibitors|mtor inhibitors|mesh-list
92535956|NCT00079456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535958|NCT00079456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535959|NCT00079456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594816|NCT00096629|Vaccines|vaccines|mesh-list
92594817|NCT00096629|Immunologic Factors|immunologic factors|mesh-ancestor
92594818|NCT00096629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594822|NCT00430651|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594823|NCT00430651|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594824|NCT00430651|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594825|NCT00430651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594826|NCT00430807|Hydroxychloroquine|hydroxychloroquine|mesh-list
92594827|NCT00430807|Antimalarials|antimalarials|mesh-ancestor
92594828|NCT00430807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92594829|NCT00430807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92594830|NCT00430807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594831|NCT00430807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594832|NCT00430807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594833|NCT00430807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594834|NCT00096668|Paclitaxel|paclitaxel|mesh-list
92594835|NCT00096668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92594836|NCT00096668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594837|NCT00096668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594838|NCT00096668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594839|NCT00096668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594840|NCT00096668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594841|NCT00430846|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92594842|NCT00430846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92594843|NCT00430846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594844|NCT00430846|Immunotoxins|immunotoxins|mesh-ancestor
92594845|NCT00430846|Immunoconjugates|immunoconjugates|mesh-ancestor
92594846|NCT00430846|Immunologic Factors|immunologic factors|mesh-ancestor
92594847|NCT00430846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594848|NCT00430885|Immunoglobulins|immunoglobulins|mesh-list
92594849|NCT00430885|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92594850|NCT00430885|gamma-Globulins|gamma-globulins|mesh-list
92594851|NCT00430885|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92594852|NCT00430885|Immunologic Factors|immunologic factors|mesh-ancestor
92594853|NCT00430885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594854|NCT00430924|Eplerenone|eplerenone|mesh-list
92594855|NCT00430924|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92594856|NCT00430924|Hormone Antagonists|hormone antagonists|mesh-ancestor
92594857|NCT00430924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594858|NCT00430924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594859|NCT00430924|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92594860|NCT00430924|Diuretics|diuretics|mesh-ancestor
92594861|NCT00430924|Natriuretic Agents|natriuretic agents|mesh-ancestor
92594862|NCT00430924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92594863|NCT00096707|Deoxyglucose|deoxyglucose|mesh-list
92594864|NCT00096707|Antimetabolites|antimetabolites|mesh-ancestor
92594865|NCT00096707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594866|NCT00096707|Antiviral Agents|antiviral agents|mesh-ancestor
92594867|NCT00096707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594868|NCT00430963|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92594869|NCT00430963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92594870|NCT00430963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594871|NCT00430963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594872|NCT00430963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92594873|NCT00430963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92535960|NCT00079456|Immunologic Factors|immunologic factors|mesh-ancestor
92535961|NCT00079456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535962|NCT00079456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535963|NCT00079456|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92535964|NCT00079456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92535965|NCT00079456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92535966|NCT00079456|Antifungal Agents|antifungal agents|mesh-ancestor
92535968|NCT04467086|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92535969|NCT04467086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92535970|NCT04467086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92535971|NCT04467086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594874|NCT00430963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594875|NCT00430963|Cholinergic Agents|cholinergic agents|mesh-ancestor
92594876|NCT00430963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594877|NCT05102409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92594878|NCT05102409|Lifitegrast|lifitegrast|mesh-list
92594879|NCT05102409|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92594880|NCT01053247|Tacrolimus|tacrolimus|mesh-list
92594881|NCT01053247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594882|NCT01053247|Immunologic Factors|immunologic factors|mesh-ancestor
92594883|NCT01053247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594884|NCT01053247|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92594885|NCT01053247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594886|NCT01053247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594887|NCT00096863|Haloperidol|haloperidol|mesh-list
92594888|NCT00096863|Haloperidol decanoate|haloperidol decanoate|mesh-list
92594889|NCT00096863|Ziprasidone|ziprasidone|mesh-list
92594890|NCT00096863|Antiemetics|antiemetics|mesh-ancestor
92594891|NCT00096863|Autonomic Agents|autonomic agents|mesh-ancestor
92594894|NCT00096863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594895|NCT00096863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92594896|NCT00096863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92594897|NCT00096863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92594898|NCT00096863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92594899|NCT00096863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92594901|NCT00096863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92594902|NCT00096863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594903|NCT00096863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92594904|NCT00096863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92594905|NCT00096863|Serotonin Agents|serotonin agents|mesh-ancestor
92594906|NCT00130767|Finasteride|finasteride|mesh-list
92594907|NCT00130767|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92594908|NCT00130767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92594909|NCT00130767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594910|NCT00130767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594911|NCT00130767|Hormone Antagonists|hormone antagonists|mesh-ancestor
92594912|NCT00130767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594913|NCT00130767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594914|NCT00130767|Urological Agents|urological agents|mesh-ancestor
92594915|NCT00431080|Paclitaxel|paclitaxel|mesh-list
92594916|NCT00431080|Docetaxel|docetaxel|mesh-list
92594917|NCT00431080|Cyclophosphamide|cyclophosphamide|mesh-list
92594918|NCT00431080|Epirubicin|epirubicin|mesh-list
92594919|NCT00431080|Fluorouracil|fluorouracil|mesh-list
92594920|NCT00431080|Lenograstim|lenograstim|mesh-list
92594921|NCT00431080|Mitogens|mitogens|mesh-list
92594922|NCT00431080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92594923|NCT00431080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594924|NCT00431080|Tubulin Modulators|tubulin modulators|mesh-ancestor
92594925|NCT00431080|Antimitotic Agents|antimitotic agents|mesh-ancestor
92594926|NCT00431080|Mitosis Modulators|mitosis modulators|mesh-ancestor
92594927|NCT00431080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594928|NCT00431080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92535972|NCT04467086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535973|NCT04467086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535974|NCT04467086|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92535975|NCT04467086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92535976|NCT04467086|Vasodilator Agents|vasodilator agents|mesh-ancestor
92535977|NCT00079612|Sorafenib|sorafenib|mesh-list
92535978|NCT00079612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92535979|NCT00079612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92535980|NCT00079612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92535981|NCT00079612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535982|NCT03526107|Theobromine|theobromine|mesh-list
92535983|NCT03526107|Caffeine|caffeine|mesh-list
92535984|NCT03526107|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92535985|NCT03526107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92535986|NCT03526107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92535987|NCT03526107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941309|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92594929|NCT00431080|Immunologic Factors|immunologic factors|mesh-ancestor
92594930|NCT00431080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594931|NCT00431080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594932|NCT00431080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92594933|NCT00431080|Alkylating Agents|alkylating agents|mesh-ancestor
92594934|NCT00431080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92594935|NCT00431080|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594936|NCT00431080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92594937|NCT00431080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594938|NCT00431080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594939|NCT00431080|Antimetabolites|antimetabolites|mesh-ancestor
92594940|NCT00431080|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594941|NCT00431080|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92594942|NCT00431119|Mycophenolic Acid|mycophenolic acid|mesh-list
92594943|NCT00431119|Azathioprine|azathioprine|mesh-list
92594944|NCT00431119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594945|NCT00431119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594946|NCT00431119|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92594947|NCT00431119|Antitubercular Agents|antitubercular agents|mesh-ancestor
92594948|NCT00431119|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92594949|NCT00431119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594950|NCT00431119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594951|NCT00431119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594952|NCT00431119|Antimetabolites|antimetabolites|mesh-ancestor
92594953|NCT00431119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92594954|NCT00431119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92594955|NCT00431119|Immunologic Factors|immunologic factors|mesh-ancestor
92594956|NCT00431119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594957|NCT00431119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92594958|NCT00097019|Bevacizumab|bevacizumab|mesh-list
92594959|NCT00097019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92594960|NCT00097019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594961|NCT00097019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92594962|NCT00097019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92594963|NCT00097019|Growth Substances|growth substances|mesh-ancestor
92594966|NCT00431197|Ketoconazole|ketoconazole|mesh-list
92594967|NCT00431197|Testosterone|testosterone|mesh-list
92594968|NCT00431197|Antifungal Agents|antifungal agents|mesh-ancestor
92594969|NCT00431197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594970|NCT00431197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92535988|NCT03526107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92535989|NCT03526107|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92535990|NCT03526107|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92535991|NCT03526107|Purinergic Agents|purinergic agents|mesh-ancestor
92535992|NCT03526107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92535993|NCT03526107|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92535994|NCT03526107|Autonomic Agents|autonomic agents|mesh-ancestor
92535995|NCT03526107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92535996|NCT03526107|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92535997|NCT03526107|Respiratory System Agents|respiratory system agents|mesh-ancestor
92535998|NCT03526107|Vasodilator Agents|vasodilator agents|mesh-ancestor
92535999|NCT00079768|Alemtuzumab|alemtuzumab|mesh-list
92536000|NCT00079768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536001|NCT00079768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536002|NCT00079807|Thioctic Acid|thioctic acid|mesh-list
92536003|NCT00079807|Antioxidants|antioxidants|mesh-ancestor
91941368|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594971|NCT00431197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92594972|NCT00431197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594973|NCT00431197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594974|NCT00431197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92594975|NCT00431197|Hormone Antagonists|hormone antagonists|mesh-ancestor
92594976|NCT00431197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594977|NCT00431197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594978|NCT00431197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92594979|NCT00431197|Androgens|androgens|mesh-ancestor
92594980|NCT00431197|Hormones|hormones|mesh-ancestor
92594981|NCT00431236|Dexamethasone|dexamethasone|mesh-list
92594982|NCT00431236|Ondansetron|ondansetron|mesh-list
92594983|NCT00431236|Casopitant|casopitant|mesh-list
92594984|NCT00431236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92594985|NCT00431236|Antiemetics|antiemetics|mesh-ancestor
92594986|NCT00431236|Autonomic Agents|autonomic agents|mesh-ancestor
92594987|NCT00431236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594988|NCT00431236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594989|NCT00431236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92594990|NCT00431236|Glucocorticoids|glucocorticoids|mesh-ancestor
92594991|NCT00431236|Hormones|hormones|mesh-ancestor
92594992|NCT00431236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92594993|NCT00431236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92594994|NCT00431236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594995|NCT00431236|Antipruritics|antipruritics|mesh-ancestor
92594996|NCT00431236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92594997|NCT00431236|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92594998|NCT00431236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92594999|NCT00431236|Serotonin Agents|serotonin agents|mesh-ancestor
92595000|NCT00431236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595001|NCT00431236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595002|NCT00431236|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92595003|NCT00431275|Tremelimumab|tremelimumab|mesh-list
92595004|NCT00431275|Ipilimumab|ipilimumab|mesh-list
92595005|NCT00431275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595006|NCT00431275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92595007|NCT00431275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92595008|NCT00431275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595009|NCT00431353|Valganciclovir|valganciclovir|mesh-list
92595010|NCT00431353|Ganciclovir|ganciclovir|mesh-list
92536004|NCT00079807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536005|NCT00079807|Protective Agents|protective agents|mesh-ancestor
92536006|NCT00079807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536007|NCT00079807|Vitamin B Complex|vitamin b complex|mesh-ancestor
92536008|NCT00079807|Vitamins|vitamins|mesh-ancestor
92536009|NCT00079807|Micronutrients|micronutrients|mesh-ancestor
92536010|NCT00079885|Tigecycline|tigecycline|mesh-list
92536011|NCT00079885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536012|NCT00079885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536013|NCT00079885|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92536014|NCT00079885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536015|NCT00079885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536016|NCT00079924|Teriparatide|teriparatide|mesh-list
92595011|NCT00431353|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92595012|NCT00431353|Antiviral Agents|antiviral agents|mesh-ancestor
92595013|NCT00431353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595014|NCT00431353|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92595015|NCT00431353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595016|NCT00431353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595017|NCT00130845|Octreotide|octreotide|mesh-list
92595018|NCT00130845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595019|NCT00130845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595020|NCT00130845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595021|NCT00431392|Atropine|atropine|mesh-list
92595022|NCT00431392|Propranolol|propranolol|mesh-list
92595023|NCT00431392|Phenylephrine|phenylephrine|mesh-list
92595024|NCT00431392|Oxymetazoline|oxymetazoline|mesh-list
92595025|NCT00431392|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92595026|NCT00431392|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92595027|NCT00431392|Mydriatics|mydriatics|mesh-ancestor
92595028|NCT00431392|Autonomic Agents|autonomic agents|mesh-ancestor
92595029|NCT00431392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595030|NCT00431392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595031|NCT00431392|Sympathomimetics|sympathomimetics|mesh-ancestor
92595032|NCT00431392|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92595033|NCT00431392|Nasal Decongestants|nasal decongestants|mesh-ancestor
92595034|NCT00431392|Respiratory System Agents|respiratory system agents|mesh-ancestor
92595035|NCT00431392|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92595036|NCT00431392|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92595037|NCT00431392|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92595038|NCT00431392|Adrenergic Agents|adrenergic agents|mesh-ancestor
92595040|NCT00431392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595043|NCT00431392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92595044|NCT00431392|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92595045|NCT00431392|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92595046|NCT00431392|Parasympatholytics|parasympatholytics|mesh-ancestor
92595047|NCT00431392|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92595048|NCT00431392|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92595049|NCT00431392|Cholinergic Agents|cholinergic agents|mesh-ancestor
92595050|NCT00431392|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92595051|NCT00431392|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92595052|NCT00431392|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92595053|NCT00431392|Vasodilator Agents|vasodilator agents|mesh-ancestor
92595054|NCT00431392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595055|NCT00130884|Simendan|simendan|mesh-list
92595056|NCT00130884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92595057|NCT00130884|Vasodilator Agents|vasodilator agents|mesh-ancestor
92595058|NCT00130884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92595059|NCT00130884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92595060|NCT00130884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595061|NCT00130884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595062|NCT00130884|Protective Agents|protective agents|mesh-ancestor
92595063|NCT00130884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536017|NCT00079924|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92536018|NCT00079924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92536019|NCT00079924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536020|NCT00079924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92536021|NCT00079924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92536022|NCT00079924|Hormone Antagonists|hormone antagonists|mesh-ancestor
92536023|NCT00079924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536024|NCT00079924|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92536025|NCT00079924|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92536026|NCT00079963|Vitamins|vitamins|mesh-list
92595064|NCT01052662|Memantine|memantine|mesh-list
92595065|NCT01052662|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92595066|NCT01052662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92595067|NCT01052662|Dopamine Agents|dopamine agents|mesh-ancestor
92595068|NCT01052662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595069|NCT01052662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595070|NCT01052662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595071|NCT01052662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92595072|NCT01052662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92595073|NCT00097214|Carboplatin|carboplatin|mesh-list
92595074|NCT00097214|Cetuximab|cetuximab|mesh-list
92595075|NCT00097214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595076|NCT00097214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92595077|NCT05049057|Erenumab|erenumab|mesh-list
92595078|NCT05049057|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92595079|NCT05049057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595080|NCT05049057|Analgesics|analgesics|mesh-ancestor
92595081|NCT05049057|Sensory System Agents|sensory system agents|mesh-ancestor
92595082|NCT05049057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595083|NCT05049057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595084|NCT00431665|Heparin|heparin|mesh-list
92595085|NCT00431665|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92595086|NCT00431665|Somatostatin|somatostatin|mesh-list
92595087|NCT00431665|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92595088|NCT00431665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595089|NCT00431665|Anticoagulants|anticoagulants|mesh-ancestor
92595090|NCT00431665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92595091|NCT00431665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92595092|NCT00431665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595093|NCT00431665|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92595094|NCT00431665|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92595095|NCT00431665|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92595096|NCT00431665|Hormones|hormones|mesh-ancestor
92595097|NCT00431665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595098|NCT00431665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595099|NCT04703608|Ivermectin|ivermectin|mesh-list
92595100|NCT04703608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92595101|NCT04703608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595102|NCT04727073|Spironolactone|spironolactone|mesh-list
92595103|NCT04727073|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92595104|NCT04727073|Hormone Antagonists|hormone antagonists|mesh-ancestor
92595105|NCT04727073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595106|NCT04727073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595107|NCT04727073|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92595108|NCT04727073|Diuretics|diuretics|mesh-ancestor
92595109|NCT04727073|Natriuretic Agents|natriuretic agents|mesh-ancestor
92595110|NCT00432016|Zidovudine|zidovudine|mesh-list
92002395|NCT04094584|Naltrexone|naltrexone|mesh-list
92595112|NCT00432016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595113|NCT00432016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92595114|NCT00432016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92536027|NCT00079963|Vitamin E|vitamin e|mesh-list
92536028|NCT00079963|Micronutrients|micronutrients|mesh-ancestor
92536029|NCT00079963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536030|NCT00079963|Antioxidants|antioxidants|mesh-ancestor
92536031|NCT00079963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536032|NCT00079963|Protective Agents|protective agents|mesh-ancestor
92536033|NCT00392886|Cyclophosphamide|cyclophosphamide|mesh-list
92536034|NCT00392886|Temozolomide|temozolomide|mesh-list
92536035|NCT00392886|Thiotepa|thiotepa|mesh-list
92536036|NCT00392886|Carboplatin|carboplatin|mesh-list
92536037|NCT00392886|Methotrexate|methotrexate|mesh-list
92536038|NCT00392886|Etoposide|etoposide|mesh-list
92536039|NCT00392886|Vincristine|vincristine|mesh-list
92536040|NCT00392886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595115|NCT00432016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595116|NCT00432016|Antiviral Agents|antiviral agents|mesh-ancestor
92595117|NCT00432016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595118|NCT00432016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92595119|NCT00432016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92595120|NCT01052077|Antidepressive Agents|antidepressive agents|mesh-list
92595121|NCT01052077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92595122|NCT00131040|Aprotinin|aprotinin|mesh-list
92595123|NCT00131040|Hemostatics|hemostatics|mesh-ancestor
92595124|NCT00131040|Coagulants|coagulants|mesh-ancestor
92595125|NCT00131040|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92595126|NCT00131040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92595127|NCT00131040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595128|NCT00131040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595129|NCT00131040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595130|NCT00400478|Rituximab|rituximab|mesh-list
92595131|NCT00400478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92595132|NCT00400478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595133|NCT00400478|Immunologic Factors|immunologic factors|mesh-ancestor
92595134|NCT00400478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595135|NCT00400478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595136|NCT01052038|Dexamethasone|dexamethasone|mesh-list
92595137|NCT01052038|Dexamethasone acetate|dexamethasone acetate|mesh-list
92595138|NCT01052038|BB 1101|bb 1101|mesh-list
92595139|NCT01052038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595140|NCT01052038|Antiemetics|antiemetics|mesh-ancestor
92595141|NCT01052038|Autonomic Agents|autonomic agents|mesh-ancestor
92595142|NCT01052038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595143|NCT01052038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595144|NCT01052038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595145|NCT01052038|Glucocorticoids|glucocorticoids|mesh-ancestor
92595146|NCT01052038|Hormones|hormones|mesh-ancestor
92595147|NCT01052038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595148|NCT01052038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595149|NCT01052038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595150|NCT01052038|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595151|NCT01052038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595152|NCT01052038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595153|NCT00432055|Botulinum Toxins|botulinum toxins|mesh-list
92595154|NCT00432055|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92595155|NCT00432055|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92595156|NCT00432055|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92595157|NCT00432055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92595158|NCT00432055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595159|NCT00432055|Cholinergic Agents|cholinergic agents|mesh-ancestor
92595160|NCT00432055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595161|NCT00432055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595162|NCT00432055|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92595163|NCT00432055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595164|NCT04711044|Menthol|menthol|mesh-list
92595165|NCT04711044|Histamine|histamine|mesh-list
92595166|NCT04711044|Antipruritics|antipruritics|mesh-ancestor
92536041|NCT00392886|Immunologic Factors|immunologic factors|mesh-ancestor
92536042|NCT00392886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536043|NCT00392886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536044|NCT00392886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92536045|NCT00392886|Alkylating Agents|alkylating agents|mesh-ancestor
92536046|NCT00392886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536047|NCT00392886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536048|NCT00392886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92536049|NCT00392886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92536050|NCT00392886|Abortifacient Agents|abortifacient agents|mesh-ancestor
92536051|NCT00392886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92536052|NCT00392886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92536053|NCT00392886|Antimetabolites|antimetabolites|mesh-ancestor
92536054|NCT00392886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92536055|NCT00392886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536056|NCT00392886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92536057|NCT00392886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92536058|NCT00392886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91941634|NCT05943990|Cyclophosphamide|cyclophosphamide|mesh-list
92595167|NCT04711044|Dermatologic Agents|dermatologic agents|mesh-ancestor
92595168|NCT04711044|Histamine Agonists|histamine agonists|mesh-ancestor
92595169|NCT04711044|Histamine Agents|histamine agents|mesh-ancestor
92595170|NCT04711044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595171|NCT04711044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595172|NCT04711044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595173|NCT01051960|Ambrisentan|ambrisentan|mesh-list
92595174|NCT01051960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92595175|NCT00432367|Artesunate|artesunate|mesh-list
92595176|NCT00432367|Pyrimethamine|pyrimethamine|mesh-list
92595177|NCT00432367|Sulfadoxine|sulfadoxine|mesh-list
92595178|NCT00432367|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92595179|NCT00432367|Amodiaquine|amodiaquine|mesh-list
92595180|NCT00432367|Antimalarials|antimalarials|mesh-ancestor
92595181|NCT00432367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92595182|NCT00432367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92595183|NCT00432367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595184|NCT00432367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595185|NCT00432367|Antiviral Agents|antiviral agents|mesh-ancestor
92595186|NCT00432367|Schistosomicides|schistosomicides|mesh-ancestor
92595188|NCT00432367|Anthelmintics|anthelmintics|mesh-ancestor
92595189|NCT00432367|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92595190|NCT00432367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595191|NCT00432367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595192|NCT00432367|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92595194|NCT00097760|Immunologic Factors|immunologic factors|mesh-ancestor
92595195|NCT00097760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595196|NCT00432406|Infliximab|infliximab|mesh-list
92595197|NCT00432406|Etanercept|etanercept|mesh-list
92595198|NCT00432406|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92595199|NCT00432406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595200|NCT00432406|Dermatologic Agents|dermatologic agents|mesh-ancestor
92595201|NCT00432406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595202|NCT00432406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595203|NCT00432406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595204|NCT00432406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92536059|NCT00392886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536060|NCT00392886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92536061|NCT00392886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536062|NCT00392886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536063|NCT00392886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536064|NCT00080041|Motexafin gadolinium|motexafin gadolinium|mesh-list
92536065|NCT00080041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536066|NCT00080041|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92536067|NCT00080041|Dermatologic Agents|dermatologic agents|mesh-ancestor
92536068|NCT00080080|Docetaxel|docetaxel|mesh-list
92536069|NCT00080080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536070|NCT00080080|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536071|NCT00080080|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536072|NCT00080080|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536073|NCT00080080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536074|NCT00080158|Mirtazapine|mirtazapine|mesh-list
92536075|NCT00080158|Citalopram|citalopram|mesh-list
92536076|NCT00080158|Bupropion|bupropion|mesh-list
92536077|NCT00080158|Fluoxetine|fluoxetine|mesh-list
92536078|NCT00080158|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92595205|NCT00432406|Analgesics|analgesics|mesh-ancestor
92595206|NCT00432406|Sensory System Agents|sensory system agents|mesh-ancestor
92595207|NCT00432406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595208|NCT00432406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595209|NCT00432406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595210|NCT00432406|Immunologic Factors|immunologic factors|mesh-ancestor
92595211|NCT00131118|Zoledronic Acid|zoledronic acid|mesh-list
92595212|NCT00131118|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92595213|NCT00131118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595214|NCT02957656|Vaccines|vaccines|mesh-list
92595215|NCT02957656|Immunologic Factors|immunologic factors|mesh-ancestor
92595216|NCT02957656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595217|NCT00097799|Ritonavir|ritonavir|mesh-list
92595218|NCT00097799|Tipranavir|tipranavir|mesh-list
92595219|NCT00097799|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92595220|NCT00097799|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92595221|NCT00097799|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595222|NCT00097799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595223|NCT00097799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595224|NCT00097799|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92595225|NCT00097799|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92595226|NCT00097799|Antiviral Agents|antiviral agents|mesh-ancestor
92595227|NCT00097799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595228|NCT00097799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92595229|NCT00097799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92595230|NCT01051921|Interferons|interferons|mesh-list
92595231|NCT01051921|Ribavirin|ribavirin|mesh-list
92595232|NCT01051921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595233|NCT01051921|Antiviral Agents|antiviral agents|mesh-ancestor
92595234|NCT01051921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595235|NCT01051921|Antimetabolites|antimetabolites|mesh-ancestor
92595236|NCT01051921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595237|NCT02273479|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92595238|NCT02273479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92595239|NCT02273518|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92595240|NCT02273518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92595241|NCT00432757|Ketotifen|ketotifen|mesh-list
92595242|NCT00432757|Antipruritics|antipruritics|mesh-ancestor
92536079|NCT00080158|Sertraline|sertraline|mesh-list
92536080|NCT00080158|Escitalopram|escitalopram|mesh-list
92536081|NCT00080158|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92536082|NCT00080158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92536083|NCT00080158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92536084|NCT00080158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536085|NCT00080158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595243|NCT00432757|Dermatologic Agents|dermatologic agents|mesh-ancestor
92595244|NCT00432757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92595245|NCT00432757|Histamine Antagonists|histamine antagonists|mesh-ancestor
92595246|NCT00432757|Histamine Agents|histamine agents|mesh-ancestor
92595247|NCT00432757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595248|NCT00432757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595249|NCT00432757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595250|NCT00432757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92595251|NCT00432796|Dalteparin|dalteparin|mesh-list
92595252|NCT00432796|Tinzaparin|tinzaparin|mesh-list
92595253|NCT00432796|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92595254|NCT00432796|Anticoagulants|anticoagulants|mesh-ancestor
92595255|NCT00432796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92595256|NCT00432796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92595257|NCT00432796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595258|NCT00097877|Insulin|insulin|mesh-list
92595259|NCT00097877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92595260|NCT00097877|Insulin Glargine|insulin glargine|mesh-list
92595264|NCT00097877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595266|NCT00097916|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92595267|NCT00097916|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92595268|NCT00097916|Dopamine Agents|dopamine agents|mesh-ancestor
92595269|NCT00097916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595270|NCT00097916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595271|NCT00097916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595272|NCT00097916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92595273|NCT00097916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92595274|NCT00433069|Pioglitazone|pioglitazone|mesh-list
92595275|NCT00433069|Interferons|interferons|mesh-list
92595276|NCT00433069|Ribavirin|ribavirin|mesh-list
92595277|NCT00433069|Interferon-alpha|interferon-alpha|mesh-list
92595278|NCT00433069|Interferon alpha-2|interferon alpha-2|mesh-list
92595279|NCT00433069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595280|NCT00433069|Antiviral Agents|antiviral agents|mesh-ancestor
92595281|NCT00433069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595282|NCT00433069|Antimetabolites|antimetabolites|mesh-ancestor
92595283|NCT00433069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595284|NCT00433069|Immunologic Factors|immunologic factors|mesh-ancestor
92595285|NCT00433069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595286|NCT00433069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92595287|NCT01580371|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92595288|NCT01580371|CKD-581|ckd-581|mesh-list
92595289|NCT01580371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595290|NCT01580371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595291|NCT00403026|Bevacizumab|bevacizumab|mesh-list
92595292|NCT00403026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92595293|NCT00403026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595294|NCT00403026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92595295|NCT00403026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92595296|NCT00403026|Growth Substances|growth substances|mesh-ancestor
92595297|NCT00403026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595298|NCT00403026|Growth Inhibitors|growth inhibitors|mesh-ancestor
92595299|NCT00131274|Imatinib Mesylate|imatinib mesylate|mesh-list
92595300|NCT00131274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595301|NCT00131274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92595302|NCT00131274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595303|NCT00131274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595304|NCT00098033|Clofarabine|clofarabine|mesh-list
92595305|NCT00098033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92595306|NCT00098033|Antimetabolites|antimetabolites|mesh-ancestor
92536086|NCT00080158|Serotonin Agents|serotonin agents|mesh-ancestor
92536087|NCT00080158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536088|NCT00080158|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92536089|NCT00080158|Antidepressive Agents|antidepressive agents|mesh-ancestor
92536090|NCT00080158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92536091|NCT00080158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92536092|NCT00080158|Dopamine Agents|dopamine agents|mesh-ancestor
92536093|NCT00080158|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92536094|NCT00080158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92536095|NCT00080158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536096|NCT00080158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92536097|NCT00080158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536098|NCT00080158|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92536099|NCT00080158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92536100|NCT00080158|Histamine Antagonists|histamine antagonists|mesh-ancestor
92536101|NCT00080158|Histamine Agents|histamine agents|mesh-ancestor
92536102|NCT00080158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92536103|NCT00080158|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92595307|NCT00098033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595308|NCT00098033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595309|NCT00403065|Dexamethasone|dexamethasone|mesh-list
92595310|NCT00403065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595311|NCT00403065|Antiemetics|antiemetics|mesh-ancestor
92595312|NCT00403065|Autonomic Agents|autonomic agents|mesh-ancestor
92595313|NCT00403065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595314|NCT00403065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595315|NCT00403065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595316|NCT00403065|Glucocorticoids|glucocorticoids|mesh-ancestor
92595317|NCT00403065|Hormones|hormones|mesh-ancestor
92595318|NCT00403065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595319|NCT00403065|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595320|NCT00403065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595321|NCT00098111|Azathioprine|azathioprine|mesh-list
92595322|NCT00098111|Antimetabolites|antimetabolites|mesh-ancestor
92595323|NCT00098111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595324|NCT00098111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92595325|NCT00098111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595326|NCT00098111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595327|NCT00098111|Immunologic Factors|immunologic factors|mesh-ancestor
92595328|NCT00098111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595329|NCT00098111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595330|NCT04702906|Trimetazidine|trimetazidine|mesh-list
92595331|NCT04702906|Vasodilator Agents|vasodilator agents|mesh-ancestor
92595332|NCT00131313|Cyclophosphamide|cyclophosphamide|mesh-list
92595336|NCT00131313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595337|NCT00131313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595338|NCT00131313|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92320185|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
92595339|NCT00131313|Alkylating Agents|alkylating agents|mesh-ancestor
92595340|NCT00131313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595341|NCT00131313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595342|NCT00131313|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92595343|NCT00131313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92595344|NCT00433186|Mycophenolic Acid|mycophenolic acid|mesh-list
92536104|NCT00080158|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92536105|NCT00080158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92536106|NCT00080158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92536107|NCT00080158|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92536108|NCT00080158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92536109|NCT00080158|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92536110|NCT00080197|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92536111|NCT00080197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536112|NCT00080197|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92536113|NCT00080197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536114|NCT00080197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536115|NCT00080275|Niacin|niacin|mesh-list
92536116|NCT00080275|Simvastatin|simvastatin|mesh-list
92536117|NCT00080275|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92536118|NCT00080275|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92536119|NCT00080275|Antimetabolites|antimetabolites|mesh-ancestor
92536120|NCT00080275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536121|NCT00080275|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92536122|NCT00080275|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92536123|NCT00080275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536124|NCT00080275|Vasodilator Agents|vasodilator agents|mesh-ancestor
92595345|NCT00433186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92595346|NCT00433186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595347|NCT00433186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92595348|NCT00433186|Antitubercular Agents|antitubercular agents|mesh-ancestor
92595349|NCT00433186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595350|NCT00433186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595351|NCT00433186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595352|NCT00433186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595353|NCT00433225|Gatifloxacin|gatifloxacin|mesh-list
92595354|NCT00433225|Prednisolone|prednisolone|mesh-list
92595355|NCT00433225|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92595356|NCT00433225|Methylprednisolone|methylprednisolone|mesh-list
92595357|NCT00433225|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92595358|NCT00433225|Prednisolone acetate|prednisolone acetate|mesh-list
92595359|NCT00433225|Ketorolac|ketorolac|mesh-list
92595360|NCT00433225|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92595361|NCT00433225|Prednisolone phosphate|prednisolone phosphate|mesh-list
92595362|NCT00433225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595363|NCT00433225|Glucocorticoids|glucocorticoids|mesh-ancestor
92595364|NCT00433225|Hormones|hormones|mesh-ancestor
92595365|NCT00433225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595366|NCT00433225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595367|NCT00433225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595368|NCT00433225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595369|NCT00433225|Antiemetics|antiemetics|mesh-ancestor
92595370|NCT00433225|Autonomic Agents|autonomic agents|mesh-ancestor
92595371|NCT00433225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595372|NCT00433225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595373|NCT00433225|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92595374|NCT00433225|Protective Agents|protective agents|mesh-ancestor
92536125|NCT00080275|Vitamin B Complex|vitamin b complex|mesh-ancestor
92536126|NCT00080275|Vitamins|vitamins|mesh-ancestor
92536127|NCT00080275|Micronutrients|micronutrients|mesh-ancestor
92536128|NCT00080275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536129|NCT00393003|Anesthetics|anesthetics|mesh-list
92536130|NCT00393003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536131|NCT00393003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536132|NCT00080314|Aripiprazole|aripiprazole|mesh-list
92536133|NCT00080314|Antidepressive Agents|antidepressive agents|mesh-ancestor
92536134|NCT00080314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92595375|NCT00433225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595376|NCT00433225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595377|NCT00433225|Analgesics|analgesics|mesh-ancestor
92595378|NCT00433225|Sensory System Agents|sensory system agents|mesh-ancestor
92595379|NCT00433225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595380|NCT00433225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92595381|NCT00433225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595382|NCT00433225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595383|NCT00433225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595384|NCT00433225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595385|NCT00433225|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92595386|NCT00433225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92595387|NCT00433225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92595388|NCT00433225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92595389|NCT00433342|Floxacillin|floxacillin|mesh-list
92595390|NCT00433342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595391|NCT00433342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595392|NCT00131391|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92595393|NCT00131391|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92595394|NCT00131391|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92595395|NCT00131391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595396|NCT00131391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595397|NCT00131391|Hormones|hormones|mesh-ancestor
92595398|NCT00131391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595399|NCT00131391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595400|NCT00433459|Prednisone|prednisone|mesh-list
92595401|NCT00433459|Prednisolone|prednisolone|mesh-list
92595405|NCT00433459|Procarbazine|procarbazine|mesh-list
92595406|NCT00433459|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92595407|NCT00433459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595408|NCT00433459|Immunologic Factors|immunologic factors|mesh-ancestor
92595409|NCT00433459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595410|NCT00433459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595411|NCT00433459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92595412|NCT00433459|Alkylating Agents|alkylating agents|mesh-ancestor
92595413|NCT00433459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595414|NCT00433459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595415|NCT00433459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92595416|NCT00433459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595417|NCT00433459|Glucocorticoids|glucocorticoids|mesh-ancestor
92595418|NCT00433459|Hormones|hormones|mesh-ancestor
92595419|NCT00433459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595420|NCT00433459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595421|NCT00433459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92595422|NCT00433459|Tubulin Modulators|tubulin modulators|mesh-ancestor
92595423|NCT00433459|Antimitotic Agents|antimitotic agents|mesh-ancestor
92595424|NCT00433459|Mitosis Modulators|mitosis modulators|mesh-ancestor
92595425|NCT00433459|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92595426|NCT00433498|Carboplatin|carboplatin|mesh-list
92595427|NCT00433498|Etoposide|etoposide|mesh-list
92595428|NCT00433498|Etoposide phosphate|etoposide phosphate|mesh-list
92595429|NCT00433498|Pravastatin|pravastatin|mesh-list
92595430|NCT00433498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595431|NCT00433498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92536135|NCT00080314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92536136|NCT00080314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92536137|NCT00080314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536138|NCT00080314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536139|NCT00080314|Dopamine Agonists|dopamine agonists|mesh-ancestor
92595432|NCT00433498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92595433|NCT00433498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92595434|NCT00433498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595435|NCT00433498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595436|NCT00433498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92595437|NCT00433498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92595438|NCT00433498|Antimetabolites|antimetabolites|mesh-ancestor
92595439|NCT00433498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92595440|NCT00433498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92595441|NCT00433576|Resveratrol|resveratrol|mesh-list
92595442|NCT00433576|Antioxidants|antioxidants|mesh-ancestor
92595443|NCT00433576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595444|NCT00433576|Protective Agents|protective agents|mesh-ancestor
92595445|NCT00433576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595446|NCT00433576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595447|NCT00433576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92595448|NCT00433615|Epoetin Alfa|epoetin alfa|mesh-list
92595449|NCT00433615|Hematinics|hematinics|mesh-ancestor
92595450|NCT00098384|Rifaximin|rifaximin|mesh-list
92595451|NCT00098384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595452|NCT00098384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595453|NCT00098384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595454|NCT00433732|Naproxen|naproxen|mesh-list
92595455|NCT00433732|Sumatriptan|sumatriptan|mesh-list
92595456|NCT00433732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595457|NCT00433732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595458|NCT00433732|Analgesics|analgesics|mesh-ancestor
92595459|NCT00433732|Sensory System Agents|sensory system agents|mesh-ancestor
92595460|NCT00433732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595461|NCT00433732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595462|NCT00433732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595463|NCT00433732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595464|NCT00433732|Gout Suppressants|gout suppressants|mesh-ancestor
92595465|NCT00433732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92595466|NCT00433732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595467|NCT00433732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595468|NCT00433732|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92595469|NCT00433732|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92595470|NCT00433732|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92595471|NCT00433732|Serotonin Agents|serotonin agents|mesh-ancestor
92595472|NCT00433732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595473|NCT00098423|Cytarabine|cytarabine|mesh-list
92595474|NCT00098423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92595478|NCT00098423|Antiviral Agents|antiviral agents|mesh-ancestor
92595479|NCT00098423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595480|NCT00098423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595481|NCT00098423|Immunologic Factors|immunologic factors|mesh-ancestor
92595482|NCT00098423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595483|NCT01050790|Lenalidomide|lenalidomide|mesh-list
92595484|NCT01050790|Azacitidine|azacitidine|mesh-list
92595485|NCT01050790|Immunologic Factors|immunologic factors|mesh-ancestor
92595486|NCT01050790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595487|NCT01050790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92595488|NCT01050790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92595489|NCT01050790|Growth Substances|growth substances|mesh-ancestor
92595490|NCT01050790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92595491|NCT01050790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595492|NCT01050790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92595493|NCT01050790|Antimetabolites|antimetabolites|mesh-ancestor
92595494|NCT01050790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595495|NCT01050790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595496|NCT00433927|Leucovorin|leucovorin|mesh-list
92595497|NCT00433927|Folic Acid|folic acid|mesh-list
92595498|NCT00433927|Bevacizumab|bevacizumab|mesh-list
92536141|NCT00080314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536142|NCT00080314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536143|NCT00080314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92536144|NCT00080314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92536145|NCT00080314|Serotonin Agents|serotonin agents|mesh-ancestor
92536146|NCT00080314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92536147|NCT00080314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92536148|NCT00080314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92536149|NCT00080314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92536150|NCT00080353|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92536151|NCT00080353|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92536152|NCT00080353|Immunologic Factors|immunologic factors|mesh-ancestor
91942088|NCT05602818|GABA Modulators|gaba modulators|mesh-ancestor
92595499|NCT00433927|Cetuximab|cetuximab|mesh-list
92595500|NCT00433927|Irinotecan|irinotecan|mesh-list
92595501|NCT00433927|Levoleucovorin|levoleucovorin|mesh-list
92595502|NCT00433927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92595503|NCT00433927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595504|NCT00433927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92595505|NCT00433927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92595506|NCT00433927|Growth Substances|growth substances|mesh-ancestor
92595507|NCT00433927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595508|NCT00433927|Growth Inhibitors|growth inhibitors|mesh-ancestor
92595509|NCT00433927|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92595510|NCT00433927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92595511|NCT00433927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595512|NCT00433927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595513|NCT00433927|Antidotes|antidotes|mesh-ancestor
92595514|NCT00433927|Protective Agents|protective agents|mesh-ancestor
92595515|NCT00433927|Vitamin B Complex|vitamin b complex|mesh-ancestor
92595516|NCT00433927|Vitamins|vitamins|mesh-ancestor
92595517|NCT00433927|Micronutrients|micronutrients|mesh-ancestor
92595518|NCT00433927|Hematinics|hematinics|mesh-ancestor
92595519|NCT00131430|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92595520|NCT00131430|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92595521|NCT00131430|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92595522|NCT00131430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595523|NCT00131430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595524|NCT00131430|Hormones|hormones|mesh-ancestor
92595525|NCT00131430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595526|NCT00131430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595527|NCT00098462|Sirolimus|sirolimus|mesh-list
92595528|NCT00098462|Gefitinib|gefitinib|mesh-list
92595529|NCT00098462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595530|NCT00098462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595531|NCT00098462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92595532|NCT00098462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595533|NCT00098462|Antifungal Agents|antifungal agents|mesh-ancestor
92595534|NCT00098462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595535|NCT00098462|Immunologic Factors|immunologic factors|mesh-ancestor
92595536|NCT00098462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595537|NCT00098462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92595538|NCT00098462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595539|NCT00098462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595540|NCT00098501|Sirolimus|sirolimus|mesh-list
92595541|NCT00098501|Temsirolimus|temsirolimus|mesh-list
92595542|NCT00098501|MTOR Inhibitors|mtor inhibitors|mesh-list
92595543|NCT00098501|EKB 569|ekb 569|mesh-list
92536153|NCT00080353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536154|NCT00080431|Daclizumab|daclizumab|mesh-list
92536155|NCT00080431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536156|NCT00080431|Immunologic Factors|immunologic factors|mesh-ancestor
92536157|NCT00080431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536158|NCT00080509|Desoxyepothilone B|desoxyepothilone b|mesh-list
92536159|NCT00080509|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536160|NCT00080509|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536161|NCT00080509|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536162|NCT00080509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536163|NCT00080509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536164|NCT03506373|Ixazomib|ixazomib|mesh-list
92536165|NCT03506373|Glycine|glycine|mesh-list
92595544|NCT00098501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92595545|NCT00098501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002834|NCT03739112|Vaccines|vaccines|mesh-list
92595546|NCT00098501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595548|NCT00098501|Immunologic Factors|immunologic factors|mesh-ancestor
92595549|NCT00098501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595550|NCT00098501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595551|NCT00098501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595552|NCT00098501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595553|NCT00098501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92595554|NCT00098501|Antifungal Agents|antifungal agents|mesh-ancestor
92595555|NCT00434005|Acetylcysteine|acetylcysteine|mesh-list
92595556|NCT00434005|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92595557|NCT00434005|Antiviral Agents|antiviral agents|mesh-ancestor
92595558|NCT00434005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595559|NCT00434005|Expectorants|expectorants|mesh-ancestor
92595560|NCT00434005|Respiratory System Agents|respiratory system agents|mesh-ancestor
92595561|NCT00434005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92320421|NCT00634322|Leucovorin|leucovorin|mesh-list
92595562|NCT00434005|Antioxidants|antioxidants|mesh-ancestor
92595563|NCT00434005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595564|NCT00434005|Protective Agents|protective agents|mesh-ancestor
92595565|NCT00434005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595566|NCT00434005|Antidotes|antidotes|mesh-ancestor
92595567|NCT00434044|Etanercept|etanercept|mesh-list
92595568|NCT00434044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595569|NCT00434044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595570|NCT00434044|Analgesics|analgesics|mesh-ancestor
92595571|NCT00434044|Sensory System Agents|sensory system agents|mesh-ancestor
92595572|NCT00434044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595573|NCT00434044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595574|NCT00434044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595575|NCT00434044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595576|NCT00434044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595577|NCT00434044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595578|NCT00434044|Immunologic Factors|immunologic factors|mesh-ancestor
92595579|NCT00434083|Naproxen|naproxen|mesh-list
92595580|NCT00434083|Sumatriptan|sumatriptan|mesh-list
92595581|NCT00434083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595582|NCT00434083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595583|NCT00434083|Analgesics|analgesics|mesh-ancestor
92595584|NCT00434083|Sensory System Agents|sensory system agents|mesh-ancestor
92595585|NCT00434083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595586|NCT00434083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595587|NCT00434083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595588|NCT00434083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595589|NCT00434083|Gout Suppressants|gout suppressants|mesh-ancestor
92595590|NCT00434083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92595591|NCT00434083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595592|NCT00434083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595593|NCT00434083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92536166|NCT03506373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536167|NCT03506373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536168|NCT03506373|Protease Inhibitors|protease inhibitors|mesh-ancestor
92536169|NCT03506373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536170|NCT03506373|Glycine Agents|glycine agents|mesh-ancestor
92536171|NCT03506373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595594|NCT00434083|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92595595|NCT00434083|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92595596|NCT00434083|Serotonin Agents|serotonin agents|mesh-ancestor
92595597|NCT00434083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595598|NCT00098540|Sorafenib|sorafenib|mesh-list
92595599|NCT00098540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595600|NCT00098540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92595601|NCT00098540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595602|NCT00098540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595603|NCT00098579|Doxorubicin|doxorubicin|mesh-list
92595604|NCT00098579|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92595605|NCT00098579|Alvocidib|alvocidib|mesh-list
92595606|NCT00098579|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92595607|NCT00098579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595608|NCT00098579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92595609|NCT00098579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92595610|NCT00098579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595611|NCT00098579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595612|NCT00098579|Growth Inhibitors|growth inhibitors|mesh-ancestor
92595613|NCT00098579|Growth Substances|growth substances|mesh-ancestor
92595614|NCT00098579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595615|NCT00098579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92595616|NCT00098618|Interferons|interferons|mesh-list
92595617|NCT00098618|Interferon-alpha|interferon-alpha|mesh-list
92595618|NCT00098618|Interferon alpha-2|interferon alpha-2|mesh-list
92595619|NCT00098618|Sorafenib|sorafenib|mesh-list
92595623|NCT00098618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92595624|NCT00098618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595625|NCT00098618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595626|NCT00098618|Immunologic Factors|immunologic factors|mesh-ancestor
92595627|NCT00098618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595628|NCT00098735|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92595629|NCT00098735|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92595630|NCT00098735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595631|NCT00098735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595632|NCT00098735|Immunologic Factors|immunologic factors|mesh-ancestor
92595633|NCT00098735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595634|NCT00098852|Rosiglitazone|rosiglitazone|mesh-list
92595635|NCT00098852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92320504|NCT00377143|Warfarin|warfarin|mesh-list
92595636|NCT00098852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595637|NCT01059448|Brodalumab|brodalumab|mesh-list
92595638|NCT01059448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92595639|NCT00098891|Entinostat|entinostat|mesh-list
92595640|NCT00098891|Isotretinoin|isotretinoin|mesh-list
92595641|NCT00098891|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92595642|NCT00098891|Dermatologic Agents|dermatologic agents|mesh-ancestor
92595643|NCT00098891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595644|NCT00098891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595645|NCT00098891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595646|NCT00098969|Resveratrol|resveratrol|mesh-list
92595647|NCT00098969|Antioxidants|antioxidants|mesh-ancestor
92595648|NCT00098969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595649|NCT00098969|Protective Agents|protective agents|mesh-ancestor
92595650|NCT00098969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595651|NCT00098969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595652|NCT00098969|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92595653|NCT00099008|Genistein|genistein|mesh-list
92595654|NCT00099008|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92595655|NCT00099008|Protective Agents|protective agents|mesh-ancestor
92595656|NCT00099008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595657|NCT00099008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595658|NCT00099008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536172|NCT03506373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536173|NCT02972411|Acetazolamide|acetazolamide|mesh-list
92536174|NCT02972411|Anticonvulsants|anticonvulsants|mesh-ancestor
92536175|NCT02972411|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92536176|NCT02972411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536177|NCT02972411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536178|NCT02972411|Diuretics|diuretics|mesh-ancestor
92536179|NCT02972411|Natriuretic Agents|natriuretic agents|mesh-ancestor
92536180|NCT02972411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536181|NCT00080626|Docetaxel|docetaxel|mesh-list
92536182|NCT00080626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595659|NCT00099008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595660|NCT00099008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595661|NCT00099008|Phytoestrogens|phytoestrogens|mesh-ancestor
92595662|NCT00099008|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92595663|NCT00099008|Estrogens|estrogens|mesh-ancestor
92595664|NCT00099008|Hormones|hormones|mesh-ancestor
92595665|NCT00099008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595666|NCT00434239|Lenalidomide|lenalidomide|mesh-list
92595667|NCT00434239|Immunologic Factors|immunologic factors|mesh-ancestor
92595668|NCT00434239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595669|NCT00434239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92595670|NCT00434239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92595671|NCT00434239|Growth Substances|growth substances|mesh-ancestor
92595672|NCT00434239|Growth Inhibitors|growth inhibitors|mesh-ancestor
92595673|NCT00434239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595674|NCT01057147|Rebamipide|rebamipide|mesh-list
92595675|NCT01057147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92595676|NCT01057147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92595677|NCT01057147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92595678|NCT01057147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595679|NCT01057147|Antioxidants|antioxidants|mesh-ancestor
92595680|NCT01057147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595681|NCT01057147|Protective Agents|protective agents|mesh-ancestor
92595682|NCT01057147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595683|NCT01057147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595684|NCT00099125|Irinotecan|irinotecan|mesh-list
92595685|NCT00099125|Temozolomide|temozolomide|mesh-list
92595686|NCT00099125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92595687|NCT00099125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92595688|NCT00099125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595689|NCT00099125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595690|NCT00099125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595696|NCT00131703|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92595697|NCT00131703|Amodiaquine|amodiaquine|mesh-list
92595698|NCT00131703|Amebicides|amebicides|mesh-ancestor
92595699|NCT00131703|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92595700|NCT00131703|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92595701|NCT00131703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595702|NCT00131703|Antimalarials|antimalarials|mesh-ancestor
92595703|NCT00131703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595704|NCT00131703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92595705|NCT00131703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595706|NCT00131703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595707|NCT00131703|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92595708|NCT01051414|Asunaprevir|asunaprevir|mesh-list
92595709|NCT01051414|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595710|NCT01051414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704670|NCT01229072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92320566|NCT01633814|Estradiol|estradiol|mesh-list
92595711|NCT01051414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595712|NCT00434317|Zoledronic Acid|zoledronic acid|mesh-list
92595713|NCT00434317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92595714|NCT00434317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536183|NCT00080626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536184|NCT00080626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536185|NCT00080626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536186|NCT00080626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536188|NCT00080665|Imatinib Mesylate|imatinib mesylate|mesh-list
92536189|NCT00080665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536190|NCT00080665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536191|NCT00080665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536192|NCT00080665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536193|NCT00080665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536194|NCT00080665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536195|NCT00080665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536196|NCT00080743|Tamoxifen|tamoxifen|mesh-list
92536197|NCT00080743|Gefitinib|gefitinib|mesh-list
92536198|NCT00080743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536199|NCT00080743|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92536200|NCT00080743|Hormone Antagonists|hormone antagonists|mesh-ancestor
92536201|NCT00080743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536237|NCT00080782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536238|NCT00080782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536239|NCT00080782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536240|NCT00080782|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92536241|NCT00080782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92536242|NCT00080860|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92536243|NCT00080860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92536244|NCT00080860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536245|NCT00080977|Aldesleukin|aldesleukin|mesh-list
92536246|NCT00080977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536247|NCT00080977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92536248|NCT00080977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92536249|NCT00080977|Antiviral Agents|antiviral agents|mesh-ancestor
92536250|NCT00080977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261028|NCT03013556|Tenofovir|tenofovir|mesh-list
92536251|NCT00081055|Cyclosporine|cyclosporine|mesh-list
92536252|NCT00081055|Cyclophosphamide|cyclophosphamide|mesh-list
92595715|NCT00099164|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92595716|NCT00099164|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92595717|NCT00099164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92595718|NCT00099164|Hormone Antagonists|hormone antagonists|mesh-ancestor
92595719|NCT00099164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595720|NCT00099164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595721|NCT00099164|Progestins|progestins|mesh-ancestor
92595722|NCT00099164|Hormones|hormones|mesh-ancestor
92595723|NCT00131742|Lamivudine|lamivudine|mesh-list
92595724|NCT00131742|Telbivudine|telbivudine|mesh-list
92595725|NCT00131742|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92595726|NCT00131742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92595727|NCT00131742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595728|NCT00131742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595729|NCT00131742|Antiviral Agents|antiviral agents|mesh-ancestor
92595730|NCT00131742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595731|NCT00131742|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92595732|NCT00131742|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92595733|NCT04621149|Lactoferrin|lactoferrin|mesh-list
92595734|NCT04621149|Chlorine dioxide|chlorine dioxide|mesh-list
92595735|NCT04621149|Famotidine|famotidine|mesh-list
92595736|NCT04621149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92595737|NCT04621149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595738|NCT04621149|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92595739|NCT04621149|Histamine Antagonists|histamine antagonists|mesh-ancestor
92595740|NCT04621149|Histamine Agents|histamine agents|mesh-ancestor
92595741|NCT04621149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595742|NCT04621149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595743|NCT04621149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595744|NCT04621149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595745|NCT04621149|Dental Disinfectants|dental disinfectants|mesh-ancestor
92595746|NCT04621149|Disinfectants|disinfectants|mesh-ancestor
92595747|NCT00099203|Zoledronic Acid|zoledronic acid|mesh-list
92595748|NCT00099203|Ibandronic Acid|ibandronic acid|mesh-list
92595749|NCT00099203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92595750|NCT00099203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595751|NCT00099242|Rivastigmine|rivastigmine|mesh-list
92595752|NCT00099242|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92595753|NCT00099242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595754|NCT00099242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595755|NCT00099242|Cholinergic Agents|cholinergic agents|mesh-ancestor
92595756|NCT00099242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536254|NCT00081055|Methotrexate|methotrexate|mesh-list
92536255|NCT00081055|Cyclosporins|cyclosporins|mesh-list
92536256|NCT00081055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536257|NCT00081055|Immunologic Factors|immunologic factors|mesh-ancestor
92536258|NCT00081055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536259|NCT00081055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536260|NCT00081055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92536261|NCT00081055|Alkylating Agents|alkylating agents|mesh-ancestor
92536262|NCT00081055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536263|NCT00081055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536264|NCT00081055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92536265|NCT00081055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92595757|NCT00099242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595758|NCT00099242|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92595759|NCT00099242|Protective Agents|protective agents|mesh-ancestor
92595760|NCT00099320|Exenatide|exenatide|mesh-list
92595766|NCT00099320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595768|NCT00403650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92595769|NCT00403650|Vasodilator Agents|vasodilator agents|mesh-ancestor
92595771|NCT00403728|Cyclosporins|cyclosporins|mesh-list
92595772|NCT00403728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360502|NCT00425802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595773|NCT00403728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595774|NCT00403728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595775|NCT00403728|Immunologic Factors|immunologic factors|mesh-ancestor
92595776|NCT00403728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595777|NCT00403728|Antifungal Agents|antifungal agents|mesh-ancestor
92595778|NCT00403728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595779|NCT00403728|Dermatologic Agents|dermatologic agents|mesh-ancestor
92595780|NCT00403728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595781|NCT00403728|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92595782|NCT00403806|Dexamethasone|dexamethasone|mesh-list
92595783|NCT00403806|Dexamethasone acetate|dexamethasone acetate|mesh-list
92595784|NCT00403806|BB 1101|bb 1101|mesh-list
92595785|NCT00403806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595786|NCT00403806|Antiemetics|antiemetics|mesh-ancestor
92595787|NCT00403806|Autonomic Agents|autonomic agents|mesh-ancestor
92595788|NCT00403806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595789|NCT00403806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595790|NCT00403806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595791|NCT00403806|Glucocorticoids|glucocorticoids|mesh-ancestor
92595792|NCT00403806|Hormones|hormones|mesh-ancestor
92595793|NCT00403806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595794|NCT00403806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92595795|NCT00403806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595796|NCT00403806|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595797|NCT00403806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595798|NCT00403806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595799|NCT00400556|Lenograstim|lenograstim|mesh-list
92595800|NCT00400556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92595801|NCT00400556|Immunologic Factors|immunologic factors|mesh-ancestor
92595802|NCT00400556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595803|NCT00400595|Mupirocin|mupirocin|mesh-list
92595804|NCT00400595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92595805|NCT00400595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595806|NCT00400595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92595807|NCT00400595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595808|NCT00400595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595809|NCT00099554|Etanercept|etanercept|mesh-list
92595810|NCT00099554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595811|NCT00099554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595812|NCT00099554|Analgesics|analgesics|mesh-ancestor
92536266|NCT00081055|Abortifacient Agents|abortifacient agents|mesh-ancestor
92536267|NCT00081055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92536268|NCT00081055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92536269|NCT00081055|Antimetabolites|antimetabolites|mesh-ancestor
92536270|NCT00081055|Dermatologic Agents|dermatologic agents|mesh-ancestor
92536271|NCT00081055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536272|NCT00081055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92536273|NCT00081055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92536274|NCT00081055|Antifungal Agents|antifungal agents|mesh-ancestor
92536275|NCT00081055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536276|NCT00081055|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92536277|NCT00081094|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92536278|NCT00081094|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92595813|NCT00099554|Sensory System Agents|sensory system agents|mesh-ancestor
92595814|NCT00099554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595815|NCT00099554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595816|NCT00099554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595817|NCT00099554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595818|NCT00099554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92595819|NCT00099554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595820|NCT00099554|Immunologic Factors|immunologic factors|mesh-ancestor
92595821|NCT00132054|Irinotecan|irinotecan|mesh-list
92595822|NCT00132054|Amrubicin|amrubicin|mesh-list
92595823|NCT00132054|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92595824|NCT00132054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92595825|NCT00132054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595826|NCT00132054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595827|NCT00132054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595828|NCT00099710|Curcumin|curcumin|mesh-list
92595829|NCT00099710|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92595830|NCT00099710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595832|NCT00099710|Sensory System Agents|sensory system agents|mesh-ancestor
92595833|NCT00099710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595834|NCT00099710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595835|NCT00099710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595836|NCT00099710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92595837|NCT00099710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595838|NCT00099710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595839|NCT00099710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595840|NCT00099749|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92595841|NCT00099749|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92595842|NCT00099749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595843|NCT00099749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595844|NCT00099749|Immunologic Factors|immunologic factors|mesh-ancestor
92595845|NCT00099749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595846|NCT00132093|Eplerenone|eplerenone|mesh-list
92595847|NCT00132093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92595848|NCT00132093|Hormone Antagonists|hormone antagonists|mesh-ancestor
92595849|NCT00132093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92595850|NCT00132093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595851|NCT00132093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92595852|NCT00132093|Diuretics|diuretics|mesh-ancestor
92595853|NCT00132093|Natriuretic Agents|natriuretic agents|mesh-ancestor
92595854|NCT00132093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92595855|NCT00099788|Ranolazine|ranolazine|mesh-list
92595856|NCT00099788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92595857|NCT00099788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92595858|NCT00099788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320722|NCT01055756|Loratadine|loratadine|mesh-list
92595860|NCT00099866|Vildagliptin|vildagliptin|mesh-list
92595861|NCT00099866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92536279|NCT00081094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536281|NCT00081133|Arsenic Trioxide|arsenic trioxide|mesh-list
92536282|NCT00081133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536283|NCT00081133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536284|NCT00081133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536285|NCT00081133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536286|NCT00081172|Antibodies|antibodies|mesh-list
92536287|NCT00081172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92536288|NCT00081172|Immunologic Factors|immunologic factors|mesh-ancestor
92536289|NCT00081172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536290|NCT03187080|Bupivacaine|bupivacaine|mesh-list
92536291|NCT03187080|Anesthetics, Local|anesthetics, local|mesh-list
92536292|NCT03187080|Anesthetics|anesthetics|mesh-list
92536293|NCT03187080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536294|NCT03187080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536295|NCT03187080|Sensory System Agents|sensory system agents|mesh-ancestor
92536296|NCT03187080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536297|NCT00081484|Epoetin Alfa|epoetin alfa|mesh-list
92536298|NCT00081484|Hematinics|hematinics|mesh-ancestor
92536299|NCT00390260|Acetaminophen|acetaminophen|mesh-list
92536300|NCT00390260|Rofecoxib|rofecoxib|mesh-list
92536301|NCT00390260|Hydrocodone|hydrocodone|mesh-list
92536302|NCT00390260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595862|NCT00099866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595863|NCT00099866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92595864|NCT00099866|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595865|NCT00099866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595866|NCT00099866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595867|NCT00099905|Vildagliptin|vildagliptin|mesh-list
92595868|NCT00099905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92595869|NCT00099905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595870|NCT00099905|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92595871|NCT00099905|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595872|NCT00099905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595873|NCT00099905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595874|NCT00132210|Interferons|interferons|mesh-list
92595875|NCT00132210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595876|NCT00132210|Antiviral Agents|antiviral agents|mesh-ancestor
92595877|NCT00132210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595878|NCT00099944|Glimepiride|glimepiride|mesh-list
92595879|NCT00099944|Vildagliptin|vildagliptin|mesh-list
92595880|NCT00099944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92595881|NCT00099944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92595882|NCT00099944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595883|NCT00099944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595884|NCT00099944|Immunologic Factors|immunologic factors|mesh-ancestor
92595885|NCT00099944|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92595886|NCT00099944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92595887|NCT00099944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595888|NCT00099944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595889|NCT04352166|Buprenorphine|buprenorphine|mesh-list
92595890|NCT04352166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92536303|NCT00390260|Analgesics|analgesics|mesh-ancestor
92536304|NCT00390260|Sensory System Agents|sensory system agents|mesh-ancestor
92536305|NCT00390260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536306|NCT00390260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536307|NCT00390260|Antipyretics|antipyretics|mesh-ancestor
92536308|NCT00390260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536309|NCT00390260|Respiratory System Agents|respiratory system agents|mesh-ancestor
92536310|NCT00390260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92536311|NCT00390260|Narcotics|narcotics|mesh-ancestor
92595891|NCT04352166|Narcotics|narcotics|mesh-ancestor
92595892|NCT04352166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92595893|NCT04352166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595894|NCT04352166|Analgesics|analgesics|mesh-ancestor
92595895|NCT04352166|Sensory System Agents|sensory system agents|mesh-ancestor
92595896|NCT04352166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595897|NCT04352166|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92595898|NCT04333914|Avdoralimab|avdoralimab|mesh-list
92595899|NCT04333914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92595900|NCT04333914|Antiviral Agents|antiviral agents|mesh-ancestor
92595901|NCT04333914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595902|NCT00100100|Modafinil|modafinil|mesh-list
92595903|NCT00100100|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92595904|NCT00100100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595905|NCT00100100|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92595906|NCT00100100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92595907|NCT00100100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92595908|NCT00100100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595910|NCT00100139|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92595911|NCT00100139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92595912|NCT00100139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595913|NCT00100139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92595914|NCT00100139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92595915|NCT00100139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92595916|NCT00100139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595917|NCT00100412|Phenylephrine|phenylephrine|mesh-list
92595918|NCT00100412|Dobutamine|dobutamine|mesh-list
92595919|NCT00100412|Oxymetazoline|oxymetazoline|mesh-list
92595920|NCT00100412|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92595921|NCT00100412|Mydriatics|mydriatics|mesh-ancestor
92595922|NCT00100412|Autonomic Agents|autonomic agents|mesh-ancestor
92595923|NCT00100412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595924|NCT00100412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595925|NCT00100412|Sympathomimetics|sympathomimetics|mesh-ancestor
92595926|NCT00100412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92595927|NCT00100412|Nasal Decongestants|nasal decongestants|mesh-ancestor
92595928|NCT00100412|Respiratory System Agents|respiratory system agents|mesh-ancestor
92595929|NCT00100412|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92595930|NCT00100412|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92595931|NCT00100412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92595932|NCT00100412|Adrenergic Agents|adrenergic agents|mesh-ancestor
92595933|NCT00100412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595934|NCT00100412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595935|NCT00100412|Protective Agents|protective agents|mesh-ancestor
92595936|NCT00100412|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92595937|NCT00100412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92595938|NCT04244058|Amantadine|amantadine|mesh-list
92595939|NCT04244058|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92595940|NCT04244058|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92595941|NCT04244058|Antiviral Agents|antiviral agents|mesh-ancestor
92595942|NCT04244058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595943|NCT04244058|Dopamine Agents|dopamine agents|mesh-ancestor
92595944|NCT04244058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595945|NCT04244058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595946|NCT04244058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595947|NCT04244058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92595948|NCT04244058|Analgesics|analgesics|mesh-ancestor
92536312|NCT00390260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536313|NCT00390260|Antitussive Agents|antitussive agents|mesh-ancestor
92536314|NCT00390260|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92536315|NCT00390260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92536316|NCT00390260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595949|NCT04244058|Sensory System Agents|sensory system agents|mesh-ancestor
92595950|NCT04244058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92595951|NCT00132444|UC-781|uc-781|mesh-list
92595952|NCT00132444|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92595953|NCT00132444|Antiviral Agents|antiviral agents|mesh-ancestor
92595954|NCT00132444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595955|NCT00100568|Lamivudine|lamivudine|mesh-list
92595956|NCT00100568|Zidovudine|zidovudine|mesh-list
92595957|NCT00100568|Efavirenz|efavirenz|mesh-list
92595958|NCT00100568|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92595959|NCT00100568|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92595960|NCT00100568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92595961|NCT00100568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595962|NCT00100568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595963|NCT00100568|Antiviral Agents|antiviral agents|mesh-ancestor
92595964|NCT00100568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595965|NCT00100568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92595966|NCT00100568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92595967|NCT00100568|Antimetabolites|antimetabolites|mesh-ancestor
92595968|NCT00100568|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92595969|NCT00100568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92595970|NCT00100568|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92595971|NCT00100568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92595972|NCT00100568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92595973|NCT00100568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92595974|NCT00132561|Artesunate|artesunate|mesh-list
92595975|NCT00132561|Pyrimethamine|pyrimethamine|mesh-list
92595976|NCT00132561|Sulfadoxine|sulfadoxine|mesh-list
92595977|NCT00132561|Antimalarials|antimalarials|mesh-ancestor
92003289|NCT03214003|Cisplatin|cisplatin|mesh-list
92595979|NCT00132561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92595980|NCT00132561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595981|NCT00132561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595982|NCT00132561|Antiviral Agents|antiviral agents|mesh-ancestor
92595983|NCT00132561|Schistosomicides|schistosomicides|mesh-ancestor
92595984|NCT00132561|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92595985|NCT00132561|Anthelmintics|anthelmintics|mesh-ancestor
92595986|NCT00132561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92595987|NCT00132561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92595988|NCT00132561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595989|NCT00132561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92595990|NCT04728659|Desogestrel|desogestrel|mesh-list
92595991|NCT04728659|Ganirelix|ganirelix|mesh-list
92595992|NCT04728659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92595993|NCT04728659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92595994|NCT04728659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92595995|NCT04728659|Contraceptive Agents|contraceptive agents|mesh-ancestor
92595996|NCT04728659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92595997|NCT04728659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595998|NCT04728659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92595999|NCT04728659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92596000|NCT04728659|Progestins|progestins|mesh-ancestor
92596001|NCT04728659|Hormones|hormones|mesh-ancestor
92596002|NCT04728659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596003|NCT04728659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92596004|NCT00132600|Bacitracin|bacitracin|mesh-list
92596005|NCT00132600|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92596006|NCT00132600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596007|NCT00132600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596008|NCT00132639|Docetaxel|docetaxel|mesh-list
92596009|NCT00132639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596010|NCT00132639|Tubulin Modulators|tubulin modulators|mesh-ancestor
92596011|NCT00132639|Antimitotic Agents|antimitotic agents|mesh-ancestor
92596012|NCT00132639|Mitosis Modulators|mitosis modulators|mesh-ancestor
92596013|NCT00132639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596014|NCT04728386|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92536317|NCT00390260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92536318|NCT00390260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536319|NCT00390260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536320|NCT00081757|Thalidomide|thalidomide|mesh-list
92536321|NCT00081757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536322|NCT00081757|Immunologic Factors|immunologic factors|mesh-ancestor
92536323|NCT00081757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536324|NCT00081757|Leprostatic Agents|leprostatic agents|mesh-ancestor
92536325|NCT00081757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536326|NCT00081757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536327|NCT00081757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92536328|NCT00081757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92536329|NCT00081757|Growth Substances|growth substances|mesh-ancestor
92536330|NCT00081757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92536331|NCT00081757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536332|NCT00081796|Capecitabine|capecitabine|mesh-list
92536333|NCT00081796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92536334|NCT00081796|Antimetabolites|antimetabolites|mesh-ancestor
92536335|NCT00081796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536336|NCT00081796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536337|NCT03152175|Propranolol|propranolol|mesh-list
92536338|NCT03152175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92536339|NCT03152175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92536340|NCT03152175|Adrenergic Agents|adrenergic agents|mesh-ancestor
92536341|NCT03152175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536342|NCT03152175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536343|NCT03152175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536344|NCT03152175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92536361|NCT00399685|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92536362|NCT00399685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536363|NCT00399685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536364|NCT00399685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92536365|NCT00399685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536366|NCT00399685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92536367|NCT00399685|Contraceptive Agents|contraceptive agents|mesh-ancestor
92536368|NCT00399685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92536369|NCT00399685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536370|NCT00399685|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92536371|NCT00399685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92536372|NCT00399685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92536373|NCT00081835|Immunoglobulins|immunoglobulins|mesh-list
92596017|NCT04728386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92596018|NCT04728386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92596019|NCT04728386|Analgesics|analgesics|mesh-ancestor
92596020|NCT04728386|Sensory System Agents|sensory system agents|mesh-ancestor
92596021|NCT04728386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596022|NCT04728386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596023|NCT04728386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596024|NCT04728386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596025|NCT04728386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596026|NCT04728386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596027|NCT04728386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596028|NCT04728386|Disinfectants|disinfectants|mesh-ancestor
92596029|NCT04728386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596030|NCT00100646|Ritonavir|ritonavir|mesh-list
92596031|NCT00100646|Lopinavir|lopinavir|mesh-list
92596032|NCT00100646|Lamivudine|lamivudine|mesh-list
92596033|NCT00100646|Stavudine|stavudine|mesh-list
92596034|NCT00100646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92596035|NCT00100646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92596036|NCT00100646|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596037|NCT00100646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596038|NCT00100646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596039|NCT00100646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92596040|NCT00100646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92596041|NCT00100646|Antiviral Agents|antiviral agents|mesh-ancestor
92596042|NCT00100646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596043|NCT00100646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92596044|NCT00100646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596045|NCT00100646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92596046|NCT00100646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92596047|NCT00100646|Antimetabolites|antimetabolites|mesh-ancestor
92596048|NCT00100685|Volociximab|volociximab|mesh-list
92596049|NCT00100685|Antibodies|antibodies|mesh-list
92596050|NCT00100685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92596051|NCT00100685|Immunologic Factors|immunologic factors|mesh-ancestor
92596052|NCT00100685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596053|NCT00100685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92596054|NCT00100685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92596056|NCT00100685|Growth Inhibitors|growth inhibitors|mesh-ancestor
92596057|NCT00100685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596058|NCT00132756|Estramustine|estramustine|mesh-list
92596059|NCT00132756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92596060|NCT00132756|Alkylating Agents|alkylating agents|mesh-ancestor
92596061|NCT00132756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596062|NCT00132756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596063|NCT00132756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92596064|NCT00100880|Lenalidomide|lenalidomide|mesh-list
92596065|NCT00100880|Immunologic Factors|immunologic factors|mesh-ancestor
92536374|NCT00081835|Antibodies|antibodies|mesh-list
92536375|NCT00081835|gamma-Globulins|gamma-globulins|mesh-list
92536376|NCT00081835|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92536377|NCT00081835|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92536378|NCT00081835|Immunologic Factors|immunologic factors|mesh-ancestor
92536379|NCT00081835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536380|NCT00081874|Everolimus|everolimus|mesh-list
92536381|NCT00081874|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92536382|NCT00081874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536383|NCT00081874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596066|NCT00100880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596067|NCT00100880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92596068|NCT00100880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92596069|NCT00100880|Growth Substances|growth substances|mesh-ancestor
92596070|NCT00100880|Growth Inhibitors|growth inhibitors|mesh-ancestor
92596071|NCT00100880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596072|NCT00100958|Indole-3-carbinol|indole-3-carbinol|mesh-list
92596073|NCT00100958|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92596074|NCT00100958|Protective Agents|protective agents|mesh-ancestor
92596075|NCT00100958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596076|NCT00100958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596077|NCT00101075|Capecitabine|capecitabine|mesh-list
92596078|NCT00101075|Oxaliplatin|oxaliplatin|mesh-list
92596079|NCT00101075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92596080|NCT00101075|Antimetabolites|antimetabolites|mesh-ancestor
92596081|NCT00101075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596082|NCT00101075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596083|NCT00132912|Vorapaxar|vorapaxar|mesh-list
92596084|NCT00132912|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92596085|NCT00403182|Letrozole|letrozole|mesh-list
92596086|NCT00403182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596087|NCT00403182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92596088|NCT00403182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92596089|NCT00403182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596090|NCT00403182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596091|NCT00403182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92596092|NCT00403182|Hormone Antagonists|hormone antagonists|mesh-ancestor
92596093|NCT00403182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596094|NCT00403182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596095|NCT00101114|Interferons|interferons|mesh-list
92596096|NCT00101114|Interferon-alpha|interferon-alpha|mesh-list
92596097|NCT00101114|Interferon alpha-2|interferon alpha-2|mesh-list
92596098|NCT00101114|Sorafenib|sorafenib|mesh-list
92596099|NCT00101114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596100|NCT00101114|Antiviral Agents|antiviral agents|mesh-ancestor
92596101|NCT00101114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596102|NCT00101114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92596103|NCT00101114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596104|NCT00101114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596105|NCT00101114|Immunologic Factors|immunologic factors|mesh-ancestor
92596106|NCT00101114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596107|NCT00101153|Cytarabine|cytarabine|mesh-list
92596108|NCT00101153|Daunorubicin|daunorubicin|mesh-list
92596109|NCT00101153|Tipifarnib|tipifarnib|mesh-list
92596110|NCT00101153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92596111|NCT00101153|Antimetabolites|antimetabolites|mesh-ancestor
92596112|NCT00101153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596113|NCT00101153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596114|NCT00101153|Antiviral Agents|antiviral agents|mesh-ancestor
92596115|NCT00101153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596116|NCT00101153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596117|NCT00101153|Immunologic Factors|immunologic factors|mesh-ancestor
92596118|NCT00101153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596119|NCT00101153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92596120|NCT00101153|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92596121|NCT00101153|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92596122|NCT00101153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536384|NCT00081874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536385|NCT00081874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536386|NCT00081874|Immunologic Factors|immunologic factors|mesh-ancestor
92536387|NCT00081874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536388|NCT00081874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536389|NCT03152097|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92536390|NCT03152097|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92536391|NCT03152097|Protective Agents|protective agents|mesh-ancestor
92536392|NCT03152097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536393|NCT03152097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536394|NCT00082186|Bosentan|bosentan|mesh-list
92536395|NCT00082186|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92536396|NCT00082186|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92536397|NCT00082186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596123|NCT00132951|Azithromycin|azithromycin|mesh-list
92596124|NCT00132951|Telithromycin|telithromycin|mesh-list
92596125|NCT00132951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596126|NCT00132951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596127|NCT00400790|Propofol|propofol|mesh-list
92596128|NCT00400790|Desflurane|desflurane|mesh-list
92003429|NCT03040596|Xhance|xhance|mesh-list
92596131|NCT00400790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596133|NCT00400790|Anesthetics, General|anesthetics, general|mesh-ancestor
92596134|NCT00400790|Anesthetics|anesthetics|mesh-ancestor
92596135|NCT00400790|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92596136|NCT00133029|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92596137|NCT00133029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596138|NCT00135408|Budesonide|budesonide|mesh-list
92596139|NCT00135408|Ipilimumab|ipilimumab|mesh-list
92596140|NCT00135408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92596141|NCT00135408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596142|NCT00135408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92596143|NCT00135408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596144|NCT00135408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596145|NCT00135408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92596146|NCT00135408|Autonomic Agents|autonomic agents|mesh-ancestor
92596147|NCT00135408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596148|NCT00135408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596149|NCT00135408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92596150|NCT00135408|Respiratory System Agents|respiratory system agents|mesh-ancestor
92596151|NCT00135408|Glucocorticoids|glucocorticoids|mesh-ancestor
92596152|NCT00135408|Hormones|hormones|mesh-ancestor
92596153|NCT00135408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596154|NCT00101231|Alvocidib|alvocidib|mesh-list
92596155|NCT00101231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596156|NCT00101231|Growth Inhibitors|growth inhibitors|mesh-ancestor
92596157|NCT00101231|Growth Substances|growth substances|mesh-ancestor
92596158|NCT00101231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596159|NCT00101231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92321018|NCT00000782|Vaccines|vaccines|mesh-list
92596160|NCT00101231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596161|NCT00101231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596162|NCT00101270|Oxaliplatin|oxaliplatin|mesh-list
92596163|NCT00101270|Irinotecan|irinotecan|mesh-list
92596164|NCT00101270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596165|NCT00101270|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92596166|NCT00101270|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92596167|NCT00101270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596168|NCT00101270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596169|NCT00101309|Aldesleukin|aldesleukin|mesh-list
92596170|NCT00101309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536398|NCT00082225|Antibodies|antibodies|mesh-list
92536399|NCT00082225|Immunologic Factors|immunologic factors|mesh-ancestor
92536400|NCT00082225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536401|NCT00082537|Caspofungin|caspofungin|mesh-list
92536402|NCT00082537|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92536403|NCT00082537|Antifungal Agents|antifungal agents|mesh-ancestor
92536404|NCT00082537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536405|NCT00082537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536406|NCT00082537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536407|NCT00082537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92536408|NCT00082537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92536409|NCT00082576|Azithromycin|azithromycin|mesh-list
92536410|NCT00082576|Chloroquine|chloroquine|mesh-list
92536411|NCT00082576|Mefloquine|mefloquine|mesh-list
92536412|NCT00082576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536413|NCT00082576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596171|NCT00101309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92596172|NCT00101309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92596173|NCT00101309|Antiviral Agents|antiviral agents|mesh-ancestor
92596174|NCT00101309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596175|NCT00101348|Bevacizumab|bevacizumab|mesh-list
92596176|NCT00101348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92596177|NCT00101348|Cetuximab|cetuximab|mesh-list
92596178|NCT00101348|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92596179|NCT00101348|Antibodies|antibodies|mesh-list
92596180|NCT00101348|Immunoglobulins|immunoglobulins|mesh-list
92596181|NCT00101348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92596182|NCT00101348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596183|NCT00101348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92596184|NCT00101348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92596185|NCT00101348|Growth Substances|growth substances|mesh-ancestor
92596186|NCT00101348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596187|NCT00101348|Growth Inhibitors|growth inhibitors|mesh-ancestor
92596188|NCT00101348|Immunologic Factors|immunologic factors|mesh-ancestor
92596189|NCT00101348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92596190|NCT00101348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596191|NCT00101348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596192|NCT00101426|Ranirestat|ranirestat|mesh-list
92596193|NCT00101426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596194|NCT00101426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596195|NCT00133185|Losartan|losartan|mesh-list
92596196|NCT00133185|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92596197|NCT00133185|Telmisartan|telmisartan|mesh-list
92596198|NCT00133185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92596199|NCT00133185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92596200|NCT00133185|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92596204|NCT00133185|Natriuretic Agents|natriuretic agents|mesh-ancestor
92596205|NCT00133185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596206|NCT00133185|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92596207|NCT00133185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596208|NCT00135603|Amoxicillin|amoxicillin|mesh-list
92596209|NCT00135603|Clavulanic Acid|clavulanic acid|mesh-list
92596210|NCT00135603|Clavulanic Acids|clavulanic acids|mesh-list
92596211|NCT00135603|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92596212|NCT00135603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596213|NCT00135603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596214|NCT00135603|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92596215|NCT00135603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596216|NCT00135603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596217|NCT00133224|Prednisone|prednisone|mesh-list
92596218|NCT00133224|Docetaxel|docetaxel|mesh-list
92596219|NCT00133224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536414|NCT00082576|Amebicides|amebicides|mesh-ancestor
92536415|NCT00082576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92536416|NCT00082576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92536417|NCT00082576|Antimalarials|antimalarials|mesh-ancestor
92536418|NCT00082576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536419|NCT00082927|Ibandronic Acid|ibandronic acid|mesh-list
92536420|NCT00082927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92536421|NCT00082927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536422|NCT00082966|Bortezomib|bortezomib|mesh-list
92536423|NCT00082966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536424|NCT00083005|Thalidomide|thalidomide|mesh-list
92536425|NCT00083005|Docetaxel|docetaxel|mesh-list
92536426|NCT00083005|Estramustine|estramustine|mesh-list
92536427|NCT00083005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536428|NCT00083005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536429|NCT00083005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536430|NCT00083005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536431|NCT00083005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536432|NCT00083005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536433|NCT00083005|Immunologic Factors|immunologic factors|mesh-ancestor
91943086|NCT03677141|Hormones|hormones|mesh-ancestor
92596220|NCT00133224|Tubulin Modulators|tubulin modulators|mesh-ancestor
92596221|NCT00133224|Antimitotic Agents|antimitotic agents|mesh-ancestor
92596222|NCT00133224|Mitosis Modulators|mitosis modulators|mesh-ancestor
92596223|NCT00133224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596224|NCT00133224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596225|NCT00133224|Glucocorticoids|glucocorticoids|mesh-ancestor
92596226|NCT00133224|Hormones|hormones|mesh-ancestor
92596227|NCT00133224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596228|NCT00133224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596229|NCT00133224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92596230|NCT00101738|Mycophenolic Acid|mycophenolic acid|mesh-list
92596231|NCT00101738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92596232|NCT00101738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596233|NCT00101738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92596234|NCT00101738|Antitubercular Agents|antitubercular agents|mesh-ancestor
92596235|NCT00101738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596236|NCT00101738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596237|NCT00101738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596238|NCT00101738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596239|NCT00135681|Nedocromil|nedocromil|mesh-list
92596240|NCT00135681|Budesonide|budesonide|mesh-list
92596241|NCT00135681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596242|NCT00135681|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92596243|NCT00135681|Autonomic Agents|autonomic agents|mesh-ancestor
92596244|NCT00135681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596245|NCT00135681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596246|NCT00135681|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92596247|NCT00135681|Respiratory System Agents|respiratory system agents|mesh-ancestor
92596248|NCT00135681|Glucocorticoids|glucocorticoids|mesh-ancestor
92596249|NCT00135681|Hormones|hormones|mesh-ancestor
92596250|NCT00135681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596251|NCT00135681|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92596252|NCT00135681|Immunologic Factors|immunologic factors|mesh-ancestor
92596253|NCT00135681|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92596254|NCT00135720|Etanercept|etanercept|mesh-list
92596255|NCT00135720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92536434|NCT00083005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536435|NCT00083005|Leprostatic Agents|leprostatic agents|mesh-ancestor
92536436|NCT00083005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536437|NCT00083005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536438|NCT00083005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92536439|NCT00083005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92536440|NCT00083005|Growth Substances|growth substances|mesh-ancestor
92596256|NCT00135720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92596257|NCT00135720|Analgesics|analgesics|mesh-ancestor
92596258|NCT00135720|Sensory System Agents|sensory system agents|mesh-ancestor
92596259|NCT00135720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596260|NCT00135720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596261|NCT00135720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596262|NCT00135720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596263|NCT00135720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596264|NCT00135720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596265|NCT00135720|Immunologic Factors|immunologic factors|mesh-ancestor
92596266|NCT00101894|Panitumumab|panitumumab|mesh-list
92596267|NCT00101894|Motesanib diphosphate|motesanib diphosphate|mesh-list
92596268|NCT00101894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92596269|NCT00101894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596270|NCT00101894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92596271|NCT00101894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596274|NCT00102050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596275|NCT00102050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596276|NCT00135759|Naltrexone|naltrexone|mesh-list
92596277|NCT00135759|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92596278|NCT00135759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92596279|NCT00135759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596280|NCT00135759|Sensory System Agents|sensory system agents|mesh-ancestor
92596281|NCT00135759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596282|NCT00133341|Parthenolide|parthenolide|mesh-list
92596283|NCT00133341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92596284|NCT00133341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92596285|NCT00133341|Analgesics|analgesics|mesh-ancestor
92596286|NCT00133341|Sensory System Agents|sensory system agents|mesh-ancestor
92596287|NCT00133341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596288|NCT00133341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596289|NCT00133341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596290|NCT00133341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596291|NCT00135837|Verteporfin|verteporfin|mesh-list
92596292|NCT00135837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92596293|NCT00135837|Dermatologic Agents|dermatologic agents|mesh-ancestor
92596294|NCT00133380|Atorvastatin|atorvastatin|mesh-list
92596295|NCT00133380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92596296|NCT00133380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92596297|NCT00133380|Antimetabolites|antimetabolites|mesh-ancestor
92596298|NCT00133380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596299|NCT00133380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92596300|NCT00133380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92596301|NCT00133380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596302|NCT00102167|Gaboxadol|gaboxadol|mesh-list
92596303|NCT00102167|Analgesics|analgesics|mesh-ancestor
92596304|NCT00102167|Sensory System Agents|sensory system agents|mesh-ancestor
92596305|NCT00102167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596306|NCT00102167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596307|NCT00102167|Anticonvulsants|anticonvulsants|mesh-ancestor
92596308|NCT00102167|GABA Agonists|gaba agonists|mesh-ancestor
92596309|NCT00102167|GABA Agents|gaba agents|mesh-ancestor
92596310|NCT00102167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596311|NCT00102167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596313|NCT00135876|Tinzaparin|tinzaparin|mesh-list
92596314|NCT00135876|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92596315|NCT00135876|Anticoagulants|anticoagulants|mesh-ancestor
92596316|NCT00135876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92596317|NCT00135876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92596318|NCT00135876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596319|NCT00102206|Ritonavir|ritonavir|mesh-list
92596320|NCT00102206|Lopinavir|lopinavir|mesh-list
92536441|NCT00083005|Growth Inhibitors|growth inhibitors|mesh-ancestor
92536442|NCT00083005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92536443|NCT00083005|Alkylating Agents|alkylating agents|mesh-ancestor
92536444|NCT00083005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92536445|NCT00083083|Paclitaxel|paclitaxel|mesh-list
92536446|NCT00083083|Etoposide|etoposide|mesh-list
92536447|NCT00083083|Vinorelbine|vinorelbine|mesh-list
92536448|NCT00083083|Vinblastine|vinblastine|mesh-list
92536449|NCT00083083|Docetaxel|docetaxel|mesh-list
92596321|NCT00102206|Saquinavir|saquinavir|mesh-list
92596322|NCT00102206|Tenofovir|tenofovir|mesh-list
92596323|NCT00102206|Lamivudine|lamivudine|mesh-list
92596324|NCT00102206|Emtricitabine|emtricitabine|mesh-list
92596325|NCT00102206|Zidovudine|zidovudine|mesh-list
92596326|NCT00102206|Abacavir|abacavir|mesh-list
92596327|NCT00102206|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92596328|NCT00102206|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92596329|NCT00102206|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596330|NCT00102206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596331|NCT00102206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596332|NCT00102206|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92596333|NCT00102206|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92596334|NCT00102206|Antiviral Agents|antiviral agents|mesh-ancestor
92596335|NCT00102206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596336|NCT00102206|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92596337|NCT00102206|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596338|NCT00102206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92596339|NCT00102206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92596340|NCT00102206|Antimetabolites|antimetabolites|mesh-ancestor
92596341|NCT00102284|Levodopa|levodopa|mesh-list
92596342|NCT00102284|Modafinil|modafinil|mesh-list
92596343|NCT00102284|Rivastigmine|rivastigmine|mesh-list
92596344|NCT00102284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92596345|NCT00102284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92596346|NCT00102284|Dopamine Agents|dopamine agents|mesh-ancestor
92596347|NCT00102284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596364|NCT00135525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596365|NCT00135525|Serotonin Agents|serotonin agents|mesh-ancestor
92596366|NCT00135525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596367|NCT00135525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92596368|NCT00135525|Antidepressive Agents|antidepressive agents|mesh-ancestor
92596369|NCT00135525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596370|NCT00135525|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92596371|NCT00135525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596372|NCT00135525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596373|NCT00403962|Paroxetine|paroxetine|mesh-list
92596374|NCT00403962|Vestipitant|vestipitant|mesh-list
92596375|NCT00403962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92596376|NCT00403962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92596377|NCT00403962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596378|NCT00403962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596379|NCT00403962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596380|NCT00403962|Serotonin Agents|serotonin agents|mesh-ancestor
92596381|NCT00403962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596382|NCT00403962|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92596383|NCT00403962|Antidepressive Agents|antidepressive agents|mesh-ancestor
92596384|NCT00403962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596385|NCT00403962|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92596386|NCT00403962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596387|NCT00403962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596388|NCT00403962|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92596389|NCT00102479|Aripiprazole|aripiprazole|mesh-list
92596390|NCT00102479|Antidepressive Agents|antidepressive agents|mesh-ancestor
92596391|NCT00102479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596392|NCT00102479|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92596393|NCT00102479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92596394|NCT00102479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596395|NCT00102479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596396|NCT00102479|Dopamine Agonists|dopamine agonists|mesh-ancestor
92536450|NCT00083083|Carboplatin|carboplatin|mesh-list
92536451|NCT00083083|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92536452|NCT00083083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92536453|NCT00083083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536454|NCT00083083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536455|NCT00083083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536456|NCT00083083|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943283|NCT02885974|Analgesics|analgesics|mesh-ancestor
92596397|NCT00102479|Dopamine Agents|dopamine agents|mesh-ancestor
92596398|NCT00102479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596399|NCT00102479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596400|NCT00102479|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92596409|NCT00135954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596410|NCT00135954|Immunologic Factors|immunologic factors|mesh-ancestor
92596411|NCT00135954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596412|NCT00135954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596413|NCT00135954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92596414|NCT00135954|Alkylating Agents|alkylating agents|mesh-ancestor
92596415|NCT00135954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596416|NCT00135954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596417|NCT00135954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92596418|NCT00135954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596419|NCT00135954|Glucocorticoids|glucocorticoids|mesh-ancestor
92596421|NCT00135954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360546|NCT00428922|Docetaxel|docetaxel|mesh-list
92596422|NCT00135954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92596423|NCT00102557|Hydroxychloroquine|hydroxychloroquine|mesh-list
92596424|NCT00102557|Antimalarials|antimalarials|mesh-ancestor
92596425|NCT00102557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92596426|NCT00102557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92596427|NCT00102557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596428|NCT00102557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596429|NCT00102557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596430|NCT00102557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596431|NCT00102635|Fenretinide|fenretinide|mesh-list
92596432|NCT00102635|Lonafarnib|lonafarnib|mesh-list
92596433|NCT00102635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596434|NCT00102635|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92596435|NCT00102635|Protective Agents|protective agents|mesh-ancestor
92596436|NCT00102635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596437|NCT00102635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596438|NCT00102635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596439|NCT00133419|Vitamins|vitamins|mesh-list
92596440|NCT00133419|Vitamin A|vitamin a|mesh-list
92596442|NCT00133419|Trace Elements|trace elements|mesh-list
92596443|NCT00133419|Micronutrients|micronutrients|mesh-list
92596444|NCT00133419|Retinol palmitate|retinol palmitate|mesh-list
92596445|NCT00133419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596446|NCT00133419|Antioxidants|antioxidants|mesh-ancestor
92596447|NCT00133419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596448|NCT00133419|Protective Agents|protective agents|mesh-ancestor
92596449|NCT00133419|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92596450|NCT00133419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596451|NCT00102674|Cangrelor|cangrelor|mesh-list
92596452|NCT00102674|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92596453|NCT00102674|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92596454|NCT00102674|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92596455|NCT00102674|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92596456|NCT00102674|Purinergic Agents|purinergic agents|mesh-ancestor
92596457|NCT00102674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596458|NCT00102674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596459|NCT00102674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596460|NCT00135993|Rotigotine|rotigotine|mesh-list
92596461|NCT00135993|Dopamine Agonists|dopamine agonists|mesh-ancestor
92596462|NCT00135993|Dopamine Agents|dopamine agents|mesh-ancestor
92596463|NCT00135993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596464|NCT00135993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596465|NCT00135993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536457|NCT00083083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536458|NCT00083083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536459|NCT00083083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92536460|NCT00083083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536461|NCT00083083|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92536462|NCT03151863|Dexmedetomidine|dexmedetomidine|mesh-list
92536463|NCT03151863|Analgesics, Opioid|analgesics, opioid|mesh-list
92596466|NCT00102713|Valproic Acid|valproic acid|mesh-list
92596467|NCT00102713|Anticonvulsants|anticonvulsants|mesh-ancestor
92003790|NCT01938261|Antipyretics|antipyretics|mesh-ancestor
92596471|NCT00102713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596472|NCT00102713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596473|NCT00102713|Antimanic Agents|antimanic agents|mesh-ancestor
92596474|NCT00102713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92596475|NCT00102713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596476|NCT00102713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596477|NCT00133458|Albendazole|albendazole|mesh-list
92596478|NCT00133458|Anthelmintics|anthelmintics|mesh-ancestor
92596479|NCT00133458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92596480|NCT00133458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596481|NCT00133458|Anticestodal Agents|anticestodal agents|mesh-ancestor
92596482|NCT00133458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92596483|NCT00133458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92596484|NCT00133458|Tubulin Modulators|tubulin modulators|mesh-ancestor
92596485|NCT00133458|Antimitotic Agents|antimitotic agents|mesh-ancestor
92596486|NCT00133458|Mitosis Modulators|mitosis modulators|mesh-ancestor
92596487|NCT00133458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596488|NCT00133458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596489|NCT00102752|Gemcitabine|gemcitabine|mesh-list
92596490|NCT00102752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92596491|NCT00102752|Antimetabolites|antimetabolites|mesh-ancestor
92596492|NCT00102752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596493|NCT00102752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596494|NCT00102830|Trebananib|trebananib|mesh-list
92596495|NCT00102830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92596496|NCT00102830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92596497|NCT00102830|Growth Substances|growth substances|mesh-ancestor
92596498|NCT00102830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596499|NCT00102830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92596500|NCT00102830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596501|NCT00136110|Valproic Acid|valproic acid|mesh-list
92596502|NCT00136110|Anticonvulsants|anticonvulsants|mesh-ancestor
92596503|NCT00136110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596504|NCT00136110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596505|NCT00136110|GABA Agents|gaba agents|mesh-ancestor
92596506|NCT00136110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596507|NCT00136110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596508|NCT00136110|Antimanic Agents|antimanic agents|mesh-ancestor
92596509|NCT00136110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92596510|NCT00136110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596511|NCT00136110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596512|NCT00136188|Folic Acid|folic acid|mesh-list
92596513|NCT00136188|Hematinics|hematinics|mesh-ancestor
92596514|NCT00136188|Vitamin B Complex|vitamin b complex|mesh-ancestor
92596515|NCT00136188|Vitamins|vitamins|mesh-ancestor
92596516|NCT00136188|Micronutrients|micronutrients|mesh-ancestor
92596517|NCT00136188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596518|NCT00102869|Levodopa|levodopa|mesh-list
92596519|NCT00102869|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92596520|NCT00102869|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92596521|NCT00102869|Dopamine Agents|dopamine agents|mesh-ancestor
92596522|NCT00102869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596523|NCT00102869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596524|NCT00102869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596525|NCT00102908|Zoledronic Acid|zoledronic acid|mesh-list
92596526|NCT00102908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92596527|NCT00102908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596528|NCT00401024|Imatinib Mesylate|imatinib mesylate|mesh-list
92596529|NCT00401024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596530|NCT00401024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536464|NCT03151863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92536465|NCT03151863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536466|NCT03151863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596531|NCT00401024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596532|NCT00401024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596533|NCT00136266|Vitamin D|vitamin d|mesh-list
92321398|NCT00000914|Ritonavir|ritonavir|mesh-list
92596534|NCT00136266|Vitamins|vitamins|mesh-list
92596535|NCT00136266|Vitamin A|vitamin a|mesh-list
92596536|NCT00136266|Ferrous fumarate|ferrous fumarate|mesh-list
92596537|NCT00136266|Micronutrients|micronutrients|mesh-ancestor
92596538|NCT00136266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596539|NCT00136266|Trace Elements|trace elements|mesh-ancestor
92596540|NCT00136266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92596559|NCT00102986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92596560|NCT00102986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92596561|NCT00102986|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596562|NCT00102986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596563|NCT00102986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596564|NCT00102986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92596565|NCT00102986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92596566|NCT00102986|Antiviral Agents|antiviral agents|mesh-ancestor
92596567|NCT00102986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596568|NCT00102986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92596569|NCT00102986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596570|NCT00136383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92596571|NCT00136383|Paroxetine|paroxetine|mesh-list
92596572|NCT00136383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92596573|NCT00136383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92596574|NCT00136383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596575|NCT00136383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596576|NCT00136383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596577|NCT00136383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596578|NCT00136383|Analgesics|analgesics|mesh-ancestor
92596579|NCT00136383|Sensory System Agents|sensory system agents|mesh-ancestor
92596580|NCT00136383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596581|NCT00136383|Antidepressive Agents|antidepressive agents|mesh-ancestor
92596582|NCT00136383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596583|NCT00136383|Dopamine Agents|dopamine agents|mesh-ancestor
92596584|NCT00136383|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92596585|NCT00136383|Serotonin Agents|serotonin agents|mesh-ancestor
92596586|NCT00136383|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92596587|NCT00136383|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92596588|NCT00136383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596589|NCT00136383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596590|NCT00103103|Leucovorin|leucovorin|mesh-list
92596591|NCT00103103|Fluorouracil|fluorouracil|mesh-list
92596592|NCT00103103|Bortezomib|bortezomib|mesh-list
92596593|NCT00103103|Calcium|calcium|mesh-list
92596594|NCT00103103|Levoleucovorin|levoleucovorin|mesh-list
92596595|NCT00103103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92596596|NCT00103103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003930|NCT01326312|Leuprolide|leuprolide|mesh-list
92596612|NCT00133692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92596613|NCT00133692|Diuretics|diuretics|mesh-ancestor
92596614|NCT00133692|Natriuretic Agents|natriuretic agents|mesh-ancestor
92596615|NCT00133692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596616|NCT00133692|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92596617|NCT00133692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596618|NCT00133692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596619|NCT00133692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92596620|NCT00133692|Sympatholytics|sympatholytics|mesh-ancestor
92596621|NCT00133692|Autonomic Agents|autonomic agents|mesh-ancestor
92596622|NCT00133692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596623|NCT00133692|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92596624|NCT00133692|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92596625|NCT00133692|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92596626|NCT00133692|Adrenergic Agents|adrenergic agents|mesh-ancestor
92596627|NCT00133692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596628|NCT00133692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92536467|NCT03151863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92536469|NCT03151863|Sensory System Agents|sensory system agents|mesh-ancestor
92536470|NCT03151863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536471|NCT03151863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92536472|NCT03151863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92596629|NCT00133692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92596630|NCT00133692|Vasodilator Agents|vasodilator agents|mesh-ancestor
92596631|NCT00133692|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92596632|NCT00133692|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596633|NCT00133692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596635|NCT00133731|Calcium heparin|calcium heparin|mesh-list
92596636|NCT00133731|Otamixaban|otamixaban|mesh-list
92596637|NCT00133731|Anticoagulants|anticoagulants|mesh-ancestor
92596638|NCT00133731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92596639|NCT00133731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92596640|NCT00133731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596641|NCT00133731|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92596642|NCT00133731|Antithrombins|antithrombins|mesh-ancestor
92596643|NCT00133731|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92596644|NCT00133731|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596645|NCT00133731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596646|NCT00103298|Leucovorin|leucovorin|mesh-list
92596647|NCT00103298|Fluorouracil|fluorouracil|mesh-list
92596648|NCT00103298|Oxaliplatin|oxaliplatin|mesh-list
92596649|NCT00103298|Melphalan|melphalan|mesh-list
92596650|NCT00103298|Calcium|calcium|mesh-list
92596651|NCT00103298|Levoleucovorin|levoleucovorin|mesh-list
92596652|NCT00103298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92596653|NCT00103298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596654|NCT00103298|Antimetabolites|antimetabolites|mesh-ancestor
92596655|NCT00103298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596656|NCT00103298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92596657|NCT00103298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596662|NCT00103298|Vitamin B Complex|vitamin b complex|mesh-ancestor
92596663|NCT00103298|Vitamins|vitamins|mesh-ancestor
92596664|NCT00103298|Micronutrients|micronutrients|mesh-ancestor
92596665|NCT00103298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92596666|NCT00103298|Alkylating Agents|alkylating agents|mesh-ancestor
92596667|NCT00103298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92596668|NCT00136461|Tretinoin|tretinoin|mesh-list
92596669|NCT00136461|Bryostatin 1|bryostatin 1|mesh-list
92596670|NCT00136461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596671|NCT00136461|Keratolytic Agents|keratolytic agents|mesh-ancestor
92596672|NCT00136461|Dermatologic Agents|dermatologic agents|mesh-ancestor
92596673|NCT00136461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92596674|NCT00136461|Immunologic Factors|immunologic factors|mesh-ancestor
92596675|NCT00136461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596676|NCT00133770|Pantoprazole|pantoprazole|mesh-list
92596677|NCT00133770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92596678|NCT00133770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596679|NCT00133770|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92596680|NCT00133770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596681|NCT00133770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596682|NCT00133848|Retapamulin|retapamulin|mesh-list
92596683|NCT00133848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596684|NCT00133848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596685|NCT00133887|Sirolimus|sirolimus|mesh-list
92596686|NCT00133887|Cyclosporine|cyclosporine|mesh-list
92596687|NCT00133887|Tacrolimus|tacrolimus|mesh-list
92596688|NCT00133887|Cyclosporins|cyclosporins|mesh-list
92596689|NCT00133887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596690|NCT00133887|Immunologic Factors|immunologic factors|mesh-ancestor
92596691|NCT00133887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596692|NCT00133887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92596693|NCT00133887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596694|NCT00133887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596695|NCT00133887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596696|NCT00133887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596697|NCT00133887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92596698|NCT00133887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536473|NCT03151863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92536474|NCT03151863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92536475|NCT03151863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536476|NCT03151863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536477|NCT03151863|Narcotics|narcotics|mesh-ancestor
92536478|NCT00083161|Cyclophosphamide|cyclophosphamide|mesh-list
92536480|NCT00083161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536481|NCT00083161|Immunologic Factors|immunologic factors|mesh-ancestor
92596699|NCT00133887|Antifungal Agents|antifungal agents|mesh-ancestor
92596700|NCT00133887|Dermatologic Agents|dermatologic agents|mesh-ancestor
92596701|NCT00133887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596702|NCT00136539|Cyclophosphamide|cyclophosphamide|mesh-list
92596703|NCT00136539|Doxorubicin|doxorubicin|mesh-list
92596704|NCT00136539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92596705|NCT00136539|Trastuzumab|trastuzumab|mesh-list
92596706|NCT00136539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596707|NCT00136539|Immunologic Factors|immunologic factors|mesh-ancestor
92596708|NCT00136539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596709|NCT00136539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596710|NCT00136539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92596711|NCT00136539|Alkylating Agents|alkylating agents|mesh-ancestor
92596712|NCT00136539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596713|NCT00136539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596714|NCT00136539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92596715|NCT00136539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92596716|NCT00136539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92596717|NCT00136539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92596718|NCT00136539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596719|NCT00136539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92596720|NCT00103571|Olanzapine|olanzapine|mesh-list
92596721|NCT00103571|Aripiprazole|aripiprazole|mesh-list
92596722|NCT00103571|Antiemetics|antiemetics|mesh-ancestor
92596723|NCT00103571|Autonomic Agents|autonomic agents|mesh-ancestor
92596724|NCT00103571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596725|NCT00103571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596726|NCT00103571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596727|NCT00103571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92596728|NCT00103571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92596729|NCT00103571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596730|NCT00103571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92004046|NCT00697684|Immunologic Factors|immunologic factors|mesh-ancestor
92596733|NCT00103571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596734|NCT00103571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596735|NCT00103571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596737|NCT00103571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92596738|NCT00103571|Dopamine Agonists|dopamine agonists|mesh-ancestor
92596739|NCT00103571|Dopamine Agents|dopamine agents|mesh-ancestor
92596740|NCT00103571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92596741|NCT00103571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92596742|NCT00103571|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92596743|NCT00103571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92596744|NCT00103571|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92596745|NCT00103571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92596746|NCT00136578|Carboplatin|carboplatin|mesh-list
92596747|NCT00136578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596748|NCT00103649|Xaliproden|xaliproden|mesh-list
92596749|NCT00103649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92596750|NCT00103649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92596751|NCT00103649|Serotonin Agents|serotonin agents|mesh-ancestor
92596752|NCT00103649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596753|NCT00103649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596754|NCT00103649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596755|NCT00136617|Chlordiazepoxide|chlordiazepoxide|mesh-list
92596756|NCT00136617|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92596757|NCT00136617|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92596758|NCT00136617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596759|NCT00136617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536482|NCT00083161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536483|NCT00083161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536484|NCT00083161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92536485|NCT00083161|Alkylating Agents|alkylating agents|mesh-ancestor
92536486|NCT00083161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596760|NCT00136617|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92321620|NCT00000254|Nitrous Oxide|nitrous oxide|mesh-list
92596761|NCT00136617|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92596762|NCT00136617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596763|NCT00136617|GABA Modulators|gaba modulators|mesh-ancestor
92596764|NCT00136617|GABA Agents|gaba agents|mesh-ancestor
92596765|NCT00136617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596766|NCT00136617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596767|NCT00103727|Risperidone|risperidone|mesh-list
92596768|NCT00103727|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92596769|NCT00103727|Serotonin Agents|serotonin agents|mesh-ancestor
92596770|NCT00103727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596771|NCT00103727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596772|NCT00103727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596773|NCT00103727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92596774|NCT00103727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92596775|NCT00103727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596776|NCT00103727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596777|NCT00103727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92596778|NCT00103727|Dopamine Agents|dopamine agents|mesh-ancestor
92596779|NCT00103766|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92596780|NCT00103766|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92596781|NCT00103766|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92596782|NCT00103766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596783|NCT00103805|Levodopa|levodopa|mesh-list
92596784|NCT00103805|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92596785|NCT00103805|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92596786|NCT00103805|Dopamine Agents|dopamine agents|mesh-ancestor
92596787|NCT00103805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596788|NCT00103805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596789|NCT00103805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596790|NCT00404040|Lactulose|lactulose|mesh-list
92596791|NCT00404040|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92596792|NCT00404040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596793|NCT00404040|Laxatives|laxatives|mesh-ancestor
92596794|NCT00103922|Cilomilast|cilomilast|mesh-list
92596795|NCT00103922|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92596796|NCT00103922|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92596797|NCT00103922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596798|NCT00103922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596799|NCT00134160|Amlodipine|amlodipine|mesh-list
92596800|NCT00134160|Olmesartan|olmesartan|mesh-list
92596803|NCT00134160|Calcium|calcium|mesh-list
92360555|NCT00428922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92596804|NCT00134160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92596805|NCT00134160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596806|NCT00134160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92596807|NCT00134160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596808|NCT00134160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596809|NCT00134160|Vasodilator Agents|vasodilator agents|mesh-ancestor
92596810|NCT00134160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92596811|NCT00134160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92596812|NCT00136656|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92596813|NCT00136656|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92596814|NCT00136656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596815|NCT00136656|Antitubercular Agents|antitubercular agents|mesh-ancestor
92596816|NCT00134199|Sibutramine|sibutramine|mesh-list
92596817|NCT00134199|Antidepressive Agents|antidepressive agents|mesh-ancestor
92596818|NCT00134199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92596819|NCT00134199|Appetite Depressants|appetite depressants|mesh-ancestor
92596820|NCT00134199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92596821|NCT04729088|Isosorbide|isosorbide|mesh-list
92596822|NCT04729088|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92596823|NCT04729088|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92536487|NCT00083161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536488|NCT00083161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92536489|NCT00083161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92596824|NCT04729088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92596825|NCT04729088|Diuretics|diuretics|mesh-ancestor
92596826|NCT04729088|Natriuretic Agents|natriuretic agents|mesh-ancestor
92596827|NCT04729088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596828|NCT04729088|Vasodilator Agents|vasodilator agents|mesh-ancestor
92596829|NCT04729088|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92596830|NCT04729088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596831|NCT00136734|Methylphenidate|methylphenidate|mesh-list
92596832|NCT00136734|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92596833|NCT00136734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596834|NCT00136734|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92596835|NCT00136734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92596836|NCT00136734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596837|NCT00136734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596839|NCT00136734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596840|NCT00136773|Amlodipine|amlodipine|mesh-list
92596841|NCT00136773|Benazepril|benazepril|mesh-list
92596842|NCT00136773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92596843|NCT00136773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92596844|NCT00136773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596845|NCT00136773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596846|NCT00136773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92596847|NCT00136773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596848|NCT00136773|Vasodilator Agents|vasodilator agents|mesh-ancestor
92596849|NCT00136773|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92596850|NCT00136773|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596851|NCT00136773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596852|NCT00136851|Amlodipine|amlodipine|mesh-list
92596853|NCT00136851|Benazepril|benazepril|mesh-list
92596854|NCT00136851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92596855|NCT00136851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92596856|NCT00136851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596857|NCT00136851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596858|NCT00136851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92596859|NCT00136851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596860|NCT00136851|Vasodilator Agents|vasodilator agents|mesh-ancestor
92596861|NCT00136851|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92596862|NCT00136851|Protease Inhibitors|protease inhibitors|mesh-ancestor
92596863|NCT00136851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596864|NCT00104273|Rasagiline|rasagiline|mesh-list
92596865|NCT00104273|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92596866|NCT00104273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596867|NCT00104273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596868|NCT00104273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92596869|NCT00104273|Protective Agents|protective agents|mesh-ancestor
92596870|NCT00104273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596871|NCT00136929|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92596872|NCT00136929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92596877|NCT00134355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596878|NCT00104429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92596879|NCT00104429|Aplaviroc|aplaviroc|mesh-list
92596880|NCT00104429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92596881|NCT00104429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92596882|NCT00104429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596883|NCT00104429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596884|NCT00104429|Antiviral Agents|antiviral agents|mesh-ancestor
92596885|NCT00104429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596886|NCT00104429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92596887|NCT00104429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92596888|NCT00104429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92596889|NCT00104429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92596890|NCT00136968|Voriconazole|voriconazole|mesh-list
92596891|NCT00136968|Antifungal Agents|antifungal agents|mesh-ancestor
92596892|NCT00136968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596893|NCT00136968|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92536490|NCT00083161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536491|NCT00083161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92536492|NCT00083161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536494|NCT00083278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536495|NCT00083278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536496|NCT00083278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92536497|NCT00083278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536498|NCT00083434|Epoetin Alfa|epoetin alfa|mesh-list
92536499|NCT00083434|Hematinics|hematinics|mesh-ancestor
92536500|NCT00083590|Huperzine A|huperzine a|mesh-list
91943786|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596894|NCT00136968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596895|NCT00136968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596896|NCT00136968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596897|NCT00136968|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92596898|NCT00136968|Hormone Antagonists|hormone antagonists|mesh-ancestor
92596899|NCT00136968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596900|NCT00136968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596901|NCT00136968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92596902|NCT00104468|Troxacitabine|troxacitabine|mesh-list
92596903|NCT00104468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596904|NCT00104468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92596905|NCT00104468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92596906|NCT00104468|Antiviral Agents|antiviral agents|mesh-ancestor
92596907|NCT00104468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596908|NCT00137007|Azithromycin|azithromycin|mesh-list
92596910|NCT00137007|Sulbactam|sulbactam|mesh-list
92596911|NCT00137007|Sultamicillin|sultamicillin|mesh-list
92596912|NCT00137007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596913|NCT00137007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596914|NCT00137007|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92596915|NCT00137007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596916|NCT00137007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596917|NCT00137085|Ketamine|ketamine|mesh-list
92596918|NCT00137085|Analgesics|analgesics|mesh-ancestor
92596919|NCT00137085|Sensory System Agents|sensory system agents|mesh-ancestor
92596920|NCT00137085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596921|NCT00137085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596922|NCT00137085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92596923|NCT00137085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92596924|NCT00137085|Anesthetics, General|anesthetics, general|mesh-ancestor
92596925|NCT00137085|Anesthetics|anesthetics|mesh-ancestor
92596926|NCT00137085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596927|NCT00137085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92596928|NCT00137085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92596929|NCT00137085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92596930|NCT00137085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596931|NCT00104546|Vitamin K|vitamin k|mesh-list
92596932|NCT00104546|Vitamins|vitamins|mesh-ancestor
92596933|NCT00104546|Micronutrients|micronutrients|mesh-ancestor
92596934|NCT00104546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596935|NCT00104546|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92596936|NCT00104546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92596937|NCT00104546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596938|NCT00104546|Hemostatics|hemostatics|mesh-ancestor
92596939|NCT00104546|Coagulants|coagulants|mesh-ancestor
92596940|NCT00134394|Etanercept|etanercept|mesh-list
92596941|NCT00134394|Tacrolimus|tacrolimus|mesh-list
92596942|NCT00134394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596943|NCT00134394|Immunologic Factors|immunologic factors|mesh-ancestor
92596948|NCT00134394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92596949|NCT00134394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92596950|NCT00134394|Analgesics|analgesics|mesh-ancestor
92536501|NCT00083590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92536502|NCT00083590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536503|NCT00083590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536504|NCT00083590|Cholinergic Agents|cholinergic agents|mesh-ancestor
92536505|NCT00083590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536506|NCT00083590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536507|NCT00083590|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92536508|NCT00083590|Protective Agents|protective agents|mesh-ancestor
92536509|NCT03151746|Gabapentin|gabapentin|mesh-list
92536510|NCT03151746|Analgesics|analgesics|mesh-ancestor
92536511|NCT03151746|Sensory System Agents|sensory system agents|mesh-ancestor
92536512|NCT03151746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536513|NCT03151746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536514|NCT03151746|Anticonvulsants|anticonvulsants|mesh-ancestor
92596951|NCT00134394|Sensory System Agents|sensory system agents|mesh-ancestor
92596952|NCT00134394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92596953|NCT00134394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92596954|NCT00134394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92596955|NCT00134394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92596956|NCT00104624|Docetaxel|docetaxel|mesh-list
92596957|NCT00104624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596958|NCT00104624|Tubulin Modulators|tubulin modulators|mesh-ancestor
92596959|NCT00104624|Antimitotic Agents|antimitotic agents|mesh-ancestor
92596960|NCT00104624|Mitosis Modulators|mitosis modulators|mesh-ancestor
92596961|NCT00104624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596962|NCT00104663|Quinacrine|quinacrine|mesh-list
92596963|NCT00104663|Anticestodal Agents|anticestodal agents|mesh-ancestor
92596964|NCT00104663|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92596965|NCT00104663|Anthelmintics|anthelmintics|mesh-ancestor
92596966|NCT00104663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92596967|NCT00104663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596968|NCT00104663|Antimalarials|antimalarials|mesh-ancestor
92596969|NCT00104663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92596970|NCT00104663|Antinematodal Agents|antinematodal agents|mesh-ancestor
92596971|NCT00104663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596972|NCT00104663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596973|NCT00104663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596974|NCT00104741|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92596975|NCT00104741|Flutamide|flutamide|mesh-list
92596976|NCT00104741|Luteolytic Agents|luteolytic agents|mesh-ancestor
92596977|NCT00104741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92596978|NCT00104741|Contraceptive Agents|contraceptive agents|mesh-ancestor
92596979|NCT00104741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92596980|NCT00104741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596981|NCT00104741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92596982|NCT00104741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92596983|NCT00104741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596985|NCT00104741|Hormone Antagonists|hormone antagonists|mesh-ancestor
92596986|NCT00104741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92596987|NCT00134511|Atorvastatin|atorvastatin|mesh-list
92596988|NCT00134511|Torcetrapib|torcetrapib|mesh-list
92596989|NCT00134511|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92596990|NCT00134511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92596991|NCT00134511|Antimetabolites|antimetabolites|mesh-ancestor
92596992|NCT00134511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596993|NCT00134511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92596994|NCT00134511|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92596995|NCT00134511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596996|NCT00104780|Freund's Adjuvant|freund's adjuvant|mesh-list
92596997|NCT00104780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92596998|NCT00104780|Immunologic Factors|immunologic factors|mesh-ancestor
92536515|NCT03151746|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92536516|NCT03151746|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92536517|NCT03151746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536518|NCT03151746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92536519|NCT03151746|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92536520|NCT03151746|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92596999|NCT00104780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597000|NCT00134550|Atorvastatin|atorvastatin|mesh-list
92597001|NCT00134550|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92597002|NCT00134550|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92597003|NCT00134550|Antimetabolites|antimetabolites|mesh-ancestor
92597004|NCT00134550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597005|NCT00134550|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92597006|NCT00134550|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92597007|NCT00134550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597008|NCT00104819|Immunoglobulins|immunoglobulins|mesh-list
92597009|NCT00104819|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92597010|NCT00104819|Antibodies|antibodies|mesh-list
92597011|NCT00104819|Sargramostim|sargramostim|mesh-list
92597012|NCT00104819|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92597013|NCT00104819|Immunologic Factors|immunologic factors|mesh-ancestor
92597014|NCT00104819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597020|NCT00137202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597021|NCT00137202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597022|NCT00137202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92597023|NCT00137202|Antipruritics|antipruritics|mesh-ancestor
92597024|NCT00137202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597025|NCT00137202|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92597026|NCT00137202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92597027|NCT00137202|Serotonin Agents|serotonin agents|mesh-ancestor
92597028|NCT00137202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597029|NCT00137202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597030|NCT00137202|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92597031|NCT00137202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92597032|NCT00137202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92597033|NCT00137202|Anesthetics, Local|anesthetics, local|mesh-ancestor
92597034|NCT00137202|Anesthetics|anesthetics|mesh-ancestor
92597035|NCT00137202|Sensory System Agents|sensory system agents|mesh-ancestor
92597036|NCT00137202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92597037|NCT00137202|Histamine Antagonists|histamine antagonists|mesh-ancestor
92597038|NCT00137202|Histamine Agents|histamine agents|mesh-ancestor
92597039|NCT00137202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92597040|NCT00104975|Fludarabine|fludarabine|mesh-list
92597041|NCT00104975|Fludarabine phosphate|fludarabine phosphate|mesh-list
92597043|NCT00104975|Alemtuzumab|alemtuzumab|mesh-list
92597044|NCT00104975|Thiotepa|thiotepa|mesh-list
92597045|NCT00104975|Tacrolimus|tacrolimus|mesh-list
92597046|NCT00104975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597047|NCT00104975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597048|NCT00104975|Antimetabolites|antimetabolites|mesh-ancestor
92597049|NCT00104975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597050|NCT00104975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597051|NCT00104975|Immunologic Factors|immunologic factors|mesh-ancestor
92597052|NCT00104975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597053|NCT00104975|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92597054|NCT00104975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597055|NCT00104975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92321970|NCT00001094|Lamivudine|lamivudine|mesh-list
92597056|NCT00104975|Alkylating Agents|alkylating agents|mesh-ancestor
92597057|NCT00104975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92597058|NCT00104975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597059|NCT00137358|Amifostine|amifostine|mesh-list
92597060|NCT00137358|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92597061|NCT00137358|Protective Agents|protective agents|mesh-ancestor
92597062|NCT00137358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597063|NCT00134667|Verteporfin|verteporfin|mesh-list
92597064|NCT00134667|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92597065|NCT00134667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597066|NCT00134706|Carboplatin|carboplatin|mesh-list
92597067|NCT00134706|Docetaxel|docetaxel|mesh-list
92536521|NCT03151746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536522|NCT03151746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536523|NCT03151746|Antimanic Agents|antimanic agents|mesh-ancestor
92536524|NCT00399724|Insulin Glargine|insulin glargine|mesh-list
92536525|NCT00399724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92536526|NCT00399724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536527|NCT00083668|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92536528|NCT00083668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92536529|NCT00083668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92536530|NCT00083668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536531|NCT00083668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536532|NCT00083668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92536533|NCT00083668|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92536534|NCT00083668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92536535|NCT00083668|Serotonin Agents|serotonin agents|mesh-ancestor
92536536|NCT00083668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536537|NCT00083668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536538|NCT00083668|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92536539|NCT00083668|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92536540|NCT00083668|Dopamine Agents|dopamine agents|mesh-ancestor
92536541|NCT00083707|Thalidomide|thalidomide|mesh-list
92536542|NCT00083707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536543|NCT00083707|Immunologic Factors|immunologic factors|mesh-ancestor
92536544|NCT00083707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536545|NCT00083707|Leprostatic Agents|leprostatic agents|mesh-ancestor
92536546|NCT00083707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536547|NCT00083707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536548|NCT00083707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92536549|NCT00083707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92536550|NCT00083707|Growth Substances|growth substances|mesh-ancestor
92261329|NCT02980094|Vitamins|vitamins|mesh-list
92536551|NCT00083707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92536552|NCT00083707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536553|NCT00083785|Talaporfin|talaporfin|mesh-list
92536562|NCT03151707|Micronutrients|micronutrients|mesh-ancestor
92536563|NCT03151707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536564|NCT03151707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92536565|NCT03151707|Antimetabolites|antimetabolites|mesh-ancestor
91944032|NCT00375791|Dexamethasone|dexamethasone|mesh-list
92597068|NCT00134706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597069|NCT00134706|Tubulin Modulators|tubulin modulators|mesh-ancestor
92597070|NCT00134706|Antimitotic Agents|antimitotic agents|mesh-ancestor
92597071|NCT00134706|Mitosis Modulators|mitosis modulators|mesh-ancestor
92597072|NCT00134706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597073|NCT00137397|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92597074|NCT00137397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92597075|NCT00137397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92597076|NCT00137397|Cholinergic Agents|cholinergic agents|mesh-ancestor
92597077|NCT00137397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597078|NCT00137397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597079|NCT00137397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597080|NCT00137397|Urological Agents|urological agents|mesh-ancestor
92597081|NCT00134745|Estradiol|estradiol|mesh-list
92597082|NCT00134745|Estrogens|estrogens|mesh-ancestor
92597083|NCT00134745|Hormones|hormones|mesh-ancestor
92597084|NCT00134745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597085|NCT00134745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597086|NCT00105209|Aspirin|aspirin|mesh-list
92597090|NCT00105209|Analgesics|analgesics|mesh-ancestor
92597091|NCT00105209|Sensory System Agents|sensory system agents|mesh-ancestor
92597092|NCT00105209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597093|NCT00105209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597094|NCT00105209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597095|NCT00105209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597096|NCT00105209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92597097|NCT00105209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92597098|NCT00105209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597099|NCT00105209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92597100|NCT00105209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92597101|NCT00105209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597102|NCT00105209|Antipyretics|antipyretics|mesh-ancestor
92597103|NCT00105209|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92597104|NCT00105209|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92597105|NCT00105209|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92597106|NCT00105209|Purinergic Agents|purinergic agents|mesh-ancestor
92597107|NCT00105209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597108|NCT00105287|Fentanyl|fentanyl|mesh-list
92597109|NCT00105287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92597110|NCT00105287|Narcotics|narcotics|mesh-ancestor
92597111|NCT00105287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92597112|NCT00105287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597113|NCT00105287|Analgesics|analgesics|mesh-ancestor
92597114|NCT00105287|Sensory System Agents|sensory system agents|mesh-ancestor
92597115|NCT00105287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597116|NCT00105287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92597117|NCT00105287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92597118|NCT00105287|Anesthetics, General|anesthetics, general|mesh-ancestor
92597119|NCT00105287|Anesthetics|anesthetics|mesh-ancestor
92597120|NCT00137514|Chloroquine|chloroquine|mesh-list
92597121|NCT00137514|Amodiaquine|amodiaquine|mesh-list
92597122|NCT00137514|Amebicides|amebicides|mesh-ancestor
92597123|NCT00137514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92597124|NCT00137514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92597125|NCT00137514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597126|NCT00137514|Antimalarials|antimalarials|mesh-ancestor
92597127|NCT00137514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597128|NCT00105326|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92597129|NCT00105326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92597130|NCT00105326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92597131|NCT00105326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321997|NCT00000332|Nimodipine|nimodipine|mesh-list
92597132|NCT00105326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597133|NCT00105326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92597134|NCT00105326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92597135|NCT00105326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92597136|NCT00105326|Serotonin Agents|serotonin agents|mesh-ancestor
92536566|NCT03151707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536567|NCT03151707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92597137|NCT00105326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597138|NCT00105326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597139|NCT00105326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92597141|NCT00105326|Dopamine Agents|dopamine agents|mesh-ancestor
92597142|NCT00137553|Pyrimethamine|pyrimethamine|mesh-list
92597143|NCT00137553|Sulfadoxine|sulfadoxine|mesh-list
92597144|NCT00137553|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92597145|NCT00137553|Antimalarials|antimalarials|mesh-ancestor
92597146|NCT00137553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92597147|NCT00137553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92597148|NCT00137553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597149|NCT00137553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92597150|NCT00137553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597151|NCT00137553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597152|NCT00137553|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92597153|NCT00105404|Triamcinolone|triamcinolone|mesh-list
92597154|NCT00105404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92597155|NCT00105404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92597156|NCT00105404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92597157|NCT00105404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597158|NCT00105404|Glucocorticoids|glucocorticoids|mesh-ancestor
92597160|NCT00105404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597161|NCT00105404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597162|NCT00105404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597163|NCT00105404|Immunologic Factors|immunologic factors|mesh-ancestor
92597164|NCT00105404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597165|NCT00105404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597166|NCT00134979|Formoterol Fumarate|formoterol fumarate|mesh-list
92597167|NCT00134979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92597168|NCT00134979|Autonomic Agents|autonomic agents|mesh-ancestor
92597169|NCT00134979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597170|NCT00134979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597171|NCT00134979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92597172|NCT00134979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92597173|NCT00134979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92597174|NCT00134979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92597175|NCT00134979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92597176|NCT00134979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92597177|NCT00134979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597178|NCT00134979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597179|NCT00135018|Celecoxib|celecoxib|mesh-list
92597180|NCT00135018|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92597181|NCT00135018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92597182|NCT00135018|Analgesics|analgesics|mesh-ancestor
92597183|NCT00135018|Sensory System Agents|sensory system agents|mesh-ancestor
92597184|NCT00135018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597185|NCT00135018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597186|NCT00135018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597187|NCT00135018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597188|NCT00135018|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92597189|NCT00135018|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92597190|NCT00135018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597191|NCT00135018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597192|NCT00137709|Lamotrigine|lamotrigine|mesh-list
92597193|NCT00137709|Valproic Acid|valproic acid|mesh-list
92597194|NCT00137709|Anticonvulsants|anticonvulsants|mesh-ancestor
92597195|NCT00137709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92597196|NCT00137709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92597197|NCT00137709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597198|NCT00137709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92597199|NCT00137709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597200|NCT00137709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92597201|NCT00137709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92597202|NCT00137709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92597203|NCT00137709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92597204|NCT00137709|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92597205|NCT00137709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536568|NCT03151707|Vasodilator Agents|vasodilator agents|mesh-ancestor
92536569|NCT03151668|Dexmedetomidine|dexmedetomidine|mesh-list
92597206|NCT00137709|GABA Agents|gaba agents|mesh-ancestor
92597207|NCT00137709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597208|NCT00137709|Antimanic Agents|antimanic agents|mesh-ancestor
92597209|NCT01054144|Dexamethasone|dexamethasone|mesh-list
92597210|NCT01054144|Prednisone|prednisone|mesh-list
92597211|NCT01054144|Lenalidomide|lenalidomide|mesh-list
92597212|NCT01054144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597213|NCT01054144|Antiemetics|antiemetics|mesh-ancestor
92597214|NCT01054144|Autonomic Agents|autonomic agents|mesh-ancestor
92597215|NCT01054144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597216|NCT01054144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597217|NCT01054144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92597218|NCT01054144|Glucocorticoids|glucocorticoids|mesh-ancestor
92597219|NCT01054144|Hormones|hormones|mesh-ancestor
92597220|NCT01054144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597221|NCT01054144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92597222|NCT01054144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597223|NCT01054144|Immunologic Factors|immunologic factors|mesh-ancestor
92597224|NCT01054144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92597225|NCT01054144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92597226|NCT01054144|Growth Substances|growth substances|mesh-ancestor
92597227|NCT01054144|Growth Inhibitors|growth inhibitors|mesh-ancestor
92597228|NCT03277495|Nicotine|nicotine|mesh-list
92597229|NCT03277495|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92597230|NCT03277495|Autonomic Agents|autonomic agents|mesh-ancestor
92597231|NCT03277495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597233|NCT03277495|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92597234|NCT03277495|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92597235|NCT03277495|Cholinergic Agents|cholinergic agents|mesh-ancestor
92597236|NCT03277495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597237|NCT03277495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597239|NCT00137787|Cefepime|cefepime|mesh-list
92597240|NCT00137787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92597241|NCT00137787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597242|NCT00137787|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92597243|NCT00137787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597244|NCT00137787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597245|NCT00137787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597246|NCT00137787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597247|NCT00137787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92597248|NCT00137787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92597249|NCT04702048|Aflibercept|aflibercept|mesh-list
92597250|NCT04702048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92597251|NCT04702048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92597252|NCT04702048|Growth Substances|growth substances|mesh-ancestor
92597253|NCT04702048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597254|NCT04702048|Growth Inhibitors|growth inhibitors|mesh-ancestor
92597255|NCT04702048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597256|NCT00434629|Tositumomab I-131|tositumomab i-131|mesh-list
92597257|NCT00434629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597258|NCT00135057|Insulin|insulin|mesh-list
92597259|NCT00135057|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92597260|NCT00135057|Insulin Glargine|insulin glargine|mesh-list
92597261|NCT00135057|Insulin glulisine|insulin glulisine|mesh-list
92597262|NCT00135057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92597263|NCT00135057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597264|NCT00434668|Cisplatin|cisplatin|mesh-list
92597265|NCT00434668|Docetaxel|docetaxel|mesh-list
92597266|NCT00434668|Vinorelbine|vinorelbine|mesh-list
92597267|NCT00434668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597268|NCT00434668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92597269|NCT00434668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92597270|NCT00434668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92597271|NCT00434668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597272|NCT00434668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92597273|NCT00434746|Fezakinumab|fezakinumab|mesh-list
92597274|NCT00434746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597275|NCT00137826|Bevacizumab|bevacizumab|mesh-list
92597276|NCT00137826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92597277|NCT00137826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597278|NCT00137826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597279|NCT00137826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92597280|NCT00137826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92536570|NCT03151668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92536571|NCT03151668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536572|NCT03151668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536573|NCT03151668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92536574|NCT03151668|Analgesics|analgesics|mesh-ancestor
92536575|NCT03151668|Sensory System Agents|sensory system agents|mesh-ancestor
92536576|NCT03151668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536577|NCT03151668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92536578|NCT03151668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92536579|NCT03151668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92536580|NCT03151668|Adrenergic Agents|adrenergic agents|mesh-ancestor
92597281|NCT00137826|Growth Substances|growth substances|mesh-ancestor
92597282|NCT00137826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597284|NCT00137826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92597285|NCT00137826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597286|NCT00137826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597287|NCT00434824|Methyltestosterone|methyltestosterone|mesh-list
92597288|NCT00434824|Testosterone|testosterone|mesh-list
92597289|NCT00434824|Testosterone undecanoate|testosterone undecanoate|mesh-list
92597290|NCT00434824|Testosterone enanthate|testosterone enanthate|mesh-list
92597291|NCT00434824|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92597292|NCT00434824|Androgens|androgens|mesh-ancestor
92597293|NCT00434824|Hormones|hormones|mesh-ancestor
92597294|NCT00434824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597295|NCT00434824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597296|NCT00434824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92597297|NCT00434824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597298|NCT00434824|Anabolic Agents|anabolic agents|mesh-ancestor
92597299|NCT00105950|Lapatinib|lapatinib|mesh-list
92597300|NCT00105950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597301|NCT00105950|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92597302|NCT00105950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597303|NCT00105950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597304|NCT00434863|Botulinum Toxins|botulinum toxins|mesh-list
92597305|NCT00434863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92597306|NCT00434863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92597309|NCT00434863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597310|NCT00434863|Cholinergic Agents|cholinergic agents|mesh-ancestor
92597311|NCT00434863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597312|NCT00434863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597313|NCT00434863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92597314|NCT00434863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597315|NCT00434941|Capecitabine|capecitabine|mesh-list
92597316|NCT00434941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597317|NCT00434941|Antimetabolites|antimetabolites|mesh-ancestor
92597318|NCT00434941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597319|NCT00434941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597320|NCT00135096|Insulin|insulin|mesh-list
92597321|NCT00135096|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92597322|NCT00135096|Insulin Glargine|insulin glargine|mesh-list
92597323|NCT00135096|Insulin glulisine|insulin glulisine|mesh-list
92597324|NCT00135096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92597325|NCT00135096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597326|NCT00435058|Timolol|timolol|mesh-list
92597327|NCT00435058|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92597328|NCT00435058|Travoprost|travoprost|mesh-list
92597329|NCT00435058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597330|NCT00435058|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92597331|NCT00435058|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92597332|NCT00435058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92597333|NCT00435058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597334|NCT00435058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597335|NCT00435058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92536581|NCT03151668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944325|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92597336|NCT00435058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92597337|NCT00435058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92597338|NCT00435058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92597339|NCT00435058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92597340|NCT00435175|Estradiol|estradiol|mesh-list
92597341|NCT00435175|Estrogens|estrogens|mesh-ancestor
92597342|NCT00435175|Hormones|hormones|mesh-ancestor
92597343|NCT00435175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597344|NCT00435175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597345|NCT00135135|Carboplatin|carboplatin|mesh-list
92597346|NCT00135135|Doxorubicin|doxorubicin|mesh-list
92597347|NCT00135135|Irinotecan|irinotecan|mesh-list
92597348|NCT00135135|Etoposide|etoposide|mesh-list
92597349|NCT00135135|Melphalan|melphalan|mesh-list
92597350|NCT00135135|Topotecan|topotecan|mesh-list
92597351|NCT00135135|Gefitinib|gefitinib|mesh-list
92597352|NCT00135135|Tretinoin|tretinoin|mesh-list
92597353|NCT00135135|Isotretinoin|isotretinoin|mesh-list
92597354|NCT00135135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597355|NCT00135135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92597356|NCT00135135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92597357|NCT00135135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597358|NCT00135135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597359|NCT00135135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597360|NCT00135135|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92597361|NCT00135135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92597362|NCT00135135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92597364|NCT00135135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92597365|NCT00135135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597366|NCT00135135|Immunologic Factors|immunologic factors|mesh-ancestor
92597367|NCT00135135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597368|NCT00135135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92597369|NCT00135135|Keratolytic Agents|keratolytic agents|mesh-ancestor
92597370|NCT00135135|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597371|NCT00435292|Naproxen|naproxen|mesh-list
92597372|NCT00435292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92597373|NCT00435292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92597374|NCT00435292|Analgesics|analgesics|mesh-ancestor
92597375|NCT00435292|Sensory System Agents|sensory system agents|mesh-ancestor
92597376|NCT00435292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597377|NCT00435292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597378|NCT00435292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597379|NCT00435292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597380|NCT00435292|Gout Suppressants|gout suppressants|mesh-ancestor
92597381|NCT00435292|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92597383|NCT00435292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597384|NCT00435331|Verapamil|verapamil|mesh-list
92597385|NCT00435331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92597386|NCT00435331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92597387|NCT00435331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92597388|NCT00435331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597389|NCT00435331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92597390|NCT00435331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597391|NCT00435331|Vasodilator Agents|vasodilator agents|mesh-ancestor
92597392|NCT00435448|Lonidamine|lonidamine|mesh-list
92597393|NCT00435448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597394|NCT00435448|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92597395|NCT00435448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597396|NCT00435448|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92597397|NCT00435448|Contraceptive Agents|contraceptive agents|mesh-ancestor
92597398|NCT00435448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92597399|NCT00435448|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92597400|NCT00435448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92597401|NCT00435448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92597402|NCT00435448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597403|NCT00435760|Bromides|bromides|mesh-list
92597404|NCT00435760|Tiotropium Bromide|tiotropium bromide|mesh-list
92597405|NCT00435760|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92597406|NCT00435760|Autonomic Agents|autonomic agents|mesh-ancestor
92597407|NCT00435760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597408|NCT00435760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597409|NCT00435760|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92536582|NCT03151668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536583|NCT05568082|Itraconazole|itraconazole|mesh-list
92536584|NCT05568082|Sotorasib|sotorasib|mesh-list
92536585|NCT05568082|Antifungal Agents|antifungal agents|mesh-ancestor
92536586|NCT05568082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597410|NCT00435760|Respiratory System Agents|respiratory system agents|mesh-ancestor
92597411|NCT00435760|Parasympatholytics|parasympatholytics|mesh-ancestor
92597412|NCT00435760|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92597413|NCT00435760|Cholinergic Agents|cholinergic agents|mesh-ancestor
92597414|NCT00435760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597415|NCT00435760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597416|NCT00435760|Anticonvulsants|anticonvulsants|mesh-ancestor
92597417|NCT00435799|Riboflavin|riboflavin|mesh-list
92597418|NCT00435799|Dextrans|dextrans|mesh-list
92597419|NCT00435799|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92597420|NCT00435799|Vitamin B Complex|vitamin b complex|mesh-ancestor
92597421|NCT00435799|Vitamins|vitamins|mesh-ancestor
92597422|NCT00435799|Micronutrients|micronutrients|mesh-ancestor
92597423|NCT00435799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597424|NCT00435799|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92597425|NCT00435799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597426|NCT00435799|Anticoagulants|anticoagulants|mesh-ancestor
92597427|NCT00435799|Plasma Substitutes|plasma substitutes|mesh-ancestor
92597428|NCT00435799|Blood Substitutes|blood substitutes|mesh-ancestor
92597429|NCT00435799|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92597430|NCT00142467|Bevacizumab|bevacizumab|mesh-list
92597431|NCT00142467|Gemcitabine|gemcitabine|mesh-list
92597432|NCT00142467|Oxaliplatin|oxaliplatin|mesh-list
92597433|NCT00142467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597434|NCT00142467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597435|NCT00142467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92597436|NCT00142467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92597437|NCT00142467|Growth Substances|growth substances|mesh-ancestor
92597438|NCT00142467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597439|NCT00142467|Growth Inhibitors|growth inhibitors|mesh-ancestor
92597440|NCT00142467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597441|NCT00142467|Antimetabolites|antimetabolites|mesh-ancestor
92597442|NCT00142467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597443|NCT00435955|Rituximab|rituximab|mesh-list
92597444|NCT00435955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597445|NCT00435955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597446|NCT00435955|Immunologic Factors|immunologic factors|mesh-ancestor
92597447|NCT00435955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597448|NCT00435955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597449|NCT00436033|Milnacipran|milnacipran|mesh-list
92597450|NCT00436033|Levomilnacipran|levomilnacipran|mesh-list
92597451|NCT00436033|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92597452|NCT00436033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92597453|NCT00436033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92597454|NCT00436033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597455|NCT00436033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597465|NCT00436072|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92597466|NCT00436072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597467|NCT00436072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597468|NCT00436072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597469|NCT00436072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597470|NCT00436072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597471|NCT03276052|Bromides|bromides|mesh-list
92597472|NCT03276052|Anticonvulsants|anticonvulsants|mesh-ancestor
92597473|NCT03273322|Rivaroxaban|rivaroxaban|mesh-list
92597474|NCT03273322|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92597475|NCT03273322|Antithrombins|antithrombins|mesh-ancestor
92597476|NCT03273322|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92597477|NCT03273322|Protease Inhibitors|protease inhibitors|mesh-ancestor
92597478|NCT03273322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597479|NCT03273322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597480|NCT03273322|Anticoagulants|anticoagulants|mesh-ancestor
92597481|NCT04702360|Ivacaftor|ivacaftor|mesh-list
92597482|NCT04702360|Elexacaftor|elexacaftor|mesh-list
92597483|NCT04702360|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92597484|NCT04702360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92536587|NCT05568082|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92536588|NCT05568082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92536589|NCT05568082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536590|NCT05568082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597485|NCT04702360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597487|NCT04702204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92597488|NCT04702204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597489|NCT00138060|Fluorouracil|fluorouracil|mesh-list
92597490|NCT00138060|Irinotecan|irinotecan|mesh-list
92597491|NCT00138060|Antimetabolites|antimetabolites|mesh-ancestor
92597492|NCT00138060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597493|NCT00138060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597494|NCT00138060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597495|NCT00138060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597496|NCT00138060|Immunologic Factors|immunologic factors|mesh-ancestor
92597497|NCT00138060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597498|NCT00138060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92597499|NCT00138060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597500|NCT00138060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597501|NCT04702009|Antibodies|antibodies|mesh-list
92597502|NCT04702009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92597503|NCT04702009|Immunologic Factors|immunologic factors|mesh-ancestor
92597504|NCT04702009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597505|NCT00106145|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92597506|NCT00106145|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92597507|NCT00106145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597508|NCT00106145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597509|NCT00142545|Apomorphine|apomorphine|mesh-list
92597510|NCT00142545|Emetics|emetics|mesh-ancestor
92597511|NCT00142545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597512|NCT00142545|Autonomic Agents|autonomic agents|mesh-ancestor
92597513|NCT00142545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597514|NCT00142545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92597515|NCT00142545|Dopamine Agonists|dopamine agonists|mesh-ancestor
92597516|NCT00142545|Dopamine Agents|dopamine agents|mesh-ancestor
92597517|NCT00142545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597518|NCT00142545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597519|NCT00106262|Irinotecan|irinotecan|mesh-list
92597520|NCT00106262|Bortezomib|bortezomib|mesh-list
92597521|NCT00106262|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92597529|NCT00106301|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92597531|NCT00106301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597532|NCT00436267|Fluorouracil|fluorouracil|mesh-list
92597533|NCT00436267|Antimetabolites|antimetabolites|mesh-ancestor
92597534|NCT00436267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597535|NCT00436267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597536|NCT00436267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597537|NCT00436267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597538|NCT00436267|Immunologic Factors|immunologic factors|mesh-ancestor
92597539|NCT00436267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597540|NCT00436306|Contraceptive Agents|contraceptive agents|mesh-list
92597541|NCT00436306|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92597542|NCT00436306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597543|NCT00138099|Dalteparin|dalteparin|mesh-list
92597544|NCT00138099|Tinzaparin|tinzaparin|mesh-list
92597545|NCT00138099|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92597546|NCT00138099|Anticoagulants|anticoagulants|mesh-ancestor
92597547|NCT00138099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92597548|NCT00138099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92597549|NCT00138099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597550|NCT00106379|Tenofovir|tenofovir|mesh-list
92597551|NCT00106379|Emtricitabine|emtricitabine|mesh-list
92597552|NCT00106379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92597553|NCT00106379|Antiviral Agents|antiviral agents|mesh-ancestor
92597554|NCT00106379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597555|NCT00106379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92536592|NCT05568082|Hormone Antagonists|hormone antagonists|mesh-ancestor
92536593|NCT05568082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944373|NCT00297089|Pemetrexed|pemetrexed|mesh-list
92597556|NCT00106379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92597557|NCT00106379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597558|NCT00106379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597559|NCT00106379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92597560|NCT00106379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92597561|NCT00436423|Gemcitabine|gemcitabine|mesh-list
92597562|NCT00436423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597563|NCT00436423|Antimetabolites|antimetabolites|mesh-ancestor
92597564|NCT00436423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597565|NCT00436423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597566|NCT00436579|Sorafenib|sorafenib|mesh-list
92597567|NCT00436579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597568|NCT00436579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92597569|NCT00436579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597570|NCT00436579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597571|NCT00436657|Cisplatin|cisplatin|mesh-list
92597572|NCT00436657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597573|NCT00106418|Romidepsin|romidepsin|mesh-list
92597574|NCT00106418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92597575|NCT00106418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597576|NCT00106418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92597577|NCT00106418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597578|NCT00106418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597579|NCT00436930|Sargramostim|sargramostim|mesh-list
92597580|NCT00436930|Immunologic Factors|immunologic factors|mesh-ancestor
92597581|NCT00436930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597582|NCT00437008|Benphothiamine|benphothiamine|mesh-list
92597583|NCT00437008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92597584|NCT00437008|Immunologic Factors|immunologic factors|mesh-ancestor
92597585|NCT00437008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597586|NCT00437008|Chelating Agents|chelating agents|mesh-ancestor
92597587|NCT00437008|Sequestering Agents|sequestering agents|mesh-ancestor
92597608|NCT00437359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92597609|NCT00437359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597610|NCT00437359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92597611|NCT00437359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92597612|NCT00437359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597613|NCT00437359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92597614|NCT00437359|Hormone Antagonists|hormone antagonists|mesh-ancestor
92597615|NCT00437359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597616|NCT00437359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597617|NCT00437359|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92597618|NCT00437359|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92597619|NCT00437359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92597620|NCT00437476|Ribavirin|ribavirin|mesh-list
92597621|NCT00437476|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92597622|NCT00437476|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92597623|NCT00437476|Antimetabolites|antimetabolites|mesh-ancestor
92597624|NCT00437476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597625|NCT00437476|Antiviral Agents|antiviral agents|mesh-ancestor
92597626|NCT00437476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597627|NCT00437476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92597628|NCT00437476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597629|NCT00437554|Glimepiride|glimepiride|mesh-list
92597630|NCT00437554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92597631|NCT00437554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92597632|NCT00437554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597633|NCT00437554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597634|NCT00437554|Immunologic Factors|immunologic factors|mesh-ancestor
92597635|NCT00437632|Caffeine|caffeine|mesh-list
92597636|NCT00437632|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92597637|NCT00437632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597638|NCT00437632|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92597639|NCT00437632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597640|NCT00437632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536594|NCT05568082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536595|NCT05568082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92597650|NCT00437671|Immunologic Factors|immunologic factors|mesh-ancestor
92597651|NCT00437671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597652|NCT00106613|Romidepsin|romidepsin|mesh-list
92597653|NCT00106613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92597654|NCT00106613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322524|NCT00000626|Bleomycin|bleomycin|mesh-list
92597655|NCT00106613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92597656|NCT00106613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597657|NCT00106613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597658|NCT00401180|Docetaxel|docetaxel|mesh-list
92597659|NCT00401180|Temozolomide|temozolomide|mesh-list
92597660|NCT00401180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597661|NCT00401180|Tubulin Modulators|tubulin modulators|mesh-ancestor
92597662|NCT00401180|Antimitotic Agents|antimitotic agents|mesh-ancestor
92597663|NCT00401180|Mitosis Modulators|mitosis modulators|mesh-ancestor
92597664|NCT00401180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597665|NCT00401180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92597666|NCT00401180|Alkylating Agents|alkylating agents|mesh-ancestor
92597667|NCT03278665|Pembrolizumab|pembrolizumab|mesh-list
92597668|NCT03278665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597669|NCT03278665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597670|NCT03278665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92597671|NCT03278665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597672|NCT00401219|Estrogens|estrogens|mesh-list
92597673|NCT00401219|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92597674|NCT00401219|Progestins|progestins|mesh-list
92597675|NCT00401219|Hormones|hormones|mesh-ancestor
92597676|NCT00401219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597677|NCT00401219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597678|NCT04701463|Calcium|calcium|mesh-list
92597679|NCT04701463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92597680|NCT04701463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597681|NCT00438139|Dronabinol|dronabinol|mesh-list
92597682|NCT00438139|Hallucinogens|hallucinogens|mesh-ancestor
92597683|NCT00438139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597684|NCT00438139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92597685|NCT00438139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92597686|NCT00438139|Analgesics|analgesics|mesh-ancestor
92597687|NCT00438139|Sensory System Agents|sensory system agents|mesh-ancestor
92597688|NCT00438139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597689|NCT00438139|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92597690|NCT00438139|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92597691|NCT00438139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597692|NCT00438139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597693|NCT00438139|Hormones|hormones|mesh-ancestor
92597694|NCT00438139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597695|NCT00438178|Obatoclax|obatoclax|mesh-list
92597696|NCT00438178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597697|NCT00438178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597698|NCT00438217|Leuprolide|leuprolide|mesh-list
92597699|NCT00438217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92597700|NCT00438217|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92597701|NCT00438217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92597702|NCT00438217|Fertility Agents|fertility agents|mesh-ancestor
92597703|NCT00438217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92597704|NCT00438217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597705|NCT00438217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92597717|NCT03279757|Carticaine|carticaine|mesh-list
92597718|NCT03279757|Epinephryl borate|epinephryl borate|mesh-list
92597719|NCT03279757|Anesthetics, Local|anesthetics, local|mesh-ancestor
92597720|NCT03279757|Anesthetics|anesthetics|mesh-ancestor
92597721|NCT03279757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92597722|NCT03279757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597723|NCT03279757|Sensory System Agents|sensory system agents|mesh-ancestor
92597724|NCT03279757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597725|NCT03279757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92597726|NCT03279757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92597727|NCT03279757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92597728|NCT03279757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92536596|NCT05568082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92536597|NCT05568082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536598|NCT05568082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536600|NCT05567653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947061|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
92597729|NCT03279757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597730|NCT03279757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92597731|NCT03279757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92597732|NCT03279757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92597733|NCT03279757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597734|NCT03279757|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92597735|NCT03279757|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92597736|NCT03279757|Autonomic Agents|autonomic agents|mesh-ancestor
92597737|NCT03279757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92597738|NCT03279757|Respiratory System Agents|respiratory system agents|mesh-ancestor
92597739|NCT03279757|Mydriatics|mydriatics|mesh-ancestor
92597740|NCT03279757|Sympathomimetics|sympathomimetics|mesh-ancestor
92597741|NCT03279757|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92597742|NCT00438568|Insulin|insulin|mesh-list
92597743|NCT00438568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92597744|NCT00438568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92597745|NCT00438568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597746|NCT00438607|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
92597747|NCT00438607|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92597748|NCT00438607|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92597749|NCT00438607|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92597750|NCT00438607|Purinergic Agents|purinergic agents|mesh-ancestor
92597751|NCT00438607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597752|NCT00438607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597753|NCT00438607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597754|NCT00106847|Infliximab|infliximab|mesh-list
92597755|NCT00106847|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92597756|NCT00106847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597757|NCT00106847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597758|NCT00106847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92597759|NCT00106847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597760|NCT00106886|Folic Acid|folic acid|mesh-list
92597761|NCT00106886|Vitamin B 6|vitamin b 6|mesh-list
92597762|NCT00106886|Pyridoxal|pyridoxal|mesh-list
92597763|NCT00106886|Pyridoxine|pyridoxine|mesh-list
92597764|NCT00106886|Vitamins|vitamins|mesh-ancestor
92597765|NCT00106886|Micronutrients|micronutrients|mesh-ancestor
92597766|NCT00106886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597767|NCT00106886|Hematinics|hematinics|mesh-ancestor
92597768|NCT00106886|Vitamin B Complex|vitamin b complex|mesh-ancestor
92597769|NCT00438841|Thalidomide|thalidomide|mesh-list
92597770|NCT00438841|Dexamethasone|dexamethasone|mesh-list
92597771|NCT00438841|Cyclophosphamide|cyclophosphamide|mesh-list
92597774|NCT00438841|Immunologic Factors|immunologic factors|mesh-ancestor
92360604|NCT00429702|Ondansetron|ondansetron|mesh-list
92597775|NCT00438841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597776|NCT00438841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92597777|NCT00438841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92597778|NCT00438841|Alkylating Agents|alkylating agents|mesh-ancestor
92597779|NCT00438841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597780|NCT00438841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597781|NCT00438841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92597782|NCT00438841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92597783|NCT00438841|Antiemetics|antiemetics|mesh-ancestor
92597784|NCT00438841|Autonomic Agents|autonomic agents|mesh-ancestor
92597785|NCT00438841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597786|NCT00438841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92597787|NCT00438841|Glucocorticoids|glucocorticoids|mesh-ancestor
92597788|NCT00438841|Hormones|hormones|mesh-ancestor
92597789|NCT00438841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597790|NCT00438841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92597791|NCT00438841|Leprostatic Agents|leprostatic agents|mesh-ancestor
92597792|NCT00438841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92597793|NCT00438841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597794|NCT00438841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92536601|NCT05567653|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92536602|NCT05567653|Antimalarials|antimalarials|mesh-ancestor
92536603|NCT05567653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92536604|NCT05567653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92536606|NCT04733508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91944381|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597795|NCT00438841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92597796|NCT00438841|Growth Substances|growth substances|mesh-ancestor
92597797|NCT00438841|Growth Inhibitors|growth inhibitors|mesh-ancestor
92597798|NCT00438958|Lenograstim|lenograstim|mesh-list
92597799|NCT00438958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92597800|NCT00438958|Immunologic Factors|immunologic factors|mesh-ancestor
92597801|NCT00438958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597802|NCT00107003|Lapatinib|lapatinib|mesh-list
92597803|NCT00107003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597804|NCT00107003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92597805|NCT00107003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597806|NCT00107003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597807|NCT00107081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92597808|NCT00107081|Amoxicillin|amoxicillin|mesh-list
92597809|NCT00107081|Ciprofloxacin|ciprofloxacin|mesh-list
92597810|NCT00107081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597811|NCT00107081|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92597812|NCT00107081|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597813|NCT00107081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597814|NCT00107081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597815|NCT00107081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597816|NCT00107081|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92597817|NCT00107081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92597818|NCT00439192|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92597819|NCT00439192|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92597820|NCT00439192|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92597821|NCT00439192|Cholinergic Agents|cholinergic agents|mesh-ancestor
92597822|NCT00439192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597823|NCT00439192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597824|NCT00439192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597825|NCT00439192|Urological Agents|urological agents|mesh-ancestor
92597826|NCT00439426|Capecitabine|capecitabine|mesh-list
92597827|NCT00439426|Oxaliplatin|oxaliplatin|mesh-list
92597828|NCT00439426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360612|NCT00429702|Hormones|hormones|mesh-ancestor
92597829|NCT00439426|Antimetabolites|antimetabolites|mesh-ancestor
92597830|NCT00439426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597831|NCT00439426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597832|NCT00138138|Methylphenidate|methylphenidate|mesh-list
92597833|NCT00138138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92597834|NCT00138138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597835|NCT00138138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92597836|NCT00138138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92597837|NCT00138138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92597838|NCT00138138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597839|NCT00138138|Dopamine Agents|dopamine agents|mesh-ancestor
92597840|NCT00138138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597841|NCT00439504|Lobeline|lobeline|mesh-list
92597842|NCT00439504|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92597843|NCT00439504|Autonomic Agents|autonomic agents|mesh-ancestor
92597846|NCT00439504|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92597847|NCT00439504|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92597848|NCT00439504|Cholinergic Agents|cholinergic agents|mesh-ancestor
92597849|NCT00439504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597850|NCT00439504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597851|NCT00439504|Respiratory System Agents|respiratory system agents|mesh-ancestor
92597852|NCT00439543|Iloprost|iloprost|mesh-list
92597853|NCT00439543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92597854|NCT00439543|Vasodilator Agents|vasodilator agents|mesh-ancestor
92597855|NCT00107237|Everolimus|everolimus|mesh-list
92597856|NCT00107237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92597857|NCT00107237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536607|NCT04733508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536608|NCT04733508|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92536609|NCT04733508|Incretins|incretins|mesh-ancestor
92536610|NCT04733508|Hormones|hormones|mesh-ancestor
91944385|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597858|NCT00107237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597859|NCT00107237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597860|NCT00107237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597861|NCT00107237|Immunologic Factors|immunologic factors|mesh-ancestor
92597862|NCT00107237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597863|NCT00107237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597864|NCT00439699|Memantine|memantine|mesh-list
92597865|NCT00439699|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92597866|NCT00439699|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92597867|NCT00439699|Dopamine Agents|dopamine agents|mesh-ancestor
92597868|NCT00439699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597869|NCT00439699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597870|NCT00439699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597871|NCT00439699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92597872|NCT00439699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92597873|NCT00439855|Heparin|heparin|mesh-list
92597874|NCT00439855|Enoxaparin|enoxaparin|mesh-list
92597875|NCT00439855|Calcium heparin|calcium heparin|mesh-list
92597876|NCT00439855|Anticoagulants|anticoagulants|mesh-ancestor
92597877|NCT00439855|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92322748|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92597878|NCT00439855|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92597879|NCT00439855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597880|NCT00107354|Cytarabine|cytarabine|mesh-list
92597881|NCT00107354|Aldesleukin|aldesleukin|mesh-list
92597882|NCT00107354|Etoposide|etoposide|mesh-list
92597883|NCT00107354|Mitoxantrone|mitoxantrone|mesh-list
92597884|NCT00107354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92597885|NCT00107354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597886|NCT00107354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92597887|NCT00107354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597888|NCT00107354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597889|NCT00107354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597890|NCT00107354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597891|NCT00107354|Antimetabolites|antimetabolites|mesh-ancestor
92597892|NCT00107354|Antiviral Agents|antiviral agents|mesh-ancestor
92597893|NCT00107354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597894|NCT00107354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597895|NCT00107354|Immunologic Factors|immunologic factors|mesh-ancestor
92597896|NCT00107354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597897|NCT00107354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92597898|NCT00107354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92597899|NCT00107354|Analgesics|analgesics|mesh-ancestor
92597900|NCT00107354|Sensory System Agents|sensory system agents|mesh-ancestor
92597901|NCT00107354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597902|NCT00138177|Leucovorin|leucovorin|mesh-list
92597903|NCT00138177|Fluorouracil|fluorouracil|mesh-list
92597904|NCT00138177|Oxaliplatin|oxaliplatin|mesh-list
92597905|NCT00138177|Vorinostat|vorinostat|mesh-list
92597906|NCT00138177|Calcium|calcium|mesh-list
92597907|NCT00138177|Levoleucovorin|levoleucovorin|mesh-list
92597908|NCT00138177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92597909|NCT00138177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597910|NCT00138177|Antimetabolites|antimetabolites|mesh-ancestor
92597911|NCT00138177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597912|NCT00138177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597913|NCT00138177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597914|NCT00138177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597915|NCT00138177|Immunologic Factors|immunologic factors|mesh-ancestor
92597916|NCT00138177|Antidotes|antidotes|mesh-ancestor
92597918|NCT00138177|Vitamin B Complex|vitamin b complex|mesh-ancestor
92597920|NCT00138177|Micronutrients|micronutrients|mesh-ancestor
92597921|NCT00138177|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92597922|NCT00138177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597923|NCT03279601|Capecitabine|capecitabine|mesh-list
92597924|NCT03279601|Temozolomide|temozolomide|mesh-list
92597925|NCT03279601|Dacarbazine|dacarbazine|mesh-list
92597926|NCT03279601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92536611|NCT04733508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536612|NCT05567536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92536614|NCT00135304|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92536615|NCT00135304|Cinacalcet|cinacalcet|mesh-list
92536616|NCT00135304|Vitamins|vitamins|mesh-ancestor
92536617|NCT00135304|Micronutrients|micronutrients|mesh-ancestor
92597927|NCT03279601|Antimetabolites|antimetabolites|mesh-ancestor
92597928|NCT03279601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597929|NCT03279601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597930|NCT03279601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92597931|NCT03279601|Alkylating Agents|alkylating agents|mesh-ancestor
92597932|NCT00107393|Capecitabine|capecitabine|mesh-list
92597933|NCT00107393|Trastuzumab|trastuzumab|mesh-list
92597934|NCT00107393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92597935|NCT00107393|Antimetabolites|antimetabolites|mesh-ancestor
92597936|NCT00107393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597937|NCT00107393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597938|NCT00107393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92597939|NCT00138216|Irinotecan|irinotecan|mesh-list
92597940|NCT00138216|Vincristine|vincristine|mesh-list
92597941|NCT00138216|Temozolomide|temozolomide|mesh-list
92597942|NCT00138216|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92597943|NCT00138216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597944|NCT00138216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597945|NCT00138216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597946|NCT00138216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597947|NCT00138216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92597948|NCT00138216|Tubulin Modulators|tubulin modulators|mesh-ancestor
92597949|NCT00138216|Antimitotic Agents|antimitotic agents|mesh-ancestor
92597950|NCT00138216|Mitosis Modulators|mitosis modulators|mesh-ancestor
92597951|NCT00138216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92597952|NCT00138216|Alkylating Agents|alkylating agents|mesh-ancestor
92597953|NCT00105586|Escitalopram|escitalopram|mesh-list
92597954|NCT00105586|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92597955|NCT00105586|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92597956|NCT00105586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92597957|NCT00105586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597958|NCT00105586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597959|NCT00105586|Serotonin Agents|serotonin agents|mesh-ancestor
92597960|NCT00105586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597961|NCT00107432|Sorafenib|sorafenib|mesh-list
92597962|NCT00107432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597963|NCT00107432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92597964|NCT00107432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597965|NCT00107432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597966|NCT00439972|Moxifloxacin|moxifloxacin|mesh-list
92597967|NCT00439972|Ortho Evra|ortho evra|mesh-list
92154046|NCT02985125|Everolimus|everolimus|mesh-list
92597968|NCT00439972|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92597969|NCT00439972|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92597970|NCT00439972|Contraceptive Agents|contraceptive agents|mesh-ancestor
92597971|NCT00439972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92597972|NCT00439972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597973|NCT00439972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92597974|NCT00439972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92597975|NCT00439972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92597976|NCT00439972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597977|NCT00439972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597978|NCT00439972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597979|NCT00439972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597980|NCT00439972|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92597981|NCT00439972|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92597982|NCT00439972|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92597983|NCT00440128|Docetaxel|docetaxel|mesh-list
92597984|NCT00440128|Casopitant|casopitant|mesh-list
92597985|NCT00440128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597986|NCT00440128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536618|NCT00135304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536619|NCT00135304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92536620|NCT00135304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92536621|NCT00135304|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92536622|NCT00135304|Hormone Antagonists|hormone antagonists|mesh-ancestor
92597987|NCT00440128|Antimitotic Agents|antimitotic agents|mesh-ancestor
92597988|NCT00440128|Mitosis Modulators|mitosis modulators|mesh-ancestor
92597989|NCT00440128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598011|NCT00107471|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92598012|NCT00107471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92598014|NCT00107471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598015|NCT00107471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598016|NCT00404157|Rituximab|rituximab|mesh-list
92598017|NCT00404157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92598018|NCT00404157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598019|NCT00404157|Immunologic Factors|immunologic factors|mesh-ancestor
92598020|NCT00404157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598021|NCT00404157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598022|NCT02957266|Gemcitabine|gemcitabine|mesh-list
92598023|NCT02957266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598024|NCT02957266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92598025|NCT02957266|Antimetabolites|antimetabolites|mesh-ancestor
92598026|NCT02957266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598027|NCT03279562|Nalmefene|nalmefene|mesh-list
92598028|NCT03279562|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92598029|NCT03279562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598030|NCT03279562|Sensory System Agents|sensory system agents|mesh-ancestor
92598031|NCT03279562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598032|NCT00404196|Calcipotriene|calcipotriene|mesh-list
92598033|NCT00404196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598034|NCT00107510|Carboplatin|carboplatin|mesh-list
92598035|NCT00107510|Docetaxel|docetaxel|mesh-list
92598036|NCT00107510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598037|NCT00107510|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598038|NCT00107510|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598039|NCT00107510|Mitosis Modulators|mitosis modulators|mesh-ancestor
92598040|NCT00107510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598041|NCT00440245|Albuterol|albuterol|mesh-list
92598042|NCT00440245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92598043|NCT00440245|Autonomic Agents|autonomic agents|mesh-ancestor
92598060|NCT00142779|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92598061|NCT00142779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598062|NCT00142779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598063|NCT00142779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598064|NCT00142779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598065|NCT00142779|Serotonin Agents|serotonin agents|mesh-ancestor
92598066|NCT00142779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598067|NCT00142779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92598068|NCT00142779|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598069|NCT00142779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598070|NCT00142779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92598071|NCT00142779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92598072|NCT00142779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598074|NCT00440323|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92598075|NCT00440323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92598076|NCT00440323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598077|NCT00440323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598078|NCT00440323|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92598079|NCT00440323|GABA Agonists|gaba agonists|mesh-ancestor
92598080|NCT00440323|GABA Agents|gaba agents|mesh-ancestor
92598081|NCT00440323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598082|NCT00440323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598083|NCT00440440|Testosterone|testosterone|mesh-list
92598084|NCT00440440|Androgens|androgens|mesh-ancestor
92598085|NCT00440440|Hormones|hormones|mesh-ancestor
92598086|NCT00440440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598087|NCT00440440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536623|NCT00135304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536625|NCT00135499|Cyclophosphamide|cyclophosphamide|mesh-list
92536626|NCT00135499|Rituximab|rituximab|mesh-list
92598088|NCT00142896|Morphine|morphine|mesh-list
92598089|NCT00142896|Tramadol|tramadol|mesh-list
92598090|NCT00142896|Naloxone|naloxone|mesh-list
92598091|NCT00142896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92598092|NCT00142896|Narcotics|narcotics|mesh-ancestor
92598093|NCT00142896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598094|NCT00142896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598095|NCT00142896|Analgesics|analgesics|mesh-ancestor
92598096|NCT00142896|Sensory System Agents|sensory system agents|mesh-ancestor
92598097|NCT00142896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598098|NCT00142896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92598099|NCT00440479|Bortezomib|bortezomib|mesh-list
92598100|NCT00440479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598110|NCT00440713|Aripiprazole|aripiprazole|mesh-list
92598111|NCT00440713|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598112|NCT00440713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598113|NCT00440713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92598114|NCT00440713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92598115|NCT00440713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598116|NCT00440713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598117|NCT00440713|Dopamine Agonists|dopamine agonists|mesh-ancestor
92598118|NCT00440713|Dopamine Agents|dopamine agents|mesh-ancestor
92598119|NCT00440713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598120|NCT00440713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598121|NCT00440713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92598122|NCT00440713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92598123|NCT00440713|Serotonin Agents|serotonin agents|mesh-ancestor
92598124|NCT00440713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92598125|NCT00440713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92598126|NCT00440713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92598127|NCT00440713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92598128|NCT00440869|Acetylcysteine|acetylcysteine|mesh-list
92598129|NCT00440869|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92598130|NCT00440869|Antiviral Agents|antiviral agents|mesh-ancestor
92598131|NCT00440869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598132|NCT00440869|Expectorants|expectorants|mesh-ancestor
92598133|NCT00440869|Respiratory System Agents|respiratory system agents|mesh-ancestor
92598134|NCT00440869|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92598135|NCT00440869|Antioxidants|antioxidants|mesh-ancestor
92598136|NCT00440869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598137|NCT00440869|Protective Agents|protective agents|mesh-ancestor
92598138|NCT00440869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598139|NCT00440869|Antidotes|antidotes|mesh-ancestor
92598140|NCT00441025|Alemtuzumab|alemtuzumab|mesh-list
92598141|NCT00441025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92598142|NCT00441025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598143|NCT00441181|Travoprost|travoprost|mesh-list
92598144|NCT00441181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92598145|NCT00441298|Tenofovir|tenofovir|mesh-list
92598146|NCT00441298|Antiviral Agents|antiviral agents|mesh-ancestor
92598147|NCT00441298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598148|NCT00441298|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92598149|NCT00441298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92598150|NCT00441298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598151|NCT00441298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598152|NCT00441298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92598153|NCT00441298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92598154|NCT00441415|Adapalene|adapalene|mesh-list
92598155|NCT00441415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598156|NCT00441415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598157|NCT00441415|Analgesics|analgesics|mesh-ancestor
92598158|NCT00441415|Sensory System Agents|sensory system agents|mesh-ancestor
92598159|NCT00441415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598160|NCT00441415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598161|NCT00441415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598162|NCT00441415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598163|NCT00441415|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598164|NCT02964728|Botulinum Toxins|botulinum toxins|mesh-list
92598165|NCT02964728|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92536627|NCT00135499|Doxorubicin|doxorubicin|mesh-list
92536628|NCT00135499|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92536629|NCT00135499|Vincristine|vincristine|mesh-list
92598178|NCT00441532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598179|NCT00441532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598180|NCT00441532|Sensory System Agents|sensory system agents|mesh-ancestor
92598181|NCT00441532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598182|NCT00441532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598183|NCT00441532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92598184|NCT00441532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92598185|NCT00441532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598186|NCT00441532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598188|NCT00441649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92598189|NCT00441649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598190|NCT00441649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92598191|NCT00441649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598192|NCT00441649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598193|NCT00441649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598194|NCT00441649|Dopamine Agents|dopamine agents|mesh-ancestor
92598195|NCT00441649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598196|NCT00107822|Lidocaine|lidocaine|mesh-list
92598197|NCT00107822|Tetracaine|tetracaine|mesh-list
92598198|NCT00107822|Anesthetics, Local|anesthetics, local|mesh-ancestor
92598199|NCT00107822|Anesthetics|anesthetics|mesh-ancestor
92598200|NCT00107822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598201|NCT00107822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598202|NCT00107822|Sensory System Agents|sensory system agents|mesh-ancestor
92598203|NCT00107822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598204|NCT00107822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598205|NCT00107822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92598206|NCT00107822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92598207|NCT00107822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598208|NCT00107822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598209|NCT03279328|Petrolatum|petrolatum|mesh-list
92598210|NCT03279328|Emollients|emollients|mesh-ancestor
92598211|NCT03279328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598212|NCT00142974|Tegaserod|tegaserod|mesh-list
92598213|NCT00142974|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92598214|NCT00142974|Serotonin Agents|serotonin agents|mesh-ancestor
92598215|NCT00142974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598216|NCT00142974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598217|NCT00142974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598218|NCT00441844|Simvastatin|simvastatin|mesh-list
92598219|NCT00441844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92598220|NCT00441844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92598221|NCT00441844|Antimetabolites|antimetabolites|mesh-ancestor
92598222|NCT00441844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005578|NCT03111433|Ubiquinone|ubiquinone|mesh-list
92598245|NCT00441922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598246|NCT00441922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598247|NCT00441922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92598248|NCT00441922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598249|NCT00441922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92598250|NCT00441961|Methotrexate|methotrexate|mesh-list
92598251|NCT00441961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92598252|NCT00441961|Abortifacient Agents|abortifacient agents|mesh-ancestor
92598253|NCT00441961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92598254|NCT00441961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598255|NCT00441961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92598256|NCT00441961|Antimetabolites|antimetabolites|mesh-ancestor
92598257|NCT00441961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598258|NCT00441961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598259|NCT00441961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598260|NCT00441961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598261|NCT00441961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92598262|NCT00441961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92598263|NCT00441961|Immunologic Factors|immunologic factors|mesh-ancestor
92598264|NCT00441961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598265|NCT00441961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92598266|NCT00138411|Ciprofloxacin|ciprofloxacin|mesh-list
91947838|NCT05158699|Analgesics|analgesics|mesh-ancestor
92598267|NCT00138411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92598268|NCT00138411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598269|NCT00138411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92598270|NCT00138411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92598271|NCT00138411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598272|NCT00138411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598273|NCT00138411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598274|NCT00138411|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92005631|NCT02327923|Anesthetics|anesthetics|mesh-ancestor
92598285|NCT00108095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598286|NCT00108095|Antipruritics|antipruritics|mesh-ancestor
92598287|NCT00108095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598288|NCT00108095|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92598289|NCT00108095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92598290|NCT00108095|Serotonin Agents|serotonin agents|mesh-ancestor
92598291|NCT00108095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598292|NCT00108095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598293|NCT03278938|Bupropion|bupropion|mesh-list
92598294|NCT03278938|Citalopram|citalopram|mesh-list
92598295|NCT03278938|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92598296|NCT03278938|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598297|NCT03278938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598298|NCT03278938|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92598299|NCT03278938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598300|NCT03278938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598301|NCT03278938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598302|NCT03278938|Dopamine Agents|dopamine agents|mesh-ancestor
92598303|NCT03278938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598304|NCT03278938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598305|NCT03278938|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92598306|NCT03278938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92598307|NCT03278938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598308|NCT03278938|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92598309|NCT03278938|Serotonin Agents|serotonin agents|mesh-ancestor
92598310|NCT03278860|Oxytocin|oxytocin|mesh-list
92598311|NCT03278860|Oxytocics|oxytocics|mesh-ancestor
92598312|NCT03278860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92598313|NCT03278860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598314|NCT00442273|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92598315|NCT00442273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92598316|NCT00442312|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92598317|NCT00442312|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92598318|NCT00442312|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92598319|NCT00442312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598320|NCT00442312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598321|NCT00442312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323195|NCT00002288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92598322|NCT00442312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598323|NCT00442312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92598324|NCT00442312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92598325|NCT00442312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92598326|NCT00442390|Hydrocortisone|hydrocortisone|mesh-list
92598327|NCT00442390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598328|NCT00442585|Ibuprofen|ibuprofen|mesh-list
92598329|NCT00442585|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598330|NCT00442585|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598331|NCT00442585|Analgesics|analgesics|mesh-ancestor
92598332|NCT00442585|Sensory System Agents|sensory system agents|mesh-ancestor
92598333|NCT00442585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598334|NCT00442585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598335|NCT00442585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005685|NCT04991207|Zamicastat|zamicastat|mesh-list
92598343|NCT00442741|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92598344|NCT00442741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598345|NCT00442741|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92598346|NCT00442741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598347|NCT00442741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598348|NCT00442741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598349|NCT00442741|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598350|NCT00442741|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598351|NCT00442741|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536630|NCT00135499|Bleomycin|bleomycin|mesh-list
92536631|NCT00135499|Vindesine|vindesine|mesh-list
92536632|NCT00135499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536633|NCT00135499|Immunologic Factors|immunologic factors|mesh-ancestor
92536634|NCT00135499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947931|NCT03511703|Apatinib|apatinib|mesh-list
92598352|NCT00442780|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
92598353|NCT00442780|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92598354|NCT00442780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92598355|NCT00442780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92598356|NCT00442780|Purinergic Agents|purinergic agents|mesh-ancestor
92598357|NCT00442780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598358|NCT00442780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598359|NCT00442780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598360|NCT00404586|Fluticasone|fluticasone|mesh-list
92598361|NCT00404586|Xhance|xhance|mesh-list
92598362|NCT00404586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598363|NCT00404586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92598364|NCT00404586|Autonomic Agents|autonomic agents|mesh-ancestor
92598365|NCT00404586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598366|NCT00404586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598367|NCT00404586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92598368|NCT00404586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92598369|NCT00404586|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598370|NCT00404586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92598371|NCT00442819|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92598372|NCT00442819|Vasodilator Agents|vasodilator agents|mesh-ancestor
92598373|NCT00442819|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92598374|NCT00442819|Protective Agents|protective agents|mesh-ancestor
92598375|NCT00442819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598376|NCT00108251|Eplerenone|eplerenone|mesh-list
92598377|NCT00108251|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92598378|NCT00108251|Hormone Antagonists|hormone antagonists|mesh-ancestor
92598379|NCT00108251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598380|NCT00108251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598381|NCT00108251|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92598382|NCT00108251|Diuretics|diuretics|mesh-ancestor
92598383|NCT00108251|Natriuretic Agents|natriuretic agents|mesh-ancestor
92598384|NCT00108251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92598385|NCT00443170|Rosiglitazone|rosiglitazone|mesh-list
92598386|NCT00443170|Flurbiprofen|flurbiprofen|mesh-list
92598387|NCT00443170|Midazolam|midazolam|mesh-list
92598388|NCT00443170|Caffeine|caffeine|mesh-list
92598389|NCT00443170|Omeprazole|omeprazole|mesh-list
92598390|NCT00443170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92598391|NCT00443170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92598392|NCT00443170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598393|NCT00443170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598394|NCT00443170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92598395|NCT00443170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92598396|NCT00443170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598397|NCT00443170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92598398|NCT00443170|Anesthetics, General|anesthetics, general|mesh-ancestor
92598399|NCT00443170|Anesthetics|anesthetics|mesh-ancestor
92598400|NCT00443170|GABA Modulators|gaba modulators|mesh-ancestor
92598401|NCT00443170|GABA Agents|gaba agents|mesh-ancestor
92598402|NCT00443170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598403|NCT00443170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598408|NCT00443170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92598409|NCT00443170|Purinergic Agents|purinergic agents|mesh-ancestor
92598410|NCT00443170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92598411|NCT00443170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598412|NCT00443170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92598413|NCT00443170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92598415|NCT00443170|Sensory System Agents|sensory system agents|mesh-ancestor
92598416|NCT00443170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598417|NCT00443170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598418|NCT00443170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598419|NCT00443170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598420|NCT00443170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536635|NCT00135499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536636|NCT00135499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92536637|NCT00135499|Alkylating Agents|alkylating agents|mesh-ancestor
92536638|NCT00135499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598421|NCT00443170|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92598422|NCT00404625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92598423|NCT00404625|Anti-Infective Agents|anti-infective agents|mesh-list
92598424|NCT00138567|Vildagliptin|vildagliptin|mesh-list
92598425|NCT00138567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92598426|NCT00138567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598427|NCT00138567|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92598428|NCT00138567|Protease Inhibitors|protease inhibitors|mesh-ancestor
92598429|NCT00138567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598430|NCT00138567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598432|NCT00108368|Risperidone|risperidone|mesh-list
92598433|NCT00108368|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92598434|NCT00108368|Serotonin Agents|serotonin agents|mesh-ancestor
92598435|NCT00108368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598436|NCT00108368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598437|NCT00108368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598438|NCT00108368|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92598439|NCT00108368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92598440|NCT00108368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598441|NCT00108368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598442|NCT00108368|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92598443|NCT00108368|Dopamine Agents|dopamine agents|mesh-ancestor
92598444|NCT00108368|Antiemetics|antiemetics|mesh-ancestor
92598445|NCT00108368|Autonomic Agents|autonomic agents|mesh-ancestor
92598446|NCT00108368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598447|NCT00108368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598448|NCT00108368|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92598449|NCT00108368|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598450|NCT00108368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598451|NCT00108446|Lidocaine|lidocaine|mesh-list
92598452|NCT00108446|Fentanyl|fentanyl|mesh-list
92598453|NCT00108446|Dextromethorphan|dextromethorphan|mesh-list
92598454|NCT00108446|Naloxone|naloxone|mesh-list
92598455|NCT00108446|Anesthetics, Local|anesthetics, local|mesh-ancestor
92598456|NCT00108446|Anesthetics|anesthetics|mesh-ancestor
92598457|NCT00108446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598458|NCT00108446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598459|NCT00108446|Sensory System Agents|sensory system agents|mesh-ancestor
92598460|NCT00108446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598461|NCT00108446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598462|NCT00108446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92598463|NCT00108446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92598464|NCT00108446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598465|NCT00108446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598466|NCT00108446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92598467|NCT00108446|Narcotics|narcotics|mesh-ancestor
92598468|NCT00108446|Analgesics|analgesics|mesh-ancestor
92598469|NCT00108446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92598470|NCT00108446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92323348|NCT00002420|Didanosine|didanosine|mesh-list
92598471|NCT00108446|Anesthetics, General|anesthetics, general|mesh-ancestor
92598472|NCT00108446|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92598473|NCT00108446|Antitussive Agents|antitussive agents|mesh-ancestor
92598477|NCT00108446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598478|NCT00138606|Vildagliptin|vildagliptin|mesh-list
92598479|NCT00138606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92598480|NCT00138606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360633|NCT00429702|Anticonvulsants|anticonvulsants|mesh-ancestor
92598481|NCT00138606|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92598482|NCT00138606|Protease Inhibitors|protease inhibitors|mesh-ancestor
92598483|NCT00138606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598484|NCT00138606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598485|NCT00443482|Formoterol Fumarate|formoterol fumarate|mesh-list
92598486|NCT00443482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92598487|NCT00443482|Autonomic Agents|autonomic agents|mesh-ancestor
92598488|NCT00443482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598489|NCT00443482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536639|NCT00135499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536640|NCT00135499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92536641|NCT00135499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536642|NCT00135499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92536643|NCT00135499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92598490|NCT00443482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92598491|NCT00443482|Respiratory System Agents|respiratory system agents|mesh-ancestor
92598492|NCT00443482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92598493|NCT00443482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92598494|NCT00443482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92598495|NCT00443482|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598496|NCT00443482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598497|NCT00443482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598498|NCT00443521|Triamcinolone|triamcinolone|mesh-list
92598499|NCT00443521|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92598500|NCT00443521|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92598501|NCT00443521|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92598502|NCT00443521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598503|NCT00443521|Glucocorticoids|glucocorticoids|mesh-ancestor
92598504|NCT00443521|Hormones|hormones|mesh-ancestor
92598505|NCT00443521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598506|NCT00443521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598507|NCT00443521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92598508|NCT00443521|Immunologic Factors|immunologic factors|mesh-ancestor
92598509|NCT00443521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598510|NCT00443521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598511|NCT03278431|Albendazole|albendazole|mesh-list
92598512|NCT03278431|Mebendazole|mebendazole|mesh-list
92598513|NCT03278431|Piperazine|piperazine|mesh-list
92598514|NCT03278431|Piperazine citrate|piperazine citrate|mesh-list
92598515|NCT03278431|Pyrantel|pyrantel|mesh-list
92598516|NCT03278431|Pyrantel Pamoate|pyrantel pamoate|mesh-list
92598517|NCT03278431|Oxantel|oxantel|mesh-list
92598518|NCT03278431|Oxantel pamoate|oxantel pamoate|mesh-list
92598519|NCT03278431|DMP 777|dmp 777|mesh-list
92598520|NCT03278431|Anthelmintics|anthelmintics|mesh-ancestor
92598521|NCT03278431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92598522|NCT03278431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598523|NCT03278431|Anticestodal Agents|anticestodal agents|mesh-ancestor
92598524|NCT03278431|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92598525|NCT03278431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92598526|NCT03278431|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598527|NCT03278431|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598528|NCT03278431|Mitosis Modulators|mitosis modulators|mesh-ancestor
92598529|NCT03278431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598530|NCT03278431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598531|NCT03278431|Antinematodal Agents|antinematodal agents|mesh-ancestor
92598532|NCT03278431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598533|NCT03278431|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92598534|NCT03278431|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92598535|NCT03278431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92598536|NCT03278431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598537|NCT03278431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598538|NCT04726332|Prednisone|prednisone|mesh-list
92598539|NCT04726332|Fulvestrant|fulvestrant|mesh-list
92598540|NCT04726332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598541|NCT04726332|Glucocorticoids|glucocorticoids|mesh-ancestor
92598542|NCT04726332|Hormones|hormones|mesh-ancestor
92598543|NCT04726332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598544|NCT04726332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323427|NCT00002432|Foscarnet|foscarnet|mesh-list
92598550|NCT00108563|Citalopram|citalopram|mesh-list
92598551|NCT00108563|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92598552|NCT00108563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598553|NCT00108563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598554|NCT00108563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598555|NCT00108563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598556|NCT00108563|Serotonin Agents|serotonin agents|mesh-ancestor
92598557|NCT00108563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536645|NCT00135499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536646|NCT00135499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536647|NCT00135499|Glucocorticoids|glucocorticoids|mesh-ancestor
92536648|NCT00135499|Hormones|hormones|mesh-ancestor
92536649|NCT00135499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598558|NCT00108563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92598559|NCT00108563|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598560|NCT00108563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598561|NCT00443716|Estrogens|estrogens|mesh-list
92598562|NCT00443716|Hormones|hormones|mesh-ancestor
92598563|NCT00443716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598564|NCT00443716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598565|NCT00443794|Aspirin|aspirin|mesh-list
92598566|NCT00443794|Atenolol|atenolol|mesh-list
92598567|NCT00443794|Ramipril|ramipril|mesh-list
92598568|NCT00443794|Simvastatin|simvastatin|mesh-list
92598569|NCT00443794|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92598570|NCT00443794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598571|NCT00443794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598572|NCT00443794|Analgesics|analgesics|mesh-ancestor
92598573|NCT00443794|Sensory System Agents|sensory system agents|mesh-ancestor
92598574|NCT00443794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598575|NCT00443794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598576|NCT00443794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598577|NCT00443794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598578|NCT00443794|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92598579|NCT00443794|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92598580|NCT00443794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598581|NCT00443794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92598582|NCT00443794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92598583|NCT00443794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598584|NCT00443794|Antipyretics|antipyretics|mesh-ancestor
92598585|NCT00443794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92598586|NCT00443794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92598587|NCT00443794|Antimetabolites|antimetabolites|mesh-ancestor
92598588|NCT00443794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92598589|NCT00443794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92598590|NCT00443794|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92598591|NCT00443794|Protease Inhibitors|protease inhibitors|mesh-ancestor
92598592|NCT00443794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92598593|NCT00443794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598594|NCT00443794|Sympatholytics|sympatholytics|mesh-ancestor
92598595|NCT00443794|Autonomic Agents|autonomic agents|mesh-ancestor
92598596|NCT00443794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92598597|NCT00443794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92598598|NCT00443794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92598599|NCT00443794|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598600|NCT00443794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598601|NCT00443794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598602|NCT00443794|Diuretics|diuretics|mesh-ancestor
92598603|NCT00443794|Natriuretic Agents|natriuretic agents|mesh-ancestor
92598604|NCT00108602|Acetazolamide|acetazolamide|mesh-list
92598605|NCT00108602|Anticonvulsants|anticonvulsants|mesh-ancestor
92598606|NCT00108602|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92598607|NCT00108602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598608|NCT00108602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598609|NCT00108602|Diuretics|diuretics|mesh-ancestor
92598610|NCT00108602|Natriuretic Agents|natriuretic agents|mesh-ancestor
92598611|NCT00108602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598612|NCT03278314|Ivacaftor|ivacaftor|mesh-list
92598613|NCT03278314|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92598634|NCT00444184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598635|NCT00444184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598636|NCT00444184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598637|NCT00444184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92598638|NCT00444223|Fluorides|fluorides|mesh-list
92598639|NCT00444223|Cariostatic Agents|cariostatic agents|mesh-ancestor
92598640|NCT00444223|Protective Agents|protective agents|mesh-ancestor
92536650|NCT00135499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92536651|NCT00135499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92536652|NCT00135499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536653|NCT00135499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536654|NCT00135499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536655|NCT03151434|Hydromorphone|hydromorphone|mesh-list
92536656|NCT03151434|Bupivacaine|bupivacaine|mesh-list
92536657|NCT03151434|Anesthetics, Local|anesthetics, local|mesh-ancestor
92536658|NCT03151434|Anesthetics|anesthetics|mesh-ancestor
92536659|NCT03151434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536660|NCT03151434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536661|NCT03151434|Sensory System Agents|sensory system agents|mesh-ancestor
92536662|NCT03151434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536663|NCT03151434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92536664|NCT03151434|Narcotics|narcotics|mesh-ancestor
92536665|NCT03151434|Analgesics|analgesics|mesh-ancestor
92536666|NCT00135577|Alvimopan|alvimopan|mesh-list
92536667|NCT00135577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598641|NCT00444223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598642|NCT03275701|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
92598643|NCT03275701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92598644|NCT03275701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92598645|NCT03275701|Antiviral Agents|antiviral agents|mesh-ancestor
92598646|NCT03275701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598647|NCT00451360|Diacerein|diacerein|mesh-list
92598648|NCT00451360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598649|NCT00451399|Metformin|metformin|mesh-list
92598650|NCT00451399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92598651|NCT00451399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598652|NCT00108797|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92598653|NCT00108797|Coagulants|coagulants|mesh-ancestor
92598654|NCT04698772|Ketamine|ketamine|mesh-list
92598655|NCT04698772|Morphine|morphine|mesh-list
92598656|NCT04698772|Analgesics|analgesics|mesh-ancestor
92598657|NCT04698772|Sensory System Agents|sensory system agents|mesh-ancestor
92598658|NCT04698772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598659|NCT04698772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598660|NCT04698772|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92598661|NCT04698772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92598662|NCT04698772|Anesthetics, General|anesthetics, general|mesh-ancestor
92598663|NCT04698772|Anesthetics|anesthetics|mesh-ancestor
92598664|NCT04698772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598665|NCT04698772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92598666|NCT04698772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92598667|NCT04698772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006044|NCT05088343|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92598677|NCT00451594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598678|NCT00451594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598679|NCT00451594|Glucocorticoids|glucocorticoids|mesh-ancestor
92598680|NCT00451594|Hormones|hormones|mesh-ancestor
92598681|NCT00451594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598682|NCT00451594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92598683|NCT00451594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598684|NCT00139035|Cyclosporine|cyclosporine|mesh-list
92598685|NCT00139035|Cyclosporins|cyclosporins|mesh-list
92598686|NCT00139035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598687|NCT00139035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598688|NCT00139035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536668|NCT00135733|Alefacept|alefacept|mesh-list
92536669|NCT00135733|Dermatologic Agents|dermatologic agents|mesh-ancestor
92536670|NCT00135733|Immunologic Factors|immunologic factors|mesh-ancestor
92536671|NCT00135733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598689|NCT00139035|Immunologic Factors|immunologic factors|mesh-ancestor
92598690|NCT00139035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598691|NCT00139035|Antifungal Agents|antifungal agents|mesh-ancestor
92598692|NCT00139035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598693|NCT00139035|Dermatologic Agents|dermatologic agents|mesh-ancestor
92598694|NCT00139035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598695|NCT00139035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92598696|NCT00451672|Bromocriptine|bromocriptine|mesh-list
92598697|NCT00451672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92598698|NCT00451672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92598699|NCT00451672|Hormone Antagonists|hormone antagonists|mesh-ancestor
92598700|NCT00451672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598701|NCT00451672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598702|NCT00451672|Dopamine Agonists|dopamine agonists|mesh-ancestor
92598703|NCT00451672|Dopamine Agents|dopamine agents|mesh-ancestor
92598704|NCT00451672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598705|NCT00451672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598706|NCT00108875|BIRC5 protein, human|birc5 protein, human|mesh-list
92598707|NCT00108875|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92598708|NCT00108875|Protease Inhibitors|protease inhibitors|mesh-ancestor
92598709|NCT00108875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598710|NCT00108875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598711|NCT00451711|Amphotericin B|amphotericin b|mesh-list
92598712|NCT00451711|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92598713|NCT00451711|Amebicides|amebicides|mesh-ancestor
92598714|NCT00451711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92598715|NCT00451711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92598716|NCT00451711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598717|NCT00451711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92598718|NCT00451711|Antifungal Agents|antifungal agents|mesh-ancestor
92598719|NCT00139074|Valproic Acid|valproic acid|mesh-list
92598720|NCT00139074|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92598721|NCT00139074|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598722|NCT00139074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598723|NCT00139074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92598724|NCT00139074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92598725|NCT00139074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598726|NCT00139074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598727|NCT00139074|Anticonvulsants|anticonvulsants|mesh-ancestor
92598728|NCT00139074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598729|NCT00139074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598730|NCT00139074|GABA Agents|gaba agents|mesh-ancestor
92598731|NCT00139074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598732|NCT00139074|Antimanic Agents|antimanic agents|mesh-ancestor
92598733|NCT00451750|Hydrocortisone|hydrocortisone|mesh-list
92598734|NCT00451750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598746|NCT00451867|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92598747|NCT00451867|Antitubercular Agents|antitubercular agents|mesh-ancestor
92598748|NCT00451867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92598749|NCT00451867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598750|NCT00451867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598751|NCT00451867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598752|NCT00143091|Sertraline|sertraline|mesh-list
92598753|NCT00143091|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598754|NCT00143091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598755|NCT00143091|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92598756|NCT00143091|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598757|NCT00143091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598758|NCT00143091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598759|NCT00143091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598760|NCT00143091|Serotonin Agents|serotonin agents|mesh-ancestor
92598761|NCT00143091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598762|NCT00451984|Interleukin-2|interleukin-2|mesh-list
92598763|NCT00451984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598764|NCT00451984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598765|NCT00451984|Analgesics|analgesics|mesh-ancestor
92598766|NCT00451984|Sensory System Agents|sensory system agents|mesh-ancestor
92536672|NCT04061798|Heparin|heparin|mesh-list
92536673|NCT04061798|Anticoagulants|anticoagulants|mesh-ancestor
92536674|NCT04061798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92536675|NCT04061798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92536676|NCT04061798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598767|NCT00451984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598768|NCT00451984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323648|NCT00002504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92598769|NCT00452062|Dexamethasone|dexamethasone|mesh-list
92598770|NCT00452062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598771|NCT00452062|Antiemetics|antiemetics|mesh-ancestor
92598772|NCT00452062|Autonomic Agents|autonomic agents|mesh-ancestor
92598773|NCT00452062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598774|NCT00452062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598775|NCT00452062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598776|NCT00452062|Glucocorticoids|glucocorticoids|mesh-ancestor
92598777|NCT00452062|Hormones|hormones|mesh-ancestor
92598778|NCT00452062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598779|NCT00452062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92598780|NCT00452062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598781|NCT00108992|Diclofenac|diclofenac|mesh-list
92598782|NCT00108992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598783|NCT00108992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598784|NCT00108992|Analgesics|analgesics|mesh-ancestor
92598785|NCT00108992|Sensory System Agents|sensory system agents|mesh-ancestor
92598786|NCT00108992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598787|NCT00108992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598788|NCT00108992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598789|NCT00108992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598790|NCT00108992|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92598791|NCT00108992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598792|NCT00108992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598793|NCT00143130|Pregabalin|pregabalin|mesh-list
92598794|NCT00143130|Analgesics|analgesics|mesh-ancestor
92598795|NCT00143130|Sensory System Agents|sensory system agents|mesh-ancestor
92598813|NCT00109070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598814|NCT00109070|Growth Inhibitors|growth inhibitors|mesh-ancestor
92598815|NCT00452218|Sorafenib|sorafenib|mesh-list
92598816|NCT00452218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598817|NCT00452218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92598818|NCT00452218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598819|NCT00452218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598820|NCT00143169|Parecoxib|parecoxib|mesh-list
92598821|NCT00143169|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92598822|NCT00143169|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92598823|NCT00143169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598824|NCT00143169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598825|NCT00143169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598826|NCT00143169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598827|NCT00143169|Analgesics|analgesics|mesh-ancestor
92598828|NCT00143169|Sensory System Agents|sensory system agents|mesh-ancestor
92598829|NCT00143169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598830|NCT00143169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598831|NCT00143169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598832|NCT00143169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598833|NCT00109109|Vorinostat|vorinostat|mesh-list
92598834|NCT00109109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598835|NCT00109109|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92598836|NCT00109109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598837|NCT00109109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598838|NCT03275116|Bromides|bromides|mesh-list
92598839|NCT03275116|Formoterol Fumarate|formoterol fumarate|mesh-list
92598840|NCT03275116|Tiotropium Bromide|tiotropium bromide|mesh-list
92598841|NCT03275116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92598842|NCT03275116|Autonomic Agents|autonomic agents|mesh-ancestor
92598843|NCT03275116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598844|NCT03275116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598845|NCT03275116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92598846|NCT03275116|Respiratory System Agents|respiratory system agents|mesh-ancestor
92536677|NCT00135811|Cyclosporine|cyclosporine|mesh-list
92536678|NCT00135811|Dexamethasone|dexamethasone|mesh-list
92536679|NCT00135811|Cyclosporins|cyclosporins|mesh-list
92536680|NCT00135811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536681|NCT00135811|Antiemetics|antiemetics|mesh-ancestor
92536682|NCT00135811|Autonomic Agents|autonomic agents|mesh-ancestor
92536683|NCT00135811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536684|NCT00135811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944445|NCT00254579|Tremelimumab|tremelimumab|mesh-list
92598847|NCT03275116|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92598848|NCT03275116|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92598849|NCT03275116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92006242|NCT04873297|Metoclopramide|metoclopramide|mesh-list
92598878|NCT00452569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598879|NCT00452569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92598880|NCT00452569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598881|NCT00452569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92598882|NCT00452569|Immunologic Factors|immunologic factors|mesh-ancestor
92598883|NCT00452569|Leprostatic Agents|leprostatic agents|mesh-ancestor
92598884|NCT00452569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92598885|NCT00452569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598886|NCT00452569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92598887|NCT00452569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92598888|NCT00452569|Growth Substances|growth substances|mesh-ancestor
92598889|NCT00452569|Growth Inhibitors|growth inhibitors|mesh-ancestor
92598890|NCT00143286|Varenicline|varenicline|mesh-list
92006305|NCT04858711|Narcotics|narcotics|mesh-ancestor
92598894|NCT00143286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598895|NCT00143286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598896|NCT00143286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598898|NCT00109187|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92598899|NCT00109187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92598900|NCT00109187|Respiratory System Agents|respiratory system agents|mesh-ancestor
92598901|NCT00452608|Atorvastatin|atorvastatin|mesh-list
92598902|NCT00452608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92598903|NCT00452608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92598904|NCT00452608|Antimetabolites|antimetabolites|mesh-ancestor
92598905|NCT00452608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598906|NCT00452608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92598907|NCT00452608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92598908|NCT00452608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598909|NCT00109226|Bevacizumab|bevacizumab|mesh-list
92598910|NCT00109226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92598911|NCT00109226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598912|NCT00109226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92598913|NCT00109226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92598914|NCT00109226|Growth Substances|growth substances|mesh-ancestor
92598915|NCT00109226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598916|NCT00109226|Growth Inhibitors|growth inhibitors|mesh-ancestor
92598918|NCT00452725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598919|NCT00452725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598920|NCT00109265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92598921|NCT00109265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598922|NCT00109265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92598923|NCT00109265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598924|NCT00109265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598925|NCT00143364|Varenicline|varenicline|mesh-list
92598926|NCT00143364|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92598927|NCT00143364|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92598928|NCT00143364|Cholinergic Agents|cholinergic agents|mesh-ancestor
92598929|NCT00143364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598930|NCT00143364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598931|NCT00143364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598932|NCT00452881|Gemcitabine|gemcitabine|mesh-list
92598933|NCT00452881|Oxaliplatin|oxaliplatin|mesh-list
92598934|NCT00452881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536685|NCT00135811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92536686|NCT00135811|Glucocorticoids|glucocorticoids|mesh-ancestor
92536687|NCT00135811|Hormones|hormones|mesh-ancestor
92536688|NCT00135811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536689|NCT00135811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92536690|NCT00135811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536691|NCT00135811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536692|NCT00135811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536693|NCT00135811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536694|NCT00135811|Immunologic Factors|immunologic factors|mesh-ancestor
92536695|NCT00135811|Antifungal Agents|antifungal agents|mesh-ancestor
92536696|NCT00135811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536697|NCT00135811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92536698|NCT00135811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536699|NCT00135811|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92536700|NCT00135928|Lenograstim|lenograstim|mesh-list
92536701|NCT00135928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92536702|NCT00135928|Immunologic Factors|immunologic factors|mesh-ancestor
92536703|NCT00135928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598935|NCT00452881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92598936|NCT00452881|Antimetabolites|antimetabolites|mesh-ancestor
92598937|NCT00452881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598938|NCT00452920|Docetaxel|docetaxel|mesh-list
92598939|NCT00452920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598940|NCT00452920|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598941|NCT00452920|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598942|NCT00452920|Mitosis Modulators|mitosis modulators|mesh-ancestor
92598943|NCT00452920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598944|NCT00143442|Reboxetine|reboxetine|mesh-list
92598945|NCT00143442|Antidepressive Agents|antidepressive agents|mesh-ancestor
92598946|NCT00143442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154047|NCT02985125|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92598947|NCT00143442|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92598948|NCT00143442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92598949|NCT00143442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598950|NCT00143442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598951|NCT00143442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598952|NCT00143442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598953|NCT00143442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598954|NCT00109382|Aspirin|aspirin|mesh-list
92598955|NCT00109382|Clopidogrel|clopidogrel|mesh-list
92598956|NCT00109382|Simvastatin|simvastatin|mesh-list
92598957|NCT00109382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598958|NCT00109382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598959|NCT00109382|Analgesics|analgesics|mesh-ancestor
92598960|NCT00109382|Sensory System Agents|sensory system agents|mesh-ancestor
92006365|NCT05619965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92598964|NCT00109382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598965|NCT00109382|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92598966|NCT00109382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92598967|NCT00109382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598968|NCT00109382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92598969|NCT00109382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92598970|NCT00109382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598971|NCT00109382|Antipyretics|antipyretics|mesh-ancestor
92261446|NCT02481219|Erythromycin|erythromycin|mesh-list
92536704|NCT00135967|Mycophenolic Acid|mycophenolic acid|mesh-list
92536705|NCT00135967|Prednisone|prednisone|mesh-list
92536706|NCT00135967|Methylprednisolone|methylprednisolone|mesh-list
92536707|NCT00135967|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92536708|NCT00135967|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92536709|NCT00135967|Prednisolone|prednisolone|mesh-list
92536710|NCT00135967|Prednisolone acetate|prednisolone acetate|mesh-list
92536711|NCT00135967|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92536712|NCT00135967|Prednisolone phosphate|prednisolone phosphate|mesh-list
92536713|NCT00135967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536714|NCT00135967|Glucocorticoids|glucocorticoids|mesh-ancestor
92536715|NCT00135967|Hormones|hormones|mesh-ancestor
92536716|NCT00135967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536717|NCT00135967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598972|NCT00109382|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92598973|NCT00109382|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92598974|NCT00109382|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92598975|NCT00109382|Purinergic Agents|purinergic agents|mesh-ancestor
92598976|NCT00109382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598977|NCT00109382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92598978|NCT00109382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92598979|NCT00109382|Antimetabolites|antimetabolites|mesh-ancestor
92598980|NCT00109382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92598981|NCT00109382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92598982|NCT00453076|Paclitaxel|paclitaxel|mesh-list
92598983|NCT00453076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92598984|NCT00453076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598985|NCT00453076|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598986|NCT00453076|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598987|NCT00453076|Mitosis Modulators|mitosis modulators|mesh-ancestor
92598988|NCT00453076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598990|NCT00453115|Oxaliplatin|oxaliplatin|mesh-list
92598991|NCT00453115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92598992|NCT00453115|Antimetabolites|antimetabolites|mesh-ancestor
92598993|NCT00453115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598994|NCT00453115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598995|NCT00143481|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92598996|NCT00143481|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92598997|NCT00143481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92598998|NCT00143481|Cholinergic Agents|cholinergic agents|mesh-ancestor
92598999|NCT00143481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599000|NCT00143481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599001|NCT00143481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599002|NCT00143481|Urological Agents|urological agents|mesh-ancestor
92599003|NCT02273557|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92599004|NCT02273557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92599005|NCT00453232|Etoposide|etoposide|mesh-list
92599006|NCT00453232|Bleomycin|bleomycin|mesh-list
92599007|NCT00453232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599008|NCT00453232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92599009|NCT00453232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92599010|NCT00453232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599011|NCT00453232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599012|NCT00453232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599013|NCT00453232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92599014|NCT00453427|Alemtuzumab|alemtuzumab|mesh-list
92599015|NCT00453427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599016|NCT00453427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599017|NCT00143520|Pioglitazone|pioglitazone|mesh-list
92536718|NCT00135967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92536719|NCT00135967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536720|NCT00135967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92536721|NCT00135967|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92536722|NCT00135967|Antitubercular Agents|antitubercular agents|mesh-ancestor
92536723|NCT00135967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944482|NCT00389675|Guanfacine|guanfacine|mesh-list
92599018|NCT00143520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92599019|NCT00143520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599020|NCT00143559|Antibodies|antibodies|mesh-list
92599021|NCT00143559|Immunologic Factors|immunologic factors|mesh-ancestor
92599022|NCT00143559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599023|NCT00453778|Fluticasone|fluticasone|mesh-list
92599024|NCT00453778|Xhance|xhance|mesh-list
92599025|NCT00453778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599026|NCT00453778|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92599027|NCT00453778|Autonomic Agents|autonomic agents|mesh-ancestor
92599028|NCT00453778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599029|NCT00453778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599030|NCT00453778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92599031|NCT00453778|Respiratory System Agents|respiratory system agents|mesh-ancestor
92599036|NCT00109616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92599037|NCT00109616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92599038|NCT00109616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599039|NCT00109616|Disinfectants|disinfectants|mesh-ancestor
92599040|NCT00109616|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599041|NCT00453856|Pyrimethamine|pyrimethamine|mesh-list
92599042|NCT00453856|Sulfadoxine|sulfadoxine|mesh-list
92599043|NCT00453856|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92599044|NCT00453856|Antimalarials|antimalarials|mesh-ancestor
92599045|NCT00453856|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92599046|NCT00453856|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92599047|NCT00453856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599048|NCT00453856|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92599049|NCT00453856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599050|NCT00453856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599051|NCT00453856|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92599052|NCT00454168|Sargramostim|sargramostim|mesh-list
92599053|NCT00454168|Immunologic Factors|immunologic factors|mesh-ancestor
92599054|NCT00454168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599055|NCT00109811|Freund's Adjuvant|freund's adjuvant|mesh-list
92599056|NCT00109811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92599057|NCT00109811|Immunologic Factors|immunologic factors|mesh-ancestor
92599058|NCT00109811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599059|NCT03274765|Estradiol|estradiol|mesh-list
92599060|NCT03274765|Estrogens|estrogens|mesh-ancestor
92599061|NCT03274765|Hormones|hormones|mesh-ancestor
92599062|NCT03274765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599063|NCT03274765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599064|NCT00454402|Alfuzosin|alfuzosin|mesh-list
92599065|NCT00454402|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92599066|NCT00454402|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92599067|NCT00454402|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92599068|NCT00454402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92599069|NCT00454402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599070|NCT00454402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599071|NCT00454402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599072|NCT00454402|Urological Agents|urological agents|mesh-ancestor
92599073|NCT00143676|Atorvastatin|atorvastatin|mesh-list
92599074|NCT00143676|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92599075|NCT00143676|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92599076|NCT00143676|Antimetabolites|antimetabolites|mesh-ancestor
92599077|NCT00143676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599078|NCT00143676|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92599079|NCT00143676|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92599080|NCT00143676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599081|NCT00454480|Cytarabine|cytarabine|mesh-list
92599082|NCT00454480|Fludarabine|fludarabine|mesh-list
92599083|NCT00454480|Fludarabine phosphate|fludarabine phosphate|mesh-list
92536724|NCT00135967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536725|NCT00135967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536726|NCT00135967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536728|NCT00135967|Autonomic Agents|autonomic agents|mesh-ancestor
91948937|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
92599084|NCT00454480|Azacitidine|azacitidine|mesh-list
92599085|NCT00454480|Melphalan|melphalan|mesh-list
92599086|NCT00454480|Busulfan|busulfan|mesh-list
92599087|NCT00454480|Daunorubicin|daunorubicin|mesh-list
92599088|NCT00454480|Alemtuzumab|alemtuzumab|mesh-list
92599089|NCT00454480|Clofarabine|clofarabine|mesh-list
92599090|NCT00454480|Arsenic Trioxide|arsenic trioxide|mesh-list
92599091|NCT00454480|Gemtuzumab|gemtuzumab|mesh-list
92599092|NCT00454480|Tipifarnib|tipifarnib|mesh-list
92599093|NCT00454480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599094|NCT00454480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92599095|NCT00454480|Antimetabolites|antimetabolites|mesh-ancestor
92599096|NCT00454480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599097|NCT00454480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599098|NCT00454480|Immunologic Factors|immunologic factors|mesh-ancestor
92599099|NCT00454480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599100|NCT00454480|Antiviral Agents|antiviral agents|mesh-ancestor
92599101|NCT00454480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599102|NCT00454480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599103|NCT00454480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92599104|NCT00454480|Alkylating Agents|alkylating agents|mesh-ancestor
92006510|NCT05392075|Vaccines|vaccines|mesh-list
92599110|NCT00454480|Immunotoxins|immunotoxins|mesh-ancestor
92599111|NCT00454480|Immunoconjugates|immunoconjugates|mesh-ancestor
92599112|NCT00110006|Prednisone|prednisone|mesh-list
92599113|NCT00110006|Cyclophosphamide|cyclophosphamide|mesh-list
92599114|NCT00110006|Rituximab|rituximab|mesh-list
92599115|NCT00110006|Doxorubicin|doxorubicin|mesh-list
92599116|NCT00110006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92599117|NCT00110006|Vincristine|vincristine|mesh-list
92599118|NCT00110006|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92599119|NCT00110006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599120|NCT00110006|Immunologic Factors|immunologic factors|mesh-ancestor
92599121|NCT00110006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599122|NCT00110006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599123|NCT00110006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92599124|NCT00110006|Alkylating Agents|alkylating agents|mesh-ancestor
92599125|NCT00110006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599126|NCT00110006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599127|NCT00110006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92599128|NCT00110006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599129|NCT00110006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92599130|NCT00110006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92599131|NCT00110006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599132|NCT00110006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599133|NCT00110006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599134|NCT00110006|Glucocorticoids|glucocorticoids|mesh-ancestor
92599135|NCT00110006|Hormones|hormones|mesh-ancestor
92599136|NCT00110006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599137|NCT00110006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324028|NCT00002618|Vincristine|vincristine|mesh-list
92599138|NCT00110006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92599139|NCT00110006|Tubulin Modulators|tubulin modulators|mesh-ancestor
92599140|NCT00110006|Antimitotic Agents|antimitotic agents|mesh-ancestor
92599141|NCT00110006|Mitosis Modulators|mitosis modulators|mesh-ancestor
92599142|NCT00110006|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92599143|NCT00454519|Mitomycins|mitomycins|mesh-list
92599144|NCT00454519|Mitomycin|mitomycin|mesh-list
92599145|NCT00454519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599146|NCT00454519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92599147|NCT00454519|Alkylating Agents|alkylating agents|mesh-ancestor
92599148|NCT00454519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599149|NCT00454519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92599150|NCT00454519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599151|NCT00112749|Infliximab|infliximab|mesh-list
92599152|NCT00112749|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92599153|NCT00112749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536729|NCT00135967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536730|NCT00135967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92536731|NCT00135967|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92536732|NCT00135967|Protective Agents|protective agents|mesh-ancestor
92536733|NCT00136045|Rotigotine|rotigotine|mesh-list
92536734|NCT00136045|Dopamine Agonists|dopamine agonists|mesh-ancestor
92536735|NCT00136045|Dopamine Agents|dopamine agents|mesh-ancestor
92599154|NCT00112749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599155|NCT00112749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599156|NCT00112749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599157|NCT00110045|Caspofungin|caspofungin|mesh-list
92599158|NCT00110045|Antifungal Agents|antifungal agents|mesh-ancestor
92599159|NCT00110045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599160|NCT00110045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599161|NCT00110045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599162|NCT00454714|Sildenafil Citrate|sildenafil citrate|mesh-list
92599163|NCT00454714|Vasodilator Agents|vasodilator agents|mesh-ancestor
92599164|NCT00454714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92599165|NCT00454714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92599166|NCT00454714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599167|NCT00454714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599168|NCT00454714|Urological Agents|urological agents|mesh-ancestor
92599169|NCT00143715|Vitamin K|vitamin k|mesh-list
92599170|NCT00143715|Vitamin K 1|vitamin k 1|mesh-list
92599171|NCT00143715|Vitamins|vitamins|mesh-ancestor
92599172|NCT00143715|Micronutrients|micronutrients|mesh-ancestor
92599173|NCT00143715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599174|NCT00143715|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92599180|NCT00454831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92599182|NCT00454831|Antimetabolites|antimetabolites|mesh-ancestor
92599183|NCT00454831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599184|NCT00454831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92599185|NCT00454831|Chelating Agents|chelating agents|mesh-ancestor
92599186|NCT00454831|Sequestering Agents|sequestering agents|mesh-ancestor
92599187|NCT00454831|Hemostatics|hemostatics|mesh-ancestor
92599188|NCT00454831|Coagulants|coagulants|mesh-ancestor
92599189|NCT00110123|Fotemustine|fotemustine|mesh-list
92599190|NCT00110123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599191|NCT00455026|Remifentanil|remifentanil|mesh-list
92599192|NCT00455026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92599193|NCT00455026|Narcotics|narcotics|mesh-ancestor
92599194|NCT00455026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599195|NCT00455026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599196|NCT00455026|Analgesics|analgesics|mesh-ancestor
92599197|NCT00455026|Sensory System Agents|sensory system agents|mesh-ancestor
92599198|NCT00455026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599199|NCT00143325|Varenicline|varenicline|mesh-list
92599200|NCT00143325|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92599201|NCT00143325|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92599202|NCT00143325|Cholinergic Agents|cholinergic agents|mesh-ancestor
92599203|NCT00143325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599204|NCT00143325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599205|NCT00143325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599206|NCT00112983|Eculizumab|eculizumab|mesh-list
92599207|NCT00112983|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92599208|NCT00112983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599209|NCT00112983|Immunologic Factors|immunologic factors|mesh-ancestor
92599210|NCT00112983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599211|NCT00110162|Hormones|hormones|mesh-list
92599212|NCT00110162|Androgen Antagonists|androgen antagonists|mesh-list
92599213|NCT00110162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599214|NCT00110162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599215|NCT00110162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92599216|NCT02273713|Paclitaxel|paclitaxel|mesh-list
92599217|NCT02273713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92599218|NCT02273713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599219|NCT02273713|Tubulin Modulators|tubulin modulators|mesh-ancestor
92599220|NCT02273713|Antimitotic Agents|antimitotic agents|mesh-ancestor
92599221|NCT02273713|Mitosis Modulators|mitosis modulators|mesh-ancestor
92599222|NCT02273713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536736|NCT00136045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536737|NCT00136045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536738|NCT00136045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536739|NCT00136201|Tigecycline|tigecycline|mesh-list
92536740|NCT00136201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92536741|NCT00136201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944498|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
92599223|NCT00110201|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92599224|NCT00110201|Natriuretic Agents|natriuretic agents|mesh-ancestor
92599225|NCT00110201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599226|NCT02273791|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92599227|NCT02273791|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92599228|NCT02273791|Clomiphene|clomiphene|mesh-list
92599229|NCT02273791|Enclomiphene|enclomiphene|mesh-list
92599230|NCT02273791|Zuclomiphene|zuclomiphene|mesh-list
92599231|NCT02273791|Estradiol|estradiol|mesh-list
92599232|NCT02273791|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92599233|NCT02273791|Estrogens|estrogens|mesh-ancestor
92599234|NCT02273791|Hormones|hormones|mesh-ancestor
92599235|NCT02273791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599236|NCT02273791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599237|NCT02273791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92599238|NCT02273791|Contraceptive Agents|contraceptive agents|mesh-ancestor
92599239|NCT02273791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92599240|NCT02273791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92599241|NCT02273791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92599242|NCT02273791|Hormone Antagonists|hormone antagonists|mesh-ancestor
92599243|NCT02273791|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92599244|NCT02273791|Fertility Agents|fertility agents|mesh-ancestor
92599245|NCT02273791|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92599264|NCT00455416|Trace Elements|trace elements|mesh-ancestor
92599265|NCT00455416|Micronutrients|micronutrients|mesh-ancestor
92599266|NCT00455416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599267|NCT00455416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92599268|NCT00455416|Antimetabolites|antimetabolites|mesh-ancestor
92599269|NCT00455416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92599270|NCT00455416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92599271|NCT00455416|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92599273|NCT00143871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599274|NCT00143871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599275|NCT00143871|Immunologic Factors|immunologic factors|mesh-ancestor
92599276|NCT00143871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599277|NCT00143871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599278|NCT00455572|Vinorelbine|vinorelbine|mesh-list
92599279|NCT00455572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599280|NCT00455572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92599281|NCT00455572|Tubulin Modulators|tubulin modulators|mesh-ancestor
92599282|NCT00455572|Antimitotic Agents|antimitotic agents|mesh-ancestor
92599283|NCT00455572|Mitosis Modulators|mitosis modulators|mesh-ancestor
92599284|NCT00455572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599285|NCT00401492|Gemcitabine|gemcitabine|mesh-list
92599286|NCT00401492|Vinorelbine|vinorelbine|mesh-list
92599287|NCT00401492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599288|NCT00401492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92599289|NCT00401492|Antimetabolites|antimetabolites|mesh-ancestor
92599290|NCT00401492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599291|NCT00401492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92599292|NCT00401492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92599293|NCT00401492|Antimitotic Agents|antimitotic agents|mesh-ancestor
92599294|NCT00401492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92599295|NCT00455806|Amoxicillin|amoxicillin|mesh-list
92599296|NCT00455806|Moxifloxacin|moxifloxacin|mesh-list
92599297|NCT00455806|Esomeprazole|esomeprazole|mesh-list
92599298|NCT00455806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92599299|NCT00455806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599300|NCT00455806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92599301|NCT00455806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599302|NCT00455806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006715|NCT05729555|Diphenhydramine|diphenhydramine|mesh-list
92536742|NCT00136201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92536743|NCT00136201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944502|NCT02288741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599303|NCT00455806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599305|NCT00455806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92599306|NCT00455806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599307|NCT00455806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92599308|NCT00455845|Levonorgestrel|levonorgestrel|mesh-list
92599309|NCT00455845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92599310|NCT00455845|Contraceptive Agents|contraceptive agents|mesh-ancestor
92599311|NCT00455845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92599312|NCT00455845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599313|NCT00455845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92599314|NCT00455845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92599315|NCT00455845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92599316|NCT00110474|Acetaminophen|acetaminophen|mesh-list
92599317|NCT00110474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92599318|NCT00110474|Analgesics|analgesics|mesh-ancestor
92599319|NCT00110474|Sensory System Agents|sensory system agents|mesh-ancestor
92599320|NCT00110474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599321|NCT00110474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599322|NCT00110474|Antipyretics|antipyretics|mesh-ancestor
92599323|NCT00113100|Ethanol|ethanol|mesh-list
92599324|NCT00113100|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92599325|NCT00113100|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92599326|NCT00113100|Estradiol|estradiol|mesh-list
92599327|NCT00113100|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92599328|NCT00113100|Estrogens|estrogens|mesh-ancestor
92599329|NCT00113100|Hormones|hormones|mesh-ancestor
92599330|NCT00113100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599331|NCT00113100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599332|NCT00113100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92599333|NCT00113100|Contraceptive Agents|contraceptive agents|mesh-ancestor
92599334|NCT00113100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92599335|NCT00113100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92599336|NCT00113100|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92599337|NCT00113100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599338|NCT00113100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599339|NCT00143949|Losartan|losartan|mesh-list
92599340|NCT00143949|Enalapril|enalapril|mesh-list
92599341|NCT00143949|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92599342|NCT00143949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92599343|NCT00143949|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92599344|NCT00143949|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92599345|NCT00143949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599346|NCT00143949|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92599347|NCT00143949|Protease Inhibitors|protease inhibitors|mesh-ancestor
92599348|NCT00143949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599349|NCT00456235|Mycophenolic Acid|mycophenolic acid|mesh-list
92599350|NCT00456235|Cyclosporine|cyclosporine|mesh-list
92599351|NCT00456235|Tacrolimus|tacrolimus|mesh-list
92599352|NCT00456235|Cyclosporins|cyclosporins|mesh-list
92599353|NCT00456235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599354|NCT00456235|Immunologic Factors|immunologic factors|mesh-ancestor
92599355|NCT00456235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599356|NCT00456235|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92599357|NCT00456235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599358|NCT00456235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599359|NCT00456235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92599360|NCT00456235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599361|NCT00456235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92599362|NCT00456235|Antitubercular Agents|antitubercular agents|mesh-ancestor
92599363|NCT00456235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92599364|NCT00456235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599365|NCT00456235|Antifungal Agents|antifungal agents|mesh-ancestor
92599366|NCT00456235|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599367|NCT00456235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599368|NCT00456313|Fluticasone|fluticasone|mesh-list
92599369|NCT00456313|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92599370|NCT00456313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92599371|NCT00456313|Autonomic Agents|autonomic agents|mesh-ancestor
92599372|NCT00456313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536744|NCT00136201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536746|NCT03151239|Vitamin B Complex|vitamin b complex|mesh-ancestor
92536747|NCT03151239|Vitamins|vitamins|mesh-ancestor
92536748|NCT03151239|Micronutrients|micronutrients|mesh-ancestor
92599373|NCT00456313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599374|NCT00456313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92599375|NCT00456313|Respiratory System Agents|respiratory system agents|mesh-ancestor
92599376|NCT00456313|Glucocorticoids|glucocorticoids|mesh-ancestor
92599380|NCT00456313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599381|NCT00456313|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599382|NCT00456313|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92599384|NCT00110630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92599385|NCT00110630|Autonomic Agents|autonomic agents|mesh-ancestor
92599386|NCT00110630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599387|NCT00110630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599388|NCT00110630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92599389|NCT00110630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92599390|NCT00110630|Cholinergic Agents|cholinergic agents|mesh-ancestor
92599391|NCT00110630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599392|NCT00110630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599393|NCT00456430|Escitalopram|escitalopram|mesh-list
92599394|NCT00456430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92599395|NCT00456430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92599396|NCT00456430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599397|NCT00456430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599398|NCT00456430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599399|NCT00456430|Serotonin Agents|serotonin agents|mesh-ancestor
92599400|NCT00456430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599401|NCT00456586|Istradefylline|istradefylline|mesh-list
92599402|NCT00456586|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92599403|NCT00456586|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92599404|NCT00456586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92599405|NCT00456586|Purinergic Agents|purinergic agents|mesh-ancestor
92599406|NCT00456586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599407|NCT00456586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599408|NCT00456586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599409|NCT00110669|Prednisone|prednisone|mesh-list
92599410|NCT00110669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599411|NCT00110669|Glucocorticoids|glucocorticoids|mesh-ancestor
92599412|NCT00110669|Hormones|hormones|mesh-ancestor
92599413|NCT00110669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599414|NCT00110669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599415|NCT00110669|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92599416|NCT00110669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599417|NCT00454558|Riociguat|riociguat|mesh-list
92599418|NCT00454558|Enzyme Activators|enzyme activators|mesh-ancestor
92599419|NCT00454558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599420|NCT00113256|Rubitecan|rubitecan|mesh-list
92599421|NCT00113256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599422|NCT00113256|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92599423|NCT00113256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599424|NCT00113256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599425|NCT00113256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599426|NCT00110708|Immunoglobulins|immunoglobulins|mesh-list
92599427|NCT00110708|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92599428|NCT00110708|Antibodies|antibodies|mesh-list
92599429|NCT00110708|Immunologic Factors|immunologic factors|mesh-ancestor
92599430|NCT00110708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599431|NCT00456820|Bupropion|bupropion|mesh-list
92599432|NCT00456820|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92599433|NCT00456820|Antidepressive Agents|antidepressive agents|mesh-ancestor
92599434|NCT00456820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92599435|NCT00456820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92599436|NCT00456820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92599437|NCT00456820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599438|NCT00456820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599439|NCT00456820|Dopamine Agents|dopamine agents|mesh-ancestor
92536749|NCT03151239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536750|NCT00136396|Rituximab|rituximab|mesh-list
92536751|NCT00136396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536752|NCT00136396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324393|NCT00002744|Cobalt|cobalt|mesh-list
92599440|NCT00456820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599441|NCT00456820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599442|NCT00456820|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92154124|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
92599443|NCT00456820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92599444|NCT00456820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599448|NCT00456898|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92599449|NCT00456898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92599451|NCT00456898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599452|NCT00456898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599453|NCT00456898|Serotonin Agents|serotonin agents|mesh-ancestor
92599454|NCT00456898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599455|NCT00456898|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92599456|NCT00456898|Antidepressive Agents|antidepressive agents|mesh-ancestor
92599457|NCT00456898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92599458|NCT00456898|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92599459|NCT00456898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92599460|NCT00456898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599461|NCT00456898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92599462|NCT00456898|Narcotics|narcotics|mesh-ancestor
92599463|NCT00456898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599464|NCT00456898|Analgesics|analgesics|mesh-ancestor
92599465|NCT00456898|Sensory System Agents|sensory system agents|mesh-ancestor
92599466|NCT00456898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599467|NCT00456898|Antitussive Agents|antitussive agents|mesh-ancestor
92599468|NCT00456898|Respiratory System Agents|respiratory system agents|mesh-ancestor
92599469|NCT00456898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92599470|NCT03274102|Vaccines|vaccines|mesh-list
92599471|NCT03274102|Immunologic Factors|immunologic factors|mesh-ancestor
92599472|NCT03274102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599473|NCT00110747|Lidocaine|lidocaine|mesh-list
92599474|NCT00110747|Tetracaine|tetracaine|mesh-list
92599475|NCT00110747|Anesthetics, Local|anesthetics, local|mesh-ancestor
92599476|NCT00110747|Anesthetics|anesthetics|mesh-ancestor
92599477|NCT00110747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599478|NCT00110747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599479|NCT00110747|Sensory System Agents|sensory system agents|mesh-ancestor
92599480|NCT00110747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599481|NCT00110747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92599482|NCT00110747|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92599483|NCT00110747|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92599484|NCT00110747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599485|NCT00110747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599486|NCT00456937|Escitalopram|escitalopram|mesh-list
92599487|NCT00456937|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92599488|NCT00456937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92599489|NCT00456937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599490|NCT00456937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599491|NCT00456937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599492|NCT00456937|Serotonin Agents|serotonin agents|mesh-ancestor
92599493|NCT00456937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599494|NCT00456976|Selegiline|selegiline|mesh-list
92599495|NCT00456976|Antidepressive Agents|antidepressive agents|mesh-ancestor
92599496|NCT00456976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92599497|NCT00456976|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92599498|NCT00456976|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92599499|NCT00456976|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92599500|NCT00456976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599501|NCT00456976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599502|NCT00456976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92599503|NCT00456976|Protective Agents|protective agents|mesh-ancestor
92599504|NCT00456976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599505|NCT00144066|Gefitinib|gefitinib|mesh-list
92599506|NCT00144066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536753|NCT00136396|Immunologic Factors|immunologic factors|mesh-ancestor
92536754|NCT00136396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536755|NCT00136396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599507|NCT00144066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92599508|NCT00144066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599509|NCT00144066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599510|NCT00457054|Lithium Carbonate|lithium carbonate|mesh-list
92599511|NCT00457054|Antidepressive Agents|antidepressive agents|mesh-ancestor
92599513|NCT00457054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599514|NCT00457054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599518|NCT00457054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599519|NCT00457093|Insulin Glargine|insulin glargine|mesh-list
92599520|NCT00457093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92599521|NCT00457093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599522|NCT00457405|Dipyridamole|dipyridamole|mesh-list
92599523|NCT00457405|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92599524|NCT00457405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599525|NCT00457405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599526|NCT00457405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92599527|NCT00457405|Vasodilator Agents|vasodilator agents|mesh-ancestor
92599528|NCT00457483|Valsartan|valsartan|mesh-list
92599529|NCT00457483|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92599530|NCT00457483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92599531|NCT00457483|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92599532|NCT00457483|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92599533|NCT00457483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599534|NCT00457483|Diuretics|diuretics|mesh-ancestor
92599535|NCT00457483|Natriuretic Agents|natriuretic agents|mesh-ancestor
92599536|NCT00457483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599537|NCT00457483|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92599538|NCT00457483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599539|NCT00110864|Insulin|insulin|mesh-list
92599540|NCT00110864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92599541|NCT00110864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599542|NCT00457678|Dexamethasone|dexamethasone|mesh-list
92599543|NCT00457678|Ranibizumab|ranibizumab|mesh-list
92599544|NCT00457678|Verteporfin|verteporfin|mesh-list
92599545|NCT00457678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599546|NCT00457678|Antiemetics|antiemetics|mesh-ancestor
92599547|NCT00457678|Autonomic Agents|autonomic agents|mesh-ancestor
92599548|NCT00457678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599549|NCT00457678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599550|NCT00457678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599551|NCT00457678|Glucocorticoids|glucocorticoids|mesh-ancestor
92599552|NCT00457678|Hormones|hormones|mesh-ancestor
92599553|NCT00457678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599554|NCT00457678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92599555|NCT00457678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599556|NCT00457678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92599557|NCT00457678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92599558|NCT00457678|Growth Substances|growth substances|mesh-ancestor
92599559|NCT00457678|Growth Inhibitors|growth inhibitors|mesh-ancestor
92599560|NCT00457678|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92599561|NCT00457678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599562|NCT00457717|Atropine|atropine|mesh-list
92599563|NCT00457717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92599564|NCT00457717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92599565|NCT00457717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92599566|NCT00457717|Autonomic Agents|autonomic agents|mesh-ancestor
92599567|NCT00457717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599568|NCT00457717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599569|NCT00457717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92599570|NCT00457717|Respiratory System Agents|respiratory system agents|mesh-ancestor
92599571|NCT00457717|Mydriatics|mydriatics|mesh-ancestor
92599572|NCT00457717|Parasympatholytics|parasympatholytics|mesh-ancestor
92599573|NCT00457717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92599574|NCT00457717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92599575|NCT00457717|Cholinergic Agents|cholinergic agents|mesh-ancestor
92599576|NCT00457717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599577|NCT00457717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536757|NCT00136474|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92536758|NCT00136474|Protective Agents|protective agents|mesh-ancestor
92536759|NCT00136474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599578|NCT00110903|Etanercept|etanercept|mesh-list
92599579|NCT00110903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92599580|NCT00110903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92599581|NCT00110903|Analgesics|analgesics|mesh-ancestor
92599582|NCT00110903|Sensory System Agents|sensory system agents|mesh-ancestor
92599583|NCT00110903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599584|NCT00110903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324486|NCT04713787|Albendazole|albendazole|mesh-list
92599585|NCT00110903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599587|NCT00110903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599588|NCT00110903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599589|NCT00110903|Immunologic Factors|immunologic factors|mesh-ancestor
92599590|NCT00144144|Calcium Channel Blockers|calcium channel blockers|mesh-list
92599591|NCT00144144|Angiotensin II|angiotensin ii|mesh-list
92599592|NCT00144144|Giapreza|giapreza|mesh-list
92599593|NCT00144144|Calcium|calcium|mesh-list
92599594|NCT00144144|Angiotensinogen|angiotensinogen|mesh-list
92599595|NCT00144144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92599596|NCT00144144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92599597|NCT00144144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599598|NCT00144144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92599599|NCT00144144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92599600|NCT00144144|Protease Inhibitors|protease inhibitors|mesh-ancestor
92599601|NCT00144144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599602|NCT00144144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599603|NCT00144144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599604|NCT00465673|Doxorubicin|doxorubicin|mesh-list
92599605|NCT00465673|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92599606|NCT00465673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92599607|NCT00465673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599608|NCT00465673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92599609|NCT00465673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599610|NCT00465673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599611|NCT00465673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599612|NCT00144183|Zidovudine|zidovudine|mesh-list
92599613|NCT00144183|Nevirapine|nevirapine|mesh-list
92599614|NCT00144183|Antimetabolites|antimetabolites|mesh-ancestor
92599615|NCT00144183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599616|NCT00144183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92599617|NCT00144183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92599618|NCT00144183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599619|NCT00144183|Antiviral Agents|antiviral agents|mesh-ancestor
92599620|NCT00144183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599621|NCT00144183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92599622|NCT00144183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92599623|NCT00144183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92599624|NCT00144183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92599625|NCT00465751|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92599626|NCT00465751|Cathartics|cathartics|mesh-ancestor
92599627|NCT00465751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599628|NCT00110981|Etanercept|etanercept|mesh-list
92599629|NCT00110981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92599630|NCT00110981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92599631|NCT00110981|Analgesics|analgesics|mesh-ancestor
92599632|NCT00110981|Sensory System Agents|sensory system agents|mesh-ancestor
92599633|NCT00110981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599634|NCT00110981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599635|NCT00110981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599636|NCT00110981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599637|NCT00110981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599638|NCT00110981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599639|NCT00110981|Immunologic Factors|immunologic factors|mesh-ancestor
92599640|NCT00465907|Paclitaxel|paclitaxel|mesh-list
92599641|NCT00465907|Carboplatin|carboplatin|mesh-list
92599642|NCT00465907|Irinotecan|irinotecan|mesh-list
92599643|NCT00465907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92599644|NCT00465907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599645|NCT00465907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92599646|NCT00465907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92599647|NCT00465907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536760|NCT00136552|Rituximab|rituximab|mesh-list
92536761|NCT00136552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536762|NCT00136552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536763|NCT00136552|Immunologic Factors|immunologic factors|mesh-ancestor
92536764|NCT00136552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536765|NCT00136552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536766|NCT00136591|Bortezomib|bortezomib|mesh-list
92599648|NCT00465907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599649|NCT00465907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92599650|NCT00465907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599651|NCT00465907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599652|NCT00113685|Dextrans|dextrans|mesh-list
92599653|NCT00113685|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92599654|NCT00113685|Anticoagulants|anticoagulants|mesh-ancestor
92599655|NCT00113685|Plasma Substitutes|plasma substitutes|mesh-ancestor
92599656|NCT00113685|Blood Substitutes|blood substitutes|mesh-ancestor
92599657|NCT00111020|Sorafenib|sorafenib|mesh-list
92599658|NCT00111020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599659|NCT00111020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92599660|NCT00111020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324561|NCT01183429|Tretinoin|tretinoin|mesh-list
92599663|NCT00466063|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92599664|NCT00466063|Chelating Agents|chelating agents|mesh-ancestor
92599665|NCT00466063|Sequestering Agents|sequestering agents|mesh-ancestor
92599666|NCT00466063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599667|NCT00466102|Everolimus|everolimus|mesh-list
92599668|NCT00466102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92599669|NCT00466102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92599670|NCT00466102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599671|NCT00466102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599672|NCT00466102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92599673|NCT00466102|Immunologic Factors|immunologic factors|mesh-ancestor
92599674|NCT00466102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599675|NCT00466102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599676|NCT00144222|Telmisartan|telmisartan|mesh-list
92599677|NCT00144222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92599678|NCT00144222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92599679|NCT00144222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92599680|NCT00144222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599681|NCT00466180|Nevirapine|nevirapine|mesh-list
92599682|NCT00466180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92599683|NCT00466180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92599684|NCT00466180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599685|NCT00466180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599686|NCT00466180|Antiviral Agents|antiviral agents|mesh-ancestor
92599687|NCT00466180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599688|NCT00466180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92599689|NCT00466180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92599690|NCT00466180|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92599691|NCT00466180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92599692|NCT00466219|Interferons|interferons|mesh-list
92599693|NCT00466219|Ribavirin|ribavirin|mesh-list
92599694|NCT00466219|Interferon-alpha|interferon-alpha|mesh-list
92599695|NCT00466219|Interferon alpha-2|interferon alpha-2|mesh-list
92599696|NCT00466219|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92599697|NCT00466219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599698|NCT00466219|Antiviral Agents|antiviral agents|mesh-ancestor
92599699|NCT00466219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599700|NCT00466219|Antimetabolites|antimetabolites|mesh-ancestor
92599701|NCT00466219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599702|NCT00466219|Immunologic Factors|immunologic factors|mesh-ancestor
92599703|NCT00466219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599704|NCT00144261|Nevirapine|nevirapine|mesh-list
92599705|NCT00144261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92599706|NCT00144261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92599707|NCT00144261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599708|NCT00144261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599709|NCT00144261|Antiviral Agents|antiviral agents|mesh-ancestor
92599710|NCT00144261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536767|NCT00136591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536768|NCT03151161|Carboplatin|carboplatin|mesh-list
92536769|NCT03151161|Pemetrexed|pemetrexed|mesh-list
92599711|NCT00144261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92599712|NCT00144261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92599713|NCT00144261|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92599714|NCT00144261|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92599715|NCT00466258|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92599716|NCT00466258|Antiviral Agents|antiviral agents|mesh-ancestor
92599717|NCT00466258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599718|NCT00144378|Irinotecan|irinotecan|mesh-list
92599719|NCT00144378|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92599720|NCT00144378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599721|NCT00144378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599722|NCT00144378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599723|NCT00144378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599724|NCT00111098|Darbepoetin alfa|darbepoetin alfa|mesh-list
92599725|NCT00111098|Hematinics|hematinics|mesh-ancestor
92599726|NCT00347698|Bevacizumab|bevacizumab|mesh-list
92599727|NCT00347698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599728|NCT00347698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599729|NCT00347698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92599730|NCT00347698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92599731|NCT00347698|Growth Substances|growth substances|mesh-ancestor
92599732|NCT00347698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599734|NCT00347737|Teriparatide|teriparatide|mesh-list
92599735|NCT00347737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92599736|NCT00347737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599737|NCT00347737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92599738|NCT00347815|Buprenorphine|buprenorphine|mesh-list
92599739|NCT00347815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92599740|NCT00347815|Narcotics|narcotics|mesh-ancestor
92599741|NCT00347815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599742|NCT00347815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599743|NCT00347815|Analgesics|analgesics|mesh-ancestor
92599744|NCT00347815|Sensory System Agents|sensory system agents|mesh-ancestor
92599745|NCT00347815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599746|NCT00347815|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92599747|NCT00113802|Epratuzumab|epratuzumab|mesh-list
92599748|NCT00113802|Antibodies|antibodies|mesh-list
92599749|NCT00113802|Immunologic Factors|immunologic factors|mesh-ancestor
92599750|NCT00113802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599751|NCT00113802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599752|NCT00113802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599753|NCT00111137|Darbepoetin alfa|darbepoetin alfa|mesh-list
92599754|NCT00111137|Hematinics|hematinics|mesh-ancestor
92599755|NCT00347854|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92599756|NCT00347854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92599757|NCT00347854|Lubricant Eye Drops|lubricant eye drops|mesh-list
92599758|NCT00347854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92599759|NCT00347854|Laxatives|laxatives|mesh-ancestor
92599760|NCT00347854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599761|NCT00347971|Rituximab|rituximab|mesh-list
92599762|NCT00347971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599763|NCT00347971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599764|NCT00347971|Immunologic Factors|immunologic factors|mesh-ancestor
92599765|NCT00347971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599766|NCT00347971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599767|NCT00113958|Cinacalcet|cinacalcet|mesh-list
92599768|NCT00113958|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92599769|NCT00113958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599770|NCT00113958|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92599771|NCT00113958|Hormone Antagonists|hormone antagonists|mesh-ancestor
92599772|NCT00113958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599773|NCT00348010|Tramadol|tramadol|mesh-list
92599774|NCT00348010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92599775|NCT00348010|Narcotics|narcotics|mesh-ancestor
92599776|NCT00348010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599777|NCT00348010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599778|NCT00348010|Analgesics|analgesics|mesh-ancestor
92599779|NCT00348010|Sensory System Agents|sensory system agents|mesh-ancestor
92599780|NCT00348010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599781|NCT00144417|Moxifloxacin|moxifloxacin|mesh-list
92599782|NCT00144417|Rifampin|rifampin|mesh-list
92599783|NCT00144417|Isoniazid|isoniazid|mesh-list
92536770|NCT03151161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536771|NCT03151161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536772|NCT03151161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599784|NCT00144417|Pyrazinamide|pyrazinamide|mesh-list
92599785|NCT00144417|Ethambutol|ethambutol|mesh-list
92599786|NCT00144417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92599787|NCT00144417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599788|NCT00144417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92599789|NCT00144417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599790|NCT00144417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599791|NCT00144417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599792|NCT00144417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599793|NCT00144417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92599794|NCT00144417|Antitubercular Agents|antitubercular agents|mesh-ancestor
92599795|NCT00144417|Leprostatic Agents|leprostatic agents|mesh-ancestor
92599796|NCT00144417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92599797|NCT00144417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92599798|NCT00144417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92599799|NCT00144417|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92599800|NCT00144417|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92599801|NCT00144417|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92599802|NCT00144417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92599803|NCT00144417|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92599804|NCT00144417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92599805|NCT00144417|Antimetabolites|antimetabolites|mesh-ancestor
92599810|NCT00111215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92599811|NCT00111215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599813|NCT00111215|Coagulants|coagulants|mesh-ancestor
92599814|NCT00111215|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92599815|NCT00111215|Natriuretic Agents|natriuretic agents|mesh-ancestor
92599816|NCT00111215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599817|NCT00348166|Cyclopentolate|cyclopentolate|mesh-list
92599818|NCT00348166|Mydriatics|mydriatics|mesh-ancestor
92599819|NCT00348166|Autonomic Agents|autonomic agents|mesh-ancestor
92599820|NCT00348166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599821|NCT00348166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599822|NCT00348166|Parasympatholytics|parasympatholytics|mesh-ancestor
92599823|NCT00348166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92599824|NCT00348166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92599825|NCT00348166|Cholinergic Agents|cholinergic agents|mesh-ancestor
92599826|NCT00348166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599827|NCT00348166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599828|NCT00348244|Prednisolone|prednisolone|mesh-list
92599829|NCT00348244|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92599830|NCT00348244|Methylprednisolone|methylprednisolone|mesh-list
92599831|NCT00348244|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92599832|NCT00348244|Prednisolone acetate|prednisolone acetate|mesh-list
92599833|NCT00348244|Ketorolac|ketorolac|mesh-list
92599834|NCT00348244|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92599835|NCT00348244|Prednisolone phosphate|prednisolone phosphate|mesh-list
92599836|NCT00348244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599837|NCT00348244|Glucocorticoids|glucocorticoids|mesh-ancestor
92599838|NCT00348244|Hormones|hormones|mesh-ancestor
92599839|NCT00348244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599840|NCT00348244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599841|NCT00348244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92599842|NCT00348244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599843|NCT00348244|Antiemetics|antiemetics|mesh-ancestor
92599844|NCT00348244|Autonomic Agents|autonomic agents|mesh-ancestor
92599845|NCT00348244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599846|NCT00348244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599847|NCT00348244|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92599848|NCT00348244|Protective Agents|protective agents|mesh-ancestor
92599849|NCT00348244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92599850|NCT00348244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92599851|NCT00348244|Analgesics|analgesics|mesh-ancestor
92599852|NCT00348244|Sensory System Agents|sensory system agents|mesh-ancestor
92599853|NCT00348244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599854|NCT00348244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92599855|NCT00348244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536773|NCT03151161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92536774|NCT03151161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92536775|NCT00404053|Clopidogrel|clopidogrel|mesh-list
92536776|NCT00404053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92536777|NCT00404053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91944527|NCT02448446|Ranibizumab|ranibizumab|mesh-list
92599856|NCT00348244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599857|NCT00348322|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92599858|NCT00348322|Lubricant Eye Drops|lubricant eye drops|mesh-list
92599859|NCT00348322|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92599860|NCT00348361|Fluticasone|fluticasone|mesh-list
92599861|NCT00348361|Xhance|xhance|mesh-list
92599862|NCT00348361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599863|NCT00348361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92599864|NCT00348361|Autonomic Agents|autonomic agents|mesh-ancestor
92599865|NCT00348361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599866|NCT00348361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599867|NCT00348361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92599868|NCT00348361|Respiratory System Agents|respiratory system agents|mesh-ancestor
92599869|NCT00348361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599870|NCT00348361|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92599871|NCT00348400|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92599872|NCT00348400|Dorzolamide|dorzolamide|mesh-list
92599873|NCT00348400|Latanoprost|latanoprost|mesh-list
92599874|NCT00348400|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92599875|NCT00348400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92599876|NCT00348400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92007300|NCT01117441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599882|NCT00348400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599883|NCT00348400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599884|NCT00348400|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92324820|NCT01583647|Niacin|niacin|mesh-list
92599885|NCT00348400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599886|NCT00144456|Alfacalcidol|alfacalcidol|mesh-list
92599887|NCT00144456|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92599888|NCT00144456|Eldecalcitol|eldecalcitol|mesh-list
92599889|NCT00144456|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92599890|NCT00144456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599891|NCT00144456|Vitamins|vitamins|mesh-ancestor
92599892|NCT00144456|Micronutrients|micronutrients|mesh-ancestor
92599893|NCT00348439|Fibrinolysin|fibrinolysin|mesh-list
92599894|NCT00348439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92599895|NCT00348439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92599896|NCT00348439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599897|NCT00348517|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92599898|NCT00348517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92599899|NCT00348517|Lubricant Eye Drops|lubricant eye drops|mesh-list
92599900|NCT00348517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92599901|NCT00348517|Laxatives|laxatives|mesh-ancestor
92599902|NCT00348517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92599903|NCT00348634|Tegaserod|tegaserod|mesh-list
92599904|NCT00348634|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92599905|NCT00348634|Serotonin Agents|serotonin agents|mesh-ancestor
92599906|NCT00348634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599907|NCT00348634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599908|NCT00348634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599909|NCT00348712|Insulin|insulin|mesh-list
92599910|NCT00348712|Metformin|metformin|mesh-list
92599911|NCT00348712|Rosiglitazone|rosiglitazone|mesh-list
92599912|NCT00348712|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92599913|NCT00348712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92599914|NCT00348712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599915|NCT02964689|Pemetrexed|pemetrexed|mesh-list
92599916|NCT02964689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599917|NCT02964689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599918|NCT02964689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599919|NCT02964689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92599920|NCT02964689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92599921|NCT00348985|Bortezomib|bortezomib|mesh-list
92599922|NCT00348985|Belinostat|belinostat|mesh-list
92599923|NCT00348985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536778|NCT00404053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92536781|NCT00404053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599924|NCT00348985|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92599925|NCT00348985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599926|NCT00348985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599927|NCT00349024|Povidone|povidone|mesh-list
92599928|NCT00349024|Hyaluronic Acid|hyaluronic acid|mesh-list
92599929|NCT00349024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92599930|NCT00349024|Immunologic Factors|immunologic factors|mesh-ancestor
92599931|NCT00349024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599932|NCT00349024|Viscosupplements|viscosupplements|mesh-ancestor
92599933|NCT00349024|Protective Agents|protective agents|mesh-ancestor
92599934|NCT00349024|Plasma Substitutes|plasma substitutes|mesh-ancestor
92599935|NCT00349024|Blood Substitutes|blood substitutes|mesh-ancestor
92599936|NCT00111371|Levodopa|levodopa|mesh-list
92599937|NCT00111371|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92599938|NCT00111371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92599939|NCT00111371|Dopamine Agents|dopamine agents|mesh-ancestor
92599940|NCT00111371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599941|NCT00111371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599942|NCT00111371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599943|NCT00349180|Enoxaparin|enoxaparin|mesh-list
92599944|NCT00349180|Enoxaparin sodium|enoxaparin sodium|mesh-list
92599945|NCT00349180|Anticoagulants|anticoagulants|mesh-ancestor
92599946|NCT00349180|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92599947|NCT00349180|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92599949|NCT00421369|Sertraline|sertraline|mesh-list
92599950|NCT00421369|Reboxetine|reboxetine|mesh-list
92599951|NCT00421369|Antidepressive Agents|antidepressive agents|mesh-ancestor
92599952|NCT00421369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92599953|NCT00421369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92599954|NCT00421369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92599955|NCT00421369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599956|NCT00421369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599957|NCT00421369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599958|NCT00421369|Serotonin Agents|serotonin agents|mesh-ancestor
92599959|NCT00421369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599960|NCT00421369|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92599961|NCT00421369|Adrenergic Agents|adrenergic agents|mesh-ancestor
92599962|NCT00111410|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92599964|NCT00421447|Anastrozole|anastrozole|mesh-list
92599965|NCT00421447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92599966|NCT00421447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599967|NCT00421447|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92599968|NCT00421447|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92599969|NCT00421447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599970|NCT00421447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599971|NCT00421447|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92599972|NCT00421447|Hormone Antagonists|hormone antagonists|mesh-ancestor
92599973|NCT00421447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599974|NCT00421447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599975|NCT04729140|Doxycycline|doxycycline|mesh-list
92599976|NCT04729140|Ivermectin|ivermectin|mesh-list
92599977|NCT04729140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92599978|NCT04729140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92599979|NCT04729140|Antimalarials|antimalarials|mesh-ancestor
92599980|NCT04729140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92599981|NCT04729140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92599982|NCT00349219|Cisplatin|cisplatin|mesh-list
92599983|NCT00349219|Gemcitabine|gemcitabine|mesh-list
92599984|NCT00349219|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92599985|NCT00349219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92599986|NCT00349219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92599987|NCT00349219|Antimetabolites|antimetabolites|mesh-ancestor
92599988|NCT00349219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599989|NCT00349219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92599990|NCT00349219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599991|NCT00111449|Etanercept|etanercept|mesh-list
92599992|NCT00111449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92599993|NCT00111449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92599994|NCT00111449|Analgesics|analgesics|mesh-ancestor
92536782|NCT00404053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536783|NCT00404053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536784|NCT03991130|Nivolumab|nivolumab|mesh-list
92599995|NCT00111449|Sensory System Agents|sensory system agents|mesh-ancestor
92599996|NCT00111449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92599997|NCT00111449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599998|NCT00111449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92599999|NCT00111449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600000|NCT00111449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600001|NCT00111449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600002|NCT00111449|Immunologic Factors|immunologic factors|mesh-ancestor
92600003|NCT00349258|Leuprolide|leuprolide|mesh-list
92600004|NCT00349258|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92600005|NCT00349258|Fertility Agents|fertility agents|mesh-ancestor
92600006|NCT00349258|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92600007|NCT00349258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600008|NCT00349258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92600009|NCT00349258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600010|NCT00349375|Simvastatin|simvastatin|mesh-list
92600011|NCT00349375|Fenofibrate|fenofibrate|mesh-list
92600012|NCT00349375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92600013|NCT00349375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92600014|NCT00349375|Antimetabolites|antimetabolites|mesh-ancestor
92600015|NCT00349375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600016|NCT00349375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92600017|NCT00349375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92600018|NCT00349375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600019|NCT00349453|Deferiprone|deferiprone|mesh-list
92600020|NCT00349453|Deferoxamine|deferoxamine|mesh-list
92600021|NCT00349453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92600023|NCT00349453|Sequestering Agents|sequestering agents|mesh-ancestor
92600024|NCT00349453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600025|NCT00349453|Siderophores|siderophores|mesh-ancestor
92600026|NCT00349492|Cisplatin|cisplatin|mesh-list
92600027|NCT00349492|Irinotecan|irinotecan|mesh-list
92600028|NCT00349492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600029|NCT00349492|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92600030|NCT00349492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600031|NCT00349492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600032|NCT00349492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600033|NCT00349531|Pramipexole|pramipexole|mesh-list
92600034|NCT00349531|Antioxidants|antioxidants|mesh-ancestor
92600035|NCT00349531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600036|NCT00349531|Protective Agents|protective agents|mesh-ancestor
92600037|NCT00349531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600038|NCT00349531|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92600039|NCT00349531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92600040|NCT00349531|Dopamine Agonists|dopamine agonists|mesh-ancestor
92600041|NCT00349531|Dopamine Agents|dopamine agents|mesh-ancestor
92600042|NCT00349531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600043|NCT00111566|Eptifibatide|eptifibatide|mesh-list
92600044|NCT00111566|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92600045|NCT00404703|Bevacizumab|bevacizumab|mesh-list
92600046|NCT00404703|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92600047|NCT00404703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600048|NCT00404703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92600049|NCT00404703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92600050|NCT00404703|Growth Substances|growth substances|mesh-ancestor
92600051|NCT00404703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600052|NCT00404703|Growth Inhibitors|growth inhibitors|mesh-ancestor
92600053|NCT00349726|Inositol|inositol|mesh-list
92600054|NCT00349726|Vitamin B Complex|vitamin b complex|mesh-ancestor
92600055|NCT00349726|Vitamins|vitamins|mesh-ancestor
92600056|NCT00349726|Micronutrients|micronutrients|mesh-ancestor
92600057|NCT00349726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600058|NCT00111644|Ceftriaxone|ceftriaxone|mesh-list
92600059|NCT00111644|Lactams|lactams|mesh-list
92600060|NCT00111644|beta-Lactams|beta-lactams|mesh-list
92600061|NCT00111644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92600062|NCT00111644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600063|NCT00350038|Irbesartan|irbesartan|mesh-list
92600064|NCT00350038|Ciprofibrate|ciprofibrate|mesh-list
92600065|NCT00350038|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92600066|NCT00350038|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92536785|NCT03991130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536786|NCT03991130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536787|NCT03991130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92536788|NCT03991130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536789|NCT00136747|Memantine|memantine|mesh-list
92600067|NCT00350038|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92600068|NCT00350038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600069|NCT00350038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92600070|NCT00350038|Antimetabolites|antimetabolites|mesh-ancestor
92600071|NCT00350038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92600072|NCT00350077|Vitamins|vitamins|mesh-list
92600073|NCT00350077|Ascorbic Acid|ascorbic acid|mesh-list
92600074|NCT00350077|Micronutrients|micronutrients|mesh-ancestor
92600075|NCT00350077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600076|NCT00350077|Antioxidants|antioxidants|mesh-ancestor
92600077|NCT00350077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600078|NCT00350077|Protective Agents|protective agents|mesh-ancestor
92600079|NCT00114153|Carboplatin|carboplatin|mesh-list
92600080|NCT00114153|Capecitabine|capecitabine|mesh-list
92600081|NCT00114153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600082|NCT00114153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600083|NCT00114153|Antimetabolites|antimetabolites|mesh-ancestor
92600084|NCT00114153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600085|NCT00350116|Vitamin B 12|vitamin b 12|mesh-list
92600086|NCT00350116|Hydroxocobalamin|hydroxocobalamin|mesh-list
92600087|NCT00350116|Vitamins|vitamins|mesh-ancestor
92600088|NCT00350116|Micronutrients|micronutrients|mesh-ancestor
92600089|NCT00350116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600090|NCT00350116|Vitamin B Complex|vitamin b complex|mesh-ancestor
92600091|NCT00350116|Hematinics|hematinics|mesh-ancestor
92600092|NCT00350155|Lumiracoxib|lumiracoxib|mesh-list
92600093|NCT00350155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92600094|NCT00350155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92600095|NCT00350155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600096|NCT00350155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600097|NCT00350155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92600098|NCT00350155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600103|NCT00350155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600104|NCT00350155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600105|NCT00404781|Aspirin|aspirin|mesh-list
92600106|NCT00404781|Cilostazol|cilostazol|mesh-list
92600107|NCT00404781|Clopidogrel|clopidogrel|mesh-list
92600108|NCT00404781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92600109|NCT00404781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600110|NCT00404781|Analgesics|analgesics|mesh-ancestor
92600111|NCT00404781|Sensory System Agents|sensory system agents|mesh-ancestor
92600112|NCT00404781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600113|NCT00404781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600114|NCT00404781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600115|NCT00404781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600116|NCT00404781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92600117|NCT00404781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92600118|NCT00404781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600119|NCT00404781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92600120|NCT00404781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92600121|NCT00404781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600122|NCT00404781|Antipyretics|antipyretics|mesh-ancestor
92600123|NCT00404781|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92600124|NCT00404781|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92600125|NCT00404781|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92600126|NCT00404781|Purinergic Agents|purinergic agents|mesh-ancestor
92600127|NCT00404781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600128|NCT00404781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92600129|NCT00404781|Autonomic Agents|autonomic agents|mesh-ancestor
92600130|NCT00404781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92600131|NCT00404781|Respiratory System Agents|respiratory system agents|mesh-ancestor
92600132|NCT00404781|Vasodilator Agents|vasodilator agents|mesh-ancestor
92600133|NCT00404781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92600134|NCT00404781|Protective Agents|protective agents|mesh-ancestor
92536791|NCT00136747|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92536792|NCT00136747|Antidepressive Agents|antidepressive agents|mesh-ancestor
91950301|NCT03130153|Aspirin|aspirin|mesh-list
92600135|NCT00404781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92600136|NCT00404781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92600137|NCT00350311|Nicotine|nicotine|mesh-list
92600138|NCT00350311|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92600139|NCT00350311|Autonomic Agents|autonomic agents|mesh-ancestor
92600140|NCT00350311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600141|NCT00350311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600142|NCT00350311|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92600143|NCT00350311|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92600144|NCT00350311|Cholinergic Agents|cholinergic agents|mesh-ancestor
92600145|NCT00350311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600146|NCT00350311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600147|NCT00114192|Thalidomide|thalidomide|mesh-list
92600148|NCT00114192|Docetaxel|docetaxel|mesh-list
92600149|NCT00114192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600150|NCT00114192|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600151|NCT00114192|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600152|NCT00114192|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600153|NCT00114192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600154|NCT00114192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600155|NCT00114192|Immunologic Factors|immunologic factors|mesh-ancestor
92600156|NCT00114192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600157|NCT00114192|Leprostatic Agents|leprostatic agents|mesh-ancestor
92600158|NCT00114192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92600159|NCT00114192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600160|NCT00114192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92600161|NCT00114192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92600162|NCT00114192|Growth Substances|growth substances|mesh-ancestor
92600163|NCT00114192|Growth Inhibitors|growth inhibitors|mesh-ancestor
92600164|NCT00350467|Olanzapine|olanzapine|mesh-list
92600165|NCT00350467|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92600166|NCT00350467|Antiemetics|antiemetics|mesh-ancestor
92600167|NCT00350467|Autonomic Agents|autonomic agents|mesh-ancestor
92600168|NCT00350467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600169|NCT00350467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007591|NCT02621021|Aldesleukin|aldesleukin|mesh-list
92600182|NCT00350467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92600183|NCT00350467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92600184|NCT00350467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92600185|NCT00350467|Dopamine Agents|dopamine agents|mesh-ancestor
92600187|NCT00350662|Deferoxamine|deferoxamine|mesh-list
92600188|NCT00350662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92600189|NCT00350662|Chelating Agents|chelating agents|mesh-ancestor
92600190|NCT00350662|Sequestering Agents|sequestering agents|mesh-ancestor
92600191|NCT00350662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600193|NCT00350818|Azacitidine|azacitidine|mesh-list
92600194|NCT00350818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600195|NCT00350818|Antimetabolites|antimetabolites|mesh-ancestor
92600196|NCT00350818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600197|NCT00350818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600198|NCT00350818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600199|NCT00350857|Carbamazepine|carbamazepine|mesh-list
92600200|NCT00350857|Anticonvulsants|anticonvulsants|mesh-ancestor
92600201|NCT00350857|Antimanic Agents|antimanic agents|mesh-ancestor
92600202|NCT00350857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600203|NCT00350857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600204|NCT00350857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600205|NCT00350857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600206|NCT00350857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600207|NCT00350857|Analgesics|analgesics|mesh-ancestor
92600208|NCT00350857|Sensory System Agents|sensory system agents|mesh-ancestor
92600209|NCT00350857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600210|NCT00350857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92600211|NCT00350857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600212|NCT00350857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600213|NCT00350857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92600214|NCT00350857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92600215|NCT00111956|Etanercept|etanercept|mesh-list
92536793|NCT00136747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92536794|NCT00136747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92536795|NCT00136747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92536796|NCT00136747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944542|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600216|NCT00111956|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92600217|NCT00111956|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600218|NCT00111956|Analgesics|analgesics|mesh-ancestor
92600219|NCT00111956|Sensory System Agents|sensory system agents|mesh-ancestor
92600220|NCT00111956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600221|NCT00111956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600222|NCT00111956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600223|NCT00111956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600224|NCT00111956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600225|NCT00111956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600226|NCT00111956|Immunologic Factors|immunologic factors|mesh-ancestor
92600227|NCT00114270|Zoledronic Acid|zoledronic acid|mesh-list
92600228|NCT00114270|Letrozole|letrozole|mesh-list
92600229|NCT00114270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600230|NCT00114270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92600233|NCT00114270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600234|NCT00114270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92600235|NCT00114270|Hormone Antagonists|hormone antagonists|mesh-ancestor
92600236|NCT00114270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92600237|NCT00114270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600238|NCT00114270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92600239|NCT00111995|Darbepoetin alfa|darbepoetin alfa|mesh-list
92600240|NCT00111995|Hematinics|hematinics|mesh-ancestor
92600241|NCT00351052|Pimecrolimus|pimecrolimus|mesh-list
92600242|NCT00351052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92600243|NCT00351052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600244|NCT00351052|Analgesics|analgesics|mesh-ancestor
92600245|NCT00351052|Sensory System Agents|sensory system agents|mesh-ancestor
92600246|NCT00351052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600247|NCT00351052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600248|NCT00351052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600249|NCT00351052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600250|NCT00351052|Dermatologic Agents|dermatologic agents|mesh-ancestor
92600251|NCT00351052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600252|NCT00351052|Immunologic Factors|immunologic factors|mesh-ancestor
92600253|NCT00351052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92600254|NCT00351052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600255|NCT00351052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600256|NCT00401609|Carboplatin|carboplatin|mesh-list
92600257|NCT00401609|Gemcitabine|gemcitabine|mesh-list
92600258|NCT00401609|Etoposide|etoposide|mesh-list
92600259|NCT00401609|Vinorelbine|vinorelbine|mesh-list
92600260|NCT00401609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600261|NCT00401609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600262|NCT00401609|Antimetabolites|antimetabolites|mesh-ancestor
92600263|NCT00401609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600264|NCT00401609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92600265|NCT00401609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92600266|NCT00401609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600267|NCT00401609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600268|NCT00401609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600269|NCT00401609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600270|NCT00401609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600271|NCT00351091|Risedronic Acid|risedronic acid|mesh-list
92600272|NCT00351091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92600273|NCT00351091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600274|NCT00351091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600275|NCT00351091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600276|NCT00351091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600277|NCT00351091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92600279|NCT00351130|Valsartan|valsartan|mesh-list
92600280|NCT00351130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92600281|NCT00351130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92536797|NCT00136747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536798|NCT00136747|Dopamine Agents|dopamine agents|mesh-ancestor
92536799|NCT00136747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536800|NCT00136747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536801|NCT00136747|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92536802|NCT00136747|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92536803|NCT00136747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536804|NCT00136747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91944547|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
92600282|NCT00351130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600283|NCT00351130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600284|NCT00351130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600285|NCT00351130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600286|NCT00351130|Vasodilator Agents|vasodilator agents|mesh-ancestor
92600287|NCT00351130|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92600288|NCT00351130|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92600289|NCT00351169|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92600290|NCT00351169|Escitalopram|escitalopram|mesh-list
92600291|NCT00351169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92600292|NCT00351169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600293|NCT00351169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600294|NCT00351169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600295|NCT00351169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600296|NCT00351169|Serotonin Agents|serotonin agents|mesh-ancestor
92600297|NCT00351169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600298|NCT00351169|Antidepressive Agents|antidepressive agents|mesh-ancestor
92600299|NCT00351169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600300|NCT00351169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92600301|NCT00351169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600305|NCT00351286|Simvastatin|simvastatin|mesh-list
92600306|NCT00351286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92600307|NCT00351286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92600308|NCT00351286|Antimetabolites|antimetabolites|mesh-ancestor
92600309|NCT00351286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600310|NCT00351286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92600311|NCT00351286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92600312|NCT00351286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600313|NCT00112034|Methylprednisolone|methylprednisolone|mesh-list
92600314|NCT00112034|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92600315|NCT00112034|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92600316|NCT00112034|Prednisolone|prednisolone|mesh-list
92600317|NCT00112034|Prednisolone acetate|prednisolone acetate|mesh-list
92600318|NCT00112034|Methotrexate|methotrexate|mesh-list
92600319|NCT00112034|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92600320|NCT00112034|Prednisolone phosphate|prednisolone phosphate|mesh-list
92600321|NCT00112034|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92600322|NCT00112034|Abortifacient Agents|abortifacient agents|mesh-ancestor
92600323|NCT00112034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92600324|NCT00112034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600325|NCT00112034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600326|NCT00112034|Antimetabolites|antimetabolites|mesh-ancestor
92600327|NCT00112034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600328|NCT00112034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600329|NCT00112034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92600330|NCT00112034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600331|NCT00112034|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92600332|NCT00112034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600333|NCT00112034|Immunologic Factors|immunologic factors|mesh-ancestor
92600334|NCT00112034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600335|NCT00112034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92600336|NCT00112034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600337|NCT00112034|Antiemetics|antiemetics|mesh-ancestor
92536805|NCT00136747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92536806|NCT00136747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92536807|NCT00136747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92600338|NCT00112034|Autonomic Agents|autonomic agents|mesh-ancestor
92600339|NCT00112034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600340|NCT00112034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600341|NCT00112034|Glucocorticoids|glucocorticoids|mesh-ancestor
92600342|NCT00112034|Hormones|hormones|mesh-ancestor
92600343|NCT00112034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92600344|NCT00112034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92600345|NCT00112034|Protective Agents|protective agents|mesh-ancestor
92600346|NCT00112034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92600347|NCT00114387|Tocopherols|tocopherols|mesh-list
92600348|NCT00114387|Vitamin E|vitamin e|mesh-list
92600349|NCT00114387|Tocotrienols|tocotrienols|mesh-list
92600350|NCT00114387|alpha-Tocopherol|alpha-tocopherol|mesh-list
92600351|NCT00114387|Antioxidants|antioxidants|mesh-ancestor
92600352|NCT00114387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600353|NCT00114387|Protective Agents|protective agents|mesh-ancestor
92600354|NCT00114387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600355|NCT00114387|Vitamins|vitamins|mesh-ancestor
92600356|NCT00114387|Micronutrients|micronutrients|mesh-ancestor
92600357|NCT00351364|Montelukast|montelukast|mesh-list
92600358|NCT00351364|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92600359|NCT00351364|Respiratory System Agents|respiratory system agents|mesh-ancestor
92600360|NCT00351364|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92600361|NCT00351364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92600362|NCT00351364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92600363|NCT00351364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600364|NCT00351364|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92600365|NCT00351364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92600366|NCT00351364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600367|NCT00351403|Ribavirin|ribavirin|mesh-list
92600368|NCT00351403|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92600369|NCT00351403|Antimetabolites|antimetabolites|mesh-ancestor
92600370|NCT00351403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600371|NCT00351403|Antiviral Agents|antiviral agents|mesh-ancestor
92600372|NCT00351403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007798|NCT04432415|Fluorides|fluorides|mesh-list
92600375|NCT05595096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600377|NCT00351637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92600378|NCT00351637|Narcotics|narcotics|mesh-ancestor
92600379|NCT00351637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600380|NCT00351637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600381|NCT00351637|Analgesics|analgesics|mesh-ancestor
92600382|NCT00351637|Sensory System Agents|sensory system agents|mesh-ancestor
92600383|NCT00351637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600384|NCT00351637|Antitussive Agents|antitussive agents|mesh-ancestor
92600385|NCT00351637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92600386|NCT00351715|Methadone|methadone|mesh-list
92600387|NCT00351715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92600388|NCT00351715|Narcotics|narcotics|mesh-ancestor
92600389|NCT00351715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600390|NCT00351715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600391|NCT00351715|Analgesics|analgesics|mesh-ancestor
92600392|NCT00351715|Sensory System Agents|sensory system agents|mesh-ancestor
92600393|NCT00351715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600394|NCT00351715|Antitussive Agents|antitussive agents|mesh-ancestor
92600395|NCT00351715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92600396|NCT00351832|Vildagliptin|vildagliptin|mesh-list
92600397|NCT00351832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92600398|NCT00351832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600399|NCT00351832|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92600400|NCT00351832|Protease Inhibitors|protease inhibitors|mesh-ancestor
92600401|NCT00351832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600402|NCT00351832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600403|NCT00351871|Ribavirin|ribavirin|mesh-list
92600404|NCT00351871|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92600405|NCT00351871|Antimetabolites|antimetabolites|mesh-ancestor
92600406|NCT00351871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600407|NCT00351871|Antiviral Agents|antiviral agents|mesh-ancestor
92536808|NCT00136786|Memantine|memantine|mesh-list
92536809|NCT00136786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92536810|NCT00136786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92600408|NCT00351871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600409|NCT00351910|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92600410|NCT00351910|Amitriptyline|amitriptyline|mesh-list
92325318|NCT00759577|Urological Agents|urological agents|mesh-ancestor
92600411|NCT00351910|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92600412|NCT00351910|Citalopram|citalopram|mesh-list
92600413|NCT00351910|Bupropion|bupropion|mesh-list
92600414|NCT00351910|Fluoxetine|fluoxetine|mesh-list
92600415|NCT00351910|Paroxetine|paroxetine|mesh-list
92600416|NCT00351910|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92600417|NCT00351910|Sertraline|sertraline|mesh-list
92600418|NCT00351910|Escitalopram|escitalopram|mesh-list
92600419|NCT00351910|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92600420|NCT00351910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600421|NCT00351910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600422|NCT00351910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600423|NCT00351910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600424|NCT00351910|Serotonin Agents|serotonin agents|mesh-ancestor
92600425|NCT00351910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600426|NCT00351910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600427|NCT00351910|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92600428|NCT00351910|Antidepressive Agents|antidepressive agents|mesh-ancestor
92600429|NCT00351910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600430|NCT00351910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92600431|NCT00351910|Dopamine Agents|dopamine agents|mesh-ancestor
92600432|NCT00351910|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92600433|NCT00351910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92600434|NCT00351910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600435|NCT00351910|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92600436|NCT00351910|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600437|NCT00351910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600438|NCT00351910|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92600439|NCT00351910|Analgesics|analgesics|mesh-ancestor
92600440|NCT00351910|Sensory System Agents|sensory system agents|mesh-ancestor
92600441|NCT00351910|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92600442|NCT00351910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600443|NCT00351910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92600444|NCT00351910|Adrenergic Agents|adrenergic agents|mesh-ancestor
92600447|NCT00112346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600449|NCT00112346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600450|NCT00112346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600451|NCT00112346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92600452|NCT00352144|Eszopiclone|eszopiclone|mesh-list
92600453|NCT00352144|Zopiclone|zopiclone|mesh-list
92600454|NCT00352144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92600455|NCT00352144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600456|NCT00352144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600457|NCT00352183|Simvastatin|simvastatin|mesh-list
92600458|NCT00352183|Fenofibrate|fenofibrate|mesh-list
92600459|NCT00352183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92600460|NCT00352183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92600461|NCT00352183|Antimetabolites|antimetabolites|mesh-ancestor
92600462|NCT00352183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600463|NCT00352183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92600464|NCT00352183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92600465|NCT00352183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600466|NCT00112619|Topotecan|topotecan|mesh-list
92600467|NCT00112619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92600468|NCT00112619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600469|NCT00112619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600470|NCT00112619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600471|NCT00112619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600472|NCT00352261|Esomeprazole|esomeprazole|mesh-list
92600473|NCT00352261|Lansoprazole|lansoprazole|mesh-list
92600474|NCT00352261|Dexlansoprazole|dexlansoprazole|mesh-list
92600475|NCT00352261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92600476|NCT00352261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600477|NCT00352261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92600478|NCT00352261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536812|NCT00136786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536813|NCT00136786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950730|NCT03317795|Hemostatics|hemostatics|mesh-ancestor
92600479|NCT00352261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600480|NCT00352300|Paclitaxel|paclitaxel|mesh-list
92600481|NCT00352300|Carboplatin|carboplatin|mesh-list
92600482|NCT00352300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92600483|NCT00352300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600484|NCT00352300|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325394|NCT05295212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600485|NCT00352300|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600486|NCT00352300|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600487|NCT00352300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600488|NCT00112658|Leucovorin|leucovorin|mesh-list
92600489|NCT00112658|Gemcitabine|gemcitabine|mesh-list
92600490|NCT00112658|Fluorouracil|fluorouracil|mesh-list
92600491|NCT00112658|Oxaliplatin|oxaliplatin|mesh-list
92600492|NCT00112658|Irinotecan|irinotecan|mesh-list
92600493|NCT00112658|Calcium|calcium|mesh-list
92600494|NCT00112658|Levoleucovorin|levoleucovorin|mesh-list
92600495|NCT00112658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600496|NCT00112658|Antimetabolites|antimetabolites|mesh-ancestor
92600497|NCT00112658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600498|NCT00112658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600499|NCT00112658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600500|NCT00112658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600501|NCT00112658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600502|NCT00112658|Immunologic Factors|immunologic factors|mesh-ancestor
92600503|NCT00112658|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92600504|NCT00112658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600505|NCT00112658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600506|NCT00112658|Antidotes|antidotes|mesh-ancestor
92600507|NCT00112658|Protective Agents|protective agents|mesh-ancestor
92600508|NCT00112658|Vitamin B Complex|vitamin b complex|mesh-ancestor
92600509|NCT00112658|Vitamins|vitamins|mesh-ancestor
92600510|NCT00112658|Micronutrients|micronutrients|mesh-ancestor
92600511|NCT00352339|Aripiprazole|aripiprazole|mesh-list
92600512|NCT00352339|Antidepressive Agents|antidepressive agents|mesh-ancestor
92600513|NCT00352339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600514|NCT00352339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92600515|NCT00352339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600516|NCT00352339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600517|NCT00352339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600518|NCT00352339|Dopamine Agonists|dopamine agonists|mesh-ancestor
92600532|NCT00352378|Capecitabine|capecitabine|mesh-list
92600533|NCT00352378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600534|NCT00352378|Immunologic Factors|immunologic factors|mesh-ancestor
92600535|NCT00352378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600536|NCT00352378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600537|NCT00352378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92600538|NCT00352378|Alkylating Agents|alkylating agents|mesh-ancestor
92600539|NCT00352378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600540|NCT00352378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600541|NCT00352378|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92600542|NCT00352378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600543|NCT00352378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600544|NCT00352378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600545|NCT00352378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92600546|NCT00352378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92600547|NCT00352378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600548|NCT00352378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600549|NCT00352378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600550|NCT00352378|Antimetabolites|antimetabolites|mesh-ancestor
92600551|NCT00352495|Carboplatin|carboplatin|mesh-list
92600552|NCT00352495|Vinblastine|vinblastine|mesh-list
92600553|NCT00352495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600554|NCT00352495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92600555|NCT00352495|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600556|NCT00352495|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600557|NCT00352495|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600558|NCT00352495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600559|NCT00112697|Docetaxel|docetaxel|mesh-list
92536814|NCT00136786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536815|NCT00136786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92536816|NCT00136786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91950845|NCT03484091|Hylan|hylan|mesh-list
92600560|NCT00112697|Fluorouracil|fluorouracil|mesh-list
92600561|NCT00112697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600562|NCT00112697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600563|NCT00112697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600564|NCT00112697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600565|NCT00112697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600566|NCT00112697|Antimetabolites|antimetabolites|mesh-ancestor
92600567|NCT00112697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600568|NCT00112697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600569|NCT00112697|Immunologic Factors|immunologic factors|mesh-ancestor
92600570|NCT00112697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600571|NCT02959606|Sarpogrelate|sarpogrelate|mesh-list
92600572|NCT02959606|Clopidogrel|clopidogrel|mesh-list
92600573|NCT02959606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92600574|NCT02959606|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92600575|NCT02959606|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92600576|NCT02959606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92600577|NCT02959606|Purinergic Agents|purinergic agents|mesh-ancestor
92600578|NCT02959606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600579|NCT02959606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600587|NCT00352651|Sensory System Agents|sensory system agents|mesh-ancestor
92600588|NCT00352651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600589|NCT00352651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600590|NCT00352651|Anticonvulsants|anticonvulsants|mesh-ancestor
92600591|NCT00352651|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92600592|NCT00352651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600593|NCT00352651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600594|NCT00352651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600595|NCT00352651|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92600596|NCT00352651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600597|NCT00352651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600598|NCT00352651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600599|NCT00112775|Imatinib Mesylate|imatinib mesylate|mesh-list
92600600|NCT00112775|Dasatinib|dasatinib|mesh-list
92600601|NCT00112775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600602|NCT00112775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92600603|NCT00112775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600604|NCT00112775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600605|NCT00352768|Fluvoxamine|fluvoxamine|mesh-list
92600606|NCT00352768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600607|NCT00352768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600608|NCT00352768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92600609|NCT00352768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600610|NCT00352768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600611|NCT00352768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600612|NCT00352768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600613|NCT00352768|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92600614|NCT00352768|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600615|NCT00352768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600616|NCT00352768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600617|NCT00352768|Serotonin Agents|serotonin agents|mesh-ancestor
92600618|NCT00352768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92600619|NCT00352768|Antidepressive Agents|antidepressive agents|mesh-ancestor
92600620|NCT00352768|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92600621|NCT00352768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92600622|NCT00352768|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92600623|NCT00352807|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92600624|NCT00352807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92600625|NCT00352807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92600626|NCT00352807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92600627|NCT00352807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92600628|NCT00352807|Adrenergic Agents|adrenergic agents|mesh-ancestor
92600629|NCT00352807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536817|NCT00136825|Acetylcysteine|acetylcysteine|mesh-list
92536818|NCT00136825|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92536819|NCT00136825|Antiviral Agents|antiviral agents|mesh-ancestor
92536820|NCT00136825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950953|NCT05152667|Hormones|hormones|mesh-ancestor
92600630|NCT00352807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600631|NCT00352807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600632|NCT00112853|Etoposide|etoposide|mesh-list
92325542|NCT00000229|Buprenorphine|buprenorphine|mesh-list
92600633|NCT00112853|Etoposide phosphate|etoposide phosphate|mesh-list
92600634|NCT00112853|Tipifarnib|tipifarnib|mesh-list
92600635|NCT00112853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92600636|NCT00112853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600637|NCT00112853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92600638|NCT00112853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600639|NCT00112853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600640|NCT00112853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600641|NCT00353002|Lidocaine|lidocaine|mesh-list
92600642|NCT00353002|Tetracaine|tetracaine|mesh-list
92600643|NCT00353002|Anesthetics, Local|anesthetics, local|mesh-ancestor
92600644|NCT00353002|Anesthetics|anesthetics|mesh-ancestor
92600645|NCT00353002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600650|NCT00353002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92600651|NCT00353002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92600652|NCT00353002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600653|NCT00353002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600654|NCT00353041|Lidocaine|lidocaine|mesh-list
92600655|NCT00353041|Anesthetics, Local|anesthetics, local|mesh-ancestor
92600656|NCT00353041|Anesthetics|anesthetics|mesh-ancestor
92600657|NCT00353041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600658|NCT00353041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600659|NCT00353041|Sensory System Agents|sensory system agents|mesh-ancestor
92600660|NCT00353041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600661|NCT00353041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92600662|NCT00353041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92600663|NCT00353041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92600664|NCT00353041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600665|NCT00353041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600666|NCT00353080|Risedronic Acid|risedronic acid|mesh-list
92600667|NCT00353080|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92600668|NCT00353080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600669|NCT00353080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600670|NCT00353080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600671|NCT00353080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600672|NCT00353080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92600673|NCT00112892|Selenium|selenium|mesh-list
92600674|NCT00112892|Irinotecan|irinotecan|mesh-list
92600675|NCT00112892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92600676|NCT00112892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92600677|NCT00112892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600678|NCT00112892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600679|NCT00112892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600680|NCT00112892|Antioxidants|antioxidants|mesh-ancestor
92600681|NCT00112892|Protective Agents|protective agents|mesh-ancestor
92600682|NCT00112892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600683|NCT00112892|Trace Elements|trace elements|mesh-ancestor
92600684|NCT00112892|Micronutrients|micronutrients|mesh-ancestor
92600685|NCT00353665|Riluzole|riluzole|mesh-list
92600686|NCT00353665|Memantine|memantine|mesh-list
92600687|NCT00353665|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92600688|NCT00353665|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92600689|NCT00353665|Dopamine Agents|dopamine agents|mesh-ancestor
92600690|NCT00353665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600691|NCT00353665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600692|NCT00353665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600693|NCT00353665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92600694|NCT00353665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92600695|NCT00353665|Anticonvulsants|anticonvulsants|mesh-ancestor
92600696|NCT00353665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92600697|NCT00353665|Protective Agents|protective agents|mesh-ancestor
92536822|NCT00136825|Respiratory System Agents|respiratory system agents|mesh-ancestor
92536823|NCT00136825|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92536824|NCT00136825|Antioxidants|antioxidants|mesh-ancestor
92536825|NCT00136825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600698|NCT05594784|Prednisone|prednisone|mesh-list
92600699|NCT05594784|Vincristine|vincristine|mesh-list
92600700|NCT05594784|Venetoclax|venetoclax|mesh-list
92600701|NCT05594784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600702|NCT05594784|Glucocorticoids|glucocorticoids|mesh-ancestor
92600703|NCT05594784|Hormones|hormones|mesh-ancestor
92600704|NCT05594784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92600705|NCT05594784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325620|NCT00000271|Desipramine|desipramine|mesh-list
92600706|NCT05594784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92600707|NCT05594784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600708|NCT05594784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92600709|NCT05594784|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600710|NCT05594784|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600711|NCT05594784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600712|NCT05594784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008159|NCT04903093|Famotidine|famotidine|mesh-list
92600716|NCT00353743|Metronidazole|metronidazole|mesh-list
92600717|NCT00353743|Doxycycline|doxycycline|mesh-list
92600718|NCT00353743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600719|NCT00353743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92600720|NCT00353743|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92600721|NCT00353743|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92600722|NCT00353743|Antimalarials|antimalarials|mesh-ancestor
92600723|NCT00113165|Lamotrigine|lamotrigine|mesh-list
92600724|NCT00113165|Anticonvulsants|anticonvulsants|mesh-ancestor
92600725|NCT00113165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92600726|NCT00113165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600727|NCT00113165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600728|NCT00113165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600729|NCT00113165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600730|NCT00113165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92600731|NCT00113165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600732|NCT00113165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600733|NCT00113165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600734|NCT00113165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92600735|NCT00354094|Reboxetine|reboxetine|mesh-list
92600736|NCT00354094|Antidepressive Agents|antidepressive agents|mesh-ancestor
92600737|NCT00354094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600738|NCT00354094|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92600739|NCT00354094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600740|NCT00354094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600741|NCT00354094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600742|NCT00354094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92600743|NCT00354094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600744|NCT00354094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600745|NCT00114816|Docetaxel|docetaxel|mesh-list
92600746|NCT00114816|Capecitabine|capecitabine|mesh-list
92600747|NCT00114816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600748|NCT00114816|Tubulin Modulators|tubulin modulators|mesh-ancestor
92600749|NCT00114816|Antimitotic Agents|antimitotic agents|mesh-ancestor
92600750|NCT00114816|Mitosis Modulators|mitosis modulators|mesh-ancestor
92600751|NCT00114816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600752|NCT00114816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600753|NCT00114816|Antimetabolites|antimetabolites|mesh-ancestor
92600754|NCT00354367|Certolizumab Pegol|certolizumab pegol|mesh-list
92600755|NCT00354367|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92600756|NCT00354367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600757|NCT00354367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600758|NCT00354367|Immunologic Factors|immunologic factors|mesh-ancestor
92600759|NCT00354367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600760|NCT00354367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600761|NCT00354406|Abciximab|abciximab|mesh-list
92600762|NCT00354406|Anticoagulants|anticoagulants|mesh-ancestor
92600763|NCT00354406|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92600764|NCT00354523|Capecitabine|capecitabine|mesh-list
92536827|NCT00136825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536828|NCT00136825|Antidotes|antidotes|mesh-ancestor
92536829|NCT00393198|Misoprostol|misoprostol|mesh-list
92600765|NCT00354523|Imatinib Mesylate|imatinib mesylate|mesh-list
92600766|NCT00354523|Dacarbazine|dacarbazine|mesh-list
92600767|NCT00354523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92600768|NCT00354523|Antimetabolites|antimetabolites|mesh-ancestor
92600769|NCT00354523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600770|NCT00354523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600771|NCT00354523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92600772|NCT00354523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600773|NCT00354523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92600774|NCT00354523|Alkylating Agents|alkylating agents|mesh-ancestor
92600775|NCT00114933|Ritonavir|ritonavir|mesh-list
92600776|NCT00114933|Lopinavir|lopinavir|mesh-list
92600777|NCT00114933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92600778|NCT00114933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92600779|NCT00114933|Protease Inhibitors|protease inhibitors|mesh-ancestor
92600780|NCT00114933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600781|NCT00114933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600782|NCT00114933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92600783|NCT00114933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92600784|NCT00114933|Antiviral Agents|antiviral agents|mesh-ancestor
92600785|NCT00114933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600786|NCT00114933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92600788|NCT00113282|Interleukin-2|interleukin-2|mesh-list
92600789|NCT00113282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600790|NCT00113282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600791|NCT00113282|Analgesics|analgesics|mesh-ancestor
92600792|NCT00113282|Sensory System Agents|sensory system agents|mesh-ancestor
92600793|NCT00113282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600794|NCT00113282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600795|NCT00425932|Rituximab|rituximab|mesh-list
92600796|NCT00425932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92600797|NCT00425932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600798|NCT00425932|Immunologic Factors|immunologic factors|mesh-ancestor
92600799|NCT00425932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600800|NCT00425932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600801|NCT00426010|Caffeine|caffeine|mesh-list
92600802|NCT00426010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92600803|NCT00426010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600804|NCT00426010|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92600805|NCT00426010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600806|NCT00426010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600807|NCT00426010|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92600808|NCT00426010|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92600809|NCT00426010|Purinergic Agents|purinergic agents|mesh-ancestor
92600810|NCT00426010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600811|NCT00115011|Escitalopram|escitalopram|mesh-list
92600812|NCT00115011|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92600813|NCT00115011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600814|NCT00115011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600815|NCT00115011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600816|NCT00115011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600817|NCT00115011|Serotonin Agents|serotonin agents|mesh-ancestor
92600818|NCT00115011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600819|NCT00113594|Olanzapine|olanzapine|mesh-list
92600820|NCT00113594|Antiemetics|antiemetics|mesh-ancestor
92600821|NCT00113594|Autonomic Agents|autonomic agents|mesh-ancestor
92600822|NCT00113594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600823|NCT00113594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600824|NCT00113594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600825|NCT00113594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92600826|NCT00113594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600827|NCT00113594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600828|NCT00113594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600829|NCT00113594|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92600830|NCT00113594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600831|NCT00113594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92536830|NCT00393198|Levonorgestrel|levonorgestrel|mesh-list
92536831|NCT00393198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92536832|NCT00393198|Contraceptive Agents|contraceptive agents|mesh-ancestor
92536833|NCT00393198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91951230|NCT02824679|Scopolamine|scopolamine|mesh-list
92600832|NCT00113594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600833|NCT00113594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600834|NCT00113594|Serotonin Agents|serotonin agents|mesh-ancestor
92600835|NCT00426049|Everolimus|everolimus|mesh-list
92600836|NCT00426049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92600837|NCT00426049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92600838|NCT00426049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600839|NCT00426049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600840|NCT00426049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600841|NCT00426049|Immunologic Factors|immunologic factors|mesh-ancestor
92600842|NCT00426049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600843|NCT00426049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600844|NCT05594433|Lenograstim|lenograstim|mesh-list
92600845|NCT05594433|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92600846|NCT05594433|Immunologic Factors|immunologic factors|mesh-ancestor
92600847|NCT05594433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600848|NCT00115089|Beclomethasone|beclomethasone|mesh-list
92600849|NCT00115089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600850|NCT00115089|Glucocorticoids|glucocorticoids|mesh-ancestor
92600851|NCT00115089|Hormones|hormones|mesh-ancestor
92600852|NCT00115089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92600853|NCT00115089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600855|NCT00115089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92600856|NCT00115128|Lenograstim|lenograstim|mesh-list
92600857|NCT00115128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92600858|NCT00115128|Immunologic Factors|immunologic factors|mesh-ancestor
92600859|NCT00115128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600863|NCT00115245|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92600864|NCT00115245|Telbivudine|telbivudine|mesh-list
92600865|NCT00115245|Antiviral Agents|antiviral agents|mesh-ancestor
92600866|NCT00115245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600867|NCT00115245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92600868|NCT00115245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92600869|NCT00115245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600870|NCT00115245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600871|NCT01059526|Ecallantide|ecallantide|mesh-list
92600872|NCT01059526|Analgesics|analgesics|mesh-ancestor
92600873|NCT01059526|Sensory System Agents|sensory system agents|mesh-ancestor
92600874|NCT01059526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600875|NCT01059526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600876|NCT01059526|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92600877|NCT01059526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600878|NCT01059526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600879|NCT01059526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600880|NCT00444340|Etanercept|etanercept|mesh-list
92600881|NCT00444340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92600882|NCT00444340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92600883|NCT00444340|Analgesics|analgesics|mesh-ancestor
92600884|NCT00444340|Sensory System Agents|sensory system agents|mesh-ancestor
92600885|NCT00444340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600886|NCT00444340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600887|NCT00444340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92600888|NCT00444340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600889|NCT00444340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600890|NCT00444340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600891|NCT00444340|Immunologic Factors|immunologic factors|mesh-ancestor
92600892|NCT00444379|Ritonavir|ritonavir|mesh-list
92600893|NCT00444379|Lopinavir|lopinavir|mesh-list
92600894|NCT00444379|Tenofovir|tenofovir|mesh-list
92600895|NCT00444379|Emtricitabine|emtricitabine|mesh-list
92600896|NCT00444379|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92600897|NCT00444379|Efavirenz|efavirenz|mesh-list
92600898|NCT00444379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92600899|NCT00444379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92600900|NCT00444379|Protease Inhibitors|protease inhibitors|mesh-ancestor
92600901|NCT00444379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536834|NCT00393198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536835|NCT00393198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92536836|NCT00393198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92536837|NCT00393198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92536838|NCT00393198|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92600902|NCT00444379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600903|NCT00444379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92600904|NCT00444379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92600905|NCT00444379|Antiviral Agents|antiviral agents|mesh-ancestor
92600906|NCT00444379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600907|NCT00444379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92600908|NCT00444379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92600909|NCT00444379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92600910|NCT00444379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92600911|NCT00444379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92600912|NCT00444379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92600913|NCT00444379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92600914|NCT00444379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92600915|NCT00444379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92600916|NCT00444418|Naltrexone|naltrexone|mesh-list
92600917|NCT00444418|Naloxone|naloxone|mesh-list
92600918|NCT00444418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92600919|NCT00444418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92600920|NCT00444418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600921|NCT00444418|Sensory System Agents|sensory system agents|mesh-ancestor
92600922|NCT00444418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600923|NCT00444574|Methylphenidate|methylphenidate|mesh-list
92600924|NCT00444574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92600925|NCT00444574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600926|NCT00444574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92600927|NCT00444574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600928|NCT00444574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600929|NCT00444574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600931|NCT00444574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600932|NCT00444652|Enoxaparin|enoxaparin|mesh-list
92600937|NCT04699903|Antibodies|antibodies|mesh-list
92600938|NCT04699903|Immunoglobulin G|immunoglobulin g|mesh-list
92600939|NCT04699903|Immunologic Factors|immunologic factors|mesh-ancestor
92600940|NCT04699903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600941|NCT00444808|Calcitonin|calcitonin|mesh-list
92600942|NCT00444808|Salmon calcitonin|salmon calcitonin|mesh-list
92600943|NCT00444808|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92600944|NCT00444808|Katacalcin|katacalcin|mesh-list
92600945|NCT00444808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92600946|NCT00444808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600947|NCT00444808|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92600948|NCT00444808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92600949|NCT00113828|Cyclosporine|cyclosporine|mesh-list
92600950|NCT00113828|Cyclosporins|cyclosporins|mesh-list
92600951|NCT00113828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600952|NCT00113828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600953|NCT00113828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92600954|NCT00113828|Immunologic Factors|immunologic factors|mesh-ancestor
92600955|NCT00113828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600956|NCT00113828|Antifungal Agents|antifungal agents|mesh-ancestor
92600957|NCT00113828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92600958|NCT00113828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92600959|NCT00113828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92600960|NCT00113828|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92600961|NCT00444886|Botulinum Toxins|botulinum toxins|mesh-list
92600962|NCT00444886|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92600963|NCT00444886|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92600964|NCT00444886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92600965|NCT00444886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600966|NCT00444886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600967|NCT00444886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92600968|NCT00444886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536839|NCT00393198|Abortifacient Agents|abortifacient agents|mesh-ancestor
92536840|NCT00393198|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92536841|NCT00393198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92536842|NCT00393198|Oxytocics|oxytocics|mesh-ancestor
92600969|NCT00444886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600970|NCT00444886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92600971|NCT00444886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600972|NCT05594121|Buprenorphine|buprenorphine|mesh-list
92600973|NCT05594121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92600974|NCT05594121|Narcotics|narcotics|mesh-ancestor
92600975|NCT05594121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600976|NCT05594121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600977|NCT05594121|Analgesics|analgesics|mesh-ancestor
92600978|NCT05594121|Sensory System Agents|sensory system agents|mesh-ancestor
92600979|NCT05594121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600980|NCT05594121|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92600981|NCT00115362|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92600982|NCT00115362|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92600983|NCT00115362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600984|NCT00115362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600985|NCT00115362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600986|NCT00115362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600987|NCT00115362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600988|NCT00115362|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92600989|NCT00115362|Antidepressive Agents|antidepressive agents|mesh-ancestor
92600990|NCT00115362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600991|NCT00445042|Sorafenib|sorafenib|mesh-list
92600992|NCT00445042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600993|NCT00445042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92600994|NCT00445042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600995|NCT00445042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600996|NCT00445081|Cyclosporine|cyclosporine|mesh-list
92600997|NCT00445081|Prednisolone|prednisolone|mesh-list
92600998|NCT00445081|Cyclosporins|cyclosporins|mesh-list
92600999|NCT00445081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601000|NCT00445081|Glucocorticoids|glucocorticoids|mesh-ancestor
92601001|NCT00445081|Hormones|hormones|mesh-ancestor
92601002|NCT00445081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601006|NCT00445081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601007|NCT00445081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601008|NCT00445081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601009|NCT00445081|Immunologic Factors|immunologic factors|mesh-ancestor
92601010|NCT00445081|Antifungal Agents|antifungal agents|mesh-ancestor
92601011|NCT00445081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601012|NCT00445081|Dermatologic Agents|dermatologic agents|mesh-ancestor
92601013|NCT00445081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601014|NCT00445081|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92601016|NCT00113906|Antioxidants|antioxidants|mesh-ancestor
92601017|NCT00113906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601018|NCT00113906|Protective Agents|protective agents|mesh-ancestor
92601019|NCT00113906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601020|NCT00113906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601022|NCT00113945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92601023|NCT00113945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601024|NCT00113945|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92601025|NCT00113945|Hormone Antagonists|hormone antagonists|mesh-ancestor
92601026|NCT00113945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601027|NCT00445159|Treprostinil|treprostinil|mesh-list
92601028|NCT00445159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601029|NCT00445276|Diacerein|diacerein|mesh-list
92601030|NCT00445276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601031|NCT00113984|Metronidazole|metronidazole|mesh-list
92601032|NCT00113984|Ipilimumab|ipilimumab|mesh-list
92601033|NCT00113984|Sargramostim|sargramostim|mesh-list
92601034|NCT00113984|Immunologic Factors|immunologic factors|mesh-ancestor
92601035|NCT00113984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601036|NCT00113984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601037|NCT00113984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601038|NCT00113984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92536843|NCT03968822|Lidocaine|lidocaine|mesh-list
92536844|NCT03968822|Bupivacaine|bupivacaine|mesh-list
92536845|NCT03968822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92601039|NCT00113984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601040|NCT00113984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601041|NCT00113984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92601042|NCT00113984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92601043|NCT00113984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92601044|NCT00445510|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
92601045|NCT00445510|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92601046|NCT00445510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92601047|NCT00445510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601048|NCT00445510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601049|NCT00114023|Imiquimod|imiquimod|mesh-list
92601050|NCT00114023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92601051|NCT00114023|Immunologic Factors|immunologic factors|mesh-ancestor
92601052|NCT00114023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601053|NCT00114023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601054|NCT00114023|Interferon Inducers|interferon inducers|mesh-ancestor
92601055|NCT00445861|Docetaxel|docetaxel|mesh-list
92601056|NCT00445861|Cetuximab|cetuximab|mesh-list
92601057|NCT00445861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601058|NCT00445861|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601059|NCT00445861|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601060|NCT00445861|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601061|NCT00445861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601062|NCT00445861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601063|NCT00445900|Thalidomide|thalidomide|mesh-list
92601064|NCT00445900|Prednisone|prednisone|mesh-list
92601065|NCT00445900|Cyclophosphamide|cyclophosphamide|mesh-list
92601066|NCT00445900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601067|NCT00445900|Immunologic Factors|immunologic factors|mesh-ancestor
92601068|NCT00445900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601069|NCT00445900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601070|NCT00445900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92601071|NCT00445900|Alkylating Agents|alkylating agents|mesh-ancestor
92601072|NCT00445900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601076|NCT00445900|Glucocorticoids|glucocorticoids|mesh-ancestor
92601078|NCT00445900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601079|NCT00445900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601080|NCT00445900|Leprostatic Agents|leprostatic agents|mesh-ancestor
92601081|NCT00445900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92601082|NCT00445900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601083|NCT00445900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92601084|NCT00445900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92601085|NCT00445900|Growth Substances|growth substances|mesh-ancestor
92601086|NCT00445900|Growth Inhibitors|growth inhibitors|mesh-ancestor
92601087|NCT00115479|Insulin|insulin|mesh-list
92601088|NCT00115479|Benzocaine|benzocaine|mesh-list
92601089|NCT00115479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601090|NCT00115479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601091|NCT00115479|Anesthetics, Local|anesthetics, local|mesh-ancestor
92601092|NCT00115479|Anesthetics|anesthetics|mesh-ancestor
92601093|NCT00115479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601094|NCT00115479|Sensory System Agents|sensory system agents|mesh-ancestor
92601095|NCT00115479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601096|NCT00446017|Milrinone|milrinone|mesh-list
92601097|NCT00446017|Epinephrine|epinephrine|mesh-list
92601098|NCT00446017|Racepinephrine|racepinephrine|mesh-list
92601099|NCT00446017|Epinephryl borate|epinephryl borate|mesh-list
92601100|NCT00446017|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92601101|NCT00446017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92601102|NCT00446017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92601103|NCT00446017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601104|NCT00446017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601105|NCT00446017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601106|NCT00446017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92601107|NCT00446017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92601108|NCT00446017|Autonomic Agents|autonomic agents|mesh-ancestor
92601109|NCT00446017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601110|NCT00446017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92536846|NCT03968822|Anesthetics, Local|anesthetics, local|mesh-ancestor
92536847|NCT03968822|Anesthetics|anesthetics|mesh-ancestor
92536848|NCT03968822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92536849|NCT03968822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536850|NCT03968822|Sensory System Agents|sensory system agents|mesh-ancestor
92536851|NCT03968822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601111|NCT00446017|Respiratory System Agents|respiratory system agents|mesh-ancestor
92601112|NCT00446017|Mydriatics|mydriatics|mesh-ancestor
92601113|NCT00446017|Sympathomimetics|sympathomimetics|mesh-ancestor
92601114|NCT00446017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92601115|NCT00446017|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92601116|NCT00446017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92601117|NCT00446017|Vasodilator Agents|vasodilator agents|mesh-ancestor
92601118|NCT00446017|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92601119|NCT00446017|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92601120|NCT00446017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601121|NCT00446017|Protective Agents|protective agents|mesh-ancestor
92601122|NCT00446173|Cyclophosphamide|cyclophosphamide|mesh-list
92601123|NCT00446173|Busulfan|busulfan|mesh-list
92601124|NCT00446173|Sargramostim|sargramostim|mesh-list
92601125|NCT00446173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601126|NCT00446173|Immunologic Factors|immunologic factors|mesh-ancestor
92601127|NCT00446173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601128|NCT00446173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601129|NCT00446173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92601130|NCT00446173|Alkylating Agents|alkylating agents|mesh-ancestor
92601131|NCT00446173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601132|NCT00446173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601133|NCT00446173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92601134|NCT00446212|Propofol|propofol|mesh-list
92601135|NCT00446212|Desflurane|desflurane|mesh-list
92601136|NCT00446212|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92601137|NCT00446212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601138|NCT00446212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601139|NCT00446212|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92601140|NCT00446212|Anesthetics, General|anesthetics, general|mesh-ancestor
92601141|NCT00446212|Anesthetics|anesthetics|mesh-ancestor
92601142|NCT00446212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92601143|NCT00446329|Cinacalcet|cinacalcet|mesh-list
92601144|NCT00446329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92601145|NCT00446329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601146|NCT00446329|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92601149|NCT00446368|Everolimus|everolimus|mesh-list
92601150|NCT00446368|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92601151|NCT00446368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601152|NCT00446368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601153|NCT00446368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601154|NCT00446368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601155|NCT00446368|Immunologic Factors|immunologic factors|mesh-ancestor
92601156|NCT00446368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601157|NCT00446368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601158|NCT00401765|Docetaxel|docetaxel|mesh-list
92601159|NCT00401765|Siltuximab|siltuximab|mesh-list
92601160|NCT00401765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601161|NCT00401765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601162|NCT00401765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601163|NCT00401765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601164|NCT00401765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601165|NCT00115518|Cetuximab|cetuximab|mesh-list
92601166|NCT00115518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601167|NCT00115518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601168|NCT00446524|Amlodipine|amlodipine|mesh-list
92601169|NCT00446524|Valsartan|valsartan|mesh-list
92601170|NCT00446524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601171|NCT00446524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92601172|NCT00446524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92601173|NCT00446524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601174|NCT00446524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92601175|NCT00446524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536852|NCT03968822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92536853|NCT03968822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92536854|NCT03968822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92601176|NCT00446524|Vasodilator Agents|vasodilator agents|mesh-ancestor
92601177|NCT00446524|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92601178|NCT00446524|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92601179|NCT00446602|Epoetin Alfa|epoetin alfa|mesh-list
92601180|NCT00446602|Hematinics|hematinics|mesh-ancestor
92601181|NCT05589753|Acetazolamide|acetazolamide|mesh-list
92601182|NCT05589753|Anticonvulsants|anticonvulsants|mesh-ancestor
92601183|NCT05589753|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92601184|NCT05589753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601185|NCT05589753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601186|NCT05589753|Diuretics|diuretics|mesh-ancestor
92601187|NCT05589753|Natriuretic Agents|natriuretic agents|mesh-ancestor
92601188|NCT05589753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601189|NCT00114179|Bevacizumab|bevacizumab|mesh-list
92601190|NCT00114179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92601191|NCT00114179|Gemcitabine|gemcitabine|mesh-list
92601192|NCT00114179|Capecitabine|capecitabine|mesh-list
92601193|NCT00114179|Antibodies|antibodies|mesh-list
92601194|NCT00114179|Immunoglobulins|immunoglobulins|mesh-list
92601195|NCT00114179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92601196|NCT00114179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601197|NCT00114179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92601198|NCT00114179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92601199|NCT00114179|Growth Substances|growth substances|mesh-ancestor
92601200|NCT00114179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601201|NCT00114179|Growth Inhibitors|growth inhibitors|mesh-ancestor
92601202|NCT00114179|Immunologic Factors|immunologic factors|mesh-ancestor
92601203|NCT00114179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601204|NCT00114179|Antimetabolites|antimetabolites|mesh-ancestor
92601205|NCT00114179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601206|NCT00446680|Mannitol|mannitol|mesh-list
92601207|NCT00446680|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92601208|NCT00446680|Diuretics|diuretics|mesh-ancestor
92601209|NCT00446680|Natriuretic Agents|natriuretic agents|mesh-ancestor
92601210|NCT00446680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601211|NCT00114257|Decitabine|decitabine|mesh-list
92601212|NCT00114257|Romidepsin|romidepsin|mesh-list
92601213|NCT00114257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601214|NCT00114257|Antimetabolites|antimetabolites|mesh-ancestor
92601215|NCT00114257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601216|NCT00114257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601217|NCT00114257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601218|NCT00114257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92601219|NCT00114257|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92601222|NCT00404937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601223|NCT00404937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601224|NCT00404937|Glucocorticoids|glucocorticoids|mesh-ancestor
91978923|NCT02105974|Xhance|xhance|mesh-list
92601225|NCT00404937|Hormones|hormones|mesh-ancestor
92360743|NCT00538824|Immunologic Factors|immunologic factors|mesh-ancestor
92601226|NCT00404937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601227|NCT00404937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601228|NCT00404937|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92601229|NCT00404937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92601230|NCT00446836|Paclitaxel|paclitaxel|mesh-list
92601231|NCT00446836|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92601232|NCT00446836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92601233|NCT00446836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601234|NCT00446836|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601235|NCT00446836|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601236|NCT00446836|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601237|NCT00446836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601238|NCT00114374|Escitalopram|escitalopram|mesh-list
92601239|NCT00114374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92601240|NCT00114374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92601241|NCT00114374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92601242|NCT00114374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601243|NCT00114374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601244|NCT00114374|Serotonin Agents|serotonin agents|mesh-ancestor
92601245|NCT00114374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536855|NCT03968822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92536856|NCT03968822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536857|NCT00136942|Atorvastatin|atorvastatin|mesh-list
92536858|NCT00136942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91951836|NCT04754035|Venetoclax|venetoclax|mesh-list
92601246|NCT00446953|Betamethasone|betamethasone|mesh-list
92601247|NCT00446953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601248|NCT00446953|Glucocorticoids|glucocorticoids|mesh-ancestor
92601249|NCT00446953|Hormones|hormones|mesh-ancestor
92601250|NCT00446953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601251|NCT00446953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601252|NCT00446953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92601253|NCT00446953|Respiratory System Agents|respiratory system agents|mesh-ancestor
92601254|NCT00447031|Triamcinolone|triamcinolone|mesh-list
92601255|NCT00447031|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92601256|NCT00447031|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92601257|NCT00447031|Bevacizumab|bevacizumab|mesh-list
92601258|NCT00447031|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92601259|NCT00447031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601260|NCT00447031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601261|NCT00447031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92601262|NCT00447031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92601263|NCT00447031|Growth Substances|growth substances|mesh-ancestor
92601264|NCT00447031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601265|NCT00447031|Growth Inhibitors|growth inhibitors|mesh-ancestor
92601266|NCT00447031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601267|NCT00447031|Glucocorticoids|glucocorticoids|mesh-ancestor
92601268|NCT00447031|Hormones|hormones|mesh-ancestor
92601269|NCT00447031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601270|NCT00447031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601271|NCT00447031|Immunologic Factors|immunologic factors|mesh-ancestor
92601272|NCT00447031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601273|NCT00447031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601274|NCT00447070|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92601275|NCT00447070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92601276|NCT00447070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92601277|NCT00447070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92601278|NCT00447070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601279|NCT00447070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601280|NCT00447070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92601281|NCT00447070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92601282|NCT00447070|Antiviral Agents|antiviral agents|mesh-ancestor
92601283|NCT00447070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601284|NCT00115635|Gemcitabine|gemcitabine|mesh-list
92601285|NCT00115635|Docetaxel|docetaxel|mesh-list
92601286|NCT00115635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601287|NCT00115635|Antimetabolites|antimetabolites|mesh-ancestor
92601288|NCT00115635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601289|NCT00115635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601290|NCT00115635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601295|NCT00447304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601296|NCT00447304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92601297|NCT00447304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326220|NCT03321799|Anti-Infective Agents|anti-infective agents|mesh-list
92601298|NCT00447304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601299|NCT00447304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601300|NCT00447304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601301|NCT00447577|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92601304|NCT00447577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601305|NCT00447577|Antiemetics|antiemetics|mesh-ancestor
92601306|NCT00447577|Autonomic Agents|autonomic agents|mesh-ancestor
92601307|NCT00447577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601308|NCT00447577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601309|NCT00447577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601310|NCT00447577|Glucocorticoids|glucocorticoids|mesh-ancestor
92601311|NCT00447577|Hormones|hormones|mesh-ancestor
92601312|NCT00447577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601313|NCT00447577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601314|NCT00447577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536859|NCT00136942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92536860|NCT00136942|Antimetabolites|antimetabolites|mesh-ancestor
91944599|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92601315|NCT00447577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92601316|NCT00447577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601317|NCT00447577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92601318|NCT00114491|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92601319|NCT00114491|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92601320|NCT00114491|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92601321|NCT00114491|Antimetabolites|antimetabolites|mesh-ancestor
92601322|NCT00114491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601323|NCT00114491|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92601324|NCT00114491|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92601325|NCT00114491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601326|NCT00114569|Lorazepam|lorazepam|mesh-list
92601327|NCT00114569|Anticonvulsants|anticonvulsants|mesh-ancestor
92601328|NCT00114569|Antiemetics|antiemetics|mesh-ancestor
92601329|NCT00114569|Autonomic Agents|autonomic agents|mesh-ancestor
92601330|NCT00114569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601331|NCT00114569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601332|NCT00114569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601333|NCT00114569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92601334|NCT00114569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601335|NCT00114569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92601336|NCT00114569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92601337|NCT00114569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92601338|NCT00114569|GABA Modulators|gaba modulators|mesh-ancestor
92601339|NCT00114569|GABA Agents|gaba agents|mesh-ancestor
92601340|NCT00114569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601341|NCT00114569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601342|NCT00447928|Nitroglycerin|nitroglycerin|mesh-list
92601343|NCT00447928|Vasodilator Agents|vasodilator agents|mesh-ancestor
92601344|NCT00447967|Leucovorin|leucovorin|mesh-list
92601345|NCT00447967|Fluorouracil|fluorouracil|mesh-list
92601346|NCT00447967|Oxaliplatin|oxaliplatin|mesh-list
92601347|NCT00447967|Irinotecan|irinotecan|mesh-list
92601348|NCT00447967|Antimetabolites|antimetabolites|mesh-ancestor
92601349|NCT00447967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601350|NCT00447967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601351|NCT00447967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601352|NCT00447967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601353|NCT00447967|Immunologic Factors|immunologic factors|mesh-ancestor
92601354|NCT00447967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601355|NCT00447967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92601356|NCT00447967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92601357|NCT00447967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601358|NCT00447967|Antidotes|antidotes|mesh-ancestor
92601359|NCT00447967|Protective Agents|protective agents|mesh-ancestor
92601360|NCT00447967|Vitamin B Complex|vitamin b complex|mesh-ancestor
92601361|NCT00447967|Vitamins|vitamins|mesh-ancestor
92601362|NCT00447967|Micronutrients|micronutrients|mesh-ancestor
92601363|NCT00401856|Eplerenone|eplerenone|mesh-list
92601366|NCT00401856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601367|NCT00401856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601368|NCT00401856|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92601369|NCT00401856|Diuretics|diuretics|mesh-ancestor
92601370|NCT00401856|Natriuretic Agents|natriuretic agents|mesh-ancestor
92601371|NCT00401856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601372|NCT00448240|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92601373|NCT00448240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601374|NCT00448240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601375|NCT00448240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601376|NCT00448240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601377|NCT00448396|Epothilone B|epothilone b|mesh-list
92601378|NCT00448396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601379|NCT00448396|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601380|NCT00448396|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601381|NCT00448396|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601382|NCT00448396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601383|NCT00114686|Valproic Acid|valproic acid|mesh-list
92601384|NCT00114686|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92601385|NCT00114686|Antidepressive Agents|antidepressive agents|mesh-ancestor
92601386|NCT00114686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92601387|NCT00114686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92536861|NCT00136942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536862|NCT00136942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92536863|NCT00136942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92536864|NCT00136942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601388|NCT00114686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92601389|NCT00114686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601390|NCT00114686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601391|NCT00114686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601392|NCT00114686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601393|NCT00114686|Antimanic Agents|antimanic agents|mesh-ancestor
92601394|NCT00114686|Anticonvulsants|anticonvulsants|mesh-ancestor
92601395|NCT00114686|GABA Agents|gaba agents|mesh-ancestor
92601396|NCT00114686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601398|NCT05553678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92601399|NCT05553678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92601400|NCT05553678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601401|NCT05553678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601402|NCT05553678|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92601403|NCT05553678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92601404|NCT05553678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92601405|NCT05553678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92601406|NCT05553678|Anesthetics, General|anesthetics, general|mesh-ancestor
92601407|NCT05553678|Anesthetics|anesthetics|mesh-ancestor
92601408|NCT05553678|GABA Modulators|gaba modulators|mesh-ancestor
92601409|NCT05553678|GABA Agents|gaba agents|mesh-ancestor
92601410|NCT05553678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601411|NCT05553678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601412|NCT00448552|Capecitabine|capecitabine|mesh-list
92601413|NCT00448552|Oxaliplatin|oxaliplatin|mesh-list
92601414|NCT00448552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601415|NCT00448552|Antimetabolites|antimetabolites|mesh-ancestor
92601416|NCT00448552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601417|NCT00448552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601418|NCT03276520|Ethanol|ethanol|mesh-list
92601419|NCT03276520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92601420|NCT03276520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601421|NCT03276520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601422|NCT03276520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601423|NCT00114764|Lenograstim|lenograstim|mesh-list
92601424|NCT00114764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92601425|NCT00114764|Immunologic Factors|immunologic factors|mesh-ancestor
92601426|NCT00114764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601427|NCT00448786|Niacinamide|niacinamide|mesh-list
92601428|NCT00448786|Motesanib diphosphate|motesanib diphosphate|mesh-list
92601429|NCT00448786|Imetelstat|imetelstat|mesh-list
92601430|NCT00448786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601431|NCT00448786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601432|NCT00448786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601433|NCT00448786|Vitamin B Complex|vitamin b complex|mesh-ancestor
92601434|NCT00448786|Vitamins|vitamins|mesh-ancestor
92601435|NCT00448786|Micronutrients|micronutrients|mesh-ancestor
92008890|NCT04526197|Choline|choline|mesh-list
92601438|NCT00114803|Salmon calcitonin|salmon calcitonin|mesh-list
92601439|NCT00114803|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92601440|NCT00114803|Katacalcin|katacalcin|mesh-list
92601441|NCT00114803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92601442|NCT00114803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601443|NCT00114803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92601444|NCT00114803|Vasodilator Agents|vasodilator agents|mesh-ancestor
92601445|NCT00448825|Topiramate|topiramate|mesh-list
92601446|NCT00448825|Anticonvulsants|anticonvulsants|mesh-ancestor
92601447|NCT00448825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601448|NCT00448825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601449|NCT00448903|Bemiparin|bemiparin|mesh-list
92601450|NCT00448903|Anticoagulants|anticoagulants|mesh-ancestor
92601452|NCT00448942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92601453|NCT00448942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601454|NCT00448942|Disinfectants|disinfectants|mesh-ancestor
92601455|NCT00402012|Pioglitazone|pioglitazone|mesh-list
92601456|NCT00402012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601457|NCT00402012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536865|NCT00136981|Atorvastatin|atorvastatin|mesh-list
92536866|NCT00136981|Torcetrapib|torcetrapib|mesh-list
92536867|NCT00136981|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92536868|NCT00136981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92536869|NCT00136981|Antimetabolites|antimetabolites|mesh-ancestor
92536870|NCT00136981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601458|NCT00448981|Hand Sanitizers|hand sanitizers|mesh-list
92601459|NCT00448981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92601460|NCT00448981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601461|NCT00448981|Disinfectants|disinfectants|mesh-ancestor
92601462|NCT03276325|Dexamethasone|dexamethasone|mesh-list
92601463|NCT03276325|Nalbuphine|nalbuphine|mesh-list
92601464|NCT03276325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601465|NCT03276325|Antiemetics|antiemetics|mesh-ancestor
92601466|NCT03276325|Autonomic Agents|autonomic agents|mesh-ancestor
92601467|NCT03276325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601468|NCT03276325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601469|NCT03276325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601470|NCT03276325|Glucocorticoids|glucocorticoids|mesh-ancestor
92601471|NCT03276325|Hormones|hormones|mesh-ancestor
92601472|NCT03276325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601473|NCT03276325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601474|NCT03276325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601475|NCT03276325|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92601476|NCT03276325|Narcotics|narcotics|mesh-ancestor
92601477|NCT03276325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601478|NCT03276325|Analgesics|analgesics|mesh-ancestor
92601479|NCT03276325|Sensory System Agents|sensory system agents|mesh-ancestor
92601480|NCT00449020|Carboplatin|carboplatin|mesh-list
92601481|NCT00449020|Docetaxel|docetaxel|mesh-list
92601482|NCT00449020|Irinotecan|irinotecan|mesh-list
92601483|NCT00449020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601484|NCT00449020|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601485|NCT00449020|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601486|NCT00449020|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601487|NCT00449020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601488|NCT00449020|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92601489|NCT00449020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92601490|NCT00449020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601491|NCT00115752|Valdecoxib|valdecoxib|mesh-list
92601492|NCT00115752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
92601493|NCT00115752|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92601494|NCT00115752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601495|NCT00115752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601496|NCT00115752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92601497|NCT00115752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92601498|NCT00115752|Analgesics|analgesics|mesh-ancestor
92601499|NCT00115752|Sensory System Agents|sensory system agents|mesh-ancestor
92601500|NCT00115752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601501|NCT00115752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601502|NCT00115752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601503|NCT00115752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601504|NCT00449059|Nitroglycerin|nitroglycerin|mesh-list
92601505|NCT00449059|Vasodilator Agents|vasodilator agents|mesh-ancestor
92601506|NCT00449137|Leucovorin|leucovorin|mesh-list
92601507|NCT00449137|Fluorouracil|fluorouracil|mesh-list
92601508|NCT00449137|Arsenic Trioxide|arsenic trioxide|mesh-list
92601509|NCT00449137|Calcium|calcium|mesh-list
92601510|NCT00449137|Levoleucovorin|levoleucovorin|mesh-list
92601511|NCT00449137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92601512|NCT00449137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601516|NCT00449137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601517|NCT00449137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601518|NCT00449137|Immunologic Factors|immunologic factors|mesh-ancestor
92601519|NCT00449137|Antidotes|antidotes|mesh-ancestor
92601520|NCT00449137|Protective Agents|protective agents|mesh-ancestor
92601521|NCT00449137|Vitamin B Complex|vitamin b complex|mesh-ancestor
92601522|NCT00449137|Vitamins|vitamins|mesh-ancestor
92601523|NCT00449137|Micronutrients|micronutrients|mesh-ancestor
92601524|NCT00449254|Oleoyl-estrone|oleoyl-estrone|mesh-list
92601525|NCT00449254|Estrone|estrone|mesh-list
92601526|NCT00449254|Estrogens|estrogens|mesh-ancestor
92601527|NCT00449254|Hormones|hormones|mesh-ancestor
92536871|NCT00136981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92536872|NCT00136981|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92601528|NCT00449254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601529|NCT00449254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601530|NCT00449254|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92601533|NCT00449410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92601534|NCT00449410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92601535|NCT00449410|Antimetabolites|antimetabolites|mesh-ancestor
92601536|NCT00449410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601537|NCT00449410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92601538|NCT00449410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92601539|NCT00449410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601540|NCT00449449|Lidocaine|lidocaine|mesh-list
92601541|NCT00449449|Anesthetics, Local|anesthetics, local|mesh-ancestor
92601542|NCT00449449|Anesthetics|anesthetics|mesh-ancestor
92601543|NCT00449449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601544|NCT00449449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601545|NCT00449449|Sensory System Agents|sensory system agents|mesh-ancestor
92601546|NCT00449449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601547|NCT00449449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92601548|NCT00449449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92601549|NCT00449449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92601550|NCT00449449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92601551|NCT00449449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601552|NCT00115115|Dopamine|dopamine|mesh-list
92601553|NCT00115115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92601554|NCT00115115|Sympathomimetics|sympathomimetics|mesh-ancestor
92601555|NCT00115115|Autonomic Agents|autonomic agents|mesh-ancestor
92601556|NCT00115115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601557|NCT00115115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601558|NCT00115115|Dopamine Agents|dopamine agents|mesh-ancestor
92601559|NCT00115115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601560|NCT00115115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601561|NCT00115115|Protective Agents|protective agents|mesh-ancestor
92601562|NCT00449488|Epoetin Alfa|epoetin alfa|mesh-list
92601563|NCT00449488|Hematinics|hematinics|mesh-ancestor
92601564|NCT00115830|Atorvastatin|atorvastatin|mesh-list
92601565|NCT00115830|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92601566|NCT00115830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92601567|NCT00115830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92601568|NCT00115830|Antimetabolites|antimetabolites|mesh-ancestor
92601569|NCT00115830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601570|NCT00115830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92601571|NCT00115830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92601572|NCT00115830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601573|NCT00115154|Imiquimod|imiquimod|mesh-list
92601574|NCT00115154|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92601575|NCT00115154|Immunologic Factors|immunologic factors|mesh-ancestor
92601576|NCT00115154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601577|NCT00115154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601578|NCT00115154|Interferon Inducers|interferon inducers|mesh-ancestor
92601579|NCT00449527|Budesonide|budesonide|mesh-list
92601580|NCT00449527|Formoterol Fumarate|formoterol fumarate|mesh-list
92601581|NCT00449527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601582|NCT00449527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92601583|NCT00449527|Autonomic Agents|autonomic agents|mesh-ancestor
92601584|NCT00449527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601585|NCT00449527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601590|NCT00449527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601591|NCT00449527|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92601592|NCT00449527|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92601593|NCT00449527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92601594|NCT00449527|Adrenergic Agents|adrenergic agents|mesh-ancestor
92601595|NCT00449527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601596|NCT00449527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601597|NCT00449683|Terazosin|terazosin|mesh-list
92601598|NCT00449683|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92601599|NCT00449683|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92601600|NCT00449683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92536873|NCT00136981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601601|NCT00449683|Adrenergic Agents|adrenergic agents|mesh-ancestor
92601602|NCT00449683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601603|NCT00449683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601604|NCT00449683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601606|NCT00449722|Mesalamine|mesalamine|mesh-list
92601607|NCT00449722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92601608|NCT00449722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92601609|NCT00449722|Analgesics|analgesics|mesh-ancestor
92601610|NCT00449722|Sensory System Agents|sensory system agents|mesh-ancestor
92601611|NCT00449722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601612|NCT00449722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601613|NCT00449722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601614|NCT00449722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601615|NCT00449800|Ceftriaxone|ceftriaxone|mesh-list
92601616|NCT00449800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92601617|NCT00449800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601618|NCT00449839|Insulin|insulin|mesh-list
92601619|NCT00449839|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92601620|NCT00449839|Insulin Aspart|insulin aspart|mesh-list
92601621|NCT00449839|Insulin, Long-Acting|insulin, long-acting|mesh-list
92601622|NCT00449839|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92601623|NCT00449839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601624|NCT00449839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601625|NCT00450229|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92601626|NCT00450229|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92601627|NCT00450229|Protective Agents|protective agents|mesh-ancestor
92601628|NCT00450229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601629|NCT00450229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601630|NCT04699279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92601631|NCT04699279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92601632|NCT04699279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92601633|NCT04699279|Antimetabolites|antimetabolites|mesh-ancestor
92405924|NCT04787848|Anticonvulsants|anticonvulsants|mesh-ancestor
92601634|NCT04699279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601635|NCT04699279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92601636|NCT04699279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92601637|NCT04699279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601638|NCT00450307|Antibodies|antibodies|mesh-list
92601639|NCT00450307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92601640|NCT00450307|Sargramostim|sargramostim|mesh-list
92601641|NCT00450307|Immunologic Factors|immunologic factors|mesh-ancestor
92601642|NCT00450307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601643|NCT03276013|Pembrolizumab|pembrolizumab|mesh-list
92601644|NCT03276013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601645|NCT03276013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601646|NCT03276013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92601647|NCT03276013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601648|NCT00450736|Celecoxib|celecoxib|mesh-list
92601649|NCT00450736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92601650|NCT00450736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92601651|NCT00450736|Analgesics|analgesics|mesh-ancestor
92601652|NCT00450736|Sensory System Agents|sensory system agents|mesh-ancestor
92601653|NCT00450736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601654|NCT00450736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601655|NCT00450736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601656|NCT00450736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601660|NCT00450736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601662|NCT05536362|Ketamine|ketamine|mesh-list
92601663|NCT05536362|Propofol|propofol|mesh-list
92601664|NCT05536362|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92601665|NCT05536362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601666|NCT05536362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601667|NCT05536362|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92601668|NCT05536362|Anesthetics, General|anesthetics, general|mesh-ancestor
92601669|NCT05536362|Anesthetics|anesthetics|mesh-ancestor
92601670|NCT05536362|Analgesics|analgesics|mesh-ancestor
92601671|NCT05536362|Sensory System Agents|sensory system agents|mesh-ancestor
92601672|NCT05536362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601673|NCT05536362|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92601674|NCT05536362|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92601675|NCT05536362|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92601676|NCT05536362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601677|NCT05536362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536875|NCT00137020|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92536876|NCT00137020|Serotonin Agents|serotonin agents|mesh-ancestor
92536877|NCT00137020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536878|NCT00137020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944610|NCT03472339|Analgesics|analgesics|mesh-ancestor
92601678|NCT05536362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601680|NCT05536362|Autonomic Agents|autonomic agents|mesh-ancestor
92601681|NCT05536362|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92601682|NCT05536362|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92601683|NCT05536362|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92601684|NCT05536362|Adrenergic Agents|adrenergic agents|mesh-ancestor
92601685|NCT00450853|Granisetron|granisetron|mesh-list
92601686|NCT00450853|Antiemetics|antiemetics|mesh-ancestor
92601687|NCT00450853|Autonomic Agents|autonomic agents|mesh-ancestor
92601688|NCT00450853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601689|NCT00450853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601690|NCT00450853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601691|NCT00450853|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92601692|NCT00450853|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92601693|NCT00450853|Serotonin Agents|serotonin agents|mesh-ancestor
92601694|NCT00450853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601695|NCT00450853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601696|NCT00450892|Docetaxel|docetaxel|mesh-list
92601697|NCT00450892|Trastuzumab|trastuzumab|mesh-list
92601698|NCT00450892|Lapatinib|lapatinib|mesh-list
92601699|NCT00450892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601700|NCT00450892|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601701|NCT00450892|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601702|NCT00450892|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601703|NCT00450892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601704|NCT00450892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601705|NCT00450892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601706|NCT00450892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601707|NCT00115310|Capsaicin|capsaicin|mesh-list
92601708|NCT00115310|Antipruritics|antipruritics|mesh-ancestor
92601709|NCT00115310|Dermatologic Agents|dermatologic agents|mesh-ancestor
92601710|NCT00115310|Sensory System Agents|sensory system agents|mesh-ancestor
92601711|NCT00115310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601712|NCT00115310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601713|NCT00115908|Ribavirin|ribavirin|mesh-list
92601714|NCT00115908|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92601715|NCT00115908|Antimetabolites|antimetabolites|mesh-ancestor
92601716|NCT00115908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601717|NCT00115908|Antiviral Agents|antiviral agents|mesh-ancestor
92601718|NCT00115908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601719|NCT00458185|Etanercept|etanercept|mesh-list
92601720|NCT00458185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92601721|NCT00458185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92601722|NCT00458185|Analgesics|analgesics|mesh-ancestor
92601723|NCT00458185|Sensory System Agents|sensory system agents|mesh-ancestor
92601724|NCT00458185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601725|NCT00458185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601726|NCT00458185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601727|NCT00458185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92601728|NCT00458185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009178|NCT04912193|Antithrombins|antithrombins|mesh-list
92601740|NCT00458458|Norethindrone|norethindrone|mesh-list
92601741|NCT00458458|Norethindrone Acetate|norethindrone acetate|mesh-list
92601742|NCT00458458|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92601743|NCT00458458|Fertility Agents|fertility agents|mesh-ancestor
92601744|NCT00458458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92601745|NCT00458458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601746|NCT00458458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601747|NCT00458458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601748|NCT00458458|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92601749|NCT00458458|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92601750|NCT00458458|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92601751|NCT00458458|Contraceptive Agents|contraceptive agents|mesh-ancestor
92601752|NCT00458458|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92536879|NCT00137020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536880|NCT00137020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92536881|NCT00137020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92536882|NCT00137020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92601753|NCT00458458|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92601755|NCT00458614|Dexlansoprazole|dexlansoprazole|mesh-list
92601756|NCT00458614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92601757|NCT00458614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601758|NCT00458614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92601759|NCT00458614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601760|NCT00458614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601761|NCT00458731|Bevacizumab|bevacizumab|mesh-list
92601762|NCT00458731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92601764|NCT00458731|Antibodies|antibodies|mesh-list
92601765|NCT00458731|Immunoglobulins|immunoglobulins|mesh-list
92601766|NCT00458731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92601767|NCT00458731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601768|NCT00458731|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92601769|NCT00458731|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92601770|NCT00458731|Growth Substances|growth substances|mesh-ancestor
92601771|NCT00458731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601772|NCT00458731|Growth Inhibitors|growth inhibitors|mesh-ancestor
92601773|NCT00458731|Immunologic Factors|immunologic factors|mesh-ancestor
92601774|NCT00458731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601775|NCT00458731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601776|NCT00458731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601777|NCT03274024|Mitomycins|mitomycins|mesh-list
92601778|NCT03274024|Mitomycin|mitomycin|mesh-list
92601779|NCT03274024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92601780|NCT03274024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601781|NCT03274024|Alkylating Agents|alkylating agents|mesh-ancestor
92601782|NCT03274024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360798|NCT00439296|Alkylating Agents|alkylating agents|mesh-ancestor
92601783|NCT03274024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92601784|NCT03274024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601785|NCT00115947|Terlipressin|terlipressin|mesh-list
92601786|NCT00115947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601787|NCT00115947|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92601788|NCT00458809|Oxaliplatin|oxaliplatin|mesh-list
92601789|NCT00458809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601790|NCT00115544|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92601791|NCT00115544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601792|NCT00115544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601793|NCT00459004|Rimonabant|rimonabant|mesh-list
92601801|NCT00459004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601802|NCT00459160|Antihypertensive Agents|antihypertensive agents|mesh-list
92601803|NCT00115583|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92601804|NCT00115583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601805|NCT00115583|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92601806|NCT00115583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601808|NCT00115622|Xhance|xhance|mesh-list
92601809|NCT00115622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601810|NCT00115622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92601811|NCT00115622|Autonomic Agents|autonomic agents|mesh-ancestor
92601812|NCT00115622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601813|NCT00115622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601814|NCT00115622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92601815|NCT00115622|Respiratory System Agents|respiratory system agents|mesh-ancestor
92601816|NCT00115622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92601817|NCT00115622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92601818|NCT00459511|Hydrocortisone|hydrocortisone|mesh-list
92601819|NCT00459511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601820|NCT00115661|Rosiglitazone|rosiglitazone|mesh-list
92601821|NCT00115661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601822|NCT00115661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601823|NCT04728321|Lenvatinib|lenvatinib|mesh-list
92601824|NCT04728321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601825|NCT04728321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601826|NCT04728321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601827|NCT04728321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601828|NCT00459901|Capecitabine|capecitabine|mesh-list
92536883|NCT00137020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92536884|NCT00137020|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92536886|NCT00137059|Acetaminophen|acetaminophen|mesh-list
92536887|NCT00137059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92536888|NCT00137059|Analgesics|analgesics|mesh-ancestor
92536889|NCT00137059|Sensory System Agents|sensory system agents|mesh-ancestor
92601829|NCT00459901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92601830|NCT00459901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601831|NCT00459901|Antimetabolites|antimetabolites|mesh-ancestor
92601832|NCT00459901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601833|NCT00459901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601834|NCT00459901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92601835|NCT00459901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601836|NCT00401804|Dexamethasone|dexamethasone|mesh-list
92601837|NCT00401804|Doxorubicin|doxorubicin|mesh-list
92601838|NCT00401804|Bortezomib|bortezomib|mesh-list
92601839|NCT00401804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601840|NCT00401804|Antiemetics|antiemetics|mesh-ancestor
92601841|NCT00401804|Autonomic Agents|autonomic agents|mesh-ancestor
92601842|NCT00401804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601843|NCT00401804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601844|NCT00401804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601845|NCT00401804|Glucocorticoids|glucocorticoids|mesh-ancestor
92601846|NCT00401804|Hormones|hormones|mesh-ancestor
92601847|NCT00401804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601848|NCT00401804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601849|NCT00401804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601850|NCT00401804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92601851|NCT00401804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92601852|NCT00401804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92601853|NCT00401804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601854|NCT00401804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601855|NCT00459940|Pioglitazone|pioglitazone|mesh-list
92601856|NCT00459940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601857|NCT00459940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601858|NCT00460057|Alendronate|alendronate|mesh-list
92601859|NCT00460057|Diphosphonates|diphosphonates|mesh-list
92601865|NCT00460174|Bevacizumab|bevacizumab|mesh-list
92601866|NCT00460174|Gemcitabine|gemcitabine|mesh-list
92601867|NCT00460174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601868|NCT00460174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601869|NCT00460174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92601870|NCT00460174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92601871|NCT00460174|Growth Substances|growth substances|mesh-ancestor
92601872|NCT00460174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601873|NCT00460174|Growth Inhibitors|growth inhibitors|mesh-ancestor
92601874|NCT00460174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601875|NCT00460174|Antimetabolites|antimetabolites|mesh-ancestor
92601876|NCT00460174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601877|NCT00460213|Valsartan|valsartan|mesh-list
92601878|NCT00460213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601879|NCT00460213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92601880|NCT00460213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92601881|NCT00460213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601882|NCT00460252|Insulin|insulin|mesh-list
92601883|NCT00460252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601884|NCT00460252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601885|NCT00115817|Atorvastatin|atorvastatin|mesh-list
92601886|NCT00115817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92601887|NCT00115817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92601888|NCT00115817|Antimetabolites|antimetabolites|mesh-ancestor
92601889|NCT00115817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601890|NCT00115817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92601891|NCT00115817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92601892|NCT00115817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601893|NCT00460369|Artesunate|artesunate|mesh-list
92601894|NCT00460369|Lumefantrine|lumefantrine|mesh-list
92601895|NCT00460369|Artemether|artemether|mesh-list
92601896|NCT00460369|Pyrimethamine|pyrimethamine|mesh-list
92536890|NCT00137059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536891|NCT00137059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536893|NCT00137098|Caffeine|caffeine|mesh-list
92536894|NCT00137098|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92536895|NCT00137098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601897|NCT00460369|Sulfadoxine|sulfadoxine|mesh-list
92601898|NCT00460369|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92601899|NCT00460369|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92601900|NCT00460369|Amodiaquine|amodiaquine|mesh-list
92601901|NCT00460369|Antimalarials|antimalarials|mesh-ancestor
92601902|NCT00460369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92601903|NCT00460369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92601904|NCT00460369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601905|NCT00460369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601907|NCT00460369|Schistosomicides|schistosomicides|mesh-ancestor
92601908|NCT00460369|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92601909|NCT00460369|Anthelmintics|anthelmintics|mesh-ancestor
92601910|NCT00460369|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92601911|NCT00460369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601912|NCT00460369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601913|NCT00460369|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92601914|NCT00460447|Gemtuzumab|gemtuzumab|mesh-list
92601915|NCT00460447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92601916|NCT00460447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601917|NCT00460447|Immunotoxins|immunotoxins|mesh-ancestor
92601918|NCT00460447|Immunoconjugates|immunoconjugates|mesh-ancestor
92601919|NCT00460447|Immunologic Factors|immunologic factors|mesh-ancestor
92601920|NCT00460447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601921|NCT00460642|Cetrorelix|cetrorelix|mesh-list
92601922|NCT00460642|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92601923|NCT00460642|Fertility Agents|fertility agents|mesh-ancestor
92601924|NCT00460642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92601925|NCT00460642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601926|NCT00460642|Hormone Antagonists|hormone antagonists|mesh-ancestor
92601927|NCT00460642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601928|NCT00460681|Thymopentin|thymopentin|mesh-list
92601929|NCT00460681|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92601930|NCT00460681|Immunologic Factors|immunologic factors|mesh-ancestor
92360804|NCT00439296|Autonomic Agents|autonomic agents|mesh-ancestor
92601935|NCT00460759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601936|NCT00460759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92601937|NCT00460759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92601938|NCT00460759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601939|NCT00460759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601940|NCT00460759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601941|NCT00460759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92601942|NCT00460759|Antitubercular Agents|antitubercular agents|mesh-ancestor
92601943|NCT00460759|Leprostatic Agents|leprostatic agents|mesh-ancestor
92601944|NCT00460837|Picosulfate sodium|picosulfate sodium|mesh-list
92601945|NCT00460837|Cathartics|cathartics|mesh-ancestor
92601946|NCT00460837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601947|NCT00460876|Topotecan|topotecan|mesh-list
92601948|NCT00460876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92601949|NCT00460876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92601950|NCT00460876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601951|NCT00460876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601952|NCT00460876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601953|NCT00460915|Amlodipine|amlodipine|mesh-list
92601954|NCT00460915|Lacidipine|lacidipine|mesh-list
92601955|NCT00460915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92601956|NCT00460915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92601957|NCT00460915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92601958|NCT00460915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601959|NCT00460915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92601960|NCT00460915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601961|NCT00460915|Vasodilator Agents|vasodilator agents|mesh-ancestor
92601962|NCT00460954|Levodopa|levodopa|mesh-list
92601963|NCT00460954|Carbidopa|carbidopa|mesh-list
92601964|NCT00460954|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92536896|NCT00137098|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92536897|NCT00137098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536898|NCT00137098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536899|NCT00137098|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92536900|NCT00137098|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91952946|NCT04771689|Naloxone|naloxone|mesh-list
92601965|NCT00460954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92601966|NCT00460954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92601967|NCT00460954|Dopamine Agents|dopamine agents|mesh-ancestor
92601968|NCT00460954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601969|NCT00460954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601970|NCT00460954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601971|NCT00460954|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92601972|NCT00460954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601973|NCT00460954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92601974|NCT00460954|Immunologic Factors|immunologic factors|mesh-ancestor
92601975|NCT00460954|Dopamine Agonists|dopamine agonists|mesh-ancestor
92601976|NCT00461149|Octreotide|octreotide|mesh-list
92601977|NCT00461149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92601978|NCT00461149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601979|NCT00461149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601980|NCT00115973|Insulin Aspart|insulin aspart|mesh-list
92601981|NCT00115973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92601982|NCT00115973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601983|NCT00461266|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92601984|NCT00461266|Enfuvirtide|enfuvirtide|mesh-list
92601985|NCT00461266|Antiviral Agents|antiviral agents|mesh-ancestor
92601986|NCT00461266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601987|NCT00461266|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92601988|NCT00461266|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92601989|NCT00461266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601990|NCT00461266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92601991|NCT00461344|Docetaxel|docetaxel|mesh-list
92601992|NCT00461344|Doxorubicin|doxorubicin|mesh-list
92601993|NCT00461344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601994|NCT00461344|Tubulin Modulators|tubulin modulators|mesh-ancestor
92601995|NCT00461344|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601996|NCT00461344|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601997|NCT00461344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601998|NCT00461344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92601999|NCT00461344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92602000|NCT00461344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92602001|NCT00461344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602002|NCT03273634|Lansoprazole|lansoprazole|mesh-list
92602006|NCT03273634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92602007|NCT03273634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602008|NCT03273634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602009|NCT03273595|Paclitaxel|paclitaxel|mesh-list
92602010|NCT03273595|Cyclophosphamide|cyclophosphamide|mesh-list
92602011|NCT03273595|Trastuzumab|trastuzumab|mesh-list
92602012|NCT03273595|Epirubicin|epirubicin|mesh-list
92602013|NCT03273595|Lapatinib|lapatinib|mesh-list
92602014|NCT03273595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92602015|NCT03273595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602016|NCT03273595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602017|NCT03273595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92602018|NCT03273595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602019|NCT03273595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602020|NCT03273595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602021|NCT03273595|Immunologic Factors|immunologic factors|mesh-ancestor
92602022|NCT03273595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602023|NCT03273595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602024|NCT03273595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92602025|NCT03273595|Alkylating Agents|alkylating agents|mesh-ancestor
92602026|NCT03273595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92602027|NCT03273595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92602028|NCT03273595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92602029|NCT03273595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536901|NCT00137098|Purinergic Agents|purinergic agents|mesh-ancestor
92536902|NCT00137098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536903|NCT00137254|Insulin|insulin|mesh-list
92536904|NCT00137254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92536905|NCT00137254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536906|NCT03151044|Rituximab|rituximab|mesh-list
92602030|NCT03273595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92602031|NCT03273595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602032|NCT03273595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92602033|NCT03273556|Lidocaine|lidocaine|mesh-list
92602034|NCT03273556|Anesthetics, Local|anesthetics, local|mesh-ancestor
92602035|NCT03273556|Anesthetics|anesthetics|mesh-ancestor
92602036|NCT03273556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602037|NCT03273556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602038|NCT03273556|Sensory System Agents|sensory system agents|mesh-ancestor
92602039|NCT03273556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602040|NCT03273556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92602041|NCT03273556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92602042|NCT03273556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92602043|NCT03273556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92602044|NCT03273556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602045|NCT04728308|Bupivacaine|bupivacaine|mesh-list
92602046|NCT04728308|Anesthetics, Local|anesthetics, local|mesh-ancestor
92602047|NCT04728308|Anesthetics|anesthetics|mesh-ancestor
92602048|NCT04728308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602049|NCT04728308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602050|NCT04728308|Sensory System Agents|sensory system agents|mesh-ancestor
92326981|NCT00002059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92602052|NCT00461422|Ganirelix|ganirelix|mesh-list
92602053|NCT00461422|Hormone Antagonists|hormone antagonists|mesh-ancestor
92602054|NCT00461422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602055|NCT00461422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602056|NCT04697992|Vitamins|vitamins|mesh-list
92602057|NCT04697992|Ascorbic Acid|ascorbic acid|mesh-list
92602058|NCT04697992|Tranexamic Acid|tranexamic acid|mesh-list
92602059|NCT04697992|Micronutrients|micronutrients|mesh-ancestor
92602060|NCT04697992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602061|NCT04697992|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92602062|NCT04697992|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92602063|NCT04697992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602064|NCT04697992|Hemostatics|hemostatics|mesh-ancestor
92602065|NCT04697992|Coagulants|coagulants|mesh-ancestor
92602066|NCT04697992|Antioxidants|antioxidants|mesh-ancestor
92602067|NCT04697992|Protective Agents|protective agents|mesh-ancestor
92602068|NCT05483634|Estrogens|estrogens|mesh-list
92602069|NCT05483634|Hormones|hormones|mesh-ancestor
92602070|NCT05483634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602071|NCT05483634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602072|NCT00461578|Artesunate|artesunate|mesh-list
92602073|NCT00461578|Dapsone|dapsone|mesh-list
92602074|NCT00461578|Chlorproguanil|chlorproguanil|mesh-list
92602075|NCT00461578|Antimalarials|antimalarials|mesh-ancestor
92602087|NCT00461578|Leprostatic Agents|leprostatic agents|mesh-ancestor
92602088|NCT00461578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92602089|NCT00461617|Mitiglinide|mitiglinide|mesh-list
92602090|NCT00461617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602091|NCT00461617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602092|NCT00116064|Lorazepam|lorazepam|mesh-list
92602093|NCT00116064|Paraldehyde|paraldehyde|mesh-list
92602094|NCT00116064|Anticonvulsants|anticonvulsants|mesh-ancestor
92602095|NCT00116064|Antiemetics|antiemetics|mesh-ancestor
92602096|NCT00116064|Autonomic Agents|autonomic agents|mesh-ancestor
92602097|NCT00116064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602098|NCT00116064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602099|NCT00116064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602100|NCT00116064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92602101|NCT00116064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602102|NCT00116064|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92602103|NCT00116064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92602104|NCT00116064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602105|NCT00116064|GABA Modulators|gaba modulators|mesh-ancestor
92602106|NCT00116064|GABA Agents|gaba agents|mesh-ancestor
92536907|NCT03151044|Epirubicin|epirubicin|mesh-list
92536908|NCT03151044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536909|NCT03151044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602107|NCT00116064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602108|NCT00116064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602109|NCT04728035|Irinotecan|irinotecan|mesh-list
92602110|NCT04728035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92602111|NCT04728035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92602112|NCT04728035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602113|NCT04728035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602114|NCT04728035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602115|NCT00461890|Naltrexone|naltrexone|mesh-list
92602116|NCT00461890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92602117|NCT00461890|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92602118|NCT00461890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602119|NCT00461890|Sensory System Agents|sensory system agents|mesh-ancestor
92602120|NCT00461890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602121|NCT00461968|Simvastatin|simvastatin|mesh-list
92602122|NCT00461968|Ezetimibe|ezetimibe|mesh-list
92602123|NCT00461968|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92602124|NCT00461968|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92602125|NCT00461968|Antimetabolites|antimetabolites|mesh-ancestor
92602126|NCT00461968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602127|NCT00461968|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92602128|NCT00461968|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92602129|NCT00461968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602130|NCT00116103|Tacrolimus|tacrolimus|mesh-list
92602131|NCT00116103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602132|NCT00116103|Immunologic Factors|immunologic factors|mesh-ancestor
92602133|NCT00116103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602134|NCT00116103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92602135|NCT00116103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602136|NCT00116103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602137|NCT02956252|Anesthetics|anesthetics|mesh-list
92602138|NCT02956252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602139|NCT02956252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602140|NCT00462358|Filanesib|filanesib|mesh-list
92602143|NCT00462358|Immunologic Factors|immunologic factors|mesh-ancestor
92602144|NCT00462358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602145|NCT00462358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92602146|NCT00462358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602147|NCT00462358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602148|NCT00462358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602149|NCT00116181|Etanercept|etanercept|mesh-list
92602150|NCT00116181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92602151|NCT00116181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602152|NCT00116181|Analgesics|analgesics|mesh-ancestor
92602153|NCT00116181|Sensory System Agents|sensory system agents|mesh-ancestor
92602154|NCT00116181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602155|NCT00116181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602156|NCT00116181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602157|NCT00116181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602158|NCT00116181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602159|NCT00116181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602160|NCT00116181|Immunologic Factors|immunologic factors|mesh-ancestor
92602161|NCT00462397|Paclitaxel|paclitaxel|mesh-list
92602162|NCT00462397|Carboplatin|carboplatin|mesh-list
92602163|NCT00462397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92602164|NCT00462397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602165|NCT00462397|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602166|NCT00462397|Antimitotic Agents|antimitotic agents|mesh-ancestor
92602167|NCT00462397|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602168|NCT00462397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602169|NCT00462475|Hormones|hormones|mesh-list
92602170|NCT00462475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602171|NCT00462475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602172|NCT00462553|Gemcitabine|gemcitabine|mesh-list
92602173|NCT00462553|Sunitinib|sunitinib|mesh-list
92602174|NCT00462553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92602175|NCT00462553|Antimetabolites|antimetabolites|mesh-ancestor
92602176|NCT00462553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536910|NCT03151044|Immunologic Factors|immunologic factors|mesh-ancestor
92536911|NCT03151044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536912|NCT03151044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536913|NCT03151044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92602177|NCT00462553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602178|NCT00462553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92602179|NCT00462553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92602180|NCT00462553|Growth Substances|growth substances|mesh-ancestor
92602181|NCT00462553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602182|NCT00462553|Growth Inhibitors|growth inhibitors|mesh-ancestor
92602183|NCT00462553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92602184|NCT00462553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602185|NCT00462592|Budesonide|budesonide|mesh-list
92602186|NCT00462592|Montelukast|montelukast|mesh-list
92602187|NCT00462592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602188|NCT00462592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92602189|NCT00462592|Autonomic Agents|autonomic agents|mesh-ancestor
92602190|NCT00462592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602191|NCT00462592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602192|NCT00462592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92602193|NCT00462592|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602194|NCT00462592|Glucocorticoids|glucocorticoids|mesh-ancestor
92602195|NCT00462592|Hormones|hormones|mesh-ancestor
92602196|NCT00462592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602197|NCT00462592|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92602198|NCT00462592|Hormone Antagonists|hormone antagonists|mesh-ancestor
92602199|NCT00462592|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92602200|NCT00462592|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92602201|NCT00462592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602203|NCT00405015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602204|NCT00405015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602205|NCT00462631|Paclitaxel|paclitaxel|mesh-list
92602206|NCT00462631|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92602207|NCT00462631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92602208|NCT00462631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602209|NCT00462631|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602210|NCT00462631|Antimitotic Agents|antimitotic agents|mesh-ancestor
92602211|NCT00462631|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602212|NCT00462631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602213|NCT00462787|Dexamethasone|dexamethasone|mesh-list
92602214|NCT00462787|Topotecan|topotecan|mesh-list
92602218|NCT00462787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602220|NCT00462787|Autonomic Agents|autonomic agents|mesh-ancestor
92602221|NCT00462787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602222|NCT00462787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602223|NCT00462787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602224|NCT00462787|Glucocorticoids|glucocorticoids|mesh-ancestor
92602225|NCT00462787|Hormones|hormones|mesh-ancestor
92602226|NCT00462787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602227|NCT00462787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92602228|NCT00462787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602229|NCT00462787|Immunologic Factors|immunologic factors|mesh-ancestor
92602230|NCT00462787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92602231|NCT00462787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92602232|NCT00462787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602233|NCT00462787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602234|NCT00462787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92602235|NCT00462787|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602236|NCT00462787|Antimitotic Agents|antimitotic agents|mesh-ancestor
92602237|NCT00462787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602238|NCT00462787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92602239|NCT00462787|Alkylating Agents|alkylating agents|mesh-ancestor
92602240|NCT00462787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92602241|NCT00462787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602242|NCT00462787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92602243|NCT00462787|Antimetabolites|antimetabolites|mesh-ancestor
92602244|NCT00463021|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92602245|NCT00463021|Vitamins|vitamins|mesh-ancestor
92602246|NCT00463021|Micronutrients|micronutrients|mesh-ancestor
92602247|NCT00463021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536914|NCT03151044|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92536915|NCT03151044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92536916|NCT03151044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536917|NCT03151044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602248|NCT00463021|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92602249|NCT00116259|Aripiprazole|aripiprazole|mesh-list
92602250|NCT00116259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92602251|NCT00116259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602252|NCT00116259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92602253|NCT00116259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92602254|NCT00116259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602255|NCT00116259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602256|NCT00116259|Dopamine Agonists|dopamine agonists|mesh-ancestor
92602257|NCT00116259|Dopamine Agents|dopamine agents|mesh-ancestor
92602258|NCT00116259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602259|NCT00116259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602260|NCT00116259|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92602261|NCT00116259|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92602262|NCT00116259|Serotonin Agents|serotonin agents|mesh-ancestor
92602263|NCT00116259|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92602264|NCT00116259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92602265|NCT00116259|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92602266|NCT00116259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92602267|NCT00116324|Montelukast|montelukast|mesh-list
92602268|NCT00116324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92602269|NCT00116324|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602270|NCT00116324|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92602271|NCT00116324|Hormone Antagonists|hormone antagonists|mesh-ancestor
92602272|NCT00116324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602273|NCT00116324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602274|NCT00116324|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92602275|NCT00116324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92602276|NCT00116324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602277|NCT00116402|Fluticasone|fluticasone|mesh-list
92602278|NCT00116402|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92602279|NCT00116402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602280|NCT00116402|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92602281|NCT00116402|Autonomic Agents|autonomic agents|mesh-ancestor
92602282|NCT00116402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602283|NCT00116402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602284|NCT00116402|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92009695|NCT04910165|Ropivacaine|ropivacaine|mesh-list
92602287|NCT00116402|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92602288|NCT00116402|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92602289|NCT00116402|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92602290|NCT00116402|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92602291|NCT00116402|Adrenergic Agents|adrenergic agents|mesh-ancestor
92602292|NCT00116402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602293|NCT00116402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602294|NCT00463723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92602295|NCT00463723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92602296|NCT00463762|Sulbactam|sulbactam|mesh-list
92602297|NCT00463762|Cefoperazone|cefoperazone|mesh-list
92602298|NCT00463762|Sulperazone|sulperazone|mesh-list
92602299|NCT00463762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92602300|NCT00463762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602301|NCT00463762|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92602302|NCT00463762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602303|NCT00463762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602304|NCT00463762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92602305|NCT00116480|Misoprostol|misoprostol|mesh-list
92602306|NCT00116480|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92602307|NCT00116480|Abortifacient Agents|abortifacient agents|mesh-ancestor
92602308|NCT00116480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92602309|NCT00116480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602310|NCT00116480|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92602311|NCT00116480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602312|NCT00116480|Oxytocics|oxytocics|mesh-ancestor
92602313|NCT00463879|Galantamine|galantamine|mesh-list
92536918|NCT00137410|Celecoxib|celecoxib|mesh-list
91944649|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602314|NCT00463879|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92602315|NCT00463879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602316|NCT00463879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602317|NCT00463879|Cholinergic Agents|cholinergic agents|mesh-ancestor
92602318|NCT00463879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602319|NCT00463879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602320|NCT00463879|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92602321|NCT00463879|Autonomic Agents|autonomic agents|mesh-ancestor
92602322|NCT00463879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602323|NCT00463879|Nootropic Agents|nootropic agents|mesh-ancestor
92602324|NCT00463918|Varenicline|varenicline|mesh-list
92602325|NCT00463918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92602326|NCT00463918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92602327|NCT00463918|Cholinergic Agents|cholinergic agents|mesh-ancestor
92602328|NCT00463918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602329|NCT00463918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602330|NCT00463918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602331|NCT00463957|Sildenafil Citrate|sildenafil citrate|mesh-list
92602332|NCT00463957|Tadalafil|tadalafil|mesh-list
92602333|NCT00463957|Vasodilator Agents|vasodilator agents|mesh-ancestor
92602334|NCT00463957|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92602335|NCT00463957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92602336|NCT00463957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602337|NCT00463957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602338|NCT00463957|Urological Agents|urological agents|mesh-ancestor
92602339|NCT00464035|Calcium|calcium|mesh-list
92602340|NCT00464035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92602341|NCT00464035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602342|NCT00116454|Ethiodized Oil|ethiodized oil|mesh-list
92602343|NCT00116454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602344|NCT00464191|Escitalopram|escitalopram|mesh-list
92602345|NCT00464191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92602346|NCT00464191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92602347|NCT00464191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92602348|NCT00464191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602349|NCT00464191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602350|NCT00464191|Serotonin Agents|serotonin agents|mesh-ancestor
92602351|NCT00464191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602352|NCT00464347|Triamcinolone|triamcinolone|mesh-list
92602353|NCT00464347|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92602354|NCT00464347|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92602355|NCT00464347|Bevacizumab|bevacizumab|mesh-list
92602356|NCT00464347|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92009758|NCT04101643|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92602360|NCT00464347|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92602361|NCT00464347|Growth Substances|growth substances|mesh-ancestor
92602362|NCT00464347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602363|NCT00464347|Growth Inhibitors|growth inhibitors|mesh-ancestor
92602364|NCT00464347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602365|NCT00464347|Glucocorticoids|glucocorticoids|mesh-ancestor
92602366|NCT00464347|Hormones|hormones|mesh-ancestor
92360816|NCT00439296|Abortifacient Agents|abortifacient agents|mesh-ancestor
92602367|NCT00464347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602368|NCT00464347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602369|NCT00464347|Immunologic Factors|immunologic factors|mesh-ancestor
92602370|NCT00464347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602371|NCT00464347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602372|NCT00116493|Folic Acid|folic acid|mesh-list
92602373|NCT00116493|Mebendazole|mebendazole|mesh-list
92602374|NCT00116493|Piperazine|piperazine|mesh-list
92602375|NCT00116493|Piperazine citrate|piperazine citrate|mesh-list
92602376|NCT00116493|DMP 777|dmp 777|mesh-list
92602377|NCT00116493|Hematinics|hematinics|mesh-ancestor
92602378|NCT00116493|Vitamin B Complex|vitamin b complex|mesh-ancestor
92602379|NCT00116493|Vitamins|vitamins|mesh-ancestor
92602380|NCT00116493|Micronutrients|micronutrients|mesh-ancestor
92602381|NCT00116493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602382|NCT00116493|Antinematodal Agents|antinematodal agents|mesh-ancestor
92602383|NCT00116493|Anthelmintics|anthelmintics|mesh-ancestor
92602384|NCT00116493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92602385|NCT00116493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602386|NCT00116493|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602387|NCT00116493|Antimitotic Agents|antimitotic agents|mesh-ancestor
92536919|NCT00137410|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92536920|NCT00137410|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602388|NCT00116493|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602389|NCT00116493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602390|NCT00116493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602391|NCT00116493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602392|NCT00464503|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92602393|NCT00464503|Pravastatin|pravastatin|mesh-list
92602394|NCT00464503|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92602395|NCT00464503|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92602396|NCT00464503|Antimetabolites|antimetabolites|mesh-ancestor
92602397|NCT00464503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602398|NCT00464503|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92602399|NCT00464503|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92602400|NCT00464503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602401|NCT00116532|Escitalopram|escitalopram|mesh-list
92602402|NCT00116532|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92602403|NCT00116532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92602404|NCT00116532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92602405|NCT00116532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602406|NCT00116532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602407|NCT00116532|Serotonin Agents|serotonin agents|mesh-ancestor
92602408|NCT00116532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602409|NCT00464854|Insulin Aspart|insulin aspart|mesh-list
92602410|NCT00464854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602411|NCT00464854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602412|NCT00464893|Catumaxomab|catumaxomab|mesh-list
92602413|NCT00464893|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92602414|NCT00464893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602415|NCT00464893|Immunologic Factors|immunologic factors|mesh-ancestor
92602416|NCT00464893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602417|NCT00464932|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92602418|NCT00464932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602419|NCT00464932|Vasodilator Agents|vasodilator agents|mesh-ancestor
92602420|NCT00464932|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92602421|NCT00464932|Protective Agents|protective agents|mesh-ancestor
92602422|NCT00464932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602423|NCT00464971|Estradiol|estradiol|mesh-list
92602424|NCT00464971|Estrogens|estrogens|mesh-ancestor
92327361|NCT00003038|Suramin|suramin|mesh-list
92602425|NCT00464971|Hormones|hormones|mesh-ancestor
92602426|NCT00464971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602427|NCT00464971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602428|NCT00116870|Lovastatin|lovastatin|mesh-list
92602435|NCT00116870|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92602436|NCT00116870|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92602437|NCT00116870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602438|NCT00465205|Valacyclovir|valacyclovir|mesh-list
92602439|NCT00465205|Antiviral Agents|antiviral agents|mesh-ancestor
92602440|NCT00465205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602441|NCT00465244|Levetiracetam|levetiracetam|mesh-list
92602442|NCT00465244|Lorazepam|lorazepam|mesh-list
92602443|NCT00465244|Anticonvulsants|anticonvulsants|mesh-ancestor
92602444|NCT00465244|Nootropic Agents|nootropic agents|mesh-ancestor
92602445|NCT00465244|Antiemetics|antiemetics|mesh-ancestor
92602446|NCT00465244|Autonomic Agents|autonomic agents|mesh-ancestor
92602447|NCT00465244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602448|NCT00465244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602449|NCT00465244|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602450|NCT00465244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92602451|NCT00465244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602452|NCT00465244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92602453|NCT00465244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92602454|NCT00465244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602455|NCT00465244|GABA Modulators|gaba modulators|mesh-ancestor
92602456|NCT00465244|GABA Agents|gaba agents|mesh-ancestor
92602457|NCT00465244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602458|NCT00465244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602459|NCT00465283|Donepezil|donepezil|mesh-list
92602460|NCT00465283|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92602461|NCT00465283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536922|NCT00137410|Sensory System Agents|sensory system agents|mesh-ancestor
92536923|NCT00137410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536924|NCT00137410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536925|NCT00137410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602462|NCT00465283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602463|NCT00465283|Cholinergic Agents|cholinergic agents|mesh-ancestor
92602464|NCT00465283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602465|NCT00465283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602466|NCT00465283|Nootropic Agents|nootropic agents|mesh-ancestor
92602468|NCT03272425|Lesinurad|lesinurad|mesh-list
92602469|NCT03272425|Antimetabolites|antimetabolites|mesh-ancestor
92602470|NCT03272425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602471|NCT03272425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602472|NCT03272425|Gout Suppressants|gout suppressants|mesh-ancestor
92602473|NCT03272425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602474|NCT03272425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92602475|NCT03272425|Antioxidants|antioxidants|mesh-ancestor
92602476|NCT03272425|Protective Agents|protective agents|mesh-ancestor
92602477|NCT03272425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602478|NCT03272425|Uricosuric Agents|uricosuric agents|mesh-ancestor
92602479|NCT00116948|Cimetidine|cimetidine|mesh-list
92602480|NCT00116948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92602481|NCT00116948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602482|NCT00116948|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92602483|NCT00116948|Histamine Antagonists|histamine antagonists|mesh-ancestor
92602484|NCT00116948|Histamine Agents|histamine agents|mesh-ancestor
92602485|NCT00116948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602486|NCT00116948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602487|NCT00116948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602488|NCT00116948|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92602489|NCT00116948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92602490|NCT00116948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602491|NCT03272503|Pimozide|pimozide|mesh-list
92602492|NCT03272503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92602493|NCT03272503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92602494|NCT03272503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602495|NCT03272503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602496|NCT03272503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602497|NCT03272503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92602498|NCT03272503|Dopamine Agents|dopamine agents|mesh-ancestor
92602499|NCT03272503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602502|NCT00465439|Lidocaine|lidocaine|mesh-list
92602503|NCT00465439|Epinephrine|epinephrine|mesh-list
92602504|NCT00465439|Racepinephrine|racepinephrine|mesh-list
92602505|NCT00465439|Epinephryl borate|epinephryl borate|mesh-list
92602506|NCT00465439|Anesthetics, Local|anesthetics, local|mesh-ancestor
92602507|NCT00465439|Anesthetics|anesthetics|mesh-ancestor
92602508|NCT00465439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602509|NCT00465439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602510|NCT00465439|Sensory System Agents|sensory system agents|mesh-ancestor
92602511|NCT00465439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602512|NCT00465439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92602513|NCT00465439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92602514|NCT00465439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92602515|NCT00465439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92602516|NCT00465439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602517|NCT00465439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92602518|NCT00465439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92602519|NCT00465439|Adrenergic Agents|adrenergic agents|mesh-ancestor
92602520|NCT00465439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602521|NCT00465439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92602522|NCT00465439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92602523|NCT00465439|Autonomic Agents|autonomic agents|mesh-ancestor
92602524|NCT00465439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92602525|NCT00465439|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602526|NCT00465439|Mydriatics|mydriatics|mesh-ancestor
92602527|NCT00465439|Sympathomimetics|sympathomimetics|mesh-ancestor
92602528|NCT00465439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92602529|NCT00116727|Etanercept|etanercept|mesh-list
92602530|NCT00116727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92536926|NCT00137410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602531|NCT00116727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602532|NCT00116727|Analgesics|analgesics|mesh-ancestor
92602533|NCT00116727|Sensory System Agents|sensory system agents|mesh-ancestor
92602534|NCT00116727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602535|NCT00116727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602536|NCT00116727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602537|NCT00116727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602538|NCT00116727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602539|NCT00116727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602540|NCT00116727|Immunologic Factors|immunologic factors|mesh-ancestor
92602541|NCT00473551|Sirolimus|sirolimus|mesh-list
92602542|NCT00473551|Cyclophosphamide|cyclophosphamide|mesh-list
92602543|NCT00473551|Rituximab|rituximab|mesh-list
92602544|NCT00473551|Fludarabine|fludarabine|mesh-list
92602545|NCT00473551|Fludarabine phosphate|fludarabine phosphate|mesh-list
92602546|NCT00473551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602547|NCT00473551|Immunologic Factors|immunologic factors|mesh-ancestor
92602548|NCT00473551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602549|NCT00473551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602550|NCT00473551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92602551|NCT00473551|Alkylating Agents|alkylating agents|mesh-ancestor
92602552|NCT00473551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602553|NCT00473551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602554|NCT00473551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92602555|NCT00473551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92602556|NCT00473551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92602557|NCT00473551|Antimetabolites|antimetabolites|mesh-ancestor
92602558|NCT00473551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602559|NCT00473551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92602560|NCT00473551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92602561|NCT00473551|Antifungal Agents|antifungal agents|mesh-ancestor
92602562|NCT00117026|Benphothiamine|benphothiamine|mesh-list
92602563|NCT00117026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92602564|NCT00117026|Immunologic Factors|immunologic factors|mesh-ancestor
92602565|NCT00117026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602566|NCT00117026|Chelating Agents|chelating agents|mesh-ancestor
92602567|NCT00117026|Sequestering Agents|sequestering agents|mesh-ancestor
92602568|NCT00117026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602569|NCT00473980|Celecoxib|celecoxib|mesh-list
92602570|NCT00473980|Indomethacin|indomethacin|mesh-list
92602571|NCT00473980|Esomeprazole|esomeprazole|mesh-list
92602572|NCT00473980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92602574|NCT00473980|Analgesics|analgesics|mesh-ancestor
92602575|NCT00473980|Sensory System Agents|sensory system agents|mesh-ancestor
92602576|NCT00473980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602577|NCT00473980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602578|NCT00473980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602579|NCT00473980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602580|NCT00473980|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92602581|NCT00473980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92602582|NCT00473980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602583|NCT00473980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602584|NCT00473980|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92602585|NCT00473980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602586|NCT00473980|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92602587|NCT00473980|Gout Suppressants|gout suppressants|mesh-ancestor
92602589|NCT00473980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92602590|NCT00474019|Esomeprazole|esomeprazole|mesh-list
92602591|NCT00474019|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92602592|NCT00474019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602593|NCT00474019|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92602594|NCT00474019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602595|NCT00474019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602596|NCT00117065|Darbepoetin alfa|darbepoetin alfa|mesh-list
92602597|NCT00117065|Hematinics|hematinics|mesh-ancestor
92602598|NCT00474136|Diclofenac|diclofenac|mesh-list
92602599|NCT00474136|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92602600|NCT00474136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602601|NCT00474136|Analgesics|analgesics|mesh-ancestor
92602602|NCT00474136|Sensory System Agents|sensory system agents|mesh-ancestor
92602603|NCT00474136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602604|NCT00474136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602605|NCT00474136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602606|NCT00474136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536927|NCT00137410|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92536928|NCT00137410|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92536929|NCT00137410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536930|NCT00137410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536931|NCT03151005|Metformin|metformin|mesh-list
92536932|NCT03151005|Liraglutide|liraglutide|mesh-list
92536933|NCT03151005|Exenatide|exenatide|mesh-list
92536934|NCT03151005|Contraceptive Agents|contraceptive agents|mesh-list
92602607|NCT00474136|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92602608|NCT00474136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602609|NCT00474136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602610|NCT00117104|Darbepoetin alfa|darbepoetin alfa|mesh-list
92602611|NCT00117104|Hematinics|hematinics|mesh-ancestor
92602612|NCT03270709|Vitamin D|vitamin d|mesh-list
92602613|NCT03270709|Cholecalciferol|cholecalciferol|mesh-list
92602614|NCT03270709|Vitamins|vitamins|mesh-ancestor
92602615|NCT03270709|Micronutrients|micronutrients|mesh-ancestor
92602616|NCT03270709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602617|NCT03270709|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92602618|NCT03270709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92602619|NCT03270553|Metformin|metformin|mesh-list
92602620|NCT03270553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602621|NCT03270553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602622|NCT00117182|Budesonide|budesonide|mesh-list
92602623|NCT00117182|Mannitol|mannitol|mesh-list
92602624|NCT00117182|Bromides|bromides|mesh-list
92602625|NCT00117182|Albuterol|albuterol|mesh-list
92602626|NCT00117182|Ipratropium|ipratropium|mesh-list
92602627|NCT00117182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602628|NCT00117182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92602629|NCT00117182|Autonomic Agents|autonomic agents|mesh-ancestor
92602630|NCT00117182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602631|NCT00117182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602632|NCT00117182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92602633|NCT00117182|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602634|NCT00117182|Glucocorticoids|glucocorticoids|mesh-ancestor
92602635|NCT00117182|Hormones|hormones|mesh-ancestor
92602636|NCT00117182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602637|NCT00117182|Anticonvulsants|anticonvulsants|mesh-ancestor
92602638|NCT00117182|Tocolytic Agents|tocolytic agents|mesh-ancestor
92602639|NCT00117182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92602640|NCT00117182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92602641|NCT00117182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92602642|NCT00117182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92602643|NCT00117182|Adrenergic Agents|adrenergic agents|mesh-ancestor
92602644|NCT00117182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602645|NCT00117182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602646|NCT00117182|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92602647|NCT00117182|Diuretics|diuretics|mesh-ancestor
92602648|NCT00117182|Natriuretic Agents|natriuretic agents|mesh-ancestor
92602649|NCT00117182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92602654|NCT00116922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602655|NCT00116961|Dexamethasone|dexamethasone|mesh-list
92602656|NCT00116961|Bortezomib|bortezomib|mesh-list
92602657|NCT00116961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602658|NCT00116961|Antiemetics|antiemetics|mesh-ancestor
92602659|NCT00116961|Autonomic Agents|autonomic agents|mesh-ancestor
92602660|NCT00116961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602661|NCT00116961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602662|NCT00116961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602663|NCT00116961|Glucocorticoids|glucocorticoids|mesh-ancestor
92602664|NCT00116961|Hormones|hormones|mesh-ancestor
92602665|NCT00116961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602666|NCT00116961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92602667|NCT00116961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602668|NCT00474721|Acetaminophen|acetaminophen|mesh-list
92602669|NCT00474721|Ibuprofen|ibuprofen|mesh-list
92602670|NCT00474721|Codeine|codeine|mesh-list
92602671|NCT00474721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602672|NCT00474721|Analgesics|analgesics|mesh-ancestor
92602673|NCT00474721|Sensory System Agents|sensory system agents|mesh-ancestor
92536935|NCT03151005|Contraceptives, Oral|contraceptives, oral|mesh-list
92536936|NCT03151005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92536937|NCT03151005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536938|NCT03151005|Incretins|incretins|mesh-ancestor
92602674|NCT00474721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602675|NCT00474721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602676|NCT00474721|Antipyretics|antipyretics|mesh-ancestor
92602677|NCT00474721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92602678|NCT00474721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602679|NCT00474721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602680|NCT00474721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92602681|NCT00474721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602682|NCT00474721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602683|NCT00474721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92602684|NCT00474721|Narcotics|narcotics|mesh-ancestor
92602685|NCT00474721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602686|NCT00474721|Antitussive Agents|antitussive agents|mesh-ancestor
92602687|NCT00474721|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602688|NCT00117260|Levonorgestrel|levonorgestrel|mesh-list
92602689|NCT00117260|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92602690|NCT00117260|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92602691|NCT00117260|Estradiol|estradiol|mesh-list
92602692|NCT00117260|Estrogens|estrogens|mesh-ancestor
92602693|NCT00117260|Hormones|hormones|mesh-ancestor
92602694|NCT00117260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602695|NCT00117260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602696|NCT00117260|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92602697|NCT00117260|Contraceptive Agents|contraceptive agents|mesh-ancestor
92602698|NCT00117260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92602699|NCT00117260|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92602700|NCT00117260|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92602701|NCT00117260|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92602702|NCT00117260|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92602703|NCT00117260|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92602704|NCT00474838|Metformin|metformin|mesh-list
92602705|NCT00474838|Glimepiride|glimepiride|mesh-list
92602706|NCT00474838|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92602707|NCT00474838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602708|NCT00474838|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92602709|NCT00474838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602710|NCT00474838|Immunologic Factors|immunologic factors|mesh-ancestor
92602711|NCT00474916|KRN 5500|krn 5500|mesh-list
92602712|NCT00474916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602713|NCT00474916|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92602714|NCT00474916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602715|NCT00474916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602716|NCT00475072|Ribavirin|ribavirin|mesh-list
92602717|NCT00475072|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92602718|NCT00475072|Antimetabolites|antimetabolites|mesh-ancestor
92602719|NCT00475072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602720|NCT00475072|Antiviral Agents|antiviral agents|mesh-ancestor
92602725|NCT00117299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602727|NCT00117000|Testosterone|testosterone|mesh-list
92602728|NCT00117000|Testosterone undecanoate|testosterone undecanoate|mesh-list
92602729|NCT00117000|Testosterone enanthate|testosterone enanthate|mesh-list
92602730|NCT00117000|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92602731|NCT00117000|Androgens|androgens|mesh-ancestor
92602732|NCT00117000|Hormones|hormones|mesh-ancestor
92602733|NCT00117000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602734|NCT00117000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360831|NCT00439374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92602735|NCT00117000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92602736|NCT00117000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602737|NCT00117000|Anabolic Agents|anabolic agents|mesh-ancestor
92602738|NCT02956408|Vitamin D|vitamin d|mesh-list
92602739|NCT02956408|Cholecalciferol|cholecalciferol|mesh-list
92602740|NCT02956408|Vitamins|vitamins|mesh-ancestor
92602741|NCT02956408|Micronutrients|micronutrients|mesh-ancestor
92602742|NCT02956408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602743|NCT02956408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92602744|NCT02956408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92536939|NCT03151005|Hormones|hormones|mesh-ancestor
92536940|NCT03151005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92536941|NCT03151005|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92536942|NCT03151005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92536943|NCT03151005|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92602745|NCT00475189|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92602746|NCT00475189|Norinyl|norinyl|mesh-list
92602747|NCT00475189|Mestranol|mestranol|mesh-list
92602748|NCT00475189|Norethindrone|norethindrone|mesh-list
92602749|NCT00475189|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92602750|NCT00475189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92602751|NCT00475189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92602752|NCT00475189|Contraceptive Agents|contraceptive agents|mesh-ancestor
92602753|NCT00475189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92602754|NCT00475189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602755|NCT00475189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92602756|NCT00475189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92602757|NCT00475189|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92602758|NCT00475189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92602759|NCT00475189|Estrogens|estrogens|mesh-ancestor
92602760|NCT00475189|Hormones|hormones|mesh-ancestor
92602761|NCT00475189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602762|NCT00117377|Pimecrolimus|pimecrolimus|mesh-list
92602763|NCT00117377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92602764|NCT00117377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602765|NCT00117377|Analgesics|analgesics|mesh-ancestor
92602766|NCT00117377|Sensory System Agents|sensory system agents|mesh-ancestor
92602767|NCT00117377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602768|NCT00117377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602769|NCT00117377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602770|NCT00117377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602771|NCT00117377|Dermatologic Agents|dermatologic agents|mesh-ancestor
92602772|NCT00117377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602773|NCT00117377|Immunologic Factors|immunologic factors|mesh-ancestor
92602774|NCT00117377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92602775|NCT00117377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602776|NCT00117377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602777|NCT02964195|Rifaximin|rifaximin|mesh-list
92602778|NCT02964195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92602779|NCT02964195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602780|NCT02964195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602781|NCT00475462|Metoprolol|metoprolol|mesh-list
92602782|NCT00475462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92602783|NCT00475462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92602784|NCT00475462|Sympatholytics|sympatholytics|mesh-ancestor
92602785|NCT00475462|Autonomic Agents|autonomic agents|mesh-ancestor
92602786|NCT00475462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602787|NCT00475462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602788|NCT00475462|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92602789|NCT00475462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92010192|NCT04394663|Omeprazole|omeprazole|mesh-list
92602794|NCT00475618|Fluorides|fluorides|mesh-list
92602795|NCT00475618|Fluorides, Topical|fluorides, topical|mesh-list
92602796|NCT00475618|Cariostatic Agents|cariostatic agents|mesh-ancestor
92602797|NCT00475618|Protective Agents|protective agents|mesh-ancestor
92602798|NCT00475618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602799|NCT00117039|Darbepoetin alfa|darbepoetin alfa|mesh-list
92602800|NCT00117039|Hematinics|hematinics|mesh-ancestor
92602801|NCT00475696|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92602802|NCT00475696|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92602803|NCT00475696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92602804|NCT00475696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92602805|NCT00475696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602807|NCT00475696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602808|NCT00475696|Analgesics|analgesics|mesh-ancestor
92602809|NCT00475696|Sensory System Agents|sensory system agents|mesh-ancestor
92602810|NCT00475696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602811|NCT00475696|Antidepressive Agents|antidepressive agents|mesh-ancestor
92536945|NCT00137527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944668|NCT03475615|Paclitaxel|paclitaxel|mesh-list
92602812|NCT00475696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602813|NCT00475696|Dopamine Agents|dopamine agents|mesh-ancestor
92602814|NCT00117455|Lenograstim|lenograstim|mesh-list
92602815|NCT00117455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92602816|NCT00117455|Immunologic Factors|immunologic factors|mesh-ancestor
92602817|NCT00117455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602818|NCT03270007|Vinorelbine|vinorelbine|mesh-list
92602819|NCT03270007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92602820|NCT03270007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602821|NCT03270007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602822|NCT03270007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92602823|NCT03270007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92602824|NCT03270007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602825|NCT00475813|Fluticasone|fluticasone|mesh-list
92602826|NCT00475813|Xhance|xhance|mesh-list
92602827|NCT00475813|Formoterol Fumarate|formoterol fumarate|mesh-list
92602828|NCT00475813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602829|NCT00475813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92602830|NCT00475813|Autonomic Agents|autonomic agents|mesh-ancestor
92602831|NCT00475813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602832|NCT00475813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602833|NCT00475813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92602834|NCT00475813|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602835|NCT00475813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92602836|NCT00475813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92602837|NCT00475813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92602838|NCT00475813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92602839|NCT00475813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92602840|NCT00475813|Adrenergic Agents|adrenergic agents|mesh-ancestor
92602841|NCT00475813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602842|NCT00475813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602843|NCT00402038|Methylnaltrexone|methylnaltrexone|mesh-list
92602844|NCT00402038|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92602845|NCT00402038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602846|NCT00402038|Sensory System Agents|sensory system agents|mesh-ancestor
92602847|NCT00402038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602848|NCT00475930|Chlorhexidine|chlorhexidine|mesh-list
92602849|NCT00475930|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92602850|NCT00475930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92602851|NCT00475930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602852|NCT00475930|Disinfectants|disinfectants|mesh-ancestor
92602853|NCT00475930|Dermatologic Agents|dermatologic agents|mesh-ancestor
92602854|NCT00475969|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92602855|NCT00475969|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92602856|NCT00475969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92602857|NCT00475969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92602858|NCT00475969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010263|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92602862|NCT00475969|Sensory System Agents|sensory system agents|mesh-ancestor
92602863|NCT00475969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602864|NCT00475969|Antidepressive Agents|antidepressive agents|mesh-ancestor
92602865|NCT00475969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602866|NCT00475969|Dopamine Agents|dopamine agents|mesh-ancestor
92602867|NCT00476164|Rituximab|rituximab|mesh-list
92602868|NCT00476164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92602869|NCT00476164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602870|NCT00476164|Immunologic Factors|immunologic factors|mesh-ancestor
92602871|NCT00476164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602872|NCT00476164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602873|NCT00402077|Pramlintide|pramlintide|mesh-list
92602874|NCT00402077|Phentermine|phentermine|mesh-list
92602875|NCT00402077|Sibutramine|sibutramine|mesh-list
92602876|NCT00402077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602877|NCT00402077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602878|NCT00402077|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92602879|NCT00402077|Appetite Depressants|appetite depressants|mesh-ancestor
92602880|NCT00402077|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92602881|NCT00402077|Sympathomimetics|sympathomimetics|mesh-ancestor
92602882|NCT00402077|Autonomic Agents|autonomic agents|mesh-ancestor
92602883|NCT00402077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536946|NCT00137527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536947|NCT00137566|Acetaminophen|acetaminophen|mesh-list
92602884|NCT00402077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92602885|NCT00402077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602886|NCT00402077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602887|NCT00402077|Antidepressive Agents|antidepressive agents|mesh-ancestor
92602888|NCT00402077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92602890|NCT00476359|Saquinavir|saquinavir|mesh-list
92602891|NCT00476359|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92602892|NCT00476359|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92602893|NCT00476359|Protease Inhibitors|protease inhibitors|mesh-ancestor
92602894|NCT00476359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602895|NCT00476359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602896|NCT00476359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92602897|NCT00476359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92602898|NCT00476359|Antiviral Agents|antiviral agents|mesh-ancestor
92602899|NCT00476359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602900|NCT00476359|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92602901|NCT00476359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92602902|NCT00117117|Darbepoetin alfa|darbepoetin alfa|mesh-list
92602903|NCT00117117|Hematinics|hematinics|mesh-ancestor
92602904|NCT00476437|Insulin|insulin|mesh-list
92602905|NCT00476437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92602906|NCT00476437|Insulin Aspart|insulin aspart|mesh-list
92602907|NCT00476437|Biphasic Insulins|biphasic insulins|mesh-list
92602908|NCT00476437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602909|NCT00476437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602910|NCT00117494|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92602911|NCT00117494|Pravastatin|pravastatin|mesh-list
92602912|NCT00117494|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92602913|NCT00117494|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92602914|NCT00117494|Antimetabolites|antimetabolites|mesh-ancestor
92602915|NCT00117494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602916|NCT00117494|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92602917|NCT00117494|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92602918|NCT00117494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602919|NCT00117533|Ribavirin|ribavirin|mesh-list
92602920|NCT00117533|Interferon alpha-2|interferon alpha-2|mesh-list
92602921|NCT00117533|Antimetabolites|antimetabolites|mesh-ancestor
92602922|NCT00117533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602923|NCT00117533|Antiviral Agents|antiviral agents|mesh-ancestor
92602924|NCT00117533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602925|NCT00117533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602926|NCT00117234|Darbepoetin alfa|darbepoetin alfa|mesh-list
92602927|NCT00117234|Hematinics|hematinics|mesh-ancestor
92602928|NCT00117611|Omalizumab|omalizumab|mesh-list
92602929|NCT00117611|Antibodies|antibodies|mesh-list
92602930|NCT00117611|Immunologic Factors|immunologic factors|mesh-ancestor
92602931|NCT00117611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602932|NCT00117611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92602933|NCT00117611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92602939|NCT04727684|Luteolytic Agents|luteolytic agents|mesh-ancestor
92602940|NCT04727684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92602941|NCT04727684|Contraceptive Agents|contraceptive agents|mesh-ancestor
92602942|NCT04727684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92602943|NCT04727684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602944|NCT04727684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92602945|NCT04727684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92602946|NCT04727684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602947|NCT04727684|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92602948|NCT04727684|Fertility Agents|fertility agents|mesh-ancestor
92602949|NCT04727684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92602950|NCT04727684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92602951|NCT03277261|Teriflunomide|teriflunomide|mesh-list
92602952|NCT03277261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92602953|NCT03277261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92602954|NCT03277261|Analgesics|analgesics|mesh-ancestor
92602955|NCT03277261|Sensory System Agents|sensory system agents|mesh-ancestor
92602956|NCT03277261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602957|NCT03277261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602958|NCT03277261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92602959|NCT03277261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602960|NCT03277261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92536948|NCT00137566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92536949|NCT00137566|Analgesics|analgesics|mesh-ancestor
92536950|NCT00137566|Sensory System Agents|sensory system agents|mesh-ancestor
92536951|NCT00137566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536952|NCT00137566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536953|NCT00137566|Antipyretics|antipyretics|mesh-ancestor
92536954|NCT00137605|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92602961|NCT03277261|Immunologic Factors|immunologic factors|mesh-ancestor
92602963|NCT02273947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92602964|NCT02273947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92602965|NCT02273947|Antiviral Agents|antiviral agents|mesh-ancestor
92602966|NCT02273947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602967|NCT05367336|Fentanyl|fentanyl|mesh-list
92602968|NCT05367336|Morphine|morphine|mesh-list
92602969|NCT05367336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92602970|NCT05367336|Narcotics|narcotics|mesh-ancestor
92602971|NCT05367336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92602972|NCT05367336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602973|NCT05367336|Analgesics|analgesics|mesh-ancestor
92602974|NCT05367336|Sensory System Agents|sensory system agents|mesh-ancestor
92602975|NCT05367336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92602976|NCT05367336|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92602977|NCT05367336|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92602978|NCT05367336|Anesthetics, General|anesthetics, general|mesh-ancestor
92602979|NCT05367336|Anesthetics|anesthetics|mesh-ancestor
92602980|NCT00476515|Rituximab|rituximab|mesh-list
92602981|NCT00476515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92602982|NCT00476515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602983|NCT00476515|Immunologic Factors|immunologic factors|mesh-ancestor
92602984|NCT00476515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602985|NCT00476515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92602986|NCT00117689|Mycophenolic Acid|mycophenolic acid|mesh-list
92602987|NCT00117689|Tacrolimus|tacrolimus|mesh-list
92602988|NCT00117689|Thymoglobulin|thymoglobulin|mesh-list
92602989|NCT00117689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92602990|NCT00117689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92602991|NCT00117689|Immunologic Factors|immunologic factors|mesh-ancestor
92602992|NCT00117689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602993|NCT00117689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92602994|NCT00117689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602995|NCT00117689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602996|NCT00117689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92602997|NCT00117689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602998|NCT00117689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92602999|NCT00117689|Antitubercular Agents|antitubercular agents|mesh-ancestor
92603000|NCT00117689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603001|NCT00117689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603002|NCT00117273|Levonorgestrel|levonorgestrel|mesh-list
92603003|NCT00117273|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92603004|NCT00117273|Estradiol|estradiol|mesh-list
92603005|NCT00117273|Estrogens|estrogens|mesh-ancestor
92603006|NCT00117273|Hormones|hormones|mesh-ancestor
92010406|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603008|NCT00117273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603009|NCT00117273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92603010|NCT00117273|Contraceptive Agents|contraceptive agents|mesh-ancestor
92603011|NCT00117273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92603012|NCT00117273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92603013|NCT00117273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92603014|NCT00117273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92603015|NCT00117273|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92603016|NCT00476710|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92603017|NCT00476710|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92603018|NCT00476710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92603019|NCT00476710|Antimetabolites|antimetabolites|mesh-ancestor
92603020|NCT00476710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603021|NCT00476710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92603023|NCT00117728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92603024|NCT00117728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92536955|NCT00137605|Immunologic Factors|immunologic factors|mesh-ancestor
92536956|NCT00137605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603025|NCT00117728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603026|NCT00117728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603027|NCT00117728|Antiviral Agents|antiviral agents|mesh-ancestor
92603028|NCT00117728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603029|NCT00117728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92603030|NCT00117728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92603031|NCT00117728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92603032|NCT00117728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92603033|NCT00117767|Terbinafine|terbinafine|mesh-list
92603034|NCT00117767|Griseofulvin|griseofulvin|mesh-list
92603035|NCT00117767|Antifungal Agents|antifungal agents|mesh-ancestor
92603036|NCT00117767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603037|NCT00117767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603038|NCT00117767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603040|NCT03277066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92603041|NCT03277066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603042|NCT03277066|Analgesics|analgesics|mesh-ancestor
92603043|NCT03277066|Sensory System Agents|sensory system agents|mesh-ancestor
92603044|NCT03277066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603045|NCT03277066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603046|NCT03277066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603047|NCT03277066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603048|NCT03277066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92603049|NCT03277066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603050|NCT03277066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603051|NCT00117351|Bortezomib|bortezomib|mesh-list
92603052|NCT00117351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603053|NCT00118196|Azacitidine|azacitidine|mesh-list
92603054|NCT00118196|Arsenic Trioxide|arsenic trioxide|mesh-list
92603055|NCT00118196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92603056|NCT00118196|Antimetabolites|antimetabolites|mesh-ancestor
92603057|NCT00118196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603058|NCT00118196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603059|NCT00118196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603060|NCT00118235|Bevacizumab|bevacizumab|mesh-list
92603061|NCT00118235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92603062|NCT00118235|Irinotecan|irinotecan|mesh-list
92603063|NCT00118235|Antibodies|antibodies|mesh-list
92603064|NCT00118235|Immunoglobulins|immunoglobulins|mesh-list
92603065|NCT00118235|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92603066|NCT00118235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603067|NCT00118235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92603068|NCT00118235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92603069|NCT00118235|Growth Substances|growth substances|mesh-ancestor
92603070|NCT00118235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603071|NCT00118235|Growth Inhibitors|growth inhibitors|mesh-ancestor
92603072|NCT00118235|Immunologic Factors|immunologic factors|mesh-ancestor
92603073|NCT00118235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92603074|NCT00118235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92603075|NCT00118235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603076|NCT00118235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603077|NCT00118313|Imiquimod|imiquimod|mesh-list
92603078|NCT00118313|Sargramostim|sargramostim|mesh-list
92603079|NCT00118313|Freund's Adjuvant|freund's adjuvant|mesh-list
92603081|NCT00118313|Immunologic Factors|immunologic factors|mesh-ancestor
92603082|NCT00118313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603083|NCT00118313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603084|NCT00118313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92603085|NCT00118313|Interferon Inducers|interferon inducers|mesh-ancestor
92603086|NCT00118313|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92603087|NCT00118313|Protective Agents|protective agents|mesh-ancestor
92603088|NCT00118313|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92603089|NCT00118313|Antioxidants|antioxidants|mesh-ancestor
92603090|NCT00118313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603091|NCT03271021|Minocycline|minocycline|mesh-list
92603092|NCT03271021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603093|NCT03271021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603094|NCT02273986|Digoxin|digoxin|mesh-list
92603095|NCT02273986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92603096|NCT02273986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92603097|NCT02273986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536958|NCT00137761|Gefitinib|gefitinib|mesh-list
92536959|NCT00137761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92536960|NCT00137761|Tubulin Modulators|tubulin modulators|mesh-ancestor
92536961|NCT00137761|Antimitotic Agents|antimitotic agents|mesh-ancestor
92603098|NCT02273986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603099|NCT02273986|Protective Agents|protective agents|mesh-ancestor
92603100|NCT02273986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603101|NCT00118508|Risedronic Acid|risedronic acid|mesh-list
92603102|NCT00118508|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92603103|NCT00118508|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603104|NCT00118508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603105|NCT00118508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92603106|NCT00118508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603107|NCT00118508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92603108|NCT00476983|Ritonavir|ritonavir|mesh-list
92603109|NCT00476983|Saquinavir|saquinavir|mesh-list
92603110|NCT00476983|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92603111|NCT00476983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92603112|NCT00476983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92603113|NCT00476983|Protease Inhibitors|protease inhibitors|mesh-ancestor
92603114|NCT00476983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603115|NCT00476983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603116|NCT00476983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92603117|NCT00476983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92603118|NCT00476983|Antiviral Agents|antiviral agents|mesh-ancestor
92603119|NCT00476983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603120|NCT00476983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92603121|NCT00476983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92603122|NCT00476983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92603123|NCT00476983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92603124|NCT00477061|Morphine|morphine|mesh-list
92603125|NCT00477061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92603126|NCT00477061|Narcotics|narcotics|mesh-ancestor
92603127|NCT00477061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603128|NCT00477061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603129|NCT00477061|Analgesics|analgesics|mesh-ancestor
92603130|NCT00477061|Sensory System Agents|sensory system agents|mesh-ancestor
92603131|NCT00477061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603132|NCT00477217|Zoledronic Acid|zoledronic acid|mesh-list
92603133|NCT00477217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92603134|NCT00477217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603135|NCT00477373|Valproic Acid|valproic acid|mesh-list
92603136|NCT00477373|Anticonvulsants|anticonvulsants|mesh-ancestor
92603137|NCT00477373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603138|NCT00477373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603139|NCT00477373|GABA Agents|gaba agents|mesh-ancestor
92603140|NCT00477373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603141|NCT00477373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603142|NCT00477373|Antimanic Agents|antimanic agents|mesh-ancestor
92603143|NCT00477373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603144|NCT00477373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603145|NCT00477373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603146|NCT00477763|Cyclosporine|cyclosporine|mesh-list
92603147|NCT00477763|Cyclosporins|cyclosporins|mesh-list
92603148|NCT00477763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603149|NCT00477763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603150|NCT00477763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603151|NCT00477763|Immunologic Factors|immunologic factors|mesh-ancestor
92603152|NCT00477763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603157|NCT00477763|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92603158|NCT00477802|Botulinum Toxins|botulinum toxins|mesh-list
92603159|NCT00477802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92603160|NCT00477802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92603161|NCT00477802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92603162|NCT00477802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603163|NCT00477802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603164|NCT00477802|Cholinergic Agents|cholinergic agents|mesh-ancestor
92603165|NCT00477802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536962|NCT00137761|Mitosis Modulators|mitosis modulators|mesh-ancestor
92536963|NCT00137761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603166|NCT00477802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603167|NCT00477802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92603168|NCT00477802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603169|NCT00477880|Cetuximab|cetuximab|mesh-list
92603170|NCT00477880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92603171|NCT00477880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603172|NCT00118820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92603173|NCT00118820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603174|NCT00477997|Hormones|hormones|mesh-list
92603175|NCT00477997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603176|NCT00477997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603177|NCT00478075|Bortezomib|bortezomib|mesh-list
92603178|NCT00478075|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92603179|NCT00478075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603180|NCT00478075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603181|NCT00478075|Analgesics|analgesics|mesh-ancestor
92603182|NCT00478075|Sensory System Agents|sensory system agents|mesh-ancestor
92603183|NCT00478075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603184|NCT00478075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603185|NCT00117078|Darbepoetin alfa|darbepoetin alfa|mesh-list
92603186|NCT00117078|Hematinics|hematinics|mesh-ancestor
92603188|NCT00478114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603189|NCT00478114|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603190|NCT00478114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603191|NCT00478114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603192|NCT00478270|Ibandronic Acid|ibandronic acid|mesh-list
92603193|NCT00478270|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92603194|NCT00478270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603195|NCT00478504|Letrozole|letrozole|mesh-list
92603196|NCT00478504|Clomiphene|clomiphene|mesh-list
92603197|NCT00478504|Enclomiphene|enclomiphene|mesh-list
92603198|NCT00478504|Zuclomiphene|zuclomiphene|mesh-list
92603199|NCT00478504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603200|NCT00478504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603201|NCT00478504|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92603202|NCT00478504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92603203|NCT00478504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603204|NCT00478504|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92603205|NCT00478504|Hormone Antagonists|hormone antagonists|mesh-ancestor
92603206|NCT00478504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603207|NCT00478504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603208|NCT00478504|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92603209|NCT00478504|Fertility Agents|fertility agents|mesh-ancestor
92603210|NCT00478504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92603211|NCT00478504|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92603212|NCT00478504|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92603213|NCT00117468|Progesterone|progesterone|mesh-list
92603214|NCT00117468|Progestins|progestins|mesh-ancestor
92603215|NCT00117468|Hormones|hormones|mesh-ancestor
92603216|NCT00117468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603217|NCT00117468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603218|NCT03271879|Empagliflozin|empagliflozin|mesh-list
92603219|NCT03271879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92603220|NCT03271879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603221|NCT03271879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603222|NCT03271879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603223|NCT00478543|Furosemide|furosemide|mesh-list
92603227|NCT00478543|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92603228|NCT00478543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603229|NCT00478543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603230|NCT00118937|Metformin|metformin|mesh-list
92603231|NCT00118937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603232|NCT00118937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603233|NCT00478621|Vaccines|vaccines|mesh-list
92603234|NCT00478621|Immunologic Factors|immunologic factors|mesh-ancestor
92603235|NCT00478621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603236|NCT00478660|Adalimumab|adalimumab|mesh-list
92603237|NCT00478660|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92603238|NCT00478660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536964|NCT00137761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536965|NCT00137761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536966|NCT00137800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92536967|NCT00137800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603239|NCT00478660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603240|NCT00478699|Cisplatin|cisplatin|mesh-list
92603241|NCT00478699|Gemcitabine|gemcitabine|mesh-list
92603242|NCT00478699|Docetaxel|docetaxel|mesh-list
92603243|NCT00478699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603244|NCT00478699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92603245|NCT00478699|Antimetabolites|antimetabolites|mesh-ancestor
92603246|NCT00478699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603247|NCT00478699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92603248|NCT00478699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92603249|NCT00478699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92603250|NCT00118976|Lisinopril|lisinopril|mesh-list
92603251|NCT00118976|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92603252|NCT00118976|Protease Inhibitors|protease inhibitors|mesh-ancestor
92603253|NCT00118976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328193|NCT00003152|Glucocorticoids|glucocorticoids|mesh-ancestor
92603254|NCT00118976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603255|NCT00118976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92603256|NCT00118976|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92603257|NCT00118976|Protective Agents|protective agents|mesh-ancestor
92603258|NCT00118976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603259|NCT00478816|Vaccines|vaccines|mesh-list
92603260|NCT00478816|Immunologic Factors|immunologic factors|mesh-ancestor
92603261|NCT00478816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603262|NCT00478855|Piperacillin|piperacillin|mesh-list
92603263|NCT00478855|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92603264|NCT00478855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603265|NCT00478855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603266|NCT00478855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92603267|NCT00478855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603268|NCT00478855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603269|NCT00117546|Methyldopa|methyldopa|mesh-list
92603270|NCT00117546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92603271|NCT00117546|Sympatholytics|sympatholytics|mesh-ancestor
92603272|NCT00117546|Autonomic Agents|autonomic agents|mesh-ancestor
92603273|NCT00117546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603274|NCT00117546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603275|NCT00117546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92603276|NCT00117546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92603277|NCT00117546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92603278|NCT00117546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92603279|NCT00117546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603280|NCT00117546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603281|NCT00479206|Artesunate|artesunate|mesh-list
92603282|NCT00479206|Antimalarials|antimalarials|mesh-ancestor
92603283|NCT00479206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92603284|NCT00479206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92360879|NCT00504504|Bleomycin|bleomycin|mesh-list
92603285|NCT00479206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603286|NCT00479206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603287|NCT00479206|Antiviral Agents|antiviral agents|mesh-ancestor
92603288|NCT00479206|Schistosomicides|schistosomicides|mesh-ancestor
92603289|NCT00479206|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92603290|NCT00479206|Anthelmintics|anthelmintics|mesh-ancestor
92603291|NCT00119132|Artesunate|artesunate|mesh-list
92603292|NCT00119132|Pyrimethamine|pyrimethamine|mesh-list
92603293|NCT00119132|Sulfadoxine|sulfadoxine|mesh-list
92603294|NCT00119132|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92603295|NCT00119132|Amodiaquine|amodiaquine|mesh-list
92603296|NCT00119132|Antimalarials|antimalarials|mesh-ancestor
92603299|NCT00119132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603300|NCT00119132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603301|NCT00119132|Antiviral Agents|antiviral agents|mesh-ancestor
92603302|NCT00119132|Schistosomicides|schistosomicides|mesh-ancestor
92603303|NCT00119132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92603304|NCT00119132|Anthelmintics|anthelmintics|mesh-ancestor
92603305|NCT00119132|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92603306|NCT00119132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603307|NCT00119132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603308|NCT00119132|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92536968|NCT00137800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536969|NCT00137800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536970|NCT00137800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603309|NCT00479323|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92603310|NCT00479323|Immunologic Factors|immunologic factors|mesh-ancestor
92603311|NCT00479323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603312|NCT00479362|Aspirin|aspirin|mesh-list
92603313|NCT00479362|Warfarin|warfarin|mesh-list
92603314|NCT00479362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92603315|NCT00479362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603316|NCT00479362|Analgesics|analgesics|mesh-ancestor
92603317|NCT00479362|Sensory System Agents|sensory system agents|mesh-ancestor
92603318|NCT00479362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603319|NCT00479362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603320|NCT00479362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603321|NCT00479362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603322|NCT00479362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92603323|NCT00479362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92603324|NCT00479362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603325|NCT00479362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92603326|NCT00479362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92603327|NCT00479362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603328|NCT00479362|Antipyretics|antipyretics|mesh-ancestor
92603329|NCT00479362|Anticoagulants|anticoagulants|mesh-ancestor
92603330|NCT00119171|Capecitabine|capecitabine|mesh-list
92603331|NCT00119171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92603332|NCT00119171|Antimetabolites|antimetabolites|mesh-ancestor
92603333|NCT00119171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603334|NCT00119171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603335|NCT00117624|Darbepoetin alfa|darbepoetin alfa|mesh-list
92603336|NCT00117624|Hematinics|hematinics|mesh-ancestor
92603337|NCT00479479|Vitamin B 12|vitamin b 12|mesh-list
92603338|NCT00479479|Hydroxocobalamin|hydroxocobalamin|mesh-list
92603339|NCT00479479|Vitamins|vitamins|mesh-ancestor
92603340|NCT00479479|Micronutrients|micronutrients|mesh-ancestor
92603341|NCT00479479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603342|NCT00479479|Vitamin B Complex|vitamin b complex|mesh-ancestor
92603343|NCT00479479|Hematinics|hematinics|mesh-ancestor
92603344|NCT00119210|Bupropion|bupropion|mesh-list
92603345|NCT00119210|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92603346|NCT00119210|Antidepressive Agents|antidepressive agents|mesh-ancestor
92603347|NCT00119210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603348|NCT00119210|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92603349|NCT00119210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92603350|NCT00119210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603351|NCT00119210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603352|NCT00119210|Dopamine Agents|dopamine agents|mesh-ancestor
92603353|NCT00119210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603354|NCT00119210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360882|NCT00504504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603355|NCT00119210|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92603356|NCT00119210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92603357|NCT00119210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603358|NCT00117663|Hormones|hormones|mesh-list
92603359|NCT00117663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603360|NCT00117663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603361|NCT00479752|Oxaliplatin|oxaliplatin|mesh-list
92603362|NCT00479752|Cetuximab|cetuximab|mesh-list
92603363|NCT00479752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603364|NCT00479752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92603365|NCT00119249|Sorafenib|sorafenib|mesh-list
92603366|NCT00119249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603367|NCT00119249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603368|NCT00119249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603369|NCT00119249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603374|NCT00479908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92603375|NCT00479908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92603376|NCT00479908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603377|NCT00479908|Urological Agents|urological agents|mesh-ancestor
92603379|NCT00479986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603380|NCT00479986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603381|NCT00480064|Cytarabine|cytarabine|mesh-list
92536971|NCT02858921|Pembrolizumab|pembrolizumab|mesh-list
92603382|NCT00480064|Lomustine|lomustine|mesh-list
92603383|NCT00480064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92603384|NCT00480064|Antimetabolites|antimetabolites|mesh-ancestor
92603385|NCT00480064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603386|NCT00480064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603387|NCT00480064|Antiviral Agents|antiviral agents|mesh-ancestor
92603388|NCT00480064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603389|NCT00480064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603390|NCT00480064|Immunologic Factors|immunologic factors|mesh-ancestor
92603391|NCT00480064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603392|NCT00480064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92603393|NCT00480064|Alkylating Agents|alkylating agents|mesh-ancestor
92603394|NCT00480103|Mineral Oil|mineral oil|mesh-list
92603395|NCT00480103|Emollients|emollients|mesh-ancestor
92603396|NCT00480103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92603397|NCT00480142|Oxycodone|oxycodone|mesh-list
92603398|NCT00480142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92603399|NCT00480142|Narcotics|narcotics|mesh-ancestor
92603400|NCT00480142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603401|NCT00480142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603402|NCT00480142|Analgesics|analgesics|mesh-ancestor
92603403|NCT00480142|Sensory System Agents|sensory system agents|mesh-ancestor
92603404|NCT00480142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603405|NCT00119483|Methyltestosterone|methyltestosterone|mesh-list
92603406|NCT00119483|Testosterone|testosterone|mesh-list
92603407|NCT00119483|Testosterone undecanoate|testosterone undecanoate|mesh-list
92603408|NCT00119483|Testosterone enanthate|testosterone enanthate|mesh-list
92603409|NCT00119483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92603410|NCT00119483|Androgens|androgens|mesh-ancestor
92603411|NCT00119483|Hormones|hormones|mesh-ancestor
92603412|NCT00119483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603413|NCT00119483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603414|NCT00119483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92603415|NCT00119483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603416|NCT00119483|Anabolic Agents|anabolic agents|mesh-ancestor
92603417|NCT00480181|Nabilone|nabilone|mesh-list
92603418|NCT00480181|Antiemetics|antiemetics|mesh-ancestor
92603419|NCT00480181|Autonomic Agents|autonomic agents|mesh-ancestor
92603420|NCT00480181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603421|NCT00480181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603422|NCT00480181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603423|NCT00480181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92603424|NCT00480181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603425|NCT00480181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603426|NCT00480181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603427|NCT00480298|Methylprednisolone|methylprednisolone|mesh-list
92603428|NCT00480298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92603429|NCT00480298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92603430|NCT00480298|Prednisolone|prednisolone|mesh-list
92603431|NCT00480298|Prednisolone acetate|prednisolone acetate|mesh-list
92603432|NCT00480298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92603433|NCT00480298|Prednisolone phosphate|prednisolone phosphate|mesh-list
92603434|NCT00480298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603435|NCT00480298|Antiemetics|antiemetics|mesh-ancestor
92603436|NCT00480298|Autonomic Agents|autonomic agents|mesh-ancestor
92603437|NCT00480298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603438|NCT00480298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603439|NCT00480298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603440|NCT00480298|Glucocorticoids|glucocorticoids|mesh-ancestor
92603441|NCT00480298|Hormones|hormones|mesh-ancestor
92010847|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
92603445|NCT00480298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92603446|NCT00480298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603447|NCT00480376|Gentamicins|gentamicins|mesh-list
92603448|NCT00480376|Ofloxacin|ofloxacin|mesh-list
92603449|NCT00480376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603450|NCT00480376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603451|NCT00480376|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92603452|NCT00480376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603453|NCT00480376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603454|NCT00480376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92603455|NCT00480376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92603456|NCT00480376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92603457|NCT00480376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603458|NCT00480376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92536973|NCT02858921|Dabrafenib|dabrafenib|mesh-list
92536974|NCT02858921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92603459|NCT00480376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92603460|NCT00117702|Everolimus|everolimus|mesh-list
92603461|NCT00117702|Tacrolimus|tacrolimus|mesh-list
92603462|NCT00117702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603463|NCT00117702|Immunologic Factors|immunologic factors|mesh-ancestor
92603464|NCT00117702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603465|NCT00117702|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92603466|NCT00117702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603467|NCT00117702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603468|NCT00117702|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92603469|NCT00117702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603470|NCT00117702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603471|NCT00480454|Vaccines|vaccines|mesh-list
92603472|NCT00480454|Immunologic Factors|immunologic factors|mesh-ancestor
92603473|NCT00480454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603474|NCT00480571|Perphenazine|perphenazine|mesh-list
92603475|NCT00480571|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92603476|NCT00480571|GABA Agents|gaba agents|mesh-ancestor
92603477|NCT00480571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603478|NCT00480571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603479|NCT00480571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603480|NCT00480571|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92603481|NCT00480571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603482|NCT00480571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603483|NCT00480571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603484|NCT00480571|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92603486|NCT00480610|Tacrolimus|tacrolimus|mesh-list
92603487|NCT00480610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603488|NCT00480610|Immunologic Factors|immunologic factors|mesh-ancestor
92603489|NCT00480610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603490|NCT00480610|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92603491|NCT00480610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603492|NCT00480610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603493|NCT00480649|Fluticasone|fluticasone|mesh-list
92603494|NCT00480649|Xhance|xhance|mesh-list
92603495|NCT00480649|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92603496|NCT00480649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603497|NCT00480649|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92603498|NCT00480649|Autonomic Agents|autonomic agents|mesh-ancestor
92603499|NCT00480649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603500|NCT00480649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603501|NCT00480649|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92603502|NCT00480649|Respiratory System Agents|respiratory system agents|mesh-ancestor
92603503|NCT00480649|Dermatologic Agents|dermatologic agents|mesh-ancestor
92603504|NCT00480649|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92603505|NCT00480649|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92603506|NCT00480649|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92603507|NCT00480649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92603508|NCT00480649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92603509|NCT00480649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603510|NCT00480649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603511|NCT00119639|Sorafenib|sorafenib|mesh-list
92603512|NCT00119639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603513|NCT00119639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603519|NCT00480844|Serotonin Agents|serotonin agents|mesh-ancestor
92603520|NCT00480844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603521|NCT00480844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603522|NCT00480844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603523|NCT00480844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92603524|NCT00480844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603525|NCT00480844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603526|NCT00480844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603527|NCT00480844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92603528|NCT00480844|Dopamine Agents|dopamine agents|mesh-ancestor
92603529|NCT00480883|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92603530|NCT00480883|Allopurinol|allopurinol|mesh-list
92603531|NCT00480883|Antimetabolites|antimetabolites|mesh-ancestor
92603532|NCT00480883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603533|NCT00480883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603534|NCT00480883|Gout Suppressants|gout suppressants|mesh-ancestor
92536976|NCT02858921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92603535|NCT00480883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603536|NCT00480883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92603537|NCT00480883|Antioxidants|antioxidants|mesh-ancestor
92603538|NCT00480883|Protective Agents|protective agents|mesh-ancestor
92603539|NCT00480883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603540|NCT00480883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92603541|NCT00480883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92603542|NCT00480883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603543|NCT05236998|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92603544|NCT05236998|Dapagliflozin|dapagliflozin|mesh-list
92603545|NCT05236998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603546|NCT05236998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603547|NCT05236998|Incretins|incretins|mesh-ancestor
92603548|NCT05236998|Hormones|hormones|mesh-ancestor
92603549|NCT05236998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603550|NCT05236998|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92603551|NCT05236998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92603552|NCT05236998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603553|NCT05236998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603554|NCT05236998|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92603555|NCT01240096|Mirtazapine|mirtazapine|mesh-list
92603556|NCT01240096|Antidepressive Agents|antidepressive agents|mesh-ancestor
92603557|NCT01240096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603558|NCT01240096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92603559|NCT01240096|Histamine Antagonists|histamine antagonists|mesh-ancestor
92603560|NCT01240096|Histamine Agents|histamine agents|mesh-ancestor
92603561|NCT01240096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603562|NCT01240096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603563|NCT01240096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603564|NCT01240096|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92603565|NCT01240096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603566|NCT01240096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603567|NCT01240096|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92603568|NCT01240096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92603569|NCT01240096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92603570|NCT01240096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92603571|NCT01240096|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92603572|NCT01240096|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92603573|NCT01240096|Serotonin Agents|serotonin agents|mesh-ancestor
92603574|NCT01240096|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92603575|NCT00119756|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92603576|NCT00119756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92603577|NCT00119756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603578|NCT00119756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603579|NCT00119756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603580|NCT00119756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603581|NCT00119756|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92603582|NCT00119756|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92603587|NCT00119756|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92603588|NCT00119756|Dopamine Agents|dopamine agents|mesh-ancestor
92603589|NCT01240174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92603590|NCT01240174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603591|NCT01240252|Insulin|insulin|mesh-list
92603592|NCT01240252|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92603593|NCT01240252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603594|NCT01240252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603595|NCT05233605|Dexmedetomidine|dexmedetomidine|mesh-list
92603596|NCT05233605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92603597|NCT05233605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603598|NCT05233605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603599|NCT05233605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603600|NCT05233605|Analgesics|analgesics|mesh-ancestor
92603601|NCT05233605|Sensory System Agents|sensory system agents|mesh-ancestor
92603602|NCT05233605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603603|NCT05233605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92603604|NCT05233605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92603605|NCT05233605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92603606|NCT05233605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92603607|NCT05233605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536977|NCT02858921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92536978|NCT02858921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92536979|NCT02858921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92536980|NCT00137995|Cytarabine|cytarabine|mesh-list
92536981|NCT00137995|Dexamethasone|dexamethasone|mesh-list
92603608|NCT05233605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603609|NCT00117780|Insulin|insulin|mesh-list
92603610|NCT00117780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92603611|NCT00117780|Insulin Aspart|insulin aspart|mesh-list
92603612|NCT00117780|Insulin Detemir|insulin detemir|mesh-list
92603613|NCT00117780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603614|NCT00117780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603615|NCT01240408|Lenvatinib|lenvatinib|mesh-list
92603616|NCT01240408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603617|NCT01240408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603618|NCT01240408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603619|NCT01240408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603620|NCT00481273|Azacitidine|azacitidine|mesh-list
92603621|NCT00481273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92603622|NCT00481273|Antimetabolites|antimetabolites|mesh-ancestor
92603623|NCT00481273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603624|NCT00481273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603625|NCT00481273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603626|NCT00481312|Midazolam|midazolam|mesh-list
92603627|NCT00481312|Dexmedetomidine|dexmedetomidine|mesh-list
92603628|NCT00481312|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92603629|NCT00481312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603630|NCT00481312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603631|NCT00481312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603632|NCT00481312|Analgesics|analgesics|mesh-ancestor
92603633|NCT00481312|Sensory System Agents|sensory system agents|mesh-ancestor
92603634|NCT00481312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603635|NCT00481312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92603636|NCT00481312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92603637|NCT00481312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92603638|NCT00481312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92603639|NCT00481312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603640|NCT00481312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603641|NCT00481312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92603642|NCT00481312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92603643|NCT00481312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603644|NCT00481312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603645|NCT00481312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92603646|NCT00481312|Anesthetics, General|anesthetics, general|mesh-ancestor
92603647|NCT00481312|Anesthetics|anesthetics|mesh-ancestor
92603648|NCT00481312|GABA Modulators|gaba modulators|mesh-ancestor
92603649|NCT00481312|GABA Agents|gaba agents|mesh-ancestor
92603650|NCT00481429|Rosiglitazone|rosiglitazone|mesh-list
92603651|NCT00481429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603652|NCT00481429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603653|NCT00119990|Dialysis Solutions|dialysis solutions|mesh-list
92603656|NCT00481624|Epoetin Alfa|epoetin alfa|mesh-list
92603657|NCT00481624|Ferric gluconate|ferric gluconate|mesh-list
92603658|NCT00481624|Hematinics|hematinics|mesh-ancestor
92603659|NCT00117897|Lenograstim|lenograstim|mesh-list
92603660|NCT00117897|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92603661|NCT00117897|Immunologic Factors|immunologic factors|mesh-ancestor
92603662|NCT00117897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603663|NCT00481663|Metformin|metformin|mesh-list
92603664|NCT00481663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92603665|NCT00481663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603666|NCT00481663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603667|NCT00481663|Incretins|incretins|mesh-ancestor
92603668|NCT00481663|Hormones|hormones|mesh-ancestor
92603669|NCT00481663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603670|NCT00481663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92603671|NCT00481663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92603672|NCT00481663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603673|NCT00481663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603674|NCT00481702|Metronidazole|metronidazole|mesh-list
92603675|NCT00481702|Ceftriaxone|ceftriaxone|mesh-list
92603676|NCT00481702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92536982|NCT00137995|Rituximab|rituximab|mesh-list
92536983|NCT00137995|Etoposide|etoposide|mesh-list
92536984|NCT00137995|Etoposide phosphate|etoposide phosphate|mesh-list
92603677|NCT00481702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603678|NCT00481702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92603679|NCT00481702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92603680|NCT00481741|Hemostatics|hemostatics|mesh-list
92603681|NCT00481741|Coagulants|coagulants|mesh-ancestor
92603682|NCT00481819|Mycophenolic Acid|mycophenolic acid|mesh-list
92603683|NCT00481819|Methylprednisolone|methylprednisolone|mesh-list
92603684|NCT00481819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92603685|NCT00481819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92603686|NCT00481819|Prednisolone|prednisolone|mesh-list
92603687|NCT00481819|Prednisolone acetate|prednisolone acetate|mesh-list
92603688|NCT00481819|Tacrolimus|tacrolimus|mesh-list
92603689|NCT00481819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92603690|NCT00481819|Prednisolone phosphate|prednisolone phosphate|mesh-list
92603691|NCT00481819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603692|NCT00481819|Immunologic Factors|immunologic factors|mesh-ancestor
92603693|NCT00481819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603694|NCT00481819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92603695|NCT00481819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603696|NCT00481819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603697|NCT00481819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92603698|NCT00481819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603699|NCT00481819|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92603700|NCT00481819|Antitubercular Agents|antitubercular agents|mesh-ancestor
92603701|NCT00481819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603702|NCT00481819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603703|NCT00481819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603704|NCT00481819|Antiemetics|antiemetics|mesh-ancestor
92603705|NCT00481819|Autonomic Agents|autonomic agents|mesh-ancestor
92603706|NCT00481819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603707|NCT00481819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603708|NCT00481819|Glucocorticoids|glucocorticoids|mesh-ancestor
92603709|NCT00481819|Hormones|hormones|mesh-ancestor
92603710|NCT00481819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603711|NCT00481819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92603712|NCT00481819|Protective Agents|protective agents|mesh-ancestor
92603713|NCT00481819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92603714|NCT02958059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92603715|NCT02958059|Cefoxitin|cefoxitin|mesh-list
92603716|NCT02958059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603717|NCT00481975|Rimonabant|rimonabant|mesh-list
92603718|NCT00481975|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92603719|NCT00481975|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92603720|NCT00481975|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92603721|NCT00481975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603722|NCT00481975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603723|NCT00481975|Hormones|hormones|mesh-ancestor
92603724|NCT00481975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603725|NCT00481975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603726|NCT00482209|Misoprostol|misoprostol|mesh-list
92603727|NCT00482209|Mifepristone|mifepristone|mesh-list
92603728|NCT00482209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92603736|NCT00482209|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92603737|NCT00482209|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92603738|NCT00482209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92603739|NCT00482209|Contraceptive Agents|contraceptive agents|mesh-ancestor
92603740|NCT00482209|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92603741|NCT00482209|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92603742|NCT00482209|Hormone Antagonists|hormone antagonists|mesh-ancestor
92603743|NCT00482209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603744|NCT00482209|Luteolytic Agents|luteolytic agents|mesh-ancestor
92603745|NCT00482209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92603746|NCT00482209|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92603748|NCT00117936|Mitosis Modulators|mitosis modulators|mesh-ancestor
92603749|NCT00117936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603750|NCT00482248|Omalizumab|omalizumab|mesh-list
92603751|NCT00482248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92603752|NCT00482248|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92603753|NCT00482248|Respiratory System Agents|respiratory system agents|mesh-ancestor
92603754|NCT00120185|Interleukin-2|interleukin-2|mesh-list
92536985|NCT00137995|Melphalan|melphalan|mesh-list
92536986|NCT00137995|Ifosfamide|ifosfamide|mesh-list
92603755|NCT00120185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603756|NCT00120185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603757|NCT00120185|Analgesics|analgesics|mesh-ancestor
92603758|NCT00120185|Sensory System Agents|sensory system agents|mesh-ancestor
92603759|NCT00120185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603760|NCT00120185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603761|NCT01240642|Vadimezan|vadimezan|mesh-list
92603762|NCT01240642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603763|NCT00117975|Galiximab|galiximab|mesh-list
92603764|NCT00117975|Rituximab|rituximab|mesh-list
92603765|NCT00117975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92603766|NCT00117975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603767|NCT00117975|Immunologic Factors|immunologic factors|mesh-ancestor
92603768|NCT00117975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603769|NCT00117975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603770|NCT00117975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603771|NCT00482521|Pomalidomide|pomalidomide|mesh-list
92603772|NCT00482521|Immunologic Factors|immunologic factors|mesh-ancestor
92603773|NCT00482521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603774|NCT00482521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92603775|NCT00482521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92603776|NCT00482521|Growth Substances|growth substances|mesh-ancestor
92603777|NCT00482521|Growth Inhibitors|growth inhibitors|mesh-ancestor
92603778|NCT00482521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603779|NCT00120302|Pimecrolimus|pimecrolimus|mesh-list
92603780|NCT00120302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92603781|NCT00120302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603782|NCT00120302|Analgesics|analgesics|mesh-ancestor
92328719|NCT00003446|Micronutrients|micronutrients|mesh-ancestor
92603783|NCT00120302|Sensory System Agents|sensory system agents|mesh-ancestor
92603784|NCT00120302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603785|NCT00120302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603786|NCT00120302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603787|NCT00120302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603788|NCT00120302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92603789|NCT00120302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603790|NCT00120302|Immunologic Factors|immunologic factors|mesh-ancestor
92603791|NCT00120302|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92603792|NCT00120302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603793|NCT00120302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603794|NCT00482716|Iron|iron|mesh-list
92603795|NCT00482716|Dextrans|dextrans|mesh-list
92603800|NCT00482716|Micronutrients|micronutrients|mesh-ancestor
92603801|NCT00482716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603802|NCT00482716|Hematinics|hematinics|mesh-ancestor
92603803|NCT00482716|Anticoagulants|anticoagulants|mesh-ancestor
92603804|NCT00482716|Plasma Substitutes|plasma substitutes|mesh-ancestor
92603805|NCT00482716|Blood Substitutes|blood substitutes|mesh-ancestor
92603806|NCT00482755|Sunitinib|sunitinib|mesh-list
92603807|NCT00482755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603808|NCT00482755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92603809|NCT00482755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92603810|NCT00482755|Growth Substances|growth substances|mesh-ancestor
92603811|NCT00482755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603812|NCT00482755|Growth Inhibitors|growth inhibitors|mesh-ancestor
92603813|NCT00482755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603814|NCT00482755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603815|NCT00482755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603816|NCT00120341|Analgesics|analgesics|mesh-list
92603817|NCT00120341|Sensory System Agents|sensory system agents|mesh-ancestor
92603818|NCT00120341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603819|NCT00120341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603820|NCT00482989|Sifalimumab|sifalimumab|mesh-list
92603821|NCT00482989|Immunologic Factors|immunologic factors|mesh-ancestor
92603822|NCT00482989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603823|NCT00120380|Iloprost|iloprost|mesh-list
92603824|NCT00120380|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92603825|NCT00120380|Vasodilator Agents|vasodilator agents|mesh-ancestor
92603826|NCT00483028|Donepezil|donepezil|mesh-list
92603827|NCT00483028|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92603828|NCT00483028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603829|NCT00483028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603830|NCT00483028|Cholinergic Agents|cholinergic agents|mesh-ancestor
92603831|NCT00483028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536987|NCT00137995|Carboplatin|carboplatin|mesh-list
92536988|NCT00137995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92536989|NCT00137995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603832|NCT00483028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603833|NCT00483028|Nootropic Agents|nootropic agents|mesh-ancestor
92603834|NCT00118014|Sertraline|sertraline|mesh-list
92603835|NCT00118014|Antidepressive Agents|antidepressive agents|mesh-ancestor
92603836|NCT00118014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603837|NCT00118014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92603838|NCT00118014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92603839|NCT00118014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603840|NCT00118014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603841|NCT00118014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603842|NCT00118014|Serotonin Agents|serotonin agents|mesh-ancestor
92603843|NCT00118014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603844|NCT00120419|Mycophenolic Acid|mycophenolic acid|mesh-list
92603845|NCT00120419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92603846|NCT00120419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603847|NCT00120419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92603848|NCT00120419|Antitubercular Agents|antitubercular agents|mesh-ancestor
92603849|NCT00120419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603850|NCT00120419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603851|NCT00120419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603852|NCT00120419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603853|NCT05176470|Cyclophosphamide|cyclophosphamide|mesh-list
92603854|NCT05176470|Pembrolizumab|pembrolizumab|mesh-list
92603855|NCT05176470|Fludarabine|fludarabine|mesh-list
92603856|NCT05176470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603857|NCT05176470|Immunologic Factors|immunologic factors|mesh-ancestor
92603858|NCT05176470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603859|NCT05176470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603860|NCT05176470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92603861|NCT05176470|Alkylating Agents|alkylating agents|mesh-ancestor
92603862|NCT05176470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603863|NCT05176470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603864|NCT05176470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92603865|NCT05176470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011272|NCT02439385|Sensory System Agents|sensory system agents|mesh-ancestor
92603869|NCT01241032|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92603870|NCT01241032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603871|NCT01241032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603872|NCT00483067|Cytarabine|cytarabine|mesh-list
92603873|NCT00483067|Cladribine|cladribine|mesh-list
92603874|NCT00483067|Lenograstim|lenograstim|mesh-list
92603875|NCT00483067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92603876|NCT00483067|Antimetabolites|antimetabolites|mesh-ancestor
92603877|NCT00483067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603878|NCT00483067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603879|NCT00483067|Antiviral Agents|antiviral agents|mesh-ancestor
92603880|NCT00483067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603881|NCT00483067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603882|NCT00483067|Immunologic Factors|immunologic factors|mesh-ancestor
92603883|NCT00483067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603884|NCT00483067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92603885|NCT00483106|Methylphenidate|methylphenidate|mesh-list
92360892|NCT00504504|Alkylating Agents|alkylating agents|mesh-ancestor
92603886|NCT00483106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92603887|NCT00483106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603888|NCT00483106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92603889|NCT00483106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92603890|NCT00483106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603891|NCT00483106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603892|NCT00483106|Dopamine Agents|dopamine agents|mesh-ancestor
92603893|NCT00483106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603894|NCT00118170|Sorafenib|sorafenib|mesh-list
92603895|NCT00118170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603896|NCT00118170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603897|NCT00118170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603898|NCT00118170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603899|NCT00120497|Hormones|hormones|mesh-list
92536990|NCT00137995|Immunologic Factors|immunologic factors|mesh-ancestor
91955640|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603900|NCT00120497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603901|NCT00120497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603902|NCT00483145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92603903|NCT00483145|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92603904|NCT00483145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92603905|NCT00483145|Dermatologic Agents|dermatologic agents|mesh-ancestor
92603906|NCT00483301|Sorafenib|sorafenib|mesh-list
92603907|NCT00483301|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92603908|NCT00483301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603909|NCT00483301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92603910|NCT00483301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603911|NCT00483301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603912|NCT00483457|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92603913|NCT00483457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603914|NCT00120536|Vildagliptin|vildagliptin|mesh-list
92603915|NCT00120536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603916|NCT00120536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603917|NCT00120536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92603918|NCT00120536|Protease Inhibitors|protease inhibitors|mesh-ancestor
92603919|NCT00120536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603920|NCT00120536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603921|NCT00483730|Actovegin|actovegin|mesh-list
92603922|NCT00483730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92603923|NCT00483730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603924|NCT00483730|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92603925|NCT00483730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603926|NCT00483730|Antioxidants|antioxidants|mesh-ancestor
92603927|NCT00483730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603928|NCT00483730|Protective Agents|protective agents|mesh-ancestor
92603929|NCT00483730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92603930|NCT00118326|Lenograstim|lenograstim|mesh-list
92603931|NCT00118326|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92603932|NCT00118326|Immunologic Factors|immunologic factors|mesh-ancestor
92603933|NCT00118326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603934|NCT00483769|Insulin Glargine|insulin glargine|mesh-list
92603935|NCT00483769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92603936|NCT00483769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603937|NCT00405171|Nevirapine|nevirapine|mesh-list
92603946|NCT00405171|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92603947|NCT00405171|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92603948|NCT00483886|Prucalopride|prucalopride|mesh-list
92603949|NCT00483886|Laxatives|laxatives|mesh-ancestor
92603950|NCT00483886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603951|NCT00483886|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92603952|NCT00483886|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92603953|NCT00483886|Serotonin Agents|serotonin agents|mesh-ancestor
92603954|NCT00483886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603955|NCT00483886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603956|NCT00483886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603957|NCT00483964|Olanzapine|olanzapine|mesh-list
92603958|NCT00483964|Antiemetics|antiemetics|mesh-ancestor
92603959|NCT00483964|Autonomic Agents|autonomic agents|mesh-ancestor
92603960|NCT00483964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603961|NCT00483964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603962|NCT00483964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603963|NCT00483964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92603964|NCT00483964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92603965|NCT00483964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92603966|NCT00483964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92603967|NCT00483964|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92603968|NCT00483964|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92603969|NCT00483964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92603970|NCT00483964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603971|NCT00483964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603972|NCT00483964|Serotonin Agents|serotonin agents|mesh-ancestor
92603973|NCT00484003|Pimecrolimus|pimecrolimus|mesh-list
92603974|NCT00484003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92603975|NCT00484003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92603976|NCT00484003|Analgesics|analgesics|mesh-ancestor
92536991|NCT00137995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92536992|NCT00137995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92536993|NCT00137995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92536994|NCT00137995|Antiemetics|antiemetics|mesh-ancestor
92536995|NCT00137995|Autonomic Agents|autonomic agents|mesh-ancestor
92603977|NCT00484003|Sensory System Agents|sensory system agents|mesh-ancestor
92603978|NCT00484003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92603979|NCT00484003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603980|NCT00484003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92603981|NCT00484003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603982|NCT00484003|Dermatologic Agents|dermatologic agents|mesh-ancestor
92603983|NCT00484003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92603984|NCT00484003|Immunologic Factors|immunologic factors|mesh-ancestor
92603985|NCT00484003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92603986|NCT00484003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603987|NCT00484003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603988|NCT01241110|Ofloxacin|ofloxacin|mesh-list
92603989|NCT01241110|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92603990|NCT01241110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603991|NCT01241110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92603992|NCT01241110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92603993|NCT01241110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92603994|NCT01241110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603995|NCT01241110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603996|NCT01241110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92603997|NCT01241110|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92603998|NCT01241110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92603999|NCT00120653|Metoclopramide|metoclopramide|mesh-list
92604000|NCT00120653|Antiemetics|antiemetics|mesh-ancestor
92604001|NCT00120653|Autonomic Agents|autonomic agents|mesh-ancestor
92011422|NCT04848467|Vaccines|vaccines|mesh-list
92604003|NCT00120653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604004|NCT00120653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92604005|NCT00120653|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92604006|NCT00120653|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92604008|NCT00120653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604009|NCT00120653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604010|NCT00484120|Diclofenac|diclofenac|mesh-list
92604011|NCT00484120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604012|NCT00484120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604013|NCT00484120|Analgesics|analgesics|mesh-ancestor
92604014|NCT00484120|Sensory System Agents|sensory system agents|mesh-ancestor
92604015|NCT00484120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604016|NCT00484120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604017|NCT00484120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604018|NCT00484120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604019|NCT00484120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92604020|NCT00484120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604021|NCT00484120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604022|NCT00484237|Etanercept|etanercept|mesh-list
92604023|NCT00484237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604024|NCT00484237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604025|NCT00484237|Analgesics|analgesics|mesh-ancestor
92604026|NCT00484237|Sensory System Agents|sensory system agents|mesh-ancestor
92604027|NCT00484237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604028|NCT00484237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604029|NCT00484237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604030|NCT00484237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604031|NCT00484237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92604032|NCT00484237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604033|NCT00484237|Immunologic Factors|immunologic factors|mesh-ancestor
92604034|NCT00120692|Epoetin Alfa|epoetin alfa|mesh-list
92604035|NCT00120692|Darbepoetin alfa|darbepoetin alfa|mesh-list
92604036|NCT00120692|Hematinics|hematinics|mesh-ancestor
92604037|NCT00484432|Doxorubicin|doxorubicin|mesh-list
92604038|NCT00484432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92604039|NCT00484432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604040|NCT00484432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92604041|NCT00484432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92604042|NCT00484432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604043|NCT00484432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604044|NCT00484510|Ascorbic Acid|ascorbic acid|mesh-list
92604045|NCT00484510|Vitamins|vitamins|mesh-ancestor
92604046|NCT00484510|Micronutrients|micronutrients|mesh-ancestor
92604047|NCT00484510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604048|NCT00484510|Antioxidants|antioxidants|mesh-ancestor
92604049|NCT00484510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604050|NCT00484510|Protective Agents|protective agents|mesh-ancestor
92604051|NCT00120731|Acetazolamide|acetazolamide|mesh-list
92604052|NCT00120731|Potassium Citrate|potassium citrate|mesh-list
92604053|NCT00120731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604054|NCT00120731|Anticonvulsants|anticonvulsants|mesh-ancestor
92604055|NCT00120731|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92604056|NCT00120731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604057|NCT00120731|Diuretics|diuretics|mesh-ancestor
92604058|NCT00120731|Natriuretic Agents|natriuretic agents|mesh-ancestor
92604059|NCT00120731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604060|NCT00120731|Expectorants|expectorants|mesh-ancestor
92604061|NCT00120731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604062|NCT00120770|Anti-Infective Agents|anti-infective agents|mesh-list
92604063|NCT00484744|Acetaminophen|acetaminophen|mesh-list
92604064|NCT00484744|Ibuprofen|ibuprofen|mesh-list
92604065|NCT00484744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604066|NCT00484744|Analgesics|analgesics|mesh-ancestor
92604067|NCT00484744|Sensory System Agents|sensory system agents|mesh-ancestor
92604068|NCT00484744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604069|NCT00484744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604070|NCT00484744|Antipyretics|antipyretics|mesh-ancestor
92604071|NCT00484744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604072|NCT00484744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604073|NCT00484744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604074|NCT00484744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92604075|NCT00484744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604080|NCT00484822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92604081|NCT00484822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92604082|NCT00484822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604083|NCT00405210|Docetaxel|docetaxel|mesh-list
92604084|NCT00405210|Sorafenib|sorafenib|mesh-list
92604085|NCT00405210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604086|NCT00405210|Tubulin Modulators|tubulin modulators|mesh-ancestor
92604087|NCT00405210|Antimitotic Agents|antimitotic agents|mesh-ancestor
92604088|NCT00405210|Mitosis Modulators|mitosis modulators|mesh-ancestor
92604089|NCT00405210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604090|NCT00405210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92604091|NCT00405210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604092|NCT00120809|Pyrimethamine|pyrimethamine|mesh-list
92604093|NCT00120809|Sulfadoxine|sulfadoxine|mesh-list
92604094|NCT00120809|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92604095|NCT00120809|Antimalarials|antimalarials|mesh-ancestor
92604096|NCT00120809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604097|NCT00120809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92604098|NCT00120809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604099|NCT00120809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92604100|NCT00120809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604101|NCT00120809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604102|NCT00120809|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92604103|NCT00484900|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92604104|NCT00484900|Antimalarials|antimalarials|mesh-ancestor
92604105|NCT00484900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604106|NCT00484900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92604107|NCT00484900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604108|NCT05062356|Ketorolac|ketorolac|mesh-list
92604109|NCT05062356|Epinephrine|epinephrine|mesh-list
92604110|NCT05062356|Bupivacaine|bupivacaine|mesh-list
92604111|NCT05062356|Prilocaine|prilocaine|mesh-list
92604112|NCT05062356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92604113|NCT05062356|Anesthetics, Local|anesthetics, local|mesh-ancestor
92604114|NCT05062356|Anesthetics|anesthetics|mesh-ancestor
92604115|NCT05062356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604116|NCT05062356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604117|NCT05062356|Sensory System Agents|sensory system agents|mesh-ancestor
92604118|NCT05062356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604119|NCT05062356|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92604120|NCT05062356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92604121|NCT05062356|Adrenergic Agents|adrenergic agents|mesh-ancestor
92604122|NCT05062356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92536996|NCT00137995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92536997|NCT00137995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92536998|NCT00137995|Glucocorticoids|glucocorticoids|mesh-ancestor
92604123|NCT05062356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604124|NCT05062356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92604125|NCT05062356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92604126|NCT05062356|Autonomic Agents|autonomic agents|mesh-ancestor
92604127|NCT05062356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92604128|NCT05062356|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604129|NCT05062356|Mydriatics|mydriatics|mesh-ancestor
92604130|NCT05062356|Sympathomimetics|sympathomimetics|mesh-ancestor
92604131|NCT05062356|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92604132|NCT05062356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604133|NCT05062356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604134|NCT05062356|Analgesics|analgesics|mesh-ancestor
92604135|NCT05062356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604136|NCT05062356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604137|NCT05062356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92604138|NCT05062356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604139|NCT01241383|Bosentan|bosentan|mesh-list
92604140|NCT01241383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92604141|NCT01241383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92604142|NCT01241383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604143|NCT00485056|Pioglitazone|pioglitazone|mesh-list
92604144|NCT00485056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604145|NCT00485056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604146|NCT00120887|Atorvastatin|atorvastatin|mesh-list
92604147|NCT00120887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92604151|NCT00120887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92604152|NCT00120887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92604153|NCT00120887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604154|NCT00118638|Darbepoetin alfa|darbepoetin alfa|mesh-list
92604155|NCT00118638|Hematinics|hematinics|mesh-ancestor
92604156|NCT00485368|Perindopril|perindopril|mesh-list
92604157|NCT00485368|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92604158|NCT00485368|Protease Inhibitors|protease inhibitors|mesh-ancestor
92604159|NCT00485368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604160|NCT00485368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604161|NCT00485368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92604162|NCT00485407|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92604163|NCT00485407|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92604164|NCT00485407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92604165|NCT00485407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604166|NCT00485407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604167|NCT00485407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92604168|NCT00485407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604169|NCT00485407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604170|NCT01241500|ON 01910|on 01910|mesh-list
92604171|NCT01241500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604172|NCT01241500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92604173|NCT01241500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604174|NCT01241500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604175|NCT05058612|Midodrine|midodrine|mesh-list
92604176|NCT05058612|Sympathomimetics|sympathomimetics|mesh-ancestor
92604177|NCT05058612|Autonomic Agents|autonomic agents|mesh-ancestor
92604178|NCT05058612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604179|NCT05058612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604180|NCT05058612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92604181|NCT05058612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92604182|NCT05058612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92604183|NCT05058612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92604184|NCT05058612|Adrenergic Agents|adrenergic agents|mesh-ancestor
92604185|NCT05058612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604186|NCT05058612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604187|NCT02274181|Enclomiphene|enclomiphene|mesh-list
92604188|NCT02274181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92604189|NCT02274181|Hormone Antagonists|hormone antagonists|mesh-ancestor
92604190|NCT02274181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604191|NCT02274181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604192|NCT02274181|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92536999|NCT00137995|Hormones|hormones|mesh-ancestor
92537000|NCT00137995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537001|NCT00137995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92537002|NCT00137995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91956035|NCT05168059|Clevidipine|clevidipine|mesh-list
92604193|NCT02274181|Fertility Agents|fertility agents|mesh-ancestor
92604194|NCT02274181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92604195|NCT02274181|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92604196|NCT02274181|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92604197|NCT01241422|Montelukast|montelukast|mesh-list
92604198|NCT01241422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92604199|NCT01241422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604200|NCT01241422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92604201|NCT01241422|Hormone Antagonists|hormone antagonists|mesh-ancestor
92604202|NCT01241422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604203|NCT01241422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604204|NCT01241422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92604205|NCT01241422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92604206|NCT01241422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604207|NCT05058417|Empagliflozin|empagliflozin|mesh-list
92604208|NCT05058417|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92604209|NCT05058417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604210|NCT05058417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604211|NCT05058417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604212|NCT02274337|Abivertinib|abivertinib|mesh-list
92604213|NCT02274337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92604214|NCT02274337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011628|NCT04853615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604218|NCT00485680|Olanzapine|olanzapine|mesh-list
92604219|NCT00485680|Lithium Carbonate|lithium carbonate|mesh-list
92604220|NCT00485680|Antiemetics|antiemetics|mesh-ancestor
92604221|NCT00485680|Autonomic Agents|autonomic agents|mesh-ancestor
92604222|NCT00485680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604223|NCT00485680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604224|NCT00485680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92604225|NCT00485680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92329180|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604226|NCT00485680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92604227|NCT00485680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604228|NCT00485680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92360923|NCT00544908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604229|NCT00485680|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92604230|NCT00485680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92604231|NCT00485680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604232|NCT00485680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604233|NCT00485680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604234|NCT00485680|Serotonin Agents|serotonin agents|mesh-ancestor
92604235|NCT00485680|Antidepressive Agents|antidepressive agents|mesh-ancestor
92604236|NCT00485680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604237|NCT00485680|Antimanic Agents|antimanic agents|mesh-ancestor
92604238|NCT00118794|Lumefantrine|lumefantrine|mesh-list
92604239|NCT00118794|Artemether|artemether|mesh-list
92604240|NCT00118794|Dapsone|dapsone|mesh-list
92604241|NCT00118794|Chlorproguanil|chlorproguanil|mesh-list
92604242|NCT00118794|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92604243|NCT00118794|Antimalarials|antimalarials|mesh-ancestor
92604244|NCT00118794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604245|NCT00118794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92604246|NCT00118794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604247|NCT00118794|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92604248|NCT00118794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604249|NCT00118794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604250|NCT00118794|Leprostatic Agents|leprostatic agents|mesh-ancestor
92604251|NCT00118794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92604252|NCT01241773|Efavirenz|efavirenz|mesh-list
92604253|NCT01241773|Raltegravir Potassium|raltegravir potassium|mesh-list
92604254|NCT01241773|Simeprevir|simeprevir|mesh-list
92604255|NCT01241773|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92604256|NCT01241773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92537003|NCT00137995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92537004|NCT00137995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92537005|NCT00137995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604257|NCT01241773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604258|NCT01241773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604260|NCT01241773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604261|NCT01241773|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92604262|NCT01241773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92604263|NCT01241773|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92604264|NCT01241773|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92604265|NCT01241773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92604266|NCT01241773|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92604267|NCT01241773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92604268|NCT01241773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92604269|NCT01241773|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92604270|NCT01241773|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92604271|NCT01241773|Protease Inhibitors|protease inhibitors|mesh-ancestor
92604272|NCT00121277|Capecitabine|capecitabine|mesh-list
92604273|NCT00121277|Vorinostat|vorinostat|mesh-list
92604274|NCT00121277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604275|NCT00121277|Antimetabolites|antimetabolites|mesh-ancestor
92604276|NCT00121277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604277|NCT00121277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604278|NCT00121277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92604279|NCT00121277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604280|NCT00485797|Methylphenidate|methylphenidate|mesh-list
92604281|NCT00485797|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92604282|NCT00485797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604283|NCT00485797|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92604291|NCT00485875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92604292|NCT00485875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604293|NCT00485875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604295|NCT00485875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604296|NCT00485875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604297|NCT00121316|Pimecrolimus|pimecrolimus|mesh-list
92329261|NCT00002689|Dexamethasone|dexamethasone|mesh-list
92604298|NCT00121316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604299|NCT00121316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604300|NCT00121316|Analgesics|analgesics|mesh-ancestor
92604301|NCT00121316|Sensory System Agents|sensory system agents|mesh-ancestor
92604302|NCT00121316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604303|NCT00121316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360926|NCT00447330|Capecitabine|capecitabine|mesh-list
92604304|NCT00121316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604305|NCT00121316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604306|NCT00121316|Dermatologic Agents|dermatologic agents|mesh-ancestor
92604307|NCT00121316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604308|NCT00121316|Immunologic Factors|immunologic factors|mesh-ancestor
92604309|NCT00121316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92604310|NCT00121316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604311|NCT00121316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604312|NCT00118950|Metformin|metformin|mesh-list
92604313|NCT00118950|Repaglinide|repaglinide|mesh-list
92604314|NCT00118950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604315|NCT00118950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604316|NCT00486187|Metformin|metformin|mesh-list
92604317|NCT00486187|Rosiglitazone|rosiglitazone|mesh-list
92604318|NCT00486187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604319|NCT00486187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604320|NCT00121394|Chlorhexidine|chlorhexidine|mesh-list
92604321|NCT00121394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92604322|NCT00121394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604323|NCT00121394|Disinfectants|disinfectants|mesh-ancestor
92604324|NCT00486343|Zileuton|zileuton|mesh-list
92604325|NCT00486343|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604326|NCT00486343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604327|NCT00486343|Analgesics|analgesics|mesh-ancestor
92604328|NCT00486343|Sensory System Agents|sensory system agents|mesh-ancestor
92604329|NCT00486343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604330|NCT00486343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604331|NCT00486343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537006|NCT00137995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537007|NCT00137995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92537008|NCT00137995|Antimetabolites|antimetabolites|mesh-ancestor
92537009|NCT00137995|Antiviral Agents|antiviral agents|mesh-ancestor
91944713|NCT05112913|Vaccines|vaccines|mesh-list
92604332|NCT00486343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604333|NCT00486343|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92604334|NCT00486343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604335|NCT00486343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604336|NCT00486343|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92604337|NCT00486343|Hormone Antagonists|hormone antagonists|mesh-ancestor
92604338|NCT00486343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604339|NCT00486421|Prednisone|prednisone|mesh-list
92604340|NCT00486421|Rituximab|rituximab|mesh-list
92604341|NCT00486421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92604342|NCT00486421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604343|NCT00486421|Immunologic Factors|immunologic factors|mesh-ancestor
92604344|NCT00486421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604345|NCT00486421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604346|NCT00486421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604347|NCT00486421|Glucocorticoids|glucocorticoids|mesh-ancestor
92604348|NCT00486421|Hormones|hormones|mesh-ancestor
92605377|NCT01244698|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92012852|NCT04813913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92605860|NCT01245244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605861|NCT01245244|Analgesics|analgesics|mesh-ancestor
92605862|NCT01245244|Sensory System Agents|sensory system agents|mesh-ancestor
92605863|NCT01245244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605864|NCT00405717|Atorvastatin|atorvastatin|mesh-list
92330862|NCT00004442|Cholic Acids|cholic acids|mesh-list
92605865|NCT00405717|Pravastatin|pravastatin|mesh-list
92605866|NCT00405717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92605867|NCT00405717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92605868|NCT00405717|Antimetabolites|antimetabolites|mesh-ancestor
92605869|NCT00405717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605870|NCT00405717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92606226|NCT00502099|Antimetabolites|antimetabolites|mesh-ancestor
92606227|NCT00502099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606228|NCT00502099|Immunologic Factors|immunologic factors|mesh-ancestor
92606229|NCT00502099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606230|NCT00502138|Pramlintide|pramlintide|mesh-list
92606385|NCT00503542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92606386|NCT00503542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92606387|NCT00503542|Hormone Antagonists|hormone antagonists|mesh-ancestor
92606388|NCT00503542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606389|NCT00503542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606390|NCT00503542|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92606391|NCT00503542|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92606393|NCT00147615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92606394|NCT00147615|Hormone Antagonists|hormone antagonists|mesh-ancestor
92606395|NCT00147615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606396|NCT00147615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606397|NCT00147615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92606398|NCT00147615|Diuretics|diuretics|mesh-ancestor
92606399|NCT00147615|Natriuretic Agents|natriuretic agents|mesh-ancestor
92606400|NCT00147615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92606401|NCT05561036|Doxorubicin|doxorubicin|mesh-list
92606402|NCT05561036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92606403|NCT05561036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606404|NCT05561036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606405|NCT05561036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606406|NCT05561036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606407|NCT05561036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606408|NCT01246804|Raltegravir Potassium|raltegravir potassium|mesh-list
92606409|NCT01246804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92611747|NCT00469690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611748|NCT00469690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92611749|NCT00469690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537010|NCT00137995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537011|NCT00137995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611750|NCT00469690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611751|NCT00469768|Dapivirine|dapivirine|mesh-list
92611752|NCT00469768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92611753|NCT00469768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92611754|NCT00469768|Antiviral Agents|antiviral agents|mesh-ancestor
92611755|NCT00469768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611756|NCT00469885|Nicotine|nicotine|mesh-list
92611757|NCT00469885|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92611758|NCT00469885|Autonomic Agents|autonomic agents|mesh-ancestor
92611759|NCT00469885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611760|NCT00469885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611761|NCT00469885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92611762|NCT00469885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92611763|NCT00469885|Cholinergic Agents|cholinergic agents|mesh-ancestor
92611764|NCT00469885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611765|NCT00469885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611766|NCT00469924|Caffeine|caffeine|mesh-list
92611767|NCT00469924|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92611768|NCT00469924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611769|NCT00469924|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92611770|NCT00469924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611771|NCT00469924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611772|NCT00469924|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92611773|NCT00469924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92611774|NCT00469924|Purinergic Agents|purinergic agents|mesh-ancestor
92611775|NCT00469924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611776|NCT00157677|Fibrin fragment D|fibrin fragment d|mesh-list
92611777|NCT00157677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92611778|NCT00157677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92611779|NCT00157677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611780|NCT00157677|Hemostatics|hemostatics|mesh-ancestor
92611781|NCT00157677|Coagulants|coagulants|mesh-ancestor
92611782|NCT00470041|Lamivudine|lamivudine|mesh-list
92611783|NCT00470041|Zidovudine|zidovudine|mesh-list
92611784|NCT00470041|Antiviral Agents|antiviral agents|mesh-list
92611785|NCT00470041|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92611786|NCT00470041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92611787|NCT00470041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611788|NCT00470041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611789|NCT00470041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611790|NCT00470041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92611791|NCT00470041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92611792|NCT00470041|Antimetabolites|antimetabolites|mesh-ancestor
92611793|NCT00157716|Pyridoxal|pyridoxal|mesh-list
92611794|NCT00157716|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
92611795|NCT00157716|Vitamin B Complex|vitamin b complex|mesh-ancestor
92611796|NCT00157716|Vitamins|vitamins|mesh-ancestor
92611797|NCT00157716|Micronutrients|micronutrients|mesh-ancestor
92611798|NCT00157716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611799|NCT00470197|Cytarabine|cytarabine|mesh-list
92611800|NCT00470197|Mitoxantrone|mitoxantrone|mesh-list
92611801|NCT00470197|Alvocidib|alvocidib|mesh-list
92611802|NCT00470197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92611803|NCT00470197|Antimetabolites|antimetabolites|mesh-ancestor
92611804|NCT00470197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611805|NCT00470197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611806|NCT00470197|Antiviral Agents|antiviral agents|mesh-ancestor
92611807|NCT00470197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611808|NCT00470197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611809|NCT00470197|Immunologic Factors|immunologic factors|mesh-ancestor
92611810|NCT00470197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611811|NCT00470197|Analgesics|analgesics|mesh-ancestor
92611812|NCT00470197|Sensory System Agents|sensory system agents|mesh-ancestor
92611813|NCT00470197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611814|NCT00470197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92611815|NCT00470197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92611816|NCT00470197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611817|NCT00470197|Growth Inhibitors|growth inhibitors|mesh-ancestor
92611818|NCT00470197|Growth Substances|growth substances|mesh-ancestor
92611822|NCT00470314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92611824|NCT00470314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611825|NCT00470314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537012|NCT00137995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92537013|NCT00137995|Alkylating Agents|alkylating agents|mesh-ancestor
92537014|NCT00137995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92537015|NCT03150888|Antihypertensive Agents|antihypertensive agents|mesh-list
92611827|NCT00149292|Antiemetics|antiemetics|mesh-ancestor
92611828|NCT00149292|Autonomic Agents|autonomic agents|mesh-ancestor
92611829|NCT00149292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611830|NCT00149292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611831|NCT00149292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611832|NCT00149292|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92611833|NCT00149292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92611834|NCT00149292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92611835|NCT00149292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92611836|NCT00149292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92611837|NCT00149292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92611838|NCT00149292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611839|NCT00149292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611840|NCT00149292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611841|NCT00149292|Serotonin Agents|serotonin agents|mesh-ancestor
92611842|NCT00470353|Cholecalciferol|cholecalciferol|mesh-list
92611843|NCT00470353|Vitamin D|vitamin d|mesh-list
92611844|NCT00470353|Calcium Carbonate|calcium carbonate|mesh-list
92611845|NCT00470353|Calcium|calcium|mesh-list
92611846|NCT00470353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92611847|NCT00470353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611848|NCT00470353|Vitamins|vitamins|mesh-ancestor
92611849|NCT00470353|Micronutrients|micronutrients|mesh-ancestor
92611850|NCT00470353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92611851|NCT00470353|Antacids|antacids|mesh-ancestor
92611852|NCT00470353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611853|NCT00470353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611854|NCT05391893|Diltiazem|diltiazem|mesh-list
92611855|NCT05391893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92611856|NCT05391893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92611857|NCT05391893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611858|NCT05391893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611859|NCT05391893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92611860|NCT05391893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611862|NCT00470509|Adalimumab|adalimumab|mesh-list
92611863|NCT00470509|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92611864|NCT00470509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611865|NCT00470509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611866|NCT05378906|Darunavir|darunavir|mesh-list
92611867|NCT05378906|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92611868|NCT05378906|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92611869|NCT05378906|Protease Inhibitors|protease inhibitors|mesh-ancestor
92611870|NCT05378906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611871|NCT05378906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611872|NCT05378906|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92611873|NCT05378906|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92611874|NCT05378906|Antiviral Agents|antiviral agents|mesh-ancestor
92611875|NCT05378906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611876|NCT00470665|Sirolimus|sirolimus|mesh-list
92611877|NCT00470665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611878|NCT00470665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611879|NCT00470665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92611880|NCT00470665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611881|NCT00470665|Antifungal Agents|antifungal agents|mesh-ancestor
92611882|NCT00470665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611883|NCT00470665|Immunologic Factors|immunologic factors|mesh-ancestor
92611884|NCT00470665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611885|NCT00470743|Ibuprofen|ibuprofen|mesh-list
92611886|NCT00470743|Indomethacin|indomethacin|mesh-list
92611887|NCT00470743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611888|NCT00470743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611889|NCT00470743|Analgesics|analgesics|mesh-ancestor
92611890|NCT00470743|Sensory System Agents|sensory system agents|mesh-ancestor
92611897|NCT00470743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611898|NCT00470743|Gout Suppressants|gout suppressants|mesh-ancestor
92611899|NCT00470743|Tocolytic Agents|tocolytic agents|mesh-ancestor
92537017|NCT00138112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537018|NCT00138112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537019|NCT00138229|Aldesleukin|aldesleukin|mesh-list
92537020|NCT00138229|Cyclophosphamide|cyclophosphamide|mesh-list
92537021|NCT00138229|Fludarabine|fludarabine|mesh-list
92537022|NCT00138229|Fludarabine phosphate|fludarabine phosphate|mesh-list
92537023|NCT00138229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537024|NCT00138229|Immunologic Factors|immunologic factors|mesh-ancestor
92611900|NCT00470743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92611901|NCT00470821|Melatonin|melatonin|mesh-list
92611902|NCT00470821|Antioxidants|antioxidants|mesh-ancestor
92611903|NCT00470821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611904|NCT00470821|Protective Agents|protective agents|mesh-ancestor
92611905|NCT00470821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611906|NCT00470821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92611907|NCT00335920|Dexamethasone|dexamethasone|mesh-list
92611908|NCT00335920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611909|NCT00335920|Antiemetics|antiemetics|mesh-ancestor
92611910|NCT00335920|Autonomic Agents|autonomic agents|mesh-ancestor
92611911|NCT00335920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611912|NCT00335920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611913|NCT00335920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611914|NCT00335920|Glucocorticoids|glucocorticoids|mesh-ancestor
92611915|NCT00335920|Hormones|hormones|mesh-ancestor
92611916|NCT00335920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92611917|NCT00335920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92611918|NCT00335920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611919|NCT00335998|Cisplatin|cisplatin|mesh-list
92611920|NCT00335998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611921|NCT00470977|Ranibizumab|ranibizumab|mesh-list
92611922|NCT00470977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92611923|NCT00470977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92611924|NCT00470977|Growth Substances|growth substances|mesh-ancestor
92611925|NCT00470977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611926|NCT00470977|Growth Inhibitors|growth inhibitors|mesh-ancestor
92611927|NCT00470977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611928|NCT05350592|Dobutamine|dobutamine|mesh-list
92611929|NCT05350592|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92611930|NCT05350592|Sympathomimetics|sympathomimetics|mesh-ancestor
92611931|NCT05350592|Autonomic Agents|autonomic agents|mesh-ancestor
92611932|NCT05350592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611933|NCT05350592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611934|NCT05350592|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92611935|NCT05350592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92611936|NCT05350592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92611937|NCT05350592|Adrenergic Agents|adrenergic agents|mesh-ancestor
92611938|NCT05350592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611939|NCT05350592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611940|NCT05350592|Protective Agents|protective agents|mesh-ancestor
92611941|NCT00471055|Capsaicin|capsaicin|mesh-list
92611942|NCT00471055|Antipruritics|antipruritics|mesh-ancestor
92611943|NCT00471055|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611944|NCT00471055|Sensory System Agents|sensory system agents|mesh-ancestor
92611945|NCT00471055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611946|NCT00471055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611947|NCT00471094|Lansoprazole|lansoprazole|mesh-list
92611948|NCT00471094|Dexlansoprazole|dexlansoprazole|mesh-list
92611949|NCT00471094|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92611950|NCT00471094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611951|NCT00471094|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92611952|NCT00471094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611953|NCT00471094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611954|NCT00157872|Naproxen|naproxen|mesh-list
92611955|NCT00157872|Rofecoxib|rofecoxib|mesh-list
92611956|NCT00157872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611957|NCT00157872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611958|NCT00157872|Analgesics|analgesics|mesh-ancestor
92611959|NCT00157872|Sensory System Agents|sensory system agents|mesh-ancestor
92537025|NCT00138229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537026|NCT00138229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537027|NCT00138229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92537028|NCT00138229|Alkylating Agents|alkylating agents|mesh-ancestor
91944729|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
92611966|NCT00157872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611967|NCT00157872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611968|NCT00157872|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92611969|NCT03271255|Bevacizumab|bevacizumab|mesh-list
92611970|NCT03271255|Apatinib|apatinib|mesh-list
92611971|NCT03271255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611972|NCT03271255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611973|NCT03271255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92611974|NCT03271255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92611975|NCT03271255|Growth Substances|growth substances|mesh-ancestor
92611976|NCT03271255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611977|NCT03271255|Growth Inhibitors|growth inhibitors|mesh-ancestor
92611978|NCT03271255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92611979|NCT03271255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611980|NCT03271255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611981|NCT00471289|Paclitaxel|paclitaxel|mesh-list
92611982|NCT00471289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92611983|NCT00471289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611984|NCT00471289|Tubulin Modulators|tubulin modulators|mesh-ancestor
92611985|NCT00471289|Antimitotic Agents|antimitotic agents|mesh-ancestor
92611986|NCT00471289|Mitosis Modulators|mitosis modulators|mesh-ancestor
92611987|NCT00471289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611988|NCT00336154|Tetracycline|tetracycline|mesh-list
92611989|NCT00336154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611990|NCT00336154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611991|NCT00336154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92611992|NCT00336154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611993|NCT00336154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611994|NCT00158028|Risperidone|risperidone|mesh-list
92611995|NCT00158028|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92611996|NCT00158028|Serotonin Agents|serotonin agents|mesh-ancestor
92611997|NCT00158028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611998|NCT00158028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611999|NCT00158028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612000|NCT00158028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92612001|NCT00158028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92612002|NCT00158028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612003|NCT00158028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612004|NCT00158028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92337058|NCT01928940|Trametinib|trametinib|mesh-list
92612005|NCT00158028|Dopamine Agents|dopamine agents|mesh-ancestor
92612006|NCT00471406|Verteporfin|verteporfin|mesh-list
92612007|NCT00471406|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92612008|NCT00471406|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612009|NCT00149565|Interferon alpha-2|interferon alpha-2|mesh-list
92612010|NCT00149565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612011|NCT00149565|Antiviral Agents|antiviral agents|mesh-ancestor
92612012|NCT00149565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612013|NCT00471484|Interferons|interferons|mesh-list
92612014|NCT00471484|Interferon-alpha|interferon-alpha|mesh-list
92612015|NCT00471484|Interferon alpha-2|interferon alpha-2|mesh-list
92612016|NCT00471484|Doxorubicin|doxorubicin|mesh-list
92612017|NCT00471484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92612018|NCT00471484|Fluorouracil|fluorouracil|mesh-list
92612019|NCT00471484|Oxaliplatin|oxaliplatin|mesh-list
92612020|NCT00471484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92612021|NCT00471484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612022|NCT00471484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92612023|NCT00471484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612024|NCT00471484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612025|NCT00471484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612026|NCT00471484|Antimetabolites|antimetabolites|mesh-ancestor
92612027|NCT00471484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612031|NCT00471484|Antiviral Agents|antiviral agents|mesh-ancestor
92612032|NCT00471484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612033|NCT00471523|Metformin|metformin|mesh-list
92537029|NCT00138229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537030|NCT00138229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612034|NCT00471523|Clomiphene|clomiphene|mesh-list
92612035|NCT00471523|Enclomiphene|enclomiphene|mesh-list
92612036|NCT00471523|Zuclomiphene|zuclomiphene|mesh-list
92612037|NCT00471523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92612038|NCT00471523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612039|NCT00471523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92612040|NCT00471523|Hormone Antagonists|hormone antagonists|mesh-ancestor
92612041|NCT00471523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612042|NCT00471523|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92612043|NCT00471523|Fertility Agents|fertility agents|mesh-ancestor
92612044|NCT00471523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92612045|NCT00471523|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92612046|NCT00471523|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92612047|NCT00471562|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92612048|NCT00471562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92612049|NCT00471562|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612050|NCT00471640|Dexamethasone|dexamethasone|mesh-list
92612051|NCT00471640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92612052|NCT00471640|Antiemetics|antiemetics|mesh-ancestor
92612053|NCT00471640|Autonomic Agents|autonomic agents|mesh-ancestor
92612054|NCT00471640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612055|NCT00471640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612056|NCT00471640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612057|NCT00471640|Glucocorticoids|glucocorticoids|mesh-ancestor
92612058|NCT00471640|Hormones|hormones|mesh-ancestor
92612059|NCT00471640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612060|NCT00471640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92612061|NCT00471640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612062|NCT00471679|Ethanol|ethanol|mesh-list
92612063|NCT00471679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92612064|NCT00471679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612065|NCT00471679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612066|NCT00471679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612067|NCT00149604|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92612068|NCT00149604|Estrogens|estrogens|mesh-list
92612069|NCT00149604|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92612070|NCT00149604|Hormones|hormones|mesh-ancestor
92612071|NCT00149604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612072|NCT00149604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612073|NCT00149604|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92612074|NCT00149604|Hormone Antagonists|hormone antagonists|mesh-ancestor
92612075|NCT00149604|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92612076|NCT00149604|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92612077|NCT00149604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92612078|NCT00471952|Caffeine|caffeine|mesh-list
92612079|NCT00471952|Rizatriptan|rizatriptan|mesh-list
92612080|NCT00471952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92337122|NCT00378833|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612081|NCT00471952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612082|NCT00471952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92612083|NCT00471952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612084|NCT00471952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612085|NCT00471952|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92612086|NCT00471952|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92612087|NCT00471952|Purinergic Agents|purinergic agents|mesh-ancestor
92612088|NCT00471952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612089|NCT00471952|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92612090|NCT00471952|Serotonin Agents|serotonin agents|mesh-ancestor
92612091|NCT00471991|Dienogest|dienogest|mesh-list
92612092|NCT00471991|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92612093|NCT00471991|Estradiol|estradiol|mesh-list
92612094|NCT00471991|Estrogens|estrogens|mesh-ancestor
92612095|NCT00471991|Hormones|hormones|mesh-ancestor
92612096|NCT00471991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612097|NCT00471991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612098|NCT00471991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92612100|NCT00471991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92612101|NCT00471991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92612102|NCT00471991|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92537031|NCT00138229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92537032|NCT00138229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92537033|NCT00138229|Antimetabolites|antimetabolites|mesh-ancestor
92612103|NCT00471991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92612104|NCT00471991|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92612105|NCT00471991|Hormone Antagonists|hormone antagonists|mesh-ancestor
92612106|NCT00471991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92612107|NCT00471991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612108|NCT00472108|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92612109|NCT00472108|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92612110|NCT00472108|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612111|NCT00336310|Repaglinide|repaglinide|mesh-list
92612112|NCT00336310|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92612113|NCT00336310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612114|NCT00336349|Botulinum Toxins|botulinum toxins|mesh-list
92612115|NCT00336349|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92612116|NCT00336349|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92612117|NCT00336349|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92612118|NCT00336349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612119|NCT00336349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612120|NCT00336349|Cholinergic Agents|cholinergic agents|mesh-ancestor
92612121|NCT00336349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612122|NCT00336349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612123|NCT00336349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92612124|NCT00336349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612125|NCT00472225|Rituximab|rituximab|mesh-list
92612126|NCT00472225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612127|NCT00472225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612128|NCT00472225|Immunologic Factors|immunologic factors|mesh-ancestor
92612129|NCT00472225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612130|NCT00472225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612131|NCT00336466|Epoetin Alfa|epoetin alfa|mesh-list
92612132|NCT00336466|Hematinics|hematinics|mesh-ancestor
92612133|NCT00472381|Insulin|insulin|mesh-list
92612134|NCT00472381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92612135|NCT00472381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612136|NCT00472459|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92612137|NCT00472459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92612138|NCT00472459|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612139|NCT00336739|Cinacalcet|cinacalcet|mesh-list
92612140|NCT00336739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612141|NCT00336739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612142|NCT00336739|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92612143|NCT00336739|Hormone Antagonists|hormone antagonists|mesh-ancestor
92612144|NCT00336739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612145|NCT00424151|Rituximab|rituximab|mesh-list
92612146|NCT00424151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612147|NCT00424151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612148|NCT00424151|Immunologic Factors|immunologic factors|mesh-ancestor
92612149|NCT00424151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612150|NCT00424151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612151|NCT00472810|Mitomycins|mitomycins|mesh-list
92612152|NCT00472810|Mitomycin|mitomycin|mesh-list
92612153|NCT00472810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92612154|NCT00472810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612155|NCT00472810|Alkylating Agents|alkylating agents|mesh-ancestor
92612156|NCT00472810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612157|NCT00472810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92612158|NCT00472810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612159|NCT00337051|Propofol|propofol|mesh-list
92612160|NCT00337051|Sevoflurane|sevoflurane|mesh-list
92612161|NCT00337051|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92612162|NCT00337051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612163|NCT00337051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612164|NCT00337051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92612165|NCT00337051|Anesthetics, General|anesthetics, general|mesh-ancestor
92612166|NCT00337051|Anesthetics|anesthetics|mesh-ancestor
92612167|NCT00337051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92612168|NCT00337051|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92612169|NCT00472927|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92612170|NCT00472927|Estrogens|estrogens|mesh-ancestor
92612171|NCT00472927|Hormones|hormones|mesh-ancestor
92019103|NCT01596127|Rituximab|rituximab|mesh-list
92537034|NCT00138229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92537035|NCT00138229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92537036|NCT00138229|Antiviral Agents|antiviral agents|mesh-ancestor
92537037|NCT00138229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537038|NCT00404131|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92537039|NCT00404131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92612179|NCT00337090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612180|NCT00337090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612181|NCT00337090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612182|NCT00337090|Urological Agents|urological agents|mesh-ancestor
92612184|NCT05262452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612185|NCT00337246|Cyclophosphamide|cyclophosphamide|mesh-list
92612186|NCT00337246|Rituximab|rituximab|mesh-list
92612187|NCT00337246|Fludarabine|fludarabine|mesh-list
92612188|NCT00337246|Fludarabine phosphate|fludarabine phosphate|mesh-list
92612189|NCT00337246|Mitoxantrone|mitoxantrone|mesh-list
92612190|NCT00337246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92612191|NCT00337246|Immunologic Factors|immunologic factors|mesh-ancestor
92612192|NCT00337246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612193|NCT00337246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612194|NCT00337246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92612195|NCT00337246|Alkylating Agents|alkylating agents|mesh-ancestor
92612196|NCT00337246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612197|NCT00337246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612198|NCT00337246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92612199|NCT00337246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612200|NCT00337246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612201|NCT00337246|Antimetabolites|antimetabolites|mesh-ancestor
92612202|NCT00337246|Analgesics|analgesics|mesh-ancestor
92612203|NCT00337246|Sensory System Agents|sensory system agents|mesh-ancestor
92612204|NCT00337246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612205|NCT00337246|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92612206|NCT00337246|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612207|NCT00337246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612208|NCT00158301|Fluoxetine|fluoxetine|mesh-list
92612209|NCT00158301|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92612210|NCT00158301|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92612211|NCT00158301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612212|NCT00158301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612213|NCT00158301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612214|NCT00158301|Serotonin Agents|serotonin agents|mesh-ancestor
92612215|NCT00158301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612216|NCT00158301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92612217|NCT00158301|Antidepressive Agents|antidepressive agents|mesh-ancestor
92612218|NCT00158301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612219|NCT00158301|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92612220|NCT00158301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92612221|NCT00158301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612222|NCT00473005|Capecitabine|capecitabine|mesh-list
92612223|NCT00473005|Everolimus|everolimus|mesh-list
92612224|NCT00473005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612225|NCT00473005|Antimetabolites|antimetabolites|mesh-ancestor
92612226|NCT00473005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612227|NCT00473005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337288|NCT01222871|Hormones|hormones|mesh-ancestor
92612228|NCT00473005|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92612229|NCT00473005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612230|NCT00473005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612231|NCT00473005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92612232|NCT00473005|Immunologic Factors|immunologic factors|mesh-ancestor
92405925|NCT04787848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92612233|NCT00473005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612234|NCT00149877|Tegaserod|tegaserod|mesh-list
92612235|NCT00149877|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92612236|NCT00149877|Serotonin Agents|serotonin agents|mesh-ancestor
92612239|NCT00149877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612240|NCT00473239|Vitamin D|vitamin d|mesh-list
92612241|NCT00473239|Cholecalciferol|cholecalciferol|mesh-list
92612242|NCT00473239|Vitamins|vitamins|mesh-ancestor
92612243|NCT00473239|Micronutrients|micronutrients|mesh-ancestor
92537040|NCT02826161|Paclitaxel|paclitaxel|mesh-list
92537041|NCT02826161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92537042|NCT02826161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537043|NCT02826161|Tubulin Modulators|tubulin modulators|mesh-ancestor
92612244|NCT00473239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612245|NCT00473239|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92612246|NCT00473239|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612247|NCT00149916|Mycophenolic Acid|mycophenolic acid|mesh-list
92612248|NCT00149916|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92612249|NCT00149916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612250|NCT00149916|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92612251|NCT00149916|Antitubercular Agents|antitubercular agents|mesh-ancestor
92612252|NCT00149916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612253|NCT00149916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612254|NCT00149916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612255|NCT00149916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612256|NCT00337441|Epoetin Alfa|epoetin alfa|mesh-list
92612257|NCT00337441|Hematinics|hematinics|mesh-ancestor
92612258|NCT05183048|Panitumumab|panitumumab|mesh-list
92612259|NCT05183048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612260|NCT05183048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612261|NCT00337519|Alemtuzumab|alemtuzumab|mesh-list
92612262|NCT00337519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612263|NCT00337519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612264|NCT00337558|Solifenacin Succinate|solifenacin succinate|mesh-list
92612265|NCT00337558|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92612266|NCT00337558|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92612267|NCT00337558|Cholinergic Agents|cholinergic agents|mesh-ancestor
92612268|NCT00337558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612269|NCT00337558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612270|NCT00337558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612271|NCT00337558|Urological Agents|urological agents|mesh-ancestor
92612272|NCT00508963|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92612273|NCT00508963|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92612274|NCT00508963|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92612275|NCT00508963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612276|NCT00508963|Schistosomicides|schistosomicides|mesh-ancestor
92612277|NCT00508963|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92612278|NCT00508963|Anthelmintics|anthelmintics|mesh-ancestor
92612279|NCT02964104|Insulin|insulin|mesh-list
92612280|NCT02964104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92612281|NCT02964104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92612282|NCT02964104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612283|NCT00158457|Tenofovir|tenofovir|mesh-list
92612284|NCT00158457|Emtricitabine|emtricitabine|mesh-list
92612285|NCT00158457|Efavirenz|efavirenz|mesh-list
92612286|NCT00158457|Antiviral Agents|antiviral agents|mesh-ancestor
92612287|NCT00158457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612288|NCT00158457|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92612289|NCT00158457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92612290|NCT00158457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612291|NCT00158457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612292|NCT00158457|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92612293|NCT00158457|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92612294|NCT00158457|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92612295|NCT00158457|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92612296|NCT00158457|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92612297|NCT00158457|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92612298|NCT00158457|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92612299|NCT00158457|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92612300|NCT00509158|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92612301|NCT00509158|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92612302|NCT00509158|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92612303|NCT00509158|Immunologic Factors|immunologic factors|mesh-ancestor
92612304|NCT00509158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612305|NCT00509158|Antacids|antacids|mesh-ancestor
92612306|NCT00509158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612307|NCT00509158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612308|NCT00405080|Rifampin|rifampin|mesh-list
92612309|NCT00405080|Casopitant|casopitant|mesh-list
92612314|NCT00405080|Leprostatic Agents|leprostatic agents|mesh-ancestor
92537044|NCT02826161|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537045|NCT02826161|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537046|NCT02826161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537047|NCT00138541|Vildagliptin|vildagliptin|mesh-list
92537048|NCT00138541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92612315|NCT00405080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92612316|NCT00405080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612317|NCT00405080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612318|NCT00405080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92612319|NCT00405080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92612320|NCT00405080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92612321|NCT00405080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92612322|NCT00405080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92612323|NCT00405080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92612324|NCT00405080|Antiemetics|antiemetics|mesh-ancestor
92612325|NCT00405080|Autonomic Agents|autonomic agents|mesh-ancestor
92612326|NCT00405080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612327|NCT00405080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612328|NCT00405080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612329|NCT00405080|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92612330|NCT00405080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612331|NCT00158496|Interferons|interferons|mesh-list
92612332|NCT00158496|Ribavirin|ribavirin|mesh-list
92612333|NCT00158496|Interferon-alpha|interferon-alpha|mesh-list
92612334|NCT00158496|Interferon alpha-2|interferon alpha-2|mesh-list
92612335|NCT00158496|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92612336|NCT00158496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612337|NCT00158496|Antiviral Agents|antiviral agents|mesh-ancestor
92612338|NCT00158496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612339|NCT00158496|Antimetabolites|antimetabolites|mesh-ancestor
92612340|NCT00158496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612341|NCT00158496|Immunologic Factors|immunologic factors|mesh-ancestor
92612342|NCT00158496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612343|NCT00337792|Fentanyl|fentanyl|mesh-list
92612344|NCT00337792|Midazolam|midazolam|mesh-list
92612345|NCT00337792|Oxycodone|oxycodone|mesh-list
92612346|NCT00337792|Lorazepam|lorazepam|mesh-list
92612347|NCT00337792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92612348|NCT00337792|Narcotics|narcotics|mesh-ancestor
92612349|NCT00337792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612350|NCT00337792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612351|NCT00337792|Analgesics|analgesics|mesh-ancestor
92612352|NCT00337792|Sensory System Agents|sensory system agents|mesh-ancestor
92612353|NCT00337792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612354|NCT00337792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92612355|NCT00337792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92612356|NCT00337792|Anesthetics, General|anesthetics, general|mesh-ancestor
92612357|NCT00337792|Anesthetics|anesthetics|mesh-ancestor
92612358|NCT00337792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92612359|NCT00337792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92612360|NCT00337792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92612361|NCT00337792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612362|NCT00337792|GABA Modulators|gaba modulators|mesh-ancestor
92612363|NCT00337792|GABA Agents|gaba agents|mesh-ancestor
92612364|NCT00337792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612365|NCT00337792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612366|NCT00337792|Anticonvulsants|anticonvulsants|mesh-ancestor
92612367|NCT00337792|Antiemetics|antiemetics|mesh-ancestor
92612368|NCT00337792|Autonomic Agents|autonomic agents|mesh-ancestor
92612369|NCT00337792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612370|NCT00509353|Irinotecan|irinotecan|mesh-list
92612371|NCT00509353|Vincristine|vincristine|mesh-list
92612372|NCT00509353|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92612373|NCT00509353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92612374|NCT00509353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612375|NCT00509353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612376|NCT00509353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612377|NCT00509353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612378|NCT00509353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92612379|NCT00509353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92612380|NCT00509353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537049|NCT00138541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537050|NCT00138541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92537051|NCT00138541|Protease Inhibitors|protease inhibitors|mesh-ancestor
92537052|NCT00138541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612381|NCT00509353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92612385|NCT00405119|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92612387|NCT00405119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92612388|NCT00405119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612389|NCT00405119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92612390|NCT00405119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612391|NCT00405119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612392|NCT00405119|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92612393|NCT00405119|Histamine Antagonists|histamine antagonists|mesh-ancestor
92612394|NCT00405119|Histamine Agents|histamine agents|mesh-ancestor
92612395|NCT00405119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612396|NCT00405119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612397|NCT04715737|Vasopressins|vasopressins|mesh-list
92612398|NCT04715737|Arginine Vasopressin|arginine vasopressin|mesh-list
92612399|NCT04715737|Oxytocin|oxytocin|mesh-list
92612400|NCT04715737|Oxytocics|oxytocics|mesh-ancestor
92612401|NCT04715737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92612402|NCT04715737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612403|NCT04715737|Hemostatics|hemostatics|mesh-ancestor
92612404|NCT04715737|Coagulants|coagulants|mesh-ancestor
92612405|NCT04715737|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92612406|NCT04715737|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92612407|NCT04715737|Natriuretic Agents|natriuretic agents|mesh-ancestor
92612408|NCT00509431|Sirolimus|sirolimus|mesh-list
92612409|NCT00509431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92612410|NCT00509431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612411|NCT00509431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612412|NCT00509431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612413|NCT00509431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612414|NCT00509431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612415|NCT00509431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612416|NCT00509431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92612417|NCT00509431|Antifungal Agents|antifungal agents|mesh-ancestor
92612418|NCT00509431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92612419|NCT00509431|Immunologic Factors|immunologic factors|mesh-ancestor
92612420|NCT00509431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612421|NCT00509470|Amlodipine|amlodipine|mesh-list
92612422|NCT00509470|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92612423|NCT00509470|Telmisartan|telmisartan|mesh-list
92612424|NCT00509470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92612425|NCT00509470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92612426|NCT00509470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612427|NCT00509470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612428|NCT00509470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612429|NCT00509470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612430|NCT00509470|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612431|NCT00509470|Diuretics|diuretics|mesh-ancestor
92612432|NCT00509470|Natriuretic Agents|natriuretic agents|mesh-ancestor
92612433|NCT00509470|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92612434|NCT00509470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92612435|NCT00509470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92612436|NCT00405158|Acetaminophen|acetaminophen|mesh-list
92612437|NCT00405158|Antipyretics|antipyretics|mesh-list
92612438|NCT00405158|Penicillins|penicillins|mesh-list
92612439|NCT00405158|Floxacillin|floxacillin|mesh-list
92612440|NCT00405158|Cefadroxil|cefadroxil|mesh-list
92612441|NCT00405158|Oxytocin|oxytocin|mesh-list
92612442|NCT00405158|Oxytocics|oxytocics|mesh-ancestor
92612443|NCT00405158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92612444|NCT00405158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612445|NCT00405158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92612446|NCT00405158|Analgesics|analgesics|mesh-ancestor
92612447|NCT00405158|Sensory System Agents|sensory system agents|mesh-ancestor
92612448|NCT00405158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612449|NCT00405158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612450|NCT00405158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612451|NCT00150072|Imatinib Mesylate|imatinib mesylate|mesh-list
92612452|NCT00150072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537053|NCT00138541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537054|NCT00138580|Vildagliptin|vildagliptin|mesh-list
91957301|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
92337493|NCT01074437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612453|NCT00150072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612454|NCT00150072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612455|NCT00150072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612456|NCT02953366|Mometasone Furoate|mometasone furoate|mesh-list
92612465|NCT00150111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612466|NCT00150111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612467|NCT00150111|Antithyroid Agents|antithyroid agents|mesh-ancestor
92612468|NCT00150111|Hormone Antagonists|hormone antagonists|mesh-ancestor
92612469|NCT00150111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612470|NCT02953210|Dexamethasone|dexamethasone|mesh-list
92612471|NCT02953210|Ketorolac|ketorolac|mesh-list
92612472|NCT02953210|Lidocaine|lidocaine|mesh-list
92612473|NCT02953210|Clonidine|clonidine|mesh-list
92612474|NCT02953210|Fentanyl|fentanyl|mesh-list
92612475|NCT02953210|Midazolam|midazolam|mesh-list
92612476|NCT02953210|Ketamine|ketamine|mesh-list
92612477|NCT02953210|Ondansetron|ondansetron|mesh-list
92612478|NCT02953210|Bupivacaine|bupivacaine|mesh-list
92612479|NCT02953210|Propofol|propofol|mesh-list
92612480|NCT02953210|Isoflurane|isoflurane|mesh-list
92612481|NCT02953210|Ranitidine|ranitidine|mesh-list
92612482|NCT02953210|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92612483|NCT02953210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92612484|NCT02953210|Rocuronium|rocuronium|mesh-list
92612485|NCT02953210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92612486|NCT02953210|Antiemetics|antiemetics|mesh-ancestor
92612487|NCT02953210|Autonomic Agents|autonomic agents|mesh-ancestor
92612488|NCT02953210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612489|NCT02953210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612490|NCT02953210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612491|NCT02953210|Glucocorticoids|glucocorticoids|mesh-ancestor
92612492|NCT02953210|Hormones|hormones|mesh-ancestor
92612493|NCT02953210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612494|NCT02953210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92612495|NCT02953210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612496|NCT02953210|Anesthetics, Local|anesthetics, local|mesh-ancestor
92612497|NCT02953210|Anesthetics|anesthetics|mesh-ancestor
92612498|NCT02953210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612499|NCT02953210|Sensory System Agents|sensory system agents|mesh-ancestor
92612500|NCT02953210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92612501|NCT02953210|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92612502|NCT02953210|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92612503|NCT02953210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612504|NCT02953210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612505|NCT02953210|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92612506|NCT02953210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92612507|NCT02953210|Anesthetics, General|anesthetics, general|mesh-ancestor
92612508|NCT02953210|Analgesics|analgesics|mesh-ancestor
92612509|NCT02953210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92612510|NCT02953210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92612511|NCT02953210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92612512|NCT02953210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612513|NCT02953210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92612514|NCT02953210|Narcotics|narcotics|mesh-ancestor
92612515|NCT02953210|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92612516|NCT02953210|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92612517|NCT02953210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92612518|NCT02953210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612519|NCT02953210|GABA Modulators|gaba modulators|mesh-ancestor
92612520|NCT02953210|GABA Agents|gaba agents|mesh-ancestor
92612521|NCT02953210|Antipruritics|antipruritics|mesh-ancestor
92612522|NCT02953210|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612523|NCT02953210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92612524|NCT02953210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92612525|NCT02953210|Serotonin Agents|serotonin agents|mesh-ancestor
92612526|NCT02953210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92612527|NCT02953210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92612530|NCT02953210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612531|NCT02953210|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92612532|NCT02953210|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92537055|NCT00138580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92537056|NCT00138580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537057|NCT00138580|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92537058|NCT00138580|Protease Inhibitors|protease inhibitors|mesh-ancestor
92537059|NCT00138580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537060|NCT00138580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537061|NCT03150771|Aripiprazole|aripiprazole|mesh-list
91957387|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
92612533|NCT02953210|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92612534|NCT02953210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92612535|NCT02953210|Sympatholytics|sympatholytics|mesh-ancestor
92612536|NCT02953210|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92612537|NCT02953210|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92612538|NCT02953210|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92612539|NCT02953210|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612540|NCT02953210|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92612541|NCT02953210|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92612542|NCT02953210|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92612543|NCT02953210|Histamine Antagonists|histamine antagonists|mesh-ancestor
92612544|NCT02953210|Histamine Agents|histamine agents|mesh-ancestor
92612545|NCT00509743|Diclofenac|diclofenac|mesh-list
92612546|NCT00509743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92612547|NCT00509743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92612548|NCT00509743|Analgesics|analgesics|mesh-ancestor
92612549|NCT00509743|Sensory System Agents|sensory system agents|mesh-ancestor
92612550|NCT00509743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612551|NCT00509743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612552|NCT00509743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92612553|NCT00509743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612554|NCT00509743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92612555|NCT00509743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612556|NCT00509743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612557|NCT00509860|Irinotecan|irinotecan|mesh-list
92612558|NCT00509860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92612559|NCT00509860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612560|NCT00509860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612561|NCT00509860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612562|NCT00509860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612563|NCT00509938|Lactoferrin|lactoferrin|mesh-list
92612564|NCT00509938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612565|NCT00337948|Epoetin Alfa|epoetin alfa|mesh-list
92612566|NCT00337948|Hematinics|hematinics|mesh-ancestor
92612567|NCT02958215|Phenylephrine|phenylephrine|mesh-list
92612568|NCT02958215|Oxymetazoline|oxymetazoline|mesh-list
92612569|NCT02958215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92612570|NCT02958215|Mydriatics|mydriatics|mesh-ancestor
92612571|NCT02958215|Autonomic Agents|autonomic agents|mesh-ancestor
92612572|NCT02958215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612573|NCT02958215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612574|NCT02958215|Sympathomimetics|sympathomimetics|mesh-ancestor
92612575|NCT02958215|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92612576|NCT02958215|Nasal Decongestants|nasal decongestants|mesh-ancestor
92612577|NCT02958215|Respiratory System Agents|respiratory system agents|mesh-ancestor
92612578|NCT02958215|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92612579|NCT02958215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92612580|NCT02958215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92612581|NCT02958215|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612582|NCT02958215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612583|NCT02958215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612584|NCT02958215|Protective Agents|protective agents|mesh-ancestor
92612585|NCT00158574|Pyrimethamine|pyrimethamine|mesh-list
92612586|NCT00158574|Sulfadoxine|sulfadoxine|mesh-list
92612587|NCT00158574|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92612588|NCT00158574|Dapsone|dapsone|mesh-list
92612589|NCT00158574|Mefloquine|mefloquine|mesh-list
92612590|NCT00158574|Chlorproguanil|chlorproguanil|mesh-list
92612591|NCT00158574|Proguanil|proguanil|mesh-list
92612592|NCT00158574|Antimalarials|antimalarials|mesh-ancestor
92612593|NCT00158574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92537062|NCT03150771|Antidepressive Agents|antidepressive agents|mesh-ancestor
92537063|NCT03150771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612594|NCT00158574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92612595|NCT00158574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612596|NCT00158574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92612597|NCT00158574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612598|NCT00158574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612599|NCT00158574|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92612600|NCT00158574|Leprostatic Agents|leprostatic agents|mesh-ancestor
92612601|NCT00158574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612602|NCT00158574|Antimetabolites|antimetabolites|mesh-ancestor
92612606|NCT00338221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612607|NCT00338221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612609|NCT00338299|Hematinics|hematinics|mesh-ancestor
92612610|NCT00510016|Clonidine|clonidine|mesh-list
92612611|NCT00510016|Analgesics|analgesics|mesh-ancestor
92612612|NCT00510016|Sensory System Agents|sensory system agents|mesh-ancestor
92612613|NCT00510016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612614|NCT00510016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612616|NCT00510016|Sympatholytics|sympatholytics|mesh-ancestor
92612617|NCT00510016|Autonomic Agents|autonomic agents|mesh-ancestor
92612618|NCT00510016|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92612619|NCT00510016|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92612620|NCT00510016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92612621|NCT00510016|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612622|NCT00510016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612623|NCT00510016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612624|NCT00150228|Varenicline|varenicline|mesh-list
92612625|NCT00150228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92612626|NCT00150228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92612627|NCT00150228|Cholinergic Agents|cholinergic agents|mesh-ancestor
92612628|NCT00150228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612629|NCT00150228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612630|NCT00150228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612631|NCT00338338|Amlodipine|amlodipine|mesh-list
92612632|NCT00338338|Lacidipine|lacidipine|mesh-list
92612633|NCT00338338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92612634|NCT00338338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92612635|NCT00338338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612636|NCT00338338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612637|NCT00338338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612638|NCT00338338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612639|NCT00338338|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612640|NCT00338416|Epoetin Alfa|epoetin alfa|mesh-list
92612641|NCT00338416|Hematinics|hematinics|mesh-ancestor
92612642|NCT00338494|Clofarabine|clofarabine|mesh-list
92612643|NCT00338494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612644|NCT00338494|Antimetabolites|antimetabolites|mesh-ancestor
92612645|NCT00338494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612646|NCT00338494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612647|NCT02953015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92612648|NCT02953015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92612649|NCT02953015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92612650|NCT02953015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612651|NCT02953015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612652|NCT02953015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92612653|NCT02953015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612654|NCT02953015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612655|NCT02953015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92612656|NCT02953015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612657|NCT00158652|Carboplatin|carboplatin|mesh-list
92612658|NCT00158652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612659|NCT00338650|Adalimumab|adalimumab|mesh-list
92612660|NCT00338650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92612661|NCT00338650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92612662|NCT00338650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612663|NCT00158691|Amifostine|amifostine|mesh-list
92612664|NCT00158691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92612665|NCT00158691|Protective Agents|protective agents|mesh-ancestor
92612666|NCT00158691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612667|NCT00338767|Fluoxetine|fluoxetine|mesh-list
92612668|NCT00338767|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92537064|NCT03150771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92537065|NCT03150771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537066|NCT03150771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537067|NCT03150771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537068|NCT03150771|Dopamine Agonists|dopamine agonists|mesh-ancestor
92537069|NCT03150771|Dopamine Agents|dopamine agents|mesh-ancestor
92537070|NCT03150771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537071|NCT03150771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537072|NCT03150771|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92537073|NCT03150771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92537074|NCT03150771|Serotonin Agents|serotonin agents|mesh-ancestor
92537075|NCT03150771|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92537076|NCT03150771|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92537077|NCT03150771|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92537078|NCT03150771|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92537079|NCT00138619|Vildagliptin|vildagliptin|mesh-list
92537080|NCT00138619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92537081|NCT00138619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537082|NCT00138619|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92537083|NCT00138619|Protease Inhibitors|protease inhibitors|mesh-ancestor
91944758|NCT03477955|Silicon|silicon|mesh-list
92612669|NCT00338767|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92612670|NCT00338767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612671|NCT00338767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612672|NCT00338767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612673|NCT00338767|Serotonin Agents|serotonin agents|mesh-ancestor
92612674|NCT00338767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612678|NCT00338767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92612679|NCT00338767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92612680|NCT00338767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612681|NCT00339001|Epoetin Alfa|epoetin alfa|mesh-list
92612682|NCT00339001|Hematinics|hematinics|mesh-ancestor
92612683|NCT00150306|Sertraline|sertraline|mesh-list
92612684|NCT00150306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92612685|NCT00150306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612686|NCT00150306|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92612687|NCT00150306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92612688|NCT00150306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612689|NCT00150306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612690|NCT00150306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612691|NCT00150306|Serotonin Agents|serotonin agents|mesh-ancestor
92612692|NCT00150306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612693|NCT00510172|Epoprostenol|epoprostenol|mesh-list
92612694|NCT00510172|Tezosentan|tezosentan|mesh-list
92612695|NCT00510172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92612696|NCT00510172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92612697|NCT00510172|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612698|NCT00420901|Sildenafil Citrate|sildenafil citrate|mesh-list
92612699|NCT00420901|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612700|NCT00420901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92612701|NCT00420901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92537084|NCT00138619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537085|NCT00138619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537086|NCT03150732|Nalbuphine|nalbuphine|mesh-list
92537087|NCT03150732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92537088|NCT03150732|Narcotics|narcotics|mesh-ancestor
92612702|NCT00420901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612703|NCT00420901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612704|NCT00420901|Urological Agents|urological agents|mesh-ancestor
92612705|NCT00150384|Amlodipine|amlodipine|mesh-list
92612706|NCT00150384|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92612707|NCT00150384|Atorvastatin|atorvastatin|mesh-list
92612708|NCT00150384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92612709|NCT00150384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92612710|NCT00150384|Antimetabolites|antimetabolites|mesh-ancestor
92612711|NCT00150384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612712|NCT00150384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92612713|NCT00150384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92612714|NCT00150384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612715|NCT00150384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92612716|NCT00150384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92612717|NCT00150384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612718|NCT00150384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612719|NCT00150384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612720|NCT00150384|Vasodilator Agents|vasodilator agents|mesh-ancestor
92612721|NCT00425191|Gemcitabine|gemcitabine|mesh-list
92612722|NCT00425191|Docetaxel|docetaxel|mesh-list
92612723|NCT00425191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612724|NCT00425191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612725|NCT00425191|Antimetabolites|antimetabolites|mesh-ancestor
92612726|NCT00425191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612727|NCT00425191|Tubulin Modulators|tubulin modulators|mesh-ancestor
92612728|NCT00425191|Antimitotic Agents|antimitotic agents|mesh-ancestor
92612729|NCT00425191|Mitosis Modulators|mitosis modulators|mesh-ancestor
92612730|NCT00339118|Doxorubicin|doxorubicin|mesh-list
92612731|NCT00339118|Cyclophosphamide|cyclophosphamide|mesh-list
92612732|NCT00339118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92612733|NCT00339118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612734|NCT00339118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92612735|NCT00339118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612736|NCT00339118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612737|NCT00339118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612738|NCT00339118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92612739|NCT00339118|Immunologic Factors|immunologic factors|mesh-ancestor
92612740|NCT00339118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612741|NCT00339118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612742|NCT00339118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92612743|NCT00339118|Alkylating Agents|alkylating agents|mesh-ancestor
92612744|NCT00339118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92612747|NCT00339196|Azacitidine|azacitidine|mesh-list
92612748|NCT00339196|Tretinoin|tretinoin|mesh-list
92612749|NCT00339196|Valproic Acid|valproic acid|mesh-list
92612750|NCT00339196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612751|NCT00339196|Antimetabolites|antimetabolites|mesh-ancestor
92612752|NCT00339196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612753|NCT00339196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612754|NCT00339196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612755|NCT00339196|Keratolytic Agents|keratolytic agents|mesh-ancestor
92612756|NCT00339196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612757|NCT00339196|Anticonvulsants|anticonvulsants|mesh-ancestor
92337790|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
92612758|NCT00339196|GABA Agents|gaba agents|mesh-ancestor
92612759|NCT00339196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612760|NCT00339196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612761|NCT00339196|Antimanic Agents|antimanic agents|mesh-ancestor
92612762|NCT00339196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92612763|NCT00339196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612764|NCT00339196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612765|NCT00158730|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92612766|NCT00158730|Antifungal Agents|antifungal agents|mesh-ancestor
92612767|NCT00158730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537089|NCT03150732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537090|NCT03150732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537091|NCT03150732|Analgesics|analgesics|mesh-ancestor
92537092|NCT03150732|Sensory System Agents|sensory system agents|mesh-ancestor
92537093|NCT03150732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537094|NCT03893825|Risperidone|risperidone|mesh-list
92537095|NCT03893825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92537096|NCT03893825|Serotonin Agents|serotonin agents|mesh-ancestor
92537097|NCT03893825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537098|NCT03893825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537099|NCT03893825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537100|NCT03893825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92537101|NCT03893825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537102|NCT03893825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537103|NCT03893825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92537104|NCT03893825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92537105|NCT03893825|Dopamine Agents|dopamine agents|mesh-ancestor
92537106|NCT00138970|Mycophenolic Acid|mycophenolic acid|mesh-list
92537107|NCT00138970|Cyclosporine|cyclosporine|mesh-list
92537108|NCT00138970|Prednisolone|prednisolone|mesh-list
92537109|NCT00138970|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92537110|NCT00138970|Methylprednisolone|methylprednisolone|mesh-list
92537111|NCT00138970|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92537112|NCT00138970|Prednisolone acetate|prednisolone acetate|mesh-list
92537113|NCT00138970|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92537114|NCT00138970|Prednisolone phosphate|prednisolone phosphate|mesh-list
92537115|NCT00138970|Daclizumab|daclizumab|mesh-list
92537116|NCT00138970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537117|NCT00138970|Glucocorticoids|glucocorticoids|mesh-ancestor
92537118|NCT00138970|Hormones|hormones|mesh-ancestor
92537119|NCT00138970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537120|NCT00138970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537121|NCT00138970|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92537122|NCT00138970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537123|NCT00138970|Antiemetics|antiemetics|mesh-ancestor
92612768|NCT00158730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92612769|NCT00158730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92612770|NCT00510211|Olanzapine|olanzapine|mesh-list
92612771|NCT00510211|Antiemetics|antiemetics|mesh-ancestor
92612772|NCT00510211|Autonomic Agents|autonomic agents|mesh-ancestor
92612773|NCT00510211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537124|NCT00138970|Autonomic Agents|autonomic agents|mesh-ancestor
92537125|NCT00138970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537126|NCT00138970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612774|NCT00510211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612775|NCT00510211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612776|NCT00510211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92612777|NCT00510211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92612778|NCT00510211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612779|NCT00510211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612780|NCT00510211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92612781|NCT00510211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92612782|NCT00510211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612783|NCT00510211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612784|NCT00510211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612785|NCT00510211|Serotonin Agents|serotonin agents|mesh-ancestor
92612786|NCT00150423|Pregabalin|pregabalin|mesh-list
92612787|NCT00150423|Analgesics|analgesics|mesh-ancestor
92612788|NCT00150423|Sensory System Agents|sensory system agents|mesh-ancestor
92612789|NCT00150423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612790|NCT00150423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612791|NCT00150423|Anticonvulsants|anticonvulsants|mesh-ancestor
92612792|NCT00150423|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92612793|NCT00150423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612794|NCT00150423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612795|NCT00150423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612796|NCT00150423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92612797|NCT00150423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92612798|NCT00150423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612799|NCT00150423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612800|NCT04988282|Methylprednisolone|methylprednisolone|mesh-list
92612801|NCT04988282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92612802|NCT04988282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92612803|NCT04988282|Prednisolone|prednisolone|mesh-list
92612804|NCT04988282|Prednisolone acetate|prednisolone acetate|mesh-list
92612805|NCT04988282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92612806|NCT04988282|Prednisolone phosphate|prednisolone phosphate|mesh-list
92612807|NCT04988282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92612808|NCT04988282|Antiemetics|antiemetics|mesh-ancestor
92612809|NCT04988282|Autonomic Agents|autonomic agents|mesh-ancestor
92612810|NCT04988282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612811|NCT04988282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612812|NCT04988282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92612813|NCT04988282|Glucocorticoids|glucocorticoids|mesh-ancestor
92612814|NCT04988282|Hormones|hormones|mesh-ancestor
92612815|NCT04988282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019748|NCT04873531|Neostigmine|neostigmine|mesh-list
92612818|NCT04988282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92612820|NCT00510250|Sorafenib|sorafenib|mesh-list
92612821|NCT00510250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612822|NCT00510250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612823|NCT00510250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612824|NCT00510250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612825|NCT04981067|Ropivacaine|ropivacaine|mesh-list
92612826|NCT04981067|Anesthetics, Local|anesthetics, local|mesh-ancestor
92612827|NCT04981067|Anesthetics|anesthetics|mesh-ancestor
92612828|NCT04981067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92612829|NCT04981067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612830|NCT04981067|Sensory System Agents|sensory system agents|mesh-ancestor
92612831|NCT04981067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612832|NCT00510367|Cyclophosphamide|cyclophosphamide|mesh-list
92337864|NCT00673595|Varenicline|varenicline|mesh-list
92612833|NCT00510367|Doxorubicin|doxorubicin|mesh-list
92612834|NCT00510367|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92612835|NCT00510367|Fluorouracil|fluorouracil|mesh-list
92612836|NCT00510367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92612837|NCT00510367|Immunologic Factors|immunologic factors|mesh-ancestor
92612838|NCT00510367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612839|NCT00510367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612840|NCT00510367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92612841|NCT00510367|Alkylating Agents|alkylating agents|mesh-ancestor
92612842|NCT00510367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537127|NCT00138970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92537129|NCT00138970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91944821|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
92612843|NCT00510367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612844|NCT00510367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92612845|NCT00510367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92612846|NCT00510367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92612847|NCT00510367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612848|NCT00510367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612849|NCT00510367|Antimetabolites|antimetabolites|mesh-ancestor
92612850|NCT00510367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612851|NCT00158847|Fluticasone|fluticasone|mesh-list
92612852|NCT00158847|Xhance|xhance|mesh-list
92612853|NCT00158847|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92612854|NCT00158847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92612855|NCT00158847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92612856|NCT00158847|Autonomic Agents|autonomic agents|mesh-ancestor
92612857|NCT00158847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612858|NCT00158847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612859|NCT00158847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92612860|NCT00158847|Respiratory System Agents|respiratory system agents|mesh-ancestor
92612861|NCT00158847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612862|NCT00158847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92612863|NCT00158847|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92612864|NCT00158847|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92612865|NCT00158847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92612866|NCT00158847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612867|NCT00158847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612868|NCT00158847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612869|NCT00339586|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92612870|NCT00339586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612871|NCT00339586|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612872|NCT00339586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612873|NCT00339586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612874|NCT00158886|Topotecan|topotecan|mesh-list
92612875|NCT00158886|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92612876|NCT00158886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92612877|NCT00158886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612878|NCT00158886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612879|NCT00158886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612880|NCT00510406|Tamsulosin|tamsulosin|mesh-list
92612881|NCT00510406|Solifenacin Succinate|solifenacin succinate|mesh-list
92612882|NCT00510406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92612883|NCT00510406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92612884|NCT00510406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92612885|NCT00510406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612886|NCT00510406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612898|NCT00165555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612899|NCT00165555|Antitubercular Agents|antitubercular agents|mesh-ancestor
92612900|NCT00165555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612901|NCT00165555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612902|NCT00165555|Chelating Agents|chelating agents|mesh-ancestor
92612903|NCT00165555|Sequestering Agents|sequestering agents|mesh-ancestor
92612904|NCT00150579|Amphetamine|amphetamine|mesh-list
92612905|NCT00150579|Dextroamphetamine|dextroamphetamine|mesh-list
92612906|NCT00150579|Adderall|adderall|mesh-list
92612907|NCT00150579|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92612908|NCT00150579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612909|NCT00150579|Sympathomimetics|sympathomimetics|mesh-ancestor
92612910|NCT00150579|Autonomic Agents|autonomic agents|mesh-ancestor
92612911|NCT00150579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92612912|NCT00150579|Dopamine Agents|dopamine agents|mesh-ancestor
92612913|NCT00150579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612914|NCT00150579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612915|NCT00150579|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612916|NCT00150579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92612917|NCT00150579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92612918|NCT00150579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612919|NCT00150579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92612920|NCT00511732|Insulin|insulin|mesh-list
92537130|NCT00138970|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92537131|NCT00138970|Antitubercular Agents|antitubercular agents|mesh-ancestor
92537132|NCT00138970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612921|NCT00511732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92612922|NCT00511732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612923|NCT00510445|Imetelstat|imetelstat|mesh-list
92612924|NCT00510445|Motesanib diphosphate|motesanib diphosphate|mesh-list
92612925|NCT00510445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612926|NCT00510445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612927|NCT00510445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612928|NCT00150657|Bevacizumab|bevacizumab|mesh-list
92612929|NCT00150657|Carboplatin|carboplatin|mesh-list
92612930|NCT00150657|Gemcitabine|gemcitabine|mesh-list
92612931|NCT00150657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612932|NCT00150657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612933|NCT00150657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92612934|NCT00150657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92612935|NCT00150657|Growth Substances|growth substances|mesh-ancestor
92612936|NCT00150657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612937|NCT00150657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92612938|NCT00150657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92612939|NCT00150657|Antimetabolites|antimetabolites|mesh-ancestor
92612940|NCT00150657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612941|NCT00511771|Tegaserod|tegaserod|mesh-list
92612942|NCT00511771|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92612943|NCT00511771|Serotonin Agents|serotonin agents|mesh-ancestor
92612944|NCT00511771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612945|NCT00511771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612946|NCT00511771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612947|NCT00165594|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92612948|NCT00165594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612949|NCT00165594|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92612951|NCT00165594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612952|NCT00511849|Paclitaxel|paclitaxel|mesh-list
92612953|NCT00511849|Carboplatin|carboplatin|mesh-list
92612954|NCT00511849|Sunitinib|sunitinib|mesh-list
92612955|NCT00511849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92612956|NCT00511849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612957|NCT00511849|Tubulin Modulators|tubulin modulators|mesh-ancestor
92612958|NCT00511849|Antimitotic Agents|antimitotic agents|mesh-ancestor
92612959|NCT00511849|Mitosis Modulators|mitosis modulators|mesh-ancestor
92612960|NCT00511849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612961|NCT00511849|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92612962|NCT00511849|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92612963|NCT00511849|Growth Substances|growth substances|mesh-ancestor
92612964|NCT00511849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612965|NCT00511849|Growth Inhibitors|growth inhibitors|mesh-ancestor
92612966|NCT00511849|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612967|NCT00511849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612968|NCT00510640|Sunitinib|sunitinib|mesh-list
92612969|NCT00510640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612970|NCT00510640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92612971|NCT00510640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92612972|NCT00510640|Growth Substances|growth substances|mesh-ancestor
92612973|NCT00510640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612974|NCT00510640|Growth Inhibitors|growth inhibitors|mesh-ancestor
92612975|NCT00510640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92612976|NCT00510640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92612977|NCT00510640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612978|NCT00150696|Risedronic Acid|risedronic acid|mesh-list
92612979|NCT00150696|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92612980|NCT00150696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92612981|NCT00150696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612982|NCT00150696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92612983|NCT00150696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612984|NCT00150696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92612985|NCT00165633|Vitamin K 2|vitamin k 2|mesh-list
92612986|NCT00165633|Menatetrenone|menatetrenone|mesh-list
92537133|NCT00138970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537134|NCT00138970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537135|NCT00138970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537136|NCT00138970|Antifungal Agents|antifungal agents|mesh-ancestor
91944828|NCT03475225|Vitamin D|vitamin d|mesh-list
92612987|NCT00165633|Hemostatics|hemostatics|mesh-ancestor
92612988|NCT00165633|Coagulants|coagulants|mesh-ancestor
92612989|NCT00165633|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92612990|NCT00165633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92612991|NCT00165633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612993|NCT00165633|Micronutrients|micronutrients|mesh-ancestor
92612994|NCT00165633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612995|NCT02952469|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92612996|NCT02952469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612997|NCT02952469|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92612998|NCT00510913|Tacrolimus|tacrolimus|mesh-list
92612999|NCT00510913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613000|NCT00510913|Immunologic Factors|immunologic factors|mesh-ancestor
92613001|NCT00510913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613002|NCT00510913|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92613003|NCT00510913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613004|NCT00510913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613005|NCT00150735|Levetiracetam|levetiracetam|mesh-list
92613006|NCT00150735|Anticonvulsants|anticonvulsants|mesh-ancestor
92613007|NCT00150735|Nootropic Agents|nootropic agents|mesh-ancestor
92613008|NCT04695925|Carboplatin|carboplatin|mesh-list
92613009|NCT04695925|Pemetrexed|pemetrexed|mesh-list
92613010|NCT04695925|Osimertinib|osimertinib|mesh-list
92613011|NCT04695925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613012|NCT04695925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613013|NCT04695925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613014|NCT04695925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92613015|NCT04695925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92613016|NCT04695925|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613017|NCT00511069|Bortezomib|bortezomib|mesh-list
92613018|NCT00511069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613019|NCT00165750|Donepezil|donepezil|mesh-list
92613020|NCT00165750|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92613021|NCT00165750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613022|NCT00165750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613023|NCT00165750|Cholinergic Agents|cholinergic agents|mesh-ancestor
92613024|NCT00165750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613032|NCT00511225|Micronutrients|micronutrients|mesh-ancestor
92613033|NCT00511225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92613034|NCT00150774|Levetiracetam|levetiracetam|mesh-list
92613035|NCT00150774|Anticonvulsants|anticonvulsants|mesh-ancestor
92613036|NCT00150774|Nootropic Agents|nootropic agents|mesh-ancestor
92613037|NCT04864067|Leucovorin|leucovorin|mesh-list
92613038|NCT04864067|Capecitabine|capecitabine|mesh-list
92613039|NCT04864067|Oxaliplatin|oxaliplatin|mesh-list
92613040|NCT04864067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613041|NCT04864067|Antimetabolites|antimetabolites|mesh-ancestor
92613042|NCT04864067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613043|NCT04864067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613044|NCT04864067|Antidotes|antidotes|mesh-ancestor
92613045|NCT04864067|Protective Agents|protective agents|mesh-ancestor
92613046|NCT04864067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613047|NCT04864067|Vitamin B Complex|vitamin b complex|mesh-ancestor
92613048|NCT04864067|Vitamins|vitamins|mesh-ancestor
92613049|NCT04864067|Micronutrients|micronutrients|mesh-ancestor
92613050|NCT00511303|Imatinib Mesylate|imatinib mesylate|mesh-list
92613051|NCT00511303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613052|NCT00511303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613053|NCT00511303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613054|NCT00511303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613055|NCT00165828|Zonisamide|zonisamide|mesh-list
92613056|NCT00165828|Anticonvulsants|anticonvulsants|mesh-ancestor
92613057|NCT00165828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92613058|NCT00165828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613059|NCT00165828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613060|NCT00165828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613061|NCT00165828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613062|NCT00511498|Sildenafil Citrate|sildenafil citrate|mesh-list
92613063|NCT00511498|Vasodilator Agents|vasodilator agents|mesh-ancestor
92613064|NCT00511498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92613065|NCT00511498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92613066|NCT00511498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613067|NCT00511498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613068|NCT00511498|Urological Agents|urological agents|mesh-ancestor
92613069|NCT00511576|Docetaxel|docetaxel|mesh-list
92613070|NCT00511576|Mocetinostat|mocetinostat|mesh-list
92613071|NCT00511576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613072|NCT00511576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613073|NCT00511576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613074|NCT00511576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613075|NCT00511576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613076|NCT00511576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92613077|NCT00511576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613078|NCT00511654|Midazolam|midazolam|mesh-list
92613079|NCT00511654|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92613080|NCT00511654|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92613081|NCT00511654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613082|NCT00511654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613083|NCT00511654|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92613084|NCT00511654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92613085|NCT00511654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92613086|NCT00511654|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92613087|NCT00511654|Anesthetics, General|anesthetics, general|mesh-ancestor
92613088|NCT00511654|Anesthetics|anesthetics|mesh-ancestor
92613089|NCT00511654|GABA Modulators|gaba modulators|mesh-ancestor
92613090|NCT00511654|GABA Agents|gaba agents|mesh-ancestor
92613091|NCT00511654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613092|NCT00511654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613093|NCT00150852|Vancomycin|vancomycin|mesh-list
92020034|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
92613101|NCT00165867|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92613102|NCT00165867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613103|NCT00165867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92613104|NCT00165867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613105|NCT00165867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613106|NCT02951806|Fentanyl|fentanyl|mesh-list
92613107|NCT02951806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92613108|NCT02951806|Narcotics|narcotics|mesh-ancestor
92613109|NCT02951806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613110|NCT02951806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613111|NCT02951806|Analgesics|analgesics|mesh-ancestor
92613112|NCT02951806|Sensory System Agents|sensory system agents|mesh-ancestor
92613113|NCT02951806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613114|NCT02951806|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92613115|NCT02951806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92613116|NCT02951806|Anesthetics, General|anesthetics, general|mesh-ancestor
92613117|NCT02951806|Anesthetics|anesthetics|mesh-ancestor
92613118|NCT00512980|Prednisone|prednisone|mesh-list
92613119|NCT00512980|Gemcitabine|gemcitabine|mesh-list
92613120|NCT00512980|Doxorubicin|doxorubicin|mesh-list
92613121|NCT00512980|Vinblastine|vinblastine|mesh-list
92613122|NCT00512980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613123|NCT00512980|Antimetabolites|antimetabolites|mesh-ancestor
92613124|NCT00512980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613125|NCT00512980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613126|NCT00512980|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92613127|NCT00512980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92613128|NCT00512980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92613129|NCT00512980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613130|NCT00512980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613131|NCT00512980|Glucocorticoids|glucocorticoids|mesh-ancestor
92338168|NCT00428207|Insulin|insulin|mesh-list
92613133|NCT00512980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613134|NCT00512980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613135|NCT00512980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92613136|NCT00512980|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613137|NCT00512980|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613138|NCT00512980|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613139|NCT00512980|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613140|NCT00150891|Cyclosporine|cyclosporine|mesh-list
92613141|NCT00150891|Mycophenolic Acid|mycophenolic acid|mesh-list
92613142|NCT00150891|Azathioprine|azathioprine|mesh-list
92537137|NCT00138970|Dermatologic Agents|dermatologic agents|mesh-ancestor
92537138|NCT00138970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537139|NCT00138970|Immunologic Factors|immunologic factors|mesh-ancestor
92537140|NCT00138970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613143|NCT00150891|Tacrolimus|tacrolimus|mesh-list
92613144|NCT00150891|Cyclosporins|cyclosporins|mesh-list
92613145|NCT00150891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613146|NCT00150891|Immunologic Factors|immunologic factors|mesh-ancestor
92613147|NCT00150891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613148|NCT00150891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92613149|NCT00150891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613150|NCT00150891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613151|NCT00150891|Antifungal Agents|antifungal agents|mesh-ancestor
92613152|NCT00150891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613153|NCT00150891|Dermatologic Agents|dermatologic agents|mesh-ancestor
92613154|NCT00150891|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613155|NCT00150891|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92613156|NCT00150891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613157|NCT00150891|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92613158|NCT00150891|Antitubercular Agents|antitubercular agents|mesh-ancestor
92613159|NCT00150891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92613160|NCT00150891|Antimetabolites|antimetabolites|mesh-ancestor
92613161|NCT00150891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613162|NCT00513058|Vinorelbine|vinorelbine|mesh-list
92613175|NCT02951962|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92613176|NCT02951962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92613177|NCT02951962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92613178|NCT02951962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613179|NCT02951962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613180|NCT02951962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613181|NCT02951962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613182|NCT02951962|Vasodilator Agents|vasodilator agents|mesh-ancestor
92613183|NCT02951962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92613184|NCT02951962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92613185|NCT02951962|Antimetabolites|antimetabolites|mesh-ancestor
92613186|NCT02951962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92613187|NCT02951962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92613188|NCT02951962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613189|NCT02951962|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92613190|NCT02951962|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92613191|NCT00513253|Lapatinib|lapatinib|mesh-list
92613192|NCT00513253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613193|NCT00513253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613194|NCT00513253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613195|NCT00513253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613196|NCT00513487|Fluticasone|fluticasone|mesh-list
92613197|NCT00513487|Methacholine Chloride|methacholine chloride|mesh-list
92613198|NCT00513487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613199|NCT00513487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92613200|NCT00513487|Autonomic Agents|autonomic agents|mesh-ancestor
92613201|NCT00513487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613202|NCT00513487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613203|NCT00513487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92613204|NCT00513487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92613205|NCT00513487|Dermatologic Agents|dermatologic agents|mesh-ancestor
92613206|NCT00513487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92613207|NCT00513487|Miotics|miotics|mesh-ancestor
92613208|NCT00513487|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92613209|NCT00513487|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92613210|NCT00513487|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92613211|NCT00513487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92613212|NCT00513487|Cholinergic Agents|cholinergic agents|mesh-ancestor
92613213|NCT00513487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613214|NCT00513487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613215|NCT00405236|Tiotropium Bromide|tiotropium bromide|mesh-list
92613216|NCT00405236|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92613217|NCT00405236|Autonomic Agents|autonomic agents|mesh-ancestor
92613218|NCT00405236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613219|NCT00405236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613220|NCT00405236|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92537141|NCT00138970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92537142|NCT00139009|Cyclosporine|cyclosporine|mesh-list
92537143|NCT00139009|Cyclosporins|cyclosporins|mesh-list
92537144|NCT00139009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944834|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92613221|NCT00405236|Respiratory System Agents|respiratory system agents|mesh-ancestor
92613222|NCT00405236|Parasympatholytics|parasympatholytics|mesh-ancestor
92613223|NCT00405236|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92613224|NCT00405236|Cholinergic Agents|cholinergic agents|mesh-ancestor
92613233|NCT00513643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92613234|NCT00513643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613235|NCT00151008|Bexarotene|bexarotene|mesh-list
92613236|NCT00151008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613237|NCT00513877|Bortezomib|bortezomib|mesh-list
92613238|NCT00513877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613239|NCT04695613|Magnesium Sulfate|magnesium sulfate|mesh-list
92613240|NCT04695613|Analgesics|analgesics|mesh-ancestor
92613241|NCT04695613|Sensory System Agents|sensory system agents|mesh-ancestor
92613242|NCT04695613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613243|NCT04695613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613244|NCT04695613|Anesthetics|anesthetics|mesh-ancestor
92613245|NCT04695613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613246|NCT04695613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92613247|NCT04695613|Anticonvulsants|anticonvulsants|mesh-ancestor
92613248|NCT04695613|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92613249|NCT04695613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613250|NCT04695613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613251|NCT04695613|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613252|NCT04695613|Tocolytic Agents|tocolytic agents|mesh-ancestor
92613253|NCT04695613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92613254|NCT00151047|Docetaxel|docetaxel|mesh-list
92613255|NCT00151047|Capecitabine|capecitabine|mesh-list
92613256|NCT00151047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613257|NCT00151047|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613258|NCT00151047|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613259|NCT00151047|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613260|NCT00151047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613261|NCT00151047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613262|NCT00151047|Antimetabolites|antimetabolites|mesh-ancestor
92613263|NCT00513955|Prednisolone|prednisolone|mesh-list
92613264|NCT00513955|Cyclophosphamide|cyclophosphamide|mesh-list
92613265|NCT00513955|Doxorubicin|doxorubicin|mesh-list
92613266|NCT00513955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92613267|NCT00513955|Vincristine|vincristine|mesh-list
92613268|NCT00513955|Bortezomib|bortezomib|mesh-list
92613269|NCT00513955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613270|NCT00513955|Immunologic Factors|immunologic factors|mesh-ancestor
92613271|NCT00513955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613272|NCT00513955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613273|NCT00513955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92613274|NCT00513955|Alkylating Agents|alkylating agents|mesh-ancestor
92613275|NCT00513955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613276|NCT00513955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613277|NCT00513955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92613278|NCT00513955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92613279|NCT00513955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92613280|NCT00513955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92613281|NCT00513955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338318|NCT00240227|Adrenergic Agents|adrenergic agents|mesh-ancestor
92613282|NCT00513955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613283|NCT00513955|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613284|NCT00513955|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613285|NCT00513955|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613286|NCT00513955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613287|NCT00513955|Glucocorticoids|glucocorticoids|mesh-ancestor
92613289|NCT00513955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613290|NCT00513955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92613291|NCT00513994|Nitroglycerin|nitroglycerin|mesh-list
92613292|NCT00513994|Vasodilator Agents|vasodilator agents|mesh-ancestor
92613293|NCT00514072|Vaccines|vaccines|mesh-list
92613298|NCT00514111|Interferons|interferons|mesh-list
92613299|NCT00514111|Ribavirin|ribavirin|mesh-list
92613300|NCT00514111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537145|NCT00139009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613301|NCT00514111|Antiviral Agents|antiviral agents|mesh-ancestor
92613302|NCT00514111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613303|NCT00514111|Antimetabolites|antimetabolites|mesh-ancestor
92360974|NCT00546156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92613304|NCT00514111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613305|NCT00151086|Vinorelbine|vinorelbine|mesh-list
92613306|NCT00151086|Estramustine|estramustine|mesh-list
92613307|NCT00151086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613308|NCT00151086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613309|NCT00151086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613310|NCT00151086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613311|NCT00151086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613312|NCT00151086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613313|NCT00151086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92613314|NCT00151086|Alkylating Agents|alkylating agents|mesh-ancestor
92613315|NCT00151086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92613316|NCT00514228|Sunitinib|sunitinib|mesh-list
92613317|NCT00514228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613318|NCT00514228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92613319|NCT00514228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92613320|NCT00514228|Growth Substances|growth substances|mesh-ancestor
92613321|NCT00514228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613322|NCT00514228|Growth Inhibitors|growth inhibitors|mesh-ancestor
92613323|NCT00514228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613324|NCT00514228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613325|NCT00514228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613326|NCT00151125|Oprelvekin|oprelvekin|mesh-list
92613327|NCT00151125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613328|NCT00514618|Misoprostol|misoprostol|mesh-list
92613329|NCT00514618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92613330|NCT00514618|Abortifacient Agents|abortifacient agents|mesh-ancestor
92613331|NCT00514618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92613332|NCT00514618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613333|NCT00514618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92613334|NCT00514618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92613335|NCT00514618|Oxytocics|oxytocics|mesh-ancestor
92613336|NCT00514657|Mitogens|mitogens|mesh-list
92613337|NCT00514657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613338|NCT00514657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613339|NCT00514774|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92613340|NCT00514774|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92613341|NCT00514774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92613342|NCT02951260|Metformin|metformin|mesh-list
92613343|NCT02951260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92613344|NCT02951260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613345|NCT02951299|Pentoxifylline|pentoxifylline|mesh-list
92613346|NCT02951299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92613347|NCT02951299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613348|NCT02951299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613349|NCT02951299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92613350|NCT02951299|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92613351|NCT02951299|Protective Agents|protective agents|mesh-ancestor
92613352|NCT02951299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613353|NCT02951299|Vasodilator Agents|vasodilator agents|mesh-ancestor
92613354|NCT02951299|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92613355|NCT02951299|Antioxidants|antioxidants|mesh-ancestor
92613356|NCT00514891|Vitamin A|vitamin a|mesh-list
92613357|NCT00514891|Vitamins|vitamins|mesh-ancestor
92613359|NCT00514891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613360|NCT00514969|Imatinib Mesylate|imatinib mesylate|mesh-list
92613361|NCT00514969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613362|NCT00514969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613363|NCT00514969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613364|NCT00514969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613365|NCT02950948|Progesterone|progesterone|mesh-list
92613366|NCT02950948|Progestins|progestins|mesh-ancestor
92613369|NCT02950948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613371|NCT00515320|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92613372|NCT00515320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92613373|NCT00515320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613374|NCT00515320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613375|NCT00515320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360976|NCT00449046|Fluticasone|fluticasone|mesh-list
92537146|NCT00139009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537147|NCT00139009|Immunologic Factors|immunologic factors|mesh-ancestor
92613376|NCT00515320|Serotonin Agents|serotonin agents|mesh-ancestor
92613377|NCT00515320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613378|NCT00515320|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92613379|NCT00515320|Antidepressive Agents|antidepressive agents|mesh-ancestor
92613380|NCT00515320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92613381|NCT00515320|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92613382|NCT00515320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92613383|NCT00515320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613384|NCT00515359|Propofol|propofol|mesh-list
92613385|NCT00515359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92613386|NCT00515359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613387|NCT00515359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613388|NCT00515359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92613389|NCT00515359|Anesthetics, General|anesthetics, general|mesh-ancestor
92613390|NCT00515359|Anesthetics|anesthetics|mesh-ancestor
92613391|NCT00515554|Rituximab|rituximab|mesh-list
92613392|NCT00515554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92613393|NCT00515554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613394|NCT00515554|Immunologic Factors|immunologic factors|mesh-ancestor
92613395|NCT00515554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613396|NCT00515554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613397|NCT00151203|Clarithromycin|clarithromycin|mesh-list
92613398|NCT00151203|Dexamethasone|dexamethasone|mesh-list
92613399|NCT00151203|Lenalidomide|lenalidomide|mesh-list
92613400|NCT00151203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613401|NCT00151203|Antiemetics|antiemetics|mesh-ancestor
92613402|NCT00151203|Autonomic Agents|autonomic agents|mesh-ancestor
92613403|NCT00151203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613404|NCT00151203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613405|NCT00151203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92613406|NCT00151203|Glucocorticoids|glucocorticoids|mesh-ancestor
92613407|NCT00151203|Hormones|hormones|mesh-ancestor
92613408|NCT00151203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613409|NCT00151203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92613410|NCT00151203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613411|NCT00151203|Immunologic Factors|immunologic factors|mesh-ancestor
92613412|NCT00151203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92613413|NCT00151203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92613414|NCT00151203|Growth Substances|growth substances|mesh-ancestor
92613415|NCT00151203|Growth Inhibitors|growth inhibitors|mesh-ancestor
92613416|NCT00151203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92613417|NCT00151203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613418|NCT00151203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92613419|NCT00151203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613420|NCT00151203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613421|NCT00151203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92613422|NCT00151203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92613423|NCT04620200|Nivolumab|nivolumab|mesh-list
92613424|NCT04620200|Ipilimumab|ipilimumab|mesh-list
92613425|NCT04620200|Immunomodulating Agents|immunomodulating agents|mesh-list
92613426|NCT04620200|Immunologic Factors|immunologic factors|mesh-list
92613427|NCT04620200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92613428|NCT04620200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613429|NCT04620200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92338472|NCT00000923|Antiviral Agents|antiviral agents|mesh-ancestor
92613430|NCT04620200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613431|NCT04620200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613432|NCT00515593|Hormones|hormones|mesh-list
92613433|NCT00515593|Parathyroid Hormone|parathyroid hormone|mesh-list
92613434|NCT00515593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020374|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
92613439|NCT00515788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613440|NCT00515788|Antimetabolites|antimetabolites|mesh-ancestor
92613441|NCT00515788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613442|NCT00515788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613443|NCT00515788|Antiviral Agents|antiviral agents|mesh-ancestor
92613444|NCT00515788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613445|NCT00515788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613446|NCT00515788|Immunologic Factors|immunologic factors|mesh-ancestor
91958532|NCT03357055|Analgesics|analgesics|mesh-ancestor
92613447|NCT00515788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613448|NCT00515788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92613449|NCT00515788|Alkylating Agents|alkylating agents|mesh-ancestor
92613450|NCT02950870|Ritonavir|ritonavir|mesh-list
92613451|NCT02950870|Ribavirin|ribavirin|mesh-list
92613452|NCT02950870|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92613453|NCT02950870|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92613454|NCT02950870|Protease Inhibitors|protease inhibitors|mesh-ancestor
92613455|NCT02950870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613456|NCT02950870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613457|NCT02950870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92613458|NCT02950870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92613459|NCT02950870|Antiviral Agents|antiviral agents|mesh-ancestor
92613460|NCT02950870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613461|NCT02950870|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92613462|NCT02950870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92613463|NCT02950870|Antimetabolites|antimetabolites|mesh-ancestor
92613464|NCT00515866|Gemcitabine|gemcitabine|mesh-list
92613465|NCT00515866|Olaparib|olaparib|mesh-list
92613466|NCT00515866|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92613467|NCT00515866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613468|NCT00515866|Antimetabolites|antimetabolites|mesh-ancestor
92613469|NCT00515866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613470|NCT00515866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613471|NCT00515866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613472|NCT00515905|Propofol|propofol|mesh-list
92613473|NCT00515905|Sevoflurane|sevoflurane|mesh-list
92613474|NCT00515905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92613475|NCT00515905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613476|NCT00515905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613477|NCT00515905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92613478|NCT00515905|Anesthetics, General|anesthetics, general|mesh-ancestor
92613479|NCT00515905|Anesthetics|anesthetics|mesh-ancestor
92613480|NCT00515905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92613481|NCT00515905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92613482|NCT00515944|Botulinum Toxins|botulinum toxins|mesh-list
92613483|NCT00515944|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92613484|NCT00515944|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92613485|NCT00515944|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92613486|NCT00515944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613487|NCT00515944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613488|NCT00515944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92613489|NCT00515944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613490|NCT00515944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613491|NCT00515944|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92613492|NCT00515944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613493|NCT00151242|Cytarabine|cytarabine|mesh-list
92613494|NCT00151242|Etoposide|etoposide|mesh-list
92613495|NCT00151242|Idarubicin|idarubicin|mesh-list
92613496|NCT00151242|Tretinoin|tretinoin|mesh-list
92613497|NCT00151242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613498|NCT00151242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613499|NCT00151242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92613500|NCT00151242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92613501|NCT00151242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613502|NCT00151242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613503|NCT00151242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613504|NCT00151242|Antimetabolites|antimetabolites|mesh-ancestor
92613505|NCT00151242|Antiviral Agents|antiviral agents|mesh-ancestor
92613509|NCT00151242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613510|NCT00151242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92613511|NCT00151242|Keratolytic Agents|keratolytic agents|mesh-ancestor
92613512|NCT00151242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92613513|NCT00516100|Pemetrexed|pemetrexed|mesh-list
92613514|NCT00516100|Bortezomib|bortezomib|mesh-list
92613515|NCT00516100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613516|NCT00516100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613517|NCT00516100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613518|NCT00516100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92613519|NCT00516100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92613520|NCT00166413|Thalidomide|thalidomide|mesh-list
92613521|NCT00166413|Lenalidomide|lenalidomide|mesh-list
92613522|NCT00166413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613523|NCT00166413|Immunologic Factors|immunologic factors|mesh-ancestor
92537148|NCT00139009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537149|NCT00139009|Antifungal Agents|antifungal agents|mesh-ancestor
92537150|NCT00139009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537151|NCT00139009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92537152|NCT00139009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537153|NCT00139009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92613524|NCT00166413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613525|NCT00166413|Leprostatic Agents|leprostatic agents|mesh-ancestor
92613526|NCT00166413|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92613527|NCT00166413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613528|NCT00166413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92613529|NCT00166413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92613530|NCT00166413|Growth Substances|growth substances|mesh-ancestor
92613531|NCT00166413|Growth Inhibitors|growth inhibitors|mesh-ancestor
92613532|NCT00166413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613534|NCT02950441|Niacin|niacin|mesh-list
92613535|NCT02950441|Nicotinic Acids|nicotinic acids|mesh-list
92613536|NCT02950441|Vitamin B Complex|vitamin b complex|mesh-ancestor
92613537|NCT02950441|Vitamins|vitamins|mesh-ancestor
92613538|NCT02950441|Micronutrients|micronutrients|mesh-ancestor
92613539|NCT02950441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613540|NCT02950441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92613541|NCT02950441|Antimetabolites|antimetabolites|mesh-ancestor
92613542|NCT02950441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613543|NCT02950441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92613544|NCT02950441|Vasodilator Agents|vasodilator agents|mesh-ancestor
92613545|NCT02950246|Chlorhexidine|chlorhexidine|mesh-list
92613546|NCT02950246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92613547|NCT02950246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613548|NCT02950246|Disinfectants|disinfectants|mesh-ancestor
92613549|NCT02950168|Edoxaban|edoxaban|mesh-list
92613550|NCT02950168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92613551|NCT02950168|Antithrombins|antithrombins|mesh-ancestor
92613552|NCT02950168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92613553|NCT02950168|Protease Inhibitors|protease inhibitors|mesh-ancestor
92613554|NCT02950168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613555|NCT02950168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613556|NCT02950168|Anticoagulants|anticoagulants|mesh-ancestor
92613557|NCT04695223|Arsenic Trioxide|arsenic trioxide|mesh-list
92613558|NCT04695223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613559|NCT00166491|Insulin|insulin|mesh-list
92613560|NCT00166491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92613561|NCT00166491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613562|NCT00508885|Niacinamide|niacinamide|mesh-list
92613563|NCT00508885|Niacin|niacin|mesh-list
92613564|NCT00508885|Nicotinic Acids|nicotinic acids|mesh-list
92613565|NCT00508885|Vitamin B Complex|vitamin b complex|mesh-ancestor
92613566|NCT00508885|Vitamins|vitamins|mesh-ancestor
92613567|NCT00508885|Micronutrients|micronutrients|mesh-ancestor
92613568|NCT00508885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613569|NCT00508885|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92613570|NCT00508885|Antimetabolites|antimetabolites|mesh-ancestor
92613571|NCT00508885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613572|NCT00508885|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92613573|NCT00508885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92613574|NCT02953405|Clopidogrel|clopidogrel|mesh-list
92613575|NCT02953405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92613576|NCT02953405|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92613577|NCT02953405|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92613578|NCT02953405|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92613579|NCT02953405|Purinergic Agents|purinergic agents|mesh-ancestor
92613580|NCT02953405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613585|NCT00516802|Dacarbazine|dacarbazine|mesh-list
92613586|NCT00516802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613587|NCT00516802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613588|NCT00516802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613589|NCT00516802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92613590|NCT00516802|Alkylating Agents|alkylating agents|mesh-ancestor
92613591|NCT05861466|Ranibizumab|ranibizumab|mesh-list
92613592|NCT05861466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92613593|NCT05861466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92537155|NCT03890666|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92537156|NCT03890666|Autonomic Agents|autonomic agents|mesh-ancestor
92537157|NCT03890666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537158|NCT03890666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537159|NCT03890666|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92613594|NCT05861466|Growth Substances|growth substances|mesh-ancestor
92613595|NCT05861466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613596|NCT05861466|Growth Inhibitors|growth inhibitors|mesh-ancestor
92613597|NCT05861466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613598|NCT05861336|Paclitaxel|paclitaxel|mesh-list
92613599|NCT05861336|Gemcitabine|gemcitabine|mesh-list
92613600|NCT05861336|Losartan|losartan|mesh-list
92613601|NCT05861336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613602|NCT05861336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613603|NCT05861336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613604|NCT05861336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613605|NCT05861336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613606|NCT05861336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613607|NCT05861336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613608|NCT05861336|Antimetabolites|antimetabolites|mesh-ancestor
92613609|NCT05861336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92613610|NCT05861336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92613611|NCT05861336|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92613612|NCT05861336|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92613613|NCT05861310|Metronidazole|metronidazole|mesh-list
92613614|NCT05861310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613615|NCT05861310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92613616|NCT05861310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92613617|NCT05861310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92613618|NCT05861297|Dexamethasone|dexamethasone|mesh-list
92613619|NCT05861297|Prednisolone|prednisolone|mesh-list
92613620|NCT05861297|Rituximab|rituximab|mesh-list
92613621|NCT05861297|Azathioprine|azathioprine|mesh-list
92613622|NCT05861297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92613623|NCT05861297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613624|NCT05861297|Immunologic Factors|immunologic factors|mesh-ancestor
92613625|NCT05861297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613626|NCT05861297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613627|NCT05861297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613628|NCT05861297|Antiemetics|antiemetics|mesh-ancestor
92613629|NCT05861297|Autonomic Agents|autonomic agents|mesh-ancestor
92613630|NCT05861297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613631|NCT05861297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92613632|NCT05861297|Glucocorticoids|glucocorticoids|mesh-ancestor
92613633|NCT05861297|Hormones|hormones|mesh-ancestor
92613634|NCT05861297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613635|NCT05861297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92613636|NCT05861297|Antimetabolites|antimetabolites|mesh-ancestor
92613637|NCT05861297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613638|NCT05861297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613639|NCT05861297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613640|NCT05861271|Capecitabine|capecitabine|mesh-list
92613641|NCT05861271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613642|NCT05861271|Antimetabolites|antimetabolites|mesh-ancestor
92613643|NCT05861271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613644|NCT05861271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613645|NCT05861206|Listerine|listerine|mesh-list
92613646|NCT05861206|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92613647|NCT05861206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613648|NCT05861154|Benzocaine|benzocaine|mesh-list
92613649|NCT05861154|Anesthetics, Local|anesthetics, local|mesh-ancestor
92613650|NCT05861154|Anesthetics|anesthetics|mesh-ancestor
92613651|NCT05861154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613652|NCT05861154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613655|NCT05861063|Lidocaine|lidocaine|mesh-list
92613656|NCT05861063|Dezocine|dezocine|mesh-list
92338706|NCT03055247|Ibuprofen|ibuprofen|mesh-list
92613658|NCT05861063|Anesthetics|anesthetics|mesh-ancestor
92613659|NCT05861063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613660|NCT05861063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613661|NCT05861063|Sensory System Agents|sensory system agents|mesh-ancestor
92613662|NCT05861063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613663|NCT05861063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92613664|NCT05861063|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92613665|NCT05861063|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92613666|NCT05861063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613667|NCT05861063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613668|NCT05861063|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92613669|NCT05861063|Narcotics|narcotics|mesh-ancestor
92613670|NCT05861063|Analgesics|analgesics|mesh-ancestor
92613671|NCT05861050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92613672|NCT05861050|Obinutuzumab|obinutuzumab|mesh-list
92613673|NCT05861050|Lenalidomide|lenalidomide|mesh-list
92613674|NCT05861050|Venetoclax|venetoclax|mesh-list
92613675|NCT05861050|Antibodies|antibodies|mesh-list
92613676|NCT05861050|Immunoglobulins|immunoglobulins|mesh-list
92613677|NCT05861050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92613678|NCT05861050|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92613679|NCT05861050|Immunologic Factors|immunologic factors|mesh-ancestor
92613680|NCT05861050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613681|NCT05861050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613682|NCT05861050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92613683|NCT05861050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92613684|NCT05861050|Growth Substances|growth substances|mesh-ancestor
92613685|NCT05861050|Growth Inhibitors|growth inhibitors|mesh-ancestor
92613686|NCT05860699|Ethanol|ethanol|mesh-list
92613687|NCT05860699|Cannabidiol|cannabidiol|mesh-list
92613688|NCT05860699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92613689|NCT05860699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613690|NCT05860699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613691|NCT05860699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613692|NCT05860699|Anticonvulsants|anticonvulsants|mesh-ancestor
92613693|NCT05860335|Paclitaxel|paclitaxel|mesh-list
92613694|NCT05860335|Nedaplatin|nedaplatin|mesh-list
92613695|NCT05860335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613696|NCT05860335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613697|NCT05860335|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613698|NCT05860335|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613699|NCT05860335|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613700|NCT05860335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613701|NCT05860244|Albuterol|albuterol|mesh-list
92613702|NCT05860244|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92613703|NCT05860244|Autonomic Agents|autonomic agents|mesh-ancestor
92613704|NCT05860244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613705|NCT05860244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613706|NCT05860244|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92613707|NCT05860244|Respiratory System Agents|respiratory system agents|mesh-ancestor
92613708|NCT05860244|Tocolytic Agents|tocolytic agents|mesh-ancestor
92613709|NCT05860244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92613710|NCT05860244|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92613711|NCT05860244|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92613712|NCT05860244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92613713|NCT05860244|Adrenergic Agents|adrenergic agents|mesh-ancestor
92613714|NCT05860244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613715|NCT05860244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613716|NCT05860153|Diazepam|diazepam|mesh-list
92613717|NCT05860153|Levetiracetam|levetiracetam|mesh-list
92613718|NCT05860153|Anticonvulsants|anticonvulsants|mesh-ancestor
92613719|NCT05860153|Nootropic Agents|nootropic agents|mesh-ancestor
92613720|NCT05860153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92613721|NCT05860153|Antiemetics|antiemetics|mesh-ancestor
92613722|NCT05860153|Autonomic Agents|autonomic agents|mesh-ancestor
92613723|NCT05860153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613724|NCT05860153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613725|NCT05860153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92613726|NCT05860153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92613730|NCT05860153|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92613731|NCT05860153|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92613732|NCT05860153|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92613733|NCT05860153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92613734|NCT05860153|Anesthetics, General|anesthetics, general|mesh-ancestor
92613735|NCT05860153|Anesthetics|anesthetics|mesh-ancestor
92613736|NCT05860153|GABA Modulators|gaba modulators|mesh-ancestor
92613737|NCT05860153|GABA Agents|gaba agents|mesh-ancestor
92613738|NCT05860153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537160|NCT03890666|Respiratory System Agents|respiratory system agents|mesh-ancestor
92537161|NCT03890666|Tocolytic Agents|tocolytic agents|mesh-ancestor
92537162|NCT03890666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537163|NCT03890666|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92537164|NCT03890666|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92613739|NCT05860153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613740|NCT05860114|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92613741|NCT05860114|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92613742|NCT05860114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613743|NCT05860114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613744|NCT05860062|Vitamin D|vitamin d|mesh-list
92613745|NCT05860062|Calcium|calcium|mesh-list
92613746|NCT05860062|Vitamins|vitamins|mesh-ancestor
92613747|NCT05860062|Micronutrients|micronutrients|mesh-ancestor
92613748|NCT05860062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613749|NCT05860062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613750|NCT05860062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92613751|NCT05860010|Epinephrine|epinephrine|mesh-list
92613752|NCT05860010|Dexmedetomidine|dexmedetomidine|mesh-list
92613753|NCT05860010|Bupivacaine|bupivacaine|mesh-list
92613754|NCT05860010|Anesthetics, Local|anesthetics, local|mesh-ancestor
92613755|NCT05860010|Anesthetics|anesthetics|mesh-ancestor
92613756|NCT05860010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613757|NCT05860010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613758|NCT05860010|Sensory System Agents|sensory system agents|mesh-ancestor
92613759|NCT05860010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613760|NCT05860010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92613761|NCT05860010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92613762|NCT05860010|Analgesics|analgesics|mesh-ancestor
92613763|NCT05860010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92613764|NCT05860010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92613765|NCT05860010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92613766|NCT05860010|Adrenergic Agents|adrenergic agents|mesh-ancestor
92613767|NCT05860010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613768|NCT05860010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613769|NCT05860010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92613770|NCT05860010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92613771|NCT05860010|Autonomic Agents|autonomic agents|mesh-ancestor
92613772|NCT05860010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92613773|NCT05860010|Respiratory System Agents|respiratory system agents|mesh-ancestor
92613774|NCT05860010|Mydriatics|mydriatics|mesh-ancestor
92613775|NCT05860010|Sympathomimetics|sympathomimetics|mesh-ancestor
92613776|NCT05860010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92613777|NCT05859984|Interferons|interferons|mesh-list
92613778|NCT05859984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613779|NCT05859984|Antiviral Agents|antiviral agents|mesh-ancestor
92613780|NCT05859984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613781|NCT05859802|4-Aminopyridine|4-aminopyridine|mesh-list
92613782|NCT05859802|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92613783|NCT05859802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92613784|NCT05859802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613785|NCT05859750|Paclitaxel|paclitaxel|mesh-list
92613786|NCT05859750|Gemcitabine|gemcitabine|mesh-list
92613787|NCT05859750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613788|NCT05859750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613789|NCT05859750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613790|NCT05859750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613791|NCT05859750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613792|NCT05859750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613793|NCT05859750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613794|NCT05859750|Antimetabolites|antimetabolites|mesh-ancestor
92613795|NCT05859477|Capecitabine|capecitabine|mesh-list
92613796|NCT05859477|Oxaliplatin|oxaliplatin|mesh-list
92613797|NCT05859477|Nivolumab|nivolumab|mesh-list
92613798|NCT05859477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613799|NCT05859477|Antimetabolites|antimetabolites|mesh-ancestor
92613819|NCT05859412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613820|NCT05859412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92613821|NCT05859412|Protective Agents|protective agents|mesh-ancestor
92613822|NCT05859412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92537165|NCT03890666|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92537166|NCT03890666|Adrenergic Agents|adrenergic agents|mesh-ancestor
92537167|NCT03890666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537168|NCT03890666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537169|NCT00139165|Budesonide|budesonide|mesh-list
92613823|NCT05859412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613824|NCT05858918|Clopidogrel|clopidogrel|mesh-list
92613825|NCT05858918|Ticagrelor|ticagrelor|mesh-list
92613826|NCT05858918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92613827|NCT05858918|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92613828|NCT05858918|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92613829|NCT05858918|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92613830|NCT05858918|Purinergic Agents|purinergic agents|mesh-ancestor
92613831|NCT05858918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613832|NCT05858918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613833|NCT05858918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613834|NCT05856877|Insulin|insulin|mesh-list
92613835|NCT05856877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92613836|NCT05856877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613837|NCT05856864|Ramucirumab|ramucirumab|mesh-list
92613838|NCT05856864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613839|NCT05852158|Cefazolin|cefazolin|mesh-list
92613840|NCT05852158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92613841|NCT05852158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613842|NCT05851924|Capecitabine|capecitabine|mesh-list
92613843|NCT05851924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613844|NCT05851924|Antimetabolites|antimetabolites|mesh-ancestor
92613845|NCT05851924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613846|NCT05851924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613847|NCT05829187|Primaquine|primaquine|mesh-list
92613848|NCT05829187|Piperaquine|piperaquine|mesh-list
92613849|NCT05829187|Artenimol|artenimol|mesh-list
92613850|NCT05829187|Antimalarials|antimalarials|mesh-ancestor
92613851|NCT05829187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92613852|NCT05829187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92613853|NCT05829187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613854|NCT05822765|Epinephrine|epinephrine|mesh-list
92613855|NCT05822765|Racepinephrine|racepinephrine|mesh-list
92613856|NCT05822765|Epinephryl borate|epinephryl borate|mesh-list
92613863|NCT05822765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92613864|NCT05822765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92613865|NCT05822765|Autonomic Agents|autonomic agents|mesh-ancestor
92613866|NCT05822765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613867|NCT05822765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92613868|NCT05822765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92613869|NCT05822765|Mydriatics|mydriatics|mesh-ancestor
92613870|NCT05822765|Sympathomimetics|sympathomimetics|mesh-ancestor
92613871|NCT05822765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92613872|NCT05816252|Carboplatin|carboplatin|mesh-list
92613873|NCT05816252|Pembrolizumab|pembrolizumab|mesh-list
92613874|NCT05816252|Osimertinib|osimertinib|mesh-list
92613875|NCT05816252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613876|NCT05816252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92613877|NCT05816252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92613878|NCT05816252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613879|NCT05816252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613880|NCT05816252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613881|NCT05779644|Metformin|metformin|mesh-list
92338925|NCT00000335|Analgesics|analgesics|mesh-ancestor
92613882|NCT05779644|Liraglutide|liraglutide|mesh-list
92613883|NCT05779644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92613884|NCT05779644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613886|NCT05779644|Hormones|hormones|mesh-ancestor
92613887|NCT05779644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613888|NCT05749211|Niraparib|niraparib|mesh-list
92613889|NCT05749211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92613890|NCT05749211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613891|NCT05749211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613892|NCT05749211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613893|NCT05748093|Cobicistat|cobicistat|mesh-list
92613894|NCT05748093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92613895|NCT05748093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92537170|NCT00139165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537171|NCT00139165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92613896|NCT05748093|Antiviral Agents|antiviral agents|mesh-ancestor
92613897|NCT05748093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613898|NCT05748093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92613899|NCT05748093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92613900|NCT05748093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613901|NCT05748093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613902|NCT05731596|Ubiquinone|ubiquinone|mesh-list
92613903|NCT05731596|Coenzyme Q10|coenzyme q10|mesh-list
92613904|NCT05731596|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92613905|NCT05731596|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92613906|NCT05731596|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92613907|NCT05731596|Antimetabolites|antimetabolites|mesh-ancestor
92613908|NCT05731596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613909|NCT05731596|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92613910|NCT05731596|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92613911|NCT05731596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613912|NCT05731596|Micronutrients|micronutrients|mesh-ancestor
92613913|NCT05731596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613914|NCT05731596|Vitamins|vitamins|mesh-ancestor
92613915|NCT05722782|Acetaminophen|acetaminophen|mesh-list
92613916|NCT05722782|Piroxicam|piroxicam|mesh-list
92613917|NCT05722782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92613918|NCT05722782|Analgesics|analgesics|mesh-ancestor
92613919|NCT05722782|Sensory System Agents|sensory system agents|mesh-ancestor
92613920|NCT05722782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613921|NCT05722782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613922|NCT05722782|Antipyretics|antipyretics|mesh-ancestor
92613923|NCT05722782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92613924|NCT05722782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613925|NCT05722782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613928|NCT05722782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613930|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92613931|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92613932|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613933|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
92613934|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
92613935|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613936|NCT05709990|Vitamin D|vitamin d|mesh-list
92613937|NCT05709990|Cholecalciferol|cholecalciferol|mesh-list
92613938|NCT05709990|Solifenacin Succinate|solifenacin succinate|mesh-list
92613939|NCT05709990|Vitamins|vitamins|mesh-ancestor
92613940|NCT05709990|Micronutrients|micronutrients|mesh-ancestor
92613941|NCT05709990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613942|NCT05709990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92613943|NCT05709990|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613944|NCT05709990|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92613945|NCT05709990|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92613946|NCT05709990|Cholinergic Agents|cholinergic agents|mesh-ancestor
92613947|NCT05709990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613948|NCT05709990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613949|NCT05709990|Urological Agents|urological agents|mesh-ancestor
92613950|NCT05684744|Methotrexate|methotrexate|mesh-list
92613951|NCT05684744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92613952|NCT05684744|Abortifacient Agents|abortifacient agents|mesh-ancestor
92613953|NCT05684744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92613954|NCT05684744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613955|NCT05684744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92613956|NCT05684744|Antimetabolites|antimetabolites|mesh-ancestor
92613957|NCT05684744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613958|NCT05684744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613959|NCT05684744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92613960|NCT05684744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613961|NCT05684744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92613962|NCT05684744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613963|NCT05684744|Immunologic Factors|immunologic factors|mesh-ancestor
92613964|NCT05684744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92613965|NCT05684744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92613966|NCT05678114|Inositol|inositol|mesh-list
92613967|NCT05678114|Vitamin B Complex|vitamin b complex|mesh-ancestor
92613968|NCT05678114|Vitamins|vitamins|mesh-ancestor
92613969|NCT05678114|Micronutrients|micronutrients|mesh-ancestor
92537172|NCT00139165|Autonomic Agents|autonomic agents|mesh-ancestor
92537173|NCT00139165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537174|NCT00139165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537175|NCT00139165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92537176|NCT00139165|Respiratory System Agents|respiratory system agents|mesh-ancestor
92613970|NCT05678114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613971|NCT05675787|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92613972|NCT05675787|Atorvastatin|atorvastatin|mesh-list
92613973|NCT05675787|Medroxyprogesterone|medroxyprogesterone|mesh-list
92613974|NCT05675787|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92613975|NCT05675787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92613976|NCT05675787|Antimetabolites|antimetabolites|mesh-ancestor
92613977|NCT05675787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613978|NCT05675787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92613979|NCT05675787|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92613980|NCT05675787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613981|NCT05675787|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92613982|NCT05675787|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92613983|NCT05675787|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92613984|NCT05675787|Contraceptive Agents|contraceptive agents|mesh-ancestor
92613985|NCT05675787|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92613986|NCT05675787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613987|NCT05675787|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92613988|NCT05675787|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92613989|NCT05675787|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92613990|NCT05675787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92613991|NCT05675787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613992|NCT05662527|Pembrolizumab|pembrolizumab|mesh-list
92613993|NCT05662527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92613994|NCT05662527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613995|NCT05662527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92613996|NCT05662527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614001|NCT05576792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614002|NCT05576792|Growth Inhibitors|growth inhibitors|mesh-ancestor
92614003|NCT05576792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614004|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
92614006|NCT05501665|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92614007|NCT05501665|Carboplatin|carboplatin|mesh-list
92614008|NCT05501665|Pembrolizumab|pembrolizumab|mesh-list
92614010|NCT05501665|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92614011|NCT05501665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92614012|NCT05501665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614013|NCT05501665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614014|NCT05501665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92614015|NCT05501665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614016|NCT05501665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614017|NCT05501665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614018|NCT05501665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614019|NCT05501665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614020|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92614021|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614022|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92614023|NCT05501665|Antimetabolites|antimetabolites|mesh-ancestor
92614024|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
92614025|NCT05501665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614026|NCT05494398|Acetylcysteine|acetylcysteine|mesh-list
92614027|NCT05494398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92614028|NCT05494398|Antiviral Agents|antiviral agents|mesh-ancestor
92614029|NCT05494398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614030|NCT05494398|Expectorants|expectorants|mesh-ancestor
92614031|NCT05494398|Respiratory System Agents|respiratory system agents|mesh-ancestor
92614032|NCT05494398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92614033|NCT05494398|Antioxidants|antioxidants|mesh-ancestor
92614034|NCT05494398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614035|NCT05494398|Protective Agents|protective agents|mesh-ancestor
92614036|NCT05494398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614037|NCT05494398|Antidotes|antidotes|mesh-ancestor
92614038|NCT05491278|Remifentanil|remifentanil|mesh-list
92537178|NCT00139165|Hormones|hormones|mesh-ancestor
92537179|NCT00139165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537180|NCT00139204|Carbon-11 methionine|carbon-11 methionine|mesh-list
92614039|NCT05491278|Propofol|propofol|mesh-list
92614040|NCT05491278|Fospropofol|fospropofol|mesh-list
92614041|NCT05491278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92614042|NCT05491278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614043|NCT05491278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614044|NCT05491278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92614045|NCT05491278|Anesthetics, General|anesthetics, general|mesh-ancestor
92614046|NCT05491278|Anesthetics|anesthetics|mesh-ancestor
92614047|NCT05491278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92614048|NCT05491278|Narcotics|narcotics|mesh-ancestor
92614049|NCT05491278|Analgesics|analgesics|mesh-ancestor
92614050|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
92614051|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614052|NCT05463783|Tenofovir|tenofovir|mesh-list
92614053|NCT05463783|Emtricitabine|emtricitabine|mesh-list
92614054|NCT05463783|Darunavir|darunavir|mesh-list
92614055|NCT05463783|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92614056|NCT05463783|Cobicistat|cobicistat|mesh-list
92614057|NCT05463783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92614058|NCT05463783|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92614059|NCT05463783|Antiviral Agents|antiviral agents|mesh-ancestor
92614060|NCT05463783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360994|NCT00449748|Everolimus|everolimus|mesh-list
92614061|NCT05463783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92614062|NCT05463783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614063|NCT05463783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614064|NCT05463783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614065|NCT05463783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92614066|NCT05463783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92614067|NCT05463783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92614068|NCT05463783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92614069|NCT05463783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92614071|NCT05463783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92614072|NCT05457582|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92614074|NCT05457582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92614075|NCT05457582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92614076|NCT05457582|Antimetabolites|antimetabolites|mesh-ancestor
92614077|NCT05457582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614078|NCT05457582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614079|NCT05457582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92614080|NCT05457582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92614081|NCT05457582|Protease Inhibitors|protease inhibitors|mesh-ancestor
92614082|NCT05405257|Oxytocin|oxytocin|mesh-list
92614083|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
92614084|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92614085|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614086|NCT05375916|Hydromorphone|hydromorphone|mesh-list
92614087|NCT05375916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92614088|NCT05375916|Narcotics|narcotics|mesh-ancestor
92614089|NCT05375916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614090|NCT05375916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614091|NCT05375916|Analgesics|analgesics|mesh-ancestor
92614092|NCT05375916|Sensory System Agents|sensory system agents|mesh-ancestor
92614093|NCT05375916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614094|NCT05359354|Vaccines|vaccines|mesh-list
92614095|NCT05359354|Immunologic Factors|immunologic factors|mesh-ancestor
92614096|NCT05359354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614097|NCT05346562|Cannabidiol|cannabidiol|mesh-list
92614098|NCT05346562|Anticonvulsants|anticonvulsants|mesh-ancestor
92614099|NCT05313529|Metformin|metformin|mesh-list
92614100|NCT05313529|Liraglutide|liraglutide|mesh-list
92614101|NCT05313529|Empagliflozin|empagliflozin|mesh-list
92614102|NCT05313529|Linagliptin|linagliptin|mesh-list
92614103|NCT05313529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92614104|NCT05313529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614105|NCT05313529|Incretins|incretins|mesh-ancestor
92614106|NCT05313529|Hormones|hormones|mesh-ancestor
92614107|NCT05313529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614108|NCT05313529|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92537181|NCT00139204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92537182|NCT00139204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537183|NCT00139243|Leucovorin|leucovorin|mesh-list
92614109|NCT05313529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614110|NCT05313529|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92614111|NCT05313529|Protease Inhibitors|protease inhibitors|mesh-ancestor
92614112|NCT05313529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614113|NCT05287633|Esomeprazole|esomeprazole|mesh-list
92614114|NCT05287633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92614115|NCT05287633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614116|NCT05287633|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92614117|NCT05287633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614118|NCT05287633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614119|NCT05285449|Cannabidiol|cannabidiol|mesh-list
92614120|NCT05285449|Anticonvulsants|anticonvulsants|mesh-ancestor
92614121|NCT05251090|Factor VIII|factor viii|mesh-list
92614122|NCT05251090|Coagulants|coagulants|mesh-ancestor
92614123|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92614124|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92614125|NCT05226598|Paclitaxel|paclitaxel|mesh-list
92614126|NCT05226598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92614127|NCT05226598|Carboplatin|carboplatin|mesh-list
92614128|NCT05226598|Pembrolizumab|pembrolizumab|mesh-list
92614129|NCT05226598|Pemetrexed|pemetrexed|mesh-list
92614130|NCT05226598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92614131|NCT05226598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614132|NCT05226598|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614133|NCT05226598|Antimitotic Agents|antimitotic agents|mesh-ancestor
92614134|NCT05226598|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614135|NCT05226598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614136|NCT05226598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614137|NCT05226598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614138|NCT05226598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614139|NCT05226598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92614140|NCT05226598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614141|NCT05221320|Hydroxychloroquine|hydroxychloroquine|mesh-list
92614142|NCT05221320|Antimalarials|antimalarials|mesh-ancestor
92614143|NCT05221320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92614144|NCT05221320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92614148|NCT05221320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92614149|NCT05211323|Bevacizumab|bevacizumab|mesh-list
92614150|NCT05211323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92614151|NCT05211323|Atezolizumab|atezolizumab|mesh-list
92614152|NCT05211323|Cisplatin|cisplatin|mesh-list
92614153|NCT05211323|Gemcitabine|gemcitabine|mesh-list
92614154|NCT05211323|Endothelial Growth Factors|endothelial growth factors|mesh-list
92614155|NCT05211323|Antibodies|antibodies|mesh-list
92614156|NCT05211323|Immunoglobulins|immunoglobulins|mesh-list
92614157|NCT05211323|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92614158|NCT05211323|Immunoglobulin G|immunoglobulin g|mesh-list
92614159|NCT05211323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614160|NCT05211323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92614161|NCT05211323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92614162|NCT05211323|Growth Substances|growth substances|mesh-ancestor
92614163|NCT05211323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614164|NCT05211323|Growth Inhibitors|growth inhibitors|mesh-ancestor
92614165|NCT05211323|Immunologic Factors|immunologic factors|mesh-ancestor
92614166|NCT05211323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614167|NCT05211323|Antimetabolites|antimetabolites|mesh-ancestor
92614168|NCT05211323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614169|NCT05211323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614170|NCT05190705|Dexamethasone|dexamethasone|mesh-list
92614171|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
92614172|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92614173|NCT05190705|BB 1101|bb 1101|mesh-list
92614174|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614175|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
92614176|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
92614177|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614178|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614179|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614180|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
92614181|NCT05190705|Hormones|hormones|mesh-ancestor
92614182|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537184|NCT00139243|Fluorouracil|fluorouracil|mesh-list
92537186|NCT00139243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537187|NCT00139243|Antimetabolites|antimetabolites|mesh-ancestor
92537188|NCT00139243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959616|NCT04507165|Anesthetics|anesthetics|mesh-list
92614183|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614184|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339222|NCT00000629|Valproic Acid|valproic acid|mesh-list
92614185|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92614186|NCT05190705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614187|NCT05190705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614188|NCT05190705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614189|NCT05188118|Nivolumab|nivolumab|mesh-list
92614190|NCT05188118|Ipilimumab|ipilimumab|mesh-list
92614191|NCT05188118|Everolimus|everolimus|mesh-list
92614192|NCT05188118|Lenvatinib|lenvatinib|mesh-list
92614193|NCT05188118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614194|NCT05188118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614195|NCT05188118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614196|NCT05188118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614197|NCT05188118|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92614198|NCT05188118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614199|NCT05188118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614200|NCT05188118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614201|NCT05188118|Immunologic Factors|immunologic factors|mesh-ancestor
92614202|NCT05188118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614203|NCT05172908|Dexamethasone|dexamethasone|mesh-list
92614204|NCT05172908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614205|NCT05172908|Antiemetics|antiemetics|mesh-ancestor
92614206|NCT05172908|Autonomic Agents|autonomic agents|mesh-ancestor
92360995|NCT00449748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92614207|NCT05172908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614208|NCT05172908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614209|NCT05172908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614210|NCT05172908|Glucocorticoids|glucocorticoids|mesh-ancestor
92614211|NCT05172908|Hormones|hormones|mesh-ancestor
92614212|NCT05172908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614213|NCT05172908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614214|NCT05172908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614215|NCT05140512|Goserelin|goserelin|mesh-list
92614216|NCT05140512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614219|NCT05110170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614220|NCT05110170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614221|NCT04971499|Dapansutrile|dapansutrile|mesh-list
92614222|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
92614223|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614224|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614225|NCT04971499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614226|NCT04971499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614227|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614228|NCT04918017|Esomeprazole|esomeprazole|mesh-list
92614229|NCT04918017|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92614230|NCT04918017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92614231|NCT04918017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614232|NCT04918017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614233|NCT04918017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614234|NCT04898231|Methylprednisolone|methylprednisolone|mesh-list
92614235|NCT04898231|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92614236|NCT04898231|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92614237|NCT04898231|Prednisolone|prednisolone|mesh-list
92614238|NCT04898231|Prednisolone acetate|prednisolone acetate|mesh-list
92614239|NCT04898231|Infliximab|infliximab|mesh-list
92614240|NCT04898231|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92614241|NCT04898231|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92614242|NCT04898231|Prednisolone phosphate|prednisolone phosphate|mesh-list
92614243|NCT04898231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614244|NCT04898231|Antiemetics|antiemetics|mesh-ancestor
92614245|NCT04898231|Autonomic Agents|autonomic agents|mesh-ancestor
92614246|NCT04898231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614247|NCT04898231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614248|NCT04898231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614249|NCT04898231|Glucocorticoids|glucocorticoids|mesh-ancestor
92614250|NCT04898231|Hormones|hormones|mesh-ancestor
92614251|NCT04898231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614252|NCT04898231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92614253|NCT04898231|Protective Agents|protective agents|mesh-ancestor
92614254|NCT04898231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614255|NCT04898231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614256|NCT04898231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92614257|NCT04898231|Dermatologic Agents|dermatologic agents|mesh-ancestor
92614258|NCT04898231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92614259|NCT04892017|Trametinib|trametinib|mesh-list
92614260|NCT04892017|Sotorasib|sotorasib|mesh-list
92614261|NCT04892017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339299|NCT00002021|Foscarnet|foscarnet|mesh-list
92614262|NCT04892017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614263|NCT04892017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614264|NCT04892017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614265|NCT04892017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614266|NCT04892017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614267|NCT04856215|Antibodies|antibodies|mesh-list
92614268|NCT04856215|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92614269|NCT04856215|Immunologic Factors|immunologic factors|mesh-ancestor
92614270|NCT04856215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614271|NCT04849026|Clozapine|clozapine|mesh-list
92614272|NCT04849026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92614273|NCT04849026|Serotonin Agents|serotonin agents|mesh-ancestor
92614274|NCT04849026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614275|NCT04849026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614276|NCT04849026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614277|NCT04849026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92614278|NCT04849026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92614279|NCT04849026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614280|NCT04849026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92614281|NCT04849026|GABA Antagonists|gaba antagonists|mesh-ancestor
92614282|NCT04849026|GABA Agents|gaba agents|mesh-ancestor
92614283|NCT04841980|Rifaximin|rifaximin|mesh-list
92614284|NCT04841980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614285|NCT04841980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614286|NCT04841980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614287|NCT04831736|Ketamine|ketamine|mesh-list
92614288|NCT04831736|Analgesics|analgesics|mesh-ancestor
92614289|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
92614290|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614294|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
92614295|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
92614296|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614297|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92614298|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92614299|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614300|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614301|NCT04830462|Rifampin|rifampin|mesh-list
92614302|NCT04830462|Isoniazid|isoniazid|mesh-list
92614303|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92614304|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
92614305|NCT04830462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614306|NCT04830462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614307|NCT04830462|Leprostatic Agents|leprostatic agents|mesh-ancestor
92614308|NCT04830462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614309|NCT04830462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614310|NCT04830462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614311|NCT04830462|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92614312|NCT04830462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92614313|NCT04830462|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92614314|NCT04830462|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92614315|NCT04830462|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92614316|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92614317|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92614318|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92614319|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
92614320|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92614321|NCT04797767|Cytarabine|cytarabine|mesh-list
92614322|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92614323|NCT04797767|Venetoclax|venetoclax|mesh-list
92614324|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
92614325|NCT04797767|Cladribine|cladribine|mesh-list
92537189|NCT00139243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92537190|NCT00139243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537191|NCT00139243|Immunologic Factors|immunologic factors|mesh-ancestor
92537192|NCT00139243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614326|NCT04797767|Lenograstim|lenograstim|mesh-list
92614327|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614328|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
92614329|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614330|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614331|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
92614332|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614333|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614334|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
92614335|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339376|NCT00000731|Acetaminophen|acetaminophen|mesh-list
92614336|NCT04797767|Analgesics|analgesics|mesh-ancestor
92614337|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
92614338|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614339|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92614340|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92614341|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614342|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92614343|NCT04787341|Panitumumab|panitumumab|mesh-list
92614344|NCT04787341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614345|NCT04787341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614346|NCT04781972|Methylphenidate|methylphenidate|mesh-list
92614347|NCT04781972|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92614348|NCT04781972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614349|NCT04781972|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92614350|NCT04781972|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92614351|NCT04781972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92614352|NCT04781972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614353|NCT04781972|Dopamine Agents|dopamine agents|mesh-ancestor
92614354|NCT04781972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614355|NCT04775381|Vitamin D|vitamin d|mesh-list
92614356|NCT04775381|Vitamins|vitamins|mesh-ancestor
92614357|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
92614358|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614359|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92614360|NCT04760275|Fluoxetine|fluoxetine|mesh-list
92614362|NCT04760275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92614363|NCT04760275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92614364|NCT04760275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614365|NCT04760275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614366|NCT04760275|Serotonin Agents|serotonin agents|mesh-ancestor
92614367|NCT04760275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614368|NCT04760275|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92614369|NCT04760275|Antidepressive Agents|antidepressive agents|mesh-ancestor
92614370|NCT04760275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92614371|NCT04760275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92614372|NCT04760275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92614373|NCT04760275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614374|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92614375|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92614376|NCT04742491|Emtricitabine|emtricitabine|mesh-list
92614377|NCT04742491|Tenofovir|tenofovir|mesh-list
92614378|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92614379|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614380|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614381|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614382|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
92614383|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614384|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92614385|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92614386|NCT04721873|Topiramate|topiramate|mesh-list
92614387|NCT04721873|Phentermine|phentermine|mesh-list
92614388|NCT04721873|Anticonvulsants|anticonvulsants|mesh-ancestor
92614389|NCT04721873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92614390|NCT04721873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537193|NCT00139243|Antidotes|antidotes|mesh-ancestor
92537194|NCT00139243|Protective Agents|protective agents|mesh-ancestor
92537195|NCT00139243|Vitamin B Complex|vitamin b complex|mesh-ancestor
92537197|NCT00139243|Micronutrients|micronutrients|mesh-ancestor
92537198|NCT00139243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614391|NCT04721873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92614392|NCT04721873|Appetite Depressants|appetite depressants|mesh-ancestor
92614393|NCT04721873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92614394|NCT04721873|Sympathomimetics|sympathomimetics|mesh-ancestor
92614395|NCT04721873|Autonomic Agents|autonomic agents|mesh-ancestor
92614396|NCT04721873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614397|NCT04721873|Adrenergic Agents|adrenergic agents|mesh-ancestor
92614398|NCT04721873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614399|NCT04721873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614400|NCT04721015|Docetaxel|docetaxel|mesh-list
92614401|NCT04721015|Osimertinib|osimertinib|mesh-list
92614402|NCT04721015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614403|NCT04721015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614404|NCT04721015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92614405|NCT04721015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614406|NCT04721015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614407|NCT04721015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614408|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614409|NCT04679389|Acetazolamide|acetazolamide|mesh-list
92614410|NCT04679389|Anticonvulsants|anticonvulsants|mesh-ancestor
92614411|NCT04679389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92614412|NCT04679389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614413|NCT04679389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614414|NCT04679389|Diuretics|diuretics|mesh-ancestor
92614415|NCT04679389|Natriuretic Agents|natriuretic agents|mesh-ancestor
92614416|NCT04679389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614417|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
92614418|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92614419|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614420|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92614421|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
92614422|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614423|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614424|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614425|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614426|NCT04644016|Cyclosporine|cyclosporine|mesh-list
92614427|NCT04644016|Mycophenolic Acid|mycophenolic acid|mesh-list
92614428|NCT04644016|Fludarabine|fludarabine|mesh-list
92614429|NCT04644016|Busulfan|busulfan|mesh-list
92614430|NCT04644016|Clofarabine|clofarabine|mesh-list
92614431|NCT04644016|Cyclosporins|cyclosporins|mesh-list
92614432|NCT04644016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021362|NCT04794127|Pioglitazone|pioglitazone|mesh-list
92614434|NCT04644016|Antimetabolites|antimetabolites|mesh-ancestor
92614435|NCT04644016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614436|NCT04644016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614437|NCT04644016|Immunologic Factors|immunologic factors|mesh-ancestor
92614438|NCT04644016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614439|NCT04644016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614440|NCT04644016|Antifungal Agents|antifungal agents|mesh-ancestor
92614441|NCT04644016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614442|NCT04644016|Dermatologic Agents|dermatologic agents|mesh-ancestor
92614443|NCT04644016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92614444|NCT04644016|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92614445|NCT04644016|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92614446|NCT04644016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92614447|NCT04644016|Antitubercular Agents|antitubercular agents|mesh-ancestor
92614448|NCT04644016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614449|NCT04644016|Alkylating Agents|alkylating agents|mesh-ancestor
92614450|NCT04644016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92614451|NCT04644016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92614452|NCT04634162|Cangrelor|cangrelor|mesh-list
92614453|NCT04634162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92614454|NCT04634162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92614455|NCT04634162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92537199|NCT00139243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537200|NCT00139243|Mitosis Modulators|mitosis modulators|mesh-ancestor
91944880|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
92614456|NCT04634162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92614457|NCT04634162|Purinergic Agents|purinergic agents|mesh-ancestor
92614458|NCT04634162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614459|NCT04634162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614460|NCT04634162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614461|NCT04616196|Cetuximab|cetuximab|mesh-list
92614462|NCT04616196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614463|NCT04616196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614464|NCT04583956|Remdesivir|remdesivir|mesh-list
92614465|NCT04583956|Antimetabolites|antimetabolites|mesh-ancestor
92614466|NCT04583956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614467|NCT04583956|Antiviral Agents|antiviral agents|mesh-ancestor
92614468|NCT04583956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614469|NCT04541407|Temozolomide|temozolomide|mesh-list
92614470|NCT04541407|Osimertinib|osimertinib|mesh-list
92614471|NCT04541407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92614472|NCT04541407|Alkylating Agents|alkylating agents|mesh-ancestor
92614473|NCT04541407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614474|NCT04541407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614475|NCT04541407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614476|NCT04541407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614477|NCT04552795|Lamivudine|lamivudine|mesh-list
92614478|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92614479|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614480|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614481|NCT04552795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614482|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
92614483|NCT04552795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614485|NCT04552795|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92614486|NCT04522336|Docetaxel|docetaxel|mesh-list
92614487|NCT04522336|Pembrolizumab|pembrolizumab|mesh-list
92614488|NCT04522336|Fluorouracil|fluorouracil|mesh-list
92614489|NCT04522336|Oxaliplatin|oxaliplatin|mesh-list
92614490|NCT04522336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614491|NCT04522336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614492|NCT04522336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92614493|NCT04522336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614494|NCT04522336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614495|NCT04522336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614496|NCT04522336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614497|NCT04522336|Antimetabolites|antimetabolites|mesh-ancestor
92614498|NCT04522336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614499|NCT04522336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614500|NCT04522336|Immunologic Factors|immunologic factors|mesh-ancestor
92614501|NCT04522336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614502|NCT04463680|Rifampin|rifampin|mesh-list
92614503|NCT04463680|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92614504|NCT04463680|Antitubercular Agents|antitubercular agents|mesh-ancestor
92614505|NCT04463680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614506|NCT04463680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614511|NCT04463680|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92614512|NCT04463680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92614513|NCT04463680|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92614514|NCT04463680|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92614515|NCT04463680|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92614516|NCT04463680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92614517|NCT04438655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92614518|NCT04438655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614519|NCT04428333|Pembrolizumab|pembrolizumab|mesh-list
92614520|NCT04428333|Fluorouracil|fluorouracil|mesh-list
92614521|NCT04428333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614522|NCT04428333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614523|NCT04428333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614524|NCT04428333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614525|NCT04428333|Antimetabolites|antimetabolites|mesh-ancestor
92614526|NCT04428333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614527|NCT04428333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614528|NCT04428333|Immunologic Factors|immunologic factors|mesh-ancestor
92614529|NCT04428333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614530|NCT04415944|Carboplatin|carboplatin|mesh-list
92614531|NCT04415944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614532|NCT04395989|Paclitaxel|paclitaxel|mesh-list
92614533|NCT04395989|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92614534|NCT04395989|Capecitabine|capecitabine|mesh-list
92614535|NCT04395989|Everolimus|everolimus|mesh-list
92614536|NCT04395989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92614537|NCT04395989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614538|NCT04395989|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614539|NCT04395989|Antimitotic Agents|antimitotic agents|mesh-ancestor
92614540|NCT04395989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614541|NCT04395989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614542|NCT04395989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614543|NCT04395989|Antimetabolites|antimetabolites|mesh-ancestor
92614544|NCT04395989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92614545|NCT04395989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614546|NCT04395989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614547|NCT04395989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614548|NCT04395989|Immunologic Factors|immunologic factors|mesh-ancestor
92614549|NCT04395989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614550|NCT04393454|Sirolimus|sirolimus|mesh-list
92614551|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614552|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614553|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92614554|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614555|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
92614556|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614557|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
92339604|NCT00002111|Saquinavir|saquinavir|mesh-list
92614558|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614560|NCT04341311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614561|NCT04341311|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92614562|NCT04341311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614563|NCT04341311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614564|NCT04304014|Sulfalene|sulfalene|mesh-list
92614565|NCT04304014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614566|NCT04304014|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92614567|NCT04304014|Antimalarials|antimalarials|mesh-ancestor
92614568|NCT04304014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92614569|NCT04304014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92614570|NCT04300231|Hydromorphone|hydromorphone|mesh-list
92614571|NCT04300231|Bupivacaine|bupivacaine|mesh-list
92614572|NCT04300231|Anesthetics, Local|anesthetics, local|mesh-ancestor
92614573|NCT04300231|Anesthetics|anesthetics|mesh-ancestor
92614574|NCT04300231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614575|NCT04300231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614576|NCT04300231|Sensory System Agents|sensory system agents|mesh-ancestor
92614961|NCT02367040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92614962|NCT02172651|Vitamin D|vitamin d|mesh-list
92614963|NCT02172651|Ergocalciferols|ergocalciferols|mesh-list
92614964|NCT02172651|Cholecalciferol|cholecalciferol|mesh-list
92614965|NCT02172651|Vitamins|vitamins|mesh-list
92614966|NCT02172651|Micronutrients|micronutrients|mesh-ancestor
92614967|NCT02172651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614968|NCT02172651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92614969|NCT02172651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92614970|NCT02144857|Cyclosporine|cyclosporine|mesh-list
92614971|NCT02144857|Etanercept|etanercept|mesh-list
92614972|NCT02144857|Apremilast|apremilast|mesh-list
92614973|NCT02144857|Ustekinumab|ustekinumab|mesh-list
92614974|NCT02144857|Cyclosporins|cyclosporins|mesh-list
92614975|NCT02144857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614976|NCT02144857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614977|NCT02144857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614978|NCT02144857|Immunologic Factors|immunologic factors|mesh-ancestor
92614979|NCT02144857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614980|NCT02144857|Antifungal Agents|antifungal agents|mesh-ancestor
92614981|NCT02144857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614982|NCT02144857|Dermatologic Agents|dermatologic agents|mesh-ancestor
92614983|NCT02144857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92614984|NCT02144857|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92614985|NCT02144857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92614986|NCT02144857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92614987|NCT02144857|Analgesics|analgesics|mesh-ancestor
92614988|NCT02144857|Sensory System Agents|sensory system agents|mesh-ancestor
92614989|NCT02144857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944883|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614990|NCT02144857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614991|NCT02144857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614992|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92614993|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92614994|NCT02131597|Guadecitabine|guadecitabine|mesh-list
92614995|NCT02131597|Azacitidine|azacitidine|mesh-list
92614996|NCT02131597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614997|NCT02131597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614998|NCT02131597|Antimetabolites|antimetabolites|mesh-ancestor
92614999|NCT02131597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615000|NCT02131597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615001|NCT02095184|Letrozole|letrozole|mesh-list
92615002|NCT02095184|Anastrozole|anastrozole|mesh-list
92615003|NCT02095184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615004|NCT02095184|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92615005|NCT02095184|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92615007|NCT02095184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615008|NCT02095184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92615009|NCT02095184|Hormone Antagonists|hormone antagonists|mesh-ancestor
92615010|NCT02095184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615011|NCT02095184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615012|NCT02095184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92615013|NCT01252953|Oxazolidinones|oxazolidinones|mesh-list
92615014|NCT01252953|Anacetrapib|anacetrapib|mesh-list
92615015|NCT01252953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92615016|NCT01252953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92615017|NCT01252953|Antimetabolites|antimetabolites|mesh-ancestor
92615018|NCT01252953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615019|NCT01252953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92615020|NCT01252953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615021|NCT01252953|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92615022|NCT01252953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615023|NCT01038778|Aldesleukin|aldesleukin|mesh-list
92615024|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
92615025|NCT01038778|Interleukin-2|interleukin-2|mesh-list
92615026|NCT01038778|Entinostat|entinostat|mesh-list
92615027|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92615028|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92615029|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615030|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615031|NCT01038778|Analgesics|analgesics|mesh-ancestor
92615032|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
92615033|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615034|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615035|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92615036|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92615038|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615039|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92615040|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615041|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615043|NCT00937131|Rituximab|rituximab|mesh-list
92615044|NCT00937131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92615045|NCT00937131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615046|NCT00937131|Immunologic Factors|immunologic factors|mesh-ancestor
92615047|NCT00937131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615048|NCT00937131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615049|NCT00837616|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92615050|NCT00837616|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92615051|NCT00837616|Estradiol|estradiol|mesh-list
92615052|NCT00837616|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92615053|NCT00837616|Estrogens|estrogens|mesh-ancestor
92615054|NCT00837616|Hormones|hormones|mesh-ancestor
92615055|NCT00837616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615056|NCT00837616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615057|NCT00837616|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92615058|NCT00837616|Contraceptive Agents|contraceptive agents|mesh-ancestor
92615059|NCT00837616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92615060|NCT00837616|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92615061|NCT00610051|Alprostadil|alprostadil|mesh-list
92615062|NCT00610051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92615063|NCT00610051|Vasodilator Agents|vasodilator agents|mesh-ancestor
92615064|NCT00610051|Urological Agents|urological agents|mesh-ancestor
92615065|NCT00176254|Paclitaxel|paclitaxel|mesh-list
92615066|NCT00176254|Carboplatin|carboplatin|mesh-list
92537202|NCT00139282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537203|NCT00139282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537204|NCT00139282|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92537205|NCT00139282|Protective Agents|protective agents|mesh-ancestor
91944886|NCT05650216|Paclitaxel|paclitaxel|mesh-list
92615067|NCT00176254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92615068|NCT00176254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615069|NCT00176254|Tubulin Modulators|tubulin modulators|mesh-ancestor
92615070|NCT00176254|Antimitotic Agents|antimitotic agents|mesh-ancestor
92615071|NCT00176254|Mitosis Modulators|mitosis modulators|mesh-ancestor
92615072|NCT00176254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615073|NCT02949895|Etoposide|etoposide|mesh-list
92615074|NCT02949895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615075|NCT02949895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92615076|NCT02949895|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92615077|NCT02949895|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92615078|NCT02949895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340127|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
92615079|NCT02949895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615081|NCT02949583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92615082|NCT02949583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615083|NCT02949583|Disinfectants|disinfectants|mesh-ancestor
92615084|NCT00516841|Volociximab|volociximab|mesh-list
92615085|NCT00516841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92615086|NCT00516841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92615087|NCT00516841|Growth Substances|growth substances|mesh-ancestor
92615088|NCT00516841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615089|NCT00516841|Growth Inhibitors|growth inhibitors|mesh-ancestor
92615090|NCT00516841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615091|NCT00516880|Rosiglitazone|rosiglitazone|mesh-list
92615092|NCT00516880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615093|NCT00516880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615094|NCT04694677|Misoprostol|misoprostol|mesh-list
92615095|NCT04694677|Tranexamic Acid|tranexamic acid|mesh-list
92615096|NCT04694677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92615097|NCT04694677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92615098|NCT04694677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615099|NCT04694677|Hemostatics|hemostatics|mesh-ancestor
92615100|NCT04694677|Coagulants|coagulants|mesh-ancestor
92615101|NCT04694677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92615102|NCT04694677|Abortifacient Agents|abortifacient agents|mesh-ancestor
92615103|NCT04694677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92615104|NCT04694677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615105|NCT04694677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92615106|NCT04694677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615107|NCT04694677|Oxytocics|oxytocics|mesh-ancestor
92615108|NCT00516958|Levofloxacin|levofloxacin|mesh-list
92615109|NCT00516958|Ofloxacin|ofloxacin|mesh-list
92615110|NCT00516958|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92022007|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615112|NCT00516958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615113|NCT00516958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615114|NCT00516958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92615115|NCT00516958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92615116|NCT00516958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615117|NCT00516958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615118|NCT00516958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615119|NCT00516958|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92615120|NCT00516958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92615121|NCT00516958|Disinfectants|disinfectants|mesh-ancestor
92615122|NCT00517114|Rabeprazole|rabeprazole|mesh-list
92615123|NCT00517114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92615124|NCT00517114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615125|NCT00517114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92615126|NCT00517114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615127|NCT00517114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615128|NCT00517270|Rabeprazole|rabeprazole|mesh-list
92615129|NCT00517270|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92615130|NCT00517270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615131|NCT00517270|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92615132|NCT00517270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537206|NCT00139282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537207|NCT00139282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960234|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615133|NCT00517270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615134|NCT00517309|Vaccines|vaccines|mesh-list
92615135|NCT00517309|Immunologic Factors|immunologic factors|mesh-ancestor
92615136|NCT00517309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615137|NCT00517387|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92615138|NCT00517387|Antidepressive Agents|antidepressive agents|mesh-ancestor
92615139|NCT00517387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92615140|NCT00517387|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92615141|NCT00517387|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92615142|NCT00517387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615143|NCT00517387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615144|NCT00517426|Acetazolamide|acetazolamide|mesh-list
92615145|NCT00517426|Anticonvulsants|anticonvulsants|mesh-ancestor
92615146|NCT00517426|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92615147|NCT00517426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615148|NCT00517426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615149|NCT00517426|Diuretics|diuretics|mesh-ancestor
92615150|NCT00517426|Natriuretic Agents|natriuretic agents|mesh-ancestor
92615151|NCT00517426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340204|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
92615152|NCT00517504|Methylphenidate|methylphenidate|mesh-list
92615153|NCT00517504|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92615154|NCT00517504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615155|NCT00517504|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92615156|NCT00517504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92615157|NCT00517504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615158|NCT00517504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615159|NCT00517504|Dopamine Agents|dopamine agents|mesh-ancestor
92615160|NCT00517504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615161|NCT00517582|Icatibant|icatibant|mesh-list
92615162|NCT00517582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92615163|NCT00517582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615164|NCT00517582|Analgesics|analgesics|mesh-ancestor
92615165|NCT00517582|Sensory System Agents|sensory system agents|mesh-ancestor
92615166|NCT00517582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615167|NCT00517582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615168|NCT00517582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615169|NCT00517582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615170|NCT00517582|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92615171|NCT00517582|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92615172|NCT00517582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615173|NCT00517582|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92615174|NCT00517582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615175|NCT00517582|Immunologic Factors|immunologic factors|mesh-ancestor
92615176|NCT00517621|Paclitaxel|paclitaxel|mesh-list
92615177|NCT00517621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92615178|NCT00517621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615179|NCT00517621|Tubulin Modulators|tubulin modulators|mesh-ancestor
92615180|NCT00517621|Antimitotic Agents|antimitotic agents|mesh-ancestor
92615181|NCT00517621|Mitosis Modulators|mitosis modulators|mesh-ancestor
92615184|NCT00151515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92615185|NCT00151515|Vasodilator Agents|vasodilator agents|mesh-ancestor
92615186|NCT00166686|Clonidine|clonidine|mesh-list
92615187|NCT00166686|Analgesics|analgesics|mesh-ancestor
92615188|NCT00166686|Sensory System Agents|sensory system agents|mesh-ancestor
92615189|NCT00166686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615190|NCT00166686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615191|NCT00166686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92615192|NCT00166686|Sympatholytics|sympatholytics|mesh-ancestor
92615193|NCT00166686|Autonomic Agents|autonomic agents|mesh-ancestor
92615194|NCT00166686|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92615195|NCT00166686|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92615196|NCT00166686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92615197|NCT00166686|Adrenergic Agents|adrenergic agents|mesh-ancestor
92615198|NCT00166686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615199|NCT00166686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615200|NCT02949778|Ropivacaine|ropivacaine|mesh-list
92537208|NCT00139282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92537209|NCT00139282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91960309|NCT02505841|Ropivacaine|ropivacaine|mesh-list
92615201|NCT02949778|Anesthetics, Local|anesthetics, local|mesh-ancestor
92615202|NCT02949778|Anesthetics|anesthetics|mesh-ancestor
92615203|NCT02949778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615204|NCT02949778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615205|NCT02949778|Sensory System Agents|sensory system agents|mesh-ancestor
92615206|NCT02949778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615207|NCT00518245|Enoxaparin|enoxaparin|mesh-list
92615208|NCT00518245|Anticoagulants|anticoagulants|mesh-ancestor
92615209|NCT00518245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92361016|NCT00509496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615210|NCT00518245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92615211|NCT00518245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615212|NCT02957903|Ropivacaine|ropivacaine|mesh-list
92615213|NCT02957903|Anesthetics, Local|anesthetics, local|mesh-ancestor
92615214|NCT02957903|Anesthetics|anesthetics|mesh-ancestor
92615215|NCT02957903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615216|NCT02957903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615217|NCT02957903|Sensory System Agents|sensory system agents|mesh-ancestor
92615218|NCT02957903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615219|NCT00518479|Amlodipine|amlodipine|mesh-list
92615220|NCT00518479|Valsartan|valsartan|mesh-list
92615221|NCT00518479|Moxonidine|moxonidine|mesh-list
92615222|NCT00518479|Bendroflumethiazide|bendroflumethiazide|mesh-list
92615223|NCT00518479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92615224|NCT00518479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92615225|NCT00518479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615226|NCT00518479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615227|NCT00518479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92615228|NCT00518479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615229|NCT00518479|Vasodilator Agents|vasodilator agents|mesh-ancestor
92615230|NCT00518479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92615231|NCT00518479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92615233|NCT00518479|Natriuretic Agents|natriuretic agents|mesh-ancestor
92615234|NCT00518479|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92615235|NCT00166725|Octreotide|octreotide|mesh-list
92615236|NCT00166725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615237|NCT00166725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92615238|NCT00166725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615239|NCT00518635|Insulin|insulin|mesh-list
92615240|NCT00518635|Hormones|hormones|mesh-list
92615241|NCT00518635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615242|NCT00518635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615243|NCT00518635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615244|NCT00151632|Mycophenolic Acid|mycophenolic acid|mesh-list
92615245|NCT00151632|Tacrolimus|tacrolimus|mesh-list
92615246|NCT00151632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615247|NCT00151632|Immunologic Factors|immunologic factors|mesh-ancestor
92615248|NCT00151632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615249|NCT00151632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92615250|NCT00151632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615251|NCT00151632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615252|NCT00151632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92615253|NCT00151632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615254|NCT00151632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92615259|NCT02949232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615260|NCT02949232|Glucocorticoids|glucocorticoids|mesh-ancestor
92615261|NCT02949232|Hormones|hormones|mesh-ancestor
92615262|NCT02949232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615263|NCT02949232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615264|NCT02949232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92615265|NCT02949232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615266|NCT00518908|Sevoflurane|sevoflurane|mesh-list
92615267|NCT00518908|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92615268|NCT00518908|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92615269|NCT00518908|Anesthetics, General|anesthetics, general|mesh-ancestor
92615270|NCT00518908|Anesthetics|anesthetics|mesh-ancestor
92615271|NCT00518908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615272|NCT00518908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615273|NCT00518947|Verapamil|verapamil|mesh-list
92537210|NCT00139282|Growth Substances|growth substances|mesh-ancestor
92537211|NCT00139282|Growth Inhibitors|growth inhibitors|mesh-ancestor
92537212|NCT03861767|Metformin|metformin|mesh-list
92537213|NCT03861767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91944895|NCT04848688|Ivermectin|ivermectin|mesh-list
92615274|NCT00518947|Lithium Carbonate|lithium carbonate|mesh-list
92615275|NCT00518947|Antidepressive Agents|antidepressive agents|mesh-ancestor
92615276|NCT00518947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92615277|NCT00518947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615278|NCT00518947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615279|NCT00518947|Antimanic Agents|antimanic agents|mesh-ancestor
92615280|NCT00518947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92615281|NCT00518947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615282|NCT00518947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615283|NCT00518947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92615284|NCT00518947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92615285|NCT00518947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615286|NCT00518947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92615287|NCT00518947|Vasodilator Agents|vasodilator agents|mesh-ancestor
92615288|NCT02949466|Triamcinolone|triamcinolone|mesh-list
92615289|NCT02949466|Hyaluronic Acid|hyaluronic acid|mesh-list
92615290|NCT02949466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615291|NCT02949466|Glucocorticoids|glucocorticoids|mesh-ancestor
92615292|NCT02949466|Hormones|hormones|mesh-ancestor
92615293|NCT02949466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615294|NCT02949466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615295|NCT02949466|Immunologic Factors|immunologic factors|mesh-ancestor
92615296|NCT02949466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92615297|NCT02949466|Viscosupplements|viscosupplements|mesh-ancestor
92615298|NCT02949466|Protective Agents|protective agents|mesh-ancestor
92615299|NCT00151710|Pioglitazone|pioglitazone|mesh-list
92615300|NCT00151710|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615301|NCT00151710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615302|NCT00519181|Valproic Acid|valproic acid|mesh-list
92615303|NCT00519181|Anticonvulsants|anticonvulsants|mesh-ancestor
92615304|NCT00519181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615305|NCT00519181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615306|NCT00519181|GABA Agents|gaba agents|mesh-ancestor
92615307|NCT00519181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615308|NCT00519181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615309|NCT00519181|Antimanic Agents|antimanic agents|mesh-ancestor
92615310|NCT00519181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92615311|NCT00519181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615312|NCT00519181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92615313|NCT00166803|Rosiglitazone|rosiglitazone|mesh-list
92615314|NCT00166803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615315|NCT00166803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615316|NCT02949310|Nefopam|nefopam|mesh-list
92615317|NCT02949310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615318|NCT02949310|Analgesics|analgesics|mesh-ancestor
92615319|NCT02949310|Sensory System Agents|sensory system agents|mesh-ancestor
92615320|NCT02949310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615321|NCT02949310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615322|NCT02949349|Mycophenolic Acid|mycophenolic acid|mesh-list
92615323|NCT02949349|Prednisolone|prednisolone|mesh-list
92615324|NCT02949349|Azathioprine|azathioprine|mesh-list
92615325|NCT02949349|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92615326|NCT02949349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615330|NCT02949349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615332|NCT02949349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615333|NCT02949349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615334|NCT02949349|Glucocorticoids|glucocorticoids|mesh-ancestor
92615335|NCT02949349|Hormones|hormones|mesh-ancestor
92615336|NCT02949349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615337|NCT02949349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615338|NCT02949349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92615339|NCT02949349|Antimetabolites|antimetabolites|mesh-ancestor
92615340|NCT02949349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615341|NCT02949349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615342|NCT02949349|Immunologic Factors|immunologic factors|mesh-ancestor
92615343|NCT02949349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615344|NCT00166842|Cyclosporine|cyclosporine|mesh-list
92615345|NCT00166842|Sirolimus|sirolimus|mesh-list
92615346|NCT00166842|Tacrolimus|tacrolimus|mesh-list
92615347|NCT00166842|Cyclosporins|cyclosporins|mesh-list
92615348|NCT00166842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615349|NCT00166842|Immunologic Factors|immunologic factors|mesh-ancestor
92615350|NCT00166842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615351|NCT00166842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92615352|NCT00166842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615353|NCT00166842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615354|NCT00166842|Antifungal Agents|antifungal agents|mesh-ancestor
92615355|NCT00166842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615356|NCT00166842|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615357|NCT00166842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615358|NCT00166842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615359|NCT00166842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92615360|NCT00166842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615361|NCT02949193|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92615362|NCT02949193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615363|NCT02949193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615364|NCT02949193|Incretins|incretins|mesh-ancestor
92615365|NCT02949193|Hormones|hormones|mesh-ancestor
92615366|NCT02949193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615367|NCT02949193|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92615368|NCT02949193|Protease Inhibitors|protease inhibitors|mesh-ancestor
92615369|NCT02949193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615370|NCT02949193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615371|NCT00519259|Lobeline|lobeline|mesh-list
92615372|NCT00519259|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92615373|NCT00519259|Autonomic Agents|autonomic agents|mesh-ancestor
92615374|NCT00519259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615375|NCT00519259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615376|NCT00519259|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92615378|NCT00519259|Cholinergic Agents|cholinergic agents|mesh-ancestor
92615379|NCT00519259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615380|NCT00519259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615381|NCT00519259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92615382|NCT00519298|Donepezil|donepezil|mesh-list
92615383|NCT00519298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92615384|NCT00519298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615385|NCT00519298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615386|NCT00519298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92615387|NCT00519298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615388|NCT00519298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615389|NCT00519298|Nootropic Agents|nootropic agents|mesh-ancestor
92615390|NCT00519337|Ascorbic Acid|ascorbic acid|mesh-list
92615391|NCT00519337|Vitamins|vitamins|mesh-ancestor
92615392|NCT00519337|Micronutrients|micronutrients|mesh-ancestor
92615393|NCT00519337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615394|NCT00519337|Antioxidants|antioxidants|mesh-ancestor
92615395|NCT00519337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615396|NCT00519337|Protective Agents|protective agents|mesh-ancestor
92615397|NCT00151749|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92361077|NCT00549822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615398|NCT00151749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92615401|NCT00151749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615402|NCT00151749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92615404|NCT00166881|Irinotecan|irinotecan|mesh-list
92615405|NCT00166881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615406|NCT00166881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92615407|NCT00166881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92615408|NCT00166881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92615409|NCT00166881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615410|NCT00166881|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92615411|NCT00166881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92615412|NCT00166881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615413|NCT02948998|Spironolactone|spironolactone|mesh-list
92615414|NCT02948998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92615415|NCT02948998|Hormone Antagonists|hormone antagonists|mesh-ancestor
92615416|NCT02948998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615417|NCT02948998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615418|NCT02948998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92615419|NCT02948998|Diuretics|diuretics|mesh-ancestor
92615420|NCT02948998|Natriuretic Agents|natriuretic agents|mesh-ancestor
92615421|NCT00519688|Thalidomide|thalidomide|mesh-list
92615422|NCT00519688|Tegafur|tegafur|mesh-list
92615423|NCT00519688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537214|NCT03861767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537215|NCT00139360|Bevacizumab|bevacizumab|mesh-list
91944899|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
92615424|NCT00519688|Immunologic Factors|immunologic factors|mesh-ancestor
92615425|NCT00519688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615426|NCT00519688|Leprostatic Agents|leprostatic agents|mesh-ancestor
92615427|NCT00519688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615428|NCT00519688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615429|NCT00519688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92615430|NCT00519688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92615431|NCT00519688|Growth Substances|growth substances|mesh-ancestor
92615432|NCT00519688|Growth Inhibitors|growth inhibitors|mesh-ancestor
92615433|NCT00519688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615434|NCT00519688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615435|NCT00519688|Antimetabolites|antimetabolites|mesh-ancestor
92615436|NCT00519688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615437|NCT02948920|Ephedrine|ephedrine|mesh-list
92615438|NCT02948920|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92615439|NCT02948920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615440|NCT02948920|Sympathomimetics|sympathomimetics|mesh-ancestor
92615441|NCT02948920|Autonomic Agents|autonomic agents|mesh-ancestor
92615442|NCT02948920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615443|NCT02948920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92615444|NCT02948920|Adrenergic Agents|adrenergic agents|mesh-ancestor
92615445|NCT02948920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615446|NCT02948920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615447|NCT00151827|Losartan|losartan|mesh-list
92615448|NCT00151827|Olmesartan|olmesartan|mesh-list
92615449|NCT00151827|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92615450|NCT00151827|Furosemide|furosemide|mesh-list
92615451|NCT00151827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92615452|NCT00151827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92615453|NCT00151827|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92615454|NCT00151827|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92615455|NCT00151827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615456|NCT00151827|Diuretics|diuretics|mesh-ancestor
92615457|NCT00151827|Natriuretic Agents|natriuretic agents|mesh-ancestor
92615458|NCT00151827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615459|NCT00151827|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92615460|NCT00151827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615461|NCT00519805|Dalteparin|dalteparin|mesh-list
92615462|NCT00519805|Tinzaparin|tinzaparin|mesh-list
92615463|NCT00519805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92615464|NCT00519805|Anticoagulants|anticoagulants|mesh-ancestor
92615465|NCT00519805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92615466|NCT00519805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92615467|NCT00519805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615468|NCT02948881|Ibandronic Acid|ibandronic acid|mesh-list
92615469|NCT02948881|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92615470|NCT02948881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615475|NCT04457180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92615477|NCT04457180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615478|NCT04457180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92615479|NCT04457180|Antidepressive Agents|antidepressive agents|mesh-ancestor
92615480|NCT04457180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92615481|NCT04457180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92615482|NCT04457180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92615483|NCT04457180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615484|NCT04457180|Dopamine Agents|dopamine agents|mesh-ancestor
92615485|NCT04457180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615486|NCT04457180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615487|NCT04457180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92615488|NCT04457180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92615489|NCT04457180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615490|NCT00520000|Carboplatin|carboplatin|mesh-list
92615491|NCT00520000|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92615492|NCT00520000|Paclitaxel|paclitaxel|mesh-list
92615493|NCT00520000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615494|NCT00520000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92615495|NCT00520000|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537216|NCT00139360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537217|NCT00139360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537218|NCT00139360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92537219|NCT00139360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92537220|NCT00139360|Growth Substances|growth substances|mesh-ancestor
91944901|NCT05369650|Lidocaine|lidocaine|mesh-list
92615496|NCT00520000|Antimitotic Agents|antimitotic agents|mesh-ancestor
92615497|NCT00520000|Mitosis Modulators|mitosis modulators|mesh-ancestor
92615498|NCT00520000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615499|NCT00151944|Mesalamine|mesalamine|mesh-list
92615500|NCT00151944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92615501|NCT00151944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615502|NCT00151944|Analgesics|analgesics|mesh-ancestor
92615503|NCT00151944|Sensory System Agents|sensory system agents|mesh-ancestor
92615504|NCT00151944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615505|NCT00151944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615506|NCT00151944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615507|NCT00151944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615508|NCT00520507|Olanzapine|olanzapine|mesh-list
92615509|NCT00520507|Antiemetics|antiemetics|mesh-ancestor
92615510|NCT00520507|Autonomic Agents|autonomic agents|mesh-ancestor
92615511|NCT00520507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615512|NCT00520507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615513|NCT00520507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615514|NCT00520507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92615515|NCT00520507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92615516|NCT00520507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615517|NCT00520507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92615518|NCT00520507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92615519|NCT00520507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92615520|NCT00520507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615521|NCT00520507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615522|NCT00520507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615523|NCT00520507|Serotonin Agents|serotonin agents|mesh-ancestor
92615524|NCT04694404|Oxaliplatin|oxaliplatin|mesh-list
92615525|NCT04694404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615527|NCT04694365|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92615528|NCT04694365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615529|NCT04694365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615530|NCT04694365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615531|NCT00151983|Methylphenidate|methylphenidate|mesh-list
92615532|NCT00151983|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92615533|NCT00151983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615534|NCT00151983|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92615535|NCT00151983|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92615536|NCT00151983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615537|NCT00151983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615538|NCT00151983|Dopamine Agents|dopamine agents|mesh-ancestor
92615539|NCT00151983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615540|NCT00520585|Atorvastatin|atorvastatin|mesh-list
92615552|NCT00152022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615554|NCT00152022|Autonomic Agents|autonomic agents|mesh-ancestor
92615555|NCT00152022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615556|NCT00152022|Dopamine Agents|dopamine agents|mesh-ancestor
92615557|NCT00152022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615558|NCT00152022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615559|NCT00152022|Adrenergic Agents|adrenergic agents|mesh-ancestor
92615560|NCT00152022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92615561|NCT00152022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92615562|NCT00152022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615563|NCT00152022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92615564|NCT00520819|Antioxidants|antioxidants|mesh-list
92615565|NCT00520819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615566|NCT00520819|Protective Agents|protective agents|mesh-ancestor
92615567|NCT00520819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615568|NCT00520897|Raltegravir Potassium|raltegravir potassium|mesh-list
92537221|NCT00139360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537223|NCT00139516|Nicotine|nicotine|mesh-list
92615569|NCT00520897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92615570|NCT00520897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92615571|NCT00520897|Antiviral Agents|antiviral agents|mesh-ancestor
92615572|NCT00520897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615573|NCT00520897|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92615574|NCT00520897|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92615575|NCT00520897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615576|NCT00520897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615577|NCT00521092|Sunitinib|sunitinib|mesh-list
92615578|NCT00521092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615579|NCT00521092|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92615580|NCT00521092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92615581|NCT00521092|Growth Substances|growth substances|mesh-ancestor
92615582|NCT00521092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615583|NCT00521092|Growth Inhibitors|growth inhibitors|mesh-ancestor
92615584|NCT00521092|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92615585|NCT00521092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615586|NCT00521092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615587|NCT00521131|Levocetirizine|levocetirizine|mesh-list
92615588|NCT00521131|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92615589|NCT00521131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92615590|NCT00521131|Histamine Antagonists|histamine antagonists|mesh-ancestor
92615591|NCT00521131|Histamine Agents|histamine agents|mesh-ancestor
92615592|NCT00521131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615593|NCT00521131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615594|NCT00521131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615595|NCT04694092|Landiolol|landiolol|mesh-list
92340665|NCT00002675|Cyclophosphamide|cyclophosphamide|mesh-list
92615596|NCT04694092|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92615597|NCT04694092|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92615598|NCT04694092|Adrenergic Agents|adrenergic agents|mesh-ancestor
92615599|NCT04694092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615600|NCT04694092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615603|NCT00521170|Levocetirizine|levocetirizine|mesh-list
92615604|NCT00521170|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92615605|NCT00521170|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92615606|NCT00521170|Histamine Antagonists|histamine antagonists|mesh-ancestor
92615607|NCT00521170|Histamine Agents|histamine agents|mesh-ancestor
92615608|NCT00521170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615609|NCT00521170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615610|NCT00521170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615611|NCT00521248|Morphine|morphine|mesh-list
92615612|NCT00521248|Buprenorphine|buprenorphine|mesh-list
92615613|NCT00521248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92615614|NCT00521248|Narcotics|narcotics|mesh-ancestor
92615615|NCT00521248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615616|NCT00521248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615617|NCT00521248|Analgesics|analgesics|mesh-ancestor
92615618|NCT00521248|Sensory System Agents|sensory system agents|mesh-ancestor
92615619|NCT00521248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615620|NCT00521248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92615621|NCT00167154|Risperidone|risperidone|mesh-list
92406002|NCT04545060|Sotrovimab|sotrovimab|mesh-list
92615622|NCT00167154|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92615623|NCT00167154|Serotonin Agents|serotonin agents|mesh-ancestor
92615624|NCT00167154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615625|NCT00167154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615626|NCT00167154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615627|NCT00167154|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92615628|NCT00167154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92615629|NCT00167154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615630|NCT00167154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92615631|NCT00167154|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92615632|NCT00167154|Dopamine Agents|dopamine agents|mesh-ancestor
92615633|NCT00521482|Thalidomide|thalidomide|mesh-list
92615634|NCT00521482|Temozolomide|temozolomide|mesh-list
92615635|NCT00521482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92615636|NCT00521482|Alkylating Agents|alkylating agents|mesh-ancestor
92615637|NCT00521482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615638|NCT00521482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537224|NCT00139516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92537225|NCT00139516|Autonomic Agents|autonomic agents|mesh-ancestor
92261971|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91944908|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92615639|NCT00521482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615640|NCT00521482|Immunologic Factors|immunologic factors|mesh-ancestor
92615641|NCT00521482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615642|NCT00521482|Leprostatic Agents|leprostatic agents|mesh-ancestor
92615643|NCT00521482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615644|NCT00521482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615645|NCT00521482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92615646|NCT00521482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92615647|NCT00521482|Growth Substances|growth substances|mesh-ancestor
92615648|NCT00521482|Growth Inhibitors|growth inhibitors|mesh-ancestor
92615649|NCT00521521|Docetaxel|docetaxel|mesh-list
92615650|NCT00521521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615651|NCT00521521|Tubulin Modulators|tubulin modulators|mesh-ancestor
92615652|NCT00521521|Antimitotic Agents|antimitotic agents|mesh-ancestor
92615653|NCT00521521|Mitosis Modulators|mitosis modulators|mesh-ancestor
92615654|NCT00521521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615655|NCT00152100|Alemtuzumab|alemtuzumab|mesh-list
92615656|NCT00152100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92615657|NCT00152100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615658|NCT00522184|Etanercept|etanercept|mesh-list
92615659|NCT00522184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92615660|NCT00522184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615661|NCT00522184|Analgesics|analgesics|mesh-ancestor
92615662|NCT00522184|Sensory System Agents|sensory system agents|mesh-ancestor
92615663|NCT00522184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615664|NCT00522184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615665|NCT00522184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615666|NCT00522184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615667|NCT00522184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615668|NCT00522184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615669|NCT00522184|Immunologic Factors|immunologic factors|mesh-ancestor
92615670|NCT03458923|Diclofenac|diclofenac|mesh-list
92615671|NCT03458923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92615672|NCT03458923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92615673|NCT03458923|Ranibizumab|ranibizumab|mesh-list
92615689|NCT04186013|Atezolizumab|atezolizumab|mesh-list
92615690|NCT04186013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92615691|NCT04186013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615692|NCT04186013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92615693|NCT04186013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615694|NCT00152139|Antibodies|antibodies|mesh-list
92615695|NCT00152139|Immunologic Factors|immunologic factors|mesh-ancestor
92615696|NCT00152139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615697|NCT04725162|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92615698|NCT04725162|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92615699|NCT04725162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615700|NCT00405431|Lubricant Eye Drops|lubricant eye drops|mesh-list
92615701|NCT00405431|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92615702|NCT00405431|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92615703|NCT00167232|Naltrexone|naltrexone|mesh-list
92615704|NCT00167232|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92361094|NCT01797198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92615705|NCT00167232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92615706|NCT00167232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615707|NCT00167232|Sensory System Agents|sensory system agents|mesh-ancestor
92615708|NCT00167232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615709|NCT00522886|Cetuximab|cetuximab|mesh-list
92615710|NCT00522886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92615711|NCT00522886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615712|NCT04083560|Hydroxocobalamin|hydroxocobalamin|mesh-list
92615713|NCT04083560|Vitamin B 12|vitamin b 12|mesh-list
92615714|NCT04083560|Hematinics|hematinics|mesh-ancestor
92615715|NCT04083560|Vitamin B Complex|vitamin b complex|mesh-ancestor
92615716|NCT04083560|Vitamins|vitamins|mesh-ancestor
92615717|NCT04083560|Micronutrients|micronutrients|mesh-ancestor
92615718|NCT04083560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615719|NCT00511966|Rabeprazole|rabeprazole|mesh-list
92615720|NCT00511966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92615721|NCT00511966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615722|NCT00511966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92537226|NCT00139516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537227|NCT00139516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615723|NCT00511966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615724|NCT00511966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615725|NCT00152178|Tamoxifen|tamoxifen|mesh-list
92615726|NCT00152178|Cyclophosphamide|cyclophosphamide|mesh-list
92615727|NCT00152178|Fluorouracil|fluorouracil|mesh-list
92615728|NCT00152178|Methotrexate|methotrexate|mesh-list
92615729|NCT00152178|Tegafur|tegafur|mesh-list
92615730|NCT00152178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615731|NCT00152178|Immunologic Factors|immunologic factors|mesh-ancestor
92615732|NCT00152178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615733|NCT00152178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022654|NCT04341571|Metformin|metformin|mesh-list
92615736|NCT00152178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615737|NCT00152178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615738|NCT00152178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92615739|NCT00152178|Antimetabolites|antimetabolites|mesh-ancestor
92615740|NCT00152178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615741|NCT00152178|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92615742|NCT00152178|Abortifacient Agents|abortifacient agents|mesh-ancestor
92615743|NCT00152178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92615744|NCT00152178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615745|NCT00152178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615746|NCT00152178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92615747|NCT00152178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92615748|NCT00152178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92615749|NCT00152178|Hormone Antagonists|hormone antagonists|mesh-ancestor
92615750|NCT00152178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615751|NCT00152178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92615752|NCT00152178|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92615753|NCT00152178|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92615754|NCT00152178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92615755|NCT00523120|Diclofenac|diclofenac|mesh-list
92615756|NCT00523120|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92615757|NCT00523120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615758|NCT00523120|Analgesics|analgesics|mesh-ancestor
92615759|NCT00523120|Sensory System Agents|sensory system agents|mesh-ancestor
92615760|NCT00523120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615761|NCT00523120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615762|NCT00523120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615763|NCT00523120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615764|NCT00523120|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92615765|NCT00523120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615766|NCT00523120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615767|NCT00523159|Sargramostim|sargramostim|mesh-list
92615768|NCT00523159|Immunologic Factors|immunologic factors|mesh-ancestor
92615769|NCT00523159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615770|NCT04693897|Solifenacin Succinate|solifenacin succinate|mesh-list
92615771|NCT04693897|Mirabegron|mirabegron|mesh-list
92615772|NCT04693897|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92615773|NCT04693897|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92615774|NCT04693897|Cholinergic Agents|cholinergic agents|mesh-ancestor
92615775|NCT04693897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615776|NCT04693897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615777|NCT04693897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615778|NCT04693897|Urological Agents|urological agents|mesh-ancestor
92615779|NCT04693897|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92615780|NCT04693897|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92615781|NCT04693897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92615782|NCT04693897|Adrenergic Agents|adrenergic agents|mesh-ancestor
92615783|NCT00424242|Pemetrexed|pemetrexed|mesh-list
92615784|NCT00424242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615785|NCT00424242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615786|NCT00424242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615787|NCT00424242|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92615788|NCT00424242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92615789|NCT04726553|Mycophenolic Acid|mycophenolic acid|mesh-list
92615790|NCT04726553|Antimalarials|antimalarials|mesh-list
92615791|NCT04726553|Methotrexate|methotrexate|mesh-list
92615792|NCT04726553|Azathioprine|azathioprine|mesh-list
92615793|NCT04726553|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92537228|NCT00139516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92537229|NCT00139516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92615794|NCT04726553|Abortifacient Agents|abortifacient agents|mesh-ancestor
92615795|NCT04726553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92615796|NCT04726553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615797|NCT04726553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615798|NCT04726553|Antimetabolites|antimetabolites|mesh-ancestor
92615799|NCT04726553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615800|NCT04726553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615801|NCT04726553|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615802|NCT04726553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615803|NCT04726553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92615805|NCT04726553|Immunologic Factors|immunologic factors|mesh-ancestor
92615806|NCT04726553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615807|NCT04726553|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92615808|NCT04726553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92615809|NCT04726553|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92615810|NCT04726553|Antitubercular Agents|antitubercular agents|mesh-ancestor
92615811|NCT04726553|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615812|NCT04726553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615813|NCT04726553|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92615814|NCT04726553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92615816|NCT02947945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92615817|NCT02947945|Respiratory System Agents|respiratory system agents|mesh-ancestor
92615818|NCT02948101|Cyclophosphamide|cyclophosphamide|mesh-list
92615819|NCT02948101|Antibodies|antibodies|mesh-list
92615820|NCT02948101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92361111|NCT00517530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615821|NCT02948101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615823|NCT02948101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615824|NCT02948101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615825|NCT02948101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92615826|NCT02948101|Alkylating Agents|alkylating agents|mesh-ancestor
92615827|NCT02948101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615828|NCT02948101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615829|NCT02948101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92615830|NCT02952157|Lidocaine|lidocaine|mesh-list
92615831|NCT02952157|Anesthetics, Local|anesthetics, local|mesh-ancestor
92615832|NCT02952157|Anesthetics|anesthetics|mesh-ancestor
92615833|NCT02952157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615834|NCT02952157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615835|NCT02952157|Sensory System Agents|sensory system agents|mesh-ancestor
92615836|NCT02952157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615837|NCT02952157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92615838|NCT02952157|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92615839|NCT02952157|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92615840|NCT02952157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92615841|NCT02952157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615842|NCT02951728|Prednisone|prednisone|mesh-list
92615843|NCT02951728|Cyclophosphamide|cyclophosphamide|mesh-list
92615844|NCT02951728|Rituximab|rituximab|mesh-list
92615845|NCT02951728|Doxorubicin|doxorubicin|mesh-list
92615846|NCT02951728|Vincristine|vincristine|mesh-list
92615847|NCT02951728|Decitabine|decitabine|mesh-list
92615848|NCT02951728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615849|NCT02951728|Immunologic Factors|immunologic factors|mesh-ancestor
92615850|NCT02951728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615851|NCT02951728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615852|NCT02951728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92615853|NCT02951728|Alkylating Agents|alkylating agents|mesh-ancestor
92615854|NCT02951728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615855|NCT02951728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615856|NCT02951728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92615857|NCT02951728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92615858|NCT02951728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92615859|NCT02951728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92615860|NCT02951728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92615861|NCT02951728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615862|NCT02951728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615863|NCT02951728|Glucocorticoids|glucocorticoids|mesh-ancestor
92615864|NCT02951728|Hormones|hormones|mesh-ancestor
92615865|NCT02951728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537230|NCT00139516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92537231|NCT00139516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537232|NCT00139516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615866|NCT02951728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92615867|NCT02951728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92615868|NCT02951728|Tubulin Modulators|tubulin modulators|mesh-ancestor
92615869|NCT02951728|Antimitotic Agents|antimitotic agents|mesh-ancestor
92615870|NCT02951728|Mitosis Modulators|mitosis modulators|mesh-ancestor
92615871|NCT02951728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615872|NCT02951728|Antimetabolites|antimetabolites|mesh-ancestor
92615873|NCT04726046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92615874|NCT04726046|Cefotetan|cefotetan|mesh-list
92615875|NCT04726046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615876|NCT00523354|Infliximab|infliximab|mesh-list
92615877|NCT00523354|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92615890|NCT00523432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92615891|NCT00523432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92615892|NCT00523432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615893|NCT00523432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615894|NCT00523432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615895|NCT00523432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92615896|NCT00523432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615897|NCT00523432|Immunologic Factors|immunologic factors|mesh-ancestor
92615898|NCT00523432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615899|NCT00523432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615900|NCT00523432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615901|NCT00523432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92615902|NCT00523432|Antifungal Agents|antifungal agents|mesh-ancestor
92615903|NCT00512044|Anesthetics|anesthetics|mesh-list
92615904|NCT00512044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615905|NCT00512044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615906|NCT04726007|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92615907|NCT04726007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92615908|NCT04726007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615909|NCT00521950|Mercaptopurine|mercaptopurine|mesh-list
92615910|NCT00521950|Azathioprine|azathioprine|mesh-list
92615911|NCT00521950|Antimetabolites|antimetabolites|mesh-ancestor
92615912|NCT00521950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615913|NCT00521950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92615914|NCT00521950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615915|NCT00521950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615916|NCT00521950|Immunologic Factors|immunologic factors|mesh-ancestor
92615917|NCT00521950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615918|NCT00521950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92615919|NCT00521950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615920|NCT00521950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615921|NCT00523666|Galantamine|galantamine|mesh-list
92615922|NCT00523666|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92615923|NCT00523666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615924|NCT00523666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615925|NCT00523666|Cholinergic Agents|cholinergic agents|mesh-ancestor
92615926|NCT00523666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92615927|NCT00523666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615928|NCT00523666|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92615929|NCT00523666|Autonomic Agents|autonomic agents|mesh-ancestor
92615930|NCT00523666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615931|NCT00523666|Nootropic Agents|nootropic agents|mesh-ancestor
92615932|NCT00167583|Interferons|interferons|mesh-list
92615933|NCT00167583|Interferon-alpha|interferon-alpha|mesh-list
92615934|NCT00167583|Interferon alpha-2|interferon alpha-2|mesh-list
92615935|NCT00167583|Cyclosporine|cyclosporine|mesh-list
92615936|NCT00167583|Cyclosporins|cyclosporins|mesh-list
92615937|NCT00167583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615938|NCT00167583|Antiviral Agents|antiviral agents|mesh-ancestor
92615939|NCT00167583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615940|NCT00167583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615941|NCT00167583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615942|NCT00167583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615944|NCT00167583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615945|NCT00167583|Antifungal Agents|antifungal agents|mesh-ancestor
92537234|NCT00139555|Benazepril|benazepril|mesh-list
92537235|NCT00139555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92537236|NCT00139555|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92615946|NCT00167583|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615947|NCT00167583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615948|NCT00167583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92615949|NCT03943511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92615950|NCT03943511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615951|NCT00172809|Interferons|interferons|mesh-list
92615952|NCT00172809|Interferon-alpha|interferon-alpha|mesh-list
92615953|NCT00172809|Interferon alpha-2|interferon alpha-2|mesh-list
92615954|NCT00172809|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92615955|NCT00172809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615956|NCT00172809|Antiviral Agents|antiviral agents|mesh-ancestor
92615957|NCT00172809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615958|NCT00172809|Immunologic Factors|immunologic factors|mesh-ancestor
92615959|NCT00172809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615960|NCT04696120|Apixaban|apixaban|mesh-list
92615961|NCT04696120|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92615962|NCT04696120|Antithrombins|antithrombins|mesh-ancestor
92615963|NCT04696120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92615964|NCT04696120|Protease Inhibitors|protease inhibitors|mesh-ancestor
92615965|NCT04696120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615966|NCT04696120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615967|NCT04696120|Anticoagulants|anticoagulants|mesh-ancestor
92615968|NCT00512395|Fentanyl|fentanyl|mesh-list
92615969|NCT00512395|Ropivacaine|ropivacaine|mesh-list
92615970|NCT00512395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92615971|NCT00512395|Narcotics|narcotics|mesh-ancestor
92615972|NCT00512395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92615973|NCT00512395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615974|NCT00512395|Analgesics|analgesics|mesh-ancestor
92615975|NCT00512395|Sensory System Agents|sensory system agents|mesh-ancestor
92615976|NCT00512395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615977|NCT00512395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92615978|NCT00512395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92615979|NCT00512395|Anesthetics, General|anesthetics, general|mesh-ancestor
92615980|NCT00512395|Anesthetics|anesthetics|mesh-ancestor
92615981|NCT00512395|Anesthetics, Local|anesthetics, local|mesh-ancestor
92615982|NCT00512473|Hormones|hormones|mesh-list
92615983|NCT00512473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92615984|NCT00512473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615985|NCT00524095|Fluticasone|fluticasone|mesh-list
92615986|NCT00524095|Xhance|xhance|mesh-list
92615987|NCT00524095|Azithromycin|azithromycin|mesh-list
92615988|NCT00524095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615989|NCT00524095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92615990|NCT00524095|Autonomic Agents|autonomic agents|mesh-ancestor
92615991|NCT00524095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615992|NCT00524095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615993|NCT00524095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92615994|NCT00524095|Respiratory System Agents|respiratory system agents|mesh-ancestor
92615995|NCT00524095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615996|NCT00524095|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92615997|NCT00524095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615998|NCT00524095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615999|NCT00512629|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92616000|NCT00512629|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92616001|NCT00512629|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92616002|NCT00512629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92616003|NCT00512668|Sirolimus|sirolimus|mesh-list
92616004|NCT00512668|Leuprolide|leuprolide|mesh-list
92616005|NCT00512668|Goserelin|goserelin|mesh-list
92616006|NCT00512668|Flutamide|flutamide|mesh-list
92616007|NCT00512668|Temsirolimus|temsirolimus|mesh-list
92616008|NCT00512668|Bicalutamide|bicalutamide|mesh-list
92616009|NCT00512668|Nilutamide|nilutamide|mesh-list
92616010|NCT00512668|MTOR Inhibitors|mtor inhibitors|mesh-list
92616011|NCT00512668|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92616012|NCT00512668|Fertility Agents|fertility agents|mesh-ancestor
92616013|NCT00512668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92616014|NCT00512668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616015|NCT00512668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92616016|NCT00512668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616017|NCT00512668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92537237|NCT00139555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537238|NCT00139555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616018|NCT00512668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616019|NCT00512668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616020|NCT00512668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616024|NCT00512668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92616025|NCT00512668|Antifungal Agents|antifungal agents|mesh-ancestor
92616026|NCT00512668|Androgen Antagonists|androgen antagonists|mesh-ancestor
92616027|NCT00512668|Hormone Antagonists|hormone antagonists|mesh-ancestor
92616028|NCT00512668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616029|NCT00167739|Pyrimethamine|pyrimethamine|mesh-list
92616030|NCT00167739|Sulfadoxine|sulfadoxine|mesh-list
92616031|NCT00167739|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92616032|NCT00167739|Quinine|quinine|mesh-list
92616033|NCT00167739|Antimalarials|antimalarials|mesh-ancestor
92616034|NCT00167739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92616035|NCT00167739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92616036|NCT00167739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616037|NCT00167739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92616038|NCT00167739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616039|NCT00167739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616040|NCT00167739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92616041|NCT00167739|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92616042|NCT00167739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616043|NCT00167739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92616044|NCT00167739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616045|NCT00167739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616046|NCT00167739|Analgesics|analgesics|mesh-ancestor
92616047|NCT00167739|Sensory System Agents|sensory system agents|mesh-ancestor
92616048|NCT00524251|Esomeprazole|esomeprazole|mesh-list
92616049|NCT00524251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92616050|NCT00524251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616051|NCT00524251|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92616052|NCT00524251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616053|NCT00524251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616054|NCT00512824|Calcium Carbonate|calcium carbonate|mesh-list
92616055|NCT00512824|Calcium|calcium|mesh-list
92616056|NCT00512824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92616057|NCT00512824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616058|NCT00512824|Antacids|antacids|mesh-ancestor
92616059|NCT00512824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616060|NCT00512824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616061|NCT00512863|Adalimumab|adalimumab|mesh-list
92616062|NCT00512863|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92616063|NCT00512863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616064|NCT00512863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616065|NCT00524407|Epoetin Alfa|epoetin alfa|mesh-list
92616066|NCT00524407|Hematinics|hematinics|mesh-ancestor
92616067|NCT00525889|Sirolimus|sirolimus|mesh-list
92616068|NCT00525889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616069|NCT00525889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616070|NCT00525889|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92616071|NCT00525889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616072|NCT00525889|Antifungal Agents|antifungal agents|mesh-ancestor
92616073|NCT00525889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616074|NCT00525889|Immunologic Factors|immunologic factors|mesh-ancestor
92616075|NCT00525889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616076|NCT00524524|Beta-lapachone|beta-lapachone|mesh-list
92616077|NCT00524524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616078|NCT00524524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92616079|NCT00524524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92616080|NCT00524524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616081|NCT00524524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616082|NCT00524524|Antiviral Agents|antiviral agents|mesh-ancestor
92616083|NCT03879122|Docetaxel|docetaxel|mesh-list
92616084|NCT03879122|Nivolumab|nivolumab|mesh-list
92616085|NCT03879122|Ipilimumab|ipilimumab|mesh-list
92616086|NCT03879122|Androgens|androgens|mesh-list
92616087|NCT03879122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616088|NCT03879122|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616089|NCT03879122|Antimitotic Agents|antimitotic agents|mesh-ancestor
92616090|NCT03879122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92616091|NCT03879122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537239|NCT00139555|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92361167|NCT00524472|Insulin|insulin|mesh-list
92537240|NCT00139555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537241|NCT00139555|Vasodilator Agents|vasodilator agents|mesh-ancestor
92537242|NCT00139555|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92537243|NCT00139555|Protease Inhibitors|protease inhibitors|mesh-ancestor
92616092|NCT03879122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616093|NCT03879122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92616098|NCT00525928|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92616099|NCT00525928|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92616100|NCT00525928|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616101|NCT00525928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616102|NCT00525928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616103|NCT00525928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616104|NCT00167817|Aripiprazole|aripiprazole|mesh-list
92616105|NCT00167817|Antidepressive Agents|antidepressive agents|mesh-ancestor
92616106|NCT00167817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92616107|NCT00167817|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92616108|NCT00167817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92616109|NCT00167817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616110|NCT00167817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616111|NCT00167817|Dopamine Agonists|dopamine agonists|mesh-ancestor
92616112|NCT00167817|Dopamine Agents|dopamine agents|mesh-ancestor
92616113|NCT00167817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616114|NCT00167817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616115|NCT00167817|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92616116|NCT00167817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92616117|NCT00167817|Serotonin Agents|serotonin agents|mesh-ancestor
92616118|NCT00167817|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92616119|NCT00167817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92616120|NCT00167817|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92616121|NCT00167817|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92616123|NCT02947711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92341213|NCT04563533|Vaccines|vaccines|mesh-list
92616124|NCT02947711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92616125|NCT02947711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616126|NCT02947711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616127|NCT02947711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92616128|NCT02947711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616129|NCT02947711|Vasodilator Agents|vasodilator agents|mesh-ancestor
92616130|NCT03845348|Ketoconazole|ketoconazole|mesh-list
92616131|NCT03845348|Antifungal Agents|antifungal agents|mesh-ancestor
92616132|NCT03845348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616133|NCT03845348|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92616134|NCT03845348|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92616135|NCT03845348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616136|NCT03845348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616137|NCT03845348|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92616138|NCT03845348|Hormone Antagonists|hormone antagonists|mesh-ancestor
92616139|NCT03845348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616140|NCT03845348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616141|NCT03845348|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92616142|NCT04723563|Heparin|heparin|mesh-list
92616143|NCT04723563|Anticoagulants|anticoagulants|mesh-ancestor
92616144|NCT04723563|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92616145|NCT04723563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92616146|NCT04723563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616147|NCT00525967|Acetaminophen|acetaminophen|mesh-list
92616148|NCT00525967|Methadone|methadone|mesh-list
92616149|NCT00525967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616150|NCT00525967|Analgesics|analgesics|mesh-ancestor
92616151|NCT00525967|Sensory System Agents|sensory system agents|mesh-ancestor
92616152|NCT00525967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616153|NCT00525967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616154|NCT00525967|Antipyretics|antipyretics|mesh-ancestor
92616155|NCT00525967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92616156|NCT00525967|Narcotics|narcotics|mesh-ancestor
92537244|NCT00139555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537245|NCT03844412|Lidocaine|lidocaine|mesh-list
92537246|NCT03844412|Nortriptyline|nortriptyline|mesh-list
92537247|NCT03844412|Estradiol|estradiol|mesh-list
92537248|NCT03844412|Anesthetics, Local|anesthetics, local|mesh-ancestor
92537249|NCT03844412|Anesthetics|anesthetics|mesh-ancestor
92616157|NCT00525967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616158|NCT00525967|Antitussive Agents|antitussive agents|mesh-ancestor
92616159|NCT00525967|Respiratory System Agents|respiratory system agents|mesh-ancestor
92616160|NCT00167856|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92023062|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92616165|NCT00167856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616166|NCT00167856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616167|NCT00167856|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92616168|NCT00167856|Antidepressive Agents|antidepressive agents|mesh-ancestor
92616169|NCT00167856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92616170|NCT00526006|Esomeprazole|esomeprazole|mesh-list
92616171|NCT00526006|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92616172|NCT00526006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616173|NCT00526006|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92616174|NCT00526006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616175|NCT00526006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616176|NCT03681275|Tofacitinib|tofacitinib|mesh-list
92616177|NCT03681275|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92616178|NCT03681275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92616179|NCT03681275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616180|NCT03681275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616181|NCT02946814|Listerine|listerine|mesh-list
92616182|NCT02946814|Sodium Fluoride|sodium fluoride|mesh-list
92616183|NCT02946814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92616184|NCT02946814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616185|NCT02946814|Cariostatic Agents|cariostatic agents|mesh-ancestor
92616186|NCT02946814|Protective Agents|protective agents|mesh-ancestor
92616187|NCT02946814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616188|NCT00524836|Levocetirizine|levocetirizine|mesh-list
92616189|NCT00524836|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92616190|NCT00524836|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92616191|NCT00524836|Histamine Antagonists|histamine antagonists|mesh-ancestor
92616192|NCT00524836|Histamine Agents|histamine agents|mesh-ancestor
92616193|NCT00524836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616194|NCT00524836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616195|NCT00524836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616196|NCT00524875|Bevacizumab|bevacizumab|mesh-list
92616197|NCT00524875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616198|NCT00524875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616199|NCT00524875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92616200|NCT00524875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92616201|NCT00524875|Growth Substances|growth substances|mesh-ancestor
92616202|NCT00524875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616203|NCT00524875|Growth Inhibitors|growth inhibitors|mesh-ancestor
92616204|NCT00524914|Apomorphine|apomorphine|mesh-list
92616205|NCT00524914|Emetics|emetics|mesh-ancestor
92616206|NCT00524914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616207|NCT00524914|Autonomic Agents|autonomic agents|mesh-ancestor
92616208|NCT00524914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616209|NCT00524914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616210|NCT00524914|Dopamine Agonists|dopamine agonists|mesh-ancestor
92616211|NCT00524914|Dopamine Agents|dopamine agents|mesh-ancestor
92616212|NCT00524914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616213|NCT00524914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616214|NCT02957864|Tenofovir|tenofovir|mesh-list
92616215|NCT02957864|Abacavir|abacavir|mesh-list
92616216|NCT02957864|Antiviral Agents|antiviral agents|mesh-ancestor
92616217|NCT02957864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616218|NCT02957864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92616219|NCT02957864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92616220|NCT02957864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616221|NCT02957864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616222|NCT02957864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92616223|NCT02957864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92616224|NCT00168012|Immunoglobulins|immunoglobulins|mesh-list
92537250|NCT03844412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537251|NCT03844412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537252|NCT03844412|Sensory System Agents|sensory system agents|mesh-ancestor
92616225|NCT00168012|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92616226|NCT00168012|Antibodies|antibodies|mesh-list
92616227|NCT00168012|Immunologic Factors|immunologic factors|mesh-ancestor
92616228|NCT00168012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616232|NCT03585452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616233|NCT03585452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616234|NCT03585452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92616235|NCT03585452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616237|NCT03585452|Sensory System Agents|sensory system agents|mesh-ancestor
92616238|NCT03585452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616239|NCT03585452|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92616240|NCT03585452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92616241|NCT03585452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92616242|NCT03585452|Adrenergic Agents|adrenergic agents|mesh-ancestor
92616243|NCT03585452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616244|NCT03585452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616245|NCT03585452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92616246|NCT03585452|Anesthetics, General|anesthetics, general|mesh-ancestor
92616247|NCT02947672|Dexamethasone|dexamethasone|mesh-list
92616248|NCT02947672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616249|NCT02947672|Antiemetics|antiemetics|mesh-ancestor
92616250|NCT02947672|Autonomic Agents|autonomic agents|mesh-ancestor
92616251|NCT02947672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616252|NCT02947672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616253|NCT02947672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616254|NCT02947672|Glucocorticoids|glucocorticoids|mesh-ancestor
92616255|NCT02947672|Hormones|hormones|mesh-ancestor
92616256|NCT02947672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616257|NCT02947672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92616258|NCT02947672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616259|NCT03539627|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92616260|NCT03539627|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92616261|NCT03539627|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92616262|NCT03539627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616263|NCT02946268|Ropivacaine|ropivacaine|mesh-list
92616264|NCT02946268|Anesthetics, Local|anesthetics, local|mesh-ancestor
92616265|NCT02946268|Anesthetics|anesthetics|mesh-ancestor
92616266|NCT02946268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616267|NCT02946268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616268|NCT02946268|Sensory System Agents|sensory system agents|mesh-ancestor
92616269|NCT02946268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616270|NCT00168051|Factor VIII|factor viii|mesh-list
92616271|NCT00168051|Coagulants|coagulants|mesh-ancestor
92616272|NCT00526318|Cyclophosphamide|cyclophosphamide|mesh-list
92616273|NCT00526318|Melphalan|melphalan|mesh-list
92616274|NCT00526318|Ifosfamide|ifosfamide|mesh-list
92616275|NCT00526318|Dacarbazine|dacarbazine|mesh-list
92616276|NCT00526318|Carboplatin|carboplatin|mesh-list
92616277|NCT00526318|Doxorubicin|doxorubicin|mesh-list
92616278|NCT00526318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92616279|NCT00526318|Etoposide|etoposide|mesh-list
92616280|NCT00526318|Vincristine|vincristine|mesh-list
92616281|NCT00526318|Topotecan|topotecan|mesh-list
92616282|NCT00526318|Etoposide phosphate|etoposide phosphate|mesh-list
92616283|NCT00526318|Vindesine|vindesine|mesh-list
92616284|NCT00526318|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92616285|NCT00526318|Isotretinoin|isotretinoin|mesh-list
92616286|NCT00526318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616287|NCT00526318|Immunologic Factors|immunologic factors|mesh-ancestor
92616288|NCT00526318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616289|NCT00526318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616290|NCT00526318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92616291|NCT00526318|Alkylating Agents|alkylating agents|mesh-ancestor
92616292|NCT00526318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616293|NCT00526318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616294|NCT00526318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361179|NCT00555048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616295|NCT00526318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92616296|NCT00526318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92616297|NCT00526318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92537253|NCT03844412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537254|NCT03844412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92616298|NCT00526318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616299|NCT00526318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92616300|NCT00526318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616301|NCT00526318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92616302|NCT00526318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92616310|NCT04693312|Prednisolone acetate|prednisolone acetate|mesh-list
92616311|NCT04693312|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92616312|NCT04693312|Prednisolone phosphate|prednisolone phosphate|mesh-list
92616313|NCT04693312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616314|NCT04693312|Antiemetics|antiemetics|mesh-ancestor
92616315|NCT04693312|Autonomic Agents|autonomic agents|mesh-ancestor
92616316|NCT04693312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616317|NCT04693312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616318|NCT04693312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616319|NCT04693312|Glucocorticoids|glucocorticoids|mesh-ancestor
92616320|NCT04693312|Hormones|hormones|mesh-ancestor
92616321|NCT04693312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616322|NCT04693312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92616323|NCT04693312|Protective Agents|protective agents|mesh-ancestor
92616324|NCT04693312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92616325|NCT04693312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616326|NCT00168090|Factor VIII|factor viii|mesh-list
92616327|NCT00168090|Coagulants|coagulants|mesh-ancestor
92616328|NCT00525382|Levocetirizine|levocetirizine|mesh-list
92616329|NCT00525382|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92616330|NCT00525382|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92616331|NCT00525382|Histamine Antagonists|histamine antagonists|mesh-ancestor
92616332|NCT00525382|Histamine Agents|histamine agents|mesh-ancestor
92616333|NCT00525382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616334|NCT00525382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616335|NCT00525382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616336|NCT00526513|Insulin glulisine|insulin glulisine|mesh-list
92616337|NCT00526513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92616338|NCT00526513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616339|NCT00168168|Lenograstim|lenograstim|mesh-list
92616340|NCT00168168|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92616341|NCT00168168|Immunologic Factors|immunologic factors|mesh-ancestor
92616342|NCT00168168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616343|NCT03225755|Hormones|hormones|mesh-list
92616344|NCT03225755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616345|NCT03225755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616346|NCT00525577|Probucol|probucol|mesh-list
92616347|NCT00525577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92616348|NCT00525577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92616349|NCT00525577|Antimetabolites|antimetabolites|mesh-ancestor
92616350|NCT00525577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616351|NCT00525577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92616352|NCT00525577|Antioxidants|antioxidants|mesh-ancestor
92616353|NCT00525577|Protective Agents|protective agents|mesh-ancestor
92616354|NCT00525577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616355|NCT03186755|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92616356|NCT03186755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92616357|NCT03186755|Hyaluronic Acid|hyaluronic acid|mesh-list
92616358|NCT03186755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92616359|NCT03186755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92616360|NCT03186755|Immunologic Factors|immunologic factors|mesh-ancestor
92616361|NCT03186755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616362|NCT03186755|Viscosupplements|viscosupplements|mesh-ancestor
92616363|NCT03186755|Protective Agents|protective agents|mesh-ancestor
92616364|NCT03186755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92616365|NCT03186755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616366|NCT03186755|Analgesics|analgesics|mesh-ancestor
92616367|NCT03186755|Sensory System Agents|sensory system agents|mesh-ancestor
92616368|NCT03186755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616369|NCT03186755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616370|NCT03186755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023277|NCT04842045|Hallucinogens|hallucinogens|mesh-ancestor
92616396|NCT00525694|Dopamine Agents|dopamine agents|mesh-ancestor
92616397|NCT00525694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616398|NCT02947243|Morphine|morphine|mesh-list
92616399|NCT02947243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92616400|NCT02947243|Narcotics|narcotics|mesh-ancestor
92537255|NCT03844412|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92537256|NCT03844412|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92537257|NCT03844412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616401|NCT02947243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616402|NCT02947243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616404|NCT02947243|Sensory System Agents|sensory system agents|mesh-ancestor
92616405|NCT02947243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616406|NCT02946970|Quinine|quinine|mesh-list
92616407|NCT02946970|Antimalarials|antimalarials|mesh-ancestor
92616408|NCT02946970|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92616409|NCT02946970|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92616410|NCT02946970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616411|NCT02946970|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92616412|NCT02946970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616413|NCT02946970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92616414|NCT02946970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616415|NCT02946970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616416|NCT02946970|Analgesics|analgesics|mesh-ancestor
92616417|NCT02946970|Sensory System Agents|sensory system agents|mesh-ancestor
92616418|NCT00527020|Nicotine|nicotine|mesh-list
92616427|NCT00527020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616428|NCT00407277|Nicotine|nicotine|mesh-list
92616429|NCT00407277|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92616430|NCT00407277|Autonomic Agents|autonomic agents|mesh-ancestor
92616431|NCT00407277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616432|NCT00407277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616433|NCT00407277|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92616434|NCT00407277|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92616435|NCT00407277|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616436|NCT00407277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616437|NCT00407277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616438|NCT00527059|Simendan|simendan|mesh-list
92616439|NCT00527059|Spironolactone|spironolactone|mesh-list
92616440|NCT00527059|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92616441|NCT00527059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92616442|NCT00527059|Hormone Antagonists|hormone antagonists|mesh-ancestor
92616443|NCT00527059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616444|NCT00527059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616445|NCT00527059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92616446|NCT00527059|Diuretics|diuretics|mesh-ancestor
92616447|NCT00527059|Natriuretic Agents|natriuretic agents|mesh-ancestor
92616448|NCT00527059|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92616449|NCT00527059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92616450|NCT00527059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616451|NCT00527059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616452|NCT00527059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92616453|NCT00527059|Vasodilator Agents|vasodilator agents|mesh-ancestor
92616454|NCT00527059|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92616455|NCT00527059|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92616456|NCT00527059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616457|NCT00527059|Protective Agents|protective agents|mesh-ancestor
92616458|NCT03156452|Mycophenolic Acid|mycophenolic acid|mesh-list
92616459|NCT03156452|Prednisolone|prednisolone|mesh-list
92616460|NCT03156452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92616461|NCT03156452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616462|NCT03156452|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92616463|NCT03156452|Antitubercular Agents|antitubercular agents|mesh-ancestor
92616464|NCT03156452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616465|NCT03156452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616466|NCT03156452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616467|NCT03156452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616468|NCT03156452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616469|NCT03156452|Glucocorticoids|glucocorticoids|mesh-ancestor
92616470|NCT03156452|Hormones|hormones|mesh-ancestor
92616471|NCT03156452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616472|NCT03156452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616473|NCT03156452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92616474|NCT00525772|Ciclesonide|ciclesonide|mesh-list
92616475|NCT00525772|Glucocorticoids|glucocorticoids|mesh-ancestor
92616476|NCT00525772|Hormones|hormones|mesh-ancestor
92537258|NCT03844412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537259|NCT03844412|Estrogens|estrogens|mesh-ancestor
92537260|NCT03844412|Hormones|hormones|mesh-ancestor
92537261|NCT03844412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616477|NCT00525772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616478|NCT00525772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616479|NCT00525772|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92616480|NCT02945956|Entecavir|entecavir|mesh-list
92616481|NCT02945956|Antiviral Agents|antiviral agents|mesh-ancestor
92616482|NCT02945956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616483|NCT03122639|Atorvastatin|atorvastatin|mesh-list
92616484|NCT03122639|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92616493|NCT02945839|Topiramate|topiramate|mesh-list
92616494|NCT02945839|Anticonvulsants|anticonvulsants|mesh-ancestor
92616495|NCT02945839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92616496|NCT02945839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616497|NCT02957786|Varenicline|varenicline|mesh-list
92616498|NCT02957786|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92616499|NCT02957786|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92616500|NCT02957786|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616501|NCT02957786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616502|NCT02957786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616503|NCT02957786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616504|NCT00407394|Amoxicillin|amoxicillin|mesh-list
92616505|NCT00407394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616506|NCT00407394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616507|NCT03109964|Hemostatics|hemostatics|mesh-list
92616508|NCT03109964|Surgiflo|surgiflo|mesh-list
92616509|NCT03109964|Coagulants|coagulants|mesh-ancestor
92616510|NCT00407433|Gemcitabine|gemcitabine|mesh-list
92616511|NCT00407433|Oxaliplatin|oxaliplatin|mesh-list
92616512|NCT00407433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92616513|NCT00407433|Antimetabolites|antimetabolites|mesh-ancestor
92616514|NCT00407433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616515|NCT00407433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616516|NCT00516412|Everolimus|everolimus|mesh-list
92616517|NCT00516412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92616518|NCT00516412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92616519|NCT00516412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616520|NCT00516412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616521|NCT00516412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616522|NCT00516412|Immunologic Factors|immunologic factors|mesh-ancestor
92616523|NCT00516412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616524|NCT00516412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616525|NCT03058835|Tenofovir|tenofovir|mesh-list
92616526|NCT03058835|Emtricitabine|emtricitabine|mesh-list
92616527|NCT03058835|Antiviral Agents|antiviral agents|mesh-ancestor
92616528|NCT03058835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616529|NCT03058835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92616530|NCT03058835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92616531|NCT03058835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616532|NCT03058835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616533|NCT03058835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92616534|NCT03058835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92616535|NCT00516490|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92616536|NCT00516490|Luteolytic Agents|luteolytic agents|mesh-ancestor
92616537|NCT00516490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92616538|NCT00516490|Contraceptive Agents|contraceptive agents|mesh-ancestor
92616539|NCT00516490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92616540|NCT00516490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616541|NCT00516490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92616542|NCT00516490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92616543|NCT00516490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616544|NCT00516607|Temozolomide|temozolomide|mesh-list
92616545|NCT00516607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92616546|NCT00516607|Alkylating Agents|alkylating agents|mesh-ancestor
92616547|NCT00516607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616548|NCT00516607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616549|NCT00173667|Nifedipine|nifedipine|mesh-list
92616550|NCT00173667|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92023465|NCT03779789|Vortioxetine|vortioxetine|mesh-list
92537262|NCT03844412|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92537263|NCT03844412|Antidepressive Agents|antidepressive agents|mesh-ancestor
92537264|NCT03844412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92537265|NCT03844412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91944938|NCT01601626|Ethambutol|ethambutol|mesh-list
92616552|NCT00173667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616554|NCT00173667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616555|NCT00173667|Vasodilator Agents|vasodilator agents|mesh-ancestor
92616556|NCT00173667|Tocolytic Agents|tocolytic agents|mesh-ancestor
92616557|NCT00173667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92616558|NCT00516685|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92616559|NCT00516685|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92616560|NCT00516685|Immunologic Factors|immunologic factors|mesh-ancestor
92616561|NCT00516685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616562|NCT03016871|Carboplatin|carboplatin|mesh-list
92616563|NCT03016871|Nivolumab|nivolumab|mesh-list
92616564|NCT03016871|Etoposide|etoposide|mesh-list
92616565|NCT03016871|Etoposide phosphate|etoposide phosphate|mesh-list
92616566|NCT03016871|Ifosfamide|ifosfamide|mesh-list
92616567|NCT03016871|Isophosphamide mustard|isophosphamide mustard|mesh-list
92616568|NCT03016871|Podophyllotoxin|podophyllotoxin|mesh-list
92616569|NCT03016871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616570|NCT03016871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616571|NCT03016871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92616572|NCT03016871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616573|NCT03016871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92616574|NCT03016871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92616575|NCT03016871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92616576|NCT03016871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616577|NCT03016871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92616578|NCT03016871|Alkylating Agents|alkylating agents|mesh-ancestor
92616579|NCT03016871|Keratolytic Agents|keratolytic agents|mesh-ancestor
92616580|NCT03016871|Dermatologic Agents|dermatologic agents|mesh-ancestor
92616581|NCT03016871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616582|NCT03016871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92616583|NCT03016871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92616584|NCT03458689|Analgesics|analgesics|mesh-list
92616585|NCT03458689|Sensory System Agents|sensory system agents|mesh-ancestor
92616586|NCT03458689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616587|NCT03458689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616588|NCT00527215|Darbepoetin alfa|darbepoetin alfa|mesh-list
92616589|NCT00527215|Hematinics|hematinics|mesh-ancestor
92616590|NCT00173745|Botulinum Toxins|botulinum toxins|mesh-list
92616591|NCT00173745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92616592|NCT00173745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92616593|NCT00173745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92616594|NCT00173745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616595|NCT00173745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616596|NCT00173745|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616597|NCT00173745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616598|NCT00173745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616599|NCT00173745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92616600|NCT00173745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616601|NCT02945644|Trazodone|trazodone|mesh-list
92616602|NCT02945644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92616603|NCT02945644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92616604|NCT02945644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616605|NCT02945644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616606|NCT02945644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92616607|NCT02945644|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92616608|NCT02945644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92616609|NCT02945644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616610|NCT02945644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616611|NCT02945644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616612|NCT02945644|Serotonin Agents|serotonin agents|mesh-ancestor
92616613|NCT02945644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92616614|NCT02945644|Antidepressive Agents|antidepressive agents|mesh-ancestor
92616615|NCT02460887|Cisplatin|cisplatin|mesh-list
92616616|NCT02460887|Gemcitabine|gemcitabine|mesh-list
92616617|NCT02460887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537266|NCT03844412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92537267|NCT03844412|Adrenergic Agents|adrenergic agents|mesh-ancestor
92537268|NCT03844412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537269|NCT00139633|Carboplatin|carboplatin|mesh-list
92616618|NCT02460887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92616619|NCT02460887|Antimetabolites|antimetabolites|mesh-ancestor
92616620|NCT02460887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616621|NCT02945527|Dexamethasone|dexamethasone|mesh-list
92616622|NCT02945527|Acetazolamide|acetazolamide|mesh-list
92616626|NCT02945527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616627|NCT02945527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616628|NCT02945527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616629|NCT02945527|Glucocorticoids|glucocorticoids|mesh-ancestor
92616630|NCT02945527|Hormones|hormones|mesh-ancestor
92616631|NCT02945527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616632|NCT02945527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92616633|NCT02945527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616634|NCT02945527|Anticonvulsants|anticonvulsants|mesh-ancestor
92616635|NCT02945527|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92616636|NCT02945527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616637|NCT02945527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616638|NCT02945527|Diuretics|diuretics|mesh-ancestor
92616639|NCT02945527|Natriuretic Agents|natriuretic agents|mesh-ancestor
92616640|NCT00168363|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92616641|NCT00168363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92616642|NCT00168363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92616643|NCT00168363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92616644|NCT00168363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92616645|NCT00168363|Adrenergic Agents|adrenergic agents|mesh-ancestor
92616646|NCT00168363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616647|NCT00168363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616648|NCT00168363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616649|NCT02448095|Ponatinib|ponatinib|mesh-list
92616650|NCT02448095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616651|NCT02448095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92616652|NCT02448095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616653|NCT02448095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616654|NCT00168402|Botulinum Toxins|botulinum toxins|mesh-list
92616655|NCT00168402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92616656|NCT00168402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92616657|NCT00168402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92616658|NCT00168402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616659|NCT00168402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616660|NCT00168402|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616661|NCT00168402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616662|NCT00168402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616663|NCT00168402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92616664|NCT00168402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616665|NCT00529594|Etoricoxib|etoricoxib|mesh-list
92616666|NCT00529594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92616667|NCT00529594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616668|NCT00529594|Analgesics|analgesics|mesh-ancestor
92616669|NCT00529594|Sensory System Agents|sensory system agents|mesh-ancestor
92616670|NCT00529594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616671|NCT00529594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616672|NCT00529594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616673|NCT00529594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616674|NCT00529594|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92616675|NCT00529594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92616676|NCT00529594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616677|NCT00529594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616678|NCT00173862|Gemcitabine|gemcitabine|mesh-list
92616679|NCT00173862|Ifosfamide|ifosfamide|mesh-list
92616680|NCT00173862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92616681|NCT00173862|Antimetabolites|antimetabolites|mesh-ancestor
92616682|NCT00173862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616683|NCT00173862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616684|NCT00173862|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92537271|NCT00139711|Docetaxel|docetaxel|mesh-list
92537272|NCT00139711|Irinotecan|irinotecan|mesh-list
92537273|NCT00139711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961906|NCT02485249|Hormones|hormones|mesh-ancestor
92616685|NCT00173862|Alkylating Agents|alkylating agents|mesh-ancestor
92616686|NCT00529750|Atenolol|atenolol|mesh-list
92616687|NCT00529750|Irbesartan|irbesartan|mesh-list
92616688|NCT00529750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92616689|NCT00529750|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92616690|NCT00529750|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92616691|NCT00529750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616692|NCT00529750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92616702|NCT00529867|Lumefantrine|lumefantrine|mesh-list
92616704|NCT00529867|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92616705|NCT00529867|Antimalarials|antimalarials|mesh-ancestor
92616706|NCT00529867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92616707|NCT00529867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92616708|NCT00529867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616709|NCT00168441|Botulinum Toxins|botulinum toxins|mesh-list
92616710|NCT00168441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92616711|NCT00168441|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92616712|NCT00168441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92616713|NCT00168441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616714|NCT00168441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616715|NCT00168441|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616716|NCT00168441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616717|NCT00168441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616718|NCT00168441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92616719|NCT00168441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616720|NCT00168480|Botulinum Toxins|botulinum toxins|mesh-list
92616721|NCT00168480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92616722|NCT00168480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92616723|NCT00168480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92616724|NCT00168480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616725|NCT00168480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616726|NCT00168480|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616727|NCT00168480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616728|NCT00168480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616729|NCT00168480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92616730|NCT00168480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616731|NCT00527449|Carboplatin|carboplatin|mesh-list
92616732|NCT00527449|Docetaxel|docetaxel|mesh-list
92616733|NCT00527449|Epirubicin|epirubicin|mesh-list
92616734|NCT00527449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616735|NCT00527449|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616736|NCT00527449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92616737|NCT00527449|Mitosis Modulators|mitosis modulators|mesh-ancestor
92616738|NCT00527449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616739|NCT00527449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92616740|NCT00527449|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92616741|NCT00527449|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92616742|NCT00527449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616743|NCT00168519|Nitroprusside|nitroprusside|mesh-list
92616744|NCT00168519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92616745|NCT00168519|Vasodilator Agents|vasodilator agents|mesh-ancestor
92616746|NCT00168519|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92616747|NCT00168519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616748|NCT04692376|Cyclosporine|cyclosporine|mesh-list
92616749|NCT04692376|Cyclosporins|cyclosporins|mesh-list
92616750|NCT04692376|Glucocorticoids|glucocorticoids|mesh-list
92616751|NCT04692376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616752|NCT04692376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616753|NCT04692376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616754|NCT04692376|Immunologic Factors|immunologic factors|mesh-ancestor
92616755|NCT04692376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616756|NCT04692376|Antifungal Agents|antifungal agents|mesh-ancestor
92023675|NCT02393625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616769|NCT00527683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616770|NCT00173901|Ceftazidime|ceftazidime|mesh-list
92616771|NCT00173901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537274|NCT00139711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537275|NCT00139711|Antimitotic Agents|antimitotic agents|mesh-ancestor
91961973|NCT05456269|Cytarabine|cytarabine|mesh-list
92616772|NCT00173901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616774|NCT00527761|Docetaxel|docetaxel|mesh-list
92616775|NCT00527761|Temozolomide|temozolomide|mesh-list
92616776|NCT00527761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616777|NCT00527761|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616778|NCT00527761|Antimitotic Agents|antimitotic agents|mesh-ancestor
92616779|NCT00527761|Mitosis Modulators|mitosis modulators|mesh-ancestor
92616780|NCT00527761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616781|NCT00527761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92616782|NCT00527761|Alkylating Agents|alkylating agents|mesh-ancestor
92616783|NCT00527800|Lumefantrine|lumefantrine|mesh-list
92616784|NCT00527800|Artemether|artemether|mesh-list
92616785|NCT00527800|Piperaquine|piperaquine|mesh-list
92616786|NCT00527800|Trimethoprim|trimethoprim|mesh-list
92616787|NCT00527800|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92616788|NCT00527800|Artenimol|artenimol|mesh-list
92616789|NCT00527800|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92616790|NCT00527800|Sulfamethoxazole|sulfamethoxazole|mesh-list
92616791|NCT00527800|Antimalarials|antimalarials|mesh-ancestor
92616792|NCT00527800|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92616793|NCT00527800|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92616794|NCT00527800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616795|NCT00527800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92616796|NCT00527800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92341883|NCT00003437|Hormones|hormones|mesh-ancestor
92616797|NCT00527800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616798|NCT00527800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616799|NCT00527800|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92616800|NCT00527800|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92616801|NCT00527800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92616802|NCT00527800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616803|NCT02945293|Oxycodone|oxycodone|mesh-list
92616804|NCT02945293|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92616805|NCT02945293|Narcotics|narcotics|mesh-ancestor
92616806|NCT02945293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616807|NCT02945293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616808|NCT02945293|Analgesics|analgesics|mesh-ancestor
92616809|NCT02945293|Sensory System Agents|sensory system agents|mesh-ancestor
92616810|NCT02945293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616811|NCT04692415|Insulin Glargine|insulin glargine|mesh-list
92616812|NCT04692415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92616813|NCT04692415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616814|NCT02945215|Rituximab|rituximab|mesh-list
92616815|NCT02945215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616816|NCT02945215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616817|NCT02945215|Immunologic Factors|immunologic factors|mesh-ancestor
92616818|NCT02945215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616819|NCT02945215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616821|NCT00144677|Tacrolimus|tacrolimus|mesh-list
92616822|NCT00144677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616823|NCT00144677|Immunologic Factors|immunologic factors|mesh-ancestor
92616824|NCT00144677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616825|NCT00144677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92616826|NCT00144677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616827|NCT00144677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616828|NCT00144677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616829|NCT00144677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616830|NCT00144677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92616831|NCT00144677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616832|NCT00144677|Antifungal Agents|antifungal agents|mesh-ancestor
92616833|NCT00531076|Bevacizumab|bevacizumab|mesh-list
92616834|NCT00531076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616835|NCT00531076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616836|NCT00531076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92616837|NCT00531076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92616838|NCT00531076|Growth Substances|growth substances|mesh-ancestor
92616839|NCT00531076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616840|NCT00531076|Growth Inhibitors|growth inhibitors|mesh-ancestor
92616841|NCT00531115|Cetuximab|cetuximab|mesh-list
92616842|NCT00531115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616843|NCT00531115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537276|NCT00139711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537277|NCT00139711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616844|NCT00144716|Insect Repellents|insect repellents|mesh-list
92616845|NCT00144716|Protective Agents|protective agents|mesh-ancestor
92616846|NCT00144716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616847|NCT00531193|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
92616848|NCT00531193|SCH 442416|sch 442416|mesh-list
92616849|NCT00531193|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92616850|NCT00531193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92616851|NCT00531193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92616852|NCT00531193|Purinergic Agents|purinergic agents|mesh-ancestor
92616853|NCT00531193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616854|NCT00531193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616855|NCT00531193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616856|NCT00144755|Darbepoetin alfa|darbepoetin alfa|mesh-list
92616857|NCT00144755|Hematinics|hematinics|mesh-ancestor
92616858|NCT00531271|Docetaxel|docetaxel|mesh-list
92616859|NCT00531271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616860|NCT00531271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616861|NCT00531271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92616862|NCT00531271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92616863|NCT00531271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616864|NCT00531310|Fludarabine|fludarabine|mesh-list
92616865|NCT00531310|Busulfan|busulfan|mesh-list
92616866|NCT00531310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616867|NCT00531310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616868|NCT00531310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92616869|NCT00531310|Immunologic Factors|immunologic factors|mesh-ancestor
92616870|NCT00531310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616871|NCT00531310|Alkylating Agents|alkylating agents|mesh-ancestor
92616872|NCT00531310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92616873|NCT00531310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92616875|NCT00407862|Telmisartan|telmisartan|mesh-list
92616876|NCT00407862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92616877|NCT00407862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92616878|NCT00407862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92616879|NCT00407862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92616880|NCT00407862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616881|NCT00527995|Sildenafil Citrate|sildenafil citrate|mesh-list
92616882|NCT00527995|Vasodilator Agents|vasodilator agents|mesh-ancestor
92616883|NCT00527995|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92616884|NCT00527995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92616885|NCT00527995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616886|NCT00527995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616887|NCT00527995|Urological Agents|urological agents|mesh-ancestor
92616888|NCT00144833|Ritonavir|ritonavir|mesh-list
92616889|NCT00144833|Lopinavir|lopinavir|mesh-list
92616890|NCT00144833|Fosamprenavir|fosamprenavir|mesh-list
92616891|NCT00144833|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92616892|NCT00144833|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92616893|NCT00144833|Protease Inhibitors|protease inhibitors|mesh-ancestor
92616903|NCT02944942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616904|NCT02944942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616906|NCT00144872|Anticonvulsants|anticonvulsants|mesh-ancestor
92616907|NCT00144872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92616908|NCT00144872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616909|NCT00144872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616910|NCT00144872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92616911|NCT00144872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616912|NCT00144872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92616913|NCT00144872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92616914|NCT00144872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616915|NCT00144872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92616916|NCT00144872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92616917|NCT02945020|Simeprevir|simeprevir|mesh-list
92616918|NCT02945020|Odalasvir|odalasvir|mesh-list
92616919|NCT02945020|Dabigatran|dabigatran|mesh-list
92616920|NCT02945020|Antithrombins|antithrombins|mesh-ancestor
92616921|NCT02945020|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92361214|NCT00525876|Alkylating Agents|alkylating agents|mesh-ancestor
92537278|NCT00139711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92537279|NCT00139711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92537280|NCT00139711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537281|NCT03837977|Leucovorin|leucovorin|mesh-list
92537282|NCT03837977|Folic Acid|folic acid|mesh-list
92537283|NCT03837977|Docetaxel|docetaxel|mesh-list
92616922|NCT02945020|Protease Inhibitors|protease inhibitors|mesh-ancestor
92616923|NCT02945020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616924|NCT02945020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616925|NCT02945020|Anticoagulants|anticoagulants|mesh-ancestor
92616926|NCT02945020|Antiviral Agents|antiviral agents|mesh-ancestor
92616927|NCT02945020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616928|NCT00528073|Rifaximin|rifaximin|mesh-list
92616929|NCT00528073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616930|NCT00528073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616931|NCT00528073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92616932|NCT00528151|Curcumin|curcumin|mesh-list
92616933|NCT00528151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92616934|NCT00528151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92616935|NCT00528151|Analgesics|analgesics|mesh-ancestor
92616936|NCT00528151|Sensory System Agents|sensory system agents|mesh-ancestor
92616937|NCT00528151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616938|NCT00528151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616939|NCT00528151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616940|NCT00528151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616941|NCT00528151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616942|NCT00528151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616943|NCT00528151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616944|NCT00144911|Fluticasone|fluticasone|mesh-list
92616945|NCT00144911|Xhance|xhance|mesh-list
92616947|NCT00144911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616948|NCT00144911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92616949|NCT00144911|Autonomic Agents|autonomic agents|mesh-ancestor
92616950|NCT00144911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616951|NCT00144911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616952|NCT00144911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92616953|NCT00144911|Respiratory System Agents|respiratory system agents|mesh-ancestor
92616954|NCT00144911|Dermatologic Agents|dermatologic agents|mesh-ancestor
92616955|NCT00144911|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92616956|NCT00144911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92616957|NCT00144911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92616958|NCT00144911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92616959|NCT00144911|Adrenergic Agents|adrenergic agents|mesh-ancestor
92616964|NCT00168597|Micronutrients|micronutrients|mesh-ancestor
92616965|NCT00168597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616966|NCT00528385|Spironolactone|spironolactone|mesh-list
92616967|NCT00528385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92616968|NCT00528385|Hormone Antagonists|hormone antagonists|mesh-ancestor
92616969|NCT00528385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616970|NCT00528385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616971|NCT00528385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92616972|NCT00528385|Diuretics|diuretics|mesh-ancestor
92616973|NCT00528385|Natriuretic Agents|natriuretic agents|mesh-ancestor
92616974|NCT02944981|Gabapentin|gabapentin|mesh-list
92616975|NCT02944981|Analgesics|analgesics|mesh-ancestor
92616976|NCT02944981|Sensory System Agents|sensory system agents|mesh-ancestor
92616977|NCT02944981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616978|NCT02944981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616979|NCT02944981|Anticonvulsants|anticonvulsants|mesh-ancestor
92616980|NCT02944981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92616981|NCT02944981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92616982|NCT02944981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616983|NCT02944981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92616984|NCT02944981|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92616985|NCT02944981|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92616986|NCT02944981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616987|NCT02944981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616988|NCT02944981|Antimanic Agents|antimanic agents|mesh-ancestor
92616989|NCT00168636|Vitamin A|vitamin a|mesh-list
92616990|NCT00168636|Vitamins|vitamins|mesh-ancestor
92616991|NCT00168636|Micronutrients|micronutrients|mesh-ancestor
92537284|NCT03837977|Fluorouracil|fluorouracil|mesh-list
92537286|NCT03837977|Levoleucovorin|levoleucovorin|mesh-list
92537287|NCT03837977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537288|NCT03837977|Tubulin Modulators|tubulin modulators|mesh-ancestor
92616992|NCT00168636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616993|NCT00144989|Cisplatin|cisplatin|mesh-list
92616994|NCT00144989|Irinotecan|irinotecan|mesh-list
92616995|NCT00144989|Etoposide|etoposide|mesh-list
92616996|NCT00144989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616997|NCT00144989|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92616998|NCT00144989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92616999|NCT00144989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617000|NCT00144989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617001|NCT00144989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92617002|NCT00144989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617003|NCT00528502|Lidocaine|lidocaine|mesh-list
92617004|NCT00528502|Anesthetics, Local|anesthetics, local|mesh-ancestor
92617005|NCT00528502|Anesthetics|anesthetics|mesh-ancestor
92617006|NCT00528502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617007|NCT00528502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617008|NCT00528502|Sensory System Agents|sensory system agents|mesh-ancestor
92617009|NCT00528502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617010|NCT00528502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92617011|NCT00528502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92617012|NCT00528502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92617013|NCT00528502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617014|NCT00528502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617015|NCT00528619|Carboplatin|carboplatin|mesh-list
92617016|NCT00528619|Pemetrexed|pemetrexed|mesh-list
92617017|NCT00528619|Sunitinib|sunitinib|mesh-list
92617018|NCT00528619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342110|NCT00003173|Thiotepa|thiotepa|mesh-list
92617019|NCT00528619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617020|NCT00528619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617021|NCT00528619|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92617022|NCT00528619|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92617023|NCT00528619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92617024|NCT00528619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92617025|NCT00528619|Growth Substances|growth substances|mesh-ancestor
92617026|NCT00528619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617027|NCT00528619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92617028|NCT00528619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92617029|NCT00168714|Interferons|interferons|mesh-list
92617033|NCT00168714|Antiviral Agents|antiviral agents|mesh-ancestor
92617034|NCT00168714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617035|NCT00168714|Immunologic Factors|immunologic factors|mesh-ancestor
92617036|NCT00168714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617037|NCT00168714|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92617038|NCT00528658|Acetaminophen|acetaminophen|mesh-list
92617039|NCT00528658|Ibuprofen|ibuprofen|mesh-list
92617040|NCT00528658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617041|NCT00528658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617042|NCT00528658|Analgesics|analgesics|mesh-ancestor
92617043|NCT00528658|Sensory System Agents|sensory system agents|mesh-ancestor
92617044|NCT00528658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617045|NCT00528658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617046|NCT00528658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617047|NCT00528658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617048|NCT00528658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617049|NCT00528658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617050|NCT00528658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617051|NCT00528658|Antipyretics|antipyretics|mesh-ancestor
92617052|NCT00145028|Carboplatin|carboplatin|mesh-list
92617053|NCT00145028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617054|NCT00528814|Hand Sanitizers|hand sanitizers|mesh-list
92617055|NCT00528814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92617056|NCT00528814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617057|NCT00528814|Disinfectants|disinfectants|mesh-ancestor
92617058|NCT00168753|Alefacept|alefacept|mesh-list
92617059|NCT00168753|Dermatologic Agents|dermatologic agents|mesh-ancestor
92617060|NCT00168753|Immunologic Factors|immunologic factors|mesh-ancestor
92537289|NCT03837977|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537290|NCT03837977|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537291|NCT03837977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962344|NCT05070195|Midazolam|midazolam|mesh-list
92617061|NCT00168753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617062|NCT00528892|Raltegravir Potassium|raltegravir potassium|mesh-list
92617063|NCT00528892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92617064|NCT00528892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92617065|NCT00528892|Antiviral Agents|antiviral agents|mesh-ancestor
92617066|NCT00528892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617067|NCT00528892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92617068|NCT00528892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92617069|NCT00528892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617070|NCT00528892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617071|NCT00531349|Propofol|propofol|mesh-list
92617072|NCT00531349|Sevoflurane|sevoflurane|mesh-list
92617073|NCT00531349|Anesthetics|anesthetics|mesh-ancestor
92617074|NCT00531349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617075|NCT00531349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617076|NCT00531349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92617077|NCT00531349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92617078|NCT00531349|Anesthetics, General|anesthetics, general|mesh-ancestor
92617079|NCT00531349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92617080|NCT00531349|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92617081|NCT00531466|Tolperisone|tolperisone|mesh-list
92617082|NCT00531466|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92617083|NCT00531466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617084|NCT00531466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92617085|NCT00531466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617086|NCT00168792|Tenecteplase|tenecteplase|mesh-list
92617087|NCT00168792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92617088|NCT00168792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92617089|NCT00168792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617090|NCT00531544|Sunitinib|sunitinib|mesh-list
92617091|NCT00531544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617092|NCT00531544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92617093|NCT00531544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92617094|NCT00531544|Growth Substances|growth substances|mesh-ancestor
92617095|NCT00531544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617096|NCT00531544|Growth Inhibitors|growth inhibitors|mesh-ancestor
92617097|NCT00531544|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92617098|NCT00531544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617099|NCT00531544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617100|NCT00145106|Minocycline|minocycline|mesh-list
92617101|NCT00145106|Tazarotene|tazarotene|mesh-list
92617102|NCT00145106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92617103|NCT00145106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617105|NCT00145106|Keratolytic Agents|keratolytic agents|mesh-ancestor
92617107|NCT00145184|Vitamin B Complex|vitamin b complex|mesh-list
92617108|NCT00145184|Micronutrients|micronutrients|mesh-ancestor
92617109|NCT00145184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617110|NCT02944357|Cisplatin|cisplatin|mesh-list
92617111|NCT02944357|Gemcitabine|gemcitabine|mesh-list
92617112|NCT02944357|Vaccines|vaccines|mesh-list
92617113|NCT02944357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617114|NCT02944357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617115|NCT02944357|Antimetabolites|antimetabolites|mesh-ancestor
92617116|NCT02944357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617117|NCT02944357|Immunologic Factors|immunologic factors|mesh-ancestor
92617118|NCT02944357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617119|NCT02944396|Paclitaxel|paclitaxel|mesh-list
92617120|NCT02944396|Carboplatin|carboplatin|mesh-list
92617121|NCT02944396|Nivolumab|nivolumab|mesh-list
92617122|NCT02944396|Pemetrexed|pemetrexed|mesh-list
92617123|NCT02944396|Veliparib|veliparib|mesh-list
92617124|NCT02944396|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92617125|NCT02944396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617126|NCT02944396|Tubulin Modulators|tubulin modulators|mesh-ancestor
92617127|NCT02944396|Antimitotic Agents|antimitotic agents|mesh-ancestor
92617128|NCT02944396|Mitosis Modulators|mitosis modulators|mesh-ancestor
92617129|NCT02944396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617130|NCT02944396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537292|NCT03837977|Antimetabolites|antimetabolites|mesh-ancestor
92537293|NCT03837977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92537294|NCT03837977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537295|NCT03837977|Immunologic Factors|immunologic factors|mesh-ancestor
92537296|NCT03837977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537297|NCT03837977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92537298|NCT03837977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92537299|NCT03837977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537300|NCT03837977|Antidotes|antidotes|mesh-ancestor
92537301|NCT03837977|Protective Agents|protective agents|mesh-ancestor
92617131|NCT02944396|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92617132|NCT02944396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617133|NCT02944396|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92617134|NCT02944396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92617135|NCT02944396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92617136|NCT00174174|Modafinil|modafinil|mesh-list
92617137|NCT00174174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92617138|NCT00174174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617139|NCT00174174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92617140|NCT00174174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92617141|NCT00174174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92617142|NCT00174174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617143|NCT00530101|Doxorubicin|doxorubicin|mesh-list
92617144|NCT00530101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92617145|NCT00530101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617146|NCT00530101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617147|NCT00530101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617148|NCT00530101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617149|NCT00530101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617150|NCT00530140|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92617151|NCT00530140|Immunologic Factors|immunologic factors|mesh-ancestor
92617152|NCT00530140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617153|NCT02944552|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92617154|NCT02944552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92617155|NCT02944552|Antimetabolites|antimetabolites|mesh-ancestor
92617156|NCT02944552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617157|NCT02944552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92617158|NCT00145301|Lumiracoxib|lumiracoxib|mesh-list
92617159|NCT00145301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92617160|NCT00145301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617161|NCT00145301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617162|NCT00145301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617163|NCT00145301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617164|NCT00145301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617165|NCT00145301|Analgesics|analgesics|mesh-ancestor
92617166|NCT00145301|Sensory System Agents|sensory system agents|mesh-ancestor
92617167|NCT00145301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617168|NCT00145301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617169|NCT00145301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617170|NCT00145301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617171|NCT00168870|Gemcitabine|gemcitabine|mesh-list
92617172|NCT00168870|Treosulfan|treosulfan|mesh-list
92617173|NCT00168870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617174|NCT00168870|Antimetabolites|antimetabolites|mesh-ancestor
92617175|NCT00168870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024078|NCT05518513|Bupivacaine|bupivacaine|mesh-list
92617181|NCT02944201|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92617182|NCT02944201|Adrenergic Agents|adrenergic agents|mesh-ancestor
92617183|NCT02944201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617184|NCT02944201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617185|NCT02944201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617186|NCT02944201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92617187|NCT02944201|Antioxidants|antioxidants|mesh-ancestor
92537302|NCT03837977|Vitamin B Complex|vitamin b complex|mesh-ancestor
92537303|NCT03837977|Vitamins|vitamins|mesh-ancestor
92537304|NCT03837977|Micronutrients|micronutrients|mesh-ancestor
92537305|NCT03837977|Hematinics|hematinics|mesh-ancestor
92617188|NCT02944201|Protective Agents|protective agents|mesh-ancestor
92617189|NCT02944201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92617190|NCT02944201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617191|NCT02944201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92617192|NCT02944201|Vasodilator Agents|vasodilator agents|mesh-ancestor
92617193|NCT02944201|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92617194|NCT02944201|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92617195|NCT00145340|Pioglitazone|pioglitazone|mesh-list
92617196|NCT00145340|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617197|NCT00145340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617198|NCT00168909|Alfacalcidol|alfacalcidol|mesh-list
92617199|NCT00168909|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92617200|NCT00168909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92617201|NCT00168909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617202|NCT00168909|Vitamins|vitamins|mesh-ancestor
92617203|NCT00168909|Micronutrients|micronutrients|mesh-ancestor
92617204|NCT00145379|Metformin|metformin|mesh-list
92617205|NCT00145379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617206|NCT00145379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617207|NCT00168948|Pyrimethamine|pyrimethamine|mesh-list
92617208|NCT00168948|Antimalarials|antimalarials|mesh-ancestor
92617209|NCT00168948|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92617210|NCT00168948|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92617211|NCT00168948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617212|NCT00168948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92617213|NCT00168948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617214|NCT00168948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617215|NCT00530413|Phenobarbital|phenobarbital|mesh-list
92617216|NCT00530413|Anticonvulsants|anticonvulsants|mesh-ancestor
92617217|NCT00530413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92617218|NCT00530413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617219|NCT00530413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617220|NCT00530413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92617221|NCT00530413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92617222|NCT00530413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617223|NCT00530413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617224|NCT00530413|GABA Modulators|gaba modulators|mesh-ancestor
92617225|NCT00530413|GABA Agents|gaba agents|mesh-ancestor
92617226|NCT00530413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92617227|NCT00530413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92617228|NCT00530413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92617229|NCT00174330|Amlodipine|amlodipine|mesh-list
92617230|NCT00174330|Atorvastatin|atorvastatin|mesh-list
92617231|NCT00174330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92617232|NCT00174330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92617233|NCT00174330|Antimetabolites|antimetabolites|mesh-ancestor
92617234|NCT00174330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617235|NCT00174330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92617236|NCT00174330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92617237|NCT00174330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617238|NCT00174330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92617239|NCT00174330|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92617240|NCT00174330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617241|NCT00174330|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92617242|NCT00174330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342333|NCT00003215|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92617243|NCT00174330|Vasodilator Agents|vasodilator agents|mesh-ancestor
92617246|NCT00531856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617248|NCT00531856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617249|NCT00531856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617250|NCT00531895|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92617251|NCT00531895|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92617252|NCT00531895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92617253|NCT00531895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617254|NCT00531895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537307|NCT00404326|Valproic Acid|valproic acid|mesh-list
92537308|NCT00404326|Anticonvulsants|anticonvulsants|mesh-ancestor
92537309|NCT00404326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537310|NCT00404326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617255|NCT00531895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617256|NCT00531895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617257|NCT00531895|Analgesics|analgesics|mesh-ancestor
92617258|NCT00531895|Sensory System Agents|sensory system agents|mesh-ancestor
92617259|NCT00531895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617260|NCT00531895|Antidepressive Agents|antidepressive agents|mesh-ancestor
92617261|NCT00531895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92617262|NCT00531895|Dopamine Agents|dopamine agents|mesh-ancestor
92617263|NCT02942914|Insulin Glargine|insulin glargine|mesh-list
92617264|NCT02942914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617265|NCT02942914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617266|NCT00169026|Antipsychotic Agents|antipsychotic agents|mesh-list
92617267|NCT00169026|Clozapine|clozapine|mesh-list
92617268|NCT00169026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92617269|NCT00169026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617270|NCT00169026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617271|NCT00169026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92617272|NCT00169026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92617273|NCT00169026|Serotonin Agents|serotonin agents|mesh-ancestor
92617274|NCT00169026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617275|NCT00169026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617276|NCT00169026|GABA Antagonists|gaba antagonists|mesh-ancestor
92617277|NCT00169026|GABA Agents|gaba agents|mesh-ancestor
92617278|NCT00145613|Antibodies|antibodies|mesh-list
92617279|NCT00145613|Immunologic Factors|immunologic factors|mesh-ancestor
92617280|NCT00145613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617281|NCT00531973|Doxorubicin|doxorubicin|mesh-list
92617282|NCT00531973|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92617283|NCT00531973|Epirubicin|epirubicin|mesh-list
92617284|NCT00531973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92617285|NCT00531973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617286|NCT00531973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617287|NCT00531973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617288|NCT00531973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617289|NCT00531973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617290|NCT00145652|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92617291|NCT00145652|Hematinics|hematinics|mesh-ancestor
92617292|NCT00174486|Tadalafil|tadalafil|mesh-list
92617293|NCT00174486|Vasodilator Agents|vasodilator agents|mesh-ancestor
92617294|NCT00174486|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92617295|NCT00174486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92617296|NCT00174486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617297|NCT00174486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617298|NCT00174486|Urological Agents|urological agents|mesh-ancestor
92617299|NCT00145691|Oxcarbazepine|oxcarbazepine|mesh-list
92617300|NCT00145691|Anticonvulsants|anticonvulsants|mesh-ancestor
92617301|NCT00145691|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92617302|NCT00145691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92617303|NCT00145691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617304|NCT00145691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617305|NCT00145691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92617306|NCT00145691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92617307|NCT05319340|Anticoagulants|anticoagulants|mesh-list
92617308|NCT05319301|Melatonin|melatonin|mesh-list
92617309|NCT05319301|Antioxidants|antioxidants|mesh-ancestor
92617310|NCT05319301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617311|NCT05319301|Protective Agents|protective agents|mesh-ancestor
92617312|NCT05319301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617313|NCT05319301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617314|NCT00169065|Olanzapine|olanzapine|mesh-list
92617315|NCT00169065|Clozapine|clozapine|mesh-list
92617327|NCT00169065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617328|NCT00169065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617329|NCT00169065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617330|NCT00169065|Serotonin Agents|serotonin agents|mesh-ancestor
92617331|NCT00169065|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92537312|NCT00404326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537313|NCT00404326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537314|NCT00404326|Antimanic Agents|antimanic agents|mesh-ancestor
92537315|NCT00404326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92617332|NCT00169065|GABA Antagonists|gaba antagonists|mesh-ancestor
92617334|NCT00145730|Ibuprofen|ibuprofen|mesh-list
92617335|NCT00145730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617336|NCT00145730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617337|NCT00145730|Analgesics|analgesics|mesh-ancestor
92617338|NCT00145730|Sensory System Agents|sensory system agents|mesh-ancestor
92617339|NCT00145730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617340|NCT00145730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617341|NCT00145730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617342|NCT00145730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617343|NCT00145730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617344|NCT00145730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617345|NCT00145730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617346|NCT00169143|Rituximab|rituximab|mesh-list
92617347|NCT00169143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92617348|NCT00169143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617349|NCT00169143|Immunologic Factors|immunologic factors|mesh-ancestor
92617350|NCT00169143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617351|NCT00169143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617352|NCT02942680|Aspirin|aspirin|mesh-list
92617353|NCT02942680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617354|NCT02942680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617355|NCT02942680|Analgesics|analgesics|mesh-ancestor
92617356|NCT02942680|Sensory System Agents|sensory system agents|mesh-ancestor
92617357|NCT02942680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617358|NCT02942680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617359|NCT02942680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617360|NCT02942680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617361|NCT02942680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92617362|NCT02942680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92617363|NCT02942680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617364|NCT02942680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92617365|NCT02942680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617366|NCT02942680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617367|NCT02942680|Antipyretics|antipyretics|mesh-ancestor
92617368|NCT00174564|Oxaliplatin|oxaliplatin|mesh-list
92617369|NCT00174564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617370|NCT02276911|Ibuprofen|ibuprofen|mesh-list
92617371|NCT02276911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617372|NCT02276911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617373|NCT02276911|Analgesics|analgesics|mesh-ancestor
92617374|NCT02276911|Sensory System Agents|sensory system agents|mesh-ancestor
92617375|NCT02276911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617376|NCT02276911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617377|NCT02276911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617378|NCT02276911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617381|NCT02276911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617382|NCT00145847|Naltrexone|naltrexone|mesh-list
92617383|NCT00145847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92617384|NCT00145847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92617385|NCT00145847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617386|NCT00145847|Sensory System Agents|sensory system agents|mesh-ancestor
92617387|NCT00145847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617388|NCT00169182|Nicotinic Acids|nicotinic acids|mesh-list
92617389|NCT00169182|Niacin|niacin|mesh-list
92617390|NCT00169182|Docetaxel|docetaxel|mesh-list
92617391|NCT00169182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617392|NCT00169182|Tubulin Modulators|tubulin modulators|mesh-ancestor
92617393|NCT00169182|Antimitotic Agents|antimitotic agents|mesh-ancestor
92617394|NCT00169182|Mitosis Modulators|mitosis modulators|mesh-ancestor
92617395|NCT00169182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617396|NCT00169182|Vitamin B Complex|vitamin b complex|mesh-ancestor
92617397|NCT00169182|Vitamins|vitamins|mesh-ancestor
92617398|NCT00169182|Micronutrients|micronutrients|mesh-ancestor
92617399|NCT00169182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617400|NCT00169182|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92537316|NCT00404326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537317|NCT00404326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92537318|NCT00404326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92617401|NCT00169182|Antimetabolites|antimetabolites|mesh-ancestor
92617402|NCT00169182|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92617403|NCT00169182|Vasodilator Agents|vasodilator agents|mesh-ancestor
92617404|NCT02944825|Ciprofloxacin|ciprofloxacin|mesh-list
92617405|NCT02944825|Trimethoprim|trimethoprim|mesh-list
92617406|NCT02944825|Sulfamethoxazole|sulfamethoxazole|mesh-list
92617407|NCT02944825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92617408|NCT02944825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617409|NCT02944825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617410|NCT02944825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617411|NCT02944825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617412|NCT02944825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617413|NCT02944825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617414|NCT02944825|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92617415|NCT02944825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92617416|NCT02944825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92617417|NCT02944825|Antimalarials|antimalarials|mesh-ancestor
92617418|NCT02944825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92617419|NCT02944825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92617420|NCT02944825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92617421|NCT02944825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92617422|NCT02944825|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92617423|NCT02942758|Pioglitazone|pioglitazone|mesh-list
92617424|NCT02942758|Azacitidine|azacitidine|mesh-list
92617426|NCT02942758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617427|NCT02942758|Antimetabolites|antimetabolites|mesh-ancestor
92617428|NCT02942758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617429|NCT02942758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617430|NCT02942758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617431|NCT02942758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617432|NCT02942758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617433|NCT02942758|Keratolytic Agents|keratolytic agents|mesh-ancestor
92617434|NCT02942758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92617435|NCT00145886|Parathyroid Hormone|parathyroid hormone|mesh-list
92617436|NCT00145886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617437|NCT00145886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92617438|NCT00174603|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92617439|NCT00174603|Antidepressive Agents|antidepressive agents|mesh-ancestor
92617440|NCT00174603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92617441|NCT00174603|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92617442|NCT00174603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92617443|NCT00174603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617444|NCT00174603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617445|NCT02942563|Capecitabine|capecitabine|mesh-list
92617446|NCT02942563|Oxaliplatin|oxaliplatin|mesh-list
92617447|NCT02942563|Irinotecan|irinotecan|mesh-list
92617448|NCT02942563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617449|NCT02942563|Antimetabolites|antimetabolites|mesh-ancestor
92617450|NCT02942563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617451|NCT02942563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617452|NCT02942563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92617458|NCT00145925|Indapamide, perindopril drug combination|indapamide, perindopril drug combination|mesh-list
92617459|NCT00145925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92617460|NCT00145925|Protease Inhibitors|protease inhibitors|mesh-ancestor
92617461|NCT00145925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617462|NCT00145925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617463|NCT00145925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92617464|NCT00145925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617465|NCT00145925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617466|NCT00145925|Diuretics|diuretics|mesh-ancestor
92617467|NCT00145925|Natriuretic Agents|natriuretic agents|mesh-ancestor
92617468|NCT00145925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92617469|NCT00145925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617470|NCT00529321|Immunomodulating Agents|immunomodulating agents|mesh-list
92617471|NCT00529321|Immunologic Factors|immunologic factors|mesh-ancestor
92617472|NCT00529321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617473|NCT00169221|Gefitinib|gefitinib|mesh-list
92537319|NCT00404326|Vasodilator Agents|vasodilator agents|mesh-ancestor
92537320|NCT00139750|Varenicline|varenicline|mesh-list
92537321|NCT00139750|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91962820|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
92617474|NCT00169221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617475|NCT00169221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92617476|NCT00169221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617477|NCT00169221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617478|NCT00529360|Clofarabine|clofarabine|mesh-list
92617479|NCT00529360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617480|NCT00529360|Antimetabolites|antimetabolites|mesh-ancestor
92617481|NCT00529360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617482|NCT00529360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617483|NCT00174642|Insulin|insulin|mesh-list
92617484|NCT00174642|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92617485|NCT00174642|Metformin|metformin|mesh-list
92617486|NCT00174642|Insulin Glargine|insulin glargine|mesh-list
92617487|NCT00174642|Insulin glulisine|insulin glulisine|mesh-list
92617488|NCT00174642|Secretagogues|secretagogues|mesh-list
92617489|NCT00174642|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617490|NCT00174642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617491|NCT00174681|Insulin Glargine|insulin glargine|mesh-list
92617492|NCT00174681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617493|NCT00174681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617494|NCT00146042|Erythromycin|erythromycin|mesh-list
92617495|NCT00146042|Erythromycin Estolate|erythromycin estolate|mesh-list
92617496|NCT00146042|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92617497|NCT00146042|Erythromycin stearate|erythromycin stearate|mesh-list
92617498|NCT00146042|Docetaxel|docetaxel|mesh-list
92617499|NCT00146042|Trastuzumab|trastuzumab|mesh-list
92617500|NCT00146042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617501|NCT00146042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92617502|NCT00146042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92617503|NCT00146042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92617504|NCT00146042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617505|NCT00146042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92617506|NCT00146042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92617507|NCT00146042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617508|NCT00146042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617509|NCT00146042|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92617510|NCT00146042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617511|NCT00169299|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92617512|NCT00169299|Medroxyprogesterone|medroxyprogesterone|mesh-list
92617513|NCT00169299|Estrogens|estrogens|mesh-list
92617514|NCT00169299|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92617515|NCT00169299|Hormones|hormones|mesh-ancestor
92617516|NCT00169299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92617517|NCT00169299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617518|NCT00169299|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92617519|NCT00169299|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92617520|NCT00169299|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92617521|NCT00169299|Contraceptive Agents|contraceptive agents|mesh-ancestor
92617522|NCT00169299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92617523|NCT00169299|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92024428|NCT05510323|Hormones|hormones|mesh-ancestor
92617528|NCT02942602|Atorvastatin|atorvastatin|mesh-list
92617529|NCT02942602|Ezetimibe|ezetimibe|mesh-list
92617530|NCT02942602|Cholestyramine Resin|cholestyramine resin|mesh-list
92617531|NCT02942602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92617532|NCT02942602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92617533|NCT02942602|Antimetabolites|antimetabolites|mesh-ancestor
92617534|NCT02942602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617535|NCT02942602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92617536|NCT02942602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92617537|NCT02942602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617538|NCT02942329|Apatinib|apatinib|mesh-list
92617539|NCT02942329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617540|NCT02942329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92617541|NCT02942329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617542|NCT02942329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617543|NCT00174720|Ciclesonide|ciclesonide|mesh-list
92617544|NCT00174720|Glucocorticoids|glucocorticoids|mesh-ancestor
92617545|NCT00174720|Hormones|hormones|mesh-ancestor
92537322|NCT00139750|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92537323|NCT00139750|Cholinergic Agents|cholinergic agents|mesh-ancestor
92537324|NCT00139750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537325|NCT00139750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537326|NCT00139750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944982|NCT02737501|Crizotinib|crizotinib|mesh-list
92617546|NCT00174720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92617547|NCT00174720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617548|NCT00174720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92617549|NCT05318794|Doxorubicin|doxorubicin|mesh-list
92617550|NCT05318794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617551|NCT05318794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92617552|NCT05318794|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617553|NCT05318794|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617554|NCT05318794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617555|NCT05318794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617556|NCT02942212|Nicotine|nicotine|mesh-list
92617557|NCT02942212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92617558|NCT02942212|Autonomic Agents|autonomic agents|mesh-ancestor
92617559|NCT02942212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617560|NCT02942212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617561|NCT02942212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92617562|NCT02942212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92617563|NCT02942212|Cholinergic Agents|cholinergic agents|mesh-ancestor
92617564|NCT02942212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617565|NCT02942212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617566|NCT00146120|Etoposide|etoposide|mesh-list
92617567|NCT00146120|Idarubicin|idarubicin|mesh-list
92617568|NCT00146120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92617569|NCT00146120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617570|NCT00146120|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617571|NCT00146120|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617572|NCT00146120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617573|NCT00146120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617574|NCT00146120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92617575|NCT00146159|Mitoxantrone|mitoxantrone|mesh-list
92617576|NCT00146159|Analgesics|analgesics|mesh-ancestor
92617577|NCT00146159|Sensory System Agents|sensory system agents|mesh-ancestor
92617578|NCT00146159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617579|NCT00146159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617580|NCT00146159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617581|NCT00146159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617582|NCT00146159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617583|NCT00146159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617584|NCT00146159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617585|NCT02276989|Riboflavin|riboflavin|mesh-list
92617586|NCT02276989|Quinine|quinine|mesh-list
92617587|NCT02276989|Acetazolamide|acetazolamide|mesh-list
92617588|NCT02276989|Vitamins|vitamins|mesh-ancestor
92617589|NCT02276989|Micronutrients|micronutrients|mesh-ancestor
92617590|NCT02276989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617591|NCT02276989|Vitamin B Complex|vitamin b complex|mesh-ancestor
92617592|NCT02276989|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92617593|NCT02276989|Dermatologic Agents|dermatologic agents|mesh-ancestor
92617594|NCT02276989|Anticonvulsants|anticonvulsants|mesh-ancestor
92617597|NCT02276989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617598|NCT02276989|Diuretics|diuretics|mesh-ancestor
92617599|NCT02276989|Natriuretic Agents|natriuretic agents|mesh-ancestor
92617600|NCT02276989|Antimalarials|antimalarials|mesh-ancestor
92617601|NCT02276989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92617602|NCT02276989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92617603|NCT02276989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617604|NCT02276989|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92617605|NCT02276989|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92617606|NCT02276989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617607|NCT02276989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617608|NCT02276989|Analgesics|analgesics|mesh-ancestor
92617609|NCT02276989|Sensory System Agents|sensory system agents|mesh-ancestor
92617610|NCT00174759|Clopidogrel|clopidogrel|mesh-list
92537327|NCT00139867|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92537328|NCT00139867|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92537329|NCT00139867|Immunologic Factors|immunologic factors|mesh-ancestor
92537330|NCT00139867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617611|NCT00174759|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92617612|NCT00174759|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92617613|NCT00174759|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92617614|NCT00174759|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92617615|NCT00174759|Purinergic Agents|purinergic agents|mesh-ancestor
92617616|NCT00174759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617617|NCT00174759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617618|NCT00174759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617619|NCT00146237|Phenytoin|phenytoin|mesh-list
92617620|NCT00146237|Anticonvulsants|anticonvulsants|mesh-ancestor
92617621|NCT00146237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92617622|NCT00146237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92617623|NCT00146237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617624|NCT00146237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617625|NCT00146237|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92617626|NCT00146237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92617627|NCT02277067|Misoprostol|misoprostol|mesh-list
92617628|NCT02277067|Carbetocin|carbetocin|mesh-list
92617629|NCT02277067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92617630|NCT02277067|Abortifacient Agents|abortifacient agents|mesh-ancestor
92617631|NCT02277067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92617632|NCT02277067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617633|NCT02277067|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92617634|NCT02277067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617635|NCT02277067|Oxytocics|oxytocics|mesh-ancestor
92617636|NCT00146276|Gemcitabine|gemcitabine|mesh-list
92617637|NCT00146276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617638|NCT00146276|Antimetabolites|antimetabolites|mesh-ancestor
92617639|NCT00146276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617640|NCT00146276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617641|NCT00174798|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92617642|NCT00174798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92617643|NCT00174798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92617644|NCT00174798|Cholinergic Agents|cholinergic agents|mesh-ancestor
92617645|NCT00174798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617646|NCT00174798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617647|NCT00174798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617648|NCT00174798|Urological Agents|urological agents|mesh-ancestor
92617649|NCT02940808|Caffeine|caffeine|mesh-list
92617650|NCT02940808|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92617651|NCT02940808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617652|NCT02940808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92617653|NCT02940808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617654|NCT02940808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617655|NCT02940808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92617656|NCT02940808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92617657|NCT02940808|Purinergic Agents|purinergic agents|mesh-ancestor
92617658|NCT02940808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617659|NCT00169416|Valacyclovir|valacyclovir|mesh-list
92617660|NCT00169416|Antiviral Agents|antiviral agents|mesh-ancestor
92617661|NCT00169416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617662|NCT00174876|Aripiprazole|aripiprazole|mesh-list
92617663|NCT00174876|Antidepressive Agents|antidepressive agents|mesh-ancestor
92617664|NCT00174876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92617665|NCT00174876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92617666|NCT00174876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92617679|NCT00174876|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92617680|NCT00146471|Levetiracetam|levetiracetam|mesh-list
92617681|NCT00146471|Anticonvulsants|anticonvulsants|mesh-ancestor
92617682|NCT00146471|Nootropic Agents|nootropic agents|mesh-ancestor
92617683|NCT00174993|Pioglitazone|pioglitazone|mesh-list
92617684|NCT00174993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617685|NCT00174993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617686|NCT02940379|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92537332|NCT00139867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92537333|NCT00139867|Dopamine Agonists|dopamine agonists|mesh-ancestor
92537334|NCT00139867|Dopamine Agents|dopamine agents|mesh-ancestor
91944987|NCT04848220|APD791|apd791|mesh-list
92617687|NCT02940379|Metoprolol|metoprolol|mesh-list
92617688|NCT02940379|Midazolam|midazolam|mesh-list
92617689|NCT02940379|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92342793|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
92617690|NCT02940379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92617691|NCT02940379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617692|NCT02940379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617694|NCT02940379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92617695|NCT02940379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92617696|NCT02940379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92617697|NCT02940379|Anesthetics, General|anesthetics, general|mesh-ancestor
92617698|NCT02940379|Anesthetics|anesthetics|mesh-ancestor
92617699|NCT02940379|GABA Modulators|gaba modulators|mesh-ancestor
92617700|NCT02940379|GABA Agents|gaba agents|mesh-ancestor
92617701|NCT02940379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617702|NCT02940379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617703|NCT02940379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92617704|NCT02940379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92617705|NCT02940379|Sympatholytics|sympatholytics|mesh-ancestor
92617706|NCT02940379|Autonomic Agents|autonomic agents|mesh-ancestor
92617707|NCT02940379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617708|NCT02940379|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92617709|NCT02940379|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92361243|NCT00527124|Prednisone|prednisone|mesh-list
92617710|NCT02940379|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92617711|NCT02940379|Adrenergic Agents|adrenergic agents|mesh-ancestor
92617712|NCT02940379|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92617713|NCT02940379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92617714|NCT00146549|Paclitaxel|paclitaxel|mesh-list
92617715|NCT00146549|Vinorelbine|vinorelbine|mesh-list
92617716|NCT00146549|Docetaxel|docetaxel|mesh-list
92617717|NCT00146549|Trastuzumab|trastuzumab|mesh-list
92617718|NCT00146549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92617719|NCT00146549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617720|NCT00146549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92617721|NCT00146549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92617722|NCT00146549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92617723|NCT00146549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617724|NCT00146549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92617725|NCT02940535|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92617726|NCT02940535|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92617727|NCT02940535|Menotropins|menotropins|mesh-list
92617729|NCT02940535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92617730|NCT02940535|Contraceptive Agents|contraceptive agents|mesh-ancestor
92617731|NCT02940535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92617732|NCT02940535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617733|NCT02940535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92617734|NCT02940535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92617735|NCT02940535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617736|NCT02940535|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92617737|NCT02940535|Fertility Agents|fertility agents|mesh-ancestor
92617738|NCT00146588|Cyclophosphamide|cyclophosphamide|mesh-list
92617739|NCT00146588|Capecitabine|capecitabine|mesh-list
92617740|NCT00146588|Epirubicin|epirubicin|mesh-list
92617741|NCT00146588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92617742|NCT00146588|Immunologic Factors|immunologic factors|mesh-ancestor
92617743|NCT00146588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617744|NCT00146588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617745|NCT00146588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92617746|NCT00146588|Alkylating Agents|alkylating agents|mesh-ancestor
92617747|NCT00146588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617748|NCT00146588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617749|NCT00146588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92617750|NCT00146588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92617751|NCT00146588|Antimetabolites|antimetabolites|mesh-ancestor
92617752|NCT00146588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92617753|NCT00146588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92617754|NCT00146588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617755|NCT00146588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617756|NCT00175032|Aspirin|aspirin|mesh-list
92617757|NCT00175032|Celecoxib|celecoxib|mesh-list
92617758|NCT00175032|Naproxen|naproxen|mesh-list
92617759|NCT00175032|Lansoprazole|lansoprazole|mesh-list
92617760|NCT00175032|Dexlansoprazole|dexlansoprazole|mesh-list
92617761|NCT00175032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617762|NCT00175032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617763|NCT00175032|Analgesics|analgesics|mesh-ancestor
92617764|NCT00175032|Sensory System Agents|sensory system agents|mesh-ancestor
92342868|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
92617765|NCT00175032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617766|NCT00175032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617767|NCT00175032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617768|NCT00175032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617769|NCT00175032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92617770|NCT00175032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92617771|NCT00175032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617772|NCT00175032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92617773|NCT00175032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617774|NCT00175032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617775|NCT00175032|Antipyretics|antipyretics|mesh-ancestor
92617776|NCT00175032|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92617777|NCT00175032|Gout Suppressants|gout suppressants|mesh-ancestor
92617778|NCT00175032|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92617779|NCT00175032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617780|NCT00175032|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92617781|NCT00146627|Eflornithine|eflornithine|mesh-list
92617782|NCT00146627|Nifurtimox|nifurtimox|mesh-list
92617783|NCT00146627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617784|NCT00146627|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92617785|NCT00146627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92617786|NCT00146627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92617787|NCT00146627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617788|NCT00146627|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92617789|NCT00146627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617790|NCT00146627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617791|NCT00169533|Lapatinib|lapatinib|mesh-list
92617792|NCT00169533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617793|NCT00169533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92617794|NCT00169533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617795|NCT00169533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617796|NCT00424229|Lenalidomide|lenalidomide|mesh-list
92617797|NCT00424229|Immunologic Factors|immunologic factors|mesh-ancestor
92617798|NCT00424229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617799|NCT00424229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92617800|NCT00424229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92617801|NCT00424229|Growth Substances|growth substances|mesh-ancestor
92617819|NCT02944045|Prednisolone acetate|prednisolone acetate|mesh-list
92617820|NCT02944045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92617821|NCT02944045|Prednisolone phosphate|prednisolone phosphate|mesh-list
92617822|NCT02944045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617823|NCT02944045|Antiemetics|antiemetics|mesh-ancestor
92617824|NCT02944045|Autonomic Agents|autonomic agents|mesh-ancestor
92617825|NCT02944045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617826|NCT02944045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617827|NCT02944045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617828|NCT02944045|Glucocorticoids|glucocorticoids|mesh-ancestor
92617829|NCT02944045|Hormones|hormones|mesh-ancestor
92617830|NCT02944045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92617831|NCT02944045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92617832|NCT02944045|Protective Agents|protective agents|mesh-ancestor
92617833|NCT02944045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92617834|NCT02944045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617835|NCT00169572|Dexamethasone|dexamethasone|mesh-list
92617836|NCT00169572|Ondansetron|ondansetron|mesh-list
92617837|NCT00169572|Aprepitant|aprepitant|mesh-list
92617838|NCT00169572|Fosaprepitant|fosaprepitant|mesh-list
92617839|NCT00169572|Casopitant|casopitant|mesh-list
92617840|NCT00169572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617841|NCT00169572|Antiemetics|antiemetics|mesh-ancestor
92617842|NCT00169572|Autonomic Agents|autonomic agents|mesh-ancestor
92617843|NCT00169572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617844|NCT00169572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617845|NCT00169572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617846|NCT00169572|Glucocorticoids|glucocorticoids|mesh-ancestor
92537335|NCT00139867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537336|NCT00139867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537337|NCT03150459|Rifaximin|rifaximin|mesh-list
92617847|NCT00169572|Hormones|hormones|mesh-ancestor
92617848|NCT00169572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92617849|NCT00169572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92617850|NCT00169572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617851|NCT00169572|Antipruritics|antipruritics|mesh-ancestor
92617852|NCT00169572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92617853|NCT00169572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92617854|NCT00169572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92617855|NCT00169572|Serotonin Agents|serotonin agents|mesh-ancestor
92617856|NCT00169572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617857|NCT00169572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617858|NCT00169572|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92617859|NCT00146783|Pyrimethamine|pyrimethamine|mesh-list
92617864|NCT00146783|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92617865|NCT00146783|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92617866|NCT00146783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617867|NCT00146783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92617868|NCT00146783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617869|NCT00146783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617870|NCT00146783|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92617871|NCT00169611|Methylphenidate|methylphenidate|mesh-list
92617872|NCT00169611|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92617873|NCT00169611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617874|NCT00169611|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92617875|NCT00169611|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92617876|NCT00169611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617877|NCT00169611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617878|NCT00169611|Dopamine Agents|dopamine agents|mesh-ancestor
92617879|NCT00169611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617880|NCT02943655|Mefenamic Acid|mefenamic acid|mesh-list
92617881|NCT02943655|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92617882|NCT02943655|Contraceptive Agents|contraceptive agents|mesh-list
92617883|NCT02943655|Medroxyprogesterone|medroxyprogesterone|mesh-list
92617884|NCT02943655|Progesterone|progesterone|mesh-list
92617885|NCT02943655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92617886|NCT02943655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617887|NCT02943655|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92617888|NCT02943655|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92617889|NCT02943655|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92617890|NCT02943655|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92617891|NCT02943655|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92617892|NCT02943655|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92617893|NCT02943655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92617894|NCT02943655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617895|NCT02943655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92617896|NCT02943655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92617897|NCT02943655|Analgesics|analgesics|mesh-ancestor
92617898|NCT02943655|Sensory System Agents|sensory system agents|mesh-ancestor
92617899|NCT02943655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617900|NCT02943655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617901|NCT02943655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617902|NCT02943655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617903|NCT02943655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617904|NCT02943655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617905|NCT02943655|Progestins|progestins|mesh-ancestor
92617906|NCT02943655|Hormones|hormones|mesh-ancestor
92617907|NCT02943655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92617908|NCT05085067|Hyaluronic Acid|hyaluronic acid|mesh-list
92617909|NCT05085067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92617910|NCT05085067|Immunologic Factors|immunologic factors|mesh-ancestor
92617911|NCT05085067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617912|NCT05085067|Viscosupplements|viscosupplements|mesh-ancestor
92617913|NCT05085067|Protective Agents|protective agents|mesh-ancestor
92617914|NCT00175227|Furosemide|furosemide|mesh-list
92617915|NCT00175227|Mannitol|mannitol|mesh-list
92617916|NCT00175227|Diuretics|diuretics|mesh-ancestor
92617917|NCT00175227|Natriuretic Agents|natriuretic agents|mesh-ancestor
92537339|NCT03150459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92537340|NCT03150459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92537341|NCT03150459|Antimetabolites|antimetabolites|mesh-ancestor
92537342|NCT03150459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617918|NCT00175227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617919|NCT00175227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92617920|NCT00175227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617921|NCT00175227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617922|NCT00175227|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92617923|NCT02940262|Edetic Acid|edetic acid|mesh-list
92617924|NCT02940262|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92617925|NCT02940262|Chelating Agents|chelating agents|mesh-ancestor
92617926|NCT02940262|Sequestering Agents|sequestering agents|mesh-ancestor
92617927|NCT02940262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617928|NCT02940262|Anticoagulants|anticoagulants|mesh-ancestor
92617929|NCT02940262|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92617932|NCT00146900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92617933|NCT00146900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92617934|NCT00146900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92617935|NCT00146900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617936|NCT00146900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617937|NCT00146900|Serotonin Agents|serotonin agents|mesh-ancestor
92617938|NCT00146900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617939|NCT02939482|Triamcinolone|triamcinolone|mesh-list
92617940|NCT02939482|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92617941|NCT02939482|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92617942|NCT02939482|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92617943|NCT02939482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617944|NCT02939482|Glucocorticoids|glucocorticoids|mesh-ancestor
92617946|NCT02939482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92617947|NCT02939482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617948|NCT02939482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92617949|NCT02939482|Immunologic Factors|immunologic factors|mesh-ancestor
92617950|NCT02939482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617951|NCT02939482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617952|NCT00175266|Infliximab|infliximab|mesh-list
92617953|NCT00175266|Alemtuzumab|alemtuzumab|mesh-list
92617954|NCT00175266|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92617955|NCT00175266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92617956|NCT00175266|Dermatologic Agents|dermatologic agents|mesh-ancestor
92617957|NCT00175266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617958|NCT00175266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92617959|NCT00175266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92617960|NCT00175266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617961|NCT05013892|Memantine|memantine|mesh-list
92617962|NCT05013892|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92617963|NCT05013892|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92617964|NCT05013892|Dopamine Agents|dopamine agents|mesh-ancestor
92617965|NCT05013892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617966|NCT05013892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617967|NCT05013892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617968|NCT05013892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92617969|NCT05013892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92617970|NCT02939248|Morphine|morphine|mesh-list
92617971|NCT02939248|Naloxone|naloxone|mesh-list
92617972|NCT02939248|Ticagrelor|ticagrelor|mesh-list
92617973|NCT02939248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92617974|NCT02939248|Narcotics|narcotics|mesh-ancestor
92617975|NCT02939248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617976|NCT02939248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617977|NCT02939248|Analgesics|analgesics|mesh-ancestor
92617978|NCT02939248|Sensory System Agents|sensory system agents|mesh-ancestor
92617979|NCT02939248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617980|NCT02939248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92617981|NCT02939248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92617982|NCT02939248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92617983|NCT02939248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92617984|NCT02939248|Purinergic Agents|purinergic agents|mesh-ancestor
92617985|NCT02939248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617986|NCT02939248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343092|NCT00004889|Immunologic Factors|immunologic factors|mesh-ancestor
92617987|NCT02939248|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92617989|NCT02938975|Insect Repellents|insect repellents|mesh-list
92617990|NCT02938975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617991|NCT02938975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617992|NCT02938975|Protective Agents|protective agents|mesh-ancestor
92617993|NCT02938975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617994|NCT02939092|Chlorhexidine|chlorhexidine|mesh-list
92617995|NCT02939092|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92617996|NCT02939092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92617997|NCT02939092|Disinfectants|disinfectants|mesh-ancestor
92617998|NCT00175305|Octreotide|octreotide|mesh-list
92617999|NCT00175305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618000|NCT00175305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92618001|NCT00175305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618011|NCT00407589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618012|NCT00407589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618013|NCT00407589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618014|NCT02938546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92618015|NCT02938546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92618016|NCT02938546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618017|NCT00175383|Hormones|hormones|mesh-list
92618018|NCT00175383|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92618019|NCT00175383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618020|NCT00175383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618021|NCT02938468|Dexamethasone|dexamethasone|mesh-list
92618022|NCT02938468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618023|NCT02938468|Antiemetics|antiemetics|mesh-ancestor
92361253|NCT00527124|Hormones|hormones|mesh-ancestor
92618024|NCT02938468|Autonomic Agents|autonomic agents|mesh-ancestor
92618025|NCT02938468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618026|NCT02938468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618027|NCT02938468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618028|NCT02938468|Glucocorticoids|glucocorticoids|mesh-ancestor
92618029|NCT02938468|Hormones|hormones|mesh-ancestor
92618030|NCT02938468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618031|NCT02938468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92618032|NCT02938468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618033|NCT02938507|Solabegron|solabegron|mesh-list
92618034|NCT02938507|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92618035|NCT02938507|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92618036|NCT02938507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92618037|NCT02938507|Adrenergic Agents|adrenergic agents|mesh-ancestor
92618038|NCT02938507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618039|NCT02938507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618040|NCT02938507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618041|NCT04836910|Metformin|metformin|mesh-list
92618042|NCT04836910|Contraceptive Agents|contraceptive agents|mesh-list
92618043|NCT04836910|Contraceptives, Oral|contraceptives, oral|mesh-list
92618044|NCT04836910|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92618045|NCT04836910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618046|NCT04836910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618047|NCT04836910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92618048|NCT04836910|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92618049|NCT00169728|Vaccines|vaccines|mesh-list
92618050|NCT00169728|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92618051|NCT00169728|Immunologic Factors|immunologic factors|mesh-ancestor
92618052|NCT00169728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618053|NCT00147524|Quinapril|quinapril|mesh-list
92618054|NCT00147524|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92618055|NCT00147524|Protease Inhibitors|protease inhibitors|mesh-ancestor
92618056|NCT00147524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618057|NCT00147524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618058|NCT00147524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618059|NCT00147563|Eplerenone|eplerenone|mesh-list
92343171|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
92618060|NCT00147563|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92618061|NCT00147563|Hormone Antagonists|hormone antagonists|mesh-ancestor
92618062|NCT00147563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618063|NCT00147563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618064|NCT00147563|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92537343|NCT03150459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92537344|NCT03150459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92537346|NCT03150459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944995|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
92618069|NCT02938273|Avelumab|avelumab|mesh-list
92618070|NCT02938273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92618071|NCT02938273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618072|NCT00147602|Atorvastatin|atorvastatin|mesh-list
92618073|NCT00147602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92618074|NCT00147602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92618075|NCT00147602|Antimetabolites|antimetabolites|mesh-ancestor
92618076|NCT00147602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618077|NCT00147602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92618078|NCT00147602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92618079|NCT00147602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618080|NCT02941744|Nivolumab|nivolumab|mesh-list
92618081|NCT02941744|Ipilimumab|ipilimumab|mesh-list
92618082|NCT02941744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92618083|NCT02941744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618084|NCT02941744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92618085|NCT02941744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618086|NCT02941822|Ambroxol|ambroxol|mesh-list
92618087|NCT02941822|Expectorants|expectorants|mesh-ancestor
92618088|NCT02941822|Respiratory System Agents|respiratory system agents|mesh-ancestor
92618089|NCT02941510|Budesonide|budesonide|mesh-list
92618090|NCT02941510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618091|NCT02941510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92618092|NCT02941510|Autonomic Agents|autonomic agents|mesh-ancestor
92618093|NCT02941510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618094|NCT02941510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618095|NCT02941510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92618096|NCT02941510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92618097|NCT02941510|Glucocorticoids|glucocorticoids|mesh-ancestor
92618098|NCT02941510|Hormones|hormones|mesh-ancestor
92618099|NCT02941510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618100|NCT00147680|Paclitaxel|paclitaxel|mesh-list
92618101|NCT00147680|Carboplatin|carboplatin|mesh-list
92618102|NCT00147680|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618103|NCT00147680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618104|NCT00147680|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618105|NCT00147680|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618106|NCT00147680|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618107|NCT00147680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618108|NCT02940184|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92618109|NCT02940184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618110|NCT02940184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618111|NCT02940184|Incretins|incretins|mesh-ancestor
92618112|NCT02940184|Hormones|hormones|mesh-ancestor
92618113|NCT02940184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618114|NCT02940184|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92618115|NCT02940184|Protease Inhibitors|protease inhibitors|mesh-ancestor
92618116|NCT02940184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618117|NCT02940184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618118|NCT03458143|Ketamine|ketamine|mesh-list
92618119|NCT03458143|Remifentanil|remifentanil|mesh-list
92618120|NCT03458143|Analgesics|analgesics|mesh-ancestor
92618121|NCT03458143|Sensory System Agents|sensory system agents|mesh-ancestor
92618122|NCT03458143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618123|NCT03458143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618124|NCT03458143|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92618125|NCT03458143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92618126|NCT03458143|Anesthetics, General|anesthetics, general|mesh-ancestor
92618127|NCT03458143|Anesthetics|anesthetics|mesh-ancestor
92618128|NCT03458143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618129|NCT03458143|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92618130|NCT03458143|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92618131|NCT03458143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618132|NCT03458143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537347|NCT03150459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537348|NCT03150459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618133|NCT03458143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92618134|NCT03458143|Narcotics|narcotics|mesh-ancestor
92618135|NCT02941198|Copper|copper|mesh-list
92618136|NCT02941198|Trace Elements|trace elements|mesh-ancestor
92618139|NCT00147719|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92618140|NCT00147719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92618141|NCT00147719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92618142|NCT00147719|Antimetabolites|antimetabolites|mesh-ancestor
92618143|NCT00147719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618144|NCT00147719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92618145|NCT05273671|Dexmedetomidine|dexmedetomidine|mesh-list
92618146|NCT05273671|Nalbuphine|nalbuphine|mesh-list
92618147|NCT05273671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92618148|NCT05273671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618149|NCT05273671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618150|NCT05273671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618151|NCT05273671|Analgesics|analgesics|mesh-ancestor
92618152|NCT05273671|Sensory System Agents|sensory system agents|mesh-ancestor
92618153|NCT05273671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618154|NCT05273671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92618155|NCT05273671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92618156|NCT05273671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92618157|NCT05273671|Adrenergic Agents|adrenergic agents|mesh-ancestor
92618158|NCT05273671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618159|NCT05273671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618160|NCT05273671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92618161|NCT05273671|Narcotics|narcotics|mesh-ancestor
92618162|NCT00147758|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92618163|NCT00147758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92618164|NCT00147758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92618165|NCT00147758|Antimetabolites|antimetabolites|mesh-ancestor
92406003|NCT04545060|Antiviral Agents|antiviral agents|mesh-ancestor
92618166|NCT00147758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618167|NCT00147758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92618168|NCT02931526|Tigecycline|tigecycline|mesh-list
92618169|NCT02931526|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618170|NCT02931526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618171|NCT02931526|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92618172|NCT02931526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618173|NCT02931526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618174|NCT00169845|Tocopherols|tocopherols|mesh-list
92618175|NCT00169845|Vitamin E|vitamin e|mesh-list
92618176|NCT00169845|alpha-Tocopherol|alpha-tocopherol|mesh-list
92618177|NCT00169845|Beta Carotene|beta carotene|mesh-list
92618178|NCT00169845|Carotenoids|carotenoids|mesh-list
92618179|NCT00169845|Antioxidants|antioxidants|mesh-ancestor
92618180|NCT00169845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618181|NCT00169845|Protective Agents|protective agents|mesh-ancestor
92618182|NCT00169845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618183|NCT00169845|Vitamins|vitamins|mesh-ancestor
92618184|NCT00169845|Micronutrients|micronutrients|mesh-ancestor
92618185|NCT00169845|Provitamins|provitamins|mesh-ancestor
92618186|NCT00147836|Insulin|insulin|mesh-list
92618187|NCT00147836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92618188|NCT00147836|Metformin|metformin|mesh-list
92618189|NCT00147836|Gliclazide|gliclazide|mesh-list
92618190|NCT00147836|Isophane Insulin, Human|isophane insulin, human|mesh-list
92618191|NCT00147836|Insulin, Isophane|insulin, isophane|mesh-list
92618192|NCT00147836|Isophane insulin, beef|isophane insulin, beef|mesh-list
92618193|NCT00147836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618194|NCT00147836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618195|NCT02931136|Huperzine A|huperzine a|mesh-list
92618196|NCT02931136|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92618197|NCT02931136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618198|NCT02931136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618199|NCT02931136|Cholinergic Agents|cholinergic agents|mesh-ancestor
92618200|NCT02931136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618201|NCT02931136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618202|NCT02931136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92618203|NCT02931136|Protective Agents|protective agents|mesh-ancestor
92618204|NCT02931175|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92618205|NCT02931175|Hormones|hormones|mesh-ancestor
92618206|NCT02931175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618207|NCT02931175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537350|NCT00140023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537351|NCT00140023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537352|NCT00140062|Latanoprost|latanoprost|mesh-list
92537353|NCT00140062|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92537354|NCT00140062|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92618208|NCT00147875|Prednisone|prednisone|mesh-list
92618209|NCT00147875|Gemcitabine|gemcitabine|mesh-list
92618210|NCT00147875|Doxorubicin|doxorubicin|mesh-list
92025130|NCT05479357|Oxytocin|oxytocin|mesh-list
92618214|NCT00147875|Antimetabolites|antimetabolites|mesh-ancestor
92618215|NCT00147875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618216|NCT00147875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618217|NCT00147875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92618218|NCT00147875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92618219|NCT00147875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92618220|NCT00147875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618221|NCT00147875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618222|NCT00147875|Glucocorticoids|glucocorticoids|mesh-ancestor
92618223|NCT00147875|Hormones|hormones|mesh-ancestor
92618224|NCT00147875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618225|NCT00147875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618226|NCT00147875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92618227|NCT00147875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618228|NCT00147875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618229|NCT00147875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618230|NCT00147875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618231|NCT00169923|Rosiglitazone|rosiglitazone|mesh-list
92618232|NCT00169923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618233|NCT00169923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618234|NCT00147914|Amoxicillin|amoxicillin|mesh-list
92618235|NCT00147914|Clavulanic Acid|clavulanic acid|mesh-list
92618236|NCT00147914|Clavulanic Acids|clavulanic acids|mesh-list
92618237|NCT00147914|Cefdinir|cefdinir|mesh-list
92361261|NCT00527592|Latanoprost|latanoprost|mesh-list
92618238|NCT00147914|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92618239|NCT00147914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618240|NCT00147914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618241|NCT00147914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92618242|NCT00147914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618243|NCT00147914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618244|NCT00147953|Rituximab|rituximab|mesh-list
92618245|NCT00147953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92618246|NCT00147953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618247|NCT00147953|Immunologic Factors|immunologic factors|mesh-ancestor
92618248|NCT00147953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618249|NCT00147953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618250|NCT02930551|Lidocaine|lidocaine|mesh-list
92618251|NCT02930551|Anesthetics, Local|anesthetics, local|mesh-ancestor
92618252|NCT02930551|Anesthetics|anesthetics|mesh-ancestor
92618253|NCT02930551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618254|NCT02930551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618255|NCT02930551|Sensory System Agents|sensory system agents|mesh-ancestor
92618256|NCT02930551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618257|NCT02930551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92618258|NCT02930551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92618259|NCT02930551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92618260|NCT02930551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618261|NCT02930551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618262|NCT00175617|Minoxidil|minoxidil|mesh-list
92618263|NCT00175617|Spironolactone|spironolactone|mesh-list
92618264|NCT00175617|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92618265|NCT00175617|Hormone Antagonists|hormone antagonists|mesh-ancestor
92618266|NCT00175617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618267|NCT00175617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618268|NCT00175617|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92618269|NCT00175617|Diuretics|diuretics|mesh-ancestor
92618270|NCT00175617|Natriuretic Agents|natriuretic agents|mesh-ancestor
92618271|NCT00175617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618272|NCT00175617|Vasodilator Agents|vasodilator agents|mesh-ancestor
92618273|NCT02930707|Magnesium Sulfate|magnesium sulfate|mesh-list
92537355|NCT00140101|Paclitaxel|paclitaxel|mesh-list
92537356|NCT00140101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92537357|NCT00140101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537358|NCT00140101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537359|NCT00140101|Antimitotic Agents|antimitotic agents|mesh-ancestor
91963667|NCT02462317|Baclofen|baclofen|mesh-list
92618274|NCT02930707|Bupivacaine|bupivacaine|mesh-list
92618275|NCT02930707|Anesthetics, Local|anesthetics, local|mesh-ancestor
92618276|NCT02930707|Anesthetics|anesthetics|mesh-ancestor
92618277|NCT02930707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618278|NCT02930707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618279|NCT02930707|Sensory System Agents|sensory system agents|mesh-ancestor
92618280|NCT02930707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618281|NCT02930707|Analgesics|analgesics|mesh-ancestor
92618291|NCT00148031|Ribavirin|ribavirin|mesh-list
92618292|NCT00148031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618293|NCT00148031|Antiviral Agents|antiviral agents|mesh-ancestor
92618294|NCT00148031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618295|NCT00148031|Antimetabolites|antimetabolites|mesh-ancestor
92618296|NCT00148031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618297|NCT02930473|Psychotropic Drugs|psychotropic drugs|mesh-list
92618298|NCT02930434|Vitamin D|vitamin d|mesh-list
92618299|NCT02930434|Cholecalciferol|cholecalciferol|mesh-list
92618300|NCT02930434|Vitamins|vitamins|mesh-ancestor
92618301|NCT02930434|Micronutrients|micronutrients|mesh-ancestor
92618302|NCT02930434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618303|NCT02930434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92618304|NCT02930434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92618305|NCT00148070|Erythromycin|erythromycin|mesh-list
92618306|NCT00148070|Erythromycin Estolate|erythromycin estolate|mesh-list
92618307|NCT00148070|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92618308|NCT00148070|Erythromycin stearate|erythromycin stearate|mesh-list
92618309|NCT00148070|Docetaxel|docetaxel|mesh-list
92618310|NCT00148070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618311|NCT00148070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618312|NCT00148070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618313|NCT00148070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618314|NCT00148070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618315|NCT00148070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618316|NCT00148070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618317|NCT00148070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618318|NCT00148070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92618319|NCT00148070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618320|NCT00175695|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92618321|NCT00175695|Protein C|protein c|mesh-list
92618322|NCT00175695|Anticoagulants|anticoagulants|mesh-ancestor
92618323|NCT00175695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92618324|NCT00175695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92618325|NCT00175695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618326|NCT00175695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618327|NCT02930317|Factor VIII|factor viii|mesh-list
92618328|NCT02930317|Coagulants|coagulants|mesh-ancestor
92618329|NCT00148148|Amphotericin B|amphotericin b|mesh-list
92618330|NCT00148148|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92618331|NCT00148148|Caspofungin|caspofungin|mesh-list
92618332|NCT00148148|Amebicides|amebicides|mesh-ancestor
92618333|NCT00148148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92618334|NCT00148148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92618335|NCT00148148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618336|NCT00148148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618337|NCT00148148|Antifungal Agents|antifungal agents|mesh-ancestor
92618338|NCT00148148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618339|NCT00148148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618340|NCT00170001|Esomeprazole|esomeprazole|mesh-list
92618341|NCT00170001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92618342|NCT00170001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618343|NCT00170001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92618344|NCT00170001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618345|NCT00170001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618346|NCT00148265|Triamcinolone|triamcinolone|mesh-list
92618347|NCT00148265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618348|NCT00148265|Glucocorticoids|glucocorticoids|mesh-ancestor
92618376|NCT02929888|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91945010|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618377|NCT02929888|Analgesics|analgesics|mesh-ancestor
92618378|NCT02929888|Sensory System Agents|sensory system agents|mesh-ancestor
92618379|NCT02929888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618380|NCT02929888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618381|NCT02929888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618382|NCT02929888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618383|NCT02929888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92618384|NCT02929888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92618385|NCT02929888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618386|NCT02929888|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92618387|NCT02929888|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92618388|NCT02929888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618389|NCT02929888|Antipyretics|antipyretics|mesh-ancestor
92618390|NCT04689412|Resveratrol|resveratrol|mesh-list
92618391|NCT04689412|Antioxidants|antioxidants|mesh-ancestor
92618392|NCT04689412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618393|NCT04689412|Protective Agents|protective agents|mesh-ancestor
92618394|NCT04689412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618395|NCT04689412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618396|NCT04689412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92618412|NCT02929459|Micronutrients|micronutrients|mesh-ancestor
92618413|NCT02929459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618414|NCT02929459|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92618415|NCT02929459|Dermatologic Agents|dermatologic agents|mesh-ancestor
92618416|NCT02929576|Paclitaxel|paclitaxel|mesh-list
92618417|NCT02929576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618418|NCT02929576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618419|NCT02929576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618420|NCT02929576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618421|NCT02929576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618422|NCT02929576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618423|NCT00175812|Tretinoin|tretinoin|mesh-list
92618424|NCT00175812|Theophylline|theophylline|mesh-list
92618425|NCT00175812|Valproic Acid|valproic acid|mesh-list
92618426|NCT00175812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618427|NCT00175812|Keratolytic Agents|keratolytic agents|mesh-ancestor
92618428|NCT00175812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92618429|NCT00175812|Anticonvulsants|anticonvulsants|mesh-ancestor
92618430|NCT00175812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618431|NCT00175812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618432|NCT00175812|GABA Agents|gaba agents|mesh-ancestor
92618433|NCT00175812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618434|NCT00175812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618435|NCT00175812|Antimanic Agents|antimanic agents|mesh-ancestor
92618436|NCT00175812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92618437|NCT00175812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618439|NCT00175812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92618440|NCT00175812|Autonomic Agents|autonomic agents|mesh-ancestor
92618441|NCT00175812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618442|NCT00175812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92618443|NCT00175812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92618444|NCT00175812|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92618445|NCT00175812|Vasodilator Agents|vasodilator agents|mesh-ancestor
92618446|NCT00175812|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92618447|NCT00175812|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92618448|NCT00175812|Purinergic Agents|purinergic agents|mesh-ancestor
92618449|NCT00148499|Benzocaine|benzocaine|mesh-list
92618450|NCT00148499|Ambroxol|ambroxol|mesh-list
92618451|NCT00148499|Anesthetics, Local|anesthetics, local|mesh-ancestor
92618452|NCT00148499|Anesthetics|anesthetics|mesh-ancestor
92618453|NCT00148499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618454|NCT00148499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618455|NCT00148499|Sensory System Agents|sensory system agents|mesh-ancestor
92618456|NCT00148499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618457|NCT00148499|Expectorants|expectorants|mesh-ancestor
92618458|NCT00148499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92618459|NCT03457597|Pioglitazone|pioglitazone|mesh-list
92618466|NCT03457597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618467|NCT03457597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618468|NCT03457597|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92618469|NCT03457597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537361|NCT00140101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618470|NCT03457597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92618471|NCT03457597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92618472|NCT03457597|Anesthetics, General|anesthetics, general|mesh-ancestor
92618474|NCT03457597|GABA Modulators|gaba modulators|mesh-ancestor
92618475|NCT03457597|GABA Agents|gaba agents|mesh-ancestor
92618476|NCT03457597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618477|NCT03457597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618478|NCT03457597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618479|NCT03457597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92618480|NCT03457597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618481|NCT03457597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92618482|NCT03457597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618483|NCT03457597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92618484|NCT03457597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618485|NCT03457597|Sympatholytics|sympatholytics|mesh-ancestor
92618486|NCT03457597|Autonomic Agents|autonomic agents|mesh-ancestor
92618487|NCT03457597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618488|NCT03457597|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92618489|NCT03457597|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92618490|NCT03457597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92618491|NCT03457597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92618492|NCT02929147|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92618493|NCT02929147|Morphine|morphine|mesh-list
92618494|NCT02929147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92618495|NCT02929147|Narcotics|narcotics|mesh-ancestor
92618496|NCT02929147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618497|NCT02929147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618498|NCT02929147|Analgesics|analgesics|mesh-ancestor
92618499|NCT02929147|Sensory System Agents|sensory system agents|mesh-ancestor
92618500|NCT02929147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618501|NCT02929147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92618502|NCT02929147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618503|NCT02929147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618504|NCT02929147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618505|NCT00175890|Levetiracetam|levetiracetam|mesh-list
92618506|NCT00175890|Anticonvulsants|anticonvulsants|mesh-ancestor
92618507|NCT00175890|Nootropic Agents|nootropic agents|mesh-ancestor
92618508|NCT00148616|Memantine|memantine|mesh-list
92618509|NCT00148616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92618510|NCT00148616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92618511|NCT00148616|Dopamine Agents|dopamine agents|mesh-ancestor
92618512|NCT00148616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618513|NCT00148616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618514|NCT00148616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618515|NCT00148616|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92618516|NCT00148616|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92618518|NCT00175929|Anticonvulsants|anticonvulsants|mesh-ancestor
92618519|NCT02928679|Liraglutide|liraglutide|mesh-list
92618520|NCT02928679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618521|NCT02928679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618522|NCT02928679|Incretins|incretins|mesh-ancestor
92618523|NCT02928679|Hormones|hormones|mesh-ancestor
92618524|NCT02928679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618525|NCT02928601|Ondansetron|ondansetron|mesh-list
92618526|NCT02928601|Antiemetics|antiemetics|mesh-ancestor
92618527|NCT02928601|Autonomic Agents|autonomic agents|mesh-ancestor
92618528|NCT02928601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618529|NCT02928601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618530|NCT02928601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618531|NCT02928601|Antipruritics|antipruritics|mesh-ancestor
92618532|NCT02928601|Dermatologic Agents|dermatologic agents|mesh-ancestor
92618546|NCT02928328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618547|NCT02928328|Sensory System Agents|sensory system agents|mesh-ancestor
92618548|NCT02928328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618549|NCT02928328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92618550|NCT02928328|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92618551|NCT02928328|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92618552|NCT02928328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618553|NCT02928328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618554|NCT02928328|Antipruritics|antipruritics|mesh-ancestor
92618555|NCT02928328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92618556|NCT02928328|Anticonvulsants|anticonvulsants|mesh-ancestor
92618557|NCT02928328|Antiemetics|antiemetics|mesh-ancestor
92537363|NCT03150420|Antidotes|antidotes|mesh-ancestor
92537364|NCT03150420|Protective Agents|protective agents|mesh-ancestor
92618558|NCT02928328|Autonomic Agents|autonomic agents|mesh-ancestor
92618559|NCT02928328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618560|NCT02928328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92618561|NCT02928328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92618562|NCT02928328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92618563|NCT02928328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92618564|NCT02928328|GABA Modulators|gaba modulators|mesh-ancestor
92618565|NCT02928328|GABA Agents|gaba agents|mesh-ancestor
92618566|NCT02928328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618567|NCT02928328|Histamine Antagonists|histamine antagonists|mesh-ancestor
92618568|NCT02928328|Histamine Agents|histamine agents|mesh-ancestor
92618569|NCT00148694|Cisplatin|cisplatin|mesh-list
92618570|NCT00148694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618571|NCT00148772|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92618572|NCT00148772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618573|NCT00148772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92618574|NCT00148772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618575|NCT00148772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618576|NCT00176046|Viscum album peptide|viscum album peptide|mesh-list
92618577|NCT00176046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618578|NCT00176046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92618579|NCT00176046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92618580|NCT00176046|Antiviral Agents|antiviral agents|mesh-ancestor
92618581|NCT00176046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618582|NCT02927587|Propofol|propofol|mesh-list
92618583|NCT02927587|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92618584|NCT02927587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618585|NCT02927587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618586|NCT02927587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92618587|NCT02927587|Anesthetics, General|anesthetics, general|mesh-ancestor
92618588|NCT02927587|Anesthetics|anesthetics|mesh-ancestor
92618589|NCT00148850|Pioglitazone|pioglitazone|mesh-list
92618590|NCT00148850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618591|NCT00148850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618593|NCT02927353|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92618594|NCT02927353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618595|NCT02927353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618596|NCT02927509|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92025516|NCT04532645|Olaparib|olaparib|mesh-list
91912318|NCT02157649|Appetite Depressants|appetite depressants|mesh-ancestor
92618600|NCT02927509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618601|NCT02927509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618603|NCT02926885|Hematinics|hematinics|mesh-ancestor
92618604|NCT02926846|Vancomycin|vancomycin|mesh-list
92618605|NCT02926846|Gentamicins|gentamicins|mesh-list
92618606|NCT02926846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618607|NCT02926846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618608|NCT02926846|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92618609|NCT02926846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618610|NCT02926846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618611|NCT02926183|Paclitaxel|paclitaxel|mesh-list
92618612|NCT02926183|Gemcitabine|gemcitabine|mesh-list
92618613|NCT02926183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618614|NCT02926183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618615|NCT02926183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618616|NCT02926183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618617|NCT02926183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618618|NCT02926183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618619|NCT02926183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92618620|NCT02926183|Antimetabolites|antimetabolites|mesh-ancestor
92618621|NCT02925832|Bupivacaine|bupivacaine|mesh-list
92618622|NCT02925832|Ropivacaine|ropivacaine|mesh-list
92618623|NCT02925832|Anesthetics, Local|anesthetics, local|mesh-list
92618624|NCT02925832|Proxymetacaine|proxymetacaine|mesh-list
92618625|NCT02925832|Anesthetics|anesthetics|mesh-list
92618626|NCT02925832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618627|NCT02925832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618628|NCT02925832|Sensory System Agents|sensory system agents|mesh-ancestor
92618629|NCT02925832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618630|NCT00170430|Fluconazole|fluconazole|mesh-list
92618631|NCT00170430|Antifungal Agents|antifungal agents|mesh-ancestor
92618632|NCT00170430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618633|NCT00170430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92537365|NCT03150420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537366|NCT03150420|Antioxidants|antioxidants|mesh-ancestor
92537367|NCT03150420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537368|NCT03150420|Antitubercular Agents|antitubercular agents|mesh-ancestor
92537369|NCT03150420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537370|NCT03150420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537371|NCT03150420|Chelating Agents|chelating agents|mesh-ancestor
92537372|NCT03150420|Sequestering Agents|sequestering agents|mesh-ancestor
92537373|NCT00140218|Pramipexole|pramipexole|mesh-list
92537374|NCT00140218|Antioxidants|antioxidants|mesh-ancestor
92537375|NCT00140218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537376|NCT00140218|Protective Agents|protective agents|mesh-ancestor
92537377|NCT00140218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537378|NCT00140218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92537379|NCT00140218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92537380|NCT00140218|Dopamine Agonists|dopamine agonists|mesh-ancestor
92537381|NCT00140218|Dopamine Agents|dopamine agents|mesh-ancestor
92537382|NCT00140218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537384|NCT00140257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92537385|NCT00140257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92537386|NCT00140257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537387|NCT00140257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537388|NCT00140257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537389|NCT00140257|Serotonin Agents|serotonin agents|mesh-ancestor
92537390|NCT00140257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537391|NCT00140296|Contraceptive Agents|contraceptive agents|mesh-list
92537392|NCT00140296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537393|NCT00140296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537394|NCT00140374|Immunomodulating Agents|immunomodulating agents|mesh-list
92537395|NCT00140374|Immunologic Factors|immunologic factors|mesh-ancestor
92537396|NCT00140374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537397|NCT00140452|Thalidomide|thalidomide|mesh-list
92537398|NCT00140452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537399|NCT00140452|Immunologic Factors|immunologic factors|mesh-ancestor
91945016|NCT03471325|Methamphetamine|methamphetamine|mesh-list
92618634|NCT00170430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92618635|NCT00170430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618636|NCT00170430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361269|NCT00556452|Immunologic Factors|immunologic factors|mesh-ancestor
92537400|NCT00140452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537401|NCT00140452|Leprostatic Agents|leprostatic agents|mesh-ancestor
92537402|NCT00140452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537403|NCT00140452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537404|NCT00140452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92537405|NCT00140452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92537406|NCT00140452|Growth Substances|growth substances|mesh-ancestor
92537407|NCT00140452|Growth Inhibitors|growth inhibitors|mesh-ancestor
92537408|NCT00140452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537409|NCT00140530|Sirolimus|sirolimus|mesh-list
92537410|NCT00140530|Paclitaxel|paclitaxel|mesh-list
92537411|NCT00140530|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92537412|NCT00140530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537413|NCT00140530|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537414|NCT00140530|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537415|NCT00140530|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537416|NCT00140530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537417|NCT00140530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537418|NCT00140530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945048|NCT04984798|Tocopherols|tocopherols|mesh-list
92618637|NCT00170430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92618638|NCT00170430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92618639|NCT00170430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618640|NCT00170430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618641|NCT00170430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92618642|NCT00170430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92618643|NCT00149084|Amoxicillin|amoxicillin|mesh-list
92618644|NCT00149084|Clarithromycin|clarithromycin|mesh-list
92618645|NCT00149084|Lansoprazole|lansoprazole|mesh-list
92618646|NCT00149084|Dexlansoprazole|dexlansoprazole|mesh-list
92618647|NCT00149084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618648|NCT00149084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618649|NCT00149084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92618650|NCT00149084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618651|NCT00149084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618652|NCT00149084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92618653|NCT00149084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92618654|NCT00149084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92618655|NCT00149084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618656|NCT00149084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92618657|NCT00170469|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92618658|NCT00170469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92618659|NCT00170469|Immunologic Factors|immunologic factors|mesh-ancestor
92618660|NCT00170469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618661|NCT00170469|Antacids|antacids|mesh-ancestor
92618662|NCT00170469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618663|NCT00170469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618664|NCT00149123|Hydrocortisone|hydrocortisone|mesh-list
92618665|NCT00149123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618667|NCT00149162|Interleukin-2|interleukin-2|mesh-list
92618668|NCT00149162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618674|NCT00149162|Analgesics|analgesics|mesh-ancestor
92618675|NCT00149162|Sensory System Agents|sensory system agents|mesh-ancestor
92618676|NCT00149162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537419|NCT00140530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92537420|NCT00140530|Antifungal Agents|antifungal agents|mesh-ancestor
92537421|NCT00140530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537422|NCT00140530|Immunologic Factors|immunologic factors|mesh-ancestor
92537423|NCT00140530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537424|NCT00140569|Interferons|interferons|mesh-list
92537425|NCT00140569|Fludarabine|fludarabine|mesh-list
92537426|NCT00140569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537427|NCT00140569|Antiviral Agents|antiviral agents|mesh-ancestor
92537428|NCT00140569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537429|NCT00140647|Rosiglitazone|rosiglitazone|mesh-list
92618677|NCT00149162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618678|NCT00170547|Vaccines|vaccines|mesh-list
92618679|NCT00170547|Immunologic Factors|immunologic factors|mesh-ancestor
92618680|NCT00170547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618681|NCT00149201|Fluorouracil|fluorouracil|mesh-list
92618682|NCT00149201|Antimetabolites|antimetabolites|mesh-ancestor
92618683|NCT00149201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618684|NCT00149201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92618685|NCT00149201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618686|NCT00149201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92618687|NCT00149201|Immunologic Factors|immunologic factors|mesh-ancestor
92618688|NCT00149201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618689|NCT02925559|Dapagliflozin|dapagliflozin|mesh-list
92618690|NCT02925559|Gliclazide|gliclazide|mesh-list
92618691|NCT02925559|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92618692|NCT02925559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618693|NCT02925559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618694|NCT02925559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618695|NCT00149240|Botulinum Toxins|botulinum toxins|mesh-list
92618696|NCT00149240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92618697|NCT00149240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92618698|NCT00149240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92618699|NCT00149240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618700|NCT00149240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618701|NCT00149240|Cholinergic Agents|cholinergic agents|mesh-ancestor
92618702|NCT00149240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618703|NCT00149240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618704|NCT00149240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92618705|NCT00149240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618706|NCT02925247|Anticoagulants|anticoagulants|mesh-list
92618707|NCT00170664|Paclitaxel|paclitaxel|mesh-list
92618708|NCT00170664|Carboplatin|carboplatin|mesh-list
92618709|NCT00170664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618710|NCT00170664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618711|NCT00170664|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618712|NCT00170664|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618713|NCT00170664|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618714|NCT00170664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618715|NCT00170742|Octreotide|octreotide|mesh-list
92618716|NCT00170742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618717|NCT00170742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92618718|NCT00170742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618719|NCT02917525|Vitamin K|vitamin k|mesh-list
92618720|NCT02917525|Vitamin K 2|vitamin k 2|mesh-list
92618721|NCT02917525|Vitamins|vitamins|mesh-ancestor
92618722|NCT02917525|Micronutrients|micronutrients|mesh-ancestor
92618723|NCT02917525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618724|NCT02917525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92618725|NCT02917525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92618726|NCT02917525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618727|NCT02917525|Hemostatics|hemostatics|mesh-ancestor
92618728|NCT02917525|Coagulants|coagulants|mesh-ancestor
92618729|NCT00170781|Lumiracoxib|lumiracoxib|mesh-list
92618730|NCT00170781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92537430|NCT00140647|Ramipril|ramipril|mesh-list
92537431|NCT00140647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92537432|NCT00140647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537433|NCT00140647|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92537434|NCT00140647|Protease Inhibitors|protease inhibitors|mesh-ancestor
92537435|NCT00140647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537436|NCT00140647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537437|NCT00140647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92537438|NCT00140725|Interferons|interferons|mesh-list
92537439|NCT00140725|Interferon-alpha|interferon-alpha|mesh-list
92537440|NCT00140725|Lamivudine|lamivudine|mesh-list
92537441|NCT00140725|Interferon alpha-2|interferon alpha-2|mesh-list
92537442|NCT00140725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537443|NCT00140725|Antiviral Agents|antiviral agents|mesh-ancestor
92537444|NCT00140725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537445|NCT00140725|Immunologic Factors|immunologic factors|mesh-ancestor
92537446|NCT00140725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537447|NCT00140725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92537448|NCT00140725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92618731|NCT00170781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92618732|NCT00170781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618733|NCT00170781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618734|NCT00170781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92618735|NCT00170781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618736|NCT00170781|Analgesics|analgesics|mesh-ancestor
92618737|NCT00170781|Sensory System Agents|sensory system agents|mesh-ancestor
92618738|NCT00170781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025649|NCT02717507|Carvedilol|carvedilol|mesh-list
92618758|NCT02917018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618759|NCT02917018|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92618761|NCT02917018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92618762|NCT02917018|Adrenergic Agents|adrenergic agents|mesh-ancestor
92618763|NCT02917018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618764|NCT02917018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618765|NCT00170859|Everolimus|everolimus|mesh-list
92618766|NCT00170859|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92618767|NCT00170859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92618768|NCT00170859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618769|NCT00170859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618770|NCT00170859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92618771|NCT00170859|Immunologic Factors|immunologic factors|mesh-ancestor
92618772|NCT00170859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618773|NCT00170859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618774|NCT02917057|Exenatide|exenatide|mesh-list
92618775|NCT02917057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92618776|NCT02917057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618777|NCT02917057|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92618778|NCT02917057|Incretins|incretins|mesh-ancestor
92618779|NCT02917057|Hormones|hormones|mesh-ancestor
92618780|NCT02917057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618781|NCT02916940|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
92618782|NCT02916940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618783|NCT02916940|Glucocorticoids|glucocorticoids|mesh-ancestor
92618784|NCT02916940|Hormones|hormones|mesh-ancestor
92537449|NCT00140725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537450|NCT00140725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537451|NCT00140725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92537452|NCT00140725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92537453|NCT00140764|Metronidazole|metronidazole|mesh-list
92537454|NCT00140764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537455|NCT00140764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537456|NCT00140764|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92537457|NCT00140764|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92537458|NCT00138736|Lectins|lectins|mesh-list
92537459|NCT00138736|Agglutinins|agglutinins|mesh-ancestor
92537460|NCT00138736|Immunologic Factors|immunologic factors|mesh-ancestor
92537461|NCT00138736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537462|NCT00138736|Coagulants|coagulants|mesh-ancestor
92537463|NCT00140920|Diclofenac|diclofenac|mesh-list
92537464|NCT00140920|Rofecoxib|rofecoxib|mesh-list
92537465|NCT00140920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92537466|NCT00140920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92537467|NCT00140920|Analgesics|analgesics|mesh-ancestor
92537468|NCT00140920|Sensory System Agents|sensory system agents|mesh-ancestor
92537469|NCT00140920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537470|NCT00140920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537471|NCT00140920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537472|NCT00140920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537473|NCT00140920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92537474|NCT00140920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618785|NCT02916940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618786|NCT02916940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618787|NCT00170898|Lumiracoxib|lumiracoxib|mesh-list
92618788|NCT00170898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92618789|NCT00170898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92618790|NCT00170898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025723|NCT04080869|Vitamin A|vitamin a|mesh-list
92618793|NCT00170898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618795|NCT00170898|Sensory System Agents|sensory system agents|mesh-ancestor
92618796|NCT00170898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618797|NCT00170898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618798|NCT00170898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618799|NCT00170898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618800|NCT02916355|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92618801|NCT02916355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618802|NCT02916511|Paclitaxel|paclitaxel|mesh-list
92618803|NCT02916511|Carboplatin|carboplatin|mesh-list
92618804|NCT02916511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618805|NCT02916511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618806|NCT02916511|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618807|NCT02916511|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618808|NCT02916511|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618809|NCT02916511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618810|NCT00170937|Valsartan|valsartan|mesh-list
92537475|NCT00140920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537476|NCT00140920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92537477|NCT03136497|Rituximab|rituximab|mesh-list
92537478|NCT03136497|Venetoclax|venetoclax|mesh-list
92537479|NCT03136497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537480|NCT03136497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537481|NCT03136497|Immunologic Factors|immunologic factors|mesh-ancestor
92537482|NCT03136497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537483|NCT03136497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537484|NCT00140998|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92537485|NCT00140998|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92537486|NCT00140998|Estradiol|estradiol|mesh-list
92618811|NCT00170937|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92618812|NCT00170937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618813|NCT00170937|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92618814|NCT00170937|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92618815|NCT00170937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618816|NCT00170937|Diuretics|diuretics|mesh-ancestor
92618817|NCT00170937|Natriuretic Agents|natriuretic agents|mesh-ancestor
92618818|NCT00170937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618819|NCT00170937|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92618820|NCT00170937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618821|NCT02916238|Fluoxetine|fluoxetine|mesh-list
92618822|NCT02916238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92618823|NCT02916238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92618824|NCT02916238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618825|NCT02916238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618826|NCT02916238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618827|NCT02916238|Serotonin Agents|serotonin agents|mesh-ancestor
92618828|NCT02916238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618829|NCT02916238|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92618830|NCT02916238|Antidepressive Agents|antidepressive agents|mesh-ancestor
92618831|NCT02916238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92618832|NCT02916238|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92618833|NCT02916238|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92618834|NCT02916238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618835|NCT00149708|Hormones|hormones|mesh-list
92618836|NCT00149708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618837|NCT00149708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618838|NCT00163761|Gemcitabine|gemcitabine|mesh-list
92618839|NCT00163761|Vinorelbine|vinorelbine|mesh-list
92618840|NCT00163761|Ifosfamide|ifosfamide|mesh-list
92618841|NCT00163761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92618842|NCT00163761|Antimetabolites|antimetabolites|mesh-ancestor
92618843|NCT00163761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618844|NCT00163761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618845|NCT00163761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92618846|NCT00163761|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618847|NCT00163761|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618848|NCT00163761|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618849|NCT00163761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92618850|NCT00163761|Alkylating Agents|alkylating agents|mesh-ancestor
92618851|NCT02916160|Valsartan|valsartan|mesh-list
92618852|NCT02916160|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92618853|NCT02916160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618854|NCT02916160|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92618855|NCT02916160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92618856|NCT02916160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618857|NCT02916121|Folic Acid|folic acid|mesh-list
92618858|NCT02916121|Vitamin B 12|vitamin b 12|mesh-list
92537488|NCT00140998|Estrogens|estrogens|mesh-ancestor
92537489|NCT00140998|Hormones|hormones|mesh-ancestor
92537490|NCT00140998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537491|NCT00140998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537492|NCT00140998|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92537493|NCT00140998|Contraceptive Agents|contraceptive agents|mesh-ancestor
92537494|NCT00140998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92537495|NCT00140998|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92537496|NCT00141154|Celecoxib|celecoxib|mesh-list
92537497|NCT00141154|Loxoprofen|loxoprofen|mesh-list
92537498|NCT00141154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92537499|NCT00141154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92537500|NCT00141154|Analgesics|analgesics|mesh-ancestor
92537501|NCT00141154|Sensory System Agents|sensory system agents|mesh-ancestor
91945142|NCT00004907|Busulfan|busulfan|mesh-list
92618862|NCT02916121|Hematinics|hematinics|mesh-ancestor
92618863|NCT02916121|Vitamin B Complex|vitamin b complex|mesh-ancestor
92618864|NCT00170976|Amlodipine|amlodipine|mesh-list
92618865|NCT00170976|Valsartan|valsartan|mesh-list
92618866|NCT00170976|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618867|NCT00170976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92618868|NCT00170976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618869|NCT00170976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618870|NCT00170976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92618871|NCT00170976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618872|NCT00170976|Vasodilator Agents|vasodilator agents|mesh-ancestor
92618873|NCT00170976|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92618874|NCT00170976|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92618875|NCT00149864|Mycophenolic Acid|mycophenolic acid|mesh-list
92618876|NCT00149864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92618877|NCT00149864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618878|NCT00149864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92618879|NCT00149864|Antitubercular Agents|antitubercular agents|mesh-ancestor
92618880|NCT00149864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618881|NCT00149864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618882|NCT00149864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618883|NCT00149864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618884|NCT00149903|Mycophenolic Acid|mycophenolic acid|mesh-list
92618885|NCT00149903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92618886|NCT00149903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618887|NCT00149903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92618888|NCT00149903|Antitubercular Agents|antitubercular agents|mesh-ancestor
92618889|NCT00149903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618890|NCT00149903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618891|NCT00149903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618892|NCT00149903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618893|NCT04688632|Moxifloxacin|moxifloxacin|mesh-list
92618894|NCT04688632|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92618895|NCT04688632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618896|NCT04688632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618897|NCT04688632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92618898|NCT04688632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92618899|NCT04688632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618900|NCT04688632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618901|NCT04688632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618902|NCT04688632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92537502|NCT00141154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537503|NCT00141154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537505|NCT00141154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537506|NCT00141154|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92537507|NCT00141154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92537508|NCT00141154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618903|NCT04688632|Contraceptive Agents|contraceptive agents|mesh-ancestor
92618904|NCT04688632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92618905|NCT04688632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618906|NCT04688632|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92618907|NCT04688632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92618908|NCT04688632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92618909|NCT00171015|Valsartan|valsartan|mesh-list
92618910|NCT00171015|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92618911|NCT00171015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618912|NCT00171015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92618913|NCT00171015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92618914|NCT00171015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618915|NCT00171015|Diuretics|diuretics|mesh-ancestor
92618916|NCT00171015|Natriuretic Agents|natriuretic agents|mesh-ancestor
92618917|NCT00171015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618918|NCT00171015|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92618919|NCT00171015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618920|NCT05786677|Serotonin|serotonin|mesh-list
92618921|NCT05786677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92618922|NCT05786677|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92618923|NCT05786677|Serotonin Agents|serotonin agents|mesh-ancestor
92618924|NCT05786677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618925|NCT05786677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618926|NCT05786677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618927|NCT05786677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92618931|NCT05786612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92618932|NCT05786495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92618933|NCT05786495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618934|NCT05786430|Carboplatin|carboplatin|mesh-list
92618935|NCT05786430|Pemetrexed|pemetrexed|mesh-list
92618936|NCT05786430|Lazertinib|lazertinib|mesh-list
92618937|NCT05786430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618938|NCT05786430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618939|NCT05786430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618940|NCT05786430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92618941|NCT05786430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92618942|NCT05786430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92618943|NCT05786365|Ketamine|ketamine|mesh-list
92618944|NCT05786365|Analgesics|analgesics|mesh-ancestor
92618945|NCT05786365|Sensory System Agents|sensory system agents|mesh-ancestor
92618946|NCT05786365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618947|NCT05786365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618948|NCT05786365|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92618949|NCT05786365|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92618950|NCT05786365|Anesthetics, General|anesthetics, general|mesh-ancestor
92618951|NCT05786365|Anesthetics|anesthetics|mesh-ancestor
92618952|NCT05786365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618953|NCT05786365|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92618954|NCT05786365|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92618955|NCT05786365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618956|NCT05786365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618958|NCT05786339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618959|NCT05786339|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92618960|NCT05786339|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92618961|NCT05786339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618962|NCT05785585|Vitamin B 12|vitamin b 12|mesh-list
92618963|NCT05785585|Hydroxocobalamin|hydroxocobalamin|mesh-list
92618964|NCT05785585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92537509|NCT00141154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537511|NCT03709706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537512|NCT03709706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537513|NCT03709706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945155|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92618965|NCT05785585|Vitamins|vitamins|mesh-ancestor
92618966|NCT05785585|Micronutrients|micronutrients|mesh-ancestor
92618967|NCT05785585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618968|NCT05785585|Hematinics|hematinics|mesh-ancestor
92618969|NCT05785442|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92618970|NCT05785442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618971|NCT05785429|Colchicine|colchicine|mesh-list
92618972|NCT05785429|Gout Suppressants|gout suppressants|mesh-ancestor
92618973|NCT05785429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618974|NCT05785429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92618975|NCT05785429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92618976|NCT05785429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92618977|NCT05785429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618978|NCT05785429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618979|NCT05785377|Bupivacaine|bupivacaine|mesh-list
92618980|NCT05785377|Neostigmine|neostigmine|mesh-list
92618981|NCT05785377|Anesthetics, Local|anesthetics, local|mesh-ancestor
92618982|NCT05785377|Anesthetics|anesthetics|mesh-ancestor
92618983|NCT05785377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618984|NCT05785377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618985|NCT05785377|Sensory System Agents|sensory system agents|mesh-ancestor
92618986|NCT05785377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618987|NCT05785377|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92618988|NCT05785377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618989|NCT05785377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618990|NCT05785377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92618991|NCT05785377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618992|NCT05785377|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92618993|NCT05785377|Autonomic Agents|autonomic agents|mesh-ancestor
92618994|NCT05785325|Bevacizumab|bevacizumab|mesh-list
92618995|NCT05785325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92618996|NCT05785325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618997|NCT05785325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92618998|NCT05785325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92618999|NCT05785325|Growth Substances|growth substances|mesh-ancestor
92619000|NCT05785325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619002|NCT05785234|Sufentanil|sufentanil|mesh-list
92619003|NCT05785234|Remifentanil|remifentanil|mesh-list
92619004|NCT05785234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92619005|NCT05785234|Narcotics|narcotics|mesh-ancestor
92619006|NCT05785234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619007|NCT05785234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619008|NCT05785234|Analgesics|analgesics|mesh-ancestor
92619009|NCT05785234|Sensory System Agents|sensory system agents|mesh-ancestor
92619010|NCT05785234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619011|NCT05785234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92619012|NCT05785234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92619013|NCT05785234|Anesthetics, General|anesthetics, general|mesh-ancestor
92619014|NCT05785234|Anesthetics|anesthetics|mesh-ancestor
92619015|NCT05785208|Osimertinib|osimertinib|mesh-list
92619016|NCT05785208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619017|NCT05785208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92619018|NCT05785208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619019|NCT05785208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619020|NCT05785026|Menthol|menthol|mesh-list
92619021|NCT05785026|Antipruritics|antipruritics|mesh-ancestor
92619022|NCT05785026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92619023|NCT05784987|Rituximab|rituximab|mesh-list
92619024|NCT05784987|Etoposide|etoposide|mesh-list
92619025|NCT05784987|Lenalidomide|lenalidomide|mesh-list
92619026|NCT05784987|Mitoxantrone|mitoxantrone|mesh-list
92619027|NCT05784987|Ifosfamide|ifosfamide|mesh-list
92619028|NCT05784987|Isophosphamide mustard|isophosphamide mustard|mesh-list
92619029|NCT05784987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619030|NCT05784987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537514|NCT03709706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537515|NCT00141193|Celecoxib|celecoxib|mesh-list
92537516|NCT00141193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91964376|NCT03285607|Paclitaxel|paclitaxel|mesh-list
92619031|NCT05784987|Immunologic Factors|immunologic factors|mesh-ancestor
92344141|NCT05480098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619032|NCT05784987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619033|NCT05784987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92619034|NCT05784987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92619035|NCT05784987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92619036|NCT05784987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92619037|NCT05784987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619038|NCT05784987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619039|NCT05784987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92619040|NCT05784987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92619041|NCT05784987|Growth Substances|growth substances|mesh-ancestor
92619042|NCT05784987|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619043|NCT05784987|Analgesics|analgesics|mesh-ancestor
92619044|NCT05784987|Sensory System Agents|sensory system agents|mesh-ancestor
92619045|NCT05784987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619046|NCT05784987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619047|NCT05784987|Alkylating Agents|alkylating agents|mesh-ancestor
92619048|NCT05784870|Ferrous succinate|ferrous succinate|mesh-list
92619049|NCT05784870|Hematinics|hematinics|mesh-ancestor
92619050|NCT05784519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92619051|NCT05784519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92619052|NCT05784467|Methamphetamine|methamphetamine|mesh-list
92619053|NCT05784467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92619054|NCT05784467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619055|NCT05784467|Sympathomimetics|sympathomimetics|mesh-ancestor
92619056|NCT05784467|Autonomic Agents|autonomic agents|mesh-ancestor
92619057|NCT05784467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619058|NCT05784467|Dopamine Agents|dopamine agents|mesh-ancestor
92619059|NCT05784467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619060|NCT05784467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619061|NCT05784467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619062|NCT05784467|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92619063|NCT05784467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619064|NCT05784467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619065|NCT05784467|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92619066|NCT05782894|Remifentanil|remifentanil|mesh-list
92619067|NCT05782894|Propofol|propofol|mesh-list
92619068|NCT05782894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92619069|NCT05782894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619070|NCT05782894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619071|NCT05782894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92619072|NCT05782894|Anesthetics, General|anesthetics, general|mesh-ancestor
92619073|NCT05782894|Anesthetics|anesthetics|mesh-ancestor
92619074|NCT05782894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92619076|NCT05782894|Analgesics|analgesics|mesh-ancestor
92619077|NCT05782894|Sensory System Agents|sensory system agents|mesh-ancestor
92619078|NCT05782894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619079|NCT05782712|Adenosine|adenosine|mesh-list
92619080|NCT05782712|Analgesics|analgesics|mesh-ancestor
92619081|NCT05782712|Sensory System Agents|sensory system agents|mesh-ancestor
92619082|NCT05782712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619083|NCT05782712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619084|NCT05782712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92619085|NCT05782712|Vasodilator Agents|vasodilator agents|mesh-ancestor
92619086|NCT05782712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92619087|NCT05782712|Purinergic Agonists|purinergic agonists|mesh-ancestor
92619088|NCT05782712|Purinergic Agents|purinergic agents|mesh-ancestor
92619089|NCT05782712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619090|NCT05782712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619091|NCT05781516|Prednisolone|prednisolone|mesh-list
92619092|NCT05781516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92619093|NCT05781516|Glucocorticoids|glucocorticoids|mesh-ancestor
92619094|NCT05781516|Hormones|hormones|mesh-ancestor
92619095|NCT05781516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619096|NCT05781516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537517|NCT00141193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92537519|NCT00141193|Sensory System Agents|sensory system agents|mesh-ancestor
92537520|NCT00141193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537521|NCT00141193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537522|NCT00141193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537523|NCT00141193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537524|NCT00141193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92537525|NCT00141193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92537526|NCT00141193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537527|NCT00141193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537528|NCT00141232|Atorvastatin|atorvastatin|mesh-list
92619097|NCT05781516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92619098|NCT05781516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619099|NCT05781321|Temozolomide|temozolomide|mesh-list
92619100|NCT05781321|Levodopa|levodopa|mesh-list
92619101|NCT05781321|Fluorides|fluorides|mesh-list
92619102|NCT05781321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619103|NCT05781321|Alkylating Agents|alkylating agents|mesh-ancestor
92619104|NCT05781321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619105|NCT05781321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619106|NCT05781321|Cariostatic Agents|cariostatic agents|mesh-ancestor
92619107|NCT05781321|Protective Agents|protective agents|mesh-ancestor
92619108|NCT05781321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619109|NCT05781321|Dopamine Agents|dopamine agents|mesh-ancestor
92619110|NCT05781321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619111|NCT05781321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92619112|NCT05781321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92619114|NCT05780437|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92619115|NCT05780437|Antimetabolites|antimetabolites|mesh-ancestor
92619116|NCT05780437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619117|NCT05780437|Antiviral Agents|antiviral agents|mesh-ancestor
92619118|NCT05780437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619119|NCT05780424|Remdesivir|remdesivir|mesh-list
92619120|NCT05780424|Antimetabolites|antimetabolites|mesh-ancestor
92619121|NCT05780424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619122|NCT05780424|Antiviral Agents|antiviral agents|mesh-ancestor
92619123|NCT05780424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619124|NCT05778266|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92619125|NCT05778266|Laxatives|laxatives|mesh-ancestor
92619126|NCT05778266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92619127|NCT05774405|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92619128|NCT05774405|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92619129|NCT05774405|Estradiol|estradiol|mesh-list
92619130|NCT05774405|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92619131|NCT05774405|Estrogens|estrogens|mesh-ancestor
92619132|NCT05774405|Hormones|hormones|mesh-ancestor
92619133|NCT05774405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619134|NCT05774405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619135|NCT05774405|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92619136|NCT05774405|Contraceptive Agents|contraceptive agents|mesh-ancestor
92619137|NCT05774405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92619138|NCT05774405|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92619139|NCT05766683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92619140|NCT05766683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92619141|NCT05766683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92619142|NCT05766683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619143|NCT05766683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619144|NCT05766683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92619145|NCT05766683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619146|NCT05766683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619147|NCT05766683|Cholinergic Agents|cholinergic agents|mesh-ancestor
92619148|NCT05766683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619149|NCT05764941|Vinorelbine|vinorelbine|mesh-list
92619152|NCT05764941|Tubulin Modulators|tubulin modulators|mesh-ancestor
92619153|NCT05764941|Antimitotic Agents|antimitotic agents|mesh-ancestor
92619154|NCT05764941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92619155|NCT05764941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619157|NCT05750017|Immunologic Factors|immunologic factors|mesh-ancestor
92619158|NCT05750017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619159|NCT05734105|Sunitinib|sunitinib|mesh-list
92619160|NCT05734105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619161|NCT05734105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92619162|NCT05734105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92619163|NCT05734105|Growth Substances|growth substances|mesh-ancestor
92619164|NCT05734105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619165|NCT05734105|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619166|NCT05734105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92619167|NCT05734105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619168|NCT05734105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619169|NCT05724316|Vitamin D|vitamin d|mesh-list
92619170|NCT05724316|Cholecalciferol|cholecalciferol|mesh-list
92619171|NCT05724316|Vitamins|vitamins|mesh-ancestor
92619172|NCT05724316|Micronutrients|micronutrients|mesh-ancestor
92619173|NCT05724316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619174|NCT05724316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92619175|NCT05724316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92619176|NCT05723705|Liver Extracts|liver extracts|mesh-list
92619177|NCT05723705|Hematinics|hematinics|mesh-ancestor
92619178|NCT05634577|Pembrolizumab|pembrolizumab|mesh-list
92619179|NCT05634577|Mitotane|mitotane|mesh-list
92619180|NCT05634577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619181|NCT05634577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619182|NCT05634577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619183|NCT05634577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619184|NCT05634577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92619185|NCT05616260|Acetazolamide|acetazolamide|mesh-list
92619186|NCT05616260|Anticonvulsants|anticonvulsants|mesh-ancestor
92619187|NCT05616260|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92619188|NCT05616260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619189|NCT05616260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619190|NCT05616260|Diuretics|diuretics|mesh-ancestor
92619191|NCT05616260|Natriuretic Agents|natriuretic agents|mesh-ancestor
92619192|NCT05616260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619193|NCT05611034|Oxaliplatin|oxaliplatin|mesh-list
92619194|NCT05611034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619195|NCT05592509|Vitamins|vitamins|mesh-list
92619196|NCT05592509|Micronutrients|micronutrients|mesh-ancestor
92619197|NCT05592509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619198|NCT05582213|Anesthetics|anesthetics|mesh-list
92619199|NCT05582213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619200|NCT05582213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619201|NCT05550597|Fentanyl|fentanyl|mesh-list
92619202|NCT05550597|Bupivacaine|bupivacaine|mesh-list
92619203|NCT05550597|Anesthetics, Local|anesthetics, local|mesh-ancestor
92619204|NCT05550597|Anesthetics|anesthetics|mesh-ancestor
92619205|NCT05550597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619206|NCT05550597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619207|NCT05550597|Sensory System Agents|sensory system agents|mesh-ancestor
92619208|NCT05550597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619209|NCT05550597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92619210|NCT05550597|Narcotics|narcotics|mesh-ancestor
92619211|NCT05550597|Analgesics|analgesics|mesh-ancestor
92619212|NCT05550597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92619213|NCT05550597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92619214|NCT05550597|Anesthetics, General|anesthetics, general|mesh-ancestor
92619215|NCT05541276|Melatonin|melatonin|mesh-list
92619216|NCT05541276|Antioxidants|antioxidants|mesh-ancestor
92619217|NCT05541276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619218|NCT05541276|Protective Agents|protective agents|mesh-ancestor
92619219|NCT05541276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619220|NCT05541276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619221|NCT05535764|Interferons|interferons|mesh-list
92619222|NCT05535764|Interferon-alpha|interferon-alpha|mesh-list
92619223|NCT05535764|Interferon alpha-2|interferon alpha-2|mesh-list
92619227|NCT05535764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537529|NCT00141232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92537530|NCT00141232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92537531|NCT00141232|Antimetabolites|antimetabolites|mesh-ancestor
91945173|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92619228|NCT05535764|Immunologic Factors|immunologic factors|mesh-ancestor
92619229|NCT05535764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619230|NCT05495269|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92619231|NCT05495269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92619232|NCT05355935|Moxifloxacin|moxifloxacin|mesh-list
92619233|NCT05355935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92619234|NCT05355935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619235|NCT05355935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92619236|NCT05355935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92619237|NCT05355935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619238|NCT05355935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619239|NCT05355935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619240|NCT05334017|Cocaine|cocaine|mesh-list
92619241|NCT05334017|Xylometazoline|xylometazoline|mesh-list
92619242|NCT05334017|Anesthetics, Local|anesthetics, local|mesh-ancestor
92619243|NCT05334017|Anesthetics|anesthetics|mesh-ancestor
92619244|NCT05334017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619245|NCT05334017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619246|NCT05334017|Sensory System Agents|sensory system agents|mesh-ancestor
92619247|NCT05334017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619248|NCT05334017|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92619249|NCT05334017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92619250|NCT05334017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619251|NCT05334017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619252|NCT05334017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619253|NCT05334017|Dopamine Agents|dopamine agents|mesh-ancestor
92619254|NCT05334017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619255|NCT05334017|Nasal Decongestants|nasal decongestants|mesh-ancestor
92619256|NCT05334017|Respiratory System Agents|respiratory system agents|mesh-ancestor
92619257|NCT05319639|Leucovorin|leucovorin|mesh-list
92619258|NCT05319639|Paclitaxel|paclitaxel|mesh-list
92619259|NCT05319639|Fluorouracil|fluorouracil|mesh-list
92619260|NCT05319639|Oxaliplatin|oxaliplatin|mesh-list
92619261|NCT05319639|Irinotecan|irinotecan|mesh-list
92619262|NCT05319639|Tislelizumab|tislelizumab|mesh-list
92619263|NCT05319639|Levoleucovorin|levoleucovorin|mesh-list
92619264|NCT05319639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92619265|NCT05319639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619266|NCT05319639|Tubulin Modulators|tubulin modulators|mesh-ancestor
92619267|NCT05319639|Antimitotic Agents|antimitotic agents|mesh-ancestor
92619268|NCT05319639|Mitosis Modulators|mitosis modulators|mesh-ancestor
92619269|NCT05319639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619270|NCT05319639|Antimetabolites|antimetabolites|mesh-ancestor
92619271|NCT05319639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619272|NCT05319639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619273|NCT05319639|Immunologic Factors|immunologic factors|mesh-ancestor
92619274|NCT05319639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619275|NCT05319639|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92619276|NCT05319639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92619277|NCT05319639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619278|NCT05319639|Antidotes|antidotes|mesh-ancestor
92619279|NCT05319639|Protective Agents|protective agents|mesh-ancestor
92619280|NCT05319639|Vitamin B Complex|vitamin b complex|mesh-ancestor
92619281|NCT05319639|Vitamins|vitamins|mesh-ancestor
92619282|NCT05319639|Micronutrients|micronutrients|mesh-ancestor
92619283|NCT05319639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619284|NCT05292339|Triamcinolone|triamcinolone|mesh-list
92619285|NCT05292339|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92619286|NCT05292339|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92619287|NCT05292339|Ketorolac|ketorolac|mesh-list
92619288|NCT05292339|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92619289|NCT05292339|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92619290|NCT05292339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92619291|NCT05292339|Glucocorticoids|glucocorticoids|mesh-ancestor
92619292|NCT05292339|Hormones|hormones|mesh-ancestor
92619293|NCT05292339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619294|NCT05292339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619295|NCT05292339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619296|NCT05292339|Immunologic Factors|immunologic factors|mesh-ancestor
92537532|NCT00141232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537533|NCT00141232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92537534|NCT00141232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92537535|NCT00141232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537536|NCT02315534|Temozolomide|temozolomide|mesh-list
92619297|NCT05292339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619304|NCT05292339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92619305|NCT05292339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92619306|NCT05291650|Hyaluronic Acid|hyaluronic acid|mesh-list
92619307|NCT05291650|Glucocorticoids|glucocorticoids|mesh-list
92619308|NCT05291650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92619309|NCT05291650|Immunologic Factors|immunologic factors|mesh-ancestor
92619310|NCT05291650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619311|NCT05291650|Viscosupplements|viscosupplements|mesh-ancestor
92619312|NCT05291650|Protective Agents|protective agents|mesh-ancestor
92619313|NCT05291650|Hormones|hormones|mesh-ancestor
92619314|NCT05291650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619315|NCT05266027|Nalbuphine|nalbuphine|mesh-list
92619316|NCT05266027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92619317|NCT05266027|Narcotics|narcotics|mesh-ancestor
92619318|NCT05266027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619319|NCT05266027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619320|NCT05266027|Analgesics|analgesics|mesh-ancestor
92619321|NCT05266027|Sensory System Agents|sensory system agents|mesh-ancestor
92619322|NCT05266027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619323|NCT05159427|Glipizide|glipizide|mesh-list
92619324|NCT05159427|Rifaximin|rifaximin|mesh-list
92619325|NCT05159427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92619326|NCT05159427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619327|NCT05159427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92619328|NCT05159427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92619329|NCT05159427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619330|NCT05157867|Trypsin Inhibitors|trypsin inhibitors|mesh-list
92619331|NCT05157867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92344466|NCT04723134|Leucovorin|leucovorin|mesh-list
92619332|NCT05157867|Protease Inhibitors|protease inhibitors|mesh-ancestor
92619333|NCT05157867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619334|NCT05157867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619335|NCT05131386|Trabectedin|trabectedin|mesh-list
92619336|NCT05131386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619337|NCT05131386|Alkylating Agents|alkylating agents|mesh-ancestor
92619338|NCT05131386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619339|NCT05131386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619340|NCT05129332|Vitamin E|vitamin e|mesh-list
92619341|NCT05129332|Vitamins|vitamins|mesh-ancestor
92619342|NCT05129332|Micronutrients|micronutrients|mesh-ancestor
92619343|NCT05129332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619344|NCT05129332|Antioxidants|antioxidants|mesh-ancestor
92619345|NCT05129332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619346|NCT05129332|Protective Agents|protective agents|mesh-ancestor
92619347|NCT05111262|Budesonide|budesonide|mesh-list
92619348|NCT05111262|Formoterol Fumarate|formoterol fumarate|mesh-list
92619349|NCT05111262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92619350|NCT05111262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92619351|NCT05111262|Autonomic Agents|autonomic agents|mesh-ancestor
92619352|NCT05111262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619353|NCT05111262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619354|NCT05111262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92619355|NCT05111262|Respiratory System Agents|respiratory system agents|mesh-ancestor
92619356|NCT05111262|Glucocorticoids|glucocorticoids|mesh-ancestor
92619357|NCT05111262|Hormones|hormones|mesh-ancestor
92619358|NCT05111262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619359|NCT05111262|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92619360|NCT05111262|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92619361|NCT05111262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92619362|NCT05111262|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619363|NCT05111262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619364|NCT05111262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619368|NCT05091242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537537|NCT02315534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92537538|NCT02315534|Alkylating Agents|alkylating agents|mesh-ancestor
92537539|NCT02315534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537540|NCT02315534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537541|NCT00141310|Sildenafil Citrate|sildenafil citrate|mesh-list
92537542|NCT00141310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619369|NCT05091242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619370|NCT05091242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92619371|NCT05091242|Sympatholytics|sympatholytics|mesh-ancestor
92619372|NCT05091242|Autonomic Agents|autonomic agents|mesh-ancestor
92619373|NCT05091242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92619374|NCT05091242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92619375|NCT05091242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92619376|NCT05091242|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619377|NCT05091242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619378|NCT05091242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619379|NCT05028140|Pioglitazone|pioglitazone|mesh-list
92619380|NCT05028140|Empagliflozin|empagliflozin|mesh-list
92619381|NCT05028140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92619382|NCT05028140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619383|NCT05028140|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92619384|NCT05028140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619385|NCT05027516|Azithromycin|azithromycin|mesh-list
92619386|NCT05027516|Ceftriaxone|ceftriaxone|mesh-list
92619387|NCT05027516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92619388|NCT05027516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619389|NCT04992013|Niraparib|niraparib|mesh-list
92619390|NCT04992013|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92619391|NCT04992013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619392|NCT04992013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619393|NCT04992013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619394|NCT04969263|Vaccines|vaccines|mesh-list
92619395|NCT04969263|Immunologic Factors|immunologic factors|mesh-ancestor
92619396|NCT04969263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619397|NCT04947124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92619398|NCT04947124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92619399|NCT04933630|Norepinephrine|norepinephrine|mesh-list
92619400|NCT04933630|Serotonin|serotonin|mesh-list
92619401|NCT04933630|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92619402|NCT04933630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92619403|NCT04933630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92619404|NCT04933630|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619405|NCT04933630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619406|NCT04933630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619407|NCT04933630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619408|NCT04933630|Sympathomimetics|sympathomimetics|mesh-ancestor
92344521|NCT04608487|Fludarabine|fludarabine|mesh-list
92619409|NCT04933630|Autonomic Agents|autonomic agents|mesh-ancestor
92619410|NCT04933630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619411|NCT04933630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92619412|NCT04933630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92619413|NCT04933630|Serotonin Agents|serotonin agents|mesh-ancestor
92619414|NCT04933630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619415|NCT04933630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619416|NCT04923841|Atropine|atropine|mesh-list
92619417|NCT04923841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92619418|NCT04923841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92619419|NCT04923841|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92619420|NCT04923841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92619421|NCT04923841|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92619422|NCT04923841|Autonomic Agents|autonomic agents|mesh-ancestor
92619423|NCT04923841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619424|NCT04923841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619425|NCT04923841|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92619426|NCT04923841|Respiratory System Agents|respiratory system agents|mesh-ancestor
92619427|NCT04923841|Mydriatics|mydriatics|mesh-ancestor
92619428|NCT04923841|Parasympatholytics|parasympatholytics|mesh-ancestor
92537543|NCT00141310|Vasodilator Agents|vasodilator agents|mesh-ancestor
92537544|NCT00141310|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92537545|NCT00141310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92619429|NCT04923841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92619430|NCT04923841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92619431|NCT04923841|Cholinergic Agents|cholinergic agents|mesh-ancestor
92619432|NCT04923841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619433|NCT04923841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619435|NCT04880863|Obinutuzumab|obinutuzumab|mesh-list
92619436|NCT04880863|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
92619455|NCT04838808|Protease Inhibitors|protease inhibitors|mesh-ancestor
92619456|NCT04838808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619457|NCT04838808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619458|NCT04838808|Anticoagulants|anticoagulants|mesh-ancestor
92619459|NCT04803877|Nivolumab|nivolumab|mesh-list
92619460|NCT04803877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619461|NCT04803877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619462|NCT04803877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619463|NCT04803877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619464|NCT04792502|Lenalidomide|lenalidomide|mesh-list
92619465|NCT04792502|Immunologic Factors|immunologic factors|mesh-ancestor
92619466|NCT04792502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619467|NCT04792502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92619468|NCT04792502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92619469|NCT04792502|Growth Substances|growth substances|mesh-ancestor
92619470|NCT04792502|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619471|NCT04792502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619472|NCT04777422|Defibrotide|defibrotide|mesh-list
92619473|NCT04777422|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92619474|NCT04777422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92619475|NCT04777422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619476|NCT04777422|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92619477|NCT04761198|Nivolumab|nivolumab|mesh-list
92619478|NCT04761198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619479|NCT04761198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619480|NCT04761198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619481|NCT04761198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619482|NCT04748276|Norepinephrine|norepinephrine|mesh-list
92619483|NCT04748276|Serotonin|serotonin|mesh-list
92619484|NCT04748276|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92619485|NCT04748276|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92619486|NCT04748276|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92619487|NCT04748276|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619488|NCT04748276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619489|NCT04748276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619490|NCT04748276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619492|NCT04748276|Autonomic Agents|autonomic agents|mesh-ancestor
92619499|NCT04659811|Pembrolizumab|pembrolizumab|mesh-list
92619500|NCT04659811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619501|NCT04659811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619502|NCT04659811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619503|NCT04659811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619505|NCT04610658|Ipilimumab|ipilimumab|mesh-list
92619506|NCT04610658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619507|NCT04610658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619508|NCT04610658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619509|NCT04610658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619510|NCT04595994|Gemcitabine|gemcitabine|mesh-list
92619511|NCT04595994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619512|NCT04595994|Antimetabolites|antimetabolites|mesh-ancestor
92619513|NCT04595994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619514|NCT04595994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619515|NCT04587791|Cannabidiol|cannabidiol|mesh-list
92619516|NCT04587791|Anticonvulsants|anticonvulsants|mesh-ancestor
92619517|NCT04538066|Bryostatin 1|bryostatin 1|mesh-list
92619518|NCT04538066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92619519|NCT04538066|Immunologic Factors|immunologic factors|mesh-ancestor
92619520|NCT04538066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619521|NCT04538066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537546|NCT00141310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537547|NCT00141310|Urological Agents|urological agents|mesh-ancestor
92537548|NCT00141388|Pregabalin|pregabalin|mesh-list
92619522|NCT04532918|Cyclosporine|cyclosporine|mesh-list
92619523|NCT04532918|Rifampin|rifampin|mesh-list
92619524|NCT04532918|Allopurinol|allopurinol|mesh-list
92619525|NCT04532918|Verinurad|verinurad|mesh-list
92619526|NCT04532918|Cyclosporins|cyclosporins|mesh-list
92619527|NCT04532918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619528|NCT04532918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619529|NCT04532918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619530|NCT04532918|Immunologic Factors|immunologic factors|mesh-ancestor
92619531|NCT04532918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619532|NCT04532918|Antifungal Agents|antifungal agents|mesh-ancestor
92619533|NCT04532918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619534|NCT04532918|Dermatologic Agents|dermatologic agents|mesh-ancestor
92619535|NCT04532918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92619536|NCT04532918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92619537|NCT04532918|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92619538|NCT04532918|Antitubercular Agents|antitubercular agents|mesh-ancestor
92619539|NCT04532918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92619540|NCT04532918|Leprostatic Agents|leprostatic agents|mesh-ancestor
92619541|NCT04532918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92619542|NCT04532918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92619543|NCT04532918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92619544|NCT04532918|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92619545|NCT04532918|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92619546|NCT04532918|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92619547|NCT04532918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92619548|NCT04532918|Antimetabolites|antimetabolites|mesh-ancestor
92619549|NCT04532918|Gout Suppressants|gout suppressants|mesh-ancestor
92619550|NCT04532918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92619551|NCT04532918|Antioxidants|antioxidants|mesh-ancestor
92619552|NCT04532918|Protective Agents|protective agents|mesh-ancestor
92619553|NCT04511247|Sirolimus|sirolimus|mesh-list
92619554|NCT04511247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92619555|NCT04511247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619556|NCT04511247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92344668|NCT04370301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92619557|NCT04511247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619558|NCT04511247|Antifungal Agents|antifungal agents|mesh-ancestor
92619559|NCT04511247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619563|NCT04387084|Nivolumab|nivolumab|mesh-list
92619564|NCT04387084|Atezolizumab|atezolizumab|mesh-list
92619565|NCT04387084|Durvalumab|durvalumab|mesh-list
92619566|NCT04387084|Avelumab|avelumab|mesh-list
92619567|NCT04387084|Cemiplimab|cemiplimab|mesh-list
92619568|NCT04387084|Immunoglobulins|immunoglobulins|mesh-list
92619569|NCT04387084|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92619570|NCT04387084|Immunoglobulin G|immunoglobulin g|mesh-list
92619571|NCT04387084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619572|NCT04387084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619573|NCT04387084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619574|NCT04387084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619575|NCT04387084|Immunologic Factors|immunologic factors|mesh-ancestor
92619576|NCT04387084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619577|NCT04347798|Hydroxychloroquine|hydroxychloroquine|mesh-list
92619578|NCT04347798|Chloroquine|chloroquine|mesh-list
92619579|NCT04347798|Antimalarials|antimalarials|mesh-ancestor
92619580|NCT04347798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92619581|NCT04347798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92619582|NCT04347798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619583|NCT04347798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619584|NCT04347798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619585|NCT04347798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92619586|NCT04347798|Amebicides|amebicides|mesh-ancestor
92619587|NCT04335669|Paclitaxel|paclitaxel|mesh-list
92619588|NCT04335669|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92619589|NCT04335669|Cyclophosphamide|cyclophosphamide|mesh-list
92619590|NCT04335669|Carboplatin|carboplatin|mesh-list
92619591|NCT04335669|Pembrolizumab|pembrolizumab|mesh-list
92619592|NCT04335669|Capecitabine|capecitabine|mesh-list
92619593|NCT04335669|Epirubicin|epirubicin|mesh-list
92619594|NCT04335669|Taxane|taxane|mesh-list
92619595|NCT04335669|Antimetabolites|antimetabolites|mesh-list
92619596|NCT04335669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92619597|NCT04335669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537550|NCT00141388|Sensory System Agents|sensory system agents|mesh-ancestor
91964931|NCT04509323|Huperzine A|huperzine a|mesh-list
92619598|NCT04335669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92619599|NCT04335669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92619600|NCT04335669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92619601|NCT04335669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619602|NCT04335669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619603|NCT04335669|Immunologic Factors|immunologic factors|mesh-ancestor
92619604|NCT04335669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619605|NCT04335669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92619606|NCT04335669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619607|NCT04335669|Alkylating Agents|alkylating agents|mesh-ancestor
92619608|NCT04335669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92619609|NCT04335669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619610|NCT04335669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619611|NCT04335669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619612|NCT04335669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92619613|NCT04335669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92619614|NCT04335669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92619615|NCT04335669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619616|NCT04332367|Paclitaxel|paclitaxel|mesh-list
92619617|NCT04332367|Carboplatin|carboplatin|mesh-list
92619618|NCT04332367|Ramucirumab|ramucirumab|mesh-list
92619619|NCT04332367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92619620|NCT04332367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619621|NCT04332367|Tubulin Modulators|tubulin modulators|mesh-ancestor
92619622|NCT04332367|Antimitotic Agents|antimitotic agents|mesh-ancestor
92619623|NCT04332367|Mitosis Modulators|mitosis modulators|mesh-ancestor
92619624|NCT04332367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619625|NCT04310176|Bevacizumab|bevacizumab|mesh-list
92619626|NCT04310176|Fluorouracil|fluorouracil|mesh-list
92619627|NCT04310176|Capecitabine|capecitabine|mesh-list
92619628|NCT04310176|Valproic Acid|valproic acid|mesh-list
92619629|NCT04310176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619630|NCT04310176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619631|NCT04310176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92619632|NCT04310176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92619633|NCT04310176|Growth Substances|growth substances|mesh-ancestor
92619634|NCT04310176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619635|NCT04310176|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619639|NCT04310176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619640|NCT04310176|Immunologic Factors|immunologic factors|mesh-ancestor
92619641|NCT04310176|Anticonvulsants|anticonvulsants|mesh-ancestor
92619642|NCT04310176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619643|NCT04310176|GABA Agents|gaba agents|mesh-ancestor
92619644|NCT04310176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619645|NCT04310176|Antimanic Agents|antimanic agents|mesh-ancestor
92619646|NCT04310176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92619647|NCT04310176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619648|NCT04310176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92619649|NCT04298983|Androgens|androgens|mesh-list
92619650|NCT04298983|Hormones|hormones|mesh-ancestor
92619651|NCT04298983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619652|NCT04298983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619653|NCT04251416|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92619654|NCT04251416|Immunoconjugates|immunoconjugates|mesh-ancestor
92619655|NCT04251416|Immunologic Factors|immunologic factors|mesh-ancestor
92619656|NCT04251416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619657|NCT04236609|Sirolimus|sirolimus|mesh-list
92619658|NCT04236609|Everolimus|everolimus|mesh-list
92619659|NCT04236609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92619660|NCT04236609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92619661|NCT04236609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619662|NCT04236609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619663|NCT04236609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619664|NCT04236609|Immunologic Factors|immunologic factors|mesh-ancestor
92619665|NCT04236609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361292|NCT01797900|Cisplatin|cisplatin|mesh-list
92619666|NCT04236609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619667|NCT04236609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92619668|NCT04236609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619669|NCT04236609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92619670|NCT04236609|Antifungal Agents|antifungal agents|mesh-ancestor
92619671|NCT04232657|Denosumab|denosumab|mesh-list
92537551|NCT00141388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537552|NCT00141388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537553|NCT00141388|Anticonvulsants|anticonvulsants|mesh-ancestor
92537554|NCT00141388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92537555|NCT00141388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619672|NCT04232657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92619673|NCT04232657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619674|NCT04173585|Bortezomib|bortezomib|mesh-list
92619675|NCT04173585|Gemtuzumab|gemtuzumab|mesh-list
92619676|NCT04173585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619677|NCT04173585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619678|NCT04173585|Immunotoxins|immunotoxins|mesh-ancestor
92619679|NCT04173585|Immunoconjugates|immunoconjugates|mesh-ancestor
92619680|NCT04173585|Immunologic Factors|immunologic factors|mesh-ancestor
92619681|NCT04173585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619682|NCT04172987|Tirzepatide|tirzepatide|mesh-list
92619683|NCT04172987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92619684|NCT04172987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619685|NCT04172987|Incretins|incretins|mesh-ancestor
92619686|NCT04172987|Hormones|hormones|mesh-ancestor
92619687|NCT04172987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619688|NCT04138381|Imatinib Mesylate|imatinib mesylate|mesh-list
92619689|NCT04138381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619690|NCT04138381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92619691|NCT04138381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619692|NCT04138381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619693|NCT04128501|Azacitidine|azacitidine|mesh-list
92619694|NCT04128501|Venetoclax|venetoclax|mesh-list
92619695|NCT04128501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619696|NCT04128501|Antimetabolites|antimetabolites|mesh-ancestor
92619697|NCT04128501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619698|NCT04128501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619699|NCT04128501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619700|NCT04127786|Vaccines|vaccines|mesh-list
92619701|NCT04127786|Immunologic Factors|immunologic factors|mesh-ancestor
92619702|NCT04127786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619703|NCT04049331|Methyltestosterone|methyltestosterone|mesh-list
92619704|NCT04049331|Testosterone|testosterone|mesh-list
92619705|NCT04049331|Testosterone undecanoate|testosterone undecanoate|mesh-list
92619706|NCT04049331|Testosterone enanthate|testosterone enanthate|mesh-list
92619707|NCT04049331|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92619708|NCT04049331|Androgens|androgens|mesh-ancestor
92619709|NCT04049331|Hormones|hormones|mesh-ancestor
92619710|NCT04049331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619713|NCT04049331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619714|NCT04049331|Anabolic Agents|anabolic agents|mesh-ancestor
92619715|NCT04033055|Ropivacaine|ropivacaine|mesh-list
92619716|NCT04033055|Anesthetics, Local|anesthetics, local|mesh-ancestor
92619717|NCT04033055|Anesthetics|anesthetics|mesh-ancestor
92619718|NCT04033055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619719|NCT04033055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619720|NCT04033055|Sensory System Agents|sensory system agents|mesh-ancestor
92619721|NCT04033055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619723|NCT04015596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92619724|NCT04015596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92619725|NCT04015596|Analgesics|analgesics|mesh-ancestor
92619726|NCT04015596|Sensory System Agents|sensory system agents|mesh-ancestor
92619727|NCT04015596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619728|NCT04015596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619729|NCT04015596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92619730|NCT04015596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92619731|NCT04015596|Gout Suppressants|gout suppressants|mesh-ancestor
92619732|NCT04015596|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92619733|NCT04015596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619734|NCT04015596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619735|NCT03985722|Trabectedin|trabectedin|mesh-list
92619736|NCT03985722|Olaratumab|olaratumab|mesh-list
92619737|NCT03985722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619738|NCT03985722|Alkylating Agents|alkylating agents|mesh-ancestor
92619739|NCT03985722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537556|NCT00141388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537557|NCT00141388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92537558|NCT00141388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92537559|NCT00141388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537560|NCT00141388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537561|NCT00141388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92537562|NCT00404404|Paclitaxel|paclitaxel|mesh-list
92537563|NCT00404404|Bevacizumab|bevacizumab|mesh-list
92537564|NCT00404404|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92537565|NCT00404404|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92537566|NCT00404404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537567|NCT00404404|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537568|NCT00404404|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537569|NCT00404404|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537570|NCT00404404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537571|NCT00404404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537572|NCT00404404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92537573|NCT00404404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92537574|NCT00404404|Growth Substances|growth substances|mesh-ancestor
92537575|NCT00404404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537576|NCT00404404|Growth Inhibitors|growth inhibitors|mesh-ancestor
92537577|NCT00404482|Cyclosporine|cyclosporine|mesh-list
92619740|NCT03985722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619741|NCT03954327|Tenofovir|tenofovir|mesh-list
92619742|NCT03954327|Emtricitabine|emtricitabine|mesh-list
92619743|NCT03954327|Raltegravir Potassium|raltegravir potassium|mesh-list
92619744|NCT03954327|Antiviral Agents|antiviral agents|mesh-ancestor
92619745|NCT03954327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92619746|NCT03954327|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92619747|NCT03954327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92619748|NCT03954327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619749|NCT03954327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619750|NCT03954327|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92619751|NCT03954327|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92619752|NCT03954327|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92619753|NCT03954327|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92619754|NCT03762096|Resveratrol|resveratrol|mesh-list
92619755|NCT03762096|Antioxidants|antioxidants|mesh-ancestor
92619756|NCT03762096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619757|NCT03762096|Protective Agents|protective agents|mesh-ancestor
92619758|NCT03762096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619759|NCT03762096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619760|NCT03762096|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92619761|NCT03737955|Gemtuzumab|gemtuzumab|mesh-list
92619762|NCT03737955|Calicheamicins|calicheamicins|mesh-list
92619763|NCT03737955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619764|NCT03737955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619765|NCT03737955|Immunotoxins|immunotoxins|mesh-ancestor
92619766|NCT03737955|Immunoconjugates|immunoconjugates|mesh-ancestor
92619767|NCT03737955|Immunologic Factors|immunologic factors|mesh-ancestor
92619768|NCT03737955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619769|NCT03737955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92537578|NCT00404482|Cyclosporins|cyclosporins|mesh-list
92537579|NCT00404482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537580|NCT00404482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537581|NCT00404482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945219|NCT00002429|Zidovudine|zidovudine|mesh-list
92619770|NCT03736720|Leucovorin|leucovorin|mesh-list
92619771|NCT03736720|Fluorouracil|fluorouracil|mesh-list
92619772|NCT03736720|Irinotecan|irinotecan|mesh-list
92619773|NCT03736720|Antimetabolites|antimetabolites|mesh-ancestor
92619774|NCT03736720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619775|NCT03736720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619776|NCT03736720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619777|NCT03736720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619778|NCT03736720|Immunologic Factors|immunologic factors|mesh-ancestor
92619779|NCT03736720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619780|NCT03736720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92619781|NCT03736720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92619782|NCT03736720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619783|NCT03736720|Antidotes|antidotes|mesh-ancestor
92344894|NCT03726879|Immunotoxins|immunotoxins|mesh-ancestor
92619788|NCT03490344|Lenalidomide|lenalidomide|mesh-list
92619789|NCT03490344|Daratumumab|daratumumab|mesh-list
92619790|NCT03490344|Immunologic Factors|immunologic factors|mesh-ancestor
92619791|NCT03490344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619792|NCT03490344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92619793|NCT03490344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92619794|NCT03490344|Growth Substances|growth substances|mesh-ancestor
92619795|NCT03490344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619796|NCT03490344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619798|NCT03460379|Escitalopram|escitalopram|mesh-list
92619799|NCT03460379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92619800|NCT03460379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619801|NCT03460379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619802|NCT03460379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619803|NCT03460379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619804|NCT03460379|Serotonin Agents|serotonin agents|mesh-ancestor
92619805|NCT03460379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619806|NCT03460379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92619807|NCT03460379|Antidepressive Agents|antidepressive agents|mesh-ancestor
92619808|NCT03460379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92619810|NCT03460366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92619811|NCT03460366|Protease Inhibitors|protease inhibitors|mesh-ancestor
92619812|NCT03460366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619813|NCT03460366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619814|NCT03460366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92619815|NCT03460353|Dextroamphetamine|dextroamphetamine|mesh-list
92619816|NCT03460353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92619817|NCT03460353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619818|NCT03460353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92619819|NCT03460353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619820|NCT03460353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619821|NCT03460353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619822|NCT03460353|Dopamine Agents|dopamine agents|mesh-ancestor
92619823|NCT03460353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619824|NCT03460327|Candesartan|candesartan|mesh-list
92619825|NCT03460327|Candesartan cilexetil|candesartan cilexetil|mesh-list
92619826|NCT03460327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92619827|NCT03460327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92619828|NCT03460327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92619829|NCT03460327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619830|NCT03460314|Buprenorphine|buprenorphine|mesh-list
92619831|NCT03460314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92619832|NCT03460314|Narcotics|narcotics|mesh-ancestor
92619833|NCT03460314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619834|NCT03460314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619835|NCT03460314|Analgesics|analgesics|mesh-ancestor
92619836|NCT03460314|Sensory System Agents|sensory system agents|mesh-ancestor
92619837|NCT03460314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537582|NCT00404482|Immunologic Factors|immunologic factors|mesh-ancestor
92537583|NCT00404482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537584|NCT00404482|Antifungal Agents|antifungal agents|mesh-ancestor
92537585|NCT00404482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537586|NCT00404482|Dermatologic Agents|dermatologic agents|mesh-ancestor
92537587|NCT00404482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945226|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619838|NCT03460314|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92619839|NCT03460210|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92619840|NCT03460210|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92619841|NCT03460210|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619842|NCT03460210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619843|NCT03460210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619844|NCT03460210|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619845|NCT03460210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619846|NCT03460210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619847|NCT03449472|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92619848|NCT03449472|Antidepressive Agents|antidepressive agents|mesh-ancestor
92619849|NCT03449472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92619850|NCT03449472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92619851|NCT03449472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92619852|NCT03449472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619854|NCT03440879|Goserelin|goserelin|mesh-list
92619855|NCT03440879|Androgens|androgens|mesh-list
92619856|NCT03440879|Hormones|hormones|mesh-ancestor
92619857|NCT03440879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619858|NCT03440879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344969|NCT03509012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92619859|NCT03440879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92619860|NCT03440879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619861|NCT03433755|Evolocumab|evolocumab|mesh-list
92619862|NCT03433755|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92619863|NCT03433755|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92619864|NCT03433755|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92619865|NCT03433755|Antimetabolites|antimetabolites|mesh-ancestor
92619866|NCT03433755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619867|NCT03433755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92619868|NCT03433755|Protease Inhibitors|protease inhibitors|mesh-ancestor
92619869|NCT03433755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619870|NCT03433755|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92619871|NCT03406507|Ravulizumab|ravulizumab|mesh-list
92619872|NCT03406507|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92619873|NCT03406507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619874|NCT03406507|Immunologic Factors|immunologic factors|mesh-ancestor
92619875|NCT03406507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619876|NCT03283150|Dexmedetomidine|dexmedetomidine|mesh-list
92619877|NCT03283150|Remifentanil|remifentanil|mesh-list
92619878|NCT03283150|Propofol|propofol|mesh-list
92619879|NCT03283150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92619880|NCT03283150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92619881|NCT03283150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619882|NCT03283150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92619883|NCT03283150|Analgesics|analgesics|mesh-ancestor
92619884|NCT03283150|Sensory System Agents|sensory system agents|mesh-ancestor
92619885|NCT03283150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619886|NCT03283150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92619887|NCT03283150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92619888|NCT03283150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92619889|NCT03283150|Adrenergic Agents|adrenergic agents|mesh-ancestor
92619890|NCT03283150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92619891|NCT03283150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619892|NCT03283150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92619893|NCT03283150|Anesthetics, General|anesthetics, general|mesh-ancestor
92619894|NCT03283150|Anesthetics|anesthetics|mesh-ancestor
92619895|NCT03283150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92619896|NCT03283150|Narcotics|narcotics|mesh-ancestor
92619897|NCT03249792|Pembrolizumab|pembrolizumab|mesh-list
92619898|NCT03249792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537588|NCT00404482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92537589|NCT03073941|Cimetidine|cimetidine|mesh-list
92537590|NCT03073941|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92537591|NCT03073941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92537592|NCT03073941|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92537593|NCT03073941|Histamine Antagonists|histamine antagonists|mesh-ancestor
92537594|NCT03073941|Histamine Agents|histamine agents|mesh-ancestor
92537595|NCT03073941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537596|NCT03073941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537597|NCT03073941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619899|NCT03249792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619900|NCT03249792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619901|NCT03249792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619902|NCT03149770|Naloxone|naloxone|mesh-list
92619903|NCT03149770|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92619904|NCT03149770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619905|NCT03149770|Sensory System Agents|sensory system agents|mesh-ancestor
92619906|NCT03149770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619907|NCT03132675|Pembrolizumab|pembrolizumab|mesh-list
92619908|NCT03132675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619909|NCT03132675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619910|NCT03132675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619911|NCT03132675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619912|NCT03127215|Olaparib|olaparib|mesh-list
92619913|NCT03127215|Trabectedin|trabectedin|mesh-list
92619914|NCT03127215|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92619915|NCT03127215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619916|NCT03127215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619917|NCT03127215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619918|NCT03127215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619919|NCT03127215|Alkylating Agents|alkylating agents|mesh-ancestor
92619920|NCT03110744|Palbociclib|palbociclib|mesh-list
92619921|NCT03110744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619922|NCT03110744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92619923|NCT03110744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619924|NCT03110744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619928|NCT03056040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92619929|NCT03056040|Immunologic Factors|immunologic factors|mesh-ancestor
92619930|NCT03056040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619931|NCT02924038|Poly ICLC|poly iclc|mesh-list
92619932|NCT02924038|Interferon Inducers|interferon inducers|mesh-ancestor
92619933|NCT02924038|Immunologic Factors|immunologic factors|mesh-ancestor
92619934|NCT02924038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619936|NCT02726581|Nivolumab|nivolumab|mesh-list
92619937|NCT02726581|Pomalidomide|pomalidomide|mesh-list
92619938|NCT02726581|Elotuzumab|elotuzumab|mesh-list
92619939|NCT02726581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92619940|NCT02726581|Antiemetics|antiemetics|mesh-ancestor
92619941|NCT02726581|Autonomic Agents|autonomic agents|mesh-ancestor
92619942|NCT02726581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619943|NCT02726581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619944|NCT02726581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92619945|NCT02726581|Glucocorticoids|glucocorticoids|mesh-ancestor
92619946|NCT02726581|Hormones|hormones|mesh-ancestor
92619947|NCT02726581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619948|NCT02726581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92619949|NCT02726581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619950|NCT02726581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619951|NCT02726581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92619952|NCT02726581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619953|NCT02726581|Immunologic Factors|immunologic factors|mesh-ancestor
92619954|NCT02726581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92619955|NCT02726581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92537598|NCT03073941|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92537599|NCT03073941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92537600|NCT03073941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92619956|NCT02726581|Growth Substances|growth substances|mesh-ancestor
92619957|NCT02726581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619958|NCT02700048|Naloxone|naloxone|mesh-list
92619959|NCT02700048|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92619960|NCT02700048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619961|NCT02700048|Sensory System Agents|sensory system agents|mesh-ancestor
92619962|NCT02700048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619963|NCT02535832|Pioglitazone|pioglitazone|mesh-list
92619964|NCT02535832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92619965|NCT02535832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619966|NCT02425904|Clofarabine|clofarabine|mesh-list
92619967|NCT02425904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619968|NCT02425904|Antimetabolites|antimetabolites|mesh-ancestor
92619969|NCT02425904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619970|NCT02425904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619971|NCT02406209|Prednisolone|prednisolone|mesh-list
92619972|NCT02406209|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92619973|NCT02406209|Methylprednisolone|methylprednisolone|mesh-list
92619974|NCT02406209|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92619975|NCT02406209|Prednisolone acetate|prednisolone acetate|mesh-list
92619976|NCT02406209|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92619977|NCT02406209|Prednisolone phosphate|prednisolone phosphate|mesh-list
92619978|NCT02406209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92619979|NCT02406209|Glucocorticoids|glucocorticoids|mesh-ancestor
92619980|NCT02406209|Hormones|hormones|mesh-ancestor
92619981|NCT02406209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92619982|NCT02406209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619983|NCT02406209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92619984|NCT02406209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619985|NCT02406209|Antiemetics|antiemetics|mesh-ancestor
92619986|NCT02406209|Autonomic Agents|autonomic agents|mesh-ancestor
92619987|NCT02406209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619988|NCT02406209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92619989|NCT02406209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92619990|NCT02406209|Protective Agents|protective agents|mesh-ancestor
92619991|NCT02295722|Gemcitabine|gemcitabine|mesh-list
92619992|NCT02295722|Melphalan|melphalan|mesh-list
92619993|NCT02295722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619994|NCT02295722|Antimetabolites|antimetabolites|mesh-ancestor
92619995|NCT02295722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619996|NCT02295722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619997|NCT02295722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92619998|NCT02295722|Alkylating Agents|alkylating agents|mesh-ancestor
92620011|NCT02282059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620012|NCT02282059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620014|NCT01964989|Immunologic Factors|immunologic factors|mesh-ancestor
92620015|NCT01964989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620016|NCT01711554|Vitamin A|vitamin a|mesh-list
92620017|NCT01711554|Lenalidomide|lenalidomide|mesh-list
92620018|NCT01711554|Tretinoin|tretinoin|mesh-list
92620019|NCT01711554|Dinutuximab|dinutuximab|mesh-list
92620020|NCT01711554|Isotretinoin|isotretinoin|mesh-list
92620021|NCT01711554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92620022|NCT01711554|Vitamins|vitamins|mesh-ancestor
92620023|NCT01711554|Micronutrients|micronutrients|mesh-ancestor
92620024|NCT01711554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620025|NCT01711554|Immunologic Factors|immunologic factors|mesh-ancestor
92620026|NCT01711554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92620027|NCT01711554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92620028|NCT01711554|Growth Substances|growth substances|mesh-ancestor
92620029|NCT01711554|Growth Inhibitors|growth inhibitors|mesh-ancestor
92620030|NCT01711554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620031|NCT01711554|Keratolytic Agents|keratolytic agents|mesh-ancestor
92620032|NCT01711554|Dermatologic Agents|dermatologic agents|mesh-ancestor
92620033|NCT01575860|Lenalidomide|lenalidomide|mesh-list
92620034|NCT01575860|Immunologic Factors|immunologic factors|mesh-ancestor
92620035|NCT01575860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620036|NCT01575860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92620037|NCT01575860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92537602|NCT00141427|Analgesics|analgesics|mesh-ancestor
92537603|NCT00141427|Sensory System Agents|sensory system agents|mesh-ancestor
92537604|NCT00141427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537605|NCT00141427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537606|NCT00141427|Anticonvulsants|anticonvulsants|mesh-ancestor
92620038|NCT01575860|Growth Substances|growth substances|mesh-ancestor
92620039|NCT01575860|Growth Inhibitors|growth inhibitors|mesh-ancestor
92620040|NCT01575860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620041|NCT01416831|Interleukin-2|interleukin-2|mesh-list
92620042|NCT01416831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620043|NCT01416831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92620044|NCT01416831|Analgesics|analgesics|mesh-ancestor
92620045|NCT01416831|Sensory System Agents|sensory system agents|mesh-ancestor
92620046|NCT01416831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620047|NCT01416831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620048|NCT01364051|Cediranib|cediranib|mesh-list
92620049|NCT01364051|Maleic acid|maleic acid|mesh-list
92620050|NCT01364051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620051|NCT01364051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620052|NCT01364051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620053|NCT01364051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620054|NCT01303341|Sorafenib|sorafenib|mesh-list
92620055|NCT01303341|Riluzole|riluzole|mesh-list
92620056|NCT01303341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620057|NCT01303341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620058|NCT01303341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620059|NCT01303341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620060|NCT01303341|Anticonvulsants|anticonvulsants|mesh-ancestor
92620061|NCT01303341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92026981|NCT05398705|Protective Agents|protective agents|mesh-ancestor
92620074|NCT01064648|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92620075|NCT01064648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92620076|NCT01064648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620077|NCT00878163|Gemcitabine|gemcitabine|mesh-list
92620078|NCT00878163|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92620079|NCT00878163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92620080|NCT00878163|Antimetabolites|antimetabolites|mesh-ancestor
92620081|NCT00878163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620082|NCT00878163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620083|NCT00878163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620084|NCT00878163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620085|NCT00635700|Ziprasidone|ziprasidone|mesh-list
92620086|NCT00635700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92620087|NCT00635700|Serotonin Agents|serotonin agents|mesh-ancestor
92620088|NCT00635700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620089|NCT00635700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620090|NCT00635700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620091|NCT00635700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92620092|NCT00635700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92620093|NCT00635700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620094|NCT00635700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620095|NCT00635700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92620096|NCT00635700|Dopamine Agents|dopamine agents|mesh-ancestor
92620097|NCT00582075|Temozolomide|temozolomide|mesh-list
92620098|NCT00582075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92620099|NCT00582075|Alkylating Agents|alkylating agents|mesh-ancestor
92620100|NCT00582075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620101|NCT00582075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620102|NCT00558961|Imatinib Mesylate|imatinib mesylate|mesh-list
92620103|NCT00558961|Chlorambucil|chlorambucil|mesh-list
92620104|NCT00558961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620105|NCT00558961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620106|NCT00558961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620107|NCT00558961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620108|NCT00558961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92620109|NCT00558961|Alkylating Agents|alkylating agents|mesh-ancestor
92620110|NCT00542451|Paclitaxel|paclitaxel|mesh-list
92620111|NCT00542451|Trastuzumab|trastuzumab|mesh-list
92620112|NCT00542451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92620113|NCT00542451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537607|NCT00141427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92537608|NCT00141427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537609|NCT00141427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537610|NCT00141427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92537611|NCT00141427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92537612|NCT00141427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537613|NCT00141427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537614|NCT00141427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92537616|NCT00141544|Estrogens|estrogens|mesh-list
92537617|NCT00141544|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
92537618|NCT00141544|Estrone|estrone|mesh-list
92537619|NCT00141544|Testosterone|testosterone|mesh-list
92537620|NCT00141544|Testosterone undecanoate|testosterone undecanoate|mesh-list
92537621|NCT00141544|Testosterone enanthate|testosterone enanthate|mesh-list
92537622|NCT00141544|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92537623|NCT00141544|Hormones|hormones|mesh-ancestor
92537624|NCT00141544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537625|NCT00141544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537626|NCT00141544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92537627|NCT00141544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537628|NCT00141544|Anabolic Agents|anabolic agents|mesh-ancestor
92537629|NCT00141544|Androgens|androgens|mesh-ancestor
92620114|NCT00542451|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620115|NCT00542451|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620116|NCT00542451|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620117|NCT00542451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620118|NCT00542451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92620119|NCT00392353|Azacitidine|azacitidine|mesh-list
92620120|NCT00392353|Vorinostat|vorinostat|mesh-list
92620121|NCT00392353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92620122|NCT00392353|Antimetabolites|antimetabolites|mesh-ancestor
92620123|NCT00392353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620124|NCT00392353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620128|NCT00382070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620129|NCT00382070|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92620130|NCT00382070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92620131|NCT00382070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620132|NCT00382070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620133|NCT00382070|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92620134|NCT00382070|Hormone Antagonists|hormone antagonists|mesh-ancestor
92620135|NCT00382070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620136|NCT00382070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620137|NCT00326456|Paclitaxel|paclitaxel|mesh-list
92620138|NCT00326456|Carboplatin|carboplatin|mesh-list
92620139|NCT00326456|Doxorubicin|doxorubicin|mesh-list
92620140|NCT00326456|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92620141|NCT00326456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92620142|NCT00326456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620143|NCT00326456|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620144|NCT00326456|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537630|NCT00141583|Candesartan|candesartan|mesh-list
92537631|NCT00141583|Candesartan cilexetil|candesartan cilexetil|mesh-list
92537632|NCT00141583|Enalapril|enalapril|mesh-list
92537633|NCT00141583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620145|NCT00326456|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620146|NCT00326456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620147|NCT00326456|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92620148|NCT00326456|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92620149|NCT00326456|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92620150|NCT00326456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620151|NCT00149942|Mycophenolic Acid|mycophenolic acid|mesh-list
92620152|NCT00149942|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92620153|NCT00149942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620154|NCT00149942|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92620155|NCT00149942|Antitubercular Agents|antitubercular agents|mesh-ancestor
92620156|NCT00149942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620157|NCT00149942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620158|NCT00149942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620159|NCT00149942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620160|NCT00149981|Everolimus|everolimus|mesh-list
92620161|NCT00149981|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92620162|NCT00149981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620163|NCT00149981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620164|NCT00149981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620165|NCT00149981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620166|NCT00149981|Immunologic Factors|immunologic factors|mesh-ancestor
92620167|NCT00149981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620168|NCT00149981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620169|NCT02915731|Vitamin A|vitamin a|mesh-list
92620170|NCT02915731|Vitamins|vitamins|mesh-ancestor
92620171|NCT02915731|Micronutrients|micronutrients|mesh-ancestor
92620172|NCT02915731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620173|NCT02915809|Vaccines|vaccines|mesh-list
92620174|NCT02915809|Immunologic Factors|immunologic factors|mesh-ancestor
92620175|NCT02915809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620176|NCT00405860|Mycophenolic Acid|mycophenolic acid|mesh-list
92620177|NCT00405860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92620178|NCT00405860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620179|NCT00405860|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92620180|NCT00405860|Antitubercular Agents|antitubercular agents|mesh-ancestor
92620181|NCT00405860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620182|NCT00405860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620183|NCT00405860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620184|NCT00405860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620185|NCT02914678|Fentanyl|fentanyl|mesh-list
92620186|NCT02914678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92620187|NCT02914678|Narcotics|narcotics|mesh-ancestor
92620188|NCT02914678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620189|NCT02914678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620190|NCT02914678|Analgesics|analgesics|mesh-ancestor
92620191|NCT02914678|Sensory System Agents|sensory system agents|mesh-ancestor
92620192|NCT02914678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620193|NCT02914678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92620194|NCT02914678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92620195|NCT02914678|Anesthetics, General|anesthetics, general|mesh-ancestor
92620196|NCT02914678|Anesthetics|anesthetics|mesh-ancestor
92620197|NCT00405977|Magnesium Sulfate|magnesium sulfate|mesh-list
92620203|NCT00405977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620204|NCT00405977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92620205|NCT00405977|Anticonvulsants|anticonvulsants|mesh-ancestor
92620206|NCT00405977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92620207|NCT00405977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620208|NCT00405977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620209|NCT00405977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92620210|NCT00405977|Tocolytic Agents|tocolytic agents|mesh-ancestor
92620211|NCT00405977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92620212|NCT00150020|Mycophenolic Acid|mycophenolic acid|mesh-list
92620213|NCT00150020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92620214|NCT00150020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620215|NCT00150020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92620216|NCT00150020|Antitubercular Agents|antitubercular agents|mesh-ancestor
92620217|NCT00150020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537696|NCT02825979|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92537697|NCT02825979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92537698|NCT02825979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537699|NCT00142207|Pyrimethamine|pyrimethamine|mesh-list
92620237|NCT00171093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620238|NCT00171093|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620239|NCT00171093|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92620240|NCT00171093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620241|NCT00171093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620242|NCT00171093|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92620243|NCT00171093|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92620244|NCT02914054|Dexamethasone|dexamethasone|mesh-list
92620245|NCT02914054|Prednisone|prednisone|mesh-list
92620246|NCT02914054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620247|NCT02914054|Antiemetics|antiemetics|mesh-ancestor
92620248|NCT02914054|Autonomic Agents|autonomic agents|mesh-ancestor
92620249|NCT02914054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620250|NCT02914054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620251|NCT02914054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620252|NCT02914054|Glucocorticoids|glucocorticoids|mesh-ancestor
92620253|NCT02914054|Hormones|hormones|mesh-ancestor
92620254|NCT02914054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620255|NCT02914054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92620256|NCT02914054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620257|NCT00150059|Pimecrolimus|pimecrolimus|mesh-list
92620258|NCT00150059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92620259|NCT00150059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92620260|NCT00150059|Analgesics|analgesics|mesh-ancestor
92620261|NCT00150059|Sensory System Agents|sensory system agents|mesh-ancestor
92620262|NCT00150059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620263|NCT00150059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620264|NCT00150059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620265|NCT00150059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92620266|NCT00150059|Dermatologic Agents|dermatologic agents|mesh-ancestor
92620267|NCT00150059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620271|NCT00150059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620272|NCT00171132|Atenolol|atenolol|mesh-list
92620273|NCT00171132|Valsartan|valsartan|mesh-list
92620274|NCT00171132|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92620275|NCT00171132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620276|NCT00171132|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92620277|NCT00171132|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92620278|NCT00171132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620279|NCT00171132|Diuretics|diuretics|mesh-ancestor
92620280|NCT00171132|Natriuretic Agents|natriuretic agents|mesh-ancestor
92620281|NCT00171132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620282|NCT00171132|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92620283|NCT00171132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620284|NCT00171132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92620285|NCT00171132|Sympatholytics|sympatholytics|mesh-ancestor
92620286|NCT00171132|Autonomic Agents|autonomic agents|mesh-ancestor
92620287|NCT00171132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620288|NCT00171132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92361313|NCT03379194|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92620289|NCT00171132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92620290|NCT00171132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92620291|NCT00171132|Adrenergic Agents|adrenergic agents|mesh-ancestor
92620292|NCT00171132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620293|NCT02913859|Androgen Antagonists|androgen antagonists|mesh-list
92620294|NCT02913859|Hormone Antagonists|hormone antagonists|mesh-ancestor
92620295|NCT02913859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620296|NCT02913859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620297|NCT00150137|Methimazole|methimazole|mesh-list
92620298|NCT00150137|Antithyroid Agents|antithyroid agents|mesh-ancestor
92620299|NCT00150137|Hormone Antagonists|hormone antagonists|mesh-ancestor
92620300|NCT00150137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620301|NCT00150137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620302|NCT00150215|Olanzapine|olanzapine|mesh-list
92620303|NCT00150215|Antiemetics|antiemetics|mesh-ancestor
92537700|NCT00142207|Sulfadoxine|sulfadoxine|mesh-list
92537701|NCT00142207|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92537702|NCT00142207|Antimalarials|antimalarials|mesh-ancestor
92537703|NCT00142207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92537704|NCT00142207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92537705|NCT00142207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537706|NCT00142207|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92537707|NCT00142207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537708|NCT00142207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537709|NCT00142207|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92537710|NCT00142246|Amodiaquine|amodiaquine|mesh-list
92537711|NCT00142246|Antimalarials|antimalarials|mesh-ancestor
92537712|NCT00142246|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92537713|NCT00142246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92537714|NCT00142246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537716|NCT00142324|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92620304|NCT00150215|Autonomic Agents|autonomic agents|mesh-ancestor
92620305|NCT00150215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620306|NCT00150215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620307|NCT00150215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620308|NCT00150215|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92620309|NCT00150215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92620310|NCT00150215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620311|NCT00150215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620312|NCT00150215|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92620313|NCT00150215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92620314|NCT00150215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620315|NCT00150215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620316|NCT00150215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620317|NCT00150215|Serotonin Agents|serotonin agents|mesh-ancestor
92620318|NCT00171171|Deferasirox|deferasirox|mesh-list
92620319|NCT00171171|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92620320|NCT00171171|Chelating Agents|chelating agents|mesh-ancestor
92620321|NCT00171171|Sequestering Agents|sequestering agents|mesh-ancestor
92620322|NCT00171171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620324|NCT02913430|Fulvestrant|fulvestrant|mesh-list
92620325|NCT02913430|Palbociclib|palbociclib|mesh-list
92620326|NCT02913430|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92620327|NCT02913430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92620328|NCT02913430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620329|NCT02913430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620330|NCT02913430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92620331|NCT02913430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620332|NCT02913430|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92620333|NCT02913430|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92620334|NCT02913430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92620335|NCT02913430|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92620336|NCT02913430|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620337|NCT02913430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620351|NCT02913469|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92620353|NCT02913469|Dopamine Agents|dopamine agents|mesh-ancestor
92620354|NCT02913469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620355|NCT02913469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620356|NCT00150254|Varenicline|varenicline|mesh-list
92620357|NCT00150254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92537717|NCT00142324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537718|NCT00142324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537719|NCT00142324|Cholinergic Agents|cholinergic agents|mesh-ancestor
92537720|NCT00142324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537721|NCT00142324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537722|NCT00142324|Nootropic Agents|nootropic agents|mesh-ancestor
92537723|NCT00142402|Modafinil|modafinil|mesh-list
92537724|NCT00142402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92537725|NCT00142402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537726|NCT00142402|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92537727|NCT00142402|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92537728|NCT00142402|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92537729|NCT00142402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537730|NCT00142480|Bevacizumab|bevacizumab|mesh-list
92537731|NCT00142480|Capecitabine|capecitabine|mesh-list
92537732|NCT00142480|Oxaliplatin|oxaliplatin|mesh-list
92537733|NCT00142480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537734|NCT00142480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537735|NCT00142480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92537736|NCT00142480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92620358|NCT00150254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92620359|NCT00150254|Cholinergic Agents|cholinergic agents|mesh-ancestor
92620360|NCT00150254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620361|NCT00150254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620362|NCT00150254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620363|NCT02913508|Vedolizumab|vedolizumab|mesh-list
92620364|NCT02913508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620365|NCT02913157|Hydroxychloroquine|hydroxychloroquine|mesh-list
92620366|NCT02913157|Antimalarials|antimalarials|mesh-ancestor
92620367|NCT02913157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92620368|NCT02913157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92620369|NCT02913157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620370|NCT02913157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620371|NCT02913157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620372|NCT02913157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92620373|NCT00150293|Pregabalin|pregabalin|mesh-list
92620374|NCT00150293|Analgesics|analgesics|mesh-ancestor
92620375|NCT00150293|Sensory System Agents|sensory system agents|mesh-ancestor
92620376|NCT00150293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620377|NCT00150293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620378|NCT00150293|Anticonvulsants|anticonvulsants|mesh-ancestor
92620379|NCT00150293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92620380|NCT00150293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92345513|NCT04563299|Hormones|hormones|mesh-ancestor
92620381|NCT00150293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620382|NCT00150293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92620383|NCT00150293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92620384|NCT00150293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92620385|NCT00150293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620386|NCT00150293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620387|NCT02913118|Amoxicillin|amoxicillin|mesh-list
92620388|NCT02913118|Azithromycin|azithromycin|mesh-list
92620389|NCT02913118|Doxycycline|doxycycline|mesh-list
92620390|NCT02913118|Minocycline|minocycline|mesh-list
92537738|NCT00142480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537739|NCT00142480|Growth Inhibitors|growth inhibitors|mesh-ancestor
91945398|NCT03527381|Antioxidants|antioxidants|mesh-ancestor
92620391|NCT02913118|Cephalosporins|cephalosporins|mesh-list
92620392|NCT02913118|Fluoroquinolones|fluoroquinolones|mesh-list
92620393|NCT02913118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620394|NCT02913118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620395|NCT02913118|Antimalarials|antimalarials|mesh-ancestor
92620396|NCT02913118|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92620397|NCT02913118|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92620398|NCT02913118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92620399|NCT02913118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620408|NCT00150371|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92620409|NCT00150371|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92620411|NCT00150371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361327|NCT03117972|Leucovorin|leucovorin|mesh-list
92620412|NCT00150371|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620413|NCT00150371|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92620414|NCT00150371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620415|NCT02912494|Darbepoetin alfa|darbepoetin alfa|mesh-list
92620416|NCT02912494|Hematinics|hematinics|mesh-ancestor
92620417|NCT00150410|Insulin|insulin|mesh-list
92620418|NCT00150410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92620419|NCT00150410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620420|NCT00171288|Ezetimibe|ezetimibe|mesh-list
92620421|NCT00171288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92620422|NCT00171288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92620423|NCT00171288|Antimetabolites|antimetabolites|mesh-ancestor
92620424|NCT00171288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620425|NCT00171288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620426|NCT00150449|Pregabalin|pregabalin|mesh-list
92620427|NCT00150449|Analgesics|analgesics|mesh-ancestor
92620428|NCT00150449|Sensory System Agents|sensory system agents|mesh-ancestor
92620429|NCT00150449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620430|NCT00150449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620431|NCT00150449|Anticonvulsants|anticonvulsants|mesh-ancestor
92620432|NCT00150449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92620433|NCT00150449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620434|NCT00150449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620435|NCT00150449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92620436|NCT00150449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92620437|NCT00150449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92620438|NCT00150449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620439|NCT00150449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620440|NCT02912182|Prednisolone|prednisolone|mesh-list
92620441|NCT02912182|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92620442|NCT02912182|Methylprednisolone|methylprednisolone|mesh-list
92620443|NCT02912182|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92620444|NCT02912182|Prednisolone acetate|prednisolone acetate|mesh-list
92620445|NCT02912182|Betamethasone|betamethasone|mesh-list
92620446|NCT02912182|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92620447|NCT02912182|Prednisolone phosphate|prednisolone phosphate|mesh-list
92620448|NCT02912182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620449|NCT02912182|Glucocorticoids|glucocorticoids|mesh-ancestor
92620450|NCT02912182|Hormones|hormones|mesh-ancestor
92620451|NCT02912182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620452|NCT02912182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620453|NCT02912182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92620454|NCT02912182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620455|NCT02912182|Antiemetics|antiemetics|mesh-ancestor
92620456|NCT02912182|Autonomic Agents|autonomic agents|mesh-ancestor
92620457|NCT02912182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620458|NCT02912182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620459|NCT02912182|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92620460|NCT02912182|Protective Agents|protective agents|mesh-ancestor
92620461|NCT02912182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92620462|NCT02912182|Respiratory System Agents|respiratory system agents|mesh-ancestor
92620463|NCT02912026|Olorofim|olorofim|mesh-list
92620464|NCT02912026|Antifungal Agents|antifungal agents|mesh-ancestor
92620465|NCT02912026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620472|NCT02911870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620474|NCT02843230|Bevacizumab|bevacizumab|mesh-list
92537740|NCT00142480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361329|NCT03117972|Fluorouracil|fluorouracil|mesh-list
92537742|NCT00142480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537743|NCT02806050|Letrozole|letrozole|mesh-list
92537744|NCT02806050|Palbociclib|palbociclib|mesh-list
92537745|NCT02806050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537746|NCT02806050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92537747|NCT02806050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92537748|NCT02806050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537749|NCT02806050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537750|NCT02806050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92620475|NCT02843230|Temozolomide|temozolomide|mesh-list
92620476|NCT02843230|Lomustine|lomustine|mesh-list
92620477|NCT02843230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92620478|NCT02843230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620479|NCT02843230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92620480|NCT02843230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92620481|NCT02843230|Growth Substances|growth substances|mesh-ancestor
92620482|NCT02843230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620483|NCT02843230|Growth Inhibitors|growth inhibitors|mesh-ancestor
92620484|NCT02843230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92620485|NCT02843230|Alkylating Agents|alkylating agents|mesh-ancestor
92620486|NCT02843230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620487|NCT02712814|Estrogens|estrogens|mesh-list
92620488|NCT02712814|Hormones|hormones|mesh-ancestor
92620489|NCT02712814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620490|NCT02712814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620491|NCT00150527|Dexamethasone|dexamethasone|mesh-list
92620492|NCT00150527|Citalopram|citalopram|mesh-list
92620493|NCT00150527|Escitalopram|escitalopram|mesh-list
92620494|NCT00150527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620495|NCT00150527|Antiemetics|antiemetics|mesh-ancestor
92620496|NCT00150527|Autonomic Agents|autonomic agents|mesh-ancestor
92620497|NCT00150527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620498|NCT00150527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620499|NCT00150527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620500|NCT00150527|Glucocorticoids|glucocorticoids|mesh-ancestor
92620501|NCT00150527|Hormones|hormones|mesh-ancestor
92620502|NCT00150527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620503|NCT00150527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92620504|NCT00150527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620505|NCT00150527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92620506|NCT00150527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92620507|NCT00150527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620508|NCT00150527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620509|NCT00150527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620510|NCT00150527|Serotonin Agents|serotonin agents|mesh-ancestor
92620511|NCT00150527|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92620512|NCT00150527|Antidepressive Agents|antidepressive agents|mesh-ancestor
92620513|NCT00150527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620514|NCT00171327|Valsartan|valsartan|mesh-list
92620515|NCT00171327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620516|NCT00171327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92620517|NCT00171327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92620518|NCT00171327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620519|NCT02911597|Naltrexone|naltrexone|mesh-list
92620520|NCT02911597|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92620521|NCT02911597|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92620522|NCT02911597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620523|NCT02911597|Sensory System Agents|sensory system agents|mesh-ancestor
92620524|NCT02911597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620525|NCT02911480|Oxytocin|oxytocin|mesh-list
92537751|NCT02806050|Hormone Antagonists|hormone antagonists|mesh-ancestor
91945411|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
92620526|NCT02911480|Oxytocics|oxytocics|mesh-ancestor
92620527|NCT02911480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92620528|NCT02911480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620529|NCT00171366|Amlodipine|amlodipine|mesh-list
92345648|NCT01618266|Dexamethasone|dexamethasone|mesh-list
92620530|NCT00171366|Benazepril|benazepril|mesh-list
92620531|NCT00171366|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620532|NCT00171366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92620533|NCT00171366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620534|NCT00171366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620535|NCT00171366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92620536|NCT00171366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620538|NCT00171366|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92620539|NCT00171366|Protease Inhibitors|protease inhibitors|mesh-ancestor
92620540|NCT00171366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620542|NCT00150605|Anticonvulsants|anticonvulsants|mesh-ancestor
92620543|NCT00150605|Antimanic Agents|antimanic agents|mesh-ancestor
92620544|NCT00150605|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92620545|NCT00150605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620546|NCT00150605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620547|NCT00150605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620548|NCT00150605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92620549|NCT00150605|Analgesics|analgesics|mesh-ancestor
92620550|NCT00150605|Sensory System Agents|sensory system agents|mesh-ancestor
92620551|NCT00150605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620552|NCT00150605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92620553|NCT00150605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620554|NCT00150605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620555|NCT00150605|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92620556|NCT00150605|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92620557|NCT02910778|Ticagrelor|ticagrelor|mesh-list
92620558|NCT02910778|Atorvastatin|atorvastatin|mesh-list
92620559|NCT02910778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92620560|NCT02910778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92620561|NCT02910778|Antimetabolites|antimetabolites|mesh-ancestor
92620562|NCT02910778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620563|NCT02910778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620564|NCT02910778|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92620565|NCT02910778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620566|NCT02910778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92620567|NCT02910778|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92620568|NCT02910778|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92620569|NCT02910778|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92620570|NCT02910778|Purinergic Agents|purinergic agents|mesh-ancestor
92620571|NCT02910778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620572|NCT02910778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620573|NCT00164112|Azithromycin|azithromycin|mesh-list
92620574|NCT00164112|Levofloxacin|levofloxacin|mesh-list
92620575|NCT00164112|Telithromycin|telithromycin|mesh-list
92620576|NCT00164112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620577|NCT00164112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620578|NCT00164112|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92620579|NCT00164112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92620580|NCT00164112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92620581|NCT00164112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620582|NCT00164112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620583|NCT00164112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620584|NCT00164112|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92620585|NCT00164112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92620586|NCT02910817|Metformin|metformin|mesh-list
92620587|NCT02910817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92620588|NCT02910817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620589|NCT00150722|Atorvastatin|atorvastatin|mesh-list
92620590|NCT00150722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92620591|NCT00150722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92620592|NCT00150722|Antimetabolites|antimetabolites|mesh-ancestor
92620593|NCT00150722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620594|NCT00150722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620595|NCT00150722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92620596|NCT00150722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620597|NCT00150761|Levocetirizine|levocetirizine|mesh-list
92620598|NCT00150761|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92620599|NCT00150761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92620600|NCT00150761|Histamine Antagonists|histamine antagonists|mesh-ancestor
92620601|NCT00150761|Histamine Agents|histamine agents|mesh-ancestor
92620602|NCT00150761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620603|NCT00150761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027526|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92620606|NCT00171483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92620607|NCT00171483|Serotonin Agents|serotonin agents|mesh-ancestor
92620608|NCT00171483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620609|NCT00171483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620610|NCT00171483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620611|NCT03777904|Iron|iron|mesh-list
92620612|NCT03777904|Trace Elements|trace elements|mesh-ancestor
92620613|NCT03777904|Micronutrients|micronutrients|mesh-ancestor
92620614|NCT03777904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620615|NCT00150839|Mirtazapine|mirtazapine|mesh-list
92620616|NCT00150839|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92620617|NCT00150839|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92620618|NCT00150839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92620619|NCT00150839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620620|NCT00150839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620621|NCT00150839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620622|NCT00150839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620623|NCT00150839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92620624|NCT00150839|Antidepressive Agents|antidepressive agents|mesh-ancestor
92620625|NCT00150839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620626|NCT00150839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92620627|NCT00150839|Histamine Antagonists|histamine antagonists|mesh-ancestor
92620628|NCT00150839|Histamine Agents|histamine agents|mesh-ancestor
92620629|NCT00150839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92620630|NCT00150839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92620631|NCT00150839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620632|NCT00150839|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92620633|NCT00150839|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92620634|NCT00150839|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92620635|NCT00150839|Adrenergic Agents|adrenergic agents|mesh-ancestor
92620636|NCT00150839|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92620637|NCT00150839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92620638|NCT00150839|Serotonin Agents|serotonin agents|mesh-ancestor
92620639|NCT00150839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92620640|NCT03782740|Melatonin|melatonin|mesh-list
92620641|NCT03782740|Antioxidants|antioxidants|mesh-ancestor
92620642|NCT03782740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620643|NCT03782740|Protective Agents|protective agents|mesh-ancestor
92620644|NCT03782740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620645|NCT03782740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620646|NCT00532168|Ritonavir|ritonavir|mesh-list
92620647|NCT00532168|Lopinavir|lopinavir|mesh-list
92620648|NCT00532168|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92620649|NCT00532168|Tenofovir|tenofovir|mesh-list
92620650|NCT00532168|Emtricitabine|emtricitabine|mesh-list
92620651|NCT00532168|Efavirenz|efavirenz|mesh-list
92620652|NCT00532168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92620653|NCT00532168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92620654|NCT00532168|Protease Inhibitors|protease inhibitors|mesh-ancestor
92620655|NCT00532168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620656|NCT00532168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620657|NCT00532168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92620658|NCT00532168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92620659|NCT00532168|Antiviral Agents|antiviral agents|mesh-ancestor
92620660|NCT00532168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620661|NCT00532168|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92620662|NCT00532168|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92620663|NCT00532168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92620664|NCT00532168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92620665|NCT00532168|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92620666|NCT00532168|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92620667|NCT00532168|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92537752|NCT02806050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537753|NCT02806050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945414|NCT03531359|Midazolam|midazolam|mesh-list
92620668|NCT00532168|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92620669|NCT00532168|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92620670|NCT00532207|Teriparatide|teriparatide|mesh-list
92361353|NCT03117972|Micronutrients|micronutrients|mesh-ancestor
92620671|NCT00532207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92620672|NCT00532207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620673|NCT00532207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92620674|NCT04723836|Riboflavin|riboflavin|mesh-list
92620678|NCT04723836|Vitamin B Complex|vitamin b complex|mesh-ancestor
92620679|NCT04723836|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92620680|NCT04723836|Dermatologic Agents|dermatologic agents|mesh-ancestor
92620681|NCT00150995|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92620682|NCT00150995|Chelating Agents|chelating agents|mesh-ancestor
92620683|NCT00150995|Sequestering Agents|sequestering agents|mesh-ancestor
92620684|NCT00150995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620685|NCT00150995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620686|NCT00150995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92620687|NCT00150995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92620688|NCT00150995|Growth Substances|growth substances|mesh-ancestor
92620689|NCT00150995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620690|NCT00150995|Growth Inhibitors|growth inhibitors|mesh-ancestor
92620691|NCT00150995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620692|NCT00532246|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92620693|NCT00532246|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92620694|NCT00532246|Hormone Antagonists|hormone antagonists|mesh-ancestor
92620695|NCT00532246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92620696|NCT00532246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620697|NCT00532246|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92620698|NCT00532246|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92620699|NCT00532246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92620700|NCT00532285|Paclitaxel|paclitaxel|mesh-list
92620701|NCT00532285|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92620702|NCT00532285|Gemcitabine|gemcitabine|mesh-list
92620703|NCT00532285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92620704|NCT00532285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620705|NCT00532285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620706|NCT00532285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620707|NCT00532285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620708|NCT00532285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620709|NCT00532285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92620710|NCT00532285|Antimetabolites|antimetabolites|mesh-ancestor
92620711|NCT00151034|Paclitaxel|paclitaxel|mesh-list
92620712|NCT00151034|Carboplatin|carboplatin|mesh-list
92620713|NCT00151034|Gemcitabine|gemcitabine|mesh-list
92620714|NCT00151034|Trastuzumab|trastuzumab|mesh-list
92620715|NCT00151034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92620716|NCT00151034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620717|NCT00151034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620718|NCT00151034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620719|NCT00151034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620720|NCT00151034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620721|NCT00151034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92620722|NCT00151034|Antimetabolites|antimetabolites|mesh-ancestor
92620723|NCT00151034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92620724|NCT02817451|Vaccines|vaccines|mesh-list
92620725|NCT02817451|Immunologic Factors|immunologic factors|mesh-ancestor
92620726|NCT02817451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620727|NCT00171522|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92620728|NCT00171522|Tegaserod|tegaserod|mesh-list
92620729|NCT00171522|Laxatives|laxatives|mesh-ancestor
92620730|NCT00171522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620731|NCT00171522|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92620732|NCT00171522|Serotonin Agents|serotonin agents|mesh-ancestor
92620733|NCT00171522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620734|NCT00171522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620735|NCT00171522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620736|NCT02716012|Sorafenib|sorafenib|mesh-list
92620737|NCT02716012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537754|NCT02806050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92537755|NCT02781792|Temozolomide|temozolomide|mesh-list
92537756|NCT02781792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92620738|NCT02716012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620739|NCT02716012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620740|NCT02716012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620741|NCT00151073|Zoledronic Acid|zoledronic acid|mesh-list
92620743|NCT00151073|Estramustine|estramustine|mesh-list
92620744|NCT00151073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620745|NCT00151073|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620746|NCT00151073|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620747|NCT00151073|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620749|NCT00151073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92620750|NCT00151073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620751|NCT00151073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92620753|NCT00151073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92620754|NCT00171561|Valsartan|valsartan|mesh-list
92620755|NCT00171561|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92620756|NCT00171561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620757|NCT00171561|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92620758|NCT00171561|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92620759|NCT00171561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620760|NCT00171561|Diuretics|diuretics|mesh-ancestor
92620761|NCT00171561|Natriuretic Agents|natriuretic agents|mesh-ancestor
92620762|NCT00171561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620763|NCT00171561|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92620764|NCT00171561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620765|NCT00151112|Anesthetics|anesthetics|mesh-list
92620766|NCT00151112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620767|NCT00151112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620768|NCT00532324|Chlorhexidine|chlorhexidine|mesh-list
92620769|NCT00532324|Mupirocin|mupirocin|mesh-list
92620770|NCT00532324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92620771|NCT00532324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620772|NCT00532324|Disinfectants|disinfectants|mesh-ancestor
92620773|NCT00532324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620774|NCT00532324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92620775|NCT00532324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620776|NCT00532324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620777|NCT00171600|Valsartan|valsartan|mesh-list
92620778|NCT00171600|Lisinopril|lisinopril|mesh-list
92620779|NCT00171600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620780|NCT00171600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92620781|NCT00171600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92620782|NCT00171600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620783|NCT00171600|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92620784|NCT00171600|Protease Inhibitors|protease inhibitors|mesh-ancestor
92620785|NCT00171600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620786|NCT00171600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92620787|NCT00171600|Protective Agents|protective agents|mesh-ancestor
92620788|NCT00171600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620789|NCT05467384|Amlodipine|amlodipine|mesh-list
92620790|NCT05467384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620791|NCT05467384|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92620792|NCT05467384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620793|NCT05467384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620794|NCT05467384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92620795|NCT05467384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620796|NCT05467384|Vasodilator Agents|vasodilator agents|mesh-ancestor
92620797|NCT05467189|Paclitaxel|paclitaxel|mesh-list
92620798|NCT05467189|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92620799|NCT05467189|Busulfan|busulfan|mesh-list
92620800|NCT05467189|Lapatinib|lapatinib|mesh-list
92620801|NCT05467189|Afatinib|afatinib|mesh-list
92620802|NCT05467189|Crizotinib|crizotinib|mesh-list
92620803|NCT05467189|Ceritinib|ceritinib|mesh-list
92620804|NCT05467189|Antineoplastic Agents|antineoplastic agents|mesh-list
92620805|NCT05467189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92620806|NCT05467189|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620807|NCT05467189|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620808|NCT05467189|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537757|NCT02781792|Alkylating Agents|alkylating agents|mesh-ancestor
92361365|NCT00561834|Ranibizumab|ranibizumab|mesh-list
92537758|NCT02781792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537759|NCT02781792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537760|NCT00142870|Bupropion|bupropion|mesh-list
92620809|NCT05467189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620810|NCT05467189|Alkylating Agents|alkylating agents|mesh-ancestor
92620811|NCT05467189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620812|NCT05467189|Immunologic Factors|immunologic factors|mesh-ancestor
92620813|NCT05467189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620814|NCT05467189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92620815|NCT05467189|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92620816|NCT05467189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620817|NCT05467189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620818|NCT00171639|Zoledronic Acid|zoledronic acid|mesh-list
92620819|NCT00171639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92620820|NCT00171639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620832|NCT05466604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620833|NCT04723875|Paclitaxel|paclitaxel|mesh-list
92620834|NCT04723875|Docetaxel|docetaxel|mesh-list
92620835|NCT04723875|Carboplatin|carboplatin|mesh-list
92620836|NCT04723875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92620837|NCT04723875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620838|NCT04723875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620839|NCT04723875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620840|NCT04723875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620841|NCT04723875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620842|NCT05466019|Leucovorin|leucovorin|mesh-list
92620843|NCT05466019|Docetaxel|docetaxel|mesh-list
92620844|NCT05466019|Oxaliplatin|oxaliplatin|mesh-list
92620845|NCT05466019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620846|NCT05466019|Tubulin Modulators|tubulin modulators|mesh-ancestor
92620847|NCT05466019|Antimitotic Agents|antimitotic agents|mesh-ancestor
92620848|NCT05466019|Mitosis Modulators|mitosis modulators|mesh-ancestor
92620849|NCT05466019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620850|NCT05466019|Antidotes|antidotes|mesh-ancestor
92620851|NCT05466019|Protective Agents|protective agents|mesh-ancestor
92620852|NCT05466019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620853|NCT05466019|Vitamin B Complex|vitamin b complex|mesh-ancestor
92620854|NCT05466019|Vitamins|vitamins|mesh-ancestor
92620855|NCT05466019|Micronutrients|micronutrients|mesh-ancestor
92620856|NCT05465902|Vaccines|vaccines|mesh-list
92620857|NCT05465902|Immunologic Factors|immunologic factors|mesh-ancestor
92620858|NCT05465902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620859|NCT00151346|Fentanyl|fentanyl|mesh-list
92620860|NCT00151346|Bupivacaine|bupivacaine|mesh-list
92620861|NCT00151346|Anesthetics, Local|anesthetics, local|mesh-ancestor
92620862|NCT00151346|Anesthetics|anesthetics|mesh-ancestor
92620863|NCT00151346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620864|NCT00151346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620865|NCT00151346|Sensory System Agents|sensory system agents|mesh-ancestor
92620866|NCT00151346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620867|NCT00151346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92620868|NCT00151346|Narcotics|narcotics|mesh-ancestor
92620869|NCT00151346|Analgesics|analgesics|mesh-ancestor
92620870|NCT00151346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92620871|NCT00151346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92620872|NCT00151346|Anesthetics, General|anesthetics, general|mesh-ancestor
92620873|NCT00164424|Acyclovir|acyclovir|mesh-list
92620874|NCT00164424|Antiviral Agents|antiviral agents|mesh-ancestor
92620875|NCT00164424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620876|NCT00532519|Citalopram|citalopram|mesh-list
92620877|NCT00532519|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92620878|NCT00532519|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92620879|NCT00532519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92620880|NCT00532519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620881|NCT00532519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620882|NCT00532519|Serotonin Agents|serotonin agents|mesh-ancestor
92620883|NCT00532519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620884|NCT00532519|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92620885|NCT00532519|Antidepressive Agents|antidepressive agents|mesh-ancestor
92620886|NCT00532519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92620887|NCT00171678|Diclofenac|diclofenac|mesh-list
92752317|NCT05940909|Diuretics|diuretics|mesh-ancestor
92537761|NCT00142870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92537762|NCT00142870|Antidepressive Agents|antidepressive agents|mesh-ancestor
92537763|NCT00142870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027820|NCT05205811|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92346019|NCT01898442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620897|NCT00171678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620898|NCT00171678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620899|NCT00151463|Sildenafil Citrate|sildenafil citrate|mesh-list
92620900|NCT00151463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620902|NCT00151463|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92620903|NCT00151463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92620904|NCT00151463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620905|NCT00151463|Urological Agents|urological agents|mesh-ancestor
92620906|NCT00171717|Cyclosporine|cyclosporine|mesh-list
92620907|NCT00171717|Cyclosporins|cyclosporins|mesh-list
92620908|NCT00171717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620909|NCT00171717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620910|NCT00171717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620911|NCT00171717|Immunologic Factors|immunologic factors|mesh-ancestor
92620912|NCT00171717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620913|NCT00171717|Antifungal Agents|antifungal agents|mesh-ancestor
92620914|NCT00171717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620915|NCT00171717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92620916|NCT00171717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92620917|NCT00171717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92620918|NCT00151502|Atorvastatin|atorvastatin|mesh-list
92620919|NCT00151502|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92620920|NCT00151502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92620921|NCT00151502|Antimetabolites|antimetabolites|mesh-ancestor
92620922|NCT00151502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620923|NCT00151502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620924|NCT00151502|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92620925|NCT00151502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620926|NCT00164463|Moxifloxacin|moxifloxacin|mesh-list
92620927|NCT00164463|Isoniazid|isoniazid|mesh-list
92620928|NCT00164463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620929|NCT00164463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620930|NCT00164463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92620931|NCT00164463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92620932|NCT00164463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620933|NCT00164463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620934|NCT00164463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620935|NCT00164463|Antitubercular Agents|antitubercular agents|mesh-ancestor
92620936|NCT00164463|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92620937|NCT00164463|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92620938|NCT00164463|Antimetabolites|antimetabolites|mesh-ancestor
92620939|NCT00164463|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92620940|NCT00171756|Atenolol|atenolol|mesh-list
92620941|NCT00171756|Valsartan|valsartan|mesh-list
92620942|NCT00171756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620943|NCT00171756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92620944|NCT00171756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92620945|NCT00171756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620946|NCT00171756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92620947|NCT00171756|Sympatholytics|sympatholytics|mesh-ancestor
92620948|NCT00171756|Autonomic Agents|autonomic agents|mesh-ancestor
92620949|NCT00171756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620950|NCT00171756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620951|NCT00171756|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92620953|NCT00171756|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92620954|NCT00171756|Adrenergic Agents|adrenergic agents|mesh-ancestor
92620955|NCT00171756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620956|NCT00171795|Rivastigmine|rivastigmine|mesh-list
92620957|NCT00171795|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92620958|NCT00171795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620959|NCT00171795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620960|NCT00171795|Cholinergic Agents|cholinergic agents|mesh-ancestor
92620961|NCT00171795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620962|NCT00171795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620963|NCT00171795|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92537764|NCT00142870|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92537765|NCT00142870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92537766|NCT00142870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945426|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
92620964|NCT00171795|Protective Agents|protective agents|mesh-ancestor
92620965|NCT00151541|Dapsone|dapsone|mesh-list
92620966|NCT00151541|Adapalene|adapalene|mesh-list
92620967|NCT00151541|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92620968|NCT00151541|Dermatologic Agents|dermatologic agents|mesh-ancestor
92620969|NCT00151541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92620970|NCT00151541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92620971|NCT00151541|Analgesics|analgesics|mesh-ancestor
92620972|NCT00151541|Sensory System Agents|sensory system agents|mesh-ancestor
92346092|NCT01856322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92620973|NCT00151541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620974|NCT00151541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620975|NCT00151541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620976|NCT00151541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92620977|NCT00151541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620978|NCT00151541|Antimalarials|antimalarials|mesh-ancestor
92620979|NCT00151541|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92620980|NCT00151541|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92620981|NCT00151541|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92620982|NCT00151541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620983|NCT00151541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620984|NCT00151541|Leprostatic Agents|leprostatic agents|mesh-ancestor
92620985|NCT00151541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620986|NCT00151580|Ribavirin|ribavirin|mesh-list
92620987|NCT00151580|Antimetabolites|antimetabolites|mesh-ancestor
92620988|NCT00151580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620989|NCT00151580|Antiviral Agents|antiviral agents|mesh-ancestor
92620990|NCT00151580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620991|NCT00171912|Imatinib Mesylate|imatinib mesylate|mesh-list
92620992|NCT00171912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620993|NCT00171912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620994|NCT00171912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620995|NCT00171912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620996|NCT00151619|Amlodipine|amlodipine|mesh-list
92620997|NCT00151619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92620998|NCT00151619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92620999|NCT00151619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621000|NCT00151619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621001|NCT00151619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92621002|NCT00151619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621003|NCT00151619|Vasodilator Agents|vasodilator agents|mesh-ancestor
92621004|NCT00532675|Lenalidomide|lenalidomide|mesh-list
92621005|NCT00532675|Panobinostat|panobinostat|mesh-list
92621006|NCT00532675|Immunologic Factors|immunologic factors|mesh-ancestor
92621007|NCT00532675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621008|NCT00532675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92621009|NCT00532675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92621010|NCT00532675|Growth Substances|growth substances|mesh-ancestor
92621011|NCT00532675|Growth Inhibitors|growth inhibitors|mesh-ancestor
92621012|NCT00532675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621013|NCT00532675|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92621014|NCT00532675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621015|NCT00532675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621016|NCT05308030|Aspirin|aspirin|mesh-list
92621017|NCT05308030|Rivaroxaban|rivaroxaban|mesh-list
92621018|NCT05308030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621019|NCT05308030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621020|NCT05308030|Analgesics|analgesics|mesh-ancestor
92621021|NCT05308030|Sensory System Agents|sensory system agents|mesh-ancestor
92621022|NCT05308030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621023|NCT05308030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621024|NCT05308030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621034|NCT05308030|Antithrombins|antithrombins|mesh-ancestor
92621035|NCT05308030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92621036|NCT05308030|Protease Inhibitors|protease inhibitors|mesh-ancestor
92621037|NCT05308030|Anticoagulants|anticoagulants|mesh-ancestor
92621038|NCT05293600|Acetazolamide|acetazolamide|mesh-list
92537767|NCT00142870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537769|NCT00142870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537770|NCT00142870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537771|NCT00142870|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92537772|NCT00142870|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92537773|NCT00142870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537774|NCT00142948|Naltrexone|naltrexone|mesh-list
92537775|NCT00142948|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92537776|NCT00142948|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92537777|NCT00142948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537778|NCT00142948|Sensory System Agents|sensory system agents|mesh-ancestor
92537779|NCT00142948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537780|NCT02780427|Dexmedetomidine|dexmedetomidine|mesh-list
92537781|NCT02780427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92537782|NCT02780427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537783|NCT02780427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537784|NCT02780427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92537785|NCT02780427|Analgesics|analgesics|mesh-ancestor
92537786|NCT02780427|Sensory System Agents|sensory system agents|mesh-ancestor
92537787|NCT02780427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621039|NCT05293600|Eszopiclone|eszopiclone|mesh-list
92621040|NCT05293600|Trazodone|trazodone|mesh-list
92621041|NCT05293600|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92621042|NCT05293600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92621043|NCT05293600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92621044|NCT05293600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621045|NCT05293600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621046|NCT05293600|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621047|NCT05293600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621048|NCT05293600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621049|NCT05293600|Anticonvulsants|anticonvulsants|mesh-ancestor
92621050|NCT05293600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92621051|NCT05293600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621052|NCT05293600|Diuretics|diuretics|mesh-ancestor
92621053|NCT05293600|Natriuretic Agents|natriuretic agents|mesh-ancestor
92621054|NCT05293600|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92621055|NCT05293600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621056|NCT05293600|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92621057|NCT05293600|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92621058|NCT05293600|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621059|NCT05293600|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92621060|NCT05293600|Serotonin Agents|serotonin agents|mesh-ancestor
92621061|NCT05293600|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92621062|NCT05293600|Antidepressive Agents|antidepressive agents|mesh-ancestor
92621063|NCT00151697|Insulin Aspart|insulin aspart|mesh-list
92621064|NCT00151697|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92621065|NCT00151697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92621066|NCT00151697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621067|NCT00532714|Capecitabine|capecitabine|mesh-list
92621068|NCT00532714|Irinotecan|irinotecan|mesh-list
91945451|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621069|NCT00532714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92621070|NCT00532714|Antimetabolites|antimetabolites|mesh-ancestor
92621071|NCT00532714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621072|NCT00532714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361396|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621073|NCT00532714|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92621074|NCT00532714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92621075|NCT00532714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621076|NCT00151736|Etodolac|etodolac|mesh-list
92621077|NCT00151736|Chlorambucil|chlorambucil|mesh-list
92621078|NCT00151736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92621079|NCT00151736|Alkylating Agents|alkylating agents|mesh-ancestor
92621080|NCT00151736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621081|NCT00151736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621082|NCT00151736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621083|NCT00151736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621084|NCT00151736|Analgesics|analgesics|mesh-ancestor
92621085|NCT00151736|Sensory System Agents|sensory system agents|mesh-ancestor
92621086|NCT00151736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621087|NCT00151736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621088|NCT00151736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028030|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
92621098|NCT00171990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621099|NCT00172029|Zoledronic Acid|zoledronic acid|mesh-list
92621100|NCT00172029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92621101|NCT00172029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621102|NCT00406094|Montelukast|montelukast|mesh-list
92621103|NCT00406094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92621104|NCT00406094|Respiratory System Agents|respiratory system agents|mesh-ancestor
92621105|NCT00406094|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92621106|NCT00406094|Hormone Antagonists|hormone antagonists|mesh-ancestor
92621107|NCT00406094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621108|NCT00406094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621109|NCT00406094|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92621110|NCT00406094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92621111|NCT00406094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621112|NCT00164736|Ritonavir|ritonavir|mesh-list
92621113|NCT00164736|Lopinavir|lopinavir|mesh-list
92621114|NCT00164736|Lamivudine|lamivudine|mesh-list
92621115|NCT00164736|Zidovudine|zidovudine|mesh-list
92621116|NCT00164736|Nevirapine|nevirapine|mesh-list
92621117|NCT00164736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92621118|NCT00164736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92621119|NCT00164736|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346245|NCT01851330|Sofosbuvir|sofosbuvir|mesh-list
92621120|NCT00164736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621121|NCT00164736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621123|NCT00164736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92621124|NCT00164736|Antiviral Agents|antiviral agents|mesh-ancestor
92621125|NCT00164736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621126|NCT00164736|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92621127|NCT00164736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92621128|NCT00164736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92621129|NCT00164736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92621130|NCT00164736|Antimetabolites|antimetabolites|mesh-ancestor
92621131|NCT00164736|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92621132|NCT00164736|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92621133|NCT05177146|Ketamine|ketamine|mesh-list
92621134|NCT05177146|Analgesics|analgesics|mesh-ancestor
92621135|NCT05177146|Sensory System Agents|sensory system agents|mesh-ancestor
92621136|NCT05177146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621137|NCT05177146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621138|NCT05177146|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92621139|NCT05177146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92621140|NCT05177146|Anesthetics, General|anesthetics, general|mesh-ancestor
92621141|NCT05177146|Anesthetics|anesthetics|mesh-ancestor
92621142|NCT05177146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621143|NCT05177146|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92621144|NCT05177146|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92621145|NCT05177146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621146|NCT05177146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621147|NCT00532909|Bevacizumab|bevacizumab|mesh-list
92537788|NCT02780427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92537789|NCT02780427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92537790|NCT02780427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91966602|NCT03235609|Fentanyl|fentanyl|mesh-list
92621148|NCT00532909|Capecitabine|capecitabine|mesh-list
92621149|NCT00532909|Oxaliplatin|oxaliplatin|mesh-list
92621150|NCT00532909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92621151|NCT00532909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621152|NCT00532909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92621153|NCT00532909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92621155|NCT00532909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621156|NCT00532909|Growth Inhibitors|growth inhibitors|mesh-ancestor
92621157|NCT00532909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92621158|NCT00532909|Antimetabolites|antimetabolites|mesh-ancestor
92621159|NCT00532909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621160|NCT00172068|Vitamin D|vitamin d|mesh-list
92621161|NCT00172068|Zoledronic Acid|zoledronic acid|mesh-list
92621162|NCT00172068|Calcium|calcium|mesh-list
92621163|NCT00172068|Vitamins|vitamins|mesh-ancestor
92621164|NCT00172068|Micronutrients|micronutrients|mesh-ancestor
92621165|NCT00172068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621166|NCT00172068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92621167|NCT00172068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92621168|NCT00151970|Methylphenidate|methylphenidate|mesh-list
92621169|NCT00151970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92621170|NCT00151970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621171|NCT00151970|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92621172|NCT00151970|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92621173|NCT00151970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621174|NCT00151970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621175|NCT00151970|Dopamine Agents|dopamine agents|mesh-ancestor
92621176|NCT00151970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621177|NCT00152048|Eflornithine|eflornithine|mesh-list
92621178|NCT00152048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621179|NCT00152048|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92621180|NCT00152048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92621181|NCT00152048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92621182|NCT00152048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621183|NCT00152048|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92621184|NCT00152048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621185|NCT00152048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621186|NCT05060068|Ketamine|ketamine|mesh-list
92621187|NCT05060068|Esketamine|esketamine|mesh-list
92621188|NCT05060068|Analgesics|analgesics|mesh-ancestor
92621189|NCT05060068|Sensory System Agents|sensory system agents|mesh-ancestor
92621190|NCT05060068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621191|NCT05060068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621192|NCT05060068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92621193|NCT05060068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92621195|NCT05060068|Anesthetics|anesthetics|mesh-ancestor
92621196|NCT05060068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621197|NCT05060068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92621198|NCT05060068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92621199|NCT05060068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621200|NCT05060068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621201|NCT05060068|Antidepressive Agents|antidepressive agents|mesh-ancestor
92621202|NCT05060068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621203|NCT04687111|Valsartan|valsartan|mesh-list
92621204|NCT04687111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92621205|NCT04687111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621206|NCT04687111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92621207|NCT04687111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92621208|NCT04687111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621209|NCT00164775|Imipramine|imipramine|mesh-list
92621210|NCT00164775|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92621211|NCT00164775|Antidepressive Agents|antidepressive agents|mesh-ancestor
92621212|NCT00164775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621213|NCT00164775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92621214|NCT00164775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92537791|NCT02780427|Adrenergic Agents|adrenergic agents|mesh-ancestor
92537792|NCT02780427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682771|NCT00474435|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92621215|NCT00164775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621216|NCT00164775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621217|NCT00164775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621218|NCT00164775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621219|NCT00164775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621220|NCT00533026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92621221|NCT00533026|Warfarin|warfarin|mesh-list
92621222|NCT00533026|Anticoagulants|anticoagulants|mesh-ancestor
92621223|NCT00533026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92621224|NCT00533026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92621233|NCT00533026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621234|NCT00533026|Dopamine Agents|dopamine agents|mesh-ancestor
92621235|NCT00152126|Melphalan|melphalan|mesh-list
92621236|NCT00152126|Busulfan|busulfan|mesh-list
92621237|NCT00152126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92621238|NCT00152126|Alkylating Agents|alkylating agents|mesh-ancestor
92621239|NCT00152126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621240|NCT00152126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621241|NCT00152126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92621242|NCT00152126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621243|NCT00152126|Immunologic Factors|immunologic factors|mesh-ancestor
92621244|NCT00152126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621245|NCT05039593|Chlorhexidine|chlorhexidine|mesh-list
92621246|NCT05039593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92621247|NCT05039593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621248|NCT05039593|Disinfectants|disinfectants|mesh-ancestor
92621249|NCT00425451|Chlorhexidine|chlorhexidine|mesh-list
92621250|NCT00425451|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92621251|NCT00425451|Flurbiprofen|flurbiprofen|mesh-list
92621252|NCT00425451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92621253|NCT00425451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621254|NCT00425451|Disinfectants|disinfectants|mesh-ancestor
92621255|NCT00425451|Dermatologic Agents|dermatologic agents|mesh-ancestor
92621256|NCT00425451|Analgesics|analgesics|mesh-ancestor
92621257|NCT00425451|Sensory System Agents|sensory system agents|mesh-ancestor
92621258|NCT00425451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621259|NCT00425451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621260|NCT00425451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621261|NCT00425451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621262|NCT00425451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621263|NCT00425451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92346391|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
92621264|NCT00425451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621265|NCT00425451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621266|NCT00425451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621267|NCT00152204|Pyrimethamine|pyrimethamine|mesh-list
92621268|NCT00152204|Sulfadoxine|sulfadoxine|mesh-list
92621269|NCT00152204|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92621270|NCT00152204|Antimalarials|antimalarials|mesh-ancestor
92621271|NCT00152204|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92621272|NCT00152204|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92621273|NCT00152204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621274|NCT00152204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92621275|NCT00152204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621276|NCT00152204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621277|NCT00152204|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92621278|NCT00533065|Donepezil|donepezil|mesh-list
92621279|NCT00533065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92621280|NCT00533065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621281|NCT00533065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621282|NCT00533065|Cholinergic Agents|cholinergic agents|mesh-ancestor
92621283|NCT00533065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621284|NCT00533065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621285|NCT00533065|Nootropic Agents|nootropic agents|mesh-ancestor
92621286|NCT00152243|Tegafur|tegafur|mesh-list
92621287|NCT00152243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92621288|NCT00152243|Antimetabolites|antimetabolites|mesh-ancestor
92752318|NCT05940909|Natriuretic Agents|natriuretic agents|mesh-ancestor
92361410|NCT02128230|Glucocorticoids|glucocorticoids|mesh-ancestor
92537793|NCT02780427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621289|NCT00152243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621293|NCT00172107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621294|NCT00152282|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92621297|NCT00152282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621298|NCT00152282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621299|NCT04922983|Botulinum Toxins|botulinum toxins|mesh-list
92621300|NCT04922983|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92621301|NCT04922983|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92621302|NCT04922983|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92621303|NCT04922983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621304|NCT04922983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621305|NCT04922983|Cholinergic Agents|cholinergic agents|mesh-ancestor
92621306|NCT04922983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621307|NCT04922983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621308|NCT04922983|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92621309|NCT04922983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621310|NCT04914247|Selexipag|selexipag|mesh-list
92621311|NCT04914247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621312|NCT00152360|Orlistat|orlistat|mesh-list
92621313|NCT00152360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621314|NCT00152360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621315|NCT00152360|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92621316|NCT00152360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92621317|NCT00164892|Rofecoxib|rofecoxib|mesh-list
92621318|NCT00164892|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92621319|NCT00164892|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621320|NCT00164892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621321|NCT00164892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621322|NCT00164892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621323|NCT00164892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621324|NCT00164892|Analgesics|analgesics|mesh-ancestor
92621325|NCT00164892|Sensory System Agents|sensory system agents|mesh-ancestor
92621326|NCT00164892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621327|NCT00164892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621328|NCT00164892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621329|NCT00164892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621330|NCT00152399|Somatostatin|somatostatin|mesh-list
92621331|NCT00152399|Hormones|hormones|mesh-ancestor
92621332|NCT00152399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621333|NCT00152399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621334|NCT00164931|Omeprazole|omeprazole|mesh-list
92621335|NCT00164931|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92346466|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621336|NCT00164931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92621337|NCT00164931|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92621338|NCT00164931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621339|NCT00164931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621340|NCT00152438|Progesterone|progesterone|mesh-list
92621341|NCT00152438|Progestins|progestins|mesh-ancestor
92621342|NCT00152438|Hormones|hormones|mesh-ancestor
92621343|NCT00152438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621344|NCT00152438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621345|NCT00164970|Vitamin B 12|vitamin b 12|mesh-list
92621346|NCT00164970|Hydroxocobalamin|hydroxocobalamin|mesh-list
92621347|NCT00164970|Vitamins|vitamins|mesh-ancestor
92621348|NCT00164970|Micronutrients|micronutrients|mesh-ancestor
92621349|NCT00164970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621350|NCT00164970|Vitamin B Complex|vitamin b complex|mesh-ancestor
92621351|NCT00164970|Hematinics|hematinics|mesh-ancestor
92621352|NCT02937844|Cyclophosphamide|cyclophosphamide|mesh-list
92621353|NCT02937844|Fludarabine|fludarabine|mesh-list
92621354|NCT02937844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621355|NCT02937844|Immunologic Factors|immunologic factors|mesh-ancestor
92621356|NCT02937844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621357|NCT02937844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621358|NCT02937844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92621359|NCT02937844|Alkylating Agents|alkylating agents|mesh-ancestor
92621365|NCT02937415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621367|NCT02937415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621368|NCT02937415|Antimetabolites|antimetabolites|mesh-ancestor
92537794|NCT00142987|Tegaserod|tegaserod|mesh-list
92537795|NCT00142987|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92537796|NCT00142987|Serotonin Agents|serotonin agents|mesh-ancestor
92621369|NCT02937415|Gasotransmitters|gasotransmitters|mesh-ancestor
92621370|NCT02937415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621371|NCT00152594|Voriconazole|voriconazole|mesh-list
92621372|NCT00152594|Antifungal Agents|antifungal agents|mesh-ancestor
92621373|NCT00152594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621374|NCT00152594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92621375|NCT00152594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92621376|NCT00152594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621377|NCT00152594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621378|NCT00152594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92621379|NCT00152594|Hormone Antagonists|hormone antagonists|mesh-ancestor
92621380|NCT00152594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621381|NCT00152594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621382|NCT00152594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92621383|NCT00407199|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92621384|NCT00407199|Antidepressive Agents|antidepressive agents|mesh-ancestor
92621385|NCT00407199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621386|NCT00407199|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92621387|NCT00407199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92621388|NCT00407199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621389|NCT00407199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621390|NCT04725422|Zoledronic Acid|zoledronic acid|mesh-list
92621391|NCT04725422|Pamidronate|pamidronate|mesh-list
92621392|NCT04725422|Sulfasalazine|sulfasalazine|mesh-list
92621393|NCT04725422|Adalimumab|adalimumab|mesh-list
92621394|NCT04725422|Infliximab|infliximab|mesh-list
92621395|NCT04725422|Golimumab|golimumab|mesh-list
92621396|NCT04725422|Certolizumab Pegol|certolizumab pegol|mesh-list
92621397|NCT04725422|Etanercept|etanercept|mesh-list
92621398|NCT04725422|Methotrexate|methotrexate|mesh-list
92621399|NCT04725422|Leflunomide|leflunomide|mesh-list
92621400|NCT04725422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92621401|NCT04725422|Abortifacient Agents|abortifacient agents|mesh-ancestor
92621402|NCT04725422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92621403|NCT04725422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621404|NCT04725422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92621405|NCT04725422|Antimetabolites|antimetabolites|mesh-ancestor
92621406|NCT04725422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621407|NCT04725422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621408|NCT04725422|Dermatologic Agents|dermatologic agents|mesh-ancestor
92621409|NCT04725422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621410|NCT04725422|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92621411|NCT04725422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621412|NCT04725422|Immunologic Factors|immunologic factors|mesh-ancestor
92621413|NCT04725422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621414|NCT04725422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92621415|NCT04725422|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92621416|NCT04725422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621417|NCT04725422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92621418|NCT04725422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621419|NCT04725422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621420|NCT04725422|Analgesics|analgesics|mesh-ancestor
92621421|NCT04725422|Sensory System Agents|sensory system agents|mesh-ancestor
92621422|NCT04725422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621423|NCT04725422|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92621424|NCT04725422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621425|NCT00152633|Losartan|losartan|mesh-list
92621426|NCT00152633|Metoprolol|metoprolol|mesh-list
92621427|NCT00152633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92621428|NCT00152633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621431|NCT00152633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621432|NCT00152633|Sympatholytics|sympatholytics|mesh-ancestor
92621433|NCT00152633|Autonomic Agents|autonomic agents|mesh-ancestor
92621434|NCT00152633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621435|NCT00152633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621436|NCT00152633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92621437|NCT00152633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92621438|NCT00152633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92621439|NCT00152633|Adrenergic Agents|adrenergic agents|mesh-ancestor
92537797|NCT00142987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537798|NCT00142987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621440|NCT00152633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621441|NCT02937181|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92621442|NCT02937181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92621443|NCT02937181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621444|NCT00425490|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92621445|NCT00425490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92621446|NCT00425490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621447|NCT00425490|Incretins|incretins|mesh-ancestor
92621448|NCT00425490|Hormones|hormones|mesh-ancestor
92621449|NCT00425490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621450|NCT00425490|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92621451|NCT00425490|Protease Inhibitors|protease inhibitors|mesh-ancestor
92621452|NCT00425490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621453|NCT00425490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621454|NCT03457753|Riluzole|riluzole|mesh-list
92621455|NCT03457753|Anticonvulsants|anticonvulsants|mesh-ancestor
92621456|NCT03457753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92621457|NCT03457753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92621458|NCT03457753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621459|NCT03457753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621460|NCT03457753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621461|NCT03457753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92621462|NCT03457753|Protective Agents|protective agents|mesh-ancestor
92621463|NCT02936830|Listerine|listerine|mesh-list
92621464|NCT02936830|Fluorides|fluorides|mesh-list
92621465|NCT02936830|Sodium Fluoride|sodium fluoride|mesh-list
92621466|NCT02936830|Fluorides, Topical|fluorides, topical|mesh-list
92621467|NCT02936830|Glycerol|glycerol|mesh-list
92621468|NCT02936830|Cariostatic Agents|cariostatic agents|mesh-ancestor
92621469|NCT02936830|Protective Agents|protective agents|mesh-ancestor
92621470|NCT02936830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621471|NCT02936830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92621472|NCT02936830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621473|NCT02936830|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92621474|NCT00165048|Rofecoxib|rofecoxib|mesh-list
92621475|NCT00165048|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92621476|NCT00165048|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621477|NCT00165048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621478|NCT00165048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621479|NCT00165048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621480|NCT00165048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621481|NCT00165048|Analgesics|analgesics|mesh-ancestor
92621482|NCT00165048|Sensory System Agents|sensory system agents|mesh-ancestor
92621483|NCT00165048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621484|NCT00165048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346617|NCT01838616|Analgesics|analgesics|mesh-ancestor
92621485|NCT00165048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621486|NCT00165048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621487|NCT04690270|Sumatriptan|sumatriptan|mesh-list
92621488|NCT04690270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92621489|NCT04690270|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92621490|NCT04690270|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92621491|NCT04690270|Serotonin Agents|serotonin agents|mesh-ancestor
92621492|NCT04690270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621493|NCT04690270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621494|NCT04690270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621495|NCT00165087|Doxorubicin|doxorubicin|mesh-list
92621496|NCT00165087|Dexrazoxane|dexrazoxane|mesh-list
92621497|NCT00165087|Asparaginase|asparaginase|mesh-list
92621498|NCT00165087|Razoxane|razoxane|mesh-list
92621499|NCT00165087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92621500|NCT00165087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621501|NCT00165087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92621502|NCT00165087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92621504|NCT00165087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621505|NCT00165087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92621506|NCT00165087|Protective Agents|protective agents|mesh-ancestor
92621507|NCT00165087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621508|NCT00165087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92621509|NCT00165087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537799|NCT00142987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537800|NCT00143026|Levodopa|levodopa|mesh-list
92537801|NCT00143026|Carbidopa|carbidopa|mesh-list
92537802|NCT00143026|Entacapone|entacapone|mesh-list
92621510|NCT00152750|Clonidine|clonidine|mesh-list
92621511|NCT00152750|Analgesics|analgesics|mesh-ancestor
92621512|NCT00152750|Sensory System Agents|sensory system agents|mesh-ancestor
92621513|NCT00152750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621514|NCT00152750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621515|NCT00152750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621516|NCT00152750|Sympatholytics|sympatholytics|mesh-ancestor
92621517|NCT00152750|Autonomic Agents|autonomic agents|mesh-ancestor
92621518|NCT00152750|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92621519|NCT00152750|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92621520|NCT00152750|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92621521|NCT00152750|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621522|NCT00152750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621523|NCT00152750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621524|NCT02936167|Plasma-lyte 148|plasma-lyte 148|mesh-list
92621525|NCT02936167|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92621526|NCT02936167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92621527|NCT00152828|Celecoxib|celecoxib|mesh-list
92621528|NCT00152828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621529|NCT00152828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621530|NCT00152828|Analgesics|analgesics|mesh-ancestor
92621531|NCT00152828|Sensory System Agents|sensory system agents|mesh-ancestor
92621532|NCT00152828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621533|NCT00152828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621534|NCT00152828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621535|NCT00152828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621536|NCT00152828|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92621537|NCT00152828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621538|NCT00152828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621539|NCT00152828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621540|NCT02935933|Dexmedetomidine|dexmedetomidine|mesh-list
92621541|NCT02935933|Morphine|morphine|mesh-list
92621542|NCT02935933|Bupivacaine|bupivacaine|mesh-list
92621543|NCT02935933|Anesthetics, Local|anesthetics, local|mesh-ancestor
92621544|NCT02935933|Anesthetics|anesthetics|mesh-ancestor
92621545|NCT02935933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621546|NCT02935933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621547|NCT02935933|Sensory System Agents|sensory system agents|mesh-ancestor
92621548|NCT02935933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621549|NCT02935933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92621550|NCT02935933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621551|NCT02935933|Analgesics|analgesics|mesh-ancestor
92621552|NCT02935933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92621553|NCT02935933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92621554|NCT02935933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92621555|NCT02935933|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621556|NCT02935933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621557|NCT02935933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621558|NCT02935933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92621559|NCT02935933|Narcotics|narcotics|mesh-ancestor
92621560|NCT00152867|Dexamethasone|dexamethasone|mesh-list
92621561|NCT00152867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621563|NCT00152867|Autonomic Agents|autonomic agents|mesh-ancestor
92621564|NCT00152867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621565|NCT00152867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361434|NCT05560620|Caffeine|caffeine|mesh-list
92621566|NCT00152867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92621567|NCT00152867|Glucocorticoids|glucocorticoids|mesh-ancestor
92621568|NCT00152867|Hormones|hormones|mesh-ancestor
92621569|NCT00152867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621570|NCT00152867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92621571|NCT00152867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621572|NCT02935972|Lidocaine|lidocaine|mesh-list
92621573|NCT02935972|Diazepam|diazepam|mesh-list
92621574|NCT02935972|Anesthetics, Local|anesthetics, local|mesh-ancestor
92621575|NCT02935972|Anesthetics|anesthetics|mesh-ancestor
92621588|NCT02935972|Autonomic Agents|autonomic agents|mesh-ancestor
92621589|NCT02935972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92621590|NCT02935972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92621591|NCT02935972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92537803|NCT00143026|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92537804|NCT00143026|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92537805|NCT00143026|Dopamine Agents|dopamine agents|mesh-ancestor
92537806|NCT00143026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621592|NCT02935972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92621593|NCT02935972|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92621594|NCT02935972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92621595|NCT02935972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621596|NCT02935972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92621597|NCT02935972|Anesthetics, General|anesthetics, general|mesh-ancestor
92621598|NCT02935972|GABA Modulators|gaba modulators|mesh-ancestor
92621599|NCT02935972|GABA Agents|gaba agents|mesh-ancestor
92621600|NCT02935972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621601|NCT02935855|Warfarin|warfarin|mesh-list
92621602|NCT02935855|Rivaroxaban|rivaroxaban|mesh-list
92621603|NCT02935855|Dabigatran|dabigatran|mesh-list
92621604|NCT02935855|Apixaban|apixaban|mesh-list
92621605|NCT02935855|Edoxaban|edoxaban|mesh-list
92621606|NCT02935855|Anticoagulants|anticoagulants|mesh-ancestor
92621607|NCT02935855|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92621608|NCT02935855|Antithrombins|antithrombins|mesh-ancestor
92621609|NCT02935855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92621610|NCT02935855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92621611|NCT02935855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621612|NCT02935855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621613|NCT02935582|Betamethasone|betamethasone|mesh-list
92621614|NCT02935582|Betamethasone Valerate|betamethasone valerate|mesh-list
92621615|NCT02935582|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92621616|NCT02935582|Betamethasone benzoate|betamethasone benzoate|mesh-list
92621617|NCT02935582|Calcipotriene|calcipotriene|mesh-list
92621618|NCT02935582|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92621619|NCT02935582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621620|NCT02935582|Glucocorticoids|glucocorticoids|mesh-ancestor
92621621|NCT02935582|Hormones|hormones|mesh-ancestor
92621622|NCT02935582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621623|NCT02935582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621624|NCT02935582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92621625|NCT02935582|Respiratory System Agents|respiratory system agents|mesh-ancestor
92621626|NCT02935582|Dermatologic Agents|dermatologic agents|mesh-ancestor
92621627|NCT00406172|Bevacizumab|bevacizumab|mesh-list
92621628|NCT00406172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92621629|NCT00406172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621630|NCT00406172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92621631|NCT00406172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92621632|NCT00406172|Growth Substances|growth substances|mesh-ancestor
92621633|NCT00406172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346811|NCT01789320|Hormones|hormones|mesh-ancestor
92621634|NCT00406172|Growth Inhibitors|growth inhibitors|mesh-ancestor
92621635|NCT00152945|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92621636|NCT00152945|Glycerol|glycerol|mesh-list
92621638|NCT00152945|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92621648|NCT02935231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92621650|NCT02935231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621651|NCT02935231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621652|NCT02935231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92621653|NCT02935231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92621654|NCT02935231|Cholinergic Agents|cholinergic agents|mesh-ancestor
92621655|NCT02935231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621656|NCT02935231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621657|NCT00172380|Docetaxel|docetaxel|mesh-list
92621658|NCT00172380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621659|NCT00172380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92621660|NCT00172380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92621661|NCT00172380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92621662|NCT00172380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621663|NCT00152984|Tiotropium Bromide|tiotropium bromide|mesh-list
92621664|NCT00152984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92621665|NCT00152984|Autonomic Agents|autonomic agents|mesh-ancestor
92621666|NCT00152984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621667|NCT00152984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621668|NCT00152984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92621669|NCT00152984|Respiratory System Agents|respiratory system agents|mesh-ancestor
92621670|NCT00152984|Parasympatholytics|parasympatholytics|mesh-ancestor
92621671|NCT00152984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92537807|NCT00143026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537808|NCT00143026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537809|NCT00143026|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92621672|NCT00152984|Cholinergic Agents|cholinergic agents|mesh-ancestor
92621673|NCT00152984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621674|NCT00152984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621676|NCT02935075|Lamivudine|lamivudine|mesh-list
92621677|NCT02935075|Efavirenz|efavirenz|mesh-list
92621678|NCT02935075|Antiviral Agents|antiviral agents|mesh-ancestor
92621679|NCT02935075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621680|NCT02935075|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92621681|NCT02935075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92621682|NCT02935075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621683|NCT02935075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621684|NCT02935075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92621685|NCT02935075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92621686|NCT02935075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92621687|NCT02935075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92621688|NCT02935075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92621689|NCT02935075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92621690|NCT02935075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92621691|NCT02935075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92621692|NCT02934919|Nalmefene|nalmefene|mesh-list
92621693|NCT02934919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92621694|NCT02934919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621695|NCT02934919|Sensory System Agents|sensory system agents|mesh-ancestor
92621696|NCT02934919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621697|NCT00172419|Atorvastatin|atorvastatin|mesh-list
92621698|NCT00172419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92621699|NCT00172419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92621700|NCT00172419|Antimetabolites|antimetabolites|mesh-ancestor
92621701|NCT00172419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621702|NCT00172419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92028647|NCT01646385|Immunologic Factors|immunologic factors|mesh-ancestor
92621703|NCT00172419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92621705|NCT00153023|Valsartan|valsartan|mesh-list
92621706|NCT00153023|Telmisartan|telmisartan|mesh-list
92621707|NCT00153023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621708|NCT00153023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92621709|NCT00153023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92621710|NCT00153023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621711|NCT00165204|Tibolone|tibolone|mesh-list
92621712|NCT00165204|Androgen Antagonists|androgen antagonists|mesh-ancestor
92621713|NCT00165204|Hormone Antagonists|hormone antagonists|mesh-ancestor
92621714|NCT00165204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621715|NCT00165204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621716|NCT00165204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621717|NCT00165204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92621718|NCT00165204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621719|NCT00165204|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92621720|NCT00165204|Anabolic Agents|anabolic agents|mesh-ancestor
92621721|NCT00165204|Hormones|hormones|mesh-ancestor
92621722|NCT02934763|Propranolol|propranolol|mesh-list
92621723|NCT02934763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92621724|NCT02934763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92621725|NCT02934763|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621726|NCT02934763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621727|NCT02934763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621728|NCT02934763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621729|NCT02934763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92621730|NCT02934763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621731|NCT02934763|Vasodilator Agents|vasodilator agents|mesh-ancestor
92621732|NCT04689958|Vitamin D|vitamin d|mesh-list
92621733|NCT04689958|Vitamins|vitamins|mesh-ancestor
92621734|NCT04689958|Micronutrients|micronutrients|mesh-ancestor
92621735|NCT04689958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621736|NCT04689958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92537810|NCT00143026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967202|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
92621737|NCT00153140|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92621738|NCT00153140|Laxatives|laxatives|mesh-ancestor
92621739|NCT00153140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92621740|NCT04684420|Metformin|metformin|mesh-list
92621741|NCT04684420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92621742|NCT04684420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621743|NCT02934607|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92621744|NCT02934607|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92621745|NCT02934607|Respiratory System Agents|respiratory system agents|mesh-ancestor
92621746|NCT00153296|Carbamazepine|carbamazepine|mesh-list
92621747|NCT00153296|Anticonvulsants|anticonvulsants|mesh-ancestor
92621748|NCT00153296|Antimanic Agents|antimanic agents|mesh-ancestor
92621749|NCT00153296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92621750|NCT00153296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621751|NCT00153296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621752|NCT00153296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92621753|NCT00153296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621754|NCT00153296|Analgesics|analgesics|mesh-ancestor
92621755|NCT00153296|Sensory System Agents|sensory system agents|mesh-ancestor
92621756|NCT00153296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621757|NCT00153296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92621758|NCT00153296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621759|NCT00153296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621760|NCT00153296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92621761|NCT00153296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92621762|NCT02934295|Antibodies|antibodies|mesh-list
92621763|NCT02934295|Immunologic Factors|immunologic factors|mesh-ancestor
92621764|NCT02934295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621765|NCT02934022|Maraviroc|maraviroc|mesh-list
92621766|NCT02934022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92621767|NCT02934022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92621768|NCT02934022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621769|NCT02934022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92621770|NCT02934022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92621771|NCT02934022|Antiviral Agents|antiviral agents|mesh-ancestor
92621772|NCT02934022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621773|NCT02934022|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92621774|NCT02934061|Tizanidine|tizanidine|mesh-list
92621775|NCT02934061|Analgesics|analgesics|mesh-ancestor
92621776|NCT02934061|Sensory System Agents|sensory system agents|mesh-ancestor
92621787|NCT02934061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621788|NCT02934061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621789|NCT02934061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621790|NCT02934217|Cyclosporine|cyclosporine|mesh-list
92621791|NCT02934217|Cyclosporins|cyclosporins|mesh-list
92621792|NCT02934217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621793|NCT02934217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621794|NCT02934217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621795|NCT02934217|Immunologic Factors|immunologic factors|mesh-ancestor
92621796|NCT02934217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621797|NCT02934217|Antifungal Agents|antifungal agents|mesh-ancestor
92621798|NCT02934217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621799|NCT02934217|Dermatologic Agents|dermatologic agents|mesh-ancestor
92621800|NCT02934217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621801|NCT02934217|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92621802|NCT00165360|Temozolomide|temozolomide|mesh-list
92621803|NCT00165360|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92621804|NCT00165360|Alkylating Agents|alkylating agents|mesh-ancestor
92361442|NCT05560620|Purinergic Agents|purinergic agents|mesh-ancestor
92621805|NCT00165360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621806|NCT00165360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621807|NCT02933905|Ranibizumab|ranibizumab|mesh-list
92621808|NCT02933905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92621809|NCT02933905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92621810|NCT02933905|Growth Substances|growth substances|mesh-ancestor
92621811|NCT02933905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621812|NCT02933905|Growth Inhibitors|growth inhibitors|mesh-ancestor
92621813|NCT02933905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621814|NCT02933788|Aspirin|aspirin|mesh-list
92621815|NCT02933788|Cilostazol|cilostazol|mesh-list
92621816|NCT02933788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621817|NCT02933788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621818|NCT02933788|Analgesics|analgesics|mesh-ancestor
92537811|NCT00143026|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92537813|NCT00404599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92621819|NCT02933788|Sensory System Agents|sensory system agents|mesh-ancestor
92621820|NCT02933788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621821|NCT02933788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621822|NCT02933788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621823|NCT02933788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621824|NCT02933788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92621825|NCT02933788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92621826|NCT02933788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621827|NCT02933788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92621828|NCT02933788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621829|NCT02933788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621830|NCT02933788|Antipyretics|antipyretics|mesh-ancestor
92621831|NCT02933788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92621832|NCT02933788|Autonomic Agents|autonomic agents|mesh-ancestor
92621833|NCT02933788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92621834|NCT02933788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92621835|NCT02933788|Vasodilator Agents|vasodilator agents|mesh-ancestor
92621836|NCT02933788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92621837|NCT02933788|Protective Agents|protective agents|mesh-ancestor
92621838|NCT02933788|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92621839|NCT02933788|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92621840|NCT00165399|Docetaxel|docetaxel|mesh-list
92621841|NCT00165399|Goserelin|goserelin|mesh-list
92621851|NCT00165399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92621852|NCT00165399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621853|NCT00165399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621854|NCT00165399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92621855|NCT00165399|Alkylating Agents|alkylating agents|mesh-ancestor
92621856|NCT02933593|Labetalol|labetalol|mesh-list
92621857|NCT02933593|Hydralazine|hydralazine|mesh-list
92621858|NCT02933593|Nifedipine|nifedipine|mesh-list
92621859|NCT02933593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92346994|NCT01768572|Analgesics|analgesics|mesh-ancestor
92621860|NCT02933593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621861|NCT02933593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621862|NCT02933593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92621863|NCT02933593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621864|NCT02933593|Vasodilator Agents|vasodilator agents|mesh-ancestor
92621865|NCT02933593|Tocolytic Agents|tocolytic agents|mesh-ancestor
92621866|NCT02933593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92621867|NCT02933593|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92621868|NCT02933593|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92621869|NCT02933593|Adrenergic Agents|adrenergic agents|mesh-ancestor
92621870|NCT02933593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621871|NCT02933593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621872|NCT02933593|Sympathomimetics|sympathomimetics|mesh-ancestor
92621873|NCT02933593|Autonomic Agents|autonomic agents|mesh-ancestor
92621874|NCT02933593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621875|NCT02933593|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92621876|NCT02933593|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92621877|NCT00153491|Lumefantrine|lumefantrine|mesh-list
92621879|NCT00153491|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92621880|NCT00153491|Antimalarials|antimalarials|mesh-ancestor
92621881|NCT00153491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92621882|NCT00153491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92621883|NCT00153491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621884|NCT02933437|Ajmaline|ajmaline|mesh-list
92621885|NCT02933437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92621886|NCT02933437|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92621887|NCT02933437|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92621888|NCT02933437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621889|NCT02933437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621890|NCT00153530|Methotrexate|methotrexate|mesh-list
92621891|NCT00153530|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92621892|NCT00153530|Abortifacient Agents|abortifacient agents|mesh-ancestor
92621893|NCT00153530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92621894|NCT00153530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537814|NCT00404599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92537815|NCT00404599|Antimetabolites|antimetabolites|mesh-ancestor
92537816|NCT00404599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537817|NCT00404599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92537818|NCT00404599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92621895|NCT00153530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92621896|NCT00153530|Antimetabolites|antimetabolites|mesh-ancestor
92621897|NCT00153530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621898|NCT00153530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621899|NCT00153530|Dermatologic Agents|dermatologic agents|mesh-ancestor
92621900|NCT00153530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621901|NCT00153530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92621902|NCT00153530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621903|NCT00153530|Immunologic Factors|immunologic factors|mesh-ancestor
92621904|NCT00153530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621905|NCT00153530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92621916|NCT02932930|Anesthetics|anesthetics|mesh-ancestor
92621917|NCT02932930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621918|NCT02932930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621919|NCT02932930|Sensory System Agents|sensory system agents|mesh-ancestor
92621920|NCT02932930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621921|NCT00165516|Sodium thiosulfate|sodium thiosulfate|mesh-list
92621922|NCT00165516|Antidotes|antidotes|mesh-ancestor
92621923|NCT00165516|Protective Agents|protective agents|mesh-ancestor
92621924|NCT00165516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621925|NCT00165516|Antioxidants|antioxidants|mesh-ancestor
92621926|NCT00165516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621927|NCT00165516|Antitubercular Agents|antitubercular agents|mesh-ancestor
92621928|NCT00165516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92621929|NCT00165516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621930|NCT00165516|Chelating Agents|chelating agents|mesh-ancestor
92621931|NCT00165516|Sequestering Agents|sequestering agents|mesh-ancestor
92621932|NCT04642378|Insulin|insulin|mesh-list
92621933|NCT04642378|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92621934|NCT04642378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92621935|NCT04642378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621936|NCT00407784|Eplerenone|eplerenone|mesh-list
92621937|NCT00407784|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92621938|NCT00407784|Hormone Antagonists|hormone antagonists|mesh-ancestor
92621939|NCT00407784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92621940|NCT00407784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621941|NCT00407784|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92621942|NCT00407784|Diuretics|diuretics|mesh-ancestor
92621943|NCT00407784|Natriuretic Agents|natriuretic agents|mesh-ancestor
92621944|NCT00407784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92621945|NCT02932774|Cetirizine|cetirizine|mesh-list
92621946|NCT02932774|Loratadine|loratadine|mesh-list
92621947|NCT02932774|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92621948|NCT02932774|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92621949|NCT02932774|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92621950|NCT02932774|Histamine Antagonists|histamine antagonists|mesh-ancestor
92621951|NCT02932774|Histamine Agents|histamine agents|mesh-ancestor
92621952|NCT02932774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621953|NCT02932774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621954|NCT02932774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621955|NCT02932774|Antipruritics|antipruritics|mesh-ancestor
92621956|NCT02932774|Dermatologic Agents|dermatologic agents|mesh-ancestor
92621957|NCT00180063|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92621958|NCT00180063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621959|NCT00180063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621960|NCT00153725|Aspirin|aspirin|mesh-list
92621961|NCT00153725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92621962|NCT00153725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92621963|NCT00153725|Analgesics|analgesics|mesh-ancestor
92621964|NCT00153725|Sensory System Agents|sensory system agents|mesh-ancestor
92621965|NCT00153725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621966|NCT00153725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537819|NCT00404599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537821|NCT00143065|Alemtuzumab|alemtuzumab|mesh-list
92537822|NCT00143065|Fludarabine|fludarabine|mesh-list
91967430|NCT05464745|Indapamide|indapamide|mesh-list
92621967|NCT00153725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92621968|NCT00153725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621969|NCT00153725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92621970|NCT00153725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92621971|NCT00153725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028918|NCT04939987|Analgesics|analgesics|mesh-ancestor
92621975|NCT00153725|Antipyretics|antipyretics|mesh-ancestor
92621976|NCT00153764|Vitamins|vitamins|mesh-list
92621977|NCT00153764|Micronutrients|micronutrients|mesh-ancestor
92621978|NCT00153764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621979|NCT00180102|Cytarabine|cytarabine|mesh-list
92621980|NCT00180102|Mitoxantrone|mitoxantrone|mesh-list
92621981|NCT00180102|Amsacrine|amsacrine|mesh-list
92621982|NCT00180102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92621983|NCT00180102|Antimetabolites|antimetabolites|mesh-ancestor
92621984|NCT00180102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621985|NCT00180102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621986|NCT00180102|Antiviral Agents|antiviral agents|mesh-ancestor
92621987|NCT00180102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621988|NCT00180102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92621989|NCT00180102|Immunologic Factors|immunologic factors|mesh-ancestor
92621990|NCT00180102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621991|NCT00180102|Analgesics|analgesics|mesh-ancestor
92621992|NCT00180102|Sensory System Agents|sensory system agents|mesh-ancestor
92621993|NCT00180102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621994|NCT00180102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92621995|NCT00180102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92621996|NCT00180102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621997|NCT04690309|Insulin|insulin|mesh-list
92621998|NCT04690309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92621999|NCT04690309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622000|NCT04690309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622001|NCT00153881|Carboplatin|carboplatin|mesh-list
92622002|NCT00153881|Docetaxel|docetaxel|mesh-list
92622003|NCT00153881|Capecitabine|capecitabine|mesh-list
92622004|NCT00153881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622005|NCT00153881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92622006|NCT00153881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92622007|NCT00153881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92622008|NCT00153881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622009|NCT00153881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622010|NCT00153881|Antimetabolites|antimetabolites|mesh-ancestor
92622011|NCT00180141|Pimecrolimus|pimecrolimus|mesh-list
92622012|NCT00180141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622013|NCT00180141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622014|NCT00180141|Analgesics|analgesics|mesh-ancestor
92622015|NCT00180141|Sensory System Agents|sensory system agents|mesh-ancestor
92622016|NCT00180141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622017|NCT00180141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622018|NCT00180141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622019|NCT00180141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622020|NCT00180141|Dermatologic Agents|dermatologic agents|mesh-ancestor
92622021|NCT00180141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622022|NCT00180141|Immunologic Factors|immunologic factors|mesh-ancestor
92622023|NCT00180141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92622024|NCT00180141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622025|NCT00180141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622026|NCT02931877|Propofol|propofol|mesh-list
92622027|NCT02931877|Sevoflurane|sevoflurane|mesh-list
92622028|NCT02931877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92622029|NCT02931877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622030|NCT02931877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622031|NCT02931877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92622032|NCT02931877|Anesthetics, General|anesthetics, general|mesh-ancestor
92622033|NCT02931877|Anesthetics|anesthetics|mesh-ancestor
92622034|NCT02931877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92622035|NCT02931877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92622036|NCT00153998|Leucovorin|leucovorin|mesh-list
92622037|NCT00153998|Folic Acid|folic acid|mesh-list
92622038|NCT00153998|Fluorouracil|fluorouracil|mesh-list
92537823|NCT00143065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92537824|NCT00143065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622039|NCT00153998|Oxaliplatin|oxaliplatin|mesh-list
92622041|NCT00153998|Cetuximab|cetuximab|mesh-list
92622042|NCT00153998|Levoleucovorin|levoleucovorin|mesh-list
92622043|NCT00153998|Antimetabolites|antimetabolites|mesh-ancestor
92622044|NCT00153998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622045|NCT00153998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622046|NCT00153998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622050|NCT00153998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92622051|NCT00153998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92622052|NCT00153998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622053|NCT00153998|Antidotes|antidotes|mesh-ancestor
92622054|NCT00153998|Protective Agents|protective agents|mesh-ancestor
92622055|NCT00153998|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622056|NCT00153998|Vitamins|vitamins|mesh-ancestor
92622057|NCT00153998|Micronutrients|micronutrients|mesh-ancestor
92622058|NCT00153998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92622059|NCT00153998|Hematinics|hematinics|mesh-ancestor
92622060|NCT02925130|Albuterol|albuterol|mesh-list
92622061|NCT02925130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92622062|NCT02925130|Autonomic Agents|autonomic agents|mesh-ancestor
92622063|NCT02925130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622064|NCT02925130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622065|NCT02925130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92622066|NCT02925130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92622067|NCT02925130|Tocolytic Agents|tocolytic agents|mesh-ancestor
92622068|NCT02925130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92622069|NCT02925130|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92622070|NCT02925130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92622071|NCT02925130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92622072|NCT02925130|Adrenergic Agents|adrenergic agents|mesh-ancestor
92622073|NCT02925130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622074|NCT02925130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622075|NCT02924974|Lidocaine|lidocaine|mesh-list
92622076|NCT02924974|Morphine|morphine|mesh-list
92622077|NCT02924974|Anesthetics, Local|anesthetics, local|mesh-ancestor
92622078|NCT02924974|Anesthetics|anesthetics|mesh-ancestor
92622079|NCT02924974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622080|NCT02924974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622081|NCT02924974|Sensory System Agents|sensory system agents|mesh-ancestor
92622082|NCT02924974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622083|NCT02924974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92622084|NCT02924974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92622085|NCT02924974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92622086|NCT02924974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622087|NCT02924974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622088|NCT02924974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92622089|NCT02924974|Narcotics|narcotics|mesh-ancestor
92622090|NCT02924974|Analgesics|analgesics|mesh-ancestor
92622091|NCT00154037|Pioglitazone|pioglitazone|mesh-list
92622092|NCT00154037|Candesartan|candesartan|mesh-list
92622093|NCT00154037|Candesartan cilexetil|candesartan cilexetil|mesh-list
92622094|NCT00154037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622095|NCT00154037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622096|NCT00154037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92622097|NCT00154037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92622098|NCT00154037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92622099|NCT00154037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622100|NCT02924857|Paclitaxel|paclitaxel|mesh-list
92622101|NCT02924857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92622102|NCT02924857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622103|NCT02924857|Tubulin Modulators|tubulin modulators|mesh-ancestor
92622104|NCT02924857|Antimitotic Agents|antimitotic agents|mesh-ancestor
92622105|NCT02924857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92622106|NCT02924857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622107|NCT00154076|Topiramate|topiramate|mesh-list
92622108|NCT00154076|Zonisamide|zonisamide|mesh-list
92622109|NCT00154076|Anticonvulsants|anticonvulsants|mesh-ancestor
92622110|NCT00154076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622111|NCT00154076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622112|NCT00154076|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92622113|NCT00154076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537825|NCT00143065|Immunologic Factors|immunologic factors|mesh-ancestor
92537826|NCT00143065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537827|NCT00143065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945486|NCT04192019|Glucagon|glucagon|mesh-list
92622114|NCT00154076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622115|NCT00154076|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92622116|NCT00154115|Simendan|simendan|mesh-list
92622117|NCT00154115|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92622118|NCT00154115|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622122|NCT00154115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622124|NCT00154115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622125|NCT02924506|Meloxicam|meloxicam|mesh-list
92622126|NCT02924506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622127|NCT02924506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622128|NCT02924506|Analgesics|analgesics|mesh-ancestor
92622129|NCT02924506|Sensory System Agents|sensory system agents|mesh-ancestor
92622130|NCT02924506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622131|NCT02924506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622132|NCT02924506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622133|NCT02924506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622134|NCT02924506|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92622135|NCT02924506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622136|NCT02924506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622137|NCT02924506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622138|NCT02924311|Aflibercept|aflibercept|mesh-list
92622139|NCT02924311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92622140|NCT02924311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92622141|NCT02924311|Growth Substances|growth substances|mesh-ancestor
92622142|NCT02924311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622143|NCT02924311|Growth Inhibitors|growth inhibitors|mesh-ancestor
92622144|NCT02924311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622145|NCT02924233|Nivolumab|nivolumab|mesh-list
92622146|NCT02924233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92622147|NCT02924233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622148|NCT02924233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92622149|NCT02924233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622150|NCT02923999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92622151|NCT02923999|Antibodies|antibodies|mesh-list
92622152|NCT02923999|Immunoglobulins|immunoglobulins|mesh-list
92622153|NCT02923999|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92622154|NCT02923999|Immunologic Factors|immunologic factors|mesh-ancestor
92622155|NCT02923999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622156|NCT02923999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622157|NCT00154193|Cyclosporine|cyclosporine|mesh-list
92622158|NCT00154193|Cyclosporins|cyclosporins|mesh-list
92622159|NCT00154193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622160|NCT00154193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622161|NCT00154193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622162|NCT00154193|Immunologic Factors|immunologic factors|mesh-ancestor
92622163|NCT00154193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622164|NCT00154193|Antifungal Agents|antifungal agents|mesh-ancestor
92622165|NCT00154193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622166|NCT00154193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92622167|NCT00154193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622168|NCT00154193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92622169|NCT00154232|Mycophenolic Acid|mycophenolic acid|mesh-list
92622170|NCT00154232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92622171|NCT00154232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622172|NCT00154232|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92622173|NCT00154232|Antitubercular Agents|antitubercular agents|mesh-ancestor
92622174|NCT00154232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92622175|NCT00154232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622176|NCT00154232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622177|NCT00154232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622178|NCT00154271|Valsartan|valsartan|mesh-list
92622179|NCT00154271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92622180|NCT00154271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92622181|NCT00154271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92537829|NCT00143104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92537830|NCT00143104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537831|NCT00143143|Pregabalin|pregabalin|mesh-list
92537832|NCT00143143|Analgesics|analgesics|mesh-ancestor
92622182|NCT00154271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622183|NCT00154349|Imatinib Mesylate|imatinib mesylate|mesh-list
92622184|NCT00154349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622185|NCT00154349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622186|NCT00154349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622187|NCT00154349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622191|NCT00187941|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92622192|NCT00187941|Antitubercular Agents|antitubercular agents|mesh-ancestor
92622193|NCT00187941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92622194|NCT00187941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622195|NCT00187941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622196|NCT00187941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622197|NCT02923687|Ketorolac|ketorolac|mesh-list
92622198|NCT02923687|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92622199|NCT02923687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622200|NCT02923687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622201|NCT02923687|Analgesics|analgesics|mesh-ancestor
92622202|NCT02923687|Sensory System Agents|sensory system agents|mesh-ancestor
92622203|NCT02923687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622204|NCT02923687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622205|NCT02923687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622206|NCT02923687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622207|NCT02923687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622208|NCT02923687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622209|NCT02923687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622210|NCT00154388|Imatinib Mesylate|imatinib mesylate|mesh-list
92622211|NCT00154388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622212|NCT00154388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622213|NCT00154388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622214|NCT00154388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622215|NCT02923258|Docetaxel|docetaxel|mesh-list
92622216|NCT02923258|Cisplatin|cisplatin|mesh-list
92622217|NCT02923258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622218|NCT02923258|Tubulin Modulators|tubulin modulators|mesh-ancestor
92622219|NCT02923258|Antimitotic Agents|antimitotic agents|mesh-ancestor
92622220|NCT02923258|Mitosis Modulators|mitosis modulators|mesh-ancestor
92622221|NCT02923258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622222|NCT02923336|Propranolol|propranolol|mesh-list
92622223|NCT02923336|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92622224|NCT02923336|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92622225|NCT02923336|Adrenergic Agents|adrenergic agents|mesh-ancestor
92622226|NCT02923336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622227|NCT02923336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622228|NCT02923336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622229|NCT02923336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92622230|NCT02923336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92622231|NCT02923336|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622232|NCT02922946|Entinostat|entinostat|mesh-list
92622233|NCT02922946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622234|NCT02922946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92622235|NCT02922946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622236|NCT02922946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622237|NCT02922712|Nimesulide|nimesulide|mesh-list
92622238|NCT02922712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622239|NCT02922712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622240|NCT02922712|Analgesics|analgesics|mesh-ancestor
92622241|NCT02922712|Sensory System Agents|sensory system agents|mesh-ancestor
92622242|NCT02922712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622243|NCT02922712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622244|NCT02922712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622245|NCT02922712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622246|NCT02922712|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622247|NCT02922712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622248|NCT02922712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622249|NCT02922673|Aspirin|aspirin|mesh-list
92537833|NCT00143143|Sensory System Agents|sensory system agents|mesh-ancestor
92537834|NCT00143143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92537835|NCT00143143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622250|NCT02922673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622251|NCT02922673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622252|NCT02922673|Analgesics|analgesics|mesh-ancestor
92622253|NCT02922673|Sensory System Agents|sensory system agents|mesh-ancestor
92622254|NCT02922673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622255|NCT02922673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622256|NCT02922673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622257|NCT02922673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622258|NCT02922673|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92622263|NCT02922673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622265|NCT02922283|Interleukin-2|interleukin-2|mesh-list
92622266|NCT02922283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622267|NCT02922283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622268|NCT02922283|Analgesics|analgesics|mesh-ancestor
92622269|NCT02922283|Sensory System Agents|sensory system agents|mesh-ancestor
92622270|NCT02922283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622271|NCT02922283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622272|NCT04705454|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92622273|NCT04705454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92622274|NCT04705454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622275|NCT02922166|SRX246|srx246|mesh-list
92622276|NCT02922166|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92622277|NCT02922166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622278|NCT02922166|Natriuretic Agents|natriuretic agents|mesh-ancestor
92622279|NCT02922166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622280|NCT02922127|Contraceptive Agents|contraceptive agents|mesh-list
92622281|NCT02922127|Ulipristal acetate|ulipristal acetate|mesh-list
92622282|NCT02922127|Contraceptives, Oral|contraceptives, oral|mesh-list
92622283|NCT02922127|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92622284|NCT02922127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92622285|NCT02922127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622286|NCT02922127|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92622287|NCT02922127|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92622288|NCT02921659|Niacinamide|niacinamide|mesh-list
92622289|NCT02921659|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622290|NCT02921659|Vitamins|vitamins|mesh-ancestor
92622291|NCT02921659|Micronutrients|micronutrients|mesh-ancestor
92622292|NCT02921659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622293|NCT04689100|Leucovorin|leucovorin|mesh-list
92622294|NCT04689100|Fluorouracil|fluorouracil|mesh-list
92622295|NCT04689100|Oxaliplatin|oxaliplatin|mesh-list
92622296|NCT04689100|Irinotecan|irinotecan|mesh-list
92622297|NCT04689100|Calcium|calcium|mesh-list
92622298|NCT04689100|Levoleucovorin|levoleucovorin|mesh-list
92622299|NCT04689100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92622300|NCT04689100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622301|NCT04689100|Antimetabolites|antimetabolites|mesh-ancestor
92622302|NCT04689100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622303|NCT04689100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622304|NCT04689100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622305|NCT04689100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622306|NCT04689100|Immunologic Factors|immunologic factors|mesh-ancestor
92347453|NCT01706328|Tocolytic Agents|tocolytic agents|mesh-ancestor
92622307|NCT04689100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92622308|NCT04689100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92622309|NCT04689100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622310|NCT04689100|Antidotes|antidotes|mesh-ancestor
92622311|NCT04689100|Protective Agents|protective agents|mesh-ancestor
92622312|NCT04689100|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622313|NCT04689100|Vitamins|vitamins|mesh-ancestor
92622314|NCT04689100|Micronutrients|micronutrients|mesh-ancestor
92622315|NCT00188136|Fludarabine|fludarabine|mesh-list
92622316|NCT00188136|Melphalan|melphalan|mesh-list
92622317|NCT00188136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622318|NCT00188136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622319|NCT00188136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622320|NCT00188136|Immunologic Factors|immunologic factors|mesh-ancestor
92622321|NCT00188136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622322|NCT00188136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92622323|NCT00188136|Alkylating Agents|alkylating agents|mesh-ancestor
92537836|NCT00143143|Anticonvulsants|anticonvulsants|mesh-ancestor
92537837|NCT00143143|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92537838|NCT00143143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92537839|NCT00143143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622324|NCT00188136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92622325|NCT00406250|Bevacizumab|bevacizumab|mesh-list
92622326|NCT00406250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92622327|NCT00406250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622328|NCT00406250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92622331|NCT00406250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622332|NCT00406250|Growth Inhibitors|growth inhibitors|mesh-ancestor
92622333|NCT00406289|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92622334|NCT00406289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92622335|NCT00406289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622336|NCT02921269|Bevacizumab|bevacizumab|mesh-list
92622337|NCT02921269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92622338|NCT02921269|Atezolizumab|atezolizumab|mesh-list
92622339|NCT02921269|Endothelial Growth Factors|endothelial growth factors|mesh-list
92622340|NCT02921269|Antibodies|antibodies|mesh-list
92622341|NCT02921269|Immunoglobulins|immunoglobulins|mesh-list
92622342|NCT02921269|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92622343|NCT02921269|Immunoglobulin G|immunoglobulin g|mesh-list
92622344|NCT02921269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622345|NCT02921269|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92622346|NCT02921269|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92622347|NCT02921269|Growth Substances|growth substances|mesh-ancestor
92622348|NCT02921269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622349|NCT02921269|Growth Inhibitors|growth inhibitors|mesh-ancestor
92622350|NCT02921269|Immunologic Factors|immunologic factors|mesh-ancestor
92622351|NCT02921269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92622352|NCT02921269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622353|NCT02920801|Metformin|metformin|mesh-list
92622354|NCT02920801|Saxagliptin|saxagliptin|mesh-list
92622355|NCT02920801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622356|NCT02920801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622357|NCT02920801|Incretins|incretins|mesh-ancestor
92622358|NCT02920801|Hormones|hormones|mesh-ancestor
92622359|NCT02920801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92622360|NCT02920801|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92622361|NCT02920801|Protease Inhibitors|protease inhibitors|mesh-ancestor
92622362|NCT02920801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622363|NCT02920801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622364|NCT00180843|Bromides|bromides|mesh-list
92622365|NCT00180843|Albuterol|albuterol|mesh-list
92622366|NCT00180843|Ipratropium|ipratropium|mesh-list
92622367|NCT00180843|Anticonvulsants|anticonvulsants|mesh-ancestor
92622368|NCT00180843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92622369|NCT00180843|Autonomic Agents|autonomic agents|mesh-ancestor
92622370|NCT00180843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622371|NCT00180843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622372|NCT00180843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92622373|NCT00180843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92622374|NCT00180843|Tocolytic Agents|tocolytic agents|mesh-ancestor
92622375|NCT00180843|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92622376|NCT00180843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92622377|NCT00180843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92622378|NCT00180843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92622379|NCT00180843|Adrenergic Agents|adrenergic agents|mesh-ancestor
92622380|NCT00180843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622381|NCT00180843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622382|NCT00180843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92622383|NCT00180843|Cholinergic Agents|cholinergic agents|mesh-ancestor
92622385|NCT02920567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92622386|NCT02920567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92622387|NCT02920567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622388|NCT00180882|Rituximab|rituximab|mesh-list
92622389|NCT00180882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92622390|NCT00180882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622391|NCT00180882|Immunologic Factors|immunologic factors|mesh-ancestor
92622392|NCT00180882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537840|NCT00143143|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92622393|NCT00180882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622394|NCT00180921|Imatinib Mesylate|imatinib mesylate|mesh-list
92622395|NCT00180921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622396|NCT00180921|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622397|NCT00180921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622398|NCT00180921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622400|NCT02920489|Dsuvia|dsuvia|mesh-list
92622401|NCT02920489|Ropivacaine|ropivacaine|mesh-list
92622402|NCT02920489|Anesthetics, Local|anesthetics, local|mesh-ancestor
92622403|NCT02920489|Anesthetics|anesthetics|mesh-ancestor
92622404|NCT02920489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622406|NCT02920489|Sensory System Agents|sensory system agents|mesh-ancestor
92622407|NCT02920489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622408|NCT02920489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92622409|NCT02920489|Narcotics|narcotics|mesh-ancestor
92622410|NCT02920489|Analgesics|analgesics|mesh-ancestor
92622411|NCT02920489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92622412|NCT02920489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92622413|NCT02920489|Anesthetics, General|anesthetics, general|mesh-ancestor
92622414|NCT02920372|Epoetin Alfa|epoetin alfa|mesh-list
92622415|NCT02920372|Hematinics|hematinics|mesh-ancestor
92622416|NCT00154661|Pentoxifylline|pentoxifylline|mesh-list
92622417|NCT00154661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92622418|NCT00154661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622419|NCT00154661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622420|NCT00154661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92622421|NCT00154661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92622422|NCT00154661|Protective Agents|protective agents|mesh-ancestor
92622423|NCT00154661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622424|NCT00154661|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622425|NCT00154661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92622426|NCT00154661|Antioxidants|antioxidants|mesh-ancestor
92622427|NCT00180960|Oxaliplatin|oxaliplatin|mesh-list
92622428|NCT00180960|Irinotecan|irinotecan|mesh-list
92622429|NCT00180960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622430|NCT00180960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92622431|NCT00180960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92622432|NCT00180960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622433|NCT00180960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622434|NCT00154700|Folic Acid|folic acid|mesh-list
92622435|NCT00154700|Paclitaxel|paclitaxel|mesh-list
92622436|NCT00154700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92622437|NCT00154700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622438|NCT00154700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92622439|NCT00154700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92622440|NCT00154700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92622441|NCT00154700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622442|NCT00154700|Hematinics|hematinics|mesh-ancestor
92622443|NCT00154700|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622444|NCT00154700|Vitamins|vitamins|mesh-ancestor
92622445|NCT00154700|Micronutrients|micronutrients|mesh-ancestor
92622446|NCT00154700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622447|NCT04688983|Imatinib Mesylate|imatinib mesylate|mesh-list
92622448|NCT04688983|Blinatumomab|blinatumomab|mesh-list
92622449|NCT04688983|Ponatinib|ponatinib|mesh-list
92622450|NCT04688983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622451|NCT04688983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622452|NCT04688983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622453|NCT04688983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622454|NCT02920060|Levetiracetam|levetiracetam|mesh-list
92622455|NCT02920060|Valproic Acid|valproic acid|mesh-list
92622456|NCT02920060|Anticonvulsants|anticonvulsants|mesh-ancestor
92622457|NCT02920060|Nootropic Agents|nootropic agents|mesh-ancestor
92622458|NCT02920060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622459|NCT02920060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622460|NCT02920060|GABA Agents|gaba agents|mesh-ancestor
92622461|NCT02920060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622462|NCT02920060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622463|NCT02920060|Antimanic Agents|antimanic agents|mesh-ancestor
92622464|NCT02920060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622465|NCT02920060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622466|NCT02920060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622467|NCT00154739|Gemcitabine|gemcitabine|mesh-list
92622468|NCT00154739|Epirubicin|epirubicin|mesh-list
92622469|NCT00154739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537841|NCT00143143|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92537842|NCT00143143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92537843|NCT00143143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537844|NCT00143143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622470|NCT00154739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622471|NCT00154739|Antimetabolites|antimetabolites|mesh-ancestor
92622472|NCT00154739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622473|NCT00154739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92622474|NCT00154739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92622475|NCT00154739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92622476|NCT00154739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622477|NCT00154778|Leucovorin|leucovorin|mesh-list
92622478|NCT00154778|Antidotes|antidotes|mesh-ancestor
92622479|NCT00154778|Protective Agents|protective agents|mesh-ancestor
92622483|NCT00154778|Micronutrients|micronutrients|mesh-ancestor
92622484|NCT02919202|Listerine|listerine|mesh-list
92622485|NCT02919202|Fluorides|fluorides|mesh-list
92622486|NCT02919202|Sodium Fluoride|sodium fluoride|mesh-list
92622487|NCT02919202|Fluorides, Topical|fluorides, topical|mesh-list
92622488|NCT02919202|Cariostatic Agents|cariostatic agents|mesh-ancestor
92622489|NCT02919202|Protective Agents|protective agents|mesh-ancestor
92622490|NCT02919202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622491|NCT02919202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92622492|NCT02919202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622493|NCT00154895|Minocycline|minocycline|mesh-list
92622494|NCT00154895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92622495|NCT00154895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622496|NCT00181116|Levetiracetam|levetiracetam|mesh-list
92622497|NCT00181116|Anticonvulsants|anticonvulsants|mesh-ancestor
92622498|NCT00181116|Nootropic Agents|nootropic agents|mesh-ancestor
92622499|NCT02918812|Diclofenac|diclofenac|mesh-list
92622500|NCT02918812|Lidocaine|lidocaine|mesh-list
92622501|NCT02918812|Anesthetics, Local|anesthetics, local|mesh-ancestor
92622502|NCT02918812|Anesthetics|anesthetics|mesh-ancestor
92622503|NCT02918812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622504|NCT02918812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622505|NCT02918812|Sensory System Agents|sensory system agents|mesh-ancestor
92361496|NCT00565266|Glucocorticoids|glucocorticoids|mesh-ancestor
92622506|NCT02918812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622507|NCT02918812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92622508|NCT02918812|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92622509|NCT02918812|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92622510|NCT02918812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622511|NCT02918812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622512|NCT02918812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622513|NCT02918812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622514|NCT02918812|Analgesics|analgesics|mesh-ancestor
92622515|NCT02918812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622516|NCT02918812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622517|NCT02918812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622518|NCT02918812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622519|NCT02918110|Misoprostol|misoprostol|mesh-list
92622520|NCT02918110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92622521|NCT02918110|Abortifacient Agents|abortifacient agents|mesh-ancestor
92622522|NCT02918110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92622523|NCT02918110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622524|NCT02918110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92622525|NCT02918110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92622526|NCT02918110|Oxytocics|oxytocics|mesh-ancestor
92622527|NCT00181272|Azithromycin|azithromycin|mesh-list
92622528|NCT00181272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92622529|NCT00181272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622530|NCT02910076|Hydroxychloroquine|hydroxychloroquine|mesh-list
92622531|NCT02910076|Antimalarials|antimalarials|mesh-ancestor
92622532|NCT02910076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92622533|NCT02910076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92622534|NCT02910076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622535|NCT02910076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622536|NCT02910076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622537|NCT02910076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622538|NCT02910115|Oxytocin|oxytocin|mesh-list
92622539|NCT02910115|Oxytocics|oxytocics|mesh-ancestor
92537845|NCT00143221|Sildenafil Citrate|sildenafil citrate|mesh-list
92537846|NCT00143221|Vasodilator Agents|vasodilator agents|mesh-ancestor
92537847|NCT00143221|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92622540|NCT02910115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92622541|NCT02910115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622542|NCT00188565|Celecoxib|celecoxib|mesh-list
92622543|NCT00188565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622544|NCT00188565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622545|NCT00188565|Analgesics|analgesics|mesh-ancestor
92622546|NCT00188565|Sensory System Agents|sensory system agents|mesh-ancestor
92622547|NCT00188565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622548|NCT00188565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622549|NCT00188565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622550|NCT00188565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622551|NCT00188565|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92622552|NCT00188565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622553|NCT00188565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029486|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
92622563|NCT00155246|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622564|NCT00155246|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92622565|NCT00155246|Antioxidants|antioxidants|mesh-ancestor
92622566|NCT02909413|Sevoflurane|sevoflurane|mesh-list
92622567|NCT02909413|Desflurane|desflurane|mesh-list
92622568|NCT02909413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92622569|NCT02909413|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92622570|NCT02909413|Anesthetics, General|anesthetics, general|mesh-ancestor
92622571|NCT02909413|Anesthetics|anesthetics|mesh-ancestor
92622572|NCT02909413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622573|NCT02909413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622574|NCT02909257|Bupivacaine|bupivacaine|mesh-list
92622575|NCT02909257|Anesthetics, Local|anesthetics, local|mesh-ancestor
92622576|NCT02909257|Anesthetics|anesthetics|mesh-ancestor
92622577|NCT02909257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622578|NCT02909257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622579|NCT02909257|Sensory System Agents|sensory system agents|mesh-ancestor
92622580|NCT02909257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622581|NCT02908945|Ketamine|ketamine|mesh-list
92622582|NCT02908945|Analgesics|analgesics|mesh-ancestor
92622583|NCT02908945|Sensory System Agents|sensory system agents|mesh-ancestor
92622584|NCT02908945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622585|NCT02908945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622586|NCT02908945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92622587|NCT02908945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92622588|NCT02908945|Anesthetics, General|anesthetics, general|mesh-ancestor
92622589|NCT02908945|Anesthetics|anesthetics|mesh-ancestor
92622590|NCT02908945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622591|NCT02908945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92622592|NCT02908945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92622593|NCT02908945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622594|NCT02908945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622595|NCT02939833|Ropivacaine|ropivacaine|mesh-list
92622596|NCT02939833|Anesthetics, Local|anesthetics, local|mesh-ancestor
92622597|NCT02939833|Anesthetics|anesthetics|mesh-ancestor
92622598|NCT02939833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622599|NCT02939833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622600|NCT02939833|Sensory System Agents|sensory system agents|mesh-ancestor
92622601|NCT02939833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622602|NCT00188604|Selenious Acid|selenious acid|mesh-list
92622603|NCT00188604|Sodium Selenite|sodium selenite|mesh-list
92622604|NCT00188604|Trace Elements|trace elements|mesh-ancestor
92622605|NCT00188604|Micronutrients|micronutrients|mesh-ancestor
92622606|NCT00188604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622607|NCT00155402|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92622608|NCT00155402|Hemostatics|hemostatics|mesh-ancestor
92622609|NCT00155402|Coagulants|coagulants|mesh-ancestor
92622610|NCT00188643|Lamotrigine|lamotrigine|mesh-list
92622611|NCT00188643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92622612|NCT00188643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92622613|NCT00188643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92622614|NCT00188643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622615|NCT00188643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622616|NCT00188643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537848|NCT00143221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92537849|NCT00143221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537850|NCT00143221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537851|NCT00143221|Urological Agents|urological agents|mesh-ancestor
92537852|NCT00143260|Sildenafil Citrate|sildenafil citrate|mesh-list
92622617|NCT00188643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622620|NCT00188643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622621|NCT00188643|Anticonvulsants|anticonvulsants|mesh-ancestor
92622622|NCT00188643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92622623|NCT00188643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92622624|NCT00188643|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92622625|NCT00188643|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622626|NCT00188643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622627|NCT00188643|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92622628|NCT00533299|Hydralazine|hydralazine|mesh-list
92622629|NCT00533299|Valproic Acid|valproic acid|mesh-list
92622630|NCT00533299|Anticonvulsants|anticonvulsants|mesh-ancestor
92622631|NCT00533299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622632|NCT00533299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622633|NCT00533299|GABA Agents|gaba agents|mesh-ancestor
92622634|NCT00533299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622635|NCT00533299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622636|NCT00533299|Antimanic Agents|antimanic agents|mesh-ancestor
92622637|NCT00533299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622638|NCT00533299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622639|NCT00533299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622640|NCT00533299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92622641|NCT00533299|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622642|NCT04788823|Prednisone|prednisone|mesh-list
92622643|NCT04788823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622644|NCT04788823|Glucocorticoids|glucocorticoids|mesh-ancestor
92622645|NCT04788823|Hormones|hormones|mesh-ancestor
92622646|NCT04788823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92622647|NCT04788823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622648|NCT04788823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92622649|NCT04788823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622650|NCT00181584|Zoledronic Acid|zoledronic acid|mesh-list
92622651|NCT00181584|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92622652|NCT00181584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622653|NCT00181662|Curcumin|curcumin|mesh-list
92622654|NCT00181662|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92622655|NCT00181662|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622656|NCT00181662|Analgesics|analgesics|mesh-ancestor
92622657|NCT00181662|Sensory System Agents|sensory system agents|mesh-ancestor
92622658|NCT00181662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622659|NCT00181662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622660|NCT00181662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92622661|NCT00181662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622662|NCT00181662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622663|NCT00181662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622664|NCT00181662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622665|NCT00533416|ON 01910|on 01910|mesh-list
92622666|NCT00533416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622667|NCT00533416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622668|NCT00533416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622669|NCT00533416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622670|NCT00155558|Leucovorin|leucovorin|mesh-list
92622671|NCT00155558|Fluorouracil|fluorouracil|mesh-list
92622672|NCT00155558|Antimetabolites|antimetabolites|mesh-ancestor
92622673|NCT00155558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622674|NCT00155558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622675|NCT00155558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622676|NCT00155558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622677|NCT00155558|Immunologic Factors|immunologic factors|mesh-ancestor
92622678|NCT00155558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622679|NCT00155558|Antidotes|antidotes|mesh-ancestor
92622680|NCT00155558|Protective Agents|protective agents|mesh-ancestor
92622681|NCT00155558|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622682|NCT00155558|Vitamins|vitamins|mesh-ancestor
92622683|NCT00155558|Micronutrients|micronutrients|mesh-ancestor
92537853|NCT00143260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537854|NCT00143260|Vasodilator Agents|vasodilator agents|mesh-ancestor
92537855|NCT00143260|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92537856|NCT00143260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92537857|NCT00143260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537858|NCT00143260|Urological Agents|urological agents|mesh-ancestor
92622684|NCT00533455|Gabapentin|gabapentin|mesh-list
92622685|NCT00533455|Analgesics|analgesics|mesh-ancestor
92622686|NCT00533455|Sensory System Agents|sensory system agents|mesh-ancestor
92622687|NCT00533455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622688|NCT00533455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622689|NCT00533455|Anticonvulsants|anticonvulsants|mesh-ancestor
92622690|NCT00533455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92622695|NCT00533455|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92622696|NCT00533455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622697|NCT00533455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622699|NCT00533533|Docetaxel|docetaxel|mesh-list
92622700|NCT00533533|Oxaliplatin|oxaliplatin|mesh-list
92622701|NCT00533533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622702|NCT00533533|Tubulin Modulators|tubulin modulators|mesh-ancestor
92622703|NCT00533533|Antimitotic Agents|antimitotic agents|mesh-ancestor
92622704|NCT00533533|Mitosis Modulators|mitosis modulators|mesh-ancestor
92622705|NCT00533533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622706|NCT00533611|Niacin|niacin|mesh-list
92622707|NCT00533611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622708|NCT00533611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622709|NCT00533611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92622710|NCT00533611|Antimetabolites|antimetabolites|mesh-ancestor
92622711|NCT00533611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92622712|NCT00533611|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622713|NCT00533611|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622714|NCT00533611|Vitamins|vitamins|mesh-ancestor
92622715|NCT00533611|Micronutrients|micronutrients|mesh-ancestor
92622716|NCT04575844|Liraglutide|liraglutide|mesh-list
92622717|NCT04575844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622718|NCT04575844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622719|NCT04575844|Incretins|incretins|mesh-ancestor
92622720|NCT04575844|Hormones|hormones|mesh-ancestor
92622721|NCT04575844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92622722|NCT00155714|Sildenafil Citrate|sildenafil citrate|mesh-list
92622723|NCT00155714|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
92622724|NCT00155714|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622725|NCT00155714|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92622726|NCT00155714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622727|NCT00155714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622728|NCT00155714|Urological Agents|urological agents|mesh-ancestor
92622729|NCT00181740|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92622730|NCT00181740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92622731|NCT00181740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92622732|NCT00181740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622733|NCT00181740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622734|NCT00181740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92622735|NCT00181740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622736|NCT00181740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622737|NCT00181779|Aripiprazole|aripiprazole|mesh-list
92622738|NCT00181779|Antidepressive Agents|antidepressive agents|mesh-ancestor
92622739|NCT00181779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622740|NCT00181779|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92622741|NCT00181779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622742|NCT00181779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622743|NCT00181779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622744|NCT00181779|Dopamine Agonists|dopamine agonists|mesh-ancestor
92622745|NCT00181779|Dopamine Agents|dopamine agents|mesh-ancestor
92622746|NCT00181779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622747|NCT00181779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622748|NCT00181779|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92622749|NCT00181779|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92622750|NCT00181779|Serotonin Agents|serotonin agents|mesh-ancestor
92537859|NCT00143299|Varenicline|varenicline|mesh-list
92537860|NCT00143299|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91968295|NCT03323567|Lidocaine|lidocaine|mesh-list
92622751|NCT00181779|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92622752|NCT00181779|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92622753|NCT00181779|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92622754|NCT00181779|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92622755|NCT00533923|Cyclosporine|cyclosporine|mesh-list
92622756|NCT00533923|Cyclophosphamide|cyclophosphamide|mesh-list
92622757|NCT00533923|Fludarabine|fludarabine|mesh-list
92622758|NCT00533923|Alemtuzumab|alemtuzumab|mesh-list
92622759|NCT00533923|Cyclosporins|cyclosporins|mesh-list
92029706|NCT02258529|Idelalisib|idelalisib|mesh-list
92622778|NCT00409227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92622779|NCT00409227|Adrenergic Agents|adrenergic agents|mesh-ancestor
92622780|NCT00409227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622781|NCT00409227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622782|NCT00409227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622783|NCT00409227|Urological Agents|urological agents|mesh-ancestor
92622784|NCT00533962|Anecortave|anecortave|mesh-list
92622785|NCT00533962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92622786|NCT00533962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92622787|NCT00533962|Growth Substances|growth substances|mesh-ancestor
92622788|NCT00533962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622789|NCT00533962|Growth Inhibitors|growth inhibitors|mesh-ancestor
92622790|NCT00533962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622791|NCT00181818|Bupropion|bupropion|mesh-list
92622792|NCT00181818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92622793|NCT00181818|Antidepressive Agents|antidepressive agents|mesh-ancestor
92622794|NCT00181818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622795|NCT00181818|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92622796|NCT00181818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92622797|NCT00181818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622798|NCT00181818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622799|NCT00181818|Dopamine Agents|dopamine agents|mesh-ancestor
92622800|NCT00181818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622801|NCT00181818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622802|NCT00181818|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92622803|NCT00181818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92622804|NCT00181818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622805|NCT04462627|Antibodies|antibodies|mesh-list
92622806|NCT04462627|Immunologic Factors|immunologic factors|mesh-ancestor
92622807|NCT04462627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622808|NCT00406601|Sorafenib|sorafenib|mesh-list
92622809|NCT00406601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622810|NCT00406601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622811|NCT00406601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622812|NCT00406601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622813|NCT00409305|Betahistine|betahistine|mesh-list
92622821|NCT00406679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92622822|NCT00406679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92622823|NCT00406679|Analgesics|analgesics|mesh-ancestor
92622824|NCT00406679|Sensory System Agents|sensory system agents|mesh-ancestor
92622825|NCT00406679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622826|NCT00406679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622827|NCT00406679|Antipyretics|antipyretics|mesh-ancestor
92622828|NCT00181896|Bupropion|bupropion|mesh-list
92622829|NCT00181896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92622830|NCT00181896|Antidepressive Agents|antidepressive agents|mesh-ancestor
92622831|NCT00181896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622832|NCT00181896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92622833|NCT00181896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92622834|NCT00181896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622835|NCT00181896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622836|NCT00181896|Dopamine Agents|dopamine agents|mesh-ancestor
92622837|NCT00181896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622838|NCT00181896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622839|NCT00181896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92622840|NCT00181896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92622841|NCT00181896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622842|NCT04686448|Fentanyl|fentanyl|mesh-list
92622843|NCT04686448|Ketamine|ketamine|mesh-list
92622844|NCT04686448|Propofol|propofol|mesh-list
92537861|NCT00143299|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92537862|NCT00143299|Cholinergic Agents|cholinergic agents|mesh-ancestor
92622845|NCT04686448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92622846|NCT04686448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622847|NCT04686448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622848|NCT04686448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92622849|NCT04686448|Anesthetics, General|anesthetics, general|mesh-ancestor
92622851|NCT04686448|Analgesics|analgesics|mesh-ancestor
92622852|NCT04686448|Sensory System Agents|sensory system agents|mesh-ancestor
92622853|NCT04686448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622854|NCT04686448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92622855|NCT04686448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92622856|NCT04686448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92622857|NCT04686448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622858|NCT04686448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622859|NCT04686448|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92622860|NCT04686448|Narcotics|narcotics|mesh-ancestor
92622861|NCT04686448|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92622862|NCT00181935|Olanzapine|olanzapine|mesh-list
92622863|NCT00181935|Risperidone|risperidone|mesh-list
92622864|NCT00181935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92622865|NCT00181935|Serotonin Agents|serotonin agents|mesh-ancestor
92622866|NCT00181935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622867|NCT00181935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622868|NCT00181935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622869|NCT00181935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92622870|NCT00181935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622871|NCT00181935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622872|NCT00181935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622873|NCT00181935|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92622874|NCT00181935|Dopamine Agents|dopamine agents|mesh-ancestor
92622875|NCT00181935|Antiemetics|antiemetics|mesh-ancestor
92622876|NCT00181935|Autonomic Agents|autonomic agents|mesh-ancestor
92622877|NCT00181935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622878|NCT00181935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92622879|NCT00181935|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92622880|NCT00181935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92622886|NCT00409383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92622887|NCT00409383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622888|NCT00409383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92622889|NCT00409383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92622890|NCT00409383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92622891|NCT00409383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622892|NCT00409383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92622893|NCT00409383|Alkylating Agents|alkylating agents|mesh-ancestor
92622894|NCT04893148|Insulin Glargine|insulin glargine|mesh-list
92622895|NCT04893148|Dulaglutide|dulaglutide|mesh-list
92622896|NCT04893148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622897|NCT04893148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622899|NCT04883632|Anesthetics, Local|anesthetics, local|mesh-ancestor
92622900|NCT04883632|Anesthetics|anesthetics|mesh-ancestor
92622901|NCT04883632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622902|NCT04883632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622903|NCT04883632|Sensory System Agents|sensory system agents|mesh-ancestor
92622904|NCT04883632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622905|NCT04883632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92622906|NCT04883632|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92622907|NCT04883632|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92622908|NCT04883632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622909|NCT04883632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622910|NCT00181974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92622911|NCT00181974|Hemostatics|hemostatics|mesh-ancestor
92622913|NCT02569645|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92622914|NCT02569645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92622915|NCT02569645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92622916|NCT02569645|Antimetabolites|antimetabolites|mesh-ancestor
92622917|NCT02569645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622918|NCT02569645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92622919|NCT02569645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92622920|NCT02569645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622921|NCT02500147|Metformin|metformin|mesh-list
92537863|NCT00143299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537864|NCT00143299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537865|NCT00143299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537866|NCT00143338|Insulin|insulin|mesh-list
91945514|NCT05446571|Letermovir|letermovir|mesh-list
92622922|NCT02500147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622923|NCT02500147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622924|NCT00182013|Olanzapine|olanzapine|mesh-list
92622925|NCT00182013|Risperidone|risperidone|mesh-list
92622926|NCT00182013|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92622927|NCT00182013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92622928|NCT00182013|Serotonin Agents|serotonin agents|mesh-ancestor
92622929|NCT00182013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622930|NCT00182013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622931|NCT00182013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622932|NCT00182013|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92622933|NCT00182013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622934|NCT00182013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622935|NCT00182013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622936|NCT00182013|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92622937|NCT00182013|Dopamine Agents|dopamine agents|mesh-ancestor
92622938|NCT00182013|Antiemetics|antiemetics|mesh-ancestor
92622939|NCT00182013|Autonomic Agents|autonomic agents|mesh-ancestor
92622940|NCT00182013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92622941|NCT00182013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92622942|NCT00182013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92622943|NCT00182013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92622944|NCT00182013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622945|NCT00182013|Antidepressive Agents|antidepressive agents|mesh-ancestor
92622946|NCT00182052|Rosiglitazone|rosiglitazone|mesh-list
92622947|NCT00182052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622948|NCT00182052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622949|NCT02081755|Mycophenolic Acid|mycophenolic acid|mesh-list
92622950|NCT02081755|Everolimus|everolimus|mesh-list
92622951|NCT02081755|Azathioprine|azathioprine|mesh-list
92622952|NCT02081755|Tacrolimus|tacrolimus|mesh-list
92622956|NCT02081755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92622957|NCT02081755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622958|NCT02081755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622959|NCT02081755|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92622960|NCT02081755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92622961|NCT02081755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622962|NCT02081755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92361523|NCT05461092|Sensory System Agents|sensory system agents|mesh-ancestor
92622963|NCT02081755|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92622964|NCT02081755|Antitubercular Agents|antitubercular agents|mesh-ancestor
92622965|NCT02081755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92622966|NCT02081755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622967|NCT02081755|Antimetabolites|antimetabolites|mesh-ancestor
92622968|NCT02081755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622969|NCT02081755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622970|NCT01715974|Molgramostim|molgramostim|mesh-list
92622971|NCT01715974|Sargramostim|sargramostim|mesh-list
92622972|NCT01715974|Immunologic Factors|immunologic factors|mesh-ancestor
92622973|NCT01715974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622974|NCT01715974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622975|NCT05471479|Charcoal|charcoal|mesh-list
92622976|NCT05471479|Antidotes|antidotes|mesh-ancestor
92622977|NCT05471479|Protective Agents|protective agents|mesh-ancestor
92622978|NCT05471479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622979|NCT00188877|Fluorouracil|fluorouracil|mesh-list
92622980|NCT00188877|Antimetabolites|antimetabolites|mesh-ancestor
92622981|NCT00188877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622982|NCT00188877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92622983|NCT00188877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622984|NCT00188877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622985|NCT00188877|Immunologic Factors|immunologic factors|mesh-ancestor
92622986|NCT00188877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622987|NCT00182169|Hormones|hormones|mesh-list
92622988|NCT00182169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92622989|NCT00182169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622990|NCT05471050|Danazol|danazol|mesh-list
92537867|NCT00143338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92622991|NCT05471050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92622992|NCT05471050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92622993|NCT05471050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92622994|NCT05471050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622995|NCT05470972|Ethanol|ethanol|mesh-list
92622996|NCT05470972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92622997|NCT05470972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622998|NCT05470972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622999|NCT05470972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623000|NCT04686058|Midazolam|midazolam|mesh-list
92623001|NCT04686058|Meperidine|meperidine|mesh-list
92623002|NCT04686058|Propofol|propofol|mesh-list
92623003|NCT04686058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92623004|NCT04686058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623005|NCT04686058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623006|NCT04686058|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92623007|NCT04686058|Anesthetics, General|anesthetics, general|mesh-ancestor
92623008|NCT04686058|Anesthetics|anesthetics|mesh-ancestor
92623009|NCT04686058|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92623010|NCT04686058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92623011|NCT04686058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92623012|NCT04686058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92623013|NCT04686058|GABA Modulators|gaba modulators|mesh-ancestor
92623014|NCT04686058|GABA Agents|gaba agents|mesh-ancestor
92623015|NCT04686058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623016|NCT04686058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623017|NCT04686058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92623018|NCT04686058|Narcotics|narcotics|mesh-ancestor
92623019|NCT04686058|Analgesics|analgesics|mesh-ancestor
92623020|NCT04686058|Sensory System Agents|sensory system agents|mesh-ancestor
92623021|NCT04686058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623022|NCT00156299|Dexamethasone|dexamethasone|mesh-list
92623023|NCT00156299|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
92623024|NCT00156299|Choline|choline|mesh-list
92623025|NCT00156299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92623033|NCT00156299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623034|NCT00156299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92623035|NCT00156299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623036|NCT00156299|Lipotropic Agents|lipotropic agents|mesh-ancestor
92623037|NCT00156299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92623038|NCT00156299|Antimetabolites|antimetabolites|mesh-ancestor
92623039|NCT00156299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623040|NCT00156299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92361527|NCT02129478|Olanzapine|olanzapine|mesh-list
92623041|NCT00156299|Nootropic Agents|nootropic agents|mesh-ancestor
92623042|NCT00156299|Analgesics|analgesics|mesh-ancestor
92623043|NCT00156299|Sensory System Agents|sensory system agents|mesh-ancestor
92623044|NCT00156299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92623045|NCT00156299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623046|NCT00156299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623047|NCT00535951|Panobinostat|panobinostat|mesh-list
92623048|NCT00535951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623049|NCT00535951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92623050|NCT00535951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623051|NCT00535951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623052|NCT00188955|Sirolimus|sirolimus|mesh-list
92623053|NCT00188955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623054|NCT00188955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623055|NCT00188955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92623056|NCT00188955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623057|NCT00188955|Antifungal Agents|antifungal agents|mesh-ancestor
92623058|NCT00188955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623059|NCT00188955|Immunologic Factors|immunologic factors|mesh-ancestor
92623060|NCT00188955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623061|NCT00536068|Acetaminophen|acetaminophen|mesh-list
92623062|NCT00536068|Aspirin|aspirin|mesh-list
92623063|NCT00536068|Diclofenac|diclofenac|mesh-list
92623065|NCT00536068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623066|NCT00536068|Analgesics|analgesics|mesh-ancestor
92623067|NCT00536068|Sensory System Agents|sensory system agents|mesh-ancestor
92623068|NCT00536068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623069|NCT00536068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623070|NCT00536068|Antipyretics|antipyretics|mesh-ancestor
92623071|NCT00536068|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92623072|NCT00536068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537868|NCT00143338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537869|NCT00143377|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92537870|NCT00143377|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92537871|NCT00143377|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92623073|NCT00536068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623074|NCT00536068|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92623075|NCT00536068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623076|NCT00536068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623077|NCT00536068|Gout Suppressants|gout suppressants|mesh-ancestor
92623078|NCT00536068|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92623079|NCT00536068|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92623080|NCT00536068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92623081|NCT05470582|Vaccines|vaccines|mesh-list
92623082|NCT05470582|Immunologic Factors|immunologic factors|mesh-ancestor
92623083|NCT05470582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623084|NCT00156377|Mupirocin|mupirocin|mesh-list
92623085|NCT00156377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623086|NCT00156377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623087|NCT00156377|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92623088|NCT00156377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623089|NCT00156377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623090|NCT00188994|Insulin|insulin|mesh-list
92623091|NCT00188994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623092|NCT00188994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623093|NCT05469880|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92623094|NCT05469880|Dermatologic Agents|dermatologic agents|mesh-ancestor
92623095|NCT00408525|Donepezil|donepezil|mesh-list
92623111|NCT05469529|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92623112|NCT05469529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92623113|NCT05469529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92623114|NCT05469529|Adrenergic Agents|adrenergic agents|mesh-ancestor
92623115|NCT05469529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623116|NCT05469529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623117|NCT00189033|Psyllium|psyllium|mesh-list
92623118|NCT00189033|Cathartics|cathartics|mesh-ancestor
92623119|NCT00189033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92623120|NCT05469061|Cisplatin|cisplatin|mesh-list
92623121|NCT05469061|Tislelizumab|tislelizumab|mesh-list
92623122|NCT05469061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623123|NCT05469061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92623124|NCT05469022|Lazertinib|lazertinib|mesh-list
92623125|NCT05469022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91916993|NCT05279183|Erythritol|erythritol|mesh-list
92623126|NCT05469022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623127|NCT05469022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623128|NCT00189072|Gabapentin|gabapentin|mesh-list
92623129|NCT00189072|Analgesics|analgesics|mesh-ancestor
92623130|NCT00189072|Sensory System Agents|sensory system agents|mesh-ancestor
92623131|NCT00189072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623132|NCT00189072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623133|NCT00189072|Anticonvulsants|anticonvulsants|mesh-ancestor
92623134|NCT00189072|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92623135|NCT00189072|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92623136|NCT00189072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623137|NCT00189072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92623138|NCT00189072|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92623139|NCT00189072|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92623140|NCT00189072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623141|NCT00189072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623142|NCT00189072|Antimanic Agents|antimanic agents|mesh-ancestor
92623143|NCT00156611|Abciximab|abciximab|mesh-list
92623144|NCT00156611|Anticoagulants|anticoagulants|mesh-ancestor
92623145|NCT00156611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92623146|NCT00156650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92623147|NCT00156650|Medroxyprogesterone|medroxyprogesterone|mesh-list
92623148|NCT00156650|Testosterone|testosterone|mesh-list
92623149|NCT00156650|Acyline|acyline|mesh-list
92623150|NCT00156650|Androgens|androgens|mesh-ancestor
92623151|NCT00156650|Hormones|hormones|mesh-ancestor
92623152|NCT00156650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623153|NCT00156650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623154|NCT00156650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92623161|NCT00156650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92537872|NCT00143377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623162|NCT00156650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92623163|NCT00156650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92623164|NCT00156650|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623165|NCT00536419|Methylphenidate|methylphenidate|mesh-list
92623166|NCT00536419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92623167|NCT00536419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623168|NCT00536419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92623169|NCT00536419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92623170|NCT00536419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623171|NCT00536419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623172|NCT00536419|Dopamine Agents|dopamine agents|mesh-ancestor
92623173|NCT00536419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623174|NCT00189150|Mycophenolic Acid|mycophenolic acid|mesh-list
92623175|NCT00189150|Valganciclovir|valganciclovir|mesh-list
92623176|NCT00189150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92623177|NCT00189150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623178|NCT00189150|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92623179|NCT00189150|Antitubercular Agents|antitubercular agents|mesh-ancestor
92623180|NCT00189150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623181|NCT00189150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623182|NCT00189150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623183|NCT00189150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623184|NCT00189150|Antiviral Agents|antiviral agents|mesh-ancestor
92623185|NCT00156689|Levetiracetam|levetiracetam|mesh-list
92623186|NCT00156689|Anticonvulsants|anticonvulsants|mesh-ancestor
92623187|NCT00156689|Nootropic Agents|nootropic agents|mesh-ancestor
92623188|NCT00536614|Cetuximab|cetuximab|mesh-list
92623189|NCT00536614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92623190|NCT00536614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623191|NCT05468203|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92623192|NCT05468203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623193|NCT05468203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623194|NCT05468203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623195|NCT05468164|Omeprazole|omeprazole|mesh-list
92623196|NCT05468164|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92623197|NCT05468164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92623198|NCT05468164|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92623199|NCT05468164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623200|NCT05468164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623201|NCT05468047|Ketamine|ketamine|mesh-list
92623202|NCT05468047|Analgesics|analgesics|mesh-ancestor
92623203|NCT05468047|Sensory System Agents|sensory system agents|mesh-ancestor
92623204|NCT05468047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623205|NCT05468047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623206|NCT05468047|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92623207|NCT05468047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92623208|NCT05468047|Anesthetics, General|anesthetics, general|mesh-ancestor
92623209|NCT05468047|Anesthetics|anesthetics|mesh-ancestor
92623210|NCT05468047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623211|NCT05468047|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92348341|NCT01585194|Nivolumab|nivolumab|mesh-list
92623212|NCT05468047|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92623213|NCT05468047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623214|NCT05468047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623215|NCT00182364|Heparin|heparin|mesh-list
92623216|NCT00182364|Calcium heparin|calcium heparin|mesh-list
92623217|NCT00182364|Dalteparin|dalteparin|mesh-list
92623218|NCT00182364|Tinzaparin|tinzaparin|mesh-list
92623219|NCT00182364|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92623220|NCT00182364|Anticoagulants|anticoagulants|mesh-ancestor
92623221|NCT00182364|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92623237|NCT00536653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92623238|NCT00536653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623239|NCT00536653|Androgen Antagonists|androgen antagonists|mesh-ancestor
92623240|NCT00536653|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623241|NCT00536653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623242|NCT00536653|Hormones|hormones|mesh-ancestor
92623243|NCT05467852|Dydrogesterone|dydrogesterone|mesh-list
92623244|NCT05467852|Progestins|progestins|mesh-ancestor
92623245|NCT05467852|Hormones|hormones|mesh-ancestor
92623246|NCT05467852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623247|NCT05467852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623248|NCT00536692|Mecamylamine|mecamylamine|mesh-list
92537873|NCT00143377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537874|NCT00143377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537875|NCT00143377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537877|NCT02972216|Docetaxel|docetaxel|mesh-list
92537878|NCT02972216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537879|NCT02972216|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537880|NCT02972216|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537881|NCT02972216|Mitosis Modulators|mitosis modulators|mesh-ancestor
92623249|NCT00536692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92623250|NCT00536692|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92623251|NCT00536692|Autonomic Agents|autonomic agents|mesh-ancestor
92623252|NCT00536692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623253|NCT00536692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623254|NCT00536692|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92623255|NCT00536692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92623256|NCT00536692|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623257|NCT00536692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623258|NCT00536692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623259|NCT00189345|Catumaxomab|catumaxomab|mesh-list
92623260|NCT00189345|Muromonab-CD3|muromonab-cd3|mesh-list
92623261|NCT00189345|Immunologic Factors|immunologic factors|mesh-ancestor
92623262|NCT00189345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623263|NCT00189345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623264|NCT00189345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92623265|NCT00156884|Cisplatin|cisplatin|mesh-list
92623266|NCT00156884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623267|NCT05464693|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92623268|NCT05464693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623269|NCT00156962|Epoetin Alfa|epoetin alfa|mesh-list
92623270|NCT00156962|Hematinics|hematinics|mesh-ancestor
92623271|NCT00182442|Olanzapine|olanzapine|mesh-list
92623272|NCT00182442|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92623273|NCT00182442|Antiemetics|antiemetics|mesh-ancestor
92623274|NCT00182442|Autonomic Agents|autonomic agents|mesh-ancestor
92623275|NCT00182442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623276|NCT00182442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623277|NCT00182442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92623278|NCT00182442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92623279|NCT00182442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92623280|NCT00182442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623281|NCT00182442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92623282|NCT00182442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92623283|NCT00182442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92623294|NCT00536770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623295|NCT00536770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623296|NCT00536770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92623297|NCT00536770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623298|NCT00536770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623299|NCT00536770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623300|NCT00536770|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92623301|NCT00536770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623302|NCT00536770|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92623304|NCT00536770|Micronutrients|micronutrients|mesh-ancestor
92623305|NCT00536770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92623306|NCT04685512|Tenofovir|tenofovir|mesh-list
92623307|NCT04685512|Emtricitabine|emtricitabine|mesh-list
92623308|NCT04685512|Antiviral Agents|antiviral agents|mesh-ancestor
92623309|NCT04685512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623310|NCT04685512|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92623311|NCT04685512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92623312|NCT04685512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623313|NCT04685512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623314|NCT04685512|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92623315|NCT04685512|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92623316|NCT00157040|Factor VIII|factor viii|mesh-list
92537882|NCT02972216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537883|NCT04726345|Fexofenadine|fexofenadine|mesh-list
92537884|NCT04726345|Terfenadine|terfenadine|mesh-list
92537885|NCT04726345|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92537886|NCT04726345|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92537887|NCT04726345|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92537888|NCT04726345|Histamine Antagonists|histamine antagonists|mesh-ancestor
92537889|NCT04726345|Histamine Agents|histamine agents|mesh-ancestor
92537890|NCT04726345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92537891|NCT04726345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537892|NCT04726345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537893|NCT00143533|Cefpodoxime|cefpodoxime|mesh-list
92537894|NCT00143533|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
92537895|NCT00143533|Irinotecan|irinotecan|mesh-list
92537896|NCT00143533|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92537897|NCT00143533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92537898|NCT00143533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537899|NCT00143533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537900|NCT00143533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537901|NCT00143533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92537902|NCT00143533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537903|NCT00143572|Hydroxyurea|hydroxyurea|mesh-list
92537904|NCT00143572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537905|NCT00143572|Antisickling Agents|antisickling agents|mesh-ancestor
92537906|NCT00143572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537907|NCT00143572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623317|NCT00157040|Coagulants|coagulants|mesh-ancestor
92623318|NCT00189384|Gentamicins|gentamicins|mesh-list
92623319|NCT00189384|Ceftriaxone|ceftriaxone|mesh-list
92623320|NCT00189384|Penicillins|penicillins|mesh-list
92623321|NCT00189384|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92623322|NCT00189384|Penicillin G Procaine|penicillin g procaine|mesh-list
92623323|NCT00189384|Penicillin G|penicillin g|mesh-list
92623324|NCT00189384|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92623325|NCT00189384|Procaine|procaine|mesh-list
92623326|NCT00189384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623327|NCT00189384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623328|NCT00189384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92623329|NCT00189384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623330|NCT00189384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623331|NCT00189384|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92623332|NCT00189384|Antimalarials|antimalarials|mesh-ancestor
92623333|NCT00189384|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92623334|NCT00189384|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92623335|NCT00189384|Anesthetics, Local|anesthetics, local|mesh-ancestor
92623336|NCT00189384|Anesthetics|anesthetics|mesh-ancestor
92623337|NCT00189384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623338|NCT00189384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623339|NCT00189384|Sensory System Agents|sensory system agents|mesh-ancestor
92537908|NCT00143572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92537910|NCT00393315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92537911|NCT00393315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92537912|NCT00393315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92537913|NCT00393315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92537914|NCT00393315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92537915|NCT00393315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537916|NCT00143689|Ritonavir|ritonavir|mesh-list
92537917|NCT00143689|Lopinavir|lopinavir|mesh-list
92537918|NCT00143689|Lamivudine|lamivudine|mesh-list
92537919|NCT00143689|Zidovudine|zidovudine|mesh-list
92537920|NCT00143689|Nevirapine|nevirapine|mesh-list
92537921|NCT00143689|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92537922|NCT00143689|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92537923|NCT00143689|Protease Inhibitors|protease inhibitors|mesh-ancestor
92537924|NCT00143689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537925|NCT00143689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537926|NCT00143689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92537927|NCT00143689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92537928|NCT00143689|Antiviral Agents|antiviral agents|mesh-ancestor
92537929|NCT00143689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537930|NCT00143689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92537931|NCT00143689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92537932|NCT00143689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92537933|NCT00143689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92537934|NCT00143689|Antimetabolites|antimetabolites|mesh-ancestor
92537935|NCT00143689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92537936|NCT00143689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92537937|NCT00143728|Lamivudine|lamivudine|mesh-list
92537938|NCT00143728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92537939|NCT00143728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92537940|NCT00143728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537941|NCT00143728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537942|NCT00143728|Antiviral Agents|antiviral agents|mesh-ancestor
92537943|NCT00143728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623340|NCT00189384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623341|NCT00536848|Metronidazole|metronidazole|mesh-list
92537945|NCT00143728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92537946|NCT00140803|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92537947|NCT00140803|Verteporfin|verteporfin|mesh-list
92537948|NCT00140803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92537949|NCT00140803|Glucocorticoids|glucocorticoids|mesh-ancestor
92537950|NCT00140803|Hormones|hormones|mesh-ancestor
92537951|NCT00140803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537952|NCT00140803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537953|NCT00140803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537954|NCT00140803|Immunologic Factors|immunologic factors|mesh-ancestor
92537955|NCT00140803|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92537956|NCT00140803|Dermatologic Agents|dermatologic agents|mesh-ancestor
92537957|NCT00143806|Cyclosporine|cyclosporine|mesh-list
92537958|NCT00143806|Alefacept|alefacept|mesh-list
92537959|NCT00143806|Cyclosporins|cyclosporins|mesh-list
92537960|NCT00143806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537961|NCT00143806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537962|NCT00143806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92537963|NCT00143806|Immunologic Factors|immunologic factors|mesh-ancestor
92537964|NCT00143806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537965|NCT00143806|Antifungal Agents|antifungal agents|mesh-ancestor
92537966|NCT00143806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537967|NCT00143806|Dermatologic Agents|dermatologic agents|mesh-ancestor
92537968|NCT00143806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92537969|NCT00143806|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92537970|NCT00390728|Insulin Glargine|insulin glargine|mesh-list
92537971|NCT00390728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92537972|NCT00390728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537973|NCT00144040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92537974|NCT00144040|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92623342|NCT00536848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623343|NCT00536848|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623344|NCT00536848|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92623345|NCT00536848|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92623346|NCT00157079|Immunoglobulins|immunoglobulins|mesh-list
92623347|NCT00157079|Antibodies|antibodies|mesh-list
92623348|NCT00157079|gamma-Globulins|gamma-globulins|mesh-list
92623349|NCT00157079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92030309|NCT03846765|Phenylephrine|phenylephrine|mesh-list
92623352|NCT00157079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623354|NCT00189501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623355|NCT00189501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623356|NCT00189501|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92623357|NCT00189501|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623358|NCT00189501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92537975|NCT00144040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537976|NCT00144040|Antitubercular Agents|antitubercular agents|mesh-ancestor
92537977|NCT00144118|Sevoflurane|sevoflurane|mesh-list
92537978|NCT00144118|Isoflurane|isoflurane|mesh-list
92537979|NCT00144118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92537980|NCT00144118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92537981|NCT00144118|Anesthetics, General|anesthetics, general|mesh-ancestor
92537982|NCT00144118|Anesthetics|anesthetics|mesh-ancestor
92537983|NCT00144118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92537984|NCT00144118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92537985|NCT00144157|Zidovudine|zidovudine|mesh-list
92537986|NCT00144157|Nevirapine|nevirapine|mesh-list
92537987|NCT00144157|Antimetabolites|antimetabolites|mesh-ancestor
92537988|NCT00144157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92537989|NCT00144157|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92537990|NCT00144157|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92537991|NCT00144157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92537992|NCT00144157|Antiviral Agents|antiviral agents|mesh-ancestor
92537993|NCT00144157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92537994|NCT00144157|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92537995|NCT00144157|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92537996|NCT00144157|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92537997|NCT00144157|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92537998|NCT00144196|Tiotropium Bromide|tiotropium bromide|mesh-list
92623359|NCT00157118|Protein C|protein c|mesh-list
92623360|NCT00157118|Anticoagulants|anticoagulants|mesh-ancestor
92623361|NCT00157118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92623362|NCT00157118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92623363|NCT00157118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623364|NCT00189579|Trastuzumab|trastuzumab|mesh-list
92623365|NCT00189579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92623366|NCT00189579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623367|NCT00157235|Bromides|bromides|mesh-list
92623368|NCT00157235|Tiotropium Bromide|tiotropium bromide|mesh-list
92623369|NCT00157235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92623370|NCT00157235|Autonomic Agents|autonomic agents|mesh-ancestor
92623371|NCT00157235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623372|NCT00157235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623373|NCT00157235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92623374|NCT00157235|Respiratory System Agents|respiratory system agents|mesh-ancestor
92623375|NCT00157235|Parasympatholytics|parasympatholytics|mesh-ancestor
92623376|NCT00157235|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92623377|NCT00157235|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623378|NCT00157235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623379|NCT00157235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623380|NCT00157235|Anticonvulsants|anticonvulsants|mesh-ancestor
92623381|NCT00182520|Topiramate|topiramate|mesh-list
92623382|NCT00182520|Anticonvulsants|anticonvulsants|mesh-ancestor
92623383|NCT00182520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623384|NCT00182520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623385|NCT00157274|Alemtuzumab|alemtuzumab|mesh-list
92537999|NCT00144196|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92538000|NCT00144196|Autonomic Agents|autonomic agents|mesh-ancestor
92538001|NCT00144196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538002|NCT00144196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538003|NCT00144196|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92538004|NCT00144196|Respiratory System Agents|respiratory system agents|mesh-ancestor
92538005|NCT00144196|Parasympatholytics|parasympatholytics|mesh-ancestor
92538006|NCT00144196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92538007|NCT00144196|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538008|NCT00144196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538009|NCT00144196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538010|NCT03276572|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92538011|NCT03276572|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92538012|NCT03276572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538013|NCT00144274|Ambroxol|ambroxol|mesh-list
92538014|NCT00144274|Expectorants|expectorants|mesh-ancestor
92538015|NCT00144274|Respiratory System Agents|respiratory system agents|mesh-ancestor
92538016|NCT00144352|Pyrimethamine|pyrimethamine|mesh-list
92538017|NCT00144352|Sulfadoxine|sulfadoxine|mesh-list
92538018|NCT00144352|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92538019|NCT00144352|Antimalarials|antimalarials|mesh-ancestor
92538020|NCT00144352|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92538021|NCT00144352|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92538022|NCT00144352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538023|NCT00144352|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92538024|NCT00144352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538025|NCT00144352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538026|NCT00144352|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92538027|NCT00144430|Pentostatin|pentostatin|mesh-list
92538028|NCT00144430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682772|NCT04701320|Methamphetamine|methamphetamine|mesh-list
92623386|NCT00157274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92623387|NCT00157274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623388|NCT04257487|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92623389|NCT04257487|Anticoagulants|anticoagulants|mesh-ancestor
92623390|NCT04257487|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92623391|NCT04257487|Antimetabolites|antimetabolites|mesh-ancestor
92623392|NCT04257487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623393|NCT04257487|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92623394|NCT04257487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92623395|NCT04257487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92623396|NCT04257487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92538029|NCT00144430|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92538030|NCT00144430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538031|NCT00144430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538032|NCT00144469|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92538033|NCT00144469|Antiviral Agents|antiviral agents|mesh-ancestor
92538034|NCT00144469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538036|NCT00404716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92538037|NCT00404716|Autonomic Agents|autonomic agents|mesh-ancestor
92538038|NCT00404716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538039|NCT00404716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538040|NCT00404716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92538041|NCT00404716|Respiratory System Agents|respiratory system agents|mesh-ancestor
92538042|NCT00404716|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92538043|NCT00404716|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92538044|NCT00404716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538045|NCT00404716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92538046|NCT00404716|Vasodilator Agents|vasodilator agents|mesh-ancestor
92538047|NCT00404716|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92538048|NCT00404716|Protective Agents|protective agents|mesh-ancestor
92538049|NCT00404716|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92262790|NCT05785195|Antioxidants|antioxidants|mesh-ancestor
92538050|NCT00404716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92623397|NCT04257487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623398|NCT00182559|Cyclosporine|cyclosporine|mesh-list
92623399|NCT00182559|Tacrolimus|tacrolimus|mesh-list
92623400|NCT00182559|Cyclosporins|cyclosporins|mesh-list
92623401|NCT00182559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623402|NCT00182559|Immunologic Factors|immunologic factors|mesh-ancestor
92623403|NCT00182559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623404|NCT00182559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92623405|NCT00182559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623406|NCT00182559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623407|NCT00182559|Antifungal Agents|antifungal agents|mesh-ancestor
92623408|NCT00182559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623409|NCT00182559|Dermatologic Agents|dermatologic agents|mesh-ancestor
92623410|NCT00182559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623411|NCT00425568|Testosterone|testosterone|mesh-list
92623412|NCT00425568|Androgens|androgens|mesh-ancestor
92623413|NCT00425568|Hormones|hormones|mesh-ancestor
92623414|NCT00425568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623415|NCT00425568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623416|NCT00157508|Nitroaspirin|nitroaspirin|mesh-list
92623417|NCT00157508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92623418|NCT00157508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623419|NCT00157508|Analgesics|analgesics|mesh-ancestor
92623420|NCT00157508|Sensory System Agents|sensory system agents|mesh-ancestor
92623421|NCT00157508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623422|NCT00157508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623425|NCT00157508|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92623426|NCT00157508|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92538052|NCT00404794|Mycophenolic Acid|mycophenolic acid|mesh-list
92538053|NCT00404794|Prednisolone|prednisolone|mesh-list
92623427|NCT00157508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623428|NCT00157508|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92623429|NCT00157508|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92623430|NCT00157508|Protease Inhibitors|protease inhibitors|mesh-ancestor
92623431|NCT00157508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623432|NCT00189618|Aspirin|aspirin|mesh-list
92623433|NCT00189618|Clopidogrel|clopidogrel|mesh-list
92623434|NCT00189618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92623435|NCT00189618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623436|NCT00189618|Analgesics|analgesics|mesh-ancestor
92623437|NCT00189618|Sensory System Agents|sensory system agents|mesh-ancestor
92623438|NCT00189618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623439|NCT00189618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623440|NCT00189618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92623441|NCT00189618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623442|NCT00189618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92623443|NCT00189618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92623444|NCT00189618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623445|NCT00189618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92623446|NCT00189618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92623447|NCT00189618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623448|NCT00189618|Antipyretics|antipyretics|mesh-ancestor
92623449|NCT00189618|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92623450|NCT00189618|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92623451|NCT00189618|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92623452|NCT00189618|Purinergic Agents|purinergic agents|mesh-ancestor
92623453|NCT00189618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623454|NCT00406796|Ranibizumab|ranibizumab|mesh-list
92623455|NCT00406796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92623456|NCT00406796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92623457|NCT00406796|Growth Substances|growth substances|mesh-ancestor
92623458|NCT00406796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623459|NCT00406796|Growth Inhibitors|growth inhibitors|mesh-ancestor
92623460|NCT00406796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623461|NCT00534391|Polymyxins|polymyxins|mesh-list
92623462|NCT00534391|Neomycin|neomycin|mesh-list
92623463|NCT00534391|Polymyxin B|polymyxin b|mesh-list
92623464|NCT00534391|Gramicidin|gramicidin|mesh-list
92623465|NCT00534391|Lubricant Eye Drops|lubricant eye drops|mesh-list
92623466|NCT00534391|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92623467|NCT00534391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92623468|NCT00534391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623469|NCT00534391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623470|NCT00534391|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92623471|NCT00534391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623472|NCT00534391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623473|NCT00534391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92623474|NCT00534508|Tacrolimus|tacrolimus|mesh-list
92623475|NCT00534508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623476|NCT00534508|Immunologic Factors|immunologic factors|mesh-ancestor
92623477|NCT00534508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623478|NCT00534508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92623479|NCT00534508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623480|NCT00534508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623481|NCT00182715|Leucovorin|leucovorin|mesh-list
92623482|NCT00182715|Fluorouracil|fluorouracil|mesh-list
92623483|NCT00182715|Capecitabine|capecitabine|mesh-list
92623484|NCT00182715|Oxaliplatin|oxaliplatin|mesh-list
92623485|NCT00182715|Cetuximab|cetuximab|mesh-list
92623486|NCT00182715|Calcium|calcium|mesh-list
92623487|NCT00182715|Levoleucovorin|levoleucovorin|mesh-list
92623488|NCT00182715|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623489|NCT00182715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623490|NCT00182715|Antimetabolites|antimetabolites|mesh-ancestor
92623491|NCT00182715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623492|NCT00182715|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92623493|NCT00182715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623494|NCT00182715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623495|NCT00182715|Immunologic Factors|immunologic factors|mesh-ancestor
92623496|NCT00182715|Antidotes|antidotes|mesh-ancestor
92623498|NCT00182715|Vitamin B Complex|vitamin b complex|mesh-ancestor
92623499|NCT00182715|Vitamins|vitamins|mesh-ancestor
92623500|NCT00182715|Micronutrients|micronutrients|mesh-ancestor
92538054|NCT00404794|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92538055|NCT00404794|Methylprednisolone|methylprednisolone|mesh-list
91969108|NCT02488889|Ethanol|ethanol|mesh-list
92623501|NCT00182715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92623502|NCT00534586|Ketamine|ketamine|mesh-list
92623503|NCT00534586|Remifentanil|remifentanil|mesh-list
92623504|NCT00534586|Propofol|propofol|mesh-list
92623505|NCT00534586|Sevoflurane|sevoflurane|mesh-list
92623506|NCT00534586|Esketamine|esketamine|mesh-list
92623507|NCT00534586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92623508|NCT00534586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623509|NCT00534586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623510|NCT00534586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92623511|NCT00534586|Anesthetics, General|anesthetics, general|mesh-ancestor
92623512|NCT00534586|Anesthetics|anesthetics|mesh-ancestor
92623513|NCT00534586|Analgesics|analgesics|mesh-ancestor
92623514|NCT00534586|Sensory System Agents|sensory system agents|mesh-ancestor
92623515|NCT00534586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623516|NCT00534586|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92623517|NCT00534586|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92623518|NCT00534586|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92623519|NCT00534586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623520|NCT00534586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623521|NCT00534586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92623522|NCT00534586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92623523|NCT00534586|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92623525|NCT00534586|Antidepressive Agents|antidepressive agents|mesh-ancestor
92623526|NCT00534586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92623527|NCT00534625|Zileuton|zileuton|mesh-list
92623528|NCT00534625|Hydroxyurea|hydroxyurea|mesh-list
92623529|NCT00534625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92623530|NCT00534625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623531|NCT00534625|Analgesics|analgesics|mesh-ancestor
92623532|NCT00534625|Sensory System Agents|sensory system agents|mesh-ancestor
92623533|NCT00534625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623534|NCT00534625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623535|NCT00534625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92623536|NCT00534625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623537|NCT00534625|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92623538|NCT00534625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623539|NCT00534625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623540|NCT00534625|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92623541|NCT00534625|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623542|NCT00534625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623543|NCT00534625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623544|NCT00534625|Antisickling Agents|antisickling agents|mesh-ancestor
92623545|NCT00534625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92623546|NCT00406874|Folic Acid|folic acid|mesh-list
92623547|NCT00406874|Hematinics|hematinics|mesh-ancestor
92623548|NCT00406874|Vitamin B Complex|vitamin b complex|mesh-ancestor
92623549|NCT00406874|Vitamins|vitamins|mesh-ancestor
92623550|NCT00406874|Micronutrients|micronutrients|mesh-ancestor
92623551|NCT00406874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623552|NCT04106830|Mycophenolic Acid|mycophenolic acid|mesh-list
92623553|NCT04106830|Azathioprine|azathioprine|mesh-list
92623554|NCT04106830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623555|NCT04106830|Immunologic Factors|immunologic factors|mesh-ancestor
92623556|NCT04106830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623557|NCT04106830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623558|NCT04106830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92623559|NCT04106830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92623560|NCT04106830|Antitubercular Agents|antitubercular agents|mesh-ancestor
92623561|NCT04106830|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623562|NCT04106830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623563|NCT04106830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623564|NCT04106830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623565|NCT04106830|Antimetabolites|antimetabolites|mesh-ancestor
92623566|NCT04106830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92623567|NCT04106830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623568|NCT00189657|Irinotecan|irinotecan|mesh-list
92623569|NCT00189657|Fluorouracil|fluorouracil|mesh-list
92623570|NCT00189657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92623571|NCT00189657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92623572|NCT00189657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538056|NCT00404794|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92538057|NCT00404794|Prednisolone acetate|prednisolone acetate|mesh-list
92538059|NCT00404794|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92538060|NCT00404794|Prednisolone phosphate|prednisolone phosphate|mesh-list
92538061|NCT00404794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030511|NCT04435431|Mesdopetam|mesdopetam|mesh-list
92623576|NCT00189657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92623577|NCT00189657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623578|NCT00189657|Immunologic Factors|immunologic factors|mesh-ancestor
92623579|NCT00189657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623580|NCT00406913|Mupirocin|mupirocin|mesh-list
92623581|NCT00406913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623582|NCT00406913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623583|NCT00406913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92623584|NCT00406913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623585|NCT00406913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623586|NCT00406952|Sertraline|sertraline|mesh-list
92623587|NCT00406952|Antidepressive Agents|antidepressive agents|mesh-ancestor
92623588|NCT00406952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92623589|NCT00406952|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92623590|NCT00406952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92623591|NCT00406952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623592|NCT00406952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623593|NCT00406952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623594|NCT00406952|Serotonin Agents|serotonin agents|mesh-ancestor
92623595|NCT00406952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623596|NCT04090879|Nicotine|nicotine|mesh-list
92623597|NCT04090879|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92623598|NCT04090879|Autonomic Agents|autonomic agents|mesh-ancestor
92623599|NCT04090879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623600|NCT04090879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623601|NCT04090879|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92623602|NCT04090879|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92623603|NCT04090879|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623604|NCT04090879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623605|NCT04090879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623606|NCT00157547|Fluvoxamine|fluvoxamine|mesh-list
92623607|NCT00157547|Citalopram|citalopram|mesh-list
92623608|NCT00157547|Fluoxetine|fluoxetine|mesh-list
92623609|NCT00157547|Paroxetine|paroxetine|mesh-list
92623610|NCT00157547|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92623611|NCT00157547|Sertraline|sertraline|mesh-list
92623612|NCT00157547|Escitalopram|escitalopram|mesh-list
92623613|NCT00157547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92623614|NCT00157547|Serotonin|serotonin|mesh-list
92623615|NCT00157547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92623616|NCT00157547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623617|NCT00157547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623618|NCT00157547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623619|NCT00157547|Serotonin Agents|serotonin agents|mesh-ancestor
92623620|NCT00157547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623621|NCT00157547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92623622|NCT00157547|Antidepressive Agents|antidepressive agents|mesh-ancestor
92623623|NCT00157547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92623624|NCT00157547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92623625|NCT00157547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92623626|NCT00157547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623627|NCT00157547|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92623628|NCT00157547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92623629|NCT00157547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92623630|NCT00157547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623631|NCT00157547|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92623632|NCT00157547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92623633|NCT00157547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92623634|NCT04061161|Bromides|bromides|mesh-list
92623635|NCT04061161|Tiotropium Bromide|tiotropium bromide|mesh-list
92623636|NCT04061161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92538062|NCT00404794|Immunologic Factors|immunologic factors|mesh-ancestor
92538063|NCT00404794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538064|NCT00404794|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92538065|NCT00404794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538066|NCT00404794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538067|NCT00404794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92538068|NCT00404794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538069|NCT00404794|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92538070|NCT00404794|Antitubercular Agents|antitubercular agents|mesh-ancestor
92538071|NCT00404794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538072|NCT00404794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538073|NCT00404794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538074|NCT00404794|Glucocorticoids|glucocorticoids|mesh-ancestor
92538075|NCT00404794|Hormones|hormones|mesh-ancestor
92623637|NCT04061161|Autonomic Agents|autonomic agents|mesh-ancestor
92623638|NCT04061161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623639|NCT04061161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623640|NCT04061161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92623641|NCT04061161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030584|NCT02242305|Scopolamine|scopolamine|mesh-list
92623644|NCT04061161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623645|NCT04061161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623646|NCT04061161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623647|NCT04061161|Anticonvulsants|anticonvulsants|mesh-ancestor
92623648|NCT00157586|Manidipine|manidipine|mesh-list
92623649|NCT00157586|Delapril|delapril|mesh-list
92623650|NCT00157586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92623651|NCT00157586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92623652|NCT00157586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623653|NCT00157586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623654|NCT00157586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623655|NCT00157586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623656|NCT00157586|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92623657|NCT00157586|Protease Inhibitors|protease inhibitors|mesh-ancestor
92623658|NCT00157586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623659|NCT00182871|Testosterone|testosterone|mesh-list
92623660|NCT00182871|Androgens|androgens|mesh-ancestor
92623661|NCT00182871|Hormones|hormones|mesh-ancestor
92623662|NCT00182871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623663|NCT00182871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348787|NCT01571232|Glucocorticoids|glucocorticoids|mesh-ancestor
92623664|NCT00189774|Nateglinide|nateglinide|mesh-list
92623665|NCT00189774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623666|NCT00189774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623667|NCT04686643|Niacin|niacin|mesh-list
92623668|NCT04686643|Amlodipine|amlodipine|mesh-list
92623669|NCT04686643|Valsartan|valsartan|mesh-list
92623670|NCT04686643|Indapamide|indapamide|mesh-list
92623671|NCT04686643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92623672|NCT04686643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92623673|NCT04686643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623674|NCT04686643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623675|NCT04686643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623676|NCT04686643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623677|NCT04686643|Vasodilator Agents|vasodilator agents|mesh-ancestor
92623678|NCT04686643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92623679|NCT04686643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92623680|NCT04686643|Diuretics|diuretics|mesh-ancestor
92623681|NCT04686643|Natriuretic Agents|natriuretic agents|mesh-ancestor
92623682|NCT04686643|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92538076|NCT00404794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538077|NCT00404794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92538078|NCT00404794|Antiemetics|antiemetics|mesh-ancestor
91969311|NCT05353361|Paclitaxel|paclitaxel|mesh-list
92623683|NCT04686643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92623684|NCT04686643|Antimetabolites|antimetabolites|mesh-ancestor
92623685|NCT04686643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92623686|NCT04686643|Vitamin B Complex|vitamin b complex|mesh-ancestor
92623687|NCT04686643|Vitamins|vitamins|mesh-ancestor
92623688|NCT04686643|Micronutrients|micronutrients|mesh-ancestor
92623689|NCT00534898|Fenretinide|fenretinide|mesh-list
92623690|NCT00534898|Bexarotene|bexarotene|mesh-list
92623691|NCT00534898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623692|NCT00534898|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92623693|NCT00534898|Protective Agents|protective agents|mesh-ancestor
92623694|NCT00534898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623695|NCT03748810|Metformin|metformin|mesh-list
92623696|NCT03748810|Dapagliflozin|dapagliflozin|mesh-list
92623697|NCT03748810|Empagliflozin|empagliflozin|mesh-list
92623698|NCT03748810|Glimepiride|glimepiride|mesh-list
92623699|NCT03748810|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92623700|NCT03748810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623701|NCT03748810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623702|NCT03748810|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92623703|NCT03748810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623704|NCT03748810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92623705|NCT03748810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92623706|NCT03748810|Immunologic Factors|immunologic factors|mesh-ancestor
92623707|NCT03748810|Protease Inhibitors|protease inhibitors|mesh-ancestor
92623708|NCT03748810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623709|NCT00157859|Chloroquine|chloroquine|mesh-list
92623710|NCT00157859|Pyrimethamine|pyrimethamine|mesh-list
92623711|NCT00157859|Sulfadoxine|sulfadoxine|mesh-list
92623712|NCT00157859|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92623713|NCT00157859|Amebicides|amebicides|mesh-ancestor
92623714|NCT00157859|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92623715|NCT00157859|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92623736|NCT03669523|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92623737|NCT03669523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623739|NCT00157976|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92623740|NCT00157976|Dermatologic Agents|dermatologic agents|mesh-ancestor
92623741|NCT03522961|Nitrofurantoin|nitrofurantoin|mesh-list
92623742|NCT03522961|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92623743|NCT03522961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623744|NCT03522961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623745|NCT00158093|Moxifloxacin|moxifloxacin|mesh-list
92623746|NCT00158093|Atenolol|atenolol|mesh-list
92623747|NCT00158093|Nebivolol|nebivolol|mesh-list
92623748|NCT00158093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623749|NCT00158093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623750|NCT00158093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92623751|NCT00158093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92623752|NCT00158093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623753|NCT00158093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623754|NCT00158093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623755|NCT00158093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623756|NCT00158093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92623757|NCT00158093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92623758|NCT00158093|Sympatholytics|sympatholytics|mesh-ancestor
92623759|NCT00158093|Autonomic Agents|autonomic agents|mesh-ancestor
92623760|NCT00158093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623761|NCT00158093|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92623762|NCT00158093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92623763|NCT00158093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92623764|NCT00158093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92623765|NCT00158093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623766|NCT00158093|Vasodilator Agents|vasodilator agents|mesh-ancestor
92623767|NCT00158093|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92623768|NCT00158093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92623769|NCT00158093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92623770|NCT03429946|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92623785|NCT00158132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92623787|NCT00158132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538079|NCT00404794|Autonomic Agents|autonomic agents|mesh-ancestor
92538080|NCT00404794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538081|NCT00404794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538082|NCT00404794|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92538083|NCT00404794|Protective Agents|protective agents|mesh-ancestor
92623788|NCT00158132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623789|NCT00158132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623790|NCT00158132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92623791|NCT00158132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92623792|NCT00158132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92623793|NCT00158132|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92623794|NCT00158132|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92623795|NCT00158132|Antiviral Agents|antiviral agents|mesh-ancestor
92623796|NCT00158132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623797|NCT00158132|Dopamine Agents|dopamine agents|mesh-ancestor
92623798|NCT00158132|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623799|NCT00158132|Analgesics|analgesics|mesh-ancestor
92623800|NCT00158132|Sensory System Agents|sensory system agents|mesh-ancestor
92623801|NCT00158132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623802|NCT00158171|Folic Acid|folic acid|mesh-list
92623803|NCT00158171|Nicotine|nicotine|mesh-list
92623804|NCT00158171|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92623805|NCT00158171|Autonomic Agents|autonomic agents|mesh-ancestor
92623806|NCT00158171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623807|NCT00158171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623808|NCT00158171|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92623809|NCT00158171|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92623810|NCT00158171|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623811|NCT00158171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623812|NCT00158171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623813|NCT00158171|Hematinics|hematinics|mesh-ancestor
92623814|NCT00158171|Vitamin B Complex|vitamin b complex|mesh-ancestor
92623815|NCT00158171|Vitamins|vitamins|mesh-ancestor
92623816|NCT00158171|Micronutrients|micronutrients|mesh-ancestor
92623817|NCT03370783|Ethanol|ethanol|mesh-list
92623818|NCT03370783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92623819|NCT03370783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623820|NCT03370783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623821|NCT03370783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623822|NCT00158210|Rivastigmine|rivastigmine|mesh-list
92623823|NCT00158210|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92623824|NCT00158210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623825|NCT00158210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623826|NCT00158210|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623827|NCT00158210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623828|NCT00158210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623829|NCT00158210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92623832|NCT00190008|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92623833|NCT00190008|Protective Agents|protective agents|mesh-ancestor
92623834|NCT00190008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623835|NCT00190008|Nootropic Agents|nootropic agents|mesh-ancestor
92623836|NCT00183222|Naltrexone|naltrexone|mesh-list
92623837|NCT00183222|Ondansetron|ondansetron|mesh-list
92623838|NCT00183222|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92623839|NCT00183222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92623840|NCT00183222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623841|NCT00183222|Sensory System Agents|sensory system agents|mesh-ancestor
92623842|NCT00183222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623843|NCT00183222|Antiemetics|antiemetics|mesh-ancestor
92623844|NCT00183222|Autonomic Agents|autonomic agents|mesh-ancestor
92623845|NCT00183222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92623846|NCT00183222|Antipruritics|antipruritics|mesh-ancestor
92623847|NCT00183222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92623848|NCT00183222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92623849|NCT00183222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92623850|NCT00183222|Serotonin Agents|serotonin agents|mesh-ancestor
92623851|NCT00183222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623852|NCT00183222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623853|NCT00158405|Ritonavir|ritonavir|mesh-list
92623854|NCT00158405|Indinavir|indinavir|mesh-list
92623855|NCT00158405|Lamivudine|lamivudine|mesh-list
92623856|NCT00158405|Zidovudine|zidovudine|mesh-list
92623857|NCT00158405|Efavirenz|efavirenz|mesh-list
92538084|NCT00404833|Mycophenolic Acid|mycophenolic acid|mesh-list
92538085|NCT00404833|Prednisolone|prednisolone|mesh-list
92538086|NCT00404833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92538087|NCT00404833|Methylprednisolone|methylprednisolone|mesh-list
92538088|NCT00404833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92538089|NCT00404833|Prednisolone acetate|prednisolone acetate|mesh-list
92538090|NCT00404833|Chlorambucil|chlorambucil|mesh-list
92538091|NCT00404833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92623858|NCT00158405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92623859|NCT00158405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92623860|NCT00158405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92623861|NCT00158405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623862|NCT00158405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623863|NCT00158405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92623864|NCT00158405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92623865|NCT00158405|Antiviral Agents|antiviral agents|mesh-ancestor
92623866|NCT00158405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623867|NCT00158405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92623868|NCT00158405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92623869|NCT00158405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92623870|NCT00158405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92623871|NCT00158405|Antimetabolites|antimetabolites|mesh-ancestor
92623872|NCT00158405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92623873|NCT00158405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92623874|NCT00158405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92623875|NCT00158405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92623876|NCT00158405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92623877|NCT00158483|Acyclovir|acyclovir|mesh-list
92623878|NCT00158483|Antiviral Agents|antiviral agents|mesh-ancestor
92623879|NCT00158483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623880|NCT00158522|Interferons|interferons|mesh-list
92623881|NCT00158522|Interferon-alpha|interferon-alpha|mesh-list
92623882|NCT00158522|Interferon alpha-2|interferon alpha-2|mesh-list
92623883|NCT00158522|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92623884|NCT00158522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623885|NCT00158522|Antiviral Agents|antiviral agents|mesh-ancestor
92623886|NCT00158522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623887|NCT00158522|Immunologic Factors|immunologic factors|mesh-ancestor
92623888|NCT00158522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623889|NCT00158561|Pyrimethamine|pyrimethamine|mesh-list
92623890|NCT00158561|Sulfadoxine|sulfadoxine|mesh-list
92623891|NCT00158561|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92623892|NCT00158561|Dapsone|dapsone|mesh-list
92623893|NCT00158561|Chlorproguanil|chlorproguanil|mesh-list
92623894|NCT00158561|Antimalarials|antimalarials|mesh-ancestor
92623895|NCT00158561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92623896|NCT00158561|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92623897|NCT00158561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623898|NCT00158561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92623899|NCT00158561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623900|NCT00158561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623901|NCT00158561|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92623902|NCT00158561|Leprostatic Agents|leprostatic agents|mesh-ancestor
92623903|NCT00158561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623905|NCT05169229|Tobramycin|tobramycin|mesh-list
92623906|NCT05169229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623907|NCT05169229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623908|NCT00538018|Telithromycin|telithromycin|mesh-list
92623917|NCT00538174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623919|NCT00538174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623920|NCT04724486|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92623921|NCT04724486|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92623922|NCT04724486|Cetrorelix|cetrorelix|mesh-list
92623923|NCT04724486|Menotropins|menotropins|mesh-list
92623924|NCT04724486|Luteolytic Agents|luteolytic agents|mesh-ancestor
92623925|NCT04724486|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92623926|NCT04724486|Contraceptive Agents|contraceptive agents|mesh-ancestor
92623927|NCT04724486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92623928|NCT04724486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538092|NCT00404833|Prednisolone phosphate|prednisolone phosphate|mesh-list
92538093|NCT00404833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92538094|NCT00404833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538095|NCT00404833|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92538096|NCT00404833|Antitubercular Agents|antitubercular agents|mesh-ancestor
92538097|NCT00404833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538098|NCT00404833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538099|NCT00404833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538100|NCT00404833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538101|NCT00404833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538102|NCT00404833|Glucocorticoids|glucocorticoids|mesh-ancestor
92538103|NCT00404833|Hormones|hormones|mesh-ancestor
92538104|NCT00404833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538105|NCT00404833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538106|NCT00404833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92538107|NCT00404833|Antiemetics|antiemetics|mesh-ancestor
92538108|NCT00404833|Autonomic Agents|autonomic agents|mesh-ancestor
92538109|NCT00404833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538110|NCT00404833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538111|NCT00404833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92538112|NCT00404833|Protective Agents|protective agents|mesh-ancestor
92538113|NCT00404833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538114|NCT00404833|Alkylating Agents|alkylating agents|mesh-ancestor
92538115|NCT05595109|Silymarin|silymarin|mesh-list
92538116|NCT05595109|Antioxidants|antioxidants|mesh-ancestor
92538117|NCT05595109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538118|NCT05595109|Protective Agents|protective agents|mesh-ancestor
92623929|NCT04724486|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92623930|NCT04724486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92623931|NCT04724486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623932|NCT04724486|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92623933|NCT04724486|Fertility Agents|fertility agents|mesh-ancestor
92623934|NCT04724486|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623935|NCT04724486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623936|NCT00538330|Tamoxifen|tamoxifen|mesh-list
92623937|NCT00538330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92623938|NCT00538330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623939|NCT00538330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623940|NCT00538330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623941|NCT00538330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92623942|NCT00538330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623943|NCT00538330|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92623944|NCT00538330|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92623945|NCT00538330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92538119|NCT05595109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538121|NCT03128021|Levomilnacipran|levomilnacipran|mesh-list
92538122|NCT03128021|Escitalopram|escitalopram|mesh-list
92262866|NCT05624151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92538123|NCT03128021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92538125|NCT03128021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538126|NCT03128021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538127|NCT03128021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538128|NCT03128021|Serotonin Agents|serotonin agents|mesh-ancestor
92538129|NCT03128021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538130|NCT03128021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538131|NCT03128021|Antidepressive Agents|antidepressive agents|mesh-ancestor
92538132|NCT03128021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92538133|NCT03128021|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92538134|NCT03128021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538135|NCT03128021|Analgesics|analgesics|mesh-ancestor
92538136|NCT03128021|Sensory System Agents|sensory system agents|mesh-ancestor
92538137|NCT01919619|Lenalidomide|lenalidomide|mesh-list
92538138|NCT01919619|Ipilimumab|ipilimumab|mesh-list
92538139|NCT01919619|Immunologic Factors|immunologic factors|mesh-ancestor
92538140|NCT01919619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538141|NCT01919619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91945767|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
92623946|NCT00158717|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92623947|NCT00158717|Antiviral Agents|antiviral agents|mesh-ancestor
92623948|NCT00158717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623949|NCT00158717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92623950|NCT00158717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92623951|NCT00158717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623952|NCT00158717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623953|NCT00538486|Metformin|metformin|mesh-list
92623954|NCT00538486|Amlodipine|amlodipine|mesh-list
92623955|NCT00538486|Telmisartan|telmisartan|mesh-list
92623956|NCT00538486|Candesartan|candesartan|mesh-list
92623957|NCT00538486|Candesartan cilexetil|candesartan cilexetil|mesh-list
92623958|NCT00538486|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623959|NCT00538486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623960|NCT00538486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92623961|NCT00538486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92623962|NCT00538486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623963|NCT00538486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623964|NCT00538486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623965|NCT00538486|Vasodilator Agents|vasodilator agents|mesh-ancestor
92623966|NCT00538486|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92623967|NCT00538486|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92623968|NCT00538525|Docetaxel|docetaxel|mesh-list
92623969|NCT00538525|Doxorubicin|doxorubicin|mesh-list
92623970|NCT00538525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623971|NCT00538525|Tubulin Modulators|tubulin modulators|mesh-ancestor
92623972|NCT00538525|Antimitotic Agents|antimitotic agents|mesh-ancestor
92538142|NCT01919619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92538143|NCT01919619|Growth Substances|growth substances|mesh-ancestor
92538144|NCT01919619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92538145|NCT01919619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538146|NCT01919619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538147|NCT01919619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92538148|NCT01919619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538149|NCT01807494|Cimetidine|cimetidine|mesh-list
92538150|NCT01807494|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92538151|NCT01807494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538152|NCT01807494|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92538153|NCT01807494|Histamine Antagonists|histamine antagonists|mesh-ancestor
92538154|NCT01807494|Histamine Agents|histamine agents|mesh-ancestor
92538155|NCT01807494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538156|NCT01807494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538157|NCT01807494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538158|NCT01807494|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92538159|NCT01807494|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92538160|NCT01807494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538161|NCT01807455|Lidocaine|lidocaine|mesh-list
92538162|NCT01807455|Anesthetics, Local|anesthetics, local|mesh-ancestor
92538163|NCT01807455|Anesthetics|anesthetics|mesh-ancestor
92538164|NCT01807455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538165|NCT01807455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538166|NCT01807455|Sensory System Agents|sensory system agents|mesh-ancestor
92538189|NCT03092453|Pembrolizumab|pembrolizumab|mesh-list
92538190|NCT03092453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538191|NCT03092453|Immunologic Factors|immunologic factors|mesh-ancestor
92538192|NCT03092453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538193|NCT03092453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538194|NCT03092453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538195|NCT03092453|Alkylating Agents|alkylating agents|mesh-ancestor
92538196|NCT03092453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538197|NCT03092453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538198|NCT03092453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92538199|NCT03092453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538200|NCT03092453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92538201|NCT01807377|Midazolam|midazolam|mesh-list
92538202|NCT01807377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92538203|NCT01807377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92538204|NCT01807377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538205|NCT01807377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538206|NCT01807377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92538207|NCT01807377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92538208|NCT01807377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92538209|NCT01807377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92538210|NCT01807377|Anesthetics, General|anesthetics, general|mesh-ancestor
92538211|NCT01807377|Anesthetics|anesthetics|mesh-ancestor
92623973|NCT00538525|Mitosis Modulators|mitosis modulators|mesh-ancestor
92030916|NCT04763577|Bradykinin|bradykinin|mesh-list
92623974|NCT00538525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623975|NCT00538525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92623976|NCT00538525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92623977|NCT00538525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92623979|NCT00538564|Tadalafil|tadalafil|mesh-list
92623980|NCT00538564|Vasodilator Agents|vasodilator agents|mesh-ancestor
92623981|NCT00538564|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92623982|NCT00538564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92623983|NCT00538564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623984|NCT00538564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623985|NCT00538564|Urological Agents|urological agents|mesh-ancestor
92623986|NCT00538603|Paclitaxel|paclitaxel|mesh-list
92623987|NCT00538603|Carboplatin|carboplatin|mesh-list
92623988|NCT00538603|Doxorubicin|doxorubicin|mesh-list
92623989|NCT00538603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92623990|NCT00538603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92623991|NCT00538603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623992|NCT00538603|Tubulin Modulators|tubulin modulators|mesh-ancestor
92623993|NCT00538603|Antimitotic Agents|antimitotic agents|mesh-ancestor
92623994|NCT00538603|Mitosis Modulators|mitosis modulators|mesh-ancestor
92623995|NCT00538603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623996|NCT00538603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92623997|NCT00538603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92623998|NCT00538603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92538212|NCT01807377|GABA Modulators|gaba modulators|mesh-ancestor
92538213|NCT01807377|GABA Agents|gaba agents|mesh-ancestor
92538214|NCT01807377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538215|NCT01807377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538216|NCT03090737|Nivolumab|nivolumab|mesh-list
92538217|NCT03090737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538218|NCT03090737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538219|NCT03090737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92538220|NCT03090737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538221|NCT02972255|Meropenem|meropenem|mesh-list
92538222|NCT02972255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538223|NCT02972255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538224|NCT05468671|Remifentanil|remifentanil|mesh-list
92538225|NCT05468671|Oxycodone|oxycodone|mesh-list
92538226|NCT05468671|Propofol|propofol|mesh-list
92538227|NCT05468671|Rocuronium|rocuronium|mesh-list
92538228|NCT05468671|Flumazenil|flumazenil|mesh-list
92538229|NCT05468671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92538230|NCT05468671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538231|NCT05468671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538232|NCT05468671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92538233|NCT05468671|Anesthetics, General|anesthetics, general|mesh-ancestor
92538234|NCT05468671|Anesthetics|anesthetics|mesh-ancestor
92538235|NCT05468671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92538236|NCT05468671|Narcotics|narcotics|mesh-ancestor
92538237|NCT05468671|Analgesics|analgesics|mesh-ancestor
92538238|NCT05468671|Sensory System Agents|sensory system agents|mesh-ancestor
92538239|NCT05468671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538240|NCT05468671|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92538241|NCT05468671|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92623999|NCT00538603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624000|NCT00158834|Fluticasone|fluticasone|mesh-list
92624002|NCT00158834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92624003|NCT00158834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624004|NCT00158834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92624005|NCT00158834|Autonomic Agents|autonomic agents|mesh-ancestor
92624006|NCT00158834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624007|NCT00158834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624008|NCT00158834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92624009|NCT00158834|Respiratory System Agents|respiratory system agents|mesh-ancestor
92624010|NCT00158834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92624011|NCT00158834|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92624012|NCT00158834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92624013|NCT00158834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92624014|NCT00158834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92624015|NCT00158834|Adrenergic Agents|adrenergic agents|mesh-ancestor
92538242|NCT05468671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92538243|NCT05468671|Antidotes|antidotes|mesh-ancestor
92538244|NCT05468671|Protective Agents|protective agents|mesh-ancestor
92538245|NCT05468671|GABA Modulators|gaba modulators|mesh-ancestor
92538246|NCT05468671|GABA Agents|gaba agents|mesh-ancestor
92538247|NCT05468671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538248|NCT05468671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538249|NCT05461807|Rivaroxaban|rivaroxaban|mesh-list
92538250|NCT05461807|Apixaban|apixaban|mesh-list
92538251|NCT05461807|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92538252|NCT05461807|Antithrombins|antithrombins|mesh-ancestor
92538253|NCT05461807|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92538254|NCT05461807|Protease Inhibitors|protease inhibitors|mesh-ancestor
92538255|NCT05461807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538256|NCT05461807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538257|NCT05461807|Anticoagulants|anticoagulants|mesh-ancestor
92538258|NCT03079427|Cisplatin|cisplatin|mesh-list
92538259|NCT03079427|Gemcitabine|gemcitabine|mesh-list
92538260|NCT03079427|Capecitabine|capecitabine|mesh-list
92624016|NCT00158834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624017|NCT00158834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624018|NCT00538720|Vitamin D|vitamin d|mesh-list
92624019|NCT00538720|Ergocalciferols|ergocalciferols|mesh-list
92624020|NCT00538720|Vitamins|vitamins|mesh-ancestor
92624021|NCT00538720|Micronutrients|micronutrients|mesh-ancestor
92624022|NCT00538720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624023|NCT00538720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92624024|NCT00538720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92624025|NCT00536887|Atorvastatin|atorvastatin|mesh-list
92624026|NCT00536887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92624027|NCT00536887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92624028|NCT00536887|Antimetabolites|antimetabolites|mesh-ancestor
92624029|NCT00536887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624030|NCT00536887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92624031|NCT00536887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92624032|NCT00536887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624033|NCT00158873|Fentanyl|fentanyl|mesh-list
92624034|NCT00158873|Midazolam|midazolam|mesh-list
92624035|NCT00158873|Morphine|morphine|mesh-list
92624036|NCT00158873|Remifentanil|remifentanil|mesh-list
92624037|NCT00158873|Lorazepam|lorazepam|mesh-list
92624038|NCT00158873|Propofol|propofol|mesh-list
92624039|NCT00158873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92624040|NCT00158873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624041|NCT00158873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624042|NCT00158873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92624043|NCT00158873|Anesthetics, General|anesthetics, general|mesh-ancestor
92624044|NCT00158873|Anesthetics|anesthetics|mesh-ancestor
92624045|NCT00158873|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92624046|NCT00158873|Narcotics|narcotics|mesh-ancestor
92624048|NCT00158873|Sensory System Agents|sensory system agents|mesh-ancestor
92624049|NCT00158873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624050|NCT00158873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92624055|NCT00158873|GABA Agents|gaba agents|mesh-ancestor
92624056|NCT00158873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624057|NCT00158873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624058|NCT00158873|Anticonvulsants|anticonvulsants|mesh-ancestor
92624059|NCT00158873|Antiemetics|antiemetics|mesh-ancestor
92624060|NCT00158873|Autonomic Agents|autonomic agents|mesh-ancestor
92624061|NCT00158873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92624062|NCT00537121|Leucovorin|leucovorin|mesh-list
92538261|NCT03079427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538262|NCT03079427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92538264|NCT03079427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538265|NCT00390923|Selegiline|selegiline|mesh-list
92538266|NCT00390923|Nicotine|nicotine|mesh-list
92538267|NCT00390923|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92538268|NCT00390923|Autonomic Agents|autonomic agents|mesh-ancestor
92538269|NCT00390923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538270|NCT00390923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538271|NCT00390923|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92538272|NCT00390923|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92538273|NCT00390923|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538274|NCT00390923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538275|NCT00390923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538276|NCT00390923|Antidepressive Agents|antidepressive agents|mesh-ancestor
92538277|NCT00390923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92538278|NCT00390923|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92538279|NCT00390923|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92538280|NCT00390923|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92538281|NCT00390923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538282|NCT00390923|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92538283|NCT00390923|Protective Agents|protective agents|mesh-ancestor
92538284|NCT00425425|Fluorouracil|fluorouracil|mesh-list
92538285|NCT00425425|Oxaliplatin|oxaliplatin|mesh-list
92538286|NCT00425425|Cetuximab|cetuximab|mesh-list
92538287|NCT00425425|Antimetabolites|antimetabolites|mesh-ancestor
92361575|NCT05362188|Nicotinic Acids|nicotinic acids|mesh-list
92538288|NCT00425425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538289|NCT00425425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92538290|NCT00425425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538291|NCT00425425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538292|NCT00425425|Immunologic Factors|immunologic factors|mesh-ancestor
92538293|NCT00425425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538294|NCT00425425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538295|NCT01806948|Ramosetron|ramosetron|mesh-list
92538296|NCT01806948|Antiemetics|antiemetics|mesh-ancestor
92538297|NCT01806948|Autonomic Agents|autonomic agents|mesh-ancestor
92624063|NCT00537121|Fluorouracil|fluorouracil|mesh-list
92624064|NCT00537121|Irinotecan|irinotecan|mesh-list
92538298|NCT01806948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538299|NCT01806948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538300|NCT01806948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538301|NCT01806948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92538302|NCT01806948|Serotonin Agents|serotonin agents|mesh-ancestor
92538303|NCT01806948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538304|NCT01806948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538305|NCT02958163|Doxorubicin|doxorubicin|mesh-list
92538306|NCT02958163|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92538307|NCT02958163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538308|NCT02958163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92538309|NCT02958163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92538310|NCT02958163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538311|NCT02958163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538312|NCT00424138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92538313|NCT00424138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92624065|NCT00537121|Vorinostat|vorinostat|mesh-list
92624066|NCT00537121|Calcium|calcium|mesh-list
92624067|NCT00537121|Levoleucovorin|levoleucovorin|mesh-list
92624068|NCT00537121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92624069|NCT00537121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624070|NCT00537121|Antimetabolites|antimetabolites|mesh-ancestor
92624071|NCT00537121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624072|NCT00537121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624073|NCT00537121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624074|NCT00537121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624075|NCT00537121|Immunologic Factors|immunologic factors|mesh-ancestor
92624076|NCT00537121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92624077|NCT00537121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624078|NCT00537121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624079|NCT00537121|Antidotes|antidotes|mesh-ancestor
92624080|NCT00537121|Protective Agents|protective agents|mesh-ancestor
92624081|NCT00537121|Vitamin B Complex|vitamin b complex|mesh-ancestor
92624082|NCT00537121|Vitamins|vitamins|mesh-ancestor
92624083|NCT00537121|Micronutrients|micronutrients|mesh-ancestor
92624084|NCT00537121|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92624085|NCT00406991|Aspirin|aspirin|mesh-list
92624086|NCT00406991|Clopidogrel|clopidogrel|mesh-list
92624087|NCT00406991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92624088|NCT00406991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92624089|NCT00406991|Analgesics|analgesics|mesh-ancestor
92624090|NCT00406991|Sensory System Agents|sensory system agents|mesh-ancestor
92624091|NCT00406991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624092|NCT00406991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624093|NCT00406991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624094|NCT00406991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624095|NCT00406991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92624096|NCT00406991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92624097|NCT00406991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624098|NCT00406991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92624099|NCT00406991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92624100|NCT00406991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624101|NCT00406991|Antipyretics|antipyretics|mesh-ancestor
92624102|NCT00406991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92624103|NCT00406991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92624104|NCT00406991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92624105|NCT00406991|Purinergic Agents|purinergic agents|mesh-ancestor
92538314|NCT00424138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538315|NCT02985866|Pancrelipase|pancrelipase|mesh-list
92538316|NCT02985866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538317|NCT01806792|Cholecalciferol|cholecalciferol|mesh-list
92538318|NCT01806792|Risedronic Acid|risedronic acid|mesh-list
92538319|NCT01806792|Etidronic Acid|etidronic acid|mesh-list
92538320|NCT01806792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92538321|NCT01806792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538322|NCT01806792|Vitamins|vitamins|mesh-ancestor
92538323|NCT01806792|Micronutrients|micronutrients|mesh-ancestor
92538324|NCT01806792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92538325|NCT01806792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92538326|NCT01806792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538327|NCT01806792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538328|NCT05228431|Capecitabine|capecitabine|mesh-list
92538329|NCT05228431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92538330|NCT05228431|Antimetabolites|antimetabolites|mesh-ancestor
92538331|NCT05228431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538332|NCT05228431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538333|NCT05227456|Etonogestrel|etonogestrel|mesh-list
92538334|NCT05227456|Desogestrel|desogestrel|mesh-list
92538335|NCT05227456|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92538336|NCT05227456|Contraceptive Agents|contraceptive agents|mesh-ancestor
92538337|NCT05227456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92538338|NCT05227456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538339|NCT05227456|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92538340|NCT05227456|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92538341|NCT05227456|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92538342|NCT05227456|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92538343|NCT05227456|Progestins|progestins|mesh-ancestor
92538344|NCT05227456|Hormones|hormones|mesh-ancestor
92538345|NCT05227456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538346|NCT01806753|Midazolam|midazolam|mesh-list
92538347|NCT01806753|Propofol|propofol|mesh-list
92624106|NCT00406991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624107|NCT05432947|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92624108|NCT05432947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92624109|NCT05432947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624110|NCT00158990|Sertraline|sertraline|mesh-list
92624111|NCT00158990|Antidepressive Agents|antidepressive agents|mesh-ancestor
92624112|NCT00158990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92263094|NCT04964869|Epinephrine|epinephrine|mesh-list
92538348|NCT01806753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92538349|NCT01806753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538350|NCT01806753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538351|NCT01806753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92538352|NCT01806753|Anesthetics, General|anesthetics, general|mesh-ancestor
92538353|NCT01806753|Anesthetics|anesthetics|mesh-ancestor
92538354|NCT01806753|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92538355|NCT01806753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92538356|NCT01806753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91945984|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
92624113|NCT00158990|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92624114|NCT00158990|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624115|NCT00158990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624116|NCT00158990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624117|NCT00158990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624118|NCT00158990|Serotonin Agents|serotonin agents|mesh-ancestor
92624119|NCT00158990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624120|NCT00537355|Histamine|histamine|mesh-list
92624121|NCT00537355|Histamine Agonists|histamine agonists|mesh-ancestor
92624122|NCT00537355|Histamine Agents|histamine agents|mesh-ancestor
92624123|NCT00537355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624128|NCT00183612|Autonomic Agents|autonomic agents|mesh-ancestor
92624129|NCT00183612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624130|NCT00183612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624131|NCT00183612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92624132|NCT00183612|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92624133|NCT00183612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92624134|NCT00183612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624135|NCT00183612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624136|NCT00183612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92624137|NCT00183612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624138|NCT00183612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624139|NCT00183612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624140|NCT00183612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624141|NCT00183612|Serotonin Agents|serotonin agents|mesh-ancestor
92624142|NCT05381623|Hemostatics|hemostatics|mesh-list
92624143|NCT05381623|Coagulants|coagulants|mesh-ancestor
92624144|NCT00537472|Bupivacaine|bupivacaine|mesh-list
92624145|NCT00537472|Anesthetics|anesthetics|mesh-list
92624146|NCT00537472|Anesthetics, Local|anesthetics, local|mesh-ancestor
92624147|NCT00537472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624148|NCT00537472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624149|NCT00537472|Sensory System Agents|sensory system agents|mesh-ancestor
92624150|NCT00537472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624151|NCT00159107|Acamprosate|acamprosate|mesh-list
92624152|NCT00159107|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92624153|NCT00537550|Methotrexate|methotrexate|mesh-list
92624154|NCT00537550|Vincristine|vincristine|mesh-list
92624155|NCT00537550|Asparaginase|asparaginase|mesh-list
92624156|NCT00537550|Daunorubicin|daunorubicin|mesh-list
92624157|NCT00537550|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92624158|NCT00537550|Abortifacient Agents|abortifacient agents|mesh-ancestor
92624159|NCT00537550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92624160|NCT00537550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624161|NCT00537550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624162|NCT00537550|Antimetabolites|antimetabolites|mesh-ancestor
92624163|NCT00537550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624164|NCT00537550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624165|NCT00537550|Dermatologic Agents|dermatologic agents|mesh-ancestor
92624166|NCT00537550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624167|NCT00537550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92624168|NCT00537550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624169|NCT00537550|Immunologic Factors|immunologic factors|mesh-ancestor
92538357|NCT01806753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92538359|NCT01806753|GABA Agents|gaba agents|mesh-ancestor
92538360|NCT01806753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538361|NCT01806753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538362|NCT05197075|Darunavir|darunavir|mesh-list
92538363|NCT05197075|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92538364|NCT05197075|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92538365|NCT05197075|Protease Inhibitors|protease inhibitors|mesh-ancestor
92538366|NCT05197075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538367|NCT05197075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538368|NCT05197075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92538369|NCT05197075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92538370|NCT05197075|Antiviral Agents|antiviral agents|mesh-ancestor
92538371|NCT05197075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538372|NCT05175430|Paroxetine|paroxetine|mesh-list
92538373|NCT05175430|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92538374|NCT05175430|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92538375|NCT05175430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92538376|NCT05175430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538377|NCT05175430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538378|NCT05175430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538379|NCT05175430|Serotonin Agents|serotonin agents|mesh-ancestor
92538380|NCT05175430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538381|NCT05175430|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92538382|NCT05175430|Antidepressive Agents|antidepressive agents|mesh-ancestor
92538383|NCT05175430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624170|NCT00537550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624171|NCT00537550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92624172|NCT00537550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92624173|NCT00537550|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624174|NCT00537550|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624175|NCT00537550|Mitosis Modulators|mitosis modulators|mesh-ancestor
92624176|NCT00537550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624177|NCT00537550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92624178|NCT00537550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624179|NCT00159146|Pindolol|pindolol|mesh-list
92624180|NCT00159146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92624181|NCT00159146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92624182|NCT00159146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92624183|NCT00159146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624184|NCT00159146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624185|NCT00159146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624186|NCT00159146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92624187|NCT00159146|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92624188|NCT00159146|Serotonin Agents|serotonin agents|mesh-ancestor
92538384|NCT05175430|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92538385|NCT05175430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92538386|NCT05175430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624189|NCT00159146|Vasodilator Agents|vasodilator agents|mesh-ancestor
92624190|NCT00537667|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92624191|NCT00537667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624192|NCT00538876|Decitabine|decitabine|mesh-list
92624193|NCT00538876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624194|NCT00538876|Antimetabolites|antimetabolites|mesh-ancestor
92031129|NCT02397889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92624196|NCT00538876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624198|NCT00538954|Magnesium Oxide|magnesium oxide|mesh-list
92624199|NCT00538954|Antacids|antacids|mesh-ancestor
92624200|NCT00538954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624201|NCT00538954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92624202|NCT00539071|Risperidone|risperidone|mesh-list
92624203|NCT00539071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92624204|NCT00539071|Serotonin Agents|serotonin agents|mesh-ancestor
92624205|NCT00539071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624206|NCT00539071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624207|NCT00539071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624208|NCT00539071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92624209|NCT00539071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92624210|NCT00539071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624211|NCT00539071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624212|NCT00539071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92624213|NCT00539071|Dopamine Agents|dopamine agents|mesh-ancestor
92624214|NCT00539149|Amoxicillin|amoxicillin|mesh-list
92624215|NCT00539149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92624216|NCT00539149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624217|NCT00183807|Celecoxib|celecoxib|mesh-list
92624218|NCT00183807|Irinotecan|irinotecan|mesh-list
92624219|NCT00183807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624220|NCT00183807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92624221|NCT00183807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624222|NCT00183807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624223|NCT00183807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624224|NCT00183807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92624225|NCT00183807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92624226|NCT00183807|Analgesics|analgesics|mesh-ancestor
92624227|NCT00183807|Sensory System Agents|sensory system agents|mesh-ancestor
92624228|NCT00183807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624229|NCT00183807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624230|NCT00183807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624231|NCT00183807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624232|NCT00183807|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92624233|NCT00183807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92624234|NCT00539773|Interferons|interferons|mesh-list
92624235|NCT00539773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624236|NCT00539773|Antiviral Agents|antiviral agents|mesh-ancestor
92361596|NCT05214222|Cisplatin|cisplatin|mesh-list
92624237|NCT00539773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624238|NCT00409461|Sirolimus|sirolimus|mesh-list
92624239|NCT00409461|Tacrolimus|tacrolimus|mesh-list
92624240|NCT00409461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624241|NCT00409461|Immunologic Factors|immunologic factors|mesh-ancestor
92624242|NCT00409461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624243|NCT00409461|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92624244|NCT00409461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624245|NCT00409461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624246|NCT00409461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92624247|NCT00409461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624248|NCT00409461|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624249|NCT00409461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624250|NCT00409461|Antifungal Agents|antifungal agents|mesh-ancestor
92624251|NCT00539890|Insulin|insulin|mesh-list
92624252|NCT00539890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92624253|NCT00539890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624254|NCT00539968|Docetaxel|docetaxel|mesh-list
92624255|NCT00539968|Lonafarnib|lonafarnib|mesh-list
92624256|NCT00539968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624257|NCT00539968|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624258|NCT00539968|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624259|NCT00539968|Mitosis Modulators|mitosis modulators|mesh-ancestor
92538388|NCT05175430|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92538389|NCT05175430|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92538390|NCT01806675|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92538391|NCT01806675|Glycine|glycine|mesh-list
92538392|NCT01806675|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92538393|NCT01806675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538394|NCT01806675|Glycine Agents|glycine agents|mesh-ancestor
92538395|NCT01806675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538396|NCT01806675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538397|NCT02762981|Paclitaxel|paclitaxel|mesh-list
92538398|NCT02762981|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91946027|NCT02728102|Lenalidomide|lenalidomide|mesh-list
92624260|NCT00539968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624261|NCT00539968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624262|NCT00183846|Irinotecan|irinotecan|mesh-list
92624263|NCT00183846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92624264|NCT00183846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624265|NCT00183846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624266|NCT00183846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624267|NCT00183846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624268|NCT00540085|Rocuronium|rocuronium|mesh-list
92624282|NCT00540202|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92624283|NCT00540202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624284|NCT00540202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92624285|NCT00540202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624286|NCT00540202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92624287|NCT00540202|Analgesics|analgesics|mesh-ancestor
92624288|NCT00540202|Sensory System Agents|sensory system agents|mesh-ancestor
92624289|NCT00540241|Pemetrexed|pemetrexed|mesh-list
92624290|NCT00540241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624291|NCT00540241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624292|NCT00540241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624293|NCT00540241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92624294|NCT00540241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92624295|NCT00159224|Ritonavir|ritonavir|mesh-list
92624296|NCT00159224|Lopinavir|lopinavir|mesh-list
92624297|NCT00159224|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92624298|NCT00159224|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92624299|NCT00159224|Protease Inhibitors|protease inhibitors|mesh-ancestor
92624300|NCT00159224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624301|NCT00159224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624302|NCT00159224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92624303|NCT00159224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92624304|NCT00159224|Antiviral Agents|antiviral agents|mesh-ancestor
92624305|NCT00159224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624306|NCT00159224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92624307|NCT00159224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92624308|NCT00540280|Gemcitabine|gemcitabine|mesh-list
92624309|NCT00540280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624310|NCT00540280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624311|NCT00540280|Antimetabolites|antimetabolites|mesh-ancestor
92624312|NCT00540280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624313|NCT00183924|Carboplatin|carboplatin|mesh-list
92624314|NCT00183924|Docetaxel|docetaxel|mesh-list
92624315|NCT00183924|Estramustine|estramustine|mesh-list
92624316|NCT00183924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624317|NCT00183924|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624318|NCT00183924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624319|NCT00183924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92624320|NCT00183924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624321|NCT00183924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538399|NCT02762981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92538400|NCT02762981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538401|NCT02762981|Tubulin Modulators|tubulin modulators|mesh-ancestor
92538402|NCT02762981|Antimitotic Agents|antimitotic agents|mesh-ancestor
92538403|NCT02762981|Mitosis Modulators|mitosis modulators|mesh-ancestor
92538404|NCT02762981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538405|NCT05065567|Droperidol|droperidol|mesh-list
92538406|NCT05065567|Haloperidol|haloperidol|mesh-list
92538407|NCT05065567|Ondansetron|ondansetron|mesh-list
92538408|NCT05065567|Haloperidol decanoate|haloperidol decanoate|mesh-list
92538409|NCT05065567|Antiemetics|antiemetics|mesh-ancestor
92624322|NCT00183924|Alkylating Agents|alkylating agents|mesh-ancestor
92624323|NCT00183924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92624324|NCT00159302|Nitric Oxide|nitric oxide|mesh-list
92624325|NCT00159302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92624326|NCT00159302|Autonomic Agents|autonomic agents|mesh-ancestor
92624327|NCT00159302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624328|NCT00159302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624329|NCT00159302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92624330|NCT00159302|Respiratory System Agents|respiratory system agents|mesh-ancestor
92624331|NCT00159302|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92624332|NCT00159302|Antioxidants|antioxidants|mesh-ancestor
92624335|NCT00159302|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92624336|NCT00159302|Vasodilator Agents|vasodilator agents|mesh-ancestor
92624337|NCT00159302|Gasotransmitters|gasotransmitters|mesh-ancestor
92624338|NCT00159302|Protective Agents|protective agents|mesh-ancestor
92624339|NCT00540631|Immunomodulating Agents|immunomodulating agents|mesh-list
92624340|NCT00540631|Immunologic Factors|immunologic factors|mesh-ancestor
92624341|NCT00540631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624342|NCT00183885|Mitomycins|mitomycins|mesh-list
92624343|NCT00183885|Mitomycin|mitomycin|mesh-list
92624344|NCT00183885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624345|NCT00183885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624346|NCT00183885|Alkylating Agents|alkylating agents|mesh-ancestor
92624347|NCT00183885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624348|NCT00183885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92624349|NCT00183885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624350|NCT00540709|Insulin Glargine|insulin glargine|mesh-list
92624351|NCT00540709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92624352|NCT00540709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624353|NCT00540748|Oxytocin|oxytocin|mesh-list
92624354|NCT00540748|Oxytocics|oxytocics|mesh-ancestor
92624355|NCT00540748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92624356|NCT00540748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624357|NCT00540787|Quinidine|quinidine|mesh-list
92624358|NCT00540787|Amiodarone|amiodarone|mesh-list
92624359|NCT00540787|Sotalol|sotalol|mesh-list
92624360|NCT00540787|Flecainide|flecainide|mesh-list
92624361|NCT00540787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92624362|NCT00540787|Propafenone|propafenone|mesh-list
92624363|NCT00540787|Dofetilide|dofetilide|mesh-list
92624364|NCT00540787|Cifenline|cifenline|mesh-list
92624365|NCT00540787|Calcium Channel Blockers|calcium channel blockers|mesh-list
92624366|NCT00540787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92624367|NCT00540787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624368|NCT00540787|Vasodilator Agents|vasodilator agents|mesh-ancestor
92624369|NCT00540787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92624370|NCT00540787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624371|NCT00540787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624372|NCT00540787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92624373|NCT00540787|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92624374|NCT00540787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92624375|NCT00540787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624376|NCT00540787|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92624377|NCT00540787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92538410|NCT05065567|Autonomic Agents|autonomic agents|mesh-ancestor
92538411|NCT05065567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538412|NCT05065567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538413|NCT05065567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538414|NCT05065567|Antipruritics|antipruritics|mesh-ancestor
92538415|NCT05065567|Dermatologic Agents|dermatologic agents|mesh-ancestor
91946048|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92624378|NCT00540787|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92624379|NCT00540787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92624380|NCT00540787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92624381|NCT00540787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92624382|NCT00540787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624383|NCT00540787|Sympatholytics|sympatholytics|mesh-ancestor
92624384|NCT00540787|Autonomic Agents|autonomic agents|mesh-ancestor
92624385|NCT00540787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624386|NCT00540787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92624387|NCT00540787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92624388|NCT00540787|Antimalarials|antimalarials|mesh-ancestor
92624389|NCT00540787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92624390|NCT00540787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92624391|NCT00540787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624392|NCT00540787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92624393|NCT00540787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92624394|NCT00540787|Cholinergic Agents|cholinergic agents|mesh-ancestor
92624395|NCT00159380|Pimagedine|pimagedine|mesh-list
92624396|NCT00159380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624397|NCT00159380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624398|NCT00540826|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92624399|NCT00540826|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92624400|NCT00540826|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624401|NCT00540826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624402|NCT00540826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624403|NCT00540826|Adrenergic Agents|adrenergic agents|mesh-ancestor
92624404|NCT00540826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624407|NCT00540943|Cetuximab|cetuximab|mesh-list
92624408|NCT00540943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92624409|NCT00540943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624410|NCT00540943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624411|NCT00540943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624412|NCT00540943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624413|NCT00540943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92624414|NCT00159458|Gemcitabine|gemcitabine|mesh-list
92624415|NCT00159458|Oxaliplatin|oxaliplatin|mesh-list
92624416|NCT00159458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624417|NCT00159458|Antimetabolites|antimetabolites|mesh-ancestor
92624418|NCT00159458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624419|NCT00159458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624420|NCT00541021|Gemcitabine|gemcitabine|mesh-list
92624421|NCT00541021|Sorafenib|sorafenib|mesh-list
92624422|NCT00541021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624424|NCT00541021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624425|NCT00541021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624426|NCT00541021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92624427|NCT00541021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624428|NCT00541138|Tamoxifen|tamoxifen|mesh-list
92624429|NCT00541138|Carboplatin|carboplatin|mesh-list
92624430|NCT00541138|Topotecan|topotecan|mesh-list
92624431|NCT00541138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624432|NCT00541138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624433|NCT00541138|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92624434|NCT00541138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624435|NCT00541138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624436|NCT00541138|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92624437|NCT00541138|Hormone Antagonists|hormone antagonists|mesh-ancestor
92624438|NCT00541138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624439|NCT00541138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538416|NCT05065567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91971636|NCT02463929|Antiemetics|antiemetics|mesh-ancestor
92624440|NCT00541138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92624441|NCT00541138|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92624442|NCT00541138|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92624443|NCT00541138|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92624444|NCT00541177|Atropine|atropine|mesh-list
92624445|NCT00541177|Tropicamide|tropicamide|mesh-list
92624446|NCT00541177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92624447|NCT00541177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92624448|NCT00541177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92624449|NCT00541177|Autonomic Agents|autonomic agents|mesh-ancestor
92624450|NCT00541177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624451|NCT00541177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624452|NCT00541177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92624453|NCT00541177|Respiratory System Agents|respiratory system agents|mesh-ancestor
92624454|NCT00541177|Mydriatics|mydriatics|mesh-ancestor
92624455|NCT00541177|Parasympatholytics|parasympatholytics|mesh-ancestor
92624456|NCT00541177|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92624457|NCT00541177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92624458|NCT00541177|Cholinergic Agents|cholinergic agents|mesh-ancestor
92624459|NCT00541177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624460|NCT00541177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624461|NCT00541216|Ephedrine|ephedrine|mesh-list
92624462|NCT00541216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92624463|NCT00541216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624464|NCT00541216|Sympathomimetics|sympathomimetics|mesh-ancestor
92624465|NCT00541216|Autonomic Agents|autonomic agents|mesh-ancestor
92624466|NCT00541216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624467|NCT00541216|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92624468|NCT00541216|Adrenergic Agents|adrenergic agents|mesh-ancestor
92624469|NCT00541216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624470|NCT00541216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624471|NCT00541333|Glatiramer Acetate|glatiramer acetate|mesh-list
92624472|NCT00541333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92624473|NCT00541333|Immunologic Factors|immunologic factors|mesh-ancestor
92624474|NCT00541333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624475|NCT00541333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624476|NCT00541333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624477|NCT00541372|Insulin|insulin|mesh-list
92624478|NCT00541372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92624482|NCT00159536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624483|NCT00541411|Dactinomycin|dactinomycin|mesh-list
92624484|NCT00541411|Vincristine|vincristine|mesh-list
92624485|NCT00541411|Ifosfamide|ifosfamide|mesh-list
92624486|NCT00541411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92624487|NCT00541411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624488|NCT00541411|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624489|NCT00541411|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624490|NCT00541411|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361625|NCT05017194|Emodepside|emodepside|mesh-list
92624491|NCT00541411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624492|NCT00541411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92624493|NCT00541411|Alkylating Agents|alkylating agents|mesh-ancestor
92624494|NCT00541411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92624495|NCT00541411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624496|NCT00541411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624497|NCT00541411|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92624499|NCT00541411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92624500|NCT00541489|Naproxen|naproxen|mesh-list
92624501|NCT00541489|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92624502|NCT00541489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92624503|NCT00541489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92624504|NCT00541489|Analgesics|analgesics|mesh-ancestor
92624505|NCT00541489|Sensory System Agents|sensory system agents|mesh-ancestor
92624506|NCT00541489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624507|NCT00541489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624508|NCT00541489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624509|NCT00541489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624510|NCT00541489|Gout Suppressants|gout suppressants|mesh-ancestor
92624511|NCT00541489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92624512|NCT00541489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624513|NCT00541489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538417|NCT05065567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92538418|NCT05065567|Serotonin Agents|serotonin agents|mesh-ancestor
92538419|NCT05065567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538420|NCT05065567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538421|NCT05065567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92263171|NCT04791943|Melatonin|melatonin|mesh-list
92538422|NCT05065567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92538423|NCT05065567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538424|NCT05065567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92538425|NCT05065567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92538426|NCT05065567|Dopamine Agents|dopamine agents|mesh-ancestor
92538427|NCT05065567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92538428|NCT05065567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92538429|NCT05065567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92538431|NCT04958044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92538432|NCT04958044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538433|NCT04871308|Dexmedetomidine|dexmedetomidine|mesh-list
92538434|NCT04871308|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91946056|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
92624514|NCT00541489|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92624515|NCT00190437|Amoxicillin|amoxicillin|mesh-list
92624516|NCT00190437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92624517|NCT00190437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624518|NCT00159575|Metformin|metformin|mesh-list
92624519|NCT00159575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92624520|NCT00159575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624521|NCT00541567|Ibipinabant|ibipinabant|mesh-list
92624522|NCT00541567|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92624523|NCT00541567|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92624524|NCT00541567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624525|NCT00541567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624526|NCT00541567|Hormones|hormones|mesh-ancestor
92624527|NCT00541567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624528|NCT00541567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624529|NCT00408798|Botulinum Toxins|botulinum toxins|mesh-list
92624530|NCT00408798|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92624531|NCT00408798|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92624532|NCT00408798|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92624533|NCT00408798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624534|NCT00408798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624535|NCT00408798|Cholinergic Agents|cholinergic agents|mesh-ancestor
92624536|NCT00408798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624537|NCT00408798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624538|NCT00408798|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92624539|NCT00408798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624540|NCT00541723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92624541|NCT00541723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92624542|NCT00541723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624543|NCT00541723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624544|NCT00541723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92624545|NCT00541723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624546|NCT00541723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624547|NCT00541723|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538435|NCT04871308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538436|NCT04871308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538437|NCT04871308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538438|NCT04871308|Analgesics|analgesics|mesh-ancestor
92538439|NCT04871308|Sensory System Agents|sensory system agents|mesh-ancestor
92538440|NCT04871308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538441|NCT04871308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92538442|NCT04871308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92538443|NCT04871308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92538444|NCT04871308|Adrenergic Agents|adrenergic agents|mesh-ancestor
92538445|NCT04871308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538446|NCT04871308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538447|NCT01806363|Telmisartan|telmisartan|mesh-list
92538448|NCT01806363|Chlorthalidone|chlorthalidone|mesh-list
92538449|NCT01806363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92624548|NCT00541723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624549|NCT00159614|Rolofylline|rolofylline|mesh-list
92624551|NCT00159614|Natriuretic Agents|natriuretic agents|mesh-ancestor
92624552|NCT00159614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624553|NCT00541840|Sorafenib|sorafenib|mesh-list
92624554|NCT00541840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624555|NCT00541840|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92624556|NCT00541840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624557|NCT00541840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624558|NCT00190476|Docetaxel|docetaxel|mesh-list
92624559|NCT00190476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624560|NCT00190476|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624561|NCT00190476|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624562|NCT00190476|Mitosis Modulators|mitosis modulators|mesh-ancestor
92624563|NCT00190476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624564|NCT00159653|Timolol|timolol|mesh-list
92624565|NCT00159653|Latanoprost|latanoprost|mesh-list
92624566|NCT00159653|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92624567|NCT00159653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92624568|NCT00159653|Adrenergic Agents|adrenergic agents|mesh-ancestor
92624569|NCT00159653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624570|NCT00159653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624571|NCT00159653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624572|NCT00159653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92624573|NCT00159653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92624574|NCT00159653|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92624575|NCT00159653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92624576|NCT00541918|Propofol|propofol|mesh-list
92624577|NCT00541918|Sevoflurane|sevoflurane|mesh-list
92624578|NCT00541918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92624579|NCT00541918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624580|NCT00541918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624581|NCT00541918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92624582|NCT00541918|Anesthetics, General|anesthetics, general|mesh-ancestor
92624583|NCT00541918|Anesthetics|anesthetics|mesh-ancestor
92624584|NCT00541918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92624585|NCT00541918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92624586|NCT00190515|Leucovorin|leucovorin|mesh-list
92624587|NCT00190515|Levoleucovorin|levoleucovorin|mesh-list
92624588|NCT00190515|Antidotes|antidotes|mesh-ancestor
92624589|NCT00190515|Protective Agents|protective agents|mesh-ancestor
92624590|NCT00190515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624591|NCT00190515|Vitamin B Complex|vitamin b complex|mesh-ancestor
92624592|NCT00190515|Vitamins|vitamins|mesh-ancestor
92624593|NCT00190515|Micronutrients|micronutrients|mesh-ancestor
92624594|NCT00159692|Amlodipine|amlodipine|mesh-list
92538450|NCT01806363|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92538451|NCT01806363|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92538452|NCT01806363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538454|NCT01806363|Natriuretic Agents|natriuretic agents|mesh-ancestor
92538455|NCT01806363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538456|NCT01806363|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92538457|NCT01806363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538458|NCT04846855|Anesthetics|anesthetics|mesh-list
92538459|NCT04846855|Anesthetics, Local|anesthetics, local|mesh-list
92538460|NCT04846855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946088|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624595|NCT00159692|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92624596|NCT00159692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92624597|NCT00159692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624598|NCT00159692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624599|NCT00159692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92624600|NCT00159692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624601|NCT00159692|Vasodilator Agents|vasodilator agents|mesh-ancestor
92624602|NCT00542074|Ethanol|ethanol|mesh-list
92624603|NCT00542074|Emollients|emollients|mesh-list
92624604|NCT00542074|Dermatologic Agents|dermatologic agents|mesh-ancestor
92624605|NCT00542074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92624606|NCT00542074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624607|NCT00542074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624608|NCT00542074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624609|NCT00542152|Cyclosporine|cyclosporine|mesh-list
92624610|NCT00542152|Infliximab|infliximab|mesh-list
92624611|NCT00542152|Cyclosporins|cyclosporins|mesh-list
92624612|NCT00542152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624613|NCT00542152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624614|NCT00542152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624615|NCT00542152|Immunologic Factors|immunologic factors|mesh-ancestor
92624616|NCT00542152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624617|NCT00542152|Antifungal Agents|antifungal agents|mesh-ancestor
92624618|NCT00542152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624619|NCT00542152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92624620|NCT00542152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624621|NCT00542152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92624622|NCT00542152|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92624623|NCT00542152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624624|NCT00542152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92624625|NCT00159731|Pregabalin|pregabalin|mesh-list
92624628|NCT00159731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624629|NCT00159731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624630|NCT00159731|Anticonvulsants|anticonvulsants|mesh-ancestor
92624631|NCT00159731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92624632|NCT00159731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624633|NCT00159731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624634|NCT00159731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92624635|NCT00159731|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92624636|NCT00159731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92624637|NCT00159731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624638|NCT00159731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624639|NCT00408915|Lisuride|lisuride|mesh-list
92624640|NCT00408915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92624641|NCT00408915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92624642|NCT00408915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92624643|NCT00408915|Serotonin Agents|serotonin agents|mesh-ancestor
92624644|NCT00408915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538461|NCT04846855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538462|NCT04846855|Sensory System Agents|sensory system agents|mesh-ancestor
92538463|NCT04846855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538465|NCT02964403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92538466|NCT02964403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538467|NCT02964403|Analgesics|analgesics|mesh-ancestor
92538468|NCT02964403|Sensory System Agents|sensory system agents|mesh-ancestor
92624645|NCT00408915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919021|NCT03169569|Hemostatics|hemostatics|mesh-list
92624646|NCT00408915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624647|NCT00408915|Dopamine Agonists|dopamine agonists|mesh-ancestor
92624648|NCT00408915|Dopamine Agents|dopamine agents|mesh-ancestor
92624649|NCT00542347|Esomeprazole|esomeprazole|mesh-list
92624650|NCT00542347|Omeprazole|omeprazole|mesh-list
92624651|NCT00542347|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92624652|NCT00542347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92624653|NCT00542347|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92624654|NCT00542347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624655|NCT00542347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624656|NCT00190554|Cisplatin|cisplatin|mesh-list
92624657|NCT00190554|Fluorouracil|fluorouracil|mesh-list
92624658|NCT00190554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624659|NCT00190554|Antimetabolites|antimetabolites|mesh-ancestor
92624660|NCT00190554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624661|NCT00190554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624662|NCT00190554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624663|NCT00190554|Immunologic Factors|immunologic factors|mesh-ancestor
92624664|NCT00190554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624665|NCT00159770|Olanzapine|olanzapine|mesh-list
92624666|NCT00159770|Risperidone|risperidone|mesh-list
92624667|NCT00159770|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92624668|NCT00159770|Ziprasidone|ziprasidone|mesh-list
92624669|NCT00159770|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92624670|NCT00159770|Serotonin Agents|serotonin agents|mesh-ancestor
92624671|NCT00159770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624672|NCT00159770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624673|NCT00159770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624674|NCT00159770|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92624675|NCT00159770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92624676|NCT00159770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624677|NCT00159770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624678|NCT00159770|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92624679|NCT00159770|Dopamine Agents|dopamine agents|mesh-ancestor
92624680|NCT00159770|Antiemetics|antiemetics|mesh-ancestor
92624681|NCT00159770|Autonomic Agents|autonomic agents|mesh-ancestor
92624682|NCT00159770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624683|NCT00159770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92624684|NCT00159770|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92624685|NCT00159770|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624686|NCT00159770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624687|NCT00159770|Antidepressive Agents|antidepressive agents|mesh-ancestor
92624688|NCT00190593|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92624689|NCT00190593|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92624690|NCT00190593|Hormone Antagonists|hormone antagonists|mesh-ancestor
92624691|NCT00190593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624692|NCT00190593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624693|NCT00190593|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92624694|NCT00190593|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92624695|NCT00190593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92624696|NCT00542893|Dacarbazine|dacarbazine|mesh-list
92624697|NCT00542893|Oblimersen|oblimersen|mesh-list
92031628|NCT02339155|Anesthetics|anesthetics|mesh-ancestor
92624701|NCT00542893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624702|NCT00184041|Cytarabine|cytarabine|mesh-list
92624703|NCT00184041|Prednisone|prednisone|mesh-list
92624704|NCT00184041|Methotrexate|methotrexate|mesh-list
92624705|NCT00184041|Cyclophosphamide|cyclophosphamide|mesh-list
92624706|NCT00184041|Vincristine|vincristine|mesh-list
92538469|NCT02964403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538470|NCT02964403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538471|NCT02964403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538472|NCT02964403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538473|NCT02964403|Gout Suppressants|gout suppressants|mesh-ancestor
92538474|NCT02964403|Tocolytic Agents|tocolytic agents|mesh-ancestor
92538475|NCT02964403|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92538476|NCT02964403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92538477|NCT02964403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538478|NCT02964403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538479|NCT04749043|Nitrous Oxide|nitrous oxide|mesh-list
92538480|NCT04749043|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92538481|NCT04749043|Anesthetics, General|anesthetics, general|mesh-ancestor
92538482|NCT04749043|Anesthetics|anesthetics|mesh-ancestor
92538483|NCT04749043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538484|NCT04749043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538485|NCT04749043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538486|NCT04749043|Analgesics|analgesics|mesh-ancestor
92538487|NCT04749043|Sensory System Agents|sensory system agents|mesh-ancestor
92538488|NCT04749043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538489|NCT00393393|Hylan|hylan|mesh-list
92538490|NCT00393393|Viscosupplements|viscosupplements|mesh-ancestor
92538491|NCT00393393|Protective Agents|protective agents|mesh-ancestor
92538492|NCT00393393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624707|NCT00184041|Daunorubicin|daunorubicin|mesh-list
92624708|NCT00184041|Asparaginase|asparaginase|mesh-list
92624709|NCT00184041|Mercaptopurine|mercaptopurine|mesh-list
92624710|NCT00184041|Thioguanine|thioguanine|mesh-list
92624711|NCT00184041|Pegaspargase|pegaspargase|mesh-list
92624712|NCT00184041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624713|NCT00184041|Glucocorticoids|glucocorticoids|mesh-ancestor
92624714|NCT00184041|Hormones|hormones|mesh-ancestor
92624715|NCT00184041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624716|NCT00184041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624717|NCT00184041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92624718|NCT00184041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624719|NCT00184041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92624720|NCT00184041|Abortifacient Agents|abortifacient agents|mesh-ancestor
92624721|NCT00184041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92624722|NCT00184041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624723|NCT00184041|Antimetabolites|antimetabolites|mesh-ancestor
92624724|NCT00184041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624725|NCT00184041|Dermatologic Agents|dermatologic agents|mesh-ancestor
92624726|NCT00184041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624727|NCT00184041|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92624728|NCT00184041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624729|NCT00184041|Immunologic Factors|immunologic factors|mesh-ancestor
92624730|NCT00184041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624731|NCT00184041|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92624732|NCT00184041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538493|NCT00405262|Ketorolac|ketorolac|mesh-list
92538494|NCT00405262|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92538495|NCT00405262|Bupivacaine|bupivacaine|mesh-list
92538496|NCT00405262|Anesthetics, Local|anesthetics, local|mesh-ancestor
92538497|NCT00405262|Anesthetics|anesthetics|mesh-ancestor
92538498|NCT00405262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538499|NCT00405262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538500|NCT00405262|Sensory System Agents|sensory system agents|mesh-ancestor
92538501|NCT00405262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538502|NCT00405262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92538503|NCT00405262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538504|NCT00405262|Analgesics|analgesics|mesh-ancestor
92538505|NCT00405262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538506|NCT00405262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538507|NCT00405262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92538508|NCT00405262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538509|NCT00405262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538510|NCT00405301|Rifampin|rifampin|mesh-list
92538511|NCT00405301|Pyrazinamide|pyrazinamide|mesh-list
92538512|NCT00405301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92538513|NCT00405301|Antitubercular Agents|antitubercular agents|mesh-ancestor
92538514|NCT00405301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538515|NCT00405301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538516|NCT00405301|Leprostatic Agents|leprostatic agents|mesh-ancestor
91946133|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
92624733|NCT00184041|Alkylating Agents|alkylating agents|mesh-ancestor
92624734|NCT00184041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92624735|NCT00184041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92624736|NCT00184041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624737|NCT00184041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624738|NCT00184041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92624739|NCT00184041|Antiviral Agents|antiviral agents|mesh-ancestor
92624740|NCT00184041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624741|NCT00184041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624742|NCT00184041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92624743|NCT00184041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624745|NCT00543049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624746|NCT00543049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92624747|NCT00543049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92624748|NCT00543049|Growth Substances|growth substances|mesh-ancestor
92624749|NCT00543049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624750|NCT00543049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92624751|NCT00543049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92624752|NCT00543049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624753|NCT00543049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624754|NCT04685005|Caffeine|caffeine|mesh-list
92624755|NCT04685005|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92624756|NCT04685005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624757|NCT04685005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92624758|NCT04685005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538517|NCT00405301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92538518|NCT00405301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538519|NCT00405301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538520|NCT00405301|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92538521|NCT00405301|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92538522|NCT00405301|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92538523|NCT00405301|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92538524|NCT00405301|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92538525|NCT00405301|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92538526|NCT00405340|Rituximab|rituximab|mesh-list
92538527|NCT00405340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538528|NCT00405340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538529|NCT00405340|Immunologic Factors|immunologic factors|mesh-ancestor
92538530|NCT00405340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538531|NCT00405340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538532|NCT04713319|Calcium|calcium|mesh-list
92624759|NCT04685005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624760|NCT04685005|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92624761|NCT04685005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92624762|NCT04685005|Purinergic Agents|purinergic agents|mesh-ancestor
92624763|NCT04685005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624764|NCT00190632|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92624765|NCT00190632|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92624766|NCT00190632|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624767|NCT00190632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92031701|NCT02374099|Fulvestrant|fulvestrant|mesh-list
92624770|NCT00190632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624771|NCT00190632|Analgesics|analgesics|mesh-ancestor
92624772|NCT00190632|Sensory System Agents|sensory system agents|mesh-ancestor
92624773|NCT00190632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624774|NCT00190632|Antidepressive Agents|antidepressive agents|mesh-ancestor
92624775|NCT00190632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624776|NCT00190632|Dopamine Agents|dopamine agents|mesh-ancestor
92624777|NCT00543166|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92624778|NCT00543166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92624779|NCT00543166|Immunologic Factors|immunologic factors|mesh-ancestor
92624780|NCT00543166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624781|NCT00543205|Oblimersen|oblimersen|mesh-list
92624782|NCT00543205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624783|NCT00159809|Sildenafil Citrate|sildenafil citrate|mesh-list
92624784|NCT00159809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624785|NCT00159809|Vasodilator Agents|vasodilator agents|mesh-ancestor
92624786|NCT00159809|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92624787|NCT00159809|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92624788|NCT00159809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624789|NCT00159809|Urological Agents|urological agents|mesh-ancestor
92624790|NCT00543244|Interferons|interferons|mesh-list
92624791|NCT00543244|Ribavirin|ribavirin|mesh-list
92624792|NCT00543244|Interferon-alpha|interferon-alpha|mesh-list
92624793|NCT00543244|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92624794|NCT00543244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624795|NCT00543244|Antiviral Agents|antiviral agents|mesh-ancestor
92624796|NCT00543244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624797|NCT00543244|Antimetabolites|antimetabolites|mesh-ancestor
92624798|NCT00543244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624799|NCT00543244|Immunologic Factors|immunologic factors|mesh-ancestor
92538533|NCT04713319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92538534|NCT04713319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538536|NCT00393471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92538537|NCT00393471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538538|NCT00393471|Analgesics|analgesics|mesh-ancestor
92538539|NCT00393471|Sensory System Agents|sensory system agents|mesh-ancestor
92538540|NCT00393471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538541|NCT00393471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538542|NCT00393471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538543|NCT00393471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946174|NCT05653024|Albuterol|albuterol|mesh-list
92624800|NCT00543244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624801|NCT00190710|Carboplatin|carboplatin|mesh-list
92624802|NCT00190710|Gemcitabine|gemcitabine|mesh-list
92624803|NCT00190710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624804|NCT00190710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92624805|NCT00190710|Antimetabolites|antimetabolites|mesh-ancestor
92624806|NCT00190710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624807|NCT03456661|Dexmedetomidine|dexmedetomidine|mesh-list
92624808|NCT03456661|Levobupivacaine|levobupivacaine|mesh-list
92624809|NCT03456661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92624810|NCT03456661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92624811|NCT03456661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624812|NCT03456661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92624813|NCT03456661|Analgesics|analgesics|mesh-ancestor
92624814|NCT03456661|Sensory System Agents|sensory system agents|mesh-ancestor
92624815|NCT03456661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624816|NCT03456661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92624817|NCT03456661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92624818|NCT03456661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92624819|NCT03456661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92624820|NCT03456661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624821|NCT03456661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624822|NCT03456661|Anesthetics, Local|anesthetics, local|mesh-ancestor
92624823|NCT03456661|Anesthetics|anesthetics|mesh-ancestor
92624824|NCT03456544|Vancomycin|vancomycin|mesh-list
92624825|NCT03456544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92624826|NCT03456544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624827|NCT00159887|Sildenafil Citrate|sildenafil citrate|mesh-list
92624828|NCT00159887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624829|NCT00159887|Vasodilator Agents|vasodilator agents|mesh-ancestor
92624830|NCT00159887|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92624831|NCT00159887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92624832|NCT00159887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624833|NCT00159887|Urological Agents|urological agents|mesh-ancestor
92624834|NCT00543361|Metformin|metformin|mesh-list
92624835|NCT00543361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92624836|NCT00543361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624837|NCT00190788|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92624838|NCT00190788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624839|NCT00543634|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92624840|NCT00543634|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92624843|NCT00543634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92624844|NCT00543634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624845|NCT00543634|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92624846|NCT00543634|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92624847|NCT00543634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92624848|NCT00543634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624850|NCT00543634|Hormones|hormones|mesh-ancestor
92624851|NCT00543634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624852|NCT00184197|Botulinum Toxins|botulinum toxins|mesh-list
92538544|NCT00393471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538545|NCT00393471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538546|NCT00393471|Immunologic Factors|immunologic factors|mesh-ancestor
92538547|NCT02647892|Lidocaine|lidocaine|mesh-list
92538548|NCT02647892|Anesthetics, Local|anesthetics, local|mesh-ancestor
92538549|NCT02647892|Anesthetics|anesthetics|mesh-ancestor
92538550|NCT02647892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538551|NCT02647892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538552|NCT02647892|Sensory System Agents|sensory system agents|mesh-ancestor
92538553|NCT02647892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538554|NCT02647892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91946190|NCT02499770|Etoposide|etoposide|mesh-list
92624853|NCT00184197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92624854|NCT00184197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624855|NCT00184197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624856|NCT00184197|Cholinergic Agents|cholinergic agents|mesh-ancestor
92624857|NCT00184197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624858|NCT00184197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624859|NCT00543829|Tamoxifen|tamoxifen|mesh-list
92624860|NCT00543829|Docetaxel|docetaxel|mesh-list
92624861|NCT00543829|Doxorubicin|doxorubicin|mesh-list
92624862|NCT00543829|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92624863|NCT00543829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624864|NCT00543829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624865|NCT00543829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624866|NCT00543829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92624867|NCT00543829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624868|NCT00543829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624869|NCT00543829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92624870|NCT00543829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624871|NCT00543829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624872|NCT00543829|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92624873|NCT00543829|Hormone Antagonists|hormone antagonists|mesh-ancestor
92624874|NCT00543829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624875|NCT00543829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624876|NCT00543829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92624877|NCT00543829|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92624878|NCT00543829|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92624879|NCT00543829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92624880|NCT00190827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92624881|NCT00190827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92624882|NCT00190827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624883|NCT00190827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624884|NCT00190827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624885|NCT00190827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624886|NCT00190827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624887|NCT00190827|Analgesics|analgesics|mesh-ancestor
92624888|NCT00190827|Sensory System Agents|sensory system agents|mesh-ancestor
92624889|NCT00190827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624890|NCT00190827|Antidepressive Agents|antidepressive agents|mesh-ancestor
92624891|NCT00190827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624892|NCT00190827|Dopamine Agents|dopamine agents|mesh-ancestor
92624893|NCT00160043|Vatalanib|vatalanib|mesh-list
92624894|NCT00160043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92624895|NCT00160043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624896|NCT00160043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624897|NCT00544063|Oxaliplatin|oxaliplatin|mesh-list
92624898|NCT00544063|Irinotecan|irinotecan|mesh-list
92624899|NCT00544063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624900|NCT00544063|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92624901|NCT00544063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92538555|NCT02647892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92538556|NCT02647892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92538557|NCT02647892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538558|NCT02647892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538559|NCT01806090|Clopidogrel|clopidogrel|mesh-list
92538560|NCT01806090|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92538561|NCT01806090|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92538562|NCT01806090|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92538563|NCT01806090|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92538564|NCT01806090|Purinergic Agents|purinergic agents|mesh-ancestor
92538565|NCT01806090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538566|NCT01806090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538567|NCT01806090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538569|NCT02505893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946197|NCT04418674|Fentanyl|fentanyl|mesh-list
92624902|NCT00544063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624903|NCT00544063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624904|NCT00544180|Risedronic Acid|risedronic acid|mesh-list
92624905|NCT00544180|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92624906|NCT00544180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624907|NCT00544180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624908|NCT00544180|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92031849|NCT02166333|Vitamin D|vitamin d|mesh-list
92624915|NCT00544219|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92624916|NCT00544219|Vincristine|vincristine|mesh-list
92624917|NCT00544219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624918|NCT00544219|Immunologic Factors|immunologic factors|mesh-ancestor
92624919|NCT00544219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624920|NCT00544219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624921|NCT00544219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92624922|NCT00544219|Alkylating Agents|alkylating agents|mesh-ancestor
92624923|NCT00544219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624924|NCT00544219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624925|NCT00544219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92624926|NCT00544219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92624927|NCT00544219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92624928|NCT00544219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92624929|NCT00544219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624930|NCT00544219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624931|NCT00544219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624932|NCT00544219|Glucocorticoids|glucocorticoids|mesh-ancestor
92624933|NCT00544219|Hormones|hormones|mesh-ancestor
92624934|NCT00544219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92624935|NCT00544219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92624936|NCT00544219|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92624937|NCT00544219|Tubulin Modulators|tubulin modulators|mesh-ancestor
92624938|NCT00544219|Antimitotic Agents|antimitotic agents|mesh-ancestor
92624939|NCT00544219|Mitosis Modulators|mitosis modulators|mesh-ancestor
92350068|NCT01426854|Analgesics|analgesics|mesh-ancestor
92624940|NCT00190866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92624941|NCT00190866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92624942|NCT00190866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624943|NCT00190866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624944|NCT00190866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538570|NCT02505893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538571|NCT02505893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92538572|NCT02505893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538573|NCT02505893|Antifungal Agents|antifungal agents|mesh-ancestor
92538574|NCT02505893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538575|NCT02505893|Immunologic Factors|immunologic factors|mesh-ancestor
92538576|NCT02505893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538577|NCT04341181|Trastuzumab|trastuzumab|mesh-list
92538578|NCT04341181|Atezolizumab|atezolizumab|mesh-list
92538579|NCT04341181|Pertuzumab|pertuzumab|mesh-list
92538580|NCT04341181|Avelumab|avelumab|mesh-list
92538581|NCT04341181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92538582|NCT04341181|Niraparib|niraparib|mesh-list
92538583|NCT04341181|Axitinib|axitinib|mesh-list
92538584|NCT04341181|Vemurafenib|vemurafenib|mesh-list
92538585|NCT04341181|Maytansine|maytansine|mesh-list
92538586|NCT04341181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538587|NCT04341181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538588|NCT04341181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92538589|NCT04341181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538590|NCT04341181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538591|NCT04341181|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92538592|NCT04341181|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92538593|NCT04341181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92538594|NCT04341181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92538595|NCT04341181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92538596|NCT04341181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92538597|NCT04341181|Immunotoxins|immunotoxins|mesh-ancestor
92538598|NCT04341181|Immunoconjugates|immunoconjugates|mesh-ancestor
92538599|NCT04341181|Immunologic Factors|immunologic factors|mesh-ancestor
92538600|NCT04341181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538601|NCT01806324|Losartan|losartan|mesh-list
92538602|NCT01806324|Atorvastatin|atorvastatin|mesh-list
92538603|NCT01806324|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92538604|NCT01806324|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92624945|NCT00190866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624946|NCT00190866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624948|NCT00190866|Sensory System Agents|sensory system agents|mesh-ancestor
92624949|NCT00190866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624950|NCT00190866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92624951|NCT00190866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624952|NCT00190866|Dopamine Agents|dopamine agents|mesh-ancestor
92624953|NCT00160160|Eprosartan|eprosartan|mesh-list
92538605|NCT01806324|Antimetabolites|antimetabolites|mesh-ancestor
92538606|NCT01806324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538607|NCT01806324|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92538608|NCT01806324|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92538609|NCT01806324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538610|NCT01806324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92538611|NCT01806324|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92538612|NCT01806324|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92538613|NCT01806324|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92538614|NCT02423876|Hydromorphone|hydromorphone|mesh-list
92538615|NCT02423876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538616|NCT02423876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538617|NCT02423876|Sensory System Agents|sensory system agents|mesh-ancestor
92538618|NCT02423876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538619|NCT02423876|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92538620|NCT02423876|Narcotics|narcotics|mesh-ancestor
92538621|NCT02423876|Analgesics|analgesics|mesh-ancestor
92624954|NCT00160160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92624955|NCT00160160|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92624956|NCT00160160|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92624957|NCT00160160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624958|NCT00544570|Cyclophosphamide|cyclophosphamide|mesh-list
92624959|NCT00544570|Melphalan|melphalan|mesh-list
92624960|NCT00544570|Carmustine|carmustine|mesh-list
92624961|NCT00544570|Etoposide|etoposide|mesh-list
92624962|NCT00544570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92624963|NCT00544570|Immunologic Factors|immunologic factors|mesh-ancestor
92624964|NCT00544570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624965|NCT00544570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92624966|NCT00544570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92624967|NCT00544570|Alkylating Agents|alkylating agents|mesh-ancestor
92624968|NCT00544570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624969|NCT00544570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624970|NCT00544570|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92624971|NCT00544570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92624972|NCT00544570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92624973|NCT00544570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92624974|NCT00544570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624975|NCT00190905|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92624976|NCT00190905|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92624979|NCT00190905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624981|NCT00190905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624982|NCT00190905|Analgesics|analgesics|mesh-ancestor
92624983|NCT00190905|Sensory System Agents|sensory system agents|mesh-ancestor
92624984|NCT00190905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624985|NCT00190905|Antidepressive Agents|antidepressive agents|mesh-ancestor
92624986|NCT00190905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624987|NCT00190905|Dopamine Agents|dopamine agents|mesh-ancestor
92624988|NCT00544609|Sorafenib|sorafenib|mesh-list
92624989|NCT00544609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92624990|NCT00544609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92624991|NCT00544609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624992|NCT00544609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624993|NCT00544687|Mometasone Furoate|mometasone furoate|mesh-list
92624994|NCT00544687|Nortriptyline|nortriptyline|mesh-list
92538622|NCT02316002|Pembrolizumab|pembrolizumab|mesh-list
92538623|NCT02316002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361686|NCT03642366|Tadalafil|tadalafil|mesh-list
92538624|NCT02316002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538625|NCT02316002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92538626|NCT02316002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538627|NCT01805895|Minocycline|minocycline|mesh-list
92538628|NCT01805895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538629|NCT01805895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538630|NCT01805856|Cefazolin|cefazolin|mesh-list
92538631|NCT01805856|Piperacillin|piperacillin|mesh-list
92538632|NCT01805856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92538633|NCT01805856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538634|NCT01805817|Copper|copper|mesh-list
92538635|NCT01805817|Drospirenone|drospirenone|mesh-list
92538636|NCT01805817|Levonorgestrel|levonorgestrel|mesh-list
92538637|NCT01805817|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92538638|NCT01805817|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92538639|NCT01805817|Estradiol|estradiol|mesh-list
92538640|NCT01805817|Estrogens|estrogens|mesh-ancestor
92538641|NCT01805817|Hormones|hormones|mesh-ancestor
92538642|NCT01805817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538643|NCT01805817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538644|NCT01805817|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92538645|NCT01805817|Contraceptive Agents|contraceptive agents|mesh-ancestor
92538646|NCT01805817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92538647|NCT01805817|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92538648|NCT01805817|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92538649|NCT01805817|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92538650|NCT01805817|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92538651|NCT01805817|Trace Elements|trace elements|mesh-ancestor
92538652|NCT01805817|Micronutrients|micronutrients|mesh-ancestor
92624995|NCT00544687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92624996|NCT00544687|Dermatologic Agents|dermatologic agents|mesh-ancestor
92624997|NCT00544687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92624998|NCT00544687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92624999|NCT00544687|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625000|NCT00544687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625001|NCT00544687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92625002|NCT00544687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625003|NCT00544687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625004|NCT00544687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625005|NCT00544687|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625006|NCT00544687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625007|NCT00544687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538653|NCT01805817|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92538654|NCT01805817|Hormone Antagonists|hormone antagonists|mesh-ancestor
92538655|NCT01805817|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92538656|NCT01805817|Diuretics|diuretics|mesh-ancestor
92538657|NCT01805817|Natriuretic Agents|natriuretic agents|mesh-ancestor
92538658|NCT04206046|Anesthetics|anesthetics|mesh-list
92538659|NCT04206046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538660|NCT04206046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538662|NCT00405418|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92538663|NCT00405418|Insulin Glargine|insulin glargine|mesh-list
92538664|NCT00405418|Insulin Detemir|insulin detemir|mesh-list
92538665|NCT00405418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92538666|NCT00405418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538667|NCT02157077|Aflibercept|aflibercept|mesh-list
92538668|NCT02157077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92538669|NCT02157077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92538670|NCT02157077|Growth Substances|growth substances|mesh-ancestor
92538671|NCT02157077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538672|NCT02157077|Growth Inhibitors|growth inhibitors|mesh-ancestor
92538673|NCT02157077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538674|NCT01805700|Caffeine|caffeine|mesh-list
92538675|NCT01805700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92538676|NCT01805700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538677|NCT01805700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92538678|NCT01805700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538679|NCT01805700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538680|NCT01805700|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92538681|NCT01805700|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92538682|NCT01805700|Purinergic Agents|purinergic agents|mesh-ancestor
92538683|NCT01805700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538684|NCT04033276|Rituximab|rituximab|mesh-list
92538685|NCT04033276|Immunoglobulins|immunoglobulins|mesh-list
92538686|NCT04033276|Antibodies|antibodies|mesh-list
92538687|NCT04033276|gamma-Globulins|gamma-globulins|mesh-list
92538689|NCT04033276|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92538694|NCT04033276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538695|NCT03969823|Osimertinib|osimertinib|mesh-list
92538696|NCT03969823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538697|NCT03969823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92538698|NCT03969823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538699|NCT03969823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538700|NCT00391157|Dexamethasone|dexamethasone|mesh-list
92538701|NCT00391157|Bortezomib|bortezomib|mesh-list
92538702|NCT00391157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538703|NCT00391157|Antiemetics|antiemetics|mesh-ancestor
92538704|NCT00391157|Autonomic Agents|autonomic agents|mesh-ancestor
92538705|NCT00391157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538706|NCT00391157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538707|NCT00391157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538708|NCT00391157|Glucocorticoids|glucocorticoids|mesh-ancestor
92538709|NCT00391157|Hormones|hormones|mesh-ancestor
92682773|NCT04701320|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92625008|NCT00160238|Betahistine|betahistine|mesh-list
92625009|NCT00160238|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625010|NCT00160238|Histamine Agonists|histamine agonists|mesh-ancestor
92625011|NCT00160238|Histamine Agents|histamine agents|mesh-ancestor
92625012|NCT00160238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625013|NCT00160238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625014|NCT00160238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625015|NCT00544804|Lapatinib|lapatinib|mesh-list
92625016|NCT00544804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625017|NCT00544804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92625018|NCT00544804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625019|NCT00544804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625020|NCT00160277|Moxonidine|moxonidine|mesh-list
92625021|NCT00160277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625022|NCT02963181|Melatonin|melatonin|mesh-list
92625023|NCT02963181|Yohimbine|yohimbine|mesh-list
92625024|NCT02963181|Antioxidants|antioxidants|mesh-ancestor
92625025|NCT02963181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625026|NCT02963181|Protective Agents|protective agents|mesh-ancestor
92625027|NCT02963181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625028|NCT02963181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625029|NCT02963181|Mydriatics|mydriatics|mesh-ancestor
92625030|NCT02963181|Autonomic Agents|autonomic agents|mesh-ancestor
92625031|NCT02963181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625032|NCT02963181|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92625033|NCT02963181|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92625034|NCT02963181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92625035|NCT02963181|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625036|NCT02963181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625037|NCT02963181|Urological Agents|urological agents|mesh-ancestor
92625038|NCT00544999|Cytarabine|cytarabine|mesh-list
92625039|NCT00544999|Everolimus|everolimus|mesh-list
92625040|NCT00544999|Daunorubicin|daunorubicin|mesh-list
92625041|NCT00544999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625042|NCT00544999|Antimetabolites|antimetabolites|mesh-ancestor
92625043|NCT00544999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625044|NCT00544999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625045|NCT00544999|Antiviral Agents|antiviral agents|mesh-ancestor
92625046|NCT00544999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625047|NCT00544999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92625051|NCT00544999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92625052|NCT00544999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538710|NCT00391157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538711|NCT00391157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92538712|NCT00391157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538713|NCT03781063|Fulvestrant|fulvestrant|mesh-list
92538714|NCT03781063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92538715|NCT03781063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538716|NCT03781063|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92538717|NCT03781063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92538718|NCT03781063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92538719|NCT03781063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538720|NCT03781063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538722|NCT01805544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92538723|NCT01805544|Antithrombins|antithrombins|mesh-ancestor
92538724|NCT01805544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92538725|NCT01805544|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946356|NCT00679120|Cimetidine|cimetidine|mesh-list
92625053|NCT00544999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92625054|NCT00544999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92625055|NCT00544999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625056|NCT00160316|Estradiol|estradiol|mesh-list
92625057|NCT00160316|Dydrogesterone|dydrogesterone|mesh-list
92625058|NCT00160316|Estrogens|estrogens|mesh-ancestor
92625059|NCT00160316|Hormones|hormones|mesh-ancestor
92625060|NCT00160316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625061|NCT00160316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625062|NCT00160316|Progestins|progestins|mesh-ancestor
92625063|NCT00545194|Dinoprostone|dinoprostone|mesh-list
92625064|NCT00545194|Oxytocics|oxytocics|mesh-ancestor
92625065|NCT00545194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92625066|NCT00545194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625067|NCT00190944|Teriparatide|teriparatide|mesh-list
92625068|NCT00190944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92625069|NCT00190944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625070|NCT00190944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92625071|NCT03456466|Rituximab|rituximab|mesh-list
92625072|NCT03456466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625073|NCT03456466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625074|NCT03456466|Immunologic Factors|immunologic factors|mesh-ancestor
92625075|NCT03456466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625076|NCT03456466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625077|NCT00160355|Fludarabine|fludarabine|mesh-list
92625078|NCT00160355|Melphalan|melphalan|mesh-list
92625079|NCT00160355|Thiotepa|thiotepa|mesh-list
92625080|NCT00160355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625081|NCT00160355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625082|NCT00160355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92625083|NCT00160355|Immunologic Factors|immunologic factors|mesh-ancestor
92625084|NCT00160355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625085|NCT00160355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92625086|NCT00160355|Alkylating Agents|alkylating agents|mesh-ancestor
92350237|NCT01386606|Clomiphene|clomiphene|mesh-list
92625087|NCT00160355|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92625088|NCT00545311|Glycopyrrolate|glycopyrrolate|mesh-list
92625089|NCT00545311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92625090|NCT00545311|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92625091|NCT00545311|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92625092|NCT00545311|Cholinergic Agents|cholinergic agents|mesh-ancestor
92625093|NCT00545311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538726|NCT01805544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538727|NCT01805544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538728|NCT01805544|Anticoagulants|anticoagulants|mesh-ancestor
92538729|NCT01903421|Fentanyl|fentanyl|mesh-list
92538730|NCT01903421|Bupivacaine|bupivacaine|mesh-list
92538731|NCT01903421|Anesthetics|anesthetics|mesh-list
92538732|NCT01903421|Propofol|propofol|mesh-list
92538733|NCT01903421|Sevoflurane|sevoflurane|mesh-list
92538734|NCT01903421|Isoflurane|isoflurane|mesh-list
92538735|NCT01903421|Anesthetics, Local|anesthetics, local|mesh-ancestor
92538736|NCT01903421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538737|NCT01903421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538738|NCT01903421|Sensory System Agents|sensory system agents|mesh-ancestor
92538739|NCT01903421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538740|NCT01903421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92538741|NCT01903421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92538742|NCT01903421|Anesthetics, General|anesthetics, general|mesh-ancestor
92538743|NCT01903421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92538744|NCT01903421|Narcotics|narcotics|mesh-ancestor
92538745|NCT01903421|Analgesics|analgesics|mesh-ancestor
92538746|NCT01903421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92538747|NCT01903421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92538748|NCT01903421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92538749|NCT03734731|Analgesics, Opioid|analgesics, opioid|mesh-list
92538750|NCT03734731|Narcotics|narcotics|mesh-ancestor
92538751|NCT03734731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538752|NCT03734731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538753|NCT03734731|Analgesics|analgesics|mesh-ancestor
92625094|NCT00545311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625095|NCT00545311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625097|NCT00160394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92625098|NCT00160394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92625099|NCT00160394|Analgesics|analgesics|mesh-ancestor
92625100|NCT00160394|Sensory System Agents|sensory system agents|mesh-ancestor
92625101|NCT00160394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625102|NCT00160394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625103|NCT00160394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625104|NCT00160394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625105|NCT00160394|Dermatologic Agents|dermatologic agents|mesh-ancestor
92625106|NCT00191022|Paroxetine|paroxetine|mesh-list
92625107|NCT00191022|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92625108|NCT00191022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625109|NCT00191022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625110|NCT00191022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625111|NCT00191022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625112|NCT00191022|Serotonin Agents|serotonin agents|mesh-ancestor
92625113|NCT00191022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538754|NCT03734731|Sensory System Agents|sensory system agents|mesh-ancestor
92538755|NCT03734731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538756|NCT01723839|Cyclophosphamide|cyclophosphamide|mesh-list
92538757|NCT01723839|Rituximab|rituximab|mesh-list
92538758|NCT01723839|Fludarabine|fludarabine|mesh-list
92538759|NCT01723839|Lenalidomide|lenalidomide|mesh-list
92538760|NCT01723839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538761|NCT01723839|Immunologic Factors|immunologic factors|mesh-ancestor
92538762|NCT01723839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538763|NCT01723839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538764|NCT01723839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538765|NCT01723839|Alkylating Agents|alkylating agents|mesh-ancestor
92538766|NCT01723839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538767|NCT01723839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538768|NCT01723839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92538769|NCT01723839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538770|NCT01723839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92538771|NCT01723839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92538772|NCT01723839|Growth Substances|growth substances|mesh-ancestor
92538773|NCT01723839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92538774|NCT03421483|Folic Acid|folic acid|mesh-list
92538775|NCT03421483|Hematinics|hematinics|mesh-ancestor
92538776|NCT03421483|Vitamin B Complex|vitamin b complex|mesh-ancestor
92538777|NCT03421483|Vitamins|vitamins|mesh-ancestor
92538778|NCT03421483|Micronutrients|micronutrients|mesh-ancestor
92538779|NCT03421483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538780|NCT03363217|Trametinib|trametinib|mesh-list
92538781|NCT03363217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538782|NCT03363217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92538783|NCT03363217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538784|NCT03363217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625114|NCT00191022|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92625115|NCT00191022|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625116|NCT00191022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625117|NCT00191022|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92625118|NCT00191022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92625122|NCT00545389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92625123|NCT00545389|Analgesics|analgesics|mesh-ancestor
92625124|NCT00545389|Sensory System Agents|sensory system agents|mesh-ancestor
92625125|NCT00545389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625126|NCT00545389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625127|NCT00545389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625128|NCT00545389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625129|NCT00545467|Aripiprazole|aripiprazole|mesh-list
92538785|NCT03341143|Pembrolizumab|pembrolizumab|mesh-list
92538786|NCT03341143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538787|NCT03341143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538788|NCT03341143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92538789|NCT03341143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538790|NCT03205696|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92538791|NCT03205696|Antiviral Agents|antiviral agents|mesh-ancestor
92538792|NCT03205696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538793|NCT00405496|Difluprednate|difluprednate|mesh-list
92538794|NCT00405496|Glucocorticoids|glucocorticoids|mesh-ancestor
92538795|NCT00405496|Hormones|hormones|mesh-ancestor
92538796|NCT00405496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92538797|NCT00405496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538798|NCT00405535|Glycine|glycine|mesh-list
92538799|NCT00405535|Glycine Agents|glycine agents|mesh-ancestor
92538800|NCT00405535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538801|NCT00405535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538802|NCT00405535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538803|NCT00405574|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92538804|NCT00405574|Chelating Agents|chelating agents|mesh-ancestor
92538805|NCT00405574|Sequestering Agents|sequestering agents|mesh-ancestor
92538806|NCT00405574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538807|NCT00405574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538808|NCT00405574|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92538809|NCT00405574|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92538810|NCT00405574|Growth Substances|growth substances|mesh-ancestor
92538811|NCT00405574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538812|NCT00405574|Growth Inhibitors|growth inhibitors|mesh-ancestor
92538813|NCT00405574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538814|NCT02993029|Celecoxib|celecoxib|mesh-list
92538815|NCT02993029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92625130|NCT00545467|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625131|NCT00545467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625132|NCT00545467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92625133|NCT00545467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92625134|NCT00545467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625135|NCT00545467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625136|NCT00545467|Dopamine Agonists|dopamine agonists|mesh-ancestor
92625137|NCT00545467|Dopamine Agents|dopamine agents|mesh-ancestor
92625138|NCT00545467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625139|NCT00545467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538816|NCT02993029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538817|NCT02993029|Analgesics|analgesics|mesh-ancestor
92538818|NCT02993029|Sensory System Agents|sensory system agents|mesh-ancestor
92538819|NCT02993029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538820|NCT02993029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538821|NCT02993029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538822|NCT02993029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538823|NCT02993029|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92538824|NCT02993029|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92538825|NCT02993029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538826|NCT02993029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538828|NCT02825641|Dinoprostone|dinoprostone|mesh-list
92538829|NCT02825641|Oxytocics|oxytocics|mesh-ancestor
92538830|NCT02825641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92538831|NCT02825641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538832|NCT01646034|Paclitaxel|paclitaxel|mesh-list
92538833|NCT01646034|Docetaxel|docetaxel|mesh-list
92538834|NCT01646034|Cyclophosphamide|cyclophosphamide|mesh-list
92538835|NCT01646034|Carboplatin|carboplatin|mesh-list
92538836|NCT01646034|Gemcitabine|gemcitabine|mesh-list
92538837|NCT01646034|Doxorubicin|doxorubicin|mesh-list
92538838|NCT01646034|Thiotepa|thiotepa|mesh-list
92538839|NCT01646034|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92538840|NCT01646034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538841|NCT01646034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92625140|NCT00545467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92625141|NCT00545467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92625142|NCT00545467|Serotonin Agents|serotonin agents|mesh-ancestor
92625143|NCT00545467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92625144|NCT00545467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92625145|NCT00545467|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92625146|NCT00545467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92625147|NCT00545857|Pioglitazone|pioglitazone|mesh-list
92625148|NCT00545857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625149|NCT00545857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625150|NCT00545935|Artesunate|artesunate|mesh-list
92625151|NCT00545935|Amodiaquine|amodiaquine|mesh-list
92625152|NCT00545935|Antimalarials|antimalarials|mesh-ancestor
92625153|NCT00545935|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92625154|NCT00545935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92625155|NCT00545935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625156|NCT00545935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625157|NCT00545935|Antiviral Agents|antiviral agents|mesh-ancestor
92625158|NCT00545935|Schistosomicides|schistosomicides|mesh-ancestor
92625159|NCT00545935|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92625160|NCT00545935|Anthelmintics|anthelmintics|mesh-ancestor
92625161|NCT00160511|Levetiracetam|levetiracetam|mesh-list
92625162|NCT00160511|Anticonvulsants|anticonvulsants|mesh-ancestor
92625163|NCT00160511|Nootropic Agents|nootropic agents|mesh-ancestor
92625164|NCT00191061|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92625165|NCT00191061|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92625166|NCT00191061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92538842|NCT01646034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92538843|NCT01646034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92538844|NCT01646034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538845|NCT01646034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538846|NCT01646034|Immunologic Factors|immunologic factors|mesh-ancestor
92538847|NCT01646034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538848|NCT01646034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538849|NCT01646034|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538850|NCT01646034|Alkylating Agents|alkylating agents|mesh-ancestor
92538851|NCT01646034|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91946472|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
92625167|NCT00191061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625168|NCT00191061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625169|NCT00191061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625170|NCT00191061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625171|NCT00191061|Analgesics|analgesics|mesh-ancestor
92625172|NCT00191061|Sensory System Agents|sensory system agents|mesh-ancestor
92625173|NCT00191061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625174|NCT00191061|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625175|NCT00191061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625176|NCT00191061|Dopamine Agents|dopamine agents|mesh-ancestor
92625177|NCT00160550|Levetiracetam|levetiracetam|mesh-list
92625178|NCT00160550|Anticonvulsants|anticonvulsants|mesh-ancestor
92625179|NCT00160550|Nootropic Agents|nootropic agents|mesh-ancestor
92625180|NCT00160589|Levocetirizine|levocetirizine|mesh-list
92625181|NCT00160589|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92625182|NCT00160589|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92625183|NCT00160589|Histamine Antagonists|histamine antagonists|mesh-ancestor
92625184|NCT00160589|Histamine Agents|histamine agents|mesh-ancestor
92625185|NCT00160589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625186|NCT00160589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625187|NCT00160589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625188|NCT00546130|polysaccharide-K|polysaccharide-k|mesh-list
92625189|NCT00546130|Cisplatin|cisplatin|mesh-list
92625190|NCT00546130|Irinotecan|irinotecan|mesh-list
92625191|NCT00546130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625194|NCT00546130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625195|NCT00546130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625196|NCT00546130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92625197|NCT00546130|Immunologic Factors|immunologic factors|mesh-ancestor
92625198|NCT00546130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625199|NCT00546130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92625200|NCT00546130|Antiviral Agents|antiviral agents|mesh-ancestor
92625201|NCT00546130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625202|NCT00546130|Interferon Inducers|interferon inducers|mesh-ancestor
92625203|NCT00546130|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92625204|NCT00546130|Protective Agents|protective agents|mesh-ancestor
92625205|NCT00191178|Insulin|insulin|mesh-list
92625206|NCT00191178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92625207|NCT00191178|Insulin Glargine|insulin glargine|mesh-list
92625208|NCT00191178|Insulin Lispro|insulin lispro|mesh-list
92625209|NCT00191178|Protamines|protamines|mesh-list
92625210|NCT00191178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625211|NCT00191178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625212|NCT00191178|Heparin Antagonists|heparin antagonists|mesh-ancestor
92625213|NCT00191178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625214|NCT00191178|Coagulants|coagulants|mesh-ancestor
92625215|NCT00546169|Thrombin|thrombin|mesh-list
92625216|NCT00546169|Hemostatics|hemostatics|mesh-ancestor
92625217|NCT00546169|Coagulants|coagulants|mesh-ancestor
92625218|NCT00160628|Levetiracetam|levetiracetam|mesh-list
92625219|NCT00160628|Anticonvulsants|anticonvulsants|mesh-ancestor
92625220|NCT00160628|Nootropic Agents|nootropic agents|mesh-ancestor
92625221|NCT00546286|Timolol|timolol|mesh-list
92625222|NCT00546286|Dorzolamide|dorzolamide|mesh-list
92625223|NCT00546286|Maleic acid|maleic acid|mesh-list
92625224|NCT00546286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538852|NCT01646034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92538853|NCT01646034|Antimetabolites|antimetabolites|mesh-ancestor
92538854|NCT01646034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92538855|NCT01646034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92538856|NCT01646034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92538857|NCT01646034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625225|NCT00546286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625226|NCT00546286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92625227|NCT00546286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92625228|NCT00546286|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625229|NCT00546286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625230|NCT00546286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625231|NCT00546286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92625232|NCT00546286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625233|NCT00546286|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92625234|NCT00546325|Rimonabant|rimonabant|mesh-list
92625235|NCT00546325|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92625236|NCT00546325|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92625237|NCT00546325|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92625238|NCT00546325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625239|NCT00546325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625240|NCT00546325|Hormones|hormones|mesh-ancestor
92625241|NCT00546325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625242|NCT00546325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625243|NCT00546403|Modafinil|modafinil|mesh-list
92625244|NCT00546403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92625245|NCT00546403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625246|NCT00546403|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92625247|NCT00546403|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92625248|NCT00546403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92625249|NCT00546403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625250|NCT00546442|Metformin|metformin|mesh-list
92625251|NCT00546442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625252|NCT00546442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625253|NCT00191256|Paclitaxel|paclitaxel|mesh-list
92625254|NCT00191256|Carboplatin|carboplatin|mesh-list
92625255|NCT00191256|Gemcitabine|gemcitabine|mesh-list
92625256|NCT00191256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92625257|NCT00191256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625258|NCT00191256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92625259|NCT00191256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92625260|NCT00191256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92625261|NCT00191256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625262|NCT00191256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625263|NCT00191256|Antimetabolites|antimetabolites|mesh-ancestor
92625264|NCT00546520|Ciclesonide|ciclesonide|mesh-list
92625265|NCT00546520|Glucocorticoids|glucocorticoids|mesh-ancestor
92625276|NCT00546559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92625277|NCT00546559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92625278|NCT00546559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625279|NCT00160745|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92625280|NCT00160745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92625281|NCT00160745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92625282|NCT00160745|Antimetabolites|antimetabolites|mesh-ancestor
92625283|NCT00160745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625284|NCT00160745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92361709|NCT03548454|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92625285|NCT00160745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92625286|NCT00160745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625287|NCT00546676|Telithromycin|telithromycin|mesh-list
92625288|NCT00546676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92625289|NCT00546676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625290|NCT00546832|Celecoxib|celecoxib|mesh-list
92625291|NCT00546832|Diclofenac|diclofenac|mesh-list
92625292|NCT00546832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92625293|NCT00546832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92625294|NCT00546832|Analgesics|analgesics|mesh-ancestor
92625295|NCT00546832|Sensory System Agents|sensory system agents|mesh-ancestor
92538858|NCT00391313|Chloroquine|chloroquine|mesh-list
92538859|NCT00391313|Amebicides|amebicides|mesh-ancestor
92538860|NCT00391313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92538861|NCT00391313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92538862|NCT00391313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538863|NCT00391313|Antimalarials|antimalarials|mesh-ancestor
92538864|NCT00391313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538865|NCT01466517|Ibuprofen|ibuprofen|mesh-list
92538866|NCT01466517|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92538867|NCT01466517|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538868|NCT01466517|Analgesics|analgesics|mesh-ancestor
92538869|NCT01466517|Sensory System Agents|sensory system agents|mesh-ancestor
92538870|NCT01466517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538871|NCT01466517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538872|NCT01466517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625296|NCT00546832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625297|NCT00546832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625298|NCT00546832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625299|NCT00546832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625300|NCT00546832|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92625301|NCT00546832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92625302|NCT00546832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625303|NCT00546832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625304|NCT00184587|Candesartan|candesartan|mesh-list
92625305|NCT00184587|Candesartan cilexetil|candesartan cilexetil|mesh-list
92625306|NCT00184587|Angiotensin II|angiotensin ii|mesh-list
92625307|NCT00184587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92625308|NCT00184587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625309|NCT00184587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92625310|NCT00184587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625311|NCT00184587|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92625312|NCT00547144|Gemcitabine|gemcitabine|mesh-list
92625313|NCT00547144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625314|NCT00547144|Antimetabolites|antimetabolites|mesh-ancestor
92625315|NCT00547144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625316|NCT00547144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625317|NCT00547183|Tadalafil|tadalafil|mesh-list
92625318|NCT00547183|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625319|NCT00547183|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92625320|NCT00547183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92625321|NCT00547183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625322|NCT00547183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625323|NCT00547183|Urological Agents|urological agents|mesh-ancestor
92625324|NCT00184626|Insulin|insulin|mesh-list
92625325|NCT00184626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92625326|NCT00184626|Metformin|metformin|mesh-list
92625327|NCT00184626|Insulin Glargine|insulin glargine|mesh-list
92625328|NCT00184626|Insulin Aspart|insulin aspart|mesh-list
92625329|NCT00184626|Biphasic Insulins|biphasic insulins|mesh-list
92625334|NCT00547417|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92625335|NCT00547417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92625336|NCT00547417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625337|NCT00547417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625338|NCT00547417|Urological Agents|urological agents|mesh-ancestor
92625339|NCT00191295|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92625340|NCT00191295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92625341|NCT00191295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625342|NCT00191295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625343|NCT00191295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538873|NCT01466517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538874|NCT01466517|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92538875|NCT01466517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538876|NCT01466517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538877|NCT01466478|Calcitriol|calcitriol|mesh-list
92538878|NCT01466478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92538879|NCT01466478|Calcipotriene|calcipotriene|mesh-list
92538880|NCT01466478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92538881|NCT01466478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92538882|NCT01466478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538883|NCT01466478|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92538884|NCT01466478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538885|NCT01466478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538886|NCT01466478|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92538887|NCT01466478|Vitamins|vitamins|mesh-ancestor
92538888|NCT01466478|Micronutrients|micronutrients|mesh-ancestor
92538889|NCT01466478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92538890|NCT01466478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538891|NCT00063830|Alicaforsen|alicaforsen|mesh-list
91946507|NCT02692313|Epinephrine|epinephrine|mesh-list
92625344|NCT00191295|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625345|NCT00191295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625346|NCT00191295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625347|NCT00547495|Tadalafil|tadalafil|mesh-list
92625348|NCT00547495|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625349|NCT00547495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92625350|NCT00547495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92625351|NCT00547495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625352|NCT00547495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625353|NCT00547495|Urological Agents|urological agents|mesh-ancestor
92625354|NCT02277223|Curcumin|curcumin|mesh-list
92625355|NCT02277223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92625356|NCT02277223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92625357|NCT02277223|Analgesics|analgesics|mesh-ancestor
92625358|NCT02277223|Sensory System Agents|sensory system agents|mesh-ancestor
92625359|NCT02277223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625360|NCT02277223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625361|NCT02277223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625362|NCT02277223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625363|NCT02277223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625364|NCT02277223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625365|NCT02277223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625366|NCT00547573|Tadalafil|tadalafil|mesh-list
92625367|NCT00547573|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625368|NCT00547573|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92625369|NCT00547573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92625370|NCT00547573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625371|NCT00547573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625372|NCT00547573|Urological Agents|urological agents|mesh-ancestor
92625373|NCT00191373|Gemcitabine|gemcitabine|mesh-list
92625374|NCT00191373|Trastuzumab|trastuzumab|mesh-list
92625375|NCT00191373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625376|NCT00191373|Antimetabolites|antimetabolites|mesh-ancestor
92625377|NCT00191373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538892|NCT00063830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538893|NCT00063830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538894|NCT00063830|Immunologic Factors|immunologic factors|mesh-ancestor
91972665|NCT00189241|Imiquimod|imiquimod|mesh-list
92625378|NCT00191373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625379|NCT00191373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625380|NCT00547612|Substance P|substance p|mesh-list
92625381|NCT00547612|Neurokinin A|neurokinin a|mesh-list
92625382|NCT00547612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625383|NCT00547612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625384|NCT00547612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625385|NCT00547768|Fexofenadine|fexofenadine|mesh-list
92625386|NCT00547768|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92625387|NCT00547768|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92625388|NCT00547768|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92625389|NCT00547768|Histamine Antagonists|histamine antagonists|mesh-ancestor
92625390|NCT00547768|Histamine Agents|histamine agents|mesh-ancestor
92625391|NCT00547768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625392|NCT00547768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625393|NCT00547768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625394|NCT00184665|Insulin|insulin|mesh-list
92625395|NCT00184665|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92625396|NCT00184665|Insulin Aspart|insulin aspart|mesh-list
92625397|NCT00184665|Insulin Detemir|insulin detemir|mesh-list
92625398|NCT00184665|Isophane Insulin, Human|isophane insulin, human|mesh-list
92625399|NCT00184665|Insulin, Isophane|insulin, isophane|mesh-list
92625402|NCT00184665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625404|NCT04983238|Trastuzumab|trastuzumab|mesh-list
92625405|NCT04983238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625406|NCT04983238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625407|NCT04983238|Antidotes|antidotes|mesh-ancestor
92625408|NCT04983238|Protective Agents|protective agents|mesh-ancestor
92625409|NCT04983238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625410|NCT04983238|Antioxidants|antioxidants|mesh-ancestor
92625411|NCT04983238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625412|NCT04983238|Antitubercular Agents|antitubercular agents|mesh-ancestor
92625413|NCT04983238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92625414|NCT04983238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625415|NCT04983238|Chelating Agents|chelating agents|mesh-ancestor
92625416|NCT04983238|Sequestering Agents|sequestering agents|mesh-ancestor
92625417|NCT04974385|Bupivacaine|bupivacaine|mesh-list
92625418|NCT04974385|Anesthetics, Local|anesthetics, local|mesh-ancestor
92625419|NCT04974385|Anesthetics|anesthetics|mesh-ancestor
92625420|NCT04974385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625421|NCT04974385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625422|NCT04974385|Sensory System Agents|sensory system agents|mesh-ancestor
92625423|NCT04974385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625424|NCT00547885|Dihydrocodeine|dihydrocodeine|mesh-list
92625425|NCT00547885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92625426|NCT00547885|Narcotics|narcotics|mesh-ancestor
92625427|NCT00547885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625428|NCT00547885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625429|NCT00547885|Analgesics|analgesics|mesh-ancestor
92625430|NCT00547885|Sensory System Agents|sensory system agents|mesh-ancestor
92625431|NCT00547885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625432|NCT00161018|Risperidone|risperidone|mesh-list
92625433|NCT00161018|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92625434|NCT00161018|Fluphenazine|fluphenazine|mesh-list
92625435|NCT00161018|Fluphenazine depot|fluphenazine depot|mesh-list
92625436|NCT00161018|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92625437|NCT00161018|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92625438|NCT00161018|Serotonin Agents|serotonin agents|mesh-ancestor
92625439|NCT00161018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625440|NCT00161018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625441|NCT00161018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625442|NCT00161018|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92625443|NCT00161018|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92625444|NCT00161018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625445|NCT00161018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625446|NCT00161018|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92625447|NCT00161018|Dopamine Agents|dopamine agents|mesh-ancestor
92625448|NCT00161018|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625449|NCT00191412|Pemetrexed|pemetrexed|mesh-list
92538895|NCT00063830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538896|NCT00062816|Ribavirin|ribavirin|mesh-list
92538897|NCT00062816|Antimetabolites|antimetabolites|mesh-ancestor
92625450|NCT00191412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625451|NCT00191412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625452|NCT00191412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625453|NCT00191412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92625454|NCT00191412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92625455|NCT00548002|Levofloxacin|levofloxacin|mesh-list
92625456|NCT00548002|Trovafloxacin|trovafloxacin|mesh-list
92625457|NCT00548002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92625458|NCT00548002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625459|NCT00548002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92625460|NCT00548002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92625461|NCT00548002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625462|NCT00548002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625463|NCT00548002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625464|NCT00548002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625465|NCT00548002|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92625466|NCT00548002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92625467|NCT00191490|Gemcitabine|gemcitabine|mesh-list
92625468|NCT00191490|Docetaxel|docetaxel|mesh-list
92625469|NCT00191490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625470|NCT00191490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625471|NCT00191490|Antimetabolites|antimetabolites|mesh-ancestor
92625472|NCT00191490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625476|NCT00548080|Caspofungin|caspofungin|mesh-list
92625477|NCT00548080|Antifungal Agents|antifungal agents|mesh-ancestor
92625478|NCT00548080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625479|NCT00548080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625480|NCT00548080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625481|NCT00161096|Pantoprazole|pantoprazole|mesh-list
92625482|NCT00161096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92625483|NCT00161096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92625484|NCT00161096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92625485|NCT00161096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625486|NCT00161096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625487|NCT00184821|Glyburide|glyburide|mesh-list
92625488|NCT00184821|Adenosine|adenosine|mesh-list
92625489|NCT00184821|Diazoxide|diazoxide|mesh-list
92625490|NCT00184821|Annexin A5|annexin a5|mesh-list
92625491|NCT00184821|Analgesics|analgesics|mesh-ancestor
92625492|NCT00184821|Sensory System Agents|sensory system agents|mesh-ancestor
92625493|NCT00184821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625494|NCT00184821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625495|NCT00184821|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92625496|NCT00184821|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625497|NCT00184821|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92625498|NCT00184821|Purinergic Agonists|purinergic agonists|mesh-ancestor
92625499|NCT00184821|Purinergic Agents|purinergic agents|mesh-ancestor
92625500|NCT00184821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625501|NCT00184821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625502|NCT00184821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625503|NCT00184821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625504|NCT00184821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625505|NCT00548509|Vitamin K|vitamin k|mesh-list
92625506|NCT00548509|Vitamin K 2|vitamin k 2|mesh-list
92625507|NCT00548509|Menatetrenone|menatetrenone|mesh-list
92625508|NCT00548509|Vitamins|vitamins|mesh-ancestor
92625509|NCT00548509|Micronutrients|micronutrients|mesh-ancestor
92625510|NCT00548509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625511|NCT00548509|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92625512|NCT00548509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92625513|NCT00548509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625514|NCT00548509|Hemostatics|hemostatics|mesh-ancestor
92625515|NCT00548509|Coagulants|coagulants|mesh-ancestor
92625516|NCT00548704|Dexrazoxane|dexrazoxane|mesh-list
92625517|NCT00548704|Razoxane|razoxane|mesh-list
92625518|NCT00548704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625519|NCT00548704|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92625520|NCT00548704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92625521|NCT00548704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625522|NCT00548704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752319|NCT05940909|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92538898|NCT00062816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538899|NCT00062816|Antiviral Agents|antiviral agents|mesh-ancestor
92538900|NCT00062816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538901|NCT00048113|Alicaforsen|alicaforsen|mesh-list
92538902|NCT00048113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92538903|NCT00048113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538904|NCT00048113|Immunologic Factors|immunologic factors|mesh-ancestor
91946522|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92625523|NCT00548704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625524|NCT00548704|Protective Agents|protective agents|mesh-ancestor
92625525|NCT00548704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625526|NCT00548704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92625527|NCT00548704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92625529|NCT00184899|Calcium heparin|calcium heparin|mesh-list
92625530|NCT00184899|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92625531|NCT00184899|Glycerol|glycerol|mesh-list
92625532|NCT00184899|Anticoagulants|anticoagulants|mesh-ancestor
92625533|NCT00184899|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92625534|NCT00184899|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92625535|NCT00184899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625536|NCT00184899|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92625537|NCT00184899|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92625538|NCT00184899|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92625539|NCT00184899|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92625540|NCT00184899|Protective Agents|protective agents|mesh-ancestor
92625541|NCT00184899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625542|NCT00548821|Cisplatin|cisplatin|mesh-list
92625543|NCT00548821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625544|NCT00161291|Bevacizumab|bevacizumab|mesh-list
92625545|NCT00161291|Letrozole|letrozole|mesh-list
92625546|NCT00161291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625547|NCT00161291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625549|NCT00161291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92625550|NCT00161291|Growth Substances|growth substances|mesh-ancestor
92625551|NCT00161291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625552|NCT00161291|Growth Inhibitors|growth inhibitors|mesh-ancestor
92625553|NCT00161291|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92625554|NCT00161291|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92625555|NCT00161291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625556|NCT00161291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625557|NCT00161291|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92625558|NCT00161291|Hormone Antagonists|hormone antagonists|mesh-ancestor
92625559|NCT00161291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625560|NCT00548899|Sorafenib|sorafenib|mesh-list
92625561|NCT00548899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625562|NCT00548899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92625563|NCT00548899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625564|NCT00548899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625565|NCT00191568|Gemcitabine|gemcitabine|mesh-list
92625566|NCT00191568|Oxaliplatin|oxaliplatin|mesh-list
92625567|NCT00191568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625568|NCT00191568|Antimetabolites|antimetabolites|mesh-ancestor
92625569|NCT00191568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625570|NCT00191568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625571|NCT00548938|Temozolomide|temozolomide|mesh-list
92625572|NCT00548938|Carmustine|carmustine|mesh-list
92625573|NCT00548938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92625574|NCT00548938|Alkylating Agents|alkylating agents|mesh-ancestor
92625575|NCT00548938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625576|NCT00548938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625577|NCT00161330|Amoxicillin|amoxicillin|mesh-list
92625578|NCT00161330|Ceftriaxone|ceftriaxone|mesh-list
92625579|NCT00161330|Clavulanic Acids|clavulanic acids|mesh-list
92625580|NCT00161330|Clavulanic Acid|clavulanic acid|mesh-list
92625581|NCT00161330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92625582|NCT00161330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92538905|NCT00048113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538907|NCT01466361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92538908|NCT01466361|Autonomic Agents|autonomic agents|mesh-ancestor
92538909|NCT01466361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538910|NCT01466361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538911|NCT01466361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92538912|NCT01466361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92538913|NCT01466361|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538914|NCT01466361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538915|NCT01466361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538916|NCT00001832|Cyclophosphamide|cyclophosphamide|mesh-list
92538917|NCT00001832|Fludarabine|fludarabine|mesh-list
92538918|NCT00001832|Interleukin-2|interleukin-2|mesh-list
92625583|NCT00161330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625584|NCT00161330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625585|NCT00161330|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92625586|NCT04939480|Atezolizumab|atezolizumab|mesh-list
92625587|NCT04939480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92625588|NCT04939480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625589|NCT04939480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625590|NCT04939480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625591|NCT00184938|Morphine|morphine|mesh-list
92625592|NCT00184938|Naloxone|naloxone|mesh-list
92625593|NCT00184938|Annexin A5|annexin a5|mesh-list
92625594|NCT00184938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92625595|NCT00184938|Narcotics|narcotics|mesh-ancestor
92625596|NCT00184938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625597|NCT00184938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625598|NCT00184938|Analgesics|analgesics|mesh-ancestor
92625599|NCT00184938|Sensory System Agents|sensory system agents|mesh-ancestor
92625600|NCT00184938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625601|NCT00184938|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92625602|NCT00184938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625603|NCT00184938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625604|NCT00549133|Irbesartan|irbesartan|mesh-list
92625605|NCT00549133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625606|NCT00549133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92625607|NCT00549133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92625608|NCT00549133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625609|NCT00191607|Gemcitabine|gemcitabine|mesh-list
92625610|NCT00191607|Doxorubicin|doxorubicin|mesh-list
92625611|NCT00191607|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92625612|NCT00191607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92350743|NCT03599466|Lisinopril|lisinopril|mesh-list
92625613|NCT00191607|Antimetabolites|antimetabolites|mesh-ancestor
92625614|NCT00191607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625615|NCT00191607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625616|NCT00191607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92625617|NCT00191607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92625618|NCT00191607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625619|NCT00191607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625623|NCT00549289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625624|NCT00549289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92625625|NCT00549289|Immunologic Factors|immunologic factors|mesh-ancestor
92625626|NCT00549289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625627|NCT00549289|Antifungal Agents|antifungal agents|mesh-ancestor
92625628|NCT00549289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625629|NCT00549289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92625630|NCT00549289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625631|NCT00549289|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92538919|NCT00001832|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92538920|NCT00001832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92538921|NCT00001832|Immunologic Factors|immunologic factors|mesh-ancestor
92538922|NCT00001832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538923|NCT00001832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92538924|NCT00001832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92538925|NCT00001832|Alkylating Agents|alkylating agents|mesh-ancestor
92538926|NCT00001832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538927|NCT00001832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538928|NCT00001832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92538929|NCT00001832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538931|NCT00001832|Sensory System Agents|sensory system agents|mesh-ancestor
91946542|NCT03386721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92625632|NCT00184977|Fluticasone|fluticasone|mesh-list
92625633|NCT00184977|Xhance|xhance|mesh-list
92625634|NCT00184977|Acetylcysteine|acetylcysteine|mesh-list
92625635|NCT00184977|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92625636|NCT00184977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625637|NCT00184977|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92625638|NCT00184977|Autonomic Agents|autonomic agents|mesh-ancestor
92625639|NCT00184977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625640|NCT00184977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625641|NCT00184977|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92625642|NCT00184977|Respiratory System Agents|respiratory system agents|mesh-ancestor
92625643|NCT00184977|Dermatologic Agents|dermatologic agents|mesh-ancestor
92625644|NCT00184977|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92625645|NCT00184977|Antiviral Agents|antiviral agents|mesh-ancestor
92625646|NCT00184977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625647|NCT00184977|Expectorants|expectorants|mesh-ancestor
92625648|NCT00184977|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92625649|NCT00184977|Antioxidants|antioxidants|mesh-ancestor
92625650|NCT00184977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625651|NCT00184977|Protective Agents|protective agents|mesh-ancestor
92625652|NCT00184977|Antidotes|antidotes|mesh-ancestor
92625653|NCT03456154|Salicylic Acid|salicylic acid|mesh-list
92625654|NCT03456154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625655|NCT03456154|Antifungal Agents|antifungal agents|mesh-ancestor
92625656|NCT03456154|Keratolytic Agents|keratolytic agents|mesh-ancestor
92625657|NCT03456154|Dermatologic Agents|dermatologic agents|mesh-ancestor
92625658|NCT00161447|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92625659|NCT00161447|Medroxyprogesterone|medroxyprogesterone|mesh-list
92625660|NCT00161447|Testosterone|testosterone|mesh-list
92625661|NCT00161447|Acyline|acyline|mesh-list
92625662|NCT00161447|Androgens|androgens|mesh-ancestor
92625663|NCT00161447|Hormones|hormones|mesh-ancestor
92625664|NCT00161447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625665|NCT00161447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625666|NCT00161447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92625667|NCT00161447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625668|NCT00161447|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92625669|NCT00161447|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92625670|NCT00161447|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92625671|NCT00161447|Contraceptive Agents|contraceptive agents|mesh-ancestor
92625672|NCT00161447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92625673|NCT00161447|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92625674|NCT00161447|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92625675|NCT00161447|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92625676|NCT00161447|Hormone Antagonists|hormone antagonists|mesh-ancestor
92625677|NCT00191685|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92625678|NCT00191685|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92538932|NCT00001832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538933|NCT00001832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92538934|NCT01466244|Cetuximab|cetuximab|mesh-list
92625679|NCT00191685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625680|NCT00191685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625681|NCT00191685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625682|NCT00191685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625683|NCT00191685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625684|NCT00191685|Analgesics|analgesics|mesh-ancestor
92625685|NCT00191685|Sensory System Agents|sensory system agents|mesh-ancestor
92625686|NCT00191685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350816|NCT00217464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92625687|NCT00191685|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625688|NCT00191685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625689|NCT00191685|Dopamine Agents|dopamine agents|mesh-ancestor
92625690|NCT00161486|Methyltestosterone|methyltestosterone|mesh-list
92625691|NCT00161486|Testosterone|testosterone|mesh-list
92625692|NCT00161486|Testosterone undecanoate|testosterone undecanoate|mesh-list
92625697|NCT00161486|Hormones|hormones|mesh-ancestor
92625698|NCT00161486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625699|NCT00161486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625700|NCT00161486|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92625701|NCT00161486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625702|NCT00161486|Anabolic Agents|anabolic agents|mesh-ancestor
92625703|NCT00161486|Hormone Antagonists|hormone antagonists|mesh-ancestor
92625704|NCT00549874|Rosiglitazone|rosiglitazone|mesh-list
92625705|NCT00549874|Glyburide|glyburide|mesh-list
92625706|NCT00549874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625707|NCT00549874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625708|NCT00191763|Gemcitabine|gemcitabine|mesh-list
92625709|NCT00191763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625710|NCT00191763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625711|NCT00191763|Antimetabolites|antimetabolites|mesh-ancestor
92625712|NCT00191763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625713|NCT00161564|Rituximab|rituximab|mesh-list
92625714|NCT00161564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625715|NCT00161564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625716|NCT00161564|Immunologic Factors|immunologic factors|mesh-ancestor
92625717|NCT00161564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625718|NCT00161564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625719|NCT00185055|Valsartan|valsartan|mesh-list
92625720|NCT00185055|Olmesartan|olmesartan|mesh-list
92625721|NCT00185055|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92625722|NCT00185055|Irbesartan|irbesartan|mesh-list
92625723|NCT00185055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625724|NCT00185055|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92625725|NCT00185055|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92625726|NCT00185055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625727|NCT00550108|Ethanol|ethanol|mesh-list
92625728|NCT00550108|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92625729|NCT00550108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625730|NCT00550108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361726|NCT03548454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625731|NCT00550108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625732|NCT00185094|Losartan|losartan|mesh-list
92625733|NCT00185094|Atenolol|atenolol|mesh-list
92625734|NCT00185094|Olmesartan|olmesartan|mesh-list
92625735|NCT00185094|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92625736|NCT00185094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92625737|NCT00185094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625738|NCT00185094|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92625739|NCT00185094|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92625740|NCT00185094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625741|NCT00185094|Sympatholytics|sympatholytics|mesh-ancestor
92625742|NCT00185094|Autonomic Agents|autonomic agents|mesh-ancestor
92625743|NCT00185094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625744|NCT00185094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625745|NCT00185094|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92625746|NCT00185094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92625747|NCT00185094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92625748|NCT00185094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625749|NCT00185094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625750|NCT00550303|Bazedoxifene|bazedoxifene|mesh-list
92538935|NCT01466244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538936|NCT01466244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92538937|NCT01466205|Dihydrexidine|dihydrexidine|mesh-list
92625751|NCT00550303|Estrogens|estrogens|mesh-list
92625752|NCT00550303|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92625753|NCT00550303|Hormones|hormones|mesh-ancestor
92625754|NCT00550303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625755|NCT00550303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625756|NCT00550303|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92625757|NCT00550303|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92625758|NCT00550303|Hormone Antagonists|hormone antagonists|mesh-ancestor
92625759|NCT00550303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92625760|NCT00550342|Rituximab|rituximab|mesh-list
92625761|NCT00550342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625762|NCT00550342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625763|NCT00550342|Immunologic Factors|immunologic factors|mesh-ancestor
92032709|NCT02123511|Expectorants|expectorants|mesh-ancestor
92625771|NCT00161681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625772|NCT00161681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625773|NCT00161681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92625774|NCT00161681|Contraceptive Agents|contraceptive agents|mesh-ancestor
92625775|NCT00161681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92625776|NCT00161681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92625777|NCT00161681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92625778|NCT00161681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92625779|NCT00161681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92625780|NCT02963454|Simendan|simendan|mesh-list
92625781|NCT02963454|Dobutamine|dobutamine|mesh-list
92625782|NCT02963454|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92625783|NCT02963454|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625784|NCT02963454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92625785|NCT02963454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92625786|NCT02963454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625787|NCT02963454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625788|NCT02963454|Protective Agents|protective agents|mesh-ancestor
92625789|NCT02963454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625790|NCT02963454|Sympathomimetics|sympathomimetics|mesh-ancestor
92625791|NCT02963454|Autonomic Agents|autonomic agents|mesh-ancestor
92625792|NCT02963454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625793|NCT02963454|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92625794|NCT02963454|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92625795|NCT02963454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92625796|NCT02963454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625797|NCT02963454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625798|NCT00191802|Teriparatide|teriparatide|mesh-list
92625799|NCT00191802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92361729|NCT00605904|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92625800|NCT00191802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625801|NCT00191802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92625802|NCT00550693|Chlorhexidine|chlorhexidine|mesh-list
92625803|NCT00550693|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92625804|NCT00550693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92625805|NCT00550693|Disinfectants|disinfectants|mesh-ancestor
92625806|NCT00550810|Sunitinib|sunitinib|mesh-list
92625807|NCT00550810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625808|NCT00550810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92625809|NCT00550810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92625810|NCT00550810|Growth Substances|growth substances|mesh-ancestor
92625811|NCT00550810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625812|NCT00550810|Growth Inhibitors|growth inhibitors|mesh-ancestor
92625813|NCT00550810|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92625814|NCT00550810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625815|NCT00550810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625816|NCT00191841|Gemcitabine|gemcitabine|mesh-list
92625817|NCT00191841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625818|NCT00191841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625819|NCT00191841|Antimetabolites|antimetabolites|mesh-ancestor
92625820|NCT00191841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625821|NCT00550927|Bevacizumab|bevacizumab|mesh-list
92625822|NCT00550927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625823|NCT00550927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92538938|NCT01466205|Dopamine Agonists|dopamine agonists|mesh-ancestor
92538939|NCT01466205|Dopamine Agents|dopamine agents|mesh-ancestor
92538940|NCT01466205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946557|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92625824|NCT00550927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92625825|NCT00550927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92625826|NCT00550927|Growth Substances|growth substances|mesh-ancestor
92625827|NCT00550927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625828|NCT00550927|Growth Inhibitors|growth inhibitors|mesh-ancestor
92625829|NCT00161720|Protein C|protein c|mesh-list
92625830|NCT00161720|Anticoagulants|anticoagulants|mesh-ancestor
92625831|NCT00161720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92625832|NCT00161720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92625833|NCT00161720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625837|NCT00185133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625839|NCT00185133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625840|NCT00185133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625841|NCT00185133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92625842|NCT00185133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625843|NCT00185133|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625844|NCT00185133|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92625845|NCT00185133|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92625846|NCT00551005|Celecoxib|celecoxib|mesh-list
92625847|NCT00551005|Etoposide|etoposide|mesh-list
92625848|NCT00551005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92625849|NCT00551005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625850|NCT00551005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92625851|NCT00551005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625852|NCT00551005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625853|NCT00551005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625854|NCT00551005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92625855|NCT00551005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92625856|NCT00551005|Analgesics|analgesics|mesh-ancestor
92625857|NCT00551005|Sensory System Agents|sensory system agents|mesh-ancestor
92625858|NCT00551005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625859|NCT00551005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625860|NCT00551005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92625861|NCT00551005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625862|NCT00551005|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92625863|NCT00551005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92625864|NCT00551044|Bicalutamide|bicalutamide|mesh-list
92625865|NCT00551044|Androgen Antagonists|androgen antagonists|mesh-ancestor
92625866|NCT00551044|Hormone Antagonists|hormone antagonists|mesh-ancestor
92625867|NCT00551044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625868|NCT00551044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625869|NCT00551044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625870|NCT00161759|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92625871|NCT00161759|Thrombin|thrombin|mesh-list
92625872|NCT00161759|Hemostatics|hemostatics|mesh-ancestor
92625873|NCT00161759|Coagulants|coagulants|mesh-ancestor
92625874|NCT00551122|Paclitaxel|paclitaxel|mesh-list
92625875|NCT00551122|Gemcitabine|gemcitabine|mesh-list
92625876|NCT00551122|Ifosfamide|ifosfamide|mesh-list
92625877|NCT00551122|Lenograstim|lenograstim|mesh-list
92625878|NCT00551122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92625879|NCT00551122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625880|NCT00551122|Tubulin Modulators|tubulin modulators|mesh-ancestor
92625881|NCT00551122|Antimitotic Agents|antimitotic agents|mesh-ancestor
92625882|NCT00551122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92625883|NCT00551122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625884|NCT00551122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625885|NCT00551122|Antimetabolites|antimetabolites|mesh-ancestor
92625886|NCT00551122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92625887|NCT00551122|Immunologic Factors|immunologic factors|mesh-ancestor
92625888|NCT00551122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625889|NCT00551122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92625890|NCT00551122|Alkylating Agents|alkylating agents|mesh-ancestor
92625891|NCT00551239|Rituximab|rituximab|mesh-list
92625892|NCT00551239|Fludarabine|fludarabine|mesh-list
92625893|NCT00551239|Fludarabine phosphate|fludarabine phosphate|mesh-list
92625894|NCT00551239|Pixantrone|pixantrone|mesh-list
92538941|NCT01466205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538942|NCT01466205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538943|NCT01466127|Oxytocin|oxytocin|mesh-list
92625895|NCT00551239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92625896|NCT00551239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625897|NCT00551239|Immunologic Factors|immunologic factors|mesh-ancestor
92625898|NCT00551239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625899|NCT00551239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625900|NCT00551239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92625901|NCT00551239|Antimetabolites|antimetabolites|mesh-ancestor
92625902|NCT00551239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625903|NCT00551239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92625904|NCT00551239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92625905|NCT00551239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625906|NCT00551239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625907|NCT00191880|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92625909|NCT00191880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625910|NCT00191880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625911|NCT00191880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625913|NCT00191880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625914|NCT00191880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625916|NCT00551317|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92625917|NCT00551317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625918|NCT00551317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625919|NCT00551356|Insulin Lispro|insulin lispro|mesh-list
92625920|NCT00551356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625921|NCT00551356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625922|NCT02963337|Remifentanil|remifentanil|mesh-list
92625923|NCT02963337|Bupivacaine|bupivacaine|mesh-list
92625924|NCT02963337|Anesthetics, Local|anesthetics, local|mesh-ancestor
92625925|NCT02963337|Anesthetics|anesthetics|mesh-ancestor
92625926|NCT02963337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92625927|NCT02963337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625928|NCT02963337|Sensory System Agents|sensory system agents|mesh-ancestor
92625929|NCT02963337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625930|NCT02963337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92625931|NCT02963337|Narcotics|narcotics|mesh-ancestor
92625932|NCT02963337|Analgesics|analgesics|mesh-ancestor
92625933|NCT00191919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92625934|NCT00191919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92625935|NCT00191919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625936|NCT00191919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625937|NCT00191919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625938|NCT00191919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625939|NCT00191919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625940|NCT00191919|Analgesics|analgesics|mesh-ancestor
92625941|NCT00191919|Sensory System Agents|sensory system agents|mesh-ancestor
92625942|NCT00191919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625943|NCT00191919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92625944|NCT00191919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625945|NCT00191919|Dopamine Agents|dopamine agents|mesh-ancestor
92625946|NCT00161837|Vaccines|vaccines|mesh-list
92625947|NCT00161837|Immunologic Factors|immunologic factors|mesh-ancestor
92625948|NCT00161837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625949|NCT00551512|Cisplatin|cisplatin|mesh-list
92625950|NCT00551512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625951|NCT00551590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92625952|NCT00551590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625953|NCT00551590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625954|NCT00551590|Incretins|incretins|mesh-ancestor
92625955|NCT00551590|Hormones|hormones|mesh-ancestor
92625956|NCT00551590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625957|NCT00551590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92625958|NCT00551590|Protease Inhibitors|protease inhibitors|mesh-ancestor
92625959|NCT00551590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625960|NCT00551590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625961|NCT00161915|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92625962|NCT00161915|Hemostatics|hemostatics|mesh-ancestor
92625963|NCT00161915|Coagulants|coagulants|mesh-ancestor
92625964|NCT00185172|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92538944|NCT01466127|Oxytocics|oxytocics|mesh-ancestor
92538945|NCT01466127|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92538946|NCT01466127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538947|NCT00009191|Sertraline|sertraline|mesh-list
92538948|NCT00009191|Antidepressive Agents|antidepressive agents|mesh-ancestor
92538949|NCT00009191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92538950|NCT00009191|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92625965|NCT00185172|Olmesartan|olmesartan|mesh-list
92625966|NCT00185172|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92625967|NCT00185172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92625968|NCT00185172|Diuretics|diuretics|mesh-ancestor
92625969|NCT00185172|Natriuretic Agents|natriuretic agents|mesh-ancestor
92625970|NCT00185172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625971|NCT00185172|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92625972|NCT00185172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625973|NCT00185172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625974|NCT00185172|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92625975|NCT00185172|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92625976|NCT00191997|Olanzapine|olanzapine|mesh-list
92625977|NCT00191997|Antiemetics|antiemetics|mesh-ancestor
92625978|NCT00191997|Autonomic Agents|autonomic agents|mesh-ancestor
92625979|NCT00191997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92625980|NCT00191997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625985|NCT00191997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92625986|NCT00191997|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92625987|NCT00191997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92625988|NCT00191997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92625989|NCT00191997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625990|NCT00191997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625991|NCT00191997|Serotonin Agents|serotonin agents|mesh-ancestor
92625992|NCT00551824|Mitomycins|mitomycins|mesh-list
92625993|NCT00551824|Mitomycin|mitomycin|mesh-list
92625994|NCT00551824|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92625995|NCT00551824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92625996|NCT00551824|Alkylating Agents|alkylating agents|mesh-ancestor
92625997|NCT00551824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625998|NCT00551824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92625999|NCT00551824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626000|NCT00185250|Interferons|interferons|mesh-list
92626001|NCT00185250|Interferon-beta|interferon-beta|mesh-list
92626002|NCT00185250|Interferon beta-1b|interferon beta-1b|mesh-list
92626003|NCT00185250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626004|NCT00185250|Antiviral Agents|antiviral agents|mesh-ancestor
92626005|NCT00185250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626006|NCT00185250|Immunologic Factors|immunologic factors|mesh-ancestor
92361746|NCT05194488|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92626007|NCT00185250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626008|NCT00185250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92626009|NCT00161993|Immunoglobulins|immunoglobulins|mesh-list
92626010|NCT00161993|Antibodies|antibodies|mesh-list
92626011|NCT00161993|gamma-Globulins|gamma-globulins|mesh-list
92626012|NCT00161993|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92626013|NCT00161993|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92626014|NCT00161993|Immunologic Factors|immunologic factors|mesh-ancestor
92626015|NCT00161993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626016|NCT00185328|Estradiol|estradiol|mesh-list
92626017|NCT00185328|Estrogens|estrogens|mesh-ancestor
92626018|NCT00185328|Hormones|hormones|mesh-ancestor
92626019|NCT00185328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626020|NCT00185328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626021|NCT00162110|Cetuximab|cetuximab|mesh-list
92626022|NCT00162110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626023|NCT00162110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626024|NCT00552370|Insulin Glargine|insulin glargine|mesh-list
92626025|NCT00552370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92626026|NCT00552370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626027|NCT00162149|Ritonavir|ritonavir|mesh-list
92626028|NCT00162149|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92626029|NCT00162149|Nevirapine|nevirapine|mesh-list
92626030|NCT00162149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92538951|NCT00009191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91973344|NCT03262727|Norethindrone Acetate|norethindrone acetate|mesh-list
92626031|NCT00162149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92626032|NCT00162149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92626033|NCT00162149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626034|NCT00162149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626035|NCT00162149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92626036|NCT00162149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92626037|NCT00162149|Antiviral Agents|antiviral agents|mesh-ancestor
92626038|NCT00162149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626039|NCT00162149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92626040|NCT00162149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92626041|NCT00162149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92626042|NCT00162149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626043|NCT00162149|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92626044|NCT00162149|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92626045|NCT00552526|Anticonvulsants|anticonvulsants|mesh-list
92626046|NCT00162188|Efavirenz|efavirenz|mesh-list
92626047|NCT00162188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92626048|NCT00162188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626049|NCT00162188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626050|NCT00162188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626051|NCT00162188|Antiviral Agents|antiviral agents|mesh-ancestor
92626055|NCT00162188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92626056|NCT00162188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92626057|NCT00162188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92626058|NCT00162188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92626060|NCT00162227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92626061|NCT00162227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626062|NCT00162227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626063|NCT00162227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626064|NCT00162227|Antiviral Agents|antiviral agents|mesh-ancestor
92626065|NCT00162227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626066|NCT00162227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92626067|NCT00162227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92626068|NCT00162227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92626069|NCT00162227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92626070|NCT00162227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92626071|NCT00162227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92626072|NCT04701580|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92626073|NCT04701580|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92626074|NCT04701580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626075|NCT00552682|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92626076|NCT00552682|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92626077|NCT00552682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92626078|NCT00552682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626079|NCT00552682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626080|NCT00552682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626081|NCT00552682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626082|NCT00552682|Analgesics|analgesics|mesh-ancestor
92626083|NCT00552682|Sensory System Agents|sensory system agents|mesh-ancestor
92626084|NCT00552682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626085|NCT00552682|Antidepressive Agents|antidepressive agents|mesh-ancestor
92626086|NCT00552682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626087|NCT00552682|Dopamine Agents|dopamine agents|mesh-ancestor
92626088|NCT04652089|Simvastatin|simvastatin|mesh-list
92626089|NCT04652089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92626090|NCT04652089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92626091|NCT04652089|Antimetabolites|antimetabolites|mesh-ancestor
92626092|NCT04652089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626093|NCT04652089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92626094|NCT04652089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92626095|NCT04652089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626096|NCT04609306|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92626097|NCT04609306|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92626098|NCT04609306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626099|NCT04684498|Oseltamivir|oseltamivir|mesh-list
92626100|NCT04684498|Antiviral Agents|antiviral agents|mesh-ancestor
92538952|NCT00009191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92538953|NCT00009191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626101|NCT04684498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626102|NCT04684498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626103|NCT04684498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626105|NCT00552799|Penicillin V|penicillin v|mesh-list
92626106|NCT00552799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92626107|NCT00552799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626108|NCT00409071|Sinomenine|sinomenine|mesh-list
92626109|NCT00409071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626110|NCT00162305|Dapagliflozin|dapagliflozin|mesh-list
92626111|NCT00162305|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92626112|NCT00162305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626113|NCT00162305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92626114|NCT00162305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626115|NCT04513015|Antioxidants|antioxidants|mesh-list
92626116|NCT04513015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626117|NCT04513015|Protective Agents|protective agents|mesh-ancestor
92626118|NCT04513015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626119|NCT00162344|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92626134|NCT00162383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626136|NCT00162383|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92626137|NCT00162383|Purinergic Agents|purinergic agents|mesh-ancestor
92626138|NCT00162383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626139|NCT00162383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626140|NCT00162383|Antimalarials|antimalarials|mesh-ancestor
92626141|NCT00162383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92626142|NCT00162383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92626143|NCT00162383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92626144|NCT00162383|Leprostatic Agents|leprostatic agents|mesh-ancestor
92626145|NCT00162383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92626146|NCT00162383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92626147|NCT00162383|Sympatholytics|sympatholytics|mesh-ancestor
92626148|NCT00162383|Autonomic Agents|autonomic agents|mesh-ancestor
92626149|NCT00162383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626150|NCT00162383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92626151|NCT00162383|Anticonvulsants|anticonvulsants|mesh-ancestor
92626152|NCT00162422|Albuterol|albuterol|mesh-list
92626153|NCT00162422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92626154|NCT00162422|Autonomic Agents|autonomic agents|mesh-ancestor
92626155|NCT00162422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626156|NCT00162422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626157|NCT00162422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92626158|NCT00162422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92626159|NCT00162422|Tocolytic Agents|tocolytic agents|mesh-ancestor
92626160|NCT00162422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92626161|NCT00162422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92626162|NCT00162422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92626163|NCT00162422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92626164|NCT00162422|Adrenergic Agents|adrenergic agents|mesh-ancestor
92626165|NCT00162422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626166|NCT00162422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626167|NCT04355143|Colchicine|colchicine|mesh-list
92626168|NCT04355143|Gout Suppressants|gout suppressants|mesh-ancestor
92626169|NCT04355143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626170|NCT04355143|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626171|NCT04355143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626172|NCT04355143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626173|NCT04355143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626174|NCT04355143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626175|NCT00185445|Fludarabine|fludarabine|mesh-list
92626176|NCT00185445|Fludarabine phosphate|fludarabine phosphate|mesh-list
92626177|NCT00185445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626178|NCT00185445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92626179|NCT00185445|Antimetabolites|antimetabolites|mesh-ancestor
92626180|NCT00185445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626181|NCT00185445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626188|NCT04233034|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92626189|NCT04233034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626190|NCT04233034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538954|NCT00009191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538956|NCT00009191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538957|NCT01466088|Donepezil|donepezil|mesh-list
92538958|NCT01466088|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92626191|NCT04233034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92626192|NCT04233034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626193|NCT04233034|Vasodilator Agents|vasodilator agents|mesh-ancestor
92626194|NCT04187053|Methylene Blue|methylene blue|mesh-list
92626195|NCT04187053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626196|NCT04187053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626197|NCT00162461|Phenytoin|phenytoin|mesh-list
92626198|NCT00162461|Anticonvulsants|anticonvulsants|mesh-ancestor
92626199|NCT00162461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92626200|NCT00162461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92626201|NCT00162461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626202|NCT00162461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626203|NCT00162461|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92626204|NCT00162461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92626205|NCT00185562|Adalimumab|adalimumab|mesh-list
92626206|NCT00185562|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92626207|NCT00185562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626208|NCT00185562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626209|NCT04095364|Paclitaxel|paclitaxel|mesh-list
92626210|NCT04095364|Carboplatin|carboplatin|mesh-list
92626211|NCT04095364|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92626212|NCT04095364|Letrozole|letrozole|mesh-list
92626213|NCT04095364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92626214|NCT04095364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626215|NCT04095364|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626216|NCT04095364|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626217|NCT04095364|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626218|NCT04095364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626219|NCT04095364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92626220|NCT04095364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92626221|NCT04095364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626222|NCT04095364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92626223|NCT04095364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92626224|NCT04095364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626225|NCT04095364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626226|NCT00162656|Cyclophosphamide|cyclophosphamide|mesh-list
92626227|NCT00162656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626228|NCT00162656|Immunologic Factors|immunologic factors|mesh-ancestor
92626229|NCT00162656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626230|NCT00162656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626231|NCT00162656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92626232|NCT00162656|Alkylating Agents|alkylating agents|mesh-ancestor
92626233|NCT00162656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626234|NCT00162656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626235|NCT00162656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92626236|NCT00162695|Etoposide|etoposide|mesh-list
92626237|NCT00162695|Vincristine|vincristine|mesh-list
92626238|NCT00162695|Epirubicin|epirubicin|mesh-list
92626239|NCT00162695|Ifosfamide|ifosfamide|mesh-list
92626240|NCT00162695|Carboplatin|carboplatin|mesh-list
92626241|NCT00162695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92626242|NCT00162695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626243|NCT00162695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92626244|NCT00162695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92626245|NCT00162695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626246|NCT00162695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626247|NCT00162695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92626248|NCT00162695|Alkylating Agents|alkylating agents|mesh-ancestor
92626249|NCT00162695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626255|NCT00162734|Interferon alfacon-1|interferon alfacon-1|mesh-list
92626256|NCT00162734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626257|NCT00162734|Antiviral Agents|antiviral agents|mesh-ancestor
92626258|NCT00162734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626259|NCT00162734|Antimetabolites|antimetabolites|mesh-ancestor
92752320|NCT05940896|Disitamab vedotin|disitamab vedotin|mesh-list
92538959|NCT01466088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538960|NCT01466088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538961|NCT01466088|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538962|NCT01466088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538963|NCT01466088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626260|NCT00162734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626261|NCT00185796|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92626262|NCT00185796|Immunologic Factors|immunologic factors|mesh-ancestor
92626263|NCT00185796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626264|NCT00185796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626265|NCT00162812|Epirubicin|epirubicin|mesh-list
92626266|NCT00162812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92626267|NCT00162812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626268|NCT00162812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92626269|NCT00162812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92626270|NCT00162812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626271|NCT00162812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626272|NCT00162851|Alemtuzumab|alemtuzumab|mesh-list
92626273|NCT00162851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626274|NCT00162851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626275|NCT04015414|Varenicline|varenicline|mesh-list
92626276|NCT04015414|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92626277|NCT04015414|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92626278|NCT04015414|Cholinergic Agents|cholinergic agents|mesh-ancestor
92626279|NCT04015414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626280|NCT04015414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626281|NCT04015414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626282|NCT00185835|Gefitinib|gefitinib|mesh-list
92626283|NCT00185835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626284|NCT00185835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92626285|NCT00185835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626286|NCT00185835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626287|NCT00162968|Escitalopram|escitalopram|mesh-list
92626288|NCT00162968|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92626289|NCT00162968|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92626290|NCT00162968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626291|NCT00162968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626292|NCT00162968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626293|NCT00162968|Serotonin Agents|serotonin agents|mesh-ancestor
92626294|NCT00162968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626295|NCT03970330|Naltrexone|naltrexone|mesh-list
92626296|NCT03970330|Norethindrone|norethindrone|mesh-list
92626297|NCT03970330|Norethindrone Acetate|norethindrone acetate|mesh-list
92626298|NCT03970330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92626299|NCT03970330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92626300|NCT03970330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626301|NCT03970330|Sensory System Agents|sensory system agents|mesh-ancestor
92626302|NCT03970330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626303|NCT03970330|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92626304|NCT03970330|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92626305|NCT03970330|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92626306|NCT03970330|Contraceptive Agents|contraceptive agents|mesh-ancestor
92626307|NCT03970330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92626308|NCT03970330|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92626309|NCT03970330|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92626310|NCT00185874|Immunomodulating Agents|immunomodulating agents|mesh-list
92626311|NCT00185874|Immunologic Factors|immunologic factors|mesh-ancestor
92626312|NCT00185874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626313|NCT03757585|Inositol|inositol|mesh-list
92626314|NCT03757585|Acetylcysteine|acetylcysteine|mesh-list
92626315|NCT03757585|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92626316|NCT03757585|Antiviral Agents|antiviral agents|mesh-ancestor
92626317|NCT03757585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626318|NCT03757585|Expectorants|expectorants|mesh-ancestor
92626319|NCT03757585|Respiratory System Agents|respiratory system agents|mesh-ancestor
92626320|NCT03757585|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92626322|NCT03757585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626323|NCT03757585|Protective Agents|protective agents|mesh-ancestor
92538964|NCT01466088|Nootropic Agents|nootropic agents|mesh-ancestor
92538965|NCT00009230|Celecoxib|celecoxib|mesh-list
92626324|NCT03757585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626325|NCT03757585|Antidotes|antidotes|mesh-ancestor
92626326|NCT03757585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92626327|NCT03757585|Vitamins|vitamins|mesh-ancestor
92626328|NCT03757585|Micronutrients|micronutrients|mesh-ancestor
92626329|NCT00163046|Gabapentin|gabapentin|mesh-list
92626330|NCT00163046|Analgesics|analgesics|mesh-ancestor
92626331|NCT00163046|Sensory System Agents|sensory system agents|mesh-ancestor
92626332|NCT00163046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626333|NCT00163046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626334|NCT00163046|Anticonvulsants|anticonvulsants|mesh-ancestor
92626335|NCT00163046|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92626336|NCT00163046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92626337|NCT00163046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626338|NCT00163046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626339|NCT00163046|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92626340|NCT00163046|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92626341|NCT00163046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626342|NCT00163046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626343|NCT00163046|Antimanic Agents|antimanic agents|mesh-ancestor
92626344|NCT00185952|Nifedipine|nifedipine|mesh-list
92626345|NCT00185952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92626346|NCT00185952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626347|NCT00185952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626348|NCT00185952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92626349|NCT00185952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626350|NCT00185952|Vasodilator Agents|vasodilator agents|mesh-ancestor
92626351|NCT00185952|Tocolytic Agents|tocolytic agents|mesh-ancestor
92626352|NCT00185952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351498|NCT03020940|Cefuroxime|cefuroxime|mesh-list
92626353|NCT03541447|Octreotide|octreotide|mesh-list
92626354|NCT03541447|Tolvaptan|tolvaptan|mesh-list
92626355|NCT03541447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92626356|NCT03541447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92626357|NCT03541447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626358|NCT03541447|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92626359|NCT03541447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626360|NCT03541447|Natriuretic Agents|natriuretic agents|mesh-ancestor
92626361|NCT03541447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626362|NCT00192621|Lamivudine|lamivudine|mesh-list
92626363|NCT00192621|Zidovudine|zidovudine|mesh-list
92626364|NCT00192621|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92626365|NCT00192621|Lopinavir|lopinavir|mesh-list
92626366|NCT00192621|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92626367|NCT00192621|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626368|NCT00192621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626369|NCT00192621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626370|NCT00192621|Antiviral Agents|antiviral agents|mesh-ancestor
92626371|NCT00192621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626372|NCT00192621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92626373|NCT00192621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92626374|NCT00192621|Antimetabolites|antimetabolites|mesh-ancestor
92626375|NCT00192621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92626376|NCT00192621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92626377|NCT00192621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92626378|NCT00192621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92626379|NCT00192621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92626380|NCT03516604|Citalopram|citalopram|mesh-list
92626381|NCT03516604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92626382|NCT03516604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92626383|NCT03516604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626384|NCT03516604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626385|NCT03516604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626386|NCT03516604|Serotonin Agents|serotonin agents|mesh-ancestor
92626387|NCT03516604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626388|NCT03516604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92626389|NCT03516604|Antidepressive Agents|antidepressive agents|mesh-ancestor
92626390|NCT03516604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626391|NCT00185991|Gentamicins|gentamicins|mesh-list
92626392|NCT00185991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752321|NCT05940896|Immunoconjugates|immunoconjugates|mesh-ancestor
92626406|NCT00163202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626408|NCT00163202|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92626409|NCT00163202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626410|NCT03318952|Lidocaine|lidocaine|mesh-list
92626411|NCT03318952|Anesthetics, Local|anesthetics, local|mesh-list
92626412|NCT03318952|Carticaine|carticaine|mesh-list
92626413|NCT03318952|Anesthetics|anesthetics|mesh-list
92626414|NCT03318952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626415|NCT03318952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626416|NCT03318952|Sensory System Agents|sensory system agents|mesh-ancestor
92626417|NCT03318952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626418|NCT03318952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92626419|NCT03318952|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92626420|NCT03318952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92626421|NCT03318952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626422|NCT03318952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626423|NCT00192660|Ritonavir|ritonavir|mesh-list
92626424|NCT00192660|Nelfinavir|nelfinavir|mesh-list
92626425|NCT00192660|Indinavir|indinavir|mesh-list
92626426|NCT00192660|Saquinavir|saquinavir|mesh-list
92626427|NCT00192660|Amprenavir|amprenavir|mesh-list
92626428|NCT00192660|Tenofovir|tenofovir|mesh-list
92626429|NCT00192660|Lamivudine|lamivudine|mesh-list
92626430|NCT00192660|Zidovudine|zidovudine|mesh-list
92626431|NCT00192660|Nevirapine|nevirapine|mesh-list
92626432|NCT00192660|Abacavir|abacavir|mesh-list
92626433|NCT00192660|Didanosine|didanosine|mesh-list
92626434|NCT00192660|Stavudine|stavudine|mesh-list
92626435|NCT00192660|Tipranavir|tipranavir|mesh-list
92626436|NCT00192660|Enfuvirtide|enfuvirtide|mesh-list
92626437|NCT00192660|Efavirenz|efavirenz|mesh-list
92626438|NCT00192660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92626439|NCT00192660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92626440|NCT00192660|Protease Inhibitors|protease inhibitors|mesh-ancestor
92626441|NCT00192660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626442|NCT00192660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626443|NCT00192660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92626444|NCT00192660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92626445|NCT00192660|Antiviral Agents|antiviral agents|mesh-ancestor
92626446|NCT00192660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626447|NCT00192660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92626448|NCT00192660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91921266|NCT02187445|Budesonide|budesonide|mesh-list
92626449|NCT00192660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92626450|NCT00192660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626451|NCT00192660|Antimetabolites|antimetabolites|mesh-ancestor
92626452|NCT00192660|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92626453|NCT00192660|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92626454|NCT00192660|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92626462|NCT00163241|Celecoxib|celecoxib|mesh-list
92626463|NCT00163241|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92626464|NCT00163241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92626465|NCT00163241|Analgesics|analgesics|mesh-ancestor
92626466|NCT00163241|Sensory System Agents|sensory system agents|mesh-ancestor
92626467|NCT00163241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626468|NCT00163241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626469|NCT00163241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626470|NCT00163241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626471|NCT00163241|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92626472|NCT00163241|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92626473|NCT00163241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626474|NCT00163241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626475|NCT03016819|Dacarbazine|dacarbazine|mesh-list
92626476|NCT03016819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92626477|NCT03016819|Alkylating Agents|alkylating agents|mesh-ancestor
92626478|NCT03016819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626479|NCT03016819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626480|NCT02916316|Doxorubicin|doxorubicin|mesh-list
92626481|NCT02916316|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92626482|NCT02916316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92626483|NCT02916316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626484|NCT02916316|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92626485|NCT02916316|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92626486|NCT02916316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626487|NCT02916316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538966|NCT00009230|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92538967|NCT00009230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92538968|NCT00009230|Analgesics|analgesics|mesh-ancestor
92538969|NCT00009230|Sensory System Agents|sensory system agents|mesh-ancestor
92626488|NCT00186264|Hydrocortisone|hydrocortisone|mesh-list
92626489|NCT00186264|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92626490|NCT00186264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626491|NCT00186264|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92626492|NCT00186264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92626493|NCT00186264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626494|NCT00186264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626495|NCT00186264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626496|NCT00186264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626497|NCT00186264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92626498|NCT00186264|Antidepressive Agents|antidepressive agents|mesh-ancestor
92351649|NCT04148820|Protease Inhibitors|protease inhibitors|mesh-ancestor
92626499|NCT00186264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626500|NCT00163319|Ciclesonide|ciclesonide|mesh-list
92626501|NCT00163319|Glucocorticoids|glucocorticoids|mesh-ancestor
92626502|NCT00163319|Hormones|hormones|mesh-ancestor
92626503|NCT00163319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626504|NCT00163319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626505|NCT00163319|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92626506|NCT02812420|Durvalumab|durvalumab|mesh-list
92626507|NCT02812420|Ipilimumab|ipilimumab|mesh-list
92626508|NCT02812420|Tremelimumab|tremelimumab|mesh-list
92626509|NCT02812420|Immunoglobulins|immunoglobulins|mesh-list
92626510|NCT02812420|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92626511|NCT02812420|Immunoglobulin G|immunoglobulin g|mesh-list
92626512|NCT02812420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626513|NCT02812420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626514|NCT02812420|Immunologic Factors|immunologic factors|mesh-ancestor
92626515|NCT02812420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626516|NCT02812420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92626517|NCT02812420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626518|NCT02556931|Mycophenolic Acid|mycophenolic acid|mesh-list
92626534|NCT02556931|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92626535|NCT02556931|Antitubercular Agents|antitubercular agents|mesh-ancestor
92626536|NCT02556931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92626537|NCT02556931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626539|NCT00163358|Glucocorticoids|glucocorticoids|mesh-ancestor
92626540|NCT00163358|Hormones|hormones|mesh-ancestor
92626541|NCT00163358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626542|NCT00163358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626543|NCT00163358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92626544|NCT00163397|Ciclesonide|ciclesonide|mesh-list
92626545|NCT00163397|Glucocorticoids|glucocorticoids|mesh-ancestor
92626546|NCT00163397|Hormones|hormones|mesh-ancestor
92626547|NCT00163397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626548|NCT00163397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626549|NCT00163397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92626550|NCT00163436|Ciclesonide|ciclesonide|mesh-list
92626551|NCT00163436|Glucocorticoids|glucocorticoids|mesh-ancestor
92626552|NCT00163436|Hormones|hormones|mesh-ancestor
92626553|NCT00163436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626554|NCT00163436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626555|NCT00163436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92626556|NCT00186420|Docetaxel|docetaxel|mesh-list
92626557|NCT00186420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626558|NCT00186420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626559|NCT00186420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626560|NCT00186420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626561|NCT00186420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626562|NCT00163514|Ciclesonide|ciclesonide|mesh-list
92626563|NCT00163514|Glucocorticoids|glucocorticoids|mesh-ancestor
92626564|NCT00163514|Hormones|hormones|mesh-ancestor
92626565|NCT00163514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626566|NCT00163514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626567|NCT00163514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92626568|NCT00717652|Triamcinolone|triamcinolone|mesh-list
92538970|NCT00009230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946581|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
92626569|NCT00717652|Tretinoin|tretinoin|mesh-list
92626570|NCT00717652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626571|NCT00717652|Glucocorticoids|glucocorticoids|mesh-ancestor
92626572|NCT00717652|Hormones|hormones|mesh-ancestor
92626573|NCT00717652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626574|NCT00717652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626575|NCT00717652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626576|NCT00717652|Keratolytic Agents|keratolytic agents|mesh-ancestor
92626577|NCT00717652|Dermatologic Agents|dermatologic agents|mesh-ancestor
92626578|NCT00066040|Chlorhexidine|chlorhexidine|mesh-list
92626587|NCT00066040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626588|NCT00066040|Disinfectants|disinfectants|mesh-ancestor
92626589|NCT00163553|Meperidine|meperidine|mesh-list
92626590|NCT00163553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92626591|NCT00163553|Narcotics|narcotics|mesh-ancestor
92626592|NCT00163553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626593|NCT00163553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626594|NCT00163553|Analgesics|analgesics|mesh-ancestor
92626595|NCT00163553|Sensory System Agents|sensory system agents|mesh-ancestor
92626596|NCT00163553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626597|NCT00163553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92626598|NCT00163592|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92626599|NCT00163592|Hemostatics|hemostatics|mesh-ancestor
92626600|NCT00163592|Coagulants|coagulants|mesh-ancestor
92626601|NCT04683445|Pembrolizumab|pembrolizumab|mesh-list
92626602|NCT04683445|Trastuzumab|trastuzumab|mesh-list
92626603|NCT04683445|Pertuzumab|pertuzumab|mesh-list
92626604|NCT04683445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626605|NCT04683445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626606|NCT04683445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92626607|NCT04683445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626608|NCT00192777|Capecitabine|capecitabine|mesh-list
92626609|NCT00192777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92626610|NCT00192777|Antimetabolites|antimetabolites|mesh-ancestor
92626611|NCT00192777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626612|NCT00192777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626613|NCT00553072|Magnesium Sulfate|magnesium sulfate|mesh-list
92626614|NCT00553072|Analgesics|analgesics|mesh-ancestor
92361782|NCT05097846|Antacids|antacids|mesh-ancestor
92626615|NCT00553072|Sensory System Agents|sensory system agents|mesh-ancestor
92626616|NCT00553072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626617|NCT00553072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626618|NCT00553072|Anesthetics|anesthetics|mesh-ancestor
92626619|NCT00553072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626620|NCT00553072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92626621|NCT00553072|Anticonvulsants|anticonvulsants|mesh-ancestor
92626622|NCT00553072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92626623|NCT00553072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626624|NCT00553072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626625|NCT00553072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92626626|NCT00553072|Tocolytic Agents|tocolytic agents|mesh-ancestor
92626627|NCT00553072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92626628|NCT05808608|Axitinib|axitinib|mesh-list
92626629|NCT05808608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626630|NCT05808608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92626631|NCT05808608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626632|NCT05808608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626633|NCT05808387|Resveratrol|resveratrol|mesh-list
92626634|NCT05808387|Antioxidants|antioxidants|mesh-ancestor
92626635|NCT05808387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626636|NCT05808387|Protective Agents|protective agents|mesh-ancestor
92626637|NCT05808387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626638|NCT05808387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626639|NCT05808387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92626640|NCT05808231|Quinine|quinine|mesh-list
92626641|NCT05808231|Antimalarials|antimalarials|mesh-ancestor
92626642|NCT05808231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92626643|NCT05808231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92626644|NCT05808231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626645|NCT05808231|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92626646|NCT05808231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626648|NCT05808231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92538971|NCT00009230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538972|NCT00009230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92538973|NCT00009230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351798|NCT03589326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626649|NCT05808231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92626650|NCT05808231|Analgesics|analgesics|mesh-ancestor
92626651|NCT05808231|Sensory System Agents|sensory system agents|mesh-ancestor
92626652|NCT05808192|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92626653|NCT05808192|Immunologic Factors|immunologic factors|mesh-ancestor
92626654|NCT05808192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626655|NCT05808049|Antioxidants|antioxidants|mesh-list
92626656|NCT05808049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626657|NCT05808049|Protective Agents|protective agents|mesh-ancestor
92626658|NCT05808049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626659|NCT05807945|Ropivacaine|ropivacaine|mesh-list
92626660|NCT05807945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92626661|NCT05807945|Anesthetics, Local|anesthetics, local|mesh-ancestor
92626662|NCT05807945|Anesthetics|anesthetics|mesh-ancestor
92626663|NCT05807945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626664|NCT05807945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626665|NCT05807945|Sensory System Agents|sensory system agents|mesh-ancestor
92626666|NCT05807945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626667|NCT05807893|Bevacizumab|bevacizumab|mesh-list
92626668|NCT05807893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626669|NCT05807893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626670|NCT05807893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92626671|NCT05807893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92626672|NCT05807893|Growth Substances|growth substances|mesh-ancestor
92626673|NCT05807893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626674|NCT05807893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92626675|NCT05807880|Capecitabine|capecitabine|mesh-list
92626676|NCT05807880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92626677|NCT05807880|Antimetabolites|antimetabolites|mesh-ancestor
92626678|NCT05807880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626679|NCT05807880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626680|NCT05807776|Lenvatinib|lenvatinib|mesh-list
92626681|NCT05807776|Tislelizumab|tislelizumab|mesh-list
92626682|NCT05807776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626683|NCT05807776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92626684|NCT05807776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626685|NCT05807776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626686|NCT05807776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626687|NCT05807711|Vitamin B 12|vitamin b 12|mesh-list
92626688|NCT05807711|Vitamin B Complex|vitamin b complex|mesh-ancestor
92626689|NCT05807711|Vitamins|vitamins|mesh-ancestor
92626690|NCT05807711|Micronutrients|micronutrients|mesh-ancestor
92626691|NCT05807711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626692|NCT05807659|Busulfan|busulfan|mesh-list
92626693|NCT05807659|Alkylating Agents|alkylating agents|mesh-ancestor
92626694|NCT05807659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626695|NCT05807659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626696|NCT05807659|Immunologic Factors|immunologic factors|mesh-ancestor
92626697|NCT05807659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626698|NCT05807659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92626699|NCT05807659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626700|NCT05807659|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92626701|NCT05807542|Paclitaxel|paclitaxel|mesh-list
92626702|NCT05807542|Carboplatin|carboplatin|mesh-list
92626703|NCT05807542|Tislelizumab|tislelizumab|mesh-list
92626704|NCT05807542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92626705|NCT05807542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626706|NCT05807542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626707|NCT05807542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626708|NCT05807542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626709|NCT05807542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626710|NCT05807542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92626711|NCT05807503|Cerebrolysin|cerebrolysin|mesh-list
92626712|NCT05807503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92626713|NCT05807503|Protective Agents|protective agents|mesh-ancestor
92626714|NCT05807503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626715|NCT05807503|Nootropic Agents|nootropic agents|mesh-ancestor
92626716|NCT05807425|Polidocanol|polidocanol|mesh-list
92538974|NCT00009230|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92538975|NCT00009230|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92538976|NCT00009230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92538977|NCT00009230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538978|NCT00009581|Acetylcholine|acetylcholine|mesh-list
91974038|NCT04939779|Delpazolid|delpazolid|mesh-list
92626717|NCT05807425|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92626718|NCT05807425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92626719|NCT05807347|Cytarabine|cytarabine|mesh-list
92626724|NCT05807347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92626726|NCT05807347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626727|NCT05807347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626728|NCT05807347|Antiviral Agents|antiviral agents|mesh-ancestor
92626729|NCT05807347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626730|NCT05807347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626731|NCT05807347|Immunologic Factors|immunologic factors|mesh-ancestor
92626732|NCT05807347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626733|NCT05807347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626734|NCT05807347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92626735|NCT05807347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92626736|NCT05807165|Memantine|memantine|mesh-list
92626737|NCT05807165|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92626738|NCT05807165|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92626739|NCT05807165|Dopamine Agents|dopamine agents|mesh-ancestor
92626740|NCT05807165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626741|NCT05807165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626742|NCT05807165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626743|NCT05807165|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92626744|NCT05807165|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92626745|NCT05807100|Salicylic Acid|salicylic acid|mesh-list
92626746|NCT05807100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626747|NCT05807100|Antifungal Agents|antifungal agents|mesh-ancestor
92626748|NCT05807100|Keratolytic Agents|keratolytic agents|mesh-ancestor
92626749|NCT05807100|Dermatologic Agents|dermatologic agents|mesh-ancestor
92626750|NCT05807035|Vaccines|vaccines|mesh-list
92626751|NCT05807035|Immunologic Factors|immunologic factors|mesh-ancestor
92626752|NCT05807035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626753|NCT05781698|Mesalamine|mesalamine|mesh-list
92626754|NCT05781698|Fenofibrate|fenofibrate|mesh-list
92626755|NCT05781698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92626756|NCT05781698|Antimetabolites|antimetabolites|mesh-ancestor
92626757|NCT05781698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626758|NCT05781698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92626759|NCT05781698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92626760|NCT05781698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92626761|NCT05781698|Analgesics|analgesics|mesh-ancestor
92626762|NCT05781698|Sensory System Agents|sensory system agents|mesh-ancestor
92626763|NCT05781698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626764|NCT05781698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626765|NCT05781698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626766|NCT05781698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626767|NCT05709509|Aspirin|aspirin|mesh-list
92626768|NCT05709509|Colchicine|colchicine|mesh-list
92626769|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92626770|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92626771|NCT05709509|Analgesics|analgesics|mesh-ancestor
92626772|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
92626773|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626774|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626775|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626776|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626777|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92626778|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92626779|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626780|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92626781|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92626782|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626783|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
92626784|NCT05709509|Gout Suppressants|gout suppressants|mesh-ancestor
92538979|NCT00009581|Vasodilator Agents|vasodilator agents|mesh-ancestor
92538980|NCT00009581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92538981|NCT00009581|Cholinergic Agents|cholinergic agents|mesh-ancestor
92538982|NCT00009581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92538983|NCT00009581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626785|NCT05709509|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626786|NCT05709509|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626787|NCT05709509|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626788|NCT05709509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626789|NCT05693844|Paclitaxel|paclitaxel|mesh-list
92626790|NCT05693844|Cyclophosphamide|cyclophosphamide|mesh-list
92626791|NCT05693844|Fludarabine|fludarabine|mesh-list
92351947|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
92626799|NCT05693844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626800|NCT05693844|Immunologic Factors|immunologic factors|mesh-ancestor
92626801|NCT05693844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626802|NCT05693844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626803|NCT05693844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92626804|NCT05693844|Alkylating Agents|alkylating agents|mesh-ancestor
92626805|NCT05693844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92626807|NCT05690698|Haloperidol decanoate|haloperidol decanoate|mesh-list
92626808|NCT05690698|Antiemetics|antiemetics|mesh-ancestor
92626809|NCT05690698|Autonomic Agents|autonomic agents|mesh-ancestor
92626810|NCT05690698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626811|NCT05690698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626812|NCT05690698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92626813|NCT05690698|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92626814|NCT05690698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92626815|NCT05690698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626816|NCT05690698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626817|NCT05690698|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92626818|NCT05690698|Dopamine Agents|dopamine agents|mesh-ancestor
92626819|NCT05690698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626820|NCT05690698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626821|NCT05690698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92626822|NCT05674513|Ulipristal acetate|ulipristal acetate|mesh-list
92626823|NCT05674513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92626824|NCT05674513|Contraceptive Agents|contraceptive agents|mesh-ancestor
92626825|NCT05674513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92626826|NCT05674513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626827|NCT05674513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92626828|NCT05644340|Methamphetamine|methamphetamine|mesh-list
92626829|NCT05644340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92626830|NCT05644340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626831|NCT05644340|Sympathomimetics|sympathomimetics|mesh-ancestor
92626832|NCT05644340|Autonomic Agents|autonomic agents|mesh-ancestor
92626833|NCT05644340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626834|NCT05644340|Dopamine Agents|dopamine agents|mesh-ancestor
92626835|NCT05644340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626836|NCT05644340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626837|NCT05644340|Adrenergic Agents|adrenergic agents|mesh-ancestor
92626838|NCT05644340|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92626839|NCT05644340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92626840|NCT05644340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626841|NCT05644340|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92626842|NCT05630872|Lamivudine|lamivudine|mesh-list
92626843|NCT05630872|Dolutegravir|dolutegravir|mesh-list
92626844|NCT05630872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92626845|NCT05630872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626846|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626847|NCT05630872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626848|NCT05630872|Antiviral Agents|antiviral agents|mesh-ancestor
92626849|NCT05630872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626850|NCT05630872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92626851|NCT05630872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92626852|NCT05630872|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92626853|NCT05630872|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92626854|NCT05627947|Cyclosporine|cyclosporine|mesh-list
92626855|NCT05627947|Mitomycins|mitomycins|mesh-list
92626856|NCT05627947|Mitomycin|mitomycin|mesh-list
92538984|NCT00009581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538985|NCT00009620|Phenobarbital|phenobarbital|mesh-list
92626857|NCT05627947|Cyclosporins|cyclosporins|mesh-list
92626858|NCT05627947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033825|NCT02141295|Leucovorin|leucovorin|mesh-list
92626863|NCT05627947|Antifungal Agents|antifungal agents|mesh-ancestor
92626864|NCT05627947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626865|NCT05627947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92626866|NCT05627947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626867|NCT05627947|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92626868|NCT05627947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92626869|NCT05627947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626870|NCT05627947|Alkylating Agents|alkylating agents|mesh-ancestor
92626871|NCT05627947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92626872|NCT05617118|Baclofen|baclofen|mesh-list
92626873|NCT05617118|Botulinum Toxins|botulinum toxins|mesh-list
92626874|NCT05617118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92626875|NCT05617118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92626876|NCT05617118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92626877|NCT05617118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626878|NCT05617118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626880|NCT05617118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626881|NCT05617118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626882|NCT05617118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92626883|NCT05617118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626884|NCT05617118|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92626885|NCT05617118|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92626886|NCT05617118|GABA Agonists|gaba agonists|mesh-ancestor
92626887|NCT05617118|GABA Agents|gaba agents|mesh-ancestor
92626888|NCT05606341|1018 oligonucleotide|1018 oligonucleotide|mesh-list
92626889|NCT05606341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92626890|NCT05606341|Immunologic Factors|immunologic factors|mesh-ancestor
92626891|NCT05606341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626892|NCT05591105|Acetaminophen|acetaminophen|mesh-list
92626893|NCT05591105|Dipyrone|dipyrone|mesh-list
92626894|NCT05591105|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92626895|NCT05591105|Lidocaine|lidocaine|mesh-list
92626896|NCT05591105|Ketamine|ketamine|mesh-list
92626897|NCT05591105|Morphine|morphine|mesh-list
92626898|NCT05591105|Anesthetics, Local|anesthetics, local|mesh-ancestor
92626899|NCT05591105|Anesthetics|anesthetics|mesh-ancestor
92626900|NCT05591105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626901|NCT05591105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626902|NCT05591105|Sensory System Agents|sensory system agents|mesh-ancestor
92626903|NCT05591105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626904|NCT05591105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92626905|NCT05591105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92626906|NCT05591105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92626907|NCT05591105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626908|NCT05591105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626909|NCT05591105|Analgesics|analgesics|mesh-ancestor
92626910|NCT05591105|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92626911|NCT05591105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92626912|NCT05591105|Anesthetics, General|anesthetics, general|mesh-ancestor
92626913|NCT05591105|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92626914|NCT05591105|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92626915|NCT05591105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626916|NCT05591105|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92626917|NCT05591105|Narcotics|narcotics|mesh-ancestor
92626918|NCT05591105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92626919|NCT05591105|Antipyretics|antipyretics|mesh-ancestor
92626920|NCT05591105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92626921|NCT05591105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626922|NCT05591105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626924|NCT05550662|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92626925|NCT05550662|Anesthetics, General|anesthetics, general|mesh-ancestor
92626926|NCT05550662|Anesthetics|anesthetics|mesh-ancestor
92626927|NCT05550662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626928|NCT05550662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626929|NCT05546658|Psilocybin|psilocybin|mesh-list
92626930|NCT05546658|Hallucinogens|hallucinogens|mesh-ancestor
92626932|NCT05546658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626933|NCT05494580|Pamiparib|pamiparib|mesh-list
92626934|NCT05494580|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92626935|NCT05494580|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92538986|NCT00009620|Anticonvulsants|anticonvulsants|mesh-ancestor
92538987|NCT00009620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92538988|NCT00009620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538989|NCT00009620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974296|NCT03238625|Lidocaine|lidocaine|mesh-list
92626936|NCT05494580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92626937|NCT05494580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626938|NCT05494580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626939|NCT05494580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626940|NCT05464654|Estrogens|estrogens|mesh-list
92626941|NCT05464654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92626942|NCT05464654|Hormones|hormones|mesh-ancestor
92626943|NCT05464654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626944|NCT05464654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626945|NCT05352516|Denosumab|denosumab|mesh-list
92626946|NCT05352516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92626947|NCT05352516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626948|NCT05280704|Lidocaine|lidocaine|mesh-list
92626949|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
92626950|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
92626951|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626952|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626953|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
92626954|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626955|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92626956|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92626957|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92626958|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626959|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626960|NCT05267873|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92626961|NCT05267873|Vortioxetine|vortioxetine|mesh-list
92626962|NCT05267873|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92626963|NCT05267873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92626964|NCT05267873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92626965|NCT05267873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626966|NCT05267873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626967|NCT05267873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626968|NCT05267873|Analgesics|analgesics|mesh-ancestor
92626969|NCT05267873|Sensory System Agents|sensory system agents|mesh-ancestor
92626970|NCT05267873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626971|NCT05267873|Antidepressive Agents|antidepressive agents|mesh-ancestor
92626972|NCT05267873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92626973|NCT05267873|Dopamine Agents|dopamine agents|mesh-ancestor
92626974|NCT05267873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92626975|NCT05267873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92626976|NCT05267873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626977|NCT05267873|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92626978|NCT05267873|Serotonin Agents|serotonin agents|mesh-ancestor
92626979|NCT05267873|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92626980|NCT05267873|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92626981|NCT05267873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92626982|NCT05267873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92626983|NCT05113901|Methylprednisolone|methylprednisolone|mesh-list
92626984|NCT05113901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92626985|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92626986|NCT05113901|Prednisolone|prednisolone|mesh-list
92626987|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
92626988|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92626989|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
92626990|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92626991|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
92626992|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
92626993|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92626994|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626995|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92626996|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
92626997|NCT05113901|Hormones|hormones|mesh-ancestor
92752322|NCT05940896|Immunologic Factors|immunologic factors|mesh-ancestor
92538990|NCT00009620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92538991|NCT00009620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92538992|NCT00009620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92626998|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92626999|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92627000|NCT05113901|Protective Agents|protective agents|mesh-ancestor
92033968|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
92627004|NCT05075603|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92627005|NCT05075603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627006|NCT05075603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627007|NCT05065216|Kallikreins|kallikreins|mesh-list
92627008|NCT05065216|Coagulants|coagulants|mesh-ancestor
92627009|NCT05065216|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92627010|NCT05065216|Fertility Agents|fertility agents|mesh-ancestor
92627011|NCT05065216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92627012|NCT05065216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627013|NCT05024214|Sunitinib|sunitinib|mesh-list
92627014|NCT05024214|Lenvatinib|lenvatinib|mesh-list
92627015|NCT05024214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627016|NCT05024214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627017|NCT05024214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92627018|NCT05024214|Growth Substances|growth substances|mesh-ancestor
92627019|NCT05024214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627020|NCT05024214|Growth Inhibitors|growth inhibitors|mesh-ancestor
92627021|NCT05024214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627022|NCT05024214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352169|NCT01674504|Montelukast|montelukast|mesh-list
92627023|NCT05024214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627024|NCT05018091|Dexamethasone|dexamethasone|mesh-list
92627025|NCT05018091|Dexamethasone acetate|dexamethasone acetate|mesh-list
92627026|NCT05018091|BB 1101|bb 1101|mesh-list
92627027|NCT05018091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627028|NCT05018091|Antiemetics|antiemetics|mesh-ancestor
92627029|NCT05018091|Autonomic Agents|autonomic agents|mesh-ancestor
92627030|NCT05018091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627031|NCT05018091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627032|NCT05018091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92627033|NCT05018091|Glucocorticoids|glucocorticoids|mesh-ancestor
92627034|NCT05018091|Hormones|hormones|mesh-ancestor
92627035|NCT05018091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627036|NCT05018091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627037|NCT05018091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627038|NCT05018091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92627039|NCT05018091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627040|NCT05018091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627041|NCT04999644|Nicotine|nicotine|mesh-list
92627042|NCT04999644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92627043|NCT04999644|Autonomic Agents|autonomic agents|mesh-ancestor
92627044|NCT04999644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627045|NCT04999644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627046|NCT04999644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92627047|NCT04999644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92627048|NCT04999644|Cholinergic Agents|cholinergic agents|mesh-ancestor
92627049|NCT04999644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627050|NCT04999644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627051|NCT04962503|Afamelanotide|afamelanotide|mesh-list
92627052|NCT04962503|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627053|NCT04916080|Acetylcysteine|acetylcysteine|mesh-list
92627054|NCT04916080|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92627055|NCT04916080|Antiviral Agents|antiviral agents|mesh-ancestor
92627056|NCT04916080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627057|NCT04916080|Expectorants|expectorants|mesh-ancestor
92627058|NCT04916080|Respiratory System Agents|respiratory system agents|mesh-ancestor
92627059|NCT04916080|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92627060|NCT04916080|Antioxidants|antioxidants|mesh-ancestor
92627061|NCT04916080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627062|NCT04916080|Protective Agents|protective agents|mesh-ancestor
92627063|NCT04916080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627064|NCT04916080|Antidotes|antidotes|mesh-ancestor
92627065|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92627066|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92627067|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538993|NCT00009620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92538994|NCT00009620|GABA Modulators|gaba modulators|mesh-ancestor
92538995|NCT00009620|GABA Agents|gaba agents|mesh-ancestor
92627068|NCT04833140|Estradiol|estradiol|mesh-list
92627069|NCT04833140|Estrogens|estrogens|mesh-ancestor
92627070|NCT04833140|Hormones|hormones|mesh-ancestor
92627071|NCT04833140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034038|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627074|NCT04826562|Dolutegravir|dolutegravir|mesh-list
92627075|NCT04826562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92627076|NCT04826562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92627077|NCT04826562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627078|NCT04826562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627079|NCT04826562|Antiviral Agents|antiviral agents|mesh-ancestor
92627080|NCT04826562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627081|NCT04826562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92627082|NCT04826562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92627083|NCT04826562|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92627084|NCT04826562|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92627085|NCT04778618|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92627086|NCT04778618|Immunologic Factors|immunologic factors|mesh-ancestor
92627087|NCT04778618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627088|NCT04778618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627089|NCT04767841|Metformin|metformin|mesh-list
92627090|NCT04767841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92627091|NCT04767841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627092|NCT04761861|Vildagliptin|vildagliptin|mesh-list
92627093|NCT04761861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92627094|NCT04761861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627095|NCT04761861|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92627096|NCT04761861|Protease Inhibitors|protease inhibitors|mesh-ancestor
92627097|NCT04761861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352246|NCT03150576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627098|NCT04761861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627099|NCT04716699|Lidocaine|lidocaine|mesh-list
92627100|NCT04716699|Anesthetics, Local|anesthetics, local|mesh-ancestor
92627101|NCT04716699|Anesthetics|anesthetics|mesh-ancestor
92627102|NCT04716699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92627103|NCT04716699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627104|NCT04716699|Sensory System Agents|sensory system agents|mesh-ancestor
92627105|NCT04716699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627106|NCT04716699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92627107|NCT04716699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92627108|NCT04716699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92627109|NCT04716699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92627110|NCT04716699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627111|NCT04691817|Atezolizumab|atezolizumab|mesh-list
92627112|NCT04691817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627113|NCT04691817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627114|NCT04691817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627115|NCT04691817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627116|NCT04685980|Morphine|morphine|mesh-list
92627117|NCT04685980|Anesthetics|anesthetics|mesh-list
92627118|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
92627119|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92627120|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627121|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92627122|NCT04685980|Narcotics|narcotics|mesh-ancestor
92627123|NCT04685980|Analgesics|analgesics|mesh-ancestor
92627124|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
92627125|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627126|NCT04657692|Anesthetics|anesthetics|mesh-list
92627127|NCT04657692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92627128|NCT04657692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627129|NCT04577690|Epinephrine|epinephrine|mesh-list
92627130|NCT04577690|Racepinephrine|racepinephrine|mesh-list
92627131|NCT04577690|Bupivacaine|bupivacaine|mesh-list
92627132|NCT04577690|Epinephryl borate|epinephryl borate|mesh-list
92627133|NCT04577690|Anesthetics, Local|anesthetics, local|mesh-ancestor
92627134|NCT04577690|Anesthetics|anesthetics|mesh-ancestor
92627135|NCT04577690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92627136|NCT04577690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92538996|NCT00009620|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92538997|NCT00009620|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92627137|NCT04577690|Sensory System Agents|sensory system agents|mesh-ancestor
92627138|NCT04577690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627139|NCT04577690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92627140|NCT04577690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92627141|NCT04577690|Adrenergic Agents|adrenergic agents|mesh-ancestor
92627142|NCT04577690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034108|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627144|NCT04577690|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92627145|NCT04577690|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92627146|NCT04577690|Autonomic Agents|autonomic agents|mesh-ancestor
92627147|NCT04577690|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92627148|NCT04577690|Respiratory System Agents|respiratory system agents|mesh-ancestor
92627149|NCT04577690|Mydriatics|mydriatics|mesh-ancestor
92627150|NCT04577690|Sympathomimetics|sympathomimetics|mesh-ancestor
92627151|NCT04577690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92627152|NCT04531176|Liraglutide|liraglutide|mesh-list
92627154|NCT04531176|Orlistat|orlistat|mesh-list
92627155|NCT04531176|Phentermine|phentermine|mesh-list
92627156|NCT04531176|Naltrexone|naltrexone|mesh-list
92627157|NCT04531176|Bupropion|bupropion|mesh-list
92627158|NCT04531176|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92627159|NCT04531176|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92627160|NCT04531176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627161|NCT04531176|Sensory System Agents|sensory system agents|mesh-ancestor
92627162|NCT04531176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627163|NCT04531176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92627164|NCT04531176|Incretins|incretins|mesh-ancestor
92627165|NCT04531176|Hormones|hormones|mesh-ancestor
92627166|NCT04531176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627167|NCT04531176|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92627168|NCT04531176|Antidepressive Agents|antidepressive agents|mesh-ancestor
92627169|NCT04531176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92627170|NCT04531176|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92627171|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92352333|NCT03875664|Bupivacaine|bupivacaine|mesh-list
92627172|NCT04531176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92627173|NCT04531176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627174|NCT04531176|Dopamine Agents|dopamine agents|mesh-ancestor
92627175|NCT04531176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627176|NCT04531176|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92627177|NCT04531176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92627178|NCT04531176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627179|NCT04531176|Anticonvulsants|anticonvulsants|mesh-ancestor
92627180|NCT04531176|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92627181|NCT04531176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92627182|NCT04531176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92627183|NCT04531176|Appetite Depressants|appetite depressants|mesh-ancestor
92627184|NCT04531176|Sympathomimetics|sympathomimetics|mesh-ancestor
92627185|NCT04531176|Autonomic Agents|autonomic agents|mesh-ancestor
92627186|NCT04531176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92627188|NCT04472767|Ipilimumab|ipilimumab|mesh-list
92627189|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627190|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627191|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627192|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627193|NCT04456946|Salicylic Acid|salicylic acid|mesh-list
92627194|NCT04456946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627195|NCT04456946|Antifungal Agents|antifungal agents|mesh-ancestor
92627196|NCT04456946|Keratolytic Agents|keratolytic agents|mesh-ancestor
92627197|NCT04456946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627198|NCT04409860|Paclitaxel|paclitaxel|mesh-list
92627199|NCT04409860|Cisplatin|cisplatin|mesh-list
92627200|NCT04409860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627201|NCT04409860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627202|NCT04409860|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627203|NCT04409860|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627204|NCT04409860|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627205|NCT04409860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627206|NCT04311099|Ropivacaine|ropivacaine|mesh-list
92627207|NCT04311099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92627208|NCT04311099|Anesthetics|anesthetics|mesh-ancestor
92627209|NCT04311099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92538998|NCT00009620|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92538999|NCT00009659|Ulipristal acetate|ulipristal acetate|mesh-list
92539000|NCT00009659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92539001|NCT00009659|Contraceptive Agents|contraceptive agents|mesh-ancestor
92539002|NCT00009659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92627210|NCT04311099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627211|NCT04311099|Sensory System Agents|sensory system agents|mesh-ancestor
92627212|NCT04311099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627213|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92627214|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
92627215|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627216|NCT04303390|Cefazolin|cefazolin|mesh-list
92627217|NCT04303390|Cefuroxime|cefuroxime|mesh-list
92627231|NCT04075110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627233|NCT04075110|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92627234|NCT04075110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92627235|NCT04075110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627236|NCT04055909|Nangibotide|nangibotide|mesh-list
92627237|NCT04055909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627238|NCT03978689|Pembrolizumab|pembrolizumab|mesh-list
92627239|NCT03978689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627240|NCT03978689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627241|NCT03978689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627242|NCT03978689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627243|NCT03910387|Paclitaxel|paclitaxel|mesh-list
92627244|NCT03910387|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92627245|NCT03910387|Gemcitabine|gemcitabine|mesh-list
92627246|NCT03910387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627247|NCT03910387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627248|NCT03910387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627249|NCT03910387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627250|NCT03910387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627251|NCT03910387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627252|NCT03910387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627253|NCT03910387|Antimetabolites|antimetabolites|mesh-ancestor
92627254|NCT03861793|Pembrolizumab|pembrolizumab|mesh-list
92627255|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627256|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627257|NCT03861793|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627258|NCT03861793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627259|NCT03816553|Apatinib|apatinib|mesh-list
92627260|NCT03816553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627261|NCT03816553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627262|NCT03816553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627263|NCT03816553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627264|NCT03729245|Nivolumab|nivolumab|mesh-list
92627265|NCT03729245|Sunitinib|sunitinib|mesh-list
92627266|NCT03729245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627267|NCT03729245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627268|NCT03729245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627269|NCT03729245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627270|NCT03729245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627271|NCT03729245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92627272|NCT03729245|Growth Substances|growth substances|mesh-ancestor
92627273|NCT03729245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627274|NCT03729245|Growth Inhibitors|growth inhibitors|mesh-ancestor
92034253|NCT02100657|Hormones|hormones|mesh-ancestor
92627278|NCT03712397|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92627279|NCT03712397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627280|NCT03712397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627281|NCT03712397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627282|NCT03712397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627283|NCT03557918|Tremelimumab|tremelimumab|mesh-list
92627284|NCT03557918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627285|NCT03544099|Pembrolizumab|pembrolizumab|mesh-list
92627286|NCT03544099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627287|NCT03544099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539003|NCT00009659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539004|NCT00009659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92539005|NCT00009698|Aldesleukin|aldesleukin|mesh-list
92627288|NCT03544099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627289|NCT03544099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627290|NCT03528408|Nivolumab|nivolumab|mesh-list
92627291|NCT03528408|Ipilimumab|ipilimumab|mesh-list
92627292|NCT03528408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627293|NCT03528408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627294|NCT03528408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627295|NCT03528408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627296|NCT03527108|Nivolumab|nivolumab|mesh-list
92627297|NCT03527108|Ramucirumab|ramucirumab|mesh-list
92627298|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627299|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627300|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627301|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627302|NCT03501381|Aldesleukin|aldesleukin|mesh-list
92627303|NCT03501381|Interleukin-2|interleukin-2|mesh-list
92627304|NCT03501381|Entinostat|entinostat|mesh-list
92627305|NCT03501381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627306|NCT03501381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92627307|NCT03501381|Analgesics|analgesics|mesh-ancestor
92627308|NCT03501381|Sensory System Agents|sensory system agents|mesh-ancestor
92627309|NCT03501381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627310|NCT03501381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627311|NCT03501381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92627312|NCT03501381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92627313|NCT03501381|Antiviral Agents|antiviral agents|mesh-ancestor
92627314|NCT03501381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627315|NCT03501381|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92627316|NCT03501381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627317|NCT03501381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627318|NCT03478488|Gemcitabine|gemcitabine|mesh-list
92627319|NCT03478488|Oxaliplatin|oxaliplatin|mesh-list
92627320|NCT03478488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627321|NCT03478488|Antimetabolites|antimetabolites|mesh-ancestor
92627322|NCT03478488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627323|NCT03478488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627324|NCT03451331|Carboplatin|carboplatin|mesh-list
92627325|NCT03451331|Gemcitabine|gemcitabine|mesh-list
92627326|NCT03451331|Oxaliplatin|oxaliplatin|mesh-list
92627327|NCT03451331|Nivolumab|nivolumab|mesh-list
92627328|NCT03451331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627329|NCT03451331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627330|NCT03451331|Antimetabolites|antimetabolites|mesh-ancestor
92627331|NCT03451331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627332|NCT03451331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627333|NCT03451331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627334|NCT03412877|Aldesleukin|aldesleukin|mesh-list
92627335|NCT03412877|Cyclophosphamide|cyclophosphamide|mesh-list
92627336|NCT03412877|Pembrolizumab|pembrolizumab|mesh-list
92627337|NCT03412877|Fludarabine|fludarabine|mesh-list
92627338|NCT03412877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627339|NCT03412877|Immunologic Factors|immunologic factors|mesh-ancestor
92627340|NCT03412877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627341|NCT03412877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627342|NCT03412877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627343|NCT03412877|Alkylating Agents|alkylating agents|mesh-ancestor
92627344|NCT03412877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627345|NCT03412877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627346|NCT03412877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92627352|NCT03412877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627354|NCT03406299|Gemcitabine|gemcitabine|mesh-list
92627355|NCT03406299|Oxaliplatin|oxaliplatin|mesh-list
92627356|NCT03406299|Tegafur|tegafur|mesh-list
92627357|NCT03406299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627358|NCT03406299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627359|NCT03406299|Antimetabolites|antimetabolites|mesh-ancestor
92627360|NCT03406299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627361|NCT03406299|Antidotes|antidotes|mesh-ancestor
92627362|NCT03406299|Protective Agents|protective agents|mesh-ancestor
92539006|NCT00009698|Interleukin-2|interleukin-2|mesh-list
92539007|NCT00009698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539008|NCT00009698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92539009|NCT00009698|Analgesics|analgesics|mesh-ancestor
92539010|NCT00009698|Sensory System Agents|sensory system agents|mesh-ancestor
92539011|NCT00009698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539012|NCT00009698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539013|NCT00009698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92539014|NCT00009698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92539015|NCT00009698|Antiviral Agents|antiviral agents|mesh-ancestor
92539016|NCT00009698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539017|NCT01465893|Vitamin D|vitamin d|mesh-list
92539018|NCT01465893|Ergocalciferols|ergocalciferols|mesh-list
92539019|NCT01465893|Cholecalciferol|cholecalciferol|mesh-list
92539020|NCT01465893|Vitamins|vitamins|mesh-list
92539021|NCT01465893|Micronutrients|micronutrients|mesh-ancestor
92539022|NCT01465893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539023|NCT01465893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92539024|NCT01465893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92539026|NCT00009776|Paclitaxel|paclitaxel|mesh-list
92539027|NCT00009776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92539028|NCT00009776|Antibodies|antibodies|mesh-list
92539029|NCT00009776|Immunoglobulins|immunoglobulins|mesh-list
92539030|NCT00009776|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92539031|NCT00009776|Cyclosporins|cyclosporins|mesh-list
92539032|NCT00009776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539033|NCT00009776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539034|NCT00009776|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539035|NCT00009776|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627363|NCT03406299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627364|NCT03406299|Vitamin B Complex|vitamin b complex|mesh-ancestor
92627365|NCT03406299|Vitamins|vitamins|mesh-ancestor
92627366|NCT03406299|Micronutrients|micronutrients|mesh-ancestor
92627367|NCT03396445|Paclitaxel|paclitaxel|mesh-list
92627368|NCT03396445|Carboplatin|carboplatin|mesh-list
92627369|NCT03396445|Pembrolizumab|pembrolizumab|mesh-list
92627370|NCT03396445|Pemetrexed|pemetrexed|mesh-list
92627371|NCT03396445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627372|NCT03396445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627373|NCT03396445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627374|NCT03396445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627375|NCT03396445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627376|NCT03396445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627377|NCT03396445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627378|NCT03396445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627379|NCT03396445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627380|NCT03396445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92627381|NCT03396445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92627382|NCT03385655|Carboplatin|carboplatin|mesh-list
92627383|NCT03385655|Durvalumab|durvalumab|mesh-list
92539036|NCT00009776|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539037|NCT00009776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539038|NCT00009776|Immunologic Factors|immunologic factors|mesh-ancestor
92539039|NCT00009776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539040|NCT00009776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539041|NCT00009776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539042|NCT00009776|Antifungal Agents|antifungal agents|mesh-ancestor
92539043|NCT00009776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539044|NCT00009776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92539045|NCT00009776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539046|NCT00009776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92539048|NCT00009815|Etoposide|etoposide|mesh-list
92539049|NCT00009815|Tegafur|tegafur|mesh-list
92539050|NCT00009815|Calcium|calcium|mesh-list
92539051|NCT00009815|Levoleucovorin|levoleucovorin|mesh-list
92539052|NCT00009815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92539053|NCT00009815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539054|NCT00009815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539055|NCT00009815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539091|NCT00009893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92539092|NCT00009893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539093|NCT00009893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539094|NCT00009893|Immunologic Factors|immunologic factors|mesh-ancestor
92539095|NCT00009893|Antidotes|antidotes|mesh-ancestor
92539096|NCT00009893|Protective Agents|protective agents|mesh-ancestor
92539097|NCT00009893|Vitamin B Complex|vitamin b complex|mesh-ancestor
92539098|NCT00009893|Vitamins|vitamins|mesh-ancestor
92539099|NCT00009893|Micronutrients|micronutrients|mesh-ancestor
92539100|NCT00009971|Fenretinide|fenretinide|mesh-list
92539101|NCT00009971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539102|NCT00009971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92539103|NCT00009971|Protective Agents|protective agents|mesh-ancestor
92539104|NCT00009971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539155|NCT00010166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539156|NCT00010166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539157|NCT01465152|Metformin|metformin|mesh-list
92539158|NCT01465152|Repaglinide|repaglinide|mesh-list
92539159|NCT01465152|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92539160|NCT01465152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539161|NCT01465113|Vitamin D|vitamin d|mesh-list
92539162|NCT01465113|Ergocalciferols|ergocalciferols|mesh-list
92539163|NCT01465113|Cholecalciferol|cholecalciferol|mesh-list
92539164|NCT01465113|Vitamins|vitamins|mesh-list
92539165|NCT01465113|Metformin|metformin|mesh-list
92539166|NCT01465113|Omeprazole|omeprazole|mesh-list
92539167|NCT01465113|Micronutrients|micronutrients|mesh-ancestor
92539168|NCT01465113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539169|NCT01465113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92539170|NCT01465113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92539171|NCT01465113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92539172|NCT01465113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92539173|NCT01465113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92263925|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92539174|NCT01465113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92539175|NCT01465113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539177|NCT01465074|Nicotine|nicotine|mesh-list
92539206|NCT00010322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539207|NCT00010361|Cyclosporine|cyclosporine|mesh-list
92539208|NCT00010361|Mycophenolic Acid|mycophenolic acid|mesh-list
92539209|NCT00010361|Fludarabine|fludarabine|mesh-list
92539210|NCT00010361|Cyclosporins|cyclosporins|mesh-list
92539211|NCT00010361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539212|NCT00010361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539213|NCT00010361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539214|NCT00010361|Immunologic Factors|immunologic factors|mesh-ancestor
92539215|NCT00010361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539216|NCT00010361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539270|NCT01464606|Alkylating Agents|alkylating agents|mesh-ancestor
92539271|NCT01464606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539272|NCT01464606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539273|NCT01464606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92539274|NCT01464606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539275|NCT01464606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539276|NCT01464606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539277|NCT01464606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539278|NCT01464606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539279|NCT01464606|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539280|NCT01464606|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539281|NCT01464606|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539282|NCT01464606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539283|NCT01464606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539284|NCT01464606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92539285|NCT01464606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92539286|NCT01464528|Hyaluronic Acid|hyaluronic acid|mesh-list
92539287|NCT01464528|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92539288|NCT01464528|Immunologic Factors|immunologic factors|mesh-ancestor
92539289|NCT01464528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539290|NCT01464528|Viscosupplements|viscosupplements|mesh-ancestor
92539291|NCT01464528|Protective Agents|protective agents|mesh-ancestor
92539292|NCT00393744|Amoxicillin|amoxicillin|mesh-list
92539293|NCT00393744|Pristinamycin|pristinamycin|mesh-list
92539294|NCT00393744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539295|NCT00393744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539296|NCT00011297|Gabapentin|gabapentin|mesh-list
92539319|NCT00011375|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539320|NCT00011375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539321|NCT00011375|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92539322|NCT00011375|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92539323|NCT00011375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539324|NCT00011375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539325|NCT00847938|Neostigmine|neostigmine|mesh-list
92539326|NCT00847938|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92539327|NCT00847938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539328|NCT00847938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539329|NCT00847938|Cholinergic Agents|cholinergic agents|mesh-ancestor
92539330|NCT00847938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539331|NCT00847938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539332|NCT00847938|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92539333|NCT00847938|Autonomic Agents|autonomic agents|mesh-ancestor
92539334|NCT00847938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539339|NCT00847860|Aspirin|aspirin|mesh-list
92539374|NCT00009932|Paclitaxel|paclitaxel|mesh-list
92539375|NCT00009932|Fenretinide|fenretinide|mesh-list
92539376|NCT00009932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539377|NCT00009932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539378|NCT00009932|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539379|NCT00009932|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539380|NCT00009932|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539381|NCT00009932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539382|NCT00009932|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92539383|NCT00009932|Protective Agents|protective agents|mesh-ancestor
92539384|NCT00009932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539385|NCT00847587|Contraceptive Agents|contraceptive agents|mesh-list
92539386|NCT00847587|Etonogestrel|etonogestrel|mesh-list
92539387|NCT00847587|Desogestrel|desogestrel|mesh-list
92539388|NCT00847587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92539389|NCT00847587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539390|NCT00847587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92539393|NCT00847587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92361834|NCT00609804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539431|NCT00011921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539432|NCT00011921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539433|NCT00011921|Alkylating Agents|alkylating agents|mesh-ancestor
92539434|NCT00011960|Paclitaxel|paclitaxel|mesh-list
92539435|NCT00011960|Cisplatin|cisplatin|mesh-list
92539436|NCT00011960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539437|NCT00011960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539438|NCT00011960|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539439|NCT00011960|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539440|NCT00011960|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539441|NCT00011960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539442|NCT00847314|Methyltestosterone|methyltestosterone|mesh-list
92539443|NCT00847314|Testosterone|testosterone|mesh-list
92539444|NCT00847314|Testosterone undecanoate|testosterone undecanoate|mesh-list
92539445|NCT00847314|Testosterone enanthate|testosterone enanthate|mesh-list
92539491|NCT00847080|Protease Inhibitors|protease inhibitors|mesh-ancestor
92539492|NCT00847080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539493|NCT00847080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539494|NCT00012194|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92539495|NCT00012194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539496|NCT00012194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92539497|NCT00012194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539498|NCT00012194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539499|NCT01818323|Immunomodulating Agents|immunomodulating agents|mesh-list
92539500|NCT01818323|Immunologic Factors|immunologic factors|mesh-ancestor
92539501|NCT01818323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539502|NCT00012311|Cyclophosphamide|cyclophosphamide|mesh-list
92539503|NCT00012311|Ifosfamide|ifosfamide|mesh-list
92539504|NCT00012311|Thiotepa|thiotepa|mesh-list
92539505|NCT00012311|Carboplatin|carboplatin|mesh-list
92539506|NCT00012311|Docetaxel|docetaxel|mesh-list
92539507|NCT00012311|Doxorubicin|doxorubicin|mesh-list
92539508|NCT00012311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92539509|NCT00012311|Fluorouracil|fluorouracil|mesh-list
92539510|NCT00012311|Methotrexate|methotrexate|mesh-list
92539511|NCT00012311|Etoposide|etoposide|mesh-list
92539512|NCT00012311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539513|NCT00012311|Immunologic Factors|immunologic factors|mesh-ancestor
92539514|NCT00012311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539515|NCT00012311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539516|NCT00012311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539517|NCT00012311|Alkylating Agents|alkylating agents|mesh-ancestor
92539538|NCT00847002|Laxatives|laxatives|mesh-ancestor
92539540|NCT00012350|Tipifarnib|tipifarnib|mesh-list
92539541|NCT00012350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539542|NCT00846963|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92539543|NCT00846963|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92539544|NCT00846963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92539545|NCT00012389|Oxaliplatin|oxaliplatin|mesh-list
92539546|NCT00012389|Irinotecan|irinotecan|mesh-list
92539547|NCT00012389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539548|NCT00012389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92539549|NCT00012389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539550|NCT00012389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539551|NCT00012389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539552|NCT00846885|Sumatriptan|sumatriptan|mesh-list
92539553|NCT00846885|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92539554|NCT00846885|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92539555|NCT00846885|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92539556|NCT00846885|Serotonin Agents|serotonin agents|mesh-ancestor
92539557|NCT00846885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539558|NCT00846885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539559|NCT00846885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539560|NCT00012467|Interferons|interferons|mesh-list
92539561|NCT00012467|Interferon-gamma|interferon-gamma|mesh-list
92539562|NCT00012467|Itraconazole|itraconazole|mesh-list
92539563|NCT00012467|Fluconazole|fluconazole|mesh-list
92539564|NCT00012467|Amphotericin B|amphotericin b|mesh-list
92539589|NCT00012506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92539590|NCT00012506|Analgesics|analgesics|mesh-ancestor
92539591|NCT00012506|Sensory System Agents|sensory system agents|mesh-ancestor
92539592|NCT00012506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539593|NCT00012506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539594|NCT00012506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92539595|NCT00012506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539596|NCT00012506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92539597|NCT00012506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539598|NCT00012506|Immunologic Factors|immunologic factors|mesh-ancestor
92539599|NCT00012584|Fluvoxamine|fluvoxamine|mesh-list
92539600|NCT00012584|Methylphenidate|methylphenidate|mesh-list
92539601|NCT00012584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92539602|NCT00012584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539603|NCT00012584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92539604|NCT00012584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92539605|NCT00012584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92539607|NCT00012584|Dopamine Agents|dopamine agents|mesh-ancestor
92539644|NCT00846690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92539645|NCT00846690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92539646|NCT00846690|Adrenergic Agents|adrenergic agents|mesh-ancestor
92539647|NCT00846690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539648|NCT00846690|Protective Agents|protective agents|mesh-ancestor
92539649|NCT00846651|Phenylephrine|phenylephrine|mesh-list
92539650|NCT00846651|Oxymetazoline|oxymetazoline|mesh-list
92539651|NCT00846651|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92539652|NCT00846651|Mydriatics|mydriatics|mesh-ancestor
92539653|NCT00846651|Autonomic Agents|autonomic agents|mesh-ancestor
92539654|NCT00846651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92539655|NCT00846651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539656|NCT00846651|Sympathomimetics|sympathomimetics|mesh-ancestor
92539657|NCT00846651|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92539658|NCT00846651|Nasal Decongestants|nasal decongestants|mesh-ancestor
92539659|NCT00846651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92539660|NCT00846651|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92539661|NCT00846651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92539662|NCT00846651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92539663|NCT00846651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92539664|NCT00846651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539665|NCT00846651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539666|NCT00846651|Protective Agents|protective agents|mesh-ancestor
92539667|NCT00846612|Bevacizumab|bevacizumab|mesh-list
92539668|NCT00846612|Doxorubicin|doxorubicin|mesh-list
92539669|NCT00846612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92539670|NCT00846612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539671|NCT00846612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92539672|NCT00846612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92539673|NCT00846612|Growth Substances|growth substances|mesh-ancestor
92539674|NCT00846612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539681|NCT00012857|Acetaminophen|acetaminophen|mesh-list
92539687|NCT00012857|Antipyretics|antipyretics|mesh-ancestor
92539688|NCT00394056|Paroxetine|paroxetine|mesh-list
92539689|NCT00394056|Vestipitant|vestipitant|mesh-list
92539690|NCT00394056|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92539691|NCT00394056|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92539692|NCT00394056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92539693|NCT00394056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539694|NCT00394056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92539695|NCT00394056|Serotonin Agents|serotonin agents|mesh-ancestor
92539696|NCT00394056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539697|NCT00394056|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92539698|NCT00394056|Antidepressive Agents|antidepressive agents|mesh-ancestor
92539699|NCT00394056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539700|NCT00394056|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92539701|NCT00394056|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92539702|NCT00394056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539703|NCT00394056|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92539704|NCT00846339|Bupropion|bupropion|mesh-list
92539705|NCT00846339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92539707|NCT00846339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92539739|NCT00845988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539740|NCT00845988|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92539741|NCT00845988|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92539742|NCT00845988|Serotonin Agents|serotonin agents|mesh-ancestor
92539743|NCT00845988|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92539744|NCT00845988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92539745|NCT00845988|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92539746|NCT00845988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92539748|NCT00845910|Docetaxel|docetaxel|mesh-list
92539749|NCT00845910|Capecitabine|capecitabine|mesh-list
92539750|NCT00845910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92539751|NCT00845910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539752|NCT00845910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92539753|NCT00845910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92539754|NCT00845910|Growth Substances|growth substances|mesh-ancestor
92539762|NCT00845910|Antimetabolites|antimetabolites|mesh-ancestor
92539797|NCT00013520|Protease Inhibitors|protease inhibitors|mesh-ancestor
92539798|NCT00013598|Pioglitazone|pioglitazone|mesh-list
92539799|NCT00013598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92539800|NCT00013598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539801|NCT00277017|Interferons|interferons|mesh-list
92539802|NCT00277017|Thalidomide|thalidomide|mesh-list
92539803|NCT00277017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539804|NCT00277017|Antiviral Agents|antiviral agents|mesh-ancestor
92539805|NCT00277017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539806|NCT00277017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539807|NCT00277017|Immunologic Factors|immunologic factors|mesh-ancestor
92539808|NCT00277017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539809|NCT00277017|Leprostatic Agents|leprostatic agents|mesh-ancestor
92539810|NCT00277017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539857|NCT00276783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92539858|NCT00276783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92539859|NCT00276705|Thalidomide|thalidomide|mesh-list
92539860|NCT00276705|Cyclophosphamide|cyclophosphamide|mesh-list
92539861|NCT00276705|Doxorubicin|doxorubicin|mesh-list
92539862|NCT00276705|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92539863|NCT00276705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92539864|NCT00276705|Immunologic Factors|immunologic factors|mesh-ancestor
92539865|NCT00276705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92539866|NCT00276705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92539867|NCT00276705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92539868|NCT00276705|Alkylating Agents|alkylating agents|mesh-ancestor
92539869|NCT00276705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539870|NCT00276705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539871|NCT00276705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92539872|NCT00276705|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92539873|NCT00276705|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92539874|NCT00276705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92539875|NCT00276705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539876|NCT00276705|Leprostatic Agents|leprostatic agents|mesh-ancestor
92539877|NCT00276705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92539878|NCT00276705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92539879|NCT00276705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92539880|NCT00276705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92539907|NCT00014144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92539908|NCT00014144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539909|NCT00276588|Paclitaxel|paclitaxel|mesh-list
92539910|NCT00276588|Carboplatin|carboplatin|mesh-list
92539911|NCT00276588|Gemcitabine|gemcitabine|mesh-list
92539912|NCT00276588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92539913|NCT00276588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539914|NCT00276588|Tubulin Modulators|tubulin modulators|mesh-ancestor
92539915|NCT00276588|Antimitotic Agents|antimitotic agents|mesh-ancestor
92539916|NCT00276588|Mitosis Modulators|mitosis modulators|mesh-ancestor
92539917|NCT00276588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92539918|NCT00276588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539919|NCT00276588|Antimetabolites|antimetabolites|mesh-ancestor
92264670|NCT02865135|Vaccines|vaccines|mesh-list
92539920|NCT00276549|Gemcitabine|gemcitabine|mesh-list
92539921|NCT00276549|Docetaxel|docetaxel|mesh-list
92539922|NCT00276549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92539923|NCT00276549|Antimetabolites|antimetabolites|mesh-ancestor
92539925|NCT00276549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92539965|NCT00014456|Antimetabolites|antimetabolites|mesh-ancestor
92540037|NCT00014729|Dermatologic Agents|dermatologic agents|mesh-ancestor
92540038|NCT00276198|Vitamin D|vitamin d|mesh-list
92540039|NCT00276198|Vitamin A|vitamin a|mesh-list
92540040|NCT00276198|Vitamins|vitamins|mesh-ancestor
92540041|NCT00276198|Micronutrients|micronutrients|mesh-ancestor
92540042|NCT00276198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540043|NCT00276198|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92540044|NCT00276081|Gabapentin|gabapentin|mesh-list
92540045|NCT00276081|Estrogens|estrogens|mesh-list
92540046|NCT00276081|Analgesics|analgesics|mesh-ancestor
92540047|NCT00276081|Sensory System Agents|sensory system agents|mesh-ancestor
92540048|NCT00276081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540049|NCT00276081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540050|NCT00276081|Anticonvulsants|anticonvulsants|mesh-ancestor
92540051|NCT00276081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92540052|NCT00276081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92540053|NCT00276081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92540054|NCT00276081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92540055|NCT00276081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92540056|NCT00276081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92540057|NCT00276081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540058|NCT00276081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540059|NCT00276081|Antimanic Agents|antimanic agents|mesh-ancestor
92540060|NCT00276081|Hormones|hormones|mesh-ancestor
92540061|NCT00276081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540086|NCT00015041|Buprenorphine|buprenorphine|mesh-list
92540087|NCT00015041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92540088|NCT00015041|Narcotics|narcotics|mesh-ancestor
92540089|NCT00015041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92540090|NCT00015041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540091|NCT00015041|Analgesics|analgesics|mesh-ancestor
92540092|NCT00015041|Sensory System Agents|sensory system agents|mesh-ancestor
92540093|NCT00015041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540094|NCT00015041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92540096|NCT00015080|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92540097|NCT00015080|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92540098|NCT00015080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540099|NCT00015080|Sensory System Agents|sensory system agents|mesh-ancestor
92540100|NCT00015080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540101|NCT00015236|Amantadine|amantadine|mesh-list
92540102|NCT00015236|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92540103|NCT00015236|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92540104|NCT00015236|Antiviral Agents|antiviral agents|mesh-ancestor
92540105|NCT00015236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540106|NCT00015236|Dopamine Agents|dopamine agents|mesh-ancestor
92540107|NCT00015236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540108|NCT00015236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540109|NCT00015236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540110|NCT00015236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92540111|NCT00015236|Analgesics|analgesics|mesh-ancestor
92540112|NCT00015236|Sensory System Agents|sensory system agents|mesh-ancestor
92540113|NCT00015236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540114|NCT00015275|Cocaine|cocaine|mesh-list
92540115|NCT00015275|Anesthetics, Local|anesthetics, local|mesh-ancestor
92540116|NCT00015275|Anesthetics|anesthetics|mesh-ancestor
92540117|NCT00015275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92540118|NCT00015275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947702|NCT03135795|Parecoxib|parecoxib|mesh-list
92627384|NCT03385655|Tremelimumab|tremelimumab|mesh-list
92627385|NCT03385655|Ipatasertib|ipatasertib|mesh-list
92627386|NCT03385655|Adavosertib|adavosertib|mesh-list
92627387|NCT03385655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627388|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627389|NCT03385655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627390|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627391|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540119|NCT00015275|Sensory System Agents|sensory system agents|mesh-ancestor
92540120|NCT00015275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540121|NCT00015275|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92540122|NCT00015275|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92540123|NCT00015275|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92540124|NCT00015275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540125|NCT00015275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540126|NCT00015275|Dopamine Agents|dopamine agents|mesh-ancestor
92540127|NCT00015275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540128|NCT00275730|Indomethacin|indomethacin|mesh-list
92540129|NCT00275730|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92540130|NCT00275730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92540131|NCT00275730|Analgesics|analgesics|mesh-ancestor
92540180|NCT00015548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540181|NCT00015548|Antidepressive Agents|antidepressive agents|mesh-ancestor
92540182|NCT00015548|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92540184|NCT00275535|Sirolimus|sirolimus|mesh-list
92540185|NCT00275535|Prednisone|prednisone|mesh-list
92540186|NCT00275535|Tacrolimus|tacrolimus|mesh-list
92540187|NCT00275535|Thymoglobulin|thymoglobulin|mesh-list
92540188|NCT00275535|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92540189|NCT00275535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540190|NCT00275535|Glucocorticoids|glucocorticoids|mesh-ancestor
92540191|NCT00275535|Hormones|hormones|mesh-ancestor
92540192|NCT00275535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540193|NCT00275535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540194|NCT00275535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92540195|NCT00275535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540196|NCT00275535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540197|NCT00275535|Immunologic Factors|immunologic factors|mesh-ancestor
92540198|NCT00275535|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92540199|NCT00275535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540200|NCT00275535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540201|NCT00275535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540202|NCT00275535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92540203|NCT00275535|Antitubercular Agents|antitubercular agents|mesh-ancestor
92540204|NCT00275535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92540205|NCT00275535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540206|NCT00275535|Antifungal Agents|antifungal agents|mesh-ancestor
92540207|NCT00015626|Metformin|metformin|mesh-list
92540208|NCT00015626|Pioglitazone|pioglitazone|mesh-list
92540209|NCT00015626|Rosiglitazone|rosiglitazone|mesh-list
92540210|NCT00015626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92540211|NCT00015626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540212|NCT00015665|Voriconazole|voriconazole|mesh-list
92540213|NCT00015665|Antifungal Agents|antifungal agents|mesh-ancestor
92627392|NCT03355469|Metformin|metformin|mesh-list
92540221|NCT00015665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540222|NCT00015665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540223|NCT00015665|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92540224|NCT00275457|Pramipexole|pramipexole|mesh-list
92540225|NCT00275457|Antioxidants|antioxidants|mesh-ancestor
92540226|NCT00275457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540227|NCT00275457|Protective Agents|protective agents|mesh-ancestor
92540228|NCT00275457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540229|NCT00275457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92540230|NCT00275457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92540231|NCT00275457|Dopamine Agonists|dopamine agonists|mesh-ancestor
92540232|NCT00275457|Dopamine Agents|dopamine agents|mesh-ancestor
92540233|NCT00275457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540234|NCT00015704|Aldesleukin|aldesleukin|mesh-list
92540240|NCT00275418|Beta Carotene|beta carotene|mesh-list
92540282|NCT00015860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540283|NCT00015860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540284|NCT00015860|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540285|NCT00015860|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540286|NCT00015860|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540287|NCT00015860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540288|NCT00015860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92540289|NCT00015860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540290|NCT00015860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540291|NCT00015860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540292|NCT00015860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540293|NCT00015899|Lonafarnib|lonafarnib|mesh-list
92540294|NCT00015899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540344|NCT00275106|Vitamin B Complex|vitamin b complex|mesh-ancestor
92540345|NCT00275106|Vitamins|vitamins|mesh-ancestor
92540346|NCT00275106|Micronutrients|micronutrients|mesh-ancestor
92540347|NCT00275106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540348|NCT00275106|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540349|NCT00275106|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540350|NCT00275106|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540351|NCT00015938|Docetaxel|docetaxel|mesh-list
92540352|NCT00015938|Vinorelbine|vinorelbine|mesh-list
92540353|NCT00015938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540354|NCT00015938|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540355|NCT00015938|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540356|NCT00015938|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540357|NCT00015938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627393|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92627394|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627395|NCT03330028|Diphenhydramine|diphenhydramine|mesh-list
92627396|NCT03330028|Promethazine|promethazine|mesh-list
92627397|NCT03330028|Dexamethasone|dexamethasone|mesh-list
92627398|NCT03330028|Paclitaxel|paclitaxel|mesh-list
92627399|NCT03330028|Cisplatin|cisplatin|mesh-list
92627400|NCT03330028|Mitomycins|mitomycins|mesh-list
92627401|NCT03330028|Mitomycin|mitomycin|mesh-list
92627402|NCT03330028|Famotidine|famotidine|mesh-list
92627403|NCT03330028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627404|NCT03330028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627405|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627406|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627407|NCT03330028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627408|NCT03330028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627409|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627410|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
92627411|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
92627412|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627413|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627414|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92627415|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
92627416|NCT03330028|Hormones|hormones|mesh-ancestor
92627417|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627418|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627419|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92627423|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92627424|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92627425|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92627426|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
92627427|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
92627428|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
92627429|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92627430|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
92627431|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
92627432|NCT03330028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627433|NCT03330028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92627434|NCT03330028|Antipruritics|antipruritics|mesh-ancestor
92627435|NCT03330028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627436|NCT03330028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92627437|NCT03330028|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92627438|NCT03324373|Everolimus|everolimus|mesh-list
92627439|NCT03324373|Lenvatinib|lenvatinib|mesh-list
92627440|NCT03324373|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92627441|NCT03324373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627442|NCT03324373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627443|NCT03324373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627444|NCT03324373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627445|NCT03324373|Immunologic Factors|immunologic factors|mesh-ancestor
92540358|NCT00015938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540359|NCT00275067|Temozolomide|temozolomide|mesh-list
92540360|NCT00275067|Arsenic Trioxide|arsenic trioxide|mesh-list
92540361|NCT00275067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540362|NCT00275067|Alkylating Agents|alkylating agents|mesh-ancestor
92540363|NCT00275067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540364|NCT00275067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540365|NCT00274989|Rituximab|rituximab|mesh-list
92540366|NCT00274989|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92540367|NCT00274989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92540368|NCT00274989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540369|NCT00274989|Immunologic Factors|immunologic factors|mesh-ancestor
92540370|NCT00274989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540371|NCT00274989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540372|NCT00274989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540373|NCT00274989|Alkylating Agents|alkylating agents|mesh-ancestor
92361861|NCT00610740|Gemcitabine|gemcitabine|mesh-list
92540374|NCT00274989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540375|NCT00015977|Interleukin-12|interleukin-12|mesh-list
92540376|NCT00015977|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92540413|NCT00274950|Ifosfamide|ifosfamide|mesh-list
92540414|NCT00274950|Bleomycin|bleomycin|mesh-list
92540415|NCT00274950|Vinblastine|vinblastine|mesh-list
92540416|NCT00274950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540417|NCT00274950|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540418|NCT00274950|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540419|NCT00274950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540420|NCT00274950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540421|NCT00274950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540422|NCT00274950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540423|NCT00274950|Alkylating Agents|alkylating agents|mesh-ancestor
92540424|NCT00274950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540425|NCT00274950|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540426|NCT00274950|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540427|NCT00274950|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540428|NCT00016016|Cytarabine|cytarabine|mesh-list
92540429|NCT00016016|Mitoxantrone|mitoxantrone|mesh-list
92540430|NCT00016016|Alvocidib|alvocidib|mesh-list
92540431|NCT00016016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540432|NCT00016016|Antimetabolites|antimetabolites|mesh-ancestor
92540433|NCT00016016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540434|NCT00016016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540435|NCT00016016|Antiviral Agents|antiviral agents|mesh-ancestor
92540436|NCT00016016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540437|NCT00016016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540438|NCT00016016|Immunologic Factors|immunologic factors|mesh-ancestor
92540439|NCT00016016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540440|NCT00016016|Analgesics|analgesics|mesh-ancestor
92540441|NCT00016016|Sensory System Agents|sensory system agents|mesh-ancestor
92540442|NCT00016016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540443|NCT00016016|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540444|NCT00016016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627446|NCT03324373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627447|NCT03324373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627448|NCT03311555|Docetaxel|docetaxel|mesh-list
92627449|NCT03311555|Androgens|androgens|mesh-list
92627450|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627451|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627452|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627453|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627454|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627455|NCT03311555|Hormones|hormones|mesh-ancestor
92627456|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627457|NCT03311555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540445|NCT00016016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540446|NCT00016016|Growth Inhibitors|growth inhibitors|mesh-ancestor
92540447|NCT00016016|Growth Substances|growth substances|mesh-ancestor
92540448|NCT00016016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92540449|NCT00130455|Escitalopram|escitalopram|mesh-list
92540450|NCT00130455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92540451|NCT00130455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92540452|NCT00130455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92540453|NCT00130455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540454|NCT00130455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540455|NCT00130455|Serotonin Agents|serotonin agents|mesh-ancestor
92540456|NCT00130455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540457|NCT00016055|Temozolomide|temozolomide|mesh-list
92540458|NCT00016055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540459|NCT00016055|Alkylating Agents|alkylating agents|mesh-ancestor
92540460|NCT00016055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540461|NCT00016055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540462|NCT00016094|Bevacizumab|bevacizumab|mesh-list
92540463|NCT00016094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92540464|NCT00016094|Antibodies|antibodies|mesh-list
92540498|NCT00016133|Protective Agents|protective agents|mesh-ancestor
92540499|NCT00016133|Vitamin B Complex|vitamin b complex|mesh-ancestor
92540500|NCT00016133|Vitamins|vitamins|mesh-ancestor
92540501|NCT00016133|Micronutrients|micronutrients|mesh-ancestor
92540502|NCT00016133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92540503|NCT00016172|Doxorubicin|doxorubicin|mesh-list
92540504|NCT00016172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92540505|NCT00016172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540506|NCT00016172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540507|NCT00016172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540508|NCT00016172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540509|NCT00016172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540510|NCT00016172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540511|NCT01470716|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92540512|NCT01470716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540513|NCT01470716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92540514|NCT01470716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540515|NCT01470716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540555|NCT00016289|Interleukin-12|interleukin-12|mesh-list
92540556|NCT00016289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92540557|NCT00016289|Immunologic Factors|immunologic factors|mesh-ancestor
92540558|NCT00016289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540559|NCT00016289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92540560|NCT00016289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92540561|NCT00016289|Growth Substances|growth substances|mesh-ancestor
92540562|NCT00016289|Growth Inhibitors|growth inhibitors|mesh-ancestor
92540563|NCT00016289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540564|NCT00130065|Folic Acid|folic acid|mesh-list
92540565|NCT00130065|Pyrimethamine|pyrimethamine|mesh-list
92540566|NCT00130065|Sulfadoxine|sulfadoxine|mesh-list
92540568|NCT00130065|Hematinics|hematinics|mesh-ancestor
92540620|NCT00016406|Cyclophosphamide|cyclophosphamide|mesh-list
92540621|NCT00016406|Doxorubicin|doxorubicin|mesh-list
92540622|NCT00016406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540623|NCT00016406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540624|NCT00016406|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540625|NCT00016406|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540626|NCT00016406|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540627|NCT00016406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540628|NCT00016406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540629|NCT00016406|Immunologic Factors|immunologic factors|mesh-ancestor
92540630|NCT00016406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540631|NCT00016406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92540632|NCT00016406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540633|NCT00016406|Alkylating Agents|alkylating agents|mesh-ancestor
92540634|NCT00016406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92540635|NCT00016406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540636|NCT00016406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540637|NCT00016406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540638|NCT00016406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540639|NCT00129870|Oxaliplatin|oxaliplatin|mesh-list
92540640|NCT00129870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540641|NCT00016445|Hormones|hormones|mesh-list
92540642|NCT00016445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540643|NCT00016445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540644|NCT00129753|Alemtuzumab|alemtuzumab|mesh-list
92540645|NCT00129753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92540646|NCT00129753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540647|NCT00016523|Nitric Oxide|nitric oxide|mesh-list
92540648|NCT00016523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92540663|NCT00129597|Analgesics|analgesics|mesh-ancestor
92540664|NCT00129597|Sensory System Agents|sensory system agents|mesh-ancestor
92540665|NCT00129597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540666|NCT00129597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540667|NCT00129597|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92540668|NCT00129597|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92540669|NCT00129597|Anesthetics, General|anesthetics, general|mesh-ancestor
92540670|NCT00129597|Anesthetics|anesthetics|mesh-ancestor
92540671|NCT00129597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92540672|NCT00129597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92540674|NCT00129597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540724|NCT00016835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92540725|NCT00016835|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92540726|NCT00016835|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92540727|NCT00016835|Antimalarials|antimalarials|mesh-ancestor
92540728|NCT00016874|Paclitaxel|paclitaxel|mesh-list
92540729|NCT00016874|Cisplatin|cisplatin|mesh-list
92540730|NCT00016874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540731|NCT00016874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540732|NCT00016874|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540733|NCT00016874|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540734|NCT00016874|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540735|NCT00016874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540736|NCT00016952|Leucovorin|leucovorin|mesh-list
92540737|NCT00016952|Fluorouracil|fluorouracil|mesh-list
92540738|NCT00016952|Irinotecan|irinotecan|mesh-list
92540739|NCT00016952|Calcium|calcium|mesh-list
92540740|NCT00016952|Levoleucovorin|levoleucovorin|mesh-list
92540741|NCT00016952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92540742|NCT00016952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540743|NCT00016952|Antimetabolites|antimetabolites|mesh-ancestor
92540744|NCT00016952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540745|NCT00016952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540779|NCT00017030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540780|NCT00017030|Alkylating Agents|alkylating agents|mesh-ancestor
92540781|NCT00017030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540782|NCT00017030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540783|NCT00017069|Dexamethasone|dexamethasone|mesh-list
92540784|NCT00017069|Arsenic Trioxide|arsenic trioxide|mesh-list
92540785|NCT00017069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540786|NCT00017069|Antiemetics|antiemetics|mesh-ancestor
92540787|NCT00017069|Autonomic Agents|autonomic agents|mesh-ancestor
92540788|NCT00017069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540789|NCT00017069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540790|NCT00017069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92540791|NCT00017069|Glucocorticoids|glucocorticoids|mesh-ancestor
92540792|NCT00017069|Hormones|hormones|mesh-ancestor
92540793|NCT00017069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540794|NCT00017069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92540795|NCT00017069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540796|NCT00129285|Modafinil|modafinil|mesh-list
92540797|NCT00129285|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92540832|NCT00129246|Dopamine Agents|dopamine agents|mesh-ancestor
92540833|NCT00129246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92540834|NCT00129246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92540835|NCT00129246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92540836|NCT00129246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540837|NCT00017147|Carmustine|carmustine|mesh-list
92540838|NCT00017147|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92540839|NCT00017147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92540840|NCT00017147|Alkylating Agents|alkylating agents|mesh-ancestor
92540841|NCT00017147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540842|NCT00017147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540843|NCT00017147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540844|NCT00129207|Bortezomib|bortezomib|mesh-list
92540845|NCT00129207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540846|NCT00129168|Cytarabine|cytarabine|mesh-list
92540847|NCT00129168|Daunorubicin|daunorubicin|mesh-list
92540848|NCT00129168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540849|NCT00129168|Antimetabolites|antimetabolites|mesh-ancestor
92540850|NCT00129168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540851|NCT00129168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540888|NCT00017225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540889|NCT00017225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540890|NCT00017225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92540891|NCT00017225|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92540892|NCT00017225|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92540893|NCT00017225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92540894|NCT00017225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92540895|NCT00017225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92540896|NCT00017225|Tubulin Modulators|tubulin modulators|mesh-ancestor
92540897|NCT00017225|Antimitotic Agents|antimitotic agents|mesh-ancestor
92540898|NCT00017225|Mitosis Modulators|mitosis modulators|mesh-ancestor
92540899|NCT00017225|Keratolytic Agents|keratolytic agents|mesh-ancestor
92540900|NCT00017225|Dermatologic Agents|dermatologic agents|mesh-ancestor
92540901|NCT00128934|Levonorgestrel|levonorgestrel|mesh-list
92540902|NCT00128934|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92540904|NCT00128934|Estrogens|estrogens|mesh-ancestor
92540905|NCT00128934|Hormones|hormones|mesh-ancestor
92540906|NCT00128934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92540907|NCT00128934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540908|NCT00128934|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92540909|NCT00128934|Contraceptive Agents|contraceptive agents|mesh-ancestor
92540910|NCT00128934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92540911|NCT00128934|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92540912|NCT00128934|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92540915|NCT00017264|Atrasentan|atrasentan|mesh-list
92540937|NCT00017342|Cytarabine|cytarabine|mesh-list
92540938|NCT00017342|Bryostatin 1|bryostatin 1|mesh-list
92540939|NCT00017342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92540940|NCT00017342|Antimetabolites|antimetabolites|mesh-ancestor
92540941|NCT00017342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540942|NCT00017342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540943|NCT00017342|Antiviral Agents|antiviral agents|mesh-ancestor
92540944|NCT00017342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540945|NCT00017342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92540946|NCT00017342|Immunologic Factors|immunologic factors|mesh-ancestor
92540947|NCT00017342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92540948|NCT00017342|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92540949|NCT00128739|Budesonide|budesonide|mesh-list
92540950|NCT00128739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92540951|NCT00128739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92540952|NCT00128739|Autonomic Agents|autonomic agents|mesh-ancestor
92540953|NCT00128739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92540994|NCT00017498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92540995|NCT00017498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92540996|NCT00128544|Telbivudine|telbivudine|mesh-list
92540997|NCT00128544|Antiviral Agents|antiviral agents|mesh-ancestor
92540998|NCT00128544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92540999|NCT00128544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92541000|NCT00128544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541001|NCT00128544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541002|NCT00128505|Mifepristone|mifepristone|mesh-list
92541003|NCT00128505|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92541004|NCT00128505|Abortifacient Agents|abortifacient agents|mesh-ancestor
92541005|NCT00128505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92541006|NCT00128505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541007|NCT00128505|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92541008|NCT00128505|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92541009|NCT00128505|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92541010|NCT00128505|Contraceptive Agents|contraceptive agents|mesh-ancestor
92541018|NCT00017576|Calcitriol|calcitriol|mesh-list
92541048|NCT00017654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92541049|NCT00017654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541050|NCT00017654|Antiemetics|antiemetics|mesh-ancestor
92541051|NCT00017654|Autonomic Agents|autonomic agents|mesh-ancestor
92541052|NCT00017654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541053|NCT00017654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92541054|NCT00017654|Glucocorticoids|glucocorticoids|mesh-ancestor
92541055|NCT00017654|Hormones|hormones|mesh-ancestor
92541056|NCT00017654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541057|NCT00017654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92541058|NCT00017654|Protective Agents|protective agents|mesh-ancestor
92541112|NCT00018642|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92541113|NCT00018642|Haloperidol decanoate|haloperidol decanoate|mesh-list
92541114|NCT00018642|Antidepressive Agents|antidepressive agents|mesh-ancestor
92541115|NCT00018642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92541116|NCT00018642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92541117|NCT00018642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92541118|NCT00018642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541119|NCT00018642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541120|NCT00018642|Antiemetics|antiemetics|mesh-ancestor
92541121|NCT00018642|Autonomic Agents|autonomic agents|mesh-ancestor
92541122|NCT00018642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541123|NCT00018642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92541124|NCT00018642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92541125|NCT00018642|Dopamine Agents|dopamine agents|mesh-ancestor
92541126|NCT00018642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541127|NCT00018642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541128|NCT00018642|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92541130|NCT00018083|Isoniazid|isoniazid|mesh-list
92541168|NCT00018200|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92541169|NCT00018200|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92541170|NCT00018200|Adrenergic Agents|adrenergic agents|mesh-ancestor
92541171|NCT00018200|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92541172|NCT00018200|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92541173|NCT00018200|Parasympatholytics|parasympatholytics|mesh-ancestor
92541175|NCT00018200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541176|NCT00018200|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92541177|NCT00018200|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92541178|NCT00018200|Cholinergic Agents|cholinergic agents|mesh-ancestor
92541179|NCT00018200|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92541180|NCT00018200|Dopamine Agents|dopamine agents|mesh-ancestor
92541181|NCT00018759|Paroxetine|paroxetine|mesh-list
92541182|NCT00018759|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92541183|NCT00018759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92541184|NCT00018759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92541224|NCT00018954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541225|NCT00018954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92541226|NCT00018954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541227|NCT00018954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541228|NCT00018954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541229|NCT00018954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541230|NCT00018954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541231|NCT00018954|Glucocorticoids|glucocorticoids|mesh-ancestor
92541232|NCT00018954|Hormones|hormones|mesh-ancestor
92541233|NCT00018954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541234|NCT00018954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92541235|NCT00018954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92541236|NCT00018954|Abortifacient Agents|abortifacient agents|mesh-ancestor
92541237|NCT00018954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92541238|NCT00018954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92541239|NCT00018954|Antimetabolites|antimetabolites|mesh-ancestor
92541282|NCT00019188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541283|NCT00019227|Calcium|calcium|mesh-list
92541284|NCT00019227|Daclizumab|daclizumab|mesh-list
92541285|NCT00019227|Pentetic Acid|pentetic acid|mesh-list
92541286|NCT00019227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92541287|NCT00019227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541288|NCT00019227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541289|NCT00019227|Immunologic Factors|immunologic factors|mesh-ancestor
92541290|NCT00019227|Antidotes|antidotes|mesh-ancestor
92541291|NCT00019227|Protective Agents|protective agents|mesh-ancestor
92541292|NCT00019227|Chelating Agents|chelating agents|mesh-ancestor
92541293|NCT00019227|Sequestering Agents|sequestering agents|mesh-ancestor
92541294|NCT00019227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541295|NCT00019227|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92541296|NCT04734041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92541297|NCT00019344|Alvocidib|alvocidib|mesh-list
92541298|NCT00019344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541341|NCT00019539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92541342|NCT00019539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541343|NCT00019539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92541344|NCT00019539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92541345|NCT00019539|Growth Substances|growth substances|mesh-ancestor
92541346|NCT00019539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541347|NCT00019539|Growth Inhibitors|growth inhibitors|mesh-ancestor
92266094|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
92541348|NCT00019539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541349|NCT00019539|Immunologic Factors|immunologic factors|mesh-ancestor
92541350|NCT00019539|Leprostatic Agents|leprostatic agents|mesh-ancestor
92541351|NCT00019539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92541352|NCT00019539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541353|NCT00019695|Alendronate|alendronate|mesh-list
92541354|NCT00019695|Ketoconazole|ketoconazole|mesh-list
92541355|NCT00019695|Antifungal Agents|antifungal agents|mesh-ancestor
92541356|NCT00019695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541357|NCT00019695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92541396|NCT00019890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541398|NCT00019968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92541399|NCT00019968|Alkylating Agents|alkylating agents|mesh-ancestor
92541400|NCT00019968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541401|NCT00019968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541402|NCT00019968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92541403|NCT00019968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92541404|NCT00019968|Immunologic Factors|immunologic factors|mesh-ancestor
92541405|NCT00019968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541406|NCT00020007|Paclitaxel|paclitaxel|mesh-list
92541407|NCT00020007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541408|NCT00020007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541409|NCT00020007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541410|NCT00020007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541451|NCT05576675|Dsuvia|dsuvia|mesh-list
92541454|NCT05576675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92541455|NCT05576675|Narcotics|narcotics|mesh-ancestor
92541456|NCT05576675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92541457|NCT05576675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541458|NCT05576675|Analgesics|analgesics|mesh-ancestor
92541459|NCT05576675|Sensory System Agents|sensory system agents|mesh-ancestor
92541460|NCT05576675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92541461|NCT05576675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92541462|NCT05576675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92541463|NCT05576675|Anesthetics, General|anesthetics, general|mesh-ancestor
92541464|NCT05576675|Anesthetics|anesthetics|mesh-ancestor
92541465|NCT00020358|Aldesleukin|aldesleukin|mesh-list
92541466|NCT00020358|Freund's Adjuvant|freund's adjuvant|mesh-list
92541467|NCT00020358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541468|NCT00020358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92541469|NCT00020358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92541470|NCT00020358|Antiviral Agents|antiviral agents|mesh-ancestor
92541471|NCT00020358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541472|NCT00020358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92541473|NCT00020358|Immunologic Factors|immunologic factors|mesh-ancestor
92541474|NCT00020358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541475|NCT00020397|Aldesleukin|aldesleukin|mesh-list
92541510|NCT05576324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92541511|NCT05576324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541513|NCT00020709|Etoposide|etoposide|mesh-list
92541514|NCT00020709|Etoposide phosphate|etoposide phosphate|mesh-list
92541515|NCT00020709|Gefitinib|gefitinib|mesh-list
92541516|NCT00020709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541517|NCT00020709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541518|NCT00020709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541519|NCT00020709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541520|NCT00020709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541521|NCT00020709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541522|NCT00020709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541523|NCT00020709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541524|NCT00020709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541525|NCT00020709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92541571|NCT00020943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92541572|NCT00020943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92541573|NCT00020943|Alkylating Agents|alkylating agents|mesh-ancestor
92541574|NCT00020943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541575|NCT00020943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266320|NCT01372202|Paclitaxel|paclitaxel|mesh-list
92541576|NCT00020943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92541577|NCT00020943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92541578|NCT00020943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92541579|NCT00020943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92541580|NCT00020943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92541581|NCT00020943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92541582|NCT00020943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92541583|NCT00020943|Glucocorticoids|glucocorticoids|mesh-ancestor
92541584|NCT00020943|Hormones|hormones|mesh-ancestor
92541585|NCT00020943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92541586|NCT00020943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92541587|NCT00020943|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92541588|NCT00020943|Abortifacient Agents|abortifacient agents|mesh-ancestor
92541589|NCT00020943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92541590|NCT00020943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92541591|NCT00020943|Antimetabolites|antimetabolites|mesh-ancestor
92541592|NCT00020943|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361884|NCT02136420|Anesthetics, Local|anesthetics, local|mesh-ancestor
92541593|NCT00020943|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92541594|NCT00020943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92541595|NCT00020943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541596|NCT00020943|Antiviral Agents|antiviral agents|mesh-ancestor
92541597|NCT00020943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92541598|NCT00020943|Antidotes|antidotes|mesh-ancestor
92541599|NCT00020943|Protective Agents|protective agents|mesh-ancestor
92541600|NCT00020943|Vitamin B Complex|vitamin b complex|mesh-ancestor
92541601|NCT00020943|Vitamins|vitamins|mesh-ancestor
92541602|NCT00020943|Micronutrients|micronutrients|mesh-ancestor
92541603|NCT00020943|Tubulin Modulators|tubulin modulators|mesh-ancestor
91949185|NCT02314871|Morphine|morphine|mesh-list
92627458|NCT03271866|Metformin|metformin|mesh-list
92627459|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92627460|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627461|NCT03259503|Rituximab|rituximab|mesh-list
92627462|NCT03259503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92627463|NCT03259503|Gemcitabine|gemcitabine|mesh-list
92541604|NCT00020943|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541605|NCT00020943|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541606|NCT00021060|Paclitaxel|paclitaxel|mesh-list
92541607|NCT00021060|Bevacizumab|bevacizumab|mesh-list
92541608|NCT00021060|Carboplatin|carboplatin|mesh-list
92541609|NCT00021060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92541610|NCT00021060|Antibodies|antibodies|mesh-list
92541611|NCT00021060|Immunoglobulins|immunoglobulins|mesh-list
92541612|NCT00021060|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92541613|NCT00021060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541614|NCT00021060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541615|NCT00021060|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541616|NCT00021060|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541617|NCT00021060|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541618|NCT00021060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541619|NCT00021060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92541620|NCT00021060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92541621|NCT00021060|Growth Substances|growth substances|mesh-ancestor
92541622|NCT00021060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92541623|NCT00021060|Growth Inhibitors|growth inhibitors|mesh-ancestor
92541624|NCT00021060|Immunologic Factors|immunologic factors|mesh-ancestor
92541625|NCT00021099|Epothilones|epothilones|mesh-list
92541626|NCT00021099|Epothilone B|epothilone b|mesh-list
92541627|NCT00021099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541628|NCT00021099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541629|NCT00021099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92541630|NCT00021099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541654|NCT00020670|Vaccines|vaccines|mesh-list
92541729|NCT00018161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92541730|NCT00018161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92541731|NCT00018161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92541732|NCT00018161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92541733|NCT00018161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92541734|NCT00018161|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92541735|NCT00018161|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92541736|NCT00018161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92541737|NCT00021450|Goserelin|goserelin|mesh-list
92541791|NCT00021528|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92541792|NCT00021528|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92541793|NCT00021528|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92541794|NCT00021567|Interferons|interferons|mesh-list
92541863|NCT00022230|Sargramostim|sargramostim|mesh-list
92541864|NCT00022230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92541865|NCT00022230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92541866|NCT00022230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92541867|NCT00022230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92541934|NCT05551871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542012|NCT00022932|Tositumomab I-131|tositumomab i-131|mesh-list
92542014|NCT00022932|Immunologic Factors|immunologic factors|mesh-ancestor
92542015|NCT00022932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542016|NCT00022932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542017|NCT00022971|Rituximab|rituximab|mesh-list
92542018|NCT00022971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542019|NCT00022971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542020|NCT00022971|Immunologic Factors|immunologic factors|mesh-ancestor
92542021|NCT00022971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542022|NCT00022971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542023|NCT05512754|Ibuprofen|ibuprofen|mesh-list
92542024|NCT05512754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92542025|NCT05512754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92542026|NCT05512754|Analgesics|analgesics|mesh-ancestor
92542027|NCT05512754|Sensory System Agents|sensory system agents|mesh-ancestor
92542028|NCT05512754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542029|NCT05512754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542030|NCT05512754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542035|NCT02971878|Thioctic Acid|thioctic acid|mesh-list
92542069|NCT00394992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92542070|NCT00394992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542071|NCT00394992|Antimetabolites|antimetabolites|mesh-ancestor
92542072|NCT00394992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542073|NCT00395031|Ziprasidone|ziprasidone|mesh-list
92542074|NCT00395031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92542075|NCT00395031|Serotonin Agents|serotonin agents|mesh-ancestor
92542076|NCT00395031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542077|NCT00395031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542078|NCT00395031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542079|NCT00395031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92542080|NCT00395031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92542081|NCT00395031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542082|NCT00395031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542083|NCT00395031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92542128|NCT00023244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92542129|NCT00023244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92542130|NCT00023244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92542131|NCT00023244|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92542132|NCT00023244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92542133|NCT00023283|Buprenorphine|buprenorphine|mesh-list
92542134|NCT00023283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92542135|NCT00023283|Narcotics|narcotics|mesh-ancestor
92542136|NCT00023283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542137|NCT00023283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542138|NCT00023283|Analgesics|analgesics|mesh-ancestor
92542139|NCT00023283|Sensory System Agents|sensory system agents|mesh-ancestor
92542140|NCT00023283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542141|NCT00023283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92542142|NCT00023361|Rifabutin|rifabutin|mesh-list
92542143|NCT00023361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542144|NCT00023361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542145|NCT00023361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92542146|NCT00023361|Antitubercular Agents|antitubercular agents|mesh-ancestor
92542147|NCT00023400|Nelfinavir|nelfinavir|mesh-list
92542148|NCT00023400|Rifabutin|rifabutin|mesh-list
92542149|NCT00023400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92542150|NCT00023400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92542181|NCT00023751|Immunologic Factors|immunologic factors|mesh-ancestor
92542182|NCT00023751|Antidotes|antidotes|mesh-ancestor
92542183|NCT00023751|Protective Agents|protective agents|mesh-ancestor
92542184|NCT00023751|Vitamin B Complex|vitamin b complex|mesh-ancestor
92542185|NCT00023751|Vitamins|vitamins|mesh-ancestor
92542186|NCT00023751|Micronutrients|micronutrients|mesh-ancestor
92542187|NCT00023790|Silicon|silicon|mesh-list
92542188|NCT00023790|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
92542189|NCT00023790|Trace Elements|trace elements|mesh-ancestor
92542190|NCT00023790|Micronutrients|micronutrients|mesh-ancestor
92542191|NCT00023790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542192|NCT00023790|Antimalarials|antimalarials|mesh-ancestor
92542193|NCT00023790|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92542194|NCT00023790|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92542195|NCT00023790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542196|NCT00023790|Antiviral Agents|antiviral agents|mesh-ancestor
92542197|NCT00023790|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92542245|NCT00023868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542246|NCT00023868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542247|NCT00023868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361893|NCT02136498|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92542248|NCT00023868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542249|NCT00023868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542250|NCT00023868|Antimetabolites|antimetabolites|mesh-ancestor
92542251|NCT00023868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542252|NCT00023868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542253|NCT00023868|Immunologic Factors|immunologic factors|mesh-ancestor
92542254|NCT00023868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92542255|NCT00023868|Antidotes|antidotes|mesh-ancestor
92542256|NCT00023868|Protective Agents|protective agents|mesh-ancestor
92542257|NCT00023868|Vitamin B Complex|vitamin b complex|mesh-ancestor
92542258|NCT00023868|Vitamins|vitamins|mesh-ancestor
92542259|NCT00023868|Micronutrients|micronutrients|mesh-ancestor
92542260|NCT00023868|Alkylating Agents|alkylating agents|mesh-ancestor
92542261|NCT00023868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92542262|NCT00023907|Paclitaxel|paclitaxel|mesh-list
92542263|NCT00023907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542264|NCT00023907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542265|NCT00023907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542266|NCT00023907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542298|NCT00024180|Romidepsin|romidepsin|mesh-list
92542299|NCT00024180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92542300|NCT00024180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542301|NCT00024180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92542302|NCT00024180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542303|NCT00024180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542304|NCT00024297|Warfarin|warfarin|mesh-list
92542305|NCT00024297|Anticoagulants|anticoagulants|mesh-ancestor
92542306|NCT00024336|Tamoxifen|tamoxifen|mesh-list
92542307|NCT00024336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92542308|NCT00024336|Hormone Antagonists|hormone antagonists|mesh-ancestor
92542309|NCT00024336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92542359|NCT00024687|Immunoconjugates|immunoconjugates|mesh-ancestor
92542360|NCT00024687|Immunologic Factors|immunologic factors|mesh-ancestor
92542361|NCT00024687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542362|NCT05072444|QPX7728|qpx7728|mesh-list
92542363|NCT05072444|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92542364|NCT05072444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542365|NCT05072444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542366|NCT05072444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542367|NCT05072444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542368|NCT00025038|Cytarabine|cytarabine|mesh-list
92542369|NCT00025038|Cyclophosphamide|cyclophosphamide|mesh-list
92542370|NCT00025038|Fludarabine|fludarabine|mesh-list
92542371|NCT00025038|Fludarabine phosphate|fludarabine phosphate|mesh-list
92542372|NCT00025038|Tipifarnib|tipifarnib|mesh-list
92542373|NCT00025038|Isotretinoin|isotretinoin|mesh-list
92542374|NCT00025038|Thymoglobulin|thymoglobulin|mesh-list
92542375|NCT00025038|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92542376|NCT00025038|Immunoglobulins|immunoglobulins|mesh-list
92542377|NCT00025038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542418|NCT00025077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542419|NCT00025077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542420|NCT00025077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542421|NCT00025077|Alkylating Agents|alkylating agents|mesh-ancestor
92542422|NCT00025077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542423|NCT00025077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542424|NCT00025077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542425|NCT05051891|Prednisone|prednisone|mesh-list
92542426|NCT05051891|Cyclophosphamide|cyclophosphamide|mesh-list
92542427|NCT05051891|Vincristine|vincristine|mesh-list
92542428|NCT05051891|Rituximab|rituximab|mesh-list
92542429|NCT05051891|Doxorubicin|doxorubicin|mesh-list
92542430|NCT05051891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542431|NCT05051891|Immunologic Factors|immunologic factors|mesh-ancestor
92542432|NCT05051891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542441|NCT05051891|Hormones|hormones|mesh-ancestor
92542478|NCT00025311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542479|NCT00025311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542480|NCT00025116|Gefitinib|gefitinib|mesh-list
92542481|NCT00025116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361898|NCT00612222|Aldesleukin|aldesleukin|mesh-list
92542482|NCT00025116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542483|NCT00025116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542484|NCT00025116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542485|NCT00025350|Gefitinib|gefitinib|mesh-list
92542486|NCT00025350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542487|NCT00025350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542488|NCT00025350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542489|NCT00025350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542490|NCT00025389|Paclitaxel|paclitaxel|mesh-list
92542491|NCT00025389|Bevacizumab|bevacizumab|mesh-list
92542492|NCT00025389|Carboplatin|carboplatin|mesh-list
92542493|NCT00025389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542495|NCT00025389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542534|NCT00025467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542535|NCT00025467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92542536|NCT00025467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92542537|NCT00025467|Growth Substances|growth substances|mesh-ancestor
92542538|NCT00025467|Growth Inhibitors|growth inhibitors|mesh-ancestor
92542539|NCT00025467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542540|NCT04964414|Budesonide|budesonide|mesh-list
92542541|NCT04964414|Glucocorticoids|glucocorticoids|mesh-list
92542542|NCT04964414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92542543|NCT04964414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92542544|NCT04964414|Autonomic Agents|autonomic agents|mesh-ancestor
92542545|NCT04964414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542546|NCT04964414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542547|NCT04964414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92542548|NCT04964414|Respiratory System Agents|respiratory system agents|mesh-ancestor
92542549|NCT04964414|Hormones|hormones|mesh-ancestor
92542550|NCT04964414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92542551|NCT00025545|Cyclophosphamide|cyclophosphamide|mesh-list
92542589|NCT00025623|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92542590|NCT00025623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92542591|NCT00025623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542592|NCT00025623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92542593|NCT00025623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92542594|NCT00025623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92542595|NCT00025623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92542596|NCT00025740|Clonazepam|clonazepam|mesh-list
92542597|NCT00025740|Paroxetine|paroxetine|mesh-list
92542598|NCT00025740|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92542600|NCT00025740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92542652|NCT00026130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542653|NCT00026130|Immunologic Factors|immunologic factors|mesh-ancestor
92542654|NCT00026130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542655|NCT00026169|Imatinib Mesylate|imatinib mesylate|mesh-list
92542656|NCT00026169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542657|NCT00026169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92542658|NCT00026169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542659|NCT00026169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542660|NCT04808414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92542661|NCT04808414|Polymyxins|polymyxins|mesh-list
92542662|NCT04808414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542663|NCT00026364|Leucovorin|leucovorin|mesh-list
92542664|NCT00026364|Fluorouracil|fluorouracil|mesh-list
92542665|NCT00026364|Irinotecan|irinotecan|mesh-list
92542666|NCT00026364|Gefitinib|gefitinib|mesh-list
92542667|NCT00026364|Calcium|calcium|mesh-list
92542668|NCT00026364|Levoleucovorin|levoleucovorin|mesh-list
92542669|NCT00026364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92542670|NCT00026364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542671|NCT00026364|Antimetabolites|antimetabolites|mesh-ancestor
92542672|NCT00026364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542673|NCT00026364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92542707|NCT00026520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542708|NCT00026520|Antiviral Agents|antiviral agents|mesh-ancestor
92542709|NCT00026520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542710|NCT00026520|Immunologic Factors|immunologic factors|mesh-ancestor
92542711|NCT00026520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542712|NCT00026520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542713|NCT00026520|Leprostatic Agents|leprostatic agents|mesh-ancestor
92542714|NCT00026520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92542715|NCT00026520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92542716|NCT00026520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92542717|NCT00026520|Growth Substances|growth substances|mesh-ancestor
92542718|NCT00026520|Growth Inhibitors|growth inhibitors|mesh-ancestor
92542720|NCT00026637|Antidepressive Agents|antidepressive agents|mesh-ancestor
92542721|NCT00026637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542722|NCT00026637|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92542723|NCT00026637|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92542724|NCT00026637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92542725|NCT00026637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542726|NCT00026637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542761|NCT00027066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92542762|NCT00027066|Antipyretics|antipyretics|mesh-ancestor
92542763|NCT00027066|Anticoagulants|anticoagulants|mesh-ancestor
92542765|NCT04473950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92542766|NCT04473950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542767|NCT04473950|Sensory System Agents|sensory system agents|mesh-ancestor
92542768|NCT04473950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92542769|NCT04473482|Ethanol|ethanol|mesh-list
92542770|NCT04473482|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92542771|NCT04473482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542772|NCT04473482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542774|NCT00027300|Natalizumab|natalizumab|mesh-list
92542825|NCT00027573|Fludarabine phosphate|fludarabine phosphate|mesh-list
92542826|NCT00027573|Tacrolimus|tacrolimus|mesh-list
92542827|NCT00027573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92542828|NCT00027573|Immunologic Factors|immunologic factors|mesh-ancestor
92542829|NCT00027573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542830|NCT00027573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92542831|NCT00027573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542832|NCT00027573|Alkylating Agents|alkylating agents|mesh-ancestor
92542833|NCT00027573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542837|NCT00027573|Abortifacient Agents|abortifacient agents|mesh-ancestor
92542891|NCT00027885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92542893|NCT00027885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542894|NCT00027885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92542895|NCT00027885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92542896|NCT00027885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92542897|NCT00027885|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92542898|NCT00027885|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92542958|NCT00027963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542959|NCT00027963|Antimanic Agents|antimanic agents|mesh-ancestor
92542960|NCT00395421|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92542961|NCT00395421|Antiviral Agents|antiviral agents|mesh-ancestor
92542962|NCT00395421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92542963|NCT00395499|Risperidone|risperidone|mesh-list
92542964|NCT00395499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92542965|NCT00395499|Serotonin Agents|serotonin agents|mesh-ancestor
92542966|NCT00395499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92542967|NCT00395499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92542968|NCT00395499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92542969|NCT00395499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92542970|NCT00395499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92542971|NCT00395499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92542972|NCT00395499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542973|NCT00395499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92542974|NCT00395499|Dopamine Agents|dopamine agents|mesh-ancestor
92542975|NCT03960125|Imipramine|imipramine|mesh-list
92542976|NCT03960125|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92542977|NCT03960125|Antidepressive Agents|antidepressive agents|mesh-ancestor
92542978|NCT03960125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92542979|NCT03960125|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92542980|NCT03960125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92543011|NCT00028275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543012|NCT00028275|Antiviral Agents|antiviral agents|mesh-ancestor
92543013|NCT00028275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543014|NCT03959969|Ibuprofen|ibuprofen|mesh-list
92543015|NCT03959969|Oxycodone|oxycodone|mesh-list
92543016|NCT03959969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92543017|NCT03959969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92543018|NCT03959969|Analgesics|analgesics|mesh-ancestor
92543019|NCT03959969|Sensory System Agents|sensory system agents|mesh-ancestor
92543020|NCT03959969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543021|NCT03959969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543022|NCT03959969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543023|NCT03959969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543024|NCT03959969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92543025|NCT03959969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543026|NCT03959969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543027|NCT03959969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92543066|NCT03959852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92543067|NCT03959852|Anesthetics, General|anesthetics, general|mesh-ancestor
92543068|NCT03959852|Anesthetics|anesthetics|mesh-ancestor
92543069|NCT03959852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92543070|NCT03959852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92543071|NCT03959852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92543072|NCT03959852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543073|NCT03959852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543074|NCT03959852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92543075|NCT03959852|Narcotics|narcotics|mesh-ancestor
92543076|NCT03959852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92543077|NCT00028431|Ipilimumab|ipilimumab|mesh-list
92543078|NCT00028431|Antibodies|antibodies|mesh-list
92543079|NCT00028431|Immunologic Factors|immunologic factors|mesh-ancestor
92543080|NCT00028431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543081|NCT00028431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543082|NCT00028431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543083|NCT00028431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92543084|NCT00028431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543085|NCT00028587|Paclitaxel|paclitaxel|mesh-list
92543086|NCT00028587|Carboplatin|carboplatin|mesh-list
92543087|NCT00028587|Bortezomib|bortezomib|mesh-list
92543088|NCT00028587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543089|NCT00028587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543117|NCT00028665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92543118|NCT00028665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543120|NCT03959540|Opicapone|opicapone|mesh-list
92543121|NCT03959540|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92543122|NCT03959540|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92543123|NCT03959540|Dopamine Agents|dopamine agents|mesh-ancestor
92543186|NCT00028899|Cytarabine|cytarabine|mesh-list
92543187|NCT00028899|Asparaginase|asparaginase|mesh-list
92543188|NCT00028899|Mitoxantrone|mitoxantrone|mesh-list
92543189|NCT00028899|Gemtuzumab|gemtuzumab|mesh-list
92543190|NCT00028899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543191|NCT00028899|Antimetabolites|antimetabolites|mesh-ancestor
92543192|NCT00028899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543193|NCT00028899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543194|NCT00028899|Antiviral Agents|antiviral agents|mesh-ancestor
92543195|NCT00028899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543196|NCT00028899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543197|NCT00028899|Immunologic Factors|immunologic factors|mesh-ancestor
92543198|NCT00028899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543199|NCT00028899|Analgesics|analgesics|mesh-ancestor
92543200|NCT00028899|Sensory System Agents|sensory system agents|mesh-ancestor
92543201|NCT00028899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543202|NCT00028899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92543203|NCT00028899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92543204|NCT00028899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543205|NCT00028899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543206|NCT00028899|Immunotoxins|immunotoxins|mesh-ancestor
92543207|NCT00028899|Immunoconjugates|immunoconjugates|mesh-ancestor
92543208|NCT03959306|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92543209|NCT03959306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543210|NCT00028938|Paclitaxel|paclitaxel|mesh-list
92543211|NCT00028938|Carboplatin|carboplatin|mesh-list
92543212|NCT00028938|Epoetin Alfa|epoetin alfa|mesh-list
92543213|NCT00028938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543214|NCT00028938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543215|NCT00028938|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543216|NCT00028938|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543217|NCT00028938|Mitosis Modulators|mitosis modulators|mesh-ancestor
91923616|NCT02150993|Ritonavir|ritonavir|mesh-list
92543218|NCT00028938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543219|NCT00028938|Hematinics|hematinics|mesh-ancestor
92543220|NCT00029250|Allicin|allicin|mesh-list
92543221|NCT00029250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543222|NCT00029250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92543223|NCT00029250|Antimetabolites|antimetabolites|mesh-ancestor
92543225|NCT00029250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92543226|NCT00029250|Antioxidants|antioxidants|mesh-ancestor
92543227|NCT00029250|Protective Agents|protective agents|mesh-ancestor
92543228|NCT00029250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543229|NCT00029250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92543230|NCT00029250|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92543231|NCT03959150|Capecitabine|capecitabine|mesh-list
92543232|NCT03959150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543233|NCT03959150|Antimetabolites|antimetabolites|mesh-ancestor
92543234|NCT03959150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543235|NCT03959150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543236|NCT00029328|Etanercept|etanercept|mesh-list
92543237|NCT00029328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92543238|NCT00029328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92543239|NCT00029328|Analgesics|analgesics|mesh-ancestor
92543240|NCT00029328|Sensory System Agents|sensory system agents|mesh-ancestor
92543284|NCT03958721|Capecitabine|capecitabine|mesh-list
92543285|NCT03958721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543286|NCT03958721|Antimetabolites|antimetabolites|mesh-ancestor
92543287|NCT03958721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543288|NCT03958721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543289|NCT00029835|Rimonabant|rimonabant|mesh-list
92543290|NCT00029835|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92543291|NCT00029835|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92543292|NCT00029835|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92543293|NCT00029835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543294|NCT00029835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543295|NCT00029835|Hormones|hormones|mesh-ancestor
92543297|NCT00029835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543347|NCT03958097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543348|NCT00030342|Interferons|interferons|mesh-list
92543349|NCT00030342|Interferon-alpha|interferon-alpha|mesh-list
92543350|NCT00030342|Fluorouracil|fluorouracil|mesh-list
92543351|NCT00030342|Sargramostim|sargramostim|mesh-list
92543352|NCT00030342|Antimetabolites|antimetabolites|mesh-ancestor
92543353|NCT00030342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543354|NCT00030342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92543355|NCT00030342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543356|NCT00030342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543357|NCT00030342|Immunologic Factors|immunologic factors|mesh-ancestor
92543358|NCT00030342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543359|NCT00030342|Antiviral Agents|antiviral agents|mesh-ancestor
92543360|NCT00030342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543361|NCT00030381|Esorubicin|esorubicin|mesh-list
92543362|NCT00030381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92543363|NCT00030381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543364|NCT00030420|Celecoxib|celecoxib|mesh-list
92543365|NCT00030420|Docetaxel|docetaxel|mesh-list
92543366|NCT00030420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543404|NCT03866408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92543405|NCT03866408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543406|NCT00030537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92543407|NCT00030537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543408|NCT00030537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92543409|NCT00030537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543410|NCT00030537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543411|NCT00030576|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92543412|NCT00030576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543470|NCT03852407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543471|NCT03852407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92543472|NCT03852407|Alkylating Agents|alkylating agents|mesh-ancestor
92543473|NCT03852407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543474|NCT03852407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543475|NCT03852407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92543476|NCT00030693|Metronidazole|metronidazole|mesh-list
92543477|NCT00030693|Vaccines|vaccines|mesh-list
92543478|NCT00030693|Immunologic Factors|immunologic factors|mesh-ancestor
92543479|NCT00030693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543480|NCT00030693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543481|NCT00030693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92543482|NCT00030693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92543483|NCT00030693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92543484|NCT03823274|Aspirin|aspirin|mesh-list
92543485|NCT03823274|Clopidogrel|clopidogrel|mesh-list
92543486|NCT03823274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92543487|NCT03823274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92543488|NCT03823274|Analgesics|analgesics|mesh-ancestor
92543527|NCT00030888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543528|NCT00030888|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92543529|NCT00030888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543530|NCT00030888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543531|NCT00030966|Natalizumab|natalizumab|mesh-list
92543532|NCT00030966|Immunologic Factors|immunologic factors|mesh-ancestor
92543533|NCT00030966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543534|NCT03715205|Pembrolizumab|pembrolizumab|mesh-list
92543535|NCT03715205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543536|NCT03715205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543537|NCT03715205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92543538|NCT03715205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543539|NCT00031044|Enfuvirtide|enfuvirtide|mesh-list
92543540|NCT00031044|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92543541|NCT00031044|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92543584|NCT04711863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92543585|NCT04711863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543586|NCT04711863|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92543587|NCT00392912|Methyltestosterone|methyltestosterone|mesh-list
92543588|NCT00392912|Testosterone|testosterone|mesh-list
92543589|NCT00392912|Testosterone undecanoate|testosterone undecanoate|mesh-list
92543590|NCT00392912|Testosterone enanthate|testosterone enanthate|mesh-list
92543591|NCT00392912|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92543592|NCT00392912|Androgens|androgens|mesh-ancestor
92543594|NCT00392912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543595|NCT00392912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543596|NCT00392912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543597|NCT00392912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543598|NCT00392912|Anabolic Agents|anabolic agents|mesh-ancestor
92543599|NCT04712058|Tenofovir|tenofovir|mesh-list
92543600|NCT04712058|Emtricitabine|emtricitabine|mesh-list
92543642|NCT04711668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543643|NCT00031161|Nitisinone|nitisinone|mesh-list
92543644|NCT00031161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543645|NCT00031161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543646|NCT00031278|Trastuzumab|trastuzumab|mesh-list
92543647|NCT00031278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543648|NCT00031278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543649|NCT00031317|Clozapine|clozapine|mesh-list
92543650|NCT00031317|Paroxetine|paroxetine|mesh-list
92543651|NCT00031317|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92543652|NCT00031317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92543653|NCT00031317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92543654|NCT00031317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543655|NCT00031317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543656|NCT00031317|Serotonin Agents|serotonin agents|mesh-ancestor
92543657|NCT00031317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543658|NCT00031317|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92543659|NCT00031317|Antidepressive Agents|antidepressive agents|mesh-ancestor
92543660|NCT00031317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92543661|NCT00031317|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92543663|NCT00031317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268424|NCT01546454|Estradiol|estradiol|mesh-list
92543693|NCT00031395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543694|NCT00031395|Dopamine Agents|dopamine agents|mesh-ancestor
92543695|NCT00031395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92543696|NCT00031395|Analgesics|analgesics|mesh-ancestor
92543697|NCT00031395|Sensory System Agents|sensory system agents|mesh-ancestor
92543698|NCT00031395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92543699|NCT00031395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92543700|NCT00031395|Sympatholytics|sympatholytics|mesh-ancestor
92543701|NCT00031395|Autonomic Agents|autonomic agents|mesh-ancestor
92543702|NCT00031395|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92543703|NCT00031395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92543704|NCT00031395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92543705|NCT00031395|Adrenergic Agents|adrenergic agents|mesh-ancestor
92543706|NCT00031434|Valganciclovir|valganciclovir|mesh-list
92543707|NCT00031434|Ganciclovir|ganciclovir|mesh-list
92543708|NCT00031434|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92543709|NCT00031434|Antiviral Agents|antiviral agents|mesh-ancestor
92543710|NCT00031434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92543711|NCT00031434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92543712|NCT00031434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543713|NCT00031434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543714|NCT03152123|Phentermine|phentermine|mesh-list
92543715|NCT03152123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92543743|NCT03152084|Dapagliflozin|dapagliflozin|mesh-list
92543744|NCT03152084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92543745|NCT03152084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543746|NCT03152084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92543747|NCT03152084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543748|NCT00031707|Megestrol|megestrol|mesh-list
92543749|NCT00031707|Megestrol Acetate|megestrol acetate|mesh-list
92543750|NCT00031707|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92543751|NCT00031707|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92543752|NCT00031707|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92543753|NCT00031707|Contraceptive Agents|contraceptive agents|mesh-ancestor
92543754|NCT00031707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92543755|NCT00031707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543756|NCT00031707|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92543757|NCT00031707|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92543758|NCT00031707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543759|NCT00031707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543760|NCT00031707|Appetite Stimulants|appetite stimulants|mesh-ancestor
92543761|NCT00031707|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92543762|NCT00031746|Caseins|caseins|mesh-list
92543763|NCT00031746|Chelating Agents|chelating agents|mesh-ancestor
92543764|NCT00031746|Sequestering Agents|sequestering agents|mesh-ancestor
92543765|NCT00031746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543766|NCT00031785|Megestrol|megestrol|mesh-list
92543767|NCT00031785|Megestrol Acetate|megestrol acetate|mesh-list
92543768|NCT00031785|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92543769|NCT00031785|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92543770|NCT00031785|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92543771|NCT00031785|Contraceptive Agents|contraceptive agents|mesh-ancestor
92543772|NCT00031785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92543773|NCT00031785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543774|NCT00031785|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92543775|NCT00031785|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92543782|NCT03151772|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92543783|NCT03151772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543784|NCT03151772|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92543785|NCT03151772|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92543786|NCT03151772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543787|NCT03151772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543788|NCT02971644|Cobalt|cobalt|mesh-list
92543789|NCT02971644|Trace Elements|trace elements|mesh-ancestor
92543790|NCT02971644|Micronutrients|micronutrients|mesh-ancestor
92543791|NCT02971644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543792|NCT00031824|Cyclosporine|cyclosporine|mesh-list
92543793|NCT00031824|Hydroxychloroquine|hydroxychloroquine|mesh-list
92543794|NCT00031824|Prednisone|prednisone|mesh-list
92543795|NCT00031824|Tacrolimus|tacrolimus|mesh-list
92543796|NCT00031824|Cyclosporins|cyclosporins|mesh-list
92543797|NCT00031824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543798|NCT00031824|Glucocorticoids|glucocorticoids|mesh-ancestor
92543799|NCT00031824|Hormones|hormones|mesh-ancestor
92543800|NCT00031824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543813|NCT00031824|Antimalarials|antimalarials|mesh-ancestor
92543838|NCT00031902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543839|NCT00031902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543840|NCT00031902|Immunologic Factors|immunologic factors|mesh-ancestor
92361919|NCT00612222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92543841|NCT00031902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543842|NCT00031902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268571|NCT04306965|Apremilast|apremilast|mesh-list
92543843|NCT00031902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92543844|NCT00031902|Tubulin Modulators|tubulin modulators|mesh-ancestor
92543845|NCT00031902|Antimitotic Agents|antimitotic agents|mesh-ancestor
92543846|NCT00031902|Mitosis Modulators|mitosis modulators|mesh-ancestor
92543847|NCT00031902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543848|NCT00031902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543849|NCT00031902|Glucocorticoids|glucocorticoids|mesh-ancestor
92543850|NCT00031902|Hormones|hormones|mesh-ancestor
92543851|NCT00031902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543896|NCT00032019|Etoposide|etoposide|mesh-list
92543897|NCT00032019|Vincristine|vincristine|mesh-list
92543898|NCT00032019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92543899|NCT00032019|Immunologic Factors|immunologic factors|mesh-ancestor
92543900|NCT00032019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543901|NCT00032019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92543902|NCT00032019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92543903|NCT00032019|Alkylating Agents|alkylating agents|mesh-ancestor
92543904|NCT00032019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543905|NCT00032019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543906|NCT00032019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92543907|NCT00032019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92543908|NCT00032019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92543909|NCT00032019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92543910|NCT00032019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92543911|NCT00032019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92543912|NCT00032019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92543952|NCT00032136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92543953|NCT00032136|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92543954|NCT00032136|Hormone Antagonists|hormone antagonists|mesh-ancestor
92543955|NCT00032136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92543956|NCT00032136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92543957|NCT00032136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92543958|NCT00032136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92543959|NCT00032136|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92543960|NCT00032136|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92543961|NCT00032136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92543962|NCT00032136|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92543963|NCT00032136|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92543964|NCT00032136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544011|NCT00032838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92544012|NCT00032838|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544013|NCT00032838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544014|NCT00032838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544015|NCT00032838|Urological Agents|urological agents|mesh-ancestor
92544016|NCT03150797|Melatonin|melatonin|mesh-list
92544017|NCT03150797|Antioxidants|antioxidants|mesh-ancestor
92544018|NCT03150797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544019|NCT03150797|Protective Agents|protective agents|mesh-ancestor
92544020|NCT03150797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544021|NCT03150797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544073|NCT00033033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544074|NCT00033033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544075|NCT00033033|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544076|NCT00033033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544077|NCT03150368|Docetaxel|docetaxel|mesh-list
92544078|NCT03150368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544079|NCT03150368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92544080|NCT03150368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92544081|NCT03150368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92544082|NCT03150368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544083|NCT00033072|Selegiline|selegiline|mesh-list
92544084|NCT00033072|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544085|NCT00033072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544086|NCT00033072|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92544097|NCT00033111|Cabergoline|cabergoline|mesh-list
92544135|NCT02984384|Dalteparin|dalteparin|mesh-list
92544136|NCT02984384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92544137|NCT02984384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544138|NCT02984384|Analgesics|analgesics|mesh-ancestor
92544139|NCT02984384|Sensory System Agents|sensory system agents|mesh-ancestor
92544140|NCT02984384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544141|NCT02984384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544142|NCT02984384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544143|NCT02984384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544144|NCT02984384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92544145|NCT02984384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92544147|NCT02984384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92544197|NCT00033696|Topotecan|topotecan|mesh-list
92544198|NCT00033696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92544199|NCT00033696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544200|NCT00033696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92544201|NCT00033696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92544202|NCT00033696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92544203|NCT00033696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544204|NCT00033696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92544205|NCT00033696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92544206|NCT00033696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544208|NCT02548559|Cannabidiol|cannabidiol|mesh-list
92544260|NCT02035397|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92544261|NCT02035397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544262|NCT02035397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544263|NCT02035397|Cholinergic Agents|cholinergic agents|mesh-ancestor
92544264|NCT02035397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544265|NCT02035397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544266|NCT02035397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92544267|NCT02035397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544268|NCT00034047|Nafarelin|nafarelin|mesh-list
92544269|NCT00034047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92544270|NCT00034047|Fertility Agents|fertility agents|mesh-ancestor
92544271|NCT00034047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92544272|NCT00034047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544273|NCT00034086|Ritonavir|ritonavir|mesh-list
92544274|NCT00034086|Lopinavir|lopinavir|mesh-list
92544275|NCT00034086|Tenofovir|tenofovir|mesh-list
92544319|NCT00034242|gamma-Globulins|gamma-globulins|mesh-list
92544320|NCT00034242|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92544321|NCT00034242|Immunologic Factors|immunologic factors|mesh-ancestor
92544322|NCT00034242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544323|NCT01807325|Pancrelipase|pancrelipase|mesh-list
92544324|NCT01807325|Pancreatin|pancreatin|mesh-list
92544325|NCT01807325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544326|NCT01807286|Dexamethasone|dexamethasone|mesh-list
92544327|NCT01807286|Melphalan|melphalan|mesh-list
92544328|NCT01807286|Pomalidomide|pomalidomide|mesh-list
92544329|NCT01807286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544330|NCT01807286|Antiemetics|antiemetics|mesh-ancestor
92544331|NCT01807286|Autonomic Agents|autonomic agents|mesh-ancestor
92544332|NCT01807286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544333|NCT01807286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544334|NCT01807286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544335|NCT01807286|Glucocorticoids|glucocorticoids|mesh-ancestor
92544336|NCT01807286|Hormones|hormones|mesh-ancestor
92544337|NCT01807286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544338|NCT01807286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92544339|NCT01807286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544340|NCT01807286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92544341|NCT01807286|Alkylating Agents|alkylating agents|mesh-ancestor
92544342|NCT01807286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544343|NCT01807286|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92544344|NCT01807286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544345|NCT01807286|Immunologic Factors|immunologic factors|mesh-ancestor
92544346|NCT01807286|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92544347|NCT01807286|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92544348|NCT01807286|Growth Substances|growth substances|mesh-ancestor
92544349|NCT01807286|Growth Inhibitors|growth inhibitors|mesh-ancestor
92544350|NCT00034359|Lamivudine|lamivudine|mesh-list
92544351|NCT00034359|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92544352|NCT00034359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92544353|NCT00034359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627464|NCT03259503|Melphalan|melphalan|mesh-list
92627465|NCT03259503|Busulfan|busulfan|mesh-list
92627466|NCT03259503|Olaparib|olaparib|mesh-list
92627467|NCT03259503|Mechlorethamine|mechlorethamine|mesh-list
92627468|NCT03259503|Vorinostat|vorinostat|mesh-list
92627469|NCT03259503|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92627470|NCT03259503|Antibodies|antibodies|mesh-list
92627471|NCT03259503|Immunoglobulins|immunoglobulins|mesh-list
92544354|NCT00034359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544355|NCT00034359|Antiviral Agents|antiviral agents|mesh-ancestor
92544356|NCT00034359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544357|NCT00034359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92544358|NCT00034359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92544359|NCT00034593|Gemcitabine|gemcitabine|mesh-list
92544360|NCT00034593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92544361|NCT00034593|Antimetabolites|antimetabolites|mesh-ancestor
92544362|NCT00034593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544363|NCT00034593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544364|NCT00034632|Posaconazole|posaconazole|mesh-list
92544365|NCT00034632|Antifungal Agents|antifungal agents|mesh-ancestor
92544366|NCT00034632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544413|NCT01806857|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92544414|NCT01806857|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92544415|NCT01806857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544416|NCT01806857|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92544417|NCT01806857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92544418|NCT00034710|Capsaicin|capsaicin|mesh-list
92544419|NCT00034710|Antipruritics|antipruritics|mesh-ancestor
92544420|NCT00034710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92544421|NCT00034710|Sensory System Agents|sensory system agents|mesh-ancestor
92544422|NCT00034710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544423|NCT00034710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544424|NCT00034749|Risperidone|risperidone|mesh-list
92544425|NCT00034749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92544426|NCT00034749|Serotonin Agents|serotonin agents|mesh-ancestor
92544427|NCT00034749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544428|NCT00034749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544429|NCT00034749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544430|NCT00034749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92544431|NCT00034749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92544432|NCT00034749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544433|NCT00034749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544434|NCT00034749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92544435|NCT00034749|Dopamine Agents|dopamine agents|mesh-ancestor
92544436|NCT00034788|Becaplermin|becaplermin|mesh-list
92544437|NCT00034788|Anticoagulants|anticoagulants|mesh-ancestor
92544438|NCT00034788|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92544460|NCT00034905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92544461|NCT00034905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544462|NCT00034905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544463|NCT00034905|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92544464|NCT00034905|Dopamine Agents|dopamine agents|mesh-ancestor
92544465|NCT00034905|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544466|NCT01806311|Amlodipine|amlodipine|mesh-list
92544467|NCT01806311|Candesartan|candesartan|mesh-list
92544468|NCT01806311|Candesartan cilexetil|candesartan cilexetil|mesh-list
92544469|NCT01806311|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92544470|NCT01806311|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92544471|NCT01806311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544472|NCT01806311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544473|NCT01806311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92544474|NCT01806311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544475|NCT01806311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92544476|NCT01806311|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92544516|NCT00035061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544517|NCT00035061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544518|NCT00035061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92544519|NCT00035061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92544520|NCT00393497|Bevacizumab|bevacizumab|mesh-list
92544521|NCT00393497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92544522|NCT00393497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544523|NCT00393497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92544524|NCT00393497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92544525|NCT00393497|Growth Substances|growth substances|mesh-ancestor
92544526|NCT00393497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544527|NCT00393497|Growth Inhibitors|growth inhibitors|mesh-ancestor
92544528|NCT00035100|Epothilones|epothilones|mesh-list
92544529|NCT00035100|Epothilone B|epothilone b|mesh-list
92544530|NCT00035100|Tubulin Modulators|tubulin modulators|mesh-ancestor
92544531|NCT00035100|Antimitotic Agents|antimitotic agents|mesh-ancestor
92544532|NCT00035100|Mitosis Modulators|mitosis modulators|mesh-ancestor
92544533|NCT00035100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544534|NCT00035100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544535|NCT00035139|Methylphenidate|methylphenidate|mesh-list
92544536|NCT00035139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92544537|NCT00035139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544567|NCT00035295|Autonomic Agents|autonomic agents|mesh-ancestor
92544568|NCT00035295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544569|NCT00035295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544570|NCT00035295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544571|NCT00035295|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92544572|NCT00035295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544573|NCT00035295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544574|NCT01806116|Decitabine|decitabine|mesh-list
92544575|NCT01806116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92544576|NCT01806116|Antimetabolites|antimetabolites|mesh-ancestor
92544577|NCT01806116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544578|NCT01806116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544579|NCT01806116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544580|NCT00035451|Sotalol|sotalol|mesh-list
92544581|NCT00035451|Azimilide|azimilide|mesh-list
92544582|NCT00035451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92544583|NCT00035451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92544584|NCT00035451|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544585|NCT00035451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544586|NCT00035451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544587|NCT00035451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544588|NCT00035451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92544589|NCT00035451|Sympatholytics|sympatholytics|mesh-ancestor
92544590|NCT00035451|Autonomic Agents|autonomic agents|mesh-ancestor
92544591|NCT00035451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544592|NCT00035451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92544593|NCT00035451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544594|NCT00035451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92544610|NCT02971254|Desflurane|desflurane|mesh-list
92544611|NCT02971254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92544612|NCT02971254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92544613|NCT02971254|Anesthetics, General|anesthetics, general|mesh-ancestor
92544614|NCT02971254|Anesthetics|anesthetics|mesh-ancestor
92544615|NCT02971254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544616|NCT02971254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544617|NCT01805882|Sofosbuvir|sofosbuvir|mesh-list
92544618|NCT01805882|Ledipasvir|ledipasvir|mesh-list
92544619|NCT01805882|Antiviral Agents|antiviral agents|mesh-ancestor
92544620|NCT01805882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92544621|NCT00035802|Topiramate|topiramate|mesh-list
92544622|NCT00035802|Anticonvulsants|anticonvulsants|mesh-ancestor
92544623|NCT00035802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92544624|NCT00035802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544625|NCT04732377|Dexmedetomidine|dexmedetomidine|mesh-list
92544626|NCT04732377|Bupivacaine|bupivacaine|mesh-list
92544627|NCT04732377|Anesthetics, Local|anesthetics, local|mesh-ancestor
92544628|NCT04732377|Anesthetics|anesthetics|mesh-ancestor
92544670|NCT00035958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92544671|NCT00035958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544672|NCT00035958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92544673|NCT00035958|Abortifacient Agents|abortifacient agents|mesh-ancestor
92544674|NCT00035958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92544675|NCT00035958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92544676|NCT00035958|Antimetabolites|antimetabolites|mesh-ancestor
92544677|NCT00035958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544678|NCT00035958|Dermatologic Agents|dermatologic agents|mesh-ancestor
92544679|NCT00035958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544680|NCT00035958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92544681|NCT00035958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544682|NCT00035958|Immunologic Factors|immunologic factors|mesh-ancestor
92544683|NCT00035958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544684|NCT00035958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92544685|NCT00035958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92544686|NCT00035958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544687|NCT00035958|Analgesics|analgesics|mesh-ancestor
92544688|NCT00035958|Sensory System Agents|sensory system agents|mesh-ancestor
92544689|NCT00035958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544690|NCT00035958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544691|NCT01805687|Zileuton|zileuton|mesh-list
92544692|NCT01805687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92544693|NCT01805687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544694|NCT01805687|Analgesics|analgesics|mesh-ancestor
92544695|NCT01805687|Sensory System Agents|sensory system agents|mesh-ancestor
92544696|NCT01805687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544697|NCT01805687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544698|NCT01805687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92544699|NCT01805687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544700|NCT01805687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92544701|NCT01805687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544702|NCT01805687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544703|NCT01805687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92544704|NCT01805687|Hormone Antagonists|hormone antagonists|mesh-ancestor
92627472|NCT03259503|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92627473|NCT03259503|Immunologic Factors|immunologic factors|mesh-ancestor
92544705|NCT01805687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544706|NCT00035997|Zoledronic Acid|zoledronic acid|mesh-list
92544707|NCT00035997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92544708|NCT00035997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544709|NCT01805570|Ticagrelor|ticagrelor|mesh-list
92544710|NCT01805570|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92544711|NCT01805570|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92544712|NCT01805570|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92544713|NCT01805570|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92544714|NCT01805570|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92544715|NCT01805570|Purinergic Agents|purinergic agents|mesh-ancestor
92544716|NCT01805570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544717|NCT01805570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544718|NCT01805570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544745|NCT01805453|Losartan|losartan|mesh-list
92544761|NCT00036153|Dermatologic Agents|dermatologic agents|mesh-ancestor
92544762|NCT00036153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544763|NCT00036153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92544764|NCT00036153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92544765|NCT00036153|Immunologic Factors|immunologic factors|mesh-ancestor
92544766|NCT00036153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544767|NCT00036153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92544768|NCT00036153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92544769|NCT00036231|Secretin|secretin|mesh-list
92544770|NCT00036231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544771|NCT00036231|Hormones|hormones|mesh-ancestor
92544772|NCT00036231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544773|NCT00036231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544774|NCT00036309|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92544775|NCT00036309|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92544776|NCT00036309|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92544777|NCT00036309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92544778|NCT00036309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544779|NCT00036309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544780|NCT00036309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544781|NCT00036309|Analgesics|analgesics|mesh-ancestor
92544782|NCT00036309|Sensory System Agents|sensory system agents|mesh-ancestor
92544783|NCT00036309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544809|NCT00036387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92544810|NCT00036387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544811|NCT00036426|Immunomodulating Agents|immunomodulating agents|mesh-list
92544812|NCT00036426|Immunologic Factors|immunologic factors|mesh-ancestor
92544813|NCT00036426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544814|NCT01466543|Udenafil|udenafil|mesh-list
92544815|NCT01466543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92544816|NCT01466543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92544817|NCT01466543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544818|NCT01466543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544819|NCT01466465|Vitamin D|vitamin d|mesh-list
92544820|NCT01466465|Cholecalciferol|cholecalciferol|mesh-list
92544821|NCT01466465|Vitamins|vitamins|mesh-ancestor
92544822|NCT01466465|Micronutrients|micronutrients|mesh-ancestor
92544823|NCT01466465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544824|NCT01466465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92544825|NCT01466465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92544826|NCT00036504|Insulin Lispro|insulin lispro|mesh-list
92544827|NCT00036504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92544828|NCT00036504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544863|NCT01466114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544864|NCT01466114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92544865|NCT01466114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92544866|NCT01466114|Hormones|hormones|mesh-ancestor
92544867|NCT01466114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544868|NCT00036777|Carboplatin|carboplatin|mesh-list
92544869|NCT00036777|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92544870|NCT00036777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544871|NCT00036777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92544872|NCT00036777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544873|NCT00036777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544874|NCT01465919|Mirtazapine|mirtazapine|mesh-list
92544875|NCT01465919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92544876|NCT01465919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92544877|NCT01465919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92544878|NCT01465919|Histamine Antagonists|histamine antagonists|mesh-ancestor
92544879|NCT01465919|Histamine Agents|histamine agents|mesh-ancestor
92544880|NCT01465919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544881|NCT01465919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544882|NCT01465919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544884|NCT01465919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92544885|NCT01465919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92544886|NCT01465919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92544887|NCT01465919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92544888|NCT01465919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92544889|NCT01465919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92544890|NCT01465919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92544891|NCT01465919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92544892|NCT01465919|Serotonin Agents|serotonin agents|mesh-ancestor
92544893|NCT01465919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92544904|NCT00396513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92544905|NCT00036855|Rituximab|rituximab|mesh-list
92544906|NCT00036855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92544907|NCT00036855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92544908|NCT00036855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92544909|NCT00036855|Immunologic Factors|immunologic factors|mesh-ancestor
92544910|NCT00036855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544911|NCT00036855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92544912|NCT00036894|Lenalidomide|lenalidomide|mesh-list
92544913|NCT00036894|Immunologic Factors|immunologic factors|mesh-ancestor
92544914|NCT00036894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544915|NCT00036894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92544968|NCT01465412|Purinergic Agonists|purinergic agonists|mesh-ancestor
92544969|NCT01465412|Purinergic Agents|purinergic agents|mesh-ancestor
92544970|NCT01465412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92544971|NCT01465412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92544972|NCT01465373|Progesterone|progesterone|mesh-list
92544973|NCT01465373|Progestins|progestins|mesh-ancestor
92544974|NCT01465373|Hormones|hormones|mesh-ancestor
92544975|NCT01465373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92544976|NCT01465373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92544977|NCT01465256|Aspirin|aspirin|mesh-list
92544978|NCT01465256|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92544979|NCT01465256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92544980|NCT01465256|Analgesics|analgesics|mesh-ancestor
92544981|NCT01465256|Sensory System Agents|sensory system agents|mesh-ancestor
92544982|NCT01465256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92544983|NCT01465256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545026|NCT01464944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545027|NCT01464944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545028|NCT01464944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269758|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
92545029|NCT01464944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92545030|NCT01464944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92545031|NCT01464944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545032|NCT01464944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92545033|NCT01464944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92545034|NCT01464944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545035|NCT01464944|Antipyretics|antipyretics|mesh-ancestor
92545036|NCT00037596|Cytarabine|cytarabine|mesh-list
92545037|NCT00037596|Gemtuzumab|gemtuzumab|mesh-list
92545038|NCT00037596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92545039|NCT00037596|Antimetabolites|antimetabolites|mesh-ancestor
92545040|NCT00037596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545041|NCT00037596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545042|NCT00037596|Antiviral Agents|antiviral agents|mesh-ancestor
92545043|NCT00037596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545044|NCT00037596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545045|NCT00037596|Immunologic Factors|immunologic factors|mesh-ancestor
92545046|NCT00037596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545047|NCT00037596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545048|NCT00037596|Immunotoxins|immunotoxins|mesh-ancestor
92545049|NCT00037596|Immunoconjugates|immunoconjugates|mesh-ancestor
92545050|NCT00037635|Cinacalcet|cinacalcet|mesh-list
92545051|NCT00037635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92545073|NCT01464671|Protease Inhibitors|protease inhibitors|mesh-ancestor
92545074|NCT01464671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545075|NCT00037869|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92545076|NCT00037869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545077|NCT00037869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545078|NCT00037869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545079|NCT00037869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92545080|NCT00393731|Misoprostol|misoprostol|mesh-list
92545081|NCT00393731|Oxytocin|oxytocin|mesh-list
92545082|NCT00393731|Oxytocics|oxytocics|mesh-ancestor
92545083|NCT00393731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92545084|NCT00393731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545085|NCT00393731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92545086|NCT00393731|Abortifacient Agents|abortifacient agents|mesh-ancestor
92545096|NCT00393770|Vitamins|vitamins|mesh-ancestor
92545135|NCT00038220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92545136|NCT00038220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92545138|NCT00038259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545139|NCT00038259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92545140|NCT00038259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92545141|NCT00038259|Antiviral Agents|antiviral agents|mesh-ancestor
92545142|NCT00038259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545143|NCT00847418|Esketamine|esketamine|mesh-list
92545144|NCT00847418|Antidepressive Agents|antidepressive agents|mesh-ancestor
92545145|NCT00847418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92545146|NCT05433597|Cisplatin|cisplatin|mesh-list
92545147|NCT05433597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545197|NCT00396747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545198|NCT00396747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545199|NCT00396747|Dermatologic Agents|dermatologic agents|mesh-ancestor
92545200|NCT00396747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545201|NCT00396747|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92545202|NCT00396747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92545203|NCT00396747|Immunologic Factors|immunologic factors|mesh-ancestor
92545204|NCT00396747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545205|NCT00396747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92545206|NCT00396747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545207|NCT00396747|Antiemetics|antiemetics|mesh-ancestor
92545208|NCT00396747|Autonomic Agents|autonomic agents|mesh-ancestor
92545209|NCT00396747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545210|NCT00396747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545211|NCT00396747|Glucocorticoids|glucocorticoids|mesh-ancestor
92545257|NCT00846911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545258|NCT00846911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545259|NCT00846911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92545260|NCT00846911|Contraceptive Agents|contraceptive agents|mesh-ancestor
92545261|NCT00846911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92545262|NCT00846911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545263|NCT00846911|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92545264|NCT00846911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92545265|NCT00846911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92545266|NCT00846872|Mannitol|mannitol|mesh-list
92545267|NCT00846872|Hormones|hormones|mesh-list
92545268|NCT00846872|Secretagogues|secretagogues|mesh-list
92545269|NCT00846872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545270|NCT00846872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545271|NCT00846872|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92545272|NCT00846872|Diuretics|diuretics|mesh-ancestor
92545314|NCT05428683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545315|NCT05428683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545316|NCT05428683|Glucocorticoids|glucocorticoids|mesh-ancestor
92545318|NCT05428683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545319|NCT05424549|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92545320|NCT05424549|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92545321|NCT00846443|Cisplatin|cisplatin|mesh-list
92545322|NCT00846443|Pemetrexed|pemetrexed|mesh-list
92545323|NCT00846443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545324|NCT00846443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545325|NCT00846443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545326|NCT00846443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92545327|NCT00846443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92545328|NCT00846326|Fluticasone|fluticasone|mesh-list
92545329|NCT00846326|Xhance|xhance|mesh-list
92545373|NCT05116059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545374|NCT05116059|Antifungal Agents|antifungal agents|mesh-ancestor
92545375|NCT00845936|Metformin|metformin|mesh-list
92545376|NCT00845936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92545377|NCT00845936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545378|NCT00277082|Camptothecin|camptothecin|mesh-list
92545379|NCT00277082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92545380|NCT00277082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545381|NCT00277082|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92545382|NCT00277082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545383|NCT00277082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545384|NCT00277082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545385|NCT04888377|Aspirin|aspirin|mesh-list
92545386|NCT04888377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92545387|NCT04888377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92545388|NCT04888377|Analgesics|analgesics|mesh-ancestor
92545389|NCT04888377|Sensory System Agents|sensory system agents|mesh-ancestor
92545390|NCT04888377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545400|NCT04888377|Antipyretics|antipyretics|mesh-ancestor
92545428|NCT00276926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545429|NCT00276926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545430|NCT00396786|Enoxaparin|enoxaparin|mesh-list
92545431|NCT00396786|Rivaroxaban|rivaroxaban|mesh-list
92545432|NCT00396786|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92545433|NCT00396786|Antithrombins|antithrombins|mesh-ancestor
92545434|NCT00396786|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92545435|NCT00396786|Protease Inhibitors|protease inhibitors|mesh-ancestor
92545436|NCT00396786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545437|NCT00396786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545438|NCT00396786|Anticoagulants|anticoagulants|mesh-ancestor
92545439|NCT00396786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92545440|NCT00396786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92545441|NCT00276848|Vidarabine|vidarabine|mesh-list
92545442|NCT00276848|Cyclophosphamide|cyclophosphamide|mesh-list
92545443|NCT00276848|Fludarabine|fludarabine|mesh-list
92545488|NCT00276809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92545489|NCT00276809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92545490|NCT00276809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545491|NCT00276809|Antiviral Agents|antiviral agents|mesh-ancestor
92545492|NCT00276809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92545493|NCT00276809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545495|NCT00276770|Cariostatic Agents|cariostatic agents|mesh-ancestor
92545496|NCT00276770|Protective Agents|protective agents|mesh-ancestor
92545497|NCT00276770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545498|NCT00276731|Cyclophosphamide|cyclophosphamide|mesh-list
92545499|NCT00276731|Carboplatin|carboplatin|mesh-list
92545500|NCT00276731|Etoposide|etoposide|mesh-list
92545553|NCT04430790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545554|NCT04430790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270288|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
92545555|NCT00041340|Imatinib Mesylate|imatinib mesylate|mesh-list
92545556|NCT00041340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545557|NCT00041340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92545558|NCT00041340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545559|NCT00041340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545560|NCT00276185|Botulinum Toxins|botulinum toxins|mesh-list
92545561|NCT00276185|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92545562|NCT00276185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545563|NCT00276185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545564|NCT00276185|Cholinergic Agents|cholinergic agents|mesh-ancestor
92545565|NCT00276185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545566|NCT00276185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545568|NCT00276146|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92545569|NCT00276146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545570|NCT00276146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545571|NCT00276146|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92545572|NCT00276146|Vasodilator Agents|vasodilator agents|mesh-ancestor
92545573|NCT00276107|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91953106|NCT05114499|Donepezil|donepezil|mesh-list
92627474|NCT03259503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627475|NCT03259503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627476|NCT03259503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627477|NCT03259503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627478|NCT03259503|Antimetabolites|antimetabolites|mesh-ancestor
92627479|NCT03259503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627480|NCT03259503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627481|NCT03259503|Alkylating Agents|alkylating agents|mesh-ancestor
92627482|NCT03259503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92627483|NCT03259503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627484|NCT03259503|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92627485|NCT03259503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627486|NCT03259503|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92627487|NCT03217565|Tedizolid|tedizolid|mesh-list
92627488|NCT03217565|Tedizolid phosphate|tedizolid phosphate|mesh-list
92627489|NCT03217565|Oxazolidinones|oxazolidinones|mesh-list
92627490|NCT03217565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92627491|NCT03217565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627492|NCT03217565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92627493|NCT03217565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034450|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92627496|NCT03214562|Fludarabine|fludarabine|mesh-list
92627497|NCT03214562|Venetoclax|venetoclax|mesh-list
92627498|NCT03214562|Idarubicin|idarubicin|mesh-list
92627499|NCT03214562|Lenograstim|lenograstim|mesh-list
92627500|NCT03214562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627501|NCT03214562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627502|NCT03214562|Antimetabolites|antimetabolites|mesh-ancestor
92545574|NCT00276107|Immunologic Factors|immunologic factors|mesh-ancestor
92545575|NCT00276107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545576|NCT04201665|Oxytocin|oxytocin|mesh-list
92545577|NCT04201665|Carbetocin|carbetocin|mesh-list
92545578|NCT04201665|Oxytocics|oxytocics|mesh-ancestor
92361962|NCT00614406|Analgesics|analgesics|mesh-ancestor
92545579|NCT04201665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92545580|NCT04201665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545581|NCT00276068|Lidocaine|lidocaine|mesh-list
92545582|NCT00276068|Desipramine|desipramine|mesh-list
92545583|NCT00276068|Anesthetics, Local|anesthetics, local|mesh-ancestor
92545584|NCT00276068|Anesthetics|anesthetics|mesh-ancestor
92545585|NCT00276068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92545586|NCT00276068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545587|NCT00276068|Sensory System Agents|sensory system agents|mesh-ancestor
92545588|NCT00276068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545589|NCT00276068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92545590|NCT00276068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92545591|NCT00276068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92545592|NCT00276068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545629|NCT04149210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92545630|NCT04149210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545631|NCT04149210|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92545632|NCT00275951|Cetuximab|cetuximab|mesh-list
92545633|NCT00275951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545634|NCT00275951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92545635|NCT00275912|Oxcarbazepine|oxcarbazepine|mesh-list
92545636|NCT00275912|Anticonvulsants|anticonvulsants|mesh-ancestor
92545637|NCT00275912|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92545638|NCT00275912|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92545639|NCT00275912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545640|NCT00275912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545641|NCT00275912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92545686|NCT00275639|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92545687|NCT00275639|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92545688|NCT00275639|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92545689|NCT00275639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545691|NCT03957057|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92545692|NCT03957057|Trace Elements|trace elements|mesh-ancestor
92545693|NCT03957057|Micronutrients|micronutrients|mesh-ancestor
92545694|NCT03957057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545695|NCT03957057|Hematinics|hematinics|mesh-ancestor
92545696|NCT00275600|Vitamin E|vitamin e|mesh-list
92545697|NCT00275600|Vitamins|vitamins|mesh-ancestor
92545698|NCT00275600|Micronutrients|micronutrients|mesh-ancestor
92545699|NCT00275600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545700|NCT00275600|Antioxidants|antioxidants|mesh-ancestor
92545701|NCT00275600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545702|NCT00275600|Protective Agents|protective agents|mesh-ancestor
92545749|NCT00041574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545750|NCT00041574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545751|NCT00041574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92545752|NCT00041574|Respiratory System Agents|respiratory system agents|mesh-ancestor
92545753|NCT00041574|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92545754|NCT00041574|Antioxidants|antioxidants|mesh-ancestor
92545755|NCT00041574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545756|NCT00041574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545757|NCT00041574|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92545758|NCT00041574|Vasodilator Agents|vasodilator agents|mesh-ancestor
92545759|NCT00041574|Gasotransmitters|gasotransmitters|mesh-ancestor
92545760|NCT00041574|Protective Agents|protective agents|mesh-ancestor
92545761|NCT00275132|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92545808|NCT00275054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92545809|NCT00275054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92545810|NCT03208179|Azithromycin|azithromycin|mesh-list
92545811|NCT03208179|Pyrimethamine|pyrimethamine|mesh-list
92545812|NCT03208179|Piperaquine|piperaquine|mesh-list
92545813|NCT03208179|Sulfadoxine|sulfadoxine|mesh-list
92545814|NCT03208179|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92545815|NCT03208179|Artenimol|artenimol|mesh-list
92545816|NCT03208179|Artemisinins|artemisinins|mesh-list
92545817|NCT03208179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92545875|NCT03062826|Analgesics|analgesics|mesh-ancestor
92545876|NCT03062826|Sensory System Agents|sensory system agents|mesh-ancestor
92545877|NCT03062826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545878|NCT03062826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545879|NCT03062826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92545880|NCT03062826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545881|NCT03062826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92545882|NCT03062826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92545883|NCT03062826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545884|NCT03062826|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92545885|NCT03062826|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92545886|NCT03062826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92545887|NCT03062826|Antipyretics|antipyretics|mesh-ancestor
92545888|NCT03062826|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92545889|NCT03062826|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92545890|NCT03062826|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92545891|NCT03062826|Purinergic Agents|purinergic agents|mesh-ancestor
92545892|NCT03062826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92545930|NCT00394394|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92545931|NCT00394394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92545932|NCT00394394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545933|NCT00394394|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92545934|NCT00394394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92545935|NCT00130091|Clonidine|clonidine|mesh-list
92545936|NCT00130091|Analgesics|analgesics|mesh-ancestor
92545937|NCT00130091|Sensory System Agents|sensory system agents|mesh-ancestor
92545938|NCT00130091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92545939|NCT00130091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92545940|NCT00130091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92545941|NCT00130091|Sympatholytics|sympatholytics|mesh-ancestor
92545942|NCT00130091|Autonomic Agents|autonomic agents|mesh-ancestor
92545943|NCT00130091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92545944|NCT00130091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92545945|NCT00130091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92545946|NCT00130091|Adrenergic Agents|adrenergic agents|mesh-ancestor
92545986|NCT00129506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92545987|NCT00129506|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92545988|NCT00129506|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92545989|NCT00129506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92545991|NCT00129233|Amlodipine|amlodipine|mesh-list
92545992|NCT00129233|Valsartan|valsartan|mesh-list
92545993|NCT00129233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92545994|NCT00129233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92545995|NCT00129233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92545996|NCT00129233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92545997|NCT00129233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92546047|NCT00129038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92546048|NCT00129038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546049|NCT00129038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92546050|NCT00129038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92546051|NCT00129038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546052|NCT00129038|Antipyretics|antipyretics|mesh-ancestor
92546053|NCT00129038|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92546054|NCT00129038|Vasodilator Agents|vasodilator agents|mesh-ancestor
92546055|NCT00470223|Zoledronic Acid|zoledronic acid|mesh-list
92546056|NCT00470223|Doxorubicin|doxorubicin|mesh-list
92546057|NCT00470223|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92546058|NCT00470223|Methotrexate|methotrexate|mesh-list
92546060|NCT00470223|Ifosfamide|ifosfamide|mesh-list
92546061|NCT00470223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546109|NCT00038376|Isotretinoin|isotretinoin|mesh-list
92546110|NCT00038376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546111|NCT00038376|Antiviral Agents|antiviral agents|mesh-ancestor
92546112|NCT00038376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546113|NCT00038376|Immunologic Factors|immunologic factors|mesh-ancestor
92546114|NCT00038376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546115|NCT00038376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92546116|NCT00128531|Leuprolide|leuprolide|mesh-list
92546117|NCT00128531|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92546118|NCT00128531|Fertility Agents|fertility agents|mesh-ancestor
92546119|NCT00128531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92546120|NCT00128531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546121|NCT00128531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92546122|NCT00128531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546123|NCT00038454|Chrysarobin|chrysarobin|mesh-list
92546171|NCT00038532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546172|NCT00038532|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92546173|NCT00038532|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92546174|NCT00038532|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92546175|NCT00038532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92546176|NCT00038532|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92546177|NCT00038532|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92546178|NCT00038532|Antitubercular Agents|antitubercular agents|mesh-ancestor
92546179|NCT00038532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92546180|NCT00038571|Bortezomib|bortezomib|mesh-list
92546181|NCT00038571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546182|NCT05770687|Dapagliflozin|dapagliflozin|mesh-list
92546183|NCT05770687|Empagliflozin|empagliflozin|mesh-list
92546184|NCT05770687|Ertugliflozin|ertugliflozin|mesh-list
92546185|NCT05770687|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92546186|NCT05770687|Ipragliflozin|ipragliflozin|mesh-list
92546228|NCT05769569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546229|NCT05769049|Vaccines|vaccines|mesh-list
92546230|NCT05769049|Immunologic Factors|immunologic factors|mesh-ancestor
92546231|NCT05769049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546232|NCT05768997|Darbepoetin alfa|darbepoetin alfa|mesh-list
92546233|NCT05768997|Hematinics|hematinics|mesh-ancestor
92546234|NCT05768945|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92546235|NCT05768945|Protease Inhibitors|protease inhibitors|mesh-ancestor
92546236|NCT05768945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546237|NCT05768945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546240|NCT05765305|Chromium|chromium|mesh-list
92546292|NCT05736978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546293|NCT05736978|Antimetabolites|antimetabolites|mesh-ancestor
92546294|NCT05736978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546295|NCT05736978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546296|NCT05736978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546297|NCT05736965|Azacitidine|azacitidine|mesh-list
92546298|NCT05736965|Venetoclax|venetoclax|mesh-list
92546299|NCT05736965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92546300|NCT05736965|Antimetabolites|antimetabolites|mesh-ancestor
92546301|NCT05736965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546302|NCT05736965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546303|NCT05736965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546304|NCT05706727|Phenylephrine|phenylephrine|mesh-list
92546305|NCT05706727|Oxymetazoline|oxymetazoline|mesh-list
92546306|NCT05706727|Mephentermine|mephentermine|mesh-list
92546307|NCT05706727|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92546308|NCT05706727|Mydriatics|mydriatics|mesh-ancestor
92546351|NCT05672225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546353|NCT05663580|Cabotegravir|cabotegravir|mesh-list
92546354|NCT05663580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92546355|NCT05663580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546356|NCT05663580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546357|NCT05663580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546358|NCT05663580|Antiviral Agents|antiviral agents|mesh-ancestor
92546359|NCT05663580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546360|NCT05663580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92546361|NCT05663580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92546362|NCT05663580|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92546363|NCT05663580|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92546364|NCT05657860|Guanfacine|guanfacine|mesh-list
92546365|NCT05657860|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92546366|NCT05657860|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92546367|NCT05657860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92546368|NCT05657860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92546369|NCT05657860|Adrenergic Agents|adrenergic agents|mesh-ancestor
92546370|NCT05657860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546405|NCT05595603|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92546406|NCT05595603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546407|NCT05595603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546408|NCT05595603|Vasodilator Agents|vasodilator agents|mesh-ancestor
92546409|NCT05595603|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92546410|NCT05595603|Protective Agents|protective agents|mesh-ancestor
92546411|NCT05595603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546412|NCT05568940|Tibolone|tibolone|mesh-list
92546413|NCT05568940|Androgen Antagonists|androgen antagonists|mesh-ancestor
92546414|NCT05568940|Hormone Antagonists|hormone antagonists|mesh-ancestor
92546415|NCT05568940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92546416|NCT05568940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546417|NCT05568940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92546418|NCT05568940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92546419|NCT05568940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546420|NCT05568940|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92546421|NCT05568940|Anabolic Agents|anabolic agents|mesh-ancestor
92546422|NCT05568940|Hormones|hormones|mesh-ancestor
92546423|NCT05562973|Psilocybin|psilocybin|mesh-list
92546424|NCT05562973|Hallucinogens|hallucinogens|mesh-ancestor
92546425|NCT05562973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546426|NCT05562973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92546427|NCT05551299|Photosensitizing Agents|photosensitizing agents|mesh-list
92546428|NCT05551299|Dermatologic Agents|dermatologic agents|mesh-ancestor
92546429|NCT05543785|Ketorolac|ketorolac|mesh-list
92546455|NCT05427786|Vitamins|vitamins|mesh-ancestor
92546456|NCT05427786|Micronutrients|micronutrients|mesh-ancestor
92546457|NCT05427786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546458|NCT05417776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92546459|NCT05417776|Chelating Agents|chelating agents|mesh-ancestor
92546460|NCT05417776|Sequestering Agents|sequestering agents|mesh-ancestor
92546461|NCT05417776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546462|NCT05406505|Dapagliflozin|dapagliflozin|mesh-list
92546463|NCT05406505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92546464|NCT05406505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546465|NCT05406505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92546466|NCT05406505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546467|NCT05402553|Ondansetron|ondansetron|mesh-list
92546468|NCT05402553|Antiemetics|antiemetics|mesh-ancestor
92546469|NCT05402553|Autonomic Agents|autonomic agents|mesh-ancestor
92546470|NCT05402553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546471|NCT05402553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546472|NCT05402553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92546473|NCT05402553|Antipruritics|antipruritics|mesh-ancestor
92546474|NCT05402553|Dermatologic Agents|dermatologic agents|mesh-ancestor
92546475|NCT05402553|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92546476|NCT05402553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92546477|NCT05402553|Serotonin Agents|serotonin agents|mesh-ancestor
92546478|NCT05402553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546479|NCT05402553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546480|NCT05379322|Adalimumab|adalimumab|mesh-list
92546481|NCT05379322|Golimumab|golimumab|mesh-list
92546482|NCT05379322|Etanercept|etanercept|mesh-list
92546483|NCT05379322|Upadacitinib|upadacitinib|mesh-list
92546484|NCT05379322|Tofacitinib|tofacitinib|mesh-list
92546485|NCT05379322|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92546486|NCT05379322|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92546487|NCT05379322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92546488|NCT05379322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92546489|NCT05379322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92546490|NCT05379322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92546492|NCT05379322|Sensory System Agents|sensory system agents|mesh-ancestor
92546493|NCT05379322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546494|NCT05379322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546495|NCT05379322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92546496|NCT05379322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92546497|NCT05379322|Immunologic Factors|immunologic factors|mesh-ancestor
92546498|NCT05379322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92546499|NCT05379322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546500|NCT05379322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546501|NCT05301023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92546502|NCT05301023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92546554|NCT05222516|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92546555|NCT05222516|Immunologic Factors|immunologic factors|mesh-ancestor
92546556|NCT05222516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546557|NCT05215730|Copper|copper|mesh-list
92546558|NCT05215730|Trace Elements|trace elements|mesh-ancestor
92546559|NCT05215730|Micronutrients|micronutrients|mesh-ancestor
92546560|NCT05215730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546561|NCT05209074|Ivosidenib|ivosidenib|mesh-list
92546562|NCT05209074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546563|NCT05209074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546564|NCT05209074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546565|NCT05192850|Metformin|metformin|mesh-list
92546566|NCT05192850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92546567|NCT05192850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546615|NCT05049603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92546616|NCT05049603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92546617|NCT05049603|Antimetabolites|antimetabolites|mesh-ancestor
92546618|NCT05049603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546619|NCT05049603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92546620|NCT05049603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92546621|NCT05049603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546622|NCT05037162|Fibrin fragment D|fibrin fragment d|mesh-list
92546623|NCT05037162|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92546624|NCT05037162|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92546678|NCT04985721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546679|NCT04952610|Etripamil|etripamil|mesh-list
92546680|NCT04952610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92546681|NCT04952610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92546682|NCT04952610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546683|NCT04952610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92546684|NCT04952610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546685|NCT04921189|Ascorbic Acid|ascorbic acid|mesh-list
92546686|NCT04921189|Thiamine|thiamine|mesh-list
92546687|NCT04921189|Hydrocortisone|hydrocortisone|mesh-list
92546688|NCT04921189|Antioxidants|antioxidants|mesh-ancestor
92546689|NCT04921189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546690|NCT04921189|Protective Agents|protective agents|mesh-ancestor
92546691|NCT04921189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546692|NCT04921189|Vitamins|vitamins|mesh-ancestor
92546736|NCT04854811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546737|NCT04854811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546738|NCT04846348|Diphenhydramine|diphenhydramine|mesh-list
92546739|NCT04846348|Promethazine|promethazine|mesh-list
92546740|NCT04846348|Cromolyn Sodium|cromolyn sodium|mesh-list
92546741|NCT04846348|Salicylates|salicylates|mesh-list
92546742|NCT04846348|Emollients|emollients|mesh-list
92546743|NCT04846348|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92546744|NCT04846348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92546745|NCT04846348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92546746|NCT04846348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546747|NCT04846348|Anesthetics, Local|anesthetics, local|mesh-ancestor
92546748|NCT04846348|Anesthetics|anesthetics|mesh-ancestor
92546749|NCT04846348|Sensory System Agents|sensory system agents|mesh-ancestor
92546750|NCT04846348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546751|NCT04846348|Antiemetics|antiemetics|mesh-ancestor
92546752|NCT04846348|Autonomic Agents|autonomic agents|mesh-ancestor
92546753|NCT04846348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92546754|NCT04846348|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92546794|NCT04769453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92546795|NCT04769453|Immunologic Factors|immunologic factors|mesh-ancestor
92546796|NCT04769453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546797|NCT04769453|Viscosupplements|viscosupplements|mesh-ancestor
92546798|NCT04769453|Protective Agents|protective agents|mesh-ancestor
92546799|NCT04765709|Carboplatin|carboplatin|mesh-list
92546800|NCT04765709|Pemetrexed|pemetrexed|mesh-list
92546801|NCT04765709|Durvalumab|durvalumab|mesh-list
92546802|NCT04765709|Vinorelbine|vinorelbine|mesh-list
92546803|NCT04765709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92546804|NCT04765709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546805|NCT04765709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546806|NCT04765709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546807|NCT04765709|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92546808|NCT04765709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546809|NCT04765709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92546810|NCT04765709|Immunologic Factors|immunologic factors|mesh-ancestor
92546811|NCT04765709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546812|NCT04765709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92546816|NCT04742699|Lemborexant|lemborexant|mesh-list
92546849|NCT04629534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546851|NCT04629534|Micronutrients|micronutrients|mesh-ancestor
92546852|NCT04629534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92546853|NCT04616183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92546854|NCT04616183|Cetuximab|cetuximab|mesh-list
92546855|NCT04616183|Antibodies|antibodies|mesh-list
92546856|NCT04616183|Immunoglobulins|immunoglobulins|mesh-list
92546857|NCT04616183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92546858|NCT04616183|Immunologic Factors|immunologic factors|mesh-ancestor
92546859|NCT04616183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546861|NCT04602065|Antibodies|antibodies|mesh-list
92546916|NCT04507711|Autonomic Agents|autonomic agents|mesh-ancestor
92546917|NCT04507711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546918|NCT04507711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546919|NCT04507711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92546920|NCT04507711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92546921|NCT04507711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92546922|NCT04507711|Serotonin Agents|serotonin agents|mesh-ancestor
92546923|NCT04507711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92546924|NCT04507711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546925|NCT04499274|Ondansetron|ondansetron|mesh-list
92546926|NCT04499274|Antiemetics|antiemetics|mesh-ancestor
92546927|NCT04499274|Autonomic Agents|autonomic agents|mesh-ancestor
92546928|NCT04499274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92546929|NCT04499274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92546930|NCT04499274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92546931|NCT04499274|Antipruritics|antipruritics|mesh-ancestor
92546932|NCT04499274|Dermatologic Agents|dermatologic agents|mesh-ancestor
92546933|NCT04499274|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92546935|NCT04499274|Serotonin Agents|serotonin agents|mesh-ancestor
92546973|NCT04351555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92546974|NCT04351555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92546975|NCT04321993|Antiviral Agents|antiviral agents|mesh-list
92546976|NCT04321993|Remdesivir|remdesivir|mesh-list
92546977|NCT04321993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92546978|NCT04321993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92546979|NCT04321993|Antimetabolites|antimetabolites|mesh-ancestor
92546980|NCT04321993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92546981|NCT04321993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92546982|NCT04321993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92546983|NCT04315948|Interferons|interferons|mesh-list
92546984|NCT04315948|Ritonavir|ritonavir|mesh-list
92546985|NCT04315948|Lopinavir|lopinavir|mesh-list
92546986|NCT04315948|Interferon-beta|interferon-beta|mesh-list
92546987|NCT04315948|Interferon beta-1a|interferon beta-1a|mesh-list
92546988|NCT04315948|Remdesivir|remdesivir|mesh-list
92546989|NCT04315948|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92546990|NCT04315948|Hydroxychloroquine|hydroxychloroquine|mesh-list
92546991|NCT04315948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92546992|NCT04315948|Antiviral Agents|antiviral agents|mesh-ancestor
92546993|NCT04315948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547029|NCT04256343|Deuterium Oxide|deuterium oxide|mesh-list
92547030|NCT04256343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547031|NCT04256343|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92547032|NCT04256343|Protective Agents|protective agents|mesh-ancestor
92547033|NCT04256343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547034|NCT04243629|Pramlintide|pramlintide|mesh-list
92547035|NCT04243629|Insulin, Short-Acting|insulin, short-acting|mesh-list
92547036|NCT04243629|Pancrelipase|pancrelipase|mesh-list
92547037|NCT04243629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92547038|NCT04243629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547039|NCT04243629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547040|NCT04202835|Cyclophosphamide|cyclophosphamide|mesh-list
92547041|NCT04202835|Thymoglobulin|thymoglobulin|mesh-list
92547042|NCT04202835|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92547043|NCT04202835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547044|NCT04202835|Immunologic Factors|immunologic factors|mesh-ancestor
92547045|NCT04202835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547046|NCT04202835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547047|NCT04202835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92547048|NCT04202835|Alkylating Agents|alkylating agents|mesh-ancestor
92547049|NCT04202835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547050|NCT04202835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547051|NCT04202835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92547052|NCT04199026|Sirolimus|sirolimus|mesh-list
92547053|NCT04199026|Doxorubicin|doxorubicin|mesh-list
92547054|NCT04199026|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92547055|NCT04199026|Daunorubicin|daunorubicin|mesh-list
92547056|NCT04199026|Irinotecan|irinotecan|mesh-list
92547057|NCT04199026|Vincristine|vincristine|mesh-list
92547058|NCT04199026|Everolimus|everolimus|mesh-list
92547059|NCT04199026|Temozolomide|temozolomide|mesh-list
92547060|NCT04199026|Temsirolimus|temsirolimus|mesh-list
92547061|NCT04199026|Ifosfamide|ifosfamide|mesh-list
92547062|NCT04199026|Isophosphamide mustard|isophosphamide mustard|mesh-list
92547063|NCT04199026|MTOR Inhibitors|mtor inhibitors|mesh-list
92547064|NCT04199026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92547072|NCT04199026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92547073|NCT04199026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92547074|NCT04199026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92547075|NCT04199026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92547076|NCT04199026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92547077|NCT04199026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547078|NCT04199026|Immunologic Factors|immunologic factors|mesh-ancestor
92547079|NCT04199026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547080|NCT04199026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92547081|NCT04199026|Alkylating Agents|alkylating agents|mesh-ancestor
92547082|NCT04199026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92547083|NCT04199026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547084|NCT04199026|Antifungal Agents|antifungal agents|mesh-ancestor
92547085|NCT04182997|Dexamethasone|dexamethasone|mesh-list
92547086|NCT04182997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547087|NCT04182997|Antiemetics|antiemetics|mesh-ancestor
92547088|NCT04182997|Autonomic Agents|autonomic agents|mesh-ancestor
92547089|NCT04182997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547090|NCT04182997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547091|NCT04182997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547092|NCT04182997|Glucocorticoids|glucocorticoids|mesh-ancestor
92547124|NCT04113109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547125|NCT04113109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547126|NCT04113109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547127|NCT04113109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547128|NCT04113109|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92547129|NCT04113109|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92547130|NCT04113109|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92547131|NCT04113109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547132|NCT04113109|Immunologic Factors|immunologic factors|mesh-ancestor
92547133|NCT04107038|Anesthetics|anesthetics|mesh-list
92547134|NCT04107038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547135|NCT04107038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547136|NCT04042233|Vancomycin|vancomycin|mesh-list
92547137|NCT04042233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92547138|NCT04042233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547139|NCT03982693|Edetic Acid|edetic acid|mesh-list
92547140|NCT03982693|Pentetic Acid|pentetic acid|mesh-list
92547182|NCT03848689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547183|NCT03848689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92547185|NCT03848689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547186|NCT03814941|Anesthetics|anesthetics|mesh-list
92547187|NCT03814941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547188|NCT03814941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547189|NCT03759938|Rivaroxaban|rivaroxaban|mesh-list
92547190|NCT03759938|Apixaban|apixaban|mesh-list
92547191|NCT03759938|Edoxaban|edoxaban|mesh-list
92547192|NCT03759938|Dabigatran|dabigatran|mesh-list
92547193|NCT03759938|Anticoagulants|anticoagulants|mesh-list
92547194|NCT03759938|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92547195|NCT03759938|Antithrombins|antithrombins|mesh-ancestor
92547196|NCT03759938|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92547197|NCT03759938|Protease Inhibitors|protease inhibitors|mesh-ancestor
92547198|NCT03759938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547199|NCT03759938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547200|NCT03737240|Insulin|insulin|mesh-list
92547201|NCT03737240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92547202|NCT03737240|Insulin Aspart|insulin aspart|mesh-list
92547203|NCT03737240|Liraglutide|liraglutide|mesh-list
92547204|NCT03737240|Insulin, Long-Acting|insulin, long-acting|mesh-list
92547205|NCT03737240|Xultophy|xultophy|mesh-list
92547208|NCT03737240|Incretins|incretins|mesh-ancestor
92547233|NCT03547908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92547234|NCT03547908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92547235|NCT03525873|Methylphenidate|methylphenidate|mesh-list
92547236|NCT03525873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92547237|NCT03525873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925003|NCT05479448|Prednisone|prednisone|mesh-list
92547238|NCT03525873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92547239|NCT03525873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92547240|NCT03525873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92547241|NCT03525873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547242|NCT03525873|Dopamine Agents|dopamine agents|mesh-ancestor
92547297|NCT03255473|BB 1101|bb 1101|mesh-list
92547298|NCT03255473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547299|NCT03255473|Antiemetics|antiemetics|mesh-ancestor
92547300|NCT03255473|Autonomic Agents|autonomic agents|mesh-ancestor
92547301|NCT03255473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547302|NCT03255473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547303|NCT03255473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547304|NCT03255473|Glucocorticoids|glucocorticoids|mesh-ancestor
92547305|NCT03255473|Hormones|hormones|mesh-ancestor
92547306|NCT03255473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547307|NCT03255473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92547308|NCT03255473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547309|NCT03255473|Protease Inhibitors|protease inhibitors|mesh-ancestor
92547310|NCT03255473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547311|NCT03255473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547312|NCT03176277|Venetoclax|venetoclax|mesh-list
92547314|NCT03173560|Everolimus|everolimus|mesh-list
92547356|NCT03017131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92547357|NCT03017131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547358|NCT03017131|Antimetabolites|antimetabolites|mesh-ancestor
92547359|NCT03017131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547360|NCT03017131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92547361|NCT03017131|Analgesics|analgesics|mesh-ancestor
92547362|NCT03017131|Sensory System Agents|sensory system agents|mesh-ancestor
92547363|NCT03017131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547364|NCT03017131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92547365|NCT03017131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92547366|NCT03017131|Antiviral Agents|antiviral agents|mesh-ancestor
92547367|NCT03017131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547368|NCT02990468|Cisplatin|cisplatin|mesh-list
92547369|NCT02990468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547370|NCT02940301|Nivolumab|nivolumab|mesh-list
92547371|NCT02940301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547417|NCT02603848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92547418|NCT02603848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547419|NCT02603848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547420|NCT02603848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92547421|NCT02603848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547422|NCT02603848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547423|NCT02512887|Anesthetics|anesthetics|mesh-list
92547424|NCT02512887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547425|NCT02512887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547426|NCT02484261|Bortezomib|bortezomib|mesh-list
92547427|NCT02484261|Pravastatin|pravastatin|mesh-list
92547428|NCT02484261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547429|NCT02484261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92547430|NCT02484261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92547431|NCT02484261|Antimetabolites|antimetabolites|mesh-ancestor
92547432|NCT02484261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547433|NCT02484261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92547434|NCT02484261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92547435|NCT02484261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547436|NCT02471430|Interferons|interferons|mesh-list
92547437|NCT02471430|Interferon-alpha|interferon-alpha|mesh-list
92547438|NCT02471430|Interferon alpha-2|interferon alpha-2|mesh-list
92547439|NCT02471430|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92547440|NCT02471430|Panobinostat|panobinostat|mesh-list
92547441|NCT02471430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547442|NCT02471430|Antiviral Agents|antiviral agents|mesh-ancestor
92547443|NCT02471430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547444|NCT02471430|Immunologic Factors|immunologic factors|mesh-ancestor
92547445|NCT02471430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547449|NCT02451943|Doxorubicin|doxorubicin|mesh-list
92547461|NCT02409342|Gemcitabine|gemcitabine|mesh-list
92547462|NCT02409342|Pemetrexed|pemetrexed|mesh-list
92547463|NCT02409342|Atezolizumab|atezolizumab|mesh-list
92547464|NCT02409342|Antibodies|antibodies|mesh-list
92547465|NCT02409342|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92547466|NCT02409342|Immunologic Factors|immunologic factors|mesh-ancestor
92361989|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92547467|NCT02409342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547468|NCT02409342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547469|NCT02409342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92547470|NCT02409342|Antimetabolites|antimetabolites|mesh-ancestor
92547471|NCT02409342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547472|NCT02409342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547473|NCT02409342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92547474|NCT02409342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92547475|NCT02409342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547476|NCT02409342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547477|NCT02399085|Lenalidomide|lenalidomide|mesh-list
92547478|NCT02399085|Immunologic Factors|immunologic factors|mesh-ancestor
92547479|NCT02399085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547480|NCT02399085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92547481|NCT02399085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92547482|NCT02399085|Growth Substances|growth substances|mesh-ancestor
92547483|NCT02399085|Growth Inhibitors|growth inhibitors|mesh-ancestor
92547484|NCT02399085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547485|NCT02255409|Vaccines|vaccines|mesh-list
92547486|NCT02255409|Immunologic Factors|immunologic factors|mesh-ancestor
92547487|NCT02255409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547488|NCT02213757|Estrogens|estrogens|mesh-list
92547489|NCT02213757|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92547490|NCT02213757|Hormones|hormones|mesh-ancestor
92547493|NCT02120404|Esmolol|esmolol|mesh-list
92547506|NCT01969227|Analgesics|analgesics|mesh-ancestor
92547507|NCT01969227|Sensory System Agents|sensory system agents|mesh-ancestor
92547508|NCT01969227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547509|NCT01969227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547510|NCT01969227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92547511|NCT01969227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92547512|NCT01969227|Anesthetics, General|anesthetics, general|mesh-ancestor
92547513|NCT01969227|Anesthetics|anesthetics|mesh-ancestor
92547514|NCT01969227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547515|NCT01969227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92547516|NCT01969227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92547517|NCT01969227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547518|NCT01969227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547519|NCT01885949|Tivozanib|tivozanib|mesh-list
92547566|NCT00465517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547567|NCT00465517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547568|NCT00465517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547569|NCT00465517|GABA Modulators|gaba modulators|mesh-ancestor
92547570|NCT00465517|GABA Agents|gaba agents|mesh-ancestor
92547571|NCT00289952|Valproic Acid|valproic acid|mesh-list
92547572|NCT00289952|Anticonvulsants|anticonvulsants|mesh-ancestor
92547573|NCT00289952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547574|NCT00289952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547575|NCT00289952|GABA Agents|gaba agents|mesh-ancestor
92547576|NCT00289952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547577|NCT00289952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547578|NCT00289952|Antimanic Agents|antimanic agents|mesh-ancestor
92547579|NCT00289952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92547629|NCT05772676|Antiemetics|antiemetics|mesh-ancestor
92547630|NCT05772676|Autonomic Agents|autonomic agents|mesh-ancestor
92547631|NCT05772676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547632|NCT05772676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547633|NCT05772676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92547634|NCT05772676|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92547635|NCT05772676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547636|NCT05772676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547637|NCT05772624|Nivolumab|nivolumab|mesh-list
92547638|NCT05772624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92547639|NCT05772624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92547640|NCT05772624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92547641|NCT05772624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547642|NCT05772546|Maleic acid|maleic acid|mesh-list
92547643|NCT05772546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547687|NCT05771038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92547688|NCT05771038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547690|NCT05771012|Cyclosporins|cyclosporins|mesh-list
92547691|NCT05771012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547692|NCT05771012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547693|NCT05771012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92547694|NCT05771012|Immunologic Factors|immunologic factors|mesh-ancestor
92547695|NCT05771012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547696|NCT05771012|Antifungal Agents|antifungal agents|mesh-ancestor
92547697|NCT05771012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92547698|NCT05771012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92547699|NCT05771012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547700|NCT05771012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92547701|NCT05770960|Codeine|codeine|mesh-list
92547702|NCT05770960|Naloxegol|naloxegol|mesh-list
92547703|NCT05770960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92547704|NCT05770960|Narcotics|narcotics|mesh-ancestor
92547705|NCT05770960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547706|NCT05770960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547707|NCT05770960|Analgesics|analgesics|mesh-ancestor
92547742|NCT05766410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92547743|NCT05766410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92547744|NCT05766410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547745|NCT05766410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547746|NCT05766410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92547747|NCT05766410|Hormone Antagonists|hormone antagonists|mesh-ancestor
92547748|NCT05766410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92547749|NCT05766410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547750|NCT05766410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92547751|NCT05757011|Bupivacaine|bupivacaine|mesh-list
92547752|NCT05757011|Anesthetics, Local|anesthetics, local|mesh-ancestor
92547753|NCT05757011|Anesthetics|anesthetics|mesh-ancestor
92547754|NCT05757011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92547755|NCT05757011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547756|NCT05757011|Sensory System Agents|sensory system agents|mesh-ancestor
92547757|NCT05757011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547758|NCT05750875|Loratadine|loratadine|mesh-list
92547759|NCT05750875|Gabapentin|gabapentin|mesh-list
92547796|NCT05715073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547797|NCT05702463|Aspirin|aspirin|mesh-list
92547798|NCT05702463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92547799|NCT05702463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92547800|NCT05702463|Analgesics|analgesics|mesh-ancestor
92547801|NCT05702463|Sensory System Agents|sensory system agents|mesh-ancestor
92547802|NCT05702463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547803|NCT05702463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547804|NCT05702463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547805|NCT05702463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92547806|NCT05702463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92547807|NCT05702463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92547808|NCT05702463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547809|NCT05702463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92547810|NCT05702463|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92547811|NCT05702463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92547812|NCT05702463|Antipyretics|antipyretics|mesh-ancestor
92547813|NCT05680584|Melatonin|melatonin|mesh-list
92547814|NCT05680584|Hydroxyzine|hydroxyzine|mesh-list
92547815|NCT05680584|Antioxidants|antioxidants|mesh-ancestor
92547816|NCT05680584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272552|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92547817|NCT05680584|Protective Agents|protective agents|mesh-ancestor
92547848|NCT05637606|Sympathomimetics|sympathomimetics|mesh-ancestor
92547849|NCT05637606|Autonomic Agents|autonomic agents|mesh-ancestor
92547850|NCT05637606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547851|NCT05637606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92547852|NCT05637606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92547853|NCT05637606|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92547854|NCT05637606|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92547855|NCT05637606|Respiratory System Agents|respiratory system agents|mesh-ancestor
92547856|NCT05637606|Nasal Decongestants|nasal decongestants|mesh-ancestor
92547857|NCT05637606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92547859|NCT05637606|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92750764|NCT05936489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547911|NCT05397639|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
92547912|NCT05397639|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92547913|NCT05397639|Serotonin Agents|serotonin agents|mesh-ancestor
92547914|NCT05397639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92547915|NCT05397639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92547916|NCT05397639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547917|NCT05375942|Infliximab|infliximab|mesh-list
92547918|NCT05375942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92547919|NCT05375942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92547923|NCT05209308|Rituximab|rituximab|mesh-list
92547972|NCT04892511|Urapidil|urapidil|mesh-list
92547973|NCT04892511|Phenylephrine|phenylephrine|mesh-list
92547974|NCT04892511|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92547975|NCT04892511|Mydriatics|mydriatics|mesh-ancestor
92547976|NCT04892511|Autonomic Agents|autonomic agents|mesh-ancestor
92547977|NCT04892511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92547978|NCT04892511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92547979|NCT04892511|Sympathomimetics|sympathomimetics|mesh-ancestor
92547980|NCT04892511|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92547981|NCT04892511|Nasal Decongestants|nasal decongestants|mesh-ancestor
92547982|NCT04892511|Respiratory System Agents|respiratory system agents|mesh-ancestor
92547983|NCT04892511|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92547984|NCT04892511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92547985|NCT04892511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92548038|NCT04752163|Vincristine|vincristine|mesh-list
92548039|NCT04752163|Azacitidine|azacitidine|mesh-list
92548040|NCT04752163|Venetoclax|venetoclax|mesh-list
92548041|NCT04752163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92548042|NCT04752163|Antibodies|antibodies|mesh-list
92548043|NCT04752163|Immunoglobulins|immunoglobulins|mesh-list
92548044|NCT04752163|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92548045|NCT04752163|Lenograstim|lenograstim|mesh-list
92548046|NCT04752163|BB 1101|bb 1101|mesh-list
92548047|NCT04752163|Mesna|mesna|mesh-list
92548048|NCT04752163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548049|NCT04752163|Immunologic Factors|immunologic factors|mesh-ancestor
92548050|NCT04752163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548051|NCT04752163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92548052|NCT04752163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92548053|NCT04752163|Alkylating Agents|alkylating agents|mesh-ancestor
92548054|NCT04752163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548055|NCT04752163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548056|NCT04752163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92548057|NCT04752163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92548058|NCT04752163|Antiemetics|antiemetics|mesh-ancestor
92548059|NCT04752163|Autonomic Agents|autonomic agents|mesh-ancestor
92548060|NCT04752163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548061|NCT04752163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548062|NCT04752163|Glucocorticoids|glucocorticoids|mesh-ancestor
92548063|NCT04752163|Hormones|hormones|mesh-ancestor
92548064|NCT04752163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548065|NCT04752163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92548066|NCT04752163|Protease Inhibitors|protease inhibitors|mesh-ancestor
92548067|NCT04752163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548068|NCT04752163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92548069|NCT04752163|Abortifacient Agents|abortifacient agents|mesh-ancestor
92548078|NCT04752163|Antidotes|antidotes|mesh-ancestor
92548081|NCT04752163|Vitamins|vitamins|mesh-ancestor
92548082|NCT04752163|Micronutrients|micronutrients|mesh-ancestor
92548083|NCT04752163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92548084|NCT04752163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548085|NCT04752163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548086|NCT04752163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548087|NCT04752163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548088|NCT04752163|Antifungal Agents|antifungal agents|mesh-ancestor
92548089|NCT04752163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92548090|NCT04752163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92548091|NCT04752163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92548092|NCT04752163|Hormone Antagonists|hormone antagonists|mesh-ancestor
92548093|NCT04752163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92548094|NCT04752163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92548098|NCT04735926|Vitamins|vitamins|mesh-ancestor
92548144|NCT04671966|Estradiol|estradiol|mesh-list
92548145|NCT04671966|Estrogens|estrogens|mesh-ancestor
92548146|NCT04671966|Hormones|hormones|mesh-ancestor
92548147|NCT04671966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548148|NCT04671966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548149|NCT04671966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92548150|NCT04671966|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92548151|NCT04671966|Fertility Agents|fertility agents|mesh-ancestor
92548152|NCT04671966|Hormone Antagonists|hormone antagonists|mesh-ancestor
92548153|NCT04641702|Atropine|atropine|mesh-list
92548154|NCT04641702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92548155|NCT04641702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92548156|NCT04641702|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92548157|NCT04641702|Autonomic Agents|autonomic agents|mesh-ancestor
92548158|NCT04641702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548159|NCT04641702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548160|NCT04641702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92548161|NCT04641702|Respiratory System Agents|respiratory system agents|mesh-ancestor
92548198|NCT04603183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548199|NCT04603183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548200|NCT04603183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548201|NCT04603183|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92548202|NCT04603183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92548203|NCT04603183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548204|NCT04603183|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92548205|NCT04603183|Hormone Antagonists|hormone antagonists|mesh-ancestor
92548206|NCT04603183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548207|NCT04603183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548208|NCT04603183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92548209|NCT04603183|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92548210|NCT04580134|Risperidone|risperidone|mesh-list
92548211|NCT04580134|Clozapine|clozapine|mesh-list
92548212|NCT04580134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92548213|NCT04580134|Serotonin Agents|serotonin agents|mesh-ancestor
92548224|NCT04580134|GABA Agents|gaba agents|mesh-ancestor
92548256|NCT04512079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92548257|NCT04512079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548258|NCT04512079|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92548259|NCT04512079|Antithrombins|antithrombins|mesh-ancestor
92548260|NCT04512079|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92548261|NCT04512079|Protease Inhibitors|protease inhibitors|mesh-ancestor
92548262|NCT04512079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548263|NCT04508725|Mitogens|mitogens|mesh-list
92548264|NCT04508725|Endothelial Growth Factors|endothelial growth factors|mesh-list
92548265|NCT04508725|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92548266|NCT04508725|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548267|NCT04508725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548268|NCT04508725|Growth Substances|growth substances|mesh-ancestor
92548317|NCT04332341|Micronutrients|micronutrients|mesh-ancestor
92548318|NCT04332341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548319|NCT04332341|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92548320|NCT04332341|Antimetabolites|antimetabolites|mesh-ancestor
92548321|NCT04332341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548322|NCT04332341|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92548323|NCT04332341|Vasodilator Agents|vasodilator agents|mesh-ancestor
92548324|NCT04323657|Cyclophosphamide|cyclophosphamide|mesh-list
92548325|NCT04323657|Fludarabine|fludarabine|mesh-list
92548326|NCT04323657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548327|NCT04323657|Immunologic Factors|immunologic factors|mesh-ancestor
92548328|NCT04323657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548329|NCT04323657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92548330|NCT04323657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92548331|NCT04323657|Alkylating Agents|alkylating agents|mesh-ancestor
92548332|NCT04323657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548374|NCT04201262|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92548375|NCT04201262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548376|NCT04201262|Immunologic Factors|immunologic factors|mesh-ancestor
92548377|NCT04201262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548379|NCT04189107|Dexamethasone acetate|dexamethasone acetate|mesh-list
92548380|NCT04189107|BB 1101|bb 1101|mesh-list
92548381|NCT04189107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92548382|NCT04189107|Antiemetics|antiemetics|mesh-ancestor
92362002|NCT00569010|Cytarabine|cytarabine|mesh-list
92548383|NCT04189107|Autonomic Agents|autonomic agents|mesh-ancestor
92548384|NCT04189107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548385|NCT04189107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548386|NCT04189107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548387|NCT04189107|Glucocorticoids|glucocorticoids|mesh-ancestor
92548388|NCT04189107|Hormones|hormones|mesh-ancestor
92548389|NCT04189107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548390|NCT04189107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92548391|NCT04189107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548430|NCT03865940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92548431|NCT03865940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92548432|NCT03865940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92548433|NCT03865940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548434|NCT03865940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92548435|NCT03865940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92548436|NCT03865940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92548437|NCT03865940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92548496|NCT03589729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92548497|NCT03589729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92548498|NCT03589729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548499|NCT03589729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92548500|NCT03589729|Immunotoxins|immunotoxins|mesh-ancestor
92548501|NCT03589729|Immunoconjugates|immunoconjugates|mesh-ancestor
92548502|NCT03589729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92548503|NCT03589729|Protective Agents|protective agents|mesh-ancestor
92548561|NCT03390933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92548563|NCT03387787|Insulin|insulin|mesh-list
92548564|NCT03387787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92273299|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
92548565|NCT03387787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548566|NCT03364036|Cladribine|cladribine|mesh-list
92548567|NCT03364036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548568|NCT03364036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92548569|NCT03364036|Immunologic Factors|immunologic factors|mesh-ancestor
92548570|NCT03364036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548571|NCT03338790|Prednisone|prednisone|mesh-list
92548572|NCT03338790|Docetaxel|docetaxel|mesh-list
92548573|NCT03338790|Nivolumab|nivolumab|mesh-list
92548574|NCT03338790|Rucaparib|rucaparib|mesh-list
92548575|NCT03338790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548576|NCT03338790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548577|NCT03338790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548578|NCT03338790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548579|NCT03338790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548580|NCT03338790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92548581|NCT03338790|Glucocorticoids|glucocorticoids|mesh-ancestor
92548582|NCT03338790|Hormones|hormones|mesh-ancestor
92548583|NCT03338790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92548584|NCT03338790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548585|NCT03338790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92548594|NCT03299660|Avelumab|avelumab|mesh-list
92548611|NCT03140358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92548612|NCT03140358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92548613|NCT03140358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92548614|NCT03140358|Autonomic Agents|autonomic agents|mesh-ancestor
92548615|NCT03140358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548616|NCT03140358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548617|NCT03140358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92548618|NCT03140358|Respiratory System Agents|respiratory system agents|mesh-ancestor
92548619|NCT03140358|Mydriatics|mydriatics|mesh-ancestor
92548620|NCT03140358|Parasympatholytics|parasympatholytics|mesh-ancestor
92548621|NCT03140358|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92548622|NCT03140358|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92548623|NCT03140358|Cholinergic Agents|cholinergic agents|mesh-ancestor
92548672|NCT02575677|Narcotics|narcotics|mesh-ancestor
92548673|NCT02575677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548674|NCT02575677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548675|NCT02575677|Analgesics|analgesics|mesh-ancestor
92548676|NCT02575677|Sensory System Agents|sensory system agents|mesh-ancestor
92548677|NCT02575677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548679|NCT02573831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92548680|NCT02573831|Narcotics|narcotics|mesh-ancestor
92548681|NCT02573831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548682|NCT02573831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548683|NCT02573831|Analgesics|analgesics|mesh-ancestor
92548684|NCT02573831|Sensory System Agents|sensory system agents|mesh-ancestor
92548685|NCT02573831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548686|NCT02571881|Oxycodone|oxycodone|mesh-list
92548687|NCT02571881|Naloxone|naloxone|mesh-list
92548733|NCT02225600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548734|NCT02211742|Dapagliflozin|dapagliflozin|mesh-list
92548735|NCT02211742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92548736|NCT02211742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548737|NCT02211742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92548738|NCT02211742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548739|NCT02101905|Lapatinib|lapatinib|mesh-list
92548740|NCT02101905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548741|NCT02101905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92548742|NCT02101905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548743|NCT02101905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548744|NCT02081404|Esomeprazole|esomeprazole|mesh-list
92548745|NCT02081404|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92548746|NCT02081404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548747|NCT02081404|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92548748|NCT02081404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548749|NCT02081404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548750|NCT01526603|Carboplatin|carboplatin|mesh-list
92548751|NCT01526603|Etoposide|etoposide|mesh-list
92548752|NCT01526603|Melphalan|melphalan|mesh-list
92548753|NCT01526603|Tretinoin|tretinoin|mesh-list
92548754|NCT01526603|Isotretinoin|isotretinoin|mesh-list
92548755|NCT01526603|Lenograstim|lenograstim|mesh-list
92548756|NCT01526603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548757|NCT01526603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548758|NCT01526603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92548771|NCT00038766|Semapimod|semapimod|mesh-list
92548781|NCT00038766|Immunologic Factors|immunologic factors|mesh-ancestor
92548782|NCT00070070|Sargramostim|sargramostim|mesh-list
92548783|NCT00070070|BCG Vaccine|bcg vaccine|mesh-list
92548784|NCT00070070|Immunologic Factors|immunologic factors|mesh-ancestor
92548785|NCT00070070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548786|NCT00070070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92548787|NCT02573909|Oxycodone|oxycodone|mesh-list
92548788|NCT02573909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92548789|NCT02573909|Narcotics|narcotics|mesh-ancestor
92548790|NCT02573909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92548791|NCT02573909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548792|NCT02573909|Analgesics|analgesics|mesh-ancestor
92548793|NCT02573909|Sensory System Agents|sensory system agents|mesh-ancestor
92548794|NCT02573909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92548795|NCT00042315|Vinorelbine|vinorelbine|mesh-list
92548796|NCT00042315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548797|NCT00042315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548798|NCT00042315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548799|NCT00042315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548838|NCT00042471|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92548839|NCT00042471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92548840|NCT00042471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548841|NCT00042471|Appetite Depressants|appetite depressants|mesh-ancestor
92548842|NCT00042471|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92548843|NCT00042471|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92548844|NCT00042471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92548845|NCT00042549|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92548846|NCT00042549|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92548847|NCT00042549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92548848|NCT00042588|Antibodies|antibodies|mesh-list
92548901|NCT00018902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92548903|NCT00018902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92548904|NCT00018902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92548905|NCT00018902|Antidepressive Agents|antidepressive agents|mesh-ancestor
92548906|NCT00018902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92548907|NCT00018902|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92548908|NCT00018902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92548909|NCT00018902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92548910|NCT00018902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92548911|NCT00038922|Oprelvekin|oprelvekin|mesh-list
92548912|NCT00038922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548913|NCT00018941|Aldesleukin|aldesleukin|mesh-list
92548914|NCT00018941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548915|NCT00018941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92548916|NCT00018941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92548917|NCT00018941|Antiviral Agents|antiviral agents|mesh-ancestor
92548918|NCT00018941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92548919|NCT00038961|PENTA|penta|mesh-list
92548920|NCT00038961|Fondaparinux|fondaparinux|mesh-list
92548955|NCT00019058|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92548956|NCT00019058|Antioxidants|antioxidants|mesh-ancestor
92548957|NCT00039039|Paclitaxel|paclitaxel|mesh-list
92548958|NCT00039039|Carboplatin|carboplatin|mesh-list
92548959|NCT00039039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92548960|NCT00039039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92548961|NCT00039039|Tubulin Modulators|tubulin modulators|mesh-ancestor
92548962|NCT00039039|Antimitotic Agents|antimitotic agents|mesh-ancestor
92548963|NCT00039039|Mitosis Modulators|mitosis modulators|mesh-ancestor
92548964|NCT00039039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549024|NCT00039234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549025|NCT00039234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549027|NCT00019331|Sargramostim|sargramostim|mesh-list
92549028|NCT00019331|Immunologic Factors|immunologic factors|mesh-ancestor
92549029|NCT00019331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549030|NCT00019331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549031|NCT00019331|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549032|NCT00019331|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549033|NCT00019331|Antiviral Agents|antiviral agents|mesh-ancestor
92549034|NCT00019331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549089|NCT00019487|Aldesleukin|aldesleukin|mesh-list
92549090|NCT00019487|Freund's Adjuvant|freund's adjuvant|mesh-list
92549091|NCT00019487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549092|NCT00019487|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549093|NCT00019487|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549094|NCT00019487|Antiviral Agents|antiviral agents|mesh-ancestor
92549095|NCT00019487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549096|NCT00019487|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92549097|NCT00019487|Immunologic Factors|immunologic factors|mesh-ancestor
92549098|NCT00019487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549100|NCT00039351|Cyclophosphamide|cyclophosphamide|mesh-list
92549101|NCT00039351|Vincristine|vincristine|mesh-list
92549102|NCT00039351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549103|NCT00039351|Immunologic Factors|immunologic factors|mesh-ancestor
92549104|NCT00039351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549105|NCT00039351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549106|NCT00039351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549107|NCT00039351|Alkylating Agents|alkylating agents|mesh-ancestor
92549109|NCT00039351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549148|NCT00019760|Antidotes|antidotes|mesh-ancestor
92549149|NCT00019760|Protective Agents|protective agents|mesh-ancestor
92549150|NCT00019760|Vitamin B Complex|vitamin b complex|mesh-ancestor
92549152|NCT00019760|Micronutrients|micronutrients|mesh-ancestor
92549153|NCT00019760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549154|NCT00019760|Alkylating Agents|alkylating agents|mesh-ancestor
92549155|NCT00019760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549156|NCT00019760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549157|NCT00019760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549158|NCT00019760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549159|NCT00019760|Immunologic Factors|immunologic factors|mesh-ancestor
92549160|NCT00019760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549161|NCT00019760|Antimetabolites|antimetabolites|mesh-ancestor
92549162|NCT00039468|Thalidomide|thalidomide|mesh-list
92549163|NCT00039468|Irinotecan|irinotecan|mesh-list
92549164|NCT00039468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92549165|NCT00039468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549166|NCT00039468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549167|NCT00039468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549168|NCT00039468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549169|NCT00039468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549170|NCT00039468|Immunologic Factors|immunologic factors|mesh-ancestor
92362015|NCT00616122|Methotrexate|methotrexate|mesh-list
92549171|NCT00039468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549172|NCT00039468|Leprostatic Agents|leprostatic agents|mesh-ancestor
92549173|NCT00039468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92549174|NCT00039468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549175|NCT00039468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92549176|NCT00039468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92549194|NCT00019916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549195|NCT00019916|Antiviral Agents|antiviral agents|mesh-ancestor
92549196|NCT00019916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549198|NCT00039546|Cyclophosphamide|cyclophosphamide|mesh-list
92549199|NCT00039546|Gemcitabine|gemcitabine|mesh-list
92549200|NCT00039546|Epirubicin|epirubicin|mesh-list
92549201|NCT00039546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549202|NCT00039546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549203|NCT00039546|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549204|NCT00039546|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549205|NCT00039546|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549206|NCT00039546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549207|NCT00039546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549208|NCT00039546|Immunologic Factors|immunologic factors|mesh-ancestor
92549209|NCT00039546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549252|NCT00020150|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92549253|NCT00020150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549254|NCT00020150|Alkylating Agents|alkylating agents|mesh-ancestor
92549255|NCT00020150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549256|NCT00020150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549257|NCT00020150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549259|NCT00039858|Antithrombins|antithrombins|mesh-ancestor
92549260|NCT00039858|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92549261|NCT00039858|Protease Inhibitors|protease inhibitors|mesh-ancestor
92549262|NCT00039858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549263|NCT00039858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549264|NCT00039858|Anticoagulants|anticoagulants|mesh-ancestor
92549265|NCT00039858|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92549266|NCT00020189|Aspirin|aspirin|mesh-list
92549267|NCT00020189|Alvocidib|alvocidib|mesh-list
92549268|NCT00020189|Clopidogrel|clopidogrel|mesh-list
92549269|NCT00020189|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92549270|NCT00020189|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92549271|NCT00020189|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92549272|NCT00020189|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92549273|NCT00020189|Purinergic Agents|purinergic agents|mesh-ancestor
92549274|NCT00020189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92549275|NCT00020189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549276|NCT00020189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549277|NCT00020189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92549278|NCT00020189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92549279|NCT00020189|Analgesics|analgesics|mesh-ancestor
92549280|NCT00020189|Sensory System Agents|sensory system agents|mesh-ancestor
92549281|NCT00020189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549282|NCT00020189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92549294|NCT00039975|Indinavir|indinavir|mesh-list
92549295|NCT00039975|Amlodipine|amlodipine|mesh-list
92549296|NCT00039975|Diltiazem|diltiazem|mesh-list
92549297|NCT00039975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92549298|NCT00039975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92549299|NCT00039975|Protease Inhibitors|protease inhibitors|mesh-ancestor
92549300|NCT00039975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549301|NCT00039975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549302|NCT00039975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549303|NCT00039975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549304|NCT00039975|Antiviral Agents|antiviral agents|mesh-ancestor
92549305|NCT00039975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549306|NCT00039975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92549307|NCT00039975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92549308|NCT00039975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92549309|NCT00039975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92549310|NCT00039975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92549313|NCT00039975|Vasodilator Agents|vasodilator agents|mesh-ancestor
92362018|NCT00616122|Immunologic Factors|immunologic factors|mesh-ancestor
92549351|NCT00040053|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92549353|NCT00040053|Serotonin Agents|serotonin agents|mesh-ancestor
92549354|NCT00040053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92549355|NCT00040053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549356|NCT00020462|Aldesleukin|aldesleukin|mesh-list
92549357|NCT00020462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549358|NCT00020462|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92549359|NCT00020462|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92549360|NCT00020462|Antiviral Agents|antiviral agents|mesh-ancestor
92549361|NCT00020462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549362|NCT00020501|Leucovorin|leucovorin|mesh-list
92549363|NCT00020501|Fluorouracil|fluorouracil|mesh-list
92549364|NCT00020501|Floxuridine|floxuridine|mesh-list
92549414|NCT00040248|Immunologic Factors|immunologic factors|mesh-ancestor
92549415|NCT00040248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549416|NCT00020618|Morphine|morphine|mesh-list
92549417|NCT00020618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92549418|NCT00020618|Narcotics|narcotics|mesh-ancestor
92549419|NCT00020618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92549420|NCT00020618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549421|NCT00020618|Analgesics|analgesics|mesh-ancestor
92549422|NCT00020618|Sensory System Agents|sensory system agents|mesh-ancestor
92549423|NCT00020618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549424|NCT00020657|Ondansetron|ondansetron|mesh-list
92549425|NCT00020657|Granisetron|granisetron|mesh-list
92549426|NCT00020657|Prochlorperazine|prochlorperazine|mesh-list
92549427|NCT00020657|Dolasetron|dolasetron|mesh-list
92549428|NCT00020657|Antiemetics|antiemetics|mesh-ancestor
92549429|NCT00020657|Autonomic Agents|autonomic agents|mesh-ancestor
92549430|NCT00020657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92549432|NCT00020657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92549473|NCT00040482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549474|NCT00040482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549475|NCT00040482|Alkylating Agents|alkylating agents|mesh-ancestor
92549476|NCT00040482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549477|NCT00040482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549478|NCT00040482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549479|NCT00020774|Gemcitabine|gemcitabine|mesh-list
92549480|NCT00020774|Lonafarnib|lonafarnib|mesh-list
92549481|NCT00020774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549482|NCT00020774|Antimetabolites|antimetabolites|mesh-ancestor
92549483|NCT00020774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549484|NCT00020774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549485|NCT00020774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549486|NCT00040521|Oprelvekin|oprelvekin|mesh-list
92549487|NCT00040521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549488|NCT00040599|Labetuzumab|labetuzumab|mesh-list
92549489|NCT00040599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92549490|NCT00040599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549532|NCT00040872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92549533|NCT00040872|Etoposide|etoposide|mesh-list
92549534|NCT00040872|Vincristine|vincristine|mesh-list
92549535|NCT00040872|Topotecan|topotecan|mesh-list
92549536|NCT00040872|Isotretinoin|isotretinoin|mesh-list
92549537|NCT00040872|Antibodies|antibodies|mesh-list
92549538|NCT00040872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92549539|NCT00040872|Sargramostim|sargramostim|mesh-list
92549540|NCT00040872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549541|NCT00040872|Immunologic Factors|immunologic factors|mesh-ancestor
92549542|NCT00040872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549543|NCT00040872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549544|NCT00040872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549545|NCT00040872|Alkylating Agents|alkylating agents|mesh-ancestor
92549546|NCT00040872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549547|NCT00040872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549548|NCT00040872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549549|NCT00040872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92549550|NCT00040872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92549551|NCT00040872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549587|NCT00021281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549588|NCT00021281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549589|NCT00021281|Antidotes|antidotes|mesh-ancestor
92549590|NCT00021281|Protective Agents|protective agents|mesh-ancestor
92549591|NCT00021281|Vitamin B Complex|vitamin b complex|mesh-ancestor
92549592|NCT00021281|Vitamins|vitamins|mesh-ancestor
92549593|NCT00021281|Micronutrients|micronutrients|mesh-ancestor
92549594|NCT00041106|Gemcitabine|gemcitabine|mesh-list
92549595|NCT00041106|Gefitinib|gefitinib|mesh-list
92549596|NCT00041106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549597|NCT00041106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549598|NCT00041106|Antimetabolites|antimetabolites|mesh-ancestor
92549653|NCT00021398|Calcium|calcium|mesh-list
92549654|NCT00021398|Levoleucovorin|levoleucovorin|mesh-list
92549655|NCT00021398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549656|NCT00021398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549657|NCT00021398|Antimetabolites|antimetabolites|mesh-ancestor
92549658|NCT00021398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549659|NCT00021398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549660|NCT00021398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549661|NCT00021398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549662|NCT00021398|Immunologic Factors|immunologic factors|mesh-ancestor
92549663|NCT00021398|Antidotes|antidotes|mesh-ancestor
92549664|NCT00021398|Protective Agents|protective agents|mesh-ancestor
92549665|NCT00021398|Vitamin B Complex|vitamin b complex|mesh-ancestor
92549666|NCT00021398|Vitamins|vitamins|mesh-ancestor
92549667|NCT00021398|Micronutrients|micronutrients|mesh-ancestor
92549668|NCT00048945|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92549713|NCT00049062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549714|NCT00049062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549715|NCT00049062|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92549716|NCT00049062|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92549717|NCT00049062|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92549718|NCT00049062|Hormone Antagonists|hormone antagonists|mesh-ancestor
92549719|NCT00049062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549720|NCT00049062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549721|NCT00049101|Leucovorin|leucovorin|mesh-list
92549722|NCT00049101|Fluorouracil|fluorouracil|mesh-list
92549723|NCT00049101|Oxaliplatin|oxaliplatin|mesh-list
92549724|NCT00049101|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92549725|NCT00049101|Calcium|calcium|mesh-list
92549726|NCT00049101|Levoleucovorin|levoleucovorin|mesh-list
92549727|NCT00049101|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92549728|NCT00049101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549729|NCT00049101|Antimetabolites|antimetabolites|mesh-ancestor
92549735|NCT00049101|Antidotes|antidotes|mesh-ancestor
92549769|NCT00049218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549771|NCT00049218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92549772|NCT00049218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549773|NCT00049218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549774|NCT00049296|Thalidomide|thalidomide|mesh-list
92549775|NCT00049296|Docetaxel|docetaxel|mesh-list
92549776|NCT00049296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549777|NCT00049296|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549778|NCT00049296|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549779|NCT00049296|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549781|NCT00049296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549833|NCT00049413|Immunologic Factors|immunologic factors|mesh-ancestor
92549834|NCT00049413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549835|NCT00049413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92549836|NCT00049413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92549837|NCT00049413|Alkylating Agents|alkylating agents|mesh-ancestor
92549838|NCT00049413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549839|NCT00049413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549840|NCT00049413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92549841|NCT00049413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92549842|NCT00049413|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92549843|NCT00049413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92549844|NCT00022022|Docetaxel|docetaxel|mesh-list
92549853|NCT00022139|Paclitaxel|paclitaxel|mesh-list
92549898|NCT00049569|Glucocorticoids|glucocorticoids|mesh-ancestor
92549899|NCT00049569|Hormones|hormones|mesh-ancestor
92549900|NCT00049569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92549901|NCT00049569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92549902|NCT00049569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92549903|NCT00049569|Abortifacient Agents|abortifacient agents|mesh-ancestor
92549904|NCT00049569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92549905|NCT00049569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92549906|NCT00049569|Antimetabolites|antimetabolites|mesh-ancestor
92549907|NCT00049569|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549908|NCT00049569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92549909|NCT00049569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92549910|NCT00049569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92549911|NCT00049569|Antiviral Agents|antiviral agents|mesh-ancestor
92549956|NCT00022217|Tubulin Modulators|tubulin modulators|mesh-ancestor
92549957|NCT00022217|Antimitotic Agents|antimitotic agents|mesh-ancestor
92549958|NCT00022217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92549959|NCT00022217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92549960|NCT00022256|Motexafin gadolinium|motexafin gadolinium|mesh-list
92549961|NCT00022256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92549962|NCT00022256|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92549963|NCT00022256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92549964|NCT00049725|Daclizumab|daclizumab|mesh-list
92549965|NCT00049725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92549966|NCT00049725|Immunologic Factors|immunologic factors|mesh-ancestor
92549967|NCT00049725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92549968|NCT00049764|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92549969|NCT00049764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92549970|NCT00049803|Sodium Oxybate|sodium oxybate|mesh-list
92549971|NCT00049803|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92550016|NCT00022607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92550017|NCT00022607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550018|NCT00022607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92550019|NCT00022607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92550020|NCT00022607|Growth Substances|growth substances|mesh-ancestor
92550021|NCT00022607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550022|NCT00022607|Growth Inhibitors|growth inhibitors|mesh-ancestor
92550023|NCT00022607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550024|NCT00022607|Immunologic Factors|immunologic factors|mesh-ancestor
92550025|NCT00022607|Leprostatic Agents|leprostatic agents|mesh-ancestor
92550026|NCT00022607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550027|NCT00022607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550028|NCT00049998|Topotecan|topotecan|mesh-list
92550029|NCT00049998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92550030|NCT00049998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550031|NCT00049998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550033|NCT00049998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550073|NCT00050271|Micronutrients|micronutrients|mesh-ancestor
92550074|NCT00050271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550075|NCT00050271|Nootropic Agents|nootropic agents|mesh-ancestor
92550076|NCT00022958|Tositumomab I-131|tositumomab i-131|mesh-list
92550077|NCT00022958|Antibodies|antibodies|mesh-list
92550078|NCT00022958|Immunologic Factors|immunologic factors|mesh-ancestor
92550079|NCT00022958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550080|NCT00022958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550081|NCT00050349|Epothilones|epothilones|mesh-list
92550082|NCT00050349|Epothilone B|epothilone b|mesh-list
92550083|NCT00050349|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550084|NCT00050349|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550085|NCT00050349|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550086|NCT00050349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550087|NCT00050349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550088|NCT00050427|Trabectedin|trabectedin|mesh-list
92550089|NCT00050427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550090|NCT00050427|Alkylating Agents|alkylating agents|mesh-ancestor
92550091|NCT00050427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550129|NCT00023231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550130|NCT00023231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92550131|NCT00023231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550132|NCT00023231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550133|NCT00023231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92550134|NCT00023231|Antitubercular Agents|antitubercular agents|mesh-ancestor
92550135|NCT00023231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92550136|NCT00023231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550137|NCT00023231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550138|NCT00023231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362030|NCT00616122|Antimetabolites|antimetabolites|mesh-ancestor
92550139|NCT00023231|Antifungal Agents|antifungal agents|mesh-ancestor
92550140|NCT00023231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550141|NCT00023231|Immunologic Factors|immunologic factors|mesh-ancestor
92550142|NCT00023231|Antiemetics|antiemetics|mesh-ancestor
92550191|NCT00050895|Antiviral Agents|antiviral agents|mesh-ancestor
92550192|NCT00050895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550193|NCT00050895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92550194|NCT00050895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92550195|NCT00050895|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92550196|NCT00050895|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550197|NCT00050895|Antimetabolites|antimetabolites|mesh-ancestor
92550198|NCT00050895|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92550199|NCT00050895|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92550200|NCT00050895|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92550201|NCT00050895|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92550250|NCT00051051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550251|NCT00051051|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92550252|NCT00051051|Protective Agents|protective agents|mesh-ancestor
92550254|NCT00051090|Efavirenz|efavirenz|mesh-list
92550255|NCT00051090|Abacavir|abacavir|mesh-list
92550256|NCT00051090|Didanosine|didanosine|mesh-list
92550257|NCT00051090|Telbivudine|telbivudine|mesh-list
92550258|NCT00051090|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92550259|NCT00051090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550260|NCT00051090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550261|NCT00051090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550262|NCT00051090|Antiviral Agents|antiviral agents|mesh-ancestor
92550263|NCT00051090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550264|NCT00051090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92550265|NCT00051090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92550266|NCT00051090|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92550267|NCT00051090|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92550268|NCT00051090|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92550306|NCT00051285|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92550307|NCT00051285|Vasodilator Agents|vasodilator agents|mesh-ancestor
92550308|NCT00051285|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92550309|NCT00051285|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92550310|NCT00051285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550311|NCT00051285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550312|NCT00051285|Protective Agents|protective agents|mesh-ancestor
92550313|NCT00051285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550314|NCT00023699|Gefitinib|gefitinib|mesh-list
92550315|NCT00023699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550316|NCT00023699|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550317|NCT00023699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550318|NCT00023699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550319|NCT00051441|Benzydamine|benzydamine|mesh-list
92550320|NCT00051441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550321|NCT00023738|Doxorubicin|doxorubicin|mesh-list
92550322|NCT00023738|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92550323|NCT00023738|Ifosfamide|ifosfamide|mesh-list
92550324|NCT00023738|Dacarbazine|dacarbazine|mesh-list
92550333|NCT00397917|Folic Acid|folic acid|mesh-list
92550364|NCT00398034|Androgens|androgens|mesh-ancestor
92550365|NCT00398034|Hormones|hormones|mesh-ancestor
92550366|NCT00398034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92550367|NCT00398034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550368|NCT00023855|Doxorubicin|doxorubicin|mesh-list
92550369|NCT00023855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92550370|NCT00023855|Bortezomib|bortezomib|mesh-list
92550371|NCT00023855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92550372|NCT00023855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550373|NCT00023855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92550374|NCT00023855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92550375|NCT00023855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550376|NCT00023855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550377|NCT00023894|Alvocidib|alvocidib|mesh-list
92550378|NCT00023894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550379|NCT00023894|Growth Inhibitors|growth inhibitors|mesh-ancestor
91925927|NCT02153879|Vitamins|vitamins|mesh-ancestor
92550380|NCT00023894|Growth Substances|growth substances|mesh-ancestor
92550383|NCT00023894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550419|NCT00051753|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92550420|NCT00024050|Cyclosporine|cyclosporine|mesh-list
92550421|NCT00024050|Cyclophosphamide|cyclophosphamide|mesh-list
92550423|NCT00024050|Methotrexate|methotrexate|mesh-list
92550424|NCT00024050|Cyclosporins|cyclosporins|mesh-list
92550425|NCT00024050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550426|NCT00024050|Immunologic Factors|immunologic factors|mesh-ancestor
92550427|NCT00024050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550428|NCT00024050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550429|NCT00024050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550430|NCT00024050|Alkylating Agents|alkylating agents|mesh-ancestor
92550432|NCT00024050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550481|NCT00024128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550482|NCT00024128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550483|NCT00024128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550484|NCT00024128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550485|NCT00024128|Antifungal Agents|antifungal agents|mesh-ancestor
92550486|NCT00024128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550487|NCT00024128|Dermatologic Agents|dermatologic agents|mesh-ancestor
92550488|NCT00024128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92550489|NCT00024206|Orantinib|orantinib|mesh-list
92550490|NCT00024206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92550491|NCT00024206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550492|NCT00024206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550493|NCT00024245|Probenecid|probenecid|mesh-list
92550494|NCT00024245|Uricosuric Agents|uricosuric agents|mesh-ancestor
92550495|NCT00024245|Gout Suppressants|gout suppressants|mesh-ancestor
92550496|NCT00024245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550497|NCT00051987|Bortezomib|bortezomib|mesh-list
92550498|NCT00051987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550499|NCT00024284|Carboplatin|carboplatin|mesh-list
92550538|NCT00024440|Immunologic Factors|immunologic factors|mesh-ancestor
92550539|NCT00024440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550540|NCT00024440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550541|NCT00024440|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550542|NCT00024440|Alkylating Agents|alkylating agents|mesh-ancestor
92550543|NCT00024440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550544|NCT00024440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550545|NCT00024440|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550546|NCT00024440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550547|NCT00024440|Antimetabolites|antimetabolites|mesh-ancestor
92550548|NCT00024518|Interferons|interferons|mesh-list
92550549|NCT00024518|Interferon-alpha|interferon-alpha|mesh-list
92550550|NCT00024518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550551|NCT00024518|Antiviral Agents|antiviral agents|mesh-ancestor
92550552|NCT00024518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550600|NCT00052377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92550601|NCT00052377|Analgesics|analgesics|mesh-ancestor
92550602|NCT00052377|Sensory System Agents|sensory system agents|mesh-ancestor
92550603|NCT00052377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550604|NCT00052377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550605|NCT00052377|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92550606|NCT00052377|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92550607|NCT00052377|Antiviral Agents|antiviral agents|mesh-ancestor
92550608|NCT00052377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92550609|NCT00052377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92550610|NCT00052377|Immunologic Factors|immunologic factors|mesh-ancestor
92550615|NCT00052416|Thalidomide|thalidomide|mesh-list
92550665|NCT00395213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92550666|NCT00395213|Serotonin Agents|serotonin agents|mesh-ancestor
92550667|NCT00395213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92550668|NCT00395213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92550669|NCT00052611|Celecoxib|celecoxib|mesh-list
92550670|NCT00052611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92550671|NCT00052611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92550672|NCT00052611|Analgesics|analgesics|mesh-ancestor
92550673|NCT00052611|Sensory System Agents|sensory system agents|mesh-ancestor
92550674|NCT00052611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92550675|NCT00052611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014521|NCT03069001|Ribavirin|ribavirin|mesh-list
92550676|NCT00052611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550677|NCT00052611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550678|NCT00052611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92550679|NCT00052611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92550680|NCT00052611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550681|NCT00052611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550682|NCT00395252|Gemcitabine|gemcitabine|mesh-list
92550721|NCT00052845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550722|NCT00052845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550723|NCT00052845|Alkylating Agents|alkylating agents|mesh-ancestor
92550724|NCT00052845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92550725|NCT00052845|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92550726|NCT00052845|Protective Agents|protective agents|mesh-ancestor
92550727|NCT00052845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550728|NCT00052845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92550729|NCT00052845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550730|NCT00052845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92550732|NCT00052845|Analgesics|analgesics|mesh-ancestor
92550786|NCT00025064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92550787|NCT00025064|Alkylating Agents|alkylating agents|mesh-ancestor
92550788|NCT00025064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92550789|NCT00025064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550790|NCT00025064|Immunologic Factors|immunologic factors|mesh-ancestor
92550791|NCT00025064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550792|NCT00025064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92550793|NCT00025064|Glucocorticoids|glucocorticoids|mesh-ancestor
92550794|NCT00025064|Hormones|hormones|mesh-ancestor
92550795|NCT00025064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92550796|NCT00025064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92550797|NCT00053001|Thalidomide|thalidomide|mesh-list
92550798|NCT00053001|Epoetin Alfa|epoetin alfa|mesh-list
92550799|NCT00053001|Hematinics|hematinics|mesh-ancestor
92550849|NCT00025142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550850|NCT00025142|Antimetabolites|antimetabolites|mesh-ancestor
92550851|NCT00025142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550852|NCT00025142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550853|NCT00025142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550854|NCT00025142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550855|NCT00025142|Immunologic Factors|immunologic factors|mesh-ancestor
92550859|NCT00025142|Vitamins|vitamins|mesh-ancestor
92550917|NCT00053196|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92550918|NCT00053196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550919|NCT00053196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92550920|NCT00053196|Antimetabolites|antimetabolites|mesh-ancestor
92550921|NCT00053196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275625|NCT01763606|Antipyretics|antipyretics|mesh-ancestor
92550922|NCT00053196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550923|NCT00053196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92550924|NCT00053196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92550925|NCT00053196|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92550926|NCT00053196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550927|NCT00053196|Immunologic Factors|immunologic factors|mesh-ancestor
92550928|NCT00053196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92550929|NCT00053196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92550943|NCT00025337|Leucovorin|leucovorin|mesh-list
92550978|NCT00025493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92550979|NCT00025493|Tubulin Modulators|tubulin modulators|mesh-ancestor
92550980|NCT00025493|Antimitotic Agents|antimitotic agents|mesh-ancestor
92550981|NCT00025493|Mitosis Modulators|mitosis modulators|mesh-ancestor
92550982|NCT00025493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92550984|NCT00025532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92550985|NCT00025532|Immunologic Factors|immunologic factors|mesh-ancestor
92550986|NCT00025532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92550987|NCT00053430|Thalidomide|thalidomide|mesh-list
92550988|NCT00053430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92550989|NCT00053430|Immunologic Factors|immunologic factors|mesh-ancestor
92550990|NCT00053430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551042|NCT00025649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362046|NCT00618540|Alemtuzumab|alemtuzumab|mesh-list
92551043|NCT00025649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551044|NCT00025649|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551045|NCT00025649|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551046|NCT00025649|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551047|NCT00025688|Paclitaxel|paclitaxel|mesh-list
92551048|NCT00025688|Carboplatin|carboplatin|mesh-list
92551049|NCT00025688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551050|NCT00025688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551051|NCT00025688|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551052|NCT00025688|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551053|NCT00025688|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551054|NCT00025688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551055|NCT00025727|Ritonavir|ritonavir|mesh-list
92551056|NCT00025727|Lopinavir|lopinavir|mesh-list
92551057|NCT00025727|Fosamprenavir|fosamprenavir|mesh-list
92551058|NCT00025727|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92551059|NCT00025727|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92551100|NCT00053937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551101|NCT00053937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551102|NCT00053976|Methylprednisolone|methylprednisolone|mesh-list
92551103|NCT00053976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92551104|NCT00053976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92551105|NCT00053976|Prednisolone|prednisolone|mesh-list
92551106|NCT00053976|Prednisolone acetate|prednisolone acetate|mesh-list
92551107|NCT00053976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92551108|NCT00053976|Prednisolone phosphate|prednisolone phosphate|mesh-list
92551109|NCT00053976|Daclizumab|daclizumab|mesh-list
92551110|NCT00053976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551111|NCT00053976|Antiemetics|antiemetics|mesh-ancestor
92551112|NCT00053976|Autonomic Agents|autonomic agents|mesh-ancestor
92551113|NCT00053976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551114|NCT00053976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551115|NCT00053976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92551116|NCT00053976|Glucocorticoids|glucocorticoids|mesh-ancestor
92551117|NCT00053976|Hormones|hormones|mesh-ancestor
92551118|NCT00053976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551158|NCT00026156|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551159|NCT00026156|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551160|NCT00026156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551161|NCT00026156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551162|NCT00054171|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92551163|NCT00054171|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92551164|NCT00054171|Dermatologic Agents|dermatologic agents|mesh-ancestor
92551165|NCT00026195|Irinotecan|irinotecan|mesh-list
92551166|NCT00026195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551167|NCT00026195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551168|NCT00026195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551169|NCT00026195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551221|NCT00026273|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551222|NCT00026273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551223|NCT00026273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551224|NCT00026273|Antidotes|antidotes|mesh-ancestor
92551225|NCT00026273|Protective Agents|protective agents|mesh-ancestor
92551226|NCT00026273|Vitamin B Complex|vitamin b complex|mesh-ancestor
92551227|NCT00026273|Vitamins|vitamins|mesh-ancestor
92275918|NCT04362293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551228|NCT00026273|Micronutrients|micronutrients|mesh-ancestor
92551229|NCT00054405|Aldesleukin|aldesleukin|mesh-list
92551230|NCT00054405|Interleukin-2|interleukin-2|mesh-list
92551231|NCT00054405|Interleukin-12|interleukin-12|mesh-list
92551232|NCT00054405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551233|NCT00054405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92551235|NCT00054405|Sensory System Agents|sensory system agents|mesh-ancestor
92551283|NCT00054522|Calcitriol|calcitriol|mesh-list
92551284|NCT00054522|Dexamethasone|dexamethasone|mesh-list
92551285|NCT00054522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551286|NCT00054522|Antiemetics|antiemetics|mesh-ancestor
92551287|NCT00054522|Autonomic Agents|autonomic agents|mesh-ancestor
92551288|NCT00054522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551289|NCT00054522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551290|NCT00054522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92551291|NCT00054522|Glucocorticoids|glucocorticoids|mesh-ancestor
92551292|NCT00054522|Hormones|hormones|mesh-ancestor
92551293|NCT00054522|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551301|NCT00054522|Vitamins|vitamins|mesh-ancestor
92551345|NCT00054873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551346|NCT00054873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551347|NCT00054873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551348|NCT00054873|Immunologic Factors|immunologic factors|mesh-ancestor
92551349|NCT00054873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551350|NCT00054873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551351|NCT00398385|Gemcitabine|gemcitabine|mesh-list
92551352|NCT00398385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551353|NCT00398385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551354|NCT00398385|Antimetabolites|antimetabolites|mesh-ancestor
92551355|NCT00398385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551356|NCT00027014|Fentanyl|fentanyl|mesh-list
92551357|NCT00027014|Oxycodone|oxycodone|mesh-list
92551358|NCT00027014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92551359|NCT00027014|Narcotics|narcotics|mesh-ancestor
92551360|NCT00027014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92551361|NCT00027014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551401|NCT00055302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551402|NCT00027248|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
92551403|NCT00027248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551404|NCT00055341|Ribavirin|ribavirin|mesh-list
92551405|NCT00055341|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92551406|NCT00055341|Antimetabolites|antimetabolites|mesh-ancestor
92551407|NCT00055341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551408|NCT00055341|Antiviral Agents|antiviral agents|mesh-ancestor
92551409|NCT00055341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551410|NCT00027287|Vitamin E|vitamin e|mesh-list
92551411|NCT00027287|Vitamins|vitamins|mesh-ancestor
92551412|NCT00027287|Micronutrients|micronutrients|mesh-ancestor
92551413|NCT00027287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551414|NCT00027287|Antioxidants|antioxidants|mesh-ancestor
92551415|NCT00027287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551416|NCT00027287|Protective Agents|protective agents|mesh-ancestor
92551417|NCT00055419|Cetuximab|cetuximab|mesh-list
92551418|NCT00055419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551419|NCT00055419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551420|NCT00055536|Natalizumab|natalizumab|mesh-list
92551421|NCT00055536|Immunologic Factors|immunologic factors|mesh-ancestor
92551422|NCT00055536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551457|NCT00055653|Cyclophosphamide|cyclophosphamide|mesh-list
92551458|NCT00055653|Melphalan|melphalan|mesh-list
92551459|NCT00055653|Busulfan|busulfan|mesh-list
92551460|NCT00055653|Fludarabine|fludarabine|mesh-list
92551461|NCT00055653|Fludarabine phosphate|fludarabine phosphate|mesh-list
92551462|NCT00055653|Cyclosporins|cyclosporins|mesh-list
92551463|NCT00055653|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92551464|NCT00055653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551465|NCT00055653|Immunologic Factors|immunologic factors|mesh-ancestor
92551466|NCT00055653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551467|NCT00055653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551468|NCT00055653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551469|NCT00055653|Alkylating Agents|alkylating agents|mesh-ancestor
92551471|NCT00055653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551520|NCT00055809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551521|NCT00055809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551522|NCT00055809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551523|NCT00055809|Growth Substances|growth substances|mesh-ancestor
92551524|NCT00055809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551525|NCT00055809|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551526|NCT00055809|Immunologic Factors|immunologic factors|mesh-ancestor
92551527|NCT00055809|Antiviral Agents|antiviral agents|mesh-ancestor
92551528|NCT00055809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551529|NCT00027677|Halofuginone|halofuginone|mesh-list
92551530|NCT00027677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551531|NCT00027677|Coccidiostats|coccidiostats|mesh-ancestor
92551532|NCT00027677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92551533|NCT00027677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92551534|NCT00027677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551535|NCT00027677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92551536|NCT00027677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551537|NCT00027677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551576|NCT00027404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551577|NCT00055965|Carboplatin|carboplatin|mesh-list
92551578|NCT00055965|Gemcitabine|gemcitabine|mesh-list
92551579|NCT00055965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551580|NCT00055965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551581|NCT00055965|Antimetabolites|antimetabolites|mesh-ancestor
92551582|NCT00055965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551583|NCT00027833|Leucovorin|leucovorin|mesh-list
92551584|NCT00027833|Fluorouracil|fluorouracil|mesh-list
92551585|NCT00027833|Irinotecan|irinotecan|mesh-list
92551586|NCT00027833|Calcium|calcium|mesh-list
92551587|NCT00027833|Levoleucovorin|levoleucovorin|mesh-list
92551588|NCT00027833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92551589|NCT00027833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551590|NCT00027833|Antimetabolites|antimetabolites|mesh-ancestor
92551591|NCT00027833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551592|NCT00027833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551593|NCT00027833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551594|NCT00027833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551595|NCT00027833|Immunologic Factors|immunologic factors|mesh-ancestor
92551596|NCT00027833|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551597|NCT00027833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551598|NCT00027833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551599|NCT00027833|Antidotes|antidotes|mesh-ancestor
92551630|NCT00056004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551631|NCT00056004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551632|NCT00056004|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92551633|NCT00056004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92551634|NCT00056004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551635|NCT00028028|Sirolimus|sirolimus|mesh-list
92551636|NCT00028028|Temsirolimus|temsirolimus|mesh-list
92551637|NCT00028028|MTOR Inhibitors|mtor inhibitors|mesh-list
92551638|NCT00028028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92551639|NCT00028028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551640|NCT00028028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551641|NCT00028028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551642|NCT00028028|Immunologic Factors|immunologic factors|mesh-ancestor
92551643|NCT00028028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551644|NCT00028028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551645|NCT00028028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92551646|NCT00028028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551647|NCT00028028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551648|NCT00028028|Antifungal Agents|antifungal agents|mesh-ancestor
92551649|NCT00028106|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92551650|NCT00028106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551651|NCT00028106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551653|NCT00028106|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92551678|NCT00028418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551680|NCT00028418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551681|NCT00028418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551682|NCT00028496|Metronidazole|metronidazole|mesh-list
92551683|NCT00028496|Molgramostim|molgramostim|mesh-list
92551685|NCT00028496|Sargramostim|sargramostim|mesh-list
92551686|NCT00028496|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
92551687|NCT00028496|Immunologic Factors|immunologic factors|mesh-ancestor
92551688|NCT00028496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551689|NCT00028496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551690|NCT00028496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551691|NCT00028496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92551741|NCT00056433|Vasodilator Agents|vasodilator agents|mesh-ancestor
92551742|NCT00056433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92551743|NCT00056433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92551744|NCT00056433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551745|NCT00056433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551746|NCT00056433|Urological Agents|urological agents|mesh-ancestor
92551747|NCT00056433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551748|NCT00056433|Antisickling Agents|antisickling agents|mesh-ancestor
92551749|NCT00056433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92551750|NCT00028613|Antibodies|antibodies|mesh-list
92551751|NCT00028613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92551752|NCT00028613|Immunologic Factors|immunologic factors|mesh-ancestor
92551753|NCT00028613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551754|NCT00028652|Interleukin-12|interleukin-12|mesh-list
92551755|NCT00028652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92551756|NCT00028652|Immunologic Factors|immunologic factors|mesh-ancestor
92551757|NCT00028652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276448|NCT03594045|Apixaban|apixaban|mesh-list
92551758|NCT00028652|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551759|NCT00028652|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551760|NCT00028652|Growth Substances|growth substances|mesh-ancestor
92551761|NCT00028652|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551762|NCT00028652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551763|NCT00028691|Chlorambucil|chlorambucil|mesh-list
92551764|NCT00028691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551765|NCT00028691|Alkylating Agents|alkylating agents|mesh-ancestor
92551766|NCT00028691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551767|NCT00028691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551768|NCT00028730|Cyclophosphamide|cyclophosphamide|mesh-list
92551770|NCT00028730|Fludarabine|fludarabine|mesh-list
92551771|NCT00028730|Fludarabine phosphate|fludarabine phosphate|mesh-list
92551772|NCT00028730|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92551773|NCT00028730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551782|NCT00028730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551783|NCT00028730|Antimetabolites|antimetabolites|mesh-ancestor
92551784|NCT00028847|Cytarabine|cytarabine|mesh-list
92551785|NCT00028847|Imatinib Mesylate|imatinib mesylate|mesh-list
92551786|NCT00028847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551787|NCT00028847|Antimetabolites|antimetabolites|mesh-ancestor
92551788|NCT00028847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551789|NCT00028847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551790|NCT00028847|Antiviral Agents|antiviral agents|mesh-ancestor
92551791|NCT00028847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551792|NCT00028847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551793|NCT00028847|Immunologic Factors|immunologic factors|mesh-ancestor
92551794|NCT00028847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551795|NCT00028847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92551796|NCT00028847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551797|NCT00028886|Interferons|interferons|mesh-list
92551798|NCT00028886|Interferon-alpha|interferon-alpha|mesh-list
92551799|NCT00028886|Thalidomide|thalidomide|mesh-list
92551800|NCT00028886|Dexamethasone|dexamethasone|mesh-list
92551801|NCT00028886|Cyclophosphamide|cyclophosphamide|mesh-list
92551802|NCT00028886|Melphalan|melphalan|mesh-list
92551803|NCT00028886|Doxorubicin|doxorubicin|mesh-list
92551804|NCT00028886|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92551805|NCT00028886|Vincristine|vincristine|mesh-list
92551806|NCT00028886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551807|NCT00028886|Immunologic Factors|immunologic factors|mesh-ancestor
92551808|NCT00028886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551809|NCT00028886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551810|NCT00028886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92551811|NCT00028886|Alkylating Agents|alkylating agents|mesh-ancestor
92551812|NCT00028886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551813|NCT00028886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551814|NCT00028886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92551815|NCT00028886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92551816|NCT00028886|Antiemetics|antiemetics|mesh-ancestor
92551817|NCT00028886|Autonomic Agents|autonomic agents|mesh-ancestor
92627503|NCT03214562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627504|NCT03214562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627505|NCT03214562|Immunologic Factors|immunologic factors|mesh-ancestor
92551818|NCT00028886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92551819|NCT00028886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92551820|NCT00028886|Glucocorticoids|glucocorticoids|mesh-ancestor
92551821|NCT00028886|Hormones|hormones|mesh-ancestor
92551822|NCT00028886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92551823|NCT00028886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92551824|NCT00028886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92551825|NCT00028886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92551826|NCT00028886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551827|NCT00028886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551828|NCT00028886|Antiviral Agents|antiviral agents|mesh-ancestor
92551829|NCT00028886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92551830|NCT00028886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92551831|NCT00028886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92551832|NCT00028886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92551833|NCT00028886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92551835|NCT00028886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92551836|NCT00028886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551837|NCT00028886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551838|NCT00028886|Growth Substances|growth substances|mesh-ancestor
92551839|NCT00028886|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551840|NCT00028925|Carboplatin|carboplatin|mesh-list
92551841|NCT00028925|Topotecan|topotecan|mesh-list
92551842|NCT00028925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551843|NCT00028925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551844|NCT00028925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551845|NCT00028925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551846|NCT00028925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551847|NCT00398463|polysaccharide-K|polysaccharide-k|mesh-list
92551848|NCT00398463|Tirofiban|tirofiban|mesh-list
92551849|NCT00398463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92551850|NCT00398463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92551853|NCT00398463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92551860|NCT00398463|Interferon Inducers|interferon inducers|mesh-ancestor
92551861|NCT00398463|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92551862|NCT00398463|Protective Agents|protective agents|mesh-ancestor
92551863|NCT00028964|Cyclophosphamide|cyclophosphamide|mesh-list
92551864|NCT00028964|Doxorubicin|doxorubicin|mesh-list
92551865|NCT00028964|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92551866|NCT00028964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551867|NCT00028964|Immunologic Factors|immunologic factors|mesh-ancestor
92551869|NCT00028964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92551927|NCT00423696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551929|NCT00423696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92551930|NCT00423696|Antimetabolites|antimetabolites|mesh-ancestor
92551931|NCT00423696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551932|NCT00423696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92551933|NCT00423696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92551934|NCT00423696|Immunologic Factors|immunologic factors|mesh-ancestor
92551935|NCT00423696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92551936|NCT00423696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92551937|NCT00423696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92551938|NCT00423696|Antidotes|antidotes|mesh-ancestor
92551939|NCT00423696|Protective Agents|protective agents|mesh-ancestor
92551940|NCT00423696|Vitamin B Complex|vitamin b complex|mesh-ancestor
92551941|NCT00423696|Vitamins|vitamins|mesh-ancestor
92551942|NCT00423696|Micronutrients|micronutrients|mesh-ancestor
92551943|NCT00029315|Plasminogen|plasminogen|mesh-list
92551944|NCT00029315|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92551945|NCT00029315|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92551946|NCT00029315|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92551947|NCT00029315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551948|NCT00056823|Ranibizumab|ranibizumab|mesh-list
92551949|NCT00056823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92551950|NCT00056823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92551951|NCT00056823|Growth Substances|growth substances|mesh-ancestor
92551952|NCT00056823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551953|NCT00056823|Growth Inhibitors|growth inhibitors|mesh-ancestor
92551954|NCT00056823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551955|NCT00029627|Yohimbine|yohimbine|mesh-list
92551956|NCT00029627|Mydriatics|mydriatics|mesh-ancestor
92551957|NCT00029627|Autonomic Agents|autonomic agents|mesh-ancestor
92551971|NCT02970084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92551972|NCT02970084|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92551973|NCT02970084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92551974|NCT02970084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92551976|NCT02970084|Coagulants|coagulants|mesh-ancestor
92551977|NCT00056979|Fludarabine|fludarabine|mesh-list
92551978|NCT00056979|Alemtuzumab|alemtuzumab|mesh-list
92551979|NCT00056979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92551980|NCT00056979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92551981|NCT00029822|Alfuzosin|alfuzosin|mesh-list
92551982|NCT00029822|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92551983|NCT00029822|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92551985|NCT00029822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92552031|NCT00057369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552032|NCT00057369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552033|NCT00057408|Olanzapine|olanzapine|mesh-list
92552034|NCT00057408|Antipsychotic Agents|antipsychotic agents|mesh-list
92552035|NCT00057408|Antiemetics|antiemetics|mesh-ancestor
92552036|NCT00057408|Autonomic Agents|autonomic agents|mesh-ancestor
92552037|NCT00057408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92552038|NCT00057408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552039|NCT00057408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92552040|NCT00057408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92552041|NCT00057408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92552042|NCT00057408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92552043|NCT00057408|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92552044|NCT00057408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92552045|NCT00057408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552046|NCT00057408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552047|NCT00057408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92552048|NCT00057408|Serotonin Agents|serotonin agents|mesh-ancestor
92552049|NCT00030056|Molgramostim|molgramostim|mesh-list
92552050|NCT00030056|Sargramostim|sargramostim|mesh-list
92552086|NCT00057564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92552087|NCT00057564|Glucocorticoids|glucocorticoids|mesh-ancestor
92552088|NCT00057564|Hormones|hormones|mesh-ancestor
92552089|NCT00057564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552090|NCT00057564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92552091|NCT00057564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552092|NCT00057564|Protease Inhibitors|protease inhibitors|mesh-ancestor
92552093|NCT00057564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552094|NCT00057564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552095|NCT00057564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552096|NCT00057564|Immunologic Factors|immunologic factors|mesh-ancestor
92552148|NCT00030446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552149|NCT00030485|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92552218|NCT02969733|Anesthetics, Local|anesthetics, local|mesh-ancestor
92552219|NCT02969733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92552220|NCT02969733|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92552221|NCT02969733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92552222|NCT02969733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92552224|NCT00030719|Melphalan|melphalan|mesh-list
92552225|NCT00030719|Busulfan|busulfan|mesh-list
92552288|NCT00030914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92552360|NCT00058305|Immunologic Factors|immunologic factors|mesh-ancestor
92552361|NCT00058305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552362|NCT00058461|Cytarabine|cytarabine|mesh-list
92552363|NCT00058461|Rituximab|rituximab|mesh-list
92552364|NCT00058461|Carboplatin|carboplatin|mesh-list
92552365|NCT00058461|Methotrexate|methotrexate|mesh-list
92552366|NCT00058461|Etoposide|etoposide|mesh-list
92552367|NCT00058461|Ifosfamide|ifosfamide|mesh-list
92552368|NCT00058461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92552369|NCT00058461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552370|NCT00058461|Immunologic Factors|immunologic factors|mesh-ancestor
92552372|NCT00058461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92552423|NCT00031187|Mitosis Modulators|mitosis modulators|mesh-ancestor
92552424|NCT00031187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552425|NCT00031187|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92552426|NCT00031187|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92552427|NCT00031187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92552428|NCT00031187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552429|NCT00031187|Immunologic Factors|immunologic factors|mesh-ancestor
92552430|NCT00031187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552431|NCT00031343|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92552487|NCT00031499|Doxycycline|doxycycline|mesh-list
92552488|NCT00031499|Penicillins|penicillins|mesh-list
92552489|NCT00031499|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92552490|NCT00031499|Penicillin G|penicillin g|mesh-list
92552491|NCT00031499|Penicillin G Procaine|penicillin g procaine|mesh-list
92552492|NCT00031499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552493|NCT00031499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552494|NCT00031499|Antimalarials|antimalarials|mesh-ancestor
92552495|NCT00031499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92552496|NCT00031499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92552497|NCT00059358|Interferons|interferons|mesh-list
92552498|NCT00059358|Ribavirin|ribavirin|mesh-list
92552499|NCT00059358|Interferon-alpha|interferon-alpha|mesh-list
92552500|NCT00059358|Interferon alpha-2|interferon alpha-2|mesh-list
92552501|NCT00059358|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92552502|NCT00059358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552503|NCT00059358|Antiviral Agents|antiviral agents|mesh-ancestor
92552504|NCT00059358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552505|NCT00059358|Antimetabolites|antimetabolites|mesh-ancestor
92552547|NCT00031655|Antitubercular Agents|antitubercular agents|mesh-ancestor
92552548|NCT00031655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552616|NCT00031889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92552617|NCT00031889|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92552618|NCT00031889|Hormone Antagonists|hormone antagonists|mesh-ancestor
92552619|NCT00031889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92552620|NCT00031889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552621|NCT00031889|Androgen Antagonists|androgen antagonists|mesh-ancestor
92552623|NCT00031928|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92552624|NCT00031928|Immunologic Factors|immunologic factors|mesh-ancestor
92552625|NCT00031928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552626|NCT00031928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92552678|NCT00032084|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92552828|NCT02968719|Nootropic Agents|nootropic agents|mesh-ancestor
92552829|NCT00060489|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92552830|NCT00060489|Antidepressive Agents|antidepressive agents|mesh-ancestor
92552836|NCT00032825|Ketoconazole|ketoconazole|mesh-list
92552900|NCT00033059|Tolcapone|tolcapone|mesh-list
92552901|NCT00033059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92552902|NCT00033059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92552904|NCT00033059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92552970|NCT00060996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92552971|NCT00033254|Thalidomide|thalidomide|mesh-list
92552972|NCT00033254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92552973|NCT00033254|Immunologic Factors|immunologic factors|mesh-ancestor
92552974|NCT00033254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92552975|NCT00033254|Leprostatic Agents|leprostatic agents|mesh-ancestor
92552976|NCT00033254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92552977|NCT00033254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92552978|NCT00033254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92552983|NCT00061074|Nicotine|nicotine|mesh-list
92553035|NCT00061113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92553036|NCT00061113|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553037|NCT00061113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553038|NCT00061113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92553039|NCT00061113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92553040|NCT00061113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553042|NCT00033449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553043|NCT00033449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92553044|NCT00033449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553045|NCT00033449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553047|NCT00061152|Antipruritics|antipruritics|mesh-ancestor
92553048|NCT00061152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553098|NCT00033683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92553099|NCT00033683|Abortifacient Agents|abortifacient agents|mesh-ancestor
92553100|NCT00033683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92553101|NCT00033683|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553102|NCT00033683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553103|NCT00033683|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92553104|NCT00033683|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92553105|NCT00033683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92553106|NCT00033683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92553107|NCT00033683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553162|NCT00061542|Autonomic Agents|autonomic agents|mesh-ancestor
92553163|NCT00061542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553164|NCT00061542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92553165|NCT00061620|Tezacitabine|tezacitabine|mesh-list
92553166|NCT00061620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553167|NCT00061620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553168|NCT00061620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553169|NCT00034151|Paclitaxel|paclitaxel|mesh-list
92553170|NCT00034151|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92553171|NCT00034151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553172|NCT00034151|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553173|NCT00034151|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553174|NCT00034151|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553176|NCT00034190|Paclitaxel|paclitaxel|mesh-list
92553224|NCT02971397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92553225|NCT02971397|Immunologic Factors|immunologic factors|mesh-ancestor
92553231|NCT00396500|Vitamin A|vitamin a|mesh-list
92553295|NCT00061815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553296|NCT00061815|Antidotes|antidotes|mesh-ancestor
92553299|NCT00061815|Vitamins|vitamins|mesh-ancestor
92553366|NCT00034775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553367|NCT00034775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92553368|NCT00034775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92553369|NCT00034775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92553370|NCT00034775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553371|NCT00034775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92553372|NCT00034775|Dopamine Agents|dopamine agents|mesh-ancestor
92553373|NCT00062127|Thalidomide|thalidomide|mesh-list
92553374|NCT00062127|Irinotecan|irinotecan|mesh-list
92553375|NCT00062127|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92553376|NCT00062127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92553377|NCT00062127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553378|NCT00062127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553428|NCT00062205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92553429|NCT00062205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553430|NCT00062244|Oblimersen|oblimersen|mesh-list
92553431|NCT00062244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553432|NCT00035009|Aprepitant|aprepitant|mesh-list
92553433|NCT00035009|Paroxetine|paroxetine|mesh-list
92553434|NCT00035009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92553435|NCT00035009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553436|NCT00035009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553437|NCT00035009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553438|NCT00035009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553439|NCT00035009|Serotonin Agents|serotonin agents|mesh-ancestor
92553440|NCT00035009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553442|NCT00035009|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553487|NCT00035165|Epothilones|epothilones|mesh-list
92553488|NCT00035165|Epothilone B|epothilone b|mesh-list
92553489|NCT00035165|Tubulin Modulators|tubulin modulators|mesh-ancestor
92553490|NCT00035165|Antimitotic Agents|antimitotic agents|mesh-ancestor
92553491|NCT00035165|Mitosis Modulators|mitosis modulators|mesh-ancestor
92553492|NCT00035165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553493|NCT00035165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92553494|NCT00035204|Galantamine|galantamine|mesh-list
92553495|NCT00035204|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92553555|NCT00035321|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92553556|NCT00035321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553625|NCT00062946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92553626|NCT00062946|Dopamine Agents|dopamine agents|mesh-ancestor
92553627|NCT00062946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553628|NCT00062946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553697|NCT00036335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92553698|NCT00036335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92553699|NCT00036335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92553700|NCT00036335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553701|NCT00036335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92553702|NCT00036335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92553703|NCT00036335|Analgesics|analgesics|mesh-ancestor
92553704|NCT00036335|Sensory System Agents|sensory system agents|mesh-ancestor
92553705|NCT00036335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92553706|NCT00036335|Antidepressive Agents|antidepressive agents|mesh-ancestor
92553707|NCT00036335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92553708|NCT00036335|Dopamine Agents|dopamine agents|mesh-ancestor
92553710|NCT00036374|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92553711|NCT00036374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92553712|NCT00036374|Dermatologic Agents|dermatologic agents|mesh-ancestor
92553713|NCT00036374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92553714|NCT00036374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92553715|NCT00036452|Ritonavir|ritonavir|mesh-list
92553716|NCT00036452|Lopinavir|lopinavir|mesh-list
92553717|NCT00036452|Tenofovir|tenofovir|mesh-list
92553718|NCT00036452|Emtricitabine|emtricitabine|mesh-list
92553719|NCT00036452|Stavudine|stavudine|mesh-list
92553720|NCT00036452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92553721|NCT00036452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92553725|NCT00036452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92553748|NCT00036491|Rituximab|rituximab|mesh-list
92553823|NCT00064194|Selenium|selenium|mesh-list
92553824|NCT00064194|Vitamins|vitamins|mesh-ancestor
92553889|NCT00064428|PENTA|penta|mesh-list
92553896|NCT00064428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92553897|NCT00064428|Anticoagulants|anticoagulants|mesh-ancestor
92553898|NCT00064428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92553900|NCT00064467|Bupropion|bupropion|mesh-list
92553967|NCT00037817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92553968|NCT00037817|Analgesics|analgesics|mesh-ancestor
92553969|NCT00037817|Sensory System Agents|sensory system agents|mesh-ancestor
92554039|NCT00065325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554040|NCT00065325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92554041|NCT00065325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92554042|NCT00065325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554043|NCT00065325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554045|NCT00038168|Estramustine|estramustine|mesh-list
92554046|NCT00038168|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554047|NCT00038168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554048|NCT00038168|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554049|NCT00038168|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554050|NCT00038168|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554051|NCT00038168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554077|NCT00038246|Paclitaxel|paclitaxel|mesh-list
92554099|NCT00398775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92554101|NCT00398814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554102|NCT00398814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92554105|NCT00065559|Celecoxib|celecoxib|mesh-list
92554172|NCT00069927|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92554173|NCT00069966|Cytarabine|cytarabine|mesh-list
92554174|NCT00069966|Methylprednisolone|methylprednisolone|mesh-list
92554175|NCT00069966|Rituximab|rituximab|mesh-list
92554176|NCT00069966|Pixantrone|pixantrone|mesh-list
92554243|NCT00070083|Immunologic Factors|immunologic factors|mesh-ancestor
92554244|NCT00070083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554245|NCT00070083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554246|NCT00070083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554247|NCT00070083|Alkylating Agents|alkylating agents|mesh-ancestor
92554248|NCT00070083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554249|NCT00070083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554250|NCT00070083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92554251|NCT00070083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554252|NCT00070083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92554253|NCT00070083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554254|NCT00070083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554255|NCT00070083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554256|NCT00070083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92554302|NCT00070200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92554375|NCT00066378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554376|NCT00066378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554377|NCT00066417|Cyclosporine|cyclosporine|mesh-list
92554378|NCT00066417|Methylprednisolone|methylprednisolone|mesh-list
92554379|NCT00066417|Cyclophosphamide|cyclophosphamide|mesh-list
92554380|NCT00066417|Thiotepa|thiotepa|mesh-list
92279070|NCT05600517|Fluorides|fluorides|mesh-list
92554382|NCT00066417|Fludarabine phosphate|fludarabine phosphate|mesh-list
92554383|NCT00066417|Cyclosporins|cyclosporins|mesh-list
92554384|NCT00066417|Immunomodulating Agents|immunomodulating agents|mesh-list
92554385|NCT00066417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92554386|NCT00066417|Immunologic Factors|immunologic factors|mesh-ancestor
92554387|NCT00066417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554388|NCT00066417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92554389|NCT00066417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554390|NCT00066417|Alkylating Agents|alkylating agents|mesh-ancestor
92554391|NCT00066417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554402|NCT00066417|Antiemetics|antiemetics|mesh-ancestor
92554434|NCT00070434|Antidotes|antidotes|mesh-ancestor
92554435|NCT00070434|Protective Agents|protective agents|mesh-ancestor
92554509|NCT00398892|Vitamins|vitamins|mesh-ancestor
92554510|NCT00398892|Micronutrients|micronutrients|mesh-ancestor
92554511|NCT05019794|Infigratinib|infigratinib|mesh-list
92554512|NCT05019794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554513|NCT00066768|Suramin|suramin|mesh-list
92554584|NCT04732364|Sensory System Agents|sensory system agents|mesh-ancestor
92554585|NCT04732364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554586|NCT04732598|Paclitaxel|paclitaxel|mesh-list
92554587|NCT04732598|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92554588|NCT04732598|Bevacizumab|bevacizumab|mesh-list
92554589|NCT04732598|Atezolizumab|atezolizumab|mesh-list
92554590|NCT04732598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92554591|NCT04732598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554592|NCT04732598|Tubulin Modulators|tubulin modulators|mesh-ancestor
92554593|NCT04732598|Antimitotic Agents|antimitotic agents|mesh-ancestor
92554594|NCT04732598|Mitosis Modulators|mitosis modulators|mesh-ancestor
92554595|NCT04732598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554647|NCT00399165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92554648|NCT00399165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92554649|NCT00399165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554650|NCT00399165|Hormone Antagonists|hormone antagonists|mesh-ancestor
92554651|NCT00067158|Nicotine|nicotine|mesh-list
92554652|NCT00067158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92554653|NCT00067158|Autonomic Agents|autonomic agents|mesh-ancestor
92554654|NCT00067158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554655|NCT00067158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554656|NCT00067158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92554657|NCT00067158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92554658|NCT00067158|Cholinergic Agents|cholinergic agents|mesh-ancestor
92554659|NCT00067158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92554661|NCT00071097|Darunavir|darunavir|mesh-list
92554709|NCT00067509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554711|NCT01349673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92554712|NCT01349673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92554713|NCT01349673|Autonomic Agents|autonomic agents|mesh-ancestor
92554714|NCT01349673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554715|NCT01349673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554716|NCT01349673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92554717|NCT01349673|Respiratory System Agents|respiratory system agents|mesh-ancestor
92554718|NCT01349673|Glucocorticoids|glucocorticoids|mesh-ancestor
92554719|NCT01349673|Hormones|hormones|mesh-ancestor
92554720|NCT01349673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92554721|NCT00071253|Valproic Acid|valproic acid|mesh-list
92554722|NCT00071253|Olanzapine|olanzapine|mesh-list
92554723|NCT00071253|Antiemetics|antiemetics|mesh-ancestor
92554724|NCT00071253|Autonomic Agents|autonomic agents|mesh-ancestor
92554725|NCT00071253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92554742|NCT00067548|EKB 569|ekb 569|mesh-list
92554766|NCT03338621|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92554767|NCT03338621|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92554768|NCT03338621|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92554769|NCT03338621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92554770|NCT03338621|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92554771|NCT03338621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92554772|NCT03338621|Antimetabolites|antimetabolites|mesh-ancestor
92554773|NCT03338621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92554775|NCT00071331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92554776|NCT00071331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554777|NCT00071331|Natriuretic Agents|natriuretic agents|mesh-ancestor
92554778|NCT00071331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554779|NCT00067626|Chromium|chromium|mesh-list
92554780|NCT00067626|Trace Elements|trace elements|mesh-ancestor
92554781|NCT00067626|Micronutrients|micronutrients|mesh-ancestor
92554782|NCT00067626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554783|NCT00067743|Lenalidomide|lenalidomide|mesh-list
92554823|NCT02599324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554824|NCT00067899|Vitamins|vitamins|mesh-list
92554825|NCT00067899|Vitamin E|vitamin e|mesh-list
92554826|NCT00067899|Micronutrients|micronutrients|mesh-ancestor
92554827|NCT00067899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554828|NCT00067899|Antioxidants|antioxidants|mesh-ancestor
92554829|NCT00067899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92554830|NCT00067899|Protective Agents|protective agents|mesh-ancestor
92554831|NCT00067938|Lamotrigine|lamotrigine|mesh-list
92554832|NCT00067938|Anticonvulsants|anticonvulsants|mesh-ancestor
92554833|NCT00067938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92554834|NCT00067938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92554835|NCT00067938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279522|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92554836|NCT00067938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92554837|NCT00067938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92554838|NCT00067938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92554839|NCT00067938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92554840|NCT00067938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92554841|NCT00067938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92554875|NCT00038402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92554876|NCT00038402|Alkylating Agents|alkylating agents|mesh-ancestor
92554877|NCT00038402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92554878|NCT00038402|Antimetabolites|antimetabolites|mesh-ancestor
92554879|NCT00038402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92554880|NCT00038402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92554881|NCT00038402|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92554882|NCT00038402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92554883|NCT00038402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92554938|NCT00202306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555012|NCT00038636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92555013|NCT00038636|Antiviral Agents|antiviral agents|mesh-ancestor
92555014|NCT00038636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555015|NCT00038636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92555016|NCT00038636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92555017|NCT00071838|Daclizumab|daclizumab|mesh-list
92555018|NCT00071838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555019|NCT00071838|Immunologic Factors|immunologic factors|mesh-ancestor
92555020|NCT00071838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555021|NCT00202852|Infliximab|infliximab|mesh-list
92555022|NCT00202852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92555023|NCT00202852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555024|NCT00202852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92555025|NCT00202852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92555026|NCT00202852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555073|NCT00203281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555074|NCT00203281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92555075|NCT00203281|Antitubercular Agents|antitubercular agents|mesh-ancestor
92555076|NCT00203281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92555077|NCT00203281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555145|NCT00203632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92555146|NCT00203632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555147|NCT00071994|Gefitinib|gefitinib|mesh-list
92555148|NCT00071994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555149|NCT00071994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555150|NCT00071994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555151|NCT00071994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555152|NCT00203788|Risperidone|risperidone|mesh-list
92555153|NCT00203788|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92555154|NCT00203788|Serotonin Agents|serotonin agents|mesh-ancestor
92555155|NCT00203788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92555156|NCT00203788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555157|NCT00203788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555158|NCT00203788|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92555159|NCT00203788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555160|NCT00203788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555161|NCT00203788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555162|NCT00203788|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92555199|NCT00072072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555200|NCT00072072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92555201|NCT00072072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92555202|NCT00072072|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92555203|NCT00072072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92555204|NCT00204022|Mycophenolic Acid|mycophenolic acid|mesh-list
92555205|NCT00204022|Azathioprine|azathioprine|mesh-list
92555206|NCT00204022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92555207|NCT00204022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555208|NCT00204022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92555209|NCT00204022|Antitubercular Agents|antitubercular agents|mesh-ancestor
92555210|NCT00204022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92555211|NCT00204022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92555261|NCT00204451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555262|NCT00204451|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92555263|NCT00204451|Contraceptive Agents|contraceptive agents|mesh-ancestor
92555333|NCT00410995|Gout Suppressants|gout suppressants|mesh-ancestor
92555334|NCT00410995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92555335|NCT00410995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555336|NCT00410995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555337|NCT00039338|Cisplatin|cisplatin|mesh-list
92555338|NCT00039338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555339|NCT00072228|Gemcitabine|gemcitabine|mesh-list
92555340|NCT00072228|Soblidotin|soblidotin|mesh-list
92555341|NCT00072228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92555342|NCT00072228|Antimetabolites|antimetabolites|mesh-ancestor
92555343|NCT00072228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555344|NCT00072228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555345|NCT00204919|Vitamin D|vitamin d|mesh-list
92555346|NCT00204919|Ergocalciferols|ergocalciferols|mesh-list
92555347|NCT00204919|Vitamins|vitamins|mesh-ancestor
92555348|NCT00204919|Micronutrients|micronutrients|mesh-ancestor
92555349|NCT00204919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555350|NCT00204919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92555351|NCT00204919|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92555352|NCT00072267|Topotecan|topotecan|mesh-list
92555353|NCT00072267|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92555354|NCT00072267|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92555355|NCT00072267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555356|NCT00072267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555357|NCT00072267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555358|NCT00072267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555359|NCT00072267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555360|NCT00039416|Imatinib Mesylate|imatinib mesylate|mesh-list
92555361|NCT00039416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555362|NCT00039416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92555363|NCT00039416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555364|NCT00039416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555365|NCT00072345|Thalidomide|thalidomide|mesh-list
92555366|NCT00072345|Temozolomide|temozolomide|mesh-list
92555367|NCT00072345|Lomustine|lomustine|mesh-list
92555368|NCT00072345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627506|NCT03214562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627507|NCT03214562|Antiviral Agents|antiviral agents|mesh-ancestor
92627508|NCT03214562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627509|NCT03214562|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92555369|NCT00072345|Alkylating Agents|alkylating agents|mesh-ancestor
92555370|NCT00072345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555371|NCT00072345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92555372|NCT00072345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92555438|NCT00205738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92555439|NCT00205738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555440|NCT00205738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92555509|NCT00206167|Glucocorticoids|glucocorticoids|mesh-ancestor
92555510|NCT00206167|Hormones|hormones|mesh-ancestor
92704602|NCT02203643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92555514|NCT00206167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92555582|NCT00411073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92555657|NCT00206635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92555658|NCT00206674|Sargramostim|sargramostim|mesh-list
92555659|NCT00206674|Immunologic Factors|immunologic factors|mesh-ancestor
92555660|NCT00206674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555661|NCT00206713|Sargramostim|sargramostim|mesh-list
92280359|NCT00000939|Efavirenz|efavirenz|mesh-list
92555662|NCT00206713|Immunologic Factors|immunologic factors|mesh-ancestor
92555663|NCT00206713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555665|NCT00040040|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92555666|NCT00040040|Antidepressive Agents|antidepressive agents|mesh-ancestor
92555707|NCT00068523|Hormones|hormones|mesh-ancestor
92555722|NCT00206947|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92555798|NCT00040391|Immunologic Factors|immunologic factors|mesh-ancestor
92555799|NCT00040391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555800|NCT00040391|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92555801|NCT00040391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92555802|NCT00040391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92555803|NCT00040391|Antidotes|antidotes|mesh-ancestor
92555867|NCT00411307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92555868|NCT00411307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555869|NCT00411307|Analgesics|analgesics|mesh-ancestor
92555872|NCT00040508|Sirolimus|sirolimus|mesh-list
92555939|NCT00208156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92555940|NCT00208156|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92555941|NCT00208156|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92556010|NCT00068952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556083|NCT00208819|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92556084|NCT00208819|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92556085|NCT00208819|Dopamine Agents|dopamine agents|mesh-ancestor
92556155|NCT00041054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92556156|NCT00041054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556157|NCT00041054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556164|NCT00041054|Analgesics|analgesics|mesh-ancestor
92556227|NCT00041171|Tubulin Modulators|tubulin modulators|mesh-ancestor
92556228|NCT00041171|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556302|NCT00209833|Antiviral Agents|antiviral agents|mesh-ancestor
92556303|NCT00209833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92556304|NCT00209833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92556376|NCT00210028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92556377|NCT00210028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556522|NCT00041327|Antimitotic Agents|antimitotic agents|mesh-ancestor
92556523|NCT00041327|Mitosis Modulators|mitosis modulators|mesh-ancestor
92556598|NCT00210886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556599|NCT00210886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92556670|NCT00211705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92556671|NCT00211705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92556673|NCT00211705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92556740|NCT00073203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92556741|NCT00073203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92556742|NCT00073203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92556753|NCT00411736|Azithromycin|azithromycin|mesh-list
92556808|NCT00213538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92556809|NCT00213538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92556882|NCT00214318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92556883|NCT00214318|Vasodilator Agents|vasodilator agents|mesh-ancestor
92556884|NCT00214318|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92556885|NCT00214318|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92556886|NCT00214318|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92556952|NCT00214942|Fentanyl|fentanyl|mesh-list
92557022|NCT00215254|Antidepressive Agents|antidepressive agents|mesh-ancestor
92557023|NCT00215254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92557024|NCT00215254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92557025|NCT00215254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557092|NCT00215995|Irinotecan|irinotecan|mesh-list
92557168|NCT00216346|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92557241|NCT00216658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557250|NCT00216697|Bortezomib|bortezomib|mesh-list
92557317|NCT00041678|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92557318|NCT00041678|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92557319|NCT00041678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92557320|NCT00041678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557321|NCT00041678|Dopamine Agonists|dopamine agonists|mesh-ancestor
92557323|NCT00041678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557324|NCT00041678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557325|NCT00041678|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92557326|NCT00041678|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92557327|NCT00041678|Serotonin Agents|serotonin agents|mesh-ancestor
92557332|NCT00217243|Lidocaine|lidocaine|mesh-list
92557378|NCT00217711|Capecitabine|capecitabine|mesh-list
92557379|NCT00217711|Oxaliplatin|oxaliplatin|mesh-list
92557380|NCT00217711|Irinotecan|irinotecan|mesh-list
92557381|NCT00217711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92557382|NCT00217711|Antimetabolites|antimetabolites|mesh-ancestor
92557383|NCT00217711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557384|NCT00217711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557385|NCT00217711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92557386|NCT00217711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92557387|NCT00217711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557388|NCT00217789|Dimercaprol|dimercaprol|mesh-list
92557389|NCT00217789|Chelating Agents|chelating agents|mesh-ancestor
92557390|NCT00217789|Sequestering Agents|sequestering agents|mesh-ancestor
92557440|NCT00042029|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92557441|NCT00042029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557442|NCT00042029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557443|NCT00218218|Nicotine|nicotine|mesh-list
92557444|NCT00218218|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92557445|NCT00218218|Autonomic Agents|autonomic agents|mesh-ancestor
92557446|NCT00218218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557447|NCT00218218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557448|NCT00218218|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92557449|NCT00218218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92557450|NCT00218218|Cholinergic Agents|cholinergic agents|mesh-ancestor
92557451|NCT00218218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557452|NCT00218218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557453|NCT00218374|Gabapentin|gabapentin|mesh-list
92557499|NCT00218569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557500|NCT00218569|Sensory System Agents|sensory system agents|mesh-ancestor
92557501|NCT00218569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557502|NCT00218608|Disulfiram|disulfiram|mesh-list
92557503|NCT00218608|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92557504|NCT00218608|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92557505|NCT00218608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557568|NCT00042302|Antimitotic Agents|antimitotic agents|mesh-ancestor
92557569|NCT00042302|Mitosis Modulators|mitosis modulators|mesh-ancestor
92557640|NCT00077337|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92557641|NCT00077337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557712|NCT00077454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92557713|NCT00077454|Alkylating Agents|alkylating agents|mesh-ancestor
92557714|NCT00077454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557715|NCT00077454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557716|NCT00077454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92557717|NCT00077454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92557718|NCT00220324|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92557719|NCT00220324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92557720|NCT00220324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92557721|NCT00220324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92557722|NCT00220324|Contraceptive Agents|contraceptive agents|mesh-ancestor
92557723|NCT00220324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92557724|NCT00220324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557725|NCT00220324|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92557726|NCT00220324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92557767|NCT00042731|Lycopene|lycopene|mesh-list
92557768|NCT00042731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92557769|NCT00042731|Antioxidants|antioxidants|mesh-ancestor
92557770|NCT00042731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557771|NCT00042731|Protective Agents|protective agents|mesh-ancestor
92557772|NCT00042731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557773|NCT00042731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92557774|NCT00042731|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92557775|NCT00042731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557776|NCT00220714|Antipsychotic Agents|antipsychotic agents|mesh-list
92282554|NCT05806515|Carboplatin|carboplatin|mesh-list
92557832|NCT00073710|Vitamins|vitamins|mesh-ancestor
92557833|NCT00073710|Micronutrients|micronutrients|mesh-ancestor
92557834|NCT00073710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92557835|NCT00042848|Modafinil|modafinil|mesh-list
92557836|NCT00042848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92557837|NCT00042848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557838|NCT00042848|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92557898|NCT00122785|Autonomic Agents|autonomic agents|mesh-ancestor
92557899|NCT00122785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557900|NCT00122785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557901|NCT00122785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92557902|NCT00122785|Glucocorticoids|glucocorticoids|mesh-ancestor
92557904|NCT00122785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92557905|NCT00122785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92557906|NCT00122785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92557907|NCT00122824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92557908|NCT00122824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92557909|NCT00122824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92557910|NCT00122824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92557911|NCT00122824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92557912|NCT00122824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92557913|NCT00122824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92557914|NCT00122824|Analgesics|analgesics|mesh-ancestor
92557915|NCT00122824|Sensory System Agents|sensory system agents|mesh-ancestor
92557916|NCT00122824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92557917|NCT00122824|Antidepressive Agents|antidepressive agents|mesh-ancestor
92557948|NCT00077688|Paclitaxel|paclitaxel|mesh-list
92557949|NCT00077688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92558019|NCT00043004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558020|NCT00043004|Growth Inhibitors|growth inhibitors|mesh-ancestor
92558021|NCT00043004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92558022|NCT00043004|Antimetabolites|antimetabolites|mesh-ancestor
92558023|NCT00043004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558024|NCT00043004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558025|NCT00043004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558026|NCT00043004|Immunologic Factors|immunologic factors|mesh-ancestor
92558027|NCT00043004|Antidotes|antidotes|mesh-ancestor
92558028|NCT00043004|Protective Agents|protective agents|mesh-ancestor
92558029|NCT00043004|Vitamin B Complex|vitamin b complex|mesh-ancestor
92558030|NCT00043004|Vitamins|vitamins|mesh-ancestor
92558031|NCT00043004|Micronutrients|micronutrients|mesh-ancestor
92558032|NCT00123331|Cyclosporine|cyclosporine|mesh-list
92558033|NCT00123331|Sirolimus|sirolimus|mesh-list
92558034|NCT00123331|Cyclosporins|cyclosporins|mesh-list
92558035|NCT00123331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558036|NCT00123331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558037|NCT00123331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558038|NCT00123331|Immunologic Factors|immunologic factors|mesh-ancestor
92558039|NCT00123331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558040|NCT00123331|Antifungal Agents|antifungal agents|mesh-ancestor
92558042|NCT00123331|Dermatologic Agents|dermatologic agents|mesh-ancestor
92558071|NCT00077805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92558072|NCT00077805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92558073|NCT00077805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558074|NCT00043082|Carboplatin|carboplatin|mesh-list
92558141|NCT00124150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558142|NCT00124150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558143|NCT00124150|Anesthetics|anesthetics|mesh-ancestor
92558144|NCT00124150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558145|NCT00124150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92558146|NCT00124150|Anticonvulsants|anticonvulsants|mesh-ancestor
92558147|NCT00124150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92558148|NCT00124150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92558149|NCT00124150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558150|NCT00124150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92362116|NCT01115803|Everolimus|everolimus|mesh-list
92558151|NCT00124150|Tocolytic Agents|tocolytic agents|mesh-ancestor
92558152|NCT00124150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92558203|NCT00043121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558204|NCT00043121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92558205|NCT00043121|Immunologic Factors|immunologic factors|mesh-ancestor
92558273|NCT00124696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92558274|NCT00124696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92283003|NCT04655157|Nivolumab|nivolumab|mesh-list
92558275|NCT00124696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558276|NCT00124696|Dopamine Agents|dopamine agents|mesh-ancestor
92558277|NCT00124696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92558279|NCT00043277|Bivalirudin|bivalirudin|mesh-list
92558339|NCT00077961|Alemtuzumab|alemtuzumab|mesh-list
92558340|NCT00077961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92558341|NCT00077961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558342|NCT00125008|Vaccines|vaccines|mesh-list
92558343|NCT00125008|Immunologic Factors|immunologic factors|mesh-ancestor
92558344|NCT00125008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558408|NCT00125827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558410|NCT00078039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92558411|NCT00078039|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92558418|NCT00078039|Serotonin Agents|serotonin agents|mesh-ancestor
92558478|NCT00126022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92558551|NCT00399399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558552|NCT00399399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92558553|NCT00399399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92558554|NCT00399399|Alkylating Agents|alkylating agents|mesh-ancestor
92558555|NCT00399399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558556|NCT00399399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558557|NCT00399399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92558558|NCT00399399|Antimetabolites|antimetabolites|mesh-ancestor
92558559|NCT00399399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92558560|NCT00126100|Lenograstim|lenograstim|mesh-list
92558561|NCT00126100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92558562|NCT00126100|Immunologic Factors|immunologic factors|mesh-ancestor
92558563|NCT00126100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558564|NCT00123253|Tesamorelin|tesamorelin|mesh-list
92558565|NCT00123253|Growth Substances|growth substances|mesh-ancestor
92558566|NCT00123253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558567|NCT00126139|Abciximab|abciximab|mesh-list
92558568|NCT00126139|Anticoagulants|anticoagulants|mesh-ancestor
92558609|NCT00074139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558681|NCT00074178|Antimetabolites|antimetabolites|mesh-ancestor
92558682|NCT00074178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92558683|NCT00074178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558684|NCT00074178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92558685|NCT00074178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92558686|NCT00074178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92558687|NCT00074178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92558688|NCT00074178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92558689|NCT00074178|Antiviral Agents|antiviral agents|mesh-ancestor
92558690|NCT00074178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92558691|NCT00126646|Antibodies|antibodies|mesh-list
92558692|NCT00126646|Immunotoxins|immunotoxins|mesh-list
92558693|NCT00126646|Immunoconjugates|immunoconjugates|mesh-list
92558694|NCT00126646|Immunologic Factors|immunologic factors|mesh-ancestor
92558695|NCT00126646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558696|NCT00126763|Fentanyl|fentanyl|mesh-list
92558697|NCT00126763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92558698|NCT00126763|Narcotics|narcotics|mesh-ancestor
92558699|NCT00126763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92558700|NCT00126763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558701|NCT00126763|Analgesics|analgesics|mesh-ancestor
92558702|NCT00126763|Sensory System Agents|sensory system agents|mesh-ancestor
92558703|NCT00126763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558704|NCT00126763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92558705|NCT00126763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92558706|NCT00126763|Anesthetics, General|anesthetics, general|mesh-ancestor
92558707|NCT00126763|Anesthetics|anesthetics|mesh-ancestor
92558715|NCT00126880|Lamivudine|lamivudine|mesh-list
92558730|NCT00127075|Estrogens|estrogens|mesh-ancestor
92558731|NCT00127075|Hormones|hormones|mesh-ancestor
92558732|NCT00127075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92558733|NCT00127075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558734|NCT00127114|Amantadine|amantadine|mesh-list
92704651|NCT04356430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92558752|NCT00127153|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92558824|NCT00127504|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92558825|NCT00127504|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92558896|NCT00402766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92558897|NCT00402766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92558899|NCT00402766|Autonomic Agents|autonomic agents|mesh-ancestor
92558900|NCT00402766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92558901|NCT00402766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92558902|NCT00402766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92558903|NCT00402766|Glucocorticoids|glucocorticoids|mesh-ancestor
92558904|NCT00402766|Hormones|hormones|mesh-ancestor
92558905|NCT00402766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92558907|NCT00402766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92558959|NCT00044057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92558960|NCT00044135|Clevudine|clevudine|mesh-list
92559013|NCT00078351|Hylan|hylan|mesh-list
92559034|NCT00078390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559035|NCT00078390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559036|NCT00044486|Posaconazole|posaconazole|mesh-list
92559105|NCT00044720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559110|NCT00403000|Dutasteride|dutasteride|mesh-list
92559178|NCT00074841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92559179|NCT00074841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92559180|NCT00074841|Antimalarials|antimalarials|mesh-ancestor
92559181|NCT00074841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92559248|NCT04731740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559249|NCT04731740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559257|NCT00044915|Serotonin Agents|serotonin agents|mesh-ancestor
92559317|NCT00079092|Leprostatic Agents|leprostatic agents|mesh-ancestor
92559318|NCT00079092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559390|NCT00075075|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92559391|NCT00075075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92559462|NCT00045422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559463|NCT00075192|Leuprolide|leuprolide|mesh-list
92559464|NCT00075192|Bicalutamide|bicalutamide|mesh-list
92559465|NCT00075192|Tremelimumab|tremelimumab|mesh-list
92559466|NCT00075192|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92559467|NCT00075192|Fertility Agents|fertility agents|mesh-ancestor
92559468|NCT00075192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92559469|NCT00075192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559470|NCT00075192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559471|NCT00075192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559472|NCT00075192|Androgen Antagonists|androgen antagonists|mesh-ancestor
92559473|NCT00075192|Hormone Antagonists|hormone antagonists|mesh-ancestor
92559474|NCT00075192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559475|NCT03739411|Temozolomide|temozolomide|mesh-list
92559477|NCT03739411|Alkylating Agents|alkylating agents|mesh-ancestor
92559520|NCT00403312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559521|NCT00079170|Docetaxel|docetaxel|mesh-list
92559593|NCT03442309|Protective Agents|protective agents|mesh-ancestor
92559594|NCT03442309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92559595|NCT03399838|Midazolam|midazolam|mesh-list
92559596|NCT03399838|Dexmedetomidine|dexmedetomidine|mesh-list
92559597|NCT03399838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92559598|NCT03399838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92559664|NCT00045812|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92559665|NCT00045812|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92559666|NCT00045812|Antimetabolites|antimetabolites|mesh-ancestor
92559667|NCT00045812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559668|NCT00045812|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92559669|NCT00079443|Rituximab|rituximab|mesh-list
92559670|NCT00079443|Fludarabine|fludarabine|mesh-list
92559671|NCT00079443|Fludarabine phosphate|fludarabine phosphate|mesh-list
92559672|NCT00079443|Romidepsin|romidepsin|mesh-list
92559673|NCT00079443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559728|NCT00046163|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92559729|NCT00046163|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92559730|NCT00046163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92559731|NCT00046163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92559732|NCT00046163|Adrenergic Agents|adrenergic agents|mesh-ancestor
92559733|NCT00046163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92559734|NCT00046163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559735|NCT01409161|Vitamins|vitamins|mesh-list
92559736|NCT01409161|Vitamin A|vitamin a|mesh-list
92559795|NCT00130468|Protective Agents|protective agents|mesh-ancestor
92559796|NCT00130507|Capecitabine|capecitabine|mesh-list
92559797|NCT00130507|Trastuzumab|trastuzumab|mesh-list
92559798|NCT00130507|Vinorelbine|vinorelbine|mesh-list
92559799|NCT00130507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559800|NCT00130507|Antimetabolites|antimetabolites|mesh-ancestor
92559801|NCT00130507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559802|NCT00130507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92559803|NCT00130507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92559804|NCT00130507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92559805|NCT00130507|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559806|NCT00130507|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559808|NCT00130546|Sirolimus|sirolimus|mesh-list
92559859|NCT00130897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92559933|NCT00131053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92559934|NCT00131053|Glucocorticoids|glucocorticoids|mesh-ancestor
92559935|NCT00131053|Hormones|hormones|mesh-ancestor
92559936|NCT00131053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92559937|NCT00131053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92559938|NCT00131053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92559939|NCT00131053|Abortifacient Agents|abortifacient agents|mesh-ancestor
92559940|NCT00131053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92559941|NCT00131053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92559942|NCT00131053|Antimetabolites|antimetabolites|mesh-ancestor
92559943|NCT00131053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92559944|NCT00131053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559945|NCT00131053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92559946|NCT00131053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92559947|NCT00131053|Antiviral Agents|antiviral agents|mesh-ancestor
92559948|NCT00131053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559949|NCT00131053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92559950|NCT00131053|Tubulin Modulators|tubulin modulators|mesh-ancestor
92559951|NCT00131053|Antimitotic Agents|antimitotic agents|mesh-ancestor
92559952|NCT00131053|Mitosis Modulators|mitosis modulators|mesh-ancestor
92559985|NCT00397709|Isoniazid|isoniazid|mesh-list
92559986|NCT00397709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92559987|NCT00397709|Antitubercular Agents|antitubercular agents|mesh-ancestor
92559988|NCT00397709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92559989|NCT00397709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92559990|NCT00397709|Leprostatic Agents|leprostatic agents|mesh-ancestor
92559991|NCT00397709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92559992|NCT00397709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92559993|NCT00397709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92559994|NCT00397709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92559995|NCT00397709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92559996|NCT00397709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92559997|NCT00397709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92559998|NCT00397709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92559999|NCT00397709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92560000|NCT00397709|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92560001|NCT00397709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92560002|NCT00397709|Antimetabolites|antimetabolites|mesh-ancestor
92560003|NCT00397709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92560004|NCT00131521|Acetylcysteine|acetylcysteine|mesh-list
92560005|NCT00131521|Antiviral Agents|antiviral agents|mesh-ancestor
92560006|NCT00131521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92560007|NCT00131521|Expectorants|expectorants|mesh-ancestor
92560010|NCT00131521|Antioxidants|antioxidants|mesh-ancestor
92560033|NCT00080145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560041|NCT00403663|Fentanyl|fentanyl|mesh-list
92560106|NCT00132106|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92560107|NCT00132106|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92560180|NCT00132886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560181|NCT00080418|Paclitaxel|paclitaxel|mesh-list
92560182|NCT00080418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560183|NCT00080418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92560184|NCT00080418|Tubulin Modulators|tubulin modulators|mesh-ancestor
92560185|NCT00080418|Antimitotic Agents|antimitotic agents|mesh-ancestor
92560186|NCT00080418|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406081|NCT03980171|Growth Substances|growth substances|mesh-ancestor
92560187|NCT00080418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560188|NCT00132925|Triamcinolone|triamcinolone|mesh-list
92560189|NCT00132925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560190|NCT00132925|Glucocorticoids|glucocorticoids|mesh-ancestor
92560191|NCT00132925|Hormones|hormones|mesh-ancestor
92560192|NCT00132925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560193|NCT00132925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560194|NCT00133003|Abciximab|abciximab|mesh-list
92560195|NCT00133003|Anticoagulants|anticoagulants|mesh-ancestor
92560240|NCT00133237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92560254|NCT00399672|Ribavirin|ribavirin|mesh-list
92560313|NCT00133393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92560314|NCT00133393|Protective Agents|protective agents|mesh-ancestor
92560315|NCT00133393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560319|NCT00046904|Etanercept|etanercept|mesh-list
92560385|NCT00133744|Vitamins|vitamins|mesh-ancestor
92560386|NCT00133744|Micronutrients|micronutrients|mesh-ancestor
92560387|NCT00133744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560388|NCT00133744|Hematinics|hematinics|mesh-ancestor
92560389|NCT00080808|Phentolamine|phentolamine|mesh-list
92560390|NCT00080808|Sildenafil Citrate|sildenafil citrate|mesh-list
92560391|NCT00080808|Alprostadil|alprostadil|mesh-list
92560392|NCT00080808|Papaverine|papaverine|mesh-list
92560393|NCT00080808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560394|NCT00080808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92560395|NCT00080808|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92560396|NCT00080808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92560397|NCT00080808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560398|NCT00080808|Urological Agents|urological agents|mesh-ancestor
92560445|NCT00133822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92560446|NCT00133822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92560447|NCT00133822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92560448|NCT00133822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92560450|NCT00133822|Antidepressive Agents|antidepressive agents|mesh-ancestor
92560451|NCT00133822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92560452|NCT00133822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92560453|NCT00133822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560454|NCT00133861|Botulinum Toxins|botulinum toxins|mesh-list
92560455|NCT00133861|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92560456|NCT00133861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92560457|NCT00133861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560458|NCT00133861|Cholinergic Agents|cholinergic agents|mesh-ancestor
92560459|NCT00133861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92560460|NCT00133861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560461|NCT00134095|Irinotecan|irinotecan|mesh-list
92560462|NCT00134095|Tegafur|tegafur|mesh-list
92560502|NCT00080847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92560503|NCT00080847|Vincristine|vincristine|mesh-list
92560504|NCT00080847|Oblimersen|oblimersen|mesh-list
92560574|NCT00134212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92560575|NCT00134212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92560576|NCT00134212|Respiratory System Agents|respiratory system agents|mesh-ancestor
92560577|NCT00134212|Mydriatics|mydriatics|mesh-ancestor
92560578|NCT00134212|Sympathomimetics|sympathomimetics|mesh-ancestor
92560579|NCT00134212|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92560646|NCT00134368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92560647|NCT00134368|Analgesics|analgesics|mesh-ancestor
92560666|NCT00047294|Celecoxib|celecoxib|mesh-list
92560718|NCT00134680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92560719|NCT00134680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92560720|NCT00134758|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92560721|NCT00134758|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92560789|NCT00134992|Prednisolone acetate|prednisolone acetate|mesh-list
92560790|NCT00134992|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92560791|NCT00134992|Prednisolone phosphate|prednisolone phosphate|mesh-list
92560792|NCT00134992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92560861|NCT00145210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560866|NCT00081276|Cisplatin|cisplatin|mesh-list
92560936|NCT00145639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92362131|NCT01115569|Analgesics|analgesics|mesh-ancestor
92560937|NCT00145639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92560938|NCT00145639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92560939|NCT00145639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92560940|NCT00145639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92560941|NCT00145639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92560942|NCT00145639|Alkylating Agents|alkylating agents|mesh-ancestor
92560943|NCT00047567|Zonisamide|zonisamide|mesh-list
92560944|NCT00047567|Anticonvulsants|anticonvulsants|mesh-ancestor
92560945|NCT00047567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92561000|NCT00146146|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92561001|NCT00146224|Epoetin Alfa|epoetin alfa|mesh-list
92561002|NCT00146224|Hematinics|hematinics|mesh-ancestor
92561003|NCT00081549|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)|bis-neodecanoato-1,2-diaminocyclohexaneplatinum(ii)|mesh-list
92561004|NCT00081549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561005|NCT00146341|Telmisartan|telmisartan|mesh-list
92561006|NCT00146341|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92561007|NCT00146341|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92561008|NCT00146341|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92561009|NCT00146341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561010|NCT00146380|Lamivudine|lamivudine|mesh-list
92561011|NCT00146380|Zidovudine|zidovudine|mesh-list
92561012|NCT00146380|Nevirapine|nevirapine|mesh-list
92561013|NCT00146380|Nelfinavir|nelfinavir|mesh-list
92561014|NCT00146380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92561028|NCT00081588|Darunavir|darunavir|mesh-list
92561060|NCT00146575|Paclitaxel|paclitaxel|mesh-list
92561061|NCT00146575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561062|NCT00146575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561063|NCT00146575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561064|NCT00146575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561065|NCT00146575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561066|NCT00146575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561067|NCT00146575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561068|NCT00146575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561070|NCT00146575|Antifungal Agents|antifungal agents|mesh-ancestor
92561125|NCT00405730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92561126|NCT00405730|Analgesics|analgesics|mesh-ancestor
92561127|NCT00405730|Sensory System Agents|sensory system agents|mesh-ancestor
92561128|NCT00405730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561129|NCT00405730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561130|NCT00405730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561131|NCT00405730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561132|NCT00405730|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92561133|NCT00405730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561134|NCT00405730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561135|NCT00405769|Red yeast rice|red yeast rice|mesh-list
92561138|NCT00405769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92561188|NCT00146926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92561189|NCT00146926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92561190|NCT00146926|Anesthetics, General|anesthetics, general|mesh-ancestor
92561191|NCT00146926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92561192|NCT00146926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92561193|NCT00146926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561194|NCT00146926|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92561195|NCT00146926|Sympathomimetics|sympathomimetics|mesh-ancestor
92561196|NCT00146926|Autonomic Agents|autonomic agents|mesh-ancestor
92561197|NCT00146926|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92561198|NCT00146926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92561199|NCT00147004|Hydrocortisone|hydrocortisone|mesh-list
92561200|NCT00147004|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92561201|NCT00147004|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92561202|NCT00147004|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92561203|NCT00147004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561204|NCT00147121|Rituximab|rituximab|mesh-list
92561205|NCT00147121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92561206|NCT00147121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561207|NCT00147121|Immunologic Factors|immunologic factors|mesh-ancestor
92561208|NCT00147121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561209|NCT00147121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561210|NCT00147160|Temozolomide|temozolomide|mesh-list
92561211|NCT00147160|Cisplatin|cisplatin|mesh-list
92561212|NCT00147160|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92561213|NCT00147160|Alkylating Agents|alkylating agents|mesh-ancestor
92362138|NCT01107886|Hormones|hormones|mesh-ancestor
92561214|NCT00147160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561215|NCT00147160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561216|NCT04732104|Lidocaine|lidocaine|mesh-list
92561217|NCT04732104|Xylometazoline|xylometazoline|mesh-list
92561218|NCT04732104|Nasal Decongestants|nasal decongestants|mesh-list
92561219|NCT04732104|Anesthetics, Local|anesthetics, local|mesh-ancestor
92561220|NCT04732104|Anesthetics|anesthetics|mesh-ancestor
92561229|NCT04732104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561231|NCT04732104|Respiratory System Agents|respiratory system agents|mesh-ancestor
92561232|NCT00147355|Acetaminophen|acetaminophen|mesh-list
92561233|NCT00147355|Ibuprofen|ibuprofen|mesh-list
92286000|NCT05578820|Ganciclovir|ganciclovir|mesh-list
92561235|NCT00147355|Ondansetron|ondansetron|mesh-list
92561236|NCT00147355|Metoclopramide|metoclopramide|mesh-list
92561237|NCT00147355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92561238|NCT00147355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92561239|NCT00147355|Analgesics|analgesics|mesh-ancestor
92561240|NCT00147355|Sensory System Agents|sensory system agents|mesh-ancestor
92561241|NCT00147355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561242|NCT00147355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561243|NCT00147355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561244|NCT00147355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561245|NCT00147355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92561246|NCT00147355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561287|NCT00147394|Serotonin Agents|serotonin agents|mesh-ancestor
92561288|NCT00147394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561362|NCT00081744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561364|NCT00081744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561433|NCT00048425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561434|NCT00148135|Carboplatin|carboplatin|mesh-list
92561435|NCT00148135|Gemcitabine|gemcitabine|mesh-list
92561504|NCT00148408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561505|NCT00048503|Tipifarnib|tipifarnib|mesh-list
92561506|NCT00048503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561507|NCT00148447|Escitalopram|escitalopram|mesh-list
92561508|NCT00148447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92561509|NCT00148447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92561510|NCT00148447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561511|NCT00148447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561512|NCT00148447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561513|NCT00148447|Serotonin Agents|serotonin agents|mesh-ancestor
92561514|NCT00148447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561515|NCT00043134|Decitabine|decitabine|mesh-list
92561516|NCT00043134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561517|NCT00043134|Antimetabolites|antimetabolites|mesh-ancestor
92561518|NCT00043134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561519|NCT00043134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561520|NCT00043134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561521|NCT00148564|Olanzapine|olanzapine|mesh-list
92561522|NCT00148564|Ziprasidone|ziprasidone|mesh-list
92561523|NCT00148564|Antiemetics|antiemetics|mesh-ancestor
92561524|NCT00148564|Autonomic Agents|autonomic agents|mesh-ancestor
92561527|NCT00148564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92561553|NCT00048659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561554|NCT00148681|Paclitaxel|paclitaxel|mesh-list
92561625|NCT00149149|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92561626|NCT00149149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92561627|NCT00149188|Lanreotide|lanreotide|mesh-list
92561628|NCT00149188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561629|NCT00043212|Immunomodulating Agents|immunomodulating agents|mesh-list
92561696|NCT00149617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561697|NCT00149617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561698|NCT00149617|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92561699|NCT00149617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92561700|NCT00149617|Serotonin Agents|serotonin agents|mesh-ancestor
92561701|NCT00149617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561702|NCT00149617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561703|NCT00043329|Interferon-gamma|interferon-gamma|mesh-list
92561704|NCT00043329|Antiviral Agents|antiviral agents|mesh-ancestor
92561705|NCT00043329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561706|NCT00149656|Selenium|selenium|mesh-list
92561707|NCT00149656|Antioxidants|antioxidants|mesh-ancestor
92561708|NCT00149656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561709|NCT00149656|Protective Agents|protective agents|mesh-ancestor
92561710|NCT00149656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561711|NCT00149656|Trace Elements|trace elements|mesh-ancestor
92561712|NCT00149656|Micronutrients|micronutrients|mesh-ancestor
92561713|NCT00082095|Doxorubicin|doxorubicin|mesh-list
92561714|NCT00082095|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92561753|NCT00049088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561754|NCT00049088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561755|NCT00049088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561756|NCT00149968|Mycophenolic Acid|mycophenolic acid|mesh-list
92561757|NCT00149968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92561758|NCT00149968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561759|NCT00149968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92561760|NCT00149968|Antitubercular Agents|antitubercular agents|mesh-ancestor
92561761|NCT00149968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561762|NCT00149968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561763|NCT00149968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561764|NCT00149968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561765|NCT04725448|Paclitaxel|paclitaxel|mesh-list
92561766|NCT04725448|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92561767|NCT04725448|Bevacizumab|bevacizumab|mesh-list
92561768|NCT04725448|Carboplatin|carboplatin|mesh-list
92561769|NCT04725448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561770|NCT04725448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561771|NCT04725448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561772|NCT04725448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561773|NCT04725448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561781|NCT00405925|Lamivudine|lamivudine|mesh-list
92561803|NCT00150007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561804|NCT00150007|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92561805|NCT00150007|Antitubercular Agents|antitubercular agents|mesh-ancestor
92561806|NCT00150007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92561807|NCT00150007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561808|NCT00150007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969391|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
92627510|NCT03214562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92627511|NCT03214562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92627512|NCT03214562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627513|NCT03214562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627514|NCT03196180|Fluorouracil|fluorouracil|mesh-list
92627515|NCT03196180|Imiquimod|imiquimod|mesh-list
92627516|NCT03196180|Antimetabolites|antimetabolites|mesh-ancestor
92627517|NCT03196180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627518|NCT03196180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627519|NCT03196180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627520|NCT03196180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627521|NCT03196180|Immunologic Factors|immunologic factors|mesh-ancestor
92627522|NCT03196180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627523|NCT03196180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92627524|NCT03196180|Interferon Inducers|interferon inducers|mesh-ancestor
92627525|NCT03162627|Olaparib|olaparib|mesh-list
92627526|NCT03162627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92627527|NCT03162627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627528|NCT03162627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627529|NCT03162627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627530|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
92627531|NCT02992743|Fludarabine|fludarabine|mesh-list
92627532|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627533|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
92627534|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627535|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627536|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627537|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
92627538|NCT02992743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627539|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627540|NCT02992743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92627541|NCT02853344|Pembrolizumab|pembrolizumab|mesh-list
92627542|NCT02853344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627543|NCT02853344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627544|NCT02853344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627545|NCT02853344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627546|NCT02738229|Valacyclovir|valacyclovir|mesh-list
92627547|NCT02738229|Antiviral Agents|antiviral agents|mesh-ancestor
92627548|NCT02738229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627549|NCT02675426|Upadacitinib|upadacitinib|mesh-list
92627550|NCT02675426|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92627551|NCT02675426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627552|NCT02675426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627553|NCT02675426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627554|NCT02675426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627555|NCT02579473|Rotigotine|rotigotine|mesh-list
92627556|NCT02579473|Dopamine Agonists|dopamine agonists|mesh-ancestor
92627557|NCT02579473|Dopamine Agents|dopamine agents|mesh-ancestor
92627558|NCT02579473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627559|NCT02579473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627560|NCT02579473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627561|NCT02427620|Cytarabine|cytarabine|mesh-list
92627562|NCT02427620|Dexamethasone|dexamethasone|mesh-list
92627563|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
92627564|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
92627565|NCT02427620|Rituximab|rituximab|mesh-list
92627566|NCT02427620|Doxorubicin|doxorubicin|mesh-list
92627567|NCT02427620|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92627580|NCT02427620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627581|NCT02427620|Alkylating Agents|alkylating agents|mesh-ancestor
92627582|NCT02427620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561809|NCT00150007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561810|NCT00150046|Everolimus|everolimus|mesh-list
92561811|NCT00150046|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92561812|NCT00150046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974976|NCT03051711|Pyrazole|pyrazole|mesh-list
92627583|NCT02427620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627584|NCT02427620|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92627585|NCT02427620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627586|NCT02427620|Antiemetics|antiemetics|mesh-ancestor
92627587|NCT02427620|Autonomic Agents|autonomic agents|mesh-ancestor
92627588|NCT02427620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627589|NCT02427620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92627590|NCT02427620|Glucocorticoids|glucocorticoids|mesh-ancestor
92627592|NCT02427620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627593|NCT02427620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627594|NCT02427620|Protease Inhibitors|protease inhibitors|mesh-ancestor
92627595|NCT02427620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627596|NCT02427620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92627597|NCT02427620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92627598|NCT02427620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627599|NCT02427620|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92627600|NCT02427620|Abortifacient Agents|abortifacient agents|mesh-ancestor
92627601|NCT02427620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92627602|NCT02427620|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627603|NCT02427620|Antimetabolites|antimetabolites|mesh-ancestor
92627604|NCT02427620|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627605|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92627606|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92627607|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
92627608|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627609|NCT02427620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627610|NCT02427620|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627611|NCT02427620|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627612|NCT02427620|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627613|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
92627614|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627615|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92627616|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627617|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627618|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
92627619|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627620|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627621|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92627622|NCT02403505|Myeloma Proteins|myeloma proteins|mesh-list
92627623|NCT02403505|Paraproteins|paraproteins|mesh-list
92627624|NCT02403505|BCG Vaccine|bcg vaccine|mesh-list
92627625|NCT02403505|Immunologic Factors|immunologic factors|mesh-ancestor
92627626|NCT02403505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627627|NCT02403505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92627628|NCT02401035|Pantoprazole|pantoprazole|mesh-list
92627629|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92627630|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034600|NCT02476175|Mirabegron|mirabegron|mesh-list
92627633|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627634|NCT02365766|Gemcitabine|gemcitabine|mesh-list
92627635|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
92627636|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627637|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627638|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
92627639|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627640|NCT02365766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627641|NCT02365766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627642|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92627643|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92627644|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627645|NCT02153944|Propranolol|propranolol|mesh-list
92627646|NCT02153944|Methylphenidate|methylphenidate|mesh-list
92627647|NCT02153944|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92561813|NCT00150046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561814|NCT00150046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627648|NCT02153944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627649|NCT02153944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92627650|NCT02153944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92627651|NCT02153944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92627652|NCT02153944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627653|NCT02153944|Dopamine Agents|dopamine agents|mesh-ancestor
92627654|NCT02153944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627655|NCT02153944|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92627656|NCT02153944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92627657|NCT02153944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92627658|NCT02153944|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92627659|NCT02153944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92627660|NCT02153944|Vasodilator Agents|vasodilator agents|mesh-ancestor
92627661|NCT02060721|Macitentan|macitentan|mesh-list
92627662|NCT02060721|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92627663|NCT02060721|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92627664|NCT02060721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627665|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92627666|NCT01527149|Cytarabine|cytarabine|mesh-list
92627667|NCT01527149|Dexamethasone|dexamethasone|mesh-list
92627668|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
92627669|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
92627670|NCT01527149|Doxorubicin|doxorubicin|mesh-list
92627671|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92627672|NCT01527149|Methotrexate|methotrexate|mesh-list
92627673|NCT01527149|Vincristine|vincristine|mesh-list
92627674|NCT01527149|Ofatumumab|ofatumumab|mesh-list
92627675|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92627676|NCT01527149|BB 1101|bb 1101|mesh-list
92627677|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627678|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
92627679|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627680|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627681|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627682|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
92627683|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627684|NCT01527149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627685|NCT01527149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92627686|NCT01527149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627687|NCT01527149|Antiemetics|antiemetics|mesh-ancestor
92627688|NCT01527149|Autonomic Agents|autonomic agents|mesh-ancestor
92627689|NCT01527149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627690|NCT01527149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92627691|NCT01527149|Glucocorticoids|glucocorticoids|mesh-ancestor
92627692|NCT01527149|Hormones|hormones|mesh-ancestor
92627693|NCT01527149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627694|NCT01527149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627695|NCT01527149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92627696|NCT01527149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92627697|NCT01527149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627698|NCT01527149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627699|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92627700|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
92627701|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92627702|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627705|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92627706|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92627707|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
92627708|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627709|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627710|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627711|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627712|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627713|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92627715|NCT01359956|Interferon-alpha|interferon-alpha|mesh-list
92627716|NCT01359956|Interferon alpha-2|interferon alpha-2|mesh-list
92627717|NCT01359956|Dacarbazine|dacarbazine|mesh-list
92627718|NCT01359956|Fotemustine|fotemustine|mesh-list
92627719|NCT01359956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627720|NCT01359956|Antiviral Agents|antiviral agents|mesh-ancestor
92627721|NCT01359956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561815|NCT00150046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561816|NCT00150046|Immunologic Factors|immunologic factors|mesh-ancestor
92561817|NCT00150046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561818|NCT00150046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561819|NCT00150085|Cyclosporine|cyclosporine|mesh-list
92627722|NCT01359956|Immunologic Factors|immunologic factors|mesh-ancestor
92627723|NCT01359956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627724|NCT01359956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627725|NCT01359956|Alkylating Agents|alkylating agents|mesh-ancestor
92627726|NCT01359956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627727|NCT01306045|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92627728|NCT01306045|Sunitinib|sunitinib|mesh-list
92627729|NCT01306045|Lapatinib|lapatinib|mesh-list
92627730|NCT01306045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627731|NCT01306045|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627732|NCT01306045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627733|NCT01306045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627734|NCT01306045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627735|NCT01306045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92627736|NCT01306045|Growth Substances|growth substances|mesh-ancestor
92627737|NCT01306045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627738|NCT01306045|Growth Inhibitors|growth inhibitors|mesh-ancestor
92627739|NCT01198067|Pomalidomide|pomalidomide|mesh-list
92627740|NCT01198067|Immunologic Factors|immunologic factors|mesh-ancestor
92627741|NCT01198067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627742|NCT01198067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627743|NCT01198067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92627744|NCT01198067|Growth Substances|growth substances|mesh-ancestor
92627745|NCT01198067|Growth Inhibitors|growth inhibitors|mesh-ancestor
92627746|NCT01198067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627747|NCT01196936|Tamoxifen|tamoxifen|mesh-list
92627748|NCT01196936|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92627749|NCT01196936|Hormone Antagonists|hormone antagonists|mesh-ancestor
92627750|NCT01196936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627751|NCT01196936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627752|NCT01196936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627753|NCT01196936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627754|NCT01196936|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92627755|NCT01196936|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92627756|NCT01196936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92627757|NCT01192568|Oxybutynin|oxybutynin|mesh-list
92627758|NCT01192568|Parasympatholytics|parasympatholytics|mesh-ancestor
92627759|NCT01192568|Autonomic Agents|autonomic agents|mesh-ancestor
92627760|NCT01192568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627761|NCT01192568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627762|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92627763|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92627764|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
92362152|NCT05767008|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627765|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627766|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627767|NCT01192568|Urological Agents|urological agents|mesh-ancestor
92627768|NCT01075971|Buprenorphine|buprenorphine|mesh-list
92627769|NCT01075971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92627770|NCT01075971|Narcotics|narcotics|mesh-ancestor
92627771|NCT01075971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92627772|NCT01075971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627773|NCT01075971|Analgesics|analgesics|mesh-ancestor
92627774|NCT01075971|Sensory System Agents|sensory system agents|mesh-ancestor
92627775|NCT01075971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627778|NCT00775749|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92627779|NCT00775749|Autonomic Agents|autonomic agents|mesh-ancestor
92627780|NCT00775749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627781|NCT00775749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627782|NCT00775749|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92627783|NCT00775749|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92627784|NCT00775749|Cholinergic Agents|cholinergic agents|mesh-ancestor
92627785|NCT00775749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627786|NCT00775749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561820|NCT00150085|Cyclosporins|cyclosporins|mesh-list
92561821|NCT00150085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561822|NCT00150085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561823|NCT00150085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561824|NCT00150085|Immunologic Factors|immunologic factors|mesh-ancestor
92561825|NCT00150085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561826|NCT00150085|Antifungal Agents|antifungal agents|mesh-ancestor
92561827|NCT00150085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561828|NCT00150085|Dermatologic Agents|dermatologic agents|mesh-ancestor
92561829|NCT00150085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561830|NCT00150085|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92561832|NCT00082251|Simvastatin|simvastatin|mesh-list
92561833|NCT00082251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92561834|NCT00082251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92561835|NCT00082251|Antimetabolites|antimetabolites|mesh-ancestor
92561836|NCT00082251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561837|NCT00082251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92561838|NCT00082251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92561839|NCT00082251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561840|NCT00082251|Vasodilator Agents|vasodilator agents|mesh-ancestor
92561841|NCT00082251|Vitamin B Complex|vitamin b complex|mesh-ancestor
92561842|NCT00082251|Vitamins|vitamins|mesh-ancestor
92561843|NCT00082251|Micronutrients|micronutrients|mesh-ancestor
92561844|NCT00082251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561845|NCT00049244|Capecitabine|capecitabine|mesh-list
92561846|NCT00049244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92561847|NCT00049244|Antimetabolites|antimetabolites|mesh-ancestor
92561848|NCT00049244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561849|NCT00049244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627788|NCT00324922|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92627789|NCT00324922|Trimethoprim|trimethoprim|mesh-list
92627790|NCT00324922|Sulfamethoxazole|sulfamethoxazole|mesh-list
92627791|NCT00324922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92627792|NCT00324922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627793|NCT00324922|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92627794|NCT00324922|Antimalarials|antimalarials|mesh-ancestor
92627795|NCT00324922|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92627796|NCT00324922|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92627797|NCT00324922|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92627798|NCT00324922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627799|NCT00324922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627800|NCT00324922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92627801|NCT00324922|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92627802|NCT00324922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92627803|NCT00192855|Entacapone|entacapone|mesh-list
92561850|NCT00150124|Methimazole|methimazole|mesh-list
92561851|NCT00150124|Antithyroid Agents|antithyroid agents|mesh-ancestor
92561852|NCT00150124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92561853|NCT00150124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627804|NCT00192855|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92627805|NCT00192855|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92627806|NCT00192855|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92627807|NCT00192855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627808|NCT00192855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627809|NCT00407186|Cisplatin|cisplatin|mesh-list
92627810|NCT00407186|Capecitabine|capecitabine|mesh-list
92627811|NCT00407186|Epirubicin|epirubicin|mesh-list
92627812|NCT00407186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627813|NCT00407186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627814|NCT00407186|Antimetabolites|antimetabolites|mesh-ancestor
92627815|NCT00407186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627816|NCT00407186|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92627817|NCT00407186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92627818|NCT00407186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627819|NCT00407186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627820|NCT00163748|Gemcitabine|gemcitabine|mesh-list
92627821|NCT00163748|Vinorelbine|vinorelbine|mesh-list
92627822|NCT00163748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627823|NCT00163748|Antimetabolites|antimetabolites|mesh-ancestor
92627824|NCT00163748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627825|NCT00163748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627826|NCT00163748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627827|NCT00163748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627828|NCT00163748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627829|NCT00163748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627830|NCT00193011|Cyclophosphamide|cyclophosphamide|mesh-list
92627831|NCT00193011|Docetaxel|docetaxel|mesh-list
92627832|NCT00193011|Fluorouracil|fluorouracil|mesh-list
92627833|NCT00193011|Methotrexate|methotrexate|mesh-list
92627834|NCT00193011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627835|NCT00193011|Immunologic Factors|immunologic factors|mesh-ancestor
92627836|NCT00193011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627837|NCT00193011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627838|NCT00193011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92627839|NCT00193011|Alkylating Agents|alkylating agents|mesh-ancestor
92627840|NCT00193011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627841|NCT00193011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627842|NCT00193011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92627843|NCT00193011|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627844|NCT00193011|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627845|NCT00193011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627846|NCT00193011|Antimetabolites|antimetabolites|mesh-ancestor
92627847|NCT00193011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627848|NCT00193011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92627851|NCT00193011|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627852|NCT00193011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627853|NCT00193011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92627854|NCT00193011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92627856|NCT00193089|Trastuzumab|trastuzumab|mesh-list
92627857|NCT00193089|Vinorelbine|vinorelbine|mesh-list
92627858|NCT00193089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627859|NCT00193089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627860|NCT00193089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627861|NCT00193089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627862|NCT00193089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627863|NCT00193089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627864|NCT00193089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627865|NCT00193167|Topotecan|topotecan|mesh-list
92627866|NCT00193167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92627867|NCT00193167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627868|NCT00193167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627869|NCT00193167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627870|NCT00193167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627871|NCT05208307|Dexamethasone|dexamethasone|mesh-list
92627872|NCT05208307|Dexamethasone acetate|dexamethasone acetate|mesh-list
92627873|NCT05208307|Pomalidomide|pomalidomide|mesh-list
92561854|NCT00150124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561856|NCT00049283|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92561857|NCT00049283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627874|NCT05208307|Ichthammol|ichthammol|mesh-list
92627875|NCT05208307|BB 1101|bb 1101|mesh-list
92362161|NCT05766631|Antitussive Agents|antitussive agents|mesh-ancestor
92627876|NCT05208307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627877|NCT05208307|Antiemetics|antiemetics|mesh-ancestor
92627878|NCT05208307|Autonomic Agents|autonomic agents|mesh-ancestor
92627879|NCT05208307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627880|NCT05208307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627881|NCT05208307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92627882|NCT05208307|Glucocorticoids|glucocorticoids|mesh-ancestor
92627883|NCT05208307|Hormones|hormones|mesh-ancestor
92627884|NCT05208307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92627885|NCT05208307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627886|NCT05208307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627887|NCT05208307|Protease Inhibitors|protease inhibitors|mesh-ancestor
92627888|NCT05208307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627889|NCT05208307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627890|NCT05208307|Immunologic Factors|immunologic factors|mesh-ancestor
92627891|NCT05208307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627892|NCT05208307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92627893|NCT05208307|Growth Substances|growth substances|mesh-ancestor
92627894|NCT05208307|Growth Inhibitors|growth inhibitors|mesh-ancestor
92627895|NCT05208307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627896|NCT00193245|Docetaxel|docetaxel|mesh-list
92627897|NCT00193245|Topotecan|topotecan|mesh-list
92627898|NCT00193245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627899|NCT00193245|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627900|NCT00193245|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627901|NCT00193245|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627902|NCT00193245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627903|NCT00193245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92627904|NCT00193245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627905|NCT00193245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627906|NCT00193284|Carboplatin|carboplatin|mesh-list
92627907|NCT00193284|Docetaxel|docetaxel|mesh-list
92627908|NCT00193284|Fluorouracil|fluorouracil|mesh-list
92627909|NCT00193284|Gefitinib|gefitinib|mesh-list
92627910|NCT00193284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627911|NCT00193284|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627912|NCT00193284|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627913|NCT00193284|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627914|NCT00193284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627915|NCT00193284|Antimetabolites|antimetabolites|mesh-ancestor
92627916|NCT00193284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627917|NCT00193284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627918|NCT00193284|Immunologic Factors|immunologic factors|mesh-ancestor
92627919|NCT00193284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627920|NCT00193284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627921|NCT00193284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627922|NCT00163982|Norfloxacin|norfloxacin|mesh-list
92627923|NCT00163982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92627924|NCT00163982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627928|NCT00163982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627929|NCT00163982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627930|NCT00163982|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92627931|NCT00163982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92627933|NCT00193323|Docetaxel|docetaxel|mesh-list
92627934|NCT00193323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627935|NCT00193323|Antimetabolites|antimetabolites|mesh-ancestor
92627936|NCT00193323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627937|NCT00193323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627938|NCT00193323|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627939|NCT00193323|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627940|NCT00193323|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627941|NCT00193362|Paclitaxel|paclitaxel|mesh-list
92627942|NCT00193362|Vinorelbine|vinorelbine|mesh-list
92627943|NCT00193362|Carboplatin|carboplatin|mesh-list
92627944|NCT00193362|Gemcitabine|gemcitabine|mesh-list
92627945|NCT00193362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92627946|NCT00193362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561858|NCT00049283|Tubulin Modulators|tubulin modulators|mesh-ancestor
92561859|NCT00049283|Antimitotic Agents|antimitotic agents|mesh-ancestor
92561860|NCT00049283|Mitosis Modulators|mitosis modulators|mesh-ancestor
92561861|NCT00049283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627947|NCT00193362|Tubulin Modulators|tubulin modulators|mesh-ancestor
92627948|NCT00193362|Antimitotic Agents|antimitotic agents|mesh-ancestor
92627949|NCT00193362|Mitosis Modulators|mitosis modulators|mesh-ancestor
92627950|NCT00193362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627951|NCT00193362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92627952|NCT00193362|Antimetabolites|antimetabolites|mesh-ancestor
92627954|NCT00193401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92627955|NCT00193401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627956|NCT00193401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627957|NCT00193401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627958|NCT00193401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627959|NCT00553189|Topotecan|topotecan|mesh-list
92627960|NCT00553189|Veliparib|veliparib|mesh-list
92627961|NCT00553189|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92627962|NCT00553189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627963|NCT00553189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627964|NCT00553189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627965|NCT00553189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627966|NCT00553189|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92627967|NCT00193440|Rituximab|rituximab|mesh-list
92627968|NCT00193440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627969|NCT00193440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627970|NCT00193440|Immunologic Factors|immunologic factors|mesh-ancestor
92627971|NCT00193440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627972|NCT00193440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627973|NCT05077969|Celecoxib|celecoxib|mesh-list
92627974|NCT05077969|Famotidine|famotidine|mesh-list
92627975|NCT05077969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92627976|NCT05077969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92627977|NCT05077969|Analgesics|analgesics|mesh-ancestor
92627978|NCT05077969|Sensory System Agents|sensory system agents|mesh-ancestor
92627979|NCT05077969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92627980|NCT05077969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627981|NCT05077969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92627982|NCT05077969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627983|NCT05077969|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92627984|NCT05077969|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92627985|NCT05077969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627986|NCT05077969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627987|NCT05077969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92627988|NCT05077969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92627989|NCT05077969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92627990|NCT05077969|Histamine Antagonists|histamine antagonists|mesh-ancestor
92627991|NCT05077969|Histamine Agents|histamine agents|mesh-ancestor
92627992|NCT05077969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92627993|NCT05063734|Aflibercept|aflibercept|mesh-list
92627994|NCT05063734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92627995|NCT05063734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92627996|NCT05063734|Growth Substances|growth substances|mesh-ancestor
92034953|NCT01613326|Tocolytic Agents|tocolytic agents|mesh-ancestor
92628000|NCT00193518|Arsenic Trioxide|arsenic trioxide|mesh-list
92628001|NCT00193518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628003|NCT00164216|Mefloquine|mefloquine|mesh-list
92628004|NCT00164216|Antimalarials|antimalarials|mesh-ancestor
92628005|NCT00164216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92628007|NCT00164216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628008|NCT00164216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628009|NCT00164216|Antiviral Agents|antiviral agents|mesh-ancestor
92628010|NCT00164216|Schistosomicides|schistosomicides|mesh-ancestor
92628011|NCT00164216|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92628012|NCT00164216|Anthelmintics|anthelmintics|mesh-ancestor
92628013|NCT00193557|Bortezomib|bortezomib|mesh-list
92628014|NCT00193557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628015|NCT00164255|Artesunate|artesunate|mesh-list
92628016|NCT00164255|Pyrimethamine|pyrimethamine|mesh-list
92628017|NCT00164255|Sulfadoxine|sulfadoxine|mesh-list
92628018|NCT00164255|Antimalarials|antimalarials|mesh-ancestor
92628019|NCT00164255|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92561862|NCT00049283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92561863|NCT00049283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561864|NCT00150241|Varenicline|varenicline|mesh-list
92561865|NCT00150241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92561866|NCT00150241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92561867|NCT00150241|Cholinergic Agents|cholinergic agents|mesh-ancestor
92561868|NCT00150241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561869|NCT00150241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561870|NCT00150241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561871|NCT00150280|Ibuprofen|ibuprofen|mesh-list
92561872|NCT00150280|Celecoxib|celecoxib|mesh-list
92561873|NCT00150280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92561874|NCT00150280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92561875|NCT00150280|Analgesics|analgesics|mesh-ancestor
92561876|NCT00150280|Sensory System Agents|sensory system agents|mesh-ancestor
92628020|NCT00164255|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92628021|NCT00164255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628022|NCT00164255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628023|NCT00164255|Antiviral Agents|antiviral agents|mesh-ancestor
92628024|NCT00164255|Schistosomicides|schistosomicides|mesh-ancestor
92628025|NCT00164255|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92628026|NCT00164255|Anthelmintics|anthelmintics|mesh-ancestor
92628027|NCT00164255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92628028|NCT00164255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628029|NCT00164255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628030|NCT00164255|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92628031|NCT00409656|Basiliximab|basiliximab|mesh-list
92628032|NCT00409656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628033|NCT00409656|Immunologic Factors|immunologic factors|mesh-ancestor
92628034|NCT00409656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628035|NCT00409695|Thymoglobulin|thymoglobulin|mesh-list
92628036|NCT00409695|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92628037|NCT00409695|Immunologic Factors|immunologic factors|mesh-ancestor
92628038|NCT00409695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628039|NCT00409695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628040|NCT04977232|Escitalopram|escitalopram|mesh-list
92628041|NCT04977232|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92628042|NCT04977232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92628043|NCT04977232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628044|NCT04977232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628045|NCT04977232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628046|NCT04977232|Serotonin Agents|serotonin agents|mesh-ancestor
92628047|NCT04977232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628048|NCT04974814|Atorvastatin|atorvastatin|mesh-list
92628049|NCT04974814|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92628050|NCT04974814|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92628051|NCT04974814|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92628052|NCT04974814|Antimetabolites|antimetabolites|mesh-ancestor
92628053|NCT04974814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628054|NCT04974814|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92628055|NCT04974814|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92628056|NCT04974814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628057|NCT00164411|Vaccines|vaccines|mesh-list
92628058|NCT00164411|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92628059|NCT00164411|Immunologic Factors|immunologic factors|mesh-ancestor
92628060|NCT00164411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628061|NCT00193635|Mycophenolic Acid|mycophenolic acid|mesh-list
92628062|NCT00193635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628063|NCT00193635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628064|NCT00193635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92561877|NCT00150280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561878|NCT00150280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561879|NCT00150280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561880|NCT00150280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628065|NCT00193635|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628066|NCT00193635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628067|NCT00193635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628068|NCT00193635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628069|NCT00193635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628070|NCT04902703|Molgramostim|molgramostim|mesh-list
92628073|NCT04902703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628074|NCT04902703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628075|NCT00193674|Dydrogesterone|dydrogesterone|mesh-list
92628076|NCT00193674|Progestins|progestins|mesh-ancestor
92628077|NCT00193674|Hormones|hormones|mesh-ancestor
92628078|NCT00193674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628079|NCT00193674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353232|NCT03087864|Paclitaxel|paclitaxel|mesh-list
92628081|NCT04899778|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92628082|NCT04899778|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92628083|NCT04899778|Contraceptive Agents|contraceptive agents|mesh-list
92628084|NCT04899778|Contraceptives, Oral|contraceptives, oral|mesh-list
92628085|NCT04899778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92628086|NCT04899778|Estradiol|estradiol|mesh-list
92628087|NCT04899778|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92628088|NCT04899778|Trace Elements|trace elements|mesh-ancestor
92628089|NCT04899778|Micronutrients|micronutrients|mesh-ancestor
92628090|NCT04899778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628091|NCT04899778|Estrogens|estrogens|mesh-ancestor
92628092|NCT04899778|Hormones|hormones|mesh-ancestor
92628093|NCT04899778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628094|NCT04899778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92628095|NCT04899778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92628096|NCT04899778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92628097|NCT00164450|Isoniazid|isoniazid|mesh-list
92628098|NCT00164450|Rifapentine|rifapentine|mesh-list
92628099|NCT00164450|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628100|NCT00164450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628101|NCT00164450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628102|NCT00164450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92628103|NCT00164450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92628104|NCT00164450|Antimetabolites|antimetabolites|mesh-ancestor
92628105|NCT00164450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628106|NCT00164450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92628107|NCT00164450|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92628108|NCT00164450|Leprostatic Agents|leprostatic agents|mesh-ancestor
92628109|NCT00193869|Dexamethasone|dexamethasone|mesh-list
92628110|NCT00193869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628111|NCT00193869|Antiemetics|antiemetics|mesh-ancestor
92628112|NCT00193869|Autonomic Agents|autonomic agents|mesh-ancestor
92628113|NCT00193869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628114|NCT00193869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628115|NCT00193869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628116|NCT00193869|Glucocorticoids|glucocorticoids|mesh-ancestor
92628117|NCT00193869|Hormones|hormones|mesh-ancestor
92628118|NCT00193869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628119|NCT00193869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628120|NCT00193869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628121|NCT04748809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92628122|NCT00176241|Paclitaxel|paclitaxel|mesh-list
92628123|NCT00176241|Gemcitabine|gemcitabine|mesh-list
92628124|NCT00176241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92628125|NCT00176241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628126|NCT00176241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92628127|NCT00176241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92628128|NCT00176241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92628129|NCT00176241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628130|NCT00176241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628131|NCT00176241|Antimetabolites|antimetabolites|mesh-ancestor
92628132|NCT04742959|Paclitaxel|paclitaxel|mesh-list
92628133|NCT04742959|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561881|NCT00150280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92561882|NCT00150280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561883|NCT00150280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969453|NCT02483195|Urological Agents|urological agents|mesh-ancestor
92628134|NCT04742959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628135|NCT04742959|Tubulin Modulators|tubulin modulators|mesh-ancestor
92628136|NCT04742959|Antimitotic Agents|antimitotic agents|mesh-ancestor
92628137|NCT04742959|Mitosis Modulators|mitosis modulators|mesh-ancestor
92628138|NCT04742959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628140|NCT00164801|Baclofen|baclofen|mesh-list
92628141|NCT00164801|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92628142|NCT00164801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628143|NCT00164801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92035102|NCT02059239|Cytarabine|cytarabine|mesh-list
92628145|NCT00164801|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92628146|NCT00164801|GABA Agonists|gaba agonists|mesh-ancestor
92628147|NCT00164801|GABA Agents|gaba agents|mesh-ancestor
92628148|NCT00164801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628149|NCT00164801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628150|NCT00164801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92628151|NCT00164801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92628152|NCT00164801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628153|NCT00164801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92628154|NCT00164801|Vasodilator Agents|vasodilator agents|mesh-ancestor
92628155|NCT00176280|Dexamethasone|dexamethasone|mesh-list
92628156|NCT00176280|Sargramostim|sargramostim|mesh-list
92628157|NCT00176280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628158|NCT00176280|Antiemetics|antiemetics|mesh-ancestor
92628159|NCT00176280|Autonomic Agents|autonomic agents|mesh-ancestor
92628160|NCT00176280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628161|NCT00176280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628162|NCT00176280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628163|NCT00176280|Glucocorticoids|glucocorticoids|mesh-ancestor
92628164|NCT00176280|Hormones|hormones|mesh-ancestor
92628165|NCT00176280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628166|NCT00176280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628167|NCT00176280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628168|NCT00176280|Immunologic Factors|immunologic factors|mesh-ancestor
92628169|NCT04723940|Doxycycline|doxycycline|mesh-list
92628170|NCT04723940|Clindamycin|clindamycin|mesh-list
92628171|NCT04723940|Clindamycin palmitate|clindamycin palmitate|mesh-list
92628172|NCT04723940|Clindamycin phosphate|clindamycin phosphate|mesh-list
92628173|NCT04723940|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92628174|NCT04723940|Cefadroxil|cefadroxil|mesh-list
92628175|NCT04723940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628176|NCT04723940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628177|NCT04723940|Antimalarials|antimalarials|mesh-ancestor
92628178|NCT04723940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92628179|NCT04723940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92628180|NCT04723940|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92628181|NCT04723940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628182|NCT04723940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628183|NCT04723940|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92628184|NCT00164840|Esomeprazole|esomeprazole|mesh-list
92628185|NCT00164840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92628186|NCT00164840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628187|NCT00164840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92628188|NCT00164840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628189|NCT00164840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628190|NCT04641247|Niraparib|niraparib|mesh-list
92628191|NCT04641247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92628192|NCT04641247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628193|NCT04641247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628194|NCT04641247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628195|NCT04635007|Misoprostol|misoprostol|mesh-list
92628196|NCT04635007|Tranexamic Acid|tranexamic acid|mesh-list
92628197|NCT04635007|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92628198|NCT04635007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92628199|NCT04635007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561884|NCT00150280|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92561885|NCT00150358|Sildenafil Citrate|sildenafil citrate|mesh-list
92561886|NCT00150358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561887|NCT00150358|Vasodilator Agents|vasodilator agents|mesh-ancestor
92628200|NCT04635007|Hemostatics|hemostatics|mesh-ancestor
92628201|NCT04635007|Coagulants|coagulants|mesh-ancestor
92628202|NCT04635007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92628203|NCT04635007|Abortifacient Agents|abortifacient agents|mesh-ancestor
92628204|NCT04635007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92628205|NCT04635007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628206|NCT04635007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92628207|NCT04635007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628208|NCT04635007|Oxytocics|oxytocics|mesh-ancestor
92628209|NCT00194064|Olanzapine|olanzapine|mesh-list
92628210|NCT00194064|Antiemetics|antiemetics|mesh-ancestor
92628211|NCT00194064|Autonomic Agents|autonomic agents|mesh-ancestor
92628212|NCT00194064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628213|NCT00194064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628214|NCT00194064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628215|NCT00194064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92628216|NCT00194064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91928374|NCT02182739|Meloxicam|meloxicam|mesh-list
92035170|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92628220|NCT00194064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92628221|NCT00194064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628222|NCT00194064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628223|NCT00194064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628225|NCT00164996|Anesthetics|anesthetics|mesh-list
92628226|NCT00164996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628227|NCT00164996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628228|NCT04418557|Antibodies|antibodies|mesh-list
92628229|NCT04418557|Immunologic Factors|immunologic factors|mesh-ancestor
92628230|NCT04418557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628231|NCT04682782|Esketamine|esketamine|mesh-list
92628232|NCT04682782|Antidepressive Agents|antidepressive agents|mesh-ancestor
92628233|NCT04682782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628234|NCT04682665|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92628235|NCT04682665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92628236|NCT04682665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92628238|NCT00165035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92628239|NCT00165035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92628240|NCT00165035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628241|NCT00165035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92628242|NCT00165035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92628243|NCT00165035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92628244|NCT00165035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628245|NCT04326673|Methyltestosterone|methyltestosterone|mesh-list
92628246|NCT04326673|Testosterone|testosterone|mesh-list
92628247|NCT04326673|Testosterone undecanoate|testosterone undecanoate|mesh-list
92628248|NCT04326673|Testosterone enanthate|testosterone enanthate|mesh-list
92628249|NCT04326673|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92628250|NCT04326673|Androgens|androgens|mesh-ancestor
92628251|NCT04326673|Hormones|hormones|mesh-ancestor
92628252|NCT04326673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628253|NCT04326673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628254|NCT04326673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628255|NCT04326673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628256|NCT04326673|Anabolic Agents|anabolic agents|mesh-ancestor
92628257|NCT00165074|Calfactant|calfactant|mesh-list
92628258|NCT00165074|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92628259|NCT00165074|Respiratory System Agents|respiratory system agents|mesh-ancestor
92628260|NCT04307953|Saracatinib|saracatinib|mesh-list
92628261|NCT04307953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628262|NCT04307953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628263|NCT04307953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628264|NCT04297267|Gemcitabine|gemcitabine|mesh-list
92628265|NCT04297267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628266|NCT04297267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628267|NCT04297267|Antimetabolites|antimetabolites|mesh-ancestor
92628268|NCT04297267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628269|NCT00176475|Rituximab|rituximab|mesh-list
92561888|NCT00150358|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92561889|NCT00150358|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92561890|NCT00150358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561891|NCT00150358|Urological Agents|urological agents|mesh-ancestor
92561892|NCT00049361|Thalidomide|thalidomide|mesh-list
92628270|NCT00176475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628271|NCT00176475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628272|NCT00176475|Immunologic Factors|immunologic factors|mesh-ancestor
92628273|NCT00176475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628274|NCT00176475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628275|NCT00165191|Doxorubicin|doxorubicin|mesh-list
92628276|NCT00165191|Fluorouracil|fluorouracil|mesh-list
92628277|NCT00165191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628278|NCT00165191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628279|NCT00165191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92628280|NCT00165191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92628281|NCT00165191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628282|NCT00165191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628283|NCT00165191|Antimetabolites|antimetabolites|mesh-ancestor
92628284|NCT00165191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628285|NCT00165191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628286|NCT00165191|Immunologic Factors|immunologic factors|mesh-ancestor
92035243|NCT02460224|Spartalizumab|spartalizumab|mesh-list
92628288|NCT04224571|Rituximab|rituximab|mesh-list
92628289|NCT04224571|Bortezomib|bortezomib|mesh-list
92628290|NCT04224571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628291|NCT04224571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628292|NCT04224571|Immunologic Factors|immunologic factors|mesh-ancestor
92628293|NCT04224571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628294|NCT04224571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628295|NCT00176514|Antineoplastic Agents|antineoplastic agents|mesh-list
92628296|NCT00165230|Thalidomide|thalidomide|mesh-list
92628297|NCT00165230|Temozolomide|temozolomide|mesh-list
92628298|NCT00165230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628299|NCT00165230|Immunologic Factors|immunologic factors|mesh-ancestor
92628300|NCT00165230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628301|NCT00165230|Leprostatic Agents|leprostatic agents|mesh-ancestor
92628302|NCT00165230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353452|NCT05684484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92628303|NCT00165230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628304|NCT00165230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92628305|NCT00165230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92628306|NCT00165230|Growth Substances|growth substances|mesh-ancestor
92628307|NCT00165230|Growth Inhibitors|growth inhibitors|mesh-ancestor
92628308|NCT00165230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628309|NCT00165230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92628310|NCT00165230|Alkylating Agents|alkylating agents|mesh-ancestor
92628311|NCT00165230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628312|NCT00176553|Dextromethorphan|dextromethorphan|mesh-list
92628313|NCT00176553|Antitussive Agents|antitussive agents|mesh-ancestor
92628314|NCT00176553|Respiratory System Agents|respiratory system agents|mesh-ancestor
92628315|NCT00176553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92628316|NCT00176553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92628317|NCT00176553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628318|NCT00176553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628319|NCT00176553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628321|NCT00165308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92628322|NCT00165308|Hormone Antagonists|hormone antagonists|mesh-ancestor
92628323|NCT00165308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628324|NCT00165308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628325|NCT00165308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628326|NCT00165308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628327|NCT00165308|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92628328|NCT00165308|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92628329|NCT00165308|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92628330|NCT00165347|Vatalanib|vatalanib|mesh-list
92628331|NCT00165347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92628332|NCT00165347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752323|NCT05940896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561894|NCT00049361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92561895|NCT00049361|Alkylating Agents|alkylating agents|mesh-ancestor
92628333|NCT00165347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628334|NCT00176670|Midazolam|midazolam|mesh-list
92628335|NCT00176670|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92628336|NCT00176670|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92628337|NCT00176670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628338|NCT00176670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628339|NCT00176670|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92628340|NCT00176670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92628341|NCT00176670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628342|NCT00176670|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92628343|NCT00176670|Anesthetics, General|anesthetics, general|mesh-ancestor
92628344|NCT00176670|Anesthetics|anesthetics|mesh-ancestor
92628345|NCT00176670|GABA Modulators|gaba modulators|mesh-ancestor
92628346|NCT00176670|GABA Agents|gaba agents|mesh-ancestor
92628347|NCT00176670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628348|NCT00176670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628349|NCT00165464|Irinotecan|irinotecan|mesh-list
92628350|NCT00165464|Docetaxel|docetaxel|mesh-list
92628351|NCT00165464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628352|NCT00165464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92362185|NCT05766514|Cytarabine|cytarabine|mesh-list
92628353|NCT00165464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92628354|NCT00165464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628355|NCT00165464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628356|NCT00165464|Tubulin Modulators|tubulin modulators|mesh-ancestor
92628357|NCT00165464|Antimitotic Agents|antimitotic agents|mesh-ancestor
92628358|NCT00165464|Mitosis Modulators|mitosis modulators|mesh-ancestor
92628359|NCT04082650|Vitamin D|vitamin d|mesh-list
92628361|NCT04082650|Micronutrients|micronutrients|mesh-ancestor
92628362|NCT04082650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628363|NCT04082650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92628364|NCT00176787|Capecitabine|capecitabine|mesh-list
92628365|NCT00176787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628366|NCT00176787|Antimetabolites|antimetabolites|mesh-ancestor
92628367|NCT00176787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628368|NCT00176787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628369|NCT00176943|Imiquimod|imiquimod|mesh-list
92628370|NCT00176943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92628371|NCT00176943|Immunologic Factors|immunologic factors|mesh-ancestor
92628372|NCT00176943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628373|NCT00176943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628374|NCT00176943|Interferon Inducers|interferon inducers|mesh-ancestor
92628375|NCT03978208|Naproxen|naproxen|mesh-list
92628376|NCT03978208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92628377|NCT03978208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92628378|NCT03978208|Analgesics|analgesics|mesh-ancestor
92628379|NCT03978208|Sensory System Agents|sensory system agents|mesh-ancestor
92628380|NCT03978208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628381|NCT03978208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628382|NCT03978208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628383|NCT03978208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628384|NCT03978208|Gout Suppressants|gout suppressants|mesh-ancestor
92628385|NCT03978208|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92628386|NCT03978208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628387|NCT03978208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628388|NCT03936829|Cyclophosphamide|cyclophosphamide|mesh-list
92628389|NCT03936829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628390|NCT03936829|Immunologic Factors|immunologic factors|mesh-ancestor
92628391|NCT03936829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628392|NCT03936829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628393|NCT03936829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92628394|NCT03936829|Alkylating Agents|alkylating agents|mesh-ancestor
92628395|NCT03936829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628396|NCT03936829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628397|NCT03936829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92628398|NCT00165659|Donepezil|donepezil|mesh-list
92628399|NCT00165659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92628400|NCT00165659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628401|NCT00165659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628402|NCT00165659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92561896|NCT00049361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561897|NCT00049361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561898|NCT00049361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561899|NCT00049361|Immunologic Factors|immunologic factors|mesh-ancestor
92561900|NCT00049361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561901|NCT00049361|Leprostatic Agents|leprostatic agents|mesh-ancestor
92561902|NCT00049361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628403|NCT00165659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628404|NCT00165659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628405|NCT00165659|Nootropic Agents|nootropic agents|mesh-ancestor
92628406|NCT00176982|Hydroxychloroquine|hydroxychloroquine|mesh-list
92628407|NCT00176982|Antimalarials|antimalarials|mesh-ancestor
92628408|NCT00176982|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92628409|NCT00176982|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92628410|NCT00176982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628411|NCT00176982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628412|NCT00176982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628413|NCT00176982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628414|NCT00165737|Donepezil|donepezil|mesh-list
92628415|NCT00165737|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92628416|NCT00165737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628417|NCT00165737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628418|NCT00165737|Cholinergic Agents|cholinergic agents|mesh-ancestor
92628419|NCT00165737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628420|NCT00165737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628421|NCT00165737|Nootropic Agents|nootropic agents|mesh-ancestor
92628422|NCT04682899|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92628423|NCT04682899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92628424|NCT04682899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628425|NCT04682899|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628426|NCT03789916|Aspirin|aspirin|mesh-list
92628427|NCT03789916|Ticagrelor|ticagrelor|mesh-list
92628428|NCT03789916|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92628429|NCT03789916|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92628430|NCT03789916|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92628431|NCT03789916|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92628432|NCT03789916|Purinergic Agents|purinergic agents|mesh-ancestor
92628433|NCT03789916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628436|NCT03789916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92628438|NCT03789916|Analgesics|analgesics|mesh-ancestor
92628439|NCT03789916|Sensory System Agents|sensory system agents|mesh-ancestor
92628440|NCT03789916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628441|NCT03789916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628442|NCT03789916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628443|NCT03789916|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92628444|NCT03789916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92628445|NCT03789916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92628446|NCT03789916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628447|NCT03789916|Antipyretics|antipyretics|mesh-ancestor
92628448|NCT00165815|Donepezil|donepezil|mesh-list
92628449|NCT00165815|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92628450|NCT00165815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628451|NCT00165815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628452|NCT00165815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92628453|NCT00165815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628455|NCT00165815|Nootropic Agents|nootropic agents|mesh-ancestor
92628456|NCT00177021|Imiquimod|imiquimod|mesh-list
92628457|NCT00177021|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92628458|NCT00177021|Immunologic Factors|immunologic factors|mesh-ancestor
92628459|NCT00177021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628460|NCT00177021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628461|NCT00177021|Interferon Inducers|interferon inducers|mesh-ancestor
92628462|NCT03697603|Brexpiprazole|brexpiprazole|mesh-list
92628463|NCT03697603|Serotonin Agents|serotonin agents|mesh-ancestor
92628464|NCT03697603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628465|NCT03697603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628466|NCT03697603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628467|NCT03697603|Dopamine Agonists|dopamine agonists|mesh-ancestor
92561903|NCT00049361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561904|NCT00049361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92561905|NCT00049361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92561906|NCT00049361|Growth Substances|growth substances|mesh-ancestor
92628468|NCT03697603|Dopamine Agents|dopamine agents|mesh-ancestor
92628469|NCT00165854|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92628470|NCT00165854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628471|NCT00165854|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92628472|NCT00165854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628473|NCT00165854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628474|NCT00177060|Hydromorphone|hydromorphone|mesh-list
92628475|NCT00177060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92628476|NCT00177060|Narcotics|narcotics|mesh-ancestor
92628477|NCT00177060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628478|NCT00177060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628479|NCT00177060|Analgesics|analgesics|mesh-ancestor
92628480|NCT00177060|Sensory System Agents|sensory system agents|mesh-ancestor
92628481|NCT00177060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628482|NCT03421639|Leuprolide|leuprolide|mesh-list
92628483|NCT03421639|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92628484|NCT03421639|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92628485|NCT03421639|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92628486|NCT03421639|Fertility Agents|fertility agents|mesh-ancestor
92628487|NCT03421639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92628488|NCT03421639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628489|NCT03421639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628490|NCT03421639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628491|NCT03421639|Hormones|hormones|mesh-ancestor
92628492|NCT03421639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628493|NCT03421639|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92628494|NCT03421639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628495|NCT03421639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628496|NCT03421639|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92628497|NCT03421639|Hormone Antagonists|hormone antagonists|mesh-ancestor
92628498|NCT00177099|Tacrolimus|tacrolimus|mesh-list
92628499|NCT00177099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628500|NCT00177099|Immunologic Factors|immunologic factors|mesh-ancestor
92628501|NCT00177099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628502|NCT00177099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92628503|NCT00177099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628504|NCT00177099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628507|NCT03413800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628508|NCT03413800|Antiemetics|antiemetics|mesh-ancestor
92628509|NCT03413800|Autonomic Agents|autonomic agents|mesh-ancestor
92628510|NCT03413800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628511|NCT03413800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628512|NCT03413800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628513|NCT03413800|Glucocorticoids|glucocorticoids|mesh-ancestor
92628514|NCT03413800|Hormones|hormones|mesh-ancestor
92628515|NCT03413800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628516|NCT03413800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628517|NCT03413800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628518|NCT03413800|Immunologic Factors|immunologic factors|mesh-ancestor
92628519|NCT03413800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92628520|NCT03413800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92628521|NCT03413800|Growth Substances|growth substances|mesh-ancestor
92628522|NCT03413800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92628523|NCT03335839|Plasminogen|plasminogen|mesh-list
92628524|NCT03335839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92628525|NCT03335839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92628526|NCT03335839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92353688|NCT03082092|Hormones|hormones|mesh-ancestor
92628527|NCT03335839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628528|NCT00166010|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92628529|NCT00166010|Natriuretic Agents|natriuretic agents|mesh-ancestor
92628530|NCT00166010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628531|NCT03104491|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92628532|NCT03104491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628533|NCT03104491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561908|NCT00150436|Pregabalin|pregabalin|mesh-list
92561909|NCT00150436|Analgesics|analgesics|mesh-ancestor
92628534|NCT03104491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628535|NCT03104491|Immunotoxins|immunotoxins|mesh-ancestor
92628536|NCT03104491|Immunoconjugates|immunoconjugates|mesh-ancestor
92628537|NCT03104491|Immunologic Factors|immunologic factors|mesh-ancestor
92628538|NCT03104491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628539|NCT05336812|Venetoclax|venetoclax|mesh-list
92628540|NCT05336812|Obinutuzumab|obinutuzumab|mesh-list
92628541|NCT05336812|Acalabrutinib|acalabrutinib|mesh-list
92628542|NCT05336812|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92628543|NCT05336812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628544|NCT05336812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628545|NCT05336812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92628546|NCT05336812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628547|NCT05336812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628548|NCT00537862|Mycophenolic Acid|mycophenolic acid|mesh-list
92628549|NCT00537862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628550|NCT00537862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628551|NCT00537862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92628552|NCT00537862|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628553|NCT00537862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628554|NCT00537862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628555|NCT00537862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628556|NCT00537862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628557|NCT00537901|Bevacizumab|bevacizumab|mesh-list
92628558|NCT00537901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628559|NCT00537901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628560|NCT00537901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92628561|NCT00537901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92628562|NCT00537901|Growth Substances|growth substances|mesh-ancestor
92628563|NCT00537901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628564|NCT00537901|Growth Inhibitors|growth inhibitors|mesh-ancestor
92628565|NCT00166127|Simendan|simendan|mesh-list
92628566|NCT00166127|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92628567|NCT00166127|Vasodilator Agents|vasodilator agents|mesh-ancestor
92628568|NCT00166127|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92628569|NCT00166127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92628570|NCT00166127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628571|NCT00166127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628572|NCT00166127|Protective Agents|protective agents|mesh-ancestor
92628573|NCT00166127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628574|NCT00194649|Miglustat|miglustat|mesh-list
92628575|NCT00194649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628576|NCT00194649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628578|NCT00194649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92628579|NCT00194649|Antiviral Agents|antiviral agents|mesh-ancestor
92628580|NCT00194649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628581|NCT00194649|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92628582|NCT00194649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92628583|NCT00194649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628584|NCT00166244|Mycophenolic Acid|mycophenolic acid|mesh-list
92628585|NCT00166244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628586|NCT00166244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628587|NCT00166244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92628588|NCT00166244|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628589|NCT00166244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628590|NCT00166244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628591|NCT00166244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628592|NCT00166244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628593|NCT00177138|Alemtuzumab|alemtuzumab|mesh-list
92628594|NCT00177138|Tacrolimus|tacrolimus|mesh-list
92628595|NCT00177138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628596|NCT00177138|Immunologic Factors|immunologic factors|mesh-ancestor
92628597|NCT00177138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628598|NCT00177138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92628599|NCT00177138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628600|NCT00177138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628601|NCT00177138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628602|NCT00177138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628603|NCT05311774|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92561910|NCT00150436|Sensory System Agents|sensory system agents|mesh-ancestor
92561911|NCT00150436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561912|NCT00150436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628604|NCT05311774|Tramadol|tramadol|mesh-list
92628605|NCT05311774|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92628606|NCT05311774|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92628607|NCT05311774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628608|NCT05311774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628609|NCT05311774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628610|NCT05311774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628611|NCT05311774|Analgesics|analgesics|mesh-ancestor
92628612|NCT05311774|Sensory System Agents|sensory system agents|mesh-ancestor
92628613|NCT05311774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628614|NCT05311774|Antidepressive Agents|antidepressive agents|mesh-ancestor
92628615|NCT05311774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628616|NCT05311774|Dopamine Agents|dopamine agents|mesh-ancestor
92628617|NCT05311774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92628618|NCT05311774|Narcotics|narcotics|mesh-ancestor
92628619|NCT05311774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628620|NCT00194727|Capecitabine|capecitabine|mesh-list
92628621|NCT00194727|Vinorelbine|vinorelbine|mesh-list
92628622|NCT00194727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628623|NCT00194727|Antimetabolites|antimetabolites|mesh-ancestor
92628624|NCT00194727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628625|NCT00194727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628626|NCT00194727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92628627|NCT00194727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92628628|NCT00194727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92628629|NCT00194727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92628630|NCT00166400|Metoprolol|metoprolol|mesh-list
92628631|NCT00166400|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92628632|NCT00166400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92628633|NCT00166400|Sympatholytics|sympatholytics|mesh-ancestor
92628634|NCT00166400|Autonomic Agents|autonomic agents|mesh-ancestor
92628635|NCT00166400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628636|NCT00166400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628637|NCT00166400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92628638|NCT00166400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92628639|NCT00166400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92628640|NCT00166400|Adrenergic Agents|adrenergic agents|mesh-ancestor
92628641|NCT00166400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628642|NCT00166400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628643|NCT02042287|Metronidazole|metronidazole|mesh-list
92628644|NCT02042287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628645|NCT02042287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628646|NCT02042287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92628647|NCT02042287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92628648|NCT05296213|Calcium|calcium|mesh-list
92628649|NCT05296213|Fluorides|fluorides|mesh-list
92628650|NCT05296213|Caseins|caseins|mesh-list
92628677|NCT00194766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92628678|NCT00194766|Alkylating Agents|alkylating agents|mesh-ancestor
92628679|NCT00194766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628680|NCT00194766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628681|NCT00166556|Alemtuzumab|alemtuzumab|mesh-list
92628683|NCT00166556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628684|NCT00166556|Immunologic Factors|immunologic factors|mesh-ancestor
92628685|NCT00166556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628686|NCT00166556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92628687|NCT00166556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628688|NCT00166556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628689|NCT00166556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628690|NCT00166556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628691|NCT00166595|Risperidone|risperidone|mesh-list
92628692|NCT00166595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92628693|NCT00166595|Serotonin Agents|serotonin agents|mesh-ancestor
92628694|NCT00166595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628695|NCT00166595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628696|NCT00166595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628727|NCT05124067|Antiemetics|antiemetics|mesh-ancestor
92628728|NCT05124067|Autonomic Agents|autonomic agents|mesh-ancestor
92628729|NCT05124067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628730|NCT05124067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628731|NCT05124067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628732|NCT05124067|Glucocorticoids|glucocorticoids|mesh-ancestor
92628733|NCT05124067|Hormones|hormones|mesh-ancestor
92628734|NCT05124067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628735|NCT05124067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92628736|NCT05124067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628737|NCT05124067|Protease Inhibitors|protease inhibitors|mesh-ancestor
92628738|NCT05124067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628739|NCT05124067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628740|NCT05124067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92628741|NCT05124067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628742|NCT05124067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92628743|NCT05124067|Analgesics|analgesics|mesh-ancestor
92628745|NCT05124067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92628746|NCT05124067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92628747|NCT05124067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92628748|NCT05124067|Adrenergic Agents|adrenergic agents|mesh-ancestor
92628749|NCT05124067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628750|NCT05124067|Antipruritics|antipruritics|mesh-ancestor
92628751|NCT05124067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92628752|NCT05124067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92628753|NCT05124067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92628754|NCT05124067|Serotonin Agents|serotonin agents|mesh-ancestor
92628755|NCT00194883|Hormones|hormones|mesh-list
92628756|NCT00194883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628757|NCT00194883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628758|NCT02277184|Cisplatin|cisplatin|mesh-list
92628759|NCT02277184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628760|NCT00166829|Mycophenolic Acid|mycophenolic acid|mesh-list
92628761|NCT00166829|Sirolimus|sirolimus|mesh-list
92628762|NCT00166829|Tacrolimus|tacrolimus|mesh-list
92628763|NCT00166829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628764|NCT00166829|Immunologic Factors|immunologic factors|mesh-ancestor
92628765|NCT00166829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628766|NCT00166829|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92628767|NCT00166829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628768|NCT00166829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628769|NCT00166829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628770|NCT00166829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628771|NCT00166829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92628772|NCT00166829|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628773|NCT00166829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628774|NCT00166829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628775|NCT00166829|Antifungal Agents|antifungal agents|mesh-ancestor
92628776|NCT00177333|Doxycycline|doxycycline|mesh-list
92628777|NCT00177333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628778|NCT00177333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628779|NCT00177333|Antimalarials|antimalarials|mesh-ancestor
92628780|NCT00177333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92628781|NCT00177333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92628782|NCT00166868|Neomycin|neomycin|mesh-list
92628783|NCT00166868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628784|NCT00166868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628785|NCT00166868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92628786|NCT00166868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628787|NCT00166868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628788|NCT00194961|Hormones|hormones|mesh-list
92628789|NCT00194961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628790|NCT00194961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628791|NCT00177372|Misoprostol|misoprostol|mesh-list
92628792|NCT00177372|Mifepristone|mifepristone|mesh-list
92628793|NCT00177372|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92628794|NCT00177372|Abortifacient Agents|abortifacient agents|mesh-ancestor
92628795|NCT00177372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92628796|NCT00177372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628797|NCT00177372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92628798|NCT00177372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628799|NCT00177372|Oxytocics|oxytocics|mesh-ancestor
92628800|NCT00177372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92628801|NCT00177372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92628802|NCT00177372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92561913|NCT00150436|Anticonvulsants|anticonvulsants|mesh-ancestor
92561914|NCT00150436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92561915|NCT00150436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561916|NCT00150436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561917|NCT00150436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91969484|NCT03213769|Ubiquinone|ubiquinone|mesh-list
92628803|NCT00177372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92628804|NCT00177372|Contraceptive Agents|contraceptive agents|mesh-ancestor
92628805|NCT00177372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92628806|NCT00177372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92628807|NCT00177372|Hormone Antagonists|hormone antagonists|mesh-ancestor
92628808|NCT00177372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628809|NCT00177372|Luteolytic Agents|luteolytic agents|mesh-ancestor
92628810|NCT00177372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92628811|NCT00177372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92628812|NCT04819399|Catumaxomab|catumaxomab|mesh-list
92628813|NCT04819399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628814|NCT00177411|Hormones|hormones|mesh-list
92628815|NCT00177411|Parathyroid Hormone|parathyroid hormone|mesh-list
92628816|NCT00177411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92035772|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
92628821|NCT00195078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628822|NCT00195078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92628823|NCT00195078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628824|NCT00195078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628825|NCT00167141|Contraceptive Agents|contraceptive agents|mesh-list
92628826|NCT00167141|Contraceptive Agents, Male|contraceptive agents, male|mesh-list
92628827|NCT00167141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92628828|NCT00167141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628830|NCT04660045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628831|NCT00177528|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92628832|NCT00177528|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92628833|NCT00177528|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92628834|NCT00177528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628835|NCT00177528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628836|NCT00177528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628837|NCT00177528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628838|NCT00177528|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92628839|NCT00177528|Antidepressive Agents|antidepressive agents|mesh-ancestor
92628840|NCT00177528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628841|NCT04566250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92628842|NCT04566250|Analgesics|analgesics|mesh-ancestor
92628843|NCT04566250|Sensory System Agents|sensory system agents|mesh-ancestor
92628844|NCT04566250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628845|NCT04566250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628846|NCT04548583|Remestemcel-l|remestemcel-l|mesh-list
92628847|NCT04548583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628848|NCT04548583|Antiviral Agents|antiviral agents|mesh-ancestor
92628849|NCT04548583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628850|NCT00167297|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92628851|NCT00167297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92628852|NCT00167297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92628853|NCT00167297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628854|NCT00167297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628855|NCT00167297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92628856|NCT00167297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628857|NCT00167297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628858|NCT00177567|Lamotrigine|lamotrigine|mesh-list
92628859|NCT00177567|Valproic Acid|valproic acid|mesh-list
92628860|NCT00177567|Olanzapine|olanzapine|mesh-list
92628861|NCT00177567|Risperidone|risperidone|mesh-list
92628862|NCT00177567|Lithium Carbonate|lithium carbonate|mesh-list
92628863|NCT00177567|Mirtazapine|mirtazapine|mesh-list
92628864|NCT00177567|Tranylcypromine|tranylcypromine|mesh-list
92628865|NCT00177567|Bupropion|bupropion|mesh-list
92628866|NCT00177567|Paroxetine|paroxetine|mesh-list
92628867|NCT00177567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92561918|NCT00150436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92561919|NCT00150436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92561920|NCT00150436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628868|NCT00177567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92628869|NCT00177567|Serotonin Agents|serotonin agents|mesh-ancestor
92628870|NCT00177567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628871|NCT00177567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628872|NCT00177567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628873|NCT00177567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92628874|NCT00177567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92628875|NCT00177567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628876|NCT00177567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628877|NCT00177567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92628878|NCT00177567|Dopamine Agents|dopamine agents|mesh-ancestor
92628879|NCT00177567|Antiemetics|antiemetics|mesh-ancestor
92628880|NCT00177567|Autonomic Agents|autonomic agents|mesh-ancestor
92628881|NCT00177567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628882|NCT00177567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92628883|NCT00177567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92628884|NCT00177567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92628888|NCT00177567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92628889|NCT00177567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92628890|NCT00177567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92628891|NCT00177567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628892|NCT00177567|Antimanic Agents|antimanic agents|mesh-ancestor
92628893|NCT00177567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92628894|NCT00177567|Anticonvulsants|anticonvulsants|mesh-ancestor
92628895|NCT00177567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92628896|NCT00177567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92628897|NCT00177567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92628898|NCT00177567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92628899|NCT00177567|Histamine Antagonists|histamine antagonists|mesh-ancestor
92628901|NCT00177567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92628902|NCT00177567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92628903|NCT00177567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92628904|NCT00177567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92628905|NCT00177567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92628906|NCT00177567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92628907|NCT00177567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92628908|NCT00177567|GABA Agents|gaba agents|mesh-ancestor
92628909|NCT00177567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92628910|NCT00195156|Valproic Acid|valproic acid|mesh-list
92628911|NCT00195156|Anticonvulsants|anticonvulsants|mesh-ancestor
92628912|NCT00195156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628913|NCT00195156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628914|NCT00195156|GABA Agents|gaba agents|mesh-ancestor
92628915|NCT00195156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92628916|NCT00195156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628917|NCT00195156|Antimanic Agents|antimanic agents|mesh-ancestor
92628918|NCT00195156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92628919|NCT00195156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628920|NCT00195156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628921|NCT00167375|Eszopiclone|eszopiclone|mesh-list
92628922|NCT00167375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92628923|NCT00167375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628924|NCT00167375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628925|NCT00195000|Cytarabine|cytarabine|mesh-list
92628926|NCT00195000|Gemtuzumab|gemtuzumab|mesh-list
92628927|NCT00195000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628928|NCT00195000|Antimetabolites|antimetabolites|mesh-ancestor
92628929|NCT00195000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628930|NCT00195000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628931|NCT00195000|Antiviral Agents|antiviral agents|mesh-ancestor
92628932|NCT00195000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628933|NCT00195000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628934|NCT00195000|Immunologic Factors|immunologic factors|mesh-ancestor
92628935|NCT00195000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628936|NCT00195000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628937|NCT00195000|Immunotoxins|immunotoxins|mesh-ancestor
92628938|NCT00195000|Immunoconjugates|immunoconjugates|mesh-ancestor
92628939|NCT00195195|Sirolimus|sirolimus|mesh-list
92628940|NCT00195195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628941|NCT00195195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628942|NCT00195195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628943|NCT00195195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628944|NCT00195195|Antifungal Agents|antifungal agents|mesh-ancestor
92628945|NCT00195195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628946|NCT00195195|Immunologic Factors|immunologic factors|mesh-ancestor
92628947|NCT00195195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628948|NCT04299880|Leucovorin|leucovorin|mesh-list
92628949|NCT04299880|Paclitaxel|paclitaxel|mesh-list
92628950|NCT04299880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92628951|NCT04299880|Bevacizumab|bevacizumab|mesh-list
92628952|NCT04299880|Gemcitabine|gemcitabine|mesh-list
92628953|NCT04299880|Fluorouracil|fluorouracil|mesh-list
92628954|NCT04299880|Nivolumab|nivolumab|mesh-list
92628955|NCT04299880|Irinotecan|irinotecan|mesh-list
92628956|NCT04299880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92628957|NCT04299880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628962|NCT04299880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92628963|NCT04299880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92628964|NCT04299880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92628965|NCT04299880|Growth Substances|growth substances|mesh-ancestor
92628966|NCT04299880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628967|NCT04299880|Growth Inhibitors|growth inhibitors|mesh-ancestor
92628968|NCT04299880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92628969|NCT04299880|Antimetabolites|antimetabolites|mesh-ancestor
92628970|NCT04299880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92628971|NCT04299880|Immunologic Factors|immunologic factors|mesh-ancestor
92628972|NCT04299880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92628973|NCT04299880|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92628974|NCT04299880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92628975|NCT04299880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628976|NCT04299880|Antidotes|antidotes|mesh-ancestor
92628977|NCT04299880|Protective Agents|protective agents|mesh-ancestor
92628978|NCT04299880|Vitamin B Complex|vitamin b complex|mesh-ancestor
92628979|NCT04299880|Vitamins|vitamins|mesh-ancestor
92628980|NCT04299880|Micronutrients|micronutrients|mesh-ancestor
92628981|NCT00167492|Mycophenolic Acid|mycophenolic acid|mesh-list
92628982|NCT00167492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92628983|NCT00167492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628984|NCT00167492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92628985|NCT00167492|Antitubercular Agents|antitubercular agents|mesh-ancestor
92628986|NCT00167492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628987|NCT00167492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628988|NCT00167492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628989|NCT00167492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628990|NCT04087096|Zoledronic Acid|zoledronic acid|mesh-list
92628991|NCT04087096|Denosumab|denosumab|mesh-list
92628992|NCT04087096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92628993|NCT04087096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628994|NCT00177684|Amphotericin B|amphotericin b|mesh-list
92628995|NCT00177684|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92628996|NCT00177684|Amebicides|amebicides|mesh-ancestor
92628997|NCT00177684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92628998|NCT00177684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92628999|NCT00177684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629000|NCT00177684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629001|NCT00177684|Antifungal Agents|antifungal agents|mesh-ancestor
92629002|NCT00532090|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92629003|NCT00532090|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92629004|NCT00532090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629005|NCT00532090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629006|NCT00195312|Bupivacaine|bupivacaine|mesh-list
92629007|NCT00195312|Anesthetics, Local|anesthetics, local|mesh-ancestor
92629008|NCT00195312|Anesthetics|anesthetics|mesh-ancestor
92629009|NCT00195312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629010|NCT00195312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629011|NCT00195312|Sensory System Agents|sensory system agents|mesh-ancestor
92629012|NCT00195312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629013|NCT00167609|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92629014|NCT00167609|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92629015|NCT00167609|Immunologic Factors|immunologic factors|mesh-ancestor
92629016|NCT00167609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629017|NCT03888079|Anesthetics|anesthetics|mesh-list
92561923|NCT00150553|Anticonvulsants|anticonvulsants|mesh-ancestor
92561924|NCT00150553|Antimanic Agents|antimanic agents|mesh-ancestor
92561925|NCT00150553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92561926|NCT00150553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561927|NCT00150553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969490|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
92629018|NCT03888079|Anesthetics, Local|anesthetics, local|mesh-list
92629019|NCT03888079|Anesthetics, General|anesthetics, general|mesh-list
92629020|NCT03888079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629021|NCT03888079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629022|NCT03888079|Sensory System Agents|sensory system agents|mesh-ancestor
92629023|NCT03888079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629024|NCT00167648|Leuprolide|leuprolide|mesh-list
92629025|NCT00167648|Goserelin|goserelin|mesh-list
92629026|NCT00167648|Estradiol|estradiol|mesh-list
92629027|NCT00167648|Estrogens|estrogens|mesh-ancestor
92629028|NCT00167648|Hormones|hormones|mesh-ancestor
92629045|NCT00167687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629046|NCT00167687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354203|NCT05249478|Bupivacaine|bupivacaine|mesh-list
92629047|NCT00167687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629048|NCT02906995|Nicotine|nicotine|mesh-list
92629049|NCT02906995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92629050|NCT02906995|Autonomic Agents|autonomic agents|mesh-ancestor
92629051|NCT02906995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629052|NCT02906995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629053|NCT02906995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92629054|NCT02906995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92629055|NCT02906995|Cholinergic Agents|cholinergic agents|mesh-ancestor
92629056|NCT02906995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629057|NCT02906995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629058|NCT00195390|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92629059|NCT00195390|Immunologic Factors|immunologic factors|mesh-ancestor
92629060|NCT00195390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629061|NCT02906800|Digoxin|digoxin|mesh-list
92629062|NCT02906800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92629063|NCT02906800|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92629064|NCT02906800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629065|NCT02906800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629066|NCT02906800|Protective Agents|protective agents|mesh-ancestor
92629067|NCT02906800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629068|NCT00195468|Cyclosporine|cyclosporine|mesh-list
92629069|NCT00195468|Cyclosporins|cyclosporins|mesh-list
92629070|NCT00195468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629071|NCT00195468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629072|NCT00195468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629073|NCT00195468|Immunologic Factors|immunologic factors|mesh-ancestor
92629074|NCT00195468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629075|NCT00195468|Antifungal Agents|antifungal agents|mesh-ancestor
92629076|NCT00195468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629077|NCT00195468|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629078|NCT00195468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629079|NCT00195468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92629080|NCT00167765|Abciximab|abciximab|mesh-list
92629081|NCT00167765|Anticoagulants|anticoagulants|mesh-ancestor
92629082|NCT00167765|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92629083|NCT02906254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92629084|NCT02906254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629087|NCT00167843|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92629089|NCT00167843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92629090|NCT00167843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92629091|NCT00167843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629092|NCT00167843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92629093|NCT00167843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629094|NCT00167843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629095|NCT00167843|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92629096|NCT02906059|Irinotecan|irinotecan|mesh-list
92629097|NCT02906059|Adavosertib|adavosertib|mesh-list
92561929|NCT00150553|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92561930|NCT00150553|Analgesics|analgesics|mesh-ancestor
92561931|NCT00150553|Sensory System Agents|sensory system agents|mesh-ancestor
92561932|NCT00150553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561933|NCT00150553|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91969497|NCT03201913|Hormones|hormones|mesh-ancestor
92629098|NCT02906059|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92629099|NCT02906059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629100|NCT02906059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629101|NCT02906059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629102|NCT02906059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629103|NCT02906176|Voriconazole|voriconazole|mesh-list
92629104|NCT02906176|Antifungal Agents|antifungal agents|mesh-ancestor
92629105|NCT02906176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629106|NCT02906176|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92629107|NCT02906176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92629108|NCT02906176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629109|NCT02906176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629110|NCT02906176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92629111|NCT02906176|Hormone Antagonists|hormone antagonists|mesh-ancestor
92629112|NCT02906176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629113|NCT02906176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629114|NCT02906176|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92629115|NCT02905864|Liraglutide|liraglutide|mesh-list
92629116|NCT02905864|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92629117|NCT02905864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629118|NCT02905864|Incretins|incretins|mesh-ancestor
92629119|NCT02905864|Hormones|hormones|mesh-ancestor
92629120|NCT02905864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629121|NCT00167882|Mesalamine|mesalamine|mesh-list
92629122|NCT00167882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92629123|NCT00167882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92629124|NCT00167882|Analgesics|analgesics|mesh-ancestor
92629125|NCT00167882|Sensory System Agents|sensory system agents|mesh-ancestor
92629126|NCT00167882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629127|NCT00167882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629128|NCT00167882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629129|NCT00167882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629130|NCT02905708|Charcoal|charcoal|mesh-list
92629131|NCT02905708|Antidotes|antidotes|mesh-ancestor
92629132|NCT02905708|Protective Agents|protective agents|mesh-ancestor
92629133|NCT02905708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629134|NCT00167921|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92629135|NCT00167921|Estrogens|estrogens|mesh-ancestor
92629136|NCT00167921|Hormones|hormones|mesh-ancestor
92629137|NCT00167921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629138|NCT00167921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629139|NCT00167960|Tazobactam|tazobactam|mesh-list
92629140|NCT00167960|Piperacillin|piperacillin|mesh-list
92629141|NCT00167960|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92629142|NCT00167960|Lactams|lactams|mesh-list
92629143|NCT00167960|beta-Lactams|beta-lactams|mesh-list
92629144|NCT00167960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629145|NCT00167960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629146|NCT00167960|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92629147|NCT00167960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629148|NCT00167960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629149|NCT02905513|Contraceptive Agents|contraceptive agents|mesh-list
92629150|NCT02905513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629151|NCT02905513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629152|NCT00167999|Tazobactam|tazobactam|mesh-list
92629153|NCT00167999|Piperacillin|piperacillin|mesh-list
92629154|NCT00167999|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92629155|NCT00167999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629156|NCT00167999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629168|NCT00177996|Serotonin Agents|serotonin agents|mesh-ancestor
92629169|NCT00177996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561934|NCT00150553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92561935|NCT00150553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561936|NCT00150553|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92561937|NCT00150553|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92561938|NCT00150631|Candesartan|candesartan|mesh-list
92629171|NCT00168077|Hemostatics|hemostatics|mesh-ancestor
92629172|NCT00168077|Coagulants|coagulants|mesh-ancestor
92629173|NCT00195585|Leucovorin|leucovorin|mesh-list
92629174|NCT00195585|Levoleucovorin|levoleucovorin|mesh-list
92629175|NCT00195585|Antidotes|antidotes|mesh-ancestor
92629176|NCT00195585|Protective Agents|protective agents|mesh-ancestor
92629177|NCT00195585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629178|NCT00195585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92629179|NCT00195585|Vitamins|vitamins|mesh-ancestor
92629180|NCT00195585|Micronutrients|micronutrients|mesh-ancestor
92629181|NCT02905045|Ketoprofen|ketoprofen|mesh-list
92629182|NCT02905045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92629183|NCT02905045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92629184|NCT02905045|Analgesics|analgesics|mesh-ancestor
92629185|NCT02905045|Sensory System Agents|sensory system agents|mesh-ancestor
92629186|NCT02905045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629187|NCT02905045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629188|NCT02905045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629189|NCT02905045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629190|NCT02905045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92629191|NCT02905045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629192|NCT02905045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629193|NCT02904772|Cyclosporine|cyclosporine|mesh-list
92629194|NCT02904772|Mycophenolic Acid|mycophenolic acid|mesh-list
92629195|NCT02904772|Prednisolone|prednisolone|mesh-list
92629196|NCT02904772|Cyclosporins|cyclosporins|mesh-list
92629197|NCT02904772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629198|NCT02904772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629199|NCT02904772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629200|NCT02904772|Immunologic Factors|immunologic factors|mesh-ancestor
92629201|NCT02904772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629202|NCT02904772|Antifungal Agents|antifungal agents|mesh-ancestor
92629203|NCT02904772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629204|NCT02904772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629205|NCT02904772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629206|NCT02904772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92629207|NCT02904772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92629208|NCT02904772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629209|NCT02904772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92629210|NCT02904772|Antitubercular Agents|antitubercular agents|mesh-ancestor
92629211|NCT02904772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629212|NCT02904772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629213|NCT02904772|Glucocorticoids|glucocorticoids|mesh-ancestor
92629214|NCT02904772|Hormones|hormones|mesh-ancestor
92629215|NCT02904772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629216|NCT02904772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92629217|NCT00195741|Valproic Acid|valproic acid|mesh-list
92629218|NCT00195741|Anticonvulsants|anticonvulsants|mesh-ancestor
92629219|NCT00195741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629228|NCT00178035|Paroxetine|paroxetine|mesh-list
92629229|NCT00178035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92629230|NCT00178035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92629231|NCT00178035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92629232|NCT00178035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629233|NCT00178035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629234|NCT00178035|Serotonin Agents|serotonin agents|mesh-ancestor
92629235|NCT00178035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629236|NCT00178035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92629237|NCT00178035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92629238|NCT00178035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629239|NCT00178035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92629240|NCT00178035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92629241|NCT00178035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629242|NCT02904538|Dexamethasone|dexamethasone|mesh-list
92561939|NCT00150631|Candesartan cilexetil|candesartan cilexetil|mesh-list
92561940|NCT00150631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92561941|NCT00150631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92561942|NCT00150631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92561943|NCT00150631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561944|NCT00082446|Vaccines|vaccines|mesh-list
91969509|NCT03212677|Iron|iron|mesh-list
92629243|NCT02904538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629244|NCT02904538|Antiemetics|antiemetics|mesh-ancestor
92629245|NCT02904538|Autonomic Agents|autonomic agents|mesh-ancestor
92629246|NCT02904538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629247|NCT02904538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629248|NCT02904538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629249|NCT02904538|Glucocorticoids|glucocorticoids|mesh-ancestor
92629250|NCT02904538|Hormones|hormones|mesh-ancestor
92629251|NCT02904538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629252|NCT02904538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92629253|NCT02904538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629254|NCT02963103|Tacrolimus|tacrolimus|mesh-list
92629255|NCT02963103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629256|NCT02963103|Immunologic Factors|immunologic factors|mesh-ancestor
92629257|NCT02963103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629258|NCT02963103|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92629259|NCT02963103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629260|NCT02963103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629261|NCT00407264|Fluticasone|fluticasone|mesh-list
92629262|NCT00407264|Xhance|xhance|mesh-list
92629263|NCT00407264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629264|NCT00407264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92629265|NCT00407264|Autonomic Agents|autonomic agents|mesh-ancestor
92629266|NCT00407264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629267|NCT00407264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629268|NCT00407264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92629269|NCT00407264|Respiratory System Agents|respiratory system agents|mesh-ancestor
92629270|NCT00407264|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629271|NCT00407264|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92629272|NCT02904499|Dabigatran|dabigatran|mesh-list
92629273|NCT02904499|Antithrombins|antithrombins|mesh-ancestor
92629274|NCT02904499|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92629275|NCT02904499|Protease Inhibitors|protease inhibitors|mesh-ancestor
92629276|NCT02904499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629277|NCT02904499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629278|NCT02904499|Anticoagulants|anticoagulants|mesh-ancestor
92629279|NCT00195780|Valproic Acid|valproic acid|mesh-list
92629280|NCT00195780|Anticonvulsants|anticonvulsants|mesh-ancestor
92629281|NCT00195780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629282|NCT00195780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629283|NCT00195780|GABA Agents|gaba agents|mesh-ancestor
92629284|NCT00195780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629285|NCT00195780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629288|NCT00195780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629289|NCT00195780|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629290|NCT00407342|Alefacept|alefacept|mesh-list
92629291|NCT00407342|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629292|NCT00407342|Immunologic Factors|immunologic factors|mesh-ancestor
92629293|NCT00407342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629294|NCT00553423|Lactulose|lactulose|mesh-list
92629295|NCT00553423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629296|NCT02904304|Ibuprofen|ibuprofen|mesh-list
92629297|NCT02904304|Phenylephrine|phenylephrine|mesh-list
92629298|NCT02904304|Oxymetazoline|oxymetazoline|mesh-list
92629299|NCT02904304|Desloratadine|desloratadine|mesh-list
92629300|NCT02904304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92629301|NCT02904304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92629302|NCT02904304|Analgesics|analgesics|mesh-ancestor
92629303|NCT02904304|Sensory System Agents|sensory system agents|mesh-ancestor
92629304|NCT02904304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629305|NCT02904304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629306|NCT02904304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92561945|NCT00082446|Immunologic Factors|immunologic factors|mesh-ancestor
92561946|NCT00082446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561947|NCT00049439|Cyclophosphamide|cyclophosphamide|mesh-list
92561948|NCT00049439|Lomustine|lomustine|mesh-list
92561949|NCT00049439|Etoposide|etoposide|mesh-list
92629307|NCT02904304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629308|NCT02904304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92629309|NCT02904304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629310|NCT02904304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629311|NCT02904304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92629312|NCT02904304|Mydriatics|mydriatics|mesh-ancestor
92629313|NCT02904304|Autonomic Agents|autonomic agents|mesh-ancestor
92629314|NCT02904304|Sympathomimetics|sympathomimetics|mesh-ancestor
92629315|NCT02904304|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92629316|NCT02904304|Nasal Decongestants|nasal decongestants|mesh-ancestor
92629317|NCT02904304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92629318|NCT02904304|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92629319|NCT02904304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92629320|NCT02904304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92629321|NCT02904304|Adrenergic Agents|adrenergic agents|mesh-ancestor
92629322|NCT02904304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629323|NCT02904304|Protective Agents|protective agents|mesh-ancestor
92629324|NCT02904304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92629325|NCT02904304|Cholinergic Agents|cholinergic agents|mesh-ancestor
92629326|NCT02904304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92629327|NCT02904304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92629328|NCT02904304|Histamine Antagonists|histamine antagonists|mesh-ancestor
92629329|NCT02904304|Histamine Agents|histamine agents|mesh-ancestor
92629330|NCT00407459|Bevacizumab|bevacizumab|mesh-list
92629331|NCT00407459|Carboplatin|carboplatin|mesh-list
92629332|NCT00407459|Pemetrexed|pemetrexed|mesh-list
92629333|NCT00407459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629334|NCT00407459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629335|NCT00407459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92629336|NCT00407459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92629337|NCT00407459|Growth Substances|growth substances|mesh-ancestor
92629338|NCT00407459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629339|NCT00407459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92629340|NCT00407459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629341|NCT00407459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629342|NCT00407459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92629343|NCT00407459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92629344|NCT02904031|Leucovorin|leucovorin|mesh-list
92629345|NCT02904031|Fluorouracil|fluorouracil|mesh-list
92629346|NCT02904031|Oxaliplatin|oxaliplatin|mesh-list
92629347|NCT02904031|Panitumumab|panitumumab|mesh-list
92629348|NCT02904031|Levoleucovorin|levoleucovorin|mesh-list
92354510|NCT05244954|Chloroquine|chloroquine|mesh-list
92629349|NCT02904031|Antimetabolites|antimetabolites|mesh-ancestor
92629350|NCT02904031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629351|NCT02904031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92629352|NCT02904031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629353|NCT02904031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629354|NCT02904031|Immunologic Factors|immunologic factors|mesh-ancestor
92629355|NCT02904031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629356|NCT02904031|Antidotes|antidotes|mesh-ancestor
92629357|NCT02904031|Protective Agents|protective agents|mesh-ancestor
92629358|NCT02904031|Vitamin B Complex|vitamin b complex|mesh-ancestor
92629359|NCT02904031|Vitamins|vitamins|mesh-ancestor
92629360|NCT02904031|Micronutrients|micronutrients|mesh-ancestor
92629364|NCT02904109|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92629365|NCT02904109|Diuretics|diuretics|mesh-ancestor
92629366|NCT02904109|Natriuretic Agents|natriuretic agents|mesh-ancestor
92629367|NCT02904109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629368|NCT02904109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92629369|NCT00178113|Lycopene|lycopene|mesh-list
92629370|NCT00178113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629371|NCT00178113|Antioxidants|antioxidants|mesh-ancestor
92629372|NCT00178113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629373|NCT00178113|Protective Agents|protective agents|mesh-ancestor
92629374|NCT00178113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629375|NCT00178113|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92629376|NCT00178113|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92561950|NCT00049439|Procarbazine|procarbazine|mesh-list
92561951|NCT00049439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92561952|NCT00049439|Immunologic Factors|immunologic factors|mesh-ancestor
92561953|NCT00049439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561954|NCT00049439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969514|NCT03199339|Bupropion|bupropion|mesh-list
92629377|NCT00178113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629378|NCT02903524|Cyclophosphamide|cyclophosphamide|mesh-list
92629379|NCT02903524|Doxorubicin|doxorubicin|mesh-list
92629380|NCT02903524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92629381|NCT02903524|Pirarubicin|pirarubicin|mesh-list
92629382|NCT02903524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629383|NCT02903524|Immunologic Factors|immunologic factors|mesh-ancestor
92629384|NCT02903524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629385|NCT02903524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629386|NCT02903524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92629387|NCT02903524|Alkylating Agents|alkylating agents|mesh-ancestor
92629388|NCT02903524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629389|NCT02903524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629390|NCT02903524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92629391|NCT02903524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92629392|NCT02903524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92629393|NCT02903524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629394|NCT02903524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629395|NCT00168350|Memantine|memantine|mesh-list
92629396|NCT00168350|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92629397|NCT00168350|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92629398|NCT00168350|Dopamine Agents|dopamine agents|mesh-ancestor
92629399|NCT00168350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629400|NCT00168350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629401|NCT00168350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629402|NCT00168350|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92629403|NCT00168350|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92629404|NCT02903485|Anesthetics|anesthetics|mesh-list
92629405|NCT02903485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629406|NCT02903485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629407|NCT02903719|Ropivacaine|ropivacaine|mesh-list
92629408|NCT02903719|Anesthetics, Local|anesthetics, local|mesh-ancestor
92629409|NCT02903719|Anesthetics|anesthetics|mesh-ancestor
92629410|NCT02903719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629411|NCT02903719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629412|NCT02903719|Sensory System Agents|sensory system agents|mesh-ancestor
92629413|NCT02903719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629414|NCT00178269|Docetaxel|docetaxel|mesh-list
92629415|NCT00178269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629416|NCT00178269|Tubulin Modulators|tubulin modulators|mesh-ancestor
92629417|NCT00178269|Antimitotic Agents|antimitotic agents|mesh-ancestor
92629418|NCT00178269|Mitosis Modulators|mitosis modulators|mesh-ancestor
92629419|NCT00178269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629420|NCT02903251|Oxytocin|oxytocin|mesh-list
92629421|NCT02903251|Oxytocics|oxytocics|mesh-ancestor
92354595|NCT00634842|Insulin|insulin|mesh-list
92629422|NCT02903251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629423|NCT02903251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629425|NCT00168467|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92629426|NCT00168467|Protease Inhibitors|protease inhibitors|mesh-ancestor
92629427|NCT00168467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629428|NCT00168467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629429|NCT00168467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92629430|NCT00195936|Cinacalcet|cinacalcet|mesh-list
92629431|NCT00195936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92629432|NCT00195936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629435|NCT00195936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629436|NCT00168506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92629437|NCT00168506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92629438|NCT00168506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92629439|NCT00168506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629440|NCT00168506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92561955|NCT00049439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92561956|NCT00049439|Alkylating Agents|alkylating agents|mesh-ancestor
92561957|NCT00049439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629442|NCT00168506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629443|NCT02902861|Methotrexate|methotrexate|mesh-list
92629444|NCT02902861|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92629445|NCT02902861|Abortifacient Agents|abortifacient agents|mesh-ancestor
92629446|NCT02902861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629447|NCT02902861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629448|NCT02902861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92629449|NCT02902861|Antimetabolites|antimetabolites|mesh-ancestor
92629450|NCT02902861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629451|NCT02902861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629452|NCT02902861|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629453|NCT02902861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629454|NCT02902861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92629455|NCT02902861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629456|NCT02902861|Immunologic Factors|immunologic factors|mesh-ancestor
92629457|NCT02902861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629458|NCT02902861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92629459|NCT02903017|Tranexamic Acid|tranexamic acid|mesh-list
92629460|NCT02903017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92629461|NCT02903017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92629462|NCT02903017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629463|NCT02903017|Hemostatics|hemostatics|mesh-ancestor
92629464|NCT02903017|Coagulants|coagulants|mesh-ancestor
92629465|NCT02902744|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92629466|NCT02902744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629467|NCT02902744|Glucocorticoids|glucocorticoids|mesh-ancestor
92629468|NCT02902744|Hormones|hormones|mesh-ancestor
92629469|NCT02902744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629470|NCT02902744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629471|NCT00168584|Vitamin A|vitamin a|mesh-list
92629472|NCT00168584|Vitamins|vitamins|mesh-ancestor
92629473|NCT00168584|Micronutrients|micronutrients|mesh-ancestor
92629474|NCT00168584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629475|NCT02902666|Acetaminophen|acetaminophen|mesh-list
92629476|NCT02902666|Codeine|codeine|mesh-list
92629477|NCT02902666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92629478|NCT02902666|Analgesics|analgesics|mesh-ancestor
92629479|NCT02902666|Sensory System Agents|sensory system agents|mesh-ancestor
92629480|NCT02902666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629481|NCT02902666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629482|NCT02902666|Antipyretics|antipyretics|mesh-ancestor
92629483|NCT02902666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92629484|NCT02902666|Narcotics|narcotics|mesh-ancestor
92629485|NCT02902666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629486|NCT02902666|Antitussive Agents|antitussive agents|mesh-ancestor
92629487|NCT02902666|Respiratory System Agents|respiratory system agents|mesh-ancestor
92629488|NCT02902354|Nifedipine|nifedipine|mesh-list
92629489|NCT02902354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92629490|NCT02902354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92629491|NCT02902354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629492|NCT02902354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92629493|NCT02902354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629494|NCT02902354|Vasodilator Agents|vasodilator agents|mesh-ancestor
92629495|NCT02902354|Tocolytic Agents|tocolytic agents|mesh-ancestor
92354657|NCT01921218|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629496|NCT02902354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629497|NCT00168623|Vitamin A|vitamin a|mesh-list
92629498|NCT00168623|Vitamins|vitamins|mesh-ancestor
92629499|NCT00168623|Micronutrients|micronutrients|mesh-ancestor
92629500|NCT00168623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629501|NCT02902315|Vitamins|vitamins|mesh-list
92629502|NCT02902315|Ascorbic Acid|ascorbic acid|mesh-list
92629503|NCT02902315|Tocopherols|tocopherols|mesh-list
92629504|NCT02902315|alpha-Tocopherol|alpha-tocopherol|mesh-list
92629517|NCT02902432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629518|NCT00168701|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92629519|NCT00168701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629520|NCT00168701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629521|NCT00168701|Immunologic Factors|immunologic factors|mesh-ancestor
92629522|NCT00168701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561958|NCT00049439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561959|NCT00049439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91977032|NCT04850235|Paclitaxel|paclitaxel|mesh-list
92629523|NCT02902042|Pembrolizumab|pembrolizumab|mesh-list
92629524|NCT02902042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629525|NCT02902042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629526|NCT02902042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92629527|NCT02902042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629528|NCT00168740|Rituximab|rituximab|mesh-list
92629529|NCT00168740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629530|NCT00168740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629531|NCT00168740|Immunologic Factors|immunologic factors|mesh-ancestor
92629532|NCT00168740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629533|NCT00168740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629534|NCT00168779|Valsartan|valsartan|mesh-list
92629535|NCT00168779|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92629536|NCT00168779|Telmisartan|telmisartan|mesh-list
92629537|NCT00168779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92629538|NCT00168779|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92629539|NCT00168779|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92629540|NCT00168779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629541|NCT00168779|Diuretics|diuretics|mesh-ancestor
92629542|NCT00168779|Natriuretic Agents|natriuretic agents|mesh-ancestor
92629543|NCT00168779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629544|NCT00168779|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92629545|NCT00168779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92629546|NCT00168857|Losartan|losartan|mesh-list
92629547|NCT00168857|Telmisartan|telmisartan|mesh-list
92629548|NCT00168857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92629549|NCT00168857|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92629550|NCT00168857|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92406082|NCT03980171|Growth Inhibitors|growth inhibitors|mesh-ancestor
92629551|NCT00168857|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92629552|NCT00168857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629553|NCT00196131|Morphine|morphine|mesh-list
92629554|NCT00196131|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92629555|NCT00196131|Narcotics|narcotics|mesh-ancestor
92629556|NCT00196131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629557|NCT00196131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629558|NCT00196131|Analgesics|analgesics|mesh-ancestor
92629559|NCT00196131|Sensory System Agents|sensory system agents|mesh-ancestor
92629560|NCT00196131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629561|NCT00168896|Carboplatin|carboplatin|mesh-list
92629562|NCT00168896|Irinotecan|irinotecan|mesh-list
92629563|NCT00168896|Etoposide|etoposide|mesh-list
92629564|NCT00168896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629565|NCT00168896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92629566|NCT00168896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629567|NCT00168896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629570|NCT00168896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92354738|NCT00989196|Factor VIII|factor viii|mesh-list
92629571|NCT02901418|Immunoglobulins|immunoglobulins|mesh-list
92629572|NCT02901418|Immunologic Factors|immunologic factors|mesh-ancestor
92629573|NCT02901418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629574|NCT02901379|Atorvastatin|atorvastatin|mesh-list
92629575|NCT02901379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92629576|NCT02901379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92629577|NCT02901379|Antimetabolites|antimetabolites|mesh-ancestor
92629578|NCT02901379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629579|NCT02901379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92629580|NCT02901379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92629581|NCT02901379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629582|NCT02901106|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92629583|NCT02901106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629584|NCT02901106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629585|NCT02901106|Immunologic Factors|immunologic factors|mesh-ancestor
92629586|NCT02901106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629587|NCT02901145|Cyclophosphamide|cyclophosphamide|mesh-list
92629589|NCT02901145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629590|NCT02901145|Immunologic Factors|immunologic factors|mesh-ancestor
92629591|NCT02901145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629592|NCT02901145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629593|NCT02901145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92561960|NCT00049439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92561961|NCT00049439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92561962|NCT00049439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629594|NCT02901145|Alkylating Agents|alkylating agents|mesh-ancestor
92629595|NCT02901145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629596|NCT02901145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629597|NCT02901145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92629598|NCT02901145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629599|NCT02901145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92629600|NCT02901301|Pembrolizumab|pembrolizumab|mesh-list
92629601|NCT02901301|Capecitabine|capecitabine|mesh-list
92629602|NCT02901301|Trastuzumab|trastuzumab|mesh-list
92629603|NCT02901301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629604|NCT02901301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629605|NCT02901301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92629606|NCT02901301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629607|NCT02901301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92629608|NCT02901301|Antimetabolites|antimetabolites|mesh-ancestor
92629609|NCT00169013|Gabapentin|gabapentin|mesh-list
92629610|NCT00169013|Analgesics|analgesics|mesh-ancestor
92629611|NCT00169013|Sensory System Agents|sensory system agents|mesh-ancestor
92629612|NCT00169013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629613|NCT00169013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629614|NCT00169013|Anticonvulsants|anticonvulsants|mesh-ancestor
92629615|NCT00169013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92629616|NCT00169013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92629617|NCT00169013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629618|NCT00169013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629619|NCT00169013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92629620|NCT00169013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92629621|NCT00169013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629622|NCT00169013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629623|NCT00169013|Antimanic Agents|antimanic agents|mesh-ancestor
92629624|NCT00169091|Haloperidol|haloperidol|mesh-list
92629625|NCT00169091|Haloperidol decanoate|haloperidol decanoate|mesh-list
92629626|NCT00169091|Clozapine|clozapine|mesh-list
92629627|NCT00169091|Antiemetics|antiemetics|mesh-ancestor
92629628|NCT00169091|Autonomic Agents|autonomic agents|mesh-ancestor
92629629|NCT00169091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629630|NCT00169091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629631|NCT00169091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629632|NCT00169091|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92629633|NCT00169091|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92629634|NCT00169091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629635|NCT00169091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629636|NCT00169091|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92629637|NCT00169091|Dopamine Agents|dopamine agents|mesh-ancestor
92629638|NCT00169091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036606|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92629653|NCT00169130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629654|NCT00169130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629655|NCT00169130|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92629656|NCT00169130|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92629657|NCT00169130|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92629658|NCT00169130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629659|NCT00169130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629660|NCT00178620|Reteplase|reteplase|mesh-list
92629661|NCT00178620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92629662|NCT00178620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92629663|NCT00178620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629664|NCT00169169|Rituximab|rituximab|mesh-list
92629665|NCT00169169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629666|NCT00169169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629667|NCT00169169|Immunologic Factors|immunologic factors|mesh-ancestor
92629668|NCT00169169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629669|NCT00169169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629670|NCT00169208|Rituximab|rituximab|mesh-list
92629671|NCT00169208|Fludarabine|fludarabine|mesh-list
92629672|NCT00169208|Mitoxantrone|mitoxantrone|mesh-list
92629673|NCT00169208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629674|NCT00169208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629675|NCT00169208|Immunologic Factors|immunologic factors|mesh-ancestor
92561963|NCT00049439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561964|NCT00150670|Cisplatin|cisplatin|mesh-list
92561965|NCT00150670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561966|NCT00150709|Levetiracetam|levetiracetam|mesh-list
92561967|NCT00150709|Anticonvulsants|anticonvulsants|mesh-ancestor
92561968|NCT00150709|Nootropic Agents|nootropic agents|mesh-ancestor
92629676|NCT00169208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629677|NCT00169208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629678|NCT00169208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629679|NCT00169208|Analgesics|analgesics|mesh-ancestor
92629680|NCT00169208|Sensory System Agents|sensory system agents|mesh-ancestor
92629681|NCT00169208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629682|NCT00169208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92629683|NCT00169208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629684|NCT00169208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629685|NCT00178698|Interferons|interferons|mesh-list
92629686|NCT00178698|Gemcitabine|gemcitabine|mesh-list
92629687|NCT00178698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629688|NCT00178698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92629689|NCT00178698|Antimetabolites|antimetabolites|mesh-ancestor
92629690|NCT00178698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629691|NCT00178698|Antiviral Agents|antiviral agents|mesh-ancestor
92629692|NCT00178698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629693|NCT00169247|Cetuximab|cetuximab|mesh-list
92629694|NCT00169247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629695|NCT00169247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629696|NCT02899702|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92629697|NCT02899702|Immunologic Factors|immunologic factors|mesh-ancestor
92629700|NCT02899507|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92629701|NCT02899507|Clavulanic Acids|clavulanic acids|mesh-list
92629702|NCT02899507|Clavulanic Acid|clavulanic acid|mesh-list
92629703|NCT02899507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629704|NCT02899507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629705|NCT02899507|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92629706|NCT02899507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629707|NCT02899507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629708|NCT00178854|Risperidone|risperidone|mesh-list
92629709|NCT00178854|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92629710|NCT00178854|Serotonin Agents|serotonin agents|mesh-ancestor
92629711|NCT00178854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629712|NCT00178854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629713|NCT00178854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629714|NCT00178854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92629715|NCT00178854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92629716|NCT00178854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629717|NCT00178854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629718|NCT00178854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92354883|NCT00982878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92629719|NCT00178854|Dopamine Agents|dopamine agents|mesh-ancestor
92629720|NCT00196365|Levonorgestrel|levonorgestrel|mesh-list
92629721|NCT00196365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92629722|NCT00196365|Contraceptive Agents|contraceptive agents|mesh-ancestor
92629723|NCT00196365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629724|NCT00196365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629725|NCT00196365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92629726|NCT00196365|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92629727|NCT00196365|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92629728|NCT02898961|Gentamicins|gentamicins|mesh-list
92629730|NCT02898961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629731|NCT02898961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629732|NCT02898961|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92629733|NCT02898961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629734|NCT02898961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629735|NCT00553618|Aldesleukin|aldesleukin|mesh-list
92629736|NCT00553618|Dacarbazine|dacarbazine|mesh-list
92629737|NCT00553618|Interleukin-2|interleukin-2|mesh-list
92629738|NCT00553618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92629739|NCT00553618|Alkylating Agents|alkylating agents|mesh-ancestor
92629740|NCT00553618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629741|NCT00553618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561969|NCT00150748|Levetiracetam|levetiracetam|mesh-list
92561970|NCT00150748|Anticonvulsants|anticonvulsants|mesh-ancestor
92561971|NCT00150748|Nootropic Agents|nootropic agents|mesh-ancestor
92561972|NCT00150787|Levetiracetam|levetiracetam|mesh-list
92629742|NCT00553618|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92629743|NCT00553618|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92629744|NCT00553618|Antiviral Agents|antiviral agents|mesh-ancestor
92629745|NCT00553618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629746|NCT00553618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92629747|NCT00553618|Analgesics|analgesics|mesh-ancestor
92629748|NCT00553618|Sensory System Agents|sensory system agents|mesh-ancestor
92629749|NCT00553618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629750|NCT00553618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629751|NCT02898376|Tocopherols|tocopherols|mesh-list
92629753|NCT02898376|Tocotrienols|tocotrienols|mesh-list
92629754|NCT02898376|alpha-Tocopherol|alpha-tocopherol|mesh-list
92629755|NCT02898376|Pentoxifylline|pentoxifylline|mesh-list
92629756|NCT02898376|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92629757|NCT02898376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629758|NCT02898376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629759|NCT02898376|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92629760|NCT02898376|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92629761|NCT02898376|Protective Agents|protective agents|mesh-ancestor
92629762|NCT02898376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629763|NCT02898376|Vasodilator Agents|vasodilator agents|mesh-ancestor
92629764|NCT02898376|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92629765|NCT02898376|Antioxidants|antioxidants|mesh-ancestor
92629766|NCT02898376|Vitamins|vitamins|mesh-ancestor
92629767|NCT02898376|Micronutrients|micronutrients|mesh-ancestor
92629768|NCT00408174|Balsalazide|balsalazide|mesh-list
92629769|NCT00408174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92036740|NCT01843660|Analgesics|analgesics|mesh-ancestor
92629772|NCT00408174|Sensory System Agents|sensory system agents|mesh-ancestor
92629773|NCT00408174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629774|NCT00408174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629775|NCT00408174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629776|NCT00408174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629777|NCT00408174|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629778|NCT00169520|Docetaxel|docetaxel|mesh-list
92629779|NCT00169520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629780|NCT00169520|Tubulin Modulators|tubulin modulators|mesh-ancestor
92629781|NCT00169520|Antimitotic Agents|antimitotic agents|mesh-ancestor
92629782|NCT00169520|Mitosis Modulators|mitosis modulators|mesh-ancestor
92629783|NCT00169520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629784|NCT02897986|Vinorelbine|vinorelbine|mesh-list
92629785|NCT02897986|Propranolol|propranolol|mesh-list
92629786|NCT02897986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92629787|NCT02897986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629788|NCT02897986|Tubulin Modulators|tubulin modulators|mesh-ancestor
92629789|NCT02897986|Antimitotic Agents|antimitotic agents|mesh-ancestor
92629790|NCT02897986|Mitosis Modulators|mitosis modulators|mesh-ancestor
92629791|NCT02897986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629792|NCT02897986|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92629793|NCT02897986|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92629794|NCT02897986|Adrenergic Agents|adrenergic agents|mesh-ancestor
92354959|NCT03064854|Antimetabolites|antimetabolites|mesh-ancestor
92629795|NCT02897986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629796|NCT02897986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629797|NCT02897986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92629798|NCT02897986|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92629799|NCT02897986|Vasodilator Agents|vasodilator agents|mesh-ancestor
92629800|NCT00169559|Fenofibrate|fenofibrate|mesh-list
92629801|NCT00169559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92629802|NCT00169559|Antimetabolites|antimetabolites|mesh-ancestor
92629803|NCT00169559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629804|NCT00169559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92629805|NCT00408213|Mycophenolic Acid|mycophenolic acid|mesh-list
92629806|NCT00408213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92629807|NCT00408213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629808|NCT00408213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92629809|NCT00408213|Antitubercular Agents|antitubercular agents|mesh-ancestor
92629810|NCT00408213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629811|NCT00408213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92561973|NCT00150787|Anticonvulsants|anticonvulsants|mesh-ancestor
92561974|NCT00150787|Nootropic Agents|nootropic agents|mesh-ancestor
92629812|NCT00408213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629813|NCT00408213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629814|NCT00408252|Sunitinib|sunitinib|mesh-list
92629815|NCT00408252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629816|NCT00408252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92629817|NCT00408252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92629818|NCT00408252|Growth Substances|growth substances|mesh-ancestor
92629819|NCT00408252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629820|NCT00408252|Growth Inhibitors|growth inhibitors|mesh-ancestor
92629821|NCT00408252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92629822|NCT00408252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629823|NCT00408252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629824|NCT02897869|Amikacin|amikacin|mesh-list
92629825|NCT02897869|Murepavadin|murepavadin|mesh-list
92629826|NCT02897869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629827|NCT02897869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629828|NCT02897830|Dexamethasone|dexamethasone|mesh-list
92629829|NCT02897830|Lenalidomide|lenalidomide|mesh-list
92629830|NCT02897830|Ixazomib|ixazomib|mesh-list
92629831|NCT02897830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629832|NCT02897830|Antiemetics|antiemetics|mesh-ancestor
92629833|NCT02897830|Autonomic Agents|autonomic agents|mesh-ancestor
92629834|NCT02897830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629835|NCT02897830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629836|NCT02897830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629837|NCT02897830|Glucocorticoids|glucocorticoids|mesh-ancestor
92629838|NCT02897830|Hormones|hormones|mesh-ancestor
92629839|NCT02897830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629840|NCT02897830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92629841|NCT02897830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629842|NCT02897830|Immunologic Factors|immunologic factors|mesh-ancestor
92629844|NCT02897830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92629845|NCT02897830|Growth Substances|growth substances|mesh-ancestor
92629846|NCT02897830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92629847|NCT02897830|Protease Inhibitors|protease inhibitors|mesh-ancestor
92629848|NCT02897830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629849|NCT02897830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629850|NCT02897557|Pancrelipase|pancrelipase|mesh-list
92629851|NCT02897557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629852|NCT02897596|Grazoprevir|grazoprevir|mesh-list
92629853|NCT02897596|Antiviral Agents|antiviral agents|mesh-ancestor
92629854|NCT02897596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629855|NCT04681027|Oxymorphone|oxymorphone|mesh-list
92629856|NCT04681027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92629857|NCT04681027|Narcotics|narcotics|mesh-ancestor
92629858|NCT04681027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629859|NCT04681027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629860|NCT04681027|Analgesics|analgesics|mesh-ancestor
92629861|NCT04681027|Sensory System Agents|sensory system agents|mesh-ancestor
92629862|NCT04681027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629863|NCT04681027|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92629864|NCT00408330|Azelaic acid|azelaic acid|mesh-list
92629865|NCT00408330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629866|NCT00408330|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629867|NCT00408369|Pafuramidine|pafuramidine|mesh-list
92629868|NCT00408369|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92629869|NCT00408369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92629870|NCT00408369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92629871|NCT00408369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629872|NCT02897206|Imipenem|imipenem|mesh-list
92629873|NCT02897206|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92629874|NCT02897206|Cilastatin|cilastatin|mesh-list
92629875|NCT02897206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629876|NCT02897206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629877|NCT02897206|Protease Inhibitors|protease inhibitors|mesh-ancestor
92629878|NCT02897206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629879|NCT02897206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629880|NCT02897401|Carbon Monoxide|carbon monoxide|mesh-list
92629881|NCT02897401|Antimetabolites|antimetabolites|mesh-ancestor
92629882|NCT02897401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629883|NCT02897401|Gasotransmitters|gasotransmitters|mesh-ancestor
92629884|NCT02897401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629885|NCT02897401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629886|NCT02897011|Methotrexate|methotrexate|mesh-list
92561975|NCT00150826|Quinapril|quinapril|mesh-list
92561976|NCT00150826|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92561977|NCT00150826|Protease Inhibitors|protease inhibitors|mesh-ancestor
92286749|NCT04341935|Incretins|incretins|mesh-ancestor
92629887|NCT02897011|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92629888|NCT02897011|Abortifacient Agents|abortifacient agents|mesh-ancestor
92629889|NCT02897011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629890|NCT02897011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629891|NCT02897011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92629892|NCT02897011|Antimetabolites|antimetabolites|mesh-ancestor
92629893|NCT02897011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629894|NCT02897011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629895|NCT02897011|Dermatologic Agents|dermatologic agents|mesh-ancestor
92629896|NCT02897011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629897|NCT02897011|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92629898|NCT02897011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629899|NCT02897011|Immunologic Factors|immunologic factors|mesh-ancestor
92629900|NCT02897011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629901|NCT02897011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92629902|NCT00169832|Rosiglitazone|rosiglitazone|mesh-list
92629903|NCT00169832|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92629904|NCT00169832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629905|NCT00196599|Emtricitabine|emtricitabine|mesh-list
92629906|NCT00196599|Efavirenz|efavirenz|mesh-list
92629907|NCT00196599|Didanosine|didanosine|mesh-list
92629908|NCT00196599|Antiviral Agents|antiviral agents|mesh-ancestor
92629909|NCT00196599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629910|NCT00196599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92629911|NCT00196599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92629912|NCT00196599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629913|NCT00196599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629914|NCT00196599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92629915|NCT00196599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92629916|NCT00196599|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92629917|NCT00196599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92629919|NCT00196599|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92629920|NCT00196599|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92629921|NCT00196599|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92629922|NCT00196599|Antimetabolites|antimetabolites|mesh-ancestor
92629924|NCT00178971|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92629925|NCT00178971|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92629926|NCT00178971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629927|NCT00178971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629928|NCT00178971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629929|NCT00178971|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92629930|NCT00178971|Serotonin Agents|serotonin agents|mesh-ancestor
92629931|NCT00178971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629932|NCT00178971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629933|NCT02896621|Amlodipine|amlodipine|mesh-list
92629934|NCT02896621|Chlorthalidone|chlorthalidone|mesh-list
92629935|NCT02896621|Amiloride|amiloride|mesh-list
92629936|NCT02896621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92629937|NCT02896621|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92629938|NCT02896621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92629939|NCT02896621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629940|NCT02896621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92629941|NCT02896621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629942|NCT02896621|Vasodilator Agents|vasodilator agents|mesh-ancestor
92629943|NCT02896621|Diuretics|diuretics|mesh-ancestor
92629944|NCT02896621|Natriuretic Agents|natriuretic agents|mesh-ancestor
92355108|NCT04554888|Histamine Agonists|histamine agonists|mesh-ancestor
92629945|NCT02896621|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92629946|NCT02896621|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92629947|NCT02896621|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92629948|NCT02896621|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92629949|NCT02896621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92629950|NCT02896582|Cytarabine|cytarabine|mesh-list
92629951|NCT02896582|Dexamethasone|dexamethasone|mesh-list
92629952|NCT02896582|Etoposide|etoposide|mesh-list
92629953|NCT02896582|Melphalan|melphalan|mesh-list
92629954|NCT02896582|Cisplatin|cisplatin|mesh-list
92561978|NCT00150826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561979|NCT00150826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629955|NCT02896582|Obinutuzumab|obinutuzumab|mesh-list
92629956|NCT02896582|Carmustine|carmustine|mesh-list
92629957|NCT02896582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92629958|NCT02896582|Antiemetics|antiemetics|mesh-ancestor
92629959|NCT02896582|Autonomic Agents|autonomic agents|mesh-ancestor
92629960|NCT02896582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92629961|NCT02896582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629962|NCT02896582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92629963|NCT02896582|Glucocorticoids|glucocorticoids|mesh-ancestor
92629964|NCT02896582|Hormones|hormones|mesh-ancestor
92629965|NCT02896582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629966|NCT02896582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92629967|NCT02896582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629968|NCT02896582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92629969|NCT02896582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92629970|NCT02896582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92629971|NCT02896582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629972|NCT02896582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629973|NCT02896582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92629974|NCT02896582|Antimetabolites|antimetabolites|mesh-ancestor
92629975|NCT02896582|Antiviral Agents|antiviral agents|mesh-ancestor
92629976|NCT02896582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629977|NCT02896582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629978|NCT02896582|Immunologic Factors|immunologic factors|mesh-ancestor
92629979|NCT02896582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92629980|NCT02896582|Alkylating Agents|alkylating agents|mesh-ancestor
92629981|NCT02896582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92629982|NCT02896582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629983|NCT00196638|Interferons|interferons|mesh-list
92629984|NCT00196638|Interferon-alpha|interferon-alpha|mesh-list
92629985|NCT00196638|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92629986|NCT00196638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629987|NCT00196638|Antiviral Agents|antiviral agents|mesh-ancestor
92629988|NCT00196638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629989|NCT00196638|Immunologic Factors|immunologic factors|mesh-ancestor
92036963|NCT02443337|Necitumumab|necitumumab|mesh-list
92629993|NCT02896270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629994|NCT02896270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629995|NCT02896270|GABA Agents|gaba agents|mesh-ancestor
92629996|NCT02896270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629997|NCT02896270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629998|NCT02896270|Antimanic Agents|antimanic agents|mesh-ancestor
92629999|NCT02896270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630000|NCT02896270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630001|NCT02896270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630002|NCT00196677|Vitamins|vitamins|mesh-list
92630003|NCT00196677|Micronutrients|micronutrients|mesh-ancestor
92630004|NCT00196677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630005|NCT02895958|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92630006|NCT02895958|Antiviral Agents|antiviral agents|mesh-ancestor
92630007|NCT02895958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630008|NCT00169949|Aripiprazole|aripiprazole|mesh-list
92630009|NCT00169949|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630010|NCT00169949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630011|NCT00169949|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92630012|NCT00169949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630013|NCT00169949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630014|NCT00169949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630015|NCT00169949|Dopamine Agonists|dopamine agonists|mesh-ancestor
92630016|NCT00169949|Dopamine Agents|dopamine agents|mesh-ancestor
92630017|NCT00169949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630018|NCT00169949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355195|NCT04760262|Propofol|propofol|mesh-list
92630019|NCT00169949|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92630020|NCT00169949|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92630021|NCT00169949|Serotonin Agents|serotonin agents|mesh-ancestor
92630022|NCT00169949|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92630023|NCT00169949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92630024|NCT00169949|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92630025|NCT00169949|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92630026|NCT00196755|Calcium|calcium|mesh-list
92561981|NCT00150865|Ropivacaine|ropivacaine|mesh-list
92561982|NCT00150865|Anesthetics, Local|anesthetics, local|mesh-ancestor
92630027|NCT00196755|Sevelamer|sevelamer|mesh-list
92630028|NCT00196755|Calcium acetate|calcium acetate|mesh-list
92630029|NCT00196755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630030|NCT00196755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630031|NCT00196755|Chelating Agents|chelating agents|mesh-ancestor
92630032|NCT00196755|Sequestering Agents|sequestering agents|mesh-ancestor
92630033|NCT00196755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630034|NCT00169988|Risperidone|risperidone|mesh-list
92630035|NCT00169988|Sertraline|sertraline|mesh-list
92630036|NCT00169988|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92630037|NCT00169988|Serotonin Agents|serotonin agents|mesh-ancestor
92630038|NCT00169988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630039|NCT00169988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630040|NCT00169988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630041|NCT00169988|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92630042|NCT00169988|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630043|NCT00169988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630044|NCT00169988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630045|NCT00169988|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92630046|NCT00169988|Dopamine Agents|dopamine agents|mesh-ancestor
92630047|NCT00169988|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630048|NCT00169988|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92630049|NCT00169988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630050|NCT00169988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630051|NCT02895529|Itraconazole|itraconazole|mesh-list
92630052|NCT02895529|Caspofungin|caspofungin|mesh-list
92630053|NCT02895529|Antifungal Agents|antifungal agents|mesh-ancestor
92630054|NCT02895529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630055|NCT02895529|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92630056|NCT02895529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92630057|NCT02895529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630058|NCT02895529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630059|NCT02895529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92630060|NCT02895529|Hormone Antagonists|hormone antagonists|mesh-ancestor
92630063|NCT02895529|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92630064|NCT02895061|Alfacalcidol|alfacalcidol|mesh-list
92630065|NCT02895061|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92630066|NCT02895061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92630067|NCT02895061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630068|NCT02895061|Vitamins|vitamins|mesh-ancestor
92630069|NCT02895061|Micronutrients|micronutrients|mesh-ancestor
92630070|NCT00170183|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92630071|NCT00170183|Natriuretic Agents|natriuretic agents|mesh-ancestor
92630072|NCT00170183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630073|NCT00170222|Doxycycline|doxycycline|mesh-list
92630074|NCT00170222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92630075|NCT00170222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630076|NCT00170222|Antimalarials|antimalarials|mesh-ancestor
92630077|NCT00170222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92630078|NCT00170222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92630079|NCT02894983|Calpastatin|calpastatin|mesh-list
92630080|NCT02894983|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92630081|NCT02894983|Protease Inhibitors|protease inhibitors|mesh-ancestor
92630082|NCT02894983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630083|NCT02894983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630084|NCT02895022|Lidocaine|lidocaine|mesh-list
92630085|NCT02895022|Anesthetics, Local|anesthetics, local|mesh-ancestor
92630086|NCT02895022|Anesthetics|anesthetics|mesh-ancestor
92630087|NCT02895022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630088|NCT02895022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630089|NCT02895022|Sensory System Agents|sensory system agents|mesh-ancestor
92630090|NCT02895022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630091|NCT02895022|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92630092|NCT02895022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92630093|NCT02895022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92630094|NCT02895022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630095|NCT02895022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630096|NCT00409851|Amlodipine|amlodipine|mesh-list
92630097|NCT00409851|Valsartan|valsartan|mesh-list
92561983|NCT00150865|Anesthetics|anesthetics|mesh-ancestor
92561984|NCT00150865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92561985|NCT00150865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561986|NCT00150865|Sensory System Agents|sensory system agents|mesh-ancestor
92561987|NCT00150865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92561988|NCT00049556|Gefitinib|gefitinib|mesh-list
92561989|NCT00049556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92561990|NCT00049556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630098|NCT00409851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630099|NCT00409851|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92630100|NCT00409851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630101|NCT00409851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630102|NCT00409851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630103|NCT00409851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630104|NCT00409851|Vasodilator Agents|vasodilator agents|mesh-ancestor
92630105|NCT00409851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630106|NCT00409851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630107|NCT05424445|Misoprostol|misoprostol|mesh-list
92630108|NCT05424445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92630109|NCT05424445|Abortifacient Agents|abortifacient agents|mesh-ancestor
92630110|NCT05424445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92630111|NCT05424445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630112|NCT05424445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92630113|NCT05424445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630114|NCT05424445|Oxytocics|oxytocics|mesh-ancestor
92630115|NCT00409890|Scopolamine|scopolamine|mesh-list
92630116|NCT00409890|Bromides|bromides|mesh-list
92630117|NCT00409890|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92630118|NCT00409890|Anticonvulsants|anticonvulsants|mesh-ancestor
92630119|NCT00409890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92630120|NCT00409890|Antiemetics|antiemetics|mesh-ancestor
92630121|NCT00409890|Autonomic Agents|autonomic agents|mesh-ancestor
92362273|NCT05766085|Hormones|hormones|mesh-ancestor
92630122|NCT00409890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630123|NCT00409890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630124|NCT00409890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630125|NCT00409890|Mydriatics|mydriatics|mesh-ancestor
92630126|NCT00409890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92630127|NCT00409890|Cholinergic Agents|cholinergic agents|mesh-ancestor
92630128|NCT00409890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630129|NCT00409890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630130|NCT00409890|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92630131|NCT00409890|Parasympatholytics|parasympatholytics|mesh-ancestor
92630140|NCT00179244|Bupropion|bupropion|mesh-list
92630141|NCT00179244|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92630142|NCT00179244|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630143|NCT00179244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630144|NCT00179244|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92630145|NCT00179244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630146|NCT00179244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630147|NCT00179244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630148|NCT00179244|Dopamine Agents|dopamine agents|mesh-ancestor
92630149|NCT00179244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630150|NCT00179244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630151|NCT00179244|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92630152|NCT00179244|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92630153|NCT00179244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630154|NCT05423197|Panitumumab|panitumumab|mesh-list
92630155|NCT05423197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92630156|NCT05423197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630157|NCT00196872|Cyclophosphamide|cyclophosphamide|mesh-list
92630158|NCT00196872|Epirubicin|epirubicin|mesh-list
92630159|NCT00196872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630160|NCT00196872|Immunologic Factors|immunologic factors|mesh-ancestor
92630161|NCT00196872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630162|NCT00196872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92561991|NCT00049556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92561992|NCT00049556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92561994|NCT00150982|Dermatologic Agents|dermatologic agents|mesh-ancestor
92561995|NCT00150982|Immunologic Factors|immunologic factors|mesh-ancestor
92561996|NCT00150982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92561997|NCT00049634|Cyclosporine|cyclosporine|mesh-list
92561998|NCT00049634|Cyclophosphamide|cyclophosphamide|mesh-list
92630163|NCT00196872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92630164|NCT00196872|Alkylating Agents|alkylating agents|mesh-ancestor
92630165|NCT00196872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630166|NCT00196872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630167|NCT00196872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92630168|NCT00196872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92630169|NCT00196872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92630170|NCT00196872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92630171|NCT00196872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630172|NCT00170456|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92630173|NCT00170456|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92630174|NCT00170456|Immunologic Factors|immunologic factors|mesh-ancestor
92630175|NCT00170456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630176|NCT00170456|Antacids|antacids|mesh-ancestor
92630177|NCT00170456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630178|NCT00170456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630179|NCT00179283|Sertraline|sertraline|mesh-list
92630180|NCT00179283|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92630181|NCT00179283|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630182|NCT00179283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630183|NCT00179283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92630184|NCT00179283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630185|NCT00179283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630186|NCT00179283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630187|NCT00179283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630188|NCT00179283|Serotonin Agents|serotonin agents|mesh-ancestor
92630189|NCT00179283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630190|NCT00179283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92630191|NCT00179283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92630192|NCT05420350|Lamotrigine|lamotrigine|mesh-list
92630193|NCT05420350|Bupropion|bupropion|mesh-list
92630194|NCT05420350|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92630195|NCT05420350|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630199|NCT05420350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630200|NCT05420350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630201|NCT05420350|Dopamine Agents|dopamine agents|mesh-ancestor
92630202|NCT05420350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630203|NCT05420350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630204|NCT05420350|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92630205|NCT05420350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92630206|NCT05420350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630207|NCT05420350|Anticonvulsants|anticonvulsants|mesh-ancestor
92630208|NCT05420350|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92630209|NCT05420350|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630210|NCT05420350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92630211|NCT05420350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630212|NCT05420350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630213|NCT05420350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92630214|NCT03097939|Nivolumab|nivolumab|mesh-list
92630215|NCT03097939|Ipilimumab|ipilimumab|mesh-list
92630216|NCT03097939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92630217|NCT03097939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630218|NCT03097939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92630219|NCT03097939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630220|NCT03014635|Botulinum Toxins|botulinum toxins|mesh-list
92630221|NCT03014635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92630222|NCT03014635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92561999|NCT00049634|Busulfan|busulfan|mesh-list
92562000|NCT00049634|Methotrexate|methotrexate|mesh-list
92562001|NCT00049634|Cyclosporins|cyclosporins|mesh-list
92630223|NCT03014635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92630224|NCT03014635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630225|NCT03014635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630226|NCT03014635|Cholinergic Agents|cholinergic agents|mesh-ancestor
92630227|NCT03014635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630228|NCT03014635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630229|NCT03014635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92630230|NCT03014635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630231|NCT00170573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92630232|NCT00170573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92630233|NCT00170573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630234|NCT02885272|Deoxyglucose|deoxyglucose|mesh-list
92630235|NCT02885272|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92630236|NCT02885272|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92630237|NCT02885272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630238|NCT02885272|Antimetabolites|antimetabolites|mesh-ancestor
92630240|NCT02885272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630241|NCT02793583|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92630242|NCT02793583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92630243|NCT02793583|Alkylating Agents|alkylating agents|mesh-ancestor
92630244|NCT02793583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630245|NCT02793583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630246|NCT00170612|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92630247|NCT00170612|Immunologic Factors|immunologic factors|mesh-ancestor
92630248|NCT00170612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630249|NCT00170690|Treosulfan|treosulfan|mesh-list
92630250|NCT00170690|Busulfan|busulfan|mesh-list
92630251|NCT00170690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92630252|NCT00170690|Alkylating Agents|alkylating agents|mesh-ancestor
92630253|NCT00170690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630254|NCT00170690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630255|NCT00170690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630256|NCT00170690|Immunologic Factors|immunologic factors|mesh-ancestor
92630257|NCT00170690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630258|NCT00170690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92630259|NCT00196989|Pioglitazone|pioglitazone|mesh-list
92630260|NCT00196989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92362277|NCT05765825|Carboplatin|carboplatin|mesh-list
92630261|NCT00196989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630262|NCT00170729|Prednisolone|prednisolone|mesh-list
92630263|NCT00170729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92630264|NCT00170729|Methylprednisolone|methylprednisolone|mesh-list
92630265|NCT00170729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92630269|NCT00170729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630271|NCT00170729|Hormones|hormones|mesh-ancestor
92630272|NCT00170729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630273|NCT00170729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630274|NCT00170729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92630275|NCT00170729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630276|NCT00170729|Antiemetics|antiemetics|mesh-ancestor
92630277|NCT00170729|Autonomic Agents|autonomic agents|mesh-ancestor
92630278|NCT00170729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630279|NCT00170729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630280|NCT00170729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92630281|NCT00170729|Protective Agents|protective agents|mesh-ancestor
92630282|NCT00170768|Oxybutynin|oxybutynin|mesh-list
92630283|NCT00170768|Darifenacin|darifenacin|mesh-list
92630284|NCT00170768|Parasympatholytics|parasympatholytics|mesh-ancestor
92630285|NCT00170768|Autonomic Agents|autonomic agents|mesh-ancestor
92630286|NCT00170768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630287|NCT00170768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630288|NCT00170768|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92630289|NCT00170768|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92630290|NCT00170768|Cholinergic Agents|cholinergic agents|mesh-ancestor
92630291|NCT00170768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630292|NCT00170768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630293|NCT00170768|Urological Agents|urological agents|mesh-ancestor
92630294|NCT02655562|Montelukast|montelukast|mesh-list
92630295|NCT02655562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92630296|NCT02655562|Respiratory System Agents|respiratory system agents|mesh-ancestor
92562002|NCT00049634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562003|NCT00049634|Immunologic Factors|immunologic factors|mesh-ancestor
92562004|NCT00049634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969551|NCT03199261|Hormones|hormones|mesh-ancestor
92630297|NCT02655562|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92630298|NCT02655562|Hormone Antagonists|hormone antagonists|mesh-ancestor
92630299|NCT02655562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630300|NCT02655562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630301|NCT02655562|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92630302|NCT02655562|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92630303|NCT02655562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630304|NCT00170885|Everolimus|everolimus|mesh-list
92630305|NCT00170885|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92630306|NCT00170885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630307|NCT00170885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630308|NCT00170885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630309|NCT00170885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630310|NCT00170885|Immunologic Factors|immunologic factors|mesh-ancestor
92630311|NCT00170885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630312|NCT00170885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630314|NCT02607748|Fluorides|fluorides|mesh-list
92630315|NCT02607748|Sodium Fluoride|sodium fluoride|mesh-list
92630316|NCT02607748|Cariostatic Agents|cariostatic agents|mesh-ancestor
92630317|NCT02607748|Protective Agents|protective agents|mesh-ancestor
92630318|NCT02607748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630319|NCT02607748|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92630320|NCT02607748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630321|NCT02502253|Resveratrol|resveratrol|mesh-list
92630322|NCT02502253|Antioxidants|antioxidants|mesh-ancestor
92630323|NCT02502253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630324|NCT02502253|Protective Agents|protective agents|mesh-ancestor
92630325|NCT02502253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630326|NCT02502253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630327|NCT02502253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92630328|NCT00170924|Valsartan|valsartan|mesh-list
92630329|NCT00170924|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630330|NCT00170924|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630331|NCT00170924|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630332|NCT00170924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630333|NCT01356940|4-Aminopyridine|4-aminopyridine|mesh-list
92630334|NCT01356940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92630335|NCT01356940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037316|NCT02435069|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92630338|NCT00170963|Valsartan|valsartan|mesh-list
92630339|NCT00170963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630340|NCT00170963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92630341|NCT00170963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630342|NCT00170963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630343|NCT00170963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630344|NCT00170963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630345|NCT00170963|Vasodilator Agents|vasodilator agents|mesh-ancestor
92630346|NCT00170963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630347|NCT00170963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630348|NCT02492776|Omeprazole|omeprazole|mesh-list
92630349|NCT02492776|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92630350|NCT02492776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630351|NCT02492776|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92630352|NCT02492776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630353|NCT02492776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630354|NCT00171002|Amlodipine|amlodipine|mesh-list
92630355|NCT00171002|Valsartan|valsartan|mesh-list
92630356|NCT00171002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630357|NCT00171002|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92630358|NCT00171002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630359|NCT00171002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630360|NCT00171002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630361|NCT00171002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630362|NCT00171002|Vasodilator Agents|vasodilator agents|mesh-ancestor
92562005|NCT00049634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562006|NCT00049634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562007|NCT00049634|Alkylating Agents|alkylating agents|mesh-ancestor
92562008|NCT00049634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630363|NCT00171002|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630364|NCT00171002|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630365|NCT05400031|Propolis|propolis|mesh-list
92630366|NCT05400031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630367|NCT00171041|Valsartan|valsartan|mesh-list
92630368|NCT00171041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630369|NCT00171041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630370|NCT00171041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630371|NCT00171041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630372|NCT05393674|Nivolumab|nivolumab|mesh-list
92630373|NCT05393674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92630374|NCT05393674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630375|NCT05393674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92630376|NCT05393674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630377|NCT05392699|Interleukin-12|interleukin-12|mesh-list
92630378|NCT05392699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92630379|NCT05392699|Immunologic Factors|immunologic factors|mesh-ancestor
92630380|NCT05392699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630381|NCT05392699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92630382|NCT05392699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92630383|NCT05392699|Growth Substances|growth substances|mesh-ancestor
92630384|NCT05392699|Growth Inhibitors|growth inhibitors|mesh-ancestor
92630385|NCT05392699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630386|NCT00171080|Valsartan|valsartan|mesh-list
92630387|NCT00171080|Irbesartan|irbesartan|mesh-list
92630388|NCT00171080|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630389|NCT00171080|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630390|NCT00171080|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630391|NCT00171080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630392|NCT02229877|Omeprazole|omeprazole|mesh-list
92630393|NCT02229877|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92630394|NCT02229877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630395|NCT02229877|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92630396|NCT02229877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630397|NCT02229877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630398|NCT00171119|Valsartan|valsartan|mesh-list
92630399|NCT00171119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630400|NCT00171119|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630401|NCT00171119|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630402|NCT00171119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630403|NCT02102113|Dronabinol|dronabinol|mesh-list
92630404|NCT02102113|Hallucinogens|hallucinogens|mesh-ancestor
92037390|NCT01817530|Estrogens|estrogens|mesh-ancestor
92630407|NCT02102113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92630408|NCT02102113|Analgesics|analgesics|mesh-ancestor
92630409|NCT02102113|Sensory System Agents|sensory system agents|mesh-ancestor
92630410|NCT02102113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630411|NCT02102113|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92630412|NCT02102113|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92630413|NCT02102113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630414|NCT02102113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630415|NCT02102113|Hormones|hormones|mesh-ancestor
92630416|NCT02102113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630417|NCT05379790|Irinotecan|irinotecan|mesh-list
92630418|NCT05379790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92630419|NCT05379790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92630420|NCT05379790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630421|NCT05379790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630422|NCT05379790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630423|NCT05349448|Triamcinolone|triamcinolone|mesh-list
92630424|NCT05349448|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92630425|NCT05349448|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92630426|NCT05349448|Dexmedetomidine|dexmedetomidine|mesh-list
92630427|NCT05349448|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92562009|NCT00049634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562010|NCT00049634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92562011|NCT00049634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92562012|NCT00049634|Abortifacient Agents|abortifacient agents|mesh-ancestor
92562013|NCT00049634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562014|NCT00049634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562015|NCT00049634|Antimetabolites|antimetabolites|mesh-ancestor
92562016|NCT00049634|Dermatologic Agents|dermatologic agents|mesh-ancestor
92562017|NCT00049634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562018|NCT00049634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92562019|NCT00049634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92562020|NCT00049634|Antifungal Agents|antifungal agents|mesh-ancestor
92562021|NCT00049634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562022|NCT00049634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92562023|NCT00151060|Paclitaxel|paclitaxel|mesh-list
92562024|NCT00151060|Etoposide|etoposide|mesh-list
92562025|NCT00151060|Estramustine|estramustine|mesh-list
92562026|NCT00151060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92562027|NCT00151060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562028|NCT00151060|Tubulin Modulators|tubulin modulators|mesh-ancestor
92562029|NCT00151060|Antimitotic Agents|antimitotic agents|mesh-ancestor
92562030|NCT00151060|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562031|NCT00151060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562032|NCT00151060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92562033|NCT00151060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562034|NCT00151060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562035|NCT00151060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562036|NCT00151060|Alkylating Agents|alkylating agents|mesh-ancestor
92562037|NCT00151060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92562038|NCT00151138|Atenolol|atenolol|mesh-list
92562039|NCT00151138|Lisinopril|lisinopril|mesh-list
92562040|NCT00151138|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92562041|NCT00151138|Protease Inhibitors|protease inhibitors|mesh-ancestor
92562050|NCT00151138|Autonomic Agents|autonomic agents|mesh-ancestor
92562051|NCT00151138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562052|NCT00151138|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92562054|NCT00151138|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92562055|NCT00151138|Adrenergic Agents|adrenergic agents|mesh-ancestor
92562056|NCT00151138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562058|NCT00082485|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92562059|NCT00082485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562060|NCT00082485|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92562061|NCT00082485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562062|NCT00082485|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92562063|NCT00082485|GABA Agonists|gaba agonists|mesh-ancestor
92630428|NCT05349448|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92630429|NCT05349448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630430|NCT05349448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630431|NCT05349448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92630432|NCT05349448|Analgesics|analgesics|mesh-ancestor
92630433|NCT05349448|Sensory System Agents|sensory system agents|mesh-ancestor
92630434|NCT05349448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630435|NCT05349448|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92630436|NCT05349448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92630437|NCT05349448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92630438|NCT05349448|Adrenergic Agents|adrenergic agents|mesh-ancestor
92630439|NCT05349448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630440|NCT05349448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630441|NCT05349448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630442|NCT05349448|Glucocorticoids|glucocorticoids|mesh-ancestor
92630443|NCT05349448|Hormones|hormones|mesh-ancestor
92630444|NCT05349448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630445|NCT05349448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630446|NCT05349448|Immunologic Factors|immunologic factors|mesh-ancestor
92630447|NCT05349448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630448|NCT00171353|Valsartan|valsartan|mesh-list
92630449|NCT00171353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630450|NCT00171353|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630451|NCT00171353|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630452|NCT00171353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630453|NCT01656343|Abatacept|abatacept|mesh-list
92630454|NCT01656343|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92630455|NCT01656343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92355635|NCT03826602|Metformin|metformin|mesh-list
92630456|NCT01656343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630457|NCT01656343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92630458|NCT01656343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630459|NCT01656343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630460|NCT01656343|Immunologic Factors|immunologic factors|mesh-ancestor
92630461|NCT01656343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630462|NCT01656343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630463|NCT01656343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630464|NCT01539811|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92630465|NCT01539811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92630466|NCT01539811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630467|NCT01539811|Antitubercular Agents|antitubercular agents|mesh-ancestor
92630468|NCT00171392|Mycophenolic Acid|mycophenolic acid|mesh-list
92630469|NCT00171392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92630470|NCT00171392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630471|NCT00171392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92630472|NCT00171392|Antitubercular Agents|antitubercular agents|mesh-ancestor
92630473|NCT00171392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752324|NCT05940701|Listerine|listerine|mesh-list
92562065|NCT00082485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562066|NCT00082485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630474|NCT00171392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630477|NCT00171431|Tegaserod|tegaserod|mesh-list
92630478|NCT00171431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92630479|NCT00171431|Serotonin Agents|serotonin agents|mesh-ancestor
92630480|NCT00171431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630481|NCT00171431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630482|NCT00171431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630483|NCT01330030|Selegiline|selegiline|mesh-list
92630484|NCT01330030|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630485|NCT01330030|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630486|NCT01330030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92630487|NCT01330030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92630488|NCT01330030|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92630489|NCT01330030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630490|NCT01330030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630491|NCT01330030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92630492|NCT01330030|Protective Agents|protective agents|mesh-ancestor
92630493|NCT01330030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630494|NCT00171470|Tegaserod|tegaserod|mesh-list
92630495|NCT00171470|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92630496|NCT00171470|Serotonin Agents|serotonin agents|mesh-ancestor
92630497|NCT00171470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630498|NCT00171470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630499|NCT00171470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630500|NCT00171509|Cyclosporine|cyclosporine|mesh-list
92630501|NCT00171509|Cyclosporins|cyclosporins|mesh-list
92630502|NCT00171509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630503|NCT00171509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630504|NCT00171509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630505|NCT00171509|Immunologic Factors|immunologic factors|mesh-ancestor
92630506|NCT00171509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630507|NCT00171509|Antifungal Agents|antifungal agents|mesh-ancestor
92630508|NCT00171509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630509|NCT00171509|Dermatologic Agents|dermatologic agents|mesh-ancestor
92630510|NCT00171509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630511|NCT00171509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92630512|NCT00179712|Topotecan|topotecan|mesh-list
92630513|NCT00179712|Lenalidomide|lenalidomide|mesh-list
92630514|NCT00179712|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92630515|NCT00179712|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92630516|NCT00179712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630517|NCT00179712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630518|NCT00179712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630519|NCT00179712|Immunologic Factors|immunologic factors|mesh-ancestor
92630520|NCT00179712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630521|NCT00179712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92630522|NCT00179712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92630523|NCT00179712|Growth Substances|growth substances|mesh-ancestor
92630524|NCT00179712|Growth Inhibitors|growth inhibitors|mesh-ancestor
92630525|NCT00611572|Flumazenil|flumazenil|mesh-list
92630526|NCT00611572|Antidotes|antidotes|mesh-ancestor
92630527|NCT00611572|Protective Agents|protective agents|mesh-ancestor
92630528|NCT00611572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630529|NCT00611572|GABA Modulators|gaba modulators|mesh-ancestor
92630530|NCT00611572|GABA Agents|gaba agents|mesh-ancestor
92630531|NCT00611572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630532|NCT00611572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630533|NCT00197340|Ropivacaine|ropivacaine|mesh-list
92630534|NCT00197340|Anesthetics, Local|anesthetics, local|mesh-ancestor
92630535|NCT00197340|Anesthetics|anesthetics|mesh-ancestor
92630536|NCT00197340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630537|NCT00197340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630538|NCT00197340|Sensory System Agents|sensory system agents|mesh-ancestor
92630539|NCT00197340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630540|NCT00171587|Vatalanib|vatalanib|mesh-list
92630541|NCT00171587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630542|NCT00171587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630543|NCT00171587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630544|NCT05265052|Oxycodone|oxycodone|mesh-list
92562067|NCT00151255|Cytarabine|cytarabine|mesh-list
92562068|NCT00151255|Mitoxantrone|mitoxantrone|mesh-list
92562069|NCT00151255|Idarubicin|idarubicin|mesh-list
92562070|NCT00151255|Tretinoin|tretinoin|mesh-list
91969610|NCT03071289|Cisplatin|cisplatin|mesh-list
92630545|NCT05265052|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92630546|NCT05265052|Narcotics|narcotics|mesh-ancestor
92630547|NCT05265052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630548|NCT05265052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630550|NCT05265052|Sensory System Agents|sensory system agents|mesh-ancestor
92630551|NCT05265052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630552|NCT00171626|Diclofenac|diclofenac|mesh-list
92630553|NCT00171626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92630554|NCT00171626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92630555|NCT00171626|Analgesics|analgesics|mesh-ancestor
92630556|NCT00171626|Sensory System Agents|sensory system agents|mesh-ancestor
92630557|NCT00171626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630558|NCT00171626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630559|NCT00171626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630560|NCT00171626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630561|NCT00171626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92630562|NCT00171626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630563|NCT00171626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630564|NCT00171665|Diclofenac|diclofenac|mesh-list
92630565|NCT00171665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92630566|NCT00171665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92630567|NCT00171665|Analgesics|analgesics|mesh-ancestor
91930730|NCT05647291|Glucocorticoids|glucocorticoids|mesh-ancestor
92630568|NCT00171665|Sensory System Agents|sensory system agents|mesh-ancestor
92630569|NCT00171665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630570|NCT00171665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630571|NCT00171665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630572|NCT00171665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630573|NCT00171665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92630574|NCT00171665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630575|NCT00171665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630576|NCT00179751|Gemcitabine|gemcitabine|mesh-list
92630577|NCT00179751|Lenalidomide|lenalidomide|mesh-list
92630578|NCT00179751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92630579|NCT00179751|Antimetabolites|antimetabolites|mesh-ancestor
92630580|NCT00179751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630581|NCT00179751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630582|NCT00179751|Immunologic Factors|immunologic factors|mesh-ancestor
92630583|NCT00179751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630584|NCT00179751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92630585|NCT00179751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92630586|NCT00179751|Growth Substances|growth substances|mesh-ancestor
92630587|NCT00179751|Growth Inhibitors|growth inhibitors|mesh-ancestor
92630588|NCT05223478|Phentolamine|phentolamine|mesh-list
92630589|NCT05223478|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92630590|NCT05223478|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92630591|NCT05223478|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92630592|NCT05223478|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92630593|NCT05223478|Adrenergic Agents|adrenergic agents|mesh-ancestor
92630594|NCT05223478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630595|NCT05223478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630596|NCT05223478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630597|NCT05223478|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630598|NCT00171743|Cyclosporine|cyclosporine|mesh-list
92630599|NCT00171743|Cyclosporins|cyclosporins|mesh-list
92630600|NCT00171743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630601|NCT00171743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630602|NCT00171743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630603|NCT00171743|Immunologic Factors|immunologic factors|mesh-ancestor
92630604|NCT00171743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630605|NCT00171743|Antifungal Agents|antifungal agents|mesh-ancestor
92630606|NCT00171743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630607|NCT00171743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92630608|NCT00171743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630609|NCT00171743|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92630610|NCT05209360|Carbon Fiber|carbon fiber|mesh-list
92630611|NCT05209360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92630612|NCT05209360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562071|NCT00151255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562072|NCT00151255|Antimetabolites|antimetabolites|mesh-ancestor
92562073|NCT00151255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630614|NCT00171782|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92630615|NCT00171782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630616|NCT00171782|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630617|NCT00171782|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630618|NCT00171782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630619|NCT00171782|Diuretics|diuretics|mesh-ancestor
92630620|NCT00171782|Natriuretic Agents|natriuretic agents|mesh-ancestor
92630621|NCT00171782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630637|NCT00197418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630639|NCT00197418|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92630640|NCT00197418|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92630641|NCT00197418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630642|NCT00197418|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92630643|NCT00171821|Deferasirox|deferasirox|mesh-list
92630644|NCT00171821|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92630645|NCT00171821|Chelating Agents|chelating agents|mesh-ancestor
92630646|NCT00171821|Sequestering Agents|sequestering agents|mesh-ancestor
92630647|NCT00171821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630648|NCT05054023|Piroxicam|piroxicam|mesh-list
92630649|NCT05054023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92630650|NCT05054023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92630651|NCT05054023|Analgesics|analgesics|mesh-ancestor
92630652|NCT05054023|Sensory System Agents|sensory system agents|mesh-ancestor
92630653|NCT05054023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630654|NCT05054023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630655|NCT05054023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630656|NCT05054023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630657|NCT05054023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92630658|NCT05054023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630659|NCT05054023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630660|NCT00171860|Imatinib Mesylate|imatinib mesylate|mesh-list
92630661|NCT00171860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630662|NCT00171860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630663|NCT00171860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630664|NCT00171860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630665|NCT00553930|Interferons|interferons|mesh-list
92630666|NCT00553930|Ribavirin|ribavirin|mesh-list
92630667|NCT00553930|Interferon-alpha|interferon-alpha|mesh-list
92630668|NCT00553930|Interferon alpha-2|interferon alpha-2|mesh-list
92630669|NCT00553930|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92630670|NCT00553930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630671|NCT00553930|Antiviral Agents|antiviral agents|mesh-ancestor
92630672|NCT00553930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630673|NCT00553930|Antimetabolites|antimetabolites|mesh-ancestor
92630674|NCT00553930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630675|NCT00553930|Immunologic Factors|immunologic factors|mesh-ancestor
92630676|NCT00553930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630677|NCT00171899|Imatinib Mesylate|imatinib mesylate|mesh-list
92630678|NCT00171899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630679|NCT00171899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630680|NCT00171899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037677|NCT01797094|Cholinergic Agents|cholinergic agents|mesh-ancestor
92630692|NCT02240407|Acetaminophen|acetaminophen|mesh-list
92630693|NCT02240407|Diphenhydramine|diphenhydramine|mesh-list
92630694|NCT02240407|Promethazine|promethazine|mesh-list
92630695|NCT02240407|Sirolimus|sirolimus|mesh-list
92630696|NCT02240407|Rituximab|rituximab|mesh-list
92630697|NCT02240407|Lidocaine|lidocaine|mesh-list
92630698|NCT02240407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92630699|NCT02240407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630700|NCT02240407|Immunologic Factors|immunologic factors|mesh-ancestor
92630701|NCT02240407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630702|NCT02240407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92630703|NCT02240407|Anesthetics, Local|anesthetics, local|mesh-ancestor
92630704|NCT02240407|Anesthetics|anesthetics|mesh-ancestor
92630705|NCT02240407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630706|NCT02240407|Sensory System Agents|sensory system agents|mesh-ancestor
92630707|NCT02240407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562074|NCT00151255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562075|NCT00151255|Antiviral Agents|antiviral agents|mesh-ancestor
92562076|NCT00151255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562077|NCT00151255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630708|NCT02240407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92630709|NCT02240407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92630710|NCT02240407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92630711|NCT02240407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630712|NCT02240407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630713|NCT02240407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92630714|NCT02240407|Analgesics|analgesics|mesh-ancestor
92630715|NCT02240407|Antipyretics|antipyretics|mesh-ancestor
92630716|NCT02240407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92630717|NCT02240407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630718|NCT02240407|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92630719|NCT02240407|Antifungal Agents|antifungal agents|mesh-ancestor
92630720|NCT02240407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630721|NCT02240407|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92630722|NCT02240407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92630723|NCT02240407|Antiemetics|antiemetics|mesh-ancestor
92630724|NCT02240407|Autonomic Agents|autonomic agents|mesh-ancestor
92630725|NCT02240407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630726|NCT02240407|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92630727|NCT02240407|Histamine Antagonists|histamine antagonists|mesh-ancestor
92630728|NCT02240407|Histamine Agents|histamine agents|mesh-ancestor
92630729|NCT02240407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630730|NCT02240407|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92630731|NCT02240407|Antipruritics|antipruritics|mesh-ancestor
92630732|NCT02240407|Dermatologic Agents|dermatologic agents|mesh-ancestor
92630733|NCT00172016|Zoledronic Acid|zoledronic acid|mesh-list
92630734|NCT00172016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92630735|NCT00172016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630736|NCT04958122|Penicillins|penicillins|mesh-list
92630737|NCT04958122|Cefixime|cefixime|mesh-list
92630738|NCT04958122|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92630739|NCT04958122|Penicillin G|penicillin g|mesh-list
92630740|NCT04958122|Penicillin G Procaine|penicillin g procaine|mesh-list
92630741|NCT04958122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92630742|NCT04958122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630743|NCT00197613|Lamivudine|lamivudine|mesh-list
92630744|NCT00197613|Zidovudine|zidovudine|mesh-list
92630745|NCT00197613|Efavirenz|efavirenz|mesh-list
92630749|NCT00197613|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92630750|NCT00197613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92630751|NCT00197613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630752|NCT00197613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630753|NCT00197613|Antiviral Agents|antiviral agents|mesh-ancestor
92630754|NCT00197613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630755|NCT00197613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92630756|NCT00197613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92630757|NCT00197613|Antimetabolites|antimetabolites|mesh-ancestor
92630758|NCT00197613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92630759|NCT00197613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92630760|NCT00197613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92630761|NCT00197613|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92630762|NCT00197613|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92630763|NCT00197613|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92630765|NCT00180024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92630766|NCT00180024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92630767|NCT00180024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92630768|NCT00180024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630769|NCT00172055|Zoledronic Acid|zoledronic acid|mesh-list
92630770|NCT00172055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92630771|NCT00172055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630772|NCT04934449|Salicylic Acid|salicylic acid|mesh-list
92630773|NCT04934449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630774|NCT04934449|Antifungal Agents|antifungal agents|mesh-ancestor
92630775|NCT04934449|Keratolytic Agents|keratolytic agents|mesh-ancestor
92630776|NCT04934449|Dermatologic Agents|dermatologic agents|mesh-ancestor
92630777|NCT03455179|Methamphetamine|methamphetamine|mesh-list
92630778|NCT03455179|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92562078|NCT00151255|Immunologic Factors|immunologic factors|mesh-ancestor
92562079|NCT00151255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562080|NCT00151255|Analgesics|analgesics|mesh-ancestor
92562081|NCT00151255|Sensory System Agents|sensory system agents|mesh-ancestor
92562082|NCT00151255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630779|NCT03455179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630780|NCT03455179|Sympathomimetics|sympathomimetics|mesh-ancestor
92630781|NCT03455179|Autonomic Agents|autonomic agents|mesh-ancestor
92630782|NCT03455179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630783|NCT03455179|Dopamine Agents|dopamine agents|mesh-ancestor
92630784|NCT03455179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630785|NCT03455179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630786|NCT03455179|Adrenergic Agents|adrenergic agents|mesh-ancestor
92630787|NCT03455179|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92630788|NCT03455179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630789|NCT03455179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630790|NCT03455179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92630791|NCT00202293|Olanzapine|olanzapine|mesh-list
92630792|NCT00202293|Chlorpromazine|chlorpromazine|mesh-list
92630793|NCT00202293|Antiemetics|antiemetics|mesh-ancestor
92630794|NCT00202293|Autonomic Agents|autonomic agents|mesh-ancestor
92630795|NCT00202293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630796|NCT00202293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630797|NCT00202293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92630798|NCT00202293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92630799|NCT00202293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630800|NCT00202293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630801|NCT00202293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630802|NCT00202293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92630803|NCT00202293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630804|NCT00202293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630805|NCT00202293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630806|NCT00202293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630807|NCT00202293|Serotonin Agents|serotonin agents|mesh-ancestor
92630808|NCT00202293|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92630809|NCT00202293|Dopamine Agents|dopamine agents|mesh-ancestor
92630810|NCT00197730|Folic Acid|folic acid|mesh-list
92630811|NCT00197730|Vitamin B Complex|vitamin b complex|mesh-list
92630812|NCT00197730|Vitamins|vitamins|mesh-ancestor
92630813|NCT00197730|Micronutrients|micronutrients|mesh-ancestor
92630814|NCT00197730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630815|NCT00197730|Hematinics|hematinics|mesh-ancestor
92630816|NCT00172172|Calcium|calcium|mesh-list
92630817|NCT00172172|Parathyroid Hormone|parathyroid hormone|mesh-list
92630818|NCT00172172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630821|NCT02908711|Anesthetics, Local|anesthetics, local|mesh-ancestor
92630822|NCT02908711|Anesthetics|anesthetics|mesh-ancestor
92630823|NCT02908711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630824|NCT02908711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630825|NCT02908711|Sensory System Agents|sensory system agents|mesh-ancestor
92630826|NCT02908711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630827|NCT04681846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92630828|NCT04681846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630830|NCT02908438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630831|NCT02908438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630832|NCT00172367|Lycopene|lycopene|mesh-list
92630833|NCT00172367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630834|NCT00172367|Antioxidants|antioxidants|mesh-ancestor
92630835|NCT00172367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630836|NCT00172367|Protective Agents|protective agents|mesh-ancestor
92630837|NCT00172367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630838|NCT00172367|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92630839|NCT00172367|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92630840|NCT00172367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630841|NCT04632316|Cyclophosphamide|cyclophosphamide|mesh-list
92630842|NCT04632316|Fludarabine|fludarabine|mesh-list
92630843|NCT04632316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92630844|NCT04632316|Immunologic Factors|immunologic factors|mesh-ancestor
92630845|NCT04632316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630846|NCT04632316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562083|NCT00151255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92562084|NCT00151255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562085|NCT00151255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562086|NCT00151255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92630847|NCT04632316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92630848|NCT04632316|Alkylating Agents|alkylating agents|mesh-ancestor
92630849|NCT04632316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630850|NCT04632316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630851|NCT04632316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92630852|NCT00197886|Norepinephrine|norepinephrine|mesh-list
92630853|NCT00197886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92630854|NCT00197886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92630855|NCT00197886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92630856|NCT00197886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630857|NCT00197886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630858|NCT00197886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630859|NCT00197886|Sympathomimetics|sympathomimetics|mesh-ancestor
92630860|NCT00197886|Autonomic Agents|autonomic agents|mesh-ancestor
92630861|NCT00197886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630862|NCT00197886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92630863|NCT02908165|Sorafenib|sorafenib|mesh-list
92630864|NCT02908165|Chlorotrianisene|chlorotrianisene|mesh-list
92630865|NCT02908165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630866|NCT02908165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630867|NCT02908165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630868|NCT02908165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630869|NCT02908165|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92630870|NCT02908165|Estrogens|estrogens|mesh-ancestor
92630871|NCT02908165|Hormones|hormones|mesh-ancestor
92630872|NCT02908165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630873|NCT02908165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630874|NCT02908165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92630875|NCT04534270|Dapagliflozin|dapagliflozin|mesh-list
92630876|NCT04534270|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92630877|NCT04534270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630878|NCT04534270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92630879|NCT04534270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630880|NCT02908282|Povidone|povidone|mesh-list
92630881|NCT02908282|Plasma Substitutes|plasma substitutes|mesh-ancestor
92630882|NCT02908282|Blood Substitutes|blood substitutes|mesh-ancestor
92630883|NCT02908126|Oxytocin|oxytocin|mesh-list
92630884|NCT02908126|Oxytocics|oxytocics|mesh-ancestor
92630885|NCT02908126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92630886|NCT02908126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630887|NCT00202605|Amphetamine|amphetamine|mesh-list
92630888|NCT00202605|Dextroamphetamine|dextroamphetamine|mesh-list
92630889|NCT00202605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92037878|NCT01865812|Cathartics|cathartics|mesh-ancestor
92630893|NCT00202605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92630894|NCT00202605|Dopamine Agents|dopamine agents|mesh-ancestor
92630895|NCT00202605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630896|NCT00202605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630897|NCT00202605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92630898|NCT00202605|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92630899|NCT00202605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630900|NCT00202605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630901|NCT00202605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92630902|NCT00198120|Cycloserine|cycloserine|mesh-list
92630903|NCT00198120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92630904|NCT00198120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630905|NCT00198120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92630906|NCT00198120|Antitubercular Agents|antitubercular agents|mesh-ancestor
92630907|NCT00198120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92630908|NCT00198120|Antimetabolites|antimetabolites|mesh-ancestor
92630909|NCT00198120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630910|NCT00198159|Gefitinib|gefitinib|mesh-list
92630911|NCT00198159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630912|NCT00198159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630913|NCT00198159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562087|NCT00151255|Keratolytic Agents|keratolytic agents|mesh-ancestor
92562088|NCT00151255|Dermatologic Agents|dermatologic agents|mesh-ancestor
92562089|NCT00049751|Adalimumab|adalimumab|mesh-list
92562090|NCT00049751|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92562091|NCT00049751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92630914|NCT00198159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630915|NCT02907307|Clotrimazole|clotrimazole|mesh-list
92630916|NCT02907307|Miconazole|miconazole|mesh-list
92630917|NCT02907307|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92630918|NCT02907307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630919|NCT02907307|Antifungal Agents|antifungal agents|mesh-ancestor
92630920|NCT02907307|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92630921|NCT02907307|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92630922|NCT02907307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630923|NCT02907307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630924|NCT02907307|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92630925|NCT02907307|Hormone Antagonists|hormone antagonists|mesh-ancestor
92630926|NCT02907307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630927|NCT02907307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630928|NCT02907307|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92630929|NCT02907307|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92630930|NCT00553345|Vitamin E|vitamin e|mesh-list
92630931|NCT00553345|Selenium|selenium|mesh-list
92630932|NCT00553345|Vitamins|vitamins|mesh-ancestor
92630933|NCT00553345|Micronutrients|micronutrients|mesh-ancestor
92630934|NCT00553345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630935|NCT00553345|Antioxidants|antioxidants|mesh-ancestor
92630936|NCT00553345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630937|NCT00553345|Protective Agents|protective agents|mesh-ancestor
92630938|NCT00553345|Trace Elements|trace elements|mesh-ancestor
92630939|NCT00407771|Tirofiban|tirofiban|mesh-list
92630940|NCT00407771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92630941|NCT00407771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92630942|NCT00407771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630943|NCT00407771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92630944|NCT00198198|Aripiprazole|aripiprazole|mesh-list
92630945|NCT00198198|Antidepressive Agents|antidepressive agents|mesh-ancestor
92630946|NCT00198198|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630947|NCT00198198|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92630948|NCT00198198|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630949|NCT00198198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630950|NCT00198198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630951|NCT00198198|Dopamine Agonists|dopamine agonists|mesh-ancestor
92630952|NCT00198198|Dopamine Agents|dopamine agents|mesh-ancestor
92630953|NCT00198198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92630954|NCT00198198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630955|NCT00198198|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92630956|NCT00198198|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92630957|NCT00198198|Serotonin Agents|serotonin agents|mesh-ancestor
92630958|NCT00198198|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92037950|NCT01772368|Xhance|xhance|mesh-list
92630964|NCT02206087|Anticoagulants|anticoagulants|mesh-ancestor
92630965|NCT02206087|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92630966|NCT02206087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92630967|NCT02206087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630968|NCT00198237|Docetaxel|docetaxel|mesh-list
92630969|NCT00198237|Capecitabine|capecitabine|mesh-list
92630970|NCT00198237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630971|NCT00198237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92630972|NCT00198237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92630973|NCT00198237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92630974|NCT00198237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630975|NCT00198237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92630976|NCT00198237|Antimetabolites|antimetabolites|mesh-ancestor
92630977|NCT00198354|Paclitaxel|paclitaxel|mesh-list
92630978|NCT00198354|Gemcitabine|gemcitabine|mesh-list
92630979|NCT00198354|Carboplatin|carboplatin|mesh-list
92630980|NCT00198354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92630981|NCT00198354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630982|NCT00198354|Tubulin Modulators|tubulin modulators|mesh-ancestor
92562092|NCT00049751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562093|NCT00151294|Dexetimide|dexetimide|mesh-list
92630983|NCT00198354|Antimitotic Agents|antimitotic agents|mesh-ancestor
92630984|NCT00198354|Mitosis Modulators|mitosis modulators|mesh-ancestor
92630985|NCT00198354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630986|NCT00198354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92630987|NCT00198354|Antimetabolites|antimetabolites|mesh-ancestor
92630988|NCT02158585|Lamotrigine|lamotrigine|mesh-list
92630989|NCT02158585|Anticonvulsants|anticonvulsants|mesh-ancestor
92630990|NCT02158585|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92630991|NCT02158585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630992|NCT02158585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630993|NCT02158585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92630994|NCT02158585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630995|NCT02158585|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92630996|NCT02158585|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92630997|NCT02158585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630998|NCT02158585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630999|NCT02158585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92631000|NCT00202917|Fludarabine|fludarabine|mesh-list
92631001|NCT00202917|Melphalan|melphalan|mesh-list
92631002|NCT00202917|Thiotepa|thiotepa|mesh-list
92631003|NCT00202917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631004|NCT00202917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631005|NCT00202917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631006|NCT00202917|Immunologic Factors|immunologic factors|mesh-ancestor
92631007|NCT00202917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631008|NCT00202917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631009|NCT00202917|Alkylating Agents|alkylating agents|mesh-ancestor
92631010|NCT00202917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631011|NCT00202995|Glatiramer Acetate|glatiramer acetate|mesh-list
92631012|NCT00202995|Interferon beta-1b|interferon beta-1b|mesh-list
92631013|NCT00202995|(T,G)-A-L|(t,g)-a-l|mesh-list
92631014|NCT00202995|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92631015|NCT00202995|Immunologic Factors|immunologic factors|mesh-ancestor
92631016|NCT00202995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631017|NCT00202995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631018|NCT00202995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631019|NCT04677868|Methotrexate|methotrexate|mesh-list
92631020|NCT04677868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92631021|NCT04677868|Abortifacient Agents|abortifacient agents|mesh-ancestor
92631022|NCT04677868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92631023|NCT04677868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631024|NCT04677868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631025|NCT04677868|Antimetabolites|antimetabolites|mesh-ancestor
92631026|NCT04677868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631027|NCT04677868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631028|NCT04677868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92631029|NCT04677868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631031|NCT04677868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631032|NCT04677868|Immunologic Factors|immunologic factors|mesh-ancestor
92631033|NCT04677868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631034|NCT04677868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92631035|NCT00198393|Gemcitabine|gemcitabine|mesh-list
92631036|NCT00198393|Docetaxel|docetaxel|mesh-list
92631037|NCT00198393|Gefitinib|gefitinib|mesh-list
92631038|NCT00198393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631039|NCT00198393|Antimetabolites|antimetabolites|mesh-ancestor
92631040|NCT00198393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631041|NCT00198393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631042|NCT00198393|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631043|NCT00198393|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631044|NCT00198393|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631045|NCT00198393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631046|NCT00198393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631047|NCT02103322|Imatinib Mesylate|imatinib mesylate|mesh-list
92631048|NCT02103322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631049|NCT02103322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631050|NCT02103322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631051|NCT02103322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631052|NCT00554827|Vitamins|vitamins|mesh-list
92631053|NCT00554827|Folic Acid|folic acid|mesh-list
92631054|NCT00554827|Vitamin B 12|vitamin b 12|mesh-list
92631055|NCT00554827|Vitamin B Complex|vitamin b complex|mesh-list
92562094|NCT00151294|Citalopram|citalopram|mesh-list
92562095|NCT00151294|Antidepressive Agents|antidepressive agents|mesh-list
92562096|NCT00151294|Escitalopram|escitalopram|mesh-list
92562097|NCT00151294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92562098|NCT00151294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562099|NCT00151294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91969629|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92631056|NCT00554827|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92631057|NCT00554827|Aminopterin|aminopterin|mesh-list
92631058|NCT00554827|Micronutrients|micronutrients|mesh-ancestor
92631059|NCT00554827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631060|NCT00554827|Hematinics|hematinics|mesh-ancestor
92631061|NCT00554827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631062|NCT00554827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631063|NCT00554827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631064|NCT00554827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631065|NCT00203034|Rasagiline|rasagiline|mesh-list
92631066|NCT00203034|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92631067|NCT00203034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631068|NCT00203034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631069|NCT00203034|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92631070|NCT00203034|Protective Agents|protective agents|mesh-ancestor
92631071|NCT00203034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631072|NCT00203073|Mitoxantrone|mitoxantrone|mesh-list
92631073|NCT00203073|Glatiramer Acetate|glatiramer acetate|mesh-list
92631074|NCT00203073|(T,G)-A-L|(t,g)-a-l|mesh-list
92631075|NCT00203073|Analgesics|analgesics|mesh-ancestor
92631076|NCT00203073|Sensory System Agents|sensory system agents|mesh-ancestor
92631077|NCT00203073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631078|NCT00203073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631079|NCT00203073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631080|NCT00203073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631081|NCT00203073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631082|NCT00203073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631083|NCT00203073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631084|NCT00203073|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92631085|NCT00203073|Immunologic Factors|immunologic factors|mesh-ancestor
92631086|NCT00203073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631087|NCT00203073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631088|NCT00198432|Paclitaxel|paclitaxel|mesh-list
92631089|NCT00198432|Vinorelbine|vinorelbine|mesh-list
92631090|NCT00198432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92631091|NCT00198432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631092|NCT00198432|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631093|NCT00198432|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631094|NCT00198432|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631095|NCT00198432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631096|NCT02072863|Prednisone|prednisone|mesh-list
92631097|NCT02072863|Melphalan|melphalan|mesh-list
92631098|NCT02072863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631099|NCT02072863|Glucocorticoids|glucocorticoids|mesh-ancestor
92631100|NCT02072863|Hormones|hormones|mesh-ancestor
92631101|NCT02072863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631102|NCT02072863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631103|NCT02072863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92631104|NCT02072863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038094|NCT02420717|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631106|NCT02072863|Alkylating Agents|alkylating agents|mesh-ancestor
92631107|NCT02072863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631108|NCT02072863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631109|NCT02072863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631110|NCT02072863|Immunologic Factors|immunologic factors|mesh-ancestor
92631111|NCT02072161|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92631112|NCT02072161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92631113|NCT02072161|Antimetabolites|antimetabolites|mesh-ancestor
92631114|NCT02072161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631115|NCT02072161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92562100|NCT00151294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978852|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
92631116|NCT02072161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631117|NCT02072161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92631118|NCT02072161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631119|NCT00203112|Minocycline|minocycline|mesh-list
92631120|NCT00203112|Glatiramer Acetate|glatiramer acetate|mesh-list
92631122|NCT00203112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631123|NCT00203112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631124|NCT00203112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92631125|NCT00203112|Immunologic Factors|immunologic factors|mesh-ancestor
92631126|NCT00203112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631127|NCT00203112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631128|NCT00203112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631129|NCT02057380|Dexamethasone|dexamethasone|mesh-list
92631130|NCT02057380|Paclitaxel|paclitaxel|mesh-list
92631131|NCT02057380|Bortezomib|bortezomib|mesh-list
92631132|NCT02057380|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92631133|NCT02057380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92631134|NCT02057380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631135|NCT02057380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631136|NCT02057380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631137|NCT02057380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631138|NCT02057380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631139|NCT02057380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631140|NCT02057380|Antiemetics|antiemetics|mesh-ancestor
92631141|NCT02057380|Autonomic Agents|autonomic agents|mesh-ancestor
92631142|NCT02057380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631143|NCT02057380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631144|NCT02057380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92631145|NCT02057380|Glucocorticoids|glucocorticoids|mesh-ancestor
92631146|NCT02057380|Hormones|hormones|mesh-ancestor
92631147|NCT02057380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631148|NCT02057380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92631149|NCT02057380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631150|NCT02057380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631151|NCT02052778|Futibatinib|futibatinib|mesh-list
92631152|NCT02052778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631153|NCT02050828|Ranibizumab|ranibizumab|mesh-list
92631154|NCT02050828|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92631155|NCT02050828|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92631156|NCT02050828|Growth Substances|growth substances|mesh-ancestor
92631157|NCT02050828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631158|NCT02050828|Growth Inhibitors|growth inhibitors|mesh-ancestor
92631159|NCT02050828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631160|NCT02046694|Allopurinol|allopurinol|mesh-list
92631161|NCT02046694|Antimetabolites|antimetabolites|mesh-ancestor
92631162|NCT02046694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631163|NCT02046694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631164|NCT02046694|Gout Suppressants|gout suppressants|mesh-ancestor
92631165|NCT02046694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631166|NCT02046694|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92631167|NCT02046694|Antioxidants|antioxidants|mesh-ancestor
92631168|NCT02046694|Protective Agents|protective agents|mesh-ancestor
92631169|NCT02046694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631170|NCT00203190|Topiramate|topiramate|mesh-list
92631171|NCT00203190|Anticonvulsants|anticonvulsants|mesh-ancestor
92631172|NCT00203190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92631173|NCT00203190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631174|NCT02019589|Progesterone|progesterone|mesh-list
92631175|NCT02019589|Progestins|progestins|mesh-ancestor
92631176|NCT02019589|Hormones|hormones|mesh-ancestor
92631177|NCT02019589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631178|NCT02019589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631179|NCT02018926|Azacitidine|azacitidine|mesh-list
92631201|NCT01989325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631202|NCT01989325|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92631203|NCT01989325|Immunologic Factors|immunologic factors|mesh-ancestor
92631204|NCT01989325|Protease Inhibitors|protease inhibitors|mesh-ancestor
92631205|NCT01989325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356385|NCT02684292|Pembrolizumab|pembrolizumab|mesh-list
92631206|NCT01989325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631207|NCT01989325|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631208|NCT01989325|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562101|NCT00151294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562102|NCT00151294|Serotonin Agents|serotonin agents|mesh-ancestor
92562103|NCT00151294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562104|NCT00151294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92562105|NCT00151294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92562106|NCT00151294|Parasympatholytics|parasympatholytics|mesh-ancestor
92562107|NCT00151294|Autonomic Agents|autonomic agents|mesh-ancestor
92562108|NCT00151294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631209|NCT01978366|Halofuginone|halofuginone|mesh-list
92631210|NCT01978366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631211|NCT01978366|Coccidiostats|coccidiostats|mesh-ancestor
92631212|NCT01978366|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92631213|NCT01978366|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92631214|NCT01978366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631215|NCT01978366|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92631216|NCT01978366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631217|NCT01978366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631218|NCT01978366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92631219|NCT01978366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92631220|NCT01978366|Growth Substances|growth substances|mesh-ancestor
92631221|NCT01978366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631222|NCT01978366|Growth Inhibitors|growth inhibitors|mesh-ancestor
92631223|NCT02962986|Phenylephrine|phenylephrine|mesh-list
92631224|NCT02962986|Oxymetazoline|oxymetazoline|mesh-list
92631225|NCT02962986|Norepinephrine|norepinephrine|mesh-list
92631226|NCT02962986|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92631227|NCT02962986|Mydriatics|mydriatics|mesh-ancestor
92631228|NCT02962986|Autonomic Agents|autonomic agents|mesh-ancestor
92631229|NCT02962986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631230|NCT02962986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631231|NCT02962986|Sympathomimetics|sympathomimetics|mesh-ancestor
92631232|NCT02962986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92038246|NCT02396537|GABA Modulators|gaba modulators|mesh-ancestor
92631234|NCT02962986|Respiratory System Agents|respiratory system agents|mesh-ancestor
92631235|NCT02962986|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92631236|NCT02962986|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92631238|NCT02962986|Adrenergic Agents|adrenergic agents|mesh-ancestor
92631239|NCT02962986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631240|NCT02962986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631241|NCT02962986|Protective Agents|protective agents|mesh-ancestor
92631242|NCT04677361|Pembrolizumab|pembrolizumab|mesh-list
92631243|NCT04677361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92631244|NCT04677361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631245|NCT04677361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92631246|NCT04677361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631247|NCT01968733|Moxifloxacin|moxifloxacin|mesh-list
92631248|NCT01968733|Solithromycin|solithromycin|mesh-list
92631249|NCT01968733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631250|NCT01968733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631251|NCT01968733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631252|NCT01968733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631253|NCT01968733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631254|NCT01968733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631255|NCT01968733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631256|NCT00410553|Gemcitabine|gemcitabine|mesh-list
92631257|NCT00410553|Halichondrin B|halichondrin b|mesh-list
92631258|NCT00410553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631259|NCT00410553|Antimetabolites|antimetabolites|mesh-ancestor
92631260|NCT00410553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631261|NCT00410553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631262|NCT00410553|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631263|NCT00410553|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631264|NCT00410553|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631265|NCT00410592|Esomeprazole|esomeprazole|mesh-list
92631266|NCT00410592|Pantoprazole|pantoprazole|mesh-list
92631267|NCT00410592|Lansoprazole|lansoprazole|mesh-list
92631268|NCT00410592|Dexlansoprazole|dexlansoprazole|mesh-list
92631269|NCT00410592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92562109|NCT00151294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92562110|NCT00151294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92631270|NCT00410592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92631271|NCT00410592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92631272|NCT00410592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631273|NCT00410592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631274|NCT00410631|Cyclophosphamide|cyclophosphamide|mesh-list
92631275|NCT00410631|Melphalan|melphalan|mesh-list
92631276|NCT00410631|Ifosfamide|ifosfamide|mesh-list
92631277|NCT00410631|Dacarbazine|dacarbazine|mesh-list
92631278|NCT00410631|Carboplatin|carboplatin|mesh-list
92631279|NCT00410631|Doxorubicin|doxorubicin|mesh-list
92631280|NCT00410631|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92631281|NCT00410631|Etoposide|etoposide|mesh-list
92631282|NCT00410631|Vincristine|vincristine|mesh-list
92631283|NCT00410631|Topotecan|topotecan|mesh-list
92631284|NCT00410631|Etoposide phosphate|etoposide phosphate|mesh-list
92631285|NCT00410631|Vindesine|vindesine|mesh-list
92631286|NCT00410631|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92631287|NCT00410631|Isotretinoin|isotretinoin|mesh-list
92631288|NCT00410631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631289|NCT00410631|Immunologic Factors|immunologic factors|mesh-ancestor
92631290|NCT00410631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631291|NCT00410631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631292|NCT00410631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631293|NCT00410631|Alkylating Agents|alkylating agents|mesh-ancestor
92631294|NCT00410631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631295|NCT00410631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631296|NCT00410631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631297|NCT00410631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92631298|NCT00410631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631299|NCT00410631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631300|NCT00410631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631301|NCT00410631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92362322|NCT05765357|Trastuzumab|trastuzumab|mesh-list
92631302|NCT00410631|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631303|NCT00410631|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631304|NCT00410631|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631305|NCT00410631|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92631306|NCT00410631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92631307|NCT00410631|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92631308|NCT01930357|Vaccines|vaccines|mesh-list
92631312|NCT01913158|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92631313|NCT01913158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631314|NCT01903954|Ribavirin|ribavirin|mesh-list
92631315|NCT01903954|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92631316|NCT01903954|Antimetabolites|antimetabolites|mesh-ancestor
92631317|NCT01903954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631318|NCT01903954|Antiviral Agents|antiviral agents|mesh-ancestor
92631319|NCT01903954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631320|NCT01893190|Nimodipine|nimodipine|mesh-list
92631321|NCT01893190|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92631322|NCT01893190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92631323|NCT01893190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92631324|NCT01893190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631325|NCT01893190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92631326|NCT01893190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631327|NCT01893190|Vasodilator Agents|vasodilator agents|mesh-ancestor
92631328|NCT00198588|Argatroban|argatroban|mesh-list
92631329|NCT00198588|Antithrombins|antithrombins|mesh-ancestor
92631330|NCT00198588|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92631331|NCT00198588|Protease Inhibitors|protease inhibitors|mesh-ancestor
92631332|NCT00198588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631333|NCT00198588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631334|NCT00198588|Anticoagulants|anticoagulants|mesh-ancestor
92631335|NCT00198588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92631336|NCT01887886|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92631337|NCT01887886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631338|NCT01887886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631339|NCT01887886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631340|NCT01887886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631341|NCT01877395|Vaccines|vaccines|mesh-list
92631342|NCT01877395|Immunologic Factors|immunologic factors|mesh-ancestor
92631343|NCT01877395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631344|NCT01874626|Ibuprofen|ibuprofen|mesh-list
92631345|NCT01874626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92562111|NCT00151294|Cholinergic Agents|cholinergic agents|mesh-ancestor
92562112|NCT00151294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92562113|NCT00151294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562114|NCT00151450|Pregabalin|pregabalin|mesh-list
92631346|NCT01874626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92631347|NCT01874626|Analgesics|analgesics|mesh-ancestor
92631348|NCT01874626|Sensory System Agents|sensory system agents|mesh-ancestor
92631349|NCT01874626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631350|NCT01874626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631351|NCT01874626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631352|NCT01874626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631353|NCT01874626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92631354|NCT01874626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631355|NCT01874626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631356|NCT00410748|Hydromorphone|hydromorphone|mesh-list
92631357|NCT00410748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92631358|NCT00410748|Narcotics|narcotics|mesh-ancestor
92631359|NCT00410748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356541|NCT02983422|Diuretics|diuretics|mesh-ancestor
92631360|NCT00410748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631361|NCT00410748|Analgesics|analgesics|mesh-ancestor
92631362|NCT00410748|Sensory System Agents|sensory system agents|mesh-ancestor
92631363|NCT00410748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631364|NCT00198627|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92631365|NCT00198627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92631366|NCT00198627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631367|NCT00198627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631368|NCT00198627|Antimalarials|antimalarials|mesh-ancestor
92631369|NCT00198627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92631370|NCT00198627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92631371|NCT01862224|Methotrexate|methotrexate|mesh-list
92631372|NCT01862224|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92631373|NCT01862224|Abortifacient Agents|abortifacient agents|mesh-ancestor
92631374|NCT01862224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92631375|NCT01862224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631376|NCT01862224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631377|NCT01862224|Antimetabolites|antimetabolites|mesh-ancestor
92631378|NCT01862224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631382|NCT01862224|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631383|NCT01862224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631384|NCT01862224|Immunologic Factors|immunologic factors|mesh-ancestor
92631385|NCT01862224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631386|NCT01862224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92631387|NCT01859962|Ribavirin|ribavirin|mesh-list
92631388|NCT01859962|Antimetabolites|antimetabolites|mesh-ancestor
92631389|NCT01859962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631390|NCT01859962|Antiviral Agents|antiviral agents|mesh-ancestor
92631391|NCT01859962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631392|NCT00173888|Cisplatin|cisplatin|mesh-list
92631393|NCT00173888|Gemcitabine|gemcitabine|mesh-list
92631394|NCT00173888|Docetaxel|docetaxel|mesh-list
92631395|NCT00173888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631396|NCT00173888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631397|NCT00173888|Antimetabolites|antimetabolites|mesh-ancestor
92631398|NCT00173888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631399|NCT00173888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631400|NCT00173888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631401|NCT00173888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631402|NCT00555022|Bromides|bromides|mesh-list
92631403|NCT00555022|Tiotropium Bromide|tiotropium bromide|mesh-list
92631404|NCT00555022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92631405|NCT00555022|Autonomic Agents|autonomic agents|mesh-ancestor
92631406|NCT00555022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631407|NCT00555022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631408|NCT00555022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92631409|NCT00555022|Respiratory System Agents|respiratory system agents|mesh-ancestor
92631410|NCT00555022|Parasympatholytics|parasympatholytics|mesh-ancestor
92631411|NCT00555022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92631412|NCT00555022|Cholinergic Agents|cholinergic agents|mesh-ancestor
92631413|NCT00555022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631414|NCT00555022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562115|NCT00151450|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92562117|NCT00151450|Sensory System Agents|sensory system agents|mesh-ancestor
92562118|NCT00151450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562119|NCT00151450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562120|NCT00151450|Anticonvulsants|anticonvulsants|mesh-ancestor
92562121|NCT00151450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562122|NCT00151450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92631415|NCT00555022|Anticonvulsants|anticonvulsants|mesh-ancestor
92631416|NCT00203385|Valproic Acid|valproic acid|mesh-list
92631417|NCT00203385|Anticonvulsants|anticonvulsants|mesh-ancestor
92631418|NCT00203385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631419|NCT00203385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631420|NCT00203385|GABA Agents|gaba agents|mesh-ancestor
92631421|NCT00203385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631422|NCT00203385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631423|NCT00203385|Antimanic Agents|antimanic agents|mesh-ancestor
92631424|NCT00203385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92631425|NCT00203385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92631426|NCT00203385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92631427|NCT00555100|Dexamethasone|dexamethasone|mesh-list
92631428|NCT00555100|Lenalidomide|lenalidomide|mesh-list
92631429|NCT00555100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631430|NCT00555100|Antiemetics|antiemetics|mesh-ancestor
92631431|NCT00555100|Autonomic Agents|autonomic agents|mesh-ancestor
92631432|NCT00555100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631433|NCT00555100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631434|NCT00555100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356613|NCT02270814|Paclitaxel|paclitaxel|mesh-list
92631436|NCT00555100|Hormones|hormones|mesh-ancestor
92631437|NCT00555100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631438|NCT00555100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92631439|NCT00555100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631440|NCT00555100|Immunologic Factors|immunologic factors|mesh-ancestor
92631441|NCT00555100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92631442|NCT00555100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92631443|NCT00555100|Growth Substances|growth substances|mesh-ancestor
92631444|NCT00555100|Growth Inhibitors|growth inhibitors|mesh-ancestor
92631445|NCT00555139|Alprazolam|alprazolam|mesh-list
92631446|NCT00555139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92631447|NCT00555139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92631448|NCT00555139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631449|NCT00555139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92631450|NCT00555139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92631451|NCT00555139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92631452|NCT00555139|GABA Modulators|gaba modulators|mesh-ancestor
92631455|NCT00555139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631456|NCT00203463|Topiramate|topiramate|mesh-list
92631457|NCT00203463|Anticonvulsants|anticonvulsants|mesh-ancestor
92631458|NCT00203463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92631459|NCT00203463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631460|NCT00407849|Triamcinolone|triamcinolone|mesh-list
92631461|NCT00407849|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92631462|NCT00407849|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92631463|NCT00407849|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92631464|NCT00407849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631465|NCT00407849|Glucocorticoids|glucocorticoids|mesh-ancestor
92631466|NCT00407849|Hormones|hormones|mesh-ancestor
92631467|NCT00407849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631468|NCT00407849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631469|NCT00407849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631470|NCT00407849|Immunologic Factors|immunologic factors|mesh-ancestor
92631471|NCT00407849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631472|NCT00407849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631473|NCT00407927|Epinastine|epinastine|mesh-list
92631474|NCT00407927|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92631475|NCT00407927|Histamine Antagonists|histamine antagonists|mesh-ancestor
92631476|NCT00407927|Histamine Agents|histamine agents|mesh-ancestor
92562123|NCT00151450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562124|NCT00151450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92631477|NCT00407927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631478|NCT00407927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631479|NCT00407927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631480|NCT01818076|Botulinum Toxins|botulinum toxins|mesh-list
92631481|NCT01818076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92631482|NCT01818076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92631483|NCT01818076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92631484|NCT01818076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92631485|NCT01818076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631486|NCT01818076|Cholinergic Agents|cholinergic agents|mesh-ancestor
92631487|NCT01818076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631488|NCT01818076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631489|NCT01818076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92631490|NCT01818076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631491|NCT01807546|ON 01910|on 01910|mesh-list
92631492|NCT01807546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631493|NCT01807546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631494|NCT01807546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631495|NCT01807546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631496|NCT03454984|Guadecitabine|guadecitabine|mesh-list
92631497|NCT03454984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631498|NCT01785433|Tiotropium Bromide|tiotropium bromide|mesh-list
92631499|NCT01785433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92631500|NCT01785433|Autonomic Agents|autonomic agents|mesh-ancestor
92631501|NCT01785433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631502|NCT01785433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631503|NCT01785433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92631504|NCT01785433|Respiratory System Agents|respiratory system agents|mesh-ancestor
92631505|NCT01785433|Parasympatholytics|parasympatholytics|mesh-ancestor
92631506|NCT01785433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92631507|NCT01785433|Cholinergic Agents|cholinergic agents|mesh-ancestor
92631508|NCT01785433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631509|NCT01785433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631510|NCT00203580|Tinzaparin|tinzaparin|mesh-list
92631511|NCT00203580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92631512|NCT00203580|Dalteparin|dalteparin|mesh-list
92631513|NCT00203580|Anticoagulants|anticoagulants|mesh-ancestor
92631514|NCT00203580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92631515|NCT00203580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92631516|NCT00203580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631517|NCT01777555|Levodopa|levodopa|mesh-list
92631518|NCT01777555|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92631519|NCT01777555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92631520|NCT01777555|Dopamine Agents|dopamine agents|mesh-ancestor
92631521|NCT01777555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631522|NCT01777555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631523|NCT01777555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631524|NCT01773928|Vaccines|vaccines|mesh-list
92631525|NCT01773928|Immunologic Factors|immunologic factors|mesh-ancestor
92631526|NCT01773928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631528|NCT01768975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631529|NCT01756924|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92631530|NCT01756924|Vancomycin|vancomycin|mesh-list
92631531|NCT01756924|Ciprofloxacin|ciprofloxacin|mesh-list
92631532|NCT01756924|Levofloxacin|levofloxacin|mesh-list
92631533|NCT01756924|Rifampin|rifampin|mesh-list
92631534|NCT01756924|Cefazolin|cefazolin|mesh-list
92631535|NCT01756924|Ceftriaxone|ceftriaxone|mesh-list
92631536|NCT01756924|Linezolid|linezolid|mesh-list
92631537|NCT01756924|Daptomycin|daptomycin|mesh-list
92631538|NCT01756924|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92631539|NCT01756924|Oxacillin|oxacillin|mesh-list
92631540|NCT01756924|Nafcillin|nafcillin|mesh-list
92631541|NCT01756924|Fusidic Acid|fusidic acid|mesh-list
92631542|NCT01756924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631543|NCT01756924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92631544|NCT01756924|Antitubercular Agents|antitubercular agents|mesh-ancestor
92631545|NCT01756924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631546|NCT01756924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631547|NCT01756924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562125|NCT00151450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92562126|NCT00151450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92286898|NCT00002937|Paclitaxel|paclitaxel|mesh-list
92562127|NCT00151450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562128|NCT00151450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969657|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92631548|NCT01756924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631549|NCT01756924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631550|NCT01756924|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92631551|NCT01756924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92631552|NCT01756924|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92631553|NCT01756924|Leprostatic Agents|leprostatic agents|mesh-ancestor
92631554|NCT01756924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92631555|NCT01756924|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92631556|NCT01756924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92631557|NCT01756924|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92631558|NCT01756924|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92631559|NCT01756924|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92631560|NCT01756924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92631561|NCT01756924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92631562|NCT01756924|Antimalarials|antimalarials|mesh-ancestor
92631563|NCT01756924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92631564|NCT01756924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92631565|NCT01756339|Moxifloxacin|moxifloxacin|mesh-list
92631566|NCT01756339|Solithromycin|solithromycin|mesh-list
92631567|NCT01756339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631568|NCT01756339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631569|NCT01756339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631570|NCT01756339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631571|NCT01756339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631572|NCT01756339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631573|NCT01756339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631574|NCT00174200|Risperidone|risperidone|mesh-list
92631575|NCT00174200|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92631576|NCT00174200|Serotonin Agents|serotonin agents|mesh-ancestor
92631577|NCT00174200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631578|NCT00174200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631579|NCT00174200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631580|NCT00174200|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92631581|NCT00174200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92631582|NCT00174200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92631583|NCT00174200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92631584|NCT00174200|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92631585|NCT00174200|Dopamine Agents|dopamine agents|mesh-ancestor
92631586|NCT00203658|Tinzaparin|tinzaparin|mesh-list
92631587|NCT00203658|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92631588|NCT00203658|Dalteparin|dalteparin|mesh-list
92631589|NCT00203658|Anticoagulants|anticoagulants|mesh-ancestor
92631590|NCT00203658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92631591|NCT00203658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92631592|NCT00203658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631593|NCT00174239|Levodopa|levodopa|mesh-list
92631594|NCT00174239|Carbidopa|carbidopa|mesh-list
92631595|NCT00174239|Cabergoline|cabergoline|mesh-list
92631596|NCT00174239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92631597|NCT00174239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92631598|NCT00174239|Dopamine Agents|dopamine agents|mesh-ancestor
92631599|NCT00174239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631600|NCT00174239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631601|NCT00174239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631605|NCT00203697|Minocycline|minocycline|mesh-list
92631606|NCT00203697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631607|NCT00203697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631608|NCT00174317|Celecoxib|celecoxib|mesh-list
92631609|NCT00174317|Diclofenac|diclofenac|mesh-list
92631610|NCT00174317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92631611|NCT00174317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92631612|NCT00174317|Analgesics|analgesics|mesh-ancestor
92631613|NCT00174317|Sensory System Agents|sensory system agents|mesh-ancestor
92562129|NCT00151450|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92562130|NCT00151450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562131|NCT00151450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969662|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631614|NCT00174317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631615|NCT00174317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631616|NCT00174317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631617|NCT00174317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631618|NCT00174317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92631619|NCT00174317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92631620|NCT00174317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631621|NCT00174317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631622|NCT01737892|Epinephrine|epinephrine|mesh-list
92631623|NCT01737892|Racepinephrine|racepinephrine|mesh-list
92631624|NCT01737892|Epinephryl borate|epinephryl borate|mesh-list
92631625|NCT01737892|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92631626|NCT01737892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92631627|NCT01737892|Adrenergic Agents|adrenergic agents|mesh-ancestor
92631628|NCT01737892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631629|NCT01737892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631630|NCT01737892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631631|NCT01737892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92631632|NCT01737892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92631633|NCT01737892|Autonomic Agents|autonomic agents|mesh-ancestor
92631634|NCT01737892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631635|NCT01737892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92631636|NCT01737892|Respiratory System Agents|respiratory system agents|mesh-ancestor
92631637|NCT01737892|Mydriatics|mydriatics|mesh-ancestor
92631638|NCT01737892|Sympathomimetics|sympathomimetics|mesh-ancestor
92631639|NCT01737892|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92631640|NCT00203736|Artesunate|artesunate|mesh-list
92631641|NCT00203736|Pyrimethamine|pyrimethamine|mesh-list
92631642|NCT00203736|Sulfadoxine|sulfadoxine|mesh-list
92631643|NCT00203736|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92631644|NCT00203736|Antimalarials|antimalarials|mesh-ancestor
92631645|NCT00203736|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92631646|NCT00203736|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92631647|NCT00203736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631648|NCT00203736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631649|NCT00203736|Antiviral Agents|antiviral agents|mesh-ancestor
92631650|NCT00203736|Schistosomicides|schistosomicides|mesh-ancestor
92631651|NCT00203736|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92631652|NCT00203736|Anthelmintics|anthelmintics|mesh-ancestor
92631653|NCT00203736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631654|NCT00203736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631655|NCT00203736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631656|NCT00203736|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92631657|NCT01719016|Adenosine|adenosine|mesh-list
92631658|NCT01719016|Analgesics|analgesics|mesh-ancestor
92631659|NCT01719016|Sensory System Agents|sensory system agents|mesh-ancestor
92631660|NCT01719016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356834|NCT01924260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631661|NCT01719016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631662|NCT01719016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92631663|NCT01719016|Vasodilator Agents|vasodilator agents|mesh-ancestor
92631664|NCT01719016|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92631665|NCT01719016|Purinergic Agonists|purinergic agonists|mesh-ancestor
92631666|NCT01719016|Purinergic Agents|purinergic agents|mesh-ancestor
92631667|NCT01719016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631668|NCT01719016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631669|NCT00174356|Paclitaxel|paclitaxel|mesh-list
92631670|NCT00174356|Carboplatin|carboplatin|mesh-list
92631671|NCT00174356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92631672|NCT00174356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631673|NCT00174356|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631678|NCT01718158|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92631679|NCT01718158|Antimetabolites|antimetabolites|mesh-ancestor
92631680|NCT01718158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631681|NCT01718158|Antiviral Agents|antiviral agents|mesh-ancestor
92631682|NCT01718158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562132|NCT00151450|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92562133|NCT00151450|Antidepressive Agents|antidepressive agents|mesh-ancestor
92562134|NCT00151489|Pregabalin|pregabalin|mesh-list
92562135|NCT00151489|Analgesics|analgesics|mesh-ancestor
92562136|NCT00151489|Sensory System Agents|sensory system agents|mesh-ancestor
92562137|NCT00151489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631683|NCT00174395|Eletriptan|eletriptan|mesh-list
92631684|NCT00174395|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92631685|NCT00174395|Serotonin Agents|serotonin agents|mesh-ancestor
92631686|NCT00174395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631687|NCT00174395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631688|NCT00174395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631689|NCT00203775|Risperidone|risperidone|mesh-list
92631690|NCT00203775|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92631691|NCT00203775|Serotonin Agents|serotonin agents|mesh-ancestor
92631692|NCT00203775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631693|NCT00203775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631694|NCT00203775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631695|NCT00203775|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92631696|NCT00203775|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92631697|NCT00203775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92631698|NCT00203775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92631699|NCT00203775|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92631700|NCT00203775|Dopamine Agents|dopamine agents|mesh-ancestor
92631701|NCT00555256|Sirolimus|sirolimus|mesh-list
92631702|NCT00555256|Sunitinib|sunitinib|mesh-list
92631703|NCT00555256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631704|NCT00555256|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92631705|NCT00555256|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92631706|NCT00555256|Growth Substances|growth substances|mesh-ancestor
92631707|NCT00555256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631708|NCT00555256|Growth Inhibitors|growth inhibitors|mesh-ancestor
92631709|NCT00555256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631710|NCT00555256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631711|NCT00555256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631712|NCT00555256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631713|NCT00555256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631714|NCT00555256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92631715|NCT00555256|Antifungal Agents|antifungal agents|mesh-ancestor
92631716|NCT00555256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631717|NCT00555256|Immunologic Factors|immunologic factors|mesh-ancestor
92631718|NCT00174434|Paclitaxel|paclitaxel|mesh-list
92631719|NCT00174434|Sunitinib|sunitinib|mesh-list
92631720|NCT00174434|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92631721|NCT00174434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631722|NCT00174434|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631723|NCT00174434|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631724|NCT00174434|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631725|NCT00174434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631726|NCT00174434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92631727|NCT00174434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92631728|NCT00174434|Growth Substances|growth substances|mesh-ancestor
92631729|NCT00174434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631730|NCT00174434|Growth Inhibitors|growth inhibitors|mesh-ancestor
92631731|NCT00174434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92631732|NCT00174434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704671|NCT01229072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704672|NCT01199978|Losartan|losartan|mesh-list
92356914|NCT02068092|Antioxidants|antioxidants|mesh-ancestor
92631734|NCT00203814|Pyrimethamine|pyrimethamine|mesh-list
92631735|NCT00203814|Sulfadoxine|sulfadoxine|mesh-list
92631736|NCT00203814|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92631737|NCT00203814|Antimalarials|antimalarials|mesh-ancestor
92631738|NCT00203814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92631739|NCT00203814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92631740|NCT00203814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631741|NCT00203814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631742|NCT00203814|Antiviral Agents|antiviral agents|mesh-ancestor
92631743|NCT00203814|Schistosomicides|schistosomicides|mesh-ancestor
92631745|NCT00203814|Anthelmintics|anthelmintics|mesh-ancestor
92562138|NCT00151489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562139|NCT00151489|Anticonvulsants|anticonvulsants|mesh-ancestor
92562140|NCT00151489|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562141|NCT00151489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562142|NCT00151489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562143|NCT00151489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92562144|NCT00151489|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92562145|NCT00151489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92631746|NCT00203814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631747|NCT00203814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631748|NCT00203814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631749|NCT00203814|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92631750|NCT00174473|Voriconazole|voriconazole|mesh-list
92631751|NCT00174473|Antifungal Agents|antifungal agents|mesh-ancestor
92631752|NCT00174473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631753|NCT00174473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92631754|NCT00174473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92631755|NCT00174473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631756|NCT00174473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631757|NCT00174473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92631758|NCT00174473|Hormone Antagonists|hormone antagonists|mesh-ancestor
92631759|NCT00174473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631760|NCT00174473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631761|NCT00174473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92631762|NCT00174512|Moxifloxacin|moxifloxacin|mesh-list
92631763|NCT00174512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92631764|NCT00174512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631765|NCT00174512|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631766|NCT00174512|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631767|NCT00174512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631768|NCT00174512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631769|NCT00174512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631770|NCT00199017|Cytarabine|cytarabine|mesh-list
92631771|NCT00199017|Dexamethasone|dexamethasone|mesh-list
92631772|NCT00199017|Prednisolone|prednisolone|mesh-list
92631773|NCT00199017|Cyclophosphamide|cyclophosphamide|mesh-list
92631774|NCT00199017|Methotrexate|methotrexate|mesh-list
92631775|NCT00199017|Vincristine|vincristine|mesh-list
92631776|NCT00199017|Doxorubicin|doxorubicin|mesh-list
92631777|NCT00199017|Daunorubicin|daunorubicin|mesh-list
92631778|NCT00199017|Asparaginase|asparaginase|mesh-list
92631779|NCT00199017|Mercaptopurine|mercaptopurine|mesh-list
92631780|NCT00199017|Cladribine|cladribine|mesh-list
92631781|NCT00199017|Thioguanine|thioguanine|mesh-list
92631782|NCT00199017|Vindesine|vindesine|mesh-list
92631783|NCT00199017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631784|NCT00199017|Immunologic Factors|immunologic factors|mesh-ancestor
92631785|NCT00199017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631786|NCT00199017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631787|NCT00199017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631788|NCT00199017|Alkylating Agents|alkylating agents|mesh-ancestor
92631789|NCT00199017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631790|NCT00199017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631791|NCT00199017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631792|NCT00199017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631793|NCT00199017|Antiemetics|antiemetics|mesh-ancestor
92631794|NCT00199017|Autonomic Agents|autonomic agents|mesh-ancestor
92631795|NCT00199017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631796|NCT00199017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92631797|NCT00199017|Glucocorticoids|glucocorticoids|mesh-ancestor
92631798|NCT00199017|Hormones|hormones|mesh-ancestor
92631799|NCT00199017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631800|NCT00199017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92631801|NCT00199017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92631802|NCT00199017|Abortifacient Agents|abortifacient agents|mesh-ancestor
92631803|NCT00199017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562146|NCT00151489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562147|NCT00151489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562148|NCT00049790|Paclitaxel|paclitaxel|mesh-list
92562149|NCT00049790|Carboplatin|carboplatin|mesh-list
92562150|NCT00049790|Angiostatins|angiostatins|mesh-list
92631804|NCT00199017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631805|NCT00199017|Antimetabolites|antimetabolites|mesh-ancestor
92631806|NCT00199017|Dermatologic Agents|dermatologic agents|mesh-ancestor
92631807|NCT00199017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631808|NCT00199017|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631809|NCT00199017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92631811|NCT00199017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631812|NCT00199017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92631813|NCT00199017|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631814|NCT00199017|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631815|NCT00199017|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631816|NCT00199017|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92631817|NCT00199017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631818|NCT00199017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631831|NCT00174551|Prazosin|prazosin|mesh-list
92631832|NCT00174551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92631833|NCT00174551|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92631834|NCT00174551|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92631835|NCT00174551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92631836|NCT00174551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92631837|NCT00174551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631838|NCT00174551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631839|NCT00174551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631840|NCT04676659|Tenecteplase|tenecteplase|mesh-list
92631841|NCT04676659|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92631842|NCT04676659|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92631843|NCT04676659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631844|NCT00174590|Risperidone|risperidone|mesh-list
92631845|NCT00174590|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92631846|NCT00174590|Serotonin Agents|serotonin agents|mesh-ancestor
92631847|NCT00174590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631848|NCT00174590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631849|NCT00174590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631850|NCT00174590|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92631851|NCT00174590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92631852|NCT00174590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92631853|NCT00174590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92631854|NCT00174590|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92631855|NCT00174590|Dopamine Agents|dopamine agents|mesh-ancestor
92631856|NCT01652482|Leucovorin|leucovorin|mesh-list
92631857|NCT01652482|Fluorouracil|fluorouracil|mesh-list
92631858|NCT01652482|Irinotecan|irinotecan|mesh-list
92631859|NCT01652482|Cetuximab|cetuximab|mesh-list
92631860|NCT01652482|Antimetabolites|antimetabolites|mesh-ancestor
92631861|NCT01652482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631862|NCT01652482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631863|NCT01652482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631864|NCT01652482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631865|NCT01652482|Immunologic Factors|immunologic factors|mesh-ancestor
92631866|NCT01652482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631867|NCT01652482|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92631868|NCT01652482|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631869|NCT01652482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631870|NCT01652482|Antidotes|antidotes|mesh-ancestor
92631871|NCT01652482|Protective Agents|protective agents|mesh-ancestor
92631872|NCT01652482|Vitamin B Complex|vitamin b complex|mesh-ancestor
92631873|NCT01652482|Vitamins|vitamins|mesh-ancestor
92631874|NCT01652482|Micronutrients|micronutrients|mesh-ancestor
92631875|NCT01652482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92631876|NCT00174629|Gemcitabine|gemcitabine|mesh-list
92631877|NCT00174629|Docetaxel|docetaxel|mesh-list
92631878|NCT00174629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631879|NCT00174629|Antimetabolites|antimetabolites|mesh-ancestor
92631880|NCT00174629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038878|NCT02336165|Bevacizumab|bevacizumab|mesh-list
92631883|NCT00174629|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631884|NCT00174629|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562151|NCT00049790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92562152|NCT00049790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562153|NCT00049790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92562154|NCT00049790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92562155|NCT00049790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631885|NCT02962947|Propranolol|propranolol|mesh-list
92631886|NCT02962947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92631887|NCT02962947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92631888|NCT02962947|Adrenergic Agents|adrenergic agents|mesh-ancestor
92631889|NCT02962947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631890|NCT02962947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631891|NCT02962947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631892|NCT02962947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92631893|NCT02962947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92631894|NCT02962947|Vasodilator Agents|vasodilator agents|mesh-ancestor
92631895|NCT00555334|Lamivudine|lamivudine|mesh-list
92631896|NCT00555334|Entecavir|entecavir|mesh-list
92631897|NCT00555334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92631898|NCT00555334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92631899|NCT00555334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631900|NCT00555334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631901|NCT00555334|Antiviral Agents|antiviral agents|mesh-ancestor
92631902|NCT00555334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92631903|NCT00555334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92631904|NCT00555334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92631905|NCT01640080|Esketamine|esketamine|mesh-list
92631906|NCT01640080|Antidepressive Agents|antidepressive agents|mesh-ancestor
92631907|NCT01640080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92631908|NCT00174668|Insulin|insulin|mesh-list
92631909|NCT00174668|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92631910|NCT00174668|Insulin Glargine|insulin glargine|mesh-list
92631911|NCT00174668|Insulin glulisine|insulin glulisine|mesh-list
92631912|NCT00174668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92631913|NCT00174668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631914|NCT00174707|Cyclophosphamide|cyclophosphamide|mesh-list
92631915|NCT00174707|Docetaxel|docetaxel|mesh-list
92631916|NCT00174707|Methotrexate|methotrexate|mesh-list
92631917|NCT00174707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631918|NCT00174707|Immunologic Factors|immunologic factors|mesh-ancestor
92631919|NCT00174707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631920|NCT00174707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631921|NCT00174707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631922|NCT00174707|Alkylating Agents|alkylating agents|mesh-ancestor
92631923|NCT00174707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631924|NCT00174707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631925|NCT00174707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631926|NCT00174707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631927|NCT00174707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631928|NCT00174707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631929|NCT00174707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92631930|NCT00174707|Abortifacient Agents|abortifacient agents|mesh-ancestor
92631931|NCT00174707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92631932|NCT00174707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631933|NCT00174707|Antimetabolites|antimetabolites|mesh-ancestor
92631934|NCT00174707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92631935|NCT00174707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631936|NCT00174707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631937|NCT00174707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92631938|NCT01235923|Epoetin Alfa|epoetin alfa|mesh-list
92631939|NCT01235923|Hematinics|hematinics|mesh-ancestor
92631940|NCT00199134|Letrozole|letrozole|mesh-list
92631941|NCT00199134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631942|NCT00199134|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92631943|NCT00199134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92631944|NCT00199134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631945|NCT00199134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631946|NCT00199134|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92631947|NCT00199134|Hormone Antagonists|hormone antagonists|mesh-ancestor
92631948|NCT00199134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631949|NCT00199134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631950|NCT00174824|Insulin Glargine|insulin glargine|mesh-list
92562156|NCT00049790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562157|NCT00049790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92562158|NCT00049790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92562159|NCT00049790|Growth Substances|growth substances|mesh-ancestor
92631951|NCT00174824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92631952|NCT00174824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631953|NCT00174863|SR 31747|sr 31747|mesh-list
92631957|NCT00174863|Immunologic Factors|immunologic factors|mesh-ancestor
92631958|NCT00174863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631959|NCT00712582|Cyclophosphamide|cyclophosphamide|mesh-list
92631960|NCT00712582|Ifosfamide|ifosfamide|mesh-list
92631961|NCT00712582|Isophosphamide mustard|isophosphamide mustard|mesh-list
92631962|NCT00712582|Carmustine|carmustine|mesh-list
92631963|NCT00712582|Rituximab|rituximab|mesh-list
92631964|NCT00712582|Carboplatin|carboplatin|mesh-list
92631965|NCT00712582|Etoposide|etoposide|mesh-list
92631966|NCT00712582|Etoposide phosphate|etoposide phosphate|mesh-list
92631967|NCT00712582|Mitoxantrone|mitoxantrone|mesh-list
92631968|NCT00712582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631969|NCT00712582|Immunologic Factors|immunologic factors|mesh-ancestor
92631970|NCT00712582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631971|NCT00712582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631972|NCT00712582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631973|NCT00712582|Alkylating Agents|alkylating agents|mesh-ancestor
92631974|NCT00712582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631975|NCT00712582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631976|NCT00712582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631977|NCT00712582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92631978|NCT00712582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92631979|NCT00712582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92631980|NCT00712582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92631981|NCT00712582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631982|NCT00712582|Analgesics|analgesics|mesh-ancestor
92631983|NCT00712582|Sensory System Agents|sensory system agents|mesh-ancestor
92631984|NCT00712582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631985|NCT00174902|Aspirin|aspirin|mesh-list
92631986|NCT00174902|Propranolol|propranolol|mesh-list
92631987|NCT00174902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92631988|NCT00174902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92631989|NCT00174902|Analgesics|analgesics|mesh-ancestor
92631990|NCT00174902|Sensory System Agents|sensory system agents|mesh-ancestor
92631991|NCT00174902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631992|NCT00174902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631993|NCT00174902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631994|NCT00174902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92631995|NCT00174902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92631996|NCT00174902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92631997|NCT00174902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631998|NCT00174902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92631999|NCT00174902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632000|NCT00174902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632001|NCT00174902|Antipyretics|antipyretics|mesh-ancestor
92632002|NCT00174902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92632003|NCT00174902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92632004|NCT00174902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92632005|NCT00174902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632006|NCT00174902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92632007|NCT00174902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92632008|NCT00174902|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632010|NCT00373711|Cadexomer iodine|cadexomer iodine|mesh-list
92632011|NCT00373711|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92632012|NCT00373711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92632013|NCT00373711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632014|NCT00373711|Trace Elements|trace elements|mesh-ancestor
92632015|NCT00373711|Micronutrients|micronutrients|mesh-ancestor
92632016|NCT00373711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632017|NCT00373711|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92632018|NCT00373711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632019|NCT00199212|Trastuzumab|trastuzumab|mesh-list
92632020|NCT00199212|Bortezomib|bortezomib|mesh-list
92632021|NCT00199212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92562160|NCT00049790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562161|NCT00049790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92562162|NCT00082524|Caspofungin|caspofungin|mesh-list
92562163|NCT00082524|Antifungal Agents|antifungal agents|mesh-ancestor
92562164|NCT00082524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562165|NCT00082524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632022|NCT00199212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632023|NCT00555373|Sirolimus|sirolimus|mesh-list
92632024|NCT00555373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92632025|NCT00555373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632026|NCT00555373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92632027|NCT00555373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632043|NCT04676776|Mifepristone|mifepristone|mesh-list
92632044|NCT04676776|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92632045|NCT04676776|Contraceptive Agents|contraceptive agents|mesh-ancestor
92632046|NCT04676776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92632047|NCT04676776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632048|NCT04676776|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92632049|NCT04676776|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92632050|NCT04676776|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92632051|NCT04676776|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92632052|NCT04676776|Abortifacient Agents|abortifacient agents|mesh-ancestor
92632053|NCT04676776|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92632054|NCT04676776|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92632055|NCT04676776|Hormone Antagonists|hormone antagonists|mesh-ancestor
92632056|NCT04676776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632057|NCT04676776|Luteolytic Agents|luteolytic agents|mesh-ancestor
92632058|NCT04676776|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92632059|NCT00175253|Alemtuzumab|alemtuzumab|mesh-list
92632060|NCT00175253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92632061|NCT00175253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632062|NCT00199329|Ondansetron|ondansetron|mesh-list
92632063|NCT00199329|Antiemetics|antiemetics|mesh-ancestor
92632064|NCT00199329|Autonomic Agents|autonomic agents|mesh-ancestor
92632065|NCT00199329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632066|NCT00199329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632067|NCT00199329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92632068|NCT00199329|Antipruritics|antipruritics|mesh-ancestor
92632069|NCT00199329|Dermatologic Agents|dermatologic agents|mesh-ancestor
92632070|NCT00199329|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92632071|NCT00199329|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92632072|NCT00199329|Serotonin Agents|serotonin agents|mesh-ancestor
92632073|NCT00199329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362375|NCT05764707|Analgesics|analgesics|mesh-ancestor
92632074|NCT00199329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632075|NCT00555607|Prednisolone|prednisolone|mesh-list
92632076|NCT00555607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632077|NCT00555607|Glucocorticoids|glucocorticoids|mesh-ancestor
92632079|NCT00555607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632080|NCT00555607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632081|NCT00555607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92632082|NCT00555607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632083|NCT00199368|Istradefylline|istradefylline|mesh-list
92632084|NCT00199368|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92632085|NCT00199368|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92039087|NCT04666701|Scopolamine|scopolamine|mesh-list
92632088|NCT00199368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632089|NCT00199368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632090|NCT00199368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632092|NCT04675528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92632093|NCT04675528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632094|NCT04675528|Tubulin Modulators|tubulin modulators|mesh-ancestor
92632095|NCT04675528|Antimitotic Agents|antimitotic agents|mesh-ancestor
92632096|NCT04675528|Mitosis Modulators|mitosis modulators|mesh-ancestor
92632097|NCT04675528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632098|NCT04675177|Polidocanol|polidocanol|mesh-list
92632099|NCT04675177|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92632100|NCT04675177|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92632101|NCT00175370|Vancomycin|vancomycin|mesh-list
92562166|NCT00082524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562167|NCT00406003|Paroxetine|paroxetine|mesh-list
92632102|NCT00175370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92632103|NCT00175370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632104|NCT00204243|Naltrexone|naltrexone|mesh-list
92632105|NCT00204243|Methadone|methadone|mesh-list
92632106|NCT00204243|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92632107|NCT00204243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92632108|NCT00204243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357295|NCT05320692|Hormones|hormones|mesh-ancestor
92632109|NCT00204243|Sensory System Agents|sensory system agents|mesh-ancestor
92632110|NCT00204243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632111|NCT00204243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92632112|NCT00204243|Narcotics|narcotics|mesh-ancestor
92632113|NCT00204243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632114|NCT00204243|Analgesics|analgesics|mesh-ancestor
92632115|NCT00204243|Antitussive Agents|antitussive agents|mesh-ancestor
92632116|NCT00204243|Respiratory System Agents|respiratory system agents|mesh-ancestor
92632117|NCT04675372|Midazolam|midazolam|mesh-list
92632118|NCT04675372|Dexmedetomidine|dexmedetomidine|mesh-list
92632119|NCT04675372|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92632120|NCT04675372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632121|NCT04675372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632122|NCT04675372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632123|NCT04675372|Analgesics|analgesics|mesh-ancestor
92632124|NCT04675372|Sensory System Agents|sensory system agents|mesh-ancestor
92632125|NCT04675372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632126|NCT04675372|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92632127|NCT04675372|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92632128|NCT04675372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92632129|NCT04675372|Adrenergic Agents|adrenergic agents|mesh-ancestor
92632130|NCT04675372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632131|NCT04675372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632132|NCT04675372|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92632133|NCT04675372|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92632134|NCT04675372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92632135|NCT04675372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632136|NCT04675372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92632137|NCT04675372|Anesthetics, General|anesthetics, general|mesh-ancestor
92632138|NCT04675372|Anesthetics|anesthetics|mesh-ancestor
92632139|NCT04675372|GABA Modulators|gaba modulators|mesh-ancestor
92632140|NCT04675372|GABA Agents|gaba agents|mesh-ancestor
92632141|NCT04424602|Cyclophosphamide|cyclophosphamide|mesh-list
92632142|NCT04424602|Dimethoate|dimethoate|mesh-list
92632143|NCT04424602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632144|NCT04424602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632145|NCT04424602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632146|NCT04424602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92632147|NCT04424602|Cholinergic Agents|cholinergic agents|mesh-ancestor
92632148|NCT04424602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632149|NCT04424602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632150|NCT04424602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632151|NCT04424602|Immunologic Factors|immunologic factors|mesh-ancestor
92632152|NCT04424602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632153|NCT04424602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92632154|NCT04424602|Alkylating Agents|alkylating agents|mesh-ancestor
92632155|NCT04424602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92632156|NCT00199407|Istradefylline|istradefylline|mesh-list
92632157|NCT00199407|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92632158|NCT00199407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92632162|NCT00199407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632163|NCT00199407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632165|NCT00199446|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92632166|NCT00199446|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92632167|NCT00199446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92632168|NCT00199446|Purinergic Agents|purinergic agents|mesh-ancestor
92632169|NCT00199446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632170|NCT00199446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632171|NCT00199446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632172|NCT04306393|Nitric Oxide|nitric oxide|mesh-list
92632173|NCT04306393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92632174|NCT04306393|Autonomic Agents|autonomic agents|mesh-ancestor
92632175|NCT04306393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562168|NCT00406003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92562169|NCT00406003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562170|NCT00406003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92632176|NCT04306393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632177|NCT04306393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92632178|NCT04306393|Respiratory System Agents|respiratory system agents|mesh-ancestor
92632179|NCT04306393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92632180|NCT04306393|Antioxidants|antioxidants|mesh-ancestor
92632181|NCT04306393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632182|NCT04306393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632183|NCT04306393|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92632185|NCT04306393|Gasotransmitters|gasotransmitters|mesh-ancestor
92632186|NCT04306393|Protective Agents|protective agents|mesh-ancestor
92632187|NCT00204321|Sirolimus|sirolimus|mesh-list
92632188|NCT00204321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92632189|NCT00204321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632190|NCT00204321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92632191|NCT00204321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632192|NCT00204321|Antifungal Agents|antifungal agents|mesh-ancestor
92632193|NCT00204321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632194|NCT00204321|Immunologic Factors|immunologic factors|mesh-ancestor
92632195|NCT00204321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632196|NCT00175565|Fluticasone|fluticasone|mesh-list
92632197|NCT00175565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632198|NCT00175565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92632199|NCT00175565|Autonomic Agents|autonomic agents|mesh-ancestor
92632200|NCT00175565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632201|NCT00175565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632202|NCT00175565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92632203|NCT00175565|Respiratory System Agents|respiratory system agents|mesh-ancestor
92632204|NCT00175565|Dermatologic Agents|dermatologic agents|mesh-ancestor
92632205|NCT00175565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92632206|NCT04230187|Leucovorin|leucovorin|mesh-list
92632207|NCT04230187|Bevacizumab|bevacizumab|mesh-list
92632208|NCT04230187|Fluorouracil|fluorouracil|mesh-list
92632209|NCT04230187|Oxaliplatin|oxaliplatin|mesh-list
92632210|NCT04230187|Irinotecan|irinotecan|mesh-list
92632211|NCT04230187|Levoleucovorin|levoleucovorin|mesh-list
92632212|NCT04230187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92632213|NCT04230187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632214|NCT04230187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92632215|NCT04230187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92632216|NCT04230187|Growth Substances|growth substances|mesh-ancestor
92632217|NCT04230187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632218|NCT04230187|Growth Inhibitors|growth inhibitors|mesh-ancestor
92632219|NCT04230187|Antimetabolites|antimetabolites|mesh-ancestor
92632220|NCT04230187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632221|NCT04230187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632222|NCT04230187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632223|NCT04230187|Immunologic Factors|immunologic factors|mesh-ancestor
92632224|NCT04230187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92632225|NCT04230187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92632226|NCT04230187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632227|NCT04230187|Antidotes|antidotes|mesh-ancestor
92632228|NCT04230187|Protective Agents|protective agents|mesh-ancestor
92632229|NCT04230187|Vitamin B Complex|vitamin b complex|mesh-ancestor
92632230|NCT04230187|Vitamins|vitamins|mesh-ancestor
92632231|NCT04230187|Micronutrients|micronutrients|mesh-ancestor
92632241|NCT00204438|Estrogens|estrogens|mesh-ancestor
92632242|NCT00204438|Hormones|hormones|mesh-ancestor
92632243|NCT00204438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632244|NCT00204438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632245|NCT00204438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92632246|NCT00204438|Contraceptive Agents|contraceptive agents|mesh-ancestor
92632247|NCT00204438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92632248|NCT00204438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92632249|NCT00204438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92632250|NCT00204438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92632251|NCT00204438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92632252|NCT00204438|Progestins|progestins|mesh-ancestor
92632253|NCT00175682|Prazosin|prazosin|mesh-list
92632254|NCT00175682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92562171|NCT00406003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980175|NCT02435537|Narcotics|narcotics|mesh-ancestor
92632255|NCT00175682|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92632256|NCT00175682|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92632257|NCT00175682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92632258|NCT00175682|Adrenergic Agents|adrenergic agents|mesh-ancestor
92632259|NCT00175682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632260|NCT00175682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632261|NCT00175682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632262|NCT00554086|Bicalutamide|bicalutamide|mesh-list
92632263|NCT00554086|Androgen Antagonists|androgen antagonists|mesh-ancestor
92632264|NCT00554086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92632265|NCT00554086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632266|NCT00554086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632267|NCT00554086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632268|NCT04173364|Ropivacaine|ropivacaine|mesh-list
92632269|NCT04173364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92632270|NCT04173364|Anesthetics, Local|anesthetics, local|mesh-ancestor
92632271|NCT04173364|Anesthetics|anesthetics|mesh-ancestor
92632272|NCT04173364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632273|NCT04173364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632274|NCT04173364|Sensory System Agents|sensory system agents|mesh-ancestor
92632275|NCT04173364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632276|NCT04171453|Pregabalin|pregabalin|mesh-list
92632277|NCT04171453|Analgesics|analgesics|mesh-ancestor
92632278|NCT04171453|Sensory System Agents|sensory system agents|mesh-ancestor
92632279|NCT04171453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632280|NCT04171453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632281|NCT04171453|Anticonvulsants|anticonvulsants|mesh-ancestor
92632282|NCT04171453|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92632283|NCT04171453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92632284|NCT04171453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632285|NCT04171453|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92632286|NCT04171453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92632287|NCT04171453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92632288|NCT04171453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362393|NCT05757622|Anesthetics|anesthetics|mesh-ancestor
92632289|NCT04171453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632290|NCT04111315|Dipyrone|dipyrone|mesh-list
92632291|NCT04111315|Ibuprofen|ibuprofen|mesh-list
92632292|NCT04111315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632293|NCT04111315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632294|NCT04111315|Analgesics|analgesics|mesh-ancestor
92632295|NCT04111315|Sensory System Agents|sensory system agents|mesh-ancestor
92632296|NCT04111315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632297|NCT04111315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632301|NCT04111315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632302|NCT04111315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632303|NCT04111315|Antipyretics|antipyretics|mesh-ancestor
92632304|NCT00199563|Sildenafil Citrate|sildenafil citrate|mesh-list
92632305|NCT00199563|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632306|NCT00199563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92632307|NCT00199563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92632308|NCT00199563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632309|NCT00199563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632310|NCT00199563|Urological Agents|urological agents|mesh-ancestor
92632311|NCT04679506|Cytarabine|cytarabine|mesh-list
92632312|NCT04679506|Etoposide|etoposide|mesh-list
92632313|NCT04679506|Cladribine|cladribine|mesh-list
92632314|NCT04679506|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92632315|NCT04679506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632316|NCT04679506|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92632317|NCT04679506|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92632318|NCT04679506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632319|NCT04679506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632320|NCT04679506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632321|NCT04679506|Antimetabolites|antimetabolites|mesh-ancestor
92632322|NCT04679506|Antiviral Agents|antiviral agents|mesh-ancestor
92632323|NCT04679506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632324|NCT04679506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632325|NCT04679506|Immunologic Factors|immunologic factors|mesh-ancestor
92632326|NCT04679506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562172|NCT00406003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562173|NCT00406003|Serotonin Agents|serotonin agents|mesh-ancestor
92562174|NCT00406003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562175|NCT00406003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92562176|NCT00406003|Antidepressive Agents|antidepressive agents|mesh-ancestor
92562177|NCT00406003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632327|NCT02962830|Sufentanil|sufentanil|mesh-list
92632328|NCT02962830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92632329|NCT02962830|Narcotics|narcotics|mesh-ancestor
92632330|NCT02962830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632331|NCT02962830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632332|NCT02962830|Analgesics|analgesics|mesh-ancestor
92632333|NCT02962830|Sensory System Agents|sensory system agents|mesh-ancestor
92632334|NCT02962830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632335|NCT02962830|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92632336|NCT02962830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92632337|NCT02962830|Anesthetics, General|anesthetics, general|mesh-ancestor
92632338|NCT02962830|Anesthetics|anesthetics|mesh-ancestor
92632339|NCT00199602|Heparin|heparin|mesh-list
92632340|NCT00199602|Anticoagulants|anticoagulants|mesh-ancestor
92632341|NCT00199602|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92632342|NCT00199602|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92632343|NCT00199602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632344|NCT00554125|Sirolimus|sirolimus|mesh-list
92632345|NCT00554125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92632346|NCT00554125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632347|NCT00554125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92632348|NCT00554125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632349|NCT00554125|Antifungal Agents|antifungal agents|mesh-ancestor
92632350|NCT00554125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632351|NCT00554125|Immunologic Factors|immunologic factors|mesh-ancestor
92632352|NCT00554125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632353|NCT00175838|Aspirin|aspirin|mesh-list
92632354|NCT00175838|Hydroxyurea|hydroxyurea|mesh-list
92632355|NCT00175838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632356|NCT00175838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632357|NCT00175838|Analgesics|analgesics|mesh-ancestor
92632358|NCT00175838|Sensory System Agents|sensory system agents|mesh-ancestor
92632359|NCT00175838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632360|NCT00175838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632361|NCT00175838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632362|NCT00175838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632363|NCT00175838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92632364|NCT00175838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92632365|NCT00175838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632366|NCT00175838|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92632367|NCT00175838|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632368|NCT00175838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632369|NCT00175838|Antipyretics|antipyretics|mesh-ancestor
92632370|NCT00175838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632372|NCT00175838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92632373|NCT00204555|Imiquimod|imiquimod|mesh-list
92632374|NCT00204555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92632375|NCT00204555|Immunologic Factors|immunologic factors|mesh-ancestor
92632376|NCT00204555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632377|NCT00204555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632378|NCT00204555|Interferon Inducers|interferon inducers|mesh-ancestor
92632379|NCT00175955|Levetiracetam|levetiracetam|mesh-list
92632380|NCT00175955|Anticonvulsants|anticonvulsants|mesh-ancestor
92632381|NCT00175955|Nootropic Agents|nootropic agents|mesh-ancestor
92632382|NCT03758287|Gefitinib|gefitinib|mesh-list
92632383|NCT03758287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632384|NCT03758287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92632385|NCT03758287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632386|NCT03758287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632387|NCT00204633|Darbepoetin alfa|darbepoetin alfa|mesh-list
92632388|NCT00204633|Hematinics|hematinics|mesh-ancestor
92632389|NCT00199719|Ribavirin|ribavirin|mesh-list
92632390|NCT00199719|Antimetabolites|antimetabolites|mesh-ancestor
92632391|NCT00199719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562178|NCT00406003|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92562179|NCT00406003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92562180|NCT00406003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562181|NCT00049829|Zoledronic Acid|zoledronic acid|mesh-list
92632392|NCT00199719|Antiviral Agents|antiviral agents|mesh-ancestor
92632393|NCT00199719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632395|NCT03430882|Carboplatin|carboplatin|mesh-list
92632396|NCT03430882|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92632397|NCT03430882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92632398|NCT03430882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632399|NCT03430882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92632400|NCT03430882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92632401|NCT03430882|Mitosis Modulators|mitosis modulators|mesh-ancestor
92632402|NCT03430882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632403|NCT00199758|Gemcitabine|gemcitabine|mesh-list
92632404|NCT00199758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632405|NCT00199758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632406|NCT00199758|Antimetabolites|antimetabolites|mesh-ancestor
92632407|NCT00199758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632408|NCT03291886|Exemestane|exemestane|mesh-list
92632409|NCT03291886|Entinostat|entinostat|mesh-list
92632410|NCT03291886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632411|NCT03291886|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92632412|NCT03291886|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92632413|NCT03291886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632414|NCT03291886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632415|NCT03291886|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92632416|NCT03291886|Hormone Antagonists|hormone antagonists|mesh-ancestor
92632417|NCT03291886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632418|NCT03291886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632419|NCT03291886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92632421|NCT03252808|Gemcitabine|gemcitabine|mesh-list
92632422|NCT03252808|Tegafur|tegafur|mesh-list
92632423|NCT03252808|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92632424|NCT03252808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632425|NCT03252808|Tubulin Modulators|tubulin modulators|mesh-ancestor
92632426|NCT03252808|Antimitotic Agents|antimitotic agents|mesh-ancestor
92632427|NCT03252808|Mitosis Modulators|mitosis modulators|mesh-ancestor
92632428|NCT03252808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632429|NCT03252808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632430|NCT03252808|Antimetabolites|antimetabolites|mesh-ancestor
92632431|NCT03191461|Adenosine|adenosine|mesh-list
92632432|NCT03191461|Analgesics|analgesics|mesh-ancestor
92632433|NCT03191461|Sensory System Agents|sensory system agents|mesh-ancestor
92632434|NCT03191461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632435|NCT03191461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632436|NCT03191461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92632437|NCT03191461|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632438|NCT03191461|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92632439|NCT03191461|Purinergic Agonists|purinergic agonists|mesh-ancestor
92632440|NCT03191461|Purinergic Agents|purinergic agents|mesh-ancestor
92632441|NCT03191461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632442|NCT03191461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632443|NCT00199953|Rabeprazole|rabeprazole|mesh-list
92632444|NCT00199953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92632445|NCT00199953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039430|NCT04672005|Irinotecan|irinotecan|mesh-list
92632447|NCT00199953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632448|NCT00199953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632449|NCT03184090|Palbociclib|palbociclib|mesh-list
92632450|NCT03184090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632451|NCT03184090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92632452|NCT03184090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632453|NCT03184090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632454|NCT03160846|Milrinone|milrinone|mesh-list
92632455|NCT03160846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92632456|NCT03160846|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92632457|NCT03160846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632458|NCT03160846|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92562182|NCT00049829|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92562183|NCT00049829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562184|NCT00406042|Prednisolone|prednisolone|mesh-list
92632459|NCT03160846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92632460|NCT03160846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632461|NCT03160846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632462|NCT03160846|Protective Agents|protective agents|mesh-ancestor
92632463|NCT03160846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632464|NCT00204789|Eflornithine|eflornithine|mesh-list
92632465|NCT00204789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632466|NCT00204789|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92632467|NCT00204789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92632468|NCT00204789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92632469|NCT00204789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632470|NCT00204789|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92632471|NCT00204789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632472|NCT00204789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632473|NCT00176540|Dextromethorphan|dextromethorphan|mesh-list
92632474|NCT00176540|Antitussive Agents|antitussive agents|mesh-ancestor
92632475|NCT00176540|Respiratory System Agents|respiratory system agents|mesh-ancestor
92632476|NCT00176540|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92632477|NCT00176540|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92632478|NCT00176540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632479|NCT00176540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632480|NCT00176540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632481|NCT02830360|Amiodarone|amiodarone|mesh-list
92632482|NCT02830360|Sotalol|sotalol|mesh-list
92632483|NCT02830360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92632484|NCT02830360|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632485|NCT02830360|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92632486|NCT02830360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92632487|NCT02830360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632488|NCT02830360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92632489|NCT02830360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92632490|NCT02830360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92632491|NCT02830360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632492|NCT02830360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92632493|NCT02830360|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92632494|NCT02830360|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92632495|NCT02830360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92632496|NCT02830360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92632497|NCT02830360|Adrenergic Agents|adrenergic agents|mesh-ancestor
92632498|NCT02830360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632499|NCT02830360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632500|NCT02830360|Sympatholytics|sympatholytics|mesh-ancestor
92632501|NCT02830360|Autonomic Agents|autonomic agents|mesh-ancestor
92632502|NCT02830360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632503|NCT02827435|Bromides|bromides|mesh-list
92632504|NCT02827435|Rocuronium|rocuronium|mesh-list
92632505|NCT02827435|Anticonvulsants|anticonvulsants|mesh-ancestor
92632506|NCT02827435|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92632507|NCT02827435|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92632508|NCT02827435|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92632509|NCT02827435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632510|NCT02827435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632511|NCT00176618|Curcumin|curcumin|mesh-list
92632512|NCT00176618|Sulindac|sulindac|mesh-list
92632513|NCT00176618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632514|NCT00176618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632515|NCT00176618|Analgesics|analgesics|mesh-ancestor
92632516|NCT00176618|Sensory System Agents|sensory system agents|mesh-ancestor
92632517|NCT00176618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632520|NCT00176618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632521|NCT00176618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632522|NCT00176618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632523|NCT00176618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632524|NCT00176618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632525|NCT02675959|Defibrotide|defibrotide|mesh-list
92632526|NCT02675959|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92632527|NCT02675959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92562185|NCT00406042|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92562186|NCT00406042|Methylprednisolone|methylprednisolone|mesh-list
92562187|NCT00406042|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92562188|NCT00406042|Prednisolone acetate|prednisolone acetate|mesh-list
92562189|NCT00406042|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92562190|NCT00406042|Prednisolone phosphate|prednisolone phosphate|mesh-list
92632528|NCT02675959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632529|NCT02675959|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92632530|NCT00410787|Hydromorphone|hydromorphone|mesh-list
92632531|NCT00410787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92632532|NCT00410787|Narcotics|narcotics|mesh-ancestor
92632533|NCT00410787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632534|NCT00410787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632535|NCT00410787|Analgesics|analgesics|mesh-ancestor
92632536|NCT00410787|Sensory System Agents|sensory system agents|mesh-ancestor
92632537|NCT00410787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632538|NCT00554164|Prednisone|prednisone|mesh-list
92632539|NCT00554164|Cyclophosphamide|cyclophosphamide|mesh-list
92632540|NCT00554164|Doxorubicin|doxorubicin|mesh-list
92632541|NCT00554164|Vincristine|vincristine|mesh-list
92632542|NCT00554164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632543|NCT00554164|Immunologic Factors|immunologic factors|mesh-ancestor
92632544|NCT00554164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632545|NCT00554164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632546|NCT00554164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92632547|NCT00554164|Alkylating Agents|alkylating agents|mesh-ancestor
92632548|NCT00554164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632549|NCT00554164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632550|NCT00554164|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92632551|NCT00554164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92632552|NCT00554164|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92632553|NCT00554164|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92632554|NCT00554164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632555|NCT00554164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632556|NCT00554164|Glucocorticoids|glucocorticoids|mesh-ancestor
92632557|NCT00554164|Hormones|hormones|mesh-ancestor
92632558|NCT00554164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632559|NCT00554164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92632560|NCT00554164|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92632561|NCT00554164|Tubulin Modulators|tubulin modulators|mesh-ancestor
92632562|NCT00554164|Antimitotic Agents|antimitotic agents|mesh-ancestor
92632563|NCT00554164|Mitosis Modulators|mitosis modulators|mesh-ancestor
92632565|NCT02572141|Fluorouracil|fluorouracil|mesh-list
92632566|NCT02572141|Capecitabine|capecitabine|mesh-list
92632567|NCT02572141|Oxaliplatin|oxaliplatin|mesh-list
92632568|NCT02572141|Levoleucovorin|levoleucovorin|mesh-list
92632569|NCT02572141|Antimetabolites|antimetabolites|mesh-ancestor
92632570|NCT02572141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632571|NCT02572141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632572|NCT02572141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632573|NCT02572141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632574|NCT02572141|Immunologic Factors|immunologic factors|mesh-ancestor
92632575|NCT02572141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632576|NCT02572141|Antidotes|antidotes|mesh-ancestor
92632577|NCT02572141|Protective Agents|protective agents|mesh-ancestor
92632578|NCT02572141|Vitamin B Complex|vitamin b complex|mesh-ancestor
92632579|NCT02572141|Vitamins|vitamins|mesh-ancestor
92632580|NCT02572141|Micronutrients|micronutrients|mesh-ancestor
92632581|NCT02470039|Insulin|insulin|mesh-list
92632582|NCT02470039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92632583|NCT02470039|Insulin Glargine|insulin glargine|mesh-list
92632584|NCT02470039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92632585|NCT02470039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632586|NCT00554203|Sulfasalazine|sulfasalazine|mesh-list
92632587|NCT00554203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632588|NCT00554203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632589|NCT00554203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632590|NCT00554203|Analgesics|analgesics|mesh-ancestor
92632591|NCT00554203|Sensory System Agents|sensory system agents|mesh-ancestor
92632592|NCT00554203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632596|NCT00554203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92632598|NCT00554242|Grape Seed Extract|grape seed extract|mesh-list
92632599|NCT00554242|Antioxidants|antioxidants|mesh-ancestor
92632600|NCT00554242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632601|NCT00554242|Protective Agents|protective agents|mesh-ancestor
92632602|NCT00554242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632603|NCT00554242|Vitamins|vitamins|mesh-ancestor
92632604|NCT00554242|Micronutrients|micronutrients|mesh-ancestor
92632605|NCT00554242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92632606|NCT00554242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632607|NCT00176735|Capecitabine|capecitabine|mesh-list
92632608|NCT00176735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632609|NCT00176735|Antimetabolites|antimetabolites|mesh-ancestor
92632610|NCT00176735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632611|NCT00176735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632612|NCT00410943|Hydromorphone|hydromorphone|mesh-list
92632613|NCT00410943|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92632614|NCT00410943|Narcotics|narcotics|mesh-ancestor
92632615|NCT00410943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632616|NCT00410943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632617|NCT00410943|Analgesics|analgesics|mesh-ancestor
92632618|NCT00410943|Sensory System Agents|sensory system agents|mesh-ancestor
92632619|NCT00410943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632620|NCT00176774|Leucovorin|leucovorin|mesh-list
92632621|NCT00176774|Fluorouracil|fluorouracil|mesh-list
92632622|NCT00176774|Irinotecan|irinotecan|mesh-list
92632623|NCT00176774|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92632624|NCT00176774|Antimetabolites|antimetabolites|mesh-ancestor
92632625|NCT00176774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632626|NCT00176774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632627|NCT00176774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632628|NCT00176774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632629|NCT00176774|Immunologic Factors|immunologic factors|mesh-ancestor
92014892|NCT05730439|Autonomic Agents|autonomic agents|mesh-ancestor
92632630|NCT00176774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632631|NCT00176774|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92632632|NCT00176774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92632633|NCT00176774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632634|NCT00176774|Antidotes|antidotes|mesh-ancestor
92632635|NCT00176774|Protective Agents|protective agents|mesh-ancestor
92632636|NCT00176774|Vitamin B Complex|vitamin b complex|mesh-ancestor
92632637|NCT00176774|Vitamins|vitamins|mesh-ancestor
92632638|NCT00176774|Micronutrients|micronutrients|mesh-ancestor
92632639|NCT00176774|Chelating Agents|chelating agents|mesh-ancestor
92632640|NCT00176774|Sequestering Agents|sequestering agents|mesh-ancestor
92632641|NCT00176774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92632642|NCT00176774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92632643|NCT00176774|Growth Substances|growth substances|mesh-ancestor
92632644|NCT00176774|Growth Inhibitors|growth inhibitors|mesh-ancestor
92632645|NCT02434744|Metformin|metformin|mesh-list
92632646|NCT02434744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92632647|NCT02434744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632648|NCT02421679|Cyclobenzaprine|cyclobenzaprine|mesh-list
92632649|NCT02421679|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92632650|NCT02421679|Antidepressive Agents|antidepressive agents|mesh-ancestor
92632651|NCT02421679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632652|NCT02421679|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92632653|NCT02421679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632654|NCT02421679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92632655|NCT02421679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632656|NCT02421679|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92632657|NCT02421679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632658|NCT00410982|Rituximab|rituximab|mesh-list
92632659|NCT00410982|Gemcitabine|gemcitabine|mesh-list
92632660|NCT00410982|Melphalan|melphalan|mesh-list
92632661|NCT00410982|Busulfan|busulfan|mesh-list
92632662|NCT00410982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92632663|NCT00410982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632664|NCT00410982|Immunologic Factors|immunologic factors|mesh-ancestor
92632665|NCT00410982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632666|NCT00410982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632668|NCT00410982|Antimetabolites|antimetabolites|mesh-ancestor
92632669|NCT00410982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632670|NCT00410982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92632671|NCT00410982|Alkylating Agents|alkylating agents|mesh-ancestor
92632672|NCT00410982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92632673|NCT00410982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632675|NCT02372578|Analgesics|analgesics|mesh-ancestor
92562191|NCT00406042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562192|NCT00406042|Glucocorticoids|glucocorticoids|mesh-ancestor
92562193|NCT00406042|Hormones|hormones|mesh-ancestor
92562194|NCT00406042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562195|NCT00406042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632676|NCT02372578|Sensory System Agents|sensory system agents|mesh-ancestor
92632677|NCT02372578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632678|NCT02372578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632679|NCT02372578|Anticonvulsants|anticonvulsants|mesh-ancestor
92632680|NCT02372578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92632681|NCT02372578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92632682|NCT02372578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632683|NCT02372578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92632684|NCT02372578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92632685|NCT02372578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92632686|NCT02372578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632687|NCT02372578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632688|NCT00554398|Raltegravir Potassium|raltegravir potassium|mesh-list
92632689|NCT00554398|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92632690|NCT00554398|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92632691|NCT00554398|Antiviral Agents|antiviral agents|mesh-ancestor
92632692|NCT00554398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632693|NCT00554398|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92632694|NCT00554398|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92632695|NCT00554398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632696|NCT00554398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632697|NCT00554476|Triamcinolone|triamcinolone|mesh-list
92632698|NCT00554476|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92632699|NCT00554476|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92632700|NCT00554476|Indomethacin|indomethacin|mesh-list
92632701|NCT00554476|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92632702|NCT00554476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632703|NCT00554476|Glucocorticoids|glucocorticoids|mesh-ancestor
92632704|NCT00554476|Hormones|hormones|mesh-ancestor
92632705|NCT00554476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632706|NCT00554476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632707|NCT00554476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632708|NCT00554476|Immunologic Factors|immunologic factors|mesh-ancestor
92632709|NCT00554476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632710|NCT00554476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632711|NCT00554476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632712|NCT00554476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632713|NCT00554476|Analgesics|analgesics|mesh-ancestor
92632714|NCT00554476|Sensory System Agents|sensory system agents|mesh-ancestor
92632715|NCT00554476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632716|NCT00554476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632717|NCT00554476|Gout Suppressants|gout suppressants|mesh-ancestor
92632718|NCT00554476|Tocolytic Agents|tocolytic agents|mesh-ancestor
92632719|NCT00554476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92632720|NCT00554476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632721|NCT02336698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92632722|NCT02336698|Immunologic Factors|immunologic factors|mesh-ancestor
92632723|NCT02336698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632724|NCT00204906|Vitamin D|vitamin d|mesh-list
92632725|NCT00204906|Vitamins|vitamins|mesh-ancestor
92632726|NCT00204906|Micronutrients|micronutrients|mesh-ancestor
92632727|NCT00204906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632728|NCT00204906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92632729|NCT02335918|Nivolumab|nivolumab|mesh-list
92632730|NCT02335918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92632731|NCT02335918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632732|NCT02335918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92632733|NCT02335918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632734|NCT00176813|Celecoxib|celecoxib|mesh-list
92632735|NCT00176813|Gemcitabine|gemcitabine|mesh-list
92632736|NCT00176813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632737|NCT00176813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632738|NCT00176813|Antimetabolites|antimetabolites|mesh-ancestor
92039725|NCT04845217|Parasympatholytics|parasympatholytics|mesh-ancestor
92562196|NCT00406042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92562198|NCT00406042|Antiemetics|antiemetics|mesh-ancestor
92562199|NCT00406042|Autonomic Agents|autonomic agents|mesh-ancestor
92632742|NCT00176813|Analgesics|analgesics|mesh-ancestor
92632743|NCT00176813|Sensory System Agents|sensory system agents|mesh-ancestor
92632744|NCT00176813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632745|NCT00176813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632746|NCT00176813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632747|NCT00176813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632748|NCT00176813|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92632749|NCT00176813|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632750|NCT00176813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632751|NCT04678531|Tea Tree Oil|tea tree oil|mesh-list
92632752|NCT04678531|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92632753|NCT04678531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632754|NCT02320708|Acetaminophen|acetaminophen|mesh-list
92632755|NCT02320708|Ibuprofen|ibuprofen|mesh-list
92632756|NCT02320708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632757|NCT02320708|Analgesics|analgesics|mesh-ancestor
92632758|NCT02320708|Sensory System Agents|sensory system agents|mesh-ancestor
92632759|NCT02320708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632760|NCT02320708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632761|NCT02320708|Antipyretics|antipyretics|mesh-ancestor
92632762|NCT02320708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632763|NCT02320708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632764|NCT02320708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632765|NCT02320708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632766|NCT02320708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632767|NCT02320708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632768|NCT02309671|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92632769|NCT02309671|Hormones|hormones|mesh-ancestor
92632770|NCT02309671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632771|NCT02309671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632772|NCT02296645|Ethanol|ethanol|mesh-list
92632773|NCT02296645|Chlorhexidine|chlorhexidine|mesh-list
92632774|NCT02296645|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92632775|NCT02296645|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92632776|NCT02296645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632777|NCT02296645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632778|NCT02296645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632779|NCT02296645|Disinfectants|disinfectants|mesh-ancestor
92632780|NCT02296645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92632781|NCT02295865|Toreforant|toreforant|mesh-list
92632782|NCT02295865|Histamine Antagonists|histamine antagonists|mesh-ancestor
92632783|NCT02295865|Histamine Agents|histamine agents|mesh-ancestor
92632784|NCT02295865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632785|NCT02295865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632786|NCT02295865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632787|NCT02282215|Lenograstim|lenograstim|mesh-list
92632788|NCT02282215|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92632789|NCT02282215|Immunologic Factors|immunologic factors|mesh-ancestor
92632790|NCT02282215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632791|NCT00176969|Capsaicin|capsaicin|mesh-list
92632792|NCT00176969|Antipruritics|antipruritics|mesh-ancestor
92632793|NCT00176969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92632794|NCT00176969|Sensory System Agents|sensory system agents|mesh-ancestor
92632795|NCT00176969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632796|NCT00176969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632797|NCT00204945|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92632798|NCT00204945|Natriuretic Agents|natriuretic agents|mesh-ancestor
92632799|NCT00204945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632800|NCT00177008|Aripiprazole|aripiprazole|mesh-list
92632801|NCT00177008|Antidepressive Agents|antidepressive agents|mesh-ancestor
92632802|NCT00177008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632803|NCT00177008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92632804|NCT00177008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92632805|NCT00177008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632806|NCT00177008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632807|NCT00177008|Dopamine Agonists|dopamine agonists|mesh-ancestor
92632808|NCT00177008|Dopamine Agents|dopamine agents|mesh-ancestor
92632809|NCT00177008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562200|NCT00406042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562201|NCT00406042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562202|NCT00406042|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92632813|NCT00177008|Serotonin Agents|serotonin agents|mesh-ancestor
92632814|NCT00177008|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92632815|NCT00177008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92632816|NCT00177008|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92632817|NCT00177008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92632818|NCT04677985|Analgesics|analgesics|mesh-list
92632819|NCT04677985|Menthol|menthol|mesh-list
92632820|NCT04677985|Sensory System Agents|sensory system agents|mesh-ancestor
92632821|NCT04677985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632822|NCT04677985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632823|NCT04677985|Antipruritics|antipruritics|mesh-ancestor
92632824|NCT04677985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92632825|NCT00554632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92632826|NCT00554632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92632827|NCT00554632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92632828|NCT00554632|Norgestimate|norgestimate|mesh-list
92632829|NCT00554632|Norelgestromin|norelgestromin|mesh-list
92632830|NCT00554632|Ortho Evra|ortho evra|mesh-list
92632831|NCT00554632|Estradiol|estradiol|mesh-list
92632832|NCT00554632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92632833|NCT00554632|Estrogens|estrogens|mesh-ancestor
92632834|NCT00554632|Hormones|hormones|mesh-ancestor
92632835|NCT00554632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632836|NCT00554632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632837|NCT00554632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92632838|NCT00554632|Contraceptive Agents|contraceptive agents|mesh-ancestor
92632839|NCT00554632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92632840|NCT00554632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92632841|NCT00554632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92632842|NCT00554632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92632843|NCT00554632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92632844|NCT00204984|Hydralazine|hydralazine|mesh-list
92632845|NCT00204984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92632846|NCT00204984|Natriuretic Agents|natriuretic agents|mesh-ancestor
92632847|NCT00204984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632848|NCT00204984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92632849|NCT00204984|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632850|NCT02236195|Mocetinostat|mocetinostat|mesh-list
92632851|NCT02236195|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92632852|NCT02236195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632853|NCT02236195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632854|NCT02236156|Metronidazole|metronidazole|mesh-list
92632855|NCT02236156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632856|NCT02236156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92632857|NCT02236156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92632858|NCT02236156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92632859|NCT00177086|Alfuzosin|alfuzosin|mesh-list
92632860|NCT00177086|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92632861|NCT00177086|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92632862|NCT00177086|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92632864|NCT00177086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632865|NCT00177086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632866|NCT00177086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632867|NCT00177086|Urological Agents|urological agents|mesh-ancestor
92632868|NCT02207257|Edoxaban|edoxaban|mesh-list
92632869|NCT02207257|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92632870|NCT02207257|Antithrombins|antithrombins|mesh-ancestor
92632871|NCT02207257|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92632872|NCT02207257|Protease Inhibitors|protease inhibitors|mesh-ancestor
92632873|NCT02207257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632874|NCT02207257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632875|NCT02207257|Anticoagulants|anticoagulants|mesh-ancestor
92632876|NCT00554710|Methylprednisolone|methylprednisolone|mesh-list
92632877|NCT00554710|Budesonide|budesonide|mesh-list
92632878|NCT00554710|Infliximab|infliximab|mesh-list
92632879|NCT00554710|Azathioprine|azathioprine|mesh-list
92632880|NCT00554710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632881|NCT00554710|Antiemetics|antiemetics|mesh-ancestor
92632882|NCT00554710|Autonomic Agents|autonomic agents|mesh-ancestor
92632883|NCT00554710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632884|NCT00554710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562203|NCT00406042|Protective Agents|protective agents|mesh-ancestor
92562204|NCT00082563|Azithromycin|azithromycin|mesh-list
92562205|NCT00082563|Chloroquine|chloroquine|mesh-list
92562206|NCT00082563|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92562207|NCT00082563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980924|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
92632885|NCT00554710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92632886|NCT00554710|Glucocorticoids|glucocorticoids|mesh-ancestor
92632888|NCT00554710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92632889|NCT00554710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92632890|NCT00554710|Protective Agents|protective agents|mesh-ancestor
92632891|NCT00554710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632892|NCT00554710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92632893|NCT00554710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92632894|NCT00554710|Respiratory System Agents|respiratory system agents|mesh-ancestor
92632895|NCT00554710|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92632896|NCT00554710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92632897|NCT00554710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632898|NCT00554710|Antimetabolites|antimetabolites|mesh-ancestor
92632899|NCT00554710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632900|NCT00554710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632901|NCT00554710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632902|NCT00554710|Immunologic Factors|immunologic factors|mesh-ancestor
92632903|NCT00200187|Anesthetics|anesthetics|mesh-list
92632904|NCT00200187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632905|NCT00200187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632906|NCT04659109|Glenzocimab|glenzocimab|mesh-list
92632907|NCT04659109|Anticoagulants|anticoagulants|mesh-ancestor
92632908|NCT00177242|Gefitinib|gefitinib|mesh-list
92632909|NCT00177242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632910|NCT00177242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92632911|NCT00177242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632912|NCT00177242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632913|NCT04659070|Telmisartan|telmisartan|mesh-list
92632914|NCT04659070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92632915|NCT04659070|Ezetimibe|ezetimibe|mesh-list
92632916|NCT04659070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92632917|NCT04659070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92632918|NCT04659070|Antimetabolites|antimetabolites|mesh-ancestor
92632919|NCT04659070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632920|NCT04659070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92632921|NCT04659070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92632922|NCT04659070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632923|NCT04659070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92632924|NCT04659070|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92632925|NCT04659070|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92632926|NCT00177281|Belotecan|belotecan|mesh-list
92632927|NCT00177281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92632928|NCT00177281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92632929|NCT00177281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92632930|NCT00177281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632931|NCT00177281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632932|NCT00200226|Vitamin B 6|vitamin b 6|mesh-list
92632933|NCT00200226|Pyridoxal|pyridoxal|mesh-list
92632934|NCT00200226|Pyridoxine|pyridoxine|mesh-list
92632935|NCT00200226|Misoprostol|misoprostol|mesh-list
92632936|NCT00200226|Vitamins|vitamins|mesh-ancestor
92632937|NCT00200226|Micronutrients|micronutrients|mesh-ancestor
92632938|NCT00200226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632939|NCT00200226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92632940|NCT00200226|Abortifacient Agents|abortifacient agents|mesh-ancestor
92632941|NCT00200226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92632942|NCT00200226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92632943|NCT00200226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92632944|NCT00200226|Oxytocics|oxytocics|mesh-ancestor
92632945|NCT00200226|Vitamin B Complex|vitamin b complex|mesh-ancestor
92632946|NCT04658329|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92632947|NCT04658329|Antiviral Agents|antiviral agents|mesh-ancestor
92632948|NCT04658329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92632949|NCT00557557|Oxaliplatin|oxaliplatin|mesh-list
92562208|NCT00082563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562209|NCT00082563|Amebicides|amebicides|mesh-ancestor
92562210|NCT00082563|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92562211|NCT00082563|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92562212|NCT00082563|Antimalarials|antimalarials|mesh-ancestor
92632950|NCT00557557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632951|NCT04658134|Glycine|glycine|mesh-list
92632952|NCT04658134|Glycine Agents|glycine agents|mesh-ancestor
92632953|NCT04658134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632954|NCT04658134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632955|NCT04658134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632956|NCT00200382|Bortezomib|bortezomib|mesh-list
92632957|NCT00200382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632958|NCT04657744|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92632959|NCT04657744|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92632963|NCT04657744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632964|NCT00177398|Insulin|insulin|mesh-list
92632965|NCT00177398|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92632966|NCT00177398|Insulin Glargine|insulin glargine|mesh-list
92632967|NCT00177398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406462|NCT01438866|Fluorides, Topical|fluorides, topical|mesh-list
92632968|NCT00177398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632969|NCT00200421|Atenolol|atenolol|mesh-list
92632970|NCT00200421|Nebivolol|nebivolol|mesh-list
92632971|NCT00200421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92632972|NCT00200421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92632973|NCT00200421|Sympatholytics|sympatholytics|mesh-ancestor
92632974|NCT00200421|Autonomic Agents|autonomic agents|mesh-ancestor
92632975|NCT00200421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92632976|NCT00200421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632977|NCT00200421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92632978|NCT00200421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92632979|NCT00200421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92632980|NCT00200421|Adrenergic Agents|adrenergic agents|mesh-ancestor
92632981|NCT00200421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632982|NCT00200421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632983|NCT00200421|Vasodilator Agents|vasodilator agents|mesh-ancestor
92632984|NCT00200421|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92632985|NCT00200421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92632986|NCT00200421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92632987|NCT04656106|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92632988|NCT04656106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92632989|NCT04656106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632990|NCT04656262|Cyclophosphamide|cyclophosphamide|mesh-list
92632991|NCT04656262|Doxorubicin|doxorubicin|mesh-list
92632992|NCT04656262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632993|NCT04656262|Immunologic Factors|immunologic factors|mesh-ancestor
92632994|NCT04656262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632995|NCT04656262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632996|NCT04656262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92632997|NCT04656262|Alkylating Agents|alkylating agents|mesh-ancestor
92632998|NCT04656262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632999|NCT04656262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633000|NCT04656262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633001|NCT04656262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633002|NCT04656262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633003|NCT04656262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633004|NCT04656262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633005|NCT00200460|Nebivolol|nebivolol|mesh-list
92633006|NCT00200460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92633007|NCT00200460|Vasodilator Agents|vasodilator agents|mesh-ancestor
92633008|NCT00200460|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92633009|NCT00200460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92633010|NCT00200460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92633011|NCT00200460|Adrenergic Agents|adrenergic agents|mesh-ancestor
92633012|NCT00200460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633013|NCT00200460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633014|NCT00200460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633016|NCT00200499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92633017|NCT00200499|Vasodilator Agents|vasodilator agents|mesh-ancestor
92633018|NCT00200499|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92562213|NCT00082563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562214|NCT00082563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92633019|NCT00200499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92633020|NCT00200499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92633021|NCT00200499|Adrenergic Agents|adrenergic agents|mesh-ancestor
92633022|NCT00200499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633023|NCT00200499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633024|NCT00200499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633025|NCT00200538|Memantine|memantine|mesh-list
92633026|NCT00200538|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92633027|NCT00200538|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92633028|NCT00200538|Dopamine Agents|dopamine agents|mesh-ancestor
92633029|NCT00200538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633030|NCT00200538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633034|NCT00177710|Amphotericin B|amphotericin b|mesh-list
92633035|NCT00177710|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92633036|NCT00177710|Amebicides|amebicides|mesh-ancestor
92633037|NCT00177710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92633038|NCT00177710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92633039|NCT00177710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633040|NCT00177710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92633041|NCT00177710|Antifungal Agents|antifungal agents|mesh-ancestor
92633042|NCT00177749|Posaconazole|posaconazole|mesh-list
92633043|NCT00177749|Antifungal Agents|antifungal agents|mesh-ancestor
92633044|NCT00177749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633045|NCT00177749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92633046|NCT00177749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92633047|NCT00177749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92633048|NCT00177749|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92633049|NCT00177749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92633050|NCT00177749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633051|NCT00177749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633052|NCT00177749|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92633053|NCT00177749|Hormone Antagonists|hormone antagonists|mesh-ancestor
92633054|NCT00177749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633055|NCT00177749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633056|NCT00205491|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92633057|NCT00205491|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92633058|NCT00205491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92633059|NCT00205491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633060|NCT00205491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633061|NCT00205491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633062|NCT00205491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633063|NCT00205491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92633064|NCT00205491|Antidepressive Agents|antidepressive agents|mesh-ancestor
92633065|NCT00205491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633066|NCT04654819|Anesthetics|anesthetics|mesh-list
92633067|NCT04654819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633068|NCT04654819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633069|NCT04654741|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92633070|NCT04654741|Medroxyprogesterone|medroxyprogesterone|mesh-list
92633071|NCT04654741|Ganirelix|ganirelix|mesh-list
92633072|NCT04654741|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92633073|NCT04654741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92633074|NCT04654741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92633075|NCT04654741|Contraceptive Agents|contraceptive agents|mesh-ancestor
92633076|NCT04654741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92633077|NCT04654741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633078|NCT04654741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92633079|NCT04654741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92633080|NCT04654741|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92633081|NCT04654741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92633082|NCT04654741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633083|NCT04654741|Hormone Antagonists|hormone antagonists|mesh-ancestor
92633084|NCT04654741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633085|NCT04654195|Cyclophosphamide|cyclophosphamide|mesh-list
92633086|NCT04654195|Doxorubicin|doxorubicin|mesh-list
92633087|NCT04654195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633088|NCT04654195|Immunologic Factors|immunologic factors|mesh-ancestor
92752325|NCT05940701|Sodium Fluoride|sodium fluoride|mesh-list
92562215|NCT00082563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92562216|NCT00082563|Analgesics|analgesics|mesh-ancestor
92633089|NCT04654195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633090|NCT04654195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633091|NCT04654195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633092|NCT04654195|Alkylating Agents|alkylating agents|mesh-ancestor
92633093|NCT04654195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633094|NCT04654195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633095|NCT04654195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633096|NCT04654195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633097|NCT04654195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633098|NCT04654195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633102|NCT03454789|Lidocaine|lidocaine|mesh-list
92633103|NCT03454789|Anesthetics, Local|anesthetics, local|mesh-ancestor
92633104|NCT03454789|Anesthetics|anesthetics|mesh-ancestor
92633105|NCT03454789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633106|NCT03454789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633107|NCT03454789|Sensory System Agents|sensory system agents|mesh-ancestor
92633108|NCT03454789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633109|NCT03454789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92633110|NCT03454789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92633111|NCT03454789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92633112|NCT03454789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633113|NCT03454789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633114|NCT00200655|Pravastatin|pravastatin|mesh-list
92633115|NCT00200655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92633116|NCT00200655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92633117|NCT00200655|Antimetabolites|antimetabolites|mesh-ancestor
92633118|NCT00200655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633119|NCT00200655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92633120|NCT00200655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92633121|NCT00200655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633122|NCT04653493|Cyclophosphamide|cyclophosphamide|mesh-list
92633123|NCT04653493|Fludarabine|fludarabine|mesh-list
92633124|NCT04653493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633125|NCT04653493|Immunologic Factors|immunologic factors|mesh-ancestor
92633126|NCT04653493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633127|NCT04653493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633128|NCT04653493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633129|NCT04653493|Alkylating Agents|alkylating agents|mesh-ancestor
92633130|NCT04653493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633131|NCT04653493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633132|NCT04653493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633133|NCT00200694|Valsartan|valsartan|mesh-list
92633134|NCT00200694|Ramipril|ramipril|mesh-list
92633135|NCT00200694|Furosemide|furosemide|mesh-list
92633136|NCT00200694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92633137|NCT00200694|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92633138|NCT00200694|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92633139|NCT00200694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633140|NCT00200694|Diuretics|diuretics|mesh-ancestor
92633141|NCT00200694|Natriuretic Agents|natriuretic agents|mesh-ancestor
92633142|NCT00200694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633143|NCT00200694|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92633144|NCT00200694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633145|NCT00200694|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92633146|NCT00200694|Protease Inhibitors|protease inhibitors|mesh-ancestor
92633147|NCT00200694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633148|NCT00557713|Bevacizumab|bevacizumab|mesh-list
92633149|NCT00557713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92633150|NCT00557713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633151|NCT00557713|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92633152|NCT00557713|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92633153|NCT00557713|Growth Substances|growth substances|mesh-ancestor
92633154|NCT00557713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633155|NCT00557713|Growth Inhibitors|growth inhibitors|mesh-ancestor
92633156|NCT00178100|Paroxetine|paroxetine|mesh-list
92633157|NCT00178100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92633158|NCT00178100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92633159|NCT00178100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562217|NCT00082563|Sensory System Agents|sensory system agents|mesh-ancestor
92562218|NCT00082563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562219|NCT00082563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981212|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
92633160|NCT00178100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633161|NCT00178100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633162|NCT00178100|Serotonin Agents|serotonin agents|mesh-ancestor
92633163|NCT00178100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633164|NCT00178100|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92633165|NCT00178100|Antidepressive Agents|antidepressive agents|mesh-ancestor
92633166|NCT00178100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633167|NCT00178100|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92633173|NCT04653415|Prednisolone|prednisolone|mesh-list
92633174|NCT04653415|Prednisolone acetate|prednisolone acetate|mesh-list
92633175|NCT04653415|Gabapentin|gabapentin|mesh-list
92633176|NCT04653415|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92633177|NCT04653415|Prednisolone phosphate|prednisolone phosphate|mesh-list
92633178|NCT04653415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633179|NCT04653415|Antiemetics|antiemetics|mesh-ancestor
92633180|NCT04653415|Autonomic Agents|autonomic agents|mesh-ancestor
92633181|NCT04653415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633182|NCT04653415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633183|NCT04653415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633184|NCT04653415|Glucocorticoids|glucocorticoids|mesh-ancestor
92633185|NCT04653415|Hormones|hormones|mesh-ancestor
92633186|NCT04653415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633187|NCT04653415|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92633188|NCT04653415|Protective Agents|protective agents|mesh-ancestor
92633189|NCT04653415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92633190|NCT04653415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633191|NCT04653415|Analgesics|analgesics|mesh-ancestor
92633192|NCT04653415|Sensory System Agents|sensory system agents|mesh-ancestor
92633193|NCT04653415|Anticonvulsants|anticonvulsants|mesh-ancestor
92633194|NCT04653415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92633195|NCT04653415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92633196|NCT04653415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633197|NCT04653415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633198|NCT04653415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92633199|NCT04653415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92633200|NCT04653415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633201|NCT04653415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633202|NCT04653415|Antimanic Agents|antimanic agents|mesh-ancestor
92633203|NCT00557791|Ranibizumab|ranibizumab|mesh-list
92633204|NCT00557791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92633205|NCT00557791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92633206|NCT00557791|Growth Substances|growth substances|mesh-ancestor
92633207|NCT00557791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633208|NCT00557791|Growth Inhibitors|growth inhibitors|mesh-ancestor
92633209|NCT00557791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633210|NCT04652284|Amoxicillin|amoxicillin|mesh-list
92633211|NCT04652284|Clarithromycin|clarithromycin|mesh-list
92633212|NCT04652284|Rifabutin|rifabutin|mesh-list
92633213|NCT04652284|Tinidazole|tinidazole|mesh-list
92633214|NCT04652284|Esomeprazole|esomeprazole|mesh-list
92633215|NCT04652284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92633216|NCT04652284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633217|NCT04652284|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92633218|NCT04652284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633219|NCT04652284|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92633220|NCT04652284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633221|NCT04652284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633222|NCT04652284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92633223|NCT04652284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92633224|NCT04652284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92633225|NCT04652284|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92633226|NCT04652284|Antitubercular Agents|antitubercular agents|mesh-ancestor
92633227|NCT04652284|Alkylating Agents|alkylating agents|mesh-ancestor
92633228|NCT04652284|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92633229|NCT04652284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92633230|NCT04652284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92358420|NCT00223236|Choline|choline|mesh-list
92562220|NCT00082563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562221|NCT00082563|Filaricides|filaricides|mesh-ancestor
92562222|NCT00082563|Antinematodal Agents|antinematodal agents|mesh-ancestor
92562223|NCT00082563|Anthelmintics|anthelmintics|mesh-ancestor
92562224|NCT00151528|Pregabalin|pregabalin|mesh-list
92562225|NCT00151528|Analgesics|analgesics|mesh-ancestor
92562226|NCT00151528|Sensory System Agents|sensory system agents|mesh-ancestor
92633231|NCT04652323|Calcium|calcium|mesh-list
92633232|NCT04652323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92633233|NCT04652323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633234|NCT04652011|Analgesics|analgesics|mesh-list
92633235|NCT04652011|Sensory System Agents|sensory system agents|mesh-ancestor
92633236|NCT04652011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633237|NCT04652011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633240|NCT04652128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633241|NCT00205725|Olanzapine|olanzapine|mesh-list
92633242|NCT00205725|Ziprasidone|ziprasidone|mesh-list
92633243|NCT00205725|Antiemetics|antiemetics|mesh-ancestor
92633244|NCT00205725|Autonomic Agents|autonomic agents|mesh-ancestor
92633245|NCT00205725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933446|NCT02231255|Pramipexole|pramipexole|mesh-list
92633246|NCT00205725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633247|NCT00205725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633248|NCT00205725|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92633249|NCT00205725|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92633250|NCT00205725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633251|NCT00205725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633252|NCT00205725|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92633253|NCT00205725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92633254|NCT00205725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633255|NCT00205725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633256|NCT00205725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633257|NCT00205725|Serotonin Agents|serotonin agents|mesh-ancestor
92633258|NCT00205725|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92633259|NCT00205725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92633260|NCT00205725|Dopamine Agents|dopamine agents|mesh-ancestor
92633261|NCT00178373|Modafinil|modafinil|mesh-list
92633262|NCT00178373|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92633263|NCT00178373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633264|NCT00178373|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92633265|NCT00178373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92633266|NCT00178373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92633267|NCT00178373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633268|NCT00205764|Melphalan|melphalan|mesh-list
92633269|NCT00205764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633270|NCT00205764|Alkylating Agents|alkylating agents|mesh-ancestor
92633271|NCT00205764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633272|NCT00205764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633273|NCT00205764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633274|NCT00205764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633275|NCT00205764|Immunologic Factors|immunologic factors|mesh-ancestor
92633276|NCT00205764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633277|NCT00558142|Acetylcysteine|acetylcysteine|mesh-list
92633278|NCT00558142|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92633279|NCT00558142|Antiviral Agents|antiviral agents|mesh-ancestor
92633280|NCT00558142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633281|NCT00558142|Expectorants|expectorants|mesh-ancestor
92633282|NCT00558142|Respiratory System Agents|respiratory system agents|mesh-ancestor
92633283|NCT00558142|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92633284|NCT00558142|Antioxidants|antioxidants|mesh-ancestor
92633285|NCT00558142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633286|NCT00558142|Protective Agents|protective agents|mesh-ancestor
92633287|NCT00558142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633288|NCT00558142|Antidotes|antidotes|mesh-ancestor
92633289|NCT00205842|Alvimopan|alvimopan|mesh-list
92633290|NCT00205842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633291|NCT00178451|Abciximab|abciximab|mesh-list
92633292|NCT00178451|Anticoagulants|anticoagulants|mesh-ancestor
92633293|NCT00178451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92633294|NCT00206115|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92562227|NCT00151528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562228|NCT00151528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562229|NCT00151528|Anticonvulsants|anticonvulsants|mesh-ancestor
92090444|NCT01903031|Efavirenz|efavirenz|mesh-list
92633295|NCT00206115|Antidepressive Agents|antidepressive agents|mesh-ancestor
92633296|NCT00206115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633297|NCT00206115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92633298|NCT00206115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92633299|NCT00206115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633300|NCT00206115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633301|NCT00206154|Budesonide|budesonide|mesh-list
92633302|NCT00206154|Formoterol Fumarate|formoterol fumarate|mesh-list
92633303|NCT00206154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633304|NCT00206154|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92358492|NCT00225498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633305|NCT00206154|Autonomic Agents|autonomic agents|mesh-ancestor
92633306|NCT00206154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633307|NCT00206154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633308|NCT00206154|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92633309|NCT00206154|Respiratory System Agents|respiratory system agents|mesh-ancestor
92633313|NCT00206154|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92633315|NCT00206154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92633316|NCT00206154|Adrenergic Agents|adrenergic agents|mesh-ancestor
92633317|NCT00206154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633318|NCT00206154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633319|NCT00559702|Natalizumab|natalizumab|mesh-list
92633320|NCT00559702|Immunologic Factors|immunologic factors|mesh-ancestor
92633321|NCT00559702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633322|NCT00559741|Leucovorin|leucovorin|mesh-list
92633323|NCT00559741|Fluorouracil|fluorouracil|mesh-list
92633324|NCT00559741|Irinotecan|irinotecan|mesh-list
92633325|NCT00559741|Cetuximab|cetuximab|mesh-list
92633326|NCT00559741|Calcium|calcium|mesh-list
92633327|NCT00559741|Levoleucovorin|levoleucovorin|mesh-list
92633328|NCT00559741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92633329|NCT00559741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633330|NCT00559741|Antimetabolites|antimetabolites|mesh-ancestor
92633331|NCT00559741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633332|NCT00559741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633333|NCT00559741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633334|NCT00559741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633335|NCT00559741|Immunologic Factors|immunologic factors|mesh-ancestor
92633336|NCT00559741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92633337|NCT00559741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633338|NCT00559741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633339|NCT00559741|Antidotes|antidotes|mesh-ancestor
92633340|NCT00559741|Protective Agents|protective agents|mesh-ancestor
92633341|NCT00559741|Vitamin B Complex|vitamin b complex|mesh-ancestor
92633342|NCT00559741|Vitamins|vitamins|mesh-ancestor
92633343|NCT00559741|Micronutrients|micronutrients|mesh-ancestor
92633344|NCT00559741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92633345|NCT00178763|Interferons|interferons|mesh-list
92633346|NCT00178763|Interferon-alpha|interferon-alpha|mesh-list
92633347|NCT00178763|Cisplatin|cisplatin|mesh-list
92633348|NCT00178763|Gemcitabine|gemcitabine|mesh-list
92633349|NCT00178763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633350|NCT00178763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633351|NCT00178763|Antimetabolites|antimetabolites|mesh-ancestor
92633352|NCT00178763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633353|NCT00178763|Antiviral Agents|antiviral agents|mesh-ancestor
92633354|NCT00178763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633355|NCT00178763|Immunologic Factors|immunologic factors|mesh-ancestor
92633356|NCT00178763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633357|NCT00559858|Pyridoxine|pyridoxine|mesh-list
92633358|NCT00559858|Vitamin B 6|vitamin b 6|mesh-list
92633359|NCT00559858|Vitamin B Complex|vitamin b complex|mesh-ancestor
92633360|NCT00559858|Vitamins|vitamins|mesh-ancestor
92633361|NCT00559858|Micronutrients|micronutrients|mesh-ancestor
92633362|NCT00559858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633363|NCT00559975|Vaccines|vaccines|mesh-list
92633364|NCT00559975|Immunologic Factors|immunologic factors|mesh-ancestor
92633365|NCT00559975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633366|NCT00206193|Misoprostol|misoprostol|mesh-list
92633367|NCT00206193|Sulprostone|sulprostone|mesh-list
92633368|NCT00206193|Mifepristone|mifepristone|mesh-list
92562230|NCT00151528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562231|NCT00151528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562232|NCT00151528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633369|NCT00206193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92633370|NCT00206193|Abortifacient Agents|abortifacient agents|mesh-ancestor
92633371|NCT00206193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92633372|NCT00206193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633373|NCT00206193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92633374|NCT00206193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633376|NCT00206193|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92633377|NCT00206193|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92633378|NCT00206193|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92633379|NCT00206193|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92358604|NCT00288600|Antibodies|antibodies|mesh-list
92633380|NCT00206193|Contraceptive Agents|contraceptive agents|mesh-ancestor
92633381|NCT00206193|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92633382|NCT00206193|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92633395|NCT04638439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633396|NCT00178802|Interferons|interferons|mesh-list
92633397|NCT00178802|Doxorubicin|doxorubicin|mesh-list
92633398|NCT00178802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92633399|NCT00178802|Fluorouracil|fluorouracil|mesh-list
92633400|NCT00178802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633401|NCT00178802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633402|NCT00178802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633403|NCT00178802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633404|NCT00178802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633405|NCT00178802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633406|NCT00178802|Antimetabolites|antimetabolites|mesh-ancestor
92633407|NCT00178802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633408|NCT00178802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633409|NCT00178802|Immunologic Factors|immunologic factors|mesh-ancestor
92633410|NCT00178802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633411|NCT00178802|Antiviral Agents|antiviral agents|mesh-ancestor
92633412|NCT00178802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633413|NCT00408239|Enoxaparin|enoxaparin|mesh-list
92633414|NCT00408239|Anticoagulants|anticoagulants|mesh-ancestor
92633415|NCT00408239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92633416|NCT00408239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92633417|NCT00408239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633418|NCT04637464|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92633419|NCT04637464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633420|NCT00408278|Mitoxantrone|mitoxantrone|mesh-list
92633421|NCT00408278|Analgesics|analgesics|mesh-ancestor
92633422|NCT00408278|Sensory System Agents|sensory system agents|mesh-ancestor
92633423|NCT00408278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633424|NCT00408278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633425|NCT00408278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633426|NCT00408278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633427|NCT00408278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633428|NCT00408278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633429|NCT00408278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633430|NCT00560092|Magnesium Sulfate|magnesium sulfate|mesh-list
92633431|NCT00560092|Analgesics|analgesics|mesh-ancestor
92633432|NCT00560092|Sensory System Agents|sensory system agents|mesh-ancestor
92633433|NCT00560092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633434|NCT00560092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633435|NCT00560092|Anesthetics|anesthetics|mesh-ancestor
92633436|NCT00560092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633437|NCT00560092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92633438|NCT00560092|Anticonvulsants|anticonvulsants|mesh-ancestor
92633439|NCT00560092|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92633440|NCT00560092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633441|NCT00560092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633442|NCT00560092|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92633443|NCT00560092|Tocolytic Agents|tocolytic agents|mesh-ancestor
92633447|NCT00560170|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92633448|NCT00560170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92633449|NCT00560170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92562233|NCT00151528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92633450|NCT00560170|Antimetabolites|antimetabolites|mesh-ancestor
92633451|NCT00560170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633452|NCT00560170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92633453|NCT00560170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92633454|NCT00560170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358652|NCT00234078|Rebamipide|rebamipide|mesh-list
92633456|NCT04637152|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92633457|NCT04637152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92633458|NCT04637152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92633459|NCT04637152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92633460|NCT04637152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633461|NCT04636918|Cyclosporine|cyclosporine|mesh-list
92633462|NCT04636918|Cyclosporins|cyclosporins|mesh-list
92633463|NCT04636918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633464|NCT04636918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633465|NCT04636918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633466|NCT04636918|Immunologic Factors|immunologic factors|mesh-ancestor
92633467|NCT04636918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633468|NCT04636918|Antifungal Agents|antifungal agents|mesh-ancestor
92633469|NCT04636918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633470|NCT04636918|Dermatologic Agents|dermatologic agents|mesh-ancestor
92633471|NCT04636918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633472|NCT04636918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92633473|NCT00560209|Landiolol|landiolol|mesh-list
92633474|NCT00560209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92633475|NCT00560209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92633476|NCT00560209|Adrenergic Agents|adrenergic agents|mesh-ancestor
92633477|NCT00560209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633478|NCT00560209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633479|NCT00560209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633480|NCT00560209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92633481|NCT04636957|Ciprofloxacin|ciprofloxacin|mesh-list
92633482|NCT04636957|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92633483|NCT04636957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92633484|NCT04636957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92633485|NCT04636957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633486|NCT04636957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633487|NCT04636957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633488|NCT04636957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633489|NCT04636957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633490|NCT04636957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633491|NCT04636957|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92633492|NCT04636957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92633493|NCT04636957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633494|NCT04636957|Glucocorticoids|glucocorticoids|mesh-ancestor
92633495|NCT04636957|Hormones|hormones|mesh-ancestor
92633496|NCT04636957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633497|NCT04636957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633498|NCT00560326|Tacrolimus|tacrolimus|mesh-list
92633499|NCT00560326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633500|NCT00560326|Immunologic Factors|immunologic factors|mesh-ancestor
92633501|NCT00560326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633502|NCT00560326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92633503|NCT00560326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633504|NCT00560326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633505|NCT00560443|Ketorolac|ketorolac|mesh-list
92633506|NCT00560443|Tramadol|tramadol|mesh-list
92633507|NCT00560443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92633508|NCT00560443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92633509|NCT00560443|Analgesics|analgesics|mesh-ancestor
92633510|NCT00560443|Sensory System Agents|sensory system agents|mesh-ancestor
92633511|NCT00560443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633512|NCT00560443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633513|NCT00560443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633516|NCT00560443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633517|NCT00560443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633518|NCT00560443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92633519|NCT00560443|Narcotics|narcotics|mesh-ancestor
92633520|NCT00560443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633521|NCT00179114|Baclofen|baclofen|mesh-list
92562234|NCT00151528|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92562235|NCT00151528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92633522|NCT00179114|Botulinum Toxins|botulinum toxins|mesh-list
92633523|NCT00179114|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92633524|NCT00179114|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92633525|NCT00179114|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92633526|NCT00179114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358721|NCT00123630|Omalizumab|omalizumab|mesh-list
92633527|NCT00179114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633528|NCT00179114|Cholinergic Agents|cholinergic agents|mesh-ancestor
92633529|NCT00179114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633530|NCT00179114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633531|NCT00179114|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92633532|NCT00179114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633533|NCT00179114|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92633534|NCT00179114|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92633535|NCT00179114|GABA Agonists|gaba agonists|mesh-ancestor
92633537|NCT00201318|Lamivudine|lamivudine|mesh-list
92633538|NCT00201318|Cyclophosphamide|cyclophosphamide|mesh-list
92633539|NCT00201318|Doxorubicin|doxorubicin|mesh-list
92633540|NCT00201318|Vincristine|vincristine|mesh-list
92633541|NCT00201318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633542|NCT00201318|Immunologic Factors|immunologic factors|mesh-ancestor
92633543|NCT00201318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633544|NCT00201318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633545|NCT00201318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633546|NCT00201318|Alkylating Agents|alkylating agents|mesh-ancestor
92633547|NCT00201318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633548|NCT00201318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633549|NCT00201318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633550|NCT00201318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633551|NCT00201318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633552|NCT00201318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633553|NCT00201318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633554|NCT00201318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92633555|NCT00201318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92633556|NCT00201318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92633557|NCT00201318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92633558|NCT00201318|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92633559|NCT00201318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92633560|NCT00201318|Antiviral Agents|antiviral agents|mesh-ancestor
92633561|NCT00201318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633562|NCT00201318|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92633563|NCT00201318|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92633564|NCT00201357|Thalidomide|thalidomide|mesh-list
92633565|NCT00201357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633566|NCT00201357|Immunologic Factors|immunologic factors|mesh-ancestor
92633567|NCT00201357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633568|NCT00201357|Leprostatic Agents|leprostatic agents|mesh-ancestor
92633569|NCT00201357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92633570|NCT00201357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633571|NCT00201357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92633572|NCT00201357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92633573|NCT00201357|Growth Substances|growth substances|mesh-ancestor
92633574|NCT00201357|Growth Inhibitors|growth inhibitors|mesh-ancestor
92633575|NCT00201357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633576|NCT00201396|Leucovorin|leucovorin|mesh-list
92633577|NCT00201396|Fluorouracil|fluorouracil|mesh-list
92633578|NCT00201396|Epirubicin|epirubicin|mesh-list
92633579|NCT00201396|Mitomycins|mitomycins|mesh-list
92633580|NCT00201396|Mitomycin|mitomycin|mesh-list
92633581|NCT00201396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633582|NCT00201396|Antimetabolites|antimetabolites|mesh-ancestor
92633583|NCT00201396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633584|NCT00201396|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633585|NCT00201396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633586|NCT00201396|Immunologic Factors|immunologic factors|mesh-ancestor
92633587|NCT00201396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633591|NCT00201396|Vitamins|vitamins|mesh-ancestor
92633592|NCT00201396|Micronutrients|micronutrients|mesh-ancestor
92633593|NCT00201396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633594|NCT00201396|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633595|NCT00201396|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562236|NCT00151528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562237|NCT00151528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91981705|NCT02416739|Vitamins|vitamins|mesh-ancestor
92633596|NCT00201396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633597|NCT00201396|Alkylating Agents|alkylating agents|mesh-ancestor
92633598|NCT00201396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92633599|NCT00201435|Paclitaxel|paclitaxel|mesh-list
92633600|NCT00201435|Docetaxel|docetaxel|mesh-list
92633601|NCT00201435|Capecitabine|capecitabine|mesh-list
92633602|NCT00201435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92633603|NCT00201435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633604|NCT00201435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92633605|NCT00201435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92633606|NCT00201435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92633607|NCT00201435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633608|NCT00201435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633609|NCT00201435|Antimetabolites|antimetabolites|mesh-ancestor
92633610|NCT00560599|Chlorhexidine|chlorhexidine|mesh-list
92633611|NCT00560599|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92633612|NCT00560599|Mupirocin|mupirocin|mesh-list
92633613|NCT00560599|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92633614|NCT00560599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633615|NCT00560599|Disinfectants|disinfectants|mesh-ancestor
92633616|NCT00560599|Dermatologic Agents|dermatologic agents|mesh-ancestor
92633617|NCT00560599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92633618|NCT00560599|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92633619|NCT00560599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633620|NCT00560599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633621|NCT04635553|Praziquantel|praziquantel|mesh-list
92633622|NCT04635553|Anthelmintics|anthelmintics|mesh-ancestor
92633623|NCT04635553|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92633624|NCT04635553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633625|NCT00560638|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92633626|NCT00560638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92633627|NCT04634656|Lidocaine|lidocaine|mesh-list
92633628|NCT04634656|Anesthetics, Local|anesthetics, local|mesh-ancestor
92633629|NCT04634656|Anesthetics|anesthetics|mesh-ancestor
92633630|NCT04634656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633631|NCT04634656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633632|NCT04634656|Sensory System Agents|sensory system agents|mesh-ancestor
92633633|NCT04634656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633634|NCT04634656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92633635|NCT04634656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92633636|NCT04634656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92633637|NCT04634656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633638|NCT04634656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633639|NCT04634500|Dapagliflozin|dapagliflozin|mesh-list
92633640|NCT04634500|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92633641|NCT04634500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633642|NCT04634500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92633643|NCT04634500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633644|NCT04633954|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92633645|NCT04633954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92633646|NCT04633954|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92633647|NCT04633954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92633648|NCT04633954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92633649|NCT04633954|Adrenergic Agents|adrenergic agents|mesh-ancestor
92633650|NCT04633954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633651|NCT04633954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633652|NCT04633954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633653|NCT00201630|Alfuzosin|alfuzosin|mesh-list
92633654|NCT00201630|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92633655|NCT00201630|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92633656|NCT00201630|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92633657|NCT00201630|Adrenergic Agents|adrenergic agents|mesh-ancestor
92633658|NCT00201630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633659|NCT00201630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633663|NCT00179231|Clozapine|clozapine|mesh-list
92633664|NCT00179231|Antiemetics|antiemetics|mesh-ancestor
92633665|NCT00179231|Autonomic Agents|autonomic agents|mesh-ancestor
92562239|NCT00397787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562240|NCT00397787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92633666|NCT00179231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633667|NCT00179231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633668|NCT00179231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633670|NCT00179231|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92633671|NCT00179231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633672|NCT00179231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633673|NCT00179231|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92633674|NCT00179231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92633675|NCT00179231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633676|NCT00179231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633678|NCT00179231|Serotonin Agents|serotonin agents|mesh-ancestor
92633679|NCT00179231|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92633680|NCT00179231|GABA Antagonists|gaba antagonists|mesh-ancestor
92633681|NCT00179231|GABA Agents|gaba agents|mesh-ancestor
92633682|NCT00201669|Clofarabine|clofarabine|mesh-list
92633683|NCT00201669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633684|NCT00201669|Antimetabolites|antimetabolites|mesh-ancestor
92633685|NCT00201669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633686|NCT00201669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633687|NCT00201708|Cyclophosphamide|cyclophosphamide|mesh-list
92633688|NCT00201708|Docetaxel|docetaxel|mesh-list
92633689|NCT00201708|Doxorubicin|doxorubicin|mesh-list
92633690|NCT00201708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633691|NCT00201708|Immunologic Factors|immunologic factors|mesh-ancestor
92633692|NCT00201708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633693|NCT00201708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633694|NCT00201708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633695|NCT00201708|Alkylating Agents|alkylating agents|mesh-ancestor
92633696|NCT00201708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633697|NCT00201708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633698|NCT00201708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633699|NCT00201708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92633700|NCT00201708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92633701|NCT00201708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92633702|NCT00201708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633703|NCT00201708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633704|NCT00201708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633705|NCT00201708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633706|NCT04632121|Nicorandil|nicorandil|mesh-list
92633707|NCT04632121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92633708|NCT04632121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92633709|NCT04632121|Vasodilator Agents|vasodilator agents|mesh-ancestor
92633710|NCT04632121|Vitamin B Complex|vitamin b complex|mesh-ancestor
92633711|NCT04632121|Vitamins|vitamins|mesh-ancestor
92633712|NCT04632121|Micronutrients|micronutrients|mesh-ancestor
92633713|NCT04632121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633714|NCT00179699|Pemetrexed|pemetrexed|mesh-list
92633715|NCT00179699|Lenalidomide|lenalidomide|mesh-list
92633716|NCT00179699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633717|NCT00179699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633718|NCT00179699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633719|NCT00179699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92633720|NCT00179699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92633721|NCT00179699|Immunologic Factors|immunologic factors|mesh-ancestor
92633722|NCT00179699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633723|NCT00179699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92633724|NCT00179699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92633725|NCT00179699|Growth Substances|growth substances|mesh-ancestor
92633726|NCT00179699|Growth Inhibitors|growth inhibitors|mesh-ancestor
92633727|NCT00201747|Mitomycins|mitomycins|mesh-list
92633728|NCT00201747|Mitomycin|mitomycin|mesh-list
92633729|NCT00201747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633730|NCT00201747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633731|NCT00201747|Alkylating Agents|alkylating agents|mesh-ancestor
92633732|NCT00201747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633733|NCT00201747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92633737|NCT00179738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633738|NCT00179738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92633739|NCT00179738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92562241|NCT00397787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92562242|NCT00397787|Growth Substances|growth substances|mesh-ancestor
91981843|NCT02415179|Hormones|hormones|mesh-ancestor
92633740|NCT00179738|Growth Substances|growth substances|mesh-ancestor
92633741|NCT00179738|Growth Inhibitors|growth inhibitors|mesh-ancestor
92633742|NCT00179738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633743|NCT04631341|Melatonin|melatonin|mesh-list
92633744|NCT04631341|Antioxidants|antioxidants|mesh-ancestor
92633745|NCT04631341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633746|NCT04631341|Protective Agents|protective agents|mesh-ancestor
92633747|NCT04631341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633748|NCT04631341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92633749|NCT04723238|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92633750|NCT04723238|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92633751|NCT04723238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92633752|NCT04723238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92633753|NCT04723238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633754|NCT04723238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633755|NCT04723238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633757|NCT04723238|Sensory System Agents|sensory system agents|mesh-ancestor
92633758|NCT04723238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633759|NCT04723238|Antidepressive Agents|antidepressive agents|mesh-ancestor
92633760|NCT04723238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92633761|NCT04723238|Dopamine Agents|dopamine agents|mesh-ancestor
92633762|NCT00201786|Pentostatin|pentostatin|mesh-list
92633763|NCT00201786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633764|NCT00201786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92633765|NCT00201786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633766|NCT00201786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633767|NCT04630522|Vitamin D|vitamin d|mesh-list
92633768|NCT04630522|Calcium, Dietary|calcium, dietary|mesh-list
92633769|NCT04630522|Calcium|calcium|mesh-list
92633770|NCT04630522|Vitamins|vitamins|mesh-ancestor
92633771|NCT04630522|Micronutrients|micronutrients|mesh-ancestor
92633772|NCT04630522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633773|NCT04630522|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92633774|NCT04630522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92633775|NCT00179816|Cyclophosphamide|cyclophosphamide|mesh-list
92633776|NCT00179816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633777|NCT00179816|Immunologic Factors|immunologic factors|mesh-ancestor
92633778|NCT00179816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633779|NCT00179816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633780|NCT00179816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633781|NCT00179816|Alkylating Agents|alkylating agents|mesh-ancestor
92633782|NCT00179816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633783|NCT00179816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633784|NCT00179816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633785|NCT04630444|Riluzole|riluzole|mesh-list
92633786|NCT04630444|Anticonvulsants|anticonvulsants|mesh-ancestor
92633787|NCT04630444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92633788|NCT04630444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92633789|NCT04630444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633790|NCT04630444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633791|NCT04630444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633792|NCT04630444|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92633793|NCT04630444|Protective Agents|protective agents|mesh-ancestor
92633794|NCT00186810|Cyclophosphamide|cyclophosphamide|mesh-list
92633795|NCT00186810|Busulfan|busulfan|mesh-list
92633796|NCT00186810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633797|NCT00186810|Immunologic Factors|immunologic factors|mesh-ancestor
92633798|NCT00186810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633799|NCT00186810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633800|NCT00186810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633801|NCT00186810|Alkylating Agents|alkylating agents|mesh-ancestor
92633802|NCT00186810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633803|NCT00186810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633804|NCT00186810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633805|NCT04630288|Clopidogrel|clopidogrel|mesh-list
92633828|NCT00561067|Autonomic Agents|autonomic agents|mesh-ancestor
92633829|NCT00561067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752326|NCT05940701|Cariostatic Agents|cariostatic agents|mesh-ancestor
92562243|NCT00397787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562244|NCT00397787|Growth Inhibitors|growth inhibitors|mesh-ancestor
92562245|NCT00397787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92562246|NCT00397787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633830|NCT00561067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633831|NCT00561067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633832|NCT00561067|Glucocorticoids|glucocorticoids|mesh-ancestor
92633833|NCT00561067|Hormones|hormones|mesh-ancestor
92633834|NCT00561067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633835|NCT00561067|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92633836|NCT00561067|Protective Agents|protective agents|mesh-ancestor
92633837|NCT00561067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92633838|NCT00561067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633839|NCT00561067|Hematinics|hematinics|mesh-ancestor
92633840|NCT00561106|Valacyclovir|valacyclovir|mesh-list
92633841|NCT00561106|Prednisone|prednisone|mesh-list
92633842|NCT00561106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633843|NCT00561106|Glucocorticoids|glucocorticoids|mesh-ancestor
92633844|NCT00561106|Hormones|hormones|mesh-ancestor
92633845|NCT00561106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633846|NCT00561106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633847|NCT00561106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92633848|NCT00561106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633849|NCT00561106|Antiviral Agents|antiviral agents|mesh-ancestor
92633850|NCT00561106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633851|NCT00561184|Vaccines|vaccines|mesh-list
92633852|NCT00561184|Immunologic Factors|immunologic factors|mesh-ancestor
92633853|NCT00561184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633854|NCT00186849|Cyclophosphamide|cyclophosphamide|mesh-list
92633855|NCT00186849|Ifosfamide|ifosfamide|mesh-list
92633856|NCT00186849|Carboplatin|carboplatin|mesh-list
92633857|NCT00186849|Doxorubicin|doxorubicin|mesh-list
92633858|NCT00186849|Etoposide|etoposide|mesh-list
92633867|NCT00186849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633868|NCT00186849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633869|NCT00186849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633870|NCT00186849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633871|NCT00186849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633872|NCT00186849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633873|NCT00186849|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92633874|NCT00186849|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92633875|NCT00201981|Rebamipide|rebamipide|mesh-list
92633876|NCT00201981|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92633877|NCT00201981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633878|NCT00201981|Antioxidants|antioxidants|mesh-ancestor
92633879|NCT00201981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633880|NCT00201981|Protective Agents|protective agents|mesh-ancestor
92633881|NCT00201981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633882|NCT00201981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633883|NCT00561223|Iloprost|iloprost|mesh-list
92633884|NCT00561223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92633885|NCT00561223|Vasodilator Agents|vasodilator agents|mesh-ancestor
92633886|NCT00180011|Omalizumab|omalizumab|mesh-list
92633887|NCT00180011|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92633888|NCT00180011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92633889|NCT00180011|Respiratory System Agents|respiratory system agents|mesh-ancestor
92633890|NCT00186966|Cytarabine|cytarabine|mesh-list
92633891|NCT00186966|Cyclophosphamide|cyclophosphamide|mesh-list
92633892|NCT00186966|Melphalan|melphalan|mesh-list
92633893|NCT00186966|Busulfan|busulfan|mesh-list
92633894|NCT00186966|Fludarabine|fludarabine|mesh-list
92633895|NCT00186966|Etoposide|etoposide|mesh-list
92633896|NCT00186966|Daunorubicin|daunorubicin|mesh-list
92633897|NCT00186966|Thioguanine|thioguanine|mesh-list
92633898|NCT00186966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633899|NCT00186966|Immunologic Factors|immunologic factors|mesh-ancestor
92633900|NCT00186966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934095|NCT02298205|Hormones|hormones|mesh-ancestor
92633901|NCT00186966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633902|NCT00186966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633903|NCT00186966|Alkylating Agents|alkylating agents|mesh-ancestor
92633904|NCT00186966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633905|NCT00186966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633906|NCT00186966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92633907|NCT00186966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562247|NCT00397787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562249|NCT00082602|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92633908|NCT00186966|Antimetabolites|antimetabolites|mesh-ancestor
92633909|NCT00186966|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92633910|NCT00186966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633911|NCT00186966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633912|NCT00186966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633913|NCT00186966|Antiviral Agents|antiviral agents|mesh-ancestor
92633914|NCT00186966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633915|NCT00186966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633916|NCT00180050|Budesonide|budesonide|mesh-list
92633917|NCT00180050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633918|NCT00180050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92633919|NCT00180050|Autonomic Agents|autonomic agents|mesh-ancestor
92633920|NCT00180050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633921|NCT00180050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633922|NCT00180050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92633923|NCT00180050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92633924|NCT00180050|Glucocorticoids|glucocorticoids|mesh-ancestor
92633925|NCT00180050|Hormones|hormones|mesh-ancestor
92682815|NCT00438152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633940|NCT00180089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633941|NCT00180089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92633942|NCT00180089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92633944|NCT00180089|Hormones|hormones|mesh-ancestor
92633945|NCT00180089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633946|NCT00575419|Acetylcysteine|acetylcysteine|mesh-list
92633947|NCT00575419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92633948|NCT00575419|Antiviral Agents|antiviral agents|mesh-ancestor
92633949|NCT00575419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633950|NCT00575419|Expectorants|expectorants|mesh-ancestor
92633951|NCT00575419|Respiratory System Agents|respiratory system agents|mesh-ancestor
92633952|NCT00575419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92633953|NCT00575419|Antioxidants|antioxidants|mesh-ancestor
92633954|NCT00575419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633955|NCT00575419|Protective Agents|protective agents|mesh-ancestor
92633956|NCT00575419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633957|NCT00575419|Antidotes|antidotes|mesh-ancestor
92633958|NCT00180128|Cytarabine|cytarabine|mesh-list
92633959|NCT00180128|Daunorubicin|daunorubicin|mesh-list
92633960|NCT00180128|Mitoxantrone|mitoxantrone|mesh-list
92633961|NCT00180128|Idarubicin|idarubicin|mesh-list
92633962|NCT00180128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92633963|NCT00180128|Antimetabolites|antimetabolites|mesh-ancestor
92362529|NCT05320380|Antiviral Agents|antiviral agents|mesh-ancestor
92633964|NCT00180128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633965|NCT00180128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633966|NCT00180128|Antiviral Agents|antiviral agents|mesh-ancestor
92633967|NCT00180128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92633968|NCT00180128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633969|NCT00180128|Immunologic Factors|immunologic factors|mesh-ancestor
92633970|NCT00180128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633971|NCT00180128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92633972|NCT00180128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92633973|NCT00180128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92633974|NCT00180128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633975|NCT00180128|Analgesics|analgesics|mesh-ancestor
92633976|NCT00180128|Sensory System Agents|sensory system agents|mesh-ancestor
92633977|NCT00180128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359174|NCT00335478|Daptomycin|daptomycin|mesh-list
92633978|NCT00575614|Prucalopride|prucalopride|mesh-list
92633979|NCT00575614|Laxatives|laxatives|mesh-ancestor
92633980|NCT00575614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92633981|NCT00575614|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92633982|NCT00575614|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92633983|NCT00575614|Serotonin Agents|serotonin agents|mesh-ancestor
92633984|NCT00575614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633988|NCT00575848|Glycine Agents|glycine agents|mesh-ancestor
92633989|NCT00575848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633990|NCT00575848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633991|NCT00575848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633992|NCT00576238|Betamethasone|betamethasone|mesh-list
92633993|NCT00576238|Betamethasone Valerate|betamethasone valerate|mesh-list
92562250|NCT00082602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562251|NCT00082602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982085|NCT02412449|Glycine|glycine|mesh-list
92633994|NCT00576238|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92633995|NCT00576238|Betamethasone benzoate|betamethasone benzoate|mesh-list
92633996|NCT00576238|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92633997|NCT00576238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633998|NCT00576238|Glucocorticoids|glucocorticoids|mesh-ancestor
92634000|NCT00576238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362559|NCT05259527|Vitamin D|vitamin d|mesh-list
92634001|NCT00576238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634002|NCT00576238|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92634003|NCT00576238|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634004|NCT00576394|Insulin|insulin|mesh-list
92634005|NCT00576394|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92634006|NCT00576394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92634007|NCT00576394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634008|NCT00576433|Rituximab|rituximab|mesh-list
92634009|NCT00576433|Methotrexate|methotrexate|mesh-list
92634010|NCT00576433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92634011|NCT00576433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634012|NCT00576433|Immunologic Factors|immunologic factors|mesh-ancestor
92634013|NCT00576433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634014|NCT00576433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634015|NCT00576433|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634016|NCT00576433|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634017|NCT00576433|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634018|NCT00576433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634019|NCT00576433|Antimetabolites|antimetabolites|mesh-ancestor
92634020|NCT00576433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634021|NCT00576433|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634022|NCT00576433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634023|NCT00576433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92634024|NCT00576433|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634025|NCT00576433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92634026|NCT00576511|Prucalopride|prucalopride|mesh-list
92634027|NCT00576511|Laxatives|laxatives|mesh-ancestor
92634028|NCT00576511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634029|NCT00576511|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92634030|NCT00576511|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92634031|NCT00576511|Serotonin Agents|serotonin agents|mesh-ancestor
92634032|NCT00576511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634033|NCT00576511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634034|NCT00576511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634035|NCT00576550|Betamethasone|betamethasone|mesh-list
92634036|NCT00576550|Betamethasone Valerate|betamethasone valerate|mesh-list
92634037|NCT00576550|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92634038|NCT00576550|Betamethasone benzoate|betamethasone benzoate|mesh-list
92362586|NCT05171660|Growth Substances|growth substances|mesh-ancestor
92634039|NCT00576550|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92634040|NCT00576550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634041|NCT00576550|Glucocorticoids|glucocorticoids|mesh-ancestor
92634042|NCT00576550|Hormones|hormones|mesh-ancestor
92634043|NCT00576550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634044|NCT00576550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634045|NCT00576550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92634046|NCT00576550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634047|NCT00576706|Misoprostol|misoprostol|mesh-list
92634048|NCT00576706|Rebamipide|rebamipide|mesh-list
92634049|NCT00576706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634050|NCT00576706|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634051|NCT00576706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634052|NCT00576706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634053|NCT00576706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92634054|NCT00576706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634059|NCT00576706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634060|NCT00576784|Pioglitazone|pioglitazone|mesh-list
92634061|NCT00576784|Glimepiride|glimepiride|mesh-list
92634062|NCT00576784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92634063|NCT00576784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634064|NCT00576784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92634065|NCT00576784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634066|NCT00576784|Immunologic Factors|immunologic factors|mesh-ancestor
92562252|NCT00082602|Cholinergic Agents|cholinergic agents|mesh-ancestor
92562253|NCT00082602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562254|NCT00082602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969754|NCT05709353|Methamphetamine|methamphetamine|mesh-list
92634067|NCT00576862|Insulin Glargine|insulin glargine|mesh-list
92634068|NCT00576862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92634069|NCT00576862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634070|NCT00202020|Aspirin|aspirin|mesh-list
92634071|NCT00202020|Cilostazol|cilostazol|mesh-list
92634072|NCT00202020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92634073|NCT00202020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92634074|NCT00202020|Analgesics|analgesics|mesh-ancestor
92634075|NCT00202020|Sensory System Agents|sensory system agents|mesh-ancestor
92634076|NCT00202020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634077|NCT00202020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634078|NCT00202020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634079|NCT00202020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634080|NCT00202020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92634081|NCT00202020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92634082|NCT00202020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634083|NCT00202020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92634084|NCT00202020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92634085|NCT00202020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634086|NCT00202020|Antipyretics|antipyretics|mesh-ancestor
92634087|NCT00202020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92634088|NCT00202020|Autonomic Agents|autonomic agents|mesh-ancestor
92634089|NCT00202020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92634090|NCT00202020|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634091|NCT00202020|Vasodilator Agents|vasodilator agents|mesh-ancestor
92634092|NCT00202020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92634093|NCT00202020|Protective Agents|protective agents|mesh-ancestor
92634094|NCT00202020|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92634095|NCT00202020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92634096|NCT00577018|Prucalopride|prucalopride|mesh-list
92634097|NCT00577018|Laxatives|laxatives|mesh-ancestor
92634098|NCT00577018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634099|NCT00577018|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92634100|NCT00577018|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92634101|NCT00577018|Serotonin Agents|serotonin agents|mesh-ancestor
92634102|NCT00577018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634103|NCT00577018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634104|NCT00577018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634105|NCT04578847|Imatinib Mesylate|imatinib mesylate|mesh-list
92634106|NCT04578847|Dasatinib|dasatinib|mesh-list
92634107|NCT04578847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634108|NCT04578847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92634109|NCT04578847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634110|NCT04578847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634111|NCT00577057|Fluorouracil|fluorouracil|mesh-list
92634112|NCT00577057|Capecitabine|capecitabine|mesh-list
92634113|NCT00577057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634114|NCT00577057|Antimetabolites|antimetabolites|mesh-ancestor
92634115|NCT00577057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634116|NCT00577057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634117|NCT00577057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634118|NCT00577057|Immunologic Factors|immunologic factors|mesh-ancestor
92634119|NCT00577057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634120|NCT00187005|Cytarabine|cytarabine|mesh-list
92634121|NCT00187005|Dexamethasone|dexamethasone|mesh-list
92634122|NCT00187005|Prednisone|prednisone|mesh-list
92634123|NCT00187005|Cyclophosphamide|cyclophosphamide|mesh-list
92634124|NCT00187005|Methotrexate|methotrexate|mesh-list
92634125|NCT00187005|Etoposide|etoposide|mesh-list
92634126|NCT00187005|Vincristine|vincristine|mesh-list
92634127|NCT00187005|Daunorubicin|daunorubicin|mesh-list
92634128|NCT00187005|Asparaginase|asparaginase|mesh-list
92634138|NCT00187005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634139|NCT00187005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634140|NCT00187005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634141|NCT00187005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634143|NCT00187005|Autonomic Agents|autonomic agents|mesh-ancestor
92634144|NCT00187005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634145|NCT00187005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562255|NCT00082602|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92562256|NCT00082602|Autonomic Agents|autonomic agents|mesh-ancestor
92562257|NCT00082602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562258|NCT00082602|Nootropic Agents|nootropic agents|mesh-ancestor
92562259|NCT00151567|Tamsulosin|tamsulosin|mesh-list
91969757|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
92634146|NCT00187005|Glucocorticoids|glucocorticoids|mesh-ancestor
92634147|NCT00187005|Hormones|hormones|mesh-ancestor
92015124|NCT05475041|Liver Extracts|liver extracts|mesh-list
92634148|NCT00187005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634149|NCT00187005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92634150|NCT00187005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634151|NCT00187005|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634152|NCT00187005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634153|NCT00187005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634154|NCT00187005|Antimetabolites|antimetabolites|mesh-ancestor
92634155|NCT00187005|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634156|NCT00187005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634157|NCT00187005|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92634158|NCT00187005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92634159|NCT00187005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634160|NCT00187005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634161|NCT00187005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634162|NCT00187005|Antiviral Agents|antiviral agents|mesh-ancestor
92634163|NCT00187005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634164|NCT00187005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634165|NCT00187005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634166|NCT00187005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634167|NCT00187005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634168|NCT00202059|Zoledronic Acid|zoledronic acid|mesh-list
92634169|NCT00202059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92634170|NCT00202059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634171|NCT00577369|Desflurane|desflurane|mesh-list
92634172|NCT00577369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92634173|NCT00577369|Anesthetics, General|anesthetics, general|mesh-ancestor
92634174|NCT00577369|Anesthetics|anesthetics|mesh-ancestor
92634175|NCT00577369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634176|NCT00577369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634177|NCT00577681|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92634178|NCT00577681|Antiviral Agents|antiviral agents|mesh-ancestor
92634179|NCT00577681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634180|NCT00577798|Doxorubicin|doxorubicin|mesh-list
92634181|NCT00577798|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92634182|NCT00577798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634183|NCT00577798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634184|NCT00577798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634185|NCT00577798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634186|NCT00577798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634187|NCT00577798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634188|NCT00187083|Dexamethasone|dexamethasone|mesh-list
92634189|NCT00187083|Methotrexate|methotrexate|mesh-list
92634190|NCT00187083|Fludarabine|fludarabine|mesh-list
92634191|NCT00187083|Etoposide|etoposide|mesh-list
92634192|NCT00187083|Vincristine|vincristine|mesh-list
92634193|NCT00187083|Topotecan|topotecan|mesh-list
92634194|NCT00187083|Asparaginase|asparaginase|mesh-list
92634195|NCT00187083|Mercaptopurine|mercaptopurine|mesh-list
92634196|NCT00187083|Idarubicin|idarubicin|mesh-list
92634212|NCT00187083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634213|NCT00187083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634214|NCT00187083|Antimetabolites|antimetabolites|mesh-ancestor
92634215|NCT00187083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634216|NCT00187083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634217|NCT00187083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634218|NCT00187083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92634219|NCT00187083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634220|NCT00187083|Immunologic Factors|immunologic factors|mesh-ancestor
92634221|NCT00187083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634222|NCT00187083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92634223|NCT00187083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634224|NCT00187083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634225|NCT00187083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562260|NCT00151567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92562261|NCT00151567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92562262|NCT00151567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92562263|NCT00151567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92562264|NCT00151567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969763|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634226|NCT00187083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634227|NCT00187083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634228|NCT00187083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634229|NCT00187083|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92634230|NCT00187083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634233|NCT00577837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92634234|NCT00577837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92634235|NCT00577837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634236|NCT00577837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92634237|NCT00577837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634238|NCT00577837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92634239|NCT00578149|Paclitaxel|paclitaxel|mesh-list
92634240|NCT00578149|Bevacizumab|bevacizumab|mesh-list
92634241|NCT00578149|Carboplatin|carboplatin|mesh-list
92634242|NCT00578149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634243|NCT00578149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634244|NCT00578149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634245|NCT00578149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634246|NCT00578149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634247|NCT00578149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634248|NCT00578149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92634249|NCT00578149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92634250|NCT00578149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92634251|NCT00578149|Growth Substances|growth substances|mesh-ancestor
92634252|NCT00578149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634253|NCT00578149|Growth Inhibitors|growth inhibitors|mesh-ancestor
92634254|NCT00187122|Cytarabine|cytarabine|mesh-list
92634255|NCT00187122|Dexamethasone|dexamethasone|mesh-list
92634256|NCT00187122|Prednisone|prednisone|mesh-list
92634262|NCT00187122|Mercaptopurine|mercaptopurine|mesh-list
92634263|NCT00187122|Daunorubicin|daunorubicin|mesh-list
92634264|NCT00187122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634265|NCT00187122|Immunologic Factors|immunologic factors|mesh-ancestor
92634266|NCT00187122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634267|NCT00187122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634268|NCT00187122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634269|NCT00187122|Alkylating Agents|alkylating agents|mesh-ancestor
92634270|NCT00187122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634271|NCT00187122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634272|NCT00187122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634273|NCT00187122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634274|NCT00187122|Antiemetics|antiemetics|mesh-ancestor
92634275|NCT00187122|Autonomic Agents|autonomic agents|mesh-ancestor
92634276|NCT00187122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634277|NCT00187122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634278|NCT00187122|Glucocorticoids|glucocorticoids|mesh-ancestor
92634279|NCT00187122|Hormones|hormones|mesh-ancestor
92634280|NCT00187122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634281|NCT00187122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92359505|NCT03983226|Taxane|taxane|mesh-list
92634282|NCT00187122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634283|NCT00187122|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634284|NCT00187122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634285|NCT00187122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634286|NCT00187122|Antimetabolites|antimetabolites|mesh-ancestor
92634287|NCT00187122|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634288|NCT00187122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634289|NCT00187122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92634290|NCT00187122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362681|NCT04964544|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92634291|NCT00187122|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634292|NCT00187122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92562265|NCT00151567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562266|NCT00151567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634293|NCT00187122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634294|NCT00187122|Antiviral Agents|antiviral agents|mesh-ancestor
92634295|NCT00187122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634296|NCT00187122|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634297|NCT00187122|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634298|NCT00187122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634299|NCT00187122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634300|NCT00180635|Pimagedine|pimagedine|mesh-list
92634301|NCT00180635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634302|NCT00180635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634303|NCT00578266|Cyclophosphamide|cyclophosphamide|mesh-list
92634304|NCT00578266|Alemtuzumab|alemtuzumab|mesh-list
92634305|NCT00578266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634306|NCT00578266|Immunologic Factors|immunologic factors|mesh-ancestor
92634307|NCT00578266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634308|NCT00578266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634309|NCT00578266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634310|NCT00578266|Alkylating Agents|alkylating agents|mesh-ancestor
92634311|NCT00578266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634312|NCT00578266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634313|NCT00578266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634314|NCT00578266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92634315|NCT04578496|Afamelanotide|afamelanotide|mesh-list
92634316|NCT04578496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634317|NCT00579046|Darbepoetin alfa|darbepoetin alfa|mesh-list
92634318|NCT00579046|Hematinics|hematinics|mesh-ancestor
92634319|NCT00579085|Ketamine|ketamine|mesh-list
92634320|NCT00579085|Analgesics|analgesics|mesh-ancestor
92634321|NCT00579085|Sensory System Agents|sensory system agents|mesh-ancestor
92634322|NCT00579085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634323|NCT00579085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634324|NCT00579085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92634325|NCT00579085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92634326|NCT00579085|Anesthetics, General|anesthetics, general|mesh-ancestor
92634327|NCT00579085|Anesthetics|anesthetics|mesh-ancestor
92682816|NCT00438152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92634330|NCT00579085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92634331|NCT00579085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634332|NCT00579085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634333|NCT00187161|Cytarabine|cytarabine|mesh-list
92634334|NCT00187161|Cyclophosphamide|cyclophosphamide|mesh-list
92634335|NCT00187161|Doxorubicin|doxorubicin|mesh-list
92634336|NCT00187161|Methotrexate|methotrexate|mesh-list
92634337|NCT00187161|Etoposide|etoposide|mesh-list
92634338|NCT00187161|Vincristine|vincristine|mesh-list
92634339|NCT00187161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362688|NCT04954196|Amlodipine|amlodipine|mesh-list
92634340|NCT00187161|Immunologic Factors|immunologic factors|mesh-ancestor
92634341|NCT00187161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634342|NCT00187161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634343|NCT00187161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634344|NCT00187161|Alkylating Agents|alkylating agents|mesh-ancestor
92634345|NCT00187161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634346|NCT00187161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634347|NCT00187161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634348|NCT00187161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634349|NCT00187161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634350|NCT00187161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634351|NCT00187161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634352|NCT00187161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634353|NCT00187161|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634354|NCT00187161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634355|NCT00187161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359541|NCT00361140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634356|NCT00187161|Antimetabolites|antimetabolites|mesh-ancestor
92634357|NCT00187161|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634358|NCT00187161|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92634359|NCT00187161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92634360|NCT00187161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634361|NCT00187161|Antiviral Agents|antiviral agents|mesh-ancestor
92562267|NCT00151567|Urological Agents|urological agents|mesh-ancestor
92562268|NCT00397826|Simvastatin|simvastatin|mesh-list
92634362|NCT00187161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634363|NCT00187161|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634364|NCT00187161|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634365|NCT00187161|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634366|NCT00579475|Mifepristone|mifepristone|mesh-list
92634367|NCT00579475|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92634368|NCT00579475|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634369|NCT00579475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634370|NCT00579475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634371|NCT00579475|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92634372|NCT00579475|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92634373|NCT00579475|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92634374|NCT00579475|Contraceptive Agents|contraceptive agents|mesh-ancestor
92634375|NCT00579475|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92634376|NCT00579475|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92634377|NCT00579475|Hormone Antagonists|hormone antagonists|mesh-ancestor
92634378|NCT00579475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634379|NCT00579475|Luteolytic Agents|luteolytic agents|mesh-ancestor
92634380|NCT00579475|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92634381|NCT00579475|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92634382|NCT00579592|Mycophenolic Acid|mycophenolic acid|mesh-list
92634383|NCT00579592|Rituximab|rituximab|mesh-list
92634384|NCT00579592|Alemtuzumab|alemtuzumab|mesh-list
92634385|NCT00579592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92634386|NCT00579592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634387|NCT00579592|Immunologic Factors|immunologic factors|mesh-ancestor
92634388|NCT00579592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634389|NCT00579592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634390|NCT00579592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634391|NCT00579592|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92634392|NCT00579592|Antitubercular Agents|antitubercular agents|mesh-ancestor
92634393|NCT00579592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92634394|NCT00579592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634395|NCT00579592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634396|NCT00579592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634397|NCT00180791|Carboplatin|carboplatin|mesh-list
92634402|NCT00180791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634403|NCT00180791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634404|NCT00180791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634405|NCT00180791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634406|NCT00180791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634407|NCT00180791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634408|NCT00180791|Alkylating Agents|alkylating agents|mesh-ancestor
92634409|NCT00180791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634410|NCT00180791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634411|NCT00180791|Immunologic Factors|immunologic factors|mesh-ancestor
92634412|NCT00180791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634413|NCT01054248|Artesunate|artesunate|mesh-list
92634414|NCT01054248|Piperaquine|piperaquine|mesh-list
92634415|NCT01054248|Artenimol|artenimol|mesh-list
92634416|NCT01054248|Mefloquine|mefloquine|mesh-list
92634417|NCT01054248|Antimalarials|antimalarials|mesh-ancestor
92634418|NCT01054248|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92634419|NCT01054248|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92634420|NCT01054248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634421|NCT01054248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634422|NCT01054248|Antiviral Agents|antiviral agents|mesh-ancestor
92634423|NCT01054248|Schistosomicides|schistosomicides|mesh-ancestor
92634424|NCT01054248|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92634425|NCT01054248|Anthelmintics|anthelmintics|mesh-ancestor
92634426|NCT00180830|Imatinib Mesylate|imatinib mesylate|mesh-list
92634427|NCT00180830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634428|NCT00180830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92634429|NCT00180830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634430|NCT00180830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634431|NCT00202176|Bromides|bromides|mesh-list
92634432|NCT00202176|Ipratropium|ipratropium|mesh-list
92634433|NCT00202176|Anticonvulsants|anticonvulsants|mesh-ancestor
92634434|NCT00202176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92634435|NCT00202176|Autonomic Agents|autonomic agents|mesh-ancestor
92634436|NCT00202176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634437|NCT00202176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562269|NCT00397826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92562271|NCT00397826|Antimetabolites|antimetabolites|mesh-ancestor
92562272|NCT00397826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562273|NCT00397826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91969770|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92634438|NCT00202176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92634439|NCT00202176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634440|NCT00202176|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92634441|NCT00202176|Cholinergic Agents|cholinergic agents|mesh-ancestor
92634442|NCT00202176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634443|NCT00202176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634444|NCT00580060|Molgramostim|molgramostim|mesh-list
92634445|NCT00580060|Sargramostim|sargramostim|mesh-list
92634446|NCT00580060|Immunologic Factors|immunologic factors|mesh-ancestor
92634447|NCT00580060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634448|NCT00580060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634449|NCT00180908|Doxorubicin|doxorubicin|mesh-list
92634450|NCT00180908|Etoposide|etoposide|mesh-list
92634451|NCT00180908|Methotrexate|methotrexate|mesh-list
92634452|NCT00180908|Ifosfamide|ifosfamide|mesh-list
92634453|NCT00180908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634454|NCT00180908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634455|NCT00180908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634456|NCT00180908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634457|NCT00180908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634458|NCT00180908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634459|NCT00180908|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634460|NCT00180908|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634461|NCT00180908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92634462|NCT00180908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634463|NCT00180908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634464|NCT00180908|Antimetabolites|antimetabolites|mesh-ancestor
92634465|NCT00180908|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634466|NCT00180908|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92634467|NCT00180908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634468|NCT00180908|Immunologic Factors|immunologic factors|mesh-ancestor
92634469|NCT00180908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634470|NCT00180908|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92634471|NCT00180908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634499|NCT00209079|Imatinib Mesylate|imatinib mesylate|mesh-list
92634500|NCT00209079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634501|NCT00209079|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634502|NCT00209079|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634503|NCT00209079|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634504|NCT00209079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634505|NCT00209079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92634506|NCT00209079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634507|NCT04576975|Dexmedetomidine|dexmedetomidine|mesh-list
92634509|NCT04576975|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92634510|NCT04576975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634511|NCT04576975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634512|NCT04576975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92634513|NCT04576975|Analgesics|analgesics|mesh-ancestor
92634514|NCT04576975|Sensory System Agents|sensory system agents|mesh-ancestor
92634515|NCT04576975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634516|NCT04576975|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92634517|NCT04576975|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92634518|NCT04576975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92634519|NCT04576975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634520|NCT04576975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634523|NCT04576975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92634524|NCT04576975|Anesthetics, General|anesthetics, general|mesh-ancestor
92634526|NCT04576975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92634527|NCT04576975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92634528|NCT00209118|Paroxetine|paroxetine|mesh-list
92634529|NCT00209118|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92634530|NCT00209118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92362747|NCT04893109|Immunotoxins|immunotoxins|mesh-ancestor
92562274|NCT00397826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92562275|NCT00397826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634531|NCT00209118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92634532|NCT00209118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634533|NCT00209118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634534|NCT00209118|Serotonin Agents|serotonin agents|mesh-ancestor
92634535|NCT00209118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634536|NCT00209118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92634537|NCT00209118|Antidepressive Agents|antidepressive agents|mesh-ancestor
92634538|NCT00209118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634539|NCT00209118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92634540|NCT00209118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92634541|NCT00209118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634542|NCT00181025|Melphalan|melphalan|mesh-list
92634543|NCT00181025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634544|NCT00181025|Alkylating Agents|alkylating agents|mesh-ancestor
92634545|NCT00181025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634546|NCT00181025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634547|NCT00181025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92634548|NCT00181025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634549|NCT00181025|Immunologic Factors|immunologic factors|mesh-ancestor
92634550|NCT00181025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634551|NCT00209313|Acyclovir|acyclovir|mesh-list
92634552|NCT00209313|Antiviral Agents|antiviral agents|mesh-ancestor
92634553|NCT00209313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634554|NCT00582634|Docetaxel|docetaxel|mesh-list
92634555|NCT00582634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634556|NCT00582634|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634557|NCT00582634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634558|NCT00582634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634559|NCT00582634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634560|NCT00209352|Acyclovir|acyclovir|mesh-list
92634561|NCT00209352|Antiviral Agents|antiviral agents|mesh-ancestor
92634562|NCT00209352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634563|NCT00181142|Daclizumab|daclizumab|mesh-list
92634564|NCT00181142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634565|NCT00181142|Immunologic Factors|immunologic factors|mesh-ancestor
92634566|NCT00181142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634567|NCT00582985|Antibodies|antibodies|mesh-list
92634568|NCT00582985|Immunologic Factors|immunologic factors|mesh-ancestor
92634569|NCT00582985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634570|NCT00187551|Enfuvirtide|enfuvirtide|mesh-list
92634571|NCT00187551|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92634572|NCT00187551|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92634573|NCT00187551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634574|NCT00187551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92634575|NCT00187551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92634576|NCT00187551|Antiviral Agents|antiviral agents|mesh-ancestor
92634577|NCT00187551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634578|NCT00181181|Atorvastatin|atorvastatin|mesh-list
92634579|NCT00181181|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92634580|NCT00181181|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92634581|NCT00181181|Antimetabolites|antimetabolites|mesh-ancestor
92634582|NCT00181181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634583|NCT00181181|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92634584|NCT00181181|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92634585|NCT00181181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634586|NCT00181220|Valproic Acid|valproic acid|mesh-list
92634587|NCT00181220|Anticonvulsants|anticonvulsants|mesh-ancestor
92634588|NCT00181220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634589|NCT00181220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634590|NCT00181220|GABA Agents|gaba agents|mesh-ancestor
92634591|NCT00181220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634595|NCT00181220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634596|NCT00181220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634597|NCT00583063|Sirolimus|sirolimus|mesh-list
92634598|NCT00583063|Sunitinib|sunitinib|mesh-list
92634599|NCT00583063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634600|NCT00583063|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92634601|NCT00583063|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92634602|NCT00583063|Growth Substances|growth substances|mesh-ancestor
92634603|NCT00583063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562277|NCT00151684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92562278|NCT00151684|Vasodilator Agents|vasodilator agents|mesh-ancestor
92634604|NCT00583063|Growth Inhibitors|growth inhibitors|mesh-ancestor
92634605|NCT00583063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92634606|NCT00583063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634607|NCT00583063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634608|NCT00583063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92634609|NCT00583063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634610|NCT00583063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92634611|NCT00583063|Antifungal Agents|antifungal agents|mesh-ancestor
92634612|NCT00583063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634613|NCT00583063|Immunologic Factors|immunologic factors|mesh-ancestor
92634614|NCT00181298|Memantine|memantine|mesh-list
92634615|NCT00181298|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92634616|NCT00181298|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92634617|NCT00181298|Dopamine Agents|dopamine agents|mesh-ancestor
92634618|NCT00181298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634619|NCT00181298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634620|NCT00181298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634621|NCT00181298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92634622|NCT00181298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92634623|NCT00583180|Capsaicin|capsaicin|mesh-list
92634624|NCT00583180|Antipruritics|antipruritics|mesh-ancestor
92634625|NCT00583180|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634626|NCT00583180|Sensory System Agents|sensory system agents|mesh-ancestor
92634627|NCT00583180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634628|NCT00583180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634629|NCT00583258|Alfuzosin|alfuzosin|mesh-list
92634630|NCT00583258|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92634631|NCT00583258|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92634632|NCT00583258|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92634633|NCT00583258|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634634|NCT00583258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634635|NCT00583258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634636|NCT00583258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634637|NCT00583258|Urological Agents|urological agents|mesh-ancestor
92634638|NCT00181532|Celecoxib|celecoxib|mesh-list
92634639|NCT00181532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92634640|NCT00181532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92634641|NCT00181532|Analgesics|analgesics|mesh-ancestor
92634642|NCT00181532|Sensory System Agents|sensory system agents|mesh-ancestor
92634643|NCT00181532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634644|NCT00181532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634645|NCT00181532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634646|NCT00181532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634647|NCT00181532|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92634648|NCT00181532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92634649|NCT00181532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634650|NCT00181532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634651|NCT04576390|Ondansetron|ondansetron|mesh-list
92634652|NCT04576390|Palonosetron|palonosetron|mesh-list
92634653|NCT04576390|Antiemetics|antiemetics|mesh-ancestor
92634654|NCT04576390|Autonomic Agents|autonomic agents|mesh-ancestor
92359842|NCT00396006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634655|NCT04576390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634656|NCT04576390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634657|NCT04576390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634658|NCT04576390|Antipruritics|antipruritics|mesh-ancestor
92634659|NCT04576390|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634660|NCT04576390|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92634661|NCT04576390|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92634662|NCT04576390|Serotonin Agents|serotonin agents|mesh-ancestor
92634666|NCT00181571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92634667|NCT00181571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634668|NCT00181571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92634669|NCT00181571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92634670|NCT00181571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92634671|NCT00181571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634673|NCT00181571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634674|NCT00187707|Gabapentin|gabapentin|mesh-list
92562279|NCT00151762|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92562280|NCT00151762|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92562281|NCT00151762|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92562282|NCT00151762|Antimetabolites|antimetabolites|mesh-ancestor
92562283|NCT00151762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562284|NCT00151762|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92562285|NCT00151801|Interferons|interferons|mesh-list
91969778|NCT02481791|Propofol|propofol|mesh-list
92634675|NCT00187707|Analgesics|analgesics|mesh-ancestor
92634676|NCT00187707|Sensory System Agents|sensory system agents|mesh-ancestor
92634677|NCT00187707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634678|NCT00187707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634679|NCT00187707|Anticonvulsants|anticonvulsants|mesh-ancestor
92634680|NCT00187707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92634681|NCT00187707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92634682|NCT00187707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634683|NCT00187707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634684|NCT00187707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92634685|NCT00187707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92634686|NCT00187707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634687|NCT00187707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634688|NCT00187707|Antimanic Agents|antimanic agents|mesh-ancestor
92634689|NCT00187746|Adefovir|adefovir|mesh-list
92634690|NCT00187746|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92634691|NCT00187746|Antiviral Agents|antiviral agents|mesh-ancestor
92634692|NCT00187746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634693|NCT00187746|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92634694|NCT00187746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92634695|NCT00187746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634696|NCT00187746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634697|NCT00181688|Anastrozole|anastrozole|mesh-list
92634698|NCT00181688|Gefitinib|gefitinib|mesh-list
92634699|NCT00181688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92634700|NCT00181688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634701|NCT00181688|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92634702|NCT00181688|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92634703|NCT00181688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634704|NCT00181688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634705|NCT00181688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92634706|NCT00181688|Hormone Antagonists|hormone antagonists|mesh-ancestor
92634707|NCT00181688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634708|NCT00181688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634709|NCT00181688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92634710|NCT00209469|Alendronate|alendronate|mesh-list
92634711|NCT00209469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92634712|NCT00209469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634713|NCT00181727|Valproic Acid|valproic acid|mesh-list
92634714|NCT00181727|Anticonvulsants|anticonvulsants|mesh-ancestor
92634715|NCT00181727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750765|NCT05936489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634716|NCT00181727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634717|NCT00181727|GABA Agents|gaba agents|mesh-ancestor
92634718|NCT00181727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634719|NCT00181727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634720|NCT00181727|Antimanic Agents|antimanic agents|mesh-ancestor
92634721|NCT00181727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92634722|NCT00181727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634723|NCT00181727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634724|NCT00584155|Ofloxacin|ofloxacin|mesh-list
92634725|NCT00584155|Levofloxacin|levofloxacin|mesh-list
92634726|NCT00584155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92634727|NCT00584155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634729|NCT00584155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92634730|NCT00584155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634731|NCT00584155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041756|NCT01961349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634733|NCT00584155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562287|NCT00151801|Interferon beta-1a|interferon beta-1a|mesh-list
92562288|NCT00151801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562289|NCT00151801|Antiviral Agents|antiviral agents|mesh-ancestor
92562290|NCT00151801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562291|NCT00151801|Immunologic Factors|immunologic factors|mesh-ancestor
92562292|NCT00151801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634734|NCT00584155|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92634735|NCT00584155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92634737|NCT00411372|Xhance|xhance|mesh-list
92634738|NCT00411372|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92634739|NCT00411372|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92634740|NCT00411372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634741|NCT00411372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92634742|NCT00411372|Autonomic Agents|autonomic agents|mesh-ancestor
92634743|NCT00411372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634744|NCT00411372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634745|NCT00411372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92634746|NCT00411372|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634747|NCT00411372|Dermatologic Agents|dermatologic agents|mesh-ancestor
92634748|NCT00411372|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92634749|NCT00411372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92634750|NCT00411372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92634751|NCT00411372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92634752|NCT00411372|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634753|NCT00411372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634754|NCT00411372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634755|NCT00411372|Glucocorticoids|glucocorticoids|mesh-ancestor
92634756|NCT00411372|Hormones|hormones|mesh-ancestor
92634757|NCT00411372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634758|NCT00411372|Sympathomimetics|sympathomimetics|mesh-ancestor
92634759|NCT00181922|Ziprasidone|ziprasidone|mesh-list
92634760|NCT00181922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92634761|NCT00181922|Serotonin Agents|serotonin agents|mesh-ancestor
92634762|NCT00181922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634763|NCT00181922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634764|NCT00181922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634765|NCT00181922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92634766|NCT00181922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92634767|NCT00181922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634768|NCT00181922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634769|NCT00181922|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92634770|NCT00181922|Dopamine Agents|dopamine agents|mesh-ancestor
92634771|NCT00182039|Metoprolol|metoprolol|mesh-list
92634772|NCT00182039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92634773|NCT00182039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92634774|NCT00182039|Sympatholytics|sympatholytics|mesh-ancestor
92634775|NCT00182039|Autonomic Agents|autonomic agents|mesh-ancestor
92634776|NCT00182039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634777|NCT00182039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634778|NCT00182039|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92634779|NCT00182039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92634780|NCT00182039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92634781|NCT00182039|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634782|NCT00182039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634783|NCT00182039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634784|NCT00584389|Rimonabant|rimonabant|mesh-list
92634785|NCT00584389|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92634786|NCT00584389|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92634787|NCT00584389|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92634788|NCT00584389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634789|NCT00584389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634790|NCT00584389|Hormones|hormones|mesh-ancestor
92634791|NCT00584389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634792|NCT00584389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634793|NCT00216372|Lanreotide|lanreotide|mesh-list
92634794|NCT00216372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562293|NCT00151801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92634795|NCT00584662|Phenylephrine|phenylephrine|mesh-list
92634796|NCT00584662|Oxymetazoline|oxymetazoline|mesh-list
92634797|NCT00584662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92634798|NCT00584662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92634799|NCT00584662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634800|NCT00584662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634801|NCT00584662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634802|NCT00584662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634812|NCT00584662|Protective Agents|protective agents|mesh-ancestor
92634814|NCT00584779|Analgesics|analgesics|mesh-ancestor
92634815|NCT00584779|Sensory System Agents|sensory system agents|mesh-ancestor
92634816|NCT00584779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634817|NCT00584779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634818|NCT00584779|Anticonvulsants|anticonvulsants|mesh-ancestor
92634819|NCT00584779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92634820|NCT00584779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92634821|NCT00584779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634822|NCT00584779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634823|NCT00584779|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92634824|NCT00584779|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92634825|NCT00584779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634826|NCT00584779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362836|NCT04718181|Omeprazole|omeprazole|mesh-list
92634827|NCT00584779|Antimanic Agents|antimanic agents|mesh-ancestor
92634828|NCT00216411|Botulinum Toxins|botulinum toxins|mesh-list
92634829|NCT00216411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92634830|NCT00216411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92634831|NCT00216411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92634832|NCT00216411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92634833|NCT00216411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634834|NCT00216411|Cholinergic Agents|cholinergic agents|mesh-ancestor
92634835|NCT00216411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634836|NCT00216411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634837|NCT00216411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92634838|NCT00216411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634839|NCT00585091|Phenylephrine|phenylephrine|mesh-list
92634840|NCT00585091|Oxymetazoline|oxymetazoline|mesh-list
92634841|NCT00585091|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92634842|NCT00585091|Mydriatics|mydriatics|mesh-ancestor
92634843|NCT00585091|Autonomic Agents|autonomic agents|mesh-ancestor
92634844|NCT00585091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634845|NCT00585091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634846|NCT00585091|Sympathomimetics|sympathomimetics|mesh-ancestor
92634847|NCT00585091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92634848|NCT00585091|Nasal Decongestants|nasal decongestants|mesh-ancestor
92634849|NCT00585091|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634850|NCT00585091|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92634851|NCT00585091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92634852|NCT00585091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92634853|NCT00585091|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634854|NCT00585091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634855|NCT00585091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634856|NCT00585091|Protective Agents|protective agents|mesh-ancestor
92634857|NCT00216450|Rabeprazole|rabeprazole|mesh-list
92634858|NCT00216450|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92634859|NCT00216450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634860|NCT00216450|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92634861|NCT00216450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634862|NCT00216450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634863|NCT00585442|Vitamin D|vitamin d|mesh-list
92634864|NCT00585442|Calcitriol|calcitriol|mesh-list
92634865|NCT00585442|Vitamins|vitamins|mesh-ancestor
92634866|NCT00585442|Micronutrients|micronutrients|mesh-ancestor
92634867|NCT00585442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634868|NCT00585442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92041902|NCT01960413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634870|NCT00585442|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92634871|NCT00585442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92634872|NCT00585442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634873|NCT00585442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92634874|NCT00585520|Progesterone|progesterone|mesh-list
92634875|NCT00585520|Progestins|progestins|mesh-ancestor
92634876|NCT00585520|Hormones|hormones|mesh-ancestor
92752327|NCT05940701|Protective Agents|protective agents|mesh-ancestor
92562294|NCT04725253|Niacinamide|niacinamide|mesh-list
92562295|NCT04725253|Niacin|niacin|mesh-list
92562296|NCT04725253|Nicotinic Acids|nicotinic acids|mesh-list
92562297|NCT04725253|Vitamin B Complex|vitamin b complex|mesh-ancestor
92562298|NCT04725253|Vitamins|vitamins|mesh-ancestor
92634877|NCT00585520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634878|NCT00585520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634879|NCT00216489|Rabeprazole|rabeprazole|mesh-list
92634880|NCT00216489|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92362848|NCT04682366|Tamsulosin|tamsulosin|mesh-list
92634881|NCT00216489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634882|NCT00216489|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92634883|NCT00216489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634884|NCT00216489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634885|NCT00585754|Guanfacine|guanfacine|mesh-list
92634886|NCT00585754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92634887|NCT00585754|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92634888|NCT00585754|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92634889|NCT00585754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92634890|NCT00585754|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634891|NCT00585754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634892|NCT00585754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634893|NCT00585754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634894|NCT00209547|Fospropofol|fospropofol|mesh-list
92634895|NCT00209547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92634896|NCT00209547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634897|NCT00209547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634898|NCT00585871|Metoprolol|metoprolol|mesh-list
92634899|NCT00585871|Clonidine|clonidine|mesh-list
92634900|NCT00585871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92634901|NCT00585871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92634902|NCT00585871|Sympatholytics|sympatholytics|mesh-ancestor
92634903|NCT00585871|Autonomic Agents|autonomic agents|mesh-ancestor
92634904|NCT00585871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634905|NCT00585871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634906|NCT00585871|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92634907|NCT00585871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92634908|NCT00585871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92634909|NCT00585871|Adrenergic Agents|adrenergic agents|mesh-ancestor
92634910|NCT00585871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634911|NCT00585871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634912|NCT00585871|Analgesics|analgesics|mesh-ancestor
92634913|NCT00585871|Sensory System Agents|sensory system agents|mesh-ancestor
92634914|NCT00585871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92634915|NCT00585871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92634916|NCT00585871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92634917|NCT03452722|Plasminogen|plasminogen|mesh-list
92634918|NCT03452722|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92634919|NCT03452722|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92634920|NCT03452722|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92634921|NCT03452722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634922|NCT00408551|Leucovorin|leucovorin|mesh-list
92634923|NCT00408551|Fluorouracil|fluorouracil|mesh-list
92634924|NCT00408551|Floxuridine|floxuridine|mesh-list
92634925|NCT00408551|Oxaliplatin|oxaliplatin|mesh-list
92634926|NCT00408551|Irinotecan|irinotecan|mesh-list
92634927|NCT00408551|Calcium|calcium|mesh-list
92634928|NCT00408551|Levoleucovorin|levoleucovorin|mesh-list
92634929|NCT00408551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92634930|NCT00408551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634931|NCT00408551|Antimetabolites|antimetabolites|mesh-ancestor
92634932|NCT00408551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634933|NCT00408551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634934|NCT00408551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634935|NCT00408551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634936|NCT00408551|Immunologic Factors|immunologic factors|mesh-ancestor
92634937|NCT00408551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92634938|NCT00408551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634939|NCT00408551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634940|NCT00408551|Antidotes|antidotes|mesh-ancestor
92634941|NCT00408551|Protective Agents|protective agents|mesh-ancestor
92634945|NCT04575415|Bevacizumab|bevacizumab|mesh-list
92634946|NCT04575415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92562299|NCT04725253|Micronutrients|micronutrients|mesh-ancestor
92562300|NCT04725253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562301|NCT04725253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92634947|NCT04575415|Gefitinib|gefitinib|mesh-list
92634948|NCT04575415|Osimertinib|osimertinib|mesh-list
92634949|NCT04575415|Afatinib|afatinib|mesh-list
92634950|NCT04575415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360158|NCT00385008|Serotonin Agents|serotonin agents|mesh-ancestor
92634951|NCT04575415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634952|NCT04575415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92634953|NCT04575415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92634954|NCT04575415|Growth Substances|growth substances|mesh-ancestor
92634955|NCT04575415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634956|NCT04575415|Growth Inhibitors|growth inhibitors|mesh-ancestor
92634957|NCT04575415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92634958|NCT04575415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634959|NCT04575415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634960|NCT00209625|Leucovorin|leucovorin|mesh-list
92634961|NCT00209625|Fluorouracil|fluorouracil|mesh-list
92634962|NCT00209625|Irinotecan|irinotecan|mesh-list
92634963|NCT00209625|Antimetabolites|antimetabolites|mesh-ancestor
92634964|NCT00209625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634965|NCT00209625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92634966|NCT00209625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634967|NCT00209625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634968|NCT00209625|Immunologic Factors|immunologic factors|mesh-ancestor
92634969|NCT00209625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634970|NCT00209625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92634971|NCT00209625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92634972|NCT00209625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634973|NCT00209625|Antidotes|antidotes|mesh-ancestor
92634974|NCT00209625|Protective Agents|protective agents|mesh-ancestor
92634975|NCT00209625|Vitamin B Complex|vitamin b complex|mesh-ancestor
92634976|NCT00209625|Vitamins|vitamins|mesh-ancestor
92634977|NCT00209625|Micronutrients|micronutrients|mesh-ancestor
92634978|NCT00216528|Risperidone|risperidone|mesh-list
92634979|NCT00216528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92634980|NCT00216528|Serotonin Agents|serotonin agents|mesh-ancestor
92634981|NCT00216528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634982|NCT00216528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634983|NCT00216528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634984|NCT00216528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92634985|NCT00216528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92634986|NCT00216528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634987|NCT00216528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92634988|NCT00216528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92634989|NCT00216528|Dopamine Agents|dopamine agents|mesh-ancestor
92634990|NCT00182312|Caffeine|caffeine|mesh-list
92634991|NCT00182312|Caffeine citrate|caffeine citrate|mesh-list
92634992|NCT00182312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634993|NCT00182312|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92634994|NCT00182312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634995|NCT00182312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92634996|NCT00182312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92634997|NCT00182312|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92634998|NCT00182312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92634999|NCT00182312|Purinergic Agents|purinergic agents|mesh-ancestor
92635000|NCT00182312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635001|NCT00209664|Irinotecan|irinotecan|mesh-list
92635002|NCT00209664|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92635003|NCT00209664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635004|NCT00209664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635005|NCT00209664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635006|NCT00209664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635007|NCT04575493|Ciprofloxacin|ciprofloxacin|mesh-list
92635008|NCT04575493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92635009|NCT04575493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635010|NCT04575493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635011|NCT04575493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635012|NCT04575493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635013|NCT04575493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635014|NCT04575493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562302|NCT04725253|Antimetabolites|antimetabolites|mesh-ancestor
92562303|NCT04725253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562304|NCT04725253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92562305|NCT04725253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92635016|NCT04575493|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92635018|NCT00587119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635019|NCT00587119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92635020|NCT00587119|Autonomic Agents|autonomic agents|mesh-ancestor
92635021|NCT00587119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635022|NCT00587119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635023|NCT00587119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92635024|NCT00587119|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635025|NCT00587119|Glucocorticoids|glucocorticoids|mesh-ancestor
92635027|NCT00587119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635028|NCT00216567|Topiramate|topiramate|mesh-list
92635029|NCT00216567|Anticonvulsants|anticonvulsants|mesh-ancestor
92635030|NCT00216567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635031|NCT00216567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635032|NCT00182351|Fibrin fragment D|fibrin fragment d|mesh-list
92635033|NCT00182351|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92635034|NCT00182351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92635035|NCT00182351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635036|NCT00182351|Hemostatics|hemostatics|mesh-ancestor
92635037|NCT00182351|Coagulants|coagulants|mesh-ancestor
92635038|NCT00587470|Candesartan|candesartan|mesh-list
92635039|NCT00587470|Candesartan cilexetil|candesartan cilexetil|mesh-list
92635040|NCT00587470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92635041|NCT00587470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92635042|NCT00587470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92635043|NCT00587470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635044|NCT00209703|Leucovorin|leucovorin|mesh-list
92635045|NCT00209703|Fluorouracil|fluorouracil|mesh-list
92635046|NCT00209703|Oxaliplatin|oxaliplatin|mesh-list
92635047|NCT00209703|Levoleucovorin|levoleucovorin|mesh-list
92635048|NCT00209703|Antimetabolites|antimetabolites|mesh-ancestor
92635049|NCT00209703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635050|NCT00209703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635051|NCT00209703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635052|NCT00209703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635053|NCT00209703|Immunologic Factors|immunologic factors|mesh-ancestor
92635054|NCT00209703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635055|NCT00209703|Antidotes|antidotes|mesh-ancestor
92635056|NCT00209703|Protective Agents|protective agents|mesh-ancestor
92635057|NCT00209703|Vitamin B Complex|vitamin b complex|mesh-ancestor
92635058|NCT00209703|Vitamins|vitamins|mesh-ancestor
92635059|NCT00209703|Micronutrients|micronutrients|mesh-ancestor
92635060|NCT04575103|Antipsychotic Agents|antipsychotic agents|mesh-list
92635061|NCT04575103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635062|NCT04575103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635063|NCT04575103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635064|NCT04575103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635065|NCT00587548|Diethylenetriamine|diethylenetriamine|mesh-list
92635066|NCT00587548|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92635067|NCT00587548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635068|NCT00216606|Topiramate|topiramate|mesh-list
92635069|NCT00216606|Anticonvulsants|anticonvulsants|mesh-ancestor
92635070|NCT00216606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635071|NCT00216606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635072|NCT00587665|Ketamine|ketamine|mesh-list
92635073|NCT00587665|Analgesics|analgesics|mesh-ancestor
92635074|NCT00587665|Sensory System Agents|sensory system agents|mesh-ancestor
92635075|NCT00587665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635076|NCT00587665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635077|NCT00587665|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92635078|NCT00587665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92635079|NCT00587665|Anesthetics, General|anesthetics, general|mesh-ancestor
92635080|NCT00587665|Anesthetics|anesthetics|mesh-ancestor
92635081|NCT00587665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635082|NCT00587665|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92635083|NCT00587665|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92562306|NCT00082719|Interferons|interferons|mesh-list
92562307|NCT00082719|Interferon-alpha|interferon-alpha|mesh-list
92562308|NCT00082719|Interferon alpha-2|interferon alpha-2|mesh-list
92562309|NCT00082719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562310|NCT00082719|Antiviral Agents|antiviral agents|mesh-ancestor
92562311|NCT00082719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562312|NCT00082719|Immunologic Factors|immunologic factors|mesh-ancestor
91969803|NCT02477969|Metformin|metformin|mesh-list
92635084|NCT00587665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635085|NCT00587665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635086|NCT00182429|Metronidazole|metronidazole|mesh-list
92635087|NCT00182429|Rifampin|rifampin|mesh-list
92635088|NCT00182429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635093|NCT00182429|Antitubercular Agents|antitubercular agents|mesh-ancestor
92635094|NCT00182429|Leprostatic Agents|leprostatic agents|mesh-ancestor
92635095|NCT00182429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92635096|NCT00182429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635097|NCT00182429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635098|NCT00182429|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92635099|NCT00182429|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92635100|NCT00182429|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92635101|NCT00182429|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92635102|NCT00182429|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92635103|NCT00182429|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92635104|NCT00216645|Doxorubicin|doxorubicin|mesh-list
92635105|NCT00216645|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92635106|NCT00216645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635107|NCT00216645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635108|NCT00216645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635109|NCT00216645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635110|NCT00216645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635111|NCT00216645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635112|NCT00588016|Itraconazole|itraconazole|mesh-list
92635113|NCT00588016|Antifungal Agents|antifungal agents|mesh-ancestor
92635114|NCT00588016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635115|NCT00588016|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92635116|NCT00588016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92635117|NCT00588016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635118|NCT00588016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635119|NCT00588016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92635120|NCT00588016|Hormone Antagonists|hormone antagonists|mesh-ancestor
92635121|NCT00588016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635122|NCT00588016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635123|NCT00588016|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92635124|NCT00216684|Fentanyl|fentanyl|mesh-list
92635125|NCT00216684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92635126|NCT00216684|Narcotics|narcotics|mesh-ancestor
92635127|NCT00216684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635128|NCT00216684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635129|NCT00216684|Analgesics|analgesics|mesh-ancestor
92635130|NCT00216684|Sensory System Agents|sensory system agents|mesh-ancestor
92635131|NCT00216684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635132|NCT00216684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92635133|NCT00216684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92635134|NCT00216684|Anesthetics, General|anesthetics, general|mesh-ancestor
92635135|NCT00216684|Anesthetics|anesthetics|mesh-ancestor
92635136|NCT00588133|Tranexamic Acid|tranexamic acid|mesh-list
92635137|NCT00588133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92635138|NCT00588133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92635139|NCT00588133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635140|NCT00588133|Hemostatics|hemostatics|mesh-ancestor
92635141|NCT00588133|Coagulants|coagulants|mesh-ancestor
92635142|NCT00588172|Metformin|metformin|mesh-list
92635143|NCT00588172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635144|NCT00588172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635145|NCT00182507|Olanzapine|olanzapine|mesh-list
92635146|NCT00182507|Antiemetics|antiemetics|mesh-ancestor
92635147|NCT00182507|Autonomic Agents|autonomic agents|mesh-ancestor
92562313|NCT00082719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635148|NCT00182507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635149|NCT00182507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635150|NCT00182507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635151|NCT00182507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92635152|NCT00182507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635153|NCT00182507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635154|NCT00182507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635155|NCT00182507|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92635156|NCT00182507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92635157|NCT00182507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635160|NCT00182507|Serotonin Agents|serotonin agents|mesh-ancestor
92635161|NCT00209742|Leucovorin|leucovorin|mesh-list
92635162|NCT00209742|polysaccharide-K|polysaccharide-k|mesh-list
92635163|NCT00209742|Tegafur|tegafur|mesh-list
92635164|NCT00209742|Levoleucovorin|levoleucovorin|mesh-list
92635165|NCT00209742|Antidotes|antidotes|mesh-ancestor
92635166|NCT00209742|Protective Agents|protective agents|mesh-ancestor
92635167|NCT00209742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635168|NCT00209742|Vitamin B Complex|vitamin b complex|mesh-ancestor
92635169|NCT00209742|Vitamins|vitamins|mesh-ancestor
92635170|NCT00209742|Micronutrients|micronutrients|mesh-ancestor
92635171|NCT00209742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635172|NCT00209742|Antimetabolites|antimetabolites|mesh-ancestor
92635173|NCT00209742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635174|NCT00209742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635175|NCT00209742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92635176|NCT00209742|Immunologic Factors|immunologic factors|mesh-ancestor
92635177|NCT00209742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635178|NCT00209742|Antiviral Agents|antiviral agents|mesh-ancestor
92635179|NCT00209742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635180|NCT00209742|Interferon Inducers|interferon inducers|mesh-ancestor
92635181|NCT00209742|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92635182|NCT00216723|Aripiprazole|aripiprazole|mesh-list
92635183|NCT00216723|Antidepressive Agents|antidepressive agents|mesh-ancestor
92635184|NCT00216723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635185|NCT00216723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92635186|NCT00216723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635187|NCT00216723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635188|NCT00216723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635189|NCT00216723|Dopamine Agonists|dopamine agonists|mesh-ancestor
92635190|NCT00216723|Dopamine Agents|dopamine agents|mesh-ancestor
92635191|NCT00216723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635192|NCT00216723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635193|NCT00216723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92635194|NCT00216723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92635195|NCT00216723|Serotonin Agents|serotonin agents|mesh-ancestor
92635196|NCT00216723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92635197|NCT00216723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92635198|NCT00216723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92635199|NCT00216723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92635200|NCT00209781|Pyrimethamine|pyrimethamine|mesh-list
92635201|NCT00209781|Sulfadoxine|sulfadoxine|mesh-list
92635202|NCT00209781|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92635203|NCT00209781|Antimalarials|antimalarials|mesh-ancestor
92635204|NCT00209781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92635205|NCT00209781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92635206|NCT00209781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635207|NCT00209781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92635208|NCT00209781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635209|NCT00209781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635210|NCT00209781|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92635211|NCT00182663|Clarithromycin|clarithromycin|mesh-list
92635212|NCT00182663|Thalidomide|thalidomide|mesh-list
92635213|NCT00182663|Dexamethasone|dexamethasone|mesh-list
92635214|NCT00182663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635215|NCT00182663|Antiemetics|antiemetics|mesh-ancestor
92635216|NCT00182663|Autonomic Agents|autonomic agents|mesh-ancestor
92635217|NCT00182663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635218|NCT00182663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635219|NCT00182663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635220|NCT00182663|Glucocorticoids|glucocorticoids|mesh-ancestor
92635221|NCT00182663|Hormones|hormones|mesh-ancestor
92562314|NCT00151957|Methylphenidate|methylphenidate|mesh-list
92562315|NCT00151957|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92562316|NCT00151957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562317|NCT00151957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92562318|NCT00151957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562319|NCT00151957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562320|NCT00151957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562321|NCT00151957|Dopamine Agents|dopamine agents|mesh-ancestor
92562322|NCT00151957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562323|NCT00049946|Risperidone|risperidone|mesh-list
92562324|NCT00049946|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92562325|NCT00049946|Serotonin Agents|serotonin agents|mesh-ancestor
92562326|NCT00049946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562327|NCT00049946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562328|NCT00049946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969806|NCT03195205|Antibodies|antibodies|mesh-list
92635222|NCT00182663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635223|NCT00182663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92635224|NCT00182663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635225|NCT00182663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92635226|NCT00182663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635227|NCT00182663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92635228|NCT00182663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635229|NCT00182663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635230|NCT00182663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92635233|NCT00182663|Immunologic Factors|immunologic factors|mesh-ancestor
92635234|NCT00182663|Leprostatic Agents|leprostatic agents|mesh-ancestor
92635235|NCT00182663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92635236|NCT00182663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92635237|NCT00182663|Growth Substances|growth substances|mesh-ancestor
92635238|NCT00182663|Growth Inhibitors|growth inhibitors|mesh-ancestor
92635240|NCT00216762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92635241|NCT00216762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635242|NCT00216762|Immunologic Factors|immunologic factors|mesh-ancestor
92635243|NCT00216762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635244|NCT00216762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635245|NCT00182702|Epothilones|epothilones|mesh-list
92635246|NCT00182702|Epothilone B|epothilone b|mesh-list
92635247|NCT00182702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92635248|NCT00182702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92635249|NCT00182702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92635250|NCT00182702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635251|NCT00182702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635252|NCT00588835|Dexamethasone|dexamethasone|mesh-list
92635253|NCT00588835|Ondansetron|ondansetron|mesh-list
92635254|NCT00588835|Aprepitant|aprepitant|mesh-list
92635255|NCT00588835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635256|NCT00588835|Antiemetics|antiemetics|mesh-ancestor
92635257|NCT00588835|Autonomic Agents|autonomic agents|mesh-ancestor
92635258|NCT00588835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635259|NCT00588835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635260|NCT00588835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635261|NCT00588835|Glucocorticoids|glucocorticoids|mesh-ancestor
92635262|NCT00588835|Hormones|hormones|mesh-ancestor
92635263|NCT00588835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635264|NCT00588835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92562329|NCT00049946|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92562330|NCT00049946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92562331|NCT00049946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562332|NCT00049946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562333|NCT00049946|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92562334|NCT00049946|Dopamine Agents|dopamine agents|mesh-ancestor
92562335|NCT00152035|Amphetamine|amphetamine|mesh-list
92562336|NCT00152035|Dextroamphetamine|dextroamphetamine|mesh-list
92562337|NCT00152035|Adderall|adderall|mesh-list
92562338|NCT00152035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92635265|NCT00588835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635266|NCT00588835|Antipruritics|antipruritics|mesh-ancestor
92635267|NCT00588835|Dermatologic Agents|dermatologic agents|mesh-ancestor
92635268|NCT00588835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92635269|NCT00588835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92635270|NCT00588835|Serotonin Agents|serotonin agents|mesh-ancestor
92635271|NCT00588835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635272|NCT00588835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635273|NCT00588835|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92635274|NCT00209859|Cyclosporine|cyclosporine|mesh-list
92635275|NCT00209859|Betamethasone|betamethasone|mesh-list
92635276|NCT00209859|Methotrexate|methotrexate|mesh-list
92635277|NCT00209859|Cyclosporins|cyclosporins|mesh-list
92635278|NCT00209859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92635279|NCT00209859|Abortifacient Agents|abortifacient agents|mesh-ancestor
92635280|NCT00209859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92635281|NCT00209859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635282|NCT00209859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635283|NCT00209859|Antimetabolites|antimetabolites|mesh-ancestor
92635284|NCT00209859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635285|NCT00209859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635286|NCT00209859|Dermatologic Agents|dermatologic agents|mesh-ancestor
92635287|NCT00209859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635288|NCT00209859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92635289|NCT00209859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635290|NCT00209859|Immunologic Factors|immunologic factors|mesh-ancestor
92635291|NCT00209859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635292|NCT00209859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92635293|NCT00209859|Antifungal Agents|antifungal agents|mesh-ancestor
92635294|NCT00209859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635295|NCT00209859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92635296|NCT00209859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635297|NCT00209859|Glucocorticoids|glucocorticoids|mesh-ancestor
92635298|NCT00209859|Hormones|hormones|mesh-ancestor
92635299|NCT00209859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635300|NCT00209859|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92635301|NCT00209859|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635302|NCT00588913|Zoledronic Acid|zoledronic acid|mesh-list
92635303|NCT00588913|Aldesleukin|aldesleukin|mesh-list
92635311|NCT00182741|Calcitriol|calcitriol|mesh-list
92635312|NCT00182741|Prednisone|prednisone|mesh-list
92635313|NCT00182741|Mitoxantrone|mitoxantrone|mesh-list
92635314|NCT00182741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635315|NCT00182741|Glucocorticoids|glucocorticoids|mesh-ancestor
92635316|NCT00182741|Hormones|hormones|mesh-ancestor
92635317|NCT00182741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635318|NCT00182741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635319|NCT00182741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92635320|NCT00182741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635321|NCT00182741|Analgesics|analgesics|mesh-ancestor
92635322|NCT00182741|Sensory System Agents|sensory system agents|mesh-ancestor
92635323|NCT00182741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635324|NCT00182741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635325|NCT00182741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635326|NCT00182741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635327|NCT00182741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562339|NCT00152035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562340|NCT00152035|Sympathomimetics|sympathomimetics|mesh-ancestor
92562341|NCT00152035|Autonomic Agents|autonomic agents|mesh-ancestor
91969830|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92635328|NCT00182741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92635329|NCT00182741|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92635330|NCT00182741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635331|NCT00182741|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92635332|NCT00182741|Vitamins|vitamins|mesh-ancestor
92635333|NCT00182741|Micronutrients|micronutrients|mesh-ancestor
92635334|NCT00182741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92635335|NCT00589186|Celecoxib|celecoxib|mesh-list
92635336|NCT00589186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92635337|NCT00589186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635338|NCT00589186|Analgesics|analgesics|mesh-ancestor
92635339|NCT00589186|Sensory System Agents|sensory system agents|mesh-ancestor
92635340|NCT00589186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635341|NCT00589186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635342|NCT00589186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635343|NCT00589186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635344|NCT00589186|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92635345|NCT00589186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92635346|NCT00589186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635347|NCT00589186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635348|NCT00589264|Copper|copper|mesh-list
92635349|NCT00589264|Trace Elements|trace elements|mesh-ancestor
92635350|NCT00589264|Micronutrients|micronutrients|mesh-ancestor
92635351|NCT00589264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635352|NCT00589381|Fenretinide|fenretinide|mesh-list
92635353|NCT00589381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635354|NCT00589381|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92635355|NCT00589381|Protective Agents|protective agents|mesh-ancestor
92635356|NCT00589381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635357|NCT00182819|Temozolomide|temozolomide|mesh-list
92635358|NCT00182819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92635359|NCT00182819|Alkylating Agents|alkylating agents|mesh-ancestor
92635360|NCT00182819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635361|NCT00182819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635362|NCT00216840|Betamethasone|betamethasone|mesh-list
92635363|NCT00216840|Betamethasone Valerate|betamethasone valerate|mesh-list
92635364|NCT00216840|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92635365|NCT00216840|Betamethasone benzoate|betamethasone benzoate|mesh-list
92635366|NCT00216840|Calcipotriene|calcipotriene|mesh-list
92635367|NCT00216840|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92635368|NCT00216840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635369|NCT00216840|Glucocorticoids|glucocorticoids|mesh-ancestor
92635370|NCT00216840|Hormones|hormones|mesh-ancestor
92635371|NCT00216840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635377|NCT00589732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92635378|NCT00589732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92635379|NCT00589732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92635380|NCT00589732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635381|NCT00216879|Betamethasone|betamethasone|mesh-list
92635382|NCT00216879|Betamethasone Valerate|betamethasone valerate|mesh-list
92635383|NCT00216879|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92635384|NCT00216879|Betamethasone benzoate|betamethasone benzoate|mesh-list
92635385|NCT00216879|Calcipotriene|calcipotriene|mesh-list
92635386|NCT00216879|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92635387|NCT00216879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635388|NCT00216879|Glucocorticoids|glucocorticoids|mesh-ancestor
92635389|NCT00216879|Hormones|hormones|mesh-ancestor
92635390|NCT00216879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635391|NCT00216879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635392|NCT00216879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92635393|NCT00216879|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635394|NCT00216879|Dermatologic Agents|dermatologic agents|mesh-ancestor
92635395|NCT00589927|Cilostazol|cilostazol|mesh-list
92635396|NCT00589927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92635397|NCT00589927|Autonomic Agents|autonomic agents|mesh-ancestor
92635398|NCT00589927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562342|NCT00152035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562343|NCT00152035|Dopamine Agents|dopamine agents|mesh-ancestor
92562344|NCT00152035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635399|NCT00589927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635400|NCT00589927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92635401|NCT00589927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635402|NCT00589927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92635403|NCT00589927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92635404|NCT00589927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635405|NCT00589927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92635406|NCT00589927|Vasodilator Agents|vasodilator agents|mesh-ancestor
92635407|NCT00589927|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92635408|NCT00589927|Protective Agents|protective agents|mesh-ancestor
92635409|NCT00589927|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92635410|NCT00589927|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92635411|NCT00589927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635412|NCT00209937|Gaboxadol|gaboxadol|mesh-list
92635413|NCT00209937|Analgesics|analgesics|mesh-ancestor
92635414|NCT00209937|Sensory System Agents|sensory system agents|mesh-ancestor
92635415|NCT00209937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635416|NCT00209937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635417|NCT00209937|Anticonvulsants|anticonvulsants|mesh-ancestor
92635418|NCT00209937|GABA Agonists|gaba agonists|mesh-ancestor
92635419|NCT00209937|GABA Agents|gaba agents|mesh-ancestor
92635420|NCT00209937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635421|NCT00209937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635422|NCT00590278|Raltitrexed|raltitrexed|mesh-list
92635423|NCT00590278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635424|NCT00590278|Antimetabolites|antimetabolites|mesh-ancestor
92635425|NCT00590278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635426|NCT00590278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635427|NCT00590278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92635428|NCT00590278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635429|NCT00216918|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92635430|NCT00216918|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92635431|NCT00216918|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92635432|NCT00216918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635433|NCT00216918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635434|NCT00216918|Adrenergic Agents|adrenergic agents|mesh-ancestor
92635435|NCT00216918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635436|NCT00216918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635437|NCT04574791|Tizanidine|tizanidine|mesh-list
92635438|NCT04574791|Analgesics|analgesics|mesh-ancestor
92635439|NCT04574791|Sensory System Agents|sensory system agents|mesh-ancestor
92635440|NCT04574791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635449|NCT04574791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92635450|NCT04574791|Adrenergic Agents|adrenergic agents|mesh-ancestor
92635451|NCT04574791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635452|NCT04574791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635453|NCT00590629|Niacin|niacin|mesh-list
92635454|NCT00590629|Nicotinic Acids|nicotinic acids|mesh-list
92635455|NCT00590629|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92635456|NCT00590629|Antimetabolites|antimetabolites|mesh-ancestor
92635457|NCT00590629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635458|NCT00590629|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92635459|NCT00590629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92635460|NCT00590629|Vitamin B Complex|vitamin b complex|mesh-ancestor
92635461|NCT00590629|Vitamins|vitamins|mesh-ancestor
92635462|NCT00590629|Micronutrients|micronutrients|mesh-ancestor
92635463|NCT00590629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635464|NCT00590785|Tamoxifen|tamoxifen|mesh-list
92635465|NCT00590785|Ciprofloxacin|ciprofloxacin|mesh-list
92635466|NCT00590785|Cyclophosphamide|cyclophosphamide|mesh-list
92635467|NCT00590785|Doxorubicin|doxorubicin|mesh-list
92635468|NCT00590785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635469|NCT00590785|Immunologic Factors|immunologic factors|mesh-ancestor
92635470|NCT00590785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635471|NCT00590785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635472|NCT00590785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92635473|NCT00590785|Alkylating Agents|alkylating agents|mesh-ancestor
92635474|NCT00590785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635475|NCT00590785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562345|NCT00152035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635476|NCT00590785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92635477|NCT00590785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635478|NCT00590785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635479|NCT00590785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635480|NCT00590785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635481|NCT00590785|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92635482|NCT00590785|Hormone Antagonists|hormone antagonists|mesh-ancestor
92635483|NCT00590785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635484|NCT00590785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92635485|NCT00590785|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92635486|NCT00590785|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92635487|NCT00590785|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92635488|NCT00590785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92635489|NCT00590785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635490|NCT00590785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92635491|NCT00590785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92635492|NCT00477295|Carbamazepine|carbamazepine|mesh-list
92635493|NCT00477295|Zonisamide|zonisamide|mesh-list
92635494|NCT00477295|Anticonvulsants|anticonvulsants|mesh-ancestor
92635495|NCT00477295|Antimanic Agents|antimanic agents|mesh-ancestor
92635496|NCT00477295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635497|NCT00477295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635498|NCT00477295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635499|NCT00477295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635500|NCT00477295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635501|NCT00477295|Analgesics|analgesics|mesh-ancestor
92635502|NCT00477295|Sensory System Agents|sensory system agents|mesh-ancestor
92635503|NCT00477295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635504|NCT00477295|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92635505|NCT00477295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635506|NCT00477295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635514|NCT00476593|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92635515|NCT00476593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635516|NCT00476593|Antiemetics|antiemetics|mesh-ancestor
92635517|NCT00476593|Autonomic Agents|autonomic agents|mesh-ancestor
92635518|NCT00476593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635519|NCT00476593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635520|NCT00476593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635521|NCT00476593|Glucocorticoids|glucocorticoids|mesh-ancestor
92635522|NCT00476593|Hormones|hormones|mesh-ancestor
92635523|NCT00476593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635524|NCT00476593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92635525|NCT00476593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635526|NCT00476593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92635527|NCT00476593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92635528|NCT00476593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635529|NCT00476593|Analgesics|analgesics|mesh-ancestor
92635530|NCT00476593|Sensory System Agents|sensory system agents|mesh-ancestor
92635531|NCT00476593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635532|NCT00476593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92635533|NCT00476593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635534|NCT00476593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635535|NCT00476593|Cathartics|cathartics|mesh-ancestor
92635536|NCT00210132|Ropivacaine|ropivacaine|mesh-list
92635537|NCT00210132|Anesthetics, Local|anesthetics, local|mesh-ancestor
92635538|NCT00210132|Anesthetics|anesthetics|mesh-ancestor
92635539|NCT00210132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635540|NCT00210132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635541|NCT00210132|Sensory System Agents|sensory system agents|mesh-ancestor
92635542|NCT00210132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635543|NCT00183404|Olanzapine|olanzapine|mesh-list
92635544|NCT00183404|Antiemetics|antiemetics|mesh-ancestor
92635545|NCT00183404|Autonomic Agents|autonomic agents|mesh-ancestor
92635546|NCT00183404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635547|NCT00183404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635548|NCT00183404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635549|NCT00183404|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92635550|NCT00183404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635551|NCT00183404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635552|NCT00183404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562347|NCT00152035|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92562348|NCT00152035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91969838|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635553|NCT00183404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92635554|NCT00183404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92635555|NCT00183404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635556|NCT00183404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635557|NCT00183404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635559|NCT00476476|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92635560|NCT00476476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635561|NCT00476476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92635562|NCT00476476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635563|NCT00476476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635564|NCT00183560|Antidepressive Agents|antidepressive agents|mesh-list
92635565|NCT00183560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635566|NCT00217152|Mycophenolic Acid|mycophenolic acid|mesh-list
92635567|NCT00217152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635568|NCT00217152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635569|NCT00217152|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92635570|NCT00217152|Antitubercular Agents|antitubercular agents|mesh-ancestor
92635571|NCT00217152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92635572|NCT00217152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635573|NCT00217152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682817|NCT00438152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92635593|NCT00476086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635595|NCT00476047|Tositumomab I-131|tositumomab i-131|mesh-list
92750766|NCT05936489|Miotics|miotics|mesh-ancestor
92635596|NCT00476047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635597|NCT00217191|Ibuprofen|ibuprofen|mesh-list
92635598|NCT00217191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92635599|NCT00217191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635600|NCT00217191|Analgesics|analgesics|mesh-ancestor
92635601|NCT00217191|Sensory System Agents|sensory system agents|mesh-ancestor
92635602|NCT00217191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635603|NCT00217191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635604|NCT00217191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635605|NCT00217191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635606|NCT00217191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92635607|NCT00217191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635608|NCT00217191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635609|NCT00476008|Memantine|memantine|mesh-list
92635610|NCT00476008|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92635611|NCT00476008|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92635612|NCT00476008|Dopamine Agents|dopamine agents|mesh-ancestor
92635613|NCT00476008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635614|NCT00476008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635615|NCT00476008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635616|NCT00476008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92635617|NCT00476008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92635618|NCT00412035|Botulinum Toxins|botulinum toxins|mesh-list
92635619|NCT00412035|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92635620|NCT00412035|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92635621|NCT00412035|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92635622|NCT00412035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635623|NCT00412035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635624|NCT00412035|Cholinergic Agents|cholinergic agents|mesh-ancestor
92635625|NCT00412035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635627|NCT00412035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92635628|NCT00412035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635629|NCT00183833|Capecitabine|capecitabine|mesh-list
92635630|NCT00183833|Imatinib Mesylate|imatinib mesylate|mesh-list
92635631|NCT00183833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635632|NCT00183833|Antimetabolites|antimetabolites|mesh-ancestor
92635633|NCT00183833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635634|NCT00183833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635635|NCT00183833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92635636|NCT00183833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635637|NCT00183911|Leucovorin|leucovorin|mesh-list
92562349|NCT00152035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562350|NCT00152035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92562351|NCT00049985|Darbepoetin alfa|darbepoetin alfa|mesh-list
92562352|NCT00049985|Hematinics|hematinics|mesh-ancestor
92562353|NCT00152191|Cyclophosphamide|cyclophosphamide|mesh-list
92562354|NCT00152191|Fluorouracil|fluorouracil|mesh-list
92635638|NCT00183911|Fluorouracil|fluorouracil|mesh-list
92635639|NCT00183911|Floxuridine|floxuridine|mesh-list
92635640|NCT00183911|Antimetabolites|antimetabolites|mesh-ancestor
92635641|NCT00183911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635642|NCT00183911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635643|NCT00183911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635644|NCT00183911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635645|NCT00183911|Immunologic Factors|immunologic factors|mesh-ancestor
92635646|NCT00183911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635647|NCT00183911|Antidotes|antidotes|mesh-ancestor
92635648|NCT00183911|Protective Agents|protective agents|mesh-ancestor
92635649|NCT00183911|Vitamin B Complex|vitamin b complex|mesh-ancestor
92635650|NCT00183911|Vitamins|vitamins|mesh-ancestor
92635651|NCT00183911|Micronutrients|micronutrients|mesh-ancestor
92635652|NCT00412152|Oxycodone|oxycodone|mesh-list
92635653|NCT00412152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92635654|NCT00412152|Narcotics|narcotics|mesh-ancestor
92635655|NCT00412152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635656|NCT00412152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635657|NCT00412152|Analgesics|analgesics|mesh-ancestor
92635658|NCT00412152|Sensory System Agents|sensory system agents|mesh-ancestor
92635659|NCT00412152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635660|NCT02963402|Adalimumab|adalimumab|mesh-list
92635661|NCT02963402|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92635662|NCT02963402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635663|NCT02963402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635664|NCT00210327|Bortezomib|bortezomib|mesh-list
92635665|NCT00210327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635666|NCT00425516|Cyclophosphamide|cyclophosphamide|mesh-list
92635667|NCT00425516|Docetaxel|docetaxel|mesh-list
92635668|NCT00425516|Fluorouracil|fluorouracil|mesh-list
92635669|NCT00425516|Epirubicin|epirubicin|mesh-list
92635670|NCT00425516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635671|NCT00425516|Immunologic Factors|immunologic factors|mesh-ancestor
92635672|NCT00425516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635673|NCT00425516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635674|NCT00425516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92635675|NCT00425516|Alkylating Agents|alkylating agents|mesh-ancestor
92635676|NCT00425516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635677|NCT00425516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635678|NCT00425516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92635679|NCT00425516|Tubulin Modulators|tubulin modulators|mesh-ancestor
92635680|NCT00425516|Antimitotic Agents|antimitotic agents|mesh-ancestor
92635681|NCT00425516|Mitosis Modulators|mitosis modulators|mesh-ancestor
92635682|NCT00425516|Antimetabolites|antimetabolites|mesh-ancestor
92635683|NCT00425516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635684|NCT00425516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635685|NCT00425516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635686|NCT00425516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635687|NCT00425516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635688|NCT00412191|Lamotrigine|lamotrigine|mesh-list
92635689|NCT00412191|Anticonvulsants|anticonvulsants|mesh-ancestor
92635690|NCT00412191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92635691|NCT00412191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635692|NCT00412191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635693|NCT00412191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92635694|NCT00412191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635695|NCT00412191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92635696|NCT00412191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635697|NCT00412191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635698|NCT00412191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635699|NCT00412191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92635700|NCT00183950|Noscapine|noscapine|mesh-list
92635701|NCT00183950|Antitussive Agents|antitussive agents|mesh-ancestor
92635706|NCT00210366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635707|NCT00210366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562355|NCT00152191|Methotrexate|methotrexate|mesh-list
92562356|NCT00152191|Tegafur|tegafur|mesh-list
92562357|NCT00152191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562358|NCT00152191|Immunologic Factors|immunologic factors|mesh-ancestor
92635708|NCT00210366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635709|NCT00210366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635710|NCT00408785|Botulinum Toxins|botulinum toxins|mesh-list
92635711|NCT00408785|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92635712|NCT00408785|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92635713|NCT00408785|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92635714|NCT00408785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635715|NCT00408785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635716|NCT00408785|Cholinergic Agents|cholinergic agents|mesh-ancestor
92635717|NCT00408785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635718|NCT00408785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635719|NCT00408785|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92635720|NCT00408785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635721|NCT00475735|Methylphenidate|methylphenidate|mesh-list
92635722|NCT00475735|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92635723|NCT00475735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635724|NCT00475735|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92635725|NCT00475735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92635726|NCT00475735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635727|NCT00475735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635728|NCT00475735|Dopamine Agents|dopamine agents|mesh-ancestor
92362928|NCT04280692|Artemether|artemether|mesh-list
92635729|NCT00475735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635730|NCT00475657|Pemetrexed|pemetrexed|mesh-list
92635731|NCT00475657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635732|NCT00475657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635733|NCT00475657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635734|NCT00475657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92635735|NCT00475657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92635736|NCT00210405|Micronutrients|micronutrients|mesh-list
92635737|NCT00210405|Trace Elements|trace elements|mesh-list
92635738|NCT00210405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635739|NCT00408941|Propofol|propofol|mesh-list
92635740|NCT00408941|Prilocaine|prilocaine|mesh-list
92635741|NCT00408941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92635742|NCT00408941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635743|NCT00408941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635744|NCT00408941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92635745|NCT00408941|Anesthetics, General|anesthetics, general|mesh-ancestor
92635746|NCT00408941|Anesthetics|anesthetics|mesh-ancestor
92635747|NCT00408941|Anesthetics, Local|anesthetics, local|mesh-ancestor
92635748|NCT00408941|Sensory System Agents|sensory system agents|mesh-ancestor
92635749|NCT00408941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635750|NCT00475423|Rituximab|rituximab|mesh-list
92635751|NCT00475423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92635752|NCT00475423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635753|NCT00475423|Immunologic Factors|immunologic factors|mesh-ancestor
92635754|NCT00475423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635755|NCT00475423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635756|NCT00210444|Botulinum Toxins|botulinum toxins|mesh-list
92635757|NCT00210444|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92635758|NCT00210444|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92635759|NCT00210444|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92635760|NCT00210444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635761|NCT00210444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635762|NCT00210444|Cholinergic Agents|cholinergic agents|mesh-ancestor
92635763|NCT00210444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635764|NCT00210444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635765|NCT00210444|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92635766|NCT00210444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635767|NCT00475306|Diphenhydramine|diphenhydramine|mesh-list
92635768|NCT00475306|Promethazine|promethazine|mesh-list
92635769|NCT00475306|Metoclopramide|metoclopramide|mesh-list
92635770|NCT00475306|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92635771|NCT00475306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92635774|NCT00475306|Anesthetics, Local|anesthetics, local|mesh-ancestor
92635775|NCT00475306|Anesthetics|anesthetics|mesh-ancestor
92635776|NCT00475306|Sensory System Agents|sensory system agents|mesh-ancestor
92562359|NCT00152191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562360|NCT00152191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562361|NCT00152191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562362|NCT00152191|Alkylating Agents|alkylating agents|mesh-ancestor
92562363|NCT00152191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635777|NCT00475306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635778|NCT00475306|Antiemetics|antiemetics|mesh-ancestor
92635779|NCT00475306|Autonomic Agents|autonomic agents|mesh-ancestor
92635780|NCT00475306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635781|NCT00475306|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92635782|NCT00475306|Histamine Antagonists|histamine antagonists|mesh-ancestor
92635783|NCT00475306|Histamine Agents|histamine agents|mesh-ancestor
92635784|NCT00475306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635785|NCT00475306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635786|NCT00475306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92635787|NCT00475306|Antipruritics|antipruritics|mesh-ancestor
92635788|NCT00475306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92635789|NCT00475306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92635790|NCT00475306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92635791|NCT00475306|Dopamine Agents|dopamine agents|mesh-ancestor
92635792|NCT00475228|Levonorgestrel|levonorgestrel|mesh-list
92635793|NCT00475228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92635794|NCT00475228|Contraceptive Agents|contraceptive agents|mesh-ancestor
92635795|NCT00475228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92635796|NCT00475228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635797|NCT00475228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92635798|NCT00475228|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92635799|NCT00475228|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92635800|NCT00183989|Rituximab|rituximab|mesh-list
92635801|NCT00183989|Fludarabine|fludarabine|mesh-list
92635802|NCT00183989|Mitoxantrone|mitoxantrone|mesh-list
92635803|NCT00183989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92635804|NCT00183989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635805|NCT00183989|Immunologic Factors|immunologic factors|mesh-ancestor
92635806|NCT00183989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635807|NCT00183989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635808|NCT00183989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635809|NCT00183989|Analgesics|analgesics|mesh-ancestor
92635810|NCT00183989|Sensory System Agents|sensory system agents|mesh-ancestor
92635811|NCT00183989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635812|NCT00183989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635813|NCT00183989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635814|NCT00183989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635815|NCT00184067|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92635816|NCT00184067|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92635817|NCT00184067|Immunologic Factors|immunologic factors|mesh-ancestor
92635818|NCT00184067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635819|NCT00184106|Paroxetine|paroxetine|mesh-list
92635820|NCT00184106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92635821|NCT00184106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92635822|NCT00184106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92635823|NCT00184106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635824|NCT00184106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635825|NCT00184106|Serotonin Agents|serotonin agents|mesh-ancestor
92635826|NCT00184106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635827|NCT00184106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92635828|NCT00184106|Antidepressive Agents|antidepressive agents|mesh-ancestor
92635829|NCT00184106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635830|NCT00184106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92635831|NCT00184106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92635832|NCT00184106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635833|NCT00210483|Almotriptan|almotriptan|mesh-list
92635834|NCT00210483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92635835|NCT00210483|Serotonin Agents|serotonin agents|mesh-ancestor
92635836|NCT00210483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635837|NCT00210483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635838|NCT00210483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562365|NCT00152191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92562366|NCT00152191|Antimetabolites|antimetabolites|mesh-ancestor
92635839|NCT00210561|Acetaminophen|acetaminophen|mesh-list
92635840|NCT00210561|Tramadol|tramadol|mesh-list
92635841|NCT00210561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635842|NCT00210561|Analgesics|analgesics|mesh-ancestor
92635843|NCT00210561|Sensory System Agents|sensory system agents|mesh-ancestor
92635849|NCT00210561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635851|NCT00210600|Hematinics|hematinics|mesh-ancestor
92635852|NCT00217386|Etanercept|etanercept|mesh-list
92635853|NCT00217386|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92635854|NCT00217386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92635855|NCT00217386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92635856|NCT00217386|Analgesics|analgesics|mesh-ancestor
92635857|NCT00217386|Sensory System Agents|sensory system agents|mesh-ancestor
92635858|NCT00217386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635859|NCT00217386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635860|NCT00217386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92635861|NCT00217386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635862|NCT00217386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92635863|NCT00217386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635864|NCT00217386|Immunologic Factors|immunologic factors|mesh-ancestor
92635865|NCT00217503|Zidovudine|zidovudine|mesh-list
92635866|NCT00217503|Valganciclovir|valganciclovir|mesh-list
92635867|NCT00217503|Ganciclovir|ganciclovir|mesh-list
92635868|NCT00217503|Cyclophosphamide|cyclophosphamide|mesh-list
92635869|NCT00217503|Bevacizumab|bevacizumab|mesh-list
92635870|NCT00217503|Doxorubicin|doxorubicin|mesh-list
92635871|NCT00217503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92635872|NCT00217503|Etoposide|etoposide|mesh-list
92635873|NCT00217503|Bortezomib|bortezomib|mesh-list
92635874|NCT00217503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635875|NCT00217503|Immunologic Factors|immunologic factors|mesh-ancestor
92635876|NCT00217503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635877|NCT00217503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92635878|NCT00217503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92635879|NCT00217503|Alkylating Agents|alkylating agents|mesh-ancestor
92635880|NCT00217503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635881|NCT00217503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635882|NCT00217503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92635883|NCT00217503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92635884|NCT00217503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92635885|NCT00217503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92635886|NCT00217503|Growth Substances|growth substances|mesh-ancestor
92635887|NCT00217503|Growth Inhibitors|growth inhibitors|mesh-ancestor
92635888|NCT00217503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635889|NCT00217503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92635890|NCT00217503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92635891|NCT00217503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635892|NCT00217503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92635893|NCT00217503|Antimetabolites|antimetabolites|mesh-ancestor
92635894|NCT00217503|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92635895|NCT00217503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92635896|NCT00217503|Antiviral Agents|antiviral agents|mesh-ancestor
92635897|NCT00217503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635898|NCT00217503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92635899|NCT00217503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92635900|NCT00217542|Interferons|interferons|mesh-list
92635901|NCT00217542|Interferon-alpha|interferon-alpha|mesh-list
92635902|NCT00217542|Interferon alpha-2|interferon alpha-2|mesh-list
92635903|NCT00217542|Azacitidine|azacitidine|mesh-list
92635904|NCT00217542|Amifostine|amifostine|mesh-list
92635905|NCT00217542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635906|NCT00217542|Antiviral Agents|antiviral agents|mesh-ancestor
92635907|NCT00217542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635908|NCT00217542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635909|NCT00217542|Antimetabolites|antimetabolites|mesh-ancestor
92635910|NCT00217542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635911|NCT00217542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635912|NCT00217542|Immunologic Factors|immunologic factors|mesh-ancestor
92635913|NCT00217542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635914|NCT00217542|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92635915|NCT00217542|Protective Agents|protective agents|mesh-ancestor
92635916|NCT00210717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92562367|NCT00152191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562368|NCT00152191|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91969855|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
92042952|NCT05649020|Prilocaine|prilocaine|mesh-list
92635919|NCT00210717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635920|NCT00210717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635921|NCT00210717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92635922|NCT00210717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92635923|NCT00210717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92635924|NCT00210717|Serotonin Agents|serotonin agents|mesh-ancestor
92635925|NCT00210717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635926|NCT00210717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635927|NCT00210717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92635928|NCT00210717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92635929|NCT00210717|Dopamine Agents|dopamine agents|mesh-ancestor
92635931|NCT00184496|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92635932|NCT00184496|Narcotics|narcotics|mesh-ancestor
92635933|NCT00184496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635934|NCT00184496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635935|NCT00184496|Analgesics|analgesics|mesh-ancestor
92635936|NCT00184496|Sensory System Agents|sensory system agents|mesh-ancestor
92635937|NCT00184496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635938|NCT00184496|Antitussive Agents|antitussive agents|mesh-ancestor
92635939|NCT00184496|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635940|NCT00210756|Epoetin Alfa|epoetin alfa|mesh-list
92635941|NCT00210756|Hematinics|hematinics|mesh-ancestor
92635942|NCT00217659|Anastrozole|anastrozole|mesh-list
92635943|NCT00217659|Goserelin|goserelin|mesh-list
92635944|NCT00217659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92635945|NCT00217659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635946|NCT00217659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92635947|NCT00217659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92635948|NCT00217659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635949|NCT00217659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635950|NCT00217659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92635951|NCT00217659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92635952|NCT00217659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92635953|NCT00217659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635954|NCT00184574|Metformin|metformin|mesh-list
92635955|NCT00184574|Insulin Aspart|insulin aspart|mesh-list
92635956|NCT00184574|Biphasic Insulins|biphasic insulins|mesh-list
92635957|NCT00184574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635958|NCT00184574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635959|NCT00210795|Epoetin Alfa|epoetin alfa|mesh-list
92635960|NCT00210795|Hematinics|hematinics|mesh-ancestor
92635961|NCT00217698|Gemcitabine|gemcitabine|mesh-list
92635962|NCT00217698|Gefitinib|gefitinib|mesh-list
92635963|NCT00217698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635964|NCT00217698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635965|NCT00217698|Antimetabolites|antimetabolites|mesh-ancestor
92635966|NCT00217698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635967|NCT00217698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92635968|NCT00217698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92635969|NCT00184613|Insulin|insulin|mesh-list
92635970|NCT00184613|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92635971|NCT00184613|Insulin Glargine|insulin glargine|mesh-list
92635972|NCT00184613|Insulin Aspart|insulin aspart|mesh-list
92635973|NCT00184613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635974|NCT00184613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635975|NCT00210834|Epoetin Alfa|epoetin alfa|mesh-list
92635976|NCT00210834|Hematinics|hematinics|mesh-ancestor
92635977|NCT00217815|Efungumab|efungumab|mesh-list
92635978|NCT00217815|Docetaxel|docetaxel|mesh-list
92635979|NCT00217815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635980|NCT00217815|Tubulin Modulators|tubulin modulators|mesh-ancestor
92635981|NCT00217815|Antimitotic Agents|antimitotic agents|mesh-ancestor
92635982|NCT00217815|Mitosis Modulators|mitosis modulators|mesh-ancestor
92635983|NCT00217815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635984|NCT00217815|Antifungal Agents|antifungal agents|mesh-ancestor
92635985|NCT00217815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635986|NCT04722471|Progesterone|progesterone|mesh-list
92635987|NCT04722471|Progestins|progestins|mesh-ancestor
92635988|NCT04722471|Hormones|hormones|mesh-ancestor
92635989|NCT04722471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562369|NCT00152191|Abortifacient Agents|abortifacient agents|mesh-ancestor
92562370|NCT00152191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562371|NCT00152191|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984252|NCT02552355|Metformin|metformin|mesh-list
92635990|NCT04722471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635991|NCT00210873|Topiramate|topiramate|mesh-list
92635992|NCT00210873|Anticonvulsants|anticonvulsants|mesh-ancestor
92635993|NCT00210873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635997|NCT00210912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92635998|NCT00210912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635999|NCT00184847|Adenosine|adenosine|mesh-list
92636000|NCT00184847|Acetylcholine|acetylcholine|mesh-list
92636001|NCT00184847|Caffeine|caffeine|mesh-list
92636002|NCT00184847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92636003|NCT00184847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636004|NCT00184847|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92636005|NCT00184847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636006|NCT00184847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636007|NCT00184847|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92636008|NCT00184847|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92636009|NCT00184847|Purinergic Agents|purinergic agents|mesh-ancestor
92636010|NCT00184847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636012|NCT00184847|Sensory System Agents|sensory system agents|mesh-ancestor
92636013|NCT00184847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636014|NCT00184847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92636015|NCT00184847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636016|NCT00184847|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92636017|NCT00184847|Purinergic Agonists|purinergic agonists|mesh-ancestor
92636018|NCT00184847|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92636019|NCT00184847|Cholinergic Agents|cholinergic agents|mesh-ancestor
92636020|NCT00184886|Methotrexate|methotrexate|mesh-list
92636021|NCT00184886|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92636022|NCT00184886|Abortifacient Agents|abortifacient agents|mesh-ancestor
92636023|NCT00184886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92636024|NCT00184886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636025|NCT00184886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636026|NCT00184886|Antimetabolites|antimetabolites|mesh-ancestor
92636027|NCT00184886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636028|NCT00184886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636029|NCT00184886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92636030|NCT00184886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636031|NCT00184886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92636032|NCT00184886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636033|NCT00184886|Immunologic Factors|immunologic factors|mesh-ancestor
92636034|NCT00184886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636035|NCT00184886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92636036|NCT00217932|Valproic Acid|valproic acid|mesh-list
92636037|NCT00217932|Anticonvulsants|anticonvulsants|mesh-ancestor
92636038|NCT00217932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636039|NCT00217932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636040|NCT00217932|GABA Agents|gaba agents|mesh-ancestor
92636041|NCT00217932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636042|NCT00217932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636043|NCT00217932|Antimanic Agents|antimanic agents|mesh-ancestor
92636044|NCT00217932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92636045|NCT00217932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636046|NCT00217932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636047|NCT00210990|Doripenem|doripenem|mesh-list
92636048|NCT00210990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92636049|NCT00210990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636050|NCT00185003|Tolbutamide|tolbutamide|mesh-list
92636051|NCT00185003|Potassium Channel Blockers|potassium channel blockers|mesh-list
92636052|NCT00185003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636053|NCT00185003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92636054|NCT00185003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636055|NCT00185003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636056|NCT00185120|Amlodipine|amlodipine|mesh-list
92636057|NCT00185120|Olmesartan|olmesartan|mesh-list
92636058|NCT00185120|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92636059|NCT00185120|Benazepril|benazepril|mesh-list
92636060|NCT00185120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636061|NCT00185120|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562372|NCT00152191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562373|NCT00152191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92562374|NCT00152191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92562375|NCT00152230|Tegafur|tegafur|mesh-list
92562376|NCT00152230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562377|NCT00152230|Antimetabolites|antimetabolites|mesh-ancestor
92562378|NCT00152230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562379|NCT00152230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636062|NCT00185120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636063|NCT00185120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636064|NCT00185120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92636065|NCT00185120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636066|NCT00185120|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636080|NCT00185159|Olmesartan|olmesartan|mesh-list
92636081|NCT00185159|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92636082|NCT00185159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636083|NCT00185159|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92636084|NCT00185159|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92636085|NCT00185159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636086|NCT00218127|Methadyl Acetate|methadyl acetate|mesh-list
92636087|NCT00218127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92636088|NCT00218127|Narcotics|narcotics|mesh-ancestor
92636089|NCT00218127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636090|NCT00218127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636091|NCT00218127|Analgesics|analgesics|mesh-ancestor
92636092|NCT00218127|Sensory System Agents|sensory system agents|mesh-ancestor
92636093|NCT00218127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636094|NCT00185198|Testosterone|testosterone|mesh-list
92636095|NCT00185198|Androgens|androgens|mesh-ancestor
92636096|NCT00185198|Hormones|hormones|mesh-ancestor
92636097|NCT00185198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636098|NCT00185198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636099|NCT00185237|Estradiol|estradiol|mesh-list
92636100|NCT00185237|Estrogens|estrogens|mesh-ancestor
92636101|NCT00185237|Hormones|hormones|mesh-ancestor
92636102|NCT00185237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636103|NCT00185237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636104|NCT00218166|Triazolam|triazolam|mesh-list
92636105|NCT00218166|Tiagabine|tiagabine|mesh-list
92636106|NCT00218166|Baclofen|baclofen|mesh-list
92636107|NCT00218166|GABA Agonists|gaba agonists|mesh-list
92636108|NCT00218166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92636109|NCT00218166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636110|NCT00218166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92636111|NCT00218166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636112|NCT00218166|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92636113|NCT00218166|GABA Agents|gaba agents|mesh-ancestor
92636114|NCT00218166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636115|NCT00218166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636116|NCT00218166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92636117|NCT00218166|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92636118|NCT00218166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92636119|NCT00218166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636120|NCT00218166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636121|NCT00218166|GABA Modulators|gaba modulators|mesh-ancestor
92636122|NCT00218166|Anticonvulsants|anticonvulsants|mesh-ancestor
92636123|NCT00218166|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92636124|NCT00218166|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636125|NCT00218166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636126|NCT00185315|Iloprost|iloprost|mesh-list
92636127|NCT00185315|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92636128|NCT00185315|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636130|NCT00409019|Adefovir|adefovir|mesh-list
92636131|NCT00409019|Telbivudine|telbivudine|mesh-list
92636132|NCT00409019|Antiviral Agents|antiviral agents|mesh-ancestor
92636133|NCT00409019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562380|NCT00152308|Sirolimus|sirolimus|mesh-list
92562381|NCT00152308|Ethanol|ethanol|mesh-list
92562382|NCT00152308|Temsirolimus|temsirolimus|mesh-list
92562383|NCT00152308|MTOR Inhibitors|mtor inhibitors|mesh-list
92562384|NCT00152308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92562385|NCT00152308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562386|NCT00152308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92562387|NCT00152308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636134|NCT00409019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92636135|NCT00409019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92636136|NCT00409019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636137|NCT00409019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636138|NCT00409019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92636139|NCT00409019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92636140|NCT00211146|Epoetin Alfa|epoetin alfa|mesh-list
92636141|NCT00211146|Hematinics|hematinics|mesh-ancestor
92636142|NCT00211224|Riluzole|riluzole|mesh-list
92636143|NCT00211224|Anticonvulsants|anticonvulsants|mesh-ancestor
92636144|NCT00211224|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92636145|NCT00211224|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92636146|NCT00211224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636147|NCT00211224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636148|NCT00211224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361368|NCT00561834|Growth Substances|growth substances|mesh-ancestor
92636149|NCT00211224|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92636150|NCT00211224|Protective Agents|protective agents|mesh-ancestor
92636151|NCT00409097|Rosiglitazone|rosiglitazone|mesh-list
92636152|NCT00409097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92636153|NCT00409097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636154|NCT00218205|Celecoxib|celecoxib|mesh-list
92636155|NCT00218205|Epirubicin|epirubicin|mesh-list
92636156|NCT00218205|Estramustine|estramustine|mesh-list
92636157|NCT00218205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92636158|NCT00218205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92636159|NCT00218205|Analgesics|analgesics|mesh-ancestor
92636160|NCT00218205|Sensory System Agents|sensory system agents|mesh-ancestor
92636161|NCT00218205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636162|NCT00218205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636163|NCT00218205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636164|NCT00218205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636165|NCT00218205|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92636166|NCT00218205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92636167|NCT00218205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636168|NCT00218205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636169|NCT00218205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92636170|NCT00218205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636171|NCT00218205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636172|NCT00218205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636173|NCT00218205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92636174|NCT00218205|Alkylating Agents|alkylating agents|mesh-ancestor
92636175|NCT00218205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92636176|NCT00185510|Methylprednisolone|methylprednisolone|mesh-list
92636177|NCT00185510|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92636178|NCT00185510|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92636179|NCT00185510|Prednisolone|prednisolone|mesh-list
92636180|NCT00185510|Prednisolone acetate|prednisolone acetate|mesh-list
92636181|NCT00185510|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
92636182|NCT00185510|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92636183|NCT00185510|Prednisolone phosphate|prednisolone phosphate|mesh-list
92636184|NCT00185510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636185|NCT00185510|Antiemetics|antiemetics|mesh-ancestor
92636186|NCT00185510|Autonomic Agents|autonomic agents|mesh-ancestor
92636187|NCT00185510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636188|NCT00185510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636189|NCT00185510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92636190|NCT00185510|Glucocorticoids|glucocorticoids|mesh-ancestor
92636191|NCT00185510|Hormones|hormones|mesh-ancestor
92636192|NCT00185510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562389|NCT00152308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562390|NCT00152308|Immunologic Factors|immunologic factors|mesh-ancestor
92562391|NCT00152308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562392|NCT00152308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92636193|NCT00185510|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92636194|NCT00185510|Protective Agents|protective agents|mesh-ancestor
92636195|NCT00185510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92636196|NCT00185510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636197|NCT00218244|Lobeline|lobeline|mesh-list
92636198|NCT00218244|Nicotine|nicotine|mesh-list
92636199|NCT00218244|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92636200|NCT00218244|Autonomic Agents|autonomic agents|mesh-ancestor
92636201|NCT00218244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043226|NCT02169505|Immunotoxins|immunotoxins|mesh-ancestor
92636205|NCT00218244|Cholinergic Agents|cholinergic agents|mesh-ancestor
92636206|NCT00218244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636207|NCT00218244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636208|NCT00218244|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636209|NCT00211302|Aripiprazole|aripiprazole|mesh-list
92636210|NCT00211302|Antidepressive Agents|antidepressive agents|mesh-ancestor
92636211|NCT00211302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636212|NCT00211302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92636213|NCT00211302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92636214|NCT00211302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636215|NCT00211302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636216|NCT00211302|Dopamine Agonists|dopamine agonists|mesh-ancestor
92636217|NCT00211302|Dopamine Agents|dopamine agents|mesh-ancestor
92636218|NCT00211302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636219|NCT00211302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636220|NCT00211302|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92636221|NCT00211302|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92636222|NCT00211302|Serotonin Agents|serotonin agents|mesh-ancestor
92636223|NCT00211302|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92636224|NCT00211302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92636225|NCT00211302|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92636226|NCT00211302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92636227|NCT00218283|Nicotine|nicotine|mesh-list
92636228|NCT00218283|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92636229|NCT00218283|Autonomic Agents|autonomic agents|mesh-ancestor
92636230|NCT00218283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636231|NCT00218283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636232|NCT00218283|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92636233|NCT00218283|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92636234|NCT00218283|Cholinergic Agents|cholinergic agents|mesh-ancestor
92636235|NCT00218283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636236|NCT00218283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636237|NCT00185705|Telmisartan|telmisartan|mesh-list
92636238|NCT00185705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636239|NCT00185705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92636240|NCT00185705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92636241|NCT00185705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636242|NCT00211341|Vitamin A|vitamin a|mesh-list
92636243|NCT00211341|Vitamins|vitamins|mesh-ancestor
92636244|NCT00211341|Micronutrients|micronutrients|mesh-ancestor
92636245|NCT00211341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636246|NCT00185783|Hydrocortisone|hydrocortisone|mesh-list
92636247|NCT00185783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636248|NCT00185861|Arsenic Trioxide|arsenic trioxide|mesh-list
92636249|NCT00185861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636250|NCT00211380|Aripiprazole|aripiprazole|mesh-list
92636251|NCT00211380|Antidepressive Agents|antidepressive agents|mesh-ancestor
92636252|NCT00211380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636253|NCT00211380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92636254|NCT00211380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92636255|NCT00211380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636256|NCT00211380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636257|NCT00211380|Dopamine Agonists|dopamine agonists|mesh-ancestor
92636258|NCT00211380|Dopamine Agents|dopamine agents|mesh-ancestor
92636259|NCT00211380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562393|NCT00152308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985499|NCT02385071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636260|NCT00211380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636261|NCT00211380|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92636262|NCT00211380|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92636263|NCT00211380|Serotonin Agents|serotonin agents|mesh-ancestor
92636264|NCT00211380|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92636265|NCT00211380|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92636266|NCT00211380|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92636267|NCT00211380|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92636268|NCT00185939|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92636269|NCT00185939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92636270|NCT00185939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636271|NCT00185939|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92636275|NCT00218322|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92636276|NCT00218322|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636277|NCT00218322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636278|NCT00218322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636279|NCT00218322|Adrenergic Agents|adrenergic agents|mesh-ancestor
92636280|NCT00218322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636281|NCT00218322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636282|NCT00218361|Hydromorphone|hydromorphone|mesh-list
92636283|NCT00218361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92636284|NCT00218361|Narcotics|narcotics|mesh-ancestor
92636285|NCT00218361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636286|NCT00218361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636287|NCT00218361|Analgesics|analgesics|mesh-ancestor
92636288|NCT00218361|Sensory System Agents|sensory system agents|mesh-ancestor
92636289|NCT00218361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636290|NCT00218517|Selegiline|selegiline|mesh-list
92636291|NCT00218517|Antidepressive Agents|antidepressive agents|mesh-ancestor
92636292|NCT00218517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636293|NCT00218517|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92636294|NCT00218517|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92636295|NCT00218517|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92636296|NCT00218517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361516|NCT05461092|Morphine|morphine|mesh-list
92636297|NCT00218517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636298|NCT00218517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92636299|NCT00218517|Protective Agents|protective agents|mesh-ancestor
92636300|NCT00218517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636301|NCT00211419|Triamcinolone|triamcinolone|mesh-list
92636302|NCT00211419|Anecortave|anecortave|mesh-list
92636303|NCT00211419|Verteporfin|verteporfin|mesh-list
92636304|NCT00211419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636305|NCT00211419|Glucocorticoids|glucocorticoids|mesh-ancestor
92636306|NCT00211419|Hormones|hormones|mesh-ancestor
92636307|NCT00211419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636308|NCT00211419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636309|NCT00211419|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92636310|NCT00211419|Dermatologic Agents|dermatologic agents|mesh-ancestor
92636311|NCT00211419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92636312|NCT00211419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92636313|NCT00211419|Growth Substances|growth substances|mesh-ancestor
92636314|NCT00211419|Growth Inhibitors|growth inhibitors|mesh-ancestor
92636315|NCT00211419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636316|NCT00211458|Anecortave|anecortave|mesh-list
92636317|NCT00211458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92636318|NCT00211458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92636319|NCT00211458|Growth Substances|growth substances|mesh-ancestor
92636320|NCT00211458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636321|NCT00211458|Growth Inhibitors|growth inhibitors|mesh-ancestor
92636322|NCT00211458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636323|NCT00211497|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
92636324|NCT00211497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636325|NCT00186329|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92636326|NCT00186329|Natriuretic Agents|natriuretic agents|mesh-ancestor
92636327|NCT00186329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636328|NCT00211614|Lansoprazole|lansoprazole|mesh-list
92636329|NCT00211614|Dexlansoprazole|dexlansoprazole|mesh-list
92636330|NCT00211614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92636331|NCT00211614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562394|NCT00152308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562395|NCT00152308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91969878|NCT03195049|Protective Agents|protective agents|mesh-ancestor
92636332|NCT00211614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92636333|NCT00211614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636334|NCT00211614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636335|NCT00218790|Dialysis Solutions|dialysis solutions|mesh-list
92636336|NCT00218790|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92636337|NCT00186797|Cyclophosphamide|cyclophosphamide|mesh-list
92636338|NCT00186797|Fludarabine|fludarabine|mesh-list
92636339|NCT00186797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636340|NCT00186797|Immunologic Factors|immunologic factors|mesh-ancestor
92636341|NCT00186797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636342|NCT00186797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636345|NCT00186797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636346|NCT00186797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636347|NCT00186797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92636348|NCT00211653|Acetylcysteine|acetylcysteine|mesh-list
92636349|NCT00211653|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92636350|NCT00211653|Antiviral Agents|antiviral agents|mesh-ancestor
92636351|NCT00211653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636352|NCT00211653|Expectorants|expectorants|mesh-ancestor
92636353|NCT00211653|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636354|NCT00211653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92636355|NCT00211653|Antioxidants|antioxidants|mesh-ancestor
92636356|NCT00211653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636357|NCT00211653|Protective Agents|protective agents|mesh-ancestor
92636358|NCT00211653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636359|NCT00211653|Antidotes|antidotes|mesh-ancestor
92636360|NCT00187031|Topotecan|topotecan|mesh-list
92636361|NCT00187031|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92636362|NCT00187031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636363|NCT00187031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636364|NCT00187031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636365|NCT00187031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636366|NCT00187070|Cytarabine|cytarabine|mesh-list
92636367|NCT00187070|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92636368|NCT00187070|Dexamethasone|dexamethasone|mesh-list
92636369|NCT00187070|Prednisone|prednisone|mesh-list
92636370|NCT00187070|Cyclophosphamide|cyclophosphamide|mesh-list
92636371|NCT00187070|Ifosfamide|ifosfamide|mesh-list
92636372|NCT00187070|Carboplatin|carboplatin|mesh-list
92361594|NCT05214222|Paclitaxel|paclitaxel|mesh-list
92636373|NCT00187070|Doxorubicin|doxorubicin|mesh-list
92636374|NCT00187070|Methotrexate|methotrexate|mesh-list
92636375|NCT00187070|Etoposide|etoposide|mesh-list
92636376|NCT00187070|Vincristine|vincristine|mesh-list
92636377|NCT00187070|Vinblastine|vinblastine|mesh-list
92636378|NCT00187070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636379|NCT00187070|Immunologic Factors|immunologic factors|mesh-ancestor
92636380|NCT00187070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636381|NCT00187070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636382|NCT00187070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92636383|NCT00187070|Alkylating Agents|alkylating agents|mesh-ancestor
92636384|NCT00187070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636385|NCT00187070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636386|NCT00187070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92636387|NCT00187070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636388|NCT00187070|Antiemetics|antiemetics|mesh-ancestor
92636389|NCT00187070|Autonomic Agents|autonomic agents|mesh-ancestor
92636390|NCT00187070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636391|NCT00187070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92636392|NCT00187070|Glucocorticoids|glucocorticoids|mesh-ancestor
92636393|NCT00187070|Hormones|hormones|mesh-ancestor
92636394|NCT00187070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636395|NCT00187070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92636396|NCT00187070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92636397|NCT00187070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636398|NCT00187070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636399|NCT00187070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636400|NCT00187070|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92636401|NCT00187070|Abortifacient Agents|abortifacient agents|mesh-ancestor
92636402|NCT00187070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562396|NCT00152308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562397|NCT00152386|Certolizumab Pegol|certolizumab pegol|mesh-list
91969881|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636403|NCT00187070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636404|NCT00187070|Antimetabolites|antimetabolites|mesh-ancestor
92636405|NCT00187070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92636406|NCT00187070|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92636407|NCT00187070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92636408|NCT00187070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92636409|NCT00187070|Antiviral Agents|antiviral agents|mesh-ancestor
92636410|NCT00187070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636411|NCT00187070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92636412|NCT00187070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92636413|NCT00187070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92636414|NCT00187070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92636415|NCT00187070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92636421|NCT00211848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636422|NCT00211848|Antiviral Agents|antiviral agents|mesh-ancestor
92636423|NCT00211848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636424|NCT00211848|Antimetabolites|antimetabolites|mesh-ancestor
92636425|NCT00211848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636426|NCT00412347|Insulin|insulin|mesh-list
92636427|NCT00412347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92636428|NCT00412347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636429|NCT00187499|Fluticasone|fluticasone|mesh-list
92636430|NCT00187499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636431|NCT00187499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92636432|NCT00187499|Autonomic Agents|autonomic agents|mesh-ancestor
92636433|NCT00187499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636434|NCT00187499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636435|NCT00187499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92636436|NCT00187499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636437|NCT00187499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92636438|NCT00187499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92636439|NCT00212004|Pioglitazone|pioglitazone|mesh-list
92636440|NCT00212004|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92636441|NCT00212004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636442|NCT00187577|Bimatoprost|bimatoprost|mesh-list
92636443|NCT00187577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92361674|NCT02783430|Anesthetics|anesthetics|mesh-ancestor
92636444|NCT00187577|Latanoprost|latanoprost|mesh-list
92636445|NCT00187577|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92636446|NCT00187577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636447|NCT00212043|Carboplatin|carboplatin|mesh-list
92636448|NCT00212043|Gemcitabine|gemcitabine|mesh-list
92636449|NCT00212043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636450|NCT00212043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636451|NCT00212043|Antimetabolites|antimetabolites|mesh-ancestor
92636452|NCT00212043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636453|NCT00212082|Docetaxel|docetaxel|mesh-list
92636454|NCT00212082|Doxorubicin|doxorubicin|mesh-list
92636455|NCT00212082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636456|NCT00212082|Tubulin Modulators|tubulin modulators|mesh-ancestor
92636457|NCT00212082|Antimitotic Agents|antimitotic agents|mesh-ancestor
92636458|NCT00212082|Mitosis Modulators|mitosis modulators|mesh-ancestor
92636459|NCT00212082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636460|NCT00212082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92636461|NCT00212082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636462|NCT00212082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636463|NCT00212082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636464|NCT00219219|Zoledronic Acid|zoledronic acid|mesh-list
92636465|NCT00219219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92636466|NCT00219219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636467|NCT00187928|Topiramate|topiramate|mesh-list
92636468|NCT00187928|Anticonvulsants|anticonvulsants|mesh-ancestor
92636469|NCT00187928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92636470|NCT00187928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636471|NCT00212199|Orlistat|orlistat|mesh-list
92636472|NCT00212199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636473|NCT00212199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636474|NCT00212199|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92636475|NCT00212199|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92636476|NCT00219258|Zoledronic Acid|zoledronic acid|mesh-list
92562398|NCT00152386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92562399|NCT00152386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636477|NCT00219258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92636478|NCT00219258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636480|NCT00188006|Anticoagulants|anticoagulants|mesh-ancestor
92636481|NCT00188006|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92636482|NCT00188006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92636483|NCT00188006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636484|NCT00188045|Propranolol|propranolol|mesh-list
92636485|NCT00188045|Spironolactone|spironolactone|mesh-list
92636486|NCT00188045|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92636487|NCT00188045|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92636488|NCT00188045|Adrenergic Agents|adrenergic agents|mesh-ancestor
92636490|NCT00188045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636491|NCT00188045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636492|NCT00188045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92636493|NCT00188045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636495|NCT00188045|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92636496|NCT00188045|Hormone Antagonists|hormone antagonists|mesh-ancestor
92636497|NCT00188045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636498|NCT00188045|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92636499|NCT00188045|Diuretics|diuretics|mesh-ancestor
92636500|NCT00188045|Natriuretic Agents|natriuretic agents|mesh-ancestor
92636501|NCT00212277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92636502|NCT00212277|Norethindrone|norethindrone|mesh-list
92636503|NCT00212277|Norethindrone Acetate|norethindrone acetate|mesh-list
92636504|NCT00212277|Estradiol|estradiol|mesh-list
92636505|NCT00212277|Estrogens|estrogens|mesh-ancestor
92636506|NCT00212277|Hormones|hormones|mesh-ancestor
92636507|NCT00212277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636508|NCT00212277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636509|NCT00212277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92636510|NCT00212277|Contraceptive Agents|contraceptive agents|mesh-ancestor
92636511|NCT00212277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92636512|NCT00212277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92636513|NCT00212277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92636514|NCT00212277|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92636515|NCT00212277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92636516|NCT00212316|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92636517|NCT00212316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636518|NCT00219375|Sivelestat|sivelestat|mesh-list
92636519|NCT00219375|Glycine|glycine|mesh-list
92636520|NCT00219375|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92636521|NCT00219375|Protease Inhibitors|protease inhibitors|mesh-ancestor
92636522|NCT00219375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636523|NCT00219375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361756|NCT05175768|Niacin|niacin|mesh-list
92636524|NCT00219375|Glycine Agents|glycine agents|mesh-ancestor
92636525|NCT00219375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636526|NCT00219375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636527|NCT00188240|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92636528|NCT00188240|Antiviral Agents|antiviral agents|mesh-ancestor
92636529|NCT00188240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636530|NCT00188396|Citalopram|citalopram|mesh-list
92636531|NCT00188396|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92636532|NCT00188396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636533|NCT00188396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636534|NCT00188396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636535|NCT00188396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636536|NCT00188396|Serotonin Agents|serotonin agents|mesh-ancestor
92636537|NCT00188396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636538|NCT00188396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92636539|NCT00188396|Antidepressive Agents|antidepressive agents|mesh-ancestor
92636540|NCT00188396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636541|NCT00219570|Clindamycin|clindamycin|mesh-list
92636542|NCT00219570|Clindamycin palmitate|clindamycin palmitate|mesh-list
92636543|NCT00219570|Clindamycin phosphate|clindamycin phosphate|mesh-list
92636544|NCT00219570|Nadifloxacin|nadifloxacin|mesh-list
92636545|NCT00219570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92636546|NCT00219570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636547|NCT00219570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92562400|NCT00152386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562401|NCT00152386|Immunologic Factors|immunologic factors|mesh-ancestor
92562402|NCT00152386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562403|NCT00152386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562404|NCT00082836|Rituximab|rituximab|mesh-list
92562405|NCT00082836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92562406|NCT00082836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636548|NCT00219570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636549|NCT00219570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636550|NCT00219570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636551|NCT00219570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636552|NCT00219570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636553|NCT00212472|Factor VIII|factor viii|mesh-list
92636554|NCT00212472|Coagulants|coagulants|mesh-ancestor
92636555|NCT00188552|Tocopherols|tocopherols|mesh-list
92636556|NCT00188552|Vitamin E|vitamin e|mesh-list
92636557|NCT00188552|Tocotrienols|tocotrienols|mesh-list
92636558|NCT00188552|alpha-Tocopherol|alpha-tocopherol|mesh-list
92636559|NCT00188552|Pentoxifylline|pentoxifylline|mesh-list
92636560|NCT00188552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92636561|NCT00188552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636566|NCT00188552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636567|NCT00188552|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636568|NCT00188552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92636569|NCT00188552|Antioxidants|antioxidants|mesh-ancestor
92636570|NCT00188552|Vitamins|vitamins|mesh-ancestor
92636571|NCT00188552|Micronutrients|micronutrients|mesh-ancestor
92636572|NCT00188630|Acetylcysteine|acetylcysteine|mesh-list
92636573|NCT00188630|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92636574|NCT00188630|Antiviral Agents|antiviral agents|mesh-ancestor
92636575|NCT00188630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636576|NCT00188630|Expectorants|expectorants|mesh-ancestor
92636577|NCT00188630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636578|NCT00188630|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92636579|NCT00188630|Antioxidants|antioxidants|mesh-ancestor
92636580|NCT00188630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636581|NCT00188630|Protective Agents|protective agents|mesh-ancestor
92636582|NCT00188630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636583|NCT00188630|Antidotes|antidotes|mesh-ancestor
92636584|NCT00188669|Tocopherols|tocopherols|mesh-list
92636585|NCT00188669|Vitamin E|vitamin e|mesh-list
92636586|NCT00188669|Tocotrienols|tocotrienols|mesh-list
92636587|NCT00188669|alpha-Tocopherol|alpha-tocopherol|mesh-list
92636588|NCT00188669|Pentoxifylline|pentoxifylline|mesh-list
92636589|NCT00188669|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92636590|NCT00188669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636591|NCT00188669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636592|NCT00188669|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92636593|NCT00188669|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92636594|NCT00188669|Protective Agents|protective agents|mesh-ancestor
92636595|NCT00188669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636596|NCT00188669|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636597|NCT00188669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92636598|NCT00188669|Antioxidants|antioxidants|mesh-ancestor
92636599|NCT00188669|Vitamins|vitamins|mesh-ancestor
92636600|NCT00188669|Micronutrients|micronutrients|mesh-ancestor
92636601|NCT00409214|Talaporfin|talaporfin|mesh-list
92636602|NCT00409214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636603|NCT00409214|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92636604|NCT00409214|Dermatologic Agents|dermatologic agents|mesh-ancestor
92636606|NCT02963051|Disulfiram|disulfiram|mesh-list
92636607|NCT02963051|Trace Elements|trace elements|mesh-ancestor
92636608|NCT02963051|Micronutrients|micronutrients|mesh-ancestor
92636609|NCT02963051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636610|NCT02963051|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92636611|NCT02963051|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92636612|NCT02963051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636613|NCT02963051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636614|NCT00219726|Imatinib Mesylate|imatinib mesylate|mesh-list
92636615|NCT00219726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636616|NCT00219726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92636617|NCT00219726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562407|NCT00082836|Immunologic Factors|immunologic factors|mesh-ancestor
92562408|NCT00082836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562409|NCT00082836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636618|NCT00219726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636619|NCT00409253|Nicardipine|nicardipine|mesh-list
92636620|NCT00409253|Urapidil|urapidil|mesh-list
92636621|NCT00409253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636622|NCT00409253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92636623|NCT00409253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636624|NCT00409253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636625|NCT00409253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92636626|NCT00409253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636627|NCT00409253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636628|NCT00409253|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92636629|NCT00409253|Serotonin Agents|serotonin agents|mesh-ancestor
92636630|NCT00409253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636631|NCT00409253|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92636632|NCT00409253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92636633|NCT00409253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92636634|NCT00409253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92636636|NCT00219765|Imatinib Mesylate|imatinib mesylate|mesh-list
92636637|NCT00219765|Daunorubicin|daunorubicin|mesh-list
92636638|NCT00219765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636639|NCT00219765|Antimetabolites|antimetabolites|mesh-ancestor
92636640|NCT00219765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636641|NCT00219765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636642|NCT00219765|Antiviral Agents|antiviral agents|mesh-ancestor
92636643|NCT00219765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636644|NCT00219765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636645|NCT00219765|Immunologic Factors|immunologic factors|mesh-ancestor
92636646|NCT00219765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636647|NCT00219765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92636648|NCT00219765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636649|NCT00219765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92636650|NCT00219765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636651|NCT00219765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636652|NCT00212589|Leucovorin|leucovorin|mesh-list
92636653|NCT00212589|Folic Acid|folic acid|mesh-list
92636654|NCT00212589|Fluorouracil|fluorouracil|mesh-list
92636655|NCT00212589|Capecitabine|capecitabine|mesh-list
92636656|NCT00212589|Levoleucovorin|levoleucovorin|mesh-list
92636657|NCT00212589|Antimetabolites|antimetabolites|mesh-ancestor
92636658|NCT00212589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636659|NCT00212589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636660|NCT00212589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636661|NCT00212589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636662|NCT00212589|Immunologic Factors|immunologic factors|mesh-ancestor
92362973|NCT04179162|Gemcitabine|gemcitabine|mesh-list
92636663|NCT00212589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636664|NCT00212589|Antidotes|antidotes|mesh-ancestor
92636665|NCT00212589|Protective Agents|protective agents|mesh-ancestor
92636666|NCT00212589|Vitamin B Complex|vitamin b complex|mesh-ancestor
92636667|NCT00212589|Vitamins|vitamins|mesh-ancestor
92636668|NCT00212589|Micronutrients|micronutrients|mesh-ancestor
92636669|NCT00212589|Hematinics|hematinics|mesh-ancestor
92636670|NCT00188825|Basiliximab|basiliximab|mesh-list
92636671|NCT00188825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636672|NCT00188825|Immunologic Factors|immunologic factors|mesh-ancestor
92636673|NCT00188825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636674|NCT00219804|Tetrabenazine|tetrabenazine|mesh-list
92636675|NCT00219804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92636676|NCT00219804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636677|NCT00219804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636678|NCT00219804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636679|NCT00219804|Adrenergic Agents|adrenergic agents|mesh-ancestor
92636680|NCT00219804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636681|NCT00219804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636682|NCT00188864|Dexamethasone|dexamethasone|mesh-list
92636683|NCT00188864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636684|NCT00188864|Antiemetics|antiemetics|mesh-ancestor
92636685|NCT00188864|Autonomic Agents|autonomic agents|mesh-ancestor
92636686|NCT00188864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636687|NCT00188864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562410|NCT00152425|Certolizumab Pegol|certolizumab pegol|mesh-list
92562411|NCT00152425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92562412|NCT00152425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562413|NCT00152425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636688|NCT00188864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92636689|NCT00188864|Glucocorticoids|glucocorticoids|mesh-ancestor
92636690|NCT00188864|Hormones|hormones|mesh-ancestor
92636691|NCT00188864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636692|NCT00188864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92636693|NCT00188864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636694|NCT00188942|Olanzapine|olanzapine|mesh-list
92636695|NCT00188942|Fluoxetine|fluoxetine|mesh-list
92636696|NCT00188942|Antiemetics|antiemetics|mesh-ancestor
92636697|NCT00188942|Autonomic Agents|autonomic agents|mesh-ancestor
92636698|NCT00188942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636699|NCT00188942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636700|NCT00188942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92636701|NCT00188942|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92636702|NCT00188942|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92636703|NCT00188942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636704|NCT00188942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636705|NCT00188942|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92636706|NCT00188942|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636707|NCT00188942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636708|NCT00188942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043730|NCT04865159|Tipifarnib|tipifarnib|mesh-list
92636724|NCT00219921|Morphine|morphine|mesh-list
92636725|NCT00219921|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92636726|NCT00219921|Narcotics|narcotics|mesh-ancestor
92636727|NCT00219921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636728|NCT00219921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636729|NCT00219921|Analgesics|analgesics|mesh-ancestor
92636730|NCT00219921|Sensory System Agents|sensory system agents|mesh-ancestor
92636731|NCT00219921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636732|NCT00212823|Almotriptan|almotriptan|mesh-list
92636733|NCT00212823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92636734|NCT00212823|Serotonin Agents|serotonin agents|mesh-ancestor
92636735|NCT00212823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636736|NCT00212823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636737|NCT00212823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636738|NCT00189059|Amitriptyline|amitriptyline|mesh-list
92636739|NCT00189059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92636740|NCT00189059|Antidepressive Agents|antidepressive agents|mesh-ancestor
92636741|NCT00189059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636742|NCT00189059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92636743|NCT00189059|Analgesics|analgesics|mesh-ancestor
92636744|NCT00189059|Sensory System Agents|sensory system agents|mesh-ancestor
92636745|NCT00189059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636746|NCT00189059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636747|NCT00189059|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92636748|NCT00189059|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636749|NCT00189059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704673|NCT01199978|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92636750|NCT00189059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636751|NCT00189059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92636752|NCT00189059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636753|NCT00189176|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92636754|NCT00189176|Chelating Agents|chelating agents|mesh-ancestor
92636755|NCT00189176|Sequestering Agents|sequestering agents|mesh-ancestor
92636756|NCT00189176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636757|NCT00189176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636758|NCT00189176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92636759|NCT00189176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92636760|NCT00189176|Growth Substances|growth substances|mesh-ancestor
92636761|NCT00189176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636762|NCT00189176|Growth Inhibitors|growth inhibitors|mesh-ancestor
92636763|NCT00189176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636765|NCT00189371|Carboplatin|carboplatin|mesh-list
92636770|NCT00189371|Antimitotic Agents|antimitotic agents|mesh-ancestor
92636771|NCT00189371|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562415|NCT00152425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562416|NCT00152425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562417|NCT00152542|Nitric Oxide|nitric oxide|mesh-list
92562418|NCT00152542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92562419|NCT00152542|Autonomic Agents|autonomic agents|mesh-ancestor
92562420|NCT00152542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636772|NCT00189371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636773|NCT00189371|Hematinics|hematinics|mesh-ancestor
92636774|NCT00189410|Carboplatin|carboplatin|mesh-list
92636775|NCT00189410|Doxorubicin|doxorubicin|mesh-list
92636776|NCT00189410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92636777|NCT00189410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636778|NCT00189410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92636779|NCT00189410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636780|NCT00189410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636781|NCT00189410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636782|NCT00189410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636783|NCT00189566|Paclitaxel|paclitaxel|mesh-list
92636784|NCT00189566|Carboplatin|carboplatin|mesh-list
92636785|NCT00189566|Topotecan|topotecan|mesh-list
92636786|NCT00189566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92636787|NCT00189566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636788|NCT00189566|Tubulin Modulators|tubulin modulators|mesh-ancestor
92636789|NCT00189566|Antimitotic Agents|antimitotic agents|mesh-ancestor
92636790|NCT00189566|Mitosis Modulators|mitosis modulators|mesh-ancestor
92636791|NCT00189566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636792|NCT00189566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92636793|NCT00189566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636794|NCT00189566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636795|NCT00220116|Capecitabine|capecitabine|mesh-list
92636796|NCT00220116|Oxaliplatin|oxaliplatin|mesh-list
92636797|NCT00220116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636798|NCT00220116|Antimetabolites|antimetabolites|mesh-ancestor
92636799|NCT00220116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636800|NCT00220116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636801|NCT02963129|Mupirocin|mupirocin|mesh-list
92636802|NCT02963129|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92636803|NCT02963129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636804|NCT02963129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92636805|NCT02963129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636806|NCT02963129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636807|NCT00220155|Gemcitabine|gemcitabine|mesh-list
92636808|NCT00220155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636809|NCT00220155|Antimetabolites|antimetabolites|mesh-ancestor
92636810|NCT00220155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636811|NCT00220155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636812|NCT00189644|Cyclophosphamide|cyclophosphamide|mesh-list
92636813|NCT00189644|Fluorouracil|fluorouracil|mesh-list
92636814|NCT00189644|Epirubicin|epirubicin|mesh-list
92636815|NCT00189644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636816|NCT00189644|Immunologic Factors|immunologic factors|mesh-ancestor
92636817|NCT00189644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636818|NCT00189644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636819|NCT00189644|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92636820|NCT00189644|Alkylating Agents|alkylating agents|mesh-ancestor
92636821|NCT00189644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636822|NCT00189644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636823|NCT00189644|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92362044|NCT00618540|Fludarabine phosphate|fludarabine phosphate|mesh-list
92636824|NCT00189644|Antimetabolites|antimetabolites|mesh-ancestor
92636825|NCT00189644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636826|NCT00189644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92636827|NCT00189644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92636828|NCT00189644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92636829|NCT00189644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636830|NCT00189683|Capecitabine|capecitabine|mesh-list
92636831|NCT00189683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562421|NCT00152542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562422|NCT00152542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92562423|NCT00152542|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636832|NCT00189683|Antimetabolites|antimetabolites|mesh-ancestor
92636833|NCT00189683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636834|NCT00189683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636835|NCT00189722|Tacrolimus|tacrolimus|mesh-list
92636837|NCT00189722|Immunologic Factors|immunologic factors|mesh-ancestor
92636838|NCT00189722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636839|NCT00189722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92636840|NCT00189722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636841|NCT00189722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636842|NCT00220194|Leuprolide|leuprolide|mesh-list
92636843|NCT00220194|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92636844|NCT00220194|Fertility Agents|fertility agents|mesh-ancestor
92636845|NCT00220194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92636846|NCT00220194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636847|NCT00220194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92636848|NCT00220194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636849|NCT00189761|Tacrolimus|tacrolimus|mesh-list
92636850|NCT00189761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636851|NCT00189761|Immunologic Factors|immunologic factors|mesh-ancestor
92636852|NCT00189761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636853|NCT00189761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92636854|NCT00189761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636855|NCT00189761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636856|NCT00213096|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92636857|NCT00213096|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92636858|NCT00213096|Levonorgestrel|levonorgestrel|mesh-list
92636859|NCT00213096|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92636860|NCT00213096|ST 1435|st 1435|mesh-list
92636861|NCT00213096|Contraceptive Agents|contraceptive agents|mesh-list
92636862|NCT00213096|Contraceptives, Oral|contraceptives, oral|mesh-list
92636863|NCT00213096|Estradiol|estradiol|mesh-list
92636864|NCT00213096|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92636865|NCT00213096|Estrogens|estrogens|mesh-ancestor
92636866|NCT00213096|Hormones|hormones|mesh-ancestor
92636867|NCT00213096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636868|NCT00213096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636869|NCT00213096|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92636870|NCT00213096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92636871|NCT00213096|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92636872|NCT00213096|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92636873|NCT00213096|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92636874|NCT00189800|Solifenacin Succinate|solifenacin succinate|mesh-list
92636875|NCT00189800|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92636876|NCT00189800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92362982|NCT04163432|Carboplatin|carboplatin|mesh-list
92636877|NCT00189800|Cholinergic Agents|cholinergic agents|mesh-ancestor
92636878|NCT00189800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636879|NCT00189800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636880|NCT00189800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636881|NCT00189800|Urological Agents|urological agents|mesh-ancestor
92636882|NCT00220233|Amlodipine|amlodipine|mesh-list
92636883|NCT00220233|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92636884|NCT00220233|Olmesartan|olmesartan|mesh-list
92636885|NCT00220233|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92636886|NCT00220233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92636887|NCT00220233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92636888|NCT00220233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636889|NCT00220233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636890|NCT00220233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92636891|NCT00220233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636892|NCT00220233|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636893|NCT00220233|Diuretics|diuretics|mesh-ancestor
92636894|NCT00220233|Natriuretic Agents|natriuretic agents|mesh-ancestor
92636895|NCT00220233|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92636896|NCT00220233|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92362126|NCT01115569|Hydrocodone|hydrocodone|mesh-list
92636897|NCT00220233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92636898|NCT00189839|Tacrolimus|tacrolimus|mesh-list
92636899|NCT00189839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562424|NCT00152542|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92562425|NCT00152542|Antioxidants|antioxidants|mesh-ancestor
92636900|NCT00189839|Immunologic Factors|immunologic factors|mesh-ancestor
92636901|NCT00189839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636902|NCT00189839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92636903|NCT00189839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636904|NCT00189839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636905|NCT00189878|Methotrexate|methotrexate|mesh-list
92636906|NCT00189878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92636907|NCT00189878|Abortifacient Agents|abortifacient agents|mesh-ancestor
92636910|NCT00189878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636911|NCT00189878|Antimetabolites|antimetabolites|mesh-ancestor
92636912|NCT00189878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636913|NCT00189878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636914|NCT00189878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362992|NCT04151706|Busulfan|busulfan|mesh-list
92636915|NCT00189878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636916|NCT00189878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92636917|NCT00189878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636918|NCT00189878|Immunologic Factors|immunologic factors|mesh-ancestor
92636919|NCT00189878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92636920|NCT00189878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92636921|NCT00220311|Fludarabine|fludarabine|mesh-list
92636922|NCT00220311|Fludarabine phosphate|fludarabine phosphate|mesh-list
92636923|NCT00220311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636924|NCT00220311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92636925|NCT00220311|Antimetabolites|antimetabolites|mesh-ancestor
92636926|NCT00220311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636927|NCT00220311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636928|NCT00220311|Immunologic Factors|immunologic factors|mesh-ancestor
92636929|NCT00220311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636930|NCT00189917|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92636931|NCT00189917|Antiviral Agents|antiviral agents|mesh-ancestor
92636932|NCT00189917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636933|NCT00189956|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92636934|NCT00189956|Antiviral Agents|antiviral agents|mesh-ancestor
92636935|NCT00189956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636936|NCT00213252|Prednisolone|prednisolone|mesh-list
92636937|NCT00213252|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92636938|NCT00213252|Methylprednisolone|methylprednisolone|mesh-list
92636939|NCT00213252|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92636940|NCT00213252|Prednisolone acetate|prednisolone acetate|mesh-list
92636941|NCT00213252|Montelukast|montelukast|mesh-list
92636942|NCT00213252|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92636943|NCT00213252|Prednisolone phosphate|prednisolone phosphate|mesh-list
92636944|NCT00213252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92636945|NCT00213252|Glucocorticoids|glucocorticoids|mesh-ancestor
92636947|NCT00213252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92636948|NCT00213252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636949|NCT00213252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92636950|NCT00213252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636951|NCT00213252|Antiemetics|antiemetics|mesh-ancestor
92636952|NCT00213252|Autonomic Agents|autonomic agents|mesh-ancestor
92636953|NCT00213252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92636954|NCT00213252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92636955|NCT00213252|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92636956|NCT00213252|Protective Agents|protective agents|mesh-ancestor
92636957|NCT00213252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92636958|NCT00213252|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636959|NCT00213252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92636960|NCT00213252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92636961|NCT00213252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92636962|NCT00213252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92636963|NCT00213252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636964|NCT00189995|Haloperidol|haloperidol|mesh-list
92636965|NCT00189995|Haloperidol decanoate|haloperidol decanoate|mesh-list
92636966|NCT00189995|Clozapine|clozapine|mesh-list
92636967|NCT00189995|Antiemetics|antiemetics|mesh-ancestor
92636968|NCT00189995|Autonomic Agents|autonomic agents|mesh-ancestor
92362195|NCT05766514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636969|NCT00189995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562426|NCT00152542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562427|NCT00152542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562428|NCT00152542|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92562429|NCT00152542|Vasodilator Agents|vasodilator agents|mesh-ancestor
92562430|NCT00152542|Gasotransmitters|gasotransmitters|mesh-ancestor
92562431|NCT00152542|Protective Agents|protective agents|mesh-ancestor
92636970|NCT00189995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636971|NCT00189995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92636972|NCT00189995|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92636973|NCT00189995|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92636974|NCT00189995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92636975|NCT00189995|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92636976|NCT00189995|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92636977|NCT00189995|Dopamine Agents|dopamine agents|mesh-ancestor
92636979|NCT00189995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636980|NCT00189995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92636981|NCT00189995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92636982|NCT00189995|Serotonin Agents|serotonin agents|mesh-ancestor
92636983|NCT00189995|GABA Antagonists|gaba antagonists|mesh-ancestor
92636985|NCT00213291|Darbepoetin alfa|darbepoetin alfa|mesh-list
92636987|NCT00190034|Acetylcysteine|acetylcysteine|mesh-list
92636988|NCT00190034|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92636989|NCT00190034|Antiviral Agents|antiviral agents|mesh-ancestor
92636990|NCT00190034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92636991|NCT00190034|Expectorants|expectorants|mesh-ancestor
92636992|NCT00190034|Respiratory System Agents|respiratory system agents|mesh-ancestor
92636993|NCT00190034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92636994|NCT00190034|Antioxidants|antioxidants|mesh-ancestor
92636995|NCT00190034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636996|NCT00190034|Protective Agents|protective agents|mesh-ancestor
92636997|NCT00190034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636998|NCT00190034|Antidotes|antidotes|mesh-ancestor
92636999|NCT00412503|Temozolomide|temozolomide|mesh-list
92637000|NCT00412503|Topotecan|topotecan|mesh-list
92637001|NCT00412503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92637002|NCT00412503|Alkylating Agents|alkylating agents|mesh-ancestor
92637003|NCT00412503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637004|NCT00412503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637005|NCT00412503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92637006|NCT00412503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92637007|NCT00412503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637008|NCT00412581|Lenalidomide|lenalidomide|mesh-list
92637009|NCT00412581|Dacarbazine|dacarbazine|mesh-list
92637010|NCT00412581|Immunologic Factors|immunologic factors|mesh-ancestor
92637011|NCT00412581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637012|NCT00412581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92637013|NCT00412581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92637014|NCT00412581|Growth Substances|growth substances|mesh-ancestor
92637015|NCT00412581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92637016|NCT00412581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637017|NCT00412581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92637018|NCT00412581|Alkylating Agents|alkylating agents|mesh-ancestor
92637019|NCT00412581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637020|NCT00190151|Ciprofloxacin|ciprofloxacin|mesh-list
92637021|NCT00190151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92637022|NCT00190151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637023|NCT00190151|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92637024|NCT00190151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92637025|NCT00190151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637026|NCT00190151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637027|NCT00190151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637028|NCT00190151|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92637029|NCT00190151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92637030|NCT00190229|Cyclophosphamide|cyclophosphamide|mesh-list
92637031|NCT00190229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92637032|NCT00190229|Immunologic Factors|immunologic factors|mesh-ancestor
92637033|NCT00190229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562432|NCT00043680|Celecoxib|celecoxib|mesh-list
92562433|NCT00043680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92562434|NCT00043680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92562435|NCT00043680|Analgesics|analgesics|mesh-ancestor
92637034|NCT00190229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637035|NCT00190229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92637036|NCT00190229|Alkylating Agents|alkylating agents|mesh-ancestor
92637037|NCT00190229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637038|NCT00190229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637039|NCT00190229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92637040|NCT00190268|Amifampridine|amifampridine|mesh-list
92637041|NCT00190268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92637042|NCT00190268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637043|NCT00190268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637044|NCT00190268|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92637045|NCT00190268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637046|NCT00190268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637047|NCT00220350|Leuprolide|leuprolide|mesh-list
92637048|NCT00220350|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92637049|NCT00220350|Fertility Agents|fertility agents|mesh-ancestor
92750767|NCT05936489|Autonomic Agents|autonomic agents|mesh-ancestor
92637050|NCT00220350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92637053|NCT00220350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637054|NCT00190307|Aspirin|aspirin|mesh-list
92637055|NCT00190307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92637056|NCT00190307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92637057|NCT00190307|Analgesics|analgesics|mesh-ancestor
92637058|NCT00190307|Sensory System Agents|sensory system agents|mesh-ancestor
92637059|NCT00190307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637060|NCT00190307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637061|NCT00190307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92637062|NCT00190307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637063|NCT00190307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92637064|NCT00190307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92637065|NCT00190307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637066|NCT00190307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92637067|NCT00190307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92637068|NCT00190307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637069|NCT00190307|Antipyretics|antipyretics|mesh-ancestor
92637070|NCT02963168|Docetaxel|docetaxel|mesh-list
92637071|NCT02963168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637072|NCT02963168|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637073|NCT02963168|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637074|NCT02963168|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637075|NCT02963168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637076|NCT00190424|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
92637077|NCT00190424|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92637078|NCT00190424|Immunologic Factors|immunologic factors|mesh-ancestor
92637079|NCT00190424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637080|NCT00190463|Amphotericin B|amphotericin b|mesh-list
92637081|NCT00190463|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92637082|NCT00190463|Amebicides|amebicides|mesh-ancestor
92637083|NCT00190463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92637084|NCT00190463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92637085|NCT00190463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637086|NCT00190463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92637087|NCT00190463|Antifungal Agents|antifungal agents|mesh-ancestor
92637088|NCT00213486|Irinotecan|irinotecan|mesh-list
92637089|NCT00213486|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92637090|NCT00213486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92637091|NCT00213486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637092|NCT00213486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637093|NCT00213486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637094|NCT00190502|Antibodies|antibodies|mesh-list
92637095|NCT00190502|Immunologic Factors|immunologic factors|mesh-ancestor
92637096|NCT00190502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637097|NCT00122837|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637098|NCT00122837|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92637099|NCT00122837|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637100|NCT00122837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637101|NCT00122837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562436|NCT00043680|Sensory System Agents|sensory system agents|mesh-ancestor
92562437|NCT00043680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562438|NCT00043680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637102|NCT00122837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637103|NCT00122837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637104|NCT00122837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637105|NCT00122837|Analgesics|analgesics|mesh-ancestor
92637106|NCT00122837|Sensory System Agents|sensory system agents|mesh-ancestor
92637107|NCT00122837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637108|NCT00122837|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637109|NCT00122837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637110|NCT00122837|Dopamine Agents|dopamine agents|mesh-ancestor
92637111|NCT00122837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92637112|NCT00190580|Valsartan|valsartan|mesh-list
92637113|NCT00190580|Antihypertensive Agents|antihypertensive agents|mesh-list
92637114|NCT00190580|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92637115|NCT00190580|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92637116|NCT00190580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637117|NCT00220506|Modafinil|modafinil|mesh-list
92637118|NCT00220506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92637119|NCT00220506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637120|NCT00220506|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92682818|NCT00438152|Antiviral Agents|antiviral agents|mesh-ancestor
92637130|NCT00190619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637131|NCT00190619|Analgesics|analgesics|mesh-ancestor
92637132|NCT00190619|Sensory System Agents|sensory system agents|mesh-ancestor
92637133|NCT00190619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637134|NCT00190619|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637135|NCT00190619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637136|NCT00190619|Dopamine Agents|dopamine agents|mesh-ancestor
92637137|NCT00213564|Infliximab|infliximab|mesh-list
92637138|NCT00213564|Methotrexate|methotrexate|mesh-list
92637139|NCT00213564|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92637140|NCT00213564|Abortifacient Agents|abortifacient agents|mesh-ancestor
92637141|NCT00213564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92637142|NCT00213564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637143|NCT00213564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637144|NCT00213564|Antimetabolites|antimetabolites|mesh-ancestor
92637145|NCT00213564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637146|NCT00213564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637147|NCT00213564|Dermatologic Agents|dermatologic agents|mesh-ancestor
92637148|NCT00213564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637149|NCT00213564|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92637150|NCT00213564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92637151|NCT00213564|Immunologic Factors|immunologic factors|mesh-ancestor
92637152|NCT00213564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637153|NCT00213564|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92637154|NCT00213564|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92637155|NCT00213564|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92637156|NCT00213564|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637157|NCT00122876|Talaporfin|talaporfin|mesh-list
92637158|NCT00122876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637159|NCT00122876|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92637160|NCT00122876|Dermatologic Agents|dermatologic agents|mesh-ancestor
92637161|NCT00190736|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92637162|NCT00190736|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92637163|NCT00190736|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637164|NCT00190736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637165|NCT00190736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637166|NCT00190736|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637167|NCT00190736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637168|NCT00190736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637169|NCT00220584|Donepezil|donepezil|mesh-list
92637170|NCT00220584|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92637171|NCT00220584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637172|NCT00220584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637173|NCT00220584|Cholinergic Agents|cholinergic agents|mesh-ancestor
92637174|NCT00220584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637175|NCT00220584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562439|NCT00043680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562440|NCT00043680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562441|NCT00043680|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92637176|NCT00220584|Nootropic Agents|nootropic agents|mesh-ancestor
92637177|NCT00190814|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637178|NCT00190814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637179|NCT00190814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637180|NCT00190814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637186|NCT00190814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637187|NCT00190814|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637188|NCT00190814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637190|NCT00220623|Antidepressive Agents|antidepressive agents|mesh-list
92637191|NCT00220623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637192|NCT00220818|Lansoprazole|lansoprazole|mesh-list
92637193|NCT00220818|Dexlansoprazole|dexlansoprazole|mesh-list
92637194|NCT00220818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92637195|NCT00220818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637196|NCT00220818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92637197|NCT00220818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637198|NCT00220818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637199|NCT00213759|Lenograstim|lenograstim|mesh-list
92637200|NCT00213759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92637201|NCT00213759|Immunologic Factors|immunologic factors|mesh-ancestor
92637202|NCT00213759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637203|NCT00190853|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637204|NCT00190853|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637205|NCT00190853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637206|NCT00190853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637207|NCT00190853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637208|NCT00190853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637209|NCT00190853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637210|NCT00190853|Analgesics|analgesics|mesh-ancestor
92637211|NCT00190853|Sensory System Agents|sensory system agents|mesh-ancestor
92637212|NCT00190853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637213|NCT00190853|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637214|NCT00190853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637215|NCT00190853|Dopamine Agents|dopamine agents|mesh-ancestor
92637216|NCT00190892|Carbamazepine|carbamazepine|mesh-list
92637217|NCT00190892|Olanzapine|olanzapine|mesh-list
92637218|NCT00190892|Antiemetics|antiemetics|mesh-ancestor
92637219|NCT00190892|Autonomic Agents|autonomic agents|mesh-ancestor
92637220|NCT00190892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637221|NCT00190892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637222|NCT00190892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637223|NCT00190892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637224|NCT00190892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637225|NCT00190892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637226|NCT00190892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637227|NCT00190892|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637228|NCT00190892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637229|NCT00190892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637230|NCT00190892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637231|NCT00190892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637232|NCT00190892|Serotonin Agents|serotonin agents|mesh-ancestor
92637233|NCT00190892|Anticonvulsants|anticonvulsants|mesh-ancestor
92637234|NCT00190892|Antimanic Agents|antimanic agents|mesh-ancestor
92637235|NCT00190892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92637236|NCT00190892|Analgesics|analgesics|mesh-ancestor
92637237|NCT00190892|Sensory System Agents|sensory system agents|mesh-ancestor
92637238|NCT00190892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92637239|NCT00190892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92637240|NCT00190892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92637241|NCT00220857|Rabeprazole|rabeprazole|mesh-list
92637242|NCT00220857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92637243|NCT00220857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637244|NCT00220857|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92637245|NCT00220857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637246|NCT00220857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637247|NCT00190931|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92637248|NCT00190931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92562442|NCT00043680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92562443|NCT00043680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562444|NCT00043680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637249|NCT00190931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637254|NCT00190931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637256|NCT00220896|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92637257|NCT00220896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637258|NCT00220896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637259|NCT00220896|Cholinergic Agents|cholinergic agents|mesh-ancestor
92637260|NCT00220896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637261|NCT00220896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637264|NCT00190970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637265|NCT00190970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637266|NCT00191009|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92637267|NCT00191009|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92637268|NCT00191009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637269|NCT00191009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637270|NCT00191009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637271|NCT00191009|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637272|NCT00191009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637273|NCT00191009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637274|NCT00191048|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92637275|NCT00191048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92637276|NCT00191048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637277|NCT00191048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637278|NCT00191048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637279|NCT00191048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637280|NCT00191048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637281|NCT00191048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637282|NCT00123149|Epoetin Alfa|epoetin alfa|mesh-list
92637283|NCT00123149|Hematinics|hematinics|mesh-ancestor
92637284|NCT00191087|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637285|NCT00191087|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637286|NCT00191087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637287|NCT00191087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637288|NCT00191087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637289|NCT00191087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637290|NCT00191087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637291|NCT00191087|Analgesics|analgesics|mesh-ancestor
92637292|NCT00191087|Sensory System Agents|sensory system agents|mesh-ancestor
92637293|NCT00191087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637294|NCT00191087|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637295|NCT00191087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637296|NCT00191087|Dopamine Agents|dopamine agents|mesh-ancestor
92637297|NCT00191126|Gemcitabine|gemcitabine|mesh-list
92637298|NCT00191126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637299|NCT00191126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637300|NCT00191126|Antimetabolites|antimetabolites|mesh-ancestor
92637301|NCT00191126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637302|NCT00221052|Diclofenac|diclofenac|mesh-list
92637303|NCT00221052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92637304|NCT00221052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92637305|NCT00221052|Analgesics|analgesics|mesh-ancestor
92637306|NCT00221052|Sensory System Agents|sensory system agents|mesh-ancestor
92637307|NCT00221052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637308|NCT00221052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637309|NCT00221052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92637310|NCT00221052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637311|NCT00221052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92637312|NCT00221052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637313|NCT00221052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637314|NCT00191204|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637315|NCT00191204|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637319|NCT00191204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637320|NCT00191204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562445|NCT00152581|Interferons|interferons|mesh-list
92562446|NCT00152581|Ribavirin|ribavirin|mesh-list
92562447|NCT00152581|Interferon-alpha|interferon-alpha|mesh-list
92562448|NCT00152581|Interferon alpha-2|interferon alpha-2|mesh-list
92562449|NCT00152581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92562450|NCT00152581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562451|NCT00152581|Antiviral Agents|antiviral agents|mesh-ancestor
92562452|NCT00152581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562453|NCT00152581|Antimetabolites|antimetabolites|mesh-ancestor
92562454|NCT00152581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562455|NCT00152581|Immunologic Factors|immunologic factors|mesh-ancestor
92562456|NCT00152581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562457|NCT00152620|Dexamethasone|dexamethasone|mesh-list
92562458|NCT00152620|Methylprednisolone|methylprednisolone|mesh-list
92562459|NCT00152620|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92562460|NCT00152620|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92562461|NCT00152620|Prednisolone|prednisolone|mesh-list
92562462|NCT00152620|Prednisolone acetate|prednisolone acetate|mesh-list
92562463|NCT00152620|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92562464|NCT00152620|Prednisolone phosphate|prednisolone phosphate|mesh-list
92562465|NCT00152620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92637321|NCT00191204|Analgesics|analgesics|mesh-ancestor
92637322|NCT00191204|Sensory System Agents|sensory system agents|mesh-ancestor
92637323|NCT00191204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637324|NCT00191204|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637325|NCT00191204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637326|NCT00191204|Dopamine Agents|dopamine agents|mesh-ancestor
92637327|NCT00123227|Rosiglitazone|rosiglitazone|mesh-list
92637328|NCT00123227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92637329|NCT00123227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637330|NCT00191243|Gemcitabine|gemcitabine|mesh-list
92637331|NCT00191243|Docetaxel|docetaxel|mesh-list
92637332|NCT00191243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637333|NCT00191243|Antimetabolites|antimetabolites|mesh-ancestor
92637334|NCT00191243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637335|NCT00191243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637336|NCT00191243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637337|NCT00191243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637338|NCT00191243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637339|NCT00214032|Pycnogenols|pycnogenols|mesh-list
92637340|NCT00214032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92637341|NCT00214032|Immunologic Factors|immunologic factors|mesh-ancestor
92637342|NCT00214032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637343|NCT00214032|Antioxidants|antioxidants|mesh-ancestor
92637344|NCT00214032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637345|NCT00214032|Protective Agents|protective agents|mesh-ancestor
92637346|NCT00214032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92637347|NCT00123266|Plasminogen|plasminogen|mesh-list
92637348|NCT00123266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92637349|NCT00123266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92637350|NCT00123266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637351|NCT00191321|Teriparatide|teriparatide|mesh-list
92637352|NCT00191321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92637353|NCT00191321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637354|NCT00191321|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92637355|NCT00123305|Plasminogen|plasminogen|mesh-list
92637356|NCT00123305|Fibrinolysin|fibrinolysin|mesh-list
92562466|NCT00152620|Antiemetics|antiemetics|mesh-ancestor
92562467|NCT00152620|Autonomic Agents|autonomic agents|mesh-ancestor
92637357|NCT00123305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92637358|NCT00123305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92637359|NCT00123305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637360|NCT00214110|Tamoxifen|tamoxifen|mesh-list
92637361|NCT00214110|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92637362|NCT00214110|Hormone Antagonists|hormone antagonists|mesh-ancestor
92637363|NCT00214110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92637364|NCT00214110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637365|NCT00214110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92637366|NCT00214110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637367|NCT00214110|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92637368|NCT00214110|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92637369|NCT00214110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92637370|NCT00191399|Olanzapine|olanzapine|mesh-list
92637371|NCT00191399|Fluoxetine|fluoxetine|mesh-list
92637372|NCT00191399|Antiemetics|antiemetics|mesh-ancestor
92637373|NCT00191399|Autonomic Agents|autonomic agents|mesh-ancestor
92637374|NCT00191399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637375|NCT00191399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637376|NCT00191399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637377|NCT00191399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637378|NCT00191399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637379|NCT00191399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637380|NCT00191399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637381|NCT00191399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637382|NCT00191399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637383|NCT00191399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637384|NCT00191399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637388|NCT00191399|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637389|NCT00191399|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92637390|NCT00191399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92637391|NCT00191399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637392|NCT00191438|Gemcitabine|gemcitabine|mesh-list
92637393|NCT00191438|Capecitabine|capecitabine|mesh-list
92637394|NCT00191438|Docetaxel|docetaxel|mesh-list
92637395|NCT00191438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937491|NCT05398874|Acetaminophen|acetaminophen|mesh-list
92637396|NCT00191438|Antimetabolites|antimetabolites|mesh-ancestor
92637397|NCT00191438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637398|NCT00191438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637399|NCT00191438|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637400|NCT00191438|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637401|NCT00191438|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637402|NCT00221286|Interferons|interferons|mesh-list
92637403|NCT00221286|Tenofovir|tenofovir|mesh-list
92637404|NCT00221286|Interferon-alpha|interferon-alpha|mesh-list
92362645|NCT05047978|Caseins|caseins|mesh-list
92637405|NCT00221286|Interferon alpha-2|interferon alpha-2|mesh-list
92637406|NCT00221286|Emtricitabine|emtricitabine|mesh-list
92637407|NCT00221286|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92637408|NCT00221286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637409|NCT00221286|Antiviral Agents|antiviral agents|mesh-ancestor
92637410|NCT00221286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637411|NCT00221286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92637412|NCT00221286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92637413|NCT00221286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637414|NCT00221286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637415|NCT00221286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92637416|NCT00221286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92637417|NCT00221286|Immunologic Factors|immunologic factors|mesh-ancestor
92637418|NCT00221286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637419|NCT00123383|Modafinil|modafinil|mesh-list
92637420|NCT00123383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92637421|NCT00123383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637422|NCT00123383|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92637423|NCT00123383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92637424|NCT00123383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92637425|NCT00123383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637426|NCT00214266|Mycophenolic Acid|mycophenolic acid|mesh-list
92637427|NCT00214266|Rituximab|rituximab|mesh-list
92637428|NCT00214266|Alemtuzumab|alemtuzumab|mesh-list
92637429|NCT00214266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92562468|NCT00152620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562469|NCT00152620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562470|NCT00152620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637430|NCT00214266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637431|NCT00214266|Immunologic Factors|immunologic factors|mesh-ancestor
92637432|NCT00214266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637433|NCT00214266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637434|NCT00214266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92637435|NCT00214266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92637436|NCT00214266|Antitubercular Agents|antitubercular agents|mesh-ancestor
92637437|NCT00214266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92637438|NCT00214266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637439|NCT00214266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637440|NCT00214266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637441|NCT00221325|Rituximab|rituximab|mesh-list
92637442|NCT00221325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92637443|NCT00221325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637444|NCT00221325|Immunologic Factors|immunologic factors|mesh-ancestor
92637445|NCT00221325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637446|NCT00221325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637447|NCT00123461|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92637448|NCT00123461|Vitamins|vitamins|mesh-ancestor
92637449|NCT00123461|Micronutrients|micronutrients|mesh-ancestor
92637450|NCT00123461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637451|NCT00123461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92637452|NCT00191516|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92637453|NCT00191516|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92637454|NCT00191516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637455|NCT00191516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637458|NCT00191516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637459|NCT00191516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637460|NCT00191555|Haloperidol|haloperidol|mesh-list
92637461|NCT00191555|Olanzapine|olanzapine|mesh-list
92637462|NCT00191555|Haloperidol decanoate|haloperidol decanoate|mesh-list
92637463|NCT00191555|Antiemetics|antiemetics|mesh-ancestor
92637464|NCT00191555|Autonomic Agents|autonomic agents|mesh-ancestor
92637465|NCT00191555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637466|NCT00191555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637467|NCT00191555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637468|NCT00191555|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637469|NCT00191555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637470|NCT00191555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637471|NCT00191555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637472|NCT00191555|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637473|NCT00191555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637474|NCT00191555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637475|NCT00191555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637476|NCT00191555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637477|NCT00191555|Serotonin Agents|serotonin agents|mesh-ancestor
92637479|NCT00191555|Dopamine Agents|dopamine agents|mesh-ancestor
92637480|NCT00191555|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92637481|NCT00221364|Azithromycin|azithromycin|mesh-list
92637482|NCT00221364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92637483|NCT00221364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637484|NCT00123539|Estrogens|estrogens|mesh-list
92637485|NCT00123539|Hormones|hormones|mesh-ancestor
92637486|NCT00123539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92637487|NCT00123539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637488|NCT00191594|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637489|NCT00191594|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637490|NCT00191594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637491|NCT00191594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637492|NCT00191594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637493|NCT00191594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637494|NCT00191594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637495|NCT00191594|Analgesics|analgesics|mesh-ancestor
92637496|NCT00191594|Sensory System Agents|sensory system agents|mesh-ancestor
92637497|NCT00191594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637498|NCT00191594|Antidepressive Agents|antidepressive agents|mesh-ancestor
92562471|NCT00152620|Glucocorticoids|glucocorticoids|mesh-ancestor
92562472|NCT00152620|Hormones|hormones|mesh-ancestor
92562473|NCT00152620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562474|NCT00152620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92637499|NCT00191594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637500|NCT00191594|Dopamine Agents|dopamine agents|mesh-ancestor
92637501|NCT00221442|Zonisamide|zonisamide|mesh-list
92637502|NCT00221442|Anticonvulsants|anticonvulsants|mesh-ancestor
92637503|NCT00221442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92637504|NCT00221442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637505|NCT00221442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637506|NCT00221442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92637507|NCT00221442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637508|NCT00123578|Pentobarbital|pentobarbital|mesh-list
92637509|NCT00123578|Lorazepam|lorazepam|mesh-list
92637510|NCT00123578|Anticonvulsants|anticonvulsants|mesh-ancestor
92637511|NCT00123578|Antiemetics|antiemetics|mesh-ancestor
92637512|NCT00123578|Autonomic Agents|autonomic agents|mesh-ancestor
92637513|NCT00123578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637514|NCT00123578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637515|NCT00123578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637516|NCT00123578|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92637517|NCT00123578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637518|NCT00123578|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92637519|NCT00123578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637520|NCT00123578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637521|NCT00123578|GABA Modulators|gaba modulators|mesh-ancestor
92637522|NCT00123578|GABA Agents|gaba agents|mesh-ancestor
92637523|NCT00123578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637524|NCT00123578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637525|NCT00123578|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92637526|NCT00221481|Valproic Acid|valproic acid|mesh-list
92637527|NCT00221481|Olanzapine|olanzapine|mesh-list
92637528|NCT00221481|Antiemetics|antiemetics|mesh-ancestor
92637531|NCT00221481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637532|NCT00221481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637533|NCT00221481|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637534|NCT00221481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637535|NCT00221481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637536|NCT00221481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637537|NCT00221481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637538|NCT00221481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637539|NCT00221481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637540|NCT00221481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637541|NCT00221481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637543|NCT00221481|Anticonvulsants|anticonvulsants|mesh-ancestor
92637544|NCT00221481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637545|NCT00221481|GABA Agents|gaba agents|mesh-ancestor
92637546|NCT00221481|Antimanic Agents|antimanic agents|mesh-ancestor
92637547|NCT00191633|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92637548|NCT00191633|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92637549|NCT00191633|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637550|NCT00191633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92362797|NCT04760691|Tenofovir|tenofovir|mesh-list
92637551|NCT00191633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637552|NCT00191633|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637553|NCT00191633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637554|NCT00191633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637555|NCT00221520|Midazolam|midazolam|mesh-list
92637556|NCT00221520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92637557|NCT00221520|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92637558|NCT00221520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637559|NCT00221520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637560|NCT00221520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92637561|NCT00221520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637562|NCT00221520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637563|NCT00221520|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92637564|NCT00221520|Anesthetics, General|anesthetics, general|mesh-ancestor
92637565|NCT00221520|Anesthetics|anesthetics|mesh-ancestor
92637566|NCT00221520|GABA Modulators|gaba modulators|mesh-ancestor
92637567|NCT00221520|GABA Agents|gaba agents|mesh-ancestor
92562475|NCT00152620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562476|NCT00152620|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92562477|NCT00152620|Protective Agents|protective agents|mesh-ancestor
92562478|NCT00050141|Tipifarnib|tipifarnib|mesh-list
92637568|NCT00221520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637569|NCT00221520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637570|NCT00191672|Paclitaxel|paclitaxel|mesh-list
92637571|NCT00191672|Docetaxel|docetaxel|mesh-list
92637572|NCT00191672|Gemcitabine|gemcitabine|mesh-list
92637573|NCT00191672|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92637574|NCT00191672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637575|NCT00191672|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637576|NCT00191672|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637577|NCT00191672|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637578|NCT00191672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637579|NCT00191672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637580|NCT00191672|Antimetabolites|antimetabolites|mesh-ancestor
92637581|NCT00214578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92637582|NCT00214578|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637583|NCT00214578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637584|NCT00214578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637585|NCT00214578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637586|NCT00214578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637587|NCT00214578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637588|NCT00191711|Gemcitabine|gemcitabine|mesh-list
92637589|NCT00191711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637590|NCT00191711|Antimetabolites|antimetabolites|mesh-ancestor
92637591|NCT00191711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637592|NCT00191711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637593|NCT00221637|Valproic Acid|valproic acid|mesh-list
92637594|NCT00221637|Anticonvulsants|anticonvulsants|mesh-ancestor
92637595|NCT00221637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637596|NCT00221637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637597|NCT00221637|GABA Agents|gaba agents|mesh-ancestor
92637598|NCT00221637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637599|NCT00221637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637614|NCT00123656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92637615|NCT00123656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92637616|NCT00123656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637617|NCT00123656|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92637618|NCT00123656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637619|NCT00123656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637620|NCT00214617|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92637621|NCT00214617|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92637622|NCT00214617|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92637623|NCT00214617|Antimetabolites|antimetabolites|mesh-ancestor
92637624|NCT00214617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637625|NCT00214617|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92637626|NCT00214617|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92637627|NCT00214617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637628|NCT00191750|Pemetrexed|pemetrexed|mesh-list
92637629|NCT00191750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637630|NCT00191750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637631|NCT00191750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637632|NCT00191750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92637633|NCT00191750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92637634|NCT00214695|Dialysis Solutions|dialysis solutions|mesh-list
92637635|NCT00214695|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92637636|NCT00221754|Pravastatin|pravastatin|mesh-list
92637637|NCT00221754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92637638|NCT00221754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92637639|NCT00221754|Antimetabolites|antimetabolites|mesh-ancestor
92637640|NCT00221754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637641|NCT00221754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92637642|NCT00221754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92637643|NCT00221754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637644|NCT00191828|Olanzapine|olanzapine|mesh-list
92637645|NCT00191828|Antiemetics|antiemetics|mesh-ancestor
92637646|NCT00191828|Autonomic Agents|autonomic agents|mesh-ancestor
92637647|NCT00191828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637648|NCT00191828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562479|NCT00050141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562480|NCT04725214|Temozolomide|temozolomide|mesh-list
92562481|NCT04725214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562482|NCT04725214|Alkylating Agents|alkylating agents|mesh-ancestor
92637649|NCT00191828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92637650|NCT00191828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637651|NCT00191828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637652|NCT00191828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637653|NCT00191828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637654|NCT00191828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637655|NCT00191828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637656|NCT00191828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637657|NCT00191828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637658|NCT00191828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637659|NCT00191828|Serotonin Agents|serotonin agents|mesh-ancestor
92637663|NCT00191867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92637664|NCT00123851|Capecitabine|capecitabine|mesh-list
92637665|NCT00123851|Oxaliplatin|oxaliplatin|mesh-list
92637666|NCT00123851|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92637667|NCT00123851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637668|NCT00123851|Antimetabolites|antimetabolites|mesh-ancestor
92637669|NCT00123851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637670|NCT00123851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637671|NCT00123851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92637672|NCT00123851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637673|NCT00123890|Aplaviroc|aplaviroc|mesh-list
92637674|NCT00123890|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92637675|NCT00123890|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92637676|NCT00123890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637677|NCT00123890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92637678|NCT00123890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92637679|NCT00123890|Antiviral Agents|antiviral agents|mesh-ancestor
92637680|NCT00123890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637681|NCT00412698|Rimonabant|rimonabant|mesh-list
92637682|NCT00412698|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92637683|NCT00412698|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92637684|NCT00412698|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92637685|NCT00412698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637686|NCT00412698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637687|NCT00412698|Hormones|hormones|mesh-ancestor
92637688|NCT00412698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92637689|NCT00412698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637690|NCT00123929|Docetaxel|docetaxel|mesh-list
92637691|NCT00123929|Doxorubicin|doxorubicin|mesh-list
92637692|NCT00123929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637693|NCT00123929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637694|NCT00123929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637695|NCT00123929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637696|NCT00123929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637697|NCT00123929|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92637698|NCT00123929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92637699|NCT00123929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92637700|NCT00123929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637702|NCT00475033|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92637703|NCT00475033|Immunologic Factors|immunologic factors|mesh-ancestor
92637704|NCT00475033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637705|NCT00192062|Gemcitabine|gemcitabine|mesh-list
92637706|NCT00192062|Vinorelbine|vinorelbine|mesh-list
92637707|NCT00192062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637708|NCT00192062|Antimetabolites|antimetabolites|mesh-ancestor
92637709|NCT00192062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637710|NCT00192062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637711|NCT00192062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92637712|NCT00192062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637713|NCT00192062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637714|NCT00192062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637715|NCT00192101|Gemcitabine|gemcitabine|mesh-list
92637716|NCT00192101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637717|NCT00192101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562483|NCT04725214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562484|NCT04725214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562486|NCT00050180|Saquinavir|saquinavir|mesh-list
92562487|NCT00050180|Midazolam|midazolam|mesh-list
92562488|NCT00050180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92562489|NCT00050180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92562490|NCT00050180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562491|NCT00050180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562492|NCT00050180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92562493|NCT00050180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92562494|NCT00050180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562495|NCT00050180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92562496|NCT00050180|Anesthetics, General|anesthetics, general|mesh-ancestor
92562497|NCT00050180|Anesthetics|anesthetics|mesh-ancestor
92637718|NCT00192101|Antimetabolites|antimetabolites|mesh-ancestor
92637719|NCT00192101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637720|NCT00215007|Levofloxacin|levofloxacin|mesh-list
92637721|NCT00215007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92637722|NCT00215007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637723|NCT00215007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92637724|NCT00215007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92637725|NCT00215007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92637726|NCT00215007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637727|NCT00215007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637728|NCT00215007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637729|NCT00215007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92637740|NCT00474994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637742|NCT00474955|Antiviral Agents|antiviral agents|mesh-ancestor
92637743|NCT00474955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637744|NCT00215046|Methotrexate|methotrexate|mesh-list
92637745|NCT00215046|Vinblastine|vinblastine|mesh-list
92637746|NCT00215046|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92637747|NCT00215046|Abortifacient Agents|abortifacient agents|mesh-ancestor
92637748|NCT00215046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92637749|NCT00215046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637750|NCT00215046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637751|NCT00215046|Antimetabolites|antimetabolites|mesh-ancestor
92637752|NCT00215046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637753|NCT00215046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637754|NCT00215046|Dermatologic Agents|dermatologic agents|mesh-ancestor
92637755|NCT00215046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637756|NCT00215046|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92637757|NCT00215046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92637758|NCT00215046|Immunologic Factors|immunologic factors|mesh-ancestor
92637759|NCT00215046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92637760|NCT00215046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92637761|NCT00215046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92637762|NCT00215046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637763|NCT00215046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637764|NCT00215046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92637765|NCT00474487|Vaccines|vaccines|mesh-list
92637766|NCT00474487|Immunologic Factors|immunologic factors|mesh-ancestor
92637767|NCT00474487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637768|NCT00124124|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92637769|NCT00124124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92637770|NCT00124124|Immunologic Factors|immunologic factors|mesh-ancestor
92637771|NCT00124124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637772|NCT00474253|Rocuronium|rocuronium|mesh-list
92637773|NCT00474253|Succinylcholine|succinylcholine|mesh-list
92562498|NCT00050180|GABA Modulators|gaba modulators|mesh-ancestor
92562499|NCT00050180|GABA Agents|gaba agents|mesh-ancestor
92562500|NCT00050180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562501|NCT00050180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562502|NCT00050180|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91969971|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
92637774|NCT00474253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92637775|NCT00474253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92637776|NCT00474253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92637777|NCT00474253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637778|NCT00474253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637779|NCT00474253|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92637781|NCT00221871|Analgesics|analgesics|mesh-ancestor
92637782|NCT00221871|Sensory System Agents|sensory system agents|mesh-ancestor
92637783|NCT00221871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637784|NCT00221871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637785|NCT00221871|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92637786|NCT00221871|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92637787|NCT00221871|Anesthetics, General|anesthetics, general|mesh-ancestor
92637788|NCT00221871|Anesthetics|anesthetics|mesh-ancestor
92637789|NCT00221871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637790|NCT00221871|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92637791|NCT00221871|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92637792|NCT00221871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682819|NCT00438152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637805|NCT02277730|Mydriatics|mydriatics|mesh-ancestor
92637806|NCT02277730|Autonomic Agents|autonomic agents|mesh-ancestor
92637807|NCT02277730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637808|NCT02277730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637809|NCT02277730|Sympathomimetics|sympathomimetics|mesh-ancestor
92637810|NCT02277730|Nasal Decongestants|nasal decongestants|mesh-ancestor
92637811|NCT02277730|Respiratory System Agents|respiratory system agents|mesh-ancestor
92637812|NCT02277730|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92637813|NCT02277730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92637814|NCT02277730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92637815|NCT02277730|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637816|NCT02277730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637817|NCT02277730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637818|NCT02277730|Protective Agents|protective agents|mesh-ancestor
92637819|NCT02277730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92637820|NCT04571437|Capecitabine|capecitabine|mesh-list
92637821|NCT04571437|Letrozole|letrozole|mesh-list
92637822|NCT04571437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637823|NCT04571437|Antimetabolites|antimetabolites|mesh-ancestor
92637824|NCT04571437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637825|NCT04571437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637826|NCT04571437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92637827|NCT04571437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92637828|NCT04571437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637829|NCT04571437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92637830|NCT04571437|Hormone Antagonists|hormone antagonists|mesh-ancestor
92637831|NCT04571437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92637832|NCT04571437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637833|NCT00215124|Lenograstim|lenograstim|mesh-list
92637834|NCT00215124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92637835|NCT00215124|Immunologic Factors|immunologic factors|mesh-ancestor
92637836|NCT00215124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637837|NCT00473824|Immunoglobulins|immunoglobulins|mesh-list
92637838|NCT00473824|Antibodies|antibodies|mesh-list
92637839|NCT00473824|gamma-Globulins|gamma-globulins|mesh-list
92637840|NCT00473824|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92637841|NCT00473824|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92637842|NCT00473824|Immunologic Factors|immunologic factors|mesh-ancestor
92637843|NCT00473824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637844|NCT00215163|Paroxetine|paroxetine|mesh-list
92637845|NCT00215163|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637846|NCT00215163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562503|NCT00050180|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92562504|NCT00050180|Protease Inhibitors|protease inhibitors|mesh-ancestor
92562505|NCT00050180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562506|NCT00050180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92562507|NCT00050180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92562508|NCT00050180|Antiviral Agents|antiviral agents|mesh-ancestor
91969975|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
92637847|NCT00215163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637848|NCT00215163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637849|NCT00215163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637851|NCT00215163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637852|NCT00215163|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92637853|NCT00215163|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637854|NCT00215163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92044919|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637856|NCT00215163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92637857|NCT00215163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637858|NCT00215202|Gefitinib|gefitinib|mesh-list
92637859|NCT00215202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637860|NCT00215202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92637861|NCT00215202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637862|NCT00215202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637863|NCT00215241|Risperidone|risperidone|mesh-list
92637864|NCT00215241|Sertraline|sertraline|mesh-list
92637865|NCT00215241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92637866|NCT00215241|Serotonin Agents|serotonin agents|mesh-ancestor
92637867|NCT00215241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637868|NCT00215241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637869|NCT00215241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637870|NCT00215241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92637871|NCT00215241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637872|NCT00215241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637873|NCT00215241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637874|NCT00215241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92637875|NCT00215241|Dopamine Agents|dopamine agents|mesh-ancestor
92637876|NCT00215241|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637877|NCT00215241|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92637878|NCT00215241|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637879|NCT00215241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637880|NCT00124241|Lamivudine|lamivudine|mesh-list
92637881|NCT00124241|Telbivudine|telbivudine|mesh-list
92637882|NCT00124241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92637883|NCT00124241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92637884|NCT00124241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637885|NCT00124241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637886|NCT00124241|Antiviral Agents|antiviral agents|mesh-ancestor
92637887|NCT00124241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637888|NCT00124241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92637889|NCT00124241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92637890|NCT00124280|Everolimus|everolimus|mesh-list
92637891|NCT00124280|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92637892|NCT00124280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92637893|NCT00124280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637894|NCT00124280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637895|NCT00124280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92637896|NCT00124280|Immunologic Factors|immunologic factors|mesh-ancestor
92637897|NCT00124280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637898|NCT00124280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637899|NCT00215280|Ivermectin|ivermectin|mesh-list
92637900|NCT00215280|Albendazole|albendazole|mesh-list
92637901|NCT00215280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92637902|NCT00215280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637903|NCT00215280|Anthelmintics|anthelmintics|mesh-ancestor
92637904|NCT00215280|Anticestodal Agents|anticestodal agents|mesh-ancestor
92637905|NCT00215280|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92637906|NCT00215280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92637907|NCT00215280|Tubulin Modulators|tubulin modulators|mesh-ancestor
92637908|NCT00215280|Antimitotic Agents|antimitotic agents|mesh-ancestor
92637909|NCT00215280|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562509|NCT00050180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562510|NCT00050180|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92562511|NCT00050180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92562512|NCT00082914|Denileukin diftitox|denileukin diftitox|mesh-list
92637910|NCT00215280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637911|NCT00215280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637912|NCT00192413|Vaccines|vaccines|mesh-list
92637913|NCT00192413|Immunologic Factors|immunologic factors|mesh-ancestor
92637914|NCT00192413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637915|NCT00215358|Formoterol Fumarate|formoterol fumarate|mesh-list
92637916|NCT00215358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92637917|NCT00215358|Autonomic Agents|autonomic agents|mesh-ancestor
92637918|NCT00215358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637919|NCT00215358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363177|NCT03439033|Edetic Acid|edetic acid|mesh-list
92637920|NCT00215358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92637921|NCT00215358|Respiratory System Agents|respiratory system agents|mesh-ancestor
92637922|NCT00215358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92637923|NCT00215358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92637924|NCT00215358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92637925|NCT00215358|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637926|NCT00215358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044981|NCT01712854|Budesonide|budesonide|mesh-list
92637945|NCT00215397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92637946|NCT00215397|Respiratory System Agents|respiratory system agents|mesh-ancestor
92637947|NCT00215397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92637948|NCT00215397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92637949|NCT00215397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92637950|NCT00215397|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637951|NCT00215397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637952|NCT00215397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637953|NCT00192608|Saquinavir|saquinavir|mesh-list
92637954|NCT00192608|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92637955|NCT00192608|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92637956|NCT00192608|Protease Inhibitors|protease inhibitors|mesh-ancestor
92637957|NCT00192608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637958|NCT00192608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637959|NCT00192608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92637960|NCT00192608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92637961|NCT00192608|Antiviral Agents|antiviral agents|mesh-ancestor
92637962|NCT00192608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637963|NCT00192608|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92637964|NCT00192608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92637965|NCT00215436|Formoterol Fumarate|formoterol fumarate|mesh-list
92637966|NCT00215436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92637967|NCT00215436|Autonomic Agents|autonomic agents|mesh-ancestor
92637968|NCT00215436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637969|NCT00215436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637970|NCT00215436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92637971|NCT00215436|Respiratory System Agents|respiratory system agents|mesh-ancestor
92637972|NCT00215436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92637973|NCT00215436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92637974|NCT00215436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92637975|NCT00215436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637976|NCT00215436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637977|NCT00215436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637978|NCT00215514|Fluorouracil|fluorouracil|mesh-list
92637979|NCT00215514|Epirubicin|epirubicin|mesh-list
92637980|NCT00215514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637981|NCT00215514|Antimetabolites|antimetabolites|mesh-ancestor
92637982|NCT00215514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637996|NCT00215592|Anticonvulsants|anticonvulsants|mesh-ancestor
92637997|NCT00215592|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92637998|NCT00215592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637999|NCT00215592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638000|NCT00215592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92638001|NCT00215592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638002|NCT00222144|Docetaxel|docetaxel|mesh-list
92638003|NCT00222144|Imatinib Mesylate|imatinib mesylate|mesh-list
92562514|NCT00152815|Vitamin E|vitamin e|mesh-list
92562515|NCT00152815|Antioxidants|antioxidants|mesh-list
92562516|NCT00152815|Vitamins|vitamins|mesh-ancestor
92562517|NCT00152815|Micronutrients|micronutrients|mesh-ancestor
92562518|NCT00152815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562519|NCT00152815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562520|NCT00152815|Protective Agents|protective agents|mesh-ancestor
92562521|NCT00043719|Vitamin D|vitamin d|mesh-list
92562522|NCT00043719|Nitroglycerin|nitroglycerin|mesh-list
92562523|NCT00043719|Calcium|calcium|mesh-list
92562524|NCT00043719|Vitamins|vitamins|mesh-ancestor
92562525|NCT00043719|Micronutrients|micronutrients|mesh-ancestor
92562526|NCT00043719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562527|NCT00043719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92562528|NCT00043719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92638004|NCT00222144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638005|NCT00222144|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638006|NCT00222144|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638007|NCT00222144|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638008|NCT00222144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638009|NCT00222144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92638010|NCT00222144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638011|NCT00222183|Pimecrolimus|pimecrolimus|mesh-list
92638012|NCT00222183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92638013|NCT00222183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92638014|NCT00222183|Analgesics|analgesics|mesh-ancestor
92638015|NCT00222183|Sensory System Agents|sensory system agents|mesh-ancestor
92638016|NCT00222183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638017|NCT00222183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638018|NCT00222183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638019|NCT00222183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638020|NCT00222183|Dermatologic Agents|dermatologic agents|mesh-ancestor
92638021|NCT00222183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638022|NCT00222183|Immunologic Factors|immunologic factors|mesh-ancestor
92638023|NCT00222183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92638024|NCT00222183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638025|NCT00222183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638026|NCT00192764|Cyclophosphamide|cyclophosphamide|mesh-list
92638027|NCT00192764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638028|NCT00192764|Immunologic Factors|immunologic factors|mesh-ancestor
92638029|NCT00192764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638030|NCT00192764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638031|NCT00192764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638032|NCT00192764|Alkylating Agents|alkylating agents|mesh-ancestor
92638033|NCT00192764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638034|NCT00192764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638035|NCT00192764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92638036|NCT00411957|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92638037|NCT00411957|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92638038|NCT00411957|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92638039|NCT00411957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92638040|NCT00411957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638041|NCT00411957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638042|NCT00411957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92045109|NCT01635764|Adalimumab|adalimumab|mesh-list
92638048|NCT00192803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92638049|NCT00192803|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92638050|NCT00192803|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92562529|NCT00043719|Vasodilator Agents|vasodilator agents|mesh-ancestor
92562530|NCT00152854|Acetaminophen|acetaminophen|mesh-list
92562531|NCT00152854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92562532|NCT00152854|Analgesics|analgesics|mesh-ancestor
92562533|NCT00152854|Sensory System Agents|sensory system agents|mesh-ancestor
92562534|NCT00152854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562535|NCT00152854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638051|NCT00192803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638053|NCT00192842|Gemcitabine|gemcitabine|mesh-list
92638054|NCT00192842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638055|NCT00192842|Antimetabolites|antimetabolites|mesh-ancestor
92638056|NCT00192842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638057|NCT00192842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638058|NCT00192842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92638059|NCT00192842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92638060|NCT00192842|Analgesics|analgesics|mesh-ancestor
92638061|NCT00192842|Sensory System Agents|sensory system agents|mesh-ancestor
92638062|NCT00192842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638063|NCT00192842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638064|NCT00192842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638065|NCT00192842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638067|NCT00411996|Ritonavir|ritonavir|mesh-list
92638068|NCT00411996|Indinavir|indinavir|mesh-list
92638069|NCT00411996|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92638070|NCT00411996|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92638071|NCT00411996|Protease Inhibitors|protease inhibitors|mesh-ancestor
92638072|NCT00411996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638073|NCT00411996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638074|NCT00411996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92638075|NCT00411996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92638076|NCT00411996|Antiviral Agents|antiviral agents|mesh-ancestor
92638077|NCT00411996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638078|NCT00411996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92638079|NCT00411996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92638080|NCT00222261|Aspirin|aspirin|mesh-list
92638081|NCT00222261|Clopidogrel|clopidogrel|mesh-list
92638082|NCT00222261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92638083|NCT00222261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92638084|NCT00222261|Analgesics|analgesics|mesh-ancestor
92638085|NCT00222261|Sensory System Agents|sensory system agents|mesh-ancestor
92638086|NCT00222261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638087|NCT00222261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638088|NCT00222261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638089|NCT00222261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638090|NCT00222261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92638091|NCT00222261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92638092|NCT00222261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638093|NCT00222261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92638094|NCT00222261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92638095|NCT00222261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638096|NCT00222261|Antipyretics|antipyretics|mesh-ancestor
92638097|NCT00222261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92638098|NCT00222261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92638099|NCT00222261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92638100|NCT00222261|Purinergic Agents|purinergic agents|mesh-ancestor
92638101|NCT00222261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638102|NCT00192959|Propofol|propofol|mesh-list
92638103|NCT00192959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92638104|NCT00192959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638105|NCT00192959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638106|NCT00192959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92638107|NCT00192959|Anesthetics, General|anesthetics, general|mesh-ancestor
92638108|NCT00192959|Anesthetics|anesthetics|mesh-ancestor
92638109|NCT00215631|Tadalafil|tadalafil|mesh-list
92638110|NCT00215631|Vasodilator Agents|vasodilator agents|mesh-ancestor
92638111|NCT00215631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92638112|NCT00215631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92562536|NCT00152854|Antipyretics|antipyretics|mesh-ancestor
92562537|NCT00050297|N-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|n-(6-methoxy-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)-2-phenylethenesulfonamide|mesh-list
92562538|NCT00050297|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92638113|NCT00215631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638116|NCT00193076|Carboplatin|carboplatin|mesh-list
92638117|NCT00193076|Gemcitabine|gemcitabine|mesh-list
92638118|NCT00193076|Trastuzumab|trastuzumab|mesh-list
92638119|NCT00193076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638120|NCT00193076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638121|NCT00193076|Antimetabolites|antimetabolites|mesh-ancestor
92638122|NCT00193076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638123|NCT00193076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638124|NCT00193115|Cyclophosphamide|cyclophosphamide|mesh-list
92638126|NCT00193115|Doxorubicin|doxorubicin|mesh-list
92638127|NCT00193115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638128|NCT00193115|Immunologic Factors|immunologic factors|mesh-ancestor
92638129|NCT00193115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638130|NCT00193115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638131|NCT00193115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638132|NCT00193115|Alkylating Agents|alkylating agents|mesh-ancestor
92638133|NCT00193115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638134|NCT00193115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638135|NCT00193115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92638136|NCT00193115|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638137|NCT00193115|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638138|NCT00193115|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363408|NCT01285817|Celecoxib|celecoxib|mesh-list
92638139|NCT00193115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92638140|NCT00193115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92638141|NCT00193115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638142|NCT00193115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638143|NCT00193154|Bevacizumab|bevacizumab|mesh-list
92638144|NCT00193154|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92638145|NCT00193154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638146|NCT00193154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638147|NCT00193154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92638148|NCT00193154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92638149|NCT00193154|Growth Substances|growth substances|mesh-ancestor
92638150|NCT00193154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638151|NCT00193154|Growth Inhibitors|growth inhibitors|mesh-ancestor
92638152|NCT00193154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92638153|NCT00193154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638154|NCT00193154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638155|NCT00193193|Paclitaxel|paclitaxel|mesh-list
92638156|NCT00193193|Carboplatin|carboplatin|mesh-list
92638157|NCT00193193|Estramustine|estramustine|mesh-list
92638158|NCT00193193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92638159|NCT00193193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638160|NCT00193193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638161|NCT00193193|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638162|NCT00193193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638163|NCT00193193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638164|NCT00193193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638165|NCT00193193|Alkylating Agents|alkylating agents|mesh-ancestor
92638166|NCT00193193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92638167|NCT00193232|Docetaxel|docetaxel|mesh-list
92638168|NCT00193232|Bortezomib|bortezomib|mesh-list
92638169|NCT00193232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638170|NCT00193232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638171|NCT00193232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638172|NCT00193232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638173|NCT00193232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638174|NCT00222495|Olanzapine|olanzapine|mesh-list
92638175|NCT00222495|Risperidone|risperidone|mesh-list
92638176|NCT00222495|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92638177|NCT00222495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92638178|NCT00222495|Serotonin Agents|serotonin agents|mesh-ancestor
92638179|NCT00222495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638180|NCT00222495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562539|NCT00050297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562540|NCT00152893|Chromium|chromium|mesh-list
92562542|NCT00152893|Trace Elements|trace elements|mesh-ancestor
92562543|NCT00152893|Micronutrients|micronutrients|mesh-ancestor
92638181|NCT00222495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638182|NCT00222495|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92638183|NCT00222495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92638184|NCT00222495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638185|NCT00222495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92638186|NCT00222495|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92638187|NCT00222495|Dopamine Agents|dopamine agents|mesh-ancestor
92638188|NCT00222495|Antiemetics|antiemetics|mesh-ancestor
92638189|NCT00222495|Autonomic Agents|autonomic agents|mesh-ancestor
92638190|NCT00222495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638191|NCT00222495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638192|NCT00222495|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92638193|NCT00222495|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92638194|NCT00222495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638195|NCT00222495|Antidepressive Agents|antidepressive agents|mesh-ancestor
92638197|NCT00193271|Estramustine|estramustine|mesh-list
92638198|NCT00193271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638199|NCT00193271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638200|NCT00193271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638201|NCT00193271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638202|NCT00193271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638203|NCT00193271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638204|NCT00193271|Alkylating Agents|alkylating agents|mesh-ancestor
92638205|NCT00193271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92638206|NCT00222534|Acetazolamide|acetazolamide|mesh-list
92638207|NCT00222534|Anticonvulsants|anticonvulsants|mesh-ancestor
92638208|NCT00222534|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92638209|NCT00222534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638210|NCT00222534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638211|NCT00222534|Diuretics|diuretics|mesh-ancestor
92638212|NCT00222534|Natriuretic Agents|natriuretic agents|mesh-ancestor
92638213|NCT00222534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638214|NCT00193310|Paclitaxel|paclitaxel|mesh-list
92638215|NCT00193310|Carboplatin|carboplatin|mesh-list
92638216|NCT00193310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92638217|NCT00193310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638218|NCT00193310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638219|NCT00193310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638220|NCT00193310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638221|NCT00193310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638222|NCT00193349|Carboplatin|carboplatin|mesh-list
92638224|NCT00193349|Imatinib Mesylate|imatinib mesylate|mesh-list
92638225|NCT00193349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638226|NCT00193349|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92638227|NCT00193349|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638228|NCT00193349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638229|NCT00193349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638230|NCT00193349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92638231|NCT00193388|Topotecan|topotecan|mesh-list
92638232|NCT00193388|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92638233|NCT00193388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638234|NCT00193388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638235|NCT00193388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638236|NCT00193388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638237|NCT00215709|Docetaxel|docetaxel|mesh-list
92638238|NCT00215709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638239|NCT00215709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638240|NCT00215709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638241|NCT00215709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638242|NCT00215709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638243|NCT00193466|Rituximab|rituximab|mesh-list
92638244|NCT00193466|Fludarabine|fludarabine|mesh-list
92363094|NCT03783026|Analgesics|analgesics|mesh-ancestor
92638245|NCT00193466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638246|NCT00193466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638247|NCT00193466|Immunologic Factors|immunologic factors|mesh-ancestor
92638248|NCT00193466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638249|NCT00193466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562544|NCT00152893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562545|NCT00152893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91970008|NCT02477267|Analgesics|analgesics|mesh-ancestor
92638250|NCT00215748|Dexamethasone|dexamethasone|mesh-list
92638251|NCT00215748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638252|NCT00215748|Antiemetics|antiemetics|mesh-ancestor
92638253|NCT00215748|Autonomic Agents|autonomic agents|mesh-ancestor
92638254|NCT00215748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638255|NCT00215748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638256|NCT00215748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638257|NCT00215748|Glucocorticoids|glucocorticoids|mesh-ancestor
92638258|NCT00215748|Hormones|hormones|mesh-ancestor
92638259|NCT00215748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638260|NCT00215748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045335|NCT01469156|Ranibizumab|ranibizumab|mesh-list
92638263|NCT00215826|Antiviral Agents|antiviral agents|mesh-ancestor
92638264|NCT00215826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638265|NCT00215826|Immunologic Factors|immunologic factors|mesh-ancestor
92638266|NCT00215826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638267|NCT00193544|Thalidomide|thalidomide|mesh-list
92638268|NCT00193544|Arsenic Trioxide|arsenic trioxide|mesh-list
92638269|NCT00193544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638270|NCT00193544|Immunologic Factors|immunologic factors|mesh-ancestor
92638271|NCT00193544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638272|NCT00193544|Leprostatic Agents|leprostatic agents|mesh-ancestor
92638273|NCT00193544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92638274|NCT00193544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638275|NCT00193544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92638276|NCT00193544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92638277|NCT00193544|Growth Substances|growth substances|mesh-ancestor
92638278|NCT00193544|Growth Inhibitors|growth inhibitors|mesh-ancestor
92638279|NCT00193544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638280|NCT00215865|Ribavirin|ribavirin|mesh-list
92638281|NCT00215865|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92638282|NCT00215865|Antimetabolites|antimetabolites|mesh-ancestor
92638283|NCT00215865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638284|NCT00215865|Antiviral Agents|antiviral agents|mesh-ancestor
92638285|NCT00215865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638286|NCT00124358|Buprenorphine|buprenorphine|mesh-list
92638287|NCT00124358|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92638288|NCT00124358|Narcotics|narcotics|mesh-ancestor
92638289|NCT00124358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638290|NCT00124358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638291|NCT00124358|Analgesics|analgesics|mesh-ancestor
92638292|NCT00124358|Sensory System Agents|sensory system agents|mesh-ancestor
92638293|NCT00124358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638294|NCT00124358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92638295|NCT00193583|Carboplatin|carboplatin|mesh-list
92638296|NCT00193583|Topotecan|topotecan|mesh-list
92638297|NCT00193583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638298|NCT00193583|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92638299|NCT00193583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638300|NCT00193583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638301|NCT00193583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638302|NCT00215982|Capecitabine|capecitabine|mesh-list
92638303|NCT00215982|Oxaliplatin|oxaliplatin|mesh-list
92638304|NCT00215982|Irinotecan|irinotecan|mesh-list
92638305|NCT00215982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638306|NCT00215982|Antimetabolites|antimetabolites|mesh-ancestor
92638307|NCT00215982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638308|NCT00215982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638309|NCT00215982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92638310|NCT00215982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638311|NCT00215982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638312|NCT00124397|Atorvastatin|atorvastatin|mesh-list
92638313|NCT00124397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92638314|NCT00124397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92638315|NCT00124397|Antimetabolites|antimetabolites|mesh-ancestor
92638316|NCT00124397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638317|NCT00124397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92638318|NCT00124397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92638319|NCT00124397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638320|NCT00216021|Capecitabine|capecitabine|mesh-list
92638321|NCT00216021|Oxaliplatin|oxaliplatin|mesh-list
92562546|NCT00152893|Antimetabolites|antimetabolites|mesh-ancestor
92562547|NCT00152893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562548|NCT00152893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92638322|NCT00216021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638323|NCT00216021|Antimetabolites|antimetabolites|mesh-ancestor
92638324|NCT00216021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638325|NCT00216021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638326|NCT00409526|Iloprost|iloprost|mesh-list
92638327|NCT00409526|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92638328|NCT00409526|Vasodilator Agents|vasodilator agents|mesh-ancestor
92638329|NCT00216138|Docetaxel|docetaxel|mesh-list
92638330|NCT00216138|Capecitabine|capecitabine|mesh-list
92638331|NCT00216138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638332|NCT00216138|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638333|NCT00216138|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638334|NCT00216138|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638335|NCT00216138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638339|NCT00216177|Infliximab|infliximab|mesh-list
92638340|NCT00216177|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92638341|NCT00216177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638342|NCT00216177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638343|NCT00216177|Dermatologic Agents|dermatologic agents|mesh-ancestor
92638344|NCT00216177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638345|NCT00216216|Pemetrexed|pemetrexed|mesh-list
92638346|NCT00216216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638347|NCT00216216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638348|NCT00216216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638349|NCT00216216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92638350|NCT00216216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92638351|NCT00473746|Dexamethasone|dexamethasone|mesh-list
92638352|NCT00473746|Prednisone|prednisone|mesh-list
92638353|NCT00473746|Prednisolone|prednisolone|mesh-list
92638354|NCT00473746|Abiraterone Acetate|abiraterone acetate|mesh-list
92638355|NCT00473746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638356|NCT00473746|Antiemetics|antiemetics|mesh-ancestor
92638357|NCT00473746|Autonomic Agents|autonomic agents|mesh-ancestor
92638358|NCT00473746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638359|NCT00473746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638360|NCT00473746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638361|NCT00473746|Glucocorticoids|glucocorticoids|mesh-ancestor
92638362|NCT00473746|Hormones|hormones|mesh-ancestor
92638363|NCT00473746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638364|NCT00473746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92638365|NCT00473746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638366|NCT00473746|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92638367|NCT00473746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638368|NCT00473746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638369|NCT00473746|Hormone Antagonists|hormone antagonists|mesh-ancestor
92638370|NCT00473746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92638371|NCT00409643|Amlodipine|amlodipine|mesh-list
92638372|NCT00409643|Valsartan|valsartan|mesh-list
92638373|NCT00409643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92638374|NCT00409643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92638375|NCT00409643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638376|NCT00409643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638377|NCT00409643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92638378|NCT00409643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638379|NCT00409643|Vasodilator Agents|vasodilator agents|mesh-ancestor
92638380|NCT00409643|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92638381|NCT00409643|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92638382|NCT00216294|Secretin|secretin|mesh-list
92638383|NCT00216294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638384|NCT00216294|Hormones|hormones|mesh-ancestor
92638385|NCT00216294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638386|NCT00216294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638387|NCT00409721|Memantine|memantine|mesh-list
92638388|NCT00409721|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92638389|NCT00409721|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92638390|NCT00409721|Dopamine Agents|dopamine agents|mesh-ancestor
92638391|NCT00409721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638392|NCT00409721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562549|NCT00152893|Vasodilator Agents|vasodilator agents|mesh-ancestor
92562550|NCT00152893|Vitamin B Complex|vitamin b complex|mesh-ancestor
92638393|NCT00409721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638394|NCT00409721|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92638395|NCT00409721|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92638396|NCT00193622|Bevacizumab|bevacizumab|mesh-list
92638397|NCT00193622|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92638398|NCT00193622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638399|NCT00193622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638400|NCT00193622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92638401|NCT00193622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92638402|NCT00193622|Growth Substances|growth substances|mesh-ancestor
92638403|NCT00193622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638404|NCT00193622|Growth Inhibitors|growth inhibitors|mesh-ancestor
92638405|NCT00193622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92638406|NCT00193622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638420|NCT00223275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638421|NCT00223275|Sensory System Agents|sensory system agents|mesh-ancestor
92638422|NCT00223275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638424|NCT00124787|Antiemetics|antiemetics|mesh-ancestor
92638425|NCT00124787|Autonomic Agents|autonomic agents|mesh-ancestor
92638426|NCT00124787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638427|NCT00124787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638428|NCT00124787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638429|NCT00124787|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92638430|NCT00124787|Histamine Antagonists|histamine antagonists|mesh-ancestor
92638431|NCT00124787|Histamine Agents|histamine agents|mesh-ancestor
92638432|NCT00124787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638433|NCT00124787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638434|NCT00193661|Testosterone|testosterone|mesh-list
92638435|NCT00193661|Androgens|androgens|mesh-ancestor
92638436|NCT00193661|Hormones|hormones|mesh-ancestor
92638437|NCT00193661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638438|NCT00193661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638439|NCT00206232|Spironolactone|spironolactone|mesh-list
92638440|NCT00206232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92638441|NCT00206232|Hormone Antagonists|hormone antagonists|mesh-ancestor
92638442|NCT00206232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638443|NCT00206232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638444|NCT00206232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92638445|NCT00206232|Diuretics|diuretics|mesh-ancestor
92638446|NCT00206232|Natriuretic Agents|natriuretic agents|mesh-ancestor
92638447|NCT00193700|Testosterone|testosterone|mesh-list
92638448|NCT00193700|Androgens|androgens|mesh-ancestor
92638449|NCT00193700|Hormones|hormones|mesh-ancestor
92638450|NCT00193700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638451|NCT00193700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638452|NCT00124826|Insulin|insulin|mesh-list
92638453|NCT00124826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92638454|NCT00124826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638455|NCT00193739|Paclitaxel|paclitaxel|mesh-list
92638456|NCT00193739|Carboplatin|carboplatin|mesh-list
92638457|NCT00193739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92638458|NCT00193739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638459|NCT00193739|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638460|NCT00193739|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638461|NCT00193739|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638462|NCT00193739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638463|NCT00206310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92638464|NCT00206310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92638465|NCT00206310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92638466|NCT00206310|Antimetabolites|antimetabolites|mesh-ancestor
92638467|NCT00206310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638469|NCT00206310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92638471|NCT00206388|Cyclophosphamide|cyclophosphamide|mesh-list
92638472|NCT00206388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638473|NCT00206388|Immunologic Factors|immunologic factors|mesh-ancestor
92638474|NCT00206388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638475|NCT00206388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638476|NCT00206388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638477|NCT00206388|Alkylating Agents|alkylating agents|mesh-ancestor
92562551|NCT00152893|Vitamins|vitamins|mesh-ancestor
92562552|NCT00152932|Dorzolamide|dorzolamide|mesh-list
92562553|NCT00152932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92562554|NCT00152932|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92638478|NCT00206388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638479|NCT00206388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638480|NCT00206388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92638481|NCT00125021|Capecitabine|capecitabine|mesh-list
92638482|NCT00125021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92638483|NCT00125021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638484|NCT00125021|Antimetabolites|antimetabolites|mesh-ancestor
92638485|NCT00125021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638486|NCT00125021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638487|NCT00125021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92638488|NCT00125021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638489|NCT00193856|Zoledronic Acid|zoledronic acid|mesh-list
92638490|NCT00193856|Leuprolide|leuprolide|mesh-list
92638491|NCT00193856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92638492|NCT00193856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638493|NCT00193856|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92638494|NCT00193856|Fertility Agents|fertility agents|mesh-ancestor
92638495|NCT00193856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92638496|NCT00193856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92638497|NCT00193856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638498|NCT00223509|Lamotrigine|lamotrigine|mesh-list
92638499|NCT00223509|Anticonvulsants|anticonvulsants|mesh-ancestor
92638500|NCT00223509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92638501|NCT00223509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638502|NCT00223509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638503|NCT00223509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92638504|NCT00223509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638505|NCT00223509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92638506|NCT00223509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92638507|NCT00223509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638508|NCT00223509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92638509|NCT00223509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92638510|NCT00193895|Carboplatin|carboplatin|mesh-list
92638511|NCT00193895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638512|NCT00223548|Mesna|mesna|mesh-list
92638513|NCT00223548|Protective Agents|protective agents|mesh-ancestor
92638514|NCT00223548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638515|NCT00125060|Simvastatin|simvastatin|mesh-list
92638516|NCT00125060|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92638517|NCT00125060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92638518|NCT00125060|Antimetabolites|antimetabolites|mesh-ancestor
92638519|NCT00125060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638520|NCT00125060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92638521|NCT00125060|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92638522|NCT00125060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638523|NCT00223626|Topiramate|topiramate|mesh-list
92638524|NCT00223626|Anticonvulsants|anticonvulsants|mesh-ancestor
92638525|NCT00223626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92638526|NCT00223626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638527|NCT00223743|Zonisamide|zonisamide|mesh-list
92638528|NCT00223743|Anticonvulsants|anticonvulsants|mesh-ancestor
92638529|NCT00223743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92638530|NCT00223743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638531|NCT00223743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638532|NCT00223743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92638533|NCT00223743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638534|NCT00193973|Methotrexate|methotrexate|mesh-list
92638535|NCT00193973|Idarubicin|idarubicin|mesh-list
92638536|NCT00193973|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92638537|NCT00193973|Abortifacient Agents|abortifacient agents|mesh-ancestor
92638538|NCT00193973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92638539|NCT00193973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638541|NCT00193973|Antimetabolites|antimetabolites|mesh-ancestor
92638542|NCT00193973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638543|NCT00193973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638544|NCT00193973|Dermatologic Agents|dermatologic agents|mesh-ancestor
92638545|NCT00193973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562555|NCT00152932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562556|NCT00152932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638546|NCT00193973|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92638547|NCT00193973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638548|NCT00193973|Immunologic Factors|immunologic factors|mesh-ancestor
92638549|NCT00193973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638550|NCT00193973|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92638551|NCT00193973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92638552|NCT00193973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92638553|NCT00193973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638554|NCT00411879|Vasopressins|vasopressins|mesh-list
92638555|NCT00411879|Arginine Vasopressin|arginine vasopressin|mesh-list
92638556|NCT00411879|Epinephrine|epinephrine|mesh-list
92638557|NCT00411879|Racepinephrine|racepinephrine|mesh-list
92638558|NCT00411879|Epinephryl borate|epinephryl borate|mesh-list
92638559|NCT00411879|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92638560|NCT00411879|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92638561|NCT00411879|Adrenergic Agents|adrenergic agents|mesh-ancestor
92638562|NCT00411879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638563|NCT00411879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638564|NCT00411879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638565|NCT00411879|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92638566|NCT00411879|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92638567|NCT00411879|Autonomic Agents|autonomic agents|mesh-ancestor
92638568|NCT00411879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638569|NCT00411879|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92638570|NCT00411879|Respiratory System Agents|respiratory system agents|mesh-ancestor
92638571|NCT00411879|Mydriatics|mydriatics|mesh-ancestor
92638572|NCT00411879|Sympathomimetics|sympathomimetics|mesh-ancestor
92638573|NCT00411879|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92638574|NCT00411879|Hemostatics|hemostatics|mesh-ancestor
92638575|NCT00411879|Coagulants|coagulants|mesh-ancestor
92638576|NCT00411879|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92638577|NCT00411879|Natriuretic Agents|natriuretic agents|mesh-ancestor
92638578|NCT00193505|Rituximab|rituximab|mesh-list
92638579|NCT00193505|Carboplatin|carboplatin|mesh-list
92638580|NCT00193505|Etoposide|etoposide|mesh-list
92638581|NCT00193505|Ifosfamide|ifosfamide|mesh-list
92638582|NCT00193505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638583|NCT00193505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638584|NCT00193505|Immunologic Factors|immunologic factors|mesh-ancestor
92638585|NCT00193505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638586|NCT00193505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638587|NCT00193505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92638588|NCT00193505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92638589|NCT00193505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638590|NCT00193505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638591|NCT00193505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638592|NCT00193505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638593|NCT00193505|Alkylating Agents|alkylating agents|mesh-ancestor
92638594|NCT00223860|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92638595|NCT00223860|Hormones|hormones|mesh-list
92638596|NCT00223860|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92638597|NCT00223860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638598|NCT00223860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638599|NCT00223860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92638600|NCT00125255|Lidocaine|lidocaine|mesh-list
92638601|NCT00125255|Tetracaine|tetracaine|mesh-list
92638602|NCT00125255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92638603|NCT00125255|Anesthetics|anesthetics|mesh-ancestor
92638604|NCT00125255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938573|NCT00904943|Topiramate|topiramate|mesh-list
92638605|NCT00125255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638606|NCT00125255|Sensory System Agents|sensory system agents|mesh-ancestor
92638607|NCT00125255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638608|NCT00125255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92638609|NCT00125255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92638610|NCT00125255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92638611|NCT00125255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638612|NCT00125255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638613|NCT00223938|Ferric gluconate|ferric gluconate|mesh-list
92638631|NCT00206466|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638632|NCT00206466|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638633|NCT00206466|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562557|NCT00083031|Cyclophosphamide|cyclophosphamide|mesh-list
92562558|NCT00083031|Bevacizumab|bevacizumab|mesh-list
92562559|NCT00083031|Methotrexate|methotrexate|mesh-list
92562560|NCT00083031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562561|NCT00083031|Immunologic Factors|immunologic factors|mesh-ancestor
92638634|NCT00206466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638635|NCT00206466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92638636|NCT00206466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92638637|NCT00206466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638638|NCT00206466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638639|NCT00206466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638640|NCT00206466|Immunologic Factors|immunologic factors|mesh-ancestor
92638641|NCT00206466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638642|NCT00206466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638643|NCT00206466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638644|NCT00206466|Alkylating Agents|alkylating agents|mesh-ancestor
92638645|NCT00206466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92638646|NCT00224094|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92638647|NCT00224094|Estrogens|estrogens|mesh-ancestor
92638649|NCT00224094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638650|NCT00224094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638651|NCT00125411|Docetaxel|docetaxel|mesh-list
92638652|NCT00125411|Satraplatin|satraplatin|mesh-list
92638653|NCT00125411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638654|NCT00125411|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638655|NCT00125411|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638656|NCT00125411|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638657|NCT00125411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638658|NCT00206505|Docetaxel|docetaxel|mesh-list
92638659|NCT00206505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638660|NCT00206505|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638661|NCT00206505|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638662|NCT00206505|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638663|NCT00206505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638664|NCT00206544|Tamoxifen|tamoxifen|mesh-list
92638665|NCT00206544|Progesterone|progesterone|mesh-list
92638666|NCT00206544|Progestins|progestins|mesh-ancestor
92638667|NCT00206544|Hormones|hormones|mesh-ancestor
92638668|NCT00206544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638669|NCT00206544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638670|NCT00206544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92638671|NCT00206544|Hormone Antagonists|hormone antagonists|mesh-ancestor
92638672|NCT00206544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92638673|NCT00206544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638675|NCT00206544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92638676|NCT00206544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92638678|NCT00194324|Clotrimazole|clotrimazole|mesh-list
92638679|NCT00194324|Antifungal Agents|antifungal agents|mesh-ancestor
92638680|NCT00194324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638681|NCT00194324|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92638682|NCT00194324|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92638683|NCT00194324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638684|NCT00194324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638685|NCT00194324|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92638686|NCT00194324|Hormone Antagonists|hormone antagonists|mesh-ancestor
92638687|NCT00194324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638688|NCT00194324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638689|NCT00194324|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92638690|NCT00194324|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92638691|NCT00194324|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92638692|NCT00206622|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92638693|NCT00206622|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92638694|NCT00206622|Levonorgestrel|levonorgestrel|mesh-list
92638695|NCT00206622|Estradiol|estradiol|mesh-list
92638696|NCT00206622|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92638697|NCT00206622|Estrogens|estrogens|mesh-ancestor
92638698|NCT00206622|Hormones|hormones|mesh-ancestor
92638699|NCT00206622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638700|NCT00206622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562562|NCT00083031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562563|NCT00083031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562564|NCT00083031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562565|NCT00083031|Alkylating Agents|alkylating agents|mesh-ancestor
91970025|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638701|NCT00206622|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92638702|NCT00206622|Contraceptive Agents|contraceptive agents|mesh-ancestor
92638703|NCT00206622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92638704|NCT00206622|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92638705|NCT00206622|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92638706|NCT00206622|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92638708|NCT00194402|Niacinamide|niacinamide|mesh-list
92638709|NCT00194402|Nicotinic Acids|nicotinic acids|mesh-list
92638710|NCT00194402|Atorvastatin|atorvastatin|mesh-list
92638711|NCT00194402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92638712|NCT00194402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92638713|NCT00194402|Antimetabolites|antimetabolites|mesh-ancestor
92638714|NCT00194402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638715|NCT00194402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92638716|NCT00194402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92638717|NCT00194402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638718|NCT00194402|Vasodilator Agents|vasodilator agents|mesh-ancestor
92638719|NCT00194402|Vitamin B Complex|vitamin b complex|mesh-ancestor
92638720|NCT00194402|Vitamins|vitamins|mesh-ancestor
92638721|NCT00194402|Micronutrients|micronutrients|mesh-ancestor
92638722|NCT00194402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638723|NCT00473512|Dexamethasone|dexamethasone|mesh-list
92638724|NCT00473512|Abiraterone Acetate|abiraterone acetate|mesh-list
92638725|NCT00473512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638726|NCT00473512|Antiemetics|antiemetics|mesh-ancestor
92638727|NCT00473512|Autonomic Agents|autonomic agents|mesh-ancestor
92638728|NCT00473512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638729|NCT00473512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638730|NCT00473512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92638731|NCT00473512|Glucocorticoids|glucocorticoids|mesh-ancestor
92638732|NCT00473512|Hormones|hormones|mesh-ancestor
92638733|NCT00473512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638734|NCT00473512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92638735|NCT00473512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638736|NCT00473512|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92638737|NCT00473512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638738|NCT00473512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638739|NCT00473512|Hormone Antagonists|hormone antagonists|mesh-ancestor
92638740|NCT00473512|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92638741|NCT00125489|Chloroquine|chloroquine|mesh-list
92638742|NCT00125489|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92638743|NCT00125489|Pyrimethamine|pyrimethamine|mesh-list
92638744|NCT00125489|Sulfadoxine|sulfadoxine|mesh-list
92638745|NCT00125489|Amebicides|amebicides|mesh-ancestor
92638758|NCT00125489|Filaricides|filaricides|mesh-ancestor
92638759|NCT00125489|Antinematodal Agents|antinematodal agents|mesh-ancestor
92638760|NCT00125489|Anthelmintics|anthelmintics|mesh-ancestor
92638761|NCT00125489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92638762|NCT00125489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638763|NCT00125489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638764|NCT00125489|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92638765|NCT00206661|Molgramostim|molgramostim|mesh-list
92638766|NCT00206661|Sargramostim|sargramostim|mesh-list
92638767|NCT00206661|Immunologic Factors|immunologic factors|mesh-ancestor
92638768|NCT00206661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638769|NCT00206661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638770|NCT00473434|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92638771|NCT00473434|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92638772|NCT00473434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92638773|NCT00473434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638774|NCT00473434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638775|NCT00473434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92638776|NCT00473434|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92638777|NCT00473434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92562566|NCT00083031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562567|NCT00083031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988137|NCT03186313|Ribavirin|ribavirin|mesh-list
92638778|NCT00473434|Serotonin Agents|serotonin agents|mesh-ancestor
92638779|NCT00473434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638780|NCT00473434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638781|NCT00473434|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92638782|NCT00473434|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92638783|NCT00473434|Dopamine Agents|dopamine agents|mesh-ancestor
92638784|NCT00125567|Levodopa|levodopa|mesh-list
92638785|NCT00125567|Carbidopa|carbidopa|mesh-list
92638786|NCT00125567|Entacapone|entacapone|mesh-list
92638787|NCT00125567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92638788|NCT00125567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92638789|NCT00125567|Dopamine Agents|dopamine agents|mesh-ancestor
92638790|NCT00125567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638791|NCT00125567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638792|NCT00125567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638793|NCT00125567|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92638794|NCT00125567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638795|NCT00125567|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92638796|NCT00473083|Minocycline|minocycline|mesh-list
92638797|NCT00473083|Clindamycin|clindamycin|mesh-list
92638798|NCT00473083|Clindamycin palmitate|clindamycin palmitate|mesh-list
92638799|NCT00473083|Clindamycin phosphate|clindamycin phosphate|mesh-list
92638800|NCT00473083|Triamcinolone|triamcinolone|mesh-list
92638801|NCT00473083|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92638802|NCT00473083|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92638803|NCT00473083|Hydrocortisone|hydrocortisone|mesh-list
92638804|NCT00473083|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92638805|NCT00473083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638806|NCT00473083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638807|NCT00473083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638808|NCT00473083|Glucocorticoids|glucocorticoids|mesh-ancestor
92638810|NCT00473083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92638812|NCT00473083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638813|NCT00473083|Immunologic Factors|immunologic factors|mesh-ancestor
92638814|NCT00473083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92638815|NCT00473083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638816|NCT00473083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92638817|NCT00194480|Interferons|interferons|mesh-list
92638818|NCT00194480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638819|NCT00194480|Antiviral Agents|antiviral agents|mesh-ancestor
92638820|NCT00194480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638821|NCT00472420|Rituximab|rituximab|mesh-list
92638822|NCT00472420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638823|NCT00472420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638824|NCT00472420|Immunologic Factors|immunologic factors|mesh-ancestor
92638825|NCT00472420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638826|NCT00472420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638827|NCT00194519|Acyclovir|acyclovir|mesh-list
92638828|NCT00194519|Antiviral Agents|antiviral agents|mesh-ancestor
92638829|NCT00194519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638830|NCT00206700|Sargramostim|sargramostim|mesh-list
92638831|NCT00206700|Immunologic Factors|immunologic factors|mesh-ancestor
92638832|NCT00206700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638833|NCT00125645|Irbesartan|irbesartan|mesh-list
92638834|NCT00125645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92638835|NCT00125645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92638836|NCT00125645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92638837|NCT00125645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638838|NCT00125684|Morphine|morphine|mesh-list
92638839|NCT00125684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92638840|NCT00125684|Narcotics|narcotics|mesh-ancestor
92638841|NCT00125684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638842|NCT00125684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638843|NCT00125684|Analgesics|analgesics|mesh-ancestor
92638844|NCT00125684|Sensory System Agents|sensory system agents|mesh-ancestor
92638845|NCT00125684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638846|NCT00194597|Sildenafil Citrate|sildenafil citrate|mesh-list
92638847|NCT00194597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638848|NCT00194597|Vasodilator Agents|vasodilator agents|mesh-ancestor
92562568|NCT00083031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92562569|NCT00083031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92562570|NCT00083031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92562571|NCT00083031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92562572|NCT00083031|Growth Substances|growth substances|mesh-ancestor
92562573|NCT00083031|Growth Inhibitors|growth inhibitors|mesh-ancestor
92638849|NCT00194597|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92638850|NCT00194597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92638851|NCT00194597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638852|NCT00194597|Urological Agents|urological agents|mesh-ancestor
92638853|NCT00206739|Pyrimethamine|pyrimethamine|mesh-list
92638854|NCT00206739|Sulfadoxine|sulfadoxine|mesh-list
92638855|NCT00206739|Antimalarials|antimalarials|mesh-ancestor
92638856|NCT00206739|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92638857|NCT00206739|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92638858|NCT00206739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638859|NCT00206739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92638860|NCT00206739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638861|NCT00206739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638862|NCT00206739|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92638863|NCT00206778|Lamotrigine|lamotrigine|mesh-list
92638864|NCT00206778|Valproic Acid|valproic acid|mesh-list
92638865|NCT00206778|Anticonvulsants|anticonvulsants|mesh-ancestor
92638866|NCT00206778|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92638867|NCT00206778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638868|NCT00206778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638869|NCT00206778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92638870|NCT00206778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638871|NCT00206778|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92638872|NCT00206778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92638873|NCT00206778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638874|NCT00206778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92638875|NCT00206778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92638876|NCT00206778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638877|NCT00206778|GABA Agents|gaba agents|mesh-ancestor
92638878|NCT00206778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638879|NCT00206778|Antimanic Agents|antimanic agents|mesh-ancestor
92638880|NCT00125801|Hydromorphone|hydromorphone|mesh-list
92638881|NCT00125801|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92638882|NCT00125801|Narcotics|narcotics|mesh-ancestor
92638885|NCT00125801|Analgesics|analgesics|mesh-ancestor
92638886|NCT00125801|Sensory System Agents|sensory system agents|mesh-ancestor
92638887|NCT00125801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638888|NCT00125840|Clofarabine|clofarabine|mesh-list
92638889|NCT00125840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638890|NCT00125840|Antimetabolites|antimetabolites|mesh-ancestor
92638891|NCT00125840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638892|NCT00125840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638894|NCT00224445|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92638895|NCT00224445|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92638896|NCT00224445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92638897|NCT00224445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92638898|NCT00224445|Protease Inhibitors|protease inhibitors|mesh-ancestor
92638899|NCT00224445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638900|NCT00224445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638901|NCT00224445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92638902|NCT00224445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92638903|NCT00224445|Antiviral Agents|antiviral agents|mesh-ancestor
92638904|NCT00224445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638905|NCT00224445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92638906|NCT00224445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92638907|NCT00224445|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92638908|NCT00224445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92638909|NCT00194753|Paclitaxel|paclitaxel|mesh-list
92638910|NCT00194753|Cyclophosphamide|cyclophosphamide|mesh-list
92638911|NCT00194753|Doxorubicin|doxorubicin|mesh-list
92638912|NCT00194753|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92638913|NCT00194753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562574|NCT00083031|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92562575|NCT00083031|Abortifacient Agents|abortifacient agents|mesh-ancestor
92562576|NCT00083031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562577|NCT00083031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562579|NCT00083031|Dermatologic Agents|dermatologic agents|mesh-ancestor
92638914|NCT00194753|Tubulin Modulators|tubulin modulators|mesh-ancestor
92638915|NCT00194753|Antimitotic Agents|antimitotic agents|mesh-ancestor
92638916|NCT00194753|Mitosis Modulators|mitosis modulators|mesh-ancestor
92638917|NCT00194753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638918|NCT00194753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92638919|NCT00194753|Immunologic Factors|immunologic factors|mesh-ancestor
92638920|NCT00194753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638921|NCT00194753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638922|NCT00194753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92638923|NCT00194753|Alkylating Agents|alkylating agents|mesh-ancestor
92638924|NCT00194753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92638925|NCT00194753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92638926|NCT00194753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92638927|NCT00194753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92638928|NCT00194753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638929|NCT00206856|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92638930|NCT00206856|Natriuretic Agents|natriuretic agents|mesh-ancestor
92638931|NCT00206856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638932|NCT00125918|Tadalafil|tadalafil|mesh-list
92638933|NCT00125918|Vasodilator Agents|vasodilator agents|mesh-ancestor
92638934|NCT00125918|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92638935|NCT00125918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92638936|NCT00125918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638937|NCT00125918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638938|NCT00125918|Urological Agents|urological agents|mesh-ancestor
92638939|NCT00224523|Mometasone Furoate|mometasone furoate|mesh-list
92638940|NCT00224523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638941|NCT00224523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92638942|NCT00224523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92638943|NCT00472303|Morphine|morphine|mesh-list
92638944|NCT00472303|Tapentadol|tapentadol|mesh-list
92638945|NCT00472303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92638946|NCT00472303|Narcotics|narcotics|mesh-ancestor
92638947|NCT00472303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638948|NCT00472303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638949|NCT00472303|Analgesics|analgesics|mesh-ancestor
92638950|NCT00472303|Sensory System Agents|sensory system agents|mesh-ancestor
92638951|NCT00472303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638952|NCT00472303|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92638953|NCT00472303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92638954|NCT00472303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638957|NCT00472303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638958|NCT00125996|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92638959|NCT00125996|Hematinics|hematinics|mesh-ancestor
92638960|NCT00206934|Dexetimide|dexetimide|mesh-list
92638961|NCT00206934|Citalopram|citalopram|mesh-list
92638962|NCT00206934|Escitalopram|escitalopram|mesh-list
92638963|NCT00206934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92638964|NCT00206934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92638965|NCT00206934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638966|NCT00206934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638967|NCT00206934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638968|NCT00206934|Serotonin Agents|serotonin agents|mesh-ancestor
92638969|NCT00206934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638970|NCT00206934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92638971|NCT00206934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92638972|NCT00206934|Parasympatholytics|parasympatholytics|mesh-ancestor
92638973|NCT00206934|Autonomic Agents|autonomic agents|mesh-ancestor
92638974|NCT00206934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638975|NCT00206934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92638976|NCT00206934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92638977|NCT00206934|Cholinergic Agents|cholinergic agents|mesh-ancestor
92638978|NCT00206934|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92638979|NCT00206934|Antidepressive Agents|antidepressive agents|mesh-ancestor
92562580|NCT00083031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562581|NCT00083031|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92562582|NCT00083031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92638980|NCT00206934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92638981|NCT00194909|Sildenafil Citrate|sildenafil citrate|mesh-list
92638982|NCT00194909|Vasodilator Agents|vasodilator agents|mesh-ancestor
92638983|NCT00194909|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92638984|NCT00194909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92638985|NCT00194909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92638986|NCT00194909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638987|NCT00194909|Urological Agents|urological agents|mesh-ancestor
92638988|NCT00224640|Iron Chelating Agents|iron chelating agents|mesh-list
92638989|NCT00224640|Chelating Agents|chelating agents|mesh-ancestor
92638990|NCT00224640|Sequestering Agents|sequestering agents|mesh-ancestor
92638991|NCT00224640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638992|NCT00194948|Escitalopram|escitalopram|mesh-list
92638993|NCT00194948|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92638994|NCT00194948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92638995|NCT00194948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92638996|NCT00194948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638997|NCT00194948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92638998|NCT00194948|Serotonin Agents|serotonin agents|mesh-ancestor
92638999|NCT00194948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639000|NCT00206973|Mannitol|mannitol|mesh-list
92639001|NCT00206973|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92639002|NCT00206973|Diuretics|diuretics|mesh-ancestor
92639003|NCT00206973|Natriuretic Agents|natriuretic agents|mesh-ancestor
92639004|NCT00206973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639005|NCT00471445|Ketamine|ketamine|mesh-list
92639006|NCT00471445|Amitriptyline|amitriptyline|mesh-list
92639007|NCT00471445|Analgesics|analgesics|mesh-ancestor
92639008|NCT00471445|Sensory System Agents|sensory system agents|mesh-ancestor
92639009|NCT00471445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639010|NCT00471445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639011|NCT00471445|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92639012|NCT00471445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92639013|NCT00471445|Anesthetics, General|anesthetics, general|mesh-ancestor
92639014|NCT00471445|Anesthetics|anesthetics|mesh-ancestor
92639015|NCT00471445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639016|NCT00471445|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92639017|NCT00471445|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92639018|NCT00471445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639019|NCT00471445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639020|NCT00471445|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92639021|NCT00471445|Antidepressive Agents|antidepressive agents|mesh-ancestor
92639022|NCT00471445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639023|NCT00471445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639024|NCT00471445|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92639025|NCT00471445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92639027|NCT00471445|Adrenergic Agents|adrenergic agents|mesh-ancestor
92639028|NCT00207051|Cetuximab|cetuximab|mesh-list
92639029|NCT00207051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639030|NCT00207051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639031|NCT00402467|Enoxaparin|enoxaparin|mesh-list
92639032|NCT00402467|Rivaroxaban|rivaroxaban|mesh-list
92639033|NCT00402467|Enoxaparin sodium|enoxaparin sodium|mesh-list
92639034|NCT00402467|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92639035|NCT00402467|Antithrombins|antithrombins|mesh-ancestor
92639036|NCT00402467|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92639037|NCT00402467|Protease Inhibitors|protease inhibitors|mesh-ancestor
92639038|NCT00402467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750768|NCT05936489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639039|NCT00402467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639040|NCT00402467|Anticoagulants|anticoagulants|mesh-ancestor
92639041|NCT00402467|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92639042|NCT00402467|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92639043|NCT00224679|Aspirin|aspirin|mesh-list
92639044|NCT00224679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92639045|NCT00224679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639046|NCT00224679|Analgesics|analgesics|mesh-ancestor
92639047|NCT00224679|Sensory System Agents|sensory system agents|mesh-ancestor
92639048|NCT00224679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562584|NCT00050336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562585|NCT00050336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562586|NCT00043758|Tolvaptan|tolvaptan|mesh-list
92639049|NCT00224679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639050|NCT00224679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639051|NCT00224679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639052|NCT00224679|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92639053|NCT00224679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92639054|NCT00224679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639055|NCT00224679|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92639056|NCT00224679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92639057|NCT00224679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639058|NCT00224679|Antipyretics|antipyretics|mesh-ancestor
92639059|NCT00402506|Pyridoxal|pyridoxal|mesh-list
92639060|NCT00402506|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
92639061|NCT00402506|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639062|NCT00402506|Vitamins|vitamins|mesh-ancestor
92639063|NCT00402506|Micronutrients|micronutrients|mesh-ancestor
92639064|NCT00402506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639065|NCT00207129|Capecitabine|capecitabine|mesh-list
92639066|NCT00207129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639067|NCT00207129|Antimetabolites|antimetabolites|mesh-ancestor
92639068|NCT00207129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639069|NCT00207129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639070|NCT00402545|Docetaxel|docetaxel|mesh-list
92639071|NCT00402545|Fluorouracil|fluorouracil|mesh-list
92639072|NCT00402545|Cetuximab|cetuximab|mesh-list
92639073|NCT00402545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639074|NCT00402545|Tubulin Modulators|tubulin modulators|mesh-ancestor
92639075|NCT00402545|Antimitotic Agents|antimitotic agents|mesh-ancestor
92639076|NCT00402545|Mitosis Modulators|mitosis modulators|mesh-ancestor
92639077|NCT00402545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639078|NCT00402545|Antimetabolites|antimetabolites|mesh-ancestor
92639079|NCT00402545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639080|NCT00402545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639081|NCT00402545|Immunologic Factors|immunologic factors|mesh-ancestor
92639082|NCT00402545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639083|NCT00402545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639084|NCT00126074|Tedisamil|tedisamil|mesh-list
92639085|NCT00126074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92639086|NCT00126074|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92639087|NCT00126074|Protective Agents|protective agents|mesh-ancestor
92639088|NCT00126074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639089|NCT00195104|Cytarabine|cytarabine|mesh-list
92639090|NCT00195104|Arsenic Trioxide|arsenic trioxide|mesh-list
92639091|NCT00195104|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639092|NCT00195104|Antimetabolites|antimetabolites|mesh-ancestor
92639093|NCT00195104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639094|NCT00195104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639095|NCT00195104|Antiviral Agents|antiviral agents|mesh-ancestor
92639096|NCT00195104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639097|NCT00195104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639098|NCT00195104|Immunologic Factors|immunologic factors|mesh-ancestor
92639099|NCT00195104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639100|NCT00413088|Bemiparin|bemiparin|mesh-list
92639101|NCT00413088|Anticoagulants|anticoagulants|mesh-ancestor
92639106|NCT00409760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92639107|NCT00409760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639108|NCT00409760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92639109|NCT00409760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639111|NCT00409760|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92750769|NCT05936489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92639112|NCT00409760|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92639113|NCT00413127|Lidocaine|lidocaine|mesh-list
92639114|NCT00413127|Anesthetics, Local|anesthetics, local|mesh-ancestor
92364387|NCT04334928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639115|NCT00413127|Anesthetics|anesthetics|mesh-ancestor
92639116|NCT00413127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639117|NCT00413127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639118|NCT00413127|Sensory System Agents|sensory system agents|mesh-ancestor
92639119|NCT00413127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562587|NCT00043758|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92562588|NCT00043758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639120|NCT00413127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92639121|NCT00413127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92639122|NCT00413127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92639123|NCT00413127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92639124|NCT00413127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639125|NCT00126230|Docetaxel|docetaxel|mesh-list
92639126|NCT00126230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639127|NCT00126230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92639128|NCT00126230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92639129|NCT00126230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92639130|NCT00126230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639131|NCT00207363|Interferons|interferons|mesh-list
92639132|NCT00207363|Ribavirin|ribavirin|mesh-list
92639133|NCT00207363|Interferon-alpha|interferon-alpha|mesh-list
92639134|NCT00207363|Interferon alpha-2|interferon alpha-2|mesh-list
92639135|NCT00207363|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92639136|NCT00207363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639137|NCT00207363|Antiviral Agents|antiviral agents|mesh-ancestor
92639138|NCT00207363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639139|NCT00207363|Antimetabolites|antimetabolites|mesh-ancestor
92639140|NCT00207363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639141|NCT00207363|Immunologic Factors|immunologic factors|mesh-ancestor
92639142|NCT00207363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639143|NCT00126269|Gemcitabine|gemcitabine|mesh-list
92639144|NCT00126269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639145|NCT00126269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639146|NCT00126269|Antimetabolites|antimetabolites|mesh-ancestor
92639147|NCT00126269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639148|NCT00207402|Rosiglitazone|rosiglitazone|mesh-list
92639149|NCT00207402|Interferons|interferons|mesh-list
92639150|NCT00207402|Ribavirin|ribavirin|mesh-list
92639151|NCT00207402|Interferon alfacon-1|interferon alfacon-1|mesh-list
92639152|NCT00207402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639153|NCT00207402|Antiviral Agents|antiviral agents|mesh-ancestor
92639154|NCT00207402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639155|NCT00207402|Antimetabolites|antimetabolites|mesh-ancestor
92639156|NCT00207402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639157|NCT00207402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92639158|NCT00207402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639159|NCT00195299|Sirolimus|sirolimus|mesh-list
92639160|NCT00195299|Temsirolimus|temsirolimus|mesh-list
92639161|NCT00195299|MTOR Inhibitors|mtor inhibitors|mesh-list
92639162|NCT00195299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92639163|NCT00195299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639164|NCT00195299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639165|NCT00195299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639166|NCT00195299|Immunologic Factors|immunologic factors|mesh-ancestor
92639167|NCT00195299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639168|NCT00195299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639169|NCT00195299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92639170|NCT00195299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046251|NCT01952145|Xultophy|xultophy|mesh-list
92639172|NCT00195299|Antifungal Agents|antifungal agents|mesh-ancestor
92639174|NCT00471328|Imatinib Mesylate|imatinib mesylate|mesh-list
92639175|NCT00471328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639176|NCT00471328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92639177|NCT00471328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92639178|NCT00471328|Growth Substances|growth substances|mesh-ancestor
92639179|NCT00471328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639180|NCT00471328|Growth Inhibitors|growth inhibitors|mesh-ancestor
92639181|NCT00471328|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92639182|NCT00471328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639183|NCT00471328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639184|NCT00225030|Antihypertensive Agents|antihypertensive agents|mesh-list
92639185|NCT00126308|Mannitol|mannitol|mesh-list
92639186|NCT00126308|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92639187|NCT00126308|Diuretics|diuretics|mesh-ancestor
92639188|NCT00126308|Natriuretic Agents|natriuretic agents|mesh-ancestor
92639189|NCT00126308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639190|NCT00195377|Etanercept|etanercept|mesh-list
92639191|NCT00195377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92639192|NCT00195377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639193|NCT00195377|Analgesics|analgesics|mesh-ancestor
92639194|NCT00195377|Sensory System Agents|sensory system agents|mesh-ancestor
92639195|NCT00195377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639196|NCT00195377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639197|NCT00195377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639198|NCT00195377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639199|NCT00195377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639200|NCT00195377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639201|NCT00195377|Immunologic Factors|immunologic factors|mesh-ancestor
92639202|NCT00225108|Tinzaparin|tinzaparin|mesh-list
92639203|NCT00225108|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92639204|NCT00225108|Dalteparin|dalteparin|mesh-list
92639205|NCT00225108|Anticoagulants|anticoagulants|mesh-ancestor
92639206|NCT00225108|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92639207|NCT00225108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92639208|NCT00225108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639209|NCT00195416|Etanercept|etanercept|mesh-list
92639210|NCT00195416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92639211|NCT00195416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639212|NCT00195416|Analgesics|analgesics|mesh-ancestor
92639213|NCT00195416|Sensory System Agents|sensory system agents|mesh-ancestor
92639214|NCT00195416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639215|NCT00195416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639216|NCT00195416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639217|NCT00195416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639218|NCT00195416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639219|NCT00195416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639220|NCT00195416|Immunologic Factors|immunologic factors|mesh-ancestor
92639221|NCT00195455|Estradiol|estradiol|mesh-list
92639222|NCT00195455|Estrogens|estrogens|mesh-ancestor
92639223|NCT00195455|Hormones|hormones|mesh-ancestor
92639224|NCT00195455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639225|NCT00195455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639226|NCT00126347|Folic Acid|folic acid|mesh-list
92639227|NCT00126347|Betaine|betaine|mesh-list
92639228|NCT00126347|Hematinics|hematinics|mesh-ancestor
92639229|NCT00126347|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639230|NCT00126347|Vitamins|vitamins|mesh-ancestor
92639231|NCT00126347|Micronutrients|micronutrients|mesh-ancestor
92639232|NCT00126347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639233|NCT00126347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639234|NCT00126347|Lipotropic Agents|lipotropic agents|mesh-ancestor
92639235|NCT00126347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92639236|NCT00126347|Antimetabolites|antimetabolites|mesh-ancestor
92639237|NCT00126347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639238|NCT00126347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92639239|NCT00225225|Rosiglitazone|rosiglitazone|mesh-list
92639240|NCT00225225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92639241|NCT00225225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639242|NCT00126386|Zoledronic Acid|zoledronic acid|mesh-list
92639243|NCT00126386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92639244|NCT00126386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639245|NCT00225264|Pioglitazone|pioglitazone|mesh-list
92639246|NCT00225264|Glimepiride|glimepiride|mesh-list
92639259|NCT00126464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639260|NCT00126464|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92639261|NCT00126464|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92639262|NCT00126464|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92639263|NCT00126464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92639264|NCT00195533|Tazobactam|tazobactam|mesh-list
92639265|NCT00195533|Piperacillin|piperacillin|mesh-list
92639266|NCT00195533|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92639267|NCT00195533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92639268|NCT00195533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639269|NCT00195533|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92639270|NCT00195533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639271|NCT00195533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639272|NCT00207558|Folic Acid|folic acid|mesh-list
92639273|NCT00207558|Hematinics|hematinics|mesh-ancestor
92639274|NCT00207558|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639275|NCT00207558|Vitamins|vitamins|mesh-ancestor
92639276|NCT00207558|Micronutrients|micronutrients|mesh-ancestor
92639277|NCT00207558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639278|NCT00195572|Leucovorin|leucovorin|mesh-list
92639279|NCT00195572|Levoleucovorin|levoleucovorin|mesh-list
92639280|NCT00195572|Antidotes|antidotes|mesh-ancestor
92639281|NCT00195572|Protective Agents|protective agents|mesh-ancestor
92639282|NCT00195572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639283|NCT00195572|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639284|NCT00195572|Vitamins|vitamins|mesh-ancestor
92639285|NCT00195572|Micronutrients|micronutrients|mesh-ancestor
92639286|NCT00202280|Folic Acid|folic acid|mesh-list
92639287|NCT00202280|Vitamin B 12|vitamin b 12|mesh-list
92639288|NCT00202280|Hydroxocobalamin|hydroxocobalamin|mesh-list
92639289|NCT00202280|Vitamins|vitamins|mesh-ancestor
92639290|NCT00202280|Micronutrients|micronutrients|mesh-ancestor
92639291|NCT00202280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639292|NCT00202280|Hematinics|hematinics|mesh-ancestor
92639293|NCT00202280|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639294|NCT00225303|Etravirine|etravirine|mesh-list
92639295|NCT00225303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92639296|NCT00225303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92639297|NCT00225303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639298|NCT00225303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639299|NCT00225303|Antiviral Agents|antiviral agents|mesh-ancestor
92639300|NCT00225303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639301|NCT00225342|Rosiglitazone|rosiglitazone|mesh-list
92639302|NCT00225342|Gliclazide|gliclazide|mesh-list
92639303|NCT00225342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750770|NCT05936229|Interferons|interferons|mesh-list
92639304|NCT00225342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639305|NCT00195611|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92639306|NCT00195611|Immunologic Factors|immunologic factors|mesh-ancestor
92639307|NCT00195611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639308|NCT00470470|Imatinib Mesylate|imatinib mesylate|mesh-list
92639309|NCT00470470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639310|NCT00470470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92046400|NCT01632566|Celecoxib|celecoxib|mesh-list
92639313|NCT00195689|Adalimumab|adalimumab|mesh-list
92639314|NCT00195689|Antibodies|antibodies|mesh-list
92639315|NCT00195689|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92639316|NCT00195689|Immunologic Factors|immunologic factors|mesh-ancestor
92639317|NCT00195689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639318|NCT00195689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92639319|NCT00195689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639320|NCT00195689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639321|NCT00470275|Cytarabine|cytarabine|mesh-list
92639322|NCT00470275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639323|NCT00470275|Antimetabolites|antimetabolites|mesh-ancestor
92639324|NCT00470275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639325|NCT00470275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639326|NCT00470275|Antiviral Agents|antiviral agents|mesh-ancestor
92639327|NCT00470275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639328|NCT00470275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639329|NCT00470275|Immunologic Factors|immunologic factors|mesh-ancestor
92639330|NCT00470275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639331|NCT00225381|Anesthetics|anesthetics|mesh-list
92639332|NCT00225381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639333|NCT00225381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639334|NCT00195728|Acetaminophen|acetaminophen|mesh-list
92639335|NCT00195728|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92639336|NCT00195728|Hydrocodone|hydrocodone|mesh-list
92639337|NCT00195728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639338|NCT00195728|Analgesics|analgesics|mesh-ancestor
92639339|NCT00195728|Sensory System Agents|sensory system agents|mesh-ancestor
92639340|NCT00195728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364613|NCT03033732|Narcotics|narcotics|mesh-ancestor
92639341|NCT00195728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639342|NCT00195728|Antipyretics|antipyretics|mesh-ancestor
92639343|NCT00195728|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92639344|NCT00195728|Narcotics|narcotics|mesh-ancestor
92639345|NCT00195728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639347|NCT00195728|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639348|NCT00195728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92639349|NCT00195728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639350|NCT00195728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639351|NCT00470158|Iron|iron|mesh-list
92639352|NCT00470158|Zinc|zinc|mesh-list
92639353|NCT00470158|Trace Elements|trace elements|mesh-ancestor
92639354|NCT00470158|Micronutrients|micronutrients|mesh-ancestor
92639355|NCT00470158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639356|NCT00472186|Lansoprazole|lansoprazole|mesh-list
92562590|NCT00043758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562592|NCT00050375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639357|NCT00472186|Dexlansoprazole|dexlansoprazole|mesh-list
92639358|NCT00472186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92639359|NCT00472186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639360|NCT00472186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92639361|NCT00472186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639362|NCT00472186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639363|NCT00195767|Valproic Acid|valproic acid|mesh-list
92639364|NCT00195767|Anticonvulsants|anticonvulsants|mesh-ancestor
92639365|NCT00195767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639366|NCT00195767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639367|NCT00195767|GABA Agents|gaba agents|mesh-ancestor
92639368|NCT00195767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639369|NCT00195767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639370|NCT00195767|Antimanic Agents|antimanic agents|mesh-ancestor
92639371|NCT00195767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639372|NCT00195767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639373|NCT00195767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639374|NCT00207675|Infliximab|infliximab|mesh-list
92639375|NCT00207675|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92639376|NCT00207675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639377|NCT00207675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92639378|NCT00207675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639379|NCT00207675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639380|NCT00202358|Atenolol|atenolol|mesh-list
92639381|NCT00202358|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92639382|NCT00202358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639383|NCT00202358|Sympatholytics|sympatholytics|mesh-ancestor
92639384|NCT00202358|Autonomic Agents|autonomic agents|mesh-ancestor
92046458|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92639392|NCT00202358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639393|NCT00479713|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92639394|NCT00479713|Simvastatin|simvastatin|mesh-list
92639395|NCT00479713|Ezetimibe|ezetimibe|mesh-list
92639396|NCT00479713|Calcium|calcium|mesh-list
92639397|NCT00479713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92639398|NCT00479713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639399|NCT00479713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92639400|NCT00479713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92639401|NCT00479713|Antimetabolites|antimetabolites|mesh-ancestor
92639402|NCT00479713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639403|NCT00479713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92639404|NCT00479713|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92639405|NCT00479713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639406|NCT00207753|Ivermectin|ivermectin|mesh-list
92639407|NCT00207753|Albendazole|albendazole|mesh-list
92639408|NCT00207753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92639409|NCT00207753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639410|NCT00207753|Anthelmintics|anthelmintics|mesh-ancestor
92639411|NCT00207753|Anticestodal Agents|anticestodal agents|mesh-ancestor
92639412|NCT00207753|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92639413|NCT00207753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92639414|NCT00207753|Tubulin Modulators|tubulin modulators|mesh-ancestor
92639415|NCT00207753|Antimitotic Agents|antimitotic agents|mesh-ancestor
92639416|NCT00207753|Mitosis Modulators|mitosis modulators|mesh-ancestor
92639417|NCT00207753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639418|NCT00207753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639419|NCT00202397|Riluzole|riluzole|mesh-list
92639420|NCT00202397|Anticonvulsants|anticonvulsants|mesh-ancestor
92639421|NCT00202397|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92639422|NCT00202397|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92639423|NCT00202397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639424|NCT00202397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639425|NCT00202397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639426|NCT00202397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92639427|NCT00202397|Protective Agents|protective agents|mesh-ancestor
92639428|NCT00478972|Rimonabant|rimonabant|mesh-list
92639429|NCT00478972|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92639430|NCT00478972|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92639431|NCT00478972|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92639432|NCT00478972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562593|NCT00050375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562594|NCT00153049|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92562595|NCT00153049|Telmisartan|telmisartan|mesh-list
92562596|NCT00153049|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92562597|NCT00153049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639433|NCT00478972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639434|NCT00478972|Hormones|hormones|mesh-ancestor
92639435|NCT00478972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639436|NCT00478972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639437|NCT00207792|Lenograstim|lenograstim|mesh-list
92639438|NCT00207792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92639439|NCT00207792|Immunologic Factors|immunologic factors|mesh-ancestor
92639440|NCT00207792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639441|NCT00195806|Valproic Acid|valproic acid|mesh-list
92639442|NCT00195806|Anticonvulsants|anticonvulsants|mesh-ancestor
92639443|NCT00195806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639444|NCT00195806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639445|NCT00195806|GABA Agents|gaba agents|mesh-ancestor
92639446|NCT00195806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639447|NCT00195806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639448|NCT00195806|Antimanic Agents|antimanic agents|mesh-ancestor
92639449|NCT00195806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639450|NCT00195806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639453|NCT00477529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639454|NCT00477529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92639455|NCT00477529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92639456|NCT00477529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92639457|NCT00477529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639458|NCT00472693|Bevacizumab|bevacizumab|mesh-list
92639459|NCT00472693|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92639460|NCT00472693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639461|NCT00472693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639462|NCT00472693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92639463|NCT00472693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92639464|NCT00472693|Growth Substances|growth substances|mesh-ancestor
92639465|NCT00472693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639466|NCT00472693|Growth Inhibitors|growth inhibitors|mesh-ancestor
92639467|NCT00195845|Galantamine|galantamine|mesh-list
92639468|NCT00195845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92639469|NCT00195845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639470|NCT00195845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639471|NCT00195845|Cholinergic Agents|cholinergic agents|mesh-ancestor
92639472|NCT00195845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639473|NCT00195845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639474|NCT00195845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92639475|NCT00195845|Autonomic Agents|autonomic agents|mesh-ancestor
92639476|NCT00195845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639477|NCT00195845|Nootropic Agents|nootropic agents|mesh-ancestor
92639478|NCT00202514|Valproic Acid|valproic acid|mesh-list
92639479|NCT00202514|Anticonvulsants|anticonvulsants|mesh-ancestor
92639480|NCT00202514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639481|NCT00202514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639482|NCT00202514|GABA Agents|gaba agents|mesh-ancestor
92639483|NCT00202514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639484|NCT00202514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639485|NCT00202514|Antimanic Agents|antimanic agents|mesh-ancestor
92639486|NCT00202514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639487|NCT00202514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639488|NCT00202514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639489|NCT00207831|Tegafur|tegafur|mesh-list
92639490|NCT00207831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639491|NCT00207831|Antimetabolites|antimetabolites|mesh-ancestor
92639492|NCT00207831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639493|NCT00207831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639494|NCT00195923|Clindamycin|clindamycin|mesh-list
92639495|NCT00195923|Clindamycin palmitate|clindamycin palmitate|mesh-list
92639496|NCT00195923|Clindamycin phosphate|clindamycin phosphate|mesh-list
92639497|NCT00195923|Gentamicins|gentamicins|mesh-list
92639498|NCT00195923|Ceftazidime|ceftazidime|mesh-list
92639499|NCT00195923|Ampicillin|ampicillin|mesh-list
92562598|NCT00153049|Diuretics|diuretics|mesh-ancestor
92562599|NCT00153049|Natriuretic Agents|natriuretic agents|mesh-ancestor
92562600|NCT00153049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639500|NCT00195923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92639501|NCT00195923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639502|NCT00195923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92639503|NCT00195923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639504|NCT00195923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639505|NCT00225615|Verapamil|verapamil|mesh-list
92639506|NCT00225615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92639507|NCT00225615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92639508|NCT00225615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92639509|NCT00225615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639510|NCT00225615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92639511|NCT00225615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639512|NCT00225615|Vasodilator Agents|vasodilator agents|mesh-ancestor
92639513|NCT00202553|Perindopril|perindopril|mesh-list
92639514|NCT00202553|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92639515|NCT00202553|Protease Inhibitors|protease inhibitors|mesh-ancestor
92639516|NCT00202553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639517|NCT00202553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639518|NCT00202553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639519|NCT00202592|Perindopril|perindopril|mesh-list
92639520|NCT00202592|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92639521|NCT00202592|Protease Inhibitors|protease inhibitors|mesh-ancestor
92639522|NCT00202592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639523|NCT00202592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639528|NCT00411333|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92639529|NCT00411333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639530|NCT00411333|Glucocorticoids|glucocorticoids|mesh-ancestor
92639532|NCT00411333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639533|NCT00411333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639534|NCT00411333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639535|NCT00411333|Immunologic Factors|immunologic factors|mesh-ancestor
92639536|NCT00411333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639537|NCT00411333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639538|NCT00225849|Aspirin|aspirin|mesh-list
92639539|NCT00225849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92639540|NCT00225849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639541|NCT00225849|Analgesics|analgesics|mesh-ancestor
92639542|NCT00225849|Sensory System Agents|sensory system agents|mesh-ancestor
92639543|NCT00225849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639544|NCT00225849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639545|NCT00225849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639546|NCT00225849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639547|NCT00225849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92639548|NCT00225849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92639549|NCT00225849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639550|NCT00225849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92639551|NCT00225849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92639552|NCT00225849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639553|NCT00225849|Antipyretics|antipyretics|mesh-ancestor
92639554|NCT00202787|Leucovorin|leucovorin|mesh-list
92639555|NCT00202787|Cetuximab|cetuximab|mesh-list
92639556|NCT00202787|Fluorouracil|fluorouracil|mesh-list
92639557|NCT00202787|Oxaliplatin|oxaliplatin|mesh-list
92639558|NCT00202787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639559|NCT00202787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639560|NCT00202787|Antimetabolites|antimetabolites|mesh-ancestor
92639561|NCT00202787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639562|NCT00202787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639563|NCT00202787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639564|NCT00202787|Immunologic Factors|immunologic factors|mesh-ancestor
92639565|NCT00202787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639566|NCT00202787|Antidotes|antidotes|mesh-ancestor
92639567|NCT00202787|Protective Agents|protective agents|mesh-ancestor
92639568|NCT00202787|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639569|NCT00202787|Vitamins|vitamins|mesh-ancestor
92639570|NCT00202787|Micronutrients|micronutrients|mesh-ancestor
92639571|NCT00424437|Insulin|insulin|mesh-list
92639572|NCT00424437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92562601|NCT00153049|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92562602|NCT00153049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562603|NCT00153049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562604|NCT00153049|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92562605|NCT00153049|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92562606|NCT00153088|Telmisartan|telmisartan|mesh-list
92562607|NCT00153088|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92562608|NCT00153088|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92562609|NCT00153088|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92562610|NCT00153088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562611|NCT00083070|Temozolomide|temozolomide|mesh-list
92562612|NCT00083070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92562613|NCT00083070|Alkylating Agents|alkylating agents|mesh-ancestor
91970057|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92639573|NCT00424437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92639574|NCT00424437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639575|NCT00202865|Infliximab|infliximab|mesh-list
92639576|NCT00202865|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92639577|NCT00202865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639578|NCT00202865|Dermatologic Agents|dermatologic agents|mesh-ancestor
92639579|NCT00202865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639580|NCT00202865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639581|NCT00226005|Vatalanib|vatalanib|mesh-list
92639582|NCT00226005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92639583|NCT00226005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639584|NCT00226005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639585|NCT00196352|Levonorgestrel|levonorgestrel|mesh-list
92639586|NCT00196352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92639587|NCT00196352|Contraceptive Agents|contraceptive agents|mesh-ancestor
92639588|NCT00196352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92639589|NCT00196352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639590|NCT00196352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92639591|NCT00196352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92639592|NCT00196352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92639593|NCT00226044|Omeprazole|omeprazole|mesh-list
92639594|NCT00226044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92639595|NCT00226044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639608|NCT00207948|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92639609|NCT00207948|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92639610|NCT00207948|Protease Inhibitors|protease inhibitors|mesh-ancestor
92639611|NCT00207948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639612|NCT00207948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363254|NCT02576717|Ozanimod|ozanimod|mesh-list
92639613|NCT00207948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92639614|NCT00207948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92639615|NCT00207948|Antiviral Agents|antiviral agents|mesh-ancestor
92639616|NCT00207948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639617|NCT00207948|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92639618|NCT00207948|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92639619|NCT00196391|Progesterone|progesterone|mesh-list
92639620|NCT00196391|Progestins|progestins|mesh-ancestor
92639621|NCT00196391|Hormones|hormones|mesh-ancestor
92639622|NCT00196391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639623|NCT00196391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639624|NCT00203060|Rasagiline|rasagiline|mesh-list
92639625|NCT00203060|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92639626|NCT00203060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639627|NCT00203060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562614|NCT00083070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562615|NCT00083070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562616|NCT00050414|Dexamethasone|dexamethasone|mesh-list
92562617|NCT00050414|Trabectedin|trabectedin|mesh-list
92639628|NCT00203060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92639629|NCT00203060|Protective Agents|protective agents|mesh-ancestor
92639630|NCT00203060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639631|NCT00226122|Indomethacin|indomethacin|mesh-list
92639632|NCT00226122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92639633|NCT00226122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639634|NCT00226122|Analgesics|analgesics|mesh-ancestor
92639635|NCT00226122|Sensory System Agents|sensory system agents|mesh-ancestor
92639636|NCT00226122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639637|NCT00226122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639638|NCT00226122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639639|NCT00226122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639640|NCT00226122|Gout Suppressants|gout suppressants|mesh-ancestor
92639641|NCT00226122|Tocolytic Agents|tocolytic agents|mesh-ancestor
92639642|NCT00226122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92639643|NCT00226122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92639644|NCT00226122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639645|NCT00226122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639647|NCT00196469|Anticoagulants|anticoagulants|mesh-ancestor
92639648|NCT00196469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92639649|NCT00196469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92639650|NCT00196469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639651|NCT00208065|Pseudoephedrine|pseudoephedrine|mesh-list
92639652|NCT00208065|Ephedrine|ephedrine|mesh-list
92639653|NCT00208065|Almotriptan|almotriptan|mesh-list
92639654|NCT00208065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92639655|NCT00208065|Autonomic Agents|autonomic agents|mesh-ancestor
92639656|NCT00208065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639657|NCT00208065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639658|NCT00208065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92639659|NCT00208065|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639685|NCT00203099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639686|NCT00203099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639687|NCT00226200|Omalizumab|omalizumab|mesh-list
92639688|NCT00226200|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92639689|NCT00226200|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92639690|NCT00226200|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639691|NCT00203138|Rasagiline|rasagiline|mesh-list
92639692|NCT00203138|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92639693|NCT00203138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639694|NCT00203138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639695|NCT00203138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92639696|NCT00203138|Protective Agents|protective agents|mesh-ancestor
92639697|NCT00203138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639698|NCT00196547|Montelukast|montelukast|mesh-list
92639699|NCT00196547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92639700|NCT00196547|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639701|NCT00196547|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92639702|NCT00196547|Hormone Antagonists|hormone antagonists|mesh-ancestor
92639703|NCT00196547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639704|NCT00196547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639705|NCT00196547|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92639706|NCT00196547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92639707|NCT00196547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639708|NCT00203177|Rasagiline|rasagiline|mesh-list
92639709|NCT00203177|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92639713|NCT00203177|Protective Agents|protective agents|mesh-ancestor
92639714|NCT00203177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639715|NCT00208143|Risperidone|risperidone|mesh-list
92639716|NCT00208143|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92639717|NCT00208143|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92639718|NCT00208143|Serotonin Agents|serotonin agents|mesh-ancestor
92364994|NCT03005184|Icatibant|icatibant|mesh-list
92639719|NCT00208143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639720|NCT00208143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639721|NCT00208143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562618|NCT00050414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562619|NCT00050414|Antiemetics|antiemetics|mesh-ancestor
92562620|NCT00050414|Autonomic Agents|autonomic agents|mesh-ancestor
92639722|NCT00208143|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92639723|NCT00208143|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639724|NCT00208143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639725|NCT00208143|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639726|NCT00208143|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92639727|NCT00208143|Dopamine Agents|dopamine agents|mesh-ancestor
92639728|NCT00208143|Antidepressive Agents|antidepressive agents|mesh-ancestor
92639729|NCT00196586|Interferons|interferons|mesh-list
92639730|NCT00196586|Ribavirin|ribavirin|mesh-list
92639731|NCT00196586|Interferon-alpha|interferon-alpha|mesh-list
92639732|NCT00196586|Interferon alpha-2|interferon alpha-2|mesh-list
92639733|NCT00196586|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92639734|NCT00196586|Interleukin-2|interleukin-2|mesh-list
92639735|NCT00196586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639736|NCT00196586|Antiviral Agents|antiviral agents|mesh-ancestor
92639737|NCT00196586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639738|NCT00196586|Antimetabolites|antimetabolites|mesh-ancestor
92639739|NCT00196586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639740|NCT00196586|Immunologic Factors|immunologic factors|mesh-ancestor
92639741|NCT00196586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639742|NCT00196586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92639743|NCT00196586|Analgesics|analgesics|mesh-ancestor
92639744|NCT00196586|Sensory System Agents|sensory system agents|mesh-ancestor
92639745|NCT00196586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639746|NCT00226317|Aripiprazole|aripiprazole|mesh-list
92639747|NCT00226317|Antidepressive Agents|antidepressive agents|mesh-ancestor
92639748|NCT00226317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639749|NCT00226317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92639750|NCT00226317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639751|NCT00226317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639752|NCT00226317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639753|NCT00226317|Dopamine Agonists|dopamine agonists|mesh-ancestor
92639754|NCT00226317|Dopamine Agents|dopamine agents|mesh-ancestor
92639755|NCT00226317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639756|NCT00226317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639757|NCT00226317|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92639758|NCT00226317|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92639759|NCT00226317|Serotonin Agents|serotonin agents|mesh-ancestor
92639760|NCT00226317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92639761|NCT00226317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92639762|NCT00226317|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92639763|NCT00226317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92639764|NCT00226356|Betaine|betaine|mesh-list
92639765|NCT00226356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639766|NCT00226356|Lipotropic Agents|lipotropic agents|mesh-ancestor
92639767|NCT00226356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92639768|NCT00226356|Antimetabolites|antimetabolites|mesh-ancestor
92639769|NCT00226356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639770|NCT00226356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92639771|NCT00208182|Risperidone|risperidone|mesh-list
92639772|NCT00208182|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92639773|NCT00208182|Serotonin Agents|serotonin agents|mesh-ancestor
92639774|NCT00208182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639775|NCT00208182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639776|NCT00208182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639777|NCT00208182|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92639778|NCT00208182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639779|NCT00208182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046865|NCT04854551|Naltrexone|naltrexone|mesh-list
92639797|NCT00208221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639798|NCT00208221|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92639799|NCT00208221|Protease Inhibitors|protease inhibitors|mesh-ancestor
92639800|NCT00208221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639801|NCT00196625|Ritonavir|ritonavir|mesh-list
92639802|NCT00196625|Amprenavir|amprenavir|mesh-list
92639803|NCT00196625|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92639804|NCT00196625|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92639805|NCT00196625|Protease Inhibitors|protease inhibitors|mesh-ancestor
92639806|NCT00196625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639807|NCT00196625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562621|NCT00050414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639808|NCT00196625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92639809|NCT00196625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92639810|NCT00196625|Antiviral Agents|antiviral agents|mesh-ancestor
92639811|NCT00196625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639812|NCT00196625|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92639813|NCT00196625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92639814|NCT00196625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92639815|NCT00196625|Antitubercular Agents|antitubercular agents|mesh-ancestor
92639816|NCT00196625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92639817|NCT00226434|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92639818|NCT00226434|Antiviral Agents|antiviral agents|mesh-ancestor
92639819|NCT00226434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639820|NCT00208260|Leucovorin|leucovorin|mesh-list
92639821|NCT00208260|Fluorouracil|fluorouracil|mesh-list
92639822|NCT00208260|Oxaliplatin|oxaliplatin|mesh-list
92639823|NCT00208260|Folfirinox|folfirinox|mesh-list
92639824|NCT00208260|Antimetabolites|antimetabolites|mesh-ancestor
92639825|NCT00208260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639826|NCT00208260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639827|NCT00208260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639828|NCT00208260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639829|NCT00208260|Immunologic Factors|immunologic factors|mesh-ancestor
92639830|NCT00208260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639831|NCT00208260|Antidotes|antidotes|mesh-ancestor
92639832|NCT00208260|Protective Agents|protective agents|mesh-ancestor
92639833|NCT00208260|Vitamin B Complex|vitamin b complex|mesh-ancestor
92639834|NCT00208260|Vitamins|vitamins|mesh-ancestor
92639835|NCT00208260|Micronutrients|micronutrients|mesh-ancestor
92639836|NCT00226473|Dacarbazine|dacarbazine|mesh-list
92639837|NCT00226473|Vindesine|vindesine|mesh-list
92046934|NCT02168816|Aztreonam|aztreonam|mesh-list
92639840|NCT00226473|Alkylating Agents|alkylating agents|mesh-ancestor
92639841|NCT00226473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639842|NCT00226473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92639843|NCT00226473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92639844|NCT00226473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92639845|NCT00226473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92639847|NCT00208299|Regadenoson|regadenoson|mesh-list
92639848|NCT00208299|Analgesics|analgesics|mesh-ancestor
92639849|NCT00208299|Sensory System Agents|sensory system agents|mesh-ancestor
92639850|NCT00208299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639851|NCT00208299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639852|NCT00208299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92639853|NCT00208299|Vasodilator Agents|vasodilator agents|mesh-ancestor
92639854|NCT00208299|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92639855|NCT00208299|Purinergic Agonists|purinergic agonists|mesh-ancestor
92639856|NCT00208299|Purinergic Agents|purinergic agents|mesh-ancestor
92639857|NCT00208299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639858|NCT00208299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639859|NCT00208299|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92639860|NCT00196664|Paroxetine|paroxetine|mesh-list
92639861|NCT00196664|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92639862|NCT00196664|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92639863|NCT00196664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92639864|NCT00196664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639865|NCT00196664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639866|NCT00196664|Serotonin Agents|serotonin agents|mesh-ancestor
92639867|NCT00196664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365192|NCT02979132|Iron|iron|mesh-list
92639868|NCT00196664|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92639869|NCT00196664|Antidepressive Agents|antidepressive agents|mesh-ancestor
92639870|NCT00196664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639871|NCT00196664|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92639872|NCT00196664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92639873|NCT00196664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639874|NCT00196703|Memantine|memantine|mesh-list
92639875|NCT00196703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92639876|NCT00196703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92639877|NCT00196703|Dopamine Agents|dopamine agents|mesh-ancestor
92639878|NCT00196703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639879|NCT00196703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639880|NCT00196703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639881|NCT00196703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92562622|NCT00050414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562623|NCT00050414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562624|NCT00050414|Glucocorticoids|glucocorticoids|mesh-ancestor
92562625|NCT00050414|Hormones|hormones|mesh-ancestor
91970078|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92639882|NCT00196703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92639883|NCT00413322|Fluorouracil|fluorouracil|mesh-list
92639884|NCT00413322|Belinostat|belinostat|mesh-list
92639885|NCT00413322|Antimetabolites|antimetabolites|mesh-ancestor
92639886|NCT00413322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639887|NCT00413322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639888|NCT00413322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639889|NCT00413322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639890|NCT00413322|Immunologic Factors|immunologic factors|mesh-ancestor
92639891|NCT00413322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639892|NCT00413322|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92639893|NCT00413322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639894|NCT00413361|Hydroxychloroquine|hydroxychloroquine|mesh-list
92639895|NCT00413361|Antimalarials|antimalarials|mesh-ancestor
92639896|NCT00413361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92639897|NCT00413361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92639898|NCT00413361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639899|NCT00413361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639900|NCT00413361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639901|NCT00413361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639902|NCT00410657|Prednisone|prednisone|mesh-list
92639903|NCT00410657|Methylprednisolone|methylprednisolone|mesh-list
92639904|NCT00410657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92639905|NCT00410657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92639906|NCT00410657|Prednisolone|prednisolone|mesh-list
92639907|NCT00410657|Prednisolone acetate|prednisolone acetate|mesh-list
92639933|NCT00410696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639934|NCT00226512|Alemtuzumab|alemtuzumab|mesh-list
92639935|NCT00226512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639936|NCT00226512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639937|NCT00410735|Pranlukast|pranlukast|mesh-list
92639938|NCT00410735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92639939|NCT00410735|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639940|NCT00410735|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92639941|NCT00410735|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704674|NCT01199978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639942|NCT00410735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639943|NCT00410735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639945|NCT00203372|Bevacizumab|bevacizumab|mesh-list
92639946|NCT00203372|Docetaxel|docetaxel|mesh-list
92639947|NCT00203372|Doxorubicin|doxorubicin|mesh-list
92639948|NCT00203372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639949|NCT00203372|Immunologic Factors|immunologic factors|mesh-ancestor
92639950|NCT00203372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639951|NCT00203372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639952|NCT00203372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92639953|NCT00203372|Alkylating Agents|alkylating agents|mesh-ancestor
92639954|NCT00203372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639955|NCT00203372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047064|NCT04373369|Atezolizumab|atezolizumab|mesh-list
92639959|NCT00203372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92639960|NCT00203372|Growth Substances|growth substances|mesh-ancestor
92639961|NCT00203372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92639962|NCT00203372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92639963|NCT00203372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92639964|NCT00203372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92639965|NCT00203372|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92639966|NCT00203372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92639967|NCT00203372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92639968|NCT00203372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639970|NCT00226551|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92639971|NCT00226551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92639972|NCT00226551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92639973|NCT00226551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639974|NCT00226551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639975|NCT00226551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562626|NCT00050414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562627|NCT00050414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92639976|NCT00226551|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92639977|NCT00226551|Autonomic Agents|autonomic agents|mesh-ancestor
92639978|NCT00226551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639979|NCT00226551|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92639980|NCT00226551|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639981|NCT00226551|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92639982|NCT00226551|Sympathomimetics|sympathomimetics|mesh-ancestor
92639983|NCT00226551|Protective Agents|protective agents|mesh-ancestor
92639984|NCT00196859|Ibandronic Acid|ibandronic acid|mesh-list
92639985|NCT00196859|Capecitabine|capecitabine|mesh-list
92639986|NCT00196859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639987|NCT00196859|Antimetabolites|antimetabolites|mesh-ancestor
92639988|NCT00196859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639989|NCT00196859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639990|NCT00196859|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92639991|NCT00196859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639992|NCT00208533|Aripiprazole|aripiprazole|mesh-list
92639993|NCT00208533|Antidepressive Agents|antidepressive agents|mesh-ancestor
92639994|NCT00208533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639995|NCT00208533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92639996|NCT00208533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92639997|NCT00208533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639998|NCT00208533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639999|NCT00208533|Dopamine Agonists|dopamine agonists|mesh-ancestor
92640000|NCT00208533|Dopamine Agents|dopamine agents|mesh-ancestor
92640001|NCT00208533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640002|NCT00208533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640003|NCT00208533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92640004|NCT00208533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92640005|NCT00208533|Serotonin Agents|serotonin agents|mesh-ancestor
92640006|NCT00208533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92640007|NCT00208533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92640008|NCT00208533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92640009|NCT00208533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92640010|NCT00203450|Zonisamide|zonisamide|mesh-list
92640011|NCT00203450|Anticonvulsants|anticonvulsants|mesh-ancestor
92640012|NCT00203450|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92640013|NCT00203450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640014|NCT00203450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640015|NCT00203450|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92640016|NCT00203450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640017|NCT00226668|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92640018|NCT00226668|Hormones|hormones|mesh-ancestor
92640019|NCT00226668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640020|NCT00226668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640021|NCT00208572|Citalopram|citalopram|mesh-list
92640022|NCT00208572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92640023|NCT00208572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92047112|NCT05398913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640025|NCT00208572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640026|NCT00208572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640027|NCT00208572|Serotonin Agents|serotonin agents|mesh-ancestor
92640028|NCT00208572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640029|NCT00208572|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92640030|NCT00208572|Antidepressive Agents|antidepressive agents|mesh-ancestor
92640031|NCT00208572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640032|NCT00226707|Pimecrolimus|pimecrolimus|mesh-list
92640033|NCT00226707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92640034|NCT00226707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640035|NCT00226707|Analgesics|analgesics|mesh-ancestor
92640036|NCT00226707|Sensory System Agents|sensory system agents|mesh-ancestor
92640037|NCT00226707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640038|NCT00226707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640039|NCT00226707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640040|NCT00226707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640041|NCT00226707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92640042|NCT00226707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562628|NCT00050414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562629|NCT00050414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640043|NCT00226707|Immunologic Factors|immunologic factors|mesh-ancestor
92640044|NCT00226707|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92640045|NCT00226707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640046|NCT00226707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640047|NCT00203528|Valproic Acid|valproic acid|mesh-list
92640048|NCT00203528|Risperidone|risperidone|mesh-list
92640049|NCT00203528|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92640050|NCT00203528|Serotonin Agents|serotonin agents|mesh-ancestor
92640051|NCT00203528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640052|NCT00203528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640053|NCT00203528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640054|NCT00203528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92640055|NCT00203528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640056|NCT00203528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640057|NCT00203528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640058|NCT00203528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92640059|NCT00203528|Dopamine Agents|dopamine agents|mesh-ancestor
92640060|NCT00203528|Anticonvulsants|anticonvulsants|mesh-ancestor
92640061|NCT00203528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640062|NCT00203528|GABA Agents|gaba agents|mesh-ancestor
92640063|NCT00203528|Antimanic Agents|antimanic agents|mesh-ancestor
92640064|NCT00208611|Vitamins|vitamins|mesh-list
92640065|NCT00208611|Vitamin B 12|vitamin b 12|mesh-list
92640066|NCT00208611|Hydroxocobalamin|hydroxocobalamin|mesh-list
92640067|NCT00208611|Vitamin B Complex|vitamin b complex|mesh-list
92640068|NCT00208611|Micronutrients|micronutrients|mesh-ancestor
92640069|NCT00208611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640070|NCT00208611|Hematinics|hematinics|mesh-ancestor
92640071|NCT00203567|Carbamazepine|carbamazepine|mesh-list
92640072|NCT00203567|Anticonvulsants|anticonvulsants|mesh-ancestor
92640073|NCT00203567|Antimanic Agents|antimanic agents|mesh-ancestor
92640074|NCT00203567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640075|NCT00203567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640076|NCT00203567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640077|NCT00203567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640078|NCT00203567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640079|NCT00203567|Analgesics|analgesics|mesh-ancestor
92640080|NCT00203567|Sensory System Agents|sensory system agents|mesh-ancestor
92640081|NCT00203567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640082|NCT00203567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92640083|NCT00203567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640084|NCT00203567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640085|NCT00203567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92640086|NCT00203567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92640087|NCT00226746|Paclitaxel|paclitaxel|mesh-list
92365367|NCT04768764|Anesthetics|anesthetics|mesh-list
92640088|NCT00226746|Gemcitabine|gemcitabine|mesh-list
92640089|NCT00226746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92640090|NCT00226746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640091|NCT00226746|Tubulin Modulators|tubulin modulators|mesh-ancestor
92640092|NCT00226746|Antimitotic Agents|antimitotic agents|mesh-ancestor
92640093|NCT00226746|Mitosis Modulators|mitosis modulators|mesh-ancestor
92640094|NCT00226746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640095|NCT00226746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92640096|NCT00226746|Antimetabolites|antimetabolites|mesh-ancestor
92640097|NCT00203606|Interferons|interferons|mesh-list
92640100|NCT00203606|Interferon alpha-2|interferon alpha-2|mesh-list
92640101|NCT00203606|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92640102|NCT00203606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640103|NCT00203606|Antiviral Agents|antiviral agents|mesh-ancestor
92640104|NCT00203606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640105|NCT00203606|Antimetabolites|antimetabolites|mesh-ancestor
92640106|NCT00203606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640107|NCT00203606|Immunologic Factors|immunologic factors|mesh-ancestor
92640108|NCT00203606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640109|NCT00203684|Flunisolide|flunisolide|mesh-list
92640110|NCT00203684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640111|NCT00203684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92640112|NCT00203684|Respiratory System Agents|respiratory system agents|mesh-ancestor
92640113|NCT00226785|Dexmedetomidine|dexmedetomidine|mesh-list
92640114|NCT00226785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92640115|NCT00226785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562630|NCT00050414|Alkylating Agents|alkylating agents|mesh-ancestor
91989528|NCT04643249|Analgesics|analgesics|mesh-ancestor
92640116|NCT00226785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640117|NCT00226785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640118|NCT00226785|Analgesics|analgesics|mesh-ancestor
92640119|NCT00226785|Sensory System Agents|sensory system agents|mesh-ancestor
92640120|NCT00226785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640121|NCT00226785|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92640122|NCT00226785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92640123|NCT00226785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92640124|NCT00226785|Adrenergic Agents|adrenergic agents|mesh-ancestor
92640125|NCT00226785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640126|NCT00226785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640127|NCT00197132|Rosiglitazone|rosiglitazone|mesh-list
92640128|NCT00197132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640129|NCT00197132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640130|NCT00226824|Galantamine|galantamine|mesh-list
92640131|NCT00226824|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92640132|NCT00226824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640133|NCT00226824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640134|NCT00226824|Cholinergic Agents|cholinergic agents|mesh-ancestor
92640135|NCT00226824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640136|NCT00226824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640137|NCT00226824|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92640138|NCT00226824|Autonomic Agents|autonomic agents|mesh-ancestor
92640139|NCT00226824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640140|NCT00226824|Nootropic Agents|nootropic agents|mesh-ancestor
92640142|NCT00197249|Immunologic Factors|immunologic factors|mesh-ancestor
92640143|NCT00197249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640144|NCT00203723|Risperidone|risperidone|mesh-list
92640145|NCT00203723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92640146|NCT00203723|Serotonin Agents|serotonin agents|mesh-ancestor
92640147|NCT00203723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640148|NCT00203723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640149|NCT00203723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640150|NCT00203723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92640151|NCT00203723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640152|NCT00203723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640153|NCT00203723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640154|NCT00203723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92640155|NCT00203723|Dopamine Agents|dopamine agents|mesh-ancestor
92640156|NCT00226902|Chrysarobin|chrysarobin|mesh-list
92640157|NCT00226902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92640158|NCT00226902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640159|NCT00226902|Analgesics|analgesics|mesh-ancestor
92640160|NCT00226902|Sensory System Agents|sensory system agents|mesh-ancestor
92640161|NCT00226902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640162|NCT00226902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640163|NCT00226902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640164|NCT00226902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640165|NCT00203762|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92640166|NCT00203762|Antiviral Agents|antiviral agents|mesh-ancestor
92640167|NCT00203762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640168|NCT00226980|Thalidomide|thalidomide|mesh-list
92640169|NCT00226980|Capecitabine|capecitabine|mesh-list
92640170|NCT00226980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92640171|NCT00226980|Antimetabolites|antimetabolites|mesh-ancestor
92047259|NCT02188784|Iron|iron|mesh-list
92640173|NCT00226980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640174|NCT00226980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640175|NCT00226980|Immunologic Factors|immunologic factors|mesh-ancestor
92640176|NCT00226980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640177|NCT00226980|Leprostatic Agents|leprostatic agents|mesh-ancestor
92640178|NCT00226980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92640179|NCT00226980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640180|NCT00226980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92640181|NCT00226980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92640182|NCT00226980|Growth Substances|growth substances|mesh-ancestor
92640183|NCT00226980|Growth Inhibitors|growth inhibitors|mesh-ancestor
92640184|NCT00203801|Artesunate|artesunate|mesh-list
92640185|NCT00203801|Lumefantrine|lumefantrine|mesh-list
92640186|NCT00203801|Artemether|artemether|mesh-list
92640187|NCT00203801|Pyrimethamine|pyrimethamine|mesh-list
92640188|NCT00203801|Sulfadoxine|sulfadoxine|mesh-list
91970087|NCT02449369|Acetaminophen|acetaminophen|mesh-list
92640189|NCT00203801|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92640190|NCT00203801|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92640191|NCT00203801|Antimalarials|antimalarials|mesh-ancestor
92640192|NCT00203801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92640193|NCT00203801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92640194|NCT00203801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640195|NCT00203801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640196|NCT00203801|Antiviral Agents|antiviral agents|mesh-ancestor
92640197|NCT00203801|Schistosomicides|schistosomicides|mesh-ancestor
92640198|NCT00203801|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92640199|NCT00203801|Anthelmintics|anthelmintics|mesh-ancestor
92640200|NCT00203801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92640201|NCT00203801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640202|NCT00203801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640203|NCT00203801|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92640204|NCT00197327|Bupivacaine|bupivacaine|mesh-list
92640205|NCT00197327|Anesthetics, Local|anesthetics, local|mesh-ancestor
92640206|NCT00197327|Anesthetics|anesthetics|mesh-ancestor
92640207|NCT00197327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640208|NCT00197327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640209|NCT00197327|Sensory System Agents|sensory system agents|mesh-ancestor
92640210|NCT00197327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640211|NCT00227097|Anticoagulants|anticoagulants|mesh-list
92640212|NCT00208923|Cyclophosphamide|cyclophosphamide|mesh-list
92640213|NCT00208923|Busulfan|busulfan|mesh-list
92640214|NCT00208923|Fludarabine|fludarabine|mesh-list
92640215|NCT00208923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640216|NCT00208923|Immunologic Factors|immunologic factors|mesh-ancestor
92640217|NCT00208923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640218|NCT00208923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640219|NCT00208923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640220|NCT00208923|Alkylating Agents|alkylating agents|mesh-ancestor
92640221|NCT00208923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640222|NCT00208923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640223|NCT00208923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92640224|NCT00227136|Serotonin|serotonin|mesh-list
92640225|NCT00227136|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92640226|NCT00227136|Serotonin Agents|serotonin agents|mesh-ancestor
92640227|NCT00227136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640228|NCT00227136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640229|NCT00227136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640230|NCT00203957|Istradefylline|istradefylline|mesh-list
92640231|NCT00203957|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92640232|NCT00203957|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92640233|NCT00203957|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92640234|NCT00203957|Purinergic Agents|purinergic agents|mesh-ancestor
92640235|NCT00203957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750771|NCT05936229|Interferon-beta|interferon-beta|mesh-list
92640236|NCT00203957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640237|NCT00203957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640238|NCT00197444|Nedaplatin|nedaplatin|mesh-list
92640239|NCT00197444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640241|NCT00204074|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92640242|NCT00204074|Estradiol|estradiol|mesh-list
92640243|NCT00204074|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92640244|NCT00204074|Estrogens|estrogens|mesh-ancestor
92640245|NCT00204074|Hormones|hormones|mesh-ancestor
92640246|NCT00204074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640248|NCT00204074|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92640249|NCT00204074|Contraceptive Agents|contraceptive agents|mesh-ancestor
92640250|NCT00204074|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92640251|NCT00204074|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92640252|NCT00227292|Escitalopram|escitalopram|mesh-list
92640253|NCT00227292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92640254|NCT00227292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92640255|NCT00227292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640256|NCT00227292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640257|NCT00227292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640258|NCT00227292|Serotonin Agents|serotonin agents|mesh-ancestor
92640259|NCT00227292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640261|NCT00197483|Dopamine Agonists|dopamine agonists|mesh-ancestor
92640262|NCT00197483|Dopamine Agents|dopamine agents|mesh-ancestor
92562631|NCT00050414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562632|NCT00153127|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92562633|NCT00153127|Laxatives|laxatives|mesh-ancestor
92562634|NCT00153127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562635|NCT00083109|Suramin|suramin|mesh-list
92562636|NCT00083109|Fluorouracil|fluorouracil|mesh-list
92562637|NCT00083109|Antimetabolites|antimetabolites|mesh-ancestor
92640263|NCT00197483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640264|NCT00197483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640265|NCT00197483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640266|NCT00230529|Infliximab|infliximab|mesh-list
92640267|NCT00230529|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92640268|NCT00230529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640269|NCT00230529|Dermatologic Agents|dermatologic agents|mesh-ancestor
92640270|NCT00230529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640271|NCT00230529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640272|NCT00230568|Donepezil|donepezil|mesh-list
92640273|NCT00230568|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92640274|NCT00230568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640275|NCT00230568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640276|NCT00230568|Cholinergic Agents|cholinergic agents|mesh-ancestor
92640277|NCT00230568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640278|NCT00230568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640279|NCT00230568|Nootropic Agents|nootropic agents|mesh-ancestor
92640280|NCT00227331|Amoxicillin|amoxicillin|mesh-list
92640281|NCT00227331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92640282|NCT00227331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640283|NCT00197561|Selenium|selenium|mesh-list
92640284|NCT00197561|Antioxidants|antioxidants|mesh-ancestor
92640285|NCT00197561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640286|NCT00197561|Protective Agents|protective agents|mesh-ancestor
92640287|NCT00197561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640288|NCT00197561|Trace Elements|trace elements|mesh-ancestor
92640289|NCT00197561|Micronutrients|micronutrients|mesh-ancestor
92640290|NCT00227409|Edetic Acid|edetic acid|mesh-list
92640291|NCT00227409|Calcium|calcium|mesh-list
92640292|NCT00227409|Pentetic Acid|pentetic acid|mesh-list
92640293|NCT00227409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92640294|NCT00227409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640295|NCT00227409|Anticoagulants|anticoagulants|mesh-ancestor
92640296|NCT00227409|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92640297|NCT00227409|Chelating Agents|chelating agents|mesh-ancestor
92640298|NCT00227409|Sequestering Agents|sequestering agents|mesh-ancestor
92640299|NCT00227409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640300|NCT00227409|Antidotes|antidotes|mesh-ancestor
92640301|NCT00227409|Protective Agents|protective agents|mesh-ancestor
92640302|NCT00227409|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92640303|NCT00197639|Ritonavir|ritonavir|mesh-list
92640304|NCT00197639|Indinavir|indinavir|mesh-list
92640305|NCT00197639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92640306|NCT00197639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92640307|NCT00197639|Protease Inhibitors|protease inhibitors|mesh-ancestor
92640308|NCT00197639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640309|NCT00197639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640310|NCT00197639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92640311|NCT00197639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92640312|NCT00197639|Antiviral Agents|antiviral agents|mesh-ancestor
92640313|NCT00197639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640314|NCT00197639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92640315|NCT00197639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92640316|NCT00227448|Phenylephrine|phenylephrine|mesh-list
92640317|NCT00227448|Oxymetazoline|oxymetazoline|mesh-list
92640318|NCT00227448|Midodrine|midodrine|mesh-list
92640319|NCT00227448|Norepinephrine|norepinephrine|mesh-list
92640320|NCT00227448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92640321|NCT00227448|Mydriatics|mydriatics|mesh-ancestor
92640337|NCT00204191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640338|NCT00204191|Immunologic Factors|immunologic factors|mesh-ancestor
92640339|NCT00204191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640340|NCT00204191|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92640341|NCT00204191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562638|NCT00083109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640342|NCT00204191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640343|NCT00204230|Mycophenolic Acid|mycophenolic acid|mesh-list
92640344|NCT00204230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92640345|NCT00204230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640346|NCT00204230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92640347|NCT00204230|Antitubercular Agents|antitubercular agents|mesh-ancestor
92640348|NCT00204230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92640349|NCT00204230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640350|NCT00204230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640351|NCT00204230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640352|NCT00204269|Testosterone|testosterone|mesh-list
92640353|NCT00204269|Androgens|androgens|mesh-ancestor
92640354|NCT00204269|Hormones|hormones|mesh-ancestor
92640355|NCT00204269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750772|NCT05936229|Interferon beta-1a|interferon beta-1a|mesh-list
92640356|NCT00204269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640357|NCT00197756|Vitamins|vitamins|mesh-list
92640358|NCT00197756|Vitamin A|vitamin a|mesh-list
92640359|NCT00197756|Retinol palmitate|retinol palmitate|mesh-list
92640360|NCT00197756|Micronutrients|micronutrients|mesh-ancestor
92640361|NCT00197756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640362|NCT00197756|Antioxidants|antioxidants|mesh-ancestor
92640363|NCT00197756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640364|NCT00197756|Protective Agents|protective agents|mesh-ancestor
92640365|NCT00197756|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92640366|NCT00197756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640367|NCT00227565|Carboplatin|carboplatin|mesh-list
92640368|NCT00227565|Pemetrexed|pemetrexed|mesh-list
92640369|NCT00227565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640370|NCT00227565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640371|NCT00227565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640372|NCT00227565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92640373|NCT00227565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92640374|NCT00204308|Tenofovir|tenofovir|mesh-list
92640375|NCT00204308|Emtricitabine|emtricitabine|mesh-list
92640376|NCT00204308|Antiviral Agents|antiviral agents|mesh-ancestor
92640377|NCT00204308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640378|NCT00204308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92640379|NCT00204308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92640380|NCT00204308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640384|NCT00204347|Risperidone|risperidone|mesh-list
92640385|NCT00204347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92640386|NCT00204347|Serotonin Agents|serotonin agents|mesh-ancestor
92640387|NCT00204347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640388|NCT00204347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640389|NCT00204347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640390|NCT00204347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92640391|NCT00204347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640392|NCT00204347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640393|NCT00204347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640394|NCT00204347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92640395|NCT00204347|Dopamine Agents|dopamine agents|mesh-ancestor
92640396|NCT00227682|Ascorbic Acid|ascorbic acid|mesh-list
92640397|NCT00227682|Thalidomide|thalidomide|mesh-list
92640398|NCT00227682|Dexamethasone|dexamethasone|mesh-list
92640399|NCT00227682|Arsenic Trioxide|arsenic trioxide|mesh-list
92640400|NCT00227682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640401|NCT00227682|Antiemetics|antiemetics|mesh-ancestor
92640402|NCT00227682|Autonomic Agents|autonomic agents|mesh-ancestor
92640403|NCT00227682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640404|NCT00227682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640405|NCT00227682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640406|NCT00227682|Glucocorticoids|glucocorticoids|mesh-ancestor
92640408|NCT00227682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640409|NCT00227682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92640410|NCT00227682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640411|NCT00227682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640412|NCT00227682|Immunologic Factors|immunologic factors|mesh-ancestor
92640413|NCT00227682|Leprostatic Agents|leprostatic agents|mesh-ancestor
92640414|NCT00227682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92640415|NCT00227682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640416|NCT00227682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92562639|NCT00083109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562640|NCT00083109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562641|NCT00083109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640417|NCT00227682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92640418|NCT00227682|Growth Substances|growth substances|mesh-ancestor
92640419|NCT00227682|Growth Inhibitors|growth inhibitors|mesh-ancestor
92640420|NCT00227682|Antioxidants|antioxidants|mesh-ancestor
92640421|NCT00227682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640422|NCT00227682|Protective Agents|protective agents|mesh-ancestor
92640423|NCT00227682|Vitamins|vitamins|mesh-ancestor
92640424|NCT00227682|Micronutrients|micronutrients|mesh-ancestor
92640425|NCT00230763|Timolol|timolol|mesh-list
92640426|NCT00230763|Latanoprost|latanoprost|mesh-list
92640427|NCT00230763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92640428|NCT00230763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92640429|NCT00230763|Adrenergic Agents|adrenergic agents|mesh-ancestor
92640430|NCT00230763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640431|NCT00230763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640432|NCT00230763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640433|NCT00230763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92640434|NCT00230763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92640435|NCT00230763|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92640436|NCT00230763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92640437|NCT00204386|Topiramate|topiramate|mesh-list
92640438|NCT00204386|Anticonvulsants|anticonvulsants|mesh-ancestor
92640439|NCT00204386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640440|NCT00204386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640441|NCT04721964|Ferrous fumarate|ferrous fumarate|mesh-list
92640442|NCT04721964|Trace Elements|trace elements|mesh-ancestor
92640443|NCT04721964|Micronutrients|micronutrients|mesh-ancestor
92640444|NCT04721964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640445|NCT00197834|Valproic Acid|valproic acid|mesh-list
92640446|NCT00197834|Anticonvulsants|anticonvulsants|mesh-ancestor
92640447|NCT00197834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640448|NCT00197834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640449|NCT00197834|GABA Agents|gaba agents|mesh-ancestor
92640450|NCT00197834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640451|NCT00197834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640452|NCT00197834|Antimanic Agents|antimanic agents|mesh-ancestor
92640453|NCT00197834|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640454|NCT00197834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640456|NCT00197912|Celecoxib|celecoxib|mesh-list
92640457|NCT00197912|Cyclophosphamide|cyclophosphamide|mesh-list
92640458|NCT00197912|Interleukin-2|interleukin-2|mesh-list
92640459|NCT00197912|Immunologic Factors|immunologic factors|mesh-ancestor
92640460|NCT00197912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640461|NCT00197912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640462|NCT00197912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365740|NCT00596622|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640463|NCT00197912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640464|NCT00197912|Alkylating Agents|alkylating agents|mesh-ancestor
92640465|NCT00197912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640466|NCT00197912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640467|NCT00197912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92640468|NCT00197912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92640469|NCT00197912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640470|NCT00197912|Analgesics|analgesics|mesh-ancestor
92640471|NCT00197912|Sensory System Agents|sensory system agents|mesh-ancestor
92640472|NCT00197912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640473|NCT00197912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640474|NCT00197912|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92640475|NCT00197912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92640476|NCT00197912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640477|NCT02962323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92640478|NCT02962323|Calcium|calcium|mesh-list
92640479|NCT02962323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92640480|NCT02962323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640481|NCT02962323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92640482|NCT02962323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92640483|NCT02962323|Antimetabolites|antimetabolites|mesh-ancestor
92640484|NCT02962323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640485|NCT02962323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92562642|NCT00083109|Immunologic Factors|immunologic factors|mesh-ancestor
92562643|NCT00083109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640486|NCT02962323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92640487|NCT02962323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640488|NCT00204503|Valproic Acid|valproic acid|mesh-list
92640489|NCT00204503|Anticonvulsants|anticonvulsants|mesh-ancestor
92640490|NCT00204503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640491|NCT00204503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640492|NCT00204503|GABA Agents|gaba agents|mesh-ancestor
92640493|NCT00204503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640494|NCT00204503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640495|NCT00204503|Antimanic Agents|antimanic agents|mesh-ancestor
92640496|NCT00204503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640497|NCT00204503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640498|NCT00204503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640499|NCT00204542|Diclofenac|diclofenac|mesh-list
92640500|NCT00204542|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92640501|NCT00204542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640502|NCT00204542|Analgesics|analgesics|mesh-ancestor
92640503|NCT00204542|Sensory System Agents|sensory system agents|mesh-ancestor
92640504|NCT00204542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640505|NCT00204542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640506|NCT00204542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640507|NCT00204542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640508|NCT00204542|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92640509|NCT00204542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640510|NCT00204542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640511|NCT00230958|Interferons|interferons|mesh-list
92640512|NCT00230958|Ribavirin|ribavirin|mesh-list
92640513|NCT00230958|Interferon-alpha|interferon-alpha|mesh-list
92640514|NCT00230958|Interferon alpha-2|interferon alpha-2|mesh-list
92640515|NCT00230958|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92640516|NCT00230958|Taribavirin|taribavirin|mesh-list
92640517|NCT00230958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640518|NCT00230958|Antiviral Agents|antiviral agents|mesh-ancestor
92640519|NCT00230958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640520|NCT00230958|Antimetabolites|antimetabolites|mesh-ancestor
92640521|NCT00230958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640522|NCT00230958|Immunologic Factors|immunologic factors|mesh-ancestor
92640523|NCT00230958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640524|NCT00227955|Imipramine|imipramine|mesh-list
92640525|NCT00227955|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92640526|NCT00227955|Antidepressive Agents|antidepressive agents|mesh-ancestor
92640527|NCT00227955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640533|NCT00227955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640534|NCT00227955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640535|NCT00228033|Calcium Carbonate|calcium carbonate|mesh-list
92640536|NCT00228033|Calcium|calcium|mesh-list
92640537|NCT00228033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92640538|NCT00228033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640539|NCT00228033|Antacids|antacids|mesh-ancestor
92640540|NCT00228033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640542|NCT00230997|Galantamine|galantamine|mesh-list
92640543|NCT00230997|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92640544|NCT00230997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640545|NCT00230997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640546|NCT00230997|Cholinergic Agents|cholinergic agents|mesh-ancestor
92640547|NCT00230997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640548|NCT00230997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640549|NCT00230997|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92640550|NCT00230997|Autonomic Agents|autonomic agents|mesh-ancestor
92640551|NCT00230997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640552|NCT00230997|Nootropic Agents|nootropic agents|mesh-ancestor
92640553|NCT00204581|Aldesleukin|aldesleukin|mesh-list
92640554|NCT00204581|Interleukin-2|interleukin-2|mesh-list
92640555|NCT00204581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640556|NCT00204581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640557|NCT00204581|Analgesics|analgesics|mesh-ancestor
92640558|NCT00204581|Sensory System Agents|sensory system agents|mesh-ancestor
92640559|NCT00204581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640560|NCT00204581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640561|NCT00204581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92640562|NCT00204581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92640563|NCT00204581|Antiviral Agents|antiviral agents|mesh-ancestor
92562644|NCT00083109|Antinematodal Agents|antinematodal agents|mesh-ancestor
92562645|NCT00083109|Anthelmintics|anthelmintics|mesh-ancestor
92562646|NCT00083109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92640564|NCT00204581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640565|NCT00231075|Paclitaxel|paclitaxel|mesh-list
92640566|NCT00231075|Carboplatin|carboplatin|mesh-list
92640567|NCT00231075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92640568|NCT00231075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640569|NCT00231075|Tubulin Modulators|tubulin modulators|mesh-ancestor
92640570|NCT00231075|Antimitotic Agents|antimitotic agents|mesh-ancestor
92640571|NCT00231075|Mitosis Modulators|mitosis modulators|mesh-ancestor
92640572|NCT00231075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640573|NCT00198146|Daclizumab|daclizumab|mesh-list
92640574|NCT00198146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640575|NCT00198146|Immunologic Factors|immunologic factors|mesh-ancestor
92640576|NCT00198146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640577|NCT00204620|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92640578|NCT00204620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640579|NCT00204620|Alkylating Agents|alkylating agents|mesh-ancestor
92640580|NCT00204620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640581|NCT00204620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640582|NCT02962518|Triamcinolone|triamcinolone|mesh-list
92640583|NCT02962518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640584|NCT02962518|Glucocorticoids|glucocorticoids|mesh-ancestor
92640585|NCT02962518|Hormones|hormones|mesh-ancestor
92640586|NCT02962518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640587|NCT02962518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640588|NCT00204659|Rituximab|rituximab|mesh-list
92640589|NCT00204659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92640590|NCT00204659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640591|NCT00204659|Immunologic Factors|immunologic factors|mesh-ancestor
92640592|NCT00204659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640593|NCT00204659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640594|NCT00231192|Repaglinide|repaglinide|mesh-list
92640595|NCT00231192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640596|NCT00231192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640597|NCT00204698|Rabeprazole|rabeprazole|mesh-list
92640599|NCT00204698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640600|NCT00204698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92640601|NCT00204698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640602|NCT00204698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640603|NCT00204737|Prednisone|prednisone|mesh-list
92640604|NCT00204737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640605|NCT00204737|Glucocorticoids|glucocorticoids|mesh-ancestor
92640606|NCT00204737|Hormones|hormones|mesh-ancestor
92640607|NCT00204737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640608|NCT00204737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640609|NCT00204737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92640610|NCT00204737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640611|NCT00198380|Gefitinib|gefitinib|mesh-list
92640612|NCT00198380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640613|NCT00198380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92640614|NCT00198380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365886|NCT00637494|Luteolytic Agents|luteolytic agents|mesh-ancestor
92640615|NCT00198380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640616|NCT00228267|Propofol|propofol|mesh-list
92640617|NCT00228267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92640618|NCT00228267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640619|NCT00228267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640620|NCT00228267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92640621|NCT00228267|Anesthetics, General|anesthetics, general|mesh-ancestor
92640622|NCT00228267|Anesthetics|anesthetics|mesh-ancestor
92640623|NCT00231348|Nefazodone|nefazodone|mesh-list
92640624|NCT00231348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92640625|NCT00231348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92640626|NCT00231348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640627|NCT00231348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640628|NCT00231348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640629|NCT00231348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640630|NCT00231348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92640631|NCT00231348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92562647|NCT00083109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640632|NCT00231348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640633|NCT00231348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92640634|NCT00231348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92640635|NCT00231348|Serotonin Agents|serotonin agents|mesh-ancestor
92640637|NCT00231387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640638|NCT00231387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640639|NCT00198536|Ecabet|ecabet|mesh-list
92640640|NCT00198536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640641|NCT00198536|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92640642|NCT00198536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640643|NCT00198536|Protease Inhibitors|protease inhibitors|mesh-ancestor
92640644|NCT00198536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640645|NCT00198536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640646|NCT00198536|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92640647|NCT00198536|Protective Agents|protective agents|mesh-ancestor
92640648|NCT00198536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640649|NCT00198536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640650|NCT00409994|Sirolimus|sirolimus|mesh-list
92640651|NCT00409994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92640652|NCT00409994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640653|NCT00409994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92640654|NCT00409994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640655|NCT00409994|Antifungal Agents|antifungal agents|mesh-ancestor
92640656|NCT00409994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640657|NCT00409994|Immunologic Factors|immunologic factors|mesh-ancestor
92640658|NCT00409994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640659|NCT00410033|Insulin|insulin|mesh-list
92640660|NCT00410033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92640661|NCT00410033|Insulin Aspart|insulin aspart|mesh-list
92640662|NCT00410033|Isophane Insulin, Human|isophane insulin, human|mesh-list
92640663|NCT00410033|Insulin, Isophane|insulin, isophane|mesh-list
92640664|NCT00410033|Isophane insulin, beef|isophane insulin, beef|mesh-list
92640665|NCT00410033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640666|NCT00410033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640667|NCT00228462|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92640668|NCT00228462|Antidepressive Agents|antidepressive agents|mesh-ancestor
92640669|NCT00228462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640670|NCT00228462|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92640676|NCT00198614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92640677|NCT00198614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92640678|NCT00198614|Sympatholytics|sympatholytics|mesh-ancestor
92640679|NCT00198614|Autonomic Agents|autonomic agents|mesh-ancestor
92640680|NCT00198614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640681|NCT00198614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640682|NCT00198614|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92640683|NCT00198614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92640684|NCT00198614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92640685|NCT00198614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92640686|NCT00198614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640687|NCT00198614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640688|NCT00198614|Antioxidants|antioxidants|mesh-ancestor
92640689|NCT00198614|Protective Agents|protective agents|mesh-ancestor
92640690|NCT00198614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92640691|NCT00198614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640692|NCT00198614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92640693|NCT00198614|Vasodilator Agents|vasodilator agents|mesh-ancestor
92640694|NCT00198614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92640695|NCT00198614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92640696|NCT00231582|Paclitaxel|paclitaxel|mesh-list
92640697|NCT00231582|Etoposide|etoposide|mesh-list
92640698|NCT00231582|Carboplatin|carboplatin|mesh-list
92640699|NCT00231582|Epirubicin|epirubicin|mesh-list
92640700|NCT00231582|Ifosfamide|ifosfamide|mesh-list
92640701|NCT00231582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92640702|NCT00231582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640703|NCT00231582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92640704|NCT00231582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92640705|NCT00231582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92640706|NCT00231582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640707|NCT00231582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92640708|NCT00231582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92640709|NCT00231582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640710|NCT00231582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92562648|NCT00083109|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91990156|NCT01619878|Lumefantrine|lumefantrine|mesh-list
92640711|NCT00231582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640712|NCT00231582|Alkylating Agents|alkylating agents|mesh-ancestor
92640713|NCT02963324|Ivermectin|ivermectin|mesh-list
92640714|NCT02963324|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92640715|NCT02963324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640716|NCT00228540|Modafinil|modafinil|mesh-list
92640717|NCT00228540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92640718|NCT00228540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640719|NCT00228540|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92640720|NCT00228540|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92640721|NCT00228540|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92640722|NCT00228540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640723|NCT00231621|Topiramate|topiramate|mesh-list
92640724|NCT00231621|Anticonvulsants|anticonvulsants|mesh-ancestor
92640725|NCT00231621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640726|NCT00231621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640727|NCT00474526|Vaccines|vaccines|mesh-list
92640728|NCT00474526|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92640729|NCT00474526|Immunologic Factors|immunologic factors|mesh-ancestor
92640730|NCT00474526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640731|NCT00231660|Topiramate|topiramate|mesh-list
92640732|NCT00231660|Anticonvulsants|anticonvulsants|mesh-ancestor
92640733|NCT00231660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640734|NCT00231660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640735|NCT00231738|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92640736|NCT00231738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92640737|NCT00231738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92640738|NCT00198848|Folic Acid|folic acid|mesh-list
92640739|NCT00198848|Hematinics|hematinics|mesh-ancestor
92640740|NCT00198848|Vitamin B Complex|vitamin b complex|mesh-ancestor
92640741|NCT00198848|Vitamins|vitamins|mesh-ancestor
92640756|NCT00231855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640757|NCT00231855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92640758|NCT00231855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92640759|NCT00231855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92640760|NCT00231855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640761|NCT00231855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92640762|NCT00231855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92640763|NCT00231855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640764|NCT00199004|Cytarabine|cytarabine|mesh-list
92640765|NCT00199004|Dexamethasone|dexamethasone|mesh-list
92640766|NCT00199004|Prednisolone|prednisolone|mesh-list
92640768|NCT00199004|Rituximab|rituximab|mesh-list
92640769|NCT00199004|Methotrexate|methotrexate|mesh-list
92640770|NCT00199004|Vincristine|vincristine|mesh-list
92640771|NCT00199004|Doxorubicin|doxorubicin|mesh-list
92640772|NCT00199004|Daunorubicin|daunorubicin|mesh-list
92640773|NCT00199004|Asparaginase|asparaginase|mesh-list
92640774|NCT00199004|Mercaptopurine|mercaptopurine|mesh-list
92640775|NCT00199004|Thioguanine|thioguanine|mesh-list
92640776|NCT00199004|Vindesine|vindesine|mesh-list
92640777|NCT00199004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640778|NCT00199004|Immunologic Factors|immunologic factors|mesh-ancestor
92640779|NCT00199004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640780|NCT00199004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640781|NCT00199004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640782|NCT00199004|Alkylating Agents|alkylating agents|mesh-ancestor
92640783|NCT00199004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640784|NCT00199004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640785|NCT00199004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92640786|NCT00199004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92640787|NCT00199004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640788|NCT00199004|Antiemetics|antiemetics|mesh-ancestor
92640789|NCT00199004|Autonomic Agents|autonomic agents|mesh-ancestor
92640790|NCT00199004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640791|NCT00199004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640792|NCT00199004|Glucocorticoids|glucocorticoids|mesh-ancestor
92640793|NCT00199004|Hormones|hormones|mesh-ancestor
92640794|NCT00199004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640795|NCT00199004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92640796|NCT00199004|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92640797|NCT00199004|Abortifacient Agents|abortifacient agents|mesh-ancestor
92640798|NCT00199004|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92640799|NCT00199004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562649|NCT00083109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92562650|NCT00153244|Lamotrigine|lamotrigine|mesh-list
92640800|NCT00199004|Antimetabolites|antimetabolites|mesh-ancestor
92640801|NCT00199004|Dermatologic Agents|dermatologic agents|mesh-ancestor
91940579|NCT05648032|Hormones|hormones|mesh-ancestor
92640802|NCT00199004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640803|NCT00199004|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92640804|NCT00199004|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92640805|NCT00199004|Antiviral Agents|antiviral agents|mesh-ancestor
92640815|NCT00228852|Busulfan|busulfan|mesh-list
92640816|NCT00228852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640817|NCT00228852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640818|NCT00228852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640819|NCT00228852|Immunologic Factors|immunologic factors|mesh-ancestor
92640820|NCT00228852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640821|NCT00228852|Alkylating Agents|alkylating agents|mesh-ancestor
92640822|NCT00228852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640823|NCT00228852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92640824|NCT00204776|Capecitabine|capecitabine|mesh-list
92640825|NCT00204776|Oxaliplatin|oxaliplatin|mesh-list
92640826|NCT00204776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92640827|NCT00204776|Antimetabolites|antimetabolites|mesh-ancestor
92640828|NCT00204776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640829|NCT00204776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640830|NCT00228891|Insulin|insulin|mesh-list
92640831|NCT00228891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92640832|NCT00228891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640833|NCT00228891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640834|NCT00477412|Cytarabine|cytarabine|mesh-list
92640835|NCT00477412|Dexamethasone|dexamethasone|mesh-list
92640836|NCT00477412|Dexamethasone acetate|dexamethasone acetate|mesh-list
92640837|NCT00477412|Cyclophosphamide|cyclophosphamide|mesh-list
92640838|NCT00477412|Rituximab|rituximab|mesh-list
92640839|NCT00477412|Doxorubicin|doxorubicin|mesh-list
92640840|NCT00477412|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92640841|NCT00477412|Methotrexate|methotrexate|mesh-list
92640842|NCT00477412|Vincristine|vincristine|mesh-list
92640843|NCT00477412|Bortezomib|bortezomib|mesh-list
92640844|NCT00477412|Daunorubicin|daunorubicin|mesh-list
92640845|NCT00477412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92640846|NCT00477412|Antibodies|antibodies|mesh-list
92640847|NCT00477412|Immunoglobulins|immunoglobulins|mesh-list
92640848|NCT00477412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92640849|NCT00477412|BB 1101|bb 1101|mesh-list
92640850|NCT00477412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640851|NCT00477412|Immunologic Factors|immunologic factors|mesh-ancestor
92640852|NCT00477412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640853|NCT00477412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640854|NCT00477412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92640855|NCT00477412|Alkylating Agents|alkylating agents|mesh-ancestor
92640856|NCT00477412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640857|NCT00477412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640858|NCT00477412|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92640859|NCT00477412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640860|NCT00477412|Antiemetics|antiemetics|mesh-ancestor
92640861|NCT00477412|Autonomic Agents|autonomic agents|mesh-ancestor
92640862|NCT00477412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640863|NCT00477412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640864|NCT00477412|Glucocorticoids|glucocorticoids|mesh-ancestor
92640865|NCT00477412|Hormones|hormones|mesh-ancestor
92640866|NCT00477412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640867|NCT00477412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92640868|NCT00477412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92640869|NCT00477412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92640870|NCT00477412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92640871|NCT00477412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640872|NCT00477412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92640873|NCT00477412|Abortifacient Agents|abortifacient agents|mesh-ancestor
92640877|NCT00477412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92640878|NCT00477412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92640879|NCT00477412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92640880|NCT00477412|Antiviral Agents|antiviral agents|mesh-ancestor
92640881|NCT00477412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640882|NCT00477412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92640883|NCT00477412|Tubulin Modulators|tubulin modulators|mesh-ancestor
92640884|NCT00477412|Antimitotic Agents|antimitotic agents|mesh-ancestor
92640885|NCT00477412|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562651|NCT00153244|Anticonvulsants|anticonvulsants|mesh-ancestor
92562652|NCT00153244|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92640886|NCT00477412|Protease Inhibitors|protease inhibitors|mesh-ancestor
92640887|NCT00410774|Bevacizumab|bevacizumab|mesh-list
92640888|NCT00410774|Gemcitabine|gemcitabine|mesh-list
92640889|NCT00410774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92640890|NCT00410774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640891|NCT00410774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92640892|NCT00410774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92640893|NCT00410774|Growth Substances|growth substances|mesh-ancestor
92640894|NCT00410774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640895|NCT00410774|Growth Inhibitors|growth inhibitors|mesh-ancestor
92640896|NCT00410774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92640897|NCT00410774|Antimetabolites|antimetabolites|mesh-ancestor
92640898|NCT00410774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640900|NCT00228930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92640901|NCT00228930|Hormone Antagonists|hormone antagonists|mesh-ancestor
92640902|NCT00228930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92640903|NCT00228930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640904|NCT00228930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92640905|NCT00228930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640906|NCT00228930|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92640907|NCT00228930|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92640908|NCT00228930|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92640909|NCT00410852|Insulin|insulin|mesh-list
92640910|NCT00410852|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92640911|NCT00410852|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92640912|NCT00410852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640913|NCT01086982|Octreotide|octreotide|mesh-list
92640914|NCT01086982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640915|NCT01086982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92640916|NCT01086982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640917|NCT00410930|Immunomodulating Agents|immunomodulating agents|mesh-list
92366191|NCT00690924|Vitamins|vitamins|mesh-ancestor
92640918|NCT00410930|Immunologic Factors|immunologic factors|mesh-ancestor
92640919|NCT00410930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640920|NCT00204893|Calcium|calcium|mesh-list
92640921|NCT00204893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92640922|NCT00204893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640923|NCT00232011|Pimecrolimus|pimecrolimus|mesh-list
92640924|NCT00232011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92640925|NCT00232011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92640926|NCT00232011|Analgesics|analgesics|mesh-ancestor
92640927|NCT00232011|Sensory System Agents|sensory system agents|mesh-ancestor
92640928|NCT00232011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640929|NCT00232011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640930|NCT00232011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92640931|NCT00232011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92640932|NCT00232011|Dermatologic Agents|dermatologic agents|mesh-ancestor
92640933|NCT00232011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92640934|NCT00232011|Immunologic Factors|immunologic factors|mesh-ancestor
92640935|NCT00232011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92640936|NCT00232011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640937|NCT00232011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640938|NCT00232050|Omalizumab|omalizumab|mesh-list
92640939|NCT00232050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92640940|NCT00232050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92640941|NCT00232050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92640942|NCT00232089|Tegaserod|tegaserod|mesh-list
92640943|NCT00232089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92640944|NCT00232089|Serotonin Agents|serotonin agents|mesh-ancestor
92640958|NCT00229125|Gabapentin|gabapentin|mesh-list
92640959|NCT00229125|Lorazepam|lorazepam|mesh-list
92640960|NCT00229125|Analgesics|analgesics|mesh-ancestor
92640961|NCT00229125|Sensory System Agents|sensory system agents|mesh-ancestor
92640962|NCT00229125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640963|NCT00229125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640964|NCT00229125|Anticonvulsants|anticonvulsants|mesh-ancestor
92640965|NCT00229125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92640966|NCT00229125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640967|NCT00229125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640968|NCT00229125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562653|NCT00153244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640969|NCT00229125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92640971|NCT00229125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640972|NCT00229125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640973|NCT00229125|Antimanic Agents|antimanic agents|mesh-ancestor
92640974|NCT00229125|Antiemetics|antiemetics|mesh-ancestor
92640975|NCT00229125|Autonomic Agents|autonomic agents|mesh-ancestor
92640976|NCT00229125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92640977|NCT00229125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92640978|NCT00229125|GABA Modulators|gaba modulators|mesh-ancestor
92640979|NCT00229125|GABA Agents|gaba agents|mesh-ancestor
92640980|NCT00205283|Nelfinavir|nelfinavir|mesh-list
92640981|NCT00205283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92640982|NCT00205283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92640983|NCT00205283|Protease Inhibitors|protease inhibitors|mesh-ancestor
92640984|NCT00205283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640985|NCT00205283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640986|NCT00205283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92640987|NCT00205283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92640988|NCT00205283|Antiviral Agents|antiviral agents|mesh-ancestor
92640989|NCT00205283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640990|NCT00232167|Indiplon|indiplon|mesh-list
92640991|NCT00232167|Sertraline|sertraline|mesh-list
92640992|NCT00232167|Antidepressive Agents|antidepressive agents|mesh-ancestor
92640993|NCT00232167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640994|NCT00232167|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92640995|NCT00232167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92640996|NCT00232167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640997|NCT00232167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640998|NCT00232167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640999|NCT00232167|Serotonin Agents|serotonin agents|mesh-ancestor
92641000|NCT00232167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641001|NCT00232167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92641002|NCT00232167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641003|NCT00232167|GABA Modulators|gaba modulators|mesh-ancestor
92641004|NCT00232167|GABA Agents|gaba agents|mesh-ancestor
92641008|NCT00205322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641009|NCT00205322|Antimetabolites|antimetabolites|mesh-ancestor
92641010|NCT00205322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641011|NCT00205322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641012|NCT00205322|Antidotes|antidotes|mesh-ancestor
92641013|NCT00205322|Protective Agents|protective agents|mesh-ancestor
92641014|NCT00205322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641015|NCT00205322|Vitamin B Complex|vitamin b complex|mesh-ancestor
92641016|NCT00205322|Vitamins|vitamins|mesh-ancestor
92641017|NCT00205322|Micronutrients|micronutrients|mesh-ancestor
92641018|NCT00232206|Docetaxel|docetaxel|mesh-list
92641019|NCT00232206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641020|NCT00232206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92641021|NCT00232206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92641022|NCT00232206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92641023|NCT00232206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641024|NCT00229242|Diuretics|diuretics|mesh-list
92641025|NCT00229242|Natriuretic Agents|natriuretic agents|mesh-ancestor
92641026|NCT00229242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641027|NCT00232284|Sertraline|sertraline|mesh-list
92641028|NCT00232284|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641029|NCT00232284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641030|NCT00232284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92641031|NCT00232284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641032|NCT00232284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641033|NCT00232284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641034|NCT00232284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641035|NCT00232284|Serotonin Agents|serotonin agents|mesh-ancestor
92641036|NCT00232284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641037|NCT00205634|Clarithromycin|clarithromycin|mesh-list
92641038|NCT00205634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641039|NCT00205634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641040|NCT00205634|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92641041|NCT00205634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641042|NCT00205634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641043|NCT00205634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92562654|NCT00153244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940795|NCT00656357|Cocaine|cocaine|mesh-list
92641044|NCT00205634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92641045|NCT00232362|Pioglitazone|pioglitazone|mesh-list
92641046|NCT00232362|Rosiglitazone|rosiglitazone|mesh-list
92641047|NCT00232362|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92641048|NCT00232362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641049|NCT00205751|Thalidomide|thalidomide|mesh-list
92641050|NCT00205751|Dexamethasone|dexamethasone|mesh-list
92641051|NCT00205751|Prednisone|prednisone|mesh-list
92641052|NCT00205751|Melphalan|melphalan|mesh-list
92641053|NCT00205751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641054|NCT00205751|Antiemetics|antiemetics|mesh-ancestor
92641055|NCT00205751|Autonomic Agents|autonomic agents|mesh-ancestor
92641056|NCT00205751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641057|NCT00205751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641058|NCT00205751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641059|NCT00205751|Glucocorticoids|glucocorticoids|mesh-ancestor
92641060|NCT00205751|Hormones|hormones|mesh-ancestor
92641061|NCT00205751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641062|NCT00205751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641063|NCT00205751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641064|NCT00205751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92641065|NCT00205751|Alkylating Agents|alkylating agents|mesh-ancestor
92641066|NCT00205751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641067|NCT00205751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92641068|NCT00205751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641069|NCT00205751|Immunologic Factors|immunologic factors|mesh-ancestor
92641070|NCT00205751|Leprostatic Agents|leprostatic agents|mesh-ancestor
92641071|NCT00205751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641072|NCT00205751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641073|NCT00205751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92641074|NCT00205751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92641075|NCT00205751|Growth Substances|growth substances|mesh-ancestor
92641076|NCT00205751|Growth Inhibitors|growth inhibitors|mesh-ancestor
92641077|NCT00229476|Sertraline|sertraline|mesh-list
92048157|NCT04641195|Vitamin D|vitamin d|mesh-list
92641078|NCT00229476|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641079|NCT00229476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641080|NCT00229476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92641081|NCT00229476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641082|NCT00229476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641083|NCT00229476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641084|NCT00229476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641085|NCT00229476|Serotonin Agents|serotonin agents|mesh-ancestor
92641086|NCT00229476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641087|NCT00205946|Bupropion|bupropion|mesh-list
92641088|NCT00205946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92641089|NCT00205946|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641090|NCT00205946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641091|NCT00205946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92641092|NCT00205946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641093|NCT00205946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641094|NCT00205946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641095|NCT00205946|Dopamine Agents|dopamine agents|mesh-ancestor
92641096|NCT00205946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641097|NCT00205946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641098|NCT00205946|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92641099|NCT00205946|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92641100|NCT00205946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641101|NCT00229515|Sirolimus|sirolimus|mesh-list
92641102|NCT00229515|polysaccharide-K|polysaccharide-k|mesh-list
92641103|NCT00229515|Temsirolimus|temsirolimus|mesh-list
92641104|NCT00229515|MTOR Inhibitors|mtor inhibitors|mesh-list
92641105|NCT00229515|Tirofiban|tirofiban|mesh-list
92641106|NCT00229515|Abciximab|abciximab|mesh-list
92641107|NCT00229515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641108|NCT00229515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641109|NCT00229515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92641110|NCT00229515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641111|NCT00229515|Antifungal Agents|antifungal agents|mesh-ancestor
92641112|NCT00229515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641113|NCT00229515|Immunologic Factors|immunologic factors|mesh-ancestor
92562655|NCT00153244|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92562656|NCT00153244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562657|NCT00153244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92562658|NCT00153244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92562659|NCT00153244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641114|NCT00229515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641115|NCT00229515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92641116|NCT00229515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641117|NCT00229515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641118|NCT00229515|Anticoagulants|anticoagulants|mesh-ancestor
92641119|NCT00229515|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92641120|NCT00229515|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92641121|NCT00229515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92641122|NCT00229515|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92641123|NCT00229515|Antiviral Agents|antiviral agents|mesh-ancestor
92641124|NCT00229515|Interferon Inducers|interferon inducers|mesh-ancestor
92641125|NCT00229515|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92641126|NCT00229515|Protective Agents|protective agents|mesh-ancestor
92641127|NCT00206024|Esomeprazole|esomeprazole|mesh-list
92641128|NCT00206024|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92641129|NCT00206024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641130|NCT00206024|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92641131|NCT00206024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641132|NCT00206024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641133|NCT00206063|Ximelagatran|ximelagatran|mesh-list
92641134|NCT00206063|Antithrombins|antithrombins|mesh-ancestor
92641135|NCT00206063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92641136|NCT00206063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92641137|NCT00206063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641138|NCT00206063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641139|NCT00206063|Anticoagulants|anticoagulants|mesh-ancestor
92641140|NCT00206141|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92641141|NCT00206141|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641142|NCT00206141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92366425|NCT00726414|Quinine|quinine|mesh-list
92641143|NCT00206141|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641144|NCT00206141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641145|NCT00206141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641146|NCT00206141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641148|NCT00229593|Testosterone|testosterone|mesh-list
92641149|NCT00229593|Androgens|androgens|mesh-ancestor
92641150|NCT00229593|Hormones|hormones|mesh-ancestor
92641151|NCT00229593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641155|NCT00229593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92641156|NCT00229593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92641157|NCT00229632|Idebenone|idebenone|mesh-list
92641158|NCT00229632|Antioxidants|antioxidants|mesh-ancestor
92641159|NCT00229632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641160|NCT00229632|Protective Agents|protective agents|mesh-ancestor
92641161|NCT00229632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641162|NCT00206180|Esomeprazole|esomeprazole|mesh-list
92641163|NCT00206180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92641164|NCT00206180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641165|NCT00206180|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92641166|NCT00206180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641167|NCT00206180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641168|NCT00206219|Methotrexate|methotrexate|mesh-list
92641169|NCT00206219|Gefitinib|gefitinib|mesh-list
92641170|NCT00206219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92641171|NCT00206219|Abortifacient Agents|abortifacient agents|mesh-ancestor
92641172|NCT00206219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92641173|NCT00206219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641174|NCT00206219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641175|NCT00206219|Antimetabolites|antimetabolites|mesh-ancestor
92641176|NCT00206219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641177|NCT00206219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562660|NCT00153244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562661|NCT00153244|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92562662|NCT00153283|Gabapentin|gabapentin|mesh-list
92562663|NCT00153283|Analgesics|analgesics|mesh-ancestor
91990595|NCT04658836|Glucocorticoids|glucocorticoids|mesh-ancestor
92641178|NCT00206219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92641179|NCT00206219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641180|NCT00206219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92641181|NCT00206219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363366|NCT02099175|Antidotes|antidotes|mesh-ancestor
92641182|NCT00206219|Immunologic Factors|immunologic factors|mesh-ancestor
92641183|NCT00206219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641184|NCT00206219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92641185|NCT00206219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92641186|NCT00206258|Pramlintide|pramlintide|mesh-list
92641187|NCT00206258|Glucagon|glucagon|mesh-list
92641188|NCT00206258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641189|NCT00206258|Hormones|hormones|mesh-ancestor
92641190|NCT00206258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641191|NCT00206258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641192|NCT00206258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641193|NCT00206297|Pramlintide|pramlintide|mesh-list
92641194|NCT00206297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641195|NCT00206297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641196|NCT00411047|Gefitinib|gefitinib|mesh-list
92641197|NCT00411047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641198|NCT00411047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92641199|NCT00411047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641200|NCT00411047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641201|NCT00411125|Calcitonin|calcitonin|mesh-list
92641202|NCT00411125|Salmon calcitonin|salmon calcitonin|mesh-list
92641203|NCT00411125|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92641204|NCT00411125|Katacalcin|katacalcin|mesh-list
92641205|NCT00411125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641206|NCT00411125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641207|NCT00411125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92641208|NCT00411125|Vasodilator Agents|vasodilator agents|mesh-ancestor
92641209|NCT00411164|Hydromorphone|hydromorphone|mesh-list
92641210|NCT00411164|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92641211|NCT00411164|Narcotics|narcotics|mesh-ancestor
92641212|NCT00411164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641213|NCT00411164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641214|NCT00411164|Analgesics|analgesics|mesh-ancestor
92641215|NCT00411164|Sensory System Agents|sensory system agents|mesh-ancestor
92641216|NCT00411164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641217|NCT00411203|Tamoxifen|tamoxifen|mesh-list
92641218|NCT00411203|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92641219|NCT00411203|Hormone Antagonists|hormone antagonists|mesh-ancestor
92641220|NCT00411203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641221|NCT00411203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641222|NCT00411203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641230|NCT00411281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641232|NCT00411281|Antiviral Agents|antiviral agents|mesh-ancestor
92641233|NCT00411281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641234|NCT00411281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641235|NCT00411281|Immunologic Factors|immunologic factors|mesh-ancestor
92641236|NCT00411281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641237|NCT00206414|Gefitinib|gefitinib|mesh-list
92641238|NCT00206414|Fulvestrant|fulvestrant|mesh-list
92641239|NCT00206414|Anastrozole|anastrozole|mesh-list
92641240|NCT00206414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641241|NCT00206414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92641242|NCT00206414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641243|NCT00206414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641244|NCT00206414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641245|NCT00206414|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92641246|NCT00206414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92641247|NCT00206414|Hormone Antagonists|hormone antagonists|mesh-ancestor
92641248|NCT00206414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641249|NCT00206414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641250|NCT00206414|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92641251|NCT00206414|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92562664|NCT00153283|Sensory System Agents|sensory system agents|mesh-ancestor
92562665|NCT00153283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562666|NCT00153283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562667|NCT00153283|Anticonvulsants|anticonvulsants|mesh-ancestor
92562668|NCT00153283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92641252|NCT00232674|Budesonide|budesonide|mesh-list
92641253|NCT00232674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641254|NCT00232674|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92641255|NCT00232674|Autonomic Agents|autonomic agents|mesh-ancestor
92641256|NCT00232674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641257|NCT00232674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641258|NCT00232674|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92641259|NCT00232674|Respiratory System Agents|respiratory system agents|mesh-ancestor
92641260|NCT00232674|Glucocorticoids|glucocorticoids|mesh-ancestor
92641261|NCT00232674|Hormones|hormones|mesh-ancestor
92641262|NCT00232674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641263|NCT00206453|Docetaxel|docetaxel|mesh-list
92641264|NCT00206453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641265|NCT00206453|Tubulin Modulators|tubulin modulators|mesh-ancestor
92641266|NCT00206453|Antimitotic Agents|antimitotic agents|mesh-ancestor
92641267|NCT00206453|Mitosis Modulators|mitosis modulators|mesh-ancestor
92641268|NCT00206453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641269|NCT00206492|Tamoxifen|tamoxifen|mesh-list
92641270|NCT00206492|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92641271|NCT00206492|Hormone Antagonists|hormone antagonists|mesh-ancestor
92641272|NCT00206492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641273|NCT00206492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641274|NCT00206492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641275|NCT00206492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641276|NCT00206492|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92641277|NCT00206492|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92641278|NCT00206492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92641279|NCT00206570|Estradiol|estradiol|mesh-list
92641280|NCT00206570|Estrogens|estrogens|mesh-ancestor
92641281|NCT00206570|Hormones|hormones|mesh-ancestor
92641282|NCT00206570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641283|NCT00206570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641284|NCT00206648|Interferon beta-1b|interferon beta-1b|mesh-list
92641285|NCT00206648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92641286|NCT00206648|Immunologic Factors|immunologic factors|mesh-ancestor
92641287|NCT00206648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641297|NCT01056159|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92641299|NCT01056159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92641300|NCT01056159|Adrenergic Agents|adrenergic agents|mesh-ancestor
92641301|NCT01056159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641302|NCT01056159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641304|NCT00206765|Paroxetine|paroxetine|mesh-list
92641305|NCT00206765|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92641306|NCT00206765|Serotonin Agents|serotonin agents|mesh-ancestor
92641307|NCT00206765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641308|NCT00206765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641309|NCT00206765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641310|NCT00206765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641311|NCT00206765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641312|NCT00206765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641313|NCT00206765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641314|NCT00206765|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92641315|NCT00206765|Dopamine Agents|dopamine agents|mesh-ancestor
92641316|NCT00206765|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92641317|NCT00206765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641318|NCT00206765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641319|NCT00206765|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92641320|NCT00206765|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641321|NCT00206765|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92641322|NCT00206765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92641323|NCT00206765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641324|NCT00424710|Ranibizumab|ranibizumab|mesh-list
92641325|NCT00424710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92562669|NCT00153283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91970120|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641326|NCT00424710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92641327|NCT00424710|Growth Substances|growth substances|mesh-ancestor
92641328|NCT00424710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641329|NCT00424710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92641330|NCT00424710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641331|NCT00206960|Risperidone|risperidone|mesh-list
92641332|NCT00206960|Clopenthixol|clopenthixol|mesh-list
92641333|NCT00206960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92641334|NCT00206960|Serotonin Agents|serotonin agents|mesh-ancestor
92641335|NCT00206960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641336|NCT00206960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641337|NCT00206960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641338|NCT00206960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641339|NCT00206960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641340|NCT00206960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641341|NCT00206960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641342|NCT00206960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92641343|NCT00206960|Dopamine Agents|dopamine agents|mesh-ancestor
92641344|NCT00206999|Imipramine|imipramine|mesh-list
92641345|NCT00206999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92641346|NCT00206999|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641347|NCT00206999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641348|NCT00206999|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92641349|NCT00206999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641350|NCT00206999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641352|NCT00206999|Adrenergic Agents|adrenergic agents|mesh-ancestor
92641353|NCT00206999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641354|NCT00206999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641355|NCT00229944|Azithromycin|azithromycin|mesh-list
92641356|NCT00229944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641357|NCT00229944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641358|NCT00207077|Cetuximab|cetuximab|mesh-list
92641359|NCT00207077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92641360|NCT00207077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92641361|NCT00207077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366645|NCT00751530|Raltegravir Potassium|raltegravir potassium|mesh-list
92641362|NCT00207077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92641363|NCT00207077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641364|NCT00207077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641365|NCT00207116|Cetuximab|cetuximab|mesh-list
92641366|NCT00207116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92641367|NCT00207116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641368|NCT00232908|Enfuvirtide|enfuvirtide|mesh-list
92641369|NCT00232908|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92641370|NCT00232908|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92641371|NCT00232908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641372|NCT00232908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92641373|NCT00232908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92641374|NCT00232908|Antiviral Agents|antiviral agents|mesh-ancestor
92641375|NCT00232908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641376|NCT00207155|Cetuximab|cetuximab|mesh-list
92641377|NCT00207155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92641378|NCT00207155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641379|NCT00232947|Vaccines|vaccines|mesh-list
92641380|NCT00232947|Immunologic Factors|immunologic factors|mesh-ancestor
92641381|NCT00232947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641382|NCT00413712|Adenosine|adenosine|mesh-list
92641383|NCT00413712|Calcium Channel Blockers|calcium channel blockers|mesh-list
92641384|NCT00413712|Calcium|calcium|mesh-list
92641385|NCT00413712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641386|NCT00413712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641387|NCT00413712|Analgesics|analgesics|mesh-ancestor
92641388|NCT00413712|Sensory System Agents|sensory system agents|mesh-ancestor
92641389|NCT00413712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641390|NCT00413712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92641391|NCT00413712|Vasodilator Agents|vasodilator agents|mesh-ancestor
92641392|NCT00413712|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92641393|NCT00413712|Purinergic Agonists|purinergic agonists|mesh-ancestor
92641394|NCT00413712|Purinergic Agents|purinergic agents|mesh-ancestor
92641395|NCT00413712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641396|NCT00413712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562670|NCT00153283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562671|NCT00153283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641397|NCT00413712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641398|NCT00230217|Rasburicase|rasburicase|mesh-list
92641399|NCT00230217|Gout Suppressants|gout suppressants|mesh-ancestor
92641400|NCT00230217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641401|NCT00207311|Interferons|interferons|mesh-list
92641402|NCT00207311|Interferon-alpha|interferon-alpha|mesh-list
92641403|NCT00207311|Interferon alpha-2|interferon alpha-2|mesh-list
92641404|NCT00207311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92641405|NCT00207311|Orlistat|orlistat|mesh-list
92641406|NCT00207311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641407|NCT00207311|Antiviral Agents|antiviral agents|mesh-ancestor
92641408|NCT00207311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641409|NCT00207311|Immunologic Factors|immunologic factors|mesh-ancestor
92641410|NCT00207311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641411|NCT00207311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641412|NCT00207311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641413|NCT00207311|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92641414|NCT00207311|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92641415|NCT00233025|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92641416|NCT00233025|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92641417|NCT00233025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641418|NCT00233025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641419|NCT00233025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641420|NCT00233025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641421|NCT00233025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641422|NCT00233025|Analgesics|analgesics|mesh-ancestor
92641424|NCT00233025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641426|NCT00233025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641427|NCT00233025|Dopamine Agents|dopamine agents|mesh-ancestor
92641428|NCT00207428|Carbamazepine|carbamazepine|mesh-list
92641429|NCT00207428|Anticonvulsants|anticonvulsants|mesh-ancestor
92641430|NCT00207428|Antimanic Agents|antimanic agents|mesh-ancestor
92641431|NCT00207428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641432|NCT00207428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641433|NCT00207428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641434|NCT00207428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641435|NCT00207428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92366715|NCT00759642|Lapatinib|lapatinib|mesh-list
92641436|NCT00207428|Analgesics|analgesics|mesh-ancestor
92641437|NCT00207428|Sensory System Agents|sensory system agents|mesh-ancestor
92641438|NCT00207428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641439|NCT00207428|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92641440|NCT00207428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641441|NCT00207428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641442|NCT00207428|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92641443|NCT00207428|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92641444|NCT00230334|Imatinib Mesylate|imatinib mesylate|mesh-list
92641445|NCT00230334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641446|NCT00230334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92641447|NCT00230334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641448|NCT00230334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641449|NCT00207584|Doxycycline|doxycycline|mesh-list
92641450|NCT00207584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641451|NCT00207584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641452|NCT00207584|Antimalarials|antimalarials|mesh-ancestor
92641453|NCT00207584|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92641454|NCT00207584|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92641455|NCT00207662|Infliximab|infliximab|mesh-list
92641456|NCT00207662|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92641457|NCT00207662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641458|NCT00207662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92641459|NCT00207662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641460|NCT00207662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641461|NCT00207701|Infliximab|infliximab|mesh-list
92641462|NCT00207701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92641463|NCT00207701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641464|NCT00207701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92641465|NCT00207701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641466|NCT00207701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641467|NCT00207779|Heparin|heparin|mesh-list
92641468|NCT00207779|Anticoagulants|anticoagulants|mesh-ancestor
92641469|NCT00207779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92562672|NCT00153283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92562673|NCT00153283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92562674|NCT00153283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641470|NCT00207779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92641471|NCT00207779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641472|NCT00230373|Imiquimod|imiquimod|mesh-list
92641473|NCT00230373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92641474|NCT00230373|Immunologic Factors|immunologic factors|mesh-ancestor
92641475|NCT00230373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641476|NCT00230373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641477|NCT00230373|Interferon Inducers|interferon inducers|mesh-ancestor
92641478|NCT00230451|Paclitaxel|paclitaxel|mesh-list
92641479|NCT00230451|Fluorouracil|fluorouracil|mesh-list
92641480|NCT00230451|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92641481|NCT00230451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641482|NCT00230451|Tubulin Modulators|tubulin modulators|mesh-ancestor
92641483|NCT00230451|Antimitotic Agents|antimitotic agents|mesh-ancestor
92641484|NCT00230451|Mitosis Modulators|mitosis modulators|mesh-ancestor
92641485|NCT00230451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641486|NCT00230451|Antimetabolites|antimetabolites|mesh-ancestor
92641487|NCT00230451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641488|NCT00230451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641489|NCT00230451|Immunologic Factors|immunologic factors|mesh-ancestor
92641490|NCT00230451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641491|NCT00411320|Dexamethasone|dexamethasone|mesh-list
92641492|NCT00411320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641493|NCT00411320|Antiemetics|antiemetics|mesh-ancestor
92641494|NCT00411320|Autonomic Agents|autonomic agents|mesh-ancestor
92641495|NCT00411320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048585|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641498|NCT00411320|Glucocorticoids|glucocorticoids|mesh-ancestor
92641499|NCT00411320|Hormones|hormones|mesh-ancestor
92641500|NCT00411320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641501|NCT00411320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641502|NCT00411320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641503|NCT00233337|Artemether|artemether|mesh-list
92641504|NCT00233337|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92641505|NCT00233337|Antimalarials|antimalarials|mesh-ancestor
92641506|NCT00233337|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92641507|NCT00233337|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92641508|NCT00233337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641509|NCT00230490|Adefovir|adefovir|mesh-list
92641510|NCT00230490|Pradefovir|pradefovir|mesh-list
92366791|NCT00765648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92641511|NCT00230490|Antiviral Agents|antiviral agents|mesh-ancestor
92641512|NCT00230490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641513|NCT00230490|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92641514|NCT00230490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92641515|NCT00230490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641516|NCT00230490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641517|NCT00230490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92641518|NCT01089556|Pregabalin|pregabalin|mesh-list
92641519|NCT01089556|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92641520|NCT01089556|Analgesics|analgesics|mesh-ancestor
92641521|NCT01089556|Sensory System Agents|sensory system agents|mesh-ancestor
92641522|NCT01089556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641523|NCT01089556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641524|NCT01089556|Anticonvulsants|anticonvulsants|mesh-ancestor
92641525|NCT01089556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92641526|NCT01089556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641527|NCT01089556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641528|NCT01089556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641529|NCT01089556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92641530|NCT01089556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641531|NCT01089556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641532|NCT01089556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641533|NCT01089556|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92641534|NCT01089556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641535|NCT01089556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641536|NCT01089556|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641537|NCT01089556|Dopamine Agents|dopamine agents|mesh-ancestor
92562675|NCT00153283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562676|NCT00153283|Antimanic Agents|antimanic agents|mesh-ancestor
92562677|NCT00050531|Interferons|interferons|mesh-list
92562678|NCT00050531|Interferon-alpha|interferon-alpha|mesh-list
92562679|NCT00050531|Interferon alpha-2|interferon alpha-2|mesh-list
92562680|NCT00050531|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92562681|NCT00050531|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92562682|NCT00050531|Imatinib Mesylate|imatinib mesylate|mesh-list
92562683|NCT00050531|Molgramostim|molgramostim|mesh-list
92562684|NCT00050531|Sargramostim|sargramostim|mesh-list
92562685|NCT00050531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562686|NCT00050531|Antiviral Agents|antiviral agents|mesh-ancestor
92562687|NCT00050531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562688|NCT00050531|Immunologic Factors|immunologic factors|mesh-ancestor
92562689|NCT00050531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562690|NCT00050531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92562691|NCT00050531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562692|NCT00050531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641538|NCT00233376|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92641539|NCT00233376|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92641540|NCT00233376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641541|NCT00233376|Antitubercular Agents|antitubercular agents|mesh-ancestor
92641542|NCT00237159|Zoledronic Acid|zoledronic acid|mesh-list
92641543|NCT00237159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92641544|NCT00237159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641545|NCT01089127|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92641546|NCT01089127|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92641547|NCT01089127|Autonomic Agents|autonomic agents|mesh-ancestor
92641548|NCT01089127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641549|NCT01089127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641550|NCT01089127|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92641551|NCT01089127|Respiratory System Agents|respiratory system agents|mesh-ancestor
92641552|NCT01089127|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92641553|NCT01089127|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92641554|NCT01089127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92641555|NCT01089127|Adrenergic Agents|adrenergic agents|mesh-ancestor
92641556|NCT01089127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641557|NCT01089127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641558|NCT00424580|Montelukast|montelukast|mesh-list
92641559|NCT00424580|Desloratadine|desloratadine|mesh-list
92641560|NCT00424580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92641561|NCT00424580|Respiratory System Agents|respiratory system agents|mesh-ancestor
92641562|NCT00424580|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92641563|NCT00424580|Hormone Antagonists|hormone antagonists|mesh-ancestor
92641564|NCT00424580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641565|NCT00424580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641568|NCT00424580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641569|NCT00424580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92641571|NCT00424580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641572|NCT00424580|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92641573|NCT00424580|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92641574|NCT00424580|Histamine Antagonists|histamine antagonists|mesh-ancestor
92641575|NCT00424580|Histamine Agents|histamine agents|mesh-ancestor
92641576|NCT00233532|Verapamil|verapamil|mesh-list
92641577|NCT00233532|Trandolapril|trandolapril|mesh-list
92641578|NCT00233532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92641579|NCT00233532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562693|NCT00083148|Capecitabine|capecitabine|mesh-list
92562694|NCT00083148|Irinotecan|irinotecan|mesh-list
92562695|NCT00083148|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641580|NCT00233532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641581|NCT00233532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641582|NCT00233532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641583|NCT00233532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641584|NCT00233532|Vasodilator Agents|vasodilator agents|mesh-ancestor
92641585|NCT00233532|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92641586|NCT00233532|Protease Inhibitors|protease inhibitors|mesh-ancestor
92641587|NCT00233532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641588|NCT00233532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92641589|NCT00233571|Adalimumab|adalimumab|mesh-list
92641590|NCT00233571|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92641591|NCT00233571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641592|NCT00233571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641593|NCT00237198|Letrozole|letrozole|mesh-list
92641594|NCT00237198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641595|NCT00237198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92641596|NCT00237198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92641597|NCT00237198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641598|NCT00237198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641599|NCT00237198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92641600|NCT00237198|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750773|NCT05936229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641601|NCT00237198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641602|NCT00237198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641603|NCT00233610|Tamoxifen|tamoxifen|mesh-list
92641604|NCT00233610|Bicalutamide|bicalutamide|mesh-list
92641605|NCT00233610|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92641606|NCT00233610|Hormone Antagonists|hormone antagonists|mesh-ancestor
92641607|NCT00233610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641608|NCT00233610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641609|NCT00233610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641610|NCT00233610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641611|NCT00233610|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92641612|NCT00233610|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92641613|NCT00233610|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92641614|NCT00233610|Androgen Antagonists|androgen antagonists|mesh-ancestor
92641615|NCT00208130|Topiramate|topiramate|mesh-list
92641616|NCT00208130|Anticonvulsants|anticonvulsants|mesh-ancestor
92641617|NCT00208130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641618|NCT00208130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641619|NCT00237237|Vildagliptin|vildagliptin|mesh-list
92641620|NCT00237237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641621|NCT00237237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641622|NCT00237237|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92641623|NCT00237237|Protease Inhibitors|protease inhibitors|mesh-ancestor
92641624|NCT00237237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641625|NCT00237237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641626|NCT00208169|Aripiprazole|aripiprazole|mesh-list
92641627|NCT00208169|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641628|NCT00208169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641629|NCT00208169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641630|NCT00208169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641631|NCT00208169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641632|NCT00208169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641633|NCT00208169|Dopamine Agonists|dopamine agonists|mesh-ancestor
92641634|NCT00208169|Dopamine Agents|dopamine agents|mesh-ancestor
92641635|NCT00208169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641638|NCT00208169|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92641639|NCT00208169|Serotonin Agents|serotonin agents|mesh-ancestor
92641640|NCT00208169|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92641641|NCT00208169|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92641642|NCT00208169|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92641643|NCT00208169|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92641644|NCT01087723|Heparin|heparin|mesh-list
92641645|NCT01087723|Bivalirudin|bivalirudin|mesh-list
92641646|NCT01087723|Anticoagulants|anticoagulants|mesh-ancestor
92641647|NCT01087723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92641648|NCT01087723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92641649|NCT01087723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562696|NCT00083148|Antimetabolites|antimetabolites|mesh-ancestor
92562697|NCT00083148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562698|NCT00083148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562699|NCT00083148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92641650|NCT01087723|Antithrombins|antithrombins|mesh-ancestor
92641651|NCT01087723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92641652|NCT01087723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92641653|NCT01087723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641654|NCT00208208|Ziprasidone|ziprasidone|mesh-list
92641655|NCT00208208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92366942|NCT00789672|Levodopa|levodopa|mesh-list
92641656|NCT00208208|Serotonin Agents|serotonin agents|mesh-ancestor
92641657|NCT00208208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641658|NCT00208208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641659|NCT00208208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641660|NCT00208208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641661|NCT00208208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641662|NCT00208208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641663|NCT00208208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641664|NCT00208208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92641665|NCT00208208|Dopamine Agents|dopamine agents|mesh-ancestor
92641666|NCT01085812|Milnacipran|milnacipran|mesh-list
92641667|NCT01085812|Levomilnacipran|levomilnacipran|mesh-list
92641668|NCT01085812|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92641669|NCT01085812|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641670|NCT01085812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641671|NCT01085812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641672|NCT01085812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641673|NCT01085812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641674|NCT01085812|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641675|NCT01085812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641676|NCT01085812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92641677|NCT01085812|Analgesics|analgesics|mesh-ancestor
92641678|NCT01085812|Sensory System Agents|sensory system agents|mesh-ancestor
92641679|NCT01085812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641680|NCT01085734|Bevacizumab|bevacizumab|mesh-list
92641681|NCT01085734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92641682|NCT01085734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641683|NCT01085734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92641684|NCT01085734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92641685|NCT01085734|Growth Substances|growth substances|mesh-ancestor
92641686|NCT01085734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641687|NCT01085734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92641688|NCT00208403|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92641689|NCT00208403|Vasodilator Agents|vasodilator agents|mesh-ancestor
92641690|NCT00208403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92641691|NCT00208403|Protective Agents|protective agents|mesh-ancestor
92641692|NCT00208403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641693|NCT01084603|Nicotine|nicotine|mesh-list
92641694|NCT01084603|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92641695|NCT01084603|Autonomic Agents|autonomic agents|mesh-ancestor
92641696|NCT01084603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641697|NCT01084603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641698|NCT01084603|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92641699|NCT01084603|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92641700|NCT01084603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92641701|NCT01084603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641702|NCT01084603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641703|NCT00208442|Methyclothiazide|methyclothiazide|mesh-list
92641704|NCT00208442|Diuretics|diuretics|mesh-ancestor
92641705|NCT00208442|Natriuretic Agents|natriuretic agents|mesh-ancestor
92641706|NCT00208442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641709|NCT00208442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641710|NCT00233766|Sirolimus|sirolimus|mesh-list
92641711|NCT00233766|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641712|NCT00233766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641713|NCT00233766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92641714|NCT00233766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562700|NCT00083148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562701|NCT00083148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641715|NCT00233766|Antifungal Agents|antifungal agents|mesh-ancestor
92641716|NCT00233766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641717|NCT00233766|Immunologic Factors|immunologic factors|mesh-ancestor
92641718|NCT00233766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641719|NCT00208520|Lamotrigine|lamotrigine|mesh-list
92641720|NCT00208520|Carbamazepine|carbamazepine|mesh-list
92641721|NCT00208520|Levetiracetam|levetiracetam|mesh-list
92641722|NCT00208520|Anticonvulsants|anticonvulsants|mesh-ancestor
92641723|NCT00208520|Nootropic Agents|nootropic agents|mesh-ancestor
92641724|NCT00208520|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92641725|NCT00208520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641726|NCT00208520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641727|NCT00208520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641728|NCT00208520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641729|NCT00208520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641731|NCT00208520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641732|NCT00208520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641733|NCT00208520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92641734|NCT00208520|Antimanic Agents|antimanic agents|mesh-ancestor
92641735|NCT00208520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92641736|NCT00208520|Analgesics|analgesics|mesh-ancestor
92641737|NCT00208520|Sensory System Agents|sensory system agents|mesh-ancestor
92641738|NCT00208520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641739|NCT00208520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92641740|NCT00208520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92641741|NCT00237393|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92641742|NCT00237393|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641743|NCT00237393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641744|NCT00237393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641745|NCT00237393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641746|NCT00237393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641747|NCT00237393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641748|NCT00208559|Ziprasidone|ziprasidone|mesh-list
92641749|NCT00208559|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92641750|NCT00208559|Serotonin Agents|serotonin agents|mesh-ancestor
92641751|NCT00208559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641752|NCT00208559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641753|NCT00208559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641754|NCT00208559|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92641755|NCT00208559|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92641756|NCT00208559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92641757|NCT00208559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641758|NCT00208559|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92641759|NCT00208559|Dopamine Agents|dopamine agents|mesh-ancestor
92641760|NCT00233805|Sirolimus|sirolimus|mesh-list
92641761|NCT00233805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641762|NCT00233805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641763|NCT00233805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92641764|NCT00233805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641765|NCT00233805|Antifungal Agents|antifungal agents|mesh-ancestor
92641766|NCT00233805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641767|NCT00233805|Immunologic Factors|immunologic factors|mesh-ancestor
92641768|NCT00233805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641769|NCT01084135|Rivastigmine|rivastigmine|mesh-list
92641770|NCT01084135|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92641771|NCT01084135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641772|NCT01084135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641773|NCT01084135|Cholinergic Agents|cholinergic agents|mesh-ancestor
92641774|NCT01084135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641775|NCT01084135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641776|NCT01084135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92641777|NCT01084135|Protective Agents|protective agents|mesh-ancestor
92641778|NCT01083316|Dexamethasone|dexamethasone|mesh-list
92641779|NCT01083316|Bortezomib|bortezomib|mesh-list
92641780|NCT01083316|Melphalan|melphalan|mesh-list
92641783|NCT01083316|Autonomic Agents|autonomic agents|mesh-ancestor
92641784|NCT01083316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641785|NCT01083316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641786|NCT01083316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641787|NCT01083316|Glucocorticoids|glucocorticoids|mesh-ancestor
92641788|NCT01083316|Hormones|hormones|mesh-ancestor
92752328|NCT05940701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562703|NCT00153517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562704|NCT00153517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92562705|NCT00153517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92562706|NCT00153517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92562707|NCT00153556|Vaccines|vaccines|mesh-list
92641789|NCT01083316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641790|NCT01083316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641791|NCT01083316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641792|NCT01083316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92641793|NCT01083316|Alkylating Agents|alkylating agents|mesh-ancestor
92641794|NCT01083316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641795|NCT01083316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92641796|NCT01083316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641797|NCT01083316|Immunologic Factors|immunologic factors|mesh-ancestor
92641798|NCT00208715|Modafinil|modafinil|mesh-list
92641799|NCT00208715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92641800|NCT00208715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641801|NCT00208715|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92641802|NCT00208715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92641803|NCT00208715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92641804|NCT00208715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641805|NCT00208793|Calcium, Dietary|calcium, dietary|mesh-list
92641806|NCT00208793|Vitamin D|vitamin d|mesh-list
92641807|NCT00208793|Ergocalciferols|ergocalciferols|mesh-list
92641808|NCT00208793|Cholecalciferol|cholecalciferol|mesh-list
92641809|NCT00208793|Vitamins|vitamins|mesh-list
92641810|NCT00208793|Calcium|calcium|mesh-list
92641811|NCT00208793|Micronutrients|micronutrients|mesh-ancestor
92641812|NCT00208793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641813|NCT00208793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641814|NCT00208793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92641815|NCT00233883|Enfuvirtide|enfuvirtide|mesh-list
92641816|NCT00233883|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92641817|NCT00233883|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92641818|NCT00233883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641819|NCT00233883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92641820|NCT00233883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92641821|NCT00233883|Antiviral Agents|antiviral agents|mesh-ancestor
92641822|NCT00233883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641823|NCT01081873|Leuprolide|leuprolide|mesh-list
92641824|NCT01081873|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92641825|NCT01081873|Fertility Agents|fertility agents|mesh-ancestor
92641826|NCT01081873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92641827|NCT01081873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641828|NCT01081873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641829|NCT01081873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641830|NCT00237471|Insulin|insulin|mesh-list
92641831|NCT00237471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641832|NCT00237471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641833|NCT00237510|Terazosin|terazosin|mesh-list
92641834|NCT00237510|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92641835|NCT00237510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92641836|NCT00237510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92641837|NCT00237510|Adrenergic Agents|adrenergic agents|mesh-ancestor
92641838|NCT00237510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641839|NCT00237510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641840|NCT00237510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641841|NCT00237510|Urological Agents|urological agents|mesh-ancestor
92641842|NCT01081795|Topiramate|topiramate|mesh-list
92641843|NCT01081795|Anticonvulsants|anticonvulsants|mesh-ancestor
92641844|NCT01081795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641845|NCT01081795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641846|NCT00233961|Lenograstim|lenograstim|mesh-list
92641847|NCT00233961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92641848|NCT00233961|Immunologic Factors|immunologic factors|mesh-ancestor
92641849|NCT00233961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641850|NCT00234000|Azacitidine|azacitidine|mesh-list
92641851|NCT00234000|Arsenic Trioxide|arsenic trioxide|mesh-list
92562708|NCT00153556|Immunologic Factors|immunologic factors|mesh-ancestor
92562709|NCT00153556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562711|NCT00083187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641852|NCT00234000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641853|NCT00234000|Antimetabolites|antimetabolites|mesh-ancestor
92641858|NCT00234117|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92641859|NCT00234117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641860|NCT00234117|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92641861|NCT00234117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641862|NCT00234117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641863|NCT00209144|Insulin|insulin|mesh-list
92641864|NCT00209144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92641865|NCT00209144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641866|NCT00209222|Cytarabine|cytarabine|mesh-list
92641867|NCT00209222|Dexamethasone|dexamethasone|mesh-list
92641868|NCT00209222|Prednisone|prednisone|mesh-list
92641869|NCT00209222|Cyclophosphamide|cyclophosphamide|mesh-list
92641870|NCT00209222|Melphalan|melphalan|mesh-list
92641871|NCT00209222|Rituximab|rituximab|mesh-list
92641872|NCT00209222|Doxorubicin|doxorubicin|mesh-list
92641873|NCT00209222|Etoposide|etoposide|mesh-list
92641874|NCT00209222|Vincristine|vincristine|mesh-list
92641875|NCT00209222|Cisplatin|cisplatin|mesh-list
92641876|NCT00209222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92641877|NCT00209222|Immunologic Factors|immunologic factors|mesh-ancestor
92641878|NCT00209222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641879|NCT00209222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92367175|NCT00806598|Antiemetics|antiemetics|mesh-ancestor
92641880|NCT00209222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92641881|NCT00209222|Alkylating Agents|alkylating agents|mesh-ancestor
92641882|NCT00209222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941689|NCT05943470|Icodextrin|icodextrin|mesh-list
92641883|NCT00209222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641884|NCT00209222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92641885|NCT00209222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92641886|NCT00209222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641888|NCT00209222|Autonomic Agents|autonomic agents|mesh-ancestor
92641889|NCT00209222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641890|NCT00209222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641891|NCT00209222|Glucocorticoids|glucocorticoids|mesh-ancestor
92641892|NCT00209222|Hormones|hormones|mesh-ancestor
92641893|NCT00209222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92641894|NCT00209222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92641895|NCT00209222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92641896|NCT00209222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92641897|NCT00209222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92641898|NCT00209222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641899|NCT00209222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92641900|NCT00209222|Tubulin Modulators|tubulin modulators|mesh-ancestor
92641901|NCT00209222|Antimitotic Agents|antimitotic agents|mesh-ancestor
92641902|NCT00209222|Mitosis Modulators|mitosis modulators|mesh-ancestor
92641903|NCT00209222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641904|NCT00209222|Antimetabolites|antimetabolites|mesh-ancestor
92641905|NCT00209222|Antiviral Agents|antiviral agents|mesh-ancestor
92641906|NCT00209222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641907|NCT00234195|Bupropion|bupropion|mesh-list
92641908|NCT00234195|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92641909|NCT00234195|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641910|NCT00234195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641911|NCT00234195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92641912|NCT00234195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641913|NCT00234195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641914|NCT00234195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641915|NCT00234195|Dopamine Agents|dopamine agents|mesh-ancestor
92641916|NCT00234195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641917|NCT00234195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641918|NCT00234195|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92641919|NCT00234195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92641920|NCT00234195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641921|NCT00209261|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92641922|NCT00209261|Hemostatics|hemostatics|mesh-ancestor
92641923|NCT00209261|Coagulants|coagulants|mesh-ancestor
92562712|NCT00083187|Antisickling Agents|antisickling agents|mesh-ancestor
92562713|NCT00083187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562714|NCT00083187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562715|NCT00083187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92562716|NCT00153634|Azithromycin|azithromycin|mesh-list
92562717|NCT00153634|Ciprofloxacin|ciprofloxacin|mesh-list
92641924|NCT00209261|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92641925|NCT00209261|Natriuretic Agents|natriuretic agents|mesh-ancestor
92641928|NCT00209300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92641930|NCT00209300|Analgesics|analgesics|mesh-ancestor
92641931|NCT00209300|Sensory System Agents|sensory system agents|mesh-ancestor
92641932|NCT00209300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641933|NCT00209300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641934|NCT00209300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641935|NCT00209300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641936|NCT00234234|Adalimumab|adalimumab|mesh-list
92641937|NCT00234234|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92641938|NCT00234234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641939|NCT00234234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92641940|NCT00237588|Losartan|losartan|mesh-list
92641941|NCT00237588|Amlodipine|amlodipine|mesh-list
92641942|NCT00237588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92641943|NCT00237588|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92641944|NCT00237588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641945|NCT00237588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641946|NCT00237588|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92641947|NCT00237588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641948|NCT00237588|Vasodilator Agents|vasodilator agents|mesh-ancestor
92641949|NCT00237588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92641950|NCT00237588|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92641951|NCT00237588|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92641952|NCT00411437|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92641953|NCT00411437|Oxybutynin|oxybutynin|mesh-list
92641954|NCT00411437|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92641955|NCT00411437|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92641956|NCT00411437|Cholinergic Agents|cholinergic agents|mesh-ancestor
92641957|NCT00411437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641958|NCT00411437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641959|NCT00411437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641960|NCT00411437|Urological Agents|urological agents|mesh-ancestor
92641961|NCT00411437|Parasympatholytics|parasympatholytics|mesh-ancestor
92641962|NCT00411437|Autonomic Agents|autonomic agents|mesh-ancestor
92641963|NCT00411437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641964|NCT00234312|Sertraline|sertraline|mesh-list
92641965|NCT00234312|Escitalopram|escitalopram|mesh-list
92641966|NCT00234312|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92641967|NCT00234312|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92641968|NCT00234312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641969|NCT00234312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641970|NCT00234312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641971|NCT00234312|Serotonin Agents|serotonin agents|mesh-ancestor
92641972|NCT00234312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641973|NCT00234312|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641974|NCT00234312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92641975|NCT00411515|Mycophenolic Acid|mycophenolic acid|mesh-list
92641976|NCT00411515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92641977|NCT00411515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641978|NCT00411515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92641979|NCT00411515|Antitubercular Agents|antitubercular agents|mesh-ancestor
92641980|NCT00411515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92641981|NCT00411515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92641982|NCT00411515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641983|NCT00411515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641984|NCT00237627|Doxorubicin|doxorubicin|mesh-list
92641985|NCT00237627|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92641986|NCT00237627|Bortezomib|bortezomib|mesh-list
92641987|NCT00237627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92641988|NCT00237627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562718|NCT00153634|Meropenem|meropenem|mesh-list
92562719|NCT00153634|Tazobactam|tazobactam|mesh-list
92562720|NCT00153634|Piperacillin|piperacillin|mesh-list
92562721|NCT00153634|Tobramycin|tobramycin|mesh-list
92562722|NCT00153634|Clavulanic Acid|clavulanic acid|mesh-list
92562723|NCT00153634|Amikacin|amikacin|mesh-list
92562724|NCT00153634|Ceftazidime|ceftazidime|mesh-list
92641989|NCT00237627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92641990|NCT00237627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92641991|NCT00237627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641992|NCT00237627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641993|NCT00209495|Dexamethasone|dexamethasone|mesh-list
92641994|NCT00209495|Pregabalin|pregabalin|mesh-list
92641995|NCT00209495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641996|NCT00209495|Antiemetics|antiemetics|mesh-ancestor
92049107|NCT02150954|Oxytocin|oxytocin|mesh-list
92642000|NCT00209495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642001|NCT00209495|Glucocorticoids|glucocorticoids|mesh-ancestor
92642002|NCT00209495|Hormones|hormones|mesh-ancestor
92642003|NCT00209495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642004|NCT00209495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92642005|NCT00209495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642006|NCT00209495|Analgesics|analgesics|mesh-ancestor
92642007|NCT00209495|Sensory System Agents|sensory system agents|mesh-ancestor
92642008|NCT00209495|Anticonvulsants|anticonvulsants|mesh-ancestor
92642009|NCT00209495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92642010|NCT00209495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642011|NCT00209495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642012|NCT00209495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92642013|NCT00209495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92642014|NCT00209495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642015|NCT00209495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642016|NCT00209495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642017|NCT00234390|Budesonide|budesonide|mesh-list
92642018|NCT00234390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92642019|NCT00234390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92642020|NCT00234390|Autonomic Agents|autonomic agents|mesh-ancestor
92642021|NCT00234390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642022|NCT00234390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642023|NCT00234390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92642024|NCT00234390|Respiratory System Agents|respiratory system agents|mesh-ancestor
92642025|NCT00234390|Glucocorticoids|glucocorticoids|mesh-ancestor
92642026|NCT00234390|Hormones|hormones|mesh-ancestor
92642027|NCT00234390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642028|NCT00209534|Fospropofol|fospropofol|mesh-list
92642029|NCT00209534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92642030|NCT00209534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642031|NCT00209534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642032|NCT00209573|Fospropofol|fospropofol|mesh-list
92642033|NCT00209573|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92642034|NCT00209573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642035|NCT00209573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642036|NCT00209612|Paclitaxel|paclitaxel|mesh-list
92642037|NCT00209612|Irinotecan|irinotecan|mesh-list
92642038|NCT00209612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92642039|NCT00209612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642040|NCT00209612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92642041|NCT00209612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92642042|NCT00209612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92642043|NCT00209612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642044|NCT00209612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92642045|NCT00209612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642046|NCT00209612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642047|NCT01081249|Oxytocin|oxytocin|mesh-list
92642048|NCT01081249|Oxytocics|oxytocics|mesh-ancestor
92642049|NCT01081249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92642050|NCT01081249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642051|NCT00234429|Gefitinib|gefitinib|mesh-list
92642052|NCT00234429|Raltitrexed|raltitrexed|mesh-list
92642053|NCT00234429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642054|NCT00234429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92642055|NCT00234429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991548|NCT04383119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642056|NCT00234429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642057|NCT00234429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642058|NCT00234429|Antimetabolites|antimetabolites|mesh-ancestor
92642059|NCT00234429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92642060|NCT00209651|Irinotecan|irinotecan|mesh-list
92642061|NCT00209651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92642062|NCT00209651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642063|NCT00209651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642064|NCT00209651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642065|NCT00209651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642066|NCT02961855|Diclofenac|diclofenac|mesh-list
92642067|NCT02961855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92642068|NCT02961855|Lidocaine|lidocaine|mesh-list
92642072|NCT02961855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642073|NCT02961855|Sensory System Agents|sensory system agents|mesh-ancestor
92642074|NCT02961855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642075|NCT02961855|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92642076|NCT02961855|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92642077|NCT02961855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92642078|NCT02961855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642079|NCT02961855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642080|NCT02961855|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92642081|NCT02961855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92642082|NCT02961855|Analgesics|analgesics|mesh-ancestor
92642083|NCT02961855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92642084|NCT02961855|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92642085|NCT02961855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642086|NCT00209690|Cisplatin|cisplatin|mesh-list
92642087|NCT00209690|Docetaxel|docetaxel|mesh-list
92642088|NCT00209690|Fluorouracil|fluorouracil|mesh-list
92642089|NCT00209690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642090|NCT00209690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92642091|NCT00209690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92642092|NCT00209690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92642093|NCT00209690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642094|NCT00209690|Antimetabolites|antimetabolites|mesh-ancestor
92642095|NCT00209690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642096|NCT00209690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642097|NCT00209690|Immunologic Factors|immunologic factors|mesh-ancestor
92642098|NCT00209690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642099|NCT01081132|Guanfacine|guanfacine|mesh-list
92642100|NCT01081132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92642101|NCT01081132|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92642102|NCT01081132|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92642103|NCT01081132|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92642104|NCT01081132|Adrenergic Agents|adrenergic agents|mesh-ancestor
92642105|NCT01081132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642106|NCT01081132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642107|NCT01081132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642108|NCT00234468|Gefitinib|gefitinib|mesh-list
92642109|NCT00234468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642110|NCT00234468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92642111|NCT00234468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642112|NCT00234468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642113|NCT01080625|Phenylephrine|phenylephrine|mesh-list
92642114|NCT01080625|Epinephrine|epinephrine|mesh-list
92642115|NCT01080625|Oxymetazoline|oxymetazoline|mesh-list
92642116|NCT01080625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92642117|NCT01080625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92642118|NCT01080625|Adrenergic Agents|adrenergic agents|mesh-ancestor
92642119|NCT01080625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642120|NCT01080625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642121|NCT01080625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642122|NCT01080625|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92642123|NCT01080625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92642124|NCT01080625|Autonomic Agents|autonomic agents|mesh-ancestor
92642125|NCT01080625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642126|NCT01080625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92642127|NCT01080625|Respiratory System Agents|respiratory system agents|mesh-ancestor
92642128|NCT01080625|Mydriatics|mydriatics|mesh-ancestor
92642129|NCT01080625|Sympathomimetics|sympathomimetics|mesh-ancestor
92642130|NCT01080625|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92562725|NCT00153634|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92562727|NCT00153634|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
92562728|NCT00153634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92562729|NCT00153634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642131|NCT01080625|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92642132|NCT01080625|Nasal Decongestants|nasal decongestants|mesh-ancestor
92642133|NCT01080625|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92642134|NCT01080625|Protective Agents|protective agents|mesh-ancestor
92642135|NCT00209729|Docetaxel|docetaxel|mesh-list
92642136|NCT00209729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642137|NCT00209729|Tubulin Modulators|tubulin modulators|mesh-ancestor
92642138|NCT00209729|Antimitotic Agents|antimitotic agents|mesh-ancestor
92642139|NCT00209729|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682820|NCT00438152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92642142|NCT00414180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92642143|NCT00414180|Antidepressive Agents|antidepressive agents|mesh-ancestor
92642144|NCT00414180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642145|NCT00414180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92642146|NCT00414180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92642147|NCT00414180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642148|NCT00414180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642149|NCT00414180|Dopamine Agents|dopamine agents|mesh-ancestor
92642150|NCT00414180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642151|NCT00414180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642152|NCT00414180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92642153|NCT00414180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92642154|NCT00414180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642155|NCT01089790|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92642156|NCT01089790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92642157|NCT01089790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642158|NCT01089790|Incretins|incretins|mesh-ancestor
92642159|NCT01089790|Hormones|hormones|mesh-ancestor
92642160|NCT01089790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642161|NCT01089790|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92642162|NCT01089790|Protease Inhibitors|protease inhibitors|mesh-ancestor
92642163|NCT01089790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642164|NCT01089790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642165|NCT00234507|Botulinum Toxins|botulinum toxins|mesh-list
92642166|NCT00234507|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92642167|NCT00234507|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92642168|NCT00234507|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92642169|NCT00234507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642170|NCT00234507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642171|NCT00234507|Cholinergic Agents|cholinergic agents|mesh-ancestor
92642172|NCT00234507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642173|NCT00234507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642174|NCT00234507|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92642175|NCT00234507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367476|NCT00834210|Vitamins|vitamins|mesh-ancestor
92642176|NCT01084330|Docetaxel|docetaxel|mesh-list
92642177|NCT01084330|Irinotecan|irinotecan|mesh-list
92642178|NCT01084330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642179|NCT01084330|Tubulin Modulators|tubulin modulators|mesh-ancestor
92642180|NCT01084330|Antimitotic Agents|antimitotic agents|mesh-ancestor
92642181|NCT01084330|Mitosis Modulators|mitosis modulators|mesh-ancestor
92642182|NCT01084330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642183|NCT01084330|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92642184|NCT01084330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642185|NCT01084330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642186|NCT00209807|Reboxetine|reboxetine|mesh-list
92642187|NCT00209807|Escitalopram|escitalopram|mesh-list
92642188|NCT00209807|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92642189|NCT00209807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92642190|NCT00209807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642191|NCT00209807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642192|NCT00209807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562730|NCT00153634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92562731|NCT00153634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562732|NCT00153634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970173|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642193|NCT00209807|Serotonin Agents|serotonin agents|mesh-ancestor
92642194|NCT00209807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642195|NCT00209807|Antidepressive Agents|antidepressive agents|mesh-ancestor
92642196|NCT00209807|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642197|NCT00209807|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92642198|NCT00209807|Adrenergic Agents|adrenergic agents|mesh-ancestor
92642199|NCT00209846|Gaboxadol|gaboxadol|mesh-list
92642200|NCT00209846|Analgesics|analgesics|mesh-ancestor
92642201|NCT00209846|Sensory System Agents|sensory system agents|mesh-ancestor
92642202|NCT00209846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642203|NCT00209846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642204|NCT00209846|Anticonvulsants|anticonvulsants|mesh-ancestor
92642205|NCT00209846|GABA Agonists|gaba agonists|mesh-ancestor
92642206|NCT00209846|GABA Agents|gaba agents|mesh-ancestor
92642207|NCT00209846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642208|NCT00209846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642209|NCT01082068|Letrozole|letrozole|mesh-list
92642214|NCT01082068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642215|NCT01082068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92642216|NCT01082068|Hormone Antagonists|hormone antagonists|mesh-ancestor
92642217|NCT01082068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642218|NCT01082068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642219|NCT01086748|Risperidone|risperidone|mesh-list
92642220|NCT01086748|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92642221|NCT01086748|Serotonin Agents|serotonin agents|mesh-ancestor
92642222|NCT01086748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642223|NCT01086748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642224|NCT01086748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642225|NCT01086748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92642226|NCT01086748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642227|NCT01086748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642228|NCT01086748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642229|NCT01086748|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642230|NCT01086748|Dopamine Agents|dopamine agents|mesh-ancestor
92642231|NCT00237705|Metoclopramide|metoclopramide|mesh-list
92642232|NCT00237705|Antiemetics|antiemetics|mesh-ancestor
92642233|NCT00237705|Autonomic Agents|autonomic agents|mesh-ancestor
92642234|NCT00237705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642235|NCT00237705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642236|NCT00237705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642237|NCT00237705|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92642238|NCT00237705|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642239|NCT00237705|Dopamine Agents|dopamine agents|mesh-ancestor
92642240|NCT00237705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642241|NCT00237705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642242|NCT00209885|Lidocaine|lidocaine|mesh-list
92642243|NCT00209885|Droperidol|droperidol|mesh-list
92642244|NCT00209885|Ketamine|ketamine|mesh-list
92642245|NCT00209885|Gabapentin|gabapentin|mesh-list
92642246|NCT00209885|Esketamine|esketamine|mesh-list
92642247|NCT00209885|Anesthetics, Local|anesthetics, local|mesh-ancestor
92642248|NCT00209885|Anesthetics|anesthetics|mesh-ancestor
92367539|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
92642249|NCT00209885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642250|NCT00209885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642251|NCT00209885|Sensory System Agents|sensory system agents|mesh-ancestor
92642252|NCT00209885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642253|NCT00209885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92642254|NCT00209885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92642255|NCT00209885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92642256|NCT00209885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642257|NCT00209885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642259|NCT00209885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92642260|NCT00209885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92642261|NCT00209885|Anesthetics, General|anesthetics, general|mesh-ancestor
92642262|NCT00209885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92642263|NCT00209885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92562733|NCT00153634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562734|NCT00153634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562735|NCT00153634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92562736|NCT00153634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92562737|NCT00153634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92642264|NCT00209885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642265|NCT00209885|Anticonvulsants|anticonvulsants|mesh-ancestor
92642266|NCT00209885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92642267|NCT00209885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642268|NCT00209885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642269|NCT00209885|Antimanic Agents|antimanic agents|mesh-ancestor
92642270|NCT00209885|Antidepressive Agents|antidepressive agents|mesh-ancestor
92642271|NCT00209885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92642272|NCT00209885|Antiemetics|antiemetics|mesh-ancestor
92642273|NCT00209885|Autonomic Agents|autonomic agents|mesh-ancestor
92642274|NCT00209885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642275|NCT00209885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92642276|NCT00209885|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92642277|NCT00209885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642278|NCT00209885|Dopamine Agents|dopamine agents|mesh-ancestor
92642279|NCT00234546|Botulinum Toxins|botulinum toxins|mesh-list
92642280|NCT00234546|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92642281|NCT00234546|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92642285|NCT00234546|Cholinergic Agents|cholinergic agents|mesh-ancestor
92642286|NCT00234546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642287|NCT00234546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642288|NCT00234546|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92642289|NCT00234546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642290|NCT00209924|Gaboxadol|gaboxadol|mesh-list
92642291|NCT00209924|Analgesics|analgesics|mesh-ancestor
92642292|NCT00209924|Sensory System Agents|sensory system agents|mesh-ancestor
92642293|NCT00209924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642294|NCT00209924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642295|NCT00209924|Anticonvulsants|anticonvulsants|mesh-ancestor
92642296|NCT00209924|GABA Agonists|gaba agonists|mesh-ancestor
92642297|NCT00209924|GABA Agents|gaba agents|mesh-ancestor
92642298|NCT00209924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642299|NCT00209924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642300|NCT00209963|Gaboxadol|gaboxadol|mesh-list
92642301|NCT00209963|Analgesics|analgesics|mesh-ancestor
92642302|NCT00209963|Sensory System Agents|sensory system agents|mesh-ancestor
92642303|NCT00209963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642304|NCT00209963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642305|NCT00209963|Anticonvulsants|anticonvulsants|mesh-ancestor
92642306|NCT00209963|GABA Agonists|gaba agonists|mesh-ancestor
92642307|NCT00209963|GABA Agents|gaba agents|mesh-ancestor
92750774|NCT05936229|Antiviral Agents|antiviral agents|mesh-ancestor
92642308|NCT00209963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642309|NCT00209963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642310|NCT00210002|Darbepoetin alfa|darbepoetin alfa|mesh-list
92642311|NCT00210002|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92642312|NCT00210002|Hematinics|hematinics|mesh-ancestor
92642313|NCT02277886|Esomeprazole|esomeprazole|mesh-list
92642314|NCT02277886|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92642315|NCT02277886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642316|NCT02277886|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92642317|NCT02277886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642318|NCT02277886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642319|NCT00413751|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92642320|NCT00413751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92642321|NCT00413751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92642322|NCT00413751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92642323|NCT00413751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92642324|NCT00413751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92642325|NCT00413751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92642326|NCT00413751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92642327|NCT00413751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642328|NCT00413751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642329|NCT00413751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642330|NCT00210041|Gemcitabine|gemcitabine|mesh-list
92642331|NCT00210041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562738|NCT00050609|Tadalafil|tadalafil|mesh-list
92562739|NCT00050609|Vasodilator Agents|vasodilator agents|mesh-ancestor
92562740|NCT00050609|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92642332|NCT00210041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642333|NCT00210041|Antimetabolites|antimetabolites|mesh-ancestor
92642334|NCT00210041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642335|NCT04990804|Analgesics, Opioid|analgesics, opioid|mesh-list
92642336|NCT04990804|Analgesics|analgesics|mesh-list
92642337|NCT04990804|Narcotics|narcotics|mesh-ancestor
92642338|NCT04990804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642339|NCT04990804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642340|NCT04990804|Sensory System Agents|sensory system agents|mesh-ancestor
92642341|NCT04990804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642342|NCT00237783|Dialysis Solutions|dialysis solutions|mesh-list
92642343|NCT00237783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92642344|NCT04991662|Phenylephrine|phenylephrine|mesh-list
92642345|NCT04991662|Oxymetazoline|oxymetazoline|mesh-list
92642346|NCT04991662|Norepinephrine|norepinephrine|mesh-list
92642347|NCT04991662|Metaraminol|metaraminol|mesh-list
92642348|NCT04991662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92642349|NCT04991662|Mydriatics|mydriatics|mesh-ancestor
92642350|NCT04991662|Autonomic Agents|autonomic agents|mesh-ancestor
92642351|NCT04991662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642352|NCT04991662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049474|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
92642355|NCT04991662|Nasal Decongestants|nasal decongestants|mesh-ancestor
92642356|NCT04991662|Respiratory System Agents|respiratory system agents|mesh-ancestor
92642357|NCT04991662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92642358|NCT04991662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92642359|NCT04991662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92642360|NCT04991662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92642361|NCT04991662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642362|NCT04991662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642363|NCT04991662|Protective Agents|protective agents|mesh-ancestor
92642364|NCT04997941|Tamoxifen|tamoxifen|mesh-list
92642365|NCT04997941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92642366|NCT04997941|Hormone Antagonists|hormone antagonists|mesh-ancestor
92642367|NCT04997941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642368|NCT04997941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642369|NCT04997941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92642370|NCT04997941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642371|NCT04997941|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92642372|NCT04997941|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92642373|NCT04997941|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92642374|NCT00210158|Nitrous Oxide|nitrous oxide|mesh-list
92642375|NCT00210158|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92642376|NCT00210158|Anesthetics, General|anesthetics, general|mesh-ancestor
92642377|NCT00210158|Anesthetics|anesthetics|mesh-ancestor
92642378|NCT00210158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642379|NCT00210158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642380|NCT00210158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92642381|NCT00210158|Analgesics|analgesics|mesh-ancestor
92642382|NCT00210158|Sensory System Agents|sensory system agents|mesh-ancestor
92642383|NCT00210158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642384|NCT00413790|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92642385|NCT00413790|Darifenacin|darifenacin|mesh-list
92642386|NCT00413790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92642387|NCT00413790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92642388|NCT00413790|Cholinergic Agents|cholinergic agents|mesh-ancestor
92642389|NCT00413790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642390|NCT00413790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642391|NCT00413790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642392|NCT00413790|Urological Agents|urological agents|mesh-ancestor
92642393|NCT01059903|Rotigotine|rotigotine|mesh-list
92642394|NCT01059903|Dopamine Agonists|dopamine agonists|mesh-ancestor
92642395|NCT01059903|Dopamine Agents|dopamine agents|mesh-ancestor
92642396|NCT01059903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642397|NCT01059903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642398|NCT01059903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642399|NCT04996771|Cisplatin|cisplatin|mesh-list
92367694|NCT00878826|Enoxaparin|enoxaparin|mesh-list
92642400|NCT04996771|Etoposide|etoposide|mesh-list
92562741|NCT00050609|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92562742|NCT00050609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562743|NCT00050609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562744|NCT00050609|Urological Agents|urological agents|mesh-ancestor
92562745|NCT00153673|Celecoxib|celecoxib|mesh-list
92562746|NCT00153673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92562747|NCT00153673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92562748|NCT00153673|Analgesics|analgesics|mesh-ancestor
91970187|NCT02475161|Rabeprazole|rabeprazole|mesh-list
92642401|NCT04996771|Etoposide phosphate|etoposide phosphate|mesh-list
92642402|NCT04996771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642403|NCT04996771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92642404|NCT04996771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92642405|NCT04996771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642406|NCT04996771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642407|NCT04996771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642408|NCT00210314|Cytarabine|cytarabine|mesh-list
92642409|NCT00210314|Methotrexate|methotrexate|mesh-list
92642410|NCT00210314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92642411|NCT00210314|Abortifacient Agents|abortifacient agents|mesh-ancestor
92642412|NCT00210314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92642413|NCT00210314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642414|NCT00210314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642415|NCT00210314|Antimetabolites|antimetabolites|mesh-ancestor
92642416|NCT00210314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642417|NCT00210314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642418|NCT00210314|Dermatologic Agents|dermatologic agents|mesh-ancestor
92642419|NCT00210314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642420|NCT00210314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92642421|NCT00210314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642422|NCT00210314|Immunologic Factors|immunologic factors|mesh-ancestor
92642423|NCT00210314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92642426|NCT00210314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642427|NCT00210392|Bortezomib|bortezomib|mesh-list
92642428|NCT00210392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642429|NCT00413829|Ranibizumab|ranibizumab|mesh-list
92642430|NCT00413829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92642431|NCT00413829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92642432|NCT00413829|Growth Substances|growth substances|mesh-ancestor
92642433|NCT00413829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642434|NCT00413829|Growth Inhibitors|growth inhibitors|mesh-ancestor
92642435|NCT00413829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642436|NCT02210104|Cyclophosphamide|cyclophosphamide|mesh-list
92642437|NCT02210104|Ipilimumab|ipilimumab|mesh-list
92642438|NCT02210104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642439|NCT02210104|Immunologic Factors|immunologic factors|mesh-ancestor
92642440|NCT02210104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642441|NCT02210104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92642442|NCT02210104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92642443|NCT02210104|Alkylating Agents|alkylating agents|mesh-ancestor
92642444|NCT02210104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642445|NCT02210104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642446|NCT02210104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92642447|NCT02210104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92642448|NCT02210104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92642449|NCT02210182|Pentamidine|pentamidine|mesh-list
92642450|NCT02210182|Antifungal Agents|antifungal agents|mesh-ancestor
92642451|NCT02210182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642452|NCT02210182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92642453|NCT02210182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92642454|NCT02210182|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92642455|NCT00210509|Almotriptan|almotriptan|mesh-list
92642456|NCT00210509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92642457|NCT00210509|Serotonin Agents|serotonin agents|mesh-ancestor
92642458|NCT00210509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642459|NCT00210509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562749|NCT00153673|Sensory System Agents|sensory system agents|mesh-ancestor
92562750|NCT00153673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562751|NCT00153673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562752|NCT00153673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562753|NCT00153673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562754|NCT00153673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92562755|NCT00153673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92562756|NCT00153673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970193|NCT03074097|Bupivacaine|bupivacaine|mesh-list
92642460|NCT00210509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642461|NCT02210260|Heroin|heroin|mesh-list
92642462|NCT02210260|Bupivacaine|bupivacaine|mesh-list
92642463|NCT02210260|Anesthetics, Local|anesthetics, local|mesh-list
92642464|NCT02210260|Anesthetics|anesthetics|mesh-list
92642465|NCT02210260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642466|NCT02210260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642467|NCT02210260|Sensory System Agents|sensory system agents|mesh-ancestor
92642468|NCT02210260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642469|NCT02210260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92642470|NCT02210260|Narcotics|narcotics|mesh-ancestor
92642471|NCT02210260|Analgesics|analgesics|mesh-ancestor
92642472|NCT00210548|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92642473|NCT00210548|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92642474|NCT00210548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642475|NCT00210548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642476|NCT00210548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642477|NCT00210548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642478|NCT00210548|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92642479|NCT00210548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92642480|NCT00210548|Serotonin Agents|serotonin agents|mesh-ancestor
92642481|NCT00210548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642482|NCT00210548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642483|NCT00210548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92642484|NCT00210548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642485|NCT00210548|Dopamine Agents|dopamine agents|mesh-ancestor
92642487|NCT00210587|Hematinics|hematinics|mesh-ancestor
92642488|NCT00210665|Trabectedin|trabectedin|mesh-list
92642489|NCT00210665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92642490|NCT00210665|Alkylating Agents|alkylating agents|mesh-ancestor
92642491|NCT00210665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642492|NCT00210665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642493|NCT04570345|Aspirin|aspirin|mesh-list
92642494|NCT04570345|Ticagrelor|ticagrelor|mesh-list
92642495|NCT04570345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92642496|NCT04570345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92642497|NCT04570345|Analgesics|analgesics|mesh-ancestor
92642498|NCT04570345|Sensory System Agents|sensory system agents|mesh-ancestor
92642505|NCT04570345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642506|NCT04570345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92642507|NCT04570345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92642508|NCT04570345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642509|NCT04570345|Antipyretics|antipyretics|mesh-ancestor
92642510|NCT04570345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92642511|NCT04570345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92642512|NCT04570345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92642513|NCT04570345|Purinergic Agents|purinergic agents|mesh-ancestor
92642514|NCT04570345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642515|NCT00234819|Bazedoxifene|bazedoxifene|mesh-list
92642516|NCT00234819|Estrogens|estrogens|mesh-list
92642517|NCT00234819|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92642518|NCT00234819|Hormones|hormones|mesh-ancestor
92642519|NCT00234819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642520|NCT00234819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642521|NCT00234819|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92642522|NCT00234819|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92642523|NCT00234819|Hormone Antagonists|hormone antagonists|mesh-ancestor
92562757|NCT00153673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562758|NCT00050648|Cyclosporine|cyclosporine|mesh-list
92562759|NCT00050648|Cyclosporins|cyclosporins|mesh-list
92562760|NCT00050648|Daclizumab|daclizumab|mesh-list
92562761|NCT00050648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562762|NCT00050648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562763|NCT00050648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562764|NCT00050648|Immunologic Factors|immunologic factors|mesh-ancestor
92562765|NCT00050648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642524|NCT00234819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92642525|NCT04570306|Belimumab|belimumab|mesh-list
92642526|NCT04570306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642527|NCT04570306|Immunologic Factors|immunologic factors|mesh-ancestor
92642528|NCT04570306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642529|NCT04570033|Parathyroid Hormone|parathyroid hormone|mesh-list
92642530|NCT04570033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92642531|NCT04570033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642532|NCT00234858|Losartan|losartan|mesh-list
92642533|NCT00234858|Verapamil|verapamil|mesh-list
92642534|NCT00234858|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92642535|NCT00234858|Trandolapril|trandolapril|mesh-list
92642536|NCT00234858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92642537|NCT00234858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92642538|NCT00234858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92642539|NCT00234858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92642540|NCT00234858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642541|NCT00234858|Diuretics|diuretics|mesh-ancestor
92642542|NCT00234858|Natriuretic Agents|natriuretic agents|mesh-ancestor
92642543|NCT00234858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642544|NCT00234858|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92642545|NCT00234858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642546|NCT00234858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92642547|NCT00234858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92642548|NCT00234858|Vasodilator Agents|vasodilator agents|mesh-ancestor
92642549|NCT00234858|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92642550|NCT00234858|Protease Inhibitors|protease inhibitors|mesh-ancestor
92642551|NCT00234858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642552|NCT04569838|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92642553|NCT04569838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92642554|NCT04569838|Alkylating Agents|alkylating agents|mesh-ancestor
92642555|NCT04569838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642556|NCT04569838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642557|NCT00210743|Epoetin Alfa|epoetin alfa|mesh-list
92642558|NCT00210743|Hematinics|hematinics|mesh-ancestor
92642560|NCT04569916|Apatinib|apatinib|mesh-list
92642561|NCT04569916|Antibodies|antibodies|mesh-list
92642562|NCT04569916|Immunologic Factors|immunologic factors|mesh-ancestor
92642563|NCT04569916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642564|NCT04569916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92642565|NCT04569916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642566|NCT04569916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642567|NCT04569916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642569|NCT04569916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92642570|NCT00210782|Topiramate|topiramate|mesh-list
92642571|NCT00210782|Phenytoin|phenytoin|mesh-list
92642572|NCT00210782|Anticonvulsants|anticonvulsants|mesh-ancestor
92642573|NCT00210782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92642574|NCT00210782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642575|NCT00210782|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92642576|NCT00210782|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92642577|NCT00210782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642578|NCT00210782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642579|NCT00210782|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92642580|NCT00210782|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92562766|NCT00050648|Antifungal Agents|antifungal agents|mesh-ancestor
92562767|NCT00050648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562768|NCT00050648|Dermatologic Agents|dermatologic agents|mesh-ancestor
92562769|NCT00050648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562770|NCT00050648|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92562771|NCT00153868|Darbepoetin alfa|darbepoetin alfa|mesh-list
92562772|NCT00153868|Hematinics|hematinics|mesh-ancestor
92562773|NCT00153907|Capecitabine|capecitabine|mesh-list
92562774|NCT00153907|Vinorelbine|vinorelbine|mesh-list
92562775|NCT00153907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562776|NCT00153907|Antimetabolites|antimetabolites|mesh-ancestor
92562777|NCT00153907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642581|NCT00237861|Olanzapine|olanzapine|mesh-list
92642582|NCT00237861|Risperidone|risperidone|mesh-list
92642583|NCT00237861|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92642584|NCT00237861|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92642585|NCT00237861|Serotonin Agents|serotonin agents|mesh-ancestor
92642586|NCT00237861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642587|NCT00237861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642588|NCT00237861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642589|NCT00237861|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92642590|NCT00237861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642591|NCT00237861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642592|NCT00237861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642593|NCT00237861|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642594|NCT00237861|Dopamine Agents|dopamine agents|mesh-ancestor
92642595|NCT00237861|Antiemetics|antiemetics|mesh-ancestor
92642596|NCT00237861|Autonomic Agents|autonomic agents|mesh-ancestor
92642597|NCT00237861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642598|NCT00237861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642599|NCT00237861|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92642600|NCT00237861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92642601|NCT00237861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642602|NCT00237861|Antidepressive Agents|antidepressive agents|mesh-ancestor
92642603|NCT00237900|Leucovorin|leucovorin|mesh-list
92642604|NCT00237900|Fluorouracil|fluorouracil|mesh-list
92642605|NCT00237900|Gefitinib|gefitinib|mesh-list
92642606|NCT00237900|Antimetabolites|antimetabolites|mesh-ancestor
92642607|NCT00237900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642608|NCT00237900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642609|NCT00237900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642610|NCT00237900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642611|NCT00237900|Immunologic Factors|immunologic factors|mesh-ancestor
92642612|NCT00237900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642613|NCT00237900|Antidotes|antidotes|mesh-ancestor
92642614|NCT00237900|Protective Agents|protective agents|mesh-ancestor
92642615|NCT00237900|Vitamin B Complex|vitamin b complex|mesh-ancestor
92642616|NCT00237900|Vitamins|vitamins|mesh-ancestor
92642617|NCT00237900|Micronutrients|micronutrients|mesh-ancestor
92642618|NCT00237900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92642619|NCT00237900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642620|NCT00210821|Topiramate|topiramate|mesh-list
92642621|NCT00210821|Anticonvulsants|anticonvulsants|mesh-ancestor
92642622|NCT00210821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92642623|NCT00210821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642624|NCT00237939|Aripiprazole|aripiprazole|mesh-list
92642625|NCT00237939|Antidepressive Agents|antidepressive agents|mesh-ancestor
92642626|NCT00237939|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642627|NCT00237939|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92642628|NCT00237939|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642629|NCT00237939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642630|NCT00237939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642631|NCT00237939|Dopamine Agonists|dopamine agonists|mesh-ancestor
92642632|NCT00237939|Dopamine Agents|dopamine agents|mesh-ancestor
92642633|NCT00237939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562778|NCT00153907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562779|NCT00153907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92562780|NCT00153907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92562781|NCT00153907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92562782|NCT00153907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562784|NCT00050726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562785|NCT00050726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92642634|NCT00237939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642635|NCT00237939|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92642636|NCT00237939|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92642637|NCT00237939|Serotonin Agents|serotonin agents|mesh-ancestor
92642638|NCT00237939|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92642639|NCT00237939|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92642640|NCT00237939|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92642655|NCT04568863|Melatonin|melatonin|mesh-list
92642656|NCT04568863|Antioxidants|antioxidants|mesh-ancestor
92642657|NCT04568863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642658|NCT04568863|Protective Agents|protective agents|mesh-ancestor
92642659|NCT04568863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642660|NCT04568863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642661|NCT00210938|Doripenem|doripenem|mesh-list
92642662|NCT00210938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92642663|NCT00210938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642664|NCT02278081|Lansoprazole|lansoprazole|mesh-list
92642665|NCT02278081|Dexlansoprazole|dexlansoprazole|mesh-list
92642666|NCT02278081|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92642667|NCT02278081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642668|NCT02278081|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92642669|NCT02278081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642670|NCT02278081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642671|NCT00211016|Doripenem|doripenem|mesh-list
92642672|NCT00211016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92642673|NCT00211016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642674|NCT00238017|Artesunate|artesunate|mesh-list
92642675|NCT00238017|Amodiaquine|amodiaquine|mesh-list
92642676|NCT00238017|Antimalarials|antimalarials|mesh-ancestor
92642677|NCT00238017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92642678|NCT00238017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92642679|NCT00238017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642680|NCT00238017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642681|NCT00238017|Antiviral Agents|antiviral agents|mesh-ancestor
92642682|NCT00238017|Schistosomicides|schistosomicides|mesh-ancestor
92642683|NCT00238017|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92642684|NCT00238017|Anthelmintics|anthelmintics|mesh-ancestor
92642685|NCT04567576|Antirheumatic Agents|antirheumatic agents|mesh-list
92642686|NCT00238056|Domperidone|domperidone|mesh-list
92642687|NCT00238056|Antiemetics|antiemetics|mesh-ancestor
92642688|NCT00238056|Autonomic Agents|autonomic agents|mesh-ancestor
92642689|NCT00238056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642690|NCT00238056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642691|NCT00238056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642692|NCT00238056|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642693|NCT00238056|Dopamine Agents|dopamine agents|mesh-ancestor
92642694|NCT00238056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642695|NCT00238056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642696|NCT04566952|Olaparib|olaparib|mesh-list
92642697|NCT04566952|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92642698|NCT04566952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642699|NCT04566952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642700|NCT04566952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642701|NCT04567069|Vaccines|vaccines|mesh-list
92642702|NCT04567069|Immunologic Factors|immunologic factors|mesh-ancestor
92642703|NCT04567069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642704|NCT04566796|Neostigmine|neostigmine|mesh-list
92642705|NCT04566796|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92642706|NCT04566796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642708|NCT04566796|Cholinergic Agents|cholinergic agents|mesh-ancestor
92562786|NCT00050726|Analgesics|analgesics|mesh-ancestor
92562787|NCT00050726|Sensory System Agents|sensory system agents|mesh-ancestor
92562788|NCT00050726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562789|NCT00050726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562790|NCT00153946|Edaravone|edaravone|mesh-list
91992305|NCT04435925|Remifentanil|remifentanil|mesh-list
92642709|NCT04566796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642710|NCT04566796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642711|NCT04566796|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92642712|NCT04566796|Autonomic Agents|autonomic agents|mesh-ancestor
92642713|NCT04566796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642714|NCT00238173|Acetylcysteine|acetylcysteine|mesh-list
92642715|NCT00238173|Sodium thiosulfate|sodium thiosulfate|mesh-list
92642716|NCT00238173|Cyclophosphamide|cyclophosphamide|mesh-list
92642717|NCT00238173|Carboplatin|carboplatin|mesh-list
92642718|NCT00238173|Etoposide|etoposide|mesh-list
92642719|NCT00238173|Etoposide phosphate|etoposide phosphate|mesh-list
92642720|NCT00238173|Mannitol|mannitol|mesh-list
92642721|NCT00238173|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92642722|NCT00238173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642723|NCT00238173|Immunologic Factors|immunologic factors|mesh-ancestor
92642724|NCT00238173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642725|NCT00238173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92642726|NCT00238173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92642727|NCT00238173|Alkylating Agents|alkylating agents|mesh-ancestor
92642728|NCT00238173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642729|NCT00238173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642730|NCT00238173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92642731|NCT00238173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92642732|NCT00238173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92642733|NCT00238173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642734|NCT00238173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642735|NCT00238173|Antiviral Agents|antiviral agents|mesh-ancestor
92642736|NCT00238173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642737|NCT00238173|Expectorants|expectorants|mesh-ancestor
92642738|NCT00238173|Respiratory System Agents|respiratory system agents|mesh-ancestor
92642739|NCT00238173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92642740|NCT00238173|Antioxidants|antioxidants|mesh-ancestor
92642741|NCT00238173|Protective Agents|protective agents|mesh-ancestor
92642742|NCT00238173|Antidotes|antidotes|mesh-ancestor
92642743|NCT00238173|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92642744|NCT00238173|Diuretics|diuretics|mesh-ancestor
92642745|NCT00238173|Natriuretic Agents|natriuretic agents|mesh-ancestor
92642746|NCT00238173|Antitubercular Agents|antitubercular agents|mesh-ancestor
92642747|NCT00238173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92642748|NCT00238173|Chelating Agents|chelating agents|mesh-ancestor
92642749|NCT00238173|Sequestering Agents|sequestering agents|mesh-ancestor
92642750|NCT00211133|Epoetin Alfa|epoetin alfa|mesh-list
92642751|NCT00211133|Hematinics|hematinics|mesh-ancestor
92642752|NCT00238212|Sorafenib|sorafenib|mesh-list
92642753|NCT00238212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642754|NCT00238212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92642755|NCT00238212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642756|NCT00238212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642757|NCT00211250|Valproic Acid|valproic acid|mesh-list
92642758|NCT00211250|Anticonvulsants|anticonvulsants|mesh-ancestor
92642759|NCT00211250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642760|NCT00211250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642761|NCT00211250|GABA Agents|gaba agents|mesh-ancestor
92642762|NCT00211250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642763|NCT00211250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642764|NCT00211250|Antimanic Agents|antimanic agents|mesh-ancestor
92642765|NCT00211250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642766|NCT00211250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642767|NCT00211250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642768|NCT00238251|Temozolomide|temozolomide|mesh-list
92642769|NCT00238251|Gefitinib|gefitinib|mesh-list
92642770|NCT00238251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92642771|NCT00238251|Alkylating Agents|alkylating agents|mesh-ancestor
92642772|NCT00238251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642773|NCT00238251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642774|NCT00238251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92562791|NCT00153946|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92562792|NCT00153946|Antioxidants|antioxidants|mesh-ancestor
92562793|NCT00153946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562794|NCT00153946|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92642775|NCT00238251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642777|NCT04566718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92642778|NCT04566718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642779|NCT02210884|Vitamin D|vitamin d|mesh-list
92642780|NCT02210884|Ergocalciferols|ergocalciferols|mesh-list
92642781|NCT02210884|Cholecalciferol|cholecalciferol|mesh-list
92642782|NCT02210884|Vitamins|vitamins|mesh-list
92642783|NCT02210884|Micronutrients|micronutrients|mesh-ancestor
92642784|NCT02210884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642785|NCT02210884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92642786|NCT02210884|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92642788|NCT00238290|Letrozole|letrozole|mesh-list
92642789|NCT00238290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92642790|NCT00238290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642791|NCT00238290|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92642792|NCT00238290|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92642793|NCT00238290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642794|NCT00238290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642795|NCT00238290|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92642796|NCT00238290|Hormone Antagonists|hormone antagonists|mesh-ancestor
92642797|NCT00238290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642798|NCT00238290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642799|NCT00211328|Anecortave|anecortave|mesh-list
92642800|NCT00211328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92642801|NCT00211328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92642802|NCT00211328|Growth Substances|growth substances|mesh-ancestor
92642803|NCT00211328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642804|NCT00211328|Growth Inhibitors|growth inhibitors|mesh-ancestor
92642805|NCT00211328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642806|NCT00238329|Interferons|interferons|mesh-list
92642807|NCT00238329|Interferon-alpha|interferon-alpha|mesh-list
92642808|NCT00238329|Interferon alpha-2|interferon alpha-2|mesh-list
92642809|NCT00238329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92642810|NCT00238329|Thalidomide|thalidomide|mesh-list
92642811|NCT00238329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642812|NCT00238329|Antiviral Agents|antiviral agents|mesh-ancestor
92642813|NCT00238329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642814|NCT00238329|Immunologic Factors|immunologic factors|mesh-ancestor
92642815|NCT00238329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642816|NCT00238329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642817|NCT00238329|Leprostatic Agents|leprostatic agents|mesh-ancestor
92642818|NCT00238329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92642819|NCT00238329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92642820|NCT00238329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92642821|NCT00238329|Growth Substances|growth substances|mesh-ancestor
92642822|NCT00238329|Growth Inhibitors|growth inhibitors|mesh-ancestor
92642823|NCT02894905|Adafosbuvir|adafosbuvir|mesh-list
92642824|NCT02894905|Antiviral Agents|antiviral agents|mesh-ancestor
92642825|NCT02894905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642826|NCT00211367|Anecortave|anecortave|mesh-list
92642827|NCT00211367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92642828|NCT00211367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92642829|NCT00211367|Growth Substances|growth substances|mesh-ancestor
92642830|NCT00211367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642831|NCT00211367|Growth Inhibitors|growth inhibitors|mesh-ancestor
92642832|NCT00211367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642833|NCT00238368|Cytarabine|cytarabine|mesh-list
92642834|NCT00238368|Prednisone|prednisone|mesh-list
92642835|NCT00238368|Methylprednisolone|methylprednisolone|mesh-list
92642836|NCT00238368|Cyclophosphamide|cyclophosphamide|mesh-list
92642837|NCT00238368|Busulfan|busulfan|mesh-list
92642838|NCT00238368|Rituximab|rituximab|mesh-list
92642839|NCT00238368|Doxorubicin|doxorubicin|mesh-list
92642840|NCT00238368|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92642841|NCT00238368|Etoposide|etoposide|mesh-list
92642842|NCT00238368|Vincristine|vincristine|mesh-list
92642843|NCT00238368|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92642844|NCT00238368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92642845|NCT00238368|Immunologic Factors|immunologic factors|mesh-ancestor
92562795|NCT00153946|Protective Agents|protective agents|mesh-ancestor
92562796|NCT00153946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562798|NCT00154024|Atorvastatin|atorvastatin|mesh-list
92562799|NCT00154024|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91992459|NCT03166111|Lidocaine|lidocaine|mesh-list
92642846|NCT00238368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642847|NCT00238368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363428|NCT01285817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92642848|NCT00238368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92642849|NCT00238368|Alkylating Agents|alkylating agents|mesh-ancestor
92642850|NCT00238368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642851|NCT00238368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642852|NCT00238368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92642853|NCT00238368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92642854|NCT00238368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92642855|NCT00238368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92368137|NCT00943098|Analgesics|analgesics|mesh-ancestor
92642856|NCT00238368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92642857|NCT00238368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642858|NCT00238368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92642859|NCT00238368|Glucocorticoids|glucocorticoids|mesh-ancestor
92642861|NCT00238368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92642862|NCT00238368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92642863|NCT00238368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92642864|NCT00238368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92642866|NCT00238368|Antiviral Agents|antiviral agents|mesh-ancestor
92642867|NCT00238368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642868|NCT00238368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92642869|NCT00238368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92642870|NCT00238368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92642871|NCT00238368|Antiemetics|antiemetics|mesh-ancestor
92642872|NCT00238368|Autonomic Agents|autonomic agents|mesh-ancestor
92642873|NCT00238368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642874|NCT00238368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642875|NCT00238368|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92642876|NCT00238368|Protective Agents|protective agents|mesh-ancestor
92642877|NCT00238368|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92642878|NCT02894593|Ethanol|ethanol|mesh-list
92642879|NCT02894593|Chlorhexidine|chlorhexidine|mesh-list
92642880|NCT02894593|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92642881|NCT02894593|Listerine|listerine|mesh-list
92642882|NCT02894593|Sodium Fluoride|sodium fluoride|mesh-list
92642883|NCT02894593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92642884|NCT02894593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642885|NCT02894593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642886|NCT02894593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642887|NCT02894593|Disinfectants|disinfectants|mesh-ancestor
92642888|NCT02894593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92642889|NCT02894593|Cariostatic Agents|cariostatic agents|mesh-ancestor
92642890|NCT02894593|Protective Agents|protective agents|mesh-ancestor
92642891|NCT00211406|Anecortave|anecortave|mesh-list
92642892|NCT00211406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92642893|NCT00211406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92642894|NCT00211406|Growth Substances|growth substances|mesh-ancestor
92642895|NCT00211406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642896|NCT00211406|Growth Inhibitors|growth inhibitors|mesh-ancestor
92642897|NCT00211406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642898|NCT02894554|Lamivudine|lamivudine|mesh-list
92642899|NCT02894554|Telbivudine|telbivudine|mesh-list
92642900|NCT02894554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92642901|NCT02894554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92642902|NCT02894554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642903|NCT02894554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642904|NCT02894554|Antiviral Agents|antiviral agents|mesh-ancestor
92642905|NCT02894554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642906|NCT02894554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92642907|NCT02894554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92642908|NCT00238407|Docetaxel|docetaxel|mesh-list
92642909|NCT00238407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642910|NCT00238407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92642911|NCT00238407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287580|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
92562800|NCT00154024|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92562801|NCT00154024|Antimetabolites|antimetabolites|mesh-ancestor
91970241|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
92642912|NCT00238407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92642913|NCT00238407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642914|NCT02894515|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92642915|NCT02894515|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92642916|NCT02894515|Serotonin Agents|serotonin agents|mesh-ancestor
92642917|NCT02894515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642918|NCT02894515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642919|NCT02894515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642920|NCT00211445|Verteporfin|verteporfin|mesh-list
92642921|NCT00211445|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92642922|NCT00211445|Dermatologic Agents|dermatologic agents|mesh-ancestor
92642923|NCT02894710|Lidocaine|lidocaine|mesh-list
92642924|NCT02894710|Anesthetics, Local|anesthetics, local|mesh-ancestor
92642925|NCT02894710|Anesthetics|anesthetics|mesh-ancestor
92642926|NCT02894710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642927|NCT02894710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642928|NCT02894710|Sensory System Agents|sensory system agents|mesh-ancestor
92642929|NCT02894710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642930|NCT02894710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92642931|NCT02894710|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92368224|NCT00955266|Calcium|calcium|mesh-list
92642932|NCT02894710|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92642934|NCT02894710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642935|NCT00211484|Anecortave|anecortave|mesh-list
92642936|NCT00211484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92642937|NCT00211484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92642938|NCT00211484|Growth Substances|growth substances|mesh-ancestor
92642939|NCT00211484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642940|NCT00211484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92642941|NCT00211484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642942|NCT05428072|Aspirin|aspirin|mesh-list
92642943|NCT05428072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92642944|NCT05428072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92642945|NCT05428072|Analgesics|analgesics|mesh-ancestor
92642946|NCT05428072|Sensory System Agents|sensory system agents|mesh-ancestor
92642947|NCT05428072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642948|NCT05428072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642949|NCT05428072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92642950|NCT05428072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92642951|NCT05428072|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92642952|NCT05428072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92642953|NCT05428072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642954|NCT05428072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92642955|NCT05428072|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92642956|NCT05428072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92642957|NCT05428072|Antipyretics|antipyretics|mesh-ancestor
92642958|NCT00211523|Omiganan pentahydrochloride|omiganan pentahydrochloride|mesh-list
92642959|NCT00211523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642960|NCT00211562|Vitamin E|vitamin e|mesh-list
92642961|NCT00211562|Olanzapine|olanzapine|mesh-list
92642962|NCT00211562|Vitamins|vitamins|mesh-ancestor
92642963|NCT00211562|Micronutrients|micronutrients|mesh-ancestor
92642964|NCT00211562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642965|NCT00211562|Antiemetics|antiemetics|mesh-ancestor
92642966|NCT00211562|Autonomic Agents|autonomic agents|mesh-ancestor
92642967|NCT00211562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642968|NCT00211562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92642969|NCT00211562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92642970|NCT00211562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92642971|NCT00211562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642972|NCT00211562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92642973|NCT00211562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92642974|NCT00211562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92642975|NCT00211562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642976|NCT00211562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642977|NCT00211562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562802|NCT00154024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642978|NCT00211562|Serotonin Agents|serotonin agents|mesh-ancestor
92642980|NCT00211562|Protective Agents|protective agents|mesh-ancestor
92642981|NCT05427721|Thymol|thymol|mesh-list
92642982|NCT05427721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642983|NCT05427721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92642984|NCT05427721|Antifungal Agents|antifungal agents|mesh-ancestor
92642985|NCT00238641|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92642986|NCT00238641|Botulinum Toxins|botulinum toxins|mesh-list
92642987|NCT00238641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92642988|NCT00238641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92363436|NCT01285817|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92642989|NCT00238641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92642990|NCT00238641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642991|NCT00238641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642992|NCT00238641|Cholinergic Agents|cholinergic agents|mesh-ancestor
92642993|NCT00238641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92642994|NCT00238641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642995|NCT00238641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92642996|NCT00238641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642997|NCT00238641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92642998|NCT05427175|Methotrexate|methotrexate|mesh-list
92642999|NCT05427175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92643000|NCT05427175|Abortifacient Agents|abortifacient agents|mesh-ancestor
92643001|NCT05427175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92643002|NCT05427175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643003|NCT05427175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643004|NCT05427175|Antimetabolites|antimetabolites|mesh-ancestor
92643005|NCT05427175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643009|NCT05427175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92643010|NCT05427175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643011|NCT05427175|Immunologic Factors|immunologic factors|mesh-ancestor
92643012|NCT05427175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643013|NCT05427175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92643014|NCT00211679|Botulinum Toxins|botulinum toxins|mesh-list
92643015|NCT00211679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92643016|NCT00211679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92643017|NCT00211679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92643018|NCT00211679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643019|NCT00211679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643020|NCT00211679|Cholinergic Agents|cholinergic agents|mesh-ancestor
92643021|NCT00211679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643022|NCT00211679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643023|NCT00211679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92643024|NCT00211679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643026|NCT04680091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643027|NCT04680091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643028|NCT04680091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92643029|NCT04680091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92643030|NCT04680091|Antiviral Agents|antiviral agents|mesh-ancestor
92643031|NCT04680091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643032|NCT04680091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92643033|NCT04680091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92643034|NCT04680091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92643035|NCT04680091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92643036|NCT04680091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92643037|NCT04680091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92643038|NCT00211718|Botulinum Toxins|botulinum toxins|mesh-list
92643039|NCT00211718|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92643040|NCT00211718|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92643041|NCT00211718|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92643042|NCT00211718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643043|NCT00211718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643044|NCT00211718|Cholinergic Agents|cholinergic agents|mesh-ancestor
92643045|NCT00211718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643046|NCT00211718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643047|NCT00211718|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92643048|NCT00211718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643049|NCT00238719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92562804|NCT00154024|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92562805|NCT00154024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643050|NCT00238719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92643051|NCT00238719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92643052|NCT00238719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643053|NCT00238719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643054|NCT00238719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643055|NCT00238719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643056|NCT00238719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92643057|NCT00238719|Antidepressive Agents|antidepressive agents|mesh-ancestor
92643058|NCT00238719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643059|NCT04680208|Anesthetics|anesthetics|mesh-list
92643060|NCT04680208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643061|NCT04680208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643062|NCT00211796|Valproic Acid|valproic acid|mesh-list
92643063|NCT00211796|Anticonvulsants|anticonvulsants|mesh-ancestor
92643064|NCT00211796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643065|NCT00211796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643066|NCT00211796|GABA Agents|gaba agents|mesh-ancestor
92643067|NCT00211796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643068|NCT00211796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643069|NCT00211796|Antimanic Agents|antimanic agents|mesh-ancestor
92643070|NCT00211796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92050185|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92643074|NCT05426824|Asparaginase|asparaginase|mesh-list
92643075|NCT05426824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643076|NCT00238797|Gefitinib|gefitinib|mesh-list
92643077|NCT00238797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643078|NCT00238797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92643079|NCT00238797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643080|NCT00238797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643082|NCT05426044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92643083|NCT05426044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643084|NCT05425654|Cyclophosphamide|cyclophosphamide|mesh-list
92643085|NCT05425654|Busulfan|busulfan|mesh-list
92643086|NCT05425654|Carmustine|carmustine|mesh-list
92643087|NCT05425654|Rituximab|rituximab|mesh-list
92643088|NCT05425654|Methotrexate|methotrexate|mesh-list
92643089|NCT05425654|Vincristine|vincristine|mesh-list
92643090|NCT05425654|Lenalidomide|lenalidomide|mesh-list
92643091|NCT05425654|Procarbazine|procarbazine|mesh-list
92643092|NCT05425654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643093|NCT05425654|Immunologic Factors|immunologic factors|mesh-ancestor
92643094|NCT05425654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643095|NCT05425654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643096|NCT05425654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92643097|NCT05425654|Alkylating Agents|alkylating agents|mesh-ancestor
92643098|NCT05425654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643099|NCT05425654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643100|NCT05425654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92643101|NCT05425654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92643102|NCT05425654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92643103|NCT05425654|Abortifacient Agents|abortifacient agents|mesh-ancestor
92643104|NCT05425654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92643105|NCT05425654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643106|NCT05425654|Antimetabolites|antimetabolites|mesh-ancestor
92643107|NCT05425654|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643108|NCT05425654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643109|NCT05425654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92643110|NCT05425654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92643111|NCT05425654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92643112|NCT05425654|Tubulin Modulators|tubulin modulators|mesh-ancestor
92643113|NCT05425654|Antimitotic Agents|antimitotic agents|mesh-ancestor
92643114|NCT05425654|Mitosis Modulators|mitosis modulators|mesh-ancestor
92643115|NCT05425654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92643116|NCT05425654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92643117|NCT05425654|Growth Substances|growth substances|mesh-ancestor
92643118|NCT05425654|Growth Inhibitors|growth inhibitors|mesh-ancestor
92643119|NCT05425576|Pembrolizumab|pembrolizumab|mesh-list
92643120|NCT05425576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92562806|NCT00154024|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92562807|NCT00154024|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92562808|NCT00154024|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92643121|NCT05425576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643122|NCT05425576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92643123|NCT05425576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643124|NCT00238914|Naltrexone|naltrexone|mesh-list
92643125|NCT00238914|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92643126|NCT00238914|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92643127|NCT00238914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643128|NCT00238914|Sensory System Agents|sensory system agents|mesh-ancestor
92643129|NCT00238914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643130|NCT04668976|Gemcitabine|gemcitabine|mesh-list
92643131|NCT04668976|Fluorouracil|fluorouracil|mesh-list
92643132|NCT04668976|Floxuridine|floxuridine|mesh-list
92643133|NCT04668976|Oxaliplatin|oxaliplatin|mesh-list
92643134|NCT04668976|Irinotecan|irinotecan|mesh-list
92643135|NCT04668976|Cetuximab|cetuximab|mesh-list
92643136|NCT04668976|Panitumumab|panitumumab|mesh-list
92643137|NCT04668976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643138|NCT04668976|Antimetabolites|antimetabolites|mesh-ancestor
92643139|NCT04668976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643140|NCT04668976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643141|NCT04668976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643142|NCT04668976|Immunologic Factors|immunologic factors|mesh-ancestor
92643143|NCT04668976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643144|NCT04668976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92643145|NCT04668976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92643147|NCT04668976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92643148|NCT00238953|Mycophenolic Acid|mycophenolic acid|mesh-list
92643149|NCT00238953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92643150|NCT00238953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643151|NCT00238953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92643152|NCT00238953|Antitubercular Agents|antitubercular agents|mesh-ancestor
92643153|NCT00238953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643154|NCT00238953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643155|NCT00238953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643156|NCT00238953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643157|NCT04669366|Sunitinib|sunitinib|mesh-list
92643158|NCT04669366|Axitinib|axitinib|mesh-list
92643159|NCT04669366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643160|NCT04669366|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92643161|NCT04669366|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92643162|NCT04669366|Growth Substances|growth substances|mesh-ancestor
92643163|NCT04669366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643164|NCT04669366|Growth Inhibitors|growth inhibitors|mesh-ancestor
92643165|NCT04669366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92643166|NCT04669366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643167|NCT04669366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643168|NCT04721301|Maraviroc|maraviroc|mesh-list
92643169|NCT04721301|Nivolumab|nivolumab|mesh-list
92643170|NCT04721301|Ipilimumab|ipilimumab|mesh-list
92643171|NCT04721301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92643172|NCT04721301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643173|NCT04721301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92643174|NCT04721301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643175|NCT04721301|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92643176|NCT04721301|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92643177|NCT04721301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92643178|NCT04721301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92643179|NCT04721301|Antiviral Agents|antiviral agents|mesh-ancestor
92643180|NCT04721301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643181|NCT04721301|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92643182|NCT00238992|Mycophenolic Acid|mycophenolic acid|mesh-list
92643183|NCT00238992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92643184|NCT00238992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643185|NCT00238992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92643186|NCT00238992|Antitubercular Agents|antitubercular agents|mesh-ancestor
92643187|NCT00238992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643188|NCT00238992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643189|NCT00238992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562809|NCT00154141|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92562810|NCT00154141|Hemostatics|hemostatics|mesh-ancestor
92562811|NCT00154141|Coagulants|coagulants|mesh-ancestor
92562812|NCT00154180|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92562813|NCT00154180|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92562814|NCT00154180|Estradiol|estradiol|mesh-list
92562815|NCT00154180|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92562816|NCT00154180|Estrogens|estrogens|mesh-list
92562817|NCT00154180|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92562818|NCT00154180|Progesterone|progesterone|mesh-list
92562819|NCT00154180|Hormones|hormones|mesh-ancestor
91970253|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
92643190|NCT00238992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643191|NCT00556465|Acetylcysteine|acetylcysteine|mesh-list
92643192|NCT00556465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92643193|NCT00556465|Antiviral Agents|antiviral agents|mesh-ancestor
92643194|NCT00556465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643195|NCT00556465|Expectorants|expectorants|mesh-ancestor
92643196|NCT00556465|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643197|NCT00556465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92643198|NCT00556465|Antioxidants|antioxidants|mesh-ancestor
92643199|NCT00556465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643200|NCT00556465|Protective Agents|protective agents|mesh-ancestor
92643201|NCT00556465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643202|NCT00556465|Antidotes|antidotes|mesh-ancestor
92643203|NCT04668469|Acetaminophen|acetaminophen|mesh-list
92643204|NCT04668469|Vitamins|vitamins|mesh-list
92643205|NCT04668469|Ascorbic Acid|ascorbic acid|mesh-list
92643206|NCT04668469|Zinc|zinc|mesh-list
92643207|NCT04668469|Azithromycin|azithromycin|mesh-list
92643208|NCT04668469|Hydroxychloroquine|hydroxychloroquine|mesh-list
92643209|NCT04668469|Ivermectin|ivermectin|mesh-list
92643210|NCT04668469|Lactoferrin|lactoferrin|mesh-list
92643211|NCT04668469|Fibrin fragment D|fibrin fragment d|mesh-list
92643212|NCT04668469|Micronutrients|micronutrients|mesh-ancestor
92643213|NCT04668469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643214|NCT04668469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643215|NCT04668469|Analgesics|analgesics|mesh-ancestor
92643216|NCT04668469|Sensory System Agents|sensory system agents|mesh-ancestor
92643217|NCT04668469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643218|NCT04668469|Antipyretics|antipyretics|mesh-ancestor
92643219|NCT04668469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643220|NCT04668469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643221|NCT04668469|Antimalarials|antimalarials|mesh-ancestor
92643222|NCT04668469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92643226|NCT04668469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643227|NCT04668469|Trace Elements|trace elements|mesh-ancestor
92643228|NCT04668469|Antioxidants|antioxidants|mesh-ancestor
92643229|NCT04668469|Protective Agents|protective agents|mesh-ancestor
92643230|NCT04668469|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92643231|NCT04668469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92643232|NCT04668469|Hemostatics|hemostatics|mesh-ancestor
92643233|NCT04668469|Coagulants|coagulants|mesh-ancestor
92643234|NCT00239031|Mycophenolic Acid|mycophenolic acid|mesh-list
92643235|NCT00239031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92643236|NCT00239031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643237|NCT00239031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92643238|NCT00239031|Antitubercular Agents|antitubercular agents|mesh-ancestor
92643239|NCT00239031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643240|NCT00239031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643241|NCT00239031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643242|NCT00239031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643243|NCT00239070|Mycophenolic Acid|mycophenolic acid|mesh-list
92643244|NCT00239070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92643245|NCT00239070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643246|NCT00239070|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92643247|NCT00239070|Antitubercular Agents|antitubercular agents|mesh-ancestor
92643248|NCT00239070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643249|NCT00239070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643250|NCT00239070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562820|NCT00154180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562821|NCT00154180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562822|NCT00154180|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92643251|NCT00239070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643253|NCT00211952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92643254|NCT00211952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643255|NCT00211952|Analgesics|analgesics|mesh-ancestor
92643256|NCT00211952|Sensory System Agents|sensory system agents|mesh-ancestor
92643257|NCT00211952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643258|NCT00211952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643259|NCT00211952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643260|NCT00211952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643261|NCT00211952|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92643262|NCT00211952|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92643263|NCT00211952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643264|NCT00211952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643265|NCT00239109|Olanzapine|olanzapine|mesh-list
92643266|NCT00239109|Ziprasidone|ziprasidone|mesh-list
92643267|NCT00239109|Antiemetics|antiemetics|mesh-ancestor
92643268|NCT00239109|Autonomic Agents|autonomic agents|mesh-ancestor
92643269|NCT00239109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643270|NCT00239109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643271|NCT00239109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92643272|NCT00239109|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92643273|NCT00239109|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92643274|NCT00239109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643275|NCT00239109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643276|NCT00239109|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92643277|NCT00239109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92643278|NCT00239109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643279|NCT00239109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643280|NCT00239109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643281|NCT00239109|Serotonin Agents|serotonin agents|mesh-ancestor
92643282|NCT00239109|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92643283|NCT00239109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92643284|NCT00239109|Dopamine Agents|dopamine agents|mesh-ancestor
92643285|NCT00212030|Nicorandil|nicorandil|mesh-list
92643286|NCT00212030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92643287|NCT00212030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92643288|NCT00212030|Vasodilator Agents|vasodilator agents|mesh-ancestor
92643289|NCT00212030|Vitamin B Complex|vitamin b complex|mesh-ancestor
92643290|NCT00212030|Vitamins|vitamins|mesh-ancestor
92643291|NCT00212030|Micronutrients|micronutrients|mesh-ancestor
92643292|NCT00212030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643293|NCT00212069|Carboplatin|carboplatin|mesh-list
92643294|NCT00212069|Gemcitabine|gemcitabine|mesh-list
92643305|NCT00212108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643306|NCT00212108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643307|NCT00212108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643308|NCT00212108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643309|NCT00212108|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92643310|NCT00212108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92643311|NCT00212108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643312|NCT00212108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643313|NCT00212108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643314|NCT00212108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92643316|NCT00212186|Antioxidants|antioxidants|mesh-ancestor
92643317|NCT00212186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643318|NCT00212186|Protective Agents|protective agents|mesh-ancestor
92643319|NCT00212186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643320|NCT00212186|Trace Elements|trace elements|mesh-ancestor
92643321|NCT00212186|Micronutrients|micronutrients|mesh-ancestor
92643322|NCT00414336|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92643323|NCT00414336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92643324|NCT00414336|Immunologic Factors|immunologic factors|mesh-ancestor
92643325|NCT00414336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643326|NCT00414336|Antacids|antacids|mesh-ancestor
92643327|NCT00414336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643328|NCT00414336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562823|NCT00154180|Contraceptive Agents|contraceptive agents|mesh-ancestor
92562824|NCT00154180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562825|NCT00154180|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92562826|NCT00154180|Progestins|progestins|mesh-ancestor
92562827|NCT00154219|Lumiracoxib|lumiracoxib|mesh-list
92643329|NCT00212342|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92643330|NCT00212342|Norethindrone|norethindrone|mesh-list
92643331|NCT00212342|Norethindrone Acetate|norethindrone acetate|mesh-list
92643332|NCT00212342|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92643333|NCT00212342|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92643334|NCT00212342|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92643335|NCT00212342|Contraceptive Agents|contraceptive agents|mesh-ancestor
92643336|NCT00212342|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92643337|NCT00212342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363455|NCT01250496|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92643338|NCT00212342|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92643339|NCT00212342|Estrogens|estrogens|mesh-ancestor
92643340|NCT00212342|Hormones|hormones|mesh-ancestor
92643341|NCT00212342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92643342|NCT00212342|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92643343|NCT00414414|Prednisone|prednisone|mesh-list
92643344|NCT00414414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643345|NCT00414414|Glucocorticoids|glucocorticoids|mesh-ancestor
92643346|NCT00414414|Hormones|hormones|mesh-ancestor
92643347|NCT00414414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92643348|NCT00414414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643349|NCT00414414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92643350|NCT00414414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643351|NCT00239304|Gefitinib|gefitinib|mesh-list
92643352|NCT00239304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643353|NCT00239304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92643354|NCT00239304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643355|NCT00239304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643356|NCT00239343|Gefitinib|gefitinib|mesh-list
92643357|NCT00239343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643358|NCT00239343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92643359|NCT00239343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643362|NCT00411593|Bortezomib|bortezomib|mesh-list
92643363|NCT00411593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92643364|NCT00411593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643365|NCT00411593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92643366|NCT00411593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92643367|NCT00411593|Growth Substances|growth substances|mesh-ancestor
92643368|NCT00411593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643369|NCT00411593|Growth Inhibitors|growth inhibitors|mesh-ancestor
92643370|NCT00239382|Meloxicam|meloxicam|mesh-list
92643371|NCT00239382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92643372|NCT00239382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643373|NCT00239382|Analgesics|analgesics|mesh-ancestor
92643374|NCT00239382|Sensory System Agents|sensory system agents|mesh-ancestor
92643375|NCT00239382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643376|NCT00239382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643377|NCT00239382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643378|NCT00239382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643379|NCT00239382|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92368664|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
92643380|NCT00239382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92643381|NCT00239382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643382|NCT00239382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643384|NCT00239421|Xhance|xhance|mesh-list
92643385|NCT00239421|Formoterol Fumarate|formoterol fumarate|mesh-list
92643386|NCT00239421|Tiotropium Bromide|tiotropium bromide|mesh-list
92643387|NCT00239421|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92643388|NCT00239421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643389|NCT00239421|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92643390|NCT00239421|Autonomic Agents|autonomic agents|mesh-ancestor
92643391|NCT00239421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643392|NCT00239421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643393|NCT00239421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92643394|NCT00239421|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643395|NCT00239421|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643396|NCT00239421|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91993035|NCT03161509|Lamotrigine|lamotrigine|mesh-list
92643397|NCT00239421|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92643398|NCT00239421|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92643399|NCT00239421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92643400|NCT00239421|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643401|NCT00239421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643402|NCT00239421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643403|NCT00239421|Parasympatholytics|parasympatholytics|mesh-ancestor
92643404|NCT00239421|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92643405|NCT00239421|Cholinergic Agents|cholinergic agents|mesh-ancestor
92643406|NCT00239460|Tiotropium Bromide|tiotropium bromide|mesh-list
92643407|NCT00239460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92643408|NCT00239460|Autonomic Agents|autonomic agents|mesh-ancestor
92643409|NCT00239460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643410|NCT00239460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643411|NCT00239460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92643412|NCT00239460|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643413|NCT00239460|Parasympatholytics|parasympatholytics|mesh-ancestor
92643414|NCT00239460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92643415|NCT00239460|Cholinergic Agents|cholinergic agents|mesh-ancestor
92643416|NCT00239460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643417|NCT00239460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643418|NCT00239499|Fluticasone|fluticasone|mesh-list
92643419|NCT00239499|Tiotropium Bromide|tiotropium bromide|mesh-list
92643420|NCT00239499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92643421|NCT00239499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643422|NCT00239499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92643423|NCT00239499|Autonomic Agents|autonomic agents|mesh-ancestor
92643424|NCT00239499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643425|NCT00239499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643426|NCT00239499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92643427|NCT00239499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643428|NCT00239499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643429|NCT00239499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92643430|NCT00239499|Parasympatholytics|parasympatholytics|mesh-ancestor
92643431|NCT00239499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92643432|NCT00239499|Cholinergic Agents|cholinergic agents|mesh-ancestor
92643443|NCT00212615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643444|NCT00212615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643446|NCT00222573|Clopidogrel|clopidogrel|mesh-list
92643447|NCT00222573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92643448|NCT00222573|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92643449|NCT00222573|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92643450|NCT00222573|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92643451|NCT00222573|Purinergic Agents|purinergic agents|mesh-ancestor
92643452|NCT00222573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643453|NCT00222573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643454|NCT00222573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643455|NCT00222573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92643456|NCT00222573|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92643457|NCT00222573|Sympatholytics|sympatholytics|mesh-ancestor
92643458|NCT00222573|Autonomic Agents|autonomic agents|mesh-ancestor
92643459|NCT00222573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643460|NCT00222573|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92643461|NCT00222573|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92643462|NCT00222573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92643463|NCT00222573|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643464|NCT00212654|Landiolol|landiolol|mesh-list
92643465|NCT00212654|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92643466|NCT00212654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92643467|NCT00212654|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643468|NCT00212654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643469|NCT00212654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643470|NCT00212654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643471|NCT00212654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92643472|NCT00239538|Valsartan|valsartan|mesh-list
92643473|NCT00239538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92643474|NCT00239538|Telmisartan|telmisartan|mesh-list
92643475|NCT00239538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92643476|NCT00239538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92643477|NCT00239538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92643478|NCT00239538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562828|NCT00154219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92562829|NCT00154219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92643479|NCT00239538|Diuretics|diuretics|mesh-ancestor
92643480|NCT00239538|Natriuretic Agents|natriuretic agents|mesh-ancestor
92643481|NCT00239538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643482|NCT00239538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92643483|NCT00239538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643484|NCT00212810|Topiramate|topiramate|mesh-list
92643485|NCT00212810|Anticonvulsants|anticonvulsants|mesh-ancestor
92643486|NCT00212810|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92643487|NCT00212810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643488|NCT00222651|Tenecteplase|tenecteplase|mesh-list
92643489|NCT00222651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92643490|NCT00222651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92643491|NCT00222651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643492|NCT00239616|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92643493|NCT00239616|Hematinics|hematinics|mesh-ancestor
92643494|NCT00213122|Miglitol|miglitol|mesh-list
92643495|NCT00213122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643498|NCT00213122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643499|NCT00213122|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92643501|NCT00213200|Tetracaine|tetracaine|mesh-list
92643502|NCT00213200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92643503|NCT00213200|Narcotics|narcotics|mesh-ancestor
92643504|NCT00213200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643505|NCT00213200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643506|NCT00213200|Analgesics|analgesics|mesh-ancestor
92643507|NCT00213200|Sensory System Agents|sensory system agents|mesh-ancestor
92643508|NCT00213200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643509|NCT00213200|Anesthetics, Local|anesthetics, local|mesh-ancestor
92643510|NCT00213200|Anesthetics|anesthetics|mesh-ancestor
92643511|NCT00239811|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92643512|NCT00239811|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92643513|NCT00239811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643514|NCT00239811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643515|NCT00239811|Immunologic Factors|immunologic factors|mesh-ancestor
92643516|NCT00239811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643517|NCT00213278|Vinblastine|vinblastine|mesh-list
92643518|NCT00213278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92643519|NCT00213278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643520|NCT00213278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92643521|NCT00213278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92643522|NCT00213278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92643523|NCT00213278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643524|NCT00239889|Calcitonin|calcitonin|mesh-list
92643525|NCT00239889|Salmon calcitonin|salmon calcitonin|mesh-list
92643526|NCT00239889|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92643527|NCT00239889|Katacalcin|katacalcin|mesh-list
92368814|NCT05385042|Vitamins|vitamins|mesh-ancestor
92643528|NCT00239889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92643529|NCT00239889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643530|NCT00239889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92643531|NCT00239889|Vasodilator Agents|vasodilator agents|mesh-ancestor
92643532|NCT00239967|Rimonabant|rimonabant|mesh-list
92643533|NCT00239967|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92643534|NCT00239967|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92643535|NCT00239967|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92643536|NCT00239967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643537|NCT00239967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643538|NCT00239967|Hormones|hormones|mesh-ancestor
92643539|NCT00239967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92643540|NCT00239967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643541|NCT00223002|Chlorhexidine|chlorhexidine|mesh-list
92643542|NCT00223002|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92643543|NCT00223002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643544|NCT00223002|Disinfectants|disinfectants|mesh-ancestor
92643545|NCT00213512|Rituximab|rituximab|mesh-list
92643546|NCT00213512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92643547|NCT00213512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643548|NCT00213512|Immunologic Factors|immunologic factors|mesh-ancestor
92643549|NCT00213512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562831|NCT00154219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562832|NCT00154219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92562833|NCT00154219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643550|NCT00213512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643551|NCT00213551|Antioxidants|antioxidants|mesh-list
92643552|NCT00213551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643553|NCT00213551|Protective Agents|protective agents|mesh-ancestor
92643554|NCT00213551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643555|NCT00240006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92643556|NCT00213590|Cyclosporine|cyclosporine|mesh-list
92643557|NCT00213590|Cyclosporins|cyclosporins|mesh-list
92643558|NCT00213590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643559|NCT00213590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643560|NCT00213590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643561|NCT00213590|Immunologic Factors|immunologic factors|mesh-ancestor
92643562|NCT00213590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643563|NCT00213590|Antifungal Agents|antifungal agents|mesh-ancestor
92643564|NCT00213590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643565|NCT00213590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643573|NCT00240045|Sympathomimetics|sympathomimetics|mesh-ancestor
92643574|NCT00240045|Autonomic Agents|autonomic agents|mesh-ancestor
92643575|NCT00240045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643576|NCT00240045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643577|NCT00240045|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92643578|NCT00240045|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92643579|NCT00240045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92643580|NCT00240045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92643581|NCT00240045|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643582|NCT00240045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643583|NCT00240045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643584|NCT00243672|Atorvastatin|atorvastatin|mesh-list
92643585|NCT00243672|Gemfibrozil|gemfibrozil|mesh-list
92643586|NCT00243672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92643587|NCT00243672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92643588|NCT00243672|Antimetabolites|antimetabolites|mesh-ancestor
92643589|NCT00243672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643590|NCT00243672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92643591|NCT00243672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92643592|NCT00243672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643593|NCT00243672|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92643594|NCT00243672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92643595|NCT00240084|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92643596|NCT00240084|Natriuretic Agents|natriuretic agents|mesh-ancestor
92643597|NCT00240084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643598|NCT00243711|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92643599|NCT00243711|Glycerol|glycerol|mesh-list
92643600|NCT00243711|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92643601|NCT00243711|Protective Agents|protective agents|mesh-ancestor
92643602|NCT00243711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643603|NCT00243711|Laxatives|laxatives|mesh-ancestor
92643604|NCT00243711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92643605|NCT00240123|Diphenhydramine|diphenhydramine|mesh-list
92643606|NCT00240123|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92643607|NCT00240123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92643608|NCT00240123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643609|NCT00240123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643610|NCT00240123|Anesthetics, Local|anesthetics, local|mesh-ancestor
92643611|NCT00240123|Anesthetics|anesthetics|mesh-ancestor
92643612|NCT00240123|Sensory System Agents|sensory system agents|mesh-ancestor
92643613|NCT00240123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643614|NCT00240123|Antiemetics|antiemetics|mesh-ancestor
92643615|NCT00240123|Autonomic Agents|autonomic agents|mesh-ancestor
92643616|NCT00240123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92643617|NCT00240123|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92643618|NCT00240123|Histamine Antagonists|histamine antagonists|mesh-ancestor
92643619|NCT00240123|Histamine Agents|histamine agents|mesh-ancestor
92643620|NCT00240123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643621|NCT00240123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643622|NCT00240123|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92643623|NCT00240279|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92562834|NCT00154219|Analgesics|analgesics|mesh-ancestor
92562835|NCT00154219|Sensory System Agents|sensory system agents|mesh-ancestor
92562836|NCT00154219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643624|NCT00240279|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92643625|NCT00240279|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92643626|NCT00240279|Antimetabolites|antimetabolites|mesh-ancestor
92643627|NCT00240279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643628|NCT00240279|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92643629|NCT00240279|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92643630|NCT00240279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643631|NCT00243750|Methotrexate|methotrexate|mesh-list
92643632|NCT00243750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92643633|NCT00243750|Abortifacient Agents|abortifacient agents|mesh-ancestor
92643644|NCT00243750|Immunologic Factors|immunologic factors|mesh-ancestor
92643645|NCT00243750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643646|NCT00243750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92643647|NCT00243789|Pentoxifylline|pentoxifylline|mesh-list
92643648|NCT00243789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92643649|NCT00243789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643650|NCT00243789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643651|NCT00243789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92643652|NCT00243789|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92643653|NCT00243789|Protective Agents|protective agents|mesh-ancestor
92643654|NCT00243789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643655|NCT00243789|Vasodilator Agents|vasodilator agents|mesh-ancestor
92643656|NCT00243789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92643657|NCT00243789|Antioxidants|antioxidants|mesh-ancestor
92643658|NCT00214058|Carboplatin|carboplatin|mesh-list
92643659|NCT00214058|Docetaxel|docetaxel|mesh-list
92643660|NCT00214058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643661|NCT00214058|Tubulin Modulators|tubulin modulators|mesh-ancestor
92643662|NCT00214058|Antimitotic Agents|antimitotic agents|mesh-ancestor
92643663|NCT00214058|Mitosis Modulators|mitosis modulators|mesh-ancestor
92643664|NCT00214058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643665|NCT00240318|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92643666|NCT00240318|Calcium|calcium|mesh-list
92643667|NCT00240318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92643668|NCT00240318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643669|NCT00240318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92643670|NCT00240318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92643671|NCT00240318|Antimetabolites|antimetabolites|mesh-ancestor
92643672|NCT00240318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643673|NCT00240318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92643674|NCT00240318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92643675|NCT00240318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643676|NCT00243945|Rotigotine|rotigotine|mesh-list
92643677|NCT00243945|Dopamine Agonists|dopamine agonists|mesh-ancestor
92643678|NCT00243945|Dopamine Agents|dopamine agents|mesh-ancestor
92643679|NCT00243945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643680|NCT00243945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643681|NCT00243945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643682|NCT00214214|Alemtuzumab|alemtuzumab|mesh-list
92643683|NCT00214214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92643684|NCT00214214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643685|NCT00214253|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92643686|NCT00214253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92643687|NCT00214253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643688|NCT00240396|Narcotics|narcotics|mesh-list
92643689|NCT00240396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643690|NCT00240396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643691|NCT00240396|Analgesics|analgesics|mesh-ancestor
92643692|NCT00240396|Sensory System Agents|sensory system agents|mesh-ancestor
92643693|NCT00240396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643694|NCT00214331|Azithromycin|azithromycin|mesh-list
92643695|NCT00214331|Ciprofloxacin|ciprofloxacin|mesh-list
92643696|NCT00214331|Gentamicins|gentamicins|mesh-list
92643697|NCT00214331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643701|NCT00214331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643702|NCT00214331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643703|NCT00214331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643704|NCT00214331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92562837|NCT00154219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562838|NCT00154219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643705|NCT00214331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92643706|NCT00214331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92643707|NCT00243984|Topiramate|topiramate|mesh-list
92643708|NCT00243984|Anticonvulsants|anticonvulsants|mesh-ancestor
92643709|NCT00243984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92643710|NCT00243984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643711|NCT00214370|Fentanyl|fentanyl|mesh-list
92643712|NCT00214370|Propofol|propofol|mesh-list
92643713|NCT00214370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92643714|NCT00214370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643715|NCT00214370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643716|NCT00214370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92643717|NCT00214370|Anesthetics, General|anesthetics, general|mesh-ancestor
92643718|NCT00214370|Anesthetics|anesthetics|mesh-ancestor
92643719|NCT00214370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92643720|NCT00214370|Narcotics|narcotics|mesh-ancestor
92643721|NCT00214370|Analgesics|analgesics|mesh-ancestor
92643722|NCT00214370|Sensory System Agents|sensory system agents|mesh-ancestor
92643723|NCT00214370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643724|NCT00214370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92643725|NCT00240435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92643726|NCT00240435|Tiotropium Bromide|tiotropium bromide|mesh-list
92643727|NCT00240435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92643728|NCT00240435|Autonomic Agents|autonomic agents|mesh-ancestor
92643729|NCT00240435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643730|NCT00240435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643731|NCT00240435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92643732|NCT00240435|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643733|NCT00240435|Parasympatholytics|parasympatholytics|mesh-ancestor
92643734|NCT00240435|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92643735|NCT00240435|Cholinergic Agents|cholinergic agents|mesh-ancestor
92643736|NCT00240435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643737|NCT00240435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643738|NCT00244023|Methyltestosterone|methyltestosterone|mesh-list
92643739|NCT00244023|Testosterone|testosterone|mesh-list
92643740|NCT00244023|Testosterone undecanoate|testosterone undecanoate|mesh-list
92643741|NCT00244023|Testosterone enanthate|testosterone enanthate|mesh-list
92643742|NCT00244023|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92643743|NCT00244023|Androgens|androgens|mesh-ancestor
92643744|NCT00244023|Hormones|hormones|mesh-ancestor
92643745|NCT00244023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92643746|NCT00244023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643747|NCT00244023|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92643748|NCT00244023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643749|NCT00244023|Anabolic Agents|anabolic agents|mesh-ancestor
92643750|NCT00240474|Amlodipine|amlodipine|mesh-list
92643751|NCT00240474|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92643752|NCT00240474|Telmisartan|telmisartan|mesh-list
92643753|NCT00240474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92643754|NCT00240474|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92643755|NCT00240474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643756|NCT00240474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643757|NCT00240474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92643758|NCT00240474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643759|NCT00240474|Vasodilator Agents|vasodilator agents|mesh-ancestor
92643760|NCT00240474|Diuretics|diuretics|mesh-ancestor
92643761|NCT00240474|Natriuretic Agents|natriuretic agents|mesh-ancestor
92643762|NCT00240474|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92643763|NCT00240474|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92643764|NCT00240474|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92643765|NCT00214604|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92643766|NCT00214604|Pravastatin|pravastatin|mesh-list
92643767|NCT00214604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92643768|NCT00214604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92643769|NCT00214604|Antimetabolites|antimetabolites|mesh-ancestor
92643772|NCT00214604|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92643773|NCT00214604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643774|NCT00214643|Clindamycin|clindamycin|mesh-list
92643775|NCT00214643|Clindamycin palmitate|clindamycin palmitate|mesh-list
92643776|NCT00214643|Clindamycin phosphate|clindamycin phosphate|mesh-list
92643777|NCT00214643|Fosmidomycin|fosmidomycin|mesh-list
92643778|NCT00214643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92562839|NCT00154219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562840|NCT00043875|Lamotrigine|lamotrigine|mesh-list
92643779|NCT00214643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643780|NCT00214643|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92643781|NCT00214643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643782|NCT00214643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643783|NCT00414531|Atorvastatin|atorvastatin|mesh-list
92643784|NCT00414531|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92643785|NCT00414531|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92643786|NCT00414531|Antimetabolites|antimetabolites|mesh-ancestor
92643787|NCT00414531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643788|NCT00414531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92643789|NCT00414531|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92643790|NCT00414531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643791|NCT00214682|Vitamin B 12|vitamin b 12|mesh-list
92643792|NCT00214682|Hydroxocobalamin|hydroxocobalamin|mesh-list
92643794|NCT00214682|Micronutrients|micronutrients|mesh-ancestor
92643795|NCT00214682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643796|NCT00214682|Vitamin B Complex|vitamin b complex|mesh-ancestor
92643797|NCT00214682|Hematinics|hematinics|mesh-ancestor
92643798|NCT00214721|Dialysis Solutions|dialysis solutions|mesh-list
92643799|NCT00214721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92643800|NCT00240513|Minocycline|minocycline|mesh-list
92643802|NCT00240513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643803|NCT00240513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643804|NCT00240513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643805|NCT00240513|Keratolytic Agents|keratolytic agents|mesh-ancestor
92643806|NCT00240513|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643807|NCT00240552|Fosamprenavir|fosamprenavir|mesh-list
92643808|NCT00240552|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92643809|NCT00240552|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92643810|NCT00240552|Protease Inhibitors|protease inhibitors|mesh-ancestor
92643811|NCT00240552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643812|NCT00240552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643813|NCT00240552|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92643814|NCT00240552|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92643815|NCT00240552|Antiviral Agents|antiviral agents|mesh-ancestor
92643816|NCT00240552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643817|NCT00214877|Methylene Blue|methylene blue|mesh-list
92643818|NCT00214877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643819|NCT00214877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643820|NCT00214955|Fentanyl|fentanyl|mesh-list
92643821|NCT00214955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92643822|NCT00214955|Narcotics|narcotics|mesh-ancestor
92643823|NCT00214955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643824|NCT00214955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643825|NCT00214955|Analgesics|analgesics|mesh-ancestor
92643826|NCT00214955|Sensory System Agents|sensory system agents|mesh-ancestor
92643827|NCT00214955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643828|NCT00214955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92643829|NCT00214955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92643830|NCT00214955|Anesthetics, General|anesthetics, general|mesh-ancestor
92643831|NCT00214955|Anesthetics|anesthetics|mesh-ancestor
92643832|NCT00244179|Interferons|interferons|mesh-list
92643833|NCT00244179|Interferon-gamma|interferon-gamma|mesh-list
92643834|NCT00244179|Infliximab|infliximab|mesh-list
92643835|NCT00244179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643836|NCT00244179|Antiviral Agents|antiviral agents|mesh-ancestor
92643837|NCT00244179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643838|NCT00244179|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92643839|NCT00244179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643840|NCT00244179|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643841|NCT00244179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92643842|NCT00244179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643843|NCT00214994|Tiagabine|tiagabine|mesh-list
92643844|NCT00214994|Anticonvulsants|anticonvulsants|mesh-ancestor
92643846|NCT00214994|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92643847|NCT00214994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643848|NCT00214994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643850|NCT00214994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643851|NCT00214994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643852|NCT00240630|Naproxen|naproxen|mesh-list
92643853|NCT00240630|Sumatriptan|sumatriptan|mesh-list
92643854|NCT00240630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92643855|NCT00240630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92562841|NCT00043875|Anticonvulsants|anticonvulsants|mesh-ancestor
92562842|NCT00043875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562843|NCT00043875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562844|NCT00043875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643856|NCT00240630|Analgesics|analgesics|mesh-ancestor
92643857|NCT00240630|Sensory System Agents|sensory system agents|mesh-ancestor
92643858|NCT00240630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643859|NCT00240630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643860|NCT00240630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643861|NCT00240630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643862|NCT00240630|Gout Suppressants|gout suppressants|mesh-ancestor
92643863|NCT00240630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92643864|NCT00240630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643865|NCT00240630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643866|NCT00240630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92643867|NCT00240630|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92643868|NCT00240630|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92643869|NCT00240630|Serotonin Agents|serotonin agents|mesh-ancestor
92643870|NCT00240630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643871|NCT00244296|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92643872|NCT00244296|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92643873|NCT00244296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92643874|NCT00244296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643875|NCT00244296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643876|NCT00244296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643877|NCT00244296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643878|NCT00244296|Analgesics|analgesics|mesh-ancestor
92643879|NCT00244296|Sensory System Agents|sensory system agents|mesh-ancestor
92643880|NCT00244296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643881|NCT00244296|Antidepressive Agents|antidepressive agents|mesh-ancestor
92643882|NCT00244296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643883|NCT00244296|Dopamine Agents|dopamine agents|mesh-ancestor
92643884|NCT00215228|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92643885|NCT00215228|Escitalopram|escitalopram|mesh-list
92643886|NCT00215228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92643887|NCT00215228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92643888|NCT00215228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92643889|NCT00215228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643890|NCT00215228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643891|NCT00215228|Serotonin Agents|serotonin agents|mesh-ancestor
92643892|NCT00215228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643893|NCT00215228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643894|NCT00215228|Antidepressive Agents|antidepressive agents|mesh-ancestor
92643895|NCT00215228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643896|NCT00215228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92643897|NCT00215228|Analgesics|analgesics|mesh-ancestor
92643898|NCT00215228|Sensory System Agents|sensory system agents|mesh-ancestor
92643899|NCT00215228|Dopamine Agents|dopamine agents|mesh-ancestor
92643900|NCT00215267|Praziquantel|praziquantel|mesh-list
92369187|NCT05668286|Hormones|hormones|mesh-ancestor
92643901|NCT00215267|Anthelmintics|anthelmintics|mesh-ancestor
92643902|NCT00215267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92643903|NCT00215267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643904|NCT00240708|Risperidone|risperidone|mesh-list
92643905|NCT00240708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92643906|NCT00240708|Serotonin Agents|serotonin agents|mesh-ancestor
92643907|NCT00240708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643908|NCT00240708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643909|NCT00240708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643910|NCT00240708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92643911|NCT00240708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92643912|NCT00240708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643913|NCT00240708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643914|NCT00240708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92643917|NCT00215345|Docetaxel|docetaxel|mesh-list
92643918|NCT00215345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643919|NCT00215345|Tubulin Modulators|tubulin modulators|mesh-ancestor
92643920|NCT00215345|Antimitotic Agents|antimitotic agents|mesh-ancestor
92643921|NCT00215345|Mitosis Modulators|mitosis modulators|mesh-ancestor
92643922|NCT00215345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643923|NCT00215345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92643924|NCT00215345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643925|NCT00215345|Analgesics|analgesics|mesh-ancestor
92643926|NCT00215345|Sensory System Agents|sensory system agents|mesh-ancestor
92643927|NCT00215345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643928|NCT00215345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643929|NCT00215345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92643930|NCT00215345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92643931|NCT00215345|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92643932|NCT00215345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92643933|NCT00215345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643934|NCT00240747|Quinupristin-dalfopristin|quinupristin-dalfopristin|mesh-list
92643935|NCT00240747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92643936|NCT00240747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643937|NCT00240747|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92643938|NCT00240747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643939|NCT00240747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643940|NCT00215384|Formoterol Fumarate|formoterol fumarate|mesh-list
92643941|NCT00215384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92643942|NCT00215384|Autonomic Agents|autonomic agents|mesh-ancestor
92643943|NCT00215384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643944|NCT00215384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643945|NCT00215384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92643946|NCT00215384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643947|NCT00215384|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92643948|NCT00215384|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92643949|NCT00215384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92643950|NCT00215384|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643951|NCT00215384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643952|NCT00215384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643953|NCT00215423|Formoterol Fumarate|formoterol fumarate|mesh-list
92643954|NCT00215423|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92643955|NCT00215423|Autonomic Agents|autonomic agents|mesh-ancestor
92643956|NCT00215423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643957|NCT00215423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643958|NCT00215423|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92643959|NCT00215423|Respiratory System Agents|respiratory system agents|mesh-ancestor
92643960|NCT00215423|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92643961|NCT00215423|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92643962|NCT00215423|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92643963|NCT00215423|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643964|NCT00215423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643965|NCT00215423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643966|NCT04668352|Dactolisib|dactolisib|mesh-list
92643967|NCT04668352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643968|NCT00215462|Vinorelbine|vinorelbine|mesh-list
92643969|NCT00215462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92643970|NCT00215462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643971|NCT00215462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92643972|NCT00215462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92643973|NCT00215462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92369261|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643974|NCT00215462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643976|NCT00215501|Capecitabine|capecitabine|mesh-list
92643977|NCT00215501|Irinotecan|irinotecan|mesh-list
92643978|NCT00215501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643979|NCT00215501|Antimetabolites|antimetabolites|mesh-ancestor
92643980|NCT00215501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643981|NCT00215501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643982|NCT00215501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643983|NCT00215501|Immunologic Factors|immunologic factors|mesh-ancestor
92643984|NCT00215501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643985|NCT00215501|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92643986|NCT00215501|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92643998|NCT00215579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92643999|NCT00215579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644000|NCT00215579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644001|NCT00215579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92644002|NCT00215579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644003|NCT00215579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562845|NCT00043875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92562846|NCT00043875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562847|NCT00043875|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92644004|NCT00215579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644005|NCT00215579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92644007|NCT00556621|Gemcitabine|gemcitabine|mesh-list
92644008|NCT00556621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644009|NCT00556621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92644010|NCT00556621|Antimetabolites|antimetabolites|mesh-ancestor
92644011|NCT00556621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644013|NCT00244452|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92644014|NCT00244452|Fertility Agents|fertility agents|mesh-ancestor
92644015|NCT00244452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92644016|NCT00244452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644017|NCT00244452|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644018|NCT00244452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644019|NCT00556699|Rituximab|rituximab|mesh-list
92644020|NCT00556699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92644021|NCT00556699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644022|NCT00556699|Immunologic Factors|immunologic factors|mesh-ancestor
92644023|NCT00556699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644024|NCT00556699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644025|NCT00411866|Ketoconazole|ketoconazole|mesh-list
92644026|NCT00411866|Antifungal Agents|antifungal agents|mesh-ancestor
92644027|NCT00411866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644028|NCT00411866|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92644029|NCT00411866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92644030|NCT00411866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644031|NCT00411866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644032|NCT00411866|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92644033|NCT00411866|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644034|NCT00411866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644035|NCT00411866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644036|NCT00411866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92644037|NCT04667299|Amoxicillin|amoxicillin|mesh-list
92644038|NCT04667299|Metronidazole|metronidazole|mesh-list
92644039|NCT04667299|Potassium Citrate|potassium citrate|mesh-list
92644040|NCT04667299|Rabeprazole|rabeprazole|mesh-list
92644041|NCT04667299|Bismuth|bismuth|mesh-list
92644042|NCT04667299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644043|NCT04667299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92644044|NCT04667299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644045|NCT04667299|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92644046|NCT04667299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92644047|NCT04667299|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92644048|NCT04667299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644049|NCT04667299|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92051167|NCT02111785|Antiemetics|antiemetics|mesh-ancestor
92644054|NCT04667299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644056|NCT04667299|Respiratory System Agents|respiratory system agents|mesh-ancestor
92644057|NCT04667143|Metformin|metformin|mesh-list
92644058|NCT04667143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92644059|NCT04667143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644060|NCT00240825|Acetaminophen|acetaminophen|mesh-list
92644061|NCT00240825|Ibuprofen|ibuprofen|mesh-list
92644062|NCT00240825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92644063|NCT00240825|Analgesics|analgesics|mesh-ancestor
92644064|NCT00240825|Sensory System Agents|sensory system agents|mesh-ancestor
92644065|NCT00240825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644066|NCT00240825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644067|NCT00240825|Antipyretics|antipyretics|mesh-ancestor
92644068|NCT00240825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92644069|NCT00240825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644070|NCT00240825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644071|NCT00240825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92644072|NCT00240825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644073|NCT00240825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644074|NCT04666675|Upadacitinib|upadacitinib|mesh-list
92644075|NCT04666675|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92644076|NCT04666675|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92562848|NCT00043875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92562849|NCT00043875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562850|NCT00043875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562851|NCT00043875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92562852|NCT00154258|Clozapine|clozapine|mesh-list
92562853|NCT00154258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92562854|NCT00154258|Serotonin Agents|serotonin agents|mesh-ancestor
92562855|NCT00154258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562856|NCT00154258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644077|NCT04666675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644078|NCT04666675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644079|NCT04666675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644080|NCT00244530|Nifedipine|nifedipine|mesh-list
92644081|NCT00244530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92644082|NCT00244530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644083|NCT00244530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644084|NCT00244530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92644085|NCT00244530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644086|NCT00244530|Vasodilator Agents|vasodilator agents|mesh-ancestor
92644087|NCT00244530|Tocolytic Agents|tocolytic agents|mesh-ancestor
92644088|NCT00244530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92644089|NCT00411905|Bortezomib|bortezomib|mesh-list
92644090|NCT00411905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644091|NCT00240864|Acetaminophen|acetaminophen|mesh-list
92644092|NCT00240864|Ibuprofen|ibuprofen|mesh-list
92644093|NCT00240864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92644094|NCT00240864|Analgesics|analgesics|mesh-ancestor
92644095|NCT00240864|Sensory System Agents|sensory system agents|mesh-ancestor
92644096|NCT00240864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644097|NCT00240864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644098|NCT00240864|Antipyretics|antipyretics|mesh-ancestor
92644099|NCT00240864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92644100|NCT00240864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644101|NCT00240864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644102|NCT00240864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92644103|NCT00240864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644104|NCT00240864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644105|NCT00557011|Amphetamine|amphetamine|mesh-list
92644106|NCT00557011|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92644107|NCT00557011|Adderall|adderall|mesh-list
92644108|NCT00557011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92644109|NCT00557011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644110|NCT00557011|Sympathomimetics|sympathomimetics|mesh-ancestor
92644111|NCT00557011|Autonomic Agents|autonomic agents|mesh-ancestor
92644112|NCT00557011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644113|NCT00557011|Dopamine Agents|dopamine agents|mesh-ancestor
92644114|NCT00557011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644115|NCT00557011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644116|NCT00557011|Adrenergic Agents|adrenergic agents|mesh-ancestor
92644117|NCT00557011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92644118|NCT00557011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92644119|NCT00557011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644120|NCT00557011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92644121|NCT04666324|Simethicone|simethicone|mesh-list
92644122|NCT04666324|Antifoaming Agents|antifoaming agents|mesh-ancestor
92644125|NCT04666324|Dermatologic Agents|dermatologic agents|mesh-ancestor
92644126|NCT04720833|Vitamin D|vitamin d|mesh-list
92644127|NCT04720833|Calcium|calcium|mesh-list
92644128|NCT04720833|Vitamins|vitamins|mesh-ancestor
92644129|NCT04720833|Micronutrients|micronutrients|mesh-ancestor
92644130|NCT04720833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644131|NCT04720833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92644132|NCT04720833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92644133|NCT00244608|Budesonide|budesonide|mesh-list
92644134|NCT00244608|Terbutaline|terbutaline|mesh-list
92644135|NCT00244608|Formoterol Fumarate|formoterol fumarate|mesh-list
92562857|NCT00154258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562858|NCT00154258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92562859|NCT00154258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91970299|NCT01375751|Protease Inhibitors|protease inhibitors|mesh-ancestor
92644136|NCT00244608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644137|NCT00244608|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92644138|NCT00244608|Autonomic Agents|autonomic agents|mesh-ancestor
92644139|NCT00244608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644140|NCT00244608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644141|NCT00244608|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92644142|NCT00244608|Respiratory System Agents|respiratory system agents|mesh-ancestor
92644143|NCT00244608|Glucocorticoids|glucocorticoids|mesh-ancestor
92644144|NCT00244608|Hormones|hormones|mesh-ancestor
92644145|NCT00244608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644146|NCT00244608|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92644147|NCT00244608|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92644148|NCT00244608|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92644149|NCT00244608|Adrenergic Agents|adrenergic agents|mesh-ancestor
92644150|NCT00244608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644151|NCT00244608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644152|NCT00244608|Sympathomimetics|sympathomimetics|mesh-ancestor
92644153|NCT00244608|Tocolytic Agents|tocolytic agents|mesh-ancestor
92644154|NCT00244608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92644155|NCT04666168|Cyclophosphamide|cyclophosphamide|mesh-list
92644156|NCT04666168|Fludarabine|fludarabine|mesh-list
92644157|NCT04666168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644158|NCT04666168|Immunologic Factors|immunologic factors|mesh-ancestor
92644159|NCT04666168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644160|NCT04666168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644161|NCT04666168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92644162|NCT04666168|Alkylating Agents|alkylating agents|mesh-ancestor
92644163|NCT04666168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644164|NCT04666168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644165|NCT04666168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92644166|NCT00215774|Flecainide|flecainide|mesh-list
92644167|NCT00215774|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92644168|NCT00215774|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92644169|NCT00215774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92644170|NCT00215774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644171|NCT00215774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644172|NCT00240942|Letrozole|letrozole|mesh-list
92644173|NCT00240942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644174|NCT00240942|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92644175|NCT00240942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92644176|NCT00240942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644177|NCT00240942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644178|NCT00240942|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92644179|NCT00240942|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644180|NCT00240942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644181|NCT00240942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644182|NCT00215891|Interferons|interferons|mesh-list
92644183|NCT00215891|Ribavirin|ribavirin|mesh-list
92644184|NCT00215891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644185|NCT00215891|Antiviral Agents|antiviral agents|mesh-ancestor
92644186|NCT00215891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644187|NCT00215891|Antimetabolites|antimetabolites|mesh-ancestor
92644188|NCT00215891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644189|NCT02961816|Pyridoxine|pyridoxine|mesh-list
92644190|NCT02961816|Dexamethasone|dexamethasone|mesh-list
92644191|NCT02961816|Rituximab|rituximab|mesh-list
92644192|NCT02961816|Gemcitabine|gemcitabine|mesh-list
92644193|NCT02961816|Melphalan|melphalan|mesh-list
92644194|NCT02961816|Busulfan|busulfan|mesh-list
92644195|NCT02961816|Panobinostat|panobinostat|mesh-list
92051299|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644198|NCT02961816|Immunologic Factors|immunologic factors|mesh-ancestor
92644199|NCT02961816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644200|NCT02961816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644201|NCT02961816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644202|NCT02961816|Antiemetics|antiemetics|mesh-ancestor
92644203|NCT02961816|Autonomic Agents|autonomic agents|mesh-ancestor
92644204|NCT02961816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92562860|NCT00154258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562861|NCT00154258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562862|NCT00154258|GABA Antagonists|gaba antagonists|mesh-ancestor
92644205|NCT02961816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644206|NCT02961816|Glucocorticoids|glucocorticoids|mesh-ancestor
92644208|NCT02961816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644209|NCT02961816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644210|NCT02961816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92644211|NCT02961816|Antimetabolites|antimetabolites|mesh-ancestor
92644212|NCT02961816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644213|NCT02961816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92644214|NCT02961816|Alkylating Agents|alkylating agents|mesh-ancestor
92644215|NCT02961816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92644216|NCT02961816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644217|NCT02961816|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92644218|NCT02961816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644219|NCT02961816|Vitamin B Complex|vitamin b complex|mesh-ancestor
92644220|NCT02961816|Vitamins|vitamins|mesh-ancestor
92644221|NCT02961816|Micronutrients|micronutrients|mesh-ancestor
92644222|NCT04665232|Progesterone|progesterone|mesh-list
92644223|NCT04665232|Progestins|progestins|mesh-ancestor
92644224|NCT04665232|Hormones|hormones|mesh-ancestor
92644225|NCT04665232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644226|NCT04665232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644227|NCT00216008|Docetaxel|docetaxel|mesh-list
92644228|NCT00216008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644229|NCT00216008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644230|NCT00216008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644231|NCT00216008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644232|NCT00216008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644233|NCT04665076|Cyclophosphamide|cyclophosphamide|mesh-list
92644234|NCT04665076|Fludarabine|fludarabine|mesh-list
92644235|NCT04665076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644236|NCT04665076|Immunologic Factors|immunologic factors|mesh-ancestor
92644237|NCT04665076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644238|NCT04665076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644239|NCT04665076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92644240|NCT04665076|Alkylating Agents|alkylating agents|mesh-ancestor
92644241|NCT04665076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644242|NCT04665076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644243|NCT04665076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92644244|NCT00241020|Octreotide|octreotide|mesh-list
92644245|NCT00241020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644246|NCT00241020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644247|NCT00241020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644248|NCT00216047|Trastuzumab|trastuzumab|mesh-list
92644249|NCT00216047|Vatalanib|vatalanib|mesh-list
92644250|NCT00216047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92644251|NCT00216047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644252|NCT00216047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92644253|NCT00216047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644254|NCT00216047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644255|NCT04665310|Tacrolimus|tacrolimus|mesh-list
92644256|NCT04665310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644257|NCT04665310|Immunologic Factors|immunologic factors|mesh-ancestor
92644258|NCT04665310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644259|NCT04665310|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92644260|NCT04665310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644261|NCT04665310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644262|NCT00241059|Mycophenolic Acid|mycophenolic acid|mesh-list
92644263|NCT00241059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92644264|NCT00241059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644265|NCT00241059|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92051373|NCT02109445|Paclitaxel|paclitaxel|mesh-list
92644270|NCT00241059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644271|NCT00216164|Rituximab|rituximab|mesh-list
92644272|NCT00216164|Gemcitabine|gemcitabine|mesh-list
92644273|NCT00216164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92644274|NCT00216164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644275|NCT00216164|Immunologic Factors|immunologic factors|mesh-ancestor
92562863|NCT00154258|GABA Agents|gaba agents|mesh-ancestor
92562864|NCT00154336|Methotrexate|methotrexate|mesh-list
92562865|NCT00154336|Imatinib Mesylate|imatinib mesylate|mesh-list
92562866|NCT00154336|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92562867|NCT00154336|Abortifacient Agents|abortifacient agents|mesh-ancestor
92644276|NCT00216164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644277|NCT00216164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644278|NCT00216164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92644279|NCT00216164|Antimetabolites|antimetabolites|mesh-ancestor
92644280|NCT00216164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644281|NCT04664803|Cefdinir|cefdinir|mesh-list
92644282|NCT04664803|Cefetamet|cefetamet|mesh-list
92644283|NCT04664803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92644284|NCT04664803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644285|NCT04664725|Repaglinide|repaglinide|mesh-list
92644286|NCT04664725|Bupropion|bupropion|mesh-list
92644287|NCT04664725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92644288|NCT04664725|Antidepressive Agents|antidepressive agents|mesh-ancestor
92644289|NCT04664725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644290|NCT04664725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92644291|NCT04664725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92644292|NCT04664725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644293|NCT04664725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644294|NCT04664725|Dopamine Agents|dopamine agents|mesh-ancestor
92644295|NCT04664725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644296|NCT04664725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644297|NCT04664725|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92644298|NCT04664725|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92644299|NCT04664725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644300|NCT04664725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92644301|NCT04664764|Insulin, Isophane|insulin, isophane|mesh-list
92644302|NCT04664764|Isophane Insulin, Human|isophane insulin, human|mesh-list
92644303|NCT04664764|Isophane insulin, beef|isophane insulin, beef|mesh-list
92644304|NCT04664764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92644305|NCT04664764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644306|NCT00241098|Valsartan|valsartan|mesh-list
92644307|NCT00241098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92644308|NCT00241098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92644309|NCT00241098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92644310|NCT00241098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644311|NCT00216281|Clozapine|clozapine|mesh-list
92644312|NCT00216281|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92644313|NCT00216281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92644314|NCT00216281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92644315|NCT00216281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644316|NCT00216281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644317|NCT00216281|Adrenergic Agents|adrenergic agents|mesh-ancestor
92644318|NCT00216281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644319|NCT00216281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644320|NCT00216281|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92644321|NCT00216281|Serotonin Agents|serotonin agents|mesh-ancestor
92644322|NCT00216281|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92644323|NCT00216281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644324|NCT00216281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644325|NCT00216281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644326|NCT00216281|GABA Antagonists|gaba antagonists|mesh-ancestor
92644327|NCT00216281|GABA Agents|gaba agents|mesh-ancestor
92644328|NCT00241137|Valsartan|valsartan|mesh-list
92644329|NCT00241137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92644330|NCT00241137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92644331|NCT00241137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92644332|NCT00241137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644333|NCT00216359|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92644334|NCT00216359|Enfuvirtide|enfuvirtide|mesh-list
92644335|NCT00216359|Antiviral Agents|antiviral agents|mesh-ancestor
92644338|NCT00216359|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92644339|NCT00216359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644340|NCT00216359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92644341|NCT04664530|Esketamine|esketamine|mesh-list
92562868|NCT00154336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92562869|NCT00154336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993957|NCT05899465|Coagulants|coagulants|mesh-ancestor
92644342|NCT04664530|Antidepressive Agents|antidepressive agents|mesh-ancestor
92644343|NCT04664530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644344|NCT00216398|Lanreotide|lanreotide|mesh-list
92644345|NCT00216398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644346|NCT00241215|Botulinum Toxins|botulinum toxins|mesh-list
92644347|NCT00241215|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92644348|NCT00241215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644349|NCT00241215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644350|NCT00241215|Cholinergic Agents|cholinergic agents|mesh-ancestor
92644351|NCT00241215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644352|NCT00241215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644353|NCT00216437|Capecitabine|capecitabine|mesh-list
92644354|NCT00216437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92644355|NCT00216437|Antimetabolites|antimetabolites|mesh-ancestor
92644356|NCT00216437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644357|NCT00216437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644358|NCT00244920|Squalamine|squalamine|mesh-list
92644359|NCT00244920|Leuprolide|leuprolide|mesh-list
92644360|NCT00244920|Bicalutamide|bicalutamide|mesh-list
92644361|NCT00244920|Hormones|hormones|mesh-list
92644362|NCT00244920|Androgen Antagonists|androgen antagonists|mesh-list
92750775|NCT05936229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644363|NCT00244920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644364|NCT00244920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644365|NCT00244920|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92644366|NCT00244920|Fertility Agents|fertility agents|mesh-ancestor
92644367|NCT00244920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92644368|NCT00244920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644369|NCT00244920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644370|NCT00244920|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644371|NCT00244920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92644372|NCT00244920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644373|NCT00244920|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92644374|NCT00244920|Protective Agents|protective agents|mesh-ancestor
92644375|NCT00244920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92644376|NCT00244920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92644377|NCT00244920|Growth Substances|growth substances|mesh-ancestor
92644378|NCT00244920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92644379|NCT04663438|Antineoplastic Agents|antineoplastic agents|mesh-list
92644380|NCT00216515|Galantamine|galantamine|mesh-list
92644381|NCT00216515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92644382|NCT00216515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644383|NCT00216515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644384|NCT00216515|Cholinergic Agents|cholinergic agents|mesh-ancestor
92644385|NCT00216515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644386|NCT00216515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644387|NCT00216515|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92644388|NCT00216515|Autonomic Agents|autonomic agents|mesh-ancestor
92644389|NCT00216515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644390|NCT00216515|Nootropic Agents|nootropic agents|mesh-ancestor
92644391|NCT00244959|Anastrozole|anastrozole|mesh-list
92644392|NCT00244959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644393|NCT00244959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644394|NCT00244959|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92644395|NCT00244959|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92644396|NCT00244959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644397|NCT00244959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644398|NCT00244959|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92644399|NCT00244959|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644400|NCT00244959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644401|NCT00244959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644402|NCT00244998|Fulvestrant|fulvestrant|mesh-list
92644403|NCT00244998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644404|NCT00244998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644405|NCT00244998|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92644406|NCT00244998|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92644407|NCT00244998|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644409|NCT00244998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644411|NCT00216554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92562870|NCT00154336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92562871|NCT00154336|Antimetabolites|antimetabolites|mesh-ancestor
92562872|NCT00154336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644412|NCT00216554|Serotonin Agents|serotonin agents|mesh-ancestor
92644413|NCT00216554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644414|NCT00216554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644415|NCT00216554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644416|NCT00216554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92644417|NCT00216554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644418|NCT00216554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644419|NCT00216554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644420|NCT00216554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92644421|NCT00216554|Dopamine Agents|dopamine agents|mesh-ancestor
92644422|NCT00241254|Methylprednisolone|methylprednisolone|mesh-list
92644423|NCT00241254|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92644424|NCT00241254|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92644426|NCT00241254|Prednisolone acetate|prednisolone acetate|mesh-list
92644427|NCT00241254|Cyclophosphamide|cyclophosphamide|mesh-list
92644428|NCT00241254|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92644429|NCT00241254|Prednisolone phosphate|prednisolone phosphate|mesh-list
92644430|NCT00241254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644431|NCT00241254|Immunologic Factors|immunologic factors|mesh-ancestor
92644432|NCT00241254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644433|NCT00241254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644434|NCT00241254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92644435|NCT00241254|Alkylating Agents|alkylating agents|mesh-ancestor
92644436|NCT00241254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644437|NCT00241254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644438|NCT00241254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92644439|NCT00241254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644440|NCT00241254|Antiemetics|antiemetics|mesh-ancestor
92644441|NCT00241254|Autonomic Agents|autonomic agents|mesh-ancestor
92644442|NCT00241254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644443|NCT00241254|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644444|NCT00241254|Glucocorticoids|glucocorticoids|mesh-ancestor
92644445|NCT00241254|Hormones|hormones|mesh-ancestor
92644446|NCT00241254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644447|NCT00241254|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92644448|NCT00241254|Protective Agents|protective agents|mesh-ancestor
92644449|NCT00241254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644450|NCT00216632|Risperidone|risperidone|mesh-list
92644451|NCT00216632|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92644452|NCT00216632|Serotonin Agents|serotonin agents|mesh-ancestor
92644453|NCT00216632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644454|NCT00216632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644455|NCT00216632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644456|NCT00216632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92644457|NCT00216632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644458|NCT00216632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644459|NCT00216632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644460|NCT00216632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92644461|NCT00216632|Dopamine Agents|dopamine agents|mesh-ancestor
92644462|NCT04662736|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92644463|NCT04662736|Tedizolid|tedizolid|mesh-list
92644464|NCT04662736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644465|NCT04662658|Xenon|xenon|mesh-list
92644466|NCT04662658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92644467|NCT04662658|Anesthetics, General|anesthetics, general|mesh-ancestor
92644468|NCT04662658|Anesthetics|anesthetics|mesh-ancestor
92644469|NCT04662658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644470|NCT04662658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644471|NCT00216788|Esomeprazole|esomeprazole|mesh-list
92644472|NCT00216788|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92644473|NCT00216788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644474|NCT00216788|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92644475|NCT00216788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644476|NCT00216788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644477|NCT00245115|Cyclophosphamide|cyclophosphamide|mesh-list
92644478|NCT00245115|Busulfan|busulfan|mesh-list
92644479|NCT00245115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644480|NCT00245115|Immunologic Factors|immunologic factors|mesh-ancestor
92644481|NCT00245115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562873|NCT00154336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287661|NCT01769209|Cytarabine|cytarabine|mesh-list
92562874|NCT00154336|Dermatologic Agents|dermatologic agents|mesh-ancestor
92562875|NCT00154336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644484|NCT00245115|Alkylating Agents|alkylating agents|mesh-ancestor
92644485|NCT00245115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644486|NCT00245115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644487|NCT00245115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92644488|NCT04662385|Listerine|listerine|mesh-list
92644489|NCT04662385|Sodium Fluoride|sodium fluoride|mesh-list
92644490|NCT04662385|Cariostatic Agents|cariostatic agents|mesh-ancestor
92644491|NCT04662385|Protective Agents|protective agents|mesh-ancestor
92644492|NCT04662385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644493|NCT04662385|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92644494|NCT04662385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644495|NCT00216827|Betamethasone|betamethasone|mesh-list
92644496|NCT00216827|Betamethasone Valerate|betamethasone valerate|mesh-list
92644497|NCT00216827|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92644498|NCT00216827|Betamethasone benzoate|betamethasone benzoate|mesh-list
92644499|NCT00216827|Calcipotriene|calcipotriene|mesh-list
92644500|NCT00216827|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92644501|NCT00216827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644502|NCT00216827|Glucocorticoids|glucocorticoids|mesh-ancestor
92644503|NCT00216827|Hormones|hormones|mesh-ancestor
92750776|NCT05936229|Immunologic Factors|immunologic factors|mesh-ancestor
92644504|NCT00216827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644505|NCT00216827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644506|NCT00216827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92644507|NCT00216827|Respiratory System Agents|respiratory system agents|mesh-ancestor
92644508|NCT00216827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92644509|NCT00241332|Fentanyl|fentanyl|mesh-list
92644510|NCT00241332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92644511|NCT00241332|Narcotics|narcotics|mesh-ancestor
92644512|NCT00241332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644513|NCT00241332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644514|NCT00241332|Analgesics|analgesics|mesh-ancestor
92644515|NCT00241332|Sensory System Agents|sensory system agents|mesh-ancestor
92644516|NCT00241332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644517|NCT00241332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92644518|NCT00241332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92644519|NCT00241332|Anesthetics, General|anesthetics, general|mesh-ancestor
92644520|NCT00241332|Anesthetics|anesthetics|mesh-ancestor
92644521|NCT00216866|Dalteparin|dalteparin|mesh-list
92644522|NCT00216866|Tinzaparin|tinzaparin|mesh-list
92644523|NCT00216866|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92644524|NCT00216866|Warfarin|warfarin|mesh-list
92644525|NCT00216866|Anticoagulants|anticoagulants|mesh-ancestor
92644526|NCT00216866|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92644527|NCT00216866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92644528|NCT00216866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644529|NCT00557206|Docetaxel|docetaxel|mesh-list
92644530|NCT00557206|Oxaliplatin|oxaliplatin|mesh-list
92644531|NCT00557206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644532|NCT00557206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644533|NCT00557206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644534|NCT00557206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644535|NCT00557206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644536|NCT00245154|Paclitaxel|paclitaxel|mesh-list
92644537|NCT00245154|Carboplatin|carboplatin|mesh-list
92644538|NCT00245154|Cediranib|cediranib|mesh-list
92644539|NCT00245154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92644540|NCT00245154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644541|NCT00245154|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644542|NCT00245154|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644543|NCT00245154|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644544|NCT00245154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644545|NCT00245154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644546|NCT00245154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92644547|NCT00241371|Clofarabine|clofarabine|mesh-list
92644548|NCT00241371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92644549|NCT00241371|Antimetabolites|antimetabolites|mesh-ancestor
92644550|NCT00241371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644551|NCT00241371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644552|NCT04660786|Vitamin D|vitamin d|mesh-list
92644553|NCT04660786|Triamcinolone|triamcinolone|mesh-list
92562876|NCT00154336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92562877|NCT00154336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562878|NCT00154336|Immunologic Factors|immunologic factors|mesh-ancestor
92562879|NCT00154336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562880|NCT00154336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92562881|NCT00154336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92562882|NCT00050804|Sertraline|sertraline|mesh-list
92562883|NCT00050804|Antidepressive Agents|antidepressive agents|mesh-ancestor
92644554|NCT04660786|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92644555|NCT04660786|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92644556|NCT04660786|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92644559|NCT04660786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644560|NCT04660786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92644561|NCT04660786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644562|NCT04660786|Glucocorticoids|glucocorticoids|mesh-ancestor
92644563|NCT04660786|Hormones|hormones|mesh-ancestor
92644564|NCT04660786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644565|NCT04660786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644566|NCT04660786|Immunologic Factors|immunologic factors|mesh-ancestor
92644567|NCT04660786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644568|NCT04660786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644569|NCT00217178|Folic Acid|folic acid|mesh-list
92644570|NCT00217178|Vitamins|vitamins|mesh-ancestor
92644571|NCT00217178|Micronutrients|micronutrients|mesh-ancestor
92644572|NCT00217178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644573|NCT00217178|Hematinics|hematinics|mesh-ancestor
92644574|NCT00217178|Vitamin B Complex|vitamin b complex|mesh-ancestor
92644575|NCT00241449|Tamoxifen|tamoxifen|mesh-list
92644576|NCT00241449|Fulvestrant|fulvestrant|mesh-list
92644577|NCT00241449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92644578|NCT00241449|Hormone Antagonists|hormone antagonists|mesh-ancestor
92644579|NCT00241449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644580|NCT00241449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644581|NCT00241449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644582|NCT00241449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644583|NCT00241449|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92644584|NCT00241449|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92644585|NCT00241449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92644586|NCT00241449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92644587|NCT00412100|Oxycodone|oxycodone|mesh-list
92644588|NCT00412100|Naloxone|naloxone|mesh-list
92644589|NCT00412100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92644590|NCT00412100|Narcotics|narcotics|mesh-ancestor
92644591|NCT00412100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644592|NCT00412100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644593|NCT00412100|Analgesics|analgesics|mesh-ancestor
92644594|NCT00412100|Sensory System Agents|sensory system agents|mesh-ancestor
92644595|NCT00412100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644596|NCT00412100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92644597|NCT00241488|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92644598|NCT00241488|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92644599|NCT00241488|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92644600|NCT00241488|Antimetabolites|antimetabolites|mesh-ancestor
92644601|NCT00241488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644602|NCT00241488|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92644603|NCT00241488|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92644604|NCT00241488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644605|NCT04659499|Paclitaxel|paclitaxel|mesh-list
92644606|NCT04659499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92644607|NCT04659499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644608|NCT04659499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644609|NCT04659499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644610|NCT04659499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644611|NCT04659499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644612|NCT00241527|Esomeprazole|esomeprazole|mesh-list
92644613|NCT00241527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92644614|NCT00241527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562884|NCT00050804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562885|NCT00050804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91994252|NCT05709444|Hormones|hormones|mesh-ancestor
92644615|NCT00241527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92644616|NCT00241527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644617|NCT00241527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644618|NCT04648813|Bromides|bromides|mesh-list
92644619|NCT04648813|Tiotropium Bromide|tiotropium bromide|mesh-list
92644620|NCT04648813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92644621|NCT04648813|Autonomic Agents|autonomic agents|mesh-ancestor
92644622|NCT04648813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644623|NCT04648813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644624|NCT04648813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92644625|NCT04648813|Respiratory System Agents|respiratory system agents|mesh-ancestor
92644626|NCT04648813|Parasympatholytics|parasympatholytics|mesh-ancestor
92644627|NCT04648813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92644628|NCT04648813|Cholinergic Agents|cholinergic agents|mesh-ancestor
92644629|NCT04648813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051740|NCT01827111|Paclitaxel|paclitaxel|mesh-list
92644632|NCT04648423|Sodium Oxybate|sodium oxybate|mesh-list
92644633|NCT04648423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92644634|NCT04648423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92644635|NCT04648423|Anesthetics, General|anesthetics, general|mesh-ancestor
92644636|NCT04648423|Anesthetics|anesthetics|mesh-ancestor
92644637|NCT04648423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644638|NCT04648423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644639|NCT00558181|Methylprednisolone|methylprednisolone|mesh-list
92644640|NCT00558181|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92644641|NCT00558181|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92644642|NCT00558181|Prednisolone|prednisolone|mesh-list
92644643|NCT00558181|Prednisolone acetate|prednisolone acetate|mesh-list
92644644|NCT00558181|Rituximab|rituximab|mesh-list
92644645|NCT00558181|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92644646|NCT00558181|Prednisolone phosphate|prednisolone phosphate|mesh-list
92644647|NCT00558181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369938|NCT03539952|Antidotes|antidotes|mesh-ancestor
92644648|NCT00558181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644649|NCT00558181|Immunologic Factors|immunologic factors|mesh-ancestor
92644650|NCT00558181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644651|NCT00558181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644652|NCT00558181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644653|NCT00558181|Antiemetics|antiemetics|mesh-ancestor
92644654|NCT00558181|Autonomic Agents|autonomic agents|mesh-ancestor
92644655|NCT00558181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644656|NCT00558181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644657|NCT00558181|Glucocorticoids|glucocorticoids|mesh-ancestor
92644658|NCT00558181|Hormones|hormones|mesh-ancestor
92644659|NCT00558181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644660|NCT00558181|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92644661|NCT00558181|Protective Agents|protective agents|mesh-ancestor
92644662|NCT00558181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644663|NCT00558220|Immunomodulating Agents|immunomodulating agents|mesh-list
92644664|NCT00558220|Immunologic Factors|immunologic factors|mesh-ancestor
92644665|NCT00558220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644666|NCT00217295|Topiramate|topiramate|mesh-list
92644667|NCT00217295|Anticonvulsants|anticonvulsants|mesh-ancestor
92644668|NCT00217295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92644669|NCT00217295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644670|NCT00245427|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92644671|NCT00245427|Lactams|lactams|mesh-list
92644672|NCT00245427|beta-Lactams|beta-lactams|mesh-list
92644673|NCT00245427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92644674|NCT00245427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644675|NCT00245427|Antitubercular Agents|antitubercular agents|mesh-ancestor
92644676|NCT00558298|Risperidone|risperidone|mesh-list
92644677|NCT00558298|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92644678|NCT00558298|Serotonin Agents|serotonin agents|mesh-ancestor
92644679|NCT00558298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644680|NCT00558298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644681|NCT00558298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644682|NCT00558298|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92644683|NCT00558298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644684|NCT00558298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644685|NCT00558298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562886|NCT00050804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562887|NCT00050804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91994334|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92644686|NCT00558298|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92644687|NCT00558298|Dopamine Agents|dopamine agents|mesh-ancestor
92644688|NCT00245505|Mesalamine|mesalamine|mesh-list
92644689|NCT00245505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92644690|NCT00245505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92644691|NCT00245505|Analgesics|analgesics|mesh-ancestor
92644692|NCT00245505|Sensory System Agents|sensory system agents|mesh-ancestor
92644693|NCT00245505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644694|NCT00245505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644695|NCT00245505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644696|NCT00245505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644697|NCT04647838|Tepotinib|tepotinib|mesh-list
92644698|NCT04647838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644699|NCT00217373|Interferons|interferons|mesh-list
92644700|NCT00217373|Interferon-alpha|interferon-alpha|mesh-list
92644701|NCT00217373|Interferon alpha-2|interferon alpha-2|mesh-list
92644702|NCT00217373|Metronidazole|metronidazole|mesh-list
92644703|NCT00217373|Vaccines|vaccines|mesh-list
92644704|NCT00217373|Sargramostim|sargramostim|mesh-list
92644709|NCT00217373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644710|NCT00217373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92644711|NCT00217373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92644712|NCT00217373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92644713|NCT04647292|Antihypertensive Agents|antihypertensive agents|mesh-list
92644714|NCT00241605|Metformin|metformin|mesh-list
92644715|NCT00241605|Rosiglitazone|rosiglitazone|mesh-list
92644716|NCT00241605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92644717|NCT00241605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644718|NCT00217412|Vorinostat|vorinostat|mesh-list
92644719|NCT00217412|Isotretinoin|isotretinoin|mesh-list
92644720|NCT00217412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644721|NCT00217412|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92644722|NCT00217412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644723|NCT00217412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644724|NCT00217412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92644725|NCT04646824|Pemetrexed|pemetrexed|mesh-list
92644726|NCT04646824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644727|NCT04646824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644728|NCT04646824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644729|NCT04646824|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92644730|NCT04646824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92644731|NCT00217451|Clindamycin|clindamycin|mesh-list
92644732|NCT00217451|Clindamycin palmitate|clindamycin palmitate|mesh-list
92644733|NCT00217451|Clindamycin phosphate|clindamycin phosphate|mesh-list
92644734|NCT00217451|Fosmidomycin|fosmidomycin|mesh-list
92644735|NCT00217451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92644736|NCT00217451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644737|NCT00217451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92644738|NCT00217451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644739|NCT00217451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644740|NCT04646707|Lidocaine|lidocaine|mesh-list
92644741|NCT04646707|Bupivacaine|bupivacaine|mesh-list
92644742|NCT04646707|Anesthetics, Local|anesthetics, local|mesh-ancestor
92644743|NCT04646707|Anesthetics|anesthetics|mesh-ancestor
92644744|NCT04646707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644745|NCT04646707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644746|NCT04646707|Sensory System Agents|sensory system agents|mesh-ancestor
92644747|NCT04646707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644748|NCT04646707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92644749|NCT04646707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92644750|NCT04646707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92644751|NCT04646707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644752|NCT04646707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644753|NCT00217529|Carboplatin|carboplatin|mesh-list
92644754|NCT00217529|Docetaxel|docetaxel|mesh-list
92644755|NCT00217529|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92644756|NCT00217529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644757|NCT00217529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644758|NCT00217529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644759|NCT00217529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752329|NCT05940701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92562888|NCT00050804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562889|NCT00050804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92562890|NCT00050804|Serotonin Agents|serotonin agents|mesh-ancestor
92562891|NCT00050804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562892|NCT00043914|Lamotrigine|lamotrigine|mesh-list
92562893|NCT00043914|Anticonvulsants|anticonvulsants|mesh-ancestor
92562894|NCT00043914|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92562895|NCT00043914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92562896|NCT00043914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562897|NCT00043914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92562898|NCT00043914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562899|NCT00043914|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92562900|NCT00043914|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92562901|NCT00043914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562902|NCT00043914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92562903|NCT00043914|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92562904|NCT04705987|Colchicine|colchicine|mesh-list
92562905|NCT04705987|Gout Suppressants|gout suppressants|mesh-ancestor
91970322|NCT03068247|Analgesics|analgesics|mesh-ancestor
92644760|NCT00217529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644761|NCT00217529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92644762|NCT00217529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644763|NCT00245661|Temazepam|temazepam|mesh-list
92644764|NCT00245661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92644765|NCT00245661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644766|NCT00245661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644767|NCT00245661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92644768|NCT00245661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644769|NCT00245661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644770|NCT00245661|GABA Modulators|gaba modulators|mesh-ancestor
92644771|NCT00245661|GABA Agents|gaba agents|mesh-ancestor
92644772|NCT00245661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644773|NCT00245661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644774|NCT04646317|Dexmedetomidine|dexmedetomidine|mesh-list
92644775|NCT04646317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92051891|NCT02178059|Terbutaline|terbutaline|mesh-list
92644778|NCT04646317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92644779|NCT04646317|Analgesics|analgesics|mesh-ancestor
92644780|NCT04646317|Sensory System Agents|sensory system agents|mesh-ancestor
92644781|NCT04646317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644782|NCT04646317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92644783|NCT04646317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92644784|NCT04646317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92644785|NCT04646317|Adrenergic Agents|adrenergic agents|mesh-ancestor
92644786|NCT04646317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644787|NCT04646317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644788|NCT00217568|Carboplatin|carboplatin|mesh-list
92644790|NCT00217568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644791|NCT00217568|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644792|NCT00217568|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644793|NCT00217568|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644794|NCT00217568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644795|NCT04646161|Misoprostol|misoprostol|mesh-list
92644796|NCT04646161|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92562906|NCT04705987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92562907|NCT04705987|Tubulin Modulators|tubulin modulators|mesh-ancestor
92562908|NCT04705987|Antimitotic Agents|antimitotic agents|mesh-ancestor
92562909|NCT04705987|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644797|NCT04646161|Abortifacient Agents|abortifacient agents|mesh-ancestor
92644798|NCT04646161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92644799|NCT04646161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644800|NCT04646161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92644801|NCT04646161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644802|NCT04646161|Oxytocics|oxytocics|mesh-ancestor
92644803|NCT00241722|Alvimopan|alvimopan|mesh-list
92644804|NCT00241722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644805|NCT00558337|Levodopa|levodopa|mesh-list
92644806|NCT00558337|Carbidopa|carbidopa|mesh-list
92644807|NCT00558337|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92644808|NCT00558337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92644809|NCT00558337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92644810|NCT00558337|Dopamine Agents|dopamine agents|mesh-ancestor
92644811|NCT00558337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644812|NCT00558337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644813|NCT00558337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644814|NCT00558337|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92644815|NCT00558337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644816|NCT00558337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92644817|NCT00558337|Immunologic Factors|immunologic factors|mesh-ancestor
92644818|NCT00558337|Dopamine Agonists|dopamine agonists|mesh-ancestor
92644819|NCT00558376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92644820|NCT00558376|Laxatives|laxatives|mesh-ancestor
92644821|NCT00558376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644822|NCT00217646|Sorafenib|sorafenib|mesh-list
92644823|NCT00217646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644824|NCT00217646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92644825|NCT00217646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644826|NCT00217646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644827|NCT00558454|Ferrous succinate|ferrous succinate|mesh-list
92644828|NCT00558454|Hematinics|hematinics|mesh-ancestor
92644829|NCT00558493|Clevudine|clevudine|mesh-list
92644830|NCT00558493|Antiviral Agents|antiviral agents|mesh-ancestor
92644831|NCT00558493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644832|NCT04645303|Triamcinolone|triamcinolone|mesh-list
92644833|NCT04645303|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92644834|NCT04645303|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92644835|NCT04645303|Hyaluronic Acid|hyaluronic acid|mesh-list
92644836|NCT04645303|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92644837|NCT04645303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644838|NCT04645303|Glucocorticoids|glucocorticoids|mesh-ancestor
92644839|NCT04645303|Hormones|hormones|mesh-ancestor
92644840|NCT04645303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644841|NCT04645303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644842|NCT04645303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644843|NCT04645303|Immunologic Factors|immunologic factors|mesh-ancestor
92644844|NCT04645303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644845|NCT04645303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644846|NCT04645303|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92644847|NCT04645303|Viscosupplements|viscosupplements|mesh-ancestor
92644848|NCT04645303|Protective Agents|protective agents|mesh-ancestor
92644855|NCT00217607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644857|NCT04644484|Immunoglobulins|immunoglobulins|mesh-list
92644858|NCT04644484|Antibodies|antibodies|mesh-list
92644859|NCT04644484|gamma-Globulins|gamma-globulins|mesh-list
92644860|NCT04644484|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92644861|NCT04644484|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92644862|NCT04644484|Immunologic Factors|immunologic factors|mesh-ancestor
92644863|NCT04644484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644864|NCT04644250|Paclitaxel|paclitaxel|mesh-list
92644865|NCT04644250|Carboplatin|carboplatin|mesh-list
92644866|NCT04644250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92644867|NCT04644250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644868|NCT04644250|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644869|NCT04644250|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644870|NCT04644250|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644871|NCT04644250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644872|NCT00245739|Darunavir|darunavir|mesh-list
92562910|NCT04705987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562911|NCT04705987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562912|NCT04705909|Pitavastatin|pitavastatin|mesh-list
92562913|NCT04705909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92562914|NCT04705909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92644873|NCT00245739|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92644874|NCT00245739|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92644875|NCT00245739|Protease Inhibitors|protease inhibitors|mesh-ancestor
92644876|NCT00245739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644877|NCT00245739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644878|NCT00245739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92644879|NCT00245739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92644880|NCT00245739|Antiviral Agents|antiviral agents|mesh-ancestor
92644881|NCT00245739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644882|NCT00558883|Acarbose|acarbose|mesh-list
92644883|NCT00558883|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92644884|NCT00558883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644885|NCT00558883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644886|NCT00558883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92644887|NCT00558883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644888|NCT04644094|Dexamethasone|dexamethasone|mesh-list
92644889|NCT04644094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644890|NCT04644094|Antiemetics|antiemetics|mesh-ancestor
92644891|NCT04644094|Autonomic Agents|autonomic agents|mesh-ancestor
92644892|NCT04644094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644893|NCT04644094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644894|NCT04644094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644895|NCT04644094|Glucocorticoids|glucocorticoids|mesh-ancestor
92644896|NCT04644094|Hormones|hormones|mesh-ancestor
92644897|NCT04644094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644898|NCT04644094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92644899|NCT04644094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644900|NCT04644406|Trastuzumab|trastuzumab|mesh-list
92644901|NCT04644406|Pertuzumab|pertuzumab|mesh-list
92644902|NCT04644406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92644903|NCT04644406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644904|NCT04643821|Calcitriol|calcitriol|mesh-list
92644905|NCT04643821|Acetylcysteine|acetylcysteine|mesh-list
92644906|NCT04643821|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92644907|NCT04643821|Antiviral Agents|antiviral agents|mesh-ancestor
92644908|NCT04643821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644909|NCT04643821|Expectorants|expectorants|mesh-ancestor
92644910|NCT04643821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92644911|NCT04643821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92644912|NCT04643821|Antioxidants|antioxidants|mesh-ancestor
92644913|NCT04643821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644914|NCT04643821|Protective Agents|protective agents|mesh-ancestor
92644915|NCT04643821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644916|NCT04643821|Antidotes|antidotes|mesh-ancestor
92644917|NCT04643821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92644918|NCT04643821|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92644920|NCT04643821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92644921|NCT04643821|Vitamins|vitamins|mesh-ancestor
92644922|NCT04643821|Micronutrients|micronutrients|mesh-ancestor
92644923|NCT04643821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92644924|NCT00218075|Levodopa|levodopa|mesh-list
92644925|NCT00218075|Carbidopa|carbidopa|mesh-list
92644926|NCT00218075|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92644927|NCT00218075|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92644928|NCT00218075|Dopamine Agents|dopamine agents|mesh-ancestor
92644929|NCT00218075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644930|NCT00218075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644931|NCT00218075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644932|NCT00218075|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92644933|NCT00218075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644934|NCT00218114|Valproic Acid|valproic acid|mesh-list
92644935|NCT00218114|Anticonvulsants|anticonvulsants|mesh-ancestor
92644936|NCT00218114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644937|NCT00218114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644938|NCT00218114|GABA Agents|gaba agents|mesh-ancestor
92562915|NCT04705909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92562916|NCT04705909|Antimetabolites|antimetabolites|mesh-ancestor
92562917|NCT04705909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562918|NCT04705909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562919|NCT04705909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91994586|NCT04733534|Dasatinib|dasatinib|mesh-list
92644939|NCT00218114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644940|NCT00218114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644941|NCT00218114|Antimanic Agents|antimanic agents|mesh-ancestor
92644942|NCT00218114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92644943|NCT00218114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644944|NCT00218114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644945|NCT00424788|Natalizumab|natalizumab|mesh-list
92644946|NCT00424788|Immunologic Factors|immunologic factors|mesh-ancestor
92644947|NCT00424788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644948|NCT00218153|Naltrexone|naltrexone|mesh-list
92644949|NCT00218153|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92644950|NCT00218153|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92644951|NCT00218153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644952|NCT00218153|Sensory System Agents|sensory system agents|mesh-ancestor
92644953|NCT00218153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644954|NCT04642846|Fluorides|fluorides|mesh-list
92644956|NCT04642846|Protective Agents|protective agents|mesh-ancestor
92644957|NCT04642846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644958|NCT00245895|Darbepoetin alfa|darbepoetin alfa|mesh-list
92644959|NCT00245895|Hematinics|hematinics|mesh-ancestor
92644960|NCT00559195|Epoetin Alfa|epoetin alfa|mesh-list
92644961|NCT00559195|Hematinics|hematinics|mesh-ancestor
92644962|NCT00245934|Etanercept|etanercept|mesh-list
92644963|NCT00245934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92644964|NCT00245934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92644965|NCT00245934|Analgesics|analgesics|mesh-ancestor
92644966|NCT00245934|Sensory System Agents|sensory system agents|mesh-ancestor
92644967|NCT00245934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644968|NCT00245934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644969|NCT00245934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92644970|NCT00245934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644971|NCT00245934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92644972|NCT00245934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92644973|NCT00245934|Immunologic Factors|immunologic factors|mesh-ancestor
92644974|NCT00218231|Bupropion|bupropion|mesh-list
92644975|NCT00218231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92644976|NCT00218231|Antidepressive Agents|antidepressive agents|mesh-ancestor
92644977|NCT00218231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92644978|NCT00218231|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92644979|NCT00218231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92644980|NCT00218231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644981|NCT00218231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644982|NCT00218231|Dopamine Agents|dopamine agents|mesh-ancestor
92644983|NCT00218231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92644984|NCT00218231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644985|NCT00218231|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92644986|NCT00218231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92644987|NCT00218231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644988|NCT00241995|Anticonvulsants|anticonvulsants|mesh-list
92644989|NCT00218309|Hydromorphone|hydromorphone|mesh-list
92644990|NCT00218309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92644991|NCT00218309|Narcotics|narcotics|mesh-ancestor
92644992|NCT00218309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644993|NCT00218309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052095|NCT02152007|Sirolimus|sirolimus|mesh-list
92645003|NCT00218348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645005|NCT00218348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645006|NCT00218348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645007|NCT00218348|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645008|NCT00218348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92645009|NCT00218348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92645010|NCT00218348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645011|NCT00218348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92562921|NCT00083304|Antisickling Agents|antisickling agents|mesh-ancestor
92562922|NCT00050843|Thalidomide|thalidomide|mesh-list
92562923|NCT00050843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562924|NCT00050843|Immunologic Factors|immunologic factors|mesh-ancestor
92562925|NCT00050843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562926|NCT00050843|Leprostatic Agents|leprostatic agents|mesh-ancestor
92562927|NCT00050843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92562928|NCT00050843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562929|NCT00050843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92562930|NCT00050843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92562931|NCT00050843|Growth Substances|growth substances|mesh-ancestor
92562932|NCT00050843|Growth Inhibitors|growth inhibitors|mesh-ancestor
92562933|NCT00050843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562934|NCT00406237|Tigecycline|tigecycline|mesh-list
92562935|NCT00406237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645012|NCT00559312|Fluticasone|fluticasone|mesh-list
92645013|NCT00559312|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92645014|NCT00559312|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92645015|NCT00559312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645016|NCT00559312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92645017|NCT00559312|Autonomic Agents|autonomic agents|mesh-ancestor
92645018|NCT00559312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645019|NCT00559312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645020|NCT00559312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645021|NCT00559312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645022|NCT00559312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645023|NCT00559312|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92645024|NCT00559312|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92645025|NCT00559312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92645026|NCT00559312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92645027|NCT00559312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645028|NCT00559312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645029|NCT00559312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645030|NCT00559312|Glucocorticoids|glucocorticoids|mesh-ancestor
92645031|NCT00559312|Hormones|hormones|mesh-ancestor
92645032|NCT00559312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645033|NCT00559312|Sympathomimetics|sympathomimetics|mesh-ancestor
92645034|NCT00559351|Fluorouracil|fluorouracil|mesh-list
92645035|NCT00559351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645036|NCT00559351|Antimetabolites|antimetabolites|mesh-ancestor
92645037|NCT00559351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645038|NCT00559351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645039|NCT00559351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645040|NCT00559351|Immunologic Factors|immunologic factors|mesh-ancestor
92645041|NCT00559351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645042|NCT00218504|Dronabinol|dronabinol|mesh-list
92645043|NCT00218504|Hallucinogens|hallucinogens|mesh-ancestor
92645044|NCT00218504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645045|NCT00218504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92645046|NCT00218504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645047|NCT00218504|Analgesics|analgesics|mesh-ancestor
92645048|NCT00218504|Sensory System Agents|sensory system agents|mesh-ancestor
92645049|NCT00218504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645050|NCT00218504|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92645051|NCT00218504|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92645052|NCT00218504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645053|NCT00218504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645054|NCT00218504|Hormones|hormones|mesh-ancestor
92562936|NCT00406237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562937|NCT00406237|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92562938|NCT00406237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562939|NCT00406237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645055|NCT00218504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645056|NCT00559429|Docetaxel|docetaxel|mesh-list
92645057|NCT00559429|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92645061|NCT00559429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92645062|NCT00559429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645063|NCT00559429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645064|NCT00559429|Analgesics|analgesics|mesh-ancestor
92645065|NCT00559429|Sensory System Agents|sensory system agents|mesh-ancestor
92645066|NCT00559429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645067|NCT00559429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645068|NCT00218621|Buprenorphine|buprenorphine|mesh-list
92645069|NCT00218621|Methadone|methadone|mesh-list
92645070|NCT00218621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92645071|NCT00218621|Narcotics|narcotics|mesh-ancestor
92645072|NCT00218621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645073|NCT00218621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645074|NCT00218621|Analgesics|analgesics|mesh-ancestor
92645075|NCT00218621|Sensory System Agents|sensory system agents|mesh-ancestor
92645076|NCT00218621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645077|NCT00218621|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92645078|NCT00218621|Antitussive Agents|antitussive agents|mesh-ancestor
92645079|NCT00218621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645080|NCT00246168|Acetaminophen|acetaminophen|mesh-list
92645081|NCT00246168|Tramadol|tramadol|mesh-list
92645082|NCT00246168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645083|NCT00246168|Analgesics|analgesics|mesh-ancestor
92645084|NCT00246168|Sensory System Agents|sensory system agents|mesh-ancestor
92645085|NCT00246168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645086|NCT00246168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645087|NCT00246168|Antipyretics|antipyretics|mesh-ancestor
92645088|NCT00246168|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92645089|NCT00246168|Narcotics|narcotics|mesh-ancestor
92645090|NCT00246168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645091|NCT00218660|Naltrexone|naltrexone|mesh-list
92645092|NCT00218660|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92645093|NCT00218660|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92645094|NCT00218660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645095|NCT00218660|Sensory System Agents|sensory system agents|mesh-ancestor
92645096|NCT00218660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645097|NCT00559546|Montelukast|montelukast|mesh-list
92645098|NCT00559546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645099|NCT00559546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645100|NCT00559546|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92645101|NCT00559546|Hormone Antagonists|hormone antagonists|mesh-ancestor
92645102|NCT00559546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645103|NCT00559546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645104|NCT00559546|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92645105|NCT00559546|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92645106|NCT00559546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645107|NCT00246207|Methylphenidate|methylphenidate|mesh-list
92645108|NCT00246207|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92645109|NCT00246207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645110|NCT00246207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92645111|NCT00246207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92645112|NCT00246207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645113|NCT00246207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645114|NCT00246207|Dopamine Agents|dopamine agents|mesh-ancestor
92645115|NCT00246207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645116|NCT04639804|Celecoxib|celecoxib|mesh-list
92645117|NCT04639804|Naproxen|naproxen|mesh-list
92645118|NCT04639804|Aceclofenac|aceclofenac|mesh-list
92645119|NCT04639804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92645120|NCT04639804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645121|NCT04639804|Analgesics|analgesics|mesh-ancestor
92645122|NCT04639804|Sensory System Agents|sensory system agents|mesh-ancestor
92562941|NCT00406432|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92562942|NCT00406432|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92562943|NCT00406432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645123|NCT04639804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645124|NCT04639804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645125|NCT04639804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645126|NCT04639804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645127|NCT04639804|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92645128|NCT04639804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92645129|NCT04639804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645131|NCT04639804|Gout Suppressants|gout suppressants|mesh-ancestor
92645133|NCT00218855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645134|NCT00218855|Immunologic Factors|immunologic factors|mesh-ancestor
92645135|NCT00218855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645136|NCT00218855|Leprostatic Agents|leprostatic agents|mesh-ancestor
92645137|NCT00218855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645138|NCT00218855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645139|NCT00218855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92645140|NCT00218855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92645141|NCT00218855|Growth Substances|growth substances|mesh-ancestor
92645142|NCT00218855|Growth Inhibitors|growth inhibitors|mesh-ancestor
92645143|NCT00218855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645144|NCT00246246|Risperidone|risperidone|mesh-list
92645145|NCT00246246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92645146|NCT00246246|Serotonin Agents|serotonin agents|mesh-ancestor
92645147|NCT00246246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645148|NCT00246246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645149|NCT00246246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645150|NCT00246246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92645151|NCT00246246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92645152|NCT00246246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645153|NCT00246246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92645154|NCT00246246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92645155|NCT00246246|Dopamine Agents|dopamine agents|mesh-ancestor
92645156|NCT00242190|Gemcitabine|gemcitabine|mesh-list
92645157|NCT00242190|Oxaliplatin|oxaliplatin|mesh-list
92645158|NCT00242190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645159|NCT00242190|Antimetabolites|antimetabolites|mesh-ancestor
92645160|NCT00242190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645161|NCT00242190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645162|NCT04628884|Heparin|heparin|mesh-list
92645163|NCT04628884|Anticoagulants|anticoagulants|mesh-ancestor
92645164|NCT04628884|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92645165|NCT04628884|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92645166|NCT04628884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645167|NCT00412334|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92645168|NCT00412334|Interferon-alpha|interferon-alpha|mesh-list
92645169|NCT00412334|Ribavirin|ribavirin|mesh-list
92645170|NCT00412334|Antiviral Agents|antiviral agents|mesh-ancestor
92645171|NCT00412334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645172|NCT00412334|Immunologic Factors|immunologic factors|mesh-ancestor
92645173|NCT00412334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645174|NCT00412334|Antimetabolites|antimetabolites|mesh-ancestor
92645175|NCT00412334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645176|NCT00561379|Rituximab|rituximab|mesh-list
92645177|NCT00561379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92645178|NCT00561379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645179|NCT00561379|Immunologic Factors|immunologic factors|mesh-ancestor
92645180|NCT00561379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645181|NCT00561379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645182|NCT04629118|Sirolimus|sirolimus|mesh-list
92645183|NCT04629118|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645184|NCT04629118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645185|NCT04629118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92645186|NCT04629118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645187|NCT04629118|Antifungal Agents|antifungal agents|mesh-ancestor
92645188|NCT04629118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645189|NCT04629118|Immunologic Factors|immunologic factors|mesh-ancestor
92645190|NCT04629118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645191|NCT00561496|Tenofovir|tenofovir|mesh-list
92562944|NCT00406432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562945|NCT00406432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287730|NCT03749629|Psychotropic Drugs|psychotropic drugs|mesh-list
92562946|NCT00406432|Serotonin Agents|serotonin agents|mesh-ancestor
92562947|NCT00406432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645192|NCT00561496|Antiviral Agents|antiviral agents|mesh-ancestor
92645193|NCT00561496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645194|NCT00561496|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92645195|NCT00561496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92645196|NCT00561496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645197|NCT00561496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645198|NCT00561496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92645199|NCT00561496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92645200|NCT00246285|Risperidone|risperidone|mesh-list
92645201|NCT00246285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92645202|NCT00246285|Serotonin Agents|serotonin agents|mesh-ancestor
92645203|NCT00246285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645211|NCT00246285|Dopamine Agents|dopamine agents|mesh-ancestor
92645212|NCT00242268|Simvastatin|simvastatin|mesh-list
92645213|NCT00242268|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92645214|NCT00242268|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92645215|NCT00242268|Antimetabolites|antimetabolites|mesh-ancestor
92645216|NCT00242268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645217|NCT00242268|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92645218|NCT00242268|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92645219|NCT00242268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645220|NCT00246363|Silymarin|silymarin|mesh-list
92645221|NCT00246363|Antioxidants|antioxidants|mesh-ancestor
92645222|NCT00246363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645223|NCT00246363|Protective Agents|protective agents|mesh-ancestor
92645224|NCT00246363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645225|NCT04628533|Oxymetazoline|oxymetazoline|mesh-list
92645226|NCT04628533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92645227|NCT04628533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92645228|NCT04628533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645229|NCT04628533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645230|NCT04628533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645231|NCT04628533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645232|NCT04628533|Sympathomimetics|sympathomimetics|mesh-ancestor
92645233|NCT04628533|Autonomic Agents|autonomic agents|mesh-ancestor
92645234|NCT04628533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645235|NCT04628533|Nasal Decongestants|nasal decongestants|mesh-ancestor
92645236|NCT04628533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92645237|NCT04628533|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645238|NCT00246402|Acipimox|acipimox|mesh-list
92645239|NCT00246402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92645240|NCT00246402|Antimetabolites|antimetabolites|mesh-ancestor
92645241|NCT00246402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645242|NCT00246402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92645243|NCT00561613|Spermatocidal Agents|spermatocidal agents|mesh-list
92645244|NCT00561613|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92645245|NCT00561613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645246|NCT00561613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92645247|NCT00561613|Contraceptive Agents|contraceptive agents|mesh-ancestor
92645248|NCT00561613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92645249|NCT00561691|Nimotuzumab|nimotuzumab|mesh-list
92645250|NCT00561691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92645251|NCT00561691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645252|NCT04628143|Nafamostat|nafamostat|mesh-list
92645253|NCT04628143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92645254|NCT04628143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645255|NCT04628143|Analgesics|analgesics|mesh-ancestor
92645256|NCT04628143|Sensory System Agents|sensory system agents|mesh-ancestor
92645257|NCT04628143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645258|NCT04628143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645259|NCT04628143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645260|NCT04628143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645261|NCT04628143|Anticoagulants|anticoagulants|mesh-ancestor
92645262|NCT04628143|Protease Inhibitors|protease inhibitors|mesh-ancestor
92562948|NCT00406432|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92562949|NCT00406432|Antidepressive Agents|antidepressive agents|mesh-ancestor
92562950|NCT00406432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91970377|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
92645263|NCT04628143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645264|NCT04628143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645265|NCT04628143|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92645266|NCT04628143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92645267|NCT04628143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92645268|NCT04628143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645269|NCT04628143|Immunologic Factors|immunologic factors|mesh-ancestor
92645277|NCT00219245|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92645278|NCT00219245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645279|NCT00219245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645280|NCT00219245|Cholinergic Agents|cholinergic agents|mesh-ancestor
92645281|NCT00219245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645282|NCT00219245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645283|NCT00219245|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92645284|NCT00219245|Protective Agents|protective agents|mesh-ancestor
92645286|NCT04627363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92645287|NCT04627363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645288|NCT04627363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92645289|NCT04627363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92645290|NCT04627363|Growth Substances|growth substances|mesh-ancestor
92645291|NCT04627363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645292|NCT04627363|Growth Inhibitors|growth inhibitors|mesh-ancestor
92645293|NCT00219323|Omalizumab|omalizumab|mesh-list
92645294|NCT00219323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92645295|NCT00219323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645296|NCT00219323|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645297|NCT00246597|Epoetin Alfa|epoetin alfa|mesh-list
92645298|NCT00246597|Hematinics|hematinics|mesh-ancestor
92645299|NCT04626739|Cyclophosphamide|cyclophosphamide|mesh-list
92645300|NCT04626739|Fludarabine|fludarabine|mesh-list
92645301|NCT04626739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645302|NCT04626739|Immunologic Factors|immunologic factors|mesh-ancestor
92645303|NCT04626739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645304|NCT04626739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645305|NCT04626739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92645306|NCT04626739|Alkylating Agents|alkylating agents|mesh-ancestor
92645307|NCT04626739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645308|NCT04626739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645309|NCT04626739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92645310|NCT00219401|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92645311|NCT00219401|Immunologic Factors|immunologic factors|mesh-ancestor
92645312|NCT00219401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645313|NCT04627129|Itraconazole|itraconazole|mesh-list
92645314|NCT04627129|Antifungal Agents|antifungal agents|mesh-ancestor
92645315|NCT04627129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645316|NCT04627129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92363557|NCT04383990|Insulin|insulin|mesh-list
92645317|NCT04627129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92645318|NCT04627129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645319|NCT04627129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645320|NCT04627129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92645321|NCT04627129|Hormone Antagonists|hormone antagonists|mesh-ancestor
92645322|NCT04627129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645323|NCT04627129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645324|NCT04627129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92645325|NCT00246636|Fenofibrate|fenofibrate|mesh-list
92645327|NCT00246636|Antimetabolites|antimetabolites|mesh-ancestor
92645328|NCT00246636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645329|NCT00246636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92645330|NCT00219440|Metformin|metformin|mesh-list
92645331|NCT00219440|Pioglitazone|pioglitazone|mesh-list
92645332|NCT00219440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92645333|NCT00219440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645334|NCT00246675|Furosemide|furosemide|mesh-list
92645335|NCT00246675|Diuretics|diuretics|mesh-ancestor
92052452|NCT02173769|Olodaterol|olodaterol|mesh-list
92562951|NCT00406432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92562952|NCT00406432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91994989|NCT03377361|Nivolumab|nivolumab|mesh-list
92645339|NCT00246675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645340|NCT00246675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645341|NCT00219479|Phenytoin|phenytoin|mesh-list
92645342|NCT00219479|Anticonvulsants|anticonvulsants|mesh-ancestor
92645343|NCT00219479|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92645344|NCT00219479|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92645345|NCT00219479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645346|NCT00219479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645347|NCT00219479|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92645348|NCT00219479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92645349|NCT04626778|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92645350|NCT04626778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92645351|NCT04626778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645352|NCT04626973|Ezetimibe|ezetimibe|mesh-list
92645353|NCT04626973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92645354|NCT04626973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92645355|NCT04626973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92645356|NCT04626973|Antimetabolites|antimetabolites|mesh-ancestor
92645357|NCT04626973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645358|NCT04626973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92645359|NCT04626973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645360|NCT00242463|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92645361|NCT00242463|Nandrolone|nandrolone|mesh-list
92645362|NCT00242463|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92645363|NCT00242463|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
92645364|NCT00242463|Androgens|androgens|mesh-ancestor
92645365|NCT00242463|Hormones|hormones|mesh-ancestor
92645366|NCT00242463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645367|NCT00242463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645368|NCT00242463|Anabolic Agents|anabolic agents|mesh-ancestor
92645369|NCT00242463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92645370|NCT00242463|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
92645371|NCT00561886|Formoterol Fumarate|formoterol fumarate|mesh-list
92645372|NCT00561886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92645373|NCT00561886|Autonomic Agents|autonomic agents|mesh-ancestor
92645374|NCT00561886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645375|NCT00561886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645376|NCT00561886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645377|NCT00561886|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645378|NCT00561886|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92645379|NCT00561886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92645380|NCT00561886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92645381|NCT00561886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645382|NCT00561886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645383|NCT00561886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645384|NCT00561964|Irbesartan|irbesartan|mesh-list
92645385|NCT00561964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92363560|NCT04381884|Ivermectin|ivermectin|mesh-list
92645386|NCT00561964|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92645387|NCT00561964|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92645388|NCT00561964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645389|NCT00219596|Timolol|timolol|mesh-list
92645390|NCT00219596|Latanoprost|latanoprost|mesh-list
92645391|NCT00219596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92645392|NCT00219596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92645393|NCT00219596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645394|NCT00219596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645395|NCT00219596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645396|NCT00219596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645397|NCT00219596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92645398|NCT00219596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92645399|NCT00219596|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92645400|NCT00219596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92645401|NCT04626193|Amoxicillin|amoxicillin|mesh-list
92645402|NCT04626193|Doxycycline|doxycycline|mesh-list
92645403|NCT04626193|Levofloxacin|levofloxacin|mesh-list
92645404|NCT04626193|Esomeprazole|esomeprazole|mesh-list
92645417|NCT04626193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92562953|NCT00406432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562954|NCT00083343|Caspofungin|caspofungin|mesh-list
92562955|NCT00083343|Antifungal Agents|antifungal agents|mesh-ancestor
92562956|NCT00083343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92562957|NCT00083343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92562958|NCT00083343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645418|NCT04626193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645419|NCT04626193|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92645420|NCT04626193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92645421|NCT00242541|Octreotide|octreotide|mesh-list
92645422|NCT00242541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645423|NCT00242541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92645424|NCT00242541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645425|NCT04625608|Acetaminophen|acetaminophen|mesh-list
92645426|NCT04625608|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645427|NCT04625608|Analgesics|analgesics|mesh-ancestor
92645428|NCT04625608|Sensory System Agents|sensory system agents|mesh-ancestor
92645429|NCT04625608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645430|NCT04625608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645431|NCT04625608|Antipyretics|antipyretics|mesh-ancestor
92645432|NCT00219713|Nitrous Oxide|nitrous oxide|mesh-list
92645433|NCT00219713|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92645434|NCT00219713|Anesthetics, General|anesthetics, general|mesh-ancestor
92645435|NCT00219713|Anesthetics|anesthetics|mesh-ancestor
92645436|NCT00219713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645437|NCT00219713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645438|NCT00219713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645439|NCT00219713|Analgesics|analgesics|mesh-ancestor
92645440|NCT00219713|Sensory System Agents|sensory system agents|mesh-ancestor
92645441|NCT00219713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645442|NCT00219752|Imatinib Mesylate|imatinib mesylate|mesh-list
92645443|NCT00219752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645444|NCT00219752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92645445|NCT00219752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645446|NCT00219752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645447|NCT00242697|Anesthetics|anesthetics|mesh-list
92645448|NCT00242697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645449|NCT00242697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645450|NCT04625179|Melatonin|melatonin|mesh-list
92645451|NCT04625179|Hyaluronic Acid|hyaluronic acid|mesh-list
92645452|NCT04625179|Antioxidants|antioxidants|mesh-ancestor
92645453|NCT04625179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645454|NCT04625179|Protective Agents|protective agents|mesh-ancestor
92645455|NCT04625179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645456|NCT04625179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645457|NCT04625179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92645458|NCT04625179|Immunologic Factors|immunologic factors|mesh-ancestor
92645459|NCT04625179|Viscosupplements|viscosupplements|mesh-ancestor
92645460|NCT02962232|Paclitaxel|paclitaxel|mesh-list
92645461|NCT02962232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92645462|NCT02962232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645463|NCT02962232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92645464|NCT02962232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92645465|NCT02962232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92645466|NCT02962232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645483|NCT00219869|Nootropic Agents|nootropic agents|mesh-ancestor
92645484|NCT04624360|Dexamethasone|dexamethasone|mesh-list
92645485|NCT04624360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645486|NCT04624360|Antiemetics|antiemetics|mesh-ancestor
92645487|NCT04624360|Autonomic Agents|autonomic agents|mesh-ancestor
92645488|NCT04624360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645489|NCT04624360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645490|NCT04624360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645491|NCT04624360|Glucocorticoids|glucocorticoids|mesh-ancestor
92645492|NCT04624360|Hormones|hormones|mesh-ancestor
92645493|NCT04624360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645494|NCT04624360|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92645495|NCT04624360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645496|NCT00219908|Mitoxantrone|mitoxantrone|mesh-list
92645497|NCT00219908|Analgesics|analgesics|mesh-ancestor
92562959|NCT00406471|Ranibizumab|ranibizumab|mesh-list
92562960|NCT00406471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92562961|NCT00406471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92562962|NCT00406471|Growth Substances|growth substances|mesh-ancestor
92645498|NCT00219908|Sensory System Agents|sensory system agents|mesh-ancestor
92645499|NCT00219908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645500|NCT00219908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645501|NCT00219908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645502|NCT00219908|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92645503|NCT00219908|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92645504|NCT00219908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645505|NCT00219908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645506|NCT00242736|Esomeprazole|esomeprazole|mesh-list
92645507|NCT00242736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92645508|NCT00242736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645509|NCT00242736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92645510|NCT00242736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645511|NCT00242736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645512|NCT00242775|Fluticasone|fluticasone|mesh-list
92645514|NCT00242775|Formoterol Fumarate|formoterol fumarate|mesh-list
92645515|NCT00242775|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92645516|NCT00242775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645517|NCT00242775|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92645518|NCT00242775|Autonomic Agents|autonomic agents|mesh-ancestor
92645519|NCT00242775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645520|NCT00242775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645521|NCT00242775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645522|NCT00242775|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645523|NCT00242775|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645524|NCT00242775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92645525|NCT00242775|Glucocorticoids|glucocorticoids|mesh-ancestor
92645528|NCT00242775|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92645530|NCT00242775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92645531|NCT00242775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645532|NCT00242775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645533|NCT00242775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645534|NCT04623619|Acetylcarnitine|acetylcarnitine|mesh-list
92645535|NCT04623619|Vitamin B Complex|vitamin b complex|mesh-ancestor
92645536|NCT04623619|Vitamins|vitamins|mesh-ancestor
92645537|NCT04623619|Micronutrients|micronutrients|mesh-ancestor
92645538|NCT04623619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645539|NCT04623619|Nootropic Agents|nootropic agents|mesh-ancestor
92645540|NCT00562198|Carbidopa|carbidopa|mesh-list
92645541|NCT00562198|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92645542|NCT00562198|Entacapone|entacapone|mesh-list
92645543|NCT00562198|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92645544|NCT00562198|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92645545|NCT00562198|Dopamine Agents|dopamine agents|mesh-ancestor
92645546|NCT00562198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645547|NCT00562198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645548|NCT00562198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645549|NCT00562198|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92645550|NCT00562198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645551|NCT00562198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92645552|NCT00562198|Immunologic Factors|immunologic factors|mesh-ancestor
92645553|NCT00562198|Dopamine Agonists|dopamine agonists|mesh-ancestor
92645554|NCT00562198|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92645556|NCT00220064|Fluorouracil|fluorouracil|mesh-list
92645557|NCT00220064|Irinotecan|irinotecan|mesh-list
92645558|NCT00220064|Antimetabolites|antimetabolites|mesh-ancestor
92645559|NCT00220064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645560|NCT00220064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645561|NCT00220064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645562|NCT00220064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645563|NCT00220064|Immunologic Factors|immunologic factors|mesh-ancestor
92645564|NCT00220064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645565|NCT00220064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92645566|NCT00220064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92645567|NCT00220064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645568|NCT00220064|Antidotes|antidotes|mesh-ancestor
92562963|NCT00406471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562964|NCT00406471|Growth Inhibitors|growth inhibitors|mesh-ancestor
92562965|NCT00406471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562966|NCT00050921|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92562967|NCT00050921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92562968|NCT00050921|Immunologic Factors|immunologic factors|mesh-ancestor
92562969|NCT00050921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562970|NCT00154687|Paclitaxel|paclitaxel|mesh-list
92562971|NCT00154687|Fluorouracil|fluorouracil|mesh-list
92562972|NCT00154687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92562973|NCT00154687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562974|NCT00154687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92562975|NCT00154687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92562976|NCT00154687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92562977|NCT00154687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92562978|NCT00154687|Antimetabolites|antimetabolites|mesh-ancestor
92562979|NCT00154687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91970397|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
92645569|NCT00220064|Protective Agents|protective agents|mesh-ancestor
92645570|NCT00220064|Vitamin B Complex|vitamin b complex|mesh-ancestor
92645571|NCT00220064|Vitamins|vitamins|mesh-ancestor
92645572|NCT00220064|Micronutrients|micronutrients|mesh-ancestor
92645573|NCT00220103|Capecitabine|capecitabine|mesh-list
92645574|NCT00220103|Epirubicin|epirubicin|mesh-list
92645575|NCT00220103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645576|NCT00220103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645577|NCT00220103|Antimetabolites|antimetabolites|mesh-ancestor
92645578|NCT00220103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645579|NCT00220103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92645580|NCT00220103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92645581|NCT00220103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92645582|NCT00220103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645583|NCT00247026|Ubiquinone|ubiquinone|mesh-list
92645584|NCT00247026|Coenzyme Q10|coenzyme q10|mesh-list
92645585|NCT00247026|Curcumin|curcumin|mesh-list
92645586|NCT00247026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92645587|NCT00247026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645588|NCT00247026|Analgesics|analgesics|mesh-ancestor
92645589|NCT00247026|Sensory System Agents|sensory system agents|mesh-ancestor
92645590|NCT00247026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645591|NCT00247026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645592|NCT00247026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645593|NCT00247026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645594|NCT00247026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645595|NCT00247026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645596|NCT00247026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645597|NCT00247026|Micronutrients|micronutrients|mesh-ancestor
92645598|NCT00247026|Vitamins|vitamins|mesh-ancestor
92645599|NCT01580683|Ascorbic Acid|ascorbic acid|mesh-list
92645636|NCT00220220|Vasodilator Agents|vasodilator agents|mesh-ancestor
92645639|NCT00242853|Nitric Oxide|nitric oxide|mesh-list
92645640|NCT00242853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92645641|NCT00242853|Autonomic Agents|autonomic agents|mesh-ancestor
92645642|NCT00242853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645643|NCT00242853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645644|NCT00242853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645645|NCT00242853|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645646|NCT00242853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92645647|NCT00242853|Antioxidants|antioxidants|mesh-ancestor
92562981|NCT00154687|Immunologic Factors|immunologic factors|mesh-ancestor
92645648|NCT00242853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645649|NCT00242853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645650|NCT00242853|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92645651|NCT00242853|Vasodilator Agents|vasodilator agents|mesh-ancestor
92645652|NCT00242853|Gasotransmitters|gasotransmitters|mesh-ancestor
92645653|NCT00242853|Protective Agents|protective agents|mesh-ancestor
92645654|NCT00220259|Fluticasone|fluticasone|mesh-list
92645655|NCT00220259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645656|NCT00220259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92645657|NCT00220259|Autonomic Agents|autonomic agents|mesh-ancestor
92645658|NCT00220259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645659|NCT00220259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645660|NCT00220259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645661|NCT00220259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92645662|NCT00220259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645663|NCT00220259|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92645664|NCT04622956|Methotrexate|methotrexate|mesh-list
92645665|NCT04622956|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92645666|NCT04622956|Abortifacient Agents|abortifacient agents|mesh-ancestor
92645667|NCT04622956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92645668|NCT04622956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645669|NCT04622956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645670|NCT04622956|Antimetabolites|antimetabolites|mesh-ancestor
92645671|NCT04622956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645672|NCT04622956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645673|NCT04622956|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645674|NCT04622956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645675|NCT04622956|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92645676|NCT04622956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645677|NCT04622956|Immunologic Factors|immunologic factors|mesh-ancestor
92645678|NCT04622956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645679|NCT04622956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92645680|NCT04622566|Pembrolizumab|pembrolizumab|mesh-list
92645681|NCT04622566|Lenvatinib|lenvatinib|mesh-list
92645682|NCT04622566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92645683|NCT04622566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645684|NCT04622566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92645685|NCT04622566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645686|NCT04622566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92645687|NCT04622566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645688|NCT04622488|Diclofenac|diclofenac|mesh-list
92645689|NCT04622488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92645690|NCT04622488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645691|NCT04622488|Analgesics|analgesics|mesh-ancestor
92645692|NCT04622488|Sensory System Agents|sensory system agents|mesh-ancestor
92645693|NCT04622488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645694|NCT04622488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645695|NCT04622488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645696|NCT04622488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645697|NCT04622488|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92370985|NCT01198158|Growth Substances|growth substances|mesh-ancestor
92645698|NCT04622488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645699|NCT04622488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645700|NCT00220298|Methyltestosterone|methyltestosterone|mesh-list
92645701|NCT00220298|Testosterone|testosterone|mesh-list
92645702|NCT00220298|Testosterone undecanoate|testosterone undecanoate|mesh-list
92645703|NCT00220298|Testosterone enanthate|testosterone enanthate|mesh-list
92645704|NCT00220298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92645705|NCT00220298|Androgens|androgens|mesh-ancestor
92645706|NCT00220298|Hormones|hormones|mesh-ancestor
92682821|NCT00438152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92645708|NCT00220298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645709|NCT00220298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92645710|NCT00220298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645712|NCT00412412|Trastuzumab|trastuzumab|mesh-list
91948645|NCT03783091|Vitamins|vitamins|mesh-ancestor
92645713|NCT00412412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92645714|NCT00412412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645715|NCT04621669|Metformin|metformin|mesh-list
92645716|NCT04621669|Digoxin|digoxin|mesh-list
92645717|NCT04621669|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92645718|NCT04621669|Calcium|calcium|mesh-list
92562982|NCT00154687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562983|NCT00083460|Thalidomide|thalidomide|mesh-list
92562984|NCT00083460|Dexamethasone|dexamethasone|mesh-list
92562985|NCT00083460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92562986|NCT00083460|Antiemetics|antiemetics|mesh-ancestor
92645719|NCT04621669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92645720|NCT04621669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645721|NCT04621669|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92645722|NCT04621669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92645723|NCT04621669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92645724|NCT04621669|Antimetabolites|antimetabolites|mesh-ancestor
92645725|NCT04621669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645726|NCT04621669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92645727|NCT04621669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92645728|NCT04621669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645729|NCT04621669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92645730|NCT04621669|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92645731|NCT04621669|Protective Agents|protective agents|mesh-ancestor
92645732|NCT00412646|Etravirine|etravirine|mesh-list
92645733|NCT00412646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92645734|NCT00412646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92645735|NCT00412646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645736|NCT00412646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645737|NCT00412646|Antiviral Agents|antiviral agents|mesh-ancestor
92645738|NCT00412646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645739|NCT00243009|Cyclosporine|cyclosporine|mesh-list
92645740|NCT00243009|Mycophenolic Acid|mycophenolic acid|mesh-list
92645741|NCT00243009|Fludarabine|fludarabine|mesh-list
92645742|NCT00243009|Fludarabine phosphate|fludarabine phosphate|mesh-list
92645743|NCT00243009|Cyclosporins|cyclosporins|mesh-list
92645744|NCT00243009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645745|NCT00243009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645746|NCT00243009|Antimetabolites|antimetabolites|mesh-ancestor
92645747|NCT00243009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645748|NCT00243009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645749|NCT00243009|Immunologic Factors|immunologic factors|mesh-ancestor
92645750|NCT00243009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645751|NCT00243009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645752|NCT00243009|Antifungal Agents|antifungal agents|mesh-ancestor
92645753|NCT00243009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645754|NCT00243009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645755|NCT00243009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645756|NCT00243009|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92645757|NCT00243009|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92645758|NCT00243009|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92645759|NCT00243009|Antitubercular Agents|antitubercular agents|mesh-ancestor
92645760|NCT00243009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645761|NCT00562510|Raltegravir Potassium|raltegravir potassium|mesh-list
92645762|NCT00562510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92645763|NCT00562510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92645764|NCT00562510|Antiviral Agents|antiviral agents|mesh-ancestor
92645765|NCT00562510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645766|NCT00562510|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92645767|NCT00562510|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92645768|NCT00562510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645769|NCT00562510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645770|NCT04621513|Montelukast|montelukast|mesh-list
92645771|NCT04621513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92645772|NCT04621513|Respiratory System Agents|respiratory system agents|mesh-ancestor
92371060|NCT01216410|Phenylephrine|phenylephrine|mesh-list
92645773|NCT04621513|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92645775|NCT04621513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645776|NCT04621513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645777|NCT04621513|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92645778|NCT04621513|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92645781|NCT00220454|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92645782|NCT00220454|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92645783|NCT00220454|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92645784|NCT00220454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92645785|NCT00562705|Hormones|hormones|mesh-list
92562987|NCT00083460|Autonomic Agents|autonomic agents|mesh-ancestor
92562988|NCT00083460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645786|NCT00562705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645787|NCT00562705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645788|NCT04620967|Insulin|insulin|mesh-list
92645789|NCT04620967|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92645790|NCT04620967|Insulin Aspart|insulin aspart|mesh-list
92645791|NCT04620967|Insulin, Long-Acting|insulin, long-acting|mesh-list
92645792|NCT04620967|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92645793|NCT04620967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92645794|NCT04620967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645795|NCT00220493|Methylphenidate|methylphenidate|mesh-list
92645796|NCT00220493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92645797|NCT00220493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645798|NCT00220493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92645799|NCT00220493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92645800|NCT00220493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645801|NCT00220493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645802|NCT00220493|Dopamine Agents|dopamine agents|mesh-ancestor
92645803|NCT00220493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645804|NCT04620616|Menthol|menthol|mesh-list
92645805|NCT04620616|Antipruritics|antipruritics|mesh-ancestor
92645806|NCT04620616|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645807|NCT00220532|Folic Acid|folic acid|mesh-list
92645808|NCT00220532|Riboflavin|riboflavin|mesh-list
92645809|NCT00220532|Hematinics|hematinics|mesh-ancestor
92645810|NCT00220532|Vitamin B Complex|vitamin b complex|mesh-ancestor
92645811|NCT00220532|Vitamins|vitamins|mesh-ancestor
92645812|NCT00220532|Micronutrients|micronutrients|mesh-ancestor
92645813|NCT00220532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645814|NCT00220532|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92645815|NCT00220532|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645816|NCT04620772|Cyclophosphamide|cyclophosphamide|mesh-list
92645817|NCT04620772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645818|NCT04620772|Immunologic Factors|immunologic factors|mesh-ancestor
92645819|NCT04620772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645820|NCT04620772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92645821|NCT04620772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92645822|NCT04620772|Alkylating Agents|alkylating agents|mesh-ancestor
92645823|NCT04620772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645824|NCT04620772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645825|NCT04620772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92645826|NCT00243204|Docetaxel|docetaxel|mesh-list
92645827|NCT00243204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645828|NCT00243204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92645829|NCT00243204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92645830|NCT00243204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92645831|NCT00243204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645832|NCT04620577|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92645833|NCT04620577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645834|NCT04620031|Propofol|propofol|mesh-list
92645835|NCT04620031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92645836|NCT04620031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645837|NCT04620031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645838|NCT04620031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92645839|NCT04620031|Anesthetics, General|anesthetics, general|mesh-ancestor
92645840|NCT04620031|Anesthetics|anesthetics|mesh-ancestor
92645841|NCT04620109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92645842|NCT04620109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92645843|NCT00220649|Leucovorin|leucovorin|mesh-list
92645844|NCT00220649|Gemcitabine|gemcitabine|mesh-list
92645845|NCT00220649|Fluorouracil|fluorouracil|mesh-list
92645846|NCT00220649|Oxaliplatin|oxaliplatin|mesh-list
92645847|NCT00220649|Irinotecan|irinotecan|mesh-list
92645848|NCT00220649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92645850|NCT00220649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645851|NCT00220649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645852|NCT00220649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92645853|NCT00220649|Immunologic Factors|immunologic factors|mesh-ancestor
92645858|NCT00220649|Antidotes|antidotes|mesh-ancestor
92645859|NCT00220649|Protective Agents|protective agents|mesh-ancestor
92645860|NCT00220649|Vitamin B Complex|vitamin b complex|mesh-ancestor
92645862|NCT00220649|Micronutrients|micronutrients|mesh-ancestor
92645863|NCT04619758|Emollients|emollients|mesh-list
92645864|NCT04619758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92562989|NCT00083460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562990|NCT00083460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92562992|NCT00083460|Hormones|hormones|mesh-ancestor
91995458|NCT01171937|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92645865|NCT04619914|Letrozole|letrozole|mesh-list
92645866|NCT04619914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645867|NCT04619914|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92645868|NCT04619914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92645869|NCT04619914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645870|NCT04619914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645871|NCT04619914|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92645872|NCT04619914|Hormone Antagonists|hormone antagonists|mesh-ancestor
92645873|NCT04619914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645874|NCT04619914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645875|NCT00220766|Immunoglobulins|immunoglobulins|mesh-list
92645876|NCT00220766|Antibodies|antibodies|mesh-list
92645877|NCT00220766|gamma-Globulins|gamma-globulins|mesh-list
92645878|NCT00220766|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92645879|NCT00220766|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92645880|NCT00220766|Immunoglobulin G|immunoglobulin g|mesh-list
92645881|NCT00220766|Immunologic Factors|immunologic factors|mesh-ancestor
92645882|NCT00220766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645883|NCT04619875|Lactulose|lactulose|mesh-list
92645884|NCT04619875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645885|NCT04619290|Methylene Blue|methylene blue|mesh-list
92645886|NCT04619290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645887|NCT04619290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645888|NCT04619563|Docetaxel|docetaxel|mesh-list
92645889|NCT04619563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645890|NCT04619563|Tubulin Modulators|tubulin modulators|mesh-ancestor
92645891|NCT04619563|Antimitotic Agents|antimitotic agents|mesh-ancestor
92645892|NCT04619563|Mitosis Modulators|mitosis modulators|mesh-ancestor
92645893|NCT04619563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645894|NCT00220844|Amitriptyline|amitriptyline|mesh-list
92645895|NCT00220844|Desipramine|desipramine|mesh-list
92645896|NCT00220844|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92645897|NCT00220844|Antidepressive Agents|antidepressive agents|mesh-ancestor
92645898|NCT00220844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92645899|NCT00220844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92645900|NCT00220844|Analgesics|analgesics|mesh-ancestor
92645901|NCT00220844|Sensory System Agents|sensory system agents|mesh-ancestor
92645902|NCT00220844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645903|NCT00220844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645904|NCT00220844|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92645905|NCT00220844|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92645906|NCT00220844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645907|NCT00220844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645908|NCT00220844|Adrenergic Agents|adrenergic agents|mesh-ancestor
92645909|NCT00220844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645910|NCT00220844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645911|NCT00247494|Mycophenolic Acid|mycophenolic acid|mesh-list
92645912|NCT00247494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92645913|NCT00247494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645914|NCT00247494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92645915|NCT00247494|Antitubercular Agents|antitubercular agents|mesh-ancestor
92645916|NCT00247494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645917|NCT00247494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645918|NCT00247494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645919|NCT00247494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645920|NCT04619251|Itraconazole|itraconazole|mesh-list
92645921|NCT04619251|Antifungal Agents|antifungal agents|mesh-ancestor
92645922|NCT04619251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645923|NCT04619251|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92645924|NCT04619251|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92645936|NCT00243399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645938|NCT00220922|Ethanol|ethanol|mesh-list
92645939|NCT00220922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92645940|NCT00220922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645941|NCT00220922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92562993|NCT00083460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92562994|NCT00083460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92562995|NCT00083460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645942|NCT00220922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645943|NCT00221000|Methoxsalen|methoxsalen|mesh-list
92645944|NCT00221000|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92645945|NCT00221000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645946|NCT00243477|Escitalopram|escitalopram|mesh-list
92645947|NCT00243477|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92645948|NCT00243477|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92645949|NCT00243477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645950|NCT00243477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645951|NCT00243477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645952|NCT00243477|Serotonin Agents|serotonin agents|mesh-ancestor
92645953|NCT00243477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645954|NCT00221039|Methoxsalen|methoxsalen|mesh-list
92645955|NCT00221039|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92645956|NCT00221039|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645957|NCT00562939|Vaccines|vaccines|mesh-list
92645958|NCT00562939|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92645959|NCT00562939|Immunologic Factors|immunologic factors|mesh-ancestor
92645960|NCT00562939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645961|NCT00221156|Acarbose|acarbose|mesh-list
92645962|NCT00221156|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92645963|NCT00221156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645964|NCT00221156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645965|NCT00221156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92645966|NCT00221156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645967|NCT04617613|Amoxicillin|amoxicillin|mesh-list
92645968|NCT04617613|Metronidazole|metronidazole|mesh-list
92645969|NCT04617613|Clarithromycin|clarithromycin|mesh-list
92645970|NCT04617613|Omeprazole|omeprazole|mesh-list
92645971|NCT04617613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645972|NCT04617613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645973|NCT04617613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92645974|NCT04617613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92645975|NCT04617613|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92645976|NCT04617613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645977|NCT04617613|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92645978|NCT04617613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645979|NCT04617613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645980|NCT04617613|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92645981|NCT04617613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92645982|NCT04617613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92645983|NCT04617652|Magnesium Sulfate|magnesium sulfate|mesh-list
92645984|NCT04617652|Analgesics|analgesics|mesh-ancestor
92645985|NCT04617652|Sensory System Agents|sensory system agents|mesh-ancestor
92645998|NCT00247572|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92645999|NCT00247572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92646000|NCT00247572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646001|NCT00247572|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92646002|NCT00247572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92646003|NCT00247572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92646004|NCT00247572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646005|NCT00247572|Dopamine Agents|dopamine agents|mesh-ancestor
92646006|NCT00247572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646007|NCT00221312|Alendronate|alendronate|mesh-list
92646008|NCT00221312|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92646009|NCT00221312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646010|NCT04616872|Methotrexate|methotrexate|mesh-list
92646011|NCT04616872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92646012|NCT04616872|Abortifacient Agents|abortifacient agents|mesh-ancestor
92646013|NCT04616872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92646014|NCT04616872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646015|NCT04616872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92646016|NCT04616872|Antimetabolites|antimetabolites|mesh-ancestor
92646017|NCT04616872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646018|NCT04616872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92562996|NCT00083460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92562997|NCT00083460|Immunologic Factors|immunologic factors|mesh-ancestor
92562998|NCT00083460|Leprostatic Agents|leprostatic agents|mesh-ancestor
92646019|NCT04616872|Dermatologic Agents|dermatologic agents|mesh-ancestor
92646020|NCT04616872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646021|NCT04616872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92646022|NCT04616872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646023|NCT04616872|Immunologic Factors|immunologic factors|mesh-ancestor
92646024|NCT04616872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646025|NCT04616872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92646026|NCT00221390|Ropinirole|ropinirole|mesh-list
92646027|NCT00221390|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92646028|NCT00221390|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92646029|NCT00221390|Dopamine Agonists|dopamine agonists|mesh-ancestor
92646030|NCT00221390|Dopamine Agents|dopamine agents|mesh-ancestor
92646031|NCT00221390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646032|NCT00221390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646033|NCT00221390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646034|NCT00247650|Zoledronic Acid|zoledronic acid|mesh-list
92646035|NCT00247650|Letrozole|letrozole|mesh-list
92646036|NCT00247650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646037|NCT00247650|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92646038|NCT00247650|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92646039|NCT00247650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646040|NCT00247650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646041|NCT00247650|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92646042|NCT00247650|Hormone Antagonists|hormone antagonists|mesh-ancestor
92053184|NCT05789381|Anesthetics|anesthetics|mesh-ancestor
92646065|NCT00563017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646066|NCT00563017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646067|NCT00563017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92646068|NCT00563017|Dopamine Agents|dopamine agents|mesh-ancestor
92646069|NCT00563056|Fluticasone|fluticasone|mesh-list
92646070|NCT00563056|Formoterol Fumarate|formoterol fumarate|mesh-list
92646071|NCT00563056|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92646072|NCT00563056|Autonomic Agents|autonomic agents|mesh-ancestor
92646073|NCT00563056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646074|NCT00563056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646075|NCT00563056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92646076|NCT00563056|Respiratory System Agents|respiratory system agents|mesh-ancestor
92646077|NCT00563056|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92646078|NCT00563056|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92646079|NCT00563056|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92646080|NCT00563056|Adrenergic Agents|adrenergic agents|mesh-ancestor
92646081|NCT00563056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646082|NCT00563056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646083|NCT00563056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646084|NCT00563056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92646085|NCT00563056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92646086|NCT00563095|Interferons|interferons|mesh-list
92646087|NCT00563095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646088|NCT00563095|Antiviral Agents|antiviral agents|mesh-ancestor
92646089|NCT00563095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646090|NCT00221468|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92646091|NCT00221468|Antidepressive Agents|antidepressive agents|mesh-ancestor
92646092|NCT00221468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646095|NCT00221468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646096|NCT00221468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646098|NCT00563212|Interferon-gamma|interferon-gamma|mesh-list
92646099|NCT00563212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646100|NCT00563212|Antiviral Agents|antiviral agents|mesh-ancestor
92646101|NCT00563212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646102|NCT00563251|Azithromycin|azithromycin|mesh-list
92646103|NCT00563251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646104|NCT00563251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646105|NCT00251082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92646106|NCT00251082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92646107|NCT00251082|Estradiol|estradiol|mesh-list
92646108|NCT00251082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92646109|NCT00251082|Dydrogesterone|dydrogesterone|mesh-list
92646110|NCT00251082|Estrogens|estrogens|mesh-ancestor
92646111|NCT00251082|Hormones|hormones|mesh-ancestor
92646112|NCT00251082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646113|NCT00251082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92562999|NCT00083460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363589|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
92646114|NCT00251082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92646115|NCT00251082|Contraceptive Agents|contraceptive agents|mesh-ancestor
92646116|NCT00251082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92646117|NCT00251082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92646118|NCT00251082|Progestins|progestins|mesh-ancestor
92646119|NCT00221624|Ribavirin|ribavirin|mesh-list
92646120|NCT00221624|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92646121|NCT00221624|Amantadine|amantadine|mesh-list
92646122|NCT00221624|Antimetabolites|antimetabolites|mesh-ancestor
92646123|NCT00221624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646124|NCT00221624|Antiviral Agents|antiviral agents|mesh-ancestor
92646125|NCT00221624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646126|NCT00221624|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92646127|NCT00221624|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92646128|NCT00221624|Dopamine Agents|dopamine agents|mesh-ancestor
92646129|NCT00221624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646130|NCT00221624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646131|NCT00221624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646132|NCT00221624|Analgesics|analgesics|mesh-ancestor
92646133|NCT00221624|Sensory System Agents|sensory system agents|mesh-ancestor
92646134|NCT00221624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646135|NCT04720092|Rivaroxaban|rivaroxaban|mesh-list
92646136|NCT04720092|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92646137|NCT04720092|Antithrombins|antithrombins|mesh-ancestor
92646138|NCT04720092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92646139|NCT04720092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92371439|NCT01285050|Tenofovir|tenofovir|mesh-list
92646140|NCT04720092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646141|NCT04720092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646142|NCT04720092|Anticoagulants|anticoagulants|mesh-ancestor
92646143|NCT00221702|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92646145|NCT00221702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646146|NCT04615702|Acetaminophen|acetaminophen|mesh-list
92646147|NCT04615702|Metronidazole|metronidazole|mesh-list
92646148|NCT04615702|Ciprofloxacin|ciprofloxacin|mesh-list
92646149|NCT04615702|Imipenem|imipenem|mesh-list
92646150|NCT04615702|Diclofenac|diclofenac|mesh-list
92646151|NCT04615702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92646152|NCT04615702|Opiate Alkaloids|opiate alkaloids|mesh-list
92646153|NCT04615702|Secretin|secretin|mesh-list
92646154|NCT04615702|Bilirubin|bilirubin|mesh-list
92646155|NCT04615702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646156|NCT04615702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646157|NCT04615702|Analgesics|analgesics|mesh-ancestor
92646158|NCT04615702|Sensory System Agents|sensory system agents|mesh-ancestor
92646159|NCT04615702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646160|NCT04615702|Antipyretics|antipyretics|mesh-ancestor
92646161|NCT04615702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646162|NCT04615702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646163|NCT04615702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92646164|NCT04615702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92646165|NCT04615702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646166|NCT04615702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646167|NCT04615702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92646168|NCT04615702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682822|NCT00438230|Warfarin|warfarin|mesh-list
92646172|NCT04615702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646173|NCT04615702|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92646174|NCT04615702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646175|NCT04615702|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92646176|NCT04615702|Narcotics|narcotics|mesh-ancestor
92646177|NCT04615702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646178|NCT04615702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646179|NCT04615702|Hormones|hormones|mesh-ancestor
92646180|NCT04615702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646181|NCT04615702|Antioxidants|antioxidants|mesh-ancestor
92646182|NCT04615702|Protective Agents|protective agents|mesh-ancestor
92646183|NCT04615351|Metformin|metformin|mesh-list
92646184|NCT04615351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92646185|NCT04615351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646186|NCT04615156|Deoxyglucose|deoxyglucose|mesh-list
92646187|NCT04615156|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92646188|NCT04615156|Antimetabolites|antimetabolites|mesh-ancestor
92646189|NCT04615156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646190|NCT04615156|Antiviral Agents|antiviral agents|mesh-ancestor
92563000|NCT00083460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563001|NCT00083460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92646191|NCT04615156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646192|NCT04615156|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92646193|NCT04614727|Calcium|calcium|mesh-list
92646194|NCT04614727|Fluorides|fluorides|mesh-list
92646195|NCT04614727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92646196|NCT04614727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646197|NCT04614727|Cariostatic Agents|cariostatic agents|mesh-ancestor
92646198|NCT04614727|Protective Agents|protective agents|mesh-ancestor
92646199|NCT04614298|Brodalumab|brodalumab|mesh-list
92646200|NCT04614298|Dermatologic Agents|dermatologic agents|mesh-ancestor
92646201|NCT04614259|Bupivacaine|bupivacaine|mesh-list
92646202|NCT04614259|Anesthetics, Local|anesthetics, local|mesh-ancestor
92646203|NCT04614259|Anesthetics|anesthetics|mesh-ancestor
92646204|NCT04614259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646205|NCT04614259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646206|NCT04614259|Sensory System Agents|sensory system agents|mesh-ancestor
92646207|NCT04614259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646208|NCT00412763|Silymarin|silymarin|mesh-list
92646209|NCT00412763|Antioxidants|antioxidants|mesh-ancestor
92646210|NCT00412763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646211|NCT00412763|Protective Agents|protective agents|mesh-ancestor
92646212|NCT00412763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646213|NCT00563446|Darbepoetin alfa|darbepoetin alfa|mesh-list
92646214|NCT00563446|Hematinics|hematinics|mesh-ancestor
92646215|NCT00563485|Doxazosin|doxazosin|mesh-list
92646216|NCT00563485|Terazosin|terazosin|mesh-list
92646217|NCT00563485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92371502|NCT01295112|Dexamethasone|dexamethasone|mesh-list
92646218|NCT00563485|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92646219|NCT00563485|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92646220|NCT00563485|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92646221|NCT00563485|Adrenergic Agents|adrenergic agents|mesh-ancestor
92646222|NCT00563485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646223|NCT00563485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646224|NCT00563485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646225|NCT00563485|Urological Agents|urological agents|mesh-ancestor
92646227|NCT00251277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92646228|NCT00251277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646229|NCT00251277|Immunologic Factors|immunologic factors|mesh-ancestor
92646230|NCT00251277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646231|NCT00251277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646232|NCT00412802|Enoxaparin|enoxaparin|mesh-list
92646233|NCT00412802|Enoxaparin sodium|enoxaparin sodium|mesh-list
92646234|NCT00412802|Anticoagulants|anticoagulants|mesh-ancestor
92646235|NCT00412802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92646236|NCT00412802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92646237|NCT00412802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646238|NCT00563524|Fezakinumab|fezakinumab|mesh-list
92646239|NCT00563524|Dermatologic Agents|dermatologic agents|mesh-ancestor
92646240|NCT04613869|Hydromorphone|hydromorphone|mesh-list
92646241|NCT04613869|Esketamine|esketamine|mesh-list
92646260|NCT04613557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646261|NCT04613557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646262|NCT04613557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92646263|NCT04613557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92646265|NCT00251355|Gemcitabine|gemcitabine|mesh-list
92646266|NCT00251355|Fluorouracil|fluorouracil|mesh-list
92646267|NCT00251355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92646268|NCT00251355|Antimetabolites|antimetabolites|mesh-ancestor
92646269|NCT00251355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646270|NCT00251355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646271|NCT00251355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646272|NCT00251355|Immunologic Factors|immunologic factors|mesh-ancestor
92646273|NCT00251355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646274|NCT02962388|Anagrelide|anagrelide|mesh-list
92646275|NCT02962388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92646276|NCT02962388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92646277|NCT02962388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646278|NCT02962388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92646279|NCT04613167|Evolocumab|evolocumab|mesh-list
92646280|NCT04613167|Alirocumab|alirocumab|mesh-list
92646281|NCT04613167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92646282|NCT04613167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92563002|NCT00083460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563003|NCT00083460|Growth Substances|growth substances|mesh-ancestor
92563004|NCT00083460|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563005|NCT00154726|Paclitaxel|paclitaxel|mesh-list
92646283|NCT04613167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92646284|NCT04613167|Antimetabolites|antimetabolites|mesh-ancestor
92646285|NCT04613167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646286|NCT04613167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92646287|NCT04613167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92646288|NCT04613167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646289|NCT04613167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92646290|NCT04613284|Durvalumab|durvalumab|mesh-list
92646291|NCT04613284|Endostar protein|endostar protein|mesh-list
92646292|NCT04613284|Endostatins|endostatins|mesh-list
92646293|NCT04613284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92646294|NCT04613284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646295|NCT04613284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92646296|NCT04613284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92646297|NCT04613284|Growth Substances|growth substances|mesh-ancestor
92646298|NCT04613284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646304|NCT00248118|Antidepressive Agents|antidepressive agents|mesh-ancestor
92646305|NCT00248118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646306|NCT00248118|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92646307|NCT00248118|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92646308|NCT00248118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92646309|NCT00248118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646310|NCT00248118|Dopamine Agents|dopamine agents|mesh-ancestor
92646311|NCT00248118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646312|NCT00248118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646313|NCT00248118|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92646314|NCT00248118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646315|NCT00248118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646316|NCT04612894|Apatinib|apatinib|mesh-list
92646317|NCT04612894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646318|NCT04612894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92646319|NCT04612894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646320|NCT04612894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646321|NCT00251394|Rituximab|rituximab|mesh-list
92646322|NCT00251394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92646323|NCT00251394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646324|NCT00251394|Immunologic Factors|immunologic factors|mesh-ancestor
92646325|NCT00251394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646326|NCT00251394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646327|NCT00221975|Lamotrigine|lamotrigine|mesh-list
92646328|NCT00221975|Valproic Acid|valproic acid|mesh-list
92646329|NCT00221975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646330|NCT00221975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646331|NCT00221975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646332|NCT00221975|Antimanic Agents|antimanic agents|mesh-ancestor
92646333|NCT00221975|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92646334|NCT00221975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646335|NCT00221975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646336|NCT00221975|Anticonvulsants|anticonvulsants|mesh-ancestor
92646337|NCT00221975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92646338|NCT00221975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92646339|NCT00221975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92646340|NCT00221975|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92646341|NCT00221975|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92646342|NCT00221975|GABA Agents|gaba agents|mesh-ancestor
92646343|NCT00221975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646344|NCT04612582|Thalidomide|thalidomide|mesh-list
92646345|NCT04612582|Cyclophosphamide|cyclophosphamide|mesh-list
92646346|NCT04612582|Bortezomib|bortezomib|mesh-list
92646347|NCT04612582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646348|NCT04612582|Immunologic Factors|immunologic factors|mesh-ancestor
92646349|NCT04612582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646350|NCT04612582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646351|NCT04612582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92646352|NCT04612582|Alkylating Agents|alkylating agents|mesh-ancestor
92646353|NCT04612582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646354|NCT04612582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363594|NCT04378608|Antimetabolites|antimetabolites|mesh-ancestor
92563006|NCT00154726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92563007|NCT00154726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563008|NCT00154726|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563009|NCT00154726|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563010|NCT00154726|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563011|NCT00154726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563012|NCT00154804|Paclitaxel|paclitaxel|mesh-list
92563013|NCT00154804|Cisplatin|cisplatin|mesh-list
92563014|NCT00154804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92563015|NCT00154804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563016|NCT00154804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563017|NCT00154804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563018|NCT00154804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563019|NCT00154804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563020|NCT00154843|Lycopene|lycopene|mesh-list
92563021|NCT00154843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563022|NCT00154843|Antioxidants|antioxidants|mesh-ancestor
92563023|NCT00154843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563024|NCT00154843|Protective Agents|protective agents|mesh-ancestor
92563025|NCT00154843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563026|NCT00154843|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92563027|NCT00154843|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92646355|NCT04612582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92646356|NCT04612582|Leprostatic Agents|leprostatic agents|mesh-ancestor
92646357|NCT04612582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646358|NCT04612582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646359|NCT04612582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92646360|NCT04612582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92646361|NCT04612582|Growth Substances|growth substances|mesh-ancestor
92646362|NCT04612582|Growth Inhibitors|growth inhibitors|mesh-ancestor
92646363|NCT00248157|Octreotide|octreotide|mesh-list
92646364|NCT00248157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646365|NCT00248157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92646366|NCT00248157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646367|NCT00251472|Paclitaxel|paclitaxel|mesh-list
92646368|NCT00251472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92646369|NCT00251472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646373|NCT00251472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646374|NCT00222053|Diphosphonates|diphosphonates|mesh-list
92646375|NCT00222053|Thalidomide|thalidomide|mesh-list
92646376|NCT00222053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646377|NCT00222053|Immunologic Factors|immunologic factors|mesh-ancestor
92646378|NCT00222053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646379|NCT00222053|Leprostatic Agents|leprostatic agents|mesh-ancestor
92646380|NCT00222053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646381|NCT00222053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646382|NCT00222053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92646383|NCT00222053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92646384|NCT00222053|Growth Substances|growth substances|mesh-ancestor
92646385|NCT00222053|Growth Inhibitors|growth inhibitors|mesh-ancestor
92646386|NCT00222053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646387|NCT00222053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92646388|NCT00251511|Arsenic Trioxide|arsenic trioxide|mesh-list
92563028|NCT00154843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563029|NCT00043953|Ritonavir|ritonavir|mesh-list
92563030|NCT00043953|Lopinavir|lopinavir|mesh-list
92563031|NCT00043953|Saquinavir|saquinavir|mesh-list
92563032|NCT00043953|Lamivudine|lamivudine|mesh-list
92563033|NCT00043953|Zidovudine|zidovudine|mesh-list
91970452|NCT03948347|Incretins|incretins|mesh-ancestor
92646389|NCT00251511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646390|NCT04611958|Bupivacaine|bupivacaine|mesh-list
92646391|NCT04611958|Anesthetics, Local|anesthetics, local|mesh-ancestor
92646392|NCT04611958|Anesthetics|anesthetics|mesh-ancestor
92646393|NCT04611958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646394|NCT04611958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646395|NCT04611958|Sensory System Agents|sensory system agents|mesh-ancestor
92646396|NCT04611958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646397|NCT00412919|Azacitidine|azacitidine|mesh-list
92646398|NCT00412919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92646399|NCT00412919|Antimetabolites|antimetabolites|mesh-ancestor
92646400|NCT00412919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646401|NCT00412919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646402|NCT00412919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646403|NCT00222170|Rabeprazole|rabeprazole|mesh-list
92646404|NCT00222170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92646405|NCT00222170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646406|NCT00222170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92646407|NCT00222170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646408|NCT00222170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646410|NCT04611724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646411|NCT00563758|Tegaserod|tegaserod|mesh-list
92646412|NCT00563758|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92646413|NCT00563758|Serotonin Agents|serotonin agents|mesh-ancestor
92646414|NCT00563758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646415|NCT00563758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646416|NCT00563758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646417|NCT00563836|Catumaxomab|catumaxomab|mesh-list
92646418|NCT00563836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646419|NCT00563875|Aspirin|aspirin|mesh-list
92646420|NCT00563875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92646421|NCT00563875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646422|NCT00563875|Analgesics|analgesics|mesh-ancestor
92646423|NCT00563875|Sensory System Agents|sensory system agents|mesh-ancestor
92646424|NCT00563875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646425|NCT00563875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646426|NCT00563875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646427|NCT00563875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646428|NCT00563875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92646429|NCT00563875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92646430|NCT00563875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646431|NCT00563875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92646432|NCT00563875|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92646433|NCT00563875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646434|NCT00563875|Antipyretics|antipyretics|mesh-ancestor
92646435|NCT04611685|Parecoxib|parecoxib|mesh-list
92646436|NCT04611685|Loxoprofen|loxoprofen|mesh-list
92646437|NCT04611685|Tramadol|tramadol|mesh-list
92646438|NCT04611685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92646439|NCT04611685|Narcotics|narcotics|mesh-ancestor
92646440|NCT04611685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646441|NCT04611685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053587|NCT05345717|Abatacept|abatacept|mesh-list
92646450|NCT04611685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646451|NCT04611685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646452|NCT04611685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646453|NCT00563914|Amodiaquine|amodiaquine|mesh-list
92646454|NCT00563914|Ferroquine|ferroquine|mesh-list
92646455|NCT00563914|Antimalarials|antimalarials|mesh-ancestor
92646456|NCT00563914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92646457|NCT00563914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92646458|NCT00563914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646459|NCT00563953|Doxorubicin|doxorubicin|mesh-list
92646460|NCT00563953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92646461|NCT00563953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646462|NCT00563953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92563034|NCT00043953|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92563035|NCT00043953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92646463|NCT00563953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92646464|NCT00563953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646465|NCT00563953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646466|NCT00563992|Valproic Acid|valproic acid|mesh-list
92646467|NCT00563992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646468|NCT00563992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646469|NCT00563992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646470|NCT00563992|Antimanic Agents|antimanic agents|mesh-ancestor
92646471|NCT00563992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92646472|NCT00563992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646473|NCT00563992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646474|NCT00563992|Anticonvulsants|anticonvulsants|mesh-ancestor
92646475|NCT00563992|GABA Agents|gaba agents|mesh-ancestor
92646476|NCT00563992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646477|NCT00251550|Pemetrexed|pemetrexed|mesh-list
92646478|NCT00251550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646479|NCT00251550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646480|NCT00251550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646481|NCT00251550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92646482|NCT00251550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92646483|NCT04611373|Levamisole|levamisole|mesh-list
92646484|NCT04611373|Acetazolamide|acetazolamide|mesh-list
92646485|NCT04611373|Anticonvulsants|anticonvulsants|mesh-ancestor
92646486|NCT04611373|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92646487|NCT04611373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646488|NCT04611373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646489|NCT04611373|Diuretics|diuretics|mesh-ancestor
92646490|NCT04611373|Natriuretic Agents|natriuretic agents|mesh-ancestor
92646491|NCT04611373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646492|NCT04611373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92646493|NCT04611373|Immunologic Factors|immunologic factors|mesh-ancestor
92646494|NCT04611373|Antinematodal Agents|antinematodal agents|mesh-ancestor
92646495|NCT04611373|Anthelmintics|anthelmintics|mesh-ancestor
92646496|NCT04611373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92646497|NCT04611373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646498|NCT04611373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646499|NCT00564031|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92646500|NCT00564031|Medroxyprogesterone|medroxyprogesterone|mesh-list
92646501|NCT00564031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92646502|NCT00564031|Contraceptive Agents|contraceptive agents|mesh-ancestor
92646503|NCT00564031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92646504|NCT00564031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646505|NCT00564031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92646506|NCT00564031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92646507|NCT00564031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92646509|NCT00564031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92646510|NCT00564031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92646511|NCT00564031|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92646512|NCT02961426|Sofosbuvir|sofosbuvir|mesh-list
92646513|NCT02961426|Antiviral Agents|antiviral agents|mesh-ancestor
92646514|NCT02961426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646515|NCT04610164|Tranexamic Acid|tranexamic acid|mesh-list
92646516|NCT04610164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92646517|NCT04610164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92646518|NCT04610164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646519|NCT04610164|Hemostatics|hemostatics|mesh-ancestor
92646521|NCT00222443|Irinotecan|irinotecan|mesh-list
92646522|NCT00222443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92646523|NCT00222443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92646524|NCT00222443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646525|NCT00222443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646526|NCT00222443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646527|NCT04610398|Dexamethasone|dexamethasone|mesh-list
92646528|NCT04610398|Dexamethasone acetate|dexamethasone acetate|mesh-list
92646529|NCT04610398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646530|NCT04610398|Antiemetics|antiemetics|mesh-ancestor
92646531|NCT04610398|Autonomic Agents|autonomic agents|mesh-ancestor
92646532|NCT04610398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646533|NCT04610398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646534|NCT04610398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646535|NCT04610398|Glucocorticoids|glucocorticoids|mesh-ancestor
92563036|NCT00043953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92563037|NCT00043953|Protease Inhibitors|protease inhibitors|mesh-ancestor
92563038|NCT00043953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563039|NCT00043953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563040|NCT00043953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92646536|NCT04610398|Hormones|hormones|mesh-ancestor
92646537|NCT04610398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646538|NCT04610398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92646539|NCT04610398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646540|NCT00222482|Valproic Acid|valproic acid|mesh-list
92646541|NCT00222482|Anticonvulsants|anticonvulsants|mesh-ancestor
92646542|NCT00222482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646543|NCT00222482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646544|NCT00222482|GABA Agents|gaba agents|mesh-ancestor
92646545|NCT00222482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646546|NCT00222482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646547|NCT00222482|Antimanic Agents|antimanic agents|mesh-ancestor
92646548|NCT00222482|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92646549|NCT00222482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646550|NCT00222482|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646551|NCT04610125|Cyclophosphamide|cyclophosphamide|mesh-list
92646552|NCT04610125|Fludarabine|fludarabine|mesh-list
92646553|NCT04610125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646554|NCT04610125|Immunologic Factors|immunologic factors|mesh-ancestor
92646555|NCT04610125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646556|NCT04610125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646557|NCT04610125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92646558|NCT04610125|Alkylating Agents|alkylating agents|mesh-ancestor
92646559|NCT04610125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646560|NCT04610125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646561|NCT04610125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92646562|NCT00564148|Bevacizumab|bevacizumab|mesh-list
92646563|NCT00564148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92646564|NCT00564148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646565|NCT00564148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92646566|NCT00564148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92646567|NCT00564148|Growth Substances|growth substances|mesh-ancestor
92646568|NCT00564148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646569|NCT00564148|Growth Inhibitors|growth inhibitors|mesh-ancestor
92646570|NCT00222521|Insulin Glargine|insulin glargine|mesh-list
92646571|NCT00222521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92646572|NCT00222521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646573|NCT04609540|Trastuzumab|trastuzumab|mesh-list
92646574|NCT04609540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92646575|NCT04609540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646576|NCT00564187|Irbesartan|irbesartan|mesh-list
92646577|NCT00564187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92646578|NCT00564187|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92646579|NCT00564187|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92646580|NCT00564187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646581|NCT00222677|Aspirin|aspirin|mesh-list
92646592|NCT00222677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646593|NCT00222677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92646594|NCT00222677|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92646595|NCT00222677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646596|NCT00222677|Antipyretics|antipyretics|mesh-ancestor
92646597|NCT00564460|Finasteride|finasteride|mesh-list
92646598|NCT00564460|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92646599|NCT00564460|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92646600|NCT00564460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646601|NCT00564460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646602|NCT00564460|Hormone Antagonists|hormone antagonists|mesh-ancestor
92646603|NCT00564460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646604|NCT00564460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646605|NCT00564460|Urological Agents|urological agents|mesh-ancestor
92646606|NCT04609033|Ketamine|ketamine|mesh-list
92646607|NCT04609033|Morphine|morphine|mesh-list
92646608|NCT04609033|Bupivacaine|bupivacaine|mesh-list
92563041|NCT00043953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92563042|NCT00043953|Antiviral Agents|antiviral agents|mesh-ancestor
91996159|NCT04230109|Pembrolizumab|pembrolizumab|mesh-list
92646609|NCT04609033|Anesthetics, Local|anesthetics, local|mesh-ancestor
92646610|NCT04609033|Anesthetics|anesthetics|mesh-ancestor
92646611|NCT04609033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646612|NCT04609033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646613|NCT04609033|Sensory System Agents|sensory system agents|mesh-ancestor
92646614|NCT04609033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646615|NCT04609033|Analgesics|analgesics|mesh-ancestor
92646616|NCT04609033|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92646617|NCT04609033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92646618|NCT04609033|Anesthetics, General|anesthetics, general|mesh-ancestor
92646619|NCT04609033|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92646620|NCT04609033|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92646621|NCT04609033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646622|NCT04609033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646623|NCT04609033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92646624|NCT04609033|Narcotics|narcotics|mesh-ancestor
92646625|NCT00248313|Sirolimus|sirolimus|mesh-list
92646626|NCT00248313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646627|NCT00248313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646628|NCT00248313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92646629|NCT00248313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646630|NCT00248313|Antifungal Agents|antifungal agents|mesh-ancestor
92646631|NCT00248313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646632|NCT00248313|Immunologic Factors|immunologic factors|mesh-ancestor
92646633|NCT00248313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646634|NCT00222794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92646635|NCT00222794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92646636|NCT00222794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92646637|NCT00222794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92646638|NCT00222794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646639|NCT00222794|Adrenergic Agents|adrenergic agents|mesh-ancestor
92646640|NCT00222794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646641|NCT00222794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646642|NCT04608253|Choline|choline|mesh-list
92646643|NCT04608253|Lipotropic Agents|lipotropic agents|mesh-ancestor
92646655|NCT00222833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646656|NCT00222833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646657|NCT00222833|Dopamine Agonists|dopamine agonists|mesh-ancestor
92646658|NCT00222833|Dopamine Agents|dopamine agents|mesh-ancestor
92646659|NCT00222833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646660|NCT00222833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646661|NCT00222833|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92646662|NCT00222833|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92646663|NCT00222833|Serotonin Agents|serotonin agents|mesh-ancestor
92646664|NCT00222833|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92646665|NCT00222833|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92371949|NCT01353144|Analgesics|analgesics|mesh-ancestor
92646667|NCT00222833|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92646669|NCT00564538|Thymoglobulin|thymoglobulin|mesh-list
92646670|NCT00564538|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92646671|NCT00564538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646672|NCT00564538|Immunologic Factors|immunologic factors|mesh-ancestor
92646673|NCT00564538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646674|NCT00564538|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92646675|NCT00564538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646676|NCT00564538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646677|NCT00251706|Amiodarone|amiodarone|mesh-list
92646678|NCT00251706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92646679|NCT00251706|Vasodilator Agents|vasodilator agents|mesh-ancestor
92646680|NCT00251706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92646681|NCT00251706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92646682|NCT00251706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646683|NCT00251706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92646684|NCT00251706|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92646685|NCT00251706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646686|NCT00251706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646687|NCT00251706|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92563043|NCT00043953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563044|NCT00043953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92563045|NCT00043953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92563046|NCT00043953|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92563047|NCT00043953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563048|NCT00043953|Antimetabolites|antimetabolites|mesh-ancestor
92563050|NCT00154882|Cisplatin|cisplatin|mesh-list
92646688|NCT00251706|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92646689|NCT00251706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92646690|NCT00199121|Zidovudine|zidovudine|mesh-list
92646691|NCT00199121|Antimetabolites|antimetabolites|mesh-ancestor
92646692|NCT00199121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646693|NCT00199121|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92646694|NCT00199121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92646695|NCT00199121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646696|NCT00199121|Antiviral Agents|antiviral agents|mesh-ancestor
92646697|NCT00199121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646698|NCT00199121|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92646699|NCT00199121|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92646700|NCT04607785|Chlorhexidine|chlorhexidine|mesh-list
92646701|NCT04607785|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92646702|NCT04607785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92646703|NCT04607785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646704|NCT04607785|Disinfectants|disinfectants|mesh-ancestor
92646705|NCT04607785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92646706|NCT00199160|Sorafenib|sorafenib|mesh-list
92363609|NCT04376970|Dermatologic Agents|dermatologic agents|mesh-ancestor
92646714|NCT04607629|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92646715|NCT04607629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92646716|NCT04607629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646717|NCT04607629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92646718|NCT04607629|Autonomic Agents|autonomic agents|mesh-ancestor
92646719|NCT04607629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646720|NCT04607629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646721|NCT04607629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92646722|NCT04607629|Respiratory System Agents|respiratory system agents|mesh-ancestor
92646723|NCT04607629|Glucocorticoids|glucocorticoids|mesh-ancestor
92646725|NCT04607629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646726|NCT04607629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92646727|NCT04607629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92646728|NCT04607629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92646729|NCT04607629|Adrenergic Agents|adrenergic agents|mesh-ancestor
92646730|NCT04607629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646731|NCT04607629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646732|NCT04607629|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92646733|NCT04607629|Immunologic Factors|immunologic factors|mesh-ancestor
92646734|NCT00251784|Sildenafil Citrate|sildenafil citrate|mesh-list
92646735|NCT00251784|Vasodilator Agents|vasodilator agents|mesh-ancestor
92646736|NCT00251784|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92646737|NCT00251784|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92646738|NCT00251784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646739|NCT00251784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646740|NCT00251784|Urological Agents|urological agents|mesh-ancestor
92646741|NCT00248430|Aldesleukin|aldesleukin|mesh-list
92646742|NCT00248430|Melphalan|melphalan|mesh-list
92646743|NCT00248430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92646744|NCT00248430|Alkylating Agents|alkylating agents|mesh-ancestor
92646745|NCT00248430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646746|NCT00248430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646747|NCT00248430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92646748|NCT00248430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646749|NCT00248430|Immunologic Factors|immunologic factors|mesh-ancestor
92646750|NCT00248430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646751|NCT00248430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92646752|NCT00248430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92563051|NCT00154882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92563053|NCT00154882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563054|NCT00154882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92646753|NCT00248430|Antiviral Agents|antiviral agents|mesh-ancestor
92646754|NCT00248430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646755|NCT05556356|Acetaminophen|acetaminophen|mesh-list
92646756|NCT05556356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646757|NCT05556356|Analgesics|analgesics|mesh-ancestor
92646758|NCT05556356|Sensory System Agents|sensory system agents|mesh-ancestor
92646759|NCT05556356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646760|NCT05556356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646761|NCT05556356|Antipyretics|antipyretics|mesh-ancestor
92646762|NCT00564655|Epinephrine|epinephrine|mesh-list
92646763|NCT00564655|Racepinephrine|racepinephrine|mesh-list
92646764|NCT00564655|Bupivacaine|bupivacaine|mesh-list
92646765|NCT00564655|Epinephryl borate|epinephryl borate|mesh-list
92646766|NCT00564655|Anesthetics, Local|anesthetics, local|mesh-ancestor
92646767|NCT00564655|Anesthetics|anesthetics|mesh-ancestor
92646768|NCT00564655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646769|NCT00564655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646770|NCT00564655|Sensory System Agents|sensory system agents|mesh-ancestor
92646771|NCT00564655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646772|NCT00564655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92646773|NCT00564655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92053932|NCT04746235|Decitabine|decitabine|mesh-list
92646781|NCT00564655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92646782|NCT00564655|Mydriatics|mydriatics|mesh-ancestor
92646783|NCT00564655|Sympathomimetics|sympathomimetics|mesh-ancestor
92646784|NCT00564655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92646785|NCT04606537|Itraconazole|itraconazole|mesh-list
92646786|NCT04606537|Rifampin|rifampin|mesh-list
92646787|NCT04606537|Antifungal Agents|antifungal agents|mesh-ancestor
92646788|NCT04606537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646789|NCT04606537|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92646790|NCT04606537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646791|NCT04606537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646792|NCT04606537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646793|NCT04606537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92646794|NCT04606537|Hormone Antagonists|hormone antagonists|mesh-ancestor
92646795|NCT04606537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646796|NCT04606537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646797|NCT04606537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92646798|NCT04606537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92646799|NCT04606537|Antitubercular Agents|antitubercular agents|mesh-ancestor
92646800|NCT04606537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646801|NCT04606537|Leprostatic Agents|leprostatic agents|mesh-ancestor
92646802|NCT04606537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92646803|NCT04606537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92646804|NCT04606537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92646805|NCT04606537|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92646806|NCT04606537|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92646807|NCT04606537|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92646808|NCT04606537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92646809|NCT00251823|Eptifibatide|eptifibatide|mesh-list
92646810|NCT00251823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92646811|NCT04606225|Losartan|losartan|mesh-list
92372099|NCT01390818|Niacinamide|niacinamide|mesh-list
92646812|NCT04606225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92646813|NCT04606225|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92646814|NCT04606225|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92646815|NCT04606225|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92646816|NCT04606225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646817|NCT04606108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92646818|NCT04606108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646819|NCT04606108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92646820|NCT04606108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646821|NCT04719507|Meperidine|meperidine|mesh-list
92646822|NCT04719507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92646823|NCT04719507|Narcotics|narcotics|mesh-ancestor
92646824|NCT04719507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646825|NCT04719507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646826|NCT04719507|Analgesics|analgesics|mesh-ancestor
92646827|NCT04719507|Sensory System Agents|sensory system agents|mesh-ancestor
92646828|NCT04719507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646829|NCT04719507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92646830|NCT04605952|Antibodies|antibodies|mesh-list
92646831|NCT04605952|Immunoglobulin G|immunoglobulin g|mesh-list
92646832|NCT04605952|Immunologic Factors|immunologic factors|mesh-ancestor
92646833|NCT04605952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646834|NCT04605562|Palbociclib|palbociclib|mesh-list
92646835|NCT04605562|Antibodies|antibodies|mesh-list
92646836|NCT04605562|Antibodies, Blocking|antibodies, blocking|mesh-list
92646837|NCT04605562|Immunologic Factors|immunologic factors|mesh-ancestor
92646838|NCT04605562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646841|NCT04605562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646842|NCT04605562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646843|NCT00251901|Esomeprazole|esomeprazole|mesh-list
92646844|NCT00251901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92646845|NCT00251901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646846|NCT00251901|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92646847|NCT00251901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646848|NCT00251901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646849|NCT05517278|Anti-Infective Agents|anti-infective agents|mesh-list
92646850|NCT05517278|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92646851|NCT00564772|Ritonavir|ritonavir|mesh-list
92646852|NCT00564772|Lopinavir|lopinavir|mesh-list
92646853|NCT00564772|Raltegravir Potassium|raltegravir potassium|mesh-list
92646854|NCT00564772|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92646855|NCT00564772|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92646856|NCT00564772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92646857|NCT00564772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646858|NCT00564772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646859|NCT00564772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92646860|NCT00564772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92646861|NCT00564772|Antiviral Agents|antiviral agents|mesh-ancestor
92646862|NCT00564772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646863|NCT00564772|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92646864|NCT00564772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646865|NCT00564772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92646866|NCT00564772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92646867|NCT00251940|Glyburide|glyburide|mesh-list
92646868|NCT00251940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92646869|NCT00251940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646870|NCT04604938|Losartan|losartan|mesh-list
92646871|NCT04604938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92646872|NCT04604938|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92646873|NCT04604938|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92646874|NCT04604938|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92646875|NCT04604938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646876|NCT00565006|Anacetrapib|anacetrapib|mesh-list
92646877|NCT00565006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92646878|NCT00565006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92646879|NCT00565006|Antimetabolites|antimetabolites|mesh-ancestor
92646880|NCT00565006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646881|NCT00565006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92646882|NCT00565123|Levofloxacin|levofloxacin|mesh-list
92646883|NCT00565123|Ofloxacin|ofloxacin|mesh-list
92646884|NCT00565123|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92646885|NCT00565123|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92372179|NCT01403376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646886|NCT00565123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92646887|NCT00565123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646888|NCT00565123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92646889|NCT00565123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92646890|NCT00565123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92646891|NCT00565123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646892|NCT00565123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646893|NCT00565123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646894|NCT00565123|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92646895|NCT00565123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646897|NCT04604509|Nicotine|nicotine|mesh-list
92646898|NCT04604509|Varenicline|varenicline|mesh-list
92646899|NCT04604509|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92563056|NCT00154882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563057|NCT00051077|Ribavirin|ribavirin|mesh-list
92563058|NCT00051077|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92563059|NCT00051077|Adefovir|adefovir|mesh-list
92563060|NCT00051077|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92563061|NCT00051077|Antimetabolites|antimetabolites|mesh-ancestor
92646900|NCT04604509|Autonomic Agents|autonomic agents|mesh-ancestor
92646901|NCT04604509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646902|NCT04604509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646903|NCT04604509|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92646904|NCT04604509|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92646905|NCT04604509|Cholinergic Agents|cholinergic agents|mesh-ancestor
92646906|NCT04604509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646907|NCT04604509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646908|NCT04604509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92646909|NCT04604509|Antidepressive Agents|antidepressive agents|mesh-ancestor
92646910|NCT04604509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646919|NCT00565162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92646920|NCT00565162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646921|NCT04603729|Dexamethasone|dexamethasone|mesh-list
92646922|NCT04603729|Methylprednisolone|methylprednisolone|mesh-list
92646923|NCT04603729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92646924|NCT04603729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92646925|NCT04603729|Prednisolone|prednisolone|mesh-list
92646926|NCT04603729|Prednisolone acetate|prednisolone acetate|mesh-list
92646927|NCT04603729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92646928|NCT04603729|Prednisolone phosphate|prednisolone phosphate|mesh-list
92646929|NCT04603729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646930|NCT04603729|Antiemetics|antiemetics|mesh-ancestor
92646931|NCT04603729|Autonomic Agents|autonomic agents|mesh-ancestor
92646932|NCT04603729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646933|NCT04603729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646934|NCT04603729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646935|NCT04603729|Glucocorticoids|glucocorticoids|mesh-ancestor
92646936|NCT04603729|Hormones|hormones|mesh-ancestor
92646937|NCT04603729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646938|NCT04603729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92646939|NCT04603729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646940|NCT04603729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92646941|NCT04603729|Protective Agents|protective agents|mesh-ancestor
92646942|NCT04603924|Niclosamide|niclosamide|mesh-list
92646943|NCT04603924|Anticestodal Agents|anticestodal agents|mesh-ancestor
92646944|NCT04603924|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92646945|NCT04603924|Anthelmintics|anthelmintics|mesh-ancestor
92646946|NCT04603924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92646947|NCT04603924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646948|NCT04603924|Antinematodal Agents|antinematodal agents|mesh-ancestor
92646949|NCT04603573|Listerine|listerine|mesh-list
92646950|NCT04603573|Fluorides|fluorides|mesh-list
92646951|NCT04603573|Sodium Fluoride|sodium fluoride|mesh-list
92646952|NCT04603573|Fluorides, Topical|fluorides, topical|mesh-list
92646953|NCT04603573|Cariostatic Agents|cariostatic agents|mesh-ancestor
92646954|NCT04603573|Protective Agents|protective agents|mesh-ancestor
92646955|NCT04603573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646956|NCT04603573|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92646957|NCT04603573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92646958|NCT05361824|Acetaminophen|acetaminophen|mesh-list
92372255|NCT01428336|Cosyntropin|cosyntropin|mesh-list
92646959|NCT05361824|Ketorolac|ketorolac|mesh-list
92646960|NCT05361824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646962|NCT05361824|Sensory System Agents|sensory system agents|mesh-ancestor
92646963|NCT05361824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646964|NCT05361824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646965|NCT05361824|Antipyretics|antipyretics|mesh-ancestor
92646966|NCT05361824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92646967|NCT05361824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646968|NCT05361824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646969|NCT05361824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92646970|NCT05361824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752330|NCT05940701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563062|NCT00051077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563063|NCT00051077|Antiviral Agents|antiviral agents|mesh-ancestor
92563064|NCT00051077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563065|NCT00051077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92563066|NCT00051077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563067|NCT00051077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646971|NCT05361824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646972|NCT04603456|Calcium Carbonate|calcium carbonate|mesh-list
92646973|NCT04603456|Antacids|antacids|mesh-ancestor
92646974|NCT04603456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646975|NCT04603456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646976|NCT05285813|Acetaminophen|acetaminophen|mesh-list
92646977|NCT05285813|Diphenhydramine|diphenhydramine|mesh-list
92646978|NCT05285813|Promethazine|promethazine|mesh-list
92646982|NCT05285813|Autonomic Agents|autonomic agents|mesh-ancestor
92646983|NCT05285813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646984|NCT05285813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646985|NCT05285813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646986|NCT05285813|Glucocorticoids|glucocorticoids|mesh-ancestor
92646987|NCT05285813|Hormones|hormones|mesh-ancestor
92646988|NCT05285813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646989|NCT05285813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92646990|NCT05285813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646991|NCT05285813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646992|NCT05285813|Analgesics|analgesics|mesh-ancestor
92646993|NCT05285813|Sensory System Agents|sensory system agents|mesh-ancestor
92646994|NCT05285813|Antipyretics|antipyretics|mesh-ancestor
92646995|NCT05285813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92646996|NCT05285813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92646997|NCT05285813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646998|NCT05285813|Anesthetics, Local|anesthetics, local|mesh-ancestor
92646999|NCT05285813|Anesthetics|anesthetics|mesh-ancestor
92647000|NCT05285813|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92647001|NCT05285813|Histamine Antagonists|histamine antagonists|mesh-ancestor
92647002|NCT05285813|Histamine Agents|histamine agents|mesh-ancestor
92647003|NCT05285813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647004|NCT05285813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647005|NCT05285813|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92647006|NCT05285813|Antipruritics|antipruritics|mesh-ancestor
92647007|NCT05285813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92647008|NCT00252291|Methacholine Chloride|methacholine chloride|mesh-list
92647009|NCT00252291|Miotics|miotics|mesh-ancestor
92647010|NCT00252291|Autonomic Agents|autonomic agents|mesh-ancestor
92647011|NCT00252291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647012|NCT00252291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647013|NCT00252291|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92647014|NCT00252291|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92647015|NCT00252291|Respiratory System Agents|respiratory system agents|mesh-ancestor
92647016|NCT00252291|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92647017|NCT00252291|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92647018|NCT00252291|Cholinergic Agents|cholinergic agents|mesh-ancestor
92647019|NCT00252291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647020|NCT00252291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647021|NCT00565240|Letrozole|letrozole|mesh-list
92647022|NCT00565240|NuvaRing|nuvaring|mesh-list
92647023|NCT00565240|Desogestrel|desogestrel|mesh-list
92647024|NCT00565240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647025|NCT00565240|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92647026|NCT00565240|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92647027|NCT00565240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647028|NCT00565240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647029|NCT00565240|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92647030|NCT00565240|Hormone Antagonists|hormone antagonists|mesh-ancestor
92647031|NCT00565240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647032|NCT00565240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647033|NCT00565240|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92647034|NCT00565240|Contraceptive Agents|contraceptive agents|mesh-ancestor
92647035|NCT00565240|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92563068|NCT00155233|Morphine|morphine|mesh-list
92563069|NCT00155233|Nalbuphine|nalbuphine|mesh-list
92563070|NCT00155233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92563071|NCT00155233|Narcotics|narcotics|mesh-ancestor
92563072|NCT00155233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647036|NCT00565240|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92647037|NCT00565240|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92647038|NCT00565240|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92647039|NCT00565240|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92647040|NCT00565240|Progestins|progestins|mesh-ancestor
92647041|NCT00565240|Hormones|hormones|mesh-ancestor
92647042|NCT04602247|Fesoterodine|fesoterodine|mesh-list
92647043|NCT04602247|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92647044|NCT04602247|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92647045|NCT04602247|Cholinergic Agents|cholinergic agents|mesh-ancestor
92647046|NCT04602247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647047|NCT04602247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647048|NCT04602247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647049|NCT04602247|Urological Agents|urological agents|mesh-ancestor
92647050|NCT00252330|Amibegron|amibegron|mesh-list
92647051|NCT00252330|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92647075|NCT04601701|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647076|NCT04601701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647078|NCT04601701|Autonomic Agents|autonomic agents|mesh-ancestor
92647079|NCT04601701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647080|NCT04601701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647081|NCT04601701|Glucocorticoids|glucocorticoids|mesh-ancestor
92647082|NCT04601701|Hormones|hormones|mesh-ancestor
92647083|NCT04601701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647084|NCT04601701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92647085|NCT00252369|Infliximab|infliximab|mesh-list
92647086|NCT00252369|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92647087|NCT00252369|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92647088|NCT00252369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647089|NCT00252369|Dermatologic Agents|dermatologic agents|mesh-ancestor
92647090|NCT00252369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647091|NCT00252369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92647092|NCT00252369|Hemostatics|hemostatics|mesh-ancestor
92647093|NCT00252369|Coagulants|coagulants|mesh-ancestor
92647094|NCT00565318|Benphothiamine|benphothiamine|mesh-list
92647095|NCT00565318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92647096|NCT00565318|Immunologic Factors|immunologic factors|mesh-ancestor
92647097|NCT00565318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647098|NCT00565318|Chelating Agents|chelating agents|mesh-ancestor
92647099|NCT00565318|Sequestering Agents|sequestering agents|mesh-ancestor
92647100|NCT00565318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647101|NCT05201144|Sildenafil Citrate|sildenafil citrate|mesh-list
92647105|NCT05201144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647106|NCT05201144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647107|NCT05201144|Urological Agents|urological agents|mesh-ancestor
92647108|NCT00252408|Hormones|hormones|mesh-list
92372423|NCT01468350|4-Aminopyridine|4-aminopyridine|mesh-list
92647109|NCT00252408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647110|NCT00252408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647112|NCT04601389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92647113|NCT04601389|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92647114|NCT04601389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92647115|NCT04601389|Respiratory System Agents|respiratory system agents|mesh-ancestor
92647116|NCT04601389|Immunologic Factors|immunologic factors|mesh-ancestor
92647117|NCT04601389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647118|NCT00565396|Losartan|losartan|mesh-list
92647119|NCT00565396|Fosinopril|fosinopril|mesh-list
92647120|NCT00565396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92647121|NCT00565396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92647122|NCT00565396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92647123|NCT00565396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92647124|NCT00565396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647125|NCT00565396|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92647126|NCT00565396|Protease Inhibitors|protease inhibitors|mesh-ancestor
92647127|NCT00565396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563073|NCT00155233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563074|NCT00155233|Analgesics|analgesics|mesh-ancestor
92563075|NCT00155233|Sensory System Agents|sensory system agents|mesh-ancestor
92563076|NCT00155233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563077|NCT00051116|Lenalidomide|lenalidomide|mesh-list
92563078|NCT00051116|Immunologic Factors|immunologic factors|mesh-ancestor
92647128|NCT04601116|Atorvastatin|atorvastatin|mesh-list
92647129|NCT04601116|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92647130|NCT04601116|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92647131|NCT04601116|Antimetabolites|antimetabolites|mesh-ancestor
92647132|NCT04601116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647133|NCT04601116|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92647134|NCT04601116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92647135|NCT04601116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647136|NCT00249132|Risperidone|risperidone|mesh-list
92647137|NCT00249132|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92647138|NCT00249132|Serotonin Agents|serotonin agents|mesh-ancestor
92647139|NCT00249132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647140|NCT00249132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647141|NCT00249132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647142|NCT00249132|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92647143|NCT00249132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647144|NCT00249132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647145|NCT00249132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647146|NCT00249132|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92647147|NCT00249132|Dopamine Agents|dopamine agents|mesh-ancestor
92647148|NCT04600492|Riociguat|riociguat|mesh-list
92647149|NCT04600492|Enzyme Activators|enzyme activators|mesh-ancestor
92647150|NCT04600492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647151|NCT04599712|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92647152|NCT04599712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647153|NCT04599712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647154|NCT00414648|Sirolimus|sirolimus|mesh-list
92647155|NCT00414648|Temsirolimus|temsirolimus|mesh-list
92647156|NCT00414648|MTOR Inhibitors|mtor inhibitors|mesh-list
92647157|NCT00414648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92647158|NCT00414648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647159|NCT00414648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92647160|NCT00414648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647161|NCT00414648|Antifungal Agents|antifungal agents|mesh-ancestor
92647162|NCT00414648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647163|NCT00414648|Immunologic Factors|immunologic factors|mesh-ancestor
92647164|NCT00414648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647165|NCT00414648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92647166|NCT00414648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647167|NCT00414648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647168|NCT00414687|Iloprost|iloprost|mesh-list
92647169|NCT00414687|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92647170|NCT00414687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92647171|NCT04599205|Tranexamic Acid|tranexamic acid|mesh-list
92647172|NCT04599205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92647174|NCT04599205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647175|NCT04599205|Hemostatics|hemostatics|mesh-ancestor
92647176|NCT04599205|Coagulants|coagulants|mesh-ancestor
92647177|NCT05070260|Glenzocimab|glenzocimab|mesh-list
92647178|NCT05070260|Anticoagulants|anticoagulants|mesh-ancestor
92647179|NCT04598737|Lithium Carbonate|lithium carbonate|mesh-list
92647180|NCT04598737|Antidepressive Agents|antidepressive agents|mesh-ancestor
92647181|NCT04598737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647182|NCT04598737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647183|NCT04598737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372477|NCT01479270|Epinephrine|epinephrine|mesh-list
92647184|NCT04598737|Antimanic Agents|antimanic agents|mesh-ancestor
92647185|NCT04598737|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647186|NCT04598737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647187|NCT04598737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647188|NCT05055128|Lansoprazole|lansoprazole|mesh-list
92647189|NCT05055128|Dexlansoprazole|dexlansoprazole|mesh-list
92647190|NCT05055128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92647191|NCT05055128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563080|NCT00051116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647192|NCT05055128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92647193|NCT05055128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647194|NCT05055128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647195|NCT00565591|Albuterol|albuterol|mesh-list
92647196|NCT00565591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92647197|NCT00565591|Autonomic Agents|autonomic agents|mesh-ancestor
92647198|NCT00565591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647199|NCT00565591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647200|NCT00565591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92647201|NCT00565591|Respiratory System Agents|respiratory system agents|mesh-ancestor
92647202|NCT00565591|Tocolytic Agents|tocolytic agents|mesh-ancestor
92647203|NCT00565591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92647204|NCT00565591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92647205|NCT00565591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92647206|NCT00565591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92647207|NCT00565591|Adrenergic Agents|adrenergic agents|mesh-ancestor
92647208|NCT00565591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647209|NCT00565591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647210|NCT00252603|Galantamine|galantamine|mesh-list
92647211|NCT00252603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92647212|NCT00252603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647213|NCT00252603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647214|NCT00252603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92647215|NCT00252603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647216|NCT00252603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647217|NCT00252603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92647218|NCT00252603|Autonomic Agents|autonomic agents|mesh-ancestor
92647219|NCT00252603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647220|NCT00252603|Nootropic Agents|nootropic agents|mesh-ancestor
92647221|NCT00565630|Moxifloxacin|moxifloxacin|mesh-list
92647222|NCT00565630|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92647223|NCT00565630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92647224|NCT00565630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647225|NCT00565630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92647226|NCT00565630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92647227|NCT00565630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647228|NCT00565630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647229|NCT00565630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647230|NCT00565630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92647231|NCT00565630|Contraceptive Agents|contraceptive agents|mesh-ancestor
92647232|NCT00565630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92647233|NCT00565630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647234|NCT00565630|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92647235|NCT00565630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92647236|NCT00565630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92647237|NCT00565708|Aspirin|aspirin|mesh-list
92647238|NCT00565708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92647239|NCT00565708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92647240|NCT00565708|Analgesics|analgesics|mesh-ancestor
92647241|NCT00565708|Sensory System Agents|sensory system agents|mesh-ancestor
92647242|NCT00565708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647243|NCT00565708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647244|NCT00565708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647274|NCT04995263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92647275|NCT04995263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647276|NCT04995263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647277|NCT04995263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92647278|NCT04995263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92647279|NCT04995263|Purinergic Agents|purinergic agents|mesh-ancestor
92647280|NCT04995263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647281|NCT04995263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647283|NCT04598191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92647284|NCT04598191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92647285|NCT04955366|Abatacept|abatacept|mesh-list
92647286|NCT04955366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92647287|NCT04955366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647291|NCT04955366|Immunologic Factors|immunologic factors|mesh-ancestor
92563081|NCT00051116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563083|NCT00051116|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563084|NCT00051116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563085|NCT00155272|Thalidomide|thalidomide|mesh-list
92563086|NCT00155272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91996808|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
92647292|NCT04955366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647293|NCT04955366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92647295|NCT00249171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92647296|NCT00249171|Serotonin Agents|serotonin agents|mesh-ancestor
92647297|NCT00249171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647298|NCT00249171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647299|NCT00249171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647300|NCT00249171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92647301|NCT00249171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647302|NCT00249171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647303|NCT00249171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647304|NCT00249171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92647305|NCT00249171|Dopamine Agents|dopamine agents|mesh-ancestor
92647306|NCT00565981|Fludarabine|fludarabine|mesh-list
92647307|NCT00565981|Fludarabine phosphate|fludarabine phosphate|mesh-list
92647308|NCT00565981|Alemtuzumab|alemtuzumab|mesh-list
92647309|NCT00565981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647310|NCT00565981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92647311|NCT00565981|Antimetabolites|antimetabolites|mesh-ancestor
92647312|NCT00565981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647313|NCT00565981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647314|NCT00565981|Immunologic Factors|immunologic factors|mesh-ancestor
92647315|NCT00565981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647316|NCT00565981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647317|NCT04952519|Amantadine|amantadine|mesh-list
92647318|NCT04952519|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92647319|NCT04952519|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92647320|NCT04952519|Antiviral Agents|antiviral agents|mesh-ancestor
92647321|NCT04952519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647322|NCT04952519|Dopamine Agents|dopamine agents|mesh-ancestor
92647323|NCT04952519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647324|NCT04952519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647325|NCT04952519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647326|NCT04952519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92647327|NCT04952519|Analgesics|analgesics|mesh-ancestor
92647328|NCT04952519|Sensory System Agents|sensory system agents|mesh-ancestor
92647329|NCT04952519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647330|NCT00414921|Clonidine|clonidine|mesh-list
92647331|NCT00414921|Methylphenidate|methylphenidate|mesh-list
92647332|NCT00414921|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92647333|NCT00414921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647334|NCT00414921|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92647335|NCT00414921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92647336|NCT00414921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92647337|NCT00414921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647338|NCT00414921|Dopamine Agents|dopamine agents|mesh-ancestor
92647339|NCT00414921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647340|NCT00414921|Analgesics|analgesics|mesh-ancestor
92647341|NCT00414921|Sensory System Agents|sensory system agents|mesh-ancestor
92647342|NCT00414921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647343|NCT00414921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92647344|NCT00414921|Sympatholytics|sympatholytics|mesh-ancestor
92647345|NCT00414921|Autonomic Agents|autonomic agents|mesh-ancestor
92647346|NCT00414921|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92647347|NCT00414921|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92647348|NCT00414921|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92647349|NCT00414921|Adrenergic Agents|adrenergic agents|mesh-ancestor
92647350|NCT04597762|Cyclosporine|cyclosporine|mesh-list
92647351|NCT04597762|Hydrocortisone|hydrocortisone|mesh-list
92647352|NCT04597762|Cyclosporins|cyclosporins|mesh-list
92647353|NCT04597762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752331|NCT05940649|Norepinephrine|norepinephrine|mesh-list
92563087|NCT00155272|Immunologic Factors|immunologic factors|mesh-ancestor
92563088|NCT00155272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647354|NCT04597762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647355|NCT04597762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647356|NCT04597762|Immunologic Factors|immunologic factors|mesh-ancestor
92647357|NCT04597762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647358|NCT04597762|Antifungal Agents|antifungal agents|mesh-ancestor
92647361|NCT04597762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92647362|NCT04597762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92647363|NCT04597762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647364|NCT00249210|Levofloxacin|levofloxacin|mesh-list
92647365|NCT00249210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92647366|NCT00249210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647367|NCT00249210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92647368|NCT00249210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92647369|NCT00249210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92647370|NCT00249210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647371|NCT00249210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647372|NCT00249210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647373|NCT00249210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92647374|NCT00249210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92647376|NCT00252798|Carboplatin|carboplatin|mesh-list
92647377|NCT00252798|Gefitinib|gefitinib|mesh-list
92647378|NCT00252798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92647379|NCT00252798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647380|NCT00252798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92647381|NCT00252798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92647382|NCT00252798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92647383|NCT00252798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647384|NCT00252798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92647385|NCT00252798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647386|NCT02961660|Odalasvir|odalasvir|mesh-list
92647387|NCT02961660|Antiviral Agents|antiviral agents|mesh-ancestor
92647388|NCT02961660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647389|NCT00403013|Anesthetics|anesthetics|mesh-list
92647390|NCT00403013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647391|NCT00403013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647392|NCT00566332|Fludarabine|fludarabine|mesh-list
92647393|NCT00566332|Chlorambucil|chlorambucil|mesh-list
92647394|NCT00566332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647395|NCT00566332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647396|NCT00566332|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92647397|NCT00566332|Alkylating Agents|alkylating agents|mesh-ancestor
92647398|NCT00403052|1018 oligonucleotide|1018 oligonucleotide|mesh-list
92647399|NCT00403052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92647400|NCT00403052|Immunologic Factors|immunologic factors|mesh-ancestor
92647401|NCT00403052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647402|NCT00566371|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92647403|NCT00566371|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92647404|NCT00566371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92647405|NCT00566371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92363633|NCT04376814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92647406|NCT00566371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647408|NCT00566371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647409|NCT00566371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647410|NCT04595929|Leucovorin|leucovorin|mesh-list
92647411|NCT04595929|Docetaxel|docetaxel|mesh-list
92647412|NCT04595929|Fluorouracil|fluorouracil|mesh-list
92647413|NCT04595929|Oxaliplatin|oxaliplatin|mesh-list
92647414|NCT04595929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647415|NCT04595929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92647416|NCT04595929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92647417|NCT04595929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92647418|NCT04595929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647419|NCT04595929|Antimetabolites|antimetabolites|mesh-ancestor
92647420|NCT04595929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92647421|NCT04595929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647422|NCT04595929|Immunologic Factors|immunologic factors|mesh-ancestor
92647423|NCT04595929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647424|NCT04595929|Antidotes|antidotes|mesh-ancestor
92647425|NCT04595929|Protective Agents|protective agents|mesh-ancestor
92647426|NCT04595929|Vitamin B Complex|vitamin b complex|mesh-ancestor
92647427|NCT04595929|Vitamins|vitamins|mesh-ancestor
92563089|NCT00155272|Leprostatic Agents|leprostatic agents|mesh-ancestor
92563090|NCT00155272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563091|NCT00155272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563092|NCT00155272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563093|NCT00155272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647428|NCT04595929|Micronutrients|micronutrients|mesh-ancestor
92647429|NCT00252954|Levetiracetam|levetiracetam|mesh-list
92647430|NCT00252954|Anticonvulsants|anticonvulsants|mesh-ancestor
92647431|NCT00252954|Nootropic Agents|nootropic agents|mesh-ancestor
92647432|NCT04595812|Misoprostol|misoprostol|mesh-list
92647433|NCT04595812|Hemostatics|hemostatics|mesh-list
92647434|NCT04595812|Oxytocin|oxytocin|mesh-list
92647435|NCT04595812|Carbetocin|carbetocin|mesh-list
92647438|NCT04595812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647439|NCT04595812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92647440|NCT04595812|Abortifacient Agents|abortifacient agents|mesh-ancestor
92647441|NCT04595812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92647442|NCT04595812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647443|NCT04595812|Coagulants|coagulants|mesh-ancestor
92647444|NCT00249366|Lorazepam|lorazepam|mesh-list
92647445|NCT00249366|Anticonvulsants|anticonvulsants|mesh-ancestor
92647446|NCT00249366|Antiemetics|antiemetics|mesh-ancestor
92647447|NCT00249366|Autonomic Agents|autonomic agents|mesh-ancestor
92647448|NCT00249366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647449|NCT00249366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647450|NCT00249366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647451|NCT00249366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92647452|NCT00249366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647453|NCT00249366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92647454|NCT00249366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647455|NCT00249366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647456|NCT00249366|GABA Modulators|gaba modulators|mesh-ancestor
92647457|NCT00249366|GABA Agents|gaba agents|mesh-ancestor
92647458|NCT00249366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647459|NCT00249366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647460|NCT04635683|Lenalidomide|lenalidomide|mesh-list
92647461|NCT04635683|Immunologic Factors|immunologic factors|mesh-ancestor
92647462|NCT04635683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647463|NCT04635683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647464|NCT04635683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647465|NCT04635683|Growth Substances|growth substances|mesh-ancestor
92647466|NCT04635683|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647467|NCT04635683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647468|NCT00249405|Citalopram|citalopram|mesh-list
92647469|NCT00249405|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92647470|NCT00249405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92647471|NCT00249405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92647472|NCT00249405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647473|NCT00249405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647474|NCT00249405|Serotonin Agents|serotonin agents|mesh-ancestor
92647475|NCT00249405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647476|NCT00249405|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92647477|NCT00249405|Antidepressive Agents|antidepressive agents|mesh-ancestor
92647478|NCT00249405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647479|NCT00566644|Levonorgestrel|levonorgestrel|mesh-list
92647480|NCT00566644|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92647481|NCT00566644|Contraceptive Agents|contraceptive agents|mesh-ancestor
92647482|NCT00566644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92647483|NCT00566644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647484|NCT00566644|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92647485|NCT00566644|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92647486|NCT00566644|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92647487|NCT00253110|Haloperidol|haloperidol|mesh-list
92647488|NCT00253110|Risperidone|risperidone|mesh-list
92647489|NCT00253110|Haloperidol decanoate|haloperidol decanoate|mesh-list
92647490|NCT00253110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92647491|NCT00253110|Serotonin Agents|serotonin agents|mesh-ancestor
92647492|NCT00253110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647493|NCT00253110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647494|NCT00253110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647495|NCT00253110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92563094|NCT00155272|Growth Substances|growth substances|mesh-ancestor
92563095|NCT00155272|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563096|NCT00155272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287883|NCT02115997|Hormones|hormones|mesh-ancestor
92647496|NCT00253110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647497|NCT00253110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647498|NCT00253110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647499|NCT00253110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92647500|NCT00253110|Dopamine Agents|dopamine agents|mesh-ancestor
92647501|NCT00253110|Antiemetics|antiemetics|mesh-ancestor
92647502|NCT00253110|Autonomic Agents|autonomic agents|mesh-ancestor
92647503|NCT00253110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647504|NCT00253110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647505|NCT00253110|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92647506|NCT00566683|Meperidine|meperidine|mesh-list
92647507|NCT00566683|Diazepam|diazepam|mesh-list
92647508|NCT00566683|Alfentanil|alfentanil|mesh-list
92647509|NCT00566683|Propofol|propofol|mesh-list
92054707|NCT02022007|Incretins|incretins|mesh-ancestor
92647511|NCT00566683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647512|NCT00566683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647513|NCT00566683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92647514|NCT00566683|Anesthetics, General|anesthetics, general|mesh-ancestor
92647515|NCT00566683|Anesthetics|anesthetics|mesh-ancestor
92647516|NCT00566683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92647517|NCT00566683|Narcotics|narcotics|mesh-ancestor
92647518|NCT00566683|Analgesics|analgesics|mesh-ancestor
92647519|NCT00566683|Sensory System Agents|sensory system agents|mesh-ancestor
92647520|NCT00566683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647521|NCT00566683|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92647522|NCT00566683|Anticonvulsants|anticonvulsants|mesh-ancestor
92647523|NCT00566683|Antiemetics|antiemetics|mesh-ancestor
92647524|NCT00566683|Autonomic Agents|autonomic agents|mesh-ancestor
92647525|NCT00566683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647526|NCT00566683|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92647527|NCT00566683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92647528|NCT00566683|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92647529|NCT00566683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647530|NCT00566683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647531|NCT00566683|GABA Modulators|gaba modulators|mesh-ancestor
92647532|NCT00566683|GABA Agents|gaba agents|mesh-ancestor
92647533|NCT00566683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647534|NCT00566683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647535|NCT00566761|Triamcinolone|triamcinolone|mesh-list
92647536|NCT00566761|Bevacizumab|bevacizumab|mesh-list
92647537|NCT00566761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647538|NCT00566761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647539|NCT00566761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647540|NCT00566761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647541|NCT00566761|Growth Substances|growth substances|mesh-ancestor
92647542|NCT00566761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647543|NCT00566761|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647544|NCT00566761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647545|NCT00566761|Glucocorticoids|glucocorticoids|mesh-ancestor
92647547|NCT00566761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647548|NCT00566800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92647549|NCT00566800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647550|NCT00566800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92647551|NCT00566800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647552|NCT00566800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647553|NCT04593706|Dexamethasone|dexamethasone|mesh-list
92647554|NCT04593706|Methylprednisolone|methylprednisolone|mesh-list
92372875|NCT01565538|Pemetrexed|pemetrexed|mesh-list
92647555|NCT04593706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92647556|NCT04593706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92647557|NCT04593706|Prednisolone|prednisolone|mesh-list
92647558|NCT04593706|Prednisolone acetate|prednisolone acetate|mesh-list
92647559|NCT04593706|Triamcinolone|triamcinolone|mesh-list
92647560|NCT04593706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92647561|NCT04593706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92647562|NCT04593706|Betamethasone|betamethasone|mesh-list
92647563|NCT04593706|Betamethasone Valerate|betamethasone valerate|mesh-list
92647564|NCT04593706|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92647565|NCT04593706|Betamethasone benzoate|betamethasone benzoate|mesh-list
92647566|NCT04593706|Dexamethasone acetate|dexamethasone acetate|mesh-list
92563098|NCT00155350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563099|NCT00155350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563100|NCT00051155|Timolol|timolol|mesh-list
92563101|NCT00051155|Travoprost|travoprost|mesh-list
92563102|NCT00051155|Latanoprost|latanoprost|mesh-list
92563103|NCT00051155|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92563104|NCT00051155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92563105|NCT00051155|Adrenergic Agents|adrenergic agents|mesh-ancestor
92647567|NCT04593706|Betamethasone acetate|betamethasone acetate|mesh-list
92647568|NCT04593706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92647569|NCT04593706|Prednisolone phosphate|prednisolone phosphate|mesh-list
92647570|NCT04593706|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92647571|NCT04593706|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92647572|NCT04593706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92647573|NCT04593706|BB 1101|bb 1101|mesh-list
92647574|NCT04593706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647575|NCT04593706|Antiemetics|antiemetics|mesh-ancestor
92647576|NCT04593706|Autonomic Agents|autonomic agents|mesh-ancestor
92647577|NCT04593706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647578|NCT04593706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647579|NCT04593706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647580|NCT04593706|Glucocorticoids|glucocorticoids|mesh-ancestor
92647581|NCT04593706|Hormones|hormones|mesh-ancestor
92647582|NCT04593706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647583|NCT04593706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92054785|NCT01822899|Fluticasone|fluticasone|mesh-list
92647586|NCT04593706|Protective Agents|protective agents|mesh-ancestor
92647587|NCT04593706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647588|NCT04593706|Immunologic Factors|immunologic factors|mesh-ancestor
92647589|NCT04593706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647590|NCT04593706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647591|NCT04593706|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92647592|NCT04593706|Respiratory System Agents|respiratory system agents|mesh-ancestor
92647593|NCT04593706|Protease Inhibitors|protease inhibitors|mesh-ancestor
92647594|NCT04593238|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92647595|NCT04593238|Calcium|calcium|mesh-list
92647596|NCT04593238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92647597|NCT04593238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647598|NCT04593238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647599|NCT04593160|Acetaminophen|acetaminophen|mesh-list
92647600|NCT04593160|Diclofenac|diclofenac|mesh-list
92647601|NCT04593160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92647602|NCT04593160|Analgesics|analgesics|mesh-ancestor
92647603|NCT04593160|Sensory System Agents|sensory system agents|mesh-ancestor
92647604|NCT04593160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647605|NCT04593160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647606|NCT04593160|Antipyretics|antipyretics|mesh-ancestor
92647607|NCT04593160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92647608|NCT04593160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647609|NCT04593160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92647610|NCT04593160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92647611|NCT04593160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647612|NCT04593160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647613|NCT00253149|Risperidone|risperidone|mesh-list
92647614|NCT00253149|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92647615|NCT00253149|Serotonin Agents|serotonin agents|mesh-ancestor
92647616|NCT00253149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647617|NCT00253149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647618|NCT00253149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647619|NCT00253149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92647620|NCT00253149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647621|NCT00253149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647622|NCT00253149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647623|NCT00253149|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92647624|NCT00253149|Dopamine Agents|dopamine agents|mesh-ancestor
92647625|NCT04539236|Lenalidomide|lenalidomide|mesh-list
92647626|NCT04539236|Luspatercept|luspatercept|mesh-list
92647627|NCT04539236|Immunologic Factors|immunologic factors|mesh-ancestor
92647628|NCT04539236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563106|NCT00051155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563107|NCT00051155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563108|NCT00051155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563109|NCT00051155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92563110|NCT00051155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92563111|NCT00051155|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92563112|NCT00051155|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92563113|NCT00083538|Thalidomide|thalidomide|mesh-list
92563114|NCT00083538|Dexamethasone|dexamethasone|mesh-list
92563115|NCT00083538|Cyclophosphamide|cyclophosphamide|mesh-list
92563116|NCT00083538|Etoposide|etoposide|mesh-list
92563117|NCT00083538|Doxorubicin|doxorubicin|mesh-list
92563118|NCT00083538|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92563119|NCT00083538|Cisplatin|cisplatin|mesh-list
92563120|NCT00083538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563121|NCT00083538|Immunologic Factors|immunologic factors|mesh-ancestor
92563122|NCT00083538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647629|NCT04539236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647630|NCT04539236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647631|NCT04539236|Growth Substances|growth substances|mesh-ancestor
92647632|NCT04539236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647633|NCT04539236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647634|NCT04539236|Hematinics|hematinics|mesh-ancestor
92647635|NCT00249483|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92647636|NCT00249483|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92647637|NCT00249483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92647638|NCT00249483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92647639|NCT00249483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647640|NCT00249483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647641|NCT00249483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647642|NCT00249483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92647643|NCT00249483|Antidepressive Agents|antidepressive agents|mesh-ancestor
92647644|NCT00249483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647646|NCT00567034|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92647647|NCT00567034|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92647648|NCT00567034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647649|NCT00567034|Sensory System Agents|sensory system agents|mesh-ancestor
92647650|NCT00567034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647651|NCT04484363|Azacitidine|azacitidine|mesh-list
92647652|NCT04484363|Pevonedistat|pevonedistat|mesh-list
92647653|NCT04484363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92647654|NCT04484363|Antimetabolites|antimetabolites|mesh-ancestor
92647655|NCT04484363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647656|NCT04484363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647669|NCT00253188|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92647670|NCT00253188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647671|NCT00253188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647672|NCT00253188|Cholinergic Agents|cholinergic agents|mesh-ancestor
92647673|NCT00253188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647674|NCT00253188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647675|NCT00253188|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92647676|NCT00253188|Autonomic Agents|autonomic agents|mesh-ancestor
92647677|NCT00253188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647678|NCT00253188|Nootropic Agents|nootropic agents|mesh-ancestor
92647679|NCT04591990|Hydrocortisone|hydrocortisone|mesh-list
92647680|NCT04591990|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92647681|NCT04591990|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92647682|NCT04591990|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92563123|NCT00083538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563124|NCT00083538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92563125|NCT00083538|Alkylating Agents|alkylating agents|mesh-ancestor
92563126|NCT00083538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563127|NCT00083538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563128|NCT00083538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91970523|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
92647683|NCT04591990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647684|NCT04438265|Levobupivacaine|levobupivacaine|mesh-list
92647685|NCT04438265|Anesthetics, Local|anesthetics, local|mesh-ancestor
92647686|NCT04438265|Anesthetics|anesthetics|mesh-ancestor
92647687|NCT04438265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647688|NCT04438265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647689|NCT04438265|Sensory System Agents|sensory system agents|mesh-ancestor
92647690|NCT04438265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647691|NCT04591795|Diclofenac|diclofenac|mesh-list
92647692|NCT04591795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92647693|NCT04591795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92647694|NCT04591795|Analgesics|analgesics|mesh-ancestor
92647695|NCT04591795|Sensory System Agents|sensory system agents|mesh-ancestor
92647696|NCT04591795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647697|NCT04591795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647698|NCT04591795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647699|NCT04591795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92647700|NCT04591795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92647701|NCT04591795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647702|NCT04591795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647703|NCT04591639|Dapagliflozin|dapagliflozin|mesh-list
92647704|NCT04591639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92647705|NCT04591639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647706|NCT04591639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92647707|NCT04591639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647708|NCT04719585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92647709|NCT04719585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647710|NCT04719585|Analgesics|analgesics|mesh-ancestor
92647711|NCT04719585|Sensory System Agents|sensory system agents|mesh-ancestor
92647712|NCT04719585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647713|NCT04719585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92647714|NCT04719585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92054935|NCT01847313|Liraglutide|liraglutide|mesh-list
92647716|NCT04719585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647717|NCT04719585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647718|NCT04719585|Antidepressive Agents|antidepressive agents|mesh-ancestor
92647719|NCT04719585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647720|NCT04719585|Dopamine Agents|dopamine agents|mesh-ancestor
92647721|NCT04592029|Bevacizumab|bevacizumab|mesh-list
92647722|NCT04592029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647723|NCT04592029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647724|NCT04592029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647725|NCT04592029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647726|NCT04592029|Growth Substances|growth substances|mesh-ancestor
92647727|NCT04592029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647728|NCT04592029|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647729|NCT04409873|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92647730|NCT04409873|Listerine|listerine|mesh-list
92647731|NCT04409873|Cetylpyridinium|cetylpyridinium|mesh-list
92647732|NCT04409873|Chlorine dioxide|chlorine dioxide|mesh-list
92647733|NCT04409873|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92647734|NCT04409873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647735|NCT04409873|Dental Disinfectants|dental disinfectants|mesh-ancestor
92647736|NCT04409873|Disinfectants|disinfectants|mesh-ancestor
92647737|NCT00253227|Galantamine|galantamine|mesh-list
92647738|NCT00253227|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92647739|NCT00253227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647740|NCT00253227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647741|NCT00253227|Cholinergic Agents|cholinergic agents|mesh-ancestor
92563129|NCT00083538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563131|NCT00083538|Autonomic Agents|autonomic agents|mesh-ancestor
92563132|NCT00083538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647742|NCT00253227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647743|NCT00253227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647744|NCT00253227|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92647745|NCT00253227|Autonomic Agents|autonomic agents|mesh-ancestor
92647746|NCT00253227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647747|NCT00253227|Nootropic Agents|nootropic agents|mesh-ancestor
92647748|NCT04591444|Fluorides|fluorides|mesh-list
92647749|NCT04591444|Fluorides, Topical|fluorides, topical|mesh-list
92647750|NCT04591444|Cariostatic Agents|cariostatic agents|mesh-ancestor
92647751|NCT04591444|Protective Agents|protective agents|mesh-ancestor
92647752|NCT04591444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647753|NCT04591327|Anesthetics|anesthetics|mesh-list
92647754|NCT04591327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647755|NCT04591327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647756|NCT00253266|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92647757|NCT00253266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92647758|NCT00253266|Antidepressive Agents|antidepressive agents|mesh-ancestor
92647759|NCT00253266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647760|NCT00253266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92647761|NCT00253266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647762|NCT00253266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647763|NCT00253266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647764|NCT00253266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92647765|NCT00253266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92647766|NCT00253266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92647767|NCT00253266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647768|NCT00253266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647769|NCT00253266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92647770|NCT00253305|Terbinafine|terbinafine|mesh-list
92647771|NCT00253305|Naftifine|naftifine|mesh-list
92647772|NCT00253305|Antifungal Agents|antifungal agents|mesh-ancestor
92647773|NCT00253305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647774|NCT00253305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647775|NCT00253305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647776|NCT04591600|Ivermectin|ivermectin|mesh-list
92647777|NCT04591600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92647778|NCT04591600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647779|NCT04591405|Vaccines|vaccines|mesh-list
92647780|NCT04591405|Immunologic Factors|immunologic factors|mesh-ancestor
92647781|NCT04591405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647782|NCT04590742|Melatonin|melatonin|mesh-list
92647783|NCT04590742|Antioxidants|antioxidants|mesh-ancestor
92647784|NCT04590742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647785|NCT04590742|Protective Agents|protective agents|mesh-ancestor
92647786|NCT04590742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647787|NCT04590742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647788|NCT00253344|Docetaxel|docetaxel|mesh-list
92647792|NCT00253344|Antimitotic Agents|antimitotic agents|mesh-ancestor
92647793|NCT00253344|Mitosis Modulators|mitosis modulators|mesh-ancestor
92647794|NCT00253344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647795|NCT00253344|Immunologic Factors|immunologic factors|mesh-ancestor
92647796|NCT00253344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647797|NCT00253344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647798|NCT00253344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647799|NCT00253344|Growth Substances|growth substances|mesh-ancestor
92647800|NCT00253344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647801|NCT00567463|Fluticasone|fluticasone|mesh-list
92647802|NCT00567463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647803|NCT00567463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92647804|NCT00567463|Autonomic Agents|autonomic agents|mesh-ancestor
92647805|NCT00567463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647806|NCT00567463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647807|NCT00567463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92647808|NCT00567463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92647809|NCT00567463|Dermatologic Agents|dermatologic agents|mesh-ancestor
92647810|NCT00567463|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92647811|NCT00253422|Fulvestrant|fulvestrant|mesh-list
92563133|NCT00083538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563134|NCT00083538|Glucocorticoids|glucocorticoids|mesh-ancestor
92563135|NCT00083538|Hormones|hormones|mesh-ancestor
92563136|NCT00083538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647812|NCT00253422|Anastrozole|anastrozole|mesh-list
92647813|NCT00253422|Exemestane|exemestane|mesh-list
92647814|NCT00253422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92647815|NCT00253422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647816|NCT00253422|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92647817|NCT00253422|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92647818|NCT00253422|Hormone Antagonists|hormone antagonists|mesh-ancestor
92647819|NCT00253422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647820|NCT00253422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647821|NCT00253422|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92647822|NCT00253422|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92647823|NCT00253422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647824|NCT00253422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647825|NCT04590625|Carboplatin|carboplatin|mesh-list
92647826|NCT04590625|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92647827|NCT04590625|Apatinib|apatinib|mesh-list
92647828|NCT04590625|Cisplatin|cisplatin|mesh-list
92647829|NCT04590625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647830|NCT04590625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647831|NCT04590625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92647832|NCT04590625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647833|NCT00253461|Topotecan|topotecan|mesh-list
92647834|NCT00253461|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92647835|NCT00253461|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92647836|NCT00253461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92647837|NCT00253461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647838|NCT00253461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647839|NCT00253461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647840|NCT00253461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92647841|NCT04272242|Pyridoxine|pyridoxine|mesh-list
92647842|NCT04272242|Pyridoxal|pyridoxal|mesh-list
92647843|NCT04272242|Vitamin B 6|vitamin b 6|mesh-list
92647844|NCT04272242|Isoniazid|isoniazid|mesh-list
92647845|NCT04272242|Rifapentine|rifapentine|mesh-list
92647846|NCT04272242|Dolutegravir|dolutegravir|mesh-list
92647847|NCT04272242|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92647848|NCT04272242|Vitamins|vitamins|mesh-ancestor
92647849|NCT04272242|Micronutrients|micronutrients|mesh-ancestor
92647850|NCT04272242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647851|NCT04272242|Vitamin B Complex|vitamin b complex|mesh-ancestor
92647852|NCT04272242|Antitubercular Agents|antitubercular agents|mesh-ancestor
92647853|NCT04272242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92647854|NCT04272242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647855|NCT04272242|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92647856|NCT04272242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92647857|NCT04272242|Antimetabolites|antimetabolites|mesh-ancestor
92647858|NCT04272242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647859|NCT04272242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92647860|NCT04272242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92647861|NCT04272242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92647862|NCT04272242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647865|NCT04272242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92647866|NCT04272242|Leprostatic Agents|leprostatic agents|mesh-ancestor
92647867|NCT04244552|Doxorubicin|doxorubicin|mesh-list
92647868|NCT04244552|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92647869|NCT04244552|Pembrolizumab|pembrolizumab|mesh-list
92647870|NCT04244552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92647871|NCT04244552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647872|NCT04244552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92647873|NCT04244552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92647874|NCT04244552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647875|NCT04244552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647876|NCT04244552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647877|NCT04244552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92647878|NCT00567658|Esomeprazole|esomeprazole|mesh-list
92647879|NCT00567658|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92647880|NCT00567658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92647881|NCT00567658|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92563137|NCT00083538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92563138|NCT00083538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997400|NCT05052359|Lectins|lectins|mesh-list
92647882|NCT00567658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647883|NCT00567658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647884|NCT00567697|Ranibizumab|ranibizumab|mesh-list
92647885|NCT00567697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647886|NCT00567697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647887|NCT00567697|Growth Substances|growth substances|mesh-ancestor
92647888|NCT00567697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647889|NCT00567697|Growth Inhibitors|growth inhibitors|mesh-ancestor
92647890|NCT00567697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647892|NCT04589494|Tramadol|tramadol|mesh-list
92647893|NCT04589494|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92647894|NCT04589494|Narcotics|narcotics|mesh-ancestor
92647895|NCT04589494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647896|NCT04589494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647897|NCT04589494|Analgesics|analgesics|mesh-ancestor
92647898|NCT04589494|Sensory System Agents|sensory system agents|mesh-ancestor
92647899|NCT04589494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647900|NCT04589299|Immunoglobulins|immunoglobulins|mesh-list
92647901|NCT04589299|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92647902|NCT04589299|Antibodies|antibodies|mesh-list
92647903|NCT04589299|Immunologic Factors|immunologic factors|mesh-ancestor
92647904|NCT04589299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647905|NCT00253500|Epirubicin|epirubicin|mesh-list
92647906|NCT00253500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92647907|NCT00253500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647908|NCT00253500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92647909|NCT00253500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92647910|NCT00253500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647911|NCT00253500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647912|NCT04589143|Agomelatine|agomelatine|mesh-list
92647913|NCT04589143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92647914|NCT04589143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647915|NCT04589143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647916|NCT04588987|Apatinib|apatinib|mesh-list
92647917|NCT04588987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647918|NCT04588987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92647919|NCT04588987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647920|NCT04588987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647921|NCT00253539|Tamoxifen|tamoxifen|mesh-list
92647922|NCT00253539|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92647923|NCT00253539|Hormone Antagonists|hormone antagonists|mesh-ancestor
92647924|NCT00253539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647925|NCT00253539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647926|NCT00253539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92647927|NCT00253539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647928|NCT00253539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92647929|NCT00253539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92647930|NCT00253539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92647931|NCT04588636|Salicylic Acid|salicylic acid|mesh-list
92647932|NCT04588636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92647933|NCT04588636|Antifungal Agents|antifungal agents|mesh-ancestor
92647934|NCT04588636|Keratolytic Agents|keratolytic agents|mesh-ancestor
92647935|NCT04588636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92647942|NCT00567814|Antimetabolites|antimetabolites|mesh-ancestor
92647943|NCT00567814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647944|NCT00567814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647945|NCT00567814|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92647946|NCT00567814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647947|NCT00567814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647948|NCT00567814|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92647949|NCT00567814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92647950|NCT00567814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92647951|NCT00567814|GABA Modulators|gaba modulators|mesh-ancestor
92647952|NCT00567814|GABA Agents|gaba agents|mesh-ancestor
92647953|NCT00567814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647954|NCT04588090|Cisplatin|cisplatin|mesh-list
92647955|NCT04588090|Paclitaxel|paclitaxel|mesh-list
92647956|NCT04588090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563140|NCT00083538|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92563141|NCT00083538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647957|NCT04588090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92647958|NCT04588090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92647959|NCT04588090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92647960|NCT04588090|Mitosis Modulators|mitosis modulators|mesh-ancestor
92647961|NCT04588090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647962|NCT00253578|Sorafenib|sorafenib|mesh-list
92647963|NCT00253578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647964|NCT00253578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92647965|NCT00253578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647966|NCT00253578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647967|NCT04588285|Ambroxol|ambroxol|mesh-list
92647968|NCT04588285|Expectorants|expectorants|mesh-ancestor
92647969|NCT04588285|Respiratory System Agents|respiratory system agents|mesh-ancestor
92647970|NCT04153565|Pembrolizumab|pembrolizumab|mesh-list
92647971|NCT04153565|Pemetrexed|pemetrexed|mesh-list
92647972|NCT04153565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647973|NCT04153565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647974|NCT04153565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92647975|NCT04153565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647976|NCT04153565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647977|NCT04153565|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92647978|NCT04153565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92647979|NCT04588324|Antineoplastic Agents|antineoplastic agents|mesh-list
92647980|NCT00253617|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92647981|NCT00253617|Trioxsalen|trioxsalen|mesh-list
92647982|NCT00253617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647983|NCT00253617|Dermatologic Agents|dermatologic agents|mesh-ancestor
92647984|NCT00253617|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92647985|NCT04587778|Ketamine|ketamine|mesh-list
92647986|NCT04587778|Esketamine|esketamine|mesh-list
92647987|NCT04587778|Analgesics|analgesics|mesh-ancestor
92647988|NCT04587778|Sensory System Agents|sensory system agents|mesh-ancestor
92647989|NCT04587778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92647990|NCT04587778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647991|NCT04587778|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92647992|NCT04587778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92647993|NCT04587778|Anesthetics, General|anesthetics, general|mesh-ancestor
92647994|NCT04587778|Anesthetics|anesthetics|mesh-ancestor
92647995|NCT04587778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92647996|NCT04587778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92647997|NCT04587778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92647998|NCT04587778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647999|NCT04587778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648000|NCT04587778|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648001|NCT04587778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648002|NCT04587505|Morphine|morphine|mesh-list
92648003|NCT04587505|Tramadol|tramadol|mesh-list
92648004|NCT04587505|Anesthetics|anesthetics|mesh-list
92648005|NCT04587505|Ropivacaine|ropivacaine|mesh-list
92648006|NCT04587505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648007|NCT04587505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648020|NCT04128683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648021|NCT04128683|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92648022|NCT04128683|Dopamine Agents|dopamine agents|mesh-ancestor
92648023|NCT04128683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648024|NCT04128683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648025|NCT04128683|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92648026|NCT04128683|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648027|NCT04128683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92648028|NCT04128683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92648029|NCT04128683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92648030|NCT04128683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648031|NCT04128683|Dopamine Agonists|dopamine agonists|mesh-ancestor
92648032|NCT04587115|Oxycodone|oxycodone|mesh-list
92648033|NCT04587115|Risperidone|risperidone|mesh-list
92648034|NCT04587115|Ziprasidone|ziprasidone|mesh-list
92648035|NCT04587115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92648036|NCT04587115|Narcotics|narcotics|mesh-ancestor
92648037|NCT04587115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563142|NCT00083538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92563143|NCT00083538|Leprostatic Agents|leprostatic agents|mesh-ancestor
92563144|NCT00083538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92648038|NCT04587115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648039|NCT04587115|Analgesics|analgesics|mesh-ancestor
92648040|NCT04587115|Sensory System Agents|sensory system agents|mesh-ancestor
92648041|NCT04587115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648042|NCT04587115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92648043|NCT04587115|Serotonin Agents|serotonin agents|mesh-ancestor
92648044|NCT04587115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648045|NCT04587115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648046|NCT04587115|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648047|NCT04587115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648048|NCT04587115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648049|NCT04587115|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92648050|NCT04587115|Dopamine Agents|dopamine agents|mesh-ancestor
92648051|NCT00403247|Vitamin B 12|vitamin b 12|mesh-list
92648052|NCT00403247|Hydroxocobalamin|hydroxocobalamin|mesh-list
92648053|NCT00403247|Pyridoxine|pyridoxine|mesh-list
92648054|NCT00403247|Vitamins|vitamins|mesh-ancestor
92648055|NCT00403247|Micronutrients|micronutrients|mesh-ancestor
92648056|NCT00403247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648057|NCT00403247|Vitamin B Complex|vitamin b complex|mesh-ancestor
92648058|NCT00403247|Hematinics|hematinics|mesh-ancestor
92648059|NCT00253773|Acetaminophen|acetaminophen|mesh-list
92648060|NCT00253773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92648061|NCT00253773|Analgesics|analgesics|mesh-ancestor
92648062|NCT00253773|Sensory System Agents|sensory system agents|mesh-ancestor
92648063|NCT00253773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648064|NCT00253773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648065|NCT00253773|Antipyretics|antipyretics|mesh-ancestor
92648066|NCT00403286|Fluticasone|fluticasone|mesh-list
92648067|NCT00403286|Xhance|xhance|mesh-list
92648068|NCT00403286|Formoterol Fumarate|formoterol fumarate|mesh-list
92648069|NCT00403286|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92648070|NCT00403286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648071|NCT00403286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92648072|NCT00403286|Autonomic Agents|autonomic agents|mesh-ancestor
92648073|NCT00403286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682823|NCT00438230|Anticoagulants|anticoagulants|mesh-ancestor
92648078|NCT00403286|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92648079|NCT00403286|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92648080|NCT00403286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92648081|NCT00403286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92648082|NCT00403286|Adrenergic Agents|adrenergic agents|mesh-ancestor
92648083|NCT00403286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648084|NCT00403286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648085|NCT04586491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92648086|NCT04586218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92648087|NCT04585867|Bupivacaine|bupivacaine|mesh-list
92648088|NCT04585867|Anesthetics, Local|anesthetics, local|mesh-ancestor
92648089|NCT04585867|Anesthetics|anesthetics|mesh-ancestor
92648090|NCT04585867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648091|NCT04585867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648092|NCT04585867|Sensory System Agents|sensory system agents|mesh-ancestor
92648093|NCT04585867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648094|NCT00253851|Heparin|heparin|mesh-list
92648095|NCT00253851|Calcium heparin|calcium heparin|mesh-list
92648096|NCT00253851|Anticoagulants|anticoagulants|mesh-ancestor
92648097|NCT00253851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92648098|NCT00253851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92648099|NCT00253851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648100|NCT00249912|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92648101|NCT00249912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92648102|NCT00249912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92648103|NCT00249912|Antimetabolites|antimetabolites|mesh-ancestor
92648104|NCT00249912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648105|NCT00249912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92648106|NCT00249912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92648107|NCT00249912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648108|NCT04585438|Diclofenac|diclofenac|mesh-list
92648109|NCT04585438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92648110|NCT04585438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92648111|NCT04585438|Analgesics|analgesics|mesh-ancestor
92563145|NCT00083538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563146|NCT00083538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563147|NCT00083538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563148|NCT00083538|Growth Substances|growth substances|mesh-ancestor
92563149|NCT00083538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563150|NCT00083577|Thalidomide|thalidomide|mesh-list
92563151|NCT00083577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648112|NCT04585438|Sensory System Agents|sensory system agents|mesh-ancestor
92648113|NCT04585438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648114|NCT04585438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648115|NCT04585438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648116|NCT04585438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648117|NCT04585438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92648118|NCT04585438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648119|NCT04585438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648120|NCT00223223|Levetiracetam|levetiracetam|mesh-list
92648121|NCT00223223|Anticonvulsants|anticonvulsants|mesh-ancestor
92648122|NCT00223223|Nootropic Agents|nootropic agents|mesh-ancestor
92648123|NCT00567931|Tryptophan|tryptophan|mesh-list
92648124|NCT00567931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92648125|NCT00567931|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648126|NCT00567931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648127|NCT00223301|Mycophenolic Acid|mycophenolic acid|mesh-list
92648128|NCT00223301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92648129|NCT00223301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648130|NCT00223301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92648131|NCT00223301|Antitubercular Agents|antitubercular agents|mesh-ancestor
92648132|NCT00223301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92648133|NCT00223301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648134|NCT00223301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648135|NCT00223301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648136|NCT04585321|Diclofenac|diclofenac|mesh-list
92648137|NCT04585321|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92648138|NCT04585321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92648139|NCT04585321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92648140|NCT04585321|Analgesics|analgesics|mesh-ancestor
92648141|NCT04585321|Sensory System Agents|sensory system agents|mesh-ancestor
92648142|NCT04585321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648143|NCT04585321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648146|NCT04585321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92648147|NCT04585321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648148|NCT04585321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648149|NCT00412997|Panobinostat|panobinostat|mesh-list
92648150|NCT00412997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648151|NCT00412997|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92648152|NCT00412997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648153|NCT00412997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648154|NCT00253929|Adenosine|adenosine|mesh-list
92648155|NCT00253929|Nitroprusside|nitroprusside|mesh-list
92648156|NCT00253929|Acetylcholine|acetylcholine|mesh-list
92648157|NCT00253929|Caffeine|caffeine|mesh-list
92648158|NCT00253929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92648159|NCT00253929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648160|NCT00253929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92648161|NCT00253929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648162|NCT00253929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648163|NCT00253929|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92648164|NCT00253929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92648165|NCT00253929|Purinergic Agents|purinergic agents|mesh-ancestor
92648166|NCT00253929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648167|NCT00253929|Analgesics|analgesics|mesh-ancestor
92648168|NCT00253929|Sensory System Agents|sensory system agents|mesh-ancestor
92648169|NCT00253929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648170|NCT00253929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92648171|NCT00253929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92648172|NCT00253929|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92648173|NCT00253929|Purinergic Agonists|purinergic agonists|mesh-ancestor
92563152|NCT00083577|Immunologic Factors|immunologic factors|mesh-ancestor
92563153|NCT00083577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563154|NCT00083577|Leprostatic Agents|leprostatic agents|mesh-ancestor
92648174|NCT00253929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92648175|NCT00253929|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92648176|NCT00253929|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92648177|NCT00253929|Cholinergic Agents|cholinergic agents|mesh-ancestor
92648178|NCT00568048|Bevacizumab|bevacizumab|mesh-list
92648179|NCT00568048|Temozolomide|temozolomide|mesh-list
92648180|NCT00568048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92648181|NCT00568048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648182|NCT00568048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92648183|NCT00568048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648184|NCT00568048|Growth Substances|growth substances|mesh-ancestor
92648185|NCT00568048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648186|NCT00568048|Growth Inhibitors|growth inhibitors|mesh-ancestor
92648187|NCT00568048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92648188|NCT00568048|Alkylating Agents|alkylating agents|mesh-ancestor
92648189|NCT00568048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648190|NCT04584580|Heparin|heparin|mesh-list
92648191|NCT04584580|Enoxaparin|enoxaparin|mesh-list
92648192|NCT04584580|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92648193|NCT04584580|Tinzaparin|tinzaparin|mesh-list
92648194|NCT04584580|Dalteparin|dalteparin|mesh-list
92648195|NCT04584580|Anticoagulants|anticoagulants|mesh-ancestor
92648196|NCT04584580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92648197|NCT04584580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92648198|NCT04584580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648199|NCT00250029|Capecitabine|capecitabine|mesh-list
92648200|NCT00250029|Oxaliplatin|oxaliplatin|mesh-list
92648201|NCT00250029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92648202|NCT00250029|Antimetabolites|antimetabolites|mesh-ancestor
92648203|NCT00250029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648204|NCT00250029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648205|NCT00223418|Aripiprazole|aripiprazole|mesh-list
92648206|NCT00223418|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648207|NCT00223418|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648208|NCT00223418|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648209|NCT00223418|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648210|NCT00223418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648211|NCT00223418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648212|NCT00223418|Dopamine Agonists|dopamine agonists|mesh-ancestor
92648213|NCT00223418|Dopamine Agents|dopamine agents|mesh-ancestor
92648214|NCT00223418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648215|NCT00223418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648216|NCT00223418|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92648218|NCT00223418|Serotonin Agents|serotonin agents|mesh-ancestor
92648219|NCT00223418|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92648220|NCT00223418|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92648221|NCT00223418|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92648222|NCT00223418|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92648224|NCT04584736|Pitavastatin|pitavastatin|mesh-list
92648225|NCT04584736|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92648226|NCT04584736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92648227|NCT04584736|Antimetabolites|antimetabolites|mesh-ancestor
92648228|NCT04584736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648229|NCT04584736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92648230|NCT04584736|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92648231|NCT04584736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648232|NCT00250068|Rubitecan|rubitecan|mesh-list
92648233|NCT00250068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648234|NCT00250068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92648235|NCT00250068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92648236|NCT00250068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648237|NCT00250068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648238|NCT04584307|Pomalidomide|pomalidomide|mesh-list
92648239|NCT04584307|Elotuzumab|elotuzumab|mesh-list
92648240|NCT04584307|Immunologic Factors|immunologic factors|mesh-ancestor
92648241|NCT04584307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648242|NCT04584307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92648243|NCT04584307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648244|NCT04584307|Growth Substances|growth substances|mesh-ancestor
92563155|NCT00083577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563156|NCT00083577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563157|NCT00083577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563158|NCT00083577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648245|NCT04584307|Growth Inhibitors|growth inhibitors|mesh-ancestor
92648246|NCT04584307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648247|NCT04584034|Albuterol|albuterol|mesh-list
92648248|NCT04584034|Bronchodilator Agents|bronchodilator agents|mesh-list
92648249|NCT04584034|Autonomic Agents|autonomic agents|mesh-ancestor
92648250|NCT04584034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648251|NCT04584034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648252|NCT04584034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92648253|NCT04584034|Respiratory System Agents|respiratory system agents|mesh-ancestor
92648254|NCT04584034|Tocolytic Agents|tocolytic agents|mesh-ancestor
92648255|NCT04584034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92648256|NCT04584034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92648257|NCT04584034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92648258|NCT04584034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92648259|NCT04584034|Adrenergic Agents|adrenergic agents|mesh-ancestor
92648260|NCT04584034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648261|NCT04584034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648262|NCT04583410|Nicotine|nicotine|mesh-list
92648263|NCT04583410|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92648264|NCT04583410|Autonomic Agents|autonomic agents|mesh-ancestor
92648265|NCT04583410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648266|NCT04583410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648267|NCT04583410|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92648268|NCT04583410|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92648269|NCT04583410|Cholinergic Agents|cholinergic agents|mesh-ancestor
92648270|NCT04583410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648271|NCT04583410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648272|NCT00254007|Citalopram|citalopram|mesh-list
92648273|NCT00254007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92648274|NCT00254007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92648275|NCT00254007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648276|NCT00254007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648277|NCT00254007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648278|NCT00254007|Serotonin Agents|serotonin agents|mesh-ancestor
92648279|NCT00254007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648280|NCT00254007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92648281|NCT00254007|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648282|NCT00254007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648283|NCT00223613|Insulin|insulin|mesh-list
92648284|NCT00223613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648285|NCT00223613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648286|NCT04583137|Lidocaine|lidocaine|mesh-list
92648287|NCT04583137|Anesthetics, Local|anesthetics, local|mesh-ancestor
92648288|NCT04583137|Anesthetics|anesthetics|mesh-ancestor
92648289|NCT04583137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648293|NCT04583137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92648294|NCT04583137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92648295|NCT04583137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92648296|NCT04583137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648297|NCT04583137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648298|NCT00223691|Acarbose|acarbose|mesh-list
92648299|NCT00223691|Diphenhydramine|diphenhydramine|mesh-list
92648300|NCT00223691|Promethazine|promethazine|mesh-list
92648301|NCT00223691|Ibuprofen|ibuprofen|mesh-list
92648302|NCT00223691|Celecoxib|celecoxib|mesh-list
92648303|NCT00223691|Indomethacin|indomethacin|mesh-list
92648304|NCT00223691|Octreotide|octreotide|mesh-list
92648305|NCT00223691|Phenylephrine|phenylephrine|mesh-list
92648306|NCT00223691|Acetazolamide|acetazolamide|mesh-list
92648307|NCT00223691|Midodrine|midodrine|mesh-list
92648308|NCT00223691|Pseudoephedrine|pseudoephedrine|mesh-list
92648309|NCT00223691|Ephedrine|ephedrine|mesh-list
92648310|NCT00223691|Oxymetazoline|oxymetazoline|mesh-list
92648311|NCT00223691|Ergotamine|ergotamine|mesh-list
92648312|NCT00223691|Bromides|bromides|mesh-list
92648313|NCT00223691|Levodopa|levodopa|mesh-list
92648314|NCT00223691|Carbidopa|carbidopa|mesh-list
92648315|NCT00223691|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92648316|NCT00223691|Tranylcypromine|tranylcypromine|mesh-list
92648317|NCT00223691|Caffeine|caffeine|mesh-list
92563159|NCT00083577|Growth Substances|growth substances|mesh-ancestor
92563160|NCT00083577|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563161|NCT00083577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563162|NCT00154414|Liraglutide|liraglutide|mesh-list
92563163|NCT00154414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648318|NCT00223691|Methylphenidate|methylphenidate|mesh-list
92648319|NCT00223691|Modafinil|modafinil|mesh-list
92648320|NCT00223691|Rivastigmine|rivastigmine|mesh-list
92648321|NCT00223691|Ranitidine|ranitidine|mesh-list
92648322|NCT00223691|Yohimbine|yohimbine|mesh-list
92648323|NCT00223691|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92648324|NCT00223691|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92648325|NCT00223691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92648326|NCT00223691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92648327|NCT00223691|Analgesics|analgesics|mesh-ancestor
92648328|NCT00223691|Sensory System Agents|sensory system agents|mesh-ancestor
92648329|NCT00223691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648330|NCT00223691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648331|NCT00223691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648332|NCT00223691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648333|NCT00223691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92648334|NCT00223691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648335|NCT00223691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648336|NCT00223691|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92648337|NCT00223691|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92648338|NCT00223691|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92648339|NCT00223691|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92648340|NCT00223691|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92648341|NCT00223691|Purinergic Agents|purinergic agents|mesh-ancestor
92648342|NCT00223691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648343|NCT00223691|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92648344|NCT00223691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92648345|NCT00223691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648346|NCT00223691|Dopamine Agents|dopamine agents|mesh-ancestor
92648347|NCT00223691|Anticonvulsants|anticonvulsants|mesh-ancestor
92648348|NCT00223691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92648349|NCT00223691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92648350|NCT00223691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92648351|NCT00223691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92648352|NCT00223691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648353|NCT00223691|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92648354|NCT00223691|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92648355|NCT00223691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92648356|NCT00223691|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92648357|NCT00223691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92648358|NCT00223691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648359|NCT00223691|Anesthetics, Local|anesthetics, local|mesh-ancestor
92648360|NCT00223691|Anesthetics|anesthetics|mesh-ancestor
92648361|NCT00223691|Antiemetics|antiemetics|mesh-ancestor
92648362|NCT00223691|Autonomic Agents|autonomic agents|mesh-ancestor
92648363|NCT00223691|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92648364|NCT00223691|Histamine Antagonists|histamine antagonists|mesh-ancestor
92648369|NCT00223691|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92648370|NCT00223691|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92648371|NCT00223691|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92648373|NCT00223691|Tocolytic Agents|tocolytic agents|mesh-ancestor
92648374|NCT00223691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92648375|NCT00223691|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92648376|NCT00223691|Diuretics|diuretics|mesh-ancestor
92648377|NCT00223691|Natriuretic Agents|natriuretic agents|mesh-ancestor
92648378|NCT00223691|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92648379|NCT00223691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648380|NCT00223691|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92648381|NCT00223691|Cholinergic Agents|cholinergic agents|mesh-ancestor
92648382|NCT00223691|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92648383|NCT00223691|Protective Agents|protective agents|mesh-ancestor
92648384|NCT00223691|Sympathomimetics|sympathomimetics|mesh-ancestor
92648385|NCT00223691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92648386|NCT00223691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92648387|NCT00223691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92563164|NCT00154414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563165|NCT00154414|Incretins|incretins|mesh-ancestor
92563166|NCT00154414|Hormones|hormones|mesh-ancestor
92563167|NCT00154414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648388|NCT00223691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92648389|NCT00223691|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92373670|NCT01695330|Bortezomib|bortezomib|mesh-list
92648390|NCT00223691|Immunologic Factors|immunologic factors|mesh-ancestor
92648391|NCT00223691|Dopamine Agonists|dopamine agonists|mesh-ancestor
92648392|NCT00223691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92648393|NCT00223691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92648394|NCT00223691|Respiratory System Agents|respiratory system agents|mesh-ancestor
92648395|NCT00223691|Nasal Decongestants|nasal decongestants|mesh-ancestor
92648396|NCT00223691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92648397|NCT00223691|Mydriatics|mydriatics|mesh-ancestor
92648398|NCT00223691|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92648399|NCT00223691|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92648400|NCT00223691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92648401|NCT00223691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92648402|NCT00223691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92648403|NCT00223691|Urological Agents|urological agents|mesh-ancestor
92648404|NCT00223691|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648405|NCT00223691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648406|NCT00223691|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92648407|NCT00223691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92648408|NCT00223691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648409|NCT00223691|Oxytocics|oxytocics|mesh-ancestor
92648410|NCT00223691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92648411|NCT00223691|Serotonin Agents|serotonin agents|mesh-ancestor
92648412|NCT04583020|Temozolomide|temozolomide|mesh-list
92648413|NCT04583020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92648414|NCT04583020|Alkylating Agents|alkylating agents|mesh-ancestor
92648415|NCT04583020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648416|NCT04583020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648417|NCT04582552|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92648418|NCT04582552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648419|NCT04582552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648420|NCT04582552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648421|NCT04582786|Morphine|morphine|mesh-list
92648422|NCT04582786|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92648423|NCT04582786|Narcotics|narcotics|mesh-ancestor
92648424|NCT04582786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648425|NCT04582786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648426|NCT04582786|Analgesics|analgesics|mesh-ancestor
92648427|NCT04582786|Sensory System Agents|sensory system agents|mesh-ancestor
92648428|NCT04582786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648429|NCT00223769|Oxandrolone|oxandrolone|mesh-list
92648430|NCT00223769|Androgens|androgens|mesh-ancestor
92648431|NCT00223769|Hormones|hormones|mesh-ancestor
92648432|NCT00223769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648433|NCT00223769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648434|NCT00223769|Anabolic Agents|anabolic agents|mesh-ancestor
92648435|NCT04582084|Etanercept|etanercept|mesh-list
92648438|NCT04582084|Analgesics|analgesics|mesh-ancestor
92648439|NCT04582084|Sensory System Agents|sensory system agents|mesh-ancestor
92648440|NCT04582084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648441|NCT04582084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648442|NCT04582084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648443|NCT04582084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648444|NCT04582084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92648445|NCT04582084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648446|NCT04582084|Immunologic Factors|immunologic factors|mesh-ancestor
92648447|NCT00254046|Etravirine|etravirine|mesh-list
92648448|NCT00254046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92648449|NCT00254046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92648450|NCT00254046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648451|NCT00254046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648452|NCT00254046|Antiviral Agents|antiviral agents|mesh-ancestor
92648453|NCT00254046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648454|NCT00223925|Maribavir|maribavir|mesh-list
92648455|NCT00223925|Antiviral Agents|antiviral agents|mesh-ancestor
92648456|NCT00223925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563168|NCT00406744|Bevacizumab|bevacizumab|mesh-list
92563169|NCT00406744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91997970|NCT01949116|Folic Acid|folic acid|mesh-list
92648457|NCT00254085|Insulin Aspart|insulin aspart|mesh-list
92648458|NCT00254085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648459|NCT00254085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648460|NCT04581967|Cyclophosphamide|cyclophosphamide|mesh-list
92648461|NCT04581967|Doxorubicin|doxorubicin|mesh-list
92648462|NCT04581967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648463|NCT04581967|Immunologic Factors|immunologic factors|mesh-ancestor
92648464|NCT04581967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648465|NCT04581967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648466|NCT04581967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92648467|NCT04581967|Alkylating Agents|alkylating agents|mesh-ancestor
92648468|NCT04581967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648469|NCT04581967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648470|NCT04581967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92648471|NCT04581967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92648472|NCT04581967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92648473|NCT04581967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92648474|NCT04581967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648475|NCT00223964|Ferric gluconate|ferric gluconate|mesh-list
92648476|NCT00223964|Hematinics|hematinics|mesh-ancestor
92648477|NCT00224081|Ferric gluconate|ferric gluconate|mesh-list
92648478|NCT00224081|Hematinics|hematinics|mesh-ancestor
92648479|NCT04581265|Paclitaxel|paclitaxel|mesh-list
92648480|NCT04581265|Ifosfamide|ifosfamide|mesh-list
92648481|NCT04581265|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92648482|NCT04581265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92648483|NCT04581265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648484|NCT04581265|Tubulin Modulators|tubulin modulators|mesh-ancestor
92648485|NCT04581265|Antimitotic Agents|antimitotic agents|mesh-ancestor
92648486|NCT04581265|Mitosis Modulators|mitosis modulators|mesh-ancestor
92648487|NCT04581265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648488|NCT04581265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92648489|NCT04581265|Alkylating Agents|alkylating agents|mesh-ancestor
92648490|NCT04580797|PF-06700841|pf-06700841|mesh-list
92648491|NCT04580797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92648492|NCT04580797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648493|NCT04580797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648494|NCT00568477|Rituximab|rituximab|mesh-list
92648495|NCT00568477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92648496|NCT00568477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648497|NCT00568477|Immunologic Factors|immunologic factors|mesh-ancestor
92648498|NCT00568477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648499|NCT00568477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648500|NCT00568711|Doxycycline|doxycycline|mesh-list
92648501|NCT00568711|Rifampin|rifampin|mesh-list
92648502|NCT00568711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92648503|NCT00568711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648504|NCT00568711|Antimalarials|antimalarials|mesh-ancestor
92648505|NCT00568711|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92648506|NCT00568711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92648507|NCT00568711|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92648508|NCT00568711|Antitubercular Agents|antitubercular agents|mesh-ancestor
92648509|NCT00568711|Leprostatic Agents|leprostatic agents|mesh-ancestor
92648511|NCT00568711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648512|NCT00568711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648513|NCT00568711|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92648514|NCT00568711|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92648515|NCT00568711|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92648516|NCT00568711|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92648517|NCT00568711|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92648518|NCT00568711|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92648519|NCT00415116|Carboplatin|carboplatin|mesh-list
92648520|NCT00415116|Docetaxel|docetaxel|mesh-list
92648521|NCT00415116|Lenalidomide|lenalidomide|mesh-list
92648522|NCT00415116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648523|NCT00415116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92648524|NCT00415116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92648525|NCT00415116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92648526|NCT00415116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648527|NCT00415116|Immunologic Factors|immunologic factors|mesh-ancestor
92563170|NCT00406744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563171|NCT00406744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563172|NCT00406744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563173|NCT00406744|Growth Substances|growth substances|mesh-ancestor
92563174|NCT00406744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563175|NCT00406744|Growth Inhibitors|growth inhibitors|mesh-ancestor
91970565|NCT00703781|Bromfenac|bromfenac|mesh-list
92648528|NCT00415116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648529|NCT00415116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92648530|NCT00415116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648531|NCT00415116|Growth Substances|growth substances|mesh-ancestor
92648532|NCT00415116|Growth Inhibitors|growth inhibitors|mesh-ancestor
92648533|NCT00568750|Dasatinib|dasatinib|mesh-list
92648534|NCT00568750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648535|NCT00568750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92648536|NCT00568750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648537|NCT00568750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648538|NCT00568789|Zolpidem|zolpidem|mesh-list
92648539|NCT00568789|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92648540|NCT00568789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92648541|NCT00568789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648542|NCT00568789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648543|NCT00568789|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92648544|NCT00568789|GABA Agonists|gaba agonists|mesh-ancestor
92648545|NCT00568789|GABA Agents|gaba agents|mesh-ancestor
92648546|NCT00568789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648547|NCT00568789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648548|NCT00254202|Iloperidone|iloperidone|mesh-list
92648549|NCT00254202|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648550|NCT00254202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648551|NCT00254202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648552|NCT00254202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648553|NCT00254202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648554|NCT00568984|Metformin|metformin|mesh-list
92648555|NCT00568984|Repaglinide|repaglinide|mesh-list
92648556|NCT00568984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648557|NCT00568984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648558|NCT00254241|Risperidone|risperidone|mesh-list
92648559|NCT00254241|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92648560|NCT00254241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92648561|NCT00254241|Serotonin Agents|serotonin agents|mesh-ancestor
92648562|NCT00254241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648563|NCT00254241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648564|NCT00254241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648565|NCT00254241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648566|NCT00254241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648567|NCT00254241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648568|NCT00254241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648569|NCT00254241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92648570|NCT00254241|Dopamine Agents|dopamine agents|mesh-ancestor
92648571|NCT00254241|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648572|NCT00224315|Risperidone|risperidone|mesh-list
92648573|NCT00224315|Ziprasidone|ziprasidone|mesh-list
92648574|NCT00224315|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92648575|NCT00224315|Serotonin Agents|serotonin agents|mesh-ancestor
92648576|NCT00224315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648577|NCT00224315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648578|NCT00224315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648579|NCT00224315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648580|NCT00224315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648581|NCT00224315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648582|NCT00224315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648585|NCT00569101|Tacrolimus|tacrolimus|mesh-list
92648586|NCT00569101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648587|NCT00569101|Immunologic Factors|immunologic factors|mesh-ancestor
92648588|NCT00569101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648589|NCT00569101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92648590|NCT00569101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752332|NCT05940649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92563176|NCT00399750|Bevacizumab|bevacizumab|mesh-list
92563177|NCT00399750|Oxaliplatin|oxaliplatin|mesh-list
92563178|NCT00399750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92563179|NCT00399750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563180|NCT00399750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563181|NCT00399750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563182|NCT00399750|Growth Substances|growth substances|mesh-ancestor
92648591|NCT00569101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648592|NCT00224354|Interleukin-2|interleukin-2|mesh-list
92648593|NCT00224354|Denileukin diftitox|denileukin diftitox|mesh-list
92648594|NCT00224354|Immunotoxins|immunotoxins|mesh-list
92648595|NCT00224354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648596|NCT00224354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92648597|NCT00224354|Analgesics|analgesics|mesh-ancestor
92648598|NCT00224354|Sensory System Agents|sensory system agents|mesh-ancestor
92648599|NCT00224354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648600|NCT00224354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648601|NCT00224354|Immunoconjugates|immunoconjugates|mesh-ancestor
92648602|NCT00224354|Immunologic Factors|immunologic factors|mesh-ancestor
92648603|NCT00569296|Aldesleukin|aldesleukin|mesh-list
92648604|NCT00569296|Sargramostim|sargramostim|mesh-list
92648605|NCT00569296|Immunologic Factors|immunologic factors|mesh-ancestor
92648606|NCT00569296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648607|NCT00569296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648608|NCT00569296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92648609|NCT00569296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92648610|NCT00569296|Antiviral Agents|antiviral agents|mesh-ancestor
92648611|NCT00569296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648612|NCT00569335|Bevacizumab|bevacizumab|mesh-list
92648613|NCT00569335|Irinotecan|irinotecan|mesh-list
92648614|NCT00569335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92648615|NCT00569335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648616|NCT00569335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92648617|NCT00569335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648618|NCT00569335|Growth Substances|growth substances|mesh-ancestor
92648619|NCT00569335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648620|NCT00569335|Growth Inhibitors|growth inhibitors|mesh-ancestor
92648621|NCT00569335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92648622|NCT00569335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92648623|NCT00569335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952524|NCT01709981|Colchicine|colchicine|mesh-list
92648624|NCT00569335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648625|NCT00254319|Bevacizumab|bevacizumab|mesh-list
92648626|NCT00254319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92648627|NCT00254319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648628|NCT00254319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92648629|NCT00254319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648630|NCT00254319|Growth Substances|growth substances|mesh-ancestor
92648631|NCT00254319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648632|NCT00254319|Growth Inhibitors|growth inhibitors|mesh-ancestor
92648633|NCT00569452|Insulin|insulin|mesh-list
92648634|NCT00569452|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92648635|NCT00569452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648636|NCT00569452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648637|NCT00569881|Moxifloxacin|moxifloxacin|mesh-list
92648638|NCT00569881|Gatifloxacin|gatifloxacin|mesh-list
92648639|NCT00569881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92648640|NCT00569881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648641|NCT00569881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92648642|NCT00569881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92648643|NCT00569881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648644|NCT00569881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648645|NCT00569881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648646|NCT00569881|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92648647|NCT00569881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92648648|NCT00224471|Vaccines|vaccines|mesh-list
92648649|NCT00224471|Immunologic Factors|immunologic factors|mesh-ancestor
92648650|NCT00224471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648651|NCT00569920|Dexamethasone|dexamethasone|mesh-list
92563183|NCT00399750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563184|NCT00399750|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563185|NCT00044148|Ruboxistaurin|ruboxistaurin|mesh-list
92648652|NCT00569920|Dexamethasone acetate|dexamethasone acetate|mesh-list
92648653|NCT00569920|BB 1101|bb 1101|mesh-list
92648654|NCT00569920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648655|NCT00569920|Antiemetics|antiemetics|mesh-ancestor
92648656|NCT00569920|Autonomic Agents|autonomic agents|mesh-ancestor
92648657|NCT00569920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648658|NCT00569920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648662|NCT00569920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648663|NCT00569920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92648664|NCT00569920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648666|NCT00569920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648667|NCT00569920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648668|NCT00224510|Lamotrigine|lamotrigine|mesh-list
92648669|NCT00224510|Anticonvulsants|anticonvulsants|mesh-ancestor
92648670|NCT00224510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92648671|NCT00224510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648672|NCT00224510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648673|NCT00224510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92648674|NCT00224510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648675|NCT00224510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648676|NCT00224510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648677|NCT00224510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648678|NCT00224510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648679|NCT00224510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92648680|NCT00570193|Ranibizumab|ranibizumab|mesh-list
92648681|NCT00570193|Verteporfin|verteporfin|mesh-list
92648682|NCT00570193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92648683|NCT00570193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92648684|NCT00570193|Growth Substances|growth substances|mesh-ancestor
92648685|NCT00570193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648686|NCT00570193|Growth Inhibitors|growth inhibitors|mesh-ancestor
92648687|NCT00570193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648688|NCT00570193|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92648689|NCT00570193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92648690|NCT00224549|Amlodipine|amlodipine|mesh-list
92648691|NCT00224549|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92648692|NCT00224549|Irbesartan|irbesartan|mesh-list
92373988|NCT05316480|Nimotuzumab|nimotuzumab|mesh-list
92648693|NCT00224549|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92648694|NCT00224549|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92648695|NCT00224549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648696|NCT00224549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648697|NCT00224549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92648698|NCT00224549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648699|NCT00224549|Vasodilator Agents|vasodilator agents|mesh-ancestor
92648700|NCT00224549|Diuretics|diuretics|mesh-ancestor
92648701|NCT00224549|Natriuretic Agents|natriuretic agents|mesh-ancestor
92648702|NCT00224549|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92648703|NCT00224549|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92648704|NCT00224549|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92648705|NCT00570544|Tiotropium Bromide|tiotropium bromide|mesh-list
92648706|NCT00570544|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92648707|NCT00570544|Autonomic Agents|autonomic agents|mesh-ancestor
92648708|NCT00570544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648709|NCT00570544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648710|NCT00570544|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92648711|NCT00570544|Respiratory System Agents|respiratory system agents|mesh-ancestor
92648712|NCT00570544|Parasympatholytics|parasympatholytics|mesh-ancestor
92648713|NCT00570544|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92648714|NCT00570544|Cholinergic Agents|cholinergic agents|mesh-ancestor
92648715|NCT00570544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648716|NCT00570544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648717|NCT00254436|Epoetin Alfa|epoetin alfa|mesh-list
92648718|NCT00254436|Hematinics|hematinics|mesh-ancestor
92648719|NCT00224588|Ketamine|ketamine|mesh-list
92648720|NCT00224588|Analgesics|analgesics|mesh-ancestor
92648721|NCT00224588|Sensory System Agents|sensory system agents|mesh-ancestor
92648722|NCT00224588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563186|NCT00044148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563187|NCT00044148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563188|NCT00156286|Imatinib Mesylate|imatinib mesylate|mesh-list
92563189|NCT00156286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563190|NCT00156286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563191|NCT00156286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648723|NCT00224588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648724|NCT00224588|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92648725|NCT00224588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92648726|NCT00224588|Anesthetics, General|anesthetics, general|mesh-ancestor
92648727|NCT00224588|Anesthetics|anesthetics|mesh-ancestor
92648728|NCT00224588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648730|NCT00224588|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92648731|NCT00224588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648732|NCT00224588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648733|NCT00570622|Pioglitazone|pioglitazone|mesh-list
92648734|NCT00570622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648735|NCT00570622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648736|NCT00254475|Valsartan|valsartan|mesh-list
92648737|NCT00254475|Simvastatin|simvastatin|mesh-list
92648738|NCT00254475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92648739|NCT00254475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92648740|NCT00254475|Antimetabolites|antimetabolites|mesh-ancestor
92648741|NCT00254475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648742|NCT00254475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92648743|NCT00254475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92648744|NCT00254475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648745|NCT00254475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92648746|NCT00254475|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92648747|NCT00254475|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92648748|NCT00570856|Folic Acid|folic acid|mesh-list
92648749|NCT00570856|Hematinics|hematinics|mesh-ancestor
92648750|NCT00570856|Vitamin B Complex|vitamin b complex|mesh-ancestor
92648751|NCT00570856|Vitamins|vitamins|mesh-ancestor
92648752|NCT00570856|Micronutrients|micronutrients|mesh-ancestor
92648753|NCT00570856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648754|NCT00570934|Calcium, Dietary|calcium, dietary|mesh-list
92648755|NCT00570934|Cholecalciferol|cholecalciferol|mesh-list
92648756|NCT00570934|Vitamin D|vitamin d|mesh-list
92648757|NCT00570934|Calcium|calcium|mesh-list
92648758|NCT00570934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92648759|NCT00570934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648760|NCT00570934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92648761|NCT00570934|Vitamins|vitamins|mesh-ancestor
92648762|NCT00570934|Micronutrients|micronutrients|mesh-ancestor
92648763|NCT00254553|Methyltestosterone|methyltestosterone|mesh-list
92648764|NCT00254553|Testosterone|testosterone|mesh-list
92648765|NCT00254553|Testosterone undecanoate|testosterone undecanoate|mesh-list
92648766|NCT00254553|Testosterone enanthate|testosterone enanthate|mesh-list
92648767|NCT00254553|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92648768|NCT00254553|Androgens|androgens|mesh-ancestor
92648769|NCT00254553|Hormones|hormones|mesh-ancestor
92648770|NCT00254553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648771|NCT00254553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648772|NCT00254553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92648773|NCT00254553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648774|NCT00254553|Anabolic Agents|anabolic agents|mesh-ancestor
92648775|NCT00571129|Mitomycins|mitomycins|mesh-list
92648776|NCT00571129|Mitomycin|mitomycin|mesh-list
92648777|NCT00571129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92648778|NCT00571129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648779|NCT00571129|Alkylating Agents|alkylating agents|mesh-ancestor
92648780|NCT00571129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648781|NCT00571129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92648782|NCT00571129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648783|NCT03453931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92648784|NCT03453931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648785|NCT03453931|Glucocorticoids|glucocorticoids|mesh-ancestor
92648786|NCT03453931|Hormones|hormones|mesh-ancestor
92563192|NCT00156286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563193|NCT00156325|Escitalopram|escitalopram|mesh-list
92563194|NCT00156325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92563195|NCT00156325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92563196|NCT00156325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563197|NCT00156325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648787|NCT03453931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648788|NCT03453931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648789|NCT03453931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92648790|NCT03453931|Protective Agents|protective agents|mesh-ancestor
92648791|NCT03453931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92648792|NCT03453931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648793|NCT00571246|Topiramate|topiramate|mesh-list
92648794|NCT00571246|Lamotrigine|lamotrigine|mesh-list
92648795|NCT00571246|Anticonvulsants|anticonvulsants|mesh-ancestor
92648796|NCT00571246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648797|NCT00571246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648798|NCT00571246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92648799|NCT00571246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648800|NCT00571246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648801|NCT00571246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92648802|NCT00571246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648804|NCT00571246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648805|NCT00571246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648806|NCT00571246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92648807|NCT00254631|Oxycodone|oxycodone|mesh-list
92648808|NCT00254631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92648809|NCT00254631|Narcotics|narcotics|mesh-ancestor
92648810|NCT00254631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648811|NCT00254631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648812|NCT00254631|Analgesics|analgesics|mesh-ancestor
92648813|NCT00254631|Sensory System Agents|sensory system agents|mesh-ancestor
92648814|NCT00254631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648815|NCT00571285|Vitamin D|vitamin d|mesh-list
92648816|NCT00571285|Ergocalciferols|ergocalciferols|mesh-list
92648817|NCT00571285|Cholecalciferol|cholecalciferol|mesh-list
92648818|NCT00571285|Vitamins|vitamins|mesh-list
92648819|NCT00571285|Micronutrients|micronutrients|mesh-ancestor
92648820|NCT00571285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648821|NCT00571285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92648822|NCT00571285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92648823|NCT00571558|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92648824|NCT00571558|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92648825|NCT00571558|Dermatologic Agents|dermatologic agents|mesh-ancestor
92648826|NCT00571636|Fentanyl|fentanyl|mesh-list
92648827|NCT00571636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92648828|NCT00571636|Narcotics|narcotics|mesh-ancestor
92648829|NCT00571636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648830|NCT00571636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648831|NCT00571636|Analgesics|analgesics|mesh-ancestor
92648832|NCT00571636|Sensory System Agents|sensory system agents|mesh-ancestor
92648833|NCT00571636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648834|NCT00571636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92648835|NCT00571636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92648836|NCT00571636|Anesthetics, General|anesthetics, general|mesh-ancestor
92648837|NCT00571636|Anesthetics|anesthetics|mesh-ancestor
92374128|NCT01740258|Bevacizumab|bevacizumab|mesh-list
92648838|NCT00571675|Prednisone|prednisone|mesh-list
92648839|NCT00571675|Docetaxel|docetaxel|mesh-list
92648840|NCT00571675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648841|NCT00571675|Tubulin Modulators|tubulin modulators|mesh-ancestor
92648842|NCT00571675|Antimitotic Agents|antimitotic agents|mesh-ancestor
92648843|NCT00571675|Mitosis Modulators|mitosis modulators|mesh-ancestor
92648844|NCT00571675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648845|NCT00571675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648846|NCT00571675|Glucocorticoids|glucocorticoids|mesh-ancestor
92648847|NCT00571675|Hormones|hormones|mesh-ancestor
92752333|NCT05940649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92563198|NCT00156325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563199|NCT00156325|Serotonin Agents|serotonin agents|mesh-ancestor
92563200|NCT00156325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563202|NCT00156403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92563203|NCT00156403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92648848|NCT00571675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648849|NCT00571675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648850|NCT00571675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92648851|NCT00571714|Ribavirin|ribavirin|mesh-list
92648852|NCT00571714|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92648853|NCT00571714|Interferon-alpha|interferon-alpha|mesh-list
92648854|NCT00571714|Betaine|betaine|mesh-list
92648855|NCT00571714|Antimetabolites|antimetabolites|mesh-ancestor
92648856|NCT00571714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648857|NCT00571714|Antiviral Agents|antiviral agents|mesh-ancestor
92648858|NCT00571714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648859|NCT00571714|Immunologic Factors|immunologic factors|mesh-ancestor
92648860|NCT00571714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648861|NCT00571714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92648862|NCT00571714|Lipotropic Agents|lipotropic agents|mesh-ancestor
92648863|NCT00571714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92648864|NCT00571714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92648865|NCT00571753|Isoniazid|isoniazid|mesh-list
92648866|NCT00571753|Antitubercular Agents|antitubercular agents|mesh-ancestor
92648867|NCT00571753|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92648868|NCT00571753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648869|NCT00571753|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92648870|NCT00571753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92648871|NCT00571753|Antimetabolites|antimetabolites|mesh-ancestor
92648872|NCT00571753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648873|NCT00571753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92648874|NCT00254709|Sirolimus|sirolimus|mesh-list
92648875|NCT00254709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92648876|NCT00254709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648877|NCT00254709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92648878|NCT00254709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648883|NCT00224822|Aripiprazole|aripiprazole|mesh-list
92648884|NCT00224822|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648885|NCT00224822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648886|NCT00224822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648887|NCT00224822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648888|NCT00224822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648889|NCT00224822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648890|NCT00224822|Dopamine Agonists|dopamine agonists|mesh-ancestor
92648891|NCT00224822|Dopamine Agents|dopamine agents|mesh-ancestor
92648892|NCT00224822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648893|NCT00224822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648894|NCT00224822|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92648895|NCT00224822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92648896|NCT00224822|Serotonin Agents|serotonin agents|mesh-ancestor
92648897|NCT00224822|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92648898|NCT00224822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92648899|NCT00224822|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92648900|NCT00224822|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92648901|NCT00571870|Cetrorelix|cetrorelix|mesh-list
92648902|NCT00571870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92648903|NCT00571870|Fertility Agents|fertility agents|mesh-ancestor
92648904|NCT00571870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92648905|NCT00571870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648906|NCT00571870|Hormone Antagonists|hormone antagonists|mesh-ancestor
92648907|NCT00571870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648908|NCT00254748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92648909|NCT00254748|Antidepressive Agents|antidepressive agents|mesh-ancestor
92648910|NCT00254748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92648911|NCT00254748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648912|NCT00254748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648913|NCT00254748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648914|NCT00254748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970592|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648915|NCT00572026|Methylphenidate|methylphenidate|mesh-list
92648916|NCT00572026|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92648917|NCT00572026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648918|NCT00572026|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92648919|NCT00572026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92648920|NCT00572026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92648921|NCT00572026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648922|NCT00572026|Dopamine Agents|dopamine agents|mesh-ancestor
92648923|NCT00572026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92648924|NCT00572065|Cytarabine|cytarabine|mesh-list
92648925|NCT00572065|Arsenic Trioxide|arsenic trioxide|mesh-list
92648926|NCT00572065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92648927|NCT00572065|Antimetabolites|antimetabolites|mesh-ancestor
92648928|NCT00572065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648929|NCT00572065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648930|NCT00572065|Antiviral Agents|antiviral agents|mesh-ancestor
92648931|NCT00572065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648932|NCT00572065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648933|NCT00572065|Immunologic Factors|immunologic factors|mesh-ancestor
92648934|NCT00572065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648935|NCT00234897|Adalimumab|adalimumab|mesh-list
92648936|NCT00234897|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92648937|NCT00234897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648938|NCT00234897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648939|NCT00572182|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92648940|NCT00572182|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92648941|NCT00572182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648942|NCT00572182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648943|NCT00572299|Alendronate|alendronate|mesh-list
92648944|NCT00572299|Prednisone|prednisone|mesh-list
92648945|NCT00572299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648946|NCT00572299|Glucocorticoids|glucocorticoids|mesh-ancestor
92648947|NCT00572299|Hormones|hormones|mesh-ancestor
92648949|NCT00572299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648950|NCT00572299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92648951|NCT00572299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648952|NCT00572299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92648953|NCT00234936|Adalimumab|adalimumab|mesh-list
92648954|NCT00234936|Methotrexate|methotrexate|mesh-list
92648955|NCT00234936|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92648956|NCT00234936|Abortifacient Agents|abortifacient agents|mesh-ancestor
92648957|NCT00234936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92648958|NCT00234936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648959|NCT00234936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92648960|NCT00234936|Antimetabolites|antimetabolites|mesh-ancestor
92648961|NCT00234936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648962|NCT00234936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648963|NCT00234936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92648964|NCT00234936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648965|NCT00234936|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92648966|NCT00234936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648967|NCT00234936|Immunologic Factors|immunologic factors|mesh-ancestor
92648968|NCT00234936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648969|NCT00234936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92648970|NCT00234936|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92648971|NCT00234936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648972|NCT00413075|Belinostat|belinostat|mesh-list
92648973|NCT00413075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92648974|NCT00413075|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92648975|NCT00413075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648976|NCT00413075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648977|NCT00572650|Vildagliptin|vildagliptin|mesh-list
92648978|NCT00572650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648979|NCT00572650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648980|NCT00572650|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92648981|NCT00572650|Protease Inhibitors|protease inhibitors|mesh-ancestor
92648982|NCT00572650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92648983|NCT00572650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92648984|NCT00572689|Exenatide|exenatide|mesh-list
92648985|NCT00572689|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92752334|NCT05940649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92563204|NCT00156403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563205|NCT00156403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563206|NCT00156403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91970593|NCT02469545|Serotonin Agents|serotonin agents|mesh-ancestor
92648986|NCT00572689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648987|NCT00572689|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92648988|NCT00572689|Incretins|incretins|mesh-ancestor
92648989|NCT00572689|Hormones|hormones|mesh-ancestor
92374282|NCT01766466|Ticagrelor|ticagrelor|mesh-list
92648990|NCT00572689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92648991|NCT00572806|Insulin Aspart|insulin aspart|mesh-list
92648992|NCT00572806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92648993|NCT00572806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648994|NCT00224978|Chloroquine|chloroquine|mesh-list
92648995|NCT00224978|Amebicides|amebicides|mesh-ancestor
92648996|NCT00224978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92648997|NCT00224978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92648998|NCT00224978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92648999|NCT00224978|Antimalarials|antimalarials|mesh-ancestor
92649000|NCT00224978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649001|NCT00572884|Permethrin|permethrin|mesh-list
92649002|NCT00572884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649003|NCT00572884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649004|NCT00573001|Ritonavir|ritonavir|mesh-list
92649005|NCT00573001|Lopinavir|lopinavir|mesh-list
92649006|NCT00573001|Tenofovir|tenofovir|mesh-list
92649007|NCT00573001|Emtricitabine|emtricitabine|mesh-list
92649008|NCT00573001|Zidovudine|zidovudine|mesh-list
92649009|NCT00573001|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92649010|NCT00573001|Nevirapine|nevirapine|mesh-list
92649011|NCT00573001|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92649012|NCT00573001|Efavirenz|efavirenz|mesh-list
92649013|NCT00573001|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92649014|NCT00573001|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92649015|NCT00573001|Protease Inhibitors|protease inhibitors|mesh-ancestor
92649016|NCT00573001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649017|NCT00573001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649018|NCT00573001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92649019|NCT00573001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92649021|NCT00573001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649022|NCT00573001|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92649023|NCT00573001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92649024|NCT00573001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92363764|NCT04365582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649025|NCT00573001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92649026|NCT00573001|Antimetabolites|antimetabolites|mesh-ancestor
92649027|NCT00573001|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92649028|NCT00573001|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92649029|NCT00573001|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92649030|NCT00573001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92649031|NCT00573001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92649032|NCT00254787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92649033|NCT00254787|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649034|NCT00254787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649035|NCT00254787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92649036|NCT00254787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649037|NCT00254787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649038|NCT00254787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649039|NCT00225056|Docetaxel|docetaxel|mesh-list
92649040|NCT00225056|Capecitabine|capecitabine|mesh-list
92649041|NCT00225056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649042|NCT00225056|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649043|NCT00225056|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649044|NCT00225056|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649045|NCT00225056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649046|NCT00225056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92649047|NCT00225056|Antimetabolites|antimetabolites|mesh-ancestor
92649048|NCT00225173|Prednisone|prednisone|mesh-list
92649049|NCT00225173|Cyclophosphamide|cyclophosphamide|mesh-list
92649050|NCT00225173|Gemcitabine|gemcitabine|mesh-list
92649051|NCT00225173|Doxorubicin|doxorubicin|mesh-list
92649052|NCT00225173|Etoposide|etoposide|mesh-list
92563207|NCT00156403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563208|NCT00156403|Vasodilator Agents|vasodilator agents|mesh-ancestor
92563209|NCT00051272|Bupropion|bupropion|mesh-list
92563210|NCT00051272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92563211|NCT00051272|Antidepressive Agents|antidepressive agents|mesh-ancestor
92563212|NCT00051272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649053|NCT00225173|Etoposide phosphate|etoposide phosphate|mesh-list
92649054|NCT00225173|Vincristine|vincristine|mesh-list
92649055|NCT00225173|Vinorelbine|vinorelbine|mesh-list
92649056|NCT00225173|Bleomycin|bleomycin|mesh-list
92649057|NCT00225173|Vinblastine|vinblastine|mesh-list
92649058|NCT00225173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92649059|NCT00225173|Immunologic Factors|immunologic factors|mesh-ancestor
92649060|NCT00225173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649061|NCT00225173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649062|NCT00225173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92649063|NCT00225173|Alkylating Agents|alkylating agents|mesh-ancestor
92649064|NCT00225173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649065|NCT00225173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649066|NCT00225173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92649067|NCT00225173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92649068|NCT00225173|Antimetabolites|antimetabolites|mesh-ancestor
92649069|NCT00225173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92649070|NCT00225173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92649071|NCT00225173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92649072|NCT00225173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649073|NCT00225173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649074|NCT00225173|Glucocorticoids|glucocorticoids|mesh-ancestor
92649076|NCT00225173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649077|NCT00225173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92649078|NCT00225173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92649079|NCT00225173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649080|NCT00225173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649081|NCT00225173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649082|NCT00234975|Ritonavir|ritonavir|mesh-list
92649083|NCT00234975|Lopinavir|lopinavir|mesh-list
92649084|NCT00234975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92649085|NCT00234975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92649086|NCT00234975|Protease Inhibitors|protease inhibitors|mesh-ancestor
92649087|NCT00234975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649088|NCT00234975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649089|NCT00234975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92649090|NCT00234975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92649091|NCT00234975|Antiviral Agents|antiviral agents|mesh-ancestor
92649092|NCT00234975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649093|NCT00234975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92649094|NCT00234975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92649096|NCT00235014|Trandolapril|trandolapril|mesh-list
92649097|NCT00235014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92649098|NCT00235014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92649099|NCT00235014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649100|NCT00235014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649101|NCT00235014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92649102|NCT00235014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649103|NCT00235014|Vasodilator Agents|vasodilator agents|mesh-ancestor
92649104|NCT00235014|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92649105|NCT00235014|Protease Inhibitors|protease inhibitors|mesh-ancestor
92649106|NCT00235014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649107|NCT00235014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649108|NCT00225290|Thalidomide|thalidomide|mesh-list
92649109|NCT00225290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92649110|NCT00225290|Immunologic Factors|immunologic factors|mesh-ancestor
92649111|NCT00225290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649112|NCT00225290|Leprostatic Agents|leprostatic agents|mesh-ancestor
92649113|NCT00225290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649114|NCT00225290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649115|NCT00225290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92649116|NCT00225290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563214|NCT00051272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92563215|NCT00051272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92563216|NCT00051272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563217|NCT00051272|Dopamine Agents|dopamine agents|mesh-ancestor
92563218|NCT00051272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563219|NCT00051272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970608|NCT03308201|Letrozole|letrozole|mesh-list
92649117|NCT00225290|Growth Substances|growth substances|mesh-ancestor
92649118|NCT00225290|Growth Inhibitors|growth inhibitors|mesh-ancestor
92649119|NCT00225290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649120|NCT00573547|Fluoxetine|fluoxetine|mesh-list
92649121|NCT00573547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92649122|NCT00573547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649123|NCT00573547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649124|NCT00573547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649125|NCT00573547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649126|NCT00573547|Serotonin Agents|serotonin agents|mesh-ancestor
92649127|NCT00573547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649128|NCT00573547|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92649129|NCT00573547|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649130|NCT00573547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649131|NCT00573547|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92649132|NCT00573547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92649133|NCT00573547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649134|NCT00573664|Gabapentin|gabapentin|mesh-list
92649135|NCT00573664|Analgesics|analgesics|mesh-ancestor
92649136|NCT00573664|Sensory System Agents|sensory system agents|mesh-ancestor
92649137|NCT00573664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649138|NCT00573664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649139|NCT00573664|Anticonvulsants|anticonvulsants|mesh-ancestor
92649140|NCT00573664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92649141|NCT00573664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649142|NCT00573664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649143|NCT00573664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649144|NCT00573664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92649145|NCT00573664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92649146|NCT00573664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649147|NCT00573664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649148|NCT00573664|Antimanic Agents|antimanic agents|mesh-ancestor
92649149|NCT00573742|Candesartan|candesartan|mesh-list
92649150|NCT00573742|Candesartan cilexetil|candesartan cilexetil|mesh-list
92649151|NCT00573742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649152|NCT00573742|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92649153|NCT00573742|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92649154|NCT00573742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649155|NCT00254865|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92649156|NCT00254865|Norelgestromin|norelgestromin|mesh-list
92649157|NCT00254865|Contraceptive Agents|contraceptive agents|mesh-list
92649158|NCT00254865|Estradiol|estradiol|mesh-list
92649159|NCT00254865|Estrogens|estrogens|mesh-ancestor
92649160|NCT00254865|Hormones|hormones|mesh-ancestor
92649161|NCT00254865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649162|NCT00254865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649163|NCT00254865|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92649164|NCT00254865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92649165|NCT00254865|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92649166|NCT00254865|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92649170|NCT00235053|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92649171|NCT00235053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649172|NCT00235053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92649173|NCT00235053|Autonomic Agents|autonomic agents|mesh-ancestor
92649174|NCT00235053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563220|NCT00051272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92563221|NCT00051272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92563222|NCT00051272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563223|NCT00044187|Sibutramine|sibutramine|mesh-list
92563224|NCT00044187|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649175|NCT00235053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649176|NCT00235053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92649177|NCT00235053|Respiratory System Agents|respiratory system agents|mesh-ancestor
92649178|NCT00235053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92649179|NCT00235053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92649180|NCT00235053|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92649181|NCT00235053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92649182|NCT00235053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92649183|NCT00235053|Adrenergic Agents|adrenergic agents|mesh-ancestor
92649184|NCT00235053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649185|NCT00235053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649186|NCT00235053|Glucocorticoids|glucocorticoids|mesh-ancestor
92649188|NCT00235053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649189|NCT00235053|Sympathomimetics|sympathomimetics|mesh-ancestor
92649190|NCT00574015|Acetaminophen|acetaminophen|mesh-list
92649191|NCT00574015|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92649192|NCT00574015|Hydrocodone|hydrocodone|mesh-list
92649193|NCT00574015|Bupivacaine|bupivacaine|mesh-list
92649194|NCT00574015|Anesthetics, Local|anesthetics, local|mesh-ancestor
92649195|NCT00574015|Anesthetics|anesthetics|mesh-ancestor
92649196|NCT00574015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649197|NCT00574015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649198|NCT00574015|Sensory System Agents|sensory system agents|mesh-ancestor
92649199|NCT00574015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649200|NCT00574015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92649201|NCT00574015|Analgesics|analgesics|mesh-ancestor
92649202|NCT00574015|Antipyretics|antipyretics|mesh-ancestor
92649203|NCT00574015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92649204|NCT00574015|Narcotics|narcotics|mesh-ancestor
92649205|NCT00574015|Antitussive Agents|antitussive agents|mesh-ancestor
92649206|NCT00574015|Respiratory System Agents|respiratory system agents|mesh-ancestor
92649207|NCT00574015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92649208|NCT00574015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649209|NCT00574015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649210|NCT00225485|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92649211|NCT00225485|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92374508|NCT01809054|Antipyretics|antipyretics|mesh-ancestor
92649212|NCT00225485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649213|NCT00225485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649214|NCT00225485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649215|NCT00225485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649216|NCT00225485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649217|NCT00225485|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92649218|NCT00225485|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649219|NCT00225485|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649221|NCT00574093|Verteporfin|verteporfin|mesh-list
92649222|NCT00574093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92649223|NCT00574093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92649224|NCT00574093|Growth Substances|growth substances|mesh-ancestor
92649225|NCT00574093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649226|NCT00574093|Growth Inhibitors|growth inhibitors|mesh-ancestor
92649227|NCT00574093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649228|NCT00574093|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92649229|NCT00574093|Dermatologic Agents|dermatologic agents|mesh-ancestor
92649231|NCT00574366|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92649232|NCT00574366|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92649233|NCT00574366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92649234|NCT00574366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649235|NCT00574366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649236|NCT00574366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92649237|NCT00574366|Immunologic Factors|immunologic factors|mesh-ancestor
92649255|NCT00574483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563225|NCT00044187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563226|NCT00044187|Appetite Depressants|appetite depressants|mesh-ancestor
92563227|NCT00044187|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92563229|NCT00156520|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92649257|NCT00574483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92649258|NCT00574483|Antinematodal Agents|antinematodal agents|mesh-ancestor
92649259|NCT00574483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649260|NCT00574483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649261|NCT00574483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649262|NCT00235092|Sirolimus|sirolimus|mesh-list
92649263|NCT00235092|Paclitaxel|paclitaxel|mesh-list
92649264|NCT00235092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92649265|NCT00235092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649266|NCT00235092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649267|NCT00235092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649268|NCT00235092|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649269|NCT00235092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649270|NCT00235092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649271|NCT00235092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649272|NCT00235092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92649273|NCT00235092|Antifungal Agents|antifungal agents|mesh-ancestor
92649274|NCT00235092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92649275|NCT00235092|Immunologic Factors|immunologic factors|mesh-ancestor
92649276|NCT00235092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649277|NCT00574600|Vaccines|vaccines|mesh-list
92649278|NCT00574600|Immunologic Factors|immunologic factors|mesh-ancestor
92649279|NCT00574600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649280|NCT00574639|Alprazolam|alprazolam|mesh-list
92649281|NCT00574639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92649282|NCT00574639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649283|NCT00574639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649284|NCT00574639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92649285|NCT00574639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649286|NCT00574639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649287|NCT00574639|GABA Modulators|gaba modulators|mesh-ancestor
92649289|NCT00574639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649290|NCT00574639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649291|NCT00255255|Budesonide|budesonide|mesh-list
92649292|NCT00255255|Formoterol Fumarate|formoterol fumarate|mesh-list
92682824|NCT00438269|Metronidazole|metronidazole|mesh-list
92649302|NCT00255255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649303|NCT00255255|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92649305|NCT00255255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92649306|NCT00255255|Adrenergic Agents|adrenergic agents|mesh-ancestor
92649307|NCT00255255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649308|NCT00255255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649309|NCT00574756|Ranolazine|ranolazine|mesh-list
92649310|NCT00574756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92649311|NCT00574756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649312|NCT00574756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649313|NCT03453346|Ribavirin|ribavirin|mesh-list
92649314|NCT03453346|Sofosbuvir|sofosbuvir|mesh-list
92649315|NCT03453346|Antimetabolites|antimetabolites|mesh-ancestor
92649316|NCT03453346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649317|NCT03453346|Antiviral Agents|antiviral agents|mesh-ancestor
92649318|NCT03453346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649319|NCT00575068|Galiximab|galiximab|mesh-list
92649320|NCT00575068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649321|NCT00575068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649322|NCT00575224|Interferons|interferons|mesh-list
92649323|NCT00575224|Ribavirin|ribavirin|mesh-list
92649324|NCT00575224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649325|NCT00575224|Antiviral Agents|antiviral agents|mesh-ancestor
92649326|NCT00575224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649327|NCT00575224|Antimetabolites|antimetabolites|mesh-ancestor
92649328|NCT00575224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649329|NCT00225797|Oxymorphone|oxymorphone|mesh-list
92649330|NCT00225797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92649331|NCT00225797|Narcotics|narcotics|mesh-ancestor
92649332|NCT00225797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563230|NCT00156520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92563231|NCT00156520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563232|NCT00156520|Hemostatics|hemostatics|mesh-ancestor
92563233|NCT00156520|Coagulants|coagulants|mesh-ancestor
92563234|NCT00083694|Thalidomide|thalidomide|mesh-list
91998851|NCT05916716|Dipyrone|dipyrone|mesh-list
92649333|NCT00225797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649334|NCT00225797|Analgesics|analgesics|mesh-ancestor
92649335|NCT00225797|Sensory System Agents|sensory system agents|mesh-ancestor
92649336|NCT00225797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649337|NCT00225797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92649338|NCT00235209|Anti-Infective Agents|anti-infective agents|mesh-list
92649339|NCT00235209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92649340|NCT00591487|Lidocaine|lidocaine|mesh-list
92649341|NCT00591487|Anesthetics, Local|anesthetics, local|mesh-ancestor
92649342|NCT00591487|Anesthetics|anesthetics|mesh-ancestor
92649343|NCT00591487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649344|NCT00591487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649345|NCT00591487|Sensory System Agents|sensory system agents|mesh-ancestor
92649346|NCT00591487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649347|NCT00591487|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92649348|NCT00591487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92649349|NCT00591487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92649350|NCT00591487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649351|NCT00591487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649352|NCT00225875|Rituximab|rituximab|mesh-list
92649353|NCT00225875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92649354|NCT00225875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649355|NCT00225875|Immunologic Factors|immunologic factors|mesh-ancestor
92649356|NCT00225875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649357|NCT00225875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649363|NCT00255372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92649365|NCT00225914|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92649366|NCT00225914|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649367|NCT00225914|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649368|NCT00225914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649369|NCT00225914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649370|NCT00225914|Serotonin Agents|serotonin agents|mesh-ancestor
92649371|NCT00225914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649372|NCT00225914|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92649373|NCT00225914|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649374|NCT00225914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649375|NCT00225914|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92649376|NCT00225914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92649377|NCT00225914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649378|NCT03451903|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92649379|NCT03451903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92649380|NCT03451903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92649381|NCT03451903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649382|NCT00235248|Aspirin|aspirin|mesh-list
92649383|NCT00235248|Warfarin|warfarin|mesh-list
92649384|NCT00235248|Clopidogrel|clopidogrel|mesh-list
92649385|NCT00235248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92649386|NCT00235248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92649387|NCT00235248|Analgesics|analgesics|mesh-ancestor
92649388|NCT00235248|Sensory System Agents|sensory system agents|mesh-ancestor
92649389|NCT00235248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649390|NCT00235248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649391|NCT00235248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649392|NCT00235248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649393|NCT00235248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92649394|NCT00235248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92649395|NCT00235248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649396|NCT00235248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92649397|NCT00235248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92649398|NCT00235248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649399|NCT00235248|Antipyretics|antipyretics|mesh-ancestor
92563236|NCT00083694|Immunologic Factors|immunologic factors|mesh-ancestor
92563237|NCT00083694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649400|NCT00235248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92649401|NCT00235248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92649402|NCT00235248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92649403|NCT00235248|Purinergic Agents|purinergic agents|mesh-ancestor
92649404|NCT00235248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649405|NCT00235248|Anticoagulants|anticoagulants|mesh-ancestor
92649406|NCT00225992|Arsenic Trioxide|arsenic trioxide|mesh-list
92649407|NCT00225992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649408|NCT03451435|Acetylcysteine|acetylcysteine|mesh-list
92649409|NCT03451435|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92649410|NCT03451435|Antiviral Agents|antiviral agents|mesh-ancestor
92649411|NCT03451435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649412|NCT03451435|Expectorants|expectorants|mesh-ancestor
92649413|NCT03451435|Respiratory System Agents|respiratory system agents|mesh-ancestor
92649414|NCT03451435|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92649415|NCT03451435|Antioxidants|antioxidants|mesh-ancestor
92649416|NCT03451435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649417|NCT03451435|Protective Agents|protective agents|mesh-ancestor
92649418|NCT03451435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649419|NCT03451435|Antidotes|antidotes|mesh-ancestor
92649420|NCT04575064|Remdesivir|remdesivir|mesh-list
92649421|NCT04575064|Antimetabolites|antimetabolites|mesh-ancestor
92649422|NCT04575064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649423|NCT04575064|Antiviral Agents|antiviral agents|mesh-ancestor
92649424|NCT04575064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649425|NCT03451318|Mometasone Furoate|mometasone furoate|mesh-list
92649426|NCT03451318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649427|NCT03451318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92649432|NCT00255450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92649433|NCT04573855|Immunoglobulins|immunoglobulins|mesh-list
92649435|NCT04573855|Antibodies|antibodies|mesh-list
92649436|NCT04573855|Immunologic Factors|immunologic factors|mesh-ancestor
92649437|NCT04573855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649438|NCT00226109|Spironolactone|spironolactone|mesh-list
92649439|NCT00226109|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92363807|NCT04364022|Lopinavir|lopinavir|mesh-list
92649440|NCT00226109|Hormone Antagonists|hormone antagonists|mesh-ancestor
92649441|NCT00226109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649442|NCT00226109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649443|NCT00226109|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92649444|NCT00226109|Diuretics|diuretics|mesh-ancestor
92649445|NCT00226109|Natriuretic Agents|natriuretic agents|mesh-ancestor
92649446|NCT04573426|Acetaminophen|acetaminophen|mesh-list
92649447|NCT04573426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92649448|NCT04573426|Analgesics|analgesics|mesh-ancestor
92649449|NCT04573426|Sensory System Agents|sensory system agents|mesh-ancestor
92649450|NCT04573426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649451|NCT04573426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649452|NCT04573426|Antipyretics|antipyretics|mesh-ancestor
92649453|NCT00235287|Candesartan|candesartan|mesh-list
92649454|NCT00235287|Candesartan cilexetil|candesartan cilexetil|mesh-list
92649455|NCT00235287|Enalapril|enalapril|mesh-list
92649456|NCT00235287|Enalaprilat|enalaprilat|mesh-list
92649457|NCT00235287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649458|NCT00235287|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92649459|NCT00235287|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92649460|NCT00235287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649461|NCT00235287|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92649462|NCT00235287|Protease Inhibitors|protease inhibitors|mesh-ancestor
92649463|NCT00235287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649464|NCT00255489|Gefitinib|gefitinib|mesh-list
92649465|NCT00255489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649466|NCT00255489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92649467|NCT00255489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649468|NCT00255489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649469|NCT04573153|Hydroxychloroquine|hydroxychloroquine|mesh-list
92649470|NCT04573153|Sorbitol|sorbitol|mesh-list
92649471|NCT04573153|Antimalarials|antimalarials|mesh-ancestor
92649472|NCT04573153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92649473|NCT04573153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92649474|NCT04573153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563238|NCT00083694|Leprostatic Agents|leprostatic agents|mesh-ancestor
92563239|NCT00083694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563240|NCT00083694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563241|NCT00083694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92649475|NCT04573153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649476|NCT04573153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649477|NCT04573153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649478|NCT04573153|Cathartics|cathartics|mesh-ancestor
92649479|NCT04573153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92649480|NCT00255528|Metoprolol|metoprolol|mesh-list
92649481|NCT00255528|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92649482|NCT00255528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649483|NCT00255528|Sympatholytics|sympatholytics|mesh-ancestor
92649484|NCT00255528|Autonomic Agents|autonomic agents|mesh-ancestor
92649485|NCT00255528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649486|NCT00255528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649487|NCT00255528|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92649488|NCT00255528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92649489|NCT00255528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92649490|NCT00255528|Adrenergic Agents|adrenergic agents|mesh-ancestor
92649491|NCT00255528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649492|NCT00255528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649493|NCT04572685|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92649494|NCT04572685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92649495|NCT04572685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649496|NCT04572685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649497|NCT04572685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649498|NCT04572685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649502|NCT04572685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649503|NCT04572685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649504|NCT04572685|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92649505|NCT04572685|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92649506|NCT04572685|Dopamine Agents|dopamine agents|mesh-ancestor
92649507|NCT04572724|Valsartan|valsartan|mesh-list
92649508|NCT04572724|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92649509|NCT04572724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649510|NCT04572724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92649511|NCT04572724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92649512|NCT04572724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649513|NCT00255567|Paromomycin|paromomycin|mesh-list
92649514|NCT00255567|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92649515|NCT00255567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649516|NCT00255567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649517|NCT00255567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92649518|NCT00255567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92649519|NCT00255567|Schistosomicides|schistosomicides|mesh-ancestor
92649520|NCT00255567|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92649521|NCT00255567|Anthelmintics|anthelmintics|mesh-ancestor
92649522|NCT03450967|Durvalumab|durvalumab|mesh-list
92649523|NCT03450967|Tremelimumab|tremelimumab|mesh-list
92649524|NCT03450967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92649525|NCT03450967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649526|NCT00255606|Prednisone|prednisone|mesh-list
92649527|NCT00255606|Docetaxel|docetaxel|mesh-list
92649528|NCT00255606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649529|NCT00255606|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649530|NCT00255606|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649531|NCT00255606|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649532|NCT00255606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649533|NCT00255606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649534|NCT00255606|Glucocorticoids|glucocorticoids|mesh-ancestor
92649535|NCT00255606|Hormones|hormones|mesh-ancestor
92649536|NCT00255606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649537|NCT00255606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649538|NCT00255606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92649539|NCT00226343|Valproic Acid|valproic acid|mesh-list
92649540|NCT00226343|Anticonvulsants|anticonvulsants|mesh-ancestor
92649541|NCT00226343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649542|NCT00226343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649543|NCT00226343|GABA Agents|gaba agents|mesh-ancestor
92563242|NCT00083694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563243|NCT00083694|Growth Substances|growth substances|mesh-ancestor
92563244|NCT00083694|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563245|NCT00083694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563247|NCT00051389|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92649544|NCT00226343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649545|NCT00226343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649546|NCT00226343|Antimanic Agents|antimanic agents|mesh-ancestor
92649547|NCT00226343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649548|NCT00226343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649549|NCT00226343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649550|NCT03450499|Ketamine|ketamine|mesh-list
92649551|NCT03450499|Analgesics|analgesics|mesh-ancestor
92649552|NCT03450499|Sensory System Agents|sensory system agents|mesh-ancestor
92649553|NCT03450499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649554|NCT03450499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649555|NCT03450499|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92649556|NCT03450499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92649557|NCT03450499|Anesthetics, General|anesthetics, general|mesh-ancestor
92649558|NCT03450499|Anesthetics|anesthetics|mesh-ancestor
92649559|NCT03450499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649560|NCT03450499|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92649561|NCT03450499|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92649562|NCT03450499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649563|NCT03450499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649564|NCT00226382|Interferons|interferons|mesh-list
92649565|NCT00226382|Interferon-alpha|interferon-alpha|mesh-list
92649566|NCT00226382|Interferon alpha-2|interferon alpha-2|mesh-list
92649567|NCT00226382|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92649568|NCT00226382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649569|NCT00226382|Antiviral Agents|antiviral agents|mesh-ancestor
92649570|NCT00226382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649573|NCT01580839|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92649574|NCT01580839|Plasminogen|plasminogen|mesh-list
92649575|NCT01580839|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92649576|NCT01580839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92649577|NCT01580839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649578|NCT03450226|Bupivacaine|bupivacaine|mesh-list
92649579|NCT03450226|Anesthetics, Local|anesthetics, local|mesh-ancestor
92649580|NCT03450226|Anesthetics|anesthetics|mesh-ancestor
92649581|NCT03450226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649582|NCT03450226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649583|NCT03450226|Sensory System Agents|sensory system agents|mesh-ancestor
92649584|NCT03450226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649585|NCT00226421|Oxymorphone|oxymorphone|mesh-list
92649586|NCT00226421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92649587|NCT00226421|Narcotics|narcotics|mesh-ancestor
92649588|NCT00226421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649589|NCT00226421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649590|NCT00226421|Analgesics|analgesics|mesh-ancestor
92649591|NCT00226421|Sensory System Agents|sensory system agents|mesh-ancestor
92649592|NCT00226421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649593|NCT00226421|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92649594|NCT04572373|SMOFlipid|smoflipid|mesh-list
92649595|NCT04572373|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92649596|NCT04572373|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92649597|NCT04572373|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92649598|NCT03450109|Goserelin|goserelin|mesh-list
92649599|NCT03450109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92649600|NCT03450109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649601|NCT00413387|Budesonide|budesonide|mesh-list
92649602|NCT00413387|Beclomethasone|beclomethasone|mesh-list
92649603|NCT00413387|Formoterol Fumarate|formoterol fumarate|mesh-list
92649604|NCT00413387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649605|NCT00413387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92649606|NCT00413387|Autonomic Agents|autonomic agents|mesh-ancestor
92649607|NCT00413387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649608|NCT00413387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649609|NCT00413387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92649610|NCT00413387|Respiratory System Agents|respiratory system agents|mesh-ancestor
92563248|NCT00051389|Protease Inhibitors|protease inhibitors|mesh-ancestor
92563249|NCT00051389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563250|NCT00051389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563251|NCT00051389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649611|NCT00413387|Glucocorticoids|glucocorticoids|mesh-ancestor
92649612|NCT00413387|Hormones|hormones|mesh-ancestor
92649613|NCT00413387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649614|NCT00413387|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92649615|NCT00413387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92649616|NCT00413387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92649617|NCT00413387|Adrenergic Agents|adrenergic agents|mesh-ancestor
92649618|NCT00413387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649619|NCT00413387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649620|NCT00413426|Darifenacin|darifenacin|mesh-list
92649621|NCT00413426|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92649622|NCT00413426|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92649623|NCT00413426|Cholinergic Agents|cholinergic agents|mesh-ancestor
92649624|NCT00413426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649625|NCT00413426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649626|NCT00413426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649627|NCT00413426|Urological Agents|urological agents|mesh-ancestor
92649628|NCT00255762|Paclitaxel|paclitaxel|mesh-list
92649629|NCT00255762|Bevacizumab|bevacizumab|mesh-list
92649630|NCT00255762|Carboplatin|carboplatin|mesh-list
92649631|NCT00255762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92649632|NCT00255762|Antibodies|antibodies|mesh-list
92649633|NCT00255762|Immunoglobulins|immunoglobulins|mesh-list
92649634|NCT00255762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92649635|NCT00255762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92649636|NCT00255762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649637|NCT00255762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649638|NCT00255762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649639|NCT00255762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649640|NCT00255762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649641|NCT00255762|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92649642|NCT00255762|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92649643|NCT00255762|Growth Substances|growth substances|mesh-ancestor
92649645|NCT00255762|Growth Inhibitors|growth inhibitors|mesh-ancestor
92649646|NCT00255762|Immunologic Factors|immunologic factors|mesh-ancestor
92649647|NCT02277457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92649648|NCT02277457|Crizotinib|crizotinib|mesh-list
92649649|NCT02277457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649650|NCT02277457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92649651|NCT02277457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649652|NCT02277457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649653|NCT00255879|Olanzapine|olanzapine|mesh-list
92649654|NCT00255879|Risperidone|risperidone|mesh-list
92649655|NCT00255879|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92649656|NCT00255879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92649657|NCT00255879|Serotonin Agents|serotonin agents|mesh-ancestor
92649658|NCT00255879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649659|NCT00255879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649660|NCT00255879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649661|NCT00255879|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92649662|NCT00255879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649663|NCT00255879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649664|NCT00255879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649665|NCT00255879|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92649666|NCT00255879|Dopamine Agents|dopamine agents|mesh-ancestor
92649667|NCT00255879|Antiemetics|antiemetics|mesh-ancestor
92649668|NCT00255879|Autonomic Agents|autonomic agents|mesh-ancestor
92649669|NCT00255879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649670|NCT00255879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92649671|NCT00255879|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92649672|NCT00255879|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649673|NCT00255879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649674|NCT00255879|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649675|NCT00413504|PENTA|penta|mesh-list
92649676|NCT00413504|Fondaparinux|fondaparinux|mesh-list
92563253|NCT00156949|Hematinics|hematinics|mesh-ancestor
92563254|NCT00156988|Sulfadiazine|sulfadiazine|mesh-list
92649677|NCT00413504|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92649678|NCT00413504|Antithrombins|antithrombins|mesh-ancestor
92649679|NCT00413504|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92649680|NCT00413504|Protease Inhibitors|protease inhibitors|mesh-ancestor
92649681|NCT00413504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649682|NCT00413504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649683|NCT00413504|Anticoagulants|anticoagulants|mesh-ancestor
92649684|NCT00413504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92649685|NCT00413504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92649686|NCT04721223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92649687|NCT04721223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649688|NCT04721223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92649689|NCT04721223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649690|NCT04710498|Atezolizumab|atezolizumab|mesh-list
92649691|NCT04710498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92649692|NCT04710498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649693|NCT04710498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92649694|NCT04710498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649695|NCT00226538|Fluconazole|fluconazole|mesh-list
92649696|NCT00226538|Rifampin|rifampin|mesh-list
92649697|NCT00226538|Diclofenac|diclofenac|mesh-list
92649698|NCT00226538|Phenytoin|phenytoin|mesh-list
92649699|NCT00226538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92649700|NCT00226538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92649701|NCT00226538|Analgesics|analgesics|mesh-ancestor
92649702|NCT00226538|Sensory System Agents|sensory system agents|mesh-ancestor
92649703|NCT00226538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649704|NCT00226538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649705|NCT00226538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649706|NCT00226538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649707|NCT00226538|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92649708|NCT00226538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649709|NCT00226538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649710|NCT00226538|Antifungal Agents|antifungal agents|mesh-ancestor
92649711|NCT00226538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649712|NCT00226538|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92649713|NCT00226538|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92649714|NCT00226538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92649715|NCT00226538|Hormone Antagonists|hormone antagonists|mesh-ancestor
92649716|NCT00226538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649720|NCT00226538|Antitubercular Agents|antitubercular agents|mesh-ancestor
92649721|NCT00226538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649722|NCT00226538|Leprostatic Agents|leprostatic agents|mesh-ancestor
92649723|NCT00226538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92649724|NCT00226538|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92363819|NCT04363866|Hydroxychloroquine|hydroxychloroquine|mesh-list
92649725|NCT00226538|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92649726|NCT00226538|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92649727|NCT00226538|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92649728|NCT00226538|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92649729|NCT00226538|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92649731|NCT00226538|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92649732|NCT00226538|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92649733|NCT00226538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649734|NCT00226538|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92649735|NCT00255918|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
92649736|NCT00255918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92649737|NCT00255918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92649738|NCT00255918|Cholinergic Agents|cholinergic agents|mesh-ancestor
92649739|NCT00255918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649740|NCT00255918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649741|NCT00255918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649742|NCT00226694|Citalopram|citalopram|mesh-list
92649743|NCT00226694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92649744|NCT00226694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649745|NCT00226694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649746|NCT00226694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649747|NCT00226694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563255|NCT00156988|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92563256|NCT00156988|Cerium nitrate|cerium nitrate|mesh-list
92563257|NCT00156988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563258|NCT00156988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563259|NCT00156988|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92563260|NCT00156988|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92563261|NCT00156988|Coccidiostats|coccidiostats|mesh-ancestor
92649748|NCT00226694|Serotonin Agents|serotonin agents|mesh-ancestor
92649749|NCT00226694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649750|NCT00226694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92649751|NCT00226694|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649752|NCT00226694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649753|NCT00255996|Linezolid|linezolid|mesh-list
92649754|NCT00255996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649755|NCT00255996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649756|NCT00255996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92649757|NCT00255996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649758|NCT00255996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649759|NCT00226889|Bosentan|bosentan|mesh-list
92649760|NCT00226889|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92649761|NCT00226889|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92649762|NCT00226889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649763|NCT00226967|Octreotide|octreotide|mesh-list
92649764|NCT00226967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92649765|NCT00226967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92649766|NCT00226967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649767|NCT00199381|Istradefylline|istradefylline|mesh-list
92649768|NCT00199381|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92649769|NCT00199381|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92649770|NCT00199381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92649771|NCT00199381|Purinergic Agents|purinergic agents|mesh-ancestor
92649772|NCT00199381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649773|NCT00199381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649774|NCT00199381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649775|NCT00227084|Hemostatics|hemostatics|mesh-list
92649776|NCT00227084|Coagulants|coagulants|mesh-ancestor
92649777|NCT00227123|Risperidone|risperidone|mesh-list
92649778|NCT00227123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92649779|NCT00227123|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92649780|NCT00227123|Serotonin Agents|serotonin agents|mesh-ancestor
92649781|NCT00227123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649782|NCT00227123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682825|NCT00438269|Ciprofloxacin|ciprofloxacin|mesh-list
92649795|NCT00235560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649796|NCT00235560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649797|NCT00235560|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92649798|NCT00235560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649800|NCT00235560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92649801|NCT00235560|Immunologic Factors|immunologic factors|mesh-ancestor
92649802|NCT00235560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649803|NCT00227318|Candesartan cilexetil|candesartan cilexetil|mesh-list
92649805|NCT00227318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92649806|NCT00227318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92649807|NCT00227318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649808|NCT00227357|Buprenorphine|buprenorphine|mesh-list
92649809|NCT00227357|Methadone|methadone|mesh-list
92649810|NCT00227357|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92649811|NCT00227357|Naloxone|naloxone|mesh-list
92649812|NCT00227357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92649813|NCT00227357|Narcotics|narcotics|mesh-ancestor
92649814|NCT00227357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649815|NCT00227357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649816|NCT00227357|Analgesics|analgesics|mesh-ancestor
92649817|NCT00227357|Sensory System Agents|sensory system agents|mesh-ancestor
92649818|NCT00227357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649819|NCT00227357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92649820|NCT00227357|Antitussive Agents|antitussive agents|mesh-ancestor
92649821|NCT00227357|Respiratory System Agents|respiratory system agents|mesh-ancestor
92563262|NCT00156988|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92563263|NCT00157066|Ergocalciferols|ergocalciferols|mesh-list
92563265|NCT00157066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92563266|NCT00157066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563267|NCT00157066|Vitamins|vitamins|mesh-ancestor
92563268|NCT00157066|Micronutrients|micronutrients|mesh-ancestor
92649822|NCT00198133|Pemetrexed|pemetrexed|mesh-list
92649823|NCT00198133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649824|NCT00198133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649825|NCT00198133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649826|NCT00198133|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92649827|NCT00198133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92649828|NCT00227474|Vaccines|vaccines|mesh-list
92649829|NCT00227474|Immunologic Factors|immunologic factors|mesh-ancestor
92649830|NCT00227474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649831|NCT00227513|Bortezomib|bortezomib|mesh-list
92649832|NCT00227513|Vorinostat|vorinostat|mesh-list
92649833|NCT00227513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649834|NCT00227513|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92649835|NCT00227513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649836|NCT00227513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649837|NCT00227630|Pemetrexed|pemetrexed|mesh-list
92649838|NCT00227630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649839|NCT00227630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649840|NCT00227630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649841|NCT00227630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92649842|NCT00227630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92649843|NCT00256230|Disulfiram|disulfiram|mesh-list
92649844|NCT00256230|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92649845|NCT00256230|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92649846|NCT00256230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649861|NCT00235794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649862|NCT00235794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649863|NCT00235794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92649864|NCT00235794|Immunologic Factors|immunologic factors|mesh-ancestor
92649865|NCT00235794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649866|NCT00235794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649867|NCT00235794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92649868|NCT00235794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649869|NCT00235794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92649870|NCT00235794|Antifungal Agents|antifungal agents|mesh-ancestor
92649871|NCT00256269|Oxaliplatin|oxaliplatin|mesh-list
92649872|NCT00256269|Irinotecan|irinotecan|mesh-list
92649873|NCT00256269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649874|NCT00256269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92649875|NCT00256269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92649876|NCT00256269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649877|NCT00256269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649878|NCT00197002|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92649879|NCT00197002|Immunologic Factors|immunologic factors|mesh-ancestor
92649880|NCT00197002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649881|NCT00227708|Docetaxel|docetaxel|mesh-list
92649882|NCT00227708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649883|NCT00227708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649884|NCT00227708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649885|NCT00227708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649886|NCT00227708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649887|NCT00235911|Budesonide|budesonide|mesh-list
92649888|NCT00235911|Formoterol Fumarate|formoterol fumarate|mesh-list
92649889|NCT00235911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649890|NCT00235911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92649891|NCT00235911|Autonomic Agents|autonomic agents|mesh-ancestor
92649892|NCT00235911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649893|NCT00235911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649894|NCT00235911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92649895|NCT00235911|Respiratory System Agents|respiratory system agents|mesh-ancestor
92649896|NCT00235911|Glucocorticoids|glucocorticoids|mesh-ancestor
92649897|NCT00235911|Hormones|hormones|mesh-ancestor
92563269|NCT00157066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92563270|NCT00157105|Factor VIII|factor viii|mesh-list
92563271|NCT00157105|Coagulants|coagulants|mesh-ancestor
92563272|NCT00083772|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92563273|NCT00083772|Natriuretic Agents|natriuretic agents|mesh-ancestor
91970653|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92649898|NCT00235911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649899|NCT00235911|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92649900|NCT00235911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92649901|NCT00235911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92649902|NCT00235911|Adrenergic Agents|adrenergic agents|mesh-ancestor
92649903|NCT00235911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649904|NCT00235911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649905|NCT00256347|Morphine|morphine|mesh-list
92649906|NCT00256347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92649907|NCT00256347|Narcotics|narcotics|mesh-ancestor
92649916|NCT00227747|Antimetabolites|antimetabolites|mesh-ancestor
92649917|NCT00227747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649918|NCT00227747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649919|NCT00235950|Clopidogrel|clopidogrel|mesh-list
92649920|NCT00235950|Atorvastatin|atorvastatin|mesh-list
92649921|NCT00235950|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92649922|NCT00235950|Simvastatin|simvastatin|mesh-list
92649923|NCT00235950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92649924|NCT00235950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92649925|NCT00235950|Antimetabolites|antimetabolites|mesh-ancestor
92649926|NCT00235950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649927|NCT00235950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92649928|NCT00235950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92649929|NCT00235950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649930|NCT00235950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92649931|NCT00235950|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92649932|NCT00235950|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92649933|NCT00235950|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92649934|NCT00235950|Purinergic Agents|purinergic agents|mesh-ancestor
92649935|NCT00235950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649936|NCT00235950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649937|NCT00227942|Zolpidem|zolpidem|mesh-list
92649938|NCT00227942|Estrogens|estrogens|mesh-list
92649939|NCT00227942|Hormones|hormones|mesh-ancestor
92649940|NCT00227942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649941|NCT00227942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649942|NCT00227942|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92649943|NCT00227942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92649944|NCT00227942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649945|NCT00227942|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92649946|NCT00227942|GABA Agonists|gaba agonists|mesh-ancestor
92649947|NCT00227942|GABA Agents|gaba agents|mesh-ancestor
92649948|NCT00227942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649949|NCT00227942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649950|NCT00227981|Fluoxetine|fluoxetine|mesh-list
92649951|NCT00227981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92649952|NCT00227981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649953|NCT00227981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649954|NCT00227981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649955|NCT00227981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649956|NCT00227981|Serotonin Agents|serotonin agents|mesh-ancestor
92649957|NCT00227981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649958|NCT00227981|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92649959|NCT00227981|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649960|NCT00227981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649961|NCT00227981|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92649962|NCT00227981|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92649963|NCT00227981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649964|NCT00236028|Infliximab|infliximab|mesh-list
92649965|NCT00236028|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92649966|NCT00236028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563274|NCT00083772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563275|NCT00157261|Tenecteplase|tenecteplase|mesh-list
92649967|NCT00236028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92649968|NCT00236028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92649969|NCT00236028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92649970|NCT00256542|Lidocaine|lidocaine|mesh-list
92649971|NCT00256542|Heparin|heparin|mesh-list
92649972|NCT00256542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92649973|NCT00256542|Anesthetics|anesthetics|mesh-ancestor
92649974|NCT00256542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649975|NCT00256542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649977|NCT00256542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649978|NCT00256542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92649979|NCT00256542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92649980|NCT00256542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92649981|NCT00256542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649982|NCT00256542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649983|NCT00256542|Anticoagulants|anticoagulants|mesh-ancestor
92649984|NCT00256542|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92649985|NCT00256542|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92649986|NCT00228020|Cyclosporine|cyclosporine|mesh-list
92649987|NCT00228020|Mycophenolic Acid|mycophenolic acid|mesh-list
92649988|NCT00228020|Prednisone|prednisone|mesh-list
92649989|NCT00228020|Cyclosporins|cyclosporins|mesh-list
92649990|NCT00228020|Basiliximab|basiliximab|mesh-list
92649991|NCT00228020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649992|NCT00228020|Glucocorticoids|glucocorticoids|mesh-ancestor
92649993|NCT00228020|Hormones|hormones|mesh-ancestor
92649994|NCT00228020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649995|NCT00228020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649996|NCT00228020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92649997|NCT00228020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649998|NCT00228020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92649999|NCT00228020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650000|NCT00228020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92650001|NCT00228020|Immunologic Factors|immunologic factors|mesh-ancestor
92650002|NCT00228020|Antifungal Agents|antifungal agents|mesh-ancestor
92650003|NCT00228020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650004|NCT00228020|Dermatologic Agents|dermatologic agents|mesh-ancestor
92650005|NCT00228020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650006|NCT00228020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92650007|NCT00228020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92650008|NCT00228020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92650009|NCT00228020|Antitubercular Agents|antitubercular agents|mesh-ancestor
92650010|NCT00228020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650011|NCT00236067|Tiagabine|tiagabine|mesh-list
92650012|NCT00236067|Anticonvulsants|anticonvulsants|mesh-ancestor
92650013|NCT00236067|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92650014|NCT00236067|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92650015|NCT00236067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650016|NCT00236067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650017|NCT00236067|GABA Agents|gaba agents|mesh-ancestor
92650018|NCT00236067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650019|NCT00236067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650020|NCT00195715|Adalimumab|adalimumab|mesh-list
92650021|NCT00195715|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92650022|NCT00195715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650023|NCT00195715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650024|NCT00236106|Mometasone Furoate|mometasone furoate|mesh-list
92650025|NCT00236106|Tacrolimus|tacrolimus|mesh-list
92375334|NCT01929642|Sirolimus|sirolimus|mesh-list
92650026|NCT00236106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92650027|NCT00236106|Immunologic Factors|immunologic factors|mesh-ancestor
92650028|NCT00236106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650029|NCT00236106|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92650030|NCT00236106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650031|NCT00236106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650032|NCT00236106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650033|NCT00236106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92650034|NCT00236106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92650036|NCT00236145|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92650037|NCT00236145|Narcotics|narcotics|mesh-ancestor
92650038|NCT00236145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650039|NCT00236145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563276|NCT00157261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92563277|NCT00157261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92563278|NCT00157261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563280|NCT00157300|Hematinics|hematinics|mesh-ancestor
92563281|NCT00157378|Haloperidol|haloperidol|mesh-list
92650040|NCT00236145|Analgesics|analgesics|mesh-ancestor
92650041|NCT00236145|Sensory System Agents|sensory system agents|mesh-ancestor
92650042|NCT00236145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650043|NCT00236145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92650044|NCT00236145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92650045|NCT00236145|Anesthetics, General|anesthetics, general|mesh-ancestor
92650046|NCT00236145|Anesthetics|anesthetics|mesh-ancestor
92650047|NCT00228254|Vitamin A|vitamin a|mesh-list
92650048|NCT00228254|Vitamins|vitamins|mesh-ancestor
92650051|NCT00195676|Adalimumab|adalimumab|mesh-list
92650052|NCT00195676|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92650053|NCT00195676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650054|NCT00195676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650055|NCT00194077|Aripiprazole|aripiprazole|mesh-list
92650056|NCT00194077|Antidepressive Agents|antidepressive agents|mesh-ancestor
92650057|NCT00194077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650058|NCT00194077|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650059|NCT00194077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650060|NCT00194077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650061|NCT00194077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650062|NCT00194077|Dopamine Agonists|dopamine agonists|mesh-ancestor
92650063|NCT00194077|Dopamine Agents|dopamine agents|mesh-ancestor
92650064|NCT00194077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650065|NCT00194077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650066|NCT00194077|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92650067|NCT00194077|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92650068|NCT00194077|Serotonin Agents|serotonin agents|mesh-ancestor
92650069|NCT00194077|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92650070|NCT00194077|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92650071|NCT00194077|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92650072|NCT00194077|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92650073|NCT00193609|Capecitabine|capecitabine|mesh-list
92650074|NCT00193609|Oxaliplatin|oxaliplatin|mesh-list
92650075|NCT00193609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650076|NCT00193609|Antimetabolites|antimetabolites|mesh-ancestor
92650077|NCT00193609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650078|NCT00193609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650079|NCT00228410|Vancomycin|vancomycin|mesh-list
92650080|NCT00228410|Tigecycline|tigecycline|mesh-list
92650081|NCT00228410|Aztreonam|aztreonam|mesh-list
92650082|NCT00228410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650083|NCT00228410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650084|NCT00228410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92650085|NCT00228410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650086|NCT00228410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650087|NCT00193180|Docetaxel|docetaxel|mesh-list
92650088|NCT00193180|Imatinib Mesylate|imatinib mesylate|mesh-list
92650089|NCT00193180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650090|NCT00193180|Tubulin Modulators|tubulin modulators|mesh-ancestor
92650091|NCT00193180|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363839|NCT04362384|Antioxidants|antioxidants|mesh-ancestor
92650092|NCT00193180|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650093|NCT00193180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650094|NCT00193180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92650095|NCT00193180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650096|NCT00193063|Gemcitabine|gemcitabine|mesh-list
92650097|NCT00193063|Trastuzumab|trastuzumab|mesh-list
92650098|NCT00193063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650099|NCT00193063|Antimetabolites|antimetabolites|mesh-ancestor
92650100|NCT00193063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650101|NCT00193063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650102|NCT00193063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92650104|NCT00228488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650105|NCT00228488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92650106|NCT00228488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563282|NCT00157378|Risperidone|risperidone|mesh-list
92563283|NCT00157378|Haloperidol decanoate|haloperidol decanoate|mesh-list
92563284|NCT00157378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92563285|NCT00157378|Serotonin Agents|serotonin agents|mesh-ancestor
92563286|NCT00157378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563287|NCT00157378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563288|NCT00157378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563289|NCT00157378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650107|NCT00228488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650108|NCT00228527|Esomeprazole|esomeprazole|mesh-list
92650109|NCT00228527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92650110|NCT00228527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650111|NCT00228527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92650112|NCT00228527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650113|NCT00228527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650114|NCT00191854|Paclitaxel|paclitaxel|mesh-list
92650115|NCT00191854|Carboplatin|carboplatin|mesh-list
92650116|NCT00191854|Gemcitabine|gemcitabine|mesh-list
92650117|NCT00191854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92650118|NCT00191854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650119|NCT00191854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92650120|NCT00191854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92650121|NCT00191854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650122|NCT00191854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650126|NCT00228605|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92650127|NCT00228605|Narcotics|narcotics|mesh-ancestor
92650128|NCT00228605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650129|NCT00228605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650130|NCT00228605|Analgesics|analgesics|mesh-ancestor
92650131|NCT00228605|Sensory System Agents|sensory system agents|mesh-ancestor
92650132|NCT00228605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650133|NCT00228605|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92650134|NCT00228605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92650135|NCT00228605|Anesthetics, General|anesthetics, general|mesh-ancestor
92650136|NCT00228605|Anesthetics|anesthetics|mesh-ancestor
92650137|NCT00191815|Gemcitabine|gemcitabine|mesh-list
92650138|NCT00191815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650139|NCT00191815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650140|NCT00191815|Antimetabolites|antimetabolites|mesh-ancestor
92650141|NCT00191815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650142|NCT00191386|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92650143|NCT00191386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92650144|NCT00191386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92650145|NCT00191386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650146|NCT00191386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650147|NCT00191386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92650148|NCT00191386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650149|NCT00191386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650150|NCT00191308|Pemetrexed|pemetrexed|mesh-list
92650151|NCT00191308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650152|NCT00191308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650153|NCT00191308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650154|NCT00191308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92650155|NCT00191308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92650156|NCT00228839|Infliximab|infliximab|mesh-list
92650157|NCT00228839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92650158|NCT00228839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650159|NCT00228839|Dermatologic Agents|dermatologic agents|mesh-ancestor
91954634|NCT03569839|Propofol|propofol|mesh-list
92650160|NCT00228839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650161|NCT00228839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650162|NCT00191269|Gemcitabine|gemcitabine|mesh-list
92650163|NCT00191269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650164|NCT00191269|Antimetabolites|antimetabolites|mesh-ancestor
92650165|NCT00191269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650166|NCT00191269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650167|NCT00228878|Insulin|insulin|mesh-list
92563290|NCT00157378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92563291|NCT00157378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92563292|NCT00157378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563293|NCT00157378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92563294|NCT00157378|Dopamine Agents|dopamine agents|mesh-ancestor
92563295|NCT00157378|Antiemetics|antiemetics|mesh-ancestor
92650168|NCT00228878|Insulin Aspart|insulin aspart|mesh-list
92650169|NCT00228878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650170|NCT00228878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650171|NCT00228995|Epoetin Alfa|epoetin alfa|mesh-list
92650172|NCT00228995|Hematinics|hematinics|mesh-ancestor
92650173|NCT00413946|Epoetin Alfa|epoetin alfa|mesh-list
92650174|NCT00413946|Hematinics|hematinics|mesh-ancestor
92650175|NCT00229112|Tazobactam|tazobactam|mesh-list
92650176|NCT00229112|Piperacillin|piperacillin|mesh-list
92650177|NCT00229112|Ertapenem|ertapenem|mesh-list
92650178|NCT00229112|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92650179|NCT00229112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650180|NCT00229112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650181|NCT00229112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650182|NCT00229112|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92650183|NCT00229112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650184|NCT00256737|Omeprazole|omeprazole|mesh-list
92650185|NCT00256737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92650186|NCT00256737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650187|NCT00256737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92650188|NCT00256737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650189|NCT00256737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650190|NCT00191191|Pemetrexed|pemetrexed|mesh-list
92650191|NCT00191191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650192|NCT00191191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650193|NCT00191191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650194|NCT00191191|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92650195|NCT00191191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92650200|NCT00414024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650201|NCT00414024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650202|NCT00256893|Ropinirole|ropinirole|mesh-list
92650203|NCT00256893|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92650204|NCT00256893|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92650205|NCT00256893|Dopamine Agonists|dopamine agonists|mesh-ancestor
92650206|NCT00256893|Dopamine Agents|dopamine agents|mesh-ancestor
92650207|NCT00256893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650208|NCT00256893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650209|NCT00256893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650210|NCT00229385|Ziprasidone|ziprasidone|mesh-list
92650211|NCT00229385|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92650212|NCT00229385|Serotonin Agents|serotonin agents|mesh-ancestor
92650213|NCT00229385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650214|NCT00229385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650215|NCT00229385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650216|NCT00229385|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650217|NCT00229385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650218|NCT00229385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650219|NCT00229385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650220|NCT00229385|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92650221|NCT00229385|Dopamine Agents|dopamine agents|mesh-ancestor
92650222|NCT00236223|Dexamethasone|dexamethasone|mesh-list
92650223|NCT00236223|Ketamine|ketamine|mesh-list
92650224|NCT00236223|Gabapentin|gabapentin|mesh-list
92650225|NCT00236223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650226|NCT00236223|Antiemetics|antiemetics|mesh-ancestor
92650227|NCT00236223|Autonomic Agents|autonomic agents|mesh-ancestor
92650228|NCT00236223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650229|NCT00236223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650230|NCT00236223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650231|NCT00236223|Glucocorticoids|glucocorticoids|mesh-ancestor
92650232|NCT00236223|Hormones|hormones|mesh-ancestor
92650233|NCT00236223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650234|NCT00236223|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92650235|NCT00236223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650236|NCT00236223|Analgesics|analgesics|mesh-ancestor
92563296|NCT00157378|Autonomic Agents|autonomic agents|mesh-ancestor
92563297|NCT00157378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563298|NCT00157378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563299|NCT00157378|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92650237|NCT00236223|Sensory System Agents|sensory system agents|mesh-ancestor
92650238|NCT00236223|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92650239|NCT00236223|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92650240|NCT00236223|Anesthetics, General|anesthetics, general|mesh-ancestor
92650241|NCT00236223|Anesthetics|anesthetics|mesh-ancestor
92650242|NCT00236223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650243|NCT00236223|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92650244|NCT00236223|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92650245|NCT00236223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650246|NCT00236223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650247|NCT00236223|Anticonvulsants|anticonvulsants|mesh-ancestor
92650248|NCT00236223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92650249|NCT00236223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650250|NCT00236223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650251|NCT00236223|Antimanic Agents|antimanic agents|mesh-ancestor
92375561|NCT05725200|Cetuximab|cetuximab|mesh-list
92650253|NCT00229424|Lafutidine|lafutidine|mesh-list
92650254|NCT00229424|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92650255|NCT00229424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650256|NCT00229424|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92650257|NCT00229424|Histamine Antagonists|histamine antagonists|mesh-ancestor
92650258|NCT00229424|Histamine Agents|histamine agents|mesh-ancestor
92650259|NCT00229424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650260|NCT00229424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650261|NCT00229424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650262|NCT00256932|Alvimopan|alvimopan|mesh-list
92650263|NCT00256932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650264|NCT00191152|Gemcitabine|gemcitabine|mesh-list
92650265|NCT00191152|Capecitabine|capecitabine|mesh-list
92650266|NCT00191152|Docetaxel|docetaxel|mesh-list
92650267|NCT00191152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650268|NCT00191152|Antimetabolites|antimetabolites|mesh-ancestor
92650272|NCT00191152|Antimitotic Agents|antimitotic agents|mesh-ancestor
92650273|NCT00191152|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650274|NCT00257049|Levofloxacin|levofloxacin|mesh-list
92650275|NCT00257049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92650276|NCT00257049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650277|NCT00257049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650278|NCT00257049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92650279|NCT00257049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92650280|NCT00257049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650281|NCT00257049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650282|NCT00257049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650283|NCT00257049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92650284|NCT00257049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92650285|NCT01059188|Docetaxel|docetaxel|mesh-list
92650286|NCT01059188|Cetuximab|cetuximab|mesh-list
92650287|NCT01059188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650288|NCT01059188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92650289|NCT01059188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92650290|NCT01059188|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650291|NCT01059188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650292|NCT01059188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92650293|NCT00236301|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92650294|NCT00236301|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92650295|NCT00236301|Estradiol|estradiol|mesh-list
92650296|NCT00236301|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92650297|NCT00236301|Estrogens|estrogens|mesh-ancestor
92650298|NCT00236301|Hormones|hormones|mesh-ancestor
92650299|NCT00236301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650300|NCT00236301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650301|NCT00236301|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92650302|NCT00236301|Contraceptive Agents|contraceptive agents|mesh-ancestor
92650303|NCT00236301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92650304|NCT00236301|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92650305|NCT00229697|Tamoxifen|tamoxifen|mesh-list
92650306|NCT00229697|Gefitinib|gefitinib|mesh-list
92650307|NCT00229697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92563300|NCT00406861|Montelukast|montelukast|mesh-list
92563301|NCT00406861|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92563302|NCT00406861|Respiratory System Agents|respiratory system agents|mesh-ancestor
92563303|NCT00406861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92650308|NCT00229697|Hormone Antagonists|hormone antagonists|mesh-ancestor
92650309|NCT00229697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650310|NCT00229697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650311|NCT00229697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92650312|NCT00229697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650313|NCT00229697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92650314|NCT00229697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92650315|NCT00229697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92650316|NCT00229697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92650317|NCT00229697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650318|NCT00229697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650319|NCT00236379|Olanzapine|olanzapine|mesh-list
92650320|NCT00236379|Risperidone|risperidone|mesh-list
92650321|NCT00236379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92650322|NCT00236379|Serotonin Agents|serotonin agents|mesh-ancestor
92650323|NCT00236379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650324|NCT00236379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650325|NCT00236379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650326|NCT00236379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650327|NCT00236379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650328|NCT00236379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650329|NCT00236379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650330|NCT00236379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92650331|NCT00236379|Dopamine Agents|dopamine agents|mesh-ancestor
92650332|NCT00236379|Antiemetics|antiemetics|mesh-ancestor
92650333|NCT00236379|Autonomic Agents|autonomic agents|mesh-ancestor
92650334|NCT00236379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650335|NCT00236379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650336|NCT00236379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92650337|NCT00236379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92682826|NCT00438269|Meropenem|meropenem|mesh-list
92650339|NCT00229775|Chloroquine|chloroquine|mesh-list
92650340|NCT00229775|Artemether|artemether|mesh-list
92650341|NCT00229775|Pyrimethamine|pyrimethamine|mesh-list
92650342|NCT00229775|Sulfadoxine|sulfadoxine|mesh-list
92650343|NCT00229775|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92650344|NCT00229775|Amebicides|amebicides|mesh-ancestor
92650345|NCT00229775|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92650346|NCT00229775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92650347|NCT00229775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650348|NCT00229775|Antimalarials|antimalarials|mesh-ancestor
92650349|NCT00229775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650350|NCT00229775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92650351|NCT00229775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650352|NCT00229775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650353|NCT00229775|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92650354|NCT00257127|Vaccines|vaccines|mesh-list
92650355|NCT00257127|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92650356|NCT00257127|Immunologic Factors|immunologic factors|mesh-ancestor
92650357|NCT00257127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650358|NCT00190684|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92650359|NCT00190684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92650360|NCT00190684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92650361|NCT00190684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650362|NCT00190684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650363|NCT00190684|Adrenergic Agents|adrenergic agents|mesh-ancestor
92650364|NCT00190684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650365|NCT00190684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650366|NCT00236418|Topiramate|topiramate|mesh-list
92650367|NCT00236418|Anticonvulsants|anticonvulsants|mesh-ancestor
92650368|NCT00236418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650369|NCT00236418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650370|NCT00236457|Risperidone|risperidone|mesh-list
92650371|NCT00236457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92650372|NCT00236457|Serotonin Agents|serotonin agents|mesh-ancestor
92650373|NCT00236457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563304|NCT00406861|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970676|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650374|NCT00236457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650375|NCT00236457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650376|NCT00236457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650377|NCT00236457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650378|NCT00236457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650379|NCT00236457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650380|NCT00236457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92650381|NCT00236457|Dopamine Agents|dopamine agents|mesh-ancestor
92650382|NCT00236496|Topiramate|topiramate|mesh-list
92650383|NCT00236496|Anticonvulsants|anticonvulsants|mesh-ancestor
92650384|NCT00236496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650385|NCT00236496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650387|NCT00199277|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92650388|NCT00199277|Trace Elements|trace elements|mesh-ancestor
92650389|NCT00199277|Micronutrients|micronutrients|mesh-ancestor
92650390|NCT00199277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650391|NCT00199277|Hematinics|hematinics|mesh-ancestor
92650392|NCT00236535|Acetaminophen|acetaminophen|mesh-list
92650393|NCT00236535|Tramadol|tramadol|mesh-list
92650394|NCT00236535|Hydrocodone|hydrocodone|mesh-list
92650395|NCT00236535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92650396|NCT00236535|Analgesics|analgesics|mesh-ancestor
92650397|NCT00236535|Sensory System Agents|sensory system agents|mesh-ancestor
92650398|NCT00236535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650399|NCT00236535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650400|NCT00236535|Antipyretics|antipyretics|mesh-ancestor
92375705|NCT04922658|Vinorelbine|vinorelbine|mesh-list
92650401|NCT00236535|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92650402|NCT00236535|Narcotics|narcotics|mesh-ancestor
92650403|NCT00236535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650404|NCT00236535|Antitussive Agents|antitussive agents|mesh-ancestor
92650405|NCT00236535|Respiratory System Agents|respiratory system agents|mesh-ancestor
92650406|NCT00193219|Leucovorin|leucovorin|mesh-list
92650407|NCT00193219|Bevacizumab|bevacizumab|mesh-list
92650408|NCT00193219|Cetuximab|cetuximab|mesh-list
92650409|NCT00193219|Fluorouracil|fluorouracil|mesh-list
92650410|NCT00193219|Oxaliplatin|oxaliplatin|mesh-list
92650411|NCT00193219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92650412|NCT00193219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650413|NCT00193219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92650425|NCT00193219|Vitamin B Complex|vitamin b complex|mesh-ancestor
92650426|NCT00193219|Vitamins|vitamins|mesh-ancestor
92650427|NCT00193219|Micronutrients|micronutrients|mesh-ancestor
92650428|NCT00199316|Morphine|morphine|mesh-list
92650429|NCT00199316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92650430|NCT00199316|Narcotics|narcotics|mesh-ancestor
92650431|NCT00199316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650432|NCT00199316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650433|NCT00199316|Analgesics|analgesics|mesh-ancestor
92650434|NCT00199316|Sensory System Agents|sensory system agents|mesh-ancestor
92650435|NCT00199316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650436|NCT00196339|Cyproterone Acetate|cyproterone acetate|mesh-list
92650437|NCT00196339|Cyproterone|cyproterone|mesh-list
92650438|NCT00196339|Androgen Antagonists|androgen antagonists|mesh-ancestor
92650439|NCT00196339|Hormone Antagonists|hormone antagonists|mesh-ancestor
92650440|NCT00196339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650441|NCT00196339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650442|NCT00196339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650443|NCT00196339|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92650444|NCT00196339|Contraceptive Agents|contraceptive agents|mesh-ancestor
92650445|NCT00196339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92650446|NCT00257361|Cycloserine|cycloserine|mesh-list
92650447|NCT00257361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92650448|NCT00257361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650449|NCT00257361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92650450|NCT00257361|Antitubercular Agents|antitubercular agents|mesh-ancestor
92650451|NCT00257361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650452|NCT00257361|Antimetabolites|antimetabolites|mesh-ancestor
92650453|NCT00257361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650454|NCT00199355|Istradefylline|istradefylline|mesh-list
92650455|NCT00199355|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92650456|NCT00199355|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92650457|NCT00199355|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92650458|NCT00199355|Purinergic Agents|purinergic agents|mesh-ancestor
92563305|NCT00406861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650459|NCT00199355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650460|NCT00199355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650461|NCT00199355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650462|NCT00179959|Mupirocin|mupirocin|mesh-list
92650463|NCT00179959|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92650464|NCT00179959|Eusol|eusol|mesh-list
92650465|NCT00179959|Petrolatum|petrolatum|mesh-list
92650466|NCT00179959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650467|NCT00179959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650468|NCT00179959|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92650469|NCT00179959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650470|NCT00179959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650471|NCT00179959|Disinfectants|disinfectants|mesh-ancestor
92650472|NCT00179959|Emollients|emollients|mesh-ancestor
92650473|NCT00179959|Dermatologic Agents|dermatologic agents|mesh-ancestor
92650474|NCT00199394|Istradefylline|istradefylline|mesh-list
92650475|NCT00199394|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92650476|NCT00199394|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92650477|NCT00199394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92650480|NCT00199394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650481|NCT00199394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650482|NCT00236574|Galantamine|galantamine|mesh-list
92650483|NCT00236574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92650484|NCT00236574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650485|NCT00236574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650486|NCT00236574|Cholinergic Agents|cholinergic agents|mesh-ancestor
92650487|NCT00236574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650488|NCT00236574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650489|NCT00236574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92650490|NCT00236574|Autonomic Agents|autonomic agents|mesh-ancestor
92650491|NCT00236574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650492|NCT00236574|Nootropic Agents|nootropic agents|mesh-ancestor
92650493|NCT00199433|Istradefylline|istradefylline|mesh-list
92650494|NCT00199433|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92650495|NCT00199433|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92650496|NCT00199433|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92650497|NCT00199433|Purinergic Agents|purinergic agents|mesh-ancestor
92650498|NCT00199433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650499|NCT00199433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650500|NCT00199433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650501|NCT00199472|Diuretics|diuretics|mesh-list
92650502|NCT00199472|Natriuretic Agents|natriuretic agents|mesh-ancestor
92650503|NCT00199472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650504|NCT00199511|Mannitol|mannitol|mesh-list
92650505|NCT00199511|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92650506|NCT00199511|Diuretics|diuretics|mesh-ancestor
92650507|NCT00199511|Natriuretic Agents|natriuretic agents|mesh-ancestor
92650508|NCT00199511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650509|NCT00236613|Topiramate|topiramate|mesh-list
92650510|NCT00236613|Anticonvulsants|anticonvulsants|mesh-ancestor
92650511|NCT00236613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650512|NCT00236613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650513|NCT00236652|Levofloxacin|levofloxacin|mesh-list
92650514|NCT00236652|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92650515|NCT00236652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650516|NCT00236652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650517|NCT00236652|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92650518|NCT00236652|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92650519|NCT00236652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650520|NCT00236652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650521|NCT00236652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650522|NCT00236652|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92650523|NCT00236652|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92650524|NCT00257595|Cetirizine|cetirizine|mesh-list
92650525|NCT00257595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92650526|NCT00257595|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92650527|NCT00257595|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92650528|NCT00257595|Histamine Antagonists|histamine antagonists|mesh-ancestor
92650529|NCT00257595|Histamine Agents|histamine agents|mesh-ancestor
92650530|NCT00257595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650531|NCT00257595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563306|NCT00406861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563307|NCT00406861|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92563308|NCT00406861|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91970678|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92650532|NCT00257595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650533|NCT00199667|Mycophenolic Acid|mycophenolic acid|mesh-list
92650534|NCT00199667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92650535|NCT00199667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650536|NCT00199667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92650537|NCT00199667|Antitubercular Agents|antitubercular agents|mesh-ancestor
92650538|NCT00199667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650539|NCT00199667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650540|NCT00199667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650541|NCT00199667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650542|NCT00236691|Topiramate|topiramate|mesh-list
92650543|NCT00236691|Anticonvulsants|anticonvulsants|mesh-ancestor
92650544|NCT00236691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650545|NCT00236691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650546|NCT00236730|Topiramate|topiramate|mesh-list
92650547|NCT00236730|Anticonvulsants|anticonvulsants|mesh-ancestor
92650548|NCT00236730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650549|NCT00236730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650609|NCT00199940|Dopamine Agents|dopamine agents|mesh-ancestor
92650610|NCT00236808|Levofloxacin|levofloxacin|mesh-list
92650611|NCT00236808|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92650612|NCT00236808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650613|NCT00236808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650614|NCT00236808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92650615|NCT00236808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92650616|NCT00236808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650617|NCT00236808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650618|NCT00236808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650619|NCT00236808|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92650620|NCT00236808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92650621|NCT00199979|Nevirapine|nevirapine|mesh-list
92650622|NCT00199979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92650623|NCT00199979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92650624|NCT00199979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650636|NCT00257634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650637|NCT00257634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650638|NCT00257634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650639|NCT00257634|Glucocorticoids|glucocorticoids|mesh-ancestor
92650640|NCT00257634|Hormones|hormones|mesh-ancestor
92650641|NCT00257634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650642|NCT00257634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92650643|NCT00257634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650644|NCT00236847|Topiramate|topiramate|mesh-list
92650645|NCT00236847|Anticonvulsants|anticonvulsants|mesh-ancestor
92650646|NCT00236847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650647|NCT00236847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650648|NCT00410306|Methyltestosterone|methyltestosterone|mesh-list
92650649|NCT00410306|Testosterone|testosterone|mesh-list
92650650|NCT00410306|Testosterone undecanoate|testosterone undecanoate|mesh-list
92650651|NCT00410306|Testosterone enanthate|testosterone enanthate|mesh-list
92650652|NCT00410306|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92650653|NCT00410306|Androgens|androgens|mesh-ancestor
92650654|NCT00410306|Hormones|hormones|mesh-ancestor
92650655|NCT00410306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650656|NCT00410306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650657|NCT00410306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92650658|NCT00410306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650659|NCT00410306|Anabolic Agents|anabolic agents|mesh-ancestor
92650660|NCT00257712|Hormones|hormones|mesh-list
92650661|NCT00257712|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92650662|NCT00257712|Tesamorelin|tesamorelin|mesh-list
92650663|NCT00257712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650664|NCT00257712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650665|NCT00257712|Growth Substances|growth substances|mesh-ancestor
92650666|NCT00179647|Dexamethasone|dexamethasone|mesh-list
92650667|NCT00179647|Lenalidomide|lenalidomide|mesh-list
92650668|NCT00179647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650669|NCT00179647|Antiemetics|antiemetics|mesh-ancestor
92650670|NCT00179647|Autonomic Agents|autonomic agents|mesh-ancestor
92650671|NCT00179647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650672|NCT00179647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650673|NCT00179647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650674|NCT00179647|Glucocorticoids|glucocorticoids|mesh-ancestor
92650675|NCT00179647|Hormones|hormones|mesh-ancestor
92650676|NCT00179647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650677|NCT00179647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92650678|NCT00179647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650679|NCT00179647|Immunologic Factors|immunologic factors|mesh-ancestor
92650680|NCT00179647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92650681|NCT00179647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92650682|NCT00179647|Growth Substances|growth substances|mesh-ancestor
92650683|NCT00179647|Growth Inhibitors|growth inhibitors|mesh-ancestor
92650684|NCT00257751|Aprotinin|aprotinin|mesh-list
92650685|NCT00257751|Hemostatics|hemostatics|mesh-ancestor
92650686|NCT00257751|Coagulants|coagulants|mesh-ancestor
92650687|NCT00257751|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92650688|NCT00257751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92057918|NCT01937312|Travoprost|travoprost|mesh-list
92650691|NCT00257751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650692|NCT00179413|Interferons|interferons|mesh-list
92650693|NCT00179413|Interferon-alpha|interferon-alpha|mesh-list
92650694|NCT00179413|Interferon alpha-2|interferon alpha-2|mesh-list
92650695|NCT00179413|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92650696|NCT00179413|Colchicine|colchicine|mesh-list
92650697|NCT00179413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650698|NCT00179413|Antiviral Agents|antiviral agents|mesh-ancestor
92650699|NCT00179413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650700|NCT00179413|Immunologic Factors|immunologic factors|mesh-ancestor
92650701|NCT00179413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650702|NCT00179413|Gout Suppressants|gout suppressants|mesh-ancestor
92650703|NCT00179413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650704|NCT00179413|Tubulin Modulators|tubulin modulators|mesh-ancestor
92650705|NCT00179413|Antimitotic Agents|antimitotic agents|mesh-ancestor
92650706|NCT00179413|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650707|NCT00179413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650709|NCT00236886|Anticonvulsants|anticonvulsants|mesh-ancestor
92650710|NCT00236886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92650711|NCT00236886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650712|NCT00257790|Tobramycin|tobramycin|mesh-list
92650713|NCT00257790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650714|NCT00257790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650715|NCT00236925|Hydrocortisone|hydrocortisone|mesh-list
92650716|NCT00236925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650717|NCT00236964|Epoetin Alfa|epoetin alfa|mesh-list
92650718|NCT00236964|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92650719|NCT00236964|Hematinics|hematinics|mesh-ancestor
92650720|NCT00200252|Oxytocin|oxytocin|mesh-list
92650721|NCT00200252|Oxytocics|oxytocics|mesh-ancestor
92650722|NCT00200252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92650723|NCT00200252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650724|NCT00177307|Bevacizumab|bevacizumab|mesh-list
92650725|NCT00177307|Capecitabine|capecitabine|mesh-list
92650726|NCT00177307|Oxaliplatin|oxaliplatin|mesh-list
92650727|NCT00177307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92650728|NCT00177307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650729|NCT00177307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92650730|NCT00177307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92650731|NCT00177307|Growth Substances|growth substances|mesh-ancestor
92650732|NCT00177307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650733|NCT00177307|Growth Inhibitors|growth inhibitors|mesh-ancestor
92650734|NCT00177307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650735|NCT00177307|Antimetabolites|antimetabolites|mesh-ancestor
92650736|NCT00177307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650737|NCT00257829|Methazolamide|methazolamide|mesh-list
92650738|NCT00257829|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92650739|NCT00257829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650740|NCT00257829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650741|NCT00257829|Diuretics|diuretics|mesh-ancestor
92650742|NCT00257829|Natriuretic Agents|natriuretic agents|mesh-ancestor
92650743|NCT00257829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650744|NCT00176644|Estradiol|estradiol|mesh-list
92650745|NCT00176644|Estrogens|estrogens|mesh-ancestor
92650746|NCT00176644|Hormones|hormones|mesh-ancestor
92650747|NCT00176644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92563309|NCT00406861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563310|NCT00044265|Ramipril|ramipril|mesh-list
92563311|NCT00044265|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92650748|NCT00176644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650749|NCT02484664|Celecoxib|celecoxib|mesh-list
92650750|NCT02484664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92650751|NCT02484664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92650752|NCT02484664|Analgesics|analgesics|mesh-ancestor
92650753|NCT02484664|Sensory System Agents|sensory system agents|mesh-ancestor
92650754|NCT02484664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650755|NCT02484664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650756|NCT02484664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650757|NCT02484664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650758|NCT02484664|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92650759|NCT02484664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92650760|NCT02484664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650761|NCT02484664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650762|NCT00257868|Rivastigmine|rivastigmine|mesh-list
92650763|NCT00257868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92650764|NCT00257868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650769|NCT00257868|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92650770|NCT00257868|Protective Agents|protective agents|mesh-ancestor
92650771|NCT00176605|Cyclophosphamide|cyclophosphamide|mesh-list
92650773|NCT00176605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92650774|NCT00176605|Immunologic Factors|immunologic factors|mesh-ancestor
92650775|NCT00176605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650776|NCT00176605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650777|NCT00176605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92650778|NCT00176605|Alkylating Agents|alkylating agents|mesh-ancestor
92650779|NCT00176605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650780|NCT00176605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650781|NCT00176605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92650782|NCT00176605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92650783|NCT00176605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92650784|NCT00176605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92650785|NCT00176605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650787|NCT00176488|Epirubicin|epirubicin|mesh-list
92650788|NCT00176488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92650789|NCT00176488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650790|NCT00176488|Tubulin Modulators|tubulin modulators|mesh-ancestor
92650791|NCT00176488|Antimitotic Agents|antimitotic agents|mesh-ancestor
92650792|NCT00176488|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650793|NCT00176488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650794|NCT00176488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92650795|NCT00176488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92650796|NCT00176488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92650797|NCT00176488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650798|NCT00200447|Carbidopa|carbidopa|mesh-list
92650799|NCT00200447|Levodopa|levodopa|mesh-list
92650800|NCT00200447|Entacapone|entacapone|mesh-list
92650801|NCT00200447|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92650802|NCT00200447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92650803|NCT00200447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92650804|NCT00200447|Dopamine Agents|dopamine agents|mesh-ancestor
92650805|NCT00200447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650806|NCT00200447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650807|NCT00200447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650808|NCT00200447|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92650809|NCT00200447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650810|NCT00200447|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92650811|NCT00237120|Imatinib Mesylate|imatinib mesylate|mesh-list
92650812|NCT00237120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650813|NCT00237120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92650814|NCT00237120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650815|NCT00237120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650816|NCT00175825|Brivaracetam|brivaracetam|mesh-list
92650817|NCT00175825|Anticonvulsants|anticonvulsants|mesh-ancestor
92650818|NCT04710329|Ascorbic Acid|ascorbic acid|mesh-list
92650819|NCT04710329|Antioxidants|antioxidants|mesh-ancestor
92650820|NCT04710329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563312|NCT00044265|Protease Inhibitors|protease inhibitors|mesh-ancestor
92563313|NCT00044265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563314|NCT00044265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563315|NCT00044265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92650821|NCT04710329|Protective Agents|protective agents|mesh-ancestor
92650822|NCT04710329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650823|NCT04710329|Vitamins|vitamins|mesh-ancestor
92650824|NCT04710329|Micronutrients|micronutrients|mesh-ancestor
92650825|NCT00200525|Apomorphine|apomorphine|mesh-list
92650826|NCT00200525|Emetics|emetics|mesh-ancestor
92650827|NCT00200525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650828|NCT00200525|Autonomic Agents|autonomic agents|mesh-ancestor
92650829|NCT00200525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650830|NCT00200525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650831|NCT00200525|Dopamine Agonists|dopamine agonists|mesh-ancestor
92650832|NCT00200525|Dopamine Agents|dopamine agents|mesh-ancestor
92650833|NCT00200525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650834|NCT00200525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650835|NCT00174967|Febuxostat|febuxostat|mesh-list
92650840|NCT00200564|Sensory System Agents|sensory system agents|mesh-ancestor
92650841|NCT00200564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650842|NCT00200564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650843|NCT00200564|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92650844|NCT00200564|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92650845|NCT00200564|Anesthetics, General|anesthetics, general|mesh-ancestor
92650846|NCT00200564|Anesthetics|anesthetics|mesh-ancestor
92650847|NCT00200564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650848|NCT00200564|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92650849|NCT00200564|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92650850|NCT00200564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650851|NCT00200564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650852|NCT00174265|Olanzapine|olanzapine|mesh-list
92650853|NCT00174265|Asenapine|asenapine|mesh-list
92650854|NCT00174265|Antiemetics|antiemetics|mesh-ancestor
92650855|NCT00174265|Autonomic Agents|autonomic agents|mesh-ancestor
92650856|NCT00174265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650857|NCT00174265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650858|NCT00174265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650859|NCT00174265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650860|NCT00174265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650861|NCT00174265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650862|NCT00174265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650863|NCT00174265|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92650864|NCT00174265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92650865|NCT00174265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650866|NCT00174265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650867|NCT00174265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650868|NCT00174265|Serotonin Agents|serotonin agents|mesh-ancestor
92650869|NCT00200603|Calcium|calcium|mesh-list
92650870|NCT00200603|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92650871|NCT00200603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650872|NCT00200681|Bortezomib|bortezomib|mesh-list
92650873|NCT00200681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650874|NCT00258063|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92650875|NCT00258063|Norelgestromin|norelgestromin|mesh-list
92650876|NCT00258063|Contraceptive Agents|contraceptive agents|mesh-list
92650877|NCT00258063|Estradiol|estradiol|mesh-list
92650878|NCT00258063|Estrogens|estrogens|mesh-ancestor
92650879|NCT00258063|Hormones|hormones|mesh-ancestor
92650880|NCT00258063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650881|NCT00258063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650882|NCT00258063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92650883|NCT00258063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92650884|NCT00258063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92650885|NCT00258063|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92650886|NCT00258063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92650887|NCT00258102|Levofloxacin|levofloxacin|mesh-list
92650888|NCT00258102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92650889|NCT00258102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563317|NCT00398099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563318|NCT00398099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563319|NCT00406978|Thalidomide|thalidomide|mesh-list
92563321|NCT00406978|Melphalan|melphalan|mesh-list
92563322|NCT00406978|Defibrotide|defibrotide|mesh-list
92563323|NCT00406978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650890|NCT00258102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650891|NCT00258102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92650892|NCT00258102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92650893|NCT00258102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650894|NCT00258102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650895|NCT00258102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650896|NCT00258102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92650897|NCT00258102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92650898|NCT00265278|Modafinil|modafinil|mesh-list
92650899|NCT00265278|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92650900|NCT00265278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650901|NCT00265278|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92650902|NCT00265278|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92650903|NCT00265278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92650904|NCT00265278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650905|NCT00258258|Zoledronic Acid|zoledronic acid|mesh-list
92650909|NCT00172042|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92650910|NCT00172042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650911|NCT00258297|Gefitinib|gefitinib|mesh-list
92650912|NCT00258297|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92650913|NCT00258297|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92650914|NCT00258297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650915|NCT00258297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92650916|NCT00258297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650917|NCT00258336|Rituximab|rituximab|mesh-list
92650918|NCT00258336|Immunoglobulins|immunoglobulins|mesh-list
92650919|NCT00258336|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92650920|NCT00258336|Antibodies|antibodies|mesh-list
92650921|NCT00258336|Sargramostim|sargramostim|mesh-list
92650922|NCT00258336|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92650923|NCT00258336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92650924|NCT00258336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650925|NCT00258336|Immunologic Factors|immunologic factors|mesh-ancestor
92650926|NCT00258336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650927|NCT00258336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650928|NCT00171925|Vitamin D|vitamin d|mesh-list
92650930|NCT00171925|Calcium|calcium|mesh-list
92650931|NCT00171925|Vitamins|vitamins|mesh-ancestor
92650932|NCT00171925|Micronutrients|micronutrients|mesh-ancestor
92650933|NCT00171925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650934|NCT00171925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92650935|NCT00171925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92650936|NCT00258375|Docetaxel|docetaxel|mesh-list
92650937|NCT00258375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650938|NCT00258375|Tubulin Modulators|tubulin modulators|mesh-ancestor
92650939|NCT00258375|Antimitotic Agents|antimitotic agents|mesh-ancestor
92650940|NCT00258375|Mitosis Modulators|mitosis modulators|mesh-ancestor
92650941|NCT00258375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650942|NCT00201305|Leucovorin|leucovorin|mesh-list
92650943|NCT00201305|Gemcitabine|gemcitabine|mesh-list
92650944|NCT00201305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650945|NCT00201305|Antimetabolites|antimetabolites|mesh-ancestor
92650946|NCT00201305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650947|NCT00201305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650948|NCT00201305|Antidotes|antidotes|mesh-ancestor
92650949|NCT00201305|Protective Agents|protective agents|mesh-ancestor
92650950|NCT00201305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650951|NCT00201305|Vitamin B Complex|vitamin b complex|mesh-ancestor
92650952|NCT00201305|Vitamins|vitamins|mesh-ancestor
92650953|NCT00201305|Micronutrients|micronutrients|mesh-ancestor
92650954|NCT00265551|Olanzapine|olanzapine|mesh-list
92650955|NCT00265551|Antiemetics|antiemetics|mesh-ancestor
92650956|NCT00265551|Autonomic Agents|autonomic agents|mesh-ancestor
92563324|NCT00406978|Glucocorticoids|glucocorticoids|mesh-ancestor
92563325|NCT00406978|Hormones|hormones|mesh-ancestor
92563326|NCT00406978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650957|NCT00265551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650958|NCT00265551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650959|NCT00265551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650960|NCT00265551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650961|NCT00265551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650962|NCT00265551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650963|NCT00265551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650964|NCT00265551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92650965|NCT00265551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92650966|NCT00265551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650967|NCT00265551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650968|NCT00265551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650969|NCT00265551|Serotonin Agents|serotonin agents|mesh-ancestor
92650970|NCT00201344|Leucovorin|leucovorin|mesh-list
92650971|NCT00201344|Antidotes|antidotes|mesh-ancestor
92650972|NCT00201344|Protective Agents|protective agents|mesh-ancestor
92650973|NCT00201344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650974|NCT00201344|Vitamin B Complex|vitamin b complex|mesh-ancestor
92650975|NCT00201344|Vitamins|vitamins|mesh-ancestor
92650976|NCT00201344|Micronutrients|micronutrients|mesh-ancestor
92650977|NCT00201383|Cisplatin|cisplatin|mesh-list
92650978|NCT00201383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650979|NCT00201422|Amoxicillin|amoxicillin|mesh-list
92650980|NCT00201422|Clarithromycin|clarithromycin|mesh-list
92650983|NCT00201422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650984|NCT00201422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92650985|NCT00201422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92650986|NCT00201422|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92650987|NCT00201422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650988|NCT00201422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650989|NCT00201422|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92650990|NCT00201422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92650991|NCT00201422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92650993|NCT00258609|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92650994|NCT00258609|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92650995|NCT00258609|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92650996|NCT00258609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650997|NCT00258609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650998|NCT00258609|Cholinergic Agents|cholinergic agents|mesh-ancestor
92650999|NCT00258609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651000|NCT00258609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651001|NCT00258609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92651002|NCT00258609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651003|NCT00265746|Metformin|metformin|mesh-list
92651004|NCT00265746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651005|NCT00265746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651006|NCT00201539|Morphine|morphine|mesh-list
92651007|NCT00201539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92651008|NCT00201539|Narcotics|narcotics|mesh-ancestor
92651009|NCT00201539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92651010|NCT00201539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651011|NCT00201539|Analgesics|analgesics|mesh-ancestor
92651012|NCT00201539|Sensory System Agents|sensory system agents|mesh-ancestor
92651013|NCT00201539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651014|NCT00265824|Bevacizumab|bevacizumab|mesh-list
92651015|NCT00265824|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92651016|NCT00265824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92651017|NCT00265824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651018|NCT00265824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92651019|NCT00265824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92651020|NCT00265824|Growth Substances|growth substances|mesh-ancestor
92651021|NCT00265824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651022|NCT00265824|Growth Inhibitors|growth inhibitors|mesh-ancestor
92651023|NCT00265824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92651024|NCT00265824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651025|NCT00265824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651026|NCT00201695|Dexamethasone|dexamethasone|mesh-list
92651027|NCT00201695|Doxorubicin|doxorubicin|mesh-list
92563327|NCT00406978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563328|NCT00406978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92563329|NCT00406978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970694|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92651028|NCT00201695|Vincristine|vincristine|mesh-list
92651029|NCT00201695|Arsenic Trioxide|arsenic trioxide|mesh-list
92651030|NCT00201695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651031|NCT00201695|Antiemetics|antiemetics|mesh-ancestor
92651032|NCT00201695|Autonomic Agents|autonomic agents|mesh-ancestor
92651033|NCT00201695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651034|NCT00201695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651035|NCT00201695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651036|NCT00201695|Glucocorticoids|glucocorticoids|mesh-ancestor
92651037|NCT00201695|Hormones|hormones|mesh-ancestor
92651038|NCT00201695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651039|NCT00201695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651040|NCT00201695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651041|NCT00201695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92651042|NCT00201695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92651043|NCT00201695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92651044|NCT00201695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651045|NCT00201695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651046|NCT00201695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92651047|NCT00201695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92651048|NCT00201695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92651049|NCT00201695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92651050|NCT00410345|Mifepristone|mifepristone|mesh-list
92651051|NCT00410345|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92651052|NCT00410345|Abortifacient Agents|abortifacient agents|mesh-ancestor
92651054|NCT00410345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651055|NCT00410345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92651056|NCT00410345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92651057|NCT00410345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92651058|NCT00410345|Contraceptive Agents|contraceptive agents|mesh-ancestor
92651059|NCT00410345|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92651060|NCT00410345|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92651061|NCT00410345|Hormone Antagonists|hormone antagonists|mesh-ancestor
92651062|NCT00410345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651063|NCT00410345|Luteolytic Agents|luteolytic agents|mesh-ancestor
92651064|NCT00410345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92651065|NCT00410345|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92651066|NCT00265863|Mitomycins|mitomycins|mesh-list
92651067|NCT00265863|Mitomycin|mitomycin|mesh-list
92651068|NCT00265863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92651069|NCT00265863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651070|NCT00265863|Alkylating Agents|alkylating agents|mesh-ancestor
92651071|NCT00265863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651072|NCT00265863|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92651073|NCT00265863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651074|NCT00410462|Doxorubicin|doxorubicin|mesh-list
92651075|NCT00410462|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92651076|NCT00410462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92651077|NCT00410462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651078|NCT00410462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92651079|NCT00410462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92651080|NCT00410462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651081|NCT00410462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651082|NCT00258765|Zoledronic Acid|zoledronic acid|mesh-list
92651084|NCT00258765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651085|NCT00258765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92651086|NCT00258765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92651087|NCT00258765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92651088|NCT00258765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651089|NCT00258765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92651090|NCT00258765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651091|NCT00410540|Morphine|morphine|mesh-list
92651092|NCT00410540|Hydromorphone|hydromorphone|mesh-list
92651093|NCT00410540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92651094|NCT00410540|Narcotics|narcotics|mesh-ancestor
92651095|NCT00410540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92651096|NCT00410540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651098|NCT00410540|Sensory System Agents|sensory system agents|mesh-ancestor
92651099|NCT00410540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651100|NCT00258804|Insulin Glargine|insulin glargine|mesh-list
92651101|NCT00258804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651102|NCT00258804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651103|NCT00201812|Dexamethasone|dexamethasone|mesh-list
92651104|NCT00201812|Etanercept|etanercept|mesh-list
92651105|NCT00201812|Docetaxel|docetaxel|mesh-list
92651106|NCT00201812|Glucocorticoids|glucocorticoids|mesh-list
92651107|NCT00201812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651108|NCT00201812|Antiemetics|antiemetics|mesh-ancestor
92651109|NCT00201812|Autonomic Agents|autonomic agents|mesh-ancestor
92651110|NCT00201812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651111|NCT00201812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651112|NCT00201812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651113|NCT00201812|Hormones|hormones|mesh-ancestor
92651114|NCT00201812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651115|NCT00201812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651116|NCT00201812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651117|NCT00201812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92651118|NCT00201812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92651119|NCT00201812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92651120|NCT00201812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651121|NCT00201812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92651122|NCT00201812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92651123|NCT00201812|Analgesics|analgesics|mesh-ancestor
92651124|NCT00201812|Sensory System Agents|sensory system agents|mesh-ancestor
92651125|NCT00201812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651126|NCT00201812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651128|NCT00258843|Vaccines|vaccines|mesh-list
92651129|NCT00258843|Immunologic Factors|immunologic factors|mesh-ancestor
92651130|NCT00258843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651131|NCT04709094|Bupropion|bupropion|mesh-list
92651132|NCT04709094|Warfarin|warfarin|mesh-list
92651133|NCT04709094|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92651134|NCT04709094|Norethindrone|norethindrone|mesh-list
92651135|NCT04709094|Norethindrone Acetate|norethindrone acetate|mesh-list
92651136|NCT04709094|Norinyl|norinyl|mesh-list
92651137|NCT04709094|Estradiol|estradiol|mesh-list
92651138|NCT04709094|Estrogens|estrogens|mesh-ancestor
92651139|NCT04709094|Hormones|hormones|mesh-ancestor
92651140|NCT04709094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651141|NCT04709094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651142|NCT04709094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92651143|NCT04709094|Contraceptive Agents|contraceptive agents|mesh-ancestor
92651144|NCT04709094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92651145|NCT04709094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92651146|NCT04709094|Anticoagulants|anticoagulants|mesh-ancestor
92651147|NCT04709094|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92651148|NCT04709094|Antidepressive Agents|antidepressive agents|mesh-ancestor
92651149|NCT04709094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92651150|NCT04709094|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92651151|NCT04709094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92651152|NCT04709094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651153|NCT04709094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651154|NCT04709094|Dopamine Agents|dopamine agents|mesh-ancestor
92651155|NCT04709094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651156|NCT04709094|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92651157|NCT04709094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92651159|NCT04709094|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92651160|NCT04709094|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92651161|NCT04709094|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92651162|NCT04709094|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92651163|NCT00171340|Zoledronic Acid|zoledronic acid|mesh-list
92651164|NCT00171340|Letrozole|letrozole|mesh-list
92651165|NCT00171340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651166|NCT00171340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92651167|NCT00171340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92651168|NCT00171340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651169|NCT00171340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651170|NCT00171340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92651171|NCT00171340|Hormone Antagonists|hormone antagonists|mesh-ancestor
92563330|NCT00406978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92563332|NCT00406978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651172|NCT00171340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651173|NCT00171340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651174|NCT00171340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92651175|NCT00202007|Risperidone|risperidone|mesh-list
92651176|NCT00202007|Aripiprazole|aripiprazole|mesh-list
92651177|NCT00202007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92651178|NCT00202007|Serotonin Agents|serotonin agents|mesh-ancestor
92651179|NCT00202007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651180|NCT00202007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651181|NCT00202007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651182|NCT00202007|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92651183|NCT00202007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92651184|NCT00202007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92651185|NCT00202007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92651186|NCT00202007|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92651187|NCT00202007|Dopamine Agents|dopamine agents|mesh-ancestor
92651188|NCT00202007|Antidepressive Agents|antidepressive agents|mesh-ancestor
92651189|NCT00202007|Dopamine Agonists|dopamine agonists|mesh-ancestor
92651190|NCT00202007|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92651191|NCT00202007|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92651192|NCT00202007|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92651193|NCT00202007|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92651194|NCT00171301|Deferasirox|deferasirox|mesh-list
92651195|NCT00171301|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92651196|NCT00171301|Chelating Agents|chelating agents|mesh-ancestor
92651197|NCT00171301|Sequestering Agents|sequestering agents|mesh-ancestor
92651198|NCT00171301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651199|NCT00266058|Ritonavir|ritonavir|mesh-list
92651200|NCT00266058|Lopinavir|lopinavir|mesh-list
92651201|NCT00266058|Efavirenz|efavirenz|mesh-list
92651207|NCT00266058|Protease Inhibitors|protease inhibitors|mesh-ancestor
92651208|NCT00266058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651209|NCT00266058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651210|NCT00266058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92651211|NCT00266058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92651212|NCT00266058|Antiviral Agents|antiviral agents|mesh-ancestor
92651213|NCT00266058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651214|NCT00266058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92651215|NCT00266058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92651216|NCT00266058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92651217|NCT00266058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92651218|NCT00266058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92651219|NCT00266058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92651220|NCT00266058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92651221|NCT00266058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92651222|NCT00266058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92651223|NCT00266058|Antimalarials|antimalarials|mesh-ancestor
92651224|NCT00266058|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92651225|NCT00266058|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92376526|NCT02179788|Metformin|metformin|mesh-list
92651226|NCT00171223|Imatinib Mesylate|imatinib mesylate|mesh-list
92651227|NCT00171223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651228|NCT00171223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92651229|NCT00171223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651230|NCT00171223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651231|NCT00202124|Tryptophan|tryptophan|mesh-list
92651232|NCT00202124|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92651233|NCT00202124|Antidepressive Agents|antidepressive agents|mesh-ancestor
92651234|NCT00202124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92651235|NCT00266097|Gemcitabine|gemcitabine|mesh-list
92651236|NCT00266097|Oxaliplatin|oxaliplatin|mesh-list
92651237|NCT00266097|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92651238|NCT00266097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92651239|NCT00266097|Antimetabolites|antimetabolites|mesh-ancestor
92651240|NCT00266097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651241|NCT00266097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563333|NCT00406978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92563334|NCT00406978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563335|NCT00406978|Immunologic Factors|immunologic factors|mesh-ancestor
92563336|NCT00406978|Leprostatic Agents|leprostatic agents|mesh-ancestor
92563337|NCT00406978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92563338|NCT00406978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651242|NCT00266097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92651243|NCT00266097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651244|NCT00202163|Testosterone|testosterone|mesh-list
92651245|NCT00202163|Androgens|androgens|mesh-ancestor
92651247|NCT00202163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651248|NCT00202163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651249|NCT00476554|Sapacitabine|sapacitabine|mesh-list
92651250|NCT00476554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651251|NCT04709289|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92651252|NCT04709289|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92651253|NCT04709289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92651254|NCT00202241|Testosterone|testosterone|mesh-list
92651255|NCT00202241|Androgens|androgens|mesh-ancestor
92651256|NCT00202241|Hormones|hormones|mesh-ancestor
92651257|NCT00202241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651258|NCT00202241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651259|NCT00266136|Cytarabine|cytarabine|mesh-list
92651260|NCT00266136|Cyclophosphamide|cyclophosphamide|mesh-list
92651261|NCT00266136|Daunorubicin|daunorubicin|mesh-list
92651262|NCT00266136|Thioguanine|thioguanine|mesh-list
92651263|NCT00266136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651264|NCT00266136|Immunologic Factors|immunologic factors|mesh-ancestor
92651265|NCT00266136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651266|NCT00266136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651267|NCT00266136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92651268|NCT00266136|Alkylating Agents|alkylating agents|mesh-ancestor
92651269|NCT00266136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651270|NCT00266136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651274|NCT00266136|Antiviral Agents|antiviral agents|mesh-ancestor
92651275|NCT00266136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651276|NCT00266136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92651277|NCT00266136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92651278|NCT00266136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92651279|NCT00266136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651280|NCT00230594|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92651281|NCT00230594|Hemostatics|hemostatics|mesh-ancestor
92651282|NCT00230594|Coagulants|coagulants|mesh-ancestor
92651283|NCT00230594|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92651284|NCT00230594|Natriuretic Agents|natriuretic agents|mesh-ancestor
92651285|NCT00230594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651286|NCT00259077|Omeprazole|omeprazole|mesh-list
92651287|NCT00259077|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92651288|NCT00259077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651289|NCT00259077|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92651290|NCT00259077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651291|NCT00259077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651292|NCT00479674|Paclitaxel|paclitaxel|mesh-list
92651293|NCT00479674|Bevacizumab|bevacizumab|mesh-list
92651294|NCT00479674|Carboplatin|carboplatin|mesh-list
92651295|NCT00479674|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92651296|NCT00479674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92651297|NCT00479674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651298|NCT00479674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92651299|NCT00479674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92651300|NCT00479674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92651301|NCT00479674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651302|NCT00479674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92651303|NCT00479674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92651304|NCT00479674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92651305|NCT00479674|Growth Substances|growth substances|mesh-ancestor
92651306|NCT00479674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651307|NCT00479674|Growth Inhibitors|growth inhibitors|mesh-ancestor
92651308|NCT02962310|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92651309|NCT02962310|Calcium|calcium|mesh-list
92563339|NCT00406978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91970705|NCT02468999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651310|NCT02962310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92651311|NCT02962310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651312|NCT02962310|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92651313|NCT02962310|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92651314|NCT02962310|Antimetabolites|antimetabolites|mesh-ancestor
92651315|NCT02962310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651316|NCT02962310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92651317|NCT02962310|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92651318|NCT02962310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651319|NCT00259116|Methocarbamol|methocarbamol|mesh-list
92651320|NCT00259116|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92651321|NCT00259116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651322|NCT00259116|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92651323|NCT00259116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651324|NCT00415779|Zoledronic Acid|zoledronic acid|mesh-list
92651326|NCT00415779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651327|NCT00415779|Tubulin Modulators|tubulin modulators|mesh-ancestor
92651328|NCT00415779|Antimitotic Agents|antimitotic agents|mesh-ancestor
92651329|NCT00415779|Mitosis Modulators|mitosis modulators|mesh-ancestor
92651330|NCT00415779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651331|NCT00415779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92651332|NCT00415779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651333|NCT00259155|Rifaximin|rifaximin|mesh-list
92651334|NCT00259155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92651335|NCT00259155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651336|NCT00259155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651337|NCT00479401|Pramipexole|pramipexole|mesh-list
92651338|NCT00479401|Antioxidants|antioxidants|mesh-ancestor
92651339|NCT00479401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651340|NCT00479401|Protective Agents|protective agents|mesh-ancestor
92651341|NCT00479401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651342|NCT00479401|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92651364|NCT00478777|Hormones|hormones|mesh-ancestor
92651365|NCT00478777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651366|NCT00478777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651367|NCT00478777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651368|NCT00478777|Immunologic Factors|immunologic factors|mesh-ancestor
92651369|NCT00478777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92651370|NCT00478777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92651371|NCT00478777|Growth Substances|growth substances|mesh-ancestor
92651372|NCT00478777|Growth Inhibitors|growth inhibitors|mesh-ancestor
92651373|NCT00477607|Thioctic Acid|thioctic acid|mesh-list
92651374|NCT00477607|Antioxidants|antioxidants|mesh-ancestor
92651375|NCT00477607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651376|NCT00477607|Protective Agents|protective agents|mesh-ancestor
92651377|NCT00477607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651378|NCT00477607|Vitamin B Complex|vitamin b complex|mesh-ancestor
92651379|NCT00477607|Vitamins|vitamins|mesh-ancestor
92651380|NCT00477607|Micronutrients|micronutrients|mesh-ancestor
92651381|NCT00230867|Acyclovir|acyclovir|mesh-list
92651382|NCT00230867|Antiviral Agents|antiviral agents|mesh-ancestor
92651383|NCT00230867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651384|NCT00266214|Lidocaine|lidocaine|mesh-list
92651385|NCT00266214|Anesthetics, Local|anesthetics, local|mesh-ancestor
92651386|NCT00266214|Anesthetics|anesthetics|mesh-ancestor
92651387|NCT00266214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92651388|NCT00266214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651389|NCT00266214|Sensory System Agents|sensory system agents|mesh-ancestor
92651390|NCT00266214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651391|NCT00266214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92651392|NCT00266214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92651393|NCT00266214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92651394|NCT00266214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651395|NCT00266214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651396|NCT00266253|Metformin|metformin|mesh-list
92651397|NCT00266253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651440|NCT00231140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651441|NCT00231140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92651442|NCT00231140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563340|NCT00406978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563341|NCT00406978|Growth Substances|growth substances|mesh-ancestor
92563342|NCT00406978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92651443|NCT00231140|Growth Substances|growth substances|mesh-ancestor
92651444|NCT00231140|Growth Inhibitors|growth inhibitors|mesh-ancestor
92651445|NCT00231140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651446|NCT00231218|Propolis|propolis|mesh-list
92651447|NCT00231218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651448|NCT00266448|Chlorhexidine|chlorhexidine|mesh-list
92651449|NCT00266448|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92651450|NCT00266448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651451|NCT00266448|Disinfectants|disinfectants|mesh-ancestor
92651452|NCT00231335|Escitalopram|escitalopram|mesh-list
92651453|NCT00231335|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92651454|NCT00231335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92651455|NCT00231335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651456|NCT00231335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651457|NCT00231335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651458|NCT00231335|Serotonin Agents|serotonin agents|mesh-ancestor
92651459|NCT00231335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651461|NCT00266487|Folic Acid|folic acid|mesh-list
92651462|NCT00266487|Vitamin B 12|vitamin b 12|mesh-list
92651463|NCT00266487|Vitamin B 6|vitamin b 6|mesh-list
92651464|NCT00266487|Pyridoxal|pyridoxal|mesh-list
92651465|NCT00266487|Pyridoxine|pyridoxine|mesh-list
92651466|NCT00266487|Vitamin B Complex|vitamin b complex|mesh-list
92651467|NCT00266487|Micronutrients|micronutrients|mesh-ancestor
92651468|NCT00266487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651469|NCT00266487|Hematinics|hematinics|mesh-ancestor
92651470|NCT00231452|Artesunate|artesunate|mesh-list
92651471|NCT00231452|Pyrimethamine|pyrimethamine|mesh-list
92651472|NCT00231452|Sulfadoxine|sulfadoxine|mesh-list
92651473|NCT00231452|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92651474|NCT00231452|Antimalarials|antimalarials|mesh-ancestor
92651475|NCT00231452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92651476|NCT00231452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92651477|NCT00231452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651478|NCT00231452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651479|NCT00231452|Antiviral Agents|antiviral agents|mesh-ancestor
92651480|NCT00231452|Schistosomicides|schistosomicides|mesh-ancestor
92651481|NCT00231452|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92651482|NCT00231452|Anthelmintics|anthelmintics|mesh-ancestor
92651483|NCT00231452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92651484|NCT00231452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651485|NCT00231452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651486|NCT00231452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92651487|NCT00231491|Botulinum Toxins|botulinum toxins|mesh-list
92651488|NCT00231491|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92651489|NCT00231491|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92651490|NCT00231491|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92651491|NCT00231491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651492|NCT00231491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651493|NCT00231491|Cholinergic Agents|cholinergic agents|mesh-ancestor
92651494|NCT00231491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651495|NCT00231491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651496|NCT00231491|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92651497|NCT00231491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651498|NCT00477490|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92651499|NCT00477490|Hemostatics|hemostatics|mesh-ancestor
92651500|NCT00477490|Coagulants|coagulants|mesh-ancestor
92651501|NCT00477490|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92651502|NCT00477490|Natriuretic Agents|natriuretic agents|mesh-ancestor
92651503|NCT00477490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651504|NCT00231530|Topiramate|topiramate|mesh-list
92651505|NCT00231530|Anticonvulsants|anticonvulsants|mesh-ancestor
92651506|NCT00231530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651507|NCT00231530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651511|NCT00231569|Antimetabolites|antimetabolites|mesh-ancestor
92651512|NCT00231569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651513|NCT00231569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92651514|NCT00477334|Famciclovir|famciclovir|mesh-list
92651515|NCT00477334|Antiviral Agents|antiviral agents|mesh-ancestor
92651516|NCT00477334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651517|NCT00477334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563343|NCT00406978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92563344|NCT00406978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92563345|NCT00406978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92651518|NCT00477334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651519|NCT00477334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651521|NCT00231608|Anticonvulsants|anticonvulsants|mesh-ancestor
92651522|NCT00231608|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91956376|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
92651523|NCT00231608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651524|NCT00266604|Topiramate|topiramate|mesh-list
92651525|NCT00266604|Anticonvulsants|anticonvulsants|mesh-ancestor
92651526|NCT00266604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651527|NCT00266604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651528|NCT04561336|Cetuximab|cetuximab|mesh-list
92651529|NCT04561336|Avelumab|avelumab|mesh-list
92376821|NCT02267772|Acetaminophen|acetaminophen|mesh-list
92651530|NCT04561336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92651531|NCT04561336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651532|NCT00259428|Dronedarone|dronedarone|mesh-list
92651533|NCT00259428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92651534|NCT00231647|Topiramate|topiramate|mesh-list
92651535|NCT00231647|Anticonvulsants|anticonvulsants|mesh-ancestor
92651536|NCT00231647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651537|NCT00231647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651538|NCT04560751|Lenvatinib|lenvatinib|mesh-list
92651539|NCT04560751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651540|NCT04560751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92651541|NCT04560751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651542|NCT04560751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651543|NCT00266643|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92651544|NCT00266643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92651545|NCT00266643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92651546|NCT00266643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651547|NCT00266643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651548|NCT00266643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651549|NCT00266643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651550|NCT00266643|Analgesics|analgesics|mesh-ancestor
92651551|NCT00266643|Sensory System Agents|sensory system agents|mesh-ancestor
92651552|NCT00266643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651553|NCT00266643|Antidepressive Agents|antidepressive agents|mesh-ancestor
92651554|NCT00266643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92651555|NCT00266643|Dopamine Agents|dopamine agents|mesh-ancestor
92651556|NCT00231725|Insulin Lispro|insulin lispro|mesh-list
92651557|NCT00231725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651558|NCT00231725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651559|NCT04560049|Phenol|phenol|mesh-list
92651560|NCT04560049|Silver Nitrate|silver nitrate|mesh-list
92651561|NCT04560049|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92651562|NCT04560049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651563|NCT04560049|Disinfectants|disinfectants|mesh-ancestor
92651564|NCT04560049|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92651565|NCT04560049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92651566|NCT04559425|Dexamethasone|dexamethasone|mesh-list
92651567|NCT04559425|Dexamethasone acetate|dexamethasone acetate|mesh-list
92651568|NCT04559425|BB 1101|bb 1101|mesh-list
92651569|NCT04559425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651570|NCT04559425|Antiemetics|antiemetics|mesh-ancestor
92651571|NCT04559425|Autonomic Agents|autonomic agents|mesh-ancestor
92651572|NCT04559425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651573|NCT04559425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651574|NCT04559425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651575|NCT04559425|Glucocorticoids|glucocorticoids|mesh-ancestor
92651576|NCT04559425|Hormones|hormones|mesh-ancestor
92651577|NCT04559425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651578|NCT04559425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651579|NCT04559425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651580|NCT04559425|Protease Inhibitors|protease inhibitors|mesh-ancestor
92651583|NCT00231764|Daclizumab|daclizumab|mesh-list
92651584|NCT00231764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651585|NCT00231764|Immunologic Factors|immunologic factors|mesh-ancestor
92651586|NCT00231764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651587|NCT04559308|Metformin|metformin|mesh-list
92651588|NCT04559308|Paclitaxel|paclitaxel|mesh-list
92651589|NCT04559308|Cyclophosphamide|cyclophosphamide|mesh-list
92651590|NCT04559308|Doxorubicin|doxorubicin|mesh-list
92563347|NCT00157651|Anticoagulants|anticoagulants|mesh-ancestor
92563348|NCT00044343|Lapatinib|lapatinib|mesh-list
92563349|NCT00044343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563350|NCT00044343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92651591|NCT04559308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92651592|NCT04559308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651593|NCT04559308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92651594|NCT04559308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363963|NCT04356144|Thrombin|thrombin|mesh-list
92651595|NCT04559308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92651596|NCT04559308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651597|NCT04559308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651598|NCT04559308|Immunologic Factors|immunologic factors|mesh-ancestor
92651599|NCT04559308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651600|NCT04559308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651601|NCT04559308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92651602|NCT04559308|Alkylating Agents|alkylating agents|mesh-ancestor
92651603|NCT04559308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92651604|NCT04559308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651605|NCT04559308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92651606|NCT04559308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92651607|NCT04559308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92651608|NCT04559308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651609|NCT04559113|Methylprednisolone|methylprednisolone|mesh-list
92651610|NCT04559113|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92651611|NCT04559113|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92651612|NCT04559113|Prednisolone|prednisolone|mesh-list
92651613|NCT04559113|Prednisolone acetate|prednisolone acetate|mesh-list
92651614|NCT04559113|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92651615|NCT04559113|Prednisolone phosphate|prednisolone phosphate|mesh-list
92651616|NCT04559113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651617|NCT04559113|Antiemetics|antiemetics|mesh-ancestor
92651618|NCT04559113|Autonomic Agents|autonomic agents|mesh-ancestor
92651619|NCT04559113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651620|NCT04559113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651621|NCT04559113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651622|NCT04559113|Glucocorticoids|glucocorticoids|mesh-ancestor
92651623|NCT04559113|Hormones|hormones|mesh-ancestor
92651624|NCT04559113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651625|NCT04559113|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92651626|NCT04559113|Protective Agents|protective agents|mesh-ancestor
92651627|NCT04559113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651628|NCT04559113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651629|NCT00266721|Pancrelipase|pancrelipase|mesh-list
92651630|NCT00266721|Pancreatin|pancreatin|mesh-list
92651631|NCT00266721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651632|NCT04559074|Amlodipine|amlodipine|mesh-list
92651633|NCT04559074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92651634|NCT04559074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92651635|NCT04559074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651636|NCT04559074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651637|NCT04559074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92651638|NCT04559074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651639|NCT04559074|Vasodilator Agents|vasodilator agents|mesh-ancestor
92651640|NCT02211976|Bisacodyl|bisacodyl|mesh-list
92651641|NCT02211976|Cathartics|cathartics|mesh-ancestor
92651642|NCT02211976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651643|NCT02211976|Laxatives|laxatives|mesh-ancestor
92651644|NCT04558684|Immunomodulating Agents|immunomodulating agents|mesh-list
92651645|NCT04558684|Immunologic Factors|immunologic factors|mesh-ancestor
92651646|NCT04558684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651647|NCT00231959|Pramipexole|pramipexole|mesh-list
92651648|NCT00231959|Antioxidants|antioxidants|mesh-ancestor
92651649|NCT00231959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651650|NCT00231959|Protective Agents|protective agents|mesh-ancestor
92651651|NCT00231959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651652|NCT00231959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92651653|NCT00231959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92651654|NCT00231959|Dopamine Agonists|dopamine agonists|mesh-ancestor
92651670|NCT00231998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651671|NCT00231998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563352|NCT00044343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563353|NCT00157690|Alendronate|alendronate|mesh-list
91970714|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92651672|NCT00266838|Dexamethasone|dexamethasone|mesh-list
92651673|NCT00266838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651674|NCT00266838|Antiemetics|antiemetics|mesh-ancestor
92651675|NCT00266838|Autonomic Agents|autonomic agents|mesh-ancestor
92651676|NCT00266838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651677|NCT00266838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651678|NCT00266838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651679|NCT00266838|Glucocorticoids|glucocorticoids|mesh-ancestor
92651680|NCT00266838|Hormones|hormones|mesh-ancestor
92651681|NCT00266838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651682|NCT00266838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651683|NCT00266838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651684|NCT00232037|Tegaserod|tegaserod|mesh-list
92651685|NCT00232037|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92651686|NCT00232037|Serotonin Agents|serotonin agents|mesh-ancestor
92651687|NCT00232037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651688|NCT00232037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651689|NCT00232037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651690|NCT02212210|Methylprednisolone|methylprednisolone|mesh-list
92651691|NCT02212210|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92651692|NCT02212210|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92651693|NCT02212210|Prednisolone|prednisolone|mesh-list
92651694|NCT02212210|Prednisolone acetate|prednisolone acetate|mesh-list
92651695|NCT02212210|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92651696|NCT02212210|Prednisolone phosphate|prednisolone phosphate|mesh-list
92651697|NCT02212210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651698|NCT02212210|Antiemetics|antiemetics|mesh-ancestor
92651699|NCT02212210|Autonomic Agents|autonomic agents|mesh-ancestor
92651700|NCT02212210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651701|NCT02212210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651702|NCT02212210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651703|NCT02212210|Glucocorticoids|glucocorticoids|mesh-ancestor
92651704|NCT02212210|Hormones|hormones|mesh-ancestor
92651705|NCT02212210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651706|NCT02212210|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92651707|NCT02212210|Protective Agents|protective agents|mesh-ancestor
92651708|NCT02212210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651709|NCT02212210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651710|NCT00232076|Cyclosporine|cyclosporine|mesh-list
92651711|NCT00232076|Cyclosporins|cyclosporins|mesh-list
92651712|NCT00232076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651713|NCT00232076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651714|NCT00232076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651719|NCT00232076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92651720|NCT00232076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651721|NCT00232076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92651722|NCT00232115|Pimecrolimus|pimecrolimus|mesh-list
92651723|NCT00232115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92651724|NCT00232115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92651725|NCT00232115|Analgesics|analgesics|mesh-ancestor
92651726|NCT00232115|Sensory System Agents|sensory system agents|mesh-ancestor
92651727|NCT00232115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651728|NCT00232115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651729|NCT00232115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651730|NCT00232115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651731|NCT00232115|Dermatologic Agents|dermatologic agents|mesh-ancestor
92651732|NCT00232115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651733|NCT00232115|Immunologic Factors|immunologic factors|mesh-ancestor
92651734|NCT00232115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92651735|NCT00232115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651736|NCT00232115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651737|NCT04558021|Niclosamide|niclosamide|mesh-list
92651738|NCT04558021|Anticestodal Agents|anticestodal agents|mesh-ancestor
92651739|NCT04558021|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92651740|NCT04558021|Anthelmintics|anthelmintics|mesh-ancestor
92651741|NCT04558021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92651742|NCT04558021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563354|NCT00157690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92563355|NCT00157690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563357|NCT00051506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651743|NCT04558021|Antinematodal Agents|antinematodal agents|mesh-ancestor
92651744|NCT00232154|Azithromycin|azithromycin|mesh-list
92651745|NCT00232154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92651746|NCT00232154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651747|NCT00259662|Atorvastatin|atorvastatin|mesh-list
92651748|NCT00259662|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92651749|NCT00259662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92651750|NCT00259662|Antimetabolites|antimetabolites|mesh-ancestor
92651751|NCT00259662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363971|NCT04355598|Anesthetics|anesthetics|mesh-ancestor
92651752|NCT00259662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92651753|NCT00259662|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92651754|NCT00259662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651755|NCT04557943|Hyaluronic Acid|hyaluronic acid|mesh-list
92651756|NCT04557943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92651757|NCT04557943|Immunologic Factors|immunologic factors|mesh-ancestor
92651758|NCT04557943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651759|NCT04557943|Viscosupplements|viscosupplements|mesh-ancestor
92651760|NCT04557943|Protective Agents|protective agents|mesh-ancestor
92651761|NCT04557475|Aspirin|aspirin|mesh-list
92651762|NCT04557475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92651763|NCT04557475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92651764|NCT04557475|Analgesics|analgesics|mesh-ancestor
92651765|NCT04557475|Sensory System Agents|sensory system agents|mesh-ancestor
92651766|NCT04557475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651767|NCT04557475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651768|NCT04557475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651769|NCT04557475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651770|NCT04557475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92651771|NCT04557475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92651772|NCT04557475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651773|NCT04557475|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92651774|NCT04557475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92651775|NCT04557475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651776|NCT04557475|Antipyretics|antipyretics|mesh-ancestor
92651777|NCT00232271|Enoxaparin|enoxaparin|mesh-list
92651778|NCT00232271|Anticoagulants|anticoagulants|mesh-ancestor
92651779|NCT00232271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92651780|NCT00232271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92651781|NCT00232271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651782|NCT04557397|Itraconazole|itraconazole|mesh-list
92651783|NCT04557397|Rifampin|rifampin|mesh-list
92651784|NCT04557397|Antifungal Agents|antifungal agents|mesh-ancestor
92651785|NCT04557397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651786|NCT04557397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92651797|NCT04557397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92651798|NCT04557397|Leprostatic Agents|leprostatic agents|mesh-ancestor
92651799|NCT04557397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92651800|NCT04557397|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92651801|NCT04557397|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92651802|NCT04557397|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92651803|NCT04557397|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92651804|NCT04557397|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92651805|NCT04557397|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92651807|NCT04557202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92651808|NCT04557202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92651809|NCT04557202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92651810|NCT04557202|Adrenergic Agents|adrenergic agents|mesh-ancestor
92651811|NCT04557202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651812|NCT04557202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651813|NCT04557202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651814|NCT04557202|Urological Agents|urological agents|mesh-ancestor
92651815|NCT00232349|Galantamine|galantamine|mesh-list
92651816|NCT00232349|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92651817|NCT00232349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651818|NCT00232349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563358|NCT00157729|Pyridoxal|pyridoxal|mesh-list
92563359|NCT00157729|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
92563360|NCT00157729|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92563361|NCT00157729|Protease Inhibitors|protease inhibitors|mesh-ancestor
91970721|NCT02468297|Analgesics|analgesics|mesh-ancestor
92651819|NCT00232349|Cholinergic Agents|cholinergic agents|mesh-ancestor
92651820|NCT00232349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651821|NCT00232349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651822|NCT00232349|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92651823|NCT00232349|Autonomic Agents|autonomic agents|mesh-ancestor
92651824|NCT00232349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651825|NCT00232349|Nootropic Agents|nootropic agents|mesh-ancestor
92651826|NCT00259701|Nitroglycerin|nitroglycerin|mesh-list
92651827|NCT00259701|Acetylcholine|acetylcholine|mesh-list
92651828|NCT00259701|Vasodilator Agents|vasodilator agents|mesh-ancestor
92651829|NCT00259701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92651830|NCT00259701|Cholinergic Agents|cholinergic agents|mesh-ancestor
92651831|NCT00259701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651832|NCT00259701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651833|NCT00259701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651834|NCT04556929|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92651835|NCT04556929|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92651836|NCT04556929|Dermatologic Agents|dermatologic agents|mesh-ancestor
92651837|NCT04566211|Amoxicillin|amoxicillin|mesh-list
92651838|NCT04566211|Metronidazole|metronidazole|mesh-list
92651839|NCT04566211|Clarithromycin|clarithromycin|mesh-list
92651840|NCT04566211|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92651841|NCT04566211|Pantoprazole|pantoprazole|mesh-list
92651842|NCT04566211|Bismuth|bismuth|mesh-list
92651843|NCT04566211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92651844|NCT04566211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651845|NCT04566211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92651846|NCT04566211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92682827|NCT00438269|Cefazolin|cefazolin|mesh-list
92651851|NCT04566211|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92651852|NCT04566211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92651853|NCT04566211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651854|NCT04566211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92651855|NCT04566211|Antacids|antacids|mesh-ancestor
92651856|NCT00259779|Prednisolone|prednisolone|mesh-list
92651857|NCT00259779|Budesonide|budesonide|mesh-list
92651858|NCT00259779|Formoterol Fumarate|formoterol fumarate|mesh-list
92651859|NCT00259779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651860|NCT00259779|Glucocorticoids|glucocorticoids|mesh-ancestor
92651861|NCT00259779|Hormones|hormones|mesh-ancestor
92651862|NCT00259779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651863|NCT00259779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651864|NCT00259779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651865|NCT00259779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651866|NCT00259779|Autonomic Agents|autonomic agents|mesh-ancestor
92651867|NCT00259779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651868|NCT00259779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92651869|NCT00259779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92651870|NCT00259779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92651871|NCT00259779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92651872|NCT00259779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92651873|NCT00259779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92651874|NCT00259779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92651875|NCT00259779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651876|NCT00259779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651877|NCT02211079|Tolbutamide|tolbutamide|mesh-list
92651878|NCT02211079|Midazolam|midazolam|mesh-list
92651879|NCT02211079|Caffeine|caffeine|mesh-list
92651880|NCT02211079|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92651881|NCT02211079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92651882|NCT02211079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92651883|NCT02211079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651884|NCT02211079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92651885|NCT02211079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92651886|NCT02211079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92651887|NCT02211079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92651888|NCT02211079|Anesthetics, General|anesthetics, general|mesh-ancestor
92651889|NCT02211079|Anesthetics|anesthetics|mesh-ancestor
92651890|NCT02211079|GABA Modulators|gaba modulators|mesh-ancestor
92563362|NCT00157729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563363|NCT00157729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563364|NCT00157729|Vitamin B Complex|vitamin b complex|mesh-ancestor
92563365|NCT00157729|Vitamins|vitamins|mesh-ancestor
92651891|NCT02211079|GABA Agents|gaba agents|mesh-ancestor
92651892|NCT02211079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651893|NCT02211079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651894|NCT02211079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92651895|NCT02211079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92651896|NCT02211079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651897|NCT02211079|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92651898|NCT02211079|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92651899|NCT02211079|Purinergic Agents|purinergic agents|mesh-ancestor
92651900|NCT02211079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651901|NCT00232622|Streptokinase|streptokinase|mesh-list
92651902|NCT00232622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92651903|NCT00232622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92651904|NCT00232622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651905|NCT00232661|Tamoxifen|tamoxifen|mesh-list
92651906|NCT00232661|Anastrozole|anastrozole|mesh-list
92377186|NCT02354352|Diuretics|diuretics|mesh-ancestor
92651907|NCT00232661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92651908|NCT00232661|Hormone Antagonists|hormone antagonists|mesh-ancestor
92651909|NCT00232661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651910|NCT00232661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651911|NCT00232661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651912|NCT00232661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651913|NCT00232661|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92651914|NCT00232661|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92682828|NCT00438269|Tazobactam|tazobactam|mesh-list
92651928|NCT00267267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651929|NCT00267267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92651930|NCT00267267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92651931|NCT00267267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651932|NCT04564690|Vitamin E|vitamin e|mesh-list
92651933|NCT04564690|Selenium|selenium|mesh-list
92651934|NCT04564690|Vitamins|vitamins|mesh-ancestor
92651935|NCT04564690|Micronutrients|micronutrients|mesh-ancestor
92651936|NCT04564690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651937|NCT04564690|Antioxidants|antioxidants|mesh-ancestor
92651938|NCT04564690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651939|NCT04564690|Protective Agents|protective agents|mesh-ancestor
92651940|NCT04564690|Trace Elements|trace elements|mesh-ancestor
92651941|NCT00232700|Escitalopram|escitalopram|mesh-list
92651942|NCT00232700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92651943|NCT00232700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92651944|NCT00232700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92651945|NCT00232700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651946|NCT00232700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651947|NCT00232700|Serotonin Agents|serotonin agents|mesh-ancestor
92651948|NCT00232700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651949|NCT04564456|Fluticasone|fluticasone|mesh-list
92651950|NCT04564456|Xhance|xhance|mesh-list
92651951|NCT04564456|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92651952|NCT04564456|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92651953|NCT04564456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651954|NCT04564456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92651955|NCT04564456|Autonomic Agents|autonomic agents|mesh-ancestor
92651956|NCT04564456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651957|NCT04564456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651958|NCT04564456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92651959|NCT04564456|Respiratory System Agents|respiratory system agents|mesh-ancestor
92651960|NCT04564456|Dermatologic Agents|dermatologic agents|mesh-ancestor
92651961|NCT04564456|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92651962|NCT04564456|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92651963|NCT04564456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92651964|NCT04564456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92651965|NCT04564456|Adrenergic Agents|adrenergic agents|mesh-ancestor
92651966|NCT04564456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563366|NCT00157729|Micronutrients|micronutrients|mesh-ancestor
92563367|NCT00157729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651967|NCT04564456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651968|NCT04564456|Glucocorticoids|glucocorticoids|mesh-ancestor
92651969|NCT04564456|Hormones|hormones|mesh-ancestor
92651970|NCT04564456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651971|NCT04564456|Sympathomimetics|sympathomimetics|mesh-ancestor
92651972|NCT04564144|Meclizine|meclizine|mesh-list
92651973|NCT04564144|Antiemetics|antiemetics|mesh-ancestor
92651974|NCT04564144|Autonomic Agents|autonomic agents|mesh-ancestor
92651975|NCT04564144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682829|NCT00438269|Piperacillin|piperacillin|mesh-list
92651982|NCT04564144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651983|NCT04564144|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92651984|NCT04564144|Cholinergic Agents|cholinergic agents|mesh-ancestor
92651985|NCT04564144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92651987|NCT00267306|Immunologic Factors|immunologic factors|mesh-ancestor
92651988|NCT00267306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651990|NCT00259896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92651991|NCT00259896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651992|NCT00259896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92651993|NCT00259896|Incretins|incretins|mesh-ancestor
92651994|NCT00259896|Hormones|hormones|mesh-ancestor
92651995|NCT00259896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651996|NCT04721795|Antitubercular Agents|antitubercular agents|mesh-list
92651997|NCT04721795|Atorvastatin|atorvastatin|mesh-list
92651998|NCT04721795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92651999|NCT04721795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92652000|NCT04721795|Antimetabolites|antimetabolites|mesh-ancestor
92652001|NCT04721795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652002|NCT04721795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92652003|NCT04721795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92652004|NCT04721795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652005|NCT04721795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652006|NCT04721795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652007|NCT04675021|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92652008|NCT04564222|Micronutrients|micronutrients|mesh-list
92652009|NCT04564222|Trace Elements|trace elements|mesh-list
92652010|NCT04564222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652011|NCT00232817|Nicotine|nicotine|mesh-list
92652012|NCT00232817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92652013|NCT00232817|Autonomic Agents|autonomic agents|mesh-ancestor
92652014|NCT00232817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652015|NCT00232817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652016|NCT00232817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92652017|NCT00232817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92652018|NCT00232817|Cholinergic Agents|cholinergic agents|mesh-ancestor
92652019|NCT00232817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652020|NCT00232817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652021|NCT00267384|Acetylcysteine|acetylcysteine|mesh-list
92652022|NCT00267384|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92652023|NCT00267384|Antiviral Agents|antiviral agents|mesh-ancestor
92652024|NCT00267384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652025|NCT00267384|Expectorants|expectorants|mesh-ancestor
92652026|NCT00267384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92652027|NCT00267384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92652028|NCT00267384|Antioxidants|antioxidants|mesh-ancestor
92652029|NCT00267384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652030|NCT00267384|Protective Agents|protective agents|mesh-ancestor
92652031|NCT00267384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652032|NCT00267384|Antidotes|antidotes|mesh-ancestor
92652033|NCT00259935|Topotecan|topotecan|mesh-list
92652034|NCT00259935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92652035|NCT00259935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92652036|NCT00259935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652037|NCT00259935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652038|NCT00259935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652039|NCT00232856|Sirolimus|sirolimus|mesh-list
92652040|NCT00232856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652041|NCT00232856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652042|NCT00232856|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92652043|NCT00232856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652044|NCT00232856|Antifungal Agents|antifungal agents|mesh-ancestor
92652045|NCT00232856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563368|NCT00051545|Seocalcitol|seocalcitol|mesh-list
92563369|NCT00051545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652066|NCT00232934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652067|NCT00232934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652068|NCT00232934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92652069|NCT00232934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92652070|NCT00232934|Growth Substances|growth substances|mesh-ancestor
92652071|NCT00232934|Growth Inhibitors|growth inhibitors|mesh-ancestor
92652072|NCT00232934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652073|NCT04673812|Fentanyl|fentanyl|mesh-list
92652074|NCT04673812|Bupivacaine|bupivacaine|mesh-list
92652075|NCT04673812|Naloxone|naloxone|mesh-list
92652076|NCT04673812|Anesthetics, Local|anesthetics, local|mesh-ancestor
92652077|NCT04673812|Anesthetics|anesthetics|mesh-ancestor
92652078|NCT04673812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652079|NCT04673812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652080|NCT04673812|Sensory System Agents|sensory system agents|mesh-ancestor
92652081|NCT04673812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652082|NCT04673812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92652083|NCT04673812|Narcotics|narcotics|mesh-ancestor
92652084|NCT04673812|Analgesics|analgesics|mesh-ancestor
92652085|NCT04673812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92652086|NCT04673812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92652087|NCT04673812|Anesthetics, General|anesthetics, general|mesh-ancestor
92652088|NCT04673812|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92652089|NCT04673461|Xylometazoline|xylometazoline|mesh-list
92652090|NCT04673461|Nasal Decongestants|nasal decongestants|mesh-ancestor
92652091|NCT04673461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92652092|NCT04673461|Respiratory System Agents|respiratory system agents|mesh-ancestor
92652093|NCT00260052|Epoetin Alfa|epoetin alfa|mesh-list
92652094|NCT00260052|Hematinics|hematinics|mesh-ancestor
92652095|NCT04673500|Lidocaine|lidocaine|mesh-list
92652096|NCT04673500|Propofol|propofol|mesh-list
92652097|NCT04673500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92652098|NCT04673500|Anesthetics|anesthetics|mesh-ancestor
92652099|NCT04673500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652100|NCT04673500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652101|NCT04673500|Sensory System Agents|sensory system agents|mesh-ancestor
92652102|NCT04673500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652103|NCT04673500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92059321|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
92652110|NCT04673500|Anesthetics, General|anesthetics, general|mesh-ancestor
92652111|NCT00233012|Topiramate|topiramate|mesh-list
92652112|NCT00233012|Anticonvulsants|anticonvulsants|mesh-ancestor
92652113|NCT00233012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92652114|NCT00233012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652115|NCT00267540|Cholecalciferol|cholecalciferol|mesh-list
92652116|NCT00267540|Vitamin D|vitamin d|mesh-list
92652117|NCT00267540|Vitamins|vitamins|mesh-ancestor
92652118|NCT00267540|Micronutrients|micronutrients|mesh-ancestor
92652119|NCT00267540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652120|NCT00267540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92652121|NCT00267540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92652122|NCT00233051|Fluticasone|fluticasone|mesh-list
92652123|NCT00233051|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92652124|NCT00233051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652125|NCT00233051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92652126|NCT00233051|Autonomic Agents|autonomic agents|mesh-ancestor
92652127|NCT00233051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652128|NCT00233051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652129|NCT00233051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92652130|NCT00233051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92652131|NCT00233051|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652132|NCT00233051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92652133|NCT00233051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92652134|NCT00233051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92652135|NCT00233051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92652136|NCT00233051|Adrenergic Agents|adrenergic agents|mesh-ancestor
92652137|NCT00233051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652138|NCT00233051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652139|NCT04672759|Durvalumab|durvalumab|mesh-list
92652140|NCT04672759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92652141|NCT04672759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652142|NCT04672759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652143|NCT04672759|Immunologic Factors|immunologic factors|mesh-ancestor
92652144|NCT04672759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652145|NCT04672330|Tislelizumab|tislelizumab|mesh-list
92563370|NCT00051545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563371|NCT00051545|Immunologic Factors|immunologic factors|mesh-ancestor
92563372|NCT00051545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563373|NCT00157885|Artesunate|artesunate|mesh-list
92563374|NCT00157885|Amodiaquine|amodiaquine|mesh-list
92652146|NCT04672330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652147|NCT04672330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652148|NCT00260247|Carbamazepine|carbamazepine|mesh-list
92652149|NCT00260247|Oxcarbazepine|oxcarbazepine|mesh-list
92652150|NCT00260247|Anticonvulsants|anticonvulsants|mesh-ancestor
92652151|NCT00260247|Antimanic Agents|antimanic agents|mesh-ancestor
92652152|NCT00260247|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92652153|NCT00260247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652154|NCT00260247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652155|NCT00260247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92652156|NCT00260247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92652157|NCT00260247|Analgesics|analgesics|mesh-ancestor
92652158|NCT00260247|Sensory System Agents|sensory system agents|mesh-ancestor
92652159|NCT00260247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652160|NCT00260247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92652161|NCT00260247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652162|NCT00260247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652163|NCT00260247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92652164|NCT00260247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92652165|NCT00260247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92652166|NCT04671589|Meropenem|meropenem|mesh-list
92652167|NCT04671589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652168|NCT04671589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652169|NCT00260325|Valdecoxib|valdecoxib|mesh-list
92652170|NCT00260325|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92059373|NCT04641728|Pembrolizumab|pembrolizumab|mesh-list
92652171|NCT00260325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92652173|NCT00260325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652174|NCT00260325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92652175|NCT00260325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92652176|NCT00260325|Analgesics|analgesics|mesh-ancestor
92652177|NCT00260325|Sensory System Agents|sensory system agents|mesh-ancestor
92652178|NCT00260325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652179|NCT00260325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652180|NCT00260325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652181|NCT00260325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652182|NCT04671160|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92652183|NCT04671160|Dalteparin|dalteparin|mesh-list
92652184|NCT04671160|Anticoagulants|anticoagulants|mesh-ancestor
92652185|NCT04671160|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92652186|NCT04671160|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92652187|NCT04671160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652188|NCT04671394|Photosensitizing Agents|photosensitizing agents|mesh-list
92652189|NCT04671394|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652190|NCT00233558|Adalimumab|adalimumab|mesh-list
92652191|NCT00233558|Methotrexate|methotrexate|mesh-list
92652192|NCT00233558|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92652193|NCT00233558|Abortifacient Agents|abortifacient agents|mesh-ancestor
92652194|NCT00233558|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92652195|NCT00233558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652196|NCT00233558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652197|NCT00233558|Antimetabolites|antimetabolites|mesh-ancestor
92652198|NCT00233558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652199|NCT00233558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652200|NCT00233558|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652201|NCT00233558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652202|NCT00233558|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92652203|NCT00233558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652204|NCT00233558|Immunologic Factors|immunologic factors|mesh-ancestor
92652205|NCT00233558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377487|NCT04621500|Vitamin D|vitamin d|mesh-list
92652206|NCT00233558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92652208|NCT00233558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652209|NCT00233636|Gefitinib|gefitinib|mesh-list
92652210|NCT00233636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563375|NCT00157885|Antimalarials|antimalarials|mesh-ancestor
92563376|NCT00157885|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92563377|NCT00157885|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92563378|NCT00157885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563379|NCT00157885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563380|NCT00157885|Antiviral Agents|antiviral agents|mesh-ancestor
92652211|NCT00233636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652212|NCT00233636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652213|NCT00233636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652214|NCT00267657|Reserpine|reserpine|mesh-list
92652215|NCT00267657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92652216|NCT00267657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92652217|NCT00267657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92652218|NCT00267657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652219|NCT00267657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652220|NCT00267657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92652221|NCT00267657|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92652222|NCT00267657|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92652223|NCT00267657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652224|NCT00267657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652225|NCT00267657|Adrenergic Agents|adrenergic agents|mesh-ancestor
92652226|NCT00267657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652227|NCT04670809|Clevidipine|clevidipine|mesh-list
91957268|NCT04448717|Antibodies|antibodies|mesh-list
92652228|NCT04670809|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92652229|NCT04670809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652230|NCT04670809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652231|NCT04670809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92652232|NCT04670809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652233|NCT00233714|Sirolimus|sirolimus|mesh-list
92652234|NCT00233714|Temsirolimus|temsirolimus|mesh-list
92652235|NCT00233714|MTOR Inhibitors|mtor inhibitors|mesh-list
92652236|NCT00233714|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652237|NCT00233714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652238|NCT00233714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92652239|NCT00233714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652240|NCT00233714|Antifungal Agents|antifungal agents|mesh-ancestor
92652241|NCT00233714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652242|NCT00233714|Immunologic Factors|immunologic factors|mesh-ancestor
92652243|NCT00233714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652246|NCT00233714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652248|NCT04670497|Racepinephrine|racepinephrine|mesh-list
92652249|NCT04670497|Bupivacaine|bupivacaine|mesh-list
92652250|NCT04670497|Epinephryl borate|epinephryl borate|mesh-list
92652251|NCT04670497|Anesthetics, Local|anesthetics, local|mesh-ancestor
92652252|NCT04670497|Anesthetics|anesthetics|mesh-ancestor
92652253|NCT04670497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652254|NCT04670497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652255|NCT04670497|Sensory System Agents|sensory system agents|mesh-ancestor
92652256|NCT04670497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652257|NCT04670497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92652258|NCT04670497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92652259|NCT04670497|Adrenergic Agents|adrenergic agents|mesh-ancestor
92652260|NCT04670497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652261|NCT04670497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652262|NCT04670497|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92652263|NCT04670497|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92652264|NCT04670497|Autonomic Agents|autonomic agents|mesh-ancestor
92652265|NCT04670497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92652266|NCT04670497|Respiratory System Agents|respiratory system agents|mesh-ancestor
92652267|NCT04670497|Mydriatics|mydriatics|mesh-ancestor
92652268|NCT04670497|Sympathomimetics|sympathomimetics|mesh-ancestor
92652269|NCT04670497|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92652270|NCT04670107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92652271|NCT04670107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652272|NCT04670107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652273|NCT04670107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652274|NCT00260364|Bevacizumab|bevacizumab|mesh-list
92652275|NCT00260364|Gemcitabine|gemcitabine|mesh-list
92563381|NCT00157885|Schistosomicides|schistosomicides|mesh-ancestor
92563382|NCT00157885|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92563383|NCT00157885|Anthelmintics|anthelmintics|mesh-ancestor
92652276|NCT00260364|Capecitabine|capecitabine|mesh-list
92652277|NCT00260364|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92377560|NCT03179436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92652278|NCT00260364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652279|NCT00260364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652280|NCT00260364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92652281|NCT00260364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92652282|NCT00260364|Growth Substances|growth substances|mesh-ancestor
92652283|NCT00260364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652284|NCT00260364|Growth Inhibitors|growth inhibitors|mesh-ancestor
92652285|NCT00260364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652286|NCT00260364|Antimetabolites|antimetabolites|mesh-ancestor
92652287|NCT00260364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652288|NCT00260364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652289|NCT00260364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652290|NCT04557007|Pembrolizumab|pembrolizumab|mesh-list
92652291|NCT04557007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652292|NCT04557007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652293|NCT04557007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92652294|NCT04557007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652296|NCT00233792|Temsirolimus|temsirolimus|mesh-list
92652297|NCT00233792|MTOR Inhibitors|mtor inhibitors|mesh-list
92652298|NCT00233792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652299|NCT00233792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652300|NCT00233792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92652301|NCT00233792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652302|NCT00233792|Antifungal Agents|antifungal agents|mesh-ancestor
92652303|NCT00233792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652304|NCT00233792|Immunologic Factors|immunologic factors|mesh-ancestor
92652305|NCT00233792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652306|NCT00233792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652307|NCT00233792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652308|NCT00233792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652309|NCT00556153|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92652310|NCT00556153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652311|NCT00556192|Rituximab|rituximab|mesh-list
92652312|NCT00556192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652313|NCT00556192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652314|NCT00556192|Immunologic Factors|immunologic factors|mesh-ancestor
92652325|NCT00556270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92652326|NCT00556270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92652327|NCT00556270|Anesthetics, General|anesthetics, general|mesh-ancestor
92652328|NCT00556270|Anesthetics|anesthetics|mesh-ancestor
92652329|NCT00260520|Dalteparin|dalteparin|mesh-list
92652330|NCT00260520|Tinzaparin|tinzaparin|mesh-list
92652331|NCT00260520|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92652332|NCT00260520|Anticoagulants|anticoagulants|mesh-ancestor
92652333|NCT00260520|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92652334|NCT00260520|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92652335|NCT00260520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652336|NCT00233909|Gemtuzumab|gemtuzumab|mesh-list
92652337|NCT00233909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652338|NCT00233909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652339|NCT00233909|Immunotoxins|immunotoxins|mesh-ancestor
92652340|NCT00233909|Immunoconjugates|immunoconjugates|mesh-ancestor
92652341|NCT00233909|Immunologic Factors|immunologic factors|mesh-ancestor
92652342|NCT00233909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652343|NCT00267813|Bupropion|bupropion|mesh-list
92652344|NCT00267813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92652345|NCT00267813|Antidepressive Agents|antidepressive agents|mesh-ancestor
92652346|NCT00267813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92652347|NCT00267813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92652348|NCT00267813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92652349|NCT00267813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652350|NCT00267813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652351|NCT00267813|Dopamine Agents|dopamine agents|mesh-ancestor
92652352|NCT00267813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652353|NCT00267813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563385|NCT00158002|Anticonvulsants|anticonvulsants|mesh-ancestor
92563386|NCT00158002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563387|NCT00158002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563388|NCT00158041|Amifostine|amifostine|mesh-list
91970745|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92652354|NCT00267813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92652355|NCT00267813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92652356|NCT00267813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652357|NCT00234026|Gemcitabine|gemcitabine|mesh-list
92652358|NCT00234026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652359|NCT00234026|Antimetabolites|antimetabolites|mesh-ancestor
92652360|NCT00234026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652361|NCT00234026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652362|NCT00234143|Darbepoetin alfa|darbepoetin alfa|mesh-list
92652363|NCT00234143|Hematinics|hematinics|mesh-ancestor
92652364|NCT00234182|Interferons|interferons|mesh-list
92652365|NCT00234182|Interferon-alpha|interferon-alpha|mesh-list
92652366|NCT00234182|Interferon alpha-2|interferon alpha-2|mesh-list
92652367|NCT00234182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652368|NCT00234182|Antiviral Agents|antiviral agents|mesh-ancestor
92652369|NCT00234182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652370|NCT00234182|Immunologic Factors|immunologic factors|mesh-ancestor
92652371|NCT00234182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652372|NCT04669990|Remdesivir|remdesivir|mesh-list
92652373|NCT04669990|Antimetabolites|antimetabolites|mesh-ancestor
92652374|NCT04669990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652375|NCT04669990|Antiviral Agents|antiviral agents|mesh-ancestor
92652376|NCT04669990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652377|NCT00556348|Bevacizumab|bevacizumab|mesh-list
92652378|NCT00556348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652379|NCT00556348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652380|NCT00556348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92652386|NCT00556387|Analgesics|analgesics|mesh-ancestor
92652387|NCT00556387|Sensory System Agents|sensory system agents|mesh-ancestor
92652388|NCT00556387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652389|NCT00556387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652390|NCT00556387|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92652391|NCT00556387|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92652392|NCT00556387|Anesthetics, General|anesthetics, general|mesh-ancestor
92652393|NCT00556387|Anesthetics|anesthetics|mesh-ancestor
92652394|NCT00556387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652395|NCT00556387|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92652396|NCT00556387|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92652397|NCT00556387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652398|NCT00556387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652399|NCT04552093|Floxuridine|floxuridine|mesh-list
92652400|NCT04552093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652401|NCT04552093|Antimetabolites|antimetabolites|mesh-ancestor
92652402|NCT04552093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652403|NCT04552093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652404|NCT04556110|Perindopril|perindopril|mesh-list
92652405|NCT04556110|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92652406|NCT04556110|Protease Inhibitors|protease inhibitors|mesh-ancestor
92652407|NCT04556110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652408|NCT04556110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652409|NCT04556110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92652410|NCT00234299|Aspirin|aspirin|mesh-list
92652411|NCT00234299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92652412|NCT00234299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92652413|NCT00234299|Analgesics|analgesics|mesh-ancestor
92652414|NCT00234299|Sensory System Agents|sensory system agents|mesh-ancestor
92652415|NCT00234299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652416|NCT00234299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652417|NCT00234299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652418|NCT00234299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652419|NCT00234299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92652420|NCT00234299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92652421|NCT00234299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563389|NCT00158041|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92563391|NCT00158041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563392|NCT00051584|Gemcitabine|gemcitabine|mesh-list
92563393|NCT00051584|Doxorubicin|doxorubicin|mesh-list
92563394|NCT00051584|Immunoconjugates|immunoconjugates|mesh-list
91970749|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92652422|NCT00234299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92652423|NCT00234299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92652424|NCT00234299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652425|NCT00234299|Antipyretics|antipyretics|mesh-ancestor
92652426|NCT04556032|Ergothioneine|ergothioneine|mesh-list
92652427|NCT04556032|Antioxidants|antioxidants|mesh-ancestor
92652428|NCT04556032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652429|NCT04556032|Protective Agents|protective agents|mesh-ancestor
92652430|NCT04556032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652431|NCT04556071|Bevacizumab|bevacizumab|mesh-list
92652432|NCT04556071|Niraparib|niraparib|mesh-list
92652433|NCT04556071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652434|NCT04556071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652435|NCT04556071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92652436|NCT04556071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92652437|NCT04556071|Growth Substances|growth substances|mesh-ancestor
92652438|NCT04556071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652439|NCT04556071|Growth Inhibitors|growth inhibitors|mesh-ancestor
92652440|NCT04556071|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92652441|NCT04556071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652442|NCT04556071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652443|NCT04563871|Osimertinib|osimertinib|mesh-list
92652444|NCT04563871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652445|NCT04563871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652446|NCT04563871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652447|NCT04563871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652448|NCT00234377|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92652452|NCT00234377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92652453|NCT00234377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652454|NCT00234377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652455|NCT02211118|Dexmedetomidine|dexmedetomidine|mesh-list
92652456|NCT02211118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92652457|NCT02211118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652458|NCT02211118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652459|NCT02211118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92652460|NCT02211118|Analgesics|analgesics|mesh-ancestor
92652461|NCT02211118|Sensory System Agents|sensory system agents|mesh-ancestor
92652462|NCT02211118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652463|NCT02211118|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92652464|NCT02211118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92652465|NCT02211118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92652466|NCT02211118|Adrenergic Agents|adrenergic agents|mesh-ancestor
92652467|NCT02211118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652468|NCT02211118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652469|NCT00234416|Gemcitabine|gemcitabine|mesh-list
92652470|NCT00234416|Gefitinib|gefitinib|mesh-list
92652471|NCT00234416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652472|NCT00234416|Antimetabolites|antimetabolites|mesh-ancestor
92652473|NCT00234416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652474|NCT00234416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652475|NCT00234416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652476|NCT00234416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652477|NCT00234455|Sirolimus|sirolimus|mesh-list
92652478|NCT00234455|Temsirolimus|temsirolimus|mesh-list
92652479|NCT00234455|MTOR Inhibitors|mtor inhibitors|mesh-list
92652480|NCT00234455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652481|NCT00234455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652482|NCT00234455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92652483|NCT00234455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652484|NCT00234455|Antifungal Agents|antifungal agents|mesh-ancestor
92652485|NCT00234455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563395|NCT00051584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92563396|NCT00051584|Antimetabolites|antimetabolites|mesh-ancestor
92563397|NCT00051584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563398|NCT00051584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652486|NCT00234455|Immunologic Factors|immunologic factors|mesh-ancestor
92652487|NCT00234455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652488|NCT00234455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652489|NCT00234455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652490|NCT00234455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652491|NCT00234572|Lanreotide|lanreotide|mesh-list
92652492|NCT00234572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652493|NCT00260793|Ropinirole|ropinirole|mesh-list
92652494|NCT00260793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92652495|NCT00260793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92652496|NCT00260793|Dopamine Agonists|dopamine agonists|mesh-ancestor
92652497|NCT00260793|Dopamine Agents|dopamine agents|mesh-ancestor
92652498|NCT00260793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652499|NCT00260793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652500|NCT00260793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652501|NCT00415935|Methotrexate|methotrexate|mesh-list
92652502|NCT00415935|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92652503|NCT00415935|Abortifacient Agents|abortifacient agents|mesh-ancestor
92652504|NCT00415935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92652505|NCT00415935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652506|NCT00415935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652507|NCT00415935|Antimetabolites|antimetabolites|mesh-ancestor
92652508|NCT00415935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652509|NCT00415935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652510|NCT00415935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92363993|NCT04355052|Camostat|camostat|mesh-list
92652511|NCT00415935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652512|NCT00415935|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92652513|NCT00415935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652514|NCT00415935|Immunologic Factors|immunologic factors|mesh-ancestor
92652515|NCT00415935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652516|NCT00415935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92652517|NCT00413738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92652518|NCT00413738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652519|NCT02211391|Caseins|caseins|mesh-list
92652520|NCT02211391|Chelating Agents|chelating agents|mesh-ancestor
92652523|NCT04562311|Tislelizumab|tislelizumab|mesh-list
92652524|NCT04562311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652525|NCT04562311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652526|NCT00234689|Naltrexone|naltrexone|mesh-list
92652527|NCT00234689|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92652528|NCT00234689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92652529|NCT00234689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652530|NCT00234689|Sensory System Agents|sensory system agents|mesh-ancestor
92652531|NCT00234689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652532|NCT04561960|Fluorides|fluorides|mesh-list
92652533|NCT04561960|Cariostatic Agents|cariostatic agents|mesh-ancestor
92652534|NCT04561960|Protective Agents|protective agents|mesh-ancestor
92652535|NCT04561960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652536|NCT04561921|Magnesium Sulfate|magnesium sulfate|mesh-list
92652537|NCT04561921|Nordefrin|nordefrin|mesh-list
92652538|NCT04561921|Mepivacaine|mepivacaine|mesh-list
92652539|NCT04561921|Analgesics|analgesics|mesh-ancestor
92652540|NCT04561921|Sensory System Agents|sensory system agents|mesh-ancestor
92652541|NCT04561921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652542|NCT04561921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652543|NCT04561921|Anesthetics|anesthetics|mesh-ancestor
92652544|NCT04561921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652545|NCT04561921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92652546|NCT04561921|Anticonvulsants|anticonvulsants|mesh-ancestor
92652547|NCT04561921|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92652548|NCT04561921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652549|NCT04561921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652550|NCT04561921|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92652551|NCT04561921|Tocolytic Agents|tocolytic agents|mesh-ancestor
92652552|NCT04561921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92652553|NCT04561921|Anesthetics, Local|anesthetics, local|mesh-ancestor
92563399|NCT00051584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92563400|NCT00051584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92563401|NCT00051584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92563403|NCT00051584|Immunologic Factors|immunologic factors|mesh-ancestor
92652554|NCT04561921|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92652555|NCT04561687|Azelastine|azelastine|mesh-list
92652556|NCT04561687|Budesonide|budesonide|mesh-list
92652557|NCT04561687|Montelukast|montelukast|mesh-list
92652558|NCT04561687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652559|NCT04561687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92652560|NCT04561687|Autonomic Agents|autonomic agents|mesh-ancestor
92652561|NCT04561687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652562|NCT04561687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652563|NCT04561687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92652564|NCT04561687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92652565|NCT04561687|Glucocorticoids|glucocorticoids|mesh-ancestor
92652566|NCT04561687|Hormones|hormones|mesh-ancestor
92652567|NCT04561687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652568|NCT04561687|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92652569|NCT04561687|Hormone Antagonists|hormone antagonists|mesh-ancestor
92652570|NCT04561687|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92652571|NCT04561687|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92652572|NCT04561687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652573|NCT04561687|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92652574|NCT04561687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652575|NCT04561687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92652576|NCT04561687|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92652577|NCT04561687|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92652578|NCT04561687|Histamine Antagonists|histamine antagonists|mesh-ancestor
92652579|NCT04561687|Histamine Agents|histamine agents|mesh-ancestor
92652580|NCT04561687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652581|NCT04561219|Nitazoxanide|nitazoxanide|mesh-list
92652582|NCT04561219|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92652583|NCT04561219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652584|NCT00234845|Adalimumab|adalimumab|mesh-list
92652585|NCT00234845|Methotrexate|methotrexate|mesh-list
92652586|NCT00234845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92652587|NCT00234845|Abortifacient Agents|abortifacient agents|mesh-ancestor
92652588|NCT00234845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92652589|NCT00234845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652590|NCT00234845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652591|NCT00234845|Antimetabolites|antimetabolites|mesh-ancestor
92652592|NCT00234845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059789|NCT01422382|Diltiazem|diltiazem|mesh-list
92652608|NCT02211625|Analgesics|analgesics|mesh-ancestor
92652609|NCT02211625|Sensory System Agents|sensory system agents|mesh-ancestor
92652610|NCT02211625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652611|NCT00234923|Ritonavir|ritonavir|mesh-list
92652612|NCT00234923|Lopinavir|lopinavir|mesh-list
92652613|NCT00234923|Lamivudine|lamivudine|mesh-list
92652614|NCT00234923|Zidovudine|zidovudine|mesh-list
92652615|NCT00234923|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92652616|NCT00234923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92652617|NCT00234923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92652618|NCT00234923|Protease Inhibitors|protease inhibitors|mesh-ancestor
92652619|NCT00234923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652620|NCT00234923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652621|NCT00234923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92652622|NCT00234923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92652623|NCT00234923|Antiviral Agents|antiviral agents|mesh-ancestor
92652624|NCT00234923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652625|NCT00234923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92652626|NCT00234923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92652627|NCT00234923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92652628|NCT00234923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92652629|NCT00234923|Antimetabolites|antimetabolites|mesh-ancestor
92652630|NCT02213887|Pantoprazole|pantoprazole|mesh-list
92652631|NCT02213887|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92652632|NCT02213887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92652633|NCT02213887|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92563404|NCT00051584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563406|NCT00044382|Immunologic Factors|immunologic factors|mesh-ancestor
92563407|NCT00044382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563408|NCT00044382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92563409|NCT00044382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92563410|NCT00044382|Growth Substances|growth substances|mesh-ancestor
92563411|NCT00044382|Growth Inhibitors|growth inhibitors|mesh-ancestor
92652634|NCT02213887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652635|NCT02213887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652636|NCT00234962|Ritonavir|ritonavir|mesh-list
92652637|NCT00234962|Lopinavir|lopinavir|mesh-list
92652638|NCT00234962|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92652639|NCT00234962|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92652640|NCT00234962|Protease Inhibitors|protease inhibitors|mesh-ancestor
92652641|NCT00234962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652642|NCT00234962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652643|NCT00234962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92652644|NCT00234962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92652645|NCT00234962|Antiviral Agents|antiviral agents|mesh-ancestor
92652646|NCT00234962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652647|NCT00234962|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92652648|NCT00234962|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92652649|NCT04551703|Epinephrine|epinephrine|mesh-list
92652650|NCT04551703|Racepinephrine|racepinephrine|mesh-list
92652651|NCT04551703|Epinephryl borate|epinephryl borate|mesh-list
92652652|NCT04551703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92652653|NCT04551703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92652661|NCT04551703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652662|NCT04551703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92652663|NCT04551703|Respiratory System Agents|respiratory system agents|mesh-ancestor
92652664|NCT04551703|Mydriatics|mydriatics|mesh-ancestor
92652665|NCT04551703|Sympathomimetics|sympathomimetics|mesh-ancestor
91957777|NCT02051309|Guanfacine|guanfacine|mesh-list
92652666|NCT04551703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92652667|NCT00235001|Verapamil|verapamil|mesh-list
92652668|NCT00235001|Trandolapril|trandolapril|mesh-list
92652669|NCT00235001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92652670|NCT00235001|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92652671|NCT00235001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652672|NCT00235001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652673|NCT00235001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92652674|NCT00235001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652675|NCT00235001|Vasodilator Agents|vasodilator agents|mesh-ancestor
92652676|NCT00235001|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92652677|NCT00235001|Protease Inhibitors|protease inhibitors|mesh-ancestor
92652678|NCT00235001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652679|NCT00235001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92652680|NCT04551781|Prednisone|prednisone|mesh-list
92652681|NCT04551781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652682|NCT04551781|Glucocorticoids|glucocorticoids|mesh-ancestor
92652683|NCT04551781|Hormones|hormones|mesh-ancestor
92652684|NCT04551781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652685|NCT04551781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652686|NCT04551781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92652687|NCT04551781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652688|NCT00424944|Vaccines|vaccines|mesh-list
92652689|NCT00424944|Immunologic Factors|immunologic factors|mesh-ancestor
92652690|NCT00424944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652691|NCT02214004|Trastuzumab|trastuzumab|mesh-list
92652692|NCT02214004|Letrozole|letrozole|mesh-list
92652693|NCT02214004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652694|NCT02214004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652695|NCT02214004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92652696|NCT02214004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92652697|NCT02214004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652698|NCT02214004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652699|NCT02214004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92563412|NCT00044382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563413|NCT00158158|Nicotine|nicotine|mesh-list
92563414|NCT00158158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92563415|NCT00158158|Autonomic Agents|autonomic agents|mesh-ancestor
92652700|NCT02214004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92652701|NCT02214004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652702|NCT02214004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652703|NCT00235079|Colchicine|colchicine|mesh-list
92652704|NCT00235079|Gout Suppressants|gout suppressants|mesh-ancestor
92652705|NCT00235079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652706|NCT00235079|Tubulin Modulators|tubulin modulators|mesh-ancestor
92652707|NCT00235079|Antimitotic Agents|antimitotic agents|mesh-ancestor
92652708|NCT00235079|Mitosis Modulators|mitosis modulators|mesh-ancestor
92652709|NCT00235079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652710|NCT00235079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652711|NCT00260988|Dalteparin|dalteparin|mesh-list
92652712|NCT00260988|Tinzaparin|tinzaparin|mesh-list
92652713|NCT00260988|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92652714|NCT00260988|Anticoagulants|anticoagulants|mesh-ancestor
92652715|NCT00260988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92652716|NCT00260988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92652717|NCT00260988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652718|NCT00235157|Sirolimus|sirolimus|mesh-list
92652719|NCT00235157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652720|NCT00235157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652724|NCT00235157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652725|NCT00235157|Immunologic Factors|immunologic factors|mesh-ancestor
92652726|NCT00235157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652727|NCT04550338|Tranexamic Acid|tranexamic acid|mesh-list
92652728|NCT04550338|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92652729|NCT04550338|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92652730|NCT04550338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652732|NCT04550338|Coagulants|coagulants|mesh-ancestor
92652733|NCT04550611|Immunoglobulins|immunoglobulins|mesh-list
92652734|NCT04550611|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92652735|NCT04550611|Antibodies|antibodies|mesh-list
92652736|NCT04550611|gamma-Globulins|gamma-globulins|mesh-list
92652737|NCT04550611|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92652738|NCT04550611|Immunologic Factors|immunologic factors|mesh-ancestor
92652739|NCT04550611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652740|NCT00235196|Anti-Infective Agents|anti-infective agents|mesh-list
92652741|NCT00235196|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92652742|NCT00261027|Exemestane|exemestane|mesh-list
92652743|NCT00261027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652744|NCT00261027|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92652745|NCT00261027|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92652746|NCT00261027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652747|NCT00261027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652748|NCT00261027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92652749|NCT00261027|Hormone Antagonists|hormone antagonists|mesh-ancestor
92652750|NCT00261027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652751|NCT00261027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652752|NCT00235235|Cyclophosphamide|cyclophosphamide|mesh-list
92652753|NCT00235235|Gemcitabine|gemcitabine|mesh-list
92652754|NCT00235235|Doxorubicin|doxorubicin|mesh-list
92652755|NCT00235235|Capecitabine|capecitabine|mesh-list
92652756|NCT00235235|Vinorelbine|vinorelbine|mesh-list
92652757|NCT00235235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652758|NCT00235235|Immunologic Factors|immunologic factors|mesh-ancestor
92652759|NCT00235235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652760|NCT00235235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652761|NCT00235235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92652762|NCT00235235|Alkylating Agents|alkylating agents|mesh-ancestor
92652763|NCT00235235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652764|NCT00235235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652765|NCT00235235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92652766|NCT00235235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652767|NCT00235235|Antimetabolites|antimetabolites|mesh-ancestor
92652768|NCT00235235|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92652769|NCT00235235|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92652770|NCT00235235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92652771|NCT00235235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563416|NCT00158158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563417|NCT00158158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563418|NCT00158158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92563419|NCT00158158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92652772|NCT00235235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92652773|NCT00235235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92652774|NCT00235235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92652775|NCT00235235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92652776|NCT00268359|Bevacizumab|bevacizumab|mesh-list
92652777|NCT00268359|Irinotecan|irinotecan|mesh-list
92652778|NCT00268359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652779|NCT00268359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652780|NCT00268359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92652781|NCT00268359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92652782|NCT00268359|Growth Substances|growth substances|mesh-ancestor
92652783|NCT00268359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652784|NCT00268359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92652785|NCT00268359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92652786|NCT00268359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92652787|NCT00268359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652788|NCT00268359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652789|NCT00235274|Secretin|secretin|mesh-list
92652790|NCT00235274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92652791|NCT00235274|Hormones|hormones|mesh-ancestor
92652792|NCT00235274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652793|NCT00235274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652797|NCT00268398|Oxaliplatin|oxaliplatin|mesh-list
92652798|NCT00268398|Irinotecan|irinotecan|mesh-list
92652799|NCT00268398|Levoleucovorin|levoleucovorin|mesh-list
92652800|NCT00268398|Antimetabolites|antimetabolites|mesh-ancestor
92652801|NCT00268398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652802|NCT00268398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652803|NCT00268398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652804|NCT00268398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652806|NCT00268398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652807|NCT00268398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92652808|NCT00268398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92652809|NCT00268398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652810|NCT00268398|Antidotes|antidotes|mesh-ancestor
92652811|NCT00268398|Protective Agents|protective agents|mesh-ancestor
92652812|NCT00268398|Vitamin B Complex|vitamin b complex|mesh-ancestor
92652813|NCT00268398|Vitamins|vitamins|mesh-ancestor
92652814|NCT00268398|Micronutrients|micronutrients|mesh-ancestor
92652815|NCT00268398|Hematinics|hematinics|mesh-ancestor
92652816|NCT00235313|Nicotine|nicotine|mesh-list
92652817|NCT00235313|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92652818|NCT00235313|Autonomic Agents|autonomic agents|mesh-ancestor
92652819|NCT00235313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652820|NCT00235313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652821|NCT00235313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92652822|NCT00235313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92652823|NCT00235313|Cholinergic Agents|cholinergic agents|mesh-ancestor
92652824|NCT00235313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652825|NCT00235313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652826|NCT04549012|Tranexamic Acid|tranexamic acid|mesh-list
92652827|NCT04549012|Oxytocin|oxytocin|mesh-list
92652828|NCT04549012|Oxytocics|oxytocics|mesh-ancestor
92652829|NCT04549012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92652830|NCT04549012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652831|NCT04549012|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92652832|NCT04549012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92652833|NCT04549012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652834|NCT04549012|Hemostatics|hemostatics|mesh-ancestor
92652835|NCT04549012|Coagulants|coagulants|mesh-ancestor
92652836|NCT00261105|Telithromycin|telithromycin|mesh-list
92652837|NCT00261105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652838|NCT00261105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652839|NCT00235508|Eszopiclone|eszopiclone|mesh-list
92652840|NCT00235508|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92652841|NCT00235508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652842|NCT00235508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652843|NCT00268515|Cyclosporine|cyclosporine|mesh-list
92652844|NCT00268515|Prednisone|prednisone|mesh-list
92563420|NCT00158158|Cholinergic Agents|cholinergic agents|mesh-ancestor
92563421|NCT00158158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652845|NCT00268515|Azathioprine|azathioprine|mesh-list
92652846|NCT00268515|Tacrolimus|tacrolimus|mesh-list
92652847|NCT00268515|Cyclosporins|cyclosporins|mesh-list
92652848|NCT00268515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652849|NCT00268515|Glucocorticoids|glucocorticoids|mesh-ancestor
92652850|NCT00268515|Hormones|hormones|mesh-ancestor
92652851|NCT00268515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652852|NCT00268515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652853|NCT00268515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92652854|NCT00268515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652855|NCT00268515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652856|NCT00268515|Immunologic Factors|immunologic factors|mesh-ancestor
92652857|NCT00268515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92652858|NCT00268515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652859|NCT00268515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652860|NCT00268515|Antifungal Agents|antifungal agents|mesh-ancestor
92652861|NCT00268515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652862|NCT00268515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652863|NCT00268515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652864|NCT00268515|Antimetabolites|antimetabolites|mesh-ancestor
92652865|NCT00268515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652866|NCT04548700|Prednisone|prednisone|mesh-list
92652867|NCT04548700|Cyclophosphamide|cyclophosphamide|mesh-list
92652868|NCT04548700|Vincristine|vincristine|mesh-list
92652869|NCT04548700|Mitoxantrone|mitoxantrone|mesh-list
92652870|NCT04548700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652871|NCT04548700|Immunologic Factors|immunologic factors|mesh-ancestor
92652876|NCT04548700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652877|NCT04548700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652878|NCT04548700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92652879|NCT04548700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652880|NCT04548700|Glucocorticoids|glucocorticoids|mesh-ancestor
92652881|NCT04548700|Hormones|hormones|mesh-ancestor
92652882|NCT04548700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652883|NCT04548700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92652884|NCT04548700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92652885|NCT04548700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92652886|NCT04548700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92652887|NCT04548700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92652888|NCT04548700|Analgesics|analgesics|mesh-ancestor
92652889|NCT04548700|Sensory System Agents|sensory system agents|mesh-ancestor
92652890|NCT04548700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652891|NCT04548700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92652892|NCT04548700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92652893|NCT04548700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652894|NCT02214433|Pantoprazole|pantoprazole|mesh-list
92652895|NCT02214433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92652896|NCT02214433|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92652897|NCT02214433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92652898|NCT02214433|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92652899|NCT02214433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652900|NCT02214433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652901|NCT02212561|Cytarabine|cytarabine|mesh-list
92652902|NCT02212561|Hydrocortisone|hydrocortisone|mesh-list
92652903|NCT02212561|Methotrexate|methotrexate|mesh-list
92652904|NCT02212561|Fludarabine phosphate|fludarabine phosphate|mesh-list
92652905|NCT02212561|Fludarabine|fludarabine|mesh-list
92652906|NCT02212561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92652907|NCT02212561|Abortifacient Agents|abortifacient agents|mesh-ancestor
92652908|NCT02212561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92652909|NCT02212561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652910|NCT02212561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92652911|NCT02212561|Antimetabolites|antimetabolites|mesh-ancestor
92652912|NCT02212561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652913|NCT02212561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652914|NCT02212561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652915|NCT02212561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652916|NCT02212561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92652917|NCT02212561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652918|NCT02212561|Immunologic Factors|immunologic factors|mesh-ancestor
92652919|NCT02212561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652920|NCT02212561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563422|NCT00158158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563423|NCT00051623|Infliximab|infliximab|mesh-list
92563424|NCT00051623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92563425|NCT00051623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92563426|NCT00051623|Dermatologic Agents|dermatologic agents|mesh-ancestor
92563427|NCT00051623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92652921|NCT02212561|Antiviral Agents|antiviral agents|mesh-ancestor
92652922|NCT02212561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652923|NCT02212561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652924|NCT00268554|Dipyridamole|dipyridamole|mesh-list
92652925|NCT00268554|Caffeine|caffeine|mesh-list
92652926|NCT00268554|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92652927|NCT00268554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652928|NCT00268554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92652929|NCT00268554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652930|NCT00268554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652931|NCT00268554|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92652932|NCT00268554|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92652933|NCT00268554|Purinergic Agents|purinergic agents|mesh-ancestor
92652934|NCT00268554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652935|NCT00268554|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92652936|NCT00268554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92652937|NCT00268593|Prednisone|prednisone|mesh-list
92652938|NCT00268593|Docetaxel|docetaxel|mesh-list
92652939|NCT00268593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652940|NCT00268593|Tubulin Modulators|tubulin modulators|mesh-ancestor
92652941|NCT00268593|Antimitotic Agents|antimitotic agents|mesh-ancestor
92652942|NCT00268593|Mitosis Modulators|mitosis modulators|mesh-ancestor
92652945|NCT00268593|Glucocorticoids|glucocorticoids|mesh-ancestor
92652946|NCT00268593|Hormones|hormones|mesh-ancestor
92652947|NCT00268593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92652948|NCT00268593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652949|NCT00268593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92652950|NCT04555525|Sarecycline|sarecycline|mesh-list
92652951|NCT04555525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92652952|NCT04555525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652953|NCT04555525|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652954|NCT00261183|Melatonin|melatonin|mesh-list
92652955|NCT00261183|Antioxidants|antioxidants|mesh-ancestor
92652956|NCT00261183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652957|NCT00261183|Protective Agents|protective agents|mesh-ancestor
92652958|NCT00261183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652959|NCT00261183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652960|NCT00268632|Risedronic Acid|risedronic acid|mesh-list
92652961|NCT00268632|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92652962|NCT00268632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652963|NCT00268632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652964|NCT00268632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92652965|NCT00268632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652966|NCT00268632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92652967|NCT04554979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92652968|NCT04554979|Hydroxychloroquine|hydroxychloroquine|mesh-list
92652969|NCT04554979|Anticoagulants|anticoagulants|mesh-list
92652970|NCT04554979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652971|NCT04554979|Antimalarials|antimalarials|mesh-ancestor
92652972|NCT04554979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92652973|NCT04554979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92652974|NCT04554979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652975|NCT04554979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652976|NCT04554979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652977|NCT00235703|Anti-Infective Agents|anti-infective agents|mesh-list
92652978|NCT00235703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92652979|NCT00261222|Amodiaquine|amodiaquine|mesh-list
92652980|NCT00261222|Antimalarials|antimalarials|mesh-ancestor
92652981|NCT00261222|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92652982|NCT00261222|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92652983|NCT00261222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92652984|NCT00235781|Thymoglobulin|thymoglobulin|mesh-list
92652985|NCT00235781|Immunologic Factors|immunologic factors|mesh-ancestor
92563428|NCT00051623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563429|NCT00158236|Buprenorphine|buprenorphine|mesh-list
92563430|NCT00158236|Hydromorphone|hydromorphone|mesh-list
92563432|NCT00158236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92563433|NCT00158236|Narcotics|narcotics|mesh-ancestor
92563434|NCT00158236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970788|NCT03303677|Hormones|hormones|mesh-ancestor
92652986|NCT00235781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652987|NCT00235781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652988|NCT04554589|Glycopyrrolate|glycopyrrolate|mesh-list
92652989|NCT04554589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92652990|NCT04554589|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92652991|NCT04554589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92652992|NCT04554589|Cholinergic Agents|cholinergic agents|mesh-ancestor
92652993|NCT04554589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652994|NCT04554589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652995|NCT04554589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652996|NCT00268671|Docetaxel|docetaxel|mesh-list
92652997|NCT00268671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652998|NCT00268671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92652999|NCT00268671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92653000|NCT00268671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92653001|NCT00268671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653002|NCT04554433|Ethanol|ethanol|mesh-list
92653003|NCT04554433|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92653004|NCT04554433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653005|NCT04554433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653006|NCT04554433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653007|NCT04721054|Lidocaine|lidocaine|mesh-list
92653008|NCT04721054|Bupivacaine|bupivacaine|mesh-list
92653009|NCT04721054|Anesthetics|anesthetics|mesh-list
92653010|NCT04721054|Anesthetics, Local|anesthetics, local|mesh-ancestor
92653011|NCT04721054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653012|NCT04721054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653013|NCT04721054|Sensory System Agents|sensory system agents|mesh-ancestor
92653014|NCT04721054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653015|NCT04721054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92653016|NCT04721054|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92653017|NCT04721054|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92653018|NCT04721054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653019|NCT04721054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653021|NCT02212639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92653022|NCT02212639|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92653023|NCT02212639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653024|NCT02212639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653025|NCT02212639|Protective Agents|protective agents|mesh-ancestor
92653026|NCT02212639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653027|NCT02212756|Metformin|metformin|mesh-list
92378317|NCT02034630|Busulfan|busulfan|mesh-list
92653028|NCT02212756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653029|NCT02212756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653030|NCT02212795|Levofloxacin|levofloxacin|mesh-list
92653031|NCT02212795|Fluoroquinolones|fluoroquinolones|mesh-list
92653032|NCT02212795|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92653033|NCT02212795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653034|NCT02212795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653035|NCT02212795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92653036|NCT02212795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92653037|NCT02212795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653038|NCT02212795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653039|NCT02212795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653040|NCT02212795|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92653041|NCT02212795|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653042|NCT02212795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92653043|NCT00261261|Midazolam|midazolam|mesh-list
92653044|NCT00261261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92653045|NCT00261261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92563435|NCT00158236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653046|NCT00261261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653047|NCT00261261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653048|NCT00261261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92653049|NCT00261261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92653050|NCT00261261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653051|NCT00261261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653052|NCT00261261|Anesthetics, General|anesthetics, general|mesh-ancestor
92653053|NCT00261261|Anesthetics|anesthetics|mesh-ancestor
92653054|NCT00261261|GABA Modulators|gaba modulators|mesh-ancestor
92653055|NCT00261261|GABA Agents|gaba agents|mesh-ancestor
92653056|NCT00261261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653057|NCT00261261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653058|NCT00235820|Adalimumab|adalimumab|mesh-list
92653059|NCT00235820|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92653060|NCT00235820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653061|NCT00235820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653062|NCT00268710|Docetaxel|docetaxel|mesh-list
92653063|NCT00268710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653064|NCT00268710|Tubulin Modulators|tubulin modulators|mesh-ancestor
92653065|NCT00268710|Antimitotic Agents|antimitotic agents|mesh-ancestor
92653066|NCT00268710|Mitosis Modulators|mitosis modulators|mesh-ancestor
92653067|NCT00268710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653068|NCT00261300|Pantoprazole|pantoprazole|mesh-list
92653069|NCT00261300|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92653070|NCT00261300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653071|NCT00261300|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92653072|NCT00261300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653073|NCT00261300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653074|NCT02212990|Acetaminophen|acetaminophen|mesh-list
92653075|NCT02212990|Ibuprofen|ibuprofen|mesh-list
92653076|NCT02212990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92653077|NCT02212990|Analgesics|analgesics|mesh-ancestor
92653078|NCT02212990|Sensory System Agents|sensory system agents|mesh-ancestor
92653079|NCT02212990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653080|NCT02212990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653081|NCT02212990|Antipyretics|antipyretics|mesh-ancestor
92653082|NCT02212990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92653083|NCT02212990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653084|NCT02212990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653085|NCT02212990|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92653086|NCT02212990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653087|NCT02212990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653090|NCT00235859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92653091|NCT00235859|Abortifacient Agents|abortifacient agents|mesh-ancestor
92653092|NCT00235859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92653093|NCT00235859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653094|NCT00235859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92653095|NCT00235859|Antimetabolites|antimetabolites|mesh-ancestor
92653096|NCT00235859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653097|NCT00235859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364014|NCT04354662|Antimetabolites|antimetabolites|mesh-ancestor
92653098|NCT00235859|Dermatologic Agents|dermatologic agents|mesh-ancestor
92653099|NCT00235859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653100|NCT00235859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92653101|NCT00235859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92653102|NCT00235859|Immunologic Factors|immunologic factors|mesh-ancestor
92653103|NCT00235859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653104|NCT00235859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92653105|NCT00235859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92653106|NCT00235859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653107|NCT02213029|Oxytocin|oxytocin|mesh-list
92653108|NCT02213029|Oxytocics|oxytocics|mesh-ancestor
92653109|NCT02213029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92653110|NCT02213029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653111|NCT02213146|Insulin|insulin|mesh-list
92653112|NCT02213146|Insulin Lispro|insulin lispro|mesh-list
92653113|NCT02213146|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92653114|NCT02213146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653115|NCT02213146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653116|NCT00268749|Glycine|glycine|mesh-list
92653117|NCT00268749|Glycine Agents|glycine agents|mesh-ancestor
92653118|NCT00268749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563437|NCT00158236|Sensory System Agents|sensory system agents|mesh-ancestor
92563438|NCT00158236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92563439|NCT00158236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92563440|NCT00158275|Antidepressive Agents|antidepressive agents|mesh-list
92563441|NCT00158275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92563442|NCT00044421|Ruboxistaurin|ruboxistaurin|mesh-list
92563443|NCT00044421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653119|NCT00268749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653120|NCT00268749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653121|NCT00235898|Leucovorin|leucovorin|mesh-list
92653122|NCT00235898|Fluorouracil|fluorouracil|mesh-list
92653123|NCT00235898|Antimetabolites|antimetabolites|mesh-ancestor
92653124|NCT00235898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653125|NCT00235898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92653126|NCT00235898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653127|NCT00235898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92653128|NCT00235898|Immunologic Factors|immunologic factors|mesh-ancestor
92653129|NCT00235898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653130|NCT00235898|Antidotes|antidotes|mesh-ancestor
92653131|NCT00235898|Protective Agents|protective agents|mesh-ancestor
92653132|NCT00235898|Vitamin B Complex|vitamin b complex|mesh-ancestor
92653133|NCT00235898|Vitamins|vitamins|mesh-ancestor
92653134|NCT00235898|Micronutrients|micronutrients|mesh-ancestor
92653135|NCT02213224|Amlodipine|amlodipine|mesh-list
92653136|NCT02213224|Telmisartan|telmisartan|mesh-list
92653137|NCT02213224|Perindopril|perindopril|mesh-list
92653138|NCT02213224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92653139|NCT02213224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92653140|NCT02213224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653141|NCT02213224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653142|NCT02213224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92653143|NCT02213224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653144|NCT02213224|Vasodilator Agents|vasodilator agents|mesh-ancestor
92653145|NCT02213224|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92653146|NCT02213224|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92653147|NCT02213224|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92653148|NCT02213224|Protease Inhibitors|protease inhibitors|mesh-ancestor
92653149|NCT02213224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653150|NCT00268788|Immunoglobulins|immunoglobulins|mesh-list
92653151|NCT00268788|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92653152|NCT00268788|Antibodies|antibodies|mesh-list
92653153|NCT00268788|gamma-Globulins|gamma-globulins|mesh-list
92653154|NCT00268788|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92653155|NCT00268788|Immunologic Factors|immunologic factors|mesh-ancestor
92653156|NCT00268788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653157|NCT00235937|Anastrozole|anastrozole|mesh-list
92653158|NCT00235937|Goserelin|goserelin|mesh-list
92653159|NCT00235937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92653160|NCT00235937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653161|NCT00235937|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92653162|NCT00235937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92653171|NCT00261339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653172|NCT00261339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92653173|NCT00261339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653174|NCT00261339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653175|NCT04553380|Insulin|insulin|mesh-list
92653176|NCT04553380|Insulin Glargine|insulin glargine|mesh-list
92653177|NCT04553380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653178|NCT04553380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653180|NCT00236015|Anticonvulsants|anticonvulsants|mesh-ancestor
92653181|NCT00236015|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92653182|NCT00236015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653183|NCT00236015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653184|NCT00236015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653185|NCT00236015|GABA Agents|gaba agents|mesh-ancestor
92653186|NCT00236015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653187|NCT00236015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653188|NCT00261378|Doxorubicin|doxorubicin|mesh-list
92653189|NCT00261378|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92563444|NCT00044421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563446|NCT00051701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92563447|NCT00051701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563448|NCT00158470|Lamivudine|lamivudine|mesh-list
92653190|NCT00261378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92653191|NCT00261378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653192|NCT00261378|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92653193|NCT00261378|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92653194|NCT00261378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653195|NCT00261378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653196|NCT04553458|Ethanol|ethanol|mesh-list
92653197|NCT04553458|Sorafenib|sorafenib|mesh-list
92653198|NCT04553458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653199|NCT04553458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92653200|NCT04553458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653201|NCT04553458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653202|NCT04553458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92653203|NCT04553458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653204|NCT04553458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653205|NCT04553458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653206|NCT00236054|Tiagabine|tiagabine|mesh-list
92653207|NCT00236054|Anticonvulsants|anticonvulsants|mesh-ancestor
92653208|NCT00236054|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92653209|NCT00236054|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653210|NCT00236054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653211|NCT00236054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653212|NCT00236054|GABA Agents|gaba agents|mesh-ancestor
92653213|NCT00236054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653214|NCT00236054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653215|NCT04552951|Vitamin D|vitamin d|mesh-list
92653216|NCT04552951|Cholecalciferol|cholecalciferol|mesh-list
92653217|NCT04552951|Vitamins|vitamins|mesh-ancestor
92653218|NCT04552951|Micronutrients|micronutrients|mesh-ancestor
92653219|NCT04552951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653220|NCT04552951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92653221|NCT04552951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92653222|NCT02213419|Ethanol|ethanol|mesh-list
92653223|NCT02213419|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92653224|NCT02213419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653225|NCT02213419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653226|NCT02213419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653227|NCT00236093|Fentanyl|fentanyl|mesh-list
92653228|NCT00236093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653232|NCT00236093|Analgesics|analgesics|mesh-ancestor
92653233|NCT00236093|Sensory System Agents|sensory system agents|mesh-ancestor
92653234|NCT00236093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653235|NCT00236093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92653236|NCT00236093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653237|NCT00236093|Anesthetics, General|anesthetics, general|mesh-ancestor
92653238|NCT00236093|Anesthetics|anesthetics|mesh-ancestor
92653239|NCT04552483|Nitazoxanide|nitazoxanide|mesh-list
92653240|NCT04552483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92653241|NCT04552483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653242|NCT02213614|Lithium Carbonate|lithium carbonate|mesh-list
92653243|NCT02213614|Antidepressive Agents|antidepressive agents|mesh-ancestor
92653244|NCT02213614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653245|NCT02213614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653246|NCT02213614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653247|NCT02213614|Antimanic Agents|antimanic agents|mesh-ancestor
92653248|NCT02213614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92653249|NCT02213614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653250|NCT02213614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653252|NCT02213653|Trace Elements|trace elements|mesh-ancestor
92653253|NCT02213653|Micronutrients|micronutrients|mesh-ancestor
92653254|NCT02213653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653255|NCT04552444|Biapenem|biapenem|mesh-list
92653256|NCT04552444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653257|NCT00236171|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
92563449|NCT00158470|Efavirenz|efavirenz|mesh-list
92563450|NCT00158470|Didanosine|didanosine|mesh-list
92563451|NCT00158470|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92563452|NCT00158470|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92002778|NCT03785873|Vitamins|vitamins|mesh-ancestor
92653258|NCT00236171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653259|NCT04552405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92653260|NCT02213848|Calcium|calcium|mesh-list
92653261|NCT02213848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92653262|NCT02213848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653263|NCT00261573|Galantamine|galantamine|mesh-list
92653264|NCT00261573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92653265|NCT00261573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653266|NCT00261573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653267|NCT00261573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92653268|NCT00261573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653269|NCT00261573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653270|NCT00261573|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92653271|NCT00261573|Autonomic Agents|autonomic agents|mesh-ancestor
92653272|NCT00261573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653273|NCT00261573|Nootropic Agents|nootropic agents|mesh-ancestor
92653274|NCT04548271|Apatinib|apatinib|mesh-list
92653275|NCT04548271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653276|NCT04548271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92653277|NCT04548271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653278|NCT04548271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653279|NCT04541719|Remifentanil|remifentanil|mesh-list
92653280|NCT04541719|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653281|NCT04541719|Narcotics|narcotics|mesh-ancestor
92653282|NCT04541719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653283|NCT04541719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653284|NCT04541719|Analgesics|analgesics|mesh-ancestor
92653285|NCT04541719|Sensory System Agents|sensory system agents|mesh-ancestor
92653286|NCT04541719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653287|NCT00414089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92653288|NCT00414089|Immunologic Factors|immunologic factors|mesh-ancestor
92653289|NCT00414089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653290|NCT00261612|Dexamethasone|dexamethasone|mesh-list
92653291|NCT00261612|Rituximab|rituximab|mesh-list
92653292|NCT00261612|Bortezomib|bortezomib|mesh-list
92653293|NCT00261612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92653294|NCT00261612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653295|NCT00261612|Immunologic Factors|immunologic factors|mesh-ancestor
92653296|NCT00261612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653297|NCT00261612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653298|NCT00261612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653299|NCT00261612|Antiemetics|antiemetics|mesh-ancestor
92653300|NCT00261612|Autonomic Agents|autonomic agents|mesh-ancestor
92653301|NCT00261612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653302|NCT00261612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653305|NCT00261612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653306|NCT00261612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92653308|NCT04547764|Calcium|calcium|mesh-list
92653309|NCT04547764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92653310|NCT04547764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653311|NCT04547764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653312|NCT04547608|Propofol|propofol|mesh-list
92653313|NCT04547608|Rocuronium|rocuronium|mesh-list
92653314|NCT04547608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92653315|NCT04547608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653316|NCT04547608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653317|NCT04547608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653318|NCT04547608|Anesthetics, General|anesthetics, general|mesh-ancestor
92653319|NCT04547608|Anesthetics|anesthetics|mesh-ancestor
92653320|NCT04547608|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92653321|NCT04547608|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92653322|NCT04547608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92653323|NCT04547608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653324|NCT00236249|Lidocaine|lidocaine|mesh-list
92653325|NCT00236249|Anesthetics, Local|anesthetics, local|mesh-ancestor
92653326|NCT00236249|Anesthetics|anesthetics|mesh-ancestor
92563453|NCT00158470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563454|NCT00158470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563455|NCT00158470|Antiviral Agents|antiviral agents|mesh-ancestor
92563456|NCT00158470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563457|NCT00158470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91970800|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
92653327|NCT00236249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653328|NCT00236249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653329|NCT00236249|Sensory System Agents|sensory system agents|mesh-ancestor
92653330|NCT00236249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653331|NCT00236249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92653332|NCT00236249|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92653333|NCT00236249|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92653334|NCT00236249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653335|NCT00236249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653336|NCT00269061|Pioglitazone|pioglitazone|mesh-list
92653337|NCT00269061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653338|NCT00269061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653339|NCT04547452|Antibodies|antibodies|mesh-list
92653340|NCT04547452|Immunologic Factors|immunologic factors|mesh-ancestor
92653341|NCT04547452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653342|NCT04547335|Voriconazole|voriconazole|mesh-list
92653343|NCT04547335|Antifungal Agents|antifungal agents|mesh-ancestor
92653344|NCT04547335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653345|NCT04547335|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92653346|NCT04547335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653347|NCT04547335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653348|NCT04547335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653349|NCT04547335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92653350|NCT04547335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92653351|NCT04547335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653352|NCT04547335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653353|NCT04547335|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92653354|NCT00236288|Bupropion|bupropion|mesh-list
92653355|NCT00236288|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92653356|NCT00236288|Antidepressive Agents|antidepressive agents|mesh-ancestor
92653357|NCT00236288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653358|NCT00236288|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92653359|NCT00236288|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653360|NCT00236288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653361|NCT00236288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653362|NCT00236288|Dopamine Agents|dopamine agents|mesh-ancestor
92653363|NCT00236288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653364|NCT00236288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653365|NCT00236288|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92653366|NCT00236288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653367|NCT00236288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653368|NCT04547296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92653369|NCT00236327|Fentanyl|fentanyl|mesh-list
92653370|NCT00236327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653371|NCT00236327|Narcotics|narcotics|mesh-ancestor
92653372|NCT00236327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653382|NCT00236366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653384|NCT00236366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653385|NCT00236366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653386|NCT00236366|Analgesics|analgesics|mesh-ancestor
92653387|NCT00236366|Sensory System Agents|sensory system agents|mesh-ancestor
92653388|NCT00236366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653389|NCT00236366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92653390|NCT00236366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653391|NCT00236366|Anesthetics, General|anesthetics, general|mesh-ancestor
92653392|NCT00236366|Anesthetics|anesthetics|mesh-ancestor
92653393|NCT04547179|Erenumab|erenumab|mesh-list
92653394|NCT04547179|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92653395|NCT04547179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563458|NCT00158470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92563459|NCT00158470|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92563460|NCT00158470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91970806|NCT02468063|Terlipressin|terlipressin|mesh-list
92653396|NCT04547179|Analgesics|analgesics|mesh-ancestor
92653397|NCT04547179|Sensory System Agents|sensory system agents|mesh-ancestor
92653398|NCT04547179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653399|NCT04547179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653400|NCT00236405|Epoetin Alfa|epoetin alfa|mesh-list
92653401|NCT00236405|Hematinics|hematinics|mesh-ancestor
92653402|NCT00236444|Risperidone|risperidone|mesh-list
92653403|NCT00236444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92653404|NCT00236444|Serotonin Agents|serotonin agents|mesh-ancestor
92653405|NCT00236444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653406|NCT00236444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653407|NCT00236444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653408|NCT00236444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92653409|NCT00236444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92653410|NCT00236444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653411|NCT00236444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653412|NCT00236444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92653413|NCT00236444|Dopamine Agents|dopamine agents|mesh-ancestor
92653415|NCT00269217|Niacinamide|niacinamide|mesh-list
92653416|NCT00269217|Nicotinic Acids|nicotinic acids|mesh-list
92653417|NCT00269217|Simvastatin|simvastatin|mesh-list
92653418|NCT00269217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92653419|NCT00269217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92653420|NCT00269217|Antimetabolites|antimetabolites|mesh-ancestor
92653421|NCT00269217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653422|NCT00269217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92653423|NCT00269217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92653424|NCT00269217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653425|NCT00269217|Vasodilator Agents|vasodilator agents|mesh-ancestor
92653426|NCT00269217|Vitamin B Complex|vitamin b complex|mesh-ancestor
92653427|NCT00269217|Vitamins|vitamins|mesh-ancestor
92653428|NCT00269217|Micronutrients|micronutrients|mesh-ancestor
92653429|NCT00269217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653430|NCT04546282|Osimertinib|osimertinib|mesh-list
92653431|NCT04546282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653432|NCT04546282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92653433|NCT04546282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653434|NCT04546282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653435|NCT00236483|Acetaminophen|acetaminophen|mesh-list
92653436|NCT00236483|Tramadol|tramadol|mesh-list
92653437|NCT00236483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92653438|NCT00236483|Analgesics|analgesics|mesh-ancestor
92653439|NCT00236483|Sensory System Agents|sensory system agents|mesh-ancestor
92060636|NCT05600686|Prednisone|prednisone|mesh-list
92653449|NCT04545970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653450|NCT04545970|Dermatologic Agents|dermatologic agents|mesh-ancestor
92653451|NCT04545931|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92653452|NCT04545931|Hemostatics|hemostatics|mesh-ancestor
92653453|NCT04545931|Coagulants|coagulants|mesh-ancestor
92653454|NCT04545931|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92653455|NCT04545931|Natriuretic Agents|natriuretic agents|mesh-ancestor
92653456|NCT04545931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653457|NCT00236522|Levofloxacin|levofloxacin|mesh-list
92653458|NCT00236522|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92653459|NCT00236522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653460|NCT00236522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653461|NCT00236522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92653462|NCT00236522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92653463|NCT00236522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653464|NCT00236522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653465|NCT00236522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653466|NCT00236522|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92653467|NCT00236522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653468|NCT00261729|Prazosin|prazosin|mesh-list
92653469|NCT00261729|Paroxetine|paroxetine|mesh-list
92653470|NCT00261729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92653471|NCT00261729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92563461|NCT00158470|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92563462|NCT00158470|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92563463|NCT00158470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92563464|NCT00158470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92653472|NCT00261729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653473|NCT00261729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653474|NCT00261729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653475|NCT00261729|Serotonin Agents|serotonin agents|mesh-ancestor
92653476|NCT00261729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653477|NCT00261729|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92653478|NCT00261729|Antidepressive Agents|antidepressive agents|mesh-ancestor
92653479|NCT00261729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653480|NCT00261729|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92653481|NCT00261729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653482|NCT00261729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653483|NCT00261729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92653484|NCT00261729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92653485|NCT00261729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92653486|NCT00261729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92653487|NCT00261729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92653488|NCT00236561|Topiramate|topiramate|mesh-list
92653489|NCT00236561|Propranolol|propranolol|mesh-list
92653490|NCT00236561|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92653491|NCT00236561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92653492|NCT00236561|Adrenergic Agents|adrenergic agents|mesh-ancestor
92653493|NCT00236561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653494|NCT00236561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653495|NCT00236561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653496|NCT00236561|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92653497|NCT00236561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92653498|NCT00236561|Vasodilator Agents|vasodilator agents|mesh-ancestor
92653499|NCT00236561|Anticonvulsants|anticonvulsants|mesh-ancestor
92653500|NCT00236561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653501|NCT02215330|Eplerenone|eplerenone|mesh-list
92653502|NCT02215330|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92653503|NCT02215330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92060701|NCT05536284|Bisoprolol|bisoprolol|mesh-list
92653506|NCT02215330|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92653507|NCT02215330|Diuretics|diuretics|mesh-ancestor
92653508|NCT02215330|Natriuretic Agents|natriuretic agents|mesh-ancestor
92653509|NCT02215330|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92653510|NCT02278510|Topotecan|topotecan|mesh-list
92653511|NCT02278510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92653512|NCT02278510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92653513|NCT02278510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653514|NCT02278510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653515|NCT02278510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653516|NCT04545892|Capsaicin|capsaicin|mesh-list
92653517|NCT04545892|Antipruritics|antipruritics|mesh-ancestor
92653518|NCT04545892|Dermatologic Agents|dermatologic agents|mesh-ancestor
92653519|NCT04545892|Sensory System Agents|sensory system agents|mesh-ancestor
92653520|NCT04545892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653521|NCT04545892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653522|NCT02214706|Sirolimus|sirolimus|mesh-list
92653523|NCT02214706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653524|NCT02214706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653525|NCT02214706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92653526|NCT02214706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653527|NCT02214706|Antifungal Agents|antifungal agents|mesh-ancestor
92653528|NCT02214706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92653529|NCT02214706|Immunologic Factors|immunologic factors|mesh-ancestor
92653530|NCT02214706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653531|NCT00236600|Topiramate|topiramate|mesh-list
92653532|NCT00236600|Anticonvulsants|anticonvulsants|mesh-ancestor
92653533|NCT00236600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653534|NCT00236600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653535|NCT00236639|Topiramate|topiramate|mesh-list
92653536|NCT00236639|Anticonvulsants|anticonvulsants|mesh-ancestor
92653537|NCT00236639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563466|NCT00158509|Valacyclovir|valacyclovir|mesh-list
92563467|NCT00158509|Antiviral Agents|antiviral agents|mesh-ancestor
92563468|NCT00158509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563469|NCT00158548|Artesunate|artesunate|mesh-list
92563470|NCT00158548|Chloroquine|chloroquine|mesh-list
92653538|NCT00236639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653539|NCT04545463|Psyllium|psyllium|mesh-list
92653540|NCT04545463|Cathartics|cathartics|mesh-ancestor
92653541|NCT04545463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653542|NCT00236678|Epoetin Alfa|epoetin alfa|mesh-list
92653543|NCT00236678|Hematinics|hematinics|mesh-ancestor
92653544|NCT00269334|Paroxetine|paroxetine|mesh-list
92653545|NCT00269334|Citalopram|citalopram|mesh-list
92653546|NCT00269334|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92653547|NCT00269334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653548|NCT00269334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653549|NCT00269334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653550|NCT00269334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653551|NCT00269334|Serotonin Agents|serotonin agents|mesh-ancestor
92653552|NCT00269334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378841|NCT02538354|Riboflavin|riboflavin|mesh-list
92653553|NCT00269334|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92653554|NCT00269334|Antidepressive Agents|antidepressive agents|mesh-ancestor
92653555|NCT00269334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653556|NCT00269334|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92653557|NCT00269334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653558|NCT00269334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653560|NCT04541251|Carboplatin|carboplatin|mesh-list
92653561|NCT04541251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92653562|NCT04541251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653563|NCT04541251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92653564|NCT04541251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92653565|NCT04541251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92653566|NCT04541251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653567|NCT00236717|Topiramate|topiramate|mesh-list
92653568|NCT00236717|Carbamazepine|carbamazepine|mesh-list
92653569|NCT00236717|Valproic Acid|valproic acid|mesh-list
92653570|NCT00236717|Anticonvulsants|anticonvulsants|mesh-ancestor
92653571|NCT00236717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653572|NCT00236717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653573|NCT00236717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653574|NCT00236717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653575|NCT00236717|GABA Agents|gaba agents|mesh-ancestor
92653576|NCT00236717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653577|NCT00236717|Antimanic Agents|antimanic agents|mesh-ancestor
92653582|NCT00236717|Analgesics|analgesics|mesh-ancestor
92653583|NCT00236717|Sensory System Agents|sensory system agents|mesh-ancestor
92653584|NCT00236717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653585|NCT00236717|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92653586|NCT00236717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653587|NCT00236717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92653588|NCT00236717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92653590|NCT00236756|Anticonvulsants|anticonvulsants|mesh-ancestor
92653591|NCT00236756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653592|NCT00236756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653593|NCT00269412|Rifaximin|rifaximin|mesh-list
92653594|NCT00269412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653595|NCT00269412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653596|NCT00269412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653597|NCT00236795|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92653598|NCT00236795|Norelgestromin|norelgestromin|mesh-list
92653599|NCT00236795|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92653600|NCT00236795|Estradiol|estradiol|mesh-list
92653601|NCT00236795|Estrogens|estrogens|mesh-ancestor
92653602|NCT00236795|Hormones|hormones|mesh-ancestor
92653603|NCT00236795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653604|NCT00236795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653605|NCT00236795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92653606|NCT00236795|Contraceptive Agents|contraceptive agents|mesh-ancestor
92653607|NCT00236795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92653608|NCT00236795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92653609|NCT00236795|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92563471|NCT00158548|Primaquine|primaquine|mesh-list
92563472|NCT00158548|Amodiaquine|amodiaquine|mesh-list
92563473|NCT00158548|Antimalarials|antimalarials|mesh-ancestor
92563474|NCT00158548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92563475|NCT00158548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92653610|NCT00236795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92653611|NCT00236795|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92653612|NCT00236795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92653613|NCT00236795|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92653614|NCT00236795|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92653615|NCT00236795|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92653616|NCT04540627|Palivizumab|palivizumab|mesh-list
92653617|NCT04540627|Antiviral Agents|antiviral agents|mesh-ancestor
92653618|NCT04540627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653619|NCT00236834|Levofloxacin|levofloxacin|mesh-list
92653620|NCT00236834|Imipenem|imipenem|mesh-list
92653621|NCT00236834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92653622|NCT00236834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653623|NCT00236834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653624|NCT00236834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92653625|NCT00236834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92653626|NCT00236834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378912|NCT02547012|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92653627|NCT00236834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653628|NCT00236834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653629|NCT00236834|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92653630|NCT00236834|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653631|NCT00236873|Topiramate|topiramate|mesh-list
92653632|NCT00236873|Anticonvulsants|anticonvulsants|mesh-ancestor
92653633|NCT00236873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653634|NCT00236873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653635|NCT00236912|Metronidazole|metronidazole|mesh-list
92653636|NCT00236912|Levofloxacin|levofloxacin|mesh-list
92653637|NCT00236912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653638|NCT00236912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653639|NCT00236912|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92653640|NCT00236912|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92653641|NCT00236912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92653642|NCT00236912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92653643|NCT00236912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92653644|NCT00236912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653645|NCT00236912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653646|NCT00236912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653651|NCT02215447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92653652|NCT02215447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653653|NCT02215447|Tubulin Modulators|tubulin modulators|mesh-ancestor
92653654|NCT02215447|Antimitotic Agents|antimitotic agents|mesh-ancestor
92653655|NCT02215447|Mitosis Modulators|mitosis modulators|mesh-ancestor
92653656|NCT02215447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653657|NCT00236990|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
92653658|NCT00236990|Anticoagulants|anticoagulants|mesh-ancestor
92653659|NCT00237068|Lansoprazole|lansoprazole|mesh-list
92653660|NCT00237068|Dexlansoprazole|dexlansoprazole|mesh-list
92653661|NCT00237068|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92653662|NCT00237068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653663|NCT00237068|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92653664|NCT00237068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653665|NCT00237068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653666|NCT00269568|Misoprostol|misoprostol|mesh-list
92653667|NCT00269568|Mifepristone|mifepristone|mesh-list
92653668|NCT00269568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92653669|NCT00269568|Abortifacient Agents|abortifacient agents|mesh-ancestor
92653670|NCT00269568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92653671|NCT00269568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653672|NCT00269568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92653673|NCT00269568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653674|NCT00269568|Oxytocics|oxytocics|mesh-ancestor
92653675|NCT00269568|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92653676|NCT00269568|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92653677|NCT00269568|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92653678|NCT00269568|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92563476|NCT00158548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563477|NCT00158548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653679|NCT00269568|Contraceptive Agents|contraceptive agents|mesh-ancestor
92653680|NCT00269568|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92653681|NCT00269568|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92653682|NCT00269568|Hormone Antagonists|hormone antagonists|mesh-ancestor
92653683|NCT00269568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653684|NCT00269568|Luteolytic Agents|luteolytic agents|mesh-ancestor
92653685|NCT00269568|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92653686|NCT00269568|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92653687|NCT00237146|Zoledronic Acid|zoledronic acid|mesh-list
92653688|NCT00237146|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92653689|NCT00237146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653690|NCT04544059|Lenalidomide|lenalidomide|mesh-list
92653691|NCT04544059|Immunologic Factors|immunologic factors|mesh-ancestor
92653692|NCT04544059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653693|NCT04544059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92653694|NCT04544059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92653695|NCT04544059|Growth Substances|growth substances|mesh-ancestor
92653696|NCT04544059|Growth Inhibitors|growth inhibitors|mesh-ancestor
92653697|NCT04544059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653698|NCT00269607|Naltrexone|naltrexone|mesh-list
92653699|NCT00269607|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92378987|NCT02572752|Nintedanib|nintedanib|mesh-list
92653700|NCT00269607|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92653701|NCT00269607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653702|NCT00269607|Sensory System Agents|sensory system agents|mesh-ancestor
92653703|NCT00269607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653704|NCT00237224|Letrozole|letrozole|mesh-list
92653705|NCT00237224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653706|NCT00237224|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92653707|NCT00237224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92653708|NCT00237224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653709|NCT00237224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653710|NCT00237224|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92653711|NCT00237224|Hormone Antagonists|hormone antagonists|mesh-ancestor
92653712|NCT00237224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653713|NCT00237224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653714|NCT00237263|Entacapone|entacapone|mesh-list
92653715|NCT00237263|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92653725|NCT00262275|Clopidogrel|clopidogrel|mesh-list
92653726|NCT00262275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92653727|NCT00262275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92653728|NCT00262275|Analgesics|analgesics|mesh-ancestor
92653729|NCT00262275|Sensory System Agents|sensory system agents|mesh-ancestor
92653730|NCT00262275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653731|NCT00262275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653732|NCT00262275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653733|NCT00262275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653734|NCT00262275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92653735|NCT00262275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92653736|NCT00262275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653737|NCT00262275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92653738|NCT00262275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92653739|NCT00262275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653740|NCT00262275|Antipyretics|antipyretics|mesh-ancestor
92653741|NCT00262275|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92653742|NCT00262275|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92653743|NCT00262275|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92653744|NCT00262275|Purinergic Agents|purinergic agents|mesh-ancestor
92653745|NCT00262275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653746|NCT02214979|Telmisartan|telmisartan|mesh-list
92653747|NCT02214979|Ramipril|ramipril|mesh-list
92653748|NCT02214979|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92653749|NCT02214979|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92653750|NCT02214979|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92653751|NCT02214979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653752|NCT02214979|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92653753|NCT02214979|Protease Inhibitors|protease inhibitors|mesh-ancestor
92653754|NCT02214979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653755|NCT00237341|Fentanyl|fentanyl|mesh-list
92563479|NCT00158548|Schistosomicides|schistosomicides|mesh-ancestor
92563480|NCT00158548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92563481|NCT00158548|Anthelmintics|anthelmintics|mesh-ancestor
92563483|NCT00158548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92563484|NCT00158587|Primaquine|primaquine|mesh-list
92563485|NCT00158587|Antimalarials|antimalarials|mesh-ancestor
92653756|NCT00237341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653757|NCT00237341|Narcotics|narcotics|mesh-ancestor
92653758|NCT00237341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653759|NCT00237341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653760|NCT00237341|Analgesics|analgesics|mesh-ancestor
92653761|NCT00237341|Sensory System Agents|sensory system agents|mesh-ancestor
92653762|NCT00237341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653763|NCT00237341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92653764|NCT00237341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653765|NCT00237341|Anesthetics, General|anesthetics, general|mesh-ancestor
92653766|NCT00237341|Anesthetics|anesthetics|mesh-ancestor
92653767|NCT04539301|Anticoagulants|anticoagulants|mesh-list
92653768|NCT00237419|Infliximab|infliximab|mesh-list
92653769|NCT00237419|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92653770|NCT00237419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653771|NCT00237419|Dermatologic Agents|dermatologic agents|mesh-ancestor
92653772|NCT00237419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653773|NCT00237419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653774|NCT04539106|Ranibizumab|ranibizumab|mesh-list
92653775|NCT04539106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92653776|NCT04539106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92653777|NCT04539106|Growth Substances|growth substances|mesh-ancestor
92653778|NCT04539106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653779|NCT04539106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92653780|NCT04539106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653781|NCT00237497|Zopiclone|zopiclone|mesh-list
92653784|NCT00237497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653785|NCT00416130|Vorinostat|vorinostat|mesh-list
92653786|NCT00416130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653787|NCT00416130|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92653788|NCT00416130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653789|NCT00416130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653790|NCT00416169|Galantamine|galantamine|mesh-list
92653791|NCT00416169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92653792|NCT00416169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653793|NCT00416169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653794|NCT00416169|Cholinergic Agents|cholinergic agents|mesh-ancestor
92653795|NCT00416169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653796|NCT00416169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653797|NCT00416169|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92653798|NCT00416169|Autonomic Agents|autonomic agents|mesh-ancestor
92653799|NCT00416169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653800|NCT00416169|Nootropic Agents|nootropic agents|mesh-ancestor
92653801|NCT00237536|Lonidamine|lonidamine|mesh-list
92653802|NCT00237536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653803|NCT00237536|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92653804|NCT00237536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653805|NCT00237536|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92653806|NCT00237536|Contraceptive Agents|contraceptive agents|mesh-ancestor
92653807|NCT00237536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92653808|NCT00237536|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92653809|NCT00237536|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92653810|NCT00237536|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92653811|NCT00237536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653812|NCT02215720|Sirolimus|sirolimus|mesh-list
92653813|NCT02215720|Cetuximab|cetuximab|mesh-list
92653814|NCT02215720|Temsirolimus|temsirolimus|mesh-list
92653815|NCT02215720|MTOR Inhibitors|mtor inhibitors|mesh-list
92653816|NCT02215720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92653817|NCT02215720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653818|NCT02215720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92653819|NCT02215720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653820|NCT02215720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653821|NCT02215720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563486|NCT00158587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92563487|NCT00158587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92653822|NCT02215720|Immunologic Factors|immunologic factors|mesh-ancestor
92653823|NCT02215720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653824|NCT02215720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92653825|NCT02215720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653826|NCT02215720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92653827|NCT02215720|Antifungal Agents|antifungal agents|mesh-ancestor
92653828|NCT00416208|Bortezomib|bortezomib|mesh-list
92653829|NCT00416208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653830|NCT02215798|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92653831|NCT02215798|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92653832|NCT02215798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653833|NCT02215798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653834|NCT02215798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653835|NCT02215798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653836|NCT02215798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653837|NCT02215798|Analgesics|analgesics|mesh-ancestor
92653838|NCT02215798|Sensory System Agents|sensory system agents|mesh-ancestor
92653839|NCT02215798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653840|NCT02215798|Antidepressive Agents|antidepressive agents|mesh-ancestor
92653841|NCT02215798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653842|NCT02215798|Dopamine Agents|dopamine agents|mesh-ancestor
92653843|NCT02215018|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92653844|NCT02215057|Lidocaine|lidocaine|mesh-list
92653845|NCT02215057|Anesthetics|anesthetics|mesh-list
92653846|NCT02215057|Anesthetics, Local|anesthetics, local|mesh-ancestor
92653847|NCT02215057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653848|NCT02215057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379138|NCT02056236|Midazolam|midazolam|mesh-list
92653849|NCT02215057|Sensory System Agents|sensory system agents|mesh-ancestor
92653850|NCT02215057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653851|NCT02215057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92653852|NCT02215057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92653862|NCT00269685|Natriuretic Agents|natriuretic agents|mesh-ancestor
92653863|NCT00269685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653864|NCT04543123|Antidepressive Agents|antidepressive agents|mesh-list
92653865|NCT04543123|Escitalopram|escitalopram|mesh-list
92653866|NCT04543123|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92653867|NCT04543123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653868|NCT04543123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653869|NCT04543123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653870|NCT04543123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653871|NCT04543123|Serotonin Agents|serotonin agents|mesh-ancestor
92653872|NCT04543123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653873|NCT04543123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653874|NCT04539418|Vitamin K|vitamin k|mesh-list
92653875|NCT04539418|Vitamin K 2|vitamin k 2|mesh-list
92653876|NCT04539418|Vitamins|vitamins|mesh-ancestor
92653877|NCT04539418|Micronutrients|micronutrients|mesh-ancestor
92653878|NCT04539418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653879|NCT04539418|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92653880|NCT04539418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92653881|NCT04539418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653882|NCT04539418|Hemostatics|hemostatics|mesh-ancestor
92653883|NCT04539418|Coagulants|coagulants|mesh-ancestor
92653884|NCT00269724|Oxybutynin|oxybutynin|mesh-list
92653885|NCT00269724|Parasympatholytics|parasympatholytics|mesh-ancestor
92653886|NCT00269724|Autonomic Agents|autonomic agents|mesh-ancestor
92653887|NCT00269724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653888|NCT00269724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653889|NCT00269724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92653890|NCT00269724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92653891|NCT00269724|Cholinergic Agents|cholinergic agents|mesh-ancestor
92653892|NCT00269724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653893|NCT00269724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653894|NCT00269724|Urological Agents|urological agents|mesh-ancestor
92653895|NCT04710017|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92653896|NCT04710017|Tranexamic Acid|tranexamic acid|mesh-list
92653897|NCT04710017|Medroxyprogesterone|medroxyprogesterone|mesh-list
92653898|NCT04710017|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92563488|NCT00158587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563489|NCT00158704|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92563490|NCT00158704|Antiviral Agents|antiviral agents|mesh-ancestor
92563491|NCT00158704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003411|NCT03087071|Trametinib|trametinib|mesh-list
92653899|NCT04710017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92653900|NCT04710017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653901|NCT04710017|Hemostatics|hemostatics|mesh-ancestor
92653902|NCT04710017|Coagulants|coagulants|mesh-ancestor
92653903|NCT04710017|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92653904|NCT04710017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92653905|NCT04710017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92653906|NCT04710017|Contraceptive Agents|contraceptive agents|mesh-ancestor
92653907|NCT04710017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92653908|NCT04710017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653909|NCT04710017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92653910|NCT04710017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92653911|NCT04710017|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92653912|NCT04710017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92653913|NCT04710017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653914|NCT04538521|Niacin|niacin|mesh-list
92653915|NCT04538521|Nicotinic Acids|nicotinic acids|mesh-list
92653916|NCT04538521|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92653917|NCT04538521|Antimetabolites|antimetabolites|mesh-ancestor
92653918|NCT04538521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653920|NCT04538521|Vasodilator Agents|vasodilator agents|mesh-ancestor
92653921|NCT04538521|Vitamin B Complex|vitamin b complex|mesh-ancestor
92653922|NCT04538521|Vitamins|vitamins|mesh-ancestor
92653923|NCT04538521|Micronutrients|micronutrients|mesh-ancestor
92653924|NCT04538521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653925|NCT00269763|Fentanyl|fentanyl|mesh-list
92653926|NCT00269763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653927|NCT00269763|Narcotics|narcotics|mesh-ancestor
92653928|NCT00269763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653929|NCT00269763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653930|NCT00269763|Analgesics|analgesics|mesh-ancestor
92653931|NCT00269763|Sensory System Agents|sensory system agents|mesh-ancestor
92653932|NCT00269763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653933|NCT00269763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92653934|NCT00269763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653935|NCT00269763|Anesthetics, General|anesthetics, general|mesh-ancestor
92653936|NCT00269763|Anesthetics|anesthetics|mesh-ancestor
92653937|NCT00237575|Gemcitabine|gemcitabine|mesh-list
92653938|NCT00237575|Sargramostim|sargramostim|mesh-list
92653939|NCT00237575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653940|NCT00237575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92653941|NCT00237575|Antimetabolites|antimetabolites|mesh-ancestor
92653942|NCT00237575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653943|NCT00237575|Immunologic Factors|immunologic factors|mesh-ancestor
92653944|NCT00237575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653945|NCT00269802|Methylphenidate|methylphenidate|mesh-list
92653946|NCT00269802|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92653947|NCT00269802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653948|NCT00269802|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92653949|NCT00269802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92653950|NCT00269802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653951|NCT00269802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653952|NCT00269802|Dopamine Agents|dopamine agents|mesh-ancestor
92653953|NCT00269802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92653954|NCT02215174|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92653955|NCT02215174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92653956|NCT02215174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92653957|NCT02215174|Antimetabolites|antimetabolites|mesh-ancestor
92653958|NCT02215174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653959|NCT02215174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92653960|NCT02215174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92653961|NCT02215174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653962|NCT00237614|Acetylcysteine|acetylcysteine|mesh-list
92653963|NCT00237614|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92653964|NCT00237614|Antiviral Agents|antiviral agents|mesh-ancestor
92563492|NCT00158704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92563493|NCT00158704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563494|NCT00158704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653965|NCT00237614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92653967|NCT00237614|Respiratory System Agents|respiratory system agents|mesh-ancestor
92653968|NCT00237614|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92653969|NCT00237614|Antioxidants|antioxidants|mesh-ancestor
92653970|NCT00237614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653971|NCT00237614|Protective Agents|protective agents|mesh-ancestor
92653972|NCT00237614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653973|NCT00237614|Antidotes|antidotes|mesh-ancestor
92653974|NCT00269841|Infliximab|infliximab|mesh-list
92653975|NCT00269841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92653976|NCT00269841|Antibodies|antibodies|mesh-list
92653977|NCT00269841|Immunoglobulins|immunoglobulins|mesh-list
92653978|NCT00269841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92653979|NCT00269841|Immunologic Factors|immunologic factors|mesh-ancestor
92653980|NCT00269841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653981|NCT00269841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653982|NCT00269841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92653983|NCT00269841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92653984|NCT00269841|Dermatologic Agents|dermatologic agents|mesh-ancestor
92653985|NCT00269841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92653986|NCT00269841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653987|NCT00414128|Mycophenolic Acid|mycophenolic acid|mesh-list
92653988|NCT00414128|Cyclophosphamide|cyclophosphamide|mesh-list
92653989|NCT00414128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92653990|NCT00414128|Immunologic Factors|immunologic factors|mesh-ancestor
92653991|NCT00414128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653992|NCT00414128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92653993|NCT00414128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92653994|NCT00414128|Alkylating Agents|alkylating agents|mesh-ancestor
92653995|NCT00414128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653996|NCT00414128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92653997|NCT00414128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92379296|NCT05419674|Amoxicillin|amoxicillin|mesh-list
92653998|NCT00414128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92653999|NCT00414128|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92654000|NCT00414128|Antitubercular Agents|antitubercular agents|mesh-ancestor
92654001|NCT00414128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654002|NCT00414128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654003|NCT00414128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654005|NCT04538365|Propranolol|propranolol|mesh-list
92654006|NCT04538365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92654007|NCT04538365|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92654008|NCT04538365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654009|NCT04538365|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92654010|NCT04538365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92654011|NCT04538365|Antimetabolites|antimetabolites|mesh-ancestor
92654012|NCT04538365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654013|NCT04538365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92654014|NCT04538365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92654015|NCT04538365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92654016|NCT04538365|Adrenergic Agents|adrenergic agents|mesh-ancestor
92654017|NCT04538365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654018|NCT04538365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654019|NCT04538365|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92654020|NCT04538365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92654021|NCT04538365|Vasodilator Agents|vasodilator agents|mesh-ancestor
92654022|NCT00414245|Metformin|metformin|mesh-list
92654023|NCT00414245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92654024|NCT00414245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654025|NCT00269880|Heparin|heparin|mesh-list
92654026|NCT00269880|Abciximab|abciximab|mesh-list
92654027|NCT00269880|Anticoagulants|anticoagulants|mesh-ancestor
92654028|NCT00269880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92654029|NCT00269880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92654030|NCT00269880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654031|NCT00269880|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92654032|NCT00237653|Valganciclovir|valganciclovir|mesh-list
92654033|NCT00237653|Antiviral Agents|antiviral agents|mesh-ancestor
92563495|NCT00158704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563496|NCT00158782|Lapatinib|lapatinib|mesh-list
92563497|NCT00158782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563498|NCT00158782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563499|NCT00158782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563500|NCT00158782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563501|NCT00158821|Tenofovir|tenofovir|mesh-list
92563502|NCT00158821|Lamivudine|lamivudine|mesh-list
92563503|NCT00158821|Efavirenz|efavirenz|mesh-list
92563504|NCT00158821|Stavudine|stavudine|mesh-list
92563505|NCT00158821|Antiviral Agents|antiviral agents|mesh-ancestor
92563506|NCT00158821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563507|NCT00158821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92563508|NCT00158821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563509|NCT00158821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563510|NCT00158821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563511|NCT00158821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92563512|NCT00158821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92563513|NCT00158821|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92563514|NCT00158821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92563515|NCT00158821|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92563516|NCT00158821|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92563517|NCT00158821|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92563518|NCT00158821|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92563519|NCT00158821|Antimetabolites|antimetabolites|mesh-ancestor
92563520|NCT05568147|Aspirin|aspirin|mesh-list
92563523|NCT05568147|Analgesics|analgesics|mesh-ancestor
92563540|NCT00051896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563541|NCT00051896|Dopamine Agents|dopamine agents|mesh-ancestor
92563542|NCT00051896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563543|NCT00051896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563544|NCT04724473|Tretinoin|tretinoin|mesh-list
92563545|NCT04724473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563546|NCT04724473|Keratolytic Agents|keratolytic agents|mesh-ancestor
92563547|NCT04724473|Dermatologic Agents|dermatologic agents|mesh-ancestor
92563548|NCT00159016|Imatinib Mesylate|imatinib mesylate|mesh-list
92563549|NCT00159016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563550|NCT00159016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92563551|NCT00159016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563552|NCT00159016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563554|NCT00159094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92563555|NCT00159094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563556|NCT00159094|Tubulin Modulators|tubulin modulators|mesh-ancestor
92563557|NCT00159094|Antimitotic Agents|antimitotic agents|mesh-ancestor
92563558|NCT00159094|Mitosis Modulators|mitosis modulators|mesh-ancestor
92563559|NCT00159094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563560|NCT02965053|Sevelamer|sevelamer|mesh-list
92563561|NCT02965053|Chelating Agents|chelating agents|mesh-ancestor
92563562|NCT02965053|Sequestering Agents|sequestering agents|mesh-ancestor
92563563|NCT02965053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563592|NCT00052013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563593|NCT00159445|Gemcitabine|gemcitabine|mesh-list
92563594|NCT00159445|Capecitabine|capecitabine|mesh-list
92563595|NCT00159445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92563596|NCT00159445|Antimetabolites|antimetabolites|mesh-ancestor
92563597|NCT00159445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563598|NCT00159445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563599|NCT00044460|Rosiglitazone|rosiglitazone|mesh-list
92563600|NCT00044460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92563601|NCT00044460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563602|NCT00159484|Celecoxib|celecoxib|mesh-list
92563603|NCT00159484|Epothilone B|epothilone b|mesh-list
92563604|NCT00159484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92563653|NCT00159718|Vasodilator Agents|vasodilator agents|mesh-ancestor
92563654|NCT00159757|Ziprasidone|ziprasidone|mesh-list
92563655|NCT00159757|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92563726|NCT00052286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563727|NCT00052286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92563728|NCT00052286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92563729|NCT00052286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92563731|NCT00160186|Pancreatin|pancreatin|mesh-list
92563795|NCT00160537|Histamine Agents|histamine agents|mesh-ancestor
92563796|NCT00160537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92563797|NCT00160537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563798|NCT00160537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563799|NCT00160576|Levetiracetam|levetiracetam|mesh-list
92563800|NCT00160576|Anticonvulsants|anticonvulsants|mesh-ancestor
92563801|NCT00160576|Nootropic Agents|nootropic agents|mesh-ancestor
92563802|NCT00160849|Lopinavir|lopinavir|mesh-list
92563865|NCT00052559|Growth Substances|growth substances|mesh-ancestor
92563866|NCT00052559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563867|NCT00052559|Growth Inhibitors|growth inhibitors|mesh-ancestor
92563868|NCT00052559|Immunologic Factors|immunologic factors|mesh-ancestor
92563869|NCT00052559|Antimetabolites|antimetabolites|mesh-ancestor
92563870|NCT00052559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563871|NCT00052559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92563872|NCT00052559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92563873|NCT00161083|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92563874|NCT00161083|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92563875|NCT00161083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92563876|NCT00044577|Tenofovir|tenofovir|mesh-list
92563877|NCT00044577|Lamivudine|lamivudine|mesh-list
92563878|NCT00044577|Abacavir|abacavir|mesh-list
92563879|NCT00044577|Dideoxynucleosides|dideoxynucleosides|mesh-list
92563880|NCT00044577|Antiviral Agents|antiviral agents|mesh-ancestor
92563881|NCT00044577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92563882|NCT00044577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92563883|NCT00044577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92563884|NCT00044577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92563885|NCT00044577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563886|NCT00044577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92563887|NCT00044577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92563888|NCT00044577|Antimetabolites|antimetabolites|mesh-ancestor
92563889|NCT00161122|Vaccines|vaccines|mesh-list
92563891|NCT00161122|Immunologic Factors|immunologic factors|mesh-ancestor
92563915|NCT00161239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563916|NCT00161239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92563917|NCT00161239|Abortifacient Agents|abortifacient agents|mesh-ancestor
92563918|NCT00161239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92563919|NCT00161239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92563920|NCT00161239|Antimetabolites|antimetabolites|mesh-ancestor
92563921|NCT00161239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92563922|NCT00161239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92563979|NCT00161668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92563981|NCT00161668|Immunoconjugates|immunoconjugates|mesh-ancestor
92563982|NCT00161668|Immunologic Factors|immunologic factors|mesh-ancestor
92563983|NCT00161668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92563985|NCT00052832|Vitamins|vitamins|mesh-ancestor
92564051|NCT00405457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564052|NCT00405457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564053|NCT00405457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564054|NCT00405457|Immunologic Factors|immunologic factors|mesh-ancestor
92564123|NCT00162487|Tocolytic Agents|tocolytic agents|mesh-ancestor
92564124|NCT00162487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92564125|NCT00162487|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92564126|NCT00162487|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92564127|NCT00162487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92564128|NCT00162487|Adrenergic Agents|adrenergic agents|mesh-ancestor
92564129|NCT00162487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564131|NCT00162526|Tocopherols|tocopherols|mesh-list
92564189|NCT00162721|Ifosfamide|ifosfamide|mesh-list
92564190|NCT00162721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564191|NCT00162721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92564192|NCT00162721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92564193|NCT00162721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92564194|NCT00162721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564195|NCT00162721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564196|NCT00162721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92564197|NCT00162721|Alkylating Agents|alkylating agents|mesh-ancestor
92564198|NCT00053222|Arsenic Trioxide|arsenic trioxide|mesh-list
92564199|NCT00053222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564200|NCT00162760|Thalidomide|thalidomide|mesh-list
92564201|NCT00162760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564202|NCT00162760|Immunologic Factors|immunologic factors|mesh-ancestor
92564203|NCT00162760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564204|NCT00162760|Leprostatic Agents|leprostatic agents|mesh-ancestor
92564205|NCT00162760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564206|NCT00162760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564207|NCT00162760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92564212|NCT00162799|Triflusal|triflusal|mesh-list
92564241|NCT00163072|Megestrol Acetate|megestrol acetate|mesh-list
92564242|NCT00163072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92564243|NCT00163072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564244|NCT00163072|Appetite Stimulants|appetite stimulants|mesh-ancestor
92564245|NCT00163072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92564246|NCT00163072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564247|NCT00163111|Amphotericin B|amphotericin b|mesh-list
92564248|NCT00163111|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92564249|NCT00163111|Fluconazole|fluconazole|mesh-list
92564250|NCT00163111|Amebicides|amebicides|mesh-ancestor
92564251|NCT00163111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92564252|NCT00163111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92564301|NCT00163384|Glucocorticoids|glucocorticoids|mesh-ancestor
92564303|NCT00163384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564304|NCT00163384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564305|NCT00163384|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92564306|NCT00163423|Ciclesonide|ciclesonide|mesh-list
92564307|NCT00163423|Glucocorticoids|glucocorticoids|mesh-ancestor
92564308|NCT00163423|Hormones|hormones|mesh-ancestor
92564309|NCT00163423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92564311|NCT00163423|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92564439|NCT00164281|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92564440|NCT00164281|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92564441|NCT00164281|Antimetabolites|antimetabolites|mesh-ancestor
92564442|NCT00164281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564443|NCT00164281|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92564445|NCT00044928|Piperacillin|piperacillin|mesh-list
92564446|NCT00044928|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92564447|NCT00044928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564448|NCT00044928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564449|NCT00044928|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92564450|NCT00044928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92564451|NCT00044928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564452|NCT00164359|Artesunate|artesunate|mesh-list
92564453|NCT00164359|Amodiaquine|amodiaquine|mesh-list
92564502|NCT00164710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92564503|NCT00045045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92564504|NCT00045045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92564505|NCT00045045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564506|NCT00164749|Curcumin|curcumin|mesh-list
92564572|NCT00165139|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92564573|NCT00165139|Lenograstim|lenograstim|mesh-list
92564574|NCT00165139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564607|NCT00165178|Leucovorin|leucovorin|mesh-list
92564645|NCT00165178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564646|NCT00165178|Antidotes|antidotes|mesh-ancestor
92564647|NCT00165178|Protective Agents|protective agents|mesh-ancestor
92564648|NCT00165178|Vitamin B Complex|vitamin b complex|mesh-ancestor
92564649|NCT00165178|Vitamins|vitamins|mesh-ancestor
92564650|NCT00165178|Micronutrients|micronutrients|mesh-ancestor
92564651|NCT00165178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92564652|NCT00165178|Tubulin Modulators|tubulin modulators|mesh-ancestor
92564653|NCT00165178|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564654|NCT00165178|Mitosis Modulators|mitosis modulators|mesh-ancestor
92564655|NCT00165178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92564656|NCT00165217|Thalidomide|thalidomide|mesh-list
92564657|NCT00165217|Capecitabine|capecitabine|mesh-list
92564658|NCT00165217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92564659|NCT00165217|Antimetabolites|antimetabolites|mesh-ancestor
92564660|NCT00165217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564661|NCT00165217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564662|NCT00165217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92564672|NCT00165295|Sildenafil Citrate|sildenafil citrate|mesh-list
92564704|NCT00165451|Immunologic Factors|immunologic factors|mesh-ancestor
92564705|NCT00165451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564706|NCT00165451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92564707|NCT00165451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92564708|NCT00165451|Alkylating Agents|alkylating agents|mesh-ancestor
92564709|NCT00165451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92564710|NCT00165451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92564771|NCT00165763|Cholinergic Agents|cholinergic agents|mesh-ancestor
92564772|NCT00165763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92564773|NCT00165763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564841|NCT00166465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92564842|NCT00166465|Antidotes|antidotes|mesh-ancestor
92564843|NCT00166465|Protective Agents|protective agents|mesh-ancestor
92564844|NCT00166465|Vitamin B Complex|vitamin b complex|mesh-ancestor
92564845|NCT00166465|Vitamins|vitamins|mesh-ancestor
92564846|NCT00166465|Micronutrients|micronutrients|mesh-ancestor
92564847|NCT00166621|Buspirone|buspirone|mesh-list
92564911|NCT04723732|Chlorhexidine|chlorhexidine|mesh-list
92564912|NCT04723732|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92564913|NCT04723732|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92564914|NCT04723732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92564983|NCT00054587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92564985|NCT00054587|Antimetabolites|antimetabolites|mesh-ancestor
92565057|NCT00167908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565058|NCT00167947|Cyclosporine|cyclosporine|mesh-list
92565059|NCT00167947|Sirolimus|sirolimus|mesh-list
92565060|NCT00167947|Cyclosporins|cyclosporins|mesh-list
92565074|NCT00167986|Vancomycin|vancomycin|mesh-list
92565127|NCT00168415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289902|NCT05688215|Antidotes|antidotes|mesh-ancestor
92565128|NCT00168415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565129|NCT00168415|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565130|NCT00168415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565273|NCT00169039|GABA Antagonists|gaba antagonists|mesh-ancestor
92565274|NCT00169039|GABA Agents|gaba agents|mesh-ancestor
92565275|NCT00169039|Antiemetics|antiemetics|mesh-ancestor
92565276|NCT00169039|Autonomic Agents|autonomic agents|mesh-ancestor
92565277|NCT00169039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92565278|NCT00169039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92565279|NCT00169039|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92565281|NCT00169078|Chloroquine|chloroquine|mesh-list
92565282|NCT00169078|Amebicides|amebicides|mesh-ancestor
92565283|NCT00169078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92565284|NCT00169078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92565285|NCT00169078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565286|NCT00169078|Antimalarials|antimalarials|mesh-ancestor
92565287|NCT00169078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565288|NCT00054977|Fluorouracil|fluorouracil|mesh-list
92565289|NCT00054977|Antimetabolites|antimetabolites|mesh-ancestor
92565290|NCT00054977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565291|NCT00054977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92565292|NCT00054977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565293|NCT00054977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92565294|NCT00054977|Immunologic Factors|immunologic factors|mesh-ancestor
92565295|NCT00054977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565296|NCT00169156|Prednisone|prednisone|mesh-list
92565297|NCT00169156|Cyclophosphamide|cyclophosphamide|mesh-list
92565327|NCT00169195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92565329|NCT00169195|Immunologic Factors|immunologic factors|mesh-ancestor
92565401|NCT00055133|Paclitaxel|paclitaxel|mesh-list
92565402|NCT00055133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92565403|NCT00055133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92565404|NCT00055133|Tubulin Modulators|tubulin modulators|mesh-ancestor
92565405|NCT00055133|Antimitotic Agents|antimitotic agents|mesh-ancestor
92565406|NCT00055133|Mitosis Modulators|mitosis modulators|mesh-ancestor
92565407|NCT00055133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565470|NCT00170755|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92565471|NCT00170755|Cholinergic Agents|cholinergic agents|mesh-ancestor
92565472|NCT00170755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92565473|NCT00170755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565537|NCT00171067|Protease Inhibitors|protease inhibitors|mesh-ancestor
92565538|NCT00171067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565539|NCT00171067|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92565540|NCT00171067|Protective Agents|protective agents|mesh-ancestor
92565541|NCT00171067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565563|NCT00055523|Adalimumab|adalimumab|mesh-list
92565605|NCT00171496|Antifungal Agents|antifungal agents|mesh-ancestor
92565606|NCT00171496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92565678|NCT00171652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92565679|NCT00171652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92565680|NCT00171652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565681|NCT00171652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92565682|NCT00171691|Diclofenac|diclofenac|mesh-list
92565683|NCT00171691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92565684|NCT00171691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92565685|NCT00171691|Analgesics|analgesics|mesh-ancestor
92565741|NCT00171964|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92565742|NCT00171964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92565743|NCT00172003|Zoledronic Acid|zoledronic acid|mesh-list
92565814|NCT04732845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92565815|NCT00055913|Bevacizumab|bevacizumab|mesh-list
92565816|NCT00055913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92565817|NCT00055913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92565890|NCT00046020|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92565891|NCT00046020|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92565892|NCT00046020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92565893|NCT00046020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92565955|NCT00174304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92565956|NCT00174304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92565957|NCT00174304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92565958|NCT00174304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92566025|NCT00174616|Oxaliplatin|oxaliplatin|mesh-list
92566026|NCT00174616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92566027|NCT00174616|Antimetabolites|antimetabolites|mesh-ancestor
92566097|NCT00046176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92566098|NCT00046176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92566099|NCT00046176|Antimetabolites|antimetabolites|mesh-ancestor
92566173|NCT00175435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566174|NCT00175513|Valacyclovir|valacyclovir|mesh-list
92566175|NCT00175513|Antiviral Agents|antiviral agents|mesh-ancestor
92566176|NCT00175513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566177|NCT00175591|Bupivacaine|bupivacaine|mesh-list
92566178|NCT00175591|Anesthetics, Local|anesthetics, local|mesh-ancestor
92566179|NCT00175591|Anesthetics|anesthetics|mesh-ancestor
92566180|NCT00175591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566181|NCT00175591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566182|NCT00175591|Sensory System Agents|sensory system agents|mesh-ancestor
92566183|NCT00175591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566184|NCT00175630|Bupivacaine|bupivacaine|mesh-list
92566185|NCT00175630|Anesthetics, Local|anesthetics, local|mesh-ancestor
92566186|NCT00175630|Anesthetics|anesthetics|mesh-ancestor
92566235|NCT00175903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566236|NCT00175903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92566237|NCT00175903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92566238|NCT00175903|Analgesics|analgesics|mesh-ancestor
92566239|NCT00175903|Sensory System Agents|sensory system agents|mesh-ancestor
92566240|NCT00175903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566241|NCT00175903|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92566242|NCT00175903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92566300|NCT00176059|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92566301|NCT00176059|Immunologic Factors|immunologic factors|mesh-ancestor
92566302|NCT00176059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566303|NCT00176098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92566304|NCT00176098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92566305|NCT00176098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566306|NCT00176293|Dexamethasone|dexamethasone|mesh-list
92566307|NCT00176293|Doxorubicin|doxorubicin|mesh-list
92566365|NCT00398450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566366|NCT00398450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566367|NCT00398450|Immunologic Factors|immunologic factors|mesh-ancestor
92566368|NCT00398450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566369|NCT00046293|Abciximab|abciximab|mesh-list
92566370|NCT00046293|Anticoagulants|anticoagulants|mesh-ancestor
92566371|NCT00046293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92566372|NCT00176527|Interferons|interferons|mesh-list
92566373|NCT00176527|Interferon-alpha|interferon-alpha|mesh-list
92566374|NCT00176527|Interferon alpha-2|interferon alpha-2|mesh-list
92566375|NCT00176527|Docetaxel|docetaxel|mesh-list
92566430|NCT00176761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566431|NCT00176995|Eflornithine|eflornithine|mesh-list
92566432|NCT00176995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566433|NCT00176995|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92566434|NCT00176995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92566435|NCT00176995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92566436|NCT00176995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566496|NCT00177853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92566497|NCT00177853|Analgesics|analgesics|mesh-ancestor
92566498|NCT00177853|Sensory System Agents|sensory system agents|mesh-ancestor
92566499|NCT00177853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92566500|NCT00177853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566563|NCT00408226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92566564|NCT00408226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92566635|NCT00179062|Serotonin Agents|serotonin agents|mesh-ancestor
92566636|NCT00179062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92566706|NCT00179686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92566708|NCT00179686|Growth Inhibitors|growth inhibitors|mesh-ancestor
92566709|NCT00179686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566710|NCT00179725|Doxorubicin|doxorubicin|mesh-list
92566711|NCT00179725|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92566712|NCT00179725|Lenalidomide|lenalidomide|mesh-list
92566713|NCT00179725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92566714|NCT00179725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566715|NCT00179725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92566716|NCT00179725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92566717|NCT00179725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566718|NCT00179725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566725|NCT00179764|Busulfan|busulfan|mesh-list
92566769|NCT00180115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92566770|NCT00180115|Antiviral Agents|antiviral agents|mesh-ancestor
92566771|NCT00180115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566772|NCT00180115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92566773|NCT00180115|Immunologic Factors|immunologic factors|mesh-ancestor
92566774|NCT00180115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566775|NCT00046527|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92566837|NCT04729491|Nitazoxanide|nitazoxanide|mesh-list
92566838|NCT04729491|Dutasteride|dutasteride|mesh-list
92566839|NCT04729491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92566840|NCT04729491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92566841|NCT04729491|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92566842|NCT04729491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92566843|NCT04729491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92566844|NCT04729491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566845|NCT04729491|Hormone Antagonists|hormone antagonists|mesh-ancestor
92566846|NCT04729491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92566847|NCT04729491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566848|NCT04729491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92566849|NCT00057356|Conivaptan|conivaptan|mesh-list
92566850|NCT00057356|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92566851|NCT00057356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566852|NCT00057356|Natriuretic Agents|natriuretic agents|mesh-ancestor
92566853|NCT00057356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566854|NCT00181012|Lidocaine|lidocaine|mesh-list
92566855|NCT00181012|Anesthetics, Local|anesthetics, local|mesh-ancestor
92566890|NCT00181597|Abortifacient Agents|abortifacient agents|mesh-ancestor
92566891|NCT00181597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92566892|NCT00181597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92566961|NCT00182143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92566962|NCT00182221|Fibrin fragment D|fibrin fragment d|mesh-list
92566963|NCT00182221|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92566966|NCT00182221|Hemostatics|hemostatics|mesh-ancestor
92567034|NCT00182650|Fludarabine phosphate|fludarabine phosphate|mesh-list
92567035|NCT00182650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92567036|NCT00182650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567037|NCT00182650|Immunologic Factors|immunologic factors|mesh-ancestor
92567038|NCT00182650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567039|NCT00182650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92567049|NCT00182806|Irinotecan|irinotecan|mesh-list
92567101|NCT00183235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92567102|NCT00183235|Serotonin Agents|serotonin agents|mesh-ancestor
92567103|NCT00183235|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92567175|NCT00183859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92567176|NCT00183859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567177|NCT00183859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567178|NCT00183859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567179|NCT00183898|Capecitabine|capecitabine|mesh-list
92567245|NCT00184171|Hormones|hormones|mesh-ancestor
92567246|NCT00184171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92567247|NCT00184171|Antacids|antacids|mesh-ancestor
92567249|NCT00184171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92567317|NCT00058292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567318|NCT00058292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567319|NCT00058292|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92567320|NCT00058292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92567321|NCT00058292|Alkylating Agents|alkylating agents|mesh-ancestor
92567322|NCT00058292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92567323|NCT03816774|Simethicone|simethicone|mesh-list
92567324|NCT03816774|Antifoaming Agents|antifoaming agents|mesh-ancestor
92567325|NCT03816774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567326|NCT03816774|Emollients|emollients|mesh-ancestor
92567327|NCT03816774|Dermatologic Agents|dermatologic agents|mesh-ancestor
92567328|NCT00184912|Caffeine|caffeine|mesh-list
92567329|NCT00184912|Annexin A5|annexin a5|mesh-list
92567330|NCT00184912|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92567331|NCT00184912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567332|NCT00184912|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92567333|NCT00184912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567334|NCT00184912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567372|NCT00185107|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92567373|NCT00185107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92567375|NCT00058448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92567442|NCT00058487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92567514|NCT00185887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92567515|NCT00185887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92567516|NCT00185887|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92567517|NCT00185887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92567518|NCT00185887|Adrenergic Agents|adrenergic agents|mesh-ancestor
92567519|NCT00185887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92567584|NCT03551964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92567587|NCT03551964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92567658|NCT00187057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567659|NCT00187057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92567660|NCT00187057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92567661|NCT00187057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92567663|NCT00046917|Alvocidib|alvocidib|mesh-list
92567729|NCT00187564|Thioctic Acid|thioctic acid|mesh-list
92567730|NCT00187564|Antioxidants|antioxidants|mesh-ancestor
92567731|NCT00187564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92567732|NCT00187564|Protective Agents|protective agents|mesh-ancestor
92567733|NCT00187564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567734|NCT00187564|Vitamin B Complex|vitamin b complex|mesh-ancestor
92567801|NCT00187915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92567802|NCT00187915|Antitubercular Agents|antitubercular agents|mesh-ancestor
92567803|NCT00187915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92567804|NCT00187993|Hormones|hormones|mesh-list
92567805|NCT00187993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92567806|NCT00187993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567807|NCT00188071|Acetaminophen|acetaminophen|mesh-list
92567808|NCT00188071|Ketoprofen|ketoprofen|mesh-list
92567809|NCT00188071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92567810|NCT00188071|Analgesics|analgesics|mesh-ancestor
92567811|NCT00188071|Sensory System Agents|sensory system agents|mesh-ancestor
92567812|NCT00188071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92567813|NCT00188071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567814|NCT00188071|Antipyretics|antipyretics|mesh-ancestor
92567862|NCT00188383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92567863|NCT00188383|Antiviral Agents|antiviral agents|mesh-ancestor
92567864|NCT00188383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92567865|NCT00188383|Dopamine Agents|dopamine agents|mesh-ancestor
92567933|NCT00188773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92567934|NCT00188773|Antidotes|antidotes|mesh-ancestor
92567935|NCT00188773|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92567936|NCT00188773|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92567937|NCT00188773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92567938|NCT00188812|Donepezil|donepezil|mesh-list
92568004|NCT00189085|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92568006|NCT00189085|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92568007|NCT00189085|Antimetabolites|antimetabolites|mesh-ancestor
92568008|NCT00189085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568009|NCT00189085|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92568010|NCT00189085|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92568068|NCT00189709|Hormone Antagonists|hormone antagonists|mesh-ancestor
92568069|NCT00189709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568070|NCT00189709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568074|NCT00189748|Tacrolimus|tacrolimus|mesh-list
92568138|NCT00190099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92568139|NCT00190099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568140|NCT00190099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92568141|NCT00190099|Glucocorticoids|glucocorticoids|mesh-ancestor
92568142|NCT00190099|Hormones|hormones|mesh-ancestor
92568143|NCT00190099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92568144|NCT00190099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92568145|NCT00190099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568146|NCT02963077|Cholestyramine Resin|cholestyramine resin|mesh-list
92568147|NCT02963077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92568148|NCT02963077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92568149|NCT02963077|Antimetabolites|antimetabolites|mesh-ancestor
92568150|NCT02963077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568151|NCT02963077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92568152|NCT00047268|Cytarabine|cytarabine|mesh-list
92568153|NCT00047268|Mercaptopurine|mercaptopurine|mesh-list
92568154|NCT00047268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92568155|NCT00047268|Antimetabolites|antimetabolites|mesh-ancestor
92568156|NCT00047268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568165|NCT00190294|Misoprostol|misoprostol|mesh-list
92568191|NCT03238365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568192|NCT03238365|Vasodilator Agents|vasodilator agents|mesh-ancestor
92568193|NCT03238365|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92568194|NCT03238365|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92568195|NCT03238365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568196|NCT03238365|Urological Agents|urological agents|mesh-ancestor
92568197|NCT00059618|Carboplatin|carboplatin|mesh-list
92568256|NCT02969252|Rifamycin SV|rifamycin sv|mesh-list
92568257|NCT02969252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568258|NCT02969252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568259|NCT02969252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92568260|NCT00190606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92568322|NCT00190918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568324|NCT00190957|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92568325|NCT00190957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568326|NCT00190957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568327|NCT00190957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568328|NCT00190957|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568329|NCT00190957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568330|NCT00190957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568331|NCT00190996|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92568332|NCT00190996|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92568333|NCT00190996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568334|NCT00190996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568352|NCT02922894|Trazodone|trazodone|mesh-list
92568377|NCT00191347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568378|NCT00191347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568379|NCT00191347|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92568380|NCT00191347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92568381|NCT00191425|Teriparatide|teriparatide|mesh-list
92568382|NCT00191425|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92568383|NCT00191425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92568384|NCT00191425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568440|NCT00191659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568441|NCT00191659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568442|NCT00191659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568443|NCT00191659|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568444|NCT00191659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568445|NCT00191659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568446|NCT00191698|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92568447|NCT00191698|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92568448|NCT00191698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92568449|NCT00191698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92568450|NCT00191698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568451|NCT00191698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92568452|NCT00191698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92568453|NCT00191698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568455|NCT02470299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92568456|NCT02470299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92568491|NCT00059813|Interferons|interferons|mesh-list
92568492|NCT00059813|Interferon-alpha|interferon-alpha|mesh-list
92568493|NCT00059813|Interferon alpha-2|interferon alpha-2|mesh-list
92568494|NCT00059813|Oblimersen|oblimersen|mesh-list
92568495|NCT00059813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92568496|NCT00059813|Antiviral Agents|antiviral agents|mesh-ancestor
92568497|NCT00059813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568498|NCT00059813|Immunologic Factors|immunologic factors|mesh-ancestor
92568559|NCT02968901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568631|NCT00193102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92568632|NCT00193102|Leprostatic Agents|leprostatic agents|mesh-ancestor
92568633|NCT00193102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92568634|NCT00193102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568635|NCT00193102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92568637|NCT00193102|Growth Substances|growth substances|mesh-ancestor
92568702|NCT00409591|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92293514|NCT02012192|Paclitaxel|paclitaxel|mesh-list
92568703|NCT00409591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92568704|NCT00409591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568705|NCT00409591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568706|NCT00409591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92568707|NCT00409591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92568708|NCT00409591|Antiviral Agents|antiviral agents|mesh-ancestor
92568709|NCT00409591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92568710|NCT00409591|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92568711|NCT00409591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92568712|NCT00409591|Antimetabolites|antimetabolites|mesh-ancestor
92568713|NCT00409591|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92568763|NCT00060242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92568764|NCT00060242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92568765|NCT00060242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568766|NCT00193921|Cisplatin|cisplatin|mesh-list
92568767|NCT00193921|Gemcitabine|gemcitabine|mesh-list
92568768|NCT00193921|Vinorelbine|vinorelbine|mesh-list
92568771|NCT00193921|Antimetabolites|antimetabolites|mesh-ancestor
92568907|NCT02963116|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92568908|NCT02963116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92568980|NCT00084240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92568981|NCT00084240|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92568983|NCT00195598|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92568984|NCT00195598|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92569048|NCT00195871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92569049|NCT00195871|Abortifacient Agents|abortifacient agents|mesh-ancestor
92569050|NCT00195871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92569052|NCT00195871|Antimetabolites|antimetabolites|mesh-ancestor
92569119|NCT00196378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92569194|NCT00084396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92569195|NCT00084396|Hormone Antagonists|hormone antagonists|mesh-ancestor
92569196|NCT00084396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92569198|NCT00196846|Goserelin|goserelin|mesh-list
92569265|NCT00409903|Eprosartan|eprosartan|mesh-list
92569266|NCT00409903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92569267|NCT00409903|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92569268|NCT00409903|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92569336|NCT00084630|Imatinib Mesylate|imatinib mesylate|mesh-list
92569337|NCT00084630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569338|NCT00084630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569339|NCT00084630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569340|NCT00084630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569341|NCT00197821|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92569342|NCT00197821|Immunologic Factors|immunologic factors|mesh-ancestor
92569399|NCT00198055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92569400|NCT00198055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92569401|NCT00198055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92569402|NCT00198055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92569403|NCT00198094|Alprazolam|alprazolam|mesh-list
92569404|NCT00198094|Sertraline|sertraline|mesh-list
92569405|NCT00198094|Antidepressive Agents|antidepressive agents|mesh-ancestor
92569406|NCT00198094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92569407|NCT00198094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92569408|NCT00198094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92569409|NCT00198094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569410|NCT00198094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569411|NCT00198094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569412|NCT00198094|Serotonin Agents|serotonin agents|mesh-ancestor
92569413|NCT00198094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569414|NCT00198094|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92569453|NCT00084708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569454|NCT00084708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92569455|NCT00084708|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92569456|NCT00084708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569457|NCT00084708|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92569459|NCT00084708|Micronutrients|micronutrients|mesh-ancestor
92569460|NCT00084708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92569461|NCT00198367|Cisplatin|cisplatin|mesh-list
92569462|NCT00198367|Carboplatin|carboplatin|mesh-list
92569463|NCT00198367|Vinorelbine|vinorelbine|mesh-list
92569464|NCT00198367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569465|NCT00198367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569466|NCT00198367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92569467|NCT00198367|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569468|NCT00198367|Antimitotic Agents|antimitotic agents|mesh-ancestor
92569469|NCT00198367|Mitosis Modulators|mitosis modulators|mesh-ancestor
92569470|NCT00198445|Bromfenac|bromfenac|mesh-list
92569471|NCT00198445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92569472|NCT00198445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92569473|NCT00198445|Analgesics|analgesics|mesh-ancestor
92569474|NCT00198445|Sensory System Agents|sensory system agents|mesh-ancestor
92569475|NCT00198445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569476|NCT00198445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569477|NCT00198445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569478|NCT00198445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569479|NCT00048399|Fludarabine|fludarabine|mesh-list
92569480|NCT00048399|Alemtuzumab|alemtuzumab|mesh-list
92654034|NCT00237653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654035|NCT00269958|Epoetin Alfa|epoetin alfa|mesh-list
92654036|NCT00269958|Hematinics|hematinics|mesh-ancestor
92654037|NCT02215876|Cyclophosphamide|cyclophosphamide|mesh-list
92654038|NCT02215876|Doxorubicin|doxorubicin|mesh-list
92654039|NCT02215876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654040|NCT02215876|Immunologic Factors|immunologic factors|mesh-ancestor
92654041|NCT02215876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654042|NCT02215876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654043|NCT02215876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92654044|NCT02215876|Alkylating Agents|alkylating agents|mesh-ancestor
92654045|NCT02215876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654046|NCT02215876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654047|NCT02215876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92654048|NCT02215876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92654049|NCT02215876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92654050|NCT02215876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92654051|NCT02215876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654052|NCT00269997|Epoetin Alfa|epoetin alfa|mesh-list
92654053|NCT00269997|Hematinics|hematinics|mesh-ancestor
92569481|NCT00048399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569482|NCT00048399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569484|NCT00060905|Anticonvulsants|anticonvulsants|mesh-ancestor
92569485|NCT00060905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569486|NCT00060905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569494|NCT00198523|Tobramycin|tobramycin|mesh-list
92569548|NCT00409981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92569549|NCT00409981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569550|NCT00409981|Tubulin Modulators|tubulin modulators|mesh-ancestor
92569621|NCT00199186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92569622|NCT00199186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92569623|NCT00199186|Protease Inhibitors|protease inhibitors|mesh-ancestor
92569624|NCT00199186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569689|NCT00199576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569690|NCT00084942|Gemcitabine|gemcitabine|mesh-list
92569691|NCT00084942|Capecitabine|capecitabine|mesh-list
92569692|NCT00084942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92569693|NCT00084942|Antimetabolites|antimetabolites|mesh-ancestor
92569695|NCT00084942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569762|NCT00061178|Growth Substances|growth substances|mesh-ancestor
92569763|NCT00061178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569764|NCT00061178|Growth Inhibitors|growth inhibitors|mesh-ancestor
92569765|NCT00200395|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92569766|NCT00200395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569767|NCT00200395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92569768|NCT00200395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92569769|NCT00200395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569771|NCT00200434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92569772|NCT00200434|Vasodilator Agents|vasodilator agents|mesh-ancestor
92569773|NCT00200434|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92569774|NCT00200434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92569823|NCT00200551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569824|NCT00200551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92569825|NCT00200551|Antitubercular Agents|antitubercular agents|mesh-ancestor
92569826|NCT00200551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92569828|NCT00061256|Alendronate|alendronate|mesh-list
92569829|NCT00061256|Calcium Carbonate|calcium carbonate|mesh-list
92569895|NCT00201682|Etanercept|etanercept|mesh-list
92569896|NCT00201682|Rituximab|rituximab|mesh-list
92569897|NCT00201682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92569898|NCT00201682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92569899|NCT00201682|Immunologic Factors|immunologic factors|mesh-ancestor
92569900|NCT00201682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569901|NCT00201682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92569902|NCT00201682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92569903|NCT00201682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92569904|NCT00201682|Analgesics|analgesics|mesh-ancestor
92569905|NCT00201682|Sensory System Agents|sensory system agents|mesh-ancestor
92569906|NCT00201682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92569907|NCT00201682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92569908|NCT00201682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92569909|NCT00201682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92569910|NCT00410371|Lamotrigine|lamotrigine|mesh-list
92569911|NCT00410371|Anticonvulsants|anticonvulsants|mesh-ancestor
92569912|NCT00410371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92569913|NCT00410371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569952|NCT00221416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92569953|NCT00221416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92569954|NCT00221416|Dopamine Agonists|dopamine agonists|mesh-ancestor
92569955|NCT00221416|Dopamine Agents|dopamine agents|mesh-ancestor
92569956|NCT00221416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92569957|NCT00221416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92569958|NCT00221416|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91960523|NCT02729545|Hormones|hormones|mesh-ancestor
92569959|NCT00221416|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92569960|NCT00221416|Serotonin Agents|serotonin agents|mesh-ancestor
92569961|NCT00221416|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92569962|NCT00221416|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92569963|NCT00221416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92569964|NCT00221416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92569965|NCT00221494|Pindolol|pindolol|mesh-list
92569966|NCT00221494|Citalopram|citalopram|mesh-list
92569967|NCT00221494|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92569968|NCT00221494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92569969|NCT00221494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92569971|NCT00221494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570005|NCT00221689|GABA Agonists|gaba agonists|mesh-ancestor
92570006|NCT00221689|GABA Agents|gaba agents|mesh-ancestor
92570007|NCT00221689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570008|NCT00221689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570009|NCT02968121|Brexpiprazole|brexpiprazole|mesh-list
92570010|NCT02968121|Serotonin Agents|serotonin agents|mesh-ancestor
92570011|NCT02968121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570012|NCT02968121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570013|NCT02968121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570014|NCT02968121|Dopamine Agonists|dopamine agonists|mesh-ancestor
92570015|NCT02968121|Dopamine Agents|dopamine agents|mesh-ancestor
92570016|NCT00412789|Epothilone B|epothilone b|mesh-list
92570017|NCT00412789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570066|NCT00221962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570067|NCT00221962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92570068|NCT00221962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92570071|NCT00221962|Dopamine Agonists|dopamine agonists|mesh-ancestor
92570135|NCT00222547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92570136|NCT00222547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92570137|NCT00222547|Anticestodal Agents|anticestodal agents|mesh-ancestor
92570138|NCT00222547|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92570139|NCT00222547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92570140|NCT00222547|Tubulin Modulators|tubulin modulators|mesh-ancestor
92570141|NCT00222547|Antimitotic Agents|antimitotic agents|mesh-ancestor
92570142|NCT00222547|Mitosis Modulators|mitosis modulators|mesh-ancestor
92570143|NCT00086034|Motexafin gadolinium|motexafin gadolinium|mesh-list
92570144|NCT00086034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570145|NCT00086034|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92570146|NCT00086034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92570147|NCT02968082|Scopolamine|scopolamine|mesh-list
92570148|NCT02968082|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92570149|NCT02968082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92570150|NCT02968082|Antiemetics|antiemetics|mesh-ancestor
92570151|NCT02968082|Autonomic Agents|autonomic agents|mesh-ancestor
92570152|NCT02968082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570153|NCT02968082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570154|NCT02968082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570190|NCT00223015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92570191|NCT00223015|Immunologic Factors|immunologic factors|mesh-ancestor
92570192|NCT00223015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570193|NCT00223015|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92570194|NCT00223015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570195|NCT00223015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570196|NCT00061763|Deferasirox|deferasirox|mesh-list
92570197|NCT00061763|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92570198|NCT00061763|Chelating Agents|chelating agents|mesh-ancestor
92570199|NCT00061763|Sequestering Agents|sequestering agents|mesh-ancestor
92570200|NCT00061763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570201|NCT00223054|Cyclosporine|cyclosporine|mesh-list
92570252|NCT00223288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570253|NCT00223288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570328|NCT00223717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92570329|NCT00223717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570330|NCT00223717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92570331|NCT00223717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92570332|NCT00223717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570333|NCT00223717|Antipyretics|antipyretics|mesh-ancestor
92570334|NCT00223717|Vasodilator Agents|vasodilator agents|mesh-ancestor
92570335|NCT00223717|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92570336|NCT00223717|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92570337|NCT00223717|Urological Agents|urological agents|mesh-ancestor
92570389|NCT00061919|Immunologic Factors|immunologic factors|mesh-ancestor
92570465|NCT00224302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92570466|NCT00224302|Dopamine Agents|dopamine agents|mesh-ancestor
92570535|NCT00062231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570536|NCT00062231|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92570607|NCT00413023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570608|NCT00413023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570609|NCT00413023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92570610|NCT00413023|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92570677|NCT00225160|Vitamins|vitamins|mesh-ancestor
92570678|NCT00225160|Micronutrients|micronutrients|mesh-ancestor
92570679|NCT00225160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570680|NCT00225160|Nootropic Agents|nootropic agents|mesh-ancestor
92570681|NCT00225238|Esomeprazole|esomeprazole|mesh-list
92570687|NCT00062426|Leucovorin|leucovorin|mesh-list
92570748|NCT00225511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92570749|NCT00225511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570750|NCT00225511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570751|NCT00225511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570752|NCT00225511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92570812|NCT00225706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570814|NCT00095667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570815|NCT00095667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92570816|NCT00095667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92570817|NCT00095667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570818|NCT00225862|Ropinirole|ropinirole|mesh-list
92570819|NCT00225862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92570820|NCT00225862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92570821|NCT00225862|Dopamine Agonists|dopamine agonists|mesh-ancestor
92570822|NCT00225862|Dopamine Agents|dopamine agents|mesh-ancestor
92570823|NCT00225862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92570824|NCT00225862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92570825|NCT00225862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570826|NCT00095706|Bevacizumab|bevacizumab|mesh-list
92570827|NCT00095706|Trastuzumab|trastuzumab|mesh-list
92570828|NCT00095706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92570829|NCT00095706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92570830|NCT00095706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92570867|NCT00226096|Labetalol|labetalol|mesh-list
92570868|NCT00226096|Hydralazine|hydralazine|mesh-list
92570869|NCT00226096|Nicardipine|nicardipine|mesh-list
92570870|NCT00226096|Phentolamine|phentolamine|mesh-list
92570871|NCT00226096|Urapidil|urapidil|mesh-list
92570872|NCT00226096|Enalaprilat|enalaprilat|mesh-list
92570873|NCT00226096|Nitroglycerin|nitroglycerin|mesh-list
92570874|NCT00226096|Esmolol|esmolol|mesh-list
92295676|NCT05570708|Psilocybin|psilocybin|mesh-list
92570875|NCT00226096|Glycerol|glycerol|mesh-list
92570876|NCT00226096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92570877|NCT00226096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92570878|NCT00226096|Sympatholytics|sympatholytics|mesh-ancestor
92570879|NCT00226096|Autonomic Agents|autonomic agents|mesh-ancestor
92570880|NCT00226096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570881|NCT00226096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570928|NCT00400374|Analgesics|analgesics|mesh-ancestor
92570929|NCT00400374|Sensory System Agents|sensory system agents|mesh-ancestor
92570930|NCT00400374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92570931|NCT00400374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570932|NCT00400374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92570933|NCT00400374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92570934|NCT00400374|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92570935|NCT00400374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92570936|NCT00226330|Pioglitazone|pioglitazone|mesh-list
92570937|NCT00226330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92570938|NCT00226330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92570939|NCT00075426|Arsenic Trioxide|arsenic trioxide|mesh-list
92570993|NCT00095823|Serotonin Agents|serotonin agents|mesh-ancestor
92570994|NCT00095823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92571066|NCT00226954|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92571067|NCT00226954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571068|NCT00227032|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92571069|NCT00227032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571070|NCT00227032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92571071|NCT00227032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571072|NCT00227032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571073|NCT00095901|Capecitabine|capecitabine|mesh-list
92571074|NCT00095901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92571075|NCT00095901|Antimetabolites|antimetabolites|mesh-ancestor
92571076|NCT00095901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571077|NCT00095901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571078|NCT00227110|Pioglitazone|pioglitazone|mesh-list
92571079|NCT00227110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571080|NCT00227110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571081|NCT00062894|Tositumomab I-131|tositumomab i-131|mesh-list
92571086|NCT00096057|Antibodies|antibodies|mesh-list
92571121|NCT00062972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92571122|NCT00062972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571123|NCT00062972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571124|NCT00062972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92571125|NCT00062972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571191|NCT00096291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92571192|NCT00096291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571193|NCT00096291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92571194|NCT00096291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92571195|NCT00096291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92571261|NCT00228046|GABA Agents|gaba agents|mesh-ancestor
92571262|NCT00228046|Antimanic Agents|antimanic agents|mesh-ancestor
92571263|NCT00228046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571264|NCT00228046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571334|NCT00228358|Sensory System Agents|sensory system agents|mesh-ancestor
92571335|NCT00228358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571336|NCT00228358|Immunoconjugates|immunoconjugates|mesh-ancestor
92571409|NCT00229138|Immunologic Factors|immunologic factors|mesh-ancestor
92571410|NCT00229138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571411|NCT00229138|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92571412|NCT00229138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571413|NCT00229138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571414|NCT00063323|Bupropion|bupropion|mesh-list
92571415|NCT00063323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92571416|NCT00063323|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571417|NCT00063323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571418|NCT00063323|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92571419|NCT00063323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92571420|NCT00063323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92571421|NCT00063323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571428|NCT00229216|Tinidazole|tinidazole|mesh-list
92571465|NCT00229528|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571466|NCT00229528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571537|NCT00413608|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92571538|NCT00413608|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92571539|NCT00413608|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92571540|NCT00413608|Purinergic Agents|purinergic agents|mesh-ancestor
92571541|NCT00413608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571542|NCT00413608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571550|NCT00229918|Hormones|hormones|mesh-ancestor
92571604|NCT00230035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92571605|NCT00230035|Antitubercular Agents|antitubercular agents|mesh-ancestor
92571606|NCT00230035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571607|NCT00230035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571608|NCT00230035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92571610|NCT00230035|Autonomic Agents|autonomic agents|mesh-ancestor
92571611|NCT00230035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571612|NCT00230035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92571613|NCT00230035|Glucocorticoids|glucocorticoids|mesh-ancestor
92571614|NCT00230035|Hormones|hormones|mesh-ancestor
92571615|NCT00230035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92571616|NCT00230035|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92571617|NCT00230035|Protective Agents|protective agents|mesh-ancestor
92571618|NCT00063401|Paclitaxel|paclitaxel|mesh-list
92571619|NCT00063401|Carboplatin|carboplatin|mesh-list
92571620|NCT00063401|Cetuximab|cetuximab|mesh-list
92571622|NCT00063401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571662|NCT00230542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92571663|NCT00063479|Zoledronic Acid|zoledronic acid|mesh-list
92571664|NCT00063479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92571665|NCT00063479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571666|NCT00097032|Risperidone|risperidone|mesh-list
92571667|NCT00097032|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92571668|NCT00097032|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92571669|NCT00097032|Serotonin Agents|serotonin agents|mesh-ancestor
92571670|NCT00097032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571671|NCT00097032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571672|NCT00097032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571673|NCT00097032|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92571674|NCT00097032|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92571675|NCT00097032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92571676|NCT00097032|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92571677|NCT00097032|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92571678|NCT00097032|Dopamine Agents|dopamine agents|mesh-ancestor
92571679|NCT00097032|Antidepressive Agents|antidepressive agents|mesh-ancestor
92571719|NCT00230698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92571720|NCT00230698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571721|NCT00230776|Pregabalin|pregabalin|mesh-list
92571722|NCT00230776|Analgesics|analgesics|mesh-ancestor
92571790|NCT00063596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571791|NCT00231244|Sirolimus|sirolimus|mesh-list
92571792|NCT00231244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92571793|NCT00231244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92571794|NCT00231244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92571795|NCT00231244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92571862|NCT00232024|Tegaserod|tegaserod|mesh-list
92571863|NCT00232024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92571864|NCT00232024|Serotonin Agents|serotonin agents|mesh-ancestor
92571865|NCT00232024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571866|NCT00232024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571867|NCT00232024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571868|NCT00232063|Cyclosporine|cyclosporine|mesh-list
92571869|NCT00232063|Cyclosporins|cyclosporins|mesh-list
92571870|NCT00232063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92571871|NCT00232063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571872|NCT00232063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92571873|NCT00232063|Immunologic Factors|immunologic factors|mesh-ancestor
92571874|NCT00232063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571875|NCT00232063|Antifungal Agents|antifungal agents|mesh-ancestor
92571923|NCT00232492|Anesthetics|anesthetics|mesh-ancestor
92571924|NCT00232492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296730|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
92571925|NCT00232492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92571926|NCT00232492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92571927|NCT00232492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571928|NCT00232492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571929|NCT00075972|Nicotine|nicotine|mesh-list
92571930|NCT00075972|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92571931|NCT00075972|Autonomic Agents|autonomic agents|mesh-ancestor
92571932|NCT00075972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571933|NCT00075972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571934|NCT00075972|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92571935|NCT00075972|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92571936|NCT00075972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92571937|NCT00075972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571938|NCT00075972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571939|NCT00063869|Etanercept|etanercept|mesh-list
92571940|NCT00063869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92571942|NCT00063869|Analgesics|analgesics|mesh-ancestor
91979384|NCT02584959|Complement C1s|complement c1s|mesh-list
92571977|NCT00097266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92571978|NCT00097266|Dopamine Agonists|dopamine agonists|mesh-ancestor
92571979|NCT00097266|Dopamine Agents|dopamine agents|mesh-ancestor
92571980|NCT00097266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92571981|NCT00097266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571982|NCT00097266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92571983|NCT00097266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92571984|NCT00097266|Serotonin Agents|serotonin agents|mesh-ancestor
92571985|NCT00097266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92571986|NCT00097266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92571987|NCT00097266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92571988|NCT00097266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92571989|NCT00097266|Antiemetics|antiemetics|mesh-ancestor
92571990|NCT00097266|Autonomic Agents|autonomic agents|mesh-ancestor
92571991|NCT00097266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92571992|NCT00097266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92571993|NCT00097266|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92571994|NCT00063947|Gemcitabine|gemcitabine|mesh-list
92571995|NCT00063947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92571996|NCT00063947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92571997|NCT00063947|Antimetabolites|antimetabolites|mesh-ancestor
92571998|NCT00063947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92571999|NCT00063947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572000|NCT00063947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572001|NCT00063947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572023|NCT00232687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572024|NCT00232687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92572025|NCT00232687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92572026|NCT00232687|Serotonin Agents|serotonin agents|mesh-ancestor
92572027|NCT00232687|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92572028|NCT00232687|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572029|NCT00232687|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92572030|NCT00232687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572031|NCT00232765|Sirolimus|sirolimus|mesh-list
92572032|NCT00232765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572088|NCT02958566|Respiratory System Agents|respiratory system agents|mesh-ancestor
92572161|NCT00097383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572162|NCT00233155|Capsaicin|capsaicin|mesh-list
92572163|NCT00233155|Antipruritics|antipruritics|mesh-ancestor
92572164|NCT00233155|Dermatologic Agents|dermatologic agents|mesh-ancestor
92572165|NCT00233155|Sensory System Agents|sensory system agents|mesh-ancestor
92572166|NCT00233155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572167|NCT00233155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572168|NCT00064142|Halofuginone|halofuginone|mesh-list
92572169|NCT00064142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572170|NCT00064142|Coccidiostats|coccidiostats|mesh-ancestor
92572171|NCT00064142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92572172|NCT00064142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92572173|NCT00064142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572174|NCT00064142|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92572175|NCT00064142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572176|NCT00064142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572177|NCT00064142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92572178|NCT00064142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92572179|NCT00064142|Growth Substances|growth substances|mesh-ancestor
92572180|NCT00064142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572181|NCT00064142|Growth Inhibitors|growth inhibitors|mesh-ancestor
92572182|NCT00064181|Leucovorin|leucovorin|mesh-list
92572183|NCT00064181|Celecoxib|celecoxib|mesh-list
92572184|NCT00064181|Fluorouracil|fluorouracil|mesh-list
92572185|NCT00064181|Capecitabine|capecitabine|mesh-list
92572186|NCT00064181|Irinotecan|irinotecan|mesh-list
92572187|NCT00064181|Calcium|calcium|mesh-list
92572188|NCT00064181|Levoleucovorin|levoleucovorin|mesh-list
92572189|NCT00064181|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92572190|NCT00064181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572208|NCT00064181|Sensory System Agents|sensory system agents|mesh-ancestor
92572209|NCT00064181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92572210|NCT00064181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572211|NCT00064181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92572212|NCT00064181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92572214|NCT00233545|Miltefosine|miltefosine|mesh-list
92572280|NCT00076206|Temsirolimus|temsirolimus|mesh-list
92572281|NCT00076206|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92572282|NCT00076206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92572283|NCT00076206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572284|NCT00076206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572285|NCT00076206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92572286|NCT00076206|Immunologic Factors|immunologic factors|mesh-ancestor
92572287|NCT00076206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572288|NCT00076206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572289|NCT00233896|Beclomethasone|beclomethasone|mesh-list
92572290|NCT00233896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92572292|NCT00233896|Hormones|hormones|mesh-ancestor
92572345|NCT04721704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572346|NCT04721704|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92572347|NCT04721704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92572348|NCT04721704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92572350|NCT00076284|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92572351|NCT00076284|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92572352|NCT00076284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572353|NCT00076284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92572354|NCT00076284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92572355|NCT00076284|Antiviral Agents|antiviral agents|mesh-ancestor
92572406|NCT00234637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572407|NCT00234637|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92572408|NCT00234637|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92572409|NCT00234637|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92572410|NCT00234637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572411|NCT00234637|Cholinergic Agents|cholinergic agents|mesh-ancestor
92572412|NCT00234637|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92572413|NCT00234637|Protective Agents|protective agents|mesh-ancestor
92572414|NCT00234676|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92572415|NCT00234676|Estrogens|estrogens|mesh-ancestor
92572416|NCT00234676|Hormones|hormones|mesh-ancestor
92572419|NCT00076362|Octreotide|octreotide|mesh-list
92572470|NCT00400491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92572471|NCT00235105|Adalimumab|adalimumab|mesh-list
92572472|NCT00235105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92572541|NCT00064649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92572542|NCT00064649|Adrenergic Agents|adrenergic agents|mesh-ancestor
92572543|NCT00064649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572613|NCT00236353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572614|NCT00236353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572615|NCT00236353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572616|NCT00236353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572617|NCT00236353|Dopamine Agents|dopamine agents|mesh-ancestor
92572619|NCT00236392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92572620|NCT00236392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92572621|NCT00236392|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92572622|NCT00236392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92572623|NCT00236392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572624|NCT00236431|Galantamine|galantamine|mesh-list
92572632|NCT00236431|Autonomic Agents|autonomic agents|mesh-ancestor
92572677|NCT00236548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572678|NCT00236548|Dopamine Agents|dopamine agents|mesh-ancestor
92572679|NCT00236587|Risperidone|risperidone|mesh-list
92572680|NCT00236587|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92572681|NCT00236587|Serotonin Agents|serotonin agents|mesh-ancestor
92572682|NCT00236587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92572683|NCT00236587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572684|NCT00236587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572685|NCT00236587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92572686|NCT00236587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92572687|NCT00236587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92572688|NCT00236587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92572689|NCT00236587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92572690|NCT00236587|Dopamine Agents|dopamine agents|mesh-ancestor
92572691|NCT00236626|Topiramate|topiramate|mesh-list
92572692|NCT00236626|Anticonvulsants|anticonvulsants|mesh-ancestor
92572693|NCT00236626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572694|NCT00236626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572695|NCT00236665|Topiramate|topiramate|mesh-list
92572696|NCT00236665|Anticonvulsants|anticonvulsants|mesh-ancestor
92572697|NCT00236665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572698|NCT00236665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572699|NCT00399282|Vitamin E|vitamin e|mesh-list
92572700|NCT00399282|Vitamins|vitamins|mesh-ancestor
92572701|NCT00399282|Micronutrients|micronutrients|mesh-ancestor
92572702|NCT00399282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572703|NCT00399282|Antioxidants|antioxidants|mesh-ancestor
92572704|NCT00399282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92572705|NCT00399282|Protective Agents|protective agents|mesh-ancestor
92572706|NCT00236704|Topiramate|topiramate|mesh-list
92572707|NCT00236704|Anticonvulsants|anticonvulsants|mesh-ancestor
92572708|NCT00236704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572709|NCT00236704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572710|NCT00236743|Topiramate|topiramate|mesh-list
92572711|NCT00236743|Anticonvulsants|anticonvulsants|mesh-ancestor
92572712|NCT00236743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92572713|NCT00236743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572714|NCT00236782|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92572715|NCT00236782|Norelgestromin|norelgestromin|mesh-list
92654054|NCT00237731|Morphine|morphine|mesh-list
92572716|NCT00236782|Estradiol|estradiol|mesh-list
92572717|NCT00236782|Estrogens|estrogens|mesh-ancestor
92572718|NCT00236782|Hormones|hormones|mesh-ancestor
92572720|NCT00236782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92572788|NCT00237211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572789|NCT00237211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92572797|NCT00098007|Everolimus|everolimus|mesh-list
92572860|NCT00237445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92572861|NCT00237445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92572862|NCT00237484|Interferons|interferons|mesh-list
92572863|NCT00237484|Ribavirin|ribavirin|mesh-list
92572864|NCT00237484|Interferon-alpha|interferon-alpha|mesh-list
92572865|NCT00237484|Interferon alpha-2|interferon alpha-2|mesh-list
92572880|NCT00237523|Iodine|iodine|mesh-list
92572930|NCT00398684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92572931|NCT00398684|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92572932|NCT00398684|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92572933|NCT00076440|Leuprolide|leuprolide|mesh-list
92572934|NCT00076440|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92572935|NCT00076440|Fertility Agents|fertility agents|mesh-ancestor
92572997|NCT00098241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92572998|NCT04721119|Anesthetics|anesthetics|mesh-list
92572999|NCT04721119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92573000|NCT04721119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573001|NCT00238147|Carboplatin|carboplatin|mesh-list
92573002|NCT00238147|Docetaxel|docetaxel|mesh-list
92573003|NCT00238147|Capecitabine|capecitabine|mesh-list
92573004|NCT00238147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573005|NCT00238147|Tubulin Modulators|tubulin modulators|mesh-ancestor
92573006|NCT00238147|Antimitotic Agents|antimitotic agents|mesh-ancestor
92573007|NCT00238147|Mitosis Modulators|mitosis modulators|mesh-ancestor
92573008|NCT00238147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573009|NCT00238147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573010|NCT00238147|Antimetabolites|antimetabolites|mesh-ancestor
92573011|NCT00065390|Pyrimethamine|pyrimethamine|mesh-list
92573012|NCT00065390|Antimalarials|antimalarials|mesh-ancestor
92573013|NCT00065390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92573014|NCT00065390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92573015|NCT00065390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573016|NCT00065390|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92573052|NCT00076518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573053|NCT00076518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92573055|NCT00065546|Estrogens|estrogens|mesh-list
92573056|NCT00065546|Hormones|hormones|mesh-ancestor
92573057|NCT00065546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297858|NCT05922501|Hormones|hormones|mesh-ancestor
92573058|NCT00065546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573059|NCT00065546|Lipotropic Agents|lipotropic agents|mesh-ancestor
92573060|NCT00065546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92573061|NCT00065546|Antimetabolites|antimetabolites|mesh-ancestor
92573062|NCT00065546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573063|NCT00065546|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92573064|NCT00065546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92573065|NCT00065546|Nootropic Agents|nootropic agents|mesh-ancestor
92573066|NCT00098280|Eculizumab|eculizumab|mesh-list
92573067|NCT00098280|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92573110|NCT00238927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573111|NCT00238927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573116|NCT00065624|Thioctic Acid|thioctic acid|mesh-list
92573180|NCT00239200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573181|NCT00239200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573182|NCT02961829|Niacinamide|niacinamide|mesh-list
92573183|NCT02961829|Dolutegravir|dolutegravir|mesh-list
92573184|NCT02961829|Maraviroc|maraviroc|mesh-list
92573185|NCT02961829|Auranofin|auranofin|mesh-list
92573186|NCT02961829|Vaccines|vaccines|mesh-list
92573187|NCT02961829|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92573188|NCT02961829|Immunologic Factors|immunologic factors|mesh-ancestor
92573189|NCT02961829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573190|NCT02961829|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92573191|NCT02961829|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92573192|NCT02961829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573193|NCT02961829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573194|NCT02961829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92573195|NCT02961829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92573196|NCT02961829|Antiviral Agents|antiviral agents|mesh-ancestor
92573197|NCT02961829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573198|NCT02961829|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92573199|NCT02961829|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92573200|NCT02961829|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92573201|NCT02961829|Vitamin B Complex|vitamin b complex|mesh-ancestor
92573202|NCT02961829|Vitamins|vitamins|mesh-ancestor
92573203|NCT02961829|Micronutrients|micronutrients|mesh-ancestor
92573204|NCT02961829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573205|NCT00239239|Darbepoetin alfa|darbepoetin alfa|mesh-list
92573206|NCT00239239|Hematinics|hematinics|mesh-ancestor
92573230|NCT00239278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92573231|NCT00239278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573232|NCT00239278|Autonomic Agents|autonomic agents|mesh-ancestor
92573233|NCT00239278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573234|NCT00239278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92573235|NCT00239278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92573243|NCT00239395|Meloxicam|meloxicam|mesh-list
92573297|NCT00239512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92573298|NCT00239512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92573299|NCT00239512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92573300|NCT00239512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573301|NCT00239512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573302|NCT00239512|Gout Suppressants|gout suppressants|mesh-ancestor
92573303|NCT00239512|Tocolytic Agents|tocolytic agents|mesh-ancestor
92573304|NCT00239512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92573305|NCT00076674|Levodopa|levodopa|mesh-list
92573306|NCT00076674|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92573307|NCT00076674|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92573308|NCT00076674|Dopamine Agents|dopamine agents|mesh-ancestor
92573309|NCT00076674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92573310|NCT00076674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573311|NCT00076674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573353|NCT00239863|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92573354|NCT00239863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573355|NCT00239863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92573357|NCT00239863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573365|NCT00239980|Tinzaparin|tinzaparin|mesh-list
92573421|NCT00240214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573422|NCT00240253|Pramlintide|pramlintide|mesh-list
92573423|NCT00240253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92573424|NCT00240253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573425|NCT00065936|Naltrexone|naltrexone|mesh-list
92573426|NCT00065936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92573427|NCT00065936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92573428|NCT00065936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298234|NCT05871606|Analgesics|analgesics|mesh-ancestor
92573429|NCT00065936|Sensory System Agents|sensory system agents|mesh-ancestor
92573430|NCT00065936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92573431|NCT00240292|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92573432|NCT00240292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92573433|NCT00240292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92573434|NCT00240292|Antimetabolites|antimetabolites|mesh-ancestor
92573435|NCT00240292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573436|NCT00240292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92573437|NCT00240292|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92573438|NCT00240292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573439|NCT00240409|Pramipexole|pramipexole|mesh-list
92573440|NCT00240409|Bromocriptine|bromocriptine|mesh-list
92573452|NCT00240448|Valsartan|valsartan|mesh-list
92573473|NCT00076791|Emtricitabine|emtricitabine|mesh-list
92573474|NCT00076791|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92573475|NCT00076791|Antiviral Agents|antiviral agents|mesh-ancestor
92573476|NCT00076791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92573477|NCT00076791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92364131|NCT04350684|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92573478|NCT00076791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92573479|NCT00076791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92573481|NCT00076791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92573540|NCT00241072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92573541|NCT00241072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92573544|NCT00241111|Zoledronic Acid|zoledronic acid|mesh-list
92573611|NCT00066326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573612|NCT00066326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92573686|NCT00241618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92573687|NCT00241618|Immunologic Factors|immunologic factors|mesh-ancestor
92573688|NCT00241618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573689|NCT00066482|Cyclophosphamide|cyclophosphamide|mesh-list
92573757|NCT00242203|Zoledronic Acid|zoledronic acid|mesh-list
92573758|NCT00242203|Docetaxel|docetaxel|mesh-list
92573759|NCT00242203|Trastuzumab|trastuzumab|mesh-list
92573760|NCT00242203|Epirubicin|epirubicin|mesh-list
92573761|NCT00242203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92573762|NCT00242203|Tubulin Modulators|tubulin modulators|mesh-ancestor
92573763|NCT00242203|Antimitotic Agents|antimitotic agents|mesh-ancestor
92573827|NCT00066794|Cytarabine|cytarabine|mesh-list
92573828|NCT00066794|Cyclosporine|cyclosporine|mesh-list
92573829|NCT00066794|Daunorubicin|daunorubicin|mesh-list
92573830|NCT00066794|Cyclosporins|cyclosporins|mesh-list
92573831|NCT00066794|Sargramostim|sargramostim|mesh-list
92573832|NCT00066794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92573855|NCT00242749|Gefitinib|gefitinib|mesh-list
92573897|NCT00099216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92573898|NCT00099216|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92573899|NCT00099216|Protective Agents|protective agents|mesh-ancestor
92573900|NCT00066989|Immunoglobulins|immunoglobulins|mesh-list
92573968|NCT00244153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92573970|NCT00244153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92573971|NCT00244153|Analgesics|analgesics|mesh-ancestor
92573972|NCT00244153|Sensory System Agents|sensory system agents|mesh-ancestor
92573973|NCT02967029|Remifentanil|remifentanil|mesh-list
92574037|NCT00244426|Indobufen|indobufen|mesh-list
92574038|NCT00244426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92574039|NCT00244426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92574040|NCT00244426|Analgesics|analgesics|mesh-ancestor
92574041|NCT00244426|Sensory System Agents|sensory system agents|mesh-ancestor
92574042|NCT00244426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574053|NCT00398957|Naltrexone|naltrexone|mesh-list
92574107|NCT00067301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574108|NCT00067301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574109|NCT00067301|Serotonin Agents|serotonin agents|mesh-ancestor
92574110|NCT00067301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574111|NCT00067301|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92574112|NCT00067301|Antidepressive Agents|antidepressive agents|mesh-ancestor
92574113|NCT00067301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92574115|NCT00244972|Tipifarnib|tipifarnib|mesh-list
92574116|NCT00244972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574117|NCT00244972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92574118|NCT00244972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574119|NCT00244972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574120|NCT00245089|Dactinomycin|dactinomycin|mesh-list
92574121|NCT00245089|Cyclophosphamide|cyclophosphamide|mesh-list
92574166|NCT00245206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92574168|NCT00245206|Dopamine Agonists|dopamine agonists|mesh-ancestor
92574238|NCT00245713|Nootropic Agents|nootropic agents|mesh-ancestor
92574239|NCT00067457|Alosetron|alosetron|mesh-list
92574240|NCT00067457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92574241|NCT00067457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92574242|NCT00067457|Serotonin Agents|serotonin agents|mesh-ancestor
92574243|NCT00067457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574244|NCT00067457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574245|NCT00067457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574246|NCT00102843|Folic Acid|folic acid|mesh-list
92574247|NCT00102843|Betaine|betaine|mesh-list
92574248|NCT00102843|Hematinics|hematinics|mesh-ancestor
92574249|NCT00102843|Vitamin B Complex|vitamin b complex|mesh-ancestor
92574250|NCT00102843|Vitamins|vitamins|mesh-ancestor
92574251|NCT00102843|Micronutrients|micronutrients|mesh-ancestor
92574252|NCT00102843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574259|NCT00245791|Levofloxacin|levofloxacin|mesh-list
92574299|NCT00246103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574300|NCT00246103|Immunologic Factors|immunologic factors|mesh-ancestor
92574301|NCT00246103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574302|NCT00246103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92574303|NCT00246103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92574304|NCT00246103|Alkylating Agents|alkylating agents|mesh-ancestor
92574306|NCT00246103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574366|NCT00102882|Hormones|hormones|mesh-ancestor
92574367|NCT00102882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574438|NCT00246610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574439|NCT00246610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92574440|NCT00246610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92574441|NCT00246610|Antiviral Agents|antiviral agents|mesh-ancestor
92574442|NCT00246610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92574455|NCT00400998|Xhance|xhance|mesh-list
92574508|NCT00099645|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92574510|NCT00247663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574511|NCT00247663|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92574512|NCT00247663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92574513|NCT00247663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574514|NCT00247663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574515|NCT00247663|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92574573|NCT00248131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92574574|NCT00248131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92574575|NCT00248209|Bupropion|bupropion|mesh-list
92574576|NCT00248209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92574577|NCT00248209|Antidepressive Agents|antidepressive agents|mesh-ancestor
92574583|NCT00248209|Dopamine Agents|dopamine agents|mesh-ancestor
92574642|NCT00249145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92574643|NCT00249145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574644|NCT00249145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92574645|NCT00249145|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92574713|NCT00249730|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92574714|NCT00249730|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92574715|NCT00249730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92574783|NCT00068315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92574784|NCT00068315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92574856|NCT00250315|Autonomic Agents|autonomic agents|mesh-ancestor
92574857|NCT00250315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92574927|NCT00103623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92574930|NCT00250861|Rituximab|rituximab|mesh-list
92574999|NCT00100074|Respiratory System Agents|respiratory system agents|mesh-ancestor
92575000|NCT00068744|Fluorouracil|fluorouracil|mesh-list
92575002|NCT00068744|Mitomycin|mitomycin|mesh-list
92575003|NCT00068744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575004|NCT00068744|Antimetabolites|antimetabolites|mesh-ancestor
92575005|NCT00068744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575006|NCT00068744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575066|NCT00100152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575067|NCT00251524|Bevacizumab|bevacizumab|mesh-list
92575068|NCT00251524|Oxaliplatin|oxaliplatin|mesh-list
92575069|NCT00251524|Pemetrexed|pemetrexed|mesh-list
92575070|NCT00251524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92575138|NCT00251680|Antimetabolites|antimetabolites|mesh-ancestor
92575139|NCT00251680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575140|NCT00251680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92575141|NCT00251680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92575142|NCT00251680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575143|NCT00251797|Thalidomide|thalidomide|mesh-list
92575144|NCT00251797|Irinotecan|irinotecan|mesh-list
92575145|NCT00251797|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92299958|NCT04252612|Pramlintide|pramlintide|mesh-list
92575147|NCT00251797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575203|NCT00399152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575204|NCT00399152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92575205|NCT00399152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92575206|NCT00399152|Growth Substances|growth substances|mesh-ancestor
92575207|NCT00399152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575208|NCT00399152|Growth Inhibitors|growth inhibitors|mesh-ancestor
92575209|NCT00399152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575210|NCT00399152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575211|NCT00399152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575213|NCT00104013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92575214|NCT00104013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92575215|NCT00104013|Serotonin Agents|serotonin agents|mesh-ancestor
92575216|NCT00104013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575217|NCT00104013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575218|NCT00104013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575219|NCT04719715|Antibodies|antibodies|mesh-list
92575220|NCT04719715|Immunologic Factors|immunologic factors|mesh-ancestor
92575222|NCT00252226|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92575258|NCT00252811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575259|NCT00252811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575260|NCT00252811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575261|NCT00252811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575262|NCT00069251|Bupropion|bupropion|mesh-list
92575263|NCT00069251|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92575264|NCT00069251|Antidepressive Agents|antidepressive agents|mesh-ancestor
92575277|NCT00252889|Topotecan|topotecan|mesh-list
92575324|NCT00253201|Nootropic Agents|nootropic agents|mesh-ancestor
92575325|NCT00253318|Dexamethasone|dexamethasone|mesh-list
92575326|NCT00253318|Docetaxel|docetaxel|mesh-list
92575327|NCT00253318|Everolimus|everolimus|mesh-list
92575328|NCT00253318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92575329|NCT00253318|Antiemetics|antiemetics|mesh-ancestor
92575330|NCT00253318|Autonomic Agents|autonomic agents|mesh-ancestor
92575331|NCT00253318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575332|NCT00253318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575333|NCT00253318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92575334|NCT00253318|Glucocorticoids|glucocorticoids|mesh-ancestor
92575335|NCT00253318|Hormones|hormones|mesh-ancestor
92575336|NCT00253318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575337|NCT00253318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575338|NCT00253318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575339|NCT00253318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575340|NCT00253318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575341|NCT00253318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575342|NCT00253318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575343|NCT00253318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92575344|NCT00253318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575345|NCT00253318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575346|NCT00253318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92575347|NCT00253318|Immunologic Factors|immunologic factors|mesh-ancestor
92575348|NCT00100464|Paroxetine|paroxetine|mesh-list
92575349|NCT00100464|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92575350|NCT00100464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92575371|NCT00253474|Interferon alpha-2|interferon alpha-2|mesh-list
92575372|NCT00253474|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92575373|NCT00253474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575374|NCT00253474|Antiviral Agents|antiviral agents|mesh-ancestor
92575441|NCT00254020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92575442|NCT00254020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575443|NCT00254020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575444|NCT00254020|Serotonin Agents|serotonin agents|mesh-ancestor
92575513|NCT00254800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92575514|NCT00254800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92575515|NCT00254800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92575516|NCT00254800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92575585|NCT00255268|Bicalutamide|bicalutamide|mesh-list
92575586|NCT00255268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575587|NCT00255268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575588|NCT00255268|Androgen Antagonists|androgen antagonists|mesh-ancestor
92575589|NCT00255268|Hormone Antagonists|hormone antagonists|mesh-ancestor
92575612|NCT00255463|Gefitinib|gefitinib|mesh-list
92575653|NCT00255658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575654|NCT00255658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92575729|NCT00070187|Immunologic Factors|immunologic factors|mesh-ancestor
92575730|NCT00070187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575731|NCT00070187|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92575799|NCT00256321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575800|NCT00256321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575801|NCT00256321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92575802|NCT00256321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92575803|NCT00256321|Analgesics|analgesics|mesh-ancestor
92575804|NCT00256321|Sensory System Agents|sensory system agents|mesh-ancestor
92575805|NCT00256321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92575806|NCT00256321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575807|NCT00256321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92575808|NCT00256321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92575809|NCT00256321|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92575810|NCT00256321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92575811|NCT00256321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575812|NCT00070304|Gemcitabine|gemcitabine|mesh-list
92575813|NCT00070304|Vinorelbine|vinorelbine|mesh-list
92575814|NCT00070304|Lenograstim|lenograstim|mesh-list
92575815|NCT00070304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575816|NCT00070304|Antimetabolites|antimetabolites|mesh-ancestor
92575817|NCT00070304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575818|NCT00070304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300639|NCT03550794|Thiamine|thiamine|mesh-list
92575819|NCT00070304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92575820|NCT00070304|Immunologic Factors|immunologic factors|mesh-ancestor
92575821|NCT00070304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575822|NCT00070304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92575847|NCT00104715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575848|NCT00104715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575849|NCT00104715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575850|NCT00104715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575851|NCT00104715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92575852|NCT00104715|Hormone Antagonists|hormone antagonists|mesh-ancestor
92575853|NCT00104715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575854|NCT00104715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575855|NCT00256711|Vinorelbine|vinorelbine|mesh-list
92575856|NCT00256711|Gefitinib|gefitinib|mesh-list
92575857|NCT00256711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92575858|NCT00256711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575859|NCT00256711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92575860|NCT00256711|Antimitotic Agents|antimitotic agents|mesh-ancestor
92575861|NCT00256711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92575863|NCT00256711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92575904|NCT00100776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575905|NCT00100776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575906|NCT00100776|Serotonin Agents|serotonin agents|mesh-ancestor
92575907|NCT00070538|Cytarabine|cytarabine|mesh-list
92575908|NCT00070538|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92575909|NCT00070538|Antimetabolites|antimetabolites|mesh-ancestor
92575910|NCT00070538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575911|NCT00070538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575967|NCT00257257|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92575968|NCT00257257|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92575969|NCT00257257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92575970|NCT00257257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575971|NCT00257257|Hormones|hormones|mesh-ancestor
92575972|NCT00257257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92575973|NCT00257257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92575974|NCT00257452|Moxifloxacin|moxifloxacin|mesh-list
92575975|NCT00257452|Tiotropium Bromide|tiotropium bromide|mesh-list
92575976|NCT00257452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92575977|NCT00257452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92575978|NCT00257452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92575979|NCT00257452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92575980|NCT00257452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92575981|NCT00257452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92575982|NCT00257452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92575993|NCT00257491|Telmisartan|telmisartan|mesh-list
92576024|NCT00257530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92576025|NCT00257530|Immunologic Factors|immunologic factors|mesh-ancestor
92576026|NCT00257530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576027|NCT00257530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576028|NCT00257530|Interferon Inducers|interferon inducers|mesh-ancestor
92576029|NCT00257569|Cetirizine|cetirizine|mesh-list
92576030|NCT00257569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92576031|NCT00257569|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92576032|NCT00257569|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92576033|NCT00257569|Histamine Antagonists|histamine antagonists|mesh-ancestor
92576034|NCT00257569|Histamine Agents|histamine agents|mesh-ancestor
92576035|NCT00257569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576036|NCT00257569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576038|NCT00100893|Proanthocyanidin|proanthocyanidin|mesh-list
92576084|NCT00257959|Sympatholytics|sympatholytics|mesh-ancestor
92576085|NCT00257959|Autonomic Agents|autonomic agents|mesh-ancestor
92576086|NCT00257959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576087|NCT00070733|Methyltestosterone|methyltestosterone|mesh-list
92576088|NCT00070733|Testosterone|testosterone|mesh-list
92576089|NCT00070733|Testosterone undecanoate|testosterone undecanoate|mesh-list
92576090|NCT00070733|Testosterone enanthate|testosterone enanthate|mesh-list
92576091|NCT00070733|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92576092|NCT00070733|Androgens|androgens|mesh-ancestor
92576093|NCT00070733|Hormones|hormones|mesh-ancestor
92576094|NCT00070733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576095|NCT00070733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576096|NCT00070733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576097|NCT00070733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576098|NCT00070733|Anabolic Agents|anabolic agents|mesh-ancestor
92576099|NCT00258076|Contraceptive Agents|contraceptive agents|mesh-list
92576100|NCT00258076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92576105|NCT00258115|Analgesics|analgesics|mesh-ancestor
92576142|NCT00258271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576143|NCT00258271|Antimetabolites|antimetabolites|mesh-ancestor
92576216|NCT00258739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576217|NCT00258739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576218|NCT00258739|Antimetabolites|antimetabolites|mesh-ancestor
92576219|NCT00258739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576220|NCT00258739|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576223|NCT00104949|Trastuzumab|trastuzumab|mesh-list
92576286|NCT00259441|Antimetabolites|antimetabolites|mesh-ancestor
92576287|NCT00259441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576288|NCT00259441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92576289|NCT00259441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92576290|NCT00259441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576352|NCT00105144|Micafungin|micafungin|mesh-list
92576353|NCT00105144|Antifungal Agents|antifungal agents|mesh-ancestor
92576354|NCT00105144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576355|NCT00105144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576356|NCT00105144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576357|NCT00259870|Olanzapine|olanzapine|mesh-list
92576423|NCT00260611|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576424|NCT00260611|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576425|NCT00260611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576426|NCT00424086|Vaccines|vaccines|mesh-list
92576427|NCT00424086|Immunologic Factors|immunologic factors|mesh-ancestor
92576491|NCT00261508|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92576492|NCT00261508|Serotonin Agents|serotonin agents|mesh-ancestor
92576493|NCT00261508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576494|NCT00261508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576495|NCT00261508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576496|NCT00261508|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92576497|NCT00261508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92576498|NCT00261508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92576499|NCT00261508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576500|NCT00261508|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92576501|NCT00261508|Dopamine Agents|dopamine agents|mesh-ancestor
92576502|NCT00261547|Rituximab|rituximab|mesh-list
92576503|NCT00261547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92576504|NCT00261547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576505|NCT00261547|Immunologic Factors|immunologic factors|mesh-ancestor
92576506|NCT00261547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576507|NCT00261547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576508|NCT00261586|Aspirin|aspirin|mesh-list
92576548|NCT00261703|Immunologic Factors|immunologic factors|mesh-ancestor
92576549|NCT00261703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576550|NCT00261742|Penicillins|penicillins|mesh-list
92576551|NCT00261742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576552|NCT00261742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576620|NCT00072137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576621|NCT00072137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576622|NCT00072137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576623|NCT00072137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92576690|NCT02966288|Sensory System Agents|sensory system agents|mesh-ancestor
92576691|NCT02966288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576692|NCT02966288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576693|NCT02966288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576694|NCT02966288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576695|NCT02966288|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92576696|NCT02966288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576697|NCT02966288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576698|NCT00262405|Prednisone|prednisone|mesh-list
92576699|NCT00262405|Zileuton|zileuton|mesh-list
92576700|NCT00262405|Azathioprine|azathioprine|mesh-list
92576701|NCT00262405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576702|NCT00262405|Glucocorticoids|glucocorticoids|mesh-ancestor
92576703|NCT00262405|Hormones|hormones|mesh-ancestor
92576704|NCT00262405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576705|NCT00262405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576706|NCT00262405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576707|NCT00262405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576708|NCT00262405|Antimetabolites|antimetabolites|mesh-ancestor
92576709|NCT00262405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576710|NCT00262405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92576711|NCT00262405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92576712|NCT00262405|Immunologic Factors|immunologic factors|mesh-ancestor
92576713|NCT00262405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576714|NCT00262405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92576737|NCT00262561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576738|NCT00262561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92576739|NCT00262561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92576740|NCT00262561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576741|NCT00262561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92576742|NCT00262561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92576743|NCT00262561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576744|NCT00262561|Antipyretics|antipyretics|mesh-ancestor
92576745|NCT00072215|Paclitaxel|paclitaxel|mesh-list
92576803|NCT00263263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92576804|NCT00263263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576805|NCT00263263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92576806|NCT00263263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576873|NCT00101790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576874|NCT00264277|Vitamin K|vitamin k|mesh-list
92576875|NCT00264277|Anticoagulants|anticoagulants|mesh-list
92576876|NCT00264277|Vitamins|vitamins|mesh-ancestor
92576877|NCT00264277|Micronutrients|micronutrients|mesh-ancestor
92576878|NCT00264277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576879|NCT00264277|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92576880|NCT00264277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92576881|NCT00264277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576882|NCT00264277|Hemostatics|hemostatics|mesh-ancestor
92576883|NCT00264277|Coagulants|coagulants|mesh-ancestor
92576884|NCT00415753|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92576885|NCT00415753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576886|NCT04709029|Dexamethasone|dexamethasone|mesh-list
92576887|NCT04709029|Dexamethasone acetate|dexamethasone acetate|mesh-list
92576888|NCT04709029|BB 1101|bb 1101|mesh-list
92576889|NCT04709029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92576890|NCT04709029|Antiemetics|antiemetics|mesh-ancestor
92576891|NCT04709029|Autonomic Agents|autonomic agents|mesh-ancestor
92576892|NCT04709029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576893|NCT04709029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576894|NCT04709029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576895|NCT04709029|Glucocorticoids|glucocorticoids|mesh-ancestor
92576896|NCT04709029|Hormones|hormones|mesh-ancestor
92576897|NCT04709029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92576898|NCT04709029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92576899|NCT04709029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576900|NCT04709029|Protease Inhibitors|protease inhibitors|mesh-ancestor
92576901|NCT04709029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576903|NCT00072722|Pomalidomide|pomalidomide|mesh-list
92576919|NCT00264355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92576920|NCT00264355|Dermatologic Agents|dermatologic agents|mesh-ancestor
92576921|NCT00264355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961618|NCT03321955|Ziconotide|ziconotide|mesh-list
92576922|NCT00264355|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92654055|NCT00237731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92654056|NCT00237731|Narcotics|narcotics|mesh-ancestor
92654057|NCT00237731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654058|NCT00237731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654059|NCT00237731|Analgesics|analgesics|mesh-ancestor
92654060|NCT00237731|Sensory System Agents|sensory system agents|mesh-ancestor
92654061|NCT00237731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654063|NCT04542226|Anticonvulsants|anticonvulsants|mesh-ancestor
92654064|NCT00270036|Epoetin Alfa|epoetin alfa|mesh-list
92654065|NCT00270036|Hematinics|hematinics|mesh-ancestor
92654066|NCT00262392|Pamidronate|pamidronate|mesh-list
92654067|NCT00262392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92654068|NCT00262392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061271|NCT04305691|Ixazomib|ixazomib|mesh-list
92654071|NCT04537780|Respiratory System Agents|respiratory system agents|mesh-ancestor
92654072|NCT04537780|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92654073|NCT04537780|Hormone Antagonists|hormone antagonists|mesh-ancestor
92654074|NCT04537780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654075|NCT04537780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654076|NCT04537780|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92654077|NCT04537780|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92654078|NCT04537780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654079|NCT00237887|Adalimumab|adalimumab|mesh-list
92654080|NCT00237887|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92654081|NCT00237887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654082|NCT00237887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654083|NCT02215993|Ticagrelor|ticagrelor|mesh-list
92654084|NCT02215993|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92654085|NCT02215993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92654086|NCT02215993|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92654087|NCT02215993|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92654088|NCT02215993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92654089|NCT02215993|Purinergic Agents|purinergic agents|mesh-ancestor
92654090|NCT02215993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654091|NCT02215993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654092|NCT02215993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654093|NCT02216149|Capecitabine|capecitabine|mesh-list
92654094|NCT02216149|Tegafur|tegafur|mesh-list
92654095|NCT02216149|Oxaliplatin|oxaliplatin|mesh-list
92654096|NCT02216149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92654097|NCT02216149|Antimetabolites|antimetabolites|mesh-ancestor
92654098|NCT02216149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654099|NCT02216149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654100|NCT00238004|Nicotinic Acids|nicotinic acids|mesh-list
92654101|NCT00238004|Niacin|niacin|mesh-list
92654102|NCT00238004|Niacinamide|niacinamide|mesh-list
92654103|NCT00238004|Vitamin B Complex|vitamin b complex|mesh-ancestor
92654104|NCT00238004|Vitamins|vitamins|mesh-ancestor
92654105|NCT00238004|Micronutrients|micronutrients|mesh-ancestor
92654106|NCT00238004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654107|NCT00238004|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92654108|NCT00238004|Antimetabolites|antimetabolites|mesh-ancestor
92654109|NCT00238004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654110|NCT00238004|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92654111|NCT00238004|Vasodilator Agents|vasodilator agents|mesh-ancestor
92654112|NCT00262548|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92654113|NCT00262548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92654114|NCT00262548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92654115|NCT00262548|Antimetabolites|antimetabolites|mesh-ancestor
92654116|NCT00262548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654117|NCT00262548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92654118|NCT00262548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92654119|NCT00262548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654120|NCT00238043|Epoetin Alfa|epoetin alfa|mesh-list
92654121|NCT00238043|Hematinics|hematinics|mesh-ancestor
92654122|NCT00415584|Cinacalcet|cinacalcet|mesh-list
92654123|NCT00415584|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92576924|NCT00264472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576925|NCT00264472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576926|NCT00101829|Rituximab|rituximab|mesh-list
92576927|NCT00101829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92576928|NCT00101829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654124|NCT00415584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654125|NCT00415584|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92654126|NCT00415584|Hormone Antagonists|hormone antagonists|mesh-ancestor
92654127|NCT00415584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654128|NCT04536922|Aldesleukin|aldesleukin|mesh-list
92654129|NCT04536922|Cyclophosphamide|cyclophosphamide|mesh-list
92654130|NCT04536922|Pembrolizumab|pembrolizumab|mesh-list
92654131|NCT04536922|Fludarabine|fludarabine|mesh-list
92654132|NCT04536922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654133|NCT04536922|Immunologic Factors|immunologic factors|mesh-ancestor
92654134|NCT04536922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654135|NCT04536922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654136|NCT04536922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92654137|NCT04536922|Alkylating Agents|alkylating agents|mesh-ancestor
92654138|NCT04536922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654139|NCT04536922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654140|NCT04536922|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92061365|NCT03896230|Ketamine|ketamine|mesh-list
92654144|NCT04536922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92654145|NCT04536922|Antiviral Agents|antiviral agents|mesh-ancestor
92654146|NCT04536922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654147|NCT04536961|Deucravacitinib|deucravacitinib|mesh-list
92654148|NCT04536961|Famotidine|famotidine|mesh-list
92654149|NCT04536961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92654151|NCT04536961|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92654152|NCT04536961|Histamine Antagonists|histamine antagonists|mesh-ancestor
92654153|NCT04536961|Histamine Agents|histamine agents|mesh-ancestor
92654154|NCT04536961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654155|NCT04536961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654156|NCT04536961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654157|NCT04536961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654158|NCT04536961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654159|NCT04536961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654160|NCT00238160|Fluorouracil|fluorouracil|mesh-list
92654161|NCT00238160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654162|NCT00238160|Antimetabolites|antimetabolites|mesh-ancestor
92654163|NCT00238160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654164|NCT00238160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92654165|NCT00238160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654166|NCT00238160|Immunologic Factors|immunologic factors|mesh-ancestor
92654167|NCT00238160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654168|NCT00415701|Hydrocortisone|hydrocortisone|mesh-list
92654169|NCT00415701|Propofol|propofol|mesh-list
92654170|NCT00415701|Etomidate|etomidate|mesh-list
92654171|NCT00415701|Cosyntropin|cosyntropin|mesh-list
92654172|NCT00415701|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92654173|NCT00415701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654174|NCT00415701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654175|NCT00415701|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92654176|NCT00415701|Anesthetics, General|anesthetics, general|mesh-ancestor
92654177|NCT00415701|Anesthetics|anesthetics|mesh-ancestor
92654178|NCT00415701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654179|NCT00415701|Hormones|hormones|mesh-ancestor
92654180|NCT00415701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654181|NCT02961998|Celecoxib|celecoxib|mesh-list
92654182|NCT02961998|Sorafenib|sorafenib|mesh-list
92654183|NCT02961998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654184|NCT02961998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654185|NCT02961998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654186|NCT02961998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654187|NCT02961998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92654188|NCT02961998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654189|NCT02961998|Analgesics|analgesics|mesh-ancestor
92654190|NCT02961998|Sensory System Agents|sensory system agents|mesh-ancestor
91984345|NCT02550795|Analgesics|analgesics|mesh-ancestor
92654191|NCT02961998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654192|NCT02961998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654193|NCT02961998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654194|NCT02961998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654195|NCT02961998|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92654196|NCT02961998|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92654197|NCT04536415|Oseltamivir|oseltamivir|mesh-list
92654198|NCT04536415|Antiviral Agents|antiviral agents|mesh-ancestor
92654199|NCT04536415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654200|NCT04536415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750777|NCT05936229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654201|NCT04536415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654202|NCT00262587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92654203|NCT00262587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92654204|NCT00262587|Autonomic Agents|autonomic agents|mesh-ancestor
92654205|NCT00262587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654206|NCT00262587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654207|NCT00262587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92654208|NCT00262587|Respiratory System Agents|respiratory system agents|mesh-ancestor
92654209|NCT00262587|Glucocorticoids|glucocorticoids|mesh-ancestor
92654210|NCT00262587|Hormones|hormones|mesh-ancestor
92654211|NCT00262587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654212|NCT00262587|Sympathomimetics|sympathomimetics|mesh-ancestor
92654213|NCT00238199|Calcitriol|calcitriol|mesh-list
92654217|NCT00238199|Antimitotic Agents|antimitotic agents|mesh-ancestor
92654218|NCT00238199|Mitosis Modulators|mitosis modulators|mesh-ancestor
92654219|NCT00238199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654220|NCT00238199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92654221|NCT00238199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654222|NCT00238199|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92654223|NCT00238199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92654224|NCT00238199|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92654225|NCT00238199|Vitamins|vitamins|mesh-ancestor
92654226|NCT00238199|Micronutrients|micronutrients|mesh-ancestor
92654227|NCT00238199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92654228|NCT04536493|Lidocaine|lidocaine|mesh-list
92654229|NCT04536493|Epinephrine|epinephrine|mesh-list
92654230|NCT04536493|Racepinephrine|racepinephrine|mesh-list
92654231|NCT04536493|Tetracaine|tetracaine|mesh-list
92654232|NCT04536493|Epinephryl borate|epinephryl borate|mesh-list
92654233|NCT04536493|Anesthetics, Local|anesthetics, local|mesh-ancestor
92654234|NCT04536493|Anesthetics|anesthetics|mesh-ancestor
92654235|NCT04536493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654236|NCT04536493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654237|NCT04536493|Sensory System Agents|sensory system agents|mesh-ancestor
92654238|NCT04536493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654239|NCT04536493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92654240|NCT04536493|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92654241|NCT04536493|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92654242|NCT04536493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92654243|NCT04536493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654244|NCT04536493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92654245|NCT04536493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92654246|NCT04536493|Adrenergic Agents|adrenergic agents|mesh-ancestor
92654247|NCT04536493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654248|NCT04536493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92654249|NCT04536493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92654250|NCT04536493|Autonomic Agents|autonomic agents|mesh-ancestor
92654251|NCT04536493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92654252|NCT04536493|Respiratory System Agents|respiratory system agents|mesh-ancestor
92654253|NCT04536493|Mydriatics|mydriatics|mesh-ancestor
92654254|NCT04536493|Sympathomimetics|sympathomimetics|mesh-ancestor
92654255|NCT04536493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92654256|NCT04536181|Prednisone|prednisone|mesh-list
92654257|NCT04536181|Prednisolone|prednisolone|mesh-list
92654258|NCT04536181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654259|NCT04536181|Glucocorticoids|glucocorticoids|mesh-ancestor
92654260|NCT04536181|Hormones|hormones|mesh-ancestor
92654261|NCT04536181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654262|NCT04536181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654263|NCT04536181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92654264|NCT04536181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654265|NCT04535869|Sofosbuvir|sofosbuvir|mesh-list
92654266|NCT04535869|Antiviral Agents|antiviral agents|mesh-ancestor
92576929|NCT00101829|Immunologic Factors|immunologic factors|mesh-ancestor
92576930|NCT00101829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576931|NCT00101829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576932|NCT00072839|Teduglutide|teduglutide|mesh-list
92576933|NCT00072839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576934|NCT00072839|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92576935|NCT00072839|Protective Agents|protective agents|mesh-ancestor
92576936|NCT00072839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576937|NCT00264628|Casopitant|casopitant|mesh-list
92576938|NCT00264628|Antiemetics|antiemetics|mesh-ancestor
92576939|NCT00264628|Autonomic Agents|autonomic agents|mesh-ancestor
92576940|NCT00264628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576941|NCT00264628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576942|NCT00264628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92576943|NCT00264628|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92576944|NCT00264628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654267|NCT04535869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654268|NCT02216227|Iodine|iodine|mesh-list
92654269|NCT02216227|Chlorhexidine|chlorhexidine|mesh-list
92654270|NCT02216227|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92654271|NCT02216227|Povidone-Iodine|povidone-iodine|mesh-list
92654272|NCT02216227|Vancomycin|vancomycin|mesh-list
92654273|NCT02216227|Cefazolin|cefazolin|mesh-list
92654274|NCT02216227|Mupirocin|mupirocin|mesh-list
92654275|NCT02216227|Povidone|povidone|mesh-list
92654276|NCT02216227|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92654277|NCT02216227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654278|NCT02216227|Disinfectants|disinfectants|mesh-ancestor
92654279|NCT02216227|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654280|NCT02216227|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654281|NCT02216227|Trace Elements|trace elements|mesh-ancestor
92654282|NCT02216227|Micronutrients|micronutrients|mesh-ancestor
92654283|NCT02216227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654284|NCT02216227|Plasma Substitutes|plasma substitutes|mesh-ancestor
92654285|NCT02216227|Blood Substitutes|blood substitutes|mesh-ancestor
92654286|NCT02216227|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92654287|NCT02216227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061488|NCT03554174|Psilocybin|psilocybin|mesh-list
92654301|NCT02216266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654303|NCT02216266|Autonomic Agents|autonomic agents|mesh-ancestor
92654304|NCT02216266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654305|NCT00238316|Letrozole|letrozole|mesh-list
92654306|NCT00238316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654307|NCT00238316|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92654308|NCT00238316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92654309|NCT00238316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654310|NCT00238316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654311|NCT00238316|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92654312|NCT00238316|Hormone Antagonists|hormone antagonists|mesh-ancestor
92654313|NCT00238316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654314|NCT00238316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654315|NCT04535518|Aspirin|aspirin|mesh-list
92654316|NCT04535518|Infliximab|infliximab|mesh-list
92654317|NCT04535518|Immunoglobulins|immunoglobulins|mesh-list
92654318|NCT04535518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92654319|NCT04535518|gamma-Globulins|gamma-globulins|mesh-list
92654320|NCT04535518|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92654321|NCT04535518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92654322|NCT04535518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654323|NCT04535518|Analgesics|analgesics|mesh-ancestor
92654324|NCT04535518|Sensory System Agents|sensory system agents|mesh-ancestor
92654325|NCT04535518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92576945|NCT00264628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576946|NCT00264901|Insulin Detemir|insulin detemir|mesh-list
92576947|NCT00264901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92576948|NCT00264901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576949|NCT00265018|Doxorubicin|doxorubicin|mesh-list
92576950|NCT00265018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92576951|NCT00265018|Bleomycin|bleomycin|mesh-list
92576952|NCT00265018|Vinblastine|vinblastine|mesh-list
92576953|NCT00265018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92576954|NCT00265018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576955|NCT00265018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92576956|NCT00265018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92576957|NCT00265018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92576958|NCT00265018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576959|NCT00265018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92576960|NCT00265018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92576961|NCT00265018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92576962|NCT00265018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92576963|NCT00265135|Siltuximab|siltuximab|mesh-list
92576964|NCT00265135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92576965|NCT00106197|Bupropion|bupropion|mesh-list
92364156|NCT04347252|Hormones|hormones|mesh-ancestor
92576966|NCT00106197|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92576967|NCT00106197|Antidepressive Agents|antidepressive agents|mesh-ancestor
92576968|NCT00106197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576969|NCT00106197|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92576970|NCT00106197|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92576971|NCT00106197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92576972|NCT00106197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92576973|NCT00106197|Dopamine Agents|dopamine agents|mesh-ancestor
92576974|NCT00106197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576979|NCT00265252|Alendronate|alendronate|mesh-list
92576987|NCT00265291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654326|NCT04535518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654327|NCT04535518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654328|NCT04535518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654329|NCT04535518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92654330|NCT04535518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92654331|NCT04535518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654332|NCT04535518|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92654333|NCT04535518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92654334|NCT04535518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654335|NCT04535518|Antipyretics|antipyretics|mesh-ancestor
92654336|NCT04535518|Immunologic Factors|immunologic factors|mesh-ancestor
92654337|NCT04535518|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92654338|NCT04535518|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654339|NCT04535518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92654340|NCT02216383|Oxytocin|oxytocin|mesh-list
92654341|NCT02216383|Carbetocin|carbetocin|mesh-list
92654342|NCT02216383|Syntometrine|syntometrine|mesh-list
92654343|NCT02216383|Ergonovine|ergonovine|mesh-list
92654344|NCT02216383|Oxytocics|oxytocics|mesh-ancestor
92654345|NCT02216383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92061570|NCT03203525|Antibodies|antibodies|mesh-list
92654348|NCT00262782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654349|NCT00238394|Cediranib|cediranib|mesh-list
92654350|NCT00238394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654351|NCT00238394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654352|NCT00238394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654353|NCT00238394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654354|NCT00238472|Nateglinide|nateglinide|mesh-list
92654355|NCT00238472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92654356|NCT00238472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654357|NCT00238628|Bexarotene|bexarotene|mesh-list
92654358|NCT00238628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654359|NCT02216617|Docetaxel|docetaxel|mesh-list
92654360|NCT02216617|Afatinib|afatinib|mesh-list
92654361|NCT02216617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654362|NCT02216617|Tubulin Modulators|tubulin modulators|mesh-ancestor
92654363|NCT02216617|Antimitotic Agents|antimitotic agents|mesh-ancestor
92654364|NCT02216617|Mitosis Modulators|mitosis modulators|mesh-ancestor
92654365|NCT02216617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654366|NCT02216617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654367|NCT02216617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654368|NCT00262977|Aspirin|aspirin|mesh-list
92654369|NCT00262977|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92654370|NCT00262977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654371|NCT00262977|Analgesics|analgesics|mesh-ancestor
92654372|NCT00262977|Sensory System Agents|sensory system agents|mesh-ancestor
92654373|NCT00262977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654374|NCT00262977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654375|NCT00262977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654376|NCT00262977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654377|NCT00262977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92654378|NCT00262977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92654379|NCT00262977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654380|NCT00262977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92654381|NCT00262977|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92654382|NCT00262977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654383|NCT00262977|Antipyretics|antipyretics|mesh-ancestor
92654384|NCT00238667|Aspirin|aspirin|mesh-list
92654385|NCT00238667|Heparin|heparin|mesh-list
92654386|NCT00238667|Calcium heparin|calcium heparin|mesh-list
92654387|NCT00238667|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92654388|NCT00238667|Dalteparin|dalteparin|mesh-list
92654389|NCT00238667|Dipyridamole|dipyridamole|mesh-list
92654390|NCT00238667|Warfarin|warfarin|mesh-list
92654391|NCT00238667|Anticoagulants|anticoagulants|mesh-list
92654392|NCT00238667|Clopidogrel|clopidogrel|mesh-list
92654393|NCT00238667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92654394|NCT00238667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654395|NCT00238667|Analgesics|analgesics|mesh-ancestor
92654396|NCT00238667|Sensory System Agents|sensory system agents|mesh-ancestor
92654397|NCT00238667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654398|NCT00238667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654399|NCT00238667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654400|NCT00238667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92576988|NCT00265291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92576989|NCT00265291|Serotonin Agents|serotonin agents|mesh-ancestor
92576990|NCT00265291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92576991|NCT00265291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92576992|NCT00265291|Antidepressive Agents|antidepressive agents|mesh-ancestor
92654401|NCT00238667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92654402|NCT00238667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92654403|NCT00238667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654404|NCT00238667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92654405|NCT00238667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92654406|NCT00238667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654407|NCT00238667|Antipyretics|antipyretics|mesh-ancestor
92654408|NCT00238667|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92654409|NCT00238667|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92654410|NCT00238667|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92654411|NCT00238667|Purinergic Agents|purinergic agents|mesh-ancestor
92654412|NCT00238667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654413|NCT00238667|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92654414|NCT00238667|Vasodilator Agents|vasodilator agents|mesh-ancestor
92654415|NCT00263016|Docetaxel|docetaxel|mesh-list
92654416|NCT00263016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654417|NCT00263016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92654418|NCT00263016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92654419|NCT00263016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92654420|NCT00263016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654425|NCT04534465|Natriuretic Agents|natriuretic agents|mesh-ancestor
92654426|NCT04534465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654428|NCT04534465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92654429|NCT02216656|Cinacalcet|cinacalcet|mesh-list
92654430|NCT02216656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92654431|NCT02216656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654432|NCT02216656|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92654433|NCT02216656|Hormone Antagonists|hormone antagonists|mesh-ancestor
92654434|NCT02216656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654435|NCT00263055|Oxaliplatin|oxaliplatin|mesh-list
92654436|NCT00263055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654437|NCT00238745|Bazedoxifene|bazedoxifene|mesh-list
92654438|NCT00238745|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92654439|NCT00238745|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92654440|NCT00238745|Hormone Antagonists|hormone antagonists|mesh-ancestor
92654441|NCT00238745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654442|NCT00238745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654443|NCT00238745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92654444|NCT04534231|Nicotine|nicotine|mesh-list
92654445|NCT04534231|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92654446|NCT04534231|Autonomic Agents|autonomic agents|mesh-ancestor
92654447|NCT04534231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654448|NCT04534231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654449|NCT04534231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92654450|NCT04534231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92654451|NCT04534231|Cholinergic Agents|cholinergic agents|mesh-ancestor
92654452|NCT04534231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654453|NCT04534231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654455|NCT00263094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92654456|NCT00263094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92654457|NCT00263094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654458|NCT00263094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654459|NCT00263094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92654460|NCT00263094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654461|NCT00263094|Analgesics|analgesics|mesh-ancestor
92654462|NCT00263094|Sensory System Agents|sensory system agents|mesh-ancestor
92654463|NCT00263094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654464|NCT00263094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654465|NCT00263094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654466|NCT00263094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654467|NCT00238784|Budesonide|budesonide|mesh-list
92654468|NCT00238784|Formoterol Fumarate|formoterol fumarate|mesh-list
92576993|NCT00265291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92576994|NCT00265291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92576995|NCT00265291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92654469|NCT00238784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654470|NCT00238784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92654471|NCT00238784|Autonomic Agents|autonomic agents|mesh-ancestor
92654472|NCT00238784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654473|NCT00238784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654474|NCT00238784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92654475|NCT00238784|Respiratory System Agents|respiratory system agents|mesh-ancestor
92654476|NCT00238784|Glucocorticoids|glucocorticoids|mesh-ancestor
92654478|NCT00238784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654479|NCT00238784|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92654480|NCT00238784|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92654481|NCT00238784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92654482|NCT00238784|Adrenergic Agents|adrenergic agents|mesh-ancestor
92654483|NCT00238784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654484|NCT00238784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654485|NCT00263133|Sertraline|sertraline|mesh-list
92654486|NCT00263133|Antidepressive Agents|antidepressive agents|mesh-ancestor
92654487|NCT00263133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92654488|NCT00263133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92654489|NCT00263133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92654490|NCT00263133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92654492|NCT00263133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654493|NCT00263133|Serotonin Agents|serotonin agents|mesh-ancestor
92654494|NCT00263133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654495|NCT04533724|Amisulpride|amisulpride|mesh-list
92654496|NCT04533724|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92654497|NCT04533724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92654498|NCT04533724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654499|NCT04533724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654500|NCT04533724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92654501|NCT04533724|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92654502|NCT04533724|Dopamine Agents|dopamine agents|mesh-ancestor
92654503|NCT04533724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654504|NCT04533724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654505|NCT04533724|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92654506|NCT04533724|Antidepressive Agents|antidepressive agents|mesh-ancestor
92654507|NCT00238901|Basiliximab|basiliximab|mesh-list
92654508|NCT00238901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654509|NCT00238901|Immunologic Factors|immunologic factors|mesh-ancestor
92654510|NCT00238901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654511|NCT00238940|Mycophenolic Acid|mycophenolic acid|mesh-list
92654512|NCT00238940|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92654513|NCT00238940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654514|NCT00238940|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92654515|NCT00238940|Antitubercular Agents|antitubercular agents|mesh-ancestor
92654516|NCT00238940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654517|NCT00238940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654518|NCT00238940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654519|NCT00238940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654520|NCT00238979|Mycophenolic Acid|mycophenolic acid|mesh-list
92654521|NCT00238979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92654522|NCT00238979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654523|NCT00238979|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92654524|NCT00238979|Antitubercular Agents|antitubercular agents|mesh-ancestor
92654525|NCT00238979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654526|NCT00238979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654527|NCT00238979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654528|NCT00238979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654529|NCT00239018|Mycophenolic Acid|mycophenolic acid|mesh-list
92654530|NCT00239018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92654531|NCT00239018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654532|NCT00239018|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92654533|NCT00239018|Antitubercular Agents|antitubercular agents|mesh-ancestor
92654534|NCT00239018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654535|NCT00239018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654536|NCT00239018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654537|NCT00239018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654538|NCT04532671|Ether|ether|mesh-list
92654539|NCT04532671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92654540|NCT04532671|Anesthetics, General|anesthetics, general|mesh-ancestor
92654541|NCT04532671|Anesthetics|anesthetics|mesh-ancestor
92654542|NCT04532671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654543|NCT04532671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654544|NCT00239057|Mycophenolic Acid|mycophenolic acid|mesh-list
92654545|NCT00239057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92654546|NCT00239057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654547|NCT00239057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92654548|NCT00239057|Antitubercular Agents|antitubercular agents|mesh-ancestor
92654549|NCT00239057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654550|NCT00239057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654551|NCT00239057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654552|NCT00239057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654553|NCT00238082|Beclomethasone|beclomethasone|mesh-list
92654554|NCT00238082|Norflurane|norflurane|mesh-list
92654555|NCT00238082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654556|NCT00238082|Glucocorticoids|glucocorticoids|mesh-ancestor
92654557|NCT00238082|Hormones|hormones|mesh-ancestor
92654558|NCT00238082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654559|NCT00238082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654560|NCT00238082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92654561|NCT00238082|Respiratory System Agents|respiratory system agents|mesh-ancestor
92654562|NCT00238082|Anesthetics|anesthetics|mesh-ancestor
92654563|NCT00238082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654565|NCT02217007|Acamprosate|acamprosate|mesh-list
92654566|NCT02217007|Calcium|calcium|mesh-list
92654567|NCT02217007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92654568|NCT02217007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654569|NCT02217007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92654570|NCT02217007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92654571|NCT05897658|Levetiracetam|levetiracetam|mesh-list
92654572|NCT05897658|Anticonvulsants|anticonvulsants|mesh-ancestor
92654573|NCT05897658|Nootropic Agents|nootropic agents|mesh-ancestor
92654574|NCT05897385|Lidocaine|lidocaine|mesh-list
92654575|NCT05897385|Anesthetics, Local|anesthetics, local|mesh-ancestor
92654576|NCT05897385|Anesthetics|anesthetics|mesh-ancestor
92654577|NCT05897385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654578|NCT05897385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654579|NCT05897385|Sensory System Agents|sensory system agents|mesh-ancestor
92654580|NCT05897385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654581|NCT05897385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92654582|NCT05897385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92654583|NCT05897385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92654584|NCT05897385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92654585|NCT05897385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654586|NCT05897372|Pentoxifylline|pentoxifylline|mesh-list
92654587|NCT05897372|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92654588|NCT05897372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654589|NCT05897372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654590|NCT05897372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92654591|NCT05897372|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92654592|NCT05897372|Protective Agents|protective agents|mesh-ancestor
92654593|NCT05897372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654594|NCT05897372|Vasodilator Agents|vasodilator agents|mesh-ancestor
92654595|NCT05897372|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92654596|NCT05897372|Antioxidants|antioxidants|mesh-ancestor
92654597|NCT05897307|Ropivacaine|ropivacaine|mesh-list
92654598|NCT05897307|Anesthetics, Local|anesthetics, local|mesh-ancestor
92654599|NCT05897307|Anesthetics|anesthetics|mesh-ancestor
92654600|NCT05897307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364166|NCT04345848|Enoxaparin|enoxaparin|mesh-list
92654601|NCT05897307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654602|NCT05897307|Sensory System Agents|sensory system agents|mesh-ancestor
92654603|NCT05897307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654604|NCT05897294|Voriconazole|voriconazole|mesh-list
92654605|NCT05897294|Antifungal Agents|antifungal agents|mesh-ancestor
92654606|NCT05897294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654607|NCT05897294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92654608|NCT05897294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92654609|NCT05897294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654610|NCT05897294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654611|NCT05897294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92654612|NCT05897294|Hormone Antagonists|hormone antagonists|mesh-ancestor
92654613|NCT05897294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654614|NCT05897294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654615|NCT05897294|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92654616|NCT05897086|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92654617|NCT05897086|Laxatives|laxatives|mesh-ancestor
92654618|NCT05897086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92654619|NCT05896943|Ustekinumab|ustekinumab|mesh-list
92654620|NCT05896943|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654621|NCT05896930|Amoxicillin|amoxicillin|mesh-list
92654623|NCT05896930|Meropenem|meropenem|mesh-list
92654624|NCT05896930|Ertapenem|ertapenem|mesh-list
92654625|NCT05896930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654626|NCT05896930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654627|NCT05896930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92654628|NCT05896930|Antitubercular Agents|antitubercular agents|mesh-ancestor
92654629|NCT05896930|Leprostatic Agents|leprostatic agents|mesh-ancestor
92654630|NCT05896930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92654631|NCT05896930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654632|NCT05896930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654633|NCT05896930|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92654634|NCT05896930|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92654635|NCT05896930|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92061849|NCT02530034|Immunologic Factors|immunologic factors|mesh-ancestor
92654638|NCT05896930|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92654639|NCT05896839|Sirolimus|sirolimus|mesh-list
92654640|NCT05896839|Prednisone|prednisone|mesh-list
92654641|NCT05896839|Cortisone|cortisone|mesh-list
92654642|NCT05896839|Nivolumab|nivolumab|mesh-list
92654643|NCT05896839|Ipilimumab|ipilimumab|mesh-list
92654644|NCT05896839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654645|NCT05896839|Glucocorticoids|glucocorticoids|mesh-ancestor
92654646|NCT05896839|Hormones|hormones|mesh-ancestor
92654647|NCT05896839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654648|NCT05896839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654649|NCT05896839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92654650|NCT05896839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654651|NCT05896839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654652|NCT05896839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92654653|NCT05896839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654654|NCT05896839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654655|NCT05896839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654656|NCT05896839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92654657|NCT05896839|Antifungal Agents|antifungal agents|mesh-ancestor
92654658|NCT05896839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654659|NCT05896839|Immunologic Factors|immunologic factors|mesh-ancestor
92654660|NCT05896800|Nitric Oxide|nitric oxide|mesh-list
92654661|NCT05896800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92654662|NCT05896800|Autonomic Agents|autonomic agents|mesh-ancestor
92654663|NCT05896800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654664|NCT05896800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654665|NCT05896800|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92654666|NCT05896800|Respiratory System Agents|respiratory system agents|mesh-ancestor
92654667|NCT05896800|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92654668|NCT05896800|Antioxidants|antioxidants|mesh-ancestor
92654669|NCT05896800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654670|NCT05896800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750778|NCT05936229|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92654671|NCT05896800|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92654672|NCT05896800|Vasodilator Agents|vasodilator agents|mesh-ancestor
92654673|NCT05896800|Gasotransmitters|gasotransmitters|mesh-ancestor
92654674|NCT05896800|Protective Agents|protective agents|mesh-ancestor
92654675|NCT05896787|Paclitaxel|paclitaxel|mesh-list
92654676|NCT05896787|Carboplatin|carboplatin|mesh-list
92654677|NCT05896787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92654678|NCT05896787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654679|NCT05896787|Tubulin Modulators|tubulin modulators|mesh-ancestor
92654680|NCT05896787|Antimitotic Agents|antimitotic agents|mesh-ancestor
92654681|NCT05896787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92654682|NCT05896787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654683|NCT05896761|Rilpivirine|rilpivirine|mesh-list
92654684|NCT05896761|Cabotegravir|cabotegravir|mesh-list
92654685|NCT05896761|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92576997|NCT00265291|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92576998|NCT00265291|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92654686|NCT05896761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92654687|NCT05896761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654688|NCT05896761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654689|NCT05896761|Antiviral Agents|antiviral agents|mesh-ancestor
92654690|NCT05896761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654691|NCT05896761|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92654692|NCT05896761|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92654693|NCT05896761|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92654694|NCT05896761|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92654696|NCT05896748|Cabotegravir|cabotegravir|mesh-list
92654697|NCT05896748|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92654698|NCT05896748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92654699|NCT05896748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654700|NCT05896748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654701|NCT05896748|Antiviral Agents|antiviral agents|mesh-ancestor
92654702|NCT05896748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654703|NCT05896748|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92654704|NCT05896748|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92654705|NCT05896748|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92654706|NCT05896748|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92654707|NCT05896683|Lazertinib|lazertinib|mesh-list
92654708|NCT05896683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654715|NCT05896631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654717|NCT05896631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654718|NCT05896605|Azathioprine|azathioprine|mesh-list
92654719|NCT05896605|Antimetabolites|antimetabolites|mesh-ancestor
92654720|NCT05896605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654721|NCT05896605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92654722|NCT05896605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654723|NCT05896605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654724|NCT05896605|Immunologic Factors|immunologic factors|mesh-ancestor
92654725|NCT05896605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654726|NCT05896605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654727|NCT05896553|Oxytocin|oxytocin|mesh-list
92654728|NCT05896553|Oxytocics|oxytocics|mesh-ancestor
92654729|NCT05896553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92654730|NCT05896553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654731|NCT05896462|Povidone-Iodine|povidone-iodine|mesh-list
92654732|NCT05896462|Povidone|povidone|mesh-list
92654733|NCT05896462|Plasma Substitutes|plasma substitutes|mesh-ancestor
92654734|NCT05896462|Blood Substitutes|blood substitutes|mesh-ancestor
92654735|NCT05896462|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92654736|NCT05896462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654737|NCT05896449|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92654738|NCT05896449|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92654739|NCT05896449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654740|NCT05896319|Hyaluronic Acid|hyaluronic acid|mesh-list
92654741|NCT05896319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92654742|NCT05896319|Immunologic Factors|immunologic factors|mesh-ancestor
92654743|NCT05896319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654744|NCT05896319|Viscosupplements|viscosupplements|mesh-ancestor
92654745|NCT05896319|Protective Agents|protective agents|mesh-ancestor
92654746|NCT05896059|Tislelizumab|tislelizumab|mesh-list
92380036|NCT05439564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92654747|NCT05896059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654748|NCT05896059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654749|NCT05896033|Menthol|menthol|mesh-list
92654750|NCT05896033|Antipruritics|antipruritics|mesh-ancestor
92654751|NCT05896033|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654752|NCT05896007|Rituximab|rituximab|mesh-list
92654753|NCT05896007|Methotrexate|methotrexate|mesh-list
92654754|NCT05896007|Temozolomide|temozolomide|mesh-list
92654755|NCT05896007|Zanubrutinib|zanubrutinib|mesh-list
92654756|NCT05896007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654757|NCT05896007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654758|NCT05896007|Immunologic Factors|immunologic factors|mesh-ancestor
92654759|NCT05896007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654760|NCT05896007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654761|NCT05896007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92654762|NCT05896007|Abortifacient Agents|abortifacient agents|mesh-ancestor
92654763|NCT05896007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92576999|NCT00265291|Adrenergic Agents|adrenergic agents|mesh-ancestor
92577000|NCT00265408|Aspirin|aspirin|mesh-list
92577001|NCT00265408|Warfarin|warfarin|mesh-list
92577002|NCT00265408|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92577003|NCT00265408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92577004|NCT00265408|Analgesics|analgesics|mesh-ancestor
92654764|NCT05896007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92654765|NCT05896007|Antimetabolites|antimetabolites|mesh-ancestor
92654766|NCT05896007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654767|NCT05896007|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654768|NCT05896007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654769|NCT05896007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92654770|NCT05896007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654771|NCT05896007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92654772|NCT05896007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92654773|NCT05896007|Alkylating Agents|alkylating agents|mesh-ancestor
92654774|NCT05896007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654775|NCT05895942|Imatinib Mesylate|imatinib mesylate|mesh-list
92654776|NCT05895942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654778|NCT05895942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654779|NCT05895942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654780|NCT05893771|Methylprednisolone|methylprednisolone|mesh-list
92654781|NCT05893771|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92654782|NCT05893771|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92654783|NCT05893771|Prednisolone|prednisolone|mesh-list
92654784|NCT05893771|Prednisolone acetate|prednisolone acetate|mesh-list
92654785|NCT05893771|Bupivacaine|bupivacaine|mesh-list
92654786|NCT05893771|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92654787|NCT05893771|Prednisolone phosphate|prednisolone phosphate|mesh-list
92654788|NCT05893771|Anesthetics, Local|anesthetics, local|mesh-ancestor
92654789|NCT05893771|Anesthetics|anesthetics|mesh-ancestor
92654790|NCT05893771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654791|NCT05893771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654792|NCT05893771|Sensory System Agents|sensory system agents|mesh-ancestor
92654793|NCT05893771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654794|NCT05893771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654795|NCT05893771|Antiemetics|antiemetics|mesh-ancestor
92654796|NCT05893771|Autonomic Agents|autonomic agents|mesh-ancestor
92654797|NCT05893771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92654798|NCT05893771|Glucocorticoids|glucocorticoids|mesh-ancestor
92654799|NCT05893771|Hormones|hormones|mesh-ancestor
92654800|NCT05893771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654801|NCT05893771|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92654802|NCT05893771|Protective Agents|protective agents|mesh-ancestor
92654803|NCT05893771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92654804|NCT05893771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654805|NCT05876715|Nivolumab|nivolumab|mesh-list
92654806|NCT05876715|Ipilimumab|ipilimumab|mesh-list
92654807|NCT05876715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654808|NCT05876715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654809|NCT05876715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92654810|NCT05876715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654811|NCT05867849|Cannabidiol|cannabidiol|mesh-list
92654812|NCT05867849|Anticonvulsants|anticonvulsants|mesh-ancestor
92654813|NCT05853120|Doxycycline|doxycycline|mesh-list
92364183|NCT04345458|Analgesics|analgesics|mesh-ancestor
92654814|NCT05853120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654815|NCT05853120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654816|NCT05853120|Antimalarials|antimalarials|mesh-ancestor
92654817|NCT05853120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92654818|NCT05853120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92654819|NCT05841160|Moxifloxacin|moxifloxacin|mesh-list
92654820|NCT05841160|Ecopipam|ecopipam|mesh-list
92654821|NCT05841160|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92654822|NCT05841160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654823|NCT05841160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92654824|NCT05841160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92654825|NCT05841160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654826|NCT05841160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654827|NCT05841160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654828|NCT05841160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577005|NCT00265408|Sensory System Agents|sensory system agents|mesh-ancestor
92577006|NCT00265408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577007|NCT00265408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577008|NCT00265408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654829|NCT05841160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92654830|NCT05841160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92654831|NCT05841160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654832|NCT05841160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92654833|NCT05841160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92654834|NCT05841160|Dopamine Agents|dopamine agents|mesh-ancestor
92654835|NCT05841160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654837|NCT05815758|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92654838|NCT05815758|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92654839|NCT05815758|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92654840|NCT05815758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92654841|NCT05815758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92654842|NCT05815758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92654843|NCT05815758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92654844|NCT05815758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92654845|NCT05815758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654846|NCT05815758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654847|NCT05815758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654848|NCT05815758|Antipruritics|antipruritics|mesh-ancestor
92654849|NCT05815758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92654850|NCT05815758|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92062065|NCT00215813|Poly I-C|poly i-c|mesh-list
92654853|NCT05815758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92654854|NCT05724849|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92654855|NCT05724849|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92654856|NCT05724849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92654857|NCT05724849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92654858|NCT05724849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654859|NCT05724849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654860|NCT05724849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654861|NCT05724849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92654862|NCT05724849|Antidepressive Agents|antidepressive agents|mesh-ancestor
92654863|NCT05724849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92654864|NCT05694533|Midazolam|midazolam|mesh-list
92654865|NCT05694533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92654866|NCT05694533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92654867|NCT05694533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654868|NCT05694533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654869|NCT05694533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92654870|NCT05694533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92654871|NCT05694533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92654872|NCT05694533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92654873|NCT05694533|Anesthetics, General|anesthetics, general|mesh-ancestor
92654874|NCT05694533|Anesthetics|anesthetics|mesh-ancestor
92654875|NCT05694533|GABA Modulators|gaba modulators|mesh-ancestor
92654876|NCT05694533|GABA Agents|gaba agents|mesh-ancestor
92654877|NCT05694533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654878|NCT05694533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654879|NCT05681390|Tislelizumab|tislelizumab|mesh-list
92654880|NCT05681390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654881|NCT05681390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654882|NCT05669547|Hormones|hormones|mesh-list
92654883|NCT05669547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92654884|NCT05669547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654885|NCT05669079|Decitabine|decitabine|mesh-list
92654886|NCT05669079|Epoetin Alfa|epoetin alfa|mesh-list
92654887|NCT05669079|Lenograstim|lenograstim|mesh-list
92654888|NCT05669079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92654889|NCT05669079|Antimetabolites|antimetabolites|mesh-ancestor
92654890|NCT05669079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654891|NCT05669079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654892|NCT05669079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654893|NCT05669079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92654894|NCT05669079|Immunologic Factors|immunologic factors|mesh-ancestor
92577009|NCT00265408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577010|NCT00265408|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92577011|NCT00265408|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92577012|NCT00265408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984419|NCT05626439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92654895|NCT05669079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654896|NCT05669079|Hematinics|hematinics|mesh-ancestor
92654897|NCT05661188|Atezolizumab|atezolizumab|mesh-list
92654898|NCT05661188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92654899|NCT05661188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654900|NCT05661188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654901|NCT05661188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654902|NCT05658510|Dexmedetomidine|dexmedetomidine|mesh-list
92654903|NCT05658510|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92654904|NCT05658510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654905|NCT05658510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654906|NCT05658510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654907|NCT05658510|Analgesics|analgesics|mesh-ancestor
92654908|NCT05658510|Sensory System Agents|sensory system agents|mesh-ancestor
92654909|NCT05658510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654910|NCT05658510|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92654911|NCT05658510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92654912|NCT05658510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92654913|NCT05658510|Adrenergic Agents|adrenergic agents|mesh-ancestor
92654914|NCT05658510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654915|NCT05658510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654916|NCT05611905|Probenecid|probenecid|mesh-list
92654917|NCT05611905|Uricosuric Agents|uricosuric agents|mesh-ancestor
92654918|NCT05611905|Gout Suppressants|gout suppressants|mesh-ancestor
92654919|NCT05611905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654920|NCT05586373|Dipyrone|dipyrone|mesh-list
92654921|NCT05586373|Ibuprofen|ibuprofen|mesh-list
92654922|NCT05586373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92654926|NCT05586373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92654927|NCT05586373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654928|NCT05586373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92654929|NCT05586373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654930|NCT05586373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92654931|NCT05586373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654932|NCT05586373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654933|NCT05586373|Antipyretics|antipyretics|mesh-ancestor
92654934|NCT05579626|Ezetimibe|ezetimibe|mesh-list
92654935|NCT05579626|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92654936|NCT05579626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92654937|NCT05579626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92654938|NCT05579626|Antimetabolites|antimetabolites|mesh-ancestor
92654939|NCT05579626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654940|NCT05579626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92654941|NCT05579626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654942|NCT05455658|Vaccines|vaccines|mesh-list
92654943|NCT05455658|Sargramostim|sargramostim|mesh-list
92654944|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
92654945|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654946|NCT05442567|Vedolizumab|vedolizumab|mesh-list
92654947|NCT05442567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92654948|NCT05442515|Cyclophosphamide|cyclophosphamide|mesh-list
92364192|NCT04344756|Heparin|heparin|mesh-list
92654949|NCT05442515|Fludarabine|fludarabine|mesh-list
92654950|NCT05442515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654951|NCT05442515|Immunologic Factors|immunologic factors|mesh-ancestor
92654952|NCT05442515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654953|NCT05442515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654954|NCT05442515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92654955|NCT05442515|Alkylating Agents|alkylating agents|mesh-ancestor
92654956|NCT05442515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654957|NCT05442515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654958|NCT05442515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92654959|NCT05434546|Pregnanolone|pregnanolone|mesh-list
92654960|NCT05434546|Anesthetics|anesthetics|mesh-ancestor
92654961|NCT05434546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577013|NCT00265408|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92577014|NCT00265408|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92577016|NCT00265408|Antipyretics|antipyretics|mesh-ancestor
92577017|NCT00265408|Anticoagulants|anticoagulants|mesh-ancestor
92654962|NCT05434546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654963|NCT05400122|Cyclophosphamide|cyclophosphamide|mesh-list
92654964|NCT05400122|Fludarabine|fludarabine|mesh-list
92654965|NCT05400122|Fludarabine phosphate|fludarabine phosphate|mesh-list
92654966|NCT05400122|Vactosertib|vactosertib|mesh-list
92654967|NCT05400122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92654968|NCT05400122|Immunologic Factors|immunologic factors|mesh-ancestor
92654969|NCT05400122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654970|NCT05400122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92654971|NCT05400122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92654972|NCT05400122|Alkylating Agents|alkylating agents|mesh-ancestor
92654973|NCT05400122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654975|NCT05400122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92654976|NCT05400122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92654977|NCT05400122|Antimetabolites|antimetabolites|mesh-ancestor
92654978|NCT05400122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654979|NCT05400122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654980|NCT05386472|Ritonavir|ritonavir|mesh-list
92654981|NCT05386472|Nirmatrelvir|nirmatrelvir|mesh-list
92654982|NCT05386472|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92654983|NCT05386472|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92654984|NCT05386472|Protease Inhibitors|protease inhibitors|mesh-ancestor
92654985|NCT05386472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654986|NCT05386472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654987|NCT05386472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92654988|NCT05386472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92654989|NCT05386472|Antiviral Agents|antiviral agents|mesh-ancestor
92654990|NCT05386472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92654991|NCT05386472|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92654992|NCT05386472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92654993|NCT05360784|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92654994|NCT05360784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92654995|NCT05360784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92654996|NCT05360784|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92655005|NCT05359939|Lipotropic Agents|lipotropic agents|mesh-ancestor
92655006|NCT05359939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92655007|NCT05359939|Antimetabolites|antimetabolites|mesh-ancestor
92655008|NCT05359939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655009|NCT05359939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655010|NCT05359939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92655011|NCT05359939|Nootropic Agents|nootropic agents|mesh-ancestor
92655012|NCT05277051|Dostarlimab|dostarlimab|mesh-list
92655013|NCT05277051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655014|NCT05261139|Ritonavir|ritonavir|mesh-list
92655015|NCT05261139|Nirmatrelvir|nirmatrelvir|mesh-list
92655016|NCT05261139|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92655017|NCT05261139|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92655018|NCT05261139|Protease Inhibitors|protease inhibitors|mesh-ancestor
92655019|NCT05261139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655020|NCT05261139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655021|NCT05261139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92655022|NCT05261139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92655023|NCT05261139|Antiviral Agents|antiviral agents|mesh-ancestor
92655024|NCT05261139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655025|NCT05261139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92364194|NCT04344756|Tinzaparin|tinzaparin|mesh-list
92655026|NCT05261139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92655027|NCT05251909|Benralizumab|benralizumab|mesh-list
92655028|NCT05251909|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92655029|NCT05251909|Respiratory System Agents|respiratory system agents|mesh-ancestor
92655030|NCT05250791|Lidocaine|lidocaine|mesh-list
92655031|NCT05250791|Anesthetics, Local|anesthetics, local|mesh-ancestor
92655032|NCT05250791|Anesthetics|anesthetics|mesh-ancestor
92655033|NCT05250791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655034|NCT05250791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655035|NCT05250791|Sensory System Agents|sensory system agents|mesh-ancestor
92655036|NCT05250791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577018|NCT00265486|Epoetin Alfa|epoetin alfa|mesh-list
92577019|NCT00265486|Hematinics|hematinics|mesh-ancestor
92577021|NCT00265642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91984426|NCT05430009|Pembrolizumab|pembrolizumab|mesh-list
92655037|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92655038|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92655039|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92655040|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92655041|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655042|NCT05241873|Carboplatin|carboplatin|mesh-list
92655043|NCT05241873|Pemetrexed|pemetrexed|mesh-list
92655044|NCT05241873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655045|NCT05241873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655046|NCT05241873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655047|NCT05241873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92655048|NCT05241873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92655049|NCT05197322|Pembrolizumab|pembrolizumab|mesh-list
92655050|NCT05197322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655051|NCT05197322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655052|NCT05197322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655053|NCT05197322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655054|NCT05193552|gamma-Globulins|gamma-globulins|mesh-list
92655055|NCT05193552|Immunologic Factors|immunologic factors|mesh-ancestor
92655056|NCT05193552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655058|NCT05145764|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92655059|NCT05145764|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92655060|NCT05145764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655061|NCT05145764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062289|NCT01739595|Hormone Antagonists|hormone antagonists|mesh-ancestor
92655063|NCT05145764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655064|NCT05145764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655066|NCT05132075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655067|NCT05132075|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655068|NCT05132075|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655069|NCT05132075|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655070|NCT05132075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655071|NCT05116189|Paclitaxel|paclitaxel|mesh-list
92655072|NCT05116189|Docetaxel|docetaxel|mesh-list
92655073|NCT05116189|Bevacizumab|bevacizumab|mesh-list
92655074|NCT05116189|Pembrolizumab|pembrolizumab|mesh-list
92655075|NCT05116189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655076|NCT05116189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655077|NCT05116189|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655078|NCT05116189|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655079|NCT05116189|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655080|NCT05116189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655081|NCT05116189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655082|NCT05116189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92655083|NCT05116189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655084|NCT05116189|Growth Substances|growth substances|mesh-ancestor
92655085|NCT05116189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655086|NCT05116189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92655087|NCT05116189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655088|NCT05276973|Paclitaxel|paclitaxel|mesh-list
92655089|NCT05276973|Carboplatin|carboplatin|mesh-list
92655090|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92655091|NCT05276973|Ipatasertib|ipatasertib|mesh-list
92655092|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655093|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655094|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655095|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655096|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655097|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655098|NCT05276973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655099|NCT05276973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655100|NCT05099848|Leucovorin|leucovorin|mesh-list
92655101|NCT05099848|Fluorouracil|fluorouracil|mesh-list
92655102|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
92655103|NCT05099848|Apatinib|apatinib|mesh-list
92655104|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
92004690|NCT02341027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92655105|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655106|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655107|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655108|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655109|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
92655110|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655111|NCT05099848|Antidotes|antidotes|mesh-ancestor
92655112|NCT05099848|Protective Agents|protective agents|mesh-ancestor
92655113|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
92655114|NCT05099848|Vitamins|vitamins|mesh-ancestor
92655115|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
92655116|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655117|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655118|NCT05085496|Atezolizumab|atezolizumab|mesh-list
92655119|NCT05085496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92655120|NCT05085496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655121|NCT05085496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655122|NCT05085496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655123|NCT05085496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655124|NCT05085496|Immunologic Factors|immunologic factors|mesh-ancestor
92655125|NCT05085496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655126|NCT05038735|Fulvestrant|fulvestrant|mesh-list
92655127|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92655128|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655129|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92655130|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92655131|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
92655132|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655133|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655134|NCT05028062|Naltrexone|naltrexone|mesh-list
92655135|NCT05028062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92655139|NCT05028062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655140|NCT04983836|Anesthetics|anesthetics|mesh-list
92655141|NCT04983836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655142|NCT04983836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655143|NCT04952753|Leucovorin|leucovorin|mesh-list
92655144|NCT04952753|Bevacizumab|bevacizumab|mesh-list
92655145|NCT04952753|Tislelizumab|tislelizumab|mesh-list
92655146|NCT04952753|Oxaliplatin|oxaliplatin|mesh-list
92655147|NCT04952753|Irinotecan|irinotecan|mesh-list
92655148|NCT04952753|Levoleucovorin|levoleucovorin|mesh-list
92655149|NCT04952753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655150|NCT04952753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655151|NCT04952753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92655152|NCT04952753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655153|NCT04952753|Growth Substances|growth substances|mesh-ancestor
92655154|NCT04952753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655155|NCT04952753|Growth Inhibitors|growth inhibitors|mesh-ancestor
92655156|NCT04952753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92655157|NCT04952753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92655158|NCT04952753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655159|NCT04952753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655160|NCT04952753|Antidotes|antidotes|mesh-ancestor
92655161|NCT04952753|Protective Agents|protective agents|mesh-ancestor
92655162|NCT04952753|Vitamin B Complex|vitamin b complex|mesh-ancestor
92655163|NCT04952753|Vitamins|vitamins|mesh-ancestor
92655164|NCT04952753|Micronutrients|micronutrients|mesh-ancestor
92655165|NCT04933383|Budesonide|budesonide|mesh-list
92655166|NCT04933383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655167|NCT04933383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92655168|NCT04933383|Autonomic Agents|autonomic agents|mesh-ancestor
92655169|NCT04933383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655170|NCT04933383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655171|NCT04933383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92655172|NCT04933383|Respiratory System Agents|respiratory system agents|mesh-ancestor
92655173|NCT04933383|Glucocorticoids|glucocorticoids|mesh-ancestor
92655174|NCT04933383|Hormones|hormones|mesh-ancestor
92655175|NCT04933383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655176|NCT04923776|Carboplatin|carboplatin|mesh-list
92655177|NCT04923776|Etoposide|etoposide|mesh-list
92655178|NCT04923776|Atezolizumab|atezolizumab|mesh-list
92655179|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655180|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655181|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577022|NCT00265642|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92577023|NCT00265642|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92004770|NCT03105115|Bupivacaine|bupivacaine|mesh-list
92655182|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92655183|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655184|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655185|NCT04923776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655186|NCT04923776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655187|NCT04899583|Sirolimus|sirolimus|mesh-list
92655188|NCT04899583|Paclitaxel|paclitaxel|mesh-list
92655189|NCT04899583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655190|NCT04899583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655191|NCT04899583|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655192|NCT04899583|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655193|NCT04899583|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655194|NCT04899583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655195|NCT04899583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92655196|NCT04899583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655197|NCT04899583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92655198|NCT04899583|Antifungal Agents|antifungal agents|mesh-ancestor
92655199|NCT04899583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655200|NCT04899583|Immunologic Factors|immunologic factors|mesh-ancestor
92655201|NCT04899583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655203|NCT04898894|Hydrocortisone|hydrocortisone|mesh-list
92655204|NCT04898894|Methotrexate|methotrexate|mesh-list
92655205|NCT04898894|Fludarabine phosphate|fludarabine phosphate|mesh-list
92655206|NCT04898894|Fludarabine|fludarabine|mesh-list
92655207|NCT04898894|Venetoclax|venetoclax|mesh-list
92655208|NCT04898894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92655209|NCT04898894|Abortifacient Agents|abortifacient agents|mesh-ancestor
92655210|NCT04898894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92655212|NCT04898894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655214|NCT04898894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655215|NCT04898894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655216|NCT04898894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92655217|NCT04898894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655218|NCT04898894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92655219|NCT04898894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655220|NCT04898894|Immunologic Factors|immunologic factors|mesh-ancestor
92655221|NCT04898894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92655222|NCT04898894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92655223|NCT04898894|Antiviral Agents|antiviral agents|mesh-ancestor
92655224|NCT04898894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655225|NCT04898894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655226|NCT04884308|BCG Vaccine|bcg vaccine|mesh-list
92655227|NCT04884308|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92655228|NCT04884308|Immunologic Factors|immunologic factors|mesh-ancestor
92655229|NCT04884308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655230|NCT04868565|Caffeine|caffeine|mesh-list
92655231|NCT04868565|Caffeine citrate|caffeine citrate|mesh-list
92655232|NCT04868565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655233|NCT04868565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92655234|NCT04868565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655235|NCT04868565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92655236|NCT04868565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655237|NCT04868565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92655238|NCT04868565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92655239|NCT04868565|Purinergic Agents|purinergic agents|mesh-ancestor
92655240|NCT04868565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655241|NCT04716881|Naltrexone|naltrexone|mesh-list
92655242|NCT04716881|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92655243|NCT04716881|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92655244|NCT04716881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655245|NCT04716881|Sensory System Agents|sensory system agents|mesh-ancestor
92655246|NCT04716881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655247|NCT04711824|Paclitaxel|paclitaxel|mesh-list
92655248|NCT04711824|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92655249|NCT04711824|Cisplatin|cisplatin|mesh-list
92655250|NCT04711824|Carboplatin|carboplatin|mesh-list
92655251|NCT04711824|Gemcitabine|gemcitabine|mesh-list
92655252|NCT04711824|Capecitabine|capecitabine|mesh-list
92655253|NCT04711824|Durvalumab|durvalumab|mesh-list
92655254|NCT04711824|Olaparib|olaparib|mesh-list
92577024|NCT00265642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655255|NCT04711824|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655256|NCT04711824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655257|NCT04711824|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655258|NCT04711824|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655259|NCT04711824|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655260|NCT04711824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655261|NCT04711824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655262|NCT04711824|Antimetabolites|antimetabolites|mesh-ancestor
92655263|NCT04711824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655264|NCT04711824|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655265|NCT04711824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655266|NCT04589845|Trastuzumab|trastuzumab|mesh-list
92655267|NCT04589845|Atezolizumab|atezolizumab|mesh-list
92655268|NCT04589845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92655269|NCT04589845|Maytansine|maytansine|mesh-list
92655270|NCT04589845|Ipatasertib|ipatasertib|mesh-list
92655271|NCT04589845|Pralsetinib|pralsetinib|mesh-list
92655272|NCT04589845|Entrectinib|entrectinib|mesh-list
92655273|NCT04589845|Inavolisib|inavolisib|mesh-list
92655274|NCT04589845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655275|NCT04589845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380560|NCT02765256|Anesthetics|anesthetics|mesh-ancestor
92655276|NCT04589845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655277|NCT04589845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655278|NCT04589845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655279|NCT04589845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655280|NCT04589845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655281|NCT04589845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655283|NCT04589845|Immunoconjugates|immunoconjugates|mesh-ancestor
92655284|NCT04589845|Immunologic Factors|immunologic factors|mesh-ancestor
92655285|NCT04589845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655289|NCT04582266|Remdesivir|remdesivir|mesh-list
92655290|NCT04582266|Antimetabolites|antimetabolites|mesh-ancestor
92655291|NCT04582266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655292|NCT04582266|Antiviral Agents|antiviral agents|mesh-ancestor
92655293|NCT04582266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655294|NCT04528134|Listerine|listerine|mesh-list
92655295|NCT04528134|Fluorides|fluorides|mesh-list
92655296|NCT04528134|Sodium Fluoride|sodium fluoride|mesh-list
92655297|NCT04528134|Fluorides, Topical|fluorides, topical|mesh-list
92655298|NCT04528134|Cariostatic Agents|cariostatic agents|mesh-ancestor
92655299|NCT04528134|Protective Agents|protective agents|mesh-ancestor
92655300|NCT04528134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655301|NCT04528134|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92655302|NCT04528134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655303|NCT04521920|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92655304|NCT04521920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92655305|NCT04521920|Narcotics|narcotics|mesh-ancestor
92655306|NCT04521920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655307|NCT04521920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655308|NCT04521920|Analgesics|analgesics|mesh-ancestor
92655309|NCT04521920|Sensory System Agents|sensory system agents|mesh-ancestor
92655310|NCT04521920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655311|NCT04521920|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92655312|NCT04482621|Decitabine|decitabine|mesh-list
92655313|NCT04482621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655314|NCT04482621|Antimetabolites|antimetabolites|mesh-ancestor
92655315|NCT04482621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655316|NCT04482621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655317|NCT04482621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655318|NCT04452877|Trametinib|trametinib|mesh-list
92655319|NCT04452877|Dabrafenib|dabrafenib|mesh-list
92655320|NCT04452877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655321|NCT04452877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655322|NCT04452877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655323|NCT04452877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655324|NCT05050916|Vitamin D|vitamin d|mesh-list
92655325|NCT05050916|Vitamins|vitamins|mesh-ancestor
92655326|NCT05050916|Micronutrients|micronutrients|mesh-ancestor
92655327|NCT05050916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655328|NCT05050916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92655329|NCT04613596|Pembrolizumab|pembrolizumab|mesh-list
92655330|NCT04613596|Pemetrexed|pemetrexed|mesh-list
92655331|NCT04613596|Adagrasib|adagrasib|mesh-list
92577025|NCT00265876|Gemcitabine|gemcitabine|mesh-list
92577026|NCT00265876|Saracatinib|saracatinib|mesh-list
92577027|NCT00265876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577028|NCT00265876|Antimetabolites|antimetabolites|mesh-ancestor
92577029|NCT00265876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577030|NCT00265876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577031|NCT00265876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577032|NCT00265915|Rituximab|rituximab|mesh-list
92577033|NCT00265915|Sargramostim|sargramostim|mesh-list
92577034|NCT00265915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92577035|NCT00265915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577036|NCT00265915|Immunologic Factors|immunologic factors|mesh-ancestor
92577037|NCT00265915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577038|NCT00265915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577039|NCT00265993|Enoxaparin|enoxaparin|mesh-list
92577040|NCT00265993|Anticoagulants|anticoagulants|mesh-ancestor
92577041|NCT00265993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92577042|NCT00265993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92655332|NCT04613596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655333|NCT04613596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655334|NCT04613596|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655335|NCT04613596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655336|NCT04613596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655337|NCT04613596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92655338|NCT04613596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92655339|NCT04381650|Pembrolizumab|pembrolizumab|mesh-list
92655340|NCT04381650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655341|NCT04381650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655342|NCT04381650|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655343|NCT04381650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655344|NCT04381143|Aspirin|aspirin|mesh-list
92655345|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92655346|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92655347|NCT04381143|Analgesics|analgesics|mesh-ancestor
92655348|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
92655349|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655350|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655351|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655352|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92655353|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92655354|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92655355|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655356|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92655357|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92655377|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
92655378|NCT04298229|Diuretics|diuretics|mesh-list
92750779|NCT05935202|Mitapivat|mitapivat|mesh-list
92655379|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92655380|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655381|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92655382|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655383|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
92655384|NCT04209660|Pembrolizumab|pembrolizumab|mesh-list
92655385|NCT04209660|Lenvatinib|lenvatinib|mesh-list
92655386|NCT04209660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655387|NCT04209660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655388|NCT04209660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92577043|NCT00265993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577044|NCT00266149|Lamotrigine|lamotrigine|mesh-list
92577045|NCT00266149|Anticonvulsants|anticonvulsants|mesh-ancestor
92577046|NCT00266149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92655389|NCT04209660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655390|NCT04209660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655391|NCT04209660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655392|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
92655393|NCT04177433|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92655394|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92655395|NCT04177433|Prednisolone|prednisolone|mesh-list
92655396|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
92655397|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92655398|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
92655399|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655400|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
92655401|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
92655402|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655403|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655404|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655405|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
92655406|NCT04177433|Hormones|hormones|mesh-ancestor
92655407|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655408|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92655409|NCT04177433|Protective Agents|protective agents|mesh-ancestor
92655410|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92655411|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655412|NCT04166383|Nivolumab|nivolumab|mesh-list
92655413|NCT04166383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655417|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
92655418|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655419|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655420|NCT04108897|Doxycycline|doxycycline|mesh-list
92655421|NCT04108897|Ivermectin|ivermectin|mesh-list
92655422|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92655423|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655424|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
92655425|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92655426|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92655428|NCT04101877|Aflibercept|aflibercept|mesh-list
92655429|NCT04101877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655430|NCT04101877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655431|NCT04101877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92655432|NCT04101877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655433|NCT04101877|Growth Substances|growth substances|mesh-ancestor
92655434|NCT04101877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655435|NCT04101877|Growth Inhibitors|growth inhibitors|mesh-ancestor
92655436|NCT04101838|Vaccines|vaccines|mesh-list
92655437|NCT04101838|Immunologic Factors|immunologic factors|mesh-ancestor
92655438|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655439|NCT04054648|Antihypertensive Agents|antihypertensive agents|mesh-list
92655440|NCT04026958|Clarithromycin|clarithromycin|mesh-list
92655441|NCT04026958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92655442|NCT04026958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655443|NCT04026958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92655444|NCT04026958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655445|NCT04026958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655446|NCT04026958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92655447|NCT04026958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92655448|NCT04024254|Folic Acid|folic acid|mesh-list
92655449|NCT04024254|Hematinics|hematinics|mesh-ancestor
92655450|NCT04024254|Vitamin B Complex|vitamin b complex|mesh-ancestor
92655451|NCT04024254|Vitamins|vitamins|mesh-ancestor
92655452|NCT04024254|Micronutrients|micronutrients|mesh-ancestor
92655453|NCT04024254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655454|NCT04023331|Copper|copper|mesh-list
92655455|NCT04023331|Trace Elements|trace elements|mesh-ancestor
92655456|NCT04023331|Micronutrients|micronutrients|mesh-ancestor
92655457|NCT04023331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655458|NCT03975829|Trametinib|trametinib|mesh-list
92655459|NCT03975829|Dabrafenib|dabrafenib|mesh-list
92655460|NCT03975829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655461|NCT03975829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92577047|NCT00266149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92577048|NCT00266149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577049|NCT00266149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92655462|NCT03975829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655463|NCT03975829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655464|NCT03939182|Abexinostat|abexinostat|mesh-list
92655465|NCT03939182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92655466|NCT03939182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655467|NCT03939182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655468|NCT03908437|Buprenorphine|buprenorphine|mesh-list
92655469|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92655470|NCT03908437|Naloxone|naloxone|mesh-list
92655471|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92655472|NCT03908437|Narcotics|narcotics|mesh-ancestor
92655473|NCT03908437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655474|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655475|NCT03908437|Analgesics|analgesics|mesh-ancestor
92655476|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
92655477|NCT03908437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655478|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92655479|NCT03887702|Tenofovir|tenofovir|mesh-list
92655480|NCT03887702|Entecavir|entecavir|mesh-list
92655481|NCT03887702|Antiviral Agents|antiviral agents|mesh-ancestor
92655482|NCT03887702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655483|NCT03887702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92655484|NCT03887702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92655485|NCT03887702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655486|NCT03887702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062697|NCT04605393|Hormones|hormones|mesh-ancestor
92655491|NCT03878589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92655492|NCT03878589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655493|NCT03875287|Decitabine|decitabine|mesh-list
92655494|NCT03875287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655495|NCT03875287|Antimetabolites|antimetabolites|mesh-ancestor
92655496|NCT03875287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655497|NCT03875287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655498|NCT03875287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380779|NCT04741620|Chelating Agents|chelating agents|mesh-ancestor
92655499|NCT03832010|Triamcinolone|triamcinolone|mesh-list
92655500|NCT03832010|Hydrocortisone|hydrocortisone|mesh-list
92655501|NCT03832010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655502|NCT03832010|Glucocorticoids|glucocorticoids|mesh-ancestor
92655503|NCT03832010|Hormones|hormones|mesh-ancestor
92655504|NCT03832010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655505|NCT03832010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655506|NCT03813836|Pembrolizumab|pembrolizumab|mesh-list
92655507|NCT03813836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655508|NCT03813836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655509|NCT03813836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655510|NCT03813836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655511|NCT03730649|Sulforaphane|sulforaphane|mesh-list
92655512|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92655513|NCT03730649|Protective Agents|protective agents|mesh-ancestor
92655514|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655515|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655516|NCT03683355|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92655517|NCT03683355|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92655518|NCT03683355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655519|NCT03632720|Vaccines|vaccines|mesh-list
92655520|NCT03632720|Immunologic Factors|immunologic factors|mesh-ancestor
92655521|NCT03632720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655522|NCT03622788|Cyclophosphamide|cyclophosphamide|mesh-list
92655523|NCT03622788|Fludarabine|fludarabine|mesh-list
92655524|NCT03622788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92655525|NCT03622788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655526|NCT03622788|Immunologic Factors|immunologic factors|mesh-ancestor
92655527|NCT03622788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655528|NCT03622788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92655529|NCT03622788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92655530|NCT03622788|Alkylating Agents|alkylating agents|mesh-ancestor
92577050|NCT00266149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577051|NCT00266149|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92577052|NCT00266149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92577053|NCT00266149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655531|NCT03622788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655532|NCT03622788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655533|NCT03622788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92655534|NCT03598426|Dexamethasone|dexamethasone|mesh-list
92655535|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655536|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
92655537|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
92655538|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655539|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655540|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655541|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
92655542|NCT03598426|Hormones|hormones|mesh-ancestor
92655543|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655544|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92655545|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655546|NCT03568890|Aspirin|aspirin|mesh-list
92655547|NCT03568890|Rivaroxaban|rivaroxaban|mesh-list
92655548|NCT03568890|Apixaban|apixaban|mesh-list
92655549|NCT03568890|Edoxaban|edoxaban|mesh-list
92655550|NCT03568890|Dabigatran|dabigatran|mesh-list
92655551|NCT03568890|Clopidogrel|clopidogrel|mesh-list
92655552|NCT03568890|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92655553|NCT03568890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92655554|NCT03568890|Analgesics|analgesics|mesh-ancestor
92655555|NCT03568890|Sensory System Agents|sensory system agents|mesh-ancestor
92655556|NCT03568890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655557|NCT03568890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655558|NCT03568890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655561|NCT03568890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92655562|NCT03568890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655563|NCT03568890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92655564|NCT03568890|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92655565|NCT03568890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655566|NCT03568890|Antipyretics|antipyretics|mesh-ancestor
92655567|NCT03568890|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92655568|NCT03568890|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92655569|NCT03568890|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92655570|NCT03568890|Purinergic Agents|purinergic agents|mesh-ancestor
92655571|NCT03568890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655572|NCT03568890|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92655573|NCT03568890|Antithrombins|antithrombins|mesh-ancestor
92655574|NCT03568890|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92655575|NCT03568890|Protease Inhibitors|protease inhibitors|mesh-ancestor
92655576|NCT03568890|Anticoagulants|anticoagulants|mesh-ancestor
92655577|NCT03521037|Rucaparib|rucaparib|mesh-list
92655578|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655579|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655580|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655581|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655582|NCT03499444|Rucaparib|rucaparib|mesh-list
92655583|NCT03499444|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655584|NCT03499444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655585|NCT03499444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655586|NCT03499444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655587|NCT03494322|Cetuximab|cetuximab|mesh-list
92655588|NCT03494322|Avelumab|avelumab|mesh-list
92655589|NCT03494322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655590|NCT03494322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655591|NCT03480191|Daptomycin|daptomycin|mesh-list
92655592|NCT03480191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92655593|NCT03480191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655594|NCT03478878|Vitamin A|vitamin a|mesh-list
92655595|NCT03478878|Retinol palmitate|retinol palmitate|mesh-list
92655596|NCT03478878|Vitamins|vitamins|mesh-ancestor
92655597|NCT03478878|Micronutrients|micronutrients|mesh-ancestor
92655598|NCT03478878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655599|NCT03478878|Antioxidants|antioxidants|mesh-ancestor
92577054|NCT00266149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92577055|NCT00266149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92577056|NCT00106314|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92577057|NCT00106314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92577058|NCT00106314|Immunologic Factors|immunologic factors|mesh-ancestor
92577059|NCT00106314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655600|NCT03478878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655601|NCT03478878|Protective Agents|protective agents|mesh-ancestor
92655602|NCT03478878|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92655603|NCT03478878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655604|NCT03441633|Rivaroxaban|rivaroxaban|mesh-list
92655605|NCT03441633|Apixaban|apixaban|mesh-list
92655606|NCT03441633|Dabigatran|dabigatran|mesh-list
92655607|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92655608|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
92655609|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92655610|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
92655611|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655612|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655613|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
92655614|NCT03436862|Nivolumab|nivolumab|mesh-list
92655615|NCT03436862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655616|NCT03436862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655617|NCT03436862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655618|NCT03436862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655619|NCT03424005|Bevacizumab|bevacizumab|mesh-list
92655620|NCT03424005|Carboplatin|carboplatin|mesh-list
92655621|NCT03424005|Gemcitabine|gemcitabine|mesh-list
92655622|NCT03424005|Capecitabine|capecitabine|mesh-list
92655623|NCT03424005|Trastuzumab|trastuzumab|mesh-list
92655624|NCT03424005|Atezolizumab|atezolizumab|mesh-list
92655625|NCT03424005|Fulvestrant|fulvestrant|mesh-list
92655626|NCT03424005|Ipatasertib|ipatasertib|mesh-list
92655627|NCT03424005|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92655628|NCT03424005|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92655629|NCT03424005|SGN-LIV1A|sgn-liv1a|mesh-list
92655630|NCT03424005|Inavolisib|inavolisib|mesh-list
92655631|NCT03424005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655632|NCT03424005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655633|NCT03424005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92062838|NCT00210964|Linezolid|linezolid|mesh-list
92655643|NCT03424005|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92655644|NCT03424005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92655645|NCT03424005|Hormone Antagonists|hormone antagonists|mesh-ancestor
92655646|NCT03424005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655647|NCT03424005|Immunoconjugates|immunoconjugates|mesh-ancestor
92655648|NCT03424005|Immunologic Factors|immunologic factors|mesh-ancestor
92655649|NCT03424005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655650|NCT03424005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655651|NCT03424005|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92655653|NCT03418961|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92655654|NCT03418961|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92655655|NCT03418961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92655656|NCT03418961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655657|NCT03418961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655658|NCT03418961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655659|NCT03418961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92655660|NCT03418961|Antioxidants|antioxidants|mesh-ancestor
92655661|NCT03418961|Protective Agents|protective agents|mesh-ancestor
92655662|NCT03418961|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92655663|NCT03418961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92655664|NCT03418961|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92655665|NCT03418961|Vasodilator Agents|vasodilator agents|mesh-ancestor
92655666|NCT03418961|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92655667|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92655668|NCT03397394|Rucaparib|rucaparib|mesh-list
92750780|NCT05935202|Enzyme Activators|enzyme activators|mesh-ancestor
92655669|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655670|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655671|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577061|NCT00415792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92005281|NCT02329561|Tramadol|tramadol|mesh-list
92655672|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655673|NCT03373760|Durvalumab|durvalumab|mesh-list
92655674|NCT03373760|Ipilimumab|ipilimumab|mesh-list
92655675|NCT03373760|Tremelimumab|tremelimumab|mesh-list
92655676|NCT03373760|Immunoglobulins|immunoglobulins|mesh-list
92655677|NCT03373760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92655678|NCT03373760|Immunoglobulin G|immunoglobulin g|mesh-list
92655679|NCT03373760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655680|NCT03373760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655681|NCT03373760|Immunologic Factors|immunologic factors|mesh-ancestor
92655682|NCT03373760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655683|NCT03373760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655684|NCT03373760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655685|NCT03354728|Vaccines|vaccines|mesh-list
92655686|NCT03354728|Immunologic Factors|immunologic factors|mesh-ancestor
92655687|NCT03354728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655688|NCT03290794|Aflibercept|aflibercept|mesh-list
92655689|NCT03290794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92655690|NCT03290794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655691|NCT03290794|Growth Substances|growth substances|mesh-ancestor
92655692|NCT03290794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655693|NCT03290794|Growth Inhibitors|growth inhibitors|mesh-ancestor
92655694|NCT03290794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655695|NCT03053440|Zanubrutinib|zanubrutinib|mesh-list
92655696|NCT03053440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655697|NCT03053440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655700|NCT02986100|Rucaparib|rucaparib|mesh-list
92655701|NCT02986100|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655702|NCT02986100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655703|NCT02986100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655704|NCT02986100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655705|NCT02965027|Prazosin|prazosin|mesh-list
92655706|NCT02965027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92655707|NCT02965027|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92655708|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92655709|NCT02965027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92655710|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
92655711|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655712|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655713|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655714|NCT02952534|Rucaparib|rucaparib|mesh-list
92655715|NCT02952534|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655716|NCT02952534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655717|NCT02952534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655718|NCT02952534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655719|NCT02949934|Tolcapone|tolcapone|mesh-list
92655720|NCT02949934|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92655721|NCT02949934|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92655722|NCT02949934|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92655723|NCT02949934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655724|NCT02949934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655725|NCT02935634|Nivolumab|nivolumab|mesh-list
92655726|NCT02935634|Ipilimumab|ipilimumab|mesh-list
92655727|NCT02935634|Relatlimab|relatlimab|mesh-list
92381003|NCT02902770|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92655728|NCT02935634|Rucaparib|rucaparib|mesh-list
92655729|NCT02935634|Linrodostat|linrodostat|mesh-list
92655730|NCT02935634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655731|NCT02935634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655732|NCT02935634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655733|NCT02935634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655734|NCT02935634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655735|NCT02935634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655736|NCT02864992|Tepotinib|tepotinib|mesh-list
92655737|NCT02864992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655738|NCT02807636|Carboplatin|carboplatin|mesh-list
92655739|NCT02807636|Gemcitabine|gemcitabine|mesh-list
92655740|NCT02807636|Atezolizumab|atezolizumab|mesh-list
92655741|NCT02807636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655742|NCT02807636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577062|NCT00415792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655743|NCT02807636|Antimetabolites|antimetabolites|mesh-ancestor
92655744|NCT02807636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655745|NCT02807636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655746|NCT02807636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655747|NCT02740712|Vitamin K|vitamin k|mesh-list
92655748|NCT02740712|Rucaparib|rucaparib|mesh-list
92655749|NCT02740712|Digoxin|digoxin|mesh-list
92655750|NCT02740712|Midazolam|midazolam|mesh-list
92655751|NCT02740712|Caffeine|caffeine|mesh-list
92655752|NCT02740712|Omeprazole|omeprazole|mesh-list
92655753|NCT02740712|Warfarin|warfarin|mesh-list
92655754|NCT02740712|Vitamins|vitamins|mesh-ancestor
92655755|NCT02740712|Micronutrients|micronutrients|mesh-ancestor
92655756|NCT02740712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655757|NCT02740712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92655758|NCT02740712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92655759|NCT02740712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655760|NCT02740712|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92655761|NCT02740712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92655762|NCT02740712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92655763|NCT02740712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92655764|NCT02740712|Anesthetics, General|anesthetics, general|mesh-ancestor
92655765|NCT02740712|Anesthetics|anesthetics|mesh-ancestor
92655766|NCT02740712|GABA Modulators|gaba modulators|mesh-ancestor
92655767|NCT02740712|GABA Agents|gaba agents|mesh-ancestor
92655768|NCT02740712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655769|NCT02740712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655770|NCT02740712|Anticoagulants|anticoagulants|mesh-ancestor
92655772|NCT02740712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92655774|NCT02740712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92655775|NCT02740712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92655776|NCT02740712|Purinergic Agents|purinergic agents|mesh-ancestor
92655777|NCT02740712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92655778|NCT02740712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655779|NCT02740712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92655780|NCT02740712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92655781|NCT02740712|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92655782|NCT02740712|Protective Agents|protective agents|mesh-ancestor
92655783|NCT02740712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92655784|NCT02740712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92655785|NCT02740712|Hemostatics|hemostatics|mesh-ancestor
92655786|NCT02740712|Coagulants|coagulants|mesh-ancestor
92655787|NCT02740712|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655788|NCT02740712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655789|NCT02684578|Metformin|metformin|mesh-list
92655790|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92655791|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655792|NCT02580305|Memantine|memantine|mesh-list
92655793|NCT02580305|Donepezil|donepezil|mesh-list
92655794|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
92655795|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92655796|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655797|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655798|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
92655799|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655800|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655801|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
92655802|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92655803|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92655804|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
92655805|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92655806|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92655807|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92655809|NCT02279394|Dexamethasone|dexamethasone|mesh-list
92655810|NCT02279394|Lenalidomide|lenalidomide|mesh-list
92655811|NCT02279394|Elotuzumab|elotuzumab|mesh-list
92655812|NCT02279394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655813|NCT02279394|Antiemetics|antiemetics|mesh-ancestor
92655814|NCT02279394|Autonomic Agents|autonomic agents|mesh-ancestor
92655815|NCT02279394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655816|NCT02279394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655817|NCT02279394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655818|NCT02279394|Glucocorticoids|glucocorticoids|mesh-ancestor
92655819|NCT02279394|Hormones|hormones|mesh-ancestor
92577065|NCT00415831|Entacapone|entacapone|mesh-list
92577066|NCT00415831|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92655820|NCT02279394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655821|NCT02279394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92655822|NCT02279394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655823|NCT02279394|Immunologic Factors|immunologic factors|mesh-ancestor
92655824|NCT02279394|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92655825|NCT02279394|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655826|NCT02279394|Growth Substances|growth substances|mesh-ancestor
92655827|NCT02279394|Growth Inhibitors|growth inhibitors|mesh-ancestor
92655828|NCT02229578|Lidocaine|lidocaine|mesh-list
92655829|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
92655830|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
92655831|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92655832|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655833|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
92655834|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655835|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92655836|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92655837|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92655838|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92655839|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655840|NCT01821781|Fludarabine|fludarabine|mesh-list
92655841|NCT01821781|Melphalan|melphalan|mesh-list
92655842|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
92655843|NCT01821781|Thiotepa|thiotepa|mesh-list
92655844|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655846|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655847|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
92655848|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655849|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92655850|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
92655851|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92655852|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655853|NCT01555463|Azelaic acid|azelaic acid|mesh-list
92655854|NCT01555463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655855|NCT01555463|Dermatologic Agents|dermatologic agents|mesh-ancestor
92655856|NCT01482715|Rucaparib|rucaparib|mesh-list
92655857|NCT01482715|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655858|NCT01482715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655859|NCT01482715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655860|NCT01482715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655861|NCT01306019|Busulfan|busulfan|mesh-list
92655862|NCT01306019|Alkylating Agents|alkylating agents|mesh-ancestor
92655863|NCT01306019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655864|NCT01306019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655865|NCT01306019|Immunologic Factors|immunologic factors|mesh-ancestor
92655866|NCT01306019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655867|NCT01306019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92655868|NCT01306019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655869|NCT01306019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92655870|NCT01257919|Azelaic acid|azelaic acid|mesh-list
92655871|NCT01257919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655872|NCT01257919|Dermatologic Agents|dermatologic agents|mesh-ancestor
92655873|NCT01081951|Paclitaxel|paclitaxel|mesh-list
92655874|NCT01081951|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92655875|NCT01081951|Carboplatin|carboplatin|mesh-list
92655876|NCT01081951|Olaparib|olaparib|mesh-list
92655877|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92655878|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381151|NCT02956044|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92655879|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
92655880|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
92655881|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
92655882|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655883|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92655884|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655885|NCT00915837|Triamcinolone|triamcinolone|mesh-list
92655886|NCT00915837|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92655887|NCT00915837|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92655888|NCT00915837|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92577067|NCT00415831|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92577068|NCT00415831|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92577069|NCT00415831|Dopamine Agents|dopamine agents|mesh-ancestor
92577070|NCT00415831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577071|NCT00415831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655889|NCT00915837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655890|NCT00915837|Glucocorticoids|glucocorticoids|mesh-ancestor
92655891|NCT00915837|Hormones|hormones|mesh-ancestor
92655892|NCT00915837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655893|NCT00915837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655894|NCT00915837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655895|NCT00915837|Immunologic Factors|immunologic factors|mesh-ancestor
92655896|NCT00915837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655897|NCT00915837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655898|NCT00239096|Losartan|losartan|mesh-list
92655899|NCT00239096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92655900|NCT00239096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92655901|NCT00239096|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92655902|NCT00239096|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92655903|NCT00239096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655904|NCT04532554|Hormones|hormones|mesh-list
92655905|NCT04532554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655906|NCT04532554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655907|NCT04532281|Carbamide Peroxide|carbamide peroxide|mesh-list
92655908|NCT04532281|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92655909|NCT04532281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655910|NCT02217163|Dexamethasone|dexamethasone|mesh-list
92655911|NCT02217163|Cyclophosphamide|cyclophosphamide|mesh-list
92655912|NCT02217163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655913|NCT02217163|Immunologic Factors|immunologic factors|mesh-ancestor
92655914|NCT02217163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063124|NCT00213148|Chelating Agents|chelating agents|mesh-ancestor
92655918|NCT02217163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655919|NCT02217163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655920|NCT02217163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92655921|NCT02217163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655922|NCT02217163|Antiemetics|antiemetics|mesh-ancestor
92655923|NCT02217163|Autonomic Agents|autonomic agents|mesh-ancestor
92655924|NCT02217163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655925|NCT02217163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655926|NCT02217163|Glucocorticoids|glucocorticoids|mesh-ancestor
92655927|NCT02217163|Hormones|hormones|mesh-ancestor
92655928|NCT02217163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655929|NCT02217163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92655930|NCT02217202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92655931|NCT02217202|Laxatives|laxatives|mesh-ancestor
92655932|NCT02217202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92655933|NCT00239174|Surinabant|surinabant|mesh-list
92655934|NCT00239174|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92655935|NCT00239174|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92655936|NCT00239174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655937|NCT00239174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655938|NCT00239174|Hormones|hormones|mesh-ancestor
92655939|NCT00239174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92655940|NCT00239174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655941|NCT04531423|Golimumab|golimumab|mesh-list
92655942|NCT04531423|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92655943|NCT04531423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92655944|NCT04531423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92655945|NCT04531423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92655946|NCT04531423|Immunologic Factors|immunologic factors|mesh-ancestor
92655947|NCT04531423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655948|NCT04531423|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92655949|NCT04531423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381230|NCT02970552|Progesterone|progesterone|mesh-list
92655950|NCT04531423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577072|NCT00415831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682782|NCT04701320|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92655952|NCT04531423|Serotonin Agents|serotonin agents|mesh-ancestor
92655953|NCT00239252|Interferons|interferons|mesh-list
92655954|NCT00239252|Interferon alfacon-1|interferon alfacon-1|mesh-list
92655955|NCT00239252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655956|NCT00239252|Antiviral Agents|antiviral agents|mesh-ancestor
92655957|NCT00239252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655958|NCT00263406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92655959|NCT00263406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92655960|NCT00263406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655961|NCT00263406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655962|NCT04531267|Calcium|calcium|mesh-list
92655963|NCT04531267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92655964|NCT04531267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655965|NCT04531228|Lenvatinib|lenvatinib|mesh-list
92655966|NCT04531228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655967|NCT04531228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655968|NCT04531228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655969|NCT04531228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655970|NCT04531072|Ritonavir|ritonavir|mesh-list
92655971|NCT04531072|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92655972|NCT04531072|Lumefantrine|lumefantrine|mesh-list
92655973|NCT04531072|Artemether|artemether|mesh-list
92655974|NCT04531072|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92655975|NCT04531072|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92655976|NCT04531072|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92655977|NCT04531072|Protease Inhibitors|protease inhibitors|mesh-ancestor
92655978|NCT04531072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655979|NCT04531072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655980|NCT04531072|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92655981|NCT04531072|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92655982|NCT04531072|Antiviral Agents|antiviral agents|mesh-ancestor
92655983|NCT04531072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92655984|NCT04531072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92655987|NCT04531072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92655988|NCT04531072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92655989|NCT00414323|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92655990|NCT00414323|Escitalopram|escitalopram|mesh-list
92655991|NCT00414323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92655992|NCT00414323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92655993|NCT00414323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92655994|NCT00414323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655995|NCT00414323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655996|NCT00414323|Serotonin Agents|serotonin agents|mesh-ancestor
92655997|NCT00414323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655998|NCT00414323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92655999|NCT00414323|Antidepressive Agents|antidepressive agents|mesh-ancestor
92656000|NCT00414323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92656001|NCT00414323|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92656002|NCT00414323|Analgesics|analgesics|mesh-ancestor
92656003|NCT00414323|Sensory System Agents|sensory system agents|mesh-ancestor
92656004|NCT00414323|Dopamine Agents|dopamine agents|mesh-ancestor
92656005|NCT00263484|Zoledronic Acid|zoledronic acid|mesh-list
92656006|NCT00263484|Thalidomide|thalidomide|mesh-list
92656007|NCT00263484|Dexamethasone|dexamethasone|mesh-list
92656008|NCT00263484|Dexamethasone acetate|dexamethasone acetate|mesh-list
92656009|NCT00263484|BB 1101|bb 1101|mesh-list
92364264|NCT04340544|Hydroxychloroquine|hydroxychloroquine|mesh-list
92656010|NCT00263484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656011|NCT00263484|Antiemetics|antiemetics|mesh-ancestor
92656012|NCT00263484|Autonomic Agents|autonomic agents|mesh-ancestor
92656013|NCT00263484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656014|NCT00263484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656015|NCT00263484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656016|NCT00263484|Glucocorticoids|glucocorticoids|mesh-ancestor
92656017|NCT00263484|Hormones|hormones|mesh-ancestor
92656018|NCT00263484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656019|NCT00263484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656020|NCT00263484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656021|NCT00263484|Protease Inhibitors|protease inhibitors|mesh-ancestor
92656022|NCT00263484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381303|NCT03020082|Ritonavir|ritonavir|mesh-list
92656023|NCT00263484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577073|NCT00415831|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92577074|NCT00415831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577075|NCT00415831|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92577076|NCT00415831|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92656024|NCT00263484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92656025|NCT00263484|Immunologic Factors|immunologic factors|mesh-ancestor
92656026|NCT00263484|Leprostatic Agents|leprostatic agents|mesh-ancestor
92656027|NCT00263484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92656028|NCT00263484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656029|NCT00263484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92656030|NCT00263484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92656031|NCT00263484|Growth Substances|growth substances|mesh-ancestor
92656032|NCT00263484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92656033|NCT00263484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92656034|NCT02217319|Sevoflurane|sevoflurane|mesh-list
92656035|NCT02217319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92656036|NCT02217319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92656037|NCT02217319|Anesthetics, General|anesthetics, general|mesh-ancestor
92656038|NCT02217319|Anesthetics|anesthetics|mesh-ancestor
92656039|NCT02217319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656040|NCT02217319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656041|NCT00263601|Immunomodulating Agents|immunomodulating agents|mesh-list
92656042|NCT00263601|Immunologic Factors|immunologic factors|mesh-ancestor
92656043|NCT00263601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656044|NCT02217514|Midazolam|midazolam|mesh-list
92656045|NCT02217514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92656046|NCT02217514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92656047|NCT02217514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656048|NCT02217514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656049|NCT02217514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92656050|NCT02217514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92656051|NCT02217514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92656052|NCT02217514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92656053|NCT02217514|Anesthetics, General|anesthetics, general|mesh-ancestor
92656054|NCT02217514|Anesthetics|anesthetics|mesh-ancestor
92656055|NCT02217514|GABA Modulators|gaba modulators|mesh-ancestor
92656056|NCT02217514|GABA Agents|gaba agents|mesh-ancestor
92656057|NCT02217514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656058|NCT02217514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656060|NCT02217553|Vitamin D|vitamin d|mesh-list
92656061|NCT02217553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656062|NCT02217553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656063|NCT02217553|Vitamins|vitamins|mesh-ancestor
92656064|NCT02217553|Micronutrients|micronutrients|mesh-ancestor
92656065|NCT02217553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92656066|NCT02217631|Prednisolone|prednisolone|mesh-list
92656067|NCT02217631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92656068|NCT02217631|Methylprednisolone|methylprednisolone|mesh-list
92656069|NCT02217631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92656070|NCT02217631|Prednisolone acetate|prednisolone acetate|mesh-list
92656071|NCT02217631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92656072|NCT02217631|Prednisolone phosphate|prednisolone phosphate|mesh-list
92656073|NCT02217631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656074|NCT02217631|Glucocorticoids|glucocorticoids|mesh-ancestor
92656075|NCT02217631|Hormones|hormones|mesh-ancestor
92656076|NCT02217631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656077|NCT02217631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656078|NCT02217631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656079|NCT02217631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656080|NCT02217631|Antiemetics|antiemetics|mesh-ancestor
92656081|NCT02217631|Autonomic Agents|autonomic agents|mesh-ancestor
92656082|NCT02217631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656083|NCT02217631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656084|NCT02217631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92656085|NCT02217631|Protective Agents|protective agents|mesh-ancestor
92656086|NCT02217670|Metformin|metformin|mesh-list
92656087|NCT02217670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92656088|NCT02217670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656089|NCT00239291|Gefitinib|gefitinib|mesh-list
92656090|NCT00239291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656091|NCT00239291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92577078|NCT00415831|Dopamine Agonists|dopamine agonists|mesh-ancestor
92577079|NCT00102141|Drospirenone|drospirenone|mesh-list
92656092|NCT00239291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656093|NCT00239291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656094|NCT00263640|Immunomodulating Agents|immunomodulating agents|mesh-list
92656095|NCT00263640|Immunologic Factors|immunologic factors|mesh-ancestor
92656096|NCT00263640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656097|NCT02217826|Octreotide|octreotide|mesh-list
92656098|NCT02217826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656099|NCT02217826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656100|NCT02217826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656102|NCT00239330|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92656103|NCT00239330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92656104|NCT00239330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92656105|NCT00239330|Antimetabolites|antimetabolites|mesh-ancestor
92656106|NCT00239330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656107|NCT00239330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92656108|NCT00239330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92656109|NCT00239330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656110|NCT02218021|Oxycodone|oxycodone|mesh-list
92656111|NCT02218021|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92656112|NCT02218021|Narcotics|narcotics|mesh-ancestor
92656113|NCT02218021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656114|NCT02218021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656115|NCT02218021|Analgesics|analgesics|mesh-ancestor
92656116|NCT02218021|Sensory System Agents|sensory system agents|mesh-ancestor
92656117|NCT02218021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656118|NCT00239369|Telmisartan|telmisartan|mesh-list
92656119|NCT00239369|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92656120|NCT00239369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656121|NCT00239369|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656122|NCT00239369|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656123|NCT00239369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656124|NCT00239369|Diuretics|diuretics|mesh-ancestor
92656125|NCT00239369|Natriuretic Agents|natriuretic agents|mesh-ancestor
92656126|NCT00239369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656127|NCT00239369|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92656128|NCT00239369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656129|NCT04529668|Vitamin D|vitamin d|mesh-list
92656130|NCT04529668|Vitamins|vitamins|mesh-ancestor
92656131|NCT04529668|Micronutrients|micronutrients|mesh-ancestor
92656132|NCT04529668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656134|NCT00239408|Bromides|bromides|mesh-list
92656135|NCT00239408|Tiotropium Bromide|tiotropium bromide|mesh-list
92656136|NCT00239408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92656137|NCT00239408|Autonomic Agents|autonomic agents|mesh-ancestor
92656138|NCT00239408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656139|NCT00239408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656140|NCT00239408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92656141|NCT00239408|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656142|NCT00239408|Parasympatholytics|parasympatholytics|mesh-ancestor
92656143|NCT00239408|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92656144|NCT00239408|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656145|NCT00239408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656146|NCT00239408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656147|NCT00239408|Anticonvulsants|anticonvulsants|mesh-ancestor
92656148|NCT02218177|Ranibizumab|ranibizumab|mesh-list
92656149|NCT02218177|Aflibercept|aflibercept|mesh-list
92656150|NCT02218177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92656151|NCT02218177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92656152|NCT02218177|Growth Substances|growth substances|mesh-ancestor
92656153|NCT02218177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656154|NCT02218177|Growth Inhibitors|growth inhibitors|mesh-ancestor
92656155|NCT02218177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656156|NCT00263718|Betamethasone|betamethasone|mesh-list
92656157|NCT00263718|Betamethasone Valerate|betamethasone valerate|mesh-list
92656158|NCT00263718|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92656159|NCT00263718|Betamethasone benzoate|betamethasone benzoate|mesh-list
92656160|NCT00263718|Calcipotriene|calcipotriene|mesh-list
92656161|NCT00263718|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92656162|NCT00263718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656163|NCT00263718|Glucocorticoids|glucocorticoids|mesh-ancestor
92577080|NCT00102141|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92577081|NCT00102141|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92577082|NCT00102141|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92656164|NCT00263718|Hormones|hormones|mesh-ancestor
92656165|NCT00263718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656166|NCT00263718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656167|NCT00263718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92656168|NCT00263718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656169|NCT00263718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92656170|NCT02218645|Brotizolam|brotizolam|mesh-list
92656171|NCT02218645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92381456|NCT03088800|Ibuprofen|ibuprofen|mesh-list
92656172|NCT02218645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656173|NCT02218645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656174|NCT02218684|Telmisartan|telmisartan|mesh-list
92656175|NCT02218684|Lacidipine|lacidipine|mesh-list
92656176|NCT02218684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656177|NCT02218684|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656178|NCT02218684|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656179|NCT02218684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656180|NCT02218684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92656181|NCT02218684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656182|NCT02218684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656183|NCT02218684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656184|NCT02278861|Tretinoin|tretinoin|mesh-list
92656185|NCT02278861|Isotretinoin|isotretinoin|mesh-list
92656186|NCT02278861|Sunscreening Agents|sunscreening agents|mesh-list
92656187|NCT02278861|Dermatologic Agents|dermatologic agents|mesh-ancestor
92656188|NCT02278861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656189|NCT02278861|Keratolytic Agents|keratolytic agents|mesh-ancestor
92656190|NCT02278861|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92656191|NCT02278861|Protective Agents|protective agents|mesh-ancestor
92656192|NCT02278861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656193|NCT01642030|Buprenorphine|buprenorphine|mesh-list
92656194|NCT01642030|Hydromorphone|hydromorphone|mesh-list
92656195|NCT01642030|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92656196|NCT01642030|Narcotics|narcotics|mesh-ancestor
92656197|NCT01642030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656198|NCT01642030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656199|NCT01642030|Analgesics|analgesics|mesh-ancestor
92656200|NCT01642030|Sensory System Agents|sensory system agents|mesh-ancestor
92656201|NCT01642030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656202|NCT01642030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92656203|NCT00239447|Tiotropium Bromide|tiotropium bromide|mesh-list
92656204|NCT00239447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92656205|NCT00239447|Autonomic Agents|autonomic agents|mesh-ancestor
92063421|NCT03828292|Dexamethasone|dexamethasone|mesh-list
92656209|NCT00239447|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656210|NCT00239447|Parasympatholytics|parasympatholytics|mesh-ancestor
92656211|NCT00239447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92656212|NCT00239447|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656213|NCT00239447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656214|NCT00239447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656215|NCT00263796|Oxytocin|oxytocin|mesh-list
92656216|NCT00263796|Oxytocics|oxytocics|mesh-ancestor
92656217|NCT00263796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92656218|NCT00263796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656219|NCT01642108|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92656220|NCT01642108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92364272|NCT04340778|Lidocaine|lidocaine|mesh-list
92656221|NCT01642108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656222|NCT01642108|Incretins|incretins|mesh-ancestor
92656223|NCT01642108|Hormones|hormones|mesh-ancestor
92656224|NCT01642108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656225|NCT01642108|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92656226|NCT01642108|Protease Inhibitors|protease inhibitors|mesh-ancestor
92656227|NCT01642108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656228|NCT01642108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656229|NCT00250185|Acetylcholine|acetylcholine|mesh-list
92656230|NCT00250185|Vasodilator Agents|vasodilator agents|mesh-ancestor
92656231|NCT00250185|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92656232|NCT00250185|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656233|NCT00250185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682783|NCT04701320|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92656234|NCT00250185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656235|NCT00250185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656236|NCT00239486|Pramipexole|pramipexole|mesh-list
92656237|NCT00239486|Antioxidants|antioxidants|mesh-ancestor
92656238|NCT00239486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656239|NCT00239486|Protective Agents|protective agents|mesh-ancestor
92656240|NCT00239486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656241|NCT00239486|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92656242|NCT00239486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92656243|NCT00239486|Dopamine Agonists|dopamine agonists|mesh-ancestor
92656244|NCT00239486|Dopamine Agents|dopamine agents|mesh-ancestor
92656245|NCT00239486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656246|NCT01642966|Ticagrelor|ticagrelor|mesh-list
92381527|NCT03177798|Icatibant|icatibant|mesh-list
92656247|NCT01642966|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92656248|NCT01642966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92656249|NCT01642966|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92656250|NCT01642966|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92656251|NCT01642966|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92656252|NCT01642966|Purinergic Agents|purinergic agents|mesh-ancestor
92656253|NCT01642966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656254|NCT01642966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656255|NCT01642966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656256|NCT01643083|Rifaximin|rifaximin|mesh-list
92656257|NCT01643083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92656258|NCT01643083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656259|NCT01643083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656260|NCT01643278|Ipilimumab|ipilimumab|mesh-list
92656261|NCT01643278|Dasatinib|dasatinib|mesh-list
92656262|NCT01643278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92656263|NCT01643278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656264|NCT01643278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92656265|NCT01643278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656266|NCT01643278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92656267|NCT01643278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656268|NCT01643629|Minoxidil|minoxidil|mesh-list
92656269|NCT01643629|Finasteride|finasteride|mesh-list
92656270|NCT01643629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656271|NCT01643629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92656272|NCT01643629|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92656273|NCT01643629|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92656274|NCT01643629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656275|NCT01643629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656278|NCT01643629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656279|NCT01643629|Urological Agents|urological agents|mesh-ancestor
92656281|NCT01644253|Obinutuzumab|obinutuzumab|mesh-list
92656282|NCT01644253|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92656283|NCT01644253|Idelalisib|idelalisib|mesh-list
92656284|NCT01644253|Immunoglobulin G|immunoglobulin g|mesh-list
92656285|NCT01644253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92656286|NCT01644253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656287|NCT01644253|Immunologic Factors|immunologic factors|mesh-ancestor
92656288|NCT01644253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656289|NCT01644253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656290|NCT01644253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92656291|NCT01644253|Alkylating Agents|alkylating agents|mesh-ancestor
92656292|NCT01644253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656293|NCT01644253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656294|NCT01644799|Lenalidomide|lenalidomide|mesh-list
92656295|NCT01644799|Idelalisib|idelalisib|mesh-list
92656296|NCT01644799|Immunologic Factors|immunologic factors|mesh-ancestor
92656297|NCT01644799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656298|NCT01644799|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92656299|NCT01644799|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92656300|NCT01644799|Growth Substances|growth substances|mesh-ancestor
92656301|NCT01644799|Growth Inhibitors|growth inhibitors|mesh-ancestor
92656302|NCT01644799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656303|NCT01644799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656304|NCT01644799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656305|NCT01644838|Promethazine|promethazine|mesh-list
92656306|NCT01644838|Diphenhydramine|diphenhydramine|mesh-list
92656307|NCT01644838|Scopolamine|scopolamine|mesh-list
92656308|NCT01644838|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577083|NCT00102141|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92577084|NCT00102141|Estradiol|estradiol|mesh-list
92577085|NCT00102141|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92577086|NCT00102141|Estrogens|estrogens|mesh-ancestor
92577087|NCT00102141|Hormones|hormones|mesh-ancestor
92577088|NCT00102141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577089|NCT00102141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577090|NCT00102141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92301914|NCT00002525|Vitamins|vitamins|mesh-ancestor
92577091|NCT00102141|Contraceptive Agents|contraceptive agents|mesh-ancestor
92577092|NCT00102141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92656309|NCT01644838|Antiemetics|antiemetics|mesh-ancestor
92656310|NCT01644838|Autonomic Agents|autonomic agents|mesh-ancestor
92656311|NCT01644838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656312|NCT01644838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656313|NCT01644838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656314|NCT01644838|Mydriatics|mydriatics|mesh-ancestor
92656315|NCT01644838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92656316|NCT01644838|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656317|NCT01644838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656318|NCT01644838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656319|NCT01644838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92656320|NCT01644838|Antipruritics|antipruritics|mesh-ancestor
92381606|NCT04589364|Botulinum Toxins|botulinum toxins|mesh-list
92656321|NCT01644838|Dermatologic Agents|dermatologic agents|mesh-ancestor
92656322|NCT01644838|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92656323|NCT01644838|Histamine Antagonists|histamine antagonists|mesh-ancestor
92656325|NCT01644838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92656326|NCT01644838|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92656327|NCT01644838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92656328|NCT01644838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656329|NCT01644838|Anesthetics, Local|anesthetics, local|mesh-ancestor
92656330|NCT01644838|Anesthetics|anesthetics|mesh-ancestor
92656331|NCT01644838|Sensory System Agents|sensory system agents|mesh-ancestor
92656332|NCT01644955|Carboplatin|carboplatin|mesh-list
92656333|NCT01644955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656334|NCT01644994|Cisplatin|cisplatin|mesh-list
92656335|NCT01644994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656336|NCT04528888|Methylprednisolone|methylprednisolone|mesh-list
92656337|NCT04528888|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92656338|NCT04528888|Heparin|heparin|mesh-list
92656339|NCT04528888|Enoxaparin|enoxaparin|mesh-list
92656340|NCT04528888|Calcium heparin|calcium heparin|mesh-list
92656341|NCT04528888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656342|NCT04528888|Antiemetics|antiemetics|mesh-ancestor
92656343|NCT04528888|Autonomic Agents|autonomic agents|mesh-ancestor
92656344|NCT04528888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656345|NCT04528888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656346|NCT04528888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656347|NCT04528888|Glucocorticoids|glucocorticoids|mesh-ancestor
92656348|NCT04528888|Hormones|hormones|mesh-ancestor
92656349|NCT04528888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656352|NCT04528888|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656353|NCT04528888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656355|NCT04528888|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92656356|NCT04528888|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92656357|NCT04528888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656358|NCT01645384|Atorvastatin|atorvastatin|mesh-list
92656359|NCT01645384|Calcium|calcium|mesh-list
92656360|NCT01645384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656361|NCT01645384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656362|NCT01645384|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92656363|NCT01645384|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92656364|NCT01645384|Antimetabolites|antimetabolites|mesh-ancestor
92656365|NCT01645384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577093|NCT00102141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92577094|NCT00102141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92577095|NCT00102141|Hormone Antagonists|hormone antagonists|mesh-ancestor
92656366|NCT01645384|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92656367|NCT01645384|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92656368|NCT01645384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656369|NCT00239798|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92656370|NCT00239798|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92656371|NCT00239798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656372|NCT00239798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92656373|NCT00239798|Immunologic Factors|immunologic factors|mesh-ancestor
92656374|NCT00239798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656375|NCT01645423|Atorvastatin|atorvastatin|mesh-list
92656376|NCT01645423|Calcium|calcium|mesh-list
92656377|NCT01645423|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656378|NCT01645423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656379|NCT01645423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92656380|NCT01645423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92656381|NCT01645423|Antimetabolites|antimetabolites|mesh-ancestor
92656382|NCT01645423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656383|NCT01645423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92656384|NCT01645423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92656385|NCT01645423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656386|NCT01645774|Oxymetazoline|oxymetazoline|mesh-list
92656387|NCT01645774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92656388|NCT01645774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92656389|NCT01645774|Adrenergic Agents|adrenergic agents|mesh-ancestor
92656390|NCT01645774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656391|NCT01645774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656392|NCT01645774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656393|NCT01645774|Sympathomimetics|sympathomimetics|mesh-ancestor
92656394|NCT01645774|Autonomic Agents|autonomic agents|mesh-ancestor
92656395|NCT01645774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656397|NCT01645774|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92656398|NCT01645774|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656399|NCT00239876|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92656400|NCT00239876|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92656401|NCT00239876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656402|NCT00239876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92656403|NCT00239876|Immunologic Factors|immunologic factors|mesh-ancestor
92656404|NCT00239876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656405|NCT02961075|Anesthetics|anesthetics|mesh-list
92656406|NCT02961075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656407|NCT02961075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656408|NCT01646281|Flecainide|flecainide|mesh-list
92656409|NCT01646281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92656410|NCT01646281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92656411|NCT01646281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92656412|NCT01646281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656413|NCT01646281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656414|NCT01646554|Oxaliplatin|oxaliplatin|mesh-list
92656415|NCT01646554|Aflibercept|aflibercept|mesh-list
92656416|NCT01646554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656417|NCT01646554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92656418|NCT01646554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92656419|NCT01646554|Growth Substances|growth substances|mesh-ancestor
92656431|NCT01646788|Paclitaxel|paclitaxel|mesh-list
92656432|NCT01646788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92656433|NCT01646788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656434|NCT01646788|Tubulin Modulators|tubulin modulators|mesh-ancestor
92656435|NCT01646788|Antimitotic Agents|antimitotic agents|mesh-ancestor
92656436|NCT01646788|Mitosis Modulators|mitosis modulators|mesh-ancestor
92656437|NCT01646788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656438|NCT01647256|Nikkomycin|nikkomycin|mesh-list
92656439|NCT01647256|Antifungal Agents|antifungal agents|mesh-ancestor
92656440|NCT01647256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656441|NCT01647256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656442|NCT01647256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577096|NCT00102141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92577097|NCT00102141|Diuretics|diuretics|mesh-ancestor
92577098|NCT00102141|Natriuretic Agents|natriuretic agents|mesh-ancestor
92577099|NCT00102141|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92577100|NCT00102141|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92656443|NCT00239954|Escitalopram|escitalopram|mesh-list
92656444|NCT00239954|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92656445|NCT00239954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92656446|NCT00239954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656447|NCT00239954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656448|NCT00239954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656449|NCT00239954|Serotonin Agents|serotonin agents|mesh-ancestor
92656450|NCT00239954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656451|NCT04528927|Azithromycin|azithromycin|mesh-list
92656452|NCT04528927|Doxycycline|doxycycline|mesh-list
92656453|NCT04528927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92656454|NCT04528927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656455|NCT04528927|Antimalarials|antimalarials|mesh-ancestor
92656456|NCT04528927|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92656457|NCT04528927|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92656458|NCT04720287|Bupivacaine|bupivacaine|mesh-list
92656459|NCT04720287|Neostigmine|neostigmine|mesh-list
92656460|NCT04720287|Anesthetics, Local|anesthetics, local|mesh-ancestor
92656461|NCT04720287|Anesthetics|anesthetics|mesh-ancestor
92656462|NCT04720287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656463|NCT04720287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656464|NCT04720287|Sensory System Agents|sensory system agents|mesh-ancestor
92656465|NCT04720287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656466|NCT04720287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92656467|NCT04720287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656468|NCT04720287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656469|NCT04720287|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656470|NCT04720287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656471|NCT04720287|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92656472|NCT04720287|Autonomic Agents|autonomic agents|mesh-ancestor
92656473|NCT00239993|Glatiramer Acetate|glatiramer acetate|mesh-list
92656474|NCT00239993|(T,G)-A-L|(t,g)-a-l|mesh-list
92656475|NCT00239993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92656476|NCT00239993|Immunologic Factors|immunologic factors|mesh-ancestor
92656477|NCT00239993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656478|NCT00239993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92656479|NCT00239993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656480|NCT00264108|Epoetin Alfa|epoetin alfa|mesh-list
92656481|NCT00264108|Darbepoetin alfa|darbepoetin alfa|mesh-list
92656482|NCT00264108|Hematinics|hematinics|mesh-ancestor
92656483|NCT01647412|Curcumin|curcumin|mesh-list
92656484|NCT01647412|Hormones|hormones|mesh-list
92656486|NCT01647412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656487|NCT01647412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92656488|NCT01647412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656490|NCT01647412|Sensory System Agents|sensory system agents|mesh-ancestor
92656491|NCT01647412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656492|NCT01647412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656493|NCT01647412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656494|NCT01647412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656495|NCT01647412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656496|NCT01647412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656497|NCT01647529|Ganciclovir|ganciclovir|mesh-list
92656498|NCT01647529|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92656499|NCT01647529|Antiviral Agents|antiviral agents|mesh-ancestor
92656500|NCT01647529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656501|NCT01647529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92656502|NCT01647529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656503|NCT01647529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656504|NCT00240032|Cetirizine|cetirizine|mesh-list
92656505|NCT00240032|Glatiramer Acetate|glatiramer acetate|mesh-list
92656506|NCT00240032|(T,G)-A-L|(t,g)-a-l|mesh-list
92656507|NCT00240032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92656508|NCT00240032|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92656509|NCT00240032|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92656510|NCT00240032|Histamine Antagonists|histamine antagonists|mesh-ancestor
92577102|NCT00266344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577103|NCT00266344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984495|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656511|NCT00240032|Histamine Agents|histamine agents|mesh-ancestor
92656512|NCT00240032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656513|NCT00240032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656514|NCT00240032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656515|NCT00240032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92656516|NCT00240032|Immunologic Factors|immunologic factors|mesh-ancestor
92656517|NCT00240032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92656518|NCT00240032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656519|NCT00240149|Insulin|insulin|mesh-list
92656520|NCT00240149|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92656521|NCT00240149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92656522|NCT00240149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656523|NCT01647646|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92656524|NCT01647646|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92656525|NCT01647646|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656526|NCT01647646|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92656527|NCT01647646|Autonomic Agents|autonomic agents|mesh-ancestor
92656528|NCT01647646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656529|NCT01647646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656530|NCT01647646|Glucocorticoids|glucocorticoids|mesh-ancestor
92656531|NCT01647646|Hormones|hormones|mesh-ancestor
92656532|NCT01647646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656533|NCT01647646|Sympathomimetics|sympathomimetics|mesh-ancestor
92656534|NCT01647685|Methylprednisolone|methylprednisolone|mesh-list
92656535|NCT01647685|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92656536|NCT01647685|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92656537|NCT01647685|Prednisolone|prednisolone|mesh-list
92656538|NCT01647685|Prednisolone acetate|prednisolone acetate|mesh-list
92656539|NCT01647685|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92656540|NCT01647685|Prednisolone phosphate|prednisolone phosphate|mesh-list
92656541|NCT01647685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656542|NCT01647685|Antiemetics|antiemetics|mesh-ancestor
92656543|NCT01647685|Autonomic Agents|autonomic agents|mesh-ancestor
92656544|NCT01647685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656545|NCT01647685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656546|NCT01647685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656547|NCT01647685|Glucocorticoids|glucocorticoids|mesh-ancestor
92656548|NCT01647685|Hormones|hormones|mesh-ancestor
92656549|NCT01647685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656550|NCT01647685|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92656551|NCT01647685|Protective Agents|protective agents|mesh-ancestor
92656552|NCT01647685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656553|NCT01647685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656554|NCT00240266|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92656555|NCT00240266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92656556|NCT00240266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92656586|NCT01648231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656588|NCT01648231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92656589|NCT01648231|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656590|NCT01648231|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656591|NCT00264186|Norepinephrine|norepinephrine|mesh-list
92656592|NCT00264186|Nitroglycerin|nitroglycerin|mesh-list
92656593|NCT00264186|Acetylcholine|acetylcholine|mesh-list
92656594|NCT00264186|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92656595|NCT00264186|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92656596|NCT00264186|Adrenergic Agents|adrenergic agents|mesh-ancestor
92656597|NCT00264186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656598|NCT00264186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063847|NCT04405960|Vitamins|vitamins|mesh-ancestor
92656601|NCT00264186|Autonomic Agents|autonomic agents|mesh-ancestor
92656602|NCT00264186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656603|NCT00264186|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92656604|NCT00264186|Vasodilator Agents|vasodilator agents|mesh-ancestor
92656605|NCT00264186|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92656606|NCT00264186|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656607|NCT00240422|Telmisartan|telmisartan|mesh-list
92656608|NCT00240422|Ramipril|ramipril|mesh-list
92656609|NCT00240422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92577104|NCT00266344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656610|NCT00240422|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656611|NCT00240422|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656612|NCT00240422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656613|NCT00240422|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92656614|NCT00240422|Protease Inhibitors|protease inhibitors|mesh-ancestor
92656615|NCT00240422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656616|NCT00264225|Codeine|codeine|mesh-list
92656617|NCT00264225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92656618|NCT00264225|Narcotics|narcotics|mesh-ancestor
92656619|NCT00264225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656620|NCT00264225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656621|NCT00264225|Analgesics|analgesics|mesh-ancestor
92656622|NCT00264225|Sensory System Agents|sensory system agents|mesh-ancestor
92656623|NCT00264225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656624|NCT00264225|Antitussive Agents|antitussive agents|mesh-ancestor
92656625|NCT00264225|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656626|NCT02279563|Fluticasone|fluticasone|mesh-list
92656627|NCT02279563|Xhance|xhance|mesh-list
92656628|NCT02279563|Azelastine|azelastine|mesh-list
92656629|NCT02279563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656630|NCT02279563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92656631|NCT02279563|Autonomic Agents|autonomic agents|mesh-ancestor
92656632|NCT02279563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656633|NCT02279563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656634|NCT02279563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92656635|NCT02279563|Respiratory System Agents|respiratory system agents|mesh-ancestor
92364315|NCT04338906|Camostat|camostat|mesh-list
92656636|NCT02279563|Dermatologic Agents|dermatologic agents|mesh-ancestor
92656637|NCT02279563|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92656638|NCT02279563|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92656639|NCT02279563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656640|NCT02279563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656641|NCT02279563|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92656642|NCT02279563|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92656643|NCT02279563|Histamine Antagonists|histamine antagonists|mesh-ancestor
92656644|NCT02279563|Histamine Agents|histamine agents|mesh-ancestor
92656645|NCT02279563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656646|NCT02279758|Metformin|metformin|mesh-list
92656647|NCT02279758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92656648|NCT02279758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656649|NCT01649245|Interferons|interferons|mesh-list
92656650|NCT01649245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656651|NCT01649245|Antiviral Agents|antiviral agents|mesh-ancestor
92656652|NCT01649245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656653|NCT01649284|Afatinib|afatinib|mesh-list
92656654|NCT01649284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656655|NCT01649284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92656656|NCT01649284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656657|NCT01649284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656658|NCT00415740|Levodopa|levodopa|mesh-list
92656659|NCT00415740|Carbidopa|carbidopa|mesh-list
92656660|NCT00415740|Entacapone|entacapone|mesh-list
92656661|NCT00415740|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92656662|NCT00415740|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92656663|NCT00415740|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92656664|NCT00415740|Dopamine Agents|dopamine agents|mesh-ancestor
92656665|NCT00415740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656666|NCT00415740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656667|NCT00415740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656668|NCT00415740|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92656669|NCT00415740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656670|NCT00415740|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92656671|NCT00415740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92656672|NCT00415740|Immunologic Factors|immunologic factors|mesh-ancestor
92656675|NCT01649479|Antibodies, Antiphospholipid|antibodies, antiphospholipid|mesh-list
92656676|NCT01649479|Immunologic Factors|immunologic factors|mesh-ancestor
92656677|NCT01649479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656678|NCT01649635|Ciprofloxacin|ciprofloxacin|mesh-list
92656679|NCT01649635|Prednisone|prednisone|mesh-list
92656680|NCT01649635|Lenograstim|lenograstim|mesh-list
92656681|NCT01649635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656682|NCT01649635|Glucocorticoids|glucocorticoids|mesh-ancestor
92656683|NCT01649635|Hormones|hormones|mesh-ancestor
92656684|NCT01649635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577105|NCT00266344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577106|NCT00266344|Analgesics|analgesics|mesh-ancestor
92656685|NCT01649635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656686|NCT01649635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656687|NCT01649635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656688|NCT01649635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92656689|NCT01649635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656690|NCT01649635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92656691|NCT01649635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92656692|NCT01649635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656693|NCT01649635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656694|NCT01649635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92656695|NCT01649635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92656696|NCT01649635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92656697|NCT01649635|Immunologic Factors|immunologic factors|mesh-ancestor
92656698|NCT00250536|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92656699|NCT00250536|Nandrolone|nandrolone|mesh-list
92656700|NCT00250536|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92656701|NCT00250536|Androgens|androgens|mesh-ancestor
92656702|NCT00250536|Hormones|hormones|mesh-ancestor
92656703|NCT00250536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656704|NCT00250536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656705|NCT00250536|Anabolic Agents|anabolic agents|mesh-ancestor
92656706|NCT00250536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92656707|NCT00240617|Naproxen|naproxen|mesh-list
92656708|NCT00240617|Sumatriptan|sumatriptan|mesh-list
92656709|NCT00240617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92656710|NCT00240617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656711|NCT00240617|Analgesics|analgesics|mesh-ancestor
92656712|NCT00240617|Sensory System Agents|sensory system agents|mesh-ancestor
92656713|NCT00240617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656714|NCT00240617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656715|NCT00240617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656716|NCT00240617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656717|NCT00240617|Gout Suppressants|gout suppressants|mesh-ancestor
92656718|NCT00240617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92656719|NCT00240617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656720|NCT00240617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656721|NCT00240617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92656722|NCT00240617|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92656723|NCT00240617|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92656724|NCT00240617|Serotonin Agents|serotonin agents|mesh-ancestor
92656725|NCT00240617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656726|NCT01649830|Temozolomide|temozolomide|mesh-list
92656727|NCT01649830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92656728|NCT01649830|Alkylating Agents|alkylating agents|mesh-ancestor
92656729|NCT01649830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656730|NCT01649830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656731|NCT00240656|Carvedilol|carvedilol|mesh-list
92656732|NCT00240656|Captopril|captopril|mesh-list
92656733|NCT00240656|Spironolactone|spironolactone|mesh-list
92656734|NCT00240656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92656735|NCT00240656|Hormone Antagonists|hormone antagonists|mesh-ancestor
92656736|NCT00240656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656737|NCT00240656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656738|NCT00240656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92656739|NCT00240656|Diuretics|diuretics|mesh-ancestor
92656740|NCT00240656|Natriuretic Agents|natriuretic agents|mesh-ancestor
92656741|NCT00240656|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92656742|NCT00240656|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92656743|NCT00240656|Adrenergic Agents|adrenergic agents|mesh-ancestor
92656744|NCT00240656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063975|NCT01710345|Dsuvia|dsuvia|mesh-list
92656755|NCT00240656|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92656756|NCT00240656|Protease Inhibitors|protease inhibitors|mesh-ancestor
92656757|NCT00240656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656758|NCT00250575|Clozapine|clozapine|mesh-list
92656759|NCT00250575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92656760|NCT00250575|Serotonin Agents|serotonin agents|mesh-ancestor
92656761|NCT00250575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656762|NCT00250575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577108|NCT00266344|Anticonvulsants|anticonvulsants|mesh-ancestor
92577109|NCT00266344|GABA Agonists|gaba agonists|mesh-ancestor
92577110|NCT00266344|GABA Agents|gaba agents|mesh-ancestor
92577111|NCT00266539|Fentanyl|fentanyl|mesh-list
92577112|NCT00266539|Morphine|morphine|mesh-list
92656763|NCT00250575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656764|NCT00250575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92656765|NCT00250575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92656766|NCT00250575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656767|NCT00250575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92656768|NCT00250575|GABA Antagonists|gaba antagonists|mesh-ancestor
92656769|NCT00250575|GABA Agents|gaba agents|mesh-ancestor
92656770|NCT00240695|Galantamine|galantamine|mesh-list
92656771|NCT00240695|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92656772|NCT00240695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656773|NCT00240695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656774|NCT00240695|Cholinergic Agents|cholinergic agents|mesh-ancestor
92656775|NCT00240695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656776|NCT00240695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656777|NCT00240695|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92656778|NCT00240695|Autonomic Agents|autonomic agents|mesh-ancestor
92656779|NCT00240695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656780|NCT00240695|Nootropic Agents|nootropic agents|mesh-ancestor
92656781|NCT00240734|Epoetin Alfa|epoetin alfa|mesh-list
92656782|NCT00240734|Hematinics|hematinics|mesh-ancestor
92656783|NCT04720248|Dipyrone|dipyrone|mesh-list
92656784|NCT04720248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92656785|NCT04720248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656786|NCT04720248|Analgesics|analgesics|mesh-ancestor
92656787|NCT04720248|Sensory System Agents|sensory system agents|mesh-ancestor
92656788|NCT04720248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656789|NCT04720248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656790|NCT04720248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656791|NCT04720248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656792|NCT04720248|Antipyretics|antipyretics|mesh-ancestor
92656793|NCT01646515|Udenafil|udenafil|mesh-list
92656794|NCT01646515|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92656795|NCT01646515|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92656796|NCT01646515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656797|NCT01646515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656798|NCT00240773|Acetaminophen|acetaminophen|mesh-list
92656799|NCT00240773|Naproxen|naproxen|mesh-list
92656800|NCT00240773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656801|NCT00240773|Analgesics|analgesics|mesh-ancestor
92656802|NCT00240773|Sensory System Agents|sensory system agents|mesh-ancestor
92656803|NCT00240773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656804|NCT00240773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656805|NCT00240773|Antipyretics|antipyretics|mesh-ancestor
92656806|NCT00240773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92656807|NCT00240773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656808|NCT00240773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656810|NCT00240773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92656811|NCT00240773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656812|NCT00240773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656813|NCT01688401|Melphalan|melphalan|mesh-list
92656814|NCT01688401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92656815|NCT01688401|Alkylating Agents|alkylating agents|mesh-ancestor
92656816|NCT01688401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656817|NCT01688401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656818|NCT01688401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92656819|NCT01688401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92656820|NCT01688401|Immunologic Factors|immunologic factors|mesh-ancestor
92656821|NCT01688401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656822|NCT04708821|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92656823|NCT04708821|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92656824|NCT04708821|Dexamethasone|dexamethasone|mesh-list
92656825|NCT04708821|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92656826|NCT04708821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656827|NCT04708821|Antiemetics|antiemetics|mesh-ancestor
92656828|NCT04708821|Autonomic Agents|autonomic agents|mesh-ancestor
92656829|NCT04708821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577113|NCT00266539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92577114|NCT00266539|Narcotics|narcotics|mesh-ancestor
92577115|NCT00266539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577116|NCT00266539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577117|NCT00266539|Analgesics|analgesics|mesh-ancestor
92656830|NCT04708821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656831|NCT04708821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92656832|NCT04708821|Glucocorticoids|glucocorticoids|mesh-ancestor
92656833|NCT04708821|Hormones|hormones|mesh-ancestor
92656834|NCT04708821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656835|NCT04708821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92656836|NCT04708821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656837|NCT04708821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92656838|NCT04708821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92656839|NCT04708821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92656840|NCT04708821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656841|NCT04708821|Analgesics|analgesics|mesh-ancestor
92656842|NCT04708821|Sensory System Agents|sensory system agents|mesh-ancestor
92656843|NCT04708821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656844|NCT04708821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92656845|NCT04708821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92656846|NCT04708821|Histamine Antagonists|histamine antagonists|mesh-ancestor
92656847|NCT04708821|Histamine Agents|histamine agents|mesh-ancestor
92656848|NCT04708821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656849|NCT04708821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656850|NCT00240812|Ibuprofen|ibuprofen|mesh-list
92656851|NCT00240812|Pseudoephedrine|pseudoephedrine|mesh-list
92656852|NCT00240812|Ephedrine|ephedrine|mesh-list
92656853|NCT00240812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92656854|NCT00240812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656855|NCT00240812|Analgesics|analgesics|mesh-ancestor
92656856|NCT00240812|Sensory System Agents|sensory system agents|mesh-ancestor
92656857|NCT00240812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656858|NCT00240812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656859|NCT00240812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656860|NCT00240812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92656861|NCT00240812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92656862|NCT00240812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656863|NCT00240812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656864|NCT00240812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92656865|NCT00240812|Autonomic Agents|autonomic agents|mesh-ancestor
92656866|NCT00240812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92656867|NCT00240812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92656868|NCT00240812|Nasal Decongestants|nasal decongestants|mesh-ancestor
92656869|NCT00240812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92656870|NCT00240812|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92656871|NCT00240812|Sympathomimetics|sympathomimetics|mesh-ancestor
92656872|NCT00240812|Adrenergic Agents|adrenergic agents|mesh-ancestor
92656873|NCT00240812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656874|NCT01688518|Lidocaine|lidocaine|mesh-list
92656875|NCT01688518|Tetracaine|tetracaine|mesh-list
92656876|NCT01688518|Anesthetics, Local|anesthetics, local|mesh-ancestor
92656877|NCT01688518|Anesthetics|anesthetics|mesh-ancestor
92656878|NCT01688518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656879|NCT01688518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656880|NCT01688518|Sensory System Agents|sensory system agents|mesh-ancestor
92656881|NCT01688518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656882|NCT01688518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92656885|NCT01688518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656886|NCT01688518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656888|NCT00240851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656889|NCT00240851|Analgesics|analgesics|mesh-ancestor
92656890|NCT00240851|Sensory System Agents|sensory system agents|mesh-ancestor
92656891|NCT00240851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656892|NCT00240851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656893|NCT00240851|Antipyretics|antipyretics|mesh-ancestor
92656894|NCT00240929|Palivizumab|palivizumab|mesh-list
92656895|NCT00240929|Antiviral Agents|antiviral agents|mesh-ancestor
92656896|NCT00240929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92656897|NCT00250692|Nitrous Oxide|nitrous oxide|mesh-list
92577118|NCT00266539|Sensory System Agents|sensory system agents|mesh-ancestor
92577119|NCT00266539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577120|NCT00266539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577121|NCT00266539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92656898|NCT00250692|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92656899|NCT00250692|Anesthetics, General|anesthetics, general|mesh-ancestor
92656900|NCT00250692|Anesthetics|anesthetics|mesh-ancestor
92656901|NCT00250692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656902|NCT00250692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656903|NCT00250692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92656904|NCT00250692|Analgesics|analgesics|mesh-ancestor
92656905|NCT00250692|Sensory System Agents|sensory system agents|mesh-ancestor
92656906|NCT00250692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656907|NCT01688791|Paclitaxel|paclitaxel|mesh-list
92656908|NCT01688791|Carboplatin|carboplatin|mesh-list
92656909|NCT01688791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92656910|NCT01688791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656911|NCT01688791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92656912|NCT01688791|Antimitotic Agents|antimitotic agents|mesh-ancestor
92656913|NCT01688791|Mitosis Modulators|mitosis modulators|mesh-ancestor
92656914|NCT01688791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656915|NCT01688947|Pregabalin|pregabalin|mesh-list
92656916|NCT01688947|Analgesics|analgesics|mesh-ancestor
92656917|NCT01688947|Sensory System Agents|sensory system agents|mesh-ancestor
92656918|NCT01688947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656919|NCT01688947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656920|NCT01688947|Anticonvulsants|anticonvulsants|mesh-ancestor
92656921|NCT01688947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92656922|NCT01688947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656923|NCT01688947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656924|NCT01688947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656925|NCT01688947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92656926|NCT01688947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92656927|NCT01688947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656928|NCT01688947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92656929|NCT00241007|Valsartan|valsartan|mesh-list
92656930|NCT00241007|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92656931|NCT00241007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656932|NCT00241007|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656933|NCT00241007|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656934|NCT00241007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656935|NCT00241007|Diuretics|diuretics|mesh-ancestor
92656936|NCT00241007|Natriuretic Agents|natriuretic agents|mesh-ancestor
92656937|NCT00241007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656938|NCT00241007|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92656939|NCT00241007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656940|NCT01689142|Insulin|insulin|mesh-list
92656941|NCT01689142|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92656942|NCT01689142|Insulin Glargine|insulin glargine|mesh-list
92656943|NCT01689142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92656944|NCT01689142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656945|NCT00241046|Letrozole|letrozole|mesh-list
92656946|NCT00241046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92656947|NCT00241046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92656948|NCT00241046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92656949|NCT00241046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656950|NCT00241046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656951|NCT00241046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92656952|NCT00241046|Hormone Antagonists|hormone antagonists|mesh-ancestor
92656953|NCT00241046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656956|NCT01689259|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92656957|NCT01689259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92656958|NCT01689259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92656959|NCT01689259|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92656960|NCT01689259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656961|NCT01689259|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92656962|NCT01689259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656963|NCT01689259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92656964|NCT01689259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577122|NCT00266539|Anesthetics, General|anesthetics, general|mesh-ancestor
92577123|NCT00266539|Anesthetics|anesthetics|mesh-ancestor
92577124|NCT00266578|Fluticasone|fluticasone|mesh-list
92577125|NCT00266578|Xhance|xhance|mesh-list
92577126|NCT00266578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92656965|NCT01689298|Oxytocin|oxytocin|mesh-list
92656966|NCT01689298|Carbetocin|carbetocin|mesh-list
92656967|NCT01689298|Oxytocics|oxytocics|mesh-ancestor
92656968|NCT01689298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92656969|NCT01689298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656970|NCT00241085|Valsartan|valsartan|mesh-list
92656971|NCT00241085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656972|NCT00241085|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656973|NCT00241085|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656974|NCT00241085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656975|NCT00241124|Valsartan|valsartan|mesh-list
92656976|NCT00241124|Lisinopril|lisinopril|mesh-list
92656977|NCT00241124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656978|NCT00241124|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92656979|NCT00241124|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92656980|NCT00241124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656981|NCT00241124|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92656982|NCT00241124|Protease Inhibitors|protease inhibitors|mesh-ancestor
92656983|NCT00241124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656984|NCT00241124|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92656985|NCT00241124|Protective Agents|protective agents|mesh-ancestor
92656986|NCT00241124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656987|NCT00241163|Thrombin|thrombin|mesh-list
92656988|NCT00241163|Hemostatics|hemostatics|mesh-ancestor
92656989|NCT00241163|Coagulants|coagulants|mesh-ancestor
92656990|NCT02277106|Brexanolone|brexanolone|mesh-list
92656991|NCT02277106|Neurosteroids|neurosteroids|mesh-ancestor
92656992|NCT02277106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92656993|NCT02277106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656994|NCT02277106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656995|NCT02277106|GABA Modulators|gaba modulators|mesh-ancestor
92656996|NCT02277106|GABA Agents|gaba agents|mesh-ancestor
92656997|NCT00241241|Interferons|interferons|mesh-list
92656998|NCT00241241|Interferon-alpha|interferon-alpha|mesh-list
92656999|NCT00241241|Interferon alpha-2|interferon alpha-2|mesh-list
92657000|NCT00241241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92657001|NCT00241241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657002|NCT00241241|Antiviral Agents|antiviral agents|mesh-ancestor
92657003|NCT00241241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657004|NCT00241241|Immunologic Factors|immunologic factors|mesh-ancestor
92657005|NCT00241241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657006|NCT02279602|Fosbretabulin|fosbretabulin|mesh-list
92657007|NCT02279602|Combretastatin|combretastatin|mesh-list
92657008|NCT02279602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657009|NCT02279602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657010|NCT02279602|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657011|NCT02279602|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657012|NCT02279602|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657013|NCT02279602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657014|NCT00241436|Anastrozole|anastrozole|mesh-list
92657015|NCT00241436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657016|NCT00241436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657017|NCT00241436|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92657018|NCT00241436|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92657019|NCT00241436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657020|NCT00241436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657021|NCT00241436|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92657022|NCT00241436|Hormone Antagonists|hormone antagonists|mesh-ancestor
92657023|NCT00241436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657024|NCT00241436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657025|NCT00264420|Zoledronic Acid|zoledronic acid|mesh-list
92657026|NCT00264420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92657030|NCT00241475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657031|NCT00241475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657032|NCT00241475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657033|NCT01685359|Epoetin Alfa|epoetin alfa|mesh-list
92657034|NCT01685359|Hematinics|hematinics|mesh-ancestor
92577127|NCT00266578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92577128|NCT00266578|Autonomic Agents|autonomic agents|mesh-ancestor
92577129|NCT00266578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577130|NCT00266578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657035|NCT02278978|Nintedanib|nintedanib|mesh-list
92657036|NCT02278978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657037|NCT02278978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657038|NCT02278978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657039|NCT02278978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657040|NCT02218762|Fluticasone|fluticasone|mesh-list
92657041|NCT02218762|Xhance|xhance|mesh-list
92657042|NCT02218762|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92657043|NCT02218762|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92657044|NCT02218762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657045|NCT02218762|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657046|NCT02218762|Autonomic Agents|autonomic agents|mesh-ancestor
92657047|NCT02218762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657048|NCT02218762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657049|NCT02218762|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657050|NCT02218762|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657051|NCT02218762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657052|NCT02218762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92657053|NCT02218762|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92657054|NCT02218762|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92657055|NCT02218762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92657056|NCT02218762|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657057|NCT02218762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657058|NCT02218762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657059|NCT02218762|Glucocorticoids|glucocorticoids|mesh-ancestor
92657060|NCT02218762|Hormones|hormones|mesh-ancestor
92657061|NCT02218762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657062|NCT02218762|Sympathomimetics|sympathomimetics|mesh-ancestor
92657063|NCT00264459|Immunomodulating Agents|immunomodulating agents|mesh-list
92657064|NCT00264459|Immunologic Factors|immunologic factors|mesh-list
92657065|NCT00264459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657066|NCT00241514|Esomeprazole|esomeprazole|mesh-list
92382354|NCT03856164|Hemostatics|hemostatics|mesh-ancestor
92657067|NCT00241514|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92657068|NCT00241514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657069|NCT00241514|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92657070|NCT00241514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657071|NCT00241514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657072|NCT02218879|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92657073|NCT02218879|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657074|NCT02218879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92657075|NCT02218879|Immunologic Factors|immunologic factors|mesh-ancestor
92657076|NCT02218879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657077|NCT00241553|Esomeprazole|esomeprazole|mesh-list
92657078|NCT00241553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92657079|NCT00241553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657080|NCT00241553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92657081|NCT00241553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657082|NCT00241553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657083|NCT02219152|Tranexamic Acid|tranexamic acid|mesh-list
92657084|NCT02219152|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92657085|NCT02219152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92657086|NCT02219152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657087|NCT02219152|Hemostatics|hemostatics|mesh-ancestor
92657088|NCT02219152|Coagulants|coagulants|mesh-ancestor
92657089|NCT00264615|Lamotrigine|lamotrigine|mesh-list
92657090|NCT00264615|Anticonvulsants|anticonvulsants|mesh-ancestor
92657091|NCT00264615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92657092|NCT00264615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657093|NCT00264615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657094|NCT00264615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92657095|NCT00264615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657096|NCT00264615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92657097|NCT00264615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92657108|NCT02219191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92657110|NCT02219191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92577131|NCT00266578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92577132|NCT00266578|Respiratory System Agents|respiratory system agents|mesh-ancestor
92577133|NCT00266578|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657111|NCT04529512|Dexamethasone|dexamethasone|mesh-list
92657112|NCT04529512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657113|NCT04529512|Antiemetics|antiemetics|mesh-ancestor
92657114|NCT04529512|Autonomic Agents|autonomic agents|mesh-ancestor
92657115|NCT04529512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657116|NCT04529512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657117|NCT04529512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657118|NCT04529512|Glucocorticoids|glucocorticoids|mesh-ancestor
92657119|NCT04529512|Hormones|hormones|mesh-ancestor
92657120|NCT04529512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657121|NCT04529512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657122|NCT04529512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657123|NCT04720131|Capecitabine|capecitabine|mesh-list
92657124|NCT04720131|Apatinib|apatinib|mesh-list
92657125|NCT04720131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92657126|NCT04720131|Antimetabolites|antimetabolites|mesh-ancestor
92657127|NCT04720131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657128|NCT04720131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657129|NCT04720131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657130|NCT04720131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657131|NCT00241670|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92657132|NCT00241670|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92657133|NCT00241670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657134|NCT02219737|Rituximab|rituximab|mesh-list
92657135|NCT02219737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92657136|NCT02219737|Carboplatin|carboplatin|mesh-list
92657137|NCT02219737|Etoposide|etoposide|mesh-list
92657138|NCT02219737|Etoposide phosphate|etoposide phosphate|mesh-list
92657139|NCT02219737|Ifosfamide|ifosfamide|mesh-list
92657140|NCT02219737|Isophosphamide mustard|isophosphamide mustard|mesh-list
92657141|NCT02219737|Podophyllotoxin|podophyllotoxin|mesh-list
92657142|NCT02219737|Antibodies|antibodies|mesh-list
92657143|NCT02219737|Immunoglobulins|immunoglobulins|mesh-list
92657144|NCT02219737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92657145|NCT02219737|Immunologic Factors|immunologic factors|mesh-ancestor
92657146|NCT02219737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657147|NCT02219737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657148|NCT02219737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657149|NCT02219737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657150|NCT02219737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92657151|NCT02219737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92657152|NCT02219737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657153|NCT02219737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657154|NCT02219737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92657155|NCT02219737|Alkylating Agents|alkylating agents|mesh-ancestor
92657156|NCT02219737|Keratolytic Agents|keratolytic agents|mesh-ancestor
92657157|NCT02219737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657158|NCT02219737|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657159|NCT02219737|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657160|NCT02219737|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657161|NCT02219893|Immunotoxins|immunotoxins|mesh-list
92657162|NCT02219893|MOC31PE immunotoxin|moc31pe immunotoxin|mesh-list
92657163|NCT02219893|Immunoconjugates|immunoconjugates|mesh-ancestor
92657166|NCT02218606|Prednisone|prednisone|mesh-list
92657167|NCT02218606|Abiraterone Acetate|abiraterone acetate|mesh-list
92657168|NCT02218606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657169|NCT02218606|Glucocorticoids|glucocorticoids|mesh-ancestor
92657170|NCT02218606|Hormones|hormones|mesh-ancestor
92657171|NCT02218606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657172|NCT02218606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657173|NCT02218606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657174|NCT02218606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657175|NCT02218606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92657176|NCT02218606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657177|NCT02218606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657178|NCT02218606|Hormone Antagonists|hormone antagonists|mesh-ancestor
92657179|NCT02218606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92657180|NCT02212951|Insulin Lispro|insulin lispro|mesh-list
92657181|NCT02212951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92657182|NCT02212951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657183|NCT02210806|Albuterol|albuterol|mesh-list
92577135|NCT00266617|Epoetin Alfa|epoetin alfa|mesh-list
92577136|NCT00266617|Hematinics|hematinics|mesh-ancestor
92577137|NCT00102219|Doxorubicin|doxorubicin|mesh-list
92577138|NCT00102219|Pemetrexed|pemetrexed|mesh-list
92364377|NCT04335786|Valsartan|valsartan|mesh-list
92657184|NCT02210806|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657185|NCT02210806|Autonomic Agents|autonomic agents|mesh-ancestor
92657186|NCT02210806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657187|NCT02210806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657188|NCT02210806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657189|NCT02210806|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657190|NCT02210806|Tocolytic Agents|tocolytic agents|mesh-ancestor
92657191|NCT02210806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92657192|NCT02210806|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92657193|NCT02210806|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92657194|NCT02210806|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92657195|NCT02210806|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657196|NCT02210806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657197|NCT02210806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657198|NCT00264654|Paroxetine|paroxetine|mesh-list
92657199|NCT00264654|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92657200|NCT00264654|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92657201|NCT00264654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657202|NCT00264654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657203|NCT00264654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657204|NCT00264654|Serotonin Agents|serotonin agents|mesh-ancestor
92657205|NCT00264654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657206|NCT00264654|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92657207|NCT00264654|Antidepressive Agents|antidepressive agents|mesh-ancestor
92657208|NCT00264654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657209|NCT00264654|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92657210|NCT00264654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92657211|NCT00264654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657212|NCT02219659|Fentanyl|fentanyl|mesh-list
92657213|NCT02219659|Midazolam|midazolam|mesh-list
92657214|NCT02219659|Propofol|propofol|mesh-list
92657215|NCT02219659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92657216|NCT02219659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657217|NCT02219659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657218|NCT02219659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92657219|NCT02219659|Anesthetics, General|anesthetics, general|mesh-ancestor
92657220|NCT02219659|Anesthetics|anesthetics|mesh-ancestor
92657221|NCT02219659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92657222|NCT02219659|Narcotics|narcotics|mesh-ancestor
92657223|NCT02219659|Analgesics|analgesics|mesh-ancestor
92657224|NCT02219659|Sensory System Agents|sensory system agents|mesh-ancestor
92657225|NCT02219659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657226|NCT02219659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92657227|NCT02219659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92657228|NCT02219659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92657229|NCT02219659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657230|NCT02219659|GABA Modulators|gaba modulators|mesh-ancestor
92657231|NCT02219659|GABA Agents|gaba agents|mesh-ancestor
92657232|NCT02219659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657233|NCT02219659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657234|NCT00241982|Prednisolone|prednisolone|mesh-list
92657235|NCT00241982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657238|NCT00241982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657239|NCT00241982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657240|NCT00241982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657241|NCT00241982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657242|NCT02212015|Paclitaxel|paclitaxel|mesh-list
92657243|NCT02212015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657244|NCT02212015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657245|NCT02212015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657246|NCT02212015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657247|NCT02212015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657248|NCT02212015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657249|NCT04720859|Canagliflozin|canagliflozin|mesh-list
92657250|NCT04720859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92577139|NCT00102219|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92577140|NCT00102219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577141|NCT00102219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577142|NCT00102219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92657251|NCT04720859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657252|NCT04720859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406463|NCT01438866|Cariostatic Agents|cariostatic agents|mesh-ancestor
92657253|NCT04720859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657254|NCT02961842|Ephedrine|ephedrine|mesh-list
92657255|NCT02961842|Fentanyl|fentanyl|mesh-list
92657256|NCT02961842|Bupivacaine|bupivacaine|mesh-list
92657257|NCT02961842|Anesthetics, Local|anesthetics, local|mesh-ancestor
92657258|NCT02961842|Anesthetics|anesthetics|mesh-ancestor
92657259|NCT02961842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657260|NCT02961842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657261|NCT02961842|Sensory System Agents|sensory system agents|mesh-ancestor
92657262|NCT02961842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657263|NCT02961842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92657264|NCT02961842|Narcotics|narcotics|mesh-ancestor
92657265|NCT02961842|Analgesics|analgesics|mesh-ancestor
92657266|NCT02961842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92657267|NCT02961842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92657268|NCT02961842|Anesthetics, General|anesthetics, general|mesh-ancestor
92657269|NCT02961842|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92657270|NCT02961842|Sympathomimetics|sympathomimetics|mesh-ancestor
92657271|NCT02961842|Autonomic Agents|autonomic agents|mesh-ancestor
92657272|NCT02961842|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92657273|NCT02961842|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657274|NCT02961842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657275|NCT02961842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657276|NCT00272805|Carvedilol|carvedilol|mesh-list
92657277|NCT00272805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92657278|NCT00272805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92657279|NCT00272805|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657280|NCT00272805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657281|NCT00272805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657282|NCT00272805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657283|NCT00272805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92657284|NCT00272805|Antioxidants|antioxidants|mesh-ancestor
92657285|NCT00272805|Protective Agents|protective agents|mesh-ancestor
92657286|NCT00272805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92657287|NCT00272805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657288|NCT00272805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92657289|NCT00272805|Vasodilator Agents|vasodilator agents|mesh-ancestor
92657290|NCT00272805|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92657291|NCT00272805|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92657292|NCT00242177|Pioglitazone|pioglitazone|mesh-list
92657293|NCT00242177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92657294|NCT00242177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657295|NCT00264927|Satavaptan|satavaptan|mesh-list
92657296|NCT00264927|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92657297|NCT00264927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657298|NCT00264927|Natriuretic Agents|natriuretic agents|mesh-ancestor
92657299|NCT00264927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657300|NCT00242372|Insulin|insulin|mesh-list
92657301|NCT00242372|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92657302|NCT00242372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657303|NCT00265005|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92657304|NCT00265005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92657305|NCT00265005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92657306|NCT00265005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657307|NCT00242411|Budesonide|budesonide|mesh-list
92657312|NCT00242411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657313|NCT00242411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657314|NCT00242411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657315|NCT00242411|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657317|NCT00242411|Hormones|hormones|mesh-ancestor
92657318|NCT00242411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657319|NCT00242411|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92577143|NCT00102219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577144|NCT00102219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577145|NCT00102219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92657320|NCT00242411|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92657321|NCT00242411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92657322|NCT00242411|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657323|NCT00242411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657324|NCT00242411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657325|NCT02962037|Melatonin|melatonin|mesh-list
92657326|NCT02962037|Antioxidants|antioxidants|mesh-ancestor
92657327|NCT02962037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657328|NCT02962037|Protective Agents|protective agents|mesh-ancestor
92657329|NCT02962037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657330|NCT02962037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657331|NCT00282399|Decitabine|decitabine|mesh-list
92657332|NCT00282399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92657333|NCT00282399|Antimetabolites|antimetabolites|mesh-ancestor
92657334|NCT00282399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657335|NCT00282399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657336|NCT00282399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657337|NCT00242450|Metoclopramide|metoclopramide|mesh-list
92657338|NCT00242450|Antiemetics|antiemetics|mesh-ancestor
92657339|NCT00242450|Autonomic Agents|autonomic agents|mesh-ancestor
92657340|NCT00242450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657341|NCT00242450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657342|NCT00242450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657343|NCT00242450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92657344|NCT00242450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92657345|NCT00242450|Dopamine Agents|dopamine agents|mesh-ancestor
92657346|NCT00242450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657347|NCT00242450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657348|NCT00273039|Paroxetine|paroxetine|mesh-list
92657349|NCT00273039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92657350|NCT00273039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92657351|NCT00273039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657352|NCT00273039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657353|NCT00273039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657354|NCT00273039|Serotonin Agents|serotonin agents|mesh-ancestor
92657355|NCT00273039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657356|NCT00273039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92657357|NCT00273039|Antidepressive Agents|antidepressive agents|mesh-ancestor
92657358|NCT00273039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657359|NCT00273039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92657360|NCT00273039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92657361|NCT00273039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657362|NCT00242528|Zoledronic Acid|zoledronic acid|mesh-list
92657363|NCT00242528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92657364|NCT00242528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657365|NCT00242606|Lamotrigine|lamotrigine|mesh-list
92657366|NCT00242606|Levetiracetam|levetiracetam|mesh-list
92657367|NCT00242606|Anticonvulsants|anticonvulsants|mesh-ancestor
92657368|NCT00242606|Nootropic Agents|nootropic agents|mesh-ancestor
92657369|NCT00242606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92657370|NCT00242606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657371|NCT00242606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657372|NCT00242606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92657373|NCT00242606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657374|NCT00242606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92657375|NCT00242606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92657376|NCT00242606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657378|NCT00242606|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92657379|NCT00242762|Docetaxel|docetaxel|mesh-list
92657380|NCT00242762|Gefitinib|gefitinib|mesh-list
92657381|NCT00242762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657382|NCT00242762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657383|NCT00242762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657384|NCT00242762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657385|NCT00242762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657386|NCT00242762|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92577146|NCT00102219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577147|NCT01349569|Lenalidomide|lenalidomide|mesh-list
92657387|NCT00242762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657388|NCT00242801|Gefitinib|gefitinib|mesh-list
92657389|NCT00242801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657390|NCT00242801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657391|NCT00242801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657392|NCT00242801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657393|NCT00242879|Ritonavir|ritonavir|mesh-list
92657394|NCT00242879|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92657395|NCT00242879|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92657396|NCT00242879|Protease Inhibitors|protease inhibitors|mesh-ancestor
92657397|NCT00242879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657398|NCT00242879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657399|NCT00242879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92657400|NCT00242879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92657401|NCT00242879|Antiviral Agents|antiviral agents|mesh-ancestor
92657402|NCT00242879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657403|NCT00242879|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92657404|NCT00242879|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92657405|NCT00282594|Insulin|insulin|mesh-list
92657406|NCT00282594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92657407|NCT00282594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657408|NCT00242918|Docetaxel|docetaxel|mesh-list
92657409|NCT00242918|Gefitinib|gefitinib|mesh-list
92657410|NCT00242918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657411|NCT00242918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657412|NCT00242918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657413|NCT00242918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657414|NCT00242918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657415|NCT00242918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657416|NCT00242918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657417|NCT00273312|Epothilone B|epothilone b|mesh-list
92657418|NCT00273312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657419|NCT00273312|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657420|NCT00273312|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657421|NCT00273312|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657422|NCT00273312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657423|NCT00242996|Cyclophosphamide|cyclophosphamide|mesh-list
92657424|NCT00242996|Carmustine|carmustine|mesh-list
92657425|NCT00242996|Rituximab|rituximab|mesh-list
92657426|NCT00242996|Etoposide|etoposide|mesh-list
92657427|NCT00242996|Sargramostim|sargramostim|mesh-list
92657428|NCT00242996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92657429|NCT00242996|Immunologic Factors|immunologic factors|mesh-ancestor
92657430|NCT00242996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657431|NCT00242996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657432|NCT00242996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92657433|NCT00242996|Alkylating Agents|alkylating agents|mesh-ancestor
92657434|NCT00242996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657435|NCT00242996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657436|NCT00242996|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92657437|NCT00242996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92657438|NCT00242996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92382726|NCT01602198|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657439|NCT00242996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92657440|NCT00242996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92657441|NCT00242996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657442|NCT00273390|Infliximab|infliximab|mesh-list
92657443|NCT00273390|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92657444|NCT00273390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657445|NCT00273390|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657446|NCT00273390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657447|NCT00273390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657448|NCT00243035|Bortezomib|bortezomib|mesh-list
92657449|NCT00243035|Tipifarnib|tipifarnib|mesh-list
92657450|NCT00243035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657452|NCT00243113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657453|NCT00243113|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657454|NCT00243113|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657455|NCT00243113|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657456|NCT00243113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657458|NCT00273429|Dorzolamide|dorzolamide|mesh-list
92657459|NCT00273429|Latanoprost|latanoprost|mesh-list
92657460|NCT00273429|Maleic acid|maleic acid|mesh-list
92577148|NCT01349569|Vaccines|vaccines|mesh-list
92577149|NCT01349569|Immunologic Factors|immunologic factors|mesh-ancestor
92577150|NCT01349569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577151|NCT01349569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92577152|NCT01349569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92007326|NCT03656627|Nivolumab|nivolumab|mesh-list
92657461|NCT00273429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657462|NCT00273429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965176|NCT04511195|Diclofenac|diclofenac|mesh-list
92657463|NCT00273429|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92657464|NCT00273429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92657465|NCT00273429|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657466|NCT00273429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657467|NCT00273429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657468|NCT00273429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92657469|NCT00273429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92657470|NCT00273429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92657471|NCT00273429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92657472|NCT00273429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92657473|NCT00273468|Granisetron|granisetron|mesh-list
92657474|NCT00273468|Antiemetics|antiemetics|mesh-ancestor
92657475|NCT00273468|Autonomic Agents|autonomic agents|mesh-ancestor
92657476|NCT00273468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657477|NCT00273468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657478|NCT00273468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657479|NCT00273468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92657480|NCT00273468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92657481|NCT00273468|Serotonin Agents|serotonin agents|mesh-ancestor
92657482|NCT00273468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657483|NCT00273468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657484|NCT00243464|Betamethasone|betamethasone|mesh-list
92657485|NCT00243464|Betamethasone Valerate|betamethasone valerate|mesh-list
92657486|NCT00243464|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92657487|NCT00243464|Betamethasone benzoate|betamethasone benzoate|mesh-list
92657488|NCT00243464|Calcipotriene|calcipotriene|mesh-list
92657489|NCT00243464|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92657490|NCT00243464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657491|NCT00243464|Glucocorticoids|glucocorticoids|mesh-ancestor
92657492|NCT00243464|Hormones|hormones|mesh-ancestor
92657493|NCT00243464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657494|NCT00243464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657495|NCT00243464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657496|NCT00243464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657497|NCT00243464|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657498|NCT00273507|Paclitaxel|paclitaxel|mesh-list
92657499|NCT00273507|Carboplatin|carboplatin|mesh-list
92657500|NCT00273507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657501|NCT00273507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657502|NCT00273507|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657503|NCT00273507|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657504|NCT00273507|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657505|NCT00273507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657506|NCT00282945|Metformin|metformin|mesh-list
92657507|NCT00282945|Rosiglitazone|rosiglitazone|mesh-list
92657508|NCT00282945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92657509|NCT00282945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657510|NCT00273546|Docetaxel|docetaxel|mesh-list
92657511|NCT00273546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657512|NCT00273546|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657513|NCT00273546|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657514|NCT00273546|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657515|NCT00273546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657516|NCT00283101|Dacetuzumab|dacetuzumab|mesh-list
92657517|NCT00283101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92657518|NCT00283101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657519|NCT00243737|Artesunate|artesunate|mesh-list
92657520|NCT00243737|Mefloquine|mefloquine|mesh-list
92657521|NCT00243737|Antimalarials|antimalarials|mesh-ancestor
92657522|NCT00243737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92657523|NCT00243737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92657524|NCT00243737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657525|NCT00243737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577153|NCT01349569|Growth Substances|growth substances|mesh-ancestor
92577154|NCT01349569|Growth Inhibitors|growth inhibitors|mesh-ancestor
92577155|NCT01349569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577156|NCT00267163|Donepezil|donepezil|mesh-list
92657526|NCT00243737|Antiviral Agents|antiviral agents|mesh-ancestor
92657531|NCT00273702|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92657532|NCT00273702|Antiviral Agents|antiviral agents|mesh-ancestor
92657533|NCT00273702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657534|NCT00273702|Expectorants|expectorants|mesh-ancestor
92657535|NCT00273702|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657536|NCT00273702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92657537|NCT00273702|Antioxidants|antioxidants|mesh-ancestor
92657538|NCT00273702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657539|NCT00273702|Protective Agents|protective agents|mesh-ancestor
92657540|NCT00273702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657541|NCT00273702|Antidotes|antidotes|mesh-ancestor
92657542|NCT00243815|Ibuprofen|ibuprofen|mesh-list
92657543|NCT00243815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92657544|NCT00243815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92657545|NCT00243815|Analgesics|analgesics|mesh-ancestor
92657546|NCT00243815|Sensory System Agents|sensory system agents|mesh-ancestor
92657547|NCT00243815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657548|NCT00243815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657549|NCT00243815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657550|NCT00243815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657551|NCT00243815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92657552|NCT00243815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657553|NCT00243815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657554|NCT00283179|Risperidone|risperidone|mesh-list
92657555|NCT00283179|Aripiprazole|aripiprazole|mesh-list
92657556|NCT00283179|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92657557|NCT00283179|Serotonin Agents|serotonin agents|mesh-ancestor
92657558|NCT00283179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657559|NCT00283179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657560|NCT00283179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657561|NCT00283179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92657562|NCT00283179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92657563|NCT00283179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657564|NCT00283179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657565|NCT00283179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92657566|NCT00283179|Dopamine Agents|dopamine agents|mesh-ancestor
92657567|NCT00283179|Antidepressive Agents|antidepressive agents|mesh-ancestor
92657568|NCT00283179|Dopamine Agonists|dopamine agonists|mesh-ancestor
92657569|NCT00283179|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92657570|NCT00283179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92657571|NCT00283179|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92657572|NCT00283179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92657573|NCT00243854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92657574|NCT00243854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657575|NCT00243854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657576|NCT00243854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657577|NCT00243854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657578|NCT00273741|Methylphenidate|methylphenidate|mesh-list
92657579|NCT00273741|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92657580|NCT00273741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657581|NCT00273741|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92657582|NCT00273741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92657583|NCT00273741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657584|NCT00273741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657585|NCT00273741|Dopamine Agents|dopamine agents|mesh-ancestor
92657586|NCT00273741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657587|NCT02279134|Paclitaxel|paclitaxel|mesh-list
92657588|NCT02279134|Nedaplatin|nedaplatin|mesh-list
92657589|NCT02279134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657590|NCT02279134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657591|NCT02279134|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657592|NCT02279134|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657593|NCT02279134|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657594|NCT02279134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657595|NCT00243893|Doxycycline|doxycycline|mesh-list
92657596|NCT00243893|Minocycline|minocycline|mesh-list
92577157|NCT00267163|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92577158|NCT00267163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577159|NCT00267163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577160|NCT00267163|Cholinergic Agents|cholinergic agents|mesh-ancestor
92577161|NCT00267163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577162|NCT00267163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577163|NCT00267163|Nootropic Agents|nootropic agents|mesh-ancestor
92657597|NCT00243893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92657600|NCT00243893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92657601|NCT00243893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92657602|NCT00283218|Insulin Aspart|insulin aspart|mesh-list
92657603|NCT00283218|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92657604|NCT00283218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92657605|NCT00283218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657606|NCT00244127|Prednisone|prednisone|mesh-list
92657607|NCT00244127|Cyclophosphamide|cyclophosphamide|mesh-list
92657608|NCT00244127|Rituximab|rituximab|mesh-list
92657609|NCT00244127|Vincristine|vincristine|mesh-list
92657610|NCT00244127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92657611|NCT00244127|Immunologic Factors|immunologic factors|mesh-ancestor
92657612|NCT00244127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657613|NCT00244127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657614|NCT00244127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92657615|NCT00244127|Alkylating Agents|alkylating agents|mesh-ancestor
92657616|NCT00244127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657617|NCT00244127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657618|NCT00244127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92657619|NCT00244127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92657620|NCT00244127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657621|NCT00244127|Glucocorticoids|glucocorticoids|mesh-ancestor
92657622|NCT00244127|Hormones|hormones|mesh-ancestor
92657623|NCT00244127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657624|NCT00244127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657625|NCT00244127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657626|NCT00244127|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657627|NCT00244127|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657628|NCT00244127|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657629|NCT00244166|Prednisolone|prednisolone|mesh-list
92657630|NCT00244166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657631|NCT00244166|Glucocorticoids|glucocorticoids|mesh-ancestor
92657632|NCT00244166|Hormones|hormones|mesh-ancestor
92657633|NCT00244166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657634|NCT00244166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657635|NCT00244166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657636|NCT00244166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657637|NCT00273975|Lamivudine|lamivudine|mesh-list
92657638|NCT00273975|Zidovudine|zidovudine|mesh-list
92657639|NCT00273975|Nevirapine|nevirapine|mesh-list
92657640|NCT00273975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92657641|NCT00273975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92657642|NCT00273975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657643|NCT00273975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657644|NCT00273975|Antiviral Agents|antiviral agents|mesh-ancestor
92657645|NCT00273975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657646|NCT00273975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92657647|NCT00273975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92657648|NCT00273975|Antimetabolites|antimetabolites|mesh-ancestor
92657649|NCT00273975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92657650|NCT00273975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92657651|NCT00244283|Sevoflurane|sevoflurane|mesh-list
92657652|NCT00244283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92657653|NCT00244283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92657654|NCT00244283|Anesthetics, General|anesthetics, general|mesh-ancestor
92657655|NCT00244283|Anesthetics|anesthetics|mesh-ancestor
92657656|NCT00244283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657657|NCT00244283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657658|NCT00283335|Gemfibrozil|gemfibrozil|mesh-list
92577164|NCT00267319|Glatiramer Acetate|glatiramer acetate|mesh-list
92577166|NCT00267319|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92577167|NCT00267319|Immunologic Factors|immunologic factors|mesh-ancestor
92007549|NCT04440371|Tacrolimus|tacrolimus|mesh-list
92657659|NCT00283335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92657660|NCT00283335|Antimetabolites|antimetabolites|mesh-ancestor
92657661|NCT00283335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657662|NCT00283335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92657663|NCT00283335|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92657664|NCT00283335|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383020|NCT00656916|Xhance|xhance|mesh-list
92657665|NCT00283335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657666|NCT00244322|N2-((2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-N1-((7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-L-alaninamide|n2-((2s)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl)-n1-((7s)-5-methyl-6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-l-alaninamide|mesh-list
92657667|NCT00244322|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92657669|NCT00244322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657671|NCT00244361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92657672|NCT00244361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657673|NCT00244361|Immunologic Factors|immunologic factors|mesh-ancestor
92657674|NCT00244361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657675|NCT00244361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657676|NCT00274014|Tiotropium Bromide|tiotropium bromide|mesh-list
92657677|NCT00274014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657678|NCT00274014|Autonomic Agents|autonomic agents|mesh-ancestor
92657679|NCT00274014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657680|NCT00274014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657681|NCT00274014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657682|NCT00274014|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657683|NCT00274014|Parasympatholytics|parasympatholytics|mesh-ancestor
92657684|NCT00274014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92657685|NCT00274014|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657686|NCT00274014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657687|NCT00274014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657688|NCT00244439|Permethrin|permethrin|mesh-list
92657689|NCT00244439|Malathion|malathion|mesh-list
92657690|NCT00244439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657691|NCT00244439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657692|NCT00244439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92657693|NCT00244439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657694|NCT00244439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657695|NCT00244439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657696|NCT00417144|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92657697|NCT00417144|Ganirelix|ganirelix|mesh-list
92657698|NCT00417144|Luteolytic Agents|luteolytic agents|mesh-ancestor
92657699|NCT00417144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92657700|NCT00417144|Contraceptive Agents|contraceptive agents|mesh-ancestor
92657701|NCT00417144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92657702|NCT00417144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657703|NCT00417144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92657704|NCT00417144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657705|NCT00417144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657706|NCT00417144|Hormone Antagonists|hormone antagonists|mesh-ancestor
92657707|NCT00417144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657708|NCT00274053|Tiotropium Bromide|tiotropium bromide|mesh-list
92657709|NCT00274053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657710|NCT00274053|Autonomic Agents|autonomic agents|mesh-ancestor
92657711|NCT00274053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657712|NCT00274053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657713|NCT00274053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657714|NCT00274053|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657715|NCT00274053|Parasympatholytics|parasympatholytics|mesh-ancestor
92657716|NCT00274053|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92657717|NCT00274053|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657718|NCT00274053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657719|NCT00274053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657720|NCT00417183|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92657721|NCT00417183|Ganirelix|ganirelix|mesh-list
92577168|NCT00267319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577169|NCT00267319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577170|NCT00267319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577171|NCT00073385|Docetaxel|docetaxel|mesh-list
92657722|NCT00417183|Luteolytic Agents|luteolytic agents|mesh-ancestor
92657723|NCT00417183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92657724|NCT00417183|Contraceptive Agents|contraceptive agents|mesh-ancestor
92657725|NCT00417183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92364409|NCT04334382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657726|NCT00417183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657727|NCT00417183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92657728|NCT00417183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657729|NCT00417183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657730|NCT00417183|Hormone Antagonists|hormone antagonists|mesh-ancestor
92657731|NCT00417183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657732|NCT00244517|Remifentanil|remifentanil|mesh-list
92657733|NCT00244517|Sevoflurane|sevoflurane|mesh-list
92657734|NCT00244517|Desflurane|desflurane|mesh-list
92657735|NCT00244517|Isoflurane|isoflurane|mesh-list
92657736|NCT00244517|Anesthetics|anesthetics|mesh-ancestor
92657737|NCT00244517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657738|NCT00244517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657739|NCT00244517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92657746|NCT00244517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657747|NCT00274092|Tiotropium Bromide|tiotropium bromide|mesh-list
92657748|NCT00274092|Ipratropium|ipratropium|mesh-list
92657749|NCT00274092|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657750|NCT00274092|Autonomic Agents|autonomic agents|mesh-ancestor
92657751|NCT00274092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657752|NCT00274092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657753|NCT00274092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657754|NCT00274092|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657755|NCT00274092|Parasympatholytics|parasympatholytics|mesh-ancestor
92657756|NCT00274092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92657757|NCT00274092|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657758|NCT00274092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657759|NCT00274092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657760|NCT00244556|Etanercept|etanercept|mesh-list
92657761|NCT00244556|Methotrexate|methotrexate|mesh-list
92657762|NCT00244556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92657763|NCT00244556|Abortifacient Agents|abortifacient agents|mesh-ancestor
92657764|NCT00244556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92657765|NCT00244556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657766|NCT00244556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92657767|NCT00244556|Antimetabolites|antimetabolites|mesh-ancestor
92657768|NCT00244556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657769|NCT00244556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657770|NCT00244556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92657771|NCT00244556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657772|NCT00244556|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92657773|NCT00244556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92657774|NCT00244556|Immunologic Factors|immunologic factors|mesh-ancestor
92657775|NCT00244556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657776|NCT00244556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92657777|NCT00244556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92657778|NCT00244556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92657779|NCT00244556|Analgesics|analgesics|mesh-ancestor
92657780|NCT00244556|Sensory System Agents|sensory system agents|mesh-ancestor
92657781|NCT00244556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657782|NCT00244556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657783|NCT00244556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657784|NCT00274131|Pramipexole|pramipexole|mesh-list
92657785|NCT00274131|Antioxidants|antioxidants|mesh-ancestor
92657786|NCT00274131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657787|NCT00274131|Protective Agents|protective agents|mesh-ancestor
92657788|NCT00274131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657789|NCT00274131|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92657790|NCT00274131|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92657791|NCT00274131|Dopamine Agonists|dopamine agonists|mesh-ancestor
92657792|NCT00274131|Dopamine Agents|dopamine agents|mesh-ancestor
92657793|NCT00274131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657794|NCT00274170|Octreotide|octreotide|mesh-list
92657795|NCT00274170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92657796|NCT00274170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92657797|NCT00274170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657798|NCT00244829|Imatinib Mesylate|imatinib mesylate|mesh-list
92657799|NCT00244829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657800|NCT00244829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657801|NCT00244829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657802|NCT00244829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657803|NCT00244907|Risedronic Acid|risedronic acid|mesh-list
92657804|NCT00244907|Genistein|genistein|mesh-list
92657805|NCT00244907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92657806|NCT00244907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657807|NCT00244907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657808|NCT00244907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92657809|NCT00244907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383113|NCT04954638|Eusol|eusol|mesh-list
92657813|NCT00244907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657814|NCT00244907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92657815|NCT00244907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657816|NCT00244907|Phytoestrogens|phytoestrogens|mesh-ancestor
92657817|NCT00244907|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92657819|NCT00244907|Hormones|hormones|mesh-ancestor
92657820|NCT00244907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92657821|NCT00244946|Cytarabine|cytarabine|mesh-list
92657822|NCT00244946|Etoposide|etoposide|mesh-list
92657823|NCT00244946|Melphalan|melphalan|mesh-list
92657824|NCT00244946|Carmustine|carmustine|mesh-list
92657825|NCT00244946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657826|NCT00244946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657827|NCT00244946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92657828|NCT00244946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92657829|NCT00244946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657830|NCT00244946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657831|NCT00244946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92657832|NCT00244946|Antimetabolites|antimetabolites|mesh-ancestor
92657833|NCT00244946|Antiviral Agents|antiviral agents|mesh-ancestor
92657834|NCT00244946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657835|NCT00244946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92657836|NCT00244946|Immunologic Factors|immunologic factors|mesh-ancestor
92657837|NCT00244946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657838|NCT00244946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92657839|NCT00244946|Alkylating Agents|alkylating agents|mesh-ancestor
92657840|NCT00244946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92657841|NCT00245024|Sulindac|sulindac|mesh-list
92657842|NCT00245024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92657843|NCT00245024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92657844|NCT00245024|Analgesics|analgesics|mesh-ancestor
92657845|NCT00245024|Sensory System Agents|sensory system agents|mesh-ancestor
92657846|NCT00245024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657847|NCT00245024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657848|NCT00245024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657849|NCT00245024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657850|NCT00245024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657851|NCT00245024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92657852|NCT00245024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657853|NCT00245024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657854|NCT00274326|Satavaptan|satavaptan|mesh-list
92657855|NCT00274326|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92657856|NCT00274326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657857|NCT00274326|Natriuretic Agents|natriuretic agents|mesh-ancestor
92657858|NCT00274326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657859|NCT00245141|Dactinomycin|dactinomycin|mesh-list
92657860|NCT00245141|Cyclophosphamide|cyclophosphamide|mesh-list
92657861|NCT00245141|Vincristine|vincristine|mesh-list
92657862|NCT00245141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92657863|NCT00245141|Immunologic Factors|immunologic factors|mesh-ancestor
92657864|NCT00245141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657865|NCT00245141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657866|NCT00245141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92657867|NCT00245141|Alkylating Agents|alkylating agents|mesh-ancestor
92657868|NCT00245141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657869|NCT00245141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577173|NCT00073385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92577174|NCT00073385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92577175|NCT00073385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577176|NCT00073385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577177|NCT00102258|Hormones|hormones|mesh-list
92577178|NCT00102258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577179|NCT00102258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577180|NCT00267514|Sevelamer|sevelamer|mesh-list
92577181|NCT00267514|Chelating Agents|chelating agents|mesh-ancestor
92577182|NCT00267514|Sequestering Agents|sequestering agents|mesh-ancestor
92577183|NCT00267514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577184|NCT00267553|Toremifene|toremifene|mesh-list
92577185|NCT00267553|Letrozole|letrozole|mesh-list
92577186|NCT00267553|Atamestane|atamestane|mesh-list
92577187|NCT00267553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577188|NCT00267553|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92577189|NCT00267553|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92577190|NCT00267553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577191|NCT00267553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657870|NCT00245141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92657871|NCT00245141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92657872|NCT00245141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92657873|NCT00245141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92657874|NCT00245141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92657875|NCT00245141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92657876|NCT00245141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657877|NCT00245141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92657878|NCT00245141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92657879|NCT00245141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657880|NCT00245141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92657881|NCT00416637|Bevacizumab|bevacizumab|mesh-list
92065115|NCT01675804|Methylphenidate|methylphenidate|mesh-list
92657883|NCT00416637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657884|NCT00416637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92657885|NCT00416637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92657886|NCT00416637|Growth Substances|growth substances|mesh-ancestor
92657887|NCT00416637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657888|NCT00416637|Growth Inhibitors|growth inhibitors|mesh-ancestor
92657889|NCT00245258|Sildenafil Citrate|sildenafil citrate|mesh-list
92657890|NCT00245258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657891|NCT00245258|Vasodilator Agents|vasodilator agents|mesh-ancestor
92657892|NCT00245258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92657893|NCT00245258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92657894|NCT00245258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657895|NCT00245258|Urological Agents|urological agents|mesh-ancestor
92657896|NCT02961803|Biotin|biotin|mesh-list
92657897|NCT02961803|Vitamin B Complex|vitamin b complex|mesh-ancestor
92657898|NCT02961803|Vitamins|vitamins|mesh-ancestor
92657899|NCT02961803|Micronutrients|micronutrients|mesh-ancestor
92657900|NCT02961803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657901|NCT00245297|Factor VIII|factor viii|mesh-list
92657902|NCT00245297|Coagulants|coagulants|mesh-ancestor
92657903|NCT00274404|Valacyclovir|valacyclovir|mesh-list
92657904|NCT00274404|Antiviral Agents|antiviral agents|mesh-ancestor
92657905|NCT00274404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657906|NCT00283764|Latanoprost|latanoprost|mesh-list
92657907|NCT00283764|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92577192|NCT00267553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92577193|NCT00267553|Hormone Antagonists|hormone antagonists|mesh-ancestor
92577194|NCT00267553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577195|NCT00267553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657908|NCT00283764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92657909|NCT00245336|Thrombin|thrombin|mesh-list
92657910|NCT00245336|Hemostatics|hemostatics|mesh-ancestor
92657911|NCT00245336|Coagulants|coagulants|mesh-ancestor
92657912|NCT00274443|Carboplatin|carboplatin|mesh-list
92657913|NCT00274443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92657914|NCT00274443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657915|NCT00245375|Acetaminophen|acetaminophen|mesh-list
92657916|NCT00245375|Ibuprofen|ibuprofen|mesh-list
92657917|NCT00245375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92657918|NCT00245375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92657919|NCT00245375|Analgesics|analgesics|mesh-ancestor
92657920|NCT00245375|Sensory System Agents|sensory system agents|mesh-ancestor
92657921|NCT00245375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657922|NCT00245375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657923|NCT00245375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657924|NCT00245375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92657925|NCT00245375|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92657926|NCT00245375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657927|NCT00245375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657928|NCT00245375|Antipyretics|antipyretics|mesh-ancestor
92657929|NCT00245414|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92657930|NCT00245414|Interferon-alpha|interferon-alpha|mesh-list
92657931|NCT00245414|Antiviral Agents|antiviral agents|mesh-ancestor
92657932|NCT00245414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657933|NCT00245414|Immunologic Factors|immunologic factors|mesh-ancestor
92657934|NCT00245414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657935|NCT00274521|Tiotropium Bromide|tiotropium bromide|mesh-list
92657936|NCT00274521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657937|NCT00274521|Autonomic Agents|autonomic agents|mesh-ancestor
92657938|NCT00274521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657939|NCT00274521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657940|NCT00274521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657941|NCT00274521|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657942|NCT00274521|Parasympatholytics|parasympatholytics|mesh-ancestor
92657943|NCT00274521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92657944|NCT00274521|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657945|NCT00274521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657946|NCT00274521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657947|NCT00245453|Azithromycin|azithromycin|mesh-list
92657948|NCT00245453|Clarithromycin|clarithromycin|mesh-list
92657949|NCT00245453|Telithromycin|telithromycin|mesh-list
92657950|NCT00245453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92657951|NCT00245453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657952|NCT00245453|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92657953|NCT00245453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657954|NCT00245453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657955|NCT00245453|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92065186|NCT01696071|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657967|NCT00274560|Cholinergic Agents|cholinergic agents|mesh-ancestor
92657968|NCT00274560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657969|NCT00274560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657970|NCT00274560|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92657971|NCT00274560|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92657972|NCT00274560|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92657973|NCT00274560|Adrenergic Agents|adrenergic agents|mesh-ancestor
92657974|NCT00245609|Pregabalin|pregabalin|mesh-list
92657975|NCT00245609|Alprazolam|alprazolam|mesh-list
92657976|NCT00245609|Analgesics|analgesics|mesh-ancestor
92657977|NCT00245609|Sensory System Agents|sensory system agents|mesh-ancestor
92657978|NCT00245609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657979|NCT00245609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657980|NCT00245609|Anticonvulsants|anticonvulsants|mesh-ancestor
92657981|NCT00245609|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92657982|NCT00245609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92657983|NCT00245609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577196|NCT00267553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92577197|NCT00267553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92577198|NCT00267553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91984573|NCT02546193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92657984|NCT00245609|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92657985|NCT00245609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92657986|NCT00245609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92657987|NCT00245609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657988|NCT00245609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657989|NCT00245609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92657990|NCT00245609|GABA Modulators|gaba modulators|mesh-ancestor
92657991|NCT00245609|GABA Agents|gaba agents|mesh-ancestor
92657992|NCT00245609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92657993|NCT00274599|Telmisartan|telmisartan|mesh-list
92657994|NCT00274599|Ramipril|ramipril|mesh-list
92657995|NCT00274599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92657996|NCT00274599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92657997|NCT00274599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92657998|NCT00274599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657999|NCT00274599|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92658000|NCT00274599|Protease Inhibitors|protease inhibitors|mesh-ancestor
92658001|NCT00274599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658002|NCT00274638|Losartan|losartan|mesh-list
92658003|NCT00274638|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92658004|NCT00274638|Telmisartan|telmisartan|mesh-list
92658005|NCT00274638|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92658006|NCT00274638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92658007|NCT00274638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92658008|NCT00274638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92658009|NCT00274638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658010|NCT00274638|Diuretics|diuretics|mesh-ancestor
92658011|NCT00274638|Natriuretic Agents|natriuretic agents|mesh-ancestor
92658012|NCT00274638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658013|NCT00274638|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92658014|NCT00274638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658015|NCT00274677|Lamotrigine|lamotrigine|mesh-list
92658016|NCT00274677|Anticonvulsants|anticonvulsants|mesh-ancestor
92658017|NCT00274677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92658018|NCT00274677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658021|NCT00274677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658022|NCT00274677|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658023|NCT00274677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658024|NCT00274677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658025|NCT00274677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658026|NCT00274677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92658027|NCT00245921|Levonorgestrel|levonorgestrel|mesh-list
92658028|NCT00245921|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92658029|NCT00245921|Estradiol|estradiol|mesh-list
92658030|NCT00245921|Estrogens|estrogens|mesh-ancestor
92658031|NCT00245921|Hormones|hormones|mesh-ancestor
92658032|NCT00245921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658033|NCT00245921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658034|NCT00245921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92658035|NCT00245921|Contraceptive Agents|contraceptive agents|mesh-ancestor
92658036|NCT00245921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92658037|NCT00245921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92658038|NCT00245921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92658039|NCT00245921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92658040|NCT00245921|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92658041|NCT00274794|Rituximab|rituximab|mesh-list
92658042|NCT00274794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92658043|NCT00274794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658044|NCT00274794|Immunologic Factors|immunologic factors|mesh-ancestor
92658045|NCT00274794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658046|NCT00274794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658047|NCT00246155|Botulinum Toxins|botulinum toxins|mesh-list
92658048|NCT00246155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92658049|NCT00246155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92658050|NCT00246155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92577199|NCT00267553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92577200|NCT00106548|Methotrexate|methotrexate|mesh-list
92577201|NCT00106548|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92658051|NCT00246155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658052|NCT00246155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658053|NCT00246155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92658054|NCT00246155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658055|NCT00246155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658056|NCT00246155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92658057|NCT00246155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658058|NCT00284193|Thrombin|thrombin|mesh-list
92658059|NCT00284193|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92658060|NCT00284193|Factor VIII|factor viii|mesh-list
92658061|NCT00284193|Hemostatics|hemostatics|mesh-ancestor
92658062|NCT00284193|Coagulants|coagulants|mesh-ancestor
92658063|NCT00246194|Risperidone|risperidone|mesh-list
92658064|NCT00246194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658065|NCT00246194|Serotonin Agents|serotonin agents|mesh-ancestor
92658066|NCT00246194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658067|NCT00246194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658068|NCT00246194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658069|NCT00246194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658070|NCT00246194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658071|NCT00246194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658072|NCT00246194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658073|NCT00246194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658074|NCT00246194|Dopamine Agents|dopamine agents|mesh-ancestor
92658075|NCT00284232|Insulin|insulin|mesh-list
92658076|NCT00284232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92658077|NCT00284232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658078|NCT00246233|Methylphenidate|methylphenidate|mesh-list
92658079|NCT00246233|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92658080|NCT00246233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658081|NCT00246233|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92658082|NCT00246233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92658083|NCT00246233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658084|NCT00246233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658085|NCT00246233|Dopamine Agents|dopamine agents|mesh-ancestor
92658086|NCT00246233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658087|NCT00274833|Temozolomide|temozolomide|mesh-list
92658088|NCT00274833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92065326|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658090|NCT00274833|Alkylating Agents|alkylating agents|mesh-ancestor
92658091|NCT00274833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658092|NCT00274833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658093|NCT00274833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658094|NCT00274833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658095|NCT00274872|Leucovorin|leucovorin|mesh-list
92658096|NCT00274872|Fluorouracil|fluorouracil|mesh-list
92658097|NCT00274872|Oxaliplatin|oxaliplatin|mesh-list
92658098|NCT00274872|Calcium|calcium|mesh-list
92658099|NCT00274872|Levoleucovorin|levoleucovorin|mesh-list
92658100|NCT00274872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92658101|NCT00274872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658102|NCT00274872|Antimetabolites|antimetabolites|mesh-ancestor
92658103|NCT00274872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658104|NCT00274872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92658105|NCT00274872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658106|NCT00274872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658107|NCT00274872|Immunologic Factors|immunologic factors|mesh-ancestor
92658108|NCT00274872|Antidotes|antidotes|mesh-ancestor
92658109|NCT00274872|Protective Agents|protective agents|mesh-ancestor
92658110|NCT00274872|Vitamin B Complex|vitamin b complex|mesh-ancestor
92658111|NCT00274872|Vitamins|vitamins|mesh-ancestor
92658112|NCT00274872|Micronutrients|micronutrients|mesh-ancestor
92658113|NCT00246272|Risperidone|risperidone|mesh-list
92658114|NCT00246272|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658115|NCT00246272|Serotonin Agents|serotonin agents|mesh-ancestor
92658116|NCT00246272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658117|NCT00246272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658118|NCT00246272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658119|NCT00246272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92577202|NCT00106548|Abortifacient Agents|abortifacient agents|mesh-ancestor
92577203|NCT00106548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92577204|NCT00106548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658120|NCT00246272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658121|NCT00246272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658122|NCT00246272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658123|NCT00246272|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658124|NCT00246272|Dopamine Agents|dopamine agents|mesh-ancestor
92658125|NCT00284271|Prednisone|prednisone|mesh-list
92658126|NCT00284271|Cyclophosphamide|cyclophosphamide|mesh-list
92658127|NCT00284271|Vincristine|vincristine|mesh-list
92658128|NCT00284271|Bleomycin|bleomycin|mesh-list
92658129|NCT00284271|Epoetin Alfa|epoetin alfa|mesh-list
92658130|NCT00284271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658131|NCT00284271|Immunologic Factors|immunologic factors|mesh-ancestor
92658132|NCT00284271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658133|NCT00284271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658134|NCT00284271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92658135|NCT00284271|Alkylating Agents|alkylating agents|mesh-ancestor
92658136|NCT00284271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658137|NCT00284271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658138|NCT00284271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92658139|NCT00284271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658140|NCT00284271|Glucocorticoids|glucocorticoids|mesh-ancestor
92658141|NCT00284271|Hormones|hormones|mesh-ancestor
92658142|NCT00284271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658143|NCT00284271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92658144|NCT00284271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92658145|NCT00284271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658146|NCT00284271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658147|NCT00284271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658148|NCT00284271|Hematinics|hematinics|mesh-ancestor
92658149|NCT00284271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92658150|NCT00246389|Cyclobenzaprine|cyclobenzaprine|mesh-list
92658151|NCT00246389|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92658152|NCT00246389|Antidepressive Agents|antidepressive agents|mesh-ancestor
92658153|NCT00246389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658154|NCT00246389|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92658155|NCT00246389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658156|NCT00246389|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92658157|NCT00246389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658158|NCT00246389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658159|NCT00246389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658160|NCT00274911|Vincristine|vincristine|mesh-list
92658161|NCT00274911|Lomustine|lomustine|mesh-list
92658162|NCT00274911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658163|NCT00274911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92658166|NCT00274911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658167|NCT00274911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658168|NCT00274911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92658169|NCT00274911|Alkylating Agents|alkylating agents|mesh-ancestor
92658170|NCT00246467|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92658171|NCT00246467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92658172|NCT00246467|Immunologic Factors|immunologic factors|mesh-ancestor
92658173|NCT00246467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658174|NCT00246467|Antacids|antacids|mesh-ancestor
92658175|NCT00246467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658176|NCT00246467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658177|NCT00277251|Alendronate|alendronate|mesh-list
92658178|NCT00277251|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92658179|NCT00277251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658180|NCT00416676|Cyclophosphamide|cyclophosphamide|mesh-list
92658181|NCT00416676|Carboplatin|carboplatin|mesh-list
92658182|NCT00416676|Etoposide|etoposide|mesh-list
92658183|NCT00416676|Vincristine|vincristine|mesh-list
92658184|NCT00416676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658185|NCT00416676|Immunologic Factors|immunologic factors|mesh-ancestor
92658186|NCT00416676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658187|NCT00416676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658188|NCT00416676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92658189|NCT00416676|Alkylating Agents|alkylating agents|mesh-ancestor
92658190|NCT00416676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577205|NCT00106548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577206|NCT00106548|Antimetabolites|antimetabolites|mesh-ancestor
92577207|NCT00106548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658191|NCT00416676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658192|NCT00416676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92658193|NCT00416676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92658194|NCT00416676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92658195|NCT00416676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92658196|NCT00416676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658197|NCT00416676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658198|NCT00416676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658199|NCT00416676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658200|NCT00246623|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92658201|NCT00246623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658202|NCT00284427|Ascorbic Acid|ascorbic acid|mesh-list
92658203|NCT00284427|Vitamins|vitamins|mesh-ancestor
92658204|NCT00284427|Micronutrients|micronutrients|mesh-ancestor
92364443|NCT04332276|Autonomic Agents|autonomic agents|mesh-ancestor
92658205|NCT00284427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658206|NCT00284427|Antioxidants|antioxidants|mesh-ancestor
92658207|NCT00284427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658208|NCT00284427|Protective Agents|protective agents|mesh-ancestor
92658209|NCT00246701|Simvastatin|simvastatin|mesh-list
92658210|NCT00246701|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92658211|NCT00246701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92658212|NCT00246701|Antimetabolites|antimetabolites|mesh-ancestor
92658213|NCT00246701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658214|NCT00246701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92658215|NCT00246701|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92658216|NCT00246701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658217|NCT00284505|Thalidomide|thalidomide|mesh-list
92658218|NCT00284505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658219|NCT00284505|Immunologic Factors|immunologic factors|mesh-ancestor
92658220|NCT00284505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658221|NCT00284505|Leprostatic Agents|leprostatic agents|mesh-ancestor
92658222|NCT00284505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92658223|NCT00284505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658224|NCT00284505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92658225|NCT00284505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92658226|NCT00284505|Growth Substances|growth substances|mesh-ancestor
92658227|NCT00284505|Growth Inhibitors|growth inhibitors|mesh-ancestor
92658228|NCT00284505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658229|NCT00246974|Gemcitabine|gemcitabine|mesh-list
92658230|NCT00246974|Gefitinib|gefitinib|mesh-list
92658231|NCT00246974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658232|NCT00246974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92658233|NCT00246974|Antimetabolites|antimetabolites|mesh-ancestor
92658234|NCT00246974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658235|NCT00246974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658236|NCT00246974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658237|NCT00284583|Lidocaine|lidocaine|mesh-list
92658241|NCT00284583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658242|NCT00284583|Sensory System Agents|sensory system agents|mesh-ancestor
92658243|NCT00284583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658244|NCT00284583|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92658245|NCT00284583|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92658246|NCT00284583|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92658247|NCT00284583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658248|NCT00284583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658249|NCT00247052|Diclofenac|diclofenac|mesh-list
92658250|NCT00247052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92658251|NCT00247052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92658252|NCT00247052|Analgesics|analgesics|mesh-ancestor
92658253|NCT00247052|Sensory System Agents|sensory system agents|mesh-ancestor
92658254|NCT00247052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658255|NCT00247052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658256|NCT00247052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92383548|NCT00000330|Analgesics|analgesics|mesh-ancestor
92658257|NCT00247052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658258|NCT00247052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92658259|NCT00247052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577208|NCT00106548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577209|NCT00106548|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577210|NCT00106548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577211|NCT00106548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92577212|NCT00106548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577213|NCT00106548|Immunologic Factors|immunologic factors|mesh-ancestor
91984587|NCT02957097|Gabapentin|gabapentin|mesh-list
92658260|NCT00247052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658262|NCT00277602|Anticonvulsants|anticonvulsants|mesh-ancestor
92658263|NCT00277602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92658264|NCT00277602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92658265|NCT00277602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658266|NCT00277602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658267|NCT00277602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658268|NCT00277602|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92658269|NCT00277602|Protective Agents|protective agents|mesh-ancestor
92658270|NCT00277641|Lamotrigine|lamotrigine|mesh-list
92658271|NCT00277641|Anticonvulsants|anticonvulsants|mesh-ancestor
92658272|NCT00277641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92658273|NCT00277641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658274|NCT00277641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658275|NCT00277641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92658276|NCT00277641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658277|NCT00277641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658278|NCT00277641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658279|NCT00277641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658280|NCT00277641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658281|NCT00277641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92658282|NCT00247130|Omeprazole|omeprazole|mesh-list
92658283|NCT00247130|Ranitidine|ranitidine|mesh-list
92658284|NCT00247130|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92658285|NCT00247130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92658286|NCT00247130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658287|NCT00247130|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92658288|NCT00247130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658289|NCT00247130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658290|NCT00247130|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92658291|NCT00247130|Histamine Antagonists|histamine antagonists|mesh-ancestor
92658292|NCT00247130|Histamine Agents|histamine agents|mesh-ancestor
92658293|NCT00247130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658294|NCT00247130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658295|NCT00247169|Progesterone|progesterone|mesh-list
92658296|NCT00247169|Progestins|progestins|mesh-ancestor
92658297|NCT00247169|Hormones|hormones|mesh-ancestor
92658298|NCT00247169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658299|NCT00247169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658300|NCT00247208|Paclitaxel|paclitaxel|mesh-list
92658301|NCT00247208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92658302|NCT00247208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658303|NCT00247208|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658304|NCT00247208|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658305|NCT00247208|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658306|NCT00247208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658307|NCT00284778|Docetaxel|docetaxel|mesh-list
92658310|NCT00284778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658311|NCT00284778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658312|NCT00284778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658313|NCT00247247|Entacapone|entacapone|mesh-list
92658314|NCT00247247|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92658315|NCT00247247|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92658316|NCT00247247|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92658317|NCT00247247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658318|NCT00247247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658319|NCT00277758|Interferons|interferons|mesh-list
92658320|NCT00277758|Ribavirin|ribavirin|mesh-list
92658321|NCT00277758|Interferon-alpha|interferon-alpha|mesh-list
92658322|NCT00277758|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92658323|NCT00277758|Interleukin-2|interleukin-2|mesh-list
92577214|NCT00106548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008272|NCT04967417|Pembrolizumab|pembrolizumab|mesh-list
92658324|NCT00277758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658325|NCT00277758|Antiviral Agents|antiviral agents|mesh-ancestor
92658326|NCT00277758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658327|NCT00277758|Antimetabolites|antimetabolites|mesh-ancestor
92658328|NCT00277758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658329|NCT00277758|Immunologic Factors|immunologic factors|mesh-ancestor
92658330|NCT00277758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658331|NCT00277758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92658332|NCT00277758|Analgesics|analgesics|mesh-ancestor
92658333|NCT00277758|Sensory System Agents|sensory system agents|mesh-ancestor
92658334|NCT00277758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658335|NCT00247364|Levetiracetam|levetiracetam|mesh-list
92658336|NCT00247364|Anticonvulsants|anticonvulsants|mesh-ancestor
92658337|NCT00247364|Nootropic Agents|nootropic agents|mesh-ancestor
92658338|NCT00247403|Deoxyglucose|deoxyglucose|mesh-list
92658339|NCT00247403|Antimetabolites|antimetabolites|mesh-ancestor
92658340|NCT00247403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658341|NCT00247403|Antiviral Agents|antiviral agents|mesh-ancestor
92658342|NCT00247403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658343|NCT00424814|Ritonavir|ritonavir|mesh-list
92658344|NCT00424814|Lopinavir|lopinavir|mesh-list
92658345|NCT00424814|Lamivudine|lamivudine|mesh-list
92658346|NCT00424814|Zidovudine|zidovudine|mesh-list
92658347|NCT00424814|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92658348|NCT00424814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92658349|NCT00424814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92658350|NCT00424814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92658351|NCT00424814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658352|NCT00424814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658353|NCT00424814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92658354|NCT00424814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92658355|NCT00424814|Antiviral Agents|antiviral agents|mesh-ancestor
92658356|NCT00424814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658357|NCT00424814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92658358|NCT00424814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92658359|NCT00424814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92658360|NCT00424814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92658361|NCT00424814|Antimetabolites|antimetabolites|mesh-ancestor
92658362|NCT00284973|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92658363|NCT00284973|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92658364|NCT00284973|Immunologic Factors|immunologic factors|mesh-ancestor
92658365|NCT00284973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658366|NCT00247481|Docetaxel|docetaxel|mesh-list
92658367|NCT00247481|Gefitinib|gefitinib|mesh-list
92658368|NCT00247481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658369|NCT00247481|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658370|NCT00247481|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658371|NCT00247481|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658372|NCT00247481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658373|NCT00247481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658374|NCT00247481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658375|NCT00247559|Botulinum Toxins|botulinum toxins|mesh-list
92658376|NCT00247559|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92658377|NCT00247559|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92658378|NCT00247559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92658379|NCT00247559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658380|NCT00247559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658381|NCT00247559|Cholinergic Agents|cholinergic agents|mesh-ancestor
92658383|NCT00247559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658384|NCT00247559|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92658385|NCT00247559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658387|NCT00285051|Antiemetics|antiemetics|mesh-ancestor
92658388|NCT00285051|Autonomic Agents|autonomic agents|mesh-ancestor
92658389|NCT00285051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658390|NCT00285051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658391|NCT00285051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658392|NCT00285051|Antipruritics|antipruritics|mesh-ancestor
92658393|NCT00285051|Dermatologic Agents|dermatologic agents|mesh-ancestor
92658394|NCT00285051|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92658395|NCT00285051|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658396|NCT00285051|Serotonin Agents|serotonin agents|mesh-ancestor
92658397|NCT00285051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577215|NCT00106548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92658398|NCT00285051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658399|NCT00247715|Pantoprazole|pantoprazole|mesh-list
92658400|NCT00247715|Ranitidine|ranitidine|mesh-list
92658401|NCT00247715|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92658402|NCT00247715|Magnesium Oxide|magnesium oxide|mesh-list
92658403|NCT00247715|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92658404|NCT00247715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92658405|NCT00247715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658406|NCT00247715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92658407|NCT00247715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364460|NCT04341870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92658408|NCT00247715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658409|NCT00247715|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92658410|NCT00247715|Histamine Antagonists|histamine antagonists|mesh-ancestor
92658411|NCT00247715|Histamine Agents|histamine agents|mesh-ancestor
92658412|NCT00247715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658413|NCT00247715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658415|NCT00247715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92658416|NCT00247715|Immunologic Factors|immunologic factors|mesh-ancestor
92658417|NCT00285090|Calcium, Dietary|calcium, dietary|mesh-list
92658418|NCT00285090|Vitamin D|vitamin d|mesh-list
92658419|NCT00285090|Ergocalciferols|ergocalciferols|mesh-list
92658420|NCT00285090|Cholecalciferol|cholecalciferol|mesh-list
92658421|NCT00285090|Vitamins|vitamins|mesh-list
92658422|NCT00285090|Calcium|calcium|mesh-list
92658423|NCT00285090|Micronutrients|micronutrients|mesh-ancestor
92658424|NCT00285090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658425|NCT00285090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92658426|NCT00285090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92658427|NCT00417222|Olmesartan|olmesartan|mesh-list
92658428|NCT00417222|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92658429|NCT00417222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92658430|NCT00417222|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92658431|NCT00417222|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92658432|NCT00417222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658433|NCT00278070|Vinorelbine|vinorelbine|mesh-list
92658434|NCT00278070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92658435|NCT00278070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658436|NCT00278070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658437|NCT00278070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658438|NCT00278070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658439|NCT00278070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658440|NCT00424983|Zoledronic Acid|zoledronic acid|mesh-list
92658441|NCT00424983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92658442|NCT00424983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658443|NCT00247910|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92658444|NCT00247910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92658445|NCT00247910|Diuretics|diuretics|mesh-ancestor
92658446|NCT00247910|Natriuretic Agents|natriuretic agents|mesh-ancestor
92658447|NCT00247910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658448|NCT00247910|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92658449|NCT00247910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658450|NCT00247910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658451|NCT00278187|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92658452|NCT00278187|Volociximab|volociximab|mesh-list
92658453|NCT00278187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658454|NCT00278187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658455|NCT00278187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065694|NCT03675256|Vaccines|vaccines|mesh-list
92658458|NCT00278187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92658460|NCT00278187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658461|NCT00278187|Growth Inhibitors|growth inhibitors|mesh-ancestor
92658462|NCT00247988|Carboplatin|carboplatin|mesh-list
92658463|NCT00247988|Docetaxel|docetaxel|mesh-list
92658464|NCT00247988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658465|NCT00247988|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658466|NCT00247988|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658467|NCT00247988|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658468|NCT00247988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658469|NCT00248144|Famciclovir|famciclovir|mesh-list
92658470|NCT00248144|Antiviral Agents|antiviral agents|mesh-ancestor
92658471|NCT00248144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658472|NCT00248144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92658473|NCT00248144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577216|NCT00267709|Visilizumab|visilizumab|mesh-list
92577217|NCT00267709|Immunologic Factors|immunologic factors|mesh-ancestor
92577218|NCT00267709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577219|NCT00267826|Rituximab|rituximab|mesh-list
92658474|NCT00248144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658475|NCT00278265|Methotrexate|methotrexate|mesh-list
92658476|NCT00278265|Fludarabine phosphate|fludarabine phosphate|mesh-list
92658477|NCT00278265|Fludarabine|fludarabine|mesh-list
92658478|NCT00278265|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92658479|NCT00278265|Abortifacient Agents|abortifacient agents|mesh-ancestor
92658480|NCT00278265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92658481|NCT00278265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658482|NCT00278265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92658483|NCT00278265|Antimetabolites|antimetabolites|mesh-ancestor
92658484|NCT00278265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658485|NCT00278265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658486|NCT00278265|Dermatologic Agents|dermatologic agents|mesh-ancestor
92658487|NCT00278265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658488|NCT00278265|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92658489|NCT00278265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658490|NCT00278265|Immunologic Factors|immunologic factors|mesh-ancestor
92658491|NCT00278265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658492|NCT00278265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92658493|NCT00248183|Naluzotan|naluzotan|mesh-list
92658494|NCT00248183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92658495|NCT00248183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92658496|NCT00248183|Serotonin Agents|serotonin agents|mesh-ancestor
92658497|NCT00248183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658498|NCT00248183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658499|NCT00248183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658500|NCT00278343|Cediranib|cediranib|mesh-list
92658501|NCT00278343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658502|NCT00278343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658503|NCT00278343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658504|NCT00278343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658505|NCT00248261|Ziprasidone|ziprasidone|mesh-list
92658506|NCT00248261|Sertraline|sertraline|mesh-list
92658507|NCT00248261|Antidepressive Agents|antidepressive agents|mesh-ancestor
92658508|NCT00248261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658509|NCT00248261|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92658510|NCT00248261|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92658511|NCT00248261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658512|NCT00248261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658513|NCT00248261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658514|NCT00248261|Serotonin Agents|serotonin agents|mesh-ancestor
92658515|NCT00248261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658516|NCT00248261|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658517|NCT00248261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658518|NCT00248261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658519|NCT00248261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658520|NCT00248261|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658521|NCT00248261|Dopamine Agents|dopamine agents|mesh-ancestor
92658522|NCT00248300|Chlorhexidine|chlorhexidine|mesh-list
92658523|NCT00248300|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92658524|NCT00248300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658525|NCT00248300|Disinfectants|disinfectants|mesh-ancestor
92658526|NCT00278382|Sorafenib|sorafenib|mesh-list
92658528|NCT00278382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658529|NCT00278382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658530|NCT00278382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658531|NCT00248339|Ribavirin|ribavirin|mesh-list
92658532|NCT00248339|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92658533|NCT00248339|Epoetin Alfa|epoetin alfa|mesh-list
92658534|NCT00248339|Antimetabolites|antimetabolites|mesh-ancestor
92658535|NCT00248339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658536|NCT00248339|Antiviral Agents|antiviral agents|mesh-ancestor
92658537|NCT00248339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658538|NCT00248339|Hematinics|hematinics|mesh-ancestor
92658539|NCT00278421|Prednisone|prednisone|mesh-list
92658540|NCT00278421|Cyclophosphamide|cyclophosphamide|mesh-list
92658541|NCT00278421|Rituximab|rituximab|mesh-list
92658542|NCT00278421|Doxorubicin|doxorubicin|mesh-list
92577220|NCT00267826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92577221|NCT00267826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577222|NCT00267826|Immunologic Factors|immunologic factors|mesh-ancestor
92008501|NCT04952051|Diuretics|diuretics|mesh-ancestor
92658543|NCT00278421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92658544|NCT00278421|Vincristine|vincristine|mesh-list
92658545|NCT00278421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658546|NCT00278421|Immunologic Factors|immunologic factors|mesh-ancestor
92658547|NCT00278421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658548|NCT00278421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658549|NCT00278421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92658550|NCT00278421|Alkylating Agents|alkylating agents|mesh-ancestor
92658551|NCT00278421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658552|NCT00278421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658553|NCT00278421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92658554|NCT00278421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92658555|NCT00278421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92383857|NCT00000864|Zidovudine|zidovudine|mesh-list
92658556|NCT00278421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92658557|NCT00278421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92658558|NCT00278421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658559|NCT00278421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658560|NCT00278421|Glucocorticoids|glucocorticoids|mesh-ancestor
92658561|NCT00278421|Hormones|hormones|mesh-ancestor
92658562|NCT00278421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658563|NCT00278421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92658564|NCT00278421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92658565|NCT00278421|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658566|NCT00278421|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658567|NCT00278421|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658568|NCT00248456|Betamethasone|betamethasone|mesh-list
92658569|NCT00248456|Betamethasone Valerate|betamethasone valerate|mesh-list
92658570|NCT00248456|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92658571|NCT00248456|Betamethasone benzoate|betamethasone benzoate|mesh-list
92658572|NCT00248456|Calcipotriene|calcipotriene|mesh-list
92658573|NCT00248456|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92658574|NCT00248456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658575|NCT00248456|Glucocorticoids|glucocorticoids|mesh-ancestor
92658576|NCT00248456|Hormones|hormones|mesh-ancestor
92658577|NCT00248456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658578|NCT00248456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658579|NCT00248456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92658580|NCT00248456|Respiratory System Agents|respiratory system agents|mesh-ancestor
92658581|NCT00248456|Dermatologic Agents|dermatologic agents|mesh-ancestor
92658582|NCT00278460|Gemcitabine|gemcitabine|mesh-list
92658583|NCT00278460|Docetaxel|docetaxel|mesh-list
92658584|NCT00278460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92658585|NCT00278460|Antimetabolites|antimetabolites|mesh-ancestor
92658586|NCT00278460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658587|NCT00278460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658588|NCT00278460|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658589|NCT00278460|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658590|NCT00278460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658591|NCT00248729|Midazolam|midazolam|mesh-list
92658592|NCT00248729|Etomidate|etomidate|mesh-list
92658593|NCT00248729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92658594|NCT00248729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92658595|NCT00248729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658596|NCT00248729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658597|NCT00248729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92658598|NCT00248729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658599|NCT00248729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658600|NCT00248729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92658601|NCT00248729|Anesthetics, General|anesthetics, general|mesh-ancestor
92658612|NCT00248963|Estrogens|estrogens|mesh-ancestor
92658613|NCT00248963|Hormones|hormones|mesh-ancestor
92658614|NCT00248963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658615|NCT00248963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658616|NCT00248963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92658617|NCT00248963|Contraceptive Agents|contraceptive agents|mesh-ancestor
92658618|NCT00248963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92577223|NCT00267826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577224|NCT00267826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577225|NCT00425620|Amphotericin B|amphotericin b|mesh-list
92658619|NCT00248963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92658620|NCT00248963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92658621|NCT00248963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92658622|NCT00248963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92658623|NCT00249041|Etanercept|etanercept|mesh-list
92658624|NCT00249041|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92658625|NCT00249041|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92658626|NCT00249041|Analgesics|analgesics|mesh-ancestor
92658627|NCT00249041|Sensory System Agents|sensory system agents|mesh-ancestor
92658628|NCT00249041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658629|NCT00249041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658630|NCT00249041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658631|NCT00249041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658633|NCT00249041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658634|NCT00249041|Immunologic Factors|immunologic factors|mesh-ancestor
92658635|NCT00285519|Doxazosin|doxazosin|mesh-list
92658636|NCT00285519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92658637|NCT00285519|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92658638|NCT00285519|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92658639|NCT00285519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92658640|NCT00285519|Adrenergic Agents|adrenergic agents|mesh-ancestor
92658641|NCT00285519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658642|NCT00285519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658643|NCT00285519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658644|NCT00278772|Valproic Acid|valproic acid|mesh-list
92658645|NCT00278772|Anticonvulsants|anticonvulsants|mesh-ancestor
92658646|NCT00278772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658647|NCT00278772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658648|NCT00278772|GABA Agents|gaba agents|mesh-ancestor
92658649|NCT00278772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658650|NCT00278772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658651|NCT00278772|Antimanic Agents|antimanic agents|mesh-ancestor
92658652|NCT00278772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658653|NCT00278772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658654|NCT00278772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658655|NCT00249119|Risperidone|risperidone|mesh-list
92658656|NCT00249119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658657|NCT00249119|Serotonin Agents|serotonin agents|mesh-ancestor
92658658|NCT00249119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658659|NCT00249119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658660|NCT00249119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658661|NCT00249119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658662|NCT00249119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658663|NCT00249119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658664|NCT00249119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658665|NCT00249119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658666|NCT00249119|Dopamine Agents|dopamine agents|mesh-ancestor
92658667|NCT00285597|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92065907|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92658671|NCT00249158|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658672|NCT00249158|Serotonin Agents|serotonin agents|mesh-ancestor
92658673|NCT00249158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658674|NCT00249158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658675|NCT00249158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658676|NCT00249158|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658677|NCT00249158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658678|NCT00249158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658679|NCT00249158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658680|NCT00249158|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658681|NCT00249158|Dopamine Agents|dopamine agents|mesh-ancestor
92658682|NCT00278928|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92658683|NCT00278928|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92658684|NCT00278928|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92658685|NCT00278928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92658686|NCT00249197|Levofloxacin|levofloxacin|mesh-list
92658687|NCT00249197|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92658688|NCT00249197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658689|NCT00249197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92577227|NCT00425620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92577228|NCT00425620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92577229|NCT00425620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658690|NCT00249197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92658691|NCT00249197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92658692|NCT00249197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658693|NCT00249197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658694|NCT00249197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658695|NCT00249197|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92364469|NCT04331418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92658696|NCT00249197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92658697|NCT00278967|Bisacodyl|bisacodyl|mesh-list
92658698|NCT00278967|Cathartics|cathartics|mesh-ancestor
92658699|NCT00278967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658700|NCT00278967|Laxatives|laxatives|mesh-ancestor
92658701|NCT00249236|Risperidone|risperidone|mesh-list
92658702|NCT00249236|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658703|NCT00249236|Serotonin Agents|serotonin agents|mesh-ancestor
92658704|NCT00249236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92384010|NCT00000954|Antimetabolites|antimetabolites|mesh-ancestor
92658705|NCT00249236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658706|NCT00249236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658707|NCT00249236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658708|NCT00249236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658709|NCT00249236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658710|NCT00249236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658711|NCT00249236|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658713|NCT00285675|Calcitriol|calcitriol|mesh-list
92658714|NCT00285675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92658715|NCT00285675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658716|NCT00285675|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92658717|NCT00285675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658718|NCT00285675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658719|NCT00285675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92658720|NCT00285675|Vitamins|vitamins|mesh-ancestor
92658721|NCT00285675|Micronutrients|micronutrients|mesh-ancestor
92658722|NCT00285675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92658723|NCT02215096|GSK2636771|gsk2636771|mesh-list
92658724|NCT02215096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658725|NCT02215096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92658726|NCT02215096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658727|NCT02215096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658728|NCT00279045|Metformin|metformin|mesh-list
92658729|NCT00279045|Rosiglitazone|rosiglitazone|mesh-list
92658730|NCT00279045|Glyburide|glyburide|mesh-list
92658731|NCT00279045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92658732|NCT00279045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658733|NCT00249353|Methylphenidate|methylphenidate|mesh-list
92658734|NCT00249353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92658735|NCT00249353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658736|NCT00249353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92658737|NCT00249353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92658738|NCT00249353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658741|NCT00249353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658742|NCT00249431|Sertraline|sertraline|mesh-list
92658743|NCT00249431|Antidepressive Agents|antidepressive agents|mesh-ancestor
92658744|NCT00249431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658745|NCT00249431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92658746|NCT00249431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92658747|NCT00249431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658748|NCT00249431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658749|NCT00249431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658750|NCT00249431|Serotonin Agents|serotonin agents|mesh-ancestor
92658751|NCT00249431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658752|NCT00249509|Bupropion|bupropion|mesh-list
92658753|NCT00249509|Nefazodone|nefazodone|mesh-list
92658754|NCT00249509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92658755|NCT00249509|Antidepressive Agents|antidepressive agents|mesh-ancestor
92658756|NCT00249509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658757|NCT00249509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92577230|NCT00425620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92658758|NCT00249509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92658759|NCT00249509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658760|NCT00249509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658761|NCT00249509|Dopamine Agents|dopamine agents|mesh-ancestor
92658762|NCT00249509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658763|NCT00249509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658764|NCT00249509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92658765|NCT00249509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92658766|NCT00249509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658767|NCT00249509|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92658768|NCT00249509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92658769|NCT00249509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658770|NCT00249509|Serotonin Agents|serotonin agents|mesh-ancestor
92658771|NCT00279084|Chrysarobin|chrysarobin|mesh-list
92658772|NCT00279084|Epoetin Alfa|epoetin alfa|mesh-list
92658773|NCT00279084|Hematinics|hematinics|mesh-ancestor
92658774|NCT00279084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92658775|NCT00279084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92658776|NCT00279084|Analgesics|analgesics|mesh-ancestor
92658777|NCT00279084|Sensory System Agents|sensory system agents|mesh-ancestor
92658778|NCT00279084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658779|NCT00279084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658780|NCT00279084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658781|NCT00279084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658782|NCT00249587|Methadone|methadone|mesh-list
92658783|NCT00249587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92658784|NCT00249587|Narcotics|narcotics|mesh-ancestor
92658785|NCT00249587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658786|NCT00249587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658787|NCT00249587|Analgesics|analgesics|mesh-ancestor
92658788|NCT00249587|Sensory System Agents|sensory system agents|mesh-ancestor
92658789|NCT00249587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658790|NCT00249587|Antitussive Agents|antitussive agents|mesh-ancestor
92658791|NCT00249587|Respiratory System Agents|respiratory system agents|mesh-ancestor
92658792|NCT00279123|Pantoprazole|pantoprazole|mesh-list
92658793|NCT00279123|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92658794|NCT00279123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658795|NCT00279123|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92658796|NCT00279123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658797|NCT00279123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658798|NCT00279162|Betamethasone|betamethasone|mesh-list
92658799|NCT00279162|Calcipotriene|calcipotriene|mesh-list
92658800|NCT00279162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658801|NCT00279162|Glucocorticoids|glucocorticoids|mesh-ancestor
92658802|NCT00279162|Hormones|hormones|mesh-ancestor
92658803|NCT00279162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92658804|NCT00279162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658805|NCT00279162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92658806|NCT00279162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92658807|NCT00279162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92658808|NCT00249704|Vitamin D|vitamin d|mesh-list
92658809|NCT00249704|Ergocalciferols|ergocalciferols|mesh-list
92658810|NCT00249704|Cholecalciferol|cholecalciferol|mesh-list
92658813|NCT00249704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658814|NCT00249704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92658815|NCT00249704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92658816|NCT00249782|Metronidazole|metronidazole|mesh-list
92658818|NCT00249782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658819|NCT00249782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92658820|NCT00249782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92658821|NCT00249782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92658822|NCT00249782|Antimalarials|antimalarials|mesh-ancestor
92658823|NCT00249782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92658824|NCT00249782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658825|NCT00249782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658826|NCT00249782|Leprostatic Agents|leprostatic agents|mesh-ancestor
92658827|NCT00279240|Metformin|metformin|mesh-list
92658828|NCT00279240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92658829|NCT00279240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658830|NCT00249860|Interferons|interferons|mesh-list
92658831|NCT00249860|Ribavirin|ribavirin|mesh-list
92658832|NCT00249860|Interferon-beta|interferon-beta|mesh-list
92658833|NCT00249860|Interferon beta-1a|interferon beta-1a|mesh-list
92577231|NCT00425620|Antifungal Agents|antifungal agents|mesh-ancestor
92577232|NCT00267943|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92577233|NCT00267943|Telmisartan|telmisartan|mesh-list
92577234|NCT00267943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92658834|NCT00249860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658835|NCT00249860|Antiviral Agents|antiviral agents|mesh-ancestor
92658836|NCT00249860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658837|NCT00249860|Antimetabolites|antimetabolites|mesh-ancestor
92658838|NCT00249860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658839|NCT00249860|Immunologic Factors|immunologic factors|mesh-ancestor
92658840|NCT00249860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658841|NCT00249860|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92658842|NCT00249899|Atorvastatin|atorvastatin|mesh-list
92658843|NCT00249899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92658844|NCT00249899|Simvastatin|simvastatin|mesh-list
92658845|NCT00249899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92658846|NCT00249899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92658847|NCT00249899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92658848|NCT00249899|Antimetabolites|antimetabolites|mesh-ancestor
92658849|NCT00249899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658850|NCT00249899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92658851|NCT00249899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384151|NCT00001428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658852|NCT00249938|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92658853|NCT00249938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92658854|NCT00249938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92658855|NCT00249938|Antimetabolites|antimetabolites|mesh-ancestor
92658856|NCT00249938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658857|NCT00249938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92658858|NCT00249977|Capecitabine|capecitabine|mesh-list
92658859|NCT00249977|Irinotecan|irinotecan|mesh-list
92658860|NCT00249977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658861|NCT00249977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92658862|NCT00249977|Antimetabolites|antimetabolites|mesh-ancestor
92658863|NCT00249977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658864|NCT00249977|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92658865|NCT00249977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92658866|NCT00249977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658867|NCT00250094|Topotecan|topotecan|mesh-list
92658868|NCT00250094|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92658869|NCT00250094|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92658870|NCT00250094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658871|NCT00250094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658872|NCT00250094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658873|NCT00279435|Visilizumab|visilizumab|mesh-list
92658874|NCT00279435|Immunologic Factors|immunologic factors|mesh-ancestor
92658875|NCT00279435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658876|NCT00286026|Azithromycin|azithromycin|mesh-list
92658877|NCT00286026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92658878|NCT00286026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658879|NCT00250172|Rolipram|rolipram|mesh-list
92658880|NCT00250172|Antidepressive Agents|antidepressive agents|mesh-ancestor
92658881|NCT00250172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658882|NCT00250172|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92658883|NCT00250172|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92066119|NCT01688739|Erenumab|erenumab|mesh-list
92658888|NCT02961608|Immunologic Factors|immunologic factors|mesh-ancestor
92658889|NCT02961608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658890|NCT02961608|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92658891|NCT02961608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658892|NCT02961608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658893|NCT00286104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92658894|NCT00286104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658895|NCT00286143|Fentanyl|fentanyl|mesh-list
92658896|NCT00286143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92658897|NCT00286143|Narcotics|narcotics|mesh-ancestor
92658898|NCT00286143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658899|NCT00286143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658900|NCT00286143|Analgesics|analgesics|mesh-ancestor
92658901|NCT00286143|Sensory System Agents|sensory system agents|mesh-ancestor
92658902|NCT00286143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658903|NCT00286143|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577235|NCT00267943|Diuretics|diuretics|mesh-ancestor
92577236|NCT00267943|Natriuretic Agents|natriuretic agents|mesh-ancestor
92577237|NCT00267943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577238|NCT00267943|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92577239|NCT00267943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92577240|NCT00267943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658904|NCT00286143|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92658905|NCT00286143|Anesthetics, General|anesthetics, general|mesh-ancestor
92658906|NCT00286143|Anesthetics|anesthetics|mesh-ancestor
92658907|NCT00286260|Levetiracetam|levetiracetam|mesh-list
92658908|NCT00286260|Anticonvulsants|anticonvulsants|mesh-ancestor
92658909|NCT00286260|Nootropic Agents|nootropic agents|mesh-ancestor
92658910|NCT00250367|Risperidone|risperidone|mesh-list
92658911|NCT00250367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92658912|NCT00250367|Serotonin Agents|serotonin agents|mesh-ancestor
92658913|NCT00250367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658914|NCT00250367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658915|NCT00250367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658916|NCT00250367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92658917|NCT00250367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92658918|NCT00250367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658919|NCT00250367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92658920|NCT00250367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92658921|NCT00250367|Dopamine Agents|dopamine agents|mesh-ancestor
92658922|NCT00250562|Valsartan|valsartan|mesh-list
92658923|NCT00250562|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92658924|NCT00250562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92658925|NCT00250562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92658926|NCT00250562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92658927|NCT00250562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658928|NCT00250562|Diuretics|diuretics|mesh-ancestor
92658929|NCT00250562|Natriuretic Agents|natriuretic agents|mesh-ancestor
92658930|NCT00250562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658931|NCT00250562|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92658932|NCT00250562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92658933|NCT02960880|Rivaroxaban|rivaroxaban|mesh-list
92658934|NCT02960880|Phenprocoumon|phenprocoumon|mesh-list
92658935|NCT02960880|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92658936|NCT02960880|Antithrombins|antithrombins|mesh-ancestor
92658937|NCT02960880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92658938|NCT02960880|Protease Inhibitors|protease inhibitors|mesh-ancestor
92658939|NCT02960880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658940|NCT02960880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658941|NCT02960880|Anticoagulants|anticoagulants|mesh-ancestor
92658942|NCT00279747|Naproxen|naproxen|mesh-list
92658943|NCT00279747|Meloxicam|meloxicam|mesh-list
92658944|NCT00279747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92658945|NCT00279747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92658946|NCT00279747|Analgesics|analgesics|mesh-ancestor
92658947|NCT00279747|Sensory System Agents|sensory system agents|mesh-ancestor
92658948|NCT00279747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92658949|NCT00279747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658950|NCT00279747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92658951|NCT00279747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92658952|NCT00279747|Gout Suppressants|gout suppressants|mesh-ancestor
92658953|NCT00279747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92658954|NCT00279747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066195|NCT01558089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658957|NCT00250640|Iloprost|iloprost|mesh-list
92658958|NCT00250640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92658959|NCT00250640|Vasodilator Agents|vasodilator agents|mesh-ancestor
92658960|NCT00250796|Interferons|interferons|mesh-list
92658961|NCT00250796|Interferon-alpha|interferon-alpha|mesh-list
92658962|NCT00250796|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92658963|NCT00250796|Thalidomide|thalidomide|mesh-list
92658964|NCT00250796|Octreotide|octreotide|mesh-list
92658965|NCT00250796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658966|NCT00250796|Antiviral Agents|antiviral agents|mesh-ancestor
92658967|NCT00250796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92658968|NCT00250796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577241|NCT00267943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92577242|NCT00267943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92577243|NCT04711265|Vaccines|vaccines|mesh-list
92658969|NCT00250796|Immunologic Factors|immunologic factors|mesh-ancestor
92658970|NCT00250796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92658971|NCT00250796|Leprostatic Agents|leprostatic agents|mesh-ancestor
92658972|NCT00250796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92658973|NCT00250796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92658974|NCT00250796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92658975|NCT00250796|Growth Substances|growth substances|mesh-ancestor
92658976|NCT00250796|Growth Inhibitors|growth inhibitors|mesh-ancestor
92658977|NCT00250796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658978|NCT00250796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92658979|NCT00286416|Omalizumab|omalizumab|mesh-list
92658980|NCT00286416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92658981|NCT00286416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92658982|NCT00286416|Respiratory System Agents|respiratory system agents|mesh-ancestor
92658983|NCT00250874|Docetaxel|docetaxel|mesh-list
92658984|NCT00250874|Doxorubicin|doxorubicin|mesh-list
92658985|NCT00250874|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92658986|NCT00250874|Trastuzumab|trastuzumab|mesh-list
92658987|NCT00250874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658988|NCT00250874|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658989|NCT00250874|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658990|NCT00250874|Mitosis Modulators|mitosis modulators|mesh-ancestor
92658991|NCT00250874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658992|NCT00250874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92658993|NCT00250874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92658994|NCT00250874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92658995|NCT00250874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658996|NCT00250874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92658997|NCT00279825|Levodopa|levodopa|mesh-list
92658998|NCT00279825|Carbidopa|carbidopa|mesh-list
92658999|NCT00279825|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92659000|NCT00279825|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92659001|NCT00279825|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92659002|NCT00279825|Dopamine Agents|dopamine agents|mesh-ancestor
92659003|NCT00279825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659004|NCT00279825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659005|NCT00279825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659006|NCT00279825|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92659007|NCT00279825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659008|NCT00279825|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92659009|NCT00279825|Immunologic Factors|immunologic factors|mesh-ancestor
92659010|NCT00279825|Dopamine Agonists|dopamine agonists|mesh-ancestor
92659011|NCT00250952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92659012|NCT00250952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92659013|NCT00250952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92659014|NCT00250952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659015|NCT00250952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659016|NCT00250952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92659017|NCT00250952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659018|NCT00250952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659019|NCT00250952|Cholinergic Agents|cholinergic agents|mesh-ancestor
92659020|NCT00250952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659021|NCT00250991|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92659022|NCT00250991|Eptifibatide|eptifibatide|mesh-list
92659023|NCT00250991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92659024|NCT00250991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92659025|NCT00250991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659026|NCT00250991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92659027|NCT00286611|Amifostine|amifostine|mesh-list
92659030|NCT00286611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659031|NCT00416832|Prednisone|prednisone|mesh-list
92659032|NCT00416832|Cyclophosphamide|cyclophosphamide|mesh-list
92659033|NCT00416832|Dacarbazine|dacarbazine|mesh-list
92659034|NCT00416832|Doxorubicin|doxorubicin|mesh-list
92659035|NCT00416832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92659036|NCT00416832|Etoposide|etoposide|mesh-list
92659037|NCT00416832|Vincristine|vincristine|mesh-list
92659038|NCT00416832|Procarbazine|procarbazine|mesh-list
92659039|NCT00416832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659040|NCT00416832|Immunologic Factors|immunologic factors|mesh-ancestor
92577244|NCT04711265|Immunologic Factors|immunologic factors|mesh-ancestor
92659041|NCT00416832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659042|NCT00416832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92659043|NCT00416832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92659044|NCT00416832|Alkylating Agents|alkylating agents|mesh-ancestor
92659045|NCT00416832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659046|NCT00416832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659047|NCT00416832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92659048|NCT00416832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92659049|NCT00416832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92659050|NCT00416832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659051|NCT00416832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659052|NCT00416832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659053|NCT00416832|Glucocorticoids|glucocorticoids|mesh-ancestor
92659054|NCT00416832|Hormones|hormones|mesh-ancestor
92659055|NCT00416832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659056|NCT00416832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92659057|NCT00416832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659058|NCT00416832|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659059|NCT00416832|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659060|NCT00416832|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659061|NCT00251030|Nelfinavir|nelfinavir|mesh-list
92659062|NCT00251030|Omeprazole|omeprazole|mesh-list
92659063|NCT00251030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92659064|NCT00251030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659065|NCT00251030|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92659066|NCT00251030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659067|NCT00251030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659068|NCT00251030|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92659069|NCT00251030|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92659070|NCT00251030|Protease Inhibitors|protease inhibitors|mesh-ancestor
92659071|NCT00251030|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92659072|NCT00251030|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92659073|NCT00251030|Antiviral Agents|antiviral agents|mesh-ancestor
92659074|NCT00251030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659075|NCT00286689|Hormones|hormones|mesh-list
92659076|NCT00286689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659077|NCT00286689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659078|NCT02961491|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92659079|NCT02961491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659080|NCT02961491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659081|NCT02961491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659082|NCT02961491|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92659083|NCT01640002|Bromides|bromides|mesh-list
92659084|NCT01640002|Propantheline|propantheline|mesh-list
92659085|NCT01640002|Anticonvulsants|anticonvulsants|mesh-ancestor
92659086|NCT01640002|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92659087|NCT01640002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659088|NCT01640002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92659089|NCT01640002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92659090|NCT01640002|Cholinergic Agents|cholinergic agents|mesh-ancestor
92659091|NCT01640002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659092|NCT01640002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659093|NCT01640002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659094|NCT00279903|Cortisone|cortisone|mesh-list
92659095|NCT00279903|Botulinum Toxins|botulinum toxins|mesh-list
92659096|NCT00279903|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92659097|NCT00279903|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92659098|NCT00279903|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92364511|NCT04329858|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92659099|NCT00279903|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659100|NCT00279903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659101|NCT00279903|Cholinergic Agents|cholinergic agents|mesh-ancestor
92659104|NCT00279903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92659105|NCT00279903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659106|NCT00279903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659107|NCT01640275|Propofol|propofol|mesh-list
92659108|NCT01640275|Isoflurane|isoflurane|mesh-list
92659109|NCT01640275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92659110|NCT01640275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659111|NCT01640275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659112|NCT01640275|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92659113|NCT01640275|Anesthetics, General|anesthetics, general|mesh-ancestor
92659114|NCT01640275|Anesthetics|anesthetics|mesh-ancestor
92659115|NCT01640275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92577245|NCT04711265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577246|NCT00268138|Fluorides|fluorides|mesh-list
92577247|NCT00268138|Cariostatic Agents|cariostatic agents|mesh-ancestor
92659116|NCT04529356|Acetaminophen|acetaminophen|mesh-list
92659117|NCT04529356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92659118|NCT04529356|Analgesics|analgesics|mesh-ancestor
92659119|NCT04529356|Sensory System Agents|sensory system agents|mesh-ancestor
92659120|NCT04529356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659121|NCT04529356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659122|NCT04529356|Antipyretics|antipyretics|mesh-ancestor
92659123|NCT01640665|Capecitabine|capecitabine|mesh-list
92659124|NCT01640665|Sorafenib|sorafenib|mesh-list
92659125|NCT01640665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659126|NCT01640665|Antimetabolites|antimetabolites|mesh-ancestor
92659127|NCT01640665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659128|NCT01640665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659129|NCT01640665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92659130|NCT01640665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659131|NCT01640782|Leucovorin|leucovorin|mesh-list
92659132|NCT01640782|Docetaxel|docetaxel|mesh-list
92659133|NCT01640782|Fluorouracil|fluorouracil|mesh-list
92659134|NCT01640782|Irinotecan|irinotecan|mesh-list
92659135|NCT01640782|Levoleucovorin|levoleucovorin|mesh-list
92659136|NCT01640782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659137|NCT01640782|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659138|NCT01640782|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659139|NCT01640782|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659140|NCT01640782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659141|NCT01640782|Antimetabolites|antimetabolites|mesh-ancestor
92659142|NCT01640782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659143|NCT01640782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659144|NCT01640782|Immunologic Factors|immunologic factors|mesh-ancestor
92659145|NCT01640782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659146|NCT01640782|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92659147|NCT01640782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659148|NCT01640782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659149|NCT01640782|Antidotes|antidotes|mesh-ancestor
92659150|NCT01640782|Protective Agents|protective agents|mesh-ancestor
92659151|NCT01640782|Vitamin B Complex|vitamin b complex|mesh-ancestor
92659152|NCT01640782|Vitamins|vitamins|mesh-ancestor
92659153|NCT01640782|Micronutrients|micronutrients|mesh-ancestor
92659154|NCT00251186|Capecitabine|capecitabine|mesh-list
92659155|NCT00251186|Cetuximab|cetuximab|mesh-list
92659156|NCT00251186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659157|NCT00251186|Antimetabolites|antimetabolites|mesh-ancestor
92659158|NCT00251186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659159|NCT00251186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659160|NCT00251186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92659161|NCT01641250|Cytarabine|cytarabine|mesh-list
92659162|NCT01641250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659163|NCT01641250|Antimetabolites|antimetabolites|mesh-ancestor
92659164|NCT01641250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659165|NCT01641250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659166|NCT01641250|Antiviral Agents|antiviral agents|mesh-ancestor
92659167|NCT01641250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659168|NCT01641250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659169|NCT01641250|Immunologic Factors|immunologic factors|mesh-ancestor
92364516|NCT05614752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659170|NCT01641250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659171|NCT01641289|Acetaminophen|acetaminophen|mesh-list
92659172|NCT01641289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92659173|NCT01641289|Analgesics|analgesics|mesh-ancestor
92659174|NCT01641289|Sensory System Agents|sensory system agents|mesh-ancestor
92659175|NCT01641289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659176|NCT01641289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659177|NCT01641289|Antipyretics|antipyretics|mesh-ancestor
92659180|NCT01641406|Docetaxel|docetaxel|mesh-list
92659181|NCT01641406|Capecitabine|capecitabine|mesh-list
92659182|NCT01641406|Trastuzumab|trastuzumab|mesh-list
92659183|NCT01641406|Epirubicin|epirubicin|mesh-list
92659184|NCT01641406|Vinorelbine|vinorelbine|mesh-list
92659185|NCT01641406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659186|NCT01641406|Immunologic Factors|immunologic factors|mesh-ancestor
92659187|NCT01641406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659188|NCT01641406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92659189|NCT01641406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92659190|NCT01641406|Alkylating Agents|alkylating agents|mesh-ancestor
92577248|NCT00268138|Protective Agents|protective agents|mesh-ancestor
92577249|NCT00268138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577250|NCT00102375|Topotecan|topotecan|mesh-list
92577251|NCT00102375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92577252|NCT00102375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659191|NCT01641406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659192|NCT01641406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659193|NCT01641406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92659194|NCT01641406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92659195|NCT01641406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92659196|NCT01641406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92659197|NCT01641406|Growth Substances|growth substances|mesh-ancestor
92659198|NCT01641406|Growth Inhibitors|growth inhibitors|mesh-ancestor
92659199|NCT01641406|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659200|NCT01641406|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659201|NCT01641406|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659202|NCT01641406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659203|NCT01641406|Antimetabolites|antimetabolites|mesh-ancestor
92659204|NCT01641406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92659205|NCT01641406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92659206|NCT01641406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659207|NCT01641406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659208|NCT01641406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659209|NCT01641523|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92659210|NCT01641523|Vasodilator Agents|vasodilator agents|mesh-ancestor
92659211|NCT01641523|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92659212|NCT01641523|Protective Agents|protective agents|mesh-ancestor
92659213|NCT01641523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659214|NCT01641796|Paromomycin|paromomycin|mesh-list
92659215|NCT01641796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92659216|NCT01641796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659217|NCT01641796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92659218|NCT01641796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92659219|NCT00280098|Docetaxel|docetaxel|mesh-list
92659220|NCT00280098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659221|NCT00280098|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659222|NCT00280098|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659223|NCT00280098|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659224|NCT00280098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659225|NCT00251381|Cetuximab|cetuximab|mesh-list
92659226|NCT00251381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92659227|NCT00251381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659228|NCT01685827|Eflornithine|eflornithine|mesh-list
92659229|NCT01685827|Nifurtimox|nifurtimox|mesh-list
92659230|NCT01685827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659231|NCT01685827|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92659232|NCT01685827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92659233|NCT01685827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92659234|NCT01685827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659235|NCT01685827|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92659236|NCT01685827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659237|NCT01685827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659238|NCT05140096|Fluconazole|fluconazole|mesh-list
92659239|NCT05140096|Isavuconazole|isavuconazole|mesh-list
92659240|NCT05140096|Acalabrutinib|acalabrutinib|mesh-list
92659241|NCT05140096|Antifungal Agents|antifungal agents|mesh-ancestor
92659242|NCT05140096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659243|NCT05140096|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92659244|NCT05140096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92659245|NCT05140096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659246|NCT05140096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659247|NCT05140096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92659248|NCT05140096|Hormone Antagonists|hormone antagonists|mesh-ancestor
92659249|NCT05140096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659250|NCT05140096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659251|NCT05140096|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92659255|NCT00251459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92659256|NCT00251459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92659257|NCT00251459|Growth Substances|growth substances|mesh-ancestor
92577253|NCT00102375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682784|NCT04701320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659258|NCT00251459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659259|NCT00251459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92659260|NCT00251459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659261|NCT04823065|Scopolamine|scopolamine|mesh-list
92659262|NCT04823065|Loperamide|loperamide|mesh-list
92659263|NCT04823065|Antidiarrheals|antidiarrheals|mesh-list
92659264|NCT04823065|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92659265|NCT04823065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659266|NCT04823065|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92659267|NCT04823065|Antiemetics|antiemetics|mesh-ancestor
92659268|NCT04823065|Autonomic Agents|autonomic agents|mesh-ancestor
92659269|NCT04823065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659270|NCT04823065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659271|NCT04823065|Mydriatics|mydriatics|mesh-ancestor
92659272|NCT04823065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92659273|NCT04823065|Cholinergic Agents|cholinergic agents|mesh-ancestor
92659274|NCT04823065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659275|NCT04823065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659276|NCT04823065|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92659277|NCT04823065|Parasympatholytics|parasympatholytics|mesh-ancestor
92659278|NCT00280176|Fluorouracil|fluorouracil|mesh-list
92659279|NCT00280176|Bortezomib|bortezomib|mesh-list
92659280|NCT00280176|Antimetabolites|antimetabolites|mesh-ancestor
92659281|NCT00280176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364525|NCT05508594|Anesthetics, General|anesthetics, general|mesh-ancestor
92659282|NCT00280176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659283|NCT00280176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659284|NCT00280176|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659285|NCT00280176|Immunologic Factors|immunologic factors|mesh-ancestor
92659286|NCT00280176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659287|NCT00280215|Losartan|losartan|mesh-list
92659288|NCT00280215|Lisinopril|lisinopril|mesh-list
92659289|NCT00280215|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92659290|NCT00280215|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92659291|NCT00280215|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92659292|NCT00280215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92659293|NCT00280215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92659294|NCT00280215|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92659295|NCT00280215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659296|NCT00280215|Protease Inhibitors|protease inhibitors|mesh-ancestor
92659297|NCT00280215|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92659298|NCT00280215|Protective Agents|protective agents|mesh-ancestor
92659299|NCT00280215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659300|NCT00251498|Cetuximab|cetuximab|mesh-list
92659301|NCT00251498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92659302|NCT00251498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659303|NCT02271334|Albuterol|albuterol|mesh-list
92659304|NCT02271334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92659305|NCT02271334|Autonomic Agents|autonomic agents|mesh-ancestor
92659306|NCT02271334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659307|NCT02271334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659308|NCT02271334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92659309|NCT02271334|Respiratory System Agents|respiratory system agents|mesh-ancestor
92659311|NCT02271334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92659312|NCT02271334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92659313|NCT02271334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659314|NCT02271334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659315|NCT02271334|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659316|NCT02271334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659317|NCT02271334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659318|NCT02276755|Vitamin D|vitamin d|mesh-list
92659319|NCT02276755|Cholecalciferol|cholecalciferol|mesh-list
92659320|NCT02276755|Vitamins|vitamins|mesh-ancestor
92659321|NCT02276755|Micronutrients|micronutrients|mesh-ancestor
92659322|NCT02276755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659323|NCT02276755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92659324|NCT02276755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92659333|NCT00280371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659334|NCT00280371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659335|NCT00280371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659336|NCT00280371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659337|NCT00280371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577254|NCT00102375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577255|NCT00102375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659340|NCT04455139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92659341|NCT04455139|Alkylating Agents|alkylating agents|mesh-ancestor
92659342|NCT04455139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659343|NCT04455139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659344|NCT04455139|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92659345|NCT04455139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659346|NCT04455139|Immunologic Factors|immunologic factors|mesh-ancestor
92659347|NCT04455139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659348|NCT04455139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92659349|NCT04455139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659350|NCT04455139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659351|NCT00251654|Anesthetics|anesthetics|mesh-list
92659352|NCT00251654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659353|NCT00251654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659354|NCT00286923|Topiramate|topiramate|mesh-list
92659355|NCT00286923|Anticonvulsants|anticonvulsants|mesh-ancestor
92659356|NCT00286923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92659357|NCT00286923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659358|NCT00251732|Antidepressive Agents|antidepressive agents|mesh-list
92659359|NCT00251732|Nortriptyline|nortriptyline|mesh-list
92659360|NCT00251732|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
92659361|NCT00251732|Rabeprazole|rabeprazole|mesh-list
92659362|NCT00251732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92659363|NCT00251732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659364|NCT00251732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92659365|NCT00251732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659366|NCT00251732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659367|NCT00251732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92659368|NCT00251732|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92659369|NCT00251732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92659370|NCT00251732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659371|NCT00251732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659372|NCT00251732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659373|NCT00251732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659374|NCT00286962|Insulin|insulin|mesh-list
92659375|NCT00286962|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92659376|NCT00286962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92659377|NCT00286962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659378|NCT04719650|Zoledronic Acid|zoledronic acid|mesh-list
92659379|NCT04719650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92659380|NCT04719650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659381|NCT00251849|KRM 1648|krm 1648|mesh-list
92659382|NCT00251849|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92659383|NCT00251849|Antitubercular Agents|antitubercular agents|mesh-ancestor
92659384|NCT00251849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92659385|NCT00251849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659386|NCT00251849|Leprostatic Agents|leprostatic agents|mesh-ancestor
92659387|NCT04822597|Lidocaine|lidocaine|mesh-list
92659388|NCT04822597|Anesthetics, Local|anesthetics, local|mesh-ancestor
92659389|NCT04822597|Anesthetics|anesthetics|mesh-ancestor
92066631|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659393|NCT04822597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659394|NCT04822597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92659395|NCT04822597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92659396|NCT04822597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92659397|NCT04822597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659398|NCT04822597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659399|NCT00251888|Irinotecan|irinotecan|mesh-list
92659400|NCT00251888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659401|NCT00251888|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92659402|NCT00251888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659403|NCT00251888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659404|NCT00251888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659405|NCT00251966|Esomeprazole|esomeprazole|mesh-list
92659406|NCT00251966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92659407|NCT00251966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659408|NCT00251966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92659409|NCT00251966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577256|NCT00268177|Fluticasone|fluticasone|mesh-list
92577257|NCT00268177|Xhance|xhance|mesh-list
92659410|NCT00251966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659411|NCT00252044|Pergolide|pergolide|mesh-list
92659412|NCT00252044|Dopamine Agonists|dopamine agonists|mesh-ancestor
92659413|NCT00252044|Dopamine Agents|dopamine agents|mesh-ancestor
92659414|NCT00252044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659415|NCT00252044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659416|NCT00252044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659417|NCT01805284|Linezolid|linezolid|mesh-list
92659418|NCT01805284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92659419|NCT01805284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659420|NCT01805284|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92659421|NCT01805284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659422|NCT01805284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659423|NCT00280605|Alfuzosin|alfuzosin|mesh-list
92659424|NCT00280605|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92659425|NCT00280605|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92659426|NCT00280605|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92659427|NCT00280605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659428|NCT00280605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659429|NCT00280605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659430|NCT00280605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659431|NCT00280605|Urological Agents|urological agents|mesh-ancestor
92659432|NCT01134601|Capecitabine|capecitabine|mesh-list
92659433|NCT01134601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659434|NCT01134601|Antimetabolites|antimetabolites|mesh-ancestor
92659435|NCT01134601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659436|NCT01134601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659437|NCT00252122|Ketamine|ketamine|mesh-list
92659438|NCT00252122|Analgesics|analgesics|mesh-ancestor
92659439|NCT00252122|Sensory System Agents|sensory system agents|mesh-ancestor
92659440|NCT00252122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659441|NCT00252122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659442|NCT00252122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92659443|NCT00252122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92659444|NCT00252122|Anesthetics, General|anesthetics, general|mesh-ancestor
92659445|NCT00252122|Anesthetics|anesthetics|mesh-ancestor
92659446|NCT00252122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659447|NCT00252122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92659448|NCT00252122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92659449|NCT00252122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659450|NCT00252122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659451|NCT00287157|Tizanidine|tizanidine|mesh-list
92659452|NCT00287157|Analgesics|analgesics|mesh-ancestor
92659453|NCT00287157|Sensory System Agents|sensory system agents|mesh-ancestor
92659454|NCT00287157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659455|NCT00287157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659456|NCT00287157|Anticonvulsants|anticonvulsants|mesh-ancestor
92659457|NCT00287157|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92659459|NCT00287157|Parasympatholytics|parasympatholytics|mesh-ancestor
92659464|NCT00287157|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659465|NCT00287157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659466|NCT00287157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659468|NCT00280644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659469|NCT00280644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659470|NCT00280644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659471|NCT00280644|Immunologic Factors|immunologic factors|mesh-ancestor
92659472|NCT00280644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659473|NCT00252200|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92659474|NCT00252200|Natriuretic Agents|natriuretic agents|mesh-ancestor
92659475|NCT00252200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659476|NCT00252278|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92659477|NCT00252278|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92659478|NCT00252278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92659479|NCT00252278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659480|NCT00252278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659481|NCT00252278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659482|NCT00252278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659483|NCT00252278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659484|NCT00252317|Captopril|captopril|mesh-list
92577258|NCT00268177|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92577259|NCT00268177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659485|NCT00252317|Trandolapril|trandolapril|mesh-list
92659486|NCT00252317|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92659487|NCT00252317|Protease Inhibitors|protease inhibitors|mesh-ancestor
92659488|NCT00252317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364578|NCT03063450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659489|NCT00252317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659490|NCT00252317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92659491|NCT00252356|Amibegron|amibegron|mesh-list
92659492|NCT00252356|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92659493|NCT00252356|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659494|NCT00252356|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659495|NCT00252356|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659496|NCT00252356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659497|NCT00252356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659498|NCT00252356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659499|NCT00252356|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92659500|NCT02753998|Paclitaxel|paclitaxel|mesh-list
92659501|NCT02753998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659502|NCT02753998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659503|NCT02753998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659504|NCT02753998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659505|NCT02753998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659506|NCT02753998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659507|NCT02754154|Warfarin|warfarin|mesh-list
92659508|NCT02754154|Rivaroxaban|rivaroxaban|mesh-list
92659509|NCT02754154|Dabigatran|dabigatran|mesh-list
92659510|NCT02754154|Apixaban|apixaban|mesh-list
92659511|NCT02754154|Anticoagulants|anticoagulants|mesh-ancestor
92659512|NCT02754154|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92659513|NCT02754154|Antithrombins|antithrombins|mesh-ancestor
92659514|NCT02754154|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92659515|NCT02754154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92659516|NCT02754154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659517|NCT02754154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659518|NCT00252434|Methamphetamine|methamphetamine|mesh-list
92659519|NCT00252434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92659520|NCT00252434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659521|NCT00252434|Sympathomimetics|sympathomimetics|mesh-ancestor
92659522|NCT00252434|Autonomic Agents|autonomic agents|mesh-ancestor
92659523|NCT00252434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659524|NCT00252434|Dopamine Agents|dopamine agents|mesh-ancestor
92659525|NCT00252434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659526|NCT00252434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659527|NCT00252434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659528|NCT00252434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92659532|NCT00280839|Topiramate|topiramate|mesh-list
92659533|NCT00280839|Anticonvulsants|anticonvulsants|mesh-ancestor
92659534|NCT00280839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92659535|NCT00280839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659536|NCT00280878|Rituximab|rituximab|mesh-list
92659537|NCT00280878|Gemcitabine|gemcitabine|mesh-list
92659538|NCT00280878|Vinorelbine|vinorelbine|mesh-list
92659539|NCT00280878|Ifosfamide|ifosfamide|mesh-list
92659540|NCT00280878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92659541|NCT00280878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659542|NCT00280878|Immunologic Factors|immunologic factors|mesh-ancestor
92659543|NCT00280878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659544|NCT00280878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92659545|NCT00280878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659546|NCT00280878|Antimetabolites|antimetabolites|mesh-ancestor
92659547|NCT00280878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659548|NCT00280878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659549|NCT00280878|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659550|NCT00280878|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659551|NCT00280878|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659552|NCT00280878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92659553|NCT00280878|Alkylating Agents|alkylating agents|mesh-ancestor
92659554|NCT02758717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92659555|NCT02758717|Nivolumab|nivolumab|mesh-list
92659556|NCT02758717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92659557|NCT02758717|Antibodies|antibodies|mesh-list
92659558|NCT02758717|Immunoglobulins|immunoglobulins|mesh-list
92659559|NCT02758717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92577260|NCT00268177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92577261|NCT00268177|Autonomic Agents|autonomic agents|mesh-ancestor
92577262|NCT00268177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577263|NCT00268177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659560|NCT02758717|Immunoconjugates|immunoconjugates|mesh-list
92659561|NCT02758717|Immunologic Factors|immunologic factors|mesh-ancestor
92659562|NCT02758717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659563|NCT02758717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659564|NCT02758717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92659565|NCT02758717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659566|NCT02758717|Immunotoxins|immunotoxins|mesh-ancestor
92659567|NCT00287313|Vitamin K|vitamin k|mesh-list
92659568|NCT00287313|Vitamins|vitamins|mesh-ancestor
92659569|NCT00287313|Micronutrients|micronutrients|mesh-ancestor
92659570|NCT00287313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659571|NCT00287313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92659572|NCT00287313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92659573|NCT00287313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659574|NCT00287313|Hemostatics|hemostatics|mesh-ancestor
92659575|NCT00287313|Coagulants|coagulants|mesh-ancestor
92659576|NCT01680250|Sirolimus|sirolimus|mesh-list
92659577|NCT01680250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92659578|NCT01680250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659579|NCT01680250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92659580|NCT01680250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659581|NCT01680250|Antifungal Agents|antifungal agents|mesh-ancestor
92659582|NCT01680250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659583|NCT01680250|Immunologic Factors|immunologic factors|mesh-ancestor
92659584|NCT01680250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659585|NCT00280956|Natalizumab|natalizumab|mesh-list
92659586|NCT00280956|Immunologic Factors|immunologic factors|mesh-ancestor
92659587|NCT00280956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659588|NCT02279875|Rifampin|rifampin|mesh-list
92659589|NCT02279875|Isoniazid|isoniazid|mesh-list
92659590|NCT02279875|Linezolid|linezolid|mesh-list
92659591|NCT02279875|Pyrazinamide|pyrazinamide|mesh-list
92659592|NCT02279875|Ethambutol|ethambutol|mesh-list
92659593|NCT02279875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92659594|NCT02279875|Antitubercular Agents|antitubercular agents|mesh-ancestor
92659595|NCT02279875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92659596|NCT02279875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659597|NCT02279875|Leprostatic Agents|leprostatic agents|mesh-ancestor
92659598|NCT02279875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92659599|NCT02279875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659600|NCT02279875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659601|NCT02279875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92659602|NCT02279875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92659605|NCT02279875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92659606|NCT02279875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92659607|NCT02279875|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92659608|NCT02279875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92659609|NCT02279875|Antimetabolites|antimetabolites|mesh-ancestor
92659610|NCT02279875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92659611|NCT02279875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92659612|NCT00280995|Mipomersen|mipomersen|mesh-list
92659613|NCT00280995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92659614|NCT00280995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92659615|NCT00280995|Antimetabolites|antimetabolites|mesh-ancestor
92659616|NCT00280995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659617|NCT00280995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92659618|NCT05139667|Tacrolimus|tacrolimus|mesh-list
92659619|NCT05139667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659620|NCT05139667|Immunologic Factors|immunologic factors|mesh-ancestor
92659621|NCT05139667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659622|NCT05139667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92659623|NCT05139667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659624|NCT05139667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659625|NCT00287352|Amantadine|amantadine|mesh-list
92659626|NCT00287352|Olanzapine|olanzapine|mesh-list
92659627|NCT00287352|Antiemetics|antiemetics|mesh-ancestor
92659628|NCT00287352|Autonomic Agents|autonomic agents|mesh-ancestor
92659629|NCT00287352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577264|NCT00268177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92577265|NCT00268177|Respiratory System Agents|respiratory system agents|mesh-ancestor
92577266|NCT00268177|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577267|NCT00268177|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92577268|NCT00268177|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92364586|NCT03035214|BB 1101|bb 1101|mesh-list
92659630|NCT00287352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659631|NCT00287352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659632|NCT00287352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92659633|NCT00287352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92659634|NCT00287352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659635|NCT00287352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92659636|NCT00287352|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92659637|NCT00287352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92659638|NCT00287352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659639|NCT00287352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659640|NCT00287352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659641|NCT00287352|Serotonin Agents|serotonin agents|mesh-ancestor
92659642|NCT00287352|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92659643|NCT00287352|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92659644|NCT00287352|Antiviral Agents|antiviral agents|mesh-ancestor
92659645|NCT00287352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659646|NCT00287352|Dopamine Agents|dopamine agents|mesh-ancestor
92659647|NCT00287352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92659648|NCT00287352|Analgesics|analgesics|mesh-ancestor
92659649|NCT00287352|Sensory System Agents|sensory system agents|mesh-ancestor
92659650|NCT04823962|Molgramostim|molgramostim|mesh-list
92659651|NCT04823962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659652|NCT00252668|Etanercept|etanercept|mesh-list
92659653|NCT00252668|Methotrexate|methotrexate|mesh-list
92659654|NCT00252668|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92659655|NCT00252668|Abortifacient Agents|abortifacient agents|mesh-ancestor
92659656|NCT00252668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92659657|NCT00252668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659658|NCT00252668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659659|NCT00252668|Antimetabolites|antimetabolites|mesh-ancestor
92659660|NCT00252668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659661|NCT00252668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659662|NCT00252668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92659663|NCT00252668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659664|NCT00252668|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92659665|NCT00252668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659666|NCT00252668|Immunologic Factors|immunologic factors|mesh-ancestor
92659667|NCT00252668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92659668|NCT00252668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92659669|NCT00252668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92659670|NCT00252668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92659671|NCT00252668|Analgesics|analgesics|mesh-ancestor
92659672|NCT00252668|Sensory System Agents|sensory system agents|mesh-ancestor
92659673|NCT00252668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659674|NCT00252668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659678|NCT02271997|Trace Elements|trace elements|mesh-ancestor
92659679|NCT02271997|Micronutrients|micronutrients|mesh-ancestor
92659680|NCT02271997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659681|NCT02271997|Hematinics|hematinics|mesh-ancestor
92659682|NCT00287391|Rabeprazole|rabeprazole|mesh-list
92659684|NCT00287391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659685|NCT00287391|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92659686|NCT00287391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659687|NCT00287391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659688|NCT00252707|Docetaxel|docetaxel|mesh-list
92659689|NCT00252707|Gefitinib|gefitinib|mesh-list
92659690|NCT00252707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659691|NCT00252707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659692|NCT00252707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659693|NCT00252707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659694|NCT00252707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659695|NCT00252707|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92659696|NCT00252707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659697|NCT01680406|Lumefantrine|lumefantrine|mesh-list
92659698|NCT01680406|Chloroquine|chloroquine|mesh-list
92577269|NCT00268177|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659699|NCT01680406|Artemether|artemether|mesh-list
92659700|NCT01680406|Primaquine|primaquine|mesh-list
92364593|NCT03035214|Glucocorticoids|glucocorticoids|mesh-ancestor
92659701|NCT01680406|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92659702|NCT01680406|Antimalarials|antimalarials|mesh-ancestor
92659703|NCT01680406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92659704|NCT01680406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92659705|NCT01680406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659706|NCT01680406|Amebicides|amebicides|mesh-ancestor
92659707|NCT01680406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92659708|NCT00287430|Hormones|hormones|mesh-list
92659709|NCT00287430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659710|NCT00287430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659711|NCT01680679|Vaccines|vaccines|mesh-list
92659712|NCT01680679|Immunologic Factors|immunologic factors|mesh-ancestor
92659713|NCT01680679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659714|NCT01680718|Vasopressins|vasopressins|mesh-list
92659715|NCT01680718|Arginine Vasopressin|arginine vasopressin|mesh-list
92659716|NCT01680718|Oxytocin|oxytocin|mesh-list
92659717|NCT01680718|Oxytocics|oxytocics|mesh-ancestor
92659718|NCT01680718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92659719|NCT01680718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659720|NCT01680718|Hemostatics|hemostatics|mesh-ancestor
92659721|NCT01680718|Coagulants|coagulants|mesh-ancestor
92659722|NCT01680718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92659723|NCT01680718|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92659724|NCT01680718|Natriuretic Agents|natriuretic agents|mesh-ancestor
92659725|NCT01680796|Dexamethasone|dexamethasone|mesh-list
92659726|NCT01680796|Bortezomib|bortezomib|mesh-list
92659727|NCT01680796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659728|NCT01680796|Antiemetics|antiemetics|mesh-ancestor
92659729|NCT01680796|Autonomic Agents|autonomic agents|mesh-ancestor
92659730|NCT01680796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659731|NCT01680796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659732|NCT01680796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659733|NCT01680796|Glucocorticoids|glucocorticoids|mesh-ancestor
92659734|NCT01680796|Hormones|hormones|mesh-ancestor
92659735|NCT01680796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659736|NCT01680796|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92659737|NCT01680796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659738|NCT00252785|Budesonide|budesonide|mesh-list
92659739|NCT00252785|Theophylline|theophylline|mesh-list
92659740|NCT00252785|Formoterol Fumarate|formoterol fumarate|mesh-list
92659741|NCT00252785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659742|NCT00252785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92659743|NCT00252785|Autonomic Agents|autonomic agents|mesh-ancestor
92659744|NCT00252785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659745|NCT00252785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659746|NCT00252785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92659747|NCT00252785|Respiratory System Agents|respiratory system agents|mesh-ancestor
92659748|NCT00252785|Glucocorticoids|glucocorticoids|mesh-ancestor
92659749|NCT00252785|Hormones|hormones|mesh-ancestor
92659750|NCT00252785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659751|NCT00252785|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92659756|NCT00252785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659757|NCT00252785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92659758|NCT00252785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659759|NCT00252785|Vasodilator Agents|vasodilator agents|mesh-ancestor
92659760|NCT00252785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92659761|NCT00252785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92659762|NCT00252785|Purinergic Agents|purinergic agents|mesh-ancestor
92659764|NCT01680913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659765|NCT01680913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659766|NCT01680952|Mycophenolic Acid|mycophenolic acid|mesh-list
92659768|NCT01680952|Tacrolimus|tacrolimus|mesh-list
92659769|NCT01680952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659770|NCT01680952|Immunologic Factors|immunologic factors|mesh-ancestor
92659771|NCT01680952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659772|NCT01680952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92659773|NCT01680952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659774|NCT01680952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659775|NCT01680952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92659776|NCT01680952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577271|NCT00268177|Adrenergic Agents|adrenergic agents|mesh-ancestor
92577272|NCT00268177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577273|NCT00268177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577274|NCT00268216|Fluticasone|fluticasone|mesh-list
92659777|NCT01680952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92659778|NCT01680952|Antitubercular Agents|antitubercular agents|mesh-ancestor
92659779|NCT01680952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92659780|NCT01680952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659781|NCT01680952|Antifungal Agents|antifungal agents|mesh-ancestor
92659782|NCT00252824|Budesonide|budesonide|mesh-list
92659783|NCT00252824|Formoterol Fumarate|formoterol fumarate|mesh-list
92659784|NCT00252824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659785|NCT00252824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92659786|NCT00252824|Autonomic Agents|autonomic agents|mesh-ancestor
92659787|NCT00252824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659788|NCT00252824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659789|NCT00252824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92659790|NCT00252824|Respiratory System Agents|respiratory system agents|mesh-ancestor
92659791|NCT00252824|Glucocorticoids|glucocorticoids|mesh-ancestor
92659792|NCT00252824|Hormones|hormones|mesh-ancestor
92659793|NCT00252824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659794|NCT00252824|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92659795|NCT00252824|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659796|NCT00252824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659797|NCT00252824|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659798|NCT00252824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659799|NCT00252824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659800|NCT00281190|Dimercaprol|dimercaprol|mesh-list
92659801|NCT00281190|Chelating Agents|chelating agents|mesh-ancestor
92659802|NCT00281190|Sequestering Agents|sequestering agents|mesh-ancestor
92659803|NCT00281190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659804|NCT00252863|Fluticasone|fluticasone|mesh-list
92659805|NCT00252863|Xhance|xhance|mesh-list
92659806|NCT00252863|Budesonide|budesonide|mesh-list
92659807|NCT00252863|Theophylline|theophylline|mesh-list
92659808|NCT00252863|Albuterol|albuterol|mesh-list
92659809|NCT00252863|Terbutaline|terbutaline|mesh-list
92659810|NCT00252863|Formoterol Fumarate|formoterol fumarate|mesh-list
92659811|NCT00252863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92659812|NCT00252863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92659813|NCT00252863|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92659814|NCT00252863|Montelukast|montelukast|mesh-list
92659815|NCT00252863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92659816|NCT00252863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92659817|NCT00252863|Autonomic Agents|autonomic agents|mesh-ancestor
92659818|NCT00252863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659819|NCT00252863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659820|NCT00252863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92659821|NCT00252863|Respiratory System Agents|respiratory system agents|mesh-ancestor
92659822|NCT00252863|Dermatologic Agents|dermatologic agents|mesh-ancestor
92659823|NCT00252863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92659827|NCT00252863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92659828|NCT00252863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659829|NCT00252863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659830|NCT00252863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659831|NCT00252863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659832|NCT00252863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659833|NCT00252863|Tocolytic Agents|tocolytic agents|mesh-ancestor
92385131|NCT00002526|Ifosfamide|ifosfamide|mesh-list
92659834|NCT00252863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92659835|NCT00252863|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92659836|NCT00252863|Hormone Antagonists|hormone antagonists|mesh-ancestor
92659837|NCT00252863|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92659838|NCT00252863|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92659839|NCT00252863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92659840|NCT00252863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659841|NCT00252863|Vasodilator Agents|vasodilator agents|mesh-ancestor
92659842|NCT00252863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92659843|NCT00252863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92659844|NCT00252863|Purinergic Agents|purinergic agents|mesh-ancestor
92659845|NCT00252863|Sympathomimetics|sympathomimetics|mesh-ancestor
92659846|NCT01681537|Cytarabine|cytarabine|mesh-list
92659847|NCT01681537|Etoposide|etoposide|mesh-list
92659848|NCT01681537|Mitoxantrone|mitoxantrone|mesh-list
92659849|NCT01681537|Lenalidomide|lenalidomide|mesh-list
92659850|NCT01681537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659851|NCT01681537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659852|NCT01681537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92659853|NCT01681537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92659854|NCT01681537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659855|NCT01681537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659856|NCT01681537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92659857|NCT01681537|Antimetabolites|antimetabolites|mesh-ancestor
92659858|NCT01681537|Antiviral Agents|antiviral agents|mesh-ancestor
92659859|NCT01681537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92659860|NCT01681537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92659861|NCT01681537|Immunologic Factors|immunologic factors|mesh-ancestor
92659862|NCT01681537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659863|NCT01681537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92659864|NCT01681537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92659865|NCT01681537|Growth Substances|growth substances|mesh-ancestor
92659866|NCT01681537|Growth Inhibitors|growth inhibitors|mesh-ancestor
92659867|NCT01681537|Analgesics|analgesics|mesh-ancestor
92659868|NCT01681537|Sensory System Agents|sensory system agents|mesh-ancestor
92659869|NCT01681537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659870|NCT01681693|Metformin|metformin|mesh-list
92659871|NCT01681693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92659872|NCT01681693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659873|NCT01681966|Ropivacaine|ropivacaine|mesh-list
92659874|NCT01681966|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92659875|NCT01681966|Anesthetics, Local|anesthetics, local|mesh-ancestor
92659876|NCT01681966|Anesthetics|anesthetics|mesh-ancestor
92659877|NCT01681966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659878|NCT01681966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659879|NCT01681966|Sensory System Agents|sensory system agents|mesh-ancestor
92659880|NCT01681966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659881|NCT01682161|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92659882|NCT01682161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92659883|NCT01682161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92659884|NCT01682161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659885|NCT01682161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659886|NCT01682161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92659887|NCT01682161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92659888|NCT01682161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92659889|NCT01682161|Serotonin Agents|serotonin agents|mesh-ancestor
92659890|NCT01682161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659891|NCT01682161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659892|NCT01682161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92659893|NCT01682161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92659894|NCT01682161|Dopamine Agents|dopamine agents|mesh-ancestor
92659897|NCT02279914|Abortifacient Agents|abortifacient agents|mesh-ancestor
92659898|NCT02279914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92659899|NCT02279914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659900|NCT02279914|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92659901|NCT02279914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659902|NCT02279914|Oxytocics|oxytocics|mesh-ancestor
92659903|NCT00281307|Tocopherols|tocopherols|mesh-list
92659904|NCT00281307|Vitamin E|vitamin e|mesh-list
92659905|NCT00281307|Tocotrienols|tocotrienols|mesh-list
92659906|NCT00281307|alpha-Tocopherol|alpha-tocopherol|mesh-list
92659907|NCT00281307|Antioxidants|antioxidants|mesh-ancestor
92659908|NCT00281307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385213|NCT00002556|Interferons|interferons|mesh-list
92659909|NCT00281307|Protective Agents|protective agents|mesh-ancestor
92659910|NCT00281307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659911|NCT00281307|Vitamins|vitamins|mesh-ancestor
92659912|NCT00281307|Micronutrients|micronutrients|mesh-ancestor
92659913|NCT01682746|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92659914|NCT01682746|Trioxsalen|trioxsalen|mesh-list
92659915|NCT01682746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659916|NCT01682746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92659917|NCT01682746|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92659918|NCT00287664|Terlipressin|terlipressin|mesh-list
92659919|NCT00287664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92659920|NCT00287664|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92659921|NCT01682902|Insulin|insulin|mesh-list
92659922|NCT01682902|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92659923|NCT01682902|Insulin Aspart|insulin aspart|mesh-list
92577276|NCT00268216|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92577277|NCT00268216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92577278|NCT00268216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92659924|NCT01682902|Insulin, Long-Acting|insulin, long-acting|mesh-list
92659925|NCT01682902|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92659926|NCT01682902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92659927|NCT01682902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659928|NCT01683175|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92659929|NCT01683175|Cisplatin|cisplatin|mesh-list
92659930|NCT01683175|Vinorelbine|vinorelbine|mesh-list
92659931|NCT01683175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659932|NCT01683175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92659933|NCT01683175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659934|NCT01683175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659935|NCT01683175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659936|NCT01683175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659937|NCT01683175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659938|NCT01683175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659939|NCT01683253|Dopamine|dopamine|mesh-list
92659940|NCT01683253|Levodopa|levodopa|mesh-list
92659941|NCT01683253|Carbidopa|carbidopa|mesh-list
92659942|NCT01683253|Dopamine Agonists|dopamine agonists|mesh-list
92659943|NCT01683253|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92659944|NCT01683253|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92659945|NCT01683253|Dopamine Agents|dopamine agents|mesh-ancestor
92659946|NCT01683253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659947|NCT01683253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659948|NCT01683253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659949|NCT01683253|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92659950|NCT01683253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659951|NCT01683253|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92659952|NCT01683253|Sympathomimetics|sympathomimetics|mesh-ancestor
92659953|NCT01683253|Autonomic Agents|autonomic agents|mesh-ancestor
92659954|NCT01683253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659955|NCT01683253|Protective Agents|protective agents|mesh-ancestor
92659956|NCT01683292|Apomorphine|apomorphine|mesh-list
92659957|NCT01683292|Emetics|emetics|mesh-ancestor
92659958|NCT01683292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659959|NCT01683292|Autonomic Agents|autonomic agents|mesh-ancestor
92659960|NCT01683292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659961|NCT01683292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659962|NCT01683292|Dopamine Agonists|dopamine agonists|mesh-ancestor
92659963|NCT01683292|Dopamine Agents|dopamine agents|mesh-ancestor
92659964|NCT01683292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659965|NCT01683292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659966|NCT00253058|Cetirizine|cetirizine|mesh-list
92659967|NCT00253058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92659968|NCT00253058|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92659969|NCT00253058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92659974|NCT00253058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659975|NCT01683682|Carboplatin|carboplatin|mesh-list
92659976|NCT01683682|Vinorelbine|vinorelbine|mesh-list
92659977|NCT01683682|Nintedanib|nintedanib|mesh-list
92659978|NCT01683682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659979|NCT01683682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92659980|NCT01683682|Tubulin Modulators|tubulin modulators|mesh-ancestor
92659981|NCT01683682|Antimitotic Agents|antimitotic agents|mesh-ancestor
92659982|NCT01683682|Mitosis Modulators|mitosis modulators|mesh-ancestor
92659983|NCT01683682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659984|NCT01683682|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92659985|NCT01683682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92659986|NCT00287742|Risperidone|risperidone|mesh-list
92659987|NCT00287742|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92659988|NCT00287742|Serotonin Agents|serotonin agents|mesh-ancestor
92659989|NCT00287742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659990|NCT00287742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92659991|NCT00287742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659992|NCT00287742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92659993|NCT00287742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92659994|NCT00287742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659995|NCT00287742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92659996|NCT00287742|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92659997|NCT00287742|Dopamine Agents|dopamine agents|mesh-ancestor
92577279|NCT00268216|Autonomic Agents|autonomic agents|mesh-ancestor
92577280|NCT00268216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577281|NCT00268216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577282|NCT00268216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92659998|NCT04527562|Colchicine|colchicine|mesh-list
92659999|NCT04527562|Gout Suppressants|gout suppressants|mesh-ancestor
92660000|NCT04527562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660001|NCT04527562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660002|NCT04527562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660003|NCT04527562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660004|NCT04527562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660005|NCT04527562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660006|NCT01684072|Vaccines|vaccines|mesh-list
92660007|NCT01684072|Immunologic Factors|immunologic factors|mesh-ancestor
92660008|NCT01684072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660009|NCT01684111|Vinorelbine|vinorelbine|mesh-list
92660010|NCT01684111|Nintedanib|nintedanib|mesh-list
92660011|NCT01684111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92660012|NCT01684111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660013|NCT01684111|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660014|NCT01684111|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660015|NCT01684111|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660016|NCT01684111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660017|NCT01684111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660018|NCT01684111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660019|NCT00253136|Risperidone|risperidone|mesh-list
92660020|NCT00253136|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92660021|NCT00253136|Serotonin Agents|serotonin agents|mesh-ancestor
92660022|NCT00253136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660023|NCT00253136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660024|NCT00253136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660025|NCT00253136|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660026|NCT00253136|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660027|NCT00253136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660028|NCT00253136|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660029|NCT00253136|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92660030|NCT00253136|Dopamine Agents|dopamine agents|mesh-ancestor
92660031|NCT01684306|Modafinil|modafinil|mesh-list
92660032|NCT01684306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92660033|NCT01684306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660034|NCT01684306|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92660035|NCT01684306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92660036|NCT01684306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92660037|NCT01684306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660038|NCT00287781|Lidocaine|lidocaine|mesh-list
92660039|NCT00287781|Anesthetics, Local|anesthetics, local|mesh-ancestor
92660040|NCT00287781|Anesthetics|anesthetics|mesh-ancestor
92660044|NCT00287781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660046|NCT00287781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92660047|NCT00287781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92660048|NCT00287781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660049|NCT00287781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660050|NCT00416871|Interferons|interferons|mesh-list
92660051|NCT00416871|Interferon-alpha|interferon-alpha|mesh-list
92660052|NCT00416871|Aldesleukin|aldesleukin|mesh-list
92660053|NCT00416871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660054|NCT00416871|Antiviral Agents|antiviral agents|mesh-ancestor
92660055|NCT00416871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660056|NCT00416871|Immunologic Factors|immunologic factors|mesh-ancestor
92660057|NCT00416871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660058|NCT00416871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92660059|NCT00416871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92660060|NCT01684657|Asenapine|asenapine|mesh-list
92660061|NCT01684657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660062|NCT01684657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660063|NCT01684657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660064|NCT01684657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660065|NCT01684657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660066|NCT00416910|Cyclophosphamide|cyclophosphamide|mesh-list
92660067|NCT00416910|Fludarabine|fludarabine|mesh-list
92660068|NCT00416910|Mitoxantrone|mitoxantrone|mesh-list
92660069|NCT00416910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577283|NCT00268216|Respiratory System Agents|respiratory system agents|mesh-ancestor
92577284|NCT00268216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577285|NCT00268216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92577286|NCT00268216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92577287|NCT00268216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92577288|NCT00268216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92577289|NCT00268216|Adrenergic Agents|adrenergic agents|mesh-ancestor
92660070|NCT00416910|Immunologic Factors|immunologic factors|mesh-ancestor
92660071|NCT00416910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660072|NCT00416910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660073|NCT00416910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92660074|NCT00416910|Alkylating Agents|alkylating agents|mesh-ancestor
92660075|NCT00416910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660076|NCT00416910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660077|NCT00416910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92660078|NCT00416910|Analgesics|analgesics|mesh-ancestor
92660079|NCT00416910|Sensory System Agents|sensory system agents|mesh-ancestor
92660080|NCT00416910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660081|NCT00416910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92660082|NCT00416910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660083|NCT00416910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660084|NCT01684774|Bupivacaine|bupivacaine|mesh-list
92660085|NCT01684774|Anesthetics, Local|anesthetics, local|mesh-ancestor
92660086|NCT01684774|Anesthetics|anesthetics|mesh-ancestor
92660087|NCT01684774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660088|NCT01684774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660089|NCT01684774|Sensory System Agents|sensory system agents|mesh-ancestor
92660090|NCT01684774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660091|NCT02279992|Carboplatin|carboplatin|mesh-list
92660092|NCT02279992|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92660093|NCT02279992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660094|NCT02279992|Vasodilator Agents|vasodilator agents|mesh-ancestor
92660095|NCT02279992|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92660096|NCT02279992|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92660097|NCT02279992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660098|NCT02279992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660099|NCT02279992|Urological Agents|urological agents|mesh-ancestor
92660100|NCT00253175|Topiramate|topiramate|mesh-list
92660101|NCT00253175|Anticonvulsants|anticonvulsants|mesh-ancestor
92660102|NCT00253175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92660103|NCT00253175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660104|NCT00287820|Olanzapine|olanzapine|mesh-list
92660105|NCT00287820|Risperidone|risperidone|mesh-list
92660106|NCT00287820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92660107|NCT00287820|Serotonin Agents|serotonin agents|mesh-ancestor
92660108|NCT00287820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660109|NCT00287820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660110|NCT00287820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660111|NCT00287820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660113|NCT00287820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660114|NCT00287820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660115|NCT00287820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92660116|NCT00287820|Dopamine Agents|dopamine agents|mesh-ancestor
92660118|NCT00287820|Autonomic Agents|autonomic agents|mesh-ancestor
92660119|NCT00287820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660120|NCT00287820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968051|NCT03087201|Analgesics|analgesics|mesh-ancestor
92660121|NCT00287820|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92660122|NCT00287820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92660123|NCT00287820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660124|NCT02272348|Insulin|insulin|mesh-list
92660125|NCT02272348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92660126|NCT02272348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660127|NCT00253214|Galantamine|galantamine|mesh-list
92660128|NCT00253214|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92660129|NCT00253214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660130|NCT00253214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660131|NCT00253214|Cholinergic Agents|cholinergic agents|mesh-ancestor
92577290|NCT00268216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577291|NCT00268216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577292|NCT00073580|Hirudins|hirudins|mesh-list
92010097|NCT04916093|Metformin|metformin|mesh-list
92660132|NCT00253214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660133|NCT00253214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660134|NCT00253214|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92385440|NCT00002634|Trace Elements|trace elements|mesh-ancestor
92660135|NCT00253214|Autonomic Agents|autonomic agents|mesh-ancestor
92660136|NCT00253214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660137|NCT00253214|Nootropic Agents|nootropic agents|mesh-ancestor
92660138|NCT00287859|Topotecan|topotecan|mesh-list
92660139|NCT00287859|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92660140|NCT00287859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660141|NCT00287859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660142|NCT00287859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660143|NCT00287859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660144|NCT01684969|Haloperidol|haloperidol|mesh-list
92660145|NCT01684969|Haloperidol decanoate|haloperidol decanoate|mesh-list
92660146|NCT01684969|Antiemetics|antiemetics|mesh-ancestor
92660147|NCT01684969|Autonomic Agents|autonomic agents|mesh-ancestor
92660148|NCT01684969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660149|NCT01684969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660150|NCT01684969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92660151|NCT01684969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660152|NCT01684969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660153|NCT01684969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660154|NCT01684969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660155|NCT01684969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92660156|NCT01684969|Dopamine Agents|dopamine agents|mesh-ancestor
92660157|NCT01684969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660158|NCT01684969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660159|NCT01684969|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92660160|NCT01685125|Prednisone|prednisone|mesh-list
92660161|NCT01685125|Dasatinib|dasatinib|mesh-list
92660162|NCT01685125|Abiraterone Acetate|abiraterone acetate|mesh-list
92660163|NCT01685125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92660164|NCT01685125|Glucocorticoids|glucocorticoids|mesh-ancestor
92660165|NCT01685125|Hormones|hormones|mesh-ancestor
92660166|NCT01685125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660167|NCT01685125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660168|NCT01685125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92660169|NCT01685125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660170|NCT01685125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660171|NCT01685125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660172|NCT01685125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660173|NCT01685125|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92660174|NCT01685125|Hormone Antagonists|hormone antagonists|mesh-ancestor
92660175|NCT01685125|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92660176|NCT04527679|Lenvatinib|lenvatinib|mesh-list
92660177|NCT04527679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660178|NCT04527679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660179|NCT04527679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660180|NCT04527679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660181|NCT01685281|Metadoxine|metadoxine|mesh-list
92660182|NCT01685281|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92660183|NCT00417066|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92660184|NCT00417066|Ganirelix|ganirelix|mesh-list
92660186|NCT00417066|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92660187|NCT00417066|Contraceptive Agents|contraceptive agents|mesh-ancestor
92660188|NCT00417066|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92660189|NCT00417066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660190|NCT00417066|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92660191|NCT00417066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92660192|NCT00417066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660193|NCT00417066|Hormone Antagonists|hormone antagonists|mesh-ancestor
92660194|NCT00417066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660195|NCT01685398|Timolol|timolol|mesh-list
92660196|NCT01685398|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92660197|NCT01685398|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92660198|NCT01685398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660199|NCT01685398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92660200|NCT01685398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92660201|NCT01685398|Adrenergic Agents|adrenergic agents|mesh-ancestor
92660202|NCT01685398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660203|NCT01685398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660204|NCT01685398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92660205|NCT01685398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92660206|NCT01685515|Decitabine|decitabine|mesh-list
92660207|NCT01685515|Tetrahydrouridine|tetrahydrouridine|mesh-list
92660208|NCT01685515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385523|NCT00002676|Antiemetics|antiemetics|mesh-ancestor
92660210|NCT01685515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660211|NCT01685515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660212|NCT01685515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660213|NCT00281502|Rifaximin|rifaximin|mesh-list
92660214|NCT00281502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660215|NCT00281502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660216|NCT00281502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92660217|NCT00253331|Nitroglycerin|nitroglycerin|mesh-list
92660218|NCT00253331|Vasodilator Agents|vasodilator agents|mesh-ancestor
92660219|NCT00253487|Temozolomide|temozolomide|mesh-list
92660220|NCT00253487|Busulfan|busulfan|mesh-list
92660221|NCT00253487|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92660222|NCT00253487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92660223|NCT00253487|Alkylating Agents|alkylating agents|mesh-ancestor
92660224|NCT00253487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660225|NCT00253487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660226|NCT00253487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660227|NCT00253487|Immunologic Factors|immunologic factors|mesh-ancestor
92660228|NCT00253487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660229|NCT00253487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92660230|NCT00253487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660231|NCT00281619|Mycophenolic Acid|mycophenolic acid|mesh-list
92660232|NCT00281619|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92660233|NCT00281619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660234|NCT00281619|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92660235|NCT00281619|Antitubercular Agents|antitubercular agents|mesh-ancestor
92660236|NCT00281619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660237|NCT00281619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660238|NCT00281619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660239|NCT00281619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660240|NCT04527211|Ivermectin|ivermectin|mesh-list
92660241|NCT04527211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92660242|NCT04527211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660243|NCT00253526|Bevacizumab|bevacizumab|mesh-list
92660244|NCT00253526|Gemcitabine|gemcitabine|mesh-list
92660245|NCT00253526|Antibodies|antibodies|mesh-list
92660246|NCT00253526|Immunoglobulins|immunoglobulins|mesh-list
92660247|NCT00253526|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92660248|NCT00253526|Mitogens|mitogens|mesh-list
92660249|NCT00253526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660250|NCT00253526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660251|NCT00253526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92660252|NCT00253526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92660253|NCT00253526|Growth Substances|growth substances|mesh-ancestor
92660254|NCT00253526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660255|NCT00253526|Growth Inhibitors|growth inhibitors|mesh-ancestor
92660256|NCT00253526|Immunologic Factors|immunologic factors|mesh-ancestor
92660257|NCT00253526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92660258|NCT00253526|Antimetabolites|antimetabolites|mesh-ancestor
92660266|NCT01686217|Immunologic Factors|immunologic factors|mesh-ancestor
92660267|NCT01686217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660268|NCT01686217|Vitamin B Complex|vitamin b complex|mesh-ancestor
92660270|NCT01686217|Micronutrients|micronutrients|mesh-ancestor
92660271|NCT00253565|Capecitabine|capecitabine|mesh-list
92660272|NCT00253565|Imatinib Mesylate|imatinib mesylate|mesh-list
92660273|NCT00253565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92660274|NCT00253565|Antimetabolites|antimetabolites|mesh-ancestor
92660275|NCT00253565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660276|NCT00253565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660277|NCT00253565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660278|NCT00253565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660279|NCT01686529|Bevacizumab|bevacizumab|mesh-list
92660280|NCT01686529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660281|NCT01686529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660282|NCT01686529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92577293|NCT00073580|Anticoagulants|anticoagulants|mesh-list
92577294|NCT00073580|Bivalirudin|bivalirudin|mesh-list
92577295|NCT00073580|Antithrombins|antithrombins|mesh-ancestor
92577296|NCT00073580|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92577297|NCT00073580|Protease Inhibitors|protease inhibitors|mesh-ancestor
92577298|NCT00073580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660283|NCT01686529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92660284|NCT01686529|Growth Substances|growth substances|mesh-ancestor
92660285|NCT01686529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660286|NCT01686529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92660287|NCT01686607|Itraconazole|itraconazole|mesh-list
92660288|NCT01686607|Fluconazole|fluconazole|mesh-list
92660289|NCT01686607|Voriconazole|voriconazole|mesh-list
92660290|NCT01686607|Amphotericin B|amphotericin b|mesh-list
92660291|NCT01686607|Caspofungin|caspofungin|mesh-list
92660292|NCT01686607|Micafungin|micafungin|mesh-list
92660293|NCT01686607|Antifungal Agents|antifungal agents|mesh-list
92660294|NCT01686607|Clotrimazole|clotrimazole|mesh-list
92660295|NCT01686607|Miconazole|miconazole|mesh-list
92660296|NCT01686607|Anidulafungin|anidulafungin|mesh-list
92660297|NCT01686607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660298|NCT01686607|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92660299|NCT01686607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92660300|NCT01686607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660301|NCT01686607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660302|NCT01686607|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92660303|NCT01686607|Hormone Antagonists|hormone antagonists|mesh-ancestor
92660304|NCT01686607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660305|NCT01686607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660306|NCT01686607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92660307|NCT01686607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92660308|NCT01686607|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92660309|NCT01686607|Amebicides|amebicides|mesh-ancestor
92660310|NCT01686607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92660311|NCT01686607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92660312|NCT01686607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660313|NCT01686607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92660314|NCT01686802|Ibuprofen|ibuprofen|mesh-list
92660315|NCT01686802|Morphine|morphine|mesh-list
92660316|NCT01686802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92660317|NCT01686802|Narcotics|narcotics|mesh-ancestor
92660318|NCT01686802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660319|NCT01686802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660320|NCT01686802|Analgesics|analgesics|mesh-ancestor
92660321|NCT01686802|Sensory System Agents|sensory system agents|mesh-ancestor
92660322|NCT01686802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660323|NCT01686802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92660324|NCT01686802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92660325|NCT01686802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92660326|NCT01686802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660331|NCT00253721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92660332|NCT00253721|Alkylating Agents|alkylating agents|mesh-ancestor
92660333|NCT00253721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660334|NCT00253721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660335|NCT00253721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92660336|NCT00253721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660337|NCT00253721|Immunologic Factors|immunologic factors|mesh-ancestor
92660338|NCT00253721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660339|NCT00281892|Vidarabine|vidarabine|mesh-list
92660340|NCT00281892|Fludarabine|fludarabine|mesh-list
92660341|NCT00281892|Fludarabine phosphate|fludarabine phosphate|mesh-list
92660342|NCT00281892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660343|NCT00281892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92660344|NCT00281892|Antimetabolites|antimetabolites|mesh-ancestor
92660345|NCT00281892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660346|NCT00281892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660347|NCT00281892|Immunologic Factors|immunologic factors|mesh-ancestor
92660348|NCT00281892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660349|NCT00281892|Antiviral Agents|antiviral agents|mesh-ancestor
92660350|NCT00281892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660351|NCT02274571|Estrogens|estrogens|mesh-list
92010317|NCT04913987|Cimetidine|cimetidine|mesh-list
92660352|NCT02274571|Hormones|hormones|mesh-ancestor
92660353|NCT02274571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660354|NCT02274571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660355|NCT00253799|Hylan|hylan|mesh-list
92660356|NCT00253799|Viscosupplements|viscosupplements|mesh-ancestor
92660357|NCT00253799|Protective Agents|protective agents|mesh-ancestor
92660358|NCT00253799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660359|NCT00281931|Cyclophosphamide|cyclophosphamide|mesh-list
92660360|NCT00281931|Rituximab|rituximab|mesh-list
92660361|NCT00281931|Fludarabine|fludarabine|mesh-list
92660362|NCT00281931|Fludarabine phosphate|fludarabine phosphate|mesh-list
92660363|NCT00281931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660364|NCT00281931|Immunologic Factors|immunologic factors|mesh-ancestor
92660365|NCT00281931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660366|NCT00281931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660367|NCT00281931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92660368|NCT00281931|Alkylating Agents|alkylating agents|mesh-ancestor
92660369|NCT00281931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660370|NCT00281931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660371|NCT00281931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92660372|NCT00281931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660373|NCT00281931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92660374|NCT00281931|Antimetabolites|antimetabolites|mesh-ancestor
92660375|NCT01687348|Lidocaine|lidocaine|mesh-list
92660376|NCT01687348|Anesthetics, Local|anesthetics, local|mesh-ancestor
92660377|NCT01687348|Anesthetics|anesthetics|mesh-ancestor
92660378|NCT01687348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660379|NCT01687348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660380|NCT01687348|Sensory System Agents|sensory system agents|mesh-ancestor
92660381|NCT01687348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660382|NCT01687348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92660383|NCT01687348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92660384|NCT01687348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92660385|NCT01687348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660386|NCT01687348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660387|NCT01687426|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92660388|NCT01687426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92660389|NCT01687426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92660390|NCT01687426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92660391|NCT01687426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92660392|NCT01687426|Adrenergic Agents|adrenergic agents|mesh-ancestor
92660393|NCT01687426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660394|NCT01687426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660395|NCT01687426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660399|NCT01687582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660400|NCT01687582|Incretins|incretins|mesh-ancestor
92660401|NCT01687582|Hormones|hormones|mesh-ancestor
92660402|NCT01687582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660403|NCT01687582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92660404|NCT01687699|Spironolactone|spironolactone|mesh-list
92660405|NCT01687699|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92660406|NCT01687699|Hormone Antagonists|hormone antagonists|mesh-ancestor
92660407|NCT01687699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364647|NCT03030690|Dopamine Agents|dopamine agents|mesh-ancestor
92660408|NCT01687699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660409|NCT01687699|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92660410|NCT01687699|Diuretics|diuretics|mesh-ancestor
92660411|NCT01687699|Natriuretic Agents|natriuretic agents|mesh-ancestor
92660412|NCT00287937|Paclitaxel|paclitaxel|mesh-list
92660413|NCT00287937|Carboplatin|carboplatin|mesh-list
92660414|NCT00287937|Vorinostat|vorinostat|mesh-list
92660415|NCT00287937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92660416|NCT00287937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660417|NCT00287937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660418|NCT00287937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660419|NCT00287937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660420|NCT00287937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660421|NCT00287937|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92660422|NCT00287937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660423|NCT01687894|Vasopressins|vasopressins|mesh-list
92660424|NCT01687894|Arginine Vasopressin|arginine vasopressin|mesh-list
92660425|NCT01687894|Propofol|propofol|mesh-list
92660426|NCT01687894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92577299|NCT00073580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577300|NCT00073580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92660427|NCT01687894|Anesthetics|anesthetics|mesh-list
92660428|NCT01687894|Sevoflurane|sevoflurane|mesh-list
92660429|NCT01687894|Anesthetics, General|anesthetics, general|mesh-list
92660430|NCT01687894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92660431|NCT01687894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660432|NCT01687894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660433|NCT01687894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92660434|NCT01687894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92660436|NCT01687894|Coagulants|coagulants|mesh-ancestor
92660437|NCT01687894|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92660438|NCT01687894|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92660439|NCT01687894|Natriuretic Agents|natriuretic agents|mesh-ancestor
92660440|NCT00287976|Irinotecan|irinotecan|mesh-list
92660441|NCT00287976|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92660442|NCT00287976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660443|NCT00287976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660444|NCT00287976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660445|NCT00287976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660446|NCT01688089|Levodopa|levodopa|mesh-list
92660447|NCT01688089|Carbidopa|carbidopa|mesh-list
92660448|NCT01688089|Entacapone|entacapone|mesh-list
92660449|NCT01688089|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92660450|NCT01688089|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92660451|NCT01688089|Dopamine Agents|dopamine agents|mesh-ancestor
92660452|NCT01688089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660453|NCT01688089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660454|NCT01688089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660455|NCT01688089|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92660456|NCT01688089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660457|NCT01688089|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92660458|NCT01688206|Atezolizumab|atezolizumab|mesh-list
92660459|NCT01688206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92660460|NCT01688206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660461|NCT01688206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660462|NCT01688206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660463|NCT00288171|Allopurinol|allopurinol|mesh-list
92660464|NCT00288171|Antimetabolites|antimetabolites|mesh-ancestor
92660465|NCT00288171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660466|NCT00288171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660467|NCT00288171|Gout Suppressants|gout suppressants|mesh-ancestor
92660468|NCT00288171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660469|NCT00288171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92660470|NCT00288171|Antioxidants|antioxidants|mesh-ancestor
92660474|NCT00253955|Tazobactam|tazobactam|mesh-list
92660475|NCT00253955|Piperacillin|piperacillin|mesh-list
92660476|NCT00253955|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92660477|NCT00253955|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92660478|NCT00253955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660479|NCT00253955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660480|NCT00253955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92660481|NCT00253955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660482|NCT00253955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660483|NCT00253955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660484|NCT00253955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660485|NCT00253955|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92660486|NCT00253955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92660487|NCT00253955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92660488|NCT00288249|Sagopilone|sagopilone|mesh-list
92660489|NCT00288249|Epothilones|epothilones|mesh-list
92660490|NCT00288249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660491|NCT00288249|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660492|NCT00288249|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660493|NCT00288249|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660494|NCT00288249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660495|NCT00254033|Methylphenidate|methylphenidate|mesh-list
92660496|NCT00254033|Dextroamphetamine|dextroamphetamine|mesh-list
92660497|NCT00254033|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92660498|NCT00254033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660499|NCT00254033|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92577301|NCT00073580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92577302|NCT00073658|Risperidone|risperidone|mesh-list
92577303|NCT00073658|Citalopram|citalopram|mesh-list
92577304|NCT00073658|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92577305|NCT00073658|Serotonin Agents|serotonin agents|mesh-ancestor
92660500|NCT00254033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92660501|NCT00254033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660502|NCT00254033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660503|NCT00254033|Dopamine Agents|dopamine agents|mesh-ancestor
92660504|NCT00254033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660505|NCT01600573|Topotecan|topotecan|mesh-list
92660506|NCT01600573|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92660507|NCT01600573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660508|NCT01600573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660509|NCT01600573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660510|NCT01600573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660511|NCT01600612|Oxytocin|oxytocin|mesh-list
92660512|NCT01600612|Carbetocin|carbetocin|mesh-list
92660513|NCT01600612|Oxytocics|oxytocics|mesh-ancestor
92660514|NCT01600612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92660515|NCT01600612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660516|NCT01600768|Lactams|lactams|mesh-list
92660517|NCT01600768|beta-Lactams|beta-lactams|mesh-list
92660518|NCT01600768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660519|NCT01600768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660520|NCT00414947|Vildagliptin|vildagliptin|mesh-list
92660521|NCT00414947|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92660522|NCT00414947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660523|NCT00414947|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92660524|NCT00414947|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364655|NCT03030300|Metformin|metformin|mesh-list
92660525|NCT00414947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660526|NCT00414947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660527|NCT00288444|Docetaxel|docetaxel|mesh-list
92660528|NCT00288444|Lonafarnib|lonafarnib|mesh-list
92660529|NCT00288444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660530|NCT00288444|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660531|NCT00288444|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660532|NCT00288444|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660533|NCT00288444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660534|NCT00288444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660535|NCT00417573|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92660536|NCT00417573|Immunologic Factors|immunologic factors|mesh-ancestor
92660537|NCT00417573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660538|NCT00415064|Dexamethasone|dexamethasone|mesh-list
92660539|NCT00415064|Lenalidomide|lenalidomide|mesh-list
92660540|NCT00415064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92660541|NCT00415064|Antiemetics|antiemetics|mesh-ancestor
92660542|NCT00415064|Autonomic Agents|autonomic agents|mesh-ancestor
92660543|NCT00415064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660546|NCT00415064|Glucocorticoids|glucocorticoids|mesh-ancestor
92660548|NCT00415064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660549|NCT00415064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92660550|NCT00415064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660551|NCT00415064|Immunologic Factors|immunologic factors|mesh-ancestor
92660552|NCT00415064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92660553|NCT00415064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92660554|NCT00415064|Growth Substances|growth substances|mesh-ancestor
92660555|NCT00415064|Growth Inhibitors|growth inhibitors|mesh-ancestor
92660556|NCT00415103|Aprepitant|aprepitant|mesh-list
92660557|NCT00415103|Palonosetron|palonosetron|mesh-list
92660558|NCT00415103|Granisetron|granisetron|mesh-list
92660559|NCT00415103|Antiemetics|antiemetics|mesh-ancestor
92660560|NCT00415103|Autonomic Agents|autonomic agents|mesh-ancestor
92660561|NCT00415103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660562|NCT00415103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660563|NCT00415103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92660564|NCT00415103|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92660565|NCT00415103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660566|NCT00415103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660567|NCT00415103|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92660568|NCT00415103|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92660569|NCT00415103|Serotonin Agents|serotonin agents|mesh-ancestor
92577306|NCT00073658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577307|NCT00073658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577308|NCT00073658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577309|NCT00073658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92577310|NCT00073658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660570|NCT00417690|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92660571|NCT00417690|Antitubercular Agents|antitubercular agents|mesh-ancestor
92660572|NCT00417690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660573|NCT00417690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92660574|NCT00417729|Acarbose|acarbose|mesh-list
92660575|NCT00417729|Glyburide|glyburide|mesh-list
92660576|NCT00417729|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92660577|NCT00417729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660578|NCT00417729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660579|NCT00417729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92660580|NCT00417729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660581|NCT00254189|Levonorgestrel|levonorgestrel|mesh-list
92660582|NCT00254189|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92660583|NCT00254189|Estradiol|estradiol|mesh-list
92385903|NCT05748990|Insulin|insulin|mesh-list
92660584|NCT00254189|Estrogens|estrogens|mesh-ancestor
92660585|NCT00254189|Hormones|hormones|mesh-ancestor
92660586|NCT00254189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660587|NCT00254189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660588|NCT00254189|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92660589|NCT00254189|Contraceptive Agents|contraceptive agents|mesh-ancestor
92660590|NCT00254189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92660591|NCT00254189|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92660592|NCT00254189|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92660593|NCT00254189|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92660594|NCT00254189|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92660595|NCT01600807|Gemcitabine|gemcitabine|mesh-list
92660596|NCT01600807|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92660597|NCT01600807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92660598|NCT01600807|Antimetabolites|antimetabolites|mesh-ancestor
92660599|NCT01600807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660600|NCT01600807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660601|NCT01600807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660602|NCT01600807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660603|NCT00288483|Policosanol|policosanol|mesh-list
92660604|NCT00288483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92660605|NCT00288483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92660606|NCT00288483|Antimetabolites|antimetabolites|mesh-ancestor
92660607|NCT00288483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660608|NCT00288483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92660609|NCT00288483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92660610|NCT01600963|Bedaquiline|bedaquiline|mesh-list
92660611|NCT01600963|Diarylquinolines|diarylquinolines|mesh-list
92660612|NCT01600963|Antitubercular Agents|antitubercular agents|mesh-ancestor
92660613|NCT01600963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92660614|NCT01600963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067855|NCT05928546|Quercetin|quercetin|mesh-list
92660620|NCT00254267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660621|NCT00254267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660622|NCT01601002|Mirtazapine|mirtazapine|mesh-list
92660623|NCT01601002|Antidepressive Agents|antidepressive agents|mesh-ancestor
92660624|NCT01601002|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660625|NCT01601002|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92660626|NCT01601002|Histamine Antagonists|histamine antagonists|mesh-ancestor
92660627|NCT01601002|Histamine Agents|histamine agents|mesh-ancestor
92660628|NCT01601002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660629|NCT01601002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660630|NCT01601002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660631|NCT01601002|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92660632|NCT01601002|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660633|NCT01601002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660634|NCT01601002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92577311|NCT00073658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577312|NCT00073658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92577313|NCT00073658|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92577315|NCT00073658|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92577316|NCT00073658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92577317|NCT00073658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92577318|NCT00073658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92577319|NCT00073658|Antidepressive Agents|antidepressive agents|mesh-ancestor
92577320|NCT00268255|Gefitinib|gefitinib|mesh-list
92577321|NCT00268255|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92577322|NCT00268255|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92577323|NCT00268255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577324|NCT00268255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92577325|NCT00268255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984669|NCT02683109|Olodaterol|olodaterol|mesh-list
92660635|NCT01601002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92660636|NCT01601002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92660637|NCT01601002|Adrenergic Agents|adrenergic agents|mesh-ancestor
92660638|NCT01601002|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92660639|NCT01601002|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92660640|NCT01601002|Serotonin Agents|serotonin agents|mesh-ancestor
92660641|NCT01601002|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92660642|NCT00288561|Ranibizumab|ranibizumab|mesh-list
92660643|NCT00288561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92660644|NCT00288561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92660645|NCT00288561|Growth Substances|growth substances|mesh-ancestor
92660646|NCT00288561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660647|NCT00288561|Growth Inhibitors|growth inhibitors|mesh-ancestor
92660648|NCT00288561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660649|NCT01607086|Lamotrigine|lamotrigine|mesh-list
92660650|NCT01607086|Anticonvulsants|anticonvulsants|mesh-ancestor
92660651|NCT01607086|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92660652|NCT01607086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660653|NCT01607086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660654|NCT01607086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92660655|NCT01607086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660656|NCT01607086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660657|NCT01607086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92385973|NCT05312112|Venetoclax|venetoclax|mesh-list
92660658|NCT01607086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660659|NCT01607086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660660|NCT01607086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92660661|NCT01607125|Vortioxetine|vortioxetine|mesh-list
92660662|NCT01607125|Antidepressive Agents|antidepressive agents|mesh-ancestor
92660663|NCT01607125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660664|NCT01607125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92660665|NCT01607125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660666|NCT01607125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660667|NCT01607125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660668|NCT01607125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92660669|NCT01607125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92660670|NCT01607125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660671|NCT01607125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660672|NCT01607125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660673|NCT01607125|Serotonin Agents|serotonin agents|mesh-ancestor
92577326|NCT00102414|Gemcitabine|gemcitabine|mesh-list
92577327|NCT00102414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577328|NCT00102414|Antimetabolites|antimetabolites|mesh-ancestor
92577329|NCT00102414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577330|NCT00102414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577331|NCT00268333|Leucovorin|leucovorin|mesh-list
92577332|NCT00268333|Fluorouracil|fluorouracil|mesh-list
92577333|NCT00268333|Oxaliplatin|oxaliplatin|mesh-list
92577334|NCT00268333|Calcium|calcium|mesh-list
92577335|NCT00268333|Levoleucovorin|levoleucovorin|mesh-list
92577336|NCT00268333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92577337|NCT00268333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577338|NCT00268333|Antimetabolites|antimetabolites|mesh-ancestor
92660674|NCT01607125|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92660675|NCT01607125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92660676|NCT01607125|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92660677|NCT01607125|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92660678|NCT00254345|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92660679|NCT00254345|Vasodilator Agents|vasodilator agents|mesh-ancestor
92660680|NCT00254345|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92660681|NCT00254345|Protective Agents|protective agents|mesh-ancestor
92660701|NCT01601314|Sensory System Agents|sensory system agents|mesh-ancestor
92660702|NCT01601314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660703|NCT01601314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660704|NCT01601314|Anesthetics|anesthetics|mesh-ancestor
92660705|NCT01601314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660706|NCT01601314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92660707|NCT01601314|Anticonvulsants|anticonvulsants|mesh-ancestor
92660708|NCT01601314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92660709|NCT01601314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660710|NCT01601314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660711|NCT01601314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92660712|NCT01601314|Tocolytic Agents|tocolytic agents|mesh-ancestor
92660713|NCT01601314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92660714|NCT00254657|Levetiracetam|levetiracetam|mesh-list
92660715|NCT00254657|Anticonvulsants|anticonvulsants|mesh-ancestor
92660716|NCT00254657|Nootropic Agents|nootropic agents|mesh-ancestor
92660717|NCT02482753|Exemestane|exemestane|mesh-list
92660718|NCT02482753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660719|NCT02482753|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92660720|NCT02482753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92660721|NCT02482753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660722|NCT02482753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660723|NCT02482753|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92660724|NCT02482753|Hormone Antagonists|hormone antagonists|mesh-ancestor
92660725|NCT02482753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660726|NCT02482753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660727|NCT00254735|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92660728|NCT00254735|Clomipramine|clomipramine|mesh-list
92660729|NCT00254735|Antidepressive Agents|antidepressive agents|mesh-ancestor
92386046|NCT04519164|Eplerenone|eplerenone|mesh-list
92660730|NCT00254735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660731|NCT00254735|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660732|NCT00254735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660733|NCT00254735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660734|NCT00254735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067997|NCT05839366|Propofol|propofol|mesh-list
92660737|NCT00254735|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92660738|NCT00254735|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660739|NCT00254735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660740|NCT00254735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660741|NCT00254735|Serotonin Agents|serotonin agents|mesh-ancestor
92577339|NCT00268333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577340|NCT00268333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92660742|NCT00288873|Cholecalciferol|cholecalciferol|mesh-list
92660743|NCT00288873|Vitamin D|vitamin d|mesh-list
92660744|NCT00288873|Ergocalciferols|ergocalciferols|mesh-list
92660745|NCT00288873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92660746|NCT00288873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660747|NCT00288873|Vitamins|vitamins|mesh-ancestor
92660748|NCT00288873|Micronutrients|micronutrients|mesh-ancestor
92660749|NCT00288873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92660750|NCT01608139|Curcumin|curcumin|mesh-list
92660751|NCT01608139|Sorafenib|sorafenib|mesh-list
92660752|NCT01608139|Vorinostat|vorinostat|mesh-list
92660753|NCT01608139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660754|NCT01608139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660755|NCT01608139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660756|NCT01608139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660757|NCT01608139|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92660758|NCT01608139|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92660759|NCT01608139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92660760|NCT01608139|Analgesics|analgesics|mesh-ancestor
92660761|NCT01608139|Sensory System Agents|sensory system agents|mesh-ancestor
92660762|NCT01608139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660763|NCT01608139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660764|NCT01608139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92660765|NCT01608139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660766|NCT01607671|Timolol|timolol|mesh-list
92660767|NCT01607671|Maleic acid|maleic acid|mesh-list
92660768|NCT01607671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660769|NCT01607671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660770|NCT01607671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92660771|NCT01607671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92660772|NCT01607671|Adrenergic Agents|adrenergic agents|mesh-ancestor
92660773|NCT01607671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660774|NCT01607671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660775|NCT01607671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92660776|NCT01607671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92660777|NCT00288951|Travoprost|travoprost|mesh-list
92660778|NCT00288951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92660779|NCT00254774|Valproic Acid|valproic acid|mesh-list
92660780|NCT00254774|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92660781|NCT00254774|Antidepressive Agents|antidepressive agents|mesh-ancestor
92660782|NCT00254774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660783|NCT00254774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660784|NCT00254774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660785|NCT00254774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660786|NCT00254774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660787|NCT00254774|Anticonvulsants|anticonvulsants|mesh-ancestor
92660788|NCT00254774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660789|NCT00254774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660790|NCT00254774|GABA Agents|gaba agents|mesh-ancestor
92660791|NCT00254774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660792|NCT00254774|Antimanic Agents|antimanic agents|mesh-ancestor
92660793|NCT01608334|Fentanyl|fentanyl|mesh-list
92660794|NCT01608334|Sufentanil|sufentanil|mesh-list
92660795|NCT01608334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92660796|NCT01608334|Narcotics|narcotics|mesh-ancestor
92660797|NCT01608334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660798|NCT01608334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660799|NCT01608334|Analgesics|analgesics|mesh-ancestor
92660800|NCT01608334|Sensory System Agents|sensory system agents|mesh-ancestor
92660801|NCT01608334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660802|NCT01608334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92660803|NCT01608334|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92660804|NCT01608334|Anesthetics, General|anesthetics, general|mesh-ancestor
92660805|NCT01608334|Anesthetics|anesthetics|mesh-ancestor
92660806|NCT01608373|Lidocaine|lidocaine|mesh-list
92660807|NCT01608373|Anesthetics, Local|anesthetics, local|mesh-ancestor
92660808|NCT01608373|Anesthetics|anesthetics|mesh-ancestor
92660822|NCT01608412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660823|NCT01608412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92660824|NCT01608412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660825|NCT01608412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660826|NCT01608412|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92577341|NCT00268333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577342|NCT00268333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577343|NCT00268333|Immunologic Factors|immunologic factors|mesh-ancestor
92577344|NCT00268333|Antidotes|antidotes|mesh-ancestor
92577345|NCT00268333|Protective Agents|protective agents|mesh-ancestor
91984688|NCT02544321|Dopamine Agents|dopamine agents|mesh-ancestor
92660827|NCT01608412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660828|NCT01608412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660829|NCT00254813|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92660830|NCT00254813|Antidepressive Agents|antidepressive agents|mesh-ancestor
92660831|NCT00254813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660832|NCT00254813|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660833|NCT00254813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660834|NCT00254813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660835|NCT00254813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660837|NCT01608646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660838|NCT01608841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92660839|NCT01608841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660840|NCT01608841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660841|NCT01608841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660842|NCT01608841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660843|NCT00254930|Risperidone|risperidone|mesh-list
92660844|NCT00254930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92660845|NCT00254930|Serotonin Agents|serotonin agents|mesh-ancestor
92660846|NCT00254930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660847|NCT00254930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660848|NCT00254930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660849|NCT00254930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92660850|NCT00254930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660851|NCT00254930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660852|NCT00254930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92660853|NCT00254930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92660854|NCT00254930|Dopamine Agents|dopamine agents|mesh-ancestor
92660855|NCT02273440|Theophylline|theophylline|mesh-list
92660856|NCT02273440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92660857|NCT02273440|Autonomic Agents|autonomic agents|mesh-ancestor
92660858|NCT02273440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660859|NCT02273440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660860|NCT02273440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92660861|NCT02273440|Respiratory System Agents|respiratory system agents|mesh-ancestor
92660862|NCT02273440|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92660863|NCT02273440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660864|NCT02273440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660865|NCT02273440|Vasodilator Agents|vasodilator agents|mesh-ancestor
92660866|NCT02273440|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92660867|NCT02273440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92660872|NCT01588717|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92660873|NCT01588717|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92660874|NCT01588717|Cholinergic Agents|cholinergic agents|mesh-ancestor
92660875|NCT01588717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660876|NCT01588717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660877|NCT01588717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660878|NCT00270075|Epoetin Alfa|epoetin alfa|mesh-list
92660879|NCT00270075|Hematinics|hematinics|mesh-ancestor
92660881|NCT01588756|Goralatide|goralatide|mesh-list
92660882|NCT01588756|Alkylating Agents|alkylating agents|mesh-ancestor
92660883|NCT01588756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660884|NCT01588756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92660885|NCT01588756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660886|NCT01588756|Growth Inhibitors|growth inhibitors|mesh-ancestor
92660887|NCT01588756|Growth Substances|growth substances|mesh-ancestor
92660888|NCT01588756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660889|NCT01588756|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92660890|NCT01588756|Protective Agents|protective agents|mesh-ancestor
92660891|NCT04719104|Bilirubin|bilirubin|mesh-list
92660892|NCT04719104|Antioxidants|antioxidants|mesh-ancestor
92660893|NCT04719104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660894|NCT04719104|Protective Agents|protective agents|mesh-ancestor
92660895|NCT04719104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577346|NCT00268333|Vitamin B Complex|vitamin b complex|mesh-ancestor
92577348|NCT00268333|Micronutrients|micronutrients|mesh-ancestor
92660896|NCT01588795|Vitamin D|vitamin d|mesh-list
92660897|NCT01588795|Cholecalciferol|cholecalciferol|mesh-list
92660898|NCT01588795|Diuretics|diuretics|mesh-list
92660899|NCT01588795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92660900|NCT01588795|Vitamins|vitamins|mesh-ancestor
92660901|NCT01588795|Micronutrients|micronutrients|mesh-ancestor
92660902|NCT01588795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660903|NCT01588795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92660904|NCT01588795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92660905|NCT01588795|Natriuretic Agents|natriuretic agents|mesh-ancestor
92660906|NCT01588795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660907|NCT00107614|Rituximab|rituximab|mesh-list
92660908|NCT00107614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660909|NCT00107614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660910|NCT00107614|Immunologic Factors|immunologic factors|mesh-ancestor
92660911|NCT00107614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660912|NCT00107614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660913|NCT00255242|Simvastatin|simvastatin|mesh-list
92660914|NCT00255242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92660915|NCT00255242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92660916|NCT00255242|Antimetabolites|antimetabolites|mesh-ancestor
92660917|NCT00255242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660918|NCT00255242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92660919|NCT00255242|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92660920|NCT00255242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660921|NCT00270114|Epoetin Alfa|epoetin alfa|mesh-list
92660922|NCT00270114|Hematinics|hematinics|mesh-ancestor
92660923|NCT00107380|Prednisone|prednisone|mesh-list
92660924|NCT00107380|Cyclophosphamide|cyclophosphamide|mesh-list
92660925|NCT00107380|Rituximab|rituximab|mesh-list
92660926|NCT00107380|Doxorubicin|doxorubicin|mesh-list
92660927|NCT00107380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92660928|NCT00107380|Vincristine|vincristine|mesh-list
92660929|NCT00107380|Tositumomab I-131|tositumomab i-131|mesh-list
92660930|NCT00107380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660931|NCT00107380|Immunologic Factors|immunologic factors|mesh-ancestor
92660932|NCT00107380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660933|NCT00107380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660934|NCT00107380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92660935|NCT00107380|Alkylating Agents|alkylating agents|mesh-ancestor
92660936|NCT00107380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660937|NCT00107380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660938|NCT00107380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92660939|NCT00107380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660940|NCT00107380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92660943|NCT00107380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660944|NCT00107380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92660946|NCT00107380|Hormones|hormones|mesh-ancestor
92660947|NCT00107380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92660948|NCT00107380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92660949|NCT00107380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92660950|NCT00107380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660951|NCT00107380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660952|NCT00107380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660953|NCT00270153|Enalapril|enalapril|mesh-list
92386263|NCT01096368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660954|NCT00270153|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92660955|NCT00270153|Protease Inhibitors|protease inhibitors|mesh-ancestor
92660956|NCT00270153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660957|NCT00270153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660958|NCT00270153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92660960|NCT04050085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92660961|NCT04050085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660962|NCT04050085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92660963|NCT04050085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660964|NCT04054531|Paclitaxel|paclitaxel|mesh-list
92660965|NCT04054531|Carboplatin|carboplatin|mesh-list
92660966|NCT04054531|Pemetrexed|pemetrexed|mesh-list
92660967|NCT04054531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92660968|NCT04054531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577349|NCT00073697|Dexetimide|dexetimide|mesh-list
92577350|NCT00073697|Citalopram|citalopram|mesh-list
92577351|NCT00073697|Escitalopram|escitalopram|mesh-list
92577352|NCT00073697|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91984692|NCT02533401|Rituximab|rituximab|mesh-list
92660969|NCT04054531|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660970|NCT04054531|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660971|NCT04054531|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660972|NCT04054531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660973|NCT04054531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660974|NCT04054531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92660975|NCT04054531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92660976|NCT00289263|Paclitaxel|paclitaxel|mesh-list
92660977|NCT00289263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92660978|NCT00289263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660979|NCT00289263|Tubulin Modulators|tubulin modulators|mesh-ancestor
92660980|NCT00289263|Antimitotic Agents|antimitotic agents|mesh-ancestor
92660981|NCT00289263|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660982|NCT00289263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660983|NCT00255437|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92660984|NCT00255437|Hematinics|hematinics|mesh-ancestor
92660985|NCT00255437|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92660986|NCT00255437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92660987|NCT00255476|Gefitinib|gefitinib|mesh-list
92660988|NCT00255476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660989|NCT00255476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660990|NCT00255476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660991|NCT00255476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660992|NCT00270270|Epoetin Alfa|epoetin alfa|mesh-list
92660993|NCT00270270|Hematinics|hematinics|mesh-ancestor
92660994|NCT04512118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92660995|NCT04512118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92660996|NCT04512118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660997|NCT00255515|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92660998|NCT00255515|Antidepressive Agents|antidepressive agents|mesh-ancestor
92660999|NCT00255515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661000|NCT00255515|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92661001|NCT00255515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661002|NCT00255515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661003|NCT00255515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661004|NCT00289419|Ketorolac|ketorolac|mesh-list
92661005|NCT00289419|Epinephrine|epinephrine|mesh-list
92661006|NCT00289419|Racepinephrine|racepinephrine|mesh-list
92661007|NCT00289419|Morphine|morphine|mesh-list
92661008|NCT00289419|Ropivacaine|ropivacaine|mesh-list
92661009|NCT00289419|Epinephryl borate|epinephryl borate|mesh-list
92661010|NCT00289419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92661011|NCT00289419|Narcotics|narcotics|mesh-ancestor
92661012|NCT00289419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068290|NCT05319587|Antimetabolites|antimetabolites|mesh-ancestor
92661015|NCT00289419|Sensory System Agents|sensory system agents|mesh-ancestor
92661016|NCT00289419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661017|NCT00289419|Anesthetics, Local|anesthetics, local|mesh-ancestor
92661019|NCT00289419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92661020|NCT00289419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92661021|NCT00289419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661022|NCT00289419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661023|NCT00289419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92661024|NCT00289419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661025|NCT00289419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661026|NCT00289419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92661027|NCT00289419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92661028|NCT00289419|Adrenergic Agents|adrenergic agents|mesh-ancestor
92661029|NCT00289419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661030|NCT00289419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92661031|NCT00289419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92661033|NCT00289419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92661034|NCT00289419|Respiratory System Agents|respiratory system agents|mesh-ancestor
92661035|NCT00289419|Mydriatics|mydriatics|mesh-ancestor
92661036|NCT00289419|Sympathomimetics|sympathomimetics|mesh-ancestor
92661037|NCT00289419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92661038|NCT00255554|Escitalopram|escitalopram|mesh-list
92577353|NCT00073697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92577354|NCT00073697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661039|NCT00255554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92661040|NCT00255554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92661041|NCT00255554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661042|NCT00255554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661043|NCT00255554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661044|NCT00255554|Serotonin Agents|serotonin agents|mesh-ancestor
92661045|NCT00255554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661046|NCT00270348|Ciclesonide|ciclesonide|mesh-list
92661047|NCT00270348|Glucocorticoids|glucocorticoids|mesh-ancestor
92661048|NCT00270348|Hormones|hormones|mesh-ancestor
92661049|NCT00270348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661050|NCT00270348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661051|NCT00270348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92661052|NCT00255593|Rituximab|rituximab|mesh-list
92661053|NCT00255593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92661054|NCT00255593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661055|NCT00255593|Immunologic Factors|immunologic factors|mesh-ancestor
92661056|NCT00255593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661057|NCT00255593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661058|NCT00270387|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92661059|NCT00270387|Natriuretic Agents|natriuretic agents|mesh-ancestor
92661060|NCT00270387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661061|NCT00255710|Mycophenolic Acid|mycophenolic acid|mesh-list
92661062|NCT00255710|Cyclophosphamide|cyclophosphamide|mesh-list
92661063|NCT00255710|Fludarabine|fludarabine|mesh-list
92661064|NCT00255710|Fludarabine phosphate|fludarabine phosphate|mesh-list
92661065|NCT00255710|Tacrolimus|tacrolimus|mesh-list
92661066|NCT00255710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661067|NCT00255710|Immunologic Factors|immunologic factors|mesh-ancestor
92661068|NCT00255710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661069|NCT00255710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661070|NCT00255710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92661071|NCT00255710|Alkylating Agents|alkylating agents|mesh-ancestor
92661072|NCT00255710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661073|NCT00255710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661074|NCT00255710|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92661075|NCT00255710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661076|NCT00255710|Antimetabolites|antimetabolites|mesh-ancestor
92661077|NCT00255710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92661078|NCT00255710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661079|NCT00255710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92661080|NCT00255710|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92661081|NCT00255710|Antitubercular Agents|antitubercular agents|mesh-ancestor
92661082|NCT00255710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661083|NCT00255710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661084|NCT00270426|Benazepril|benazepril|mesh-list
92661085|NCT00270426|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92661087|NCT00270426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661088|NCT00270426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661089|NCT00270426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92661091|NCT00255749|Hematinics|hematinics|mesh-ancestor
92661092|NCT00255788|Everolimus|everolimus|mesh-list
92661093|NCT00255788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92661094|NCT00255788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92661095|NCT00255788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661096|NCT00255788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661097|NCT00255788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661098|NCT00255788|Immunologic Factors|immunologic factors|mesh-ancestor
92661099|NCT00255788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661100|NCT00255788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661101|NCT04482361|Antibodies|antibodies|mesh-list
92661102|NCT04482361|Immunologic Factors|immunologic factors|mesh-ancestor
92386417|NCT00002880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661103|NCT04482361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661104|NCT00270543|Leucovorin|leucovorin|mesh-list
92661105|NCT00270543|Fluorouracil|fluorouracil|mesh-list
92661106|NCT00270543|Docetaxel|docetaxel|mesh-list
92661107|NCT00270543|Antimetabolites|antimetabolites|mesh-ancestor
92661108|NCT00270543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661109|NCT00270543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661110|NCT00270543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661111|NCT00270543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661112|NCT00270543|Immunologic Factors|immunologic factors|mesh-ancestor
92661113|NCT00270543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661114|NCT00270543|Antidotes|antidotes|mesh-ancestor
92661115|NCT00270543|Protective Agents|protective agents|mesh-ancestor
92661116|NCT00270543|Vitamin B Complex|vitamin b complex|mesh-ancestor
92661117|NCT00270543|Vitamins|vitamins|mesh-ancestor
92661118|NCT00270543|Micronutrients|micronutrients|mesh-ancestor
92661119|NCT00270543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661120|NCT00270543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661121|NCT00270543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661122|NCT02960919|Amoxicillin|amoxicillin|mesh-list
92661123|NCT02960919|Gentamicins|gentamicins|mesh-list
92661124|NCT02960919|Penicillins|penicillins|mesh-list
92661125|NCT02960919|Ampicillin|ampicillin|mesh-list
92661126|NCT02960919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661127|NCT02960919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661128|NCT02960919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92661129|NCT02960919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661130|NCT02960919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661131|NCT00270582|Gemcitabine|gemcitabine|mesh-list
92661132|NCT00270582|Docetaxel|docetaxel|mesh-list
92661133|NCT00270582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661134|NCT00270582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661135|NCT00270582|Antimetabolites|antimetabolites|mesh-ancestor
92661136|NCT00270582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661137|NCT00270582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661138|NCT00270582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661139|NCT00270582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661140|NCT01600456|Sertraline|sertraline|mesh-list
92661141|NCT01600456|Antidepressive Agents|antidepressive agents|mesh-ancestor
92661142|NCT01600456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661143|NCT01600456|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92661144|NCT01600456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92661145|NCT01600456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661146|NCT01600456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661147|NCT01600456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661148|NCT01600456|Serotonin Agents|serotonin agents|mesh-ancestor
92661149|NCT01600456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661150|NCT00289809|Ifosfamide|ifosfamide|mesh-list
92661151|NCT00289809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92661152|NCT00289809|Alkylating Agents|alkylating agents|mesh-ancestor
92661153|NCT00289809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661154|NCT00289809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661155|NCT00256100|PENTA|penta|mesh-list
92661156|NCT00256100|Fondaparinux|fondaparinux|mesh-list
92661157|NCT00256100|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92661158|NCT00256100|Antithrombins|antithrombins|mesh-ancestor
92661159|NCT00256100|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92661160|NCT00256100|Protease Inhibitors|protease inhibitors|mesh-ancestor
92661171|NCT01609192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661172|NCT01609192|Antisickling Agents|antisickling agents|mesh-ancestor
92661173|NCT01609192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661174|NCT01609192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661175|NCT01609192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92661176|NCT01609387|Tocopherols|tocopherols|mesh-list
92661177|NCT01609387|Antioxidants|antioxidants|mesh-ancestor
92661178|NCT01609387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661179|NCT01609387|Protective Agents|protective agents|mesh-ancestor
92661180|NCT01609387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661181|NCT01609387|Vitamins|vitamins|mesh-ancestor
92661182|NCT01609387|Micronutrients|micronutrients|mesh-ancestor
92661183|NCT00256178|Simvastatin|simvastatin|mesh-list
92661184|NCT00256178|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92661185|NCT00256178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92661186|NCT00256178|Antimetabolites|antimetabolites|mesh-ancestor
92661187|NCT00256178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661188|NCT00256178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92661189|NCT00256178|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92661190|NCT00256178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661191|NCT02488408|Cytarabine|cytarabine|mesh-list
92661192|NCT02488408|Decitabine|decitabine|mesh-list
92661193|NCT02488408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661194|NCT02488408|Antimetabolites|antimetabolites|mesh-ancestor
92577355|NCT00073697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577356|NCT00073697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661195|NCT02488408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661196|NCT02488408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661197|NCT02488408|Antiviral Agents|antiviral agents|mesh-ancestor
92661198|NCT02488408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661199|NCT02488408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661200|NCT02488408|Immunologic Factors|immunologic factors|mesh-ancestor
92661201|NCT02488408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661202|NCT02488408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661203|NCT00270777|Promethazine|promethazine|mesh-list
92661204|NCT00270777|Diphenhydramine|diphenhydramine|mesh-list
92661205|NCT00270777|Hydrocortisone|hydrocortisone|mesh-list
92661206|NCT00270777|Epinephrine|epinephrine|mesh-list
92661207|NCT00270777|Racepinephrine|racepinephrine|mesh-list
92661208|NCT00270777|Epinephryl borate|epinephryl borate|mesh-list
92661209|NCT00270777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661210|NCT00270777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92661211|NCT00270777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92661212|NCT00270777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92661213|NCT00270777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661214|NCT00270777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661215|NCT00270777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661216|NCT00270777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92661217|NCT00270777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92661218|NCT00270777|Autonomic Agents|autonomic agents|mesh-ancestor
92661219|NCT00270777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661220|NCT00270777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92661221|NCT00270777|Respiratory System Agents|respiratory system agents|mesh-ancestor
92661222|NCT00270777|Mydriatics|mydriatics|mesh-ancestor
92661223|NCT00270777|Sympathomimetics|sympathomimetics|mesh-ancestor
92661224|NCT00270777|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92661225|NCT00270777|Antipruritics|antipruritics|mesh-ancestor
92068510|NCT04722822|Vaccines|vaccines|mesh-list
92661237|NCT00270777|Antiemetics|antiemetics|mesh-ancestor
92661238|NCT00270777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661239|NCT00256256|Glucagon|glucagon|mesh-list
92661240|NCT00256256|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92661241|NCT00256256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661242|NCT00256256|Hormones|hormones|mesh-ancestor
92661243|NCT00256256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661244|NCT00256256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661245|NCT00256256|Incretins|incretins|mesh-ancestor
92661246|NCT00256334|Resveratrol|resveratrol|mesh-list
92661247|NCT00256334|Antioxidants|antioxidants|mesh-ancestor
92661248|NCT00256334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661249|NCT00256334|Protective Agents|protective agents|mesh-ancestor
92661250|NCT00256334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661251|NCT00256334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661252|NCT00256334|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92661253|NCT01609855|Scopolamine|scopolamine|mesh-list
92661254|NCT01609855|Bromides|bromides|mesh-list
92661255|NCT01609855|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92661256|NCT01609855|Anticonvulsants|anticonvulsants|mesh-ancestor
92661257|NCT01609855|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92661258|NCT01609855|Antiemetics|antiemetics|mesh-ancestor
92661259|NCT01609855|Autonomic Agents|autonomic agents|mesh-ancestor
92661260|NCT01609855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661261|NCT01609855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661262|NCT01609855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661263|NCT01609855|Mydriatics|mydriatics|mesh-ancestor
92661264|NCT01609855|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92661265|NCT01609855|Cholinergic Agents|cholinergic agents|mesh-ancestor
92661266|NCT01609855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661267|NCT01609855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661268|NCT01609855|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92661269|NCT01609855|Parasympatholytics|parasympatholytics|mesh-ancestor
92661270|NCT00270816|Interferons|interferons|mesh-list
92661271|NCT00270816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661272|NCT00270816|Antiviral Agents|antiviral agents|mesh-ancestor
92661273|NCT00270816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661274|NCT00290004|Motexafin gadolinium|motexafin gadolinium|mesh-list
92661275|NCT00290004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661276|NCT00290004|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92661277|NCT00290004|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577357|NCT00073697|Serotonin Agents|serotonin agents|mesh-ancestor
92577358|NCT00073697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577359|NCT00073697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92577360|NCT00073697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92577361|NCT00073697|Parasympatholytics|parasympatholytics|mesh-ancestor
92661278|NCT01609816|Dasatinib|dasatinib|mesh-list
92661279|NCT01609816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661280|NCT01609816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92661281|NCT01609816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661282|NCT01609816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661283|NCT00290043|Insulin glulisine|insulin glulisine|mesh-list
92661284|NCT00290043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92661285|NCT00290043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661286|NCT00290082|Midazolam|midazolam|mesh-list
92661287|NCT00290082|Loxapine|loxapine|mesh-list
92661288|NCT00290082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92661289|NCT00290082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92661290|NCT00290082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661291|NCT00290082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661302|NCT00290082|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92661303|NCT00290082|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92661304|NCT00290082|Dopamine Agents|dopamine agents|mesh-ancestor
92661305|NCT00256646|Rosiglitazone|rosiglitazone|mesh-list
92661306|NCT00256646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92661307|NCT00256646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661308|NCT02270437|Epinephrine|epinephrine|mesh-list
92661309|NCT02270437|Racepinephrine|racepinephrine|mesh-list
92661310|NCT02270437|Fentanyl|fentanyl|mesh-list
92661311|NCT02270437|Ropivacaine|ropivacaine|mesh-list
92661312|NCT02270437|Epinephryl borate|epinephryl borate|mesh-list
92661313|NCT02270437|Anesthetics, Local|anesthetics, local|mesh-ancestor
92661314|NCT02270437|Anesthetics|anesthetics|mesh-ancestor
92661315|NCT02270437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661316|NCT02270437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661317|NCT02270437|Sensory System Agents|sensory system agents|mesh-ancestor
92661318|NCT02270437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661319|NCT02270437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92661320|NCT02270437|Narcotics|narcotics|mesh-ancestor
92661321|NCT02270437|Analgesics|analgesics|mesh-ancestor
92661322|NCT02270437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92661323|NCT02270437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92661324|NCT02270437|Anesthetics, General|anesthetics, general|mesh-ancestor
92661325|NCT02270437|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92661326|NCT02270437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92661327|NCT02270437|Adrenergic Agents|adrenergic agents|mesh-ancestor
92661328|NCT02270437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661329|NCT02270437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661330|NCT02270437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92661331|NCT02270437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92386642|NCT00003072|Amifostine|amifostine|mesh-list
92661332|NCT02270437|Autonomic Agents|autonomic agents|mesh-ancestor
92661333|NCT02270437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92661334|NCT02270437|Respiratory System Agents|respiratory system agents|mesh-ancestor
92661336|NCT02270437|Sympathomimetics|sympathomimetics|mesh-ancestor
92661337|NCT02270437|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92661338|NCT02270749|Vitamin B 12|vitamin b 12|mesh-list
92661339|NCT02270749|Hydroxocobalamin|hydroxocobalamin|mesh-list
92661340|NCT02270749|Vitamins|vitamins|mesh-ancestor
92661341|NCT02270749|Micronutrients|micronutrients|mesh-ancestor
92661342|NCT02270749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661343|NCT02270749|Vitamin B Complex|vitamin b complex|mesh-ancestor
92661344|NCT02270749|Hematinics|hematinics|mesh-ancestor
92661345|NCT02270788|Leucovorin|leucovorin|mesh-list
92661346|NCT02270788|Cytarabine|cytarabine|mesh-list
92661347|NCT02270788|Hydrocortisone|hydrocortisone|mesh-list
92661348|NCT02270788|Methotrexate|methotrexate|mesh-list
92661349|NCT02270788|Sorafenib|sorafenib|mesh-list
92661350|NCT02270788|Crenolanib|crenolanib|mesh-list
92661351|NCT02270788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92661352|NCT02270788|Abortifacient Agents|abortifacient agents|mesh-ancestor
92661353|NCT02270788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92661354|NCT02270788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661355|NCT02270788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661356|NCT02270788|Antimetabolites|antimetabolites|mesh-ancestor
92011308|NCT03981211|Sofosbuvir|sofosbuvir|mesh-list
92011311|NCT04856111|Pirfenidone|pirfenidone|mesh-list
92661357|NCT02270788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661358|NCT02270788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661359|NCT02270788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92661360|NCT02270788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068647|NCT04416451|Immunologic Factors|immunologic factors|mesh-ancestor
92661363|NCT02270788|Immunologic Factors|immunologic factors|mesh-ancestor
92661364|NCT02270788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661365|NCT02270788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92661367|NCT02270788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661368|NCT02270788|Antidotes|antidotes|mesh-ancestor
92661369|NCT02270788|Protective Agents|protective agents|mesh-ancestor
92661370|NCT02270788|Vitamin B Complex|vitamin b complex|mesh-ancestor
92661371|NCT02270788|Vitamins|vitamins|mesh-ancestor
92661372|NCT02270788|Micronutrients|micronutrients|mesh-ancestor
92661373|NCT02270788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92661374|NCT02270788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661375|NCT02270827|Hydrocortisone|hydrocortisone|mesh-list
92661376|NCT02270827|Aminophylline|aminophylline|mesh-list
92661377|NCT02270827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661378|NCT02270827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92661379|NCT02270827|Autonomic Agents|autonomic agents|mesh-ancestor
92661380|NCT02270827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661381|NCT02270827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661382|NCT02270827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92661383|NCT02270827|Respiratory System Agents|respiratory system agents|mesh-ancestor
92661384|NCT02270827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92661385|NCT02270827|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92661386|NCT02270827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661387|NCT02270827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661388|NCT02270827|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92661389|NCT02270827|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92661390|NCT02270827|Purinergic Agents|purinergic agents|mesh-ancestor
92661391|NCT02270827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661392|NCT02270827|Protective Agents|protective agents|mesh-ancestor
92661393|NCT00290121|Olanzapine|olanzapine|mesh-list
92661394|NCT00290121|Antiemetics|antiemetics|mesh-ancestor
92661395|NCT00290121|Autonomic Agents|autonomic agents|mesh-ancestor
92661396|NCT00290121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661397|NCT00290121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661398|NCT00290121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661399|NCT00290121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92661400|NCT00290121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661401|NCT00290121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661402|NCT00290121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661403|NCT00290121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92661404|NCT00290121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92661405|NCT00290121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661406|NCT00290121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661407|NCT00290121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661408|NCT00290121|Serotonin Agents|serotonin agents|mesh-ancestor
92661409|NCT04709744|Vitamin D|vitamin d|mesh-list
92661410|NCT04709744|Ergocalciferols|ergocalciferols|mesh-list
92661411|NCT04709744|Cholecalciferol|cholecalciferol|mesh-list
92661412|NCT04709744|Vitamins|vitamins|mesh-list
92661413|NCT04709744|Micronutrients|micronutrients|mesh-ancestor
92661414|NCT04709744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661415|NCT04709744|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92661416|NCT04709744|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92661417|NCT02271295|Enoxaparin|enoxaparin|mesh-list
92661418|NCT02271295|Anticoagulants|anticoagulants|mesh-ancestor
92661419|NCT02271295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92661420|NCT02271295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92661421|NCT02271295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661422|NCT02271412|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92661423|NCT02271412|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92661424|NCT02271412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92661425|NCT02271412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661426|NCT02271412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661427|NCT02271412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661428|NCT02271412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661429|NCT02271412|Antidepressive Agents|antidepressive agents|mesh-ancestor
92577362|NCT00073697|Autonomic Agents|autonomic agents|mesh-ancestor
92577363|NCT00073697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577364|NCT00073697|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92011395|NCT01553071|Safingol|safingol|mesh-list
92661430|NCT02271412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661431|NCT00271050|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92661432|NCT00271050|Immunologic Factors|immunologic factors|mesh-ancestor
92661440|NCT02271646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661442|NCT02271802|Histamine Antagonists|histamine antagonists|mesh-ancestor
92661443|NCT02271802|Histamine Agents|histamine agents|mesh-ancestor
92661444|NCT02271802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661445|NCT02271802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661446|NCT02271802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661447|NCT02271958|Mifepristone|mifepristone|mesh-list
92661448|NCT02271958|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92661449|NCT02271958|Abortifacient Agents|abortifacient agents|mesh-ancestor
92661450|NCT02271958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92661451|NCT02271958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661452|NCT02271958|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92661453|NCT02271958|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92661454|NCT02271958|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92661455|NCT02271958|Contraceptive Agents|contraceptive agents|mesh-ancestor
92661456|NCT02271958|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92661457|NCT02271958|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92661458|NCT02271958|Hormone Antagonists|hormone antagonists|mesh-ancestor
92661459|NCT02271958|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661460|NCT02271958|Luteolytic Agents|luteolytic agents|mesh-ancestor
92661461|NCT02271958|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92661462|NCT02271958|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92661463|NCT00257036|Levofloxacin|levofloxacin|mesh-list
92661464|NCT00257036|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92661465|NCT00257036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661466|NCT00257036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661467|NCT00257036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92661468|NCT00257036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92661469|NCT00257036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661470|NCT00257036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661471|NCT00257036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661472|NCT00257036|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92661473|NCT00257036|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92661474|NCT00257075|Risperidone|risperidone|mesh-list
92661475|NCT00257075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92661476|NCT00257075|Serotonin Agents|serotonin agents|mesh-ancestor
92661477|NCT00257075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661478|NCT00257075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661479|NCT00257075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661480|NCT00257075|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92661481|NCT00257075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661482|NCT00257075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386792|NCT00003018|Leucovorin|leucovorin|mesh-list
92661484|NCT00257075|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92661485|NCT00257075|Dopamine Agents|dopamine agents|mesh-ancestor
92661486|NCT02272270|Minocycline|minocycline|mesh-list
92661487|NCT02272270|Temozolomide|temozolomide|mesh-list
92661488|NCT02272270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92661489|NCT02272270|Alkylating Agents|alkylating agents|mesh-ancestor
92661490|NCT02272270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661491|NCT02272270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661492|NCT02272270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661493|NCT02272270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661494|NCT02272387|Vitamin D|vitamin d|mesh-list
92661495|NCT02272387|Cholecalciferol|cholecalciferol|mesh-list
92661496|NCT02272387|Vitamins|vitamins|mesh-ancestor
92661497|NCT02272387|Micronutrients|micronutrients|mesh-ancestor
92661498|NCT02272387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661500|NCT02272387|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92661502|NCT00257114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661503|NCT00271206|Progesterone|progesterone|mesh-list
92661504|NCT00271206|Progestins|progestins|mesh-ancestor
92661505|NCT00271206|Hormones|hormones|mesh-ancestor
92577365|NCT00073697|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92577366|NCT00073697|Cholinergic Agents|cholinergic agents|mesh-ancestor
91984702|NCT02533401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92661506|NCT00271206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661507|NCT00271206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661509|NCT02272582|Anticoagulants|anticoagulants|mesh-ancestor
92661510|NCT02272582|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92661511|NCT02272582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92661512|NCT02272582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661513|NCT02272660|Parecoxib|parecoxib|mesh-list
92661514|NCT02272660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92661515|NCT02272660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92661516|NCT02272660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661517|NCT02272660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661518|NCT02272660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92661519|NCT02272660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92661520|NCT02272660|Analgesics|analgesics|mesh-ancestor
92661521|NCT02272660|Sensory System Agents|sensory system agents|mesh-ancestor
92661522|NCT02272660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661523|NCT02272660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661524|NCT02272660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661525|NCT02272660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661526|NCT02272699|Paclitaxel|paclitaxel|mesh-list
92661527|NCT02272699|Nimotuzumab|nimotuzumab|mesh-list
92661528|NCT02272699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92661529|NCT02272699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661530|NCT02272699|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661531|NCT02272699|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661532|NCT02272699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661533|NCT02272699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661534|NCT02272699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92661535|NCT02272738|Paclitaxel|paclitaxel|mesh-list
92661536|NCT02272738|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92661537|NCT02272738|Gemcitabine|gemcitabine|mesh-list
92661538|NCT02272738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92661539|NCT02272738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661540|NCT02272738|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661541|NCT02272738|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661542|NCT02272738|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661543|NCT02272738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661544|NCT02272738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661545|NCT02272738|Antimetabolites|antimetabolites|mesh-ancestor
92661546|NCT00271245|Selenium|selenium|mesh-list
92661547|NCT00271245|Selenic Acid|selenic acid|mesh-list
92661548|NCT00271245|Antioxidants|antioxidants|mesh-ancestor
92661549|NCT00271245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661550|NCT00271245|Protective Agents|protective agents|mesh-ancestor
92661551|NCT00271245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661552|NCT00271245|Trace Elements|trace elements|mesh-ancestor
92661553|NCT00271245|Micronutrients|micronutrients|mesh-ancestor
92661554|NCT02272855|Ipilimumab|ipilimumab|mesh-list
92661555|NCT02272855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92661556|NCT02272855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661557|NCT02272855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92661558|NCT02272855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661559|NCT00257270|Gabapentin|gabapentin|mesh-list
92661560|NCT00257270|Analgesics|analgesics|mesh-ancestor
92661561|NCT00257270|Sensory System Agents|sensory system agents|mesh-ancestor
92661562|NCT00257270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661563|NCT00257270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661564|NCT00257270|Anticonvulsants|anticonvulsants|mesh-ancestor
92661565|NCT00257270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92661566|NCT00257270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661567|NCT00257270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661568|NCT00257270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661569|NCT00257270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92661570|NCT00257270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92661572|NCT00257270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661573|NCT00257270|Antimanic Agents|antimanic agents|mesh-ancestor
92577367|NCT00073697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92577368|NCT00073697|Antidepressive Agents|antidepressive agents|mesh-ancestor
92577370|NCT00268372|Docetaxel|docetaxel|mesh-list
92661574|NCT00290394|Rosiglitazone|rosiglitazone|mesh-list
92661575|NCT00290394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92661576|NCT00290394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661577|NCT00257348|Docetaxel|docetaxel|mesh-list
92661578|NCT00257348|Capecitabine|capecitabine|mesh-list
92661579|NCT00257348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661580|NCT00257348|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661581|NCT00257348|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661582|NCT00257348|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661583|NCT00257348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661584|NCT00257348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661585|NCT00257348|Antimetabolites|antimetabolites|mesh-ancestor
92661586|NCT02273128|Calcitonin|calcitonin|mesh-list
92661587|NCT02273128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92661588|NCT02273128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661589|NCT02273128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92661590|NCT00257387|Cyclosporine|cyclosporine|mesh-list
92661591|NCT00257387|Cyclosporins|cyclosporins|mesh-list
92661592|NCT00257387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661593|NCT00257387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661594|NCT00257387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661595|NCT00257387|Immunologic Factors|immunologic factors|mesh-ancestor
92661596|NCT00257387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661597|NCT00257387|Antifungal Agents|antifungal agents|mesh-ancestor
92661598|NCT00257387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661599|NCT00257387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92661600|NCT00257387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661601|NCT00257387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92661602|NCT00257426|Octreotide|octreotide|mesh-list
92661603|NCT00257426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661604|NCT00257426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92661605|NCT00257426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661606|NCT01601509|Tramazoline|tramazoline|mesh-list
92661607|NCT01601509|Sympathomimetics|sympathomimetics|mesh-ancestor
92661608|NCT01601509|Autonomic Agents|autonomic agents|mesh-ancestor
92661609|NCT01601509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661610|NCT01601509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661611|NCT00416325|Lycopene|lycopene|mesh-list
92661612|NCT00416325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661613|NCT00416325|Antioxidants|antioxidants|mesh-ancestor
92661614|NCT00416325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661615|NCT00416325|Protective Agents|protective agents|mesh-ancestor
92661616|NCT00416325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661617|NCT00416325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92661618|NCT00416325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92661619|NCT00416325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661620|NCT00257465|Vaccines|vaccines|mesh-list
92661621|NCT00257465|Immunologic Factors|immunologic factors|mesh-ancestor
92661622|NCT00257465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661623|NCT01601899|Tenofovir|tenofovir|mesh-list
92661624|NCT01601899|Lamivudine|lamivudine|mesh-list
92661625|NCT01601899|Efavirenz|efavirenz|mesh-list
92661626|NCT01601899|Stavudine|stavudine|mesh-list
92661627|NCT01601899|Antiviral Agents|antiviral agents|mesh-ancestor
92661628|NCT01601899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661629|NCT01601899|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92661630|NCT01601899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92661631|NCT01601899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661632|NCT01601899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661633|NCT01601899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92661634|NCT01601899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92661635|NCT01601899|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92661636|NCT01601899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92661637|NCT01601899|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92661638|NCT01601899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92661639|NCT01601899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92661640|NCT01601899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92661641|NCT01601899|Antimetabolites|antimetabolites|mesh-ancestor
92577371|NCT00268372|Fluorouracil|fluorouracil|mesh-list
92577372|NCT00268372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577373|NCT00268372|Tubulin Modulators|tubulin modulators|mesh-ancestor
91984707|NCT05178173|Ethanol|ethanol|mesh-list
92661642|NCT01601938|Selenium|selenium|mesh-list
92661643|NCT01601938|Antioxidants|antioxidants|mesh-ancestor
92661644|NCT01601938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661645|NCT01601938|Protective Agents|protective agents|mesh-ancestor
92661646|NCT01601938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661648|NCT01601938|Micronutrients|micronutrients|mesh-ancestor
92661649|NCT01602055|Azithromycin|azithromycin|mesh-list
92661650|NCT01602055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661651|NCT01602055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661652|NCT01602250|Ropivacaine|ropivacaine|mesh-list
92661653|NCT01602250|Levobupivacaine|levobupivacaine|mesh-list
92661654|NCT01602250|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92661655|NCT01602250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92661656|NCT01602250|Anesthetics|anesthetics|mesh-ancestor
92661657|NCT01602250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661658|NCT01602250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661659|NCT01602250|Sensory System Agents|sensory system agents|mesh-ancestor
92661660|NCT01602250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661661|NCT01602250|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92661662|NCT01602250|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92661663|NCT01602250|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92661664|NCT00257582|Cetirizine|cetirizine|mesh-list
92661665|NCT00257582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92661666|NCT00257582|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92661667|NCT00257582|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92661668|NCT00257582|Histamine Antagonists|histamine antagonists|mesh-ancestor
92661669|NCT00257582|Histamine Agents|histamine agents|mesh-ancestor
92661670|NCT00257582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661671|NCT00257582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661672|NCT00257582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661673|NCT01602289|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92661674|NCT01602289|Gefitinib|gefitinib|mesh-list
92661675|NCT01602289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661676|NCT01602289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92661677|NCT01602289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661678|NCT01602289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661679|NCT00257621|Ritonavir|ritonavir|mesh-list
92661680|NCT00257621|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92661681|NCT00257621|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92661682|NCT00257621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92661683|NCT00257621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661684|NCT00257621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661685|NCT00257621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92661686|NCT00257621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92661687|NCT00257621|Antiviral Agents|antiviral agents|mesh-ancestor
92661688|NCT00257621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661689|NCT00257621|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92661690|NCT00257621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92661691|NCT01602406|Trastuzumab|trastuzumab|mesh-list
92661692|NCT01602406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92661693|NCT01602406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661694|NCT00290628|Cyclosporine|cyclosporine|mesh-list
92661695|NCT00290628|Mycophenolic Acid|mycophenolic acid|mesh-list
92661696|NCT00290628|Methylprednisolone|methylprednisolone|mesh-list
92661697|NCT00290628|Cyclophosphamide|cyclophosphamide|mesh-list
92661698|NCT00290628|Melphalan|melphalan|mesh-list
92661699|NCT00290628|Busulfan|busulfan|mesh-list
92661700|NCT00290628|Cyclosporins|cyclosporins|mesh-list
92661701|NCT00290628|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92661702|NCT00290628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661703|NCT00290628|Immunologic Factors|immunologic factors|mesh-ancestor
92661704|NCT00290628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661705|NCT00290628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661706|NCT00290628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92661707|NCT00290628|Alkylating Agents|alkylating agents|mesh-ancestor
92661708|NCT00290628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661709|NCT00290628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661710|NCT00290628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92661711|NCT00290628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661712|NCT00290628|Antifungal Agents|antifungal agents|mesh-ancestor
92661713|NCT00290628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661714|NCT00290628|Dermatologic Agents|dermatologic agents|mesh-ancestor
92661715|NCT00290628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92661716|NCT00290628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92661717|NCT00290628|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92661718|NCT00290628|Antitubercular Agents|antitubercular agents|mesh-ancestor
92661719|NCT00290628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661720|NCT00290628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661736|NCT01602523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661737|NCT01602523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92661738|NCT01602523|Respiratory System Agents|respiratory system agents|mesh-ancestor
92661739|NCT01602523|Glucocorticoids|glucocorticoids|mesh-ancestor
92661740|NCT01602523|Hormones|hormones|mesh-ancestor
92661741|NCT01602523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661742|NCT01602523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92661743|NCT01602523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92661744|NCT01602523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92661745|NCT01602523|Adrenergic Agents|adrenergic agents|mesh-ancestor
92661746|NCT01602523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661747|NCT01602523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661748|NCT00415298|Oxaliplatin|oxaliplatin|mesh-list
92661749|NCT00415298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661750|NCT01602640|Fentanyl|fentanyl|mesh-list
92661751|NCT01602640|Midazolam|midazolam|mesh-list
92661752|NCT01602640|Morphine|morphine|mesh-list
92661753|NCT01602640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92661754|NCT01602640|Narcotics|narcotics|mesh-ancestor
92661755|NCT01602640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661756|NCT01602640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661757|NCT01602640|Analgesics|analgesics|mesh-ancestor
92661758|NCT01602640|Sensory System Agents|sensory system agents|mesh-ancestor
92661759|NCT01602640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661760|NCT01602640|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92661761|NCT01602640|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92661762|NCT01602640|Anesthetics, General|anesthetics, general|mesh-ancestor
92661763|NCT01602640|Anesthetics|anesthetics|mesh-ancestor
92661764|NCT01602640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92661765|NCT01602640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92661766|NCT01602640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661767|NCT01602640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661768|NCT01602640|GABA Modulators|gaba modulators|mesh-ancestor
92661769|NCT01602640|GABA Agents|gaba agents|mesh-ancestor
92661770|NCT01602640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661771|NCT01602640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661772|NCT00290667|Prednisone|prednisone|mesh-list
92661773|NCT00290667|Cyclophosphamide|cyclophosphamide|mesh-list
92661774|NCT00290667|Rituximab|rituximab|mesh-list
92661775|NCT00290667|Doxorubicin|doxorubicin|mesh-list
92661776|NCT00290667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92661777|NCT00290667|Vincristine|vincristine|mesh-list
92661778|NCT00290667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661779|NCT00290667|Immunologic Factors|immunologic factors|mesh-ancestor
92661780|NCT00290667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661781|NCT00290667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92661782|NCT00290667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92661783|NCT00290667|Alkylating Agents|alkylating agents|mesh-ancestor
92661784|NCT00290667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661786|NCT00290667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92661787|NCT00290667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92661788|NCT00290667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92661789|NCT00290667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92661790|NCT00290667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92661791|NCT00290667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661792|NCT00290667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661793|NCT00290667|Glucocorticoids|glucocorticoids|mesh-ancestor
92661794|NCT00290667|Hormones|hormones|mesh-ancestor
92661795|NCT00290667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661796|NCT00290667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92661797|NCT00290667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92661798|NCT00290667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661799|NCT00290667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661800|NCT00290667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661801|NCT01602757|Lidocaine|lidocaine|mesh-list
92661802|NCT01602757|Tetracaine|tetracaine|mesh-list
92577375|NCT00268372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577376|NCT00268372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577377|NCT00268372|Antimetabolites|antimetabolites|mesh-ancestor
91984713|NCT02536833|Lorecivivint|lorecivivint|mesh-list
92661803|NCT01602757|Anesthetics, Local|anesthetics, local|mesh-ancestor
92661804|NCT01602757|Anesthetics|anesthetics|mesh-ancestor
92661805|NCT01602757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661806|NCT01602757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661807|NCT01602757|Sensory System Agents|sensory system agents|mesh-ancestor
92661808|NCT01602757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661809|NCT01602757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92661810|NCT01602757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92661811|NCT01602757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92661812|NCT01602757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661813|NCT01602757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661815|NCT02961101|Antibodies|antibodies|mesh-list
92661816|NCT02961101|Immunologic Factors|immunologic factors|mesh-ancestor
92661817|NCT02961101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661818|NCT02961101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92661819|NCT02961101|Antimetabolites|antimetabolites|mesh-ancestor
92661820|NCT02961101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661821|NCT02961101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661822|NCT02961101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661823|NCT01602913|Paroxetine|paroxetine|mesh-list
92661824|NCT01602913|Pravastatin|pravastatin|mesh-list
92661825|NCT01602913|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92661826|NCT01602913|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92661827|NCT01602913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661828|NCT01602913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661829|NCT01602913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661830|NCT01602913|Serotonin Agents|serotonin agents|mesh-ancestor
92661831|NCT01602913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661832|NCT01602913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92661833|NCT01602913|Antidepressive Agents|antidepressive agents|mesh-ancestor
92661834|NCT01602913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661835|NCT01602913|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92661836|NCT01602913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92661837|NCT01602913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661838|NCT01602913|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92661839|NCT01602913|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92661840|NCT01602913|Antimetabolites|antimetabolites|mesh-ancestor
92661841|NCT01602913|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92661842|NCT01602913|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92661843|NCT00257699|Metronidazole|metronidazole|mesh-list
92661844|NCT00257699|Ciprofloxacin|ciprofloxacin|mesh-list
92661845|NCT00257699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661846|NCT00257699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661847|NCT00257699|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92661848|NCT00257699|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92661849|NCT00257699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92661850|NCT00257699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92661851|NCT00257699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661852|NCT00257699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661853|NCT00257699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661854|NCT00257699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92069138|NCT03196466|Phenytoin|phenytoin|mesh-list
92661868|NCT01603030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661870|NCT01603030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92661871|NCT01603030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661872|NCT01603030|Antiemetics|antiemetics|mesh-ancestor
92661873|NCT01603030|Autonomic Agents|autonomic agents|mesh-ancestor
92661874|NCT01603030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661875|NCT01603030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661876|NCT01603030|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92661877|NCT01603030|Protective Agents|protective agents|mesh-ancestor
92661878|NCT01603030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661879|NCT01603030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577378|NCT00268372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577379|NCT00268372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577380|NCT00268372|Immunologic Factors|immunologic factors|mesh-ancestor
92577381|NCT00268372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577382|NCT00268411|Gemcitabine|gemcitabine|mesh-list
92661880|NCT01603030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92661881|NCT01603030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92661882|NCT01603030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661883|NCT01603030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661884|NCT01603030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92661885|NCT01603030|Contraceptive Agents|contraceptive agents|mesh-ancestor
92661886|NCT01603030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92661887|NCT01603030|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92661888|NCT01603030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92661889|NCT01603030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92661890|NCT01603108|Rifaximin|rifaximin|mesh-list
92661891|NCT01603108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92661892|NCT01603108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661893|NCT01603108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661894|NCT00290823|Albendazole|albendazole|mesh-list
92661895|NCT00290823|Dexamethasone|dexamethasone|mesh-list
92661896|NCT00290823|Omeprazole|omeprazole|mesh-list
92661897|NCT00290823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661898|NCT00290823|Antiemetics|antiemetics|mesh-ancestor
92661899|NCT00290823|Autonomic Agents|autonomic agents|mesh-ancestor
92661900|NCT00290823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661901|NCT00290823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661902|NCT00290823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661903|NCT00290823|Glucocorticoids|glucocorticoids|mesh-ancestor
92661904|NCT00290823|Hormones|hormones|mesh-ancestor
92661905|NCT00290823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661906|NCT00290823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92661907|NCT00290823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661908|NCT00290823|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92661909|NCT00290823|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92661910|NCT00290823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661911|NCT00290823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661912|NCT00290823|Anthelmintics|anthelmintics|mesh-ancestor
92661913|NCT00290823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92661914|NCT00290823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92661915|NCT00290823|Anticestodal Agents|anticestodal agents|mesh-ancestor
92661917|NCT00290823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92661918|NCT00290823|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661919|NCT00290823|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661920|NCT00290823|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661921|NCT01603186|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92661922|NCT01603186|Antidepressive Agents|antidepressive agents|mesh-ancestor
92661923|NCT01603186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661924|NCT01603186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92661925|NCT01603186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661926|NCT01603186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661927|NCT01603186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661928|NCT00271284|Insulin|insulin|mesh-list
92661929|NCT00271284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92661930|NCT00271284|Insulin Glargine|insulin glargine|mesh-list
92661931|NCT00271284|Insulin Detemir|insulin detemir|mesh-list
92661932|NCT00271284|Insulin glulisine|insulin glulisine|mesh-list
92661933|NCT00271284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92661934|NCT00271284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661935|NCT00257816|Topotecan|topotecan|mesh-list
92661936|NCT00257816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661937|NCT00257816|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92661938|NCT00257816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92661939|NCT00257816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661940|NCT00257816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661941|NCT00271323|Docetaxel|docetaxel|mesh-list
92661942|NCT00271323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661943|NCT00271323|Tubulin Modulators|tubulin modulators|mesh-ancestor
92661944|NCT00271323|Antimitotic Agents|antimitotic agents|mesh-ancestor
92661945|NCT00271323|Mitosis Modulators|mitosis modulators|mesh-ancestor
92661946|NCT00271323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577384|NCT00268411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577385|NCT00268411|Antimetabolites|antimetabolites|mesh-ancestor
92018789|NCT04888819|Fexuprazan|fexuprazan|mesh-list
92661947|NCT01603342|Clopidogrel|clopidogrel|mesh-list
92661948|NCT01603342|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92661949|NCT01603342|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92661950|NCT01603342|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92661951|NCT01603342|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92661952|NCT01603342|Purinergic Agents|purinergic agents|mesh-ancestor
92661953|NCT01603342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661954|NCT01603342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661955|NCT01603342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661956|NCT00257855|Lamotrigine|lamotrigine|mesh-list
92661957|NCT00257855|Anticonvulsants|anticonvulsants|mesh-ancestor
92661958|NCT00257855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92661959|NCT00257855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92661960|NCT00257855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661961|NCT00257855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92661962|NCT00257855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661963|NCT00257855|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92661964|NCT00257855|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661965|NCT00257855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661966|NCT00257855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661967|NCT00257855|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92661968|NCT01603498|Dexamethasone|dexamethasone|mesh-list
92661969|NCT01603498|Methylprednisolone|methylprednisolone|mesh-list
92661970|NCT01603498|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92661971|NCT01603498|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92661972|NCT01603498|Prednisolone|prednisolone|mesh-list
92661973|NCT01603498|Prednisolone acetate|prednisolone acetate|mesh-list
92661974|NCT01603498|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92661975|NCT01603498|Prednisolone phosphate|prednisolone phosphate|mesh-list
92661976|NCT01603498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661977|NCT01603498|Antiemetics|antiemetics|mesh-ancestor
92661978|NCT01603498|Autonomic Agents|autonomic agents|mesh-ancestor
92661979|NCT01603498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661980|NCT01603498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661981|NCT01603498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661982|NCT01603498|Glucocorticoids|glucocorticoids|mesh-ancestor
92661983|NCT01603498|Hormones|hormones|mesh-ancestor
92661984|NCT01603498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661985|NCT01603498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92661986|NCT01603498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661987|NCT01603498|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92661988|NCT01603498|Protective Agents|protective agents|mesh-ancestor
92661989|NCT01603654|Ascorbic Acid|ascorbic acid|mesh-list
92661992|NCT01603654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661993|NCT01603654|Antioxidants|antioxidants|mesh-ancestor
92661994|NCT01603654|Protective Agents|protective agents|mesh-ancestor
92661995|NCT01603654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661996|NCT01603654|Vitamins|vitamins|mesh-ancestor
92661997|NCT01603654|Micronutrients|micronutrients|mesh-ancestor
92661998|NCT01603654|Cathartics|cathartics|mesh-ancestor
92661999|NCT01603654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662000|NCT00257972|Aripiprazole|aripiprazole|mesh-list
92662001|NCT00257972|Antidepressive Agents|antidepressive agents|mesh-ancestor
92662002|NCT00257972|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662003|NCT00257972|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92662004|NCT00257972|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662005|NCT00257972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662006|NCT00257972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662007|NCT00257972|Dopamine Agonists|dopamine agonists|mesh-ancestor
92662008|NCT00257972|Dopamine Agents|dopamine agents|mesh-ancestor
92662009|NCT00257972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662010|NCT00257972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662011|NCT00257972|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92662012|NCT00257972|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92662013|NCT00257972|Serotonin Agents|serotonin agents|mesh-ancestor
92364733|NCT03017430|Loperamide|loperamide|mesh-list
92662014|NCT00257972|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92662015|NCT00257972|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92577386|NCT00268411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577387|NCT00268411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577388|NCT00073736|Cytarabine|cytarabine|mesh-list
92577389|NCT00073736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577390|NCT00073736|Antimetabolites|antimetabolites|mesh-ancestor
92682785|NCT04701320|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92662016|NCT00257972|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92662017|NCT00257972|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92662018|NCT01603693|Calcium|calcium|mesh-list
92662019|NCT01603693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92662020|NCT01603693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662021|NCT00258050|Lapatinib|lapatinib|mesh-list
92662022|NCT00258050|Midazolam|midazolam|mesh-list
92662023|NCT00258050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92662024|NCT00258050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92662025|NCT00258050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662026|NCT00258050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662027|NCT00258050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92662028|NCT00258050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662029|NCT00258050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662030|NCT00258050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92662031|NCT00258050|Anesthetics, General|anesthetics, general|mesh-ancestor
92662032|NCT00258050|Anesthetics|anesthetics|mesh-ancestor
92662033|NCT00258050|GABA Modulators|gaba modulators|mesh-ancestor
92662034|NCT00258050|GABA Agents|gaba agents|mesh-ancestor
92662035|NCT00258050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662036|NCT00258050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662037|NCT00258050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662038|NCT00258050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92662039|NCT00258050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662040|NCT00271401|Heparin|heparin|mesh-list
92662041|NCT00271401|Anticoagulants|anticoagulants|mesh-ancestor
92662042|NCT00271401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92662043|NCT00271401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92662044|NCT00271401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662045|NCT00258089|Levofloxacin|levofloxacin|mesh-list
92662046|NCT00258089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92662047|NCT00258089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662048|NCT00258089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92662049|NCT00258089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92662050|NCT00258089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92662051|NCT00258089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662052|NCT00258089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662053|NCT00258089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662054|NCT00258089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92662055|NCT00258089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92662056|NCT00290901|Celecoxib|celecoxib|mesh-list
92662057|NCT00290901|Tramadol|tramadol|mesh-list
92662058|NCT00290901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92662059|NCT00290901|Narcotics|narcotics|mesh-ancestor
92662060|NCT00290901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662061|NCT00290901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662062|NCT00290901|Analgesics|analgesics|mesh-ancestor
92662063|NCT00290901|Sensory System Agents|sensory system agents|mesh-ancestor
92662068|NCT00290901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662069|NCT00290901|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92662070|NCT00290901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92662071|NCT00290901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662072|NCT00290901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662073|NCT00258245|Aspirin|aspirin|mesh-list
92662074|NCT00258245|Vitamins|vitamins|mesh-list
92662075|NCT00258245|Ascorbic Acid|ascorbic acid|mesh-list
92662076|NCT00258245|Thalidomide|thalidomide|mesh-list
92662077|NCT00258245|Dexamethasone|dexamethasone|mesh-list
92662078|NCT00258245|Dexamethasone acetate|dexamethasone acetate|mesh-list
92662079|NCT00258245|Aspirin, aluminum hydroxide, magnesium hydroxide drug combination|aspirin, aluminum hydroxide, magnesium hydroxide drug combination|mesh-list
92662080|NCT00258245|Bortezomib|bortezomib|mesh-list
92662081|NCT00258245|Arsenic Trioxide|arsenic trioxide|mesh-list
92662082|NCT00258245|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92387397|NCT00003804|Dactinomycin|dactinomycin|mesh-list
92577391|NCT00073736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577392|NCT00073736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302220|NCT04486352|Maytansine|maytansine|mesh-list
92577393|NCT00073736|Antiviral Agents|antiviral agents|mesh-ancestor
92018924|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
92662084|NCT00258245|Micronutrients|micronutrients|mesh-ancestor
92662085|NCT00258245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662086|NCT00258245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662087|NCT00258245|Antiemetics|antiemetics|mesh-ancestor
92662088|NCT00258245|Autonomic Agents|autonomic agents|mesh-ancestor
92662089|NCT00258245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662090|NCT00258245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662091|NCT00258245|Glucocorticoids|glucocorticoids|mesh-ancestor
92662092|NCT00258245|Hormones|hormones|mesh-ancestor
92662093|NCT00258245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662094|NCT00258245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92662095|NCT00258245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662096|NCT00258245|Protease Inhibitors|protease inhibitors|mesh-ancestor
92662097|NCT00258245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662098|NCT00258245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662099|NCT00258245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662100|NCT00258245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662101|NCT00258245|Analgesics|analgesics|mesh-ancestor
92662102|NCT00258245|Sensory System Agents|sensory system agents|mesh-ancestor
92662103|NCT00258245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662104|NCT00258245|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92662105|NCT00258245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92662106|NCT00258245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92662107|NCT00258245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92662108|NCT00258245|Antipyretics|antipyretics|mesh-ancestor
92662109|NCT00258245|Antioxidants|antioxidants|mesh-ancestor
92662110|NCT00258245|Protective Agents|protective agents|mesh-ancestor
92662111|NCT00258245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662112|NCT00258245|Immunologic Factors|immunologic factors|mesh-ancestor
92662113|NCT00258245|Leprostatic Agents|leprostatic agents|mesh-ancestor
92662114|NCT00258245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92662115|NCT00258245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662116|NCT00258245|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92662117|NCT00258245|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92662118|NCT00258245|Growth Substances|growth substances|mesh-ancestor
92662119|NCT00258245|Growth Inhibitors|growth inhibitors|mesh-ancestor
92662120|NCT00271440|Chlorhexidine|chlorhexidine|mesh-list
92662121|NCT00271440|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92662122|NCT00271440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662123|NCT00271440|Disinfectants|disinfectants|mesh-ancestor
92662124|NCT01604629|Adalimumab|adalimumab|mesh-list
92662125|NCT01604629|Infliximab|infliximab|mesh-list
92662126|NCT01604629|Golimumab|golimumab|mesh-list
92662127|NCT01604629|Etanercept|etanercept|mesh-list
92662128|NCT01604629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92662129|NCT01604629|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92662130|NCT01604629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662131|NCT01604629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662132|NCT01604629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92662133|NCT01604629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662134|NCT01604629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662135|NCT01604629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662136|NCT01604629|Analgesics|analgesics|mesh-ancestor
92662148|NCT00258284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662149|NCT00258284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92662150|NCT00258284|Antimetabolites|antimetabolites|mesh-ancestor
92662151|NCT00290940|Metformin|metformin|mesh-list
92662152|NCT00290940|Pioglitazone|pioglitazone|mesh-list
92662153|NCT00290940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92662154|NCT00290940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662155|NCT00258323|Fluorouracil|fluorouracil|mesh-list
92662156|NCT00258323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662157|NCT00258323|Antimetabolites|antimetabolites|mesh-ancestor
92662158|NCT00258323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662159|NCT00258323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92662160|NCT00258323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662161|NCT00258323|Immunologic Factors|immunologic factors|mesh-ancestor
92577394|NCT00073736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577395|NCT00073736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662162|NCT00258323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662163|NCT01604863|Paclitaxel|paclitaxel|mesh-list
92662164|NCT01604863|Etoposide|etoposide|mesh-list
92662165|NCT01604863|Docetaxel|docetaxel|mesh-list
92662166|NCT01604863|Carboplatin|carboplatin|mesh-list
92662167|NCT01604863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92662168|NCT01604863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662169|NCT01604863|Tubulin Modulators|tubulin modulators|mesh-ancestor
92662170|NCT01604863|Antimitotic Agents|antimitotic agents|mesh-ancestor
92662171|NCT01604863|Mitosis Modulators|mitosis modulators|mesh-ancestor
92662172|NCT01604863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662173|NCT01604863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92662174|NCT01604863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92662175|NCT01604863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662176|NCT00290979|Insulin glulisine|insulin glulisine|mesh-list
92662177|NCT00290979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92662178|NCT00290979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662179|NCT00258479|Modafinil|modafinil|mesh-list
92662180|NCT00258479|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92662181|NCT00258479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662182|NCT00258479|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92662183|NCT00258479|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92662184|NCT00258479|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92662185|NCT00258479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662186|NCT00271518|Hormones|hormones|mesh-list
92662187|NCT00271518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662188|NCT00271518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662189|NCT01340014|Timolol|timolol|mesh-list
92662190|NCT01340014|Dorzolamide|dorzolamide|mesh-list
92662191|NCT01340014|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92662192|NCT01340014|Brinzolamide|brinzolamide|mesh-list
92662193|NCT01340014|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92662194|NCT01340014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92662195|NCT01340014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92662196|NCT01340014|Adrenergic Agents|adrenergic agents|mesh-ancestor
92662197|NCT01340014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662198|NCT01340014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662199|NCT01340014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662200|NCT01340014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92662206|NCT00258557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92662207|NCT00258557|Protease Inhibitors|protease inhibitors|mesh-ancestor
92662208|NCT00258557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662209|NCT00258557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662210|NCT00258557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92662211|NCT00258557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92662212|NCT00258557|Antiviral Agents|antiviral agents|mesh-ancestor
92662213|NCT00258557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662214|NCT00271557|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92662215|NCT00271557|Natriuretic Agents|natriuretic agents|mesh-ancestor
92662216|NCT00271557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662217|NCT00271635|Ascorbic Acid|ascorbic acid|mesh-list
92662218|NCT00271635|Vitamins|vitamins|mesh-ancestor
92662219|NCT00271635|Micronutrients|micronutrients|mesh-ancestor
92662220|NCT00271635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662221|NCT00271635|Antioxidants|antioxidants|mesh-ancestor
92662222|NCT00271635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662223|NCT00271635|Protective Agents|protective agents|mesh-ancestor
92662224|NCT00258596|Sirolimus|sirolimus|mesh-list
92662225|NCT00258596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92662226|NCT00258596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662227|NCT00258596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92662228|NCT00258596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662229|NCT00258596|Antifungal Agents|antifungal agents|mesh-ancestor
92662230|NCT00258596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662231|NCT00258596|Immunologic Factors|immunologic factors|mesh-ancestor
92662232|NCT00258596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662233|NCT01339273|Anesthetics|anesthetics|mesh-list
92662234|NCT01339273|Anesthetics, Local|anesthetics, local|mesh-list
92662235|NCT01339273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662236|NCT01339273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662238|NCT01339273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577396|NCT00073736|Immunologic Factors|immunologic factors|mesh-ancestor
92577397|NCT00073736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577398|NCT00268489|Bevacizumab|bevacizumab|mesh-list
92577399|NCT00268489|Pemetrexed|pemetrexed|mesh-list
91971379|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
92577400|NCT00268489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92662239|NCT04709315|Choline|choline|mesh-list
92662240|NCT04709315|Rocuronium|rocuronium|mesh-list
92662241|NCT04709315|Succinylcholine|succinylcholine|mesh-list
92662242|NCT04709315|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92662243|NCT04709315|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92662244|NCT04709315|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92662245|NCT04709315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662246|NCT04709315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662247|NCT04709315|Lipotropic Agents|lipotropic agents|mesh-ancestor
92662248|NCT04709315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92662249|NCT04709315|Antimetabolites|antimetabolites|mesh-ancestor
92662250|NCT04709315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662251|NCT04709315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662252|NCT04709315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92662253|NCT04709315|Nootropic Agents|nootropic agents|mesh-ancestor
92662254|NCT04709315|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92662255|NCT01334710|Sorafenib|sorafenib|mesh-list
92662256|NCT01334710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662257|NCT01334710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92662258|NCT01334710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662259|NCT01334710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662260|NCT00271713|Calcium, Dietary|calcium, dietary|mesh-list
92662261|NCT00271713|Vitamin D|vitamin d|mesh-list
92662262|NCT00271713|Ergocalciferols|ergocalciferols|mesh-list
92662263|NCT00271713|Cholecalciferol|cholecalciferol|mesh-list
92662264|NCT00271713|Ibandronic Acid|ibandronic acid|mesh-list
92662265|NCT00271713|Vitamins|vitamins|mesh-list
92662266|NCT00271713|Calcium|calcium|mesh-list
92662267|NCT00271713|Micronutrients|micronutrients|mesh-ancestor
92662268|NCT00271713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662269|NCT00271713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92662270|NCT00271713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92662271|NCT01334554|Sildenafil Citrate|sildenafil citrate|mesh-list
92662272|NCT01334554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92662273|NCT01334554|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92662283|NCT01332799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662284|NCT01332799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662285|NCT01332799|Gout Suppressants|gout suppressants|mesh-ancestor
92662286|NCT01332799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662287|NCT01332799|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92662288|NCT01332799|Antioxidants|antioxidants|mesh-ancestor
92662289|NCT01332799|Protective Agents|protective agents|mesh-ancestor
92662290|NCT01332799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662291|NCT00258791|Ibuprofen|ibuprofen|mesh-list
92662292|NCT00258791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662293|NCT00258791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662294|NCT00258791|Analgesics|analgesics|mesh-ancestor
92662295|NCT00258791|Sensory System Agents|sensory system agents|mesh-ancestor
92662296|NCT00258791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662297|NCT00258791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662298|NCT00258791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662299|NCT00258791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662300|NCT00258791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92662301|NCT00258791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662302|NCT00258791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662303|NCT00291369|Interferons|interferons|mesh-list
92662304|NCT00291369|Interferon-alpha|interferon-alpha|mesh-list
92662305|NCT00291369|Interleukin-2|interleukin-2|mesh-list
92662306|NCT00291369|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92662307|NCT00291369|Medroxyprogesterone|medroxyprogesterone|mesh-list
92662308|NCT00291369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662309|NCT00291369|Antiviral Agents|antiviral agents|mesh-ancestor
92662310|NCT00291369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662311|NCT00291369|Immunologic Factors|immunologic factors|mesh-ancestor
92662312|NCT00291369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662313|NCT00291369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662315|NCT00291369|Sensory System Agents|sensory system agents|mesh-ancestor
92577401|NCT00268489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577402|NCT00268489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92662316|NCT00291369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662317|NCT00291369|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92662318|NCT00291369|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92662319|NCT00291369|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92662320|NCT00291369|Contraceptive Agents|contraceptive agents|mesh-ancestor
92662321|NCT00291369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92662322|NCT00291369|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92662323|NCT00291369|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92662324|NCT00291369|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92662325|NCT00291369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92662326|NCT00291408|Nitric Oxide|nitric oxide|mesh-list
92662327|NCT00291408|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92662328|NCT00291408|Autonomic Agents|autonomic agents|mesh-ancestor
92662329|NCT00291408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662330|NCT00291408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662331|NCT00291408|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92662332|NCT00291408|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662333|NCT00291408|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92662334|NCT00291408|Antioxidants|antioxidants|mesh-ancestor
92662335|NCT00291408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662336|NCT00291408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662337|NCT00291408|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92662338|NCT00291408|Vasodilator Agents|vasodilator agents|mesh-ancestor
92662339|NCT00291408|Gasotransmitters|gasotransmitters|mesh-ancestor
92662340|NCT00291408|Protective Agents|protective agents|mesh-ancestor
92662353|NCT00259064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92662354|NCT00259064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662355|NCT00259064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662357|NCT01332292|Xhance|xhance|mesh-list
92662358|NCT01332292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662359|NCT01332292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92662360|NCT01332292|Autonomic Agents|autonomic agents|mesh-ancestor
92662361|NCT01332292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662362|NCT01332292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662363|NCT01332292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92662364|NCT01332292|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662365|NCT01332292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92662366|NCT01332292|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92662367|NCT00259142|Chloroquine|chloroquine|mesh-list
92662368|NCT00259142|Pyrimethamine|pyrimethamine|mesh-list
92662369|NCT00259142|Sulfadoxine|sulfadoxine|mesh-list
92662370|NCT00259142|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92662371|NCT00259142|Amebicides|amebicides|mesh-ancestor
92662372|NCT00259142|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92662373|NCT00259142|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92662374|NCT00259142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662375|NCT00259142|Antimalarials|antimalarials|mesh-ancestor
92662376|NCT00259142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662377|NCT00259142|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92662378|NCT00259142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662379|NCT00259142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662380|NCT00259142|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92662381|NCT00259181|Chlorhexidine|chlorhexidine|mesh-list
92662382|NCT00259181|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92662383|NCT00259181|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92662384|NCT00259181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92662385|NCT00259181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662386|NCT00259181|Disinfectants|disinfectants|mesh-ancestor
92662388|NCT00259181|Vasodilator Agents|vasodilator agents|mesh-ancestor
92662389|NCT00259181|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92662390|NCT00259181|Protective Agents|protective agents|mesh-ancestor
92662391|NCT00259181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662392|NCT00291720|Spironolactone|spironolactone|mesh-list
92662393|NCT00291720|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92662394|NCT00291720|Hormone Antagonists|hormone antagonists|mesh-ancestor
92662395|NCT00291720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662396|NCT00291720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662397|NCT00291720|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92662398|NCT00291720|Diuretics|diuretics|mesh-ancestor
92662399|NCT00291720|Natriuretic Agents|natriuretic agents|mesh-ancestor
92577403|NCT00268489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92577404|NCT00268489|Growth Substances|growth substances|mesh-ancestor
92577405|NCT00268489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019227|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
92662400|NCT00259220|Erythromycin|erythromycin|mesh-list
92662401|NCT00259220|Erythromycin Estolate|erythromycin estolate|mesh-list
92662402|NCT00259220|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92662403|NCT00259220|Erythromycin stearate|erythromycin stearate|mesh-list
92662404|NCT00259220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92069712|NCT00634504|Leucovorin|leucovorin|mesh-list
92662405|NCT00259220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662406|NCT00259220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662407|NCT00259220|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92662408|NCT00259220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662409|NCT00259220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662411|NCT00291759|Anastrozole|anastrozole|mesh-list
92662412|NCT00291759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92662413|NCT00291759|Hormone Antagonists|hormone antagonists|mesh-ancestor
92662414|NCT00291759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662415|NCT00291759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662416|NCT00291759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92662417|NCT00291759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662418|NCT00291759|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92662419|NCT00291759|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92662420|NCT00291759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92662421|NCT00291759|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92662422|NCT00291759|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92662423|NCT00291759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662424|NCT00291759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662425|NCT00272025|Escitalopram|escitalopram|mesh-list
92662426|NCT00272025|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92662427|NCT00272025|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92662428|NCT00272025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662429|NCT00272025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662430|NCT00272025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662431|NCT00272025|Serotonin Agents|serotonin agents|mesh-ancestor
92662432|NCT00272025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662433|NCT04709081|Itraconazole|itraconazole|mesh-list
92662434|NCT04709081|Digoxin|digoxin|mesh-list
92662435|NCT04709081|Midazolam|midazolam|mesh-list
92662436|NCT04709081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92662437|NCT04709081|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92662438|NCT04709081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662439|NCT04709081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662440|NCT04709081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92662441|NCT04709081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662442|NCT04709081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662443|NCT04709081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92662444|NCT04709081|Anesthetics, General|anesthetics, general|mesh-ancestor
92662445|NCT04709081|Anesthetics|anesthetics|mesh-ancestor
92662446|NCT04709081|GABA Modulators|gaba modulators|mesh-ancestor
92662447|NCT04709081|GABA Agents|gaba agents|mesh-ancestor
92662448|NCT04709081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662449|NCT04709081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662450|NCT04709081|Antifungal Agents|antifungal agents|mesh-ancestor
92662451|NCT04709081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662452|NCT04709081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92662453|NCT04709081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92662454|NCT04709081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662455|NCT04709081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92662456|NCT04709081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92662457|NCT04709081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662458|NCT04709081|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92662459|NCT04709081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92662461|NCT04709081|Protective Agents|protective agents|mesh-ancestor
92662462|NCT00272064|Insulin|insulin|mesh-list
92662463|NCT00272064|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92662464|NCT00272064|Metformin|metformin|mesh-list
92662465|NCT00272064|Insulin Glargine|insulin glargine|mesh-list
92662466|NCT00272064|Insulin glulisine|insulin glulisine|mesh-list
92577407|NCT00268489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577408|NCT00268489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577409|NCT00268489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92577410|NCT00268489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577411|NCT00268528|Methotrexate|methotrexate|mesh-list
92662467|NCT00272064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92662468|NCT00272064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662469|NCT00259376|Dronedarone|dronedarone|mesh-list
92662470|NCT00259376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92662471|NCT01332019|Interferons|interferons|mesh-list
92662472|NCT01332019|Interferon-beta|interferon-beta|mesh-list
92662473|NCT01332019|Interferon beta-1a|interferon beta-1a|mesh-list
92662474|NCT01332019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662475|NCT01332019|Antiviral Agents|antiviral agents|mesh-ancestor
92662476|NCT01332019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662477|NCT01332019|Immunologic Factors|immunologic factors|mesh-ancestor
92662478|NCT01332019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662479|NCT01332019|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92662482|NCT00415376|Nootropic Agents|nootropic agents|mesh-ancestor
92662484|NCT00291915|Methotrexate|methotrexate|mesh-list
92662485|NCT00291915|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92662486|NCT00291915|Abortifacient Agents|abortifacient agents|mesh-ancestor
92662487|NCT00291915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92662488|NCT00291915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662489|NCT00291915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92662490|NCT00291915|Antimetabolites|antimetabolites|mesh-ancestor
92662491|NCT00291915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662492|NCT00291915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662493|NCT00291915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92662494|NCT00291915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662495|NCT00291915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92662496|NCT00291915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662497|NCT00291915|Immunologic Factors|immunologic factors|mesh-ancestor
92662498|NCT00291915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662499|NCT00291915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92662500|NCT00291915|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92662501|NCT00291915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662502|NCT00259766|Budesonide|budesonide|mesh-list
92662503|NCT00259766|Terbutaline|terbutaline|mesh-list
92662504|NCT00259766|Formoterol Fumarate|formoterol fumarate|mesh-list
92662505|NCT00259766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662506|NCT00259766|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92662507|NCT00259766|Autonomic Agents|autonomic agents|mesh-ancestor
92662508|NCT00259766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662509|NCT00259766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662510|NCT00259766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92662511|NCT00259766|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662512|NCT00259766|Glucocorticoids|glucocorticoids|mesh-ancestor
92662513|NCT00259766|Hormones|hormones|mesh-ancestor
92662514|NCT00259766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662515|NCT00259766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92662516|NCT00259766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92662517|NCT00259766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92662518|NCT00259766|Adrenergic Agents|adrenergic agents|mesh-ancestor
92662519|NCT00259766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662520|NCT00259766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662521|NCT00259766|Sympathomimetics|sympathomimetics|mesh-ancestor
92662522|NCT00259766|Tocolytic Agents|tocolytic agents|mesh-ancestor
92662523|NCT00259766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92662524|NCT00292071|Caspofungin|caspofungin|mesh-list
92662525|NCT00292071|Antifungal Agents|antifungal agents|mesh-ancestor
92662526|NCT00292071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662527|NCT00292071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662528|NCT00292071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662529|NCT00292110|Methadone|methadone|mesh-list
92662530|NCT00292110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92662531|NCT00292110|Narcotics|narcotics|mesh-ancestor
92662532|NCT00292110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577412|NCT00268528|Mercaptopurine|mercaptopurine|mesh-list
92577413|NCT00268528|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92577414|NCT00268528|Abortifacient Agents|abortifacient agents|mesh-ancestor
92577415|NCT00268528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92577416|NCT00268528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662533|NCT00292110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662534|NCT00292110|Analgesics|analgesics|mesh-ancestor
92662535|NCT00292110|Sensory System Agents|sensory system agents|mesh-ancestor
92662536|NCT00292110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662537|NCT00292110|Antitussive Agents|antitussive agents|mesh-ancestor
92662538|NCT00292110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662539|NCT00259805|Rituximab|rituximab|mesh-list
92662540|NCT00259805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92662541|NCT00259805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662542|NCT00259805|Immunologic Factors|immunologic factors|mesh-ancestor
92662543|NCT00259805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662544|NCT00259805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662545|NCT00259883|Paroxetine|paroxetine|mesh-list
92662546|NCT00259883|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92662547|NCT00259883|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92662548|NCT00259883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662549|NCT00259883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662550|NCT00259883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662551|NCT00259883|Serotonin Agents|serotonin agents|mesh-ancestor
92069844|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662568|NCT04718376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662570|NCT00272415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92662571|NCT00272415|Alkylating Agents|alkylating agents|mesh-ancestor
92662572|NCT00272415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662573|NCT00272415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662574|NCT00259922|Alvimopan|alvimopan|mesh-list
92662575|NCT00259922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662576|NCT00272454|Aspirin|aspirin|mesh-list
92662577|NCT00272454|Cilostazol|cilostazol|mesh-list
92662578|NCT00272454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662579|NCT00272454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662580|NCT00272454|Analgesics|analgesics|mesh-ancestor
92662581|NCT00272454|Sensory System Agents|sensory system agents|mesh-ancestor
92662582|NCT00272454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662583|NCT00272454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662584|NCT00272454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662585|NCT00272454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662586|NCT00272454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92662587|NCT00272454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92662588|NCT00272454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662589|NCT00272454|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92662590|NCT00272454|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92662591|NCT00272454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662592|NCT00272454|Antipyretics|antipyretics|mesh-ancestor
92662593|NCT00272454|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92662594|NCT00272454|Autonomic Agents|autonomic agents|mesh-ancestor
92662595|NCT00272454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92662596|NCT00272454|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662597|NCT00272454|Vasodilator Agents|vasodilator agents|mesh-ancestor
92662598|NCT00272454|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92662599|NCT00272454|Protective Agents|protective agents|mesh-ancestor
92662600|NCT00272454|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92662601|NCT00272454|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92662602|NCT00272493|Vaccines|vaccines|mesh-list
92662603|NCT00272493|Immunologic Factors|immunologic factors|mesh-ancestor
92662604|NCT00272493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662605|NCT00292266|Interferon beta-1a|interferon beta-1a|mesh-list
92662606|NCT00292266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92662607|NCT00292266|Immunologic Factors|immunologic factors|mesh-ancestor
92069918|NCT01929031|Analgesics|analgesics|mesh-ancestor
92662627|NCT00272610|Vitamins|vitamins|mesh-ancestor
92662628|NCT00272610|Micronutrients|micronutrients|mesh-ancestor
92662629|NCT00272610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662630|NCT00260351|Vaccines|vaccines|mesh-list
92662631|NCT00260351|Immunologic Factors|immunologic factors|mesh-ancestor
92577417|NCT00268528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577418|NCT00268528|Antimetabolites|antimetabolites|mesh-ancestor
92577419|NCT00268528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577420|NCT00268528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019457|NCT04877509|Copper|copper|mesh-list
92662632|NCT00260351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662633|NCT00272688|Levodopa|levodopa|mesh-list
92662634|NCT00272688|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92662635|NCT00272688|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92662636|NCT00272688|Dopamine Agents|dopamine agents|mesh-ancestor
92662637|NCT00272688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662638|NCT00272688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662639|NCT00272688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662640|NCT00260390|Methyltestosterone|methyltestosterone|mesh-list
92662641|NCT00260390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92662642|NCT00260390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662643|NCT00260390|Anabolic Agents|anabolic agents|mesh-ancestor
92662644|NCT00260390|Hormones|hormones|mesh-ancestor
92662645|NCT00260390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662646|NCT00260390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662647|NCT00260624|Escitalopram|escitalopram|mesh-list
92662648|NCT00260624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92662649|NCT00260624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92662650|NCT00260624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662651|NCT00260624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662652|NCT00260624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662653|NCT00260624|Serotonin Agents|serotonin agents|mesh-ancestor
92662654|NCT00260624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662655|NCT00292695|Ifosfamide|ifosfamide|mesh-list
92662656|NCT00292695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662657|NCT00292695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92662658|NCT00292695|Alkylating Agents|alkylating agents|mesh-ancestor
92662659|NCT00292695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662660|NCT00292734|Zolpidem|zolpidem|mesh-list
92662661|NCT00292734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92662662|NCT00292734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92662663|NCT00292734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662664|NCT00292734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662669|NCT00292734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662670|NCT00260702|Omalizumab|omalizumab|mesh-list
92662671|NCT00260702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92662672|NCT00260702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92662673|NCT00260702|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662674|NCT00260819|Bosentan|bosentan|mesh-list
92662675|NCT00260819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92662676|NCT00260819|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92662677|NCT00260819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662678|NCT00298350|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
92662679|NCT00298350|Integrase Inhibitors|integrase inhibitors|mesh-list
92662680|NCT00298350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662681|NCT00298350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662682|NCT00298350|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92662683|NCT00298350|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388009|NCT00004224|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92662684|NCT00298350|Antiviral Agents|antiviral agents|mesh-ancestor
92662685|NCT00298350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662686|NCT00292890|Insulin|insulin|mesh-list
92662687|NCT00292890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92662688|NCT00292890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662689|NCT00292929|Artesunate|artesunate|mesh-list
92662690|NCT00292929|Antimalarials|antimalarials|mesh-ancestor
92662691|NCT00292929|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92662692|NCT00292929|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92662693|NCT00292929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662694|NCT00292929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662695|NCT00292929|Antiviral Agents|antiviral agents|mesh-ancestor
92662696|NCT00292929|Schistosomicides|schistosomicides|mesh-ancestor
92662697|NCT00292929|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92662698|NCT00292929|Anthelmintics|anthelmintics|mesh-ancestor
92577421|NCT00268528|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577422|NCT00268528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577423|NCT00268528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92577424|NCT00268528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984754|NCT02532855|Metformin|metformin|mesh-list
92662699|NCT00424853|Cisplatin|cisplatin|mesh-list
92662700|NCT00424853|Gemcitabine|gemcitabine|mesh-list
92662701|NCT00424853|Docetaxel|docetaxel|mesh-list
92662702|NCT00424853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662703|NCT00424853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92662704|NCT00424853|Antimetabolites|antimetabolites|mesh-ancestor
92662705|NCT00424853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662706|NCT00424853|Tubulin Modulators|tubulin modulators|mesh-ancestor
92662707|NCT00424853|Antimitotic Agents|antimitotic agents|mesh-ancestor
92662708|NCT00424853|Mitosis Modulators|mitosis modulators|mesh-ancestor
92662709|NCT00298506|Mycophenolic Acid|mycophenolic acid|mesh-list
92662710|NCT00298506|Tacrolimus|tacrolimus|mesh-list
92662711|NCT00298506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662712|NCT00298506|Immunologic Factors|immunologic factors|mesh-ancestor
92662713|NCT00298506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662714|NCT00298506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92662715|NCT00298506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662716|NCT00298506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662717|NCT00298506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92662718|NCT00298506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662719|NCT00298506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92662720|NCT00298506|Antitubercular Agents|antitubercular agents|mesh-ancestor
92662721|NCT00298506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92662722|NCT00298506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662723|NCT00424892|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92662724|NCT00424892|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92662725|NCT00424892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92662726|NCT00424892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662727|NCT00424892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662728|NCT00424892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662729|NCT00424892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662730|NCT00424892|Antidepressive Agents|antidepressive agents|mesh-ancestor
92662731|NCT00424892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662732|NCT00424931|Modafinil|modafinil|mesh-list
92662733|NCT00424931|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92662734|NCT00424931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662735|NCT00424931|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92662739|NCT00298545|Calcitriol|calcitriol|mesh-list
92662740|NCT00298545|Calcium|calcium|mesh-list
92662741|NCT00298545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92662742|NCT00298545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662743|NCT00298545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92662744|NCT00298545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662745|NCT00298545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662746|NCT00298545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92662747|NCT00298545|Vitamins|vitamins|mesh-ancestor
92662748|NCT00298545|Micronutrients|micronutrients|mesh-ancestor
92662749|NCT00298545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92662750|NCT01331161|Vaccines|vaccines|mesh-list
92662751|NCT01331161|Immunologic Factors|immunologic factors|mesh-ancestor
92662752|NCT01331161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662753|NCT00424970|Acetazolamide|acetazolamide|mesh-list
92662754|NCT00424970|Anticonvulsants|anticonvulsants|mesh-ancestor
92662755|NCT00424970|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92662756|NCT00424970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662757|NCT00424970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662758|NCT00424970|Diuretics|diuretics|mesh-ancestor
92662759|NCT00424970|Natriuretic Agents|natriuretic agents|mesh-ancestor
92364782|NCT03016806|Melphalan|melphalan|mesh-list
92662760|NCT00424970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662761|NCT01331005|Nepafenac|nepafenac|mesh-list
92662762|NCT01331005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662763|NCT01331005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662764|NCT01331005|Analgesics|analgesics|mesh-ancestor
92662765|NCT01331005|Sensory System Agents|sensory system agents|mesh-ancestor
92662766|NCT01331005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577425|NCT00268528|Immunologic Factors|immunologic factors|mesh-ancestor
92577426|NCT00268528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577427|NCT00268528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577428|NCT00073814|Albuterol|albuterol|mesh-list
92577429|NCT00073814|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92662767|NCT01331005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662768|NCT01331005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662769|NCT01331005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662770|NCT01330459|Acetaminophen|acetaminophen|mesh-list
92662771|NCT01330459|Ibuprofen|ibuprofen|mesh-list
92662772|NCT01330459|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92662773|NCT01330459|Lidocaine|lidocaine|mesh-list
92662774|NCT01330459|Hydrocodone|hydrocodone|mesh-list
92662775|NCT01330459|Lorazepam|lorazepam|mesh-list
92662776|NCT01330459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92662777|NCT01330459|Anesthetics|anesthetics|mesh-ancestor
92662778|NCT01330459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662779|NCT01330459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662780|NCT01330459|Sensory System Agents|sensory system agents|mesh-ancestor
92662781|NCT01330459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662782|NCT01330459|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92662783|NCT01330459|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92662784|NCT01330459|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92662785|NCT01330459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662786|NCT01330459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662787|NCT01330459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662788|NCT01330459|Analgesics|analgesics|mesh-ancestor
92662789|NCT01330459|Antipyretics|antipyretics|mesh-ancestor
92662790|NCT01330459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662791|NCT01330459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662792|NCT01330459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662793|NCT01330459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92662794|NCT01330459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662795|NCT01330459|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92662796|NCT01330459|Narcotics|narcotics|mesh-ancestor
92662797|NCT01330459|Antitussive Agents|antitussive agents|mesh-ancestor
92662798|NCT01330459|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662799|NCT01330459|Anticonvulsants|anticonvulsants|mesh-ancestor
92662800|NCT01330459|Antiemetics|antiemetics|mesh-ancestor
92662801|NCT01330459|Autonomic Agents|autonomic agents|mesh-ancestor
92662802|NCT01330459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662803|NCT01330459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92662804|NCT01330459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92662805|NCT01330459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662806|NCT01330459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070107|NCT00985426|Vaccines|vaccines|mesh-list
92662810|NCT00293085|Docetaxel|docetaxel|mesh-list
92662811|NCT00293085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662812|NCT00293085|Tubulin Modulators|tubulin modulators|mesh-ancestor
92662813|NCT00293085|Antimitotic Agents|antimitotic agents|mesh-ancestor
92662814|NCT00293085|Mitosis Modulators|mitosis modulators|mesh-ancestor
92662815|NCT00293085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662816|NCT00261053|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92662817|NCT00261053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92662818|NCT00261053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662819|NCT00261053|Immunologic Factors|immunologic factors|mesh-ancestor
92662820|NCT00261053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662821|NCT00298662|Interferons|interferons|mesh-list
92662822|NCT00298662|Interferon-beta|interferon-beta|mesh-list
92662823|NCT00298662|Tacrolimus|tacrolimus|mesh-list
92662824|NCT00298662|Interferon beta-1b|interferon beta-1b|mesh-list
92662825|NCT00298662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662826|NCT00298662|Antiviral Agents|antiviral agents|mesh-ancestor
92662827|NCT00298662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662828|NCT00298662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662829|NCT00298662|Immunologic Factors|immunologic factors|mesh-ancestor
92364786|NCT03016806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662830|NCT00298662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662831|NCT00298662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92388165|NCT00004422|Antibodies|antibodies|mesh-list
92662832|NCT00298662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662833|NCT00298662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662834|NCT00298662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92577430|NCT00073814|Autonomic Agents|autonomic agents|mesh-ancestor
92577431|NCT00073814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577432|NCT00073814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662835|NCT01330381|Prucalopride|prucalopride|mesh-list
92662836|NCT01330381|Laxatives|laxatives|mesh-ancestor
92662837|NCT01330381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662838|NCT01330381|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92662839|NCT01330381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92662840|NCT01330381|Serotonin Agents|serotonin agents|mesh-ancestor
92662841|NCT01330381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662842|NCT01330381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662843|NCT01330381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662844|NCT00261092|Oxaliplatin|oxaliplatin|mesh-list
92662845|NCT00261092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662846|NCT00293124|Imatinib Mesylate|imatinib mesylate|mesh-list
92662847|NCT00293124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662848|NCT00293124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92662849|NCT00293124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662850|NCT00293124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662851|NCT01330108|Ambrisentan|ambrisentan|mesh-list
92662852|NCT01330108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92662853|NCT00261131|Botulinum Toxins|botulinum toxins|mesh-list
92662854|NCT00261131|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92662855|NCT00261131|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92662856|NCT00261131|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92662857|NCT00261131|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662858|NCT00261131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662859|NCT00261131|Cholinergic Agents|cholinergic agents|mesh-ancestor
92662860|NCT00261131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662861|NCT00261131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662862|NCT00261131|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92662863|NCT00261131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662864|NCT00261170|Bupropion|bupropion|mesh-list
92662865|NCT00261170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92662866|NCT00261170|Antidepressive Agents|antidepressive agents|mesh-ancestor
92662867|NCT00261170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662868|NCT00261170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92662869|NCT00261170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92662870|NCT00261170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92662871|NCT00261170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662872|NCT00261170|Dopamine Agents|dopamine agents|mesh-ancestor
92662873|NCT00261170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662874|NCT00261170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662875|NCT00261170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92662876|NCT00261170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92070181|NCT00984022|Laxatives|laxatives|mesh-ancestor
92662878|NCT00261287|Ciclesonide|ciclesonide|mesh-list
92662879|NCT00261287|Glucocorticoids|glucocorticoids|mesh-ancestor
92662880|NCT00261287|Hormones|hormones|mesh-ancestor
92662881|NCT00261287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662882|NCT00261287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662883|NCT00261287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92662884|NCT00261326|Simvastatin|simvastatin|mesh-list
92662885|NCT00261326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92662886|NCT00261326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92662887|NCT00261326|Antimetabolites|antimetabolites|mesh-ancestor
92662888|NCT00261326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662889|NCT00261326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92662890|NCT00261326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92662891|NCT00261326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662893|NCT00293163|Viscosupplements|viscosupplements|mesh-ancestor
92662894|NCT00293163|Protective Agents|protective agents|mesh-ancestor
92662895|NCT00293163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662896|NCT00261365|Ipilimumab|ipilimumab|mesh-list
92662897|NCT00261365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92662898|NCT00261365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662899|NCT00261365|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92662900|NCT00261365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662901|NCT00293280|Lomustine|lomustine|mesh-list
92577433|NCT00073814|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92577434|NCT00073814|Respiratory System Agents|respiratory system agents|mesh-ancestor
92577435|NCT00073814|Tocolytic Agents|tocolytic agents|mesh-ancestor
92577436|NCT00073814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92577437|NCT00073814|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92019740|NCT04868227|Vitamin D|vitamin d|mesh-list
92662902|NCT00293280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92662903|NCT00293280|Alkylating Agents|alkylating agents|mesh-ancestor
92662904|NCT00293280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662905|NCT00293280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662906|NCT00298779|Bortezomib|bortezomib|mesh-list
92662907|NCT00298779|Omeprazole|omeprazole|mesh-list
92662908|NCT00298779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662909|NCT00298779|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92662910|NCT00298779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662911|NCT00298779|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92662912|NCT00298779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662913|NCT00298779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662914|NCT00261482|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92662915|NCT00261482|Norelgestromin|norelgestromin|mesh-list
92662916|NCT00261482|Estradiol|estradiol|mesh-list
92662917|NCT00261482|Estrogens|estrogens|mesh-ancestor
92662918|NCT00261482|Hormones|hormones|mesh-ancestor
92662919|NCT00261482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662920|NCT00261482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662921|NCT00261482|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92662922|NCT00261482|Contraceptive Agents|contraceptive agents|mesh-ancestor
92662923|NCT00261482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92662924|NCT00261482|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92662925|NCT00261482|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92662926|NCT00261482|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92662927|NCT00261521|Epoetin Alfa|epoetin alfa|mesh-list
92662928|NCT00261521|Hematinics|hematinics|mesh-ancestor
92662929|NCT00298857|Valproic Acid|valproic acid|mesh-list
92662930|NCT00298857|Anticonvulsants|anticonvulsants|mesh-ancestor
92662931|NCT00298857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662932|NCT00298857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662933|NCT00298857|GABA Agents|gaba agents|mesh-ancestor
92662934|NCT00298857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662935|NCT00298857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662936|NCT00298857|Antimanic Agents|antimanic agents|mesh-ancestor
92662937|NCT00298857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662938|NCT00298857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662939|NCT00298857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662940|NCT00261560|Acetaminophen|acetaminophen|mesh-list
92662941|NCT00261560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662942|NCT00261560|Analgesics|analgesics|mesh-ancestor
92662943|NCT00261560|Sensory System Agents|sensory system agents|mesh-ancestor
92662944|NCT00261560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662945|NCT00261560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662946|NCT00261560|Antipyretics|antipyretics|mesh-ancestor
92662947|NCT00261599|Midazolam|midazolam|mesh-list
92662948|NCT00261599|Fospropofol|fospropofol|mesh-list
92662949|NCT00261599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92662950|NCT00261599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92662951|NCT00261599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662952|NCT00261599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662954|NCT00261599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92662955|NCT00261599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662956|NCT00261599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92662957|NCT00261599|Anesthetics, General|anesthetics, general|mesh-ancestor
92662958|NCT00261599|Anesthetics|anesthetics|mesh-ancestor
92662959|NCT00261599|GABA Modulators|gaba modulators|mesh-ancestor
92662960|NCT00261599|GABA Agents|gaba agents|mesh-ancestor
92662961|NCT00261599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662962|NCT00261599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662963|NCT00293319|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92662964|NCT00293319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662965|NCT00293319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662966|NCT00293319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577438|NCT00073814|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92577439|NCT00073814|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92577440|NCT00073814|Adrenergic Agents|adrenergic agents|mesh-ancestor
92577441|NCT00073814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577442|NCT00073814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577443|NCT00102453|Pentoxifylline|pentoxifylline|mesh-list
92577444|NCT00102453|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92662967|NCT00293319|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92662968|NCT00293358|Carboplatin|carboplatin|mesh-list
92662969|NCT00293358|Etoposide|etoposide|mesh-list
92662970|NCT00293358|Ifosfamide|ifosfamide|mesh-list
92662971|NCT00293358|Etoposide phosphate|etoposide phosphate|mesh-list
92662972|NCT00293358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662973|NCT00293358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92662974|NCT00293358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92662975|NCT00293358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92662976|NCT00293358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662977|NCT00293358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662978|NCT00293358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92662979|NCT00293358|Alkylating Agents|alkylating agents|mesh-ancestor
92662980|NCT00261677|Epoetin Alfa|epoetin alfa|mesh-list
92662981|NCT00261677|Hematinics|hematinics|mesh-ancestor
92662982|NCT00298974|Acetaminophen|acetaminophen|mesh-list
92662983|NCT00298974|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92662984|NCT00298974|Hydrocodone|hydrocodone|mesh-list
92662985|NCT00298974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662986|NCT00298974|Analgesics|analgesics|mesh-ancestor
92662987|NCT00298974|Sensory System Agents|sensory system agents|mesh-ancestor
92662988|NCT00298974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662989|NCT00298974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662990|NCT00298974|Antipyretics|antipyretics|mesh-ancestor
92662991|NCT00298974|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92662992|NCT00298974|Narcotics|narcotics|mesh-ancestor
92662993|NCT00298974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92662994|NCT00298974|Antitussive Agents|antitussive agents|mesh-ancestor
92662995|NCT00298974|Respiratory System Agents|respiratory system agents|mesh-ancestor
92662996|NCT00298974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662997|NCT00298974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662998|NCT00298974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92662999|NCT00293436|Celecoxib|celecoxib|mesh-list
92663000|NCT00293436|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92663001|NCT00293436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663002|NCT00293436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92663003|NCT00293436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663004|NCT00293436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663005|NCT00293436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92663006|NCT00293436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663007|NCT00293436|Analgesics|analgesics|mesh-ancestor
92663008|NCT00293436|Sensory System Agents|sensory system agents|mesh-ancestor
92663009|NCT00293436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663010|NCT00293436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663011|NCT00293436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663012|NCT00293436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663013|NCT00293436|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92663014|NCT00293436|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92663015|NCT00261872|Methylphenidate|methylphenidate|mesh-list
92663016|NCT00261872|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92663017|NCT00261872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663018|NCT00261872|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92663019|NCT00261872|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92364795|NCT03016806|Protective Agents|protective agents|mesh-ancestor
92663020|NCT00261872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663021|NCT00261872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663022|NCT00261872|Dopamine Agents|dopamine agents|mesh-ancestor
92663023|NCT00261872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663024|NCT00293475|Sodium thiosulfate|sodium thiosulfate|mesh-list
92663025|NCT00293475|Rituximab|rituximab|mesh-list
92070325|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577445|NCT00102453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577446|NCT00102453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577447|NCT00102453|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92577448|NCT00102453|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92577449|NCT00102453|Protective Agents|protective agents|mesh-ancestor
92663038|NCT00293475|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92663039|NCT00293475|Abortifacient Agents|abortifacient agents|mesh-ancestor
92663040|NCT00293475|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92663041|NCT00293475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663042|NCT00293475|Antimetabolites|antimetabolites|mesh-ancestor
92663043|NCT00293475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663044|NCT00293475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92663045|NCT00293475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663046|NCT00293475|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92663047|NCT00293475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92663048|NCT00293475|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92663049|NCT00293475|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92663051|NCT00293475|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663052|NCT00293475|Protective Agents|protective agents|mesh-ancestor
92663053|NCT00293475|Antioxidants|antioxidants|mesh-ancestor
92663054|NCT00293475|Antitubercular Agents|antitubercular agents|mesh-ancestor
92663055|NCT00293475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663056|NCT00293475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663057|NCT00293475|Chelating Agents|chelating agents|mesh-ancestor
92663058|NCT00293475|Sequestering Agents|sequestering agents|mesh-ancestor
92663059|NCT00261911|Sibutramine|sibutramine|mesh-list
92663060|NCT00261911|Antidepressive Agents|antidepressive agents|mesh-ancestor
92663061|NCT00261911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92663062|NCT00261911|Appetite Depressants|appetite depressants|mesh-ancestor
92663063|NCT00261911|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92663065|NCT00299013|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92663066|NCT00299013|Methylprednisolone|methylprednisolone|mesh-list
92663067|NCT00299013|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92663068|NCT00299013|Prednisolone acetate|prednisolone acetate|mesh-list
92663069|NCT00299013|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92663070|NCT00299013|Prednisolone phosphate|prednisolone phosphate|mesh-list
92663071|NCT00299013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663072|NCT00299013|Glucocorticoids|glucocorticoids|mesh-ancestor
92663073|NCT00299013|Hormones|hormones|mesh-ancestor
92663074|NCT00299013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663075|NCT00299013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663076|NCT00299013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663077|NCT00299013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663078|NCT00299013|Antiemetics|antiemetics|mesh-ancestor
92663079|NCT00299013|Autonomic Agents|autonomic agents|mesh-ancestor
92663080|NCT00299013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663081|NCT00299013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663082|NCT00299013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92663083|NCT00299013|Protective Agents|protective agents|mesh-ancestor
92663084|NCT00293514|Thrombin|thrombin|mesh-list
92663085|NCT00293514|Hemostatics|hemostatics|mesh-ancestor
92663086|NCT00293514|Coagulants|coagulants|mesh-ancestor
92663087|NCT00299091|Efavirenz|efavirenz|mesh-list
92663088|NCT00299091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92663089|NCT00299091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92663090|NCT00299091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663091|NCT00299091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663092|NCT00299091|Antiviral Agents|antiviral agents|mesh-ancestor
92663093|NCT00299091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663096|NCT00299091|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92663097|NCT00299091|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92663098|NCT00299091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92663099|NCT00299091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92663101|NCT00299208|Artesunate|artesunate|mesh-list
92663102|NCT00299208|Quinine|quinine|mesh-list
92663103|NCT00299208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663104|NCT00299208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663105|NCT00299208|Antimalarials|antimalarials|mesh-ancestor
92663106|NCT00299208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92577450|NCT00102453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577451|NCT00102453|Vasodilator Agents|vasodilator agents|mesh-ancestor
92577452|NCT00102453|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92663107|NCT00299208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92663108|NCT00299208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663109|NCT00299208|Antiviral Agents|antiviral agents|mesh-ancestor
92663110|NCT00299208|Schistosomicides|schistosomicides|mesh-ancestor
92663111|NCT00299208|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92663112|NCT00299208|Anthelmintics|anthelmintics|mesh-ancestor
92663113|NCT00299208|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92663114|NCT00299208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663115|NCT00299208|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92663116|NCT00299208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663117|NCT00299208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663118|NCT00299208|Analgesics|analgesics|mesh-ancestor
92663119|NCT00299208|Sensory System Agents|sensory system agents|mesh-ancestor
92663120|NCT00418119|Epoetin Alfa|epoetin alfa|mesh-list
92663121|NCT00418119|Hematinics|hematinics|mesh-ancestor
92663122|NCT00293592|Dexamethasone|dexamethasone|mesh-list
92663123|NCT00293592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663124|NCT00293592|Antiemetics|antiemetics|mesh-ancestor
92663125|NCT00293592|Autonomic Agents|autonomic agents|mesh-ancestor
92663126|NCT00293592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663127|NCT00293592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663128|NCT00293592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663129|NCT00293592|Glucocorticoids|glucocorticoids|mesh-ancestor
92663130|NCT00293592|Hormones|hormones|mesh-ancestor
92663131|NCT00293592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663132|NCT00293592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663133|NCT00293592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663134|NCT00293631|Ketorolac|ketorolac|mesh-list
92663135|NCT00293631|Lornoxicam|lornoxicam|mesh-list
92663136|NCT00293631|Piroxicam|piroxicam|mesh-list
92663137|NCT00293631|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92663138|NCT00293631|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663139|NCT00293631|Analgesics|analgesics|mesh-ancestor
92663140|NCT00293631|Sensory System Agents|sensory system agents|mesh-ancestor
92663141|NCT00293631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663142|NCT00293631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663143|NCT00293631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663144|NCT00293631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663145|NCT00293631|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92663146|NCT00293631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663147|NCT00293631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663148|NCT00262262|Levetiracetam|levetiracetam|mesh-list
92663149|NCT00262262|Anticonvulsants|anticonvulsants|mesh-ancestor
92663150|NCT00262262|Nootropic Agents|nootropic agents|mesh-ancestor
92663151|NCT00293670|Goserelin|goserelin|mesh-list
92663152|NCT00293670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663153|NCT00293670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663154|NCT00262379|Epoetin Alfa|epoetin alfa|mesh-list
92663155|NCT00262379|Hematinics|hematinics|mesh-ancestor
92663156|NCT00299247|Pyrimethamine|pyrimethamine|mesh-list
92663157|NCT00299247|Sulfadoxine|sulfadoxine|mesh-list
92663158|NCT00299247|Antimalarials|antimalarials|mesh-ancestor
92663159|NCT00299247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92663160|NCT00299247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92663161|NCT00299247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663162|NCT00299247|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92663163|NCT00299247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663164|NCT00299247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663165|NCT00299247|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92663166|NCT00262418|Ivermectin|ivermectin|mesh-list
92663167|NCT00262418|Permethrin|permethrin|mesh-list
92663168|NCT00262418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92663172|NCT00299286|Lapatinib|lapatinib|mesh-list
92663173|NCT00299286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663174|NCT00299286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92663175|NCT00299286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663176|NCT00299286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663177|NCT00293787|Timolol|timolol|mesh-list
92663178|NCT00293787|Travoprost|travoprost|mesh-list
92663179|NCT00293787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92663180|NCT00293787|Latanoprost|latanoprost|mesh-list
92663181|NCT00293787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92577453|NCT00102453|Antioxidants|antioxidants|mesh-ancestor
92577454|NCT00268567|Prednisone|prednisone|mesh-list
92577455|NCT00268567|Leflunomide|leflunomide|mesh-list
92577456|NCT00268567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92577457|NCT00268567|Glucocorticoids|glucocorticoids|mesh-ancestor
92577458|NCT00268567|Hormones|hormones|mesh-ancestor
92663182|NCT00293787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663183|NCT00293787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92663184|NCT00293787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92663185|NCT00293787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92663186|NCT00293787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663187|NCT00293787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663188|NCT00293787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92663189|NCT00293787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663190|NCT00299364|Tibolone|tibolone|mesh-list
92663191|NCT00299364|Androgen Antagonists|androgen antagonists|mesh-ancestor
92663192|NCT00299364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92663193|NCT00299364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663194|NCT00299364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663195|NCT00299364|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663196|NCT00299364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663197|NCT00299364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663198|NCT00299364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92663199|NCT00299364|Anabolic Agents|anabolic agents|mesh-ancestor
92663200|NCT00299364|Hormones|hormones|mesh-ancestor
92663201|NCT00293826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92663202|NCT00293826|Immunologic Factors|immunologic factors|mesh-ancestor
92663203|NCT00293826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663204|NCT00262574|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92663205|NCT00262574|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663206|NCT00262574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663207|NCT00262769|Cisplatin|cisplatin|mesh-list
92663208|NCT00262769|Gemcitabine|gemcitabine|mesh-list
92663209|NCT00262769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663210|NCT00262769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663211|NCT00262769|Antimetabolites|antimetabolites|mesh-ancestor
92663212|NCT00262769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663213|NCT00299520|Linezolid|linezolid|mesh-list
92663214|NCT00299520|Iclaprim|iclaprim|mesh-list
92663215|NCT00299520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663216|NCT00299520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663217|NCT00299520|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92663218|NCT00299520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663219|NCT00299520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663220|NCT00299520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92663221|NCT00261755|Analgesics|analgesics|mesh-list
92663222|NCT00261755|Sensory System Agents|sensory system agents|mesh-ancestor
92663223|NCT00261755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663224|NCT00261755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663225|NCT00262808|Leucovorin|leucovorin|mesh-list
92663226|NCT00262808|Fluorouracil|fluorouracil|mesh-list
92663227|NCT00262808|Oxaliplatin|oxaliplatin|mesh-list
92663228|NCT00262808|Calcium|calcium|mesh-list
92663229|NCT00262808|Sargramostim|sargramostim|mesh-list
92663230|NCT00262808|Levoleucovorin|levoleucovorin|mesh-list
92663231|NCT00262808|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92663232|NCT00262808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663233|NCT00262808|Antimetabolites|antimetabolites|mesh-ancestor
92663234|NCT00262808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663235|NCT00262808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663236|NCT00262808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663237|NCT00262808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92663238|NCT00262808|Immunologic Factors|immunologic factors|mesh-ancestor
92663239|NCT00262808|Antidotes|antidotes|mesh-ancestor
92663240|NCT00262808|Protective Agents|protective agents|mesh-ancestor
92663241|NCT00262808|Vitamin B Complex|vitamin b complex|mesh-ancestor
92663244|NCT00262886|Mycophenolic Acid|mycophenolic acid|mesh-list
92663245|NCT00262886|Cyclophosphamide|cyclophosphamide|mesh-list
92663246|NCT00262886|Fludarabine|fludarabine|mesh-list
92663247|NCT00262886|Fludarabine phosphate|fludarabine phosphate|mesh-list
92663248|NCT00262886|Tacrolimus|tacrolimus|mesh-list
92663249|NCT00262886|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92663250|NCT00262886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577459|NCT00268567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577460|NCT00268567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577461|NCT00268567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92577462|NCT00268567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577463|NCT00268567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663251|NCT00262886|Immunologic Factors|immunologic factors|mesh-ancestor
92663252|NCT00262886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663253|NCT00262886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663254|NCT00262886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92663255|NCT00262886|Alkylating Agents|alkylating agents|mesh-ancestor
92663256|NCT00262886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663257|NCT00262886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663258|NCT00262886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92663259|NCT00262886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663260|NCT00262886|Antimetabolites|antimetabolites|mesh-ancestor
92663261|NCT00262886|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92663262|NCT00262886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663263|NCT00262886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92663264|NCT00262886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92663265|NCT00262886|Antitubercular Agents|antitubercular agents|mesh-ancestor
92663266|NCT00262886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663267|NCT00262886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663268|NCT00263003|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92663269|NCT00263003|Irbesartan|irbesartan|mesh-list
92663270|NCT00263003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663271|NCT00263003|Diuretics|diuretics|mesh-ancestor
92663272|NCT00263003|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663273|NCT00263003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663274|NCT00263003|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92663275|NCT00263003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663276|NCT00263003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663277|NCT00263003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92663278|NCT00263003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92663279|NCT00299559|Camphor|camphor|mesh-list
92663280|NCT00299559|Menthol|menthol|mesh-list
92663281|NCT00299559|Antipruritics|antipruritics|mesh-ancestor
92663282|NCT00299559|Dermatologic Agents|dermatologic agents|mesh-ancestor
92663283|NCT00299559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92663284|NCT00299559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663285|NCT00299598|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92663286|NCT00299598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663287|NCT00263198|Letrozole|letrozole|mesh-list
92663288|NCT00263198|Vatalanib|vatalanib|mesh-list
92663289|NCT00263198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663290|NCT00263198|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92663291|NCT00263198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92663292|NCT00263198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663293|NCT00263198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663294|NCT00263198|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92663295|NCT00263198|Hormone Antagonists|hormone antagonists|mesh-ancestor
92663296|NCT00263198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663297|NCT00263198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663298|NCT00263198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92663299|NCT00294099|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92663300|NCT00294099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92663301|NCT00294099|Immunologic Factors|immunologic factors|mesh-ancestor
92663302|NCT00294099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663303|NCT00294099|Antacids|antacids|mesh-ancestor
92663304|NCT00294099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663305|NCT00294099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663306|NCT00299676|Galantamine|galantamine|mesh-list
92663307|NCT00299676|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92663308|NCT00299676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663309|NCT00299676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663310|NCT00299676|Cholinergic Agents|cholinergic agents|mesh-ancestor
92364814|NCT03016260|Etanercept|etanercept|mesh-list
92663311|NCT00299676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663312|NCT00299676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577464|NCT00268567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577465|NCT00268567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577466|NCT00268567|Immunologic Factors|immunologic factors|mesh-ancestor
92577467|NCT00268645|Insulin Glargine|insulin glargine|mesh-list
92577468|NCT00268645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92682786|NCT00438113|Atenolol|atenolol|mesh-list
92663313|NCT00299676|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92663314|NCT00299676|Autonomic Agents|autonomic agents|mesh-ancestor
92070605|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
92663332|NCT00263315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92663333|NCT00263315|Amebicides|amebicides|mesh-ancestor
92663334|NCT00263315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92663335|NCT00263315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92663336|NCT00263315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663337|NCT00263315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663338|NCT00263315|Antifungal Agents|antifungal agents|mesh-ancestor
92663339|NCT00417807|Imatinib Mesylate|imatinib mesylate|mesh-list
92663340|NCT00417807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663341|NCT00417807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92663342|NCT00417807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663343|NCT00417807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663344|NCT00263354|Oxaliplatin|oxaliplatin|mesh-list
92663345|NCT00263354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663346|NCT00263393|Atenolol|atenolol|mesh-list
92663347|NCT00263393|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92663348|NCT00263393|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92663349|NCT00263393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663350|NCT00263393|Diuretics|diuretics|mesh-ancestor
92663351|NCT00263393|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663352|NCT00263393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663353|NCT00263393|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92663354|NCT00263393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663355|NCT00263393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663356|NCT00263393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92663357|NCT00263393|Sympatholytics|sympatholytics|mesh-ancestor
92663358|NCT00263393|Autonomic Agents|autonomic agents|mesh-ancestor
92663359|NCT00263393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663360|NCT00263393|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92663361|NCT00263393|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92663362|NCT00263393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92663363|NCT00263393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92663364|NCT00263393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388682|NCT00005586|Fluorouracil|fluorouracil|mesh-list
92663365|NCT00263393|Protease Inhibitors|protease inhibitors|mesh-ancestor
92663366|NCT00263393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663367|NCT00299871|Lixisenatide|lixisenatide|mesh-list
92663368|NCT00299871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92663369|NCT00299871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663370|NCT00299910|Montelukast|montelukast|mesh-list
92070681|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92663385|NCT00425594|Cathartics|cathartics|mesh-ancestor
92663386|NCT00425594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663387|NCT00425594|Laxatives|laxatives|mesh-ancestor
92663388|NCT00294255|Risperidone|risperidone|mesh-list
92663389|NCT00294255|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92663390|NCT00294255|Serotonin Agents|serotonin agents|mesh-ancestor
92663391|NCT00294255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663392|NCT00294255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663393|NCT00294255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663394|NCT00294255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92663395|NCT00294255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92663396|NCT00294255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92663397|NCT00294255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92663398|NCT00294255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92663399|NCT00294255|Dopamine Agents|dopamine agents|mesh-ancestor
92663400|NCT00263705|Capecitabine|capecitabine|mesh-list
92663401|NCT00263705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663402|NCT00263705|Antimetabolites|antimetabolites|mesh-ancestor
92663403|NCT00263705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663404|NCT00263705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577469|NCT00268645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577470|NCT00268684|Temozolomide|temozolomide|mesh-list
92577471|NCT00268684|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92663405|NCT00263744|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92663406|NCT00263744|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92663407|NCT00263744|Immunologic Factors|immunologic factors|mesh-ancestor
92663408|NCT00263744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663409|NCT00263744|Antacids|antacids|mesh-ancestor
92663410|NCT00263744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663411|NCT00263744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663412|NCT00294294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92663413|NCT00294294|Immunologic Factors|immunologic factors|mesh-ancestor
92663414|NCT00294294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663415|NCT00263822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92663416|NCT00263822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663417|NCT00263822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92663418|NCT00263822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663419|NCT00263822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663420|NCT00300222|Capsaicin|capsaicin|mesh-list
92663421|NCT00300222|Antipruritics|antipruritics|mesh-ancestor
92663422|NCT00300222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92663423|NCT00300222|Sensory System Agents|sensory system agents|mesh-ancestor
92663424|NCT00300222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663425|NCT00300222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663426|NCT00263978|Defibrotide|defibrotide|mesh-list
92663427|NCT00263978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92663428|NCT00263978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92663429|NCT00263978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663433|NCT00264134|Irinotecan|irinotecan|mesh-list
92663434|NCT00264134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663435|NCT00264134|Tubulin Modulators|tubulin modulators|mesh-ancestor
92663436|NCT00264134|Antimitotic Agents|antimitotic agents|mesh-ancestor
92663437|NCT00264134|Mitosis Modulators|mitosis modulators|mesh-ancestor
92663438|NCT00264134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663440|NCT00264134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92663441|NCT00264134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663442|NCT00300339|Clopidogrel|clopidogrel|mesh-list
92663443|NCT00300339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92663444|NCT00300339|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92663445|NCT00300339|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92663446|NCT00300339|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92663447|NCT00300339|Purinergic Agents|purinergic agents|mesh-ancestor
92663448|NCT00300339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663449|NCT00300339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663450|NCT00300339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663451|NCT00264173|Valproic Acid|valproic acid|mesh-list
92663452|NCT00264173|Anticonvulsants|anticonvulsants|mesh-ancestor
92663453|NCT00264173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663454|NCT00264173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663455|NCT00264173|GABA Agents|gaba agents|mesh-ancestor
92663456|NCT00264173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663457|NCT00264173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663458|NCT00264173|Antimanic Agents|antimanic agents|mesh-ancestor
92663459|NCT00264173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92663460|NCT00264173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92663461|NCT00264173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92663462|NCT00264212|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92663463|NCT00264212|Irbesartan|irbesartan|mesh-list
92663464|NCT00264212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663465|NCT00264212|Diuretics|diuretics|mesh-ancestor
92663466|NCT00264212|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663467|NCT00264212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663468|NCT00264212|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92663469|NCT00264212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663470|NCT00264212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663471|NCT00264212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92663472|NCT00264212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92663473|NCT00300378|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92663474|NCT00300378|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92577472|NCT00268684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92577473|NCT00268684|Alkylating Agents|alkylating agents|mesh-ancestor
92577474|NCT00268684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577475|NCT00268684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663475|NCT00300378|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92663476|NCT00300378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663477|NCT00300378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663478|NCT00300378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663479|NCT00300378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663480|NCT00300378|Antidepressive Agents|antidepressive agents|mesh-ancestor
92663481|NCT00300378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92663482|NCT00264251|Rosiglitazone|rosiglitazone|mesh-list
92663483|NCT00264251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92663484|NCT00264251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663485|NCT00294567|Amlodipine|amlodipine|mesh-list
92663486|NCT00294567|Calcium Channel Blockers|calcium channel blockers|mesh-list
92663487|NCT00294567|Calcium|calcium|mesh-list
92663488|NCT00294567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92663489|NCT00294567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663490|NCT00294567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663491|NCT00294567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663492|NCT00294567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663493|NCT00294567|Vasodilator Agents|vasodilator agents|mesh-ancestor
92663494|NCT00294606|Phenylephrine|phenylephrine|mesh-list
92663495|NCT00294606|Oxymetazoline|oxymetazoline|mesh-list
92663496|NCT00294606|Norepinephrine|norepinephrine|mesh-list
92663497|NCT00294606|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92663498|NCT00294606|Mydriatics|mydriatics|mesh-ancestor
92663499|NCT00294606|Autonomic Agents|autonomic agents|mesh-ancestor
92663500|NCT00294606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070802|NCT04273282|Protective Agents|protective agents|mesh-ancestor
92663503|NCT00294606|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92663504|NCT00294606|Nasal Decongestants|nasal decongestants|mesh-ancestor
92663505|NCT00294606|Respiratory System Agents|respiratory system agents|mesh-ancestor
92663506|NCT00294606|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92663507|NCT00294606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92663508|NCT00294606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92663509|NCT00294606|Adrenergic Agents|adrenergic agents|mesh-ancestor
92663510|NCT00294606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663511|NCT00294606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663512|NCT00294606|Protective Agents|protective agents|mesh-ancestor
92663513|NCT04708964|Flurbiprofen|flurbiprofen|mesh-list
92663514|NCT04708964|Analgesics|analgesics|mesh-ancestor
92663515|NCT04708964|Sensory System Agents|sensory system agents|mesh-ancestor
92663516|NCT04708964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663517|NCT04708964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663518|NCT04708964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92663519|NCT04708964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663520|NCT04708964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663521|NCT04708964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663522|NCT04708964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92663523|NCT04708964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663524|NCT04708964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663525|NCT00264368|Ganciclovir|ganciclovir|mesh-list
92663526|NCT00264368|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92663527|NCT00264368|Antiviral Agents|antiviral agents|mesh-ancestor
92663528|NCT00264368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663529|NCT00264368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92663530|NCT00264368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663531|NCT00264368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663532|NCT00264407|Hormones|hormones|mesh-list
92663533|NCT00264407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663534|NCT00264407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663535|NCT00300573|Dexelvucitabine|dexelvucitabine|mesh-list
92663536|NCT00300573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92663537|NCT00300573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92663538|NCT00300573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682787|NCT00438113|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92663539|NCT00300573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663540|NCT00300573|Antiviral Agents|antiviral agents|mesh-ancestor
92663541|NCT00300573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663542|NCT00300573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92663543|NCT00300573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92663544|NCT00264446|Eniluracil|eniluracil|mesh-list
92663545|NCT00264446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663546|NCT00264446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663547|NCT00264485|Fentanyl|fentanyl|mesh-list
92663548|NCT00264485|Morphine|morphine|mesh-list
92663549|NCT00264485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92663550|NCT00264485|Narcotics|narcotics|mesh-ancestor
92663551|NCT00264485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92663552|NCT00264485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663553|NCT00264485|Analgesics|analgesics|mesh-ancestor
92663554|NCT00264485|Sensory System Agents|sensory system agents|mesh-ancestor
92663555|NCT00264485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663556|NCT00264485|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92663557|NCT00264485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92663558|NCT00264485|Anesthetics, General|anesthetics, general|mesh-ancestor
92663559|NCT00264485|Anesthetics|anesthetics|mesh-ancestor
92663560|NCT00294918|Hormones|hormones|mesh-list
92663561|NCT00294918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663562|NCT00294918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663563|NCT00264680|Lamotrigine|lamotrigine|mesh-list
92663564|NCT00264680|Anticonvulsants|anticonvulsants|mesh-list
92663565|NCT00264680|Valproic Acid|valproic acid|mesh-list
92663566|NCT00264680|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92663567|NCT00264680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663568|NCT00264680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663569|NCT00264680|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92663570|NCT00264680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070875|NCT01456546|Clopidogrel|clopidogrel|mesh-list
92663573|NCT00264680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92663574|NCT00264680|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92663575|NCT00264680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92663576|NCT00264680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663577|NCT00264680|GABA Agents|gaba agents|mesh-ancestor
92663578|NCT00264680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663579|NCT00264680|Antimanic Agents|antimanic agents|mesh-ancestor
92663580|NCT00300729|Celecoxib|celecoxib|mesh-list
92663581|NCT00300729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92663582|NCT00300729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663583|NCT00300729|Analgesics|analgesics|mesh-ancestor
92388911|NCT00356460|Antibodies|antibodies|mesh-list
92663584|NCT00300729|Sensory System Agents|sensory system agents|mesh-ancestor
92663585|NCT00300729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663586|NCT00300729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663587|NCT00300729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663588|NCT00300729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663589|NCT00300729|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92663590|NCT00300729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92663591|NCT00300729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663592|NCT00300729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663593|NCT00264719|Metoclopramide|metoclopramide|mesh-list
92663594|NCT00264719|Antiemetics|antiemetics|mesh-ancestor
92663595|NCT00264719|Autonomic Agents|autonomic agents|mesh-ancestor
92663596|NCT00264719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663597|NCT00264719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663598|NCT00264719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663599|NCT00264719|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92663600|NCT00264719|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92663601|NCT00264719|Dopamine Agents|dopamine agents|mesh-ancestor
92663602|NCT00264719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663603|NCT00264719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663604|NCT00264914|Satavaptan|satavaptan|mesh-list
92663605|NCT00264914|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92663606|NCT00264914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663607|NCT00264914|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663608|NCT00264914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663609|NCT00264953|Prednisone|prednisone|mesh-list
92663610|NCT00264953|Etoposide|etoposide|mesh-list
92663611|NCT00264953|Vincristine|vincristine|mesh-list
92663612|NCT00264953|Doxorubicin|doxorubicin|mesh-list
92577476|NCT00268684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92577477|NCT00268684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577478|NCT00106821|Bromides|bromides|mesh-list
92577479|NCT00106821|Tiotropium Bromide|tiotropium bromide|mesh-list
92663613|NCT00264953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92663614|NCT00264953|Bleomycin|bleomycin|mesh-list
92663615|NCT00264953|Vinblastine|vinblastine|mesh-list
92663616|NCT00264953|Procarbazine|procarbazine|mesh-list
92663617|NCT00264953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663618|NCT00264953|Glucocorticoids|glucocorticoids|mesh-ancestor
92663619|NCT00264953|Hormones|hormones|mesh-ancestor
92663620|NCT00264953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663621|NCT00264953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663622|NCT00264953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663623|NCT00264953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663624|NCT00264953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92663625|NCT00264953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92663626|NCT00264953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92663627|NCT00264953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663628|NCT00264953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663629|NCT00264953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92663630|NCT00264953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92663631|NCT00264953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92663632|NCT00264953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92663633|NCT00300846|Aripiprazole|aripiprazole|mesh-list
92663634|NCT00300846|Antidepressive Agents|antidepressive agents|mesh-ancestor
92663635|NCT00300846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92663636|NCT00300846|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92663637|NCT00300846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92663638|NCT00300846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92663639|NCT00300846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663640|NCT00300846|Dopamine Agonists|dopamine agonists|mesh-ancestor
92663641|NCT00300846|Dopamine Agents|dopamine agents|mesh-ancestor
92663642|NCT00300846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070946|NCT02873806|Dexamethasone|dexamethasone|mesh-list
92663644|NCT00300846|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92663646|NCT00300846|Serotonin Agents|serotonin agents|mesh-ancestor
92663647|NCT00300846|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92663648|NCT00300846|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92663649|NCT00300846|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92663650|NCT00300846|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92663651|NCT00294996|Doxorubicin|doxorubicin|mesh-list
92663652|NCT00294996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92663653|NCT00294996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663654|NCT00294996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92663655|NCT00294996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92663656|NCT00294996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663657|NCT00294996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663658|NCT00265031|Prednisone|prednisone|mesh-list
92663659|NCT00265031|Cyclophosphamide|cyclophosphamide|mesh-list
92663660|NCT00265031|Etoposide|etoposide|mesh-list
92663661|NCT00265031|Vincristine|vincristine|mesh-list
92663662|NCT00265031|Doxorubicin|doxorubicin|mesh-list
92663663|NCT00265031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92663664|NCT00265031|Bleomycin|bleomycin|mesh-list
92663665|NCT00265031|Procarbazine|procarbazine|mesh-list
92663666|NCT00265031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92663667|NCT00265031|Immunologic Factors|immunologic factors|mesh-ancestor
92663668|NCT00265031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663669|NCT00265031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663670|NCT00265031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92663671|NCT00265031|Alkylating Agents|alkylating agents|mesh-ancestor
92663672|NCT00265031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663673|NCT00265031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663674|NCT00265031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92663675|NCT00265031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663676|NCT00265031|Glucocorticoids|glucocorticoids|mesh-ancestor
92663677|NCT00265031|Hormones|hormones|mesh-ancestor
92663678|NCT00265031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663679|NCT00265031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663680|NCT00265031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92663681|NCT00265031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577480|NCT00106821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92577481|NCT00106821|Autonomic Agents|autonomic agents|mesh-ancestor
92663682|NCT00265031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92663683|NCT00265031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663684|NCT00265031|Tubulin Modulators|tubulin modulators|mesh-ancestor
92663685|NCT00265031|Antimitotic Agents|antimitotic agents|mesh-ancestor
92663686|NCT00265031|Mitosis Modulators|mitosis modulators|mesh-ancestor
92663687|NCT00265031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92663688|NCT00300924|Acetaminophen|acetaminophen|mesh-list
92663689|NCT00300924|Rizatriptan|rizatriptan|mesh-list
92663690|NCT00300924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663691|NCT00300924|Analgesics|analgesics|mesh-ancestor
92663692|NCT00300924|Sensory System Agents|sensory system agents|mesh-ancestor
92663693|NCT00300924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663694|NCT00300924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663695|NCT00300924|Antipyretics|antipyretics|mesh-ancestor
92663696|NCT00300924|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92663697|NCT00300924|Serotonin Agents|serotonin agents|mesh-ancestor
92663698|NCT00300924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663699|NCT00300924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663700|NCT00265070|Gefitinib|gefitinib|mesh-list
92663701|NCT00265070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663702|NCT00265070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92663703|NCT00265070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663704|NCT00265070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663705|NCT00295035|Celecoxib|celecoxib|mesh-list
92663706|NCT00295035|Curcumin|curcumin|mesh-list
92663707|NCT00295035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92663708|NCT00295035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663709|NCT00295035|Analgesics|analgesics|mesh-ancestor
92663710|NCT00295035|Sensory System Agents|sensory system agents|mesh-ancestor
92663711|NCT00295035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663712|NCT00295035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663713|NCT00295035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663714|NCT00295035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071020|NCT01892332|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92663718|NCT00295035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663720|NCT00265265|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92663721|NCT00265265|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92663722|NCT00265265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92663723|NCT00265265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663724|NCT00265265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663725|NCT00265265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92663726|NCT00265265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663727|NCT00265265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663728|NCT00418275|Plasminogen|plasminogen|mesh-list
92663729|NCT00418275|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92364865|NCT03010098|Remifentanil|remifentanil|mesh-list
92663730|NCT00418275|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92663731|NCT00418275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663732|NCT00265304|Ketoprofen|ketoprofen|mesh-list
92663733|NCT00265304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92663734|NCT00265304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92663736|NCT00265304|Sensory System Agents|sensory system agents|mesh-ancestor
92663737|NCT00265304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663738|NCT00265304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663739|NCT00265304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663740|NCT00265304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663741|NCT00265304|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92663742|NCT00265304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663743|NCT00265304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663744|NCT00295191|Dialysis Solutions|dialysis solutions|mesh-list
92663745|NCT00295191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92663746|NCT00265460|Lobeline|lobeline|mesh-list
92663747|NCT00265460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92663748|NCT00265460|Autonomic Agents|autonomic agents|mesh-ancestor
92663749|NCT00265460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663750|NCT00265460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663751|NCT00265460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92663752|NCT00265460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92663753|NCT00265460|Cholinergic Agents|cholinergic agents|mesh-ancestor
92663754|NCT00265460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663755|NCT00265460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577482|NCT00106821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020586|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
92663756|NCT00265460|Respiratory System Agents|respiratory system agents|mesh-ancestor
92663758|NCT00301002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92663759|NCT00301002|Immunologic Factors|immunologic factors|mesh-ancestor
92663760|NCT00301002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663761|NCT00265694|Carboplatin|carboplatin|mesh-list
92663762|NCT00265694|Gemcitabine|gemcitabine|mesh-list
92663763|NCT00265694|Vinorelbine|vinorelbine|mesh-list
92663764|NCT00265694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663765|NCT00265694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663766|NCT00265694|Antimetabolites|antimetabolites|mesh-ancestor
92663767|NCT00265694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663768|NCT00265694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92663769|NCT00265694|Tubulin Modulators|tubulin modulators|mesh-ancestor
92663770|NCT00265694|Antimitotic Agents|antimitotic agents|mesh-ancestor
92663771|NCT00265694|Mitosis Modulators|mitosis modulators|mesh-ancestor
92663772|NCT00265733|Paclitaxel|paclitaxel|mesh-list
92663773|NCT00265733|Capecitabine|capecitabine|mesh-list
92663774|NCT00265733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92663775|NCT00265733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92663776|NCT00265733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663777|NCT00265733|Tubulin Modulators|tubulin modulators|mesh-ancestor
92663778|NCT00265733|Antimitotic Agents|antimitotic agents|mesh-ancestor
92663779|NCT00265733|Mitosis Modulators|mitosis modulators|mesh-ancestor
92663780|NCT00265733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663781|NCT00265733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92663782|NCT00265733|Antimetabolites|antimetabolites|mesh-ancestor
92663783|NCT00265772|Prednisolone|prednisolone|mesh-list
92663784|NCT00265772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663785|NCT00265772|Glucocorticoids|glucocorticoids|mesh-ancestor
92663788|NCT00265772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663789|NCT00265772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92663790|NCT00265772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663791|NCT00265811|Cetuximab|cetuximab|mesh-list
92663792|NCT00265811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92663793|NCT00265811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663794|NCT00295308|Clonidine|clonidine|mesh-list
92663795|NCT00295308|Analgesics|analgesics|mesh-ancestor
92663796|NCT00295308|Sensory System Agents|sensory system agents|mesh-ancestor
92663797|NCT00295308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663798|NCT00295308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663799|NCT00295308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663800|NCT00295308|Sympatholytics|sympatholytics|mesh-ancestor
92663801|NCT00295308|Autonomic Agents|autonomic agents|mesh-ancestor
92663802|NCT00295308|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92663803|NCT00295308|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92663804|NCT00295308|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92663805|NCT00295308|Adrenergic Agents|adrenergic agents|mesh-ancestor
92663806|NCT00295308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389144|NCT00359892|Obatoclax|obatoclax|mesh-list
92663807|NCT00295308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663809|NCT00265928|Bortezomib|bortezomib|mesh-list
92663810|NCT00265928|Antibodies|antibodies|mesh-list
92663811|NCT00265928|Immunoglobulins|immunoglobulins|mesh-list
92663812|NCT00265928|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92663813|NCT00265928|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92663814|NCT00265928|Immunologic Factors|immunologic factors|mesh-ancestor
92663815|NCT00265928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663816|NCT00265928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92663817|NCT00265928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663818|NCT00265928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663819|NCT00265928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663820|NCT00295347|Fludrocortisone|fludrocortisone|mesh-list
92663821|NCT00295347|Spironolactone|spironolactone|mesh-list
92663822|NCT00295347|Escitalopram|escitalopram|mesh-list
92663823|NCT00295347|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92663824|NCT00295347|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92663825|NCT00295347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663826|NCT00295347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663827|NCT00295347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663828|NCT00295347|Serotonin Agents|serotonin agents|mesh-ancestor
92663829|NCT00295347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577483|NCT00106821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577484|NCT00106821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92577485|NCT00106821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92663830|NCT00295347|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92663831|NCT00295347|Hormone Antagonists|hormone antagonists|mesh-ancestor
92663832|NCT00295347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663833|NCT00295347|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92663834|NCT00295347|Diuretics|diuretics|mesh-ancestor
92663835|NCT00295347|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663836|NCT00295347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663837|NCT00265967|Irbesartan|irbesartan|mesh-list
92663838|NCT00265967|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663839|NCT00265967|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92663840|NCT00265967|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92663841|NCT00265967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663842|NCT00295386|Zopiclone|zopiclone|mesh-list
92663843|NCT00295386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92663844|NCT00295386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92663845|NCT00295386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663846|NCT00301236|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92663847|NCT00301236|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92663848|NCT00301236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663849|NCT00301236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92663850|NCT00301236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92663851|NCT00301236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663852|NCT00301236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663853|NCT00301236|Dopamine Agents|dopamine agents|mesh-ancestor
92663854|NCT00301236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663855|NCT00295425|Cyclosporine|cyclosporine|mesh-list
92663857|NCT00295425|Cyclosporins|cyclosporins|mesh-list
92663858|NCT00295425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663859|NCT00295425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663860|NCT00295425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92663861|NCT00295425|Immunologic Factors|immunologic factors|mesh-ancestor
92663862|NCT00295425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663863|NCT00295425|Antifungal Agents|antifungal agents|mesh-ancestor
92663864|NCT00295425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663865|NCT00295425|Dermatologic Agents|dermatologic agents|mesh-ancestor
92663866|NCT00295425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663867|NCT00295425|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92663868|NCT00295425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92663869|NCT00295425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663870|NCT00295425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92364873|NCT03010098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92663871|NCT00295425|Antitubercular Agents|antitubercular agents|mesh-ancestor
92663872|NCT00295425|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663874|NCT00266123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92663875|NCT00266123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663876|NCT00266123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92663877|NCT00266123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389212|NCT00361686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663878|NCT00266123|Antifungal Agents|antifungal agents|mesh-ancestor
92663879|NCT00266123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92663880|NCT00266123|Immunologic Factors|immunologic factors|mesh-ancestor
92663881|NCT00266123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663882|NCT00266162|Bosentan|bosentan|mesh-list
92663883|NCT00266162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663884|NCT00266162|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92663885|NCT00266162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663886|NCT00295464|Betamethasone|betamethasone|mesh-list
92663887|NCT00295464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92663888|NCT00295464|Glucocorticoids|glucocorticoids|mesh-ancestor
92663889|NCT00295464|Hormones|hormones|mesh-ancestor
92663890|NCT00295464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663891|NCT00295464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663892|NCT00295464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92663893|NCT00295464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92663894|NCT00415766|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92663895|NCT00415766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92663896|NCT00415766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663897|NCT00301392|Pitavastatin|pitavastatin|mesh-list
92663898|NCT00301392|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92663899|NCT00301392|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92663900|NCT00301392|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92663901|NCT00301392|Antimetabolites|antimetabolites|mesh-ancestor
92663902|NCT00301392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663903|NCT00301392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663904|NCT00301392|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92663905|NCT00415844|Levodopa|levodopa|mesh-list
92663906|NCT00415844|Carbidopa|carbidopa|mesh-list
92663907|NCT00415844|Entacapone|entacapone|mesh-list
92663908|NCT00415844|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92663909|NCT00415844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92663910|NCT00415844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92663911|NCT00415844|Dopamine Agents|dopamine agents|mesh-ancestor
92663912|NCT00415844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663913|NCT00415844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663914|NCT00415844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663915|NCT00415844|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92663916|NCT00415844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663917|NCT00415844|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92663918|NCT00415844|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92663919|NCT00415844|Immunologic Factors|immunologic factors|mesh-ancestor
92663920|NCT00415844|Dopamine Agonists|dopamine agonists|mesh-ancestor
92663921|NCT00415883|Valsartan|valsartan|mesh-list
92663922|NCT00415883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92663923|NCT00415883|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92663924|NCT00415883|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92663925|NCT00415883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663926|NCT00295542|Atenolol|atenolol|mesh-list
92663927|NCT00295542|Valsartan|valsartan|mesh-list
92663943|NCT00295542|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92663944|NCT00295542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663945|NCT00295542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92663946|NCT00295542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92663947|NCT00295542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663948|NCT00295542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663950|NCT00295542|Protective Agents|protective agents|mesh-ancestor
92663951|NCT00295542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92389294|NCT00363948|Hormones|hormones|mesh-ancestor
92663952|NCT00295542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92663953|NCT00295542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92663955|NCT00295542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92663956|NCT00295542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92663957|NCT00295542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92663958|NCT00295542|Protease Inhibitors|protease inhibitors|mesh-ancestor
92663959|NCT00295542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663960|NCT00295542|Natriuretic Agents|natriuretic agents|mesh-ancestor
92663961|NCT00295542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92663962|NCT00295542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92663963|NCT00295542|Sympatholytics|sympatholytics|mesh-ancestor
92663964|NCT00295542|Autonomic Agents|autonomic agents|mesh-ancestor
92663965|NCT00295542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663966|NCT00295542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92663967|NCT00295542|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92663968|NCT00295542|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92663969|NCT00295542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92663970|NCT00295542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92663971|NCT00295542|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92663972|NCT00266318|Interferons|interferons|mesh-list
92663973|NCT00266318|Ribavirin|ribavirin|mesh-list
92663974|NCT00266318|Interferon alfacon-1|interferon alfacon-1|mesh-list
92663975|NCT00266318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663976|NCT00266318|Antiviral Agents|antiviral agents|mesh-ancestor
92663977|NCT00266318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663978|NCT00266318|Antimetabolites|antimetabolites|mesh-ancestor
92663979|NCT00266318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663980|NCT00266357|Gaboxadol|gaboxadol|mesh-list
92663981|NCT00266357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92663982|NCT00266357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663983|NCT00266357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577486|NCT00106821|Parasympatholytics|parasympatholytics|mesh-ancestor
92577487|NCT00106821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92577488|NCT00106821|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682788|NCT00438113|Terazosin|terazosin|mesh-list
92663984|NCT00266357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663985|NCT00266357|Analgesics|analgesics|mesh-ancestor
92663986|NCT00266357|Sensory System Agents|sensory system agents|mesh-ancestor
92663987|NCT00266357|Anticonvulsants|anticonvulsants|mesh-ancestor
92663988|NCT00266357|GABA Agonists|gaba agonists|mesh-ancestor
92663989|NCT00266357|GABA Agents|gaba agents|mesh-ancestor
92663990|NCT00301509|Ribavirin|ribavirin|mesh-list
92663991|NCT00301509|Antimetabolites|antimetabolites|mesh-ancestor
92071312|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663994|NCT00301509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663995|NCT00295698|Diethylcarbamazine|diethylcarbamazine|mesh-list
92663996|NCT00295698|Filaricides|filaricides|mesh-ancestor
92663997|NCT00295698|Antinematodal Agents|antinematodal agents|mesh-ancestor
92663998|NCT00295698|Anthelmintics|anthelmintics|mesh-ancestor
92663999|NCT00295698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92664000|NCT00295698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664001|NCT00295698|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92664002|NCT00295698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664003|NCT00295698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664004|NCT00266552|Risperidone|risperidone|mesh-list
92664005|NCT00266552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92664006|NCT00266552|Serotonin Agents|serotonin agents|mesh-ancestor
92664007|NCT00266552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664008|NCT00266552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664009|NCT00266552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664010|NCT00266552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92664011|NCT00266552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92664012|NCT00266552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664013|NCT00266552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664014|NCT00266552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92664015|NCT00266552|Dopamine Agents|dopamine agents|mesh-ancestor
92664016|NCT00301587|Folic Acid|folic acid|mesh-list
92664017|NCT00301587|Moxifloxacin|moxifloxacin|mesh-list
92664018|NCT00301587|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92664019|NCT00301587|Norgestimate|norgestimate|mesh-list
92664020|NCT00301587|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92664021|NCT00301587|Estradiol|estradiol|mesh-list
92664022|NCT00301587|Estrogens|estrogens|mesh-ancestor
92664023|NCT00301587|Hormones|hormones|mesh-ancestor
92664024|NCT00301587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664025|NCT00301587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664026|NCT00301587|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92664027|NCT00301587|Contraceptive Agents|contraceptive agents|mesh-ancestor
92664028|NCT00301587|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92664029|NCT00301587|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92664030|NCT00301587|Hematinics|hematinics|mesh-ancestor
92664031|NCT00301587|Vitamin B Complex|vitamin b complex|mesh-ancestor
92664032|NCT00301587|Vitamins|vitamins|mesh-ancestor
92664033|NCT00301587|Micronutrients|micronutrients|mesh-ancestor
92664034|NCT00301587|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92664035|NCT00301587|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92664036|NCT00301587|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92664037|NCT00301587|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92664038|NCT00301587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664039|NCT00301587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92664040|NCT00301587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92664041|NCT00301587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664042|NCT00301587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664043|NCT00301587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664044|NCT00301587|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92664045|NCT00266591|Topiramate|topiramate|mesh-list
92664046|NCT00266591|Anticonvulsants|anticonvulsants|mesh-ancestor
92664047|NCT00266591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92664048|NCT00266591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664049|NCT00301665|Botulinum Toxins|botulinum toxins|mesh-list
92664050|NCT00301665|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92664051|NCT00301665|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92664052|NCT00301665|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92664053|NCT00301665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664054|NCT00301665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577489|NCT00106821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577490|NCT00106821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577491|NCT00106821|Anticonvulsants|anticonvulsants|mesh-ancestor
92577492|NCT00073931|Tositumomab I-131|tositumomab i-131|mesh-list
92577493|NCT00073931|Sargramostim|sargramostim|mesh-list
92664055|NCT00301665|Cholinergic Agents|cholinergic agents|mesh-ancestor
92664056|NCT00301665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664057|NCT00301665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664058|NCT00301665|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92664059|NCT00301665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664060|NCT00295776|Lamotrigine|lamotrigine|mesh-list
92664061|NCT00295776|Anticonvulsants|anticonvulsants|mesh-ancestor
92664062|NCT00295776|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92664063|NCT00295776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664064|NCT00295776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664067|NCT00295776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92664068|NCT00295776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92664069|NCT00295776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664070|NCT00295776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664071|NCT00295776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92664072|NCT00266669|Nitroglycerin|nitroglycerin|mesh-list
92664073|NCT00266669|Vasodilator Agents|vasodilator agents|mesh-ancestor
92664074|NCT00266747|Amibegron|amibegron|mesh-list
92664075|NCT00266747|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92664076|NCT00266747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92664077|NCT00266747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92664078|NCT00266747|Adrenergic Agents|adrenergic agents|mesh-ancestor
92664079|NCT00266747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664080|NCT00266747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664081|NCT00266747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664082|NCT00266747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92664083|NCT00266786|Ketorolac|ketorolac|mesh-list
92664084|NCT00266786|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92664085|NCT00266786|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92664086|NCT00266786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664087|NCT00266786|Analgesics|analgesics|mesh-ancestor
92664088|NCT00266786|Sensory System Agents|sensory system agents|mesh-ancestor
92664089|NCT00266786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664090|NCT00266786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664091|NCT00266786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664092|NCT00266786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664093|NCT00266786|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92664094|NCT00266786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664095|NCT00266786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664096|NCT00295815|Lomustine|lomustine|mesh-list
92664097|NCT00295815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92664098|NCT00295815|Alkylating Agents|alkylating agents|mesh-ancestor
92664099|NCT00295815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664100|NCT00295815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664101|NCT00295971|Fludarabine|fludarabine|mesh-list
92664102|NCT00295971|Fludarabine phosphate|fludarabine phosphate|mesh-list
92664104|NCT00295971|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92664105|NCT00295971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664106|NCT00295971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664107|NCT00295971|Antimetabolites|antimetabolites|mesh-ancestor
92664108|NCT00295971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664109|NCT00295971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664110|NCT00295971|Immunologic Factors|immunologic factors|mesh-ancestor
92664111|NCT00295971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664112|NCT00295971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92664113|NCT00295971|Alkylating Agents|alkylating agents|mesh-ancestor
92664114|NCT00295971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92664115|NCT00267176|Lumiracoxib|lumiracoxib|mesh-list
92664116|NCT00267176|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92664117|NCT00267176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92664118|NCT00267176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664119|NCT00267176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577494|NCT00073931|Immunologic Factors|immunologic factors|mesh-ancestor
92577495|NCT00073931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664120|NCT00267176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92664121|NCT00267176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664122|NCT00267176|Analgesics|analgesics|mesh-ancestor
92664123|NCT00267176|Sensory System Agents|sensory system agents|mesh-ancestor
92664124|NCT00267176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664125|NCT00267176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664126|NCT00267176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664127|NCT00267176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664128|NCT00296010|Cyclophosphamide|cyclophosphamide|mesh-list
92664129|NCT00296010|Doxorubicin|doxorubicin|mesh-list
92664130|NCT00296010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92664131|NCT00296010|Methotrexate|methotrexate|mesh-list
92664132|NCT00296010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664133|NCT00296010|Immunologic Factors|immunologic factors|mesh-ancestor
92664134|NCT00296010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664135|NCT00296010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664136|NCT00296010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92664140|NCT00296010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92664141|NCT00296010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92664142|NCT00296010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92664143|NCT00296010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92664144|NCT00296010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664145|NCT00296010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92664146|NCT00296010|Abortifacient Agents|abortifacient agents|mesh-ancestor
92664147|NCT00296010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92664148|NCT00296010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664149|NCT00296010|Antimetabolites|antimetabolites|mesh-ancestor
92664150|NCT00296010|Dermatologic Agents|dermatologic agents|mesh-ancestor
92664151|NCT00296010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92664152|NCT00296010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92664153|NCT00267215|Lumiracoxib|lumiracoxib|mesh-list
92664154|NCT00267215|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92664155|NCT00267215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92664156|NCT00267215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664157|NCT00267215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664158|NCT00267215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92664159|NCT00267215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664160|NCT00267215|Analgesics|analgesics|mesh-ancestor
92664161|NCT00267215|Sensory System Agents|sensory system agents|mesh-ancestor
92664162|NCT00267215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664163|NCT00267215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664164|NCT00267215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664165|NCT00267215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664166|NCT00296049|Vancomycin|vancomycin|mesh-list
92664167|NCT00296049|Daptomycin|daptomycin|mesh-list
92664168|NCT00296049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92664169|NCT00296049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664170|NCT00267254|Atorvastatin|atorvastatin|mesh-list
92664171|NCT00267254|Simvastatin|simvastatin|mesh-list
92664172|NCT00267254|Torcetrapib|torcetrapib|mesh-list
92664173|NCT00267254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92664174|NCT00267254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92664175|NCT00267254|Antimetabolites|antimetabolites|mesh-ancestor
92664176|NCT00267254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664177|NCT00267254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92664178|NCT00267254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92664179|NCT00267254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664180|NCT00301782|Carboplatin|carboplatin|mesh-list
92664182|NCT00301782|Vincristine|vincristine|mesh-list
92664183|NCT00301782|Bleomycin|bleomycin|mesh-list
92664184|NCT00301782|Etoposide phosphate|etoposide phosphate|mesh-list
92664185|NCT00301782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664186|NCT00301782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664187|NCT00301782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92664188|NCT00301782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92664189|NCT00301782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664190|NCT00301782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664191|NCT00301782|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664192|NCT00301782|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664193|NCT00301782|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664194|NCT00301782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92577496|NCT00073931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577497|NCT00268723|Albuterol|albuterol|mesh-list
92577498|NCT00268723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92577499|NCT00268723|Autonomic Agents|autonomic agents|mesh-ancestor
92664195|NCT00267332|Modafinil|modafinil|mesh-list
92664196|NCT00267332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92664197|NCT00267332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664198|NCT00267332|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92664199|NCT00267332|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92664200|NCT00267332|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92664201|NCT00267332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664202|NCT04718649|Celecoxib|celecoxib|mesh-list
92664203|NCT04718649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92664204|NCT04718649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664205|NCT04718649|Analgesics|analgesics|mesh-ancestor
92664206|NCT04718649|Sensory System Agents|sensory system agents|mesh-ancestor
92664207|NCT04718649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071522|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
92664208|NCT04718649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664209|NCT04718649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664211|NCT04718649|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92664212|NCT04718649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92664213|NCT04718649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664214|NCT04718649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664215|NCT00301860|Cyclosporine|cyclosporine|mesh-list
92664216|NCT00301860|Methotrexate|methotrexate|mesh-list
92664217|NCT00301860|Fludarabine phosphate|fludarabine phosphate|mesh-list
92664218|NCT00301860|Fludarabine|fludarabine|mesh-list
92664219|NCT00301860|Melphalan|melphalan|mesh-list
92664220|NCT00301860|Cyclosporins|cyclosporins|mesh-list
92664221|NCT00301860|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92664222|NCT00301860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92664223|NCT00301860|Abortifacient Agents|abortifacient agents|mesh-ancestor
92664224|NCT00301860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92664225|NCT00301860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664226|NCT00301860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664227|NCT00301860|Antimetabolites|antimetabolites|mesh-ancestor
92664228|NCT00301860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664229|NCT00301860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664230|NCT00301860|Dermatologic Agents|dermatologic agents|mesh-ancestor
92664231|NCT00301860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664232|NCT00301860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92664233|NCT00301860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664234|NCT00301860|Immunologic Factors|immunologic factors|mesh-ancestor
92664235|NCT00301860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664236|NCT00301860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92664237|NCT00301860|Antifungal Agents|antifungal agents|mesh-ancestor
92664238|NCT00301860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664239|NCT00301860|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92664240|NCT00301860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92664241|NCT00301860|Alkylating Agents|alkylating agents|mesh-ancestor
92664242|NCT00301860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92664243|NCT00301899|Trastuzumab|trastuzumab|mesh-list
92664244|NCT00301899|Pertuzumab|pertuzumab|mesh-list
92664245|NCT00301899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92664246|NCT00301899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664247|NCT00296127|Celecoxib|celecoxib|mesh-list
92664248|NCT00296127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92664249|NCT00296127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664250|NCT00296127|Analgesics|analgesics|mesh-ancestor
92389596|NCT00371124|Atropine|atropine|mesh-list
92664251|NCT00296127|Sensory System Agents|sensory system agents|mesh-ancestor
92664252|NCT00296127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664253|NCT00296127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664254|NCT00296127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664255|NCT00296127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664256|NCT00296127|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92664257|NCT00296127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92664258|NCT00296127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664259|NCT00296127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664260|NCT00296205|Cyclophosphamide|cyclophosphamide|mesh-list
92577500|NCT00268723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577501|NCT00268723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577502|NCT00268723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92664261|NCT00296205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664262|NCT00296205|Immunologic Factors|immunologic factors|mesh-ancestor
92664263|NCT00296205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664264|NCT00296205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664265|NCT00296205|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92664266|NCT00296205|Alkylating Agents|alkylating agents|mesh-ancestor
92664267|NCT00296205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664268|NCT00296205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664269|NCT00296205|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92664270|NCT00267683|Insulin Aspart|insulin aspart|mesh-list
92664271|NCT00267683|Glyburide|glyburide|mesh-list
92664272|NCT00267683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92664273|NCT00267683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664274|NCT00267722|Visilizumab|visilizumab|mesh-list
92664275|NCT00267722|Immunologic Factors|immunologic factors|mesh-ancestor
92664276|NCT00267722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664277|NCT00301938|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92664278|NCT00301938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664279|NCT00301938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92664280|NCT00301938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071601|NCT01896193|Sofosbuvir|sofosbuvir|mesh-list
92664281|NCT00301938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664283|NCT00267917|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
92664284|NCT00267917|Ipratropium|ipratropium|mesh-list
92664285|NCT00267917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92664286|NCT00267917|Autonomic Agents|autonomic agents|mesh-ancestor
92664287|NCT00267917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664288|NCT00267917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664289|NCT00267917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92664290|NCT00267917|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664291|NCT00267917|Sympathomimetics|sympathomimetics|mesh-ancestor
92664292|NCT00267917|Tocolytic Agents|tocolytic agents|mesh-ancestor
92664293|NCT00267917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92664294|NCT00267917|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92664295|NCT00267917|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92664296|NCT00267917|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92664297|NCT00267917|Adrenergic Agents|adrenergic agents|mesh-ancestor
92664298|NCT00267917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664299|NCT00267917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664300|NCT00267917|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92664301|NCT00267917|Cholinergic Agents|cholinergic agents|mesh-ancestor
92664302|NCT00296361|Tacrolimus|tacrolimus|mesh-list
92664303|NCT00296361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664304|NCT00296361|Immunologic Factors|immunologic factors|mesh-ancestor
92664305|NCT00296361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664306|NCT00296361|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92664307|NCT00296361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664308|NCT00296361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664309|NCT00415922|Levodopa|levodopa|mesh-list
92664310|NCT00415922|Carbidopa|carbidopa|mesh-list
92664311|NCT00415922|Entacapone|entacapone|mesh-list
92664312|NCT00415922|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92664313|NCT00415922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92664314|NCT00415922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92664315|NCT00415922|Dopamine Agents|dopamine agents|mesh-ancestor
92664316|NCT00415922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664317|NCT00415922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664318|NCT00415922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664319|NCT00415922|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92664320|NCT00415922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664321|NCT00415922|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92664322|NCT00415922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92664323|NCT00415922|Immunologic Factors|immunologic factors|mesh-ancestor
92664324|NCT00415922|Dopamine Agonists|dopamine agonists|mesh-ancestor
92664326|NCT00415961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664327|NCT00415961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664328|NCT00415961|Tubulin Modulators|tubulin modulators|mesh-ancestor
92577503|NCT00268723|Respiratory System Agents|respiratory system agents|mesh-ancestor
92577504|NCT00268723|Tocolytic Agents|tocolytic agents|mesh-ancestor
92577505|NCT00268723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92021194|NCT04357795|Cyclosporine|cyclosporine|mesh-list
92664329|NCT00415961|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664330|NCT00415961|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664331|NCT00415961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664332|NCT00416039|Midazolam|midazolam|mesh-list
92664333|NCT00416039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92664334|NCT00416039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92664335|NCT00416039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664336|NCT00416039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664337|NCT00416039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92664338|NCT00416039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92664339|NCT00416039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664340|NCT00416039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92664341|NCT00416039|Anesthetics, General|anesthetics, general|mesh-ancestor
92664342|NCT00416039|Anesthetics|anesthetics|mesh-ancestor
92664343|NCT00416039|GABA Modulators|gaba modulators|mesh-ancestor
92664344|NCT00416039|GABA Agents|gaba agents|mesh-ancestor
92664345|NCT00416039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664346|NCT00416039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664347|NCT00296478|Progesterone|progesterone|mesh-list
92664348|NCT00296478|Progestins|progestins|mesh-ancestor
92664349|NCT00296478|Hormones|hormones|mesh-ancestor
92664350|NCT00296478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664351|NCT00296478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664352|NCT00268151|Capecitabine|capecitabine|mesh-list
92664353|NCT00268151|Oxaliplatin|oxaliplatin|mesh-list
92664354|NCT00268151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664355|NCT00268151|Antimetabolites|antimetabolites|mesh-ancestor
92664360|NCT00418080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92664361|NCT00418080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664362|NCT00418080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664363|NCT00418080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664364|NCT00268229|Cytarabine|cytarabine|mesh-list
92664365|NCT00268229|Imatinib Mesylate|imatinib mesylate|mesh-list
92664366|NCT00268229|Daunorubicin|daunorubicin|mesh-list
92664367|NCT00268229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664368|NCT00268229|Antimetabolites|antimetabolites|mesh-ancestor
92664369|NCT00268229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664370|NCT00268229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664371|NCT00268229|Antiviral Agents|antiviral agents|mesh-ancestor
92664372|NCT00268229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664373|NCT00268229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664374|NCT00268229|Immunologic Factors|immunologic factors|mesh-ancestor
92664375|NCT00268229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664376|NCT00268229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92664377|NCT00268229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664378|NCT00268229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92664379|NCT00268229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92664380|NCT00268229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92664381|NCT00302289|Caffeine|caffeine|mesh-list
92664382|NCT00302289|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92664383|NCT00302289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664384|NCT00302289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92664385|NCT00302289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664386|NCT00302289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664387|NCT00302289|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92664388|NCT00302289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92664389|NCT00302289|Purinergic Agents|purinergic agents|mesh-ancestor
92664390|NCT00302289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664391|NCT00296634|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92664392|NCT00296634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92664393|NCT00296634|Immunologic Factors|immunologic factors|mesh-ancestor
92664394|NCT00296634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664395|NCT00296634|Antacids|antacids|mesh-ancestor
92664396|NCT00296634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664397|NCT00296634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92664398|NCT00268619|Ramipril|ramipril|mesh-list
92664399|NCT00268619|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92577506|NCT00268723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92577507|NCT00268723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92577508|NCT00268723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92577509|NCT00268723|Adrenergic Agents|adrenergic agents|mesh-ancestor
92664401|NCT00268619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664402|NCT00268619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664403|NCT00268619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92664404|NCT00296712|Dexetimide|dexetimide|mesh-list
92664405|NCT00296712|Citalopram|citalopram|mesh-list
92664406|NCT00296712|Bupropion|bupropion|mesh-list
92664407|NCT00296712|Escitalopram|escitalopram|mesh-list
92664408|NCT00296712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92664409|NCT00296712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92664410|NCT00296712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664411|NCT00296712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664412|NCT00296712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664413|NCT00296712|Serotonin Agents|serotonin agents|mesh-ancestor
92664414|NCT00296712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664415|NCT00296712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92664416|NCT00296712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92664417|NCT00296712|Parasympatholytics|parasympatholytics|mesh-ancestor
92664418|NCT00296712|Autonomic Agents|autonomic agents|mesh-ancestor
92664419|NCT00296712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664420|NCT00296712|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92664421|NCT00296712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92664422|NCT00296712|Cholinergic Agents|cholinergic agents|mesh-ancestor
92664423|NCT00296712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92664424|NCT00296712|Antidepressive Agents|antidepressive agents|mesh-ancestor
92664425|NCT00296712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664427|NCT00296712|Dopamine Agents|dopamine agents|mesh-ancestor
92664428|NCT00296712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92664429|NCT00296712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92364902|NCT03007992|Vinorelbine|vinorelbine|mesh-list
92664430|NCT00296712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664432|NCT00268697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92664433|NCT00268697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92664434|NCT00268697|Antimetabolites|antimetabolites|mesh-ancestor
92664435|NCT00268697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664436|NCT00268697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92664437|NCT00296751|Fentanyl|fentanyl|mesh-list
92664438|NCT00296751|Meperidine|meperidine|mesh-list
92664439|NCT00296751|Bupivacaine|bupivacaine|mesh-list
92664440|NCT00296751|Anesthetics, Local|anesthetics, local|mesh-ancestor
92664441|NCT00296751|Anesthetics|anesthetics|mesh-ancestor
92664442|NCT00296751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664443|NCT00296751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664444|NCT00296751|Sensory System Agents|sensory system agents|mesh-ancestor
92664445|NCT00296751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664446|NCT00296751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92664447|NCT00296751|Narcotics|narcotics|mesh-ancestor
92664448|NCT00296751|Analgesics|analgesics|mesh-ancestor
92664449|NCT00296751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92664450|NCT00296751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92664451|NCT00296751|Anesthetics, General|anesthetics, general|mesh-ancestor
92664452|NCT00302367|Methylphenidate|methylphenidate|mesh-list
92664453|NCT00302367|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92664454|NCT00302367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664455|NCT00302367|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92664456|NCT00302367|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92664457|NCT00302367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664458|NCT00302367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664459|NCT00302367|Dopamine Agents|dopamine agents|mesh-ancestor
92664460|NCT00302367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664461|NCT00296790|Zolpidem|zolpidem|mesh-list
92664462|NCT00296790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92664463|NCT00296790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92664464|NCT00296790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664465|NCT00296790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664466|NCT00296790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92664467|NCT00296790|GABA Agonists|gaba agonists|mesh-ancestor
92664468|NCT00296790|GABA Agents|gaba agents|mesh-ancestor
92664469|NCT00296790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577510|NCT00268723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577511|NCT00268723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577513|NCT00268840|Docetaxel|docetaxel|mesh-list
92577514|NCT00268840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577515|NCT00268840|Antimetabolites|antimetabolites|mesh-ancestor
92577516|NCT00268840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664470|NCT00296790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664471|NCT00302406|Methylphenidate|methylphenidate|mesh-list
92389808|NCT00378066|Bevacizumab|bevacizumab|mesh-list
92664472|NCT00302406|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92664473|NCT00302406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664474|NCT00302406|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92664475|NCT00302406|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92664476|NCT00302406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664477|NCT00302406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664478|NCT00302406|Dopamine Agents|dopamine agents|mesh-ancestor
92664479|NCT00302406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664480|NCT00268814|Methadone|methadone|mesh-list
92664481|NCT00268814|Heroin|heroin|mesh-list
92664482|NCT00268814|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92664483|NCT00268814|Narcotics|narcotics|mesh-ancestor
92664484|NCT00268814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664485|NCT00268814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664486|NCT00268814|Analgesics|analgesics|mesh-ancestor
92664487|NCT00268814|Sensory System Agents|sensory system agents|mesh-ancestor
92664488|NCT00268814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664489|NCT00268814|Antitussive Agents|antitussive agents|mesh-ancestor
92664490|NCT00268814|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664491|NCT00302484|Zoledronic Acid|zoledronic acid|mesh-list
92664492|NCT00302484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92664493|NCT00302484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664494|NCT00296868|Ascorbic Acid|ascorbic acid|mesh-list
92664495|NCT00296868|Vitamins|vitamins|mesh-ancestor
92664496|NCT00296868|Micronutrients|micronutrients|mesh-ancestor
92664497|NCT00296868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664498|NCT00296868|Antioxidants|antioxidants|mesh-ancestor
92664500|NCT00296868|Protective Agents|protective agents|mesh-ancestor
92664502|NCT00268970|Satraplatin|satraplatin|mesh-list
92664503|NCT00268970|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664504|NCT00268970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664505|NCT00268970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664506|NCT00268970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664507|NCT00268970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664508|NCT00268970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664509|NCT00296946|Bromides|bromides|mesh-list
92664510|NCT00296946|Ipratropium|ipratropium|mesh-list
92664511|NCT00296946|Anticonvulsants|anticonvulsants|mesh-ancestor
92664512|NCT00296946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92664513|NCT00296946|Autonomic Agents|autonomic agents|mesh-ancestor
92664514|NCT00296946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664515|NCT00296946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664516|NCT00296946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92664517|NCT00296946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664518|NCT00296946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92664519|NCT00296946|Cholinergic Agents|cholinergic agents|mesh-ancestor
92664520|NCT00296946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664521|NCT00296946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664522|NCT00269048|Darapladib|darapladib|mesh-list
92664523|NCT00269048|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92664524|NCT00269048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664525|NCT00269048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664526|NCT00302523|Tacrolimus|tacrolimus|mesh-list
92664527|NCT00302523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664528|NCT00302523|Immunologic Factors|immunologic factors|mesh-ancestor
92664529|NCT00302523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664530|NCT00302523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92577517|NCT00268840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577518|NCT00268840|Tubulin Modulators|tubulin modulators|mesh-ancestor
92577519|NCT00268840|Antimitotic Agents|antimitotic agents|mesh-ancestor
92577520|NCT00268840|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577521|NCT00268879|Renzapride|renzapride|mesh-list
91984831|NCT02055352|Fluticasone|fluticasone|mesh-list
92664531|NCT00302523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664532|NCT00302523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664533|NCT02960412|Furosemide|furosemide|mesh-list
92664534|NCT02960412|Diuretics|diuretics|mesh-ancestor
92664535|NCT02960412|Natriuretic Agents|natriuretic agents|mesh-ancestor
92664536|NCT02960412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664537|NCT02960412|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92664538|NCT02960412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664539|NCT02960412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664540|NCT00269126|Fluticasone|fluticasone|mesh-list
92664541|NCT00269126|Xhance|xhance|mesh-list
92664542|NCT00269126|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92664543|NCT00269126|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92664544|NCT00269126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664545|NCT00269126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92389886|NCT00380406|Leuprolide|leuprolide|mesh-list
92664546|NCT00269126|Autonomic Agents|autonomic agents|mesh-ancestor
92664547|NCT00269126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664548|NCT00269126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664549|NCT00269126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92664550|NCT00269126|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664551|NCT00269126|Dermatologic Agents|dermatologic agents|mesh-ancestor
92664552|NCT00269126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92664553|NCT00269126|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92664554|NCT00269126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92664555|NCT00269126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92364915|NCT03007524|Calcium, Dietary|calcium, dietary|mesh-list
92664556|NCT00269126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92664557|NCT00269126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664558|NCT00269126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664559|NCT00269126|Glucocorticoids|glucocorticoids|mesh-ancestor
92664560|NCT00269126|Hormones|hormones|mesh-ancestor
92664561|NCT00269126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664562|NCT00269126|Sympathomimetics|sympathomimetics|mesh-ancestor
92664563|NCT00269204|Niacin|niacin|mesh-list
92664564|NCT00269204|Niacinamide|niacinamide|mesh-list
92664565|NCT00269204|Nicotinic Acids|nicotinic acids|mesh-list
92664566|NCT00269204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92664567|NCT00269204|Antimetabolites|antimetabolites|mesh-ancestor
92664568|NCT00269204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664569|NCT00269204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92664570|NCT00269204|Vasodilator Agents|vasodilator agents|mesh-ancestor
92664572|NCT00269204|Vitamins|vitamins|mesh-ancestor
92664573|NCT00269204|Micronutrients|micronutrients|mesh-ancestor
92664574|NCT00269204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664575|NCT00297141|Capecitabine|capecitabine|mesh-list
92664576|NCT00297141|Oxaliplatin|oxaliplatin|mesh-list
92664577|NCT00297141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664578|NCT00297141|Antimetabolites|antimetabolites|mesh-ancestor
92664579|NCT00297141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664580|NCT00297141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664581|NCT00269243|Quinapril|quinapril|mesh-list
92664582|NCT00269243|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92664583|NCT00269243|Protease Inhibitors|protease inhibitors|mesh-ancestor
92664584|NCT00269243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664585|NCT00269243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664586|NCT00269243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92664587|NCT04718064|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92664588|NCT04718064|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92664589|NCT04718064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664590|NCT04718064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664591|NCT04718064|Immunologic Factors|immunologic factors|mesh-ancestor
92664592|NCT04718064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664593|NCT00297219|Calcium, Dietary|calcium, dietary|mesh-list
92577522|NCT00268879|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92577523|NCT00268879|Serotonin Agents|serotonin agents|mesh-ancestor
92577524|NCT00268879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021472|NCT04802083|Eculizumab|eculizumab|mesh-list
92664594|NCT00297219|Dialysis Solutions|dialysis solutions|mesh-list
92664595|NCT00297219|Calcium|calcium|mesh-list
92664596|NCT00297219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92664597|NCT00297219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664598|NCT00297219|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92664599|NCT00297219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92664600|NCT00302640|Nitazoxanide|nitazoxanide|mesh-list
92664601|NCT00302640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92664602|NCT00302640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664603|NCT00418353|Dexamethasone|dexamethasone|mesh-list
92664604|NCT00418353|Betamethasone|betamethasone|mesh-list
92664605|NCT00418353|Betamethasone Valerate|betamethasone valerate|mesh-list
92664606|NCT00418353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92664607|NCT00418353|Betamethasone benzoate|betamethasone benzoate|mesh-list
92664608|NCT00418353|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
92664609|NCT00418353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92664610|NCT00418353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664611|NCT00418353|Antiemetics|antiemetics|mesh-ancestor
92664612|NCT00418353|Autonomic Agents|autonomic agents|mesh-ancestor
92664613|NCT00418353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664614|NCT00418353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664615|NCT00418353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92664616|NCT00418353|Glucocorticoids|glucocorticoids|mesh-ancestor
92664617|NCT00418353|Hormones|hormones|mesh-ancestor
92664618|NCT00418353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389960|NCT00381732|Tadalafil|tadalafil|mesh-list
92664619|NCT00418353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92664620|NCT00418353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664621|NCT00418353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92664622|NCT00418353|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664623|NCT00418353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92664624|NCT00418392|Minocycline|minocycline|mesh-list
92664625|NCT00418392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92664626|NCT00418392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664627|NCT00269555|Genistein|genistein|mesh-list
92664628|NCT00269555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92664629|NCT00269555|Protective Agents|protective agents|mesh-ancestor
92664630|NCT00269555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664631|NCT00269555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664632|NCT00269555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92664633|NCT00269555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664634|NCT00269555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664635|NCT00269555|Phytoestrogens|phytoestrogens|mesh-ancestor
92664636|NCT00269555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92664637|NCT00269555|Estrogens|estrogens|mesh-ancestor
92664638|NCT00269555|Hormones|hormones|mesh-ancestor
92664639|NCT00269555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664640|NCT00418431|Bevacizumab|bevacizumab|mesh-list
92664641|NCT00418431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92664642|NCT00418431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664643|NCT00418431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92664645|NCT00418431|Growth Substances|growth substances|mesh-ancestor
92664646|NCT00418431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664647|NCT00418431|Growth Inhibitors|growth inhibitors|mesh-ancestor
92664649|NCT00269594|Anticonvulsants|anticonvulsants|mesh-ancestor
92664650|NCT00269594|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92664651|NCT00269594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664652|NCT00269594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664653|NCT00269594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92664654|NCT00269594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664655|NCT00269594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92664656|NCT00269594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92664657|NCT00269594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664658|NCT00269594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664659|NCT00269594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92664660|NCT00418470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92664661|NCT00418470|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92577525|NCT00268879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577526|NCT00268879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577527|NCT00268918|Docetaxel|docetaxel|mesh-list
92577528|NCT00268918|Vatalanib|vatalanib|mesh-list
92664662|NCT00418470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664663|NCT00418470|Antitubercular Agents|antitubercular agents|mesh-ancestor
92664664|NCT00269672|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92664665|NCT00269672|Immunologic Factors|immunologic factors|mesh-ancestor
92664666|NCT00269672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664667|NCT00302835|Analgesics|analgesics|mesh-list
92664668|NCT00302835|Sensory System Agents|sensory system agents|mesh-ancestor
92664669|NCT00302835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664670|NCT00302835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664671|NCT00269750|Oxybutynin|oxybutynin|mesh-list
92664672|NCT00269750|Parasympatholytics|parasympatholytics|mesh-ancestor
92664673|NCT00269750|Autonomic Agents|autonomic agents|mesh-ancestor
92664674|NCT00269750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664675|NCT00269750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664676|NCT00269750|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92664677|NCT00269750|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92664678|NCT00269750|Cholinergic Agents|cholinergic agents|mesh-ancestor
92664679|NCT00269750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664680|NCT00269750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364939|NCT03005496|Dexamethasone|dexamethasone|mesh-list
92664681|NCT00269750|Urological Agents|urological agents|mesh-ancestor
92664682|NCT00269789|Methylphenidate|methylphenidate|mesh-list
92664683|NCT00269789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92664684|NCT00269789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664685|NCT00269789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92664686|NCT00269789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92664687|NCT00269789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664688|NCT00269789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664689|NCT00269789|Dopamine Agents|dopamine agents|mesh-ancestor
92664690|NCT00269789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664691|NCT00302913|Clopidogrel|clopidogrel|mesh-list
92664692|NCT00302913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92664693|NCT00302913|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92664694|NCT00302913|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92664695|NCT00302913|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92664696|NCT00302913|Purinergic Agents|purinergic agents|mesh-ancestor
92664697|NCT00302913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664698|NCT00302913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664699|NCT00302913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664700|NCT00269828|Paclitaxel|paclitaxel|mesh-list
92664701|NCT00269828|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92664702|NCT00269828|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92664703|NCT00269828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664704|NCT00269828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664705|NCT00269828|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664706|NCT00269828|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664707|NCT00269828|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664708|NCT00269828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664709|NCT00269867|Infliximab|infliximab|mesh-list
92664710|NCT00269867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92664711|NCT00269867|Antibodies|antibodies|mesh-list
92664712|NCT00269867|Immunoglobulins|immunoglobulins|mesh-list
92664713|NCT00269867|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92664714|NCT00269867|Immunologic Factors|immunologic factors|mesh-ancestor
92664717|NCT00269867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92664718|NCT00269867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664719|NCT00269867|Dermatologic Agents|dermatologic agents|mesh-ancestor
92664720|NCT00269867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92664721|NCT00269867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664722|NCT00269906|Abciximab|abciximab|mesh-list
92664723|NCT00269906|Anticoagulants|anticoagulants|mesh-ancestor
92664724|NCT00269906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92664725|NCT00269945|Epoetin Alfa|epoetin alfa|mesh-list
92664726|NCT00269945|Hematinics|hematinics|mesh-ancestor
92664727|NCT00269984|Epoetin Alfa|epoetin alfa|mesh-list
92664728|NCT00269984|Hematinics|hematinics|mesh-ancestor
92664729|NCT00297336|Topiramate|topiramate|mesh-list
92664730|NCT00297336|Anticonvulsants|anticonvulsants|mesh-ancestor
92577529|NCT00268918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577530|NCT00268918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92577531|NCT00268918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92577532|NCT00268918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664731|NCT00297336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92664732|NCT00297336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664733|NCT00270023|Epoetin Alfa|epoetin alfa|mesh-list
92664734|NCT00270023|Hematinics|hematinics|mesh-ancestor
92664735|NCT00297375|Acetaminophen|acetaminophen|mesh-list
92664736|NCT00297375|Tramadol|tramadol|mesh-list
92664737|NCT00297375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664738|NCT00297375|Analgesics|analgesics|mesh-ancestor
92664739|NCT00297375|Sensory System Agents|sensory system agents|mesh-ancestor
92664740|NCT00297375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664741|NCT00297375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664742|NCT00297375|Antipyretics|antipyretics|mesh-ancestor
92664743|NCT00297375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92664744|NCT00297375|Narcotics|narcotics|mesh-ancestor
92664745|NCT00297375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664746|NCT00270062|Epoetin Alfa|epoetin alfa|mesh-list
92664747|NCT00270062|Hematinics|hematinics|mesh-ancestor
92664748|NCT00270101|Epoetin Alfa|epoetin alfa|mesh-list
92664749|NCT00270101|Hematinics|hematinics|mesh-ancestor
92664750|NCT00270140|Epoetin Alfa|epoetin alfa|mesh-list
92664751|NCT00270140|Hematinics|hematinics|mesh-ancestor
92664752|NCT00270179|Epoetin Alfa|epoetin alfa|mesh-list
92364945|NCT03005496|Vitamins|vitamins|mesh-ancestor
92664753|NCT00270179|Hematinics|hematinics|mesh-ancestor
92664754|NCT00297570|Interferons|interferons|mesh-list
92664755|NCT00297570|Imatinib Mesylate|imatinib mesylate|mesh-list
92664756|NCT00297570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664757|NCT00297570|Antiviral Agents|antiviral agents|mesh-ancestor
92664758|NCT00297570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664759|NCT00297570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92664760|NCT00297570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664761|NCT00297570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664762|NCT00270335|Propofol|propofol|mesh-list
92664763|NCT00270335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92664764|NCT00270335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664765|NCT00270335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664766|NCT00270335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92664767|NCT00270335|Anesthetics, General|anesthetics, general|mesh-ancestor
92664768|NCT00270335|Anesthetics|anesthetics|mesh-ancestor
92664769|NCT00270374|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92664770|NCT00270374|Natriuretic Agents|natriuretic agents|mesh-ancestor
92664771|NCT00270374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664772|NCT00270491|Paclitaxel|paclitaxel|mesh-list
92664773|NCT00270491|Capecitabine|capecitabine|mesh-list
92664774|NCT00270491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664775|NCT00270491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664776|NCT00270491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664777|NCT00270491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664778|NCT00270491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664779|NCT00270491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664780|NCT00270491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664781|NCT00270491|Antimetabolites|antimetabolites|mesh-ancestor
92664782|NCT00270530|Pyrimethamine|pyrimethamine|mesh-list
92664783|NCT00270530|Sulfadoxine|sulfadoxine|mesh-list
92664784|NCT00270530|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92664785|NCT00270530|Antimalarials|antimalarials|mesh-ancestor
92664786|NCT00270530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92664787|NCT00270530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92664788|NCT00270530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664789|NCT00270530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92664790|NCT00270530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664791|NCT00270530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664792|NCT00270530|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92664795|NCT00297765|Immunologic Factors|immunologic factors|mesh-ancestor
92664796|NCT00297765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664797|NCT00297765|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92664798|NCT00297765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664799|NCT00297765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664800|NCT00270569|Cisplatin|cisplatin|mesh-list
92664801|NCT00270569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664802|NCT00297804|Paclitaxel|paclitaxel|mesh-list
92664803|NCT00297804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91984843|NCT02055352|Glucocorticoids|glucocorticoids|mesh-ancestor
92664804|NCT00297804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664805|NCT00297804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664806|NCT00297804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664807|NCT00297804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664808|NCT00297804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664809|NCT00270647|Vitamins|vitamins|mesh-list
92664810|NCT00270647|Vitamin E|vitamin e|mesh-list
92664811|NCT00270647|Beta Carotene|beta carotene|mesh-list
92664812|NCT00270647|Carotenoids|carotenoids|mesh-list
92664813|NCT00270647|Micronutrients|micronutrients|mesh-ancestor
92664814|NCT00270647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664815|NCT00270647|Antioxidants|antioxidants|mesh-ancestor
92664816|NCT00270647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664817|NCT00270647|Protective Agents|protective agents|mesh-ancestor
92664818|NCT00270647|Provitamins|provitamins|mesh-ancestor
92664819|NCT00297960|Olanzapine|olanzapine|mesh-list
92664820|NCT00297960|Ziprasidone|ziprasidone|mesh-list
92664821|NCT00297960|Antiemetics|antiemetics|mesh-ancestor
92664822|NCT00297960|Autonomic Agents|autonomic agents|mesh-ancestor
92664823|NCT00297960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664824|NCT00297960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664825|NCT00297960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92664826|NCT00297960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92664827|NCT00297960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92664828|NCT00297960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664829|NCT00297960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664830|NCT00297960|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92664831|NCT00297960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92664832|NCT00297960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664833|NCT00297960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664834|NCT00297960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664835|NCT00297960|Serotonin Agents|serotonin agents|mesh-ancestor
92664836|NCT00297960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92664837|NCT00297960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92664838|NCT00297960|Dopamine Agents|dopamine agents|mesh-ancestor
92664839|NCT00270881|Cytarabine|cytarabine|mesh-list
92664840|NCT00270881|Cyclophosphamide|cyclophosphamide|mesh-list
92664841|NCT00270881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664842|NCT00270881|Immunologic Factors|immunologic factors|mesh-ancestor
92664843|NCT00270881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664844|NCT00270881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664845|NCT00270881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92664846|NCT00270881|Alkylating Agents|alkylating agents|mesh-ancestor
92390185|NCT00422682|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664847|NCT00270881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664848|NCT00270881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664849|NCT00270881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92664850|NCT00270881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664851|NCT00270881|Antimetabolites|antimetabolites|mesh-ancestor
92664852|NCT00270881|Antiviral Agents|antiviral agents|mesh-ancestor
92664853|NCT00270881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664854|NCT00298194|Z 338|z 338|mesh-list
92664855|NCT00298194|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92664856|NCT00298194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664857|NCT00298194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664858|NCT00298194|Cholinergic Agents|cholinergic agents|mesh-ancestor
92664859|NCT00298194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92664860|NCT00298194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664861|NCT00298194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92664862|NCT00418548|Etanercept|etanercept|mesh-list
92664863|NCT00418548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92664864|NCT00418548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92664865|NCT00418548|Analgesics|analgesics|mesh-ancestor
92664866|NCT00418548|Sensory System Agents|sensory system agents|mesh-ancestor
92664871|NCT00418548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92664872|NCT00418548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664873|NCT00418548|Immunologic Factors|immunologic factors|mesh-ancestor
92664874|NCT00418587|Vitamin D|vitamin d|mesh-list
92664875|NCT00418587|Ergocalciferols|ergocalciferols|mesh-list
92664876|NCT00418587|Cholecalciferol|cholecalciferol|mesh-list
92664877|NCT00418587|Vitamins|vitamins|mesh-list
92664878|NCT00418587|Micronutrients|micronutrients|mesh-ancestor
92664879|NCT00418587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664880|NCT00418587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92664881|NCT00418587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92577533|NCT00268918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577534|NCT00268918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92664882|NCT00416273|Bortezomib|bortezomib|mesh-list
92664883|NCT00416273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664884|NCT00306462|Magnesium Sulfate|magnesium sulfate|mesh-list
92664885|NCT00306462|Nifedipine|nifedipine|mesh-list
92664886|NCT00306462|Analgesics|analgesics|mesh-ancestor
92664887|NCT00306462|Sensory System Agents|sensory system agents|mesh-ancestor
92664888|NCT00306462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664889|NCT00306462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664890|NCT00306462|Anesthetics|anesthetics|mesh-ancestor
92664891|NCT00306462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664892|NCT00306462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92664893|NCT00306462|Anticonvulsants|anticonvulsants|mesh-ancestor
92664894|NCT00306462|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92664895|NCT00306462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92364954|NCT03005496|Hormones|hormones|mesh-ancestor
92664896|NCT00306462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664897|NCT00306462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92664898|NCT00306462|Tocolytic Agents|tocolytic agents|mesh-ancestor
92664899|NCT00306462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92664900|NCT00306462|Vasodilator Agents|vasodilator agents|mesh-ancestor
92664901|NCT00416390|Lycopene|lycopene|mesh-list
92664902|NCT00416390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664903|NCT00416390|Antioxidants|antioxidants|mesh-ancestor
92664904|NCT00416390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664905|NCT00416390|Protective Agents|protective agents|mesh-ancestor
92664906|NCT00416390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664907|NCT00416390|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92664908|NCT00416390|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92664909|NCT00416390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664910|NCT00416429|Interferons|interferons|mesh-list
92664911|NCT00416429|Interferon-alpha|interferon-alpha|mesh-list
92664912|NCT00416429|Interferon alpha-2|interferon alpha-2|mesh-list
92664913|NCT00416429|Aldesleukin|aldesleukin|mesh-list
92664914|NCT00416429|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92664915|NCT00416429|Medroxyprogesterone|medroxyprogesterone|mesh-list
92664916|NCT00416429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664917|NCT00416429|Antiviral Agents|antiviral agents|mesh-ancestor
92664918|NCT00416429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92664919|NCT00416429|Immunologic Factors|immunologic factors|mesh-ancestor
92390274|NCT02998242|Apatinib|apatinib|mesh-list
92664920|NCT00416429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664921|NCT00416429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92664922|NCT00416429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92664923|NCT00416429|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92664924|NCT00416429|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92664925|NCT00416429|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92664926|NCT00416429|Contraceptive Agents|contraceptive agents|mesh-ancestor
92664927|NCT00416429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92664928|NCT00416429|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92664929|NCT00416429|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92664930|NCT00416429|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92664931|NCT00416429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92664932|NCT00306540|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92664933|NCT00306540|Antidepressive Agents|antidepressive agents|mesh-ancestor
92664934|NCT00306540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92664935|NCT00306540|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92664936|NCT00306540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92664937|NCT00306540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664940|NCT00271271|Vinorelbine|vinorelbine|mesh-list
92664941|NCT00271271|Oxaliplatin|oxaliplatin|mesh-list
92664942|NCT00271271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92664943|NCT00271271|Antimetabolites|antimetabolites|mesh-ancestor
92664944|NCT00271271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664945|NCT00271271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664946|NCT00271271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92664947|NCT00271271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664948|NCT00271271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92664949|NCT00271271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664950|NCT00306618|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92664951|NCT00306618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664952|NCT00306618|Tubulin Modulators|tubulin modulators|mesh-ancestor
92664953|NCT00306618|Antimitotic Agents|antimitotic agents|mesh-ancestor
92577535|NCT00268918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92664954|NCT00306618|Mitosis Modulators|mitosis modulators|mesh-ancestor
92664955|NCT00306618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664957|NCT00271349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664958|NCT00271349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92664959|NCT00271349|Autonomic Agents|autonomic agents|mesh-ancestor
92664960|NCT00271349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664961|NCT00271349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664962|NCT00271349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92664963|NCT00271349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92664964|NCT00271349|Glucocorticoids|glucocorticoids|mesh-ancestor
92664965|NCT00271349|Hormones|hormones|mesh-ancestor
92664966|NCT00271349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664967|NCT00306696|Rosiglitazone|rosiglitazone|mesh-list
92664968|NCT00306696|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92664969|NCT00306696|Spironolactone|spironolactone|mesh-list
92664970|NCT00306696|Furosemide|furosemide|mesh-list
92664971|NCT00306696|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92664972|NCT00306696|Diuretics|diuretics|mesh-ancestor
92664973|NCT00306696|Natriuretic Agents|natriuretic agents|mesh-ancestor
92664974|NCT00306696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664975|NCT00306696|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92664976|NCT00306696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92664977|NCT00306696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664978|NCT00306696|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92664979|NCT00306696|Hormone Antagonists|hormone antagonists|mesh-ancestor
92664980|NCT00306696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92664981|NCT00306696|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92664982|NCT00306696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92664983|NCT00306696|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92664984|NCT00271427|Selenium|selenium|mesh-list
92664985|NCT00271427|Antioxidants|antioxidants|mesh-ancestor
92664986|NCT00271427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664987|NCT00271427|Protective Agents|protective agents|mesh-ancestor
92664988|NCT00271427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664989|NCT00271427|Trace Elements|trace elements|mesh-ancestor
92664990|NCT00271427|Micronutrients|micronutrients|mesh-ancestor
92664991|NCT00271466|Fentanyl|fentanyl|mesh-list
92664992|NCT00271466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92664993|NCT00271466|Narcotics|narcotics|mesh-ancestor
92664994|NCT00271466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92664995|NCT00271466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664996|NCT00271466|Analgesics|analgesics|mesh-ancestor
92664997|NCT00271466|Sensory System Agents|sensory system agents|mesh-ancestor
92664998|NCT00271466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664999|NCT00271466|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92665000|NCT00271466|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92665001|NCT00271466|Anesthetics, General|anesthetics, general|mesh-ancestor
92665002|NCT00271466|Anesthetics|anesthetics|mesh-ancestor
92665003|NCT00306735|Palonosetron|palonosetron|mesh-list
92665004|NCT00306735|Antiemetics|antiemetics|mesh-ancestor
92665005|NCT00306735|Autonomic Agents|autonomic agents|mesh-ancestor
92665006|NCT00306735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665007|NCT00306735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665008|NCT00306735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665009|NCT00306735|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92665010|NCT00306735|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92665011|NCT00306735|Serotonin Agents|serotonin agents|mesh-ancestor
92665015|NCT00271583|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92665016|NCT00271583|Contraceptive Agents|contraceptive agents|mesh-ancestor
92665017|NCT00271583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92665018|NCT00271583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665019|NCT00271583|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92665020|NCT00271583|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92665021|NCT00271583|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92665022|NCT00306774|Vitamin D|vitamin d|mesh-list
92665023|NCT00306774|Cholecalciferol|cholecalciferol|mesh-list
92665024|NCT00306774|Vitamins|vitamins|mesh-ancestor
92665025|NCT00306774|Micronutrients|micronutrients|mesh-ancestor
92665026|NCT00306774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665027|NCT00306774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92665028|NCT00306774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92577537|NCT00268957|Chelating Agents|chelating agents|mesh-ancestor
92577538|NCT00268957|Sequestering Agents|sequestering agents|mesh-ancestor
92022258|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92665029|NCT00306813|Lenalidomide|lenalidomide|mesh-list
92665030|NCT00306813|Immunologic Factors|immunologic factors|mesh-ancestor
92665031|NCT00306813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665032|NCT00306813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92665033|NCT00306813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92665034|NCT00306813|Growth Substances|growth substances|mesh-ancestor
92665035|NCT00306813|Growth Inhibitors|growth inhibitors|mesh-ancestor
92665036|NCT00306813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665037|NCT00271973|Oxycodone|oxycodone|mesh-list
92665038|NCT00271973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92665039|NCT00271973|Narcotics|narcotics|mesh-ancestor
92665040|NCT00271973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665041|NCT00271973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665042|NCT00271973|Analgesics|analgesics|mesh-ancestor
92665043|NCT00271973|Sensory System Agents|sensory system agents|mesh-ancestor
92665044|NCT00271973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665045|NCT00306969|Bexarotene|bexarotene|mesh-list
92665046|NCT00306969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665047|NCT00272012|Insulin glulisine|insulin glulisine|mesh-list
92665048|NCT00272012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92665049|NCT00272012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665050|NCT00307008|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92665051|NCT00307008|Immunologic Factors|immunologic factors|mesh-ancestor
92665052|NCT00307008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665053|NCT00272051|Xaliproden|xaliproden|mesh-list
92665054|NCT00272051|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92665055|NCT00272051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92665056|NCT00272051|Serotonin Agents|serotonin agents|mesh-ancestor
92665057|NCT00272051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665058|NCT00272051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665059|NCT00272051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665060|NCT00307203|Bupropion|bupropion|mesh-list
92665061|NCT00307203|Nicotine|nicotine|mesh-list
92665062|NCT00307203|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92665063|NCT00307203|Autonomic Agents|autonomic agents|mesh-ancestor
92665064|NCT00307203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665065|NCT00307203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665066|NCT00307203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92665067|NCT00307203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92665068|NCT00307203|Cholinergic Agents|cholinergic agents|mesh-ancestor
92665069|NCT00307203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665070|NCT00307203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665071|NCT00307203|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92665072|NCT00307203|Antidepressive Agents|antidepressive agents|mesh-ancestor
92665073|NCT00307203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665074|NCT00307203|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92665075|NCT00307203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92665076|NCT00307203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665077|NCT00307203|Dopamine Agents|dopamine agents|mesh-ancestor
92364992|NCT03005340|Hormone Antagonists|hormone antagonists|mesh-ancestor
92665078|NCT00307203|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92665079|NCT00307203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92665080|NCT00307203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665081|NCT00272090|Insulin Glargine|insulin glargine|mesh-list
92665082|NCT00272090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92665084|NCT00272207|Nabilone|nabilone|mesh-list
92665085|NCT00272207|Antiemetics|antiemetics|mesh-ancestor
92665086|NCT00272207|Autonomic Agents|autonomic agents|mesh-ancestor
92665087|NCT00272207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665088|NCT00272207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665089|NCT00272207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665090|NCT00272207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92665091|NCT00272207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92665092|NCT00272207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665093|NCT00272207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665094|NCT00307515|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92665095|NCT00307515|Hemostatics|hemostatics|mesh-ancestor
92665096|NCT00307515|Coagulants|coagulants|mesh-ancestor
92665097|NCT00272285|Granisetron|granisetron|mesh-list
92665098|NCT00272285|Ramosetron|ramosetron|mesh-list
92665099|NCT00272285|Antiemetics|antiemetics|mesh-ancestor
92665100|NCT00272285|Autonomic Agents|autonomic agents|mesh-ancestor
92577539|NCT00268957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577540|NCT00073970|Celecoxib|celecoxib|mesh-list
92577541|NCT00073970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92577542|NCT00073970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92577543|NCT00073970|Analgesics|analgesics|mesh-ancestor
92577544|NCT00073970|Sensory System Agents|sensory system agents|mesh-ancestor
92022334|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
92665101|NCT00272285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665102|NCT00272285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665103|NCT00272285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665104|NCT00272285|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92665105|NCT00272285|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92665106|NCT00272285|Serotonin Agents|serotonin agents|mesh-ancestor
92665107|NCT00272285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665108|NCT00272285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665109|NCT00272324|Aspirin|aspirin|mesh-list
92665110|NCT00272324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92665111|NCT00272324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92665112|NCT00272324|Analgesics|analgesics|mesh-ancestor
92665113|NCT00272324|Sensory System Agents|sensory system agents|mesh-ancestor
92665114|NCT00272324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665115|NCT00272324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665116|NCT00272324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665117|NCT00272324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665118|NCT00272324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92665119|NCT00272324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92665120|NCT00272324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665121|NCT00272324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92665122|NCT00272324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92665123|NCT00272324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665124|NCT00272324|Antipyretics|antipyretics|mesh-ancestor
92665125|NCT00307593|Infliximab|infliximab|mesh-list
92665126|NCT00307593|Rituximab|rituximab|mesh-list
92665127|NCT00307593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92665128|NCT00307593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665129|NCT00307593|Immunologic Factors|immunologic factors|mesh-ancestor
92665130|NCT00307593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665131|NCT00307593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665132|NCT00307593|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92665133|NCT00307593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665134|NCT00307593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92665135|NCT00307593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665136|NCT00307632|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92665137|NCT00307632|Estradiol|estradiol|mesh-list
92665138|NCT00307632|Estrogens|estrogens|mesh-ancestor
92665139|NCT00307632|Hormones|hormones|mesh-ancestor
92665140|NCT00307632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665141|NCT00307632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665142|NCT00307632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92665143|NCT00307632|Contraceptive Agents|contraceptive agents|mesh-ancestor
92665144|NCT00307632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92665145|NCT00307632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92665146|NCT00307632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92665147|NCT00307632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92665148|NCT00272480|Lamivudine|lamivudine|mesh-list
92665149|NCT00272480|Zidovudine|zidovudine|mesh-list
92665150|NCT00272480|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92665151|NCT00272480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92665152|NCT00272480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665153|NCT00272480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665154|NCT00272480|Antiviral Agents|antiviral agents|mesh-ancestor
92665155|NCT00272480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665156|NCT00272480|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92072482|NCT02477644|Olaparib|olaparib|mesh-list
92665170|NCT00307671|Prednisolone phosphate|prednisolone phosphate|mesh-list
92665171|NCT00307671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92665172|NCT00307671|Immunologic Factors|immunologic factors|mesh-ancestor
92577545|NCT00073970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577546|NCT00073970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577547|NCT00073970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92577548|NCT00073970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577549|NCT00073970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92577550|NCT00073970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92577551|NCT00073970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665173|NCT00307671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665174|NCT00307671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665175|NCT00307671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92665176|NCT00307671|Alkylating Agents|alkylating agents|mesh-ancestor
92665177|NCT00307671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665178|NCT00307671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665179|NCT00307671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92665180|NCT00307671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665181|NCT00307671|Glucocorticoids|glucocorticoids|mesh-ancestor
92665182|NCT00307671|Hormones|hormones|mesh-ancestor
92665183|NCT00307671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665184|NCT00307671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92665185|NCT00307671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92665186|NCT00307671|Abortifacient Agents|abortifacient agents|mesh-ancestor
92665187|NCT00307671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92665188|NCT00307671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92665189|NCT00307671|Antimetabolites|antimetabolites|mesh-ancestor
92665190|NCT00307671|Dermatologic Agents|dermatologic agents|mesh-ancestor
92665191|NCT00307671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665192|NCT00307671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92665193|NCT00307671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92665194|NCT00307671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92665195|NCT00307671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92665196|NCT00307671|Antitubercular Agents|antitubercular agents|mesh-ancestor
92665197|NCT00307671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92665198|NCT00307671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665199|NCT00307671|Antiemetics|antiemetics|mesh-ancestor
92665200|NCT00307671|Autonomic Agents|autonomic agents|mesh-ancestor
92665201|NCT00307671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665202|NCT00307671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665203|NCT00307671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92665204|NCT00307671|Protective Agents|protective agents|mesh-ancestor
92665205|NCT00272558|Carboplatin|carboplatin|mesh-list
92665206|NCT00272558|Vinorelbine|vinorelbine|mesh-list
92665207|NCT00272558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665208|NCT00272558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92665209|NCT00272558|Tubulin Modulators|tubulin modulators|mesh-ancestor
92665210|NCT00272558|Antimitotic Agents|antimitotic agents|mesh-ancestor
92665211|NCT00272558|Mitosis Modulators|mitosis modulators|mesh-ancestor
92665212|NCT00272558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665213|NCT00272597|Risperidone|risperidone|mesh-list
92665214|NCT00272597|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92665215|NCT00272597|Serotonin Agents|serotonin agents|mesh-ancestor
92665216|NCT00272597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665217|NCT00272597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665218|NCT00272597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665219|NCT00272597|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92665220|NCT00272597|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92665223|NCT00272597|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92665224|NCT00272597|Dopamine Agents|dopamine agents|mesh-ancestor
92665225|NCT00272636|Amiodarone|amiodarone|mesh-list
92665226|NCT00272636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92665227|NCT00272636|Vasodilator Agents|vasodilator agents|mesh-ancestor
92665228|NCT00272636|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92665229|NCT00272636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665230|NCT00272636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665231|NCT00272636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92665232|NCT00272636|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92665233|NCT00272636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92577552|NCT00073970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577553|NCT00102492|Casopitant|casopitant|mesh-list
92577554|NCT00102492|Antiemetics|antiemetics|mesh-ancestor
92577555|NCT00102492|Autonomic Agents|autonomic agents|mesh-ancestor
92577556|NCT00102492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665234|NCT00272636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665235|NCT00272636|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92665236|NCT00272636|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92665237|NCT00272636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92665238|NCT00281970|Docetaxel|docetaxel|mesh-list
92665239|NCT00281970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665240|NCT00281970|Tubulin Modulators|tubulin modulators|mesh-ancestor
92665241|NCT00281970|Antimitotic Agents|antimitotic agents|mesh-ancestor
92665242|NCT00281970|Mitosis Modulators|mitosis modulators|mesh-ancestor
92665243|NCT00281970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665244|NCT00272675|Chlorhexidine|chlorhexidine|mesh-list
92665245|NCT00272675|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92665246|NCT00272675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92665247|NCT00272675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665248|NCT00272675|Disinfectants|disinfectants|mesh-ancestor
92665249|NCT00272675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92665250|NCT00307827|Visilizumab|visilizumab|mesh-list
92665251|NCT00307827|Immunologic Factors|immunologic factors|mesh-ancestor
92665252|NCT00307827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665253|NCT00272714|Afimoxifene|afimoxifene|mesh-list
92665254|NCT00272714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665255|NCT00272714|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92665256|NCT00272714|Hormone Antagonists|hormone antagonists|mesh-ancestor
92665257|NCT00272714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665258|NCT00272714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665259|NCT00272714|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92665260|NCT00272714|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92665261|NCT00272753|Budesonide|budesonide|mesh-list
92665262|NCT00272753|Albuterol|albuterol|mesh-list
92665263|NCT00272753|Formoterol Fumarate|formoterol fumarate|mesh-list
92665264|NCT00272753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665265|NCT00272753|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665266|NCT00272753|Autonomic Agents|autonomic agents|mesh-ancestor
92665267|NCT00272753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665268|NCT00272753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665269|NCT00272753|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665270|NCT00272753|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665271|NCT00272753|Glucocorticoids|glucocorticoids|mesh-ancestor
92665272|NCT00272753|Hormones|hormones|mesh-ancestor
92665273|NCT00272753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665274|NCT00272753|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92665275|NCT00272753|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92665276|NCT00272753|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92665277|NCT00272753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92665278|NCT00272753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665279|NCT00272753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665280|NCT00272753|Tocolytic Agents|tocolytic agents|mesh-ancestor
92665281|NCT00272753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92665282|NCT00272831|Cilostazol|cilostazol|mesh-list
92665283|NCT00272831|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665284|NCT00272831|Autonomic Agents|autonomic agents|mesh-ancestor
92665285|NCT00272831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665286|NCT00272831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665287|NCT00272831|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665288|NCT00272831|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665289|NCT00272831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92665290|NCT00272831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92665291|NCT00272831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390636|NCT01278576|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92665297|NCT00272831|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92665299|NCT00416468|Valsartan|valsartan|mesh-list
92665300|NCT00416468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665301|NCT00416468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92665302|NCT00416468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92577557|NCT00102492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577558|NCT00102492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92577559|NCT00102492|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92577560|NCT00102492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577561|NCT00102492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577562|NCT00269035|Risperidone|risperidone|mesh-list
92665303|NCT00416468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665304|NCT00307944|Pantoprazole|pantoprazole|mesh-list
92665305|NCT00307944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92665306|NCT00307944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665307|NCT00307944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92665308|NCT00307944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665309|NCT00307944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665310|NCT00416507|Gemcitabine|gemcitabine|mesh-list
92665311|NCT00416507|Fluorouracil|fluorouracil|mesh-list
92665312|NCT00416507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665313|NCT00416507|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92665314|NCT00416507|Antimetabolites|antimetabolites|mesh-ancestor
92665315|NCT00416507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665316|NCT00416507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92665317|NCT00416507|Immunologic Factors|immunologic factors|mesh-ancestor
92665318|NCT00416507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665319|NCT00282126|Potassium Citrate|potassium citrate|mesh-list
92665320|NCT00282126|Diuretics|diuretics|mesh-ancestor
92665321|NCT00282126|Natriuretic Agents|natriuretic agents|mesh-ancestor
92665322|NCT00282126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665323|NCT00282126|Expectorants|expectorants|mesh-ancestor
92665324|NCT00282126|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665325|NCT00272870|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92665326|NCT00272870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665327|NCT00272870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665328|NCT00272870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665329|NCT00272909|Piclozotan|piclozotan|mesh-list
92665330|NCT00272909|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92665331|NCT00272909|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92665332|NCT00272909|Serotonin Agents|serotonin agents|mesh-ancestor
92665333|NCT00272909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665334|NCT00272909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665335|NCT00272909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665336|NCT00282165|Naratriptan|naratriptan|mesh-list
92665337|NCT00282165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92665338|NCT00282165|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92665339|NCT00282165|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92665340|NCT00282165|Serotonin Agents|serotonin agents|mesh-ancestor
92665341|NCT00282165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665342|NCT00282165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665343|NCT00282165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665344|NCT00272948|Defibrotide|defibrotide|mesh-list
92665345|NCT00272948|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92665346|NCT00272948|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92665347|NCT00272948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665348|NCT00272948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92665349|NCT00308100|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92665350|NCT00308100|Plasma Substitutes|plasma substitutes|mesh-ancestor
92665351|NCT00308100|Blood Substitutes|blood substitutes|mesh-ancestor
92665352|NCT00273026|Fluticasone|fluticasone|mesh-list
92665353|NCT00273026|Xhance|xhance|mesh-list
92665354|NCT00273026|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92665355|NCT00273026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665356|NCT00273026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665357|NCT00273026|Autonomic Agents|autonomic agents|mesh-ancestor
92665358|NCT00273026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665359|NCT00273026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665360|NCT00273026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665363|NCT00273026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92665364|NCT00273026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92665365|NCT00273026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92577563|NCT00269035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92577564|NCT00269035|Serotonin Agents|serotonin agents|mesh-ancestor
92665366|NCT00273026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92665367|NCT00273026|Adrenergic Agents|adrenergic agents|mesh-ancestor
92665368|NCT00273026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665369|NCT00273026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665370|NCT00308178|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92665371|NCT00308178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665372|NCT00282360|Trimetazidine|trimetazidine|mesh-list
92665373|NCT00282360|Vasodilator Agents|vasodilator agents|mesh-ancestor
92665374|NCT00273065|Neosaxitoxin|neosaxitoxin|mesh-list
92665375|NCT00273065|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92665376|NCT00273065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92665377|NCT00273065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665378|NCT00273065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665380|NCT00418704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92665381|NCT00418704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665382|NCT00418704|Tubulin Modulators|tubulin modulators|mesh-ancestor
92665383|NCT00418704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92665384|NCT00418704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92665385|NCT00418704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665386|NCT00418704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92665387|NCT00418704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665388|NCT00313950|Vaccines|vaccines|mesh-list
92665389|NCT00313950|Immunologic Factors|immunologic factors|mesh-ancestor
92665390|NCT00313950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665391|NCT00273299|Valsartan|valsartan|mesh-list
92665392|NCT00273299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92665393|NCT00273299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665394|NCT00273299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92665395|NCT00273299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92665396|NCT00273299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665397|NCT00273299|Diuretics|diuretics|mesh-ancestor
92665398|NCT00273299|Natriuretic Agents|natriuretic agents|mesh-ancestor
92665399|NCT00273299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665400|NCT00273299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92665401|NCT00273299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665402|NCT00418782|Naproxen|naproxen|mesh-list
92665403|NCT00418782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92665404|NCT00418782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92665405|NCT00418782|Analgesics|analgesics|mesh-ancestor
92665406|NCT00418782|Sensory System Agents|sensory system agents|mesh-ancestor
92665407|NCT00418782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665408|NCT00418782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665409|NCT00418782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665410|NCT00418782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665411|NCT00418782|Gout Suppressants|gout suppressants|mesh-ancestor
92665412|NCT00418782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92665413|NCT00418782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665414|NCT00418782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665415|NCT00273338|Calcitriol|calcitriol|mesh-list
92665416|NCT00273338|Docetaxel|docetaxel|mesh-list
92665417|NCT00273338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665418|NCT00273338|Tubulin Modulators|tubulin modulators|mesh-ancestor
92665419|NCT00273338|Antimitotic Agents|antimitotic agents|mesh-ancestor
92665420|NCT00273338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92665421|NCT00273338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665422|NCT00273338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92665423|NCT00273338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665424|NCT00273338|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92665425|NCT00273338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665426|NCT00273338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92665427|NCT00273338|Vitamins|vitamins|mesh-ancestor
92665428|NCT00273338|Micronutrients|micronutrients|mesh-ancestor
92665429|NCT00273338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92665430|NCT00273377|Dexamethasone|dexamethasone|mesh-list
92665431|NCT00273377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665432|NCT00273377|Antiemetics|antiemetics|mesh-ancestor
92665433|NCT00273377|Autonomic Agents|autonomic agents|mesh-ancestor
92665438|NCT00273377|Hormones|hormones|mesh-ancestor
92665439|NCT00273377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665440|NCT00273377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92577565|NCT00269035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577566|NCT00269035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577567|NCT00269035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577568|NCT00269035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91984870|NCT01374425|Antimetabolites|antimetabolites|mesh-ancestor
92665441|NCT00273377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665442|NCT00273416|Sildenafil Citrate|sildenafil citrate|mesh-list
92665443|NCT00273416|Vasodilator Agents|vasodilator agents|mesh-ancestor
92390788|NCT01274988|Analgesics|analgesics|mesh-ancestor
92665444|NCT00273416|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92665445|NCT00273416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92665446|NCT00273416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665447|NCT00273416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665448|NCT00273416|Urological Agents|urological agents|mesh-ancestor
92665449|NCT00314184|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92665450|NCT00314184|Antidepressive Agents|antidepressive agents|mesh-ancestor
92665451|NCT00314184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665452|NCT00314184|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92665453|NCT00314184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92665454|NCT00314184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665455|NCT00314184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665457|NCT00273455|Bimatoprost|bimatoprost|mesh-list
92665458|NCT00273455|Dorzolamide|dorzolamide|mesh-list
92665459|NCT00273455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665460|NCT00273455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665461|NCT00273455|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92665462|NCT00273455|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92665463|NCT00273455|Adrenergic Agents|adrenergic agents|mesh-ancestor
92665464|NCT00273455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665465|NCT00273455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665466|NCT00273455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92665467|NCT00273455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665468|NCT00273455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92665469|NCT00273533|Ramipril|ramipril|mesh-list
92665470|NCT00273533|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92665471|NCT00273533|Protease Inhibitors|protease inhibitors|mesh-ancestor
92665472|NCT00273533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665473|NCT00273533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665474|NCT00273533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665475|NCT00273611|Vitamin D|vitamin d|mesh-list
92665476|NCT00273611|Vitamins|vitamins|mesh-ancestor
92665477|NCT00273611|Micronutrients|micronutrients|mesh-ancestor
92665478|NCT00273611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665479|NCT00273611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92665480|NCT00273689|Albuterol|albuterol|mesh-list
92665481|NCT00273689|Montelukast|montelukast|mesh-list
92665482|NCT00273689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665483|NCT00273689|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665484|NCT00273689|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92665485|NCT00273689|Hormone Antagonists|hormone antagonists|mesh-ancestor
92665486|NCT00273689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665487|NCT00273689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665488|NCT00273689|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92665489|NCT00273689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92665490|NCT00273689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665491|NCT00273689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665492|NCT00273689|Autonomic Agents|autonomic agents|mesh-ancestor
92665493|NCT00273689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665494|NCT00273689|Tocolytic Agents|tocolytic agents|mesh-ancestor
92665495|NCT00273689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92665496|NCT00273689|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92665497|NCT00273689|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92665498|NCT00273689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92665499|NCT00273689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92665500|NCT00273689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665501|NCT00308334|Domperidone|domperidone|mesh-list
92665502|NCT00308334|Antiemetics|antiemetics|mesh-ancestor
92665506|NCT00308334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92577569|NCT00269035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92577570|NCT00269035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577571|NCT00269035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92577572|NCT00269035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92577573|NCT00269035|Dopamine Agents|dopamine agents|mesh-ancestor
92577574|NCT00074009|Bortezomib|bortezomib|mesh-list
92577575|NCT00074009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577576|NCT00269269|Antihypertensive Agents|antihypertensive agents|mesh-list
92665507|NCT00308334|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92665508|NCT00308334|Dopamine Agents|dopamine agents|mesh-ancestor
92665509|NCT00308334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665510|NCT00308334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665511|NCT00273767|Epoetin Alfa|epoetin alfa|mesh-list
92665512|NCT00273767|Hematinics|hematinics|mesh-ancestor
92665513|NCT00314379|Vitamin E|vitamin e|mesh-list
92665514|NCT00314379|Vitamins|vitamins|mesh-ancestor
92665515|NCT00314379|Micronutrients|micronutrients|mesh-ancestor
92665516|NCT00314379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665517|NCT00314379|Antioxidants|antioxidants|mesh-ancestor
92665518|NCT00314379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665519|NCT00314379|Protective Agents|protective agents|mesh-ancestor
92665520|NCT00273884|Cytarabine|cytarabine|mesh-list
92665521|NCT00273884|Amonafide|amonafide|mesh-list
92665522|NCT00273884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92665523|NCT00273884|Antimetabolites|antimetabolites|mesh-ancestor
92665524|NCT00273884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665525|NCT00273884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665526|NCT00273884|Antiviral Agents|antiviral agents|mesh-ancestor
92665527|NCT00273884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665528|NCT00273884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92665529|NCT00273884|Immunologic Factors|immunologic factors|mesh-ancestor
92665530|NCT00273884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665531|NCT00273884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665532|NCT00308373|Metformin|metformin|mesh-list
92665533|NCT00308373|Pioglitazone|pioglitazone|mesh-list
92665534|NCT00308373|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92665535|NCT00308373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92665536|NCT00308373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665537|NCT00273962|Albuterol|albuterol|mesh-list
92665538|NCT00273962|Ipratropium|ipratropium|mesh-list
92665539|NCT00273962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665540|NCT00273962|Autonomic Agents|autonomic agents|mesh-ancestor
92665541|NCT00273962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665542|NCT00273962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665543|NCT00273962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665544|NCT00273962|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665545|NCT00273962|Tocolytic Agents|tocolytic agents|mesh-ancestor
92665546|NCT00273962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92665547|NCT00273962|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92665548|NCT00273962|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92665549|NCT00273962|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92665550|NCT00273962|Adrenergic Agents|adrenergic agents|mesh-ancestor
92665551|NCT00273962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665552|NCT00273962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665553|NCT00273962|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92665554|NCT00273962|Cholinergic Agents|cholinergic agents|mesh-ancestor
92665555|NCT00274001|Nevirapine|nevirapine|mesh-list
92665556|NCT00274001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92665557|NCT00274001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92665558|NCT00274001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665559|NCT00274001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665560|NCT00274001|Antiviral Agents|antiviral agents|mesh-ancestor
92665561|NCT00274001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665562|NCT00274001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92665563|NCT00274001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92665564|NCT00274001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92665565|NCT00274001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92665566|NCT00274040|Tiotropium Bromide|tiotropium bromide|mesh-list
92665567|NCT00274040|Ipratropium|ipratropium|mesh-list
92577577|NCT00269386|Clarithromycin|clarithromycin|mesh-list
92577578|NCT00269386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92665568|NCT00274040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665569|NCT00274040|Autonomic Agents|autonomic agents|mesh-ancestor
92665570|NCT00274040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665571|NCT00274040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665572|NCT00274040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665573|NCT00274040|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665574|NCT00274040|Parasympatholytics|parasympatholytics|mesh-ancestor
92665575|NCT00274040|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92665579|NCT00314457|Bupivacaine|bupivacaine|mesh-list
92665580|NCT00314457|Anesthetics, Local|anesthetics, local|mesh-ancestor
92665581|NCT00314457|Anesthetics|anesthetics|mesh-ancestor
92665582|NCT00314457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665583|NCT00314457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665584|NCT00314457|Sensory System Agents|sensory system agents|mesh-ancestor
92665585|NCT00314457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665587|NCT00308451|Biotin|biotin|mesh-list
92665588|NCT00308451|Picolinic acid|picolinic acid|mesh-list
92390933|NCT03804372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665589|NCT00308451|Trace Elements|trace elements|mesh-ancestor
92665590|NCT00308451|Micronutrients|micronutrients|mesh-ancestor
92665591|NCT00308451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665592|NCT00308451|Vitamin B Complex|vitamin b complex|mesh-ancestor
92665593|NCT00308451|Vitamins|vitamins|mesh-ancestor
92665594|NCT00308451|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92665595|NCT00308451|Chelating Agents|chelating agents|mesh-ancestor
92665596|NCT00308451|Sequestering Agents|sequestering agents|mesh-ancestor
92665597|NCT00308451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665598|NCT00274079|Tiotropium Bromide|tiotropium bromide|mesh-list
92665599|NCT00274079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665600|NCT00274079|Autonomic Agents|autonomic agents|mesh-ancestor
92665601|NCT00274079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665602|NCT00274079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665603|NCT00274079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665604|NCT00274079|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665605|NCT00274079|Parasympatholytics|parasympatholytics|mesh-ancestor
92665606|NCT00274079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92665607|NCT00274079|Cholinergic Agents|cholinergic agents|mesh-ancestor
92665608|NCT00274079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665609|NCT00274079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665610|NCT00274118|Telmisartan|telmisartan|mesh-list
92665612|NCT00274118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665613|NCT00274118|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92665614|NCT00274118|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92665615|NCT00274118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665616|NCT00274118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92665617|NCT00274118|Protease Inhibitors|protease inhibitors|mesh-ancestor
92665618|NCT00274118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665619|NCT00308490|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92665620|NCT00308490|Hematinics|hematinics|mesh-ancestor
92665621|NCT00416585|Isotretinoin|isotretinoin|mesh-list
92665622|NCT00416585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92665623|NCT00308529|Bevacizumab|bevacizumab|mesh-list
92665624|NCT00308529|Carboplatin|carboplatin|mesh-list
92665625|NCT00308529|Irinotecan|irinotecan|mesh-list
92665626|NCT00308529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92665627|NCT00308529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665628|NCT00308529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92665629|NCT00308529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92665630|NCT00308529|Growth Substances|growth substances|mesh-ancestor
92665631|NCT00308529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665632|NCT00308529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92665633|NCT00308529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92665634|NCT00308529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92665635|NCT00308529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665636|NCT00308529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665637|NCT00274235|Pyrimethamine|pyrimethamine|mesh-list
92665638|NCT00274235|Sulfadoxine|sulfadoxine|mesh-list
92665639|NCT00274235|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92665640|NCT00274235|Mefloquine|mefloquine|mesh-list
92665641|NCT00274235|Antimalarials|antimalarials|mesh-ancestor
92665642|NCT00274235|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92577579|NCT00269386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577580|NCT00269386|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92577581|NCT00269386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665643|NCT00274235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92665644|NCT00274235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665645|NCT00274235|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92665646|NCT00274235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665647|NCT00274235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665656|NCT00308607|Interferon-alpha|interferon-alpha|mesh-list
92665657|NCT00308607|Interferon alpha-2|interferon alpha-2|mesh-list
92665658|NCT00308607|Bevacizumab|bevacizumab|mesh-list
92665659|NCT00308607|Dacarbazine|dacarbazine|mesh-list
92665660|NCT00308607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92665661|NCT00308607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665662|NCT00308607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92665663|NCT00308607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92665664|NCT00308607|Growth Substances|growth substances|mesh-ancestor
92665665|NCT00308607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665666|NCT00308607|Growth Inhibitors|growth inhibitors|mesh-ancestor
92665667|NCT00308607|Antiviral Agents|antiviral agents|mesh-ancestor
92665668|NCT00308607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665669|NCT00308607|Immunologic Factors|immunologic factors|mesh-ancestor
92391009|NCT04151940|Immunologic Factors|immunologic factors|mesh-ancestor
92665670|NCT00308607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92665672|NCT00308607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665673|NCT00314613|Risperidone|risperidone|mesh-list
92665674|NCT00314613|Antipsychotic Agents|antipsychotic agents|mesh-list
92665675|NCT00314613|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92665676|NCT00314613|Serotonin Agents|serotonin agents|mesh-ancestor
92665677|NCT00314613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665678|NCT00314613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665679|NCT00314613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665680|NCT00314613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92665681|NCT00314613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665682|NCT00314613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665683|NCT00314613|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92665684|NCT00314613|Dopamine Agents|dopamine agents|mesh-ancestor
92665685|NCT00274352|Adalimumab|adalimumab|mesh-list
92665686|NCT00274352|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92665687|NCT00274352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665688|NCT00274352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665689|NCT00314652|Buprenorphine|buprenorphine|mesh-list
92665690|NCT00314652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92665691|NCT00314652|Narcotics|narcotics|mesh-ancestor
92665692|NCT00314652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665693|NCT00314652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665694|NCT00314652|Analgesics|analgesics|mesh-ancestor
92665695|NCT00314652|Sensory System Agents|sensory system agents|mesh-ancestor
92665696|NCT00314652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665697|NCT00314652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92665698|NCT00274391|Amiloride|amiloride|mesh-list
92665699|NCT00274391|Diuretics|diuretics|mesh-ancestor
92665700|NCT00274391|Natriuretic Agents|natriuretic agents|mesh-ancestor
92665701|NCT00274391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665702|NCT00274391|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92665703|NCT00274391|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92665704|NCT00274391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665705|NCT00274391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665706|NCT00274391|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92665707|NCT00274391|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92665708|NCT00274430|Dexamethasone|dexamethasone|mesh-list
92665709|NCT00274430|Tadalafil|tadalafil|mesh-list
92665710|NCT00274430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665711|NCT00274430|Antiemetics|antiemetics|mesh-ancestor
92665712|NCT00274430|Autonomic Agents|autonomic agents|mesh-ancestor
92665713|NCT00274430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665714|NCT00274430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665715|NCT00274430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073055|NCT02144584|Memantine|memantine|mesh-list
92665727|NCT00274508|Bromides|bromides|mesh-list
92665728|NCT00274508|Tiotropium Bromide|tiotropium bromide|mesh-list
92665729|NCT00274508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665730|NCT00274508|Autonomic Agents|autonomic agents|mesh-ancestor
92665731|NCT00274508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665732|NCT00274508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665733|NCT00274508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665734|NCT00274508|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665735|NCT00274508|Parasympatholytics|parasympatholytics|mesh-ancestor
92665736|NCT00274508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92665737|NCT00274508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92665738|NCT00274508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665739|NCT00274508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665740|NCT00274508|Anticonvulsants|anticonvulsants|mesh-ancestor
92665741|NCT00274547|Tiotropium Bromide|tiotropium bromide|mesh-list
92665742|NCT00274547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92665743|NCT00274547|Autonomic Agents|autonomic agents|mesh-ancestor
92665744|NCT00274547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665745|NCT00274547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665746|NCT00274547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92665747|NCT00274547|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665748|NCT00274547|Parasympatholytics|parasympatholytics|mesh-ancestor
92665749|NCT00274547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92665750|NCT00274547|Cholinergic Agents|cholinergic agents|mesh-ancestor
92665751|NCT00274547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665752|NCT00274547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665754|NCT00308763|Nicotine|nicotine|mesh-list
92665755|NCT00308763|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92665756|NCT00308763|Autonomic Agents|autonomic agents|mesh-ancestor
92665757|NCT00308763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665758|NCT00308763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665759|NCT00308763|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92665760|NCT00308763|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92665761|NCT00308763|Cholinergic Agents|cholinergic agents|mesh-ancestor
92665762|NCT00308763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665763|NCT00308763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665764|NCT00308763|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92665765|NCT00308763|Antidepressive Agents|antidepressive agents|mesh-ancestor
92665766|NCT00308763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665767|NCT00308763|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92665768|NCT00308763|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92665769|NCT00308763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665770|NCT00308763|Dopamine Agents|dopamine agents|mesh-ancestor
92665771|NCT00308763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92665772|NCT00308763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92665773|NCT00308763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665774|NCT00274586|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92665775|NCT00274586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92665776|NCT00274820|Ascorbic Acid|ascorbic acid|mesh-list
92665780|NCT00274820|Vitamins|vitamins|mesh-ancestor
92665781|NCT00274820|Micronutrients|micronutrients|mesh-ancestor
92665782|NCT00274820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665783|NCT00274820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665784|NCT00274820|Antiemetics|antiemetics|mesh-ancestor
92665785|NCT00274820|Autonomic Agents|autonomic agents|mesh-ancestor
92665786|NCT00274820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665787|NCT00274820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665788|NCT00274820|Glucocorticoids|glucocorticoids|mesh-ancestor
92665789|NCT00274820|Hormones|hormones|mesh-ancestor
92665790|NCT00274820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665791|NCT00274820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92665792|NCT00274820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665793|NCT00274820|Antioxidants|antioxidants|mesh-ancestor
92665794|NCT00274820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665795|NCT00274820|Protective Agents|protective agents|mesh-ancestor
92665796|NCT00274820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92665797|NCT00274820|Immunologic Factors|immunologic factors|mesh-ancestor
92665798|NCT00274820|Leprostatic Agents|leprostatic agents|mesh-ancestor
92665799|NCT00274820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92665800|NCT00274820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665801|NCT00274820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92665802|NCT00274820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92665803|NCT00274820|Growth Substances|growth substances|mesh-ancestor
92665804|NCT00274820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92665805|NCT00308841|Lidocaine|lidocaine|mesh-list
92665806|NCT00308841|Anesthetics, Local|anesthetics, local|mesh-ancestor
92665807|NCT00308841|Anesthetics|anesthetics|mesh-ancestor
92577582|NCT00269386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577583|NCT00269386|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92577584|NCT00269386|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92577586|NCT00074087|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92665808|NCT00308841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665809|NCT00308841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665810|NCT00308841|Sensory System Agents|sensory system agents|mesh-ancestor
92665811|NCT00308841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665812|NCT00308841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92665813|NCT00308841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92665814|NCT00308841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92665815|NCT00308841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665816|NCT00308841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665817|NCT00274859|Gemcitabine|gemcitabine|mesh-list
92665818|NCT00274859|Oxaliplatin|oxaliplatin|mesh-list
92665819|NCT00274859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92665820|NCT00274859|Antimetabolites|antimetabolites|mesh-ancestor
92665821|NCT00274859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665822|NCT00274859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665823|NCT00274898|Celecoxib|celecoxib|mesh-list
92665824|NCT00274898|Docetaxel|docetaxel|mesh-list
92665825|NCT00274898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665826|NCT00274898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92665827|NCT00274898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92665828|NCT00274898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92665829|NCT00274898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665830|NCT00274898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92665831|NCT00274898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92665832|NCT00274898|Analgesics|analgesics|mesh-ancestor
92665833|NCT00274898|Sensory System Agents|sensory system agents|mesh-ancestor
92665834|NCT00274898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665835|NCT00274898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665836|NCT00274898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92665837|NCT00274898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665838|NCT00274898|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92665839|NCT00274898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92665840|NCT00274898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665841|NCT00308880|Tranexamic Acid|tranexamic acid|mesh-list
92665842|NCT00308880|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92665843|NCT00308880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92665844|NCT00308880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665845|NCT00308880|Hemostatics|hemostatics|mesh-ancestor
92665846|NCT00308880|Coagulants|coagulants|mesh-ancestor
92665847|NCT00277199|Abatacept|abatacept|mesh-list
92665848|NCT00277199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92665849|NCT00277199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665850|NCT00277199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92665852|NCT00277199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92665853|NCT00277199|Immunologic Factors|immunologic factors|mesh-ancestor
92665854|NCT00277199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665855|NCT00277199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665856|NCT00277472|Valsartan|valsartan|mesh-list
91946611|NCT02243176|Saxagliptin|saxagliptin|mesh-list
92665857|NCT00277472|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92665858|NCT00277472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92665859|NCT00277472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92665860|NCT00277472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92665861|NCT00277472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665862|NCT00277472|Diuretics|diuretics|mesh-ancestor
92665863|NCT00277472|Natriuretic Agents|natriuretic agents|mesh-ancestor
92665864|NCT00277472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665865|NCT00277472|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92665866|NCT00277472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92665867|NCT00277511|Levofloxacin|levofloxacin|mesh-list
92665868|NCT00277511|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92665869|NCT00277511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577587|NCT00074087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92577588|NCT00074087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984888|NCT02085460|Protective Agents|protective agents|mesh-ancestor
92665870|NCT00277511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92665871|NCT00277511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92665872|NCT00277511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92665873|NCT00277511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665874|NCT00277511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665875|NCT00277511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665876|NCT00277511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92665877|NCT00277511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92665878|NCT00315003|Azithromycin|azithromycin|mesh-list
92665879|NCT00315003|Telithromycin|telithromycin|mesh-list
92665880|NCT00315003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92665881|NCT00315003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665882|NCT00277550|Tegaserod|tegaserod|mesh-list
92665883|NCT00277550|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92665884|NCT00277550|Serotonin Agents|serotonin agents|mesh-ancestor
92665885|NCT00277550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665886|NCT00277550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665887|NCT00277550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665888|NCT00277589|Iodine|iodine|mesh-list
92665889|NCT00277589|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92665890|NCT00277589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665891|NCT00277589|Trace Elements|trace elements|mesh-ancestor
92665893|NCT00277589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665894|NCT00315042|Penicillins|penicillins|mesh-list
92665895|NCT00315042|Telithromycin|telithromycin|mesh-list
92665896|NCT00315042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92665897|NCT00315042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665898|NCT00277667|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92665899|NCT00277667|Antidepressive Agents|antidepressive agents|mesh-ancestor
92665900|NCT00277667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665901|NCT00277667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92665902|NCT00277667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92665903|NCT00277667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665904|NCT00277667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665905|NCT00315081|Bromocriptine|bromocriptine|mesh-list
92665906|NCT00315081|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92665907|NCT00315081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92665908|NCT00315081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92665909|NCT00315081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665910|NCT00315081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665911|NCT00315081|Dopamine Agonists|dopamine agonists|mesh-ancestor
92665912|NCT00315081|Dopamine Agents|dopamine agents|mesh-ancestor
92665913|NCT00315081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665914|NCT00315081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665915|NCT00277706|Vitamin D|vitamin d|mesh-list
92665916|NCT00277706|Calcium|calcium|mesh-list
92665917|NCT00277706|Vitamins|vitamins|mesh-ancestor
92665918|NCT00277706|Micronutrients|micronutrients|mesh-ancestor
92665919|NCT00277706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665920|NCT00277706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92665921|NCT00277706|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92665922|NCT00277862|Ribavirin|ribavirin|mesh-list
92665923|NCT00277862|Interferon-alpha|interferon-alpha|mesh-list
92665924|NCT00277862|Interferon alpha-2|interferon alpha-2|mesh-list
92665927|NCT00277862|Antimetabolites|antimetabolites|mesh-ancestor
92665928|NCT00277862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665929|NCT00277862|Antiviral Agents|antiviral agents|mesh-ancestor
92665930|NCT00277862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665931|NCT00277862|Immunologic Factors|immunologic factors|mesh-ancestor
92665932|NCT00277862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665933|NCT00277862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665934|NCT00278018|Immunomodulating Agents|immunomodulating agents|mesh-list
92665935|NCT00278018|Immunologic Factors|immunologic factors|mesh-ancestor
92665936|NCT00278018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665937|NCT00309270|Alemtuzumab|alemtuzumab|mesh-list
92665938|NCT00309270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92665939|NCT00309270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665940|NCT00315276|Modafinil|modafinil|mesh-list
92665941|NCT00315276|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92577589|NCT00074087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577590|NCT00074087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92577591|NCT00074087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577592|NCT00074087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665942|NCT00315276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665943|NCT00315276|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92665944|NCT00315276|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92665945|NCT00315276|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92665946|NCT00315276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665947|NCT00309309|Rosiglitazone|rosiglitazone|mesh-list
92665948|NCT00309309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92665949|NCT00309309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665950|NCT00278174|Interferons|interferons|mesh-list
92665951|NCT00278174|Interferon-alpha|interferon-alpha|mesh-list
92665952|NCT00278174|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92665953|NCT00278174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665954|NCT00278174|Antiviral Agents|antiviral agents|mesh-ancestor
92665955|NCT00278174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665956|NCT00278174|Immunologic Factors|immunologic factors|mesh-ancestor
92665957|NCT00278174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665958|NCT00278213|Cyclophosphamide|cyclophosphamide|mesh-list
92665959|NCT00278213|Fludarabine|fludarabine|mesh-list
92665960|NCT00278213|Fludarabine phosphate|fludarabine phosphate|mesh-list
92665961|NCT00278213|Mitoxantrone|mitoxantrone|mesh-list
92665962|NCT00278213|Alemtuzumab|alemtuzumab|mesh-list
92665963|NCT00278213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92665964|NCT00278213|Immunologic Factors|immunologic factors|mesh-ancestor
92665965|NCT00278213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665966|NCT00278213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92665967|NCT00278213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92665968|NCT00278213|Alkylating Agents|alkylating agents|mesh-ancestor
92665969|NCT00278213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665970|NCT00278213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665971|NCT00278213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92665972|NCT00278213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92665973|NCT00278213|Antimetabolites|antimetabolites|mesh-ancestor
92665974|NCT00278213|Analgesics|analgesics|mesh-ancestor
92665975|NCT00278213|Sensory System Agents|sensory system agents|mesh-ancestor
92665976|NCT00278213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665977|NCT00278213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92665978|NCT00278213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92665979|NCT00278213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665980|NCT00278213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92665981|NCT00278252|Etoposide|etoposide|mesh-list
92665982|NCT00278252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92665983|NCT00278252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665984|NCT00278252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92665985|NCT00278252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92665986|NCT00278252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665987|NCT00278252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665988|NCT00315432|Interferons|interferons|mesh-list
92665989|NCT00315432|Ribavirin|ribavirin|mesh-list
92665990|NCT00315432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665991|NCT00315432|Antiviral Agents|antiviral agents|mesh-ancestor
92665992|NCT00315432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92665993|NCT00315432|Antimetabolites|antimetabolites|mesh-ancestor
92665994|NCT00315432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665995|NCT00278330|Vorinostat|vorinostat|mesh-list
92665996|NCT00278330|Alvocidib|alvocidib|mesh-list
92665997|NCT00278330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665998|NCT00278330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92666003|NCT00278330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666004|NCT00278330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666005|NCT00315510|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92666006|NCT00315510|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92666007|NCT00315510|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92666008|NCT00315510|Antimetabolites|antimetabolites|mesh-ancestor
92666009|NCT00315510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666010|NCT00315510|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92666011|NCT00315510|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92577594|NCT00269542|Folic Acid|folic acid|mesh-list
92577595|NCT00269542|Vitamin B Complex|vitamin b complex|mesh-list
92577596|NCT00269542|Trace Elements|trace elements|mesh-ancestor
92577597|NCT00269542|Micronutrients|micronutrients|mesh-ancestor
92666012|NCT00315510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666014|NCT00278369|Interleukin-2|interleukin-2|mesh-list
92666015|NCT00278369|Denileukin diftitox|denileukin diftitox|mesh-list
92666016|NCT00278369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666017|NCT00278369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666018|NCT00278369|Analgesics|analgesics|mesh-ancestor
92666019|NCT00278369|Sensory System Agents|sensory system agents|mesh-ancestor
92666020|NCT00278369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666021|NCT00278369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666022|NCT00278369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92666023|NCT00278369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92666024|NCT00278369|Antiviral Agents|antiviral agents|mesh-ancestor
92666025|NCT00278369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666026|NCT00315549|Penicillins|penicillins|mesh-list
92666027|NCT00315549|Telithromycin|telithromycin|mesh-list
92666028|NCT00315549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92666029|NCT00315549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666030|NCT00278408|Prednisone|prednisone|mesh-list
92666031|NCT00278408|Cyclophosphamide|cyclophosphamide|mesh-list
92666032|NCT00278408|Rituximab|rituximab|mesh-list
92666033|NCT00278408|Doxorubicin|doxorubicin|mesh-list
92666034|NCT00278408|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92666035|NCT00278408|Vincristine|vincristine|mesh-list
92666036|NCT00278408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666037|NCT00278408|Immunologic Factors|immunologic factors|mesh-ancestor
92666038|NCT00278408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666039|NCT00278408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666040|NCT00278408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92666041|NCT00278408|Alkylating Agents|alkylating agents|mesh-ancestor
92666042|NCT00278408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666043|NCT00278408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666044|NCT00278408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92666045|NCT00278408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92666046|NCT00278408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92666047|NCT00278408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666048|NCT00278408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666049|NCT00278408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666050|NCT00278408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666051|NCT00278408|Glucocorticoids|glucocorticoids|mesh-ancestor
92666052|NCT00278408|Hormones|hormones|mesh-ancestor
92666053|NCT00278408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666054|NCT00278408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92666055|NCT00278408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666056|NCT00278408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666057|NCT00278408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92666058|NCT00278408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666059|NCT00315666|Memantine|memantine|mesh-list
92666060|NCT00315666|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92666061|NCT00315666|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92666062|NCT00315666|Dopamine Agents|dopamine agents|mesh-ancestor
92666063|NCT00315666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666064|NCT00315666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666065|NCT00315666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666066|NCT00315666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92666067|NCT00315666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92666068|NCT00315744|Fluticasone|fluticasone|mesh-list
92666069|NCT00315744|Xhance|xhance|mesh-list
92666087|NCT00315744|Tocolytic Agents|tocolytic agents|mesh-ancestor
92666088|NCT00315744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92666089|NCT00309543|Leucovorin|leucovorin|mesh-list
92666090|NCT00309543|Fluorouracil|fluorouracil|mesh-list
92666091|NCT00309543|Antimetabolites|antimetabolites|mesh-ancestor
92666092|NCT00309543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666093|NCT00309543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666094|NCT00309543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666095|NCT00309543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666096|NCT00309543|Immunologic Factors|immunologic factors|mesh-ancestor
92666097|NCT00309543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666098|NCT00309543|Antidotes|antidotes|mesh-ancestor
92577598|NCT00269542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577599|NCT00269542|Hematinics|hematinics|mesh-ancestor
92577600|NCT00269542|Vitamins|vitamins|mesh-ancestor
92666099|NCT00309543|Protective Agents|protective agents|mesh-ancestor
92666100|NCT00309543|Vitamin B Complex|vitamin b complex|mesh-ancestor
92666101|NCT00309543|Vitamins|vitamins|mesh-ancestor
92666102|NCT00309543|Micronutrients|micronutrients|mesh-ancestor
92666103|NCT00315861|Pemetrexed|pemetrexed|mesh-list
92666104|NCT00315861|Topotecan|topotecan|mesh-list
92666105|NCT00315861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666106|NCT00315861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666107|NCT00315861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666108|NCT00315861|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92666109|NCT00315861|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92666110|NCT00315861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92666111|NCT00315861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666112|NCT00309660|Rosiglitazone|rosiglitazone|mesh-list
92666113|NCT00309660|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92666114|NCT00309660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666115|NCT00315900|Valproic Acid|valproic acid|mesh-list
92666116|NCT00315900|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92666117|NCT00315900|Antidepressive Agents|antidepressive agents|mesh-ancestor
92666118|NCT00315900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92666119|NCT00315900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92666121|NCT00315900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666122|NCT00315900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666123|NCT00315900|Anticonvulsants|anticonvulsants|mesh-ancestor
92666124|NCT00315900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666125|NCT00315900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666126|NCT00315900|GABA Agents|gaba agents|mesh-ancestor
92666127|NCT00315900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666128|NCT00315900|Antimanic Agents|antimanic agents|mesh-ancestor
92666131|NCT00279110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666132|NCT00309699|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92666133|NCT00309699|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92666134|NCT00309699|Antidepressive Agents|antidepressive agents|mesh-ancestor
92666135|NCT00309699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92666136|NCT00309699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92666137|NCT00309699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92666138|NCT00309699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666139|NCT00309699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666140|NCT00309699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92666141|NCT00309699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92666142|NCT00309699|Serotonin Agents|serotonin agents|mesh-ancestor
92666143|NCT00309699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666144|NCT00309699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666145|NCT00309699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92666146|NCT00309699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92666147|NCT00309699|Dopamine Agents|dopamine agents|mesh-ancestor
92666148|NCT00309816|Sildenafil Citrate|sildenafil citrate|mesh-list
92666149|NCT00309816|Vasodilator Agents|vasodilator agents|mesh-ancestor
92666150|NCT00309816|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92666151|NCT00309816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92666152|NCT00309816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666153|NCT00309816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666154|NCT00309816|Urological Agents|urological agents|mesh-ancestor
92666155|NCT00279266|Thiamine|thiamine|mesh-list
92666156|NCT00279266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92666157|NCT00279266|Vitamins|vitamins|mesh-ancestor
92666158|NCT00279266|Micronutrients|micronutrients|mesh-ancestor
92666159|NCT00279266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666160|NCT00316095|Telmisartan|telmisartan|mesh-list
92666161|NCT00316095|Simvastatin|simvastatin|mesh-list
92666162|NCT00316095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92666163|NCT00316095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92666164|NCT00316095|Antimetabolites|antimetabolites|mesh-ancestor
92666165|NCT00316095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666166|NCT00316095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92666167|NCT00316095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92666168|NCT00316095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666169|NCT00316095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92666170|NCT00316095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92666171|NCT00316095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92577601|NCT00269620|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92577602|NCT00269620|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92577603|NCT00269620|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92666172|NCT00279344|Fentanyl|fentanyl|mesh-list
92666173|NCT00279344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92666174|NCT00279344|Narcotics|narcotics|mesh-ancestor
92666175|NCT00279344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666176|NCT00279344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666177|NCT00279344|Analgesics|analgesics|mesh-ancestor
92666178|NCT00279344|Sensory System Agents|sensory system agents|mesh-ancestor
92666179|NCT00279344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666180|NCT00279344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92666181|NCT00279344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92666182|NCT00279344|Anesthetics, General|anesthetics, general|mesh-ancestor
92666183|NCT00279344|Anesthetics|anesthetics|mesh-ancestor
92666184|NCT00418860|Aspirin|aspirin|mesh-list
92666185|NCT00418860|Clopidogrel|clopidogrel|mesh-list
92666186|NCT00418860|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92666187|NCT00418860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666188|NCT00418860|Analgesics|analgesics|mesh-ancestor
92666189|NCT00418860|Sensory System Agents|sensory system agents|mesh-ancestor
92666190|NCT00418860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666191|NCT00418860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666192|NCT00418860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666193|NCT00418860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666194|NCT00418860|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92666195|NCT00418860|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92666196|NCT00418860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666197|NCT00418860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92666198|NCT00418860|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92666199|NCT00418860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666200|NCT00418860|Antipyretics|antipyretics|mesh-ancestor
92666201|NCT00418860|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92666203|NCT00418860|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92666204|NCT00418860|Purinergic Agents|purinergic agents|mesh-ancestor
92666205|NCT00418860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666207|NCT00316212|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92666208|NCT00316212|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92666209|NCT00316212|Purinergic Agents|purinergic agents|mesh-ancestor
92666210|NCT00316212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666211|NCT00316212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666212|NCT00316212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666213|NCT00309855|Anastrozole|anastrozole|mesh-list
92666214|NCT00309855|Testosterone|testosterone|mesh-list
92666215|NCT00309855|Dutasteride|dutasteride|mesh-list
92666216|NCT00309855|Androgens|androgens|mesh-ancestor
92666217|NCT00309855|Hormones|hormones|mesh-ancestor
92666218|NCT00309855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666219|NCT00309855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666220|NCT00309855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92666221|NCT00309855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666222|NCT00309855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92666223|NCT00309855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92666224|NCT00309855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666225|NCT00309855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666226|NCT00309855|Hormone Antagonists|hormone antagonists|mesh-ancestor
92666227|NCT00309855|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92666228|NCT00309855|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92666229|NCT00279383|Thrombin|thrombin|mesh-list
92666230|NCT00279383|Hemostatics|hemostatics|mesh-ancestor
92666231|NCT00279383|Coagulants|coagulants|mesh-ancestor
92666232|NCT00279422|Visilizumab|visilizumab|mesh-list
92666233|NCT00279422|Immunologic Factors|immunologic factors|mesh-ancestor
92666234|NCT00279422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666235|NCT00309894|Ketoconazole|ketoconazole|mesh-list
92666236|NCT00309894|Hydrocortisone|hydrocortisone|mesh-list
92666237|NCT00309894|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92666238|NCT00309894|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92666239|NCT00309894|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92666240|NCT00309894|Sargramostim|sargramostim|mesh-list
92666241|NCT00309894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666242|NCT00309894|Immunologic Factors|immunologic factors|mesh-ancestor
92666243|NCT00309894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577604|NCT00269620|Etonogestrel|etonogestrel|mesh-list
92577605|NCT00269620|NuvaRing|nuvaring|mesh-list
92577606|NCT00269620|Norelgestromin|norelgestromin|mesh-list
92577607|NCT00269620|Ortho Evra|ortho evra|mesh-list
91984902|NCT02084134|BB 1101|bb 1101|mesh-list
92666244|NCT00309894|Antifungal Agents|antifungal agents|mesh-ancestor
92666245|NCT00309894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666246|NCT00309894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92666247|NCT00309894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92666248|NCT00309894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666249|NCT00309894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666250|NCT00309894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92666251|NCT00309894|Hormone Antagonists|hormone antagonists|mesh-ancestor
92666252|NCT00309894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666253|NCT00309894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92666254|NCT00279461|Vitamin D|vitamin d|mesh-list
92666255|NCT00279461|Ergocalciferols|ergocalciferols|mesh-list
92666256|NCT00279461|Cholecalciferol|cholecalciferol|mesh-list
92666257|NCT00279461|Vitamins|vitamins|mesh-list
92666258|NCT00279461|Micronutrients|micronutrients|mesh-ancestor
92666259|NCT00279461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666260|NCT00279461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92666261|NCT00279461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92666262|NCT00316329|Artesunate|artesunate|mesh-list
92666263|NCT00316329|Amodiaquine|amodiaquine|mesh-list
92666264|NCT00316329|Antimalarials|antimalarials|mesh-ancestor
92666265|NCT00316329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92666266|NCT00316329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92666267|NCT00316329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666268|NCT00316329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666269|NCT00316329|Antiviral Agents|antiviral agents|mesh-ancestor
92666271|NCT00316329|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92666272|NCT00316329|Anthelmintics|anthelmintics|mesh-ancestor
92666273|NCT00279539|Mitogens|mitogens|mesh-list
92666274|NCT00279539|Endothelial Growth Factors|endothelial growth factors|mesh-list
92666275|NCT00279539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666276|NCT00279539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666279|NCT00279578|Tranexamic Acid|tranexamic acid|mesh-list
92666280|NCT00279578|Factor VIII|factor viii|mesh-list
92666281|NCT00279578|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92666282|NCT00279578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92666283|NCT00279578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666284|NCT00279578|Hemostatics|hemostatics|mesh-ancestor
92666285|NCT00279578|Coagulants|coagulants|mesh-ancestor
92666286|NCT00279617|Levetiracetam|levetiracetam|mesh-list
92666287|NCT00279617|Anticonvulsants|anticonvulsants|mesh-ancestor
92666288|NCT00279617|Nootropic Agents|nootropic agents|mesh-ancestor
92666289|NCT00310011|Paclitaxel|paclitaxel|mesh-list
92666290|NCT00310011|Gemcitabine|gemcitabine|mesh-list
92666291|NCT00310011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666292|NCT00310011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666293|NCT00310011|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666294|NCT00310011|Antimitotic Agents|antimitotic agents|mesh-ancestor
92666295|NCT00310011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666296|NCT00310011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666297|NCT00310011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666298|NCT00310011|Antimetabolites|antimetabolites|mesh-ancestor
92666299|NCT00316407|Paclitaxel|paclitaxel|mesh-list
92666300|NCT00316407|Carboplatin|carboplatin|mesh-list
92666301|NCT00316407|Lapatinib|lapatinib|mesh-list
92666302|NCT00316407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666303|NCT00316407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666304|NCT00316407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666305|NCT00316407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92666306|NCT00316407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666307|NCT00316407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666308|NCT00316407|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666309|NCT00316407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666310|NCT00310089|Cyclophosphamide|cyclophosphamide|mesh-list
92666311|NCT00310089|Docetaxel|docetaxel|mesh-list
92666312|NCT00310089|Doxorubicin|doxorubicin|mesh-list
92666313|NCT00310089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92666314|NCT00310089|Cediranib|cediranib|mesh-list
92666315|NCT00310089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666316|NCT00310089|Immunologic Factors|immunologic factors|mesh-ancestor
92577608|NCT00269620|Contraceptive Agents|contraceptive agents|mesh-list
92577609|NCT00269620|Estradiol|estradiol|mesh-list
92577610|NCT00269620|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92577611|NCT00269620|Estrogens|estrogens|mesh-ancestor
92577612|NCT00269620|Hormones|hormones|mesh-ancestor
91984903|NCT02084134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666317|NCT00310089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666318|NCT00310089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666319|NCT00310089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92666320|NCT00310089|Alkylating Agents|alkylating agents|mesh-ancestor
92666321|NCT00310089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666322|NCT00310089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666323|NCT00310089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92666324|NCT00310089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666325|NCT00310089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92666326|NCT00310089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666327|NCT00310089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92666328|NCT00310089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666329|NCT00310089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666330|NCT00310089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666331|NCT00310089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666332|NCT00279734|Abatacept|abatacept|mesh-list
92666333|NCT00279734|Vaccines|vaccines|mesh-list
92666334|NCT00279734|Immunologic Factors|immunologic factors|mesh-ancestor
92666335|NCT00279734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666336|NCT00279734|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92666337|NCT00279734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666338|NCT00279734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92666339|NCT00279734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666340|NCT00279734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666341|NCT00279734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666342|NCT00310128|Cytarabine|cytarabine|mesh-list
92666343|NCT00310128|Methylprednisolone|methylprednisolone|mesh-list
92666344|NCT00310128|Rituximab|rituximab|mesh-list
92666345|NCT00310128|Etoposide|etoposide|mesh-list
92666346|NCT00310128|Antibodies|antibodies|mesh-list
92666347|NCT00310128|Immunoglobulins|immunoglobulins|mesh-list
92666348|NCT00310128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92666349|NCT00310128|Immunologic Factors|immunologic factors|mesh-ancestor
92666350|NCT00310128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666351|NCT00310128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92666352|NCT00310128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666358|NCT00310128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666359|NCT00310128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666360|NCT00310128|Antimetabolites|antimetabolites|mesh-ancestor
92666361|NCT00310128|Antiviral Agents|antiviral agents|mesh-ancestor
92666362|NCT00310128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666363|NCT00310128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666364|NCT00310128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666365|NCT00310128|Antiemetics|antiemetics|mesh-ancestor
92666366|NCT00310128|Autonomic Agents|autonomic agents|mesh-ancestor
92666367|NCT00310128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666368|NCT00310128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666369|NCT00310128|Glucocorticoids|glucocorticoids|mesh-ancestor
92666370|NCT00310128|Hormones|hormones|mesh-ancestor
92666371|NCT00310128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666372|NCT00310128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92666373|NCT00310128|Protective Agents|protective agents|mesh-ancestor
92666374|NCT00316563|Dronabinol|dronabinol|mesh-list
92666375|NCT00316563|Hallucinogens|hallucinogens|mesh-ancestor
92666376|NCT00316563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666377|NCT00316563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92666378|NCT00316563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666379|NCT00316563|Analgesics|analgesics|mesh-ancestor
92666380|NCT00316563|Sensory System Agents|sensory system agents|mesh-ancestor
92365067|NCT03000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666381|NCT00316563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666382|NCT00316563|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92666383|NCT00316563|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92666384|NCT00316563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666385|NCT00316563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666386|NCT00316563|Hormones|hormones|mesh-ancestor
92577613|NCT00269620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984909|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
92666387|NCT00316563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666388|NCT00416819|Leucovorin|leucovorin|mesh-list
92666389|NCT00416819|Cytarabine|cytarabine|mesh-list
92666390|NCT00416819|Rituximab|rituximab|mesh-list
92666391|NCT00416819|Methotrexate|methotrexate|mesh-list
92666392|NCT00416819|Etoposide|etoposide|mesh-list
92666393|NCT00416819|Temozolomide|temozolomide|mesh-list
92666394|NCT00416819|Etoposide phosphate|etoposide phosphate|mesh-list
92666395|NCT00416819|Levoleucovorin|levoleucovorin|mesh-list
92666396|NCT00416819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92666397|NCT00416819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666398|NCT00416819|Immunologic Factors|immunologic factors|mesh-ancestor
92666399|NCT00416819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666400|NCT00416819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666401|NCT00416819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92666402|NCT00416819|Abortifacient Agents|abortifacient agents|mesh-ancestor
92666403|NCT00416819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92666404|NCT00416819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666405|NCT00416819|Antimetabolites|antimetabolites|mesh-ancestor
92666406|NCT00416819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666407|NCT00416819|Dermatologic Agents|dermatologic agents|mesh-ancestor
92666408|NCT00416819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666409|NCT00416819|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92666410|NCT00416819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666411|NCT00416819|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92666412|NCT00416819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666413|NCT00416819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666414|NCT00416819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666415|NCT00416819|Antiviral Agents|antiviral agents|mesh-ancestor
92666416|NCT00416819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666417|NCT00416819|Antidotes|antidotes|mesh-ancestor
92666418|NCT00416819|Protective Agents|protective agents|mesh-ancestor
92666419|NCT00416819|Vitamin B Complex|vitamin b complex|mesh-ancestor
92666420|NCT00416819|Vitamins|vitamins|mesh-ancestor
92666421|NCT00416819|Micronutrients|micronutrients|mesh-ancestor
92666422|NCT00416819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92073744|NCT03364348|Maytansine|maytansine|mesh-list
92666452|NCT00310323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666453|NCT00310323|Antitussive Agents|antitussive agents|mesh-ancestor
92666454|NCT00310323|Respiratory System Agents|respiratory system agents|mesh-ancestor
92666455|NCT00310323|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92666456|NCT00310323|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92666457|NCT00280280|Baclofen|baclofen|mesh-list
92666458|NCT00280280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92666459|NCT00280280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666460|NCT00280280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92666461|NCT00280280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666462|NCT00280280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92666463|NCT00280280|GABA Agonists|gaba agonists|mesh-ancestor
92666464|NCT00280280|GABA Agents|gaba agents|mesh-ancestor
92666465|NCT00280280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666466|NCT00280280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666467|NCT00316758|Metformin|metformin|mesh-list
92666469|NCT00316758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666470|NCT00280358|Fluticasone|fluticasone|mesh-list
92666472|NCT00280358|Formoterol Fumarate|formoterol fumarate|mesh-list
92666473|NCT00280358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666474|NCT00280358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92666475|NCT00280358|Autonomic Agents|autonomic agents|mesh-ancestor
92666476|NCT00280358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666477|NCT00280358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666478|NCT00280358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92666479|NCT00280358|Respiratory System Agents|respiratory system agents|mesh-ancestor
92666480|NCT00280358|Dermatologic Agents|dermatologic agents|mesh-ancestor
92666481|NCT00280358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92666482|NCT00280358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92666483|NCT00280358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92666484|NCT00280358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92666485|NCT00280358|Adrenergic Agents|adrenergic agents|mesh-ancestor
92666486|NCT00280358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666487|NCT00280358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577614|NCT00269620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577615|NCT00269620|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92577616|NCT00269620|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92577617|NCT00269620|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92666488|NCT00310518|Beta-lapachone|beta-lapachone|mesh-list
92666489|NCT00310518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666490|NCT00310518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92666491|NCT00310518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92666492|NCT00310518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666493|NCT00310518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666494|NCT00310518|Antiviral Agents|antiviral agents|mesh-ancestor
92666495|NCT00280436|Casopitant|casopitant|mesh-list
92391928|NCT01042938|Curcumin|curcumin|mesh-list
92666496|NCT00280436|Antiemetics|antiemetics|mesh-ancestor
92666497|NCT00280436|Autonomic Agents|autonomic agents|mesh-ancestor
92666498|NCT00280436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666499|NCT00280436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666500|NCT00280436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666501|NCT00280436|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92666502|NCT00280436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666503|NCT00280436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666504|NCT00280514|Moxifloxacin|moxifloxacin|mesh-list
92666505|NCT00280514|Cefpirome|cefpirome|mesh-list
92666506|NCT00280514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92666507|NCT00280514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666508|NCT00280514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666509|NCT00280514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666510|NCT00280514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666511|NCT00280514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666512|NCT00280514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666513|NCT00280553|Bupivacaine|bupivacaine|mesh-list
92666514|NCT00280553|Anesthetics, Local|anesthetics, local|mesh-ancestor
92666515|NCT00280553|Anesthetics|anesthetics|mesh-ancestor
92666516|NCT00280553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666517|NCT00280553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666518|NCT00280553|Sensory System Agents|sensory system agents|mesh-ancestor
92666519|NCT00280553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666520|NCT00316875|Doxorubicin|doxorubicin|mesh-list
92666521|NCT00316875|Lapatinib|lapatinib|mesh-list
92666522|NCT00316875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92666523|NCT00316875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666524|NCT00316875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666525|NCT00316875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666526|NCT00316875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666527|NCT00316875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666528|NCT00316875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666529|NCT00316953|Dasatinib|dasatinib|mesh-list
92666530|NCT00316953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666531|NCT00316953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666532|NCT00316953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666533|NCT00316953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666534|NCT00419172|Rifampin|rifampin|mesh-list
92666535|NCT00419172|Deferasirox|deferasirox|mesh-list
92666536|NCT00419172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92666537|NCT00419172|Antitubercular Agents|antitubercular agents|mesh-ancestor
92666538|NCT00419172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92666539|NCT00419172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666540|NCT00419172|Leprostatic Agents|leprostatic agents|mesh-ancestor
92666553|NCT00280787|Paclitaxel|paclitaxel|mesh-list
92666554|NCT00280787|Carboplatin|carboplatin|mesh-list
92666555|NCT00280787|Irinotecan|irinotecan|mesh-list
92666556|NCT00280787|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666557|NCT00280787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666558|NCT00280787|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666559|NCT00280787|Antimitotic Agents|antimitotic agents|mesh-ancestor
92666560|NCT00280787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666561|NCT00280787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666562|NCT00280787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92666563|NCT00280787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666564|NCT00280787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666565|NCT00310596|Moxifloxacin|moxifloxacin|mesh-list
92666566|NCT00310596|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92666567|NCT00310596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92666568|NCT00310596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666569|NCT00310596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666570|NCT00310596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666571|NCT00310596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392001|NCT03403452|Apatinib|apatinib|mesh-list
92666572|NCT00310596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666573|NCT00310596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666574|NCT00310596|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92666575|NCT00310596|Contraceptive Agents|contraceptive agents|mesh-ancestor
92666576|NCT00310596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92666577|NCT00310596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666578|NCT00310596|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92666579|NCT00310596|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92666580|NCT00310596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92666581|NCT00280865|Pioglitazone|pioglitazone|mesh-list
92666582|NCT00280865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92666583|NCT00280865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666584|NCT00317031|Naltrexone|naltrexone|mesh-list
92666585|NCT00317031|Acamprosate|acamprosate|mesh-list
92666586|NCT00317031|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92666587|NCT00317031|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92666588|NCT00317031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666589|NCT00317031|Sensory System Agents|sensory system agents|mesh-ancestor
92666590|NCT00317031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666591|NCT00317070|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92666592|NCT00317070|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92666593|NCT00317070|Protective Agents|protective agents|mesh-ancestor
92666594|NCT00317070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666595|NCT00317070|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92666596|NCT00317070|Antioxidants|antioxidants|mesh-ancestor
92666597|NCT00317070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666598|NCT00281255|Allopurinol|allopurinol|mesh-list
92666599|NCT00281255|Dobutamine|dobutamine|mesh-list
92073946|NCT02090374|Vitamin D|vitamin d|mesh-list
92666601|NCT00281255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666602|NCT00281255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666603|NCT00281255|Gout Suppressants|gout suppressants|mesh-ancestor
92666604|NCT00281255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666605|NCT00281255|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92666607|NCT00281255|Protective Agents|protective agents|mesh-ancestor
92666608|NCT00281255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666609|NCT00281255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92666610|NCT00281255|Sympathomimetics|sympathomimetics|mesh-ancestor
92666611|NCT00281255|Autonomic Agents|autonomic agents|mesh-ancestor
92666612|NCT00281255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666613|NCT00281255|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92666614|NCT00281255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92666615|NCT00281255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92666616|NCT00281255|Adrenergic Agents|adrenergic agents|mesh-ancestor
92666617|NCT00281255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666618|NCT00317187|Vaccines|vaccines|mesh-list
92666619|NCT00317187|Immunologic Factors|immunologic factors|mesh-ancestor
92666620|NCT00317187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666621|NCT00310908|Tramadol|tramadol|mesh-list
92666622|NCT00310908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92666623|NCT00310908|Narcotics|narcotics|mesh-ancestor
92666624|NCT00310908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666625|NCT00310908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666626|NCT00310908|Analgesics|analgesics|mesh-ancestor
92666627|NCT00310908|Sensory System Agents|sensory system agents|mesh-ancestor
92666628|NCT00310908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666629|NCT00281489|Anesthetics|anesthetics|mesh-list
92666630|NCT00281489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666631|NCT00281489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666632|NCT00317343|Anticoagulants|anticoagulants|mesh-list
92666633|NCT00317343|Bivalirudin|bivalirudin|mesh-list
92666634|NCT00317343|Thrombin|thrombin|mesh-list
92666635|NCT00317343|Hemostatics|hemostatics|mesh-ancestor
92666636|NCT00317343|Coagulants|coagulants|mesh-ancestor
92666637|NCT00317343|Antithrombins|antithrombins|mesh-ancestor
92666638|NCT00317343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92666639|NCT00317343|Protease Inhibitors|protease inhibitors|mesh-ancestor
92666640|NCT00317343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666641|NCT00317343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666642|NCT00416858|Fluorouracil|fluorouracil|mesh-list
92023912|NCT04302181|Anesthetics|anesthetics|mesh-ancestor
92023913|NCT04302181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666643|NCT00416858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666644|NCT00416858|Antimetabolites|antimetabolites|mesh-ancestor
92666645|NCT00416858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666646|NCT00416858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666647|NCT00416858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666648|NCT00416858|Immunologic Factors|immunologic factors|mesh-ancestor
92666650|NCT00416897|Dexamethasone|dexamethasone|mesh-list
92666651|NCT00416897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666652|NCT00416897|Antiemetics|antiemetics|mesh-ancestor
92666653|NCT00416897|Autonomic Agents|autonomic agents|mesh-ancestor
92666654|NCT00416897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666655|NCT00416897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666656|NCT00416897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666657|NCT00416897|Glucocorticoids|glucocorticoids|mesh-ancestor
92666659|NCT00416897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666660|NCT00416897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92666661|NCT00416897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666662|NCT00417014|Prednisolone|prednisolone|mesh-list
92666663|NCT00417014|Vinblastine|vinblastine|mesh-list
92666664|NCT00417014|Procarbazine|procarbazine|mesh-list
92666665|NCT00417014|Chlorambucil|chlorambucil|mesh-list
92666666|NCT00417014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666667|NCT00417014|Glucocorticoids|glucocorticoids|mesh-ancestor
92666668|NCT00417014|Hormones|hormones|mesh-ancestor
92666669|NCT00417014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666670|NCT00417014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666671|NCT00417014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92666672|NCT00417014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666673|NCT00417014|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666674|NCT00417014|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666675|NCT00417014|Antimitotic Agents|antimitotic agents|mesh-ancestor
92074001|NCT05411380|Letrozole|letrozole|mesh-list
92666678|NCT00417014|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92666679|NCT00417014|Alkylating Agents|alkylating agents|mesh-ancestor
92666680|NCT00317421|Sildenafil Citrate|sildenafil citrate|mesh-list
92666681|NCT00317421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666682|NCT00317421|Vasodilator Agents|vasodilator agents|mesh-ancestor
92666683|NCT00317421|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92666684|NCT00317421|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92666685|NCT00317421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666686|NCT00317421|Urological Agents|urological agents|mesh-ancestor
92666687|NCT00417053|Cyclophosphamide|cyclophosphamide|mesh-list
92666688|NCT00417053|Melphalan|melphalan|mesh-list
92666689|NCT00417053|Busulfan|busulfan|mesh-list
92666690|NCT00417053|Carboplatin|carboplatin|mesh-list
92666691|NCT00417053|Doxorubicin|doxorubicin|mesh-list
92666692|NCT00417053|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92666693|NCT00417053|Etoposide|etoposide|mesh-list
92666694|NCT00417053|Vincristine|vincristine|mesh-list
92666695|NCT00417053|Etoposide phosphate|etoposide phosphate|mesh-list
92666696|NCT00417053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666697|NCT00417053|Immunologic Factors|immunologic factors|mesh-ancestor
92666698|NCT00417053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666699|NCT00417053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666700|NCT00417053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92666701|NCT00417053|Alkylating Agents|alkylating agents|mesh-ancestor
92666702|NCT00417053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666703|NCT00417053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365079|NCT02995824|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92666704|NCT00417053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92666705|NCT00417053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92666706|NCT00417053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666707|NCT00417053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666708|NCT00417053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666709|NCT00417053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666710|NCT00417053|Tubulin Modulators|tubulin modulators|mesh-ancestor
92666711|NCT00417053|Antimitotic Agents|antimitotic agents|mesh-ancestor
92666712|NCT00417053|Mitosis Modulators|mitosis modulators|mesh-ancestor
92666713|NCT00281567|Tiotropium Bromide|tiotropium bromide|mesh-list
92666714|NCT00281567|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92666715|NCT00281567|Autonomic Agents|autonomic agents|mesh-ancestor
92666716|NCT00281567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577618|NCT00269620|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92577619|NCT00269620|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92577620|NCT00074204|Carboplatin|carboplatin|mesh-list
92577621|NCT00074204|Gemcitabine|gemcitabine|mesh-list
92577623|NCT00074204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666717|NCT00281567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666718|NCT00281567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92666719|NCT00281567|Respiratory System Agents|respiratory system agents|mesh-ancestor
92666720|NCT00281567|Parasympatholytics|parasympatholytics|mesh-ancestor
92666721|NCT00281567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92666722|NCT00281567|Cholinergic Agents|cholinergic agents|mesh-ancestor
92666723|NCT00281567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666724|NCT00281567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666726|NCT00317499|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92666727|NCT00317499|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666728|NCT00317499|Analgesics|analgesics|mesh-ancestor
92666729|NCT00317499|Sensory System Agents|sensory system agents|mesh-ancestor
92666730|NCT00317499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666731|NCT00317499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666732|NCT00317499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666733|NCT00317499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666734|NCT00317499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666735|NCT00317499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666736|NCT00317499|Immunologic Factors|immunologic factors|mesh-ancestor
92666737|NCT00281606|Ritonavir|ritonavir|mesh-list
92666738|NCT00281606|Lopinavir|lopinavir|mesh-list
92666739|NCT00281606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92666740|NCT00281606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92666741|NCT00281606|Protease Inhibitors|protease inhibitors|mesh-ancestor
92666742|NCT00281606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666743|NCT00281606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666744|NCT00281606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92666745|NCT00281606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92666746|NCT00281606|Antiviral Agents|antiviral agents|mesh-ancestor
92666747|NCT00281606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666748|NCT00281606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92074071|NCT03026907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666750|NCT00317538|Infliximab|infliximab|mesh-list
92666751|NCT00317538|Etanercept|etanercept|mesh-list
92666752|NCT00317538|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92666753|NCT00317538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666754|NCT00317538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92666755|NCT00317538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666756|NCT00317538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666757|NCT00317538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92666758|NCT00317538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666759|NCT00317538|Analgesics|analgesics|mesh-ancestor
92666760|NCT00317538|Sensory System Agents|sensory system agents|mesh-ancestor
92666761|NCT00317538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666762|NCT00317538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666763|NCT00317538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666764|NCT00317538|Immunologic Factors|immunologic factors|mesh-ancestor
92666765|NCT00281645|Analgesics|analgesics|mesh-list
92666766|NCT00281645|Sensory System Agents|sensory system agents|mesh-ancestor
92666767|NCT00281645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666768|NCT00281645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666769|NCT00317577|Timolol|timolol|mesh-list
92666770|NCT00317577|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92666771|NCT00317577|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92666772|NCT00317577|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92666773|NCT00317577|Adrenergic Agents|adrenergic agents|mesh-ancestor
92666774|NCT00317577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666775|NCT00317577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666776|NCT00317577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666777|NCT00317577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92666778|NCT00317577|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92666779|NCT00317577|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92666780|NCT00317577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92666781|NCT00317577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92666782|NCT00317655|Ibuprofen|ibuprofen|mesh-list
92577624|NCT00074204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577625|NCT00074204|Antimetabolites|antimetabolites|mesh-ancestor
92577626|NCT00074204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666783|NCT00317655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92666784|NCT00317655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666785|NCT00317655|Analgesics|analgesics|mesh-ancestor
92666786|NCT00317655|Sensory System Agents|sensory system agents|mesh-ancestor
92666787|NCT00317655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666788|NCT00317655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666789|NCT00317655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666790|NCT00317655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666791|NCT00317655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92666792|NCT00317655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666793|NCT00317655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666794|NCT00281996|Gemcitabine|gemcitabine|mesh-list
92666795|NCT00281996|Imatinib Mesylate|imatinib mesylate|mesh-list
92666796|NCT00281996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666797|NCT00281996|Antimetabolites|antimetabolites|mesh-ancestor
92666798|NCT00281996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666799|NCT00281996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666800|NCT00281996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666801|NCT00281996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666802|NCT00311259|Melatonin|melatonin|mesh-list
92666803|NCT00311259|Antioxidants|antioxidants|mesh-ancestor
92666804|NCT00311259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666805|NCT00311259|Protective Agents|protective agents|mesh-ancestor
92666806|NCT00311259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666807|NCT00311259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666808|NCT00317733|Ketoprofen|ketoprofen|mesh-list
92666809|NCT00317733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92666810|NCT00317733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666811|NCT00317733|Analgesics|analgesics|mesh-ancestor
92666812|NCT00317733|Sensory System Agents|sensory system agents|mesh-ancestor
92666813|NCT00317733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666814|NCT00317733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666815|NCT00317733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666816|NCT00317733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666817|NCT00317733|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92666818|NCT00317733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666819|NCT00317733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666820|NCT00311337|Bortezomib|bortezomib|mesh-list
92074144|NCT01475721|Fluticasone|fluticasone|mesh-list
92666824|NCT00317811|Melphalan|melphalan|mesh-list
92666825|NCT00317811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666826|NCT00317811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92666827|NCT00317811|Alkylating Agents|alkylating agents|mesh-ancestor
92666828|NCT00317811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666829|NCT00317811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92666830|NCT00317811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92666831|NCT00317811|Immunologic Factors|immunologic factors|mesh-ancestor
92666832|NCT00317811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666833|NCT00317811|Antioxidants|antioxidants|mesh-ancestor
92666834|NCT00317811|Protective Agents|protective agents|mesh-ancestor
92666835|NCT00317811|Vitamins|vitamins|mesh-ancestor
92666836|NCT00317811|Micronutrients|micronutrients|mesh-ancestor
92666837|NCT00282386|Rofecoxib|rofecoxib|mesh-list
92666838|NCT00282386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666839|NCT00282386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365087|NCT02989272|Magnesium Sulfate|magnesium sulfate|mesh-list
92666840|NCT00282386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666841|NCT00282386|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92666842|NCT00282386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92666843|NCT00282386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666844|NCT00282386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92666845|NCT00282386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666846|NCT00282386|Analgesics|analgesics|mesh-ancestor
92666847|NCT00282386|Sensory System Agents|sensory system agents|mesh-ancestor
92666848|NCT00282386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666849|NCT00282386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666850|NCT00317850|Gabapentin|gabapentin|mesh-list
92666851|NCT00317850|Analgesics|analgesics|mesh-ancestor
92666852|NCT00317850|Sensory System Agents|sensory system agents|mesh-ancestor
92577627|NCT00074204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92577628|NCT00074204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92577629|NCT00074204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577630|NCT00416143|Prednisone|prednisone|mesh-list
92577631|NCT00416143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666853|NCT00317850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666854|NCT00317850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666855|NCT00317850|Anticonvulsants|anticonvulsants|mesh-ancestor
92666856|NCT00317850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92666857|NCT00317850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92666858|NCT00317850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666859|NCT00317850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92666860|NCT00317850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92666861|NCT00317850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92666862|NCT00317850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666863|NCT00317850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666864|NCT00317850|Antimanic Agents|antimanic agents|mesh-ancestor
92666865|NCT00282503|Methylprednisolone|methylprednisolone|mesh-list
92666866|NCT00282503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92666867|NCT00282503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92666868|NCT00282503|Prednisolone|prednisolone|mesh-list
92666869|NCT00282503|Prednisolone acetate|prednisolone acetate|mesh-list
92666870|NCT00282503|Methoxsalen|methoxsalen|mesh-list
92666871|NCT00282503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92666872|NCT00282503|Prednisolone phosphate|prednisolone phosphate|mesh-list
92666873|NCT00282503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666874|NCT00282503|Antiemetics|antiemetics|mesh-ancestor
92666875|NCT00282503|Autonomic Agents|autonomic agents|mesh-ancestor
92666876|NCT00282503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666877|NCT00282503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666878|NCT00282503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666879|NCT00282503|Glucocorticoids|glucocorticoids|mesh-ancestor
92666880|NCT00282503|Hormones|hormones|mesh-ancestor
92666881|NCT00282503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666882|NCT00282503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92666883|NCT00282503|Protective Agents|protective agents|mesh-ancestor
92666884|NCT00282503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92666885|NCT00282503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666886|NCT00282503|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92666887|NCT00282503|Dermatologic Agents|dermatologic agents|mesh-ancestor
92666888|NCT00317928|Metformin|metformin|mesh-list
92666889|NCT00317928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92666890|NCT00317928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666891|NCT00282698|Insulin|insulin|mesh-list
92666892|NCT00282698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92666893|NCT00282698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666894|NCT00317967|Atorvastatin|atorvastatin|mesh-list
92666897|NCT00317967|Antimetabolites|antimetabolites|mesh-ancestor
92666898|NCT00317967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666899|NCT00317967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92666900|NCT00317967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92666901|NCT00317967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666902|NCT00318084|Esomeprazole|esomeprazole|mesh-list
92666903|NCT00318084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92666904|NCT00318084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666905|NCT00318084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92666906|NCT00318084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666907|NCT00318084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666908|NCT00282932|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92666909|NCT00282932|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92666910|NCT00282932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92666911|NCT00282932|Cholinergic Agents|cholinergic agents|mesh-ancestor
92666912|NCT00282932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666913|NCT00282932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666914|NCT00282932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666915|NCT00282932|Urological Agents|urological agents|mesh-ancestor
92666916|NCT00318162|Naltrexone|naltrexone|mesh-list
92666917|NCT00318162|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92666918|NCT00318162|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92666919|NCT00318162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666920|NCT00318162|Sensory System Agents|sensory system agents|mesh-ancestor
92577632|NCT00416143|Glucocorticoids|glucocorticoids|mesh-ancestor
92577633|NCT00416143|Hormones|hormones|mesh-ancestor
92024203|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
92666921|NCT00318162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666922|NCT00283088|Plasminogen|plasminogen|mesh-list
92666923|NCT00283088|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92666924|NCT00283088|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92666925|NCT00283088|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92666926|NCT00283088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666927|NCT00318201|Erythromycin|erythromycin|mesh-list
92666928|NCT00318201|Erythromycin Estolate|erythromycin estolate|mesh-list
92666929|NCT00318201|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92666930|NCT00318201|Erythromycin stearate|erythromycin stearate|mesh-list
92666931|NCT00318201|Diltiazem|diltiazem|mesh-list
92666932|NCT00318201|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92666933|NCT00318201|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92666934|NCT00318201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92666935|NCT00318201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666936|NCT00318201|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92666937|NCT00318201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666938|NCT00318201|Vasodilator Agents|vasodilator agents|mesh-ancestor
92666939|NCT00318201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92666940|NCT00318201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666941|NCT00318201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92666942|NCT00318201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92666943|NCT00318201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666944|NCT00311688|Interleukin-2|interleukin-2|mesh-list
92666945|NCT00311688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666946|NCT00311688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92666947|NCT00311688|Analgesics|analgesics|mesh-ancestor
92666948|NCT00311688|Sensory System Agents|sensory system agents|mesh-ancestor
92666949|NCT00311688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666950|NCT00311688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666951|NCT00283478|Gemcitabine|gemcitabine|mesh-list
92666952|NCT00283478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92666953|NCT00283478|Antimetabolites|antimetabolites|mesh-ancestor
92666954|NCT00283478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666955|NCT00283478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666956|NCT00318318|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92666957|NCT00318318|Estrogens|estrogens|mesh-ancestor
92666958|NCT00318318|Hormones|hormones|mesh-ancestor
92666959|NCT00318318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92666960|NCT00318318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666961|NCT00283517|Antipsychotic Agents|antipsychotic agents|mesh-list
92666962|NCT00283517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92666963|NCT00283517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92666964|NCT00283517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666965|NCT00283517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92666970|NCT00311883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666972|NCT00311883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666973|NCT00311883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666974|NCT00283556|Irinotecan|irinotecan|mesh-list
92666975|NCT00283556|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92666976|NCT00283556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666977|NCT00283556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666978|NCT00283556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666979|NCT00283556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666980|NCT00283634|Bortezomib|bortezomib|mesh-list
92666981|NCT00283634|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92666982|NCT00283634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666983|NCT00283634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92666984|NCT00283634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666985|NCT00283634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666986|NCT00318513|Bevacizumab|bevacizumab|mesh-list
92666987|NCT00318513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92666988|NCT00318513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666989|NCT00318513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92666990|NCT00318513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92666991|NCT00318513|Growth Substances|growth substances|mesh-ancestor
92666992|NCT00318513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666993|NCT00318513|Growth Inhibitors|growth inhibitors|mesh-ancestor
92577634|NCT00416143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577635|NCT00416143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577636|NCT00416143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92666995|NCT00318552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92666996|NCT00318552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92666997|NCT00283751|Insulin|insulin|mesh-list
92666998|NCT00283751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92666999|NCT00283751|Insulin Glargine|insulin glargine|mesh-list
92667000|NCT00283751|Insulin Detemir|insulin detemir|mesh-list
92667001|NCT00283751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667002|NCT00283751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667003|NCT00318630|Rosiglitazone|rosiglitazone|mesh-list
92667004|NCT00318630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667005|NCT00318630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667006|NCT00283790|Zolpidem|zolpidem|mesh-list
92667007|NCT00283790|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92667008|NCT00283790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92667009|NCT00283790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667010|NCT00283790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667011|NCT00283790|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92667012|NCT00283790|GABA Agonists|gaba agonists|mesh-ancestor
92667013|NCT00283790|GABA Agents|gaba agents|mesh-ancestor
92667014|NCT00283790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667015|NCT00283790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667016|NCT00318669|Paroxetine|paroxetine|mesh-list
92667017|NCT00318669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92667018|NCT00318669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92667019|NCT00318669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92667020|NCT00318669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392442|NCT02249364|Propofol|propofol|mesh-list
92667021|NCT00318669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667022|NCT00318669|Serotonin Agents|serotonin agents|mesh-ancestor
92667023|NCT00318669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667024|NCT00318669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92667025|NCT00318669|Antidepressive Agents|antidepressive agents|mesh-ancestor
92667026|NCT00318669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667027|NCT00318669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92667028|NCT00318669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92667029|NCT00318669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667030|NCT00283829|Docetaxel|docetaxel|mesh-list
92667031|NCT00283829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667032|NCT00283829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667033|NCT00283829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667034|NCT00283829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074357|NCT00078754|Antimanic Agents|antimanic agents|mesh-ancestor
92667037|NCT00311961|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92667038|NCT00311961|Methylprednisolone|methylprednisolone|mesh-list
92667039|NCT00311961|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92667040|NCT00311961|Prednisolone acetate|prednisolone acetate|mesh-list
92667041|NCT00311961|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92667042|NCT00311961|Prednisolone phosphate|prednisolone phosphate|mesh-list
92667043|NCT00311961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667044|NCT00311961|Glucocorticoids|glucocorticoids|mesh-ancestor
92667045|NCT00311961|Hormones|hormones|mesh-ancestor
92667046|NCT00311961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667047|NCT00311961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667048|NCT00311961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92667049|NCT00311961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667050|NCT00311961|Antiemetics|antiemetics|mesh-ancestor
92667051|NCT00311961|Autonomic Agents|autonomic agents|mesh-ancestor
92667052|NCT00311961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667053|NCT00311961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667054|NCT00311961|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92667055|NCT00311961|Protective Agents|protective agents|mesh-ancestor
92667056|NCT00283946|Zolpidem|zolpidem|mesh-list
92667057|NCT00283946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92667058|NCT00283946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92667059|NCT00283946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667060|NCT00283946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667061|NCT00283946|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92577637|NCT00416143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577638|NCT00416221|Antidepressive Agents|antidepressive agents|mesh-list
92577639|NCT00416221|Escitalopram|escitalopram|mesh-list
92024361|NCT05515315|Paclitaxel|paclitaxel|mesh-list
92667062|NCT00283946|GABA Agonists|gaba agonists|mesh-ancestor
92667063|NCT00283946|GABA Agents|gaba agents|mesh-ancestor
92667064|NCT00283946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667065|NCT00283946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667066|NCT00312000|Capecitabine|capecitabine|mesh-list
92667067|NCT00312000|Irinotecan|irinotecan|mesh-list
92667068|NCT00312000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92667069|NCT00312000|Antimetabolites|antimetabolites|mesh-ancestor
92667070|NCT00312000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667071|NCT00312000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667072|NCT00312000|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92667073|NCT00312000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667074|NCT00312000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667075|NCT00283985|Dexamethasone|dexamethasone|mesh-list
92667076|NCT00283985|Methotrexate|methotrexate|mesh-list
92667077|NCT00283985|Asparaginase|asparaginase|mesh-list
92667078|NCT00283985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667079|NCT00283985|Antiemetics|antiemetics|mesh-ancestor
92667080|NCT00283985|Autonomic Agents|autonomic agents|mesh-ancestor
92667081|NCT00283985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667082|NCT00283985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667083|NCT00283985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667084|NCT00283985|Glucocorticoids|glucocorticoids|mesh-ancestor
92667085|NCT00283985|Hormones|hormones|mesh-ancestor
92667086|NCT00283985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667087|NCT00283985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92667088|NCT00283985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667089|NCT00283985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92667090|NCT00283985|Abortifacient Agents|abortifacient agents|mesh-ancestor
92667091|NCT00283985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667092|NCT00283985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92667093|NCT00283985|Antimetabolites|antimetabolites|mesh-ancestor
92667094|NCT00283985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667095|NCT00283985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92667096|NCT00283985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667097|NCT00283985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92667098|NCT00283985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667099|NCT00283985|Immunologic Factors|immunologic factors|mesh-ancestor
92667100|NCT00283985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667101|NCT00283985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92667103|NCT00419250|Immunologic Factors|immunologic factors|mesh-ancestor
92667104|NCT00419250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667105|NCT00419250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92667106|NCT00419250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92667107|NCT00419250|Growth Substances|growth substances|mesh-ancestor
92667112|NCT00284024|Autonomic Agents|autonomic agents|mesh-ancestor
92667113|NCT00284024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667114|NCT00284024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667115|NCT00284024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667116|NCT00284024|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92667117|NCT00284024|Dopamine Agents|dopamine agents|mesh-ancestor
92667118|NCT00284024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667119|NCT00284024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667120|NCT00312039|Lamivudine|lamivudine|mesh-list
92667121|NCT00312039|Dexelvucitabine|dexelvucitabine|mesh-list
92667122|NCT00312039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92667123|NCT00312039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92667124|NCT00312039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667125|NCT00312039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667126|NCT00312039|Antiviral Agents|antiviral agents|mesh-ancestor
92667127|NCT00312039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667128|NCT00312039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92667129|NCT00312039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92667130|NCT00284258|Irinotecan|irinotecan|mesh-list
92667131|NCT00284258|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92667132|NCT00284258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667133|NCT00284258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667134|NCT00284258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667135|NCT00284258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667136|NCT00318786|Insulin Aspart|insulin aspart|mesh-list
92667137|NCT00318786|Biphasic Insulins|biphasic insulins|mesh-list
92667138|NCT00318786|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667139|NCT00318786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667140|NCT00284336|Cyclophosphamide|cyclophosphamide|mesh-list
92667141|NCT00284336|Doxorubicin|doxorubicin|mesh-list
92667142|NCT00284336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92667143|NCT00284336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667144|NCT00284336|Immunologic Factors|immunologic factors|mesh-ancestor
92667145|NCT00284336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667146|NCT00284336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667147|NCT00284336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92667148|NCT00284336|Alkylating Agents|alkylating agents|mesh-ancestor
92667149|NCT00284336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667150|NCT00284336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667151|NCT00284336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92667152|NCT00284336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92667153|NCT00284336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92667154|NCT00284336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667155|NCT00284336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667156|NCT00312156|Insulin|insulin|mesh-list
92667157|NCT00312156|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92667158|NCT00312156|Insulin Aspart|insulin aspart|mesh-list
92667159|NCT00312156|Insulin Detemir|insulin detemir|mesh-list
92667160|NCT00312156|Isophane Insulin, Human|isophane insulin, human|mesh-list
92667161|NCT00312156|Insulin, Isophane|insulin, isophane|mesh-list
92667162|NCT00312156|Isophane insulin, beef|isophane insulin, beef|mesh-list
92667163|NCT00312156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667164|NCT00312156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667165|NCT00318825|Nitrous Oxide|nitrous oxide|mesh-list
92667166|NCT00318825|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92667167|NCT00318825|Anesthetics, General|anesthetics, general|mesh-ancestor
92667168|NCT00318825|Anesthetics|anesthetics|mesh-ancestor
92667169|NCT00318825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667170|NCT00318825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392592|NCT00557466|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92667171|NCT00318825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92667172|NCT00318825|Analgesics|analgesics|mesh-ancestor
92667173|NCT00318825|Sensory System Agents|sensory system agents|mesh-ancestor
92667174|NCT00318825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667176|NCT00284531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667177|NCT00284531|Immunologic Factors|immunologic factors|mesh-ancestor
92667178|NCT00284531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667179|NCT00312273|Aminophylline|aminophylline|mesh-list
92667180|NCT00312273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92667189|NCT00312273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667190|NCT00312273|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92667191|NCT00312273|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92667193|NCT00312273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667194|NCT00312273|Protective Agents|protective agents|mesh-ancestor
92667195|NCT00312312|Immunomodulating Agents|immunomodulating agents|mesh-list
92667196|NCT00312312|Immunologic Factors|immunologic factors|mesh-ancestor
92667197|NCT00312312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667198|NCT00284687|Artesunate|artesunate|mesh-list
92667199|NCT00284687|Antimalarials|antimalarials|mesh-ancestor
92667200|NCT00284687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92667201|NCT00284687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92667202|NCT00284687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667203|NCT00284687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667204|NCT00284687|Antiviral Agents|antiviral agents|mesh-ancestor
92667205|NCT00284687|Schistosomicides|schistosomicides|mesh-ancestor
92667206|NCT00284687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92667207|NCT00284687|Anthelmintics|anthelmintics|mesh-ancestor
92667208|NCT00284765|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92667209|NCT00284765|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92667210|NCT00284765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92667211|NCT00284765|Analgesics|analgesics|mesh-ancestor
92667212|NCT00284765|Sensory System Agents|sensory system agents|mesh-ancestor
92667213|NCT00284765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667214|NCT00284765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667215|NCT00284765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667216|NCT00284765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667217|NCT00318981|Methylphenidate|methylphenidate|mesh-list
92667218|NCT00318981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92577640|NCT00416221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92577641|NCT00416221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92577642|NCT00416221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92667219|NCT00318981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667220|NCT00318981|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92667221|NCT00318981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92667222|NCT00318981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92667223|NCT00318981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667224|NCT00318981|Dopamine Agents|dopamine agents|mesh-ancestor
92667225|NCT00318981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667226|NCT00284921|Mycophenolic Acid|mycophenolic acid|mesh-list
92667227|NCT00284921|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92667228|NCT00284921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667229|NCT00284921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92667230|NCT00284921|Antitubercular Agents|antitubercular agents|mesh-ancestor
92667231|NCT00284921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92667232|NCT00284921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667233|NCT00284921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667234|NCT00284921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667235|NCT00319059|Annexin A5|annexin a5|mesh-list
92667236|NCT00319059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667237|NCT00319059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667238|NCT00312507|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92667239|NCT00312507|Respiratory System Agents|respiratory system agents|mesh-ancestor
92667240|NCT00312546|Enfuvirtide|enfuvirtide|mesh-list
92667241|NCT00312546|Valproic Acid|valproic acid|mesh-list
92667242|NCT00312546|Anticonvulsants|anticonvulsants|mesh-ancestor
92667243|NCT00312546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667244|NCT00312546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667245|NCT00312546|GABA Agents|gaba agents|mesh-ancestor
92667260|NCT00425009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667262|NCT04718402|Analgesics|analgesics|mesh-ancestor
92667263|NCT04718402|Sensory System Agents|sensory system agents|mesh-ancestor
92667264|NCT04718402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667265|NCT04718402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667266|NCT04718402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667267|NCT04718402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92667268|NCT04718402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667269|NCT04718402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667270|NCT04718402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667271|NCT00319215|Zopiclone|zopiclone|mesh-list
92667272|NCT00319215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92667273|NCT00319215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667274|NCT00319215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667275|NCT00285155|Bupropion|bupropion|mesh-list
92667276|NCT00285155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92667277|NCT00285155|Antidepressive Agents|antidepressive agents|mesh-ancestor
92667278|NCT00285155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667279|NCT00285155|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92667280|NCT00285155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92667281|NCT00285155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92667282|NCT00285155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667283|NCT00285155|Dopamine Agents|dopamine agents|mesh-ancestor
92667284|NCT00285155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667285|NCT00285155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667286|NCT00285155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92667287|NCT00285155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92667288|NCT00285155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667289|NCT00319293|Metformin|metformin|mesh-list
92667290|NCT00319293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667291|NCT00319293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667292|NCT00319332|Tositumomab I-131|tositumomab i-131|mesh-list
92667293|NCT00319332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667294|NCT00285350|Mycophenolic Acid|mycophenolic acid|mesh-list
92667295|NCT00285350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92667296|NCT00285350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667297|NCT00285350|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92667298|NCT00285350|Antitubercular Agents|antitubercular agents|mesh-ancestor
92667299|NCT00285350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92577643|NCT00416221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92577644|NCT00416221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577645|NCT00416221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577646|NCT00416221|Serotonin Agents|serotonin agents|mesh-ancestor
92667300|NCT00285350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667301|NCT00285350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667302|NCT00285350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667303|NCT00285389|Dexamethasone|dexamethasone|mesh-list
92667304|NCT00285389|Cyclophosphamide|cyclophosphamide|mesh-list
92667305|NCT00285389|Melphalan|melphalan|mesh-list
92667309|NCT00285389|Doxorubicin|doxorubicin|mesh-list
92667310|NCT00285389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667311|NCT00285389|Immunologic Factors|immunologic factors|mesh-ancestor
92667312|NCT00285389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667313|NCT00285389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667314|NCT00285389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92667315|NCT00285389|Alkylating Agents|alkylating agents|mesh-ancestor
92667316|NCT00285389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667317|NCT00285389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667318|NCT00285389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92667319|NCT00285389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92667320|NCT00285389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667322|NCT00285389|Autonomic Agents|autonomic agents|mesh-ancestor
92667323|NCT00285389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667324|NCT00285389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667325|NCT00285389|Glucocorticoids|glucocorticoids|mesh-ancestor
92667326|NCT00285389|Hormones|hormones|mesh-ancestor
92667327|NCT00285389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667328|NCT00285389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92667329|NCT00285389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92667330|NCT00285389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667331|NCT00285389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667332|NCT00285389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667333|NCT00285389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92667334|NCT00285389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92667335|NCT00285389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667336|NCT00285389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667337|NCT00285428|Veltuzumab|veltuzumab|mesh-list
92667338|NCT00285428|Antibodies|antibodies|mesh-list
92667339|NCT00285428|Immunologic Factors|immunologic factors|mesh-ancestor
92667340|NCT00285428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667341|NCT00285428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667342|NCT00312819|Disulfiram|disulfiram|mesh-list
92667343|NCT00312819|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92667344|NCT00312819|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92667345|NCT00312819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667346|NCT00312819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667347|NCT00319488|Budesonide|budesonide|mesh-list
92667348|NCT00319488|Albuterol|albuterol|mesh-list
92667349|NCT00319488|Montelukast|montelukast|mesh-list
92667350|NCT00319488|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92667351|NCT00319488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667352|NCT00319488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92667353|NCT00319488|Autonomic Agents|autonomic agents|mesh-ancestor
92667354|NCT00319488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667355|NCT00319488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667356|NCT00319488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92667357|NCT00319488|Respiratory System Agents|respiratory system agents|mesh-ancestor
92667358|NCT00319488|Glucocorticoids|glucocorticoids|mesh-ancestor
92667359|NCT00319488|Hormones|hormones|mesh-ancestor
92667360|NCT00319488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667361|NCT00319488|Hormone Antagonists|hormone antagonists|mesh-ancestor
92667362|NCT00319488|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92667363|NCT00319488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92667364|NCT00319488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667365|NCT00319488|Tocolytic Agents|tocolytic agents|mesh-ancestor
92667366|NCT00319488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667367|NCT00319488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92667368|NCT00319488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92577647|NCT00416221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667369|NCT00319488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92667370|NCT00319488|Adrenergic Agents|adrenergic agents|mesh-ancestor
92667371|NCT00319488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667372|NCT00285623|Thrombin|thrombin|mesh-list
92667373|NCT00285623|Hemostatics|hemostatics|mesh-ancestor
92667374|NCT00285623|Coagulants|coagulants|mesh-ancestor
92667375|NCT00285662|Artesunate|artesunate|mesh-list
92667376|NCT00285662|Pyrimethamine|pyrimethamine|mesh-list
92667377|NCT00285662|Sulfadoxine|sulfadoxine|mesh-list
92667378|NCT00285662|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92667379|NCT00285662|Amodiaquine|amodiaquine|mesh-list
92667380|NCT00285662|Antimalarials|antimalarials|mesh-ancestor
92667390|NCT00285662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667391|NCT00285662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667392|NCT00285662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92667393|NCT00319566|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92667394|NCT00319566|Medroxyprogesterone|medroxyprogesterone|mesh-list
92667395|NCT00319566|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92667396|NCT00319566|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92667398|NCT00319566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92667399|NCT00319566|Contraceptive Agents|contraceptive agents|mesh-ancestor
92667400|NCT00319566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667401|NCT00319566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667402|NCT00319566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92667403|NCT00319566|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92667404|NCT00319566|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92667405|NCT00319566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92667406|NCT00319566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667407|NCT00319566|Estrogens|estrogens|mesh-ancestor
92667408|NCT00319566|Hormones|hormones|mesh-ancestor
92667409|NCT00319566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667410|NCT00319605|Levetiracetam|levetiracetam|mesh-list
92667411|NCT00319605|Anticonvulsants|anticonvulsants|mesh-ancestor
92667412|NCT00319605|Nootropic Agents|nootropic agents|mesh-ancestor
92667413|NCT00313053|Vincristine|vincristine|mesh-list
92667414|NCT00313053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92667415|NCT00313053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667416|NCT00313053|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667417|NCT00313053|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667418|NCT00313053|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667419|NCT00313053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667420|NCT00285896|Glucagon|glucagon|mesh-list
92667421|NCT00285896|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92667422|NCT00285896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667423|NCT00285896|Hormones|hormones|mesh-ancestor
92667424|NCT00285896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667425|NCT00285896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667426|NCT00285896|Incretins|incretins|mesh-ancestor
92667427|NCT00319683|Eniluracil|eniluracil|mesh-list
92667428|NCT00319683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667429|NCT00319683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667430|NCT00286052|Naloxone|naloxone|mesh-list
92667431|NCT00286052|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92667432|NCT00286052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667433|NCT00286052|Sensory System Agents|sensory system agents|mesh-ancestor
92667434|NCT00286052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667435|NCT00319761|Calcitriol|calcitriol|mesh-list
92667436|NCT00319761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92667437|NCT00319761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667438|NCT00319761|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92667439|NCT00319761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92667440|NCT00319761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667441|NCT00319761|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92667442|NCT00319761|Vitamins|vitamins|mesh-ancestor
92667443|NCT00319761|Micronutrients|micronutrients|mesh-ancestor
92667444|NCT00319761|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92667445|NCT00286130|Leucovorin|leucovorin|mesh-list
92667446|NCT00286130|Oxaliplatin|oxaliplatin|mesh-list
92667447|NCT00286130|Irinotecan|irinotecan|mesh-list
92667458|NCT00286130|Vitamins|vitamins|mesh-ancestor
92667459|NCT00286130|Micronutrients|micronutrients|mesh-ancestor
92667460|NCT00286130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92667461|NCT00286208|Misoprostol|misoprostol|mesh-list
92667462|NCT00286208|Mifepristone|mifepristone|mesh-list
92577649|NCT00269737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92577650|NCT00269737|Narcotics|narcotics|mesh-ancestor
92577651|NCT00269737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577652|NCT00269737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667463|NCT00286208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92667464|NCT00286208|Abortifacient Agents|abortifacient agents|mesh-ancestor
92667465|NCT00286208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667466|NCT00286208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667467|NCT00286208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92667468|NCT00286208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667469|NCT00286208|Oxytocics|oxytocics|mesh-ancestor
92667470|NCT00286208|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92667471|NCT00286208|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92667472|NCT00286208|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92667473|NCT00286208|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92667474|NCT00286208|Contraceptive Agents|contraceptive agents|mesh-ancestor
92667475|NCT00286208|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92667476|NCT00286208|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92667477|NCT00286208|Hormone Antagonists|hormone antagonists|mesh-ancestor
92667478|NCT00286208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667479|NCT00286208|Luteolytic Agents|luteolytic agents|mesh-ancestor
92667480|NCT00286208|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92667481|NCT00286208|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92667482|NCT00319800|Irinotecan|irinotecan|mesh-list
92667483|NCT00319800|Gefitinib|gefitinib|mesh-list
92667484|NCT00319800|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92667485|NCT00319800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667486|NCT00319800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667487|NCT00319800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667488|NCT00319800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667489|NCT00319800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92667490|NCT00313131|Metronidazole|metronidazole|mesh-list
92667491|NCT00313131|Fluconazole|fluconazole|mesh-list
92667492|NCT00313131|Clotrimazole|clotrimazole|mesh-list
92667493|NCT00313131|Miconazole|miconazole|mesh-list
92667494|NCT00313131|Tinidazole|tinidazole|mesh-list
92667495|NCT00313131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667496|NCT00313131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92667497|NCT00313131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92667498|NCT00313131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92667499|NCT00313131|Antifungal Agents|antifungal agents|mesh-ancestor
92667500|NCT00313131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92667501|NCT00313131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92667502|NCT00313131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667503|NCT00313131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667504|NCT00313131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92667505|NCT00313131|Hormone Antagonists|hormone antagonists|mesh-ancestor
92667506|NCT00313131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667507|NCT00313131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667508|NCT00313131|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92667509|NCT00313131|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92667510|NCT00313131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92667511|NCT00313131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92667518|NCT00319878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667519|NCT00319878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667520|NCT00319878|Immunologic Factors|immunologic factors|mesh-ancestor
92667521|NCT00319878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667522|NCT00319878|Antifungal Agents|antifungal agents|mesh-ancestor
92667523|NCT00319878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667524|NCT00319878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92667525|NCT00319878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667526|NCT00319878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92667527|NCT00319878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92667528|NCT00319878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92667529|NCT00319878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667530|NCT00286364|Androgens|androgens|mesh-list
92667531|NCT00286364|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92667532|NCT00286364|Hormones|hormones|mesh-ancestor
92577653|NCT00269737|Analgesics|analgesics|mesh-ancestor
92577654|NCT00269737|Sensory System Agents|sensory system agents|mesh-ancestor
92577655|NCT00269737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577656|NCT00269737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577657|NCT00269737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92577658|NCT00269737|Anesthetics, General|anesthetics, general|mesh-ancestor
92667533|NCT00286364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667534|NCT00286364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667535|NCT00286364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92667536|NCT00286364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667537|NCT00286364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667538|NCT00286364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92667539|NCT00286364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92667540|NCT00319917|Tacrolimus|tacrolimus|mesh-list
92667541|NCT00319917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667542|NCT00319917|Immunologic Factors|immunologic factors|mesh-ancestor
92667543|NCT00319917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667544|NCT00319917|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92667546|NCT00319917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667547|NCT00286403|Fenoldopam|fenoldopam|mesh-list
92667548|NCT00286403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667549|NCT00286403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92667550|NCT00286403|Vasodilator Agents|vasodilator agents|mesh-ancestor
92667551|NCT00286403|Dopamine Agonists|dopamine agonists|mesh-ancestor
92667552|NCT00286403|Dopamine Agents|dopamine agents|mesh-ancestor
92667553|NCT00286403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667554|NCT00286403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667555|NCT00313287|Clevudine|clevudine|mesh-list
92667556|NCT00313287|Antiviral Agents|antiviral agents|mesh-ancestor
92667557|NCT00313287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667558|NCT00286481|Simvastatin|simvastatin|mesh-list
92667559|NCT00286481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92667560|NCT00286481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92667561|NCT00286481|Antimetabolites|antimetabolites|mesh-ancestor
92667562|NCT00286481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667563|NCT00286481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92667564|NCT00286481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92667565|NCT00286481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667566|NCT00320034|Albuterol|albuterol|mesh-list
92667567|NCT00320034|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92667568|NCT00320034|Autonomic Agents|autonomic agents|mesh-ancestor
92667569|NCT00320034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667570|NCT00320034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667571|NCT00320034|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92667572|NCT00320034|Respiratory System Agents|respiratory system agents|mesh-ancestor
92667573|NCT00320034|Tocolytic Agents|tocolytic agents|mesh-ancestor
92667574|NCT00320034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667575|NCT00320034|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92667576|NCT00320034|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92667577|NCT00320034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92667578|NCT00320034|Adrenergic Agents|adrenergic agents|mesh-ancestor
92667579|NCT00320034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667580|NCT00320034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667581|NCT00320073|Pemetrexed|pemetrexed|mesh-list
92667582|NCT00320073|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92667586|NCT00320073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92667587|NCT00320073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92667588|NCT00320073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92667589|NCT00286871|Tacrolimus|tacrolimus|mesh-list
92667590|NCT00286871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667591|NCT00286871|Immunologic Factors|immunologic factors|mesh-ancestor
92667592|NCT00286871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667593|NCT00286871|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92667594|NCT00286871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667595|NCT00286871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667596|NCT00417326|Sivelestat|sivelestat|mesh-list
92667597|NCT00417326|Glycine|glycine|mesh-list
92667598|NCT00417326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92577659|NCT00269737|Anesthetics|anesthetics|mesh-ancestor
92577660|NCT00269776|Methylphenidate|methylphenidate|mesh-list
91984946|NCT03163277|Maraviroc|maraviroc|mesh-list
92667599|NCT00417326|Protease Inhibitors|protease inhibitors|mesh-ancestor
92667600|NCT00417326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667601|NCT00417326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667602|NCT00417326|Glycine Agents|glycine agents|mesh-ancestor
92667603|NCT00417326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667604|NCT00417326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667605|NCT00320229|Abciximab|abciximab|mesh-list
92667606|NCT00320229|Anticoagulants|anticoagulants|mesh-ancestor
92667607|NCT00320229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92667608|NCT00320268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92667609|NCT00320268|Antidepressive Agents|antidepressive agents|mesh-ancestor
92667610|NCT00320268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667611|NCT00320268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92667612|NCT00320268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92667613|NCT00320268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667614|NCT00320268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667615|NCT00417404|Vitamins|vitamins|mesh-list
92667616|NCT00417404|Vitamin A|vitamin a|mesh-list
92667617|NCT00417404|Retinol palmitate|retinol palmitate|mesh-list
92667618|NCT00417404|Micronutrients|micronutrients|mesh-ancestor
92393036|NCT05767255|Incretins|incretins|mesh-ancestor
92667619|NCT00417404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667620|NCT00417404|Antioxidants|antioxidants|mesh-ancestor
92667621|NCT00417404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667622|NCT00417404|Protective Agents|protective agents|mesh-ancestor
92667623|NCT00417404|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92667624|NCT00417404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667625|NCT00417443|Clonidine|clonidine|mesh-list
92667626|NCT00417443|Analgesics|analgesics|mesh-ancestor
92667627|NCT00417443|Sensory System Agents|sensory system agents|mesh-ancestor
92667628|NCT00417443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667629|NCT00417443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667630|NCT00417443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92667631|NCT00417443|Sympatholytics|sympatholytics|mesh-ancestor
92667632|NCT00417443|Autonomic Agents|autonomic agents|mesh-ancestor
92667633|NCT00417443|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92667634|NCT00417443|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92667635|NCT00417443|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92667636|NCT00417443|Adrenergic Agents|adrenergic agents|mesh-ancestor
92667637|NCT00417443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667638|NCT00417443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667639|NCT00313482|Prednisone|prednisone|mesh-list
92667640|NCT00313482|Docetaxel|docetaxel|mesh-list
92667641|NCT00313482|Sargramostim|sargramostim|mesh-list
92667642|NCT00313482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667643|NCT00313482|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667644|NCT00313482|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667645|NCT00313482|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667646|NCT00313482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667647|NCT00313482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667648|NCT00313482|Glucocorticoids|glucocorticoids|mesh-ancestor
92667649|NCT00313482|Hormones|hormones|mesh-ancestor
92667650|NCT00313482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667651|NCT00313482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667652|NCT00313482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92667653|NCT00313482|Immunologic Factors|immunologic factors|mesh-ancestor
92667654|NCT00286988|Topiramate|topiramate|mesh-list
92667657|NCT00286988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667658|NCT00320307|Abacavir|abacavir|mesh-list
92667659|NCT00320307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92667660|NCT00320307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92667661|NCT00320307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667662|NCT00320307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667663|NCT00320307|Antiviral Agents|antiviral agents|mesh-ancestor
92667664|NCT00320307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667665|NCT00320307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92667666|NCT00320307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92667667|NCT00287027|Antipsychotic Agents|antipsychotic agents|mesh-list
92667668|NCT00287027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667669|NCT00287027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92667670|NCT00287027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577661|NCT00269776|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92024970|NCT05494411|Mitomycin|mitomycin|mesh-list
92667671|NCT00287027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667672|NCT02960906|Nivolumab|nivolumab|mesh-list
92667673|NCT02960906|Ipilimumab|ipilimumab|mesh-list
92667674|NCT02960906|Sunitinib|sunitinib|mesh-list
92667675|NCT02960906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92667676|NCT02960906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667677|NCT02960906|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92667678|NCT02960906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667679|NCT02960906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92667680|NCT02960906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92667681|NCT02960906|Growth Substances|growth substances|mesh-ancestor
92667682|NCT02960906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667683|NCT02960906|Growth Inhibitors|growth inhibitors|mesh-ancestor
92667684|NCT02960906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92667685|NCT02960906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667686|NCT00287066|Insulin|insulin|mesh-list
92667687|NCT00287066|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92667688|NCT00287066|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667689|NCT00287066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667690|NCT00313521|Thiotepa|thiotepa|mesh-list
92667691|NCT00313521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92667692|NCT00313521|Alkylating Agents|alkylating agents|mesh-ancestor
92667693|NCT00313521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667694|NCT00313521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667695|NCT00313521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92667696|NCT00313521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667697|NCT00313521|Immunologic Factors|immunologic factors|mesh-ancestor
92667698|NCT00313521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667699|NCT00287261|Zoledronic Acid|zoledronic acid|mesh-list
92667700|NCT00287261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92667701|NCT00287261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667703|NCT00313599|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92667704|NCT00313599|Lapatinib|lapatinib|mesh-list
92667705|NCT00313599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92667706|NCT00313599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667707|NCT00313599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667708|NCT00313599|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667709|NCT00313599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667710|NCT00313599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667711|NCT00313599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92667712|NCT00313599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667713|NCT00287300|Azithromycin|azithromycin|mesh-list
92667714|NCT00287300|Artesunate|artesunate|mesh-list
92667715|NCT00287300|Pyrimethamine|pyrimethamine|mesh-list
92667716|NCT00287300|Sulfadoxine|sulfadoxine|mesh-list
92667717|NCT00287300|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92667718|NCT00287300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92667719|NCT00287300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667720|NCT00287300|Antimalarials|antimalarials|mesh-ancestor
92667721|NCT00287300|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92667722|NCT00287300|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92667723|NCT00287300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667724|NCT00287300|Antiviral Agents|antiviral agents|mesh-ancestor
92667725|NCT00287300|Schistosomicides|schistosomicides|mesh-ancestor
92667726|NCT00287300|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92667727|NCT00287300|Anthelmintics|anthelmintics|mesh-ancestor
92667728|NCT00287300|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92667729|NCT00287300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667730|NCT00287300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667732|NCT00287378|Omalizumab|omalizumab|mesh-list
92667733|NCT00287378|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92667734|NCT00287378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92667735|NCT00287378|Respiratory System Agents|respiratory system agents|mesh-ancestor
92667736|NCT00320580|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92667737|NCT00320580|Norelgestromin|norelgestromin|mesh-list
92667738|NCT00320580|Estradiol|estradiol|mesh-list
92667739|NCT00320580|Estrogens|estrogens|mesh-ancestor
92667740|NCT00320580|Hormones|hormones|mesh-ancestor
92667741|NCT00320580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667742|NCT00320580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667743|NCT00320580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92667744|NCT00320580|Contraceptive Agents|contraceptive agents|mesh-ancestor
92577662|NCT00269776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577663|NCT00269776|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92577664|NCT00269776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92577665|NCT00269776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92667745|NCT00320580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667746|NCT00320580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92667747|NCT00320580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92667748|NCT00320580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92667749|NCT00320619|Aminocaproic Acid|aminocaproic acid|mesh-list
92667750|NCT00320619|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92667751|NCT00320619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92667752|NCT00320619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667753|NCT00320619|Hemostatics|hemostatics|mesh-ancestor
92667754|NCT00320619|Coagulants|coagulants|mesh-ancestor
92667755|NCT00287456|Insulin|insulin|mesh-list
92667756|NCT00287456|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92667757|NCT00287456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667758|NCT00287456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667759|NCT00313833|Buprenorphine|buprenorphine|mesh-list
92667760|NCT00313833|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92667761|NCT00313833|Narcotics|narcotics|mesh-ancestor
92667762|NCT00313833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667763|NCT00313833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667764|NCT00313833|Analgesics|analgesics|mesh-ancestor
92667765|NCT00313833|Sensory System Agents|sensory system agents|mesh-ancestor
92667766|NCT00313833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667767|NCT00313833|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92667768|NCT00287495|Sorafenib|sorafenib|mesh-list
92667769|NCT00287495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667770|NCT00287495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92667771|NCT00287495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667772|NCT00287495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667773|NCT00320658|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92667774|NCT00320658|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92667775|NCT00320658|Immunologic Factors|immunologic factors|mesh-ancestor
92667776|NCT00320658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667777|NCT00320658|Antacids|antacids|mesh-ancestor
92667778|NCT00320658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667779|NCT00320658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92667780|NCT00287534|Tamoxifen|tamoxifen|mesh-list
92667781|NCT00287534|Anastrozole|anastrozole|mesh-list
92667782|NCT00287534|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92667783|NCT00287534|Hormone Antagonists|hormone antagonists|mesh-ancestor
92667784|NCT00287534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92667785|NCT00287534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667786|NCT00287534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92667787|NCT00287534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667788|NCT00287534|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92667789|NCT00287534|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92667790|NCT00287534|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92667791|NCT00287534|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92667792|NCT00287534|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92667793|NCT00287534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667794|NCT00287534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667795|NCT00320697|Bupropion|bupropion|mesh-list
92667796|NCT00320697|Nicotine|nicotine|mesh-list
92667797|NCT00320697|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92667798|NCT00320697|Autonomic Agents|autonomic agents|mesh-ancestor
92667799|NCT00320697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667800|NCT00320697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667801|NCT00320697|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92667802|NCT00320697|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92667803|NCT00320697|Cholinergic Agents|cholinergic agents|mesh-ancestor
92667834|NCT00287768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667835|NCT00287768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667836|NCT00287768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667837|NCT00287768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667838|NCT00287768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667839|NCT00320775|Aflibercept|aflibercept|mesh-list
92667840|NCT00320775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92577666|NCT00269776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577667|NCT00269776|Dopamine Agents|dopamine agents|mesh-ancestor
92577668|NCT00269776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577669|NCT00269815|Methylphenidate|methylphenidate|mesh-list
92577670|NCT00269815|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92577671|NCT00269815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577672|NCT00269815|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92577673|NCT00269815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92577674|NCT00269815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92577675|NCT00269815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577676|NCT00269815|Dopamine Agents|dopamine agents|mesh-ancestor
92577677|NCT00269815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577678|NCT00269854|Infliximab|infliximab|mesh-list
92577679|NCT00269854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92667841|NCT00320775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92667842|NCT00320775|Growth Substances|growth substances|mesh-ancestor
92667843|NCT00320775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667844|NCT00320775|Growth Inhibitors|growth inhibitors|mesh-ancestor
92667845|NCT00320775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667846|NCT00320814|Aflibercept|aflibercept|mesh-list
92667847|NCT00320814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92667848|NCT00320814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92667850|NCT00320814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667851|NCT00320814|Growth Inhibitors|growth inhibitors|mesh-ancestor
92667852|NCT00320814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667853|NCT00287846|Imatinib Mesylate|imatinib mesylate|mesh-list
92667854|NCT00287846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667855|NCT00287846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92667856|NCT00287846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667857|NCT00287846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667858|NCT00322413|Epoetin Alfa|epoetin alfa|mesh-list
92667859|NCT00322413|Hematinics|hematinics|mesh-ancestor
92667860|NCT00320853|Vitamin D|vitamin d|mesh-list
92667861|NCT00320853|Vitamins|vitamins|mesh-ancestor
92667862|NCT00320853|Micronutrients|micronutrients|mesh-ancestor
92667863|NCT00320853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667864|NCT00320853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92667865|NCT00287885|Docetaxel|docetaxel|mesh-list
92667866|NCT00287885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667867|NCT00287885|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667868|NCT00287885|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667869|NCT00287885|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667870|NCT00287885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667871|NCT00287924|Methotrexate|methotrexate|mesh-list
92667872|NCT00287924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92667873|NCT00287924|Abortifacient Agents|abortifacient agents|mesh-ancestor
92667874|NCT00287924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667875|NCT00287924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667876|NCT00287924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92667877|NCT00287924|Antimetabolites|antimetabolites|mesh-ancestor
92667878|NCT00287924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667879|NCT00287924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667880|NCT00287924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92667881|NCT00287924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667882|NCT00287924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92667883|NCT00287924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667884|NCT00287924|Immunologic Factors|immunologic factors|mesh-ancestor
92667885|NCT00287924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667886|NCT00287924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577680|NCT00269854|Antibodies|antibodies|mesh-list
92577681|NCT00269854|Immunoglobulins|immunoglobulins|mesh-list
92577682|NCT00269854|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92577683|NCT00269854|Immunologic Factors|immunologic factors|mesh-ancestor
92667887|NCT00287963|Topotecan|topotecan|mesh-list
92667888|NCT00287963|Vinorelbine|vinorelbine|mesh-list
92667889|NCT00287963|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92667890|NCT00287963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667891|NCT00287963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667892|NCT00287963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667893|NCT00287963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667894|NCT00287963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92667895|NCT00287963|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667896|NCT00287963|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667897|NCT00287963|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667898|NCT00320892|Atropine|atropine|mesh-list
92667899|NCT00320892|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92667900|NCT00320892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92667901|NCT00320892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92667902|NCT00320892|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92667903|NCT00320892|Autonomic Agents|autonomic agents|mesh-ancestor
92667904|NCT00320892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667905|NCT00320892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667906|NCT00320892|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92667907|NCT00320892|Respiratory System Agents|respiratory system agents|mesh-ancestor
92667908|NCT00320892|Mydriatics|mydriatics|mesh-ancestor
92667909|NCT00320892|Parasympatholytics|parasympatholytics|mesh-ancestor
92667910|NCT00320892|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92667911|NCT00320892|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92667912|NCT00320892|Cholinergic Agents|cholinergic agents|mesh-ancestor
92667913|NCT00320892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667914|NCT00320892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667915|NCT00320892|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92667916|NCT00288002|Cyclophosphamide|cyclophosphamide|mesh-list
92667917|NCT00288002|Docetaxel|docetaxel|mesh-list
92667918|NCT00288002|Capecitabine|capecitabine|mesh-list
92667919|NCT00288002|Trastuzumab|trastuzumab|mesh-list
92667920|NCT00288002|Epirubicin|epirubicin|mesh-list
92667921|NCT00288002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667922|NCT00288002|Immunologic Factors|immunologic factors|mesh-ancestor
92667923|NCT00288002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667925|NCT00288002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92667926|NCT00288002|Alkylating Agents|alkylating agents|mesh-ancestor
92667927|NCT00288002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667928|NCT00288002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667929|NCT00288002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92667930|NCT00288002|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667931|NCT00288002|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667932|NCT00288002|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667933|NCT00288002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92667934|NCT00288002|Antimetabolites|antimetabolites|mesh-ancestor
92667935|NCT00288002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92667936|NCT00288002|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92667937|NCT00288002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92667938|NCT00288002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667939|NCT00288002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667940|NCT00322569|Pimecrolimus|pimecrolimus|mesh-list
92667942|NCT00322569|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92667943|NCT00322569|Tacrolimus|tacrolimus|mesh-list
92667944|NCT00322569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92667945|NCT00322569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667946|NCT00322569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667947|NCT00322569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667948|NCT00322569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667949|NCT00322569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667950|NCT00322569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92667951|NCT00322569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92667952|NCT00322569|Analgesics|analgesics|mesh-ancestor
92667953|NCT00322569|Sensory System Agents|sensory system agents|mesh-ancestor
92667954|NCT00322569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667955|NCT00322569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667956|NCT00322569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92667957|NCT00322569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577684|NCT00269854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577685|NCT00269854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667958|NCT00322569|Dermatologic Agents|dermatologic agents|mesh-ancestor
92667959|NCT00322569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92667960|NCT00322569|Immunologic Factors|immunologic factors|mesh-ancestor
92667961|NCT00322569|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92667962|NCT00322569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667963|NCT00288041|Paclitaxel|paclitaxel|mesh-list
92667964|NCT00288041|Carboplatin|carboplatin|mesh-list
92667965|NCT00288041|Bortezomib|bortezomib|mesh-list
92667966|NCT00288041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92667967|NCT00288041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667968|NCT00288041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92667969|NCT00288041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92667970|NCT00288041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92667971|NCT00288041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667972|NCT00320970|Candesartan|candesartan|mesh-list
92667973|NCT00320970|Candesartan cilexetil|candesartan cilexetil|mesh-list
92667974|NCT00320970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92667975|NCT00320970|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92667976|NCT00320970|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92667977|NCT00320970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667978|NCT00288158|Allopurinol|allopurinol|mesh-list
92667979|NCT00288158|Probenecid|probenecid|mesh-list
92667980|NCT00288158|Antimetabolites|antimetabolites|mesh-ancestor
92667981|NCT00288158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667982|NCT00288158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667983|NCT00288158|Gout Suppressants|gout suppressants|mesh-ancestor
92667984|NCT00288158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667985|NCT00288158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92667986|NCT00288158|Antioxidants|antioxidants|mesh-ancestor
92667987|NCT00288158|Protective Agents|protective agents|mesh-ancestor
92667988|NCT00288158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667989|NCT00288158|Uricosuric Agents|uricosuric agents|mesh-ancestor
92667990|NCT04717752|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92667991|NCT04717752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92667992|NCT04717752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667993|NCT00288197|Voriconazole|voriconazole|mesh-list
92667994|NCT00288197|Antifungal Agents|antifungal agents|mesh-ancestor
92667995|NCT00288197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667996|NCT00288197|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92667997|NCT00288197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92668020|NCT00288353|Antidepressive Agents|antidepressive agents|mesh-ancestor
92668021|NCT00288353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668022|NCT00288353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92668023|NCT00288353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668024|NCT00288353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668025|NCT00288353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668026|NCT00288353|Dopamine Agonists|dopamine agonists|mesh-ancestor
92668027|NCT00288353|Dopamine Agents|dopamine agents|mesh-ancestor
92668028|NCT00288353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668029|NCT00288353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668030|NCT00288353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92668031|NCT00288353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92668032|NCT00288353|Serotonin Agents|serotonin agents|mesh-ancestor
92668033|NCT00288353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92668034|NCT00288353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92668035|NCT00288353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92668036|NCT00288353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92668037|NCT00288431|Sirolimus|sirolimus|mesh-list
92668038|NCT00288431|Doxorubicin|doxorubicin|mesh-list
92668039|NCT00288431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92668040|NCT00288431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668041|NCT00288431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92668042|NCT00288431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92668043|NCT00288431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668044|NCT00288431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668045|NCT00288431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92668046|NCT00288431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668050|NCT00288431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668051|NCT00321165|Taurolidine|taurolidine|mesh-list
92577686|NCT00269854|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92577687|NCT00269854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92577688|NCT00269854|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577689|NCT00269854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92577690|NCT00269854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92577691|NCT00269893|Abciximab|abciximab|mesh-list
92668052|NCT00321165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668053|NCT00321165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92668054|NCT00321165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668055|NCT00322803|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydroimidazol-2-one|mesh-list
92668056|NCT00322803|Anticonvulsants|anticonvulsants|mesh-ancestor
92668057|NCT00322803|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92668058|NCT00322803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668059|NCT00322803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668060|NCT00322803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668061|NCT00322803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668062|NCT00322803|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92668063|NCT00322803|GABA Agonists|gaba agonists|mesh-ancestor
92668064|NCT00322803|GABA Agents|gaba agents|mesh-ancestor
92668065|NCT00322803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668066|NCT00322803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668067|NCT00322920|Topotecan|topotecan|mesh-list
92668068|NCT00322920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668069|NCT00322920|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92668070|NCT00322920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92668071|NCT00322920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668072|NCT00322920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668073|NCT00321009|Enoxaparin|enoxaparin|mesh-list
92668074|NCT00321009|Anticoagulants|anticoagulants|mesh-ancestor
92668075|NCT00321009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92668076|NCT00321009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92668077|NCT00321009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668078|NCT00417677|Sirolimus|sirolimus|mesh-list
92668079|NCT00417677|Sunitinib|sunitinib|mesh-list
92668080|NCT00417677|Temsirolimus|temsirolimus|mesh-list
92668081|NCT00417677|MTOR Inhibitors|mtor inhibitors|mesh-list
92668082|NCT00417677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668083|NCT00417677|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92668084|NCT00417677|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92668085|NCT00417677|Growth Substances|growth substances|mesh-ancestor
92668086|NCT00417677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668087|NCT00417677|Growth Inhibitors|growth inhibitors|mesh-ancestor
92668088|NCT00417677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92668089|NCT00417677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668090|NCT00417677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668091|NCT00417677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668092|NCT00417677|Immunologic Factors|immunologic factors|mesh-ancestor
92668093|NCT00417677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92668094|NCT00417677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668095|NCT00417677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92668096|NCT00417677|Antifungal Agents|antifungal agents|mesh-ancestor
92668097|NCT00417716|Bevacizumab|bevacizumab|mesh-list
92668098|NCT00417716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92668099|NCT00417716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668100|NCT00417716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92668101|NCT00417716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92668102|NCT00417716|Growth Substances|growth substances|mesh-ancestor
92668103|NCT00417716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668104|NCT00417716|Growth Inhibitors|growth inhibitors|mesh-ancestor
92668106|NCT00288470|Viscosupplements|viscosupplements|mesh-ancestor
92668107|NCT00288470|Protective Agents|protective agents|mesh-ancestor
92668108|NCT00288470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668109|NCT00321360|Propofol|propofol|mesh-list
92668110|NCT00321360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92668111|NCT00321360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668112|NCT00321360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668113|NCT00321360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92668114|NCT00321360|Anesthetics, General|anesthetics, general|mesh-ancestor
92668115|NCT00321360|Anesthetics|anesthetics|mesh-ancestor
92668116|NCT00288548|Metoprolol|metoprolol|mesh-list
92577692|NCT00269893|Anticoagulants|anticoagulants|mesh-ancestor
92577693|NCT00269893|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92577694|NCT00074321|Capecitabine|capecitabine|mesh-list
92577695|NCT00074321|Oxaliplatin|oxaliplatin|mesh-list
92668117|NCT00288548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92668118|NCT00288548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92668119|NCT00288548|Sympatholytics|sympatholytics|mesh-ancestor
92668120|NCT00288548|Autonomic Agents|autonomic agents|mesh-ancestor
92668123|NCT00288548|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92668124|NCT00288548|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92668125|NCT00288548|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92668126|NCT00288548|Adrenergic Agents|adrenergic agents|mesh-ancestor
92668127|NCT00288548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668128|NCT00288548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668130|NCT00321477|Antiemetics|antiemetics|mesh-ancestor
92668131|NCT00321477|Autonomic Agents|autonomic agents|mesh-ancestor
92668132|NCT00321477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668133|NCT00321477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668134|NCT00321477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668135|NCT00321477|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92668136|NCT00321477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668137|NCT00321477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668138|NCT00321516|Aripiprazole|aripiprazole|mesh-list
92668139|NCT00321516|Antidepressive Agents|antidepressive agents|mesh-ancestor
92668140|NCT00321516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668141|NCT00321516|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92668142|NCT00321516|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668143|NCT00321516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668144|NCT00321516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668145|NCT00321516|Dopamine Agonists|dopamine agonists|mesh-ancestor
92668146|NCT00321516|Dopamine Agents|dopamine agents|mesh-ancestor
92668147|NCT00321516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668148|NCT00321516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668149|NCT00321516|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92668150|NCT00321516|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92668151|NCT00321516|Serotonin Agents|serotonin agents|mesh-ancestor
92668152|NCT00321516|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92668153|NCT00321516|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92668154|NCT00321516|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92668155|NCT00321516|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92668157|NCT00288743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668158|NCT00288743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668159|NCT00321633|Carboplatin|carboplatin|mesh-list
92668160|NCT00321633|Docetaxel|docetaxel|mesh-list
92668161|NCT00321633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668162|NCT00321633|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668163|NCT00321633|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668164|NCT00321633|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668165|NCT00321633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668166|NCT00288782|Mirtazapine|mirtazapine|mesh-list
92668167|NCT00288782|Antidepressive Agents|antidepressive agents|mesh-ancestor
92668168|NCT00288782|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668169|NCT00288782|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92668170|NCT00288782|Histamine Antagonists|histamine antagonists|mesh-ancestor
92668171|NCT00288782|Histamine Agents|histamine agents|mesh-ancestor
92668172|NCT00288782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668173|NCT00288782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668174|NCT00288782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668175|NCT00288782|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92668176|NCT00288782|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668177|NCT00288782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668178|NCT00288782|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92365160|NCT02982486|Nivolumab|nivolumab|mesh-list
92668179|NCT00288782|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92668180|NCT00288782|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92668181|NCT00288782|Adrenergic Agents|adrenergic agents|mesh-ancestor
92668182|NCT00288782|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92668183|NCT00288782|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92668184|NCT00288782|Serotonin Agents|serotonin agents|mesh-ancestor
92668185|NCT00288782|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92668186|NCT01059825|Metformin|metformin|mesh-list
92577696|NCT00074321|Irinotecan|irinotecan|mesh-list
92577697|NCT00074321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668187|NCT01059825|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92668188|NCT01059825|Ertugliflozin|ertugliflozin|mesh-list
92668189|NCT01059825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668190|NCT01059825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668191|NCT01059825|Incretins|incretins|mesh-ancestor
92668192|NCT01059825|Hormones|hormones|mesh-ancestor
92668197|NCT01059825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668199|NCT00321750|Pimecrolimus|pimecrolimus|mesh-list
92668200|NCT00321750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92668201|NCT00321750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92668202|NCT00321750|Analgesics|analgesics|mesh-ancestor
92668203|NCT00321750|Sensory System Agents|sensory system agents|mesh-ancestor
92668204|NCT00321750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668205|NCT00321750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668206|NCT00321750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668207|NCT00321750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668208|NCT00321750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92668209|NCT00321750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668210|NCT00321750|Immunologic Factors|immunologic factors|mesh-ancestor
92668211|NCT00321750|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92668212|NCT00321750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668213|NCT00321750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668214|NCT00321945|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92668215|NCT00321945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92668216|NCT00321945|Protease Inhibitors|protease inhibitors|mesh-ancestor
92668217|NCT00321945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668218|NCT00321945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668219|NCT00323076|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92668220|NCT00323076|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92668221|NCT00323076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668222|NCT00323154|Nalbuphine|nalbuphine|mesh-list
92668223|NCT00323154|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92668224|NCT00323154|Narcotics|narcotics|mesh-ancestor
92668225|NCT00323154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668226|NCT00323154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668227|NCT00323154|Analgesics|analgesics|mesh-ancestor
92668228|NCT00323154|Sensory System Agents|sensory system agents|mesh-ancestor
92668229|NCT00323154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668230|NCT00289250|Artesunate|artesunate|mesh-list
92668231|NCT00289250|Pyrimethamine|pyrimethamine|mesh-list
92668232|NCT00289250|Sulfadoxine|sulfadoxine|mesh-list
92668233|NCT00289250|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92668234|NCT00289250|Antimalarials|antimalarials|mesh-ancestor
92668235|NCT00289250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92668236|NCT00289250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92668237|NCT00289250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668238|NCT00289250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668239|NCT00289250|Antiviral Agents|antiviral agents|mesh-ancestor
92668240|NCT00289250|Schistosomicides|schistosomicides|mesh-ancestor
92668241|NCT00289250|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92668242|NCT00289250|Anthelmintics|anthelmintics|mesh-ancestor
92668243|NCT00289250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92668244|NCT00289250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668245|NCT00289250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668246|NCT00289250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92668247|NCT00323505|Interferons|interferons|mesh-list
92668248|NCT00323505|Interferon-alpha|interferon-alpha|mesh-list
92668249|NCT00323505|Interferon alpha-2|interferon alpha-2|mesh-list
92668250|NCT00323505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668251|NCT00323505|Antiviral Agents|antiviral agents|mesh-ancestor
92668252|NCT00323505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668253|NCT00323505|Immunologic Factors|immunologic factors|mesh-ancestor
92668254|NCT00323505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668255|NCT00289406|Amlodipine|amlodipine|mesh-list
92668256|NCT00289406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92668257|NCT00289406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92668258|NCT00289406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92668259|NCT00289406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075583|NCT05700344|Avelumab|avelumab|mesh-list
92668261|NCT00289406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668262|NCT00289406|Vasodilator Agents|vasodilator agents|mesh-ancestor
92668264|NCT00323544|Lamivudine|lamivudine|mesh-list
92577698|NCT00074321|Antimetabolites|antimetabolites|mesh-ancestor
92025590|NCT05507957|Povidone|povidone|mesh-list
92668265|NCT00323544|Emtricitabine|emtricitabine|mesh-list
92668266|NCT00323544|Zidovudine|zidovudine|mesh-list
92668267|NCT00323544|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92668268|NCT00323544|Antiviral Agents|antiviral agents|mesh-ancestor
92668269|NCT00323544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668270|NCT00323544|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92668271|NCT00323544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92668272|NCT00323544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668273|NCT00323544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668274|NCT00323544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92668275|NCT00323544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92668276|NCT00323544|Antimetabolites|antimetabolites|mesh-ancestor
92668277|NCT00289445|Leucovorin|leucovorin|mesh-list
92668278|NCT00289445|Folic Acid|folic acid|mesh-list
92668279|NCT00289445|Mitomycins|mitomycins|mesh-list
92668280|NCT00289445|Mitomycin|mitomycin|mesh-list
92668281|NCT00289445|Levoleucovorin|levoleucovorin|mesh-list
92668282|NCT00289445|Antidotes|antidotes|mesh-ancestor
92668283|NCT00289445|Protective Agents|protective agents|mesh-ancestor
92668284|NCT00289445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668285|NCT00289445|Vitamin B Complex|vitamin b complex|mesh-ancestor
92668286|NCT00289445|Vitamins|vitamins|mesh-ancestor
92668287|NCT00289445|Micronutrients|micronutrients|mesh-ancestor
92668288|NCT00289445|Hematinics|hematinics|mesh-ancestor
92668289|NCT00289445|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92668290|NCT00289445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668291|NCT00289445|Alkylating Agents|alkylating agents|mesh-ancestor
92668292|NCT00289445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668293|NCT00289445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92668294|NCT00289445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668295|NCT00323583|Leucovorin|leucovorin|mesh-list
92668296|NCT00323583|Paclitaxel|paclitaxel|mesh-list
92668297|NCT00323583|Fluorouracil|fluorouracil|mesh-list
92668298|NCT00323583|Oxaliplatin|oxaliplatin|mesh-list
92668299|NCT00323583|Calcium|calcium|mesh-list
92668300|NCT00323583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92668301|NCT00323583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668302|NCT00323583|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668303|NCT00323583|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668304|NCT00323583|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668305|NCT00323583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668306|NCT00323583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92668307|NCT00323583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668308|NCT00323583|Antimetabolites|antimetabolites|mesh-ancestor
92668309|NCT00323583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668310|NCT00323583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668311|NCT00323583|Immunologic Factors|immunologic factors|mesh-ancestor
92668312|NCT00323583|Antidotes|antidotes|mesh-ancestor
92668313|NCT00323583|Protective Agents|protective agents|mesh-ancestor
92668314|NCT00323583|Vitamin B Complex|vitamin b complex|mesh-ancestor
92668315|NCT00323583|Vitamins|vitamins|mesh-ancestor
92668316|NCT00323583|Micronutrients|micronutrients|mesh-ancestor
92668317|NCT00289601|Eptifibatide|eptifibatide|mesh-list
92668318|NCT00289601|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92668319|NCT00323778|Hyaluronic Acid|hyaluronic acid|mesh-list
92668320|NCT00323778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92668321|NCT00323778|Immunologic Factors|immunologic factors|mesh-ancestor
92668322|NCT00323778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668323|NCT00323778|Viscosupplements|viscosupplements|mesh-ancestor
92668324|NCT00323778|Protective Agents|protective agents|mesh-ancestor
92668325|NCT00323817|Z 338|z 338|mesh-list
92668326|NCT00323817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92668327|NCT00323817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668328|NCT00323817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668329|NCT00323817|Cholinergic Agents|cholinergic agents|mesh-ancestor
92668330|NCT00323817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668331|NCT00323817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668332|NCT00323817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668333|NCT00289835|Paclitaxel|paclitaxel|mesh-list
92668334|NCT00289835|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92668335|NCT00289835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92668336|NCT00289835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668340|NCT00289835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668341|NCT00303225|Tecovirimat|tecovirimat|mesh-list
92668342|NCT00303225|Antiviral Agents|antiviral agents|mesh-ancestor
92577699|NCT00074321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577700|NCT00074321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577701|NCT00074321|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92668343|NCT00303225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668344|NCT00323934|Mocetinostat|mocetinostat|mesh-list
92668345|NCT00323934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92668346|NCT00323934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668347|NCT00323934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668348|NCT00290030|Alfuzosin|alfuzosin|mesh-list
92668349|NCT00290030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92668350|NCT00290030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92668351|NCT00290030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92668352|NCT00290030|Adrenergic Agents|adrenergic agents|mesh-ancestor
92668353|NCT00290030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668354|NCT00290030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668355|NCT00290030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668356|NCT00290030|Urological Agents|urological agents|mesh-ancestor
92668357|NCT00303264|Esomeprazole|esomeprazole|mesh-list
92668358|NCT00303264|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92668359|NCT00303264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668360|NCT00303264|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92668361|NCT00303264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668362|NCT00303264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668363|NCT00290069|Sirolimus|sirolimus|mesh-list
92668364|NCT00290069|Tacrolimus|tacrolimus|mesh-list
92668365|NCT00290069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668366|NCT00290069|Immunologic Factors|immunologic factors|mesh-ancestor
92668367|NCT00290069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668368|NCT00290069|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92668369|NCT00290069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668370|NCT00290069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668371|NCT00290069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92668372|NCT00290069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668373|NCT00290069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92668374|NCT00290069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668375|NCT00290069|Antifungal Agents|antifungal agents|mesh-ancestor
92668377|NCT04718259|Bupivacaine|bupivacaine|mesh-list
92668378|NCT04718259|Anesthetics, Local|anesthetics, local|mesh-ancestor
92668379|NCT04718259|Anesthetics|anesthetics|mesh-ancestor
92668380|NCT04718259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668381|NCT04718259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668382|NCT04718259|Sensory System Agents|sensory system agents|mesh-ancestor
92668383|NCT04718259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668384|NCT04718259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92668385|NCT04718259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92668386|NCT04718259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92668387|NCT04718259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668388|NCT04718259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668389|NCT04718259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92668390|NCT04718259|Anesthetics, General|anesthetics, general|mesh-ancestor
92668391|NCT04718259|GABA Modulators|gaba modulators|mesh-ancestor
92668392|NCT04718259|GABA Agents|gaba agents|mesh-ancestor
92668393|NCT04718259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668394|NCT04718259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668395|NCT00290108|Propofol|propofol|mesh-list
92668396|NCT00290108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92668397|NCT00290108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668398|NCT00290108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668399|NCT00290108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92668400|NCT00290108|Anesthetics, General|anesthetics, general|mesh-ancestor
92668401|NCT00290108|Anesthetics|anesthetics|mesh-ancestor
92668402|NCT00323973|Bisoprolol|bisoprolol|mesh-list
92668403|NCT00323973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92668404|NCT00323973|Sympatholytics|sympatholytics|mesh-ancestor
92668405|NCT00323973|Autonomic Agents|autonomic agents|mesh-ancestor
92668406|NCT00323973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668407|NCT00323973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668408|NCT00323973|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92668409|NCT00323973|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92668431|NCT00290264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577702|NCT00074321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92577703|NCT00074321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577705|NCT00102609|Doxorubicin|doxorubicin|mesh-list
92577706|NCT00102609|Trabectedin|trabectedin|mesh-list
91984985|NCT02679755|Palbociclib|palbociclib|mesh-list
92668433|NCT00290264|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92668434|NCT00290264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92668435|NCT00290264|Adrenergic Agents|adrenergic agents|mesh-ancestor
92668436|NCT00290264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668437|NCT00290264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668438|NCT00324051|Olanzapine|olanzapine|mesh-list
92668439|NCT00324051|Antiemetics|antiemetics|mesh-ancestor
92668440|NCT00324051|Autonomic Agents|autonomic agents|mesh-ancestor
92668441|NCT00324051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668442|NCT00324051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668443|NCT00324051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668444|NCT00324051|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92668445|NCT00324051|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668446|NCT00324051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668447|NCT00324051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668448|NCT00324051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92668449|NCT00324051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92668450|NCT00324051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92668451|NCT00324051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668452|NCT00324051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668453|NCT00324051|Serotonin Agents|serotonin agents|mesh-ancestor
92668454|NCT00303381|Interferons|interferons|mesh-list
92668455|NCT00303381|Interferon-beta|interferon-beta|mesh-list
92668456|NCT00303381|Interferon beta-1a|interferon beta-1a|mesh-list
92668457|NCT00303381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668458|NCT00303381|Antiviral Agents|antiviral agents|mesh-ancestor
92668459|NCT00303381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668460|NCT00303381|Immunologic Factors|immunologic factors|mesh-ancestor
92668461|NCT00303381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668465|NCT00290420|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92668466|NCT00290420|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92668467|NCT00290420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668468|NCT00290420|Antimalarials|antimalarials|mesh-ancestor
92668469|NCT00290420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668470|NCT00303420|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92668471|NCT00303420|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92668472|NCT00303420|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92668473|NCT00303420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668474|NCT00324129|Mocetinostat|mocetinostat|mesh-list
92668475|NCT00324129|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92668476|NCT00324129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668477|NCT00324129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668478|NCT00303537|Metformin|metformin|mesh-list
92668479|NCT00303537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668480|NCT00303537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668481|NCT00290849|Bivalirudin|bivalirudin|mesh-list
92668482|NCT00290849|Antithrombins|antithrombins|mesh-ancestor
92668483|NCT00290849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92668484|NCT00290849|Protease Inhibitors|protease inhibitors|mesh-ancestor
92668485|NCT00290849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668486|NCT00290849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668487|NCT00290849|Anticoagulants|anticoagulants|mesh-ancestor
92668488|NCT00290927|Insulin glulisine|insulin glulisine|mesh-list
92668489|NCT00290927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92365174|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
92668490|NCT00290927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668491|NCT00303576|Dapivirine|dapivirine|mesh-list
92668492|NCT00303576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92668493|NCT00303576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92668494|NCT00303576|Antiviral Agents|antiviral agents|mesh-ancestor
92668495|NCT00303576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668496|NCT00291005|Docetaxel|docetaxel|mesh-list
92668497|NCT00291005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668498|NCT00291005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668499|NCT00291005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668500|NCT00291005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577707|NCT00102609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92577708|NCT00102609|Antiemetics|antiemetics|mesh-ancestor
92668501|NCT00291005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668502|NCT00303615|Anastrozole|anastrozole|mesh-list
92668503|NCT00303615|Fluoxymesterone|fluoxymesterone|mesh-list
92668504|NCT00303615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92668505|NCT00303615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668506|NCT00303615|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92668507|NCT00303615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92668508|NCT00303615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668509|NCT00303615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668510|NCT00303615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92668511|NCT00303615|Hormone Antagonists|hormone antagonists|mesh-ancestor
92668512|NCT00303615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668513|NCT00303615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668514|NCT00303615|Anabolic Agents|anabolic agents|mesh-ancestor
92668515|NCT00303615|Hormones|hormones|mesh-ancestor
92668516|NCT00324324|Moxifloxacin|moxifloxacin|mesh-list
92668517|NCT00324324|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92668518|NCT00324324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92668519|NCT00324324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668520|NCT00324324|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92668521|NCT00324324|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92393942|NCT03332667|Vorinostat|vorinostat|mesh-list
92668522|NCT00324324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668523|NCT00324324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668524|NCT00324324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668525|NCT00324324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92668526|NCT00324324|Contraceptive Agents|contraceptive agents|mesh-ancestor
92668527|NCT00324324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92668528|NCT00324324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668529|NCT00324324|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92668530|NCT00324324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92668531|NCT00324324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92668532|NCT00291122|Celecoxib|celecoxib|mesh-list
92668533|NCT00291122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92668541|NCT00291122|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92668542|NCT00291122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92668543|NCT00291122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668544|NCT00291122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668546|NCT00324363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668547|NCT00324363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668548|NCT00324363|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92668549|NCT00324363|Incretins|incretins|mesh-ancestor
92668550|NCT00324363|Hormones|hormones|mesh-ancestor
92668551|NCT00324363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668552|NCT00303732|Everolimus|everolimus|mesh-list
92668553|NCT00303732|Vatalanib|vatalanib|mesh-list
92668554|NCT00303732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92668555|NCT00303732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92668556|NCT00303732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668557|NCT00303732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668558|NCT00303732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668559|NCT00303732|Immunologic Factors|immunologic factors|mesh-ancestor
92668560|NCT00303732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668561|NCT00303732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668562|NCT00303771|Leucovorin|leucovorin|mesh-list
92668563|NCT00303771|Fluorouracil|fluorouracil|mesh-list
92668564|NCT00303771|Irinotecan|irinotecan|mesh-list
92668565|NCT00303771|Calcium|calcium|mesh-list
92668566|NCT00303771|Levoleucovorin|levoleucovorin|mesh-list
92668567|NCT00303771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92668568|NCT00303771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668569|NCT00303771|Antimetabolites|antimetabolites|mesh-ancestor
92668570|NCT00303771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668571|NCT00303771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668572|NCT00303771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668573|NCT00303771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668574|NCT00303771|Immunologic Factors|immunologic factors|mesh-ancestor
92668575|NCT00303771|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92668576|NCT00303771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92668577|NCT00303771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577709|NCT00102609|Autonomic Agents|autonomic agents|mesh-ancestor
92577710|NCT00102609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025922|NCT02545075|Ipilimumab|ipilimumab|mesh-list
92668578|NCT00303771|Antidotes|antidotes|mesh-ancestor
92668579|NCT00303771|Protective Agents|protective agents|mesh-ancestor
92668580|NCT00303771|Vitamin B Complex|vitamin b complex|mesh-ancestor
92668581|NCT00303771|Vitamins|vitamins|mesh-ancestor
92668582|NCT00303771|Micronutrients|micronutrients|mesh-ancestor
92668583|NCT00303810|Cyclophosphamide|cyclophosphamide|mesh-list
92668584|NCT00303810|Thiotepa|thiotepa|mesh-list
92668585|NCT00303810|Lomustine|lomustine|mesh-list
92668586|NCT00303810|Carboplatin|carboplatin|mesh-list
92668587|NCT00303810|Methotrexate|methotrexate|mesh-list
92668588|NCT00303810|Etoposide|etoposide|mesh-list
92668589|NCT00303810|Vincristine|vincristine|mesh-list
92668590|NCT00303810|Etoposide phosphate|etoposide phosphate|mesh-list
92668591|NCT00303810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668592|NCT00303810|Immunologic Factors|immunologic factors|mesh-ancestor
92668593|NCT00303810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668594|NCT00303810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668595|NCT00303810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92668596|NCT00303810|Alkylating Agents|alkylating agents|mesh-ancestor
92668597|NCT00303810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668598|NCT00303810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668599|NCT00303810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92668600|NCT00303810|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92668601|NCT00303810|Abortifacient Agents|abortifacient agents|mesh-ancestor
92668602|NCT00303810|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92075921|NCT05144542|Autonomic Agents|autonomic agents|mesh-ancestor
92668622|NCT00324480|Growth Substances|growth substances|mesh-ancestor
92668623|NCT00324480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668624|NCT00324480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92668625|NCT00303888|Docetaxel|docetaxel|mesh-list
92668626|NCT00303888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668627|NCT00303888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668628|NCT00303888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668629|NCT00303888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668630|NCT00303888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668631|NCT00291707|Pemetrexed|pemetrexed|mesh-list
92668632|NCT00291707|Cetuximab|cetuximab|mesh-list
92668633|NCT00291707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668634|NCT00291707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668635|NCT00291707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668636|NCT00291707|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92668637|NCT00291707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92668638|NCT00291707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92668639|NCT00324519|Misoprostol|misoprostol|mesh-list
92668640|NCT00324519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92668641|NCT00324519|Abortifacient Agents|abortifacient agents|mesh-ancestor
92668642|NCT00324519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92668643|NCT00324519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668644|NCT00324519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92668645|NCT00324519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668646|NCT00324519|Oxytocics|oxytocics|mesh-ancestor
92668647|NCT00291746|Esomeprazole|esomeprazole|mesh-list
92668648|NCT00291746|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92668649|NCT00291746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668650|NCT00291746|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92668651|NCT00291746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668652|NCT00291746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668653|NCT00303927|Capecitabine|capecitabine|mesh-list
92668654|NCT00303927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668655|NCT00303927|Antimetabolites|antimetabolites|mesh-ancestor
92365178|NCT02980926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668656|NCT00303927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668657|NCT00303927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668661|NCT00291785|Leucovorin|leucovorin|mesh-list
92668662|NCT00291785|Folic Acid|folic acid|mesh-list
92668663|NCT00291785|Fluorouracil|fluorouracil|mesh-list
92668664|NCT00291785|Levoleucovorin|levoleucovorin|mesh-list
92668665|NCT00291785|Antimetabolites|antimetabolites|mesh-ancestor
92668666|NCT00291785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668667|NCT00291785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668668|NCT00291785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668669|NCT00291785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668670|NCT00291785|Immunologic Factors|immunologic factors|mesh-ancestor
92577711|NCT00102609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577712|NCT00102609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92577713|NCT00102609|Glucocorticoids|glucocorticoids|mesh-ancestor
92577714|NCT00102609|Hormones|hormones|mesh-ancestor
92577715|NCT00102609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984991|NCT02679755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92668671|NCT00291785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668672|NCT00291785|Antidotes|antidotes|mesh-ancestor
92668673|NCT00291785|Protective Agents|protective agents|mesh-ancestor
92668674|NCT00291785|Vitamin B Complex|vitamin b complex|mesh-ancestor
92668676|NCT00291785|Micronutrients|micronutrients|mesh-ancestor
92668677|NCT00291785|Hematinics|hematinics|mesh-ancestor
92668678|NCT00324558|Bemiparin|bemiparin|mesh-list
92668679|NCT00324558|Anticoagulants|anticoagulants|mesh-ancestor
92668680|NCT00291863|Simvastatin|simvastatin|mesh-list
92668681|NCT00291863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92668682|NCT00291863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92668683|NCT00291863|Antimetabolites|antimetabolites|mesh-ancestor
92668684|NCT00291863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668685|NCT00291863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92668686|NCT00291863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92668687|NCT00291863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668688|NCT00304200|Temozolomide|temozolomide|mesh-list
92668689|NCT00304200|Sunitinib|sunitinib|mesh-list
92668690|NCT00304200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92668691|NCT00304200|Alkylating Agents|alkylating agents|mesh-ancestor
92668692|NCT00304200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668693|NCT00304200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668694|NCT00304200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92668695|NCT00304200|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92668696|NCT00304200|Growth Substances|growth substances|mesh-ancestor
92668697|NCT00304200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668698|NCT00304200|Growth Inhibitors|growth inhibitors|mesh-ancestor
92668699|NCT00304200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92668700|NCT00304200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668701|NCT00291980|Vaccines|vaccines|mesh-list
92668702|NCT00291980|Immunologic Factors|immunologic factors|mesh-ancestor
92668703|NCT00291980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668704|NCT00324597|Gemcitabine|gemcitabine|mesh-list
92668705|NCT00324597|Motesanib diphosphate|motesanib diphosphate|mesh-list
92668706|NCT00324597|Imetelstat|imetelstat|mesh-list
92668707|NCT00324597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668708|NCT00324597|Antimetabolites|antimetabolites|mesh-ancestor
92668709|NCT00324597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668710|NCT00324597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668711|NCT00324597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92668712|NCT00324597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668713|NCT00324714|Risedronic Acid|risedronic acid|mesh-list
92668714|NCT00324714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92668715|NCT00324714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92668716|NCT00324714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668717|NCT00324714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92668718|NCT00324714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668719|NCT00324714|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92668720|NCT00304317|Celecoxib|celecoxib|mesh-list
92668721|NCT00304317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92668722|NCT00304317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92668723|NCT00304317|Analgesics|analgesics|mesh-ancestor
92668724|NCT00304317|Sensory System Agents|sensory system agents|mesh-ancestor
92668725|NCT00304317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668726|NCT00304317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668727|NCT00304317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668728|NCT00304317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668729|NCT00304317|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92668730|NCT00304317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92668731|NCT00304317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668734|NCT00324792|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668735|NCT00324792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577716|NCT00102609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92577717|NCT00102609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577718|NCT00102609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92668737|NCT00292214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92668738|NCT00292214|Analgesics|analgesics|mesh-ancestor
92668739|NCT00292214|Sensory System Agents|sensory system agents|mesh-ancestor
92668740|NCT00292214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668741|NCT00292214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668742|NCT00292214|Antipyretics|antipyretics|mesh-ancestor
92668743|NCT00324831|Prednisone|prednisone|mesh-list
92668744|NCT00324831|Cyclophosphamide|cyclophosphamide|mesh-list
92668745|NCT00324831|Rituximab|rituximab|mesh-list
92668746|NCT00324831|Doxorubicin|doxorubicin|mesh-list
92668747|NCT00324831|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92394197|NCT02296229|Androgens|androgens|mesh-list
92668748|NCT00324831|Vincristine|vincristine|mesh-list
92668749|NCT00324831|Vaccines|vaccines|mesh-list
92668750|NCT00324831|Antibodies|antibodies|mesh-list
92668752|NCT00324831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92668753|NCT00324831|Sargramostim|sargramostim|mesh-list
92668754|NCT00324831|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92668755|NCT00324831|Immunomodulating Agents|immunomodulating agents|mesh-list
92668756|NCT00324831|Immunologic Factors|immunologic factors|mesh-ancestor
92668757|NCT00324831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668758|NCT00324831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668759|NCT00324831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668760|NCT00324831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92668761|NCT00324831|Alkylating Agents|alkylating agents|mesh-ancestor
92668762|NCT00324831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668763|NCT00324831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668764|NCT00324831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92668765|NCT00324831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92668766|NCT00324831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92668767|NCT00324831|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92668768|NCT00324831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92668769|NCT00324831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668770|NCT00324831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668771|NCT00324831|Glucocorticoids|glucocorticoids|mesh-ancestor
92668772|NCT00324831|Hormones|hormones|mesh-ancestor
92668773|NCT00324831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668774|NCT00324831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92668775|NCT00324831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92668776|NCT00324831|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668777|NCT00324831|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668778|NCT00324831|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668779|NCT00292253|Interferon beta-1a|interferon beta-1a|mesh-list
92668780|NCT00292253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92668781|NCT00292253|Immunologic Factors|immunologic factors|mesh-ancestor
92668782|NCT00292253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668783|NCT00292253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668784|NCT00292253|Antiviral Agents|antiviral agents|mesh-ancestor
92668785|NCT00292253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668786|NCT00304434|Oseltamivir|oseltamivir|mesh-list
92668787|NCT00304434|Probenecid|probenecid|mesh-list
92668788|NCT00304434|Antiviral Agents|antiviral agents|mesh-ancestor
92668789|NCT00304434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668790|NCT00304434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668791|NCT00304434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668792|NCT00304434|Uricosuric Agents|uricosuric agents|mesh-ancestor
92668793|NCT00304434|Gout Suppressants|gout suppressants|mesh-ancestor
92668794|NCT00304434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668795|NCT00292409|Aripiprazole|aripiprazole|mesh-list
92668796|NCT00292409|Antidepressive Agents|antidepressive agents|mesh-ancestor
92668797|NCT00292409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668798|NCT00292409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92668799|NCT00292409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668800|NCT00292409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365184|NCT02978976|Betamethasone|betamethasone|mesh-list
92668801|NCT00292409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668802|NCT00292409|Dopamine Agonists|dopamine agonists|mesh-ancestor
92668803|NCT00292409|Dopamine Agents|dopamine agents|mesh-ancestor
92668804|NCT00292409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668805|NCT00292409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668806|NCT00292409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92577719|NCT00102609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577720|NCT00102609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92577721|NCT00102609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668815|NCT00304473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92668816|NCT00304473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92668817|NCT00304473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92668818|NCT00304473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92668819|NCT00304473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668820|NCT00292448|Tiotropium Bromide|tiotropium bromide|mesh-list
92668821|NCT00292448|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92668822|NCT00292448|Autonomic Agents|autonomic agents|mesh-ancestor
92668823|NCT00292448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668824|NCT00292448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668825|NCT00292448|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92668826|NCT00292448|Respiratory System Agents|respiratory system agents|mesh-ancestor
92668827|NCT00292448|Parasympatholytics|parasympatholytics|mesh-ancestor
92668828|NCT00292448|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92668829|NCT00292448|Cholinergic Agents|cholinergic agents|mesh-ancestor
92668830|NCT00292448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668831|NCT00292448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668832|NCT00324948|Alprostadil|alprostadil|mesh-list
92668833|NCT00324948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92668834|NCT00324948|Vasodilator Agents|vasodilator agents|mesh-ancestor
92668835|NCT00324948|Urological Agents|urological agents|mesh-ancestor
92668836|NCT00304551|Ribavirin|ribavirin|mesh-list
92668837|NCT00304551|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92668838|NCT00304551|Interferon-alpha|interferon-alpha|mesh-list
92668839|NCT00304551|Antimetabolites|antimetabolites|mesh-ancestor
92668840|NCT00304551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668841|NCT00304551|Antiviral Agents|antiviral agents|mesh-ancestor
92668842|NCT00304551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668843|NCT00304551|Immunologic Factors|immunologic factors|mesh-ancestor
92668844|NCT00304551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668845|NCT00325026|Misoprostol|misoprostol|mesh-list
92668846|NCT00325026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92668847|NCT00325026|Abortifacient Agents|abortifacient agents|mesh-ancestor
92668848|NCT00325026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92668849|NCT00325026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668850|NCT00325026|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92668851|NCT00325026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92668852|NCT00325026|Oxytocics|oxytocics|mesh-ancestor
92668853|NCT00325104|Calcium|calcium|mesh-list
92668854|NCT00325104|Parathyroid Hormone|parathyroid hormone|mesh-list
92668855|NCT00325104|Hormones|hormones|mesh-list
92668856|NCT00325104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92668857|NCT00325104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668858|NCT00325104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668859|NCT00292526|Enalapril|enalapril|mesh-list
92668860|NCT00292526|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92668861|NCT00292526|Protease Inhibitors|protease inhibitors|mesh-ancestor
92668862|NCT00292526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668863|NCT00292526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668864|NCT00292526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92668865|NCT00418509|Mometasone Furoate|mometasone furoate|mesh-list
92668866|NCT00418509|Formoterol Fumarate|formoterol fumarate|mesh-list
92668867|NCT00418509|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92668868|NCT00418509|Autonomic Agents|autonomic agents|mesh-ancestor
92668869|NCT00418509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668870|NCT00418509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668871|NCT00418509|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92668872|NCT00418509|Respiratory System Agents|respiratory system agents|mesh-ancestor
92668883|NCT00292721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92668885|NCT00292721|Analgesics|analgesics|mesh-ancestor
92668886|NCT00292721|Sensory System Agents|sensory system agents|mesh-ancestor
92668887|NCT00292721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668888|NCT00292721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668889|NCT00292721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668890|NCT00292721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668891|NCT00292721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92668892|NCT00292721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92668893|NCT00292721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577722|NCT00102609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577723|NCT00102609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92577724|NCT00102609|Alkylating Agents|alkylating agents|mesh-ancestor
92577725|NCT00269932|Levofloxacin|levofloxacin|mesh-list
92668894|NCT00292721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668895|NCT00292760|Alemtuzumab|alemtuzumab|mesh-list
92668896|NCT00292760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92668897|NCT00292760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668898|NCT00325182|Levetiracetam|levetiracetam|mesh-list
92668899|NCT00325182|Anticonvulsants|anticonvulsants|mesh-ancestor
92668900|NCT00325182|Nootropic Agents|nootropic agents|mesh-ancestor
92668901|NCT00292799|Metformin|metformin|mesh-list
92668902|NCT00292799|Orlistat|orlistat|mesh-list
92668903|NCT00292799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668904|NCT00292799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668905|NCT00292799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668906|NCT00292799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668907|NCT00292799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92668908|NCT00292799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92668909|NCT00304629|Galantamine|galantamine|mesh-list
92668910|NCT00304629|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92668911|NCT00304629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668912|NCT00304629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668913|NCT00304629|Cholinergic Agents|cholinergic agents|mesh-ancestor
92668914|NCT00304629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668915|NCT00304629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668916|NCT00304629|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92668917|NCT00304629|Autonomic Agents|autonomic agents|mesh-ancestor
92668918|NCT00304629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668919|NCT00304629|Nootropic Agents|nootropic agents|mesh-ancestor
92668920|NCT00292838|Fluticasone|fluticasone|mesh-list
92668921|NCT00292838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668922|NCT00292838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92668923|NCT00292838|Autonomic Agents|autonomic agents|mesh-ancestor
92668924|NCT00292838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668925|NCT00292838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668926|NCT00292838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92668927|NCT00292838|Respiratory System Agents|respiratory system agents|mesh-ancestor
92668928|NCT00292838|Dermatologic Agents|dermatologic agents|mesh-ancestor
92668929|NCT00292838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92668930|NCT00304668|Dapivirine|dapivirine|mesh-list
92668931|NCT00304668|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92668932|NCT00304668|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92668933|NCT00304668|Antiviral Agents|antiviral agents|mesh-ancestor
92668934|NCT00304668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668935|NCT00292955|Cetuximab|cetuximab|mesh-list
92668936|NCT00292955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076266|NCT04655222|Interferons|interferons|mesh-list
92668939|NCT00293072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92668940|NCT00293072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668941|NCT00293072|Immunologic Factors|immunologic factors|mesh-ancestor
92668942|NCT00293072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668943|NCT00293072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668944|NCT00293111|Etodolac|etodolac|mesh-list
92668945|NCT00293111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92668946|NCT00293111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92668947|NCT00293111|Analgesics|analgesics|mesh-ancestor
92668948|NCT00293111|Sensory System Agents|sensory system agents|mesh-ancestor
92668949|NCT00293111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668950|NCT00293111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668951|NCT00293111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668952|NCT00293111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668953|NCT00293111|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92365193|NCT02979132|Trace Elements|trace elements|mesh-ancestor
92668954|NCT00293111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92668955|NCT00293111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668956|NCT00293111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668957|NCT00304785|Latanoprost|latanoprost|mesh-list
92668958|NCT00304785|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92668959|NCT00304785|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92668960|NCT00293150|Eplerenone|eplerenone|mesh-list
92668961|NCT00293150|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92577726|NCT00269932|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92577727|NCT00269932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577728|NCT00269932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92577729|NCT00269932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577730|NCT00269932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92668962|NCT00293150|Hormone Antagonists|hormone antagonists|mesh-ancestor
92668963|NCT00293150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668964|NCT00293150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668965|NCT00293150|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92668966|NCT00293150|Diuretics|diuretics|mesh-ancestor
92668967|NCT00293150|Natriuretic Agents|natriuretic agents|mesh-ancestor
92668968|NCT00293150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92668969|NCT00293228|Isoniazid|isoniazid|mesh-list
92668970|NCT00293228|Antitubercular Agents|antitubercular agents|mesh-ancestor
92668971|NCT00293228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92668972|NCT00293228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92668973|NCT00293228|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92668974|NCT00293228|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92668976|NCT00293228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668977|NCT00293228|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92668978|NCT00293345|Gemcitabine|gemcitabine|mesh-list
92668979|NCT00293345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668980|NCT00293345|Antimetabolites|antimetabolites|mesh-ancestor
92668981|NCT00293345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668982|NCT00293345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668983|NCT00293501|Tinzaparin|tinzaparin|mesh-list
92668984|NCT00293501|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92668985|NCT00293501|Dalteparin|dalteparin|mesh-list
92668986|NCT00293501|Anticoagulants|anticoagulants|mesh-ancestor
92668987|NCT00293501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92668988|NCT00293501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92668989|NCT00293501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668990|NCT00325455|Anacetrapib|anacetrapib|mesh-list
92668991|NCT00325455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92668992|NCT00325455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92668993|NCT00325455|Antimetabolites|antimetabolites|mesh-ancestor
92668994|NCT00325455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668995|NCT00325455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92668996|NCT00293657|Lornoxicam|lornoxicam|mesh-list
92668997|NCT00293657|Piroxicam|piroxicam|mesh-list
92668998|NCT00293657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92668999|NCT00293657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92669000|NCT00293657|Analgesics|analgesics|mesh-ancestor
92669001|NCT00293657|Sensory System Agents|sensory system agents|mesh-ancestor
92669002|NCT00293657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669003|NCT00293657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669004|NCT00293657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92669005|NCT00293657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92669006|NCT00293657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92669007|NCT00293657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669008|NCT00293657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669009|NCT00293696|Goserelin|goserelin|mesh-list
92669010|NCT00293696|Bicalutamide|bicalutamide|mesh-list
92669013|NCT00293696|Androgen Antagonists|androgen antagonists|mesh-ancestor
92669014|NCT00293696|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669015|NCT00293696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669016|NCT00293696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669018|NCT00293735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92669019|NCT00293735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92669020|NCT00293735|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669021|NCT00293735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669022|NCT00293735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669023|NCT00293735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669024|NCT00293735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92669025|NCT00293735|Sympathomimetics|sympathomimetics|mesh-ancestor
92669026|NCT00293735|Autonomic Agents|autonomic agents|mesh-ancestor
92669027|NCT00293735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669028|NCT00293735|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92577731|NCT00269932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577732|NCT00269932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577733|NCT00269932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669029|NCT00293735|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92669030|NCT00304980|Lumefantrine|lumefantrine|mesh-list
92669031|NCT00304980|Artemether|artemether|mesh-list
92669032|NCT00304980|Pyrimethamine|pyrimethamine|mesh-list
92669033|NCT00304980|Sulfadoxine|sulfadoxine|mesh-list
92669034|NCT00304980|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92669035|NCT00304980|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92669036|NCT00304980|Antimalarials|antimalarials|mesh-ancestor
92669037|NCT00304980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92669038|NCT00304980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92669039|NCT00304980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669040|NCT00304980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92669041|NCT00304980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669042|NCT00304980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669043|NCT00304980|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92669044|NCT00293891|Tacrolimus|tacrolimus|mesh-list
92669045|NCT00293891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669046|NCT00293891|Immunologic Factors|immunologic factors|mesh-ancestor
92669047|NCT00293891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394471|NCT01385020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669048|NCT00293891|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669049|NCT00293891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669050|NCT00293891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669052|NCT00293930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669053|NCT00293930|Immunologic Factors|immunologic factors|mesh-ancestor
92669054|NCT00293930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669055|NCT00293930|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669056|NCT00293930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669057|NCT00293930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669058|NCT00305019|Clevudine|clevudine|mesh-list
92669059|NCT00305019|Antiviral Agents|antiviral agents|mesh-ancestor
92669060|NCT00305019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669061|NCT00293969|Morphine|morphine|mesh-list
92669062|NCT00293969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92669063|NCT00293969|Narcotics|narcotics|mesh-ancestor
92669064|NCT00293969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669065|NCT00293969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669066|NCT00293969|Analgesics|analgesics|mesh-ancestor
92669067|NCT00293969|Sensory System Agents|sensory system agents|mesh-ancestor
92669068|NCT00293969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669069|NCT00294008|Risperidone|risperidone|mesh-list
92669070|NCT00294008|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92669071|NCT00294008|Serotonin Agents|serotonin agents|mesh-ancestor
92669072|NCT00294008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669073|NCT00294008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669074|NCT00294008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669075|NCT00294008|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92669076|NCT00294008|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669077|NCT00294008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669078|NCT00294008|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669079|NCT00294008|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92669080|NCT00294008|Dopamine Agents|dopamine agents|mesh-ancestor
92669081|NCT00294086|Valsartan|valsartan|mesh-list
92669082|NCT00294086|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92669085|NCT00294086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669087|NCT00325689|Aripiprazole|aripiprazole|mesh-list
92669088|NCT00325689|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92669089|NCT00325689|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92669090|NCT00325689|Serotonin Agents|serotonin agents|mesh-ancestor
92669091|NCT00325689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669092|NCT00325689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669093|NCT00325689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669094|NCT00325689|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92669095|NCT00325689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92406464|NCT01438866|Protective Agents|protective agents|mesh-ancestor
92669096|NCT00325689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669097|NCT00325689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669098|NCT00325689|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92669099|NCT00325689|Dopamine Agents|dopamine agents|mesh-ancestor
92669100|NCT00325689|Antidepressive Agents|antidepressive agents|mesh-ancestor
92577734|NCT00269932|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92577735|NCT00269932|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92577736|NCT00269971|Epoetin Alfa|epoetin alfa|mesh-list
92577737|NCT00269971|Hematinics|hematinics|mesh-ancestor
92577738|NCT00270010|Epoetin Alfa|epoetin alfa|mesh-list
92577739|NCT00270010|Hematinics|hematinics|mesh-ancestor
92577740|NCT00270049|Epoetin Alfa|epoetin alfa|mesh-list
92669101|NCT00325689|Dopamine Agonists|dopamine agonists|mesh-ancestor
92669102|NCT00325689|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92669103|NCT00325689|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92669104|NCT00325689|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92669105|NCT00325689|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92669106|NCT00294164|Hormones|hormones|mesh-list
92669107|NCT00294164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669108|NCT00294164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669109|NCT00417794|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92669110|NCT00417794|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92669111|NCT00417794|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92669112|NCT00417794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669113|NCT00417794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669114|NCT00417794|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669115|NCT00417794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669116|NCT00417794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669117|NCT00417833|Bevacizumab|bevacizumab|mesh-list
92669118|NCT00417833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92669119|NCT00417833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394548|NCT01385956|Hormones|hormones|mesh-ancestor
92669120|NCT00417833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92669121|NCT00417833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92669122|NCT00417833|Growth Substances|growth substances|mesh-ancestor
92669123|NCT00417833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669124|NCT00417833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92669125|NCT00417872|Metronidazole|metronidazole|mesh-list
92669126|NCT00417872|Nitazoxanide|nitazoxanide|mesh-list
92669127|NCT00417872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669128|NCT00417872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669129|NCT00417872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92669130|NCT00417872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92669131|NCT00294203|Epoetin Alfa|epoetin alfa|mesh-list
92669132|NCT00294203|Hematinics|hematinics|mesh-ancestor
92669133|NCT00305292|Modafinil|modafinil|mesh-list
92669134|NCT00305292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92669135|NCT00305292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669136|NCT00305292|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92669137|NCT00305292|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92669138|NCT00305292|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92669139|NCT00305292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669140|NCT00305331|Domperidone|domperidone|mesh-list
92669141|NCT00305331|Antiemetics|antiemetics|mesh-ancestor
92669142|NCT00305331|Autonomic Agents|autonomic agents|mesh-ancestor
92669143|NCT00305331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669144|NCT00305331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669145|NCT00305331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92669146|NCT00305331|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92669147|NCT00305331|Dopamine Agents|dopamine agents|mesh-ancestor
92669148|NCT00305331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669149|NCT00305331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669150|NCT00325767|Albuterol|albuterol|mesh-list
92669153|NCT00325767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669154|NCT00325767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669155|NCT00325767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92669156|NCT00325767|Respiratory System Agents|respiratory system agents|mesh-ancestor
92669157|NCT00325767|Tocolytic Agents|tocolytic agents|mesh-ancestor
92669158|NCT00325767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92669159|NCT00325767|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92669160|NCT00325767|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92577741|NCT00270049|Hematinics|hematinics|mesh-ancestor
92577742|NCT00107016|Letrozole|letrozole|mesh-list
92577743|NCT00107016|Everolimus|everolimus|mesh-list
92669161|NCT00325767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92669162|NCT00325767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669163|NCT00325767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669164|NCT00325767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669165|NCT00294359|Bevacizumab|bevacizumab|mesh-list
92669166|NCT00294359|Capecitabine|capecitabine|mesh-list
92669167|NCT00294359|Mitomycins|mitomycins|mesh-list
92669168|NCT00294359|Mitomycin|mitomycin|mesh-list
92669169|NCT00294359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92669170|NCT00294359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669171|NCT00294359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92669172|NCT00294359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92669173|NCT00294359|Growth Substances|growth substances|mesh-ancestor
92669174|NCT00294359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669175|NCT00294359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92669176|NCT00294359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92669177|NCT00294359|Antimetabolites|antimetabolites|mesh-ancestor
92669178|NCT00294359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669179|NCT00294359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669180|NCT00294359|Alkylating Agents|alkylating agents|mesh-ancestor
92669181|NCT00294359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92669182|NCT00294359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669183|NCT00294437|Zoledronic Acid|zoledronic acid|mesh-list
92669184|NCT00294437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92669185|NCT00294437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669186|NCT00305370|Aripiprazole|aripiprazole|mesh-list
92669187|NCT00305370|Antidepressive Agents|antidepressive agents|mesh-ancestor
92669188|NCT00305370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669189|NCT00305370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92669190|NCT00305370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669191|NCT00305370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669192|NCT00305370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669193|NCT00305370|Dopamine Agonists|dopamine agonists|mesh-ancestor
92669194|NCT00305370|Dopamine Agents|dopamine agents|mesh-ancestor
92669195|NCT00305370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669196|NCT00305370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669197|NCT00305370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92669198|NCT00305370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92669199|NCT00305370|Serotonin Agents|serotonin agents|mesh-ancestor
92669200|NCT00305370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92365209|NCT02976246|Vitamin K|vitamin k|mesh-list
92669201|NCT00305370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92669202|NCT00305370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92669203|NCT00305370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92669205|NCT00325806|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92669206|NCT00325806|Protease Inhibitors|protease inhibitors|mesh-ancestor
92669207|NCT00325806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669208|NCT00325806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669209|NCT00325806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92669210|NCT00305409|Sulfalene|sulfalene|mesh-list
92669211|NCT00305409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669212|NCT00305409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92669213|NCT00305409|Antimalarials|antimalarials|mesh-ancestor
92669214|NCT00305409|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92669215|NCT00305409|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92669216|NCT00294593|Leucovorin|leucovorin|mesh-list
92669217|NCT00294593|Folic Acid|folic acid|mesh-list
92669218|NCT00294593|Levoleucovorin|levoleucovorin|mesh-list
92669219|NCT00294593|Antidotes|antidotes|mesh-ancestor
92669220|NCT00294593|Protective Agents|protective agents|mesh-ancestor
92669221|NCT00294593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669222|NCT00294593|Vitamin B Complex|vitamin b complex|mesh-ancestor
92669223|NCT00294593|Vitamins|vitamins|mesh-ancestor
92669224|NCT00294593|Micronutrients|micronutrients|mesh-ancestor
92669229|NCT00325845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669230|NCT00294749|Ciprofloxacin|ciprofloxacin|mesh-list
92669231|NCT00294749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669232|NCT00294749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669233|NCT00294749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92669234|NCT00294749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92669235|NCT00294749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669236|NCT00294749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577744|NCT00107016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577745|NCT00107016|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92577746|NCT00107016|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92577747|NCT00107016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577748|NCT00107016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577749|NCT00107016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92577750|NCT00107016|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669237|NCT00294749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669238|NCT00294749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92669239|NCT00294749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669240|NCT00325962|Verapamil|verapamil|mesh-list
92669241|NCT00325962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92669242|NCT00325962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92669243|NCT00325962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669244|NCT00325962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669245|NCT00325962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92669246|NCT00325962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669247|NCT00325962|Vasodilator Agents|vasodilator agents|mesh-ancestor
92669248|NCT00305487|Ciclesonide|ciclesonide|mesh-list
92669249|NCT00305487|Glucocorticoids|glucocorticoids|mesh-ancestor
92669250|NCT00305487|Hormones|hormones|mesh-ancestor
92669251|NCT00305487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669252|NCT00305487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669253|NCT00305487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92669254|NCT00294944|Idazoxan|idazoxan|mesh-list
92669255|NCT00294944|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92669256|NCT00294944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92669257|NCT00294944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92669258|NCT00294944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669259|NCT00294944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669260|NCT00294944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669261|NCT00294944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669262|NCT00326157|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92669263|NCT00326157|Antifungal Agents|antifungal agents|mesh-ancestor
92669264|NCT00326157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669265|NCT00326157|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92669266|NCT00326157|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92669267|NCT00295100|Tamoxifen|tamoxifen|mesh-list
92669268|NCT00295100|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92669269|NCT00295100|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669270|NCT00295100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669271|NCT00295100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669272|NCT00295100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92669273|NCT00295100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669274|NCT00295100|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92669275|NCT00295100|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92669276|NCT00295100|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92669278|NCT00326235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92669279|NCT00326235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669280|NCT00326235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669281|NCT00326235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669282|NCT00326235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669283|NCT00326235|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92669284|NCT00326235|Serotonin Agents|serotonin agents|mesh-ancestor
92669285|NCT00326235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669286|NCT00326235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669287|NCT00295178|Vancomycin|vancomycin|mesh-list
92669288|NCT00295178|Daptomycin|daptomycin|mesh-list
92669289|NCT00295178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669290|NCT00295178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669291|NCT00305838|Tamoxifen|tamoxifen|mesh-list
92669292|NCT00305838|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92669293|NCT00305838|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669294|NCT00305838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669295|NCT00305838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577751|NCT00107016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577752|NCT00107016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026635|NCT04882839|Psilocybin|psilocybin|mesh-list
92669298|NCT00305838|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92669300|NCT00305838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92669301|NCT00295373|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92669302|NCT00295373|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92669303|NCT00295373|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92669304|NCT00295373|Antimetabolites|antimetabolites|mesh-ancestor
92669305|NCT00295373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669306|NCT00295373|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92669307|NCT00295373|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92669308|NCT00295373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669309|NCT00295412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92669310|NCT00295412|Antidepressive Agents|antidepressive agents|mesh-ancestor
92669311|NCT00295412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669312|NCT00295412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92669313|NCT00295412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669314|NCT00295412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669315|NCT00295412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669316|NCT00326352|Remifentanil|remifentanil|mesh-list
92669317|NCT00326352|Propofol|propofol|mesh-list
92669318|NCT00326352|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92669319|NCT00326352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669320|NCT00326352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669321|NCT00326352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92669322|NCT00326352|Anesthetics, General|anesthetics, general|mesh-ancestor
92669323|NCT00326352|Anesthetics|anesthetics|mesh-ancestor
92669324|NCT00326352|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92669325|NCT00326352|Narcotics|narcotics|mesh-ancestor
92669326|NCT00326352|Analgesics|analgesics|mesh-ancestor
92669327|NCT00326352|Sensory System Agents|sensory system agents|mesh-ancestor
92669328|NCT00326352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669329|NCT00419601|Fentanyl|fentanyl|mesh-list
92669330|NCT00419601|Remifentanil|remifentanil|mesh-list
92669331|NCT00419601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92669332|NCT00419601|Narcotics|narcotics|mesh-ancestor
92669333|NCT00419601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669334|NCT00419601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669335|NCT00419601|Analgesics|analgesics|mesh-ancestor
92669336|NCT00419601|Sensory System Agents|sensory system agents|mesh-ancestor
92669337|NCT00419601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669338|NCT00419601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92669339|NCT00419601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92669340|NCT00419601|Anesthetics, General|anesthetics, general|mesh-ancestor
92669341|NCT00419601|Anesthetics|anesthetics|mesh-ancestor
92669342|NCT00306033|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92669343|NCT00306033|gamma-Globulins|gamma-globulins|mesh-list
92669344|NCT00306033|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92669345|NCT00306033|Immunoglobulins|immunoglobulins|mesh-list
92669346|NCT00306033|Immunologic Factors|immunologic factors|mesh-ancestor
92669347|NCT00306033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669348|NCT00295607|Antibodies|antibodies|mesh-list
92669349|NCT00295607|Tacrolimus|tacrolimus|mesh-list
92669350|NCT00295607|Immunologic Factors|immunologic factors|mesh-ancestor
92669351|NCT00295607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669352|NCT00295607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669353|NCT00295607|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669354|NCT00295607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669355|NCT00295607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669356|NCT00326391|Methylphenidate|methylphenidate|mesh-list
92669357|NCT00326391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92669358|NCT00326391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669359|NCT00326391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92669360|NCT00326391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92669361|NCT00326391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669362|NCT00326391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669363|NCT00326391|Dopamine Agents|dopamine agents|mesh-ancestor
92669364|NCT00326391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669365|NCT00295685|Antacids|antacids|mesh-list
92669366|NCT00295685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577754|NCT00107016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92577755|NCT00107016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577756|NCT00107016|Immunologic Factors|immunologic factors|mesh-ancestor
92076687|NCT03869034|Leucovorin|leucovorin|mesh-list
92669368|NCT00306150|Aprotinin|aprotinin|mesh-list
92669369|NCT00306150|Hemostatics|hemostatics|mesh-ancestor
92669370|NCT00306150|Coagulants|coagulants|mesh-ancestor
92669371|NCT00306150|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92669372|NCT00306150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92669373|NCT00306150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92669374|NCT00306150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669375|NCT00306150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669376|NCT00417911|Bortezomib|bortezomib|mesh-list
92669377|NCT00417911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669378|NCT00326469|Lanreotide|lanreotide|mesh-list
92669379|NCT00326469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669380|NCT00417950|Acarbose|acarbose|mesh-list
92669381|NCT00417950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92669382|NCT00417950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669383|NCT00417950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669384|NCT00417950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92669385|NCT00417950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669386|NCT00306267|Epoetin Alfa|epoetin alfa|mesh-list
92669387|NCT00306267|Hematinics|hematinics|mesh-ancestor
92669388|NCT00326508|Daclizumab|daclizumab|mesh-list
92669389|NCT00326508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669390|NCT00326508|Immunologic Factors|immunologic factors|mesh-ancestor
92669391|NCT00326508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669392|NCT00326586|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92669393|NCT00326586|Androgen Antagonists|androgen antagonists|mesh-ancestor
92669394|NCT00326586|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669395|NCT00326586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669396|NCT00326586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669397|NCT00295841|Cytarabine|cytarabine|mesh-list
92669398|NCT00295841|Clofarabine|clofarabine|mesh-list
92669399|NCT00295841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92669400|NCT00295841|Antimetabolites|antimetabolites|mesh-ancestor
92669401|NCT00295841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669402|NCT00295841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669403|NCT00295841|Antiviral Agents|antiviral agents|mesh-ancestor
92669404|NCT00295841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669405|NCT00295841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669406|NCT00295841|Immunologic Factors|immunologic factors|mesh-ancestor
92669407|NCT00295841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669408|NCT00326664|Cediranib|cediranib|mesh-list
92669409|NCT00326664|Maleic acid|maleic acid|mesh-list
92669410|NCT00326664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669411|NCT00326664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669412|NCT00326664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669413|NCT00326664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92669414|NCT00295919|Ketoconazole|ketoconazole|mesh-list
92669415|NCT00295919|Fenretinide|fenretinide|mesh-list
92669416|NCT00295919|Antifungal Agents|antifungal agents|mesh-ancestor
92669417|NCT00295919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394841|NCT01387373|Oxaliplatin|oxaliplatin|mesh-list
92669418|NCT00295919|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92669419|NCT00295919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669420|NCT00295919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669421|NCT00295919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669422|NCT00295919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92669423|NCT00295919|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669424|NCT00295919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669425|NCT00295919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669426|NCT00295919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92669427|NCT00295919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669428|NCT00295919|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92669429|NCT00295919|Protective Agents|protective agents|mesh-ancestor
92669430|NCT00295958|Freund's Adjuvant|freund's adjuvant|mesh-list
92669431|NCT00295958|Immunotoxins|immunotoxins|mesh-list
92669432|NCT00295958|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92669433|NCT00295958|Immunologic Factors|immunologic factors|mesh-ancestor
92577757|NCT00270088|Epoetin Alfa|epoetin alfa|mesh-list
92577758|NCT00270088|Hematinics|hematinics|mesh-ancestor
92669434|NCT00295958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669435|NCT00295958|Immunoconjugates|immunoconjugates|mesh-ancestor
92669436|NCT00295997|Mycophenolic Acid|mycophenolic acid|mesh-list
92669437|NCT00295997|Cyclophosphamide|cyclophosphamide|mesh-list
92669439|NCT00295997|Methotrexate|methotrexate|mesh-list
92669440|NCT00295997|Fludarabine|fludarabine|mesh-list
92669441|NCT00295997|Fludarabine phosphate|fludarabine phosphate|mesh-list
92669442|NCT00295997|Tacrolimus|tacrolimus|mesh-list
92669446|NCT00295997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669447|NCT00295997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92669448|NCT00295997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92669449|NCT00295997|Alkylating Agents|alkylating agents|mesh-ancestor
92669450|NCT00295997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669451|NCT00295997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669452|NCT00295997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92669453|NCT00295997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92669454|NCT00295997|Abortifacient Agents|abortifacient agents|mesh-ancestor
92669455|NCT00295997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92669456|NCT00295997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92669457|NCT00295997|Antimetabolites|antimetabolites|mesh-ancestor
92669458|NCT00295997|Dermatologic Agents|dermatologic agents|mesh-ancestor
92669459|NCT00295997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669460|NCT00295997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92669461|NCT00295997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92669462|NCT00295997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669463|NCT00295997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669464|NCT00295997|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92669465|NCT00295997|Antitubercular Agents|antitubercular agents|mesh-ancestor
92669466|NCT00295997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669467|NCT00295997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669468|NCT00418067|Sirolimus|sirolimus|mesh-list
92669469|NCT00418067|Paclitaxel|paclitaxel|mesh-list
92669470|NCT00418067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92669471|NCT00418067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669472|NCT00418067|Tubulin Modulators|tubulin modulators|mesh-ancestor
92669473|NCT00418067|Antimitotic Agents|antimitotic agents|mesh-ancestor
92669474|NCT00418067|Mitosis Modulators|mitosis modulators|mesh-ancestor
92669475|NCT00418067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669476|NCT00418067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669477|NCT00418067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669478|NCT00418067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669479|NCT00418067|Antifungal Agents|antifungal agents|mesh-ancestor
92669480|NCT00418067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669481|NCT00418067|Immunologic Factors|immunologic factors|mesh-ancestor
92669482|NCT00418067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669483|NCT00296309|Tacrolimus|tacrolimus|mesh-list
92669484|NCT00296309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669485|NCT00296309|Immunologic Factors|immunologic factors|mesh-ancestor
92365240|NCT02975076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92669486|NCT00296309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669487|NCT00296309|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669488|NCT00296309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669489|NCT00296309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669490|NCT00296348|Mycophenolic Acid|mycophenolic acid|mesh-list
92669491|NCT00296348|Tacrolimus|tacrolimus|mesh-list
92669492|NCT00296348|Daclizumab|daclizumab|mesh-list
92669493|NCT00296348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669494|NCT00296348|Immunologic Factors|immunologic factors|mesh-ancestor
92669495|NCT00296348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669496|NCT00296348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669497|NCT00296348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669498|NCT00296348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669499|NCT00296348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669500|NCT00296348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669501|NCT00296348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92669502|NCT00296348|Antitubercular Agents|antitubercular agents|mesh-ancestor
92669503|NCT00296348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669504|NCT00296348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669506|NCT00296387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92669507|NCT00296387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92669508|NCT00296387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92669509|NCT00296387|Antimetabolites|antimetabolites|mesh-ancestor
92669510|NCT00296387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577760|NCT00270127|Hematinics|hematinics|mesh-ancestor
92577761|NCT00270166|Epoetin Alfa|epoetin alfa|mesh-list
92577762|NCT00270166|Hematinics|hematinics|mesh-ancestor
92577763|NCT00074399|Nevirapine|nevirapine|mesh-list
91985025|NCT03114215|Biotin|biotin|mesh-list
92669511|NCT00296387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92669512|NCT00296387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92669513|NCT00296387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669514|NCT00326820|Zoledronic Acid|zoledronic acid|mesh-list
92669516|NCT00326820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92669517|NCT00326820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669518|NCT00296465|Citric Acid|citric acid|mesh-list
92669519|NCT00296465|Sodium Citrate|sodium citrate|mesh-list
92669520|NCT00296465|Clomiphene|clomiphene|mesh-list
92669521|NCT00296465|Enclomiphene|enclomiphene|mesh-list
92669522|NCT00296465|Zuclomiphene|zuclomiphene|mesh-list
92669523|NCT00296465|Hormones|hormones|mesh-list
92669524|NCT00296465|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92669525|NCT00296465|Anticoagulants|anticoagulants|mesh-ancestor
92669526|NCT00296465|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92669527|NCT00296465|Chelating Agents|chelating agents|mesh-ancestor
92669528|NCT00296465|Sequestering Agents|sequestering agents|mesh-ancestor
92669529|NCT00296465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669530|NCT00296465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669531|NCT00296465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669532|NCT00296465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92669533|NCT00296465|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669534|NCT00296465|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92669535|NCT00296465|Fertility Agents|fertility agents|mesh-ancestor
92669536|NCT00296465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92669537|NCT00296465|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92669538|NCT00296465|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92669539|NCT00326859|Remifentanil|remifentanil|mesh-list
92669540|NCT00326859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92669541|NCT00326859|Narcotics|narcotics|mesh-ancestor
92669542|NCT00326859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669543|NCT00326859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669544|NCT00326859|Analgesics|analgesics|mesh-ancestor
92669545|NCT00326859|Sensory System Agents|sensory system agents|mesh-ancestor
92669546|NCT00326859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669547|NCT00296699|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92669548|NCT00296699|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92669549|NCT00296699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92669550|NCT00296699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669551|NCT00296699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669552|NCT00296699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669553|NCT00296699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669554|NCT00296699|Analgesics|analgesics|mesh-ancestor
92669555|NCT00296699|Sensory System Agents|sensory system agents|mesh-ancestor
92669556|NCT00296699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669557|NCT00296699|Antidepressive Agents|antidepressive agents|mesh-ancestor
92669558|NCT00296699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669559|NCT00296699|Dopamine Agents|dopamine agents|mesh-ancestor
92669560|NCT00296777|Bupropion|bupropion|mesh-list
92669561|NCT00296777|Imipramine|imipramine|mesh-list
92669562|NCT00296777|Escitalopram|escitalopram|mesh-list
92669563|NCT00296777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92669564|NCT00296777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92669565|NCT00296777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669566|NCT00296777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669567|NCT00296777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669568|NCT00296777|Serotonin Agents|serotonin agents|mesh-ancestor
92669569|NCT00296777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669570|NCT00296777|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92669571|NCT00296777|Antidepressive Agents|antidepressive agents|mesh-ancestor
92669572|NCT00296777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669573|NCT00296777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92669574|NCT00296777|Dopamine Agents|dopamine agents|mesh-ancestor
92669575|NCT00296777|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92577764|NCT00074399|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91985026|NCT03114215|Vitamin B Complex|vitamin b complex|mesh-ancestor
92669576|NCT00296777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669577|NCT00296777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669578|NCT00296777|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92669579|NCT00296777|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92669580|NCT00296777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669581|NCT00296894|Adalimumab|adalimumab|mesh-list
92669582|NCT00296894|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92669583|NCT00296894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92669584|NCT00296894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92669585|NCT00296933|Bupropion|bupropion|mesh-list
92669586|NCT00296933|Escitalopram|escitalopram|mesh-list
92669587|NCT00296933|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92669594|NCT00296933|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92669595|NCT00296933|Antidepressive Agents|antidepressive agents|mesh-ancestor
92669596|NCT00296933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669597|NCT00296933|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92669598|NCT00296933|Dopamine Agents|dopamine agents|mesh-ancestor
92669599|NCT00296933|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92669600|NCT00296933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669601|NCT00296933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669602|NCT00296972|Interferons|interferons|mesh-list
92669603|NCT00296972|Ribavirin|ribavirin|mesh-list
92669604|NCT00296972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669605|NCT00296972|Antiviral Agents|antiviral agents|mesh-ancestor
92669606|NCT00296972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669607|NCT00296972|Antimetabolites|antimetabolites|mesh-ancestor
92669608|NCT00296972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669609|NCT00297011|Valacyclovir|valacyclovir|mesh-list
92669610|NCT00297011|Clobetasol|clobetasol|mesh-list
92669611|NCT00297011|Antiviral Agents|antiviral agents|mesh-ancestor
92669612|NCT00297011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669613|NCT00297011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92669614|NCT00297011|Glucocorticoids|glucocorticoids|mesh-ancestor
92669615|NCT00297011|Hormones|hormones|mesh-ancestor
92669616|NCT00297011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669617|NCT00297011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669618|NCT00327093|Bevacizumab|bevacizumab|mesh-list
92669619|NCT00327093|Cetuximab|cetuximab|mesh-list
92669620|NCT00327093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92669621|NCT00327093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669622|NCT00327093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92669623|NCT00327093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92669624|NCT00327093|Growth Substances|growth substances|mesh-ancestor
92669625|NCT00327093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669626|NCT00327093|Growth Inhibitors|growth inhibitors|mesh-ancestor
92669627|NCT00297050|Peramivir|peramivir|mesh-list
92669628|NCT00297050|Antiviral Agents|antiviral agents|mesh-ancestor
92669629|NCT00297050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669630|NCT00297050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669631|NCT00297050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669632|NCT00297128|Capecitabine|capecitabine|mesh-list
92669633|NCT00297128|Cetuximab|cetuximab|mesh-list
92669634|NCT00297128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92669635|NCT00297128|Antimetabolites|antimetabolites|mesh-ancestor
92669636|NCT00297128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669637|NCT00297128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669638|NCT00297128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92669639|NCT00327132|Amoxicillin|amoxicillin|mesh-list
92669640|NCT00327132|Clarithromycin|clarithromycin|mesh-list
92669641|NCT00327132|Omeprazole|omeprazole|mesh-list
92669642|NCT00327132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669643|NCT00327132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669644|NCT00327132|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92669645|NCT00327132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92669646|NCT00327132|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92669647|NCT00327132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669648|NCT00327132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669649|NCT00327132|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92669650|NCT00327132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92669651|NCT00327132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669652|NCT00297206|Valacyclovir|valacyclovir|mesh-list
92669653|NCT00297206|Antiviral Agents|antiviral agents|mesh-ancestor
92577765|NCT00074399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577766|NCT00074399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577767|NCT00074399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669654|NCT00297206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076985|NCT03194867|Cemiplimab|cemiplimab|mesh-list
92669658|NCT04485195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92669659|NCT04485195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669660|NCT04485195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669661|NCT04478019|Povidone-Iodine|povidone-iodine|mesh-list
92669662|NCT04478019|Povidone|povidone|mesh-list
92669663|NCT04478019|Plasma Substitutes|plasma substitutes|mesh-ancestor
92669664|NCT04478019|Blood Substitutes|blood substitutes|mesh-ancestor
92669665|NCT04478019|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92669666|NCT04478019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669667|NCT00297284|Modafinil|modafinil|mesh-list
92669668|NCT00297284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92669669|NCT00297284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669670|NCT00297284|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92669671|NCT00297284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92669672|NCT00297284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92669673|NCT00297284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669674|NCT04392531|Cyclosporine|cyclosporine|mesh-list
92669675|NCT04392531|Cyclosporins|cyclosporins|mesh-list
92669676|NCT04392531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669677|NCT04392531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669678|NCT04392531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669679|NCT04392531|Immunologic Factors|immunologic factors|mesh-ancestor
92669680|NCT04392531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669681|NCT04392531|Antifungal Agents|antifungal agents|mesh-ancestor
92669682|NCT04392531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669683|NCT04392531|Dermatologic Agents|dermatologic agents|mesh-ancestor
92669684|NCT04392531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92669685|NCT04392531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92669686|NCT00297323|Topiramate|topiramate|mesh-list
92669687|NCT00297323|Anticonvulsants|anticonvulsants|mesh-ancestor
92669688|NCT00297323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92669689|NCT00297323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669690|NCT00327288|Docetaxel|docetaxel|mesh-list
92669691|NCT00327288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669692|NCT00327288|Tubulin Modulators|tubulin modulators|mesh-ancestor
92669693|NCT00327288|Antimitotic Agents|antimitotic agents|mesh-ancestor
92669694|NCT00327288|Mitosis Modulators|mitosis modulators|mesh-ancestor
92669695|NCT00327288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669696|NCT04333134|Fluzoparib|fluzoparib|mesh-list
92669697|NCT04333134|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92669698|NCT04333134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669699|NCT04333134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365248|NCT02974920|Aspirin|aspirin|mesh-list
92669700|NCT04333134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669701|NCT00327327|Gemcitabine|gemcitabine|mesh-list
92669702|NCT00327327|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92669703|NCT00327327|Antimetabolites|antimetabolites|mesh-ancestor
92669704|NCT00327327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669705|NCT00327327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669706|NCT00297362|Galantamine|galantamine|mesh-list
92669707|NCT00297362|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92669708|NCT00297362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669709|NCT00297362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669710|NCT00297362|Cholinergic Agents|cholinergic agents|mesh-ancestor
92669711|NCT00297362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669712|NCT00297362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669713|NCT00297362|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92669714|NCT00297362|Autonomic Agents|autonomic agents|mesh-ancestor
92669715|NCT00297362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669716|NCT00297362|Nootropic Agents|nootropic agents|mesh-ancestor
92669717|NCT04231773|Nitric Oxide|nitric oxide|mesh-list
92669718|NCT04231773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92669719|NCT04231773|Autonomic Agents|autonomic agents|mesh-ancestor
92669720|NCT04231773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669721|NCT04231773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669722|NCT04231773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92577769|NCT00074399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669723|NCT04231773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92669724|NCT04231773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92669725|NCT04231773|Antioxidants|antioxidants|mesh-ancestor
92669729|NCT04231773|Vasodilator Agents|vasodilator agents|mesh-ancestor
92669730|NCT04231773|Gasotransmitters|gasotransmitters|mesh-ancestor
92669731|NCT04231773|Protective Agents|protective agents|mesh-ancestor
92669732|NCT00297674|Clarithromycin|clarithromycin|mesh-list
92669733|NCT00297674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669734|NCT00297674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669735|NCT00297674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92669736|NCT00297674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669737|NCT00297674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669738|NCT00297674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92669739|NCT00297674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669740|NCT00297752|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92669741|NCT00297752|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92669742|NCT00297752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669743|NCT00297947|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92669744|NCT00297947|Antidepressive Agents|antidepressive agents|mesh-ancestor
92669745|NCT00297947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669746|NCT00297947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92669747|NCT00297947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669748|NCT00297947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669749|NCT00297947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669750|NCT04718714|Midazolam|midazolam|mesh-list
92669751|NCT04718714|Dexmedetomidine|dexmedetomidine|mesh-list
92669752|NCT04718714|Propofol|propofol|mesh-list
92669753|NCT04718714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92669754|NCT04718714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669755|NCT04718714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669756|NCT04718714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92669757|NCT04718714|Analgesics|analgesics|mesh-ancestor
92669758|NCT04718714|Sensory System Agents|sensory system agents|mesh-ancestor
92669759|NCT04718714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669760|NCT04718714|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92669761|NCT04718714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92669762|NCT04718714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92669763|NCT04718714|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669764|NCT04718714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669765|NCT04718714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669766|NCT04718714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92669767|NCT04718714|Anesthetics, General|anesthetics, general|mesh-ancestor
92669768|NCT04718714|Anesthetics|anesthetics|mesh-ancestor
92669769|NCT04718714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92669770|NCT04718714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92669771|NCT04718714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669772|NCT04718714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669773|NCT04718714|GABA Modulators|gaba modulators|mesh-ancestor
92669774|NCT04718714|GABA Agents|gaba agents|mesh-ancestor
92669775|NCT00298025|Cetrorelix|cetrorelix|mesh-list
92669776|NCT00298025|Menotropins|menotropins|mesh-list
92669777|NCT00298025|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92669778|NCT00298025|Hormones|hormones|mesh-list
92669779|NCT00298025|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92669780|NCT00298025|Ganirelix|ganirelix|mesh-list
92669781|NCT00298025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669782|NCT00298025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669783|NCT00298025|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669784|NCT00298025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92669785|NCT00298025|Fertility Agents|fertility agents|mesh-ancestor
92669786|NCT00298025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92669787|NCT00298181|polysaccharide-K|polysaccharide-k|mesh-list
92669788|NCT00298181|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92395215|NCT01389557|Artenimol|artenimol|mesh-list
92669789|NCT00298181|Immunologic Factors|immunologic factors|mesh-ancestor
92669790|NCT00298181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669791|NCT00298181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669792|NCT00298181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669794|NCT00298181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669795|NCT00298181|Interferon Inducers|interferon inducers|mesh-ancestor
92669796|NCT00298181|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92669797|NCT00298181|Protective Agents|protective agents|mesh-ancestor
92577770|NCT00074399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92577771|NCT00074399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92669800|NCT05458089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669802|NCT03754140|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92669803|NCT03754140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92669804|NCT00298415|Paclitaxel|paclitaxel|mesh-list
92669805|NCT00298415|Vinorelbine|vinorelbine|mesh-list
92669806|NCT00298415|Carboplatin|carboplatin|mesh-list
92669807|NCT00298415|Gemcitabine|gemcitabine|mesh-list
92669808|NCT00298415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92669809|NCT00298415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92669810|NCT00298415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669811|NCT00298415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92669812|NCT00298415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92669813|NCT00298415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92669814|NCT00298415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669815|NCT00298415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92669816|NCT00298415|Antimetabolites|antimetabolites|mesh-ancestor
92669817|NCT00298415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92669818|NCT00298415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669819|NCT00298454|Furosemide|furosemide|mesh-list
92669820|NCT00298454|Diuretics|diuretics|mesh-ancestor
92669821|NCT00298454|Natriuretic Agents|natriuretic agents|mesh-ancestor
92669822|NCT00298454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669823|NCT00298454|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92669824|NCT00298454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669825|NCT00298454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669826|NCT00298571|Epinephrine|epinephrine|mesh-list
92669827|NCT00298571|Bupivacaine|bupivacaine|mesh-list
92669828|NCT00298571|Anesthetics, Local|anesthetics, local|mesh-ancestor
92669829|NCT00298571|Anesthetics|anesthetics|mesh-ancestor
92669830|NCT00298571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669831|NCT00298571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669832|NCT00298571|Sensory System Agents|sensory system agents|mesh-ancestor
92669833|NCT00298571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669834|NCT00298571|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92669835|NCT00298571|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92669836|NCT00298571|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669837|NCT00298571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669838|NCT00298571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669839|NCT00298571|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92669840|NCT00298571|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92669841|NCT00298571|Autonomic Agents|autonomic agents|mesh-ancestor
92669842|NCT00298571|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92669843|NCT00298571|Respiratory System Agents|respiratory system agents|mesh-ancestor
92669844|NCT00298571|Mydriatics|mydriatics|mesh-ancestor
92669845|NCT00298571|Sympathomimetics|sympathomimetics|mesh-ancestor
92669846|NCT00298571|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92669847|NCT00298688|Gefitinib|gefitinib|mesh-list
92669848|NCT00298688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669849|NCT00298688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92669850|NCT00298688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669851|NCT00298688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669852|NCT05457894|Vaccines|vaccines|mesh-list
92669853|NCT05457894|Immunologic Factors|immunologic factors|mesh-ancestor
92669854|NCT05457894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669855|NCT00298883|Mycophenolic Acid|mycophenolic acid|mesh-list
92669856|NCT00298883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669857|NCT00298883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669858|NCT00298883|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92669859|NCT00298883|Antitubercular Agents|antitubercular agents|mesh-ancestor
92669860|NCT00298883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669861|NCT00298883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669862|NCT00298883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669863|NCT00298883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669864|NCT00298922|Azithromycin|azithromycin|mesh-list
92669865|NCT00298922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92669866|NCT00298922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669867|NCT00299039|Acetaminophen|acetaminophen|mesh-list
92669868|NCT00299039|Ibuprofen|ibuprofen|mesh-list
92669869|NCT00299039|Codeine|codeine|mesh-list
92669870|NCT00299039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92669871|NCT00299039|Analgesics|analgesics|mesh-ancestor
92669873|NCT00299039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577772|NCT00074399|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92577773|NCT00074399|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92577774|NCT00270283|Epoetin Alfa|epoetin alfa|mesh-list
92669874|NCT00299039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669875|NCT00299039|Antipyretics|antipyretics|mesh-ancestor
92669876|NCT00299039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92669877|NCT00299039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92669878|NCT00299039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92669879|NCT00299039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92669880|NCT00299039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669881|NCT00299039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669882|NCT00299039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92669883|NCT00299039|Narcotics|narcotics|mesh-ancestor
92669884|NCT00299039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669885|NCT00299039|Antitussive Agents|antitussive agents|mesh-ancestor
92669886|NCT00299039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92669887|NCT00299234|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92669888|NCT00299234|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92669889|NCT00299234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92669890|NCT00299234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669891|NCT00299234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669892|NCT00299234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92669893|NCT00299234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669894|NCT00299234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669895|NCT00299351|Romidepsin|romidepsin|mesh-list
92669896|NCT00299351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92669897|NCT00299351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669898|NCT00299351|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92669899|NCT00299351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669900|NCT00299351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669901|NCT00299390|Sagopilone|sagopilone|mesh-list
92669902|NCT00299390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669903|NCT02808585|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
92669904|NCT02808585|Vasodilator Agents|vasodilator agents|mesh-ancestor
92669905|NCT00299819|Sifalimumab|sifalimumab|mesh-list
92669906|NCT00299819|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92669907|NCT00299819|Immunologic Factors|immunologic factors|mesh-ancestor
92669908|NCT00299819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669909|NCT00299858|Theophylline|theophylline|mesh-list
92669910|NCT00299858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92669911|NCT00299858|Autonomic Agents|autonomic agents|mesh-ancestor
92669912|NCT00299858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669913|NCT00299858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669914|NCT00299858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92669915|NCT00299858|Respiratory System Agents|respiratory system agents|mesh-ancestor
92669916|NCT00299858|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92669917|NCT00299858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669918|NCT00299858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669919|NCT00299858|Vasodilator Agents|vasodilator agents|mesh-ancestor
92669920|NCT00299858|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92669921|NCT00299858|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92669922|NCT00299858|Purinergic Agents|purinergic agents|mesh-ancestor
92669923|NCT00299858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669924|NCT05455944|Pregabalin|pregabalin|mesh-list
92669925|NCT05455944|Analgesics|analgesics|mesh-ancestor
92669926|NCT05455944|Sensory System Agents|sensory system agents|mesh-ancestor
92669927|NCT05455944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669928|NCT05455944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669929|NCT05455944|Anticonvulsants|anticonvulsants|mesh-ancestor
92669930|NCT05455944|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92669931|NCT05455944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669932|NCT05455944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669933|NCT05455944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92669934|NCT05455944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92669935|NCT05455944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669936|NCT05455944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669937|NCT05455944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669938|NCT00299936|Ribavirin|ribavirin|mesh-list
92669939|NCT00299936|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92669941|NCT00299936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577776|NCT00270322|Fentanyl|fentanyl|mesh-list
92577777|NCT00270322|Morphine|morphine|mesh-list
92577778|NCT00270322|Bupivacaine|bupivacaine|mesh-list
92577779|NCT00270322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92669942|NCT00299936|Antiviral Agents|antiviral agents|mesh-ancestor
92669943|NCT00299936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669944|NCT00300014|Triamcinolone|triamcinolone|mesh-list
92669948|NCT00300014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669949|NCT00300014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669950|NCT00300131|Everolimus|everolimus|mesh-list
92669951|NCT00300131|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92669952|NCT00300131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92669953|NCT00300131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669954|NCT00300131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669955|NCT00300131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669956|NCT00300131|Immunologic Factors|immunologic factors|mesh-ancestor
92669957|NCT00300131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669958|NCT00300131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669959|NCT01785459|Prochlorperazine|prochlorperazine|mesh-list
92669960|NCT01785459|Bupivacaine|bupivacaine|mesh-list
92669961|NCT01785459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92669962|NCT01785459|Anesthetics|anesthetics|mesh-ancestor
92669963|NCT01785459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92669964|NCT01785459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669965|NCT01785459|Sensory System Agents|sensory system agents|mesh-ancestor
92669966|NCT01785459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92669967|NCT01785459|Antiemetics|antiemetics|mesh-ancestor
92669968|NCT01785459|Autonomic Agents|autonomic agents|mesh-ancestor
92669969|NCT01785459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92669970|NCT01785459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92669971|NCT01785459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92669972|NCT01785459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92669973|NCT01785459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92669974|NCT01785459|Dopamine Agents|dopamine agents|mesh-ancestor
92669975|NCT01785459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669976|NCT01785459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669977|NCT04716894|Itraconazole|itraconazole|mesh-list
92669978|NCT04716894|Antifungal Agents|antifungal agents|mesh-ancestor
92669979|NCT04716894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92669980|NCT04716894|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92669981|NCT04716894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92669982|NCT04716894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669983|NCT04716894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669984|NCT04716894|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92669985|NCT04716894|Hormone Antagonists|hormone antagonists|mesh-ancestor
92669986|NCT04716894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92669987|NCT04716894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669988|NCT04716894|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92669989|NCT00300287|Vildagliptin|vildagliptin|mesh-list
92669990|NCT00300287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92669991|NCT00300287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669992|NCT00300287|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92669993|NCT00300287|Protease Inhibitors|protease inhibitors|mesh-ancestor
92669994|NCT00300287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92669995|NCT00300287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669996|NCT00300404|Leucovorin|leucovorin|mesh-list
92669997|NCT00300404|Folic Acid|folic acid|mesh-list
92669998|NCT00300404|Pyrimethamine|pyrimethamine|mesh-list
92669999|NCT00300404|Levoleucovorin|levoleucovorin|mesh-list
92670000|NCT00300404|Antidotes|antidotes|mesh-ancestor
92670001|NCT00300404|Protective Agents|protective agents|mesh-ancestor
92670002|NCT00300404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670003|NCT00300404|Vitamin B Complex|vitamin b complex|mesh-ancestor
92670004|NCT00300404|Vitamins|vitamins|mesh-ancestor
92670005|NCT00300404|Micronutrients|micronutrients|mesh-ancestor
92670006|NCT00300404|Hematinics|hematinics|mesh-ancestor
92670007|NCT00300404|Antimalarials|antimalarials|mesh-ancestor
92670008|NCT00300404|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92670009|NCT00300404|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92670010|NCT00300404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670011|NCT00300404|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92670012|NCT00300404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577780|NCT00270322|Narcotics|narcotics|mesh-ancestor
92577781|NCT00270322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670013|NCT00300404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670014|NCT01539447|Naproxen|naproxen|mesh-list
92670015|NCT01539447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92670016|NCT01539447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670017|NCT01539447|Analgesics|analgesics|mesh-ancestor
92670019|NCT01539447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670020|NCT01539447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670021|NCT01539447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670022|NCT01539447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670023|NCT01539447|Gout Suppressants|gout suppressants|mesh-ancestor
92670024|NCT01539447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92670025|NCT01539447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670026|NCT01539447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670027|NCT00300443|Bimatoprost|bimatoprost|mesh-list
92670028|NCT00300443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670029|NCT00300560|Colistin|colistin|mesh-list
92670030|NCT00300560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670031|NCT00300560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670032|NCT00327522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92670033|NCT00327522|Immunologic Factors|immunologic factors|mesh-ancestor
92670034|NCT00327522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670035|NCT00300716|Memantine|memantine|mesh-list
92670036|NCT00300716|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92670037|NCT00300716|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92670038|NCT00300716|Dopamine Agents|dopamine agents|mesh-ancestor
92670039|NCT00300716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670040|NCT00300716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670041|NCT00300716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670042|NCT00300716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92670043|NCT00300716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92670044|NCT00300794|Ketamine|ketamine|mesh-list
92670045|NCT00300794|Analgesics|analgesics|mesh-ancestor
92670046|NCT00300794|Sensory System Agents|sensory system agents|mesh-ancestor
92670047|NCT00300794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670048|NCT00300794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670049|NCT00300794|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92670050|NCT00300794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92670051|NCT00300794|Anesthetics, General|anesthetics, general|mesh-ancestor
92670052|NCT00300794|Anesthetics|anesthetics|mesh-ancestor
92670053|NCT00300794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670054|NCT00300794|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92670055|NCT00300794|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92670056|NCT00300794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670057|NCT00300794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670058|NCT05373303|Epoetin Alfa|epoetin alfa|mesh-list
92670059|NCT05373303|Hematinics|hematinics|mesh-ancestor
92670060|NCT00300833|Tirofiban|tirofiban|mesh-list
92670061|NCT00300833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92670062|NCT00300833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92670063|NCT00300833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670064|NCT00300833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92670065|NCT00300911|Rosiglitazone|rosiglitazone|mesh-list
92670066|NCT00300911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92670067|NCT00300911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670068|NCT00327678|Rituximab|rituximab|mesh-list
92670069|NCT00327678|Imatinib Mesylate|imatinib mesylate|mesh-list
92670070|NCT00327678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670071|NCT00327678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670072|NCT00327678|Immunologic Factors|immunologic factors|mesh-ancestor
92670073|NCT00327678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670074|NCT00327678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670075|NCT00327678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92670076|NCT00327678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670077|NCT00327678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670078|NCT00300950|Gemcitabine|gemcitabine|mesh-list
92670079|NCT00300950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670080|NCT00300950|Antimetabolites|antimetabolites|mesh-ancestor
92670081|NCT00300950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670082|NCT00300950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670083|NCT00327756|Ubiquinone|ubiquinone|mesh-list
92577782|NCT00270322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577783|NCT00270322|Analgesics|analgesics|mesh-ancestor
92577784|NCT00270322|Sensory System Agents|sensory system agents|mesh-ancestor
92670084|NCT00327756|Coenzyme Q10|coenzyme q10|mesh-list
92670085|NCT00327756|Micronutrients|micronutrients|mesh-ancestor
92670086|NCT00327756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670087|NCT00327756|Vitamins|vitamins|mesh-ancestor
92670088|NCT00301106|Interleukin-12|interleukin-12|mesh-list
92395517|NCT01391377|Vitamins|vitamins|mesh-ancestor
92670089|NCT00301106|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92670090|NCT00301106|Immunologic Factors|immunologic factors|mesh-ancestor
92670093|NCT00301106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92670094|NCT00301106|Growth Substances|growth substances|mesh-ancestor
92670095|NCT00301106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92670096|NCT00301106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670097|NCT00301145|Varenicline|varenicline|mesh-list
92670098|NCT00301145|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92670099|NCT00301145|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92670100|NCT00301145|Cholinergic Agents|cholinergic agents|mesh-ancestor
92670101|NCT00301145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670102|NCT00301145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670103|NCT00301145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670104|NCT00301223|Pregabalin|pregabalin|mesh-list
92670105|NCT00301223|Analgesics|analgesics|mesh-ancestor
92670106|NCT00301223|Sensory System Agents|sensory system agents|mesh-ancestor
92670107|NCT00301223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670108|NCT00301223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670109|NCT00301223|Anticonvulsants|anticonvulsants|mesh-ancestor
92670110|NCT00301223|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92670111|NCT00301223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670112|NCT00301223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670113|NCT00301223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92670114|NCT00301223|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92670115|NCT00301223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92670116|NCT00301223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670117|NCT00301223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92670118|NCT00301301|Rituximab|rituximab|mesh-list
92670119|NCT00301301|Gemcitabine|gemcitabine|mesh-list
92670120|NCT00301301|Cisplatin|cisplatin|mesh-list
92670121|NCT00301301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670122|NCT00301301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670123|NCT00301301|Immunologic Factors|immunologic factors|mesh-ancestor
92670124|NCT00301301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670125|NCT00301301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670126|NCT00301301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670127|NCT00301301|Antimetabolites|antimetabolites|mesh-ancestor
92670128|NCT00301301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670129|NCT00301535|Chrysarobin|chrysarobin|mesh-list
92670130|NCT00301535|HBOC 201|hboc 201|mesh-list
92670131|NCT00301535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92670132|NCT00301535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670133|NCT00301535|Analgesics|analgesics|mesh-ancestor
92670134|NCT00301535|Sensory System Agents|sensory system agents|mesh-ancestor
92670135|NCT00301535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670136|NCT00301535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670137|NCT00301535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670138|NCT00301535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670139|NCT00301535|Blood Substitutes|blood substitutes|mesh-ancestor
92670140|NCT00301574|Galantamine|galantamine|mesh-list
92670141|NCT00301574|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92670142|NCT00301574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670143|NCT00301574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670144|NCT00301574|Cholinergic Agents|cholinergic agents|mesh-ancestor
92670145|NCT00301574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670146|NCT00301574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670147|NCT00301574|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92670148|NCT00301574|Autonomic Agents|autonomic agents|mesh-ancestor
92670149|NCT00301574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670150|NCT00301574|Nootropic Agents|nootropic agents|mesh-ancestor
92670151|NCT00327834|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92670152|NCT00327834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92670153|NCT00327834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92670154|NCT00327834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92577785|NCT00270322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577786|NCT00270322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577787|NCT00270322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92577788|NCT00270322|Anesthetics, General|anesthetics, general|mesh-ancestor
92670155|NCT00327834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670156|NCT00327834|Adrenergic Agents|adrenergic agents|mesh-ancestor
92670157|NCT00327834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670158|NCT00327834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670159|NCT00301613|Mycophenolic Acid|mycophenolic acid|mesh-list
92670160|NCT00301613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92670161|NCT00301613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670162|NCT00301613|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92670168|NCT00301652|Mycophenolic Acid|mycophenolic acid|mesh-list
92670169|NCT00301652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92670170|NCT00301652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670171|NCT00301652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92670172|NCT00301652|Antitubercular Agents|antitubercular agents|mesh-ancestor
92670173|NCT00301652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670174|NCT00301652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670175|NCT00301652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670176|NCT00301652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670177|NCT00301730|Aldesleukin|aldesleukin|mesh-list
92670179|NCT00301730|Trastuzumab|trastuzumab|mesh-list
92670180|NCT00301730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92670181|NCT00301730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670182|NCT00301730|Tubulin Modulators|tubulin modulators|mesh-ancestor
92670183|NCT00301730|Antimitotic Agents|antimitotic agents|mesh-ancestor
92670184|NCT00301730|Mitosis Modulators|mitosis modulators|mesh-ancestor
92670185|NCT00301730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670186|NCT00301730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670187|NCT00301730|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92670188|NCT00301730|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92670189|NCT00301730|Antiviral Agents|antiviral agents|mesh-ancestor
92670190|NCT00301730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670191|NCT00301847|Sorafenib|sorafenib|mesh-list
92670192|NCT00301847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670193|NCT00301847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92670194|NCT00301847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670195|NCT00301847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670196|NCT00327990|Alendronate|alendronate|mesh-list
92670197|NCT00327990|Ibandronic Acid|ibandronic acid|mesh-list
92670198|NCT00327990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92670199|NCT00327990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670200|NCT00301886|Zoledronic Acid|zoledronic acid|mesh-list
92670201|NCT00301886|Ibandronic Acid|ibandronic acid|mesh-list
92670202|NCT00301886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92670203|NCT00301886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670204|NCT05238831|Paclitaxel|paclitaxel|mesh-list
92670205|NCT05238831|Vinorelbine|vinorelbine|mesh-list
92670206|NCT05238831|Maytansine|maytansine|mesh-list
92670207|NCT05238831|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92670208|NCT05238831|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92670209|NCT05238831|Bevacizumab|bevacizumab|mesh-list
92670210|NCT05238831|Carboplatin|carboplatin|mesh-list
92670211|NCT05238831|Capecitabine|capecitabine|mesh-list
92670212|NCT05238831|Trastuzumab|trastuzumab|mesh-list
92670213|NCT05238831|Irinotecan|irinotecan|mesh-list
92670214|NCT05238831|Atezolizumab|atezolizumab|mesh-list
92670215|NCT05238831|Letrozole|letrozole|mesh-list
92670216|NCT05238831|Fulvestrant|fulvestrant|mesh-list
92670217|NCT05238831|Olaparib|olaparib|mesh-list
92670218|NCT05238831|Palbociclib|palbociclib|mesh-list
92670219|NCT05238831|Pertuzumab|pertuzumab|mesh-list
92670220|NCT05238831|Anastrozole|anastrozole|mesh-list
92670221|NCT05238831|Niraparib|niraparib|mesh-list
92670222|NCT05238831|Vemurafenib|vemurafenib|mesh-list
92670223|NCT05238831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92670224|NCT05238831|Endothelial Growth Factors|endothelial growth factors|mesh-list
92670225|NCT05238831|Antibodies|antibodies|mesh-list
92670226|NCT05238831|Immunoglobulins|immunoglobulins|mesh-list
92670227|NCT05238831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92670228|NCT05238831|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92670229|NCT05238831|Immunoglobulin G|immunoglobulin g|mesh-list
92670230|NCT05238831|Entrectinib|entrectinib|mesh-list
92577789|NCT00270322|Anesthetics|anesthetics|mesh-ancestor
92577790|NCT00270322|Anesthetics, Local|anesthetics, local|mesh-ancestor
92577791|NCT00270361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92577792|NCT00270361|Natriuretic Agents|natriuretic agents|mesh-ancestor
92670231|NCT05238831|Immunoconjugates|immunoconjugates|mesh-list
92670232|NCT05238831|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
92670233|NCT05238831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92670234|NCT05238831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670235|NCT05238831|Tubulin Modulators|tubulin modulators|mesh-ancestor
92670236|NCT05238831|Antimitotic Agents|antimitotic agents|mesh-ancestor
92670238|NCT05238831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670240|NCT05238831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92670241|NCT05238831|Growth Substances|growth substances|mesh-ancestor
92670242|NCT05238831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670243|NCT05238831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92670244|NCT05238831|Immunologic Factors|immunologic factors|mesh-ancestor
92670245|NCT05238831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670246|NCT05238831|Antimetabolites|antimetabolites|mesh-ancestor
92670247|NCT05238831|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92670248|NCT05238831|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92670249|NCT05238831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670250|NCT05238831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92670251|NCT05238831|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92670252|NCT05238831|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92670253|NCT05238831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92670254|NCT05238831|Hormone Antagonists|hormone antagonists|mesh-ancestor
92670255|NCT05238831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670256|NCT05238831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92670257|NCT05238831|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92670258|NCT05238831|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92670259|NCT05238831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92670260|NCT05238831|Immunotoxins|immunotoxins|mesh-ancestor
92670261|NCT00301925|Cyclophosphamide|cyclophosphamide|mesh-list
92670262|NCT00301925|Fluorouracil|fluorouracil|mesh-list
92670263|NCT00301925|Capecitabine|capecitabine|mesh-list
92670264|NCT00301925|Methotrexate|methotrexate|mesh-list
92670266|NCT00301925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670267|NCT00301925|Immunologic Factors|immunologic factors|mesh-ancestor
92670268|NCT00301925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670269|NCT00301925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670270|NCT00301925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92670271|NCT00301925|Alkylating Agents|alkylating agents|mesh-ancestor
92670272|NCT00301925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670273|NCT00301925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670274|NCT00301925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92670275|NCT00301925|Antimetabolites|antimetabolites|mesh-ancestor
92670276|NCT00301925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670277|NCT00301925|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92670278|NCT00301925|Abortifacient Agents|abortifacient agents|mesh-ancestor
92670279|NCT00301925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92670280|NCT00301925|Dermatologic Agents|dermatologic agents|mesh-ancestor
92670281|NCT00301925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670282|NCT00301925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92670283|NCT00301925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92670284|NCT00301925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92670285|NCT00301925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92670286|NCT00301925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92670287|NCT00328029|Busulfan|busulfan|mesh-list
92670288|NCT00328029|Alkylating Agents|alkylating agents|mesh-ancestor
92670289|NCT00328029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670290|NCT00328029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670291|NCT00328029|Immunologic Factors|immunologic factors|mesh-ancestor
92670292|NCT00328029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670293|NCT00328029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92670294|NCT00328029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670295|NCT00328029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92670296|NCT00302354|Methylphenidate|methylphenidate|mesh-list
92670297|NCT00302354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92670298|NCT00302354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577793|NCT00270361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577794|NCT02966249|Levobupivacaine|levobupivacaine|mesh-list
92577795|NCT02966249|Anesthetics, Local|anesthetics, local|mesh-ancestor
92577796|NCT02966249|Anesthetics|anesthetics|mesh-ancestor
92577797|NCT02966249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027747|NCT04239313|Vaccines|vaccines|mesh-list
92670299|NCT00302354|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92670300|NCT00302354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92670301|NCT00302354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670302|NCT00302354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670303|NCT00302354|Dopamine Agents|dopamine agents|mesh-ancestor
92670304|NCT00302354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670305|NCT00302393|Methylphenidate|methylphenidate|mesh-list
92670329|NCT00302549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670330|NCT00302549|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92670331|NCT00302549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670332|NCT00302549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670333|NCT00419991|Tigecycline|tigecycline|mesh-list
92670334|NCT00419991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670335|NCT00419991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670336|NCT00419991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92670337|NCT00419991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670338|NCT00419991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670339|NCT00302627|Calcium, Dietary|calcium, dietary|mesh-list
92670340|NCT00302627|Vitamin D|vitamin d|mesh-list
92670341|NCT00302627|Ergocalciferols|ergocalciferols|mesh-list
92670342|NCT00302627|Cholecalciferol|cholecalciferol|mesh-list
92670343|NCT00302627|Pamidronate|pamidronate|mesh-list
92670344|NCT00302627|Vitamins|vitamins|mesh-list
92670345|NCT00302627|Calcium Carbonate|calcium carbonate|mesh-list
92670346|NCT00302627|Calcium|calcium|mesh-list
92670347|NCT00302627|Micronutrients|micronutrients|mesh-ancestor
92670348|NCT00302627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670349|NCT00302627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92670350|NCT00302627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92670351|NCT00302627|Antacids|antacids|mesh-ancestor
92670352|NCT00302627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670353|NCT00302627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92670354|NCT00302666|Dienogest|dienogest|mesh-list
92670355|NCT00302666|Nandrolone|nandrolone|mesh-list
92670356|NCT00302666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92670357|NCT00302666|Contraceptive Agents|contraceptive agents|mesh-ancestor
92670358|NCT00302666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92670360|NCT00302666|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92670361|NCT00302666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92670362|NCT00302666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92670363|NCT00302666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92670364|NCT00302666|Hormone Antagonists|hormone antagonists|mesh-ancestor
92670365|NCT00302666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670366|NCT00302666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92670367|NCT00302666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670368|NCT00302666|Androgens|androgens|mesh-ancestor
92670369|NCT00302666|Hormones|hormones|mesh-ancestor
92670370|NCT00302666|Anabolic Agents|anabolic agents|mesh-ancestor
92670371|NCT00328302|Candesartan|candesartan|mesh-list
92670372|NCT00328302|Candesartan cilexetil|candesartan cilexetil|mesh-list
92670373|NCT00328302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670374|NCT00328302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92670375|NCT00328302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92670376|NCT00328302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670377|NCT00328380|Rifaximin|rifaximin|mesh-list
92670378|NCT00328380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670379|NCT00328380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670380|NCT00328380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92670381|NCT00418496|Aldesleukin|aldesleukin|mesh-list
92670382|NCT00418496|Sorafenib|sorafenib|mesh-list
92670383|NCT00418496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670384|NCT00418496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92670385|NCT00418496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670386|NCT00418496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577798|NCT02966249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577799|NCT02966249|Sensory System Agents|sensory system agents|mesh-ancestor
92670387|NCT00418496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92670388|NCT00418496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92670389|NCT00418496|Antiviral Agents|antiviral agents|mesh-ancestor
92670390|NCT00418496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670392|NCT00302705|Enalapril|enalapril|mesh-list
92670393|NCT00302705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670394|NCT00302705|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92670395|NCT00302705|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92670396|NCT00302705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670397|NCT00302705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92670398|NCT00302705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92670399|NCT00302705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670400|NCT00302822|Tenofovir|tenofovir|mesh-list
92670401|NCT00302822|Emtricitabine|emtricitabine|mesh-list
92670402|NCT00302822|Efavirenz|efavirenz|mesh-list
92670403|NCT00302822|Lopinavir|lopinavir|mesh-list
92670404|NCT00302822|Enfuvirtide|enfuvirtide|mesh-list
92670405|NCT00302822|Antiviral Agents|antiviral agents|mesh-ancestor
92670406|NCT00302822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670407|NCT00302822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92670408|NCT00302822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92670409|NCT00302822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670410|NCT00302822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670411|NCT00302822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92670412|NCT00302822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92670413|NCT00302822|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92670414|NCT00302822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92670415|NCT00302822|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92670416|NCT00302822|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92670417|NCT00302822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92670418|NCT00302822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92670419|NCT00302822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92670420|NCT00302822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92670421|NCT00302822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92670422|NCT00302822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92670423|NCT00302822|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92670424|NCT00302822|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92670425|NCT00328458|Epothilones|epothilones|mesh-list
92670426|NCT00328458|Epothilone B|epothilone b|mesh-list
92670427|NCT00328458|Tubulin Modulators|tubulin modulators|mesh-ancestor
92670428|NCT00328458|Antimitotic Agents|antimitotic agents|mesh-ancestor
92670429|NCT00328458|Mitosis Modulators|mitosis modulators|mesh-ancestor
92670430|NCT00328458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670431|NCT00328458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670432|NCT00303017|Naproxen|naproxen|mesh-list
92670435|NCT00303017|Analgesics|analgesics|mesh-ancestor
92670436|NCT00303017|Sensory System Agents|sensory system agents|mesh-ancestor
92670437|NCT00303017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670438|NCT00303017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670439|NCT00303017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670440|NCT00303017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670441|NCT00303017|Gout Suppressants|gout suppressants|mesh-ancestor
92670442|NCT00303017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92670443|NCT00303017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670444|NCT00303017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670445|NCT00303056|Icatibant|icatibant|mesh-list
92670446|NCT00303056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92670447|NCT00303056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670448|NCT00303056|Analgesics|analgesics|mesh-ancestor
92670449|NCT00303056|Sensory System Agents|sensory system agents|mesh-ancestor
92670450|NCT00303056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670451|NCT00303056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670452|NCT00303056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670453|NCT00303056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670454|NCT00303056|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92670455|NCT00303056|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92670456|NCT00303056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670457|NCT00303056|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92670458|NCT00303056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577800|NCT02966249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577801|NCT00270400|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92670459|NCT00303056|Immunologic Factors|immunologic factors|mesh-ancestor
92670460|NCT00328497|Bevacizumab|bevacizumab|mesh-list
92670461|NCT00328497|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92670462|NCT00328497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670463|NCT00328497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670464|NCT00328497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92670465|NCT00328497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92670466|NCT00328497|Growth Substances|growth substances|mesh-ancestor
92670467|NCT00328497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670468|NCT00328497|Growth Inhibitors|growth inhibitors|mesh-ancestor
92670469|NCT00328497|Tubulin Modulators|tubulin modulators|mesh-ancestor
92670470|NCT00328497|Antimitotic Agents|antimitotic agents|mesh-ancestor
92670471|NCT00328497|Mitosis Modulators|mitosis modulators|mesh-ancestor
92670472|NCT00328497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670473|NCT00303290|Interferons|interferons|mesh-list
92670475|NCT00303290|Interferon-alpha|interferon-alpha|mesh-list
92670476|NCT00303290|Interferon alpha-2|interferon alpha-2|mesh-list
92670477|NCT00303290|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92670478|NCT00303290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670479|NCT00303290|Antiviral Agents|antiviral agents|mesh-ancestor
92670480|NCT00303290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670481|NCT00303290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670482|NCT00303290|Antimetabolites|antimetabolites|mesh-ancestor
92670483|NCT00303290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670484|NCT00303290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670485|NCT00303290|Immunologic Factors|immunologic factors|mesh-ancestor
92670486|NCT00303290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670487|NCT00328692|Rolofylline|rolofylline|mesh-list
92670488|NCT00328692|Diuretics|diuretics|mesh-ancestor
92670489|NCT00328692|Natriuretic Agents|natriuretic agents|mesh-ancestor
92670490|NCT00328692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670491|NCT00419718|Insulin|insulin|mesh-list
92670492|NCT00419718|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92670493|NCT00419718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92670494|NCT00419718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670495|NCT00303407|Nadroparin|nadroparin|mesh-list
92670496|NCT00303407|Anticoagulants|anticoagulants|mesh-ancestor
92670497|NCT00303407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92670498|NCT00303407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92670499|NCT00303407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670500|NCT00303524|Goserelin|goserelin|mesh-list
92670501|NCT00303524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92670502|NCT00303524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670503|NCT00419796|Lumiracoxib|lumiracoxib|mesh-list
92670504|NCT00419796|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92670505|NCT00419796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92670510|NCT00419796|Analgesics|analgesics|mesh-ancestor
92670511|NCT00419796|Sensory System Agents|sensory system agents|mesh-ancestor
92670512|NCT00419796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670513|NCT00419796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670514|NCT00419796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670515|NCT00419796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670516|NCT00419835|Losartan|losartan|mesh-list
92670517|NCT00419835|Enalapril|enalapril|mesh-list
92670518|NCT00419835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92670519|NCT00419835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670520|NCT00419835|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92670521|NCT00419835|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92670522|NCT00419835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670523|NCT00419835|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92670524|NCT00419835|Protease Inhibitors|protease inhibitors|mesh-ancestor
92670525|NCT00419835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670526|NCT00328809|Spironolactone|spironolactone|mesh-list
92670527|NCT00328809|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92670528|NCT00328809|Hormone Antagonists|hormone antagonists|mesh-ancestor
92670529|NCT00328809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670530|NCT00328809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670531|NCT00328809|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92670532|NCT00328809|Diuretics|diuretics|mesh-ancestor
92670533|NCT00328809|Natriuretic Agents|natriuretic agents|mesh-ancestor
92670534|NCT00420030|Abciximab|abciximab|mesh-list
92577802|NCT00270400|Natriuretic Agents|natriuretic agents|mesh-ancestor
92577803|NCT00270400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027927|NCT05189977|Prazosin|prazosin|mesh-list
92670535|NCT00420030|Anticoagulants|anticoagulants|mesh-ancestor
92670536|NCT00420030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92670537|NCT00303758|Leucovorin|leucovorin|mesh-list
92670539|NCT00303758|Fluorouracil|fluorouracil|mesh-list
92670540|NCT00303758|Calcium|calcium|mesh-list
92670541|NCT00303758|Levoleucovorin|levoleucovorin|mesh-list
92670542|NCT00303758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670543|NCT00303758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670544|NCT00303758|Antimetabolites|antimetabolites|mesh-ancestor
92670545|NCT00303758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670546|NCT00303758|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92670547|NCT00303758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670548|NCT00303758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670549|NCT00303758|Immunologic Factors|immunologic factors|mesh-ancestor
92670550|NCT00303758|Antidotes|antidotes|mesh-ancestor
92670551|NCT00303758|Protective Agents|protective agents|mesh-ancestor
92670552|NCT00303758|Vitamin B Complex|vitamin b complex|mesh-ancestor
92670553|NCT00303758|Vitamins|vitamins|mesh-ancestor
92670554|NCT00303758|Micronutrients|micronutrients|mesh-ancestor
92670555|NCT00303797|Bortezomib|bortezomib|mesh-list
92670556|NCT00303797|Sorafenib|sorafenib|mesh-list
92670557|NCT00303797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670558|NCT00303797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92670559|NCT00303797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670560|NCT00303797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670561|NCT00303836|Aldesleukin|aldesleukin|mesh-list
92670562|NCT00303836|Cyclophosphamide|cyclophosphamide|mesh-list
92670563|NCT00303836|Fludarabine|fludarabine|mesh-list
92670564|NCT00303836|Fludarabine phosphate|fludarabine phosphate|mesh-list
92670565|NCT00303836|Interleukin-2|interleukin-2|mesh-list
92670566|NCT00303836|Freund's Adjuvant|freund's adjuvant|mesh-list
92670567|NCT00303836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670568|NCT00303836|Immunologic Factors|immunologic factors|mesh-ancestor
92670569|NCT00303836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670570|NCT00303836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670571|NCT00303836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92670572|NCT00303836|Alkylating Agents|alkylating agents|mesh-ancestor
92670573|NCT00303836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670574|NCT00303836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670575|NCT00303836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92670576|NCT00303836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670577|NCT00303836|Antimetabolites|antimetabolites|mesh-ancestor
92670582|NCT00303836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670583|NCT00303836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92670584|NCT00303836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92670585|NCT00303836|Antiviral Agents|antiviral agents|mesh-ancestor
92670586|NCT00303836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670587|NCT00303992|Trastuzumab|trastuzumab|mesh-list
92670588|NCT00303992|Irinotecan|irinotecan|mesh-list
92670589|NCT00303992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92670590|NCT00303992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670591|NCT00303992|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92670592|NCT00303992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92670593|NCT00303992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670594|NCT00303992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670595|NCT00304226|Amlodipine|amlodipine|mesh-list
92670596|NCT00304226|Valsartan|valsartan|mesh-list
92670597|NCT00304226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670598|NCT00304226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92670599|NCT00304226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670600|NCT00304226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670601|NCT00304226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92670602|NCT00304226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670603|NCT00304226|Vasodilator Agents|vasodilator agents|mesh-ancestor
92670604|NCT00304226|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92670605|NCT00304226|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92670606|NCT00332319|Casopitant|casopitant|mesh-list
92670607|NCT00332319|Antiemetics|antiemetics|mesh-ancestor
92670608|NCT00332319|Autonomic Agents|autonomic agents|mesh-ancestor
92670609|NCT00332319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670610|NCT00332319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577804|NCT00107094|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92670611|NCT00332319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396036|NCT01394471|Oxytocics|oxytocics|mesh-ancestor
92670612|NCT00332319|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92670613|NCT00332319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670614|NCT00332319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670615|NCT00304382|Vaccines|vaccines|mesh-list
92670616|NCT00304382|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92670617|NCT00304382|Immunologic Factors|immunologic factors|mesh-ancestor
92670618|NCT00304382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670619|NCT00304421|Rabeprazole|rabeprazole|mesh-list
92670620|NCT00304421|Pantoprazole|pantoprazole|mesh-list
92670621|NCT00304421|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92670622|NCT00304421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92670623|NCT00304421|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92670624|NCT00304421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670625|NCT00304421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670626|NCT00332397|Sirolimus|sirolimus|mesh-list
92670627|NCT00332397|Temsirolimus|temsirolimus|mesh-list
92670628|NCT00332397|MTOR Inhibitors|mtor inhibitors|mesh-list
92670629|NCT00332397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670630|NCT00332397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670631|NCT00332397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91962375|NCT05714371|Dabrafenib|dabrafenib|mesh-list
92670632|NCT00332397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670633|NCT00332397|Antifungal Agents|antifungal agents|mesh-ancestor
92670634|NCT00332397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670635|NCT00332397|Immunologic Factors|immunologic factors|mesh-ancestor
92670636|NCT00332397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670637|NCT00332397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92670638|NCT00332397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670639|NCT00332397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670640|NCT00304460|Aldesleukin|aldesleukin|mesh-list
92670641|NCT00304460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670642|NCT00304460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92670643|NCT00304460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92670644|NCT00304460|Antiviral Agents|antiviral agents|mesh-ancestor
92670645|NCT00304460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670646|NCT00304499|Oxybutynin|oxybutynin|mesh-list
92670647|NCT00304499|Parasympatholytics|parasympatholytics|mesh-ancestor
92670648|NCT00304499|Autonomic Agents|autonomic agents|mesh-ancestor
92670652|NCT00304499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92670653|NCT00304499|Cholinergic Agents|cholinergic agents|mesh-ancestor
92670654|NCT00304499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670655|NCT00304499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670656|NCT00304499|Urological Agents|urological agents|mesh-ancestor
92670658|NCT00304538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92670659|NCT00304538|Hormones|hormones|mesh-ancestor
92670660|NCT00304538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670661|NCT00304538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670662|NCT00420498|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92670663|NCT00420498|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92670664|NCT00420498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92670665|NCT00420498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670666|NCT00420498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670667|NCT00420498|Adrenergic Agents|adrenergic agents|mesh-ancestor
92670668|NCT00420498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670669|NCT00420498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670670|NCT00328965|Lacidipine|lacidipine|mesh-list
92670671|NCT00328965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670672|NCT00328965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92670673|NCT00328965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670674|NCT00328965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670675|NCT00328965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92670676|NCT00328965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670677|NCT00304616|Olanzapine|olanzapine|mesh-list
92670678|NCT00304616|Risperidone|risperidone|mesh-list
92670679|NCT00304616|Aripiprazole|aripiprazole|mesh-list
92670680|NCT00304616|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92670681|NCT00304616|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92670682|NCT00304616|Serotonin Agents|serotonin agents|mesh-ancestor
92670683|NCT00304616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670684|NCT00304616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670685|NCT00304616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577805|NCT00107094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577806|NCT00270478|Hydroxyurea|hydroxyurea|mesh-list
92577807|NCT00270478|Epoetin Alfa|epoetin alfa|mesh-list
92577808|NCT00270478|Hematinics|hematinics|mesh-ancestor
92577809|NCT00270478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577810|NCT00270478|Antisickling Agents|antisickling agents|mesh-ancestor
92577811|NCT00270478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577812|NCT00270478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670686|NCT00304616|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92670687|NCT00304616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92670688|NCT00304616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670689|NCT00304616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92670690|NCT00304616|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92670691|NCT00304616|Dopamine Agents|dopamine agents|mesh-ancestor
92670692|NCT00304616|Antiemetics|antiemetics|mesh-ancestor
92670693|NCT00304616|Autonomic Agents|autonomic agents|mesh-ancestor
92670694|NCT00304616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670695|NCT00304616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92670696|NCT00304616|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92670697|NCT00304616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92670698|NCT00304616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670699|NCT00304616|Antidepressive Agents|antidepressive agents|mesh-ancestor
92670700|NCT00304616|Dopamine Agonists|dopamine agonists|mesh-ancestor
92670701|NCT00304616|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92670702|NCT00304616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92670703|NCT00304616|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92670704|NCT00304616|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92670705|NCT00332436|Timolol|timolol|mesh-list
92670706|NCT00332436|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92670707|NCT00332436|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92670708|NCT00332436|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92670709|NCT00332436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92670710|NCT00332436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670711|NCT00332436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670712|NCT00332436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670713|NCT00332436|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92670714|NCT00332436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670715|NCT00332436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92670716|NCT00332436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92670719|NCT00304655|Antidepressive Agents|antidepressive agents|mesh-ancestor
92670720|NCT00304655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92670721|NCT00304655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92670722|NCT00304655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92670723|NCT00304655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670724|NCT00304655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670725|NCT00304655|Dopamine Agonists|dopamine agonists|mesh-ancestor
92670726|NCT00304655|Dopamine Agents|dopamine agents|mesh-ancestor
92670727|NCT00304655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670728|NCT00304655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670729|NCT00304655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92670730|NCT00304655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92670731|NCT00304655|Serotonin Agents|serotonin agents|mesh-ancestor
92670732|NCT00304655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92670733|NCT00304655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92670734|NCT00304655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92670735|NCT00304655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92670736|NCT00332553|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92670737|NCT00332553|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92670738|NCT00332553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92670739|NCT00332553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92670740|NCT00332553|Medroxyprogesterone|medroxyprogesterone|mesh-list
92670741|NCT00332553|Estradiol|estradiol|mesh-list
92670742|NCT00332553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92670743|NCT00332553|Estrogens|estrogens|mesh-list
92670744|NCT00332553|Hormones|hormones|mesh-ancestor
92670745|NCT00332553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577813|NCT00270478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577814|NCT00270517|Telithromycin|telithromycin|mesh-list
92028156|NCT04226365|Nortriptyline|nortriptyline|mesh-list
92670746|NCT00332553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670747|NCT00332553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92670748|NCT00332553|Contraceptive Agents|contraceptive agents|mesh-ancestor
92670749|NCT00332553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92670750|NCT00332553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92670751|NCT00332553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92670752|NCT00332553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92670753|NCT00332553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92670754|NCT00332553|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92670755|NCT00332553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92670756|NCT00332553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670757|NCT00332553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92670758|NCT00332553|Hormone Antagonists|hormone antagonists|mesh-ancestor
92396190|NCT01395199|Amlodipine|amlodipine|mesh-list
92670759|NCT00332553|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92670760|NCT00332553|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92365328|NCT02641782|Antiviral Agents|antiviral agents|mesh-ancestor
92670761|NCT00332553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92670762|NCT00332631|Acetylcysteine|acetylcysteine|mesh-list
92670763|NCT00332631|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92670764|NCT00332631|Antiviral Agents|antiviral agents|mesh-ancestor
92670765|NCT00332631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670766|NCT00332631|Expectorants|expectorants|mesh-ancestor
92670767|NCT00332631|Respiratory System Agents|respiratory system agents|mesh-ancestor
92670768|NCT00332631|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92670769|NCT00332631|Antioxidants|antioxidants|mesh-ancestor
92670770|NCT00332631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670771|NCT00332631|Protective Agents|protective agents|mesh-ancestor
92670772|NCT00332631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670773|NCT00332631|Antidotes|antidotes|mesh-ancestor
92670774|NCT00304772|Fluconazole|fluconazole|mesh-list
92670775|NCT00304772|Micafungin|micafungin|mesh-list
92670776|NCT00304772|Antifungal Agents|antifungal agents|mesh-ancestor
92670777|NCT00304772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670778|NCT00304772|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92670779|NCT00304772|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92670780|NCT00304772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670781|NCT00304772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670782|NCT00304772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92670783|NCT00304772|Hormone Antagonists|hormone antagonists|mesh-ancestor
92670784|NCT00304772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670785|NCT00304772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670786|NCT00304772|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92078124|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670791|NCT00304811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670792|NCT00304811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670793|NCT00304811|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92670794|NCT00304811|Antitubercular Agents|antitubercular agents|mesh-ancestor
92670795|NCT00304811|Leprostatic Agents|leprostatic agents|mesh-ancestor
92670796|NCT00304811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92670797|NCT00304811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670798|NCT00304811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670799|NCT00304811|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92670800|NCT00304811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92670801|NCT00304811|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92670802|NCT00304811|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92670803|NCT00304811|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92670804|NCT00304811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92670805|NCT00304811|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92670806|NCT00332787|Fluoxetine|fluoxetine|mesh-list
92670807|NCT00332787|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92670808|NCT00332787|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92670809|NCT00332787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670810|NCT00332787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670811|NCT00332787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670812|NCT00332787|Serotonin Agents|serotonin agents|mesh-ancestor
92670813|NCT00332787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577815|NCT00270517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92577816|NCT00270517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577817|NCT00270556|Tenofovir|tenofovir|mesh-list
92577818|NCT00270556|Abacavir|abacavir|mesh-list
92577819|NCT00270556|Antiviral Agents|antiviral agents|mesh-ancestor
92670814|NCT00332787|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92670815|NCT00332787|Antidepressive Agents|antidepressive agents|mesh-ancestor
92670816|NCT00332787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92670817|NCT00332787|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92670818|NCT00332787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92670819|NCT00332787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670820|NCT00304850|Ketamine|ketamine|mesh-list
92670821|NCT00304850|Analgesics|analgesics|mesh-ancestor
92670822|NCT00304850|Sensory System Agents|sensory system agents|mesh-ancestor
92670823|NCT00304850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670824|NCT00304850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670825|NCT00304850|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92670826|NCT00304850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92670827|NCT00304850|Anesthetics, General|anesthetics, general|mesh-ancestor
92670828|NCT00304850|Anesthetics|anesthetics|mesh-ancestor
92670829|NCT00304850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670830|NCT00304850|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92670831|NCT00304850|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92670832|NCT00304850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670833|NCT00304850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670835|NCT00329316|Progestins|progestins|mesh-ancestor
92670836|NCT00329316|Hormones|hormones|mesh-ancestor
92670837|NCT00329316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670838|NCT00329316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670839|NCT00332826|Insulin|insulin|mesh-list
92670840|NCT00332826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92670841|NCT00332826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670842|NCT00305201|Pravastatin|pravastatin|mesh-list
92670843|NCT00305201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92670844|NCT00305201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92670845|NCT00305201|Antimetabolites|antimetabolites|mesh-ancestor
92670846|NCT00305201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670847|NCT00305201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92670848|NCT00305201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92670849|NCT00305201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670850|NCT00329355|Naproxen|naproxen|mesh-list
92670851|NCT00329355|Sumatriptan|sumatriptan|mesh-list
92670852|NCT00329355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92670853|NCT00329355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670854|NCT00329355|Analgesics|analgesics|mesh-ancestor
92670855|NCT00329355|Sensory System Agents|sensory system agents|mesh-ancestor
92670856|NCT00329355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670858|NCT00329355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670859|NCT00329355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92670860|NCT00329355|Gout Suppressants|gout suppressants|mesh-ancestor
92670861|NCT00329355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92670862|NCT00329355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670863|NCT00329355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670864|NCT00329355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92670865|NCT00329355|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92670866|NCT00329355|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92670867|NCT00329355|Serotonin Agents|serotonin agents|mesh-ancestor
92670868|NCT00329355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670869|NCT00332904|Propranolol|propranolol|mesh-list
92670870|NCT00332904|Spironolactone|spironolactone|mesh-list
92670871|NCT00332904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92670872|NCT00332904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92670873|NCT00332904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92670874|NCT00332904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670875|NCT00332904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670876|NCT00332904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670877|NCT00332904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92670878|NCT00332904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670879|NCT00332904|Vasodilator Agents|vasodilator agents|mesh-ancestor
92577820|NCT00270556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577821|NCT00270556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92577822|NCT00270556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577823|NCT00270556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670880|NCT00332904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92670881|NCT00332904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92670882|NCT00332904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670883|NCT00332904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92670884|NCT00332904|Diuretics|diuretics|mesh-ancestor
92670885|NCT00332904|Natriuretic Agents|natriuretic agents|mesh-ancestor
92670886|NCT00329394|Ketamine|ketamine|mesh-list
92670887|NCT00329394|Analgesics|analgesics|mesh-ancestor
92670888|NCT00329394|Sensory System Agents|sensory system agents|mesh-ancestor
92670889|NCT00329394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670890|NCT00329394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670891|NCT00329394|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92670892|NCT00329394|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92670893|NCT00329394|Anesthetics, General|anesthetics, general|mesh-ancestor
92670894|NCT00329394|Anesthetics|anesthetics|mesh-ancestor
92670895|NCT00329394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670896|NCT00329394|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92670897|NCT00329394|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92670898|NCT00329394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965471|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670899|NCT00329394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670900|NCT00305396|Sirolimus|sirolimus|mesh-list
92670901|NCT00305396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670902|NCT00305396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396335|NCT01395862|Autonomic Agents|autonomic agents|mesh-ancestor
92670903|NCT00305396|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92670905|NCT00305396|Antifungal Agents|antifungal agents|mesh-ancestor
92670906|NCT00305396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670907|NCT00305396|Immunologic Factors|immunologic factors|mesh-ancestor
92670908|NCT00305396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670909|NCT00329472|Gemcitabine|gemcitabine|mesh-list
92670910|NCT00329472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670911|NCT00329472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92670912|NCT00329472|Antimetabolites|antimetabolites|mesh-ancestor
92670913|NCT00329472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670914|NCT00305474|Risperidone|risperidone|mesh-list
92670915|NCT00305474|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92670916|NCT00305474|Serotonin Agents|serotonin agents|mesh-ancestor
92670917|NCT00305474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670918|NCT00305474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670919|NCT00305474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670920|NCT00305474|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92670921|NCT00305474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92670922|NCT00305474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92670923|NCT00305474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92670924|NCT00305474|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92670925|NCT00305474|Dopamine Agents|dopamine agents|mesh-ancestor
92670926|NCT00329511|Clonidine|clonidine|mesh-list
92670927|NCT00329511|Methyldopa|methyldopa|mesh-list
92670928|NCT00329511|Analgesics|analgesics|mesh-ancestor
92670929|NCT00329511|Sensory System Agents|sensory system agents|mesh-ancestor
92670932|NCT00329511|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92670933|NCT00329511|Sympatholytics|sympatholytics|mesh-ancestor
92670934|NCT00329511|Autonomic Agents|autonomic agents|mesh-ancestor
92670935|NCT00329511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92670936|NCT00329511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92670937|NCT00329511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92670938|NCT00329511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92670939|NCT00329511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670940|NCT00329511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670942|NCT00305513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92670943|NCT00305513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670944|NCT00305513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92670945|NCT00305513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670946|NCT00305513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670947|NCT00305513|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92577824|NCT00270556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577825|NCT00270556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92577826|NCT00270556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92577827|NCT00074438|Rituximab|rituximab|mesh-list
92670948|NCT00305513|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92670949|NCT00305513|Purinergic Agents|purinergic agents|mesh-ancestor
92670950|NCT00305513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670952|NCT00333021|Fondaparinux|fondaparinux|mesh-list
92670953|NCT00333021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92670954|NCT00333021|Antithrombins|antithrombins|mesh-ancestor
92670955|NCT00333021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92670956|NCT00333021|Protease Inhibitors|protease inhibitors|mesh-ancestor
92670957|NCT00333021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670958|NCT00333021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670959|NCT00333021|Anticoagulants|anticoagulants|mesh-ancestor
92670960|NCT00333021|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92670961|NCT00333021|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92670962|NCT00305552|Thalidomide|thalidomide|mesh-list
92670963|NCT00305552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670964|NCT00305552|Immunologic Factors|immunologic factors|mesh-ancestor
92670965|NCT00305552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670966|NCT00305552|Leprostatic Agents|leprostatic agents|mesh-ancestor
92670967|NCT00305552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670968|NCT00305552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670969|NCT00305552|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92670970|NCT00305552|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92670971|NCT00305552|Growth Substances|growth substances|mesh-ancestor
92670972|NCT00305552|Growth Inhibitors|growth inhibitors|mesh-ancestor
92670973|NCT00305552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670974|NCT00329589|Bortezomib|bortezomib|mesh-list
92670975|NCT00329589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92670976|NCT00305591|N-Methylaspartate|n-methylaspartate|mesh-list
92396405|NCT01395992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670977|NCT00305591|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92670978|NCT00305591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92670979|NCT00305591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670980|NCT00305591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670981|NCT00305591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670982|NCT00333060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92670983|NCT00333060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92670984|NCT00305630|Triamcinolone|triamcinolone|mesh-list
92670985|NCT00305630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92670986|NCT00305630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92670987|NCT00305630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92670988|NCT00305630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92670989|NCT00305630|Glucocorticoids|glucocorticoids|mesh-ancestor
92670990|NCT00305630|Hormones|hormones|mesh-ancestor
92670991|NCT00305630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92670992|NCT00305630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670993|NCT00305630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670994|NCT00305630|Immunologic Factors|immunologic factors|mesh-ancestor
92670995|NCT00305630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670996|NCT00305630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670997|NCT00329628|Enoxaparin|enoxaparin|mesh-list
92670998|NCT00329628|Rivaroxaban|rivaroxaban|mesh-list
92670999|NCT00329628|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92671000|NCT00329628|Antithrombins|antithrombins|mesh-ancestor
92671004|NCT00329628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671005|NCT00329628|Anticoagulants|anticoagulants|mesh-ancestor
92671006|NCT00329628|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92671007|NCT00329628|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92671008|NCT00305669|Sargramostim|sargramostim|mesh-list
92671009|NCT00305669|Immunologic Factors|immunologic factors|mesh-ancestor
92671010|NCT00305669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671011|NCT00305708|Fludarabine|fludarabine|mesh-list
92671012|NCT00305708|Fludarabine phosphate|fludarabine phosphate|mesh-list
92671013|NCT00305708|Busulfan|busulfan|mesh-list
92671014|NCT00305708|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92671015|NCT00305708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671016|NCT00305708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671017|NCT00305708|Antimetabolites|antimetabolites|mesh-ancestor
92577828|NCT00074438|Methotrexate|methotrexate|mesh-list
92577829|NCT00074438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92577830|NCT00074438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577831|NCT00074438|Immunologic Factors|immunologic factors|mesh-ancestor
92577832|NCT00074438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577833|NCT00074438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028447|NCT02512861|Bupivacaine|bupivacaine|mesh-list
92671018|NCT00305708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671019|NCT00305708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671020|NCT00305708|Immunologic Factors|immunologic factors|mesh-ancestor
92671021|NCT00305708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671022|NCT00305708|Alkylating Agents|alkylating agents|mesh-ancestor
92671023|NCT00305708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92671024|NCT00305708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92671025|NCT00305747|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92671026|NCT00305747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92671027|NCT00305747|Protective Agents|protective agents|mesh-ancestor
92671028|NCT00305747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671029|NCT00305747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671030|NCT00333255|Nepafenac|nepafenac|mesh-list
92671031|NCT00333255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671032|NCT00333255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671033|NCT00333255|Analgesics|analgesics|mesh-ancestor
92671034|NCT00333255|Sensory System Agents|sensory system agents|mesh-ancestor
92671035|NCT00333255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671036|NCT00333255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671037|NCT00333255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671038|NCT00333255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671039|NCT00305786|Gemcitabine|gemcitabine|mesh-list
92671040|NCT00305786|Oxaliplatin|oxaliplatin|mesh-list
92671041|NCT00305786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671042|NCT00305786|Antimetabolites|antimetabolites|mesh-ancestor
92671043|NCT00305786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671044|NCT00305786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671045|NCT00305825|Bevacizumab|bevacizumab|mesh-list
92671046|NCT00305825|Letrozole|letrozole|mesh-list
92671047|NCT00305825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92671048|NCT00305825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671049|NCT00305825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92671050|NCT00305825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92396481|NCT01396720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671051|NCT00305825|Growth Substances|growth substances|mesh-ancestor
92671052|NCT00305825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671053|NCT00305825|Growth Inhibitors|growth inhibitors|mesh-ancestor
92671054|NCT00305825|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92671055|NCT00305825|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92671056|NCT00305825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671057|NCT00305825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671058|NCT00305825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92671059|NCT00305825|Hormone Antagonists|hormone antagonists|mesh-ancestor
92671060|NCT00305825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92671061|NCT00333294|Vinorelbine|vinorelbine|mesh-list
92671062|NCT00333294|Gefitinib|gefitinib|mesh-list
92671063|NCT00333294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671064|NCT00333294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92671065|NCT00333294|Tubulin Modulators|tubulin modulators|mesh-ancestor
92671066|NCT00333294|Antimitotic Agents|antimitotic agents|mesh-ancestor
92671067|NCT00333294|Mitosis Modulators|mitosis modulators|mesh-ancestor
92671068|NCT00333294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671069|NCT00333294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92671070|NCT00333294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671071|NCT00305903|Memantine|memantine|mesh-list
92671076|NCT00305903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671077|NCT00305903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671078|NCT00305903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671079|NCT00305903|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92671080|NCT00305903|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92577834|NCT00074438|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92577835|NCT00074438|Abortifacient Agents|abortifacient agents|mesh-ancestor
92577836|NCT00074438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92577837|NCT00074438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577838|NCT00074438|Antimetabolites|antimetabolites|mesh-ancestor
92577839|NCT00074438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577840|NCT00074438|Dermatologic Agents|dermatologic agents|mesh-ancestor
92577841|NCT00074438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577842|NCT00074438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92577843|NCT00074438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577844|NCT00074438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577845|NCT00270751|Minocycline|minocycline|mesh-list
92577846|NCT00270751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92577847|NCT00270751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577848|NCT00270829|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92577849|NCT00270829|Natriuretic Agents|natriuretic agents|mesh-ancestor
92577850|NCT00270829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577851|NCT04730375|Dexmedetomidine|dexmedetomidine|mesh-list
92577852|NCT04730375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92577853|NCT04730375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577854|NCT04730375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577855|NCT04730375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92577856|NCT04730375|Analgesics|analgesics|mesh-ancestor
92577857|NCT04730375|Sensory System Agents|sensory system agents|mesh-ancestor
92577858|NCT04730375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577859|NCT04730375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92671081|NCT00305903|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92671082|NCT00305903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671083|NCT00305903|Cholinergic Agents|cholinergic agents|mesh-ancestor
92671084|NCT00305903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92671085|NCT00305903|Protective Agents|protective agents|mesh-ancestor
92671087|NCT00329823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671088|NCT00329823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671089|NCT00329823|Analgesics|analgesics|mesh-ancestor
92671090|NCT00329823|Sensory System Agents|sensory system agents|mesh-ancestor
92671091|NCT00329823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671092|NCT00329823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671093|NCT00329823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671094|NCT00329823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671095|NCT00329823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671096|NCT00329823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671097|NCT00329823|Immunologic Factors|immunologic factors|mesh-ancestor
92671098|NCT00306020|Morphine|morphine|mesh-list
92671099|NCT00306020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92671100|NCT00306020|Narcotics|narcotics|mesh-ancestor
92671101|NCT00306020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577860|NCT04730375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92577861|NCT04730375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92577862|NCT04730375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92577863|NCT04730375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577864|NCT04730375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577865|NCT00270907|Gemcitabine|gemcitabine|mesh-list
92577866|NCT00270907|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92577867|NCT00270907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577868|NCT00270907|Antimetabolites|antimetabolites|mesh-ancestor
92577869|NCT00270907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577870|NCT00270907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577871|NCT00271063|Annamycin|annamycin|mesh-list
92577872|NCT00271063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92577873|NCT00271063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577874|NCT00107523|Cytarabine|cytarabine|mesh-list
92577875|NCT00107523|Idarubicin|idarubicin|mesh-list
92671102|NCT00306020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671103|NCT00306020|Analgesics|analgesics|mesh-ancestor
92671104|NCT00306020|Sensory System Agents|sensory system agents|mesh-ancestor
92671105|NCT00306020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671106|NCT00306137|Aprotinin|aprotinin|mesh-list
92671107|NCT00306137|Hemostatics|hemostatics|mesh-ancestor
92671108|NCT00306137|Coagulants|coagulants|mesh-ancestor
92671109|NCT00306137|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92671110|NCT00306137|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92671111|NCT00306137|Protease Inhibitors|protease inhibitors|mesh-ancestor
92671112|NCT00306137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671113|NCT00306137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671114|NCT00329940|Letrozole|letrozole|mesh-list
92671115|NCT00329940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671116|NCT00329940|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92671117|NCT00329940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92671118|NCT00329940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671119|NCT00329940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671120|NCT00329940|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92671121|NCT00329940|Hormone Antagonists|hormone antagonists|mesh-ancestor
92671122|NCT00329940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92671123|NCT00329940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671124|NCT00306176|Rosiglitazone|rosiglitazone|mesh-list
92396554|NCT01397305|Pemetrexed|pemetrexed|mesh-list
92671125|NCT00306176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671126|NCT00306176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671127|NCT00333372|Z 338|z 338|mesh-list
92671128|NCT00333372|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92671129|NCT00333372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671130|NCT00333372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671131|NCT00333372|Cholinergic Agents|cholinergic agents|mesh-ancestor
92671132|NCT00333372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671133|NCT00333372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671134|NCT00333372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671135|NCT00330018|Valganciclovir|valganciclovir|mesh-list
92671136|NCT00330018|Acyclovir|acyclovir|mesh-list
92671137|NCT00330018|Antiviral Agents|antiviral agents|mesh-ancestor
92671138|NCT00330018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671139|NCT00333450|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92671140|NCT00333450|Immunologic Factors|immunologic factors|mesh-ancestor
92671141|NCT00333450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671142|NCT00306254|Enoxaparin|enoxaparin|mesh-list
92671143|NCT00306254|N-(4-chlorophenyl)-N-(2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|n-(4-chlorophenyl)-n-(2-fluoro-4-(2-oxopyridin-1(2h)-yl)phenyl)-4-methoxypyrrolidiine-1,2-dicarboxamide|mesh-list
92577876|NCT00107523|Pravastatin|pravastatin|mesh-list
92577877|NCT00107523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92577878|NCT00107523|Antimetabolites|antimetabolites|mesh-ancestor
92577879|NCT00107523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577880|NCT00107523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577881|NCT00107523|Antiviral Agents|antiviral agents|mesh-ancestor
92577882|NCT00107523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577883|NCT00107523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92577884|NCT00107523|Immunologic Factors|immunologic factors|mesh-ancestor
92577885|NCT00107523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577886|NCT00107523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92577887|NCT00107523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92671146|NCT00306254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92671147|NCT00306254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671148|NCT00306254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92671149|NCT00306254|Antithrombins|antithrombins|mesh-ancestor
92671150|NCT00306254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92671151|NCT00306254|Protease Inhibitors|protease inhibitors|mesh-ancestor
92671152|NCT00306254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671153|NCT00333489|Valsartan|valsartan|mesh-list
92671154|NCT00333489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671155|NCT00333489|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92671156|NCT00333489|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92671157|NCT00333489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671158|NCT00330135|Hyaluronic Acid|hyaluronic acid|mesh-list
92671159|NCT00330135|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92671160|NCT00330135|Immunologic Factors|immunologic factors|mesh-ancestor
92671161|NCT00330135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671162|NCT00330135|Viscosupplements|viscosupplements|mesh-ancestor
92671163|NCT00330135|Protective Agents|protective agents|mesh-ancestor
92671164|NCT03275558|Sunitinib|sunitinib|mesh-list
92671165|NCT03275558|Axitinib|axitinib|mesh-list
92671166|NCT03275558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671167|NCT03275558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92671168|NCT03275558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92671169|NCT03275558|Growth Substances|growth substances|mesh-ancestor
92671170|NCT03275558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671171|NCT03275558|Growth Inhibitors|growth inhibitors|mesh-ancestor
92671172|NCT03275558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92671173|NCT03275558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671174|NCT03275558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671175|NCT03275519|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92671176|NCT03275519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92671177|NCT03275519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671178|NCT03275519|Antitubercular Agents|antitubercular agents|mesh-ancestor
92671179|NCT00333567|Lumiracoxib|lumiracoxib|mesh-list
92671180|NCT00333567|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92671181|NCT00333567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92671182|NCT00333567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671183|NCT00333567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671184|NCT00333567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671185|NCT00333567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671186|NCT00333567|Analgesics|analgesics|mesh-ancestor
92671187|NCT00333567|Sensory System Agents|sensory system agents|mesh-ancestor
92671188|NCT00333567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671189|NCT00333567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671190|NCT00333567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671191|NCT00333567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671192|NCT00330252|Rituximab|rituximab|mesh-list
92671193|NCT00330252|Alemtuzumab|alemtuzumab|mesh-list
92671194|NCT00330252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92577888|NCT00107523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92577889|NCT00107523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577890|NCT00107523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92671195|NCT00330252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671196|NCT00330252|Immunologic Factors|immunologic factors|mesh-ancestor
92671197|NCT00330252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671198|NCT00330252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671200|NCT00333645|Antifungal Agents|antifungal agents|mesh-ancestor
92671201|NCT00333645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671202|NCT00333645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671203|NCT00333645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671204|NCT00451100|Glycopyrrolate|glycopyrrolate|mesh-list
92671205|NCT00451100|Neostigmine|neostigmine|mesh-list
92671206|NCT00451100|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92671207|NCT00451100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671208|NCT00451100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671209|NCT00451100|Cholinergic Agents|cholinergic agents|mesh-ancestor
92671210|NCT00451100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671211|NCT00451100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671212|NCT00451100|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92671213|NCT00451100|Autonomic Agents|autonomic agents|mesh-ancestor
92671214|NCT00451100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671227|NCT00420537|Antifungal Agents|antifungal agents|mesh-ancestor
92671228|NCT00420537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671229|NCT00420537|Dermatologic Agents|dermatologic agents|mesh-ancestor
92671230|NCT00420537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671231|NCT00420537|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92671232|NCT00420537|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92671233|NCT00420537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92671234|NCT00420537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671235|NCT00420537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92671236|NCT00420537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92671237|NCT00420537|Antitubercular Agents|antitubercular agents|mesh-ancestor
92671238|NCT00420537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92671239|NCT00451139|Lumefantrine|lumefantrine|mesh-list
92671240|NCT00451139|Artemether|artemether|mesh-list
92671241|NCT00451139|Quinine|quinine|mesh-list
92671242|NCT00451139|Atovaquone|atovaquone|mesh-list
92671243|NCT00451139|Proguanil|proguanil|mesh-list
92671244|NCT00451139|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92671245|NCT00451139|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92671246|NCT00451139|Antimalarials|antimalarials|mesh-ancestor
92671247|NCT00451139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92671248|NCT00451139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92671249|NCT00451139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671250|NCT00451139|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92671251|NCT00451139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671252|NCT00451139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92671253|NCT00451139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671254|NCT00451139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671255|NCT00451139|Analgesics|analgesics|mesh-ancestor
92671256|NCT00451139|Sensory System Agents|sensory system agents|mesh-ancestor
92671257|NCT00451139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671258|NCT00451139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671259|NCT00451139|Antimetabolites|antimetabolites|mesh-ancestor
92671260|NCT00330486|Acamprosate|acamprosate|mesh-list
92671261|NCT00330486|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92671262|NCT00451373|Vancomycin|vancomycin|mesh-list
92671263|NCT00451373|Daptomycin|daptomycin|mesh-list
92671264|NCT00451373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92671265|NCT00451373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671266|NCT00333723|Rosiglitazone|rosiglitazone|mesh-list
92671267|NCT00333723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671268|NCT00333723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671269|NCT00451412|Heparin|heparin|mesh-list
92671270|NCT00451412|Calcium heparin|calcium heparin|mesh-list
92396710|NCT03283813|Inositol|inositol|mesh-list
92671271|NCT00451412|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92671272|NCT00451412|Tinzaparin|tinzaparin|mesh-list
92671273|NCT00451412|Dalteparin|dalteparin|mesh-list
92671274|NCT00451412|Certoparin|certoparin|mesh-list
92671275|NCT00451412|Anticoagulants|anticoagulants|mesh-ancestor
92671276|NCT00451412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92671277|NCT00451412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92671278|NCT00451412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577891|NCT00107523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92577892|NCT00107523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92577893|NCT00107523|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92577894|NCT00416377|Prednisolone|prednisolone|mesh-list
92577895|NCT00416377|Doxorubicin|doxorubicin|mesh-list
92671280|NCT00451490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92671281|NCT00451490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671284|NCT00330525|Antidepressive Agents|antidepressive agents|mesh-ancestor
92671285|NCT00330525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92671286|NCT00330525|Appetite Depressants|appetite depressants|mesh-ancestor
92671287|NCT00330525|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92671289|NCT00333918|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92671290|NCT00333918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92671291|NCT00333918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671292|NCT00333918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671293|NCT00333918|Analgesics|analgesics|mesh-ancestor
92671294|NCT00333918|Sensory System Agents|sensory system agents|mesh-ancestor
92671295|NCT00333918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671296|NCT00333918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671297|NCT00333918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671298|NCT00333918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671299|NCT00451568|Metformin|metformin|mesh-list
92671300|NCT00451568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671301|NCT00451568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671302|NCT00451646|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92671303|NCT00451646|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92671304|NCT00451646|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92671305|NCT00451646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92671306|NCT00451724|Ketamine|ketamine|mesh-list
92671307|NCT00451724|Analgesics|analgesics|mesh-ancestor
92671308|NCT00451724|Sensory System Agents|sensory system agents|mesh-ancestor
92671309|NCT00451724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671310|NCT00451724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671311|NCT00451724|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92671312|NCT00451724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92671313|NCT00451724|Anesthetics, General|anesthetics, general|mesh-ancestor
92671314|NCT00451724|Anesthetics|anesthetics|mesh-ancestor
92671315|NCT00451724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671316|NCT00451724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92671317|NCT00451724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92671318|NCT00451724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671319|NCT00451724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671320|NCT00451763|Bevacizumab|bevacizumab|mesh-list
92671321|NCT00451763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92671322|NCT00451763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671323|NCT00451763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92671324|NCT00451763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92671325|NCT00451763|Growth Substances|growth substances|mesh-ancestor
92671326|NCT00451763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671327|NCT00451763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92671328|NCT00330798|Ketorolac|ketorolac|mesh-list
92671329|NCT00330798|Nepafenac|nepafenac|mesh-list
92671330|NCT00330798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671331|NCT00330798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671332|NCT00330798|Analgesics|analgesics|mesh-ancestor
92671333|NCT00330798|Sensory System Agents|sensory system agents|mesh-ancestor
92671334|NCT00330798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671335|NCT00330798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671336|NCT00330798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671337|NCT00330798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671338|NCT00330798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92671339|NCT00330798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671340|NCT00330798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671341|NCT00451880|Famotidine|famotidine|mesh-list
92671342|NCT00451880|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92671343|NCT00451880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671344|NCT00451880|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92671345|NCT00451880|Histamine Antagonists|histamine antagonists|mesh-ancestor
92671346|NCT00451880|Histamine Agents|histamine agents|mesh-ancestor
92577896|NCT00416377|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92577897|NCT00416377|Bleomycin|bleomycin|mesh-list
92577898|NCT00416377|Vincristine|vincristine|mesh-list
92577899|NCT00416377|Dacarbazine|dacarbazine|mesh-list
92365357|NCT04769076|Cisplatin|cisplatin|mesh-list
92671347|NCT00451880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671348|NCT00451880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671349|NCT00451880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671350|NCT00451997|Cytarabine|cytarabine|mesh-list
92671352|NCT00451997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671353|NCT00451997|Antimetabolites|antimetabolites|mesh-ancestor
92671354|NCT00451997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671360|NCT00451997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671361|NCT00451997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92671362|NCT00451997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671363|NCT00330993|Misoprostol|misoprostol|mesh-list
92671364|NCT00330993|Mifepristone|mifepristone|mesh-list
92671365|NCT00330993|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92671366|NCT00330993|Abortifacient Agents|abortifacient agents|mesh-ancestor
92671367|NCT00330993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92671368|NCT00330993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671369|NCT00330993|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92671370|NCT00330993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671371|NCT00330993|Oxytocics|oxytocics|mesh-ancestor
92671372|NCT00330993|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92671373|NCT00330993|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92671374|NCT00330993|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92671375|NCT00330993|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92671376|NCT00330993|Contraceptive Agents|contraceptive agents|mesh-ancestor
92671377|NCT00330993|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92671378|NCT00330993|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92671379|NCT00330993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92671380|NCT00330993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92671381|NCT00330993|Luteolytic Agents|luteolytic agents|mesh-ancestor
92671382|NCT00330993|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92671383|NCT00330993|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92671384|NCT00452075|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92671385|NCT00452075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671386|NCT00452075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92671387|NCT00452075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671388|NCT00452075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671389|NCT00331071|Contraceptive Agents|contraceptive agents|mesh-list
92671390|NCT00331071|Ortho Evra|ortho evra|mesh-list
92671391|NCT00331071|Contraceptives, Oral|contraceptives, oral|mesh-list
92671392|NCT00331071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92671393|NCT00331071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671394|NCT00331071|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92671395|NCT00331071|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92671396|NCT00333996|Dexamethasone|dexamethasone|mesh-list
92671397|NCT00333996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671398|NCT00333996|Antiemetics|antiemetics|mesh-ancestor
92671399|NCT00333996|Autonomic Agents|autonomic agents|mesh-ancestor
92671400|NCT00333996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671401|NCT00333996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671402|NCT00333996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671403|NCT00333996|Glucocorticoids|glucocorticoids|mesh-ancestor
92671404|NCT00333996|Hormones|hormones|mesh-ancestor
92671405|NCT00333996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92671406|NCT00333996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92671407|NCT00333996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671408|NCT00452192|Telmisartan|telmisartan|mesh-list
92671409|NCT00452192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671410|NCT00452192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92671411|NCT00452192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92671412|NCT00452192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671413|NCT00334035|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92671414|NCT00334035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92671415|NCT00334035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92671416|NCT00334035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92671417|NCT00334035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92671418|NCT00334035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577900|NCT00416377|Vinblastine|vinblastine|mesh-list
92577901|NCT00416377|Procarbazine|procarbazine|mesh-list
92577902|NCT00416377|Chlorambucil|chlorambucil|mesh-list
92577903|NCT00416377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91985148|NCT04103489|Eculizumab|eculizumab|mesh-list
92671419|NCT00334035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671420|NCT00334152|Casopitant|casopitant|mesh-list
92671421|NCT00334152|Antiemetics|antiemetics|mesh-ancestor
92671422|NCT00334152|Autonomic Agents|autonomic agents|mesh-ancestor
92671423|NCT00334152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671427|NCT00334152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671428|NCT00334152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671429|NCT04698512|Sirolimus|sirolimus|mesh-list
92671430|NCT04698512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92671431|NCT04698512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671432|NCT04698512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92671433|NCT04698512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671434|NCT04698512|Antifungal Agents|antifungal agents|mesh-ancestor
92671435|NCT04698512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671436|NCT04698512|Immunologic Factors|immunologic factors|mesh-ancestor
92671437|NCT04698512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671438|NCT00334308|Caseins|caseins|mesh-list
92671439|NCT00334308|Chelating Agents|chelating agents|mesh-ancestor
92671440|NCT00334308|Sequestering Agents|sequestering agents|mesh-ancestor
92671441|NCT00334308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671442|NCT00334347|Valproic Acid|valproic acid|mesh-list
92671443|NCT00334347|Anticonvulsants|anticonvulsants|mesh-ancestor
92671444|NCT00334347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671445|NCT00334347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671446|NCT00334347|GABA Agents|gaba agents|mesh-ancestor
92671447|NCT00334347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671448|NCT00334347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671449|NCT00334347|Antimanic Agents|antimanic agents|mesh-ancestor
92671450|NCT00334347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92671451|NCT00334347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671452|NCT00334347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92671453|NCT00334386|Torsemide|torsemide|mesh-list
92671454|NCT00334386|Diuretics|diuretics|mesh-list
92671455|NCT00334386|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92671456|NCT00334386|Natriuretic Agents|natriuretic agents|mesh-ancestor
92671457|NCT00334386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671458|NCT00334386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92671459|NCT00334386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671460|NCT00334386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671461|NCT00452231|Cycloserine|cycloserine|mesh-list
92671462|NCT00452231|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92671463|NCT00452231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671464|NCT00452231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92671465|NCT00452231|Antitubercular Agents|antitubercular agents|mesh-ancestor
92671466|NCT00452231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92671467|NCT00452231|Antimetabolites|antimetabolites|mesh-ancestor
92671468|NCT00452231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671469|NCT00334425|Menotropins|menotropins|mesh-list
92671470|NCT00334425|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92671471|NCT00334425|Fertility Agents|fertility agents|mesh-ancestor
92671472|NCT00334425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92671473|NCT00334425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671474|NCT03275207|Dexmedetomidine|dexmedetomidine|mesh-list
92671475|NCT03275207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92671476|NCT03275207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671477|NCT03275207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671478|NCT03275207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671479|NCT03275207|Analgesics|analgesics|mesh-ancestor
92671480|NCT03275207|Sensory System Agents|sensory system agents|mesh-ancestor
92671481|NCT03275207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671482|NCT03275207|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92671483|NCT03275207|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92671484|NCT03275207|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92671485|NCT03275207|Adrenergic Agents|adrenergic agents|mesh-ancestor
92671486|NCT03275207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671487|NCT03275207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577904|NCT00416377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577905|NCT00416377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92577906|NCT00416377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92577907|NCT00416377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577908|NCT00416377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577909|NCT00416377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92671489|NCT00334464|Anticoagulants|anticoagulants|mesh-ancestor
92671490|NCT03275012|Morphine|morphine|mesh-list
92671491|NCT03275012|Gabapentin|gabapentin|mesh-list
92671492|NCT03275012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92671493|NCT03275012|Narcotics|narcotics|mesh-ancestor
92671494|NCT03275012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671495|NCT03275012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671496|NCT03275012|Analgesics|analgesics|mesh-ancestor
92671498|NCT03275012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671499|NCT03275012|Anticonvulsants|anticonvulsants|mesh-ancestor
92671500|NCT03275012|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92671501|NCT03275012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92671502|NCT03275012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92671503|NCT03275012|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92671504|NCT03275012|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92671505|NCT03275012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671506|NCT03275012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671507|NCT03275012|Antimanic Agents|antimanic agents|mesh-ancestor
92671508|NCT00334503|Miglitol|miglitol|mesh-list
92671509|NCT00334503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671510|NCT00334503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671511|NCT00334503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671512|NCT00334503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671513|NCT00334503|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92671514|NCT00334581|Irbesartan|irbesartan|mesh-list
92671515|NCT00334581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671516|NCT00334581|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92671517|NCT00334581|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92671518|NCT00334581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671519|NCT00452270|Xylometazoline|xylometazoline|mesh-list
92671520|NCT00452270|Nasal Decongestants|nasal decongestants|mesh-ancestor
92671521|NCT00452270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92671522|NCT00452270|Respiratory System Agents|respiratory system agents|mesh-ancestor
92671523|NCT00452582|Sildenafil Citrate|sildenafil citrate|mesh-list
92671524|NCT00452582|Vasodilator Agents|vasodilator agents|mesh-ancestor
92671525|NCT00452582|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92671526|NCT00452582|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92671527|NCT00452582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671528|NCT00452582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671529|NCT00452582|Urological Agents|urological agents|mesh-ancestor
92671530|NCT00334698|Cetirizine|cetirizine|mesh-list
92671531|NCT00334698|Pseudoephedrine|pseudoephedrine|mesh-list
92671532|NCT00334698|Ephedrine|ephedrine|mesh-list
92671533|NCT00334698|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92671534|NCT00334698|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92671535|NCT00334698|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92671536|NCT00334698|Histamine Antagonists|histamine antagonists|mesh-ancestor
92671537|NCT00334698|Histamine Agents|histamine agents|mesh-ancestor
92671538|NCT00334698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671539|NCT00334698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671540|NCT00334698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671541|NCT00334698|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92671542|NCT00334698|Autonomic Agents|autonomic agents|mesh-ancestor
92671543|NCT00334698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671544|NCT00334698|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92671545|NCT00334698|Respiratory System Agents|respiratory system agents|mesh-ancestor
92671546|NCT00334698|Nasal Decongestants|nasal decongestants|mesh-ancestor
92671547|NCT00334698|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92671548|NCT00334698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92671549|NCT00334698|Sympathomimetics|sympathomimetics|mesh-ancestor
92671550|NCT00334698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92577910|NCT00416377|Tubulin Modulators|tubulin modulators|mesh-ancestor
92365366|NCT04768764|Bupivacaine|bupivacaine|mesh-list
92577911|NCT00416377|Antimitotic Agents|antimitotic agents|mesh-ancestor
92577912|NCT00416377|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577913|NCT00416377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92577914|NCT00416377|Glucocorticoids|glucocorticoids|mesh-ancestor
92577915|NCT00416377|Hormones|hormones|mesh-ancestor
92671551|NCT00452660|Deferasirox|deferasirox|mesh-list
92671552|NCT00452660|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92671553|NCT00452660|Chelating Agents|chelating agents|mesh-ancestor
92671554|NCT00452660|Sequestering Agents|sequestering agents|mesh-ancestor
92671555|NCT00452660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671556|NCT00334854|Doxorubicin|doxorubicin|mesh-list
92671557|NCT00334854|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92671558|NCT00334854|Ifosfamide|ifosfamide|mesh-list
92671559|NCT00334854|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92671560|NCT00334854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671561|NCT00334854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92671562|NCT00334854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92671563|NCT00334854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671564|NCT00334854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671565|NCT00334854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92671566|NCT00334854|Alkylating Agents|alkylating agents|mesh-ancestor
92671567|NCT00334932|Doxorubicin|doxorubicin|mesh-list
92671568|NCT00334932|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92671569|NCT00334932|Bortezomib|bortezomib|mesh-list
92671570|NCT00334932|Melphalan|melphalan|mesh-list
92671573|NCT00334932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92671574|NCT00334932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92671575|NCT00334932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671576|NCT00334932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671577|NCT00334932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92671578|NCT00334932|Alkylating Agents|alkylating agents|mesh-ancestor
92671579|NCT00334932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92671580|NCT00334932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671581|NCT00334932|Immunologic Factors|immunologic factors|mesh-ancestor
92671582|NCT00334932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671583|NCT00335010|Nitroglycerin|nitroglycerin|mesh-list
92671584|NCT00335010|Vasodilator Agents|vasodilator agents|mesh-ancestor
92671585|NCT00452855|Remifentanil|remifentanil|mesh-list
92671586|NCT00452855|Sevoflurane|sevoflurane|mesh-list
92671587|NCT00452855|Anesthetics|anesthetics|mesh-ancestor
92671588|NCT00452855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671589|NCT00452855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671590|NCT00452855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92671591|NCT00452855|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92671592|NCT00452855|Anesthetics, General|anesthetics, general|mesh-ancestor
92671593|NCT00452855|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92671594|NCT00452855|Narcotics|narcotics|mesh-ancestor
92671595|NCT00452855|Analgesics|analgesics|mesh-ancestor
92671596|NCT00452855|Sensory System Agents|sensory system agents|mesh-ancestor
92671597|NCT00452855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671599|NCT00335088|Moxifloxacin|moxifloxacin|mesh-list
92671600|NCT00335088|Povidone-Iodine|povidone-iodine|mesh-list
92671601|NCT00335088|Povidone|povidone|mesh-list
92671602|NCT00335088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92671603|NCT00335088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671604|NCT00335088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92671605|NCT00335088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92671606|NCT00335088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671607|NCT00335088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671608|NCT00335088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671609|NCT00335088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671610|NCT00335088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92671611|NCT00335088|Trace Elements|trace elements|mesh-ancestor
92671612|NCT00335088|Micronutrients|micronutrients|mesh-ancestor
92671613|NCT00335088|Plasma Substitutes|plasma substitutes|mesh-ancestor
92671614|NCT00335088|Blood Substitutes|blood substitutes|mesh-ancestor
92671615|NCT00452894|Varenicline|varenicline|mesh-list
92671616|NCT00452894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92671617|NCT00452894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92671618|NCT00452894|Cholinergic Agents|cholinergic agents|mesh-ancestor
92671619|NCT00452894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92577916|NCT00416377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577917|NCT00416377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577918|NCT00416377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92577919|NCT00416377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92671620|NCT00452894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671621|NCT00452894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671622|NCT00335166|Pramipexole|pramipexole|mesh-list
92671623|NCT00335166|Antioxidants|antioxidants|mesh-ancestor
92671624|NCT00335166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671625|NCT00335166|Protective Agents|protective agents|mesh-ancestor
92671626|NCT00335166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671627|NCT00335166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92671628|NCT00335166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92671629|NCT00335166|Dopamine Agonists|dopamine agonists|mesh-ancestor
92671630|NCT00335166|Dopamine Agents|dopamine agents|mesh-ancestor
92671631|NCT00335166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671632|NCT00452972|Anesthetics|anesthetics|mesh-list
92671633|NCT00452972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671634|NCT00452972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671635|NCT00335205|Ropinirole|ropinirole|mesh-list
92671636|NCT00335205|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92671637|NCT00335205|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92671638|NCT00335205|Dopamine Agonists|dopamine agonists|mesh-ancestor
92671639|NCT00335205|Dopamine Agents|dopamine agents|mesh-ancestor
92671640|NCT00335205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671641|NCT00335205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671642|NCT00335205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671643|NCT00453050|Imiquimod|imiquimod|mesh-list
92671644|NCT00453050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92671645|NCT00453050|Immunologic Factors|immunologic factors|mesh-ancestor
92671646|NCT00453050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671647|NCT00453050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671648|NCT00453050|Interferon Inducers|interferon inducers|mesh-ancestor
92671649|NCT00335400|Anesthetics|anesthetics|mesh-list
92671650|NCT00335400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671651|NCT00335400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671652|NCT00420615|Epothilone B|epothilone b|mesh-list
92671653|NCT00420615|Epothilones|epothilones|mesh-list
92671654|NCT00420615|Omeprazole|omeprazole|mesh-list
92671655|NCT00420615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92671656|NCT00420615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671657|NCT00420615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92671658|NCT00420615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671659|NCT00420615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671660|NCT00420615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671661|NCT00420615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92671662|NCT00420615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92671663|NCT00420615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92671664|NCT00453167|Paclitaxel|paclitaxel|mesh-list
92671665|NCT00453167|Gemcitabine|gemcitabine|mesh-list
92671666|NCT00453167|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92671667|NCT00453167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671668|NCT00453167|Tubulin Modulators|tubulin modulators|mesh-ancestor
92671669|NCT00453167|Antimitotic Agents|antimitotic agents|mesh-ancestor
92671670|NCT00453167|Mitosis Modulators|mitosis modulators|mesh-ancestor
92671671|NCT00453167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671672|NCT00453167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671673|NCT00453167|Antimetabolites|antimetabolites|mesh-ancestor
92671674|NCT00420654|Hormones|hormones|mesh-list
92671675|NCT00420654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92671676|NCT00420654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671677|NCT00420693|Sevoflurane|sevoflurane|mesh-list
92671678|NCT00420693|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92671679|NCT00420693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92671680|NCT00420693|Anesthetics, General|anesthetics, general|mesh-ancestor
92671681|NCT00420693|Anesthetics|anesthetics|mesh-ancestor
92671682|NCT00420693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671683|NCT00420693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671684|NCT03274895|Biguanides|biguanides|mesh-list
92577920|NCT00416377|Alkylating Agents|alkylating agents|mesh-ancestor
92577921|NCT02965859|Adefovir|adefovir|mesh-list
92577922|NCT02965859|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92577923|NCT02965859|Antiviral Agents|antiviral agents|mesh-ancestor
92577924|NCT02965859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92577925|NCT02965859|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91985164|NCT02391077|Disinfectants|disinfectants|mesh-ancestor
92671685|NCT03274895|Polihexanide|polihexanide|mesh-list
92671686|NCT03274895|Dibrompropamidine|dibrompropamidine|mesh-list
92671687|NCT03274895|Propamidine|propamidine|mesh-list
92671688|NCT03274895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671689|NCT03274895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671690|NCT03274895|Disinfectants|disinfectants|mesh-ancestor
92671691|NCT03274895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671692|NCT03274895|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92671693|NCT03274895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92671694|NCT03274895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92671695|NCT00453323|Paclitaxel|paclitaxel|mesh-list
92671696|NCT00453323|Capecitabine|capecitabine|mesh-list
92671697|NCT00453323|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92671698|NCT00453323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671699|NCT00453323|Tubulin Modulators|tubulin modulators|mesh-ancestor
92671700|NCT00453323|Antimitotic Agents|antimitotic agents|mesh-ancestor
92671701|NCT00453323|Mitosis Modulators|mitosis modulators|mesh-ancestor
92671702|NCT00453323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671703|NCT00453323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671704|NCT00453323|Antimetabolites|antimetabolites|mesh-ancestor
92671705|NCT00335439|Ketorolac|ketorolac|mesh-list
92671706|NCT00335439|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92671707|NCT00335439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671708|NCT00335439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671709|NCT00335439|Analgesics|analgesics|mesh-ancestor
92671710|NCT00335439|Sensory System Agents|sensory system agents|mesh-ancestor
92671711|NCT00335439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671712|NCT00335439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671713|NCT00335439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671714|NCT00335439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671715|NCT00335439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92671716|NCT00335439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671717|NCT00335439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671718|NCT00453401|5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol|5-((2-(6-amino-9h-purin-9-yl) ethyl) amino)-1-pentanol|mesh-list
92671720|NCT00453401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671721|NCT00453401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397152|NCT05162118|Nivolumab|nivolumab|mesh-list
92671723|NCT00335673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671724|NCT00335673|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92671725|NCT00335673|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92671726|NCT00335673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671727|NCT00453635|Carboplatin|carboplatin|mesh-list
92671728|NCT00453635|Docetaxel|docetaxel|mesh-list
92671729|NCT00453635|Trastuzumab|trastuzumab|mesh-list
92671730|NCT00453635|Vinorelbine|vinorelbine|mesh-list
92671731|NCT00453635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671732|NCT00453635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92671733|NCT00453635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92671734|NCT00453635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92671735|NCT00453635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671736|NCT00453635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92671737|NCT00453635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92671738|NCT00335907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92671739|NCT00335985|Immunoglobulins|immunoglobulins|mesh-list
92671740|NCT00335985|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92671741|NCT00335985|gamma-Globulins|gamma-globulins|mesh-list
92671742|NCT00335985|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92671743|NCT00335985|Immunologic Factors|immunologic factors|mesh-ancestor
92671744|NCT00335985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671745|NCT00336141|Vorinostat|vorinostat|mesh-list
92671746|NCT00336141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671747|NCT00336141|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92577926|NCT02965859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92577927|NCT02965859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577928|NCT02965859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577930|NCT00271336|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92671748|NCT00336141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671749|NCT00336141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365382|NCT04745286|Esketamine|esketamine|mesh-list
92671751|NCT00336219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92671752|NCT00336219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671753|NCT00336219|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92671754|NCT00336219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671755|NCT00336219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671756|NCT00453908|Alfuzosin|alfuzosin|mesh-list
92671757|NCT00453908|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92671758|NCT00453908|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92671759|NCT00453908|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92671760|NCT00453908|Adrenergic Agents|adrenergic agents|mesh-ancestor
92671761|NCT00453908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671762|NCT00453908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671763|NCT00453908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671764|NCT00453908|Urological Agents|urological agents|mesh-ancestor
92671765|NCT00336336|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92671766|NCT00336336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92671767|NCT00336336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92671768|NCT00336336|Antimetabolites|antimetabolites|mesh-ancestor
92671769|NCT00336336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671770|NCT00336336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92671771|NCT00336336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92671772|NCT00336336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671773|NCT00336375|Lumefantrine|lumefantrine|mesh-list
92671774|NCT00336375|Artemether|artemether|mesh-list
92671775|NCT00336375|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92671776|NCT00336375|Antimalarials|antimalarials|mesh-ancestor
92671777|NCT00336375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92671778|NCT00336375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92671779|NCT00336375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671780|NCT00336414|Prednisone|prednisone|mesh-list
92671781|NCT00336414|Cyclophosphamide|cyclophosphamide|mesh-list
92671782|NCT00336414|Azathioprine|azathioprine|mesh-list
92671783|NCT00336414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671784|NCT00336414|Immunologic Factors|immunologic factors|mesh-ancestor
92671785|NCT00336414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671786|NCT00336414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671787|NCT00336414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92671788|NCT00336414|Alkylating Agents|alkylating agents|mesh-ancestor
92671789|NCT00336414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079141|NCT01519167|Narcotics|narcotics|mesh-ancestor
92671793|NCT00336414|Glucocorticoids|glucocorticoids|mesh-ancestor
92671794|NCT00336414|Hormones|hormones|mesh-ancestor
92671795|NCT00336414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92671796|NCT00336414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92671797|NCT00336414|Antimetabolites|antimetabolites|mesh-ancestor
92671798|NCT00336414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671799|NCT00336453|Hemagglutinins|hemagglutinins|mesh-list
92671800|NCT00336453|Agglutinins|agglutinins|mesh-ancestor
92671801|NCT00336453|Immunologic Factors|immunologic factors|mesh-ancestor
92671802|NCT00336453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671803|NCT00336453|Coagulants|coagulants|mesh-ancestor
92671804|NCT00336531|Itraconazole|itraconazole|mesh-list
92671805|NCT00336531|Antifungal Agents|antifungal agents|mesh-ancestor
92671806|NCT00336531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671807|NCT00336531|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92671808|NCT00336531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92671809|NCT00336531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671810|NCT00336531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671811|NCT00336531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92671812|NCT00336531|Hormone Antagonists|hormone antagonists|mesh-ancestor
92671813|NCT00336531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92577931|NCT00271336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682789|NCT00438113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671814|NCT00336531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671815|NCT00336531|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92671816|NCT00322062|Ascorbic Acid|ascorbic acid|mesh-list
92671817|NCT00322062|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92671818|NCT00322062|Antioxidants|antioxidants|mesh-ancestor
92671819|NCT00322062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671820|NCT00322062|Protective Agents|protective agents|mesh-ancestor
92407690|NCT01446276|Resveratrol|resveratrol|mesh-list
92671821|NCT00322062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671822|NCT00322062|Vitamins|vitamins|mesh-ancestor
92671823|NCT00322062|Micronutrients|micronutrients|mesh-ancestor
92671824|NCT00322062|Laxatives|laxatives|mesh-ancestor
92671825|NCT00322062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671826|NCT00336648|Bevacizumab|bevacizumab|mesh-list
92671827|NCT00336648|Gemcitabine|gemcitabine|mesh-list
92671828|NCT00336648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92671829|NCT00336648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671830|NCT00336648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92671831|NCT00336648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92671832|NCT00336648|Growth Substances|growth substances|mesh-ancestor
92671833|NCT00336648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671834|NCT00336648|Growth Inhibitors|growth inhibitors|mesh-ancestor
92671835|NCT00336648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671836|NCT00336648|Antimetabolites|antimetabolites|mesh-ancestor
92671837|NCT00336648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671838|NCT03274817|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92671839|NCT03274817|Escitalopram|escitalopram|mesh-list
92671840|NCT03274817|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92671841|NCT03274817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92671842|NCT03274817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92671843|NCT03274817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671844|NCT03274817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671845|NCT03274817|Serotonin Agents|serotonin agents|mesh-ancestor
92671846|NCT03274817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671847|NCT03274817|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92671848|NCT03274817|Antidepressive Agents|antidepressive agents|mesh-ancestor
92671849|NCT03274817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92671850|NCT03274817|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92671851|NCT00230204|Antibodies|antibodies|mesh-list
92671852|NCT00230204|Immunologic Factors|immunologic factors|mesh-ancestor
92671853|NCT00230204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671854|NCT00230321|Darbepoetin alfa|darbepoetin alfa|mesh-list
92671855|NCT00230321|Hematinics|hematinics|mesh-ancestor
92671856|NCT00230399|Celecoxib|celecoxib|mesh-list
92671857|NCT00230399|Capecitabine|capecitabine|mesh-list
92671858|NCT00230399|Irinotecan|irinotecan|mesh-list
92671859|NCT00230399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671860|NCT00230399|Antimetabolites|antimetabolites|mesh-ancestor
92671862|NCT00230399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671863|NCT00230399|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92671864|NCT00230399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92671865|NCT00230399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671866|NCT00230399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671867|NCT00230399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671868|NCT00230399|Analgesics|analgesics|mesh-ancestor
92671869|NCT00230399|Sensory System Agents|sensory system agents|mesh-ancestor
92671870|NCT00230399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671871|NCT00230399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671872|NCT00230399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671873|NCT00230399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671874|NCT00230399|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92671875|NCT00230399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92671877|NCT00336765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671878|NCT00336765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92671879|NCT00336765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671880|NCT00336765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671881|NCT00230477|Lamivudine|lamivudine|mesh-list
92671882|NCT00230477|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92671883|NCT00230477|Adefovir|adefovir|mesh-list
92671884|NCT00230477|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92671885|NCT00230477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92671886|NCT00230477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577932|NCT00271336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577933|NCT00271336|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92577934|NCT00271336|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92029367|NCT02463331|Amebicides|amebicides|mesh-ancestor
92671887|NCT00230477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671888|NCT00230477|Antiviral Agents|antiviral agents|mesh-ancestor
92671889|NCT00230477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671890|NCT00230477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92671891|NCT00230477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92671892|NCT00230516|Lansoprazole|lansoprazole|mesh-list
92671893|NCT00230516|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92671894|NCT00230516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92671895|NCT00230516|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92671896|NCT00230516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671897|NCT00230516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671898|NCT00336882|Midazolam|midazolam|mesh-list
92671899|NCT00336882|Propofol|propofol|mesh-list
92671900|NCT00336882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92671901|NCT00336882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671902|NCT00336882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671903|NCT00336882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92671904|NCT00336882|Anesthetics, General|anesthetics, general|mesh-ancestor
92671905|NCT00336882|Anesthetics|anesthetics|mesh-ancestor
92671906|NCT00336882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92671907|NCT00336882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92671908|NCT00336882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92671909|NCT00336882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92671910|NCT00336882|GABA Modulators|gaba modulators|mesh-ancestor
92671911|NCT00336882|GABA Agents|gaba agents|mesh-ancestor
92671912|NCT00336882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671913|NCT00336882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671914|NCT00336921|Alfuzosin|alfuzosin|mesh-list
92671915|NCT00336921|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92671916|NCT00336921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92671917|NCT00336921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92671918|NCT00336921|Adrenergic Agents|adrenergic agents|mesh-ancestor
92671919|NCT00336921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92671920|NCT00336921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671921|NCT00336921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671922|NCT00336921|Urological Agents|urological agents|mesh-ancestor
92671923|NCT00336960|Celecoxib|celecoxib|mesh-list
92671924|NCT00336960|Fluorouracil|fluorouracil|mesh-list
92671925|NCT00336960|Antimetabolites|antimetabolites|mesh-ancestor
92671926|NCT00336960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671927|NCT00336960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671928|NCT00336960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671929|NCT00336960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671930|NCT00336960|Immunologic Factors|immunologic factors|mesh-ancestor
92671931|NCT00336960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671932|NCT00336960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92671933|NCT00336960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92671934|NCT00336960|Analgesics|analgesics|mesh-ancestor
92671937|NCT00336960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92671938|NCT00336960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92671939|NCT00336960|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92671940|NCT00336960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92671941|NCT00336960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671943|NCT00306410|Vitamin D|vitamin d|mesh-list
92671944|NCT00306410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92397377|NCT04768829|Carbamide Peroxide|carbamide peroxide|mesh-list
92671945|NCT00306410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671946|NCT00306410|Vitamins|vitamins|mesh-ancestor
92671947|NCT00306410|Micronutrients|micronutrients|mesh-ancestor
92671948|NCT00306410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92671949|NCT00340080|Abacavir|abacavir|mesh-list
92671950|NCT00340080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92671951|NCT00340080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92671952|NCT00340080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671953|NCT00340080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671954|NCT00340080|Antiviral Agents|antiviral agents|mesh-ancestor
92577935|NCT00271336|Protective Agents|protective agents|mesh-ancestor
92577936|NCT00271336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577937|NCT00271336|Vasodilator Agents|vasodilator agents|mesh-ancestor
92577938|NCT00271336|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92577939|NCT00271336|Antioxidants|antioxidants|mesh-ancestor
92577940|NCT00271414|Fentanyl|fentanyl|mesh-list
92671955|NCT00340080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671956|NCT00340080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92671957|NCT00340080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92671958|NCT00418535|Cisplatin|cisplatin|mesh-list
92671959|NCT00418535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671960|NCT02960711|Metformin|metformin|mesh-list
92671961|NCT02960711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671962|NCT02960711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671963|NCT00337155|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92671964|NCT00337155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671965|NCT00340314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92671966|NCT00306644|Rosiglitazone|rosiglitazone|mesh-list
92671967|NCT00306644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92671968|NCT00306644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671969|NCT00306683|Diazoxide|diazoxide|mesh-list
92671970|NCT00306683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92671971|NCT00306683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92671972|NCT00306722|Fospropofol|fospropofol|mesh-list
92671973|NCT00306722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92671974|NCT00306722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92671975|NCT00306722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671976|NCT00337389|Leucovorin|leucovorin|mesh-list
92671977|NCT00337389|Bevacizumab|bevacizumab|mesh-list
92671978|NCT00337389|Fluorouracil|fluorouracil|mesh-list
92671979|NCT00337389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92671980|NCT00337389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671981|NCT00337389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92671982|NCT00337389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92671983|NCT00337389|Growth Substances|growth substances|mesh-ancestor
92671984|NCT00337389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671985|NCT00337389|Growth Inhibitors|growth inhibitors|mesh-ancestor
92671986|NCT00337389|Antimetabolites|antimetabolites|mesh-ancestor
92671987|NCT00337389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671988|NCT00337389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92671989|NCT00337389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671990|NCT00337389|Immunologic Factors|immunologic factors|mesh-ancestor
92671991|NCT00337389|Antidotes|antidotes|mesh-ancestor
92671992|NCT00337389|Protective Agents|protective agents|mesh-ancestor
92671993|NCT00337389|Vitamin B Complex|vitamin b complex|mesh-ancestor
92671994|NCT00337389|Vitamins|vitamins|mesh-ancestor
92671995|NCT00337389|Micronutrients|micronutrients|mesh-ancestor
92671996|NCT00306800|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92671997|NCT00306800|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92671998|NCT00306800|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92671999|NCT00306800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92672000|NCT00306878|Abatacept|abatacept|mesh-list
92672001|NCT00306878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92672002|NCT00306878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672003|NCT00306878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92672004|NCT00306878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672005|NCT00306878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672006|NCT00306878|Immunologic Factors|immunologic factors|mesh-ancestor
92672007|NCT00306878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672015|NCT00337506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672016|NCT00337506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672017|NCT00337506|Glucocorticoids|glucocorticoids|mesh-ancestor
92672018|NCT00337506|Hormones|hormones|mesh-ancestor
92672019|NCT00337506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397452|NCT04496245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92672020|NCT00337506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672021|NCT00337506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672023|NCT00307307|Simvastatin|simvastatin|mesh-list
92672024|NCT00307307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92672025|NCT00307307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92672026|NCT00307307|Antimetabolites|antimetabolites|mesh-ancestor
92577941|NCT00271414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92577942|NCT00271414|Narcotics|narcotics|mesh-ancestor
92577943|NCT00271414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577944|NCT00271414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672027|NCT00307307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672028|NCT00307307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92672029|NCT00307307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92672030|NCT00307307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672031|NCT00307307|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672032|NCT00307307|Vitamin B Complex|vitamin b complex|mesh-ancestor
92672033|NCT00307307|Vitamins|vitamins|mesh-ancestor
92672034|NCT00307307|Micronutrients|micronutrients|mesh-ancestor
92672035|NCT00307307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672036|NCT00337623|Prednisolone|prednisolone|mesh-list
92672037|NCT00337623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672038|NCT00337623|Glucocorticoids|glucocorticoids|mesh-ancestor
92672039|NCT00337623|Hormones|hormones|mesh-ancestor
92672040|NCT00337623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672041|NCT00337623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672042|NCT00337623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672043|NCT00337623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672044|NCT00337701|Enfuvirtide|enfuvirtide|mesh-list
92672045|NCT00337701|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92672046|NCT00337701|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92672047|NCT00337701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672048|NCT00337701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92672049|NCT00337701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92672050|NCT00337701|Antiviral Agents|antiviral agents|mesh-ancestor
92672051|NCT00337701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672052|NCT00307463|Antihypertensive Agents|antihypertensive agents|mesh-list
92672053|NCT00337740|Propranolol|propranolol|mesh-list
92672054|NCT00337740|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92672055|NCT00337740|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92672056|NCT00337740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672057|NCT00337740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672058|NCT00337740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672059|NCT00337740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672060|NCT00337740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92672061|NCT00337740|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672062|NCT00337740|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672063|NCT00307502|Ritonavir|ritonavir|mesh-list
92672064|NCT00307502|Lopinavir|lopinavir|mesh-list
92672065|NCT00307502|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92672066|NCT00307502|Darunavir|darunavir|mesh-list
92672067|NCT00307502|Nelfinavir|nelfinavir|mesh-list
92672068|NCT00307502|Indinavir|indinavir|mesh-list
92672069|NCT00307502|Saquinavir|saquinavir|mesh-list
92672070|NCT00307502|Amprenavir|amprenavir|mesh-list
92672071|NCT00307502|Fosamprenavir|fosamprenavir|mesh-list
92672072|NCT00307502|Nevirapine|nevirapine|mesh-list
92672073|NCT00307502|Tipranavir|tipranavir|mesh-list
92672074|NCT00307502|Efavirenz|efavirenz|mesh-list
92672075|NCT00307502|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92672076|NCT00307502|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92672077|NCT00307502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92672078|NCT00307502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672079|NCT00307502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672086|NCT00307502|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92672087|NCT00307502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92672088|NCT00307502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92672089|NCT00307502|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92672090|NCT00307502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92672091|NCT00307502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92672092|NCT00307502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92672093|NCT00307502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92672094|NCT00307502|Antitubercular Agents|antitubercular agents|mesh-ancestor
92672095|NCT00307502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92672096|NCT00307580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92672097|NCT00307580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92672098|NCT00307580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92672099|NCT00307580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577946|NCT00271414|Sensory System Agents|sensory system agents|mesh-ancestor
92577947|NCT00271414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577948|NCT00271414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577949|NCT00271414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92577950|NCT00271414|Anesthetics, General|anesthetics, general|mesh-ancestor
92577951|NCT00271414|Anesthetics|anesthetics|mesh-ancestor
92672101|NCT00307619|Anticonvulsants|anticonvulsants|mesh-ancestor
92672102|NCT00307619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92672103|NCT00307619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672104|NCT00307658|Immunoglobulins|immunoglobulins|mesh-list
92672105|NCT00307658|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92672106|NCT00307658|Antibodies|antibodies|mesh-list
92672107|NCT00307658|Immunoglobulin G|immunoglobulin g|mesh-list
92672108|NCT00307658|gamma-Globulins|gamma-globulins|mesh-list
92672109|NCT00307658|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92672110|NCT00307658|Immunologic Factors|immunologic factors|mesh-ancestor
92672111|NCT00307658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672112|NCT00337545|Everolimus|everolimus|mesh-list
92672113|NCT00337545|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92672114|NCT00337545|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92672115|NCT00337545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672116|NCT00337545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672117|NCT00337545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672118|NCT00337545|Immunologic Factors|immunologic factors|mesh-ancestor
92672119|NCT00337545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672120|NCT00337545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672121|NCT00307775|Estradiol|estradiol|mesh-list
92672122|NCT00307775|Estrogens|estrogens|mesh-ancestor
92672123|NCT00307775|Hormones|hormones|mesh-ancestor
92672124|NCT00307775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672125|NCT00307775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672126|NCT00307814|Epoetin Alfa|epoetin alfa|mesh-list
92672127|NCT00307814|Hematinics|hematinics|mesh-ancestor
92672128|NCT00341055|Epoetin Alfa|epoetin alfa|mesh-list
92672129|NCT00341055|Hematinics|hematinics|mesh-ancestor
92672130|NCT00338052|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92672131|NCT00338052|Norethindrone|norethindrone|mesh-list
92672132|NCT00338052|Norethindrone Acetate|norethindrone acetate|mesh-list
92672133|NCT00338052|Estradiol|estradiol|mesh-list
92672134|NCT00338052|Estrogens|estrogens|mesh-ancestor
92672135|NCT00338052|Hormones|hormones|mesh-ancestor
92672136|NCT00338052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672137|NCT00338052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672138|NCT00338052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92672139|NCT00338052|Contraceptive Agents|contraceptive agents|mesh-ancestor
92672140|NCT00338052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92672141|NCT00338052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92672142|NCT00338052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92672143|NCT00338052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92672144|NCT00338052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92672145|NCT00338091|Losartan|losartan|mesh-list
92672146|NCT00338091|Benazepril|benazepril|mesh-list
92672147|NCT00338091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92672148|NCT00338091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672151|NCT00338091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672152|NCT00338091|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92672154|NCT00338091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672155|NCT00308048|Interferons|interferons|mesh-list
92672156|NCT00308048|Ribavirin|ribavirin|mesh-list
92672157|NCT00308048|Interferon-alpha|interferon-alpha|mesh-list
92672158|NCT00308048|Interferon alpha-2|interferon alpha-2|mesh-list
92672159|NCT00308048|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92672160|NCT00308048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672161|NCT00308048|Antiviral Agents|antiviral agents|mesh-ancestor
92672162|NCT00308048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672163|NCT00308048|Antimetabolites|antimetabolites|mesh-ancestor
92672164|NCT00308048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672165|NCT00308048|Immunologic Factors|immunologic factors|mesh-ancestor
92672166|NCT00308048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672167|NCT00338130|Temozolomide|temozolomide|mesh-list
92672168|NCT00338130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92672169|NCT00338130|Alkylating Agents|alkylating agents|mesh-ancestor
92672170|NCT00338130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672171|NCT00338130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672172|NCT00308126|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92672173|NCT00308126|Plasma Substitutes|plasma substitutes|mesh-ancestor
92672174|NCT00308126|Blood Substitutes|blood substitutes|mesh-ancestor
92672176|NCT00308165|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92672177|NCT00308165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92672178|NCT00308165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672179|NCT00308165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672180|NCT00308165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672181|NCT00425334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92672182|NCT00338247|Capecitabine|capecitabine|mesh-list
92672183|NCT00338247|Lapatinib|lapatinib|mesh-list
92672184|NCT00338247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672185|NCT00338247|Antimetabolites|antimetabolites|mesh-ancestor
92672186|NCT00338247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672187|NCT00338247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672188|NCT00338247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92672189|NCT00338247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672190|NCT00308321|Prednisolone|prednisolone|mesh-list
92672191|NCT00308321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92672192|NCT00308321|Methylprednisolone|methylprednisolone|mesh-list
92672193|NCT00308321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92672194|NCT00308321|Prednisolone acetate|prednisolone acetate|mesh-list
92672195|NCT00308321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92672196|NCT00308321|Prednisolone phosphate|prednisolone phosphate|mesh-list
92672197|NCT00308321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672198|NCT00308321|Glucocorticoids|glucocorticoids|mesh-ancestor
92672199|NCT00308321|Hormones|hormones|mesh-ancestor
92672200|NCT00308321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672201|NCT00308321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672202|NCT00308321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672203|NCT00308321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672204|NCT00308321|Antiemetics|antiemetics|mesh-ancestor
92672205|NCT00308321|Autonomic Agents|autonomic agents|mesh-ancestor
92672206|NCT00308321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672207|NCT00308321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672208|NCT00308321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92672209|NCT00308321|Protective Agents|protective agents|mesh-ancestor
92672210|NCT00308360|Valproic Acid|valproic acid|mesh-list
92672211|NCT00308360|Risperidone|risperidone|mesh-list
92672212|NCT00308360|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92672213|NCT00308360|Serotonin Agents|serotonin agents|mesh-ancestor
92672214|NCT00308360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672215|NCT00308360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672216|NCT00308360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672217|NCT00308360|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92672218|NCT00308360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92672219|NCT00308360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672220|NCT00308360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92672233|NCT00341250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672234|NCT00308438|Teduglutide|teduglutide|mesh-list
92672235|NCT00308438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672236|NCT00308438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92672237|NCT00308438|Protective Agents|protective agents|mesh-ancestor
92672238|NCT00308438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672239|NCT00308477|Dexamethasone|dexamethasone|mesh-list
92672240|NCT00308477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672241|NCT00308477|Antiemetics|antiemetics|mesh-ancestor
92672242|NCT00308477|Autonomic Agents|autonomic agents|mesh-ancestor
92672243|NCT00308477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672244|NCT00308477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672245|NCT00308477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672246|NCT00308477|Glucocorticoids|glucocorticoids|mesh-ancestor
92672247|NCT00308477|Hormones|hormones|mesh-ancestor
92397683|NCT03661996|Sensory System Agents|sensory system agents|mesh-ancestor
92672248|NCT00308477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672249|NCT00308477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672250|NCT00308477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672252|NCT00308594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672253|NCT00308594|Antiemetics|antiemetics|mesh-ancestor
92672254|NCT00308594|Autonomic Agents|autonomic agents|mesh-ancestor
92672255|NCT00308594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577952|NCT00271453|Fentanyl|fentanyl|mesh-list
92672256|NCT00308594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672257|NCT00308594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672258|NCT00308594|Glucocorticoids|glucocorticoids|mesh-ancestor
92672259|NCT00308594|Hormones|hormones|mesh-ancestor
92672260|NCT00308594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672261|NCT00308594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672262|NCT00308594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672263|NCT00308945|Travoprost|travoprost|mesh-list
92672264|NCT00308945|Latanoprost|latanoprost|mesh-list
92672265|NCT00308945|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92672266|NCT00308945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92672267|NCT00308945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672268|NCT00338481|Morphine|morphine|mesh-list
92672269|NCT00338481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92672270|NCT00338481|Narcotics|narcotics|mesh-ancestor
92672271|NCT00338481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672272|NCT00338481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672273|NCT00338481|Analgesics|analgesics|mesh-ancestor
92672274|NCT00338481|Sensory System Agents|sensory system agents|mesh-ancestor
92672275|NCT00338481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672276|NCT00309101|Tacrolimus|tacrolimus|mesh-list
92672277|NCT00309101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672278|NCT00309101|Immunologic Factors|immunologic factors|mesh-ancestor
92672279|NCT00309101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672280|NCT00309101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92672281|NCT00309101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672282|NCT00309101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672283|NCT00309218|Methylprednisolone|methylprednisolone|mesh-list
92672284|NCT00309218|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92672285|NCT00309218|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92672289|NCT00309218|Prednisolone phosphate|prednisolone phosphate|mesh-list
92672290|NCT00309218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672292|NCT00309218|Autonomic Agents|autonomic agents|mesh-ancestor
92672293|NCT00309218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672294|NCT00309218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672295|NCT00309218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672296|NCT00309218|Glucocorticoids|glucocorticoids|mesh-ancestor
92672297|NCT00309218|Hormones|hormones|mesh-ancestor
92672298|NCT00309218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672299|NCT00309218|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92672300|NCT00309218|Protective Agents|protective agents|mesh-ancestor
92672301|NCT00309218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672302|NCT00309218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672303|NCT00309335|Phentolamine|phentolamine|mesh-list
92672304|NCT00309335|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92672305|NCT00309335|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92672306|NCT00309335|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672307|NCT00309335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672308|NCT00309335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672309|NCT00309335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672310|NCT00309335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672311|NCT00309374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92672312|NCT00309374|Simvastatin|simvastatin|mesh-list
92672313|NCT00309374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92672314|NCT00309374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92672315|NCT00309374|Antimetabolites|antimetabolites|mesh-ancestor
92672316|NCT00309374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672317|NCT00309374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92672318|NCT00309374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92672319|NCT00309374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397759|NCT03289325|Analgesics|analgesics|mesh-ancestor
92672320|NCT00309413|Cannabidiol|cannabidiol|mesh-list
92672321|NCT00309413|Anticonvulsants|anticonvulsants|mesh-ancestor
92672322|NCT00309491|Tamoxifen|tamoxifen|mesh-list
92672323|NCT00309491|Aminoglutethimide|aminoglutethimide|mesh-list
92672324|NCT00309491|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92672325|NCT00309491|Hormone Antagonists|hormone antagonists|mesh-ancestor
92672326|NCT00309491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672327|NCT00309491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672328|NCT00309491|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672329|NCT00309491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672330|NCT00309491|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92672331|NCT00309491|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92577953|NCT00271453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92577954|NCT00271453|Narcotics|narcotics|mesh-ancestor
92577955|NCT00271453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92577956|NCT00271453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577957|NCT00271453|Analgesics|analgesics|mesh-ancestor
92672332|NCT00309491|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92672333|NCT00309491|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92672334|NCT00309491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92672335|NCT00309491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672336|NCT00309491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672337|NCT02960048|Salicylic Acid|salicylic acid|mesh-list
92672338|NCT02960048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672339|NCT02960048|Antifungal Agents|antifungal agents|mesh-ancestor
92672340|NCT02960048|Keratolytic Agents|keratolytic agents|mesh-ancestor
92672341|NCT02960048|Dermatologic Agents|dermatologic agents|mesh-ancestor
92672342|NCT00309530|Interferons|interferons|mesh-list
92672343|NCT00309530|Fluorouracil|fluorouracil|mesh-list
92672344|NCT00309530|Antimetabolites|antimetabolites|mesh-ancestor
92672345|NCT00309530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672346|NCT00309530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672347|NCT00309530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672348|NCT00309530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672349|NCT00309530|Immunologic Factors|immunologic factors|mesh-ancestor
92672350|NCT00309530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672351|NCT00309530|Antiviral Agents|antiviral agents|mesh-ancestor
92672352|NCT00309530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672353|NCT00309569|Cyclophosphamide|cyclophosphamide|mesh-list
92672354|NCT00309569|Fluorouracil|fluorouracil|mesh-list
92672355|NCT00309569|Methotrexate|methotrexate|mesh-list
92672357|NCT00309569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672379|NCT00309686|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92672380|NCT00309686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92672381|NCT00309686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672382|NCT00309686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672383|NCT00309686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92672384|NCT00309686|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92672385|NCT00309686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92672386|NCT00309686|Serotonin Agents|serotonin agents|mesh-ancestor
92672387|NCT00309686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672388|NCT00309686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672389|NCT00309686|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92672390|NCT00309686|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92672391|NCT00309686|Dopamine Agents|dopamine agents|mesh-ancestor
92672393|NCT00309725|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92672394|NCT00309725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672395|NCT00309725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672396|NCT00309725|Cholinergic Agents|cholinergic agents|mesh-ancestor
92672397|NCT00309725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672398|NCT00309725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672399|NCT00309725|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92672401|NCT00309725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672402|NCT00309725|Nootropic Agents|nootropic agents|mesh-ancestor
92672403|NCT00338754|Adalimumab|adalimumab|mesh-list
92672404|NCT00338754|Antibodies|antibodies|mesh-list
92672405|NCT00338754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92672406|NCT00338754|Immunologic Factors|immunologic factors|mesh-ancestor
92672407|NCT00338754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672408|NCT00338754|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92079796|NCT00417274|Quinacrine|quinacrine|mesh-list
92672409|NCT00338754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672411|NCT00338793|Prednisolone|prednisolone|mesh-list
92672412|NCT00338793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672413|NCT00338793|Glucocorticoids|glucocorticoids|mesh-ancestor
92672414|NCT00338793|Hormones|hormones|mesh-ancestor
92672415|NCT00338793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672416|NCT00338793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672417|NCT00338793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672418|NCT00338793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672419|NCT00418847|Miglustat|miglustat|mesh-list
92672420|NCT00418847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92577958|NCT00271453|Sensory System Agents|sensory system agents|mesh-ancestor
92577959|NCT00271453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92577960|NCT00271453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92577961|NCT00271453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92577962|NCT00271453|Anesthetics, General|anesthetics, general|mesh-ancestor
92577963|NCT00271453|Anesthetics|anesthetics|mesh-ancestor
92577964|NCT00271492|Atrasentan|atrasentan|mesh-list
92577965|NCT00271492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577966|NCT00271492|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92577967|NCT00271492|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92672421|NCT00418847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672422|NCT00418847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92672423|NCT00418847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92672424|NCT00418847|Antiviral Agents|antiviral agents|mesh-ancestor
92672425|NCT00418847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672426|NCT00418847|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92672427|NCT00418847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92672428|NCT00418847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672429|NCT00309881|Prednisone|prednisone|mesh-list
92672430|NCT00309881|Cyclophosphamide|cyclophosphamide|mesh-list
92672431|NCT00309881|Rituximab|rituximab|mesh-list
92672432|NCT00309881|Doxorubicin|doxorubicin|mesh-list
92672433|NCT00309881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92672434|NCT00309881|Vincristine|vincristine|mesh-list
92672435|NCT00309881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672436|NCT00309881|Immunologic Factors|immunologic factors|mesh-ancestor
92672437|NCT00309881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672438|NCT00309881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672439|NCT00309881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92672440|NCT00309881|Alkylating Agents|alkylating agents|mesh-ancestor
92672441|NCT00309881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672442|NCT00309881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672443|NCT00309881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92672444|NCT00309881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92672445|NCT00309881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92672446|NCT00309881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92672447|NCT00309881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92672448|NCT00309881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672449|NCT00309881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672450|NCT00309881|Glucocorticoids|glucocorticoids|mesh-ancestor
92672451|NCT00309881|Hormones|hormones|mesh-ancestor
92672452|NCT00309881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672453|NCT00309881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672454|NCT00309881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92672455|NCT00309881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672456|NCT00309881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672457|NCT00309881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672458|NCT00309920|Cyclophosphamide|cyclophosphamide|mesh-list
92672459|NCT00309920|Docetaxel|docetaxel|mesh-list
92672460|NCT00309920|Doxorubicin|doxorubicin|mesh-list
92672461|NCT00309920|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92672462|NCT00309920|Fluorouracil|fluorouracil|mesh-list
92672463|NCT00309920|Epirubicin|epirubicin|mesh-list
92672464|NCT00309920|Darbepoetin alfa|darbepoetin alfa|mesh-list
92672465|NCT00309920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672466|NCT00309920|Immunologic Factors|immunologic factors|mesh-ancestor
92672467|NCT00309920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672468|NCT00309920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672469|NCT00309920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92672470|NCT00309920|Alkylating Agents|alkylating agents|mesh-ancestor
92672471|NCT00309920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672472|NCT00309920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672473|NCT00309920|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92672474|NCT00309920|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672475|NCT00309920|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672476|NCT00309920|Mitosis Modulators|mitosis modulators|mesh-ancestor
92577968|NCT00271492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577969|NCT00271804|Bortezomib|bortezomib|mesh-list
92577970|NCT00271804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577971|NCT00107601|Insulin|insulin|mesh-list
92672477|NCT00309920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92672478|NCT00309920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92672479|NCT00309920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92672480|NCT00309920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672481|NCT00309920|Antimetabolites|antimetabolites|mesh-ancestor
92672482|NCT00309920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672483|NCT00309920|Hematinics|hematinics|mesh-ancestor
92672484|NCT00309998|Bevacizumab|bevacizumab|mesh-list
92672493|NCT00309998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92672495|NCT00309998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672496|NCT00309998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672497|NCT00309998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672498|NCT04715217|Cyclophosphamide|cyclophosphamide|mesh-list
92672499|NCT04715217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672500|NCT04715217|Immunologic Factors|immunologic factors|mesh-ancestor
92672501|NCT04715217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672502|NCT04715217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672503|NCT04715217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92672504|NCT04715217|Alkylating Agents|alkylating agents|mesh-ancestor
92672505|NCT04715217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672506|NCT04715217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672507|NCT04715217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92672508|NCT00310154|Docetaxel|docetaxel|mesh-list
92672509|NCT00310154|Gefitinib|gefitinib|mesh-list
92672510|NCT00310154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672511|NCT00310154|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672512|NCT00310154|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672513|NCT00310154|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672514|NCT00310154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672515|NCT00310154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92672516|NCT00310154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672517|NCT00338910|Metronidazole|metronidazole|mesh-list
92672518|NCT00338910|Budesonide|budesonide|mesh-list
92672519|NCT00338910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672520|NCT00338910|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92672521|NCT00338910|Autonomic Agents|autonomic agents|mesh-ancestor
92672522|NCT00338910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672523|NCT00338910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672524|NCT00338910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92672525|NCT00338910|Respiratory System Agents|respiratory system agents|mesh-ancestor
92672526|NCT00338910|Glucocorticoids|glucocorticoids|mesh-ancestor
92672527|NCT00338910|Hormones|hormones|mesh-ancestor
92672528|NCT00338910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672529|NCT00338910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672530|NCT00338910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92672531|NCT00338910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92672532|NCT00338910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92672533|NCT00310232|Epoetin Alfa|epoetin alfa|mesh-list
92672534|NCT00310232|Hematinics|hematinics|mesh-ancestor
92672535|NCT00418730|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92672536|NCT00418730|Protease Inhibitors|protease inhibitors|mesh-ancestor
92672537|NCT00418730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672538|NCT00418730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672539|NCT00310349|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92672540|NCT00310349|Immunologic Factors|immunologic factors|mesh-ancestor
92672541|NCT00310349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672542|NCT00310505|Amphotericin B|amphotericin b|mesh-list
92672543|NCT00310505|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92672544|NCT00310505|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92672545|NCT00310505|Deoxycholic Acid|deoxycholic acid|mesh-list
92672546|NCT00310505|Amebicides|amebicides|mesh-ancestor
92672547|NCT00310505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92672548|NCT00310505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92672549|NCT00310505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672550|NCT00310505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92672553|NCT00310505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672554|NCT00339066|Sertraline|sertraline|mesh-list
92672555|NCT00339066|Antidepressive Agents|antidepressive agents|mesh-ancestor
92577972|NCT00107601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92577973|NCT00107601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577974|NCT00272077|Insulin Glargine|insulin glargine|mesh-list
92577975|NCT00272077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92577976|NCT00272077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577977|NCT00272116|Vitamins|vitamins|mesh-list
92577978|NCT00272116|Vitamin A|vitamin a|mesh-list
92577979|NCT00272116|Retinol palmitate|retinol palmitate|mesh-list
92672556|NCT00339066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92672557|NCT00339066|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92672558|NCT00339066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92672559|NCT00339066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92672560|NCT00339066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672561|NCT00339066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672562|NCT00339066|Serotonin Agents|serotonin agents|mesh-ancestor
92672563|NCT00339066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672564|NCT00310583|Pregabalin|pregabalin|mesh-list
92672565|NCT00310583|Analgesics|analgesics|mesh-ancestor
92672566|NCT00310583|Sensory System Agents|sensory system agents|mesh-ancestor
92672567|NCT00310583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672568|NCT00310583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672569|NCT00310583|Anticonvulsants|anticonvulsants|mesh-ancestor
92672570|NCT00310583|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92672571|NCT00310583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92672572|NCT00310583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672573|NCT00310583|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92672574|NCT00310583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92672575|NCT00310583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92672576|NCT00310583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672577|NCT00310583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92672578|NCT00421044|Epothilone B|epothilone b|mesh-list
92672579|NCT00421044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672580|NCT00421044|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672581|NCT00421044|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672582|NCT00421044|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672583|NCT00421044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672584|NCT00425217|Rituximab|rituximab|mesh-list
92672585|NCT00425217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92672586|NCT00425217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672587|NCT00425217|Immunologic Factors|immunologic factors|mesh-ancestor
92672588|NCT00425217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672589|NCT00425217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672590|NCT00310778|Atenolol|atenolol|mesh-list
92672591|NCT00310778|Valsartan|valsartan|mesh-list
92672592|NCT00310778|Candesartan|candesartan|mesh-list
92672593|NCT00310778|Candesartan cilexetil|candesartan cilexetil|mesh-list
92672594|NCT00310778|Ramipril|ramipril|mesh-list
92672595|NCT00310778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672596|NCT00310778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92672597|NCT00310778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92672598|NCT00310778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672599|NCT00310778|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92672600|NCT00310778|Protease Inhibitors|protease inhibitors|mesh-ancestor
92672601|NCT00310778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672602|NCT00310778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92672603|NCT00310778|Sympatholytics|sympatholytics|mesh-ancestor
92672604|NCT00310778|Autonomic Agents|autonomic agents|mesh-ancestor
92672605|NCT00310778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672606|NCT00310778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672607|NCT00310778|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92672608|NCT00310778|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92672609|NCT00310778|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92672610|NCT00310778|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672611|NCT00310778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672612|NCT00421083|Tadalafil|tadalafil|mesh-list
92672613|NCT00421083|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672614|NCT00421083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92577980|NCT00272116|Micronutrients|micronutrients|mesh-ancestor
92577981|NCT00272116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92577982|NCT00272116|Antioxidants|antioxidants|mesh-ancestor
92577983|NCT00272116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577984|NCT00272116|Protective Agents|protective agents|mesh-ancestor
92672615|NCT00421083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92672616|NCT00421083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672617|NCT00421083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672618|NCT00421083|Urological Agents|urological agents|mesh-ancestor
92672619|NCT00310895|Imetelstat|imetelstat|mesh-list
92672620|NCT00310895|Motesanib diphosphate|motesanib diphosphate|mesh-list
92672621|NCT00310895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672622|NCT00310895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672627|NCT00310934|Narcotics|narcotics|mesh-ancestor
92672628|NCT00310934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672629|NCT00310934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672630|NCT00310934|Analgesics|analgesics|mesh-ancestor
92672631|NCT00310934|Sensory System Agents|sensory system agents|mesh-ancestor
92672632|NCT00310934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672633|NCT00310934|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92672634|NCT00310934|Antitussive Agents|antitussive agents|mesh-ancestor
92672635|NCT00310934|Respiratory System Agents|respiratory system agents|mesh-ancestor
92672636|NCT00421122|Budesonide|budesonide|mesh-list
92672637|NCT00421122|Terbutaline|terbutaline|mesh-list
92672638|NCT00421122|Formoterol Fumarate|formoterol fumarate|mesh-list
92672639|NCT00421122|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92672640|NCT00421122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672641|NCT00421122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92672642|NCT00421122|Autonomic Agents|autonomic agents|mesh-ancestor
92672643|NCT00421122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672644|NCT00421122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672645|NCT00421122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92672646|NCT00421122|Respiratory System Agents|respiratory system agents|mesh-ancestor
92672647|NCT00421122|Glucocorticoids|glucocorticoids|mesh-ancestor
92672648|NCT00421122|Hormones|hormones|mesh-ancestor
92672649|NCT00421122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672650|NCT00421122|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92672651|NCT00421122|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92672652|NCT00421122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92672653|NCT00421122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672654|NCT00421122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672655|NCT00421122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672656|NCT00421122|Sympathomimetics|sympathomimetics|mesh-ancestor
92672657|NCT00421122|Tocolytic Agents|tocolytic agents|mesh-ancestor
92672658|NCT00421122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92672659|NCT00311051|Ramatroban|ramatroban|mesh-list
92672660|NCT00311051|Montelukast|montelukast|mesh-list
92672661|NCT00311051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92672662|NCT00311051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92672663|NCT00311051|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92672664|NCT00311051|Hormone Antagonists|hormone antagonists|mesh-ancestor
92672665|NCT00311051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672666|NCT00311051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672667|NCT00311051|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92672668|NCT00311051|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92672669|NCT00311051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672670|NCT00311051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92672671|NCT00311129|Rituximab|rituximab|mesh-list
92672672|NCT00311129|Fludarabine|fludarabine|mesh-list
92672673|NCT00311129|Fludarabine phosphate|fludarabine phosphate|mesh-list
92672674|NCT00311129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92672675|NCT00311129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672676|NCT00311129|Immunologic Factors|immunologic factors|mesh-ancestor
92672677|NCT00311129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672678|NCT00311129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672679|NCT00311129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672680|NCT00311129|Antimetabolites|antimetabolites|mesh-ancestor
92577985|NCT00272116|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92577986|NCT00272116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92577987|NCT00272428|Ascorbic Acid|ascorbic acid|mesh-list
92577988|NCT00272428|Vitamin E|vitamin e|mesh-list
92577989|NCT00272428|Beta Carotene|beta carotene|mesh-list
92672681|NCT00311129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672682|NCT00311129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672683|NCT00311285|Hydrocortisone|hydrocortisone|mesh-list
92672684|NCT00311285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672685|NCT00342381|Amifampridine|amifampridine|mesh-list
92672686|NCT00342381|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92672687|NCT00342381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672688|NCT00342381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672689|NCT00342381|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92672690|NCT00342381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92672691|NCT00342381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672692|NCT00311558|Interferons|interferons|mesh-list
92672703|NCT00311558|Schistosomicides|schistosomicides|mesh-ancestor
92672704|NCT00311558|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92672705|NCT00311558|Anthelmintics|anthelmintics|mesh-ancestor
92672706|NCT00418925|Dronabinol|dronabinol|mesh-list
92672707|NCT00418925|Hallucinogens|hallucinogens|mesh-ancestor
92672708|NCT00418925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672709|NCT00418925|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92672710|NCT00418925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92672711|NCT00418925|Analgesics|analgesics|mesh-ancestor
92672712|NCT00418925|Sensory System Agents|sensory system agents|mesh-ancestor
92672713|NCT00418925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672714|NCT00418925|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92672715|NCT00418925|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92672716|NCT00418925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672717|NCT00418925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672718|NCT00418925|Hormones|hormones|mesh-ancestor
92672719|NCT00418925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672720|NCT00339417|Ivermectin|ivermectin|mesh-list
92672721|NCT00339417|Albendazole|albendazole|mesh-list
92672722|NCT00339417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92672723|NCT00339417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672724|NCT00339417|Anthelmintics|anthelmintics|mesh-ancestor
92672725|NCT00339417|Anticestodal Agents|anticestodal agents|mesh-ancestor
92672726|NCT00339417|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92672727|NCT00339417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92672728|NCT00339417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672729|NCT00339417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672730|NCT00339417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672731|NCT00339417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672732|NCT00339417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672733|NCT00311636|Paclitaxel|paclitaxel|mesh-list
92672734|NCT00311636|Docetaxel|docetaxel|mesh-list
92672735|NCT00311636|Cyclophosphamide|cyclophosphamide|mesh-list
92672736|NCT00311636|Doxorubicin|doxorubicin|mesh-list
92672737|NCT00311636|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92672738|NCT00311636|Fluorouracil|fluorouracil|mesh-list
92672739|NCT00311636|Methotrexate|methotrexate|mesh-list
92672740|NCT00311636|Epirubicin|epirubicin|mesh-list
92672741|NCT00311636|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92672742|NCT00311636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92672743|NCT00311636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672744|NCT00311636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672745|NCT00311636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672746|NCT00311636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672747|NCT00311636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672748|NCT00311636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672749|NCT00311636|Immunologic Factors|immunologic factors|mesh-ancestor
92672750|NCT00311636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672751|NCT00311636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672752|NCT00311636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92672753|NCT00311636|Alkylating Agents|alkylating agents|mesh-ancestor
92672754|NCT00311636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92672755|NCT00311636|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92672756|NCT00311636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92672757|NCT00311636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92577991|NCT00272428|Carotenoids|carotenoids|mesh-list
92577992|NCT00272428|Vitamins|vitamins|mesh-ancestor
92577993|NCT00272428|Micronutrients|micronutrients|mesh-ancestor
92577994|NCT00272428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672758|NCT00311636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672759|NCT00311636|Antimetabolites|antimetabolites|mesh-ancestor
92080116|NCT00377572|Omalizumab|omalizumab|mesh-list
92672761|NCT00311636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92672762|NCT00311636|Abortifacient Agents|abortifacient agents|mesh-ancestor
92672763|NCT00311636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92672764|NCT00311636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92672765|NCT00311636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92672766|NCT00311636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92672767|NCT00311636|Luteolytic Agents|luteolytic agents|mesh-ancestor
92672768|NCT00311636|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92672769|NCT00311636|Contraceptive Agents|contraceptive agents|mesh-ancestor
92672770|NCT00311636|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92672771|NCT00311636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92672773|NCT00311753|Certoparin|certoparin|mesh-list
92672774|NCT00311753|Anticoagulants|anticoagulants|mesh-ancestor
92672775|NCT00311753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92672776|NCT00311753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92672777|NCT00311753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672778|NCT00311870|Lisinopril|lisinopril|mesh-list
92672779|NCT00311870|Nisoldipine|nisoldipine|mesh-list
92672780|NCT00311870|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92672781|NCT00311870|Protease Inhibitors|protease inhibitors|mesh-ancestor
92672782|NCT00311870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672783|NCT00311870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672784|NCT00311870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672785|NCT00311870|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92672786|NCT00311870|Protective Agents|protective agents|mesh-ancestor
92672787|NCT00311870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672788|NCT00311870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92672789|NCT00311870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92672790|NCT00311870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92672791|NCT00311870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672792|NCT00311987|3,5-diiodothyropropionic acid|3,5-diiodothyropropionic acid|mesh-list
92672793|NCT00311987|Hormones|hormones|mesh-ancestor
92672794|NCT00311987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672795|NCT00311987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672796|NCT00342849|Succimer|succimer|mesh-list
92672797|NCT00342849|Antidotes|antidotes|mesh-ancestor
92672798|NCT00342849|Protective Agents|protective agents|mesh-ancestor
92672799|NCT00342849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672800|NCT00342849|Chelating Agents|chelating agents|mesh-ancestor
92672801|NCT00342849|Sequestering Agents|sequestering agents|mesh-ancestor
92672802|NCT00342849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672803|NCT00312104|Insulin|insulin|mesh-list
92672804|NCT00312104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92672805|NCT00312104|Insulin Glargine|insulin glargine|mesh-list
92672806|NCT00312104|Insulin Aspart|insulin aspart|mesh-list
92672807|NCT00312104|Insulin Detemir|insulin detemir|mesh-list
92672808|NCT00312104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92672809|NCT00312104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672810|NCT00312143|Mycophenolic Acid|mycophenolic acid|mesh-list
92672811|NCT00312143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92672812|NCT00312143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672813|NCT00312143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92672814|NCT00312143|Antitubercular Agents|antitubercular agents|mesh-ancestor
92672815|NCT00312143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92672816|NCT00312143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672817|NCT00312143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672818|NCT00312143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672819|NCT00343005|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92672820|NCT00343005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92672821|NCT00343005|Immunologic Factors|immunologic factors|mesh-ancestor
92672822|NCT00343005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672823|NCT00343005|Antacids|antacids|mesh-ancestor
92672824|NCT00343005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672825|NCT00343005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672826|NCT00312182|Nelfinavir|nelfinavir|mesh-list
92672827|NCT00312182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92672828|NCT00312182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92672829|NCT00312182|Protease Inhibitors|protease inhibitors|mesh-ancestor
92672830|NCT00312182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672831|NCT00312182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080180|NCT00427804|Calcitriol|calcitriol|mesh-list
92672835|NCT00312182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672836|NCT00312260|Gabapentin|gabapentin|mesh-list
92672837|NCT00312260|Amitriptyline|amitriptyline|mesh-list
92672838|NCT00312260|Analgesics|analgesics|mesh-ancestor
92672839|NCT00312260|Sensory System Agents|sensory system agents|mesh-ancestor
92672840|NCT00312260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672841|NCT00312260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672842|NCT00312260|Anticonvulsants|anticonvulsants|mesh-ancestor
92672843|NCT00312260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92672844|NCT00312260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92672845|NCT00312260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672846|NCT00312260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92672847|NCT00312260|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92672848|NCT00312260|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92672849|NCT00312260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672850|NCT00312260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672851|NCT00312260|Antimanic Agents|antimanic agents|mesh-ancestor
92672852|NCT00312260|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92672853|NCT00312260|Antidepressive Agents|antidepressive agents|mesh-ancestor
92672854|NCT00312260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92672855|NCT00312260|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92672856|NCT00312260|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92672857|NCT00312260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92672858|NCT00312260|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672859|NCT00312299|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92672860|NCT00312299|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672861|NCT00312299|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92672862|NCT00312299|Protective Agents|protective agents|mesh-ancestor
92672863|NCT00312299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672864|NCT00312416|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92672865|NCT00312416|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672866|NCT00312416|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92672867|NCT00312416|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92672868|NCT00312416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92672869|NCT00312416|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672870|NCT00312416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672871|NCT00312416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672872|NCT00312416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672873|NCT00339768|Amoxicillin|amoxicillin|mesh-list
92672874|NCT00339768|Omeprazole|omeprazole|mesh-list
92672875|NCT00339768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92672876|NCT00339768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672877|NCT00339768|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92672878|NCT00339768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672879|NCT00339768|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92672880|NCT00339768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672881|NCT00339768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672882|NCT00343161|Esomeprazole|esomeprazole|mesh-list
92672883|NCT00343161|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92672884|NCT00343161|Magnesium trisilicate|magnesium trisilicate|mesh-list
92672885|NCT00343161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92672886|NCT00343161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672887|NCT00343161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92672888|NCT00343161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672889|NCT00343161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672890|NCT00343161|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92672891|NCT00343161|Immunologic Factors|immunologic factors|mesh-ancestor
92672892|NCT00343161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672893|NCT00343161|Antacids|antacids|mesh-ancestor
92672894|NCT00312533|Hylan|hylan|mesh-list
92672895|NCT00312533|Viscosupplements|viscosupplements|mesh-ancestor
92672896|NCT00312533|Protective Agents|protective agents|mesh-ancestor
92672897|NCT00312533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672898|NCT00312650|Gemcitabine|gemcitabine|mesh-list
92672899|NCT00312650|Doxorubicin|doxorubicin|mesh-list
92672900|NCT00312650|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92672901|NCT00312650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672902|NCT00312650|Antimetabolites|antimetabolites|mesh-ancestor
92577995|NCT00272428|Antioxidants|antioxidants|mesh-ancestor
92577996|NCT00272428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92577997|NCT00272428|Protective Agents|protective agents|mesh-ancestor
92577998|NCT00272428|Trace Elements|trace elements|mesh-ancestor
92577999|NCT00272428|Provitamins|provitamins|mesh-ancestor
92578000|NCT00272467|Omeprazole|omeprazole|mesh-list
92672903|NCT00312650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672904|NCT00312650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672908|NCT00312650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672909|NCT00343200|Sildenafil Citrate|sildenafil citrate|mesh-list
92672910|NCT00343200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672911|NCT00343200|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672912|NCT00343200|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92672913|NCT00343200|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92672914|NCT00343200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672915|NCT00343200|Urological Agents|urological agents|mesh-ancestor
92672916|NCT00312806|Pantoprazole|pantoprazole|mesh-list
92672917|NCT00312806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92672918|NCT00312806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92672919|NCT00312806|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92672920|NCT00312806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672921|NCT00312806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672922|NCT00347685|Tramadol|tramadol|mesh-list
92672923|NCT00347685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92672924|NCT00347685|Narcotics|narcotics|mesh-ancestor
92672925|NCT00347685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672926|NCT00347685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672927|NCT00347685|Analgesics|analgesics|mesh-ancestor
92672928|NCT00347685|Sensory System Agents|sensory system agents|mesh-ancestor
92672929|NCT00347685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672930|NCT00343239|Docetaxel|docetaxel|mesh-list
92672931|NCT00343239|Fluorouracil|fluorouracil|mesh-list
92672932|NCT00343239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672933|NCT00343239|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672934|NCT00343239|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672935|NCT00343239|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672936|NCT00343239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672937|NCT00343239|Antimetabolites|antimetabolites|mesh-ancestor
92672938|NCT00343239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672939|NCT00343239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92672940|NCT00343239|Immunologic Factors|immunologic factors|mesh-ancestor
92672941|NCT00343239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672942|NCT00313001|Insulin Aspart|insulin aspart|mesh-list
92672943|NCT00313001|Exenatide|exenatide|mesh-list
92672944|NCT00313001|Biphasic Insulins|biphasic insulins|mesh-list
92672945|NCT00313001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92672946|NCT00313001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672947|NCT00313001|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92672948|NCT00313001|Incretins|incretins|mesh-ancestor
92672949|NCT00313001|Hormones|hormones|mesh-ancestor
92672950|NCT00313001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92672951|NCT00343278|Valacyclovir|valacyclovir|mesh-list
92672952|NCT00343278|Antiviral Agents|antiviral agents|mesh-ancestor
92672953|NCT00343278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672954|NCT00343317|Cefoxitin|cefoxitin|mesh-list
92672955|NCT00343317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92672956|NCT00343317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672957|NCT00313079|Vincristine|vincristine|mesh-list
92672958|NCT00313079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92672959|NCT00313079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672960|NCT00313079|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672961|NCT00313079|Antimitotic Agents|antimitotic agents|mesh-ancestor
92672962|NCT00313079|Mitosis Modulators|mitosis modulators|mesh-ancestor
92672963|NCT00313079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672964|NCT00347724|Tramadol|tramadol|mesh-list
92672965|NCT00347724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92672966|NCT00347724|Narcotics|narcotics|mesh-ancestor
92672967|NCT00347724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92672968|NCT00347724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672969|NCT00347724|Analgesics|analgesics|mesh-ancestor
92672970|NCT00347724|Sensory System Agents|sensory system agents|mesh-ancestor
92578001|NCT00272467|Rebamipide|rebamipide|mesh-list
92578002|NCT00272467|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92578003|NCT00272467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578004|NCT00272467|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92578005|NCT00272467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682790|NCT00438113|Diuretics|diuretics|mesh-ancestor
92672971|NCT00347724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672972|NCT00313157|Metoprolol|metoprolol|mesh-list
92672973|NCT00313157|Verapamil|verapamil|mesh-list
92672974|NCT00313157|Carvedilol|carvedilol|mesh-list
92672975|NCT00313157|Diltiazem|diltiazem|mesh-list
92672976|NCT00313157|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92672977|NCT00313157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92672978|NCT00313157|Sympatholytics|sympatholytics|mesh-ancestor
92672979|NCT00313157|Autonomic Agents|autonomic agents|mesh-ancestor
92672984|NCT00313157|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92672985|NCT00313157|Adrenergic Agents|adrenergic agents|mesh-ancestor
92672986|NCT00313157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92672987|NCT00313157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672988|NCT00313157|Antioxidants|antioxidants|mesh-ancestor
92672989|NCT00313157|Protective Agents|protective agents|mesh-ancestor
92672990|NCT00313157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92672991|NCT00313157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92672992|NCT00313157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92672993|NCT00313157|Vasodilator Agents|vasodilator agents|mesh-ancestor
92672994|NCT00313157|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92672995|NCT00313157|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92672996|NCT00347763|Permethrin|permethrin|mesh-list
92672997|NCT00347763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672998|NCT00347763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672999|NCT00313235|Cyclophosphamide|cyclophosphamide|mesh-list
92673000|NCT00313235|Vaccines|vaccines|mesh-list
92673001|NCT00313235|Immunologic Factors|immunologic factors|mesh-ancestor
92673002|NCT00313235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673003|NCT00313235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673004|NCT00313235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673005|NCT00313235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673006|NCT00313235|Alkylating Agents|alkylating agents|mesh-ancestor
92673007|NCT00313235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673008|NCT00313235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673009|NCT00313235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673010|NCT00347802|Bimatoprost|bimatoprost|mesh-list
92673011|NCT00347802|Travoprost|travoprost|mesh-list
92673012|NCT00347802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92673013|NCT00313274|Clevudine|clevudine|mesh-list
92673014|NCT00313274|Antiviral Agents|antiviral agents|mesh-ancestor
92673015|NCT00313274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673016|NCT00419042|Gemcitabine|gemcitabine|mesh-list
92673017|NCT00419042|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92673018|NCT00419042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673019|NCT00419042|Antimetabolites|antimetabolites|mesh-ancestor
92673020|NCT00419042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673021|NCT00419042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673022|NCT00419042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92673023|NCT00419042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673024|NCT00347841|Bimatoprost|bimatoprost|mesh-list
92673025|NCT00347841|Latanoprost|latanoprost|mesh-list
92673026|NCT00347841|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92673027|NCT00347841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92673028|NCT00347841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92673029|NCT00425126|Epoetin Alfa|epoetin alfa|mesh-list
92673030|NCT00425126|Hematinics|hematinics|mesh-ancestor
92673031|NCT00343629|Sulindac|sulindac|mesh-list
92673032|NCT00343629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92673033|NCT00343629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92673034|NCT00343629|Analgesics|analgesics|mesh-ancestor
92673035|NCT00343629|Sensory System Agents|sensory system agents|mesh-ancestor
92673036|NCT00343629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673037|NCT00343629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673038|NCT00343629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673039|NCT00343629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673040|NCT00343629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578006|NCT00272467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578008|NCT00272467|Protective Agents|protective agents|mesh-ancestor
92578009|NCT00272467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578010|NCT00272584|Risperidone|risperidone|mesh-list
92030570|NCT04251819|GABA Agents|gaba agents|mesh-ancestor
92673041|NCT00343629|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92673042|NCT00343629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673043|NCT00343629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673044|NCT00343668|Irinotecan|irinotecan|mesh-list
92673045|NCT00343668|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92673046|NCT00343668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92673047|NCT00343668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673048|NCT00343668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673049|NCT00343668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673057|NCT00343707|Serotonin Agents|serotonin agents|mesh-ancestor
92673058|NCT00343707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673059|NCT00343707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92673060|NCT00343707|Antidepressive Agents|antidepressive agents|mesh-ancestor
92673061|NCT00343707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92673062|NCT00343707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92673063|NCT00343707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92673064|NCT00343707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673065|NCT00343707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92673066|NCT00313391|Risperidone|risperidone|mesh-list
92673067|NCT00313391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92673068|NCT00313391|Serotonin Agents|serotonin agents|mesh-ancestor
92673069|NCT00313391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673070|NCT00313391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673071|NCT00313391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673072|NCT00313391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92673073|NCT00313391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92673074|NCT00313391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673075|NCT00313391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92673076|NCT00313391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92673077|NCT00313391|Dopamine Agents|dopamine agents|mesh-ancestor
92673079|NCT00348153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92673080|NCT00348153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673081|NCT00348153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673082|NCT00313508|Vidarabine|vidarabine|mesh-list
92673083|NCT00313508|Fludarabine|fludarabine|mesh-list
92673084|NCT00313508|Fludarabine phosphate|fludarabine phosphate|mesh-list
92673085|NCT00313508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673086|NCT00313508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673087|NCT00313508|Antimetabolites|antimetabolites|mesh-ancestor
92673088|NCT00313508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673089|NCT00313508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673090|NCT00313508|Immunologic Factors|immunologic factors|mesh-ancestor
92673091|NCT00313508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673092|NCT00313508|Antiviral Agents|antiviral agents|mesh-ancestor
92673093|NCT00313508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673094|NCT00313547|Amlodipine|amlodipine|mesh-list
92673095|NCT00313547|Quinapril|quinapril|mesh-list
92673096|NCT00313547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92673097|NCT00313547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92673098|NCT00313547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92673099|NCT00313547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673100|NCT00313547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92673101|NCT00313547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673102|NCT00313547|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673103|NCT00313547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92673104|NCT00313547|Protease Inhibitors|protease inhibitors|mesh-ancestor
92673105|NCT00313547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673106|NCT00348192|Donepezil|donepezil|mesh-list
92673107|NCT00348192|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92673108|NCT00348192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673109|NCT00348192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578011|NCT00272584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92578012|NCT00272584|Serotonin Agents|serotonin agents|mesh-ancestor
92578013|NCT00272584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578014|NCT00272584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682791|NCT00438113|Natriuretic Agents|natriuretic agents|mesh-ancestor
92673110|NCT00348192|Cholinergic Agents|cholinergic agents|mesh-ancestor
92673111|NCT00348192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673112|NCT00348192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673113|NCT00348192|Nootropic Agents|nootropic agents|mesh-ancestor
92673114|NCT00313625|Methotrexate|methotrexate|mesh-list
92673115|NCT00313625|Melphalan|melphalan|mesh-list
92673116|NCT00313625|Busulfan|busulfan|mesh-list
92673120|NCT00313625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92673121|NCT00313625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673122|NCT00313625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673124|NCT00313625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673125|NCT00313625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673126|NCT00313625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92673127|NCT00313625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673128|NCT00313625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92673129|NCT00313625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673130|NCT00313625|Immunologic Factors|immunologic factors|mesh-ancestor
92673131|NCT00313625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673132|NCT00313625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673133|NCT00313625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92673134|NCT00313625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673135|NCT00313625|Alkylating Agents|alkylating agents|mesh-ancestor
92673136|NCT00313625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673137|NCT00343980|Insulin|insulin|mesh-list
92673138|NCT00343980|Glimepiride|glimepiride|mesh-list
92673139|NCT00343980|Rosiglitazone|rosiglitazone|mesh-list
92673140|NCT00343980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92673141|NCT00343980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673142|NCT00343980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673143|NCT00343980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92673144|NCT00343980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673145|NCT00343980|Immunologic Factors|immunologic factors|mesh-ancestor
92673146|NCT00313742|Insulin|insulin|mesh-list
92673147|NCT00313742|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92673148|NCT00313742|Insulin Glargine|insulin glargine|mesh-list
92673149|NCT00313742|Insulin Detemir|insulin detemir|mesh-list
92398591|NCT01398046|Betaine|betaine|mesh-list
92673150|NCT00313742|Isophane Insulin, Human|isophane insulin, human|mesh-list
92673151|NCT00313742|Insulin, Isophane|insulin, isophane|mesh-list
92673152|NCT00313742|Isophane insulin, beef|isophane insulin, beef|mesh-list
92673153|NCT00313742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673154|NCT00313742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673155|NCT00313859|Simvastatin|simvastatin|mesh-list
92673156|NCT00313859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92673157|NCT00313859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673158|NCT00313859|Antimetabolites|antimetabolites|mesh-ancestor
92673159|NCT00313859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673160|NCT00313859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673161|NCT00313859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92673162|NCT00313859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673163|NCT00348231|Insulin|insulin|mesh-list
92673164|NCT00348231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673165|NCT00348231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673166|NCT00313898|Sildenafil Citrate|sildenafil citrate|mesh-list
92673167|NCT00313898|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673168|NCT00313898|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92673169|NCT00313898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92673170|NCT00313898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673171|NCT00313898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673172|NCT00313898|Urological Agents|urological agents|mesh-ancestor
92673173|NCT00344058|Magnesium Sulfate|magnesium sulfate|mesh-list
92673174|NCT00344058|Analgesics|analgesics|mesh-ancestor
92673175|NCT00344058|Sensory System Agents|sensory system agents|mesh-ancestor
92673176|NCT00344058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673177|NCT00344058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673178|NCT00344058|Anesthetics|anesthetics|mesh-ancestor
92578015|NCT00272584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578016|NCT00272584|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92578017|NCT00272584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578018|NCT00272584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030710|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
92673179|NCT00344058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673180|NCT00344058|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92673181|NCT00344058|Anticonvulsants|anticonvulsants|mesh-ancestor
92673182|NCT00344058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92673183|NCT00344058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92673184|NCT00344058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673185|NCT00344058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92673186|NCT00344058|Tocolytic Agents|tocolytic agents|mesh-ancestor
92673187|NCT00344058|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92673190|NCT00313937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673192|NCT00313976|Interferon-beta|interferon-beta|mesh-list
92673193|NCT00313976|Interferon beta-1b|interferon beta-1b|mesh-list
92673194|NCT00313976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673195|NCT00313976|Antiviral Agents|antiviral agents|mesh-ancestor
92673196|NCT00313976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673197|NCT00313976|Immunologic Factors|immunologic factors|mesh-ancestor
92673198|NCT00313976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673199|NCT00313976|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92673201|NCT00348387|Immunologic Factors|immunologic factors|mesh-ancestor
92673202|NCT00348387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673203|NCT00314171|Timolol|timolol|mesh-list
92673204|NCT00314171|Dorzolamide|dorzolamide|mesh-list
92673205|NCT00314171|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92673206|NCT00314171|Brinzolamide|brinzolamide|mesh-list
92673207|NCT00314171|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92673208|NCT00314171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92673209|NCT00314171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92673210|NCT00314171|Adrenergic Agents|adrenergic agents|mesh-ancestor
92673211|NCT00314171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673212|NCT00314171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673213|NCT00314171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673214|NCT00314171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92673215|NCT00314171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92673216|NCT00314171|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92673217|NCT00314171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673218|NCT00348426|Antitoxins|antitoxins|mesh-list
92673219|NCT00348426|Botulinum Antitoxin|botulinum antitoxin|mesh-list
92673220|NCT00348426|Immunologic Factors|immunologic factors|mesh-ancestor
92673221|NCT00348426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673222|NCT00314210|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92673223|NCT00314210|Antidepressive Agents|antidepressive agents|mesh-ancestor
92673224|NCT00314210|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92673225|NCT00314210|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92673226|NCT00314210|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92673227|NCT00314210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673228|NCT00314210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673229|NCT00344253|Interferons|interferons|mesh-list
92673230|NCT00344253|Interferon-beta|interferon-beta|mesh-list
92673231|NCT00344253|Methotrexate|methotrexate|mesh-list
92673232|NCT00344253|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92673233|NCT00344253|Abortifacient Agents|abortifacient agents|mesh-ancestor
92673234|NCT00344253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92673235|NCT00344253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673236|NCT00344253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673237|NCT00344253|Antimetabolites|antimetabolites|mesh-ancestor
92673238|NCT00344253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673239|NCT00344253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673240|NCT00344253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92673241|NCT00344253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673242|NCT00344253|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92673243|NCT00344253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673244|NCT00344253|Immunologic Factors|immunologic factors|mesh-ancestor
92673245|NCT00344253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673246|NCT00344253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92578019|NCT00272584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578020|NCT00272584|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92578021|NCT00272584|Dopamine Agents|dopamine agents|mesh-ancestor
92578022|NCT00272701|Esomeprazole|esomeprazole|mesh-list
92578023|NCT00272701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92673247|NCT00344253|Antiviral Agents|antiviral agents|mesh-ancestor
92673248|NCT00344253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673249|NCT00314405|Methylene Blue|methylene blue|mesh-list
92673250|NCT00314405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673251|NCT00314405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673252|NCT04715295|Azithromycin|azithromycin|mesh-list
92673253|NCT04715295|Doxycycline|doxycycline|mesh-list
92673254|NCT04715295|Hydroxychloroquine|hydroxychloroquine|mesh-list
92673255|NCT04715295|Rivaroxaban|rivaroxaban|mesh-list
92673256|NCT04715295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92673257|NCT04715295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673258|NCT04715295|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92673259|NCT04715295|Antithrombins|antithrombins|mesh-ancestor
92673260|NCT04715295|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92673261|NCT04715295|Protease Inhibitors|protease inhibitors|mesh-ancestor
92673262|NCT04715295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673279|NCT00348504|Sympathomimetics|sympathomimetics|mesh-ancestor
92673280|NCT00348504|Autonomic Agents|autonomic agents|mesh-ancestor
92673281|NCT00348504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673282|NCT00348504|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92673283|NCT00348504|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92673284|NCT00348504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92673285|NCT00348504|Adrenergic Agents|adrenergic agents|mesh-ancestor
92673286|NCT00348504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673287|NCT00314561|Pioglitazone|pioglitazone|mesh-list
92673288|NCT00314561|Rosiglitazone|rosiglitazone|mesh-list
92673289|NCT00314561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673290|NCT00314561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673291|NCT00344409|Darbepoetin alfa|darbepoetin alfa|mesh-list
92673292|NCT00344409|Hematinics|hematinics|mesh-ancestor
92673293|NCT00348582|Ketorolac|ketorolac|mesh-list
92673294|NCT00348582|Nepafenac|nepafenac|mesh-list
92673295|NCT00348582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92673296|NCT00348582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92673297|NCT00348582|Analgesics|analgesics|mesh-ancestor
92673298|NCT00348582|Sensory System Agents|sensory system agents|mesh-ancestor
92673299|NCT00348582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673300|NCT00348582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673301|NCT00348582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398746|NCT01398618|Antimetabolites|antimetabolites|mesh-ancestor
92673302|NCT00348582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673303|NCT00348582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92673304|NCT00348582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673305|NCT00348582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673306|NCT00314639|Modafinil|modafinil|mesh-list
92673307|NCT00314639|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92673308|NCT00314639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673309|NCT00314639|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92673310|NCT00314639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92673311|NCT00314639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92673312|NCT00314639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673313|NCT00314678|Paclitaxel|paclitaxel|mesh-list
92673314|NCT00314678|Topotecan|topotecan|mesh-list
92673315|NCT00314678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92673316|NCT00314678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673317|NCT00314678|Tubulin Modulators|tubulin modulators|mesh-ancestor
92673318|NCT00314678|Antimitotic Agents|antimitotic agents|mesh-ancestor
92673319|NCT00314678|Mitosis Modulators|mitosis modulators|mesh-ancestor
92673320|NCT00314678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673340|NCT00344526|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673341|NCT00344526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673342|NCT00344526|Immunologic Factors|immunologic factors|mesh-ancestor
92673343|NCT00314756|Imiquimod|imiquimod|mesh-list
92673344|NCT00314756|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92673345|NCT00314756|Immunologic Factors|immunologic factors|mesh-ancestor
92673346|NCT00314756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673347|NCT00314756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673348|NCT00314756|Interferon Inducers|interferon inducers|mesh-ancestor
92578024|NCT00272701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92578025|NCT00272701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92578026|NCT00272701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673349|NCT00344565|Modafinil|modafinil|mesh-list
92673350|NCT00344565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92673351|NCT00344565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673352|NCT00344565|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92673353|NCT00344565|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92673354|NCT00344565|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92673355|NCT00344565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673356|NCT00314873|Imatinib Mesylate|imatinib mesylate|mesh-list
92673357|NCT00314873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673358|NCT00314873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92673359|NCT00314873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673360|NCT00314873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673361|NCT00348738|Epoetin Alfa|epoetin alfa|mesh-list
92673362|NCT00348738|Hematinics|hematinics|mesh-ancestor
92673363|NCT00314912|Tramiprosate|tramiprosate|mesh-list
92673364|NCT00314912|Anticonvulsants|anticonvulsants|mesh-ancestor
92673365|NCT00314912|GABA Agonists|gaba agonists|mesh-ancestor
92673366|NCT00314912|GABA Agents|gaba agents|mesh-ancestor
92673367|NCT00314912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673368|NCT00314912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673369|NCT00314912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673370|NCT00314990|Folic Acid|folic acid|mesh-list
92673371|NCT00314990|Pyridoxine|pyridoxine|mesh-list
92673372|NCT00314990|Vitamin B 12|vitamin b 12|mesh-list
92673373|NCT00314990|Hydroxocobalamin|hydroxocobalamin|mesh-list
92673374|NCT00314990|Hematinics|hematinics|mesh-ancestor
92673375|NCT00314990|Vitamin B Complex|vitamin b complex|mesh-ancestor
92673376|NCT00314990|Vitamins|vitamins|mesh-ancestor
92673381|NCT02960126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92673382|NCT02960126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92673383|NCT02960126|Analgesics|analgesics|mesh-ancestor
92673384|NCT02960126|Sensory System Agents|sensory system agents|mesh-ancestor
92673385|NCT02960126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673386|NCT02960126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673387|NCT02960126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673388|NCT02960126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673389|NCT02960126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92673390|NCT02960126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92673391|NCT02960126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673392|NCT02960126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92673393|NCT02960126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92673394|NCT02960126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673395|NCT02960126|Antipyretics|antipyretics|mesh-ancestor
92673396|NCT02960126|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92673397|NCT02960126|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92673398|NCT02960126|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92673399|NCT02960126|Purinergic Agents|purinergic agents|mesh-ancestor
92673400|NCT02960126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673401|NCT00315185|Cetuximab|cetuximab|mesh-list
92673402|NCT00315185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92673403|NCT00315185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673404|NCT00344760|Tenofovir|tenofovir|mesh-list
92673405|NCT00344760|Lamivudine|lamivudine|mesh-list
92673406|NCT00344760|Efavirenz|efavirenz|mesh-list
92673407|NCT00344760|Enfuvirtide|enfuvirtide|mesh-list
92673408|NCT00344760|Antiviral Agents|antiviral agents|mesh-ancestor
92673409|NCT00344760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673410|NCT00344760|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92673411|NCT00344760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673412|NCT00344760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673413|NCT00344760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673414|NCT00344760|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92673415|NCT00344760|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92673416|NCT00344760|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92673417|NCT00344760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92673418|NCT00344760|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92673419|NCT00344760|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92673420|NCT00344760|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92673421|NCT00344760|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92682792|NCT00438113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673422|NCT00344760|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92673423|NCT00344760|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92673424|NCT00348894|Reboxetine|reboxetine|mesh-list
92673425|NCT00348894|Antidepressive Agents|antidepressive agents|mesh-ancestor
92673426|NCT00348894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92673427|NCT00348894|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92673428|NCT00348894|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92673429|NCT00348894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92673430|NCT00348894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673431|NCT00348894|Adrenergic Agents|adrenergic agents|mesh-ancestor
92673432|NCT00348894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673433|NCT00348894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673434|NCT00315536|Glycopyrrolate|glycopyrrolate|mesh-list
92673435|NCT00315536|Remifentanil|remifentanil|mesh-list
92673436|NCT00315536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92673437|NCT00315536|Narcotics|narcotics|mesh-ancestor
92365650|NCT00393354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673438|NCT00315536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673439|NCT00315536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673440|NCT00315536|Analgesics|analgesics|mesh-ancestor
92673441|NCT00315536|Sensory System Agents|sensory system agents|mesh-ancestor
92673442|NCT00315536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673443|NCT00315536|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92673444|NCT00315536|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92673445|NCT00315536|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92673446|NCT00315536|Cholinergic Agents|cholinergic agents|mesh-ancestor
92673447|NCT00315536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673450|NCT00348972|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673451|NCT00348972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673452|NCT00349089|Pemetrexed|pemetrexed|mesh-list
92673453|NCT00349089|Vinorelbine|vinorelbine|mesh-list
92673454|NCT00349089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673455|NCT00349089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673456|NCT00349089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673457|NCT00349089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92673458|NCT00349089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673459|NCT00349089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92673460|NCT00349089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92673461|NCT00349089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92673462|NCT00349089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92673463|NCT00349128|Metformin|metformin|mesh-list
92673464|NCT00349128|Fenofibrate|fenofibrate|mesh-list
92673465|NCT00349128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673466|NCT00349128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673467|NCT00349128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673468|NCT00349128|Antimetabolites|antimetabolites|mesh-ancestor
92673469|NCT00349128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673470|NCT00349128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673471|NCT00315848|Buprenorphine|buprenorphine|mesh-list
92673472|NCT00315848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92673473|NCT00315848|Narcotics|narcotics|mesh-ancestor
92673474|NCT00315848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673475|NCT00315848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673476|NCT00315848|Analgesics|analgesics|mesh-ancestor
92673477|NCT00315848|Sensory System Agents|sensory system agents|mesh-ancestor
92673478|NCT00315848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673479|NCT00315848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92673480|NCT00349206|Sirolimus|sirolimus|mesh-list
92673481|NCT00349206|Sorafenib|sorafenib|mesh-list
92673482|NCT00349206|Temsirolimus|temsirolimus|mesh-list
92673483|NCT00349206|MTOR Inhibitors|mtor inhibitors|mesh-list
92673484|NCT00349206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673485|NCT00349206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92673486|NCT00349206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673487|NCT00349206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673488|NCT00349206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673489|NCT00349206|Immunologic Factors|immunologic factors|mesh-ancestor
92673490|NCT00349206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673491|NCT00349206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92673492|NCT00349206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673493|NCT00349206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92673494|NCT00349206|Antifungal Agents|antifungal agents|mesh-ancestor
92673495|NCT00315887|Buprenorphine|buprenorphine|mesh-list
92673496|NCT00315887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92673497|NCT00315887|Narcotics|narcotics|mesh-ancestor
92578027|NCT00272701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578028|NCT00272740|Fulvestrant|fulvestrant|mesh-list
91985257|NCT02390063|Alkylating Agents|alkylating agents|mesh-ancestor
92673498|NCT00315887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673499|NCT00315887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673500|NCT00315887|Analgesics|analgesics|mesh-ancestor
92673501|NCT00315887|Sensory System Agents|sensory system agents|mesh-ancestor
92673502|NCT00315887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673503|NCT00315887|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92673504|NCT00421395|Epratuzumab|epratuzumab|mesh-list
92673505|NCT00421395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92673506|NCT00421395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673507|NCT00315926|Melatonin|melatonin|mesh-list
92673508|NCT00315926|Antioxidants|antioxidants|mesh-ancestor
92673509|NCT00315926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673510|NCT00315926|Protective Agents|protective agents|mesh-ancestor
92673511|NCT00315926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673512|NCT00315926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673513|NCT00421434|Ribavirin|ribavirin|mesh-list
92673514|NCT00421434|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92673515|NCT00421434|Interferon-alpha|interferon-alpha|mesh-list
92673516|NCT00421434|Nitazoxanide|nitazoxanide|mesh-list
92673517|NCT00421434|Antimetabolites|antimetabolites|mesh-ancestor
92673518|NCT00421434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673519|NCT00421434|Antiviral Agents|antiviral agents|mesh-ancestor
92673520|NCT00421434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673521|NCT00421434|Immunologic Factors|immunologic factors|mesh-ancestor
92673525|NCT00315965|Carbon Monoxide|carbon monoxide|mesh-list
92673526|NCT00315965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92673527|NCT00315965|Autonomic Agents|autonomic agents|mesh-ancestor
92673528|NCT00315965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673529|NCT00315965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673530|NCT00315965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92673531|NCT00315965|Respiratory System Agents|respiratory system agents|mesh-ancestor
92673532|NCT00315965|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92673533|NCT00315965|Antioxidants|antioxidants|mesh-ancestor
92673534|NCT00315965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673535|NCT00315965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673536|NCT00315965|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92673537|NCT00315965|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673538|NCT00315965|Gasotransmitters|gasotransmitters|mesh-ancestor
92673539|NCT00315965|Protective Agents|protective agents|mesh-ancestor
92673540|NCT00315965|Antimetabolites|antimetabolites|mesh-ancestor
92673541|NCT00349245|Dexmedetomidine|dexmedetomidine|mesh-list
92673542|NCT00349245|Remifentanil|remifentanil|mesh-list
92673543|NCT00349245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92673544|NCT00349245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673545|NCT00349245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673546|NCT00349245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92673547|NCT00349245|Analgesics|analgesics|mesh-ancestor
92673548|NCT00349245|Sensory System Agents|sensory system agents|mesh-ancestor
92673549|NCT00349245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673550|NCT00349245|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92673551|NCT00349245|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92673552|NCT00349245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92673553|NCT00349245|Adrenergic Agents|adrenergic agents|mesh-ancestor
92673554|NCT00349245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673555|NCT00349245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673556|NCT00349245|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92673557|NCT00349245|Narcotics|narcotics|mesh-ancestor
92673558|NCT00349284|Ezetimibe|ezetimibe|mesh-list
92673559|NCT00349284|Fenofibrate|fenofibrate|mesh-list
92673560|NCT00349284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92673561|NCT00349284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673562|NCT00349284|Antimetabolites|antimetabolites|mesh-ancestor
92673563|NCT00349284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673564|NCT00349284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673565|NCT00316160|Bupropion|bupropion|mesh-list
92673566|NCT00316160|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92673567|NCT00316160|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92673568|NCT00316160|Antidepressive Agents|antidepressive agents|mesh-ancestor
92673569|NCT00316160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031102|NCT02427841|Tubulin Modulators|tubulin modulators|mesh-ancestor
92673570|NCT00316160|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92673571|NCT00316160|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92673572|NCT00316160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92673573|NCT00316160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673574|NCT00316160|Dopamine Agents|dopamine agents|mesh-ancestor
92673575|NCT00316160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673576|NCT00316160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673577|NCT00316160|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92673578|NCT00316160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92673579|NCT00316160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673580|NCT00316160|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92673581|NCT00349362|Testosterone|testosterone|mesh-list
92673582|NCT00349362|Androgens|androgens|mesh-ancestor
92673583|NCT00349362|Hormones|hormones|mesh-ancestor
92673584|NCT00349362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673585|NCT00349362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673586|NCT00316238|Olanzapine|olanzapine|mesh-list
92673587|NCT00316238|Antiemetics|antiemetics|mesh-ancestor
92673588|NCT00316238|Autonomic Agents|autonomic agents|mesh-ancestor
92673589|NCT00316238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673590|NCT00316238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673591|NCT00316238|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92673592|NCT00316238|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92673600|NCT00316238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673602|NCT00349401|Ketorolac|ketorolac|mesh-list
92673603|NCT00349401|Morphine|morphine|mesh-list
92673604|NCT00349401|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92673605|NCT00349401|Narcotics|narcotics|mesh-ancestor
92673606|NCT00349401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673607|NCT00349401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673608|NCT00349401|Analgesics|analgesics|mesh-ancestor
92673609|NCT00349401|Sensory System Agents|sensory system agents|mesh-ancestor
92673610|NCT00349401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673611|NCT00349401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92673612|NCT00349401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92673613|NCT00349401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673614|NCT00349401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673615|NCT00349401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92673616|NCT00349401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673617|NCT00349401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673618|NCT00349440|Cyclosporine|cyclosporine|mesh-list
92673619|NCT00349440|Cyclosporins|cyclosporins|mesh-list
92673620|NCT00349440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673621|NCT00349440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673622|NCT00349440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673623|NCT00349440|Immunologic Factors|immunologic factors|mesh-ancestor
92673624|NCT00349440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673625|NCT00349440|Antifungal Agents|antifungal agents|mesh-ancestor
92673626|NCT00349440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673627|NCT00349440|Dermatologic Agents|dermatologic agents|mesh-ancestor
92673628|NCT00349440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673629|NCT00349440|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92673630|NCT00316433|Oxaliplatin|oxaliplatin|mesh-list
92673631|NCT00316433|Irinotecan|irinotecan|mesh-list
92673632|NCT00316433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673633|NCT00316433|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92673634|NCT00316433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92673635|NCT00316433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673636|NCT00316433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673637|NCT00349518|Dasatinib|dasatinib|mesh-list
92673638|NCT00349518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673639|NCT00349518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92673640|NCT00349518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673641|NCT00349518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673642|NCT00316472|Niacinamide|niacinamide|mesh-list
92673644|NCT00316472|Nicotinic Acids|nicotinic acids|mesh-list
92673645|NCT00316472|Vitamin B Complex|vitamin b complex|mesh-ancestor
92673646|NCT00316472|Vitamins|vitamins|mesh-ancestor
92673647|NCT00316472|Micronutrients|micronutrients|mesh-ancestor
92673648|NCT00316472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673649|NCT00316472|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673650|NCT00316472|Antimetabolites|antimetabolites|mesh-ancestor
92578029|NCT00272740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92578030|NCT00272740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578031|NCT00272740|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92673651|NCT00316472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673652|NCT00316472|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673653|NCT00316472|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673654|NCT00349557|Bevacizumab|bevacizumab|mesh-list
92673655|NCT00349557|Goserelin|goserelin|mesh-list
92673656|NCT00349557|Bicalutamide|bicalutamide|mesh-list
92673657|NCT00349557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92673658|NCT00349557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673659|NCT00349557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92673662|NCT00349557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673663|NCT00349557|Growth Inhibitors|growth inhibitors|mesh-ancestor
92673664|NCT00349557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92673665|NCT00349557|Androgen Antagonists|androgen antagonists|mesh-ancestor
92673666|NCT00349557|Hormone Antagonists|hormone antagonists|mesh-ancestor
92673667|NCT00349557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673668|NCT00349596|Decitabine|decitabine|mesh-list
92673669|NCT00349596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673670|NCT00349596|Antimetabolites|antimetabolites|mesh-ancestor
92673671|NCT00349596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673672|NCT00349596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673673|NCT00349596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673674|NCT00349635|Metformin|metformin|mesh-list
92673675|NCT00349635|Fenofibrate|fenofibrate|mesh-list
92673676|NCT00349635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673677|NCT00349635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673678|NCT00349635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673679|NCT00349635|Antimetabolites|antimetabolites|mesh-ancestor
92673680|NCT00349635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673681|NCT00349635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673682|NCT00316745|Leucovorin|leucovorin|mesh-list
92673683|NCT00316745|Fluorouracil|fluorouracil|mesh-list
92673684|NCT00316745|Oxaliplatin|oxaliplatin|mesh-list
92673685|NCT00316745|Irinotecan|irinotecan|mesh-list
92673686|NCT00316745|Antimetabolites|antimetabolites|mesh-ancestor
92673687|NCT00316745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673688|NCT00316745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673689|NCT00316745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673690|NCT00316745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673691|NCT00316745|Immunologic Factors|immunologic factors|mesh-ancestor
92673692|NCT00316745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673693|NCT00316745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92673694|NCT00316745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92673695|NCT00316745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673696|NCT00316745|Antidotes|antidotes|mesh-ancestor
92673697|NCT00316745|Protective Agents|protective agents|mesh-ancestor
92673698|NCT00316745|Vitamin B Complex|vitamin b complex|mesh-ancestor
92673699|NCT00316745|Vitamins|vitamins|mesh-ancestor
92673700|NCT00316745|Micronutrients|micronutrients|mesh-ancestor
92673701|NCT00349674|Methotrexate|methotrexate|mesh-list
92673702|NCT00349674|Azathioprine|azathioprine|mesh-list
92673703|NCT00349674|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92673704|NCT00349674|Abortifacient Agents|abortifacient agents|mesh-ancestor
92673705|NCT00349674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92673706|NCT00349674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673707|NCT00349674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673708|NCT00349674|Antimetabolites|antimetabolites|mesh-ancestor
92673709|NCT00349674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673710|NCT00349674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673711|NCT00349674|Dermatologic Agents|dermatologic agents|mesh-ancestor
92673712|NCT00349674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673713|NCT00349674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92673714|NCT00349674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673715|NCT00349674|Immunologic Factors|immunologic factors|mesh-ancestor
92673716|NCT00349674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673717|NCT00349674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673718|NCT00344916|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92673719|NCT00344916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673720|NCT00344916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673721|NCT00344955|Atorvastatin|atorvastatin|mesh-list
92578032|NCT00272740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92578033|NCT00272740|Hormone Antagonists|hormone antagonists|mesh-ancestor
92578034|NCT00272740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673722|NCT00344955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92673723|NCT00344955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673724|NCT00344955|Antimetabolites|antimetabolites|mesh-ancestor
92673725|NCT00344955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673726|NCT00344955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673727|NCT00344955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92673728|NCT00344955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673729|NCT00316901|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92673730|NCT00316901|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92673731|NCT00316901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673732|NCT00316940|Bortezomib|bortezomib|mesh-list
92673745|NCT00344994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92673746|NCT00344994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92673747|NCT00344994|Dopamine Agonists|dopamine agonists|mesh-ancestor
92673748|NCT00344994|Dopamine Agents|dopamine agents|mesh-ancestor
92673749|NCT00344994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673750|NCT00349791|Testosterone|testosterone|mesh-list
92673751|NCT00349791|Androgens|androgens|mesh-ancestor
92673752|NCT00349791|Hormones|hormones|mesh-ancestor
92673753|NCT00349791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673754|NCT00349791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673756|NCT00317096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92673757|NCT00317096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673758|NCT00317096|Immunologic Factors|immunologic factors|mesh-ancestor
92673759|NCT00317096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673760|NCT00317096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673761|NCT00317135|Vaccines|vaccines|mesh-list
92673762|NCT00317135|Immunologic Factors|immunologic factors|mesh-ancestor
92673763|NCT00317135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673764|NCT00349986|Insulin Glargine|insulin glargine|mesh-list
92673765|NCT00349986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673766|NCT00349986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673767|NCT00345150|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92673768|NCT00345150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673769|NCT00345150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673770|NCT00317252|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92673771|NCT00317252|Protease Inhibitors|protease inhibitors|mesh-ancestor
92673772|NCT00317252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673773|NCT00317252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673774|NCT00317330|Rifampin|rifampin|mesh-list
92673775|NCT00317330|Isoniazid|isoniazid|mesh-list
92673776|NCT00317330|Pyrazinamide|pyrazinamide|mesh-list
92673777|NCT00317330|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92673778|NCT00317330|Antitubercular Agents|antitubercular agents|mesh-ancestor
92673779|NCT00317330|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92673780|NCT00317330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673781|NCT00317330|Leprostatic Agents|leprostatic agents|mesh-ancestor
92673782|NCT00317330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673783|NCT00317330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673784|NCT00317330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673785|NCT00317330|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92673786|NCT00317330|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92673787|NCT00317330|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92673788|NCT00317330|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92673789|NCT00317330|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92673790|NCT00317330|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92673791|NCT00317330|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92673792|NCT00317330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673793|NCT00317330|Antimetabolites|antimetabolites|mesh-ancestor
92673794|NCT00317330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673795|NCT00317408|Leucovorin|leucovorin|mesh-list
92673799|NCT00317408|Prednisolone|prednisolone|mesh-list
92673800|NCT00317408|Carboplatin|carboplatin|mesh-list
92673801|NCT00317408|Methotrexate|methotrexate|mesh-list
92673802|NCT00317408|Etoposide|etoposide|mesh-list
92673803|NCT00317408|Melphalan|melphalan|mesh-list
92673804|NCT00317408|Busulfan|busulfan|mesh-list
92673805|NCT00317408|Ifosfamide|ifosfamide|mesh-list
92673806|NCT00317408|Mitoxantrone|mitoxantrone|mesh-list
92578035|NCT00272740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578036|NCT00074750|Molgramostim|molgramostim|mesh-list
92578037|NCT00074750|Sargramostim|sargramostim|mesh-list
92578038|NCT00074750|Immunologic Factors|immunologic factors|mesh-ancestor
92578039|NCT00074750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578040|NCT00074750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673807|NCT00317408|Idarubicin|idarubicin|mesh-list
92673808|NCT00317408|Thiotepa|thiotepa|mesh-list
92673809|NCT00317408|Carmustine|carmustine|mesh-list
92673810|NCT00317408|Vinblastine|vinblastine|mesh-list
92673811|NCT00317408|Lomustine|lomustine|mesh-list
92673812|NCT00317408|Etoposide phosphate|etoposide phosphate|mesh-list
92673813|NCT00317408|Vindesine|vindesine|mesh-list
92673814|NCT00317408|Cyclosporins|cyclosporins|mesh-list
92673815|NCT00317408|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92673816|NCT00317408|Levoleucovorin|levoleucovorin|mesh-list
92673817|NCT00317408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673818|NCT00317408|Antiemetics|antiemetics|mesh-ancestor
92673819|NCT00317408|Autonomic Agents|autonomic agents|mesh-ancestor
92673820|NCT00317408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673821|NCT00317408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673822|NCT00317408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92673823|NCT00317408|Glucocorticoids|glucocorticoids|mesh-ancestor
92673824|NCT00317408|Hormones|hormones|mesh-ancestor
92673825|NCT00317408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673826|NCT00317408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92673827|NCT00317408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399265|NCT01402622|Propofol|propofol|mesh-list
92673828|NCT00317408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92673829|NCT00317408|Abortifacient Agents|abortifacient agents|mesh-ancestor
92673830|NCT00317408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92673831|NCT00317408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673832|NCT00317408|Antimetabolites|antimetabolites|mesh-ancestor
92673833|NCT00317408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673834|NCT00317408|Dermatologic Agents|dermatologic agents|mesh-ancestor
92673835|NCT00317408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673836|NCT00317408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92673837|NCT00317408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673838|NCT00317408|Immunologic Factors|immunologic factors|mesh-ancestor
92673839|NCT00317408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673840|NCT00317408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673841|NCT00317408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92673842|NCT00317408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92673843|NCT00317408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92673844|NCT00317408|Antiviral Agents|antiviral agents|mesh-ancestor
92673845|NCT00317408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673847|NCT00317408|Protective Agents|protective agents|mesh-ancestor
92673848|NCT00317408|Vitamin B Complex|vitamin b complex|mesh-ancestor
92673849|NCT00317408|Vitamins|vitamins|mesh-ancestor
92673850|NCT00317408|Micronutrients|micronutrients|mesh-ancestor
92673851|NCT00317408|Antifungal Agents|antifungal agents|mesh-ancestor
92673852|NCT00317408|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92673853|NCT00317408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673854|NCT00317408|Alkylating Agents|alkylating agents|mesh-ancestor
92673855|NCT00317408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673856|NCT00317408|Analgesics|analgesics|mesh-ancestor
91977603|NCT03204929|Copper|copper|mesh-list
92673857|NCT00317408|Sensory System Agents|sensory system agents|mesh-ancestor
92673858|NCT00317408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92673859|NCT00317408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92673860|NCT00317408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92673861|NCT00317408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92673862|NCT00317447|Prednisone|prednisone|mesh-list
92673863|NCT00317447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673864|NCT00317447|Glucocorticoids|glucocorticoids|mesh-ancestor
92673865|NCT00317447|Hormones|hormones|mesh-ancestor
92673866|NCT00317447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673867|NCT00317447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673868|NCT00317447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92673869|NCT00317447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673870|NCT02959554|Nivolumab|nivolumab|mesh-list
92673871|NCT02959554|Sunitinib|sunitinib|mesh-list
92673872|NCT02959554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92578041|NCT00416533|Prednisone|prednisone|mesh-list
92578042|NCT00416533|Docetaxel|docetaxel|mesh-list
92673873|NCT02959554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081200|NCT01445535|Prednisone|prednisone|mesh-list
92673882|NCT02959554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673883|NCT00345306|Progesterone|progesterone|mesh-list
92673884|NCT00345306|Progestins|progestins|mesh-ancestor
92673885|NCT00345306|Hormones|hormones|mesh-ancestor
92673886|NCT00345306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673887|NCT00345306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673888|NCT00317681|Tacrolimus|tacrolimus|mesh-list
92673889|NCT00317681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673890|NCT00317681|Immunologic Factors|immunologic factors|mesh-ancestor
92673891|NCT00317681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673892|NCT00317681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92673893|NCT00317681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673894|NCT00317681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673895|NCT00350181|Mycophenolic Acid|mycophenolic acid|mesh-list
92673896|NCT00350181|Sirolimus|sirolimus|mesh-list
92673897|NCT00350181|Cyclophosphamide|cyclophosphamide|mesh-list
92673898|NCT00350181|Busulfan|busulfan|mesh-list
92673899|NCT00350181|Carmustine|carmustine|mesh-list
92673900|NCT00350181|Etoposide|etoposide|mesh-list
92673901|NCT00350181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673902|NCT00350181|Immunologic Factors|immunologic factors|mesh-ancestor
92673903|NCT00350181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673904|NCT00350181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673905|NCT00350181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673906|NCT00350181|Alkylating Agents|alkylating agents|mesh-ancestor
92673907|NCT00350181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673908|NCT00350181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673909|NCT00350181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673910|NCT00350181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92673911|NCT00350181|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92673912|NCT00350181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92673913|NCT00350181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673914|NCT00350181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92673915|NCT00350181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92673916|NCT00350181|Antitubercular Agents|antitubercular agents|mesh-ancestor
92673917|NCT00350181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92673918|NCT00350181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673919|NCT00350181|Antifungal Agents|antifungal agents|mesh-ancestor
92673920|NCT00317759|Fludarabine|fludarabine|mesh-list
92673921|NCT00317759|Fludarabine phosphate|fludarabine phosphate|mesh-list
92673922|NCT00317759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673923|NCT00317759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673924|NCT00317759|Antimetabolites|antimetabolites|mesh-ancestor
92673925|NCT00317759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673926|NCT00317759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673927|NCT00317759|Immunologic Factors|immunologic factors|mesh-ancestor
92673928|NCT00317759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673929|NCT00317798|Sirolimus|sirolimus|mesh-list
92673930|NCT00317798|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92673931|NCT00317798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92673932|NCT00317798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673933|NCT00317798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92673934|NCT00317798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673935|NCT00317798|Antifungal Agents|antifungal agents|mesh-ancestor
92673936|NCT00317798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673937|NCT00317798|Immunologic Factors|immunologic factors|mesh-ancestor
92673938|NCT00317798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673939|NCT00345501|Iloprost|iloprost|mesh-list
92673953|NCT00345657|Micronutrients|micronutrients|mesh-ancestor
92673954|NCT00345657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673955|NCT00345657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92673956|NCT00345657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92673957|NCT00345657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673959|NCT00317876|Cyclophosphamide|cyclophosphamide|mesh-list
92673960|NCT00317876|Methotrexate|methotrexate|mesh-list
92673961|NCT00317876|Cyclosporins|cyclosporins|mesh-list
92673962|NCT00317876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673963|NCT00317876|Immunologic Factors|immunologic factors|mesh-ancestor
92673964|NCT00317876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673965|NCT00317876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673966|NCT00317876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673967|NCT00317876|Alkylating Agents|alkylating agents|mesh-ancestor
92578043|NCT00416533|Doxorubicin|doxorubicin|mesh-list
92031487|NCT02212197|Leuprolide|leuprolide|mesh-list
92673968|NCT00317876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673969|NCT00317876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673970|NCT00317876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673971|NCT00317876|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92673972|NCT00317876|Abortifacient Agents|abortifacient agents|mesh-ancestor
92673973|NCT00317876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92673974|NCT00317876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92673975|NCT00317876|Antimetabolites|antimetabolites|mesh-ancestor
92673976|NCT00317876|Dermatologic Agents|dermatologic agents|mesh-ancestor
92673977|NCT00317876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673978|NCT00317876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92673979|NCT00317876|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92673980|NCT00317876|Antifungal Agents|antifungal agents|mesh-ancestor
92399418|NCT01403506|Antidotes|antidotes|mesh-ancestor
92673981|NCT00317876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92673982|NCT00317876|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92673983|NCT04714827|Cyclophosphamide|cyclophosphamide|mesh-list
92673984|NCT04714827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92673985|NCT04714827|Immunologic Factors|immunologic factors|mesh-ancestor
92673986|NCT04714827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673987|NCT04714827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673988|NCT04714827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673989|NCT04714827|Alkylating Agents|alkylating agents|mesh-ancestor
92673990|NCT04714827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673991|NCT04714827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673992|NCT04714827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92673993|NCT00317915|Irbesartan|irbesartan|mesh-list
92673994|NCT00317915|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92673995|NCT00317915|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92673996|NCT00317915|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92673997|NCT00317915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673998|NCT00317954|Spironolactone|spironolactone|mesh-list
92673999|NCT00317954|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92674000|NCT00317954|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081346|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
92674002|NCT00317954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674003|NCT00317954|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92674004|NCT00317954|Diuretics|diuretics|mesh-ancestor
92674005|NCT00317954|Natriuretic Agents|natriuretic agents|mesh-ancestor
92674006|NCT00317993|Simvastatin|simvastatin|mesh-list
92674007|NCT00317993|Ezetimibe|ezetimibe|mesh-list
92674008|NCT00317993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92674009|NCT00317993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92674010|NCT00317993|Antimetabolites|antimetabolites|mesh-ancestor
92674011|NCT00317993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674012|NCT00317993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92674013|NCT00317993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92674014|NCT00317993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674015|NCT00350415|Mesalamine|mesalamine|mesh-list
92674016|NCT00350415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92674017|NCT00350415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92674018|NCT00350415|Analgesics|analgesics|mesh-ancestor
92674019|NCT00350415|Sensory System Agents|sensory system agents|mesh-ancestor
92674020|NCT00350415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674021|NCT00350415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674022|NCT00350415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674023|NCT00350415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674024|NCT00345696|Bevacizumab|bevacizumab|mesh-list
92674025|NCT00345696|Capecitabine|capecitabine|mesh-list
92674026|NCT00345696|Oxaliplatin|oxaliplatin|mesh-list
92674027|NCT00345696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92674028|NCT00345696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674029|NCT00345696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92674030|NCT00345696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674031|NCT00345696|Growth Substances|growth substances|mesh-ancestor
92674032|NCT00345696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674033|NCT00345696|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674034|NCT00345696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674035|NCT00345696|Antimetabolites|antimetabolites|mesh-ancestor
92674036|NCT00345696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674037|NCT00350454|Sirolimus|sirolimus|mesh-list
92578044|NCT00416533|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92578045|NCT00416533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578046|NCT00416533|Tubulin Modulators|tubulin modulators|mesh-ancestor
92578047|NCT00416533|Antimitotic Agents|antimitotic agents|mesh-ancestor
92578048|NCT00416533|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682793|NCT00438113|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92674039|NCT00350454|MTOR Inhibitors|mtor inhibitors|mesh-list
92674040|NCT00350454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92674041|NCT00350454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674042|NCT00350454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92674043|NCT00350454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674044|NCT00350454|Antifungal Agents|antifungal agents|mesh-ancestor
92674045|NCT00350454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674046|NCT00350454|Immunologic Factors|immunologic factors|mesh-ancestor
92674047|NCT00350454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674048|NCT00350454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674049|NCT00350454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674050|NCT00350454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674051|NCT00345735|Fentanyl|fentanyl|mesh-list
92674052|NCT00345735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92674053|NCT00345735|Narcotics|narcotics|mesh-ancestor
92399492|NCT01404104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674054|NCT00345735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674055|NCT00345735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674057|NCT00345735|Sensory System Agents|sensory system agents|mesh-ancestor
92674058|NCT00345735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674059|NCT00345735|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92674060|NCT00345735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92674061|NCT00345735|Anesthetics, General|anesthetics, general|mesh-ancestor
92674062|NCT00345735|Anesthetics|anesthetics|mesh-ancestor
92674063|NCT02959749|Bevacizumab|bevacizumab|mesh-list
92674064|NCT02959749|Docetaxel|docetaxel|mesh-list
92674065|NCT02959749|Osimertinib|osimertinib|mesh-list
92674066|NCT02959749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92674067|NCT02959749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674068|NCT02959749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92674069|NCT02959749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674070|NCT02959749|Growth Substances|growth substances|mesh-ancestor
92674071|NCT02959749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674072|NCT02959749|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674073|NCT02959749|Tubulin Modulators|tubulin modulators|mesh-ancestor
92674074|NCT02959749|Antimitotic Agents|antimitotic agents|mesh-ancestor
92674076|NCT02959749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674077|NCT02959749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674078|NCT02959749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674080|NCT00318383|Immunologic Factors|immunologic factors|mesh-ancestor
92674081|NCT00318383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674082|NCT00318422|Liraglutide|liraglutide|mesh-list
92674083|NCT00318422|Glimepiride|glimepiride|mesh-list
92674084|NCT00318422|Rosiglitazone|rosiglitazone|mesh-list
92674085|NCT00318422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674086|NCT00318422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674087|NCT00318422|Incretins|incretins|mesh-ancestor
92674088|NCT00318422|Hormones|hormones|mesh-ancestor
92674089|NCT00318422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674090|NCT00318422|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92674091|NCT00318422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674092|NCT00318422|Immunologic Factors|immunologic factors|mesh-ancestor
92674093|NCT00318539|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92674094|NCT00318539|Antidepressive Agents|antidepressive agents|mesh-ancestor
92674095|NCT00318539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674096|NCT00318539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92674097|NCT00318539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92674098|NCT00318539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674099|NCT00318539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674100|NCT00346047|Buprenorphine|buprenorphine|mesh-list
92674101|NCT00346047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92674102|NCT00346047|Narcotics|narcotics|mesh-ancestor
92674103|NCT00346047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578049|NCT00416533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674104|NCT00346047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674105|NCT00346047|Analgesics|analgesics|mesh-ancestor
92674106|NCT00346047|Sensory System Agents|sensory system agents|mesh-ancestor
92674107|NCT00346047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674108|NCT00346047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92674109|NCT00421200|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92674110|NCT00421200|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92674111|NCT00421200|Plasma Substitutes|plasma substitutes|mesh-ancestor
92674112|NCT00421200|Blood Substitutes|blood substitutes|mesh-ancestor
92674113|NCT00318773|Sertraline|sertraline|mesh-list
92674114|NCT00318773|Antidepressive Agents|antidepressive agents|mesh-ancestor
92674115|NCT00318773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674116|NCT00318773|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92674117|NCT00318773|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92674118|NCT00318773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92674119|NCT00318773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674120|NCT00318773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674121|NCT00318773|Serotonin Agents|serotonin agents|mesh-ancestor
92674122|NCT00318773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674123|NCT00318890|Docetaxel|docetaxel|mesh-list
92674124|NCT00318890|Amifostine|amifostine|mesh-list
92674125|NCT00318890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674126|NCT00318890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92674127|NCT00318890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92674128|NCT00318890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399572|NCT01404312|Leprostatic Agents|leprostatic agents|mesh-ancestor
92674129|NCT00318890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674130|NCT00318890|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92674131|NCT00318890|Protective Agents|protective agents|mesh-ancestor
92674132|NCT00318890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674133|NCT00318968|Esomeprazole|esomeprazole|mesh-list
92674134|NCT00318968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92674135|NCT00318968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674136|NCT00318968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92674137|NCT00318968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674138|NCT00318968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674139|NCT00319007|Sulindac|sulindac|mesh-list
92674140|NCT00319007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92674141|NCT00319007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92674142|NCT00319007|Analgesics|analgesics|mesh-ancestor
92674143|NCT00319007|Sensory System Agents|sensory system agents|mesh-ancestor
92674144|NCT00319007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674145|NCT00319007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674146|NCT00319007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674147|NCT00319007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674151|NCT00319007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674152|NCT00350961|Gemcitabine|gemcitabine|mesh-list
92674153|NCT00350961|Capecitabine|capecitabine|mesh-list
92674154|NCT00350961|Oxaliplatin|oxaliplatin|mesh-list
92674155|NCT00350961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674156|NCT00350961|Antimetabolites|antimetabolites|mesh-ancestor
92674157|NCT00350961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674158|NCT00350961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674159|NCT00346242|Zoledronic Acid|zoledronic acid|mesh-list
92674160|NCT00346242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92674161|NCT00346242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674162|NCT00421473|Atovaquone|atovaquone|mesh-list
92674163|NCT00421473|Proguanil|proguanil|mesh-list
92674164|NCT00421473|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92674165|NCT00421473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674166|NCT00421473|Antimalarials|antimalarials|mesh-ancestor
92674167|NCT00421473|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92674168|NCT00421473|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92674169|NCT00421473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674170|NCT00421473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674171|NCT00421473|Antimetabolites|antimetabolites|mesh-ancestor
92674172|NCT00319163|Levonorgestrel|levonorgestrel|mesh-list
92674173|NCT00319163|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92674174|NCT00319163|Estradiol|estradiol|mesh-list
92674175|NCT00319163|Estrogens|estrogens|mesh-ancestor
92674176|NCT00319163|Hormones|hormones|mesh-ancestor
92674177|NCT00319163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578050|NCT00416533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92578051|NCT00416533|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92578052|NCT00416533|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674178|NCT00319163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674179|NCT00319163|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92674180|NCT00319163|Contraceptive Agents|contraceptive agents|mesh-ancestor
92674181|NCT00319163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92674182|NCT00319163|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92674183|NCT00319163|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92674184|NCT00319163|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92674185|NCT00319163|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92674186|NCT00319202|Candesartan|candesartan|mesh-list
92674187|NCT00319202|Candesartan cilexetil|candesartan cilexetil|mesh-list
92674188|NCT00319202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92674189|NCT00319202|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92674190|NCT00319202|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92674191|NCT00319202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674192|NCT00421512|Bevacizumab|bevacizumab|mesh-list
92674193|NCT00421512|Sunitinib|sunitinib|mesh-list
92674194|NCT00421512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92674195|NCT00421512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674196|NCT00421512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92674197|NCT00421512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674198|NCT00421512|Growth Substances|growth substances|mesh-ancestor
92674199|NCT00421512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674200|NCT00421512|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674201|NCT00421512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674202|NCT00421512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674203|NCT00421512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674205|NCT00319319|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92674206|NCT00319319|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92674207|NCT00319319|Autonomic Agents|autonomic agents|mesh-ancestor
92674208|NCT00319319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674209|NCT00319319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674210|NCT00319319|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92674211|NCT00319319|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92674212|NCT00319319|Cholinergic Agents|cholinergic agents|mesh-ancestor
92674213|NCT00319319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674214|NCT00319319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674215|NCT00346359|Methotrexate|methotrexate|mesh-list
92674216|NCT00346359|Fludarabine phosphate|fludarabine phosphate|mesh-list
92674217|NCT00346359|Fludarabine|fludarabine|mesh-list
92674218|NCT00346359|Busulfan|busulfan|mesh-list
92674219|NCT00346359|Tacrolimus|tacrolimus|mesh-list
92674220|NCT00346359|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92674223|NCT00346359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92674224|NCT00346359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674225|NCT00346359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674227|NCT00346359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674228|NCT00346359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674229|NCT00346359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92674230|NCT00346359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674231|NCT00346359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92674232|NCT00346359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674233|NCT00346359|Immunologic Factors|immunologic factors|mesh-ancestor
92674234|NCT00346359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674235|NCT00346359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92674236|NCT00346359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92674237|NCT00346359|Alkylating Agents|alkylating agents|mesh-ancestor
92674238|NCT00346359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92674239|NCT00346359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92674240|NCT00319358|Antioxidants|antioxidants|mesh-list
92674241|NCT00319358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674242|NCT00319358|Protective Agents|protective agents|mesh-ancestor
92674243|NCT00319358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674244|NCT00319514|Docetaxel|docetaxel|mesh-list
92674245|NCT00319514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674246|NCT00319514|Tubulin Modulators|tubulin modulators|mesh-ancestor
92674247|NCT00319514|Antimitotic Agents|antimitotic agents|mesh-ancestor
92674248|NCT00319514|Mitosis Modulators|mitosis modulators|mesh-ancestor
92578053|NCT00416533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578054|NCT00416533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92578055|NCT00416533|Glucocorticoids|glucocorticoids|mesh-ancestor
92674249|NCT00319514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674250|NCT00319670|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92674251|NCT00319670|Laxatives|laxatives|mesh-ancestor
92674252|NCT00319670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674253|NCT00351195|Capecitabine|capecitabine|mesh-list
92674254|NCT00351195|Oxaliplatin|oxaliplatin|mesh-list
92674255|NCT00351195|Etoposide|etoposide|mesh-list
92674256|NCT00351195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674257|NCT00351195|Antimetabolites|antimetabolites|mesh-ancestor
92674258|NCT00351195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674259|NCT00351195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674260|NCT00351195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92674261|NCT00351195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92674262|NCT00351195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674263|NCT00351195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674264|NCT00319709|Amibegron|amibegron|mesh-list
92674265|NCT00319709|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92674266|NCT00319709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92674267|NCT00319709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92674268|NCT00319709|Adrenergic Agents|adrenergic agents|mesh-ancestor
92674269|NCT00319709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674270|NCT00319709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674271|NCT00319709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674272|NCT00319709|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92674273|NCT00319787|Gefitinib|gefitinib|mesh-list
92674274|NCT00319787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674275|NCT00319787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674276|NCT00319787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674277|NCT00319787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674278|NCT00319865|Thalidomide|thalidomide|mesh-list
92674279|NCT00319865|Dexamethasone|dexamethasone|mesh-list
92674280|NCT00319865|Doxorubicin|doxorubicin|mesh-list
92674281|NCT00319865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92674282|NCT00319865|Bortezomib|bortezomib|mesh-list
92674283|NCT00319865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674284|NCT00319865|Antiemetics|antiemetics|mesh-ancestor
92674285|NCT00319865|Autonomic Agents|autonomic agents|mesh-ancestor
92674286|NCT00319865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674287|NCT00319865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674288|NCT00319865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674289|NCT00319865|Glucocorticoids|glucocorticoids|mesh-ancestor
92674290|NCT00319865|Hormones|hormones|mesh-ancestor
92674291|NCT00319865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674292|NCT00319865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92674296|NCT00319865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674297|NCT00319865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674298|NCT00319865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674299|NCT00319865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674300|NCT00319865|Immunologic Factors|immunologic factors|mesh-ancestor
92674301|NCT00319865|Leprostatic Agents|leprostatic agents|mesh-ancestor
92674302|NCT00319865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92674303|NCT00319865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674304|NCT00319865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92674305|NCT00319865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674306|NCT00319865|Growth Substances|growth substances|mesh-ancestor
92674307|NCT00319865|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674308|NCT00320021|Pyridoxamine|pyridoxamine|mesh-list
92674309|NCT00320021|Vitamin B Complex|vitamin b complex|mesh-ancestor
92674310|NCT00320021|Vitamins|vitamins|mesh-ancestor
92674311|NCT00320021|Micronutrients|micronutrients|mesh-ancestor
92674312|NCT00320021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674313|NCT00320060|Pyridoxamine|pyridoxamine|mesh-list
92674314|NCT00320060|Vitamin B Complex|vitamin b complex|mesh-ancestor
92674315|NCT00320060|Vitamins|vitamins|mesh-ancestor
92674316|NCT00320060|Micronutrients|micronutrients|mesh-ancestor
92674317|NCT00320060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674318|NCT00320099|Insulin|insulin|mesh-list
92674319|NCT00320099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92674320|NCT00320099|Hydrocortisone|hydrocortisone|mesh-list
92674321|NCT00320099|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92674322|NCT00320099|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92578056|NCT00416533|Hormones|hormones|mesh-ancestor
92578057|NCT00416533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578058|NCT00416533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674323|NCT00320099|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92674324|NCT00320099|Fludrocortisone|fludrocortisone|mesh-list
92674325|NCT00320099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674326|NCT00320099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674327|NCT00320099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674328|NCT00320294|Irinotecan|irinotecan|mesh-list
92674329|NCT00320294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674330|NCT00320294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92674331|NCT00320294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674332|NCT00320294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674333|NCT00320294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674334|NCT00346749|Fluticasone|fluticasone|mesh-list
92674335|NCT00346749|Xhance|xhance|mesh-list
92674336|NCT00346749|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92674337|NCT00346749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674338|NCT00346749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92674339|NCT00346749|Autonomic Agents|autonomic agents|mesh-ancestor
92674340|NCT00346749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674341|NCT00346749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674342|NCT00346749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92674343|NCT00346749|Respiratory System Agents|respiratory system agents|mesh-ancestor
92674344|NCT00346749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92674345|NCT00346749|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92674346|NCT00346749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92674347|NCT00346749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92674348|NCT00346749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92674349|NCT00346749|Adrenergic Agents|adrenergic agents|mesh-ancestor
92674350|NCT00346749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674351|NCT00346749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674352|NCT00351507|Vildagliptin|vildagliptin|mesh-list
92674353|NCT00351507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674355|NCT00351507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92674356|NCT00351507|Protease Inhibitors|protease inhibitors|mesh-ancestor
92674357|NCT00351507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674358|NCT00351507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674359|NCT00320567|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92674360|NCT00320567|Norgestimate|norgestimate|mesh-list
92674361|NCT00320567|Estradiol|estradiol|mesh-list
92674362|NCT00320567|Estrogens|estrogens|mesh-ancestor
92674363|NCT00320567|Hormones|hormones|mesh-ancestor
92674364|NCT00320567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674365|NCT00320567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365789|NCT00603720|Mydriatics|mydriatics|mesh-ancestor
92674366|NCT00320567|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92674370|NCT00320567|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92674371|NCT00320567|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92674372|NCT00320567|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92674374|NCT00346827|Emetics|emetics|mesh-ancestor
92674375|NCT00346827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674376|NCT00346827|Autonomic Agents|autonomic agents|mesh-ancestor
92674377|NCT00346827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674378|NCT00346827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674379|NCT00346827|Dopamine Agonists|dopamine agonists|mesh-ancestor
92674380|NCT00346827|Dopamine Agents|dopamine agents|mesh-ancestor
92674381|NCT00346827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674382|NCT00346827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674383|NCT00346866|Anecortave|anecortave|mesh-list
92674384|NCT00346866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92674385|NCT00346866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674386|NCT00346866|Growth Substances|growth substances|mesh-ancestor
92674387|NCT00346866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674388|NCT00346866|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674389|NCT00346866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674390|NCT00320723|Bupropion|bupropion|mesh-list
92674391|NCT00320723|Nicotine|nicotine|mesh-list
92674392|NCT00320723|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92674393|NCT00320723|Autonomic Agents|autonomic agents|mesh-ancestor
92674394|NCT00320723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674395|NCT00320723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578059|NCT00416533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92578060|NCT00107796|Modafinil|modafinil|mesh-list
92578061|NCT00107796|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92578062|NCT00107796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674396|NCT00320723|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92674397|NCT00320723|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92674398|NCT00320723|Cholinergic Agents|cholinergic agents|mesh-ancestor
92674399|NCT00320723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674400|NCT00320723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674401|NCT00320723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92674402|NCT00320723|Antidepressive Agents|antidepressive agents|mesh-ancestor
92674403|NCT00320723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674404|NCT00320723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92674405|NCT00320723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92674406|NCT00320723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92674407|NCT00320723|Dopamine Agents|dopamine agents|mesh-ancestor
92674408|NCT00320723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92674409|NCT00320723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92674410|NCT00320723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674411|NCT00351546|Vildagliptin|vildagliptin|mesh-list
92674412|NCT00351546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674413|NCT00351546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674414|NCT00351546|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92674415|NCT00351546|Protease Inhibitors|protease inhibitors|mesh-ancestor
92674416|NCT00351546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674417|NCT00351546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674418|NCT00351585|Vildagliptin|vildagliptin|mesh-list
92674419|NCT00351585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674420|NCT00351585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674421|NCT00351585|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92674422|NCT00351585|Protease Inhibitors|protease inhibitors|mesh-ancestor
92674423|NCT00351585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674424|NCT00351585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674425|NCT00320879|Irbesartan|irbesartan|mesh-list
92674426|NCT00320879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92674427|NCT00320879|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92674428|NCT00320879|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92674429|NCT00320879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674430|NCT00347100|Metformin|metformin|mesh-list
92674431|NCT00347100|Insulin Glargine|insulin glargine|mesh-list
92674432|NCT00347100|Glyburide|glyburide|mesh-list
92674433|NCT00347100|Glipizide|glipizide|mesh-list
92674434|NCT00347100|Gliclazide|gliclazide|mesh-list
92674435|NCT00347100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674436|NCT00347100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674437|NCT00347139|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92674473|NCT00347295|Estazolam|estazolam|mesh-list
92674474|NCT00347295|Brotizolam|brotizolam|mesh-list
92674475|NCT00347295|Anticonvulsants|anticonvulsants|mesh-ancestor
92674476|NCT00347295|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92674477|NCT00347295|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92674478|NCT00347295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674479|NCT00347295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674480|NCT00347295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674481|NCT00347295|GABA Modulators|gaba modulators|mesh-ancestor
92674482|NCT00347295|GABA Agents|gaba agents|mesh-ancestor
92674483|NCT00347295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674484|NCT00347295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674485|NCT00347295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92674486|NCT00321191|Nitrous Oxide|nitrous oxide|mesh-list
92674487|NCT00321191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92674488|NCT00321191|Anesthetics, General|anesthetics, general|mesh-ancestor
92674489|NCT00321191|Anesthetics|anesthetics|mesh-ancestor
92674490|NCT00321191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674491|NCT00321191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674492|NCT00321191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92674493|NCT00321191|Analgesics|analgesics|mesh-ancestor
92674494|NCT00321191|Sensory System Agents|sensory system agents|mesh-ancestor
92674495|NCT00321191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674496|NCT00321230|Ascorbic Acid|ascorbic acid|mesh-list
92578063|NCT00107796|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92578064|NCT00107796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92578065|NCT00107796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92578066|NCT00107796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578067|NCT00272896|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92578068|NCT00272896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674497|NCT00321230|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92674498|NCT00321230|Antioxidants|antioxidants|mesh-ancestor
92674499|NCT00321230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674500|NCT00321230|Protective Agents|protective agents|mesh-ancestor
92674501|NCT00321230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674502|NCT00321230|Vitamins|vitamins|mesh-ancestor
92674503|NCT00321230|Micronutrients|micronutrients|mesh-ancestor
92674504|NCT00321230|Laxatives|laxatives|mesh-ancestor
92674505|NCT00321230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674507|NCT00351663|Anticoagulants|anticoagulants|mesh-ancestor
92674508|NCT00351663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92674509|NCT00351663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92674510|NCT00351663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674511|NCT00321347|Lidocaine|lidocaine|mesh-list
92674512|NCT00321347|Anesthetics, Local|anesthetics, local|mesh-ancestor
92674513|NCT00321347|Anesthetics|anesthetics|mesh-ancestor
92674514|NCT00321347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674515|NCT00321347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674516|NCT00321347|Sensory System Agents|sensory system agents|mesh-ancestor
92674517|NCT00321347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674518|NCT00321347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92674519|NCT00321347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92674520|NCT00321347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92674521|NCT00321347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92674522|NCT00321347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674523|NCT00351702|Isoniazid|isoniazid|mesh-list
92674524|NCT00351702|Ethambutol|ethambutol|mesh-list
92674525|NCT00351702|Antitubercular Agents|antitubercular agents|mesh-ancestor
92674526|NCT00351702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92674527|NCT00351702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674528|NCT00351702|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92674529|NCT00351702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92674530|NCT00351702|Antimetabolites|antimetabolites|mesh-ancestor
92674531|NCT00351702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674532|NCT00351702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92674533|NCT00351975|Azacitidine|azacitidine|mesh-list
92674534|NCT00351975|Belinostat|belinostat|mesh-list
92674535|NCT00351975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674536|NCT00351975|Antimetabolites|antimetabolites|mesh-ancestor
92674537|NCT00351975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674538|NCT00351975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674539|NCT00351975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674540|NCT00351975|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92674541|NCT00321581|Cediranib|cediranib|mesh-list
92674542|NCT00321581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674543|NCT00321581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674544|NCT00321581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674545|NCT00321581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674549|NCT00352092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92674550|NCT00352092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674551|NCT00352092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92674552|NCT00352092|Antitubercular Agents|antitubercular agents|mesh-ancestor
92674553|NCT00352092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92674554|NCT00352092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674555|NCT00352092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674556|NCT00352092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674557|NCT00352092|Antifungal Agents|antifungal agents|mesh-ancestor
92674558|NCT00352092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674559|NCT00352092|Immunologic Factors|immunologic factors|mesh-ancestor
92674560|NCT00352092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578069|NCT00272896|Vasodilator Agents|vasodilator agents|mesh-ancestor
92578070|NCT00272896|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92578071|NCT00272896|Protective Agents|protective agents|mesh-ancestor
92578072|NCT00272896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578073|NCT00272935|Estrogens|estrogens|mesh-list
92578074|NCT00272935|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92578075|NCT00272935|Estrogens, conjugated synthetic A|estrogens, conjugated synthetic a|mesh-list
91985295|NCT02388581|Amoxicillin|amoxicillin|mesh-list
92674561|NCT00322127|Plerixafor|plerixafor|mesh-list
92674562|NCT00322127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92674563|NCT00322127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92674564|NCT00322127|Antiviral Agents|antiviral agents|mesh-ancestor
92674565|NCT00322127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674566|NCT00352170|Calcium, Dietary|calcium, dietary|mesh-list
92674567|NCT00352170|Vitamin D|vitamin d|mesh-list
92674568|NCT00352170|Cholecalciferol|cholecalciferol|mesh-list
92674569|NCT00352170|Calcium|calcium|mesh-list
92674570|NCT00352170|Vitamins|vitamins|mesh-ancestor
92674571|NCT00352170|Micronutrients|micronutrients|mesh-ancestor
92674572|NCT00352170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674573|NCT00352170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92674574|NCT00352170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92674575|NCT00322166|Calcium|calcium|mesh-list
92674576|NCT00322166|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92674577|NCT00322166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674578|NCT02959580|Hydrocortisone|hydrocortisone|mesh-list
92674579|NCT02959580|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
92674580|NCT02959580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674581|NCT02959580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92674582|NCT00352287|Pioglitazone|pioglitazone|mesh-list
92674583|NCT00352287|Hormones|hormones|mesh-list
92674584|NCT00352287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674585|NCT00352287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674586|NCT00352287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674587|NCT00352443|Everolimus|everolimus|mesh-list
92674588|NCT00352443|Lapatinib|lapatinib|mesh-list
92674589|NCT00352443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92674590|NCT00352443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674591|NCT00352443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674592|NCT00352443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674593|NCT00352443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674594|NCT00352443|Immunologic Factors|immunologic factors|mesh-ancestor
92674595|NCT00352443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674596|NCT00352443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674597|NCT00352482|Sildenafil Citrate|sildenafil citrate|mesh-list
92674598|NCT00352482|Vasodilator Agents|vasodilator agents|mesh-ancestor
92674599|NCT00352482|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92674600|NCT00352482|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92674601|NCT00352482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674602|NCT00352482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674603|NCT00352482|Urological Agents|urological agents|mesh-ancestor
92674604|NCT00322400|Paclitaxel|paclitaxel|mesh-list
92674605|NCT00322400|Docetaxel|docetaxel|mesh-list
92674606|NCT00322400|Motesanib diphosphate|motesanib diphosphate|mesh-list
92674607|NCT00322400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92674608|NCT00322400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674609|NCT00322400|Tubulin Modulators|tubulin modulators|mesh-ancestor
92674610|NCT00322400|Antimitotic Agents|antimitotic agents|mesh-ancestor
92674611|NCT00322400|Mitosis Modulators|mitosis modulators|mesh-ancestor
92674612|NCT00322400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674613|NCT00322400|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674614|NCT00322400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674615|NCT00352521|Bevacizumab|bevacizumab|mesh-list
92674616|NCT00352521|Irinotecan|irinotecan|mesh-list
92674617|NCT00352521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92674618|NCT00352521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674619|NCT00352521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92082133|NCT01831765|Insulin Aspart|insulin aspart|mesh-list
92674630|NCT00352599|Dihydromevinolin|dihydromevinolin|mesh-list
92674631|NCT00352599|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92578077|NCT00272935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578078|NCT00272935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578080|NCT00273013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92674632|NCT00352599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92674633|NCT00352599|Antimetabolites|antimetabolites|mesh-ancestor
92674634|NCT00352599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674635|NCT00352599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92674636|NCT00352599|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92674637|NCT00352599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674638|NCT00322595|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92674639|NCT00322595|Paroxetine|paroxetine|mesh-list
92674640|NCT00322595|Antidepressive Agents|antidepressive agents|mesh-ancestor
92674641|NCT00322595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674642|NCT00322595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92674643|NCT00322595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92674644|NCT00322595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674645|NCT00322595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674646|NCT00322595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92674647|NCT00322595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92674648|NCT00322595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92674649|NCT00322595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674650|NCT00322595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674651|NCT00322595|Serotonin Agents|serotonin agents|mesh-ancestor
92365830|NCT00626340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674652|NCT00322595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92674653|NCT00322595|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92674654|NCT00322595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92674655|NCT00322595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674656|NCT00352677|Bafetinib|bafetinib|mesh-list
92674657|NCT00352677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674658|NCT00352677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674659|NCT00352677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674660|NCT00331149|Ropinirole|ropinirole|mesh-list
92674661|NCT00331149|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92674662|NCT00331149|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92674663|NCT00331149|Dopamine Agonists|dopamine agonists|mesh-ancestor
92674664|NCT00331149|Dopamine Agents|dopamine agents|mesh-ancestor
92674665|NCT00331149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674666|NCT00331149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674667|NCT00331149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674668|NCT00331188|Vapreotide|vapreotide|mesh-list
92674669|NCT00331188|Analgesics|analgesics|mesh-ancestor
92674670|NCT00331188|Sensory System Agents|sensory system agents|mesh-ancestor
92674671|NCT00331188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674672|NCT00331188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674673|NCT00331188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674674|NCT00352833|Catumaxomab|catumaxomab|mesh-list
92674675|NCT00352833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674676|NCT00331305|Sertraline|sertraline|mesh-list
92674677|NCT00331305|Antidepressive Agents|antidepressive agents|mesh-ancestor
92674678|NCT00331305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674679|NCT00331305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92674680|NCT00331305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92674681|NCT00331305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92674682|NCT00331305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674686|NCT00322751|Topotecan|topotecan|mesh-list
92674687|NCT00322751|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92674688|NCT00322751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674689|NCT00322751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674690|NCT00322751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674691|NCT00322751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674692|NCT00352950|Panitumumab|panitumumab|mesh-list
92674693|NCT00352950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92674694|NCT00352950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674695|NCT00322907|Mefloquine|mefloquine|mesh-list
92674696|NCT00322907|Quinine|quinine|mesh-list
92674697|NCT00322907|Antimalarials|antimalarials|mesh-ancestor
92674698|NCT00322907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92578081|NCT00273013|Respiratory System Agents|respiratory system agents|mesh-ancestor
92578082|NCT00273013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92578083|NCT00273013|Hormone Antagonists|hormone antagonists|mesh-ancestor
92578084|NCT00273013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578150|NCT00273481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578223|NCT00274066|Fenoterol|fenoterol|mesh-list
92578224|NCT00274066|Tiotropium Bromide|tiotropium bromide|mesh-list
92578225|NCT00274066|Ipratropium|ipratropium|mesh-list
92578226|NCT00274066|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92578292|NCT00274495|Antimetabolites|antimetabolites|mesh-ancestor
92578293|NCT00274495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578364|NCT00274807|Antiviral Agents|antiviral agents|mesh-ancestor
92578365|NCT00274807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92578366|NCT00274807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92578367|NCT00274807|Immunologic Factors|immunologic factors|mesh-ancestor
92578368|NCT00274807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578369|NCT00274807|Analgesics|analgesics|mesh-ancestor
92578432|NCT00108498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578433|NCT00108498|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92578434|NCT00108498|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92578435|NCT00108498|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92578501|NCT00108576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578504|NCT00075491|Fenretinide|fenretinide|mesh-list
92578575|NCT00278278|Immunologic Factors|immunologic factors|mesh-ancestor
92578576|NCT00278278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365833|NCT00626574|Epoetin Alfa|epoetin alfa|mesh-list
92578577|NCT00278278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92578649|NCT00279253|Sensory System Agents|sensory system agents|mesh-ancestor
92578650|NCT00279253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578651|NCT00279253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578652|NCT00279253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92578653|NCT00279253|Sympatholytics|sympatholytics|mesh-ancestor
92578654|NCT00279253|Autonomic Agents|autonomic agents|mesh-ancestor
92578655|NCT00279253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92578656|NCT00279253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92578657|NCT00279253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92578658|NCT00279253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92578659|NCT00279253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578660|NCT00279253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578661|NCT00109044|Escitalopram|escitalopram|mesh-list
92578662|NCT00109044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92578663|NCT00109044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92578664|NCT00109044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92578665|NCT00109044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578666|NCT00109044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578667|NCT00109044|Serotonin Agents|serotonin agents|mesh-ancestor
92578668|NCT00109044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578669|NCT00279448|Tamoxifen|tamoxifen|mesh-list
92578670|NCT00279448|Exemestane|exemestane|mesh-list
92578671|NCT00279448|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92578672|NCT00279448|Hormone Antagonists|hormone antagonists|mesh-ancestor
92578673|NCT00279448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92578674|NCT00279448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578675|NCT00279448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92578676|NCT00279448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578677|NCT00279448|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91985881|NCT02371577|Lenalidomide|lenalidomide|mesh-list
92674699|NCT00322907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92674700|NCT00322907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674701|NCT00322907|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92674702|NCT00322907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674703|NCT00322907|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92674704|NCT00322907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674705|NCT00322907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92674706|NCT00322907|Analgesics|analgesics|mesh-ancestor
92674707|NCT00322907|Sensory System Agents|sensory system agents|mesh-ancestor
92674708|NCT00331500|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92674709|NCT00331500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92674710|NCT00331500|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92578678|NCT00279448|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92578679|NCT00279448|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92578680|NCT00279448|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92578681|NCT00279448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92578682|NCT00279448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578683|NCT00279448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578684|NCT00075959|Disufenton sodium|disufenton sodium|mesh-list
92578685|NCT00075959|Antioxidants|antioxidants|mesh-ancestor
92578686|NCT00075959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578687|NCT00075959|Protective Agents|protective agents|mesh-ancestor
92578688|NCT00075959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578689|NCT00279487|Gabapentin|gabapentin|mesh-list
92578690|NCT00279487|Analgesics|analgesics|mesh-ancestor
92578691|NCT00279487|Sensory System Agents|sensory system agents|mesh-ancestor
92578692|NCT00279487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92578693|NCT00279487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578694|NCT00279487|Anticonvulsants|anticonvulsants|mesh-ancestor
92578695|NCT00279487|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92578696|NCT00279487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92578697|NCT00279487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92578698|NCT00279487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92578699|NCT00279487|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92578700|NCT00279487|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92578701|NCT00279487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92578702|NCT00279487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578703|NCT00279487|Antimanic Agents|antimanic agents|mesh-ancestor
92578704|NCT00279565|Interferons|interferons|mesh-list
92578705|NCT00279565|Ribavirin|ribavirin|mesh-list
92578706|NCT00279565|Interferon-alpha|interferon-alpha|mesh-list
92578707|NCT00279565|Interferon alpha-2|interferon alpha-2|mesh-list
92578708|NCT00279565|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92578709|NCT00279565|Buprenorphine|buprenorphine|mesh-list
92578710|NCT00279565|Methadone|methadone|mesh-list
92578711|NCT00279565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578712|NCT00279565|Antiviral Agents|antiviral agents|mesh-ancestor
92578717|NCT00279565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92578793|NCT00109239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92578866|NCT00076349|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92578867|NCT00076349|Alkylating Agents|alkylating agents|mesh-ancestor
92578868|NCT00076349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578937|NCT00281008|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92578938|NCT00281008|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92578939|NCT00281008|Antimetabolites|antimetabolites|mesh-ancestor
92578940|NCT00281008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578941|NCT00281008|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92578942|NCT00281125|Pemetrexed|pemetrexed|mesh-list
92578943|NCT00281125|Vatalanib|vatalanib|mesh-list
92578944|NCT00281125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92578945|NCT00281125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92578946|NCT00281125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92578947|NCT00281125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92578948|NCT00281125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92578950|NCT00109746|Chromium|chromium|mesh-list
92578999|NCT00281476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579000|NCT00416923|Rituximab|rituximab|mesh-list
92579001|NCT00416923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92579002|NCT00416923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579003|NCT00416923|Immunologic Factors|immunologic factors|mesh-ancestor
92579004|NCT00416923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579005|NCT00416923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92579006|NCT00416962|Oseltamivir|oseltamivir|mesh-list
92579007|NCT00416962|Amantadine|amantadine|mesh-list
92579008|NCT00416962|Antiviral Agents|antiviral agents|mesh-ancestor
92579009|NCT00416962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92579010|NCT00416962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579011|NCT00416962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579012|NCT00416962|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92579013|NCT00416962|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92579061|NCT00281710|Methylprednisolone|methylprednisolone|mesh-list
92579062|NCT00281710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92579063|NCT00281710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92579064|NCT00281710|Prednisolone|prednisolone|mesh-list
92579065|NCT00281710|Prednisolone acetate|prednisolone acetate|mesh-list
92579066|NCT00281710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92579067|NCT00281710|Prednisolone phosphate|prednisolone phosphate|mesh-list
92579068|NCT00281710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92579069|NCT00281710|Antiemetics|antiemetics|mesh-ancestor
92579070|NCT00281710|Autonomic Agents|autonomic agents|mesh-ancestor
92579071|NCT00281710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579072|NCT00281710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579073|NCT00281710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92579074|NCT00281710|Glucocorticoids|glucocorticoids|mesh-ancestor
92579122|NCT00281905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92579123|NCT00281905|Abortifacient Agents|abortifacient agents|mesh-ancestor
92579124|NCT00281905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92579125|NCT00281905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579126|NCT00281905|Antimetabolites|antimetabolites|mesh-ancestor
92579127|NCT00281905|Dermatologic Agents|dermatologic agents|mesh-ancestor
92579128|NCT00281905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579129|NCT00281905|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92579130|NCT00281905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92579131|NCT00281905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92579132|NCT00281905|Tubulin Modulators|tubulin modulators|mesh-ancestor
92579162|NCT00281944|Leucovorin|leucovorin|mesh-list
92579189|NCT00281983|Cyclosporins|cyclosporins|mesh-list
92579190|NCT00281983|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92579191|NCT00281983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579259|NCT00282178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92579260|NCT00282178|Candesartan|candesartan|mesh-list
92579263|NCT00282178|Diuretics|diuretics|mesh-ancestor
92579330|NCT00283036|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92579331|NCT00283036|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92579476|NCT00077168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92579549|NCT00077246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579620|NCT00285415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579621|NCT00285415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92579622|NCT00285415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92579623|NCT00285415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92579624|NCT00285415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579625|NCT00285493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92579627|NCT00285727|Ropinirole|ropinirole|mesh-list
92579688|NCT00110877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92579689|NCT00110877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92579690|NCT00110877|Antiviral Agents|antiviral agents|mesh-ancestor
92579762|NCT00286585|Anesthetics, General|anesthetics, general|mesh-ancestor
92579836|NCT00111150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579838|NCT00111150|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92579839|NCT00417430|Fulvestrant|fulvestrant|mesh-list
92579840|NCT00417430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92579907|NCT00287170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92579908|NCT00287170|Antimetabolites|antimetabolites|mesh-ancestor
92579909|NCT00287170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92579910|NCT00287170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92579911|NCT00287170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92579912|NCT00287170|Immunologic Factors|immunologic factors|mesh-ancestor
92579913|NCT00287170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92579914|NCT00287170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92579915|NCT00287209|Amiodarone|amiodarone|mesh-list
92579916|NCT00287209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92579917|NCT00287209|Vasodilator Agents|vasodilator agents|mesh-ancestor
92579918|NCT00287209|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92579919|NCT00287209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92579920|NCT00287209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92579921|NCT00287209|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92579922|NCT00287209|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92579928|NCT00077948|Metoprolol|metoprolol|mesh-list
92579964|NCT00287326|Anesthetics|anesthetics|mesh-ancestor
92579965|NCT00287326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92579966|NCT00287326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92579967|NCT00287326|Sensory System Agents|sensory system agents|mesh-ancestor
92579968|NCT00287326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92579969|NCT00287326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92579970|NCT00287326|Narcotics|narcotics|mesh-ancestor
92579971|NCT00287326|Analgesics|analgesics|mesh-ancestor
92579972|NCT00287326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92580029|NCT00287794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580106|NCT00288379|Glucocorticoids|glucocorticoids|mesh-ancestor
92580254|NCT00112086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580255|NCT00290173|Ritodrine|ritodrine|mesh-list
92580256|NCT00290173|Sympathomimetics|sympathomimetics|mesh-ancestor
92580257|NCT00290173|Autonomic Agents|autonomic agents|mesh-ancestor
92580258|NCT00290173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580259|NCT00290173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580260|NCT00290173|Tocolytic Agents|tocolytic agents|mesh-ancestor
92580261|NCT00290173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92580262|NCT00290173|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92580263|NCT00290173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92580264|NCT00290173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92580317|NCT00290641|Antimetabolites|antimetabolites|mesh-ancestor
92580318|NCT00290641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580391|NCT00290992|Gout Suppressants|gout suppressants|mesh-ancestor
92580392|NCT00290992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92580464|NCT00291616|Interferon-alpha|interferon-alpha|mesh-list
92580465|NCT00291616|Interferon alpha-2|interferon alpha-2|mesh-list
92580466|NCT00291616|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92580467|NCT00291616|Thymalfasin|thymalfasin|mesh-list
92580468|NCT00291616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580538|NCT00078845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92580539|NCT00078845|Protective Agents|protective agents|mesh-ancestor
92580540|NCT00078845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580608|NCT00275041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92580609|NCT00274963|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92580611|NCT00274963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92580612|NCT00274963|Alkylating Agents|alkylating agents|mesh-ancestor
92580613|NCT00274963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580614|NCT00274963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580615|NCT00274963|Analgesics|analgesics|mesh-ancestor
92580616|NCT00274963|Sensory System Agents|sensory system agents|mesh-ancestor
92305461|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580617|NCT00274963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92580618|NCT00274963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580619|NCT00274963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92580620|NCT00274963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580621|NCT00274963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580622|NCT00102765|Fluticasone|fluticasone|mesh-list
92580623|NCT00102765|Xhance|xhance|mesh-list
92580624|NCT00102765|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92580625|NCT00102765|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92580626|NCT00102765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580660|NCT00130312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92580661|NCT00130312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92580662|NCT00130312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92580663|NCT00130312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580664|NCT00130234|Omalizumab|omalizumab|mesh-list
92580665|NCT00130234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92580666|NCT00130234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92580667|NCT00130234|Respiratory System Agents|respiratory system agents|mesh-ancestor
92580668|NCT00119301|Leucovorin|leucovorin|mesh-list
92580669|NCT00119301|Trimetrexate|trimetrexate|mesh-list
92580670|NCT00119301|Methotrexate|methotrexate|mesh-list
92580671|NCT00119301|Calcium|calcium|mesh-list
92580672|NCT00119301|Levoleucovorin|levoleucovorin|mesh-list
92580673|NCT00119301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92580674|NCT00119301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580676|NCT00119301|Abortifacient Agents|abortifacient agents|mesh-ancestor
92580723|NCT00130195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92580797|NCT00130000|Eculizumab|eculizumab|mesh-list
92580798|NCT00130000|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92580799|NCT00130000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92580800|NCT00130000|Immunologic Factors|immunologic factors|mesh-ancestor
92580801|NCT00130000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580802|NCT00079235|Sirolimus|sirolimus|mesh-list
92580803|NCT00079235|Temsirolimus|temsirolimus|mesh-list
92580804|NCT00079235|MTOR Inhibitors|mtor inhibitors|mesh-list
92580805|NCT00079235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580863|NCT00079352|Antimetabolites|antimetabolites|mesh-ancestor
92580864|NCT00079352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365873|NCT00637494|Mifepristone|mifepristone|mesh-list
92580865|NCT00079352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580866|NCT00079352|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92580867|NCT00079352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92580868|NCT00079352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92580869|NCT00079352|Growth Inhibitors|growth inhibitors|mesh-ancestor
92580870|NCT00079352|Growth Substances|growth substances|mesh-ancestor
92580871|NCT00079352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580872|NCT00079352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92580873|NCT00119496|Rosiglitazone|rosiglitazone|mesh-list
92580882|NCT00119496|Hormones|hormones|mesh-ancestor
92580927|NCT00079430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92580928|NCT00079430|Antibodies|antibodies|mesh-list
92580929|NCT00079430|Immunoglobulins|immunoglobulins|mesh-list
92580930|NCT00079430|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92580931|NCT00079430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92580932|NCT00079430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92580933|NCT00079430|Tubulin Modulators|tubulin modulators|mesh-ancestor
92580934|NCT00079430|Antimitotic Agents|antimitotic agents|mesh-ancestor
92580935|NCT00079430|Mitosis Modulators|mitosis modulators|mesh-ancestor
92580936|NCT00079430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92580937|NCT00079430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92580938|NCT00079430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92580939|NCT00079430|Growth Substances|growth substances|mesh-ancestor
92580940|NCT00079430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92580941|NCT00079430|Growth Inhibitors|growth inhibitors|mesh-ancestor
92580942|NCT00079430|Immunologic Factors|immunologic factors|mesh-ancestor
92580943|NCT00298597|Epoetin Alfa|epoetin alfa|mesh-list
92580944|NCT00298597|Hematinics|hematinics|mesh-ancestor
92580945|NCT00298636|Adenosine|adenosine|mesh-list
92580982|NCT00079469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581056|NCT00079586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581057|NCT00418132|Thalidomide|thalidomide|mesh-list
92581058|NCT00418132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581059|NCT00418132|Immunologic Factors|immunologic factors|mesh-ancestor
92581060|NCT00418132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581061|NCT00418132|Leprostatic Agents|leprostatic agents|mesh-ancestor
92581062|NCT00418132|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92581063|NCT00418132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581064|NCT00418132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92581065|NCT00418132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92581066|NCT00418132|Growth Substances|growth substances|mesh-ancestor
92581067|NCT00418132|Growth Inhibitors|growth inhibitors|mesh-ancestor
92581117|NCT00299845|Lansoprazole|lansoprazole|mesh-list
92581118|NCT00299845|Dexlansoprazole|dexlansoprazole|mesh-list
92581124|NCT00299884|Atorvastatin|atorvastatin|mesh-list
92581189|NCT00418171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581190|NCT00418171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92581191|NCT00418171|Serotonin Agents|serotonin agents|mesh-ancestor
92581192|NCT00418171|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92581193|NCT00418171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92581194|NCT00418171|Dopamine Agents|dopamine agents|mesh-ancestor
92581195|NCT00119691|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92581196|NCT00119691|Natriuretic Agents|natriuretic agents|mesh-ancestor
92581197|NCT00119691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581198|NCT00300040|Chrysarobin|chrysarobin|mesh-list
92581200|NCT00300040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92581201|NCT00300040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92581202|NCT00300040|Analgesics|analgesics|mesh-ancestor
92581203|NCT00300040|Sensory System Agents|sensory system agents|mesh-ancestor
92581204|NCT00300040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581249|NCT00300196|Anticoagulants|anticoagulants|mesh-ancestor
92581250|NCT00300196|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92581251|NCT00300196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92581252|NCT00300196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581253|NCT00119769|Hormones|hormones|mesh-list
92581318|NCT00300586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581319|NCT00086541|Interferons|interferons|mesh-list
92581320|NCT00086541|Ribavirin|ribavirin|mesh-list
92581321|NCT00086541|Interferon alfacon-1|interferon alfacon-1|mesh-list
92581389|NCT00301171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581390|NCT00301171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581391|NCT00301171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92581392|NCT00301171|Respiratory System Agents|respiratory system agents|mesh-ancestor
92581395|NCT00301210|Tramadol|tramadol|mesh-list
92581459|NCT00292123|Sensory System Agents|sensory system agents|mesh-ancestor
92581460|NCT00292123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581533|NCT00080522|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92581534|NCT00080522|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92581535|NCT00080522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92581536|NCT00080522|Antimetabolites|antimetabolites|mesh-ancestor
92581537|NCT00080522|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92581538|NCT00080522|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92581539|NCT00080522|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92581540|NCT00080522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92581541|NCT00080522|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92581542|NCT00086775|Rituximab|rituximab|mesh-list
92581543|NCT00086775|Alemtuzumab|alemtuzumab|mesh-list
92581544|NCT00086775|Fludarabine|fludarabine|mesh-list
92581595|NCT00201721|Pentostatin|pentostatin|mesh-list
92581596|NCT00201721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581668|NCT00120120|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92581670|NCT00120120|Growth Inhibitors|growth inhibitors|mesh-ancestor
92581671|NCT00120120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581672|NCT00202189|Budesonide|budesonide|mesh-list
92581673|NCT00202189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581674|NCT00202189|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92581675|NCT00202189|Autonomic Agents|autonomic agents|mesh-ancestor
92581676|NCT00202189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581677|NCT00202189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581678|NCT00202189|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92581733|NCT00087048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581735|NCT00080951|Fluorouracil|fluorouracil|mesh-list
92581736|NCT00080951|Oxaliplatin|oxaliplatin|mesh-list
92581737|NCT00080951|Irinotecan|irinotecan|mesh-list
92581738|NCT00080951|Calcium|calcium|mesh-list
92581805|NCT00080990|Micronutrients|micronutrients|mesh-ancestor
92581806|NCT00080990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92581807|NCT00080990|Growth Substances|growth substances|mesh-ancestor
92581808|NCT00080990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92581878|NCT00302224|Antifungal Agents|antifungal agents|mesh-ancestor
92581879|NCT00302224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92581880|NCT00302224|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92581881|NCT00302224|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92581882|NCT00302224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581883|NCT00302224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581884|NCT00302224|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92581885|NCT00302224|Hormone Antagonists|hormone antagonists|mesh-ancestor
92581886|NCT00302224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92581887|NCT00302224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581888|NCT00302224|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92581889|NCT00081068|Alemtuzumab|alemtuzumab|mesh-list
92581890|NCT00081068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92581891|NCT00081068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581892|NCT00087165|Prednisone|prednisone|mesh-list
92581893|NCT00087165|Docetaxel|docetaxel|mesh-list
92581894|NCT00087165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581895|NCT00087165|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581896|NCT00087165|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581897|NCT00087165|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581898|NCT00087165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581927|NCT00302497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581928|NCT00302497|Immunologic Factors|immunologic factors|mesh-ancestor
92581929|NCT00302497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581930|NCT00081107|Epothilones|epothilones|mesh-list
92581931|NCT00081107|Desoxyepothilone B|desoxyepothilone b|mesh-list
92581932|NCT00081107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92581933|NCT00081107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92581934|NCT00081107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92581935|NCT00081107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581936|NCT00081107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581937|NCT00302536|Tacrolimus|tacrolimus|mesh-list
92581938|NCT00302536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92581939|NCT00302536|Immunologic Factors|immunologic factors|mesh-ancestor
92581940|NCT00302536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581941|NCT00302536|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92581942|NCT00302536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581943|NCT00302536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581944|NCT00081224|Celecoxib|celecoxib|mesh-list
92581945|NCT00081224|Capecitabine|capecitabine|mesh-list
92581946|NCT00081224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92581947|NCT00081224|Antimetabolites|antimetabolites|mesh-ancestor
92581948|NCT00081224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92581949|NCT00081224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92581950|NCT00081224|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92581951|NCT00081224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92581952|NCT00081224|Analgesics|analgesics|mesh-ancestor
92581953|NCT00081224|Sensory System Agents|sensory system agents|mesh-ancestor
92581954|NCT00081224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581955|NCT00081224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92581956|NCT00081224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92581957|NCT00081224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92581958|NCT00081224|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92581959|NCT00081224|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92581960|NCT00081224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92581961|NCT00120237|Misoprostol|misoprostol|mesh-list
92674711|NCT00331500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92674712|NCT00331500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92674713|NCT00331500|Analgesics|analgesics|mesh-ancestor
92674714|NCT00331500|Sensory System Agents|sensory system agents|mesh-ancestor
92674715|NCT00331500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92581962|NCT00120237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92581963|NCT00120237|Abortifacient Agents|abortifacient agents|mesh-ancestor
92582035|NCT00418483|Fibrinolysin|fibrinolysin|mesh-list
92582108|NCT00081614|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92582109|NCT00081614|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92582127|NCT00303433|Memantine|memantine|mesh-list
92582180|NCT00081848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92582181|NCT00081848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582255|NCT00304018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582327|NCT00304447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92582328|NCT00304447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582329|NCT00304447|Immunotoxins|immunotoxins|mesh-ancestor
92582330|NCT00304447|Immunoconjugates|immunoconjugates|mesh-ancestor
92582397|NCT00120510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92582398|NCT00120510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92582399|NCT00120510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92582469|NCT00082394|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92582470|NCT00082394|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92582471|NCT00082394|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92582472|NCT00082394|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92582473|NCT00082394|Protease Inhibitors|protease inhibitors|mesh-ancestor
92582474|NCT00082394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582475|NCT00082394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582476|NCT00082394|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92582477|NCT00082394|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92582478|NCT00082394|Antiviral Agents|antiviral agents|mesh-ancestor
92582479|NCT00082394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92582480|NCT00082394|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92582481|NCT00082394|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92582482|NCT00305500|Escitalopram|escitalopram|mesh-list
92582483|NCT00305500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92582484|NCT00305500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92582485|NCT00305500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92582486|NCT00305500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582487|NCT00305500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92582488|NCT00305500|Serotonin Agents|serotonin agents|mesh-ancestor
92582489|NCT00305500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582521|NCT00305812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92582522|NCT00305812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582523|NCT00305812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582524|NCT00305812|Glucocorticoids|glucocorticoids|mesh-ancestor
92582590|NCT00306748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92582591|NCT00082784|Bortezomib|bortezomib|mesh-list
92582592|NCT00082784|Alvocidib|alvocidib|mesh-list
92582593|NCT00082784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582594|NCT00082784|Growth Inhibitors|growth inhibitors|mesh-ancestor
92582595|NCT00082784|Growth Substances|growth substances|mesh-ancestor
92582596|NCT00082784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582597|NCT00082784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92582598|NCT00082784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92582599|NCT00082784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92582600|NCT00306826|Pioglitazone|pioglitazone|mesh-list
92582601|NCT00306826|Simvastatin|simvastatin|mesh-list
92582602|NCT00306826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92582603|NCT00306826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92582654|NCT00120705|Hematinics|hematinics|mesh-ancestor
92582655|NCT00307255|Paclitaxel|paclitaxel|mesh-list
92582656|NCT00307255|Gemcitabine|gemcitabine|mesh-list
92582657|NCT00307255|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92582727|NCT00307645|Methylprednisolone|methylprednisolone|mesh-list
92582728|NCT00307645|Cyclophosphamide|cyclophosphamide|mesh-list
92582729|NCT00307645|Azathioprine|azathioprine|mesh-list
92582730|NCT00307645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92582800|NCT00120822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92582801|NCT00083213|Aflibercept|aflibercept|mesh-list
92582802|NCT00083213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92582875|NCT00308425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92582876|NCT00308425|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92582877|NCT00308425|Antitubercular Agents|antitubercular agents|mesh-ancestor
92582948|NCT00309088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583020|NCT00088491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583094|NCT00309712|Simvastatin|simvastatin|mesh-list
92583095|NCT00309712|Fenofibrate|fenofibrate|mesh-list
92583167|NCT00083681|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92583241|NCT00310531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92583242|NCT00309673|Lidocaine|lidocaine|mesh-list
92583313|NCT00121329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583314|NCT00311038|Landiolol|landiolol|mesh-list
92583315|NCT00311038|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92583384|NCT00311467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583385|NCT00311467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583386|NCT00311467|Antiviral Agents|antiviral agents|mesh-ancestor
92583387|NCT00311467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92583388|NCT00311545|Siltuximab|siltuximab|mesh-list
92583389|NCT00311545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583390|NCT00089037|Sirolimus|sirolimus|mesh-list
92583391|NCT00089037|Methotrexate|methotrexate|mesh-list
92583392|NCT00089037|Tacrolimus|tacrolimus|mesh-list
92583393|NCT00089037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92583394|NCT00089037|Abortifacient Agents|abortifacient agents|mesh-ancestor
92583395|NCT00089037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92583398|NCT00089037|Antimetabolites|antimetabolites|mesh-ancestor
92583447|NCT00121446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583448|NCT00121446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583449|NCT00121446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583450|NCT00121446|Anticoagulants|anticoagulants|mesh-ancestor
92583451|NCT00121446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92583452|NCT00121446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92583453|NCT00311974|Dihydralazine|dihydralazine|mesh-list
92583454|NCT00311974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583455|NCT00312013|Nadroparin|nadroparin|mesh-list
92583456|NCT00312013|Anticoagulants|anticoagulants|mesh-ancestor
92583457|NCT00312013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92583458|NCT00312013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92583459|NCT00312013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583460|NCT00121524|Atropine|atropine|mesh-list
92583461|NCT00121524|Amiodarone|amiodarone|mesh-list
92583462|NCT00121524|Epinephrine|epinephrine|mesh-list
92583463|NCT00121524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92583464|NCT00121524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92583465|NCT00121524|Adrenergic Agents|adrenergic agents|mesh-ancestor
92583466|NCT00121524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308330|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92583467|NCT00121524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583498|NCT00312130|Protease Inhibitors|protease inhibitors|mesh-ancestor
92583504|NCT00089115|Antibodies|antibodies|mesh-list
92583575|NCT00293176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583576|NCT00293176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583650|NCT00293371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92583651|NCT00293371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92583652|NCT00293371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92583653|NCT00293410|Cyclophosphamide|cyclophosphamide|mesh-list
92583654|NCT00293410|Clofarabine|clofarabine|mesh-list
92583655|NCT00293410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92583656|NCT00293410|Immunologic Factors|immunologic factors|mesh-ancestor
92583657|NCT00293410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583658|NCT00293410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92583659|NCT00293410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92583660|NCT00293410|Alkylating Agents|alkylating agents|mesh-ancestor
92583661|NCT00293410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583662|NCT00293410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92583663|NCT00293410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92583664|NCT00293410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92583665|NCT00293410|Antimetabolites|antimetabolites|mesh-ancestor
92583666|NCT00121602|Darbepoetin alfa|darbepoetin alfa|mesh-list
92583667|NCT00121602|Hematinics|hematinics|mesh-ancestor
92583668|NCT00293527|Interferons|interferons|mesh-list
92583706|NCT00293800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92583707|NCT00293800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92583708|NCT00293800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92583709|NCT00423969|Galantamine|galantamine|mesh-list
92583710|NCT00423969|Escitalopram|escitalopram|mesh-list
92583711|NCT00423969|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92583712|NCT00423969|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92583713|NCT00423969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92583714|NCT00423969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583715|NCT00423969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92583769|NCT00417898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92583770|NCT00417898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92583771|NCT00417898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92583772|NCT00417898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92583840|NCT00089349|Mercaptopurine|mercaptopurine|mesh-list
92583912|NCT00089427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92583985|NCT00295672|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584062|NCT00296023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584063|NCT00296023|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92584135|NCT00296530|Respiratory System Agents|respiratory system agents|mesh-ancestor
92584209|NCT00122070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584210|NCT00122070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584281|NCT00297583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584283|NCT00297661|Paclitaxel|paclitaxel|mesh-list
92365923|NCT00644592|Fenofibrate|fenofibrate|mesh-list
92584284|NCT00297661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92584285|NCT00297661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584286|NCT00297661|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584287|NCT00297661|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584288|NCT00297661|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584289|NCT00297661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584290|NCT00297661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92584291|NCT00297661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584345|NCT00090324|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92584346|NCT00090324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92584347|NCT00090324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584348|NCT00090324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584349|NCT00122226|Ritonavir|ritonavir|mesh-list
92584350|NCT00122226|Lopinavir|lopinavir|mesh-list
92584351|NCT00122226|Lamivudine|lamivudine|mesh-list
92584352|NCT00122226|Zidovudine|zidovudine|mesh-list
92584353|NCT00122226|Nevirapine|nevirapine|mesh-list
92584354|NCT00122226|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92584355|NCT00122226|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92584356|NCT00122226|Protease Inhibitors|protease inhibitors|mesh-ancestor
92584357|NCT00122226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584359|NCT00122226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584405|NCT00122304|Immunologic Factors|immunologic factors|mesh-ancestor
92584406|NCT00122304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584407|NCT00322543|Pimecrolimus|pimecrolimus|mesh-list
92584408|NCT00322543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92584409|NCT00322543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92584410|NCT00322543|Analgesics|analgesics|mesh-ancestor
92584411|NCT00322543|Sensory System Agents|sensory system agents|mesh-ancestor
92584412|NCT00322543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584413|NCT00322543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584414|NCT00322543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92584415|NCT00322543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92584416|NCT00322543|Dermatologic Agents|dermatologic agents|mesh-ancestor
92584417|NCT00322543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584418|NCT00322543|Immunologic Factors|immunologic factors|mesh-ancestor
92584419|NCT00322543|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92584420|NCT00322543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584421|NCT00322543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584422|NCT00313963|Magnesium Sulfate|magnesium sulfate|mesh-list
92584423|NCT00313963|Analgesics|analgesics|mesh-ancestor
92584424|NCT00313963|Sensory System Agents|sensory system agents|mesh-ancestor
92584425|NCT00313963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92584426|NCT00313963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584427|NCT00313963|Anesthetics|anesthetics|mesh-ancestor
92584428|NCT00313963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92584429|NCT00313963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92584430|NCT00313963|Anticonvulsants|anticonvulsants|mesh-ancestor
92584431|NCT00313963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92584432|NCT00313963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92584433|NCT00313963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584448|NCT00314080|Immunologic Factors|immunologic factors|mesh-ancestor
92584449|NCT00314080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584450|NCT00314158|Timolol|timolol|mesh-list
92584452|NCT00314158|Brinzolamide|brinzolamide|mesh-list
92584523|NCT00323011|Hematinics|hematinics|mesh-ancestor
92584524|NCT00323011|Anticoagulants|anticoagulants|mesh-ancestor
92584525|NCT00323011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92584526|NCT00323011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92584527|NCT00323206|Interleukin-12|interleukin-12|mesh-list
92584528|NCT00323206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92584529|NCT00323206|Immunologic Factors|immunologic factors|mesh-ancestor
92584530|NCT00323206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92584531|NCT00323206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92584532|NCT00323206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92584533|NCT00323206|Growth Substances|growth substances|mesh-ancestor
92584534|NCT00323206|Growth Inhibitors|growth inhibitors|mesh-ancestor
92584535|NCT00323206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584536|NCT04717531|Cyclophosphamide|cyclophosphamide|mesh-list
92584537|NCT04717531|Docetaxel|docetaxel|mesh-list
92584538|NCT04717531|Trastuzumab|trastuzumab|mesh-list
92584539|NCT04717531|Epirubicin|epirubicin|mesh-list
92584540|NCT04717531|Pertuzumab|pertuzumab|mesh-list
92584541|NCT04717531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92584582|NCT00323323|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584583|NCT00323323|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584584|NCT00323323|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584585|NCT00323323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92584586|NCT00122499|Tadalafil|tadalafil|mesh-list
92584587|NCT00122499|Vasodilator Agents|vasodilator agents|mesh-ancestor
92584588|NCT00122499|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92584589|NCT00122499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92584590|NCT00122499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584591|NCT00122499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584592|NCT00122499|Urological Agents|urological agents|mesh-ancestor
92584593|NCT00312598|Aripiprazole|aripiprazole|mesh-list
92584594|NCT00312598|Antidepressive Agents|antidepressive agents|mesh-ancestor
92584621|NCT00312871|Epoetin Alfa|epoetin alfa|mesh-list
92584644|NCT00122538|Antiviral Agents|antiviral agents|mesh-ancestor
92584645|NCT00122538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584718|NCT00425152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584719|NCT00425152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584720|NCT00425152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584791|NCT00314626|Efavirenz|efavirenz|mesh-list
92584792|NCT00314626|Abacavir|abacavir|mesh-list
92584793|NCT00314626|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92584794|NCT00314626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584795|NCT00314626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584796|NCT00314626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584797|NCT00314626|Antiviral Agents|antiviral agents|mesh-ancestor
92584798|NCT00314626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92584799|NCT00314626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92584800|NCT00314626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92584801|NCT00314626|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92584802|NCT00314626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92584803|NCT00314626|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92584853|NCT04943627|Topotecan|topotecan|mesh-list
92584854|NCT04943627|Vinorelbine|vinorelbine|mesh-list
92584855|NCT04943627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92584856|NCT04943627|Antimetabolites|antimetabolites|mesh-ancestor
92584857|NCT04943627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584858|NCT04943627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92584859|NCT04943627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92584860|NCT04943627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92584861|NCT04943627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92584862|NCT04943627|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92584863|NCT04943627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92584864|NCT04943627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92584865|NCT04943627|Tubulin Modulators|tubulin modulators|mesh-ancestor
92584866|NCT04943627|Antimitotic Agents|antimitotic agents|mesh-ancestor
92584867|NCT04943627|Mitosis Modulators|mitosis modulators|mesh-ancestor
92584868|NCT00314743|Dexamethasone|dexamethasone|mesh-list
92584869|NCT00314743|Ondansetron|ondansetron|mesh-list
92584870|NCT00314743|Aprepitant|aprepitant|mesh-list
92584872|NCT00314743|Antiemetics|antiemetics|mesh-ancestor
92584908|NCT00314821|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92584909|NCT00314821|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92584910|NCT00314821|Dopamine Agonists|dopamine agonists|mesh-ancestor
92584911|NCT00314821|Dopamine Agents|dopamine agents|mesh-ancestor
92674716|NCT00331500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674717|NCT00331500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674718|NCT00331500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674719|NCT00331500|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92674720|NCT00331500|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92674721|NCT00331500|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92674722|NCT00331500|Histamine Antagonists|histamine antagonists|mesh-ancestor
92674723|NCT00331500|Histamine Agents|histamine agents|mesh-ancestor
92674724|NCT00331500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674725|NCT00331500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674726|NCT00322985|Lenalidomide|lenalidomide|mesh-list
92674727|NCT00322985|Immunologic Factors|immunologic factors|mesh-ancestor
92674728|NCT00322985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674729|NCT00322985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92674730|NCT00322985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674731|NCT00322985|Growth Substances|growth substances|mesh-ancestor
92674732|NCT00322985|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674733|NCT00322985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674734|NCT00353028|Fluvoxamine|fluvoxamine|mesh-list
92674735|NCT00353028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365927|NCT00644592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92674736|NCT00353028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674737|NCT00353028|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92674738|NCT00353028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92674739|NCT00353028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674740|NCT00353028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674741|NCT00353028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92674742|NCT00353028|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92674743|NCT00353028|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92674744|NCT00353028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92674745|NCT00353028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674746|NCT00353028|Serotonin Agents|serotonin agents|mesh-ancestor
92674747|NCT00353028|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92674748|NCT00353028|Antidepressive Agents|antidepressive agents|mesh-ancestor
92674749|NCT00353028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92674750|NCT00353028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92674751|NCT00353028|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92674752|NCT00353067|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid|mesh-list
92674756|NCT00353067|Sensory System Agents|sensory system agents|mesh-ancestor
92674757|NCT00353067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674758|NCT00353067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674759|NCT00353067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674760|NCT00353067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674761|NCT00353067|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92674762|NCT00353067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674763|NCT00353067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674764|NCT00323219|Moxifloxacin|moxifloxacin|mesh-list
92674766|NCT00323219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92674767|NCT00323219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674768|NCT00323219|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92674769|NCT00323219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674770|NCT00323219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674771|NCT00323219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674772|NCT00323219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674773|NCT00323375|Chloroquine|chloroquine|mesh-list
92674774|NCT00323375|Amebicides|amebicides|mesh-ancestor
92674775|NCT00323375|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92674776|NCT00323375|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92674777|NCT00323375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674778|NCT00323375|Antimalarials|antimalarials|mesh-ancestor
92674779|NCT00323375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674780|NCT00331695|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92674781|NCT00331695|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92674782|NCT00331695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92674783|NCT00331695|Hormone Antagonists|hormone antagonists|mesh-ancestor
92584912|NCT00314821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584913|NCT00314821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92584985|NCT00313885|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92584986|NCT00313885|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92584987|NCT00313885|Serotonin Agents|serotonin agents|mesh-ancestor
92584988|NCT00313885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92584990|NCT00091143|Fludarabine|fludarabine|mesh-list
92585057|NCT04551170|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92585058|NCT04551170|Autonomic Agents|autonomic agents|mesh-ancestor
92585064|NCT04551170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585128|NCT00122889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585129|NCT00122889|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92585130|NCT00122889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585132|NCT00122889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585199|NCT00315016|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92585272|NCT00123201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585273|NCT03031483|Clarithromycin|clarithromycin|mesh-list
92585274|NCT03031483|Lenalidomide|lenalidomide|mesh-list
92585341|NCT00123318|Cisplatin|cisplatin|mesh-list
92585342|NCT00123318|Fluorouracil|fluorouracil|mesh-list
92585344|NCT00123318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585345|NCT00123318|Antimetabolites|antimetabolites|mesh-ancestor
92585347|NCT00123318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92585413|NCT00092001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585414|NCT00092001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92585415|NCT00092001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92310287|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
92585416|NCT00092001|Growth Substances|growth substances|mesh-ancestor
92674784|NCT00331695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674785|NCT00331695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674786|NCT00331695|Progestins|progestins|mesh-ancestor
92674787|NCT00331695|Hormones|hormones|mesh-ancestor
92674788|NCT00353145|Gemcitabine|gemcitabine|mesh-list
92674789|NCT00353145|Oxaliplatin|oxaliplatin|mesh-list
92674790|NCT00353145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674791|NCT00353145|Antimetabolites|antimetabolites|mesh-ancestor
92674792|NCT00353145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674793|NCT00353145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674794|NCT00323648|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92674795|NCT00323648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674796|NCT00353184|Montelukast|montelukast|mesh-list
92674797|NCT00353184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92674798|NCT00353184|Respiratory System Agents|respiratory system agents|mesh-ancestor
92674799|NCT00353184|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92674800|NCT00353184|Hormone Antagonists|hormone antagonists|mesh-ancestor
92674801|NCT00353184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674802|NCT00353184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674803|NCT00353184|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92674804|NCT00353184|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92674805|NCT00353184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674806|NCT00323687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92674807|NCT00323687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92674808|NCT00323687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92674810|NCT00323687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674811|NCT00323687|Antiviral Agents|antiviral agents|mesh-ancestor
92674812|NCT00323687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674813|NCT00323687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92674814|NCT00323687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92674815|NCT00323804|Ribavirin|ribavirin|mesh-list
92674816|NCT00323804|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92674817|NCT00323804|Antimetabolites|antimetabolites|mesh-ancestor
92674818|NCT00323804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674819|NCT00323804|Antiviral Agents|antiviral agents|mesh-ancestor
92674820|NCT00323804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674821|NCT00353340|Acetylcysteine|acetylcysteine|mesh-list
92674822|NCT00353340|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92674823|NCT00353340|Antiviral Agents|antiviral agents|mesh-ancestor
92674827|NCT00353340|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92674828|NCT00353340|Antioxidants|antioxidants|mesh-ancestor
92674829|NCT00353340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674830|NCT00353340|Protective Agents|protective agents|mesh-ancestor
92674831|NCT00353340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674832|NCT00353340|Antidotes|antidotes|mesh-ancestor
92674833|NCT00323843|Isoproterenol|isoproterenol|mesh-list
92674834|NCT00323843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92674835|NCT00323843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92674836|NCT00323843|Adrenergic Agents|adrenergic agents|mesh-ancestor
92674837|NCT00323843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674838|NCT00323843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674839|NCT00323843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674840|NCT00323843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92674841|NCT00323843|Autonomic Agents|autonomic agents|mesh-ancestor
92674842|NCT00323843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674843|NCT00323843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92674844|NCT00323843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92674845|NCT00323843|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92674846|NCT00323843|Sympathomimetics|sympathomimetics|mesh-ancestor
92674847|NCT00323843|Protective Agents|protective agents|mesh-ancestor
92674848|NCT00323921|Dermatologic Agents|dermatologic agents|mesh-list
92674849|NCT00331851|Metformin|metformin|mesh-list
92674850|NCT00331851|Insulin Glargine|insulin glargine|mesh-list
92674851|NCT00331851|Liraglutide|liraglutide|mesh-list
92585417|NCT00092001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585418|NCT00092001|Growth Inhibitors|growth inhibitors|mesh-ancestor
92585419|NCT00092001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92585420|NCT00092001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585421|NCT00092001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585422|NCT03883919|Vitamin D|vitamin d|mesh-list
92585423|NCT03883919|Leucovorin|leucovorin|mesh-list
92585424|NCT03883919|Fluorouracil|fluorouracil|mesh-list
92585425|NCT03883919|Irinotecan|irinotecan|mesh-list
92585426|NCT03883919|Vitamins|vitamins|mesh-ancestor
92585427|NCT03883919|Micronutrients|micronutrients|mesh-ancestor
92585428|NCT03883919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585429|NCT03883919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92585430|NCT03883919|Antimetabolites|antimetabolites|mesh-ancestor
92585431|NCT03883919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585432|NCT03883919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92585433|NCT03883919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92585434|NCT03883919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585435|NCT03883919|Immunologic Factors|immunologic factors|mesh-ancestor
92585436|NCT03883919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92585437|NCT03883919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92585438|NCT03883919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585439|NCT03883919|Antidotes|antidotes|mesh-ancestor
92585440|NCT03883919|Protective Agents|protective agents|mesh-ancestor
92585441|NCT03883919|Vitamin B Complex|vitamin b complex|mesh-ancestor
92585442|NCT00327808|Budesonide|budesonide|mesh-list
92585443|NCT00327808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92585444|NCT00327808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92585445|NCT00327808|Autonomic Agents|autonomic agents|mesh-ancestor
92585446|NCT00327808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92585447|NCT00327808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92585448|NCT00327808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92585449|NCT00327808|Respiratory System Agents|respiratory system agents|mesh-ancestor
92585450|NCT00327808|Glucocorticoids|glucocorticoids|mesh-ancestor
92585451|NCT00327808|Hormones|hormones|mesh-ancestor
92674852|NCT00331851|Glimepiride|glimepiride|mesh-list
92674853|NCT00331851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674854|NCT00331851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674855|NCT00331851|Incretins|incretins|mesh-ancestor
92674856|NCT00331851|Hormones|hormones|mesh-ancestor
92674857|NCT00331851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674858|NCT00331851|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92674859|NCT00331851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92585452|NCT00327808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92585453|NCT00092079|Cholecalciferol|cholecalciferol|mesh-list
92585455|NCT00092079|Alendronate|alendronate|mesh-list
92585456|NCT00092079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92585458|NCT00092079|Vitamins|vitamins|mesh-ancestor
92585523|NCT00315679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585524|NCT00315679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92585599|NCT00123552|Schistosomicides|schistosomicides|mesh-ancestor
92585600|NCT00123552|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92585606|NCT03352427|Everolimus|everolimus|mesh-list
92585672|NCT00316849|Antifungal Agents|antifungal agents|mesh-ancestor
92585674|NCT03272477|Paclitaxel|paclitaxel|mesh-list
92585675|NCT03272477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92585676|NCT03272477|Cyclophosphamide|cyclophosphamide|mesh-list
92585745|NCT00316927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585746|NCT00316927|Antipyretics|antipyretics|mesh-ancestor
92585747|NCT00316927|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92585748|NCT00316927|Estrogens|estrogens|mesh-ancestor
92585816|NCT02571725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92585889|NCT00328939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92585965|NCT00329446|Antidepressive Agents|antidepressive agents|mesh-ancestor
92365947|NCT00648648|Antimetabolites|antimetabolites|mesh-ancestor
92586038|NCT00329758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586039|NCT00329758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92586111|NCT00330577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586121|NCT00083993|Sirolimus|sirolimus|mesh-list
92586182|NCT00323947|Dopamine Agents|dopamine agents|mesh-ancestor
92586183|NCT00323947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586184|NCT00323986|Azithromycin|azithromycin|mesh-list
92586185|NCT00323986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92586187|NCT00324025|Efungumab|efungumab|mesh-list
92586254|NCT00084227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586255|NCT00084227|Antimetabolites|antimetabolites|mesh-ancestor
92586326|NCT00324571|Chelating Agents|chelating agents|mesh-ancestor
92586327|NCT00324571|Sequestering Agents|sequestering agents|mesh-ancestor
92586397|NCT00318175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92586398|NCT00318175|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92586409|NCT00325000|Sertraline|sertraline|mesh-list
92586468|NCT00084695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92586538|NCT00325546|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92586683|NCT00085163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92586757|NCT00326092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92586760|NCT00326092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92586830|NCT00093678|Sensory System Agents|sensory system agents|mesh-ancestor
92586831|NCT00093678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92586833|NCT00093678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92586899|NCT00400335|Testosterone enanthate|testosterone enanthate|mesh-list
92586900|NCT00400335|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92586901|NCT00400335|Dutasteride|dutasteride|mesh-list
92586902|NCT00400335|Androgens|androgens|mesh-ancestor
92586903|NCT00400335|Hormones|hormones|mesh-ancestor
92586969|NCT00320125|Calcium|calcium|mesh-list
92586970|NCT00320125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92586971|NCT00320125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92586972|NCT00093873|Motesanib diphosphate|motesanib diphosphate|mesh-list
92586973|NCT00093873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92586974|NCT00093873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92586975|NCT00093873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92586976|NCT00320320|Irinotecan|irinotecan|mesh-list
92586977|NCT00320320|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92586978|NCT00320320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92587031|NCT00085943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587032|NCT00085943|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92587040|NCT00327184|PENTA|penta|mesh-list
92587102|NCT00320632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587103|NCT00320632|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92587172|NCT00086294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92587173|NCT00086294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92587178|NCT00086294|Serotonin Agents|serotonin agents|mesh-ancestor
92587246|NCT00419653|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587247|NCT00094341|Etanercept|etanercept|mesh-list
92587248|NCT00094341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92587318|NCT05457751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92587319|NCT05457751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92587388|NCT05457361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92587389|NCT05457361|Antimetabolites|antimetabolites|mesh-ancestor
92587390|NCT05457361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92587391|NCT05457361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587392|NCT05457361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92587459|NCT00124683|Antidepressive Agents|antidepressive agents|mesh-ancestor
92587460|NCT00124683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92587461|NCT00124683|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92587462|NCT00124683|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92587528|NCT00322075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92587529|NCT00322075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587532|NCT00322114|Antioxidants|antioxidants|mesh-ancestor
92587599|NCT00094692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92587600|NCT00094692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92587672|NCT00094848|Mapatumumab|mapatumumab|mesh-list
92587673|NCT00094848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587674|NCT00087425|Rituximab|rituximab|mesh-list
92587675|NCT00087425|Bryostatin 1|bryostatin 1|mesh-list
92587682|NCT00330655|Memantine|memantine|mesh-list
92587744|NCT00331084|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92587745|NCT00331084|BB 1101|bb 1101|mesh-list
92587746|NCT00331084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92587747|NCT00331084|Antiemetics|antiemetics|mesh-ancestor
92587814|NCT00124956|Doxorubicin|doxorubicin|mesh-list
92587815|NCT00124956|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92587816|NCT00124956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92587817|NCT00124956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92587823|NCT00087581|Tacrolimus|tacrolimus|mesh-list
92588032|NCT00332137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92588033|NCT00332137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92588034|NCT00332137|Cholinergic Agents|cholinergic agents|mesh-ancestor
92588179|NCT05830071|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92588180|NCT05830071|Adrenergic Agents|adrenergic agents|mesh-ancestor
92588181|NCT05830071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92588182|NCT05830071|Anticonvulsants|anticonvulsants|mesh-ancestor
92588189|NCT05830071|Hormones|hormones|mesh-ancestor
92588250|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92588251|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92588253|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92588322|NCT05628363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588324|NCT05574400|Caffeine citrate|caffeine citrate|mesh-list
92588325|NCT05574400|Citric Acid|citric acid|mesh-list
92588326|NCT05574400|Sodium Citrate|sodium citrate|mesh-list
92588393|NCT05413330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588394|NCT05271630|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92588395|NCT05271630|Immunomodulating Agents|immunomodulating agents|mesh-list
92588396|NCT05271630|Protease Inhibitors|protease inhibitors|mesh-ancestor
92588397|NCT05271630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92588398|NCT05271630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588399|NCT05271630|Immunologic Factors|immunologic factors|mesh-ancestor
92588460|NCT05142241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92588461|NCT05142241|Alkylating Agents|alkylating agents|mesh-ancestor
92588462|NCT05142241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92588463|NCT05142241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92588466|NCT05141474|Aldesleukin|aldesleukin|mesh-list
92588530|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92588531|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588534|NCT04981509|Listerine|listerine|mesh-list
92588604|NCT04800393|Sevoflurane|sevoflurane|mesh-list
92588605|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92588606|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92588678|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
92588679|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92588682|NCT04401748|Azacitidine|azacitidine|mesh-list
92588751|NCT04302870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92588752|NCT04302870|Antidepressive Agents|antidepressive agents|mesh-ancestor
92588754|NCT04294628|Camptothecin|camptothecin|mesh-list
92588824|NCT04098744|Artemisinins|artemisinins|mesh-list
92588825|NCT04098744|Artemisinin|artemisinin|mesh-list
92588826|NCT04098744|Antimalarials|antimalarials|mesh-ancestor
92588827|NCT04098744|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92588896|NCT03956680|Nivolumab|nivolumab|mesh-list
92588897|NCT03956680|Ipilimumab|ipilimumab|mesh-list
92588902|NCT03952273|Sirolimus|sirolimus|mesh-list
92588968|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92588969|NCT03711253|Tenofovir|tenofovir|mesh-list
92588970|NCT03711253|Emtricitabine|emtricitabine|mesh-list
92588971|NCT03711253|Antiviral Agents|antiviral agents|mesh-ancestor
92588979|NCT03643822|Dexamethasone|dexamethasone|mesh-list
92589041|NCT03575000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92589042|NCT03575000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92589043|NCT03575000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92589111|NCT03191864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92589112|NCT03191864|Respiratory System Agents|respiratory system agents|mesh-ancestor
92589185|NCT02975882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92589186|NCT02975882|Alkylating Agents|alkylating agents|mesh-ancestor
92589187|NCT02975882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92589188|NCT02975882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92589254|NCT02807805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92589257|NCT02807805|Hormone Antagonists|hormone antagonists|mesh-ancestor
92589326|NCT02636725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92589327|NCT02636725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589328|NCT02595866|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92589329|NCT02595866|Pembrolizumab|pembrolizumab|mesh-list
92589331|NCT02595866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589400|NCT02465268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589401|NCT02465268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92589402|NCT02408861|Nivolumab|nivolumab|mesh-list
92589474|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
92589475|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92589476|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92589477|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92589478|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92589541|NCT01946477|Dexamethasone|dexamethasone|mesh-list
92589542|NCT01946477|Daratumumab|daratumumab|mesh-list
92589543|NCT01946477|Pomalidomide|pomalidomide|mesh-list
92589544|NCT01946477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92589545|NCT01946477|Antiemetics|antiemetics|mesh-ancestor
92589546|NCT01946477|Autonomic Agents|autonomic agents|mesh-ancestor
92589612|NCT05952882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589613|NCT05952882|Incretins|incretins|mesh-ancestor
92589614|NCT05952882|Hormones|hormones|mesh-ancestor
92589683|NCT05952557|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92589684|NCT05952557|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92589685|NCT05952557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92589686|NCT05952505|Vaccines|vaccines|mesh-list
92589758|NCT05951816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92589830|NCT05951387|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92589831|NCT05951387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92589903|NCT05938699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92589904|NCT05938699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92589905|NCT05938699|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92589906|NCT05938699|Respiratory System Agents|respiratory system agents|mesh-ancestor
92589975|NCT05904379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92589976|NCT05904379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92589977|NCT05904379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92589978|NCT05904379|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92590048|NCT05860933|Analgesics|analgesics|mesh-ancestor
92590117|NCT05789524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92590118|NCT05789524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590193|NCT05726110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590265|NCT05645718|Mitosis Modulators|mitosis modulators|mesh-ancestor
92590266|NCT05645718|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92590267|NCT05645718|Immunotoxins|immunotoxins|mesh-ancestor
92590268|NCT05645718|Immunoconjugates|immunoconjugates|mesh-ancestor
92590336|NCT05592418|Interferon Inducers|interferon inducers|mesh-ancestor
92590337|NCT05592418|Immunologic Factors|immunologic factors|mesh-ancestor
92590338|NCT05592418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590339|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
92590408|NCT05457855|Fluticasone|fluticasone|mesh-list
92590409|NCT05457855|Montelukast|montelukast|mesh-list
92590410|NCT05457855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590481|NCT05383352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92590482|NCT05382559|Cetuximab|cetuximab|mesh-list
92590484|NCT05382559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590553|NCT05350371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92590554|NCT05350371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590555|NCT05343312|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92590626|NCT05222971|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92590627|NCT05222971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590629|NCT05211895|Durvalumab|durvalumab|mesh-list
92590699|NCT05083780|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92590700|NCT05083780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92590701|NCT05083780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92590774|NCT05020236|Pomalidomide|pomalidomide|mesh-list
92590775|NCT05020236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590776|NCT05020236|Antiemetics|antiemetics|mesh-ancestor
92590777|NCT05020236|Autonomic Agents|autonomic agents|mesh-ancestor
92590782|NCT05020236|Hormones|hormones|mesh-ancestor
92590845|NCT04963153|Immunologic Factors|immunologic factors|mesh-ancestor
92590919|NCT04799275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92590920|NCT04799275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92590921|NCT04799275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92590922|NCT04799275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92590992|NCT04759586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92590993|NCT04759586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92590994|NCT04759586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92590995|NCT04759586|Glucocorticoids|glucocorticoids|mesh-ancestor
92590996|NCT04759586|Hormones|hormones|mesh-ancestor
92591065|NCT04635189|Lenalidomide|lenalidomide|mesh-list
92591066|NCT04635189|Daratumumab|daratumumab|mesh-list
92591067|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92591140|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591142|NCT04485039|Tecovirimat|tecovirimat|mesh-list
92591143|NCT04485039|Sevelamer|sevelamer|mesh-list
92591144|NCT04485039|Calcium acetate|calcium acetate|mesh-list
92591214|NCT04285567|Alkylating Agents|alkylating agents|mesh-ancestor
92591215|NCT04285567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591216|NCT04285567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591217|NCT04285567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92591285|NCT04161898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591286|NCT04161898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591289|NCT04153487|Vitamins|vitamins|mesh-ancestor
92591356|NCT03811002|Immunologic Factors|immunologic factors|mesh-ancestor
92591357|NCT03811002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92591358|NCT03811002|Keratolytic Agents|keratolytic agents|mesh-ancestor
92591359|NCT03811002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92591430|NCT03678883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591436|NCT03671109|Piperaquine|piperaquine|mesh-list
92591503|NCT03486873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591504|NCT03464942|Atezolizumab|atezolizumab|mesh-list
92591573|NCT03407144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591574|NCT03407144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92316448|NCT03117140|Clonidine|clonidine|mesh-list
92591646|NCT03269669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591647|NCT03269669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591648|NCT03269669|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92591649|NCT03269669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92591650|NCT03269669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92591714|NCT03012529|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92591715|NCT03012529|Antitubercular Agents|antitubercular agents|mesh-ancestor
92591716|NCT03012529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92591717|NCT03012529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92591718|NCT03012529|Leprostatic Agents|leprostatic agents|mesh-ancestor
92591719|NCT03012529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92591720|NCT03012529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92591721|NCT03012529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591722|NCT03012529|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92591723|NCT03012529|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92591728|NCT03012529|Vitamin B Complex|vitamin b complex|mesh-ancestor
92591777|NCT02912559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92591778|NCT02912559|Hematinics|hematinics|mesh-ancestor
92591779|NCT02849639|Scopolamine|scopolamine|mesh-list
92591851|NCT02421939|Idarubicin|idarubicin|mesh-list
92591852|NCT02421939|Lenograstim|lenograstim|mesh-list
92591853|NCT02421939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92591854|NCT02421939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92591921|NCT02169310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92591922|NCT02108964|Nazartinib|nazartinib|mesh-list
92591924|NCT01952782|Naloxone|naloxone|mesh-list
92591996|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92592068|NCT00567580|Luteolytic Agents|luteolytic agents|mesh-ancestor
92592139|NCT00088049|Serotonin Agents|serotonin agents|mesh-ancestor
92592140|NCT00088049|Antidepressive Agents|antidepressive agents|mesh-ancestor
92592141|NCT00088049|Dopamine Agonists|dopamine agonists|mesh-ancestor
92592142|NCT00088049|Dopamine Agents|dopamine agents|mesh-ancestor
92592143|NCT00088049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92592144|NCT00088049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92592145|NCT00088049|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92592146|NCT00088049|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92592147|NCT00088049|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92592148|NCT00088049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92592149|NCT00088088|Paclitaxel|paclitaxel|mesh-list
92592150|NCT00088088|Carboplatin|carboplatin|mesh-list
92592151|NCT00088088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92592152|NCT00088088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592153|NCT00088088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92592154|NCT00088088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92592155|NCT00088088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592197|NCT00088478|Olanzapine|olanzapine|mesh-list
92592198|NCT00088478|Antiemetics|antiemetics|mesh-ancestor
92592199|NCT00088478|Autonomic Agents|autonomic agents|mesh-ancestor
92592200|NCT00088478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92592201|NCT00088478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592202|NCT00088478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92592203|NCT00088478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92592212|NCT00088478|Serotonin Agents|serotonin agents|mesh-ancestor
92592263|NCT00125424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592264|NCT00125424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92592265|NCT00125424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92592266|NCT00125424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92592267|NCT00125424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92592268|NCT00125424|Anesthetics, General|anesthetics, general|mesh-ancestor
92592269|NCT00125424|Anesthetics|anesthetics|mesh-ancestor
92592270|NCT00125424|GABA Modulators|gaba modulators|mesh-ancestor
92592271|NCT00125424|GABA Agents|gaba agents|mesh-ancestor
92592329|NCT00421018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92592330|NCT00421018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592331|NCT00421096|Gemcitabine|gemcitabine|mesh-list
92592332|NCT00421096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592398|NCT00334360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92592399|NCT00334360|Adrenergic Agents|adrenergic agents|mesh-ancestor
92592400|NCT00334360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592470|NCT00334672|Cyclophosphamide|cyclophosphamide|mesh-list
92592471|NCT00334672|Busulfan|busulfan|mesh-list
92592472|NCT00334672|Methotrexate|methotrexate|mesh-list
92592473|NCT00334672|Etoposide|etoposide|mesh-list
92592474|NCT00334672|Cyclosporins|cyclosporins|mesh-list
92592541|NCT00089492|Antiviral Agents|antiviral agents|mesh-ancestor
92592542|NCT00089492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592543|NCT00127686|Dextromethorphan|dextromethorphan|mesh-list
92592544|NCT00127686|Antitussive Agents|antitussive agents|mesh-ancestor
92592545|NCT00127686|Respiratory System Agents|respiratory system agents|mesh-ancestor
92592546|NCT00127686|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92592547|NCT00127686|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92592548|NCT00127686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92592549|NCT00127686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92592550|NCT00127686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92592551|NCT00334789|Vitamin A|vitamin a|mesh-list
92592552|NCT00334789|Tretinoin|tretinoin|mesh-list
92592553|NCT00334789|Belinostat|belinostat|mesh-list
92592606|NCT04715152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92592607|NCT04715152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92592608|NCT04715152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92592678|NCT00335179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92592679|NCT00335179|Immunologic Factors|immunologic factors|mesh-ancestor
92592753|NCT00343369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92592754|NCT00343408|Leucovorin|leucovorin|mesh-list
92592755|NCT00343408|Gemcitabine|gemcitabine|mesh-list
92592756|NCT00343408|Fluorouracil|fluorouracil|mesh-list
92592758|NCT00343408|Cediranib|cediranib|mesh-list
92592825|NCT00127920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92592826|NCT00343798|Cyclosporine|cyclosporine|mesh-list
92592852|NCT00343876|Aspirin|aspirin|mesh-list
92592974|NCT00127959|Antiviral Agents|antiviral agents|mesh-ancestor
92592975|NCT00127959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92592978|NCT00127959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92593043|NCT00344695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593044|NCT00344695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92593045|NCT00344695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92593046|NCT00344695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92593113|NCT00090194|Immunoglobulins|immunoglobulins|mesh-list
92593114|NCT00090194|Antibodies|antibodies|mesh-list
92593115|NCT00090194|gamma-Globulins|gamma-globulins|mesh-list
92593121|NCT00345163|Irinotecan|irinotecan|mesh-list
92593187|NCT04708249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593262|NCT00346294|Analgesics|analgesics|mesh-ancestor
92593263|NCT00346294|Sensory System Agents|sensory system agents|mesh-ancestor
92593264|NCT00346294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92593265|NCT00346294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593266|NCT00346294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92593267|NCT00346294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92593268|NCT00346294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92593269|NCT00346294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593270|NCT00346294|Immunologic Factors|immunologic factors|mesh-ancestor
92593271|NCT00346489|Fluorouracil|fluorouracil|mesh-list
92593272|NCT00346489|Mitomycins|mitomycins|mesh-list
92593327|NCT00346684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593332|NCT04728932|Simendan|simendan|mesh-list
92593400|NCT00126009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593401|NCT00126009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92593402|NCT00126009|Antidepressive Agents|antidepressive agents|mesh-ancestor
92593403|NCT00346918|Sirolimus|sirolimus|mesh-list
92593404|NCT00346918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593405|NCT00346918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593406|NCT00346918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92593407|NCT00346918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593408|NCT00346918|Antifungal Agents|antifungal agents|mesh-ancestor
92593409|NCT00346918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92593465|NCT00347152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92593466|NCT00347152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92593467|NCT00347152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92593468|NCT00090896|Ipilimumab|ipilimumab|mesh-list
92593469|NCT00090896|Antibodies|antibodies|mesh-list
92593470|NCT00090896|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92593471|NCT00090896|Immunologic Factors|immunologic factors|mesh-ancestor
92593472|NCT00090896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593473|NCT00090896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92593474|NCT00090896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593475|NCT00090896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92593531|NCT00347425|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92593532|NCT00347425|Dopamine Agents|dopamine agents|mesh-ancestor
92593602|NCT00421252|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92593603|NCT00421252|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92593604|NCT00421252|Purinergic Agents|purinergic agents|mesh-ancestor
92593605|NCT00421252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92593608|NCT00126204|Doxycycline|doxycycline|mesh-list
92593673|NCT00126282|Antimetabolites|antimetabolites|mesh-ancestor
92593674|NCT00126282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593675|NCT04705129|Tislelizumab|tislelizumab|mesh-list
92593676|NCT04705129|Zanubrutinib|zanubrutinib|mesh-list
92593678|NCT04705129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593742|NCT00126399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92593743|NCT01058395|Minocycline|minocycline|mesh-list
92593744|NCT01058395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92593745|NCT01058395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92593746|NCT00091325|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92593747|NCT00091325|Antioxidants|antioxidants|mesh-ancestor
92593748|NCT00091325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593749|NCT00091325|Protective Agents|protective agents|mesh-ancestor
92593750|NCT00091325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593751|NCT00091325|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92593752|NCT00091325|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92593753|NCT00091325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92593754|NCT00091325|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92593755|NCT00126516|Angiotensin II|angiotensin ii|mesh-list
92593756|NCT00126516|Giapreza|giapreza|mesh-list
92593757|NCT00126516|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92593758|NCT00126516|Angiotensinogen|angiotensinogen|mesh-list
92593759|NCT00126516|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92593762|NCT00126516|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92593799|NCT00426829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593800|NCT00426829|Growth Inhibitors|growth inhibitors|mesh-ancestor
92593871|NCT00427570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92593873|NCT00427570|Tubulin Modulators|tubulin modulators|mesh-ancestor
92593944|NCT00092183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92593945|NCT00092183|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92594018|NCT00092339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594019|NCT00092339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594020|NCT00092339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92594091|NCT05561049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594167|NCT05549895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92594168|NCT05549895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594243|NCT01055314|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92594244|NCT01055314|Irinotecan|irinotecan|mesh-list
92594245|NCT01055314|Etoposide|etoposide|mesh-list
92594246|NCT01055314|Vincristine|vincristine|mesh-list
92594247|NCT01055314|Etoposide phosphate|etoposide phosphate|mesh-list
92594315|NCT02823366|Antimetabolites|antimetabolites|mesh-ancestor
92594317|NCT02823366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92594388|NCT00094640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92594460|NCT00403611|Anthelmintics|anthelmintics|mesh-ancestor
92594461|NCT00403611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92594462|NCT00403611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92594463|NCT00428896|Gefitinib|gefitinib|mesh-list
92594531|NCT00429442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92594603|NCT00095927|Paclitaxel|paclitaxel|mesh-list
92594680|NCT01803594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92594681|NCT01803594|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92594682|NCT01803594|Vasodilator Agents|vasodilator agents|mesh-ancestor
92594683|NCT00430066|Imatinib Mesylate|imatinib mesylate|mesh-list
92594684|NCT00430066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594686|NCT00430066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92594749|NCT01726452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92594750|NCT01726452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92594751|NCT01726452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92594819|NCT00430651|Carboplatin|carboplatin|mesh-list
92594820|NCT00430651|Docetaxel|docetaxel|mesh-list
92594821|NCT00430651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92594892|NCT00096863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92594893|NCT00096863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92594900|NCT00096863|Dopamine Agents|dopamine agents|mesh-ancestor
92594964|NCT00097019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595039|NCT00431392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92595042|NCT00431392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92595111|NCT00432016|Antimetabolites|antimetabolites|mesh-ancestor
92595187|NCT00432367|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92595262|NCT00097877|Biphasic Insulins|biphasic insulins|mesh-list
92595263|NCT00097877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92595265|NCT00097916|Memantine|memantine|mesh-list
92595334|NCT00131313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595335|NCT00131313|Immunologic Factors|immunologic factors|mesh-ancestor
92595402|NCT00433459|Cyclophosphamide|cyclophosphamide|mesh-list
92595403|NCT00433459|Dacarbazine|dacarbazine|mesh-list
92595404|NCT00433459|Vincristine|vincristine|mesh-list
92595475|NCT00098423|Antimetabolites|antimetabolites|mesh-ancestor
92595476|NCT00098423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92595477|NCT00098423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595547|NCT00098501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92595620|NCT00098618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92595621|NCT00098618|Antiviral Agents|antiviral agents|mesh-ancestor
92595622|NCT00098618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92595691|NCT00099125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92595692|NCT00099125|Alkylating Agents|alkylating agents|mesh-ancestor
92595693|NCT00131703|Chloroquine|chloroquine|mesh-list
92595694|NCT00131703|Pyrimethamine|pyrimethamine|mesh-list
92595695|NCT00131703|Sulfadoxine|sulfadoxine|mesh-list
92595761|NCT00099320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92595762|NCT00099320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92595763|NCT00099320|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92595764|NCT00099320|Incretins|incretins|mesh-ancestor
92595765|NCT00099320|Hormones|hormones|mesh-ancestor
92595767|NCT00403650|Iloprost|iloprost|mesh-list
92595770|NCT00403728|Cyclosporine|cyclosporine|mesh-list
92595831|NCT00099710|Analgesics|analgesics|mesh-ancestor
92595909|NCT00100139|Paclitaxel|paclitaxel|mesh-list
92595978|NCT00132561|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92596055|NCT00100685|Growth Substances|growth substances|mesh-ancestor
92596129|NCT00400790|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92596130|NCT00400790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92596132|NCT00400790|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92596202|NCT00133185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596203|NCT00133185|Diuretics|diuretics|mesh-ancestor
92596272|NCT00101894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596273|NCT00102050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-list
92596348|NCT00102284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596349|NCT00102284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596350|NCT00102284|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92596352|NCT00102284|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92596353|NCT00102284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92596354|NCT00102284|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92596355|NCT00102284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596356|NCT00102284|Cholinergic Agents|cholinergic agents|mesh-ancestor
92596357|NCT00102284|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92596358|NCT00102284|Protective Agents|protective agents|mesh-ancestor
92596359|NCT00135525|Paroxetine|paroxetine|mesh-list
92596360|NCT00135525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92596361|NCT00135525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92596362|NCT00135525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92596363|NCT00135525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596401|NCT00102479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92596403|NCT00102479|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92596404|NCT00102479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92596405|NCT00102479|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92596406|NCT00102479|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92596407|NCT00135954|Prednisolone|prednisolone|mesh-list
92596408|NCT00135954|Cyclophosphamide|cyclophosphamide|mesh-list
92596441|NCT00133419|Zinc|zinc|mesh-list
92596469|NCT00102713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596470|NCT00102713|GABA Agents|gaba agents|mesh-ancestor
92596542|NCT00102947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596543|NCT00102947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596544|NCT00136344|Levofloxacin|levofloxacin|mesh-list
92596545|NCT00136344|Cefuroxime|cefuroxime|mesh-list
92596546|NCT00136344|Cefuroxime axetil|cefuroxime axetil|mesh-list
92596547|NCT00136344|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92596548|NCT00136344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92596549|NCT00136344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92596550|NCT00136344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92596551|NCT00136344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92596552|NCT00136344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596553|NCT00136344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596554|NCT00136344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596555|NCT00136344|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92596556|NCT00136344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92596557|NCT00102986|Ritonavir|ritonavir|mesh-list
92596558|NCT00102986|Lopinavir|lopinavir|mesh-list
92596597|NCT00103103|Antimetabolites|antimetabolites|mesh-ancestor
92596598|NCT00103103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596599|NCT00103103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92596600|NCT00103103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92596601|NCT00103103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596602|NCT00103103|Immunologic Factors|immunologic factors|mesh-ancestor
92596603|NCT00103103|Antidotes|antidotes|mesh-ancestor
92596604|NCT00103103|Protective Agents|protective agents|mesh-ancestor
92596605|NCT00103103|Vitamin B Complex|vitamin b complex|mesh-ancestor
92596606|NCT00103103|Vitamins|vitamins|mesh-ancestor
92596607|NCT00103103|Micronutrients|micronutrients|mesh-ancestor
92596608|NCT00133692|Atenolol|atenolol|mesh-list
92596609|NCT00133692|Verapamil|verapamil|mesh-list
92321484|NCT00000944|Lamivudine|lamivudine|mesh-list
92596610|NCT00133692|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92596611|NCT00133692|Trandolapril|trandolapril|mesh-list
92596634|NCT00133731|Heparin|heparin|mesh-list
92596658|NCT00103298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92596659|NCT00103298|Immunologic Factors|immunologic factors|mesh-ancestor
92596661|NCT00103298|Protective Agents|protective agents|mesh-ancestor
92596731|NCT00103571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92596732|NCT00103571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92596736|NCT00103571|Serotonin Agents|serotonin agents|mesh-ancestor
92596801|NCT00134160|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92596802|NCT00134160|Calcium Channel Blockers|calcium channel blockers|mesh-list
92596873|NCT00136929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92596875|NCT00134355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92596876|NCT00134355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596944|NCT00134394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92596945|NCT00134394|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92596946|NCT00134394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92596947|NCT00134394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597015|NCT00137202|Diphenhydramine|diphenhydramine|mesh-list
92597016|NCT00137202|Promethazine|promethazine|mesh-list
92597017|NCT00137202|Ondansetron|ondansetron|mesh-list
92597018|NCT00137202|Antiemetics|antiemetics|mesh-ancestor
92597019|NCT00137202|Autonomic Agents|autonomic agents|mesh-ancestor
92597042|NCT00104975|Melphalan|melphalan|mesh-list
92597087|NCT00105209|Clopidogrel|clopidogrel|mesh-list
92597088|NCT00105209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92597089|NCT00105209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92597232|NCT03277495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597238|NCT00137787|Ciprofloxacin|ciprofloxacin|mesh-list
92597307|NCT00434863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92597308|NCT00434863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92597382|NCT00435292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597456|NCT00436033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597457|NCT00436033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92597458|NCT00436033|Analgesics|analgesics|mesh-ancestor
92597459|NCT00436033|Sensory System Agents|sensory system agents|mesh-ancestor
92597460|NCT00436033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597461|NCT00436033|Antidepressive Agents|antidepressive agents|mesh-ancestor
92597462|NCT00436033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92597463|NCT00436072|Irinotecan|irinotecan|mesh-list
92597464|NCT00436072|Cetuximab|cetuximab|mesh-list
92597522|NCT00106262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92597523|NCT00106262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597524|NCT00106262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597525|NCT00106262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597526|NCT00106301|Romidepsin|romidepsin|mesh-list
92597527|NCT00106301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92597528|NCT00106301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597530|NCT00106301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597588|NCT00437008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597589|NCT00437086|Bortezomib|bortezomib|mesh-list
92597590|NCT00437086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597591|NCT00437164|Insulin|insulin|mesh-list
92597592|NCT00437164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92597593|NCT00437164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92597594|NCT00437164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597595|NCT00437320|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92597596|NCT00437320|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92597597|NCT00437320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92597598|NCT00106496|Tacrolimus|tacrolimus|mesh-list
92597599|NCT00106496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597600|NCT00106496|Immunologic Factors|immunologic factors|mesh-ancestor
92597601|NCT00106496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597602|NCT00106496|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92597603|NCT00106496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92597604|NCT00106496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597605|NCT00437359|Toremifene|toremifene|mesh-list
92597606|NCT00437359|Anastrozole|anastrozole|mesh-list
92597607|NCT00437359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92597641|NCT00437632|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92597642|NCT00437632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92597643|NCT00437632|Purinergic Agents|purinergic agents|mesh-ancestor
92597644|NCT00437632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597645|NCT00437671|Immunoglobulins|immunoglobulins|mesh-list
92597646|NCT00437671|Antibodies|antibodies|mesh-list
92597647|NCT00437671|gamma-Globulins|gamma-globulins|mesh-list
92597648|NCT00437671|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92597649|NCT00437671|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92597706|NCT00438217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92597708|NCT00438217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92597709|NCT00438217|Luteolytic Agents|luteolytic agents|mesh-ancestor
92597710|NCT00438217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92597711|NCT00438217|Contraceptive Agents|contraceptive agents|mesh-ancestor
92597712|NCT00438217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92597713|NCT03279757|Lidocaine|lidocaine|mesh-list
92597714|NCT03279757|Epinephrine|epinephrine|mesh-list
92597715|NCT03279757|Racepinephrine|racepinephrine|mesh-list
92597716|NCT03279757|Tetracaine|tetracaine|mesh-list
92597772|NCT00438841|Bortezomib|bortezomib|mesh-list
92597773|NCT00438841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92597844|NCT00439504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597845|NCT00439504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597917|NCT00138177|Protective Agents|protective agents|mesh-ancestor
92597919|NCT00138177|Vitamins|vitamins|mesh-ancestor
92597990|NCT00440128|Antiemetics|antiemetics|mesh-ancestor
92597991|NCT00440128|Autonomic Agents|autonomic agents|mesh-ancestor
92597992|NCT00440128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92597993|NCT00440128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92597994|NCT00440128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92597995|NCT00440128|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92597996|NCT00440128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92597997|NCT00440167|Gemcitabine|gemcitabine|mesh-list
92597998|NCT00440167|Capecitabine|capecitabine|mesh-list
92597999|NCT00440167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92598000|NCT00440167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92598001|NCT00440167|Antimetabolites|antimetabolites|mesh-ancestor
92598002|NCT00440167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598003|NCT00440167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598004|NCT00440167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92598005|NCT00440167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598006|NCT00107471|Topotecan|topotecan|mesh-list
92598007|NCT00107471|Lenograstim|lenograstim|mesh-list
92598008|NCT00107471|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92598009|NCT00107471|Immunologic Factors|immunologic factors|mesh-ancestor
92598010|NCT00107471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598013|NCT00107471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598044|NCT00440245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598045|NCT00440245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598046|NCT00440245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92598047|NCT00440245|Respiratory System Agents|respiratory system agents|mesh-ancestor
92598048|NCT00440245|Tocolytic Agents|tocolytic agents|mesh-ancestor
92598049|NCT00440245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92598050|NCT00440245|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92598051|NCT00440245|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92598052|NCT00440245|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92598053|NCT00440245|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598054|NCT00440245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598055|NCT00440245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598057|NCT00440284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92598058|NCT00440284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598059|NCT00142779|Fluoxetine|fluoxetine|mesh-list
92598073|NCT00440323|Zolpidem|zolpidem|mesh-list
92598101|NCT00440635|Bortezomib|bortezomib|mesh-list
92322982|NCT04070287|Antibodies|antibodies|mesh-list
92598102|NCT00440635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598103|NCT00440674|Paclitaxel|paclitaxel|mesh-list
92598104|NCT00440674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92598105|NCT00440674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598106|NCT00440674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92598107|NCT00440674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92598108|NCT00440674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92598109|NCT00440674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598166|NCT02964728|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92598167|NCT02964728|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92598168|NCT02964728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598169|NCT02964728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598170|NCT02964728|Cholinergic Agents|cholinergic agents|mesh-ancestor
92598171|NCT02964728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598172|NCT02964728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598173|NCT02964728|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92598174|NCT02964728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598175|NCT00441532|Lidocaine|lidocaine|mesh-list
92598176|NCT00441532|Anesthetics, Local|anesthetics, local|mesh-ancestor
92598177|NCT00441532|Anesthetics|anesthetics|mesh-ancestor
92323054|NCT00001646|Amebicides|amebicides|mesh-ancestor
92598187|NCT00441649|Methylphenidate|methylphenidate|mesh-list
92598223|NCT00441844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92598224|NCT00441844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92598225|NCT00441844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598226|NCT03279133|Ledipasvir|ledipasvir|mesh-list
92598227|NCT03279133|Antiviral Agents|antiviral agents|mesh-ancestor
92598228|NCT03279133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92598229|NCT00108017|Timolol|timolol|mesh-list
92598230|NCT00108017|Dorzolamide|dorzolamide|mesh-list
92598231|NCT00108017|Maleic acid|maleic acid|mesh-list
92598232|NCT00108017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598233|NCT00108017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598234|NCT00108017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92598235|NCT00108017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92598236|NCT00108017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598237|NCT00108017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598238|NCT00108017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598239|NCT00108017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92598240|NCT00108017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92598241|NCT00108017|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92598242|NCT00441922|Docetaxel|docetaxel|mesh-list
92598243|NCT00441922|Vinorelbine|vinorelbine|mesh-list
92598244|NCT00441922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598275|NCT00138411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92598276|NCT00442234|Monteplase|monteplase|mesh-list
92598277|NCT00442234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92598278|NCT00442234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92598279|NCT00442234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598280|NCT00108095|Ondansetron|ondansetron|mesh-list
92598281|NCT00108095|Antiemetics|antiemetics|mesh-ancestor
92598282|NCT00108095|Autonomic Agents|autonomic agents|mesh-ancestor
92598283|NCT00108095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598284|NCT00108095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598337|NCT00442585|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92598338|NCT00442585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598339|NCT00442585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598340|NCT00442741|Epothilone B|epothilone b|mesh-list
92598341|NCT00442741|Epothilones|epothilones|mesh-list
92598342|NCT00442741|Omeprazole|omeprazole|mesh-list
92598404|NCT00443170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92598405|NCT00443170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92598406|NCT00443170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598407|NCT00443170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92598414|NCT00443170|Analgesics|analgesics|mesh-ancestor
92598474|NCT00108446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92598475|NCT00108446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92598476|NCT00108446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92598545|NCT04726332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92598546|NCT04726332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598547|NCT04726332|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92598548|NCT04726332|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92598549|NCT04726332|Hormone Antagonists|hormone antagonists|mesh-ancestor
92598614|NCT03278314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598615|NCT03278314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598617|NCT00443950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92598618|NCT00443950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92598619|NCT00443950|Analgesics|analgesics|mesh-ancestor
92598620|NCT00443950|Sensory System Agents|sensory system agents|mesh-ancestor
92598621|NCT00443950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598622|NCT00443950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598623|NCT00443950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598624|NCT00443950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92598625|NCT00443950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598626|NCT00443950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92598627|NCT00443950|Immunologic Factors|immunologic factors|mesh-ancestor
92598628|NCT00444184|Timolol|timolol|mesh-list
92598629|NCT00444184|Travoprost|travoprost|mesh-list
92598630|NCT00444184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92598631|NCT00444184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92598632|NCT00444184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598633|NCT00444184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598668|NCT04698772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598669|NCT04698772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92598670|NCT04698772|Narcotics|narcotics|mesh-ancestor
92598671|NCT00451594|Dexamethasone|dexamethasone|mesh-list
92598672|NCT00451594|Prednisolone|prednisolone|mesh-list
92598673|NCT00451594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598674|NCT00451594|Antiemetics|antiemetics|mesh-ancestor
92598675|NCT00451594|Autonomic Agents|autonomic agents|mesh-ancestor
92598676|NCT00451594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598735|NCT00451828|Simvastatin|simvastatin|mesh-list
92598736|NCT00451828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92598737|NCT00451828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92598738|NCT00451828|Antimetabolites|antimetabolites|mesh-ancestor
92598739|NCT00451828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598740|NCT00451828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92598741|NCT00451828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92598742|NCT00451828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92598743|NCT00451867|Mycophenolic Acid|mycophenolic acid|mesh-list
92598744|NCT00451867|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92598745|NCT00451867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598796|NCT00143130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598797|NCT00143130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598798|NCT00143130|Anticonvulsants|anticonvulsants|mesh-ancestor
92598799|NCT00143130|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92598800|NCT00143130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92598801|NCT00143130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598802|NCT00143130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92598803|NCT00143130|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92598804|NCT00143130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92598805|NCT00143130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92598806|NCT00143130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92598807|NCT00109070|Bevacizumab|bevacizumab|mesh-list
92598808|NCT00109070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92598809|NCT00109070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92598810|NCT00109070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92598811|NCT00109070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92598812|NCT00109070|Growth Substances|growth substances|mesh-ancestor
92598850|NCT03275116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92598851|NCT03275116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598852|NCT03275116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598853|NCT03275116|Parasympatholytics|parasympatholytics|mesh-ancestor
92598854|NCT03275116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92598855|NCT03275116|Cholinergic Agents|cholinergic agents|mesh-ancestor
92598856|NCT03275116|Anticonvulsants|anticonvulsants|mesh-ancestor
92598857|NCT00109148|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92598858|NCT00109148|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92598859|NCT00109148|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92598860|NCT00109148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92598861|NCT00109148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92598862|NCT00109148|Hormones|hormones|mesh-ancestor
92598863|NCT00109148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92598864|NCT00109148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598865|NCT00452296|Insulin|insulin|mesh-list
92598866|NCT00452296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92598867|NCT00452296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598868|NCT00452569|Thalidomide|thalidomide|mesh-list
92598869|NCT00452569|Dexamethasone|dexamethasone|mesh-list
92598870|NCT00452569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92598871|NCT00452569|Antiemetics|antiemetics|mesh-ancestor
92598872|NCT00452569|Autonomic Agents|autonomic agents|mesh-ancestor
92598873|NCT00452569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598874|NCT00452569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92598875|NCT00452569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92598876|NCT00452569|Glucocorticoids|glucocorticoids|mesh-ancestor
92598877|NCT00452569|Hormones|hormones|mesh-ancestor
92598891|NCT00143286|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92598892|NCT00143286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92598893|NCT00143286|Cholinergic Agents|cholinergic agents|mesh-ancestor
92598897|NCT00109187|Omalizumab|omalizumab|mesh-list
92598961|NCT00109382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92598962|NCT00109382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599032|NCT00453778|Dermatologic Agents|dermatologic agents|mesh-ancestor
92599033|NCT00453778|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92599034|NCT00109616|Chlorhexidine|chlorhexidine|mesh-list
92599035|NCT00109616|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92599106|NCT00454480|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92599107|NCT00454480|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92599108|NCT00454480|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92599109|NCT00454480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92599175|NCT00143715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92599176|NCT00143715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599177|NCT00143715|Hemostatics|hemostatics|mesh-ancestor
92599178|NCT00143715|Coagulants|coagulants|mesh-ancestor
92599179|NCT00454831|Chitosan|chitosan|mesh-list
92599181|NCT00454831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92599246|NCT02273791|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92599248|NCT00110240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92599249|NCT00110240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599250|NCT00110240|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92599251|NCT00110240|Protease Inhibitors|protease inhibitors|mesh-ancestor
92599252|NCT00110240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599253|NCT00110240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599254|NCT00455416|Selenium|selenium|mesh-list
92599255|NCT00455416|Allicin|allicin|mesh-list
92599256|NCT00455416|Resveratrol|resveratrol|mesh-list
92599257|NCT00455416|Quercetin|quercetin|mesh-list
92599258|NCT00455416|Antioxidants|antioxidants|mesh-ancestor
92599259|NCT00455416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599260|NCT00455416|Protective Agents|protective agents|mesh-ancestor
92599261|NCT00455416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92599262|NCT00455416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92599263|NCT00455416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92599272|NCT00143871|Rituximab|rituximab|mesh-list
92599378|NCT00456313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92599379|NCT00456313|Sympathomimetics|sympathomimetics|mesh-ancestor
92599383|NCT00110630|Nicotine|nicotine|mesh-list
92599445|NCT00456898|Codeine|codeine|mesh-list
92599446|NCT00456898|Paroxetine|paroxetine|mesh-list
92599447|NCT00456898|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92599450|NCT00456898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92599516|NCT00457054|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92599517|NCT00457054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92599586|NCT00110903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92599661|NCT00111020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92599662|NCT00466063|Deferasirox|deferasirox|mesh-list
92599733|NCT00347698|Growth Inhibitors|growth inhibitors|mesh-ancestor
92324636|NCT00002780|Aldesleukin|aldesleukin|mesh-list
92599806|NCT00144417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92599807|NCT00111215|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92599808|NCT00111215|Tranexamic Acid|tranexamic acid|mesh-list
92599809|NCT00111215|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92599812|NCT00111215|Hemostatics|hemostatics|mesh-ancestor
92599877|NCT00348400|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92599878|NCT00348400|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92599879|NCT00348400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92599880|NCT00348400|Adrenergic Agents|adrenergic agents|mesh-ancestor
92599881|NCT00348400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92599948|NCT00349180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600022|NCT00349453|Chelating Agents|chelating agents|mesh-ancestor
92600099|NCT00350155|Analgesics|analgesics|mesh-ancestor
92600100|NCT00350155|Sensory System Agents|sensory system agents|mesh-ancestor
92600101|NCT00350155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600102|NCT00350155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600170|NCT00350467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92600172|NCT00350467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92600173|NCT00350467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600174|NCT00350467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92600175|NCT00350467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92600176|NCT00350467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92600177|NCT00350467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92600178|NCT00350467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600179|NCT00350467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600180|NCT00350467|Serotonin Agents|serotonin agents|mesh-ancestor
92600181|NCT00350467|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92600186|NCT00350662|Deferiprone|deferiprone|mesh-list
92600231|NCT00114270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92600232|NCT00114270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92600302|NCT00351169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600303|NCT00401648|Brivaracetam|brivaracetam|mesh-list
92600304|NCT00401648|Anticonvulsants|anticonvulsants|mesh-ancestor
92600373|NCT05595096|Anesthetics|anesthetics|mesh-list
92600374|NCT05595096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92600445|NCT00112346|Gemcitabine|gemcitabine|mesh-list
92600446|NCT00112346|Cetuximab|cetuximab|mesh-list
92600448|NCT00112346|Antimetabolites|antimetabolites|mesh-ancestor
92600520|NCT00352339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92600521|NCT00352339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92600522|NCT00352339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92600523|NCT00352339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92600524|NCT00352339|Serotonin Agents|serotonin agents|mesh-ancestor
92600525|NCT00352339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92600526|NCT00352339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92600527|NCT00352339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92600528|NCT00352339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92600529|NCT00352378|Cyclophosphamide|cyclophosphamide|mesh-list
92600530|NCT00352378|Docetaxel|docetaxel|mesh-list
92600531|NCT00352378|Doxorubicin|doxorubicin|mesh-list
92600580|NCT02959606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600581|NCT02959606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92600582|NCT02959606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92600583|NCT02959606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92600584|NCT02959606|Serotonin Agents|serotonin agents|mesh-ancestor
92600585|NCT00352651|Pregabalin|pregabalin|mesh-list
92600586|NCT00352651|Analgesics|analgesics|mesh-ancestor
92600646|NCT00353002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92600647|NCT00353002|Sensory System Agents|sensory system agents|mesh-ancestor
92600648|NCT00353002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92600649|NCT00353002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92600714|NCT00113048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92600715|NCT00113048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92600787|NCT00114933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92600860|NCT00115167|Darbepoetin alfa|darbepoetin alfa|mesh-list
92600861|NCT00115167|Hematinics|hematinics|mesh-ancestor
92600862|NCT00115245|Adefovir|adefovir|mesh-list
92600934|NCT00444652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92600935|NCT00444652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92600936|NCT00444652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601003|NCT00445081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601004|NCT00445081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92601005|NCT00445081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601021|NCT00113945|Cinacalcet|cinacalcet|mesh-list
92601073|NCT00445900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92601074|NCT00445900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92601075|NCT00445900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92601147|NCT00446329|Hormone Antagonists|hormone antagonists|mesh-ancestor
92601148|NCT00446329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601220|NCT00404937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92601221|NCT00404937|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92601291|NCT00115635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92601292|NCT00115635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92601293|NCT00447304|Moxifloxacin|moxifloxacin|mesh-list
92601294|NCT00447304|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92601303|NCT00447577|Dexamethasone|dexamethasone|mesh-list
92601364|NCT00401856|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92601397|NCT05553678|Midazolam|midazolam|mesh-list
92601436|NCT00448786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601437|NCT00114803|Calcitonin|calcitonin|mesh-list
92601513|NCT00449137|Antimetabolites|antimetabolites|mesh-ancestor
92601514|NCT00449137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601515|NCT00449137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92601586|NCT00449527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92601587|NCT00449527|Respiratory System Agents|respiratory system agents|mesh-ancestor
92601588|NCT00449527|Glucocorticoids|glucocorticoids|mesh-ancestor
92601589|NCT00449527|Hormones|hormones|mesh-ancestor
92601658|NCT00450736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92601659|NCT00450736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92601661|NCT05536362|Clonidine|clonidine|mesh-list
92601729|NCT00458185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92601730|NCT00458185|Immunologic Factors|immunologic factors|mesh-ancestor
92601731|NCT00458263|Hormones|hormones|mesh-list
92601732|NCT00458263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601733|NCT00458263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601734|NCT00458419|Naloxone|naloxone|mesh-list
92601735|NCT00458419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92601736|NCT00458419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601737|NCT00458419|Sensory System Agents|sensory system agents|mesh-ancestor
92601738|NCT00458419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92601739|NCT00458458|Leuprolide|leuprolide|mesh-list
92601794|NCT00459004|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92601795|NCT00459004|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92601796|NCT00459004|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92601797|NCT00459004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92601798|NCT00459004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92601799|NCT00459004|Hormones|hormones|mesh-ancestor
92601800|NCT00459004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92601807|NCT00115622|Fluticasone|fluticasone|mesh-list
92601860|NCT00460057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92601861|NCT00460057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601862|NCT00401921|Minocycline|minocycline|mesh-list
92601863|NCT00401921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92601864|NCT00401921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92601931|NCT00460681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92601933|NCT00460759|Rifapentine|rifapentine|mesh-list
92601934|NCT00460759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92602004|NCT03273634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92602005|NCT03273634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92602076|NCT00461578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92602077|NCT00461578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92602078|NCT00461578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602079|NCT00461578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602080|NCT00461578|Antiviral Agents|antiviral agents|mesh-ancestor
92602081|NCT00461578|Schistosomicides|schistosomicides|mesh-ancestor
92602082|NCT00461578|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92602083|NCT00461578|Anthelmintics|anthelmintics|mesh-ancestor
92602084|NCT00461578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92602085|NCT00461578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602086|NCT00461578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602141|NCT00462358|Lenograstim|lenograstim|mesh-list
92602142|NCT00462358|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92602215|NCT00462787|Vinorelbine|vinorelbine|mesh-list
92602216|NCT00462787|Thiotepa|thiotepa|mesh-list
92602217|NCT00462787|Clofarabine|clofarabine|mesh-list
92602219|NCT00462787|Antiemetics|antiemetics|mesh-ancestor
92602285|NCT00116402|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602286|NCT00116402|Dermatologic Agents|dermatologic agents|mesh-ancestor
92602357|NCT00464347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92602358|NCT00464347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92602359|NCT00464347|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92602429|NCT00116870|L 647318|l 647318|mesh-list
92602430|NCT00116870|Dihydromevinolin|dihydromevinolin|mesh-list
92602431|NCT00116870|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92602432|NCT00116870|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92602433|NCT00116870|Antimetabolites|antimetabolites|mesh-ancestor
92602434|NCT00116870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602500|NCT03272503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602501|NCT03272503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92602650|NCT00117182|Cholinergic Agents|cholinergic agents|mesh-ancestor
92602651|NCT00116922|Metformin|metformin|mesh-list
92327582|NCT01568918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92602652|NCT00116922|Rosiglitazone|rosiglitazone|mesh-list
92602653|NCT00116922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92602721|NCT00475072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92602722|NCT00117299|Vatalanib|vatalanib|mesh-list
92602723|NCT00117299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92602724|NCT00117299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92602726|NCT00117000|Methyltestosterone|methyltestosterone|mesh-list
92602790|NCT00475462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92602792|NCT00475462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602793|NCT00475462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92602859|NCT00475969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92602860|NCT00475969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92602861|NCT00475969|Analgesics|analgesics|mesh-ancestor
92602934|NCT00117611|Respiratory System Agents|respiratory system agents|mesh-ancestor
92602935|NCT04727684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92602936|NCT04727684|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92602937|NCT04727684|Cetrorelix|cetrorelix|mesh-list
92602938|NCT04727684|Menotropins|menotropins|mesh-list
92603007|NCT00117273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603080|NCT00118313|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92603153|NCT00477763|Antifungal Agents|antifungal agents|mesh-ancestor
92603154|NCT00477763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603155|NCT00477763|Dermatologic Agents|dermatologic agents|mesh-ancestor
92603156|NCT00477763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92603224|NCT00478543|Diuretics|diuretics|mesh-ancestor
92603225|NCT00478543|Natriuretic Agents|natriuretic agents|mesh-ancestor
92603226|NCT00478543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603297|NCT00119132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92603298|NCT00119132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92603370|NCT00479908|Sildenafil Citrate|sildenafil citrate|mesh-list
92603372|NCT00479908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603373|NCT00479908|Vasodilator Agents|vasodilator agents|mesh-ancestor
92603378|NCT00479986|Pioglitazone|pioglitazone|mesh-list
92603442|NCT00480298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92603443|NCT00480298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92603444|NCT00480298|Protective Agents|protective agents|mesh-ancestor
92603514|NCT00119639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603515|NCT00119639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603516|NCT00480844|Risperidone|risperidone|mesh-list
92603517|NCT00480844|Sertindole|sertindole|mesh-list
92603518|NCT00480844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92603583|NCT00119756|Serotonin Agents|serotonin agents|mesh-ancestor
92603584|NCT00119756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92603585|NCT00119756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603586|NCT00119756|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92603655|NCT00119990|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92603729|NCT00482209|Abortifacient Agents|abortifacient agents|mesh-ancestor
92603730|NCT00482209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92603731|NCT00482209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92603732|NCT00482209|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92603733|NCT00482209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92603734|NCT00482209|Oxytocics|oxytocics|mesh-ancestor
92603735|NCT00482209|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92603747|NCT00117936|Mitogens|mitogens|mesh-list
92603797|NCT00482716|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92603798|NCT00482716|Iron-Dextran Complex|iron-dextran complex|mesh-list
92603799|NCT00482716|Trace Elements|trace elements|mesh-ancestor
92603868|NCT01241032|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92603938|NCT00405171|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92603939|NCT00405171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92603940|NCT00405171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92603941|NCT00405171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92603942|NCT00405171|Antiviral Agents|antiviral agents|mesh-ancestor
92603943|NCT00405171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92603944|NCT00405171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92603945|NCT00405171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92604002|NCT00120653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604007|NCT00120653|Dopamine Agents|dopamine agents|mesh-ancestor
92604076|NCT00484744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604077|NCT00484822|Heparin|heparin|mesh-list
92604078|NCT00484822|Calcium heparin|calcium heparin|mesh-list
92604079|NCT00484822|Anticoagulants|anticoagulants|mesh-ancestor
92604148|NCT00120887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92604149|NCT00120887|Antimetabolites|antimetabolites|mesh-ancestor
92604150|NCT00120887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604215|NCT02274337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604216|NCT00121043|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92604217|NCT00121043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604284|NCT00485797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92604285|NCT00485797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604286|NCT00485797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604287|NCT00485797|Dopamine Agents|dopamine agents|mesh-ancestor
92604288|NCT00485797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604289|NCT00485875|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92604290|NCT00485875|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92604294|NCT00485875|Adrenergic Agents|adrenergic agents|mesh-ancestor
92604349|NCT00486421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604350|NCT00486421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92604352|NCT00486460|Celecoxib|celecoxib|mesh-list
92604353|NCT00486460|Gemcitabine|gemcitabine|mesh-list
92604354|NCT00486460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604355|NCT00486460|Antimetabolites|antimetabolites|mesh-ancestor
92604356|NCT00486460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604357|NCT00486460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604358|NCT00486460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604359|NCT00486460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604360|NCT00486460|Analgesics|analgesics|mesh-ancestor
92604361|NCT00486460|Sensory System Agents|sensory system agents|mesh-ancestor
92604362|NCT00486460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604363|NCT00486460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674860|NCT00331851|Immunologic Factors|immunologic factors|mesh-ancestor
92674861|NCT00331890|Choline|choline|mesh-list
92674862|NCT00331890|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92674863|NCT00331890|Lipotropic Agents|lipotropic agents|mesh-ancestor
92674864|NCT00331890|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92674865|NCT00331890|Antimetabolites|antimetabolites|mesh-ancestor
92366060|NCT00672438|Alfentanil|alfentanil|mesh-list
92674866|NCT00331890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674867|NCT00331890|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674868|NCT00331890|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92674869|NCT00331890|Nootropic Agents|nootropic agents|mesh-ancestor
92674870|NCT01059773|Methotrexate|methotrexate|mesh-list
92674871|NCT01059773|Ustekinumab|ustekinumab|mesh-list
92674872|NCT01059773|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92674873|NCT01059773|Abortifacient Agents|abortifacient agents|mesh-ancestor
92674874|NCT01059773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92674875|NCT01059773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674876|NCT01059773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92674877|NCT01059773|Antimetabolites|antimetabolites|mesh-ancestor
92674878|NCT01059773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674879|NCT01059773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674880|NCT01059773|Dermatologic Agents|dermatologic agents|mesh-ancestor
92674881|NCT01059773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674882|NCT01059773|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92674883|NCT01059773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674884|NCT01059773|Immunologic Factors|immunologic factors|mesh-ancestor
92674885|NCT01059773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674886|NCT01059773|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92674887|NCT00353379|Guanfacine|guanfacine|mesh-list
92674888|NCT00353379|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92674889|NCT00353379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92674890|NCT00353379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92674891|NCT00353379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92674892|NCT00353379|Adrenergic Agents|adrenergic agents|mesh-ancestor
92674893|NCT00353379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674894|NCT00353379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674895|NCT00353379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674896|NCT00324077|Imatinib Mesylate|imatinib mesylate|mesh-list
92674900|NCT00324077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674901|NCT00324077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674902|NCT00324194|Mocetinostat|mocetinostat|mesh-list
92674903|NCT00324194|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92674904|NCT00324194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604364|NCT00486460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604366|NCT00486460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604367|NCT00486460|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92604368|NCT00486460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92674905|NCT00324194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674906|NCT00324389|Interferons|interferons|mesh-list
92674907|NCT00324389|Interferon-alpha|interferon-alpha|mesh-list
92674908|NCT00324389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674909|NCT00324389|Antiviral Agents|antiviral agents|mesh-ancestor
92674910|NCT00324389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674911|NCT00324389|Immunologic Factors|immunologic factors|mesh-ancestor
92674912|NCT00324389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674913|NCT00353691|Metformin|metformin|mesh-list
92674914|NCT00353691|Glimepiride|glimepiride|mesh-list
92674915|NCT00353691|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92674916|NCT00353691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674917|NCT00353691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92674918|NCT00353691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674919|NCT00353691|Immunologic Factors|immunologic factors|mesh-ancestor
92674920|NCT00332046|Casopitant|casopitant|mesh-list
92674921|NCT00332046|Antiemetics|antiemetics|mesh-ancestor
92674922|NCT00332046|Autonomic Agents|autonomic agents|mesh-ancestor
92674923|NCT00332046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674924|NCT00332046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674925|NCT00332046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674926|NCT00332046|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92674927|NCT00332046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674928|NCT00332046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674929|NCT00324467|Acetaminophen|acetaminophen|mesh-list
92674930|NCT00324467|Diphenhydramine|diphenhydramine|mesh-list
92674931|NCT00324467|Promethazine|promethazine|mesh-list
92674932|NCT00324467|Dexamethasone|dexamethasone|mesh-list
92674933|NCT00324467|Dexamethasone acetate|dexamethasone acetate|mesh-list
92674934|NCT00324467|Prednisone|prednisone|mesh-list
92674935|NCT00324467|Cyclophosphamide|cyclophosphamide|mesh-list
92674936|NCT00324467|Ifosfamide|ifosfamide|mesh-list
92674937|NCT00324467|Rituximab|rituximab|mesh-list
92674938|NCT00324467|Carboplatin|carboplatin|mesh-list
92674939|NCT00324467|Doxorubicin|doxorubicin|mesh-list
92674940|NCT00324467|Etoposide|etoposide|mesh-list
92674941|NCT00324467|Vincristine|vincristine|mesh-list
92674942|NCT00324467|Ondansetron|ondansetron|mesh-list
92674943|NCT00324467|BB 1101|bb 1101|mesh-list
92674944|NCT00324467|Mesna|mesna|mesh-list
92674945|NCT00324467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674946|NCT00324467|Immunologic Factors|immunologic factors|mesh-ancestor
92674947|NCT00324467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674948|NCT00324467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92674949|NCT00324467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92674950|NCT00324467|Alkylating Agents|alkylating agents|mesh-ancestor
92674951|NCT00324467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674952|NCT00324467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674954|NCT00324467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92674955|NCT00324467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92674956|NCT00324467|Antiemetics|antiemetics|mesh-ancestor
92674957|NCT00324467|Autonomic Agents|autonomic agents|mesh-ancestor
92674958|NCT00324467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674959|NCT00324467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92674960|NCT00324467|Glucocorticoids|glucocorticoids|mesh-ancestor
92674961|NCT00324467|Hormones|hormones|mesh-ancestor
92674962|NCT00324467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674963|NCT00324467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92674964|NCT00324467|Protease Inhibitors|protease inhibitors|mesh-ancestor
92674965|NCT00324467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674966|NCT00324467|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92674967|NCT00324467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92674968|NCT00324467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674969|NCT00324467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92674970|NCT00324467|Tubulin Modulators|tubulin modulators|mesh-ancestor
92674971|NCT00324467|Antimitotic Agents|antimitotic agents|mesh-ancestor
92674972|NCT00324467|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082489|NCT03596385|Metoprolol|metoprolol|mesh-list
92674974|NCT00324467|Analgesics|analgesics|mesh-ancestor
92011859|NCT03594175|Reteplase|reteplase|mesh-list
92604369|NCT00121511|Fluorouracil|fluorouracil|mesh-list
92604370|NCT00121511|Antimetabolites|antimetabolites|mesh-ancestor
92604371|NCT00121511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604372|NCT00121511|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604373|NCT00121511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604374|NCT00121511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604375|NCT00121511|Immunologic Factors|immunologic factors|mesh-ancestor
92604376|NCT00121511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604378|NCT00486694|Chloroquine|chloroquine|mesh-list
92604379|NCT00486694|Pyrimethamine|pyrimethamine|mesh-list
92604380|NCT00486694|Sulfadoxine|sulfadoxine|mesh-list
92604381|NCT00486694|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92604382|NCT00486694|Antimalarials|antimalarials|mesh-ancestor
92604383|NCT00486694|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604384|NCT00486694|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92604385|NCT00486694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604386|NCT00486694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604387|NCT00486694|Antiviral Agents|antiviral agents|mesh-ancestor
92604388|NCT00486694|Schistosomicides|schistosomicides|mesh-ancestor
92604389|NCT00486694|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92604390|NCT00486694|Anthelmintics|anthelmintics|mesh-ancestor
92674975|NCT00324467|Sensory System Agents|sensory system agents|mesh-ancestor
92674976|NCT00324467|Antipyretics|antipyretics|mesh-ancestor
92674977|NCT00324467|Antipruritics|antipruritics|mesh-ancestor
92674978|NCT00324467|Dermatologic Agents|dermatologic agents|mesh-ancestor
92674979|NCT00324467|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92674980|NCT00324467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92674981|NCT00324467|Serotonin Agents|serotonin agents|mesh-ancestor
92674982|NCT00324467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674983|NCT00324467|Protective Agents|protective agents|mesh-ancestor
92674984|NCT00324467|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92674985|NCT00324467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92366071|NCT00672594|Sunitinib|sunitinib|mesh-list
92674986|NCT00324467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92674987|NCT00324467|Anesthetics, Local|anesthetics, local|mesh-ancestor
92674988|NCT00324467|Anesthetics|anesthetics|mesh-ancestor
92674989|NCT00324467|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92674990|NCT00324467|Histamine Antagonists|histamine antagonists|mesh-ancestor
92674991|NCT00324467|Histamine Agents|histamine agents|mesh-ancestor
92674992|NCT00324467|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92674994|NCT00332085|Picolinic acid|picolinic acid|mesh-list
92674995|NCT00332085|Trace Elements|trace elements|mesh-ancestor
92674996|NCT00332085|Micronutrients|micronutrients|mesh-ancestor
92674997|NCT00332085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674998|NCT00332085|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92674999|NCT00332085|Chelating Agents|chelating agents|mesh-ancestor
92675000|NCT00332085|Sequestering Agents|sequestering agents|mesh-ancestor
92675001|NCT00332085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675002|NCT00324506|Mycophenolic Acid|mycophenolic acid|mesh-list
92675003|NCT00324506|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92675004|NCT00324506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675005|NCT00324506|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92675006|NCT00324506|Antitubercular Agents|antitubercular agents|mesh-ancestor
92675007|NCT00324506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675008|NCT00324506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675009|NCT00324506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604392|NCT00486694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604393|NCT00486694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92604394|NCT00486694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604395|NCT00486694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604396|NCT00486694|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92604397|NCT00486772|Calcium|calcium|mesh-list
92604398|NCT00486772|Sevelamer|sevelamer|mesh-list
92604399|NCT00486772|Calcium acetate|calcium acetate|mesh-list
92604400|NCT00486772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92604401|NCT00486772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604402|NCT00486772|Chelating Agents|chelating agents|mesh-ancestor
92675010|NCT00324506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675011|NCT00332124|Choline|choline|mesh-list
92675012|NCT00332124|Lipotropic Agents|lipotropic agents|mesh-ancestor
92675013|NCT00332124|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92675014|NCT00332124|Antimetabolites|antimetabolites|mesh-ancestor
92675015|NCT00332124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675016|NCT00332124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675017|NCT00332124|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92675018|NCT00332124|Nootropic Agents|nootropic agents|mesh-ancestor
92675019|NCT04714554|Erythromycin|erythromycin|mesh-list
92675020|NCT04714554|Erythromycin Estolate|erythromycin estolate|mesh-list
92675021|NCT04714554|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92675022|NCT04714554|Erythromycin stearate|erythromycin stearate|mesh-list
92675023|NCT04714554|Relugolix|relugolix|mesh-list
92675024|NCT04714554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675025|NCT04714554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675026|NCT04714554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675027|NCT04714554|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92675028|NCT04714554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675029|NCT04714554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675030|NCT04714554|Androgen Antagonists|androgen antagonists|mesh-ancestor
92675031|NCT04714554|Hormone Antagonists|hormone antagonists|mesh-ancestor
92675032|NCT04714554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675033|NCT04714554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675034|NCT00419471|Escitalopram|escitalopram|mesh-list
92675035|NCT00419471|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92675036|NCT00419471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92675037|NCT00419471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675038|NCT00419471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675039|NCT00419471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675040|NCT00419471|Serotonin Agents|serotonin agents|mesh-ancestor
92675041|NCT00419471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675042|NCT00426348|Valsartan|valsartan|mesh-list
92675043|NCT00426348|Probucol|probucol|mesh-list
92675044|NCT00426348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675045|NCT00426348|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92675046|NCT00426348|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92675048|NCT00426348|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92675049|NCT00426348|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92675050|NCT00426348|Antimetabolites|antimetabolites|mesh-ancestor
92675051|NCT00426348|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92675053|NCT00426348|Protective Agents|protective agents|mesh-ancestor
92675054|NCT00426348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675055|NCT00353808|Reboxetine|reboxetine|mesh-list
92675056|NCT00353808|Antidepressive Agents|antidepressive agents|mesh-ancestor
92675057|NCT00353808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675058|NCT00353808|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92675059|NCT00353808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92675060|NCT00353808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604403|NCT00486772|Sequestering Agents|sequestering agents|mesh-ancestor
92604404|NCT00486772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604405|NCT00121550|Clarithromycin|clarithromycin|mesh-list
92604406|NCT00121550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92604407|NCT00121550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604408|NCT00121550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92604409|NCT00121550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604410|NCT00121550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604411|NCT00121550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92604412|NCT00121550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92604413|NCT01242046|Caffeine|caffeine|mesh-list
92604414|NCT01242046|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92011885|NCT03043157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675061|NCT00353808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675062|NCT00353808|Adrenergic Agents|adrenergic agents|mesh-ancestor
92675063|NCT00353808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675064|NCT00353808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675065|NCT00324623|Cyclophosphamide|cyclophosphamide|mesh-list
92675066|NCT00324623|Fludarabine|fludarabine|mesh-list
92675067|NCT00324623|Fludarabine phosphate|fludarabine phosphate|mesh-list
92675068|NCT00324623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675069|NCT00324623|Immunologic Factors|immunologic factors|mesh-ancestor
92675070|NCT00324623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675071|NCT00324623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675072|NCT00324623|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92675073|NCT00324623|Alkylating Agents|alkylating agents|mesh-ancestor
92675074|NCT00324623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675075|NCT00324623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675076|NCT00324623|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92675077|NCT00324623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92675078|NCT00324623|Antimetabolites|antimetabolites|mesh-ancestor
92675079|NCT00324779|Rituximab|rituximab|mesh-list
92675080|NCT00324779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675081|NCT00324779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675082|NCT00324779|Immunologic Factors|immunologic factors|mesh-ancestor
92675083|NCT00324779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675084|NCT00324779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675085|NCT00324818|Azithromycin|azithromycin|mesh-list
92675086|NCT00324818|Metronidazole|metronidazole|mesh-list
92675087|NCT00324818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675088|NCT00324818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675089|NCT00324818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92675090|NCT00324818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92675091|NCT00324974|Lansoprazole|lansoprazole|mesh-list
92675092|NCT00324974|Dexlansoprazole|dexlansoprazole|mesh-list
92675093|NCT00324974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92675094|NCT00324974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675095|NCT00324974|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92675096|NCT00324974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675097|NCT00324974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675098|NCT00325169|Tiotropium Bromide|tiotropium bromide|mesh-list
92675099|NCT00325169|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92675100|NCT00325169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92675101|NCT00325169|Autonomic Agents|autonomic agents|mesh-ancestor
92400575|NCT01409694|Vitamin D|vitamin d|mesh-list
92675102|NCT00325169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675103|NCT00325169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675104|NCT00325169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92675105|NCT00325169|Respiratory System Agents|respiratory system agents|mesh-ancestor
92675106|NCT00325169|Parasympatholytics|parasympatholytics|mesh-ancestor
92604415|NCT01242046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604416|NCT01242046|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92604417|NCT01242046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604418|NCT01242046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604419|NCT01242046|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92604420|NCT01242046|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92604421|NCT01242046|Purinergic Agents|purinergic agents|mesh-ancestor
92604422|NCT01242046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604423|NCT01242202|Acarbose|acarbose|mesh-list
92604424|NCT01242202|Voglibose|voglibose|mesh-list
92604425|NCT01242202|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92604426|NCT01242202|Miglitol|miglitol|mesh-list
92604427|NCT01242202|Ipragliflozin|ipragliflozin|mesh-list
92604428|NCT01242202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604429|NCT01242202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604430|NCT01242202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604431|NCT01242202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604432|NCT01242202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92604433|NCT00119145|Artesunate|artesunate|mesh-list
92604434|NCT00119145|Amodiaquine|amodiaquine|mesh-list
92604435|NCT00119145|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92604436|NCT00119145|Antimalarials|antimalarials|mesh-ancestor
92604437|NCT00119145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604438|NCT00119145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92675107|NCT00325169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92675108|NCT00325169|Cholinergic Agents|cholinergic agents|mesh-ancestor
92675109|NCT00325169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675110|NCT00325169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675111|NCT00325169|Glucocorticoids|glucocorticoids|mesh-ancestor
92675112|NCT00325169|Hormones|hormones|mesh-ancestor
92675113|NCT00325169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675114|NCT00325169|Sympathomimetics|sympathomimetics|mesh-ancestor
92675115|NCT00426543|Rituximab|rituximab|mesh-list
92675116|NCT00426543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675117|NCT00426543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675118|NCT00426543|Immunologic Factors|immunologic factors|mesh-ancestor
92675122|NCT00325286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675123|NCT00325286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675124|NCT00325286|Antimanic Agents|antimanic agents|mesh-ancestor
92675125|NCT00325286|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92675126|NCT00325286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675127|NCT00325286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675128|NCT00325286|Anticonvulsants|anticonvulsants|mesh-ancestor
92675129|NCT00325286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675130|NCT00325286|Analgesics|analgesics|mesh-ancestor
92675131|NCT00325286|Sensory System Agents|sensory system agents|mesh-ancestor
92675132|NCT00325286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675133|NCT00325286|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92675134|NCT00325286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604439|NCT00119145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604440|NCT00119145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604442|NCT00119145|Schistosomicides|schistosomicides|mesh-ancestor
92604443|NCT00119145|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92604444|NCT00119145|Anthelmintics|anthelmintics|mesh-ancestor
92604445|NCT00119184|Anesthetics|anesthetics|mesh-list
92604446|NCT00119184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604447|NCT00119184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604448|NCT00487123|Valsartan|valsartan|mesh-list
92604449|NCT00487123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92604450|NCT00487123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92604451|NCT00487123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92604452|NCT00487123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92011922|NCT04843007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675135|NCT00325286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92675136|NCT00325286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92675137|NCT00325325|Everolimus|everolimus|mesh-list
92675138|NCT00325325|Tacrolimus|tacrolimus|mesh-list
92675139|NCT00325325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675140|NCT00325325|Immunologic Factors|immunologic factors|mesh-ancestor
92675141|NCT00325325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675142|NCT00325325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92675143|NCT00325325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675144|NCT00325325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675145|NCT00325325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92675146|NCT00325325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92675147|NCT00325325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675148|NCT00354081|Vitamins|vitamins|mesh-list
92675149|NCT00354081|Folic Acid|folic acid|mesh-list
92675150|NCT00354081|Hydroxocobalamin|hydroxocobalamin|mesh-list
92675151|NCT00354081|Vitamin B 12|vitamin b 12|mesh-list
92675152|NCT00354081|Pyridoxine|pyridoxine|mesh-list
92675153|NCT00354081|Pyridoxal|pyridoxal|mesh-list
92675154|NCT00354081|Vitamin B 6|vitamin b 6|mesh-list
92675155|NCT00354081|Vitamin B Complex|vitamin b complex|mesh-list
92675156|NCT00354081|Micronutrients|micronutrients|mesh-ancestor
92675157|NCT00354081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675158|NCT00354081|Hematinics|hematinics|mesh-ancestor
92675159|NCT00325637|Losartan|losartan|mesh-list
92675160|NCT00325637|Cilnidipine|cilnidipine|mesh-list
92675161|NCT00325637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92675162|NCT00325637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675163|NCT00325637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92675164|NCT00325637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92675165|NCT00325637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675166|NCT00325637|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92675167|NCT00325637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675168|NCT00325637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92675169|NCT00325637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675170|NCT04714593|Cyclophosphamide|cyclophosphamide|mesh-list
92675171|NCT04714593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675172|NCT04714593|Immunologic Factors|immunologic factors|mesh-ancestor
92675173|NCT04714593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675174|NCT04714593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400624|NCT01410201|Glucocorticoids|glucocorticoids|mesh-ancestor
92675175|NCT04714593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92675176|NCT04714593|Alkylating Agents|alkylating agents|mesh-ancestor
92675177|NCT04714593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675178|NCT04714593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675179|NCT04714593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92011936|NCT05072899|Immunologic Factors|immunologic factors|mesh-ancestor
92604453|NCT00487123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604454|NCT00487123|Diuretics|diuretics|mesh-ancestor
92604455|NCT00487123|Natriuretic Agents|natriuretic agents|mesh-ancestor
92604456|NCT00487123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604457|NCT00487123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92604458|NCT00487123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604459|NCT00487591|Simvastatin|simvastatin|mesh-list
92675180|NCT00426582|Epothilone B|epothilone b|mesh-list
92675181|NCT00426582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675182|NCT00426582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675183|NCT00426582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675184|NCT00426582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675185|NCT00426582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675186|NCT00354198|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92675187|NCT00354198|Pentoxifylline|pentoxifylline|mesh-list
92675188|NCT00354198|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92675189|NCT00354198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082712|NCT04199013|Anesthetics|anesthetics|mesh-ancestor
92675203|NCT00354198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92675204|NCT00354198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675206|NCT00325676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92675207|NCT00325676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675208|NCT00325676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92675209|NCT00325676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675210|NCT00325676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675211|NCT00325715|Esomeprazole|esomeprazole|mesh-list
92675212|NCT00325715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92675213|NCT00325715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675214|NCT00325715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92675215|NCT00325715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675216|NCT00325715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675217|NCT00354237|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92675218|NCT00354237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675219|NCT00325793|Nicardipine|nicardipine|mesh-list
92675220|NCT00325793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675221|NCT00325793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92675222|NCT00325793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675223|NCT00325793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675224|NCT00325793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92675225|NCT00325793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675226|NCT00325793|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675227|NCT00426621|Diclofenac|diclofenac|mesh-list
92675228|NCT00426621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92675229|NCT00426621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675230|NCT00426621|Analgesics|analgesics|mesh-ancestor
92675231|NCT00426621|Sensory System Agents|sensory system agents|mesh-ancestor
92675232|NCT00426621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675233|NCT00426621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675234|NCT00426621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675235|NCT00426621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675236|NCT00426621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92675237|NCT00426621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675238|NCT00426621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675239|NCT04714242|Ranibizumab|ranibizumab|mesh-list
92675240|NCT04714242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92675241|NCT04714242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92675242|NCT04714242|Growth Substances|growth substances|mesh-ancestor
92675243|NCT04714242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675244|NCT04714242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92675245|NCT04714242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675246|NCT00354276|Cytarabine|cytarabine|mesh-list
92675247|NCT00354276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92082790|NCT03591471|Hormones|hormones|mesh-ancestor
92675250|NCT00354276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604460|NCT00487591|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92604461|NCT00487591|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92604462|NCT00487591|Antimetabolites|antimetabolites|mesh-ancestor
92604463|NCT00487591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604464|NCT00487591|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92604465|NCT00487591|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92604466|NCT00487591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604467|NCT00487786|Docetaxel|docetaxel|mesh-list
92604468|NCT00487786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604469|NCT00487786|Tubulin Modulators|tubulin modulators|mesh-ancestor
92604470|NCT00487786|Antimitotic Agents|antimitotic agents|mesh-ancestor
92604471|NCT00487786|Mitosis Modulators|mitosis modulators|mesh-ancestor
92604472|NCT00487786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604473|NCT00488137|Prucalopride|prucalopride|mesh-list
92604474|NCT00488137|Laxatives|laxatives|mesh-ancestor
92604475|NCT00488137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92604476|NCT00488137|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92675252|NCT00354276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675253|NCT00354276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675254|NCT00354276|Immunologic Factors|immunologic factors|mesh-ancestor
92675255|NCT00354276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675257|NCT00325910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92675258|NCT00325910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675259|NCT00325949|Acetaminophen|acetaminophen|mesh-list
92675260|NCT00325949|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92675261|NCT00325949|Hydrocodone|hydrocodone|mesh-list
92675262|NCT00325949|Oxycodone|oxycodone|mesh-list
92675263|NCT00325949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675264|NCT00325949|Analgesics|analgesics|mesh-ancestor
92675265|NCT00325949|Sensory System Agents|sensory system agents|mesh-ancestor
92675266|NCT00325949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675267|NCT00325949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675268|NCT00325949|Antipyretics|antipyretics|mesh-ancestor
92675269|NCT00325949|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92675270|NCT00325949|Narcotics|narcotics|mesh-ancestor
92675271|NCT00325949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675272|NCT00325949|Antitussive Agents|antitussive agents|mesh-ancestor
92675273|NCT00325949|Respiratory System Agents|respiratory system agents|mesh-ancestor
92675274|NCT00325949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92675275|NCT00325949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675276|NCT00325949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675277|NCT00326027|Pantoprazole|pantoprazole|mesh-list
92675278|NCT00326027|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92675279|NCT00326027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675280|NCT00326027|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92675281|NCT00326027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675282|NCT00326027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675283|NCT01059318|Everolimus|everolimus|mesh-list
92675284|NCT01059318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92675285|NCT01059318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92675286|NCT01059318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675287|NCT01059318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675288|NCT01059318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675289|NCT01059318|Immunologic Factors|immunologic factors|mesh-ancestor
92675290|NCT01059318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675291|NCT01059318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675292|NCT04714515|Hydroxychloroquine|hydroxychloroquine|mesh-list
92366104|NCT00676806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604477|NCT00488137|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92604478|NCT00488137|Serotonin Agents|serotonin agents|mesh-ancestor
92604479|NCT00488137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604480|NCT00488137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604481|NCT00488137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604482|NCT00488176|Cetirizine|cetirizine|mesh-list
92604483|NCT00488176|Montelukast|montelukast|mesh-list
92604484|NCT00488176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92604485|NCT00488176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604486|NCT00488176|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92604487|NCT00488176|Hormone Antagonists|hormone antagonists|mesh-ancestor
92604488|NCT00488176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604489|NCT00488176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604490|NCT00488176|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92604491|NCT00488176|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92604492|NCT00488176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011963|NCT04842383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675293|NCT04714515|Ivermectin|ivermectin|mesh-list
92675294|NCT04714515|Montelukast|montelukast|mesh-list
92675295|NCT04714515|Antimalarials|antimalarials|mesh-ancestor
92675296|NCT04714515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92675297|NCT04714515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92675298|NCT04714515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675299|NCT04714515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675300|NCT04714515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675301|NCT04714515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675302|NCT04714515|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92675303|NCT04714515|Respiratory System Agents|respiratory system agents|mesh-ancestor
92675304|NCT04714515|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92675305|NCT04714515|Hormone Antagonists|hormone antagonists|mesh-ancestor
92675306|NCT04714515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675307|NCT04714515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675308|NCT04714515|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92675309|NCT04714515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92675310|NCT00326105|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92675311|NCT00326105|Antidepressive Agents|antidepressive agents|mesh-ancestor
92675312|NCT00326105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675313|NCT00326105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92675314|NCT00326105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92675315|NCT00326105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675316|NCT00326105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675317|NCT00354354|Ipratropium|ipratropium|mesh-list
92675318|NCT00354354|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92675319|NCT00354354|Autonomic Agents|autonomic agents|mesh-ancestor
92675320|NCT00354354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675323|NCT00354354|Respiratory System Agents|respiratory system agents|mesh-ancestor
92675324|NCT00354354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675325|NCT00354354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675326|NCT00354354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92675327|NCT00354354|Cholinergic Agents|cholinergic agents|mesh-ancestor
92675328|NCT00326144|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92675329|NCT00326144|Antidepressive Agents|antidepressive agents|mesh-ancestor
92675330|NCT00326144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675331|NCT00326144|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92604493|NCT00488176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92604494|NCT00488176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92604495|NCT00488176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92604496|NCT00488176|Histamine Antagonists|histamine antagonists|mesh-ancestor
92604497|NCT00488176|Histamine Agents|histamine agents|mesh-ancestor
92604498|NCT00488176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604499|NCT00488215|Prucalopride|prucalopride|mesh-list
92604500|NCT00488215|Laxatives|laxatives|mesh-ancestor
92604501|NCT00488215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92604502|NCT00488215|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92604503|NCT00488215|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92604504|NCT00488215|Serotonin Agents|serotonin agents|mesh-ancestor
92604505|NCT00488215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604506|NCT00488215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604507|NCT00488215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675332|NCT00326144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92675333|NCT00326144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675334|NCT00326144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675335|NCT01058655|Everolimus|everolimus|mesh-list
92675336|NCT01058655|Tivozanib|tivozanib|mesh-list
92675337|NCT01058655|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92675338|NCT01058655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92675339|NCT01058655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675340|NCT01058655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675341|NCT01058655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675342|NCT01058655|Immunologic Factors|immunologic factors|mesh-ancestor
92675343|NCT01058655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675344|NCT01058655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675345|NCT00326300|Methylphenidate|methylphenidate|mesh-list
92675346|NCT00326300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92675347|NCT00326300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675348|NCT00326300|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92675349|NCT00326300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92675350|NCT00326300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675351|NCT00326300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675352|NCT00326300|Dopamine Agents|dopamine agents|mesh-ancestor
92675353|NCT00326300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675354|NCT00426777|Risedronic Acid|risedronic acid|mesh-list
92675355|NCT00426777|Etidronic Acid|etidronic acid|mesh-list
92675356|NCT00426777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92675357|NCT00426777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675358|NCT00426777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675359|NCT00426777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92675360|NCT00426777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675361|NCT00426777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92675362|NCT00419549|Valdecoxib|valdecoxib|mesh-list
92675363|NCT00419549|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92675364|NCT00419549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92675365|NCT00419549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675366|NCT00419549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675367|NCT00419549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92675368|NCT00419549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675369|NCT00419549|Analgesics|analgesics|mesh-ancestor
92675370|NCT00419549|Sensory System Agents|sensory system agents|mesh-ancestor
92675371|NCT00419549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675372|NCT00419549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604508|NCT00121628|Motesanib diphosphate|motesanib diphosphate|mesh-list
92604509|NCT00121628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92604510|NCT00121628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604511|NCT00121628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604512|NCT00488371|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92604513|NCT00488371|Immunologic Factors|immunologic factors|mesh-ancestor
92604514|NCT00488371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675373|NCT00419549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675374|NCT00419549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675375|NCT00326378|Docetaxel|docetaxel|mesh-list
92675376|NCT00326378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675377|NCT00326378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675378|NCT00326378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675379|NCT00326378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675380|NCT00326378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675381|NCT00326768|Telmisartan|telmisartan|mesh-list
92675382|NCT00326768|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92675383|NCT00326768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675384|NCT00326768|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92675385|NCT00326768|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92675386|NCT00326768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675387|NCT00326768|Diuretics|diuretics|mesh-ancestor
92675388|NCT00326768|Natriuretic Agents|natriuretic agents|mesh-ancestor
92675389|NCT00326768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675390|NCT00326768|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92675406|NCT00354549|Growth Substances|growth substances|mesh-ancestor
92675407|NCT00354549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675408|NCT00354549|Growth Inhibitors|growth inhibitors|mesh-ancestor
92675409|NCT00354549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92675410|NCT00354549|Antimetabolites|antimetabolites|mesh-ancestor
92675411|NCT00354549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675412|NCT00354549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92675413|NCT00354549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675414|NCT01057251|Nebivolol|nebivolol|mesh-list
92675415|NCT01057251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675416|NCT01057251|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675417|NCT01057251|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92675418|NCT01057251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92675419|NCT01057251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92675420|NCT01057251|Adrenergic Agents|adrenergic agents|mesh-ancestor
92675421|NCT01057251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675422|NCT01057251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675423|NCT01057251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675424|NCT04708353|Pregabalin|pregabalin|mesh-list
92675425|NCT04708353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675426|NCT04708353|Analgesics|analgesics|mesh-ancestor
92675427|NCT04708353|Sensory System Agents|sensory system agents|mesh-ancestor
92675428|NCT04708353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675429|NCT04708353|Anticonvulsants|anticonvulsants|mesh-ancestor
92675430|NCT04708353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92675431|NCT04708353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675432|NCT04708353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675433|NCT04708353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92675434|NCT04708353|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92675435|NCT04708353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92675436|NCT04708353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675437|NCT04708353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675438|NCT00425646|Bevacizumab|bevacizumab|mesh-list
92675439|NCT00425646|Imatinib Mesylate|imatinib mesylate|mesh-list
92675440|NCT00425646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675441|NCT00425646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675442|NCT00425646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92675443|NCT00425646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92675444|NCT00425646|Growth Substances|growth substances|mesh-ancestor
92675445|NCT00425646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604516|NCT00488527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604517|NCT00488527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604518|NCT00488566|Lamotrigine|lamotrigine|mesh-list
92604519|NCT00488566|Anticonvulsants|anticonvulsants|mesh-ancestor
92329492|NCT00003602|Cytarabine|cytarabine|mesh-list
92604520|NCT00488566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92604521|NCT00488566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604522|NCT00488566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604523|NCT00488566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92604524|NCT00488566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604526|NCT00488566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92604527|NCT00488566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604528|NCT00488566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92604529|NCT00488566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92604530|NCT00488605|Leucovorin|leucovorin|mesh-list
92604531|NCT00488605|Prednisone|prednisone|mesh-list
92604532|NCT00488605|Methotrexate|methotrexate|mesh-list
92604533|NCT00488605|Vinblastine|vinblastine|mesh-list
92604534|NCT00488605|Levoleucovorin|levoleucovorin|mesh-list
92675446|NCT00425646|Growth Inhibitors|growth inhibitors|mesh-ancestor
92675447|NCT00425646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92675448|NCT00425646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675449|NCT00425646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675458|NCT00327119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675459|NCT00327119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675460|NCT00426933|Vancomycin|vancomycin|mesh-list
92675461|NCT00426933|Daptomycin|daptomycin|mesh-list
92675462|NCT00426933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675463|NCT00426933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675464|NCT00327197|Prednisolone|prednisolone|mesh-list
92675465|NCT00327197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675466|NCT00327197|Glucocorticoids|glucocorticoids|mesh-ancestor
92675467|NCT00327197|Hormones|hormones|mesh-ancestor
92675468|NCT00327197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675469|NCT00327197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400925|NCT01412632|Narcotics|narcotics|mesh-ancestor
92675471|NCT00327197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675472|NCT00425724|Cyclosporine|cyclosporine|mesh-list
92675473|NCT00425724|Prednisone|prednisone|mesh-list
92675474|NCT00425724|Methylprednisolone|methylprednisolone|mesh-list
92675475|NCT00425724|Cyclosporins|cyclosporins|mesh-list
92675476|NCT00425724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675477|NCT00425724|Glucocorticoids|glucocorticoids|mesh-ancestor
92675478|NCT00425724|Hormones|hormones|mesh-ancestor
92675479|NCT00425724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675480|NCT00425724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675481|NCT00425724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92675482|NCT00425724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675483|NCT00425724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675484|NCT00425724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675485|NCT00425724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675486|NCT00425724|Immunologic Factors|immunologic factors|mesh-ancestor
92675487|NCT00425724|Antifungal Agents|antifungal agents|mesh-ancestor
92675488|NCT00425724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675489|NCT00425724|Dermatologic Agents|dermatologic agents|mesh-ancestor
92675490|NCT00425724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604535|NCT00488605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604536|NCT00488605|Glucocorticoids|glucocorticoids|mesh-ancestor
92604537|NCT00488605|Hormones|hormones|mesh-ancestor
92604538|NCT00488605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604539|NCT00488605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604540|NCT00488605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92604541|NCT00488605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604542|NCT00488605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92604543|NCT00488605|Abortifacient Agents|abortifacient agents|mesh-ancestor
92604544|NCT00488605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92675491|NCT00425724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92675492|NCT00425724|Antiemetics|antiemetics|mesh-ancestor
92675493|NCT00425724|Autonomic Agents|autonomic agents|mesh-ancestor
92675494|NCT00425724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675495|NCT00425724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675496|NCT00425724|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92675497|NCT00425724|Protective Agents|protective agents|mesh-ancestor
92675498|NCT00426972|Estradiol|estradiol|mesh-list
92675499|NCT00426972|Estrogens|estrogens|mesh-ancestor
92675500|NCT00426972|Hormones|hormones|mesh-ancestor
92675501|NCT00426972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675502|NCT00426972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675503|NCT00327353|Formoterol Fumarate|formoterol fumarate|mesh-list
92675504|NCT00327353|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92675505|NCT00327353|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92675506|NCT00327353|Autonomic Agents|autonomic agents|mesh-ancestor
92675507|NCT00327353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675508|NCT00327353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675509|NCT00327353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92675510|NCT00327353|Respiratory System Agents|respiratory system agents|mesh-ancestor
92675511|NCT00327353|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92675512|NCT00327353|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92675513|NCT00327353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92675514|NCT00327353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92675515|NCT00327353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675516|NCT00327353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675517|NCT00425841|Gemcitabine|gemcitabine|mesh-list
92366358|NCT00717054|Scopolamine|scopolamine|mesh-list
92675521|NCT00425841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675522|NCT00425841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675523|NCT00427089|Ascorbic Acid|ascorbic acid|mesh-list
92675524|NCT00427089|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92675525|NCT00427089|Antioxidants|antioxidants|mesh-ancestor
92675526|NCT00427089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675527|NCT00427089|Protective Agents|protective agents|mesh-ancestor
92675528|NCT00427089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675529|NCT00427089|Vitamins|vitamins|mesh-ancestor
92675530|NCT00427089|Micronutrients|micronutrients|mesh-ancestor
92675531|NCT00427089|Laxatives|laxatives|mesh-ancestor
92675532|NCT00427089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675533|NCT00427128|Fluoxetine|fluoxetine|mesh-list
92675534|NCT00427128|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92675535|NCT00427128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92675536|NCT00427128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675537|NCT00427128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675538|NCT00427128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675539|NCT00427128|Serotonin Agents|serotonin agents|mesh-ancestor
92675540|NCT00427128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675541|NCT00427128|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92675542|NCT00427128|Antidepressive Agents|antidepressive agents|mesh-ancestor
92675543|NCT00427128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675544|NCT00427128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92675545|NCT00427128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92012032|NCT04622917|Glucocorticoids|glucocorticoids|mesh-ancestor
92604545|NCT00488605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604546|NCT00488605|Antimetabolites|antimetabolites|mesh-ancestor
92604547|NCT00488605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604548|NCT00488605|Dermatologic Agents|dermatologic agents|mesh-ancestor
92604549|NCT00488605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604550|NCT00488605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92604551|NCT00488605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604552|NCT00488605|Immunologic Factors|immunologic factors|mesh-ancestor
92604553|NCT00488605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604554|NCT00488605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92604556|NCT00488605|Protective Agents|protective agents|mesh-ancestor
92604557|NCT00488605|Vitamin B Complex|vitamin b complex|mesh-ancestor
92675546|NCT00427128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675547|NCT00427167|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92675548|NCT00427167|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92675549|NCT00427167|Immunologic Factors|immunologic factors|mesh-ancestor
92675550|NCT00427167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675551|NCT00427167|Antacids|antacids|mesh-ancestor
92675552|NCT00427167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675553|NCT00427167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675554|NCT00427206|Acetaminophen|acetaminophen|mesh-list
92675555|NCT00427206|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675556|NCT00427206|Analgesics|analgesics|mesh-ancestor
92675557|NCT00427206|Sensory System Agents|sensory system agents|mesh-ancestor
92675558|NCT00427206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675559|NCT00427206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675560|NCT00427206|Antipyretics|antipyretics|mesh-ancestor
92675561|NCT00425997|Amlodipine|amlodipine|mesh-list
92675562|NCT00425997|Valsartan|valsartan|mesh-list
92675563|NCT00425997|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92675564|NCT00425997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675565|NCT00425997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92675566|NCT00425997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675567|NCT00425997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675568|NCT00425997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92675569|NCT00425997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675570|NCT00425997|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675571|NCT00425997|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92675572|NCT00425997|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92675573|NCT00425997|Diuretics|diuretics|mesh-ancestor
92675574|NCT00425997|Natriuretic Agents|natriuretic agents|mesh-ancestor
92675575|NCT00425997|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92675576|NCT00427245|Cyclophosphamide|cyclophosphamide|mesh-list
92675577|NCT00427245|Goserelin|goserelin|mesh-list
92675578|NCT00427245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675579|NCT00427245|Immunologic Factors|immunologic factors|mesh-ancestor
92675580|NCT00427245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675581|NCT00427245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675582|NCT00427245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92675583|NCT00427245|Alkylating Agents|alkylating agents|mesh-ancestor
92675584|NCT00427245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675585|NCT00427245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675586|NCT00427245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92675587|NCT00427245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92675588|NCT05458076|Ritonavir|ritonavir|mesh-list
92675592|NCT05458076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675593|NCT05458076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675594|NCT05458076|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92604558|NCT00488605|Vitamins|vitamins|mesh-ancestor
92604559|NCT00488605|Micronutrients|micronutrients|mesh-ancestor
92604560|NCT00488605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92604561|NCT00488605|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675595|NCT05458076|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92675596|NCT05458076|Antiviral Agents|antiviral agents|mesh-ancestor
92675597|NCT05458076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675598|NCT05458076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92675599|NCT05458076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92675600|NCT00427362|Adalimumab|adalimumab|mesh-list
92675601|NCT00427362|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92675602|NCT00427362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675603|NCT00427362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675604|NCT00426192|Mannitol|mannitol|mesh-list
92675605|NCT00426192|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92675606|NCT00426192|Diuretics|diuretics|mesh-ancestor
92675607|NCT00426192|Natriuretic Agents|natriuretic agents|mesh-ancestor
92675608|NCT00426192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675609|NCT05457530|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92675610|NCT05457530|Antiviral Agents|antiviral agents|mesh-ancestor
92675611|NCT05457530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675612|NCT05457530|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92675613|NCT05457530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92675614|NCT05457530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675615|NCT05457530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675616|NCT05457530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92675617|NCT05457530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92675619|NCT00432393|Carbidopa|carbidopa|mesh-list
92675620|NCT00432393|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92675621|NCT00432393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92675622|NCT00432393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92675623|NCT00432393|Dopamine Agents|dopamine agents|mesh-ancestor
92366486|NCT00731874|Tacrolimus|tacrolimus|mesh-list
92675624|NCT00432393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675625|NCT00432393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675626|NCT00432393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675627|NCT00432393|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92675628|NCT00432393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675629|NCT00432393|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92675630|NCT00432393|Immunologic Factors|immunologic factors|mesh-ancestor
92675631|NCT00432393|Dopamine Agonists|dopamine agonists|mesh-ancestor
92675632|NCT05453045|Albendazole|albendazole|mesh-list
92675633|NCT05453045|Anthelmintics|anthelmintics|mesh-ancestor
92675634|NCT05453045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92675635|NCT05453045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675636|NCT05453045|Anticestodal Agents|anticestodal agents|mesh-ancestor
92675637|NCT05453045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92675638|NCT05453045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92675639|NCT05453045|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675640|NCT05453045|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675641|NCT05453045|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675642|NCT05453045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675643|NCT05453045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675644|NCT00432432|Infliximab|infliximab|mesh-list
92675645|NCT00432432|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92675646|NCT00432432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675647|NCT00432432|Dermatologic Agents|dermatologic agents|mesh-ancestor
92675648|NCT00432432|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675649|NCT00432432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675650|NCT02957448|Rifampin|rifampin|mesh-list
92675651|NCT02957448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92675652|NCT02957448|Antitubercular Agents|antitubercular agents|mesh-ancestor
92675653|NCT02957448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675654|NCT02957448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675655|NCT02957448|Leprostatic Agents|leprostatic agents|mesh-ancestor
92675656|NCT02957448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92675657|NCT02957448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675658|NCT02957448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675659|NCT02957448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92675660|NCT02957448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92675675|NCT00432510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92675676|NCT00432510|Immunologic Factors|immunologic factors|mesh-ancestor
92604562|NCT00488605|Antimitotic Agents|antimitotic agents|mesh-ancestor
92604563|NCT00488605|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675677|NCT00432510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675678|NCT00432510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92675679|NCT00432510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675680|NCT05354258|Pyrimethamine|pyrimethamine|mesh-list
92675681|NCT05354258|Sulfadoxine|sulfadoxine|mesh-list
92675682|NCT05354258|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92675683|NCT05354258|Amodiaquine|amodiaquine|mesh-list
92675684|NCT05354258|Albendazole|albendazole|mesh-list
92675685|NCT05354258|Praziquantel|praziquantel|mesh-list
92675686|NCT05354258|Antimalarials|antimalarials|mesh-ancestor
92675687|NCT05354258|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92675688|NCT05354258|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92675689|NCT05354258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675690|NCT05354258|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92675691|NCT05354258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675692|NCT05354258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675693|NCT05354258|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92675695|NCT05354258|Anticestodal Agents|anticestodal agents|mesh-ancestor
92675696|NCT05354258|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92675697|NCT05354258|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675698|NCT05354258|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675699|NCT05354258|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675700|NCT05354258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675701|NCT05338580|Pembrolizumab|pembrolizumab|mesh-list
92675702|NCT05338580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675703|NCT05338580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675704|NCT05338580|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92675705|NCT05338580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675706|NCT02273466|Desipramine|desipramine|mesh-list
92675707|NCT02273466|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92675708|NCT02273466|Antidepressive Agents|antidepressive agents|mesh-ancestor
92675709|NCT02273466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92675710|NCT02273466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675711|NCT02273466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675712|NCT02273466|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92675713|NCT02273466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92675714|NCT02273466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675715|NCT02273466|Adrenergic Agents|adrenergic agents|mesh-ancestor
92675716|NCT02273466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675717|NCT02273466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675718|NCT00427713|Capecitabine|capecitabine|mesh-list
92675719|NCT00427713|Oxaliplatin|oxaliplatin|mesh-list
92675722|NCT00427713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675724|NCT02273505|Aspirin|aspirin|mesh-list
92675725|NCT02273505|Salicylic Acid|salicylic acid|mesh-list
92675726|NCT02273505|Salicylates|salicylates|mesh-list
92675727|NCT02273505|Dipyridamole|dipyridamole|mesh-list
92675728|NCT02273505|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92675729|NCT02273505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675730|NCT02273505|Antifungal Agents|antifungal agents|mesh-ancestor
92675731|NCT02273505|Keratolytic Agents|keratolytic agents|mesh-ancestor
92675732|NCT02273505|Dermatologic Agents|dermatologic agents|mesh-ancestor
92675733|NCT02273505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92675734|NCT02273505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675735|NCT02273505|Analgesics|analgesics|mesh-ancestor
92675736|NCT02273505|Sensory System Agents|sensory system agents|mesh-ancestor
92675737|NCT02273505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675738|NCT02273505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675739|NCT02273505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675740|NCT02273505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675741|NCT02273505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92675742|NCT02273505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675743|NCT02273505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675744|NCT02273505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92675745|NCT02273505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92675746|NCT02273505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92675747|NCT02273505|Antipyretics|antipyretics|mesh-ancestor
92675748|NCT02273505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92675749|NCT02273505|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675750|NCT05210621|Ocrelizumab|ocrelizumab|mesh-list
92675751|NCT05210621|Immunologic Factors|immunologic factors|mesh-ancestor
92604564|NCT00488722|Goserelin|goserelin|mesh-list
92604565|NCT00488722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92604566|NCT00488722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604567|NCT00488761|Tigecycline|tigecycline|mesh-list
92604568|NCT00488761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92604569|NCT00488761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604570|NCT00488761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92604571|NCT00488761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604572|NCT00488761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604573|NCT00121784|Mycophenolic Acid|mycophenolic acid|mesh-list
92604574|NCT00121784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92604575|NCT00121784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604576|NCT00121784|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92604577|NCT00121784|Antitubercular Agents|antitubercular agents|mesh-ancestor
92604578|NCT00121784|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92604579|NCT00121784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604580|NCT00121784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604581|NCT00121784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604582|NCT00145236|Nebivolol|nebivolol|mesh-list
92604583|NCT00145236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675752|NCT05210621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675753|NCT05198960|Aspirin|aspirin|mesh-list
92675754|NCT05198960|Anticoagulants|anticoagulants|mesh-list
92675755|NCT05198960|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92675756|NCT05198960|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675757|NCT05198960|Analgesics|analgesics|mesh-ancestor
92675758|NCT05198960|Sensory System Agents|sensory system agents|mesh-ancestor
92675759|NCT05198960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675760|NCT05198960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675761|NCT05198960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675762|NCT05198960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675763|NCT05198960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92675764|NCT05198960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92401236|NCT01415505|Valsartan|valsartan|mesh-list
92675765|NCT05198960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675766|NCT05198960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92366630|NCT00743730|Morphine|morphine|mesh-list
92675767|NCT05198960|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92675769|NCT05198960|Antipyretics|antipyretics|mesh-ancestor
92675770|NCT00432549|Topiramate|topiramate|mesh-list
92675771|NCT00432549|Almotriptan|almotriptan|mesh-list
92675772|NCT00432549|Anticonvulsants|anticonvulsants|mesh-ancestor
92675773|NCT00432549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92675774|NCT00432549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675775|NCT00432549|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92675776|NCT00432549|Serotonin Agents|serotonin agents|mesh-ancestor
92675777|NCT00432549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675778|NCT00432549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675779|NCT00427947|Ropivacaine|ropivacaine|mesh-list
92675780|NCT00427947|Anesthetics, Local|anesthetics, local|mesh-ancestor
92675781|NCT00427947|Anesthetics|anesthetics|mesh-ancestor
92675782|NCT00427947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675783|NCT00427947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675784|NCT00427947|Sensory System Agents|sensory system agents|mesh-ancestor
92675785|NCT00427947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675786|NCT00432588|Misoprostol|misoprostol|mesh-list
92675787|NCT00432588|Dinoprostone|dinoprostone|mesh-list
92604584|NCT00145236|Vasodilator Agents|vasodilator agents|mesh-ancestor
92604585|NCT00145236|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92604586|NCT00145236|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92604587|NCT00145236|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92604588|NCT00145236|Adrenergic Agents|adrenergic agents|mesh-ancestor
92604589|NCT00145236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604590|NCT00145236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604591|NCT00145236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604592|NCT01242592|Antitubercular Agents|antitubercular agents|mesh-list
92012071|NCT03042377|Calcium|calcium|mesh-list
92675788|NCT00432588|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92675789|NCT00432588|Abortifacient Agents|abortifacient agents|mesh-ancestor
92675790|NCT00432588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92675791|NCT00432588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675792|NCT00432588|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92675796|NCT00428025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92675797|NCT00428025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675798|NCT00428025|Analgesics|analgesics|mesh-ancestor
92675799|NCT00428025|Sensory System Agents|sensory system agents|mesh-ancestor
92675800|NCT00428025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675801|NCT00428025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675802|NCT00428025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675803|NCT00428025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675804|NCT00428025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92675805|NCT00428025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675806|NCT00428025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675807|NCT00428064|Cyclosporine|cyclosporine|mesh-list
92675808|NCT00428064|Sirolimus|sirolimus|mesh-list
92675809|NCT00428064|Cyclosporins|cyclosporins|mesh-list
92675810|NCT00428064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675811|NCT00428064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675812|NCT00428064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675813|NCT00428064|Immunologic Factors|immunologic factors|mesh-ancestor
92675814|NCT00428064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675815|NCT00428064|Antifungal Agents|antifungal agents|mesh-ancestor
92675816|NCT00428064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675817|NCT00428064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92675818|NCT00428064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675819|NCT00428064|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92675820|NCT00428064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675821|NCT00428064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92675822|NCT00428064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675823|NCT00432627|Deferasirox|deferasirox|mesh-list
92675824|NCT00432627|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92675825|NCT00432627|Chelating Agents|chelating agents|mesh-ancestor
92675826|NCT00432627|Sequestering Agents|sequestering agents|mesh-ancestor
92675827|NCT00432627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675828|NCT00419783|Moxifloxacin|moxifloxacin|mesh-list
92675829|NCT00419783|Ketoconazole|ketoconazole|mesh-list
92675830|NCT00419783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675831|NCT00419783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675832|NCT00419783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92675833|NCT00419783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92675834|NCT00419783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675835|NCT00419783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675836|NCT00419783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401302|NCT01415765|Vincristine|vincristine|mesh-list
92675837|NCT00419783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675838|NCT00419783|Antifungal Agents|antifungal agents|mesh-ancestor
92675840|NCT00419783|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92675841|NCT00419783|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92675842|NCT00419783|Hormone Antagonists|hormone antagonists|mesh-ancestor
92675843|NCT00419783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604593|NCT01242592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92604594|NCT01242592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604595|NCT00488800|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92604596|NCT00488800|Immunologic Factors|immunologic factors|mesh-ancestor
92604597|NCT00488800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604598|NCT00145275|Zoledronic Acid|zoledronic acid|mesh-list
92604599|NCT00145275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92604600|NCT00145275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604601|NCT00488995|Tremelimumab|tremelimumab|mesh-list
92604602|NCT00488995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604603|NCT04911816|Hydroxychloroquine|hydroxychloroquine|mesh-list
92604604|NCT04911816|Antimalarials|antimalarials|mesh-ancestor
92604605|NCT04911816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604606|NCT04911816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92604607|NCT04911816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604608|NCT04911816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012079|NCT04859777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675844|NCT00419783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92675845|NCT00428142|Prednisone|prednisone|mesh-list
92675846|NCT00428142|Cyclophosphamide|cyclophosphamide|mesh-list
92675847|NCT00428142|Rituximab|rituximab|mesh-list
92675848|NCT00428142|Vincristine|vincristine|mesh-list
92675849|NCT00428142|Bortezomib|bortezomib|mesh-list
92675850|NCT00428142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675851|NCT00428142|Immunologic Factors|immunologic factors|mesh-ancestor
92675852|NCT00428142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675853|NCT00428142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675854|NCT00428142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92675855|NCT00428142|Alkylating Agents|alkylating agents|mesh-ancestor
92675856|NCT00428142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675857|NCT00428142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675858|NCT00428142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92675859|NCT00428142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675860|NCT00428142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675861|NCT00428142|Glucocorticoids|glucocorticoids|mesh-ancestor
92675862|NCT00428142|Hormones|hormones|mesh-ancestor
92675863|NCT00428142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675864|NCT00428142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92675867|NCT00428142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675868|NCT00428142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675870|NCT00428181|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92675871|NCT00428181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675872|NCT00428181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675873|NCT00428181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675874|NCT00432861|Pancrelipase|pancrelipase|mesh-list
92675875|NCT00432861|Pancreatin|pancreatin|mesh-list
92675876|NCT00432861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675877|NCT04575233|Ropivacaine|ropivacaine|mesh-list
92675878|NCT04575233|Anesthetics, Local|anesthetics, local|mesh-ancestor
92675879|NCT04575233|Anesthetics|anesthetics|mesh-ancestor
92675880|NCT04575233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92675881|NCT04575233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675882|NCT04575233|Sensory System Agents|sensory system agents|mesh-ancestor
92675883|NCT04575233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675884|NCT04507412|Dexamethasone|dexamethasone|mesh-list
92675885|NCT04507412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675886|NCT04507412|Antiemetics|antiemetics|mesh-ancestor
92675887|NCT04507412|Autonomic Agents|autonomic agents|mesh-ancestor
92675888|NCT04507412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604609|NCT04911816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604610|NCT04911816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604611|NCT00489073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92033371|NCT04881799|Anticonvulsants|anticonvulsants|mesh-ancestor
92675889|NCT04507412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675890|NCT04507412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675891|NCT04507412|Glucocorticoids|glucocorticoids|mesh-ancestor
92675892|NCT04507412|Hormones|hormones|mesh-ancestor
92675893|NCT04507412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675894|NCT04507412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92675895|NCT04507412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675896|NCT00428454|Sirolimus|sirolimus|mesh-list
92675897|NCT00428454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92675898|NCT00428454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92675899|NCT00428454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92675900|NCT00428454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675901|NCT00428454|Antifungal Agents|antifungal agents|mesh-ancestor
92675902|NCT00428454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675903|NCT00428454|Immunologic Factors|immunologic factors|mesh-ancestor
92675904|NCT00428454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675905|NCT00432978|Bosentan|bosentan|mesh-list
92675906|NCT00432978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675907|NCT00432978|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92675908|NCT00432978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675909|NCT01051791|Everolimus|everolimus|mesh-list
92675910|NCT01051791|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92675911|NCT01051791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92675912|NCT01051791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675913|NCT01051791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675914|NCT01051791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92675915|NCT01051791|Immunologic Factors|immunologic factors|mesh-ancestor
92675916|NCT01051791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675917|NCT01051791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675918|NCT01056510|Rituximab|rituximab|mesh-list
92675919|NCT01056510|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92675920|NCT01056510|Chlorambucil|chlorambucil|mesh-list
92675921|NCT01056510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675922|NCT01056510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675923|NCT01056510|Immunologic Factors|immunologic factors|mesh-ancestor
92675924|NCT01056510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675925|NCT01056510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675926|NCT01056510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92675927|NCT01056510|Alkylating Agents|alkylating agents|mesh-ancestor
92675928|NCT01056510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675929|NCT01056276|Dexamethasone|dexamethasone|mesh-list
92675930|NCT01056276|Bortezomib|bortezomib|mesh-list
92675931|NCT01056276|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92675932|NCT01056276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675933|NCT01056276|Antiemetics|antiemetics|mesh-ancestor
92675934|NCT01056276|Autonomic Agents|autonomic agents|mesh-ancestor
92675935|NCT01056276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675936|NCT01056276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675937|NCT01056276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675942|NCT01056276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675943|NCT01056276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92675944|NCT01056276|Alkylating Agents|alkylating agents|mesh-ancestor
92675945|NCT01056276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675946|NCT01055886|Nicotine|nicotine|mesh-list
92675947|NCT01055886|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92675948|NCT01055886|Autonomic Agents|autonomic agents|mesh-ancestor
92675949|NCT01055886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675950|NCT01055886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675951|NCT01055886|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92675952|NCT01055886|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92675953|NCT01055886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92675954|NCT01055886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675955|NCT01055886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675956|NCT00433095|Trastuzumab|trastuzumab|mesh-list
92675957|NCT00433095|Vinorelbine|vinorelbine|mesh-list
92675958|NCT00433095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033453|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92033454|NCT05124899|Protective Agents|protective agents|mesh-ancestor
92675959|NCT00433095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675960|NCT00433095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92675961|NCT00433095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675962|NCT00433095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675963|NCT00433095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675964|NCT00433095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675965|NCT01055613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92675966|NCT01055457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92675968|NCT00428649|Antioxidants|antioxidants|mesh-ancestor
92675969|NCT00428649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675970|NCT00428649|Protective Agents|protective agents|mesh-ancestor
92675971|NCT00428649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675972|NCT00428649|Trace Elements|trace elements|mesh-ancestor
92675973|NCT00428649|Micronutrients|micronutrients|mesh-ancestor
92675974|NCT03852992|Minoxidil|minoxidil|mesh-list
92675975|NCT03852992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92675976|NCT03852992|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675977|NCT00433173|Anastrozole|anastrozole|mesh-list
92675978|NCT00433173|Goserelin|goserelin|mesh-list
92675979|NCT00433173|Testosterone|testosterone|mesh-list
92675980|NCT00433173|Androgens|androgens|mesh-ancestor
92675981|NCT00433173|Hormones|hormones|mesh-ancestor
92675982|NCT00433173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675983|NCT00433173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675984|NCT00433173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92675985|NCT00433173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675986|NCT00433173|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92675987|NCT00433173|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92675988|NCT00433173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92675989|NCT00433173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675990|NCT00433173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92675991|NCT00433173|Hormone Antagonists|hormone antagonists|mesh-ancestor
92675992|NCT01055028|Paclitaxel|paclitaxel|mesh-list
92675993|NCT01055028|Bevacizumab|bevacizumab|mesh-list
92675994|NCT01055028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92675995|NCT01055028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675996|NCT01055028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675997|NCT01055028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92675998|NCT01055028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92675999|NCT01055028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676000|NCT01055028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92676001|NCT01055028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92676002|NCT01055028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92676003|NCT01055028|Growth Substances|growth substances|mesh-ancestor
92676004|NCT01055028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676005|NCT01055028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92676006|NCT00428727|Nitric Oxide|nitric oxide|mesh-list
92676007|NCT00428727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92676008|NCT00428727|Autonomic Agents|autonomic agents|mesh-ancestor
92676010|NCT00428727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676011|NCT00428727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92676012|NCT00428727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92676013|NCT00428727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92676014|NCT00428727|Antioxidants|antioxidants|mesh-ancestor
92676015|NCT00428727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676016|NCT00428727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676017|NCT00428727|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92676018|NCT00428727|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676019|NCT00428727|Gasotransmitters|gasotransmitters|mesh-ancestor
92676020|NCT00428727|Protective Agents|protective agents|mesh-ancestor
92676021|NCT00433368|N-Methylaspartate|n-methylaspartate|mesh-list
92676022|NCT00433368|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92676023|NCT00433368|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92676024|NCT00433368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676025|NCT00433368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676026|NCT00433368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676027|NCT00428766|Farletuzumab|farletuzumab|mesh-list
92676028|NCT00428766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676029|NCT04716569|Ivermectin|ivermectin|mesh-list
92676030|NCT04716569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92033533|NCT04751877|Bortezomib|bortezomib|mesh-list
92033534|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033535|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
92033536|NCT04751877|Autonomic Agents|autonomic agents|mesh-ancestor
92676031|NCT04716569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676032|NCT04703127|Lidocaine|lidocaine|mesh-list
92676033|NCT04703127|Tadalafil|tadalafil|mesh-list
92676034|NCT04703127|Anesthetics, Local|anesthetics, local|mesh-ancestor
92676035|NCT04703127|Anesthetics|anesthetics|mesh-ancestor
92676036|NCT04703127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676037|NCT04703127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676038|NCT04703127|Sensory System Agents|sensory system agents|mesh-ancestor
92676039|NCT04703127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676040|NCT04703127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92676041|NCT04703127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92676042|NCT04703127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92676043|NCT04703127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676044|NCT04703127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676045|NCT04703127|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676046|NCT04703127|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92676047|NCT04703127|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92676048|NCT04703127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676049|NCT04703127|Urological Agents|urological agents|mesh-ancestor
92676050|NCT00428883|Acetylcysteine|acetylcysteine|mesh-list
92676051|NCT00428883|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92676052|NCT00428883|Antiviral Agents|antiviral agents|mesh-ancestor
92676053|NCT00428883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676054|NCT00428883|Expectorants|expectorants|mesh-ancestor
92676055|NCT00428883|Respiratory System Agents|respiratory system agents|mesh-ancestor
92676056|NCT00428883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92676057|NCT00428883|Antioxidants|antioxidants|mesh-ancestor
92676058|NCT00428883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676059|NCT00428883|Protective Agents|protective agents|mesh-ancestor
92676060|NCT00428883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676061|NCT00428883|Antidotes|antidotes|mesh-ancestor
92676062|NCT04702971|Flunarizine|flunarizine|mesh-list
92676063|NCT04702971|Anticonvulsants|anticonvulsants|mesh-ancestor
92676064|NCT04702971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92676065|NCT04702971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676066|NCT04702971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676067|NCT04702971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92676068|NCT04702971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676069|NCT04702971|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92676070|NCT04702971|Histamine Antagonists|histamine antagonists|mesh-ancestor
92676071|NCT04702971|Histamine Agents|histamine agents|mesh-ancestor
92676072|NCT04702971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676073|NCT04702971|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676074|NCT00433407|Trastuzumab|trastuzumab|mesh-list
92676075|NCT00433407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366905|NCT00787722|Prednisolone phosphate|prednisolone phosphate|mesh-list
92676076|NCT00433407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676077|NCT00433485|Sirolimus|sirolimus|mesh-list
92676078|NCT00433485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676079|NCT00433485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676080|NCT00433485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92676081|NCT00433485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676083|NCT00433485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92676084|NCT00433485|Immunologic Factors|immunologic factors|mesh-ancestor
92676085|NCT00433485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676087|NCT02676791|Povidone|povidone|mesh-list
92676088|NCT02676791|Plasma Substitutes|plasma substitutes|mesh-ancestor
92676089|NCT02676791|Blood Substitutes|blood substitutes|mesh-ancestor
92676090|NCT02676791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92676091|NCT02676791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676092|NCT01600079|Vaccines|vaccines|mesh-list
92676093|NCT01600079|Immunologic Factors|immunologic factors|mesh-ancestor
92676094|NCT01600079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676095|NCT01370486|Melatonin|melatonin|mesh-list
92676096|NCT01370486|Antioxidants|antioxidants|mesh-ancestor
92676097|NCT01370486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676098|NCT01370486|Protective Agents|protective agents|mesh-ancestor
92676099|NCT01370486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676100|NCT01370486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676101|NCT00327587|Amlodipine|amlodipine|mesh-list
92604612|NCT00489073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92604613|NCT00489073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92604614|NCT00489073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012097|NCT04859621|Vitamin D|vitamin d|mesh-list
92676102|NCT00327587|Valsartan|valsartan|mesh-list
92676103|NCT00327587|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92676104|NCT00327587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676105|NCT00327587|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92676106|NCT00327587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676107|NCT00327587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676108|NCT00327587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92676109|NCT00327587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676110|NCT00327587|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676111|NCT00327587|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92676112|NCT00327587|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92676113|NCT00327587|Diuretics|diuretics|mesh-ancestor
92676114|NCT00327587|Natriuretic Agents|natriuretic agents|mesh-ancestor
92676115|NCT00327587|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92676116|NCT00327665|Vaccines|vaccines|mesh-list
92676117|NCT00327665|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92676118|NCT00327665|Immunologic Factors|immunologic factors|mesh-ancestor
92676119|NCT00327665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676120|NCT00433641|Sibutramine|sibutramine|mesh-list
92676121|NCT00433641|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676122|NCT00433641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676123|NCT00433641|Appetite Depressants|appetite depressants|mesh-ancestor
92676124|NCT00433641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92676125|NCT00429234|Gemcitabine|gemcitabine|mesh-list
92676126|NCT00429234|Dasatinib|dasatinib|mesh-list
92676127|NCT00429234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92676128|NCT00429234|Antimetabolites|antimetabolites|mesh-ancestor
92676129|NCT00429234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676130|NCT00429234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676131|NCT00429234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92676132|NCT00429234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676133|NCT00433719|Efavirenz|efavirenz|mesh-list
92676134|NCT00433719|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92676135|NCT00433719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92676136|NCT00433719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92676137|NCT00433719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676138|NCT00433719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676139|NCT00433719|Antiviral Agents|antiviral agents|mesh-ancestor
92676140|NCT00433719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676141|NCT00433719|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92676142|NCT00433719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92676143|NCT00433719|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92676144|NCT00433719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92676145|NCT00433719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92676146|NCT00433719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92676147|NCT00433719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92676148|NCT00433719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92676149|NCT04704297|Acetaminophen|acetaminophen|mesh-list
92676150|NCT04704297|Ibuprofen|ibuprofen|mesh-list
92676151|NCT04704297|Ketorolac|ketorolac|mesh-list
92676152|NCT04704297|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92676153|NCT04704297|Amitriptyline|amitriptyline|mesh-list
92676154|NCT04704297|Bupivacaine|bupivacaine|mesh-list
92676155|NCT04704297|Cyclobenzaprine|cyclobenzaprine|mesh-list
92676158|NCT04704297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676159|NCT04704297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676160|NCT04704297|Sensory System Agents|sensory system agents|mesh-ancestor
92676161|NCT04704297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676162|NCT04704297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92676164|NCT04704297|Antipyretics|antipyretics|mesh-ancestor
92676165|NCT04704297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92676166|NCT04704297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676167|NCT04704297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92676168|NCT04704297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92676169|NCT04704297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604615|NCT00489073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604616|NCT00489073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604617|NCT00489073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604619|NCT00489073|Sensory System Agents|sensory system agents|mesh-ancestor
92604620|NCT00489073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012100|NCT04859621|Vitamins|vitamins|mesh-list
92676170|NCT04704297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676171|NCT04704297|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92676172|NCT04704297|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676173|NCT04704297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676174|NCT04704297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92676175|NCT04704297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92676176|NCT04704297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92676177|NCT04704297|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92676178|NCT04704297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92676179|NCT04704297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676180|NCT04704297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676181|NCT04704297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676182|NCT00328211|Bile Acids and Salts|bile acids and salts|mesh-list
92676183|NCT00328211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92676184|NCT00328367|Aripiprazole|aripiprazole|mesh-list
92676185|NCT00328367|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676186|NCT00328367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676187|NCT00328367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92676188|NCT00328367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92676189|NCT00328367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676190|NCT00328367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676191|NCT00328367|Dopamine Agonists|dopamine agonists|mesh-ancestor
92676192|NCT00328367|Dopamine Agents|dopamine agents|mesh-ancestor
92676193|NCT00328367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676194|NCT00328367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676195|NCT00328367|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92676196|NCT00328367|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92676197|NCT00328367|Serotonin Agents|serotonin agents|mesh-ancestor
92676198|NCT00328367|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92676199|NCT00328367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92676200|NCT00328367|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92676201|NCT00328367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92676202|NCT04703088|Ondansetron|ondansetron|mesh-list
92676203|NCT04703088|Antiemetics|antiemetics|mesh-ancestor
92676204|NCT04703088|Autonomic Agents|autonomic agents|mesh-ancestor
92676205|NCT04703088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676206|NCT04703088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676207|NCT04703088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92676208|NCT04703088|Antipruritics|antipruritics|mesh-ancestor
92676209|NCT04703088|Dermatologic Agents|dermatologic agents|mesh-ancestor
92676210|NCT04703088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92676211|NCT04703088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92401691|NCT01418131|Tacrolimus|tacrolimus|mesh-list
92676212|NCT04703088|Serotonin Agents|serotonin agents|mesh-ancestor
92676213|NCT04703088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676214|NCT04703088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676215|NCT00328718|Fluticasone|fluticasone|mesh-list
92676216|NCT00328718|Xhance|xhance|mesh-list
92676217|NCT00328718|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92676218|NCT00328718|Montelukast|montelukast|mesh-list
92676219|NCT00328718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676220|NCT00328718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92676221|NCT00328718|Autonomic Agents|autonomic agents|mesh-ancestor
92676222|NCT00328718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676223|NCT00328718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676224|NCT00328718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92676225|NCT00328718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92676226|NCT00328718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083760|NCT01613131|Estradiol|estradiol|mesh-list
92676241|NCT00328796|Anesthetics|anesthetics|mesh-ancestor
92604621|NCT00489073|Antidepressive Agents|antidepressive agents|mesh-ancestor
92604622|NCT00489073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92604623|NCT00489073|Dopamine Agents|dopamine agents|mesh-ancestor
92604624|NCT00489151|Lamivudine|lamivudine|mesh-list
92604625|NCT00489151|Adefovir|adefovir|mesh-list
92604626|NCT00489151|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92604627|NCT00489151|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92604628|NCT00489151|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92604629|NCT00489151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604630|NCT00489151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604631|NCT00489151|Antiviral Agents|antiviral agents|mesh-ancestor
92604632|NCT00489151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604633|NCT00489151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92604634|NCT00489151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92604635|NCT00145314|Leucovorin|leucovorin|mesh-list
92604636|NCT00145314|Folic Acid|folic acid|mesh-list
92676242|NCT00328796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676243|NCT00328796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676244|NCT00328796|Sensory System Agents|sensory system agents|mesh-ancestor
92676245|NCT00328796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676246|NCT00328796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92676247|NCT00328796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92676248|NCT00328796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92676249|NCT00328796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676250|NCT00328796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676251|NCT00429468|Acetaminophen|acetaminophen|mesh-list
92676252|NCT00429468|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92676253|NCT00429468|Hydrocodone|hydrocodone|mesh-list
92676254|NCT00429468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92676255|NCT00429468|Analgesics|analgesics|mesh-ancestor
92676256|NCT00429468|Sensory System Agents|sensory system agents|mesh-ancestor
92676257|NCT00429468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676258|NCT00429468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676259|NCT00429468|Antipyretics|antipyretics|mesh-ancestor
92676260|NCT00429468|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92676261|NCT00429468|Narcotics|narcotics|mesh-ancestor
92676262|NCT00429468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676263|NCT00429468|Antitussive Agents|antitussive agents|mesh-ancestor
92676264|NCT00429468|Respiratory System Agents|respiratory system agents|mesh-ancestor
92676265|NCT00429468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92676266|NCT00429468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676267|NCT00429468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92676268|NCT04702698|Peposertib|peposertib|mesh-list
92676269|NCT04702698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92676270|NCT04702698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676271|NCT04702698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676272|NCT00328874|Ubiquinone|ubiquinone|mesh-list
92676273|NCT00328874|Coenzyme Q10|coenzyme q10|mesh-list
92676274|NCT00328874|Micronutrients|micronutrients|mesh-ancestor
92676275|NCT00328874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676276|NCT00328874|Vitamins|vitamins|mesh-ancestor
92676277|NCT00328913|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92676278|NCT00328913|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92676279|NCT00328913|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676280|NCT00328913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676281|NCT00433953|Mycophenolic Acid|mycophenolic acid|mesh-list
92676282|NCT00433953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92676283|NCT00433953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676284|NCT00433953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92676288|NCT00433953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604637|NCT00145314|Fluorouracil|fluorouracil|mesh-list
92604638|NCT00145314|Oxaliplatin|oxaliplatin|mesh-list
92604639|NCT00145314|Cetuximab|cetuximab|mesh-list
92676289|NCT00433953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676291|NCT02957643|Trace Elements|trace elements|mesh-ancestor
92676292|NCT02957643|Micronutrients|micronutrients|mesh-ancestor
92676293|NCT02957643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676294|NCT02957604|Evolocumab|evolocumab|mesh-list
92676295|NCT02957604|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92676296|NCT02957604|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92676297|NCT02957604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92676298|NCT02957604|Antimetabolites|antimetabolites|mesh-ancestor
92676299|NCT02957604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676300|NCT02957604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92676301|NCT02957604|Protease Inhibitors|protease inhibitors|mesh-ancestor
92676302|NCT02957604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676303|NCT02957604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92676304|NCT00329069|Atorvastatin|atorvastatin|mesh-list
92676305|NCT00329069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92676306|NCT00329069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92676307|NCT00329069|Antimetabolites|antimetabolites|mesh-ancestor
92676308|NCT00329069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676309|NCT00329069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92676310|NCT00329069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92676311|NCT00329069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676312|NCT00429624|Acetaminophen|acetaminophen|mesh-list
92676313|NCT00429624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92676314|NCT00429624|Analgesics|analgesics|mesh-ancestor
92676315|NCT00429624|Sensory System Agents|sensory system agents|mesh-ancestor
92676316|NCT00429624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676317|NCT00429624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676318|NCT00429624|Antipyretics|antipyretics|mesh-ancestor
92676319|NCT00329147|Paroxetine|paroxetine|mesh-list
92676320|NCT00329147|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92676321|NCT00329147|Desipramine|desipramine|mesh-list
92676322|NCT00329147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92676323|NCT00329147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92676324|NCT00329147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676325|NCT00329147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676326|NCT00329147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676327|NCT00329147|Serotonin Agents|serotonin agents|mesh-ancestor
92676328|NCT00329147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676329|NCT00329147|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92676330|NCT00329147|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676331|NCT00329147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676332|NCT00329147|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92676333|NCT00329147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92676334|NCT00329147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676335|NCT00329147|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92676336|NCT00329147|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92676337|NCT00329147|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92676338|NCT00329147|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676339|NCT00329186|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92676340|NCT00329186|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92676341|NCT00329186|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92676342|NCT00329186|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92676343|NCT00329186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676344|NCT00329186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676345|NCT00329186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676346|NCT00329186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676347|NCT00329186|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92676348|NCT00329186|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676349|NCT00329186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676350|NCT00434031|Cyclophosphamide|cyclophosphamide|mesh-list
92676351|NCT00434031|Docetaxel|docetaxel|mesh-list
92676352|NCT00434031|Doxorubicin|doxorubicin|mesh-list
92676353|NCT00434031|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92676354|NCT00434031|Trastuzumab|trastuzumab|mesh-list
92083902|NCT04505566|Ketorolac|ketorolac|mesh-list
92676357|NCT00434031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676358|NCT00434031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604640|NCT00145314|Levoleucovorin|levoleucovorin|mesh-list
92604641|NCT00145314|Antimetabolites|antimetabolites|mesh-ancestor
92604642|NCT00145314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604643|NCT00145314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92012121|NCT03039257|Vitamin A|vitamin a|mesh-list
92676359|NCT00434031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92676360|NCT00434031|Alkylating Agents|alkylating agents|mesh-ancestor
92676361|NCT00434031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676362|NCT00434031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676363|NCT00434031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92676364|NCT00434031|Tubulin Modulators|tubulin modulators|mesh-ancestor
92676365|NCT00434031|Antimitotic Agents|antimitotic agents|mesh-ancestor
92676366|NCT00434031|Mitosis Modulators|mitosis modulators|mesh-ancestor
92676367|NCT00434031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92676368|NCT00434031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92676369|NCT00434031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92676370|NCT00434031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676371|NCT00434031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92676373|NCT00329225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92676374|NCT00329225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676375|NCT01050543|Neostigmine|neostigmine|mesh-list
92676376|NCT01050543|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92676377|NCT01050543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676378|NCT01050543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676379|NCT01050543|Cholinergic Agents|cholinergic agents|mesh-ancestor
92676380|NCT01050543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676381|NCT01050543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676382|NCT01050543|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92676383|NCT01050543|Autonomic Agents|autonomic agents|mesh-ancestor
92676384|NCT01050543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676385|NCT00329264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92676386|NCT00329264|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676387|NCT00329264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676388|NCT00329264|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92676389|NCT00329264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92676390|NCT00329264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676391|NCT00329264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676392|NCT00329381|Omalizumab|omalizumab|mesh-list
92676393|NCT00329381|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92676394|NCT00329381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92676395|NCT00329381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92676396|NCT00329381|Respiratory System Agents|respiratory system agents|mesh-ancestor
92676397|NCT00329381|Immunologic Factors|immunologic factors|mesh-ancestor
92676398|NCT00329381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676399|NCT00429780|Aluminum sulfate|aluminum sulfate|mesh-list
92676400|NCT00429780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92676401|NCT00429780|Immunologic Factors|immunologic factors|mesh-ancestor
92676402|NCT00429780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676403|NCT00329459|Naproxen|naproxen|mesh-list
92676404|NCT00329459|Sumatriptan|sumatriptan|mesh-list
92676405|NCT00329459|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92676406|NCT00329459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92676407|NCT00329459|Analgesics|analgesics|mesh-ancestor
92676408|NCT00329459|Sensory System Agents|sensory system agents|mesh-ancestor
92676409|NCT00329459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676410|NCT00329459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676411|NCT00329459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676412|NCT00329459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92676413|NCT00329459|Gout Suppressants|gout suppressants|mesh-ancestor
92676414|NCT00329459|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92676415|NCT00329459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676416|NCT00329459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676417|NCT00329459|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92676418|NCT00329459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92676419|NCT00329459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92676420|NCT00329459|Serotonin Agents|serotonin agents|mesh-ancestor
92676421|NCT00329459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676422|NCT00329498|Ascorbic Acid|ascorbic acid|mesh-list
92676423|NCT00329498|Antioxidants|antioxidants|mesh-ancestor
92012125|NCT03038009|Pantoprazole|pantoprazole|mesh-list
92604644|NCT00145314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604645|NCT00145314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604646|NCT00145314|Immunologic Factors|immunologic factors|mesh-ancestor
92604647|NCT00145314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604648|NCT00145314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92604649|NCT00145314|Antidotes|antidotes|mesh-ancestor
92604650|NCT00145314|Protective Agents|protective agents|mesh-ancestor
92604651|NCT00145314|Vitamin B Complex|vitamin b complex|mesh-ancestor
92604652|NCT00145314|Vitamins|vitamins|mesh-ancestor
92604653|NCT00145314|Micronutrients|micronutrients|mesh-ancestor
92604654|NCT00145314|Hematinics|hematinics|mesh-ancestor
92604655|NCT00489190|Insulin glulisine|insulin glulisine|mesh-list
92604656|NCT00489190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604657|NCT00489190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604658|NCT00489229|Rosiglitazone|rosiglitazone|mesh-list
92604659|NCT00489229|Ramipril|ramipril|mesh-list
92604660|NCT00489229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604661|NCT00489229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604662|NCT00489229|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92604663|NCT00489229|Protease Inhibitors|protease inhibitors|mesh-ancestor
92604664|NCT00489229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604665|NCT00489229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604666|NCT00489229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92604667|NCT00489385|Ribavirin|ribavirin|mesh-list
92604668|NCT00489385|Antimetabolites|antimetabolites|mesh-ancestor
92604669|NCT00489385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604670|NCT00489385|Antiviral Agents|antiviral agents|mesh-ancestor
92012126|NCT03038009|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92676424|NCT00329498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676425|NCT00329498|Protective Agents|protective agents|mesh-ancestor
92676426|NCT00329498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676430|NCT00329537|Immunologic Factors|immunologic factors|mesh-ancestor
92676431|NCT00329537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676432|NCT00429897|Bendroflumethiazide|bendroflumethiazide|mesh-list
92401899|NCT01419353|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92676433|NCT00429897|Amiloride|amiloride|mesh-list
92676434|NCT00429897|Spironolactone|spironolactone|mesh-list
92676435|NCT00429897|Furosemide|furosemide|mesh-list
92676436|NCT00429897|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92676437|NCT00429897|Hormone Antagonists|hormone antagonists|mesh-ancestor
92676438|NCT00429897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676439|NCT00429897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676440|NCT00429897|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92676441|NCT00429897|Diuretics|diuretics|mesh-ancestor
92676442|NCT00429897|Natriuretic Agents|natriuretic agents|mesh-ancestor
92676443|NCT00429897|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92604671|NCT00489385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604673|NCT01242631|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92604674|NCT01242631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92604675|NCT01242631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676444|NCT00429897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92676445|NCT00429897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676446|NCT00429897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676447|NCT00429897|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92676448|NCT00429897|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92676449|NCT00429897|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676450|NCT00429897|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92676451|NCT00429936|Fenretinide|fenretinide|mesh-list
92676452|NCT00429936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676453|NCT00429936|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92676454|NCT00429936|Protective Agents|protective agents|mesh-ancestor
92676455|NCT00429936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676456|NCT00429975|Levofloxacin|levofloxacin|mesh-list
92676457|NCT00429975|Ceftriaxone|ceftriaxone|mesh-list
92676458|NCT00429975|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92676459|NCT00429975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676460|NCT00429975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676461|NCT00429975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92676462|NCT00429975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92676463|NCT00429975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676464|NCT00429975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676465|NCT00429975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676466|NCT00429975|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92676467|NCT00429975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92676468|NCT00329615|Isophane Insulin, Human|isophane insulin, human|mesh-list
92676469|NCT00329615|Insulin, Isophane|insulin, isophane|mesh-list
92676470|NCT00329615|Isophane insulin, beef|isophane insulin, beef|mesh-list
92676471|NCT00329615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92676472|NCT00329615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676473|NCT04716686|Niraparib|niraparib|mesh-list
92676474|NCT04716686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92676475|NCT04716686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676476|NCT04716686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019562|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
92676477|NCT04716686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676478|NCT01056393|Ibalizumab|ibalizumab|mesh-list
92676479|NCT01056393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92676480|NCT01056393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92676481|NCT01056393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92676482|NCT01056393|Antiviral Agents|antiviral agents|mesh-ancestor
92676483|NCT01056393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676484|NCT01056393|Immunologic Factors|immunologic factors|mesh-ancestor
92676485|NCT01056393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676486|NCT01055106|Metronidazole|metronidazole|mesh-list
92676487|NCT01055106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676488|NCT01055106|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676489|NCT01055106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92676490|NCT01055106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92676491|NCT00329693|Quinagolide|quinagolide|mesh-list
92676492|NCT00329693|Dopamine Agonists|dopamine agonists|mesh-ancestor
92676493|NCT00329693|Dopamine Agents|dopamine agents|mesh-ancestor
92676494|NCT00329693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676495|NCT00329693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676496|NCT00329693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676497|NCT00329810|Aripiprazole|aripiprazole|mesh-list
92676500|NCT00329810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92676501|NCT00329810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92676502|NCT00329810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676503|NCT00329810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676504|NCT00329810|Dopamine Agonists|dopamine agonists|mesh-ancestor
92676505|NCT00329810|Dopamine Agents|dopamine agents|mesh-ancestor
92676506|NCT00329810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676507|NCT00329810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676508|NCT00329810|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92676509|NCT00329810|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92676510|NCT00329810|Serotonin Agents|serotonin agents|mesh-ancestor
92676511|NCT00329810|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92034063|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676512|NCT00329810|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92676513|NCT00329810|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92676514|NCT00329810|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92676516|NCT00430170|Caffeine|caffeine|mesh-list
92676517|NCT00430170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92676518|NCT00430170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676519|NCT00430170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92676520|NCT00430170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676521|NCT00430170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676522|NCT00430170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92676523|NCT00430170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92676524|NCT00430170|Purinergic Agents|purinergic agents|mesh-ancestor
92676525|NCT00430170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676526|NCT00430170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92676527|NCT00430170|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676528|NCT00330044|Carboplatin|carboplatin|mesh-list
92676529|NCT00330044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676530|NCT00430365|Lenalidomide|lenalidomide|mesh-list
92676531|NCT00430365|Immunologic Factors|immunologic factors|mesh-ancestor
92676532|NCT00430365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676533|NCT00430365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92676534|NCT00430365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92676535|NCT00430365|Growth Substances|growth substances|mesh-ancestor
92676536|NCT00430365|Growth Inhibitors|growth inhibitors|mesh-ancestor
92676537|NCT00430365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676538|NCT00330239|Paroxetine|paroxetine|mesh-list
92676539|NCT00330239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92676540|NCT00330239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92676541|NCT00330239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676542|NCT00330239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676543|NCT00330239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676544|NCT00330239|Serotonin Agents|serotonin agents|mesh-ancestor
92676545|NCT00330239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676546|NCT00330239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92676547|NCT00330239|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676548|NCT00330239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676549|NCT00330239|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92676550|NCT00330239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92676551|NCT00330239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676552|NCT01051557|Sirolimus|sirolimus|mesh-list
92676553|NCT01051557|Temsirolimus|temsirolimus|mesh-list
92676554|NCT01051557|MTOR Inhibitors|mtor inhibitors|mesh-list
92676555|NCT01051557|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676556|NCT01051557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676557|NCT01051557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92676558|NCT01051557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676559|NCT01051557|Antifungal Agents|antifungal agents|mesh-ancestor
92676560|NCT01051557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92676561|NCT01051557|Immunologic Factors|immunologic factors|mesh-ancestor
92676562|NCT01051557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676563|NCT01051557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92676564|NCT01051557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676565|NCT01051557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676566|NCT00330278|Cefazolin|cefazolin|mesh-list
92676567|NCT00330278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676568|NCT00330278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676569|NCT00330317|Letrozole|letrozole|mesh-list
92676572|NCT00330317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92676573|NCT00330317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676574|NCT00330317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676575|NCT00330317|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92676576|NCT00330317|Hormone Antagonists|hormone antagonists|mesh-ancestor
92676577|NCT00330317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676578|NCT00330317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676579|NCT00430443|Annamycin|annamycin|mesh-list
92676580|NCT00430443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92676581|NCT00430443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676582|NCT00330395|Caspofungin|caspofungin|mesh-list
92676583|NCT00330395|Antifungal Agents|antifungal agents|mesh-ancestor
92676584|NCT00330395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604676|NCT01242631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604677|NCT01242631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604678|NCT01242631|Immunologic Factors|immunologic factors|mesh-ancestor
92604679|NCT01242631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604680|NCT01242631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604681|NCT01242826|Insulin Aspart|insulin aspart|mesh-list
92604682|NCT01242826|Biphasic Insulins|biphasic insulins|mesh-list
92604683|NCT01242826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604684|NCT01242826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604685|NCT01242904|Icodextrin|icodextrin|mesh-list
92604686|NCT01242904|Dialysis Solutions|dialysis solutions|mesh-ancestor
92604687|NCT01242904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92604688|NCT00145353|Insulin Aspart|insulin aspart|mesh-list
92604689|NCT00145353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604690|NCT00145353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604691|NCT00121979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92604692|NCT00121979|Racivir|racivir|mesh-list
92604693|NCT00121979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92604694|NCT00121979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604695|NCT00121979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604696|NCT00121979|Antiviral Agents|antiviral agents|mesh-ancestor
92676585|NCT00330395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676586|NCT00330395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676587|NCT00434382|Fentanyl|fentanyl|mesh-list
92676588|NCT00434382|Sufentanil|sufentanil|mesh-list
92676589|NCT00434382|Remifentanil|remifentanil|mesh-list
92676590|NCT00434382|Alfentanil|alfentanil|mesh-list
92676591|NCT00434382|Propofol|propofol|mesh-list
92676592|NCT00434382|Sevoflurane|sevoflurane|mesh-list
92676593|NCT00434382|Desflurane|desflurane|mesh-list
92676594|NCT00434382|Isoflurane|isoflurane|mesh-list
92676595|NCT00434382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92676596|NCT00434382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676597|NCT00434382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676598|NCT00434382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92676599|NCT00434382|Anesthetics, General|anesthetics, general|mesh-ancestor
92676600|NCT00434382|Anesthetics|anesthetics|mesh-ancestor
92676601|NCT00434382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92676602|NCT00434382|Narcotics|narcotics|mesh-ancestor
92676603|NCT00434382|Analgesics|analgesics|mesh-ancestor
92676604|NCT00434382|Sensory System Agents|sensory system agents|mesh-ancestor
92676605|NCT00434382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676606|NCT00434382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92676607|NCT00434382|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92676608|NCT00434382|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92676609|NCT00330707|Interferons|interferons|mesh-list
92676610|NCT00330707|Interferon-alpha|interferon-alpha|mesh-list
92676611|NCT00330707|BCG Vaccine|bcg vaccine|mesh-list
92676612|NCT00330707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676613|NCT00330707|Antiviral Agents|antiviral agents|mesh-ancestor
92676614|NCT00330707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676615|NCT00330707|Immunologic Factors|immunologic factors|mesh-ancestor
92676616|NCT00330707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676617|NCT00330707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92012175|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92604697|NCT00121979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604698|NCT00489658|Eflornithine|eflornithine|mesh-list
92604699|NCT00489658|Nifurtimox|nifurtimox|mesh-list
92604700|NCT00489658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604701|NCT00489658|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92604702|NCT00489658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92604703|NCT00489658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92604704|NCT00489658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604705|NCT00489658|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92604706|NCT00489658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604707|NCT00489658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604708|NCT00122018|Acetylcysteine|acetylcysteine|mesh-list
92604709|NCT00122018|Fenoldopam|fenoldopam|mesh-list
92676618|NCT00330746|Gemcitabine|gemcitabine|mesh-list
92676619|NCT00330746|Cetuximab|cetuximab|mesh-list
92676620|NCT00330746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92676621|NCT00330746|Antimetabolites|antimetabolites|mesh-ancestor
92676622|NCT00330746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676623|NCT00330746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676624|NCT00330746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92676625|NCT01053741|Plasma-lyte 148|plasma-lyte 148|mesh-list
92676626|NCT01053741|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92676627|NCT01053741|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92676628|NCT00330785|Amlodipine|amlodipine|mesh-list
92676629|NCT00330785|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92676630|NCT00330785|Atorvastatin|atorvastatin|mesh-list
92676631|NCT00330785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92676632|NCT00330785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92676633|NCT00330785|Antimetabolites|antimetabolites|mesh-ancestor
92676634|NCT00330785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676635|NCT00330785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92676636|NCT00330785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92676637|NCT00330785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676638|NCT00330785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676639|NCT00330785|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92676640|NCT00330785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676641|NCT00330785|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92676642|NCT00330785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676643|NCT00330785|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676644|NCT00330824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92676647|NCT00330824|Dexamethasone acetate|dexamethasone acetate|mesh-list
92676648|NCT00330824|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92676649|NCT00330824|BB 1101|bb 1101|mesh-list
92676650|NCT00330824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676651|NCT00330824|Antiemetics|antiemetics|mesh-ancestor
92676652|NCT00330824|Autonomic Agents|autonomic agents|mesh-ancestor
92676653|NCT00330824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676654|NCT00330824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676655|NCT00330824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92676656|NCT00330824|Glucocorticoids|glucocorticoids|mesh-ancestor
92676657|NCT00330824|Hormones|hormones|mesh-ancestor
92367108|NCT00803010|Sirolimus|sirolimus|mesh-list
92676658|NCT00330824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676659|NCT00330824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92676660|NCT00330824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676661|NCT00330824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92676662|NCT00330824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676663|NCT00330824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676664|NCT00330824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676665|NCT00330824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92676666|NCT00330824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92012186|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92604710|NCT00122018|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92604711|NCT00122018|Antiviral Agents|antiviral agents|mesh-ancestor
92604712|NCT00122018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604713|NCT00122018|Expectorants|expectorants|mesh-ancestor
92604714|NCT00122018|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604715|NCT00122018|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92604716|NCT00122018|Antioxidants|antioxidants|mesh-ancestor
92604717|NCT00122018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604718|NCT00122018|Protective Agents|protective agents|mesh-ancestor
92604719|NCT00122018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604720|NCT00122018|Antidotes|antidotes|mesh-ancestor
92604721|NCT00122018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92604722|NCT00122018|Vasodilator Agents|vasodilator agents|mesh-ancestor
92604723|NCT00122018|Dopamine Agonists|dopamine agonists|mesh-ancestor
92604724|NCT00122018|Dopamine Agents|dopamine agents|mesh-ancestor
92604725|NCT00122018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676667|NCT00330824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92676668|NCT00330824|Contraceptive Agents|contraceptive agents|mesh-ancestor
92676669|NCT00330824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92676670|NCT00330824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92676671|NCT00330824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92676672|NCT00330824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92676673|NCT00330902|Artesunate|artesunate|mesh-list
92676674|NCT00330902|Pyrimethamine|pyrimethamine|mesh-list
92676675|NCT00330902|Primaquine|primaquine|mesh-list
92676676|NCT00330902|Sulfadoxine|sulfadoxine|mesh-list
92676677|NCT00330902|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92676678|NCT00330902|Antimalarials|antimalarials|mesh-ancestor
92676679|NCT00330902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92676680|NCT00330902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92676681|NCT00330902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676682|NCT00330902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676683|NCT00330902|Antiviral Agents|antiviral agents|mesh-ancestor
92676684|NCT00330902|Schistosomicides|schistosomicides|mesh-ancestor
92676685|NCT00330902|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92676686|NCT00330902|Anthelmintics|anthelmintics|mesh-ancestor
92676687|NCT00330902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92676688|NCT00330902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676689|NCT00330902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676690|NCT00330902|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92676691|NCT04703868|Rabeprazole|rabeprazole|mesh-list
92676692|NCT04703868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92676693|NCT04703868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92676694|NCT04703868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92676695|NCT04703868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676696|NCT04703868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676697|NCT00430794|Spironolactone|spironolactone|mesh-list
92676698|NCT00430794|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92676699|NCT00430794|Hormone Antagonists|hormone antagonists|mesh-ancestor
92367116|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
92676700|NCT00430794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676701|NCT00430794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676702|NCT00430794|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92676703|NCT00430794|Diuretics|diuretics|mesh-ancestor
92676704|NCT00430794|Natriuretic Agents|natriuretic agents|mesh-ancestor
92676705|NCT00330980|Simvastatin|simvastatin|mesh-list
92676706|NCT00330980|Pravastatin|pravastatin|mesh-list
92676707|NCT00330980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92676708|NCT00330980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012202|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
92604726|NCT00489775|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92604727|NCT00489775|Paroxetine|paroxetine|mesh-list
92604728|NCT00489775|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92604729|NCT00489775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92604730|NCT00489775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92604731|NCT00489775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604732|NCT00489775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604733|NCT00489775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604734|NCT00489775|Analgesics|analgesics|mesh-ancestor
92604735|NCT00489775|Sensory System Agents|sensory system agents|mesh-ancestor
92604736|NCT00489775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604737|NCT00489775|Antidepressive Agents|antidepressive agents|mesh-ancestor
92604738|NCT00489775|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92604739|NCT00489775|Dopamine Agents|dopamine agents|mesh-ancestor
92604740|NCT00489775|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92012203|NCT03036605|Hormones|hormones|mesh-ancestor
92676709|NCT00330980|Antimetabolites|antimetabolites|mesh-ancestor
92676710|NCT00330980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676711|NCT00330980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92676712|NCT00330980|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92676713|NCT00330980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676714|NCT00430833|Candesartan|candesartan|mesh-list
92676715|NCT00430833|Candesartan cilexetil|candesartan cilexetil|mesh-list
92676716|NCT00430833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676717|NCT00430833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92676718|NCT00430833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92676719|NCT00430833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676721|NCT00331058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676722|NCT00331058|Glucocorticoids|glucocorticoids|mesh-ancestor
92676723|NCT00331058|Hormones|hormones|mesh-ancestor
92676724|NCT00331058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676725|NCT00331058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676726|NCT00331058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92676727|NCT00331058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676728|NCT00331097|Cyclophosphamide|cyclophosphamide|mesh-list
92676729|NCT00331097|Docetaxel|docetaxel|mesh-list
92676730|NCT00331097|Fluorouracil|fluorouracil|mesh-list
92676731|NCT00331097|Methotrexate|methotrexate|mesh-list
92676732|NCT00331097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92676733|NCT00331097|Immunologic Factors|immunologic factors|mesh-ancestor
92676734|NCT00331097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676735|NCT00331097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92676736|NCT00331097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92676737|NCT00331097|Alkylating Agents|alkylating agents|mesh-ancestor
92676738|NCT00331097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676739|NCT00331097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676740|NCT00331097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92676741|NCT00331097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92676742|NCT00331097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92676743|NCT00331097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92676745|NCT00331097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92676746|NCT00331097|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92676747|NCT00331097|Abortifacient Agents|abortifacient agents|mesh-ancestor
92676748|NCT00331097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92604741|NCT00489775|Serotonin Agents|serotonin agents|mesh-ancestor
92604742|NCT00489775|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92604743|NCT00489775|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92604744|NCT00489775|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92604745|NCT00489775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604746|NCT00122057|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92604747|NCT00122057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604748|NCT00489892|Modafinil|modafinil|mesh-list
92604749|NCT00489892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92604750|NCT00489892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676749|NCT00331097|Dermatologic Agents|dermatologic agents|mesh-ancestor
92676750|NCT00331097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676751|NCT00331097|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92676752|NCT00331097|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92676753|NCT00331214|Testosterone|testosterone|mesh-list
92676754|NCT00331214|Androgens|androgens|mesh-ancestor
92676755|NCT00331214|Hormones|hormones|mesh-ancestor
92676756|NCT00331214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676757|NCT00331214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676758|NCT00434772|Glucagon|glucagon|mesh-list
92676759|NCT00434772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92676760|NCT00434772|Hormones|hormones|mesh-ancestor
92676761|NCT00434772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676762|NCT00434772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676763|NCT00431028|Ciprofloxacin|ciprofloxacin|mesh-list
92676764|NCT00431028|Triamcinolone|triamcinolone|mesh-list
92676765|NCT00431028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676766|NCT00431028|Glucocorticoids|glucocorticoids|mesh-ancestor
92676767|NCT00431028|Hormones|hormones|mesh-ancestor
92676768|NCT00431028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676769|NCT00431028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676770|NCT00431028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676771|NCT00431028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676772|NCT00431028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676773|NCT00431028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676774|NCT00431028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92676775|NCT00431028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92676776|NCT00431028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676777|NCT00431028|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92676778|NCT00431028|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92676779|NCT00431106|Gemcitabine|gemcitabine|mesh-list
92676780|NCT00431106|Capecitabine|capecitabine|mesh-list
92676781|NCT00431106|Vinorelbine|vinorelbine|mesh-list
92676782|NCT00431106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92676783|NCT00431106|Antimetabolites|antimetabolites|mesh-ancestor
92676784|NCT00431106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676785|NCT00431106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676786|NCT00431106|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92676787|NCT00431106|Tubulin Modulators|tubulin modulators|mesh-ancestor
92676788|NCT00431106|Antimitotic Agents|antimitotic agents|mesh-ancestor
92676789|NCT00431106|Mitosis Modulators|mitosis modulators|mesh-ancestor
92676790|NCT00431145|Niacin|niacin|mesh-list
92676791|NCT00431145|Niacinamide|niacinamide|mesh-list
92676792|NCT00431145|Nicotinic Acids|nicotinic acids|mesh-list
92676794|NCT00431145|Antimetabolites|antimetabolites|mesh-ancestor
92676795|NCT00431145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676796|NCT00431145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92676797|NCT00431145|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676798|NCT00431145|Vitamin B Complex|vitamin b complex|mesh-ancestor
92676799|NCT00431145|Vitamins|vitamins|mesh-ancestor
92676800|NCT00431145|Micronutrients|micronutrients|mesh-ancestor
92676801|NCT00431145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676802|NCT00331487|Pioglitazone|pioglitazone|mesh-list
92676803|NCT00331487|Rosiglitazone|rosiglitazone|mesh-list
92676804|NCT00331487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604751|NCT00489892|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92604752|NCT00489892|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92604753|NCT00489892|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92604754|NCT00489892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604755|NCT00490087|Levonorgestrel|levonorgestrel|mesh-list
92604756|NCT00490087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92604757|NCT00490087|Contraceptive Agents|contraceptive agents|mesh-ancestor
92604758|NCT00490087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92604759|NCT00490087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604760|NCT00490087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92604761|NCT00490087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92604762|NCT00490087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92604763|NCT01243060|Zolpidem|zolpidem|mesh-list
92604764|NCT01243060|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92604765|NCT01243060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92604766|NCT01243060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604767|NCT01243060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604768|NCT01243060|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92604769|NCT01243060|GABA Agonists|gaba agonists|mesh-ancestor
92604770|NCT01243060|GABA Agents|gaba agents|mesh-ancestor
92604771|NCT01243060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604772|NCT01243060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604773|NCT00490204|Cetirizine|cetirizine|mesh-list
92604774|NCT00490204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92604775|NCT00490204|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92604776|NCT00490204|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92604777|NCT00490204|Histamine Antagonists|histamine antagonists|mesh-ancestor
92604778|NCT00490204|Histamine Agents|histamine agents|mesh-ancestor
92604779|NCT00490204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604780|NCT00490204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604781|NCT00490204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604782|NCT00122096|Valdecoxib|valdecoxib|mesh-list
92604783|NCT00122096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92604784|NCT00122096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92604785|NCT00122096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676805|NCT00331487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676806|NCT00331526|Aldesleukin|aldesleukin|mesh-list
92604786|NCT00122096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604787|NCT00122096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92604788|NCT00122096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92604789|NCT00122096|Analgesics|analgesics|mesh-ancestor
92604790|NCT00122096|Sensory System Agents|sensory system agents|mesh-ancestor
92604791|NCT00122096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604792|NCT00122096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604793|NCT00122096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604794|NCT00122096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604795|NCT00490243|Budesonide|budesonide|mesh-list
92604796|NCT00490243|Formoterol Fumarate|formoterol fumarate|mesh-list
92676807|NCT00331526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676808|NCT00331526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92676809|NCT00331526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92676810|NCT00331526|Antiviral Agents|antiviral agents|mesh-ancestor
92676811|NCT00331526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676812|NCT00431262|Disulfiram|disulfiram|mesh-list
92676813|NCT00431262|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92676814|NCT00431262|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92676815|NCT00431262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676816|NCT00431262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676817|NCT00331604|Insulin|insulin|mesh-list
92676818|NCT00331604|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92676819|NCT00331604|Insulin Aspart|insulin aspart|mesh-list
92676820|NCT00331604|Insulin, Long-Acting|insulin, long-acting|mesh-list
92676821|NCT00331604|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92676822|NCT00331604|Insulin Detemir|insulin detemir|mesh-list
92676823|NCT00331604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92676824|NCT00331604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676825|NCT00331643|Epothilones|epothilones|mesh-list
92676826|NCT00331643|Epothilone B|epothilone b|mesh-list
92676827|NCT00331643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92676828|NCT00331643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92676829|NCT00331643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92676830|NCT00331643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676831|NCT00331643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676832|NCT00431340|Belinostat|belinostat|mesh-list
92676833|NCT00431340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676834|NCT00431340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92676835|NCT00431340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676836|NCT00431340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676837|NCT00431379|Tenecteplase|tenecteplase|mesh-list
92676838|NCT00431379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92676839|NCT00431379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92676840|NCT00431379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676841|NCT00331838|Enoxaparin|enoxaparin|mesh-list
92676842|NCT00331838|Semuloparin|semuloparin|mesh-list
92676843|NCT00331838|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92676844|NCT00331838|Enoxaparin sodium|enoxaparin sodium|mesh-list
92676845|NCT00331838|Anticoagulants|anticoagulants|mesh-ancestor
92676846|NCT00331838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92676847|NCT00331838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92676848|NCT00331838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676849|NCT00431418|Sildenafil Citrate|sildenafil citrate|mesh-list
92676850|NCT00431418|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676851|NCT00431418|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92676852|NCT00431418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92676853|NCT00431418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676854|NCT00431418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676855|NCT00431418|Urological Agents|urological agents|mesh-ancestor
92676856|NCT00331955|Doxorubicin|doxorubicin|mesh-list
92676857|NCT00331955|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92676858|NCT00331955|Vorinostat|vorinostat|mesh-list
92676859|NCT00331955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92012276|NCT00794599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92604797|NCT00490243|Montelukast|montelukast|mesh-list
92604798|NCT00490243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604799|NCT00490243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92604800|NCT00490243|Autonomic Agents|autonomic agents|mesh-ancestor
92604801|NCT00490243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604802|NCT00490243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604803|NCT00490243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92604804|NCT00490243|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604805|NCT00490243|Glucocorticoids|glucocorticoids|mesh-ancestor
92604806|NCT00490243|Hormones|hormones|mesh-ancestor
92604807|NCT00490243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92604808|NCT00490243|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92604809|NCT00490243|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92012277|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
92676860|NCT00331955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676861|NCT00331955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92676862|NCT00331955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92676863|NCT00331955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676864|NCT00331955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676865|NCT00331955|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92676866|NCT03277482|Durvalumab|durvalumab|mesh-list
92676867|NCT03277482|Tremelimumab|tremelimumab|mesh-list
92084404|NCT00668902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92676868|NCT03277482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92676869|NCT03277482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676871|NCT00331994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676872|NCT00331994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676873|NCT00331994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92676874|NCT00331994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92676875|NCT00332033|Pirfenidone|pirfenidone|mesh-list
92676876|NCT00332033|Analgesics|analgesics|mesh-ancestor
92676877|NCT00332033|Sensory System Agents|sensory system agents|mesh-ancestor
92676878|NCT00332033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676879|NCT00332033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676880|NCT00332033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92676881|NCT00332033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92676882|NCT00332033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92676883|NCT00332033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92676884|NCT00332033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676885|NCT00435279|Eszopiclone|eszopiclone|mesh-list
92676886|NCT00435279|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92676887|NCT00435279|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92676888|NCT00435279|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92676889|NCT00435279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92676890|NCT00435279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676891|NCT00435279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676892|NCT00435279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676893|NCT00435279|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92676894|NCT00435279|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676895|NCT00435279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676896|NCT00435279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92676897|NCT00435279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676898|NCT00332072|Timolol|timolol|mesh-list
92676899|NCT00332072|Bimatoprost|bimatoprost|mesh-list
92676900|NCT00332072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92676901|NCT00332072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92604810|NCT00490243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92604811|NCT00490243|Adrenergic Agents|adrenergic agents|mesh-ancestor
92604812|NCT00490243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676902|NCT00332072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676903|NCT00332072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676904|NCT00332072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676905|NCT00332072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676906|NCT00332072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92676907|NCT00332072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676908|NCT00431613|Carboplatin|carboplatin|mesh-list
92676909|NCT00431613|Gemcitabine|gemcitabine|mesh-list
92676910|NCT00431613|Docetaxel|docetaxel|mesh-list
92676911|NCT00431613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676912|NCT00431613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92676913|NCT00431613|Antimetabolites|antimetabolites|mesh-ancestor
92676914|NCT00431613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676915|NCT00431613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92676916|NCT00431613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92676917|NCT00431613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92676918|NCT00332228|Naltrexone|naltrexone|mesh-list
92676919|NCT00332228|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92676920|NCT00332228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92676921|NCT00332228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676922|NCT00332228|Sensory System Agents|sensory system agents|mesh-ancestor
92676923|NCT00332228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676924|NCT00431691|Nitroglycerin|nitroglycerin|mesh-list
92676925|NCT00431691|Vasodilator Agents|vasodilator agents|mesh-ancestor
92676926|NCT00332306|Lamivudine|lamivudine|mesh-list
92676927|NCT00332306|Efavirenz|efavirenz|mesh-list
92676928|NCT00332306|Nevirapine|nevirapine|mesh-list
92676929|NCT00332306|Didanosine|didanosine|mesh-list
92676930|NCT00332306|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92676931|NCT00332306|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92676932|NCT00332306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676933|NCT00332306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676934|NCT00332306|Antiviral Agents|antiviral agents|mesh-ancestor
92676935|NCT00332306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676936|NCT00332306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92676937|NCT00332306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92676938|NCT00332306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92676939|NCT00332306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92676940|NCT00332306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92084477|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676942|NCT00332306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92676943|NCT00332306|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92676944|NCT00332306|Antimetabolites|antimetabolites|mesh-ancestor
92676945|NCT00332345|Timolol|timolol|mesh-list
92676946|NCT00332345|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92676947|NCT00332345|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92676948|NCT00332345|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92676949|NCT00332345|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676950|NCT00332345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676951|NCT00332345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676952|NCT00332345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676953|NCT00332345|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92676954|NCT00332345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676955|NCT00332345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92402440|NCT01422707|Hydrocortisone|hydrocortisone|mesh-list
92676956|NCT00332345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92676957|NCT00332345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92676959|NCT00332384|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92676960|NCT00332384|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92676961|NCT00332384|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92676962|NCT00332384|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676963|NCT00332384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676964|NCT00332384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676965|NCT00332384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676966|NCT00332384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92676967|NCT00332384|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676968|NCT00332384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92676969|NCT00332384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92676970|NCT00332384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92604813|NCT00490243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604814|NCT00490243|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92604815|NCT00490243|Hormone Antagonists|hormone antagonists|mesh-ancestor
92604816|NCT00490243|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92329788|NCT00002761|Cytarabine|cytarabine|mesh-list
92676971|NCT00435435|Disulfiram|disulfiram|mesh-list
92676972|NCT00435435|Acamprosate|acamprosate|mesh-list
92676973|NCT00435435|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92676974|NCT00435435|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92676975|NCT00435435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92676976|NCT00435435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676977|NCT00332540|Timolol|timolol|mesh-list
92676978|NCT00332540|Bimatoprost|bimatoprost|mesh-list
92367186|NCT00807768|Paclitaxel|paclitaxel|mesh-list
92676979|NCT00332540|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92676980|NCT00332540|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92676981|NCT00332540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676982|NCT00332540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676983|NCT00332540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676984|NCT00332540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676985|NCT00332540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92676986|NCT00332540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92676987|NCT00332618|Glycerol|glycerol|mesh-list
92676988|NCT00332618|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92676989|NCT00332618|Protective Agents|protective agents|mesh-ancestor
92676990|NCT00332618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676991|NCT00332735|Bupivacaine|bupivacaine|mesh-list
92676992|NCT00332735|Carticaine|carticaine|mesh-list
92676993|NCT00332735|Anesthetics, Local|anesthetics, local|mesh-ancestor
92676994|NCT00332735|Anesthetics|anesthetics|mesh-ancestor
92676995|NCT00332735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92676996|NCT00332735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92676997|NCT00332735|Sensory System Agents|sensory system agents|mesh-ancestor
92676998|NCT00332735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676999|NCT00332774|Ketorolac|ketorolac|mesh-list
92677000|NCT00332774|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92677001|NCT00332774|Nepafenac|nepafenac|mesh-list
92677002|NCT00332774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92677003|NCT00332774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92677004|NCT00332774|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92677005|NCT00332774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92677006|NCT00332774|Analgesics|analgesics|mesh-ancestor
92677007|NCT00332774|Sensory System Agents|sensory system agents|mesh-ancestor
92677008|NCT00332774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677009|NCT00332774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677010|NCT00332774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677011|NCT00332774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677012|NCT00332774|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92677013|NCT00332774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677024|NCT00332852|Hormone Antagonists|hormone antagonists|mesh-ancestor
92677025|NCT00332852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677026|NCT00332852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677027|NCT00332891|Amibegron|amibegron|mesh-list
92677028|NCT00332891|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92402509|NCT01423175|Clofarabine|clofarabine|mesh-list
92677029|NCT00332891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92677030|NCT00332891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92677031|NCT00332891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92677032|NCT00332891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677033|NCT00332891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677034|NCT00332891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677035|NCT00332891|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92677036|NCT00332930|Interferons|interferons|mesh-list
92677037|NCT00332930|Interferon-gamma|interferon-gamma|mesh-list
92677038|NCT00332930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677039|NCT00332930|Antiviral Agents|antiviral agents|mesh-ancestor
92677040|NCT00332930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677041|NCT00332969|Octreotide|octreotide|mesh-list
92677042|NCT00332969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677043|NCT00332969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92604817|NCT00490243|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92604818|NCT00490360|Gemcitabine|gemcitabine|mesh-list
92604819|NCT00490360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604820|NCT00490360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604821|NCT00490360|Antimetabolites|antimetabolites|mesh-ancestor
92604822|NCT00490360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604823|NCT00490399|Gemcitabine|gemcitabine|mesh-list
92604824|NCT00490399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604825|NCT00490399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604826|NCT00490399|Antimetabolites|antimetabolites|mesh-ancestor
92604827|NCT00490399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677044|NCT00332969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677045|NCT00333008|Prednisone|prednisone|mesh-list
92677046|NCT00333008|Cyclophosphamide|cyclophosphamide|mesh-list
92677047|NCT00333008|Rituximab|rituximab|mesh-list
92677048|NCT00333008|Vincristine|vincristine|mesh-list
92677049|NCT00333008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677050|NCT00333008|Immunologic Factors|immunologic factors|mesh-ancestor
92677051|NCT00333008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677052|NCT00333008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677053|NCT00333008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92677054|NCT00333008|Alkylating Agents|alkylating agents|mesh-ancestor
92677055|NCT00333008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677056|NCT00333008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677057|NCT00333008|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92677058|NCT00333008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92677059|NCT00333008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677060|NCT00333008|Glucocorticoids|glucocorticoids|mesh-ancestor
92677061|NCT00333008|Hormones|hormones|mesh-ancestor
92677062|NCT00333008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677063|NCT00333008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677064|NCT00333008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92677065|NCT00333008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677066|NCT00333008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677067|NCT00333008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677068|NCT00435747|Parecoxib|parecoxib|mesh-list
92677069|NCT00435747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92677070|NCT00435747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92677071|NCT00435747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677072|NCT00435747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677073|NCT00435747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92677074|NCT00435747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92677075|NCT00435747|Analgesics|analgesics|mesh-ancestor
92677076|NCT00435747|Sensory System Agents|sensory system agents|mesh-ancestor
92677080|NCT00435747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677081|NCT00333047|Letrozole|letrozole|mesh-list
92677082|NCT00333047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677083|NCT00333047|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92677084|NCT00333047|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92677085|NCT00333047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677086|NCT00333047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677087|NCT00333047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92677088|NCT00333047|Hormone Antagonists|hormone antagonists|mesh-ancestor
92677089|NCT00333047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677090|NCT00333047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677091|NCT00333086|Letrozole|letrozole|mesh-list
92677092|NCT00333086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677093|NCT00333086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92677094|NCT00333086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92677095|NCT00333086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677096|NCT00333086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604828|NCT04844385|Paclitaxel|paclitaxel|mesh-list
92604829|NCT04844385|Capecitabine|capecitabine|mesh-list
92604830|NCT04844385|Nedaplatin|nedaplatin|mesh-list
92604831|NCT04844385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92604832|NCT04844385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604833|NCT04844385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92604834|NCT04844385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677097|NCT00333086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92677098|NCT00333086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92677099|NCT00333086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677100|NCT00333086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677101|NCT00333125|Timolol|timolol|mesh-list
92677102|NCT00333125|Travoprost|travoprost|mesh-list
92677103|NCT00333125|Dorzolamide|dorzolamide|mesh-list
92677104|NCT00333125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92677105|NCT00333125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92677106|NCT00333125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92677107|NCT00333125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92677108|NCT00333125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92677109|NCT00333125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677110|NCT00333125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677111|NCT00333125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677112|NCT00333125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92677113|NCT00333125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92677114|NCT00333125|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92677115|NCT00333125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677117|NCT00333164|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92677118|NCT00333164|Autonomic Agents|autonomic agents|mesh-ancestor
92677119|NCT00333164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677120|NCT00333164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677121|NCT00333164|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92677122|NCT00333164|Respiratory System Agents|respiratory system agents|mesh-ancestor
92677123|NCT00333164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92677124|NCT00333164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92677125|NCT00333164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677126|NCT00333164|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92677127|NCT00333164|Vasodilator Agents|vasodilator agents|mesh-ancestor
92677128|NCT00333164|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92677129|NCT00333164|Protective Agents|protective agents|mesh-ancestor
92677130|NCT00333164|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92677131|NCT00333164|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92677132|NCT00333164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677133|NCT01052493|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
92677134|NCT01052493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677135|NCT01052493|Hormones|hormones|mesh-ancestor
92677136|NCT01052493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677137|NCT01052493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677138|NCT00333242|Dextromethorphan|dextromethorphan|mesh-list
92677139|NCT00333242|Antitussive Agents|antitussive agents|mesh-ancestor
92677140|NCT00333242|Respiratory System Agents|respiratory system agents|mesh-ancestor
92677141|NCT00333242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92677142|NCT00333242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92677143|NCT00333242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677144|NCT00333242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677145|NCT00333242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677146|NCT00333281|Tadalafil|tadalafil|mesh-list
92677149|NCT00333281|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92677150|NCT00333281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677151|NCT00333281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677152|NCT00333281|Urological Agents|urological agents|mesh-ancestor
92677153|NCT00333398|Vaccines|vaccines|mesh-list
92677154|NCT00333398|Immunologic Factors|immunologic factors|mesh-ancestor
92677155|NCT00333398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677156|NCT00333476|Squalamine|squalamine|mesh-list
92677157|NCT00333476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677158|NCT00333476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677159|NCT00333476|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92677160|NCT00333476|Protective Agents|protective agents|mesh-ancestor
92604836|NCT04844385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604837|NCT04844385|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604838|NCT04844385|Antimetabolites|antimetabolites|mesh-ancestor
92677161|NCT00333476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677162|NCT00333476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677163|NCT00333476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92677164|NCT00333476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92677165|NCT00333476|Growth Substances|growth substances|mesh-ancestor
92677166|NCT00333476|Growth Inhibitors|growth inhibitors|mesh-ancestor
92677167|NCT00435981|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92677168|NCT00435981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92677169|NCT00435981|Immunologic Factors|immunologic factors|mesh-ancestor
92677170|NCT00435981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677171|NCT00435981|Antacids|antacids|mesh-ancestor
92677172|NCT00435981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677173|NCT00435981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677174|NCT00432081|Indomethacin|indomethacin|mesh-list
92677175|NCT00432081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402654|NCT01423864|Methylprednisolone|methylprednisolone|mesh-list
92677176|NCT00432081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92677177|NCT00432081|Analgesics|analgesics|mesh-ancestor
92677178|NCT00432081|Sensory System Agents|sensory system agents|mesh-ancestor
92677179|NCT00432081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677180|NCT00432081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677181|NCT00432081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677182|NCT00432081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677183|NCT00432081|Gout Suppressants|gout suppressants|mesh-ancestor
92677184|NCT00432081|Tocolytic Agents|tocolytic agents|mesh-ancestor
92677185|NCT00432081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92677186|NCT00432081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92677187|NCT00432081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367202|NCT00808470|Protective Agents|protective agents|mesh-ancestor
92677188|NCT00432081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677189|NCT00333632|Fentanyl|fentanyl|mesh-list
92677190|NCT00333632|Midazolam|midazolam|mesh-list
92677191|NCT00333632|Dexmedetomidine|dexmedetomidine|mesh-list
92677192|NCT00333632|Propofol|propofol|mesh-list
92677193|NCT00333632|Isoflurane|isoflurane|mesh-list
92677194|NCT00333632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92677195|NCT00333632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677196|NCT00333632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677197|NCT00333632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92677198|NCT00333632|Analgesics|analgesics|mesh-ancestor
92677199|NCT00333632|Sensory System Agents|sensory system agents|mesh-ancestor
92677200|NCT00333632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677201|NCT00333632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92677202|NCT00333632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92677203|NCT00333632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92677204|NCT00333632|Adrenergic Agents|adrenergic agents|mesh-ancestor
92677205|NCT00333632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677206|NCT00333632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677207|NCT00333632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92677208|NCT00333632|Anesthetics, General|anesthetics, general|mesh-ancestor
92677209|NCT00333632|Anesthetics|anesthetics|mesh-ancestor
92677210|NCT00333632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92677211|NCT00333632|Narcotics|narcotics|mesh-ancestor
92677212|NCT00333632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92677213|NCT00333632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92677214|NCT00333632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677215|NCT00333632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677216|NCT00333632|GABA Modulators|gaba modulators|mesh-ancestor
92677217|NCT00333632|GABA Agents|gaba agents|mesh-ancestor
92677218|NCT00333632|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92677219|NCT00436059|Bortezomib|bortezomib|mesh-list
92084757|NCT00705874|Bevacizumab|bevacizumab|mesh-list
92677223|NCT00420524|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677224|NCT00420524|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677225|NCT00420524|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677226|NCT00420524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677227|NCT00432120|Clopidogrel|clopidogrel|mesh-list
92677228|NCT00432120|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92677229|NCT00432120|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92604840|NCT00490633|Hand Sanitizers|hand sanitizers|mesh-list
92604841|NCT00490633|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92604842|NCT00490633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604843|NCT00490633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604844|NCT00490633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604845|NCT00490633|Disinfectants|disinfectants|mesh-ancestor
92604847|NCT00490711|Carboplatin|carboplatin|mesh-list
92604848|NCT00490711|Gemcitabine|gemcitabine|mesh-list
92604849|NCT00490711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92604850|NCT00490711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604851|NCT00490711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92012319|NCT00751075|Amoxicillin|amoxicillin|mesh-list
92677230|NCT00432120|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92677231|NCT00432120|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92677232|NCT00432120|Purinergic Agents|purinergic agents|mesh-ancestor
92677233|NCT00432120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677234|NCT00432120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677235|NCT00432120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677236|NCT00432198|Zolpidem|zolpidem|mesh-list
92677237|NCT00432198|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92677238|NCT00432198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92677239|NCT00432198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677240|NCT00432198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677241|NCT00432198|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92677242|NCT00432198|GABA Agonists|gaba agonists|mesh-ancestor
92677243|NCT00432198|GABA Agents|gaba agents|mesh-ancestor
92677244|NCT00432198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677245|NCT00432198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677246|NCT00420563|Cyclophosphamide|cyclophosphamide|mesh-list
92677247|NCT00420563|Megestrol|megestrol|mesh-list
92677248|NCT00420563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677249|NCT00420563|Immunologic Factors|immunologic factors|mesh-ancestor
92677250|NCT00420563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677251|NCT00420563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677253|NCT00420563|Alkylating Agents|alkylating agents|mesh-ancestor
92677254|NCT00420563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677255|NCT00420563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677256|NCT00420563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92677257|NCT00420563|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92677258|NCT00420563|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92677259|NCT00420563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92677260|NCT00420563|Contraceptive Agents|contraceptive agents|mesh-ancestor
92677261|NCT00420563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92677262|NCT00420563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92677263|NCT00420563|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92677264|NCT00420563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677265|NCT00432315|Docetaxel|docetaxel|mesh-list
92677266|NCT00432315|Cisplatin|cisplatin|mesh-list
92677267|NCT00432315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677268|NCT00432315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677269|NCT00432315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677270|NCT00432315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677271|NCT00432315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677272|NCT00333671|Glycerol|glycerol|mesh-list
92677273|NCT00333671|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92677274|NCT00333671|Protective Agents|protective agents|mesh-ancestor
92677275|NCT00333671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677276|NCT00432354|Atorvastatin|atorvastatin|mesh-list
92677277|NCT00432354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92677278|NCT00432354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012331|NCT04836299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604852|NCT00490711|Antimitotic Agents|antimitotic agents|mesh-ancestor
92604853|NCT00490711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92604854|NCT00490711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604855|NCT00490711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604856|NCT00490711|Antimetabolites|antimetabolites|mesh-ancestor
92604857|NCT00122291|Capecitabine|capecitabine|mesh-list
92604858|NCT00122291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92604859|NCT00122291|Antimetabolites|antimetabolites|mesh-ancestor
92604860|NCT00122291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604861|NCT00122291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604862|NCT00490789|Sirolimus|sirolimus|mesh-list
92604863|NCT00490789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92604864|NCT00490789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604865|NCT00490789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92604866|NCT00490789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677279|NCT00432354|Antimetabolites|antimetabolites|mesh-ancestor
92677280|NCT00432354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677281|NCT00432354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92677282|NCT00432354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92677283|NCT00432354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677284|NCT00333944|Pralidoxime|pralidoxime|mesh-list
92677285|NCT00333944|Antidotes|antidotes|mesh-ancestor
92677286|NCT00333944|Protective Agents|protective agents|mesh-ancestor
92677287|NCT00333944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677288|NCT00333944|Cholinesterase Reactivators|cholinesterase reactivators|mesh-ancestor
92677289|NCT00333944|Enzyme Reactivators|enzyme reactivators|mesh-ancestor
92677290|NCT00333944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677291|NCT00333944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92677296|NCT00334022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677297|NCT00334022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92677298|NCT00334022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92677299|NCT00334022|Antiviral Agents|antiviral agents|mesh-ancestor
92677300|NCT00334022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677301|NCT04701528|Tacrolimus|tacrolimus|mesh-list
92677302|NCT04701528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677303|NCT04701528|Immunologic Factors|immunologic factors|mesh-ancestor
92677304|NCT04701528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677305|NCT04701528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92677306|NCT04701528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677307|NCT04701528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677308|NCT00334139|Zoledronic Acid|zoledronic acid|mesh-list
92677309|NCT00334139|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92677310|NCT00334139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677311|NCT03279978|Midazolam|midazolam|mesh-list
92677312|NCT03279978|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92677313|NCT03279978|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92677314|NCT03279978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677315|NCT03279978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677316|NCT03279978|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92677317|NCT03279978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677318|NCT03279978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677319|NCT03279978|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92677320|NCT03279978|Anesthetics, General|anesthetics, general|mesh-ancestor
92677321|NCT03279978|Anesthetics|anesthetics|mesh-ancestor
92677322|NCT03279978|GABA Modulators|gaba modulators|mesh-ancestor
92677323|NCT03279978|GABA Agents|gaba agents|mesh-ancestor
92677324|NCT03279978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604867|NCT00490789|Antifungal Agents|antifungal agents|mesh-ancestor
92604868|NCT00490789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604869|NCT00490789|Immunologic Factors|immunologic factors|mesh-ancestor
92604870|NCT00490789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604871|NCT00490828|Hydrocortisone|hydrocortisone|mesh-list
92604872|NCT00490828|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92604873|NCT00490828|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92604874|NCT00490828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92604875|NCT00490828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92604876|NCT00490867|Thioctic Acid|thioctic acid|mesh-list
92604877|NCT00490867|Antioxidants|antioxidants|mesh-ancestor
92604878|NCT00490867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604879|NCT00490867|Protective Agents|protective agents|mesh-ancestor
92604880|NCT00490867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012347|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92402799|NCT01424709|Irinotecan|irinotecan|mesh-list
92677325|NCT03279978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677326|NCT00438048|Pilocarpine|pilocarpine|mesh-list
92677328|NCT00438048|Autonomic Agents|autonomic agents|mesh-ancestor
92677329|NCT00438048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677330|NCT00438048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677331|NCT00438048|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92677332|NCT00438048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92677333|NCT00438048|Cholinergic Agents|cholinergic agents|mesh-ancestor
92677334|NCT00438048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677335|NCT00438048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677336|NCT00334256|Tenofovir|tenofovir|mesh-list
92677337|NCT00334256|Emtricitabine|emtricitabine|mesh-list
92677338|NCT00334256|Antiviral Agents|antiviral agents|mesh-ancestor
92677339|NCT00334256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677340|NCT00334256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92677341|NCT00334256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92677342|NCT00334256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677343|NCT00334256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677344|NCT00334256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92677345|NCT00334256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92677346|NCT00438087|Methylprednisolone|methylprednisolone|mesh-list
92677347|NCT00438087|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92677348|NCT00438087|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92677349|NCT00438087|Prednisolone|prednisolone|mesh-list
92677350|NCT00438087|Prednisolone acetate|prednisolone acetate|mesh-list
92677351|NCT00438087|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92677352|NCT00438087|Prednisolone phosphate|prednisolone phosphate|mesh-list
92677353|NCT00438087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677354|NCT00438087|Antiemetics|antiemetics|mesh-ancestor
92677355|NCT00438087|Autonomic Agents|autonomic agents|mesh-ancestor
92677356|NCT00438087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677357|NCT00438087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677358|NCT00438087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677359|NCT00438087|Glucocorticoids|glucocorticoids|mesh-ancestor
92677360|NCT00438087|Hormones|hormones|mesh-ancestor
92677361|NCT00438087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677362|NCT00438087|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92677363|NCT00438087|Protective Agents|protective agents|mesh-ancestor
92677365|NCT00438087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677367|NCT00334412|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92677368|NCT00334412|Antifungal Agents|antifungal agents|mesh-ancestor
92677369|NCT00334412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677370|NCT00334412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604881|NCT00490867|Vitamin B Complex|vitamin b complex|mesh-ancestor
92604882|NCT00490867|Vitamins|vitamins|mesh-ancestor
92604883|NCT00490867|Micronutrients|micronutrients|mesh-ancestor
92604884|NCT00122330|Eculizumab|eculizumab|mesh-list
92604885|NCT00122330|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92604886|NCT00122330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604887|NCT00122330|Immunologic Factors|immunologic factors|mesh-ancestor
92604888|NCT00122330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604889|NCT00490906|Interferons|interferons|mesh-list
92604890|NCT00490906|Interferon-beta|interferon-beta|mesh-list
92604891|NCT00490906|Interferon beta-1a|interferon beta-1a|mesh-list
92604892|NCT00490906|Glatiramer Acetate|glatiramer acetate|mesh-list
92604893|NCT00490906|(T,G)-A-L|(t,g)-a-l|mesh-list
92604894|NCT00490906|Interferon beta-1b|interferon beta-1b|mesh-list
92604895|NCT00490906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604896|NCT00490906|Antiviral Agents|antiviral agents|mesh-ancestor
92604897|NCT00490906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604898|NCT00490906|Immunologic Factors|immunologic factors|mesh-ancestor
92604899|NCT00490906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677371|NCT00334412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677372|NCT00334412|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92677373|NCT00334412|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92677374|NCT00334490|Sildenafil Citrate|sildenafil citrate|mesh-list
92677375|NCT00334490|Vasodilator Agents|vasodilator agents|mesh-ancestor
92677376|NCT00334490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92677377|NCT00334490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92677378|NCT00334490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677379|NCT00334490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677380|NCT00334490|Urological Agents|urological agents|mesh-ancestor
92677381|NCT00334529|Oseltamivir|oseltamivir|mesh-list
92677382|NCT00334529|Antiviral Agents|antiviral agents|mesh-ancestor
92677383|NCT00334529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677384|NCT00334529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677385|NCT00334529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677386|NCT00334568|Rosiglitazone|rosiglitazone|mesh-list
92677387|NCT00334568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92677388|NCT00334568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677389|NCT02273544|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92677390|NCT02273544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92677391|NCT00436293|Docetaxel|docetaxel|mesh-list
92677392|NCT00436293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677393|NCT00436293|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677394|NCT00436293|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677395|NCT00436293|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677396|NCT00436293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677397|NCT00334646|Cyclophosphamide|cyclophosphamide|mesh-list
92677398|NCT00334646|Casopitant|casopitant|mesh-list
92677399|NCT00334646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677400|NCT00334646|Immunologic Factors|immunologic factors|mesh-ancestor
92677401|NCT00334646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677402|NCT00334646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677403|NCT00334646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92677404|NCT00334646|Alkylating Agents|alkylating agents|mesh-ancestor
92677405|NCT00334646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677406|NCT00334646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677407|NCT00334646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92677409|NCT00334646|Autonomic Agents|autonomic agents|mesh-ancestor
92677410|NCT00334646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604900|NCT00490906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92604901|NCT00490906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604902|NCT00490906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92604903|NCT00122486|Tenofovir|tenofovir|mesh-list
92604904|NCT00122486|Antiviral Agents|antiviral agents|mesh-ancestor
92677411|NCT00334646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677412|NCT00334646|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92677413|NCT00334646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677414|NCT04701606|Artesunate|artesunate|mesh-list
92677415|NCT04701606|Pyronaridine|pyronaridine|mesh-list
92677416|NCT04701606|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92677417|NCT04701606|Antimalarials|antimalarials|mesh-ancestor
92677418|NCT04701606|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92677419|NCT04701606|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92677420|NCT04701606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677421|NCT04701606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677422|NCT04701606|Antiviral Agents|antiviral agents|mesh-ancestor
92677423|NCT04701606|Schistosomicides|schistosomicides|mesh-ancestor
92677424|NCT04701606|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92677425|NCT04701606|Anthelmintics|anthelmintics|mesh-ancestor
92677426|NCT00334685|Pregabalin|pregabalin|mesh-list
92677427|NCT00334685|Reboxetine|reboxetine|mesh-list
92677428|NCT00334685|Analgesics|analgesics|mesh-ancestor
92677429|NCT00334685|Sensory System Agents|sensory system agents|mesh-ancestor
92677430|NCT00334685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677431|NCT00334685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677432|NCT00334685|Anticonvulsants|anticonvulsants|mesh-ancestor
92677433|NCT00334685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92677434|NCT00334685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92677435|NCT00334685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677436|NCT00334685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92677437|NCT00334685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92677441|NCT00334685|Antidepressive Agents|antidepressive agents|mesh-ancestor
92677442|NCT00334685|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92677443|NCT00334685|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92677444|NCT00334685|Adrenergic Agents|adrenergic agents|mesh-ancestor
92677445|NCT00334685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677446|NCT00436371|Amisulpride|amisulpride|mesh-list
92677447|NCT00436371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92677448|NCT00436371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677449|NCT00436371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677450|NCT00436371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677451|NCT00436371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677452|NCT00436371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92677453|NCT00436371|Dopamine Agents|dopamine agents|mesh-ancestor
92677454|NCT00436371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677455|NCT00436371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677456|NCT00436371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92677457|NCT00436371|Antidepressive Agents|antidepressive agents|mesh-ancestor
92677458|NCT00334763|Paclitaxel|paclitaxel|mesh-list
92677459|NCT00334763|Bevacizumab|bevacizumab|mesh-list
92677460|NCT00334763|Carboplatin|carboplatin|mesh-list
92677461|NCT00334763|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92677462|NCT00334763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677463|NCT00334763|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677464|NCT00334763|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677465|NCT00334763|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677466|NCT00334763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677467|NCT00334763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92677468|NCT00334763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92677469|NCT00334763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92677470|NCT00334763|Growth Substances|growth substances|mesh-ancestor
92677471|NCT00334763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677472|NCT00334763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92402947|NCT01425411|Valsartan|valsartan|mesh-list
92677473|NCT00436722|Immunoglobulins|immunoglobulins|mesh-list
92677474|NCT00436722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92677475|NCT00436722|Immunologic Factors|immunologic factors|mesh-ancestor
92677476|NCT00436722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677477|NCT00436722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677478|NCT00334880|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92012380|NCT02603393|Autonomic Agents|autonomic agents|mesh-ancestor
92604905|NCT00122486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604906|NCT00122486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92604907|NCT00122486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92604908|NCT00122486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604909|NCT00122486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604910|NCT00122486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92604911|NCT00122486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92604912|NCT00491413|Epoetin Alfa|epoetin alfa|mesh-list
92604913|NCT00491413|Hematinics|hematinics|mesh-ancestor
92604914|NCT00145665|Telbivudine|telbivudine|mesh-list
92604915|NCT00145665|Antiviral Agents|antiviral agents|mesh-ancestor
92604916|NCT00145665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012381|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035075|NCT02492165|Vaccines|vaccines|mesh-list
92677479|NCT00334880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92677480|NCT00334880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677481|NCT00334880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92677482|NCT00334880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92677483|NCT00334880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92677484|NCT00334880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677485|NCT00334880|Dopamine Agents|dopamine agents|mesh-ancestor
92677486|NCT00334880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677487|NCT00436761|Cyclosporine|cyclosporine|mesh-list
92677488|NCT00436761|Methylprednisolone|methylprednisolone|mesh-list
92677489|NCT00436761|Melphalan|melphalan|mesh-list
92677490|NCT00436761|Busulfan|busulfan|mesh-list
92677491|NCT00436761|Cyclosporins|cyclosporins|mesh-list
92677492|NCT00436761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92677493|NCT00436761|Sargramostim|sargramostim|mesh-list
92677494|NCT00436761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677495|NCT00436761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677496|NCT00436761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677497|NCT00436761|Immunologic Factors|immunologic factors|mesh-ancestor
92677498|NCT00436761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677499|NCT00436761|Antifungal Agents|antifungal agents|mesh-ancestor
92677500|NCT00436761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677501|NCT00436761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92677502|NCT00436761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677503|NCT00436761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92677504|NCT00436761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677505|NCT00436761|Antiemetics|antiemetics|mesh-ancestor
92677506|NCT00436761|Autonomic Agents|autonomic agents|mesh-ancestor
92677507|NCT00436761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677508|NCT00436761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677512|NCT00436761|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92677513|NCT00436761|Protective Agents|protective agents|mesh-ancestor
92677514|NCT00436761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677515|NCT00436761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92677516|NCT00436761|Alkylating Agents|alkylating agents|mesh-ancestor
92677517|NCT00436761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92677518|NCT00436800|Gemcitabine|gemcitabine|mesh-list
92677519|NCT00436800|Oxaliplatin|oxaliplatin|mesh-list
92677520|NCT00436800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92677521|NCT00436800|Antimetabolites|antimetabolites|mesh-ancestor
92677522|NCT00436800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677523|NCT00436800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677524|NCT00436839|Prednisone|prednisone|mesh-list
92677525|NCT00436839|Docetaxel|docetaxel|mesh-list
92677526|NCT00436839|Mitoxantrone|mitoxantrone|mesh-list
92677527|NCT00436839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677528|NCT00436839|Tubulin Modulators|tubulin modulators|mesh-ancestor
92604917|NCT00145665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92604918|NCT00145665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604919|NCT00145665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604920|NCT00491725|Metformin|metformin|mesh-list
92604921|NCT00491725|Repaglinide|repaglinide|mesh-list
92604922|NCT00491725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92604923|NCT00491725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604924|NCT00491803|Sildenafil Citrate|sildenafil citrate|mesh-list
92604925|NCT00491803|Vasodilator Agents|vasodilator agents|mesh-ancestor
92604926|NCT00491803|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92604927|NCT00491803|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92604928|NCT00491803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604929|NCT00491803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604930|NCT00491803|Urological Agents|urological agents|mesh-ancestor
92604931|NCT00122603|Saquinavir|saquinavir|mesh-list
92604932|NCT00122603|Fosamprenavir|fosamprenavir|mesh-list
92604933|NCT00122603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92604934|NCT00122603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92604935|NCT00122603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92604936|NCT00122603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604937|NCT00122603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604938|NCT00122603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92677529|NCT00436839|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677530|NCT00436839|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677531|NCT00436839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677532|NCT00436839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677533|NCT00436839|Glucocorticoids|glucocorticoids|mesh-ancestor
92677534|NCT00436839|Hormones|hormones|mesh-ancestor
92677535|NCT00436839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677536|NCT00436839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677537|NCT00436839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677538|NCT00436839|Analgesics|analgesics|mesh-ancestor
92677539|NCT00436839|Sensory System Agents|sensory system agents|mesh-ancestor
92677540|NCT00436839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677541|NCT00436839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92677542|NCT00436839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92677543|NCT00436839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677544|NCT00335075|Temozolomide|temozolomide|mesh-list
92677545|NCT00335075|Semustine|semustine|mesh-list
92677546|NCT00335075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92677547|NCT00335075|Alkylating Agents|alkylating agents|mesh-ancestor
92677548|NCT00335075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677549|NCT00335075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677551|NCT00436995|Hematinics|hematinics|mesh-ancestor
92677552|NCT04716179|Hormones|hormones|mesh-list
92677553|NCT04716179|Testosterone|testosterone|mesh-list
92677554|NCT04716179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677555|NCT04716179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677556|NCT04716179|Androgens|androgens|mesh-ancestor
92677557|NCT00437229|Dexamethasone|dexamethasone|mesh-list
92604940|NCT00122603|Antiviral Agents|antiviral agents|mesh-ancestor
92604941|NCT00122603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604942|NCT00122603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92604943|NCT00122603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92604944|NCT00491920|Vitamin D|vitamin d|mesh-list
92604945|NCT00491920|Cholecalciferol|cholecalciferol|mesh-list
92604946|NCT00491920|Vitamins|vitamins|mesh-ancestor
92604947|NCT00491920|Micronutrients|micronutrients|mesh-ancestor
92604948|NCT00491920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604949|NCT00491920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92604950|NCT00491920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92604951|NCT00491998|Entacapone|entacapone|mesh-list
92604952|NCT00491998|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92604953|NCT00491998|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92604954|NCT00491998|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92604955|NCT00491998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012413|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92677558|NCT00437229|Dexamethasone acetate|dexamethasone acetate|mesh-list
92677559|NCT00437229|Ondansetron|ondansetron|mesh-list
92677560|NCT00437229|Casopitant|casopitant|mesh-list
92677561|NCT00437229|BB 1101|bb 1101|mesh-list
92677562|NCT00437229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677563|NCT00437229|Antiemetics|antiemetics|mesh-ancestor
92677564|NCT00437229|Autonomic Agents|autonomic agents|mesh-ancestor
92677565|NCT00437229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677566|NCT00437229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677567|NCT00437229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677568|NCT00437229|Glucocorticoids|glucocorticoids|mesh-ancestor
92677569|NCT00437229|Hormones|hormones|mesh-ancestor
92677570|NCT00437229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677571|NCT00437229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677572|NCT00437229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677573|NCT00437229|Protease Inhibitors|protease inhibitors|mesh-ancestor
92677574|NCT00437229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677575|NCT00437229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677576|NCT00437229|Antipruritics|antipruritics|mesh-ancestor
92677577|NCT00437229|Dermatologic Agents|dermatologic agents|mesh-ancestor
92677578|NCT00437229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92677579|NCT00437229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92677580|NCT00437229|Serotonin Agents|serotonin agents|mesh-ancestor
92677581|NCT00437229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677582|NCT00437229|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92677609|NCT00335231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677611|NCT00335270|Amprenavir|amprenavir|mesh-list
92677612|NCT00335270|Fosamprenavir|fosamprenavir|mesh-list
92677613|NCT00335270|Lamivudine|lamivudine|mesh-list
92677614|NCT00335270|Abacavir|abacavir|mesh-list
92677615|NCT00335270|Calcium|calcium|mesh-list
92677616|NCT00335270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92677617|NCT00335270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677618|NCT00335270|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92677619|NCT00335270|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92677620|NCT00335270|Protease Inhibitors|protease inhibitors|mesh-ancestor
92677621|NCT00335270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677622|NCT00335270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677623|NCT00335270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92677624|NCT00335270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92604956|NCT00491998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604957|NCT00492037|Conivaptan|conivaptan|mesh-list
92604958|NCT00492037|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92604959|NCT00492037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604960|NCT00492037|Natriuretic Agents|natriuretic agents|mesh-ancestor
92604961|NCT00492037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604962|NCT00402272|Everolimus|everolimus|mesh-list
92604963|NCT00402272|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92604964|NCT00402272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92604965|NCT00402272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92604966|NCT00402272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604967|NCT00402272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92604968|NCT00402272|Immunologic Factors|immunologic factors|mesh-ancestor
92604969|NCT00402272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604970|NCT00402272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604972|NCT00492388|Analgesics|analgesics|mesh-ancestor
92604973|NCT00492388|Sensory System Agents|sensory system agents|mesh-ancestor
92604974|NCT00492388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92604975|NCT00492388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604976|NCT00492388|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92677625|NCT00335270|Antiviral Agents|antiviral agents|mesh-ancestor
92677626|NCT00335270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677627|NCT00335270|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92677628|NCT00335270|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92677629|NCT00335270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92677630|NCT00335270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085210|NCT00713284|Sirolimus|sirolimus|mesh-list
92677633|NCT00335270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677634|NCT00437385|Lithium Carbonate|lithium carbonate|mesh-list
92677635|NCT00437385|Antidepressive Agents|antidepressive agents|mesh-ancestor
92677636|NCT00437385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677637|NCT00437385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677638|NCT00437385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677639|NCT00437385|Antimanic Agents|antimanic agents|mesh-ancestor
92677640|NCT00437385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677641|NCT00437385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677642|NCT00437385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677643|NCT00335309|Amoxicillin|amoxicillin|mesh-list
92677644|NCT00335309|Clavulanic Acid|clavulanic acid|mesh-list
92677645|NCT00335309|Clavulanic Acids|clavulanic acids|mesh-list
92677646|NCT00335309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677647|NCT00335309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677648|NCT00335309|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92677649|NCT00335309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677650|NCT00335309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677651|NCT00335348|Dexamethasone|dexamethasone|mesh-list
92677652|NCT00335348|Bortezomib|bortezomib|mesh-list
92677653|NCT00335348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92677654|NCT00335348|Antiemetics|antiemetics|mesh-ancestor
92677655|NCT00335348|Autonomic Agents|autonomic agents|mesh-ancestor
92677656|NCT00335348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677657|NCT00335348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604977|NCT00492388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92604978|NCT00492388|Anesthetics, General|anesthetics, general|mesh-ancestor
92604979|NCT00492388|Anesthetics|anesthetics|mesh-ancestor
92604980|NCT00492388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92604981|NCT00492388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92035228|NCT01896700|Methylphenidate|methylphenidate|mesh-list
92677658|NCT00335348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92677659|NCT00335348|Glucocorticoids|glucocorticoids|mesh-ancestor
92677660|NCT00335348|Hormones|hormones|mesh-ancestor
92677661|NCT00335348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677662|NCT00335348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677663|NCT00335348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677664|NCT00334919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92677665|NCT00437463|Ramipril|ramipril|mesh-list
92677666|NCT00437463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92677667|NCT00437463|Protease Inhibitors|protease inhibitors|mesh-ancestor
92677668|NCT00437463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677669|NCT00437463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677670|NCT00437463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92677671|NCT00437502|Vaccines|vaccines|mesh-list
92677672|NCT00437502|Immunologic Factors|immunologic factors|mesh-ancestor
92677673|NCT00437502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677674|NCT00420797|Phenylephrine|phenylephrine|mesh-list
92677675|NCT00420797|Oxymetazoline|oxymetazoline|mesh-list
92677676|NCT00420797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92677677|NCT00420797|Mydriatics|mydriatics|mesh-ancestor
92677678|NCT00420797|Autonomic Agents|autonomic agents|mesh-ancestor
92677679|NCT00420797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677680|NCT00420797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677681|NCT00420797|Sympathomimetics|sympathomimetics|mesh-ancestor
92677682|NCT00420797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92677683|NCT00420797|Nasal Decongestants|nasal decongestants|mesh-ancestor
92677684|NCT00420797|Respiratory System Agents|respiratory system agents|mesh-ancestor
92677685|NCT00420797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92677686|NCT00420797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92677687|NCT00420797|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92677688|NCT00420797|Adrenergic Agents|adrenergic agents|mesh-ancestor
92677689|NCT00420797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677690|NCT00420797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677691|NCT00420797|Protective Agents|protective agents|mesh-ancestor
92677692|NCT00437619|Calcipotriene|calcipotriene|mesh-list
92677693|NCT00437619|Dermatologic Agents|dermatologic agents|mesh-ancestor
92677694|NCT00420836|Tobramycin|tobramycin|mesh-list
92677695|NCT00420836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677696|NCT00420836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677697|NCT00437697|Dalteparin|dalteparin|mesh-list
92677698|NCT00437697|Tinzaparin|tinzaparin|mesh-list
92677699|NCT00437697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92677700|NCT00437697|Anticoagulants|anticoagulants|mesh-ancestor
92677701|NCT00437697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92677702|NCT00437697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92677703|NCT00437697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677704|NCT00335465|Insulin Glargine|insulin glargine|mesh-list
92677708|NCT00335543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677709|NCT00335543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92677710|NCT00335543|Antimetabolites|antimetabolites|mesh-ancestor
92677711|NCT00335543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677712|NCT00437814|Ketamine|ketamine|mesh-list
92677713|NCT00437814|Analgesics|analgesics|mesh-ancestor
92677714|NCT00437814|Sensory System Agents|sensory system agents|mesh-ancestor
92677715|NCT00437814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677716|NCT00437814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677717|NCT00437814|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92677718|NCT00437814|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92677719|NCT00437814|Anesthetics, General|anesthetics, general|mesh-ancestor
92677720|NCT00437814|Anesthetics|anesthetics|mesh-ancestor
92677721|NCT00437814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677722|NCT00437814|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92677723|NCT00437814|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92677724|NCT00437814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604982|NCT00492388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92604983|NCT00492388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92604984|NCT00492388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92604986|NCT01243528|Vitamins|vitamins|mesh-ancestor
92604987|NCT01243528|Micronutrients|micronutrients|mesh-ancestor
92035296|NCT02491463|Vaccines|vaccines|mesh-list
92677725|NCT00437814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677726|NCT00335582|Clonidine|clonidine|mesh-list
92677727|NCT00335582|Analgesics|analgesics|mesh-ancestor
92677728|NCT00335582|Sensory System Agents|sensory system agents|mesh-ancestor
92677729|NCT00335582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677730|NCT00335582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677731|NCT00335582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92677732|NCT00335582|Sympatholytics|sympatholytics|mesh-ancestor
92677733|NCT00335582|Autonomic Agents|autonomic agents|mesh-ancestor
92677734|NCT00335582|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92677735|NCT00335582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92677736|NCT00335582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92677737|NCT00335582|Adrenergic Agents|adrenergic agents|mesh-ancestor
92677738|NCT00335582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677739|NCT00335582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677740|NCT00437853|Anastrozole|anastrozole|mesh-list
92677741|NCT00437853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677742|NCT00437853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677743|NCT00437853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92677744|NCT00437853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92677745|NCT00437853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677746|NCT00437853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677747|NCT00437853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92677748|NCT00437853|Hormone Antagonists|hormone antagonists|mesh-ancestor
92677749|NCT00437853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677750|NCT00437853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677751|NCT00335621|Tiotropium Bromide|tiotropium bromide|mesh-list
92677752|NCT00335621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92677753|NCT00335621|Autonomic Agents|autonomic agents|mesh-ancestor
92677754|NCT00335621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677755|NCT00335621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677756|NCT00335621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92677757|NCT00335621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92677758|NCT00335621|Parasympatholytics|parasympatholytics|mesh-ancestor
92677759|NCT00335621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92677760|NCT00335621|Cholinergic Agents|cholinergic agents|mesh-ancestor
92677761|NCT00335621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677762|NCT00335621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677763|NCT00437892|Atorvastatin|atorvastatin|mesh-list
92677764|NCT00437892|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92677765|NCT00437892|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92677766|NCT00437892|Antimetabolites|antimetabolites|mesh-ancestor
92677767|NCT00437892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677768|NCT00437892|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92677769|NCT00437892|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92677770|NCT00437892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677771|NCT00437970|Metformin|metformin|mesh-list
92677772|NCT00437970|Pioglitazone|pioglitazone|mesh-list
92677773|NCT00437970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92677774|NCT00437970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677776|NCT00335699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92677777|NCT00335699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92677778|NCT00335699|Antimetabolites|antimetabolites|mesh-ancestor
92677779|NCT00335699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677780|NCT00335699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92677781|NCT00335699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92677782|NCT00335699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677783|NCT03277170|Montelukast|montelukast|mesh-list
92677784|NCT03277170|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92677785|NCT03277170|Respiratory System Agents|respiratory system agents|mesh-ancestor
92604988|NCT01243528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604989|NCT01243528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92604990|NCT00492427|Epoetin Alfa|epoetin alfa|mesh-list
92604991|NCT00492427|Hematinics|hematinics|mesh-ancestor
92677786|NCT03277170|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92677787|NCT03277170|Hormone Antagonists|hormone antagonists|mesh-ancestor
92677788|NCT03277170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677789|NCT03277170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677790|NCT03277170|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92677791|NCT03277170|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92677792|NCT03277170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677793|NCT00335933|Gabapentin|gabapentin|mesh-list
92677794|NCT00335933|Analgesics|analgesics|mesh-ancestor
92677795|NCT00335933|Sensory System Agents|sensory system agents|mesh-ancestor
92677796|NCT00335933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677797|NCT00335933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677798|NCT00335933|Anticonvulsants|anticonvulsants|mesh-ancestor
92677799|NCT00335933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92677800|NCT00335933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677801|NCT00335933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677802|NCT00335933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677803|NCT00335933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92677804|NCT00335933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92677805|NCT00335933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677806|NCT00335933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677807|NCT00335933|Antimanic Agents|antimanic agents|mesh-ancestor
92677808|NCT00336167|Bezafibrate|bezafibrate|mesh-list
92677809|NCT00336167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92677810|NCT00336167|Antimetabolites|antimetabolites|mesh-ancestor
92677811|NCT00336167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677812|NCT00336167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92677813|NCT00336206|Alemtuzumab|alemtuzumab|mesh-list
92677814|NCT00336206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92677815|NCT00336206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677816|NCT00336245|Copper|copper|mesh-list
92677817|NCT00336245|Contraceptive Agents|contraceptive agents|mesh-list
92677818|NCT00336245|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92677819|NCT00336245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677820|NCT00336245|Trace Elements|trace elements|mesh-ancestor
92677821|NCT00336245|Micronutrients|micronutrients|mesh-ancestor
92677822|NCT00336362|Hydroxyurea|hydroxyurea|mesh-list
92677823|NCT00336362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677824|NCT00336362|Antisickling Agents|antisickling agents|mesh-ancestor
92677825|NCT00336362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677826|NCT00336362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677827|NCT00336362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92677828|NCT00336401|Propofol|propofol|mesh-list
92677829|NCT00336401|Sevoflurane|sevoflurane|mesh-list
92677830|NCT00336401|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92677831|NCT00336401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677832|NCT00336401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677833|NCT00336401|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92677834|NCT00336401|Anesthetics, General|anesthetics, general|mesh-ancestor
92677835|NCT00336401|Anesthetics|anesthetics|mesh-ancestor
92677836|NCT00336401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92677837|NCT00336401|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92677838|NCT00336518|Ribavirin|ribavirin|mesh-list
92677839|NCT00336518|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92677840|NCT00336518|Antimetabolites|antimetabolites|mesh-ancestor
92677841|NCT00336518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677842|NCT00336518|Antiviral Agents|antiviral agents|mesh-ancestor
92677843|NCT00336518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677844|NCT03277872|Pyrithione zinc|pyrithione zinc|mesh-list
92677845|NCT03277872|Keratolytic Agents|keratolytic agents|mesh-ancestor
92677846|NCT03277872|Dermatologic Agents|dermatologic agents|mesh-ancestor
92677847|NCT00347490|Enoxaparin|enoxaparin|mesh-list
92677848|NCT00347490|Anticoagulants|anticoagulants|mesh-ancestor
92677851|NCT00347490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677852|NCT00336674|Insulin|insulin|mesh-list
92677853|NCT00336674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92677854|NCT00336674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92604992|NCT00492466|Interferons|interferons|mesh-list
92604993|NCT00492466|Interferon-beta|interferon-beta|mesh-list
92604994|NCT00492466|Interferon beta-1a|interferon beta-1a|mesh-list
92604995|NCT00492466|Methylprednisolone|methylprednisolone|mesh-list
92604996|NCT00492466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92604997|NCT00492466|Antiviral Agents|antiviral agents|mesh-ancestor
92604998|NCT00492466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92604999|NCT00492466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605000|NCT00492466|Antiemetics|antiemetics|mesh-ancestor
92605001|NCT00492466|Autonomic Agents|autonomic agents|mesh-ancestor
92605002|NCT00492466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605003|NCT00492466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605004|NCT00492466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92605005|NCT00492466|Glucocorticoids|glucocorticoids|mesh-ancestor
92605006|NCT00492466|Hormones|hormones|mesh-ancestor
92605007|NCT00492466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605008|NCT00492466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92605009|NCT00492466|Protective Agents|protective agents|mesh-ancestor
92605010|NCT00492466|Immunologic Factors|immunologic factors|mesh-ancestor
92605011|NCT00492466|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92677855|NCT00444522|Alprazolam|alprazolam|mesh-list
92677856|NCT00444522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92677857|NCT00444522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677858|NCT00444522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677859|NCT00444522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92677860|NCT00444522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677861|NCT00444522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677862|NCT00444522|GABA Modulators|gaba modulators|mesh-ancestor
92677863|NCT00444522|GABA Agents|gaba agents|mesh-ancestor
92677864|NCT00444522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677865|NCT00444522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677866|NCT00336791|Paclitaxel|paclitaxel|mesh-list
92677867|NCT00336791|Cyclophosphamide|cyclophosphamide|mesh-list
92677868|NCT00336791|Doxorubicin|doxorubicin|mesh-list
92677869|NCT00336791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92677870|NCT00336791|Fluorouracil|fluorouracil|mesh-list
92677871|NCT00336791|Epirubicin|epirubicin|mesh-list
92677872|NCT00336791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92677873|NCT00336791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677874|NCT00336791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677875|NCT00336791|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677876|NCT00336791|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677877|NCT00336791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677878|NCT00336791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677879|NCT00336791|Immunologic Factors|immunologic factors|mesh-ancestor
92677880|NCT00336791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677881|NCT00336791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92677882|NCT00336791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92677883|NCT00336791|Alkylating Agents|alkylating agents|mesh-ancestor
92677884|NCT00336791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92677885|NCT00336791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92677886|NCT00336791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92677887|NCT00336791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92677888|NCT00336791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677889|NCT00336791|Antimetabolites|antimetabolites|mesh-ancestor
92677890|NCT00336791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92677891|NCT00444561|Pramlintide|pramlintide|mesh-list
92012484|NCT04821947|Bupivacaine|bupivacaine|mesh-list
92605012|NCT00492505|Tamoxifen|tamoxifen|mesh-list
92605013|NCT00492505|Sorafenib|sorafenib|mesh-list
92605014|NCT00492505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605015|NCT00492505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605016|NCT00492505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605017|NCT00492505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605018|NCT00492505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92605019|NCT00492505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605020|NCT00492505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605021|NCT00492505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605022|NCT00492505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605023|NCT00492505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92605024|NCT00492505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92605025|NCT00492505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92605026|NCT00492661|Tacrolimus|tacrolimus|mesh-list
92677892|NCT00444561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92677893|NCT00444561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677894|NCT00444639|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92677895|NCT00444639|Luteolytic Agents|luteolytic agents|mesh-ancestor
92677896|NCT00444639|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92677897|NCT00444639|Contraceptive Agents|contraceptive agents|mesh-ancestor
92677898|NCT00444639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92677899|NCT00444639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677900|NCT00444639|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92677901|NCT00444639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677902|NCT00444639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677903|NCT00336947|Tegafur|tegafur|mesh-list
92677904|NCT00336947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92677905|NCT00336947|Antimetabolites|antimetabolites|mesh-ancestor
92677906|NCT00336947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677907|NCT00336947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677908|NCT00444717|Pitavastatin|pitavastatin|mesh-list
92677909|NCT00444717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92677910|NCT00444717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92677911|NCT00444717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92677912|NCT00444717|Antimetabolites|antimetabolites|mesh-ancestor
92677913|NCT00444717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677914|NCT00444717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677915|NCT00444717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92677916|NCT00347646|Fibrinolysin|fibrinolysin|mesh-list
92677917|NCT00347646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92677918|NCT00347646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92677919|NCT00347646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677920|NCT00421317|Imatinib Mesylate|imatinib mesylate|mesh-list
92677923|NCT00421317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677924|NCT00421317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677926|NCT00337259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92677927|NCT00337259|Antimetabolites|antimetabolites|mesh-ancestor
92677928|NCT00337259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677929|NCT00337259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677931|NCT04699734|Anesthetics, Local|anesthetics, local|mesh-ancestor
92677932|NCT04699734|Anesthetics|anesthetics|mesh-ancestor
92677933|NCT04699734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367285|NCT04603248|Nivolumab|nivolumab|mesh-list
92677934|NCT04699734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605027|NCT00492661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605028|NCT00492661|Immunologic Factors|immunologic factors|mesh-ancestor
92605029|NCT00492661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605030|NCT00492661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92605031|NCT00492661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605032|NCT00492661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605033|NCT00492700|Rosiglitazone|rosiglitazone|mesh-list
92605034|NCT00492700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92605035|NCT00492700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605036|NCT00402350|Fentanyl|fentanyl|mesh-list
92605037|NCT00402350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92605038|NCT00402350|Narcotics|narcotics|mesh-ancestor
92677935|NCT04699734|Sensory System Agents|sensory system agents|mesh-ancestor
92677936|NCT04699734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677937|NCT04699734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92677938|NCT04699734|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92677939|NCT04699734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92677940|NCT04699734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92677941|NCT04699734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677942|NCT00337298|Amlodipine|amlodipine|mesh-list
92677943|NCT00337298|Lisinopril|lisinopril|mesh-list
92677944|NCT00337298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92677945|NCT00337298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92677946|NCT00337298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92677947|NCT00337298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677948|NCT00337298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92677949|NCT00337298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677950|NCT00337298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92677951|NCT00337298|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92677952|NCT00337298|Protease Inhibitors|protease inhibitors|mesh-ancestor
92677953|NCT00337298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677954|NCT00337298|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92677955|NCT00337298|Protective Agents|protective agents|mesh-ancestor
92677956|NCT00337376|Sirolimus|sirolimus|mesh-list
92677957|NCT00337376|Paclitaxel|paclitaxel|mesh-list
92677958|NCT00337376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92677959|NCT00337376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92677960|NCT00337376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677961|NCT00337376|Tubulin Modulators|tubulin modulators|mesh-ancestor
92677962|NCT00337376|Antimitotic Agents|antimitotic agents|mesh-ancestor
92677963|NCT00337376|Mitosis Modulators|mitosis modulators|mesh-ancestor
92677964|NCT00337376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677965|NCT00337376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677966|NCT00337376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677967|NCT00337376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92677968|NCT00337376|Antifungal Agents|antifungal agents|mesh-ancestor
92677969|NCT00337376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677970|NCT00337376|Immunologic Factors|immunologic factors|mesh-ancestor
92677971|NCT00337376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677972|NCT00337493|Cyclosporine|cyclosporine|mesh-list
92677973|NCT00337493|Mycophenolic Acid|mycophenolic acid|mesh-list
92677974|NCT00337493|Tacrolimus|tacrolimus|mesh-list
92677975|NCT00337493|Cyclosporins|cyclosporins|mesh-list
92677976|NCT00337493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92677977|NCT00337493|Immunologic Factors|immunologic factors|mesh-ancestor
92677978|NCT00337493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677979|NCT00337493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92677980|NCT00337493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677981|NCT00337493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677982|NCT00337493|Antifungal Agents|antifungal agents|mesh-ancestor
92677983|NCT00337493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677984|NCT00337493|Dermatologic Agents|dermatologic agents|mesh-ancestor
92677985|NCT00337493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605039|NCT00402350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605040|NCT00402350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605041|NCT00402350|Analgesics|analgesics|mesh-ancestor
92605042|NCT00402350|Sensory System Agents|sensory system agents|mesh-ancestor
92605043|NCT00402350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605044|NCT00402350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92605045|NCT00402350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92605046|NCT00402350|Anesthetics, General|anesthetics, general|mesh-ancestor
92605047|NCT00402350|Anesthetics|anesthetics|mesh-ancestor
92605048|NCT00122720|Darbepoetin alfa|darbepoetin alfa|mesh-list
92605049|NCT00122720|Hematinics|hematinics|mesh-ancestor
92605050|NCT00492934|Menotropins|menotropins|mesh-list
92605051|NCT00492934|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92677986|NCT00337493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92677987|NCT00337493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677988|NCT00337493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92677989|NCT00337493|Antitubercular Agents|antitubercular agents|mesh-ancestor
92677990|NCT00337493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677991|NCT00444756|Lidocaine|lidocaine|mesh-list
92677994|NCT00444756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677995|NCT00444756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677996|NCT00444756|Sensory System Agents|sensory system agents|mesh-ancestor
92403479|NCT03444753|Nivolumab|nivolumab|mesh-list
92677997|NCT00444756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677998|NCT00444756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92677999|NCT00444756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92678000|NCT00444756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92678001|NCT00444756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678002|NCT00444756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678003|NCT00444834|Carvedilol|carvedilol|mesh-list
92678004|NCT00444834|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92678005|NCT00444834|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92678006|NCT00444834|Adrenergic Agents|adrenergic agents|mesh-ancestor
92678007|NCT00444834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678008|NCT00444834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678009|NCT00444834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678010|NCT00444834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92678011|NCT00444834|Antioxidants|antioxidants|mesh-ancestor
92678012|NCT00444834|Protective Agents|protective agents|mesh-ancestor
92678013|NCT00444834|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92678014|NCT00444834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678015|NCT00444834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678016|NCT00444834|Vasodilator Agents|vasodilator agents|mesh-ancestor
92678017|NCT00444834|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92678018|NCT00444834|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92678019|NCT00337766|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92678020|NCT00337766|Hemostatics|hemostatics|mesh-ancestor
92678021|NCT00337766|Coagulants|coagulants|mesh-ancestor
92678022|NCT00337766|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92678023|NCT00337766|Natriuretic Agents|natriuretic agents|mesh-ancestor
92678024|NCT00337766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678025|NCT00444873|Lanreotide|lanreotide|mesh-list
92678026|NCT00444873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678027|NCT00337805|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92678028|NCT00337805|Plasma Substitutes|plasma substitutes|mesh-ancestor
92678029|NCT00337805|Blood Substitutes|blood substitutes|mesh-ancestor
92678030|NCT00337883|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92678031|NCT00337883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678032|NCT00337883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92678033|NCT00337883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605052|NCT00492934|Fertility Agents|fertility agents|mesh-ancestor
92367309|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
92605053|NCT00492934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92605054|NCT00492934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605056|NCT02274454|Calcium|calcium|mesh-list
92605057|NCT02274454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92605058|NCT02274454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605059|NCT02274454|Oxytocics|oxytocics|mesh-ancestor
92605060|NCT02274454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92678034|NCT00337883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678035|NCT00451113|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92678036|NCT00451113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92678037|NCT00451113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678038|NCT00451113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678039|NCT00451113|Incretins|incretins|mesh-ancestor
92678040|NCT00451113|Hormones|hormones|mesh-ancestor
92678041|NCT00451113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678042|NCT00451113|Protease Inhibitors|protease inhibitors|mesh-ancestor
92678043|NCT00451113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678044|NCT00451113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678045|NCT00337922|Lamivudine|lamivudine|mesh-list
92678046|NCT00337922|Abacavir|abacavir|mesh-list
92678047|NCT00337922|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92678048|NCT00337922|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92678049|NCT00337922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678050|NCT00337922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678051|NCT00337922|Antiviral Agents|antiviral agents|mesh-ancestor
92678052|NCT00337922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678053|NCT00337922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92678054|NCT00337922|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678055|NCT00451230|Hydrocortisone|hydrocortisone|mesh-list
92678056|NCT00451230|Cocaine|cocaine|mesh-list
92678057|NCT00451230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92678058|NCT00451230|Anesthetics, Local|anesthetics, local|mesh-ancestor
92678059|NCT00451230|Anesthetics|anesthetics|mesh-ancestor
92678060|NCT00451230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678061|NCT00451230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678062|NCT00451230|Sensory System Agents|sensory system agents|mesh-ancestor
92678072|NCT00338000|Hematinics|hematinics|mesh-ancestor
92678073|NCT00338117|Galantamine|galantamine|mesh-list
92678074|NCT00338117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92678075|NCT00338117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678076|NCT00338117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678077|NCT00338117|Cholinergic Agents|cholinergic agents|mesh-ancestor
92678078|NCT00338117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678079|NCT00338117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678080|NCT00338117|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92678081|NCT00338117|Autonomic Agents|autonomic agents|mesh-ancestor
92678082|NCT00338117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678083|NCT00338117|Nootropic Agents|nootropic agents|mesh-ancestor
92678084|NCT00338195|Caffeine|caffeine|mesh-list
92678085|NCT00338195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92678086|NCT00338195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678087|NCT00338195|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92678088|NCT00338195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678089|NCT00338195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678090|NCT00338195|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92678091|NCT00338195|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92678092|NCT00338195|Purinergic Agents|purinergic agents|mesh-ancestor
92678093|NCT00338195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678094|NCT00338273|Aripiprazole|aripiprazole|mesh-list
92678095|NCT00338273|Antidepressive Agents|antidepressive agents|mesh-ancestor
92678096|NCT00338273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92678097|NCT00338273|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92678098|NCT00338273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92678099|NCT00338273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678100|NCT00338273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605061|NCT04760730|Vaccines|vaccines|mesh-list
92605062|NCT04760730|Immunologic Factors|immunologic factors|mesh-ancestor
92605063|NCT04760730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605064|NCT00122759|Ketamine|ketamine|mesh-list
92605065|NCT00122759|Analgesics|analgesics|mesh-ancestor
92605066|NCT00122759|Sensory System Agents|sensory system agents|mesh-ancestor
92605067|NCT00122759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605068|NCT00122759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605069|NCT00122759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92605070|NCT00122759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92605071|NCT00122759|Anesthetics, General|anesthetics, general|mesh-ancestor
92605072|NCT00122759|Anesthetics|anesthetics|mesh-ancestor
92605073|NCT00122759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605074|NCT00122759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92605075|NCT00122759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92605076|NCT00122759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605077|NCT00122759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605078|NCT00493129|Denileukin diftitox|denileukin diftitox|mesh-list
92012541|NCT05062681|Hormones|hormones|mesh-ancestor
92678101|NCT00338273|Dopamine Agonists|dopamine agonists|mesh-ancestor
92678102|NCT00338273|Dopamine Agents|dopamine agents|mesh-ancestor
92678103|NCT00338273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678104|NCT00338273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678105|NCT00338273|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92678106|NCT00338273|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92678107|NCT00338273|Serotonin Agents|serotonin agents|mesh-ancestor
92678108|NCT00338273|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92678109|NCT00338273|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92678110|NCT00338273|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92678111|NCT00338273|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92678112|NCT00338312|Testosterone|testosterone|mesh-list
92678113|NCT00338312|Androgens|androgens|mesh-ancestor
92678114|NCT00338312|Hormones|hormones|mesh-ancestor
92678115|NCT00338312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678116|NCT00338312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678117|NCT00451386|Ceftriaxone|ceftriaxone|mesh-list
92678118|NCT00451386|Ertapenem|ertapenem|mesh-list
92678119|NCT00451386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678120|NCT00451386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678121|NCT00338390|Lamivudine|lamivudine|mesh-list
92678122|NCT00338390|Abacavir|abacavir|mesh-list
92678123|NCT00338390|Dideoxynucleosides|dideoxynucleosides|mesh-list
92678124|NCT00338390|Didanosine|didanosine|mesh-list
92678125|NCT00338390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92678126|NCT00338390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92678127|NCT00338390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678130|NCT00338390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678131|NCT00338390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92678132|NCT00338390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678133|NCT00338390|Antimetabolites|antimetabolites|mesh-ancestor
92678135|NCT00338468|Hematinics|hematinics|mesh-ancestor
92678136|NCT00338507|Erdosteine|erdosteine|mesh-list
92678137|NCT00338507|Expectorants|expectorants|mesh-ancestor
92678138|NCT00338507|Respiratory System Agents|respiratory system agents|mesh-ancestor
92678139|NCT00445185|Vaccines|vaccines|mesh-list
92678140|NCT00445185|Immunologic Factors|immunologic factors|mesh-ancestor
92678141|NCT00445185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678142|NCT00338546|Cocaine|cocaine|mesh-list
92678143|NCT00338546|Dexmedetomidine|dexmedetomidine|mesh-list
92605079|NCT00493129|Interleukin-2|interleukin-2|mesh-list
92605080|NCT00493129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605081|NCT00493129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92605082|NCT00493129|Analgesics|analgesics|mesh-ancestor
92605083|NCT00493129|Sensory System Agents|sensory system agents|mesh-ancestor
92678144|NCT00338546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92678145|NCT00338546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403622|NCT01426087|Somatostatin|somatostatin|mesh-list
92678146|NCT00338546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678147|NCT00338546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92678148|NCT00338546|Analgesics|analgesics|mesh-ancestor
92678149|NCT00338546|Sensory System Agents|sensory system agents|mesh-ancestor
92678150|NCT00338546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678151|NCT00338546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92678152|NCT00338546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92678153|NCT00338546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92678154|NCT00338546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92678155|NCT00338546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678156|NCT00338546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678157|NCT00338546|Anesthetics, Local|anesthetics, local|mesh-ancestor
92678158|NCT00338546|Anesthetics|anesthetics|mesh-ancestor
92678159|NCT00338546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92678160|NCT00338546|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92678161|NCT00338546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92678162|NCT00338546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678163|NCT00338546|Dopamine Agents|dopamine agents|mesh-ancestor
92678164|NCT00338624|Oxybutynin|oxybutynin|mesh-list
92678165|NCT00338624|Parasympatholytics|parasympatholytics|mesh-ancestor
92678166|NCT00338624|Autonomic Agents|autonomic agents|mesh-ancestor
92678167|NCT00338624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678168|NCT00338624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678169|NCT00338624|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92678170|NCT00338624|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92678171|NCT00338624|Cholinergic Agents|cholinergic agents|mesh-ancestor
92678172|NCT00338624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678173|NCT00338624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678174|NCT00338624|Urological Agents|urological agents|mesh-ancestor
92678175|NCT00338780|Lamivudine|lamivudine|mesh-list
92678176|NCT00338780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92678177|NCT00338780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92678178|NCT00338780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678179|NCT00338780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678180|NCT00338780|Antiviral Agents|antiviral agents|mesh-ancestor
92678181|NCT00338780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678182|NCT00338780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92678183|NCT00338780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678184|NCT00451620|Glyburide|glyburide|mesh-list
92678185|NCT00451620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678186|NCT00451620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678187|NCT00445497|Amoxicillin|amoxicillin|mesh-list
92678188|NCT00445497|Ciprofloxacin|ciprofloxacin|mesh-list
92678189|NCT00445497|Clavulanic Acid|clavulanic acid|mesh-list
92678190|NCT00445497|Clavulanic Acids|clavulanic acids|mesh-list
92678191|NCT00445497|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92678192|NCT00445497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678193|NCT00445497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678194|NCT00445497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92678195|NCT00445497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92678196|NCT00445497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678197|NCT00445497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678198|NCT00445497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678199|NCT00445497|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92678203|NCT00451776|Etomidate|etomidate|mesh-list
92678204|NCT00451776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92678205|NCT00451776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678206|NCT00451776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678207|NCT00451776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92678208|NCT00451776|Anesthetics, General|anesthetics, general|mesh-ancestor
92678209|NCT00451776|Anesthetics|anesthetics|mesh-ancestor
92678210|NCT00338936|Valsartan|valsartan|mesh-list
92605084|NCT00493129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605085|NCT00493129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605086|NCT00126542|Bevacizumab|bevacizumab|mesh-list
92678211|NCT00338936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92678212|NCT00338936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92678213|NCT00338936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92678214|NCT00338936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92678215|NCT00338936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678216|NCT00338936|Diuretics|diuretics|mesh-ancestor
92403696|NCT01426542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678217|NCT00338936|Natriuretic Agents|natriuretic agents|mesh-ancestor
92678218|NCT00338936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678219|NCT00338936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92678220|NCT00338936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678222|NCT00445575|Etidronic Acid|etidronic acid|mesh-list
92678223|NCT00445575|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92678224|NCT00445575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678225|NCT00445575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678226|NCT00445575|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678227|NCT00445575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678228|NCT00445575|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92678229|NCT00451815|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|mesh-list
92678230|NCT00451815|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92678231|NCT00451815|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92678232|NCT00451815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92678233|NCT00451815|Purinergic Agents|purinergic agents|mesh-ancestor
92678234|NCT00451815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678235|NCT00451815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678236|NCT00451815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678237|NCT00339014|Zonisamide|zonisamide|mesh-list
92678238|NCT00339014|Bupropion|bupropion|mesh-list
92678239|NCT00339014|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92678240|NCT00339014|Antidepressive Agents|antidepressive agents|mesh-ancestor
92678241|NCT00339014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92678242|NCT00339014|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92678243|NCT00339014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92678244|NCT00339014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678245|NCT00339014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678246|NCT00339014|Dopamine Agents|dopamine agents|mesh-ancestor
92678247|NCT00339014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678248|NCT00339014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678249|NCT00339014|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92678250|NCT00339014|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92678251|NCT00339014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678252|NCT00339014|Anticonvulsants|anticonvulsants|mesh-ancestor
92678253|NCT00339014|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92678254|NCT00339014|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678255|NCT00420953|Amiodarone|amiodarone|mesh-list
92678256|NCT00420953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92678257|NCT00420953|Vasodilator Agents|vasodilator agents|mesh-ancestor
92678258|NCT00420953|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92678259|NCT00420953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678260|NCT00420953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678261|NCT00420953|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92678262|NCT00420953|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92678263|NCT00420953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92678264|NCT00420953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678265|NCT00420953|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92085811|NCT00722566|Bortezomib|bortezomib|mesh-list
92678269|NCT00425204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92678270|NCT00425204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678271|NCT00425243|Zolpidem|zolpidem|mesh-list
92678272|NCT00425243|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92678273|NCT00425243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92678274|NCT00425243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678275|NCT00425243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012557|NCT05045443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605087|NCT00126542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92605088|NCT00126542|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92605089|NCT00126542|Antibodies|antibodies|mesh-list
92605090|NCT00126542|Immunoglobulins|immunoglobulins|mesh-list
92605091|NCT00126542|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92605092|NCT00126542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605093|NCT00126542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92605094|NCT00126542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92605095|NCT00126542|Growth Substances|growth substances|mesh-ancestor
92605096|NCT00126542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605097|NCT00126542|Growth Inhibitors|growth inhibitors|mesh-ancestor
92605098|NCT00126542|Immunologic Factors|immunologic factors|mesh-ancestor
92605099|NCT00126542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605100|NCT00126542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605101|NCT00126542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605102|NCT00493324|Alefacept|alefacept|mesh-list
92605103|NCT00493324|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92605104|NCT00493324|Immunologic Factors|immunologic factors|mesh-ancestor
92605105|NCT00493324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605106|NCT00493324|Dermatologic Agents|dermatologic agents|mesh-ancestor
92605107|NCT01243801|Ketamine|ketamine|mesh-list
92605108|NCT01243801|Analgesics|analgesics|mesh-ancestor
92605109|NCT01243801|Sensory System Agents|sensory system agents|mesh-ancestor
92678276|NCT00425243|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92678277|NCT00425243|GABA Agonists|gaba agonists|mesh-ancestor
92678278|NCT00425243|GABA Agents|gaba agents|mesh-ancestor
92678279|NCT00425243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678280|NCT00425243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678281|NCT00339131|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92678282|NCT00339131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678283|NCT00339131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678284|NCT00339131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678285|NCT00339131|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92678286|NCT00451971|Leflunomide|leflunomide|mesh-list
92678287|NCT00451971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678288|NCT00451971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678289|NCT00451971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92678290|NCT00451971|Immunologic Factors|immunologic factors|mesh-ancestor
92678291|NCT00451971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678292|NCT00452166|Rosiglitazone|rosiglitazone|mesh-list
92678293|NCT00452166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678294|NCT00452166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678295|NCT00446004|Imatinib Mesylate|imatinib mesylate|mesh-list
92678296|NCT00446004|Omeprazole|omeprazole|mesh-list
92678297|NCT00446004|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92678298|NCT00446004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678299|NCT00446004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92678300|NCT00446004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678301|NCT00446004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678302|NCT00446004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92678303|NCT00446004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92605110|NCT01243801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605111|NCT01243801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605112|NCT01243801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92678305|NCT00446082|Hormones|hormones|mesh-ancestor
92678306|NCT00446082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678307|NCT00446082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678308|NCT03275376|Atorvastatin|atorvastatin|mesh-list
92678309|NCT03275376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678310|NCT03275376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92678311|NCT03275376|Antimetabolites|antimetabolites|mesh-ancestor
92678312|NCT03275376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678313|NCT03275376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678314|NCT03275376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92678315|NCT03275376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678316|NCT00340184|Paclitaxel|paclitaxel|mesh-list
92678317|NCT00340184|Carboplatin|carboplatin|mesh-list
92678318|NCT00340184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92678319|NCT00340184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678320|NCT00340184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678321|NCT00340184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678322|NCT00340184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678323|NCT00340184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678324|NCT00446316|Imatinib Mesylate|imatinib mesylate|mesh-list
92678325|NCT00446316|Antacids|antacids|mesh-list
92678326|NCT00446316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678327|NCT00446316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92678328|NCT00446316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678329|NCT00446316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678330|NCT00446316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92678331|NCT00446433|Lenalidomide|lenalidomide|mesh-list
92678332|NCT00446433|Immunologic Factors|immunologic factors|mesh-ancestor
92678333|NCT00446433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678334|NCT00446433|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92678335|NCT00446433|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92678336|NCT00446433|Growth Substances|growth substances|mesh-ancestor
92678342|NCT00340574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678344|NCT00340574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678345|NCT00340574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92678346|NCT00340613|Insulin Glargine|insulin glargine|mesh-list
92678347|NCT00340613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678348|NCT00340613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678349|NCT00340691|Doxycycline|doxycycline|mesh-list
92678350|NCT00340691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678351|NCT00340691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678352|NCT00340691|Antimalarials|antimalarials|mesh-ancestor
92678353|NCT00340691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92678354|NCT00340691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678355|NCT00452244|Gefitinib|gefitinib|mesh-list
92678356|NCT00452244|Simvastatin|simvastatin|mesh-list
92678357|NCT00452244|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678358|NCT00452244|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92678359|NCT00452244|Antimetabolites|antimetabolites|mesh-ancestor
92678360|NCT00452244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678361|NCT00452244|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678362|NCT00452244|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92678363|NCT00452244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678364|NCT00452244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678365|NCT00452244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92678366|NCT00446472|Becaplermin|becaplermin|mesh-list
92678367|NCT00446472|Anticoagulants|anticoagulants|mesh-ancestor
92678368|NCT00446472|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92678369|NCT00446472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92678370|NCT00446472|Growth Substances|growth substances|mesh-ancestor
92678371|NCT00446472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678372|NCT00446589|Teriparatide|teriparatide|mesh-list
92678373|NCT00446589|Ibandronic Acid|ibandronic acid|mesh-list
92678374|NCT00446589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678375|NCT00446589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678376|NCT00446589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92678377|NCT00452322|Methyltestosterone|methyltestosterone|mesh-list
92605113|NCT01243801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92605114|NCT01243801|Anesthetics, General|anesthetics, general|mesh-ancestor
92605115|NCT01243801|Anesthetics|anesthetics|mesh-ancestor
92012581|NCT05060419|Tazobactam|tazobactam|mesh-list
92678378|NCT00452322|Testosterone|testosterone|mesh-list
92678379|NCT00452322|Testosterone undecanoate|testosterone undecanoate|mesh-list
92678380|NCT00452322|Testosterone enanthate|testosterone enanthate|mesh-list
92678381|NCT00452322|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92678382|NCT00452322|Androgens|androgens|mesh-ancestor
92678383|NCT00452322|Hormones|hormones|mesh-ancestor
92678384|NCT00452322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678385|NCT00452322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678386|NCT00452322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92678387|NCT00452322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678388|NCT00452322|Anabolic Agents|anabolic agents|mesh-ancestor
92678389|NCT00452556|Docetaxel|docetaxel|mesh-list
92678390|NCT00452556|Leuprolide|leuprolide|mesh-list
92678391|NCT00452556|Androgens|androgens|mesh-list
92678392|NCT00452556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678393|NCT00452556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678394|NCT00452556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678395|NCT00452556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678396|NCT00452556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678397|NCT00452556|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92678398|NCT00452556|Fertility Agents|fertility agents|mesh-ancestor
92678399|NCT00452556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92678400|NCT00452556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678401|NCT00452556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92678402|NCT00452556|Hormones|hormones|mesh-ancestor
92678403|NCT00452556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678404|NCT00446667|Mannitol|mannitol|mesh-list
92678405|NCT00446667|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92678406|NCT00446667|Diuretics|diuretics|mesh-ancestor
92678407|NCT00446667|Natriuretic Agents|natriuretic agents|mesh-ancestor
92678411|NCT03277755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678412|NCT00452595|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92678413|NCT00452595|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92678414|NCT00452595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92678415|NCT00452595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678416|NCT00452595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678417|NCT00452595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678418|NCT00452595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678419|NCT00452595|Antidepressive Agents|antidepressive agents|mesh-ancestor
92678420|NCT00452595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92678421|NCT00341432|Nicotine|nicotine|mesh-list
92678422|NCT00341432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92678423|NCT00341432|Autonomic Agents|autonomic agents|mesh-ancestor
92678424|NCT00341432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678425|NCT00341432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678426|NCT00341432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92678427|NCT00341432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92678428|NCT00341432|Cholinergic Agents|cholinergic agents|mesh-ancestor
92678429|NCT00341432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678430|NCT00341432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678431|NCT00452634|Irinotecan|irinotecan|mesh-list
92678432|NCT00452634|Simvastatin|simvastatin|mesh-list
92678433|NCT00452634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678434|NCT00452634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92678435|NCT00452634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92678436|NCT00452634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678437|NCT00452634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678438|NCT00452634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678440|NCT00452634|Antimetabolites|antimetabolites|mesh-ancestor
92678441|NCT00452634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678442|NCT00452634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92678443|NCT03277599|Tramadol|tramadol|mesh-list
92678444|NCT03277599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92678445|NCT03277599|Narcotics|narcotics|mesh-ancestor
92678446|NCT03277599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678447|NCT03277599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678448|NCT03277599|Analgesics|analgesics|mesh-ancestor
92678449|NCT03277599|Sensory System Agents|sensory system agents|mesh-ancestor
92605116|NCT01243801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605117|NCT01243801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92605118|NCT01243801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92330097|NCT00004190|Antimetabolites|antimetabolites|mesh-ancestor
92605119|NCT01243801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605120|NCT01243801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605121|NCT00126620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92605123|NCT00126620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605124|NCT00126620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92678450|NCT03277599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678451|NCT00452829|Folic Acid|folic acid|mesh-list
92678452|NCT00452829|Vitamin B Complex|vitamin b complex|mesh-list
92678453|NCT00452829|Inositol|inositol|mesh-list
92678454|NCT00452829|Hematinics|hematinics|mesh-ancestor
92678455|NCT00452829|Vitamins|vitamins|mesh-ancestor
92678456|NCT00452829|Micronutrients|micronutrients|mesh-ancestor
92678457|NCT00452829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678458|NCT00452907|Artesunate|artesunate|mesh-list
92678459|NCT00452907|Lumefantrine|lumefantrine|mesh-list
92678460|NCT00452907|Pyrimethamine|pyrimethamine|mesh-list
92678461|NCT00452907|Sulfadoxine|sulfadoxine|mesh-list
92678462|NCT00452907|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92678463|NCT00452907|Antimalarials|antimalarials|mesh-ancestor
92678464|NCT00452907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92678465|NCT00452907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678466|NCT00452907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678467|NCT00452907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678468|NCT00452907|Antiviral Agents|antiviral agents|mesh-ancestor
92678469|NCT00452907|Schistosomicides|schistosomicides|mesh-ancestor
92678470|NCT00452907|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92678471|NCT00452907|Anthelmintics|anthelmintics|mesh-ancestor
92678472|NCT00452907|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92678473|NCT00452907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678474|NCT00452907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678475|NCT00452907|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92678476|NCT00446784|Methotrexate|methotrexate|mesh-list
92678477|NCT00446784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92678478|NCT00446784|Abortifacient Agents|abortifacient agents|mesh-ancestor
92678479|NCT00446784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92678480|NCT00446784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086020|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678485|NCT00446784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92678486|NCT00446784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678487|NCT00446784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92678488|NCT00446784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92678489|NCT00446784|Immunologic Factors|immunologic factors|mesh-ancestor
92678490|NCT00446784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92678491|NCT00446784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92678492|NCT00452985|Carboplatin|carboplatin|mesh-list
92678493|NCT00452985|Docetaxel|docetaxel|mesh-list
92678494|NCT00452985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678495|NCT00452985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678496|NCT00452985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678497|NCT00452985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678498|NCT00452985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678499|NCT03277209|Plerixafor|plerixafor|mesh-list
92678500|NCT03277209|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92678501|NCT03277209|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678502|NCT03277209|Antiviral Agents|antiviral agents|mesh-ancestor
92678503|NCT03277209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678504|NCT00453141|Betamethasone|betamethasone|mesh-list
92678505|NCT00453141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92678506|NCT00453141|Glucocorticoids|glucocorticoids|mesh-ancestor
92678507|NCT00453141|Hormones|hormones|mesh-ancestor
92678508|NCT00453141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678509|NCT00453141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605125|NCT00126620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605126|NCT00126620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605127|NCT00493363|Artesunate|artesunate|mesh-list
92605128|NCT00493363|Mefloquine|mefloquine|mesh-list
92605129|NCT00493363|Antimalarials|antimalarials|mesh-ancestor
92605130|NCT00493363|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92605131|NCT00493363|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92605132|NCT00493363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678510|NCT00453141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92367371|NCT00824460|Iron|iron|mesh-list
92678511|NCT00453141|Respiratory System Agents|respiratory system agents|mesh-ancestor
92678512|NCT00421109|Levocetirizine|levocetirizine|mesh-list
92678513|NCT00421109|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92678514|NCT00421109|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92678515|NCT00421109|Histamine Antagonists|histamine antagonists|mesh-ancestor
92678516|NCT00421109|Histamine Agents|histamine agents|mesh-ancestor
92678517|NCT00421109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678518|NCT00421109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678519|NCT00421109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678520|NCT02273583|Cyclophosphamide|cyclophosphamide|mesh-list
92678521|NCT02273583|Methotrexate|methotrexate|mesh-list
92678522|NCT02273583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92678523|NCT02273583|Immunologic Factors|immunologic factors|mesh-ancestor
92678524|NCT02273583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678525|NCT02273583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92678526|NCT02273583|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92678527|NCT02273583|Alkylating Agents|alkylating agents|mesh-ancestor
92678528|NCT02273583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678529|NCT02273583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678530|NCT02273583|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92678531|NCT02273583|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92678532|NCT02273583|Abortifacient Agents|abortifacient agents|mesh-ancestor
92678533|NCT02273583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92678534|NCT02273583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92678535|NCT02273583|Antimetabolites|antimetabolites|mesh-ancestor
92678536|NCT02273583|Dermatologic Agents|dermatologic agents|mesh-ancestor
92678537|NCT02273583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678538|NCT02273583|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92678539|NCT02273583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92678540|NCT00446862|Losartan|losartan|mesh-list
92678541|NCT00446862|Enalapril|enalapril|mesh-list
92678542|NCT00446862|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92678543|NCT00446862|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92678544|NCT00446862|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92678545|NCT00446862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92678546|NCT00446862|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92678547|NCT00446862|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92678548|NCT00446862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678549|NCT00446862|Protease Inhibitors|protease inhibitors|mesh-ancestor
92678550|NCT00446901|Selenium|selenium|mesh-list
92678552|NCT00446901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678554|NCT00446901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678555|NCT00446901|Trace Elements|trace elements|mesh-ancestor
92678556|NCT00446901|Micronutrients|micronutrients|mesh-ancestor
92678557|NCT00453375|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
92678558|NCT00453375|Antioxidants|antioxidants|mesh-ancestor
92678559|NCT00453375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678560|NCT00453375|Protective Agents|protective agents|mesh-ancestor
92678561|NCT00453375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678562|NCT00446940|Atorvastatin|atorvastatin|mesh-list
92678563|NCT00446940|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92678564|NCT00446940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678565|NCT00446940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92678566|NCT00446940|Antimetabolites|antimetabolites|mesh-ancestor
92678567|NCT00446940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678568|NCT00446940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678569|NCT00446940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92012599|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92605133|NCT00493363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605134|NCT00493363|Antiviral Agents|antiviral agents|mesh-ancestor
92605135|NCT00493363|Schistosomicides|schistosomicides|mesh-ancestor
92605136|NCT00493363|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92605137|NCT00493363|Anthelmintics|anthelmintics|mesh-ancestor
92605138|NCT00126698|Ciprofloxacin|ciprofloxacin|mesh-list
92605139|NCT00126698|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92605140|NCT00126698|Trimethoprim|trimethoprim|mesh-list
92605141|NCT00126698|Sulfamethoxazole|sulfamethoxazole|mesh-list
92605142|NCT00126698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605143|NCT00126698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605144|NCT00126698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92605145|NCT00126698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92605146|NCT00126698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012600|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678570|NCT00446940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678571|NCT00453414|Iloprost|iloprost|mesh-list
92678572|NCT00453414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92678573|NCT00453414|Vasodilator Agents|vasodilator agents|mesh-ancestor
92678574|NCT00446979|UC-781|uc-781|mesh-list
92678575|NCT00446979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678576|NCT00446979|Antiviral Agents|antiviral agents|mesh-ancestor
92678577|NCT00446979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678578|NCT00453453|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92678579|NCT00453453|Natriuretic Agents|natriuretic agents|mesh-ancestor
92678580|NCT00453453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678581|NCT00447018|Mannitol|mannitol|mesh-list
92678582|NCT00447018|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92678583|NCT00447018|Diuretics|diuretics|mesh-ancestor
92678584|NCT00447018|Natriuretic Agents|natriuretic agents|mesh-ancestor
92678585|NCT00447018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678586|NCT00343070|Escitalopram|escitalopram|mesh-list
92678587|NCT00343070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92678588|NCT00343070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92404072|NCT01428544|PENTA|penta|mesh-list
92678589|NCT00343070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678590|NCT00343070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678591|NCT00343070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678592|NCT00343070|Serotonin Agents|serotonin agents|mesh-ancestor
92678593|NCT00343070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678594|NCT00453492|Risedronic Acid|risedronic acid|mesh-list
92678595|NCT00453492|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92678596|NCT00453492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678597|NCT00453492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678598|NCT00453492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678599|NCT00453492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678600|NCT00453492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92678601|NCT00343187|Dapsone|dapsone|mesh-list
92678602|NCT00343187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678603|NCT00343187|Antimalarials|antimalarials|mesh-ancestor
92678604|NCT00343187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92678605|NCT00343187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678606|NCT00343187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92678607|NCT00343187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678608|NCT00343187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678609|NCT00343187|Leprostatic Agents|leprostatic agents|mesh-ancestor
92367397|NCT00826800|Bevacizumab|bevacizumab|mesh-list
92678610|NCT00343187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678611|NCT00343226|Basiliximab|basiliximab|mesh-list
92678612|NCT00343226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605147|NCT00126698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605148|NCT00126698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605149|NCT00126698|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92605150|NCT00126698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92605151|NCT00126698|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92605152|NCT00126698|Antimalarials|antimalarials|mesh-ancestor
92605153|NCT00126698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92605154|NCT00126698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92605155|NCT00126698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92605156|NCT00126698|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92605157|NCT00126698|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92605158|NCT00493402|Chlorotrianisene|chlorotrianisene|mesh-list
92605159|NCT00493402|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92605160|NCT00493402|Estrogens|estrogens|mesh-ancestor
92678613|NCT00343226|Immunologic Factors|immunologic factors|mesh-ancestor
92678614|NCT00343226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678615|NCT00343265|Progesterone|progesterone|mesh-list
92678616|NCT00343265|Progestins|progestins|mesh-ancestor
92678617|NCT00343265|Hormones|hormones|mesh-ancestor
92678618|NCT00343265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678619|NCT00343265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678620|NCT00453609|Naltrexone|naltrexone|mesh-list
92678621|NCT00453609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92678622|NCT00453609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92086164|NCT02984865|Dsuvia|dsuvia|mesh-list
92678625|NCT00453609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678627|NCT00447213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92678628|NCT00447213|Insulin Glargine|insulin glargine|mesh-list
92678629|NCT00447213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678630|NCT00447213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678631|NCT00453648|Vitamin A|vitamin a|mesh-list
92678632|NCT00453648|Retinol palmitate|retinol palmitate|mesh-list
92678633|NCT00453648|Antioxidants|antioxidants|mesh-ancestor
92678634|NCT00453648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678635|NCT00453648|Protective Agents|protective agents|mesh-ancestor
92678636|NCT00453648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678637|NCT00453648|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92678638|NCT00453648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678639|NCT00453648|Vitamins|vitamins|mesh-ancestor
92678640|NCT00453648|Micronutrients|micronutrients|mesh-ancestor
92678641|NCT00343421|Vaccines|vaccines|mesh-list
92678642|NCT00343421|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92678643|NCT00343421|Immunologic Factors|immunologic factors|mesh-ancestor
92678644|NCT00343421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678645|NCT00343499|Valsartan|valsartan|mesh-list
92678646|NCT00343499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92678647|NCT00343499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92678648|NCT00343499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92678649|NCT00343499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678650|NCT04715360|Favipiravir|favipiravir|mesh-list
92678651|NCT04715360|Antiviral Agents|antiviral agents|mesh-ancestor
92678652|NCT04715360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678653|NCT00447369|Pregabalin|pregabalin|mesh-list
92678654|NCT00447369|Valproic Acid|valproic acid|mesh-list
92678655|NCT00447369|Analgesics|analgesics|mesh-ancestor
92678656|NCT00447369|Sensory System Agents|sensory system agents|mesh-ancestor
92678657|NCT00447369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678658|NCT00447369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678659|NCT00447369|Anticonvulsants|anticonvulsants|mesh-ancestor
92678660|NCT00447369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92678661|NCT00447369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92605161|NCT00493402|Hormones|hormones|mesh-ancestor
92605162|NCT00493402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605163|NCT00493402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605164|NCT00493402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605165|NCT00493402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605166|NCT00145938|Sildenafil Citrate|sildenafil citrate|mesh-list
92605167|NCT00145938|Vasodilator Agents|vasodilator agents|mesh-ancestor
92605168|NCT00145938|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92605169|NCT00145938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92605170|NCT00145938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605171|NCT00145938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605172|NCT00145938|Urological Agents|urological agents|mesh-ancestor
92605173|NCT00493480|Propranolol|propranolol|mesh-list
92605174|NCT00493480|Carvedilol|carvedilol|mesh-list
92605175|NCT00493480|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92605176|NCT00493480|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92605177|NCT00493480|Adrenergic Agents|adrenergic agents|mesh-ancestor
92605178|NCT00493480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605179|NCT00493480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605180|NCT00493480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605181|NCT00493480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92605182|NCT00493480|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92605183|NCT00493480|Vasodilator Agents|vasodilator agents|mesh-ancestor
92605184|NCT00493480|Antioxidants|antioxidants|mesh-ancestor
92605185|NCT00493480|Protective Agents|protective agents|mesh-ancestor
92605186|NCT00493480|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92678662|NCT00447369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678663|NCT00447369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678664|NCT00447369|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92678665|NCT00447369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92678666|NCT00447369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678667|NCT00447369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92678668|NCT00447369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678669|NCT00447369|GABA Agents|gaba agents|mesh-ancestor
92678670|NCT00447369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678671|NCT00447369|Antimanic Agents|antimanic agents|mesh-ancestor
92678672|NCT00343655|Atorvastatin|atorvastatin|mesh-list
92678673|NCT00343655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678674|NCT00343655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92678675|NCT00343655|Antimetabolites|antimetabolites|mesh-ancestor
92678676|NCT00343655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678677|NCT00343655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678678|NCT00343655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92678679|NCT00343655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678680|NCT00453765|Montelukast|montelukast|mesh-list
92678681|NCT00453765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92678682|NCT00453765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92605187|NCT00493480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92605188|NCT00493480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92605189|NCT00493480|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92605190|NCT00493480|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92605191|NCT01243996|Ibuprofen|ibuprofen|mesh-list
92330176|NCT00004868|Semaxinib|semaxinib|mesh-list
92605192|NCT01243996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92605193|NCT01243996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92605194|NCT01243996|Analgesics|analgesics|mesh-ancestor
92605195|NCT01243996|Sensory System Agents|sensory system agents|mesh-ancestor
92605196|NCT01243996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605197|NCT01243996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605198|NCT01243996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605199|NCT01243996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605200|NCT01243996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92605201|NCT01243996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367424|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605202|NCT01243996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605203|NCT01244113|Propofol|propofol|mesh-list
92605204|NCT01244113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92605205|NCT01244113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605206|NCT01244113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605207|NCT01244113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92605208|NCT01244113|Anesthetics, General|anesthetics, general|mesh-ancestor
92605209|NCT01244113|Anesthetics|anesthetics|mesh-ancestor
92605210|NCT00405249|Dexelvucitabine|dexelvucitabine|mesh-list
92605211|NCT00405249|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92605212|NCT00405249|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92605213|NCT00405249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605214|NCT00405249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605215|NCT00405249|Antiviral Agents|antiviral agents|mesh-ancestor
92605216|NCT00405249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605217|NCT00405249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92605218|NCT00405249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92605219|NCT00493987|Methyltestosterone|methyltestosterone|mesh-list
92605220|NCT00493987|Testosterone|testosterone|mesh-list
92678683|NCT00453765|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92678684|NCT00453765|Hormone Antagonists|hormone antagonists|mesh-ancestor
92012689|NCT04821323|Analgesics|analgesics|mesh-ancestor
92605221|NCT00493987|Testosterone undecanoate|testosterone undecanoate|mesh-list
92605222|NCT00493987|Testosterone enanthate|testosterone enanthate|mesh-list
92605223|NCT00493987|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92605224|NCT00493987|Dutasteride|dutasteride|mesh-list
92605225|NCT00493987|Androgens|androgens|mesh-ancestor
92605226|NCT00493987|Hormones|hormones|mesh-ancestor
92605227|NCT00493987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605228|NCT00493987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605229|NCT00493987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605230|NCT00493987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605231|NCT00493987|Anabolic Agents|anabolic agents|mesh-ancestor
92605232|NCT00493987|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92605233|NCT00493987|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92605234|NCT00493987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605235|NCT00493987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605236|NCT00493987|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605237|NCT00494104|Vitamin D|vitamin d|mesh-list
92605238|NCT00494104|Vitamins|vitamins|mesh-ancestor
92605239|NCT00494104|Micronutrients|micronutrients|mesh-ancestor
92605240|NCT00494104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605241|NCT00494104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92605242|NCT00405366|Sorafenib|sorafenib|mesh-list
92605243|NCT00405366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605244|NCT00405366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605245|NCT00405366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605246|NCT00405366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678685|NCT00453765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678686|NCT00453765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678687|NCT00453765|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92678688|NCT00453765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92678689|NCT00453765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678690|NCT00343733|Fentanyl|fentanyl|mesh-list
92678691|NCT00343733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92678692|NCT00343733|Narcotics|narcotics|mesh-ancestor
92678693|NCT00343733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086240|NCT03586791|Anesthetics|anesthetics|mesh-list
92678695|NCT00343733|Analgesics|analgesics|mesh-ancestor
92678696|NCT00343733|Sensory System Agents|sensory system agents|mesh-ancestor
92678697|NCT00343733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678698|NCT00343733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92678699|NCT00343733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92678700|NCT00343733|Anesthetics, General|anesthetics, general|mesh-ancestor
92678701|NCT00343733|Anesthetics|anesthetics|mesh-ancestor
92678702|NCT00343811|Modafinil|modafinil|mesh-list
92678703|NCT00343811|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92678704|NCT00343811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605247|NCT00494338|Docetaxel|docetaxel|mesh-list
92605248|NCT00494338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605249|NCT00494338|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605250|NCT00494338|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605251|NCT00494338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605252|NCT00494338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605253|NCT00494377|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92605254|NCT00494377|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92605255|NCT00494377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92605256|NCT00494377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92605257|NCT00494377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605258|NCT00494377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605259|NCT00494377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605260|NCT00494377|Analgesics|analgesics|mesh-ancestor
92605261|NCT00494377|Sensory System Agents|sensory system agents|mesh-ancestor
92605262|NCT00494377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605263|NCT00494377|Antidepressive Agents|antidepressive agents|mesh-ancestor
92605264|NCT00494377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605265|NCT00494377|Dopamine Agents|dopamine agents|mesh-ancestor
92605266|NCT00146016|Amantadine|amantadine|mesh-list
92605267|NCT00146016|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92605268|NCT00146016|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92605269|NCT00146016|Antiviral Agents|antiviral agents|mesh-ancestor
92605270|NCT00146016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605271|NCT00146016|Dopamine Agents|dopamine agents|mesh-ancestor
92605272|NCT00146016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605273|NCT00146016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605274|NCT00146016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605275|NCT00146016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92678705|NCT00343811|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92678706|NCT00343811|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92678707|NCT00343811|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92678708|NCT00343811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678709|NCT00453804|Naltrexone|naltrexone|mesh-list
92678710|NCT00453804|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92678711|NCT00453804|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92678712|NCT00453804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678713|NCT00453804|Sensory System Agents|sensory system agents|mesh-ancestor
92678714|NCT00453804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678715|NCT00343850|Mesalamine|mesalamine|mesh-list
92678716|NCT00343850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92678717|NCT00343850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92678718|NCT00343850|Analgesics|analgesics|mesh-ancestor
92605276|NCT00146016|Analgesics|analgesics|mesh-ancestor
92605277|NCT00146016|Sensory System Agents|sensory system agents|mesh-ancestor
92605278|NCT00146016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605279|NCT00126971|Dapsone|dapsone|mesh-list
92605280|NCT00126971|Chlorproguanil|chlorproguanil|mesh-list
92605281|NCT00126971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605282|NCT00126971|Antimalarials|antimalarials|mesh-ancestor
92605283|NCT00126971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92605284|NCT00126971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92605285|NCT00126971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92605286|NCT00126971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605287|NCT00126971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605288|NCT00126971|Leprostatic Agents|leprostatic agents|mesh-ancestor
92605289|NCT00126971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605290|NCT01244230|Fexofenadine|fexofenadine|mesh-list
92605291|NCT01244230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92605292|NCT01244230|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92605293|NCT01244230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92605294|NCT01244230|Histamine Antagonists|histamine antagonists|mesh-ancestor
92605295|NCT01244230|Histamine Agents|histamine agents|mesh-ancestor
92605296|NCT01244230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012746|NCT04816253|Hormones|hormones|mesh-ancestor
92678719|NCT00343850|Sensory System Agents|sensory system agents|mesh-ancestor
92678720|NCT00343850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678721|NCT00343850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678722|NCT00343850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92678723|NCT00343850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92678724|NCT00344006|Artesunate|artesunate|mesh-list
92678725|NCT00344006|Lumefantrine|lumefantrine|mesh-list
92678726|NCT00344006|Artemether|artemether|mesh-list
92678727|NCT00344006|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92678728|NCT00344006|Dapsone|dapsone|mesh-list
92678729|NCT00344006|Chlorproguanil|chlorproguanil|mesh-list
92678730|NCT00344006|Proguanil|proguanil|mesh-list
92678731|NCT00344006|Antimalarials|antimalarials|mesh-ancestor
92678732|NCT00344006|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92678733|NCT00344006|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678734|NCT00344006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678735|NCT00344006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678736|NCT00344006|Antiviral Agents|antiviral agents|mesh-ancestor
92678737|NCT00344006|Schistosomicides|schistosomicides|mesh-ancestor
92678738|NCT00344006|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92678739|NCT00344006|Anthelmintics|anthelmintics|mesh-ancestor
92678740|NCT00344006|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92678741|NCT00344006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678742|NCT00344006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678743|NCT00344006|Leprostatic Agents|leprostatic agents|mesh-ancestor
92678744|NCT00344006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678745|NCT00344006|Antimetabolites|antimetabolites|mesh-ancestor
92678746|NCT02273661|Amphotericin B|amphotericin b|mesh-list
92678747|NCT02273661|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92678748|NCT02273661|Amebicides|amebicides|mesh-ancestor
92678749|NCT02273661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92678750|NCT02273661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678751|NCT02273661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678752|NCT02273661|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678753|NCT02273661|Antifungal Agents|antifungal agents|mesh-ancestor
92605297|NCT01244230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605298|NCT01244230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605299|NCT01244269|Methylphenidate|methylphenidate|mesh-list
92605300|NCT01244269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92605301|NCT01244269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605302|NCT01244269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92605303|NCT01244269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92605304|NCT01244269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92605305|NCT01244269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605306|NCT01244269|Dopamine Agents|dopamine agents|mesh-ancestor
92605307|NCT01244269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605309|NCT00127010|Immunologic Factors|immunologic factors|mesh-ancestor
92605310|NCT00127010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012767|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678754|NCT00344123|Ritonavir|ritonavir|mesh-list
92678755|NCT00344123|Tipranavir|tipranavir|mesh-list
92678756|NCT00344123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92678757|NCT00344123|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92678758|NCT00344123|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92678759|NCT00344123|Protease Inhibitors|protease inhibitors|mesh-ancestor
92678760|NCT00344123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678761|NCT00344123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678762|NCT00344123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92678763|NCT00344123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678764|NCT00344123|Antiviral Agents|antiviral agents|mesh-ancestor
92367452|NCT00832338|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678765|NCT00344123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678766|NCT00344123|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92678767|NCT00344123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92678768|NCT00344123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678769|NCT00344123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92678771|NCT00344123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678772|NCT00344123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92678773|NCT00344201|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92678774|NCT00344201|Hemostatics|hemostatics|mesh-ancestor
92678775|NCT00344201|Coagulants|coagulants|mesh-ancestor
92678776|NCT00453960|Norethindrone|norethindrone|mesh-list
92678777|NCT00453960|Norethindrone Acetate|norethindrone acetate|mesh-list
92678778|NCT00453960|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92678779|NCT00453960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92678780|NCT00453960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92678781|NCT00453960|Contraceptive Agents|contraceptive agents|mesh-ancestor
92678782|NCT00453960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92678783|NCT00453960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678784|NCT00453960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92678785|NCT00453960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92678786|NCT00447681|Fezakinumab|fezakinumab|mesh-list
92678787|NCT00447681|Dermatologic Agents|dermatologic agents|mesh-ancestor
92678788|NCT00447759|Ibuprofen|ibuprofen|mesh-list
92678789|NCT00447759|Celecoxib|celecoxib|mesh-list
92678790|NCT00447759|Diclofenac|diclofenac|mesh-list
92678791|NCT00447759|Naproxen|naproxen|mesh-list
92678792|NCT00447759|Meloxicam|meloxicam|mesh-list
92678793|NCT00447759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92678794|NCT00447759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92678795|NCT00447759|Analgesics|analgesics|mesh-ancestor
92678796|NCT00447759|Sensory System Agents|sensory system agents|mesh-ancestor
92678797|NCT00447759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605311|NCT00494533|Treprostinil|treprostinil|mesh-list
92605312|NCT00494533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92605313|NCT00494572|Montelukast|montelukast|mesh-list
92605314|NCT00494572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92605315|NCT00494572|Respiratory System Agents|respiratory system agents|mesh-ancestor
92605316|NCT00494572|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92605317|NCT00494572|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605318|NCT00494572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605319|NCT00494572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605320|NCT00494572|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92605321|NCT00494572|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92605322|NCT00494572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605323|NCT00494611|Cetuximab|cetuximab|mesh-list
92605324|NCT00494611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92605325|NCT00494611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605326|NCT00127049|Gemcitabine|gemcitabine|mesh-list
92605327|NCT00127049|Ifosfamide|ifosfamide|mesh-list
92605328|NCT00127049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605329|NCT00127049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605330|NCT00127049|Antimetabolites|antimetabolites|mesh-ancestor
92605331|NCT00127049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605332|NCT00127049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92605333|NCT00127049|Alkylating Agents|alkylating agents|mesh-ancestor
92605334|NCT00494884|Vildagliptin|vildagliptin|mesh-list
92605335|NCT00494884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92605336|NCT00494884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605337|NCT00494884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92605338|NCT00494884|Protease Inhibitors|protease inhibitors|mesh-ancestor
92330329|NCT00004886|Docetaxel|docetaxel|mesh-list
92605339|NCT00494884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678798|NCT00447759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678799|NCT00447759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92678800|NCT00447759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92678801|NCT00447759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92678802|NCT00447759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678803|NCT00447759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678804|NCT00447759|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92678805|NCT00447759|Gout Suppressants|gout suppressants|mesh-ancestor
92678806|NCT00344513|Carvedilol|carvedilol|mesh-list
92678807|NCT00344513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92678808|NCT00344513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92678809|NCT00344513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92605340|NCT00494884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605342|NCT00127088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605343|NCT00127088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605344|NCT00127088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605345|NCT00127088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605346|NCT00127088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605348|NCT02957877|Calcium heparin|calcium heparin|mesh-list
92605349|NCT02957877|Nadroparin|nadroparin|mesh-list
92605350|NCT02957877|Anticoagulants|anticoagulants|mesh-ancestor
92605351|NCT02957877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92605352|NCT02957877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92605353|NCT02957877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605354|NCT01244581|Amoxicillin|amoxicillin|mesh-list
92605355|NCT01244581|Clavulanic Acid|clavulanic acid|mesh-list
92605356|NCT01244581|Clavulanic Acids|clavulanic acids|mesh-list
92605357|NCT01244581|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92605358|NCT01244581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605359|NCT01244581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605360|NCT01244581|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92605361|NCT01244581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605362|NCT01244581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605363|NCT01244659|Tacrolimus|tacrolimus|mesh-list
92605364|NCT01244659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605365|NCT01244659|Immunologic Factors|immunologic factors|mesh-ancestor
92605366|NCT01244659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605367|NCT01244659|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92605368|NCT01244659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605369|NCT01244659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605370|NCT01244698|Clindamycin|clindamycin|mesh-list
92605371|NCT01244698|Clindamycin palmitate|clindamycin palmitate|mesh-list
92605372|NCT01244698|Clindamycin phosphate|clindamycin phosphate|mesh-list
92605373|NCT01244698|Cefazolin|cefazolin|mesh-list
92605374|NCT01244698|Cefadroxil|cefadroxil|mesh-list
92605375|NCT01244698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605376|NCT01244698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605378|NCT01244698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605379|NCT01244698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605380|NCT00495118|Risperidone|risperidone|mesh-list
92605381|NCT00495118|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92605382|NCT00495118|Serotonin Agents|serotonin agents|mesh-ancestor
92605383|NCT00495118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605384|NCT00495118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605385|NCT00495118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605386|NCT00495118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92605387|NCT00495118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92605388|NCT00495118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605389|NCT00495118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605390|NCT00495118|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92605391|NCT00495118|Dopamine Agents|dopamine agents|mesh-ancestor
92605392|NCT00495313|Metronidazole|metronidazole|mesh-list
92605393|NCT00495313|Doxycycline|doxycycline|mesh-list
92605394|NCT00495313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605395|NCT00495313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605396|NCT00495313|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92605397|NCT00495313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92605398|NCT00495313|Antimalarials|antimalarials|mesh-ancestor
92605399|NCT00495352|Bupropion|bupropion|mesh-list
92605400|NCT00495352|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92605401|NCT00495352|Antidepressive Agents|antidepressive agents|mesh-ancestor
92605402|NCT00495352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605403|NCT00495352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92605404|NCT00495352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92605405|NCT00495352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92605406|NCT00495352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605407|NCT00495352|Dopamine Agents|dopamine agents|mesh-ancestor
92605408|NCT00495352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605409|NCT00495352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605410|NCT00495352|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92605411|NCT00495352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92605412|NCT00495352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605413|NCT00495547|Azacitidine|azacitidine|mesh-list
92605414|NCT00495547|Epoetin Alfa|epoetin alfa|mesh-list
92605415|NCT00495547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605416|NCT00495547|Antimetabolites|antimetabolites|mesh-ancestor
92605417|NCT00495547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605418|NCT00495547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605419|NCT00495547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605420|NCT00495547|Hematinics|hematinics|mesh-ancestor
92605421|NCT00495781|Iron|iron|mesh-list
92605422|NCT00495781|Trace Elements|trace elements|mesh-ancestor
92605423|NCT00495781|Micronutrients|micronutrients|mesh-ancestor
92605424|NCT00495781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605425|NCT00405405|Bevacizumab|bevacizumab|mesh-list
92605426|NCT00405405|Cisplatin|cisplatin|mesh-list
92605427|NCT00405405|Docetaxel|docetaxel|mesh-list
92605428|NCT00405405|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92605429|NCT00405405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92605430|NCT00405405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605431|NCT00405405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92605432|NCT00405405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92605433|NCT00405405|Growth Substances|growth substances|mesh-ancestor
92605434|NCT00405405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605435|NCT00405405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92605436|NCT00405405|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605437|NCT00405405|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605438|NCT00405405|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605439|NCT00405405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605440|NCT00405405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605441|NCT00405405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605442|NCT00495898|Sirolimus|sirolimus|mesh-list
92605443|NCT00495898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605444|NCT00495898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605445|NCT00495898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92678810|NCT00344513|Adrenergic Agents|adrenergic agents|mesh-ancestor
92678811|NCT00344513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678812|NCT00344513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678813|NCT00344513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678814|NCT00344513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92678815|NCT00344513|Antioxidants|antioxidants|mesh-ancestor
92678816|NCT00344513|Protective Agents|protective agents|mesh-ancestor
92678817|NCT00344513|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92367495|NCT00835224|Midodrine|midodrine|mesh-list
92678818|NCT00344513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678819|NCT00344513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678820|NCT00344513|Vasodilator Agents|vasodilator agents|mesh-ancestor
92678821|NCT00344513|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92678822|NCT00344513|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92605446|NCT00495898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605447|NCT00495898|Antifungal Agents|antifungal agents|mesh-ancestor
92605448|NCT00495898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605449|NCT00495898|Immunologic Factors|immunologic factors|mesh-ancestor
92605450|NCT00495898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605451|NCT00496093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92605452|NCT00496093|Immunologic Factors|immunologic factors|mesh-ancestor
92605453|NCT00496093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605454|NCT00127478|Atrasentan|atrasentan|mesh-list
92605455|NCT00127478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605456|NCT00127478|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92605457|NCT00127478|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92605458|NCT00127478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605459|NCT00146211|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92605460|NCT00146211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92605461|NCT00146211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92605462|NCT00496405|Bevacizumab|bevacizumab|mesh-list
92605463|NCT00496405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92678823|NCT00344513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92678824|NCT00344513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678826|NCT00344552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92678827|NCT00344552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678828|NCT00344552|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678829|NCT00344552|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678830|NCT00344552|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678831|NCT00344552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678832|NCT00447915|Vitamin D|vitamin d|mesh-list
92678833|NCT00447915|Cholecalciferol|cholecalciferol|mesh-list
92678834|NCT00447915|Ibandronic Acid|ibandronic acid|mesh-list
92678835|NCT00447915|Calcium|calcium|mesh-list
92678836|NCT00447915|Vitamins|vitamins|mesh-ancestor
92678837|NCT00447915|Micronutrients|micronutrients|mesh-ancestor
92678838|NCT00447915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678839|NCT00447915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92678840|NCT00447915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92678841|NCT00344669|Albendazole|albendazole|mesh-list
92678842|NCT00344669|Anthelmintics|anthelmintics|mesh-ancestor
92678843|NCT00344669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92678844|NCT00344669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678845|NCT00344669|Anticestodal Agents|anticestodal agents|mesh-ancestor
92678849|NCT00344669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678850|NCT00344669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678851|NCT00344669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678852|NCT00344669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678853|NCT04715165|Dexmedetomidine|dexmedetomidine|mesh-list
92678854|NCT04715165|Bupivacaine|bupivacaine|mesh-list
92678855|NCT04715165|Anesthetics, Local|anesthetics, local|mesh-ancestor
92678856|NCT04715165|Anesthetics|anesthetics|mesh-ancestor
92678857|NCT04715165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92678858|NCT04715165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678859|NCT04715165|Sensory System Agents|sensory system agents|mesh-ancestor
92678860|NCT04715165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678861|NCT04715165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92678862|NCT04715165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92678863|NCT04715165|Analgesics|analgesics|mesh-ancestor
92678864|NCT04715165|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92605464|NCT00496405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605465|NCT00496405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92367507|NCT00835926|Vaccines|vaccines|mesh-list
92605466|NCT00496405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92605467|NCT00496405|Growth Substances|growth substances|mesh-ancestor
92605468|NCT00496405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605469|NCT00496405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92605470|NCT00496444|Azacitidine|azacitidine|mesh-list
92605471|NCT00496444|Valproic Acid|valproic acid|mesh-list
92605472|NCT00496444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605473|NCT00496444|Antimetabolites|antimetabolites|mesh-ancestor
92605474|NCT00496444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605475|NCT00496444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605476|NCT00496444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605477|NCT00496444|Anticonvulsants|anticonvulsants|mesh-ancestor
92605478|NCT00496444|GABA Agents|gaba agents|mesh-ancestor
92605479|NCT00496444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605480|NCT00496444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605481|NCT00496444|Antimanic Agents|antimanic agents|mesh-ancestor
92605482|NCT00496444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92605483|NCT00496444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605484|NCT00496444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605485|NCT00496561|Immunomodulating Agents|immunomodulating agents|mesh-list
92605486|NCT00496561|Immunologic Factors|immunologic factors|mesh-list
92605487|NCT00496561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605488|NCT00146250|Nitrous Oxide|nitrous oxide|mesh-list
92330480|NCT00004316|Capsaicin|capsaicin|mesh-list
92605489|NCT00146250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92605490|NCT00146250|Anesthetics, General|anesthetics, general|mesh-ancestor
92605491|NCT00146250|Anesthetics|anesthetics|mesh-ancestor
92605492|NCT00146250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012938|NCT05032261|Norepinephrine|norepinephrine|mesh-list
92678865|NCT04715165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92678866|NCT04715165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92678867|NCT04715165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92678868|NCT04715165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678869|NCT04715165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678870|NCT00454233|Metformin|metformin|mesh-list
92678871|NCT00454233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92678872|NCT00454233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678873|NCT00454272|Vancomycin|vancomycin|mesh-list
92678874|NCT00454272|Teicoplanin|teicoplanin|mesh-list
92678875|NCT00454272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92678876|NCT00454272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678877|NCT00344825|Fludarabine|fludarabine|mesh-list
92678878|NCT00344825|Fludarabine phosphate|fludarabine phosphate|mesh-list
92678879|NCT00344825|Alemtuzumab|alemtuzumab|mesh-list
92605493|NCT00146250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605494|NCT00146250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92605495|NCT00146250|Analgesics|analgesics|mesh-ancestor
92605496|NCT00146250|Sensory System Agents|sensory system agents|mesh-ancestor
92605497|NCT00146250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605498|NCT00496600|Everolimus|everolimus|mesh-list
92605499|NCT00496600|Epothilone B|epothilone b|mesh-list
92605500|NCT00496600|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92605501|NCT00496600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605502|NCT00496600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605503|NCT00496600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605504|NCT00496600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605505|NCT00496600|Immunologic Factors|immunologic factors|mesh-ancestor
92605506|NCT00496600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605507|NCT00496600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605508|NCT00496600|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605509|NCT00496600|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605510|NCT00496600|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605511|NCT00127595|Gemcitabine|gemcitabine|mesh-list
92605512|NCT00127595|Oxaliplatin|oxaliplatin|mesh-list
92605513|NCT00127595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605514|NCT00127595|Antimetabolites|antimetabolites|mesh-ancestor
92367517|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605515|NCT00127595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605516|NCT00127595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605517|NCT04665765|Rituximab|rituximab|mesh-list
92605518|NCT04665765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92605519|NCT04665765|Carboplatin|carboplatin|mesh-list
92605520|NCT04665765|Etoposide|etoposide|mesh-list
92605521|NCT04665765|Etoposide phosphate|etoposide phosphate|mesh-list
92605522|NCT04665765|Ifosfamide|ifosfamide|mesh-list
92605523|NCT04665765|Isophosphamide mustard|isophosphamide mustard|mesh-list
92605524|NCT04665765|Podophyllotoxin|podophyllotoxin|mesh-list
92678880|NCT00344825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678881|NCT00344825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92678882|NCT00344825|Antimetabolites|antimetabolites|mesh-ancestor
92678883|NCT00344825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678884|NCT00344825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92678885|NCT00344825|Immunologic Factors|immunologic factors|mesh-ancestor
92678886|NCT00344825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678887|NCT00344825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92678888|NCT00448110|Diclofenac|diclofenac|mesh-list
92678889|NCT00448110|Ketorolac|ketorolac|mesh-list
92678890|NCT00448110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92678891|NCT00448110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92678892|NCT00448110|Analgesics|analgesics|mesh-ancestor
92605525|NCT04665765|Antibodies|antibodies|mesh-list
92605526|NCT04665765|Immunoglobulins|immunoglobulins|mesh-list
92605527|NCT04665765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92605528|NCT04665765|Immunoconjugates|immunoconjugates|mesh-list
92605529|NCT04665765|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92605530|NCT04665765|Immunologic Factors|immunologic factors|mesh-ancestor
92605531|NCT04665765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605532|NCT04665765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605533|NCT04665765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605534|NCT04665765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92605535|NCT04665765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92605536|NCT04665765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92605537|NCT04665765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605538|NCT04665765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605539|NCT04665765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92605540|NCT04665765|Alkylating Agents|alkylating agents|mesh-ancestor
92605541|NCT04665765|Keratolytic Agents|keratolytic agents|mesh-ancestor
92605542|NCT04665765|Dermatologic Agents|dermatologic agents|mesh-ancestor
92605543|NCT04665765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605544|NCT04665765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605545|NCT04665765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605546|NCT00497107|Calcium, Dietary|calcium, dietary|mesh-list
92605547|NCT00497107|Leucovorin|leucovorin|mesh-list
92605548|NCT00497107|Calcium|calcium|mesh-list
92605549|NCT00497107|Levoleucovorin|levoleucovorin|mesh-list
92605550|NCT00497107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92605551|NCT00497107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605552|NCT00497107|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92605553|NCT00497107|Antidotes|antidotes|mesh-ancestor
92605554|NCT00497107|Protective Agents|protective agents|mesh-ancestor
92605555|NCT00497107|Vitamin B Complex|vitamin b complex|mesh-ancestor
92605556|NCT00497107|Vitamins|vitamins|mesh-ancestor
92678893|NCT00448110|Sensory System Agents|sensory system agents|mesh-ancestor
92678894|NCT00448110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678895|NCT00448110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678896|NCT00448110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92678897|NCT00448110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92678898|NCT00448110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92678899|NCT00448110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678900|NCT00448110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678902|NCT00448149|Sorafenib|sorafenib|mesh-list
92678903|NCT00448149|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92678904|NCT00448149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92678905|NCT00448149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605557|NCT00497107|Micronutrients|micronutrients|mesh-ancestor
92605558|NCT00146289|Telmisartan|telmisartan|mesh-list
92605559|NCT00146289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92605560|NCT00146289|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92605561|NCT00146289|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92678906|NCT00448149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678907|NCT00448149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92678908|NCT00448149|Immunologic Factors|immunologic factors|mesh-ancestor
92678909|NCT00448149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678910|NCT00448149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678911|NCT00344942|Triamcinolone|triamcinolone|mesh-list
92678912|NCT00344942|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92678913|NCT00344942|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92678914|NCT00344942|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92678915|NCT00344942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92678916|NCT00344942|Glucocorticoids|glucocorticoids|mesh-ancestor
92678918|NCT00344942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92678922|NCT00344942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678923|NCT00344942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678924|NCT00454350|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92678925|NCT00454350|Vitamins|vitamins|mesh-ancestor
92678926|NCT00454350|Micronutrients|micronutrients|mesh-ancestor
92678927|NCT00454350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678928|NCT00454350|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92678929|NCT00454389|Ranibizumab|ranibizumab|mesh-list
92678930|NCT00454389|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92678931|NCT00454389|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92678932|NCT00454389|Growth Substances|growth substances|mesh-ancestor
92678933|NCT00454389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678934|NCT00454389|Growth Inhibitors|growth inhibitors|mesh-ancestor
92678935|NCT00454389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678936|NCT00344981|Tenofovir|tenofovir|mesh-list
92678937|NCT00344981|Hydroxyurea|hydroxyurea|mesh-list
92678938|NCT00344981|Antiviral Agents|antiviral agents|mesh-ancestor
92678939|NCT00344981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92678940|NCT00344981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92678941|NCT00344981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92678942|NCT00344981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678943|NCT00344981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678944|NCT00344981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92678945|NCT00344981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92678946|NCT00344981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678947|NCT00344981|Antisickling Agents|antisickling agents|mesh-ancestor
92678948|NCT00448266|Cyclophosphamide|cyclophosphamide|mesh-list
92678949|NCT00448266|Thiotepa|thiotepa|mesh-list
92678950|NCT00448266|Carboplatin|carboplatin|mesh-list
92678951|NCT00448266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92678952|NCT00448266|Immunologic Factors|immunologic factors|mesh-ancestor
92678953|NCT00448266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678954|NCT00448266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92678955|NCT00448266|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92678956|NCT00448266|Alkylating Agents|alkylating agents|mesh-ancestor
92678957|NCT00448266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678958|NCT00448266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678959|NCT00448266|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92678960|NCT00454545|Atorvastatin|atorvastatin|mesh-list
92678961|NCT00454545|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92678962|NCT00454545|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92678963|NCT00454545|Antimetabolites|antimetabolites|mesh-ancestor
92678964|NCT00454545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678965|NCT00454545|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92678966|NCT00454545|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92678967|NCT00454545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678968|NCT00345059|Gemcitabine|gemcitabine|mesh-list
92678969|NCT00345059|Capecitabine|capecitabine|mesh-list
92678970|NCT00345059|Docetaxel|docetaxel|mesh-list
92678971|NCT00345059|Vinorelbine|vinorelbine|mesh-list
92678972|NCT00345059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92678973|NCT00345059|Antimetabolites|antimetabolites|mesh-ancestor
92605562|NCT00146289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605563|NCT01244932|Bupivacaine|bupivacaine|mesh-list
92605564|NCT01244932|Anesthetics, Local|anesthetics, local|mesh-ancestor
92605565|NCT01244932|Anesthetics|anesthetics|mesh-ancestor
92678974|NCT00345059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678975|NCT00345059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678976|NCT00345059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678977|NCT00345059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678978|NCT00345059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678979|NCT00345059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92678980|NCT00345098|Amibegron|amibegron|mesh-list
92678981|NCT00345098|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92678982|NCT00345098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92678983|NCT00345098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92678984|NCT00345098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92678985|NCT00345098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678986|NCT00345098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678987|NCT00345098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678988|NCT00345098|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92678989|NCT00448305|Paclitaxel|paclitaxel|mesh-list
92086528|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
92679018|NCT00454662|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92679019|NCT00454662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92679020|NCT00454662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679021|NCT00454662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92679022|NCT00454662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679024|NCT00454662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92679025|NCT00454662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92679026|NCT00345644|Risedronic Acid|risedronic acid|mesh-list
92679027|NCT00345644|Etidronic Acid|etidronic acid|mesh-list
92679028|NCT00345644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92679029|NCT00345644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92679030|NCT00345644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679031|NCT00345644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92679032|NCT00345644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679033|NCT00345644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92679034|NCT00454701|Alefacept|alefacept|mesh-list
92679037|NCT00454701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679038|NCT00345761|Bevacizumab|bevacizumab|mesh-list
92679039|NCT00345761|Capecitabine|capecitabine|mesh-list
92679040|NCT00345761|Oxaliplatin|oxaliplatin|mesh-list
92404527|NCT01431326|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92679041|NCT00345761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679042|NCT00345761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679043|NCT00345761|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679044|NCT00345761|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679045|NCT00345761|Growth Substances|growth substances|mesh-ancestor
92679046|NCT00345761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679047|NCT00345761|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679048|NCT00345761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92679049|NCT00345761|Antimetabolites|antimetabolites|mesh-ancestor
92679050|NCT00345761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679051|NCT00345800|Sodium Oxybate|sodium oxybate|mesh-list
92679052|NCT00345800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92679053|NCT00345800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92679054|NCT00345800|Anesthetics, General|anesthetics, general|mesh-ancestor
92679055|NCT00345800|Anesthetics|anesthetics|mesh-ancestor
92679056|NCT00345800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679057|NCT00345800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679058|NCT00454740|Solifenacin Succinate|solifenacin succinate|mesh-list
92679059|NCT00454740|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92679060|NCT00454740|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92679061|NCT00454740|Cholinergic Agents|cholinergic agents|mesh-ancestor
92679062|NCT00454740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679063|NCT00454740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679064|NCT00454740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679065|NCT00454740|Urological Agents|urological agents|mesh-ancestor
92679066|NCT03276858|Midazolam|midazolam|mesh-list
92605566|NCT01244932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605568|NCT01244932|Sensory System Agents|sensory system agents|mesh-ancestor
92605569|NCT01244932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605570|NCT01244971|Acarbose|acarbose|mesh-list
92679067|NCT03276858|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92679068|NCT03276858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92679069|NCT03276858|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92679070|NCT03276858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679071|NCT03276858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679072|NCT03276858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92679073|NCT03276858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92679074|NCT03276858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92679075|NCT03276858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92679076|NCT03276858|Anesthetics, General|anesthetics, general|mesh-ancestor
92679077|NCT03276858|Anesthetics|anesthetics|mesh-ancestor
92679078|NCT03276858|GABA Modulators|gaba modulators|mesh-ancestor
92679079|NCT03276858|GABA Agents|gaba agents|mesh-ancestor
92679080|NCT03276858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679081|NCT03276858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679082|NCT00421187|Amphotericin B|amphotericin b|mesh-list
92679083|NCT00421187|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92679084|NCT00421187|Amebicides|amebicides|mesh-ancestor
92679085|NCT00421187|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92679086|NCT00421187|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92679087|NCT00421187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679088|NCT00421187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679089|NCT00421187|Antifungal Agents|antifungal agents|mesh-ancestor
92679090|NCT00454896|Solifenacin Succinate|solifenacin succinate|mesh-list
92679091|NCT00454896|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92679092|NCT00454896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92679093|NCT00454896|Cholinergic Agents|cholinergic agents|mesh-ancestor
92679094|NCT00454896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679095|NCT00454896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679096|NCT00454896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679097|NCT00454896|Urological Agents|urological agents|mesh-ancestor
92679098|NCT00346190|Alendronate|alendronate|mesh-list
92679099|NCT00346190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92679100|NCT00346190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679101|NCT00346229|Doxorubicin|doxorubicin|mesh-list
92679102|NCT00346229|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92679103|NCT00346229|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92679104|NCT00346229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679105|NCT00346229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92679106|NCT00346229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92679107|NCT00346229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679110|NCT00346385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679111|NCT00346385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679112|NCT00346385|Immunotoxins|immunotoxins|mesh-ancestor
92679113|NCT00346385|Immunoconjugates|immunoconjugates|mesh-ancestor
92679114|NCT00346385|Immunologic Factors|immunologic factors|mesh-ancestor
92679115|NCT00346385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679116|NCT00346385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92679117|NCT00448578|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92679118|NCT00448578|Antidepressive Agents|antidepressive agents|mesh-ancestor
92679119|NCT00448578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92679120|NCT00448578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92679121|NCT00448578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92679122|NCT00448578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679123|NCT00448578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679124|NCT00346463|Allopurinol|allopurinol|mesh-list
92679125|NCT00346463|Antimetabolites|antimetabolites|mesh-ancestor
92679126|NCT00346463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679127|NCT00346463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679128|NCT00346463|Gout Suppressants|gout suppressants|mesh-ancestor
92679129|NCT00346463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679130|NCT00346463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92679131|NCT00346463|Antioxidants|antioxidants|mesh-ancestor
92679132|NCT00346463|Protective Agents|protective agents|mesh-ancestor
92679133|NCT00346463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679134|NCT00455091|Lamivudine|lamivudine|mesh-list
92679135|NCT00455091|Adefovir|adefovir|mesh-list
92679136|NCT00455091|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92013044|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
92605571|NCT01244971|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92605572|NCT01244971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605573|NCT01244971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605574|NCT01244971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92605575|NCT01244971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605576|NCT04599894|Pregabalin|pregabalin|mesh-list
92605577|NCT04599894|Analgesics|analgesics|mesh-ancestor
92605578|NCT04599894|Sensory System Agents|sensory system agents|mesh-ancestor
92605579|NCT04599894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605580|NCT04599894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605581|NCT04599894|Anticonvulsants|anticonvulsants|mesh-ancestor
92605582|NCT04599894|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92605583|NCT04599894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92605584|NCT04599894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605585|NCT04599894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92605586|NCT04599894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92605587|NCT04599894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92605588|NCT04599894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679137|NCT00455091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92679138|NCT00455091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92679139|NCT00455091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679140|NCT00455091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679141|NCT00455091|Antiviral Agents|antiviral agents|mesh-ancestor
92679142|NCT00455091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679143|NCT00455091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92679144|NCT00455091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92679145|NCT00346580|Nelfinavir|nelfinavir|mesh-list
92679146|NCT00346580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92679147|NCT00346580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92679148|NCT00346580|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679149|NCT00346580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679150|NCT00346580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679151|NCT00346580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92679152|NCT00346580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92679153|NCT00346580|Antiviral Agents|antiviral agents|mesh-ancestor
92679154|NCT00346580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679155|NCT00346619|Nelfinavir|nelfinavir|mesh-list
92679156|NCT00346619|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92679157|NCT00346619|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92679158|NCT00346619|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679159|NCT00346619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679160|NCT00346619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679161|NCT00346619|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92679162|NCT00346619|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92679163|NCT00346619|Antiviral Agents|antiviral agents|mesh-ancestor
92679164|NCT00346619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679165|NCT02273700|Rivaroxaban|rivaroxaban|mesh-list
92679166|NCT02273700|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92679167|NCT02273700|Antithrombins|antithrombins|mesh-ancestor
92679168|NCT02273700|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92679169|NCT02273700|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679170|NCT02273700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679171|NCT02273700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605589|NCT04599894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605590|NCT00497224|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92605591|NCT00497224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605592|NCT00497224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605593|NCT00497224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605594|NCT00497224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605595|NCT04726982|Acetazolamide|acetazolamide|mesh-list
92605596|NCT04726982|Anticonvulsants|anticonvulsants|mesh-ancestor
92605597|NCT04726982|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92605598|NCT04726982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605599|NCT04726982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605600|NCT04726982|Diuretics|diuretics|mesh-ancestor
92605601|NCT04726982|Natriuretic Agents|natriuretic agents|mesh-ancestor
92605602|NCT04726982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605603|NCT00497341|Cefuroxime|cefuroxime|mesh-list
92605604|NCT00497341|Cefuroxime axetil|cefuroxime axetil|mesh-list
92605605|NCT00497341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605606|NCT00497341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605607|NCT00127829|Gefitinib|gefitinib|mesh-list
92605608|NCT00127829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605609|NCT00127829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92013070|NCT05028049|Dsuvia|dsuvia|mesh-list
92679172|NCT02273700|Anticoagulants|anticoagulants|mesh-ancestor
92679173|NCT02959658|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92679174|NCT02959658|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679175|NCT02959658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679176|NCT02959658|Immunologic Factors|immunologic factors|mesh-ancestor
92679177|NCT02959658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679178|NCT04698213|Avelumab|avelumab|mesh-list
92679179|NCT04698213|Axitinib|axitinib|mesh-list
92679180|NCT04698213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679181|NCT04698213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679184|NCT04698213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679186|NCT02273817|Glucocorticoids|glucocorticoids|mesh-ancestor
92679187|NCT02273817|Hormones|hormones|mesh-ancestor
92679188|NCT02273817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679189|NCT02273817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679190|NCT02273817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92679191|NCT00346853|Fomepizole|fomepizole|mesh-list
92679192|NCT00346853|Antidotes|antidotes|mesh-ancestor
92679193|NCT00346853|Protective Agents|protective agents|mesh-ancestor
92679194|NCT00346853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679195|NCT00346853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367591|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92679196|NCT00346853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679197|NCT00346970|Niacin|niacin|mesh-list
92679198|NCT00346970|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92679199|NCT00346970|Antimetabolites|antimetabolites|mesh-ancestor
92679200|NCT00346970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679201|NCT00346970|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92679202|NCT00346970|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679203|NCT00346970|Vitamin B Complex|vitamin b complex|mesh-ancestor
92679204|NCT00346970|Vitamins|vitamins|mesh-ancestor
92679205|NCT00346970|Micronutrients|micronutrients|mesh-ancestor
92679206|NCT00346970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679207|NCT00455130|Mannitol|mannitol|mesh-list
92605610|NCT00127829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605611|NCT00127829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605612|NCT00497458|Testosterone|testosterone|mesh-list
92605613|NCT00497458|Androgens|androgens|mesh-ancestor
92605614|NCT00497458|Hormones|hormones|mesh-ancestor
92605615|NCT00497458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605616|NCT00497458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605617|NCT00497497|Bevacizumab|bevacizumab|mesh-list
92605618|NCT00497497|Cetuximab|cetuximab|mesh-list
92679208|NCT00455130|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92679209|NCT00455130|Diuretics|diuretics|mesh-ancestor
92679210|NCT00455130|Natriuretic Agents|natriuretic agents|mesh-ancestor
92679211|NCT00455130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679212|NCT00347048|Tacrolimus|tacrolimus|mesh-list
92679213|NCT00347048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679214|NCT00347048|Immunologic Factors|immunologic factors|mesh-ancestor
92679215|NCT00347048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679216|NCT00347048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92679217|NCT00347048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679218|NCT00347048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679219|NCT00347087|Irbesartan|irbesartan|mesh-list
92679220|NCT00347087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679221|NCT00347087|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92679222|NCT00347087|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92679223|NCT00347087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679224|NCT00347165|Bevacizumab|bevacizumab|mesh-list
92679225|NCT00347165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679226|NCT00347165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679227|NCT00347165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679228|NCT00347165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679229|NCT00347165|Growth Substances|growth substances|mesh-ancestor
92679230|NCT00347165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679231|NCT00347165|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679232|NCT00347204|Ketorolac|ketorolac|mesh-list
92679233|NCT00347204|Nepafenac|nepafenac|mesh-list
92679234|NCT00347204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92679235|NCT00347204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92679236|NCT00347204|Analgesics|analgesics|mesh-ancestor
92679237|NCT00347204|Sensory System Agents|sensory system agents|mesh-ancestor
92679238|NCT00347204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679239|NCT00347204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679240|NCT00347204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679241|NCT00347204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679242|NCT00347204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92679243|NCT00347204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679244|NCT00347204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679245|NCT00455286|Methylprednisolone|methylprednisolone|mesh-list
92679246|NCT00455286|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92679247|NCT00455286|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92679248|NCT00455286|Prednisolone|prednisolone|mesh-list
92679249|NCT00455286|Prednisolone acetate|prednisolone acetate|mesh-list
92679250|NCT00455286|Methotrexate|methotrexate|mesh-list
92679251|NCT00455286|Temozolomide|temozolomide|mesh-list
92679252|NCT00455286|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92679253|NCT00455286|Prednisolone phosphate|prednisolone phosphate|mesh-list
92679254|NCT00455286|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92679257|NCT00455286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679258|NCT00455286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92679260|NCT00455286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679261|NCT00455286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679262|NCT00455286|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679263|NCT00455286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679264|NCT00455286|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92679265|NCT00455286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679266|NCT00455286|Immunologic Factors|immunologic factors|mesh-ancestor
92679267|NCT00455286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92013095|NCT05027581|Hyaluronic Acid|hyaluronic acid|mesh-list
92605619|NCT00497497|Irinotecan|irinotecan|mesh-list
92605620|NCT00497497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92605621|NCT00497497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605622|NCT00497497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92605623|NCT00497497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92605624|NCT00497497|Growth Substances|growth substances|mesh-ancestor
92605625|NCT00497497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605626|NCT00497497|Growth Inhibitors|growth inhibitors|mesh-ancestor
92605627|NCT00497497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92605628|NCT00497497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92605629|NCT00497497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605630|NCT00497497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605631|NCT00127868|Selenium|selenium|mesh-list
92605632|NCT00127868|Ketoconazole|ketoconazole|mesh-list
92605633|NCT00127868|Ciclopirox|ciclopirox|mesh-list
92605634|NCT00127868|Griseofulvin|griseofulvin|mesh-list
92605635|NCT00127868|Selenium disulfide|selenium disulfide|mesh-list
92605636|NCT00127868|Antifungal Agents|antifungal agents|mesh-ancestor
92605637|NCT00127868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605638|NCT00127868|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92605639|NCT00127868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92605640|NCT00127868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605641|NCT00127868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679268|NCT00455286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92679269|NCT00455286|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92679270|NCT00455286|Alkylating Agents|alkylating agents|mesh-ancestor
92679271|NCT00455286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679272|NCT00455286|Antiemetics|antiemetics|mesh-ancestor
92679273|NCT00455286|Autonomic Agents|autonomic agents|mesh-ancestor
92679274|NCT00455286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679275|NCT00455286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92679276|NCT00455286|Glucocorticoids|glucocorticoids|mesh-ancestor
92679277|NCT00455286|Hormones|hormones|mesh-ancestor
92679278|NCT00455286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679279|NCT00455286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92679280|NCT00455286|Protective Agents|protective agents|mesh-ancestor
92679281|NCT00455286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679282|NCT00455364|Voriconazole|voriconazole|mesh-list
92679283|NCT00455364|Antifungal Agents|antifungal agents|mesh-ancestor
92679284|NCT00455364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679285|NCT00455364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92679286|NCT00455364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92679287|NCT00455364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679288|NCT00455364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679289|NCT00455364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92679290|NCT00455364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92679291|NCT00455364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679292|NCT00455364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605642|NCT00127868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92605643|NCT00127868|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605644|NCT00127868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605645|NCT00127868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605646|NCT00127868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92605648|NCT00127868|Protective Agents|protective agents|mesh-ancestor
92605649|NCT00127868|Trace Elements|trace elements|mesh-ancestor
92605650|NCT00127868|Micronutrients|micronutrients|mesh-ancestor
92605651|NCT00127868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92605652|NCT00497536|Insulin|insulin|mesh-list
92605653|NCT00497536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92605654|NCT00497536|Insulin Aspart|insulin aspart|mesh-list
92605655|NCT00497536|Insulin, Long-Acting|insulin, long-acting|mesh-list
92605656|NCT00497536|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92605657|NCT00497536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92605658|NCT00497536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605659|NCT00497614|Adalimumab|adalimumab|mesh-list
92605660|NCT00497614|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92605661|NCT00497614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605662|NCT00497614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605663|NCT00127907|Vasopressins|vasopressins|mesh-list
92679293|NCT00455364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92679294|NCT00347399|Bevacizumab|bevacizumab|mesh-list
92679295|NCT00347399|Verteporfin|verteporfin|mesh-list
92679296|NCT00347399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679297|NCT00347399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679298|NCT00347399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679299|NCT00347399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679300|NCT00347399|Growth Substances|growth substances|mesh-ancestor
92679301|NCT00347399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679302|NCT00347399|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679303|NCT00347399|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92679304|NCT00347399|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679305|NCT00455442|Mifepristone|mifepristone|mesh-list
92679306|NCT00455442|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92679307|NCT00455442|Abortifacient Agents|abortifacient agents|mesh-ancestor
92679308|NCT00455442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92679309|NCT00455442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679310|NCT00455442|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92679311|NCT00455442|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92679312|NCT00455442|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92679313|NCT00455442|Contraceptive Agents|contraceptive agents|mesh-ancestor
92679314|NCT00455442|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92679315|NCT00455442|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92679316|NCT00455442|Hormone Antagonists|hormone antagonists|mesh-ancestor
92679317|NCT00455442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679318|NCT00455442|Luteolytic Agents|luteolytic agents|mesh-ancestor
92679319|NCT00455442|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92679320|NCT00455442|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92679321|NCT00347555|Aluminum phosphate|aluminum phosphate|mesh-list
92679322|NCT00347555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92013140|NCT03093805|Calcipotriene|calcipotriene|mesh-list
92605664|NCT00127907|Arginine Vasopressin|arginine vasopressin|mesh-list
92605665|NCT00127907|Epinephrine|epinephrine|mesh-list
92605666|NCT00127907|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92605667|NCT00127907|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92605668|NCT00127907|Adrenergic Agents|adrenergic agents|mesh-ancestor
92605669|NCT00127907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92605670|NCT00127907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605671|NCT00127907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605672|NCT00127907|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92605673|NCT00127907|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92605674|NCT00127907|Autonomic Agents|autonomic agents|mesh-ancestor
92605675|NCT00127907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679323|NCT00347555|Immunologic Factors|immunologic factors|mesh-ancestor
92086867|NCT01279876|Melatonin|melatonin|mesh-list
92679326|NCT00347555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679327|NCT00347555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92679328|NCT00455637|Botulinum Toxins|botulinum toxins|mesh-list
92679329|NCT00455637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92679330|NCT00455637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92679331|NCT00455637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92679332|NCT00455637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92679333|NCT00455637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679334|NCT00455637|Cholinergic Agents|cholinergic agents|mesh-ancestor
92679335|NCT00455637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679336|NCT00455637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679337|NCT00455637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92679338|NCT00455637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404827|NCT01432717|Luspatercept|luspatercept|mesh-list
92679339|NCT00347750|Lopinavir|lopinavir|mesh-list
92679340|NCT00347750|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92679341|NCT00347750|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92679342|NCT00347750|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679343|NCT00347750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679344|NCT00347750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679345|NCT00347750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92679346|NCT00347750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92679347|NCT00347750|Antiviral Agents|antiviral agents|mesh-ancestor
92679348|NCT00347750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679349|NCT00347750|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92679350|NCT00347750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92679351|NCT00347828|Moxifloxacin|moxifloxacin|mesh-list
92679352|NCT00347828|Gatifloxacin|gatifloxacin|mesh-list
92679353|NCT00347828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92679354|NCT00347828|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92679355|NCT00347828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679356|NCT00347828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679357|NCT00347828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92679358|NCT00347828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92679359|NCT00347828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679360|NCT00347828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679361|NCT00347828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679362|NCT00347867|Sildenafil Citrate|sildenafil citrate|mesh-list
92679363|NCT00347867|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679364|NCT00347867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92679365|NCT00347867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92679366|NCT00347867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679367|NCT00347867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679368|NCT00347867|Urological Agents|urological agents|mesh-ancestor
92679369|NCT00449202|Oleoyl-estrone|oleoyl-estrone|mesh-list
92679370|NCT00449202|Estrone|estrone|mesh-list
92679371|NCT00449202|Estrogens|estrogens|mesh-ancestor
92605676|NCT00127907|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92605677|NCT00127907|Respiratory System Agents|respiratory system agents|mesh-ancestor
92605678|NCT00127907|Mydriatics|mydriatics|mesh-ancestor
92605679|NCT00127907|Sympathomimetics|sympathomimetics|mesh-ancestor
92605680|NCT00127907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92605681|NCT00127907|Hemostatics|hemostatics|mesh-ancestor
92605682|NCT00127907|Coagulants|coagulants|mesh-ancestor
92605683|NCT00127907|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92605684|NCT00127907|Natriuretic Agents|natriuretic agents|mesh-ancestor
92605685|NCT00497809|Lenograstim|lenograstim|mesh-list
92605686|NCT00497809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92605687|NCT00497809|Immunologic Factors|immunologic factors|mesh-ancestor
92605688|NCT00497809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605689|NCT00146484|Insulin|insulin|mesh-list
92605690|NCT00146484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92605691|NCT00146484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605692|NCT00402584|Sibutramine|sibutramine|mesh-list
92605693|NCT00402584|Antidepressive Agents|antidepressive agents|mesh-ancestor
92605694|NCT00402584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605695|NCT00402584|Appetite Depressants|appetite depressants|mesh-ancestor
92605696|NCT00402584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92605697|NCT00498004|Risperidone|risperidone|mesh-list
92605698|NCT00498004|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92605699|NCT00498004|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92605700|NCT00498004|Serotonin Agents|serotonin agents|mesh-ancestor
92605701|NCT00498004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013147|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92679372|NCT00449202|Hormones|hormones|mesh-ancestor
92679373|NCT00449202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679374|NCT00449202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679375|NCT00449202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92679376|NCT00455715|Sildenafil Citrate|sildenafil citrate|mesh-list
92679377|NCT00455715|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679378|NCT00455715|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92679379|NCT00455715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92679380|NCT00455715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679381|NCT00455715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679382|NCT00455715|Urological Agents|urological agents|mesh-ancestor
92679383|NCT00455754|Esomeprazole|esomeprazole|mesh-list
92679384|NCT00455754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92679385|NCT00455754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92679386|NCT00455754|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92679387|NCT00455754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679388|NCT00455754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679389|NCT00347984|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92679390|NCT00347984|Lubricant Eye Drops|lubricant eye drops|mesh-list
92679391|NCT00347984|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92679392|NCT00348023|Timolol|timolol|mesh-list
92679393|NCT00348023|Bimatoprost|bimatoprost|mesh-list
92679394|NCT00348023|Travoprost|travoprost|mesh-list
92679395|NCT00348023|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92679398|NCT00348023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013171|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92605702|NCT00498004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605703|NCT00498004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605704|NCT00498004|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92605705|NCT00498004|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92605706|NCT00498004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605707|NCT00498004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92605708|NCT00498004|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92605709|NCT00498004|Dopamine Agents|dopamine agents|mesh-ancestor
92605710|NCT00498004|Antidepressive Agents|antidepressive agents|mesh-ancestor
92605711|NCT00146523|Mifepristone|mifepristone|mesh-list
92605712|NCT00146523|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92605713|NCT00146523|Abortifacient Agents|abortifacient agents|mesh-ancestor
92605714|NCT00146523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92605715|NCT00146523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605716|NCT00146523|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92679399|NCT00348023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679400|NCT00348023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679401|NCT00348023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92679402|NCT00348023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679404|NCT00348062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679405|NCT00348101|Enoximone|enoximone|mesh-list
92679406|NCT00348101|Esmolol|esmolol|mesh-list
92679407|NCT00348101|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92679408|NCT00348101|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92679409|NCT00348101|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92679410|NCT00348101|Adrenergic Agents|adrenergic agents|mesh-ancestor
92679411|NCT00348101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679412|NCT00348101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679413|NCT00348101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679414|NCT00348101|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92679415|NCT00348101|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679416|NCT00348101|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92679417|NCT00348101|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92679418|NCT00348101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679419|NCT00348101|Protective Agents|protective agents|mesh-ancestor
92679420|NCT00455832|Ribavirin|ribavirin|mesh-list
92679421|NCT00455832|Antimetabolites|antimetabolites|mesh-ancestor
92679422|NCT00455832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679423|NCT00455832|Antiviral Agents|antiviral agents|mesh-ancestor
92679424|NCT00455832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679425|NCT00455871|Ranibizumab|ranibizumab|mesh-list
92679426|NCT00455871|Verteporfin|verteporfin|mesh-list
92679427|NCT00455871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679428|NCT00455871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679429|NCT00455871|Growth Substances|growth substances|mesh-ancestor
92679430|NCT00455871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679431|NCT00455871|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679432|NCT00455871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679433|NCT00455871|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92679434|NCT00455871|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679435|NCT00449280|Sirolimus|sirolimus|mesh-list
92679436|NCT00449280|Sorafenib|sorafenib|mesh-list
92679437|NCT00449280|Temsirolimus|temsirolimus|mesh-list
92679438|NCT00449280|MTOR Inhibitors|mtor inhibitors|mesh-list
92679439|NCT00449280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679440|NCT00449280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92679441|NCT00449280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605717|NCT00146523|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92605718|NCT00146523|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92605719|NCT00146523|Contraceptive Agents|contraceptive agents|mesh-ancestor
92605720|NCT00146523|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92605721|NCT00146523|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92605722|NCT00146523|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605723|NCT00146523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605724|NCT00146523|Luteolytic Agents|luteolytic agents|mesh-ancestor
92605725|NCT00146523|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92605726|NCT00146523|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92605727|NCT00402623|Quercetin|quercetin|mesh-list
92605728|NCT00402623|Antioxidants|antioxidants|mesh-ancestor
92605729|NCT00402623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605730|NCT00402623|Protective Agents|protective agents|mesh-ancestor
92605731|NCT00402623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605732|NCT00402662|Everolimus|everolimus|mesh-list
92605733|NCT00402662|Imatinib Mesylate|imatinib mesylate|mesh-list
92605734|NCT00402662|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92605735|NCT00402662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605736|NCT00402662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605737|NCT00402662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605738|NCT00402662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605739|NCT00402662|Immunologic Factors|immunologic factors|mesh-ancestor
92605740|NCT00402662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605741|NCT00402662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605742|NCT00498316|Mycophenolic Acid|mycophenolic acid|mesh-list
92367669|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92679442|NCT00449280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679443|NCT00449280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679444|NCT00449280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679445|NCT00449280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92679446|NCT00449280|Antifungal Agents|antifungal agents|mesh-ancestor
92679447|NCT00449280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679448|NCT00449280|Immunologic Factors|immunologic factors|mesh-ancestor
92679449|NCT00449280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679450|NCT00455910|Thalidomide|thalidomide|mesh-list
92679451|NCT00455910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679452|NCT00455910|Immunologic Factors|immunologic factors|mesh-ancestor
92679453|NCT00455910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679454|NCT00455910|Leprostatic Agents|leprostatic agents|mesh-ancestor
92679455|NCT00455910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679456|NCT00455910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679457|NCT00455910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679458|NCT00455910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679459|NCT00455910|Growth Substances|growth substances|mesh-ancestor
92679460|NCT00455910|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679461|NCT00455910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605743|NCT00498316|Cyclophosphamide|cyclophosphamide|mesh-list
92605744|NCT00498316|Melphalan|melphalan|mesh-list
92605745|NCT00498316|Busulfan|busulfan|mesh-list
92605746|NCT00498316|Rituximab|rituximab|mesh-list
92605747|NCT00498316|Fludarabine|fludarabine|mesh-list
92605748|NCT00498316|Fludarabine phosphate|fludarabine phosphate|mesh-list
92605749|NCT00498316|Clofarabine|clofarabine|mesh-list
92605750|NCT00498316|Tacrolimus|tacrolimus|mesh-list
92605751|NCT00498316|Thymoglobulin|thymoglobulin|mesh-list
92605752|NCT00498316|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92605753|NCT00498316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605754|NCT00498316|Immunologic Factors|immunologic factors|mesh-ancestor
92605755|NCT00498316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605756|NCT00498316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605757|NCT00498316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92679462|NCT00348296|Immunoglobulins|immunoglobulins|mesh-list
92679463|NCT00348296|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92679464|NCT00348296|Antibodies|antibodies|mesh-list
92679465|NCT00348296|gamma-Globulins|gamma-globulins|mesh-list
92679466|NCT00348296|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92679467|NCT00348296|Immunologic Factors|immunologic factors|mesh-ancestor
92679468|NCT00348296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679469|NCT00449319|Daunorubicin|daunorubicin|mesh-list
92679470|NCT00449319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92679472|NCT00449319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92679473|NCT00449319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92679474|NCT00449319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679475|NCT00449319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679476|NCT00348335|Cyclosporine|cyclosporine|mesh-list
92679477|NCT00348335|Cyclosporins|cyclosporins|mesh-list
92679478|NCT00348335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679479|NCT00348335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679480|NCT00348335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679481|NCT00348335|Immunologic Factors|immunologic factors|mesh-ancestor
92679482|NCT00348335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679483|NCT00348335|Antifungal Agents|antifungal agents|mesh-ancestor
92679484|NCT00348335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679485|NCT00348335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679486|NCT00348335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679487|NCT00348335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92679488|NCT00348413|Methylprednisolone|methylprednisolone|mesh-list
92679489|NCT00348413|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92679490|NCT00348413|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92679492|NCT00348413|Prednisolone acetate|prednisolone acetate|mesh-list
92679493|NCT00348413|Methotrexate|methotrexate|mesh-list
92679494|NCT00348413|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92679495|NCT00348413|Prednisolone phosphate|prednisolone phosphate|mesh-list
92679496|NCT00348413|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92679497|NCT00348413|Abortifacient Agents|abortifacient agents|mesh-ancestor
92679498|NCT00348413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367680|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92679499|NCT00348413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679500|NCT00348413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92679501|NCT00348413|Antimetabolites|antimetabolites|mesh-ancestor
92679502|NCT00348413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679503|NCT00348413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679504|NCT00348413|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679505|NCT00348413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679506|NCT00348413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92679507|NCT00348413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679508|NCT00348413|Immunologic Factors|immunologic factors|mesh-ancestor
92679509|NCT00348413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679510|NCT00348413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92679511|NCT00348413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679512|NCT00348413|Antiemetics|antiemetics|mesh-ancestor
92013224|NCT03079453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92605758|NCT00498316|Alkylating Agents|alkylating agents|mesh-ancestor
92605759|NCT00498316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605760|NCT00498316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605761|NCT00498316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92605762|NCT00498316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92605763|NCT00498316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605764|NCT00498316|Antimetabolites|antimetabolites|mesh-ancestor
92605765|NCT00498316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605766|NCT00498316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92605767|NCT00498316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605768|NCT00498316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92605769|NCT00498316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92605770|NCT00498316|Antitubercular Agents|antitubercular agents|mesh-ancestor
92605771|NCT00498316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605772|NCT01245166|Metformin|metformin|mesh-list
92605773|NCT01245166|Acarbose|acarbose|mesh-list
92605774|NCT01245166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92679513|NCT00348413|Autonomic Agents|autonomic agents|mesh-ancestor
92679514|NCT00348413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679515|NCT00348413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92679516|NCT00348413|Glucocorticoids|glucocorticoids|mesh-ancestor
92679517|NCT00348413|Hormones|hormones|mesh-ancestor
92679518|NCT00348413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679519|NCT00348413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92679520|NCT00348413|Protective Agents|protective agents|mesh-ancestor
92679521|NCT00348413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679522|NCT00348452|Celecoxib|celecoxib|mesh-list
92679523|NCT00348452|Tramadol|tramadol|mesh-list
92679524|NCT00348452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92679525|NCT00348452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92679526|NCT00348452|Analgesics|analgesics|mesh-ancestor
92679527|NCT00348452|Sensory System Agents|sensory system agents|mesh-ancestor
92679528|NCT00348452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679529|NCT00348452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679530|NCT00348452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679531|NCT00348452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679532|NCT00348452|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92679533|NCT00348452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92679534|NCT00348452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679535|NCT00348452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679536|NCT00348452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92679537|NCT00348452|Narcotics|narcotics|mesh-ancestor
92679538|NCT00348452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679539|NCT00449397|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92679540|NCT00449397|Antidepressive Agents|antidepressive agents|mesh-ancestor
92679541|NCT00449397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92679542|NCT00449397|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92679543|NCT00449397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92087083|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92679547|NCT00348491|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92679548|NCT00348491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92679550|NCT00348491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679551|NCT00348491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92679552|NCT00348491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92679553|NCT00348491|Analgesics|analgesics|mesh-ancestor
92605775|NCT01245166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605776|NCT01245166|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92605777|NCT01245166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605778|NCT01245166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605779|NCT00146601|Fulvestrant|fulvestrant|mesh-list
92605780|NCT00146601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605781|NCT00146601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605782|NCT00146601|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92605783|NCT00146601|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92013242|NCT05008939|Anesthetics|anesthetics|mesh-ancestor
92679554|NCT00348491|Sensory System Agents|sensory system agents|mesh-ancestor
92679555|NCT00348491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679556|NCT00348491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679557|NCT00348491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679558|NCT00348491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679560|NCT03274323|Latanoprost|latanoprost|mesh-list
92679561|NCT03274323|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92679562|NCT03274323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92679563|NCT03274323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679564|NCT00348530|Verapamil|verapamil|mesh-list
92405074|NCT01434212|Ribavirin|ribavirin|mesh-list
92679565|NCT00348530|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92679566|NCT00348530|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92679567|NCT00348530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92679568|NCT00348530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679569|NCT00348530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92679570|NCT00348530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679571|NCT00348530|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679572|NCT00449436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92679573|NCT00449436|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92679574|NCT00449436|Protease Inhibitors|protease inhibitors|mesh-list
92679575|NCT00449436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92679576|NCT00449436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679577|NCT00449436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679578|NCT00449436|Antiviral Agents|antiviral agents|mesh-ancestor
92679579|NCT00449436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679580|NCT00449436|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92679581|NCT00449436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92679582|NCT00449436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92679583|NCT00456027|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92679584|NCT00456027|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92679585|NCT00456027|Immunologic Factors|immunologic factors|mesh-ancestor
92679586|NCT00456027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679587|NCT00456027|Antacids|antacids|mesh-ancestor
92679588|NCT00456027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679589|NCT00456027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92679590|NCT00448734|Docetaxel|docetaxel|mesh-list
92679591|NCT00448734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679592|NCT00448734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92679593|NCT00448734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92679594|NCT00448734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92679595|NCT00448734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679596|NCT00348725|Metformin|metformin|mesh-list
92679597|NCT00348725|Fenofibrate|fenofibrate|mesh-list
92679598|NCT00348725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92679599|NCT00348725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679600|NCT00348725|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92679601|NCT00348725|Antimetabolites|antimetabolites|mesh-ancestor
92679602|NCT00348725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679603|NCT00348725|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92679604|NCT00348764|Polidocanol|polidocanol|mesh-list
92679605|NCT00348764|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92679606|NCT00348764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92679607|NCT03276156|Apatinib|apatinib|mesh-list
92605784|NCT00146601|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605785|NCT00146601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605786|NCT00146601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605787|NCT00498589|Methotrexate|methotrexate|mesh-list
92605788|NCT00498589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92605789|NCT00498589|Abortifacient Agents|abortifacient agents|mesh-ancestor
92605790|NCT00498589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92330780|NCT00004424|Fentanyl|fentanyl|mesh-list
92605791|NCT00498589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605792|NCT00498589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605793|NCT00498589|Antimetabolites|antimetabolites|mesh-ancestor
92605794|NCT00498589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605795|NCT00498589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605796|NCT00498589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92605797|NCT00498589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605798|NCT00498589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92605799|NCT00498589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605800|NCT00498589|Immunologic Factors|immunologic factors|mesh-ancestor
92605801|NCT00498589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605802|NCT00498589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92605803|NCT00498784|Levonorgestrel|levonorgestrel|mesh-list
92605804|NCT00498784|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92605805|NCT00498784|Contraceptive Agents|contraceptive agents|mesh-ancestor
92605806|NCT00498784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92605807|NCT00498784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679608|NCT03276156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679609|NCT03276156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92679610|NCT03276156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679611|NCT03276156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679612|NCT00456144|Hormones|hormones|mesh-list
92087157|NCT03806374|Narcotics|narcotics|mesh-ancestor
92679613|NCT00456144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679614|NCT00456144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679616|NCT00348920|Anesthetics, Local|anesthetics, local|mesh-ancestor
92679617|NCT00348920|Anesthetics|anesthetics|mesh-ancestor
92679618|NCT00348920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679619|NCT00348920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679620|NCT00348920|Sensory System Agents|sensory system agents|mesh-ancestor
92679621|NCT00348920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679622|NCT00449514|Tamoxifen|tamoxifen|mesh-list
92679623|NCT00449514|Clomiphene|clomiphene|mesh-list
92679624|NCT00449514|Enclomiphene|enclomiphene|mesh-list
92679625|NCT00449514|Zuclomiphene|zuclomiphene|mesh-list
92679626|NCT00449514|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92679627|NCT00449514|Hormone Antagonists|hormone antagonists|mesh-ancestor
92679628|NCT00449514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679629|NCT00449514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679630|NCT00449514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605808|NCT00498784|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92605809|NCT00498784|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92605810|NCT00498784|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92605811|NCT00498901|Letrozole|letrozole|mesh-list
92605812|NCT00498901|Leuprolide|leuprolide|mesh-list
92605813|NCT00498901|Goserelin|goserelin|mesh-list
92605814|NCT00498901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605815|NCT00498901|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92605816|NCT00498901|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92605817|NCT00498901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605818|NCT00498901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605819|NCT00498901|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92679631|NCT00449514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679632|NCT00449514|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92679633|NCT00449514|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92679634|NCT00449514|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92679635|NCT00449514|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92679636|NCT00449514|Fertility Agents|fertility agents|mesh-ancestor
92679637|NCT00449514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92679638|NCT00348998|Bevacizumab|bevacizumab|mesh-list
92679639|NCT00348998|Goserelin|goserelin|mesh-list
92679640|NCT00348998|Bicalutamide|bicalutamide|mesh-list
92679641|NCT00348998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679642|NCT00348998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679643|NCT00348998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679644|NCT00348998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679645|NCT00348998|Growth Substances|growth substances|mesh-ancestor
92679646|NCT00348998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679647|NCT00348998|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679648|NCT00348998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679649|NCT00348998|Androgen Antagonists|androgen antagonists|mesh-ancestor
92679650|NCT00348998|Hormone Antagonists|hormone antagonists|mesh-ancestor
92679651|NCT00348998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679652|NCT00449553|Metformin|metformin|mesh-list
92679653|NCT00449553|Pioglitazone|pioglitazone|mesh-list
92679654|NCT00449553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92679655|NCT00449553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679656|NCT00349076|Oxaliplatin|oxaliplatin|mesh-list
92679657|NCT00349076|Fluorouracil|fluorouracil|mesh-list
92679658|NCT00349076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679659|NCT00349076|Antimetabolites|antimetabolites|mesh-ancestor
92679660|NCT00349076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679661|NCT00349076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92679662|NCT00349076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679663|NCT00349076|Immunologic Factors|immunologic factors|mesh-ancestor
92679664|NCT00349076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679665|NCT00349115|Thalidomide|thalidomide|mesh-list
92679666|NCT00349115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679667|NCT00349115|Immunologic Factors|immunologic factors|mesh-ancestor
92679668|NCT00349115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679669|NCT00349115|Leprostatic Agents|leprostatic agents|mesh-ancestor
92679670|NCT00349115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679671|NCT00349115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679672|NCT00349115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679673|NCT00349115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679674|NCT00349115|Growth Substances|growth substances|mesh-ancestor
92679675|NCT00349115|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679676|NCT00349115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679677|NCT00456339|Amoxicillin|amoxicillin|mesh-list
92679678|NCT00456339|Clavulanic Acid|clavulanic acid|mesh-list
92679679|NCT00456339|Clavulanic Acids|clavulanic acids|mesh-list
92679680|NCT00456339|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92679681|NCT00456339|Prednisolone|prednisolone|mesh-list
92679682|NCT00456339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605820|NCT00498901|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605821|NCT00498901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605822|NCT00498901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605823|NCT00498901|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92605824|NCT00498901|Fertility Agents|fertility agents|mesh-ancestor
92605825|NCT00498901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92605826|NCT00498901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605827|NCT00498979|Interferons|interferons|mesh-list
92679683|NCT00456339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679684|NCT00456339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679685|NCT00456339|Glucocorticoids|glucocorticoids|mesh-ancestor
92679686|NCT00456339|Hormones|hormones|mesh-ancestor
92087228|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
92679689|NCT00456339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679691|NCT00456339|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92679692|NCT00456339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679693|NCT00456339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679694|NCT00421421|Dutasteride|dutasteride|mesh-list
92679695|NCT00421421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92679696|NCT00421421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92679697|NCT00421421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679698|NCT00421421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679699|NCT00421421|Hormone Antagonists|hormone antagonists|mesh-ancestor
92679700|NCT00421421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679701|NCT00421421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679702|NCT00421460|Methyltestosterone|methyltestosterone|mesh-list
92679703|NCT00421460|Testosterone|testosterone|mesh-list
92679704|NCT00421460|Testosterone undecanoate|testosterone undecanoate|mesh-list
92679705|NCT00421460|Testosterone enanthate|testosterone enanthate|mesh-list
92679706|NCT00421460|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92679707|NCT00421460|Androgens|androgens|mesh-ancestor
92679708|NCT00421460|Hormones|hormones|mesh-ancestor
92679709|NCT00421460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679710|NCT00421460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679711|NCT00421460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679712|NCT00421460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679713|NCT00421460|Anabolic Agents|anabolic agents|mesh-ancestor
92679714|NCT00349310|Pramipexole|pramipexole|mesh-list
92679715|NCT00349310|Antioxidants|antioxidants|mesh-ancestor
92679716|NCT00349310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679717|NCT00349310|Protective Agents|protective agents|mesh-ancestor
92679718|NCT00349310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679719|NCT00349310|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92679720|NCT00349310|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92679721|NCT00349310|Dopamine Agonists|dopamine agonists|mesh-ancestor
92679722|NCT00349310|Dopamine Agents|dopamine agents|mesh-ancestor
92679723|NCT00349310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679724|NCT03274167|Gabapentin|gabapentin|mesh-list
92679725|NCT03274167|Analgesics|analgesics|mesh-ancestor
92679726|NCT03274167|Sensory System Agents|sensory system agents|mesh-ancestor
92679727|NCT03274167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679728|NCT03274167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679729|NCT03274167|Anticonvulsants|anticonvulsants|mesh-ancestor
92679730|NCT03274167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92679731|NCT03274167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92679732|NCT03274167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679733|NCT03274167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92679734|NCT03274167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92679735|NCT03274167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92679736|NCT03274167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679737|NCT03274167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679738|NCT03274167|Antimanic Agents|antimanic agents|mesh-ancestor
92679739|NCT00349427|Rosiglitazone|rosiglitazone|mesh-list
92679740|NCT00349427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92679741|NCT00349427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679742|NCT00349583|Cyclosporine|cyclosporine|mesh-list
92605828|NCT00498979|Interferon-alpha|interferon-alpha|mesh-list
92605829|NCT00498979|Interferon alpha-2|interferon alpha-2|mesh-list
92605830|NCT00498979|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92605831|NCT00498979|Dacarbazine|dacarbazine|mesh-list
92605832|NCT00498979|Vinblastine|vinblastine|mesh-list
92605833|NCT00498979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605834|NCT00498979|Antiviral Agents|antiviral agents|mesh-ancestor
92605835|NCT00498979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605836|NCT00498979|Immunologic Factors|immunologic factors|mesh-ancestor
92605837|NCT00498979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605838|NCT00498979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92605839|NCT00498979|Alkylating Agents|alkylating agents|mesh-ancestor
92605840|NCT00498979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605841|NCT00498979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92605842|NCT00498979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605843|NCT00498979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605844|NCT00498979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605845|NCT00498979|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92605846|NCT00498979|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92605847|NCT00498979|Schistosomicides|schistosomicides|mesh-ancestor
92605848|NCT00498979|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92605849|NCT00498979|Anthelmintics|anthelmintics|mesh-ancestor
92605850|NCT01245205|Lapatinib|lapatinib|mesh-list
92605851|NCT01245205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605852|NCT01245205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605853|NCT01245205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605854|NCT01245205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605855|NCT01245244|Morphine|morphine|mesh-list
92605856|NCT01245244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92605857|NCT01245244|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92605858|NCT01245244|Narcotics|narcotics|mesh-ancestor
92605859|NCT01245244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92605871|NCT00405717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92605872|NCT00405717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605874|NCT00499018|Prednisone|prednisone|mesh-list
92605875|NCT00499018|Rituximab|rituximab|mesh-list
92605876|NCT00499018|Mitoxantrone|mitoxantrone|mesh-list
92605877|NCT00499018|Cyclophosphamide|cyclophosphamide|mesh-list
92605878|NCT00499018|Vincristine|vincristine|mesh-list
92605879|NCT00499018|Doxorubicin|doxorubicin|mesh-list
92605880|NCT00499018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92605881|NCT00499018|Lenograstim|lenograstim|mesh-list
92013339|NCT05016349|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92679743|NCT00349583|Cyclosporins|cyclosporins|mesh-list
92679744|NCT00349583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679745|NCT00349583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679746|NCT00349583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679747|NCT00349583|Immunologic Factors|immunologic factors|mesh-ancestor
92679748|NCT00349583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679749|NCT00349583|Antifungal Agents|antifungal agents|mesh-ancestor
92679750|NCT00349583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679751|NCT00349583|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679752|NCT00349583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679753|NCT00349583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92679754|NCT00349739|Anecortave|anecortave|mesh-list
92679755|NCT00349739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679756|NCT00349739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679759|NCT00349739|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679760|NCT00349739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679761|NCT00456729|Metronidazole|metronidazole|mesh-list
92679762|NCT00456729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679763|NCT00456729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679764|NCT00456729|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92679765|NCT00456729|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92679766|NCT00450099|Bupivacaine|bupivacaine|mesh-list
92679767|NCT00450099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92679768|NCT00450099|Anesthetics|anesthetics|mesh-ancestor
92679769|NCT00450099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679770|NCT00450099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679771|NCT00450099|Sensory System Agents|sensory system agents|mesh-ancestor
92679772|NCT00450099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679773|NCT00450138|Cisplatin|cisplatin|mesh-list
92679774|NCT00450138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679775|NCT00350051|Prednisone|prednisone|mesh-list
92679776|NCT00350051|Sagopilone|sagopilone|mesh-list
92679777|NCT00350051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679778|NCT00350051|Glucocorticoids|glucocorticoids|mesh-ancestor
92679779|NCT00350051|Hormones|hormones|mesh-ancestor
92679780|NCT00350051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679781|NCT00350051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679782|NCT00350051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679783|NCT00350051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679784|NCT00350090|Epoetin Alfa|epoetin alfa|mesh-list
92679785|NCT00350090|Hematinics|hematinics|mesh-ancestor
92679786|NCT04699110|Adenosine|adenosine|mesh-list
92679787|NCT04699110|Epinephrine|epinephrine|mesh-list
92679788|NCT04699110|Racepinephrine|racepinephrine|mesh-list
92679789|NCT04699110|Epinephryl borate|epinephryl borate|mesh-list
92679790|NCT04699110|Analgesics|analgesics|mesh-ancestor
92679791|NCT04699110|Sensory System Agents|sensory system agents|mesh-ancestor
92679792|NCT04699110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679793|NCT04699110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679794|NCT04699110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92679796|NCT04699110|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92679797|NCT04699110|Purinergic Agonists|purinergic agonists|mesh-ancestor
92679798|NCT04699110|Purinergic Agents|purinergic agents|mesh-ancestor
92679799|NCT04699110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679800|NCT04699110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679801|NCT04699110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92679802|NCT04699110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92013350|NCT05380635|Antiviral Agents|antiviral agents|mesh-ancestor
92605882|NCT00499018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92605883|NCT00499018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605884|NCT00499018|Immunologic Factors|immunologic factors|mesh-ancestor
92605885|NCT00499018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605886|NCT00499018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605887|NCT00499018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605888|NCT00499018|Glucocorticoids|glucocorticoids|mesh-ancestor
92605889|NCT00499018|Hormones|hormones|mesh-ancestor
92605890|NCT00499018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605891|NCT00499018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605892|NCT00499018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92605893|NCT00499018|Antimetabolites|antimetabolites|mesh-ancestor
92605894|NCT00499018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605895|NCT00499018|Antiviral Agents|antiviral agents|mesh-ancestor
92605896|NCT00499018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605897|NCT00499018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92605898|NCT00499018|Analgesics|analgesics|mesh-ancestor
92605899|NCT00499018|Sensory System Agents|sensory system agents|mesh-ancestor
92605900|NCT00499018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605901|NCT00499018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92605902|NCT00499018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92605903|NCT00499018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605904|NCT00499018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92679803|NCT04699110|Adrenergic Agents|adrenergic agents|mesh-ancestor
92679804|NCT04699110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92679805|NCT04699110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92679806|NCT04699110|Autonomic Agents|autonomic agents|mesh-ancestor
92679807|NCT04699110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92679808|NCT04699110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92679809|NCT04699110|Mydriatics|mydriatics|mesh-ancestor
92679810|NCT04699110|Sympathomimetics|sympathomimetics|mesh-ancestor
92679811|NCT04699110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92679812|NCT00350168|Amlodipine|amlodipine|mesh-list
92679813|NCT00350168|Valsartan|valsartan|mesh-list
92679814|NCT00350168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679815|NCT00350168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92679816|NCT00350168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367749|NCT00887562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679817|NCT00350168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679818|NCT00350168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92679819|NCT00350168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679820|NCT00350168|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679821|NCT00350168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92679822|NCT00350168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92679823|NCT00105534|Azithromycin|azithromycin|mesh-list
92679824|NCT00105534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679825|NCT00105534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679826|NCT00350441|Sildenafil Citrate|sildenafil citrate|mesh-list
92605905|NCT00499018|Alkylating Agents|alkylating agents|mesh-ancestor
92605906|NCT00499018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92605907|NCT00499018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92605908|NCT00499018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92605909|NCT00499018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605910|NCT00499018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605911|NCT00499018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605912|NCT00499018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92605913|NCT00127985|Prednisolone|prednisolone|mesh-list
92605914|NCT00127985|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92605915|NCT00127985|Methylprednisolone|methylprednisolone|mesh-list
92605916|NCT00127985|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92605917|NCT00127985|Prednisolone acetate|prednisolone acetate|mesh-list
92605918|NCT00127985|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92605919|NCT00127985|Prednisolone phosphate|prednisolone phosphate|mesh-list
92679827|NCT00350441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679828|NCT00350441|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679829|NCT00350441|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92679830|NCT00350441|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92679831|NCT00350441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679839|NCT00350480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679840|NCT00350480|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92679841|NCT00350480|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92679842|NCT00350480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92679843|NCT00350480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679844|NCT00456963|Losartan|losartan|mesh-list
92679845|NCT00456963|Enalapril|enalapril|mesh-list
92679846|NCT00456963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92679847|NCT00456963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679848|NCT00456963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92679849|NCT00456963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92679850|NCT00456963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679851|NCT00456963|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92679852|NCT00456963|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679853|NCT00456963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679854|NCT00350597|Molgramostim|molgramostim|mesh-list
92679855|NCT00350597|Sargramostim|sargramostim|mesh-list
92679856|NCT00350597|Immunologic Factors|immunologic factors|mesh-ancestor
92679857|NCT00350597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679858|NCT00350597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679859|NCT00350753|Bevacizumab|bevacizumab|mesh-list
92679860|NCT00350753|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92679861|NCT00350753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92679862|NCT00350753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099589|NCT00631137|Testosterone|testosterone|mesh-list
92679863|NCT00350753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92679864|NCT00350753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92679865|NCT00350753|Growth Substances|growth substances|mesh-ancestor
92679866|NCT00350753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679867|NCT00350753|Growth Inhibitors|growth inhibitors|mesh-ancestor
92679868|NCT00350753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92679869|NCT00350753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679870|NCT00350753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679872|NCT00457119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92679873|NCT00457119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92679874|NCT00457119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679875|NCT00457119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679876|NCT00457119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92679877|NCT00457119|Immunologic Factors|immunologic factors|mesh-ancestor
92605920|NCT00127985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605922|NCT00127985|Hormones|hormones|mesh-ancestor
92605923|NCT00127985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605924|NCT00127985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605925|NCT00127985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605926|NCT00127985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605927|NCT00127985|Antiemetics|antiemetics|mesh-ancestor
92605928|NCT00127985|Autonomic Agents|autonomic agents|mesh-ancestor
92605929|NCT00127985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92605930|NCT00127985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92605931|NCT00127985|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92605932|NCT00127985|Protective Agents|protective agents|mesh-ancestor
92605933|NCT00424164|Tamoxifen|tamoxifen|mesh-list
92605934|NCT00424164|Lapatinib|lapatinib|mesh-list
92605935|NCT00424164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605936|NCT00424164|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92605937|NCT00424164|Hormone Antagonists|hormone antagonists|mesh-ancestor
92605938|NCT00424164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92605939|NCT00424164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605940|NCT00424164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92605941|NCT00424164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679878|NCT00457119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679879|NCT00457119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679880|NCT00350948|Doxorubicin|doxorubicin|mesh-list
92679881|NCT00350948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92679882|NCT00350948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92679883|NCT00350948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679884|NCT00350948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92679885|NCT00350948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92679886|NCT00350948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679887|NCT00350948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679888|NCT00450567|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92679889|NCT00450567|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92679890|NCT00450567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679891|NCT00421538|Nadroparin|nadroparin|mesh-list
92679892|NCT00421538|Calcium|calcium|mesh-list
92367784|NCT00889200|Eszopiclone|eszopiclone|mesh-list
92679893|NCT00421538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92679894|NCT00421538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679895|NCT00421538|Anticoagulants|anticoagulants|mesh-ancestor
92679896|NCT00421538|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92679897|NCT00421538|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92679903|NCT00351026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679904|NCT00351026|Analgesics|analgesics|mesh-ancestor
92679905|NCT00351026|Sensory System Agents|sensory system agents|mesh-ancestor
92679906|NCT00351026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679907|NCT00351026|Antitussive Agents|antitussive agents|mesh-ancestor
92679908|NCT00351026|Respiratory System Agents|respiratory system agents|mesh-ancestor
92679909|NCT00351104|Ketoprofen|ketoprofen|mesh-list
92679910|NCT00351104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92679911|NCT00351104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92679912|NCT00351104|Analgesics|analgesics|mesh-ancestor
92605942|NCT00424164|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92605943|NCT00424164|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92605944|NCT00424164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92605945|NCT00424164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605946|NCT00424164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605947|NCT00499135|Alovudine|alovudine|mesh-list
92605948|NCT00499135|Sunitinib|sunitinib|mesh-list
92605949|NCT00499135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605950|NCT00499135|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92605951|NCT00499135|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92605952|NCT00499135|Growth Substances|growth substances|mesh-ancestor
92605953|NCT00499135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605954|NCT00499135|Growth Inhibitors|growth inhibitors|mesh-ancestor
92605955|NCT00499135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605956|NCT00499135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013411|NCT05014711|Fentanyl|fentanyl|mesh-list
92679913|NCT00351104|Sensory System Agents|sensory system agents|mesh-ancestor
92679914|NCT00351104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679915|NCT00351104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679916|NCT00351104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679917|NCT00351104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679918|NCT00351104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92679919|NCT00351104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679920|NCT00351104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679921|NCT00351143|Fluticasone|fluticasone|mesh-list
92679922|NCT00351143|Xhance|xhance|mesh-list
92679923|NCT00351143|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92679924|NCT00351143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679925|NCT00351143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92679926|NCT00351143|Autonomic Agents|autonomic agents|mesh-ancestor
92679927|NCT00351143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92679928|NCT00351143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679929|NCT00351143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92679930|NCT00351143|Respiratory System Agents|respiratory system agents|mesh-ancestor
92679931|NCT00351143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679932|NCT00351143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92679933|NCT00351143|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92679934|NCT00351143|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92679935|NCT00351143|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92679936|NCT00351143|Adrenergic Agents|adrenergic agents|mesh-ancestor
92679937|NCT00351143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92679938|NCT00351143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679939|NCT00457470|Rucaparib|rucaparib|mesh-list
92679940|NCT00457470|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92679941|NCT00457470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679942|NCT00457470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679943|NCT00457470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679944|NCT00457509|Vaccines|vaccines|mesh-list
92679945|NCT00457509|Immunologic Factors|immunologic factors|mesh-ancestor
92679946|NCT00457509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679947|NCT00450645|Heparin|heparin|mesh-list
92679948|NCT00450645|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92679949|NCT00450645|Tinzaparin|tinzaparin|mesh-list
92679950|NCT00450645|Dalteparin|dalteparin|mesh-list
92679951|NCT00450645|Anticoagulants|anticoagulants|mesh-ancestor
92679952|NCT00450645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92679953|NCT00450645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92679954|NCT00450645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679955|NCT00351182|Doxycycline|doxycycline|mesh-list
92013426|NCT05018923|Tetracycline|tetracycline|mesh-list
92605957|NCT00499135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605958|NCT00499135|Antiviral Agents|antiviral agents|mesh-ancestor
92605959|NCT00499135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92605960|NCT01245361|Infliximab|infliximab|mesh-list
92605961|NCT01245361|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92605962|NCT01245361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92605963|NCT01245361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92605964|NCT01245361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92605965|NCT01245361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605966|NCT00424203|Cyclophosphamide|cyclophosphamide|mesh-list
92605967|NCT00424203|Doxorubicin|doxorubicin|mesh-list
92605968|NCT00424203|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92605969|NCT00424203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92013429|NCT05018923|Bismuth|bismuth|mesh-list
92679956|NCT00351182|Telithromycin|telithromycin|mesh-list
92679957|NCT00351182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92679958|NCT00351182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92679959|NCT00351182|Antimalarials|antimalarials|mesh-ancestor
92679960|NCT00351182|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92679961|NCT00351182|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92679962|NCT00457860|Immunotoxin HA22|immunotoxin ha22|mesh-list
92679963|NCT00457860|Immunotoxins|immunotoxins|mesh-list
92679964|NCT00457860|Immunoconjugates|immunoconjugates|mesh-ancestor
92679965|NCT00457860|Immunologic Factors|immunologic factors|mesh-ancestor
92679966|NCT00457860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679967|NCT00457860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679968|NCT00457899|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92679972|NCT00457899|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92679973|NCT00457899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679974|NCT00457899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679975|NCT00351884|Vildagliptin|vildagliptin|mesh-list
92679976|NCT00351884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92679977|NCT00351884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679978|NCT00351884|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92679979|NCT00351884|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679980|NCT00351884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679981|NCT00351884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679982|NCT00458055|Niacin|niacin|mesh-list
92679983|NCT00458055|Atorvastatin|atorvastatin|mesh-list
92679984|NCT00458055|Fenofibrate|fenofibrate|mesh-list
92679985|NCT00458055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92679986|NCT00458055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92679987|NCT00458055|Antimetabolites|antimetabolites|mesh-ancestor
92679988|NCT00458055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679989|NCT00458055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92679990|NCT00458055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92679991|NCT00458055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679992|NCT00458055|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679993|NCT00458055|Vitamin B Complex|vitamin b complex|mesh-ancestor
92679994|NCT00458055|Vitamins|vitamins|mesh-ancestor
92679995|NCT00458055|Micronutrients|micronutrients|mesh-ancestor
92679996|NCT00458055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679997|NCT00450762|Carboplatin|carboplatin|mesh-list
92679998|NCT00450762|Gemcitabine|gemcitabine|mesh-list
92679999|NCT00450762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680000|NCT00450762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92680001|NCT00450762|Antimetabolites|antimetabolites|mesh-ancestor
92680002|NCT00450762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680003|NCT00352079|Gefitinib|gefitinib|mesh-list
92680004|NCT00352079|BCG Vaccine|bcg vaccine|mesh-list
92680005|NCT00352079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680006|NCT00352079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680007|NCT00352079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605970|NCT00424203|Immunologic Factors|immunologic factors|mesh-ancestor
92605971|NCT00424203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92605972|NCT00424203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92605973|NCT00424203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92605974|NCT00424203|Alkylating Agents|alkylating agents|mesh-ancestor
92605975|NCT00424203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605976|NCT00424203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680008|NCT00352079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680009|NCT00352079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92680010|NCT00352079|Immunologic Factors|immunologic factors|mesh-ancestor
92680011|NCT00352079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680012|NCT00450840|Simvastatin|simvastatin|mesh-list
92680013|NCT00450840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92680014|NCT00450840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92680015|NCT00450840|Antimetabolites|antimetabolites|mesh-ancestor
92680016|NCT00450840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680017|NCT00450840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92680018|NCT00450840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92680019|NCT00450840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680020|NCT00352196|Risperidone|risperidone|mesh-list
92680021|NCT00352196|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92680022|NCT00352196|Serotonin Agents|serotonin agents|mesh-ancestor
92680023|NCT00352196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680024|NCT00352196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680025|NCT00352196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680026|NCT00352196|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92680027|NCT00352196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92680028|NCT00352196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680029|NCT00352196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92680030|NCT00352196|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92680031|NCT00352196|Dopamine Agents|dopamine agents|mesh-ancestor
92680032|NCT00352235|KRN 7000|krn 7000|mesh-list
92680033|NCT00352235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92680034|NCT00352235|Immunologic Factors|immunologic factors|mesh-ancestor
92680035|NCT00352235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680036|NCT00352235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680037|NCT00352313|Carboplatin|carboplatin|mesh-list
92680038|NCT00352313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680039|NCT00450957|Lycopene|lycopene|mesh-list
92680040|NCT00450957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680041|NCT00450957|Antioxidants|antioxidants|mesh-ancestor
92680043|NCT00450957|Protective Agents|protective agents|mesh-ancestor
92680044|NCT00450957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680045|NCT00450957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92680046|NCT00450957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92680047|NCT00450957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680048|NCT00352430|Nitric Oxide|nitric oxide|mesh-list
92680049|NCT00352430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92680050|NCT00352430|Autonomic Agents|autonomic agents|mesh-ancestor
92680051|NCT00352430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680052|NCT00352430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680053|NCT00352430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92680054|NCT00352430|Respiratory System Agents|respiratory system agents|mesh-ancestor
92680055|NCT00352430|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92680056|NCT00352430|Antioxidants|antioxidants|mesh-ancestor
92680057|NCT00352430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680058|NCT00352430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680059|NCT00352430|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92680060|NCT00352430|Vasodilator Agents|vasodilator agents|mesh-ancestor
92680061|NCT00352430|Gasotransmitters|gasotransmitters|mesh-ancestor
92680062|NCT00352430|Protective Agents|protective agents|mesh-ancestor
92680063|NCT00352469|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92680064|NCT00352469|Antidepressive Agents|antidepressive agents|mesh-ancestor
92680065|NCT00352469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92680066|NCT00352469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92680067|NCT00352469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92013446|NCT05018923|Respiratory System Agents|respiratory system agents|mesh-ancestor
92605977|NCT00424203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92605978|NCT00424203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92605979|NCT00424203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92605980|NCT00424203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92605982|NCT01245556|Ipilimumab|ipilimumab|mesh-list
92605983|NCT01245556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92605984|NCT01245556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367810|NCT00895752|Riluzole|riluzole|mesh-list
92605985|NCT01245556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92605986|NCT01245556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605987|NCT00499525|Paclitaxel|paclitaxel|mesh-list
92605988|NCT00499525|Sorafenib|sorafenib|mesh-list
92605989|NCT00499525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92605990|NCT00499525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92605991|NCT00499525|Tubulin Modulators|tubulin modulators|mesh-ancestor
92605992|NCT00499525|Antimitotic Agents|antimitotic agents|mesh-ancestor
92605993|NCT00499525|Mitosis Modulators|mitosis modulators|mesh-ancestor
92605994|NCT00499525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92605995|NCT00499525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92605996|NCT00499525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92605997|NCT00499642|Moxifloxacin|moxifloxacin|mesh-list
92605998|NCT00499642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92605999|NCT00499642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606000|NCT00499642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606001|NCT00499642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606002|NCT00499642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680068|NCT00352469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680069|NCT00352469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680070|NCT00451074|Gentamicins|gentamicins|mesh-list
92680071|NCT00451074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680072|NCT00451074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680073|NCT00451074|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92680074|NCT00451074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680075|NCT00451074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680076|NCT00465621|Latanoprost|latanoprost|mesh-list
92680077|NCT00465621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92680078|NCT00465621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92680079|NCT00352625|Ketoprofen|ketoprofen|mesh-list
92680080|NCT00352625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92680081|NCT00352625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92680082|NCT00352625|Analgesics|analgesics|mesh-ancestor
92680083|NCT00352625|Sensory System Agents|sensory system agents|mesh-ancestor
92680084|NCT00352625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680085|NCT00352625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680086|NCT00352625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606003|NCT00499642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606004|NCT00499642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606005|NCT00499720|Aztreonam|aztreonam|mesh-list
92606006|NCT00499720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606007|NCT00499720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606008|NCT05562518|Estrogens|estrogens|mesh-list
92606009|NCT05562518|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92606010|NCT05562518|Hormones|hormones|mesh-ancestor
92606011|NCT05562518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013471|NCT03085849|Tremelimumab|tremelimumab|mesh-list
92680087|NCT00352625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680088|NCT00352625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92680089|NCT00352625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680090|NCT00352625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680091|NCT00352742|Bortezomib|bortezomib|mesh-list
92680092|NCT00352742|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92680093|NCT00352742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680094|NCT00352742|Chelating Agents|chelating agents|mesh-ancestor
92680095|NCT00352742|Sequestering Agents|sequestering agents|mesh-ancestor
92680096|NCT00352742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680097|NCT00352742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680098|NCT00352742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92680099|NCT00352742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92680100|NCT00352742|Growth Substances|growth substances|mesh-ancestor
92680101|NCT00352742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680102|NCT00352742|Growth Inhibitors|growth inhibitors|mesh-ancestor
92680103|NCT00352859|Interferons|interferons|mesh-list
92680104|NCT00352859|Gemcitabine|gemcitabine|mesh-list
92680105|NCT00352859|Sorafenib|sorafenib|mesh-list
92680106|NCT00352859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92680107|NCT00352859|Antimetabolites|antimetabolites|mesh-ancestor
92680108|NCT00352859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680109|NCT00352859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680110|NCT00352859|Antiviral Agents|antiviral agents|mesh-ancestor
92680111|NCT00352859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680112|NCT00352859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680113|NCT00352859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680114|NCT00105183|Immunoglobulins|immunoglobulins|mesh-list
92680118|NCT00105183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92680119|NCT00105183|Immunoglobulin G|immunoglobulin g|mesh-list
92680120|NCT00105183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92680121|NCT00105183|Immunologic Factors|immunologic factors|mesh-ancestor
92680122|NCT00105183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680123|NCT00105183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680124|NCT00466089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92680125|NCT00466089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680126|NCT00466089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680127|NCT00466089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680128|NCT00466089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680129|NCT00466128|Indomethacin|indomethacin|mesh-list
92680130|NCT00466128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92680131|NCT00466128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92680132|NCT00466128|Analgesics|analgesics|mesh-ancestor
92680133|NCT00466128|Sensory System Agents|sensory system agents|mesh-ancestor
92680134|NCT00466128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680135|NCT00466128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680136|NCT00466128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680137|NCT00466128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680138|NCT00466128|Gout Suppressants|gout suppressants|mesh-ancestor
92680139|NCT00466128|Tocolytic Agents|tocolytic agents|mesh-ancestor
92680140|NCT00466128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92680141|NCT00466128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92680142|NCT00466128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680143|NCT00466128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680144|NCT00353015|Cisplatin|cisplatin|mesh-list
92013481|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92606012|NCT05562518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606013|NCT05562518|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92606014|NCT05562518|Immunologic Factors|immunologic factors|mesh-ancestor
92331007|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606016|NCT00499837|Protein C Inhibitor|protein c inhibitor|mesh-list
92606017|NCT00499837|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92606018|NCT00499837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92606019|NCT00499837|Protease Inhibitors|protease inhibitors|mesh-ancestor
92606020|NCT00499837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606021|NCT00499837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606023|NCT00499876|Antimalarials|antimalarials|mesh-ancestor
92606024|NCT00499876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92606025|NCT00499876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92606026|NCT00499876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606027|NCT00146718|Pyrimethamine|pyrimethamine|mesh-list
92606028|NCT00146718|Sulfadoxine|sulfadoxine|mesh-list
92606029|NCT00146718|Amodiaquine|amodiaquine|mesh-list
92606030|NCT00146718|Antimalarials|antimalarials|mesh-ancestor
92606031|NCT00146718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92606032|NCT00146718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680145|NCT00353015|Irinotecan|irinotecan|mesh-list
92680146|NCT00353015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680147|NCT00353015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92680148|NCT00353015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92680149|NCT00353015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367830|NCT00899574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92680150|NCT00353015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680151|NCT00466284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92680152|NCT00466284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680153|NCT00466284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680154|NCT00466284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680155|NCT00466284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680156|NCT00353054|Calcium Carbonate|calcium carbonate|mesh-list
92680157|NCT00353054|Antacids|antacids|mesh-ancestor
92680158|NCT00353054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680159|NCT00353054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680160|NCT00466401|Simvastatin|simvastatin|mesh-list
92680161|NCT00466401|Ezetimibe|ezetimibe|mesh-list
92680162|NCT00466401|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92680163|NCT00466401|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92680164|NCT00466401|Antimetabolites|antimetabolites|mesh-ancestor
92680165|NCT00466401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680166|NCT00466401|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92680167|NCT00466401|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92680169|NCT00466479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92680170|NCT00466479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92680171|NCT00466479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92680172|NCT00466479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92680173|NCT00466479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92680174|NCT00466479|Adrenergic Agents|adrenergic agents|mesh-ancestor
92680175|NCT00466479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680176|NCT00466479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606033|NCT00146718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606034|NCT00146718|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92606035|NCT00146718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606036|NCT00146718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606037|NCT00146718|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92606038|NCT00499993|Lanreotide|lanreotide|mesh-list
92606039|NCT00499993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606040|NCT00500188|Imatinib Mesylate|imatinib mesylate|mesh-list
92606041|NCT00500188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606042|NCT00500188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606043|NCT00500188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680177|NCT00466479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680178|NCT00466518|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92680179|NCT00466518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92680180|NCT00466518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680181|NCT00466518|Incretins|incretins|mesh-ancestor
92680182|NCT00466518|Hormones|hormones|mesh-ancestor
92680183|NCT00466518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92680184|NCT00466518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92680185|NCT00466518|Protease Inhibitors|protease inhibitors|mesh-ancestor
92680186|NCT00466518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680189|NCT00353561|Antifungal Agents|antifungal agents|mesh-ancestor
92680190|NCT00353561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680191|NCT00353561|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92680192|NCT00353561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92680193|NCT00353561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680194|NCT00353561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680195|NCT00353561|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92680196|NCT00353561|Hormone Antagonists|hormone antagonists|mesh-ancestor
92680197|NCT00353561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92680198|NCT00353561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680199|NCT00353561|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92680200|NCT00353561|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92680201|NCT00466596|Vitamins|vitamins|mesh-list
92680202|NCT00466596|Vitamin E|vitamin e|mesh-list
92680203|NCT00466596|Tocopherols|tocopherols|mesh-list
92680204|NCT00466596|Tocotrienols|tocotrienols|mesh-list
92680205|NCT00466596|alpha-Tocopherol|alpha-tocopherol|mesh-list
92680206|NCT00466596|gamma-Tocopherol|gamma-tocopherol|mesh-list
92680207|NCT00466596|Micronutrients|micronutrients|mesh-ancestor
92680208|NCT00466596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680209|NCT00466596|Antioxidants|antioxidants|mesh-ancestor
92680210|NCT00466596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680211|NCT00466596|Protective Agents|protective agents|mesh-ancestor
92680212|NCT00353678|Darexaban|darexaban|mesh-list
92680213|NCT00353678|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92680214|NCT00353678|Antithrombins|antithrombins|mesh-ancestor
92680215|NCT00353678|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92680216|NCT00353678|Protease Inhibitors|protease inhibitors|mesh-ancestor
92680217|NCT00353678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680218|NCT00353678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680219|NCT00353678|Anticoagulants|anticoagulants|mesh-ancestor
92680220|NCT00458250|Cyclosporine|cyclosporine|mesh-list
92680221|NCT00458250|Cyclophosphamide|cyclophosphamide|mesh-list
92680222|NCT00458250|Busulfan|busulfan|mesh-list
92680223|NCT00458250|Methotrexate|methotrexate|mesh-list
92680224|NCT00458250|Alemtuzumab|alemtuzumab|mesh-list
92680225|NCT00458250|Cyclosporins|cyclosporins|mesh-list
92680226|NCT00458250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680227|NCT00458250|Immunologic Factors|immunologic factors|mesh-ancestor
92680228|NCT00458250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680229|NCT00458250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680230|NCT00458250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92680231|NCT00458250|Alkylating Agents|alkylating agents|mesh-ancestor
92606044|NCT00500188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606045|NCT04710914|Midazolam|midazolam|mesh-list
92606046|NCT04710914|Isoflurane|isoflurane|mesh-list
92606047|NCT04710914|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92606048|NCT04710914|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92606049|NCT04710914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606050|NCT04710914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606051|NCT04710914|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92680232|NCT00458250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680233|NCT00458250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680234|NCT00458250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92680235|NCT00458250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92680236|NCT00458250|Abortifacient Agents|abortifacient agents|mesh-ancestor
92680237|NCT00458250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92680238|NCT00458250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92680239|NCT00458250|Antimetabolites|antimetabolites|mesh-ancestor
92680240|NCT00458250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367871|NCT00904488|Metolazone|metolazone|mesh-list
92680241|NCT00458250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680242|NCT00458250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92680243|NCT00458250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92680244|NCT00458250|Antifungal Agents|antifungal agents|mesh-ancestor
92680245|NCT00458250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680246|NCT00458250|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92680247|NCT00458250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680248|NCT00353717|Paclitaxel|paclitaxel|mesh-list
92680249|NCT00353717|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92680250|NCT00353717|Cetuximab|cetuximab|mesh-list
92680251|NCT00353717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92680252|NCT00353717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680253|NCT00353717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92680254|NCT00353717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92680255|NCT00353717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92680256|NCT00353717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680257|NCT00353717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680258|NCT00466713|Rosiglitazone|rosiglitazone|mesh-list
92680259|NCT00466713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92680262|NCT00466791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92680263|NCT00466791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680264|NCT00466791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92680265|NCT00466791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92680266|NCT00466791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92680267|NCT00466791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680269|NCT00466791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680270|NCT00353912|Amlodipine|amlodipine|mesh-list
92680271|NCT00353912|Valsartan|valsartan|mesh-list
92680272|NCT00353912|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92680273|NCT00353912|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92680274|NCT00353912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92680275|NCT00353912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680276|NCT00353912|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92680277|NCT00353912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680278|NCT00353912|Vasodilator Agents|vasodilator agents|mesh-ancestor
92680279|NCT00353912|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92680280|NCT00353912|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92680281|NCT00353990|Insulin Aspart|insulin aspart|mesh-list
92680282|NCT00353990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92680283|NCT00353990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680285|NCT00458328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92680286|NCT00458328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680287|NCT00458328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680288|NCT00458328|Cholinergic Agents|cholinergic agents|mesh-ancestor
92680289|NCT00458328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680290|NCT00458328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606053|NCT04710914|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92606054|NCT04710914|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92606055|NCT04710914|Anesthetics, General|anesthetics, general|mesh-ancestor
92606056|NCT04710914|Anesthetics|anesthetics|mesh-ancestor
92606057|NCT04710914|GABA Modulators|gaba modulators|mesh-ancestor
92606058|NCT04710914|GABA Agents|gaba agents|mesh-ancestor
92606059|NCT04710914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606060|NCT04710914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606061|NCT04710914|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92606062|NCT00500344|Ranibizumab|ranibizumab|mesh-list
92606063|NCT00500344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92606064|NCT00500344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92606065|NCT00500344|Growth Substances|growth substances|mesh-ancestor
92606066|NCT00500344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606067|NCT00500344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92606068|NCT00500344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606069|NCT00146835|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92606070|NCT00146835|Immunologic Factors|immunologic factors|mesh-ancestor
92606071|NCT00146835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606072|NCT01245868|Lidocaine|lidocaine|mesh-list
92606073|NCT01245868|Bupivacaine|bupivacaine|mesh-list
92606074|NCT01245868|Anesthetics, Local|anesthetics, local|mesh-ancestor
92606075|NCT01245868|Anesthetics|anesthetics|mesh-ancestor
92606076|NCT01245868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606077|NCT01245868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606078|NCT01245868|Sensory System Agents|sensory system agents|mesh-ancestor
92606079|NCT01245868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606080|NCT01245868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92013522|NCT05006911|Sympathomimetics|sympathomimetics|mesh-ancestor
92680291|NCT00458328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680292|NCT00354068|Temozolomide|temozolomide|mesh-list
92680293|NCT00354068|Imatinib Mesylate|imatinib mesylate|mesh-list
92680294|NCT00354068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92680295|NCT00354068|Alkylating Agents|alkylating agents|mesh-ancestor
92680296|NCT00354068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680297|NCT00354068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680298|NCT00354068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680299|NCT00354068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680300|NCT00466869|Betahistine|betahistine|mesh-list
92680301|NCT00466869|Vasodilator Agents|vasodilator agents|mesh-ancestor
92680302|NCT00466869|Histamine Agonists|histamine agonists|mesh-ancestor
92680303|NCT00466869|Histamine Agents|histamine agents|mesh-ancestor
92680304|NCT00466869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680305|NCT00466869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606081|NCT01245868|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92606082|NCT01245868|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92606083|NCT01245868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92606084|NCT01245868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606085|NCT00500422|Gemcitabine|gemcitabine|mesh-list
92606086|NCT00500422|Doxorubicin|doxorubicin|mesh-list
92606087|NCT00500422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92606088|NCT00500422|Bortezomib|bortezomib|mesh-list
92606089|NCT00500422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606090|NCT00500422|Antimetabolites|antimetabolites|mesh-ancestor
92606091|NCT00500422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606092|NCT00500422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606093|NCT00500422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92606094|NCT00500422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606095|NCT00500422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606096|NCT00500422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606097|NCT01245946|Doxycycline|doxycycline|mesh-list
92606098|NCT01245946|Adapalene|adapalene|mesh-list
92606099|NCT01245946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606100|NCT01245946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606101|NCT01245946|Antimalarials|antimalarials|mesh-ancestor
92606102|NCT01245946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92606103|NCT01245946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92606104|NCT01245946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606105|NCT01245946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606106|NCT01245946|Analgesics|analgesics|mesh-ancestor
92606107|NCT01245946|Sensory System Agents|sensory system agents|mesh-ancestor
92606108|NCT01245946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606109|NCT01245946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606110|NCT01245946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606111|NCT01245946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606112|NCT01245946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92606113|NCT00146913|Interferons|interferons|mesh-list
92606114|NCT00146913|Imatinib Mesylate|imatinib mesylate|mesh-list
92606115|NCT00146913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606116|NCT00146913|Antiviral Agents|antiviral agents|mesh-ancestor
92013553|NCT02637037|Metformin|metformin|mesh-list
92367895|NCT00908466|Sirolimus|sirolimus|mesh-list
92680306|NCT00466869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680307|NCT00354146|Tipifarnib|tipifarnib|mesh-list
92013587|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92606117|NCT00146913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606118|NCT00146913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606119|NCT00146913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606120|NCT00146913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606122|NCT00501124|Antiviral Agents|antiviral agents|mesh-ancestor
92606123|NCT00501124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606124|NCT00501241|ATI 7505|ati 7505|mesh-list
92606125|NCT00501241|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92606126|NCT00501241|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92606127|NCT00501241|Serotonin Agents|serotonin agents|mesh-ancestor
92606128|NCT00501241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606129|NCT00501241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680308|NCT00354146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680309|NCT00458367|Risperidone|risperidone|mesh-list
92680310|NCT00458367|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92680311|NCT00458367|Serotonin Agents|serotonin agents|mesh-ancestor
92680312|NCT00458367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680313|NCT00458367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680314|NCT00458367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680315|NCT00458367|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92680316|NCT00458367|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92680317|NCT00458367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680318|NCT00458367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92680319|NCT00458367|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92680321|NCT00354185|Belinostat|belinostat|mesh-list
92680322|NCT00354185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680323|NCT00354185|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92680324|NCT00354185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680325|NCT00354185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680326|NCT00466986|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92680327|NCT00466986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680328|NCT00354302|Calcium, Dietary|calcium, dietary|mesh-list
92680329|NCT00354302|Cholecalciferol|cholecalciferol|mesh-list
92680330|NCT00354302|Alendronate|alendronate|mesh-list
92680331|NCT00354302|Risedronic Acid|risedronic acid|mesh-list
92680334|NCT00354302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92680335|NCT00354302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680336|NCT00354302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92680337|NCT00354302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680338|NCT00354302|Vitamins|vitamins|mesh-ancestor
92680339|NCT00354302|Micronutrients|micronutrients|mesh-ancestor
92680340|NCT00354302|Antacids|antacids|mesh-ancestor
92680341|NCT00354302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680342|NCT00354302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92680343|NCT00354302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92680344|NCT04714229|Vaccines|vaccines|mesh-list
92680345|NCT04714229|Immunologic Factors|immunologic factors|mesh-ancestor
92680346|NCT04714229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680347|NCT00458523|Alemtuzumab|alemtuzumab|mesh-list
92680348|NCT00458523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680349|NCT00458523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680350|NCT00354380|Artesunate|artesunate|mesh-list
92680351|NCT00354380|Amodiaquine|amodiaquine|mesh-list
92680352|NCT00354380|Methylene Blue|methylene blue|mesh-list
92680353|NCT00354380|Antimalarials|antimalarials|mesh-ancestor
92680354|NCT00354380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92680355|NCT00354380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680356|NCT00354380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680357|NCT00354380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013602|NCT05305911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92606130|NCT00501241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606131|NCT01246180|Diclofenac|diclofenac|mesh-list
92606132|NCT01246180|Amiloride|amiloride|mesh-list
92606133|NCT01246180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606134|NCT01246180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606135|NCT01246180|Analgesics|analgesics|mesh-ancestor
92606136|NCT01246180|Sensory System Agents|sensory system agents|mesh-ancestor
92606137|NCT01246180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606138|NCT01246180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606139|NCT01246180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606140|NCT01246180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606141|NCT01246180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92606142|NCT01246180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606143|NCT01246180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606144|NCT01246180|Diuretics|diuretics|mesh-ancestor
92606145|NCT01246180|Natriuretic Agents|natriuretic agents|mesh-ancestor
92606146|NCT01246180|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92606147|NCT01246180|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92606148|NCT01246180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92680358|NCT00354380|Antiviral Agents|antiviral agents|mesh-ancestor
92680359|NCT00354380|Schistosomicides|schistosomicides|mesh-ancestor
92680360|NCT00354380|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92680361|NCT00354380|Anthelmintics|anthelmintics|mesh-ancestor
92680362|NCT00354380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680363|NCT00354380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680364|NCT00354419|Cyclosporine|cyclosporine|mesh-list
92680365|NCT00354419|Mycophenolic Acid|mycophenolic acid|mesh-list
92680366|NCT00354419|Cyclophosphamide|cyclophosphamide|mesh-list
92680367|NCT00354419|Cyclosporins|cyclosporins|mesh-list
92680368|NCT00354419|Thymoglobulin|thymoglobulin|mesh-list
92680369|NCT00354419|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92680370|NCT00354419|Lenograstim|lenograstim|mesh-list
92680371|NCT00354419|Immunoglobulins|immunoglobulins|mesh-list
92680372|NCT00354419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680373|NCT00354419|Immunologic Factors|immunologic factors|mesh-ancestor
92680374|NCT00354419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680375|NCT00354419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680376|NCT00354419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92680377|NCT00354419|Alkylating Agents|alkylating agents|mesh-ancestor
92680378|NCT00354419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680379|NCT00354419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680380|NCT00354419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92680381|NCT00354419|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92680382|NCT00354419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680383|NCT00354419|Antifungal Agents|antifungal agents|mesh-ancestor
92680384|NCT00354419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680385|NCT00354419|Dermatologic Agents|dermatologic agents|mesh-ancestor
92680386|NCT00354419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92680387|NCT00354419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92680388|NCT00354419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92680389|NCT00354419|Antitubercular Agents|antitubercular agents|mesh-ancestor
92680390|NCT00354419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680392|NCT00354458|Diuretics|diuretics|mesh-ancestor
92680393|NCT00354458|Natriuretic Agents|natriuretic agents|mesh-ancestor
92606149|NCT01246180|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92606150|NCT01246180|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92606151|NCT05561972|Hyaluronic Acid|hyaluronic acid|mesh-list
92606152|NCT05561972|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92606153|NCT05561972|Immunologic Factors|immunologic factors|mesh-ancestor
92606154|NCT05561972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606155|NCT05561972|Viscosupplements|viscosupplements|mesh-ancestor
92606156|NCT05561972|Protective Agents|protective agents|mesh-ancestor
92606157|NCT02274610|Docetaxel|docetaxel|mesh-list
92606158|NCT02274610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606159|NCT02274610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92606160|NCT02274610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92606161|NCT02274610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92606162|NCT02274610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606163|NCT00501397|Ketoconazole|ketoconazole|mesh-list
92606164|NCT00501397|Antifungal Agents|antifungal agents|mesh-ancestor
92606165|NCT00501397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331161|NCT00004682|Antibodies|antibodies|mesh-list
92606166|NCT00501397|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92606167|NCT00501397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92606168|NCT00501397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606169|NCT00501397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606170|NCT00501397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92606171|NCT00501397|Hormone Antagonists|hormone antagonists|mesh-ancestor
92013619|NCT05000281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680394|NCT00354458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680395|NCT00458718|Rimonabant|rimonabant|mesh-list
92680396|NCT00458718|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92680397|NCT00458718|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92680398|NCT00458718|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92680399|NCT00458718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680400|NCT00458718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680401|NCT00458718|Hormones|hormones|mesh-ancestor
92680402|NCT00458718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92680403|NCT00458718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680404|NCT00467181|Fenoldopam|fenoldopam|mesh-list
92680405|NCT00467181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92680406|NCT00467181|Vasodilator Agents|vasodilator agents|mesh-ancestor
92680407|NCT00467181|Dopamine Agonists|dopamine agonists|mesh-ancestor
92680408|NCT00467181|Dopamine Agents|dopamine agents|mesh-ancestor
92680411|NCT00467181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680412|NCT00425711|Acamprosate|acamprosate|mesh-list
92680413|NCT00425711|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92680414|NCT03274011|Apatinib|apatinib|mesh-list
92680415|NCT03274011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680416|NCT03274011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680417|NCT03274011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680418|NCT03274011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680419|NCT00425906|Nicotine|nicotine|mesh-list
92606172|NCT00501397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606173|NCT00501397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606174|NCT00501397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92606176|NCT00501514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606177|NCT00501514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606179|NCT00147186|Viscosupplements|viscosupplements|mesh-ancestor
92606180|NCT00147186|Protective Agents|protective agents|mesh-ancestor
92606181|NCT00147186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606182|NCT00501748|Rituximab|rituximab|mesh-list
92606183|NCT00501748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606184|NCT00501748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606185|NCT00501748|Immunologic Factors|immunologic factors|mesh-ancestor
92606186|NCT00501748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606187|NCT00501748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606188|NCT00501787|Metformin|metformin|mesh-list
92606189|NCT00501787|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92606190|NCT00501787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680420|NCT00425906|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92680421|NCT00425906|Autonomic Agents|autonomic agents|mesh-ancestor
92680422|NCT00425906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680423|NCT00425906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680424|NCT00425906|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92680425|NCT00425906|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92680426|NCT00425906|Cholinergic Agents|cholinergic agents|mesh-ancestor
92680427|NCT00425906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680428|NCT00425906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680429|NCT00467376|Insulin|insulin|mesh-list
92680430|NCT00467376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92680431|NCT00467376|Insulin Glargine|insulin glargine|mesh-list
92680432|NCT00467376|Insulin glulisine|insulin glulisine|mesh-list
92680433|NCT00467376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92680434|NCT00467376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680435|NCT00426023|Ketotifen|ketotifen|mesh-list
92680436|NCT00426023|Cyclosporine|cyclosporine|mesh-list
92680437|NCT00426023|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92680438|NCT00426023|Cyclosporins|cyclosporins|mesh-list
92680439|NCT00426023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680440|NCT00426023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680441|NCT00426023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680442|NCT00426023|Immunologic Factors|immunologic factors|mesh-ancestor
92680443|NCT00426023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680444|NCT00426023|Antifungal Agents|antifungal agents|mesh-ancestor
92680445|NCT00426023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680446|NCT00426023|Dermatologic Agents|dermatologic agents|mesh-ancestor
92680447|NCT00426023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680448|NCT00426023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92680449|NCT00426023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92680450|NCT00426023|Antipruritics|antipruritics|mesh-ancestor
92680451|NCT00426023|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92680452|NCT00426023|Histamine Antagonists|histamine antagonists|mesh-ancestor
92680453|NCT00426023|Histamine Agents|histamine agents|mesh-ancestor
92680454|NCT00426023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680455|NCT00426023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92680456|NCT00467454|Naltrexone|naltrexone|mesh-list
92680457|NCT00467454|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92606191|NCT00147264|Telmisartan|telmisartan|mesh-list
92606192|NCT00147264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92606193|NCT00147264|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92606194|NCT00147264|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92606195|NCT00147264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606196|NCT00501904|Metformin|metformin|mesh-list
92606197|NCT00501904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92606198|NCT00501904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606199|NCT00501982|Poractant alfa|poractant alfa|mesh-list
92606200|NCT00501982|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92606201|NCT00501982|Respiratory System Agents|respiratory system agents|mesh-ancestor
92606202|NCT00147303|Sarpogrelate|sarpogrelate|mesh-list
92606203|NCT00147303|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92606204|NCT00147303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92606205|NCT00147303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606206|NCT00147303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92606207|NCT00147303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92606208|NCT00147303|Serotonin Agents|serotonin agents|mesh-ancestor
92606209|NCT00147303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606210|NCT00147303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606211|NCT00502060|Cediranib|cediranib|mesh-list
92606212|NCT00502060|Gefitinib|gefitinib|mesh-list
92606213|NCT00502060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606214|NCT00502060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606215|NCT00502060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606216|NCT00502060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606217|NCT00502099|Interferons|interferons|mesh-list
92606218|NCT00502099|Ribavirin|ribavirin|mesh-list
92606219|NCT00502099|Interferon-alpha|interferon-alpha|mesh-list
92606220|NCT00502099|Interferon alpha-2|interferon alpha-2|mesh-list
92606221|NCT00502099|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92606222|NCT00502099|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92606223|NCT00502099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606224|NCT00502099|Antiviral Agents|antiviral agents|mesh-ancestor
92606225|NCT00502099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989466|NCT02414581|Ethanol|ethanol|mesh-list
92606231|NCT00502138|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92606232|NCT00502138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92606233|NCT00502138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606234|NCT00502138|Appetite Depressants|appetite depressants|mesh-ancestor
92606235|NCT00502138|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92606236|NCT00502138|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92606237|NCT00502138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331241|NCT00004748|Methotrexate|methotrexate|mesh-list
92606239|NCT00502294|Immunologic Factors|immunologic factors|mesh-ancestor
92606240|NCT00502294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606241|NCT00502411|Doxorubicin|doxorubicin|mesh-list
92606242|NCT00502411|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92606243|NCT00502411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92606244|NCT00502411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606245|NCT00502411|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606246|NCT00502411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606247|NCT00502411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606248|NCT00502411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606249|NCT00502528|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92606250|NCT00502528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92606251|NCT00502528|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92606252|NCT00502528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606253|NCT00147381|Alemtuzumab|alemtuzumab|mesh-list
92606254|NCT00147381|Tacrolimus|tacrolimus|mesh-list
92606255|NCT00147381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606256|NCT00147381|Immunologic Factors|immunologic factors|mesh-ancestor
92606257|NCT00147381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606258|NCT00147381|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92606259|NCT00147381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606260|NCT00147381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013702|NCT05554419|Antiviral Agents|antiviral agents|mesh-ancestor
92680458|NCT00467454|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92680459|NCT00467454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680460|NCT00467454|Sensory System Agents|sensory system agents|mesh-ancestor
92680461|NCT00467454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680462|NCT00426101|Cyclosporine|cyclosporine|mesh-list
92680463|NCT00426101|Dexamethasone|dexamethasone|mesh-list
92680464|NCT00426101|Etoposide|etoposide|mesh-list
92680465|NCT00426101|Cyclosporins|cyclosporins|mesh-list
92680466|NCT00426101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680467|NCT00426101|Antiemetics|antiemetics|mesh-ancestor
92680468|NCT00426101|Autonomic Agents|autonomic agents|mesh-ancestor
92013739|NCT05294835|Ketamine|ketamine|mesh-list
92606261|NCT00147381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606262|NCT00147381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606263|NCT00502567|Leucovorin|leucovorin|mesh-list
92606264|NCT00502567|Docetaxel|docetaxel|mesh-list
92606265|NCT00502567|Fluorouracil|fluorouracil|mesh-list
92606266|NCT00502567|Oxaliplatin|oxaliplatin|mesh-list
92606267|NCT00502567|Irinotecan|irinotecan|mesh-list
92606268|NCT00502567|Pemetrexed|pemetrexed|mesh-list
92606269|NCT00502567|Cetuximab|cetuximab|mesh-list
92606270|NCT00502567|Cediranib|cediranib|mesh-list
92606271|NCT00502567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606272|NCT00502567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92606273|NCT00502567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92606274|NCT00502567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92606275|NCT00502567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606276|NCT00502567|Antimetabolites|antimetabolites|mesh-ancestor
92606277|NCT00502567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606278|NCT00502567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606279|NCT00502567|Immunologic Factors|immunologic factors|mesh-ancestor
92606280|NCT00502567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680469|NCT00426101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680470|NCT00426101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680471|NCT00426101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680472|NCT00426101|Glucocorticoids|glucocorticoids|mesh-ancestor
92680473|NCT00426101|Hormones|hormones|mesh-ancestor
92680474|NCT00426101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92680475|NCT00426101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92680476|NCT00426101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680477|NCT00426101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92680478|NCT00426101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92680479|NCT00426101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92680480|NCT00426101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680481|NCT00426101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680482|NCT00426101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680484|NCT00426101|Antifungal Agents|antifungal agents|mesh-ancestor
92680485|NCT00426101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680486|NCT00426101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92680487|NCT00426101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680488|NCT00426101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92680489|NCT00426140|Epothilone B|epothilone b|mesh-list
92680490|NCT00426140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680491|NCT00426140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92680492|NCT00426140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92680493|NCT00426140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92680494|NCT00426140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680495|NCT00467493|Anastrozole|anastrozole|mesh-list
92680496|NCT00467493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92680497|NCT00467493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680498|NCT00467493|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92680499|NCT00467493|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92680500|NCT00467493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680501|NCT00467493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680502|NCT00467493|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92680503|NCT00467493|Hormone Antagonists|hormone antagonists|mesh-ancestor
92680504|NCT00467493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606281|NCT00502567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92606282|NCT00502567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606283|NCT00502567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606284|NCT00502567|Antidotes|antidotes|mesh-ancestor
92606285|NCT00502567|Protective Agents|protective agents|mesh-ancestor
92606286|NCT00502567|Vitamin B Complex|vitamin b complex|mesh-ancestor
92606287|NCT00502567|Vitamins|vitamins|mesh-ancestor
92606288|NCT00502567|Micronutrients|micronutrients|mesh-ancestor
92606289|NCT00502567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92606290|NCT00502567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92606291|NCT00502567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606292|NCT00502567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606293|NCT05561231|Pyrithione zinc|pyrithione zinc|mesh-list
92606294|NCT05561231|Keratolytic Agents|keratolytic agents|mesh-ancestor
92606295|NCT05561231|Dermatologic Agents|dermatologic agents|mesh-ancestor
92606296|NCT00502684|Etodolac|etodolac|mesh-list
92606297|NCT00502684|Propranolol|propranolol|mesh-list
92606298|NCT00502684|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92606299|NCT00502684|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92606300|NCT00502684|Adrenergic Agents|adrenergic agents|mesh-ancestor
92606301|NCT00502684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367956|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92606302|NCT00502684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606303|NCT00502684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606304|NCT00502684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92606305|NCT00502684|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92606306|NCT00502684|Vasodilator Agents|vasodilator agents|mesh-ancestor
92606307|NCT00502684|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606308|NCT00502684|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606309|NCT00502684|Analgesics|analgesics|mesh-ancestor
92606310|NCT00502684|Sensory System Agents|sensory system agents|mesh-ancestor
92606311|NCT00502684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331315|NCT00004784|Methotrexate|methotrexate|mesh-list
92606312|NCT00502684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606313|NCT00502684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606314|NCT00502684|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92606315|NCT00502684|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92606316|NCT00502684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680505|NCT00467493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680506|NCT00426179|Imatinib Mesylate|imatinib mesylate|mesh-list
92606318|NCT00502762|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92606319|NCT00502762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606320|NCT00502762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606321|NCT00502762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606322|NCT00502762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606323|NCT00502879|Etanercept|etanercept|mesh-list
92606324|NCT00502879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606325|NCT00502879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606326|NCT00502879|Analgesics|analgesics|mesh-ancestor
92606327|NCT00502879|Sensory System Agents|sensory system agents|mesh-ancestor
92606328|NCT00502879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606329|NCT00502879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606330|NCT00502879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606331|NCT00502879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606332|NCT00502879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606333|NCT00502879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606334|NCT00502879|Immunologic Factors|immunologic factors|mesh-ancestor
92606335|NCT00503152|Valsartan|valsartan|mesh-list
92606336|NCT00503152|Benazepril|benazepril|mesh-list
92606337|NCT00503152|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92606338|NCT00503152|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92606339|NCT00503152|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92606340|NCT00503152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606341|NCT00503152|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92606342|NCT00503152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92606343|NCT00503152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606344|NCT00503347|Bavituximab|bavituximab|mesh-list
92606345|NCT00503347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606346|NCT00503347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606347|NCT00503386|Palonosetron|palonosetron|mesh-list
92606348|NCT00503386|Granisetron|granisetron|mesh-list
92606349|NCT00503386|Antiemetics|antiemetics|mesh-ancestor
92680507|NCT00426179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680508|NCT00426179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680509|NCT00426179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680510|NCT00426179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680511|NCT00458913|Bortezomib|bortezomib|mesh-list
92680512|NCT00458913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680513|NCT00458991|Dextromethorphan|dextromethorphan|mesh-list
92680514|NCT00458991|Caffeine|caffeine|mesh-list
92680515|NCT00458991|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92680516|NCT00458991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680517|NCT00458991|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92606351|NCT00503386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606352|NCT00503386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606353|NCT00503386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606354|NCT00503386|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92606355|NCT00503386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92606356|NCT00503386|Serotonin Agents|serotonin agents|mesh-ancestor
92606357|NCT00503386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606358|NCT00503386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606359|NCT00503503|Etanercept|etanercept|mesh-list
92606360|NCT00503503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92680518|NCT00458991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680519|NCT00458991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680520|NCT00458991|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92680521|NCT00458991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92680522|NCT00458991|Purinergic Agents|purinergic agents|mesh-ancestor
92680523|NCT00458991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680524|NCT00458991|Antitussive Agents|antitussive agents|mesh-ancestor
92680525|NCT00458991|Respiratory System Agents|respiratory system agents|mesh-ancestor
92680526|NCT00458991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92680527|NCT00458991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92680528|NCT01059617|Vaccines|vaccines|mesh-list
92680529|NCT01059617|Immunologic Factors|immunologic factors|mesh-ancestor
92680530|NCT01059617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680531|NCT04705337|Simendan|simendan|mesh-list
92680532|NCT04705337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92680533|NCT04705337|Vasodilator Agents|vasodilator agents|mesh-ancestor
92680534|NCT04705337|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92680535|NCT04705337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92680536|NCT04705337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680537|NCT04705337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100248|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680538|NCT04705337|Protective Agents|protective agents|mesh-ancestor
92680539|NCT04705337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680541|NCT00467571|Clarithromycin|clarithromycin|mesh-list
92680542|NCT00467571|Lansoprazole|lansoprazole|mesh-list
92680543|NCT00467571|Dexlansoprazole|dexlansoprazole|mesh-list
92680544|NCT00467571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680545|NCT00467571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680546|NCT00467571|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92680547|NCT00467571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680548|NCT00467571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680549|NCT00467571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92680550|NCT00467571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92680551|NCT00467571|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92680552|NCT00467571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680553|NCT00467571|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92680554|NCT00426296|Ritonavir|ritonavir|mesh-list
92680555|NCT00426296|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92680558|NCT00426296|Protease Inhibitors|protease inhibitors|mesh-ancestor
92680559|NCT00426296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680560|NCT00426296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680561|NCT00426296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92680562|NCT00426296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92680563|NCT00426296|Antiviral Agents|antiviral agents|mesh-ancestor
92680564|NCT00426296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367999|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680565|NCT00426296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92680566|NCT00426296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92680568|NCT03271905|Albuterol|albuterol|mesh-list
92680569|NCT03271905|Ipratropium|ipratropium|mesh-list
92680570|NCT03271905|Anticonvulsants|anticonvulsants|mesh-ancestor
92680571|NCT03271905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92606361|NCT00503503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606362|NCT00503503|Analgesics|analgesics|mesh-ancestor
92606363|NCT00503503|Sensory System Agents|sensory system agents|mesh-ancestor
92606364|NCT00503503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606365|NCT00503503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606366|NCT00503503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606367|NCT00503503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606368|NCT00503503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606369|NCT00503503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606370|NCT00503503|Immunologic Factors|immunologic factors|mesh-ancestor
92606371|NCT00503542|Metronidazole|metronidazole|mesh-list
92606372|NCT00503542|Clindamycin|clindamycin|mesh-list
92606373|NCT00503542|Clindamycin palmitate|clindamycin palmitate|mesh-list
92606374|NCT00503542|Clindamycin phosphate|clindamycin phosphate|mesh-list
92606375|NCT00503542|Fluconazole|fluconazole|mesh-list
92606376|NCT00503542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606377|NCT00503542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606378|NCT00503542|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92606379|NCT00503542|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92606380|NCT00503542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92606381|NCT00503542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606382|NCT00503542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606383|NCT00503542|Antifungal Agents|antifungal agents|mesh-ancestor
92606384|NCT00503542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92606392|NCT00147615|Eplerenone|eplerenone|mesh-list
92606410|NCT01246804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92606411|NCT01246804|Antiviral Agents|antiviral agents|mesh-ancestor
92606412|NCT01246804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606413|NCT01246804|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92606414|NCT01246804|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92606415|NCT01246804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606416|NCT01246804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606417|NCT00147654|Tamsulosin|tamsulosin|mesh-list
92606418|NCT00147654|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92606419|NCT00147654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92606420|NCT00147654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92606421|NCT00147654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92680572|NCT03271905|Autonomic Agents|autonomic agents|mesh-ancestor
92680573|NCT03271905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680574|NCT03271905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680575|NCT03271905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92680576|NCT03271905|Respiratory System Agents|respiratory system agents|mesh-ancestor
92680577|NCT03271905|Tocolytic Agents|tocolytic agents|mesh-ancestor
92680578|NCT03271905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92680579|NCT03271905|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92680580|NCT03271905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92680581|NCT03271905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92680582|NCT03271905|Adrenergic Agents|adrenergic agents|mesh-ancestor
92680583|NCT03271905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680584|NCT03271905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680585|NCT03271905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92680586|NCT03271905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92680587|NCT00426413|Pioglitazone|pioglitazone|mesh-list
92680588|NCT00426413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92680589|NCT00426413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680590|NCT00459264|Folic Acid|folic acid|mesh-list
92680591|NCT00459264|Hematinics|hematinics|mesh-ancestor
92680592|NCT00459264|Vitamin B Complex|vitamin b complex|mesh-ancestor
92680593|NCT00459264|Vitamins|vitamins|mesh-ancestor
92680594|NCT00459264|Micronutrients|micronutrients|mesh-ancestor
92680595|NCT00459264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680596|NCT00426452|Vatalanib|vatalanib|mesh-list
92680597|NCT00426452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680598|NCT00426452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680599|NCT00426452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680600|NCT00426491|Misoprostol|misoprostol|mesh-list
92680601|NCT00426491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92680602|NCT00426491|Abortifacient Agents|abortifacient agents|mesh-ancestor
92680603|NCT00426491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92680604|NCT00426491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680605|NCT00426491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92680606|NCT00426491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680607|NCT00426491|Oxytocics|oxytocics|mesh-ancestor
92680608|NCT00426530|Everolimus|everolimus|mesh-list
92680609|NCT00426530|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92680610|NCT00426530|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680611|NCT00426530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680612|NCT00426530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680613|NCT00426530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680614|NCT00426530|Immunologic Factors|immunologic factors|mesh-ancestor
92680615|NCT00426530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680616|NCT00426530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680617|NCT00459420|Caffeine|caffeine|mesh-list
92680618|NCT00459420|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92680619|NCT00459420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680620|NCT00459420|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92680621|NCT00459420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680622|NCT00459420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606422|NCT00147654|Adrenergic Agents|adrenergic agents|mesh-ancestor
92606423|NCT00147654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606424|NCT00147654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606425|NCT00147654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606426|NCT00147654|Urological Agents|urological agents|mesh-ancestor
92680623|NCT00459420|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92680624|NCT00459420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92680625|NCT00459420|Purinergic Agents|purinergic agents|mesh-ancestor
92680626|NCT00459420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680627|NCT00467766|Donepezil|donepezil|mesh-list
92680628|NCT00467766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92680632|NCT00467766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680633|NCT00467766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680634|NCT00467766|Nootropic Agents|nootropic agents|mesh-ancestor
92680635|NCT04705415|Niclosamide|niclosamide|mesh-list
92680636|NCT04705415|Anticestodal Agents|anticestodal agents|mesh-ancestor
92680637|NCT04705415|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92680638|NCT04705415|Anthelmintics|anthelmintics|mesh-ancestor
92680639|NCT04705415|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680640|NCT04705415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680641|NCT04705415|Antinematodal Agents|antinematodal agents|mesh-ancestor
92680642|NCT00467883|Amphotericin B|amphotericin b|mesh-list
92680643|NCT00467883|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92680644|NCT00467883|Amebicides|amebicides|mesh-ancestor
92680645|NCT00467883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92680646|NCT00467883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680647|NCT00467883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680648|NCT00467883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680649|NCT00467883|Antifungal Agents|antifungal agents|mesh-ancestor
92680650|NCT00426608|Alprazolam|alprazolam|mesh-list
92680651|NCT00426608|Metyrapone|metyrapone|mesh-list
92680652|NCT00426608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92680653|NCT00426608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680654|NCT00426608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680655|NCT00426608|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92680656|NCT00426608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92680657|NCT00426608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92680658|NCT00426608|GABA Modulators|gaba modulators|mesh-ancestor
92680659|NCT00426608|GABA Agents|gaba agents|mesh-ancestor
92680660|NCT00426608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680661|NCT00426608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680662|NCT00426608|Antimetabolites|antimetabolites|mesh-ancestor
92680663|NCT00426608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680664|NCT00426647|Buprenorphine|buprenorphine|mesh-list
92680665|NCT00426647|Tramadol|tramadol|mesh-list
92680666|NCT00426647|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92680667|NCT00426647|Narcotics|narcotics|mesh-ancestor
92680668|NCT00426647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680669|NCT00426647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680670|NCT00426647|Analgesics|analgesics|mesh-ancestor
92680671|NCT00426647|Sensory System Agents|sensory system agents|mesh-ancestor
92680672|NCT00426647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680673|NCT00426647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92680674|NCT01059071|Eflornithine|eflornithine|mesh-list
92680675|NCT01059071|Etoposide|etoposide|mesh-list
92680676|NCT01059071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92680677|NCT01059071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680678|NCT01059071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92680679|NCT01059071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92680680|NCT01059071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680681|NCT01059071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680682|NCT01059071|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92680683|NCT01059071|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92680684|NCT01059071|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680685|NCT01059071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680686|NCT01059071|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92680687|NCT00468234|Nicotine|nicotine|mesh-list
92680688|NCT00468234|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92680689|NCT00468234|Autonomic Agents|autonomic agents|mesh-ancestor
92680690|NCT00468234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680691|NCT00468234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680692|NCT00468234|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92606427|NCT00147654|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92606428|NCT00147654|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92606429|NCT00147654|Cholinergic Agents|cholinergic agents|mesh-ancestor
92606430|NCT01246921|Fluticasone|fluticasone|mesh-list
92680693|NCT00468234|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92680694|NCT00468234|Cholinergic Agents|cholinergic agents|mesh-ancestor
92680695|NCT00468234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680696|NCT00468234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680697|NCT00459615|Artesunate|artesunate|mesh-list
92680698|NCT00459615|Antimalarials|antimalarials|mesh-ancestor
92680699|NCT00459615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92680700|NCT00459615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680701|NCT00459615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680702|NCT00459615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680706|NCT00459615|Anthelmintics|anthelmintics|mesh-ancestor
92680707|NCT00468351|Triamcinolone|triamcinolone|mesh-list
92680708|NCT00468351|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92680709|NCT00468351|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92680710|NCT00468351|Bevacizumab|bevacizumab|mesh-list
92680711|NCT00468351|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92680712|NCT00468351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680713|NCT00468351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680714|NCT00468351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92680715|NCT00468351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92680716|NCT00468351|Growth Substances|growth substances|mesh-ancestor
92680717|NCT00468351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680718|NCT00468351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92680719|NCT00468351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680720|NCT00468351|Glucocorticoids|glucocorticoids|mesh-ancestor
92680721|NCT00468351|Hormones|hormones|mesh-ancestor
92680722|NCT00468351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92680723|NCT00468351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680724|NCT00468351|Immunologic Factors|immunologic factors|mesh-ancestor
92680725|NCT00468351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680726|NCT00468351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680727|NCT00459654|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92680728|NCT00459654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680729|NCT00468429|Bevacizumab|bevacizumab|mesh-list
92680730|NCT00468429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680731|NCT00468429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680732|NCT00468429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92680733|NCT00468429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92680734|NCT00468429|Growth Substances|growth substances|mesh-ancestor
92680735|NCT00468429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680736|NCT00468429|Growth Inhibitors|growth inhibitors|mesh-ancestor
92680737|NCT00459771|Candesartan|candesartan|mesh-list
92680738|NCT00459771|Candesartan cilexetil|candesartan cilexetil|mesh-list
92680739|NCT00459771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92680740|NCT00459771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92680741|NCT00459771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92680742|NCT00459771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680743|NCT01058369|Deferasirox|deferasirox|mesh-list
92680744|NCT01058369|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92680745|NCT01058369|Chelating Agents|chelating agents|mesh-ancestor
92680746|NCT01058369|Sequestering Agents|sequestering agents|mesh-ancestor
92680747|NCT01058369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680748|NCT01057433|Ritonavir|ritonavir|mesh-list
92680749|NCT01057433|Lopinavir|lopinavir|mesh-list
92680750|NCT01057433|Pitavastatin|pitavastatin|mesh-list
92680751|NCT01057433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92680752|NCT01057433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92680753|NCT01057433|Protease Inhibitors|protease inhibitors|mesh-ancestor
92680754|NCT01057433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680755|NCT01057433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680756|NCT01057433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92680757|NCT01057433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92680758|NCT01057433|Antiviral Agents|antiviral agents|mesh-ancestor
92680759|NCT01057433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680760|NCT01057433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92680761|NCT01057433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92680762|NCT01057433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92606431|NCT01246921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606432|NCT01246921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92606433|NCT01246921|Autonomic Agents|autonomic agents|mesh-ancestor
92368060|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
92606434|NCT01246921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606435|NCT01246921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606436|NCT01246921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92606437|NCT01246921|Respiratory System Agents|respiratory system agents|mesh-ancestor
92606438|NCT01246921|Dermatologic Agents|dermatologic agents|mesh-ancestor
92606439|NCT01246921|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92606440|NCT04696939|Carboplatin|carboplatin|mesh-list
92606441|NCT04696939|Etoposide|etoposide|mesh-list
92606442|NCT04696939|Atezolizumab|atezolizumab|mesh-list
92606443|NCT04696939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606444|NCT04696939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92606445|NCT04696939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606446|NCT04696939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606447|NCT04696939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606448|NCT04696939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606449|NCT04696939|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92606450|NCT04696939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680763|NCT01057433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92680764|NCT01057433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92680765|NCT01057433|Antimetabolites|antimetabolites|mesh-ancestor
92680766|NCT01057433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92680767|NCT01058642|Pregabalin|pregabalin|mesh-list
92680768|NCT01058642|Analgesics|analgesics|mesh-ancestor
92680769|NCT01058642|Sensory System Agents|sensory system agents|mesh-ancestor
92680770|NCT01058642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680771|NCT01058642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680772|NCT01058642|Anticonvulsants|anticonvulsants|mesh-ancestor
92680773|NCT01058642|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92680774|NCT01058642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92680779|NCT01058642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680780|NCT01058642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92680781|NCT00426920|Insulin|insulin|mesh-list
92680782|NCT00426920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92680783|NCT00426920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680784|NCT00426998|Bevacizumab|bevacizumab|mesh-list
92680785|NCT00426998|Verteporfin|verteporfin|mesh-list
92680786|NCT00426998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680787|NCT00426998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680788|NCT00426998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92680789|NCT00426998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92680790|NCT00426998|Growth Substances|growth substances|mesh-ancestor
92680791|NCT00426998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680792|NCT00426998|Growth Inhibitors|growth inhibitors|mesh-ancestor
92680793|NCT00426998|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92680794|NCT00426998|Dermatologic Agents|dermatologic agents|mesh-ancestor
92680795|NCT00427076|Vancomycin|vancomycin|mesh-list
92680796|NCT00427076|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92680797|NCT00427076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680798|NCT00427076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680799|NCT00427076|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92680800|NCT00427076|Antimalarials|antimalarials|mesh-ancestor
92606451|NCT05560919|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92606452|NCT05560919|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92606453|NCT05560919|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92606454|NCT05560919|Protective Agents|protective agents|mesh-ancestor
92606455|NCT05560919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606456|NCT05560919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92606457|NCT05560919|Antioxidants|antioxidants|mesh-ancestor
92606458|NCT05560919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606460|NCT05560919|Micronutrients|micronutrients|mesh-ancestor
92013920|NCT01658943|Fluorouracil|fluorouracil|mesh-list
92680801|NCT00427076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92680802|NCT00427076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92680804|NCT00427232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92680805|NCT00427232|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92680806|NCT00427232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680807|NCT00427232|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92680808|NCT00427271|Aspirin|aspirin|mesh-list
92680809|NCT00427271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92680810|NCT00427271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92680811|NCT00427271|Analgesics|analgesics|mesh-ancestor
92680812|NCT00427271|Sensory System Agents|sensory system agents|mesh-ancestor
92680813|NCT00427271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680814|NCT00427271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680815|NCT00427271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680816|NCT00427271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680817|NCT00427271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92680818|NCT00427271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92680819|NCT00427271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680820|NCT00427271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92680821|NCT00427271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92680822|NCT00427271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680823|NCT00427271|Antipyretics|antipyretics|mesh-ancestor
92680824|NCT00460083|Pimecrolimus|pimecrolimus|mesh-list
92680825|NCT00460083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92680826|NCT00460083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92680827|NCT00460083|Analgesics|analgesics|mesh-ancestor
92680828|NCT00460083|Sensory System Agents|sensory system agents|mesh-ancestor
92680829|NCT00460083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680830|NCT00460083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680831|NCT00460083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680832|NCT00460083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92680833|NCT00460083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92680834|NCT00460083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680835|NCT00460083|Immunologic Factors|immunologic factors|mesh-ancestor
92680836|NCT00460083|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92680837|NCT00460083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680838|NCT00460083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680839|NCT00427310|Fluorouracil|fluorouracil|mesh-list
92680840|NCT00427310|Heparin|heparin|mesh-list
92680841|NCT00427310|Calcium heparin|calcium heparin|mesh-list
92680842|NCT00427310|Antimetabolites|antimetabolites|mesh-ancestor
92680843|NCT00427310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680844|NCT00427310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92680847|NCT00427310|Immunologic Factors|immunologic factors|mesh-ancestor
92680848|NCT00427310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680849|NCT00427310|Anticoagulants|anticoagulants|mesh-ancestor
92680850|NCT00427310|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92680851|NCT00427310|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92680852|NCT00427388|Methylprednisolone|methylprednisolone|mesh-list
92680853|NCT00427388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92680854|NCT00427388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92680856|NCT00427388|Prednisolone acetate|prednisolone acetate|mesh-list
92680857|NCT00427388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92606461|NCT05560919|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92606462|NCT00503620|Botulinum Toxins|botulinum toxins|mesh-list
92606463|NCT00503620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92606464|NCT00503620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92606465|NCT00503620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92606466|NCT00503620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92606467|NCT00503620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606468|NCT00503620|Cholinergic Agents|cholinergic agents|mesh-ancestor
92606469|NCT00503620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606470|NCT00503620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606471|NCT00503620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92606472|NCT00503620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606473|NCT00503659|Methacholine Chloride|methacholine chloride|mesh-list
92606474|NCT00503659|Miotics|miotics|mesh-ancestor
92606475|NCT00503659|Autonomic Agents|autonomic agents|mesh-ancestor
92606476|NCT00503659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606477|NCT00503659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606478|NCT00503659|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92606479|NCT00503659|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92606480|NCT00503659|Respiratory System Agents|respiratory system agents|mesh-ancestor
92606481|NCT00503659|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92606482|NCT00503659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92606483|NCT00503659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92606484|NCT00503659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606485|NCT00503659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606486|NCT04063163|Carboplatin|carboplatin|mesh-list
92680858|NCT00427388|Prednisolone phosphate|prednisolone phosphate|mesh-list
92680859|NCT00427388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92680860|NCT00427388|Antiemetics|antiemetics|mesh-ancestor
92680861|NCT00427388|Autonomic Agents|autonomic agents|mesh-ancestor
92680862|NCT00427388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680863|NCT00427388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680864|NCT00427388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680865|NCT00427388|Glucocorticoids|glucocorticoids|mesh-ancestor
92680866|NCT00427388|Hormones|hormones|mesh-ancestor
92680867|NCT00427388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92680868|NCT00427388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92680869|NCT00427388|Protective Agents|protective agents|mesh-ancestor
92680870|NCT00427388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92680871|NCT00427388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680872|NCT00427427|Trastuzumab|trastuzumab|mesh-list
92680873|NCT00427427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92680874|NCT00427427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680875|NCT04704947|Alendronate|alendronate|mesh-list
92680876|NCT04704947|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92680877|NCT04704947|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-list
92680878|NCT04704947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92606488|NCT04063163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606489|NCT04063163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92606490|NCT04063163|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606491|NCT04063163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606492|NCT04063163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606493|NCT04063163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606494|NCT00503815|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92606495|NCT00503815|Laxatives|laxatives|mesh-ancestor
92606496|NCT00503815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606497|NCT01247077|Selenium|selenium|mesh-list
92606498|NCT01247077|Antioxidants|antioxidants|mesh-ancestor
92680879|NCT04704947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680880|NCT04704947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92680881|NCT04704947|Adrenergic Agents|adrenergic agents|mesh-ancestor
92680882|NCT04704947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680883|NCT04704947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680884|NCT00427466|Pemetrexed|pemetrexed|mesh-list
92680885|NCT00427466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680886|NCT00427466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680887|NCT00427466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680888|NCT00427466|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92680889|NCT00427466|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92680890|NCT00427505|Deferasirox|deferasirox|mesh-list
92680891|NCT00427505|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92680892|NCT00427505|Chelating Agents|chelating agents|mesh-ancestor
92680893|NCT00427505|Sequestering Agents|sequestering agents|mesh-ancestor
92680894|NCT00427505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680895|NCT00427583|Imatinib Mesylate|imatinib mesylate|mesh-list
92680896|NCT00427583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680897|NCT00427583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92680898|NCT00427583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680899|NCT00427583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680900|NCT00468936|Mycophenolic Acid|mycophenolic acid|mesh-list
92680901|NCT00468936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92680902|NCT00468936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680903|NCT00468936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92680904|NCT00468936|Antitubercular Agents|antitubercular agents|mesh-ancestor
92680905|NCT00468936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680906|NCT00468936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680907|NCT00468936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680908|NCT00468936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680909|NCT00469053|Buprenorphine|buprenorphine|mesh-list
92680910|NCT00469053|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92680911|NCT00469053|Narcotics|narcotics|mesh-ancestor
92680912|NCT00469053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92100629|NCT00986427|Cyclosporins|cyclosporins|mesh-list
92680913|NCT00469053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680914|NCT00469053|Analgesics|analgesics|mesh-ancestor
92680915|NCT00469053|Sensory System Agents|sensory system agents|mesh-ancestor
92680920|NCT00469131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680921|NCT00469131|Immunologic Factors|immunologic factors|mesh-ancestor
92680922|NCT00469131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680923|NCT00469131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92680924|NCT00469131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680925|NCT00469131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680926|NCT00469131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92680927|NCT00469131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680928|NCT00469131|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92680929|NCT00469131|Antitubercular Agents|antitubercular agents|mesh-ancestor
92680930|NCT00469131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92680931|NCT00469131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680932|NCT00428129|Plasminogen|plasminogen|mesh-list
92013966|NCT03077503|Dexmedetomidine|dexmedetomidine|mesh-list
92606499|NCT01247077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606500|NCT01247077|Protective Agents|protective agents|mesh-ancestor
92606501|NCT01247077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606502|NCT01247077|Trace Elements|trace elements|mesh-ancestor
92606503|NCT01247077|Micronutrients|micronutrients|mesh-ancestor
92606504|NCT03990467|Tazobactam|tazobactam|mesh-list
92606505|NCT03990467|Piperacillin|piperacillin|mesh-list
92606506|NCT03990467|Amikacin|amikacin|mesh-list
92606507|NCT03990467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606508|NCT03990467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606509|NCT03990467|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92606510|NCT03990467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606511|NCT03990467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606512|NCT01247311|Vitamin D|vitamin d|mesh-list
92606513|NCT01247311|Ergocalciferols|ergocalciferols|mesh-list
92680933|NCT00428129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92680934|NCT00428129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92680935|NCT00428129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680936|NCT00428168|Betahistine|betahistine|mesh-list
92680937|NCT00428168|Vasodilator Agents|vasodilator agents|mesh-ancestor
92680938|NCT00428168|Histamine Agonists|histamine agonists|mesh-ancestor
92680939|NCT00428168|Histamine Agents|histamine agents|mesh-ancestor
92680940|NCT00428168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680941|NCT00428168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680942|NCT00428168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680943|NCT00428480|Methamphetamine|methamphetamine|mesh-list
92680944|NCT00428480|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92680945|NCT00428480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680946|NCT00428480|Sympathomimetics|sympathomimetics|mesh-ancestor
92680947|NCT00428480|Autonomic Agents|autonomic agents|mesh-ancestor
92680948|NCT00428480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680949|NCT00428480|Dopamine Agents|dopamine agents|mesh-ancestor
92680950|NCT00428480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680951|NCT00428480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680952|NCT00428480|Adrenergic Agents|adrenergic agents|mesh-ancestor
92680953|NCT00428480|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92680954|NCT00428480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92680955|NCT00428480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92680956|NCT00428480|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92680957|NCT00460473|Dexmedetomidine|dexmedetomidine|mesh-list
92680958|NCT00460473|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92680959|NCT00460473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680960|NCT00460473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680961|NCT00460473|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92680962|NCT00460473|Analgesics|analgesics|mesh-ancestor
92680963|NCT00460473|Sensory System Agents|sensory system agents|mesh-ancestor
92680964|NCT00460473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680965|NCT00460473|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92680966|NCT00460473|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92680967|NCT00460473|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92680968|NCT00460473|Adrenergic Agents|adrenergic agents|mesh-ancestor
92680969|NCT00460473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680970|NCT00460473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680971|NCT00428519|Aprepitant|aprepitant|mesh-list
92680972|NCT00428519|Fosaprepitant|fosaprepitant|mesh-list
92680973|NCT00428519|Antiemetics|antiemetics|mesh-ancestor
92680974|NCT00428519|Autonomic Agents|autonomic agents|mesh-ancestor
92680975|NCT00428519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013980|NCT03077503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92606514|NCT01247311|Cholecalciferol|cholecalciferol|mesh-list
92606516|NCT01247311|Micronutrients|micronutrients|mesh-ancestor
92606517|NCT01247311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606518|NCT01247311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92606519|NCT01247311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92606520|NCT00147771|Imiquimod|imiquimod|mesh-list
92606521|NCT00147771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92606522|NCT00147771|Immunologic Factors|immunologic factors|mesh-ancestor
92606523|NCT00147771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606524|NCT00147771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606525|NCT00147771|Interferon Inducers|interferon inducers|mesh-ancestor
92606526|NCT00503932|Capecitabine|capecitabine|mesh-list
92606527|NCT00503932|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606528|NCT00503932|Antimetabolites|antimetabolites|mesh-ancestor
92606529|NCT00503932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606530|NCT00503932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606531|NCT03981146|Nivolumab|nivolumab|mesh-list
92606532|NCT03981146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606533|NCT03981146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606534|NCT03981146|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92606535|NCT03981146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606536|NCT01247857|Ropivacaine|ropivacaine|mesh-list
92606537|NCT01247857|Anesthetics, Local|anesthetics, local|mesh-ancestor
92606538|NCT01247857|Anesthetics|anesthetics|mesh-ancestor
92606539|NCT01247857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92680976|NCT00428519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680977|NCT00428519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92680978|NCT00428519|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92680979|NCT00428519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680980|NCT00428519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680981|NCT00428558|Cytarabine|cytarabine|mesh-list
92680982|NCT00428558|Daunorubicin|daunorubicin|mesh-list
92680983|NCT00428558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92680984|NCT00428558|Antimetabolites|antimetabolites|mesh-ancestor
92680985|NCT00428558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680986|NCT00428558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680988|NCT00428558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92680989|NCT00428558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680990|NCT00428558|Immunologic Factors|immunologic factors|mesh-ancestor
92680991|NCT00428558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680992|NCT00428558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92680993|NCT00428558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92680994|NCT00428558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92680995|NCT00428558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606540|NCT01247857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606541|NCT01247857|Sensory System Agents|sensory system agents|mesh-ancestor
92606542|NCT01247857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606543|NCT04331730|Aflibercept|aflibercept|mesh-list
92606544|NCT04331730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92606545|NCT04331730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92606546|NCT04331730|Growth Substances|growth substances|mesh-ancestor
92606547|NCT04331730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606548|NCT04331730|Growth Inhibitors|growth inhibitors|mesh-ancestor
92606549|NCT04331730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606550|NCT01248091|Nitroprusside|nitroprusside|mesh-list
92606551|NCT01248091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92606552|NCT01248091|Vasodilator Agents|vasodilator agents|mesh-ancestor
92606553|NCT01248091|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92606554|NCT01248091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606555|NCT00503971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92606556|NCT00503971|Vorinostat|vorinostat|mesh-list
92606557|NCT00503971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606558|NCT00503971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606559|NCT00503971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606560|NCT00503971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606561|NCT00503971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92606562|NCT01248325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92606563|NCT02274961|Pantoprazole|pantoprazole|mesh-list
92606564|NCT02274961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92680996|NCT00460512|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92680997|NCT00460512|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92680998|NCT00460512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92680999|NCT00460512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681000|NCT00460512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681001|NCT00460512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681002|NCT00460512|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92681003|NCT00460512|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92681004|NCT00460512|Serotonin Agents|serotonin agents|mesh-ancestor
92681005|NCT00460512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681006|NCT00460512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681007|NCT00460512|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92681008|NCT00460512|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92681009|NCT00460512|Dopamine Agents|dopamine agents|mesh-ancestor
92681010|NCT01056380|Nitazoxanide|nitazoxanide|mesh-list
92681011|NCT01056380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92681012|NCT01056380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681013|NCT01055834|Eszopiclone|eszopiclone|mesh-list
92681014|NCT01055834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92681015|NCT01055834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681016|NCT01055834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681017|NCT00469326|Atorvastatin|atorvastatin|mesh-list
92681018|NCT00469326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92681019|NCT00469326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92681020|NCT00469326|Antimetabolites|antimetabolites|mesh-ancestor
92014030|NCT04433611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92606565|NCT02274961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606566|NCT02274961|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92606567|NCT02274961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606568|NCT02274961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606569|NCT02275039|Gemcitabine|gemcitabine|mesh-list
92606571|NCT02275039|Immunologic Factors|immunologic factors|mesh-ancestor
92606572|NCT02275039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014031|NCT04433611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92681021|NCT00469326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681022|NCT00469326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92681023|NCT00469326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92681024|NCT00469326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681025|NCT04704713|Afamelanotide|afamelanotide|mesh-list
92681026|NCT04704713|Dermatologic Agents|dermatologic agents|mesh-ancestor
92681027|NCT00460707|Ketoconazole|ketoconazole|mesh-list
92681029|NCT00460707|Antifungal Agents|antifungal agents|mesh-ancestor
92681030|NCT00460707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681031|NCT00460707|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92681032|NCT00460707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92681033|NCT00460707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681034|NCT00460707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681035|NCT00460707|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92681036|NCT00460707|Hormone Antagonists|hormone antagonists|mesh-ancestor
92681037|NCT00460707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681038|NCT00460707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681039|NCT00460707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92681040|NCT00460707|Antiemetics|antiemetics|mesh-ancestor
92681041|NCT00460707|Autonomic Agents|autonomic agents|mesh-ancestor
92681042|NCT00460707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681043|NCT00460707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681044|NCT00460707|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92681045|NCT00460707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681046|NCT00469404|Buprenorphine|buprenorphine|mesh-list
92681047|NCT00469404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92681048|NCT00469404|Narcotics|narcotics|mesh-ancestor
92681049|NCT00469404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681050|NCT00469404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681051|NCT00469404|Analgesics|analgesics|mesh-ancestor
92681052|NCT00469404|Sensory System Agents|sensory system agents|mesh-ancestor
92681053|NCT00469404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681054|NCT00469404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92681055|NCT00460785|Analgesics, Opioid|analgesics, opioid|mesh-list
92681056|NCT00460785|Narcotics|narcotics|mesh-ancestor
92681057|NCT00460785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681058|NCT00460785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681059|NCT00460785|Analgesics|analgesics|mesh-ancestor
92681061|NCT00460785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681062|NCT01054976|Galantamine|galantamine|mesh-list
92681063|NCT01054976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92681064|NCT01054976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681065|NCT01054976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681066|NCT01054976|Cholinergic Agents|cholinergic agents|mesh-ancestor
92681067|NCT01054976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681068|NCT01054976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681069|NCT01054976|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92681070|NCT01054976|Autonomic Agents|autonomic agents|mesh-ancestor
92681071|NCT01054976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681072|NCT01054976|Nootropic Agents|nootropic agents|mesh-ancestor
92681074|NCT00469443|Bevacizumab|bevacizumab|mesh-list
92681075|NCT00469443|Fluorouracil|fluorouracil|mesh-list
92681076|NCT00469443|Capecitabine|capecitabine|mesh-list
92681077|NCT00469443|Irinotecan|irinotecan|mesh-list
92606573|NCT02275039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606574|NCT02275039|Antimetabolites|antimetabolites|mesh-ancestor
92606575|NCT02275039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606576|NCT02275039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606577|NCT01248403|Paclitaxel|paclitaxel|mesh-list
92606578|NCT01248403|Everolimus|everolimus|mesh-list
92606579|NCT01248403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92681078|NCT00469443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92681079|NCT00469443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681080|NCT00469443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92681081|NCT00469443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92681082|NCT00469443|Growth Substances|growth substances|mesh-ancestor
92681083|NCT00469443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681084|NCT00469443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92681085|NCT00469443|Antimetabolites|antimetabolites|mesh-ancestor
92681086|NCT00469443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681087|NCT00469443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681088|NCT00469443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681089|NCT00469443|Immunologic Factors|immunologic factors|mesh-ancestor
92681090|NCT00469443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92681091|NCT00469443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681092|NCT00469443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681093|NCT00469443|Antidotes|antidotes|mesh-ancestor
92681094|NCT00469443|Protective Agents|protective agents|mesh-ancestor
92681095|NCT00469443|Vitamin B Complex|vitamin b complex|mesh-ancestor
92681096|NCT00469443|Vitamins|vitamins|mesh-ancestor
92681097|NCT00469443|Micronutrients|micronutrients|mesh-ancestor
92681098|NCT00460863|Dialysis Solutions|dialysis solutions|mesh-list
92681099|NCT00460863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92681100|NCT00428909|Acetaminophen|acetaminophen|mesh-list
92681101|NCT00428909|Imatinib Mesylate|imatinib mesylate|mesh-list
92681102|NCT00428909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92681103|NCT00428909|Analgesics|analgesics|mesh-ancestor
92681104|NCT00428909|Sensory System Agents|sensory system agents|mesh-ancestor
92681105|NCT00428909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681106|NCT00428909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681107|NCT00428909|Antipyretics|antipyretics|mesh-ancestor
92681108|NCT00428909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681109|NCT00428909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92681110|NCT00428909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681111|NCT00428909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681112|NCT00429065|Rituximab|rituximab|mesh-list
92681113|NCT00429065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92681114|NCT00429065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681115|NCT00429065|Immunologic Factors|immunologic factors|mesh-ancestor
92681116|NCT00429065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681117|NCT00429065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681118|NCT00469560|Deferasirox|deferasirox|mesh-list
92368166|NCT00943878|Vaccines|vaccines|mesh-list
92681119|NCT00469560|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92681120|NCT00469560|Chelating Agents|chelating agents|mesh-ancestor
92681121|NCT00469560|Sequestering Agents|sequestering agents|mesh-ancestor
92681122|NCT00469560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681123|NCT00469599|Alfacalcidol|alfacalcidol|mesh-list
92681124|NCT00469599|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92681125|NCT00469599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92681126|NCT00469599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681127|NCT00469599|Vitamins|vitamins|mesh-ancestor
92681128|NCT00469599|Micronutrients|micronutrients|mesh-ancestor
92681129|NCT00429377|Tacrolimus|tacrolimus|mesh-list
92100853|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681130|NCT00429377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681131|NCT00429377|Immunologic Factors|immunologic factors|mesh-ancestor
92681132|NCT00429377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681133|NCT00429377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92681134|NCT00429377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681135|NCT00429377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681137|NCT00469716|Plasma Substitutes|plasma substitutes|mesh-ancestor
92681138|NCT00469716|Blood Substitutes|blood substitutes|mesh-ancestor
92681139|NCT00429533|Dapsone|dapsone|mesh-list
92606580|NCT01248403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606581|NCT01248403|Tubulin Modulators|tubulin modulators|mesh-ancestor
92606582|NCT01248403|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681140|NCT00429533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681141|NCT00429533|Antimalarials|antimalarials|mesh-ancestor
92681142|NCT00429533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92681143|NCT00429533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92681144|NCT00429533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92681145|NCT00429533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681146|NCT00429533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681147|NCT00429533|Leprostatic Agents|leprostatic agents|mesh-ancestor
92681148|NCT00429533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92681150|NCT04704245|Mitogens|mitogens|mesh-list
92681151|NCT04704245|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681152|NCT04704245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681153|NCT04704245|Emollients|emollients|mesh-ancestor
92681154|NCT04704245|Dermatologic Agents|dermatologic agents|mesh-ancestor
92681155|NCT00429806|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92681156|NCT00429806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92681157|NCT00429806|Immunologic Factors|immunologic factors|mesh-ancestor
92681158|NCT00429806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681159|NCT00429962|Ranibizumab|ranibizumab|mesh-list
92681160|NCT00429962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92681161|NCT00429962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92681162|NCT00429962|Growth Substances|growth substances|mesh-ancestor
92681163|NCT00429962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681164|NCT00429962|Growth Inhibitors|growth inhibitors|mesh-ancestor
92681165|NCT00429962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681166|NCT00430001|Docetaxel|docetaxel|mesh-list
92681167|NCT00430001|Trastuzumab|trastuzumab|mesh-list
92681168|NCT00430001|Vinorelbine|vinorelbine|mesh-list
92681169|NCT00430001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681170|NCT00430001|Tubulin Modulators|tubulin modulators|mesh-ancestor
92681171|NCT00430001|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681172|NCT00430001|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681173|NCT00430001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681174|NCT00430001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92681175|NCT00430001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92681176|NCT00430079|Etanidazole|etanidazole|mesh-list
92681177|NCT00430079|Imidazole|imidazole|mesh-list
92681178|NCT00430079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681179|NCT00430079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681180|NCT00430079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681181|NCT00430118|Cytarabine|cytarabine|mesh-list
92681182|NCT00430118|Dexamethasone|dexamethasone|mesh-list
92681183|NCT00430118|Prednisone|prednisone|mesh-list
92681184|NCT00430118|Cyclophosphamide|cyclophosphamide|mesh-list
92681185|NCT00430118|Ifosfamide|ifosfamide|mesh-list
92681186|NCT00430118|Doxorubicin|doxorubicin|mesh-list
92681187|NCT00430118|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92681188|NCT00430118|Methotrexate|methotrexate|mesh-list
92681189|NCT00430118|Etoposide|etoposide|mesh-list
92681190|NCT00430118|Vincristine|vincristine|mesh-list
92681191|NCT00430118|Daunorubicin|daunorubicin|mesh-list
92681192|NCT00430118|Asparaginase|asparaginase|mesh-list
92681193|NCT00430118|Mercaptopurine|mercaptopurine|mesh-list
92681194|NCT00430118|Thioguanine|thioguanine|mesh-list
92681195|NCT00430118|Vindesine|vindesine|mesh-list
92681196|NCT00430118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681197|NCT00430118|Immunologic Factors|immunologic factors|mesh-ancestor
92681198|NCT00430118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681199|NCT00430118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681200|NCT00430118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92681201|NCT00430118|Alkylating Agents|alkylating agents|mesh-ancestor
92681202|NCT00430118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681203|NCT00430118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681204|NCT00430118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92681205|NCT00430118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92681206|NCT00430118|Antiemetics|antiemetics|mesh-ancestor
92681207|NCT00430118|Autonomic Agents|autonomic agents|mesh-ancestor
92681208|NCT00430118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681209|NCT00430118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681210|NCT00430118|Glucocorticoids|glucocorticoids|mesh-ancestor
92681211|NCT00430118|Hormones|hormones|mesh-ancestor
92681212|NCT00430118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606583|NCT01248403|Mitosis Modulators|mitosis modulators|mesh-ancestor
92606584|NCT01248403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606585|NCT01248403|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92606586|NCT01248403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606587|NCT01248403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606588|NCT01248403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606589|NCT01248403|Immunologic Factors|immunologic factors|mesh-ancestor
92681216|NCT00430118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681217|NCT00430118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681218|NCT00430118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92681219|NCT00430118|Abortifacient Agents|abortifacient agents|mesh-ancestor
92681220|NCT00430118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681221|NCT00430118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681222|NCT00430118|Antimetabolites|antimetabolites|mesh-ancestor
92681223|NCT00430118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92681224|NCT00430118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92681225|NCT00430118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92681226|NCT00430118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92681227|NCT00430118|Antiviral Agents|antiviral agents|mesh-ancestor
92681228|NCT00430118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681229|NCT00430118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92681230|NCT00430118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681231|NCT00430118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681232|NCT00430157|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
92681233|NCT00430157|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92681234|NCT00430157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92681235|NCT00430157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681236|NCT00430157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681237|NCT00461565|Sildenafil Citrate|sildenafil citrate|mesh-list
92681238|NCT00461565|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92681239|NCT00461565|Vasodilator Agents|vasodilator agents|mesh-ancestor
92681240|NCT00461565|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92681241|NCT00461565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92681242|NCT00461565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681243|NCT00461565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681244|NCT00461565|Urological Agents|urological agents|mesh-ancestor
92681245|NCT00430196|Tizanidine|tizanidine|mesh-list
92681246|NCT00430196|Analgesics|analgesics|mesh-ancestor
92681247|NCT00430196|Sensory System Agents|sensory system agents|mesh-ancestor
92681248|NCT00430196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681249|NCT00430196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681250|NCT00430196|Anticonvulsants|anticonvulsants|mesh-ancestor
92681251|NCT00430196|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92681252|NCT00430196|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92681253|NCT00430196|Parasympatholytics|parasympatholytics|mesh-ancestor
92681254|NCT00430196|Autonomic Agents|autonomic agents|mesh-ancestor
92681255|NCT00430196|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92681256|NCT00430196|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92681257|NCT00430196|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92681258|NCT00430196|Adrenergic Agents|adrenergic agents|mesh-ancestor
92681259|NCT00430196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681260|NCT00430196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681261|NCT00430235|Sorafenib|sorafenib|mesh-list
92681262|NCT00430235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681263|NCT00430235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92681264|NCT00430235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681265|NCT00430235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681266|NCT00470340|Gemcitabine|gemcitabine|mesh-list
92681267|NCT00470340|Oxaliplatin|oxaliplatin|mesh-list
92681268|NCT00470340|Ethiodized Oil|ethiodized oil|mesh-list
92681269|NCT00470340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681270|NCT00470340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681271|NCT00470340|Antimetabolites|antimetabolites|mesh-ancestor
92681272|NCT00470340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681273|NCT00430469|Lactoferrin|lactoferrin|mesh-list
92606590|NCT01248403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606591|NCT01248442|Cholecalciferol|cholecalciferol|mesh-list
92606592|NCT01248442|Vitamin D|vitamin d|mesh-list
92606593|NCT01248442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92606594|NCT01248442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606595|NCT01248442|Vitamins|vitamins|mesh-ancestor
92681274|NCT00430469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681275|NCT00461643|Metformin|metformin|mesh-list
92681276|NCT00461643|Citric Acid|citric acid|mesh-list
92681277|NCT00461643|Sodium Citrate|sodium citrate|mesh-list
92681278|NCT00461643|Clomiphene|clomiphene|mesh-list
92681279|NCT00461643|Enclomiphene|enclomiphene|mesh-list
92681280|NCT00461643|Zuclomiphene|zuclomiphene|mesh-list
92681281|NCT00461643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92681282|NCT00461643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681283|NCT00461643|Anticoagulants|anticoagulants|mesh-ancestor
92681299|NCT00430547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681301|NCT00430586|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92681302|NCT00430586|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92681303|NCT00430586|Botulinum Toxins|botulinum toxins|mesh-list
92681304|NCT00430586|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92681305|NCT00430586|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92681306|NCT00430586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681307|NCT00430586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681308|NCT00430586|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92681309|NCT00430586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92681310|NCT00430586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681311|NCT00430586|Cholinergic Agents|cholinergic agents|mesh-ancestor
92681312|NCT00430586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681313|NCT01053962|Plecanatide|plecanatide|mesh-list
92681314|NCT01053962|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92681315|NCT01053962|Enzyme Activators|enzyme activators|mesh-ancestor
92681316|NCT01053962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681317|NCT01053962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681318|NCT00461799|Orlistat|orlistat|mesh-list
92681319|NCT00461799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681320|NCT00461799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681321|NCT00461799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92681322|NCT00461799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92681323|NCT00430664|Povidone-Iodine|povidone-iodine|mesh-list
92681324|NCT00430664|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92681325|NCT00430664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681326|NCT00430742|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92681327|NCT00430742|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92681328|NCT00430742|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92681329|NCT00430742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681330|NCT00430742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681331|NCT00430742|Hormones|hormones|mesh-ancestor
92681332|NCT00430742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681333|NCT00430742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681334|NCT00470457|Immunomodulating Agents|immunomodulating agents|mesh-list
92681351|NCT00461916|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92681353|NCT00461916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681354|NCT00461916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681355|NCT00461916|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92681356|NCT00461916|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92681357|NCT00461916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101074|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681358|NCT00461916|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92681359|NCT00461916|Fertility Agents|fertility agents|mesh-ancestor
92681360|NCT02957409|Valsartan|valsartan|mesh-list
92681361|NCT02957409|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92681362|NCT02957409|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92681363|NCT02957409|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92681364|NCT02957409|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92606596|NCT01248442|Micronutrients|micronutrients|mesh-ancestor
92606597|NCT01248442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92606599|NCT01248481|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92681365|NCT02957409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681366|NCT01053221|Mycophenolic Acid|mycophenolic acid|mesh-list
92681367|NCT01053221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92681368|NCT01053221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681369|NCT01053221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92681370|NCT01053221|Antitubercular Agents|antitubercular agents|mesh-ancestor
92681371|NCT01053221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92681372|NCT01053221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681373|NCT01053221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681374|NCT01053221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681375|NCT00431054|Docetaxel|docetaxel|mesh-list
92681376|NCT00431054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681377|NCT00431054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92681378|NCT00431054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681379|NCT00431054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681380|NCT00431054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681381|NCT00431171|Lithium Carbonate|lithium carbonate|mesh-list
92681382|NCT00431171|Antidepressive Agents|antidepressive agents|mesh-ancestor
92681383|NCT00431171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681384|NCT00431171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681385|NCT00431171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681386|NCT00431171|Antimanic Agents|antimanic agents|mesh-ancestor
92681387|NCT00431171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92681388|NCT00431171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681389|NCT00431171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681390|NCT00431210|Immunomodulating Agents|immunomodulating agents|mesh-list
92681391|NCT00431210|Immunologic Factors|immunologic factors|mesh-ancestor
92681394|NCT00431249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92681395|NCT00431249|Autonomic Agents|autonomic agents|mesh-ancestor
92681396|NCT00431249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681397|NCT00431249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681398|NCT00431249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92681399|NCT00431249|Respiratory System Agents|respiratory system agents|mesh-ancestor
92681400|NCT00431249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92681401|NCT00431249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92681402|NCT00431249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681403|NCT00431249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92681404|NCT00431249|Vasodilator Agents|vasodilator agents|mesh-ancestor
92681405|NCT00431249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92681406|NCT00431249|Protective Agents|protective agents|mesh-ancestor
92681407|NCT00431249|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92681408|NCT00431249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92681409|NCT00431249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681410|NCT00470886|Telmisartan|telmisartan|mesh-list
92681411|NCT00470886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92681412|NCT00470886|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92681413|NCT00470886|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92681414|NCT00470886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681415|NCT00431522|Valproic Acid|valproic acid|mesh-list
92681416|NCT00431522|Anticonvulsants|anticonvulsants|mesh-ancestor
92681417|NCT00431522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681418|NCT00431522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681419|NCT00431522|GABA Agents|gaba agents|mesh-ancestor
92681420|NCT00431522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681421|NCT00431522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681422|NCT00431522|Antimanic Agents|antimanic agents|mesh-ancestor
92681423|NCT00431522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92681424|NCT00431522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681425|NCT00431522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681426|NCT00462111|Indomethacin|indomethacin|mesh-list
92681427|NCT00462111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92681428|NCT00462111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92681429|NCT00462111|Analgesics|analgesics|mesh-ancestor
92681430|NCT00462111|Sensory System Agents|sensory system agents|mesh-ancestor
92681431|NCT00462111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606600|NCT01248481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606601|NCT01248481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606602|NCT01248481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92606603|NCT01248481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681432|NCT00462111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681433|NCT00462111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92681434|NCT00462111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681435|NCT00462111|Gout Suppressants|gout suppressants|mesh-ancestor
92681436|NCT00462111|Tocolytic Agents|tocolytic agents|mesh-ancestor
92681437|NCT00462111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681438|NCT00462111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92681439|NCT00462111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681440|NCT00462111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681441|NCT00431561|Temozolomide|temozolomide|mesh-list
92681442|NCT00431561|Lomustine|lomustine|mesh-list
92681443|NCT00431561|Trabedersen|trabedersen|mesh-list
92681444|NCT00431561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92681445|NCT00431561|Alkylating Agents|alkylating agents|mesh-ancestor
92681446|NCT00431561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681447|NCT00431561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681448|NCT00462189|Immunotoxin HA22|immunotoxin ha22|mesh-list
92681449|NCT00462189|Immunotoxins|immunotoxins|mesh-list
92681450|NCT00462189|Immunoconjugates|immunoconjugates|mesh-ancestor
92681451|NCT00462189|Immunologic Factors|immunologic factors|mesh-ancestor
92681452|NCT00462189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681453|NCT00462189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681454|NCT00431678|Moxifloxacin|moxifloxacin|mesh-list
92681455|NCT00431678|Levofloxacin|levofloxacin|mesh-list
92681456|NCT00431678|Ceftriaxone|ceftriaxone|mesh-list
92681457|NCT00431678|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92681458|NCT00431678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92681459|NCT00431678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681460|NCT00431678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92681461|NCT00431678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681462|NCT00431678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681463|NCT00431678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681466|NCT00431678|Contraceptive Agents|contraceptive agents|mesh-ancestor
92681467|NCT00431678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681468|NCT00431678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681469|NCT00431678|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92681470|NCT00431678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92681471|NCT00431678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92681472|NCT00431678|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92681473|NCT00431678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92681474|NCT00431678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92681476|NCT00471003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92681477|NCT00471003|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92681478|NCT00471003|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92681479|NCT00471003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681480|NCT00471042|Buprenorphine|buprenorphine|mesh-list
92681481|NCT00471042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92681482|NCT00471042|Narcotics|narcotics|mesh-ancestor
92681483|NCT00471042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681484|NCT00471042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681485|NCT00471042|Analgesics|analgesics|mesh-ancestor
92681486|NCT00471042|Sensory System Agents|sensory system agents|mesh-ancestor
92681487|NCT00471042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681488|NCT00471042|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92681489|NCT00462540|Bromides|bromides|mesh-list
92681490|NCT00462540|Albuterol|albuterol|mesh-list
92681491|NCT00462540|Formoterol Fumarate|formoterol fumarate|mesh-list
92681492|NCT00462540|Ipratropium|ipratropium|mesh-list
92681493|NCT00462540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92681494|NCT00462540|Autonomic Agents|autonomic agents|mesh-ancestor
92681495|NCT00462540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681496|NCT00462540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681497|NCT00462540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92681498|NCT00462540|Respiratory System Agents|respiratory system agents|mesh-ancestor
92681499|NCT00462540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92606605|NCT01249339|Nicotine|nicotine|mesh-list
92606606|NCT01249339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92606607|NCT01249339|Autonomic Agents|autonomic agents|mesh-ancestor
92606608|NCT01249339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606609|NCT01249339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039266|NCT01642615|Dexlansoprazole|dexlansoprazole|mesh-list
92681500|NCT00462540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92681501|NCT00462540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92681502|NCT00462540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92681503|NCT00462540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681504|NCT00462540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681505|NCT00462540|Anticonvulsants|anticonvulsants|mesh-ancestor
92681506|NCT00462540|Tocolytic Agents|tocolytic agents|mesh-ancestor
92681507|NCT00462540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681508|NCT00462540|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92681509|NCT00462540|Cholinergic Agents|cholinergic agents|mesh-ancestor
92681510|NCT04703465|Tenofovir|tenofovir|mesh-list
92681511|NCT04703465|Antiviral Agents|antiviral agents|mesh-ancestor
92681512|NCT04703465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681513|NCT04703465|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92681514|NCT04703465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92681515|NCT04703465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681516|NCT04703465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681517|NCT04703465|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92681518|NCT04703465|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92681519|NCT00471159|Docetaxel|docetaxel|mesh-list
92681520|NCT00471159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681521|NCT00471159|Tubulin Modulators|tubulin modulators|mesh-ancestor
92681522|NCT00471159|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681523|NCT00471159|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681524|NCT00471159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681525|NCT00462618|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92681526|NCT00462618|Antidepressive Agents|antidepressive agents|mesh-ancestor
92681527|NCT00462618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681528|NCT00462618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92681529|NCT00462618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92681530|NCT00462618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681531|NCT00462618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681532|NCT00431795|Doxorubicin|doxorubicin|mesh-list
92681533|NCT00431795|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92681534|NCT00431795|Epirubicin|epirubicin|mesh-list
92681535|NCT00431795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92681536|NCT00431795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681537|NCT00431795|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92681538|NCT00431795|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681540|NCT00431795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681541|NCT00462657|Dimercaprol|dimercaprol|mesh-list
92681542|NCT00462657|Chelating Agents|chelating agents|mesh-ancestor
92681543|NCT00462657|Sequestering Agents|sequestering agents|mesh-ancestor
92681544|NCT00462657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681545|NCT00431990|Dexamethasone|dexamethasone|mesh-list
92681546|NCT00431990|Bortezomib|bortezomib|mesh-list
92681547|NCT00431990|Romidepsin|romidepsin|mesh-list
92681548|NCT00431990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92681549|NCT00431990|Antiemetics|antiemetics|mesh-ancestor
92681550|NCT00431990|Autonomic Agents|autonomic agents|mesh-ancestor
92681551|NCT00431990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681552|NCT00431990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681553|NCT00431990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681554|NCT00431990|Glucocorticoids|glucocorticoids|mesh-ancestor
92681555|NCT00431990|Hormones|hormones|mesh-ancestor
92681556|NCT00431990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681557|NCT00431990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92681558|NCT00431990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681559|NCT00431990|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92681560|NCT00431990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92681561|NCT00431990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681562|NCT00431990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606610|NCT01249339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92606611|NCT01249339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92606612|NCT01249339|Cholinergic Agents|cholinergic agents|mesh-ancestor
92606613|NCT01249339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606614|NCT01249339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606615|NCT01249339|Respiratory System Agents|respiratory system agents|mesh-ancestor
92606616|NCT03809429|Cetrorelix|cetrorelix|mesh-list
92681563|NCT00462696|Docetaxel|docetaxel|mesh-list
92681564|NCT00462696|Epirubicin|epirubicin|mesh-list
92681565|NCT00462696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681566|NCT00462696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92681567|NCT00462696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681568|NCT00462696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681569|NCT00462696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681570|NCT00462696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92681571|NCT00462696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92681572|NCT00462696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681573|NCT00462696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681574|NCT00462813|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92368238|NCT00964548|Dantrolene|dantrolene|mesh-list
92681575|NCT00462813|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92681576|NCT00462813|Protective Agents|protective agents|mesh-ancestor
92681577|NCT00462813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681578|NCT00462813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681579|NCT01052012|Bupivacaine|bupivacaine|mesh-list
92101303|NCT01272388|Tadalafil|tadalafil|mesh-list
92681580|NCT01052012|Anesthetics, Local|anesthetics, local|mesh-ancestor
92681581|NCT01052012|Anesthetics|anesthetics|mesh-ancestor
92681582|NCT01052012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681583|NCT01052012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681584|NCT01052012|Sensory System Agents|sensory system agents|mesh-ancestor
92681585|NCT01052012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681586|NCT00462852|Gemcitabine|gemcitabine|mesh-list
92681587|NCT00462852|Dalteparin|dalteparin|mesh-list
92681588|NCT00462852|Tinzaparin|tinzaparin|mesh-list
92681589|NCT00462852|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92681590|NCT00462852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681591|NCT00462852|Antimetabolites|antimetabolites|mesh-ancestor
92681592|NCT00462852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681593|NCT00462852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681594|NCT00462852|Anticoagulants|anticoagulants|mesh-ancestor
92681595|NCT00462852|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92681596|NCT00462852|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92681597|NCT00471393|Diclofenac|diclofenac|mesh-list
92681598|NCT00471393|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92681599|NCT00471393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92681600|NCT00471393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92681601|NCT00471393|Analgesics|analgesics|mesh-ancestor
92681602|NCT00471393|Sensory System Agents|sensory system agents|mesh-ancestor
92681603|NCT00471393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681604|NCT00471393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681605|NCT00471393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92681606|NCT00471393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681607|NCT00471393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92681608|NCT00471393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681609|NCT00471393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681614|NCT00432068|Octreotide|octreotide|mesh-list
92681615|NCT00432068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681616|NCT00432068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92681617|NCT00432068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681618|NCT03273231|Ketamine|ketamine|mesh-list
92681619|NCT03273231|Analgesics|analgesics|mesh-ancestor
92681620|NCT03273231|Sensory System Agents|sensory system agents|mesh-ancestor
92681621|NCT03273231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681622|NCT03273231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681623|NCT03273231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92681624|NCT03273231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92681625|NCT03273231|Anesthetics, General|anesthetics, general|mesh-ancestor
92681626|NCT03273231|Anesthetics|anesthetics|mesh-ancestor
92681627|NCT03273231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606617|NCT03809429|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92606618|NCT03809429|Hormones|hormones|mesh-ancestor
92606619|NCT03809429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606620|NCT03809429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606621|NCT03809429|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92039409|NCT01981473|Infliximab|infliximab|mesh-list
92681628|NCT03273231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92681629|NCT03273231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92681630|NCT03273231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681631|NCT03273231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681632|NCT00432146|Lugol's solution|lugol's solution|mesh-list
92681633|NCT00432146|Hemostatics|hemostatics|mesh-ancestor
92681634|NCT00432146|Coagulants|coagulants|mesh-ancestor
92681635|NCT00432302|Sagopilone|sagopilone|mesh-list
92681636|NCT00432302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681637|NCT00463008|Methotrexate|methotrexate|mesh-list
92681638|NCT00463008|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92681639|NCT00463008|Abortifacient Agents|abortifacient agents|mesh-ancestor
92681640|NCT00463008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681641|NCT00463008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681642|NCT00463008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681643|NCT00463008|Antimetabolites|antimetabolites|mesh-ancestor
92681644|NCT00463008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681645|NCT00463008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681646|NCT00463008|Dermatologic Agents|dermatologic agents|mesh-ancestor
92681647|NCT00463008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681648|NCT00463008|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92681649|NCT00463008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681650|NCT00463008|Immunologic Factors|immunologic factors|mesh-ancestor
92681651|NCT00463008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681652|NCT00463008|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92681653|NCT00471432|Docetaxel|docetaxel|mesh-list
92681654|NCT00471432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681655|NCT00471432|Tubulin Modulators|tubulin modulators|mesh-ancestor
92681656|NCT00471432|Antimitotic Agents|antimitotic agents|mesh-ancestor
92681657|NCT00471432|Mitosis Modulators|mitosis modulators|mesh-ancestor
92681658|NCT00471432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681660|NCT00463086|Antitubercular Agents|antitubercular agents|mesh-ancestor
92681661|NCT00463086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92681662|NCT00463086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681663|NCT00463086|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92681664|NCT00463086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92681665|NCT00463086|Antimetabolites|antimetabolites|mesh-ancestor
92681666|NCT00463086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681667|NCT00463086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92681668|NCT02957435|Eplerenone|eplerenone|mesh-list
92681669|NCT02957435|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92681670|NCT02957435|Hormone Antagonists|hormone antagonists|mesh-ancestor
92681671|NCT02957435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681672|NCT02957435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681673|NCT02957435|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92681674|NCT02957435|Diuretics|diuretics|mesh-ancestor
92681675|NCT02957435|Natriuretic Agents|natriuretic agents|mesh-ancestor
92681676|NCT02957435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92681677|NCT00471471|Sargramostim|sargramostim|mesh-list
92681678|NCT00471471|Immunologic Factors|immunologic factors|mesh-ancestor
92681679|NCT00471471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681680|NCT02273492|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92681681|NCT02273492|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92681685|NCT00471510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681686|NCT02273531|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92681687|NCT02273531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92681688|NCT00463203|Bevacizumab|bevacizumab|mesh-list
92681689|NCT00463203|Irinotecan|irinotecan|mesh-list
92681690|NCT00463203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92681691|NCT00463203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606622|NCT03809429|Fertility Agents|fertility agents|mesh-ancestor
92606623|NCT03809429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92606624|NCT03809429|Hormone Antagonists|hormone antagonists|mesh-ancestor
92606625|NCT00504127|Naproxen|naproxen|mesh-list
92606626|NCT00504127|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92681692|NCT00463203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92681693|NCT00463203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92681694|NCT00463203|Growth Substances|growth substances|mesh-ancestor
92681695|NCT00463203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681696|NCT00463203|Growth Inhibitors|growth inhibitors|mesh-ancestor
92681697|NCT00463203|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92681698|NCT00463203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681699|NCT00463203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681700|NCT00463203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681701|NCT00471549|Simvastatin|simvastatin|mesh-list
92681702|NCT00471549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92681703|NCT00471549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92681704|NCT00471549|Antimetabolites|antimetabolites|mesh-ancestor
92681705|NCT00471549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681706|NCT00471549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92681707|NCT00471549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92681708|NCT00471549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681709|NCT00432575|Surinabant|surinabant|mesh-list
92681710|NCT00432575|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92681711|NCT00432575|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92681712|NCT00432575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681713|NCT00432575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681714|NCT00432575|Hormones|hormones|mesh-ancestor
92681715|NCT00432575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681716|NCT00432575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681717|NCT00432614|Escitalopram|escitalopram|mesh-list
92681718|NCT00432614|Amibegron|amibegron|mesh-list
92681719|NCT00432614|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92681720|NCT00432614|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92681721|NCT00432614|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92681722|NCT00432614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92681723|NCT00432614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681724|NCT00432614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681725|NCT00432614|Serotonin Agents|serotonin agents|mesh-ancestor
92681726|NCT00432614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681727|NCT00432614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92681728|NCT00432614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92681729|NCT00432614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92681730|NCT00432614|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92681731|NCT00463320|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92681732|NCT00463320|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92681734|NCT00432653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92681735|NCT00432653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681736|NCT00432653|Immunologic Factors|immunologic factors|mesh-ancestor
92681737|NCT00432653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681738|NCT00432653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681739|NCT00471588|Pramipexole|pramipexole|mesh-list
92681740|NCT00471588|Amisulpride|amisulpride|mesh-list
92681741|NCT00471588|Antioxidants|antioxidants|mesh-ancestor
92681742|NCT00471588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681743|NCT00471588|Protective Agents|protective agents|mesh-ancestor
92681744|NCT00471588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681745|NCT00471588|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92681746|NCT00471588|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92681747|NCT00471588|Dopamine Agonists|dopamine agonists|mesh-ancestor
92681748|NCT00471588|Dopamine Agents|dopamine agents|mesh-ancestor
92681749|NCT00471588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681750|NCT00471588|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92681751|NCT00471588|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92681752|NCT00471588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681755|NCT00471588|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92681756|NCT00471588|Antidepressive Agents|antidepressive agents|mesh-ancestor
92681757|NCT00463359|Imiquimod|imiquimod|mesh-list
92606627|NCT00504127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606629|NCT00504127|Analgesics|analgesics|mesh-ancestor
92606630|NCT00504127|Sensory System Agents|sensory system agents|mesh-ancestor
92681758|NCT00463359|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92681759|NCT00463359|Immunologic Factors|immunologic factors|mesh-ancestor
92681760|NCT00463359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681761|NCT00463359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681762|NCT00463359|Interferon Inducers|interferon inducers|mesh-ancestor
92681763|NCT00471627|Pancrelipase|pancrelipase|mesh-list
92681764|NCT00471627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681765|NCT00432887|Caffeine|caffeine|mesh-list
92681766|NCT00432887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92681767|NCT00432887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681768|NCT00432887|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92681769|NCT00432887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681770|NCT00432887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681771|NCT00432887|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92681772|NCT00432887|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92681773|NCT00432887|Purinergic Agents|purinergic agents|mesh-ancestor
92681774|NCT00432887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681775|NCT00471744|Levetiracetam|levetiracetam|mesh-list
92681776|NCT00471744|Sulthiame|sulthiame|mesh-list
92681777|NCT00471744|Anticonvulsants|anticonvulsants|mesh-ancestor
92681778|NCT00471744|Nootropic Agents|nootropic agents|mesh-ancestor
92681779|NCT00471783|Chlorhexidine|chlorhexidine|mesh-list
92681780|NCT00471783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92681781|NCT00471783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681782|NCT00471783|Disinfectants|disinfectants|mesh-ancestor
92681783|NCT00463515|Carboplatin|carboplatin|mesh-list
92681784|NCT00463515|Gemcitabine|gemcitabine|mesh-list
92681785|NCT00463515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681786|NCT00463515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681787|NCT00463515|Antimetabolites|antimetabolites|mesh-ancestor
92681788|NCT00463515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681789|NCT00433043|Metoprolol|metoprolol|mesh-list
92681790|NCT00433043|Carvedilol|carvedilol|mesh-list
92681791|NCT00433043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92681792|NCT00433043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92681793|NCT00433043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92681794|NCT00433043|Sympatholytics|sympatholytics|mesh-ancestor
92681795|NCT00433043|Autonomic Agents|autonomic agents|mesh-ancestor
92681796|NCT00433043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681797|NCT00433043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681798|NCT00433043|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92681799|NCT00433043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92681800|NCT00433043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92681801|NCT00433043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681802|NCT00433043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681804|NCT00433043|Protective Agents|protective agents|mesh-ancestor
92681805|NCT00433043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92681806|NCT00433043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92681807|NCT00433043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92681808|NCT00433043|Vasodilator Agents|vasodilator agents|mesh-ancestor
92681809|NCT00433043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92681810|NCT00433043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92681811|NCT03273075|Ticagrelor|ticagrelor|mesh-list
92681812|NCT03273075|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92681813|NCT03273075|Cangrelor|cangrelor|mesh-list
92681814|NCT03273075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92681815|NCT03273075|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92681816|NCT03273075|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92681817|NCT03273075|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92681818|NCT03273075|Purinergic Agents|purinergic agents|mesh-ancestor
92681819|NCT03273075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681820|NCT03273075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681821|NCT03273075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681822|NCT00471900|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92681823|NCT00471900|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92681824|NCT00471900|Immunologic Factors|immunologic factors|mesh-ancestor
92606631|NCT00504127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606632|NCT00504127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606633|NCT00504127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606634|NCT00504127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606635|NCT00504127|Gout Suppressants|gout suppressants|mesh-ancestor
92606636|NCT00504127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92606637|NCT00504127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014087|NCT04811573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92681825|NCT00471900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681826|NCT01051661|Vaccines|vaccines|mesh-list
92681828|NCT01051661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681829|NCT01051466|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92681830|NCT01051466|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92681831|NCT01051466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92681832|NCT01051466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92681833|NCT01051466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681834|NCT01051466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681835|NCT01051466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681837|NCT01051466|Sensory System Agents|sensory system agents|mesh-ancestor
92681838|NCT01051466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681839|NCT01051466|Antidepressive Agents|antidepressive agents|mesh-ancestor
92681840|NCT01051466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681841|NCT01051466|Dopamine Agents|dopamine agents|mesh-ancestor
92681842|NCT04446793|Bevacizumab|bevacizumab|mesh-list
92681843|NCT04446793|Onvansertib|onvansertib|mesh-list
92681844|NCT04446793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92681845|NCT04446793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681846|NCT04446793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92681847|NCT04446793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92681848|NCT04446793|Growth Substances|growth substances|mesh-ancestor
92681849|NCT04446793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681850|NCT04446793|Growth Inhibitors|growth inhibitors|mesh-ancestor
92681851|NCT04446793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92681852|NCT04446793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681853|NCT04446793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681854|NCT01051349|Daclizumab|daclizumab|mesh-list
92681855|NCT01051349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681856|NCT01051349|Immunologic Factors|immunologic factors|mesh-ancestor
92681857|NCT01051349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681858|NCT00433121|Olanzapine|olanzapine|mesh-list
92681859|NCT00433121|Risperidone|risperidone|mesh-list
92681860|NCT00433121|Citalopram|citalopram|mesh-list
92681861|NCT00433121|Escitalopram|escitalopram|mesh-list
92681862|NCT00433121|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92368309|NCT00974376|Gabapentin|gabapentin|mesh-list
92681863|NCT00433121|Serotonin Agents|serotonin agents|mesh-ancestor
92681864|NCT00433121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681865|NCT00433121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681866|NCT00433121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681867|NCT00433121|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92681868|NCT00433121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92681869|NCT00433121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681870|NCT00433121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681871|NCT00433121|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92681872|NCT00433121|Dopamine Agents|dopamine agents|mesh-ancestor
92681873|NCT00433121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92681874|NCT00433121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92681875|NCT00433121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92681876|NCT00433121|Autonomic Agents|autonomic agents|mesh-ancestor
92681877|NCT00433121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681878|NCT00433121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92681879|NCT00433121|Antidepressive Agents|antidepressive agents|mesh-ancestor
92681880|NCT00433121|Antiemetics|antiemetics|mesh-ancestor
92681881|NCT00433121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681882|NCT00463671|Acetylcysteine|acetylcysteine|mesh-list
92681883|NCT00463671|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92606638|NCT00504127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606639|NCT00504127|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92606640|NCT04088292|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92606641|NCT04088292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92606642|NCT04088292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92039679|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
92681884|NCT00463671|Antiviral Agents|antiviral agents|mesh-ancestor
92681885|NCT00463671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681886|NCT00463671|Expectorants|expectorants|mesh-ancestor
92681887|NCT00463671|Respiratory System Agents|respiratory system agents|mesh-ancestor
92681888|NCT00463671|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92681889|NCT00463671|Antioxidants|antioxidants|mesh-ancestor
92681890|NCT00463671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681891|NCT00463671|Protective Agents|protective agents|mesh-ancestor
92681892|NCT00463671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681893|NCT00463671|Antidotes|antidotes|mesh-ancestor
92681894|NCT00591526|Cytarabine|cytarabine|mesh-list
92681895|NCT00591526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92681896|NCT00591526|Antimetabolites|antimetabolites|mesh-ancestor
92681897|NCT00591526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681898|NCT00591526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681899|NCT00591526|Antiviral Agents|antiviral agents|mesh-ancestor
92681902|NCT00591526|Immunologic Factors|immunologic factors|mesh-ancestor
92681903|NCT00591526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681904|NCT00463710|Interferon beta-1a|interferon beta-1a|mesh-list
92681905|NCT00463710|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92681906|NCT00463710|Immunologic Factors|immunologic factors|mesh-ancestor
92681907|NCT00463710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681908|NCT00463710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681909|NCT00463710|Antiviral Agents|antiviral agents|mesh-ancestor
92681910|NCT00463710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681911|NCT00433277|Cyclosporine|cyclosporine|mesh-list
92681912|NCT00433277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92681913|NCT00433277|Cyclosporins|cyclosporins|mesh-list
92681914|NCT00433277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681915|NCT00433277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681916|NCT00433277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681917|NCT00433277|Immunologic Factors|immunologic factors|mesh-ancestor
92681918|NCT00433277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681919|NCT00433277|Antifungal Agents|antifungal agents|mesh-ancestor
92681920|NCT00433277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681921|NCT00433277|Dermatologic Agents|dermatologic agents|mesh-ancestor
92681922|NCT00433277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681923|NCT00433277|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92681924|NCT00433277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92681925|NCT00463827|Atorvastatin|atorvastatin|mesh-list
92681926|NCT00463827|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92681927|NCT00463827|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92681928|NCT00463827|Antimetabolites|antimetabolites|mesh-ancestor
92681929|NCT00463827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681930|NCT00463827|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92681931|NCT00463827|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92681932|NCT00463827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681933|NCT00433316|Ropivacaine|ropivacaine|mesh-list
92681934|NCT00433316|Anesthetics, Local|anesthetics, local|mesh-ancestor
92681935|NCT00433316|Anesthetics|anesthetics|mesh-ancestor
92681936|NCT00433316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681937|NCT00433316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681938|NCT00433316|Sensory System Agents|sensory system agents|mesh-ancestor
92681939|NCT00433316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681940|NCT00472134|Bupivacaine|bupivacaine|mesh-list
92681941|NCT00472134|Anesthetics, Local|anesthetics, local|mesh-ancestor
92681942|NCT00472134|Anesthetics|anesthetics|mesh-ancestor
92681943|NCT00472134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92681944|NCT00472134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681945|NCT00472134|Sensory System Agents|sensory system agents|mesh-ancestor
92681946|NCT00472134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92681947|NCT00433433|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92681948|NCT00433433|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92606643|NCT04088292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606644|NCT00504205|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92606645|NCT00504205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92606646|NCT00504205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039748|NCT05011513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92681949|NCT00433433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681950|NCT03270969|Tenofovir|tenofovir|mesh-list
92101674|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
92681951|NCT03270969|Emtricitabine|emtricitabine|mesh-list
92681952|NCT03270969|Antiviral Agents|antiviral agents|mesh-ancestor
92681953|NCT03270969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681954|NCT03270969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92681955|NCT03270969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92681956|NCT03270969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681957|NCT03270969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681958|NCT03270969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92681959|NCT03270969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92681960|NCT00463983|Octreotide|octreotide|mesh-list
92681961|NCT00463983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92681962|NCT00463983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92681963|NCT00463983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681964|NCT01050998|Mavrilimumab|mavrilimumab|mesh-list
92681965|NCT01050998|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92681966|NCT01050998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92681967|NCT01050998|Immunologic Factors|immunologic factors|mesh-ancestor
92681968|NCT01050998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681969|NCT00472173|Calcium|calcium|mesh-list
92681970|NCT00472173|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92681971|NCT00472173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681972|NCT00472329|Fludarabine|fludarabine|mesh-list
92681992|NCT00464256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92681993|NCT00464256|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92681994|NCT00464256|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92681995|NCT00464256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681996|NCT00464256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681997|NCT00464256|Hormones|hormones|mesh-ancestor
92681998|NCT00464256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681999|NCT00464256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682000|NCT00433823|Atorvastatin|atorvastatin|mesh-list
92682001|NCT00433823|Ezetimibe|ezetimibe|mesh-list
92682002|NCT00433823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92682003|NCT00433823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92682004|NCT00433823|Antimetabolites|antimetabolites|mesh-ancestor
92682005|NCT00433823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682006|NCT00433823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92682007|NCT00433823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92682008|NCT00433823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682009|NCT00464295|Capecitabine|capecitabine|mesh-list
92682010|NCT00464295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92682011|NCT00464295|Antimetabolites|antimetabolites|mesh-ancestor
92682012|NCT00464295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682013|NCT00464295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682014|NCT03273036|Triamcinolone|triamcinolone|mesh-list
92682015|NCT03273036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92682016|NCT03273036|Glucocorticoids|glucocorticoids|mesh-ancestor
92682017|NCT03273036|Hormones|hormones|mesh-ancestor
92682018|NCT03273036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682019|NCT03273036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682020|NCT03270735|Thrombin|thrombin|mesh-list
92682021|NCT03270735|Hemostatics|hemostatics|mesh-ancestor
92682022|NCT03270735|Coagulants|coagulants|mesh-ancestor
92682023|NCT04702685|Ropivacaine|ropivacaine|mesh-list
92682024|NCT04702685|Anesthetics, Local|anesthetics, local|mesh-ancestor
92682025|NCT04702685|Anesthetics|anesthetics|mesh-ancestor
92682026|NCT04702685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682028|NCT04702685|Sensory System Agents|sensory system agents|mesh-ancestor
92682029|NCT04702685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682031|NCT00464373|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92682032|NCT00464373|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92606647|NCT00504205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606648|NCT04085250|Nivolumab|nivolumab|mesh-list
92682033|NCT00464373|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92682034|NCT00464373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682035|NCT00464373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682036|NCT00464373|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682037|NCT00464373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682038|NCT00464373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682039|NCT00464373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92682040|NCT00464373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682042|NCT00472368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682043|NCT00472368|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92682044|NCT00472368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682045|NCT00472368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682046|NCT00106028|Risedronic Acid|risedronic acid|mesh-list
92682047|NCT00106028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92682048|NCT00106028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682049|NCT00106028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682050|NCT00106028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92682051|NCT00106028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682052|NCT00106028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92682053|NCT00464451|Dexmedetomidine|dexmedetomidine|mesh-list
92682054|NCT00464451|Chloral Hydrate|chloral hydrate|mesh-list
92682055|NCT00464451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92682056|NCT00464451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682057|NCT00464451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682058|NCT00464451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92682059|NCT00464451|Analgesics|analgesics|mesh-ancestor
92682060|NCT00464451|Sensory System Agents|sensory system agents|mesh-ancestor
92682061|NCT00464451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682062|NCT00464451|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92682063|NCT00464451|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92682064|NCT00464451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92682065|NCT00464451|Adrenergic Agents|adrenergic agents|mesh-ancestor
92682066|NCT00464451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682067|NCT00464451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682068|NCT00433940|Prednisolone|prednisolone|mesh-list
92682069|NCT00433940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92682070|NCT00433940|Glucocorticoids|glucocorticoids|mesh-ancestor
92682071|NCT00433940|Hormones|hormones|mesh-ancestor
92682072|NCT00433940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682073|NCT00433940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682074|NCT00433940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92682075|NCT00433940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682076|NCT00433979|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92682077|NCT00433979|Antiviral Agents|antiviral agents|mesh-ancestor
92682078|NCT00433979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682079|NCT01050764|Vidarabine|vidarabine|mesh-list
92682080|NCT01050764|Fludarabine|fludarabine|mesh-list
92682081|NCT01050764|Fludarabine phosphate|fludarabine phosphate|mesh-list
92682082|NCT01050764|Melphalan|melphalan|mesh-list
92682083|NCT01050764|Thiotepa|thiotepa|mesh-list
92682084|NCT01050764|Thymoglobulin|thymoglobulin|mesh-list
92682085|NCT01050764|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92682086|NCT01050764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682087|NCT01050764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92682088|NCT01050764|Antimetabolites|antimetabolites|mesh-ancestor
92682089|NCT01050764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682090|NCT01050764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92682091|NCT01050764|Immunologic Factors|immunologic factors|mesh-ancestor
92682092|NCT01050764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682093|NCT01050764|Antiviral Agents|antiviral agents|mesh-ancestor
92682094|NCT01050764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682095|NCT01050764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92682096|NCT01050764|Alkylating Agents|alkylating agents|mesh-ancestor
92682097|NCT01050764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92682098|NCT00434096|Rimonabant|rimonabant|mesh-list
92682099|NCT00434096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92682115|NCT01050569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682116|NCT01050569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682117|NCT04702490|Empagliflozin|empagliflozin|mesh-list
92682118|NCT04702490|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92682119|NCT04702490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682120|NCT04702490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92682121|NCT04702490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682122|NCT00464763|Dexmedetomidine|dexmedetomidine|mesh-list
92682123|NCT00464763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92682124|NCT00464763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682125|NCT00464763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682126|NCT00464763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92682127|NCT00464763|Analgesics|analgesics|mesh-ancestor
92682128|NCT00464763|Sensory System Agents|sensory system agents|mesh-ancestor
92682129|NCT00464763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682130|NCT00464763|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92682131|NCT00464763|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92682132|NCT00464763|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92682133|NCT00464763|Adrenergic Agents|adrenergic agents|mesh-ancestor
92682134|NCT00464763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682135|NCT00464763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682136|NCT00434135|Paclitaxel|paclitaxel|mesh-list
92682137|NCT00434135|Gemcitabine|gemcitabine|mesh-list
92682138|NCT00434135|Pemetrexed|pemetrexed|mesh-list
92682139|NCT00434135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92682140|NCT00434135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682141|NCT00434135|Tubulin Modulators|tubulin modulators|mesh-ancestor
92682142|NCT00434135|Antimitotic Agents|antimitotic agents|mesh-ancestor
92682143|NCT00434135|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682144|NCT00434135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682145|NCT00434135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92682146|NCT00434135|Antimetabolites|antimetabolites|mesh-ancestor
92682147|NCT00434135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682148|NCT00434135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92682149|NCT00434135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92682150|NCT01050530|Tolvaptan|tolvaptan|mesh-list
92682151|NCT01050530|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92682152|NCT01050530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682153|NCT01050530|Natriuretic Agents|natriuretic agents|mesh-ancestor
92682154|NCT01050530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089734|NCT01592695|Ethanol|ethanol|mesh-list
92682158|NCT01050257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682159|NCT01050257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682160|NCT03272802|Riluzole|riluzole|mesh-list
92682161|NCT03272802|Edaravone|edaravone|mesh-list
92682162|NCT03272802|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92682163|NCT03272802|Antioxidants|antioxidants|mesh-ancestor
92682164|NCT03272802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682165|NCT03272802|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92682166|NCT03272802|Protective Agents|protective agents|mesh-ancestor
92682167|NCT03272802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682168|NCT03272802|Anticonvulsants|anticonvulsants|mesh-ancestor
92682169|NCT03272802|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92682170|NCT03272802|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92101907|NCT03127800|Morphine|morphine|mesh-list
92682171|NCT03272802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682172|NCT01050218|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92682173|NCT01050218|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92682174|NCT01050218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92682175|NCT01050218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682176|NCT01050218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682177|NCT01050218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682178|NCT01050218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682179|NCT01050218|Antidepressive Agents|antidepressive agents|mesh-ancestor
92682180|NCT01050218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92682181|NCT01050062|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92682182|NCT01050062|Telmisartan|telmisartan|mesh-list
92682183|NCT01050062|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92682184|NCT01050062|Diuretics|diuretics|mesh-ancestor
92682185|NCT01050062|Natriuretic Agents|natriuretic agents|mesh-ancestor
92682186|NCT01050062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682187|NCT01050062|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92682188|NCT01050062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682189|NCT01050062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682190|NCT01050062|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92606649|NCT04085250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606650|NCT04085250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606651|NCT04085250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92606652|NCT04085250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682191|NCT01050062|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92682193|NCT00464919|Tegafur|tegafur|mesh-list
92682194|NCT00464919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682195|NCT00464919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92682196|NCT00464919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682197|NCT00464919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682198|NCT00464919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92682199|NCT00464919|Antimetabolites|antimetabolites|mesh-ancestor
92682200|NCT00434174|Pemetrexed|pemetrexed|mesh-list
92682201|NCT00434174|Everolimus|everolimus|mesh-list
92682202|NCT00434174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682203|NCT00434174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682204|NCT00434174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682205|NCT00434174|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92682206|NCT00434174|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92682207|NCT00434174|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92682208|NCT00434174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92682209|NCT00434174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92682210|NCT00434174|Immunologic Factors|immunologic factors|mesh-ancestor
92682211|NCT00434174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682212|NCT00464958|Tizanidine|tizanidine|mesh-list
92682213|NCT00464958|Analgesics|analgesics|mesh-ancestor
92682214|NCT00464958|Sensory System Agents|sensory system agents|mesh-ancestor
92682215|NCT00464958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682216|NCT00464958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682217|NCT00464958|Anticonvulsants|anticonvulsants|mesh-ancestor
92682218|NCT00464958|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92682219|NCT00464958|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92682220|NCT00464958|Parasympatholytics|parasympatholytics|mesh-ancestor
92682221|NCT00464958|Autonomic Agents|autonomic agents|mesh-ancestor
92682222|NCT00464958|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92682223|NCT00464958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92682224|NCT00464958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92682225|NCT00464958|Adrenergic Agents|adrenergic agents|mesh-ancestor
92682239|NCT01055444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92682240|NCT01055444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92682241|NCT01055444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92682242|NCT01055444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101974|NCT01842581|Rifaximin|rifaximin|mesh-list
92682243|NCT01055444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682244|NCT01055015|Morphine|morphine|mesh-list
92682245|NCT01055015|Oxycodone|oxycodone|mesh-list
92682246|NCT01055015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92682247|NCT01055015|Narcotics|narcotics|mesh-ancestor
92682248|NCT01055015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682249|NCT01055015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682250|NCT01055015|Analgesics|analgesics|mesh-ancestor
92682251|NCT01055015|Sensory System Agents|sensory system agents|mesh-ancestor
92682252|NCT01055015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682253|NCT00472875|Glyburide|glyburide|mesh-list
92682254|NCT00472875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92682255|NCT00472875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682256|NCT00434291|Nemonoxacin|nemonoxacin|mesh-list
92682257|NCT00434291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682258|NCT00434291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682259|NCT00434447|Zoledronic Acid|zoledronic acid|mesh-list
92682260|NCT00434447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92682261|NCT00434447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682262|NCT00472953|Insulin|insulin|mesh-list
92682263|NCT00472953|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92682264|NCT00472953|Insulin Aspart|insulin aspart|mesh-list
92682265|NCT00472953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92682266|NCT00472953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682267|NCT02957630|Drospirenone|drospirenone|mesh-list
92682268|NCT02957630|Levonorgestrel|levonorgestrel|mesh-list
92682269|NCT02957630|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92682270|NCT02957630|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92606654|NCT01249690|Dexamethasone|dexamethasone|mesh-list
92606655|NCT01249690|Dexamethasone acetate|dexamethasone acetate|mesh-list
92606656|NCT01249690|Bortezomib|bortezomib|mesh-list
92606657|NCT01249690|Pirarubicin|pirarubicin|mesh-list
92606658|NCT01249690|Doxorubicin|doxorubicin|mesh-list
92682271|NCT02957630|Contraceptive Agents|contraceptive agents|mesh-ancestor
92682272|NCT02957630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92682273|NCT02957630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682274|NCT02957630|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92682275|NCT02957630|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92682276|NCT02957630|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92682277|NCT02957630|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92682278|NCT02957630|Estrogens|estrogens|mesh-ancestor
92682279|NCT02957630|Hormones|hormones|mesh-ancestor
92682280|NCT02957630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682281|NCT02957630|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92682282|NCT02957630|Hormone Antagonists|hormone antagonists|mesh-ancestor
92682283|NCT02957630|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92682284|NCT02957630|Diuretics|diuretics|mesh-ancestor
92682285|NCT02957630|Natriuretic Agents|natriuretic agents|mesh-ancestor
92682286|NCT00465036|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92089857|NCT01711645|Antacids|antacids|mesh-ancestor
92682290|NCT04702061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682291|NCT04702061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682293|NCT00465075|Estrogens|estrogens|mesh-list
92682294|NCT00465075|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92682295|NCT00465075|Hormones|hormones|mesh-ancestor
92682296|NCT00465075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682297|NCT00465075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682298|NCT00465075|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92682299|NCT00465075|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92682300|NCT00465075|Hormone Antagonists|hormone antagonists|mesh-ancestor
92682301|NCT00465075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92682302|NCT00465192|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92682303|NCT00465192|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92682304|NCT00465192|Estradiol|estradiol|mesh-list
92682305|NCT00465192|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92682306|NCT00465192|Estrogens|estrogens|mesh-ancestor
92682307|NCT00465192|Hormones|hormones|mesh-ancestor
92682308|NCT00465192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682309|NCT00465192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682310|NCT00465192|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92682311|NCT00465192|Contraceptive Agents|contraceptive agents|mesh-ancestor
92682312|NCT00465192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92682313|NCT00465192|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92682314|NCT00434681|Acetaminophen|acetaminophen|mesh-list
92682315|NCT00434681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102052|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
92682316|NCT00434681|Analgesics|analgesics|mesh-ancestor
92682317|NCT00434681|Sensory System Agents|sensory system agents|mesh-ancestor
92682319|NCT00434681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682320|NCT00434681|Antipyretics|antipyretics|mesh-ancestor
92682321|NCT00473070|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92682322|NCT00473070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92682323|NCT00473070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682324|NCT00473070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682325|NCT00473070|Glucocorticoids|glucocorticoids|mesh-ancestor
92682326|NCT00473070|Hormones|hormones|mesh-ancestor
92682327|NCT00473070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682328|NCT00473070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682329|NCT00473070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92682330|NCT00473070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92682331|NCT03272568|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92682332|NCT03272568|Immunologic Factors|immunologic factors|mesh-ancestor
92682333|NCT03272568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682334|NCT04702334|Lidocaine|lidocaine|mesh-list
92682335|NCT04702334|Hyaluronic Acid|hyaluronic acid|mesh-list
92682336|NCT04702334|Anesthetics, Local|anesthetics, local|mesh-ancestor
92682337|NCT04702334|Anesthetics|anesthetics|mesh-ancestor
92682338|NCT04702334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606659|NCT01249690|BB 1101|bb 1101|mesh-list
92606660|NCT01249690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606661|NCT01249690|Antiemetics|antiemetics|mesh-ancestor
92606662|NCT01249690|Autonomic Agents|autonomic agents|mesh-ancestor
92682339|NCT04702334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682340|NCT04702334|Sensory System Agents|sensory system agents|mesh-ancestor
92682341|NCT04702334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682342|NCT04702334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92682343|NCT04702334|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92682344|NCT04702334|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92682345|NCT04702334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682346|NCT04702334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682347|NCT04702334|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92682348|NCT04702334|Immunologic Factors|immunologic factors|mesh-ancestor
92682349|NCT04702334|Viscosupplements|viscosupplements|mesh-ancestor
92682350|NCT04702334|Protective Agents|protective agents|mesh-ancestor
92682351|NCT00473460|Moxifloxacin|moxifloxacin|mesh-list
92682352|NCT00473460|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92682353|NCT00473460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682354|NCT00473460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682355|NCT00473460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92682356|NCT00473460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92682357|NCT00473460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682369|NCT00435305|Linezolid|linezolid|mesh-list
92682370|NCT00435305|Tazobactam|tazobactam|mesh-list
92682371|NCT00435305|Piperacillin|piperacillin|mesh-list
92682372|NCT00435305|Ceftazidime|ceftazidime|mesh-list
92682373|NCT00435305|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92682374|NCT00435305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682375|NCT00435305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682376|NCT00435305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92682377|NCT00435305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682378|NCT00435305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682379|NCT00435305|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92682380|NCT00465543|Rosmarinic acid|rosmarinic acid|mesh-list
92682381|NCT00465543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92682382|NCT00465543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92682383|NCT00465543|Analgesics|analgesics|mesh-ancestor
92682384|NCT00465543|Sensory System Agents|sensory system agents|mesh-ancestor
92682385|NCT00465543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682386|NCT00465543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682387|NCT00465543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92682388|NCT00465543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92682389|NCT00465543|Antioxidants|antioxidants|mesh-ancestor
92102129|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
92682390|NCT00465543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682391|NCT00465543|Protective Agents|protective agents|mesh-ancestor
92682392|NCT00465543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92682393|NCT00465543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92682394|NCT00465543|Protease Inhibitors|protease inhibitors|mesh-ancestor
92682395|NCT00465543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682396|NCT00435500|Fluorides|fluorides|mesh-list
92682397|NCT00435500|Fluorides, Topical|fluorides, topical|mesh-list
92682398|NCT00435500|Cariostatic Agents|cariostatic agents|mesh-ancestor
92682399|NCT00435500|Protective Agents|protective agents|mesh-ancestor
92682400|NCT00435500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682401|NCT03272412|Progesterone|progesterone|mesh-list
92682402|NCT03272412|Progestins|progestins|mesh-ancestor
92682403|NCT03272412|Hormones|hormones|mesh-ancestor
92682404|NCT03272412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682405|NCT03272412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682406|NCT00473616|Irinotecan|irinotecan|mesh-list
92682407|NCT00473616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92682408|NCT00473616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92682409|NCT00473616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682410|NCT00473616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682411|NCT00473616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682412|NCT00435851|Hormones|hormones|mesh-list
92682413|NCT00435851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682414|NCT00435851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682415|NCT00436124|Oseltamivir|oseltamivir|mesh-list
92606663|NCT01249690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606664|NCT01249690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606665|NCT01249690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606666|NCT01249690|Glucocorticoids|glucocorticoids|mesh-ancestor
92606667|NCT01249690|Hormones|hormones|mesh-ancestor
92606668|NCT01249690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606669|NCT01249690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92682416|NCT00436124|Antiviral Agents|antiviral agents|mesh-ancestor
92682417|NCT00436124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682418|NCT00436124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682419|NCT00436124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682442|NCT00436241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92682443|NCT00436241|Antimetabolites|antimetabolites|mesh-ancestor
92682444|NCT00436241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682445|NCT00436241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682446|NCT00481455|Temozolomide|temozolomide|mesh-list
92682447|NCT00481455|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92682448|NCT00481455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92682449|NCT00481455|Alkylating Agents|alkylating agents|mesh-ancestor
92682450|NCT00481455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682451|NCT00481455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682452|NCT00481455|Tubulin Modulators|tubulin modulators|mesh-ancestor
92682453|NCT00481455|Antimitotic Agents|antimitotic agents|mesh-ancestor
92682454|NCT00481455|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682455|NCT00481533|Oxytocin|oxytocin|mesh-list
92682456|NCT00481533|Ergonovine|ergonovine|mesh-list
92682457|NCT00481533|Oxytocics|oxytocics|mesh-ancestor
92682458|NCT00481533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92682459|NCT00481533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682460|NCT00481572|Terlipressin|terlipressin|mesh-list
92682461|NCT00481572|Vasopressins|vasopressins|mesh-list
92682462|NCT00481572|Arginine Vasopressin|arginine vasopressin|mesh-list
92682463|NCT00481572|Norepinephrine|norepinephrine|mesh-list
92682464|NCT00481572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92682465|NCT00481572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92682466|NCT00481572|Adrenergic Agents|adrenergic agents|mesh-ancestor
92682467|NCT00481572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682468|NCT00481572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682469|NCT00481572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682470|NCT00481572|Sympathomimetics|sympathomimetics|mesh-ancestor
92682471|NCT00481572|Autonomic Agents|autonomic agents|mesh-ancestor
92682472|NCT00481572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682473|NCT00481572|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92682474|NCT00481572|Hemostatics|hemostatics|mesh-ancestor
92682475|NCT00481572|Coagulants|coagulants|mesh-ancestor
92682478|NCT00481572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92682479|NCT00474006|Daunorubicin|daunorubicin|mesh-list
92682480|NCT00474006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92682481|NCT00474006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682482|NCT00474006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92682483|NCT00474006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92682484|NCT00474006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682485|NCT00474006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682486|NCT04697745|Dexamethasone|dexamethasone|mesh-list
92682487|NCT04697745|Dexmedetomidine|dexmedetomidine|mesh-list
92682488|NCT04697745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92682489|NCT04697745|Antiemetics|antiemetics|mesh-ancestor
92682490|NCT04697745|Autonomic Agents|autonomic agents|mesh-ancestor
92682491|NCT04697745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682492|NCT04697745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682493|NCT04697745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682494|NCT04697745|Glucocorticoids|glucocorticoids|mesh-ancestor
92682496|NCT04697745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682497|NCT04697745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92682498|NCT04697745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682499|NCT04697745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92682500|NCT04697745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606670|NCT01249690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606671|NCT01249690|Protease Inhibitors|protease inhibitors|mesh-ancestor
92606672|NCT01249690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014119|NCT03072121|Aspirin|aspirin|mesh-list
92682501|NCT04697745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92682502|NCT04697745|Analgesics|analgesics|mesh-ancestor
92682503|NCT04697745|Sensory System Agents|sensory system agents|mesh-ancestor
92682504|NCT04697745|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92682505|NCT04697745|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92682506|NCT04697745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92682507|NCT04697745|Adrenergic Agents|adrenergic agents|mesh-ancestor
92682508|NCT04697745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682509|NCT04697745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682510|NCT00481689|Ciprofloxacin|ciprofloxacin|mesh-list
92682511|NCT00481689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682512|NCT00481689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682513|NCT00481689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92682514|NCT00481689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92682515|NCT00481689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682516|NCT00481689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682517|NCT00481689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682518|NCT00481689|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92682519|NCT00481689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92682520|NCT00436709|Paclitaxel|paclitaxel|mesh-list
92682521|NCT00436709|Cyclophosphamide|cyclophosphamide|mesh-list
92682522|NCT00436709|Bevacizumab|bevacizumab|mesh-list
92682523|NCT00436709|Doxorubicin|doxorubicin|mesh-list
92682524|NCT00436709|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92682525|NCT00436709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92682526|NCT00436709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92682527|NCT00436709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682528|NCT00436709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92682529|NCT00436709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92682530|NCT00436709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682531|NCT00436709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682532|NCT00436709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92682533|NCT00436709|Immunologic Factors|immunologic factors|mesh-ancestor
92682534|NCT00436709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682535|NCT00436709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92682536|NCT00436709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92682537|NCT00436709|Alkylating Agents|alkylating agents|mesh-ancestor
92682538|NCT00436709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92682539|NCT00436709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92102285|NCT03403842|Sufentanil|sufentanil|mesh-list
92682540|NCT00436709|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92682541|NCT00436709|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92682542|NCT00436709|Growth Substances|growth substances|mesh-ancestor
92682543|NCT00436709|Growth Inhibitors|growth inhibitors|mesh-ancestor
92682544|NCT00436709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92682545|NCT00436709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92682546|NCT00436709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92682547|NCT00436709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682549|NCT00436787|Fondaparinux|fondaparinux|mesh-list
92682550|NCT00436787|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92682551|NCT00436787|Antithrombins|antithrombins|mesh-ancestor
92682552|NCT00436787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92682553|NCT00436787|Protease Inhibitors|protease inhibitors|mesh-ancestor
92682554|NCT00436787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682555|NCT00436787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682556|NCT00436787|Anticoagulants|anticoagulants|mesh-ancestor
92682557|NCT00436787|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92682558|NCT00436787|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92682559|NCT00481728|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92682560|NCT00481728|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92682561|NCT00481728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92682562|NCT00481728|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682563|NCT00481728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682564|NCT00481728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682565|NCT00481728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682566|NCT00481728|Urological Agents|urological agents|mesh-ancestor
92682567|NCT00436943|Bupropion|bupropion|mesh-list
92682568|NCT00436943|Nicotine|nicotine|mesh-list
92606673|NCT01249690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606674|NCT01249690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606676|NCT01249690|Leprostatic Agents|leprostatic agents|mesh-ancestor
92606677|NCT01249690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606678|NCT01249690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606679|NCT01249690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92606680|NCT01249690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92606681|NCT01249690|Growth Substances|growth substances|mesh-ancestor
92606682|NCT01249690|Growth Inhibitors|growth inhibitors|mesh-ancestor
92606683|NCT01249690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92606684|NCT01249690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606685|NCT01249690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606686|NCT03712826|Ustekinumab|ustekinumab|mesh-list
92606687|NCT03712826|Dermatologic Agents|dermatologic agents|mesh-ancestor
92014121|NCT03072121|Isosorbide|isosorbide|mesh-list
92682569|NCT00436943|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92682570|NCT00436943|Autonomic Agents|autonomic agents|mesh-ancestor
92682571|NCT00436943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682572|NCT00436943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682573|NCT00436943|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92682574|NCT00436943|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92682575|NCT00436943|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682576|NCT00436943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682577|NCT00436943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682578|NCT00436943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92682579|NCT00436943|Antidepressive Agents|antidepressive agents|mesh-ancestor
92682580|NCT00436943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92682581|NCT00436943|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92682582|NCT00436943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92682583|NCT00436943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682584|NCT00436943|Dopamine Agents|dopamine agents|mesh-ancestor
92682585|NCT00436943|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92682586|NCT00436943|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92682587|NCT00436943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682588|NCT00474162|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92682589|NCT00474162|Plasma Substitutes|plasma substitutes|mesh-ancestor
92682590|NCT00474162|Blood Substitutes|blood substitutes|mesh-ancestor
92682591|NCT00481884|Petrolatum|petrolatum|mesh-list
92682592|NCT00481884|Emollients|emollients|mesh-ancestor
92682593|NCT00481884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92682594|NCT00481923|Rimonabant|rimonabant|mesh-list
92682595|NCT00481923|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92682596|NCT00481923|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92682597|NCT00481923|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92682598|NCT00481923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682599|NCT00481923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682600|NCT00481923|Hormones|hormones|mesh-ancestor
92682601|NCT00481923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682602|NCT00481923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682603|NCT00481962|Tigecycline|tigecycline|mesh-list
92682604|NCT00481962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682605|NCT00481962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682606|NCT00481962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92682607|NCT00481962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682608|NCT00481962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682609|NCT00437177|Apomorphine|apomorphine|mesh-list
92682610|NCT00437177|Emetics|emetics|mesh-ancestor
92606689|NCT01249846|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92606690|NCT01249846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92606691|NCT01249846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606693|NCT01249846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92606694|NCT00504244|Mycophenolic Acid|mycophenolic acid|mesh-list
92606695|NCT00504244|Azathioprine|azathioprine|mesh-list
92606696|NCT00504244|Antimetabolites|antimetabolites|mesh-ancestor
92606697|NCT00504244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606698|NCT00504244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606699|NCT00504244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606700|NCT00504244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606701|NCT00504244|Immunologic Factors|immunologic factors|mesh-ancestor
92606702|NCT00504244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606703|NCT00504244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606704|NCT00504244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92606705|NCT00504244|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92606706|NCT00504244|Antitubercular Agents|antitubercular agents|mesh-ancestor
92606707|NCT00504244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606708|NCT00504244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606709|NCT00504244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606710|NCT00405444|Fentanyl|fentanyl|mesh-list
92606711|NCT00405444|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92606712|NCT00405444|Narcotics|narcotics|mesh-ancestor
92606713|NCT00405444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606714|NCT00405444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606715|NCT00405444|Analgesics|analgesics|mesh-ancestor
92606716|NCT00405444|Sensory System Agents|sensory system agents|mesh-ancestor
92606717|NCT00405444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606718|NCT00405444|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92606719|NCT00405444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92606720|NCT00405444|Anesthetics, General|anesthetics, general|mesh-ancestor
92606721|NCT00405444|Anesthetics|anesthetics|mesh-ancestor
92606722|NCT00504283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92682611|NCT00437177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682612|NCT00437177|Autonomic Agents|autonomic agents|mesh-ancestor
92682613|NCT00437177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682614|NCT00437177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682615|NCT00437177|Dopamine Agonists|dopamine agonists|mesh-ancestor
92682616|NCT00437177|Dopamine Agents|dopamine agents|mesh-ancestor
92606723|NCT00504283|Morphine|morphine|mesh-list
92606724|NCT00504283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92606725|NCT00504283|Narcotics|narcotics|mesh-ancestor
92606726|NCT00504283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606727|NCT00504283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606728|NCT00504283|Analgesics|analgesics|mesh-ancestor
92682617|NCT00437177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682618|NCT00437177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682620|NCT00437333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92682621|NCT00437333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682623|NCT00482079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92682624|NCT00482079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682625|NCT00482079|Incretins|incretins|mesh-ancestor
92682626|NCT00482079|Hormones|hormones|mesh-ancestor
92682627|NCT00482079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682628|NCT00482079|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92682629|NCT00482079|Protease Inhibitors|protease inhibitors|mesh-ancestor
92682630|NCT00482079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682631|NCT00482079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682632|NCT00437372|Sunitinib|sunitinib|mesh-list
92682633|NCT00437372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682634|NCT00437372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92682635|NCT00437372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92682636|NCT00437372|Growth Substances|growth substances|mesh-ancestor
92682637|NCT00437372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682638|NCT00437372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92682639|NCT00437372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92682640|NCT00437372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682641|NCT00437372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682642|NCT00437450|Epoetin Alfa|epoetin alfa|mesh-list
92682643|NCT00437450|Hematinics|hematinics|mesh-ancestor
92682644|NCT04701710|Ivermectin|ivermectin|mesh-list
92682645|NCT04701710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92682646|NCT04701710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682647|NCT00437606|Ethanol|ethanol|mesh-list
92682648|NCT00437606|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92682649|NCT00437606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682650|NCT00437606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682651|NCT00437606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682652|NCT00482313|Methylphenidate|methylphenidate|mesh-list
92682653|NCT00482313|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92682654|NCT00482313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682655|NCT00482313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92368501|NCT01003080|Hemostatics|hemostatics|mesh-list
92682656|NCT00482313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92682657|NCT00482313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682658|NCT00482313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682659|NCT00482313|Dopamine Agents|dopamine agents|mesh-ancestor
92682660|NCT00482313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682661|NCT00437684|Ribavirin|ribavirin|mesh-list
92682662|NCT00437684|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92682663|NCT00437684|Antimetabolites|antimetabolites|mesh-ancestor
92682664|NCT00437684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682665|NCT00437684|Antiviral Agents|antiviral agents|mesh-ancestor
92682666|NCT00437684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682667|NCT00437723|Epoetin Alfa|epoetin alfa|mesh-list
92682668|NCT00437723|Hematinics|hematinics|mesh-ancestor
92682669|NCT00437762|Botulinum Toxins|botulinum toxins|mesh-list
92682670|NCT00437762|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92682671|NCT00437762|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92682672|NCT00437762|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92682673|NCT00437762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682674|NCT00437762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682675|NCT00437762|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682676|NCT00437762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682677|NCT00437762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682678|NCT00437762|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92682679|NCT00437762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682680|NCT00482508|Omalizumab|omalizumab|mesh-list
92606729|NCT00504283|Sensory System Agents|sensory system agents|mesh-ancestor
92606730|NCT00504283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606731|NCT00504283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606732|NCT00504283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92682681|NCT00482508|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92682682|NCT00482508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92682683|NCT00482508|Respiratory System Agents|respiratory system agents|mesh-ancestor
92682684|NCT00437918|Acarbose|acarbose|mesh-list
92682685|NCT00437918|Nateglinide|nateglinide|mesh-list
92682686|NCT00437918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92682687|NCT00437918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682688|NCT00437918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682690|NCT00437918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682691|NCT00437957|Temozolomide|temozolomide|mesh-list
92682692|NCT00437957|Valproic Acid|valproic acid|mesh-list
92682693|NCT00437957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92682694|NCT00437957|Alkylating Agents|alkylating agents|mesh-ancestor
92682695|NCT00437957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682697|NCT00437957|Anticonvulsants|anticonvulsants|mesh-ancestor
92682698|NCT00437957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682699|NCT00437957|GABA Agents|gaba agents|mesh-ancestor
92682700|NCT00437957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682701|NCT00437957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682702|NCT00437957|Antimanic Agents|antimanic agents|mesh-ancestor
92682703|NCT00437957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92682704|NCT00437957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682705|NCT00437957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92682706|NCT03270176|Avelumab|avelumab|mesh-list
92682707|NCT03270176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92682708|NCT03270176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682709|NCT00474279|Hormones|hormones|mesh-list
92682710|NCT00474279|Secretagogues|secretagogues|mesh-list
92368511|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
92682711|NCT00474279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682712|NCT00474279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682713|NCT03270696|Propofol|propofol|mesh-list
92682714|NCT03270696|Rocuronium|rocuronium|mesh-list
92682715|NCT03270696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92682716|NCT03270696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682717|NCT03270696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682718|NCT03270696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92682719|NCT03270696|Anesthetics, General|anesthetics, general|mesh-ancestor
92682720|NCT03270696|Anesthetics|anesthetics|mesh-ancestor
92682721|NCT03270696|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92682722|NCT03270696|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92682723|NCT03270696|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92682724|NCT03270696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682725|NCT00437996|Clonidine|clonidine|mesh-list
92682726|NCT00437996|Sufentanil|sufentanil|mesh-list
92682727|NCT00437996|Levobupivacaine|levobupivacaine|mesh-list
92682728|NCT00437996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92682729|NCT00437996|Narcotics|narcotics|mesh-ancestor
92682730|NCT00437996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682731|NCT00437996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682732|NCT00437996|Analgesics|analgesics|mesh-ancestor
92682733|NCT00437996|Sensory System Agents|sensory system agents|mesh-ancestor
92682734|NCT00437996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682735|NCT00437996|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92682736|NCT00437996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92682737|NCT00437996|Anesthetics, General|anesthetics, general|mesh-ancestor
92682738|NCT00437996|Anesthetics|anesthetics|mesh-ancestor
92682739|NCT00437996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92682740|NCT00437996|Sympatholytics|sympatholytics|mesh-ancestor
92682741|NCT00437996|Autonomic Agents|autonomic agents|mesh-ancestor
92682742|NCT00437996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92682743|NCT00437996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92682744|NCT00437996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92682745|NCT00437996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92682746|NCT00437996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682747|NCT00437996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606733|NCT00504283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606734|NCT00504283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92682748|NCT00437996|Anesthetics, Local|anesthetics, local|mesh-ancestor
92682750|NCT04701242|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92682751|NCT04701242|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92682752|NCT04701242|Antimetabolites|antimetabolites|mesh-ancestor
92682753|NCT04701242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682754|NCT04701242|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92682755|NCT00474435|Tenofovir|tenofovir|mesh-list
92682756|NCT00474435|Emtricitabine|emtricitabine|mesh-list
92682757|NCT00474435|Efavirenz|efavirenz|mesh-list
92682758|NCT00474435|Antiviral Agents|antiviral agents|mesh-ancestor
92682759|NCT00474435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682760|NCT00474435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92682761|NCT00474435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92682762|NCT00474435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682763|NCT00474435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682764|NCT00474435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92682765|NCT00474435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92682766|NCT00474435|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92682767|NCT00474435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92682768|NCT00474435|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92682769|NCT00474435|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92682770|NCT00474435|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92682842|NCT00438269|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92682843|NCT00474591|PENTA|penta|mesh-list
92682844|NCT00474591|Fondaparinux|fondaparinux|mesh-list
92682845|NCT00474591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92682846|NCT00474591|Antithrombins|antithrombins|mesh-ancestor
92682847|NCT00474591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92682848|NCT00474591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92682849|NCT00474591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682850|NCT00474591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682851|NCT00474591|Anticoagulants|anticoagulants|mesh-ancestor
92682852|NCT00474591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92682853|NCT00474591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92682854|NCT03279809|Aspirin|aspirin|mesh-list
92682855|NCT03279809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92682856|NCT03279809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92682857|NCT03279809|Analgesics|analgesics|mesh-ancestor
92682858|NCT03279809|Sensory System Agents|sensory system agents|mesh-ancestor
92682859|NCT03279809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682860|NCT03279809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682861|NCT03279809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92682862|NCT03279809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92682863|NCT03279809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92682864|NCT03279809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92682865|NCT03279809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682866|NCT03279809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92682867|NCT03279809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92682868|NCT03279809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682869|NCT03279809|Antipyretics|antipyretics|mesh-ancestor
92682870|NCT00438386|Aripiprazole|aripiprazole|mesh-list
92682871|NCT00438386|Antidepressive Agents|antidepressive agents|mesh-ancestor
92682872|NCT00438386|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92682873|NCT00438386|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92682874|NCT00438386|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92682875|NCT00438386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682876|NCT00438386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682877|NCT00438386|Dopamine Agonists|dopamine agonists|mesh-ancestor
92682878|NCT00438386|Dopamine Agents|dopamine agents|mesh-ancestor
92682879|NCT00438386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682880|NCT00438386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682881|NCT00438386|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92682882|NCT00438386|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92682883|NCT00438386|Serotonin Agents|serotonin agents|mesh-ancestor
92682884|NCT00438386|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92682885|NCT00438386|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92682886|NCT00438386|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92682887|NCT00438386|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92682888|NCT00475059|Cimetidine|cimetidine|mesh-list
92682889|NCT00475059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92606735|NCT00504283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92606736|NCT00504283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606737|NCT00504283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606738|NCT00504400|Ranibizumab|ranibizumab|mesh-list
92606739|NCT00504400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92606740|NCT00504400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92682890|NCT00475059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682896|NCT00475059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682897|NCT00475059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92682898|NCT00475059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92682900|NCT00475098|Tinzaparin|tinzaparin|mesh-list
92682901|NCT00475098|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92682902|NCT00475098|Dalteparin|dalteparin|mesh-list
92682903|NCT00475098|Anticoagulants|anticoagulants|mesh-ancestor
92682904|NCT00475098|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92682905|NCT00475098|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92682906|NCT00475098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682907|NCT00475137|Lamotrigine|lamotrigine|mesh-list
92682908|NCT00475137|Anticonvulsants|anticonvulsants|mesh-list
92682909|NCT00475137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92682910|NCT00475137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682911|NCT00475137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682912|NCT00475137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92102667|NCT04697693|Analgesics|analgesics|mesh-ancestor
92682913|NCT00475137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682914|NCT00475137|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92682915|NCT00475137|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92682916|NCT00475137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682917|NCT00475137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92682918|NCT00475137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92682919|NCT00438581|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92682920|NCT00438581|Immunologic Factors|immunologic factors|mesh-ancestor
92682921|NCT00438581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682922|NCT00475293|Panitumumab|panitumumab|mesh-list
92682923|NCT00475293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682924|NCT00475293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92682925|NCT00438737|Leucovorin|leucovorin|mesh-list
92682926|NCT00438737|Bevacizumab|bevacizumab|mesh-list
92682927|NCT00438737|Cetuximab|cetuximab|mesh-list
92682928|NCT00438737|Fluorouracil|fluorouracil|mesh-list
92682929|NCT00438737|Oxaliplatin|oxaliplatin|mesh-list
92682930|NCT00438737|Calcium|calcium|mesh-list
92682931|NCT00438737|Levoleucovorin|levoleucovorin|mesh-list
92682932|NCT00438737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92682933|NCT00438737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682934|NCT00438737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92682935|NCT00438737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92682936|NCT00438737|Growth Substances|growth substances|mesh-ancestor
92682937|NCT00438737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682938|NCT00438737|Growth Inhibitors|growth inhibitors|mesh-ancestor
92682939|NCT00438737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92682940|NCT00438737|Antimetabolites|antimetabolites|mesh-ancestor
92682941|NCT00438737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682942|NCT00438737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92682943|NCT00438737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92682944|NCT00438737|Immunologic Factors|immunologic factors|mesh-ancestor
92682945|NCT00438737|Antidotes|antidotes|mesh-ancestor
92682946|NCT00438737|Protective Agents|protective agents|mesh-ancestor
92682947|NCT00438737|Vitamin B Complex|vitamin b complex|mesh-ancestor
92682948|NCT00438737|Vitamins|vitamins|mesh-ancestor
92682949|NCT00438737|Micronutrients|micronutrients|mesh-ancestor
92682950|NCT00438776|Olanzapine|olanzapine|mesh-list
92682951|NCT00438776|Antiemetics|antiemetics|mesh-ancestor
92682952|NCT00438776|Autonomic Agents|autonomic agents|mesh-ancestor
92682953|NCT00438776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682954|NCT00438776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682955|NCT00438776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682956|NCT00438776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92682957|NCT00438776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92606741|NCT00504400|Growth Substances|growth substances|mesh-ancestor
92606742|NCT00504400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682958|NCT00438776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682959|NCT00438776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92682973|NCT00475527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682974|NCT00475527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682976|NCT00475527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92682977|NCT00475527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92682978|NCT00475527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682979|NCT00475527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92682980|NCT00475527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682981|NCT00475527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682982|NCT00475527|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92682983|NCT00475527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92682984|NCT00475527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92682985|NCT00439049|Naltrexone|naltrexone|mesh-list
92682986|NCT00439049|Modafinil|modafinil|mesh-list
92682987|NCT00439049|Amphetamine|amphetamine|mesh-list
92682988|NCT00439049|Dextroamphetamine|dextroamphetamine|mesh-list
92682989|NCT00439049|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92682990|NCT00439049|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92682991|NCT00439049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368532|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
92682992|NCT00439049|Sensory System Agents|sensory system agents|mesh-ancestor
92682993|NCT00439049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682994|NCT00439049|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92682995|NCT00439049|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92682996|NCT00439049|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92682997|NCT00439049|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92682998|NCT00439049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682999|NCT00439049|Sympathomimetics|sympathomimetics|mesh-ancestor
92683000|NCT00439049|Autonomic Agents|autonomic agents|mesh-ancestor
92683001|NCT00439049|Dopamine Agents|dopamine agents|mesh-ancestor
92683002|NCT00439049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683003|NCT00439049|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683004|NCT00439049|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92683005|NCT00439049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92683006|NCT00439049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683007|NCT00439049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92683008|NCT00475566|Everolimus|everolimus|mesh-list
92683009|NCT00475566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92683010|NCT00475566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92683011|NCT00475566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683012|NCT00475566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683013|NCT00475566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683014|NCT00475566|Immunologic Factors|immunologic factors|mesh-ancestor
92683015|NCT00475566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683016|NCT00475566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683017|NCT00439166|Doxycycline|doxycycline|mesh-list
92683018|NCT00439166|Rifampin|rifampin|mesh-list
92683019|NCT00439166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92683020|NCT00439166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683021|NCT00439166|Antimalarials|antimalarials|mesh-ancestor
92683038|NCT00439283|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92683039|NCT00439283|Abortifacient Agents|abortifacient agents|mesh-ancestor
92683040|NCT00439283|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92683041|NCT00439283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683042|NCT00439283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683043|NCT00439283|Antimetabolites|antimetabolites|mesh-ancestor
92683044|NCT00439283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683045|NCT00439283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683046|NCT00439283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92683047|NCT00439283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683048|NCT00439283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92683049|NCT00439283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683050|NCT00439283|Immunologic Factors|immunologic factors|mesh-ancestor
92683051|NCT00439283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683052|NCT00439283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683053|NCT00439283|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92683054|NCT00439283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683055|NCT00439283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683056|NCT00475800|Lumiracoxib|lumiracoxib|mesh-list
92683057|NCT00475800|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92606744|NCT00504400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606745|NCT00504439|Simvastatin|simvastatin|mesh-list
92606746|NCT00504439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92683058|NCT00475800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683059|NCT00475800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683060|NCT00475800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683061|NCT00475800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683062|NCT00475800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683063|NCT00475800|Analgesics|analgesics|mesh-ancestor
92683064|NCT00475800|Sensory System Agents|sensory system agents|mesh-ancestor
92683065|NCT00475800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683066|NCT00475800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683067|NCT00475800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683068|NCT00475800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683069|NCT00439361|Carboplatin|carboplatin|mesh-list
92683070|NCT00439361|Etoposide|etoposide|mesh-list
92683071|NCT00439361|Bortezomib|bortezomib|mesh-list
92683072|NCT00439361|Ifosfamide|ifosfamide|mesh-list
92683073|NCT00439361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683074|NCT00439361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92683075|NCT00439361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92683076|NCT00439361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92683077|NCT00439361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683079|NCT00439361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92683080|NCT00439361|Alkylating Agents|alkylating agents|mesh-ancestor
92683081|NCT00475917|Gemcitabine|gemcitabine|mesh-list
92683082|NCT00475917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683083|NCT00475917|Antimetabolites|antimetabolites|mesh-ancestor
92683084|NCT00475917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683085|NCT00475917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683086|NCT00474669|Docetaxel|docetaxel|mesh-list
92683087|NCT00474669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683088|NCT00474669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92683089|NCT00474669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92683090|NCT00474669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92683091|NCT00474669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683092|NCT00439400|Doxycycline|doxycycline|mesh-list
92683093|NCT00439400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92683094|NCT00439400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683095|NCT00439400|Antimalarials|antimalarials|mesh-ancestor
92683096|NCT00439400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92683097|NCT00439400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92683098|NCT00475956|Cediranib|cediranib|mesh-list
92683099|NCT00475956|Saracatinib|saracatinib|mesh-list
92683100|NCT00475956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683101|NCT00475956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92683102|NCT00475956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683103|NCT00475956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683104|NCT00476034|Lumiracoxib|lumiracoxib|mesh-list
92683105|NCT00476034|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92683106|NCT00476034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683107|NCT00476034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683108|NCT00476034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683109|NCT00476034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683110|NCT00476034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683111|NCT00476034|Analgesics|analgesics|mesh-ancestor
92683112|NCT00476034|Sensory System Agents|sensory system agents|mesh-ancestor
92683113|NCT00476034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683114|NCT00476034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683115|NCT00476034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683116|NCT00476034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683117|NCT00476073|Fluticasone|fluticasone|mesh-list
92683118|NCT00476073|Xhance|xhance|mesh-list
92683119|NCT00476073|Formoterol Fumarate|formoterol fumarate|mesh-list
92683120|NCT00476073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683121|NCT00476073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92683122|NCT00476073|Autonomic Agents|autonomic agents|mesh-ancestor
92683123|NCT00476073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683124|NCT00476073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683125|NCT00476073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92683126|NCT00476073|Respiratory System Agents|respiratory system agents|mesh-ancestor
92606747|NCT00504439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92606748|NCT00504439|Antimetabolites|antimetabolites|mesh-ancestor
92606749|NCT00504439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606750|NCT00504439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92683127|NCT00476073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92683128|NCT00476073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92683129|NCT00476073|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92683130|NCT00476073|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92683131|NCT00476073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92683132|NCT00476073|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683133|NCT00476073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683134|NCT00476073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683136|NCT00476268|Formoterol Fumarate|formoterol fumarate|mesh-list
92683137|NCT00476268|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92683138|NCT00476268|Autonomic Agents|autonomic agents|mesh-ancestor
92683139|NCT00476268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683140|NCT00476268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683141|NCT00476268|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92683142|NCT00476268|Respiratory System Agents|respiratory system agents|mesh-ancestor
92683143|NCT00476268|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92683144|NCT00476268|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92683145|NCT00476268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92683146|NCT00476268|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683147|NCT00476268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683148|NCT00476268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683149|NCT00476268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683150|NCT00476268|Glucocorticoids|glucocorticoids|mesh-ancestor
92683154|NCT00105989|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92683155|NCT00105989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92683156|NCT00105989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683157|NCT00105989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683158|NCT00105989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683159|NCT00105989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683161|NCT00105989|Sensory System Agents|sensory system agents|mesh-ancestor
92683162|NCT00105989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683163|NCT00105989|Antidepressive Agents|antidepressive agents|mesh-ancestor
92683164|NCT00105989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92683165|NCT00105989|Dopamine Agents|dopamine agents|mesh-ancestor
92683166|NCT00476346|Vitamin D|vitamin d|mesh-list
92683167|NCT00476346|Calcium|calcium|mesh-list
92683168|NCT00476346|Vitamins|vitamins|mesh-ancestor
92683169|NCT00476346|Micronutrients|micronutrients|mesh-ancestor
92683170|NCT00476346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683171|NCT00476346|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92683172|NCT00476346|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92683173|NCT00476424|Efavirenz|efavirenz|mesh-list
92683174|NCT00476424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92683175|NCT00476424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683176|NCT00476424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683177|NCT00476424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683178|NCT00476424|Antiviral Agents|antiviral agents|mesh-ancestor
92683179|NCT00476424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683180|NCT00476424|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92683181|NCT00476424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92683182|NCT00476424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92683183|NCT00476424|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92683184|NCT00476424|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92683185|NCT00476424|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92683186|NCT00439712|Levocetirizine|levocetirizine|mesh-list
92683187|NCT00439712|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92683188|NCT00439712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92683189|NCT00439712|Histamine Antagonists|histamine antagonists|mesh-ancestor
92683190|NCT00439712|Histamine Agents|histamine agents|mesh-ancestor
92683191|NCT00439712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683192|NCT00439712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683193|NCT00439712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606751|NCT00504439|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92606753|NCT04054830|Diclofenac|diclofenac|mesh-list
92606754|NCT04054830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606755|NCT04054830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606756|NCT04054830|Analgesics|analgesics|mesh-ancestor
92014195|NCT04991155|Zamicastat|zamicastat|mesh-list
92683194|NCT00476463|Emtricitabine|emtricitabine|mesh-list
92683195|NCT00476463|Antiviral Agents|antiviral agents|mesh-ancestor
92683196|NCT00476463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683197|NCT00476463|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92683198|NCT00476463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683199|NCT00476463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683200|NCT00476463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683201|NCT00476463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92683202|NCT00476463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92683203|NCT00439751|Goserelin|goserelin|mesh-list
92683204|NCT00439751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92683205|NCT00439751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683206|NCT00438243|Bromfenac|bromfenac|mesh-list
92683207|NCT00438243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683208|NCT00438243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683209|NCT00438243|Analgesics|analgesics|mesh-ancestor
92102955|NCT03389490|Insulin|insulin|mesh-list
92683210|NCT00438243|Sensory System Agents|sensory system agents|mesh-ancestor
92683211|NCT00438243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683212|NCT00438243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683213|NCT00438243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683214|NCT00438243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683215|NCT00439829|Cetrorelix|cetrorelix|mesh-list
92683216|NCT00439829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92683217|NCT00439829|Fertility Agents|fertility agents|mesh-ancestor
92683218|NCT00439829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92683225|NCT03277248|Analgesics|analgesics|mesh-ancestor
92683226|NCT03277248|Sensory System Agents|sensory system agents|mesh-ancestor
92683227|NCT03277248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683228|NCT03277248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683229|NCT03277248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683230|NCT03277248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683231|NCT03277248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683232|NCT03277248|Immunologic Factors|immunologic factors|mesh-ancestor
92683233|NCT00440024|Tazarotene|tazarotene|mesh-list
92683234|NCT00440024|Dermatologic Agents|dermatologic agents|mesh-ancestor
92683235|NCT00440024|Keratolytic Agents|keratolytic agents|mesh-ancestor
92683236|NCT00440063|Epoetin Alfa|epoetin alfa|mesh-list
92683237|NCT00440063|Hematinics|hematinics|mesh-ancestor
92683238|NCT00440102|Ketamine|ketamine|mesh-list
92683239|NCT00440102|Etomidate|etomidate|mesh-list
92683240|NCT00440102|Analgesics|analgesics|mesh-ancestor
92683241|NCT00440102|Sensory System Agents|sensory system agents|mesh-ancestor
92683242|NCT00440102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683243|NCT00440102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683244|NCT00440102|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92683245|NCT00440102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92683246|NCT00440102|Anesthetics, General|anesthetics, general|mesh-ancestor
92683247|NCT00440102|Anesthetics|anesthetics|mesh-ancestor
92683248|NCT00440102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683249|NCT00440102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92683250|NCT00440102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92683251|NCT00440102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683252|NCT00440102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683253|NCT00440102|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92683254|NCT00476541|Gemtuzumab|gemtuzumab|mesh-list
92683255|NCT00476541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683256|NCT00476541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683257|NCT00476541|Immunotoxins|immunotoxins|mesh-ancestor
92683258|NCT00476541|Immunoconjugates|immunoconjugates|mesh-ancestor
92683259|NCT00476541|Immunologic Factors|immunologic factors|mesh-ancestor
92683260|NCT00476541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683261|NCT00440141|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92606757|NCT04054830|Sensory System Agents|sensory system agents|mesh-ancestor
92606758|NCT04054830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606759|NCT04054830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014198|NCT04462315|Cobalt|cobalt|mesh-list
92683262|NCT00440141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92683263|NCT00440141|Latanoprost|latanoprost|mesh-list
92683264|NCT00440141|Brinzolamide|brinzolamide|mesh-list
92683265|NCT00440141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92683266|NCT00440141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92683267|NCT00440141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92683268|NCT00440141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92683269|NCT00440141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92683270|NCT00440141|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683271|NCT00440141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683272|NCT00440141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683273|NCT00440141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683274|NCT00440141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92683275|NCT00440141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683276|NCT00438321|Anastrozole|anastrozole|mesh-list
92683277|NCT00438321|Goserelin|goserelin|mesh-list
92683278|NCT00438321|Testosterone|testosterone|mesh-list
92683279|NCT00438321|Androgens|androgens|mesh-ancestor
92683280|NCT00438321|Hormones|hormones|mesh-ancestor
92683281|NCT00438321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683282|NCT00438321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683283|NCT00438321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92683284|NCT00438321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683285|NCT00438321|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92683286|NCT00438321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92683287|NCT00438321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683294|NCT03279536|Dextrans|dextrans|mesh-list
92683295|NCT03279536|Iron-Dextran Complex|iron-dextran complex|mesh-list
92683296|NCT03279536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683297|NCT03279536|Anticoagulants|anticoagulants|mesh-ancestor
92683298|NCT03279536|Plasma Substitutes|plasma substitutes|mesh-ancestor
92683299|NCT03279536|Blood Substitutes|blood substitutes|mesh-ancestor
92683300|NCT03279536|Hematinics|hematinics|mesh-ancestor
92683301|NCT00440219|Prednisone|prednisone|mesh-list
92683302|NCT00440219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683303|NCT00440219|Glucocorticoids|glucocorticoids|mesh-ancestor
92683304|NCT00440219|Hormones|hormones|mesh-ancestor
92683305|NCT00440219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683306|NCT00440219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683307|NCT00440219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92683308|NCT00440219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683309|NCT00438477|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92683310|NCT00438477|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92683311|NCT00438477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683312|NCT00440258|Cabergoline|cabergoline|mesh-list
92683313|NCT00440258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92683314|NCT00440258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92683315|NCT00440258|Dopamine Agonists|dopamine agonists|mesh-ancestor
92683316|NCT00440258|Dopamine Agents|dopamine agents|mesh-ancestor
92683317|NCT00440258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683318|NCT00440258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683319|NCT00440258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683320|NCT00440336|Latanoprost|latanoprost|mesh-list
92683321|NCT00440336|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92683322|NCT00440336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92683323|NCT00440375|Rosiglitazone|rosiglitazone|mesh-list
92683324|NCT00440375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92683325|NCT00440375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683326|NCT00440414|Pemetrexed|pemetrexed|mesh-list
92683327|NCT00440414|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92683328|NCT00440414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683329|NCT00440414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683330|NCT00440414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683331|NCT00440414|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92683332|NCT00440414|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683333|NCT00440414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92683334|NCT03270462|Tacrolimus|tacrolimus|mesh-list
92683335|NCT03270462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606760|NCT04054830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606761|NCT04054830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606762|NCT04054830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92606763|NCT04054830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606764|NCT04054830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606765|NCT03622775|Daratumumab|daratumumab|mesh-list
92606766|NCT03622775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606767|NCT01249651|Esomeprazole|esomeprazole|mesh-list
92606768|NCT01249651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92606769|NCT01249651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606770|NCT01249651|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92606771|NCT01249651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606772|NCT01249651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606773|NCT03999723|Ascorbic Acid|ascorbic acid|mesh-list
92606775|NCT03999723|Micronutrients|micronutrients|mesh-ancestor
92683336|NCT03270462|Immunologic Factors|immunologic factors|mesh-ancestor
92683337|NCT03270462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683338|NCT03270462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92683339|NCT03270462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683340|NCT03270462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683341|NCT00440609|Ranibizumab|ranibizumab|mesh-list
92683342|NCT00440609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92683343|NCT00440609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92683344|NCT00440609|Growth Substances|growth substances|mesh-ancestor
92683345|NCT00440609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683346|NCT00440609|Growth Inhibitors|growth inhibitors|mesh-ancestor
92683347|NCT00440609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683348|NCT00440648|Sevelamer|sevelamer|mesh-list
92683349|NCT00440648|Chelating Agents|chelating agents|mesh-ancestor
92683350|NCT00440648|Sequestering Agents|sequestering agents|mesh-ancestor
92683351|NCT00440648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683352|NCT00440687|Fluticasone|fluticasone|mesh-list
92683353|NCT00440687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683354|NCT00440687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92683355|NCT00440687|Autonomic Agents|autonomic agents|mesh-ancestor
92683356|NCT00440687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683357|NCT00440687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683390|NCT00440843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683391|NCT00440843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92683392|NCT00440843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92368608|NCT01010568|Ofatumumab|ofatumumab|mesh-list
92683393|NCT00440843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92683394|NCT00440843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683395|NCT00440843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683396|NCT00440843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683397|NCT00440843|Serotonin Agents|serotonin agents|mesh-ancestor
92683398|NCT00438789|Eculizumab|eculizumab|mesh-list
92683399|NCT00438789|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92683428|NCT00440960|GABA Modulators|gaba modulators|mesh-ancestor
92683429|NCT00440960|GABA Agents|gaba agents|mesh-ancestor
92683430|NCT00440960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683431|NCT00440960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92683432|NCT00440960|Narcotics|narcotics|mesh-ancestor
92683433|NCT00440960|Analgesics|analgesics|mesh-ancestor
92683434|NCT00438828|Dexamethasone|dexamethasone|mesh-list
92683435|NCT00438828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683436|NCT00438828|Antiemetics|antiemetics|mesh-ancestor
92683437|NCT00438828|Autonomic Agents|autonomic agents|mesh-ancestor
92683438|NCT00438828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014216|NCT03071731|Ipratropium|ipratropium|mesh-list
92683439|NCT00438828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683440|NCT00438828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683441|NCT00438828|Glucocorticoids|glucocorticoids|mesh-ancestor
92683442|NCT00438828|Hormones|hormones|mesh-ancestor
92683443|NCT00438828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683444|NCT00438828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92683445|NCT00438828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683446|NCT00441155|Imatinib Mesylate|imatinib mesylate|mesh-list
92683447|NCT00441155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683448|NCT00441155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92683455|NCT00106002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92683456|NCT00106002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683457|NCT00476853|Nevirapine|nevirapine|mesh-list
92683458|NCT00476853|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92683459|NCT00476853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683460|NCT00476853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683461|NCT00476853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683462|NCT00476853|Antiviral Agents|antiviral agents|mesh-ancestor
92683463|NCT00476853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683464|NCT00476853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92683465|NCT00476853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92683466|NCT00476853|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92683467|NCT00476853|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92683468|NCT00438906|Secretin|secretin|mesh-list
92683469|NCT00438906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683470|NCT00438906|Hormones|hormones|mesh-ancestor
92683471|NCT00438906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683472|NCT00438906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683473|NCT00438945|Eprosartan|eprosartan|mesh-list
92683474|NCT00438945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92683475|NCT00438945|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92683476|NCT00438945|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92683477|NCT00438945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683478|NCT00441428|Solifenacin Succinate|solifenacin succinate|mesh-list
92683479|NCT00441428|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92683480|NCT00441428|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92683481|NCT00441428|Cholinergic Agents|cholinergic agents|mesh-ancestor
92683482|NCT00441428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683483|NCT00441428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683484|NCT00441428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683485|NCT00441428|Urological Agents|urological agents|mesh-ancestor
92683486|NCT00438984|Aldesleukin|aldesleukin|mesh-list
92683487|NCT00438984|Cyclophosphamide|cyclophosphamide|mesh-list
92683488|NCT00438984|Interleukin-2|interleukin-2|mesh-list
92683489|NCT00438984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683490|NCT00438984|Immunologic Factors|immunologic factors|mesh-ancestor
92683491|NCT00438984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683492|NCT00438984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683493|NCT00438984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92683494|NCT00438984|Alkylating Agents|alkylating agents|mesh-ancestor
92683495|NCT00438984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683496|NCT00438984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683497|NCT00438984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92683498|NCT00438984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683499|NCT00438984|Analgesics|analgesics|mesh-ancestor
92683500|NCT00438984|Sensory System Agents|sensory system agents|mesh-ancestor
92683501|NCT00438984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683502|NCT00438984|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92683503|NCT00438984|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92683504|NCT00438984|Antiviral Agents|antiviral agents|mesh-ancestor
92683505|NCT00438984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683506|NCT00441506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92683507|NCT00441506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683508|NCT00441506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683509|NCT00441662|Triamcinolone|triamcinolone|mesh-list
92683510|NCT00441662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103253|NCT01497496|Ofatumumab|ofatumumab|mesh-list
92683511|NCT00441662|Glucocorticoids|glucocorticoids|mesh-ancestor
92683513|NCT00441662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683514|NCT00441662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683521|NCT02957162|Antimetabolites|antimetabolites|mesh-ancestor
92014217|NCT03071731|Bronchodilator Agents|bronchodilator agents|mesh-list
92606776|NCT03999723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606777|NCT03999723|Antioxidants|antioxidants|mesh-ancestor
92606778|NCT03999723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606779|NCT03999723|Protective Agents|protective agents|mesh-ancestor
92606780|NCT01249417|Botulinum Toxins|botulinum toxins|mesh-list
92606781|NCT01249417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92606782|NCT01249417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92606783|NCT01249417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92606784|NCT01249417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92606785|NCT01249417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606786|NCT01249417|Cholinergic Agents|cholinergic agents|mesh-ancestor
92606787|NCT01249417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606788|NCT01249417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683522|NCT02957162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683523|NCT02957162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92683524|NCT02957162|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92683525|NCT02957162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683526|NCT00441740|Gemcitabine|gemcitabine|mesh-list
92683527|NCT00441740|Docetaxel|docetaxel|mesh-list
92683528|NCT00441740|Vinorelbine|vinorelbine|mesh-list
92683529|NCT00441740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683530|NCT00441740|Antimetabolites|antimetabolites|mesh-ancestor
92683531|NCT00441740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683532|NCT00441740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683533|NCT00441740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92683534|NCT00441740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92683535|NCT00441740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92683536|NCT00441740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92683537|NCT02274012|Paclitaxel|paclitaxel|mesh-list
92683538|NCT02274012|Afatinib|afatinib|mesh-list
92683539|NCT02274012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92683540|NCT02274012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683541|NCT02274012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92683542|NCT02274012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92683543|NCT02274012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92683544|NCT02274012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683545|NCT02274012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92683546|NCT02274012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683547|NCT00477048|Saquinavir|saquinavir|mesh-list
92683548|NCT00477048|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92683549|NCT00477048|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92683550|NCT00477048|Protease Inhibitors|protease inhibitors|mesh-ancestor
92683551|NCT00477048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683552|NCT00477048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683553|NCT00477048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92683554|NCT00477048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92683555|NCT00477048|Antiviral Agents|antiviral agents|mesh-ancestor
92683556|NCT00477048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683557|NCT00477048|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92683558|NCT00477048|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92683559|NCT00477126|Ritonavir|ritonavir|mesh-list
92683560|NCT00477126|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92683561|NCT00477126|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92683562|NCT00477126|Protease Inhibitors|protease inhibitors|mesh-ancestor
92683563|NCT00477126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683564|NCT00477126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683565|NCT00477126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92606789|NCT01249417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92606790|NCT01249417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606791|NCT00403325|Ranibizumab|ranibizumab|mesh-list
92606792|NCT00403325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92606793|NCT00403325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92683566|NCT00477126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92683567|NCT00477126|Antiviral Agents|antiviral agents|mesh-ancestor
92683568|NCT00477126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683569|NCT00477126|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92683570|NCT00477126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92683571|NCT03279341|Prucalopride|prucalopride|mesh-list
92683572|NCT03279341|Bisacodyl|bisacodyl|mesh-list
92683573|NCT03279341|Laxatives|laxatives|mesh-ancestor
92683574|NCT03279341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683575|NCT03279341|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92683576|NCT03279341|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92683577|NCT03279341|Serotonin Agents|serotonin agents|mesh-ancestor
92683578|NCT03279341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683579|NCT03279341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683580|NCT03279341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683581|NCT03279341|Cathartics|cathartics|mesh-ancestor
92683582|NCT03279146|Tenofovir|tenofovir|mesh-list
92683583|NCT03279146|Antiviral Agents|antiviral agents|mesh-ancestor
92683584|NCT03279146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683587|NCT03279146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683588|NCT03279146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683589|NCT03279146|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92683590|NCT03279146|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92683591|NCT00442052|Aspirin|aspirin|mesh-list
92683592|NCT00442052|Omeprazole|omeprazole|mesh-list
92683593|NCT00442052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683594|NCT00442052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683595|NCT00442052|Analgesics|analgesics|mesh-ancestor
92683596|NCT00442052|Sensory System Agents|sensory system agents|mesh-ancestor
92683597|NCT00442052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683598|NCT00442052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683599|NCT00442052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683600|NCT00442052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683601|NCT00442052|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92683602|NCT00442052|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92683603|NCT00442052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683604|NCT00442052|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92683605|NCT00442052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683606|NCT00442052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683607|NCT00442052|Antipyretics|antipyretics|mesh-ancestor
92683608|NCT00442052|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92683609|NCT00442052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683610|NCT00442052|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92683611|NCT00477282|Topotecan|topotecan|mesh-list
92683612|NCT00477282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92683613|NCT00477282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92683614|NCT00477282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683615|NCT00477282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683616|NCT00477282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683617|NCT00439530|Oseltamivir|oseltamivir|mesh-list
92683618|NCT00439530|Probenecid|probenecid|mesh-list
92683619|NCT00439530|Antiviral Agents|antiviral agents|mesh-ancestor
92683620|NCT00439530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683621|NCT00439530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683622|NCT00439530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683623|NCT00439530|Uricosuric Agents|uricosuric agents|mesh-ancestor
92683624|NCT00439530|Gout Suppressants|gout suppressants|mesh-ancestor
92683625|NCT00439530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683626|NCT00442325|Atorvastatin|atorvastatin|mesh-list
92683627|NCT00442325|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92683628|NCT00442325|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92683629|NCT00442325|Antimetabolites|antimetabolites|mesh-ancestor
92683630|NCT00442325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683631|NCT00442325|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92683632|NCT00442325|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92606794|NCT00403325|Growth Substances|growth substances|mesh-ancestor
92606795|NCT00403325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606796|NCT00403325|Growth Inhibitors|growth inhibitors|mesh-ancestor
92606797|NCT00403325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606798|NCT04725747|Midazolam|midazolam|mesh-list
92606799|NCT04725747|Ketamine|ketamine|mesh-list
92606800|NCT04725747|Analgesics|analgesics|mesh-ancestor
92606801|NCT04725747|Sensory System Agents|sensory system agents|mesh-ancestor
92683633|NCT00442325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683634|NCT00477516|Dialysis Solutions|dialysis solutions|mesh-list
92683635|NCT00477516|Calcium|calcium|mesh-list
92683636|NCT00477516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92683637|NCT00477516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683638|NCT00477516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92683639|NCT00477711|Capecitabine|capecitabine|mesh-list
92683640|NCT00477711|Cetuximab|cetuximab|mesh-list
92683641|NCT00477711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683642|NCT00477711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683643|NCT00477711|Antimetabolites|antimetabolites|mesh-ancestor
92683644|NCT00477711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683645|NCT00477711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683646|NCT00442403|Chloroquine|chloroquine|mesh-list
92683647|NCT00442403|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92683648|NCT00442403|Amebicides|amebicides|mesh-ancestor
92683649|NCT00442403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92683650|NCT00442403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92683651|NCT00442403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683652|NCT00442403|Antimalarials|antimalarials|mesh-ancestor
92683653|NCT00442403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683654|NCT00442403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683655|NCT00442403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92683656|NCT00442403|Immunologic Factors|immunologic factors|mesh-ancestor
92683657|NCT00477789|Allopurinol|allopurinol|mesh-list
92683661|NCT00477789|Gout Suppressants|gout suppressants|mesh-ancestor
92683663|NCT00477789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92683664|NCT00477789|Antioxidants|antioxidants|mesh-ancestor
92683665|NCT00477789|Protective Agents|protective agents|mesh-ancestor
92683666|NCT00477789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683667|NCT00442481|Escitalopram|escitalopram|mesh-list
92683668|NCT00442481|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92683669|NCT00442481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92683670|NCT00442481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683671|NCT00442481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683672|NCT00442481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683673|NCT00442481|Serotonin Agents|serotonin agents|mesh-ancestor
92683674|NCT00442481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683675|NCT00442637|Bevacizumab|bevacizumab|mesh-list
92683676|NCT00442637|Capecitabine|capecitabine|mesh-list
92683677|NCT00442637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683678|NCT00442637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683679|NCT00442637|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92683680|NCT00442637|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92683681|NCT00442637|Growth Substances|growth substances|mesh-ancestor
92683682|NCT00442637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683683|NCT00442637|Growth Inhibitors|growth inhibitors|mesh-ancestor
92683684|NCT00442637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683685|NCT00442637|Antimetabolites|antimetabolites|mesh-ancestor
92683686|NCT00442637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683687|NCT00442676|Celecoxib|celecoxib|mesh-list
92683688|NCT00442676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683689|NCT00442676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683690|NCT00442676|Analgesics|analgesics|mesh-ancestor
92683691|NCT00442676|Sensory System Agents|sensory system agents|mesh-ancestor
92683692|NCT00442676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683693|NCT00442676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683694|NCT00442676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683695|NCT00442676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683696|NCT00442676|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92606802|NCT04725747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606803|NCT04725747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041398|NCT02409810|Dexmedetomidine|dexmedetomidine|mesh-list
92683697|NCT00442676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683698|NCT00442676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683699|NCT00442676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683701|NCT00477945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683702|NCT00477945|Antimetabolites|antimetabolites|mesh-ancestor
92683703|NCT00477945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683704|NCT00477945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683705|NCT00442793|Epoetin Alfa|epoetin alfa|mesh-list
92683706|NCT00442793|Hematinics|hematinics|mesh-ancestor
92683707|NCT00442832|Vancomycin|vancomycin|mesh-list
92683708|NCT00442832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92683709|NCT00442832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683710|NCT00477984|Ethanol|ethanol|mesh-list
92683711|NCT00477984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92683712|NCT00477984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683713|NCT00477984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683714|NCT00477984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683715|NCT00478101|Fentanyl|fentanyl|mesh-list
92683716|NCT00478101|Oxycodone|oxycodone|mesh-list
92683717|NCT00478101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92683718|NCT00478101|Narcotics|narcotics|mesh-ancestor
92683719|NCT00478101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683720|NCT00478101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683721|NCT00478101|Analgesics|analgesics|mesh-ancestor
92683722|NCT00478101|Sensory System Agents|sensory system agents|mesh-ancestor
92683723|NCT00478101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683724|NCT00478101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92683725|NCT00478101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92683726|NCT00478101|Anesthetics, General|anesthetics, general|mesh-ancestor
92683727|NCT00478101|Anesthetics|anesthetics|mesh-ancestor
92683728|NCT00440076|Bortezomib|bortezomib|mesh-list
92683729|NCT00440076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683730|NCT00443105|Tacrolimus|tacrolimus|mesh-list
92683734|NCT00443105|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92103474|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
92683735|NCT00443105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683736|NCT00443105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683737|NCT00443144|Hormones|hormones|mesh-list
92683738|NCT00443144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683739|NCT00443144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683740|NCT00440154|Ezetimibe|ezetimibe|mesh-list
92683741|NCT00440154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92683742|NCT00440154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92683743|NCT00440154|Antimetabolites|antimetabolites|mesh-ancestor
92683744|NCT00440154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683745|NCT00440154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92683746|NCT00478374|Doxorubicin|doxorubicin|mesh-list
92683747|NCT00478374|Sorafenib|sorafenib|mesh-list
92683748|NCT00478374|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92683749|NCT00478374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683750|NCT00478374|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92683751|NCT00478374|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92683752|NCT00478374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683753|NCT00478374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683754|NCT00478374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92683755|NCT00478452|Cyclophosphamide|cyclophosphamide|mesh-list
92683756|NCT00478452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683757|NCT00478452|Immunologic Factors|immunologic factors|mesh-ancestor
92683758|NCT00478452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683759|NCT00478452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683760|NCT00478452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92683761|NCT00478452|Alkylating Agents|alkylating agents|mesh-ancestor
92683762|NCT00478452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683763|NCT00478452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683764|NCT00478452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92683765|NCT03279549|Mitogens|mitogens|mesh-list
92683766|NCT03279549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92683767|NCT03279549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606804|NCT04725747|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92606805|NCT04725747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92606806|NCT04725747|Anesthetics, General|anesthetics, general|mesh-ancestor
92606807|NCT04725747|Anesthetics|anesthetics|mesh-ancestor
92606808|NCT04725747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606809|NCT04725747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92014242|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92683768|NCT03271983|Metronidazole|metronidazole|mesh-list
92683769|NCT03271983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683770|NCT03271983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92683771|NCT03271983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92683772|NCT03271983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92683773|NCT00443222|Infliximab|infliximab|mesh-list
92683774|NCT00443222|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92683775|NCT00443222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683776|NCT00443222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92683777|NCT00443222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683778|NCT00443222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683779|NCT00440349|Tamoxifen|tamoxifen|mesh-list
92683780|NCT00440349|Prednisone|prednisone|mesh-list
92683781|NCT00440349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683782|NCT00440349|Glucocorticoids|glucocorticoids|mesh-ancestor
92683783|NCT00440349|Hormones|hormones|mesh-ancestor
92683784|NCT00440349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683785|NCT00440349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683786|NCT00440349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92683787|NCT00440349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683788|NCT00440349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92683789|NCT00440349|Hormone Antagonists|hormone antagonists|mesh-ancestor
92683790|NCT00440349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92683791|NCT00440349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92683792|NCT00440349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92683793|NCT00443339|Darbepoetin alfa|darbepoetin alfa|mesh-list
92683794|NCT00443339|Hematinics|hematinics|mesh-ancestor
92683795|NCT04700228|Dexmedetomidine|dexmedetomidine|mesh-list
92683796|NCT04700228|Bupivacaine|bupivacaine|mesh-list
92683797|NCT04700228|Anesthetics, Local|anesthetics, local|mesh-ancestor
92683798|NCT04700228|Anesthetics|anesthetics|mesh-ancestor
92683799|NCT04700228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683800|NCT04700228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683801|NCT04700228|Sensory System Agents|sensory system agents|mesh-ancestor
92683816|NCT00440427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683817|NCT00440427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683818|NCT00440427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683819|NCT00440427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92683820|NCT00440427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92683821|NCT03278522|Ramosetron|ramosetron|mesh-list
92683822|NCT03278522|Antiemetics|antiemetics|mesh-ancestor
92683823|NCT03278522|Autonomic Agents|autonomic agents|mesh-ancestor
92683824|NCT03278522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683825|NCT03278522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683826|NCT03278522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683827|NCT03278522|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92683828|NCT03278522|Serotonin Agents|serotonin agents|mesh-ancestor
92683829|NCT03278522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683830|NCT03278522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683831|NCT00440622|Gemcitabine|gemcitabine|mesh-list
92683832|NCT00440622|Capecitabine|capecitabine|mesh-list
92683833|NCT00440622|Trastuzumab|trastuzumab|mesh-list
92683834|NCT00440622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92683835|NCT00440622|Antimetabolites|antimetabolites|mesh-ancestor
92683836|NCT00440622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683837|NCT00440622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683838|NCT00440622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683839|NCT00440661|Diacerein|diacerein|mesh-list
92683840|NCT00440661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683841|NCT03278444|Trimetazidine|trimetazidine|mesh-list
92683842|NCT03278444|Vasodilator Agents|vasodilator agents|mesh-ancestor
92683843|NCT00440739|Etoricoxib|etoricoxib|mesh-list
92606810|NCT04725747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92606811|NCT04725747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92606812|NCT04725747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606813|NCT04725747|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92606814|NCT04725747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92041556|NCT00565851|Docetaxel|docetaxel|mesh-list
92683844|NCT00440739|Flavoxate|flavoxate|mesh-list
92683845|NCT00440739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683846|NCT00440739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683847|NCT00440739|Analgesics|analgesics|mesh-ancestor
92683848|NCT00440739|Sensory System Agents|sensory system agents|mesh-ancestor
92683849|NCT00440739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683850|NCT00440739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683851|NCT00440739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683852|NCT00440739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683853|NCT00440739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92683854|NCT00440739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683855|NCT00440739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683856|NCT00440739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683857|NCT00440739|Parasympatholytics|parasympatholytics|mesh-ancestor
92683858|NCT00440739|Autonomic Agents|autonomic agents|mesh-ancestor
92683859|NCT00440739|Urological Agents|urological agents|mesh-ancestor
92683860|NCT00443573|Protein C|protein c|mesh-list
92683861|NCT00443573|Anticoagulants|anticoagulants|mesh-list
92683862|NCT00443573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92683864|NCT00443573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683866|NCT00478764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683867|NCT00478764|Glucocorticoids|glucocorticoids|mesh-ancestor
92683868|NCT00478764|Hormones|hormones|mesh-ancestor
92683869|NCT00478764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683870|NCT00478764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683871|NCT00440778|Abciximab|abciximab|mesh-list
92683872|NCT00440778|Anticoagulants|anticoagulants|mesh-ancestor
92683873|NCT00440778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92683874|NCT03278405|Avelumab|avelumab|mesh-list
92683875|NCT03278405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683876|NCT03278405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683877|NCT00443612|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92683878|NCT00443612|Irbesartan|irbesartan|mesh-list
92683879|NCT00443612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92683880|NCT00443612|Diuretics|diuretics|mesh-ancestor
92683881|NCT00443612|Natriuretic Agents|natriuretic agents|mesh-ancestor
92683882|NCT00443612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683883|NCT00443612|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92683884|NCT00443612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683885|NCT00443612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683886|NCT00443612|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92683887|NCT00443612|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92683889|NCT00443690|Diuretics|diuretics|mesh-ancestor
92683890|NCT00443690|Natriuretic Agents|natriuretic agents|mesh-ancestor
92683891|NCT00443690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683892|NCT00440895|Abciximab|abciximab|mesh-list
92683893|NCT00440895|Anticoagulants|anticoagulants|mesh-ancestor
92683894|NCT00440895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92683895|NCT00440973|Bevacizumab|bevacizumab|mesh-list
92683896|NCT00440973|Interleukin-2|interleukin-2|mesh-list
92683897|NCT00440973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683898|NCT00440973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683899|NCT00440973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92683900|NCT00440973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92683901|NCT00440973|Growth Substances|growth substances|mesh-ancestor
92683902|NCT00440973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683903|NCT00440973|Growth Inhibitors|growth inhibitors|mesh-ancestor
92683904|NCT00440973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683905|NCT00440973|Analgesics|analgesics|mesh-ancestor
92683906|NCT00440973|Sensory System Agents|sensory system agents|mesh-ancestor
92683907|NCT00440973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683908|NCT00443924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92606815|NCT04725747|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92606816|NCT04725747|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92606817|NCT04725747|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92683909|NCT00443924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92683911|NCT00441051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683912|NCT00441051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683913|NCT00441051|Analgesics|analgesics|mesh-ancestor
92683914|NCT00441051|Sensory System Agents|sensory system agents|mesh-ancestor
92683915|NCT00441051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683916|NCT00441051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683917|NCT00441051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683918|NCT00441051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683919|NCT00441051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683920|NCT00441051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683921|NCT00441051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683922|NCT00443963|Esomeprazole|esomeprazole|mesh-list
92683923|NCT00443963|Ranitidine|ranitidine|mesh-list
92683924|NCT00443963|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92683925|NCT00443963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683926|NCT00443963|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92683927|NCT00443963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683928|NCT00443963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683929|NCT00443963|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92683930|NCT00443963|Histamine Antagonists|histamine antagonists|mesh-ancestor
92683931|NCT00443963|Histamine Agents|histamine agents|mesh-ancestor
92683932|NCT00443963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683933|NCT00443963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683934|NCT00441207|Ascorbic Acid|ascorbic acid|mesh-list
92683935|NCT00441207|Antioxidants|antioxidants|mesh-ancestor
92327586|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683943|NCT00444041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683944|NCT00444041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92683945|NCT00444041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92683946|NCT00444041|Growth Substances|growth substances|mesh-ancestor
92683947|NCT00444041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683948|NCT00444041|Growth Inhibitors|growth inhibitors|mesh-ancestor
92683949|NCT00441246|Phenylpropanolamine|phenylpropanolamine|mesh-list
92683950|NCT00441246|Pseudoephedrine|pseudoephedrine|mesh-list
92683951|NCT00441246|Ephedrine|ephedrine|mesh-list
92683952|NCT00441246|Guaifenesin|guaifenesin|mesh-list
92683953|NCT00441246|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92683954|NCT00441246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92683955|NCT00441246|Autonomic Agents|autonomic agents|mesh-ancestor
92683956|NCT00441246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683957|NCT00441246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683958|NCT00441246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92103701|NCT05565274|Pentazocine|pentazocine|mesh-list
92683959|NCT00441246|Respiratory System Agents|respiratory system agents|mesh-ancestor
92683960|NCT00441246|Nasal Decongestants|nasal decongestants|mesh-ancestor
92683961|NCT00441246|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92683962|NCT00441246|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92683963|NCT00441246|Sympathomimetics|sympathomimetics|mesh-ancestor
92683964|NCT00441246|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683965|NCT00441246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683966|NCT00441246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683967|NCT00441246|Expectorants|expectorants|mesh-ancestor
92683968|NCT00441246|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92683969|NCT00441246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92683970|NCT00441246|Appetite Depressants|appetite depressants|mesh-ancestor
92683971|NCT00441246|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92683972|NCT00478959|Lenalidomide|lenalidomide|mesh-list
92683973|NCT00478959|Immunologic Factors|immunologic factors|mesh-ancestor
92683974|NCT00478959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683975|NCT00478959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92683976|NCT00478959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92683977|NCT00478959|Growth Substances|growth substances|mesh-ancestor
92683978|NCT00478959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92683979|NCT00478959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683980|NCT00444236|Esomeprazole|esomeprazole|mesh-list
92683981|NCT00444236|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92683982|NCT00444236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683983|NCT00444236|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92014254|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
92606818|NCT04725747|GABA Modulators|gaba modulators|mesh-ancestor
92606819|NCT04725747|GABA Agents|gaba agents|mesh-ancestor
92606820|NCT03546686|Nivolumab|nivolumab|mesh-list
92606821|NCT03546686|Ipilimumab|ipilimumab|mesh-list
92606822|NCT03546686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606823|NCT03546686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606824|NCT03546686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92606825|NCT03546686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606826|NCT04725942|Posaconazole|posaconazole|mesh-list
92606827|NCT04725942|Antifungal Agents|antifungal agents|mesh-ancestor
92606828|NCT04725942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606829|NCT04725942|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92606830|NCT04725942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92606831|NCT04725942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92606832|NCT04725942|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92606833|NCT04725942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92606834|NCT04725942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606835|NCT04725942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606836|NCT04725942|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92606837|NCT04725942|Hormone Antagonists|hormone antagonists|mesh-ancestor
92606838|NCT04725942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92606839|NCT04725942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606840|NCT01249261|Risedronic Acid|risedronic acid|mesh-list
92606841|NCT01249261|Etidronic Acid|etidronic acid|mesh-list
92683984|NCT00444236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683985|NCT00444236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683986|NCT00478998|Tamsulosin|tamsulosin|mesh-list
92683987|NCT00478998|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92683988|NCT00478998|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92683989|NCT00478998|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92683990|NCT00478998|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683991|NCT00478998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683992|NCT00478998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683993|NCT00478998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683994|NCT00478998|Urological Agents|urological agents|mesh-ancestor
92683995|NCT02957279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92683996|NCT02957279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683997|NCT00479076|Aflibercept|aflibercept|mesh-list
92683998|NCT00479076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92683999|NCT00479076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684000|NCT00479076|Growth Substances|growth substances|mesh-ancestor
92684001|NCT00479076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091557|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
92684026|NCT00441597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92684027|NCT00441597|Antimetabolites|antimetabolites|mesh-ancestor
92684028|NCT00441597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684029|NCT00441597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92606842|NCT01249261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92606843|NCT01249261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014279|NCT04986319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684030|NCT00441597|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92684031|NCT00441597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684032|NCT00479193|Bacitracin|bacitracin|mesh-list
92103778|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
92684033|NCT00479193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92684034|NCT00479193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684035|NCT00479193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684036|NCT03278015|Paclitaxel|paclitaxel|mesh-list
92684037|NCT03278015|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92684038|NCT03278015|Gemcitabine|gemcitabine|mesh-list
92684039|NCT03278015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92684040|NCT03278015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684041|NCT03278015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92684042|NCT03278015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92684043|NCT03278015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92684044|NCT03278015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684045|NCT03278015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92684046|NCT03278015|Antimetabolites|antimetabolites|mesh-ancestor
92684047|NCT00444314|Sunitinib|sunitinib|mesh-list
92684048|NCT00444314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684049|NCT00444314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684050|NCT00444314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684051|NCT00444314|Growth Substances|growth substances|mesh-ancestor
92684057|NCT02274051|Kinetin|kinetin|mesh-list
92684058|NCT02274051|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92684059|NCT02274051|Growth Substances|growth substances|mesh-ancestor
92684060|NCT02274051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684061|NCT00444470|Tranexamic Acid|tranexamic acid|mesh-list
92684062|NCT00444470|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92684063|NCT00444470|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92684064|NCT00444470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684065|NCT00444470|Hemostatics|hemostatics|mesh-ancestor
92684066|NCT00444470|Coagulants|coagulants|mesh-ancestor
92684067|NCT00444548|Reboxetine|reboxetine|mesh-list
92684068|NCT00444548|Antidepressive Agents|antidepressive agents|mesh-ancestor
92684069|NCT00444548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684070|NCT00444548|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92684071|NCT00444548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92684072|NCT00444548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684073|NCT00444548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684074|NCT00444548|Adrenergic Agents|adrenergic agents|mesh-ancestor
92684075|NCT00444548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684076|NCT00444548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684077|NCT00444665|Travoprost|travoprost|mesh-list
92684078|NCT00444665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92684079|NCT04699643|Pembrolizumab|pembrolizumab|mesh-list
92684080|NCT04699643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92684081|NCT04699643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684082|NCT04699643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92684083|NCT04699643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684084|NCT02274090|Metformin|metformin|mesh-list
92684085|NCT02274090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92684086|NCT02274090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684087|NCT00479661|Dexmedetomidine|dexmedetomidine|mesh-list
92684088|NCT00479661|Propofol|propofol|mesh-list
92684089|NCT00479661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92684090|NCT00479661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684091|NCT00479661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684092|NCT00479661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92684093|NCT00479661|Analgesics|analgesics|mesh-ancestor
92684094|NCT00479661|Sensory System Agents|sensory system agents|mesh-ancestor
92684095|NCT00479661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684096|NCT00479661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92684097|NCT00479661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92684098|NCT00479661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92684099|NCT00479661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92684100|NCT00479661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684101|NCT00479661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606844|NCT01249261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606845|NCT01249261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92606846|NCT01249261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606847|NCT01249261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92606848|NCT03890952|Bevacizumab|bevacizumab|mesh-list
92606849|NCT03890952|Nivolumab|nivolumab|mesh-list
92606850|NCT03890952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92606851|NCT03890952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606852|NCT03890952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606853|NCT03890952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92606854|NCT03890952|Growth Substances|growth substances|mesh-ancestor
92014292|NCT05001919|Mitogens|mitogens|mesh-list
92684102|NCT00479661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92684103|NCT00479661|Anesthetics, General|anesthetics, general|mesh-ancestor
92684104|NCT00479661|Anesthetics|anesthetics|mesh-ancestor
92684105|NCT04700670|Platelet Factor 4|platelet factor 4|mesh-list
92684106|NCT04700670|Coagulants|coagulants|mesh-ancestor
92103855|NCT01516684|Narcotics|narcotics|mesh-ancestor
92684107|NCT00441870|Folic Acid|folic acid|mesh-list
92684108|NCT00441870|Vitamin B Complex|vitamin b complex|mesh-list
92684109|NCT00441870|Hematinics|hematinics|mesh-ancestor
92684110|NCT00441870|Vitamins|vitamins|mesh-ancestor
92684111|NCT00441870|Micronutrients|micronutrients|mesh-ancestor
92684112|NCT00441870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684113|NCT04700592|Ketamine|ketamine|mesh-list
92684114|NCT04700592|Gabapentin|gabapentin|mesh-list
92684115|NCT04700592|Analgesics|analgesics|mesh-ancestor
92684116|NCT04700592|Sensory System Agents|sensory system agents|mesh-ancestor
92684117|NCT04700592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684118|NCT04700592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684119|NCT04700592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92684120|NCT04700592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92684121|NCT04700592|Anesthetics, General|anesthetics, general|mesh-ancestor
92684124|NCT04700592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92684126|NCT04700592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684127|NCT04700592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684128|NCT04700592|Anticonvulsants|anticonvulsants|mesh-ancestor
92684129|NCT04700592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92684130|NCT04700592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92684131|NCT04700592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684132|NCT04700592|Antimanic Agents|antimanic agents|mesh-ancestor
92684133|NCT00441909|UC-781|uc-781|mesh-list
92684134|NCT00441909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92684135|NCT00441909|Antiviral Agents|antiviral agents|mesh-ancestor
92684136|NCT00441909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684137|NCT00445016|Anesthetics|anesthetics|mesh-list
92684138|NCT00445016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684139|NCT00445016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684140|NCT00445055|Droperidol|droperidol|mesh-list
92684141|NCT00445055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92684142|NCT00445055|Antiemetics|antiemetics|mesh-ancestor
92684143|NCT00445055|Autonomic Agents|autonomic agents|mesh-ancestor
92684144|NCT00445055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684145|NCT00445055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684146|NCT00445055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92684147|NCT00445055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92684148|NCT00445055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92684149|NCT00445055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684150|NCT00445055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684151|NCT00445055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92684152|NCT00445055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92684153|NCT00445055|Dopamine Agents|dopamine agents|mesh-ancestor
92684154|NCT00445055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684155|NCT00445055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684156|NCT00479739|Fluticasone|fluticasone|mesh-list
92606855|NCT03890952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606856|NCT03890952|Growth Inhibitors|growth inhibitors|mesh-ancestor
92606857|NCT03890952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92606858|NCT03890952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684158|NCT00479739|Budesonide|budesonide|mesh-list
92684159|NCT00479739|Formoterol Fumarate|formoterol fumarate|mesh-list
92684160|NCT00479739|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92684161|NCT00479739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684162|NCT00479739|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92684163|NCT00479739|Autonomic Agents|autonomic agents|mesh-ancestor
92684164|NCT00479739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684165|NCT00479739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684166|NCT00479739|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92684167|NCT00479739|Respiratory System Agents|respiratory system agents|mesh-ancestor
92684168|NCT00479739|Dermatologic Agents|dermatologic agents|mesh-ancestor
92684169|NCT00479739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92684170|NCT00479739|Glucocorticoids|glucocorticoids|mesh-ancestor
92684171|NCT00479739|Hormones|hormones|mesh-ancestor
92684172|NCT00479739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684173|NCT00479739|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92684174|NCT00479739|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92684175|NCT00479739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92684176|NCT00479739|Adrenergic Agents|adrenergic agents|mesh-ancestor
92684177|NCT00479739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684178|NCT00479739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684179|NCT00445094|Vancomycin|vancomycin|mesh-list
92684180|NCT00445094|Imipenem|imipenem|mesh-list
92684181|NCT00445094|Amikacin|amikacin|mesh-list
92684182|NCT00445094|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92684183|NCT00445094|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92684184|NCT00445094|Cilastatin|cilastatin|mesh-list
92684185|NCT00445094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684186|NCT00445094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684187|NCT00445094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684188|NCT00445094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92684189|NCT00445094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684190|NCT00445094|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92684191|NCT00479778|Bazedoxifene|bazedoxifene|mesh-list
92684192|NCT00479778|Estrogens|estrogens|mesh-list
92684193|NCT00479778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92684194|NCT00479778|Hormones|hormones|mesh-ancestor
92091749|NCT03407404|Midazolam|midazolam|mesh-list
92684196|NCT00479778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684197|NCT00479778|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92684198|NCT00479778|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92684199|NCT00479778|Hormone Antagonists|hormone antagonists|mesh-ancestor
92684200|NCT00479778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92684201|NCT00442026|Gemcitabine|gemcitabine|mesh-list
92684202|NCT00442026|Docetaxel|docetaxel|mesh-list
92684203|NCT00442026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92684204|NCT00442026|Antimetabolites|antimetabolites|mesh-ancestor
92684205|NCT00442026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684206|NCT00442026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684207|NCT00442026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92684208|NCT00442026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92684209|NCT00442026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92684210|NCT00479895|Chrysarobin|chrysarobin|mesh-list
92684211|NCT00479895|HBOC 201|hboc 201|mesh-list
92684212|NCT00479895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92684213|NCT00479895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92684214|NCT00479895|Analgesics|analgesics|mesh-ancestor
92684215|NCT00479895|Sensory System Agents|sensory system agents|mesh-ancestor
92684216|NCT00479895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684217|NCT00479895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684218|NCT00479895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684219|NCT00479895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684220|NCT00479895|Blood Substitutes|blood substitutes|mesh-ancestor
92684221|NCT00445250|Calcipotriene|calcipotriene|mesh-list
92684222|NCT00445250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92684223|NCT03279120|Tenofovir|tenofovir|mesh-list
92684224|NCT03279120|Levonorgestrel|levonorgestrel|mesh-list
92606860|NCT03868722|Acalabrutinib|acalabrutinib|mesh-list
92684225|NCT03279120|Antiviral Agents|antiviral agents|mesh-ancestor
92684226|NCT03279120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684227|NCT03279120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92684228|NCT03279120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92684229|NCT03279120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684230|NCT03279120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684231|NCT03279120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92684232|NCT03279120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92684233|NCT03279120|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92684234|NCT03279120|Contraceptive Agents|contraceptive agents|mesh-ancestor
92684235|NCT03279120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92684236|NCT03279120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684237|NCT03279120|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92684238|NCT03279120|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92684239|NCT03279120|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92684240|NCT00479934|Imatinib Mesylate|imatinib mesylate|mesh-list
92684241|NCT00479934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684242|NCT00479934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684243|NCT00479934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684244|NCT00479934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684245|NCT00442182|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92684246|NCT00442182|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92684247|NCT00442182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684248|NCT00442182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684249|NCT03274700|Tamsulosin|tamsulosin|mesh-list
92684250|NCT03274700|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92684251|NCT03274700|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92684252|NCT03274700|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92684253|NCT03274700|Adrenergic Agents|adrenergic agents|mesh-ancestor
92684254|NCT03274700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684255|NCT03274700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684256|NCT03274700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684257|NCT03274700|Urological Agents|urological agents|mesh-ancestor
92684258|NCT00442221|Naproxen|naproxen|mesh-list
92684259|NCT00442221|Sumatriptan|sumatriptan|mesh-list
92684260|NCT00442221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92684261|NCT00442221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92684262|NCT00442221|Analgesics|analgesics|mesh-ancestor
92684263|NCT00442221|Sensory System Agents|sensory system agents|mesh-ancestor
92684264|NCT00442221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684265|NCT00442221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684266|NCT00442221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684274|NCT00442221|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92684275|NCT00442221|Serotonin Agents|serotonin agents|mesh-ancestor
92684276|NCT00442221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684278|NCT00454259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92684279|NCT00454259|Narcotics|narcotics|mesh-ancestor
92684280|NCT00454259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684281|NCT00454259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684282|NCT00454259|Analgesics|analgesics|mesh-ancestor
92684283|NCT00454259|Sensory System Agents|sensory system agents|mesh-ancestor
92684284|NCT00454259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684285|NCT00454259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92684286|NCT00454259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92684287|NCT00454259|Anesthetics, General|anesthetics, general|mesh-ancestor
92684288|NCT00454259|Anesthetics|anesthetics|mesh-ancestor
92684289|NCT03278808|Azithromycin|azithromycin|mesh-list
92684290|NCT03278808|Chloroquine|chloroquine|mesh-list
92684291|NCT03278808|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92684292|NCT03278808|Atovaquone|atovaquone|mesh-list
92684293|NCT03278808|Proguanil|proguanil|mesh-list
92684294|NCT03278808|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92684295|NCT03278808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92368846|NCT01842672|Mitoxantrone|mitoxantrone|mesh-list
92684296|NCT03278808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684297|NCT03278808|Amebicides|amebicides|mesh-ancestor
92684298|NCT03278808|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92684299|NCT03278808|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92684300|NCT03278808|Antimalarials|antimalarials|mesh-ancestor
92684301|NCT03278808|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684302|NCT03278808|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92684303|NCT03278808|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92684304|NCT03278808|Analgesics|analgesics|mesh-ancestor
92606861|NCT03868722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606862|NCT03761511|Niacinamide|niacinamide|mesh-list
92606863|NCT03761511|Niacin|niacin|mesh-list
92606864|NCT03761511|Nicotinic Acids|nicotinic acids|mesh-list
92606865|NCT03761511|Vitamin B Complex|vitamin b complex|mesh-ancestor
92606866|NCT03761511|Vitamins|vitamins|mesh-ancestor
92684305|NCT03278808|Sensory System Agents|sensory system agents|mesh-ancestor
92684306|NCT03278808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684307|NCT03278808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684308|NCT03278808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684309|NCT03278808|Filaricides|filaricides|mesh-ancestor
92684310|NCT03278808|Antinematodal Agents|antinematodal agents|mesh-ancestor
92684311|NCT03278808|Anthelmintics|anthelmintics|mesh-ancestor
92684312|NCT03278808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684313|NCT03278808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684314|NCT03278808|Antimetabolites|antimetabolites|mesh-ancestor
92684315|NCT00480090|Cytarabine|cytarabine|mesh-list
92684316|NCT00480090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92684317|NCT00480090|Antimetabolites|antimetabolites|mesh-ancestor
92684318|NCT00480090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684319|NCT00480090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684320|NCT00480090|Antiviral Agents|antiviral agents|mesh-ancestor
92684321|NCT00480090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684322|NCT00480090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684323|NCT00480090|Immunologic Factors|immunologic factors|mesh-ancestor
92684324|NCT00480090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684325|NCT00454883|Ziprasidone|ziprasidone|mesh-list
92684326|NCT00454883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92684327|NCT00454883|Serotonin Agents|serotonin agents|mesh-ancestor
92684328|NCT00454883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684329|NCT00454883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684330|NCT00454883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684331|NCT00454883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92684332|NCT00454883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92104072|NCT01578772|Telmisartan|telmisartan|mesh-list
92684333|NCT00454883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684335|NCT00454883|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92684336|NCT00454883|Dopamine Agents|dopamine agents|mesh-ancestor
92684338|NCT03278652|Sensory System Agents|sensory system agents|mesh-ancestor
92684339|NCT03278652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684340|NCT03278652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684341|NCT00454961|Lumefantrine|lumefantrine|mesh-list
92684342|NCT00454961|Artemether|artemether|mesh-list
92684343|NCT00454961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92684344|NCT00454961|Antimalarials|antimalarials|mesh-ancestor
92684345|NCT00454961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92684346|NCT00454961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92684347|NCT00454961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684348|NCT00455039|Lapatinib|lapatinib|mesh-list
92684349|NCT00455039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684350|NCT00455039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684351|NCT00455039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684352|NCT00455039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684353|NCT00480207|Folic Acid|folic acid|mesh-list
92684354|NCT00480207|Vitamin B Complex|vitamin b complex|mesh-list
92684355|NCT00480207|Hematinics|hematinics|mesh-ancestor
92684356|NCT00480207|Vitamins|vitamins|mesh-ancestor
92684357|NCT00480207|Micronutrients|micronutrients|mesh-ancestor
92368866|NCT01034592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684358|NCT00480207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684359|NCT00442455|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92684360|NCT00442455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684361|NCT00442455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684362|NCT00442455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684363|NCT00442455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684364|NCT02956655|Insulin|insulin|mesh-list
92684365|NCT02956655|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92684366|NCT02956655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92684367|NCT02956655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684368|NCT00480246|Perphenazine|perphenazine|mesh-list
92684369|NCT00480246|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92684370|NCT00480246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92684371|NCT00480246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606867|NCT03761511|Micronutrients|micronutrients|mesh-ancestor
92606868|NCT03761511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606869|NCT03761511|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92684372|NCT00480246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684373|NCT00480246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684374|NCT00480246|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92684375|NCT00480246|Dopamine Agents|dopamine agents|mesh-ancestor
92684376|NCT00480246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684377|NCT00480246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684378|NCT00455117|Parecoxib|parecoxib|mesh-list
92684379|NCT00455117|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92684380|NCT00455117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92684381|NCT00455117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684382|NCT00455117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684383|NCT00455117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92684384|NCT00455117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92684385|NCT00455117|Analgesics|analgesics|mesh-ancestor
92684386|NCT00455117|Sensory System Agents|sensory system agents|mesh-ancestor
92684387|NCT00455117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684388|NCT00455117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684389|NCT00455117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684390|NCT00455117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684391|NCT00442494|Hydrocortisone|hydrocortisone|mesh-list
92684392|NCT00442494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684393|NCT03274427|Trimetazidine|trimetazidine|mesh-list
92684394|NCT03274427|Vasodilator Agents|vasodilator agents|mesh-ancestor
92684395|NCT00455234|Promethazine|promethazine|mesh-list
92684396|NCT00455234|Diphenhydramine|diphenhydramine|mesh-list
92684397|NCT00455234|Haloperidol|haloperidol|mesh-list
92684398|NCT00455234|Haloperidol decanoate|haloperidol decanoate|mesh-list
92684399|NCT00455234|Antiemetics|antiemetics|mesh-ancestor
92684400|NCT00455234|Autonomic Agents|autonomic agents|mesh-ancestor
92684401|NCT00455234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684402|NCT00455234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684403|NCT00455234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92684404|NCT00455234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92684405|NCT00455234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92684406|NCT00455234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684407|NCT00455234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684408|NCT00455234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92684409|NCT00455234|Dopamine Agents|dopamine agents|mesh-ancestor
92684410|NCT00455234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684411|NCT00455234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327587|NCT01568918|Urological Agents|urological agents|mesh-ancestor
92684422|NCT00455234|Anesthetics|anesthetics|mesh-ancestor
92684423|NCT00455234|Sensory System Agents|sensory system agents|mesh-ancestor
92684424|NCT00480363|Dexamethasone|dexamethasone|mesh-list
92684425|NCT00480363|Lenalidomide|lenalidomide|mesh-list
92684426|NCT00480363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684427|NCT00480363|Antiemetics|antiemetics|mesh-ancestor
92684428|NCT00480363|Autonomic Agents|autonomic agents|mesh-ancestor
92684429|NCT00480363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684430|NCT00480363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684431|NCT00480363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92684432|NCT00480363|Glucocorticoids|glucocorticoids|mesh-ancestor
92684433|NCT00480363|Hormones|hormones|mesh-ancestor
92684434|NCT00480363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684435|NCT00480363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92684436|NCT00480363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684437|NCT00480363|Immunologic Factors|immunologic factors|mesh-ancestor
92684438|NCT00480363|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684439|NCT00480363|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684440|NCT00480363|Growth Substances|growth substances|mesh-ancestor
92684441|NCT00480363|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684442|NCT00455390|Psychotropic Drugs|psychotropic drugs|mesh-list
92684443|NCT00442845|Atorvastatin|atorvastatin|mesh-list
92684444|NCT00442845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92684445|NCT00442845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92684446|NCT00442845|Antimetabolites|antimetabolites|mesh-ancestor
92684447|NCT00442845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684448|NCT00442845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92684449|NCT00442845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92684450|NCT00442845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606870|NCT03761511|Antimetabolites|antimetabolites|mesh-ancestor
92606871|NCT03761511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684451|NCT00455507|Istradefylline|istradefylline|mesh-list
92684452|NCT00455507|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92684453|NCT00455507|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92684454|NCT00455507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92684455|NCT00455507|Purinergic Agents|purinergic agents|mesh-ancestor
92684456|NCT00455507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684457|NCT00455507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684458|NCT00455507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684459|NCT00480402|Progesterone|progesterone|mesh-list
92684460|NCT00480402|Progestins|progestins|mesh-ancestor
92684461|NCT00480402|Hormones|hormones|mesh-ancestor
92684462|NCT00480402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684463|NCT00480402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684464|NCT00455585|Lamivudine|lamivudine|mesh-list
92684465|NCT00455585|Nevirapine|nevirapine|mesh-list
92684466|NCT00455585|Stavudine|stavudine|mesh-list
92684467|NCT00455585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92684468|NCT00455585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92684469|NCT00455585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684470|NCT00455585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684471|NCT00455585|Antiviral Agents|antiviral agents|mesh-ancestor
92684472|NCT00455585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684473|NCT00455585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92684474|NCT00455585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92684475|NCT00455585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92684476|NCT00455585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92092039|NCT01592708|Droperidol|droperidol|mesh-list
92684483|NCT00455897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92684484|NCT00455897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104220|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684486|NCT00455897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684487|NCT00455897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684488|NCT00455936|Gefitinib|gefitinib|mesh-list
92684489|NCT00455936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684490|NCT00455936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684491|NCT00455936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684492|NCT00455936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684493|NCT00443235|Thalidomide|thalidomide|mesh-list
92684494|NCT00443235|Prednisone|prednisone|mesh-list
92684495|NCT00443235|Melphalan|melphalan|mesh-list
92684496|NCT00443235|Bortezomib|bortezomib|mesh-list
92684497|NCT00443235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684498|NCT00443235|Glucocorticoids|glucocorticoids|mesh-ancestor
92684499|NCT00443235|Hormones|hormones|mesh-ancestor
92684500|NCT00443235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684501|NCT00443235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684502|NCT00443235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92684503|NCT00443235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684504|NCT00443235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92684505|NCT00443235|Alkylating Agents|alkylating agents|mesh-ancestor
92684506|NCT00443235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684507|NCT00443235|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92684508|NCT00443235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684509|NCT00443235|Immunologic Factors|immunologic factors|mesh-ancestor
92684510|NCT00443235|Leprostatic Agents|leprostatic agents|mesh-ancestor
92684511|NCT00443235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684512|NCT00443235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684513|NCT00443235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684514|NCT00443235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684515|NCT00443235|Growth Substances|growth substances|mesh-ancestor
92684516|NCT00443235|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684517|NCT04700943|Anesthetics|anesthetics|mesh-list
92684518|NCT04700943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684519|NCT04700943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684520|NCT00456248|Ribavirin|ribavirin|mesh-list
92684521|NCT00456248|Interferon alfacon-1|interferon alfacon-1|mesh-list
92684522|NCT00456248|Antimetabolites|antimetabolites|mesh-ancestor
92684523|NCT00456248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684524|NCT00456248|Antiviral Agents|antiviral agents|mesh-ancestor
92684525|NCT00456248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606872|NCT03761511|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92606873|NCT03761511|Vasodilator Agents|vasodilator agents|mesh-ancestor
92606874|NCT02952092|Darbepoetin alfa|darbepoetin alfa|mesh-list
92684526|NCT00480558|Vaccines|vaccines|mesh-list
92684527|NCT00480558|Immunologic Factors|immunologic factors|mesh-ancestor
92684528|NCT00480558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684529|NCT04700709|Mycophenolic Acid|mycophenolic acid|mesh-list
92684530|NCT04700709|Sirolimus|sirolimus|mesh-list
92684531|NCT04700709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92684532|NCT04700709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684533|NCT04700709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92684534|NCT04700709|Antitubercular Agents|antitubercular agents|mesh-ancestor
92684535|NCT04700709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684536|NCT04700709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684537|NCT04700709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684538|NCT04700709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684539|NCT04700709|Antifungal Agents|antifungal agents|mesh-ancestor
92684540|NCT04700709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684541|NCT04700709|Immunologic Factors|immunologic factors|mesh-ancestor
92684542|NCT04700709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684543|NCT04698317|Mitogens|mitogens|mesh-list
92684544|NCT04698317|Mitosis Modulators|mitosis modulators|mesh-ancestor
92684545|NCT04698317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684546|NCT04700475|Citric Acid|citric acid|mesh-list
92684573|NCT00456482|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92684574|NCT00456482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684575|NCT00456482|Glucocorticoids|glucocorticoids|mesh-ancestor
92684576|NCT00456482|Hormones|hormones|mesh-ancestor
92684577|NCT00456482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684578|NCT00456482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684579|NCT00480675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92684580|NCT00480675|Methylprednisolone|methylprednisolone|mesh-list
92684581|NCT00480675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92684582|NCT00480675|Prednisolone|prednisolone|mesh-list
92684583|NCT00480675|Prednisolone acetate|prednisolone acetate|mesh-list
92684584|NCT00480675|Bupivacaine|bupivacaine|mesh-list
92684585|NCT00480675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92684586|NCT00480675|Prednisolone phosphate|prednisolone phosphate|mesh-list
92684587|NCT00480675|Anesthetics, Local|anesthetics, local|mesh-ancestor
92684588|NCT00480675|Anesthetics|anesthetics|mesh-ancestor
92684589|NCT00480675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684590|NCT00480675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684591|NCT00480675|Sensory System Agents|sensory system agents|mesh-ancestor
92684592|NCT00480675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684593|NCT00480675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684594|NCT00480675|Antiemetics|antiemetics|mesh-ancestor
92092184|NCT01702298|Incretins|incretins|mesh-ancestor
92684607|NCT00456560|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92684608|NCT00456560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684609|NCT00456560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684610|NCT00456560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684611|NCT00456560|Serotonin Agents|serotonin agents|mesh-ancestor
92684612|NCT00456560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684613|NCT00456560|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92684614|NCT00456560|Antidepressive Agents|antidepressive agents|mesh-ancestor
92684615|NCT00456560|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684616|NCT00456560|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92684617|NCT00456560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92684618|NCT00456560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684619|NCT00456560|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92684620|NCT00456560|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92684621|NCT00456560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684622|NCT00456560|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92684623|NCT00456560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92684624|NCT00456677|Minocycline|minocycline|mesh-list
92684625|NCT00456677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684626|NCT00456677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684627|NCT00456716|Sorafenib|sorafenib|mesh-list
92684628|NCT00456716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684629|NCT00456716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684630|NCT00456716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684631|NCT00456716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042294|NCT01545271|Anesthetics|anesthetics|mesh-ancestor
92684632|NCT04700397|Nitroglycerin|nitroglycerin|mesh-list
92684633|NCT04700397|Vasodilator Agents|vasodilator agents|mesh-ancestor
92684635|NCT00456794|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92684636|NCT00456794|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92684637|NCT00456794|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92684638|NCT00456794|Purinergic Agents|purinergic agents|mesh-ancestor
92684639|NCT00456794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684640|NCT00456794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684641|NCT00456794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684642|NCT00456833|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92684643|NCT00456833|Everolimus|everolimus|mesh-list
92684644|NCT00456833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684645|NCT00456833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684646|NCT00456833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684647|NCT00456833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684648|NCT00456833|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92684649|NCT00456833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684650|NCT00456833|Immunologic Factors|immunologic factors|mesh-ancestor
92684651|NCT00456833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684652|NCT00456872|Lidocaine|lidocaine|mesh-list
92684653|NCT00456872|Anesthetics, Local|anesthetics, local|mesh-ancestor
92684654|NCT00456872|Anesthetics|anesthetics|mesh-ancestor
92684655|NCT00456872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684656|NCT00456872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684659|NCT00456872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92684660|NCT00456872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92684661|NCT00456872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92684662|NCT00456872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684663|NCT00456872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684665|NCT00480753|Vasodilator Agents|vasodilator agents|mesh-ancestor
92684666|NCT04700046|Mexiletine|mexiletine|mesh-list
92684667|NCT04700046|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92684668|NCT04700046|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92684669|NCT04700046|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92684670|NCT04700046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684671|NCT04700046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684672|NCT00457067|Ranibizumab|ranibizumab|mesh-list
92684673|NCT00457067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684674|NCT00457067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684675|NCT00457067|Growth Substances|growth substances|mesh-ancestor
92684676|NCT00457067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684677|NCT00457067|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684678|NCT00457067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684679|NCT00480870|Donepezil|donepezil|mesh-list
92684680|NCT00480870|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92684681|NCT00480870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684682|NCT00480870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684683|NCT00480870|Cholinergic Agents|cholinergic agents|mesh-ancestor
92684684|NCT00480870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684685|NCT00480870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684686|NCT00480870|Nootropic Agents|nootropic agents|mesh-ancestor
92684687|NCT00457106|Risperidone|risperidone|mesh-list
92684688|NCT00457106|Paroxetine|paroxetine|mesh-list
92684689|NCT00457106|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92684690|NCT00457106|Serotonin Agents|serotonin agents|mesh-ancestor
92684691|NCT00457106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684692|NCT00457106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684693|NCT00457106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684694|NCT00457106|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92684695|NCT00457106|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92684696|NCT00457106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684697|NCT00457106|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92684698|NCT00457106|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92684699|NCT00457106|Dopamine Agents|dopamine agents|mesh-ancestor
92684700|NCT00457106|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92684701|NCT00457106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92684702|NCT00457106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684703|NCT00457106|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92684704|NCT00457106|Antidepressive Agents|antidepressive agents|mesh-ancestor
92684705|NCT00457106|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92606875|NCT02952092|Hematinics|hematinics|mesh-ancestor
92606876|NCT00139152|Omalizumab|omalizumab|mesh-list
92606877|NCT00139152|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92606878|NCT00139152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92684706|NCT00457106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92684707|NCT00457106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684708|NCT00457145|Ranibizumab|ranibizumab|mesh-list
92684709|NCT00457145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684710|NCT00457145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684711|NCT00457145|Growth Substances|growth substances|mesh-ancestor
92684712|NCT00457145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684713|NCT00457145|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684714|NCT00457145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684715|NCT00457223|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92684716|NCT00457223|Hemostatics|hemostatics|mesh-ancestor
92684717|NCT00457223|Coagulants|coagulants|mesh-ancestor
92684718|NCT00443508|Everolimus|everolimus|mesh-list
92684719|NCT00443508|Tacrolimus|tacrolimus|mesh-list
92684720|NCT00443508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684721|NCT00443508|Immunologic Factors|immunologic factors|mesh-ancestor
92684722|NCT00443508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684723|NCT00443508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92684724|NCT00443508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684725|NCT00443508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684726|NCT00443508|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92684727|NCT00443508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684735|NCT00457340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92684736|NCT00457340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684738|NCT03278379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92684739|NCT03278379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684740|NCT02956538|Thalidomide|thalidomide|mesh-list
92684741|NCT02956538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684742|NCT02956538|Immunologic Factors|immunologic factors|mesh-ancestor
92684743|NCT02956538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684744|NCT02956538|Leprostatic Agents|leprostatic agents|mesh-ancestor
92684745|NCT02956538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684746|NCT02956538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684747|NCT02956538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684748|NCT02956538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684749|NCT02956538|Growth Substances|growth substances|mesh-ancestor
92684750|NCT02956538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684751|NCT02956538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684752|NCT00457652|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92684753|NCT00457652|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92684754|NCT00457652|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92684755|NCT00457652|Antimetabolites|antimetabolites|mesh-ancestor
92684756|NCT00457652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684757|NCT00457652|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92684758|NCT00457652|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92684759|NCT00457652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684760|NCT00457769|Donepezil|donepezil|mesh-list
92684761|NCT00457769|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92684762|NCT00457769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684763|NCT00457769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684764|NCT00457769|Cholinergic Agents|cholinergic agents|mesh-ancestor
92684765|NCT00457769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684766|NCT00457769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684767|NCT00457769|Nootropic Agents|nootropic agents|mesh-ancestor
92684768|NCT00457808|Sirolimus|sirolimus|mesh-list
92684769|NCT00457808|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684770|NCT00457808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684771|NCT00457808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92684772|NCT00457808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684773|NCT00457808|Antifungal Agents|antifungal agents|mesh-ancestor
92684774|NCT00457808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684775|NCT00457808|Immunologic Factors|immunologic factors|mesh-ancestor
92684776|NCT00457808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684777|NCT00481143|Deferasirox|deferasirox|mesh-list
92684778|NCT00481143|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92684779|NCT00481143|Chelating Agents|chelating agents|mesh-ancestor
92104518|NCT04129437|Ibuprofen|ibuprofen|mesh-list
92684780|NCT00481143|Sequestering Agents|sequestering agents|mesh-ancestor
92606879|NCT00139152|Respiratory System Agents|respiratory system agents|mesh-ancestor
92606880|NCT02824523|Aspirin|aspirin|mesh-list
92014307|NCT02592551|Tremelimumab|tremelimumab|mesh-list
92684781|NCT00481143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684782|NCT00457964|Everolimus|everolimus|mesh-list
92684783|NCT00457964|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92684784|NCT00457964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684785|NCT00457964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684786|NCT00457964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684787|NCT00457964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684788|NCT00457964|Immunologic Factors|immunologic factors|mesh-ancestor
92684789|NCT00457964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684790|NCT00457964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684791|NCT00458042|Treprostinil|treprostinil|mesh-list
92684792|NCT00458042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92684793|NCT00458081|Rimonabant|rimonabant|mesh-list
92684794|NCT00458081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92684798|NCT00458081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684800|NCT00458081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684801|NCT00458081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684802|NCT00481182|Ritonavir|ritonavir|mesh-list
92684803|NCT00481182|Fosamprenavir|fosamprenavir|mesh-list
92684804|NCT00481182|Methadone|methadone|mesh-list
92684805|NCT00481182|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92684806|NCT00481182|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92684807|NCT00481182|Protease Inhibitors|protease inhibitors|mesh-ancestor
92684808|NCT00481182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684809|NCT00481182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684810|NCT00481182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92684811|NCT00481182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92684812|NCT00481182|Antiviral Agents|antiviral agents|mesh-ancestor
92684813|NCT00481182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684814|NCT00481182|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92684815|NCT00481182|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92684816|NCT00481182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92684817|NCT00481182|Narcotics|narcotics|mesh-ancestor
92684818|NCT00481182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684819|NCT00481182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684820|NCT00481182|Analgesics|analgesics|mesh-ancestor
92684821|NCT00481182|Sensory System Agents|sensory system agents|mesh-ancestor
92684822|NCT00481182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684823|NCT00481182|Antitussive Agents|antitussive agents|mesh-ancestor
92684824|NCT00481182|Respiratory System Agents|respiratory system agents|mesh-ancestor
92684825|NCT00443937|Mycophenolic Acid|mycophenolic acid|mesh-list
92684826|NCT00443937|Everolimus|everolimus|mesh-list
92684827|NCT00443937|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92684828|NCT00443937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684829|NCT00443937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684830|NCT00443937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684831|NCT00443937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684832|NCT00443937|Immunologic Factors|immunologic factors|mesh-ancestor
92684833|NCT00443937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684834|NCT00443937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684835|NCT00443937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92684836|NCT00443937|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92684837|NCT00443937|Antitubercular Agents|antitubercular agents|mesh-ancestor
92684838|NCT00443937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684839|NCT00443937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684840|NCT00458315|Paclitaxel|paclitaxel|mesh-list
92684841|NCT00458315|Bevacizumab|bevacizumab|mesh-list
92684842|NCT00458315|Gemcitabine|gemcitabine|mesh-list
92684843|NCT00458315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92684844|NCT00458315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684845|NCT00458315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92684846|NCT00458315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92684847|NCT00458315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92684848|NCT00458315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684849|NCT00458315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92684850|NCT00458315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684851|NCT00458315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684852|NCT00458315|Growth Substances|growth substances|mesh-ancestor
92684853|NCT00458315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369006|NCT05821751|Nivolumab|nivolumab|mesh-list
92606881|NCT02824523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92606882|NCT02824523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92606884|NCT02824523|Sensory System Agents|sensory system agents|mesh-ancestor
92684854|NCT00458315|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684855|NCT00458315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92684856|NCT00458315|Antimetabolites|antimetabolites|mesh-ancestor
92684857|NCT00444015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92684858|NCT00444015|Dasatinib|dasatinib|mesh-list
92684859|NCT00444015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684860|NCT00444015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684861|NCT00444015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684862|NCT00444015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684863|NCT00458510|Fentanyl|fentanyl|mesh-list
92684864|NCT00458510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92684874|NCT00458510|Anesthetics|anesthetics|mesh-ancestor
92684875|NCT00444132|Clopidogrel|clopidogrel|mesh-list
92684876|NCT00444132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92684877|NCT00444132|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92684878|NCT00444132|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92684879|NCT00444132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92684880|NCT00444132|Purinergic Agents|purinergic agents|mesh-ancestor
92684881|NCT00444132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684882|NCT00444132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684883|NCT00444132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684884|NCT00444171|Insulin|insulin|mesh-list
92684885|NCT00444171|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92684886|NCT00444171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92684887|NCT00444171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684888|NCT00458900|Moxifloxacin|moxifloxacin|mesh-list
92684889|NCT00458900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92684890|NCT00458900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684891|NCT00458900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92684892|NCT00458900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92684893|NCT00458900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684894|NCT00458900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684895|NCT00458900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684896|NCT00488163|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92684897|NCT00488163|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92684898|NCT00488163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92684899|NCT00488163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684900|NCT00488163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684901|NCT00488163|Adrenergic Agents|adrenergic agents|mesh-ancestor
92684902|NCT00488163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684903|NCT00488163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684904|NCT00459173|Rimonabant|rimonabant|mesh-list
92684905|NCT00459173|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92684906|NCT00459173|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92684907|NCT00459173|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92684908|NCT00459173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684909|NCT00459173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684910|NCT00459173|Hormones|hormones|mesh-ancestor
92684911|NCT00459173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684912|NCT00459173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684913|NCT00444249|Dipivefrin|dipivefrin|mesh-list
92684914|NCT00444249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92684915|NCT00444249|Adrenergic Agents|adrenergic agents|mesh-ancestor
92684916|NCT00444249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684917|NCT00444249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684918|NCT00444249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684919|NCT00459407|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92369032|NCT05821478|Rifampin|rifampin|mesh-list
92684920|NCT00459407|Antioxidants|antioxidants|mesh-ancestor
92684921|NCT00459407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684922|NCT00459407|Protective Agents|protective agents|mesh-ancestor
92684923|NCT00459407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684924|NCT00459407|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92684925|NCT00459407|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92684926|NCT00459407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606885|NCT02824523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606886|NCT02824523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606887|NCT02824523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606888|NCT02824523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684927|NCT00459407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92684937|NCT00459485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684938|NCT00459485|Dermatologic Agents|dermatologic agents|mesh-ancestor
92684939|NCT00459563|Vitamin D|vitamin d|mesh-list
92684940|NCT00459563|Calcitriol|calcitriol|mesh-list
92684941|NCT00459563|Vitamins|vitamins|mesh-ancestor
92684942|NCT00459563|Micronutrients|micronutrients|mesh-ancestor
92684943|NCT00459563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684944|NCT00459563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92684945|NCT00459563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92684946|NCT00459563|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92684947|NCT00459563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684948|NCT00459563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684949|NCT00459563|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92684950|NCT01242384|Silicon|silicon|mesh-list
92684951|NCT01242384|Trace Elements|trace elements|mesh-ancestor
92684952|NCT01242384|Micronutrients|micronutrients|mesh-ancestor
92684953|NCT01242384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684954|NCT00488436|Cyclosporine|cyclosporine|mesh-list
92684955|NCT00488436|Cyclosporins|cyclosporins|mesh-list
92684956|NCT00488436|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92684957|NCT00488436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684958|NCT00488436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684959|NCT00488436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684960|NCT00488436|Immunologic Factors|immunologic factors|mesh-ancestor
92684961|NCT00488436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684962|NCT00488436|Antifungal Agents|antifungal agents|mesh-ancestor
92684963|NCT00488436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92684964|NCT00488436|Dermatologic Agents|dermatologic agents|mesh-ancestor
92684965|NCT00488436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684966|NCT00488436|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92684967|NCT00459719|Tacrolimus|tacrolimus|mesh-list
92684968|NCT00459719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92684969|NCT00459719|Immunologic Factors|immunologic factors|mesh-ancestor
92684970|NCT00459719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684971|NCT00459719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92684972|NCT00459719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684973|NCT00459719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684974|NCT00495183|Biperiden|biperiden|mesh-list
92684975|NCT00495183|Caffeine|caffeine|mesh-list
92684976|NCT00495183|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92684977|NCT00495183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684978|NCT00495183|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92684979|NCT00495183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684980|NCT00495183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684981|NCT00495183|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92684982|NCT00495183|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92684983|NCT00495183|Purinergic Agents|purinergic agents|mesh-ancestor
92684984|NCT00495183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684985|NCT00495183|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92684986|NCT00495183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92684987|NCT00495183|Parasympatholytics|parasympatholytics|mesh-ancestor
92684988|NCT00495183|Autonomic Agents|autonomic agents|mesh-ancestor
92684989|NCT00495183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684990|NCT00495183|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92684991|NCT00495183|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92684992|NCT00495183|Cholinergic Agents|cholinergic agents|mesh-ancestor
92684993|NCT00488670|Escitalopram|escitalopram|mesh-list
92684994|NCT00488670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92685007|NCT00459836|Tubulin Modulators|tubulin modulators|mesh-ancestor
92685008|NCT00459836|Antimitotic Agents|antimitotic agents|mesh-ancestor
92685009|NCT00459836|Mitosis Modulators|mitosis modulators|mesh-ancestor
92685010|NCT00488709|Cytarabine|cytarabine|mesh-list
92685011|NCT00488709|Fludarabine|fludarabine|mesh-list
92685012|NCT00488709|Topotecan|topotecan|mesh-list
92685013|NCT00488709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685014|NCT00488709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685015|NCT00488709|Antimetabolites|antimetabolites|mesh-ancestor
92606889|NCT02824523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92606890|NCT02824523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92606891|NCT02824523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606892|NCT02824523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92685016|NCT00488709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685017|NCT00488709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685018|NCT00488709|Immunologic Factors|immunologic factors|mesh-ancestor
92685019|NCT00488709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685020|NCT00488709|Antiviral Agents|antiviral agents|mesh-ancestor
92685021|NCT00488709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685022|NCT00488709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92685023|NCT00488709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92685024|NCT00488709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685025|NCT00459992|Betahistine|betahistine|mesh-list
92685026|NCT00459992|Vasodilator Agents|vasodilator agents|mesh-ancestor
92685027|NCT00459992|Histamine Agonists|histamine agonists|mesh-ancestor
92685028|NCT00459992|Histamine Agents|histamine agents|mesh-ancestor
92685029|NCT00459992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685030|NCT00459992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685031|NCT00459992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685032|NCT00495339|Levofloxacin|levofloxacin|mesh-list
92685033|NCT00495339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92685034|NCT00495339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685035|NCT00495339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685036|NCT00495339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92685037|NCT00495339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92685038|NCT00495339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685039|NCT00495339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685040|NCT00495339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685041|NCT00495339|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92685042|NCT00495339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685043|NCT00460148|Ropinirole|ropinirole|mesh-list
92685044|NCT00460148|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92685045|NCT00460148|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92685046|NCT00460148|Dopamine Agonists|dopamine agonists|mesh-ancestor
92685047|NCT00460148|Dopamine Agents|dopamine agents|mesh-ancestor
92685048|NCT00460148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685049|NCT00460148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685050|NCT00460148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685051|NCT00460226|Lamotrigine|lamotrigine|mesh-list
92685052|NCT00460226|Anticonvulsants|anticonvulsants|mesh-ancestor
92685053|NCT00460226|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92685054|NCT00460226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685055|NCT00460226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092627|NCT00895791|Umirolimus|umirolimus|mesh-list
92685062|NCT00460226|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92685063|NCT00495378|Epoetin Alfa|epoetin alfa|mesh-list
92685064|NCT00495378|Hematinics|hematinics|mesh-ancestor
92685065|NCT00460304|Pramlintide|pramlintide|mesh-list
92685066|NCT00460304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685067|NCT00460304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685068|NCT00460382|Ritonavir|ritonavir|mesh-list
92685069|NCT00460382|Darunavir|darunavir|mesh-list
92685070|NCT00460382|Raltegravir Potassium|raltegravir potassium|mesh-list
92685071|NCT00460382|Enfuvirtide|enfuvirtide|mesh-list
92685072|NCT00460382|Etravirine|etravirine|mesh-list
92685073|NCT00460382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92685074|NCT00460382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92685075|NCT00460382|Protease Inhibitors|protease inhibitors|mesh-ancestor
92685076|NCT00460382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104824|NCT01900002|Sorafenib|sorafenib|mesh-list
92685077|NCT00460382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685078|NCT00460382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92685079|NCT00460382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92685080|NCT00460382|Antiviral Agents|antiviral agents|mesh-ancestor
92685081|NCT00460382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685082|NCT00460382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92685083|NCT00460382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685084|NCT00460382|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92685085|NCT00460382|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92606893|NCT02824523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92606894|NCT02824523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606895|NCT02824523|Antipyretics|antipyretics|mesh-ancestor
92606896|NCT02736422|Xenon|xenon|mesh-list
92606897|NCT02736422|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92606898|NCT02736422|Anesthetics, General|anesthetics, general|mesh-ancestor
92606899|NCT02736422|Anesthetics|anesthetics|mesh-ancestor
92685086|NCT00460382|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92685087|NCT00460382|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92685088|NCT00460382|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92685089|NCT00460382|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92685090|NCT01242579|Maraviroc|maraviroc|mesh-list
92685091|NCT01242579|Dapivirine|dapivirine|mesh-list
92685092|NCT01242579|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92685093|NCT01242579|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92685094|NCT01242579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685095|NCT01242579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92685096|NCT01242579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92685097|NCT01242579|Antiviral Agents|antiviral agents|mesh-ancestor
92685098|NCT01242579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685099|NCT01242579|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92685100|NCT00460499|Insulin|insulin|mesh-list
92685101|NCT00460499|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685102|NCT00460499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685103|NCT00495573|Acyclovir|acyclovir|mesh-list
92685104|NCT00495573|Antiviral Agents|antiviral agents|mesh-ancestor
92685105|NCT00495573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685106|NCT00488787|Ketamine|ketamine|mesh-list
92685107|NCT00488787|Analgesics|analgesics|mesh-ancestor
92685108|NCT00488787|Sensory System Agents|sensory system agents|mesh-ancestor
92685109|NCT00488787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685110|NCT00488787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685111|NCT00488787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92685112|NCT00488787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92685113|NCT00488787|Anesthetics, General|anesthetics, general|mesh-ancestor
92685114|NCT00488787|Anesthetics|anesthetics|mesh-ancestor
92685115|NCT00488787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685116|NCT00488787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92685117|NCT00488787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92685118|NCT00488787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685119|NCT00488787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685120|NCT00460616|Cabergoline|cabergoline|mesh-list
92685121|NCT00460616|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92685122|NCT00460616|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92685123|NCT00460616|Dopamine Agonists|dopamine agonists|mesh-ancestor
92685124|NCT00460616|Dopamine Agents|dopamine agents|mesh-ancestor
92685146|NCT00460733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92685147|NCT00460733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92685149|NCT00460733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685150|NCT00460733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104896|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
92685151|NCT00460850|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92685152|NCT00460850|Antiviral Agents|antiviral agents|mesh-ancestor
92685153|NCT00460850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685154|NCT00495729|Simvastatin|simvastatin|mesh-list
92685155|NCT00495729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92685156|NCT00495729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92685157|NCT00495729|Antimetabolites|antimetabolites|mesh-ancestor
92685158|NCT00495729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685159|NCT00495729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92685160|NCT00495729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92685161|NCT00495729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685162|NCT00460928|Immunoglobulins|immunoglobulins|mesh-list
92685163|NCT00460928|Antibodies|antibodies|mesh-list
92685164|NCT00460928|gamma-Globulins|gamma-globulins|mesh-list
92685165|NCT00460928|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92685166|NCT00460928|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92685167|NCT00460928|Immunologic Factors|immunologic factors|mesh-ancestor
92685168|NCT00460928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685169|NCT00461084|Clarithromycin|clarithromycin|mesh-list
92606900|NCT02736422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92606901|NCT02736422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606902|NCT03721497|Methyltestosterone|methyltestosterone|mesh-list
92606903|NCT03721497|Testosterone|testosterone|mesh-list
92606904|NCT03721497|Testosterone undecanoate|testosterone undecanoate|mesh-list
92606905|NCT03721497|Testosterone enanthate|testosterone enanthate|mesh-list
92606906|NCT03721497|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92685170|NCT00461084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685171|NCT00461084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685172|NCT00461084|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92685173|NCT00461084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685174|NCT00461084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685175|NCT00461084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92685176|NCT00461084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685192|NCT00105482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685193|NCT00105482|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92685194|NCT00105482|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92685195|NCT00105482|Sensory System Agents|sensory system agents|mesh-ancestor
92685197|NCT00496002|Clevudine|clevudine|mesh-list
92685198|NCT00496002|Antiviral Agents|antiviral agents|mesh-ancestor
92685199|NCT00496002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685200|NCT00496002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92685201|NCT00496002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92685202|NCT00496002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685203|NCT00496002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685204|NCT00489099|Vaccines|vaccines|mesh-list
92685205|NCT00489099|Immunologic Factors|immunologic factors|mesh-ancestor
92685206|NCT00489099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685207|NCT00496158|Adefovir|adefovir|mesh-list
92685208|NCT00496158|Clevudine|clevudine|mesh-list
92685209|NCT00496158|Antiviral Agents|antiviral agents|mesh-ancestor
92685210|NCT00496158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685211|NCT00496158|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92685212|NCT00496158|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92685213|NCT00496158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685214|NCT00496158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685215|NCT00489138|Ertapenem|ertapenem|mesh-list
92685216|NCT00489138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685217|NCT00489138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685218|NCT00461396|Interferons|interferons|mesh-list
92685219|NCT00461396|Interferon beta-1b|interferon beta-1b|mesh-list
92685220|NCT00461396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685221|NCT00461396|Antiviral Agents|antiviral agents|mesh-ancestor
92685222|NCT00461396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685223|NCT00461396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92685224|NCT00461396|Immunologic Factors|immunologic factors|mesh-ancestor
92685225|NCT00461396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104973|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
92685226|NCT01327651|Tenofovir|tenofovir|mesh-list
92685227|NCT01327651|Emtricitabine|emtricitabine|mesh-list
92685228|NCT01327651|Antiviral Agents|antiviral agents|mesh-ancestor
92685229|NCT01327651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685230|NCT01327651|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92685231|NCT01327651|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92685232|NCT01327651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685233|NCT01327651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685234|NCT01327651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92685235|NCT01327651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92685237|NCT00496275|Gemcitabine|gemcitabine|mesh-list
92685238|NCT00496275|Vinorelbine|vinorelbine|mesh-list
92327588|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
92685243|NCT00496275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92685244|NCT00496275|Tubulin Modulators|tubulin modulators|mesh-ancestor
92685245|NCT00496275|Antimitotic Agents|antimitotic agents|mesh-ancestor
92685246|NCT00496275|Mitosis Modulators|mitosis modulators|mesh-ancestor
92685247|NCT00591604|Vitamin D|vitamin d|mesh-list
92685248|NCT00591604|Vitamins|vitamins|mesh-ancestor
92685249|NCT00591604|Micronutrients|micronutrients|mesh-ancestor
92685250|NCT00591604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606907|NCT03721497|Androgens|androgens|mesh-ancestor
92606908|NCT03721497|Hormones|hormones|mesh-ancestor
92606909|NCT03721497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685251|NCT00591604|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92685252|NCT00591643|Epinephrine|epinephrine|mesh-list
92685253|NCT00591643|Racepinephrine|racepinephrine|mesh-list
92685254|NCT00591643|Epinephryl borate|epinephryl borate|mesh-list
92685255|NCT00591643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92685256|NCT00591643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92685257|NCT00591643|Adrenergic Agents|adrenergic agents|mesh-ancestor
92685258|NCT00591643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685259|NCT00591643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685260|NCT00591643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685261|NCT00591643|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92685262|NCT00591643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92685263|NCT00591643|Autonomic Agents|autonomic agents|mesh-ancestor
92685264|NCT00591643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685265|NCT00591643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92685266|NCT00591643|Respiratory System Agents|respiratory system agents|mesh-ancestor
92685267|NCT00591643|Mydriatics|mydriatics|mesh-ancestor
92685268|NCT00591643|Sympathomimetics|sympathomimetics|mesh-ancestor
92685269|NCT00591643|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92685270|NCT00461747|Thalidomide|thalidomide|mesh-list
92685271|NCT00461747|Dexamethasone|dexamethasone|mesh-list
92685272|NCT00461747|Dexamethasone acetate|dexamethasone acetate|mesh-list
92685273|NCT00461747|Bortezomib|bortezomib|mesh-list
92685274|NCT00461747|BB 1101|bb 1101|mesh-list
92685275|NCT00461747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685276|NCT00461747|Antiemetics|antiemetics|mesh-ancestor
92685277|NCT00461747|Autonomic Agents|autonomic agents|mesh-ancestor
92685278|NCT00461747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685279|NCT00461747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685280|NCT00461747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92685281|NCT00461747|Glucocorticoids|glucocorticoids|mesh-ancestor
92685282|NCT00461747|Hormones|hormones|mesh-ancestor
92685283|NCT00461747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685284|NCT00461747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92685285|NCT00461747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685286|NCT00461747|Protease Inhibitors|protease inhibitors|mesh-ancestor
92685287|NCT00461747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685288|NCT00461747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685289|NCT00461747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685290|NCT00461747|Immunologic Factors|immunologic factors|mesh-ancestor
92685291|NCT00461747|Leprostatic Agents|leprostatic agents|mesh-ancestor
92685292|NCT00461747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685293|NCT00461747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685294|NCT00461747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92685295|NCT00461747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92685296|NCT00461747|Growth Substances|growth substances|mesh-ancestor
92685297|NCT00461747|Growth Inhibitors|growth inhibitors|mesh-ancestor
92685298|NCT00461825|Cyclosporine|cyclosporine|mesh-list
92685299|NCT00461825|Mycophenolic Acid|mycophenolic acid|mesh-list
92685300|NCT00461825|Azathioprine|azathioprine|mesh-list
92685301|NCT00461825|Cyclosporins|cyclosporins|mesh-list
92685302|NCT00461825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685303|NCT00461825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685304|NCT00461825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685305|NCT00461825|Immunologic Factors|immunologic factors|mesh-ancestor
92685306|NCT00461825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685307|NCT00461825|Antifungal Agents|antifungal agents|mesh-ancestor
92685308|NCT00461825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685309|NCT00461825|Dermatologic Agents|dermatologic agents|mesh-ancestor
92685310|NCT00461825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92685314|NCT00461825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92685315|NCT00461825|Antitubercular Agents|antitubercular agents|mesh-ancestor
92685316|NCT00461825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685317|NCT00461825|Antimetabolites|antimetabolites|mesh-ancestor
92685318|NCT00461825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685319|NCT04433026|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92685320|NCT04433026|Natriuretic Agents|natriuretic agents|mesh-ancestor
92685321|NCT04433026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685322|NCT00489372|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
92685323|NCT00489372|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92606910|NCT03721497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606911|NCT03721497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92685324|NCT00489372|Protective Agents|protective agents|mesh-ancestor
92685325|NCT00489372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685326|NCT00489372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685327|NCT00461903|Perindopril|perindopril|mesh-list
92685328|NCT00461903|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92685329|NCT00461903|Protease Inhibitors|protease inhibitors|mesh-ancestor
92685330|NCT00461903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685331|NCT00461903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685332|NCT00461903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92685333|NCT00496392|Fentanyl|fentanyl|mesh-list
92685334|NCT00496392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92685335|NCT00496392|Narcotics|narcotics|mesh-ancestor
92685336|NCT00496392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685337|NCT00496392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685338|NCT00496392|Analgesics|analgesics|mesh-ancestor
92685339|NCT00496392|Sensory System Agents|sensory system agents|mesh-ancestor
92685340|NCT00496392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685341|NCT00496392|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92685342|NCT00496392|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92685343|NCT00496392|Anesthetics, General|anesthetics, general|mesh-ancestor
92685344|NCT00496392|Anesthetics|anesthetics|mesh-ancestor
92685345|NCT02893618|Diazoxide|diazoxide|mesh-list
92685346|NCT02893618|Choline|choline|mesh-list
92685347|NCT02893618|Lipotropic Agents|lipotropic agents|mesh-ancestor
92685348|NCT02893618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92685349|NCT02893618|Antimetabolites|antimetabolites|mesh-ancestor
92685350|NCT02893618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685351|NCT02893618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92685352|NCT02893618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92685353|NCT02893618|Nootropic Agents|nootropic agents|mesh-ancestor
92685354|NCT02893618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92685355|NCT02893618|Vasodilator Agents|vasodilator agents|mesh-ancestor
92685356|NCT00496665|Cyclophosphamide|cyclophosphamide|mesh-list
92685357|NCT00496665|Methotrexate|methotrexate|mesh-list
92685358|NCT00496665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685359|NCT00496665|Immunologic Factors|immunologic factors|mesh-ancestor
92685360|NCT00496665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685361|NCT00496665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92685362|NCT00496665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92685363|NCT00496665|Alkylating Agents|alkylating agents|mesh-ancestor
92685364|NCT00496665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685365|NCT00496665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685366|NCT00496665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92685367|NCT00496665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92685368|NCT00496665|Abortifacient Agents|abortifacient agents|mesh-ancestor
92685369|NCT00496665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92685370|NCT00496665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685371|NCT00496665|Antimetabolites|antimetabolites|mesh-ancestor
92685372|NCT00496665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92685373|NCT00496665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685374|NCT00496665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92685375|NCT00496665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92685376|NCT00496704|Gemcitabine|gemcitabine|mesh-list
92685377|NCT00496704|Capecitabine|capecitabine|mesh-list
92685378|NCT00496704|Oxaliplatin|oxaliplatin|mesh-list
92685379|NCT00496704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685380|NCT00496704|Antimetabolites|antimetabolites|mesh-ancestor
92685381|NCT00496704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685382|NCT00496704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685383|NCT00591916|Thrombin|thrombin|mesh-list
92685387|NCT00591916|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92685388|NCT00591916|Immunologic Factors|immunologic factors|mesh-ancestor
92685389|NCT00591916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685390|NCT00591916|Viscosupplements|viscosupplements|mesh-ancestor
92685391|NCT00591916|Protective Agents|protective agents|mesh-ancestor
92685392|NCT00462215|Vaccines|vaccines|mesh-list
92685393|NCT00462215|Immunologic Factors|immunologic factors|mesh-ancestor
92685394|NCT00462215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685395|NCT00462371|Insulin|insulin|mesh-list
92685396|NCT00462371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685397|NCT00462371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685398|NCT00497016|Atorvastatin|atorvastatin|mesh-list
92606912|NCT03721497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331918|NCT04123717|Ibuprofen|ibuprofen|mesh-list
92606913|NCT03721497|Anabolic Agents|anabolic agents|mesh-ancestor
92606914|NCT03682029|Ascorbic Acid|ascorbic acid|mesh-list
92606915|NCT03682029|Vitamins|vitamins|mesh-ancestor
92606916|NCT03682029|Micronutrients|micronutrients|mesh-ancestor
92606917|NCT03682029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685399|NCT00497016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92685400|NCT00497016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92685401|NCT00497016|Antimetabolites|antimetabolites|mesh-ancestor
92685402|NCT00497016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685403|NCT00497016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92685404|NCT00497016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92685405|NCT00497016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685406|NCT00222872|Hormones|hormones|mesh-list
92685407|NCT00222872|Parathyroid Hormone|parathyroid hormone|mesh-list
92685408|NCT00222872|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92685409|NCT00222872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685410|NCT00222872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685411|NCT00222872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92685412|NCT00497172|Sirolimus|sirolimus|mesh-list
92685413|NCT00497172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685414|NCT00497172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685415|NCT00497172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92685416|NCT00497172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685417|NCT00497172|Antifungal Agents|antifungal agents|mesh-ancestor
92685418|NCT00497172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685419|NCT00497172|Immunologic Factors|immunologic factors|mesh-ancestor
92685420|NCT00497172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685421|NCT03273296|Amoxicillin|amoxicillin|mesh-list
92685422|NCT03273296|Azithromycin|azithromycin|mesh-list
92685423|NCT03273296|Vancomycin|vancomycin|mesh-list
92685424|NCT03273296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685425|NCT03273296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685426|NCT00497250|Gefitinib|gefitinib|mesh-list
92685427|NCT00497250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685428|NCT00497250|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685429|NCT00497250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685430|NCT00497250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685431|NCT00462878|Vancomycin|vancomycin|mesh-list
92685432|NCT00462878|Meropenem|meropenem|mesh-list
92685433|NCT00462878|Teicoplanin|teicoplanin|mesh-list
92685434|NCT00462878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685435|NCT00462878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685436|NCT00462956|Lapatinib|lapatinib|mesh-list
92685437|NCT00462956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685438|NCT00462956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685439|NCT00462956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685440|NCT00462956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685441|NCT00462995|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92685442|NCT00462995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685443|NCT00462995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685444|NCT00462995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685445|NCT00462995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685446|NCT00489528|Hormones|hormones|mesh-list
92685447|NCT00489528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685448|NCT00489528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685449|NCT00463073|Bevacizumab|bevacizumab|mesh-list
92685450|NCT00463073|Cetuximab|cetuximab|mesh-list
92685451|NCT00463073|Irinotecan|irinotecan|mesh-list
92685452|NCT00463073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92685453|NCT00463073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685454|NCT00463073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92685455|NCT00463073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92685456|NCT00463073|Growth Substances|growth substances|mesh-ancestor
92093009|NCT03626337|Thiamine|thiamine|mesh-list
92685461|NCT00463073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685462|NCT00463073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685463|NCT00463112|Sibutramine|sibutramine|mesh-list
92685464|NCT00463112|Antidepressive Agents|antidepressive agents|mesh-ancestor
92606918|NCT03682029|Antioxidants|antioxidants|mesh-ancestor
92606919|NCT03682029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606920|NCT03682029|Protective Agents|protective agents|mesh-ancestor
92606921|NCT00139230|Leucovorin|leucovorin|mesh-list
92685465|NCT00463112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92685466|NCT00463112|Appetite Depressants|appetite depressants|mesh-ancestor
92685467|NCT00463112|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92685468|NCT00223028|Sirolimus|sirolimus|mesh-list
92685469|NCT00223028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685470|NCT00223028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685471|NCT00223028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92685472|NCT00223028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685473|NCT00223028|Antifungal Agents|antifungal agents|mesh-ancestor
92685474|NCT00223028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685475|NCT00223028|Immunologic Factors|immunologic factors|mesh-ancestor
92685476|NCT00223028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685477|NCT00489645|Pramlintide|pramlintide|mesh-list
92685478|NCT00489645|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92685479|NCT00489645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685480|NCT00489645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685481|NCT00489645|Appetite Depressants|appetite depressants|mesh-ancestor
92685482|NCT00489645|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92685483|NCT00489645|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92685484|NCT00489645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685485|NCT00463268|Vitamin D|vitamin d|mesh-list
92685486|NCT00463268|Alendronate|alendronate|mesh-list
92685487|NCT00463268|Calcium|calcium|mesh-list
92685488|NCT00463268|Vitamins|vitamins|mesh-ancestor
92685489|NCT00463268|Micronutrients|micronutrients|mesh-ancestor
92685490|NCT00463268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685491|NCT00463268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92685492|NCT00463268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92685493|NCT00489723|Tamsulosin|tamsulosin|mesh-list
92685494|NCT00489723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92685495|NCT00489723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92685496|NCT00489723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92685497|NCT00489723|Adrenergic Agents|adrenergic agents|mesh-ancestor
92685498|NCT00489723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685499|NCT00489723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685500|NCT00489723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685501|NCT00489723|Urological Agents|urological agents|mesh-ancestor
92685502|NCT00105443|Sorafenib|sorafenib|mesh-list
92685503|NCT00105443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685504|NCT00105443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685505|NCT00105443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685506|NCT00105443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685507|NCT00489840|Hydrocortisone|hydrocortisone|mesh-list
92685508|NCT00489840|Anecortave|anecortave|mesh-list
92685509|NCT00489840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92369160|NCT05796570|Antimetabolites|antimetabolites|mesh-ancestor
92685510|NCT00489840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92685511|NCT00489840|Growth Substances|growth substances|mesh-ancestor
92685512|NCT00489840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685513|NCT00489840|Growth Inhibitors|growth inhibitors|mesh-ancestor
92685514|NCT00489840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685515|NCT00489840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685516|NCT00463502|Metformin|metformin|mesh-list
92685517|NCT00463502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685518|NCT00463502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685519|NCT00489996|Gemcitabine|gemcitabine|mesh-list
92685520|NCT00489996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685521|NCT00489996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685522|NCT00489996|Antimetabolites|antimetabolites|mesh-ancestor
92685523|NCT00489996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685524|NCT00463541|Solifenacin Succinate|solifenacin succinate|mesh-list
92685525|NCT00463541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92685526|NCT00463541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92685527|NCT00463541|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093083|NCT03705429|Paclitaxel|paclitaxel|mesh-list
92685529|NCT00463541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685530|NCT00463541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685532|NCT00490113|Pyridoxamine|pyridoxamine|mesh-list
92685533|NCT00490113|Vitamin B Complex|vitamin b complex|mesh-ancestor
92606922|NCT00139230|Ciprofloxacin|ciprofloxacin|mesh-list
92606923|NCT00139230|Fluorouracil|fluorouracil|mesh-list
92606924|NCT00139230|Docetaxel|docetaxel|mesh-list
92606925|NCT00139230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606926|NCT00139230|Antimetabolites|antimetabolites|mesh-ancestor
92606927|NCT00139230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685534|NCT00490113|Vitamins|vitamins|mesh-ancestor
92685535|NCT00490113|Micronutrients|micronutrients|mesh-ancestor
92685536|NCT00490113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685537|NCT01243203|Varenicline|varenicline|mesh-list
92685538|NCT01243203|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92685539|NCT01243203|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92685540|NCT01243203|Cholinergic Agents|cholinergic agents|mesh-ancestor
92685541|NCT01243203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685542|NCT01243203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685543|NCT01243203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685544|NCT00497328|Acetylcysteine|acetylcysteine|mesh-list
92685545|NCT00497328|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92685546|NCT00497328|Antiviral Agents|antiviral agents|mesh-ancestor
92685547|NCT00497328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685548|NCT00497328|Expectorants|expectorants|mesh-ancestor
92685549|NCT00497328|Respiratory System Agents|respiratory system agents|mesh-ancestor
92685550|NCT00497328|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92685551|NCT00497328|Antioxidants|antioxidants|mesh-ancestor
92685552|NCT00497328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685553|NCT00497328|Protective Agents|protective agents|mesh-ancestor
92685554|NCT00497328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685555|NCT00497328|Antidotes|antidotes|mesh-ancestor
92685556|NCT00466076|Glatiramer Acetate|glatiramer acetate|mesh-list
92685557|NCT00466076|(T,G)-A-L|(t,g)-a-l|mesh-list
92685558|NCT00466076|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92685559|NCT00466076|Immunologic Factors|immunologic factors|mesh-ancestor
92685560|NCT00466076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685561|NCT00466076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685562|NCT00466076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92685563|NCT00466154|Aspirin|aspirin|mesh-list
92685564|NCT00466154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92685565|NCT00466154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92685566|NCT00466154|Analgesics|analgesics|mesh-ancestor
92685567|NCT00466154|Sensory System Agents|sensory system agents|mesh-ancestor
92685568|NCT00466154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685569|NCT00466154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685570|NCT00466154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685571|NCT00466154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92685572|NCT00466154|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92685573|NCT00466154|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92685574|NCT00466154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685575|NCT00466154|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92685576|NCT00466154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92685577|NCT00466154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685578|NCT00466154|Antipyretics|antipyretics|mesh-ancestor
92685579|NCT00490308|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92685580|NCT00490308|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92685581|NCT00490308|Estradiol|estradiol|mesh-list
92685582|NCT00490308|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92685583|NCT00490308|Estrogens|estrogens|mesh-ancestor
92685584|NCT00490308|Hormones|hormones|mesh-ancestor
92685585|NCT00490308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685586|NCT00490308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685587|NCT00490308|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92685588|NCT00490308|Contraceptive Agents|contraceptive agents|mesh-ancestor
92685589|NCT00490308|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92685590|NCT00490308|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92685591|NCT00463736|Magnesium Sulfate|magnesium sulfate|mesh-list
92685592|NCT00463736|Analgesics|analgesics|mesh-ancestor
92685593|NCT00463736|Sensory System Agents|sensory system agents|mesh-ancestor
92685594|NCT00463736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685595|NCT00463736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685596|NCT00463736|Anesthetics|anesthetics|mesh-ancestor
92685597|NCT00463736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685598|NCT00463736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92606928|NCT00139230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606929|NCT00139230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606930|NCT00139230|Immunologic Factors|immunologic factors|mesh-ancestor
92685599|NCT00463736|Anticonvulsants|anticonvulsants|mesh-ancestor
92685600|NCT00463736|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92685601|NCT00463736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685603|NCT00463736|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92685604|NCT00463736|Tocolytic Agents|tocolytic agents|mesh-ancestor
92685605|NCT00463736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92685606|NCT00490464|Nicardipine|nicardipine|mesh-list
92685607|NCT00490464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92685608|NCT00490464|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92685609|NCT00490464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685610|NCT00490464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685611|NCT00490464|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92685612|NCT00490464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685613|NCT00490464|Vasodilator Agents|vasodilator agents|mesh-ancestor
92685614|NCT00497523|Beclomethasone|beclomethasone|mesh-list
92685615|NCT00497523|Albuterol|albuterol|mesh-list
92685616|NCT00497523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92685617|NCT00497523|Autonomic Agents|autonomic agents|mesh-ancestor
92685618|NCT00497523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685619|NCT00497523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685620|NCT00497523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92685621|NCT00497523|Respiratory System Agents|respiratory system agents|mesh-ancestor
92685622|NCT00497523|Tocolytic Agents|tocolytic agents|mesh-ancestor
92685623|NCT00497523|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92685624|NCT00497523|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92685625|NCT00497523|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92685626|NCT00497523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92685627|NCT00497523|Adrenergic Agents|adrenergic agents|mesh-ancestor
92685628|NCT00497523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685629|NCT00497523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685630|NCT00497523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685631|NCT00497523|Glucocorticoids|glucocorticoids|mesh-ancestor
92685632|NCT00497523|Hormones|hormones|mesh-ancestor
92685633|NCT00497523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685634|NCT00463775|Topiramate|topiramate|mesh-list
92685635|NCT00463775|Anticonvulsants|anticonvulsants|mesh-ancestor
92685636|NCT00463775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685637|NCT00463775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685638|NCT00490620|Antiviral Agents|antiviral agents|mesh-list
92369183|NCT05668286|Prilocaine|prilocaine|mesh-list
92685639|NCT00490620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685640|NCT00466232|Sorafenib|sorafenib|mesh-list
92685641|NCT00466232|Topotecan|topotecan|mesh-list
92685642|NCT00466232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685643|NCT00466232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685644|NCT00466232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685645|NCT00466232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685646|NCT00466232|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92685647|NCT00466232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92685648|NCT00490659|Gemcitabine|gemcitabine|mesh-list
92685649|NCT00490659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685650|NCT00490659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685651|NCT00490659|Antimetabolites|antimetabolites|mesh-ancestor
92685652|NCT00490659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685653|NCT00490737|Daptomycin|daptomycin|mesh-list
92685654|NCT00490737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685655|NCT00490737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685656|NCT00497562|Tramadol|tramadol|mesh-list
92685657|NCT00497562|Amitriptyline|amitriptyline|mesh-list
92685658|NCT00497562|Fluoxetine|fluoxetine|mesh-list
92685659|NCT00497562|Hormones|hormones|mesh-list
92685660|NCT00497562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685661|NCT00497562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685662|NCT00497562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92685663|NCT00497562|Narcotics|narcotics|mesh-ancestor
92685664|NCT00497562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685665|NCT00497562|Analgesics|analgesics|mesh-ancestor
92685666|NCT00497562|Sensory System Agents|sensory system agents|mesh-ancestor
92685667|NCT00497562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92606931|NCT00139230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685668|NCT00497562|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92685669|NCT00497562|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92685670|NCT00497562|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685671|NCT00497562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685672|NCT00497562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685674|NCT00497562|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92685675|NCT00497562|Antidepressive Agents|antidepressive agents|mesh-ancestor
92685676|NCT00497562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92685677|NCT00497562|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92685678|NCT00497562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685679|NCT00497562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685680|NCT00497562|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92685681|NCT00497562|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92685682|NCT00497562|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92685683|NCT00497562|Adrenergic Agents|adrenergic agents|mesh-ancestor
92685685|NCT00497601|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92685686|NCT00497601|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92685687|NCT00497601|Amebicides|amebicides|mesh-ancestor
92685688|NCT00497601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92685689|NCT00497601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92685690|NCT00497601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685691|NCT00497601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685692|NCT00497601|Antifungal Agents|antifungal agents|mesh-ancestor
92685693|NCT00497601|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92685694|NCT00497601|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92685695|NCT00497601|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92685697|NCT00466388|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92685698|NCT00466388|Autonomic Agents|autonomic agents|mesh-ancestor
92685699|NCT00466388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685700|NCT00466388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685701|NCT00466388|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92685702|NCT00466388|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92685703|NCT00466388|Cholinergic Agents|cholinergic agents|mesh-ancestor
92685704|NCT00466388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685705|NCT00466388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685706|NCT00466466|Everolimus|everolimus|mesh-list
92685707|NCT00466466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92685708|NCT00466466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685709|NCT00466466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369186|NCT05668286|Glucocorticoids|glucocorticoids|mesh-ancestor
92685710|NCT00466466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685711|NCT00466466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685712|NCT00466466|Immunologic Factors|immunologic factors|mesh-ancestor
92685713|NCT00466466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685714|NCT00466466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685715|NCT00490854|Insulin|insulin|mesh-list
92685716|NCT00490854|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92685717|NCT00490854|Insulin, Isophane|insulin, isophane|mesh-list
92685718|NCT00490854|Isophane Insulin, Human|isophane insulin, human|mesh-list
92685719|NCT00490854|Isophane insulin, beef|isophane insulin, beef|mesh-list
92685720|NCT00490854|Protamines|protamines|mesh-list
92685721|NCT00490854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685722|NCT00490854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685723|NCT00490854|Heparin Antagonists|heparin antagonists|mesh-ancestor
92685724|NCT00490854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685725|NCT00490854|Coagulants|coagulants|mesh-ancestor
92685726|NCT00490893|Insulin Detemir|insulin detemir|mesh-list
92685727|NCT00490893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685728|NCT00490893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685729|NCT03272126|Vitamin D|vitamin d|mesh-list
92685730|NCT03272126|Vitamins|vitamins|mesh-ancestor
92685731|NCT03272126|Micronutrients|micronutrients|mesh-ancestor
92685732|NCT03272126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685733|NCT03272126|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92685734|NCT00491049|Levofloxacin|levofloxacin|mesh-list
92685735|NCT00491049|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92685736|NCT00491049|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92685737|NCT00491049|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92685738|NCT00491049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685739|NCT00491049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685740|NCT00491049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92685741|NCT00491049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606932|NCT00139230|Antidotes|antidotes|mesh-ancestor
92043416|NCT02225353|Hormones|hormones|mesh-ancestor
92685742|NCT00491049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685743|NCT00491049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685744|NCT00491049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685745|NCT00491049|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92685746|NCT00491049|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685759|NCT00497913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92685760|NCT00497913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685761|NCT00497913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685762|NCT00497913|Cholinergic Agents|cholinergic agents|mesh-ancestor
92685763|NCT00497913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685764|NCT00497913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685765|NCT00497913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92685766|NCT00497913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685767|NCT03272321|Oxytocin|oxytocin|mesh-list
92685768|NCT03272321|Oxytocics|oxytocics|mesh-ancestor
92685769|NCT03272321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92685770|NCT03272321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685771|NCT00491127|Dexamethasone|dexamethasone|mesh-list
92685772|NCT00491127|Gemcitabine|gemcitabine|mesh-list
92685773|NCT00491127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685774|NCT00491127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685775|NCT00491127|Antiemetics|antiemetics|mesh-ancestor
92685776|NCT00491127|Autonomic Agents|autonomic agents|mesh-ancestor
92685777|NCT00491127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685778|NCT00491127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685779|NCT00491127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92685780|NCT00491127|Glucocorticoids|glucocorticoids|mesh-ancestor
92685781|NCT00491127|Hormones|hormones|mesh-ancestor
92685782|NCT00491127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685783|NCT00491127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92685784|NCT00491127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685785|NCT00491127|Antimetabolites|antimetabolites|mesh-ancestor
92685786|NCT00491127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685787|NCT00491166|Bromfenac|bromfenac|mesh-list
92685788|NCT00491166|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92685789|NCT00491166|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92685790|NCT00491166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92685791|NCT00491166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92685792|NCT00491166|Analgesics|analgesics|mesh-ancestor
92685793|NCT00491166|Sensory System Agents|sensory system agents|mesh-ancestor
92685794|NCT00491166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685795|NCT00491166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685796|NCT00491166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92685797|NCT00491166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92685798|NCT03273062|Tolcapone|tolcapone|mesh-list
92685799|NCT03273062|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92685800|NCT03273062|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92685801|NCT03273062|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92685802|NCT03273062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685803|NCT03273062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685804|NCT00498108|Rotigotine|rotigotine|mesh-list
92685805|NCT00498108|Dopamine Agonists|dopamine agonists|mesh-ancestor
92685806|NCT00498108|Dopamine Agents|dopamine agents|mesh-ancestor
92685807|NCT00498108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685818|NCT00466622|Metformin|metformin|mesh-list
92685819|NCT00466622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685820|NCT00466622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685821|NCT01327612|Leucovorin|leucovorin|mesh-list
92685822|NCT01327612|Bevacizumab|bevacizumab|mesh-list
92685823|NCT01327612|Conatumumab|conatumumab|mesh-list
92685824|NCT01327612|Fluorouracil|fluorouracil|mesh-list
92685825|NCT01327612|Oxaliplatin|oxaliplatin|mesh-list
92685826|NCT01327612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92685827|NCT01327612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685828|NCT01327612|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92105567|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
92685829|NCT01327612|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92685830|NCT01327612|Growth Substances|growth substances|mesh-ancestor
92685831|NCT01327612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685832|NCT01327612|Growth Inhibitors|growth inhibitors|mesh-ancestor
92685833|NCT01327612|Antimetabolites|antimetabolites|mesh-ancestor
92685834|NCT01327612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606933|NCT00139230|Protective Agents|protective agents|mesh-ancestor
92606934|NCT00139230|Vitamin B Complex|vitamin b complex|mesh-ancestor
92606936|NCT00139230|Micronutrients|micronutrients|mesh-ancestor
92606937|NCT00139230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92606938|NCT00139230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92685835|NCT01327612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685836|NCT01327612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685837|NCT01327612|Immunologic Factors|immunologic factors|mesh-ancestor
92685838|NCT01327612|Antidotes|antidotes|mesh-ancestor
92685839|NCT01327612|Protective Agents|protective agents|mesh-ancestor
92685840|NCT01327612|Vitamin B Complex|vitamin b complex|mesh-ancestor
92685841|NCT01327612|Vitamins|vitamins|mesh-ancestor
92685842|NCT01327612|Micronutrients|micronutrients|mesh-ancestor
92685843|NCT01243281|Entecavir|entecavir|mesh-list
92685844|NCT01243281|Antiviral Agents|antiviral agents|mesh-ancestor
92685845|NCT01243281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685846|NCT00464399|Everolimus|everolimus|mesh-list
92685847|NCT00464399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92685848|NCT00464399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685849|NCT00464399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685850|NCT00464399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685851|NCT00464399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685852|NCT00464399|Immunologic Factors|immunologic factors|mesh-ancestor
92685853|NCT00464399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685854|NCT00464399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685855|NCT04132882|Sodium thiosulfate|sodium thiosulfate|mesh-list
92685856|NCT04132882|Antidotes|antidotes|mesh-ancestor
92685857|NCT04132882|Protective Agents|protective agents|mesh-ancestor
92685858|NCT04132882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685859|NCT04132882|Antioxidants|antioxidants|mesh-ancestor
92369199|NCT05665465|Nicotine|nicotine|mesh-list
92685860|NCT04132882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685861|NCT04132882|Antitubercular Agents|antitubercular agents|mesh-ancestor
92685862|NCT04132882|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685863|NCT04132882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685864|NCT04132882|Chelating Agents|chelating agents|mesh-ancestor
92685865|NCT04132882|Sequestering Agents|sequestering agents|mesh-ancestor
92685866|NCT01243359|Bevacizumab|bevacizumab|mesh-list
92685867|NCT01243359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92685868|NCT01243359|Sunitinib|sunitinib|mesh-list
92685869|NCT01243359|Antibodies|antibodies|mesh-list
92685870|NCT01243359|Immunoglobulins|immunoglobulins|mesh-list
92685871|NCT01243359|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92685872|NCT01243359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685876|NCT01243359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685877|NCT01243359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92685878|NCT01243359|Immunologic Factors|immunologic factors|mesh-ancestor
92685879|NCT01243359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92685880|NCT01243359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685881|NCT01243359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685882|NCT00498342|Acetylcysteine|acetylcysteine|mesh-list
92685883|NCT00498342|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92685884|NCT00498342|Antiviral Agents|antiviral agents|mesh-ancestor
92685885|NCT00498342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685886|NCT00498342|Expectorants|expectorants|mesh-ancestor
92685887|NCT00498342|Respiratory System Agents|respiratory system agents|mesh-ancestor
92685888|NCT00498342|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92685889|NCT00498342|Antioxidants|antioxidants|mesh-ancestor
92685890|NCT00498342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685891|NCT00498342|Protective Agents|protective agents|mesh-ancestor
92685892|NCT00498342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685893|NCT00498342|Antidotes|antidotes|mesh-ancestor
92685894|NCT00466856|Octreotide|octreotide|mesh-list
92685895|NCT00466856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92685896|NCT00466856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92685897|NCT00466856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685898|NCT01243437|Ciprofloxacin|ciprofloxacin|mesh-list
92685899|NCT01243437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685900|NCT01243437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685901|NCT01243437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92685902|NCT01243437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92685903|NCT01243437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685904|NCT01243437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606939|NCT00139230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92606940|NCT00139230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606941|NCT00139230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105645|NCT03364218|Antidotes|antidotes|mesh-ancestor
92685905|NCT01243437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685906|NCT01243437|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92685907|NCT01243437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685909|NCT00591994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92685910|NCT00591994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92685911|NCT00591994|Dopamine Agonists|dopamine agonists|mesh-ancestor
92685912|NCT00591994|Dopamine Agents|dopamine agents|mesh-ancestor
92685913|NCT00591994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685914|NCT00591994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685915|NCT00591994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685916|NCT00464594|Metformin|metformin|mesh-list
92685917|NCT00464594|Acarbose|acarbose|mesh-list
92685918|NCT00464594|Gliclazide|gliclazide|mesh-list
92685919|NCT00464594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92685920|NCT00464594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685921|NCT00464594|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92685922|NCT00464594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92685923|NCT00464594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685924|NCT04397302|Valsartan|valsartan|mesh-list
92685925|NCT04397302|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92685926|NCT04397302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92685927|NCT04397302|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92685928|NCT04397302|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92685929|NCT04397302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685930|NCT00466895|Lenalidomide|lenalidomide|mesh-list
92685931|NCT00466895|Immunologic Factors|immunologic factors|mesh-ancestor
92685932|NCT00466895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685933|NCT00466895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92685934|NCT00466895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92685935|NCT00466895|Growth Substances|growth substances|mesh-ancestor
92685936|NCT00466895|Growth Inhibitors|growth inhibitors|mesh-ancestor
92685937|NCT00466895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685938|NCT02893540|Capecitabine|capecitabine|mesh-list
92685939|NCT02893540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685940|NCT02893540|Antimetabolites|antimetabolites|mesh-ancestor
92685941|NCT02893540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685942|NCT02893540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685943|NCT01327573|Eculizumab|eculizumab|mesh-list
92685956|NCT02893228|Anesthetics|anesthetics|mesh-ancestor
92685957|NCT02893228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685958|NCT02893228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685959|NCT02893228|Sensory System Agents|sensory system agents|mesh-ancestor
92685960|NCT02893228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685961|NCT00498537|Spironolactone|spironolactone|mesh-list
92685962|NCT00498537|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92685963|NCT00498537|Hormone Antagonists|hormone antagonists|mesh-ancestor
92685964|NCT00498537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685965|NCT00498537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685966|NCT00498537|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92685967|NCT00498537|Diuretics|diuretics|mesh-ancestor
92685968|NCT00498537|Natriuretic Agents|natriuretic agents|mesh-ancestor
92685969|NCT00491478|Sertraline|sertraline|mesh-list
92685970|NCT00491478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92685971|NCT00491478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92685972|NCT00491478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92685973|NCT00491478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92685974|NCT00491478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92685975|NCT00491478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685976|NCT00491478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685977|NCT00491478|Serotonin Agents|serotonin agents|mesh-ancestor
92685978|NCT00491478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685979|NCT00491517|Sirolimus|sirolimus|mesh-list
92685980|NCT00491517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685981|NCT00491517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685982|NCT00491517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92685983|NCT00491517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606942|NCT00139230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92606943|NCT00139230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92606944|NCT00139230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606945|NCT00139230|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92606946|NCT00139230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92685984|NCT00491517|Antifungal Agents|antifungal agents|mesh-ancestor
92685985|NCT00491517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685986|NCT00491517|Immunologic Factors|immunologic factors|mesh-ancestor
92685987|NCT00491517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685988|NCT00464789|Bazedoxifene|bazedoxifene|mesh-list
92685989|NCT00464789|Estrogens|estrogens|mesh-list
92685990|NCT00464789|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92685991|NCT00464789|Hormones|hormones|mesh-ancestor
92685992|NCT00464789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685993|NCT00464789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685994|NCT00464789|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92685995|NCT00464789|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92685996|NCT00464789|Hormone Antagonists|hormone antagonists|mesh-ancestor
92685997|NCT00464789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92685998|NCT00467012|Paclitaxel|paclitaxel|mesh-list
92685999|NCT00467012|Bevacizumab|bevacizumab|mesh-list
92686000|NCT00467012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92686001|NCT00467012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686002|NCT00467012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686003|NCT00467012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686004|NCT00467012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686010|NCT00467012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686011|NCT00467012|Growth Inhibitors|growth inhibitors|mesh-ancestor
92686012|NCT03272867|Mannitol|mannitol|mesh-list
92686013|NCT03272867|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92686014|NCT03272867|Diuretics|diuretics|mesh-ancestor
92686015|NCT03272867|Natriuretic Agents|natriuretic agents|mesh-ancestor
92686016|NCT03272867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686017|NCT01327495|Methyltestosterone|methyltestosterone|mesh-list
92686018|NCT01327495|Testosterone|testosterone|mesh-list
92686019|NCT01327495|Testosterone undecanoate|testosterone undecanoate|mesh-list
92686020|NCT01327495|Testosterone enanthate|testosterone enanthate|mesh-list
92686021|NCT01327495|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92686022|NCT01327495|Acyline|acyline|mesh-list
92686023|NCT01327495|Androgens|androgens|mesh-ancestor
92686024|NCT01327495|Hormones|hormones|mesh-ancestor
92686025|NCT01327495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686026|NCT01327495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686027|NCT01327495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92686028|NCT01327495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686029|NCT01327495|Anabolic Agents|anabolic agents|mesh-ancestor
92686030|NCT01327495|Hormone Antagonists|hormone antagonists|mesh-ancestor
92686031|NCT00491634|Treosulfan|treosulfan|mesh-list
92686032|NCT00491634|Busulfan|busulfan|mesh-list
92686033|NCT00491634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92686034|NCT00491634|Alkylating Agents|alkylating agents|mesh-ancestor
92686035|NCT00491634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686036|NCT00491634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686037|NCT00491634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686038|NCT00491634|Immunologic Factors|immunologic factors|mesh-ancestor
92686039|NCT00491634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686040|NCT00491634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92686041|NCT01327339|Ropinirole|ropinirole|mesh-list
92686042|NCT01327339|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92686043|NCT01327339|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92686044|NCT01327339|Dopamine Agonists|dopamine agonists|mesh-ancestor
92686045|NCT01327339|Dopamine Agents|dopamine agents|mesh-ancestor
92686046|NCT01327339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686047|NCT01327339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686048|NCT01327339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686049|NCT01327300|Mesalamine|mesalamine|mesh-list
92686050|NCT01327300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92686051|NCT01327300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92686052|NCT01327300|Analgesics|analgesics|mesh-ancestor
92686053|NCT01327300|Sensory System Agents|sensory system agents|mesh-ancestor
92606947|NCT02086175|Rituximab|rituximab|mesh-list
92606948|NCT02086175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606949|NCT02086175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686054|NCT01327300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686055|NCT01327300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686056|NCT01327300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686057|NCT01327300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686058|NCT00467207|Botulinum Toxins|botulinum toxins|mesh-list
92686059|NCT00467207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92686060|NCT00467207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92686061|NCT00467207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92686062|NCT00467207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686063|NCT00467207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686064|NCT00467207|Cholinergic Agents|cholinergic agents|mesh-ancestor
92686065|NCT00467207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686066|NCT00467207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686067|NCT00467207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92686068|NCT00467207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686069|NCT00592111|Prednisone|prednisone|mesh-list
92686070|NCT00592111|Cyclophosphamide|cyclophosphamide|mesh-list
92686071|NCT00592111|Etoposide|etoposide|mesh-list
92686072|NCT00592111|Vincristine|vincristine|mesh-list
92686073|NCT00592111|Doxorubicin|doxorubicin|mesh-list
92686074|NCT00592111|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92686077|NCT00592111|Procarbazine|procarbazine|mesh-list
92686078|NCT00592111|Mitogens|mitogens|mesh-list
92686079|NCT00592111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686080|NCT00592111|Immunologic Factors|immunologic factors|mesh-ancestor
92686081|NCT00592111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686082|NCT00592111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686083|NCT00592111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92686084|NCT00592111|Alkylating Agents|alkylating agents|mesh-ancestor
92686085|NCT00592111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686086|NCT00592111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686087|NCT00592111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92686088|NCT00592111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686089|NCT00592111|Glucocorticoids|glucocorticoids|mesh-ancestor
92686090|NCT00592111|Hormones|hormones|mesh-ancestor
92686091|NCT00592111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686092|NCT00592111|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92686093|NCT00592111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92369257|NCT05500599|Anesthetics|anesthetics|mesh-ancestor
92686094|NCT00592111|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92686095|NCT00592111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92686096|NCT00592111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686097|NCT00592111|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686098|NCT00592111|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686099|NCT00592111|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686100|NCT00592111|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92686101|NCT00592150|Fenoldopam|fenoldopam|mesh-list
92686102|NCT00592150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92686103|NCT00592150|Vasodilator Agents|vasodilator agents|mesh-ancestor
92686104|NCT00592150|Dopamine Agonists|dopamine agonists|mesh-ancestor
92686105|NCT00592150|Dopamine Agents|dopamine agents|mesh-ancestor
92686106|NCT00592150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686107|NCT00592150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686108|NCT00592150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686109|NCT00592306|Thymoglobulin|thymoglobulin|mesh-list
92686110|NCT00592306|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92686111|NCT00592306|Immunologic Factors|immunologic factors|mesh-ancestor
92686112|NCT00592306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686113|NCT00592306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686114|NCT00467246|Insulin Detemir|insulin detemir|mesh-list
92686115|NCT00467246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686116|NCT00467246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686117|NCT04377295|Ranibizumab|ranibizumab|mesh-list
92686118|NCT04377295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92686119|NCT04377295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92686120|NCT04377295|Growth Substances|growth substances|mesh-ancestor
92686121|NCT04377295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686122|NCT04377295|Growth Inhibitors|growth inhibitors|mesh-ancestor
92686123|NCT04377295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686124|NCT00491712|Triamcinolone|triamcinolone|mesh-list
92686125|NCT00491712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92606950|NCT02086175|Immunologic Factors|immunologic factors|mesh-ancestor
92606951|NCT02086175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606952|NCT02086175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606953|NCT00139269|Docetaxel|docetaxel|mesh-list
92606954|NCT00139269|Fluorouracil|fluorouracil|mesh-list
92606955|NCT00139269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606956|NCT00139269|Tubulin Modulators|tubulin modulators|mesh-ancestor
92606957|NCT00139269|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686126|NCT00491712|Glucocorticoids|glucocorticoids|mesh-ancestor
92686127|NCT00491712|Hormones|hormones|mesh-ancestor
92686128|NCT00491712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686129|NCT00491712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686130|NCT02893111|Bortezomib|bortezomib|mesh-list
92686131|NCT02893111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686132|NCT04328272|Azithromycin|azithromycin|mesh-list
92686133|NCT04328272|Hydroxychloroquine|hydroxychloroquine|mesh-list
92686134|NCT04328272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686135|NCT04328272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686136|NCT04328272|Antimalarials|antimalarials|mesh-ancestor
92686137|NCT04328272|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92686138|NCT04328272|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92686139|NCT04328272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686140|NCT04328272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686141|NCT04328272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686142|NCT04328194|Thrombin|thrombin|mesh-list
92686143|NCT04328194|Hemostatics|hemostatics|mesh-ancestor
92686144|NCT04328194|Coagulants|coagulants|mesh-ancestor
92686145|NCT00491790|Montelukast|montelukast|mesh-list
92686146|NCT00491790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92686147|NCT00491790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92686148|NCT00491790|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92686149|NCT00491790|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327589|NCT00003086|Carboplatin|carboplatin|mesh-list
92686166|NCT00498888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92686167|NCT00498888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92686168|NCT00498888|Cholinergic Agents|cholinergic agents|mesh-ancestor
92686169|NCT00498888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686170|NCT00498888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686171|NCT00498888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686172|NCT00498888|Urological Agents|urological agents|mesh-ancestor
92686173|NCT00491868|Epoetin Alfa|epoetin alfa|mesh-list
92686174|NCT00491868|Hematinics|hematinics|mesh-ancestor
92686175|NCT00491907|Folic Acid|folic acid|mesh-list
92686176|NCT00491907|Hematinics|hematinics|mesh-ancestor
92686177|NCT00491907|Vitamin B Complex|vitamin b complex|mesh-ancestor
92686178|NCT00491907|Vitamins|vitamins|mesh-ancestor
92686179|NCT00491907|Micronutrients|micronutrients|mesh-ancestor
92686180|NCT00491907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686181|NCT00499005|Carbetocin|carbetocin|mesh-list
92686182|NCT00499005|Oxytocin|oxytocin|mesh-list
92686183|NCT00499005|Oxytocics|oxytocics|mesh-ancestor
92686184|NCT00499005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92686185|NCT00499005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686186|NCT00491946|Dactinomycin|dactinomycin|mesh-list
92686187|NCT00491946|Vincristine|vincristine|mesh-list
92686188|NCT00491946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92686189|NCT00491946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686190|NCT00491946|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686191|NCT00491946|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686192|NCT00491946|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686193|NCT00491946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686194|NCT00491946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686195|NCT00491946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686196|NCT00491946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92686197|NCT00491946|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92686198|NCT00491946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686199|NCT00491946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92686200|NCT00491985|Vaccines|vaccines|mesh-list
92686201|NCT00491985|Immunologic Factors|immunologic factors|mesh-ancestor
92686202|NCT00491985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686203|NCT02892916|Ketamine|ketamine|mesh-list
92686204|NCT02892916|Analgesics|analgesics|mesh-ancestor
92606958|NCT00139269|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686205|NCT02892916|Sensory System Agents|sensory system agents|mesh-ancestor
92686206|NCT02892916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686207|NCT02892916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686208|NCT02892916|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92686227|NCT00467636|Insulin glulisine|insulin glulisine|mesh-list
92686228|NCT00467636|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686229|NCT00467636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686230|NCT00492141|Temozolomide|temozolomide|mesh-list
92686231|NCT00492141|Camptothecin|camptothecin|mesh-list
92686232|NCT00492141|Rubitecan|rubitecan|mesh-list
92686233|NCT00492141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92686234|NCT00492141|Alkylating Agents|alkylating agents|mesh-ancestor
92686235|NCT00492141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686236|NCT00492141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686237|NCT00492141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92686238|NCT00492141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92686239|NCT00492141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92686240|NCT00492141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686241|NCT04327726|Dexmedetomidine|dexmedetomidine|mesh-list
92686242|NCT04327726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92686243|NCT04327726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686244|NCT04327726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686245|NCT04327726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92686246|NCT04327726|Analgesics|analgesics|mesh-ancestor
92686247|NCT04327726|Sensory System Agents|sensory system agents|mesh-ancestor
92686248|NCT04327726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686249|NCT04327726|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92686250|NCT04327726|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92686251|NCT04327726|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92686252|NCT04327726|Adrenergic Agents|adrenergic agents|mesh-ancestor
92686253|NCT04327726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686254|NCT04327726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686255|NCT00492219|Cimetidine|cimetidine|mesh-list
92686256|NCT00492219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92686257|NCT00492219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686258|NCT00492219|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92686259|NCT00492219|Histamine Antagonists|histamine antagonists|mesh-ancestor
92686260|NCT00492219|Histamine Agents|histamine agents|mesh-ancestor
92686274|NCT00465257|Antiviral Agents|antiviral agents|mesh-ancestor
92686275|NCT00465257|Schistosomicides|schistosomicides|mesh-ancestor
92686276|NCT00465257|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92686277|NCT00465257|Anthelmintics|anthelmintics|mesh-ancestor
92686278|NCT04130776|Kallikreins|kallikreins|mesh-list
92686279|NCT04130776|Coagulants|coagulants|mesh-ancestor
92106026|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
92686280|NCT04130776|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92686281|NCT04130776|Fertility Agents|fertility agents|mesh-ancestor
92686282|NCT04130776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92686283|NCT04130776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686284|NCT00492258|Sorafenib|sorafenib|mesh-list
92686285|NCT00492258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686286|NCT00492258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92686287|NCT00492258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686288|NCT00492258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686289|NCT02955810|Dexamethasone|dexamethasone|mesh-list
92686290|NCT02955810|Cyclophosphamide|cyclophosphamide|mesh-list
92686291|NCT02955810|Bortezomib|bortezomib|mesh-list
92686292|NCT02955810|Daratumumab|daratumumab|mesh-list
92686293|NCT02955810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686294|NCT02955810|Immunologic Factors|immunologic factors|mesh-ancestor
92686295|NCT02955810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686296|NCT02955810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686297|NCT02955810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92686298|NCT02955810|Alkylating Agents|alkylating agents|mesh-ancestor
92686299|NCT02955810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686300|NCT02955810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686301|NCT02955810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92686302|NCT02955810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686303|NCT02955810|Antiemetics|antiemetics|mesh-ancestor
92686304|NCT02955810|Autonomic Agents|autonomic agents|mesh-ancestor
92686305|NCT02955810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686306|NCT02955810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686307|NCT02955810|Glucocorticoids|glucocorticoids|mesh-ancestor
92686308|NCT02955810|Hormones|hormones|mesh-ancestor
92606959|NCT00139269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606960|NCT00139269|Antimetabolites|antimetabolites|mesh-ancestor
92606961|NCT00139269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92686309|NCT02955810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686310|NCT02955810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92686311|NCT00465296|Rosiglitazone|rosiglitazone|mesh-list
92686312|NCT00465296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686313|NCT00465296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686314|NCT00492414|Paroxetine|paroxetine|mesh-list
92686315|NCT00492414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92686316|NCT00492414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92686317|NCT00492414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686318|NCT00492414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686319|NCT00492414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686320|NCT00492414|Serotonin Agents|serotonin agents|mesh-ancestor
92686321|NCT00492414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106103|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92686352|NCT00592618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686353|NCT00592618|Expectorants|expectorants|mesh-ancestor
92686354|NCT00592618|Respiratory System Agents|respiratory system agents|mesh-ancestor
92686356|NCT00592618|Antioxidants|antioxidants|mesh-ancestor
92686357|NCT00592618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686358|NCT00592618|Protective Agents|protective agents|mesh-ancestor
92686359|NCT00592618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686360|NCT00592618|Antidotes|antidotes|mesh-ancestor
92686361|NCT01243710|Taurolidine|taurolidine|mesh-list
92686362|NCT01243710|Heparin|heparin|mesh-list
92686363|NCT01243710|Anticoagulants|anticoagulants|mesh-ancestor
92686364|NCT01243710|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92686365|NCT01243710|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92686366|NCT01243710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686375|NCT01245543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686376|NCT01245543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686377|NCT01245543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686378|NCT01245543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686379|NCT01245543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686380|NCT00592930|Olanzapine|olanzapine|mesh-list
92686381|NCT00592930|Antiemetics|antiemetics|mesh-ancestor
92686382|NCT00592930|Autonomic Agents|autonomic agents|mesh-ancestor
92686383|NCT00592930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686384|NCT00592930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686385|NCT00592930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686386|NCT00592930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92686387|NCT00592930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92686388|NCT00592930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686389|NCT00592930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92686390|NCT00592930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92686391|NCT00592930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92686392|NCT00592930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686393|NCT00592930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686394|NCT00592930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686395|NCT00592930|Serotonin Agents|serotonin agents|mesh-ancestor
92686396|NCT00592969|Metformin|metformin|mesh-list
92686397|NCT00592969|Insulin Aspart|insulin aspart|mesh-list
92686398|NCT00592969|Biphasic Insulins|biphasic insulins|mesh-list
92686399|NCT00592969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686400|NCT00592969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686401|NCT01245582|Capecitabine|capecitabine|mesh-list
92686402|NCT01245582|Oxaliplatin|oxaliplatin|mesh-list
92686403|NCT01245582|Sorafenib|sorafenib|mesh-list
92686404|NCT01245582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92686405|NCT01245582|Antimetabolites|antimetabolites|mesh-ancestor
92686406|NCT01245582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686407|NCT01245582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686408|NCT01245582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92686409|NCT01245582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686410|NCT00593008|Sirolimus|sirolimus|mesh-list
92686411|NCT00593008|Gemcitabine|gemcitabine|mesh-list
92686412|NCT00593008|Temsirolimus|temsirolimus|mesh-list
92686413|NCT00593008|MTOR Inhibitors|mtor inhibitors|mesh-list
92686414|NCT00593008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92606962|NCT00139269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606963|NCT00139269|Immunologic Factors|immunologic factors|mesh-ancestor
92606964|NCT00139269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686415|NCT00593008|Antimetabolites|antimetabolites|mesh-ancestor
92686416|NCT00593008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686417|NCT00593008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686418|NCT00593008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92686419|NCT00593008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686420|NCT00593008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686421|NCT00593008|Immunologic Factors|immunologic factors|mesh-ancestor
92686422|NCT00593008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686423|NCT00593008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686424|NCT00593008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686425|NCT00593008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92686426|NCT00593008|Antifungal Agents|antifungal agents|mesh-ancestor
92686427|NCT02956200|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92686428|NCT02956200|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92686429|NCT02956200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686430|NCT02956200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686431|NCT02956200|Immunologic Factors|immunologic factors|mesh-ancestor
92686432|NCT02956200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686433|NCT00593125|Levetiracetam|levetiracetam|mesh-list
92686437|NCT00593164|Analgesics|analgesics|mesh-ancestor
92686438|NCT00593164|Sensory System Agents|sensory system agents|mesh-ancestor
92686439|NCT00593164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686440|NCT00593164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686441|NCT00593164|Anesthetics|anesthetics|mesh-ancestor
92686442|NCT00593164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686443|NCT00593164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92686444|NCT00593164|Anticonvulsants|anticonvulsants|mesh-ancestor
92686445|NCT00593164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92686446|NCT00593164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686447|NCT00593164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686448|NCT00593164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92686449|NCT00593164|Tocolytic Agents|tocolytic agents|mesh-ancestor
92686450|NCT00593164|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92686451|NCT01316107|Ipragliflozin|ipragliflozin|mesh-list
92686452|NCT01316107|Nateglinide|nateglinide|mesh-list
92686453|NCT01316107|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92686454|NCT01316107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686455|NCT01316107|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686456|NCT01316107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686457|NCT05654194|Azacitidine|azacitidine|mesh-list
92686458|NCT05654194|Venetoclax|venetoclax|mesh-list
92686459|NCT05654194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92686460|NCT05654194|Antimetabolites|antimetabolites|mesh-ancestor
92686461|NCT05654194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686462|NCT05654194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686463|NCT05654194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686464|NCT05653453|Paclitaxel|paclitaxel|mesh-list
92686465|NCT05653453|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92686466|NCT05653453|Gemcitabine|gemcitabine|mesh-list
92686467|NCT05653453|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92686468|NCT05653453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686469|NCT05653453|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686470|NCT05653453|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686471|NCT05653453|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686472|NCT05653453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686473|NCT05653453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92686474|NCT05653453|Antimetabolites|antimetabolites|mesh-ancestor
92686475|NCT00468182|Interferons|interferons|mesh-list
92686476|NCT00468182|Interferon-beta|interferon-beta|mesh-list
92686477|NCT00468182|Interferon beta-1b|interferon beta-1b|mesh-list
92686478|NCT00468182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686479|NCT00468182|Antiviral Agents|antiviral agents|mesh-ancestor
92686480|NCT00468182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686481|NCT00468182|Immunologic Factors|immunologic factors|mesh-ancestor
92686482|NCT00468182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686483|NCT00468182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92686484|NCT05649163|Disitamab vedotin|disitamab vedotin|mesh-list
92686485|NCT05649163|Immunoconjugates|immunoconjugates|mesh-ancestor
92606965|NCT02065154|Cyclophosphamide|cyclophosphamide|mesh-list
92606966|NCT02065154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606967|NCT02065154|Immunologic Factors|immunologic factors|mesh-ancestor
92606968|NCT02065154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92606969|NCT02065154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92606970|NCT02065154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92686486|NCT05649163|Immunologic Factors|immunologic factors|mesh-ancestor
92686487|NCT05649163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686488|NCT00465452|Dopamine|dopamine|mesh-list
92686489|NCT00465452|Dopamine Agonists|dopamine agonists|mesh-list
92686490|NCT00465452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92686491|NCT00465452|Sympathomimetics|sympathomimetics|mesh-ancestor
92686492|NCT00465452|Autonomic Agents|autonomic agents|mesh-ancestor
92686493|NCT00465452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686494|NCT00465452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686495|NCT00465452|Dopamine Agents|dopamine agents|mesh-ancestor
92686496|NCT00465452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686497|NCT00465452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686498|NCT00465452|Protective Agents|protective agents|mesh-ancestor
92686499|NCT01379521|Everolimus|everolimus|mesh-list
92686500|NCT01379521|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92686501|NCT01379521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92686502|NCT01379521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106247|NCT02253108|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92686503|NCT01379521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686504|NCT01379521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686505|NCT01379521|Immunologic Factors|immunologic factors|mesh-ancestor
92327590|NCT00003086|Doxorubicin|doxorubicin|mesh-list
92686535|NCT01371877|Vitamins|vitamins|mesh-list
92686536|NCT01371877|Micronutrients|micronutrients|mesh-ancestor
92686537|NCT01371877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686538|NCT01371877|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92686539|NCT01371877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92686540|NCT01245816|Eflornithine|eflornithine|mesh-list
92686541|NCT01245816|Sulindac|sulindac|mesh-list
92686542|NCT01245816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686543|NCT01245816|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92686544|NCT01245816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92686545|NCT01245816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92686546|NCT01245816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686547|NCT01245816|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92686548|NCT01245816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686549|NCT01245816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327591|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92686573|NCT00492687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92686575|NCT01371838|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92686576|NCT01371838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686577|NCT01371838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686578|NCT01245855|Alprostadil|alprostadil|mesh-list
92686579|NCT01245855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92686580|NCT01245855|Vasodilator Agents|vasodilator agents|mesh-ancestor
92686581|NCT01245855|Urological Agents|urological agents|mesh-ancestor
92686582|NCT00473603|Heparin|heparin|mesh-list
92686583|NCT00473603|Anticoagulants|anticoagulants|mesh-ancestor
92686584|NCT00473603|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92686585|NCT00473603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92686586|NCT00473603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686587|NCT00492765|Interferons|interferons|mesh-list
92686588|NCT00492765|Interferon-beta|interferon-beta|mesh-list
92686589|NCT00492765|Interferon beta-1a|interferon beta-1a|mesh-list
92686590|NCT00492765|Simvastatin|simvastatin|mesh-list
92686591|NCT00492765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686592|NCT00492765|Antiviral Agents|antiviral agents|mesh-ancestor
92686593|NCT00492765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686594|NCT00492765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92686595|NCT00492765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92686596|NCT00492765|Antimetabolites|antimetabolites|mesh-ancestor
92686597|NCT00492765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686598|NCT00492765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92686605|NCT00468533|Antidepressive Agents|antidepressive agents|mesh-ancestor
92686606|NCT00468533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92606971|NCT02065154|Alkylating Agents|alkylating agents|mesh-ancestor
92606972|NCT02065154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606973|NCT02065154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606974|NCT02065154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92606975|NCT00403364|Amoxicillin|amoxicillin|mesh-list
92686607|NCT00468533|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92686608|NCT00468533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92686609|NCT00468533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686610|NCT00468533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686611|NCT00468533|Dopamine Agonists|dopamine agonists|mesh-ancestor
92686613|NCT00468533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686614|NCT00468533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686615|NCT00468533|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92686616|NCT00468533|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92686617|NCT00468533|Serotonin Agents|serotonin agents|mesh-ancestor
92686618|NCT00468533|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92686619|NCT00468533|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92686620|NCT00468533|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92686621|NCT00468533|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92686622|NCT00473720|Paclitaxel|paclitaxel|mesh-list
92686623|NCT00473720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92686624|NCT00473720|Satraplatin|satraplatin|mesh-list
92686625|NCT00473720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92686626|NCT00473720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686627|NCT00473720|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686628|NCT00473720|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686629|NCT00473720|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686630|NCT00473720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686631|NCT00499668|Ondansetron|ondansetron|mesh-list
92686632|NCT00499668|Aprepitant|aprepitant|mesh-list
92686633|NCT00499668|Antiemetics|antiemetics|mesh-ancestor
92686634|NCT00499668|Autonomic Agents|autonomic agents|mesh-ancestor
92686635|NCT00499668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369370|NCT05270863|Miotics|miotics|mesh-ancestor
92686636|NCT00499668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686637|NCT00499668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686638|NCT00499668|Antipruritics|antipruritics|mesh-ancestor
92686639|NCT00499668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92686640|NCT00499668|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92686641|NCT00499668|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92686642|NCT00499668|Serotonin Agents|serotonin agents|mesh-ancestor
92686643|NCT00499668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686644|NCT00499668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686645|NCT00499668|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92686646|NCT00499707|Metformin|metformin|mesh-list
92686647|NCT00499707|Rosiglitazone|rosiglitazone|mesh-list
92686648|NCT00499707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686649|NCT00499707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686650|NCT01366534|Vaccines|vaccines|mesh-list
92686651|NCT01366534|Immunologic Factors|immunologic factors|mesh-ancestor
92106397|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
92686652|NCT01366534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686653|NCT00492843|Ibandronic Acid|ibandronic acid|mesh-list
92686654|NCT00492843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92686655|NCT00492843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686656|NCT01605487|Cyproheptadine|cyproheptadine|mesh-list
92686657|NCT01605487|Antipruritics|antipruritics|mesh-ancestor
92686658|NCT01605487|Dermatologic Agents|dermatologic agents|mesh-ancestor
92686659|NCT01605487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686660|NCT01605487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92686661|NCT01605487|Histamine Antagonists|histamine antagonists|mesh-ancestor
92686662|NCT01605487|Histamine Agents|histamine agents|mesh-ancestor
92686663|NCT01605487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686664|NCT01605487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686665|NCT01605487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686697|NCT00473915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686698|NCT00473915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686699|NCT00473915|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92686700|NCT00473915|Respiratory System Agents|respiratory system agents|mesh-ancestor
92686701|NCT00473915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92606976|NCT00403364|Clarithromycin|clarithromycin|mesh-list
92606977|NCT00403364|Tinidazole|tinidazole|mesh-list
92606978|NCT00403364|Pantoprazole|pantoprazole|mesh-list
92606979|NCT00403364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92606980|NCT00403364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92606981|NCT00403364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92686702|NCT00473915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92686704|NCT00493077|Interferon-beta|interferon-beta|mesh-list
92686705|NCT00493077|Interferon beta-1a|interferon beta-1a|mesh-list
92686709|NCT00493077|Immunologic Factors|immunologic factors|mesh-ancestor
92686710|NCT00493077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686711|NCT00493077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92686712|NCT00474071|Remifentanil|remifentanil|mesh-list
92686713|NCT00474071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92686714|NCT00474071|Narcotics|narcotics|mesh-ancestor
92686715|NCT00474071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686716|NCT00474071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686717|NCT00474071|Analgesics|analgesics|mesh-ancestor
92686718|NCT00474071|Sensory System Agents|sensory system agents|mesh-ancestor
92686719|NCT00474071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686720|NCT00474110|Ketamine|ketamine|mesh-list
92686721|NCT00474110|Hydromorphone|hydromorphone|mesh-list
92686722|NCT00474110|Analgesics|analgesics|mesh-ancestor
92686723|NCT00474110|Sensory System Agents|sensory system agents|mesh-ancestor
92686724|NCT00474110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686725|NCT00474110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686726|NCT00474110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92106476|NCT01794689|Morphine|morphine|mesh-list
92686727|NCT00474110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92686728|NCT00474110|Anesthetics, General|anesthetics, general|mesh-ancestor
92686730|NCT00474110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686731|NCT00474110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92686732|NCT00474110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92686733|NCT00474110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686734|NCT00474110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686735|NCT00474110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92686736|NCT00474110|Narcotics|narcotics|mesh-ancestor
92686737|NCT00500058|Rituximab|rituximab|mesh-list
92686738|NCT00500058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92686739|NCT00500058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686740|NCT00500058|Immunologic Factors|immunologic factors|mesh-ancestor
92686741|NCT00500058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686742|NCT00500058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686743|NCT00468923|Candesartan|candesartan|mesh-list
92686744|NCT00468923|Candesartan cilexetil|candesartan cilexetil|mesh-list
92686745|NCT00468923|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92686746|NCT00468923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92686747|NCT00468923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92686748|NCT00468923|Antimetabolites|antimetabolites|mesh-ancestor
92686749|NCT00468923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686750|NCT00468923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92686751|NCT00468923|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92686752|NCT00468923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686753|NCT00468923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92686754|NCT00468923|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92686755|NCT00468923|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92686756|NCT01365481|Amlodipine|amlodipine|mesh-list
92686757|NCT01365481|Valsartan|valsartan|mesh-list
92686758|NCT01365481|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92686759|NCT01365481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92686760|NCT01365481|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92686761|NCT01365481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686762|NCT01365481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686763|NCT01365481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92686764|NCT01365481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686765|NCT01365481|Vasodilator Agents|vasodilator agents|mesh-ancestor
92686766|NCT01365481|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92686767|NCT01365481|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92686768|NCT01365481|Diuretics|diuretics|mesh-ancestor
92686769|NCT01365481|Natriuretic Agents|natriuretic agents|mesh-ancestor
92606982|NCT00403364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92606983|NCT00403364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92606984|NCT00403364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92606985|NCT00403364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92686770|NCT01365481|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92686771|NCT00493116|Interferons|interferons|mesh-list
92686772|NCT00493116|Interferon-beta|interferon-beta|mesh-list
92686773|NCT00493116|Interferon beta-1a|interferon beta-1a|mesh-list
92686774|NCT00493116|Methylprednisolone|methylprednisolone|mesh-list
92686775|NCT00493116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686776|NCT00493116|Antiviral Agents|antiviral agents|mesh-ancestor
92686777|NCT00493116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686779|NCT00493116|Antiemetics|antiemetics|mesh-ancestor
92686780|NCT00493116|Autonomic Agents|autonomic agents|mesh-ancestor
92686781|NCT00493116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686782|NCT00493116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686783|NCT00493116|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686784|NCT00493116|Glucocorticoids|glucocorticoids|mesh-ancestor
92686785|NCT00493116|Hormones|hormones|mesh-ancestor
92686786|NCT00493116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686787|NCT00493116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92686788|NCT00493116|Protective Agents|protective agents|mesh-ancestor
92686789|NCT00493116|Immunologic Factors|immunologic factors|mesh-ancestor
92686790|NCT00493116|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92686791|NCT00493194|Cyclosporine|cyclosporine|mesh-list
92686792|NCT00493194|Sirolimus|sirolimus|mesh-list
92686793|NCT00493194|Cyclosporins|cyclosporins|mesh-list
92686794|NCT00493194|Daclizumab|daclizumab|mesh-list
92686795|NCT00493194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686796|NCT00493194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686797|NCT00493194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686798|NCT00493194|Immunologic Factors|immunologic factors|mesh-ancestor
92686799|NCT00493194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106551|NCT02513004|Ticagrelor|ticagrelor|mesh-list
92686800|NCT00493194|Antifungal Agents|antifungal agents|mesh-ancestor
92686801|NCT00493194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686802|NCT00493194|Dermatologic Agents|dermatologic agents|mesh-ancestor
92686803|NCT00493194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686804|NCT00493194|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92686805|NCT00493194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686806|NCT00493194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92686807|NCT00493194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686809|NCT01605721|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92686810|NCT01605721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92686811|NCT01605721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686812|NCT01605721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686813|NCT01605721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92686814|NCT01605721|Immunologic Factors|immunologic factors|mesh-ancestor
92686815|NCT01605721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686816|NCT01605721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686817|NCT01605760|Immunomodulating Agents|immunomodulating agents|mesh-list
92686818|NCT01605760|Immunologic Factors|immunologic factors|mesh-ancestor
92686819|NCT01605760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686820|NCT01350271|Mebendazole|mebendazole|mesh-list
92686821|NCT01350271|Piperazine|piperazine|mesh-list
92686822|NCT01350271|Piperazine citrate|piperazine citrate|mesh-list
92686823|NCT01350271|DMP 777|dmp 777|mesh-list
92686824|NCT01350271|Antinematodal Agents|antinematodal agents|mesh-ancestor
92686825|NCT01350271|Anthelmintics|anthelmintics|mesh-ancestor
92686826|NCT01350271|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92686827|NCT01350271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686828|NCT01350271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686829|NCT01350271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686830|NCT01350271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686831|NCT01350271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686832|NCT01350271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686833|NCT01350271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686834|NCT00493233|Olanzapine|olanzapine|mesh-list
92686835|NCT00493233|Risperidone|risperidone|mesh-list
92686836|NCT00493233|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92686837|NCT00493233|Antipsychotic Agents|antipsychotic agents|mesh-list
92686838|NCT00493233|Clozapine|clozapine|mesh-list
92686839|NCT00493233|Perphenazine|perphenazine|mesh-list
92606986|NCT00403364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92606987|NCT00403364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92606988|NCT00403364|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92606989|NCT00403364|Alkylating Agents|alkylating agents|mesh-ancestor
92606990|NCT00403364|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92686840|NCT00493233|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92686841|NCT00493233|Serotonin Agents|serotonin agents|mesh-ancestor
92686842|NCT00493233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686843|NCT00493233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686844|NCT00493233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686845|NCT00493233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92686846|NCT00493233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686847|NCT00493233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92686848|NCT00493233|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92686849|NCT00493233|Dopamine Agents|dopamine agents|mesh-ancestor
92686850|NCT00493233|Antiemetics|antiemetics|mesh-ancestor
92686851|NCT00493233|Autonomic Agents|autonomic agents|mesh-ancestor
92686852|NCT00493233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686853|NCT00493233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92327592|NCT00003086|Fluorouracil|fluorouracil|mesh-list
92686863|NCT00500253|Autonomic Agents|autonomic agents|mesh-ancestor
92686864|NCT00500253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686865|NCT00500253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686866|NCT00500253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92686867|NCT00500253|Respiratory System Agents|respiratory system agents|mesh-ancestor
92686868|NCT00500253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92686869|NCT00500253|Antioxidants|antioxidants|mesh-ancestor
92686870|NCT00500253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686871|NCT00500253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686872|NCT00500253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92686873|NCT00500253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92686874|NCT00500253|Gasotransmitters|gasotransmitters|mesh-ancestor
92686875|NCT00500253|Protective Agents|protective agents|mesh-ancestor
92686876|NCT00500253|Miotics|miotics|mesh-ancestor
92686877|NCT00500253|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92686878|NCT00500253|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92686879|NCT00500253|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92686880|NCT00500253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92686881|NCT00500253|Cholinergic Agents|cholinergic agents|mesh-ancestor
92686882|NCT01243788|Fluticasone|fluticasone|mesh-list
92686884|NCT01243788|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92686885|NCT01243788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686886|NCT01243788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92686887|NCT01243788|Autonomic Agents|autonomic agents|mesh-ancestor
92686888|NCT01243788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686889|NCT01243788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686890|NCT01243788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92686891|NCT01243788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92686892|NCT01243788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92686893|NCT01243788|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92686894|NCT01243788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92686895|NCT01243788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92686896|NCT01243788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92686897|NCT01243788|Adrenergic Agents|adrenergic agents|mesh-ancestor
92686898|NCT01243788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686899|NCT01243788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686900|NCT01243827|Carvedilol|carvedilol|mesh-list
92686901|NCT01243827|Bisoprolol|bisoprolol|mesh-list
92686902|NCT01243827|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92686903|NCT01243827|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92686904|NCT01243827|Adrenergic Agents|adrenergic agents|mesh-ancestor
92686905|NCT01243827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686906|NCT01243827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686907|NCT01243827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686908|NCT01243827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92686909|NCT01243827|Antioxidants|antioxidants|mesh-ancestor
92686910|NCT01243827|Protective Agents|protective agents|mesh-ancestor
92686911|NCT01243827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92686912|NCT01243827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686913|NCT01243827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92606991|NCT00403364|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92606992|NCT00403364|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92606994|NCT00403442|Verteporfin|verteporfin|mesh-list
92686914|NCT01243827|Vasodilator Agents|vasodilator agents|mesh-ancestor
92686915|NCT01243827|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92686916|NCT01243827|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92686917|NCT01243827|Sympatholytics|sympatholytics|mesh-ancestor
92686918|NCT01243827|Autonomic Agents|autonomic agents|mesh-ancestor
92094495|NCT03034408|Mannitol|mannitol|mesh-list
92686932|NCT00469352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686934|NCT00469430|Cefotaxime|cefotaxime|mesh-list
92686935|NCT00469430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686936|NCT00469430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686937|NCT00469430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92686938|NCT00469430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92686939|NCT00469469|Bevacizumab|bevacizumab|mesh-list
92686940|NCT00469469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92686941|NCT00469469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686942|NCT00469469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92686943|NCT00469469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92686944|NCT00469469|Growth Substances|growth substances|mesh-ancestor
92686945|NCT00469469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686946|NCT00469469|Growth Inhibitors|growth inhibitors|mesh-ancestor
92686947|NCT00500565|Bupivacaine|bupivacaine|mesh-list
92686948|NCT00500565|Anesthetics, Local|anesthetics, local|mesh-ancestor
92686949|NCT00500565|Anesthetics|anesthetics|mesh-ancestor
92686950|NCT00500565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686951|NCT00500565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686952|NCT00500565|Sensory System Agents|sensory system agents|mesh-ancestor
92686953|NCT00500565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686955|NCT00469547|Anti-Infective Agents|anti-infective agents|mesh-list
92686956|NCT00469547|Emollients|emollients|mesh-list
92686957|NCT00469547|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92686958|NCT00469547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686959|NCT00469547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686960|NCT00469547|Dermatologic Agents|dermatologic agents|mesh-ancestor
92686961|NCT00500604|Valsartan|valsartan|mesh-list
92686962|NCT00500604|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92686963|NCT00500604|Irbesartan|irbesartan|mesh-list
92686964|NCT00500604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92686965|NCT00500604|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92686966|NCT00500604|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92686967|NCT00500604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686968|NCT00500604|Diuretics|diuretics|mesh-ancestor
92686969|NCT00500604|Natriuretic Agents|natriuretic agents|mesh-ancestor
92686970|NCT00500604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686971|NCT00500604|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92686972|NCT00500604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686973|NCT00493389|Hormones|hormones|mesh-list
92686974|NCT00493389|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92686975|NCT00493389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686976|NCT00493389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686977|NCT01605994|Antacids|antacids|mesh-list
92686978|NCT01605994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686979|NCT01605994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92686980|NCT00500721|Desipramine|desipramine|mesh-list
92686983|NCT00500721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92686984|NCT00500721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686985|NCT00500721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686986|NCT00500721|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92686987|NCT00500721|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92686988|NCT00500721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686989|NCT00500721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92686990|NCT00500721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686991|NCT00500721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686992|NCT00469586|Insulin|insulin|mesh-list
92686993|NCT00469586|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92686994|NCT00469586|Metformin|metformin|mesh-list
92686995|NCT00469586|Glimepiride|glimepiride|mesh-list
92686996|NCT00469586|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92686997|NCT00469586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686998|NCT00469586|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92686999|NCT00469586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92606995|NCT00403442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92606996|NCT00403442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92606997|NCT00403442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92606998|NCT00403442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92606999|NCT00403442|Growth Substances|growth substances|mesh-ancestor
92687000|NCT00469586|Immunologic Factors|immunologic factors|mesh-ancestor
92687001|NCT01606111|Cerebrolysin|cerebrolysin|mesh-list
92687002|NCT01606111|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92687003|NCT01606111|Protective Agents|protective agents|mesh-ancestor
92369437|NCT05114837|Cyclophosphamide|cyclophosphamide|mesh-list
92687004|NCT01606111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687005|NCT01606111|Nootropic Agents|nootropic agents|mesh-ancestor
92687006|NCT00493428|Baclofen|baclofen|mesh-list
92687007|NCT00493428|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92687008|NCT00493428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687009|NCT00493428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92687010|NCT00493428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687011|NCT00493428|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92687012|NCT00493428|GABA Agonists|gaba agonists|mesh-ancestor
92687013|NCT00493428|GABA Agents|gaba agents|mesh-ancestor
92687014|NCT00493428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687015|NCT00493428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687016|NCT01342510|Lidocaine|lidocaine|mesh-list
92687017|NCT01342510|Magnesium Sulfate|magnesium sulfate|mesh-list
92687018|NCT01342510|Anesthetics, Local|anesthetics, local|mesh-ancestor
92687019|NCT01342510|Anesthetics|anesthetics|mesh-ancestor
92687020|NCT01342510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687021|NCT01342510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687022|NCT01342510|Sensory System Agents|sensory system agents|mesh-ancestor
92687023|NCT01342510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687024|NCT01342510|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92687025|NCT01342510|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92687026|NCT01342510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92687027|NCT01342510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687028|NCT01342510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687030|NCT01342510|Anticonvulsants|anticonvulsants|mesh-ancestor
92687031|NCT01342510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92687032|NCT01342510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92687033|NCT01342510|Tocolytic Agents|tocolytic agents|mesh-ancestor
92687034|NCT01342510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92687035|NCT01606345|Valrubicin|valrubicin|mesh-list
92687036|NCT01606345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687037|NCT01606345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92687038|NCT01606345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92687039|NCT01606345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687040|NCT01606345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687041|NCT01245894|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92687042|NCT01245894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92687043|NCT01245894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92687044|NCT01245894|Antimetabolites|antimetabolites|mesh-ancestor
92687045|NCT01245894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687046|NCT01245894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92687047|NCT01245894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92687048|NCT01245894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687049|NCT00469664|Guanfacine|guanfacine|mesh-list
92687050|NCT00469664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92687051|NCT00469664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92687052|NCT00469664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92687053|NCT00469664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92687055|NCT00469664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687056|NCT00469664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687057|NCT00469664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687058|NCT00469703|Thalidomide|thalidomide|mesh-list
92687059|NCT00469703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92687060|NCT00469703|Immunologic Factors|immunologic factors|mesh-ancestor
92687061|NCT00469703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687062|NCT00469703|Leprostatic Agents|leprostatic agents|mesh-ancestor
92687063|NCT00469703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92687064|NCT00469703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607000|NCT00403442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607002|NCT00403442|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92687065|NCT00469703|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687066|NCT00469703|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687067|NCT00469703|Growth Substances|growth substances|mesh-ancestor
92687068|NCT00469703|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687069|NCT00469703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687071|NCT01244100|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92687072|NCT01244100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687073|NCT01244100|Analgesics|analgesics|mesh-ancestor
92687074|NCT01244100|Sensory System Agents|sensory system agents|mesh-ancestor
92687075|NCT01244100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687076|NCT01244100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687077|NCT01244100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687078|NCT01244100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687079|NCT01244100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92687080|NCT01244100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92687081|NCT01244100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687082|NCT01244100|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92687083|NCT01244100|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92687084|NCT01244100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687085|NCT01244100|Antipyretics|antipyretics|mesh-ancestor
92687086|NCT01340872|Ferric maltol|ferric maltol|mesh-list
92687087|NCT01340872|Hematinics|hematinics|mesh-ancestor
92687088|NCT00469781|Bromfenac|bromfenac|mesh-list
92687089|NCT00469781|Prednisolone acetate|prednisolone acetate|mesh-list
92687090|NCT00469781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92687091|NCT00469781|Methylprednisolone|methylprednisolone|mesh-list
92687092|NCT00469781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92687093|NCT00469781|Prednisolone|prednisolone|mesh-list
92687094|NCT00469781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92687095|NCT00469781|Prednisolone phosphate|prednisolone phosphate|mesh-list
92687096|NCT00469781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92687097|NCT00469781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687098|NCT00469781|Analgesics|analgesics|mesh-ancestor
92687099|NCT00469781|Sensory System Agents|sensory system agents|mesh-ancestor
92687100|NCT00469781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687101|NCT00469781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687102|NCT00469781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687103|NCT00469781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687104|NCT00469781|Antiemetics|antiemetics|mesh-ancestor
92687105|NCT00469781|Autonomic Agents|autonomic agents|mesh-ancestor
92687106|NCT00469781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687107|NCT00469781|Glucocorticoids|glucocorticoids|mesh-ancestor
92687108|NCT00469781|Hormones|hormones|mesh-ancestor
92687109|NCT00469781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687110|NCT00469781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92687111|NCT00469781|Protective Agents|protective agents|mesh-ancestor
92687112|NCT00469781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92687113|NCT00469781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687114|NCT00474695|Ranibizumab|ranibizumab|mesh-list
92687115|NCT00474695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687116|NCT00474695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687117|NCT00474695|Growth Substances|growth substances|mesh-ancestor
92687118|NCT00474695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687119|NCT00474695|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687120|NCT00474695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687121|NCT03271502|Anesthetics|anesthetics|mesh-list
92687122|NCT03271502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687123|NCT03271502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687124|NCT00500955|Rosiglitazone|rosiglitazone|mesh-list
92687125|NCT00500955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92687126|NCT00500955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687127|NCT00474773|Celecoxib|celecoxib|mesh-list
92327593|NCT00003086|Melphalan|melphalan|mesh-list
92687159|NCT00501111|Cholinergic Agents|cholinergic agents|mesh-ancestor
92687160|NCT00501111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687161|NCT00501111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687162|NCT00501111|Nootropic Agents|nootropic agents|mesh-ancestor
92687163|NCT00501150|Linezolid|linezolid|mesh-list
92687164|NCT00501150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92687165|NCT00501150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607003|NCT00403442|Dermatologic Agents|dermatologic agents|mesh-ancestor
92607004|NCT00139386|Candesartan|candesartan|mesh-list
92607005|NCT00139386|Candesartan cilexetil|candesartan cilexetil|mesh-list
92607006|NCT00139386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92607007|NCT00139386|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92607008|NCT00139386|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92687166|NCT00501150|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92687167|NCT00501150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687168|NCT00501150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687171|NCT01340209|Autonomic Agents|autonomic agents|mesh-ancestor
92687172|NCT01340209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687173|NCT01340209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687174|NCT01340209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92687175|NCT01340209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92687176|NCT01340209|Parasympatholytics|parasympatholytics|mesh-ancestor
92687177|NCT01340209|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92687178|NCT01340209|Cholinergic Agents|cholinergic agents|mesh-ancestor
92687179|NCT01340209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687180|NCT01340209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687181|NCT01246089|Ranibizumab|ranibizumab|mesh-list
92687182|NCT01246089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687183|NCT01246089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687184|NCT01246089|Growth Substances|growth substances|mesh-ancestor
92687185|NCT01246089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687186|NCT01246089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687187|NCT01246089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687188|NCT00598897|Clarithromycin|clarithromycin|mesh-list
92687189|NCT00598897|Rifabutin|rifabutin|mesh-list
92687190|NCT00598897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92687191|NCT00598897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687192|NCT00598897|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92687193|NCT00598897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687194|NCT00598897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687195|NCT00598897|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92687196|NCT00598897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92687197|NCT00598897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92687198|NCT00598897|Antitubercular Agents|antitubercular agents|mesh-ancestor
92687199|NCT04697732|Anesthetics|anesthetics|mesh-list
92687200|NCT04697732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687201|NCT04697732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687202|NCT00501267|Oxybutynin|oxybutynin|mesh-list
92687203|NCT00501267|Solabegron|solabegron|mesh-list
92687204|NCT00501267|Parasympatholytics|parasympatholytics|mesh-ancestor
92687205|NCT00501267|Autonomic Agents|autonomic agents|mesh-ancestor
92687206|NCT00501267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687207|NCT00501267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687208|NCT00501267|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92687209|NCT00501267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92687210|NCT00501267|Cholinergic Agents|cholinergic agents|mesh-ancestor
92687211|NCT00501267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687212|NCT00501267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687213|NCT00501267|Urological Agents|urological agents|mesh-ancestor
92687214|NCT00501267|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92687215|NCT00501267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92687216|NCT00501267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92687217|NCT00501267|Adrenergic Agents|adrenergic agents|mesh-ancestor
92687218|NCT00469937|Lithium Carbonate|lithium carbonate|mesh-list
92687219|NCT00469937|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687220|NCT00469937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687221|NCT00469937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687222|NCT00469937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687223|NCT00469937|Antimanic Agents|antimanic agents|mesh-ancestor
92687224|NCT00469937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92687225|NCT00469937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687226|NCT00469937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687227|NCT00599287|Haloperidol|haloperidol|mesh-list
92687228|NCT00599287|Haloperidol decanoate|haloperidol decanoate|mesh-list
92687229|NCT00599287|Methylphenidate|methylphenidate|mesh-list
92607009|NCT00139386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607010|NCT00402974|Vitamin K 2|vitamin k 2|mesh-list
92607012|NCT00402974|Menaquinone 7|menaquinone 7|mesh-list
92687230|NCT00599287|Rivastigmine|rivastigmine|mesh-list
92687231|NCT00599287|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92687232|NCT00599287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687233|NCT00599287|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92687234|NCT00599287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92687235|NCT00599287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687236|NCT00599287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687237|NCT00599287|Dopamine Agents|dopamine agents|mesh-ancestor
92687238|NCT00599287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687239|NCT00599287|Antiemetics|antiemetics|mesh-ancestor
92687240|NCT00599287|Autonomic Agents|autonomic agents|mesh-ancestor
92687261|NCT00501384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687263|NCT00599560|Arginine Vasopressin|arginine vasopressin|mesh-list
92687264|NCT00599560|Hemostatics|hemostatics|mesh-ancestor
92687265|NCT00599560|Coagulants|coagulants|mesh-ancestor
92687266|NCT00599560|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92687267|NCT00599560|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92687268|NCT00599560|Natriuretic Agents|natriuretic agents|mesh-ancestor
92687269|NCT00599560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687270|NCT00599716|Hyaluronic Acid|hyaluronic acid|mesh-list
92687271|NCT00599716|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92687272|NCT00599716|Immunologic Factors|immunologic factors|mesh-ancestor
92687273|NCT00599716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687274|NCT00599716|Viscosupplements|viscosupplements|mesh-ancestor
92687275|NCT00599716|Protective Agents|protective agents|mesh-ancestor
92687276|NCT01246284|Triamcinolone|triamcinolone|mesh-list
92687277|NCT01246284|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92687278|NCT01246284|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92687279|NCT01246284|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92687280|NCT01246284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687281|NCT01246284|Glucocorticoids|glucocorticoids|mesh-ancestor
92687282|NCT01246284|Hormones|hormones|mesh-ancestor
92687283|NCT01246284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687284|NCT01246284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687285|NCT01246284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92687286|NCT01246284|Immunologic Factors|immunologic factors|mesh-ancestor
92687287|NCT01246284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687288|NCT01246284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687289|NCT00599833|Cetuximab|cetuximab|mesh-list
92687290|NCT00599833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92687291|NCT00599833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687292|NCT00469976|Bevacizumab|bevacizumab|mesh-list
92687293|NCT00469976|Carboplatin|carboplatin|mesh-list
92687294|NCT00469976|Gemcitabine|gemcitabine|mesh-list
92094873|NCT03430947|Vemurafenib|vemurafenib|mesh-list
92687324|NCT00599950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92687325|NCT00599950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687326|NCT00600145|Mirtazapine|mirtazapine|mesh-list
92687327|NCT00600145|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687328|NCT00600145|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687329|NCT00600145|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92687330|NCT00600145|Histamine Antagonists|histamine antagonists|mesh-ancestor
92687331|NCT00600145|Histamine Agents|histamine agents|mesh-ancestor
92687332|NCT00600145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687333|NCT00600145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687334|NCT00600145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687337|NCT00600145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687338|NCT00600145|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92687339|NCT00600145|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92687340|NCT00600145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92687341|NCT00600145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92687342|NCT00600145|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92687343|NCT00600145|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92687344|NCT00600145|Serotonin Agents|serotonin agents|mesh-ancestor
92687345|NCT00600145|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92687346|NCT00470015|Aldesleukin|aldesleukin|mesh-list
92687347|NCT00470015|Interleukin-2|interleukin-2|mesh-list
92687348|NCT00470015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607013|NCT00402974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92607014|NCT00402974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607015|NCT00402974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607016|NCT00402974|Hemostatics|hemostatics|mesh-ancestor
92607017|NCT00402974|Coagulants|coagulants|mesh-ancestor
92687349|NCT00470015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687350|NCT00470015|Analgesics|analgesics|mesh-ancestor
92687351|NCT00470015|Sensory System Agents|sensory system agents|mesh-ancestor
92687352|NCT00470015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687353|NCT00470015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687354|NCT00470015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92687355|NCT00470015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92687356|NCT00470015|Antiviral Agents|antiviral agents|mesh-ancestor
92687357|NCT00470015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687358|NCT00600262|Bevacizumab|bevacizumab|mesh-list
92687359|NCT00600262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92687360|NCT00600262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687361|NCT00600262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687362|NCT00600262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687363|NCT00600262|Growth Substances|growth substances|mesh-ancestor
92687364|NCT00600262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687365|NCT00600262|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687366|NCT00600301|Triamcinolone|triamcinolone|mesh-list
92687367|NCT00600301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92687368|NCT00600301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92687369|NCT00600301|Bevacizumab|bevacizumab|mesh-list
92687370|NCT00600301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92687371|NCT00600301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92687372|NCT00600301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687373|NCT00600301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687374|NCT00600301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687375|NCT00600301|Growth Substances|growth substances|mesh-ancestor
92687376|NCT00600301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687377|NCT00600301|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687378|NCT00600301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687379|NCT00600301|Glucocorticoids|glucocorticoids|mesh-ancestor
92687380|NCT00600301|Hormones|hormones|mesh-ancestor
92687381|NCT00600301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687382|NCT00600301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92687383|NCT00600301|Immunologic Factors|immunologic factors|mesh-ancestor
92687384|NCT00600301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687385|NCT00600301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687386|NCT00501579|Prednisolone|prednisolone|mesh-list
92687387|NCT00501579|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92687388|NCT00501579|Methylprednisolone|methylprednisolone|mesh-list
92687389|NCT00501579|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92687390|NCT00501579|Prednisolone acetate|prednisolone acetate|mesh-list
92687391|NCT00501579|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92687392|NCT00501579|Prednisolone phosphate|prednisolone phosphate|mesh-list
92687393|NCT00501579|Difluprednate|difluprednate|mesh-list
92687394|NCT00501579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687395|NCT00501579|Glucocorticoids|glucocorticoids|mesh-ancestor
92687396|NCT00501579|Hormones|hormones|mesh-ancestor
92687397|NCT00501579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687398|NCT00501579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107151|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687399|NCT00501579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92687400|NCT00501579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687401|NCT00501579|Antiemetics|antiemetics|mesh-ancestor
92687402|NCT00501579|Autonomic Agents|autonomic agents|mesh-ancestor
92687403|NCT00501579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687404|NCT00501579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687405|NCT00501579|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92687406|NCT00501579|Protective Agents|protective agents|mesh-ancestor
92687407|NCT00501618|Clozapine|clozapine|mesh-list
92687412|NCT00501618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687414|NCT00501618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92687415|NCT00501618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687416|NCT00501618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687417|NCT00501618|GABA Antagonists|gaba antagonists|mesh-ancestor
92687418|NCT00501618|GABA Agents|gaba agents|mesh-ancestor
92607018|NCT00402974|Vitamins|vitamins|mesh-ancestor
92607019|NCT00402974|Micronutrients|micronutrients|mesh-ancestor
92607020|NCT00402974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607021|NCT01731236|Aspirin|aspirin|mesh-list
92607022|NCT01731236|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92607023|NCT01731236|Vancomycin|vancomycin|mesh-list
92607024|NCT01731236|Ciprofloxacin|ciprofloxacin|mesh-list
92607025|NCT01731236|Neomycin|neomycin|mesh-list
92687419|NCT00600535|Abiraterone Acetate|abiraterone acetate|mesh-list
92687420|NCT00600535|Glucocorticoids|glucocorticoids|mesh-list
92687421|NCT00600535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687422|NCT00600535|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92687423|NCT00600535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687424|NCT00600535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687425|NCT00600535|Hormone Antagonists|hormone antagonists|mesh-ancestor
92687426|NCT00600535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687427|NCT00600535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687428|NCT00600535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92687429|NCT00600535|Hormones|hormones|mesh-ancestor
92687430|NCT00600691|Finasteride|finasteride|mesh-list
92687431|NCT00600691|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92687432|NCT00600691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92687433|NCT00600691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687434|NCT00600691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687435|NCT00600691|Hormone Antagonists|hormone antagonists|mesh-ancestor
92687436|NCT00600691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687437|NCT00600691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687438|NCT00600691|Urological Agents|urological agents|mesh-ancestor
92687439|NCT00623077|Etoposide|etoposide|mesh-list
92687440|NCT00623077|Melphalan|melphalan|mesh-list
92687441|NCT00623077|Busulfan|busulfan|mesh-list
92687442|NCT00623077|Ifosfamide|ifosfamide|mesh-list
92687443|NCT00623077|Thiotepa|thiotepa|mesh-list
92687444|NCT00623077|Sargramostim|sargramostim|mesh-list
92687446|NCT00623077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92687447|NCT00623077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687448|NCT00623077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92687449|NCT00623077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92687450|NCT00623077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687451|NCT00623077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687452|NCT00623077|Immunologic Factors|immunologic factors|mesh-ancestor
92687453|NCT00623077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687454|NCT00623077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92687455|NCT00623077|Alkylating Agents|alkylating agents|mesh-ancestor
92687456|NCT00623077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92687457|NCT00623077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92687458|NCT00623077|Protective Agents|protective agents|mesh-ancestor
92687459|NCT00475358|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92687460|NCT00475358|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92687461|NCT00475358|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92687462|NCT00475358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687463|NCT00475358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687464|NCT00475358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687465|NCT00475358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687466|NCT00475358|Analgesics|analgesics|mesh-ancestor
92687467|NCT00475358|Sensory System Agents|sensory system agents|mesh-ancestor
92687468|NCT00475358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687469|NCT00475358|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687470|NCT00475358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687471|NCT00475358|Dopamine Agents|dopamine agents|mesh-ancestor
92687472|NCT00623116|Testosterone|testosterone|mesh-list
92687474|NCT00623116|Androgens|androgens|mesh-ancestor
92687475|NCT00623116|Hormones|hormones|mesh-ancestor
92687476|NCT00623116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687477|NCT00623116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687483|NCT00623155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92687484|NCT00623155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687485|NCT00623155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92607027|NCT01731236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92607028|NCT01731236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92607029|NCT01731236|Analgesics|analgesics|mesh-ancestor
92607030|NCT01731236|Sensory System Agents|sensory system agents|mesh-ancestor
92607031|NCT01731236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607032|NCT01731236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687486|NCT00623155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687487|NCT00623155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687488|NCT00623155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92687489|NCT00600730|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92687490|NCT00600730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687491|NCT00600769|Clarithromycin|clarithromycin|mesh-list
92687492|NCT00600769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92687493|NCT00600769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687494|NCT00600769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92687495|NCT00600769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687496|NCT00600769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687497|NCT00600769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92687498|NCT00600769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92687499|NCT00470210|Ribavirin|ribavirin|mesh-list
92687500|NCT00470210|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92687501|NCT00470210|Antimetabolites|antimetabolites|mesh-ancestor
92369521|NCT04838379|Analgesics|analgesics|mesh-ancestor
92687502|NCT00470210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687503|NCT00470210|Antiviral Agents|antiviral agents|mesh-ancestor
92687504|NCT00470210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687505|NCT00600847|Loratadine|loratadine|mesh-list
92687506|NCT00600847|Desloratadine|desloratadine|mesh-list
92687507|NCT00600847|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92687508|NCT00600847|Cholinergic Agents|cholinergic agents|mesh-ancestor
92687509|NCT00600847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687510|NCT00600847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687511|NCT00600847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687512|NCT00600847|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92687513|NCT00600847|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92687514|NCT00600847|Histamine Antagonists|histamine antagonists|mesh-ancestor
92687515|NCT00600847|Histamine Agents|histamine agents|mesh-ancestor
92687516|NCT00600847|Antipruritics|antipruritics|mesh-ancestor
92687517|NCT00600847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92687518|NCT00600847|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92687519|NCT04325932|Kallikreins|kallikreins|mesh-list
92687520|NCT04325932|Coagulants|coagulants|mesh-ancestor
92687521|NCT04325932|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92687522|NCT04325932|Fertility Agents|fertility agents|mesh-ancestor
92687523|NCT04325932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92687524|NCT04325932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687525|NCT00501657|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92687526|NCT00501657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92687527|NCT00501657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687528|NCT00501657|Incretins|incretins|mesh-ancestor
92687529|NCT00501657|Hormones|hormones|mesh-ancestor
92687530|NCT00501657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687531|NCT00501657|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92687532|NCT00501657|Protease Inhibitors|protease inhibitors|mesh-ancestor
92687533|NCT00501657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687534|NCT00501657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687535|NCT00600964|Obatoclax|obatoclax|mesh-list
92687536|NCT00600964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687537|NCT00600964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687538|NCT00475397|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92687539|NCT00475397|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92687540|NCT00475397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92687541|NCT00475397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687542|NCT00475397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687543|NCT00475397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607033|NCT01731236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607034|NCT01731236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607035|NCT01731236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92607036|NCT01731236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92687544|NCT00475397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687545|NCT00475397|Analgesics|analgesics|mesh-ancestor
92327594|NCT00003086|Ifosfamide|ifosfamide|mesh-list
92687559|NCT00601042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687560|NCT00601042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687561|NCT00601042|Respiratory System Agents|respiratory system agents|mesh-ancestor
92687562|NCT00501696|Naltrexone|naltrexone|mesh-list
92687563|NCT00501696|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92687564|NCT00501696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92687565|NCT00501696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687566|NCT00501696|Sensory System Agents|sensory system agents|mesh-ancestor
92687567|NCT00501696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687568|NCT00601198|Leucovorin|leucovorin|mesh-list
92687569|NCT00601198|Oxaliplatin|oxaliplatin|mesh-list
92687570|NCT00601198|Levoleucovorin|levoleucovorin|mesh-list
92687571|NCT00601198|Amifostine|amifostine|mesh-list
92687572|NCT00601198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687573|NCT00601198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687574|NCT00601198|Antidotes|antidotes|mesh-ancestor
92687575|NCT00601198|Protective Agents|protective agents|mesh-ancestor
92687576|NCT00601198|Vitamin B Complex|vitamin b complex|mesh-ancestor
92687577|NCT00601198|Vitamins|vitamins|mesh-ancestor
92687578|NCT00601198|Micronutrients|micronutrients|mesh-ancestor
92687579|NCT00601198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92687580|NCT00601276|Leuprolide|leuprolide|mesh-list
92687581|NCT00601276|Cyproterone Acetate|cyproterone acetate|mesh-list
92687582|NCT00601276|Cyproterone|cyproterone|mesh-list
92687583|NCT00601276|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92687584|NCT00601276|Fertility Agents|fertility agents|mesh-ancestor
92687585|NCT00601276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92687586|NCT00601276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687587|NCT00601276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92687588|NCT00601276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687589|NCT00601276|Androgen Antagonists|androgen antagonists|mesh-ancestor
92687590|NCT00601276|Hormone Antagonists|hormone antagonists|mesh-ancestor
92687591|NCT00601276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687592|NCT00601276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92687593|NCT00601276|Contraceptive Agents|contraceptive agents|mesh-ancestor
92687594|NCT00601315|Clarithromycin|clarithromycin|mesh-list
92687595|NCT00601315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92687596|NCT00601315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687597|NCT00601315|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92687598|NCT00601315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687599|NCT00601315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687600|NCT00601315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92687601|NCT00601315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92687602|NCT00470249|Carboplatin|carboplatin|mesh-list
92687603|NCT00470249|Gemcitabine|gemcitabine|mesh-list
92687604|NCT00470249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687605|NCT00470249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687606|NCT00470249|Antimetabolites|antimetabolites|mesh-ancestor
92687607|NCT00470249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687608|NCT04325893|Hydroxychloroquine|hydroxychloroquine|mesh-list
92687609|NCT04325893|Antimalarials|antimalarials|mesh-ancestor
92687610|NCT04325893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92687614|NCT04325893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687616|NCT00601432|Levofloxacin|levofloxacin|mesh-list
92687617|NCT00601432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92687618|NCT00601432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687619|NCT00601432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92687620|NCT00601432|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92687621|NCT00601432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92687623|NCT00601432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687624|NCT00601432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687625|NCT00601432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92687626|NCT00601432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92687627|NCT00475514|Frovatriptan|frovatriptan|mesh-list
92045076|NCT02158039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045077|NCT03563222|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92687628|NCT00475514|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92687629|NCT00475514|Serotonin Agents|serotonin agents|mesh-ancestor
92687630|NCT00475514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687631|NCT00475514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687632|NCT00475514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687633|NCT00601510|Capecitabine|capecitabine|mesh-list
92687634|NCT00601510|Imatinib Mesylate|imatinib mesylate|mesh-list
92687635|NCT00601510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687636|NCT00601510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687637|NCT00601510|Antimetabolites|antimetabolites|mesh-ancestor
92687638|NCT00601510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687639|NCT00601510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92687640|NCT00601510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687641|NCT00601588|Sertraline|sertraline|mesh-list
92687642|NCT00601588|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687643|NCT00601588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687644|NCT00601588|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92687645|NCT00601588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92687646|NCT00601588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687647|NCT00601588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687648|NCT00601588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687649|NCT00601588|Serotonin Agents|serotonin agents|mesh-ancestor
92687650|NCT00601588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687651|NCT00601666|Zolpidem|zolpidem|mesh-list
92687652|NCT00601666|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92687653|NCT00601666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92687654|NCT00601666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687655|NCT00601666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687656|NCT00601666|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92687657|NCT00601666|GABA Agonists|gaba agonists|mesh-ancestor
92687658|NCT00601666|GABA Agents|gaba agents|mesh-ancestor
92687659|NCT00601666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687660|NCT00601666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687661|NCT01246362|Etoricoxib|etoricoxib|mesh-list
92687662|NCT01246362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92687663|NCT01246362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687664|NCT01246362|Analgesics|analgesics|mesh-ancestor
92687665|NCT01246362|Sensory System Agents|sensory system agents|mesh-ancestor
92687666|NCT01246362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687667|NCT01246362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687668|NCT01246362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687669|NCT01246362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687670|NCT01246362|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92687671|NCT01246362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92687672|NCT01246362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687673|NCT01246362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687674|NCT00470405|Oxaliplatin|oxaliplatin|mesh-list
92687675|NCT00470405|Pemetrexed|pemetrexed|mesh-list
92687676|NCT00470405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687677|NCT00470405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687678|NCT00470405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687679|NCT00470405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92327595|NCT00003086|Thiotepa|thiotepa|mesh-list
92687684|NCT00601978|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92687685|NCT00601978|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92687686|NCT00601978|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92687688|NCT00601978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687689|NCT00601978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687690|NCT00601978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687691|NCT00601978|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92687692|NCT00601978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107471|NCT01669642|Ketamine|ketamine|mesh-list
92687693|NCT00601978|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92687694|NCT00601978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92687695|NCT00601978|Immunologic Factors|immunologic factors|mesh-ancestor
92687696|NCT00601978|Dopamine Agonists|dopamine agonists|mesh-ancestor
92687697|NCT00601159|Gemcitabine|gemcitabine|mesh-list
92687698|NCT00601159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607037|NCT01731236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607038|NCT01731236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92607039|NCT01731236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92607040|NCT01731236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607041|NCT01731236|Antipyretics|antipyretics|mesh-ancestor
92607042|NCT01731236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607043|NCT01731236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607044|NCT01731236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607045|NCT01731236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607046|NCT01731236|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92607047|NCT01731236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92014435|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
92687699|NCT00601159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687700|NCT00601159|Antimetabolites|antimetabolites|mesh-ancestor
92687701|NCT00601159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687702|NCT00602017|Amlodipine|amlodipine|mesh-list
92687703|NCT00602017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92687704|NCT00602017|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92687705|NCT00602017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687706|NCT00602017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687707|NCT00602017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92687708|NCT00602017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687709|NCT00602017|Vasodilator Agents|vasodilator agents|mesh-ancestor
92687710|NCT00470483|Paroxetine|paroxetine|mesh-list
92687711|NCT00470483|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92687712|NCT00470483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92687713|NCT00470483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687714|NCT00470483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687715|NCT00470483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687716|NCT00470483|Serotonin Agents|serotonin agents|mesh-ancestor
92687717|NCT00470483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687718|NCT00470483|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92687719|NCT00470483|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687720|NCT00470483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687721|NCT00470483|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92687722|NCT00470483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92687723|NCT00470483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687724|NCT00602095|Misoprostol|misoprostol|mesh-list
92687725|NCT00602095|Dinoprostone|dinoprostone|mesh-list
92687726|NCT00602095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92687727|NCT00602095|Abortifacient Agents|abortifacient agents|mesh-ancestor
92687728|NCT00602095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92687729|NCT00602095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687730|NCT00602095|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92687731|NCT00602095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687732|NCT00602095|Oxytocics|oxytocics|mesh-ancestor
92687733|NCT00475553|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92687734|NCT00475553|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92687735|NCT00475553|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92687736|NCT00475553|Etonogestrel|etonogestrel|mesh-list
92687737|NCT00475553|Desogestrel|desogestrel|mesh-list
92687738|NCT00475553|NuvaRing|nuvaring|mesh-list
92687739|NCT00475553|Estradiol|estradiol|mesh-list
92687740|NCT00475553|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92687741|NCT00475553|Estrogens|estrogens|mesh-ancestor
92687742|NCT00475553|Hormones|hormones|mesh-ancestor
92687743|NCT00475553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687744|NCT00475553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687745|NCT00475553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92687746|NCT00475553|Contraceptive Agents|contraceptive agents|mesh-ancestor
92607048|NCT01731236|Lipotropic Agents|lipotropic agents|mesh-ancestor
92607049|NCT01731236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92607050|NCT01731236|Antimetabolites|antimetabolites|mesh-ancestor
92607051|NCT01731236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607052|NCT01731236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92607053|NCT01731236|Nootropic Agents|nootropic agents|mesh-ancestor
92607054|NCT01731236|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92607055|NCT03510078|Insulin|insulin|mesh-list
92607056|NCT03510078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92607057|NCT03510078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607058|NCT00139581|Pimecrolimus|pimecrolimus|mesh-list
92607059|NCT00139581|Tacrolimus|tacrolimus|mesh-list
92607060|NCT00139581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92607061|NCT00139581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92607062|NCT00139581|Analgesics|analgesics|mesh-ancestor
92607063|NCT00139581|Sensory System Agents|sensory system agents|mesh-ancestor
92607064|NCT00139581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607065|NCT00139581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332066|NCT00002923|KRN 5500|krn 5500|mesh-list
92607066|NCT00139581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687747|NCT00475553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92687748|NCT00475553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92687758|NCT00502164|Cediranib|cediranib|mesh-list
92687759|NCT00502164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687760|NCT00502164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92687761|NCT00502164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687762|NCT00502164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687763|NCT00470522|Folic Acid|folic acid|mesh-list
92687764|NCT00470522|Methotrexate|methotrexate|mesh-list
92687765|NCT00470522|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92687766|NCT00470522|Abortifacient Agents|abortifacient agents|mesh-ancestor
92687767|NCT00470522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92687768|NCT00470522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687769|NCT00470522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687770|NCT00470522|Antimetabolites|antimetabolites|mesh-ancestor
92687771|NCT00470522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687772|NCT00470522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687773|NCT00470522|Dermatologic Agents|dermatologic agents|mesh-ancestor
92687774|NCT00470522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687775|NCT00470522|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92687776|NCT00470522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92687777|NCT00470522|Immunologic Factors|immunologic factors|mesh-ancestor
92687778|NCT00470522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687779|NCT00470522|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92687781|NCT00470522|Vitamin B Complex|vitamin b complex|mesh-ancestor
92687782|NCT00470522|Vitamins|vitamins|mesh-ancestor
92687783|NCT00470522|Micronutrients|micronutrients|mesh-ancestor
92687784|NCT01244178|Insulin|insulin|mesh-list
92687785|NCT01244178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92687786|NCT01244178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92687787|NCT01244178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687788|NCT00470561|Aspirin|aspirin|mesh-list
92687789|NCT00470561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92687790|NCT00470561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687791|NCT00470561|Analgesics|analgesics|mesh-ancestor
92687792|NCT00470561|Sensory System Agents|sensory system agents|mesh-ancestor
92687793|NCT00470561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607067|NCT00139581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607068|NCT00139581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92687794|NCT00470561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687795|NCT00470561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687796|NCT00470561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687797|NCT00470561|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92369583|NCT04783857|Progesterone|progesterone|mesh-list
92687798|NCT00470561|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92687799|NCT00470561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687800|NCT00470561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92687801|NCT00470561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92687802|NCT00470561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687804|NCT00475826|Ezetimibe|ezetimibe|mesh-list
92687805|NCT00475826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92687806|NCT00475826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92687807|NCT00475826|Antimetabolites|antimetabolites|mesh-ancestor
92687808|NCT00475826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687809|NCT00475826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92687810|NCT00502437|Granisetron|granisetron|mesh-list
92687811|NCT00502437|Antiemetics|antiemetics|mesh-ancestor
92687812|NCT00502437|Autonomic Agents|autonomic agents|mesh-ancestor
92687813|NCT00502437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687814|NCT00502437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687815|NCT00502437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687826|NCT00470678|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687827|NCT00470678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687828|NCT00502476|Chlorhexidine|chlorhexidine|mesh-list
92687829|NCT00502476|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92687830|NCT00502476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687831|NCT00502476|Disinfectants|disinfectants|mesh-ancestor
92687832|NCT00493545|Poly ICLC|poly iclc|mesh-list
92687833|NCT00493545|Interferon Inducers|interferon inducers|mesh-ancestor
92687834|NCT00493545|Immunologic Factors|immunologic factors|mesh-ancestor
92687835|NCT00493545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687836|NCT00470873|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92687837|NCT00470873|Vasodilator Agents|vasodilator agents|mesh-ancestor
92687838|NCT00470873|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92687839|NCT00470873|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92687840|NCT00470873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687841|NCT00470873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687842|NCT00470873|Urological Agents|urological agents|mesh-ancestor
92687843|NCT00493623|Ibandronic Acid|ibandronic acid|mesh-list
92687844|NCT00493623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92687845|NCT00493623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687846|NCT00476099|Budesonide|budesonide|mesh-list
92687847|NCT00476099|Beclomethasone|beclomethasone|mesh-list
92687848|NCT00476099|Formoterol Fumarate|formoterol fumarate|mesh-list
92687849|NCT00476099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687850|NCT00476099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92687851|NCT00476099|Autonomic Agents|autonomic agents|mesh-ancestor
92687852|NCT00476099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687853|NCT00476099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687854|NCT00476099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92687855|NCT00476099|Respiratory System Agents|respiratory system agents|mesh-ancestor
92687856|NCT00476099|Glucocorticoids|glucocorticoids|mesh-ancestor
92687857|NCT00476099|Hormones|hormones|mesh-ancestor
92687858|NCT00476099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687859|NCT00476099|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92687860|NCT00476099|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92687861|NCT00476099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92687862|NCT00476099|Adrenergic Agents|adrenergic agents|mesh-ancestor
92687863|NCT00476099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687864|NCT00476099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687865|NCT00493662|Hyaluronic Acid|hyaluronic acid|mesh-list
92687866|NCT00493662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92687867|NCT00493662|Immunologic Factors|immunologic factors|mesh-ancestor
92687868|NCT00493662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687869|NCT00493662|Viscosupplements|viscosupplements|mesh-ancestor
92687870|NCT00493662|Protective Agents|protective agents|mesh-ancestor
92687871|NCT00470912|Sunscreening Agents|sunscreening agents|mesh-list
92687872|NCT00470912|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92687873|NCT00470912|Protective Agents|protective agents|mesh-ancestor
92687874|NCT00470912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687875|NCT00470912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92607069|NCT00139581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014465|NCT02595749|Oxytocin|oxytocin|mesh-list
92687876|NCT00476138|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92687877|NCT00476138|Antioxidants|antioxidants|mesh-ancestor
92687878|NCT00476138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687879|NCT00476138|Protective Agents|protective agents|mesh-ancestor
92687892|NCT01246440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687894|NCT00471029|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92687895|NCT00471029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687896|NCT00471029|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92687897|NCT00471029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687898|NCT00471029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687899|NCT00476216|Fondaparinux|fondaparinux|mesh-list
92687900|NCT00476216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92687901|NCT00476216|Antithrombins|antithrombins|mesh-ancestor
92687902|NCT00476216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92687903|NCT00476216|Protease Inhibitors|protease inhibitors|mesh-ancestor
92687904|NCT00476216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687905|NCT00476216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687906|NCT00476216|Anticoagulants|anticoagulants|mesh-ancestor
92687907|NCT00471185|Acyline|acyline|mesh-list
92687908|NCT00471185|Hormone Antagonists|hormone antagonists|mesh-ancestor
92687909|NCT00471185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687910|NCT00471185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687911|NCT00493857|Nimotuzumab|nimotuzumab|mesh-list
92687912|NCT00493857|Antibodies|antibodies|mesh-list
92687913|NCT00493857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92687914|NCT00493857|Immunologic Factors|immunologic factors|mesh-ancestor
92687915|NCT00493857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687916|NCT00493857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92687917|NCT00493857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687918|NCT00502788|Ribavirin|ribavirin|mesh-list
92687919|NCT00502788|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92687920|NCT00502788|Antimetabolites|antimetabolites|mesh-ancestor
92687921|NCT00502788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687922|NCT00502788|Antiviral Agents|antiviral agents|mesh-ancestor
92687923|NCT00502788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687924|NCT00602134|Mercaptopurine|mercaptopurine|mesh-list
92687925|NCT00602134|Antimetabolites|antimetabolites|mesh-ancestor
92687926|NCT00602134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687927|NCT00602134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687928|NCT00602134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687929|NCT00602134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92687930|NCT00602134|Immunologic Factors|immunologic factors|mesh-ancestor
92687931|NCT00602134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687932|NCT00602134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92687933|NCT00602134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687934|NCT00494208|Testosterone|testosterone|mesh-list
92687935|NCT00494208|Androgens|androgens|mesh-ancestor
92687936|NCT00494208|Hormones|hormones|mesh-ancestor
92687937|NCT00494208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687938|NCT00494208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687939|NCT00471341|Celecoxib|celecoxib|mesh-list
92687940|NCT00471341|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92095526|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
92687943|NCT00471341|Sensory System Agents|sensory system agents|mesh-ancestor
92687944|NCT00471341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687945|NCT00471341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687946|NCT00471341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687948|NCT00471341|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92687949|NCT00471341|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92687950|NCT00471341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687951|NCT00471341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687952|NCT01325428|Vinorelbine|vinorelbine|mesh-list
92687953|NCT01325428|Afatinib|afatinib|mesh-list
92687954|NCT01325428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92687955|NCT01325428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687956|NCT01325428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92687957|NCT01325428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92687958|NCT01325428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92687959|NCT01325428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607071|NCT00139581|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92607072|NCT00139581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607073|NCT00139581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607075|NCT03500913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014469|NCT05221749|Fluorides|fluorides|mesh-list
92687960|NCT01325428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92687961|NCT01325428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687962|NCT00494247|Antibodies|antibodies|mesh-list
92687963|NCT00494247|Immunologic Factors|immunologic factors|mesh-ancestor
92687964|NCT00494247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687965|NCT00471419|Rimexolone|rimexolone|mesh-list
92687966|NCT00471419|Glucocorticoids|glucocorticoids|mesh-ancestor
92687967|NCT00471419|Hormones|hormones|mesh-ancestor
92687968|NCT00471419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687969|NCT00471419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687970|NCT01325350|Bimatoprost|bimatoprost|mesh-list
92687971|NCT01325350|Minoxidil|minoxidil|mesh-list
92687972|NCT01325350|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92687973|NCT01325350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92687974|NCT01325350|Vasodilator Agents|vasodilator agents|mesh-ancestor
92687975|NCT01324999|Tadalafil|tadalafil|mesh-list
92687976|NCT01324999|Vasodilator Agents|vasodilator agents|mesh-ancestor
92687977|NCT01324999|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92687978|NCT01324999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92687979|NCT01324999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687980|NCT01324999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687981|NCT01324999|Urological Agents|urological agents|mesh-ancestor
92687982|NCT01324570|Buprenorphine|buprenorphine|mesh-list
92687983|NCT01324570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92687984|NCT01324570|Narcotics|narcotics|mesh-ancestor
92687985|NCT01324570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687986|NCT01324570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687987|NCT01324570|Analgesics|analgesics|mesh-ancestor
92687988|NCT01324570|Sensory System Agents|sensory system agents|mesh-ancestor
92687989|NCT01324570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687990|NCT01324570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92107753|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
92687991|NCT04325698|Paclitaxel|paclitaxel|mesh-list
92687993|NCT04325698|Carboplatin|carboplatin|mesh-list
92687994|NCT04325698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92687995|NCT04325698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687996|NCT04325698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92687997|NCT04325698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92687998|NCT04325698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92687999|NCT04325698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688000|NCT04325698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688001|NCT04325698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92688002|NCT04325698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92688003|NCT04325698|Growth Substances|growth substances|mesh-ancestor
92688004|NCT04325698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688005|NCT04325698|Growth Inhibitors|growth inhibitors|mesh-ancestor
92688006|NCT01324141|Fluorouracil|fluorouracil|mesh-list
92688007|NCT01324141|Mitomycins|mitomycins|mesh-list
92688008|NCT01324141|Mitomycin|mitomycin|mesh-list
92688009|NCT01324141|Tempol|tempol|mesh-list
92688010|NCT01324141|Antimetabolites|antimetabolites|mesh-ancestor
92688011|NCT01324141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688012|NCT01324141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688013|NCT01324141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688014|NCT01324141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688016|NCT01324141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688017|NCT01324141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92688018|NCT01324141|Alkylating Agents|alkylating agents|mesh-ancestor
92688019|NCT01324141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92688020|NCT01324141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688021|NCT01324141|Antioxidants|antioxidants|mesh-ancestor
92688022|NCT01324141|Protective Agents|protective agents|mesh-ancestor
92688023|NCT01324141|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92688024|NCT01324141|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92688025|NCT01324141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92607076|NCT03500913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607077|NCT00139620|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92607078|NCT00139620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607079|NCT00139620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92607080|NCT00139620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014470|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
92688026|NCT01324024|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92688027|NCT01324024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92688028|NCT01324024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688029|NCT01324024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92688030|NCT01324024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92688031|NCT01324024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92688032|NCT01324024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688033|NCT01324024|Dopamine Agents|dopamine agents|mesh-ancestor
92688034|NCT01324024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688035|NCT01244217|Fexofenadine|fexofenadine|mesh-list
92688036|NCT01244217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92688037|NCT01244217|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92688038|NCT01244217|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92688039|NCT01244217|Histamine Antagonists|histamine antagonists|mesh-ancestor
92688040|NCT01244217|Histamine Agents|histamine agents|mesh-ancestor
92688041|NCT01244217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688042|NCT01244217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688043|NCT01244217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688044|NCT00471653|Temozolomide|temozolomide|mesh-list
92688045|NCT00471653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92688046|NCT00471653|Alkylating Agents|alkylating agents|mesh-ancestor
92688047|NCT00471653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688048|NCT00471653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688049|NCT00494559|Pioglitazone|pioglitazone|mesh-list
92688050|NCT00494559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92688051|NCT00494559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688053|NCT00494598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92688054|NCT00494598|Narcotics|narcotics|mesh-ancestor
92688055|NCT00494598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688056|NCT00494598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688057|NCT00494598|Analgesics|analgesics|mesh-ancestor
92688058|NCT00494598|Sensory System Agents|sensory system agents|mesh-ancestor
92688059|NCT00494598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688060|NCT00494598|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92688061|NCT00494598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92688062|NCT00494598|Anesthetics, General|anesthetics, general|mesh-ancestor
92688063|NCT00494598|Anesthetics|anesthetics|mesh-ancestor
92688064|NCT00503412|Cediranib|cediranib|mesh-list
92688065|NCT00503412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688066|NCT00503412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688067|NCT00503412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688068|NCT00503412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688070|NCT00503451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369616|NCT04704141|Hormones|hormones|mesh-list
92688071|NCT00503451|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92688072|NCT00503451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688073|NCT00503451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688074|NCT00471809|Azithromycin|azithromycin|mesh-list
92688075|NCT00471809|Budesonide|budesonide|mesh-list
92688076|NCT00471809|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92688077|NCT00471809|Montelukast|montelukast|mesh-list
92688078|NCT00471809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688079|NCT00471809|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92688080|NCT00471809|Autonomic Agents|autonomic agents|mesh-ancestor
92688081|NCT00471809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688082|NCT00471809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688083|NCT00471809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92688084|NCT00471809|Respiratory System Agents|respiratory system agents|mesh-ancestor
92688085|NCT00471809|Glucocorticoids|glucocorticoids|mesh-ancestor
92688086|NCT00471809|Hormones|hormones|mesh-ancestor
92688087|NCT00471809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607081|NCT00139620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607082|NCT00130481|Atorvastatin|atorvastatin|mesh-list
92607083|NCT00130481|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92014477|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
92688088|NCT00471809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688108|NCT00503490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688109|NCT00503490|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92688110|NCT00503490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92688111|NCT00471965|Leucovorin|leucovorin|mesh-list
92688112|NCT00471965|Doxorubicin|doxorubicin|mesh-list
92688113|NCT00471965|Fluorouracil|fluorouracil|mesh-list
92688114|NCT00471965|Oxaliplatin|oxaliplatin|mesh-list
92688115|NCT00471965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92688116|NCT00471965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688117|NCT00471965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92688118|NCT00471965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92688119|NCT00471965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688120|NCT00471965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688121|NCT00471965|Antimetabolites|antimetabolites|mesh-ancestor
92688122|NCT00471965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688123|NCT00471965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688124|NCT00471965|Immunologic Factors|immunologic factors|mesh-ancestor
92688125|NCT00471965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688126|NCT00471965|Antidotes|antidotes|mesh-ancestor
92688127|NCT00471965|Protective Agents|protective agents|mesh-ancestor
92688128|NCT00471965|Vitamin B Complex|vitamin b complex|mesh-ancestor
92688129|NCT00471965|Vitamins|vitamins|mesh-ancestor
92688130|NCT00471965|Micronutrients|micronutrients|mesh-ancestor
92688131|NCT00472004|Tibolone|tibolone|mesh-list
92688132|NCT00472004|Estradiol|estradiol|mesh-list
92688133|NCT00472004|Estrogens|estrogens|mesh-ancestor
92688134|NCT00472004|Hormones|hormones|mesh-ancestor
92688135|NCT00472004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688136|NCT00472004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688137|NCT00472004|Androgen Antagonists|androgen antagonists|mesh-ancestor
92688138|NCT00472004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92688139|NCT00472004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92107910|NCT01712230|Leuprolide|leuprolide|mesh-list
92688140|NCT00472004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92688141|NCT00472004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688142|NCT00472004|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92688155|NCT00472043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688156|NCT03271073|Apatinib|apatinib|mesh-list
92688157|NCT03271073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688158|NCT03271073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688159|NCT03271073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688160|NCT03271073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688161|NCT01246557|Dexamethasone|dexamethasone|mesh-list
92688162|NCT01246557|Lenalidomide|lenalidomide|mesh-list
92688163|NCT01246557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688164|NCT01246557|Antiemetics|antiemetics|mesh-ancestor
92688165|NCT01246557|Autonomic Agents|autonomic agents|mesh-ancestor
92688166|NCT01246557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688167|NCT01246557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369633|NCT04675931|Antiviral Agents|antiviral agents|mesh-ancestor
92688168|NCT01246557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688169|NCT01246557|Glucocorticoids|glucocorticoids|mesh-ancestor
92688170|NCT01246557|Hormones|hormones|mesh-ancestor
92688171|NCT01246557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688172|NCT01246557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92688173|NCT01246557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688174|NCT01246557|Immunologic Factors|immunologic factors|mesh-ancestor
92688175|NCT01246557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92688176|NCT01246557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92688177|NCT01246557|Growth Substances|growth substances|mesh-ancestor
92688178|NCT01246557|Growth Inhibitors|growth inhibitors|mesh-ancestor
92688179|NCT00476918|Triamcinolone|triamcinolone|mesh-list
92688180|NCT00476918|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92688181|NCT00476918|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92688182|NCT00476918|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92688183|NCT00476918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688184|NCT00476918|Glucocorticoids|glucocorticoids|mesh-ancestor
92688185|NCT00476918|Hormones|hormones|mesh-ancestor
92688186|NCT00476918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607084|NCT00130481|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92607085|NCT00130481|Antimetabolites|antimetabolites|mesh-ancestor
92607086|NCT00130481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607087|NCT00130481|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92014480|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92688187|NCT00476918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688188|NCT00476918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688189|NCT00476918|Immunologic Factors|immunologic factors|mesh-ancestor
92688190|NCT00476918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688191|NCT00476918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688192|NCT01323790|Naloxegol|naloxegol|mesh-list
92688193|NCT01323790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92688194|NCT01323790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688195|NCT01323790|Sensory System Agents|sensory system agents|mesh-ancestor
92688196|NCT01323790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688197|NCT00477035|Cyclophosphamide|cyclophosphamide|mesh-list
92688198|NCT00477035|Melphalan|melphalan|mesh-list
92688199|NCT00477035|Carmustine|carmustine|mesh-list
92688200|NCT00477035|Gemcitabine|gemcitabine|mesh-list
92688201|NCT00477035|Etoposide|etoposide|mesh-list
92688202|NCT00477035|Vinorelbine|vinorelbine|mesh-list
92688203|NCT00477035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688204|NCT00477035|Immunologic Factors|immunologic factors|mesh-ancestor
92688205|NCT00477035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688206|NCT00477035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92688207|NCT00477035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92688218|NCT00477035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688219|NCT00477035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92688220|NCT00477035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92688222|NCT00494832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688223|NCT00494832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688224|NCT00494832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688225|NCT00494832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92688227|NCT00494832|Sensory System Agents|sensory system agents|mesh-ancestor
92688228|NCT00494832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688229|NCT00494832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92688230|NCT00494832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92688231|NCT00494832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688232|NCT00494832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688233|NCT00494832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688234|NCT00494832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688235|NCT00477074|Dimercaprol|dimercaprol|mesh-list
92688236|NCT00477074|Chelating Agents|chelating agents|mesh-ancestor
92688237|NCT00477074|Sequestering Agents|sequestering agents|mesh-ancestor
92688238|NCT00477074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688239|NCT01323673|Clobetasol|clobetasol|mesh-list
92688240|NCT01323673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688241|NCT01323673|Glucocorticoids|glucocorticoids|mesh-ancestor
92688242|NCT01323673|Hormones|hormones|mesh-ancestor
92688243|NCT01323673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688244|NCT01323673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688245|NCT00494949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92688246|NCT01246752|Cytarabine|cytarabine|mesh-list
92688247|NCT01246752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688248|NCT01246752|Antimetabolites|antimetabolites|mesh-ancestor
92688249|NCT01246752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688250|NCT01246752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688251|NCT01246752|Antiviral Agents|antiviral agents|mesh-ancestor
92688252|NCT01246752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688253|NCT01246752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688254|NCT01246752|Immunologic Factors|immunologic factors|mesh-ancestor
92688255|NCT01246752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688256|NCT01323634|Fluticasone|fluticasone|mesh-list
92688257|NCT01323634|Xhance|xhance|mesh-list
92688258|NCT01323634|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92688259|NCT01323634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688260|NCT01323634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92688261|NCT01323634|Autonomic Agents|autonomic agents|mesh-ancestor
92688262|NCT01323634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688263|NCT01323634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607088|NCT00130481|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92607089|NCT00130481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688264|NCT01323634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92688265|NCT01323634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92688266|NCT01323634|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688267|NCT01323634|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92688268|NCT01323634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92688269|NCT01323634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92688270|NCT01323634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688271|NCT01323634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688275|NCT05645302|Anesthetics, Local|anesthetics, local|mesh-ancestor
92688276|NCT05645302|Anesthetics|anesthetics|mesh-ancestor
92688277|NCT05645302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688278|NCT05645302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688279|NCT05645302|Sensory System Agents|sensory system agents|mesh-ancestor
92688280|NCT05645302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688281|NCT05645302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92688282|NCT05645302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92688283|NCT05645302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92688284|NCT05645302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92688285|NCT05645302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688286|NCT00494988|Insulin|insulin|mesh-list
92688287|NCT00494988|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92688288|NCT00494988|Insulin Aspart|insulin aspart|mesh-list
92688289|NCT00494988|Isophane Insulin, Human|isophane insulin, human|mesh-list
92688290|NCT00494988|Insulin, Isophane|insulin, isophane|mesh-list
92688291|NCT00494988|Isophane insulin, beef|isophane insulin, beef|mesh-list
92688292|NCT00494988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92688293|NCT00494988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688294|NCT01323478|Vortioxetine|vortioxetine|mesh-list
92688295|NCT01323478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92688296|NCT01323478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92688297|NCT01323478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92688298|NCT01323478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92688299|NCT01323478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688300|NCT01323478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688301|NCT01323478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92688302|NCT01323478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92688303|NCT01323478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92688304|NCT01323478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688305|NCT01323478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688306|NCT01323478|Serotonin Agents|serotonin agents|mesh-ancestor
92688307|NCT01323478|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92688308|NCT01323478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92688309|NCT01323478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92688310|NCT01323478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92688311|NCT00472355|Apomorphine|apomorphine|mesh-list
92688312|NCT00472355|Emetics|emetics|mesh-ancestor
92688313|NCT00472355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688314|NCT00472355|Autonomic Agents|autonomic agents|mesh-ancestor
92688315|NCT00472355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688316|NCT00472355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688317|NCT00472355|Dopamine Agonists|dopamine agonists|mesh-ancestor
92688318|NCT00472355|Dopamine Agents|dopamine agents|mesh-ancestor
92688319|NCT00472355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688320|NCT00472355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688321|NCT04325581|Liraglutide|liraglutide|mesh-list
92688322|NCT04325581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92688323|NCT04325581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688324|NCT04325581|Incretins|incretins|mesh-ancestor
92688325|NCT04325581|Hormones|hormones|mesh-ancestor
92688326|NCT04325581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688327|NCT04325776|Zoledronic Acid|zoledronic acid|mesh-list
92688328|NCT04325776|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92688329|NCT04325776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688330|NCT01322386|Vancomycin|vancomycin|mesh-list
92688331|NCT01322386|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688332|NCT01322386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688333|NCT00495066|Ipilimumab|ipilimumab|mesh-list
92688334|NCT00495066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688335|NCT00495066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607090|NCT00139698|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92607091|NCT00139698|Olmesartan|olmesartan|mesh-list
92607092|NCT00139698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92607093|NCT00139698|Diuretics|diuretics|mesh-ancestor
92688336|NCT00495066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92688337|NCT00495066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688338|NCT00472433|Alemtuzumab|alemtuzumab|mesh-list
92688339|NCT00472433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688340|NCT00472433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688341|NCT00472472|Paclitaxel|paclitaxel|mesh-list
92688345|NCT00472472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92688346|NCT00472472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92688347|NCT00472472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688348|NCT00503568|Vaccines|vaccines|mesh-list
92688349|NCT00503568|Immunologic Factors|immunologic factors|mesh-ancestor
92688350|NCT00503568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688351|NCT00472550|Esomeprazole|esomeprazole|mesh-list
92688352|NCT00472550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92688353|NCT00472550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688354|NCT00472550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92688355|NCT00472550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688356|NCT00472550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688357|NCT00503607|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92688358|NCT00503607|Laxatives|laxatives|mesh-ancestor
92688359|NCT00503607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688360|NCT00477503|Pentetic Acid|pentetic acid|mesh-list
92688361|NCT00477503|Gallium citrate|gallium citrate|mesh-list
92688362|NCT00477503|Chelating Agents|chelating agents|mesh-ancestor
92688363|NCT00477503|Sequestering Agents|sequestering agents|mesh-ancestor
92688364|NCT00477503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688365|NCT00477503|Antidotes|antidotes|mesh-ancestor
92688366|NCT00477503|Protective Agents|protective agents|mesh-ancestor
92688367|NCT00477503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688368|NCT00477503|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92688369|NCT00477503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92688370|NCT01244334|Prednisolone|prednisolone|mesh-list
92688371|NCT01244334|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92688372|NCT01244334|Methylprednisolone|methylprednisolone|mesh-list
92688373|NCT01244334|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92688374|NCT01244334|Prednisolone acetate|prednisolone acetate|mesh-list
92688375|NCT01244334|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92688376|NCT01244334|Prednisolone phosphate|prednisolone phosphate|mesh-list
92688377|NCT01244334|Difluprednate|difluprednate|mesh-list
92688378|NCT01244334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688379|NCT01244334|Glucocorticoids|glucocorticoids|mesh-ancestor
92688380|NCT01244334|Hormones|hormones|mesh-ancestor
92688381|NCT01244334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688382|NCT01244334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688383|NCT01244334|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92688384|NCT01244334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688385|NCT01244334|Antiemetics|antiemetics|mesh-ancestor
92688386|NCT01244334|Autonomic Agents|autonomic agents|mesh-ancestor
92688387|NCT01244334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688388|NCT01244334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688389|NCT01244334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92688390|NCT01244334|Protective Agents|protective agents|mesh-ancestor
92688391|NCT00477542|Clofarabine|clofarabine|mesh-list
92688392|NCT00477542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688393|NCT00477542|Antimetabolites|antimetabolites|mesh-ancestor
92688394|NCT00477542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688395|NCT00477542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688396|NCT00503763|Simvastatin|simvastatin|mesh-list
92688397|NCT00503763|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92688398|NCT00503763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92688399|NCT00503763|Antimetabolites|antimetabolites|mesh-ancestor
92688400|NCT00503763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688401|NCT00503763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92688402|NCT00503763|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92688403|NCT00503763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688404|NCT00477581|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92688405|NCT00477581|Exenatide|exenatide|mesh-list
92688406|NCT00477581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92688407|NCT00477581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607094|NCT00139698|Natriuretic Agents|natriuretic agents|mesh-ancestor
92607095|NCT00139698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607096|NCT00139698|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92607097|NCT00139698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369688|NCT04573751|Epinephryl borate|epinephryl borate|mesh-list
92607098|NCT00139698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607099|NCT00139698|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92688408|NCT00477581|Incretins|incretins|mesh-ancestor
92688410|NCT00477581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688411|NCT00477581|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92688412|NCT00477581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92688413|NCT00477581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688429|NCT00477776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688430|NCT00477776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688432|NCT00477776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92688433|NCT00477776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92688434|NCT00477776|Dopamine Agents|dopamine agents|mesh-ancestor
92688435|NCT00477776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688436|NCT00477776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688437|NCT00477815|Rituximab|rituximab|mesh-list
92688438|NCT00477815|Melphalan|melphalan|mesh-list
92688439|NCT00477815|Sargramostim|sargramostim|mesh-list
92688440|NCT00477815|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92688441|NCT00477815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688442|NCT00477815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688443|NCT00477815|Immunologic Factors|immunologic factors|mesh-ancestor
92688444|NCT00477815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688445|NCT00477815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92688446|NCT00477815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92688447|NCT00477815|Alkylating Agents|alkylating agents|mesh-ancestor
92688448|NCT00477815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688449|NCT00477815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92688450|NCT00477815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688451|NCT00477854|Chromium|chromium|mesh-list
92688452|NCT00477854|Picolinic acid|picolinic acid|mesh-list
92688453|NCT00477854|Trace Elements|trace elements|mesh-ancestor
92688454|NCT00477854|Micronutrients|micronutrients|mesh-ancestor
92688455|NCT00477854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688456|NCT00477854|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92688457|NCT00477854|Chelating Agents|chelating agents|mesh-ancestor
92688458|NCT00477854|Sequestering Agents|sequestering agents|mesh-ancestor
92688459|NCT00477854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688460|NCT00477893|Adalimumab|adalimumab|mesh-list
92688461|NCT00477893|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92688462|NCT00477893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688463|NCT00477893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92688464|NCT01247337|Gemcitabine|gemcitabine|mesh-list
92688465|NCT01247337|Capecitabine|capecitabine|mesh-list
92688466|NCT01247337|Oxaliplatin|oxaliplatin|mesh-list
92688467|NCT01247337|Cetuximab|cetuximab|mesh-list
92688468|NCT01247337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688469|NCT01247337|Antimetabolites|antimetabolites|mesh-ancestor
92688470|NCT01247337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688471|NCT01247337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688472|NCT01247337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688473|NCT00478049|Docetaxel|docetaxel|mesh-list
92688474|NCT00478049|Gefitinib|gefitinib|mesh-list
92688477|NCT00478049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92688478|NCT00478049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92688479|NCT00478049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688480|NCT00478049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688481|NCT00478049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688482|NCT01248975|Montelukast|montelukast|mesh-list
92688483|NCT01248975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92688484|NCT01248975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92688485|NCT01248975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92688486|NCT01248975|Hormone Antagonists|hormone antagonists|mesh-ancestor
92607100|NCT00139698|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92607101|NCT00130676|Mifepristone|mifepristone|mesh-list
92607102|NCT00130676|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92607103|NCT00130676|Abortifacient Agents|abortifacient agents|mesh-ancestor
92607104|NCT00130676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92688487|NCT01248975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688488|NCT01248975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688489|NCT01248975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92688490|NCT01248975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92688491|NCT01248975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688492|NCT02955927|Atropine|atropine|mesh-list
92688493|NCT02955927|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92688494|NCT02955927|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92688495|NCT02955927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92688496|NCT02955927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92688497|NCT02955927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92688498|NCT02955927|Autonomic Agents|autonomic agents|mesh-ancestor
92688499|NCT02955927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688500|NCT02955927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688501|NCT02955927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92688502|NCT02955927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92688503|NCT02955927|Mydriatics|mydriatics|mesh-ancestor
92688504|NCT02955927|Parasympatholytics|parasympatholytics|mesh-ancestor
92688505|NCT02955927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92688506|NCT02955927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92688507|NCT02955927|Cholinergic Agents|cholinergic agents|mesh-ancestor
92688508|NCT02955927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688509|NCT02955927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688510|NCT01322347|Dialysis Solutions|dialysis solutions|mesh-list
92688511|NCT01322347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92688512|NCT01247493|Cytarabine|cytarabine|mesh-list
92688513|NCT01247493|Fludarabine|fludarabine|mesh-list
92688514|NCT01247493|Idarubicin|idarubicin|mesh-list
92688515|NCT01247493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688516|NCT01247493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688518|NCT01247493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688519|NCT01247493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688520|NCT01247493|Immunologic Factors|immunologic factors|mesh-ancestor
92688521|NCT01247493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688522|NCT01247493|Antiviral Agents|antiviral agents|mesh-ancestor
92688523|NCT01247493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688524|NCT01247493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92688525|NCT01247493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92688526|NCT01247493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92688527|NCT01247493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688528|NCT04325425|Carboplatin|carboplatin|mesh-list
92688529|NCT04325425|Etoposide|etoposide|mesh-list
92688530|NCT04325425|Folfirinox|folfirinox|mesh-list
92688531|NCT04325425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688532|NCT04325425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92688533|NCT04325425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92688534|NCT04325425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92688535|NCT04325425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688536|NCT04325425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688537|NCT02891395|Imatinib Mesylate|imatinib mesylate|mesh-list
92688538|NCT02891395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688539|NCT02891395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688540|NCT02891395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688541|NCT02891395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688542|NCT00478517|Epoetin Alfa|epoetin alfa|mesh-list
92688543|NCT00478517|Hematinics|hematinics|mesh-ancestor
92688544|NCT01321879|Telavancin|telavancin|mesh-list
92688545|NCT01321879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688546|NCT01321879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688547|NCT01321723|Teriparatide|teriparatide|mesh-list
92688548|NCT01321723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92688552|NCT00478634|Cetuximab|cetuximab|mesh-list
92688553|NCT00478634|Everolimus|everolimus|mesh-list
92688554|NCT00478634|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92688555|NCT00478634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607105|NCT00130676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607106|NCT00130676|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92607107|NCT00130676|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92607108|NCT00130676|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92688556|NCT00478634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688557|NCT00478634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688558|NCT00478634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688559|NCT00478634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688560|NCT00478634|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92688561|NCT00478634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688562|NCT00478634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688563|NCT00478634|Immunologic Factors|immunologic factors|mesh-ancestor
92688564|NCT00478634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688565|NCT01247688|Fludarabine|fludarabine|mesh-list
92688566|NCT01247688|Cyclophosphamide|cyclophosphamide|mesh-list
92688567|NCT01247688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688568|NCT01247688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688569|NCT01247688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688570|NCT01247688|Immunologic Factors|immunologic factors|mesh-ancestor
92688571|NCT01247688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688572|NCT01247688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92688573|NCT01247688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92688574|NCT01247688|Alkylating Agents|alkylating agents|mesh-ancestor
92688575|NCT01247688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92688576|NCT00478907|Ketamine|ketamine|mesh-list
92688577|NCT00478907|Thiopental|thiopental|mesh-list
92688578|NCT00478907|Propofol|propofol|mesh-list
92688579|NCT00478907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688580|NCT00478907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688581|NCT00478907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688582|NCT00478907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92688583|NCT00478907|Anesthetics, General|anesthetics, general|mesh-ancestor
92688584|NCT00478907|Anesthetics|anesthetics|mesh-ancestor
92688585|NCT00478907|Analgesics|analgesics|mesh-ancestor
92688586|NCT00478907|Sensory System Agents|sensory system agents|mesh-ancestor
92688587|NCT00478907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688588|NCT00478907|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92688589|NCT00478907|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92688590|NCT00478907|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92688591|NCT00478907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688592|NCT00478907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688593|NCT00478907|Anticonvulsants|anticonvulsants|mesh-ancestor
92688594|NCT00478907|GABA Modulators|gaba modulators|mesh-ancestor
92688596|NCT00478946|Leucovorin|leucovorin|mesh-list
92688597|NCT00478946|Antidotes|antidotes|mesh-ancestor
92688598|NCT00478946|Protective Agents|protective agents|mesh-ancestor
92688599|NCT00478946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688600|NCT00478946|Vitamin B Complex|vitamin b complex|mesh-ancestor
92688601|NCT00478946|Vitamins|vitamins|mesh-ancestor
92688602|NCT00478946|Micronutrients|micronutrients|mesh-ancestor
92688603|NCT01247961|Dexamethasone|dexamethasone|mesh-list
92688604|NCT01247961|Dexamethasone acetate|dexamethasone acetate|mesh-list
92688605|NCT01247961|BB 1101|bb 1101|mesh-list
92688606|NCT01247961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688607|NCT01247961|Antiemetics|antiemetics|mesh-ancestor
92688608|NCT01247961|Autonomic Agents|autonomic agents|mesh-ancestor
92688609|NCT01247961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688610|NCT01247961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688611|NCT01247961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688612|NCT01247961|Glucocorticoids|glucocorticoids|mesh-ancestor
92688613|NCT01247961|Hormones|hormones|mesh-ancestor
92688614|NCT01247961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688615|NCT01247961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92688616|NCT01247961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688617|NCT01247961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92688618|NCT01247961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369722|NCT04432207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92688619|NCT01247961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688620|NCT00478985|Imatinib Mesylate|imatinib mesylate|mesh-list
92688621|NCT00478985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688622|NCT00478985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92607109|NCT00130676|Contraceptive Agents|contraceptive agents|mesh-ancestor
92607110|NCT00130676|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92014500|NCT05214573|Hormones|hormones|mesh-ancestor
92688626|NCT01248078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688627|NCT01248078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688629|NCT00472823|Cholecalciferol|cholecalciferol|mesh-list
92688630|NCT00472823|Calcium|calcium|mesh-list
92688631|NCT00472823|Vitamins|vitamins|mesh-ancestor
92688632|NCT00472823|Micronutrients|micronutrients|mesh-ancestor
92688633|NCT00472823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688634|NCT00472823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92688635|NCT00472823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92688636|NCT02275416|Ipilimumab|ipilimumab|mesh-list
92688637|NCT02275416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688638|NCT02275416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688639|NCT02275416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92688640|NCT02275416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688641|NCT00472901|Afamelanotide|afamelanotide|mesh-list
92688642|NCT00472901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688643|NCT02483247|Paclitaxel|paclitaxel|mesh-list
92688644|NCT02483247|Doxorubicin|doxorubicin|mesh-list
92688645|NCT02483247|Pembrolizumab|pembrolizumab|mesh-list
92688646|NCT02483247|Capecitabine|capecitabine|mesh-list
92688647|NCT02483247|Nivolumab|nivolumab|mesh-list
92688648|NCT02483247|Sunitinib|sunitinib|mesh-list
92688649|NCT02483247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92688650|NCT02483247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688651|NCT02483247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688652|NCT02483247|Antimitotic Agents|antimitotic agents|mesh-ancestor
92688653|NCT02483247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92688654|NCT02483247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688655|NCT02483247|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92688656|NCT02483247|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92688657|NCT02483247|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92688658|NCT02483247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688659|NCT02483247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688660|NCT02483247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92688661|NCT02483247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688662|NCT02483247|Antimetabolites|antimetabolites|mesh-ancestor
92688663|NCT02483247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92688664|NCT02483247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92688665|NCT02483247|Growth Substances|growth substances|mesh-ancestor
92688666|NCT02483247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688667|NCT02483247|Growth Inhibitors|growth inhibitors|mesh-ancestor
92688668|NCT02483247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688669|NCT02482233|Nicotine|nicotine|mesh-list
92688670|NCT02482233|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92688671|NCT02482233|Autonomic Agents|autonomic agents|mesh-ancestor
92688672|NCT02482233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688673|NCT02482233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688674|NCT02482233|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92688675|NCT02482233|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92688676|NCT02482233|Cholinergic Agents|cholinergic agents|mesh-ancestor
92688677|NCT02482233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688678|NCT02482233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688679|NCT01248117|Ranibizumab|ranibizumab|mesh-list
92688680|NCT01248117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92688681|NCT01248117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92688682|NCT01248117|Growth Substances|growth substances|mesh-ancestor
92688683|NCT01248117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688684|NCT01248117|Growth Inhibitors|growth inhibitors|mesh-ancestor
92369726|NCT04425447|Anesthetics|anesthetics|mesh-list
92688685|NCT01248117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688686|NCT01248234|Propofol|propofol|mesh-list
92688687|NCT01248234|Etomidate|etomidate|mesh-list
92688688|NCT01248234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688689|NCT01248234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688690|NCT01248234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688691|NCT01248234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92688692|NCT01248234|Anesthetics, General|anesthetics, general|mesh-ancestor
92688693|NCT01248234|Anesthetics|anesthetics|mesh-ancestor
92688694|NCT01248273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92688695|NCT01248273|Immunologic Factors|immunologic factors|mesh-ancestor
92688715|NCT01319383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607111|NCT00130676|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92607112|NCT00130676|Hormone Antagonists|hormone antagonists|mesh-ancestor
92607113|NCT00130676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607114|NCT00130676|Luteolytic Agents|luteolytic agents|mesh-ancestor
92014503|NCT05214573|Incretins|incretins|mesh-ancestor
92688716|NCT01319383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688717|NCT05645029|Chlorhexidine|chlorhexidine|mesh-list
92688718|NCT05645029|Methamphetamine|methamphetamine|mesh-list
92688719|NCT05645029|Titanium dioxide|titanium dioxide|mesh-list
92688720|NCT05645029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92688721|NCT05645029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688722|NCT05645029|Disinfectants|disinfectants|mesh-ancestor
92688723|NCT05645029|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688724|NCT05645029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92688725|NCT05645029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688726|NCT05645029|Sympathomimetics|sympathomimetics|mesh-ancestor
92688727|NCT05645029|Autonomic Agents|autonomic agents|mesh-ancestor
92688728|NCT05645029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688729|NCT05645029|Dopamine Agents|dopamine agents|mesh-ancestor
92688730|NCT05645029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688731|NCT05645029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688732|NCT05645029|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688733|NCT05645029|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92688734|NCT05645029|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92688735|NCT05645029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92688736|NCT05645029|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92688737|NCT05645029|Sunscreening Agents|sunscreening agents|mesh-ancestor
92688738|NCT05645029|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92688739|NCT05645029|Protective Agents|protective agents|mesh-ancestor
92688740|NCT05645029|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92688741|NCT00479609|Testosterone|testosterone|mesh-list
92688742|NCT00479609|Androgens|androgens|mesh-ancestor
92688743|NCT00479609|Hormones|hormones|mesh-ancestor
92688744|NCT00479609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688745|NCT00479609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688746|NCT04325113|Levobupivacaine|levobupivacaine|mesh-list
92688747|NCT04325113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92688748|NCT04325113|Anesthetics|anesthetics|mesh-ancestor
92688749|NCT04325113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688750|NCT04325113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688761|NCT02955732|Dexmedetomidine|dexmedetomidine|mesh-list
92688762|NCT02955732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688763|NCT02955732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688764|NCT02955732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688765|NCT02955732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92688766|NCT02955732|Analgesics|analgesics|mesh-ancestor
92688767|NCT02955732|Sensory System Agents|sensory system agents|mesh-ancestor
92688768|NCT02955732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688769|NCT02955732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92688770|NCT02955732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92688771|NCT02955732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688772|NCT02955732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688773|NCT02955732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688774|NCT02955732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688775|NCT01315678|Tobramycin|tobramycin|mesh-list
92688776|NCT01315678|Amikacin|amikacin|mesh-list
92688777|NCT01315678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688778|NCT01315678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688779|NCT02955693|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92688780|NCT02955693|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688781|NCT02955693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688782|NCT02955693|Immunologic Factors|immunologic factors|mesh-ancestor
92688783|NCT02955693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688784|NCT00479726|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92688785|NCT00479726|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92688786|NCT00479726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92688787|NCT00479726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014507|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92607115|NCT00130676|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92607116|NCT00130676|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92607117|NCT00404274|Casopitant|casopitant|mesh-list
92607118|NCT00404274|Warfarin|warfarin|mesh-list
92607119|NCT00404274|Anticoagulants|anticoagulants|mesh-ancestor
92607120|NCT00404274|Antiemetics|antiemetics|mesh-ancestor
92607121|NCT00404274|Autonomic Agents|autonomic agents|mesh-ancestor
92607122|NCT00404274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607123|NCT00404274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607124|NCT00404274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607125|NCT00404274|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92607126|NCT00404274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607127|NCT00404274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607128|NCT00130754|Thymoglobulin|thymoglobulin|mesh-list
92607129|NCT00130754|Immunologic Factors|immunologic factors|mesh-ancestor
92607130|NCT00130754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607131|NCT00130754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92607132|NCT00130871|Simendan|simendan|mesh-list
92607133|NCT00130871|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92607134|NCT00130871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92688788|NCT00479726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688789|NCT00479726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688790|NCT00479726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688791|NCT00479726|Analgesics|analgesics|mesh-ancestor
92688792|NCT00479726|Sensory System Agents|sensory system agents|mesh-ancestor
92688793|NCT00479726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688794|NCT00479726|Antidepressive Agents|antidepressive agents|mesh-ancestor
92688795|NCT00479726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92688796|NCT00479726|Dopamine Agents|dopamine agents|mesh-ancestor
92688797|NCT01315249|Fluticasone|fluticasone|mesh-list
92688798|NCT01315249|Xhance|xhance|mesh-list
92688799|NCT01315249|Glycopyrrolate|glycopyrrolate|mesh-list
92688800|NCT01315249|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92688801|NCT01315249|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92688802|NCT01315249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92688803|NCT01315249|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92688804|NCT01315249|Autonomic Agents|autonomic agents|mesh-ancestor
92688805|NCT01315249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688806|NCT01315249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688807|NCT01315249|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92688808|NCT01315249|Respiratory System Agents|respiratory system agents|mesh-ancestor
92688809|NCT01315249|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688810|NCT01315249|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92688811|NCT01315249|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92688812|NCT01315249|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92688823|NCT01315249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92688824|NCT01315249|Sympathomimetics|sympathomimetics|mesh-ancestor
92688826|NCT04207411|Bupivacaine|bupivacaine|mesh-list
92688827|NCT04207411|Anesthetics, Local|anesthetics, local|mesh-ancestor
92688828|NCT04207411|Anesthetics|anesthetics|mesh-ancestor
92369745|NCT04345718|Sensory System Agents|sensory system agents|mesh-ancestor
92688829|NCT04207411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688830|NCT04207411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607135|NCT00130871|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92607136|NCT00130871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92607137|NCT00130871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607138|NCT00130871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607139|NCT00130871|Protective Agents|protective agents|mesh-ancestor
92607140|NCT00130871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607141|NCT00130910|Albendazole|albendazole|mesh-list
92688831|NCT04207411|Sensory System Agents|sensory system agents|mesh-ancestor
92688832|NCT04207411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688833|NCT04207411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92688834|NCT04207411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92688835|NCT04207411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92688836|NCT04207411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92688837|NCT04207411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688838|NCT00473486|Carboplatin|carboplatin|mesh-list
92688839|NCT00473486|Pemetrexed|pemetrexed|mesh-list
92688840|NCT00473486|Sorafenib|sorafenib|mesh-list
92688841|NCT00473486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688842|NCT00473486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688843|NCT00473486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688844|NCT00473486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92688845|NCT00473486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92688846|NCT00473486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688847|NCT05644483|Propofol|propofol|mesh-list
92688848|NCT05644483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688849|NCT05644483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688850|NCT05644483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688851|NCT05644483|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92688852|NCT05644483|Anesthetics, General|anesthetics, general|mesh-ancestor
92688853|NCT05644483|Anesthetics|anesthetics|mesh-ancestor
92688854|NCT01248819|Ropivacaine|ropivacaine|mesh-list
92688855|NCT01248819|Anesthetics, Local|anesthetics, local|mesh-ancestor
92688856|NCT01248819|Anesthetics|anesthetics|mesh-ancestor
92688857|NCT01248819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688858|NCT01248819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688859|NCT01248819|Sensory System Agents|sensory system agents|mesh-ancestor
92688860|NCT01248819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688861|NCT01313767|Botulinum Toxins|botulinum toxins|mesh-list
92688862|NCT01313767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92688863|NCT01313767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92688864|NCT01313767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92688865|NCT01313767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92688866|NCT01313767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688867|NCT01313767|Cholinergic Agents|cholinergic agents|mesh-ancestor
92688868|NCT01313767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688869|NCT01313767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688870|NCT01313767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92688871|NCT01313767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688872|NCT01248858|Trametinib|trametinib|mesh-list
92688873|NCT01248858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688874|NCT01248858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92688875|NCT01248858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688888|NCT01313728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688890|NCT01313728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92108648|NCT02990962|Triamcinolone|triamcinolone|mesh-list
92688891|NCT00481364|Atorvastatin|atorvastatin|mesh-list
92688892|NCT00481364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92688893|NCT00481364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92688894|NCT00481364|Antimetabolites|antimetabolites|mesh-ancestor
92688895|NCT00481364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688896|NCT00481364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92688897|NCT00481364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92688898|NCT00481364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688899|NCT00481442|Phenylephrine|phenylephrine|mesh-list
92688900|NCT00481442|Oxymetazoline|oxymetazoline|mesh-list
92607143|NCT00130910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92046315|NCT04769414|Gemcitabine|gemcitabine|mesh-list
92688901|NCT00481442|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92688902|NCT00481442|Mydriatics|mydriatics|mesh-ancestor
92688903|NCT00481442|Autonomic Agents|autonomic agents|mesh-ancestor
92688904|NCT00481442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688905|NCT00481442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688906|NCT00481442|Sympathomimetics|sympathomimetics|mesh-ancestor
92688907|NCT00481442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92688908|NCT00481442|Nasal Decongestants|nasal decongestants|mesh-ancestor
92688909|NCT00481442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92688910|NCT00481442|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92688911|NCT00481442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92688912|NCT00481442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688913|NCT00481442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688914|NCT00481442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688915|NCT00481442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688916|NCT00481442|Protective Agents|protective agents|mesh-ancestor
92688917|NCT04697537|Dexmedetomidine|dexmedetomidine|mesh-list
92688918|NCT04697537|Ropivacaine|ropivacaine|mesh-list
92688919|NCT04697537|Anesthetics|anesthetics|mesh-ancestor
92688920|NCT04697537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688921|NCT04697537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688922|NCT04697537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688923|NCT04697537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92688924|NCT04697537|Analgesics|analgesics|mesh-ancestor
92688925|NCT04697537|Sensory System Agents|sensory system agents|mesh-ancestor
92688926|NCT04697537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688927|NCT04697537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92688928|NCT04697537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92688929|NCT04697537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688930|NCT04697537|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688931|NCT04697537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688932|NCT04697537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688933|NCT04697537|Anesthetics, Local|anesthetics, local|mesh-ancestor
92688934|NCT00481481|Tacrolimus|tacrolimus|mesh-list
92688935|NCT00481481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92688936|NCT00481481|Immunologic Factors|immunologic factors|mesh-ancestor
92688937|NCT00481481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688947|NCT04516317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688948|NCT04516317|Antiviral Agents|antiviral agents|mesh-ancestor
92688949|NCT04516317|Schistosomicides|schistosomicides|mesh-ancestor
92688950|NCT04516317|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92688951|NCT04516317|Anthelmintics|anthelmintics|mesh-ancestor
92688952|NCT04516317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92688953|NCT04516317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688954|NCT04516317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92688955|NCT04516317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688956|NCT04516317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92688957|NCT04516317|Analgesics|analgesics|mesh-ancestor
92688958|NCT04516317|Sensory System Agents|sensory system agents|mesh-ancestor
92688959|NCT02891083|Paclitaxel|paclitaxel|mesh-list
92688960|NCT02891083|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92688961|NCT02891083|Cisplatin|cisplatin|mesh-list
92688962|NCT02891083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92688963|NCT02891083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688964|NCT02891083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688965|NCT02891083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92108727|NCT03833362|Ritonavir|ritonavir|mesh-list
92688966|NCT02891083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92688967|NCT02891083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688968|NCT04515147|Vaccines|vaccines|mesh-list
92688969|NCT04515147|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92688970|NCT04515147|Immunologic Factors|immunologic factors|mesh-ancestor
92688971|NCT04515147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688972|NCT05661253|Bupivacaine|bupivacaine|mesh-list
92688973|NCT05661253|Anesthetics, Local|anesthetics, local|mesh-ancestor
92688974|NCT05661253|Anesthetics|anesthetics|mesh-ancestor
92688975|NCT05661253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688976|NCT05661253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688977|NCT05661253|Sensory System Agents|sensory system agents|mesh-ancestor
92688978|NCT05661253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688979|NCT02891005|Paclitaxel|paclitaxel|mesh-list
92607144|NCT00130910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607145|NCT00130910|Anticestodal Agents|anticestodal agents|mesh-ancestor
92607146|NCT00130910|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92607147|NCT00130910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92607148|NCT00130910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92607149|NCT00130910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92688980|NCT02891005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92688981|NCT02891005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688982|NCT02891005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688983|NCT02891005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92688984|NCT02891005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92688985|NCT02891005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688986|NCT00504816|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92688987|NCT00504816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92688988|NCT00504816|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92688989|NCT00504816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92688990|NCT00504816|Contraceptive Agents|contraceptive agents|mesh-ancestor
92688991|NCT00504816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92688992|NCT00504816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688993|NCT00504816|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92688994|NCT00504816|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92688995|NCT00504816|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92688996|NCT00504816|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92688998|NCT00480116|Immunologic Factors|immunologic factors|mesh-ancestor
92688999|NCT00480116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689000|NCT00504855|Calpastatin|calpastatin|mesh-list
92689001|NCT00504855|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92689014|NCT01313299|Botulinum Toxins|botulinum toxins|mesh-list
92689015|NCT01313299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92689016|NCT01313299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92689017|NCT01313299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92689018|NCT01313299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689019|NCT01313299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689020|NCT01313299|Cholinergic Agents|cholinergic agents|mesh-ancestor
92689021|NCT01313299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689022|NCT01313299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689023|NCT01313299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92689024|NCT01313299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689025|NCT01313221|Etanercept|etanercept|mesh-list
92689026|NCT01313221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92689027|NCT01313221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689028|NCT01313221|Analgesics|analgesics|mesh-ancestor
92689029|NCT01313221|Sensory System Agents|sensory system agents|mesh-ancestor
92689030|NCT01313221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689031|NCT01313221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689032|NCT01313221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689033|NCT01313221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689034|NCT01313221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92689035|NCT01313221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92689036|NCT01313221|Immunologic Factors|immunologic factors|mesh-ancestor
92689037|NCT01313182|Povidone-Iodine|povidone-iodine|mesh-list
92689038|NCT01313182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92689041|NCT01313182|Calcium|calcium|mesh-list
92689042|NCT01313182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92689043|NCT01313182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689044|NCT01313182|Plasma Substitutes|plasma substitutes|mesh-ancestor
92689045|NCT01313182|Blood Substitutes|blood substitutes|mesh-ancestor
92689046|NCT01313182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689047|NCT01313182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92689048|NCT01313182|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92689049|NCT01313182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689050|NCT01313182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689051|NCT00480194|Xylometazoline|xylometazoline|mesh-list
92689052|NCT00480194|Bromides|bromides|mesh-list
92689053|NCT00480194|Ipratropium|ipratropium|mesh-list
92689054|NCT00480194|Anticonvulsants|anticonvulsants|mesh-ancestor
92607150|NCT00130910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607151|NCT00130910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689055|NCT00480194|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92689056|NCT00480194|Autonomic Agents|autonomic agents|mesh-ancestor
92689057|NCT00480194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689058|NCT00480194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689059|NCT00480194|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92689060|NCT00480194|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689061|NCT00480194|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92689062|NCT00480194|Cholinergic Agents|cholinergic agents|mesh-ancestor
92689063|NCT00480194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689064|NCT00480194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689068|NCT00505089|Immunologic Factors|immunologic factors|mesh-ancestor
92689069|NCT00505089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689071|NCT00505167|Donepezil|donepezil|mesh-list
92689072|NCT00505167|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92689073|NCT00505167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689074|NCT00505167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689075|NCT00505167|Cholinergic Agents|cholinergic agents|mesh-ancestor
92689076|NCT00505167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689077|NCT00505167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689078|NCT00505167|Nootropic Agents|nootropic agents|mesh-ancestor
92689079|NCT00505167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92689080|NCT00505167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92689081|NCT00505167|Dopamine Agents|dopamine agents|mesh-ancestor
92689082|NCT00505167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92689083|NCT00505167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92689084|NCT00480272|Prednisone|prednisone|mesh-list
92689085|NCT00480272|Adalimumab|adalimumab|mesh-list
92689086|NCT00480272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689087|NCT00480272|Glucocorticoids|glucocorticoids|mesh-ancestor
92689088|NCT00480272|Hormones|hormones|mesh-ancestor
92689089|NCT00480272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689090|NCT00480272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689091|NCT00480272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689092|NCT00480272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689093|NCT00480272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92689094|NCT00480272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689095|NCT04517058|Antidepressive Agents|antidepressive agents|mesh-list
92689096|NCT04517058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92689097|NCT00480389|Sorafenib|sorafenib|mesh-list
92689098|NCT00480389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689099|NCT00480389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92689100|NCT00480389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689101|NCT00480389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689102|NCT04519710|Rituximab|rituximab|mesh-list
92689103|NCT04519710|Ocrelizumab|ocrelizumab|mesh-list
92689104|NCT04519710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689105|NCT04519710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689106|NCT04519710|Immunologic Factors|immunologic factors|mesh-ancestor
92689107|NCT04519710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689108|NCT04519710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689109|NCT00482027|Vaccines|vaccines|mesh-list
92689110|NCT00482027|Immunologic Factors|immunologic factors|mesh-ancestor
92689111|NCT00482027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689112|NCT00482066|Abatacept|abatacept|mesh-list
92689113|NCT00482066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92108871|NCT01751386|Baclofen|baclofen|mesh-list
92689114|NCT00482066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689115|NCT00482066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689117|NCT00482066|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92689118|NCT00482066|Immunologic Factors|immunologic factors|mesh-ancestor
92689119|NCT00482066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689120|NCT00482066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689121|NCT00482183|Pioglitazone|pioglitazone|mesh-list
92689122|NCT00482183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92689123|NCT00482183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689124|NCT01312909|Varenicline|varenicline|mesh-list
92689125|NCT01312909|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92689126|NCT01312909|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92689127|NCT01312909|Cholinergic Agents|cholinergic agents|mesh-ancestor
92689128|NCT01312909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607152|NCT00130910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607153|NCT03226821|Tesamorelin|tesamorelin|mesh-list
92607154|NCT03226821|Growth Substances|growth substances|mesh-ancestor
92689129|NCT01312909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689130|NCT01312909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689131|NCT00482222|Leucovorin|leucovorin|mesh-list
92689132|NCT00482222|Fluorouracil|fluorouracil|mesh-list
92689133|NCT00482222|Capecitabine|capecitabine|mesh-list
92689134|NCT00482222|Oxaliplatin|oxaliplatin|mesh-list
92689135|NCT00482222|Cetuximab|cetuximab|mesh-list
92689136|NCT00482222|Calcium|calcium|mesh-list
92689137|NCT00482222|Levoleucovorin|levoleucovorin|mesh-list
92689138|NCT00482222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92689142|NCT00482222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92689143|NCT00482222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689144|NCT00482222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92689145|NCT00482222|Immunologic Factors|immunologic factors|mesh-ancestor
92689146|NCT00482222|Antidotes|antidotes|mesh-ancestor
92689147|NCT00482222|Protective Agents|protective agents|mesh-ancestor
92689148|NCT00482222|Vitamin B Complex|vitamin b complex|mesh-ancestor
92689149|NCT00482222|Vitamins|vitamins|mesh-ancestor
92689150|NCT00482222|Micronutrients|micronutrients|mesh-ancestor
92689151|NCT00482222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689152|NCT01312129|Sulfasalazine|sulfasalazine|mesh-list
92689153|NCT01312129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689154|NCT01312129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92689155|NCT01312129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689156|NCT01312129|Analgesics|analgesics|mesh-ancestor
92689157|NCT01312129|Sensory System Agents|sensory system agents|mesh-ancestor
92689158|NCT01312129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689159|NCT01312129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689160|NCT01312129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689161|NCT01312129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689162|NCT01312129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92689163|NCT04518852|Sorafenib|sorafenib|mesh-list
92689164|NCT04518852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689165|NCT04518852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92689166|NCT04518852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689167|NCT04518852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689168|NCT01311661|Olodaterol|olodaterol|mesh-list
92689169|NCT01311661|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92689170|NCT01311661|Autonomic Agents|autonomic agents|mesh-ancestor
92689171|NCT01311661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689172|NCT01311661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689173|NCT01311661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92689174|NCT01311661|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689175|NCT04518735|Anticoagulants|anticoagulants|mesh-list
92689176|NCT00482261|Aspirin|aspirin|mesh-list
92689177|NCT00482261|Dexamethasone|dexamethasone|mesh-list
92689178|NCT00482261|Lenalidomide|lenalidomide|mesh-list
92689179|NCT00482261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689180|NCT00482261|Antiemetics|antiemetics|mesh-ancestor
92689181|NCT00482261|Autonomic Agents|autonomic agents|mesh-ancestor
92689182|NCT00482261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689183|NCT00482261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689184|NCT00482261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92689185|NCT00482261|Glucocorticoids|glucocorticoids|mesh-ancestor
92689186|NCT00482261|Hormones|hormones|mesh-ancestor
92689187|NCT00482261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689188|NCT00482261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689189|NCT00482261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689190|NCT00482261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92689191|NCT00482261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689192|NCT00482261|Analgesics|analgesics|mesh-ancestor
92689193|NCT00482261|Sensory System Agents|sensory system agents|mesh-ancestor
92689194|NCT00482261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689195|NCT00482261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92689196|NCT00482261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92689197|NCT00482261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689198|NCT00482261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92689199|NCT00482261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92689200|NCT00482261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689201|NCT00482261|Antipyretics|antipyretics|mesh-ancestor
92689202|NCT00482261|Immunologic Factors|immunologic factors|mesh-ancestor
92607155|NCT03226821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607156|NCT00139815|Enoxaparin|enoxaparin|mesh-list
92607157|NCT00139815|PENTA|penta|mesh-list
92607158|NCT00139815|Fondaparinux|fondaparinux|mesh-list
92607159|NCT00139815|Anticoagulants|anticoagulants|mesh-ancestor
92689203|NCT00482261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92689204|NCT00482261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92689205|NCT00482261|Growth Substances|growth substances|mesh-ancestor
92689206|NCT00482261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92689207|NCT04518618|Fentanyl|fentanyl|mesh-list
92689208|NCT04518618|Naloxone|naloxone|mesh-list
92689209|NCT04518618|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92689210|NCT04518618|Narcotics|narcotics|mesh-ancestor
92689211|NCT04518618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689219|NCT04518618|Anesthetics|anesthetics|mesh-ancestor
92689220|NCT04518618|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92689221|NCT00480584|Gemcitabine|gemcitabine|mesh-list
92689222|NCT00480584|Capecitabine|capecitabine|mesh-list
92689223|NCT00480584|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92689224|NCT00480584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92689225|NCT00480584|Antimetabolites|antimetabolites|mesh-ancestor
92689226|NCT00480584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689227|NCT00480584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689228|NCT00480584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92689229|NCT00480584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689230|NCT01311505|Rifampin|rifampin|mesh-list
92689231|NCT01311505|Isoniazid|isoniazid|mesh-list
92689232|NCT01311505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92689233|NCT01311505|Antitubercular Agents|antitubercular agents|mesh-ancestor
92689234|NCT01311505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92689235|NCT01311505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689236|NCT01311505|Leprostatic Agents|leprostatic agents|mesh-ancestor
92689237|NCT01311505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92689238|NCT01311505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689239|NCT01311505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689240|NCT01311505|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92689241|NCT01311505|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92689242|NCT01311505|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92689243|NCT01311505|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92689244|NCT01311505|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92689245|NCT01311505|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92689246|NCT01311505|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92689247|NCT01311505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92689248|NCT01311505|Antimetabolites|antimetabolites|mesh-ancestor
92689249|NCT01311505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92689250|NCT01240538|Cyclophosphamide|cyclophosphamide|mesh-list
92689251|NCT01240538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92689252|NCT01240538|Immunologic Factors|immunologic factors|mesh-ancestor
92689253|NCT01240538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689254|NCT01240538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689255|NCT01240538|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92689256|NCT01240538|Alkylating Agents|alkylating agents|mesh-ancestor
92689257|NCT01240538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689258|NCT01240538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689259|NCT01240538|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92689260|NCT01310803|Valrubicin|valrubicin|mesh-list
92689261|NCT01310803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689262|NCT01310803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92689263|NCT01310803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92109027|NCT02254252|Vitamins|vitamins|mesh-ancestor
92689264|NCT01310803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689265|NCT01310803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689266|NCT04518540|Thioctic Acid|thioctic acid|mesh-list
92689267|NCT04518540|Antioxidants|antioxidants|mesh-ancestor
92689268|NCT04518540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689269|NCT04518540|Protective Agents|protective agents|mesh-ancestor
92689270|NCT04518540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689271|NCT04518540|Vitamin B Complex|vitamin b complex|mesh-ancestor
92689272|NCT04518540|Vitamins|vitamins|mesh-ancestor
92689273|NCT04518540|Micronutrients|micronutrients|mesh-ancestor
92689274|NCT00480623|Satraplatin|satraplatin|mesh-list
92689275|NCT00480623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607160|NCT00139815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92689276|NCT01240655|Paclitaxel|paclitaxel|mesh-list
92689277|NCT01240655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92689278|NCT01240655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689281|NCT01240655|Mitosis Modulators|mitosis modulators|mesh-ancestor
92689282|NCT01240655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689283|NCT04518189|Lidocaine|lidocaine|mesh-list
92689284|NCT04518189|Anesthetics, Local|anesthetics, local|mesh-ancestor
92689285|NCT04518189|Anesthetics|anesthetics|mesh-ancestor
92689286|NCT04518189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689287|NCT04518189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689288|NCT04518189|Sensory System Agents|sensory system agents|mesh-ancestor
92689289|NCT04518189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689290|NCT04518189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92689291|NCT04518189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92689292|NCT04518189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92689293|NCT04518189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689294|NCT04518189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689295|NCT00482378|Zoledronic Acid|zoledronic acid|mesh-list
92689296|NCT00482378|Pamidronate|pamidronate|mesh-list
92689297|NCT00482378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92689298|NCT00482378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689299|NCT00482456|Nitrous Oxide|nitrous oxide|mesh-list
92689300|NCT00482456|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92689301|NCT00482456|Anesthetics, General|anesthetics, general|mesh-ancestor
92689302|NCT00482456|Anesthetics|anesthetics|mesh-ancestor
92689303|NCT00482456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689304|NCT00482456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689305|NCT00482456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689306|NCT00482456|Analgesics|analgesics|mesh-ancestor
92689307|NCT00482456|Sensory System Agents|sensory system agents|mesh-ancestor
92689308|NCT00482456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689309|NCT00480896|Tacrolimus|tacrolimus|mesh-list
92689310|NCT00480896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92689311|NCT00480896|Immunologic Factors|immunologic factors|mesh-ancestor
92689312|NCT00480896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689313|NCT00480896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92689314|NCT00480896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689315|NCT00480896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689316|NCT01309828|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92689317|NCT01309828|Olmesartan|olmesartan|mesh-list
92689318|NCT01309828|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92689319|NCT01309828|Chlorthalidone|chlorthalidone|mesh-list
92689320|NCT01309828|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92689321|NCT01309828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92689322|NCT01309828|Diuretics|diuretics|mesh-ancestor
92689323|NCT01309828|Natriuretic Agents|natriuretic agents|mesh-ancestor
92689324|NCT01309828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689325|NCT01309828|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92689326|NCT01309828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689327|NCT01309828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689328|NCT01309828|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92689329|NCT01309828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92689330|NCT00482495|Bevacizumab|bevacizumab|mesh-list
92689331|NCT00482495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689332|NCT00482495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689333|NCT00482495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92689334|NCT00482495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92689335|NCT00482495|Growth Substances|growth substances|mesh-ancestor
92689336|NCT00482495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689337|NCT00482495|Growth Inhibitors|growth inhibitors|mesh-ancestor
92689338|NCT00480935|Sunitinib|sunitinib|mesh-list
92689339|NCT00480935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689340|NCT00480935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92689341|NCT00480935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92689342|NCT00480935|Growth Substances|growth substances|mesh-ancestor
92689343|NCT00480935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689344|NCT00480935|Growth Inhibitors|growth inhibitors|mesh-ancestor
92689345|NCT00480935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92689346|NCT00480935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689347|NCT00480935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689348|NCT00482573|Epinephrine|epinephrine|mesh-list
92689349|NCT00482573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92607161|NCT00139815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607162|NCT00139815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607163|NCT00139815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92607164|NCT00139815|Antithrombins|antithrombins|mesh-ancestor
92689350|NCT00482573|Anesthetics|anesthetics|mesh-list
92689362|NCT00482573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92689363|NCT00482573|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689365|NCT00482573|Sympathomimetics|sympathomimetics|mesh-ancestor
92689366|NCT00482976|Ruboxistaurin|ruboxistaurin|mesh-list
92689367|NCT00482976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689368|NCT00482976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689369|NCT00481013|Valproic Acid|valproic acid|mesh-list
92689370|NCT00481013|Anticonvulsants|anticonvulsants|mesh-ancestor
92689371|NCT00481013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689372|NCT00481013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689373|NCT00481013|GABA Agents|gaba agents|mesh-ancestor
92689374|NCT00481013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689375|NCT00481013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689376|NCT00481013|Antimanic Agents|antimanic agents|mesh-ancestor
92689377|NCT00481013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92689378|NCT00481013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689379|NCT00481013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92689380|NCT01309243|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92689381|NCT01309243|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
92689382|NCT01309243|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92689383|NCT01309243|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92689384|NCT01309243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689385|NCT01309243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689386|NCT01309243|Antiviral Agents|antiviral agents|mesh-ancestor
92689387|NCT01309243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689388|NCT01309243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92689389|NCT01309243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92689390|NCT01240109|Remifentanil|remifentanil|mesh-list
92689391|NCT01240109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92689392|NCT01240109|Narcotics|narcotics|mesh-ancestor
92689393|NCT01240109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689394|NCT01240109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689395|NCT01240109|Analgesics|analgesics|mesh-ancestor
92689396|NCT01240109|Sensory System Agents|sensory system agents|mesh-ancestor
92689397|NCT01240109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689398|NCT04517526|Bevacizumab|bevacizumab|mesh-list
92689399|NCT04517526|Durvalumab|durvalumab|mesh-list
92689400|NCT04517526|Carboplatin|carboplatin|mesh-list
92689401|NCT04517526|Pemetrexed|pemetrexed|mesh-list
92689402|NCT04517526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689403|NCT04517526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689404|NCT04517526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92689405|NCT04517526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92689406|NCT04517526|Growth Substances|growth substances|mesh-ancestor
92689407|NCT04517526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689408|NCT04517526|Growth Inhibitors|growth inhibitors|mesh-ancestor
92689409|NCT04517526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689410|NCT04517526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109172|NCT01809106|Buprenorphine|buprenorphine|mesh-list
92689414|NCT01309204|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92689415|NCT01309204|Brinzolamide|brinzolamide|mesh-list
92689416|NCT01309204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92689417|NCT01309204|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92689418|NCT01309204|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92689419|NCT01309204|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92689420|NCT01309204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92689421|NCT01309204|Adrenergic Agents|adrenergic agents|mesh-ancestor
92689422|NCT01309204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689423|NCT01309204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689424|NCT01309204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689425|NCT01309204|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92689426|NCT01309204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689427|NCT00482807|Docetaxel|docetaxel|mesh-list
92689428|NCT00482807|Goserelin|goserelin|mesh-list
92689429|NCT00482807|Bicalutamide|bicalutamide|mesh-list
92607165|NCT00139815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92607166|NCT00139815|Protease Inhibitors|protease inhibitors|mesh-ancestor
92607167|NCT00139815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607169|NCT00131027|Dexamethasone|dexamethasone|mesh-list
92607170|NCT00131027|Prednisolone|prednisolone|mesh-list
92689430|NCT00482807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689431|NCT00482807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92689432|NCT00482807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92689433|NCT00482807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92689434|NCT00482807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689435|NCT00482807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689436|NCT00482807|Androgen Antagonists|androgen antagonists|mesh-ancestor
92689437|NCT00482807|Hormone Antagonists|hormone antagonists|mesh-ancestor
92689438|NCT00482807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689439|NCT00482807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689440|NCT01240148|Lidocaine|lidocaine|mesh-list
92689441|NCT01240148|Anesthetics, Local|anesthetics, local|mesh-ancestor
92689442|NCT01240148|Anesthetics|anesthetics|mesh-ancestor
92689443|NCT01240148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689444|NCT01240148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689445|NCT01240148|Sensory System Agents|sensory system agents|mesh-ancestor
92689446|NCT01240148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689447|NCT01240148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92689448|NCT01240148|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92689449|NCT01240148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92689450|NCT01240148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689451|NCT01240148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689452|NCT04325191|Melatonin|melatonin|mesh-list
92689453|NCT04325191|Antioxidants|antioxidants|mesh-ancestor
92689454|NCT04325191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689455|NCT04325191|Protective Agents|protective agents|mesh-ancestor
92689456|NCT04325191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689457|NCT04325191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689458|NCT04517292|Cisplatin|cisplatin|mesh-list
92689459|NCT04517292|Gemcitabine|gemcitabine|mesh-list
92689460|NCT04517292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689461|NCT04517292|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92689462|NCT04517292|Antimetabolites|antimetabolites|mesh-ancestor
92689463|NCT04517292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689464|NCT00482846|Melphalan|melphalan|mesh-list
92689465|NCT00482846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92689466|NCT00482846|Alkylating Agents|alkylating agents|mesh-ancestor
92689467|NCT00482846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689468|NCT00482846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689469|NCT00482846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92689470|NCT00482846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92689471|NCT00482846|Immunologic Factors|immunologic factors|mesh-ancestor
92689472|NCT00482846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689473|NCT01308736|Varenicline|varenicline|mesh-list
92689474|NCT01308736|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92689475|NCT01308736|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92689476|NCT01308736|Cholinergic Agents|cholinergic agents|mesh-ancestor
92689477|NCT01308736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689478|NCT01308736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689479|NCT01308736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689480|NCT04517214|Gemcitabine|gemcitabine|mesh-list
92109247|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689483|NCT04517214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92689485|NCT04517214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689486|NCT00483054|Efavirenz|efavirenz|mesh-list
92689487|NCT00483054|Nevirapine|nevirapine|mesh-list
92689488|NCT00483054|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92689489|NCT00483054|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92689490|NCT00483054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689491|NCT00483054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689492|NCT00483054|Antiviral Agents|antiviral agents|mesh-ancestor
92689493|NCT00483054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607171|NCT00131027|Cyclophosphamide|cyclophosphamide|mesh-list
92607172|NCT00131027|Doxorubicin|doxorubicin|mesh-list
92607173|NCT00131027|Methotrexate|methotrexate|mesh-list
92607174|NCT00131027|Etoposide|etoposide|mesh-list
92689494|NCT00483054|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92689495|NCT00483054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92689496|NCT00483054|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92689497|NCT00483054|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92689498|NCT00483054|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92689499|NCT00483054|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92689500|NCT00483054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92689501|NCT00483054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92689502|NCT01240226|Ketoconazole|ketoconazole|mesh-list
92689503|NCT01240226|Antifungal Agents|antifungal agents|mesh-ancestor
92689504|NCT01240226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689505|NCT01240226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92689506|NCT01240226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92689507|NCT01240226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689508|NCT01240226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689509|NCT01240226|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92689510|NCT01240226|Hormone Antagonists|hormone antagonists|mesh-ancestor
92689511|NCT01240226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689512|NCT01240226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689513|NCT01240226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92689514|NCT01240824|Aminophylline|aminophylline|mesh-list
92689515|NCT01240824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92689516|NCT01240824|Autonomic Agents|autonomic agents|mesh-ancestor
92689517|NCT01240824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689518|NCT01240824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689519|NCT01240824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92689520|NCT01240824|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689521|NCT01240824|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92689522|NCT01240824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92689523|NCT01240824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689524|NCT01240824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689525|NCT01240824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92689526|NCT01240824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92689527|NCT01240824|Purinergic Agents|purinergic agents|mesh-ancestor
92689528|NCT01240824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689529|NCT01240824|Protective Agents|protective agents|mesh-ancestor
92689530|NCT01240941|Exemestane|exemestane|mesh-list
92689531|NCT01240941|Goserelin|goserelin|mesh-list
92689532|NCT01240941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689533|NCT01240941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92689534|NCT01240941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92689535|NCT01240941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689536|NCT01240941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689537|NCT01240941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92689538|NCT01240941|Hormone Antagonists|hormone antagonists|mesh-ancestor
92689539|NCT01240941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689540|NCT01240941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689541|NCT01240941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689542|NCT00482963|Efavirenz|efavirenz|mesh-list
92689543|NCT00482963|Levonorgestrel|levonorgestrel|mesh-list
92689544|NCT00482963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92689545|NCT00482963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92689546|NCT00482963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689547|NCT00482963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689548|NCT00482963|Antiviral Agents|antiviral agents|mesh-ancestor
92689549|NCT00482963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689568|NCT01240928|Goserelin|goserelin|mesh-list
92689569|NCT01240928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689570|NCT01240928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92689571|NCT01240928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92689572|NCT01240928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689573|NCT01240928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689574|NCT01240928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92689575|NCT01240928|Hormone Antagonists|hormone antagonists|mesh-ancestor
92607175|NCT00131027|Vincristine|vincristine|mesh-list
92607176|NCT00131027|Daunorubicin|daunorubicin|mesh-list
92607177|NCT00131027|Asparaginase|asparaginase|mesh-list
92607178|NCT00131027|Mercaptopurine|mercaptopurine|mesh-list
92607179|NCT00131027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014560|NCT05211609|Methyldopa|methyldopa|mesh-list
92689576|NCT01240928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689577|NCT01240928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689578|NCT01240928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689579|NCT00481169|Bazedoxifene|bazedoxifene|mesh-list
92689580|NCT00481169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92689581|NCT00481169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92689582|NCT00481169|Hormone Antagonists|hormone antagonists|mesh-ancestor
92689583|NCT00481169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689584|NCT00481169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689585|NCT00481169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92689586|NCT00483093|Cisplatin|cisplatin|mesh-list
92689587|NCT00483093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689588|NCT00483132|Interferons|interferons|mesh-list
92689589|NCT00483132|Interferon-alpha|interferon-alpha|mesh-list
92689590|NCT00483132|Interferon alpha-2|interferon alpha-2|mesh-list
92689591|NCT00483132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689592|NCT00483132|Antiviral Agents|antiviral agents|mesh-ancestor
92689593|NCT00483132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689594|NCT00483132|Immunologic Factors|immunologic factors|mesh-ancestor
92689595|NCT00483132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689596|NCT00483210|Fenofibrate|fenofibrate|mesh-list
92689597|NCT00483210|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92689598|NCT00483210|Antimetabolites|antimetabolites|mesh-ancestor
92689599|NCT00483210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689600|NCT00483210|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92689601|NCT00487994|Atorvastatin|atorvastatin|mesh-list
92689602|NCT00487994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92689603|NCT00487994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92689604|NCT00487994|Antimetabolites|antimetabolites|mesh-ancestor
92689609|NCT00483158|Finafloxacin|finafloxacin|mesh-list
92689610|NCT00483158|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92689611|NCT00483158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689612|NCT00483158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92689613|NCT00483158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92689614|NCT00483158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92689615|NCT00483158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689616|NCT00483158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689617|NCT00483158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689618|NCT00483366|Gemcitabine|gemcitabine|mesh-list
92689619|NCT00483366|Capecitabine|capecitabine|mesh-list
92689620|NCT00483366|Imatinib Mesylate|imatinib mesylate|mesh-list
92689621|NCT00483366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92689622|NCT00483366|Antimetabolites|antimetabolites|mesh-ancestor
92689623|NCT00483366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689624|NCT00483366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689625|NCT00483366|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92689626|NCT00483366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689628|NCT01308580|Prednisolone|prednisolone|mesh-list
92689629|NCT01308580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689630|NCT01308580|Glucocorticoids|glucocorticoids|mesh-ancestor
92689631|NCT01308580|Hormones|hormones|mesh-ancestor
92689632|NCT01308580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689633|NCT01308580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689634|NCT01308580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689635|NCT01308580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689636|NCT00483275|Alfacalcidol|alfacalcidol|mesh-list
92689637|NCT00483275|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92689638|NCT00483275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92689639|NCT00483275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689640|NCT00483275|Vitamins|vitamins|mesh-ancestor
92689641|NCT00483275|Micronutrients|micronutrients|mesh-ancestor
92689642|NCT00483314|Acetylcysteine|acetylcysteine|mesh-list
92689643|NCT00483314|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92689644|NCT00483314|Antiviral Agents|antiviral agents|mesh-ancestor
92689645|NCT00483314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607180|NCT00131027|Immunologic Factors|immunologic factors|mesh-ancestor
92607181|NCT00131027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607182|NCT00131027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047148|NCT05387759|Aticaprant|aticaprant|mesh-list
92689646|NCT00483314|Expectorants|expectorants|mesh-ancestor
92689647|NCT00483314|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689648|NCT00483314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92689649|NCT00483314|Antioxidants|antioxidants|mesh-ancestor
92689650|NCT00483314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689651|NCT00483314|Protective Agents|protective agents|mesh-ancestor
92689652|NCT00483314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689653|NCT00483314|Antidotes|antidotes|mesh-ancestor
92689654|NCT00483392|Metformin|metformin|mesh-list
92689655|NCT00483392|Rosiglitazone|rosiglitazone|mesh-list
92689656|NCT00483392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92689657|NCT00483392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689658|NCT00483431|Menaquinone 7|menaquinone 7|mesh-list
92689659|NCT00483431|Hemostatics|hemostatics|mesh-ancestor
92689660|NCT00483431|Coagulants|coagulants|mesh-ancestor
92689661|NCT00483600|PENTA|penta|mesh-list
92689662|NCT00483600|Fondaparinux|fondaparinux|mesh-list
92689663|NCT00483600|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92689664|NCT00483600|Antithrombins|antithrombins|mesh-ancestor
92689665|NCT00483600|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92689666|NCT00483600|Protease Inhibitors|protease inhibitors|mesh-ancestor
92689667|NCT00483600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689668|NCT00483600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689669|NCT00483600|Anticoagulants|anticoagulants|mesh-ancestor
92689670|NCT00483600|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92689671|NCT00483600|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92689672|NCT00488189|Tazobactam|tazobactam|mesh-list
92689673|NCT00488189|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92689674|NCT00488189|Piperacillin|piperacillin|mesh-list
92689675|NCT00488189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92689677|NCT00488189|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92689678|NCT00488189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689679|NCT00488189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689681|NCT02956421|Immunologic Factors|immunologic factors|mesh-ancestor
92689682|NCT02956421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689683|NCT00483470|Vaccines|vaccines|mesh-list
92689684|NCT00483470|Immunologic Factors|immunologic factors|mesh-ancestor
92689685|NCT00483470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689686|NCT00488306|Tigecycline|tigecycline|mesh-list
92689687|NCT00488306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92689688|NCT00488306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689689|NCT00488306|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92689690|NCT00488306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689691|NCT00488306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689692|NCT00483626|Sildenafil Citrate|sildenafil citrate|mesh-list
92689693|NCT00483626|Vasodilator Agents|vasodilator agents|mesh-ancestor
92689694|NCT00483626|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92689695|NCT00483626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92689696|NCT00483626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689697|NCT00483626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689698|NCT00483626|Urological Agents|urological agents|mesh-ancestor
92689699|NCT00483795|Citric Acid|citric acid|mesh-list
92689700|NCT00483795|Sodium Citrate|sodium citrate|mesh-list
92109473|NCT04945824|Dexamethasone|dexamethasone|mesh-list
92689701|NCT00483795|Anticoagulants|anticoagulants|mesh-ancestor
92689702|NCT00483795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92689703|NCT00483795|Chelating Agents|chelating agents|mesh-ancestor
92689704|NCT00483795|Sequestering Agents|sequestering agents|mesh-ancestor
92689705|NCT00483795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689707|NCT05644210|Hydroxychloroquine|hydroxychloroquine|mesh-list
92689708|NCT05644210|Prednisone|prednisone|mesh-list
92689709|NCT05644210|Rituximab|rituximab|mesh-list
92689710|NCT05644210|Warfarin|warfarin|mesh-list
92689711|NCT05644210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689712|NCT05644210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689713|NCT05644210|Immunologic Factors|immunologic factors|mesh-ancestor
92689714|NCT05644210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689715|NCT05644210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689716|NCT05644210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689717|NCT05644210|Glucocorticoids|glucocorticoids|mesh-ancestor
92607183|NCT00131027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92607184|NCT00131027|Alkylating Agents|alkylating agents|mesh-ancestor
92689718|NCT05644210|Hormones|hormones|mesh-ancestor
92689719|NCT05644210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689720|NCT05644210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92689721|NCT05644210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92689722|NCT05644210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689723|NCT05644210|Analgesics|analgesics|mesh-ancestor
92689724|NCT05644210|Sensory System Agents|sensory system agents|mesh-ancestor
92689725|NCT05644210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689726|NCT05644210|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92689727|NCT05644210|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92689728|NCT05644210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689729|NCT05644210|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92689730|NCT05644210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92689731|NCT05644210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689732|NCT05644210|Antipyretics|antipyretics|mesh-ancestor
92689733|NCT05644210|Anticoagulants|anticoagulants|mesh-ancestor
92689734|NCT05644210|Antimalarials|antimalarials|mesh-ancestor
92689735|NCT05644210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92689736|NCT05644210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92689737|NCT05644210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689738|NCT00488384|Acitretin|acitretin|mesh-list
92689739|NCT00488384|Keratolytic Agents|keratolytic agents|mesh-ancestor
92689740|NCT00488384|Dermatologic Agents|dermatologic agents|mesh-ancestor
92689741|NCT00483834|Bevacizumab|bevacizumab|mesh-list
92689742|NCT00483834|Capecitabine|capecitabine|mesh-list
92689743|NCT00483834|Irinotecan|irinotecan|mesh-list
92689744|NCT00483834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689745|NCT00483834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689746|NCT00483834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92689747|NCT00483834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92689748|NCT00483834|Growth Substances|growth substances|mesh-ancestor
92689749|NCT00483834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689750|NCT00483834|Growth Inhibitors|growth inhibitors|mesh-ancestor
92689754|NCT00483834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92689755|NCT00483834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92689757|NCT01307449|Vaccines|vaccines|mesh-list
92689758|NCT01307449|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92689759|NCT01307449|Immunologic Factors|immunologic factors|mesh-ancestor
92689760|NCT01307449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689761|NCT01307020|Ibuprofen|ibuprofen|mesh-list
92689762|NCT01307020|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92689763|NCT01307020|Ketoprofen|ketoprofen|mesh-list
92689764|NCT01307020|Tramadol|tramadol|mesh-list
92689765|NCT01307020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92689766|NCT01307020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689767|NCT01307020|Analgesics|analgesics|mesh-ancestor
92689768|NCT01307020|Sensory System Agents|sensory system agents|mesh-ancestor
92689769|NCT01307020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689770|NCT01307020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689771|NCT01307020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689772|NCT01307020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689773|NCT01307020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92689774|NCT01307020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689775|NCT01307020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689776|NCT01307020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92689777|NCT01307020|Narcotics|narcotics|mesh-ancestor
92689778|NCT01307020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689779|NCT00483743|Budesonide|budesonide|mesh-list
92689780|NCT00483743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689781|NCT00483743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92689782|NCT00483743|Autonomic Agents|autonomic agents|mesh-ancestor
92689783|NCT00483743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689784|NCT00483743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689785|NCT00483743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92689786|NCT00483743|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689787|NCT00483743|Glucocorticoids|glucocorticoids|mesh-ancestor
92689788|NCT00483743|Hormones|hormones|mesh-ancestor
92689789|NCT00483743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689790|NCT00483782|Paclitaxel|paclitaxel|mesh-list
92689791|NCT00483782|Bevacizumab|bevacizumab|mesh-list
92689792|NCT00483782|Carboplatin|carboplatin|mesh-list
92689793|NCT00483782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92607185|NCT00131027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607186|NCT00131027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607187|NCT00131027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92689794|NCT00483782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689795|NCT00483782|Tubulin Modulators|tubulin modulators|mesh-ancestor
92689796|NCT00483782|Antimitotic Agents|antimitotic agents|mesh-ancestor
92689797|NCT00483782|Mitosis Modulators|mitosis modulators|mesh-ancestor
92689798|NCT00483782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689799|NCT00483782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92689800|NCT00483782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92689801|NCT00483782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92689802|NCT00483782|Growth Substances|growth substances|mesh-ancestor
92689803|NCT00483782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689804|NCT00483782|Growth Inhibitors|growth inhibitors|mesh-ancestor
92689806|NCT02890771|Antioxidants|antioxidants|mesh-ancestor
92689807|NCT02890771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689808|NCT02890771|Protective Agents|protective agents|mesh-ancestor
92689809|NCT02890771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689810|NCT01306162|Dronedarone|dronedarone|mesh-list
92689811|NCT01306162|Dabigatran|dabigatran|mesh-list
92689812|NCT01306162|Antithrombins|antithrombins|mesh-ancestor
92689813|NCT01306162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92689814|NCT01306162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92689815|NCT01306162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689816|NCT01306162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689817|NCT01306162|Anticoagulants|anticoagulants|mesh-ancestor
92689818|NCT01306162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92689819|NCT04515732|Apremilast|apremilast|mesh-list
92689820|NCT04515732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92689821|NCT04515732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689824|NCT04515732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689825|NCT04515732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689826|NCT04515732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92689828|NCT04515732|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92689829|NCT04515732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92689830|NCT04515732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689831|NCT04515732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689832|NCT01305577|Deoxycholic Acid|deoxycholic acid|mesh-list
92689833|NCT01305577|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92689834|NCT01305577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92689835|NCT00483990|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92689836|NCT00483990|Anesthetics, Local|anesthetics, local|mesh-ancestor
92689837|NCT00483990|Anesthetics|anesthetics|mesh-ancestor
92689838|NCT00483990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689839|NCT00483990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689840|NCT00483990|Sensory System Agents|sensory system agents|mesh-ancestor
92689841|NCT00483990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689842|NCT00483990|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92689843|NCT01304329|Empagliflozin|empagliflozin|mesh-list
92689844|NCT01304329|Simvastatin|simvastatin|mesh-list
92689845|NCT01304329|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92689846|NCT01304329|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92689847|NCT01304329|Antimetabolites|antimetabolites|mesh-ancestor
92689848|NCT01304329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689849|NCT01304329|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92689850|NCT01304329|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92689851|NCT01304329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689852|NCT01304329|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92689853|NCT01304329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92689854|NCT01304329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689855|NCT04515420|Norepinephrine|norepinephrine|mesh-list
92689856|NCT04515420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92689857|NCT04515420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92689858|NCT04515420|Adrenergic Agents|adrenergic agents|mesh-ancestor
92689859|NCT04515420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689860|NCT04515420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689861|NCT04515420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689862|NCT04515420|Sympathomimetics|sympathomimetics|mesh-ancestor
92047343|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92047348|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
92689864|NCT04515420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689865|NCT04515420|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92689866|NCT00488540|Acetaminophen|acetaminophen|mesh-list
92689867|NCT00488540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92689868|NCT00488540|Analgesics|analgesics|mesh-ancestor
92689869|NCT00488540|Sensory System Agents|sensory system agents|mesh-ancestor
92689870|NCT00488540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689871|NCT00488540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689872|NCT00488540|Antipyretics|antipyretics|mesh-ancestor
92689873|NCT00484068|Enalapril|enalapril|mesh-list
92689874|NCT00484068|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92689875|NCT00484068|Protease Inhibitors|protease inhibitors|mesh-ancestor
92689876|NCT00484068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689877|NCT00484068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689878|NCT00484068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92689879|NCT00483860|Topotecan|topotecan|mesh-list
92689880|NCT00483860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92689881|NCT00483860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92689882|NCT00483860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689883|NCT00483860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689884|NCT00483860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689885|NCT01241097|Simvastatin|simvastatin|mesh-list
92689886|NCT01241097|Ezetimibe|ezetimibe|mesh-list
92689887|NCT01241097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92689888|NCT01241097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92689889|NCT01241097|Antimetabolites|antimetabolites|mesh-ancestor
92689890|NCT01241097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689891|NCT01241097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92689892|NCT01241097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92689896|NCT01303861|Varenicline|varenicline|mesh-list
92689897|NCT01303861|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92689898|NCT01303861|Autonomic Agents|autonomic agents|mesh-ancestor
92689899|NCT01303861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689900|NCT01303861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689901|NCT01303861|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92689902|NCT01303861|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92689903|NCT01303861|Cholinergic Agents|cholinergic agents|mesh-ancestor
92689904|NCT01303861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689905|NCT01303861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689906|NCT01303861|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92689907|NCT01303861|Antidepressive Agents|antidepressive agents|mesh-ancestor
92689908|NCT01303861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92689909|NCT01303861|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92689910|NCT01303861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92689911|NCT01303861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689912|NCT01303861|Dopamine Agents|dopamine agents|mesh-ancestor
92689913|NCT01303861|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92689914|NCT01303861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92689915|NCT01303861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689916|NCT01303627|Remifentanil|remifentanil|mesh-list
92689917|NCT01303627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92689918|NCT01303627|Narcotics|narcotics|mesh-ancestor
92689919|NCT01303627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689920|NCT01303627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689921|NCT01303627|Analgesics|analgesics|mesh-ancestor
92689922|NCT01303627|Sensory System Agents|sensory system agents|mesh-ancestor
92689923|NCT01303627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689924|NCT01241175|Magnesium Sulfate|magnesium sulfate|mesh-list
92689925|NCT01241175|Analgesics|analgesics|mesh-ancestor
92689926|NCT01241175|Sensory System Agents|sensory system agents|mesh-ancestor
92689927|NCT01241175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689928|NCT01241175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689930|NCT01241175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689931|NCT01241175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92689932|NCT01241175|Anticonvulsants|anticonvulsants|mesh-ancestor
92689933|NCT01241175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92689934|NCT01241175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689935|NCT01241175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369961|NCT03278691|Ketorolac|ketorolac|mesh-list
92607188|NCT00131027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607189|NCT00131027|Antiemetics|antiemetics|mesh-ancestor
92047427|NCT04104646|Morphine|morphine|mesh-list
92689936|NCT01241175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92689937|NCT01241175|Tocolytic Agents|tocolytic agents|mesh-ancestor
92689938|NCT01241175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92689939|NCT00484107|Estrogens|estrogens|mesh-list
92689940|NCT00484107|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92689941|NCT00484107|Hormones|hormones|mesh-ancestor
92689942|NCT00484107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689943|NCT00484107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689944|NCT01302964|Mirtazapine|mirtazapine|mesh-list
92689945|NCT01302964|Antidepressive Agents|antidepressive agents|mesh-ancestor
92689946|NCT01302964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92689947|NCT01302964|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92689948|NCT01302964|Histamine Antagonists|histamine antagonists|mesh-ancestor
92689949|NCT01302964|Histamine Agents|histamine agents|mesh-ancestor
92689950|NCT01302964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689951|NCT01302964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689952|NCT01302964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689953|NCT01302964|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92689954|NCT01302964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92689955|NCT01302964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689956|NCT01302964|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92689957|NCT01302964|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92689958|NCT01302964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92689959|NCT01302964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92689960|NCT01302964|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92689961|NCT01302964|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92689962|NCT01302964|Serotonin Agents|serotonin agents|mesh-ancestor
92689963|NCT01302964|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92689964|NCT00484055|Gentamicins|gentamicins|mesh-list
92689972|NCT01302691|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92689973|NCT01302691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92689974|NCT01302691|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92689975|NCT01302691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92689976|NCT01302691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689977|NCT01302691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92689978|NCT01302691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689979|NCT01302691|Vasodilator Agents|vasodilator agents|mesh-ancestor
92689980|NCT01302691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92689981|NCT01302691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92689982|NCT01302691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92689983|NCT01302691|Diuretics|diuretics|mesh-ancestor
92689984|NCT01302691|Natriuretic Agents|natriuretic agents|mesh-ancestor
92689985|NCT01302691|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92689986|NCT01241084|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92689987|NCT01241084|Hormone Antagonists|hormone antagonists|mesh-ancestor
92689988|NCT01241084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92689989|NCT01241084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689990|NCT01241084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92689991|NCT01241084|Respiratory System Agents|respiratory system agents|mesh-ancestor
92689992|NCT05643820|Ivermectin|ivermectin|mesh-list
92689993|NCT05643820|Permethrin|permethrin|mesh-list
92689994|NCT05643820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92689995|NCT05643820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689996|NCT05643820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689997|NCT05643820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689998|NCT01242449|Trastuzumab|trastuzumab|mesh-list
92689999|NCT01242449|Vinorelbine|vinorelbine|mesh-list
92690000|NCT01242449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92690001|NCT01242449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690002|NCT01242449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92690003|NCT01242449|Tubulin Modulators|tubulin modulators|mesh-ancestor
92690004|NCT01242449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92690005|NCT01242449|Mitosis Modulators|mitosis modulators|mesh-ancestor
92690006|NCT01242449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690008|NCT01241162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690009|NCT01241162|Antimetabolites|antimetabolites|mesh-ancestor
92607191|NCT00131027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607192|NCT00131027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607193|NCT00131027|Glucocorticoids|glucocorticoids|mesh-ancestor
92607194|NCT00131027|Hormones|hormones|mesh-ancestor
92607195|NCT00131027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014573|NCT05615987|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92690010|NCT01241162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690011|NCT01241162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690012|NCT01241162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690013|NCT00484133|Dobutamine|dobutamine|mesh-list
92690014|NCT00484133|Dopamine|dopamine|mesh-list
92690015|NCT00484133|Enoximone|enoximone|mesh-list
92690016|NCT00484133|Norepinephrine|norepinephrine|mesh-list
92690017|NCT00484133|Nitroglycerin|nitroglycerin|mesh-list
92690018|NCT00484133|Vasodilator Agents|vasodilator agents|mesh-ancestor
92690019|NCT00484133|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92690020|NCT00484133|Sympathomimetics|sympathomimetics|mesh-ancestor
92690021|NCT00484133|Autonomic Agents|autonomic agents|mesh-ancestor
92690022|NCT00484133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690023|NCT00484133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690024|NCT00484133|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92690025|NCT00484133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92690026|NCT00484133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92690027|NCT00484133|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690028|NCT00484133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690029|NCT00484133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690030|NCT00484133|Protective Agents|protective agents|mesh-ancestor
92690031|NCT00484133|Dopamine Agents|dopamine agents|mesh-ancestor
92690032|NCT00484133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92690036|NCT00484133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690037|NCT00484341|Doxorubicin|doxorubicin|mesh-list
92690038|NCT00484341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690039|NCT00484341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690040|NCT00484341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92690041|NCT00484341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92690042|NCT00484341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690043|NCT00484341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690044|NCT01242566|Temozolomide|temozolomide|mesh-list
92690045|NCT01242566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92690046|NCT01242566|Alkylating Agents|alkylating agents|mesh-ancestor
92690047|NCT01242566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690048|NCT01242566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690049|NCT04514835|Capecitabine|capecitabine|mesh-list
92690050|NCT04514835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690051|NCT04514835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690052|NCT04514835|Antimetabolites|antimetabolites|mesh-ancestor
92690053|NCT04514835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690054|NCT00488813|Cephalosporins|cephalosporins|mesh-list
92690055|NCT00488813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690056|NCT00488813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690057|NCT00484250|Metronidazole|metronidazole|mesh-list
92690058|NCT00484250|Doxycycline|doxycycline|mesh-list
92690059|NCT00484250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690060|NCT00484250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690061|NCT00484250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92690062|NCT00484250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92690063|NCT00484250|Antimalarials|antimalarials|mesh-ancestor
92690064|NCT00488891|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92690065|NCT00488891|Antipsychotic Agents|antipsychotic agents|mesh-list
92690066|NCT00488891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690067|NCT00488891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690068|NCT00488891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690069|NCT00488891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690070|NCT00488891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92690071|NCT00488891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92690072|NCT00488891|Serotonin Agents|serotonin agents|mesh-ancestor
92690073|NCT00488891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109844|NCT01806779|Bupropion|bupropion|mesh-list
92607196|NCT00131027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92607197|NCT00131027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690074|NCT00488891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690075|NCT00488891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92690077|NCT00488891|Dopamine Agents|dopamine agents|mesh-ancestor
92690078|NCT00484328|Ribavirin|ribavirin|mesh-list
92690079|NCT00484328|Antimetabolites|antimetabolites|mesh-ancestor
92690080|NCT00484328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690081|NCT00484328|Antiviral Agents|antiviral agents|mesh-ancestor
92690082|NCT00484328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690083|NCT00484575|Propofol|propofol|mesh-list
92690084|NCT00484575|Sevoflurane|sevoflurane|mesh-list
92690085|NCT00484575|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92690086|NCT00484575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690087|NCT00484575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690088|NCT00484575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92690089|NCT00484575|Anesthetics, General|anesthetics, general|mesh-ancestor
92690090|NCT00484575|Anesthetics|anesthetics|mesh-ancestor
92690091|NCT00484575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92690092|NCT00484575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92690093|NCT04514796|Adalimumab|adalimumab|mesh-list
92690094|NCT04514796|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92690095|NCT04514796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690096|NCT04514796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690097|NCT00488969|Morphine|morphine|mesh-list
92690098|NCT00488969|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92690099|NCT00488969|Narcotics|narcotics|mesh-ancestor
92690100|NCT00488969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690101|NCT00488969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690102|NCT00488969|Analgesics|analgesics|mesh-ancestor
92690103|NCT00488969|Sensory System Agents|sensory system agents|mesh-ancestor
92690104|NCT00488969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690105|NCT00484692|Bupropion|bupropion|mesh-list
92690110|NCT00484692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690111|NCT00484692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690112|NCT00484692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690113|NCT00484692|Dopamine Agents|dopamine agents|mesh-ancestor
92690114|NCT00484692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690115|NCT00484692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690116|NCT00484692|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92690117|NCT00484692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92690118|NCT00484692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690119|NCT00484731|Bupivacaine|bupivacaine|mesh-list
92690120|NCT00484731|Anesthetics, Local|anesthetics, local|mesh-ancestor
92690121|NCT00484731|Anesthetics|anesthetics|mesh-ancestor
92690122|NCT00484731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690123|NCT00484731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690124|NCT00484731|Sensory System Agents|sensory system agents|mesh-ancestor
92690125|NCT00484731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690127|NCT00484484|Analgesics|analgesics|mesh-ancestor
92690128|NCT00484484|Sensory System Agents|sensory system agents|mesh-ancestor
92369993|NCT03070223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92690129|NCT00484484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690130|NCT00484484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690131|NCT00484484|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92690132|NCT00484484|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92690133|NCT00484484|Anesthetics, General|anesthetics, general|mesh-ancestor
92690134|NCT00484484|Anesthetics|anesthetics|mesh-ancestor
92690135|NCT00484484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690136|NCT00484484|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92690137|NCT00484484|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92690138|NCT00484484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690139|NCT00484484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690140|NCT00484601|Doxorubicin|doxorubicin|mesh-list
92690141|NCT00484601|Ifosfamide|ifosfamide|mesh-list
92690142|NCT00484601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690143|NCT00484601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690144|NCT00484601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92690145|NCT00484601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92690146|NCT00484601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690147|NCT00484601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607198|NCT00131027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607199|NCT00131027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607200|NCT00131027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607201|NCT00131027|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92607202|NCT00131027|Abortifacient Agents|abortifacient agents|mesh-ancestor
92607203|NCT00131027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92109916|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690148|NCT00484601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92690149|NCT00484601|Alkylating Agents|alkylating agents|mesh-ancestor
92690150|NCT00484770|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92690151|NCT00484770|Natriuretic Agents|natriuretic agents|mesh-ancestor
92690152|NCT00484770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690153|NCT00484640|Warfarin|warfarin|mesh-list
92690154|NCT00484640|Anticoagulants|anticoagulants|mesh-ancestor
92690155|NCT00489164|Sirolimus|sirolimus|mesh-list
92690156|NCT00489164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690157|NCT00489164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690158|NCT00489164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690159|NCT00489164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690160|NCT00489164|Antifungal Agents|antifungal agents|mesh-ancestor
92690161|NCT00489164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690162|NCT00489164|Immunologic Factors|immunologic factors|mesh-ancestor
92690163|NCT00489164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690164|NCT00484809|Etanercept|etanercept|mesh-list
92690165|NCT00484809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92690166|NCT00484809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690167|NCT00484809|Analgesics|analgesics|mesh-ancestor
92690168|NCT00484809|Sensory System Agents|sensory system agents|mesh-ancestor
92690169|NCT00484809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690170|NCT00484809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690171|NCT00484809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690172|NCT00484809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690184|NCT00484926|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690185|NCT00484926|Analgesics|analgesics|mesh-ancestor
92690186|NCT00484926|Sensory System Agents|sensory system agents|mesh-ancestor
92690187|NCT00484926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690188|NCT00484926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690189|NCT00484926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690190|NCT00484926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690191|NCT00484926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92690192|NCT00484926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92690193|NCT00484926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690194|NCT00484926|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92690195|NCT00484926|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92690196|NCT00484926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690197|NCT00484926|Antipyretics|antipyretics|mesh-ancestor
92690198|NCT00484926|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92690199|NCT00484926|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92690200|NCT00484926|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92690201|NCT00484926|Purinergic Agents|purinergic agents|mesh-ancestor
92690202|NCT00484926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690203|NCT02275806|Irinotecan|irinotecan|mesh-list
92690204|NCT02275806|Camptothecin|camptothecin|mesh-list
92690205|NCT02275806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690206|NCT02275806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92690207|NCT02275806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92690208|NCT02275806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690209|NCT02275806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690210|NCT02275806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92690211|NCT01241409|Rabeprazole|rabeprazole|mesh-list
92690212|NCT01241409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92690213|NCT01241409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690214|NCT01241409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92690215|NCT01241409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690216|NCT01241409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690217|NCT02275845|Metformin|metformin|mesh-list
92690218|NCT02275845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92607204|NCT00131027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92607205|NCT00131027|Antimetabolites|antimetabolites|mesh-ancestor
92607206|NCT00131027|Dermatologic Agents|dermatologic agents|mesh-ancestor
92607207|NCT00131027|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92607208|NCT00131027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92607209|NCT00131027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92607210|NCT00131027|Antiviral Agents|antiviral agents|mesh-ancestor
92607211|NCT00131027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014582|NCT02594735|Abatacept|abatacept|mesh-list
92690219|NCT02275845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690220|NCT00489398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92690221|NCT00489398|Epinastine|epinastine|mesh-list
92690222|NCT00489398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92690223|NCT00489398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690224|NCT00489398|Analgesics|analgesics|mesh-ancestor
92690225|NCT00489398|Sensory System Agents|sensory system agents|mesh-ancestor
92690226|NCT00489398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690227|NCT00489398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690228|NCT00489398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690229|NCT00489398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690230|NCT00489398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92690231|NCT00489398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92690232|NCT00489398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92690233|NCT00489398|Histamine Antagonists|histamine antagonists|mesh-ancestor
92690234|NCT00489398|Histamine Agents|histamine agents|mesh-ancestor
92690235|NCT00489398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690238|NCT00485004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690239|NCT00485004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690240|NCT00485004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690241|NCT00485004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690242|NCT00485004|Antifungal Agents|antifungal agents|mesh-ancestor
92690243|NCT00485004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690244|NCT00485004|Immunologic Factors|immunologic factors|mesh-ancestor
92690245|NCT00485004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690246|NCT00484991|Verapamil|verapamil|mesh-list
92690247|NCT00484991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92690248|NCT00484991|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92690249|NCT00484991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690250|NCT00484991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690251|NCT00484991|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92370006|NCT02621489|Incretins|incretins|mesh-ancestor
92690252|NCT00484991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690253|NCT00484991|Vasodilator Agents|vasodilator agents|mesh-ancestor
92690254|NCT00485121|Ezetimibe|ezetimibe|mesh-list
92690255|NCT00485121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92690256|NCT00485121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92690257|NCT00485121|Antimetabolites|antimetabolites|mesh-ancestor
92690258|NCT00485121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690259|NCT00485121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92690260|NCT00489437|Heparin|heparin|mesh-list
92690261|NCT00489437|Antibodies|antibodies|mesh-list
92690262|NCT00489437|Immunologic Factors|immunologic factors|mesh-ancestor
92690263|NCT00489437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690264|NCT00489437|Anticoagulants|anticoagulants|mesh-ancestor
92690265|NCT00489437|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92690266|NCT00489437|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92690267|NCT00489437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690268|NCT00485160|Ibuprofen|ibuprofen|mesh-list
92690269|NCT00485160|Indomethacin|indomethacin|mesh-list
92690270|NCT00485160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92690271|NCT00485160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690272|NCT00485160|Analgesics|analgesics|mesh-ancestor
92690273|NCT00485160|Sensory System Agents|sensory system agents|mesh-ancestor
92690274|NCT00485160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690275|NCT00485160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690276|NCT00485160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607212|NCT00131027|Tubulin Modulators|tubulin modulators|mesh-ancestor
92607213|NCT00131027|Antimitotic Agents|antimitotic agents|mesh-ancestor
92607214|NCT00131027|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607215|NCT00139854|Alprazolam|alprazolam|mesh-list
92690277|NCT00485160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690278|NCT00485160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92690279|NCT00485160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690280|NCT00485160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690281|NCT00485160|Gout Suppressants|gout suppressants|mesh-ancestor
92690282|NCT00485160|Tocolytic Agents|tocolytic agents|mesh-ancestor
92690283|NCT00485160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92690284|NCT00485030|Sirolimus|sirolimus|mesh-list
92690285|NCT00485030|Everolimus|everolimus|mesh-list
92690286|NCT00485030|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92690287|NCT00485030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92690288|NCT00485030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690289|NCT00485030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690290|NCT00485030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690291|NCT00485030|Immunologic Factors|immunologic factors|mesh-ancestor
92690292|NCT00485030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690293|NCT00485030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690294|NCT00485030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690295|NCT00485030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690296|NCT00485030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690297|NCT00485030|Antifungal Agents|antifungal agents|mesh-ancestor
92110067|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
92690299|NCT04513821|Ethanol|ethanol|mesh-list
92690300|NCT04513821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690301|NCT04513821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690302|NCT04513821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92690303|NCT04513821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690304|NCT04513821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690305|NCT00485108|Prednisolone|prednisolone|mesh-list
92690306|NCT00485108|Ketorolac|ketorolac|mesh-list
92690307|NCT00485108|Lubricant Eye Drops|lubricant eye drops|mesh-list
92690308|NCT00485108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690316|NCT00485108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92690317|NCT00485108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690318|NCT00485108|Analgesics|analgesics|mesh-ancestor
92690319|NCT00485108|Sensory System Agents|sensory system agents|mesh-ancestor
92690320|NCT00485108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690321|NCT00485108|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92690322|NCT00485108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690323|NCT00485108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690324|NCT00485108|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92690325|NCT00485108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92690326|NCT00485238|Acetazolamide|acetazolamide|mesh-list
92690327|NCT00485238|Anticonvulsants|anticonvulsants|mesh-ancestor
92690328|NCT00485238|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92690329|NCT00485238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690330|NCT00485238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690331|NCT00485238|Diuretics|diuretics|mesh-ancestor
92690332|NCT00485238|Natriuretic Agents|natriuretic agents|mesh-ancestor
92690333|NCT00485238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690334|NCT00485277|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92690335|NCT00485277|Antiviral Agents|antiviral agents|mesh-ancestor
92690336|NCT00485277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690337|NCT04513509|Propranolol|propranolol|mesh-list
92690338|NCT04513509|Metoprolol|metoprolol|mesh-list
92690339|NCT04513509|Digoxin|digoxin|mesh-list
92690340|NCT04513509|Atenolol|atenolol|mesh-list
92690341|NCT04513509|Verapamil|verapamil|mesh-list
92690342|NCT04513509|Nebivolol|nebivolol|mesh-list
92690343|NCT04513509|Bisoprolol|bisoprolol|mesh-list
92690344|NCT04513509|Diltiazem|diltiazem|mesh-list
92690345|NCT04513509|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92690346|NCT04513509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92690347|NCT04513509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690348|NCT04513509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690349|NCT04513509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690350|NCT04513509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690351|NCT04513509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92690352|NCT04513509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92690353|NCT04513509|Vasodilator Agents|vasodilator agents|mesh-ancestor
92690354|NCT04513509|Sympatholytics|sympatholytics|mesh-ancestor
92690355|NCT04513509|Autonomic Agents|autonomic agents|mesh-ancestor
92690356|NCT04513509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690357|NCT04513509|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92690358|NCT04513509|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92690359|NCT04513509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690360|NCT04513509|Protective Agents|protective agents|mesh-ancestor
92690361|NCT04513509|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92690362|NCT04513509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92690363|NCT04513509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92690364|NCT04513509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92690365|NCT04513509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690366|NCT04513509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92690367|NCT00485342|Interferons|interferons|mesh-list
92690369|NCT00485342|Interferon-alpha|interferon-alpha|mesh-list
92690370|NCT00485342|Interferon alpha-2|interferon alpha-2|mesh-list
92690371|NCT00485342|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92690372|NCT00485342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690373|NCT00485342|Antiviral Agents|antiviral agents|mesh-ancestor
92690374|NCT00485342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690375|NCT00485342|Antimetabolites|antimetabolites|mesh-ancestor
92690378|NCT00485342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690380|NCT00489593|Fluoxetine|fluoxetine|mesh-list
92690381|NCT00489593|Antiemetics|antiemetics|mesh-ancestor
92690382|NCT00489593|Autonomic Agents|autonomic agents|mesh-ancestor
92690383|NCT00489593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690384|NCT00489593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690385|NCT00489593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690386|NCT00489593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690387|NCT00489593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690388|NCT00489593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690389|NCT00489593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690390|NCT00489593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690391|NCT00489593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690392|NCT00489593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690393|NCT00489593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690394|NCT00489593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690395|NCT00489593|Serotonin Agents|serotonin agents|mesh-ancestor
92690396|NCT00489593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92690397|NCT00489593|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690398|NCT00489593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92690399|NCT00489593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92690400|NCT00489593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690401|NCT01241487|Amlodipine|amlodipine|mesh-list
92690402|NCT01241487|Valsartan|valsartan|mesh-list
92690403|NCT01241487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92690404|NCT01241487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92690405|NCT01241487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690406|NCT01241487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690407|NCT01241487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92690408|NCT01241487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690409|NCT01241487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92690410|NCT01241487|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92690411|NCT01241487|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92690412|NCT00505791|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92690413|NCT00505791|Natriuretic Agents|natriuretic agents|mesh-ancestor
92690414|NCT00505791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690415|NCT04513626|Raltegravir Potassium|raltegravir potassium|mesh-list
92690416|NCT04513626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92690417|NCT04513626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92690418|NCT04513626|Antiviral Agents|antiviral agents|mesh-ancestor
92690419|NCT04513626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690420|NCT04513626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92690421|NCT04513626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92690422|NCT04513626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690423|NCT04513626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690424|NCT00485459|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690425|NCT00485459|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690426|NCT00485459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690427|NCT00485459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607216|NCT00139854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92607217|NCT00139854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607218|NCT00139854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607219|NCT00139854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92690428|NCT00485459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690429|NCT00485459|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690430|NCT00485459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690431|NCT00485459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690432|NCT00489710|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92690433|NCT00489710|Immunomodulating Agents|immunomodulating agents|mesh-list
92690434|NCT00489710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690435|NCT00489710|Immunologic Factors|immunologic factors|mesh-ancestor
92690436|NCT00489710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690438|NCT04697511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92690439|NCT04697511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92690440|NCT04697511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690441|NCT04697511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690442|NCT04697511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92690443|NCT04697511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690444|NCT04697511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690446|NCT04697511|Anesthetics, General|anesthetics, general|mesh-ancestor
92690447|NCT04697511|Anesthetics|anesthetics|mesh-ancestor
92690448|NCT04697511|GABA Modulators|gaba modulators|mesh-ancestor
92690449|NCT04697511|GABA Agents|gaba agents|mesh-ancestor
92690450|NCT04697511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690451|NCT04697511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690452|NCT00485511|Hydroxyurea|hydroxyurea|mesh-list
92690453|NCT00485511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690454|NCT00485511|Antisickling Agents|antisickling agents|mesh-ancestor
92690455|NCT00485511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690456|NCT00485511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690457|NCT00485511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92690458|NCT00485498|Olanzapine|olanzapine|mesh-list
92690459|NCT00485498|Risperidone|risperidone|mesh-list
92690460|NCT00485498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92690461|NCT00485498|Serotonin Agents|serotonin agents|mesh-ancestor
92690462|NCT00485498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690463|NCT00485498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690464|NCT00485498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690465|NCT00485498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690466|NCT00485498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690467|NCT00485498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690468|NCT00485498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690469|NCT00485498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92690470|NCT00485498|Dopamine Agents|dopamine agents|mesh-ancestor
92690471|NCT00485498|Antiemetics|antiemetics|mesh-ancestor
92690472|NCT00485498|Autonomic Agents|autonomic agents|mesh-ancestor
92690473|NCT00485498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690474|NCT00485498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690475|NCT00485498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690476|NCT00485498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690477|NCT00485498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690478|NCT01302067|Fesoterodine|fesoterodine|mesh-list
92690479|NCT01302067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92690480|NCT01302067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92690481|NCT01302067|Cholinergic Agents|cholinergic agents|mesh-ancestor
92690482|NCT01302067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690483|NCT01302067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690484|NCT01302067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690485|NCT01302067|Urological Agents|urological agents|mesh-ancestor
92690486|NCT00485550|Methylphenidate|methylphenidate|mesh-list
92690487|NCT00485550|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690488|NCT00485550|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92690489|NCT00485550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690490|NCT00485550|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92690491|NCT00485550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690492|NCT00485550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607220|NCT00139854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607221|NCT00139854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607222|NCT00139854|GABA Modulators|gaba modulators|mesh-ancestor
92690493|NCT00485550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690494|NCT00485550|Dopamine Agents|dopamine agents|mesh-ancestor
92690495|NCT00485550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690496|NCT00485550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690497|NCT00485550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690498|NCT00485628|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690499|NCT00485628|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690500|NCT00485628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690501|NCT00485628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690502|NCT00485628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690503|NCT00485628|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690504|NCT00485628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690505|NCT00485628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690506|NCT00485576|Eculizumab|eculizumab|mesh-list
92690507|NCT00485576|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92690508|NCT00485576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690509|NCT00485576|Immunologic Factors|immunologic factors|mesh-ancestor
92690510|NCT00485576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690511|NCT00485667|Moxifloxacin|moxifloxacin|mesh-list
92690512|NCT00485667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690513|NCT00485667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690514|NCT00485667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92690515|NCT00485667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92690527|NCT00489944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92690528|NCT00489944|Growth Substances|growth substances|mesh-ancestor
92690529|NCT00489944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690530|NCT00489944|Growth Inhibitors|growth inhibitors|mesh-ancestor
92690531|NCT00489944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92690532|NCT00489944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690533|NCT00489944|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92690534|NCT00489944|Hormone Antagonists|hormone antagonists|mesh-ancestor
92690535|NCT00489944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92690536|NCT00489944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92690537|NCT00489944|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92690538|NCT00489944|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92690539|NCT00489944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92690540|NCT00485706|Dialysis Solutions|dialysis solutions|mesh-list
92690541|NCT00485706|Calcium|calcium|mesh-list
92370095|NCT01053078|Naltrexone|naltrexone|mesh-list
92690542|NCT00485706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92690543|NCT00485706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690544|NCT00485706|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92690545|NCT00505947|Infliximab|infliximab|mesh-list
92690546|NCT00505947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92690547|NCT00505947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690548|NCT00505947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92690549|NCT00505947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690550|NCT00505947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690551|NCT00489983|Gemcitabine|gemcitabine|mesh-list
92690552|NCT00489983|Pemetrexed|pemetrexed|mesh-list
92690553|NCT00489983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690554|NCT00489983|Antimetabolites|antimetabolites|mesh-ancestor
92690555|NCT00489983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690556|NCT00489983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690557|NCT00489983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690558|NCT00489983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92690559|NCT00489983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92690560|NCT01241682|Cyclophosphamide|cyclophosphamide|mesh-list
92690561|NCT01241682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690562|NCT01241682|Immunologic Factors|immunologic factors|mesh-ancestor
92690563|NCT01241682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690564|NCT01241682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690565|NCT01241682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92690566|NCT01241682|Alkylating Agents|alkylating agents|mesh-ancestor
92690567|NCT01241682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690568|NCT01241682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690569|NCT01241682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92690570|NCT00490178|Metformin|metformin|mesh-list
92690571|NCT00490178|Fenofibrate|fenofibrate|mesh-list
92607223|NCT00139854|GABA Agents|gaba agents|mesh-ancestor
92607224|NCT00139854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607225|NCT00139854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607227|NCT00131144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607228|NCT00131144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92607229|NCT00131144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690572|NCT00490178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92690573|NCT00490178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690574|NCT00490178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92690575|NCT00490178|Antimetabolites|antimetabolites|mesh-ancestor
92690576|NCT00490178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690577|NCT00490178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92690592|NCT00485771|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690593|NCT00485771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690594|NCT00485771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690595|NCT00485771|Serotonin Agents|serotonin agents|mesh-ancestor
92690596|NCT00485771|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92690597|NCT00485771|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690598|NCT00485771|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92690599|NCT00485771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92690600|NCT00485771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690601|NCT00485771|Anticonvulsants|anticonvulsants|mesh-ancestor
92690602|NCT00485771|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92690603|NCT00485771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92690604|NCT00485771|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92690605|NCT00485810|Olanzapine|olanzapine|mesh-list
92690606|NCT00485810|Antiemetics|antiemetics|mesh-ancestor
92690607|NCT00485810|Autonomic Agents|autonomic agents|mesh-ancestor
92690608|NCT00485810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690609|NCT00485810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690610|NCT00485810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690611|NCT00485810|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690612|NCT00485810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690613|NCT00485810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690614|NCT00485810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690615|NCT00485810|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690616|NCT00485810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690617|NCT00485810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690618|NCT00485810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690619|NCT00485810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690620|NCT00485810|Serotonin Agents|serotonin agents|mesh-ancestor
92690621|NCT00490373|Pemetrexed|pemetrexed|mesh-list
92690622|NCT00490373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690623|NCT00490373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690624|NCT00490373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690625|NCT00490373|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92690626|NCT00490373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92690627|NCT00485823|Olanzapine|olanzapine|mesh-list
92690628|NCT00485823|Antiemetics|antiemetics|mesh-ancestor
92690629|NCT00485823|Autonomic Agents|autonomic agents|mesh-ancestor
92690630|NCT00485823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690631|NCT00485823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690632|NCT00485823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690633|NCT00485823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690634|NCT00485823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690635|NCT00485823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690639|NCT00485823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690640|NCT00485823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690641|NCT00485823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690643|NCT00485849|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690644|NCT00485849|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690645|NCT00485849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690646|NCT00485849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690647|NCT00485849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607230|NCT00139893|Metoclopramide|metoclopramide|mesh-list
92607231|NCT00139893|Antiemetics|antiemetics|mesh-ancestor
92607232|NCT00139893|Autonomic Agents|autonomic agents|mesh-ancestor
92607233|NCT00139893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690648|NCT00485849|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690649|NCT00485849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690650|NCT00485849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690651|NCT00485888|Escitalopram|escitalopram|mesh-list
92690652|NCT00485888|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690653|NCT00485888|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690654|NCT00485888|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690655|NCT00485888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690656|NCT00485888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690657|NCT00485888|Serotonin Agents|serotonin agents|mesh-ancestor
92690658|NCT00485888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690659|NCT00485862|Sertraline|sertraline|mesh-list
92690660|NCT00485862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690661|NCT00485862|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690662|NCT00485862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690663|NCT00485862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690664|NCT00485862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690665|NCT00485862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690666|NCT00485862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690667|NCT00485862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690668|NCT00485862|Serotonin Agents|serotonin agents|mesh-ancestor
92690669|NCT00485862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690670|NCT00485862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690671|NCT00485862|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690672|NCT00485901|Haloperidol|haloperidol|mesh-list
92690674|NCT00485901|Haloperidol decanoate|haloperidol decanoate|mesh-list
92690675|NCT00485901|Antiemetics|antiemetics|mesh-ancestor
92690676|NCT00485901|Autonomic Agents|autonomic agents|mesh-ancestor
92690677|NCT00485901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690678|NCT00485901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690679|NCT00485901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690680|NCT00485901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690681|NCT00485901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690682|NCT00485901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690683|NCT00485901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690684|NCT00485901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690685|NCT00485901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690686|NCT00485901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690687|NCT00485901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690688|NCT00485901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690689|NCT00485901|Serotonin Agents|serotonin agents|mesh-ancestor
92690690|NCT00485901|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92690691|NCT00485901|Dopamine Agents|dopamine agents|mesh-ancestor
92690692|NCT00485901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92690693|NCT00490412|Vitamin D|vitamin d|mesh-list
92690694|NCT00490412|Vitamins|vitamins|mesh-ancestor
92690695|NCT00490412|Micronutrients|micronutrients|mesh-ancestor
92690696|NCT00490412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690697|NCT00490412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92690698|NCT00485940|Prucalopride|prucalopride|mesh-list
92690699|NCT00485940|Laxatives|laxatives|mesh-ancestor
92690700|NCT00485940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690701|NCT00485940|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92690702|NCT00485940|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92690703|NCT00485940|Serotonin Agents|serotonin agents|mesh-ancestor
92690704|NCT00485940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690708|NCT00486005|Nizatidine|nizatidine|mesh-list
92690709|NCT00486005|Antiemetics|antiemetics|mesh-ancestor
92690710|NCT00486005|Autonomic Agents|autonomic agents|mesh-ancestor
92690711|NCT00486005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690712|NCT00486005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690713|NCT00486005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690714|NCT00486005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690715|NCT00486005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690716|NCT00486005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690717|NCT00486005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690718|NCT00486005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92014603|NCT04793243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92607234|NCT00139893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607235|NCT00139893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607236|NCT00139893|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92607238|NCT00139893|Dopamine Agents|dopamine agents|mesh-ancestor
92607239|NCT00139893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607240|NCT00139893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607241|NCT00131183|Testosterone undecanoate|testosterone undecanoate|mesh-list
92607242|NCT00131183|Androgens|androgens|mesh-ancestor
92607243|NCT00131183|Hormones|hormones|mesh-ancestor
92607244|NCT00131183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607245|NCT00131183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607246|NCT00139932|Formoterol Fumarate|formoterol fumarate|mesh-list
92607247|NCT00139932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92607248|NCT00139932|Autonomic Agents|autonomic agents|mesh-ancestor
92607249|NCT00139932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607250|NCT00139932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607251|NCT00139932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92607252|NCT00139932|Respiratory System Agents|respiratory system agents|mesh-ancestor
92690719|NCT00486005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690720|NCT00486005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690721|NCT00486005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690722|NCT00486005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370138|NCT01061034|Aspirin|aspirin|mesh-list
92690723|NCT00486005|Serotonin Agents|serotonin agents|mesh-ancestor
92690724|NCT00486005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92690725|NCT00486005|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92690726|NCT00486005|Histamine Antagonists|histamine antagonists|mesh-ancestor
92690727|NCT00486005|Histamine Agents|histamine agents|mesh-ancestor
92690728|NCT00485979|Docetaxel|docetaxel|mesh-list
92690729|NCT00485979|Trastuzumab|trastuzumab|mesh-list
92690730|NCT00485979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690731|NCT00485979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92690732|NCT00485979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92690733|NCT00485979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92690734|NCT00485979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690735|NCT00485979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92690736|NCT00486083|Methylphenidate|methylphenidate|mesh-list
92690737|NCT00486083|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690738|NCT00486083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92690739|NCT00486083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690740|NCT00486083|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92690741|NCT00486083|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690742|NCT00486083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690743|NCT00486083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690744|NCT00486083|Dopamine Agents|dopamine agents|mesh-ancestor
92690745|NCT00486083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690746|NCT00486083|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690747|NCT00486083|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690748|NCT00490685|Sorafenib|sorafenib|mesh-list
92690749|NCT00490685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690750|NCT00490685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92014623|NCT05157711|Respiratory System Agents|respiratory system agents|mesh-ancestor
92690751|NCT00490685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690752|NCT00490685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690753|NCT00486122|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92690754|NCT00486122|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92690755|NCT00486122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690756|NCT00486122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690757|NCT00486122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690758|NCT00486122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690759|NCT00486122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690760|NCT00486122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690761|NCT04511715|Bevacizumab|bevacizumab|mesh-list
92690762|NCT04511715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92690763|NCT04511715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690764|NCT04511715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92690765|NCT04511715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92690766|NCT04511715|Growth Substances|growth substances|mesh-ancestor
92690767|NCT04511715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690768|NCT04511715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92690769|NCT00486317|Calcitonin|calcitonin|mesh-list
92690770|NCT00486317|Salmon calcitonin|salmon calcitonin|mesh-list
92690771|NCT00486317|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92690772|NCT00486317|Katacalcin|katacalcin|mesh-list
92690773|NCT00486317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92690784|NCT00486174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690786|NCT00486356|Capecitabine|capecitabine|mesh-list
92690787|NCT00486356|Epirubicin|epirubicin|mesh-list
92690788|NCT00486356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370141|NCT01061034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690789|NCT00486356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690790|NCT00486356|Antimetabolites|antimetabolites|mesh-ancestor
92690791|NCT00486356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690792|NCT00486356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690793|NCT00486356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92690794|NCT00486356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92690795|NCT00486356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690796|NCT00490958|Telmisartan|telmisartan|mesh-list
92690797|NCT00490958|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92690798|NCT00490958|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92690799|NCT00490958|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92690800|NCT00490958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690801|NCT00486213|Pyridoxine|pyridoxine|mesh-list
92690802|NCT00486213|Vitamin B 6|vitamin b 6|mesh-list
92690803|NCT00486213|Vitamin B Complex|vitamin b complex|mesh-ancestor
92690804|NCT00486213|Vitamins|vitamins|mesh-ancestor
92690805|NCT00486213|Micronutrients|micronutrients|mesh-ancestor
92690806|NCT00486213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690807|NCT00486369|Calcitonin|calcitonin|mesh-list
92690808|NCT00486369|Salmon calcitonin|salmon calcitonin|mesh-list
92690809|NCT00486369|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92690810|NCT00486369|Katacalcin|katacalcin|mesh-list
92690811|NCT00486369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92690812|NCT00486369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690813|NCT00486369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92690814|NCT00486369|Vasodilator Agents|vasodilator agents|mesh-ancestor
92690815|NCT00490997|Ketamine|ketamine|mesh-list
92690816|NCT00490997|Propofol|propofol|mesh-list
92690817|NCT00490997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92690818|NCT00490997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690819|NCT00490997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690820|NCT00490997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92690821|NCT00490997|Anesthetics, General|anesthetics, general|mesh-ancestor
92690822|NCT00490997|Anesthetics|anesthetics|mesh-ancestor
92690823|NCT00490997|Analgesics|analgesics|mesh-ancestor
92690824|NCT00490997|Sensory System Agents|sensory system agents|mesh-ancestor
92690825|NCT00490997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690826|NCT00490997|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92690827|NCT00490997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92690828|NCT00490997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92690829|NCT00490997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690830|NCT00490997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690831|NCT04511637|Rivaroxaban|rivaroxaban|mesh-list
92690832|NCT04511637|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92690833|NCT04511637|Antithrombins|antithrombins|mesh-ancestor
92607253|NCT00139932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92607254|NCT00139932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92607255|NCT00139932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92690834|NCT04511637|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92690835|NCT04511637|Protease Inhibitors|protease inhibitors|mesh-ancestor
92690836|NCT04511637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327596|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92690840|NCT00486486|Bimatoprost|bimatoprost|mesh-list
92690841|NCT00486486|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92690842|NCT00486486|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92690843|NCT00486486|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690844|NCT00486486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690845|NCT00486486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690846|NCT00486486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690847|NCT00486486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92690848|NCT00486486|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92690849|NCT00491114|Gemcitabine|gemcitabine|mesh-list
92370158|NCT01065558|Ecopipam|ecopipam|mesh-list
92690850|NCT00491114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690851|NCT00491114|Antimetabolites|antimetabolites|mesh-ancestor
92690852|NCT00491114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690853|NCT00491114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690854|NCT00486564|Nifurtimox|nifurtimox|mesh-list
92690855|NCT00486564|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92690856|NCT00486564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92690857|NCT00486564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92690858|NCT00486564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690859|NCT00486668|Paclitaxel|paclitaxel|mesh-list
92690860|NCT00486668|Cyclophosphamide|cyclophosphamide|mesh-list
92690861|NCT00486668|Doxorubicin|doxorubicin|mesh-list
92690862|NCT00486668|Trastuzumab|trastuzumab|mesh-list
92690863|NCT00486668|Lapatinib|lapatinib|mesh-list
92690864|NCT00486668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92690865|NCT00486668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690866|NCT00486668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92690867|NCT00486668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92690868|NCT00486668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92690869|NCT00486668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690870|NCT00486668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690871|NCT00486668|Immunologic Factors|immunologic factors|mesh-ancestor
92690872|NCT00486668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690873|NCT00486668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690874|NCT00486668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92690875|NCT00486668|Alkylating Agents|alkylating agents|mesh-ancestor
92690876|NCT00486668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92690877|NCT00486668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690878|NCT00486668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92690879|NCT00486668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92690880|NCT00486668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690881|NCT00486668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92690882|NCT00486668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92690883|NCT04510935|Anesthetics|anesthetics|mesh-list
92690884|NCT04510935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690885|NCT04510935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690886|NCT00491192|Diclofenac|diclofenac|mesh-list
92690887|NCT00491192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92690888|NCT00491192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92690889|NCT00491192|Analgesics|analgesics|mesh-ancestor
92690890|NCT00491192|Sensory System Agents|sensory system agents|mesh-ancestor
92690891|NCT00491192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690892|NCT00491192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690893|NCT00491192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690894|NCT00491192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92690895|NCT00491192|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92690896|NCT00491192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690897|NCT00491192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690898|NCT00486798|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92690899|NCT00486798|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690900|NCT00486798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690901|NCT00486798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690902|NCT00486798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690903|NCT00486798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607256|NCT00139932|Adrenergic Agents|adrenergic agents|mesh-ancestor
92607257|NCT00139932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690904|NCT00486798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690906|NCT01301833|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92690907|NCT01301833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92690908|NCT01301833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690912|NCT00486785|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92690913|NCT00486785|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92690914|NCT00486785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92690915|NCT00486785|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690916|NCT00486785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690917|NCT00486785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690918|NCT00486785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690919|NCT00486785|Urological Agents|urological agents|mesh-ancestor
92690920|NCT04324411|Sirolimus|sirolimus|mesh-list
92690921|NCT04324411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92690922|NCT04324411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92690923|NCT04324411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92690924|NCT04324411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690925|NCT04324411|Antifungal Agents|antifungal agents|mesh-ancestor
92690926|NCT04324411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690927|NCT04324411|Immunologic Factors|immunologic factors|mesh-ancestor
92690928|NCT04324411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690929|NCT00486876|Tofisopam|tofisopam|mesh-list
92690930|NCT00486876|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690931|NCT00486876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690932|NCT05643586|Ticagrelor|ticagrelor|mesh-list
92690933|NCT05643586|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92690934|NCT05643586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92690935|NCT05643586|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92690936|NCT05643586|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92690937|NCT05643586|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92690938|NCT05643586|Purinergic Agents|purinergic agents|mesh-ancestor
92690939|NCT05643586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690940|NCT05643586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690941|NCT05643586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690942|NCT01242072|Isophosphamide mustard|isophosphamide mustard|mesh-list
92690943|NCT01242072|Ifosfamide|ifosfamide|mesh-list
92690944|NCT01242072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92370199|NCT01085760|Metronidazole|metronidazole|mesh-list
92690945|NCT01242072|Alkylating Agents|alkylating agents|mesh-ancestor
92690946|NCT01242072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690947|NCT01242072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690948|NCT00491348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92690949|NCT00491348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92690950|NCT00491348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690951|NCT00491348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92690952|NCT00491348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690953|NCT00491348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690954|NCT00491348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690955|NCT00491348|Analgesics|analgesics|mesh-ancestor
92690956|NCT00491348|Sensory System Agents|sensory system agents|mesh-ancestor
92110739|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
92690957|NCT00491348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690958|NCT00491348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690959|NCT00491348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690960|NCT00491348|Dopamine Agents|dopamine agents|mesh-ancestor
92690962|NCT01242098|Beclomethasone|beclomethasone|mesh-list
92690963|NCT01242098|Formoterol Fumarate|formoterol fumarate|mesh-list
92690964|NCT01242098|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92690965|NCT01242098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92690966|NCT01242098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92690967|NCT01242098|Autonomic Agents|autonomic agents|mesh-ancestor
92690968|NCT01242098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690969|NCT01242098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690970|NCT01242098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92690971|NCT01242098|Respiratory System Agents|respiratory system agents|mesh-ancestor
92690972|NCT01242098|Dermatologic Agents|dermatologic agents|mesh-ancestor
92690973|NCT01242098|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92690974|NCT01242098|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92690975|NCT01242098|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92048518|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92690977|NCT01242098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92690978|NCT01242098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92690980|NCT01242098|Glucocorticoids|glucocorticoids|mesh-ancestor
92690981|NCT01242098|Hormones|hormones|mesh-ancestor
92690982|NCT01242098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92690983|NCT01301092|Dulaglutide|dulaglutide|mesh-list
92690984|NCT01301092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92690985|NCT01301092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690986|NCT04510623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92690987|NCT04510623|Protease Inhibitors|protease inhibitors|mesh-ancestor
92690988|NCT04510623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690989|NCT04510623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690990|NCT04510818|Capecitabine|capecitabine|mesh-list
92690991|NCT04510818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690992|NCT04510818|Antimetabolites|antimetabolites|mesh-ancestor
92690993|NCT04510818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690994|NCT04510818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690995|NCT05642845|Atorvastatin|atorvastatin|mesh-list
92690996|NCT05642845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92690997|NCT05642845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92690998|NCT05642845|Antimetabolites|antimetabolites|mesh-ancestor
92690999|NCT05642845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691000|NCT05642845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92691001|NCT05642845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92691002|NCT05642845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691003|NCT04510662|Telmisartan|telmisartan|mesh-list
92691004|NCT04510662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92691005|NCT04510662|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92691006|NCT04510662|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92691007|NCT04510662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691008|NCT05642689|Iron|iron|mesh-list
92691009|NCT05642689|Trace Elements|trace elements|mesh-ancestor
92691010|NCT05642689|Micronutrients|micronutrients|mesh-ancestor
92691011|NCT05642689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691012|NCT01300819|Rotigotine|rotigotine|mesh-list
92691013|NCT01300819|Dopamine Agonists|dopamine agonists|mesh-ancestor
92691014|NCT01300819|Dopamine Agents|dopamine agents|mesh-ancestor
92691015|NCT01300819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691016|NCT01300819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691017|NCT01300819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691018|NCT00486980|Peramivir|peramivir|mesh-list
92691019|NCT00486980|Antiviral Agents|antiviral agents|mesh-ancestor
92691020|NCT00486980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691021|NCT00486980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691022|NCT00486980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691023|NCT01300741|Contact Lens Solutions|contact lens solutions|mesh-list
92691024|NCT01300741|Disinfectants|disinfectants|mesh-ancestor
92691025|NCT01300741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691026|NCT02275962|Rifampin|rifampin|mesh-list
92691027|NCT02275962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92691028|NCT02275962|Antitubercular Agents|antitubercular agents|mesh-ancestor
92691029|NCT02275962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92691030|NCT02275962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691031|NCT02275962|Leprostatic Agents|leprostatic agents|mesh-ancestor
92691032|NCT02275962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92691033|NCT02275962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691034|NCT02275962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691035|NCT02275962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92691036|NCT02275962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92691037|NCT02275962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92691038|NCT02275962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92691039|NCT02275962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92691040|NCT02275962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92691041|NCT00487032|Fluticasone|fluticasone|mesh-list
92691042|NCT00487032|Xhance|xhance|mesh-list
92691043|NCT00487032|Prazosin|prazosin|mesh-list
92691044|NCT00487032|Phenylephrine|phenylephrine|mesh-list
92691045|NCT00487032|Oxymetazoline|oxymetazoline|mesh-list
92691046|NCT00487032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691047|NCT00487032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92691048|NCT00487032|Autonomic Agents|autonomic agents|mesh-ancestor
92607258|NCT00139932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607260|NCT00131261|Belinostat|belinostat|mesh-list
92607261|NCT00131261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691049|NCT00487032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691050|NCT00487032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691059|NCT00487032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691060|NCT00487032|Sympathomimetics|sympathomimetics|mesh-ancestor
92691061|NCT00487032|Nasal Decongestants|nasal decongestants|mesh-ancestor
92691062|NCT00487032|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92691063|NCT00487032|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92691064|NCT00487032|Mydriatics|mydriatics|mesh-ancestor
92691065|NCT00487032|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92370239|NCT01094574|Narcotics|narcotics|mesh-ancestor
92691066|NCT00487032|Protective Agents|protective agents|mesh-ancestor
92691067|NCT00487032|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92691068|NCT00487032|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92691069|NCT00487032|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92691070|NCT00487032|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92691071|NCT00491426|Metronidazole|metronidazole|mesh-list
92691072|NCT00491426|Tazobactam|tazobactam|mesh-list
92691073|NCT00491426|Amphotericin B|amphotericin b|mesh-list
92691074|NCT00491426|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92691075|NCT00491426|Piperacillin|piperacillin|mesh-list
92691076|NCT00491426|Acyclovir|acyclovir|mesh-list
92691077|NCT00491426|Ampicillin|ampicillin|mesh-list
92691078|NCT00491426|Caspofungin|caspofungin|mesh-list
92691079|NCT00491426|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92691080|NCT00491426|Anidulafungin|anidulafungin|mesh-list
92691081|NCT00491426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691082|NCT00491426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92691083|NCT00491426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92691084|NCT00491426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92691085|NCT00491426|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92691086|NCT00491426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691087|NCT00491426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691088|NCT00491426|Amebicides|amebicides|mesh-ancestor
92691089|NCT00491426|Antifungal Agents|antifungal agents|mesh-ancestor
92691090|NCT00491426|Antiviral Agents|antiviral agents|mesh-ancestor
92691091|NCT01300546|Naproxen|naproxen|mesh-list
92691092|NCT01300546|Sumatriptan|sumatriptan|mesh-list
92691093|NCT01300546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92691094|NCT01300546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92691095|NCT01300546|Analgesics|analgesics|mesh-ancestor
92691096|NCT01300546|Sensory System Agents|sensory system agents|mesh-ancestor
92691097|NCT01300546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691098|NCT01300546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691099|NCT01300546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691100|NCT01300546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691101|NCT01300546|Gout Suppressants|gout suppressants|mesh-ancestor
92691102|NCT01300546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92691103|NCT01300546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691104|NCT01300546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691105|NCT01300546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92691106|NCT01300546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92691107|NCT01300546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92691108|NCT01300546|Serotonin Agents|serotonin agents|mesh-ancestor
92691109|NCT01300546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691110|NCT00487110|Acetaminophen|acetaminophen|mesh-list
92691111|NCT00487110|Tropisetron|tropisetron|mesh-list
92691112|NCT00487110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92691113|NCT00487110|Analgesics|analgesics|mesh-ancestor
92691114|NCT00487110|Sensory System Agents|sensory system agents|mesh-ancestor
92691115|NCT00487110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691116|NCT00487110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691117|NCT00487110|Antipyretics|antipyretics|mesh-ancestor
92691118|NCT00487110|Antiemetics|antiemetics|mesh-ancestor
92691119|NCT00487110|Autonomic Agents|autonomic agents|mesh-ancestor
92691146|NCT02276001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691147|NCT02276001|Dermatologic Agents|dermatologic agents|mesh-ancestor
92691148|NCT02276001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691149|NCT02276001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92691151|NCT00491582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607263|NCT00131261|Autonomic Agents|autonomic agents|mesh-ancestor
92607264|NCT00131261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607265|NCT00131261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691152|NCT00491582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691153|NCT00487175|Tramadol|tramadol|mesh-list
92691154|NCT00487175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92691155|NCT00487175|Narcotics|narcotics|mesh-ancestor
92691156|NCT00487175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691157|NCT00487175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691158|NCT00487175|Analgesics|analgesics|mesh-ancestor
92691159|NCT00487175|Sensory System Agents|sensory system agents|mesh-ancestor
92691160|NCT00487175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691161|NCT00487227|Caffeine|caffeine|mesh-list
92691162|NCT00487227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92691163|NCT00487227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691164|NCT00487227|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92691165|NCT00487227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691166|NCT00487227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691177|NCT01300351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691178|NCT01300351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691180|NCT00487253|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92691181|NCT00487253|Antifungal Agents|antifungal agents|mesh-ancestor
92691182|NCT00487253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691183|NCT00487253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691184|NCT00487253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92691185|NCT00487253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92691186|NCT04510233|Ivermectin|ivermectin|mesh-list
92691187|NCT04510233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92691188|NCT04510233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691189|NCT05641909|Fentanyl|fentanyl|mesh-list
92691190|NCT05641909|Remifentanil|remifentanil|mesh-list
92691191|NCT05641909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92691192|NCT05641909|Narcotics|narcotics|mesh-ancestor
92691193|NCT05641909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691194|NCT05641909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691195|NCT05641909|Analgesics|analgesics|mesh-ancestor
92691196|NCT05641909|Sensory System Agents|sensory system agents|mesh-ancestor
92691197|NCT05641909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691198|NCT05641909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92691199|NCT05641909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92691200|NCT05641909|Anesthetics, General|anesthetics, general|mesh-ancestor
92691201|NCT05641909|Anesthetics|anesthetics|mesh-ancestor
92691202|NCT05641753|Atorvastatin|atorvastatin|mesh-list
92691203|NCT05641753|Ezetimibe|ezetimibe|mesh-list
92691204|NCT05641753|Evolocumab|evolocumab|mesh-list
92691205|NCT05641753|Calcium|calcium|mesh-list
92691206|NCT05641753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691207|NCT05641753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691208|NCT05641753|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92691209|NCT05641753|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92691210|NCT05641753|Antimetabolites|antimetabolites|mesh-ancestor
92691211|NCT05641753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691212|NCT05641753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92691213|NCT05641753|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92691214|NCT05641753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691215|NCT05641753|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92691216|NCT05641753|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92691217|NCT05641753|Protease Inhibitors|protease inhibitors|mesh-ancestor
92691218|NCT02276196|Insulin glulisine|insulin glulisine|mesh-list
92691219|NCT02276196|Lixisenatide|lixisenatide|mesh-list
92691220|NCT02276196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691221|NCT02276196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691222|NCT00487422|Prucalopride|prucalopride|mesh-list
92691223|NCT00487422|Laxatives|laxatives|mesh-ancestor
92691224|NCT00487422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92691225|NCT00487422|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92691226|NCT00487422|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92691227|NCT00487422|Serotonin Agents|serotonin agents|mesh-ancestor
92691228|NCT00487422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691229|NCT00487422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691230|NCT00487422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607266|NCT00131261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607267|NCT00131261|Glucocorticoids|glucocorticoids|mesh-ancestor
92607268|NCT00131261|Hormones|hormones|mesh-ancestor
92607269|NCT00131261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607270|NCT00131261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92691231|NCT04697355|Beta Carotene|beta carotene|mesh-list
92691232|NCT04697355|Naringenin|naringenin|mesh-list
92111041|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92111042|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92111043|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111044|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92111045|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
92111046|NCT04745130|Cetuximab|cetuximab|mesh-list
92111049|NCT02462304|Bevacizumab|bevacizumab|mesh-list
92691245|NCT04697355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691246|NCT00491816|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92691247|NCT00491816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691248|NCT00491816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92691249|NCT00491816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691250|NCT00491816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691251|NCT00491855|Paclitaxel|paclitaxel|mesh-list
92691252|NCT00491855|Bevacizumab|bevacizumab|mesh-list
92691253|NCT00491855|Oxaliplatin|oxaliplatin|mesh-list
92691254|NCT00491855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92691255|NCT00491855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691256|NCT00491855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92691257|NCT00491855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92691258|NCT00491855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92691259|NCT00491855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691260|NCT00491855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691261|NCT00491855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92691262|NCT00491855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92691263|NCT00491855|Growth Substances|growth substances|mesh-ancestor
92691264|NCT00491855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691265|NCT00491855|Growth Inhibitors|growth inhibitors|mesh-ancestor
92691266|NCT04697277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92691267|NCT04697277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691268|NCT00487448|Cytarabine|cytarabine|mesh-list
92691269|NCT00487448|Fludarabine|fludarabine|mesh-list
92691270|NCT00487448|Idarubicin|idarubicin|mesh-list
92691271|NCT00487448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691272|NCT00487448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92691273|NCT00487448|Antimetabolites|antimetabolites|mesh-ancestor
92691274|NCT00487448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691275|NCT00487448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691276|NCT00487448|Immunologic Factors|immunologic factors|mesh-ancestor
92691277|NCT00487448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691278|NCT00487448|Antiviral Agents|antiviral agents|mesh-ancestor
92691279|NCT00487448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691280|NCT00487448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92691294|NCT00506298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691296|NCT00506298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92691297|NCT00506298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92691298|NCT00506298|Analgesics|analgesics|mesh-ancestor
92691299|NCT00506298|Sensory System Agents|sensory system agents|mesh-ancestor
92691300|NCT00506298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691301|NCT00506298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691302|NCT00506298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691303|NCT00506298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691304|NCT00506298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92691305|NCT00506298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691306|NCT01242215|Glimepiride|glimepiride|mesh-list
92691307|NCT01242215|Gliclazide|gliclazide|mesh-list
92691308|NCT01242215|Glyburide|glyburide|mesh-list
92691309|NCT01242215|Ipragliflozin|ipragliflozin|mesh-list
92691310|NCT01242215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92691311|NCT01242215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691312|NCT01242215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691313|NCT01242215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691314|NCT01242215|Immunologic Factors|immunologic factors|mesh-ancestor
92607271|NCT00131261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607272|NCT00131261|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92607273|NCT00131261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607274|NCT00131261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607276|NCT00131300|Viscosupplements|viscosupplements|mesh-ancestor
92691315|NCT01242215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92691316|NCT01242215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691317|NCT01242228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92691318|NCT01242228|Vildagliptin|vildagliptin|mesh-list
92691319|NCT01242228|Saxagliptin|saxagliptin|mesh-list
92691320|NCT01242228|Alogliptin|alogliptin|mesh-list
92691321|NCT01242228|Ipragliflozin|ipragliflozin|mesh-list
92111110|NCT02717130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92691322|NCT01242228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92691323|NCT01242228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691324|NCT01242228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691325|NCT01242228|Incretins|incretins|mesh-ancestor
92691326|NCT01242228|Hormones|hormones|mesh-ancestor
92691327|NCT01242228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691328|NCT01242228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92691329|NCT01242228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691330|NCT01242228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691331|NCT01242228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92691332|NCT01242306|Acetylcholine|acetylcholine|mesh-list
92691333|NCT01242306|Vasodilator Agents|vasodilator agents|mesh-ancestor
92691334|NCT01242306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92691335|NCT01242306|Cholinergic Agents|cholinergic agents|mesh-ancestor
92691336|NCT01242306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691337|NCT01242306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691338|NCT01242306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691339|NCT00492128|Losartan|losartan|mesh-list
92691340|NCT00492128|Amlodipine|amlodipine|mesh-list
92691341|NCT00492128|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92691345|NCT00492128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691346|NCT00492128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691347|NCT00492128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691348|NCT00492128|Vasodilator Agents|vasodilator agents|mesh-ancestor
92691349|NCT00492128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92370309|NCT01100112|Hormones|hormones|mesh-ancestor
92691350|NCT00492128|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92691351|NCT00492128|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92691352|NCT00492128|Diuretics|diuretics|mesh-ancestor
92691353|NCT00492128|Natriuretic Agents|natriuretic agents|mesh-ancestor
92691354|NCT00492128|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92691355|NCT00487734|Methyltestosterone|methyltestosterone|mesh-list
92691356|NCT00487734|Testosterone|testosterone|mesh-list
92691357|NCT00487734|Testosterone undecanoate|testosterone undecanoate|mesh-list
92691358|NCT00487734|Testosterone enanthate|testosterone enanthate|mesh-list
92691359|NCT00487734|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92691360|NCT00487734|Androgens|androgens|mesh-ancestor
92691361|NCT00487734|Hormones|hormones|mesh-ancestor
92691362|NCT00487734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691363|NCT00487734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691364|NCT00487734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92691365|NCT00487734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691366|NCT00487734|Anabolic Agents|anabolic agents|mesh-ancestor
92691367|NCT01300234|Tenofovir|tenofovir|mesh-list
92691368|NCT01300234|Adefovir|adefovir|mesh-list
92691369|NCT01300234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92691370|NCT01300234|Antiviral Agents|antiviral agents|mesh-ancestor
92691371|NCT01300234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691372|NCT01300234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92691373|NCT01300234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92691374|NCT01300234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691375|NCT01300234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691376|NCT01300234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92691377|NCT01300234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92691378|NCT01242332|Pregabalin|pregabalin|mesh-list
92607277|NCT00131300|Protective Agents|protective agents|mesh-ancestor
92607278|NCT00131300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607279|NCT00131339|Cycloserine|cycloserine|mesh-list
92607280|NCT00131339|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92607281|NCT00131339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607282|NCT00131339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92691379|NCT01242332|Analgesics|analgesics|mesh-ancestor
92691380|NCT01242332|Sensory System Agents|sensory system agents|mesh-ancestor
92691381|NCT01242332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691382|NCT01242332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691383|NCT01242332|Anticonvulsants|anticonvulsants|mesh-ancestor
92691384|NCT01242332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92691385|NCT01242332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92691386|NCT01242332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691387|NCT01242332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691388|NCT01242332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92691389|NCT01242332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92691390|NCT01242332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691391|NCT01242332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92691392|NCT00487773|Cholecalciferol|cholecalciferol|mesh-list
92691393|NCT00487773|Budesonide|budesonide|mesh-list
92691394|NCT00487773|Albuterol|albuterol|mesh-list
92691395|NCT00487773|Montelukast|montelukast|mesh-list
92111191|NCT01606787|Mannitol|mannitol|mesh-list
92691396|NCT00487773|Vitamins|vitamins|mesh-ancestor
92691397|NCT00487773|Micronutrients|micronutrients|mesh-ancestor
92691398|NCT00487773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691399|NCT00487773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691400|NCT00487773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92691401|NCT00487773|Autonomic Agents|autonomic agents|mesh-ancestor
92691402|NCT00487773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691403|NCT00487773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92691404|NCT00487773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691405|NCT00487773|Glucocorticoids|glucocorticoids|mesh-ancestor
92691406|NCT00487773|Hormones|hormones|mesh-ancestor
92691407|NCT00487773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691408|NCT00487773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92691409|NCT00487773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92691410|NCT00487773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92691411|NCT00487773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92327597|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691428|NCT01299961|Immunologic Factors|immunologic factors|mesh-ancestor
92691429|NCT01299961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691430|NCT01299961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691431|NCT00492245|Mitomycins|mitomycins|mesh-list
92691432|NCT00492245|Mitomycin|mitomycin|mesh-list
92691433|NCT00492245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92691434|NCT00492245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691435|NCT00492245|Alkylating Agents|alkylating agents|mesh-ancestor
92691436|NCT00492245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691437|NCT00492245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92691438|NCT00492245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691439|NCT00487812|Dobutamine|dobutamine|mesh-list
92691440|NCT00487812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92691441|NCT00487812|Sympathomimetics|sympathomimetics|mesh-ancestor
92691442|NCT00487812|Autonomic Agents|autonomic agents|mesh-ancestor
92691443|NCT00487812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691444|NCT00487812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691445|NCT00487812|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92691446|NCT00487812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92691447|NCT00487812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92691448|NCT00487812|Adrenergic Agents|adrenergic agents|mesh-ancestor
92691449|NCT00487812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691450|NCT00487812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691451|NCT00487812|Protective Agents|protective agents|mesh-ancestor
92691452|NCT01299805|Vortioxetine|vortioxetine|mesh-list
92691453|NCT01299805|Antidepressive Agents|antidepressive agents|mesh-ancestor
92691454|NCT01299805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92691455|NCT01299805|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92691456|NCT01299805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607283|NCT00131339|Antitubercular Agents|antitubercular agents|mesh-ancestor
92607284|NCT00131339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92691457|NCT01299805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691458|NCT01299805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691459|NCT01299805|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92370353|NCT01105650|Cyclosporine|cyclosporine|mesh-list
92691460|NCT01299805|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92691461|NCT01299805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92691462|NCT01299805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691463|NCT01299805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691464|NCT01299805|Serotonin Agents|serotonin agents|mesh-ancestor
92691465|NCT01299805|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92691470|NCT00487682|Antiviral Agents|antiviral agents|mesh-ancestor
92691471|NCT00487682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691472|NCT04512261|Pembrolizumab|pembrolizumab|mesh-list
92691473|NCT04512261|Trastuzumab|trastuzumab|mesh-list
92691475|NCT04512261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691476|NCT04512261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691477|NCT04512261|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92691478|NCT04512261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691479|NCT04512261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92691480|NCT04512261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691481|NCT00487799|Ularitide|ularitide|mesh-list
92691482|NCT00487799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92691483|NCT00487799|Autonomic Agents|autonomic agents|mesh-ancestor
92691484|NCT00487799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691485|NCT00487799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691486|NCT00487799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92691487|NCT00487799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691488|NCT00487799|Diuretics|diuretics|mesh-ancestor
92691489|NCT00487799|Natriuretic Agents|natriuretic agents|mesh-ancestor
92691490|NCT05149170|Antibodies|antibodies|mesh-list
92691491|NCT05149170|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92691492|NCT05149170|Immunologic Factors|immunologic factors|mesh-ancestor
92691493|NCT05149170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691494|NCT05149092|Caseins|caseins|mesh-list
92691495|NCT05149092|Chelating Agents|chelating agents|mesh-ancestor
92691496|NCT05149092|Sequestering Agents|sequestering agents|mesh-ancestor
92691497|NCT05149092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691498|NCT04518501|Arsenic Trioxide|arsenic trioxide|mesh-list
92691499|NCT04518501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691500|NCT00495287|Cytarabine|cytarabine|mesh-list
92691501|NCT00495287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92691502|NCT00495287|Antimetabolites|antimetabolites|mesh-ancestor
92691503|NCT00495287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691504|NCT00495287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691505|NCT00495287|Antiviral Agents|antiviral agents|mesh-ancestor
92691506|NCT00495287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691507|NCT00495287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691508|NCT00495287|Immunologic Factors|immunologic factors|mesh-ancestor
92691509|NCT00495287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691510|NCT04696185|Dapagliflozin|dapagliflozin|mesh-list
92691511|NCT04696185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92691512|NCT04696185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691513|NCT04696185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691514|NCT04696185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691515|NCT00495326|Efavirenz|efavirenz|mesh-list
92691516|NCT00495326|Nevirapine|nevirapine|mesh-list
92691517|NCT00495326|Rifampin|rifampin|mesh-list
92691518|NCT00495326|Isoniazid|isoniazid|mesh-list
92691519|NCT00495326|Ethambutol|ethambutol|mesh-list
92691520|NCT00495326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92691521|NCT00495326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92691522|NCT00495326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691523|NCT00495326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691524|NCT00495326|Antiviral Agents|antiviral agents|mesh-ancestor
92691525|NCT00495326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691526|NCT00495326|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92691527|NCT00495326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92691528|NCT00495326|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92691529|NCT00495326|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92691530|NCT00495326|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92607285|NCT00131339|Antimetabolites|antimetabolites|mesh-ancestor
92607286|NCT00131339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607287|NCT00139971|Gemcitabine|gemcitabine|mesh-list
92607288|NCT00139971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92607289|NCT00139971|Antimetabolites|antimetabolites|mesh-ancestor
92014651|NCT03424525|Trimethoprim|trimethoprim|mesh-list
92691531|NCT00495326|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92691532|NCT00495326|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92691533|NCT00495326|Antitubercular Agents|antitubercular agents|mesh-ancestor
92691534|NCT00495326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92691535|NCT00495326|Leprostatic Agents|leprostatic agents|mesh-ancestor
92691536|NCT00495326|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92691537|NCT00495326|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92691547|NCT00492479|Growth Substances|growth substances|mesh-ancestor
92691548|NCT00492479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691549|NCT00495365|Epoetin Alfa|epoetin alfa|mesh-list
92691550|NCT00495365|Hematinics|hematinics|mesh-ancestor
92691551|NCT00492518|Acetylcysteine|acetylcysteine|mesh-list
92691552|NCT00492518|Theophylline|theophylline|mesh-list
92691553|NCT00492518|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92691554|NCT00492518|Antiviral Agents|antiviral agents|mesh-ancestor
92691555|NCT00492518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691556|NCT00492518|Expectorants|expectorants|mesh-ancestor
92691557|NCT00492518|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691558|NCT00492518|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92691559|NCT00492518|Antioxidants|antioxidants|mesh-ancestor
92691560|NCT00492518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691561|NCT00492518|Protective Agents|protective agents|mesh-ancestor
92691562|NCT00492518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691563|NCT00492518|Antidotes|antidotes|mesh-ancestor
92691564|NCT00492518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92691565|NCT00492518|Autonomic Agents|autonomic agents|mesh-ancestor
92691566|NCT00492518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691567|NCT00492518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92691568|NCT00492518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92691569|NCT00492518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691570|NCT00492518|Vasodilator Agents|vasodilator agents|mesh-ancestor
92691571|NCT00492518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92691572|NCT00492518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92691573|NCT00492518|Purinergic Agents|purinergic agents|mesh-ancestor
92691574|NCT00492518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691575|NCT04513860|Cenobamate|cenobamate|mesh-list
92691576|NCT04513860|Anticonvulsants|anticonvulsants|mesh-ancestor
92691577|NCT00495560|Misoprostol|misoprostol|mesh-list
92691578|NCT00495560|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92691579|NCT00495560|Abortifacient Agents|abortifacient agents|mesh-ancestor
92691580|NCT00495560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92691581|NCT00495560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691582|NCT00495560|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92691583|NCT00495560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92691584|NCT00495560|Oxytocics|oxytocics|mesh-ancestor
92691585|NCT00506844|Capecitabine|capecitabine|mesh-list
92691586|NCT00506844|Irinotecan|irinotecan|mesh-list
92691587|NCT00506844|Cetuximab|cetuximab|mesh-list
92691588|NCT00506844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92691589|NCT00506844|Antimetabolites|antimetabolites|mesh-ancestor
92691590|NCT00506844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691591|NCT00506844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691592|NCT00506844|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92691593|NCT00506844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92691594|NCT00506844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691595|NCT00506844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691596|NCT00506961|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92691597|NCT00506961|Simvastatin|simvastatin|mesh-list
92691598|NCT00506961|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92691599|NCT00506961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92691600|NCT00506961|Antimetabolites|antimetabolites|mesh-ancestor
92691601|NCT00506961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691602|NCT00506961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92691603|NCT00506961|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92607290|NCT00139971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607291|NCT00139971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607292|NCT00140010|Epoetin Alfa|epoetin alfa|mesh-list
92607293|NCT00140010|Hematinics|hematinics|mesh-ancestor
92607294|NCT00131495|Testosterone|testosterone|mesh-list
92607295|NCT00131495|Androgens|androgens|mesh-ancestor
92607296|NCT00131495|Hormones|hormones|mesh-ancestor
92691604|NCT00506961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691605|NCT00492635|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92691618|NCT00507000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691620|NCT00495872|Sunitinib|sunitinib|mesh-list
92691621|NCT00495872|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92691622|NCT00495872|Sorafenib|sorafenib|mesh-list
92691623|NCT00495872|Dasatinib|dasatinib|mesh-list
92691624|NCT00495872|Lapatinib|lapatinib|mesh-list
92691625|NCT00495872|Valproic Acid|valproic acid|mesh-list
92691626|NCT00495872|Immunologic Factors|immunologic factors|mesh-ancestor
92691627|NCT00495872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691628|NCT00495872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92691629|NCT00495872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92691630|NCT00495872|Growth Substances|growth substances|mesh-ancestor
92691631|NCT00495872|Growth Inhibitors|growth inhibitors|mesh-ancestor
92691632|NCT00495872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691633|NCT00495872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92691634|NCT00495872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691635|NCT00495872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691636|NCT00495872|Anticonvulsants|anticonvulsants|mesh-ancestor
92691637|NCT00495872|GABA Agents|gaba agents|mesh-ancestor
92691638|NCT00495872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691639|NCT00495872|Antimanic Agents|antimanic agents|mesh-ancestor
92691640|NCT00495872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92691641|NCT00495872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691642|NCT00495872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92691643|NCT00507117|Eszopiclone|eszopiclone|mesh-list
92691644|NCT00507117|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92691645|NCT00507117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691646|NCT00507117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691647|NCT00492830|Antibodies|antibodies|mesh-list
92691648|NCT00492830|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92691649|NCT00492830|Immunologic Factors|immunologic factors|mesh-ancestor
92691650|NCT00492830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691651|NCT01299571|Dutasteride|dutasteride|mesh-list
92691652|NCT01299571|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92691653|NCT01299571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92691654|NCT01299571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691655|NCT01299571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691656|NCT01299571|Hormone Antagonists|hormone antagonists|mesh-ancestor
92691657|NCT01299571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691658|NCT01299571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691659|NCT01243736|Metoclopramide|metoclopramide|mesh-list
92691660|NCT01243736|Simethicone|simethicone|mesh-list
92691661|NCT01243736|Antiemetics|antiemetics|mesh-ancestor
92691662|NCT01243736|Autonomic Agents|autonomic agents|mesh-ancestor
92691663|NCT01243736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691664|NCT01243736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691665|NCT01243736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92691666|NCT01243736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92691667|NCT01243736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92691684|NCT01243970|Autonomic Agents|autonomic agents|mesh-ancestor
92691685|NCT01243970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691686|NCT01243970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691687|NCT01243970|Sympathomimetics|sympathomimetics|mesh-ancestor
92691688|NCT01243970|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92691689|NCT01243970|Nasal Decongestants|nasal decongestants|mesh-ancestor
92691690|NCT01243970|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691691|NCT01243970|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92691692|NCT01243970|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92691693|NCT01243970|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92691694|NCT01243970|Adrenergic Agents|adrenergic agents|mesh-ancestor
92691695|NCT01243970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607297|NCT00131495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607298|NCT00131495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607299|NCT04726631|Insulin|insulin|mesh-list
92691696|NCT01243970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691697|NCT01243970|Protective Agents|protective agents|mesh-ancestor
92691698|NCT01243970|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92691699|NCT04515576|Dulaglutide|dulaglutide|mesh-list
92691700|NCT04515576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691701|NCT04515576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691702|NCT01298362|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92691703|NCT01298362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92691704|NCT01298362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691705|NCT01298362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691706|NCT01298362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92691707|NCT01298362|Hormone Antagonists|hormone antagonists|mesh-ancestor
92691708|NCT01298362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691709|NCT01298362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691710|NCT00493415|Nitroglycerin|nitroglycerin|mesh-list
92691711|NCT00493415|Vasodilator Agents|vasodilator agents|mesh-ancestor
92691712|NCT01244009|Niraparib|niraparib|mesh-list
92691713|NCT01244009|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92691714|NCT01244009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691715|NCT01244009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691716|NCT01244009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691717|NCT04511832|Diclofenac|diclofenac|mesh-list
92691718|NCT04511832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92691719|NCT04511832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92691720|NCT04511832|Analgesics|analgesics|mesh-ancestor
92691721|NCT04511832|Sensory System Agents|sensory system agents|mesh-ancestor
92691722|NCT04511832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691723|NCT04511832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691724|NCT04511832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691725|NCT04511832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691726|NCT04511832|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92691729|NCT01244204|Vitamin D|vitamin d|mesh-list
92691730|NCT01244204|Vitamins|vitamins|mesh-ancestor
92691731|NCT01244204|Micronutrients|micronutrients|mesh-ancestor
92691732|NCT01244204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691733|NCT01244204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92691734|NCT00496028|Paclitaxel|paclitaxel|mesh-list
92691735|NCT00496028|Carboplatin|carboplatin|mesh-list
92691736|NCT00496028|Saracatinib|saracatinib|mesh-list
92691737|NCT00496028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92691738|NCT00496028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691739|NCT00496028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92691740|NCT00496028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92691741|NCT00496028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92691742|NCT00496028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691743|NCT00496028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691744|NCT04516278|Bevacizumab|bevacizumab|mesh-list
92691745|NCT04516278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691746|NCT04516278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691747|NCT04516278|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92691748|NCT04516278|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92691749|NCT04516278|Growth Substances|growth substances|mesh-ancestor
92691750|NCT04516278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691751|NCT04516278|Growth Inhibitors|growth inhibitors|mesh-ancestor
92691752|NCT00493532|Ibandronic Acid|ibandronic acid|mesh-list
92691753|NCT00493532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92691754|NCT00493532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691755|NCT01297465|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92691756|NCT01297465|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92691757|NCT01297465|Hormones|hormones|mesh-ancestor
92691758|NCT01297465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691759|NCT01297465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691760|NCT01297465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92691761|NCT04518462|Bupivacaine|bupivacaine|mesh-list
92691762|NCT04518462|Anesthetics, Local|anesthetics, local|mesh-ancestor
92691763|NCT04518462|Anesthetics|anesthetics|mesh-ancestor
92691764|NCT04518462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607300|NCT04726631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92691765|NCT04518462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691766|NCT04518462|Sensory System Agents|sensory system agents|mesh-ancestor
92691767|NCT04518462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691768|NCT00496184|Nifedipine|nifedipine|mesh-list
92691769|NCT00496184|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92691770|NCT00496184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92691771|NCT00496184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691772|NCT00496184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691773|NCT00496184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691774|NCT00496184|Vasodilator Agents|vasodilator agents|mesh-ancestor
92691775|NCT00496184|Tocolytic Agents|tocolytic agents|mesh-ancestor
92691776|NCT00496184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92691777|NCT00493610|Acetylcysteine|acetylcysteine|mesh-list
92691778|NCT00493610|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92691779|NCT00493610|Antiviral Agents|antiviral agents|mesh-ancestor
92691780|NCT00493610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691781|NCT00493610|Expectorants|expectorants|mesh-ancestor
92691782|NCT00493610|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691783|NCT00493610|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92691784|NCT00493610|Antioxidants|antioxidants|mesh-ancestor
92691785|NCT00493610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691786|NCT00493610|Protective Agents|protective agents|mesh-ancestor
92691787|NCT00493610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691788|NCT00493610|Antidotes|antidotes|mesh-ancestor
92691789|NCT02274506|Cyclophosphamide|cyclophosphamide|mesh-list
92691790|NCT02274506|Fludarabine|fludarabine|mesh-list
92691791|NCT02274506|Fludarabine phosphate|fludarabine phosphate|mesh-list
92691792|NCT02274506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691793|NCT02274506|Immunologic Factors|immunologic factors|mesh-ancestor
92691794|NCT02274506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691795|NCT02274506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691796|NCT02274506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92691797|NCT02274506|Alkylating Agents|alkylating agents|mesh-ancestor
92691798|NCT02274506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691800|NCT02274506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92691801|NCT02274506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92691802|NCT02274506|Antimetabolites|antimetabolites|mesh-ancestor
92691803|NCT00496223|Sunitinib|sunitinib|mesh-list
92691804|NCT00496223|Dacarbazine|dacarbazine|mesh-list
92691805|NCT00496223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691806|NCT00496223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92691807|NCT00496223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92691808|NCT00496223|Growth Substances|growth substances|mesh-ancestor
92691809|NCT00496223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691810|NCT00496223|Growth Inhibitors|growth inhibitors|mesh-ancestor
92691811|NCT00496223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92691812|NCT00496223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691813|NCT00496223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691814|NCT00496223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92691815|NCT00496223|Alkylating Agents|alkylating agents|mesh-ancestor
92691816|NCT00496301|Gemcitabine|gemcitabine|mesh-list
92691817|NCT00496301|Capecitabine|capecitabine|mesh-list
92691818|NCT00496301|Sorafenib|sorafenib|mesh-list
92691819|NCT00496301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92691820|NCT00496301|Antimetabolites|antimetabolites|mesh-ancestor
92691821|NCT00496301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691822|NCT00496301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691823|NCT00496301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92691824|NCT00496301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691825|NCT05141838|Vitamin D|vitamin d|mesh-list
92691826|NCT05141838|Vitamins|vitamins|mesh-ancestor
92691827|NCT05141838|Micronutrients|micronutrients|mesh-ancestor
92691828|NCT05141838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691829|NCT05141838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92691830|NCT00493727|Acetylcysteine|acetylcysteine|mesh-list
92691831|NCT00493727|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92691832|NCT00493727|Antiviral Agents|antiviral agents|mesh-ancestor
92691833|NCT00493727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691834|NCT00493727|Expectorants|expectorants|mesh-ancestor
92691835|NCT00493727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691836|NCT00493727|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92691837|NCT00493727|Antioxidants|antioxidants|mesh-ancestor
92607301|NCT04726631|Insulin, Short-Acting|insulin, short-acting|mesh-list
92607303|NCT04726631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014663|NCT05104983|Sirolimus|sirolimus|mesh-list
92691838|NCT00493727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691839|NCT00493727|Protective Agents|protective agents|mesh-ancestor
92691840|NCT00493727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691841|NCT00493727|Antidotes|antidotes|mesh-ancestor
92691842|NCT00493766|Panobinostat|panobinostat|mesh-list
92691843|NCT00493766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691844|NCT00493766|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92691845|NCT00493766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691846|NCT00493766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691847|NCT05146479|Fluorides|fluorides|mesh-list
92691848|NCT05146479|Fluorides, Topical|fluorides, topical|mesh-list
92691849|NCT05146479|Cariostatic Agents|cariostatic agents|mesh-ancestor
92691850|NCT05146479|Protective Agents|protective agents|mesh-ancestor
92691851|NCT05146479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691852|NCT05145621|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92691853|NCT05145621|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92691854|NCT05145621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691855|NCT05145621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691856|NCT05145621|Immunologic Factors|immunologic factors|mesh-ancestor
92691857|NCT05145621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691858|NCT01296568|Gemcitabine|gemcitabine|mesh-list
92691859|NCT01296568|Pemetrexed|pemetrexed|mesh-list
92691860|NCT01296568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92691861|NCT01296568|Antimetabolites|antimetabolites|mesh-ancestor
92691862|NCT01296568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691863|NCT01296568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691864|NCT01296568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691865|NCT01296568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92691866|NCT01296568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92691867|NCT02598999|Lactoferrin|lactoferrin|mesh-list
92691868|NCT02598999|Hypothiocyanite ion|hypothiocyanite ion|mesh-list
92691869|NCT02598999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691870|NCT01296412|Metformin|metformin|mesh-list
92691871|NCT01296412|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92691872|NCT01296412|Liraglutide|liraglutide|mesh-list
92691873|NCT01296412|Glimepiride|glimepiride|mesh-list
92691874|NCT01296412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691878|NCT01296412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92691879|NCT01296412|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92691881|NCT01296412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691882|NCT01296412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691883|NCT01296412|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92691884|NCT01296412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691885|NCT01296412|Immunologic Factors|immunologic factors|mesh-ancestor
92691886|NCT00496652|Zalutumumab|zalutumumab|mesh-list
92691887|NCT00496652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691888|NCT00496652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691889|NCT02597634|Ibuprofen|ibuprofen|mesh-list
92691890|NCT02597634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92691891|NCT02597634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92691892|NCT02597634|Analgesics|analgesics|mesh-ancestor
92691893|NCT02597634|Sensory System Agents|sensory system agents|mesh-ancestor
92691894|NCT02597634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691895|NCT02597634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691896|NCT02597634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691897|NCT02597634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691898|NCT02597634|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92691899|NCT02597634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691900|NCT02597634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691901|NCT02591199|Lidocaine|lidocaine|mesh-list
92691902|NCT02591199|Heparin|heparin|mesh-list
92691903|NCT02591199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92691904|NCT02591199|Anesthetics|anesthetics|mesh-ancestor
92691905|NCT02591199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691906|NCT02591199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691907|NCT02591199|Sensory System Agents|sensory system agents|mesh-ancestor
92691908|NCT02591199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607304|NCT04726631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607305|NCT04726631|Heparin Antagonists|heparin antagonists|mesh-ancestor
92014667|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691909|NCT02591199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92691910|NCT02591199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92691911|NCT02591199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92691912|NCT02591199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92691913|NCT02591199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691914|NCT02591199|Anticoagulants|anticoagulants|mesh-ancestor
92691915|NCT02591199|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92691916|NCT02591199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92691917|NCT00494078|Insulin Aspart|insulin aspart|mesh-list
92691918|NCT00494078|Insulin, Long-Acting|insulin, long-acting|mesh-list
92691919|NCT00494078|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92691920|NCT00494078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691921|NCT00494078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691922|NCT02596035|Nivolumab|nivolumab|mesh-list
92691923|NCT02596035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691924|NCT02596035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691925|NCT02596035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92691926|NCT02596035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691927|NCT00494156|Aspirin|aspirin|mesh-list
92691928|NCT00494156|Heparin|heparin|mesh-list
92691929|NCT00494156|Clopidogrel|clopidogrel|mesh-list
92691930|NCT00494156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92691931|NCT00494156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92691932|NCT00494156|Analgesics|analgesics|mesh-ancestor
92691933|NCT00494156|Sensory System Agents|sensory system agents|mesh-ancestor
92691934|NCT00494156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691935|NCT00494156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691936|NCT00494156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92691937|NCT00494156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92691938|NCT00494156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92691939|NCT00494156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92691940|NCT00494156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691941|NCT00494156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92691942|NCT00494156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92691943|NCT00494156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691944|NCT00494156|Antipyretics|antipyretics|mesh-ancestor
92691947|NCT00494156|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92691948|NCT00494156|Purinergic Agents|purinergic agents|mesh-ancestor
92691949|NCT00494156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691950|NCT00494156|Anticoagulants|anticoagulants|mesh-ancestor
92691951|NCT02595489|Vitamin D|vitamin d|mesh-list
92691952|NCT02595489|Ergocalciferols|ergocalciferols|mesh-list
92691953|NCT02595489|Cholecalciferol|cholecalciferol|mesh-list
92691954|NCT02595489|Vitamins|vitamins|mesh-list
92691955|NCT02595489|Micronutrients|micronutrients|mesh-ancestor
92691956|NCT02595489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691957|NCT02595489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92691958|NCT02595489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691959|NCT00497003|Metoprolol|metoprolol|mesh-list
92691960|NCT00497003|Carvedilol|carvedilol|mesh-list
92691961|NCT00497003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92691962|NCT00497003|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92691963|NCT00497003|Sympatholytics|sympatholytics|mesh-ancestor
92691964|NCT00497003|Autonomic Agents|autonomic agents|mesh-ancestor
92691965|NCT00497003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92691966|NCT00497003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691967|NCT00497003|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92691968|NCT00497003|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92691969|NCT00497003|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92691970|NCT00497003|Adrenergic Agents|adrenergic agents|mesh-ancestor
92691971|NCT00497003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691972|NCT00497003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691973|NCT00497003|Antioxidants|antioxidants|mesh-ancestor
92691974|NCT00497003|Protective Agents|protective agents|mesh-ancestor
92691975|NCT00497003|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92691976|NCT00497003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92691977|NCT00497003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691978|NCT00497003|Vasodilator Agents|vasodilator agents|mesh-ancestor
92607306|NCT04726631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607308|NCT02957760|Hydroxyurea|hydroxyurea|mesh-list
92607309|NCT02957760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607310|NCT02957760|Antisickling Agents|antisickling agents|mesh-ancestor
92607311|NCT02957760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691979|NCT00497003|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92691980|NCT00497003|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92691981|NCT00494312|Pioglitazone|pioglitazone|mesh-list
92691982|NCT00494312|Glyburide|glyburide|mesh-list
92691983|NCT00494312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92691984|NCT00494312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691985|NCT02595372|Omeprazole|omeprazole|mesh-list
92691986|NCT02595372|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92691987|NCT02595372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92691988|NCT02595372|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92691989|NCT02595372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691990|NCT02595372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691991|NCT05142969|Chlorhexidine|chlorhexidine|mesh-list
92691992|NCT05142969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92691993|NCT05142969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92691994|NCT05142969|Disinfectants|disinfectants|mesh-ancestor
92691995|NCT02596503|Cefixime|cefixime|mesh-list
92691996|NCT02596503|Irinotecan|irinotecan|mesh-list
92691997|NCT02596503|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92691998|NCT02596503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92691999|NCT02596503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692000|NCT02596503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692001|NCT02596503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692002|NCT02596503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692003|NCT02596503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692004|NCT00494429|Morphine|morphine|mesh-list
92692005|NCT00494429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92692006|NCT00494429|Narcotics|narcotics|mesh-ancestor
92692007|NCT00494429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692008|NCT00494429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692009|NCT00494429|Analgesics|analgesics|mesh-ancestor
92692010|NCT00494429|Sensory System Agents|sensory system agents|mesh-ancestor
92692011|NCT00494429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692012|NCT00497120|Acetazolamide|acetazolamide|mesh-list
92692013|NCT00497120|Anticonvulsants|anticonvulsants|mesh-ancestor
92692014|NCT00497120|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92692015|NCT00497120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692016|NCT00497120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692017|NCT00497120|Diuretics|diuretics|mesh-ancestor
92692018|NCT00497120|Natriuretic Agents|natriuretic agents|mesh-ancestor
92692022|NCT00494468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92692023|NCT00494468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692024|NCT00494468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692025|NCT00494468|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92692026|NCT00494468|GABA Agonists|gaba agonists|mesh-ancestor
92692027|NCT00494468|GABA Agents|gaba agents|mesh-ancestor
92692028|NCT00494468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692029|NCT00494468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692030|NCT00497237|Fluticasone|fluticasone|mesh-list
92692031|NCT00497237|Beclomethasone|beclomethasone|mesh-list
92692032|NCT00497237|Formoterol Fumarate|formoterol fumarate|mesh-list
92692033|NCT00497237|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92692034|NCT00497237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692035|NCT00497237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92692036|NCT00497237|Autonomic Agents|autonomic agents|mesh-ancestor
92692037|NCT00497237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692038|NCT00497237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692039|NCT00497237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92692040|NCT00497237|Respiratory System Agents|respiratory system agents|mesh-ancestor
92692041|NCT00497237|Dermatologic Agents|dermatologic agents|mesh-ancestor
92692042|NCT00497237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92692043|NCT00497237|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92692044|NCT00497237|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92692045|NCT00497237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92607312|NCT02957760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607313|NCT02957760|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92692046|NCT00497237|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692047|NCT00497237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370530|NCT04187352|Cisplatin|cisplatin|mesh-list
92692048|NCT00497237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692049|NCT00497237|Glucocorticoids|glucocorticoids|mesh-ancestor
92692050|NCT00497237|Hormones|hormones|mesh-ancestor
92692051|NCT00497237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692052|NCT00497315|Pemetrexed|pemetrexed|mesh-list
92692053|NCT00497315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692054|NCT00497315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692055|NCT00497315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692056|NCT00497315|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92692057|NCT00497315|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92692058|NCT05142072|Vitamin D|vitamin d|mesh-list
92692059|NCT05142072|Cholecalciferol|cholecalciferol|mesh-list
92692060|NCT05142072|Vitamins|vitamins|mesh-ancestor
92692061|NCT05142072|Micronutrients|micronutrients|mesh-ancestor
92692062|NCT05142072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692063|NCT05142072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92692064|NCT05142072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692065|NCT00497354|Anesthetics|anesthetics|mesh-list
92692066|NCT00497354|Anesthetics, Local|anesthetics, local|mesh-list
92692067|NCT00497354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692068|NCT00497354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692069|NCT00497354|Sensory System Agents|sensory system agents|mesh-ancestor
92692070|NCT00497354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692071|NCT00494624|Prednisolone|prednisolone|mesh-list
92692072|NCT00494624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692073|NCT00494624|Glucocorticoids|glucocorticoids|mesh-ancestor
92692075|NCT00494624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692076|NCT00494624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692077|NCT00494624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92692078|NCT00494624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692079|NCT00494663|Ketoconazole|ketoconazole|mesh-list
92692080|NCT00494663|Antifungal Agents|antifungal agents|mesh-ancestor
92692081|NCT00494663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692082|NCT00494663|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92692083|NCT00494663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92692084|NCT00494663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692085|NCT00494663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692086|NCT00494663|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92692087|NCT00494663|Hormone Antagonists|hormone antagonists|mesh-ancestor
92692088|NCT00494663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692089|NCT00494663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692093|NCT05146674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92692094|NCT05146674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92692095|NCT05146674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692096|NCT05146674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692097|NCT05146674|Urological Agents|urological agents|mesh-ancestor
92692098|NCT00507195|Midazolam|midazolam|mesh-list
92692099|NCT00507195|Propofol|propofol|mesh-list
92692100|NCT00507195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92692101|NCT00507195|Sevoflurane|sevoflurane|mesh-list
92692102|NCT00507195|Desflurane|desflurane|mesh-list
92692103|NCT00507195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370562|NCT03697356|Hormones|hormones|mesh-ancestor
92692104|NCT00507195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692105|NCT00507195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92692106|NCT00507195|Anesthetics, General|anesthetics, general|mesh-ancestor
92692107|NCT00507195|Anesthetics|anesthetics|mesh-ancestor
92692108|NCT00507195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92692109|NCT00507195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92692110|NCT00507195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92692111|NCT00507195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92692112|NCT00507195|GABA Modulators|gaba modulators|mesh-ancestor
92692113|NCT00507195|GABA Agents|gaba agents|mesh-ancestor
92692114|NCT00507195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692115|NCT00507195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607315|NCT03117309|Ipilimumab|ipilimumab|mesh-list
92607316|NCT03117309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607317|NCT03117309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607318|NCT03117309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92607319|NCT03117309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607320|NCT00140166|Pyridoxine|pyridoxine|mesh-list
92607321|NCT00140166|Niacinamide|niacinamide|mesh-list
92607322|NCT00140166|Niacin|niacin|mesh-list
92607323|NCT00140166|Nicotinic Acids|nicotinic acids|mesh-list
92607324|NCT00140166|Vitamin B Complex|vitamin b complex|mesh-ancestor
92607325|NCT00140166|Vitamins|vitamins|mesh-ancestor
92692116|NCT00507195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92692117|NCT00507195|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92692118|NCT00497471|Pyrimethamine|pyrimethamine|mesh-list
92692119|NCT00497471|Dapsone|dapsone|mesh-list
92692120|NCT00497471|Antimalarials|antimalarials|mesh-ancestor
92692121|NCT00497471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92692122|NCT00497471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92692123|NCT00497471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692124|NCT00497471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92692125|NCT00497471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692126|NCT00497471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692127|NCT00497471|Leprostatic Agents|leprostatic agents|mesh-ancestor
92692128|NCT00497471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692129|NCT05146635|Epirubicin|epirubicin|mesh-list
92692130|NCT05146635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92692131|NCT05146635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692132|NCT05146635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92692133|NCT05146635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92692134|NCT05146635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692135|NCT05146635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692136|NCT00494741|Mycophenolic Acid|mycophenolic acid|mesh-list
92692137|NCT00494741|Azathioprine|azathioprine|mesh-list
92692138|NCT00494741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92692139|NCT00494741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692140|NCT00494741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92692141|NCT00494741|Antitubercular Agents|antitubercular agents|mesh-ancestor
92692142|NCT00494741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692143|NCT00494741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692144|NCT00494741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111946|NCT01734785|Hormones|hormones|mesh-ancestor
92692145|NCT00494741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692146|NCT00494741|Antimetabolites|antimetabolites|mesh-ancestor
92692147|NCT00494741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692148|NCT00494741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692149|NCT00494741|Immunologic Factors|immunologic factors|mesh-ancestor
92692150|NCT00494741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692151|NCT00494741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692152|NCT00507234|Formoterol Fumarate|formoterol fumarate|mesh-list
92692153|NCT00507234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92692154|NCT00507234|Autonomic Agents|autonomic agents|mesh-ancestor
92692155|NCT00507234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692156|NCT00507234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692157|NCT00507234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92001186|NCT04913805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92692158|NCT00507234|Respiratory System Agents|respiratory system agents|mesh-ancestor
92692159|NCT00507234|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92692160|NCT00507234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92692161|NCT00507234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92692182|NCT05149560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692183|NCT05149560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692184|NCT00494897|Cytarabine|cytarabine|mesh-list
92692185|NCT00494897|Prednisone|prednisone|mesh-list
92692186|NCT00494897|Cyclophosphamide|cyclophosphamide|mesh-list
92692187|NCT00494897|Methotrexate|methotrexate|mesh-list
92692188|NCT00494897|Vincristine|vincristine|mesh-list
92692189|NCT00494897|Daunorubicin|daunorubicin|mesh-list
92692190|NCT00494897|Asparaginase|asparaginase|mesh-list
92014687|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607326|NCT00140166|Micronutrients|micronutrients|mesh-ancestor
92607327|NCT00140166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607328|NCT00140166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92607329|NCT00140166|Antimetabolites|antimetabolites|mesh-ancestor
92607330|NCT00140166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607331|NCT00140166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92607332|NCT00140166|Vasodilator Agents|vasodilator agents|mesh-ancestor
92607333|NCT03095274|Durvalumab|durvalumab|mesh-list
92692191|NCT00494897|Mercaptopurine|mercaptopurine|mesh-list
92692192|NCT00494897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692193|NCT00494897|Immunologic Factors|immunologic factors|mesh-ancestor
92692194|NCT00494897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692195|NCT00494897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692196|NCT00494897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92692197|NCT00494897|Alkylating Agents|alkylating agents|mesh-ancestor
92692198|NCT00494897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692199|NCT00494897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692200|NCT00494897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92692201|NCT00494897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692202|NCT00494897|Glucocorticoids|glucocorticoids|mesh-ancestor
92692203|NCT00494897|Hormones|hormones|mesh-ancestor
92692204|NCT00494897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692205|NCT00494897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92692206|NCT00494897|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92692207|NCT00494897|Abortifacient Agents|abortifacient agents|mesh-ancestor
92692208|NCT00494897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92692209|NCT00494897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692210|NCT00494897|Antimetabolites|antimetabolites|mesh-ancestor
92692211|NCT00494897|Dermatologic Agents|dermatologic agents|mesh-ancestor
92692212|NCT00494897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692213|NCT00494897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92692214|NCT00494897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92692215|NCT00494897|Antiviral Agents|antiviral agents|mesh-ancestor
92692216|NCT00494897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692217|NCT00494897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92692228|NCT00495092|Caffeine|caffeine|mesh-list
92692229|NCT00495092|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92692230|NCT00495092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692231|NCT00495092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92692232|NCT00495092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692233|NCT00495092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692234|NCT00495092|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92692235|NCT00495092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92692236|NCT00495092|Purinergic Agents|purinergic agents|mesh-ancestor
92692237|NCT00495092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692238|NCT00495092|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92692239|NCT00495092|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92692240|NCT00495092|Parasympatholytics|parasympatholytics|mesh-ancestor
92692241|NCT00495092|Autonomic Agents|autonomic agents|mesh-ancestor
92692242|NCT00495092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692243|NCT00495092|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92692244|NCT00495092|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92692245|NCT00495092|Cholinergic Agents|cholinergic agents|mesh-ancestor
92692246|NCT01244360|Resveratrol|resveratrol|mesh-list
92692247|NCT01244360|Antioxidants|antioxidants|mesh-ancestor
92692248|NCT01244360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692249|NCT01244360|Protective Agents|protective agents|mesh-ancestor
92692250|NCT01244360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692251|NCT01244360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692252|NCT01244360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92692253|NCT00506571|Oxaliplatin|oxaliplatin|mesh-list
92692254|NCT00506571|Irinotecan|irinotecan|mesh-list
92692255|NCT00506571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692256|NCT00506571|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92607334|NCT03095274|Tremelimumab|tremelimumab|mesh-list
92607335|NCT03095274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607336|NCT03095274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607337|NCT00131768|Hylan|hylan|mesh-list
92692257|NCT00506571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92692258|NCT00506571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692259|NCT00506571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692260|NCT00497900|Vitamin D|vitamin d|mesh-list
92692261|NCT00497900|Vitamins|vitamins|mesh-ancestor
92692262|NCT00497900|Micronutrients|micronutrients|mesh-ancestor
92692263|NCT00497900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692264|NCT00497900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92692265|NCT05143125|Decitabine|decitabine|mesh-list
92692266|NCT05143125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692267|NCT05143125|Antimetabolites|antimetabolites|mesh-ancestor
92692268|NCT05143125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692269|NCT05143125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692270|NCT05143125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692271|NCT00497939|Saw palmetto extract|saw palmetto extract|mesh-list
92692272|NCT00497939|Urological Agents|urological agents|mesh-ancestor
92692273|NCT00498134|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92692274|NCT00498134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92692275|NCT00498134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692276|NCT00498134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692277|NCT00498134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92692278|NCT00498134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92692279|NCT00498134|Analgesics|analgesics|mesh-ancestor
92692280|NCT00498134|Sensory System Agents|sensory system agents|mesh-ancestor
92692281|NCT00498134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692282|NCT00498134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692283|NCT00498134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692284|NCT00498134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692300|NCT00498251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692302|NCT00498251|Cholinergic Agents|cholinergic agents|mesh-ancestor
92692303|NCT00502658|Vitamins|vitamins|mesh-list
92692304|NCT00502658|Micronutrients|micronutrients|mesh-ancestor
92692305|NCT00502658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692306|NCT00502736|Ibandronic Acid|ibandronic acid|mesh-list
92692307|NCT00502736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92692308|NCT00502736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692309|NCT05146245|Risperidone|risperidone|mesh-list
92692310|NCT05146245|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92692311|NCT05146245|Serotonin Agents|serotonin agents|mesh-ancestor
92692312|NCT05146245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692313|NCT05146245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692314|NCT05146245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692315|NCT05146245|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92692316|NCT05146245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92692317|NCT05146245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692318|NCT05146245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92692319|NCT05146245|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92692320|NCT05146245|Dopamine Agents|dopamine agents|mesh-ancestor
92692321|NCT05146089|Bosentan|bosentan|mesh-list
92692322|NCT05146089|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92692323|NCT05146089|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92692324|NCT05146089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692325|NCT02954913|Liver Extracts|liver extracts|mesh-list
92692326|NCT02954913|Hematinics|hematinics|mesh-ancestor
92692327|NCT00502892|Carboplatin|carboplatin|mesh-list
92692328|NCT00502892|Topotecan|topotecan|mesh-list
92692329|NCT00502892|Ifosfamide|ifosfamide|mesh-list
92692330|NCT00502892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692331|NCT00502892|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92692332|NCT00502892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92692333|NCT00502892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692334|NCT00502892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692335|NCT00502892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92692336|NCT00502892|Alkylating Agents|alkylating agents|mesh-ancestor
92692337|NCT00502970|Interferons|interferons|mesh-list
92692338|NCT00502970|Ribavirin|ribavirin|mesh-list
92692339|NCT00502970|Iron-Dextran Complex|iron-dextran complex|mesh-list
92692340|NCT00502970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607338|NCT00131768|Viscosupplements|viscosupplements|mesh-ancestor
92607339|NCT00131768|Protective Agents|protective agents|mesh-ancestor
92607340|NCT00131768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607341|NCT01248949|Paclitaxel|paclitaxel|mesh-list
92607342|NCT01248949|Bevacizumab|bevacizumab|mesh-list
92607343|NCT01248949|Carboplatin|carboplatin|mesh-list
92692341|NCT00502970|Antiviral Agents|antiviral agents|mesh-ancestor
92692342|NCT00502970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692343|NCT00502970|Antimetabolites|antimetabolites|mesh-ancestor
92692344|NCT00502970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692355|NCT05149287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92692357|NCT05149287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692358|NCT05149287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692359|NCT05149287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692360|NCT05149287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692361|NCT00498680|Sildenafil Citrate|sildenafil citrate|mesh-list
92692362|NCT00498680|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92692363|NCT00498680|Vasodilator Agents|vasodilator agents|mesh-ancestor
92692364|NCT00498680|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92692365|NCT00498680|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92692366|NCT00498680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370625|NCT01130844|Mesalamine|mesalamine|mesh-list
92692367|NCT00498680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112172|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
92692368|NCT00498680|Urological Agents|urological agents|mesh-ancestor
92692369|NCT00498953|Carboplatin|carboplatin|mesh-list
92692370|NCT00498953|Docetaxel|docetaxel|mesh-list
92692371|NCT00498953|Fluorouracil|fluorouracil|mesh-list
92692372|NCT00498953|Lapatinib|lapatinib|mesh-list
92692373|NCT00498953|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92692374|NCT00498953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692375|NCT00498953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92692376|NCT00498953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92692377|NCT00498953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92692378|NCT00498953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692379|NCT00498953|Antimetabolites|antimetabolites|mesh-ancestor
92692380|NCT00498953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692381|NCT00498953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692382|NCT00498953|Immunologic Factors|immunologic factors|mesh-ancestor
92692383|NCT00498953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692384|NCT00498953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92692385|NCT00498953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692386|NCT00498953|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92692387|NCT00503126|Bivalirudin|bivalirudin|mesh-list
92692388|NCT00503126|Antithrombins|antithrombins|mesh-ancestor
92692389|NCT00503126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92692390|NCT00503126|Protease Inhibitors|protease inhibitors|mesh-ancestor
92692391|NCT00503126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692392|NCT00503126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692393|NCT00503126|Anticoagulants|anticoagulants|mesh-ancestor
92692394|NCT05145543|Dexamethasone|dexamethasone|mesh-list
92692395|NCT05145543|Fentanyl|fentanyl|mesh-list
92692396|NCT05145543|Levobupivacaine|levobupivacaine|mesh-list
92692397|NCT05145543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692398|NCT05145543|Antiemetics|antiemetics|mesh-ancestor
92692399|NCT05145543|Autonomic Agents|autonomic agents|mesh-ancestor
92692400|NCT05145543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692401|NCT05145543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692402|NCT05145543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92692403|NCT05145543|Glucocorticoids|glucocorticoids|mesh-ancestor
92692404|NCT05145543|Hormones|hormones|mesh-ancestor
92692405|NCT05145543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692406|NCT05145543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92692407|NCT05145543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692408|NCT05145543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92692409|NCT05145543|Narcotics|narcotics|mesh-ancestor
92692417|NCT05145543|Anesthetics, Local|anesthetics, local|mesh-ancestor
92692418|NCT00503204|Cediranib|cediranib|mesh-list
92692419|NCT00503204|Lomustine|lomustine|mesh-list
92692420|NCT00503204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692421|NCT00503204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92692422|NCT00503204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607344|NCT01248949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92607345|NCT01248949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607346|NCT01248949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92607347|NCT01248949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92607348|NCT01248949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92692423|NCT00503204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692424|NCT00503204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92692425|NCT00503204|Alkylating Agents|alkylating agents|mesh-ancestor
92692426|NCT00503243|Mesalamine|mesalamine|mesh-list
92692427|NCT00503243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92692428|NCT00503243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92692429|NCT00503243|Analgesics|analgesics|mesh-ancestor
92692430|NCT00503243|Sensory System Agents|sensory system agents|mesh-ancestor
92692431|NCT00503243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692432|NCT00503243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370650|NCT01135368|Lansoprazole|lansoprazole|mesh-list
92692433|NCT00503243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692434|NCT00503243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692435|NCT00498992|Vitamin E|vitamin e|mesh-list
92692436|NCT00498992|Lidocaine|lidocaine|mesh-list
92692437|NCT00498992|Vitamins|vitamins|mesh-ancestor
92692438|NCT00498992|Micronutrients|micronutrients|mesh-ancestor
92692439|NCT00498992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692440|NCT00498992|Anesthetics, Local|anesthetics, local|mesh-ancestor
92692441|NCT00498992|Anesthetics|anesthetics|mesh-ancestor
92692442|NCT00498992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692443|NCT00498992|Sensory System Agents|sensory system agents|mesh-ancestor
92692444|NCT00498992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692445|NCT00498992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92692446|NCT00498992|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92692447|NCT00498992|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92692448|NCT00498992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692449|NCT00498992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692451|NCT00498992|Protective Agents|protective agents|mesh-ancestor
92692452|NCT02276391|Telmisartan|telmisartan|mesh-list
92692453|NCT02276391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92692454|NCT02276391|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92692455|NCT02276391|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92692456|NCT02276391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692457|NCT05145270|Sulforaphane|sulforaphane|mesh-list
92692458|NCT05145270|Dexetimide|dexetimide|mesh-list
92692459|NCT05145270|Citalopram|citalopram|mesh-list
92692460|NCT05145270|Escitalopram|escitalopram|mesh-list
92692461|NCT05145270|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92692462|NCT05145270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92692463|NCT05145270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692464|NCT05145270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692465|NCT05145270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692466|NCT05145270|Serotonin Agents|serotonin agents|mesh-ancestor
92692467|NCT05145270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692468|NCT05145270|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92692469|NCT05145270|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92692470|NCT05145270|Parasympatholytics|parasympatholytics|mesh-ancestor
92692471|NCT05145270|Autonomic Agents|autonomic agents|mesh-ancestor
92692472|NCT05145270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692473|NCT05145270|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92692474|NCT05145270|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92692475|NCT05145270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92692476|NCT05145270|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92692477|NCT05145270|Antidepressive Agents|antidepressive agents|mesh-ancestor
92692482|NCT01245179|Panobinostat|panobinostat|mesh-list
92692483|NCT01245179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692484|NCT01245179|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92692485|NCT01245179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692486|NCT01245179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692487|NCT00503321|polysaccharide-K|polysaccharide-k|mesh-list
92692488|NCT00503321|Tegafur|tegafur|mesh-list
92692489|NCT00503321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692490|NCT00503321|Antimetabolites|antimetabolites|mesh-ancestor
92607349|NCT01248949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607350|NCT01248949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607351|NCT01248949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92607352|NCT01248949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92607353|NCT01248949|Growth Substances|growth substances|mesh-ancestor
92607354|NCT01248949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607355|NCT01248949|Growth Inhibitors|growth inhibitors|mesh-ancestor
92607356|NCT00403637|Maleic acid|maleic acid|mesh-list
92607357|NCT00403637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607358|NCT00403637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607359|NCT04696666|Hyaluronic Acid|hyaluronic acid|mesh-list
92607360|NCT04696666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92607361|NCT04696666|Immunologic Factors|immunologic factors|mesh-ancestor
92607362|NCT04696666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692491|NCT00503321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692492|NCT00503321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692493|NCT00503321|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92692494|NCT00503321|Immunologic Factors|immunologic factors|mesh-ancestor
92692495|NCT00503321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692496|NCT00503321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92692497|NCT00503321|Antiviral Agents|antiviral agents|mesh-ancestor
92692498|NCT00503321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692499|NCT00503321|Interferon Inducers|interferon inducers|mesh-ancestor
92692500|NCT00503321|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92692501|NCT00503321|Protective Agents|protective agents|mesh-ancestor
92692502|NCT00503477|Cediranib|cediranib|mesh-list
92692503|NCT00503477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692504|NCT00503477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92692505|NCT00503477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692506|NCT00503477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692507|NCT05144295|Lactulose|lactulose|mesh-list
92692508|NCT05144295|Bisacodyl|bisacodyl|mesh-list
92692509|NCT05144295|Picosulfate sodium|picosulfate sodium|mesh-list
92692510|NCT05144295|Lubiprostone|lubiprostone|mesh-list
92692511|NCT05144295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92692512|NCT05144295|Cathartics|cathartics|mesh-ancestor
92692513|NCT05144295|Laxatives|laxatives|mesh-ancestor
92692514|NCT05144295|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92692515|NCT05144295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692516|NCT05144295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692517|NCT01245452|Methotrexate|methotrexate|mesh-list
92692518|NCT01245452|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92692519|NCT01245452|Abortifacient Agents|abortifacient agents|mesh-ancestor
92692520|NCT01245452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92692521|NCT01245452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692522|NCT01245452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692523|NCT01245452|Antimetabolites|antimetabolites|mesh-ancestor
92692524|NCT01245452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692525|NCT01245452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692526|NCT01245452|Dermatologic Agents|dermatologic agents|mesh-ancestor
92692527|NCT01245452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692528|NCT01245452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92692529|NCT01245452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692530|NCT01245452|Immunologic Factors|immunologic factors|mesh-ancestor
92692531|NCT01245452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692532|NCT01245452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92692533|NCT00503516|Megestrol|megestrol|mesh-list
92692534|NCT00503516|Megestrol Acetate|megestrol acetate|mesh-list
92692535|NCT00503516|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92332366|NCT00003439|Immunologic Factors|immunologic factors|mesh-ancestor
92607364|NCT04696666|Protective Agents|protective agents|mesh-ancestor
92607365|NCT01248793|Golimumab|golimumab|mesh-list
92692536|NCT00503516|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92692537|NCT00503516|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92692538|NCT00503516|Contraceptive Agents|contraceptive agents|mesh-ancestor
92692539|NCT00503516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92692540|NCT00503516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692541|NCT00503516|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92692542|NCT00503516|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92692543|NCT00503516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92692544|NCT00503516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692545|NCT00503516|Appetite Stimulants|appetite stimulants|mesh-ancestor
92692546|NCT00503516|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92692547|NCT05148195|Leucovorin|leucovorin|mesh-list
92692548|NCT05148195|Docetaxel|docetaxel|mesh-list
92692549|NCT05148195|Irinotecan|irinotecan|mesh-list
92692558|NCT05148195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692559|NCT05148195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92692560|NCT05148195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92692561|NCT05148195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692562|NCT05148195|Antidotes|antidotes|mesh-ancestor
92692563|NCT05148195|Protective Agents|protective agents|mesh-ancestor
92692564|NCT05148195|Vitamin B Complex|vitamin b complex|mesh-ancestor
92692565|NCT05148195|Vitamins|vitamins|mesh-ancestor
92692566|NCT05148195|Micronutrients|micronutrients|mesh-ancestor
92692567|NCT00499265|Gemcitabine|gemcitabine|mesh-list
92692568|NCT00499265|Protease Inhibitors|protease inhibitors|mesh-list
92692569|NCT00499265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-list
92692570|NCT00499265|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692571|NCT00499265|Antimetabolites|antimetabolites|mesh-ancestor
92692572|NCT00499265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692573|NCT00499265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692574|NCT00499265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692575|NCT01246622|Cytarabine|cytarabine|mesh-list
92692576|NCT01246622|Lenalidomide|lenalidomide|mesh-list
92692577|NCT01246622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692578|NCT01246622|Antimetabolites|antimetabolites|mesh-ancestor
92692579|NCT01246622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692580|NCT01246622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692581|NCT01246622|Antiviral Agents|antiviral agents|mesh-ancestor
92692582|NCT01246622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692583|NCT01246622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692584|NCT01246622|Immunologic Factors|immunologic factors|mesh-ancestor
92692585|NCT01246622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692586|NCT01246622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92692587|NCT01246622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92692588|NCT01246622|Growth Substances|growth substances|mesh-ancestor
92692589|NCT01246622|Growth Inhibitors|growth inhibitors|mesh-ancestor
92692590|NCT01245530|Donepezil|donepezil|mesh-list
92692591|NCT01245530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92692592|NCT01245530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692593|NCT01245530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692594|NCT01245530|Cholinergic Agents|cholinergic agents|mesh-ancestor
92692595|NCT01245530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692596|NCT01245530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692597|NCT01245530|Nootropic Agents|nootropic agents|mesh-ancestor
92692598|NCT05148312|Budesonide|budesonide|mesh-list
92692599|NCT05148312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692600|NCT05148312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92692601|NCT05148312|Autonomic Agents|autonomic agents|mesh-ancestor
92692602|NCT05148312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692603|NCT05148312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692604|NCT05148312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92692605|NCT05148312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92692606|NCT05148312|Glucocorticoids|glucocorticoids|mesh-ancestor
92692607|NCT05148312|Hormones|hormones|mesh-ancestor
92692608|NCT05148312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692609|NCT01246817|Sirolimus|sirolimus|mesh-list
92692610|NCT01246817|Temsirolimus|temsirolimus|mesh-list
92692611|NCT01246817|MTOR Inhibitors|mtor inhibitors|mesh-list
92692612|NCT01246817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92692613|NCT01246817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607367|NCT01248793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92607368|NCT01248793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607369|NCT01248793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92607370|NCT01248793|Immunologic Factors|immunologic factors|mesh-ancestor
92607371|NCT01248793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607372|NCT00403715|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92607373|NCT00403715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92607374|NCT01248364|Empagliflozin|empagliflozin|mesh-list
92607375|NCT01248364|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92014724|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92692614|NCT01246817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692615|NCT01246817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692616|NCT01246817|Immunologic Factors|immunologic factors|mesh-ancestor
92692617|NCT01246817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692620|NCT01246817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692621|NCT01246817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92692622|NCT01246817|Antifungal Agents|antifungal agents|mesh-ancestor
92692623|NCT01245803|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92692624|NCT01245803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92692625|NCT01245803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92692626|NCT01245803|Antimetabolites|antimetabolites|mesh-ancestor
92692627|NCT01245803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692628|NCT01245803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92692629|NCT01245803|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92692630|NCT01245803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692631|NCT05148975|Dimercaprol|dimercaprol|mesh-list
92692632|NCT05148975|Chelating Agents|chelating agents|mesh-ancestor
92692633|NCT05148975|Sequestering Agents|sequestering agents|mesh-ancestor
92692634|NCT05148975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692635|NCT00499577|Vaccines|vaccines|mesh-list
92692636|NCT00499577|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92692637|NCT00499577|Immunologic Factors|immunologic factors|mesh-ancestor
92692638|NCT00499577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692639|NCT02274740|Metformin|metformin|mesh-list
92692640|NCT02274740|Lixisenatide|lixisenatide|mesh-list
92692641|NCT02274740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92692642|NCT02274740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692643|NCT00499733|Cyclophosphamide|cyclophosphamide|mesh-list
92692644|NCT00499733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692645|NCT00499733|Immunologic Factors|immunologic factors|mesh-ancestor
92692646|NCT00499733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692647|NCT00499733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692648|NCT00499733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92692649|NCT00499733|Alkylating Agents|alkylating agents|mesh-ancestor
92692650|NCT00499733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692651|NCT00499733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692652|NCT00499733|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92692653|NCT00503594|Cytarabine|cytarabine|mesh-list
92692654|NCT00503594|Methotrexate|methotrexate|mesh-list
92112470|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112471|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112472|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692655|NCT00503594|Vincristine|vincristine|mesh-list
92112473|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
92112474|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
92112475|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
92112476|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
92112477|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112478|NCT01454115|BMS 708163|bms 708163|mesh-list
92112479|NCT01454115|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92112480|NCT01454115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112481|NCT01454115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607376|NCT01248364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607377|NCT01248364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92607378|NCT01248364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112482|NCT01455597|Estradiol|estradiol|mesh-list
92112483|NCT01455597|Estrogens|estrogens|mesh-ancestor
92112484|NCT01455597|Hormones|hormones|mesh-ancestor
92692656|NCT00503594|Temozolomide|temozolomide|mesh-list
92692657|NCT00503594|Procarbazine|procarbazine|mesh-list
92692658|NCT00503594|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92692659|NCT00503594|Abortifacient Agents|abortifacient agents|mesh-ancestor
92692660|NCT00503594|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92692661|NCT00503594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692662|NCT00503594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692663|NCT00503594|Antimetabolites|antimetabolites|mesh-ancestor
92692664|NCT00503594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692665|NCT00503594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692666|NCT00503594|Dermatologic Agents|dermatologic agents|mesh-ancestor
92692667|NCT00503594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692668|NCT00503594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92692669|NCT00503594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692670|NCT00503594|Immunologic Factors|immunologic factors|mesh-ancestor
92692671|NCT00503594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692672|NCT00503594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92692673|NCT00503594|Antiviral Agents|antiviral agents|mesh-ancestor
92692674|NCT00503594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692675|NCT00503594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92692676|NCT00503594|Tubulin Modulators|tubulin modulators|mesh-ancestor
92692708|NCT00503828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92692709|NCT00503828|Analgesics|analgesics|mesh-ancestor
92692710|NCT00503828|Sensory System Agents|sensory system agents|mesh-ancestor
92692711|NCT00503828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692712|NCT00503828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692713|NCT00503828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692714|NCT00503828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692715|NCT00503828|Gout Suppressants|gout suppressants|mesh-ancestor
92692716|NCT00503828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92692717|NCT00503828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692718|NCT00503828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692720|NCT00500006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692721|NCT00500006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92692722|NCT00500006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692723|NCT00500006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692740|NCT00506727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692741|NCT00506727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92692742|NCT00506727|Sympathomimetics|sympathomimetics|mesh-ancestor
92692743|NCT00506727|Autonomic Agents|autonomic agents|mesh-ancestor
92692744|NCT00506727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692745|NCT00506727|Dopamine Agents|dopamine agents|mesh-ancestor
92692746|NCT00506727|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92692747|NCT03455517|Rituximab|rituximab|mesh-list
92692748|NCT03455517|Venetoclax|venetoclax|mesh-list
92692749|NCT03455517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92692750|NCT03455517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692751|NCT03455517|Immunologic Factors|immunologic factors|mesh-ancestor
92692752|NCT03455517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692753|NCT03455517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692754|NCT04696536|Listerine|listerine|mesh-list
92692755|NCT04696536|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92692756|NCT04696536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692757|NCT00500279|Celecoxib|celecoxib|mesh-list
92692758|NCT00500279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92692759|NCT00500279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92692760|NCT00500279|Analgesics|analgesics|mesh-ancestor
92692761|NCT00500279|Sensory System Agents|sensory system agents|mesh-ancestor
92692762|NCT00500279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692763|NCT00500279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692764|NCT00500279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692765|NCT00500279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692766|NCT00500279|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92692767|NCT00500279|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92692768|NCT00500279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607380|NCT00140361|Lumefantrine|lumefantrine|mesh-list
92607381|NCT00140361|Artemether|artemether|mesh-list
92370690|NCT01142310|Anticonvulsants|anticonvulsants|mesh-ancestor
92692769|NCT00500279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692770|NCT01245881|Sunscreening Agents|sunscreening agents|mesh-list
92692771|NCT01245881|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92692772|NCT01245881|Protective Agents|protective agents|mesh-ancestor
92692773|NCT01245881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692774|NCT01245881|Dermatologic Agents|dermatologic agents|mesh-ancestor
92692775|NCT03458247|Abiraterone Acetate|abiraterone acetate|mesh-list
92692776|NCT03458247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692777|NCT03458247|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92692778|NCT03458247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692779|NCT03458247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692780|NCT03458247|Hormone Antagonists|hormone antagonists|mesh-ancestor
92692790|NCT00500552|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92692791|NCT00500552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692792|NCT00500552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692793|NCT00500552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692794|NCT00500552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692795|NCT00500552|Vasodilator Agents|vasodilator agents|mesh-ancestor
92692796|NCT00508209|Bortezomib|bortezomib|mesh-list
92692797|NCT00508209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692798|NCT00500669|Povidone-Iodine|povidone-iodine|mesh-list
92692799|NCT00500669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92692800|NCT00500669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692801|NCT00507585|Leucovorin|leucovorin|mesh-list
92692802|NCT00507585|Bevacizumab|bevacizumab|mesh-list
92692803|NCT00507585|Fluorouracil|fluorouracil|mesh-list
92692804|NCT00507585|Oxaliplatin|oxaliplatin|mesh-list
92692805|NCT00507585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92692806|NCT00507585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692807|NCT00507585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92692808|NCT00507585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92692809|NCT00507585|Growth Substances|growth substances|mesh-ancestor
92692810|NCT00507585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692811|NCT00507585|Growth Inhibitors|growth inhibitors|mesh-ancestor
92692812|NCT00507585|Antimetabolites|antimetabolites|mesh-ancestor
92692813|NCT00507585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692814|NCT00507585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692815|NCT00507585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692816|NCT00507585|Immunologic Factors|immunologic factors|mesh-ancestor
92692817|NCT00507585|Antidotes|antidotes|mesh-ancestor
92692818|NCT00507585|Protective Agents|protective agents|mesh-ancestor
92692819|NCT00507585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92692820|NCT00507585|Vitamins|vitamins|mesh-ancestor
92692821|NCT00507585|Micronutrients|micronutrients|mesh-ancestor
92692822|NCT01247714|Phentermine|phentermine|mesh-list
92692823|NCT01247714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92692824|NCT01247714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692825|NCT01247714|Appetite Depressants|appetite depressants|mesh-ancestor
92692826|NCT01247714|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92692827|NCT01247714|Sympathomimetics|sympathomimetics|mesh-ancestor
92692828|NCT01247714|Autonomic Agents|autonomic agents|mesh-ancestor
92692829|NCT01247714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692830|NCT01247714|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692831|NCT01247714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692832|NCT01247714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692833|NCT00507663|Atenolol|atenolol|mesh-list
92692834|NCT00507663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92692835|NCT00507663|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92692836|NCT00507663|Sympatholytics|sympatholytics|mesh-ancestor
92692837|NCT00507663|Autonomic Agents|autonomic agents|mesh-ancestor
92692838|NCT00507663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692839|NCT00507663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692840|NCT00507663|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92692841|NCT00507663|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92692842|NCT00507663|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92692843|NCT00507663|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692844|NCT00507663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692845|NCT00507663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692847|NCT00508287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92692848|NCT00508287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014739|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
92607383|NCT00140361|Sulfadoxine|sulfadoxine|mesh-list
92607384|NCT00140361|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92607385|NCT00140361|Antimalarials|antimalarials|mesh-ancestor
92607386|NCT00140361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92607387|NCT00140361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92607388|NCT00140361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607389|NCT00140361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607390|NCT00140361|Antiviral Agents|antiviral agents|mesh-ancestor
92607391|NCT00140361|Schistosomicides|schistosomicides|mesh-ancestor
92607392|NCT00140361|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92607393|NCT00140361|Anthelmintics|anthelmintics|mesh-ancestor
92692849|NCT00508287|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92692851|NCT00508287|Hormones|hormones|mesh-ancestor
92692852|NCT00508287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692853|NCT00508326|Paclitaxel|paclitaxel|mesh-list
92692854|NCT00508326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92692855|NCT00508326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692856|NCT00508326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92692857|NCT00508326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92692858|NCT00508326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92692859|NCT00508326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692860|NCT00507858|Dexamethasone|dexamethasone|mesh-list
92692861|NCT00507858|Pemetrexed|pemetrexed|mesh-list
92692862|NCT00507858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692863|NCT00507858|Antiemetics|antiemetics|mesh-ancestor
92692864|NCT00507858|Autonomic Agents|autonomic agents|mesh-ancestor
92692865|NCT00507858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692866|NCT00507858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692867|NCT00507858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92692868|NCT00507858|Glucocorticoids|glucocorticoids|mesh-ancestor
92692869|NCT00507858|Hormones|hormones|mesh-ancestor
92692870|NCT00507858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692871|NCT00507858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92692872|NCT00507858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692873|NCT00507858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692874|NCT00507858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692875|NCT00507858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92692876|NCT00507858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92692877|NCT00508365|Carvedilol|carvedilol|mesh-list
92692878|NCT00508365|Lisinopril|lisinopril|mesh-list
92692879|NCT00508365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92692880|NCT00508365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92692881|NCT00508365|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692883|NCT00508365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692884|NCT00508365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692885|NCT00508365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92692886|NCT00508365|Antioxidants|antioxidants|mesh-ancestor
92692887|NCT00508365|Protective Agents|protective agents|mesh-ancestor
92692888|NCT00508365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92692889|NCT00508365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692890|NCT00508365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692891|NCT00508365|Vasodilator Agents|vasodilator agents|mesh-ancestor
92692892|NCT00508365|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92692893|NCT00508365|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92692894|NCT00508365|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92692895|NCT00508365|Protease Inhibitors|protease inhibitors|mesh-ancestor
92692896|NCT00508365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692897|NCT00508365|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92692898|NCT00500864|Magnesium Sulfate|magnesium sulfate|mesh-list
92692899|NCT00500864|Analgesics|analgesics|mesh-ancestor
92692900|NCT00500864|Sensory System Agents|sensory system agents|mesh-ancestor
92607394|NCT00140361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92607395|NCT00140361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692901|NCT00500864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692902|NCT00500864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692903|NCT00500864|Anesthetics|anesthetics|mesh-ancestor
92692904|NCT00500864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692905|NCT00500864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92692906|NCT00500864|Anticonvulsants|anticonvulsants|mesh-ancestor
92692907|NCT00500864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92692908|NCT00500864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692909|NCT00500864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692910|NCT00500864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692911|NCT00500864|Tocolytic Agents|tocolytic agents|mesh-ancestor
92692912|NCT00500864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92692913|NCT00507975|Nicotine|nicotine|mesh-list
92692914|NCT00507975|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92692915|NCT00507975|Autonomic Agents|autonomic agents|mesh-ancestor
92692916|NCT00507975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692917|NCT00507975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692918|NCT00507975|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92692919|NCT00507975|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92692927|NCT01247909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692928|NCT01247909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92692929|NCT01247909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692930|NCT01247909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692931|NCT01245998|Dalteparin|dalteparin|mesh-list
92692932|NCT01245998|Tinzaparin|tinzaparin|mesh-list
92692933|NCT01245998|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92692934|NCT01245998|Anticoagulants|anticoagulants|mesh-ancestor
92692935|NCT01245998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92692936|NCT01245998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92692937|NCT01245998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692938|NCT02954484|Acetaminophen|acetaminophen|mesh-list
92692939|NCT02954484|Etoricoxib|etoricoxib|mesh-list
92692940|NCT02954484|Pregabalin|pregabalin|mesh-list
92692941|NCT02954484|Morphine|morphine|mesh-list
92692942|NCT02954484|Ropivacaine|ropivacaine|mesh-list
92692943|NCT02954484|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92692944|NCT02954484|Narcotics|narcotics|mesh-ancestor
92692945|NCT02954484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692946|NCT02954484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692947|NCT02954484|Analgesics|analgesics|mesh-ancestor
92692948|NCT02954484|Sensory System Agents|sensory system agents|mesh-ancestor
92692949|NCT02954484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692950|NCT02954484|Anesthetics, Local|anesthetics, local|mesh-ancestor
92692951|NCT02954484|Anesthetics|anesthetics|mesh-ancestor
92692952|NCT02954484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92692953|NCT02954484|Antipyretics|antipyretics|mesh-ancestor
92692954|NCT02954484|Anticonvulsants|anticonvulsants|mesh-ancestor
92692955|NCT02954484|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92692956|NCT02954484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692957|NCT02954484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692958|NCT02954484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692959|NCT02954484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92692960|NCT02954484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92692961|NCT02954484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92692962|NCT02954484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92692963|NCT02954484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92692964|NCT02954484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92692965|NCT02954484|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92692966|NCT02954484|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92692967|NCT02954484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692968|NCT00501020|Rosiglitazone|rosiglitazone|mesh-list
92692969|NCT00501020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92692970|NCT00501020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692971|NCT00501098|Caspofungin|caspofungin|mesh-list
92692972|NCT00501098|Antifungal Agents|antifungal agents|mesh-ancestor
92692973|NCT00501098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692974|NCT00501098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692975|NCT00501098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692976|NCT00501137|Vaccines|vaccines|mesh-list
92692977|NCT00501137|Immunologic Factors|immunologic factors|mesh-ancestor
92692978|NCT00501137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692979|NCT01248260|Folic Acid|folic acid|mesh-list
92014751|NCT05204667|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92050372|NCT01499134|Nebivolol|nebivolol|mesh-list
92692980|NCT01248260|Hematinics|hematinics|mesh-ancestor
92692981|NCT01248260|Vitamin B Complex|vitamin b complex|mesh-ancestor
92692982|NCT01248260|Vitamins|vitamins|mesh-ancestor
92692983|NCT01248260|Micronutrients|micronutrients|mesh-ancestor
92692984|NCT01248260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692985|NCT01246037|Bisoprolol|bisoprolol|mesh-list
92692986|NCT01246037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92692987|NCT01246037|Sympatholytics|sympatholytics|mesh-ancestor
92692988|NCT01246037|Autonomic Agents|autonomic agents|mesh-ancestor
92692989|NCT01246037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692996|NCT01246037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692998|NCT00501215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692999|NCT00501215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693000|NCT00509184|Rituximab|rituximab|mesh-list
92693001|NCT00509184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92693002|NCT00509184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693003|NCT00509184|Immunologic Factors|immunologic factors|mesh-ancestor
92693004|NCT00509184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693005|NCT00509184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693006|NCT00501254|Aspirin|aspirin|mesh-list
92693007|NCT00501254|Salicylic Acid|salicylic acid|mesh-list
92693008|NCT00501254|Salicylates|salicylates|mesh-list
92693009|NCT00501254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693010|NCT00501254|Antifungal Agents|antifungal agents|mesh-ancestor
92693011|NCT00501254|Keratolytic Agents|keratolytic agents|mesh-ancestor
92693012|NCT00501254|Dermatologic Agents|dermatologic agents|mesh-ancestor
92693013|NCT00501254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92693014|NCT00501254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92693015|NCT00501254|Analgesics|analgesics|mesh-ancestor
92693016|NCT00501254|Sensory System Agents|sensory system agents|mesh-ancestor
92693017|NCT00501254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693018|NCT00501254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693019|NCT00501254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693020|NCT00501254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693021|NCT00501254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92693022|NCT00501254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693023|NCT00501254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693024|NCT00501254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92693025|NCT00501254|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92693026|NCT00501254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92693027|NCT00501254|Antipyretics|antipyretics|mesh-ancestor
92693028|NCT01248338|Metoprolol|metoprolol|mesh-list
92693029|NCT01248338|Nebivolol|nebivolol|mesh-list
92693030|NCT01248338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92693031|NCT01248338|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92693032|NCT01248338|Sympatholytics|sympatholytics|mesh-ancestor
92693033|NCT01248338|Autonomic Agents|autonomic agents|mesh-ancestor
92693034|NCT01248338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693035|NCT01248338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693036|NCT01248338|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92693037|NCT01248338|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92693038|NCT01248338|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92693039|NCT01248338|Adrenergic Agents|adrenergic agents|mesh-ancestor
92693040|NCT01248338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693041|NCT01248338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693042|NCT01248338|Vasodilator Agents|vasodilator agents|mesh-ancestor
92693043|NCT01248338|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92693044|NCT01248338|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92693045|NCT01248338|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92693046|NCT02953743|Lenvatinib|lenvatinib|mesh-list
92693047|NCT02953743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693048|NCT02953743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693049|NCT02953743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693050|NCT02953743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693051|NCT00509379|Rituximab|rituximab|mesh-list
92693052|NCT00509379|Bortezomib|bortezomib|mesh-list
92693053|NCT00509379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92693054|NCT00509379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693055|NCT00509379|Immunologic Factors|immunologic factors|mesh-ancestor
92693056|NCT00509379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693069|NCT02274974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014752|NCT05204667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92693070|NCT02274974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693071|NCT02274974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92693072|NCT02274974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92693073|NCT02274974|Adrenergic Agents|adrenergic agents|mesh-ancestor
92693074|NCT02274974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693075|NCT02274974|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92693076|NCT02274974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92693077|NCT02274974|Autonomic Agents|autonomic agents|mesh-ancestor
92693078|NCT02274974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92693079|NCT02274974|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693080|NCT02274974|Mydriatics|mydriatics|mesh-ancestor
92693081|NCT02274974|Sympathomimetics|sympathomimetics|mesh-ancestor
92693082|NCT02274974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92693083|NCT02274545|Vaccines|vaccines|mesh-list
92693084|NCT02274545|Immunologic Factors|immunologic factors|mesh-ancestor
92693085|NCT02274545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693086|NCT02275013|Simendan|simendan|mesh-list
92693087|NCT02275013|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92693088|NCT02275013|Vasodilator Agents|vasodilator agents|mesh-ancestor
92693089|NCT02275013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92693090|NCT02275013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92693091|NCT02275013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693092|NCT02275013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693093|NCT02275013|Protective Agents|protective agents|mesh-ancestor
92693094|NCT02275013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693095|NCT02274623|Calcifediol|calcifediol|mesh-list
92693096|NCT02274623|Vitamins|vitamins|mesh-ancestor
92693097|NCT02274623|Micronutrients|micronutrients|mesh-ancestor
92693098|NCT02274623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693099|NCT02274623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92693100|NCT00509613|Sirolimus|sirolimus|mesh-list
92693101|NCT00509613|Sorafenib|sorafenib|mesh-list
92693102|NCT00509613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693103|NCT00509613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693104|NCT00509613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693105|NCT00509613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693106|NCT00509613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92112926|NCT05824832|Clonidine|clonidine|mesh-list
92693107|NCT00509613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693108|NCT00509613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92693109|NCT00509613|Antifungal Agents|antifungal agents|mesh-ancestor
92693110|NCT00509613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693111|NCT00509613|Immunologic Factors|immunologic factors|mesh-ancestor
92693112|NCT00509613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693113|NCT00501410|Leucovorin|leucovorin|mesh-list
92693114|NCT00501410|Fluorouracil|fluorouracil|mesh-list
92693115|NCT00501410|Oxaliplatin|oxaliplatin|mesh-list
92693116|NCT00501410|Cetuximab|cetuximab|mesh-list
92693117|NCT00501410|Dasatinib|dasatinib|mesh-list
92693118|NCT00501410|Antimetabolites|antimetabolites|mesh-ancestor
92693119|NCT00501410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693123|NCT00501410|Immunologic Factors|immunologic factors|mesh-ancestor
92693124|NCT00501410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693125|NCT00501410|Antidotes|antidotes|mesh-ancestor
92693126|NCT00501410|Protective Agents|protective agents|mesh-ancestor
92693127|NCT00501410|Vitamin B Complex|vitamin b complex|mesh-ancestor
92693128|NCT00501410|Vitamins|vitamins|mesh-ancestor
92693129|NCT00501410|Micronutrients|micronutrients|mesh-ancestor
92693130|NCT00501410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92693131|NCT00501410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693132|NCT00501410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693133|NCT02953275|Pentoxifylline|pentoxifylline|mesh-list
92693134|NCT02953275|Vedolizumab|vedolizumab|mesh-list
92693135|NCT02953275|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92693136|NCT02953275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693137|NCT02953275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693138|NCT02953275|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92693139|NCT02953275|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92693140|NCT02953275|Protective Agents|protective agents|mesh-ancestor
92693141|NCT02953275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693142|NCT02953275|Vasodilator Agents|vasodilator agents|mesh-ancestor
92693143|NCT02953275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92693144|NCT02953275|Antioxidants|antioxidants|mesh-ancestor
92693145|NCT02953275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92693146|NCT00501488|Rosiglitazone|rosiglitazone|mesh-list
92607396|NCT00140361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607397|NCT00140361|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92607398|NCT00131846|Diuretics|diuretics|mesh-list
92607399|NCT00131846|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92607400|NCT00131846|Natriuretic Agents|natriuretic agents|mesh-ancestor
92607401|NCT00131846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693147|NCT00501488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693148|NCT00501488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693149|NCT00508911|Contraceptive Agents|contraceptive agents|mesh-list
92693150|NCT00508911|Contraceptives, Oral|contraceptives, oral|mesh-list
92693151|NCT00508911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92693152|NCT00508911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693153|NCT00508911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92693154|NCT02955719|Sertraline|sertraline|mesh-list
92693155|NCT02955719|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92693156|NCT02955719|Antidepressive Agents|antidepressive agents|mesh-ancestor
92693157|NCT02955719|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92693158|NCT02955719|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92693159|NCT02955719|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92693160|NCT02955719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92693161|NCT02955719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693162|NCT02955719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693163|NCT02955719|Serotonin Agents|serotonin agents|mesh-ancestor
92693164|NCT02955719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693165|NCT02955719|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92693166|NCT02955719|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92693167|NCT00501527|Immunomodulating Agents|immunomodulating agents|mesh-list
92693168|NCT00501527|Immunologic Factors|immunologic factors|mesh-ancestor
92693169|NCT00501527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693170|NCT02955524|Lidocaine|lidocaine|mesh-list
92693171|NCT02955524|Tetracaine|tetracaine|mesh-list
92693172|NCT02955524|Anesthetics, Local|anesthetics, local|mesh-ancestor
92693173|NCT02955524|Anesthetics|anesthetics|mesh-ancestor
92693174|NCT02955524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693175|NCT02955524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693176|NCT02955524|Sensory System Agents|sensory system agents|mesh-ancestor
92693177|NCT02955524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693178|NCT02955524|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92693179|NCT02955524|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92693180|NCT02955524|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92113004|NCT05821543|Metformin|metformin|mesh-list
92693181|NCT02955524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92693182|NCT02955524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693183|NCT02953041|Glycopyrrolate|glycopyrrolate|mesh-list
92693184|NCT02953041|Bromides|bromides|mesh-list
92693185|NCT02953041|Anticonvulsants|anticonvulsants|mesh-ancestor
92693186|NCT02953041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92693187|NCT02953041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92693188|NCT02953041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92693189|NCT02953041|Cholinergic Agents|cholinergic agents|mesh-ancestor
92693203|NCT00509847|Lactoferrin|lactoferrin|mesh-list
92693204|NCT00509847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693205|NCT01248494|Letrozole|letrozole|mesh-list
92693206|NCT01248494|Dactolisib|dactolisib|mesh-list
92693207|NCT01248494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693208|NCT01248494|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92693209|NCT01248494|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92693210|NCT01248494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693211|NCT01248494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693212|NCT01248494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92693213|NCT01248494|Hormone Antagonists|hormone antagonists|mesh-ancestor
92693214|NCT01248494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693215|NCT01248494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693216|NCT02952573|Dexamethasone|dexamethasone|mesh-list
92693217|NCT02952573|Dexamethasone acetate|dexamethasone acetate|mesh-list
92693218|NCT02952573|BB 1101|bb 1101|mesh-list
92607402|NCT00131846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607403|NCT00131846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607404|NCT00131963|Paclitaxel|paclitaxel|mesh-list
92607405|NCT00131963|Cyclophosphamide|cyclophosphamide|mesh-list
92607406|NCT00131963|Doxorubicin|doxorubicin|mesh-list
92050592|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92693219|NCT02952573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693220|NCT02952573|Antiemetics|antiemetics|mesh-ancestor
92693221|NCT02952573|Autonomic Agents|autonomic agents|mesh-ancestor
92693222|NCT02952573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693223|NCT02952573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693224|NCT02952573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92693225|NCT02952573|Glucocorticoids|glucocorticoids|mesh-ancestor
92693226|NCT02952573|Hormones|hormones|mesh-ancestor
92693227|NCT02952573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693228|NCT02952573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92693229|NCT02952573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693230|NCT02952573|Protease Inhibitors|protease inhibitors|mesh-ancestor
92693231|NCT02952573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693232|NCT02952573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693233|NCT00501722|Satavaptan|satavaptan|mesh-list
92693234|NCT00501722|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92693235|NCT00501722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693236|NCT00501722|Natriuretic Agents|natriuretic agents|mesh-ancestor
92693237|NCT00501722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693238|NCT01248611|Fentanyl|fentanyl|mesh-list
92693239|NCT01248611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92693240|NCT01248611|Narcotics|narcotics|mesh-ancestor
92693241|NCT01248611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693242|NCT01248611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693243|NCT01248611|Analgesics|analgesics|mesh-ancestor
92693244|NCT01248611|Sensory System Agents|sensory system agents|mesh-ancestor
92693245|NCT01248611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693246|NCT01248611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92693247|NCT01248611|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92693248|NCT01248611|Anesthetics, General|anesthetics, general|mesh-ancestor
92693252|NCT00509964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92693253|NCT00509964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693254|NCT00509964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693255|NCT00509964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693256|NCT00510471|Immunoglobulins|immunoglobulins|mesh-list
92693257|NCT00510471|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92693258|NCT00510471|Antibodies|antibodies|mesh-list
92693259|NCT00510471|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92693260|NCT00510471|Immunologic Factors|immunologic factors|mesh-ancestor
92693261|NCT00510471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693262|NCT00501839|Clomiphene|clomiphene|mesh-list
92693263|NCT00501839|Enclomiphene|enclomiphene|mesh-list
92693264|NCT00501839|Zuclomiphene|zuclomiphene|mesh-list
92693265|NCT00501839|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92693266|NCT00501839|Hormone Antagonists|hormone antagonists|mesh-ancestor
92693267|NCT00501839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693268|NCT00501839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693269|NCT00501839|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92693270|NCT00501839|Fertility Agents|fertility agents|mesh-ancestor
92693271|NCT00501839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92693272|NCT00501839|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92693273|NCT00501839|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92693274|NCT00510003|Pimecrolimus|pimecrolimus|mesh-list
92693275|NCT00510003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92693276|NCT00510003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92693277|NCT00510003|Analgesics|analgesics|mesh-ancestor
92693278|NCT00510003|Sensory System Agents|sensory system agents|mesh-ancestor
92693279|NCT00510003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693280|NCT00510003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693281|NCT00510003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693282|NCT00510003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693283|NCT00510003|Dermatologic Agents|dermatologic agents|mesh-ancestor
92050669|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050686|NCT04541290|Tacrolimus|tacrolimus|mesh-list
92693284|NCT00510003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693285|NCT00510003|Immunologic Factors|immunologic factors|mesh-ancestor
92693286|NCT00510003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92693287|NCT00510003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693288|NCT00510003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693289|NCT00501878|Phenylephrine|phenylephrine|mesh-list
92693290|NCT00501878|Oxymetazoline|oxymetazoline|mesh-list
92693291|NCT00501878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92693292|NCT00501878|Mydriatics|mydriatics|mesh-ancestor
92693293|NCT00501878|Autonomic Agents|autonomic agents|mesh-ancestor
92693294|NCT00501878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693295|NCT00501878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693296|NCT00501878|Sympathomimetics|sympathomimetics|mesh-ancestor
92693297|NCT00501878|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92693298|NCT00501878|Nasal Decongestants|nasal decongestants|mesh-ancestor
92693299|NCT00501878|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693300|NCT00501878|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92693301|NCT00501878|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92693302|NCT00501878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92693303|NCT00501878|Adrenergic Agents|adrenergic agents|mesh-ancestor
92693304|NCT00501878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693305|NCT00501878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693306|NCT00501878|Protective Agents|protective agents|mesh-ancestor
92693307|NCT00501917|Darbepoetin alfa|darbepoetin alfa|mesh-list
92693308|NCT00501917|Hematinics|hematinics|mesh-ancestor
92693309|NCT00510588|Metformin|metformin|mesh-list
92693310|NCT00510588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693311|NCT00510588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693312|NCT00510627|Oxaliplatin|oxaliplatin|mesh-list
92693313|NCT00510627|Irinotecan|irinotecan|mesh-list
92693314|NCT00510627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693315|NCT00510627|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92693316|NCT00510627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92693317|NCT00510627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693318|NCT00510627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693319|NCT00502034|Interferons|interferons|mesh-list
92693320|NCT00502034|Interferon-alpha|interferon-alpha|mesh-list
92693321|NCT00502034|Interferon alpha-2|interferon alpha-2|mesh-list
92693322|NCT00502034|Interleukin-2|interleukin-2|mesh-list
92693336|NCT00510666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693337|NCT00510666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693338|NCT00510666|Analgesics|analgesics|mesh-ancestor
92693339|NCT00510666|Sensory System Agents|sensory system agents|mesh-ancestor
92693340|NCT00510666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693341|NCT00510666|Antitussive Agents|antitussive agents|mesh-ancestor
92693342|NCT00510666|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693343|NCT00510666|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92693344|NCT00508092|Anesthetics|anesthetics|mesh-list
92693345|NCT00508092|Anesthetics, Local|anesthetics, local|mesh-list
92693346|NCT00508092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693347|NCT00508092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693348|NCT00508092|Sensory System Agents|sensory system agents|mesh-ancestor
92693349|NCT00508092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693351|NCT00510705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693352|NCT00510705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693353|NCT00502073|Cyclosporine|cyclosporine|mesh-list
92693354|NCT00502073|Cyclosporins|cyclosporins|mesh-list
92693355|NCT00502073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693356|NCT00502073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693357|NCT00502073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693358|NCT00502073|Immunologic Factors|immunologic factors|mesh-ancestor
92693359|NCT00502073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693360|NCT00502073|Antifungal Agents|antifungal agents|mesh-ancestor
92693361|NCT00502073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693362|NCT00502073|Dermatologic Agents|dermatologic agents|mesh-ancestor
92693363|NCT00502073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693364|NCT00502073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92693365|NCT01248923|Dexamethasone|dexamethasone|mesh-list
92693366|NCT01248923|Bortezomib|bortezomib|mesh-list
92693367|NCT01248923|Filanesib|filanesib|mesh-list
92693368|NCT01248923|Lenograstim|lenograstim|mesh-list
92693369|NCT01248923|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92693370|NCT01248923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693371|NCT01248923|Antiemetics|antiemetics|mesh-ancestor
92607407|NCT00131963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92607408|NCT00131963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607409|NCT00131963|Tubulin Modulators|tubulin modulators|mesh-ancestor
92693372|NCT01248923|Autonomic Agents|autonomic agents|mesh-ancestor
92693373|NCT01248923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693374|NCT01248923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693375|NCT01248923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92693376|NCT01248923|Glucocorticoids|glucocorticoids|mesh-ancestor
92693377|NCT01248923|Hormones|hormones|mesh-ancestor
92693378|NCT01248923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693379|NCT01248923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92693380|NCT01248923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693381|NCT01248923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92693382|NCT01248923|Immunologic Factors|immunologic factors|mesh-ancestor
92693383|NCT01248923|Protease Inhibitors|protease inhibitors|mesh-ancestor
92693384|NCT01248923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693385|NCT01248923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693386|NCT01248923|Antimitotic Agents|antimitotic agents|mesh-ancestor
92693387|NCT01248923|Mitosis Modulators|mitosis modulators|mesh-ancestor
92693388|NCT01249001|Aprepitant|aprepitant|mesh-list
92693393|NCT01249001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693394|NCT01249001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92693395|NCT01249001|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92693396|NCT01249001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370785|NCT01163214|Anesthetics|anesthetics|mesh-ancestor
92693397|NCT01249001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693398|NCT00502112|Lenalidomide|lenalidomide|mesh-list
92693399|NCT00502112|Lintuzumab|lintuzumab|mesh-list
92693400|NCT00502112|Immunologic Factors|immunologic factors|mesh-ancestor
92693401|NCT00502112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693402|NCT00502112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92693403|NCT00502112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92693404|NCT00502112|Growth Substances|growth substances|mesh-ancestor
92693405|NCT00502112|Growth Inhibitors|growth inhibitors|mesh-ancestor
92693406|NCT00502112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693407|NCT00502112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92693408|NCT00502190|Silicon|silicon|mesh-list
92693409|NCT00502190|Trace Elements|trace elements|mesh-ancestor
92693410|NCT00502190|Micronutrients|micronutrients|mesh-ancestor
92693411|NCT00502190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693412|NCT00502229|Metformin|metformin|mesh-list
92693413|NCT00502229|Clomiphene|clomiphene|mesh-list
92693414|NCT00502229|Enclomiphene|enclomiphene|mesh-list
92693415|NCT00502229|Zuclomiphene|zuclomiphene|mesh-list
92693416|NCT00502229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693417|NCT00502229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693418|NCT00502229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92693419|NCT00502229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92693420|NCT00502229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693421|NCT00502229|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92693422|NCT00502229|Fertility Agents|fertility agents|mesh-ancestor
92693423|NCT00502229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92693424|NCT00502229|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92693425|NCT00502229|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92693426|NCT00502268|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92693427|NCT00502268|Ergocalciferols|ergocalciferols|mesh-list
92693428|NCT00502268|Vitamins|vitamins|mesh-ancestor
92693429|NCT00502268|Micronutrients|micronutrients|mesh-ancestor
92693430|NCT00502268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693431|NCT00502268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92693432|NCT00502268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92693433|NCT00510081|Calcium|calcium|mesh-list
92693434|NCT00510081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92693435|NCT00510081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693436|NCT00502385|Cediranib|cediranib|mesh-list
92693437|NCT00502385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693438|NCT00502385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693439|NCT00502385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693440|NCT00502385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693441|NCT00510159|Artesunate|artesunate|mesh-list
92693442|NCT00510159|Sulfalene|sulfalene|mesh-list
92693443|NCT00510159|Praziquantel|praziquantel|mesh-list
92693444|NCT00510159|Antimalarials|antimalarials|mesh-ancestor
92607411|NCT00131963|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607412|NCT00131963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607413|NCT00131963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014764|NCT04340141|Leucovorin|leucovorin|mesh-list
92693445|NCT00510159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92693446|NCT00510159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92693447|NCT00510159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693448|NCT00510159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693449|NCT00510159|Antiviral Agents|antiviral agents|mesh-ancestor
92693450|NCT00510159|Schistosomicides|schistosomicides|mesh-ancestor
92693451|NCT00510159|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92693452|NCT00510159|Anthelmintics|anthelmintics|mesh-ancestor
92693453|NCT00510159|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92693454|NCT00502463|Immunomodulating Agents|immunomodulating agents|mesh-list
92693455|NCT00502463|Immunologic Factors|immunologic factors|mesh-ancestor
92693456|NCT00502463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693457|NCT02952807|Misoprostol|misoprostol|mesh-list
92693458|NCT02952807|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92693459|NCT02952807|Abortifacient Agents|abortifacient agents|mesh-ancestor
92693460|NCT02952807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92693475|NCT03459417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693476|NCT03459417|Analgesics|analgesics|mesh-ancestor
92693477|NCT03459417|Sensory System Agents|sensory system agents|mesh-ancestor
92693478|NCT03459417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693479|NCT03459417|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92693480|NCT03459417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92693481|NCT03459417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92693482|NCT03459417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92693483|NCT03459417|Dopamine Agents|dopamine agents|mesh-ancestor
92693484|NCT03459417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693485|NCT03459417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693486|NCT03459417|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92693487|NCT03459417|Antidepressive Agents|antidepressive agents|mesh-ancestor
92693488|NCT00502541|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92693489|NCT00502541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693491|NCT00502541|Hormones|hormones|mesh-ancestor
92693492|NCT00502541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693493|NCT00502541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693494|NCT01249430|Cytarabine|cytarabine|mesh-list
92693495|NCT01249430|Etoposide|etoposide|mesh-list
92693496|NCT01249430|Mitoxantrone|mitoxantrone|mesh-list
92693497|NCT01249430|Azacitidine|azacitidine|mesh-list
92693498|NCT01249430|Etoposide phosphate|etoposide phosphate|mesh-list
92693499|NCT01249430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92693500|NCT01249430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693501|NCT01249430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92693502|NCT01249430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92693503|NCT01249430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693504|NCT01249430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693505|NCT01249430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92693506|NCT01249430|Antimetabolites|antimetabolites|mesh-ancestor
92693507|NCT01249430|Antiviral Agents|antiviral agents|mesh-ancestor
92693508|NCT01249430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693509|NCT01249430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693510|NCT01249430|Immunologic Factors|immunologic factors|mesh-ancestor
92693511|NCT01249430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693512|NCT01249430|Analgesics|analgesics|mesh-ancestor
92693513|NCT01249430|Sensory System Agents|sensory system agents|mesh-ancestor
92693514|NCT01249430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693515|NCT02952963|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92693516|NCT02952963|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92693517|NCT02952963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92693518|NCT02952963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92693519|NCT02952963|Antimetabolites|antimetabolites|mesh-ancestor
92693520|NCT02952963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693521|NCT02952963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92693522|NCT02952963|Cathartics|cathartics|mesh-ancestor
92693523|NCT02952963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607414|NCT00131963|Immunologic Factors|immunologic factors|mesh-ancestor
92607415|NCT00131963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693527|NCT00504062|Fluticasone|fluticasone|mesh-list
92693528|NCT00504062|Budesonide|budesonide|mesh-list
92693529|NCT00504062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693530|NCT00504062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92693531|NCT00504062|Autonomic Agents|autonomic agents|mesh-ancestor
92693532|NCT00504062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693533|NCT00504062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693534|NCT00504062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92693535|NCT00504062|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693536|NCT00504062|Dermatologic Agents|dermatologic agents|mesh-ancestor
92693537|NCT00504062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92693538|NCT00504062|Glucocorticoids|glucocorticoids|mesh-ancestor
92693539|NCT00504062|Hormones|hormones|mesh-ancestor
92693540|NCT00504062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693541|NCT00504101|Bortezomib|bortezomib|mesh-list
92693542|NCT00504101|Melphalan|melphalan|mesh-list
92693543|NCT00504101|Arsenic Trioxide|arsenic trioxide|mesh-list
92693544|NCT00504101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693545|NCT00504101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92693546|NCT00504101|Alkylating Agents|alkylating agents|mesh-ancestor
92693547|NCT00504101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693548|NCT00504101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92693549|NCT00504101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693550|NCT00504101|Immunologic Factors|immunologic factors|mesh-ancestor
92693551|NCT00504101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693552|NCT00504140|Interferons|interferons|mesh-list
92693553|NCT00504140|Interferon-alpha|interferon-alpha|mesh-list
92693554|NCT00504140|Etoposide|etoposide|mesh-list
92693555|NCT00504140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92693556|NCT00504140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693557|NCT00504140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92693558|NCT00504140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92693559|NCT00504140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693560|NCT00504140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693561|NCT00504140|Antiviral Agents|antiviral agents|mesh-ancestor
92693562|NCT00504140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693563|NCT00504140|Immunologic Factors|immunologic factors|mesh-ancestor
92693564|NCT00504140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693565|NCT00511017|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92693566|NCT00511017|Vitamins|vitamins|mesh-ancestor
92693567|NCT00511017|Micronutrients|micronutrients|mesh-ancestor
92693568|NCT00511017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693569|NCT00511017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92693570|NCT00511212|Immunoglobulins|immunoglobulins|mesh-list
92693571|NCT00511212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92693572|NCT00511212|Antibodies|antibodies|mesh-list
92693573|NCT00511212|gamma-Globulins|gamma-globulins|mesh-list
92693574|NCT00511212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92693575|NCT00511212|Immunologic Factors|immunologic factors|mesh-ancestor
92693576|NCT00511212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693577|NCT00510354|Imatinib Mesylate|imatinib mesylate|mesh-list
92693578|NCT00510354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693579|NCT00510354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693580|NCT00510354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693581|NCT00510354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693582|NCT01241006|Dexamethasone|dexamethasone|mesh-list
92693583|NCT01241006|Prednisone|prednisone|mesh-list
92693584|NCT01241006|Glucocorticoids|glucocorticoids|mesh-list
92693585|NCT01241006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693586|NCT01241006|Antiemetics|antiemetics|mesh-ancestor
92693587|NCT01241006|Autonomic Agents|autonomic agents|mesh-ancestor
92693588|NCT01241006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693589|NCT01241006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693590|NCT01241006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92693591|NCT01241006|Hormones|hormones|mesh-ancestor
92693592|NCT01241006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693593|NCT01241006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92693594|NCT01241006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693595|NCT00510393|Everolimus|everolimus|mesh-list
92693596|NCT00510393|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92693597|NCT00510393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693598|NCT00510393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693601|NCT00510393|Immunologic Factors|immunologic factors|mesh-ancestor
92607416|NCT00131963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607417|NCT00131963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92607418|NCT00131963|Alkylating Agents|alkylating agents|mesh-ancestor
92607419|NCT00131963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92050978|NCT01490086|RP5063|rp5063|mesh-list
92693602|NCT00510393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693603|NCT00510393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693605|NCT01249547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693606|NCT01249547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693607|NCT01249547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693608|NCT01249547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693609|NCT00511719|Insulin|insulin|mesh-list
92693610|NCT00511719|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92693611|NCT00511719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693612|NCT00511719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693613|NCT01246232|Amisulpride|amisulpride|mesh-list
92693614|NCT01246232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92693615|NCT01246232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92693616|NCT01246232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693617|NCT01246232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693618|NCT01246232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92693619|NCT01246232|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92693620|NCT01246232|Dopamine Agents|dopamine agents|mesh-ancestor
92693621|NCT01246232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693622|NCT01246232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693623|NCT01246232|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92693624|NCT01246232|Antidepressive Agents|antidepressive agents|mesh-ancestor
92693625|NCT01248962|Carboplatin|carboplatin|mesh-list
92693626|NCT01248962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693627|NCT00511446|Docetaxel|docetaxel|mesh-list
92693628|NCT00511446|Capecitabine|capecitabine|mesh-list
92693629|NCT00511446|Oxaliplatin|oxaliplatin|mesh-list
92693630|NCT00511446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693631|NCT00511446|Tubulin Modulators|tubulin modulators|mesh-ancestor
92693632|NCT00511446|Antimitotic Agents|antimitotic agents|mesh-ancestor
92693633|NCT00511446|Mitosis Modulators|mitosis modulators|mesh-ancestor
92693634|NCT00511446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693635|NCT00511446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92693636|NCT00511446|Antimetabolites|antimetabolites|mesh-ancestor
92693637|NCT02955446|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92693638|NCT02955446|Nirogacestat|nirogacestat|mesh-list
92693639|NCT02955446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693640|NCT02955446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693641|NCT00511602|Insulin|insulin|mesh-list
92693642|NCT00511602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693643|NCT00511602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693644|NCT00511953|Gabapentin|gabapentin|mesh-list
92693645|NCT00511953|Analgesics|analgesics|mesh-ancestor
92693646|NCT00511953|Sensory System Agents|sensory system agents|mesh-ancestor
92370850|NCT01171794|Ibuprofen|ibuprofen|mesh-list
92693647|NCT00511953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693648|NCT00511953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693649|NCT00511953|Anticonvulsants|anticonvulsants|mesh-ancestor
92693650|NCT00511953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92693651|NCT00511953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92693652|NCT00511953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693653|NCT00511953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92693654|NCT00511953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92693655|NCT00511953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92693656|NCT00511953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693657|NCT00511953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693658|NCT00511953|Antimanic Agents|antimanic agents|mesh-ancestor
92693659|NCT01249820|Anidulafungin|anidulafungin|mesh-list
92693660|NCT01249820|Antifungal Agents|antifungal agents|mesh-ancestor
92693661|NCT01249820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693662|NCT01247090|Vasopressins|vasopressins|mesh-list
92693663|NCT01247090|Arginine Vasopressin|arginine vasopressin|mesh-list
92693664|NCT01247090|Hemostatics|hemostatics|mesh-ancestor
92693665|NCT01247090|Coagulants|coagulants|mesh-ancestor
92693666|NCT01247090|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92693667|NCT01247090|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92693668|NCT01247090|Natriuretic Agents|natriuretic agents|mesh-ancestor
92607420|NCT00131963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92607421|NCT00131963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607422|NCT00131963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92693669|NCT01247090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693671|NCT00504764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693675|NCT02951754|Methylphenidate|methylphenidate|mesh-list
92693676|NCT02951754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92693677|NCT02951754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693678|NCT02951754|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92693679|NCT02951754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92693680|NCT02951754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92693681|NCT02951754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693682|NCT02951754|Dopamine Agents|dopamine agents|mesh-ancestor
92693683|NCT02951754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693684|NCT00504413|Digoxin|digoxin|mesh-list
92693685|NCT00504413|Midazolam|midazolam|mesh-list
92693686|NCT00504413|Methadone|methadone|mesh-list
92693687|NCT00504413|Bupropion|bupropion|mesh-list
92693688|NCT00504413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92693689|NCT00504413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92693690|NCT00504413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693691|NCT00504413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693692|NCT00504413|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92693693|NCT00504413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92693694|NCT00504413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92693695|NCT00504413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92693696|NCT00504413|Anesthetics, General|anesthetics, general|mesh-ancestor
92693697|NCT00504413|Anesthetics|anesthetics|mesh-ancestor
92693698|NCT00504413|GABA Modulators|gaba modulators|mesh-ancestor
92693699|NCT00504413|GABA Agents|gaba agents|mesh-ancestor
92693700|NCT00504413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693701|NCT00504413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693702|NCT00504413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92693703|NCT00504413|Antidepressive Agents|antidepressive agents|mesh-ancestor
92693704|NCT00504413|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92693705|NCT00504413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92693706|NCT00504413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92693707|NCT00504413|Dopamine Agents|dopamine agents|mesh-ancestor
92693708|NCT00504413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92693709|NCT00504413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92693710|NCT00504413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693711|NCT00504413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92693712|NCT00504413|Narcotics|narcotics|mesh-ancestor
92693713|NCT00504413|Analgesics|analgesics|mesh-ancestor
92693714|NCT00504413|Sensory System Agents|sensory system agents|mesh-ancestor
92693715|NCT00504413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693716|NCT00504413|Antitussive Agents|antitussive agents|mesh-ancestor
92693717|NCT00504413|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693718|NCT00504413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92693719|NCT00504413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92693720|NCT00504413|Protective Agents|protective agents|mesh-ancestor
92693722|NCT01243658|Oxytocin|oxytocin|mesh-list
92693723|NCT01243658|Oxytocics|oxytocics|mesh-ancestor
92693724|NCT01243658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92693725|NCT01243658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693726|NCT01249664|Aflibercept|aflibercept|mesh-list
92693727|NCT01249664|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92693728|NCT01249664|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92693729|NCT01249664|Growth Substances|growth substances|mesh-ancestor
92693730|NCT01249664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693731|NCT01249664|Growth Inhibitors|growth inhibitors|mesh-ancestor
92693732|NCT01249664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693733|NCT00513162|Etoposide|etoposide|mesh-list
92693734|NCT00513162|Valproic Acid|valproic acid|mesh-list
92693735|NCT00513162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92693736|NCT00513162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693737|NCT00513162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92693738|NCT00513162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92693739|NCT00513162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693740|NCT00513162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693741|NCT00513162|Anticonvulsants|anticonvulsants|mesh-ancestor
92607423|NCT00131963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607424|NCT00140400|Immunomodulating Agents|immunomodulating agents|mesh-list
92607425|NCT00140400|Immunologic Factors|immunologic factors|mesh-ancestor
92014777|NCT04340141|Immunologic Factors|immunologic factors|mesh-ancestor
92693743|NCT00513162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693759|NCT00512265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92693761|NCT00512265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693762|NCT00512265|Protective Agents|protective agents|mesh-ancestor
92693763|NCT00512265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693764|NCT00512265|Antidotes|antidotes|mesh-ancestor
92693765|NCT00513396|Isoniazid|isoniazid|mesh-list
92693766|NCT00513396|Antitubercular Agents|antitubercular agents|mesh-ancestor
92693767|NCT00513396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92693768|NCT00513396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693769|NCT00513396|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92693770|NCT00513396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92693771|NCT00513396|Antimetabolites|antimetabolites|mesh-ancestor
92693772|NCT00513396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693773|NCT00513396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92693774|NCT01249274|Progesterone|progesterone|mesh-list
92693775|NCT01249274|Progestins|progestins|mesh-ancestor
92693776|NCT01249274|Hormones|hormones|mesh-ancestor
92693777|NCT01249274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92693778|NCT01249274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693779|NCT00513513|Ritonavir|ritonavir|mesh-list
92693780|NCT00513513|Darunavir|darunavir|mesh-list
92693781|NCT00513513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92693782|NCT00513513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92693783|NCT00513513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92693784|NCT00513513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693785|NCT00513513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693786|NCT00513513|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92693787|NCT00513513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92113601|NCT04447027|Hormones|hormones|mesh-ancestor
92693788|NCT00513513|Antiviral Agents|antiviral agents|mesh-ancestor
92693789|NCT00513513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693790|NCT00513513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92693791|NCT00513513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92693792|NCT00504959|Ranibizumab|ranibizumab|mesh-list
92693793|NCT00504959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92693794|NCT00504959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92693795|NCT00504959|Growth Substances|growth substances|mesh-ancestor
92693796|NCT00504959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693797|NCT00504959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92693798|NCT00504959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693799|NCT00512616|Ceftriaxone|ceftriaxone|mesh-list
92693800|NCT00512616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92693801|NCT00512616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693802|NCT00505037|Sevelamer|sevelamer|mesh-list
92693803|NCT00505037|Chelating Agents|chelating agents|mesh-ancestor
92693818|NCT00513552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693819|NCT00513552|Leprostatic Agents|leprostatic agents|mesh-ancestor
92693820|NCT00513630|Metformin|metformin|mesh-list
92693821|NCT00513630|Glipizide|glipizide|mesh-list
92693822|NCT00513630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693823|NCT00513630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693824|NCT02275247|Ropivacaine|ropivacaine|mesh-list
92693825|NCT02275247|Anesthetics, Local|anesthetics, local|mesh-ancestor
92693826|NCT02275247|Anesthetics|anesthetics|mesh-ancestor
92693827|NCT02275247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693828|NCT02275247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693829|NCT02275247|Sensory System Agents|sensory system agents|mesh-ancestor
92693830|NCT02275247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693831|NCT04515719|Belimumab|belimumab|mesh-list
92693832|NCT04515719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693833|NCT04515719|Immunologic Factors|immunologic factors|mesh-ancestor
92693834|NCT04515719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693835|NCT00513786|Paclitaxel|paclitaxel|mesh-list
92693836|NCT00513786|Bevacizumab|bevacizumab|mesh-list
92693837|NCT00513786|Carboplatin|carboplatin|mesh-list
92693838|NCT00513786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92051190|NCT02097823|Aprepitant|aprepitant|mesh-list
92693839|NCT00513786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693840|NCT00513786|Tubulin Modulators|tubulin modulators|mesh-ancestor
92693841|NCT00513786|Antimitotic Agents|antimitotic agents|mesh-ancestor
92693842|NCT00513786|Mitosis Modulators|mitosis modulators|mesh-ancestor
92693843|NCT00513786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693844|NCT00513786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92693845|NCT00513786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92693846|NCT00513786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92693847|NCT00513786|Growth Substances|growth substances|mesh-ancestor
92693848|NCT00513786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693849|NCT00513786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92693850|NCT00504491|Rituximab|rituximab|mesh-list
92693851|NCT00504491|Alemtuzumab|alemtuzumab|mesh-list
92693852|NCT00504491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113672|NCT04235608|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92113673|NCT04235608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370889|NCT01177098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113674|NCT04235608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113675|NCT04235608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113676|NCT04235608|Anesthetics, General|anesthetics, general|mesh-ancestor
92113677|NCT04235608|Anesthetics|anesthetics|mesh-ancestor
92113678|NCT04235608|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92113679|NCT04235608|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92113680|NCT04232306|Bupivacaine|bupivacaine|mesh-list
92113681|NCT04232306|Anesthetics, Local|anesthetics, local|mesh-ancestor
92113682|NCT04232306|Anesthetics|anesthetics|mesh-ancestor
92693853|NCT00504491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693855|NCT00504491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693856|NCT00504491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693857|NCT00512811|Furosemide|furosemide|mesh-list
92693858|NCT00512811|Diuretics|diuretics|mesh-ancestor
92693859|NCT00512811|Natriuretic Agents|natriuretic agents|mesh-ancestor
92693860|NCT00512811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693861|NCT00512811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92693862|NCT00512811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92693863|NCT00512811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693864|NCT00513864|Morphine|morphine|mesh-list
92693865|NCT00513864|Codeine|codeine|mesh-list
92693866|NCT00513864|Dextromethorphan|dextromethorphan|mesh-list
92693867|NCT00513864|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92693868|NCT00513864|Narcotics|narcotics|mesh-ancestor
92693869|NCT00513864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693870|NCT00513864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693871|NCT00513864|Analgesics|analgesics|mesh-ancestor
92693872|NCT00513864|Sensory System Agents|sensory system agents|mesh-ancestor
92693873|NCT00513864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693874|NCT00513864|Antitussive Agents|antitussive agents|mesh-ancestor
92693875|NCT00513864|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693876|NCT00513864|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92693877|NCT00513864|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92693878|NCT00513864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693879|NCT00513864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693880|NCT01248884|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92693881|NCT01248884|Immunologic Factors|immunologic factors|mesh-ancestor
92693882|NCT01248884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693883|NCT00512850|Folic Acid|folic acid|mesh-list
92693884|NCT00512850|Hematinics|hematinics|mesh-ancestor
92693885|NCT00512850|Vitamin B Complex|vitamin b complex|mesh-ancestor
92693886|NCT00512850|Vitamins|vitamins|mesh-ancestor
92693887|NCT00512850|Micronutrients|micronutrients|mesh-ancestor
92693888|NCT00512850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693889|NCT00512928|Vitamin K 2|vitamin k 2|mesh-list
92693890|NCT00512928|Vitamin K|vitamin k|mesh-list
92693891|NCT00512928|Acenocoumarol|acenocoumarol|mesh-list
92693892|NCT00512928|Menaquinone 7|menaquinone 7|mesh-list
92693893|NCT00512928|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92693894|NCT00512928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92693895|NCT00512928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693896|NCT00512928|Hemostatics|hemostatics|mesh-ancestor
92693897|NCT00512928|Coagulants|coagulants|mesh-ancestor
92693898|NCT00512928|Vitamins|vitamins|mesh-ancestor
92693899|NCT00512928|Micronutrients|micronutrients|mesh-ancestor
92693900|NCT00512928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693901|NCT00512928|Anticoagulants|anticoagulants|mesh-ancestor
92693902|NCT00505154|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92607426|NCT00140400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607427|NCT00132119|Nalmefene|nalmefene|mesh-list
92607428|NCT00132119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92051267|NCT02187809|Clobazam|clobazam|mesh-list
92693903|NCT00505154|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92693904|NCT00505154|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92693905|NCT00505154|Antimetabolites|antimetabolites|mesh-ancestor
92693906|NCT00505154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693907|NCT00505154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92693908|NCT00505154|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92693909|NCT00505154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693910|NCT01246973|Curcumin|curcumin|mesh-list
92693911|NCT01246973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92693912|NCT01246973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92693913|NCT01246973|Analgesics|analgesics|mesh-ancestor
92693914|NCT01246973|Sensory System Agents|sensory system agents|mesh-ancestor
92693915|NCT01246973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693916|NCT01246973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693917|NCT01246973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693918|NCT01246973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693919|NCT01246973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693920|NCT01246973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693921|NCT01246973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693922|NCT00514605|Antibodies|antibodies|mesh-list
92693923|NCT00514605|Immunoglobulins|immunoglobulins|mesh-list
92693924|NCT00514605|Immunologic Factors|immunologic factors|mesh-ancestor
92693925|NCT00514605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113751|NCT03936777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92113752|NCT03936777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92693928|NCT00513981|Calcium|calcium|mesh-list
92693929|NCT00513981|Levoleucovorin|levoleucovorin|mesh-list
92693930|NCT00513981|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92693931|NCT00513981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693932|NCT00513981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92693933|NCT00513981|Abortifacient Agents|abortifacient agents|mesh-ancestor
92693934|NCT00513981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92693935|NCT00513981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92693936|NCT00513981|Antimetabolites|antimetabolites|mesh-ancestor
92693937|NCT00513981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693938|NCT00513981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693939|NCT00513981|Dermatologic Agents|dermatologic agents|mesh-ancestor
92693940|NCT00513981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693941|NCT00513981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92693942|NCT00513981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693943|NCT00513981|Immunologic Factors|immunologic factors|mesh-ancestor
92693944|NCT00513981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693945|NCT00513981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92693946|NCT00513981|Antidotes|antidotes|mesh-ancestor
92693947|NCT00513981|Protective Agents|protective agents|mesh-ancestor
92693948|NCT00513981|Vitamin B Complex|vitamin b complex|mesh-ancestor
92693949|NCT00513981|Vitamins|vitamins|mesh-ancestor
92693950|NCT00513981|Micronutrients|micronutrients|mesh-ancestor
92693951|NCT00505232|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92693952|NCT00505232|Immunologic Factors|immunologic factors|mesh-ancestor
92693953|NCT00505232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693954|NCT00514761|Capecitabine|capecitabine|mesh-list
92693955|NCT00514761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92693956|NCT00514761|Antimetabolites|antimetabolites|mesh-ancestor
92693957|NCT00514761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693958|NCT00514761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693959|NCT04695600|Botulinum Toxins|botulinum toxins|mesh-list
92693960|NCT04695600|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92693961|NCT04695600|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92693962|NCT04695600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92693963|NCT04695600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92693964|NCT04695600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693965|NCT04695600|Cholinergic Agents|cholinergic agents|mesh-ancestor
92693966|NCT04695600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693967|NCT04695600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693968|NCT04695600|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92607429|NCT00132119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607430|NCT00132119|Sensory System Agents|sensory system agents|mesh-ancestor
92607431|NCT00132119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693969|NCT04695600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693970|NCT01245140|Alitretinoin|alitretinoin|mesh-list
92693971|NCT01245140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693972|NCT01245140|Dermatologic Agents|dermatologic agents|mesh-ancestor
92693973|NCT02951637|Carboplatin|carboplatin|mesh-list
92693974|NCT02951637|Pemetrexed|pemetrexed|mesh-list
92693975|NCT02951637|Gefitinib|gefitinib|mesh-list
92693976|NCT02951637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693977|NCT02951637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693978|NCT02951637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693979|NCT02951637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92693980|NCT02951637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92693981|NCT02951637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693982|NCT01245101|Raltegravir Potassium|raltegravir potassium|mesh-list
92693983|NCT01245101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92693984|NCT01245101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92693985|NCT01245101|Antiviral Agents|antiviral agents|mesh-ancestor
92693986|NCT01245101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693987|NCT01245101|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92693988|NCT01245101|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92693989|NCT01245101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693990|NCT01245101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693991|NCT01245062|Trametinib|trametinib|mesh-list
92693992|NCT01245062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693993|NCT01245062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693994|NCT01245062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693995|NCT01245062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370935|NCT01188876|Folic Acid|folic acid|mesh-list
92694006|NCT01244984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92694007|NCT04695483|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92694008|NCT04695483|Hormones|hormones|mesh-ancestor
92694009|NCT04695483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92694010|NCT04695483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694011|NCT01244126|Fentanyl|fentanyl|mesh-list
92694012|NCT01244126|Morphine|morphine|mesh-list
92694013|NCT01244126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92694014|NCT01244126|Narcotics|narcotics|mesh-ancestor
92694015|NCT01244126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694016|NCT01244126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694017|NCT01244126|Analgesics|analgesics|mesh-ancestor
92694018|NCT01244126|Sensory System Agents|sensory system agents|mesh-ancestor
92694019|NCT01244126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694020|NCT01244126|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92694021|NCT01244126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92694022|NCT01244126|Anesthetics, General|anesthetics, general|mesh-ancestor
92694023|NCT01244126|Anesthetics|anesthetics|mesh-ancestor
92694024|NCT01243775|Docetaxel|docetaxel|mesh-list
92694025|NCT01243775|Oxaliplatin|oxaliplatin|mesh-list
92694026|NCT01243775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694027|NCT01243775|Tubulin Modulators|tubulin modulators|mesh-ancestor
92694028|NCT01243775|Antimitotic Agents|antimitotic agents|mesh-ancestor
92694029|NCT01243775|Mitosis Modulators|mitosis modulators|mesh-ancestor
92694030|NCT01243775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694031|NCT00514293|Carboplatin|carboplatin|mesh-list
92694032|NCT00514293|Docetaxel|docetaxel|mesh-list
92694033|NCT00514293|Capecitabine|capecitabine|mesh-list
92694034|NCT00514293|Tretinoin|tretinoin|mesh-list
92694035|NCT00514293|Bexarotene|bexarotene|mesh-list
92694036|NCT00514293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694037|NCT00514293|Tubulin Modulators|tubulin modulators|mesh-ancestor
92694038|NCT00514293|Antimitotic Agents|antimitotic agents|mesh-ancestor
92694039|NCT00514293|Mitosis Modulators|mitosis modulators|mesh-ancestor
92694040|NCT00514293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694041|NCT00514293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694042|NCT00514293|Antimetabolites|antimetabolites|mesh-ancestor
92694043|NCT00514293|Keratolytic Agents|keratolytic agents|mesh-ancestor
92694044|NCT00514293|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694045|NCT02955641|Dexamethasone|dexamethasone|mesh-list
92694046|NCT02955641|Nepafenac|nepafenac|mesh-list
92694047|NCT02955641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92694048|NCT02955641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92694049|NCT02955641|Antiemetics|antiemetics|mesh-ancestor
92694050|NCT02955641|Autonomic Agents|autonomic agents|mesh-ancestor
92607432|NCT00132158|Irinotecan|irinotecan|mesh-list
92607433|NCT00132158|Gefitinib|gefitinib|mesh-list
92607434|NCT00132158|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92694051|NCT02955641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694052|NCT02955641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694053|NCT02955641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92694054|NCT02955641|Glucocorticoids|glucocorticoids|mesh-ancestor
92694055|NCT02955641|Hormones|hormones|mesh-ancestor
92694056|NCT02955641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92694057|NCT02955641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92694058|NCT02955641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694059|NCT02955641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92694060|NCT02955641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92694061|NCT02955641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92694062|NCT02955641|Analgesics|analgesics|mesh-ancestor
92694063|NCT02955641|Sensory System Agents|sensory system agents|mesh-ancestor
92694074|NCT00514995|Anesthetics|anesthetics|mesh-ancestor
92694075|NCT00514995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113898|NCT03164447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92694076|NCT00514995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694077|NCT01242176|Empagliflozin|empagliflozin|mesh-list
92694078|NCT01242176|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92694079|NCT01242176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694080|NCT01242176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694081|NCT01242176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694084|NCT00515151|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92694085|NCT00515151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694086|NCT00515151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694087|NCT00515151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694088|NCT01241786|Lenalidomide|lenalidomide|mesh-list
92694089|NCT01241786|Azacitidine|azacitidine|mesh-list
92694090|NCT01241786|Immunologic Factors|immunologic factors|mesh-ancestor
92694091|NCT01241786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694092|NCT01241786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92694093|NCT01241786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92694094|NCT01241786|Growth Substances|growth substances|mesh-ancestor
92694095|NCT01241786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92694096|NCT01241786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694097|NCT01241786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694098|NCT01241786|Antimetabolites|antimetabolites|mesh-ancestor
92694099|NCT01241786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694100|NCT01241786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694101|NCT00514410|Folic Acid|folic acid|mesh-list
92694102|NCT00514410|Hematinics|hematinics|mesh-ancestor
92694103|NCT00514410|Vitamin B Complex|vitamin b complex|mesh-ancestor
92694104|NCT00514410|Vitamins|vitamins|mesh-ancestor
92694105|NCT00514410|Micronutrients|micronutrients|mesh-ancestor
92694106|NCT00514410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694107|NCT01241318|Chlorhexidine|chlorhexidine|mesh-list
92694108|NCT01241318|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92694109|NCT01241318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92694110|NCT01241318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694111|NCT01241318|Disinfectants|disinfectants|mesh-ancestor
92694112|NCT01241318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694113|NCT00514488|Imatinib Mesylate|imatinib mesylate|mesh-list
92694114|NCT00514488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694115|NCT00514488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92694116|NCT00514488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694117|NCT00514488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694118|NCT00514527|Oritavancin|oritavancin|mesh-list
92694119|NCT00514527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694120|NCT00514527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694121|NCT01241240|Timolol|timolol|mesh-list
92694122|NCT01241240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92694123|NCT01241240|Bimatoprost|bimatoprost|mesh-list
92694124|NCT01241240|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92694125|NCT01241240|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92694126|NCT01241240|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92694137|NCT02950623|Titanium dioxide|titanium dioxide|mesh-list
92694138|NCT02950623|Sunscreening Agents|sunscreening agents|mesh-ancestor
92694139|NCT02950623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92694140|NCT02950623|Protective Agents|protective agents|mesh-ancestor
92694141|NCT02950623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694142|NCT02950623|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694143|NCT02950623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92694145|NCT00516009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92694146|NCT00516009|Antiemetics|antiemetics|mesh-ancestor
92694147|NCT00516009|Autonomic Agents|autonomic agents|mesh-ancestor
92694148|NCT00516009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694149|NCT00516009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694150|NCT00516009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92694151|NCT00516009|Glucocorticoids|glucocorticoids|mesh-ancestor
92694152|NCT00516009|Hormones|hormones|mesh-ancestor
92694153|NCT00516009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113976|NCT01126957|Anesthetics|anesthetics|mesh-ancestor
92694154|NCT00516009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92694155|NCT00516009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694156|NCT02950584|Titanium dioxide|titanium dioxide|mesh-list
92694157|NCT02950584|Sunscreening Agents|sunscreening agents|mesh-ancestor
92694158|NCT02950584|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92694159|NCT02950584|Protective Agents|protective agents|mesh-ancestor
92694160|NCT02950584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694161|NCT02950584|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694162|NCT02950584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92694164|NCT01240811|Levonorgestrel|levonorgestrel|mesh-list
92694165|NCT01240811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92694166|NCT01240811|Contraceptive Agents|contraceptive agents|mesh-ancestor
92694167|NCT01240811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694168|NCT01240811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694169|NCT01240811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92694170|NCT01240811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92694171|NCT01240811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92694172|NCT01240811|Trace Elements|trace elements|mesh-ancestor
92694173|NCT01240811|Micronutrients|micronutrients|mesh-ancestor
92694174|NCT03459144|Ranibizumab|ranibizumab|mesh-list
92694175|NCT03459144|Verteporfin|verteporfin|mesh-list
92694176|NCT03459144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92694177|NCT03459144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92694178|NCT03459144|Growth Substances|growth substances|mesh-ancestor
92694179|NCT03459144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694180|NCT03459144|Growth Inhibitors|growth inhibitors|mesh-ancestor
92694181|NCT03459144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694182|NCT03459144|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92694183|NCT03459144|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694184|NCT03459105|Bupivacaine|bupivacaine|mesh-list
92694185|NCT03459105|Anesthetics|anesthetics|mesh-list
92694186|NCT03459105|Anesthetics, Local|anesthetics, local|mesh-ancestor
92694187|NCT03459105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694188|NCT03459105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694189|NCT03459105|Sensory System Agents|sensory system agents|mesh-ancestor
92694190|NCT03459105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694192|NCT01240382|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92694193|NCT01240382|Hyaluronic Acid|hyaluronic acid|mesh-list
92694194|NCT01240382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92694195|NCT01240382|Immunologic Factors|immunologic factors|mesh-ancestor
92694196|NCT01240382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694197|NCT01240382|Viscosupplements|viscosupplements|mesh-ancestor
92694198|NCT01240382|Protective Agents|protective agents|mesh-ancestor
92694199|NCT01244828|Asenapine|asenapine|mesh-list
92694200|NCT01244828|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92694201|NCT01244828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92694202|NCT01244828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694203|NCT01244828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694204|NCT01244828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92694205|NCT00504192|Gemcitabine|gemcitabine|mesh-list
92694206|NCT00504192|Oxaliplatin|oxaliplatin|mesh-list
92694207|NCT00504192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694208|NCT00504192|Antimetabolites|antimetabolites|mesh-ancestor
92694209|NCT00504192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694210|NCT00504192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694211|NCT01243346|Crenolanib|crenolanib|mesh-list
92694212|NCT01243346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694213|NCT01249443|Paclitaxel|paclitaxel|mesh-list
92694214|NCT01249443|Carboplatin|carboplatin|mesh-list
92694215|NCT01249443|Vorinostat|vorinostat|mesh-list
92694216|NCT01249443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92694217|NCT01249443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694218|NCT01249443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92607435|NCT00132158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607436|NCT00132158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607437|NCT00132158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694219|NCT01249443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92694220|NCT01249443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92694221|NCT01249443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694222|NCT01249443|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92694223|NCT01249443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694224|NCT01243073|Imetelstat|imetelstat|mesh-list
92694225|NCT01243073|Motesanib diphosphate|motesanib diphosphate|mesh-list
92694226|NCT01243073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694227|NCT01243073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694228|NCT01243073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114053|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
92694229|NCT00516243|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92694231|NCT00516243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694232|NCT00516243|Protective Agents|protective agents|mesh-ancestor
92694233|NCT00516243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694234|NCT00516243|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92694235|NCT00516243|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92694236|NCT00516243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694237|NCT00516243|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92694238|NCT01240889|Fluticasone|fluticasone|mesh-list
92694239|NCT01240889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92694240|NCT01240889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92694241|NCT01240889|Autonomic Agents|autonomic agents|mesh-ancestor
92694242|NCT01240889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694243|NCT01240889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694244|NCT01240889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92694245|NCT01240889|Respiratory System Agents|respiratory system agents|mesh-ancestor
92694246|NCT01240889|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694247|NCT01240889|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92694248|NCT00516282|Temozolomide|temozolomide|mesh-list
92694249|NCT00516282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92694250|NCT00516282|Alkylating Agents|alkylating agents|mesh-ancestor
92694251|NCT00516282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694252|NCT00516282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694253|NCT01249521|Bevacizumab|bevacizumab|mesh-list
92694254|NCT01249521|Trebananib|trebananib|mesh-list
92694255|NCT01249521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694256|NCT01249521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694257|NCT01249521|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92694258|NCT01249521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92694259|NCT01249521|Growth Substances|growth substances|mesh-ancestor
92694260|NCT01249521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694261|NCT01249521|Growth Inhibitors|growth inhibitors|mesh-ancestor
92694262|NCT01249677|Insulin Glargine|insulin glargine|mesh-list
92694263|NCT01249677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694264|NCT01249677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694265|NCT04511975|Azacitidine|azacitidine|mesh-list
92694279|NCT04519463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694280|NCT04519463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92694281|NCT04519463|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92694282|NCT04519463|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92694283|NCT04519463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694284|NCT04519463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694285|NCT04696848|Durvalumab|durvalumab|mesh-list
92694286|NCT04696848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694287|NCT04696848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694288|NCT01244256|Gentamicins|gentamicins|mesh-list
92694289|NCT01244256|Clotrimazole|clotrimazole|mesh-list
92694290|NCT01244256|Miconazole|miconazole|mesh-list
92694291|NCT01244256|Beclomethasone|beclomethasone|mesh-list
92694292|NCT01244256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694293|NCT01244256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694294|NCT01244256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92694295|NCT01244256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694296|NCT01244256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694297|NCT01244256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92694298|NCT01244256|Glucocorticoids|glucocorticoids|mesh-ancestor
92694299|NCT01244256|Hormones|hormones|mesh-ancestor
92607438|NCT00132158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607439|NCT00132158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92332442|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92694300|NCT01244256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92694301|NCT01244256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694302|NCT01244256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92694303|NCT01244256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92694304|NCT01244256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92694305|NCT01244256|Antifungal Agents|antifungal agents|mesh-ancestor
92694306|NCT01244256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92694307|NCT01244256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92694308|NCT01244256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92694309|NCT01244256|Hormone Antagonists|hormone antagonists|mesh-ancestor
92694310|NCT01244256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92694311|NCT01244256|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92694312|NCT01249833|Oseltamivir|oseltamivir|mesh-list
92694313|NCT01249833|Antiviral Agents|antiviral agents|mesh-ancestor
92694314|NCT01249833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694315|NCT01249833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694316|NCT01249833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694317|NCT02950233|N-Methylaspartate|n-methylaspartate|mesh-list
92694318|NCT02950233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92694319|NCT02950233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92694320|NCT02950233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694321|NCT02950233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694322|NCT02950233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694323|NCT01249404|Botulinum Toxins|botulinum toxins|mesh-list
92694324|NCT01249404|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92694325|NCT01249404|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92694334|NCT04511000|Atorvastatin|atorvastatin|mesh-list
92694335|NCT04511000|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92694336|NCT04511000|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92694337|NCT04511000|Antimetabolites|antimetabolites|mesh-ancestor
92694338|NCT04511000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694339|NCT04511000|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92694340|NCT04511000|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92694341|NCT04511000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694342|NCT04519385|Dexamethasone|dexamethasone|mesh-list
92694343|NCT04519385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92694344|NCT04519385|Antiemetics|antiemetics|mesh-ancestor
92694345|NCT04519385|Autonomic Agents|autonomic agents|mesh-ancestor
92694346|NCT04519385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694347|NCT04519385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694348|NCT04519385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92694349|NCT04519385|Glucocorticoids|glucocorticoids|mesh-ancestor
92694350|NCT04519385|Hormones|hormones|mesh-ancestor
92694351|NCT04519385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92694352|NCT04519385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92694353|NCT04519385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694354|NCT00506051|Pemetrexed|pemetrexed|mesh-list
92694355|NCT00506051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694356|NCT00506051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694357|NCT00506051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694358|NCT00506051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92694359|NCT00506051|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694360|NCT00504465|Dinoprostone|dinoprostone|mesh-list
92694361|NCT00504465|Oxytocics|oxytocics|mesh-ancestor
92694362|NCT00504465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694363|NCT00504465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694364|NCT00516360|Chlorhexidine|chlorhexidine|mesh-list
92694365|NCT00516360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92694366|NCT00516360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694367|NCT00516360|Disinfectants|disinfectants|mesh-ancestor
92694368|NCT04510649|Rifampin|rifampin|mesh-list
92694369|NCT04510649|Rabeprazole|rabeprazole|mesh-list
92694370|NCT04510649|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92694371|NCT04510649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92694372|NCT04510649|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92694373|NCT04510649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694374|NCT04510649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607440|NCT00140478|Mifepristone|mifepristone|mesh-list
92607441|NCT00140478|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92607442|NCT00140478|Abortifacient Agents|abortifacient agents|mesh-ancestor
92607443|NCT00140478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92014793|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
92694375|NCT04510649|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92694376|NCT04510649|Antitubercular Agents|antitubercular agents|mesh-ancestor
92694377|NCT04510649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694378|NCT04510649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694379|NCT04510649|Leprostatic Agents|leprostatic agents|mesh-ancestor
92694380|NCT04510649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694381|NCT04510649|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92694382|NCT04510649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92694383|NCT04510649|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92694384|NCT04510649|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92694385|NCT04510649|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92694386|NCT04510649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92694387|NCT01249092|Pentoxifylline|pentoxifylline|mesh-list
92694388|NCT01249092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92694389|NCT01249092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694393|NCT01249092|Protective Agents|protective agents|mesh-ancestor
92694394|NCT01249092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694395|NCT01249092|Vasodilator Agents|vasodilator agents|mesh-ancestor
92694396|NCT01249092|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92694397|NCT01249092|Antioxidants|antioxidants|mesh-ancestor
92694398|NCT02275182|Dexmedetomidine|dexmedetomidine|mesh-list
92694399|NCT02275182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92694400|NCT02275182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694401|NCT02275182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694402|NCT02275182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92694403|NCT02275182|Analgesics|analgesics|mesh-ancestor
92694404|NCT02275182|Sensory System Agents|sensory system agents|mesh-ancestor
92694405|NCT02275182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694406|NCT02275182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92694407|NCT02275182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92694408|NCT02275182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92694409|NCT02275182|Adrenergic Agents|adrenergic agents|mesh-ancestor
92694410|NCT02275182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694411|NCT02275182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694412|NCT01248780|Golimumab|golimumab|mesh-list
92694413|NCT01248780|Methotrexate|methotrexate|mesh-list
92694414|NCT01248780|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92694415|NCT01248780|Abortifacient Agents|abortifacient agents|mesh-ancestor
92694416|NCT01248780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694417|NCT01248780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694418|NCT01248780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694419|NCT01248780|Antimetabolites|antimetabolites|mesh-ancestor
92694420|NCT01248780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694421|NCT01248780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694422|NCT01248780|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694423|NCT01248780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694424|NCT01248780|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92694425|NCT01248780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694426|NCT01248780|Immunologic Factors|immunologic factors|mesh-ancestor
92694427|NCT01248780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694428|NCT01248780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694429|NCT01248780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92694430|NCT01248780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92694431|NCT01248468|Aspirin|aspirin|mesh-list
92694432|NCT01248468|Acetaminophen|acetaminophen|mesh-list
92694433|NCT01248468|Sumatriptan|sumatriptan|mesh-list
92694434|NCT01248468|Caffeine|caffeine|mesh-list
92694435|NCT01248468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92694436|NCT01248468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92694437|NCT01248468|Analgesics|analgesics|mesh-ancestor
92694438|NCT01248468|Sensory System Agents|sensory system agents|mesh-ancestor
92694439|NCT01248468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694440|NCT01248468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694441|NCT01248468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607444|NCT00140478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607445|NCT00140478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92607446|NCT00140478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92607447|NCT00140478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92607448|NCT00140478|Contraceptive Agents|contraceptive agents|mesh-ancestor
92694442|NCT01248468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694443|NCT01248468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92694444|NCT01248468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92694445|NCT01248468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694446|NCT01248468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92694447|NCT01248468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92694448|NCT01248468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694449|NCT01248468|Antipyretics|antipyretics|mesh-ancestor
92694450|NCT01248468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92694452|NCT01248468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92694453|NCT01248468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92694454|NCT01248468|Purinergic Agents|purinergic agents|mesh-ancestor
92694455|NCT01248468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694456|NCT01248468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92694457|NCT01248468|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92694458|NCT01248468|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92694459|NCT01248468|Serotonin Agents|serotonin agents|mesh-ancestor
92694460|NCT02275299|Methotrexate|methotrexate|mesh-list
92694475|NCT02275299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694476|NCT02275299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694477|NCT01247922|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92694478|NCT01247922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694479|NCT01247922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92694480|NCT01247922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694481|NCT01247922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694483|NCT01246206|Thymoglobulin|thymoglobulin|mesh-list
92694484|NCT01246206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694485|NCT01246206|Immunologic Factors|immunologic factors|mesh-ancestor
92694486|NCT01246206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694487|NCT01246206|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92694488|NCT01246206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694489|NCT01246206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694490|NCT04510610|Decitabine|decitabine|mesh-list
92694491|NCT04510610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694492|NCT04510610|Antimetabolites|antimetabolites|mesh-ancestor
92694493|NCT04510610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694494|NCT04510610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694495|NCT04510610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694496|NCT01246011|Warfarin|warfarin|mesh-list
92694497|NCT01246011|Argatroban|argatroban|mesh-list
92694498|NCT01246011|Anticoagulants|anticoagulants|mesh-ancestor
92694499|NCT01246011|Antithrombins|antithrombins|mesh-ancestor
92694500|NCT01246011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92694501|NCT01246011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92694502|NCT01246011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694503|NCT01246011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694504|NCT01246011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92694505|NCT01244490|Guanfacine|guanfacine|mesh-list
92694506|NCT01244490|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92694507|NCT01244490|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92694508|NCT01244490|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92003330|NCT03160079|Blinatumomab|blinatumomab|mesh-list
92694509|NCT01244490|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694510|NCT01244490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694511|NCT01244490|Adrenergic Agents|adrenergic agents|mesh-ancestor
92694512|NCT01244490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694513|NCT01244490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694514|NCT01244490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92694515|NCT01244490|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92694516|NCT01244490|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92694517|NCT01244490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92694518|NCT01243944|Lenalidomide|lenalidomide|mesh-list
92694519|NCT01243944|Pomalidomide|pomalidomide|mesh-list
92694523|NCT01243944|Immunologic Factors|immunologic factors|mesh-ancestor
92607449|NCT00140478|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92607450|NCT00140478|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92607451|NCT00140478|Hormone Antagonists|hormone antagonists|mesh-ancestor
92607452|NCT00140478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607453|NCT00140478|Luteolytic Agents|luteolytic agents|mesh-ancestor
92051874|NCT01627067|Metformin|metformin|mesh-list
92694524|NCT01243944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694525|NCT01243944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92694526|NCT01243944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92694527|NCT01243944|Growth Substances|growth substances|mesh-ancestor
92694528|NCT01243944|Growth Inhibitors|growth inhibitors|mesh-ancestor
92694529|NCT01243944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694530|NCT01243944|Antisickling Agents|antisickling agents|mesh-ancestor
92694531|NCT01243944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694532|NCT01243944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694533|NCT01243944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694534|NCT01243944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92694535|NCT01243944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92694536|NCT01243944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92694537|NCT01243944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92694538|NCT01243944|Alkylating Agents|alkylating agents|mesh-ancestor
92694539|NCT00516399|Povidone-Iodine|povidone-iodine|mesh-list
92694541|NCT00516399|Povidone|povidone|mesh-list
92694542|NCT00516399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92694543|NCT00516399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92694544|NCT00516399|Plasma Substitutes|plasma substitutes|mesh-ancestor
92694545|NCT00516399|Blood Substitutes|blood substitutes|mesh-ancestor
92694546|NCT00516399|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92694547|NCT00516399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694548|NCT00516399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694549|NCT00516399|Antifungal Agents|antifungal agents|mesh-ancestor
92694550|NCT00516438|Topotecan|topotecan|mesh-list
92694551|NCT00516438|Olaparib|olaparib|mesh-list
92694552|NCT00516438|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92694553|NCT00516438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92694554|NCT00516438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92694555|NCT00516438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694556|NCT00516438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694557|NCT00516438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694558|NCT02275988|Clarithromycin|clarithromycin|mesh-list
92694559|NCT02275988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694560|NCT02275988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694561|NCT02275988|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92694562|NCT02275988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694563|NCT02275988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694564|NCT02275988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92694565|NCT02275988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92694566|NCT02950155|Rituximab|rituximab|mesh-list
92694567|NCT02950155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694568|NCT02950155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694569|NCT02950155|Immunologic Factors|immunologic factors|mesh-ancestor
92694570|NCT02950155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694571|NCT02950155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694572|NCT00516672|Lapatinib|lapatinib|mesh-list
92694573|NCT00516672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694574|NCT00516672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92694575|NCT00516672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694576|NCT00516672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694577|NCT00516711|Sevoflurane|sevoflurane|mesh-list
92694578|NCT00516711|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92694579|NCT00516711|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92694580|NCT00516711|Anesthetics, General|anesthetics, general|mesh-ancestor
92694581|NCT00516711|Anesthetics|anesthetics|mesh-ancestor
92694582|NCT00516711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694583|NCT00516711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694584|NCT00516750|Doxorubicin|doxorubicin|mesh-list
92694585|NCT00516750|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92607454|NCT00140478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92607455|NCT00140478|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92607457|NCT00140517|Pyrimethamine|pyrimethamine|mesh-list
92607458|NCT00140517|Sulfadoxine|sulfadoxine|mesh-list
92607459|NCT00140517|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92607460|NCT00140517|Amebicides|amebicides|mesh-ancestor
92694586|NCT00516750|Methotrexate|methotrexate|mesh-list
92694587|NCT00516750|Vinblastine|vinblastine|mesh-list
92694588|NCT00516750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694589|NCT00516750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92694590|NCT00516750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92694591|NCT00516750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92694592|NCT00516750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694593|NCT00516750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694596|NCT00516750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694597|NCT00516750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694598|NCT00516750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694600|NCT00516750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694601|NCT00516750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92694602|NCT00516750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694603|NCT00516750|Immunologic Factors|immunologic factors|mesh-ancestor
92694604|NCT00516750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694605|NCT00516750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694606|NCT00516750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92694607|NCT00516750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92694608|NCT00516750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92694609|NCT00516750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92694610|NCT00505427|Thioctic Acid|thioctic acid|mesh-list
92694611|NCT00505427|Antioxidants|antioxidants|mesh-ancestor
92694612|NCT00505427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694613|NCT00505427|Protective Agents|protective agents|mesh-ancestor
92694614|NCT00505427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694615|NCT00505427|Vitamin B Complex|vitamin b complex|mesh-ancestor
92694616|NCT00505427|Vitamins|vitamins|mesh-ancestor
92694617|NCT00505427|Micronutrients|micronutrients|mesh-ancestor
92694618|NCT00506168|Capecitabine|capecitabine|mesh-list
92694619|NCT00506168|Irinotecan|irinotecan|mesh-list
92694620|NCT00506168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694621|NCT00506168|Antimetabolites|antimetabolites|mesh-ancestor
92694622|NCT00506168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694623|NCT00506168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694624|NCT00506168|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92694625|NCT00506168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92694626|NCT00506168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694627|NCT02950038|Nivolumab|nivolumab|mesh-list
92694628|NCT02950038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694629|NCT02950038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694630|NCT02950038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92694631|NCT02950038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694632|NCT04510220|Ofatumumab|ofatumumab|mesh-list
92694633|NCT04510220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694634|NCT02949648|Nicotine|nicotine|mesh-list
92694635|NCT02949648|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92694636|NCT02949648|Autonomic Agents|autonomic agents|mesh-ancestor
92694637|NCT02949648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694638|NCT02949648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694639|NCT02949648|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92694640|NCT02949648|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92694641|NCT02949648|Cholinergic Agents|cholinergic agents|mesh-ancestor
92694642|NCT02949648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694643|NCT02949648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694644|NCT04510337|Magnesium Sulfate|magnesium sulfate|mesh-list
92694645|NCT04510337|Rocuronium|rocuronium|mesh-list
92694646|NCT04510337|Analgesics|analgesics|mesh-ancestor
92694647|NCT04510337|Sensory System Agents|sensory system agents|mesh-ancestor
92694648|NCT04510337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694649|NCT04510337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694650|NCT04510337|Anesthetics|anesthetics|mesh-ancestor
92694651|NCT04510337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607461|NCT00140517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92607462|NCT00140517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92051980|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92694652|NCT04510337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92694653|NCT04510337|Anticonvulsants|anticonvulsants|mesh-ancestor
92694654|NCT04510337|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92694655|NCT04510337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694656|NCT04510337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694657|NCT04510337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92694658|NCT04510337|Tocolytic Agents|tocolytic agents|mesh-ancestor
92694659|NCT04510337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694660|NCT04510337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92694661|NCT04510337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92694662|NCT04510337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92694663|NCT00516828|Cytarabine|cytarabine|mesh-list
92694664|NCT00516828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694665|NCT00516828|Antimetabolites|antimetabolites|mesh-ancestor
92694686|NCT00516945|Antiviral Agents|antiviral agents|mesh-ancestor
92694687|NCT00516945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694688|NCT00516945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92694689|NCT00516945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92694690|NCT02275598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92694691|NCT02275598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694692|NCT02275598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694693|NCT02275598|Immunotoxins|immunotoxins|mesh-ancestor
92694694|NCT02275598|Immunoconjugates|immunoconjugates|mesh-ancestor
92694695|NCT02275598|Immunologic Factors|immunologic factors|mesh-ancestor
92694696|NCT02275598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694697|NCT00517062|Hormones|hormones|mesh-list
92694698|NCT00517062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92694699|NCT00517062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694700|NCT00517179|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92694701|NCT00517179|Vasodilator Agents|vasodilator agents|mesh-ancestor
92694702|NCT00517179|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92694703|NCT00517179|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92694704|NCT00517179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371053|NCT01215786|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92694705|NCT00517179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694706|NCT00517179|Urological Agents|urological agents|mesh-ancestor
92694707|NCT00517218|Oblimersen|oblimersen|mesh-list
92694708|NCT00517218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694709|NCT00506207|Oxaliplatin|oxaliplatin|mesh-list
92694710|NCT00506207|Irinotecan|irinotecan|mesh-list
92694711|NCT00506207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694712|NCT00506207|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92694713|NCT00506207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92694714|NCT00506207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694715|NCT00506207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694716|NCT00517257|Atorvastatin|atorvastatin|mesh-list
92694717|NCT00517257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92694718|NCT00517257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92694719|NCT00517257|Antimetabolites|antimetabolites|mesh-ancestor
92694722|NCT00517257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92694723|NCT00517257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694724|NCT00506246|Propofol|propofol|mesh-list
92694725|NCT00506246|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92694726|NCT00506246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694727|NCT00506246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694728|NCT00506246|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92694729|NCT00506246|Anesthetics, General|anesthetics, general|mesh-ancestor
92694730|NCT00506246|Anesthetics|anesthetics|mesh-ancestor
92694731|NCT01243242|Metadoxine|metadoxine|mesh-list
92694732|NCT01243242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92694733|NCT00517491|Lanreotide|lanreotide|mesh-list
92694734|NCT00517491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694735|NCT04517201|Insulin|insulin|mesh-list
92694736|NCT04517201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92694737|NCT04517201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694738|NCT04517201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694739|NCT01241292|Elotuzumab|elotuzumab|mesh-list
92694740|NCT01241292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694741|NCT00517725|Carvedilol|carvedilol|mesh-list
92694742|NCT00517725|Nebivolol|nebivolol|mesh-list
92694743|NCT00517725|Bisoprolol|bisoprolol|mesh-list
92607463|NCT00140517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607464|NCT00140517|Antimalarials|antimalarials|mesh-ancestor
92694744|NCT00517725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92694745|NCT00517725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92694746|NCT00517725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92694747|NCT00517725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694748|NCT00517725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694749|NCT00517725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694750|NCT00517725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92694752|NCT00517725|Protective Agents|protective agents|mesh-ancestor
92694753|NCT00517725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92694754|NCT00517725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694755|NCT00517725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92694756|NCT00517725|Vasodilator Agents|vasodilator agents|mesh-ancestor
92694757|NCT00517725|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92371077|NCT01216410|Mydriatics|mydriatics|mesh-ancestor
92694758|NCT00517725|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92694759|NCT00517725|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92694760|NCT00517725|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92694761|NCT00517725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92694762|NCT00517725|Sympatholytics|sympatholytics|mesh-ancestor
92694763|NCT00517725|Autonomic Agents|autonomic agents|mesh-ancestor
92694764|NCT00517725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694765|NCT00517725|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92694766|NCT01240863|Hydrocodone|hydrocodone|mesh-list
92694767|NCT01240863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92694768|NCT01240863|Narcotics|narcotics|mesh-ancestor
92694769|NCT01240863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694770|NCT01240863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694771|NCT01240863|Analgesics|analgesics|mesh-ancestor
92694772|NCT01240863|Sensory System Agents|sensory system agents|mesh-ancestor
92694773|NCT01240863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694774|NCT01240863|Antitussive Agents|antitussive agents|mesh-ancestor
92694775|NCT01240863|Respiratory System Agents|respiratory system agents|mesh-ancestor
92694776|NCT01240746|Vaccines|vaccines|mesh-list
92694777|NCT01240746|Immunologic Factors|immunologic factors|mesh-ancestor
92694778|NCT01240746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694779|NCT01240590|Cisplatin|cisplatin|mesh-list
92694780|NCT01240590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694781|NCT01240200|Insulin Glargine|insulin glargine|mesh-list
92694782|NCT01240200|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694783|NCT01240200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694784|NCT00504543|Everolimus|everolimus|mesh-list
92694785|NCT00504543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694786|NCT00504543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694787|NCT00504543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694788|NCT00504543|Immunologic Factors|immunologic factors|mesh-ancestor
92694789|NCT00504543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694790|NCT00504543|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92694791|NCT00504543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92694792|NCT00504543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694793|NCT02949843|Pembrolizumab|pembrolizumab|mesh-list
92694803|NCT00517764|Escitalopram|escitalopram|mesh-list
92694804|NCT00517764|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92694805|NCT00517764|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92694806|NCT00517764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694807|NCT00517764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694808|NCT00517764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694809|NCT00517764|Serotonin Agents|serotonin agents|mesh-ancestor
92694810|NCT00517764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694811|NCT00517764|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92694812|NCT00517764|Antidepressive Agents|antidepressive agents|mesh-ancestor
92694813|NCT00517764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92694814|NCT00517803|Micronutrients|micronutrients|mesh-list
92694815|NCT00517803|Trace Elements|trace elements|mesh-list
92694816|NCT00517803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694817|NCT04516304|Equol|equol|mesh-list
92694818|NCT04516304|Phytoestrogens|phytoestrogens|mesh-ancestor
92694819|NCT04516304|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92694820|NCT04516304|Estrogens|estrogens|mesh-ancestor
92694821|NCT04516304|Hormones|hormones|mesh-ancestor
92694822|NCT04516304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92694823|NCT04516304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607465|NCT00140517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607466|NCT00140517|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92607467|NCT00140517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607468|NCT00140517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694825|NCT01242930|Lenalidomide|lenalidomide|mesh-list
92694826|NCT01242930|Imetelstat|imetelstat|mesh-list
92694827|NCT01242930|Motesanib diphosphate|motesanib diphosphate|mesh-list
92694828|NCT01242930|Immunologic Factors|immunologic factors|mesh-ancestor
92371094|NCT01218984|Naltrexone|naltrexone|mesh-list
92694829|NCT01242930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694830|NCT01242930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92694831|NCT01242930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92694832|NCT01242930|Growth Substances|growth substances|mesh-ancestor
92694833|NCT01242930|Growth Inhibitors|growth inhibitors|mesh-ancestor
92694834|NCT01242930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694835|NCT01242930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694836|NCT01242930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694837|NCT01242930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92694838|NCT01242930|Vitamin B Complex|vitamin b complex|mesh-ancestor
92694839|NCT01242930|Vitamins|vitamins|mesh-ancestor
92694840|NCT01242930|Micronutrients|micronutrients|mesh-ancestor
92694841|NCT01241214|Cetirizine|cetirizine|mesh-list
92694842|NCT01241214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92694843|NCT01241214|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92694844|NCT01241214|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92694845|NCT01241214|Histamine Antagonists|histamine antagonists|mesh-ancestor
92694846|NCT01241214|Histamine Agents|histamine agents|mesh-ancestor
92694847|NCT01241214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694848|NCT01241214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694849|NCT01241214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694850|NCT01240512|Vitamin D|vitamin d|mesh-list
92694851|NCT01240512|Cholecalciferol|cholecalciferol|mesh-list
92694852|NCT01240512|Vitamins|vitamins|mesh-ancestor
92694853|NCT01240512|Micronutrients|micronutrients|mesh-ancestor
92694854|NCT01240512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694855|NCT01240512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92694856|NCT01240512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92694857|NCT01240629|Doxorubicin|doxorubicin|mesh-list
92694858|NCT01240629|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92694859|NCT01240629|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92694873|NCT00518232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694874|NCT00505505|Insulin|insulin|mesh-list
92694875|NCT00505505|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92694876|NCT00505505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694877|NCT00505505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694878|NCT00518271|Sirolimus|sirolimus|mesh-list
92694879|NCT00518271|Tacrolimus|tacrolimus|mesh-list
92694880|NCT00518271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694881|NCT00518271|Immunologic Factors|immunologic factors|mesh-ancestor
92694882|NCT00518271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694883|NCT00518271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92694884|NCT00518271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694885|NCT00518271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694886|NCT00518271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694887|NCT00518271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694888|NCT00518271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92694889|NCT00518271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694890|NCT00518271|Antifungal Agents|antifungal agents|mesh-ancestor
92694891|NCT00518193|Cetuximab|cetuximab|mesh-list
92694892|NCT00518193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694893|NCT00518193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694894|NCT00518427|Insulin Glargine|insulin glargine|mesh-list
92114737|NCT05719714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114742|NCT02284516|Lifitegrast|lifitegrast|mesh-list
92114743|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92114744|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92694895|NCT00518427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694896|NCT00518427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694898|NCT00518466|Phentermine|phentermine|mesh-list
92694899|NCT00518466|Anticonvulsants|anticonvulsants|mesh-ancestor
92694900|NCT00518466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92694901|NCT00518466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607469|NCT00140517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92607470|NCT00132236|Nicotine|nicotine|mesh-list
92607471|NCT00132236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92607472|NCT00132236|Autonomic Agents|autonomic agents|mesh-ancestor
92607473|NCT00132236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607474|NCT00132236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607475|NCT00132236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92607476|NCT00132236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92371105|NCT01218984|Analgesics|analgesics|mesh-ancestor
92694902|NCT00518466|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92694903|NCT00518466|Appetite Depressants|appetite depressants|mesh-ancestor
92694904|NCT00518466|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92694905|NCT00518466|Sympathomimetics|sympathomimetics|mesh-ancestor
92694906|NCT00518466|Autonomic Agents|autonomic agents|mesh-ancestor
92694907|NCT00518466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694908|NCT00518466|Adrenergic Agents|adrenergic agents|mesh-ancestor
92694909|NCT00518466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694910|NCT00518466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694911|NCT00518583|Paclitaxel|paclitaxel|mesh-list
92694912|NCT00518583|Doxorubicin|doxorubicin|mesh-list
92694913|NCT00518583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92694914|NCT00518583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92694915|NCT00518583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694916|NCT00518583|Tubulin Modulators|tubulin modulators|mesh-ancestor
92694920|NCT00518583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92694921|NCT00518583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92694922|NCT00518583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92694923|NCT00518583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694924|NCT00519753|Timolol|timolol|mesh-list
92694925|NCT00519753|Travoprost|travoprost|mesh-list
92694926|NCT00519753|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92694927|NCT00519753|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92694928|NCT00519753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694929|NCT00519753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92694930|NCT00519753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92694931|NCT00519753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92694932|NCT00519753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694933|NCT00519753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694934|NCT00519753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92694935|NCT00519753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92694936|NCT00519870|Losartan|losartan|mesh-list
92694937|NCT00519870|Nifedipine|nifedipine|mesh-list
92694938|NCT00519870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92694939|NCT00519870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92694940|NCT00519870|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92694941|NCT00519870|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92694942|NCT00519870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694943|NCT00519870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92694944|NCT00519870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694945|NCT00519870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92694946|NCT00519870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694947|NCT00519870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92694948|NCT00519870|Tocolytic Agents|tocolytic agents|mesh-ancestor
92694949|NCT00519870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694950|NCT00519909|Calcium|calcium|mesh-list
92694951|NCT00519909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92694952|NCT00519909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694953|NCT02949492|Interleukin-2|interleukin-2|mesh-list
92694954|NCT02949492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694955|NCT02949492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92694956|NCT02949492|Analgesics|analgesics|mesh-ancestor
92694957|NCT02949492|Sensory System Agents|sensory system agents|mesh-ancestor
92694958|NCT02949492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694959|NCT02949492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694960|NCT04511234|Sirolimus|sirolimus|mesh-list
92694961|NCT04511234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92694962|NCT04511234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694963|NCT04511234|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92014821|NCT04798703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607477|NCT00132236|Cholinergic Agents|cholinergic agents|mesh-ancestor
92607478|NCT00132236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607479|NCT00132236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607480|NCT00132275|Amoxicillin|amoxicillin|mesh-list
92607481|NCT00132275|Clavulanic Acid|clavulanic acid|mesh-list
92607482|NCT00132275|Clavulanic Acids|clavulanic acids|mesh-list
92607483|NCT00132275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92607484|NCT00132275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014822|NCT04798703|Tubulin Modulators|tubulin modulators|mesh-ancestor
92694964|NCT04511234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694965|NCT04511234|Antifungal Agents|antifungal agents|mesh-ancestor
92694966|NCT04511234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694967|NCT04511234|Immunologic Factors|immunologic factors|mesh-ancestor
92694968|NCT04511234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694969|NCT04514588|Caffeine|caffeine|mesh-list
92694970|NCT04514588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92694971|NCT04514588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694972|NCT04514588|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92694973|NCT04514588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694974|NCT04514588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694975|NCT04514588|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92694976|NCT04514588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92694977|NCT04514588|Purinergic Agents|purinergic agents|mesh-ancestor
92694978|NCT04514588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694979|NCT02276300|Cyclophosphamide|cyclophosphamide|mesh-list
92694980|NCT02276300|Imiquimod|imiquimod|mesh-list
92694981|NCT02276300|Sargramostim|sargramostim|mesh-list
92694982|NCT02276300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694983|NCT02276300|Immunologic Factors|immunologic factors|mesh-ancestor
92694984|NCT02276300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694985|NCT02276300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694986|NCT02276300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92694987|NCT02276300|Alkylating Agents|alkylating agents|mesh-ancestor
92695005|NCT02955251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92695006|NCT02955251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695007|NCT00518895|Dacarbazine|dacarbazine|mesh-list
92695008|NCT00518895|Oblimersen|oblimersen|mesh-list
92695009|NCT00518895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92695010|NCT00518895|Alkylating Agents|alkylating agents|mesh-ancestor
92695011|NCT00518895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695012|NCT00518895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695013|NCT00520104|Ketamine|ketamine|mesh-list
92695014|NCT00520104|Analgesics|analgesics|mesh-ancestor
92695015|NCT00520104|Sensory System Agents|sensory system agents|mesh-ancestor
92695016|NCT00520104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695017|NCT00520104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695018|NCT00520104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92695019|NCT00520104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92695020|NCT00520104|Anesthetics, General|anesthetics, general|mesh-ancestor
92695021|NCT00520104|Anesthetics|anesthetics|mesh-ancestor
92695022|NCT00520104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695023|NCT00520104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92695024|NCT00520104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92695025|NCT00520104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695026|NCT00520104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695027|NCT00519012|Sertraline|sertraline|mesh-list
92695028|NCT00519012|Paroxetine|paroxetine|mesh-list
92695029|NCT00519012|Antidepressive Agents|antidepressive agents|mesh-ancestor
92695030|NCT00519012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92695031|NCT00519012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92695032|NCT00519012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92695033|NCT00519012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607485|NCT00132275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92607486|NCT00132275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607487|NCT00132275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695034|NCT00519012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695035|NCT00519012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695036|NCT00519012|Serotonin Agents|serotonin agents|mesh-ancestor
92695037|NCT00519012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695038|NCT00519012|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92695039|NCT00519012|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92695040|NCT00519012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92695041|NCT00519012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695054|NCT00520260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695056|NCT00520338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695057|NCT00520338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695058|NCT00520338|Analgesics|analgesics|mesh-ancestor
92695059|NCT00520338|Sensory System Agents|sensory system agents|mesh-ancestor
92695060|NCT00520338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695061|NCT00520338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695062|NCT00520338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695063|NCT00520338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695064|NCT00520338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92695065|NCT00520338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92695066|NCT00520338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695067|NCT00520338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695068|NCT02594072|Goserelin|goserelin|mesh-list
92695069|NCT02594072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92695070|NCT02594072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695071|NCT00519051|Fluoxetine|fluoxetine|mesh-list
92695072|NCT00519051|Antidepressive Agents|antidepressive agents|mesh-list
92695073|NCT00519051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92695074|NCT00519051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92695075|NCT00519051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695076|NCT00519051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695077|NCT00519051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695078|NCT00519051|Serotonin Agents|serotonin agents|mesh-ancestor
92695079|NCT00519051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695080|NCT00519051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92695081|NCT00519051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92695082|NCT00519051|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92695083|NCT00519051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92695084|NCT00519051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695085|NCT02275832|Minoxidil|minoxidil|mesh-list
92695086|NCT02275832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92695087|NCT02275832|Vasodilator Agents|vasodilator agents|mesh-ancestor
92695088|NCT00519207|Lidocaine|lidocaine|mesh-list
92695089|NCT00519207|Anesthetics, Local|anesthetics, local|mesh-ancestor
92695090|NCT00519207|Anesthetics|anesthetics|mesh-ancestor
92695091|NCT00519207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695092|NCT00519207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695093|NCT00519207|Sensory System Agents|sensory system agents|mesh-ancestor
92695094|NCT00519207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695095|NCT00519207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92695096|NCT00519207|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92695097|NCT00519207|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92695098|NCT00519207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695099|NCT00519207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695100|NCT02590094|Bevacizumab|bevacizumab|mesh-list
92695101|NCT02590094|Aflibercept|aflibercept|mesh-list
92695102|NCT02590094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92695116|NCT00520455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92695117|NCT02949258|Oxaliplatin|oxaliplatin|mesh-list
92695119|NCT02949258|Epirubicin|epirubicin|mesh-list
92695120|NCT02949258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695121|NCT02949258|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92695122|NCT02949258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92695123|NCT02949258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92695124|NCT02949258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607488|NCT01246999|Vaccines|vaccines|mesh-list
92607489|NCT01246999|Immunologic Factors|immunologic factors|mesh-ancestor
92607490|NCT01246999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607491|NCT00140595|Cyclophosphamide|cyclophosphamide|mesh-list
92607492|NCT00140595|Rituximab|rituximab|mesh-list
92607493|NCT00140595|Doxorubicin|doxorubicin|mesh-list
92607494|NCT00140595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695125|NCT02949258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695126|NCT02949258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92695127|NCT04514081|Decitabine|decitabine|mesh-list
92695128|NCT04514081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92695129|NCT04514081|Antimetabolites|antimetabolites|mesh-ancestor
92695130|NCT04514081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695131|NCT04514081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695132|NCT04514081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695133|NCT00519246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92695134|NCT00519246|Analgesics, Opioid|analgesics, opioid|mesh-list
92695135|NCT00519246|Narcotics|narcotics|mesh-ancestor
92695136|NCT00519246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695137|NCT00519246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695138|NCT00519246|Analgesics|analgesics|mesh-ancestor
92695139|NCT00519246|Sensory System Agents|sensory system agents|mesh-ancestor
92695140|NCT00519246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695141|NCT00519246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695142|NCT00519246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695143|NCT00519246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695144|NCT00519987|Ketamine|ketamine|mesh-list
92695145|NCT00519987|Analgesics|analgesics|mesh-ancestor
92695146|NCT00519987|Sensory System Agents|sensory system agents|mesh-ancestor
92695147|NCT00519987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695148|NCT00519987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695149|NCT00519987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92695150|NCT00519987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92695151|NCT00519987|Anesthetics, General|anesthetics, general|mesh-ancestor
92695152|NCT00519987|Anesthetics|anesthetics|mesh-ancestor
92695153|NCT00519987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695154|NCT00519987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92695155|NCT00519987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92695156|NCT00519987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695157|NCT00519987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695158|NCT00519324|Everolimus|everolimus|mesh-list
92695159|NCT00519324|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92695160|NCT00519324|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92695179|NCT00520650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92695180|NCT00520650|Serotonin Agents|serotonin agents|mesh-ancestor
92695181|NCT00520650|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92695182|NCT00520650|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92695183|NCT00520650|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92695184|NCT00520650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92695185|NCT00519363|Atorvastatin|atorvastatin|mesh-list
92695186|NCT00519363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92695187|NCT00519363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92695188|NCT00519363|Antimetabolites|antimetabolites|mesh-ancestor
92695189|NCT00519363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695190|NCT00519363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92695191|NCT00519363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92695192|NCT00519363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695193|NCT00519480|Metformin|metformin|mesh-list
92695194|NCT00519480|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695195|NCT00519480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695196|NCT02955056|Teriparatide|teriparatide|mesh-list
92695197|NCT02955056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695198|NCT02955056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92695199|NCT02955056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92695200|NCT02954939|Prednisone|prednisone|mesh-list
92695201|NCT02954939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695202|NCT02954939|Glucocorticoids|glucocorticoids|mesh-ancestor
92695203|NCT02954939|Hormones|hormones|mesh-ancestor
92607495|NCT00140595|Immunologic Factors|immunologic factors|mesh-ancestor
92607496|NCT00140595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607497|NCT00140595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695204|NCT02954939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695205|NCT02954939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695206|NCT02954939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92695207|NCT02954939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695208|NCT00519519|Omeprazole|omeprazole|mesh-list
92695209|NCT00519519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92695210|NCT00519519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695211|NCT00519519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92695212|NCT00519519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695213|NCT00519519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695214|NCT02598557|Exemestane|exemestane|mesh-list
92695218|NCT02598557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695219|NCT02598557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695220|NCT02598557|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92695221|NCT02598557|Hormone Antagonists|hormone antagonists|mesh-ancestor
92695222|NCT02598557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695223|NCT02598557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695224|NCT00520806|Methocarbamol|methocarbamol|mesh-list
92695225|NCT00520806|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92695226|NCT00520806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695227|NCT00520806|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92695228|NCT00520806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695229|NCT00505739|Mifepristone|mifepristone|mesh-list
92695230|NCT00505739|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92695231|NCT00505739|Abortifacient Agents|abortifacient agents|mesh-ancestor
92695232|NCT00505739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695233|NCT00505739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695234|NCT00505739|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92695235|NCT00505739|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92695236|NCT00505739|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92695237|NCT00505739|Contraceptive Agents|contraceptive agents|mesh-ancestor
92695238|NCT00505739|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92695239|NCT00505739|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92695240|NCT00505739|Hormone Antagonists|hormone antagonists|mesh-ancestor
92695241|NCT00505739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695242|NCT00505739|Luteolytic Agents|luteolytic agents|mesh-ancestor
92695243|NCT00505739|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92695244|NCT00505739|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92695245|NCT02948985|Cetuximab|cetuximab|mesh-list
92695246|NCT02948985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92695247|NCT02948985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695248|NCT04513457|Liver Extracts|liver extracts|mesh-list
92695249|NCT04513457|Hematinics|hematinics|mesh-ancestor
92695250|NCT00521040|Levocetirizine|levocetirizine|mesh-list
92695251|NCT00521040|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92695252|NCT00521040|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92695253|NCT00521040|Histamine Antagonists|histamine antagonists|mesh-ancestor
92695254|NCT00521040|Histamine Agents|histamine agents|mesh-ancestor
92695255|NCT00521040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695256|NCT00521040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695257|NCT00521040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695258|NCT04513340|Levodopa|levodopa|mesh-list
92695259|NCT04513340|Carbidopa|carbidopa|mesh-list
92695260|NCT04513340|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92695261|NCT04513340|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92695262|NCT04513340|Dopamine Agents|dopamine agents|mesh-ancestor
92695263|NCT04513340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695264|NCT04513340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695265|NCT04513340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695266|NCT04513340|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92695267|NCT04513340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695268|NCT05144945|Vaccines|vaccines|mesh-list
92695269|NCT05144945|Immunologic Factors|immunologic factors|mesh-ancestor
92695270|NCT05144945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695271|NCT04513379|Efavirenz|efavirenz|mesh-list
92695272|NCT04513379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92607498|NCT00140595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92607499|NCT00140595|Alkylating Agents|alkylating agents|mesh-ancestor
92607500|NCT00140595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607501|NCT00140595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695273|NCT04513379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92695274|NCT04513379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695275|NCT04513379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695276|NCT04513379|Antiviral Agents|antiviral agents|mesh-ancestor
92695277|NCT04513379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695278|NCT04513379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92695279|NCT04513379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92695280|NCT04513379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92695281|NCT04513379|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92695282|NCT04513379|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92695283|NCT04513379|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92695295|NCT00505817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695296|NCT00505817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92695297|NCT00505817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695298|NCT00505817|Hormone Antagonists|hormone antagonists|mesh-ancestor
92695299|NCT00505817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695300|NCT00521430|Cyclosporine|cyclosporine|mesh-list
92695301|NCT00521430|Methylprednisolone|methylprednisolone|mesh-list
92695302|NCT00521430|Methotrexate|methotrexate|mesh-list
92695303|NCT00521430|Fludarabine phosphate|fludarabine phosphate|mesh-list
92695304|NCT00521430|Fludarabine|fludarabine|mesh-list
92695305|NCT00521430|Busulfan|busulfan|mesh-list
92695306|NCT00521430|Cyclosporins|cyclosporins|mesh-list
92695307|NCT00521430|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92695308|NCT00521430|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92695309|NCT00521430|Abortifacient Agents|abortifacient agents|mesh-ancestor
92695310|NCT00521430|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695311|NCT00521430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695312|NCT00521430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92695313|NCT00521430|Antimetabolites|antimetabolites|mesh-ancestor
92695314|NCT00521430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695315|NCT00521430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695316|NCT00521430|Dermatologic Agents|dermatologic agents|mesh-ancestor
92695317|NCT00521430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695318|NCT00521430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92695319|NCT00521430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695320|NCT00521430|Immunologic Factors|immunologic factors|mesh-ancestor
92695321|NCT00521430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695322|NCT00521430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92695323|NCT00521430|Antifungal Agents|antifungal agents|mesh-ancestor
92695324|NCT00521430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695325|NCT00521430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92695326|NCT00521430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695327|NCT00521430|Antiemetics|antiemetics|mesh-ancestor
92695328|NCT00521430|Autonomic Agents|autonomic agents|mesh-ancestor
92695329|NCT00521430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695330|NCT00521430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695331|NCT00521430|Glucocorticoids|glucocorticoids|mesh-ancestor
92695332|NCT00521430|Hormones|hormones|mesh-ancestor
92695333|NCT00521430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695334|NCT00521430|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92695335|NCT00521430|Protective Agents|protective agents|mesh-ancestor
92695336|NCT00521430|Alkylating Agents|alkylating agents|mesh-ancestor
92695337|NCT00521430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92695338|NCT00521430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92695339|NCT00521274|Docetaxel|docetaxel|mesh-list
92695340|NCT00521274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695341|NCT00521274|Tubulin Modulators|tubulin modulators|mesh-ancestor
92695342|NCT00521274|Antimitotic Agents|antimitotic agents|mesh-ancestor
92695343|NCT00521274|Mitosis Modulators|mitosis modulators|mesh-ancestor
92695344|NCT00521274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695345|NCT05146778|Lidocaine|lidocaine|mesh-list
92695346|NCT05146778|Fentanyl|fentanyl|mesh-list
92695347|NCT05146778|Dexmedetomidine|dexmedetomidine|mesh-list
92695348|NCT05146778|Analgesics, Opioid|analgesics, opioid|mesh-list
92695349|NCT05146778|Anesthetics|anesthetics|mesh-list
92607502|NCT00140595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92607503|NCT00140595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607504|NCT00140595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92695350|NCT05146778|Anesthetics, Local|anesthetics, local|mesh-ancestor
92695364|NCT05146778|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92695365|NCT05146778|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92695366|NCT05146778|Adrenergic Agents|adrenergic agents|mesh-ancestor
92695367|NCT05146778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695368|NCT05146778|Narcotics|narcotics|mesh-ancestor
92695369|NCT05146778|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92695370|NCT05146778|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92695371|NCT05146778|Anesthetics, General|anesthetics, general|mesh-ancestor
92695372|NCT00505700|Cytarabine|cytarabine|mesh-list
92695373|NCT00505700|Bortezomib|bortezomib|mesh-list
92695374|NCT00505700|Idarubicin|idarubicin|mesh-list
92695375|NCT00505700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92695376|NCT00505700|Antimetabolites|antimetabolites|mesh-ancestor
92695377|NCT00505700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695378|NCT00505700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695379|NCT00505700|Antiviral Agents|antiviral agents|mesh-ancestor
92695380|NCT00505700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695381|NCT00505700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695382|NCT00505700|Immunologic Factors|immunologic factors|mesh-ancestor
92695383|NCT00505700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695384|NCT00505700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92695385|NCT00505700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92695386|NCT00505700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92695387|NCT00505700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695388|NCT02948283|Metformin|metformin|mesh-list
92695389|NCT02948283|Ritonavir|ritonavir|mesh-list
92695390|NCT02948283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695391|NCT02948283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695392|NCT02948283|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92695393|NCT02948283|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92695394|NCT02948283|Protease Inhibitors|protease inhibitors|mesh-ancestor
92695395|NCT02948283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695396|NCT02948283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695397|NCT02948283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92695398|NCT02948283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92695399|NCT02948283|Antiviral Agents|antiviral agents|mesh-ancestor
92695400|NCT02948283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695401|NCT02948283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92695402|NCT02948283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92695403|NCT04512872|Denosumab|denosumab|mesh-list
92695404|NCT04512872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92695405|NCT04512872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695406|NCT00523185|Diazepam|diazepam|mesh-list
92695407|NCT00523185|Lorazepam|lorazepam|mesh-list
92695408|NCT00523185|Anticonvulsants|anticonvulsants|mesh-ancestor
92695409|NCT00523185|Antiemetics|antiemetics|mesh-ancestor
92695410|NCT00523185|Autonomic Agents|autonomic agents|mesh-ancestor
92695411|NCT00523185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695457|NCT00521781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92695458|NCT00521781|Leuprolide|leuprolide|mesh-list
92695459|NCT00521781|Bicalutamide|bicalutamide|mesh-list
92695460|NCT00521781|Androgens|androgens|mesh-list
92695461|NCT00521781|Androgen Antagonists|androgen antagonists|mesh-list
92695462|NCT00521781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695463|NCT00521781|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92695464|NCT00521781|Fertility Agents|fertility agents|mesh-ancestor
92695465|NCT00521781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695466|NCT00521781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695467|NCT00521781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92695468|NCT00521781|Hormones|hormones|mesh-ancestor
92695469|NCT00521781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695470|NCT00521781|Hormone Antagonists|hormone antagonists|mesh-ancestor
92695471|NCT00521820|Pioglitazone|pioglitazone|mesh-list
92695472|NCT00521820|Glyburide|glyburide|mesh-list
92695473|NCT00521820|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695474|NCT00521820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695475|NCT00523263|Heparin|heparin|mesh-list
92695476|NCT00523263|Anticoagulants|anticoagulants|mesh-ancestor
92695477|NCT00523263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92695478|NCT00523263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607505|NCT00140595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607506|NCT00140595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607507|NCT00140595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695479|NCT00523263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695480|NCT00521859|Fludarabine|fludarabine|mesh-list
92695481|NCT00521859|Fludarabine phosphate|fludarabine phosphate|mesh-list
92695482|NCT00521859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695483|NCT00521859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92695484|NCT00521859|Antimetabolites|antimetabolites|mesh-ancestor
92695485|NCT00521859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695486|NCT00521859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695487|NCT00521859|Immunologic Factors|immunologic factors|mesh-ancestor
92695488|NCT00521859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695489|NCT02954822|Glimepiride|glimepiride|mesh-list
92695490|NCT02954822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92695491|NCT02954822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695492|NCT02954822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695493|NCT02954822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695494|NCT02954822|Immunologic Factors|immunologic factors|mesh-ancestor
92695495|NCT00522015|Rivastigmine|rivastigmine|mesh-list
92695496|NCT00522015|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92695497|NCT00522015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695498|NCT00522015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695499|NCT00522015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92695500|NCT00522015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695501|NCT00522015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695502|NCT00522015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92695503|NCT00522015|Protective Agents|protective agents|mesh-ancestor
92695504|NCT00523380|Doxorubicin|doxorubicin|mesh-list
92695505|NCT00523380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92695506|NCT00523380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92695509|NCT00523380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92695510|NCT00523380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695511|NCT00523380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695513|NCT00523458|Nevirapine|nevirapine|mesh-list
92695514|NCT00523458|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92695515|NCT00523458|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92695516|NCT00523458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695517|NCT00523458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695518|NCT00523458|Antiviral Agents|antiviral agents|mesh-ancestor
92695519|NCT00523458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695520|NCT00523458|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92695521|NCT00523458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92695522|NCT00523458|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92695523|NCT00523458|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92695524|NCT00523458|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92695525|NCT00523458|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92695526|NCT00523458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92695527|NCT00523458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92695528|NCT00507065|Amphetamine|amphetamine|mesh-list
92695529|NCT00507065|Adderall|adderall|mesh-list
92695530|NCT00507065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92695531|NCT00507065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695532|NCT00507065|Sympathomimetics|sympathomimetics|mesh-ancestor
92695533|NCT00507065|Autonomic Agents|autonomic agents|mesh-ancestor
92695534|NCT00507065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695535|NCT00507065|Dopamine Agents|dopamine agents|mesh-ancestor
92695536|NCT00507065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695537|NCT00507065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695538|NCT00507065|Adrenergic Agents|adrenergic agents|mesh-ancestor
92695539|NCT00507065|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92695540|NCT00507065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92695541|NCT00507065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695542|NCT00507065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92695543|NCT00522132|Artesunate|artesunate|mesh-list
92695544|NCT00522132|Antimalarials|antimalarials|mesh-ancestor
92695545|NCT00522132|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92695546|NCT00522132|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92695547|NCT00522132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695548|NCT00522132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607508|NCT04696783|Esomeprazole|esomeprazole|mesh-list
92607509|NCT04696783|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92607510|NCT04696783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695549|NCT00522132|Antiviral Agents|antiviral agents|mesh-ancestor
92695550|NCT00522132|Schistosomicides|schistosomicides|mesh-ancestor
92695551|NCT00522132|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92695552|NCT00522132|Anthelmintics|anthelmintics|mesh-ancestor
92695553|NCT00522210|Insulin|insulin|mesh-list
92695554|NCT00522210|Isophane Insulin, Human|isophane insulin, human|mesh-list
92695555|NCT00522210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695556|NCT00522210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695557|NCT00522249|Interferons|interferons|mesh-list
92695558|NCT00522249|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92695559|NCT00522249|Interferon-alpha|interferon-alpha|mesh-list
92695560|NCT00522249|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92695561|NCT00522249|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92695562|NCT00522249|Sunitinib|sunitinib|mesh-list
92695563|NCT00522249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695564|NCT00522249|Antiviral Agents|antiviral agents|mesh-ancestor
92695565|NCT00522249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695566|NCT00522249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92695567|NCT00522249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695568|NCT00522249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695569|NCT00522249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92695570|NCT00522249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92695571|NCT00522249|Growth Substances|growth substances|mesh-ancestor
92695572|NCT00522249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695573|NCT00522249|Growth Inhibitors|growth inhibitors|mesh-ancestor
92695574|NCT00522249|Immunologic Factors|immunologic factors|mesh-ancestor
92695575|NCT05148767|Irinotecan|irinotecan|mesh-list
92695576|NCT05148767|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92695577|NCT05148767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92695578|NCT05148767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695606|NCT00523692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695607|NCT00523692|Analgesics|analgesics|mesh-ancestor
92695608|NCT00523692|Sensory System Agents|sensory system agents|mesh-ancestor
92695609|NCT00523692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695610|NCT00523692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695611|NCT00523692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695612|NCT00523692|Antiemetics|antiemetics|mesh-ancestor
92695613|NCT00523692|Autonomic Agents|autonomic agents|mesh-ancestor
92695614|NCT00523692|Glucocorticoids|glucocorticoids|mesh-ancestor
92695615|NCT00523692|Hormones|hormones|mesh-ancestor
92695616|NCT00523692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695617|NCT00523692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92695618|NCT00523692|Protective Agents|protective agents|mesh-ancestor
92695619|NCT00523692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92695620|NCT05148689|Phenylephrine|phenylephrine|mesh-list
92695621|NCT05148689|Oxymetazoline|oxymetazoline|mesh-list
92695622|NCT05148689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92695623|NCT05148689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92695624|NCT05148689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92695625|NCT05148689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695627|NCT05148689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695628|NCT05148689|Sympathomimetics|sympathomimetics|mesh-ancestor
92695629|NCT05148689|Autonomic Agents|autonomic agents|mesh-ancestor
92695630|NCT05148689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695631|NCT05148689|Nasal Decongestants|nasal decongestants|mesh-ancestor
92695632|NCT05148689|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92695633|NCT05148689|Respiratory System Agents|respiratory system agents|mesh-ancestor
92695634|NCT05148689|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92695635|NCT05148689|Mydriatics|mydriatics|mesh-ancestor
92695636|NCT05148689|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92695637|NCT05148689|Protective Agents|protective agents|mesh-ancestor
92695638|NCT00522444|Magnesium Sulfate|magnesium sulfate|mesh-list
92695639|NCT00522444|Analgesics|analgesics|mesh-ancestor
92695640|NCT00522444|Sensory System Agents|sensory system agents|mesh-ancestor
92695641|NCT00522444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695642|NCT00522444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695643|NCT00522444|Anesthetics|anesthetics|mesh-ancestor
92695644|NCT00522444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695645|NCT00522444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92695646|NCT00522444|Anticonvulsants|anticonvulsants|mesh-ancestor
92695647|NCT00522444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92607511|NCT04696783|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92607512|NCT04696783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695648|NCT00522444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695649|NCT00522444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695650|NCT00522444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92695651|NCT00522444|Tocolytic Agents|tocolytic agents|mesh-ancestor
92695652|NCT00522444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695653|NCT05148143|Raltitrexed|raltitrexed|mesh-list
92695654|NCT05148143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92695655|NCT05148143|Antimetabolites|antimetabolites|mesh-ancestor
92695656|NCT05148143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695657|NCT05148143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695658|NCT05148143|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92695659|NCT05148143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695660|NCT00523887|Fentanyl|fentanyl|mesh-list
92695661|NCT00523887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92695662|NCT00523887|Narcotics|narcotics|mesh-ancestor
92695663|NCT00523887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695664|NCT00523887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695665|NCT00523887|Analgesics|analgesics|mesh-ancestor
92695666|NCT00523887|Sensory System Agents|sensory system agents|mesh-ancestor
92695667|NCT00523887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695668|NCT00523887|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92695669|NCT00523887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92695670|NCT00523887|Anesthetics, General|anesthetics, general|mesh-ancestor
92695671|NCT00523887|Anesthetics|anesthetics|mesh-ancestor
92695672|NCT05145218|Paclitaxel|paclitaxel|mesh-list
92695673|NCT05145218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92695674|NCT05145218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695675|NCT05145218|Tubulin Modulators|tubulin modulators|mesh-ancestor
92695676|NCT05145218|Antimitotic Agents|antimitotic agents|mesh-ancestor
92695677|NCT05145218|Mitosis Modulators|mitosis modulators|mesh-ancestor
92695678|NCT05145218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695679|NCT00523926|Bedaquiline|bedaquiline|mesh-list
92695680|NCT00523926|Antitubercular Agents|antitubercular agents|mesh-ancestor
92695681|NCT00523926|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92695682|NCT00523926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695683|NCT05146271|Anesthetics|anesthetics|mesh-list
92695684|NCT05146271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695685|NCT05146271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695686|NCT00522639|Deoxyglucose|deoxyglucose|mesh-list
92695687|NCT00522639|Antimetabolites|antimetabolites|mesh-ancestor
92695688|NCT00522639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695689|NCT00522639|Antiviral Agents|antiviral agents|mesh-ancestor
92695690|NCT00522639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695691|NCT05142098|Dexamethasone|dexamethasone|mesh-list
92695692|NCT05142098|Etoricoxib|etoricoxib|mesh-list
92695693|NCT05142098|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92695694|NCT05142098|Glucocorticoids|glucocorticoids|mesh-list
92695695|NCT05142098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695696|NCT05142098|Antiemetics|antiemetics|mesh-ancestor
92695697|NCT05142098|Autonomic Agents|autonomic agents|mesh-ancestor
92695698|NCT05142098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695700|NCT05142098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695701|NCT05142098|Hormones|hormones|mesh-ancestor
92695702|NCT05142098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695703|NCT05142098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92695704|NCT05142098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695705|NCT05142098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695706|NCT05142098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695707|NCT05142098|Analgesics|analgesics|mesh-ancestor
92695708|NCT05142098|Sensory System Agents|sensory system agents|mesh-ancestor
92695709|NCT05142098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695710|NCT05142098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92695711|NCT05142098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695712|NCT05142098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695713|NCT00523965|Amphotericin B|amphotericin b|mesh-list
92695714|NCT00523965|Paromomycin|paromomycin|mesh-list
92695715|NCT00523965|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92695716|NCT00523965|Miltefosine|miltefosine|mesh-list
92695717|NCT00523965|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92695718|NCT00523965|Deoxycholic Acid|deoxycholic acid|mesh-list
92695719|NCT00523965|Amebicides|amebicides|mesh-ancestor
92014852|NCT04848857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607513|NCT04696783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607514|NCT00132431|Cinacalcet|cinacalcet|mesh-list
92607515|NCT00132431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92607516|NCT00132431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607517|NCT00132431|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92607518|NCT00132431|Hormone Antagonists|hormone antagonists|mesh-ancestor
92607519|NCT00132431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607521|NCT00140712|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92607522|NCT00140712|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92607523|NCT00140712|Dopamine Agonists|dopamine agonists|mesh-ancestor
92607524|NCT00140712|Dopamine Agents|dopamine agents|mesh-ancestor
92607525|NCT00140712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014858|NCT04338659|Antibodies|antibodies|mesh-list
92695720|NCT00523965|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92695721|NCT00523965|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92695722|NCT00523965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695723|NCT00523965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92695724|NCT00523965|Antifungal Agents|antifungal agents|mesh-ancestor
92695725|NCT00523965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695726|NCT00523965|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92695727|NCT00523965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695728|NCT05141669|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92695729|NCT05141669|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92695730|NCT05141669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695731|NCT05141669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695732|NCT05141669|Immunologic Factors|immunologic factors|mesh-ancestor
92695733|NCT05141669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695734|NCT05141240|Palbociclib|palbociclib|mesh-list
92695735|NCT05141240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695736|NCT05141240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92695737|NCT05141240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695738|NCT05141240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695739|NCT00524004|Immunoglobulin G|immunoglobulin g|mesh-list
92695740|NCT00524004|Immunologic Factors|immunologic factors|mesh-ancestor
92695741|NCT00524004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695742|NCT05148377|Heparin|heparin|mesh-list
92695743|NCT05148377|Anticoagulants|anticoagulants|mesh-ancestor
92695744|NCT05148377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92695745|NCT05148377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92695746|NCT05148377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695747|NCT00524160|Fentanyl|fentanyl|mesh-list
92695748|NCT00524160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92695749|NCT00524160|Narcotics|narcotics|mesh-ancestor
92695750|NCT00524160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695751|NCT00524160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695752|NCT00524160|Analgesics|analgesics|mesh-ancestor
92695753|NCT00524160|Sensory System Agents|sensory system agents|mesh-ancestor
92695754|NCT00524160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695755|NCT00524160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92695756|NCT00524160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92695757|NCT00524160|Anesthetics, General|anesthetics, general|mesh-ancestor
92695758|NCT00524160|Anesthetics|anesthetics|mesh-ancestor
92695759|NCT00524199|Mesna|mesna|mesh-list
92695760|NCT00524199|Protective Agents|protective agents|mesh-ancestor
92695761|NCT00524199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695762|NCT00523068|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92695763|NCT00523068|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92695764|NCT00523068|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92695765|NCT00523068|Cholinergic Agents|cholinergic agents|mesh-ancestor
92607526|NCT00140712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607527|NCT00140712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607528|NCT00132548|Artesunate|artesunate|mesh-list
92695766|NCT00523068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695767|NCT00523068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695768|NCT00523068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695769|NCT00523068|Urological Agents|urological agents|mesh-ancestor
92695770|NCT02276378|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92695771|NCT02276378|Telmisartan|telmisartan|mesh-list
92695772|NCT02276378|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92695776|NCT02276378|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92695777|NCT02276378|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695778|NCT02276378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978489|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
92695779|NCT02276378|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92695780|NCT02276378|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92695781|NCT04696250|Antineoplastic Agents|antineoplastic agents|mesh-list
92695782|NCT04696250|Immunomodulating Agents|immunomodulating agents|mesh-list
92695783|NCT04696250|Immunologic Factors|immunologic factors|mesh-ancestor
92695784|NCT04696250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695785|NCT00524433|Tezosentan|tezosentan|mesh-list
92695786|NCT00524433|Vasodilator Agents|vasodilator agents|mesh-ancestor
92695787|NCT02947932|Indomethacin|indomethacin|mesh-list
92695788|NCT02947932|Resveratrol|resveratrol|mesh-list
92695789|NCT02947932|Antioxidants|antioxidants|mesh-ancestor
92695790|NCT02947932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695791|NCT02947932|Protective Agents|protective agents|mesh-ancestor
92695792|NCT02947932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695793|NCT02947932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695794|NCT02947932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92695795|NCT02947932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695796|NCT02947932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695797|NCT02947932|Analgesics|analgesics|mesh-ancestor
92695798|NCT02947932|Sensory System Agents|sensory system agents|mesh-ancestor
92695799|NCT02947932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695800|NCT02947932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695801|NCT02947932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695802|NCT02947932|Gout Suppressants|gout suppressants|mesh-ancestor
92695803|NCT02947932|Tocolytic Agents|tocolytic agents|mesh-ancestor
92695804|NCT02947932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695805|NCT02947932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92695806|NCT05146154|Imipenem|imipenem|mesh-list
92695807|NCT05146154|Relebactam|relebactam|mesh-list
92695808|NCT05146154|Cilastatin|cilastatin|mesh-list
92695809|NCT05146154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92695810|NCT05146154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695811|NCT05146154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92695812|NCT05146154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695813|NCT05146154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695814|NCT05146154|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92695815|NCT00524667|Fludarabine|fludarabine|mesh-list
92695816|NCT00524667|Valproic Acid|valproic acid|mesh-list
92695817|NCT00524667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695818|NCT00524667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695819|NCT00524667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695820|NCT00524667|Anticonvulsants|anticonvulsants|mesh-ancestor
92695821|NCT00524667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695822|NCT00524667|GABA Agents|gaba agents|mesh-ancestor
92695823|NCT00524667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695824|NCT00524667|Antimanic Agents|antimanic agents|mesh-ancestor
92695825|NCT00524667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92695826|NCT00524667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695827|NCT00524667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92695828|NCT00524706|Leucovorin|leucovorin|mesh-list
92695829|NCT00524706|Oxaliplatin|oxaliplatin|mesh-list
92695830|NCT00524706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695831|NCT00524706|Antidotes|antidotes|mesh-ancestor
92695832|NCT00524706|Protective Agents|protective agents|mesh-ancestor
92695833|NCT00524706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695834|NCT00524706|Vitamin B Complex|vitamin b complex|mesh-ancestor
92695835|NCT00524706|Vitamins|vitamins|mesh-ancestor
92695836|NCT00524706|Micronutrients|micronutrients|mesh-ancestor
92695837|NCT00507143|Irinotecan|irinotecan|mesh-list
92695838|NCT00507143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92607530|NCT00132548|Sulfadoxine|sulfadoxine|mesh-list
92607531|NCT00132548|Amodiaquine|amodiaquine|mesh-list
92607532|NCT00132548|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92607533|NCT00132548|Antimalarials|antimalarials|mesh-ancestor
92607534|NCT00132548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92607535|NCT00132548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92607536|NCT00132548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607537|NCT00132548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607538|NCT00132548|Antiviral Agents|antiviral agents|mesh-ancestor
92607539|NCT00132548|Schistosomicides|schistosomicides|mesh-ancestor
92695839|NCT00507143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92695840|NCT00507143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695841|NCT00507143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695842|NCT00507143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695843|NCT00525993|Etoricoxib|etoricoxib|mesh-list
92695844|NCT00525993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695845|NCT00525993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695846|NCT00525993|Analgesics|analgesics|mesh-ancestor
92695858|NCT02947854|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92695859|NCT02947854|Interferon Inducers|interferon inducers|mesh-ancestor
92695860|NCT02947854|Immunologic Factors|immunologic factors|mesh-ancestor
92695861|NCT02947854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695862|NCT02947854|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92695863|NCT02947854|Dermatologic Agents|dermatologic agents|mesh-ancestor
92115716|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92695864|NCT02947815|Botulinum Toxins|botulinum toxins|mesh-list
92695865|NCT02947815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92695866|NCT02947815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92695867|NCT02947815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92695868|NCT02947815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695869|NCT02947815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695870|NCT02947815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92695871|NCT02947815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695872|NCT02947815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695873|NCT02947815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92695874|NCT02947815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695875|NCT00507221|Albendazole|albendazole|mesh-list
92695876|NCT00507221|Praziquantel|praziquantel|mesh-list
92695877|NCT00507221|Anthelmintics|anthelmintics|mesh-ancestor
92695878|NCT00507221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92695879|NCT00507221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695880|NCT00507221|Anticestodal Agents|anticestodal agents|mesh-ancestor
92695881|NCT00507221|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92695882|NCT00507221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92695883|NCT00507221|Tubulin Modulators|tubulin modulators|mesh-ancestor
92695884|NCT00507221|Antimitotic Agents|antimitotic agents|mesh-ancestor
92695885|NCT00507221|Mitosis Modulators|mitosis modulators|mesh-ancestor
92695886|NCT00507221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695887|NCT00507221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695888|NCT02947737|Gentamicins|gentamicins|mesh-list
92695889|NCT02947737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92695890|NCT02947737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695891|NCT02947737|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92695892|NCT02947737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695893|NCT02947737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695894|NCT05146895|Imiquimod|imiquimod|mesh-list
92695895|NCT05146895|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92695896|NCT05146895|Immunologic Factors|immunologic factors|mesh-ancestor
92695897|NCT05146895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695898|NCT05146895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695899|NCT05146895|Interferon Inducers|interferon inducers|mesh-ancestor
92695900|NCT05143073|Ethanol|ethanol|mesh-list
92695901|NCT05143073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92695902|NCT05143073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695903|NCT05143073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695904|NCT05143073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695905|NCT00524901|Epoetin Alfa|epoetin alfa|mesh-list
92695906|NCT00524901|Hematinics|hematinics|mesh-ancestor
92695907|NCT02954588|Pyridoxamine|pyridoxamine|mesh-list
92695908|NCT02954588|Vitamin B Complex|vitamin b complex|mesh-ancestor
92695909|NCT02954588|Vitamins|vitamins|mesh-ancestor
92695912|NCT02954549|Vitamin D|vitamin d|mesh-list
92695913|NCT02954549|Cholecalciferol|cholecalciferol|mesh-list
92695914|NCT02954549|Vitamins|vitamins|mesh-ancestor
92695915|NCT02954549|Micronutrients|micronutrients|mesh-ancestor
92695916|NCT02954549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695917|NCT02954549|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92695918|NCT02954549|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92695919|NCT05145608|Lamotrigine|lamotrigine|mesh-list
92695920|NCT05145608|Anticonvulsants|anticonvulsants|mesh-list
92695921|NCT05145608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92695922|NCT05145608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695923|NCT05145608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695924|NCT05145608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92695925|NCT05145608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695926|NCT05145608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92695927|NCT05145608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92695928|NCT05145608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695929|NCT05145608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92695930|NCT05145608|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92695931|NCT02946294|Epinephrine|epinephrine|mesh-list
92695932|NCT02946294|Racepinephrine|racepinephrine|mesh-list
92695933|NCT02946294|Bupivacaine|bupivacaine|mesh-list
92695934|NCT02946294|Epinephryl borate|epinephryl borate|mesh-list
92695935|NCT02946294|Anesthetics, Local|anesthetics, local|mesh-ancestor
92695936|NCT02946294|Anesthetics|anesthetics|mesh-ancestor
92695937|NCT02946294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695938|NCT02946294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695939|NCT02946294|Sensory System Agents|sensory system agents|mesh-ancestor
92695940|NCT02946294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695941|NCT02946294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92695942|NCT02946294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92695943|NCT02946294|Adrenergic Agents|adrenergic agents|mesh-ancestor
92695944|NCT02946294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695945|NCT02946294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695946|NCT02946294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92695947|NCT02946294|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92695948|NCT02946294|Autonomic Agents|autonomic agents|mesh-ancestor
92695949|NCT02946294|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92695950|NCT02946294|Respiratory System Agents|respiratory system agents|mesh-ancestor
92695951|NCT02946294|Mydriatics|mydriatics|mesh-ancestor
92695952|NCT02946294|Sympathomimetics|sympathomimetics|mesh-ancestor
92695953|NCT02946294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92695954|NCT05146232|Anesthetics|anesthetics|mesh-list
92695955|NCT05146232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695956|NCT05146232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695957|NCT00525096|Celecoxib|celecoxib|mesh-list
92695958|NCT00525096|Exemestane|exemestane|mesh-list
92695959|NCT00525096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695960|NCT00525096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695961|NCT00525096|Analgesics|analgesics|mesh-ancestor
92695962|NCT00525096|Sensory System Agents|sensory system agents|mesh-ancestor
92695963|NCT00525096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695964|NCT00525096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695965|NCT00525096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695966|NCT00525096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695967|NCT00525096|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92695968|NCT00525096|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92695969|NCT00525096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695970|NCT00525096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695971|NCT00525096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695972|NCT00525096|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92695973|NCT00525096|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92695974|NCT00525096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92695975|NCT00525096|Hormone Antagonists|hormone antagonists|mesh-ancestor
92695976|NCT00525096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92695977|NCT04693026|Remdesivir|remdesivir|mesh-list
92695978|NCT04693026|Antimetabolites|antimetabolites|mesh-ancestor
92695979|NCT04693026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695980|NCT04693026|Antiviral Agents|antiviral agents|mesh-ancestor
92695981|NCT04693026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607540|NCT00132548|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92014878|NCT05189535|Antioxidants|antioxidants|mesh-ancestor
92695982|NCT02276859|Insulin|insulin|mesh-list
92695986|NCT02276859|Insulin glulisine|insulin glulisine|mesh-list
92695987|NCT02276859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695988|NCT02276859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695989|NCT05143970|Trastuzumab|trastuzumab|mesh-list
92695990|NCT05143970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92695991|NCT05143970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695992|NCT05147090|Empagliflozin|empagliflozin|mesh-list
92695993|NCT05147090|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92695994|NCT05147090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695995|NCT05147090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695996|NCT05147090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695997|NCT00525252|Baclofen|baclofen|mesh-list
92695998|NCT00525252|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92695999|NCT00525252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696000|NCT00525252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92696001|NCT00525252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696002|NCT00525252|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92696003|NCT00525252|GABA Agonists|gaba agonists|mesh-ancestor
92696004|NCT00525252|GABA Agents|gaba agents|mesh-ancestor
92696005|NCT00525252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696006|NCT00525252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696007|NCT02947113|Etoposide|etoposide|mesh-list
92696008|NCT02947113|Pemetrexed|pemetrexed|mesh-list
92696009|NCT02947113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696010|NCT02947113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92696011|NCT02947113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696012|NCT02947113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696013|NCT02947113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696014|NCT02947113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696015|NCT02947113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92696016|NCT02947113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92696018|NCT05149274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696019|NCT02276690|Hepcidins|hepcidins|mesh-list
92696020|NCT02276690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696021|NCT02947269|Prucalopride|prucalopride|mesh-list
92696022|NCT02947269|Laxatives|laxatives|mesh-ancestor
92696023|NCT02947269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696024|NCT02947269|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92696025|NCT02947269|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92696026|NCT02947269|Serotonin Agents|serotonin agents|mesh-ancestor
92696027|NCT02947269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696028|NCT02947269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696029|NCT02947269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696030|NCT00526305|Cytarabine|cytarabine|mesh-list
92696031|NCT00526305|Dexamethasone|dexamethasone|mesh-list
92696032|NCT00526305|Prednisone|prednisone|mesh-list
92696033|NCT00526305|Hydrocortisone|hydrocortisone|mesh-list
92696034|NCT00526305|Cyclophosphamide|cyclophosphamide|mesh-list
92696035|NCT00526305|Vincristine|vincristine|mesh-list
92696036|NCT00526305|Daunorubicin|daunorubicin|mesh-list
92696037|NCT00526305|Asparaginase|asparaginase|mesh-list
92696038|NCT00526305|Mitoxantrone|mitoxantrone|mesh-list
92696039|NCT00526305|Mercaptopurine|mercaptopurine|mesh-list
92696040|NCT00526305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696041|NCT00526305|Immunologic Factors|immunologic factors|mesh-ancestor
92696042|NCT00526305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696043|NCT00526305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696044|NCT00526305|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696045|NCT00526305|Alkylating Agents|alkylating agents|mesh-ancestor
92696046|NCT00526305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696047|NCT00526305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696048|NCT00526305|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92696049|NCT00526305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696050|NCT00526305|Antiemetics|antiemetics|mesh-ancestor
92696051|NCT00526305|Autonomic Agents|autonomic agents|mesh-ancestor
92696052|NCT00526305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696053|NCT00526305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696054|NCT00526305|Glucocorticoids|glucocorticoids|mesh-ancestor
92696055|NCT00526305|Hormones|hormones|mesh-ancestor
92696056|NCT00526305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607542|NCT00132548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92607543|NCT00132548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607544|NCT00132548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053419|NCT05554146|Dronabinol|dronabinol|mesh-list
92696060|NCT00526305|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696061|NCT00526305|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696062|NCT00526305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696063|NCT00526305|Antimetabolites|antimetabolites|mesh-ancestor
92696064|NCT00526305|Antiviral Agents|antiviral agents|mesh-ancestor
92696065|NCT00526305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696066|NCT00526305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92696067|NCT00526305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696068|NCT00526305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696069|NCT00526305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696070|NCT00526305|Analgesics|analgesics|mesh-ancestor
92696071|NCT00526305|Sensory System Agents|sensory system agents|mesh-ancestor
92696072|NCT00526305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92696073|NCT02276768|Trimebutine|trimebutine|mesh-list
92696074|NCT02276768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696075|NCT02276768|Parasympatholytics|parasympatholytics|mesh-ancestor
92696076|NCT02276768|Autonomic Agents|autonomic agents|mesh-ancestor
92696077|NCT02276768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696078|NCT02276768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696079|NCT00526383|Antidepressive Agents|antidepressive agents|mesh-list
92696080|NCT00526383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
92696081|NCT00526383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92696082|NCT05147753|Moxonidine|moxonidine|mesh-list
92696083|NCT05147753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92696084|NCT00525408|Docetaxel|docetaxel|mesh-list
92696085|NCT00525408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696086|NCT00525408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696087|NCT00525408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696088|NCT00525408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92115942|NCT03298074|Etoposide|etoposide|mesh-list
92696089|NCT00525408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696090|NCT00525447|Dexamethasone|dexamethasone|mesh-list
92696091|NCT00525447|Lenalidomide|lenalidomide|mesh-list
92696092|NCT00525447|Dacetuzumab|dacetuzumab|mesh-list
92696093|NCT00525447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696094|NCT00525447|Antiemetics|antiemetics|mesh-ancestor
92696095|NCT00525447|Autonomic Agents|autonomic agents|mesh-ancestor
92696096|NCT00525447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696097|NCT00525447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696098|NCT00525447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696099|NCT00525447|Glucocorticoids|glucocorticoids|mesh-ancestor
92696100|NCT00525447|Hormones|hormones|mesh-ancestor
92696101|NCT00525447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696102|NCT00525447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92696103|NCT00525447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696104|NCT00525447|Immunologic Factors|immunologic factors|mesh-ancestor
92696105|NCT00525447|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92696106|NCT00525447|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92696107|NCT00525447|Growth Substances|growth substances|mesh-ancestor
92696108|NCT00525447|Growth Inhibitors|growth inhibitors|mesh-ancestor
92696109|NCT00525447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696110|NCT00525486|Nifedipine|nifedipine|mesh-list
92696111|NCT00525486|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92696112|NCT00525486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696113|NCT00525486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696114|NCT00525486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696115|NCT00525486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696116|NCT00525486|Vasodilator Agents|vasodilator agents|mesh-ancestor
92696117|NCT00525486|Tocolytic Agents|tocolytic agents|mesh-ancestor
92696118|NCT00525486|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92696119|NCT05145101|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92696120|NCT05145101|Immunologic Factors|immunologic factors|mesh-ancestor
92696121|NCT05145101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696122|NCT02946060|TEMPO|tempo|mesh-list
92696123|NCT02946060|Antioxidants|antioxidants|mesh-ancestor
92696124|NCT02946060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696125|NCT02946060|Protective Agents|protective agents|mesh-ancestor
92053444|NCT05535738|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92696126|NCT02946060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696127|NCT00525564|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92696146|NCT00525642|Immunologic Factors|immunologic factors|mesh-ancestor
92696147|NCT00525642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696148|NCT00525642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696149|NCT00525642|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696150|NCT00525642|Alkylating Agents|alkylating agents|mesh-ancestor
92696151|NCT00525642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696152|NCT00525642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696153|NCT00525642|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92696154|NCT00525642|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696155|NCT00525642|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696156|NCT00525642|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696157|NCT00525642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92696158|NCT00525642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696159|NCT00525642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696160|NCT00525642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696161|NCT00525681|Cyclosporine|cyclosporine|mesh-list
92696162|NCT00525681|Tacrolimus|tacrolimus|mesh-list
92696163|NCT00525681|Cyclosporins|cyclosporins|mesh-list
92696164|NCT00525681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696165|NCT00525681|Immunologic Factors|immunologic factors|mesh-ancestor
92696166|NCT00525681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116016|NCT01994746|Incretins|incretins|mesh-ancestor
92696167|NCT00525681|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92696168|NCT00525681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696169|NCT00525681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696170|NCT00525681|Antifungal Agents|antifungal agents|mesh-ancestor
92696171|NCT00525681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696172|NCT00525681|Dermatologic Agents|dermatologic agents|mesh-ancestor
92696173|NCT00525681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696174|NCT03456635|Anti-Infective Agents|anti-infective agents|mesh-list
92696175|NCT03456635|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92696176|NCT02945982|Entecavir|entecavir|mesh-list
92696177|NCT02945982|Carvedilol|carvedilol|mesh-list
92696178|NCT02945982|Antiviral Agents|antiviral agents|mesh-ancestor
92696179|NCT02945982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696180|NCT02945982|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92696181|NCT02945982|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92696182|NCT02945982|Adrenergic Agents|adrenergic agents|mesh-ancestor
92696183|NCT02945982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696184|NCT02945982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696187|NCT02945982|Antioxidants|antioxidants|mesh-ancestor
92696188|NCT02945982|Protective Agents|protective agents|mesh-ancestor
92696189|NCT02945982|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92696190|NCT02945982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696191|NCT02945982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696192|NCT02945982|Vasodilator Agents|vasodilator agents|mesh-ancestor
92696193|NCT02945982|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92696194|NCT02945982|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92696195|NCT02954393|Amoxicillin|amoxicillin|mesh-list
92696196|NCT02954393|Metronidazole|metronidazole|mesh-list
92696197|NCT02954393|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92696198|NCT02954393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696199|NCT02954393|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92696200|NCT02954393|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92696201|NCT02954276|Sumatriptan|sumatriptan|mesh-list
92696202|NCT02954276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92696203|NCT02954276|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92696204|NCT02954276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92696205|NCT02954276|Serotonin Agents|serotonin agents|mesh-ancestor
92696206|NCT02954276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696207|NCT02954276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696208|NCT02954276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696209|NCT00507494|Pioglitazone|pioglitazone|mesh-list
92696210|NCT00507494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92696211|NCT00507494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696212|NCT00526617|Temozolomide|temozolomide|mesh-list
92696213|NCT00526617|Veliparib|veliparib|mesh-list
92696214|NCT00526617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696215|NCT00526617|Alkylating Agents|alkylating agents|mesh-ancestor
92696216|NCT00526617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696217|NCT00526617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607545|NCT00132548|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92607546|NCT00140751|Ritonavir|ritonavir|mesh-list
92696218|NCT00526617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92696219|NCT00526617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696220|NCT00507845|Felodipine|felodipine|mesh-list
92696221|NCT00507845|Ramipril|ramipril|mesh-list
92696222|NCT00507845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92696223|NCT00507845|Protease Inhibitors|protease inhibitors|mesh-ancestor
92696224|NCT00507845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696225|NCT00507845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696226|NCT00507845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92696227|NCT00507845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92696228|NCT00507845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92696229|NCT00507845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696230|NCT00507845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696231|NCT00507845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696232|NCT00507845|Vasodilator Agents|vasodilator agents|mesh-ancestor
92696233|NCT00525759|Zoledronic Acid|zoledronic acid|mesh-list
92696234|NCT00525759|Cyclophosphamide|cyclophosphamide|mesh-list
92696235|NCT00525759|Docetaxel|docetaxel|mesh-list
92696236|NCT00525759|Fluorouracil|fluorouracil|mesh-list
92696237|NCT00525759|Epirubicin|epirubicin|mesh-list
92696238|NCT00525759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696239|NCT00525759|Immunologic Factors|immunologic factors|mesh-ancestor
92696240|NCT00525759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696241|NCT00525759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116099|NCT02461056|Narcotics|narcotics|mesh-ancestor
92696242|NCT00525759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696243|NCT00525759|Alkylating Agents|alkylating agents|mesh-ancestor
92696244|NCT00525759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696245|NCT00525759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696246|NCT00525759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92696247|NCT00525759|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696248|NCT00525759|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696249|NCT00525759|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696250|NCT00525759|Antimetabolites|antimetabolites|mesh-ancestor
92696251|NCT00525759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696252|NCT00525759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92696253|NCT00525759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696254|NCT00525759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696255|NCT00525759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696268|NCT00508040|Interferon alpha-2|interferon alpha-2|mesh-list
92696269|NCT00508040|Prednisone|prednisone|mesh-list
92696270|NCT00508040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696271|NCT00508040|Glucocorticoids|glucocorticoids|mesh-ancestor
92696272|NCT00508040|Hormones|hormones|mesh-ancestor
92696273|NCT00508040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696274|NCT00508040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696275|NCT00508040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92696276|NCT00508040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696277|NCT00508040|Antiviral Agents|antiviral agents|mesh-ancestor
92696278|NCT00508040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696279|NCT00508040|Immunologic Factors|immunologic factors|mesh-ancestor
92696280|NCT00508664|Docetaxel|docetaxel|mesh-list
92696281|NCT00508664|Fluorouracil|fluorouracil|mesh-list
92696282|NCT00508664|Cetuximab|cetuximab|mesh-list
92696283|NCT00508664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696284|NCT00508664|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696285|NCT00508664|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696286|NCT00508664|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696287|NCT00508664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696288|NCT00508664|Antimetabolites|antimetabolites|mesh-ancestor
92696289|NCT00508664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696290|NCT00508664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696291|NCT00508664|Immunologic Factors|immunologic factors|mesh-ancestor
92696292|NCT00508664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696293|NCT00508664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696294|NCT02946684|Letrozole|letrozole|mesh-list
92696295|NCT02946684|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92696296|NCT02946684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696297|NCT02946684|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92696298|NCT02946684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696299|NCT02946684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607547|NCT00140751|Lopinavir|lopinavir|mesh-list
92607548|NCT00140751|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92607549|NCT00140751|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92053632|NCT05245968|Sunitinib|sunitinib|mesh-list
92696300|NCT02946684|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92696301|NCT02946684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92696302|NCT02946684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696303|NCT02946684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696304|NCT02953379|Mometasone Furoate|mometasone furoate|mesh-list
92696305|NCT02953379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696306|NCT02953379|Dermatologic Agents|dermatologic agents|mesh-ancestor
92696307|NCT02953379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92696308|NCT02946801|Listerine|listerine|mesh-list
92696309|NCT02946801|Sodium Fluoride|sodium fluoride|mesh-list
92696310|NCT02946801|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92696311|NCT02946801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696312|NCT02946801|Cariostatic Agents|cariostatic agents|mesh-ancestor
92696313|NCT02946801|Protective Agents|protective agents|mesh-ancestor
92696314|NCT02946801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696315|NCT02953847|Rifampin|rifampin|mesh-list
92696316|NCT02953847|Isoniazid|isoniazid|mesh-list
92116170|NCT03283410|Propofol|propofol|mesh-list
92696317|NCT02953847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92696318|NCT02953847|Antitubercular Agents|antitubercular agents|mesh-ancestor
92696319|NCT02953847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92696320|NCT02953847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696336|NCT00526695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92696337|NCT00526695|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92696338|NCT00526695|Anesthetics, General|anesthetics, general|mesh-ancestor
92696339|NCT00526695|Anesthetics|anesthetics|mesh-ancestor
92696340|NCT00526695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696341|NCT00526695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696342|NCT00526929|Darbepoetin alfa|darbepoetin alfa|mesh-list
92696343|NCT00526929|Hematinics|hematinics|mesh-ancestor
92696344|NCT02953535|Sofosbuvir|sofosbuvir|mesh-list
92696345|NCT02953535|Antiviral Agents|antiviral agents|mesh-ancestor
92696346|NCT02953535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696347|NCT00526734|Melphalan|melphalan|mesh-list
92696348|NCT00526734|Immunologic Factors|immunologic factors|mesh-ancestor
92696349|NCT00526734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696350|NCT00526734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696351|NCT00526734|Alkylating Agents|alkylating agents|mesh-ancestor
92696352|NCT00526734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696353|NCT00526734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696354|NCT00526734|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92696355|NCT00526734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696356|NCT00508859|Sertraline|sertraline|mesh-list
92696357|NCT00508859|Antidepressive Agents|antidepressive agents|mesh-ancestor
92696358|NCT00508859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92696359|NCT00508859|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92696360|NCT00508859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92696361|NCT00508859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696362|NCT00508859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696363|NCT00508859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696364|NCT00508859|Serotonin Agents|serotonin agents|mesh-ancestor
92696365|NCT00508859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696366|NCT00508898|Calcitriol|calcitriol|mesh-list
92696367|NCT00508898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696368|NCT00508898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696369|NCT00508898|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92696370|NCT00508898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696371|NCT00508898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696372|NCT00508898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92696373|NCT00508898|Vitamins|vitamins|mesh-ancestor
92696374|NCT00508898|Micronutrients|micronutrients|mesh-ancestor
92696375|NCT00508898|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92696376|NCT04692558|Hyaluronic Acid|hyaluronic acid|mesh-list
92696382|NCT02952599|Edoxaban|edoxaban|mesh-list
92696383|NCT02952599|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92696384|NCT02952599|Antithrombins|antithrombins|mesh-ancestor
92696385|NCT02952599|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92696386|NCT02952599|Protease Inhibitors|protease inhibitors|mesh-ancestor
92607550|NCT00140751|Protease Inhibitors|protease inhibitors|mesh-ancestor
92607551|NCT00140751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607552|NCT00140751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607553|NCT00140751|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92607554|NCT00140751|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92607555|NCT00140751|Antiviral Agents|antiviral agents|mesh-ancestor
92696387|NCT02952599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696388|NCT02952599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696389|NCT02952599|Anticoagulants|anticoagulants|mesh-ancestor
92696390|NCT00510419|Sumatriptan|sumatriptan|mesh-list
92696392|NCT00510419|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92696393|NCT00510419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92696394|NCT00510419|Serotonin Agents|serotonin agents|mesh-ancestor
92696395|NCT00510419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696396|NCT00510419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696397|NCT00510419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696398|NCT00510536|Acetaminophen|acetaminophen|mesh-list
92696399|NCT00510536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92696400|NCT00510536|Analgesics|analgesics|mesh-ancestor
92696401|NCT00510536|Sensory System Agents|sensory system agents|mesh-ancestor
92696402|NCT00510536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696403|NCT00510536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696404|NCT00510536|Antipyretics|antipyretics|mesh-ancestor
92696405|NCT03458715|Empagliflozin|empagliflozin|mesh-list
92696406|NCT03458715|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92696407|NCT03458715|Linagliptin|linagliptin|mesh-list
92696408|NCT03458715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92696409|NCT03458715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696410|NCT03458715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92696411|NCT03458715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696412|NCT03458715|Incretins|incretins|mesh-ancestor
92696413|NCT03458715|Hormones|hormones|mesh-ancestor
92696414|NCT03458715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696415|NCT03458715|Protease Inhibitors|protease inhibitors|mesh-ancestor
92696416|NCT03458715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696417|NCT00510614|Tinidazole|tinidazole|mesh-list
92696418|NCT00510614|Alkylating Agents|alkylating agents|mesh-ancestor
92696419|NCT00510614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696420|NCT00510614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92696421|NCT00510614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696422|NCT00510614|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92696423|NCT00510614|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92696424|NCT00510614|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92696425|NCT00508976|Lidocaine|lidocaine|mesh-list
92696426|NCT00508976|Bupivacaine|bupivacaine|mesh-list
92696427|NCT00508976|Anesthetics, Local|anesthetics, local|mesh-ancestor
92696428|NCT00508976|Anesthetics|anesthetics|mesh-ancestor
92696429|NCT00508976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696430|NCT00508976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696431|NCT00508976|Sensory System Agents|sensory system agents|mesh-ancestor
92696432|NCT00508976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696433|NCT00508976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92696434|NCT00508976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92696435|NCT00508976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92696436|NCT00508976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696437|NCT00508976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696438|NCT04692285|Zolpidem|zolpidem|mesh-list
92696439|NCT04692285|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92696440|NCT04692285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982991|NCT02040532|Gabapentin|gabapentin|mesh-list
92696441|NCT04692285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696442|NCT04692285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696443|NCT04692285|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92696444|NCT04692285|GABA Agonists|gaba agonists|mesh-ancestor
92696445|NCT04692285|GABA Agents|gaba agents|mesh-ancestor
92696446|NCT04692285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696464|NCT00509015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607556|NCT00140751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607557|NCT00140751|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92607558|NCT00140751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92607559|NCT00132587|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92607560|NCT00132587|Vasodilator Agents|vasodilator agents|mesh-ancestor
92607561|NCT00132587|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92607562|NCT00132587|Protective Agents|protective agents|mesh-ancestor
92696465|NCT00509015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92696467|NCT00528060|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92696468|NCT00528060|Tenofovir|tenofovir|mesh-list
92696469|NCT00528060|Emtricitabine|emtricitabine|mesh-list
92696470|NCT00528060|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92696471|NCT00528060|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92696472|NCT00528060|Protease Inhibitors|protease inhibitors|mesh-ancestor
92696473|NCT00528060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696474|NCT00528060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696475|NCT00528060|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92696476|NCT00528060|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92696477|NCT00528060|Antiviral Agents|antiviral agents|mesh-ancestor
92696478|NCT00528060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696479|NCT00528060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92696480|NCT00528060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92696481|NCT00528060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92696482|NCT00528060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92696483|NCT00527085|Cinacalcet|cinacalcet|mesh-list
92696484|NCT00527085|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696485|NCT00527085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696486|NCT00527085|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92696487|NCT00527085|Hormone Antagonists|hormone antagonists|mesh-ancestor
92696488|NCT00527085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696489|NCT00509327|Bisacodyl|bisacodyl|mesh-list
92696490|NCT00509327|Cathartics|cathartics|mesh-ancestor
92696491|NCT00509327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696492|NCT00509327|Laxatives|laxatives|mesh-ancestor
92696493|NCT00509405|Potassium Citrate|potassium citrate|mesh-list
92696494|NCT00509405|Diuretics|diuretics|mesh-ancestor
92696495|NCT00509405|Natriuretic Agents|natriuretic agents|mesh-ancestor
92696496|NCT00509405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696497|NCT00509405|Expectorants|expectorants|mesh-ancestor
92696498|NCT00509405|Respiratory System Agents|respiratory system agents|mesh-ancestor
92696499|NCT00509561|Capecitabine|capecitabine|mesh-list
92696500|NCT00509561|Cetuximab|cetuximab|mesh-list
92696501|NCT00509561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696502|NCT00509561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696503|NCT00509561|Antimetabolites|antimetabolites|mesh-ancestor
92696504|NCT00509561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696505|NCT00509561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696517|NCT00528177|Analgesics|analgesics|mesh-ancestor
92696518|NCT00528177|Sensory System Agents|sensory system agents|mesh-ancestor
92696519|NCT00528177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696520|NCT00509678|Rituximab|rituximab|mesh-list
92696521|NCT00509678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696522|NCT00509678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696523|NCT00509678|Immunologic Factors|immunologic factors|mesh-ancestor
92696524|NCT00509678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696525|NCT00509678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696526|NCT00528216|Capsaicin|capsaicin|mesh-list
92696527|NCT00528216|Antipruritics|antipruritics|mesh-ancestor
92696528|NCT00528216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92696529|NCT00528216|Sensory System Agents|sensory system agents|mesh-ancestor
92696530|NCT00528216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696531|NCT00528216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696532|NCT00528255|Misoprostol|misoprostol|mesh-list
92696533|NCT00528255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92696534|NCT00528255|Abortifacient Agents|abortifacient agents|mesh-ancestor
92696535|NCT00528255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92696536|NCT00528255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696537|NCT00528255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92607563|NCT00132587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607564|NCT00140790|Valsartan|valsartan|mesh-list
92607565|NCT00140790|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92607566|NCT00140790|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92607567|NCT00140790|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92607568|NCT00140790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607569|NCT01245673|Lenalidomide|lenalidomide|mesh-list
92696538|NCT00528255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696539|NCT00528255|Oxytocics|oxytocics|mesh-ancestor
92116403|NCT03289182|Rituximab|rituximab|mesh-list
92696540|NCT02953106|Fluticasone|fluticasone|mesh-list
92696541|NCT02953106|Azelastine|azelastine|mesh-list
92696542|NCT02953106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696543|NCT02953106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92696544|NCT02953106|Autonomic Agents|autonomic agents|mesh-ancestor
92696545|NCT02953106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696546|NCT02953106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696547|NCT02953106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92696548|NCT02953106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92696549|NCT02953106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92696550|NCT02953106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92696551|NCT02953106|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92696552|NCT02953106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696553|NCT02953106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696554|NCT02953106|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92696555|NCT02953106|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92696556|NCT02953106|Histamine Antagonists|histamine antagonists|mesh-ancestor
92696557|NCT02953106|Histamine Agents|histamine agents|mesh-ancestor
92696558|NCT02953106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696559|NCT02952989|Pembrolizumab|pembrolizumab|mesh-list
92696560|NCT02952989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696561|NCT02952989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696562|NCT02952989|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92696563|NCT02952989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696564|NCT00510926|Imatinib Mesylate|imatinib mesylate|mesh-list
92696565|NCT00510926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696566|NCT00510926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92696567|NCT00510926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696568|NCT00510926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696569|NCT00509834|Lactoferrin|lactoferrin|mesh-list
92696570|NCT00509834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696574|NCT03459404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696575|NCT03459404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696576|NCT03459404|Analgesics|analgesics|mesh-ancestor
92696577|NCT03459404|Sensory System Agents|sensory system agents|mesh-ancestor
92696578|NCT03459404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696579|NCT03459404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92696580|NCT03459404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92696581|NCT03459404|Anesthetics, General|anesthetics, general|mesh-ancestor
92696582|NCT03459404|Anesthetics|anesthetics|mesh-ancestor
92696583|NCT00527202|Botulinum Toxins|botulinum toxins|mesh-list
92696584|NCT00527202|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92696585|NCT00527202|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92696586|NCT00527202|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92696587|NCT00527202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696588|NCT00527202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696589|NCT00527202|Cholinergic Agents|cholinergic agents|mesh-ancestor
92696590|NCT00527202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696591|NCT00527202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696592|NCT00527202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92696593|NCT00527202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696594|NCT00510965|Ranibizumab|ranibizumab|mesh-list
92696595|NCT00510965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92696596|NCT00510965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92696597|NCT00510965|Growth Substances|growth substances|mesh-ancestor
92696598|NCT00510965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607570|NCT01245673|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92607571|NCT01245673|Poly ICLC|poly iclc|mesh-list
92607572|NCT01245673|Immunologic Factors|immunologic factors|mesh-ancestor
92696599|NCT00510965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92696600|NCT00510965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696601|NCT00509990|Pimecrolimus|pimecrolimus|mesh-list
92696602|NCT00509990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92696603|NCT00509990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92696604|NCT00509990|Analgesics|analgesics|mesh-ancestor
92696605|NCT00509990|Sensory System Agents|sensory system agents|mesh-ancestor
92696606|NCT00509990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696607|NCT00509990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696608|NCT00509990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696609|NCT00509990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696610|NCT00509990|Dermatologic Agents|dermatologic agents|mesh-ancestor
92696611|NCT00509990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696612|NCT00509990|Immunologic Factors|immunologic factors|mesh-ancestor
92696613|NCT00509990|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92696614|NCT00509990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696615|NCT00509990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696616|NCT03459911|Losartan|losartan|mesh-list
92696617|NCT03459911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92696618|NCT03459911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92696619|NCT03459911|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92696620|NCT03459911|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92696621|NCT03459911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696622|NCT03459833|Hyaluronic Acid|hyaluronic acid|mesh-list
92696623|NCT03459833|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92696624|NCT03459833|Immunologic Factors|immunologic factors|mesh-ancestor
92696625|NCT03459833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696626|NCT03459833|Viscosupplements|viscosupplements|mesh-ancestor
92696627|NCT03459833|Protective Agents|protective agents|mesh-ancestor
92696628|NCT05648487|Antibodies|antibodies|mesh-list
92696629|NCT05648487|Immunologic Factors|immunologic factors|mesh-ancestor
92696630|NCT05648487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696631|NCT00511121|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92696632|NCT00511121|Imatinib Mesylate|imatinib mesylate|mesh-list
92696633|NCT00511121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696634|NCT00511121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92696635|NCT00511121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696636|NCT00511121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696637|NCT00511121|Antiviral Agents|antiviral agents|mesh-ancestor
92696638|NCT00511121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696639|NCT04692051|Paclitaxel|paclitaxel|mesh-list
92696640|NCT04692051|Cisplatin|cisplatin|mesh-list
92696641|NCT04692051|Gemcitabine|gemcitabine|mesh-list
92696642|NCT04692051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92696655|NCT00528723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92696656|NCT00528723|Respiratory System Agents|respiratory system agents|mesh-ancestor
92696657|NCT00528723|Tocolytic Agents|tocolytic agents|mesh-ancestor
92696658|NCT00528723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92696659|NCT00528723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92696660|NCT00528723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92696661|NCT00528723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92696662|NCT00528723|Adrenergic Agents|adrenergic agents|mesh-ancestor
92696663|NCT00528723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696664|NCT00528723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696665|NCT00510107|Oxaliplatin|oxaliplatin|mesh-list
92696666|NCT00510107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696667|NCT01580514|Exenatide|exenatide|mesh-list
92696668|NCT01580514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92696669|NCT01580514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696670|NCT01580514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92696671|NCT01580514|Incretins|incretins|mesh-ancestor
92696672|NCT01580514|Hormones|hormones|mesh-ancestor
92696673|NCT01580514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696674|NCT00528918|Insulin glulisine|insulin glulisine|mesh-list
92696675|NCT00528918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92696676|NCT00528918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696677|NCT00515190|Oxaliplatin|oxaliplatin|mesh-list
92696678|NCT00515190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696679|NCT00511277|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92607573|NCT01245673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607574|NCT01245673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053997|NCT04254627|Etanercept|etanercept|mesh-list
92696680|NCT00511277|Antidepressive Agents|antidepressive agents|mesh-ancestor
92696681|NCT00511277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92696682|NCT00511277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92696683|NCT00511277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92696684|NCT00511277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696685|NCT00511277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696686|NCT02953184|Vitamins|vitamins|mesh-list
92696687|NCT02953184|Vitamin B Complex|vitamin b complex|mesh-list
92696688|NCT02953184|Cyclophosphamide|cyclophosphamide|mesh-list
92696689|NCT02953184|Docetaxel|docetaxel|mesh-list
92696690|NCT02953184|Doxorubicin|doxorubicin|mesh-list
92696691|NCT02953184|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92696692|NCT02953184|Dexrazoxane|dexrazoxane|mesh-list
92696694|NCT02953184|Pirarubicin|pirarubicin|mesh-list
92696695|NCT02953184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696696|NCT02953184|Immunologic Factors|immunologic factors|mesh-ancestor
92696697|NCT02953184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696698|NCT02953184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696699|NCT02953184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696700|NCT02953184|Alkylating Agents|alkylating agents|mesh-ancestor
92696701|NCT02953184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696702|NCT02953184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696703|NCT02953184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92696704|NCT02953184|Micronutrients|micronutrients|mesh-ancestor
92696705|NCT02953184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696706|NCT02953184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696707|NCT02953184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696721|NCT00515229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696722|NCT00515229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696723|NCT00515229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92696724|NCT00515229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92696725|NCT00515229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696726|NCT00515229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696727|NCT00515229|Adrenergic Agents|adrenergic agents|mesh-ancestor
92696728|NCT00515229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696730|NCT00511316|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92696731|NCT00511316|Respiratory System Agents|respiratory system agents|mesh-ancestor
92696732|NCT00511316|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92696733|NCT00511316|Hormone Antagonists|hormone antagonists|mesh-ancestor
92696734|NCT00511316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696735|NCT00511316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696736|NCT00511316|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92696737|NCT00511316|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92696738|NCT00511316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696739|NCT00529269|Mycophenolic Acid|mycophenolic acid|mesh-list
92696740|NCT00529269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92696741|NCT00529269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696742|NCT00529269|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92696743|NCT00529269|Antitubercular Agents|antitubercular agents|mesh-ancestor
92696744|NCT00529269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92696745|NCT00529269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696746|NCT00529269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696747|NCT00529269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696748|NCT00515268|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
92696749|NCT00515268|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92696750|NCT00515268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92696751|NCT00515268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696752|NCT00515268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696753|NCT01356966|Folic Acid|folic acid|mesh-list
92696754|NCT01356966|Hematinics|hematinics|mesh-ancestor
92696755|NCT01356966|Vitamin B Complex|vitamin b complex|mesh-ancestor
92696756|NCT01356966|Vitamins|vitamins|mesh-ancestor
92696757|NCT01356966|Micronutrients|micronutrients|mesh-ancestor
92696758|NCT01356966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696759|NCT02944734|Amlodipine|amlodipine|mesh-list
92696760|NCT02944734|Candesartan|candesartan|mesh-list
92696761|NCT02944734|Candesartan cilexetil|candesartan cilexetil|mesh-list
92607575|NCT01245673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92607576|NCT01245673|Growth Substances|growth substances|mesh-ancestor
92054082|NCT04081389|Paclitaxel|paclitaxel|mesh-list
92696762|NCT02944734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92696763|NCT02944734|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92116634|NCT02460432|Paclitaxel|paclitaxel|mesh-list
92696764|NCT02944734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92696767|NCT02944734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696768|NCT02944734|Vasodilator Agents|vasodilator agents|mesh-ancestor
92696769|NCT02944734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92696770|NCT02944734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92696771|NCT00510263|Valacyclovir|valacyclovir|mesh-list
92696772|NCT00510263|Prednisolone|prednisolone|mesh-list
92696773|NCT00510263|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92696774|NCT00510263|Methylprednisolone|methylprednisolone|mesh-list
92696775|NCT00510263|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92696776|NCT00510263|Prednisolone acetate|prednisolone acetate|mesh-list
92696777|NCT00510263|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92696778|NCT00510263|Prednisolone phosphate|prednisolone phosphate|mesh-list
92696779|NCT00510263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696780|NCT00510263|Glucocorticoids|glucocorticoids|mesh-ancestor
92696781|NCT00510263|Hormones|hormones|mesh-ancestor
92696782|NCT00510263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696783|NCT00510263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371350|NCT01267656|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92696784|NCT00510263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92696785|NCT00510263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696786|NCT00510263|Antiemetics|antiemetics|mesh-ancestor
92696787|NCT00510263|Autonomic Agents|autonomic agents|mesh-ancestor
92696788|NCT00510263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696789|NCT00510263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696790|NCT00510263|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92696791|NCT00510263|Protective Agents|protective agents|mesh-ancestor
92696792|NCT00510263|Antiviral Agents|antiviral agents|mesh-ancestor
92696793|NCT00510263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696794|NCT00511628|Risperidone|risperidone|mesh-list
92696795|NCT00511628|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92696796|NCT00511628|Serotonin Agents|serotonin agents|mesh-ancestor
92696797|NCT00511628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696798|NCT00511628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696799|NCT00511628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696800|NCT00511628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92696801|NCT00511628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92696802|NCT00511628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696803|NCT00511628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92696804|NCT00511628|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92696805|NCT00511628|Dopamine Agents|dopamine agents|mesh-ancestor
92696806|NCT00529425|Ropivacaine|ropivacaine|mesh-list
92696807|NCT00529425|Anesthetics, Local|anesthetics, local|mesh-ancestor
92696808|NCT00529425|Anesthetics|anesthetics|mesh-ancestor
92696809|NCT00529425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696810|NCT00529425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696811|NCT00529425|Sensory System Agents|sensory system agents|mesh-ancestor
92696812|NCT00529425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696813|NCT02950935|Progesterone|progesterone|mesh-list
92696814|NCT02950935|Progestins|progestins|mesh-ancestor
92696815|NCT02950935|Hormones|hormones|mesh-ancestor
92696816|NCT02950935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696817|NCT02950935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696818|NCT00529620|Pyrimethamine|pyrimethamine|mesh-list
92696819|NCT00529620|Piperaquine|piperaquine|mesh-list
92696820|NCT00529620|Sulfadoxine|sulfadoxine|mesh-list
92696821|NCT00529620|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92696822|NCT00529620|Amodiaquine|amodiaquine|mesh-list
92696823|NCT00529620|Artenimol|artenimol|mesh-list
92696824|NCT00529620|Sulfalene|sulfalene|mesh-list
92696825|NCT00529620|Antimalarials|antimalarials|mesh-ancestor
92696826|NCT00529620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92696827|NCT00529620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92696828|NCT00529620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696829|NCT00529620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92696830|NCT00529620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696831|NCT00529620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696832|NCT00529620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92607577|NCT01245673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92607578|NCT01245673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607579|NCT01245673|Interferon Inducers|interferon inducers|mesh-ancestor
92696833|NCT00512993|Zoledronic Acid|zoledronic acid|mesh-list
92696834|NCT00512993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92696835|NCT00512993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696837|NCT00513032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696852|NCT02951897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696853|NCT02951897|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92696854|NCT02951897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92696855|NCT00511823|Rosiglitazone|rosiglitazone|mesh-list
92696856|NCT00511823|Granisetron|granisetron|mesh-list
92696857|NCT00511823|Casopitant|casopitant|mesh-list
92696858|NCT00511823|Dolasetron|dolasetron|mesh-list
92696859|NCT00511823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92696860|NCT00511823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696861|NCT00511823|Antiemetics|antiemetics|mesh-ancestor
92696862|NCT00511823|Autonomic Agents|autonomic agents|mesh-ancestor
92696863|NCT00511823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696864|NCT00511823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92696865|NCT00511823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92696866|NCT00511823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92696867|NCT00511823|Serotonin Agents|serotonin agents|mesh-ancestor
92696868|NCT00511823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696869|NCT00511823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696870|NCT00511823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92696871|NCT00515736|Vitamins|vitamins|mesh-list
92696872|NCT00515736|Vitamin E|vitamin e|mesh-list
92696873|NCT00515736|Thiamine|thiamine|mesh-list
92696874|NCT00515736|Zinc|zinc|mesh-list
92696875|NCT00515736|Selenium|selenium|mesh-list
92696876|NCT00515736|Micronutrients|micronutrients|mesh-ancestor
92696877|NCT00515736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696878|NCT00515736|Trace Elements|trace elements|mesh-ancestor
92696879|NCT00515736|Antioxidants|antioxidants|mesh-ancestor
92696880|NCT00515736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696881|NCT00515736|Protective Agents|protective agents|mesh-ancestor
92696882|NCT00515736|Vitamin B Complex|vitamin b complex|mesh-ancestor
92696883|NCT00511940|Acamprosate|acamprosate|mesh-list
92696884|NCT00511940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92696885|NCT00513149|Clopidogrel|clopidogrel|mesh-list
92696886|NCT00513149|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92696887|NCT00513149|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92696888|NCT00513149|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92696889|NCT00513149|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92696890|NCT00513149|Purinergic Agents|purinergic agents|mesh-ancestor
92696891|NCT00513149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696892|NCT00513149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696893|NCT00513149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696894|NCT02944227|Ranibizumab|ranibizumab|mesh-list
92696895|NCT02944227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92696896|NCT02944227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92696897|NCT02944227|Growth Substances|growth substances|mesh-ancestor
92696900|NCT02944227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696901|NCT00513188|Leucovorin|leucovorin|mesh-list
92696902|NCT00513188|Cytarabine|cytarabine|mesh-list
92696903|NCT00513188|Prednisone|prednisone|mesh-list
92696904|NCT00513188|Cyclophosphamide|cyclophosphamide|mesh-list
92696905|NCT00513188|Doxorubicin|doxorubicin|mesh-list
92696906|NCT00513188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92696907|NCT00513188|Methotrexate|methotrexate|mesh-list
92696908|NCT00513188|Vincristine|vincristine|mesh-list
92696909|NCT00513188|Denileukin diftitox|denileukin diftitox|mesh-list
92696910|NCT00513188|Levoleucovorin|levoleucovorin|mesh-list
92696911|NCT00513188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696912|NCT00513188|Immunologic Factors|immunologic factors|mesh-ancestor
92696913|NCT00513188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696914|NCT00513188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92696915|NCT00513188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92696916|NCT00513188|Alkylating Agents|alkylating agents|mesh-ancestor
92696917|NCT00513188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696918|NCT00513188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696919|NCT00513188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92696920|NCT00513188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92607580|NCT02261415|Tranexamic Acid|tranexamic acid|mesh-list
92054242|NCT03384238|Panitumumab|panitumumab|mesh-list
92696921|NCT00513188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696922|NCT00513188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696923|NCT00513188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696924|NCT00513188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92696925|NCT00513188|Glucocorticoids|glucocorticoids|mesh-ancestor
92696927|NCT00513188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92696928|NCT00513188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92696929|NCT00513188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92696930|NCT00513188|Abortifacient Agents|abortifacient agents|mesh-ancestor
92696931|NCT00513188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92696932|NCT00513188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696933|NCT00513188|Antimetabolites|antimetabolites|mesh-ancestor
92696934|NCT00513188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92696935|NCT00513188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92696936|NCT00513188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92696937|NCT00513188|Antiviral Agents|antiviral agents|mesh-ancestor
92696938|NCT00513188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696939|NCT00513188|Antidotes|antidotes|mesh-ancestor
92696940|NCT00513188|Protective Agents|protective agents|mesh-ancestor
92696941|NCT00513188|Vitamin B Complex|vitamin b complex|mesh-ancestor
92696942|NCT00513188|Vitamins|vitamins|mesh-ancestor
92696943|NCT00513188|Micronutrients|micronutrients|mesh-ancestor
92696944|NCT00513188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92696945|NCT00513188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696946|NCT00513188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696947|NCT00513188|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696948|NCT00513266|Leucovorin|leucovorin|mesh-list
92696949|NCT00513266|Bevacizumab|bevacizumab|mesh-list
92696950|NCT00513266|Cetuximab|cetuximab|mesh-list
92696951|NCT00513266|Fluorouracil|fluorouracil|mesh-list
92696952|NCT00513266|Oxaliplatin|oxaliplatin|mesh-list
92696953|NCT00513266|Irinotecan|irinotecan|mesh-list
92696954|NCT00513266|Calcium|calcium|mesh-list
92696955|NCT00513266|Levoleucovorin|levoleucovorin|mesh-list
92696956|NCT00513266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696957|NCT00513266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696958|NCT00513266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92696959|NCT00513266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92696960|NCT00513266|Growth Substances|growth substances|mesh-ancestor
92696961|NCT00513266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696962|NCT00513266|Growth Inhibitors|growth inhibitors|mesh-ancestor
92696963|NCT00513266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696964|NCT00513266|Antimetabolites|antimetabolites|mesh-ancestor
92696965|NCT00513266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696966|NCT00513266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696967|NCT00513266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696968|NCT00513266|Immunologic Factors|immunologic factors|mesh-ancestor
92696969|NCT00513266|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92696970|NCT00513266|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696971|NCT00513266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696972|NCT00513266|Antidotes|antidotes|mesh-ancestor
92696973|NCT00513266|Protective Agents|protective agents|mesh-ancestor
92696974|NCT00513266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92696993|NCT00513383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92696995|NCT00515892|Antibodies|antibodies|mesh-list
92696996|NCT00515892|Immunoglobulins|immunoglobulins|mesh-list
92696997|NCT00515892|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92696998|NCT00515892|Immunotoxins|immunotoxins|mesh-list
92696999|NCT00515892|Immunologic Factors|immunologic factors|mesh-ancestor
92697000|NCT00515892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697001|NCT00515892|Immunoconjugates|immunoconjugates|mesh-ancestor
92697002|NCT00515892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697003|NCT00513539|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92697004|NCT00513539|Trioxsalen|trioxsalen|mesh-list
92697005|NCT00513539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697006|NCT00513539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697007|NCT00513539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92697008|NCT00511979|Insulin|insulin|mesh-list
92697009|NCT00511979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92697010|NCT00511979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92697011|NCT00511979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697012|NCT00513578|Sargramostim|sargramostim|mesh-list
92697013|NCT00513578|Freund's Adjuvant|freund's adjuvant|mesh-list
92697014|NCT00513578|Immunologic Factors|immunologic factors|mesh-ancestor
92697015|NCT00513578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607581|NCT02261415|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92607582|NCT02261415|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607583|NCT02261415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697016|NCT00513578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92697017|NCT00513656|Oxycodone|oxycodone|mesh-list
92697018|NCT00513656|Naloxone|naloxone|mesh-list
92697019|NCT00513656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92697020|NCT00513656|Narcotics|narcotics|mesh-ancestor
92697021|NCT00513656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697022|NCT00513656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697023|NCT00513656|Analgesics|analgesics|mesh-ancestor
92697024|NCT00513656|Sensory System Agents|sensory system agents|mesh-ancestor
92697025|NCT00513656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697026|NCT00513656|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92697027|NCT00530127|Deferiprone|deferiprone|mesh-list
92697028|NCT00530127|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92697029|NCT00530127|Chelating Agents|chelating agents|mesh-ancestor
92697030|NCT00530127|Sequestering Agents|sequestering agents|mesh-ancestor
92697031|NCT00530127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697032|NCT04691934|Anesthetics|anesthetics|mesh-list
92697033|NCT04691934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697034|NCT04691934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697035|NCT00512057|Allopurinol|allopurinol|mesh-list
92697042|NCT00512057|Antioxidants|antioxidants|mesh-ancestor
92697043|NCT00512057|Protective Agents|protective agents|mesh-ancestor
92697044|NCT00512057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697045|NCT00513929|Zinc Sulfate|zinc sulfate|mesh-list
92697046|NCT00513929|Astringents|astringents|mesh-ancestor
92697047|NCT00513929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697048|NCT00513929|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697049|NCT00513968|Adefovir|adefovir|mesh-list
92697050|NCT00513968|Antiviral Agents|antiviral agents|mesh-ancestor
92697051|NCT00513968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697052|NCT00513968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92697053|NCT00513968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92697054|NCT00513968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697055|NCT00513968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697056|NCT02944500|Liraglutide|liraglutide|mesh-list
92697057|NCT02944500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92697058|NCT02944500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697059|NCT02944500|Incretins|incretins|mesh-ancestor
92697060|NCT02944500|Hormones|hormones|mesh-ancestor
92697061|NCT02944500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697062|NCT03459248|Anesthetics|anesthetics|mesh-list
92697063|NCT03459248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697064|NCT03459248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697065|NCT00512291|Olanzapine|olanzapine|mesh-list
92697066|NCT00512291|Fluoxetine|fluoxetine|mesh-list
92697067|NCT00512291|Antiemetics|antiemetics|mesh-ancestor
92697068|NCT00512291|Autonomic Agents|autonomic agents|mesh-ancestor
92697069|NCT00512291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697070|NCT00512291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697071|NCT00512291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697072|NCT00512291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92697073|NCT00512291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697074|NCT00512291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697075|NCT00512291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697076|NCT00512291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92697077|NCT00512291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92697078|NCT00512291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92697079|NCT00512291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697080|NCT00512291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697081|NCT00512291|Serotonin Agents|serotonin agents|mesh-ancestor
92697082|NCT00512291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92697083|NCT00512291|Antidepressive Agents|antidepressive agents|mesh-ancestor
92697084|NCT00512291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92697085|NCT00512291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92697086|NCT00512291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697087|NCT00514163|Gemcitabine|gemcitabine|mesh-list
92697088|NCT00514163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92697089|NCT00514163|Antimetabolites|antimetabolites|mesh-ancestor
92607584|NCT02261415|Hemostatics|hemostatics|mesh-ancestor
92607585|NCT02261415|Coagulants|coagulants|mesh-ancestor
92697090|NCT00514163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697091|NCT00514163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697092|NCT00514202|Dextroamphetamine|dextroamphetamine|mesh-list
92697093|NCT00514202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92697094|NCT00514202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697095|NCT00514202|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92697096|NCT00514202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92697097|NCT00514202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92697098|NCT00514202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697099|NCT00514202|Dopamine Agents|dopamine agents|mesh-ancestor
92697100|NCT00514202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697101|NCT00530361|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92697102|NCT00530361|Natriuretic Agents|natriuretic agents|mesh-ancestor
92697112|NCT00530400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697114|NCT00531336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697115|NCT00531336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697116|NCT00531336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697117|NCT00531336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697118|NCT00531336|Growth Substances|growth substances|mesh-ancestor
92697119|NCT00531336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697120|NCT00531336|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697121|NCT00530478|Donepezil|donepezil|mesh-list
92697122|NCT00530478|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92697123|NCT00530478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697124|NCT00530478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697125|NCT00530478|Cholinergic Agents|cholinergic agents|mesh-ancestor
92697126|NCT00530478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697127|NCT00530478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697128|NCT00530478|Nootropic Agents|nootropic agents|mesh-ancestor
92697129|NCT00530556|Zolpidem|zolpidem|mesh-list
92697130|NCT00530556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92697131|NCT00530556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92697132|NCT00530556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697133|NCT00530556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697134|NCT00530556|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92697135|NCT00530556|GABA Agonists|gaba agonists|mesh-ancestor
92697136|NCT00530556|GABA Agents|gaba agents|mesh-ancestor
92697137|NCT00530556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697138|NCT00530556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697139|NCT00512486|Benralizumab|benralizumab|mesh-list
92697140|NCT00512486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92697141|NCT00512486|Respiratory System Agents|respiratory system agents|mesh-ancestor
92697142|NCT00530595|Losartan|losartan|mesh-list
92697143|NCT00530595|Valsartan|valsartan|mesh-list
92697144|NCT00530595|Candesartan|candesartan|mesh-list
92697145|NCT00530595|Candesartan cilexetil|candesartan cilexetil|mesh-list
92697146|NCT00530595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92697147|NCT00530595|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92697148|NCT00530595|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92697149|NCT00530595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697150|NCT00530595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92697151|NCT02943759|Chlorhexidine|chlorhexidine|mesh-list
92697152|NCT02943759|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92697153|NCT02943759|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92697154|NCT02943759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697155|NCT02943759|Disinfectants|disinfectants|mesh-ancestor
92697156|NCT02943759|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697157|NCT02944110|Glucagon|glucagon|mesh-list
92697158|NCT02944110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697159|NCT02944110|Hormones|hormones|mesh-ancestor
92697160|NCT02944110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697161|NCT02944110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697162|NCT02951975|Dexamethasone|dexamethasone|mesh-list
92697163|NCT02951975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697164|NCT02951975|Antiemetics|antiemetics|mesh-ancestor
92697165|NCT02951975|Autonomic Agents|autonomic agents|mesh-ancestor
92697166|NCT02951975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697167|NCT02951975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697168|NCT02951975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697169|NCT02951975|Glucocorticoids|glucocorticoids|mesh-ancestor
92697170|NCT02951975|Hormones|hormones|mesh-ancestor
92607586|NCT00132743|Cilostazol|cilostazol|mesh-list
92607587|NCT00132743|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92607588|NCT00132743|Autonomic Agents|autonomic agents|mesh-ancestor
92607589|NCT00132743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697181|NCT00514397|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697182|NCT02943603|Pembrolizumab|pembrolizumab|mesh-list
92697183|NCT02943603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697184|NCT02943603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697185|NCT02943603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92697186|NCT02943603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697187|NCT00531687|Paclitaxel|paclitaxel|mesh-list
92697188|NCT00531687|Gemcitabine|gemcitabine|mesh-list
92697189|NCT00531687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92697190|NCT00531687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697191|NCT00531687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92697192|NCT00531687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92697193|NCT00531687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92697194|NCT00531687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697195|NCT00531687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92697196|NCT00531687|Antimetabolites|antimetabolites|mesh-ancestor
92697197|NCT00514475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92697198|NCT00514475|Immunologic Factors|immunologic factors|mesh-ancestor
92697199|NCT00514475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697200|NCT00512681|Oxaliplatin|oxaliplatin|mesh-list
92697201|NCT00512681|Irinotecan|irinotecan|mesh-list
92697202|NCT00512681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697203|NCT00512681|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92697204|NCT00512681|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92697205|NCT00512681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697206|NCT00512681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697207|NCT00530868|Bevacizumab|bevacizumab|mesh-list
92697208|NCT00530868|Letrozole|letrozole|mesh-list
92697209|NCT00530868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697210|NCT00530868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697211|NCT00530868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697212|NCT00530868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697213|NCT00530868|Growth Substances|growth substances|mesh-ancestor
92697214|NCT00530868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697215|NCT00530868|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697216|NCT00530868|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92697217|NCT00530868|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92697218|NCT00530868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697219|NCT00530868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697220|NCT00530868|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92697221|NCT00530868|Hormone Antagonists|hormone antagonists|mesh-ancestor
92697222|NCT00530868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697223|NCT00530907|Bevacizumab|bevacizumab|mesh-list
92697224|NCT00530907|Valproic Acid|valproic acid|mesh-list
92697225|NCT00530907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697226|NCT00530907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697227|NCT00530907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697228|NCT00530907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697229|NCT00530907|Growth Substances|growth substances|mesh-ancestor
92697230|NCT00530907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697231|NCT00530907|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697232|NCT00530907|Anticonvulsants|anticonvulsants|mesh-ancestor
92697245|NCT00531024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697246|NCT00531024|Growth Substances|growth substances|mesh-ancestor
92697247|NCT00531024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697248|NCT00531024|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697249|NCT00512759|Nitroglycerin|nitroglycerin|mesh-list
92697250|NCT00512759|Vasodilator Agents|vasodilator agents|mesh-ancestor
92697251|NCT00514670|Hand Sanitizers|hand sanitizers|mesh-list
92697252|NCT00514670|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92697253|NCT00514670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697254|NCT00514670|Disinfectants|disinfectants|mesh-ancestor
92697255|NCT00531063|Everolimus|everolimus|mesh-list
92697256|NCT00531063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92697257|NCT00531063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92697258|NCT00531063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697259|NCT00531063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607590|NCT00132743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697260|NCT00531063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697261|NCT00531063|Immunologic Factors|immunologic factors|mesh-ancestor
92697262|NCT00531063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697263|NCT00531063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697264|NCT02943798|Paclitaxel|paclitaxel|mesh-list
92697265|NCT02943798|Etoposide|etoposide|mesh-list
92697266|NCT02943798|Carboplatin|carboplatin|mesh-list
92371459|NCT01286454|Urological Agents|urological agents|mesh-ancestor
92697267|NCT02943798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92697268|NCT02943798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697269|NCT02943798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92697270|NCT02943798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92697271|NCT02943798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92697272|NCT02943798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697273|NCT02943798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92697274|NCT02943798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92697275|NCT02943798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697276|NCT02943369|Ticagrelor|ticagrelor|mesh-list
92697277|NCT02943369|Cangrelor|cangrelor|mesh-list
92697278|NCT02943369|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92697279|NCT02943369|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92697280|NCT02943369|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92697281|NCT02943369|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92697282|NCT02943369|Purinergic Agents|purinergic agents|mesh-ancestor
92697283|NCT02943369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697284|NCT02943369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697285|NCT02943369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697286|NCT00514748|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92697287|NCT00514748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92697288|NCT00514748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92697289|NCT00514748|Analgesics|analgesics|mesh-ancestor
92697290|NCT00514748|Sensory System Agents|sensory system agents|mesh-ancestor
92697291|NCT00514748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697292|NCT00514748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697293|NCT00514748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697294|NCT00514748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697295|NCT00515957|Antibodies|antibodies|mesh-list
92697298|NCT02943642|Vorinostat|vorinostat|mesh-list
92697299|NCT02943642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697300|NCT02943642|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92697301|NCT02943642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697302|NCT02943642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697303|NCT04695509|Propofol|propofol|mesh-list
92697304|NCT04695509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92697305|NCT04695509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697306|NCT04695509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697307|NCT04695509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92697308|NCT04695509|Anesthetics, General|anesthetics, general|mesh-ancestor
92697309|NCT04695509|Anesthetics|anesthetics|mesh-ancestor
92697310|NCT02943135|Lidocaine|lidocaine|mesh-list
92697311|NCT02943135|Anesthetics, Local|anesthetics, local|mesh-ancestor
92697312|NCT02943135|Anesthetics|anesthetics|mesh-ancestor
92697313|NCT02943135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697314|NCT02943135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697315|NCT02943135|Sensory System Agents|sensory system agents|mesh-ancestor
92697316|NCT02943135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697317|NCT02943135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92697318|NCT02943135|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92697319|NCT02943135|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92697320|NCT02943135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92697321|NCT02943135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697322|NCT02951234|Aspirin|aspirin|mesh-list
92697323|NCT02951234|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92697324|NCT02951234|gamma-Globulins|gamma-globulins|mesh-list
92697325|NCT02951234|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92697326|NCT02951234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92697327|NCT02951234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92697328|NCT02951234|Analgesics|analgesics|mesh-ancestor
92697329|NCT02951234|Sensory System Agents|sensory system agents|mesh-ancestor
92697330|NCT02951234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697331|NCT02951234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697332|NCT02951234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697333|NCT02951234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607591|NCT00132743|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92607592|NCT00132743|Respiratory System Agents|respiratory system agents|mesh-ancestor
92697334|NCT02951234|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92697335|NCT02951234|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92697336|NCT02951234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697337|NCT02951234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92697338|NCT02951234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92697339|NCT02951234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697340|NCT02951234|Antipyretics|antipyretics|mesh-ancestor
92697341|NCT02951234|Immunologic Factors|immunologic factors|mesh-ancestor
92697342|NCT02943252|Apatinib|apatinib|mesh-list
92697343|NCT02943252|Tegafur|tegafur|mesh-list
92697344|NCT02943252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697345|NCT02943252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92697346|NCT02943252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697347|NCT02943252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697348|NCT02943252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92697349|NCT02943252|Antimetabolites|antimetabolites|mesh-ancestor
92697350|NCT00514982|Adalimumab|adalimumab|mesh-list
92697351|NCT00514982|Infliximab|infliximab|mesh-list
92697352|NCT00514982|Mesalamine|mesalamine|mesh-list
92697353|NCT00514982|Mercaptopurine|mercaptopurine|mesh-list
92697354|NCT00514982|Tacrolimus|tacrolimus|mesh-list
92697355|NCT00514982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697356|NCT00514982|Immunologic Factors|immunologic factors|mesh-ancestor
92697357|NCT00514982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697358|NCT00514982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92697359|NCT00514982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697360|NCT00514982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697361|NCT00514982|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92697362|NCT00514982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697363|NCT00514982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697364|NCT00514982|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697365|NCT00514982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117231|NCT03262740|Estradiol|estradiol|mesh-list
92697366|NCT00514982|Antimetabolites|antimetabolites|mesh-ancestor
92697367|NCT00514982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92697382|NCT00531999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697383|NCT00531999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92697384|NCT00531999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92697385|NCT00531999|Antiviral Agents|antiviral agents|mesh-ancestor
92697386|NCT00531999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697387|NCT00531999|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92697388|NCT00531999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92697389|NCT00531999|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92697390|NCT00531999|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92697391|NCT05319912|Molybdenum|molybdenum|mesh-list
92697392|NCT05319912|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92697393|NCT05319912|Choline|choline|mesh-list
92697394|NCT05319912|Omeprazole|omeprazole|mesh-list
92697395|NCT05319912|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92697396|NCT05319912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697397|NCT05319912|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92697398|NCT05319912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697399|NCT05319912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697400|NCT05319912|Lipotropic Agents|lipotropic agents|mesh-ancestor
92697401|NCT05319912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92697402|NCT05319912|Antimetabolites|antimetabolites|mesh-ancestor
92697403|NCT05319912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92697404|NCT05319912|Nootropic Agents|nootropic agents|mesh-ancestor
92697405|NCT05319912|Chelating Agents|chelating agents|mesh-ancestor
92697406|NCT05319912|Sequestering Agents|sequestering agents|mesh-ancestor
92697407|NCT05319912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697408|NCT05319912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697409|NCT05319912|Growth Substances|growth substances|mesh-ancestor
92697410|NCT05319912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697411|NCT05319912|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697412|NCT05319912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697413|NCT05319912|Trace Elements|trace elements|mesh-ancestor
92697414|NCT05319912|Micronutrients|micronutrients|mesh-ancestor
92697415|NCT00515138|Rituximab|rituximab|mesh-list
92697416|NCT00515138|Carboplatin|carboplatin|mesh-list
92697417|NCT00515138|Etoposide|etoposide|mesh-list
92697418|NCT00515138|Bortezomib|bortezomib|mesh-list
92697419|NCT00515138|Ifosfamide|ifosfamide|mesh-list
92697420|NCT00515138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607593|NCT00132743|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92607594|NCT00132743|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607595|NCT00132743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607596|NCT00132743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92607597|NCT00132743|Vasodilator Agents|vasodilator agents|mesh-ancestor
92697421|NCT00515138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697422|NCT00515138|Immunologic Factors|immunologic factors|mesh-ancestor
92697423|NCT00515138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697424|NCT00515138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697425|NCT00515138|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92697426|NCT00515138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92697427|NCT00515138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92697428|NCT00515138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697429|NCT00515138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697446|NCT05319834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697447|NCT05319834|Antipyretics|antipyretics|mesh-ancestor
92697448|NCT00515255|Minocycline|minocycline|mesh-list
92697449|NCT00515255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92697450|NCT00515255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697451|NCT00516113|Paroxetine|paroxetine|mesh-list
92697452|NCT00516113|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92697453|NCT00516113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92697454|NCT00516113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92697455|NCT00516113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697456|NCT00516113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697457|NCT00516113|Serotonin Agents|serotonin agents|mesh-ancestor
92697458|NCT00516113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697459|NCT00516113|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92697460|NCT00516113|Antidepressive Agents|antidepressive agents|mesh-ancestor
92697461|NCT00516113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697462|NCT00516113|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92371493|NCT01293396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92697463|NCT00516113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92697464|NCT00516113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697465|NCT04695197|Artesunate|artesunate|mesh-list
92697466|NCT04695197|Lumefantrine|lumefantrine|mesh-list
92697467|NCT04695197|Artemether|artemether|mesh-list
92697468|NCT04695197|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92697469|NCT04695197|Pyronaridine|pyronaridine|mesh-list
92697470|NCT04695197|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92697471|NCT04695197|Antimalarials|antimalarials|mesh-ancestor
92697472|NCT04695197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92697473|NCT04695197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92697474|NCT04695197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697475|NCT04695197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697476|NCT04695197|Antiviral Agents|antiviral agents|mesh-ancestor
92697477|NCT04695197|Schistosomicides|schistosomicides|mesh-ancestor
92697478|NCT04695197|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92697479|NCT04695197|Anthelmintics|anthelmintics|mesh-ancestor
92697480|NCT00516152|Methotrexate|methotrexate|mesh-list
92697481|NCT00516152|Fludarabine phosphate|fludarabine phosphate|mesh-list
92697482|NCT00516152|Fludarabine|fludarabine|mesh-list
92697483|NCT00516152|Busulfan|busulfan|mesh-list
92697484|NCT00516152|Tacrolimus|tacrolimus|mesh-list
92697485|NCT00516152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92697486|NCT00516152|Abortifacient Agents|abortifacient agents|mesh-ancestor
92697489|NCT00516152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92697490|NCT00516152|Antimetabolites|antimetabolites|mesh-ancestor
92697491|NCT00516152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697492|NCT00516152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697493|NCT00516152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697494|NCT00516152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697495|NCT00516152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92697496|NCT00516152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697497|NCT00516152|Immunologic Factors|immunologic factors|mesh-ancestor
92697498|NCT00516152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697499|NCT00516152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92697500|NCT00516152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92607598|NCT00132743|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92607599|NCT00132743|Protective Agents|protective agents|mesh-ancestor
92697501|NCT00516152|Alkylating Agents|alkylating agents|mesh-ancestor
92697502|NCT00516152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92697503|NCT00516152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92697505|NCT00516191|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92697506|NCT00516191|Bortezomib|bortezomib|mesh-list
92697507|NCT00516191|Melphalan|melphalan|mesh-list
92697508|NCT00516191|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92697509|NCT00516191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697510|NCT00516191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92697511|NCT00516191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92697512|NCT00516191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697513|NCT00516191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697514|NCT00516191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92697515|NCT00516191|Alkylating Agents|alkylating agents|mesh-ancestor
92697516|NCT00516191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92697517|NCT00516191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697518|NCT00516191|Immunologic Factors|immunologic factors|mesh-ancestor
92697519|NCT00516191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697520|NCT00515450|Immunoglobulins|immunoglobulins|mesh-list
92697521|NCT00515450|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92697522|NCT00515450|Antibodies|antibodies|mesh-list
92697523|NCT00515450|gamma-Globulins|gamma-globulins|mesh-list
92371537|NCT01304082|Lidocaine|lidocaine|mesh-list
92697524|NCT00515450|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92697525|NCT00515450|Immunologic Factors|immunologic factors|mesh-ancestor
92697526|NCT00515450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697527|NCT00515489|Risperidone|risperidone|mesh-list
92697528|NCT00515489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92697529|NCT00515489|Serotonin Agents|serotonin agents|mesh-ancestor
92697530|NCT00515489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697531|NCT00515489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697532|NCT00515489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697533|NCT00515489|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92697534|NCT00515489|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697535|NCT00515489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697536|NCT00515489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697537|NCT00515489|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92697538|NCT00515489|Dopamine Agents|dopamine agents|mesh-ancestor
92697539|NCT02941575|Methamphetamine|methamphetamine|mesh-list
92697540|NCT02941575|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92697541|NCT02941575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697542|NCT02941575|Sympathomimetics|sympathomimetics|mesh-ancestor
92697543|NCT02941575|Autonomic Agents|autonomic agents|mesh-ancestor
92697544|NCT02941575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697545|NCT02941575|Dopamine Agents|dopamine agents|mesh-ancestor
92697546|NCT02941575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697547|NCT02941575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697548|NCT02941575|Adrenergic Agents|adrenergic agents|mesh-ancestor
92697549|NCT02941575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92697550|NCT02941575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92697551|NCT02941575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92697552|NCT02941575|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92697553|NCT02941731|Oseltamivir|oseltamivir|mesh-list
92697554|NCT02941731|Antiviral Agents|antiviral agents|mesh-ancestor
92697555|NCT02941731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697556|NCT02941731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697557|NCT02941731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697558|NCT02951039|Edoxaban|edoxaban|mesh-list
92697577|NCT02951117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92697578|NCT02951117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697579|NCT02950220|Pembrolizumab|pembrolizumab|mesh-list
92697580|NCT02950220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697581|NCT02950220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697582|NCT02950220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92697583|NCT02950220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697584|NCT00515684|Bevacizumab|bevacizumab|mesh-list
92371539|NCT01304082|Anesthetics|anesthetics|mesh-ancestor
92697585|NCT00515684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697586|NCT00515684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697587|NCT00515684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697588|NCT00515684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92607600|NCT00132743|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92607601|NCT00132743|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92607602|NCT00132743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607603|NCT00132821|Bupropion|bupropion|mesh-list
92607604|NCT00132821|Nicotine|nicotine|mesh-list
92607605|NCT00132821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92607606|NCT00132821|Autonomic Agents|autonomic agents|mesh-ancestor
92697589|NCT00515684|Growth Substances|growth substances|mesh-ancestor
92697590|NCT00515684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697591|NCT00515684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697592|NCT05317767|Vaccines|vaccines|mesh-list
92697593|NCT05317767|Immunologic Factors|immunologic factors|mesh-ancestor
92697594|NCT05317767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697595|NCT00515801|Glyburide|glyburide|mesh-list
92697596|NCT00515801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92117452|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
92697597|NCT00515801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697598|NCT05317611|Ondansetron|ondansetron|mesh-list
92697599|NCT05317611|Bupivacaine|bupivacaine|mesh-list
92697600|NCT05317611|Anesthetics, Local|anesthetics, local|mesh-ancestor
92697601|NCT05317611|Anesthetics|anesthetics|mesh-ancestor
92697602|NCT05317611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697603|NCT05317611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697604|NCT05317611|Sensory System Agents|sensory system agents|mesh-ancestor
92697605|NCT05317611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697606|NCT05317611|Antiemetics|antiemetics|mesh-ancestor
92697607|NCT05317611|Autonomic Agents|autonomic agents|mesh-ancestor
92697608|NCT05317611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697609|NCT05317611|Antipruritics|antipruritics|mesh-ancestor
92697610|NCT05317611|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697611|NCT05317611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92697612|NCT05317611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92697613|NCT05317611|Serotonin Agents|serotonin agents|mesh-ancestor
92697614|NCT05317611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697635|NCT00516425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697636|NCT00516425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92697637|NCT00516425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92697638|NCT00516425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92697639|NCT00516425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92697640|NCT00516425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697641|NCT02942706|Cetuximab|cetuximab|mesh-list
92697642|NCT02942706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697643|NCT02942706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697644|NCT00516464|Ranibizumab|ranibizumab|mesh-list
92697645|NCT00516464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697646|NCT00516464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697647|NCT00516464|Growth Substances|growth substances|mesh-ancestor
92697648|NCT00516464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697649|NCT00516464|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697650|NCT00516464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697651|NCT00516542|Letrozole|letrozole|mesh-list
92697652|NCT00516542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697653|NCT00516542|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92697654|NCT00516542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92697655|NCT00516542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697656|NCT00516542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697657|NCT00516542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92697658|NCT00516542|Hormone Antagonists|hormone antagonists|mesh-ancestor
92697659|NCT00516542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697660|NCT00516542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697661|NCT03458481|Sofosbuvir|sofosbuvir|mesh-list
92697662|NCT03458481|Yimitasvir|yimitasvir|mesh-list
92697663|NCT03458481|Antiviral Agents|antiviral agents|mesh-ancestor
92697664|NCT03458481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697665|NCT02949752|Aripiprazole|aripiprazole|mesh-list
92697666|NCT02949752|Antidepressive Agents|antidepressive agents|mesh-ancestor
92697667|NCT02949752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697668|NCT02949752|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92697669|NCT02949752|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697678|NCT02949752|Serotonin Agents|serotonin agents|mesh-ancestor
92607607|NCT00132821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607608|NCT00132821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607609|NCT00132821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92697679|NCT02949752|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92697680|NCT02949752|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92697681|NCT02949752|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92697682|NCT02949752|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92697683|NCT02942550|Bromides|bromides|mesh-list
92697684|NCT02942550|Methylnaltrexone|methylnaltrexone|mesh-list
92697685|NCT02942550|Anticonvulsants|anticonvulsants|mesh-ancestor
92697686|NCT02942550|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92697687|NCT02942550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697688|NCT02942550|Sensory System Agents|sensory system agents|mesh-ancestor
92697689|NCT02942550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697690|NCT04694612|Remdesivir|remdesivir|mesh-list
92697691|NCT04694612|Favipiravir|favipiravir|mesh-list
92697692|NCT04694612|Antimetabolites|antimetabolites|mesh-ancestor
92697693|NCT04694612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697694|NCT04694612|Antiviral Agents|antiviral agents|mesh-ancestor
92697695|NCT04694612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697696|NCT02941224|Sirolimus|sirolimus|mesh-list
92697697|NCT02941224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92697698|NCT02941224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697699|NCT02941224|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92697700|NCT02941224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697701|NCT02941224|Antifungal Agents|antifungal agents|mesh-ancestor
92697702|NCT02941224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697703|NCT02941224|Immunologic Factors|immunologic factors|mesh-ancestor
92697704|NCT02941224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697705|NCT00516854|Chlordiazepoxide|chlordiazepoxide|mesh-list
92697706|NCT00516854|Clidinium|clidinium|mesh-list
92697707|NCT00516854|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92697708|NCT00516854|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92697709|NCT00516854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697710|NCT00516854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697711|NCT00516854|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92697712|NCT00516854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697713|NCT00516854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697714|NCT00516854|GABA Modulators|gaba modulators|mesh-ancestor
92697715|NCT00516854|GABA Agents|gaba agents|mesh-ancestor
92697716|NCT00516854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697717|NCT00516854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697718|NCT00516854|Parasympatholytics|parasympatholytics|mesh-ancestor
92697719|NCT00516854|Autonomic Agents|autonomic agents|mesh-ancestor
92697720|NCT00516854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697721|NCT02940990|Paclitaxel|paclitaxel|mesh-list
92697722|NCT02940990|Etoposide|etoposide|mesh-list
92697723|NCT02940990|Vinorelbine|vinorelbine|mesh-list
92697724|NCT02940990|Docetaxel|docetaxel|mesh-list
92697725|NCT02940990|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92697726|NCT02940990|Carboplatin|carboplatin|mesh-list
92697727|NCT02940990|Gemcitabine|gemcitabine|mesh-list
92697728|NCT02940990|Pemetrexed|pemetrexed|mesh-list
92697729|NCT02940990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92697730|NCT02940990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697731|NCT02940990|Tubulin Modulators|tubulin modulators|mesh-ancestor
92697732|NCT02940990|Antimitotic Agents|antimitotic agents|mesh-ancestor
92697733|NCT02940990|Mitosis Modulators|mitosis modulators|mesh-ancestor
92697734|NCT02940990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697735|NCT02940990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92697736|NCT02940990|Antimetabolites|antimetabolites|mesh-ancestor
92697769|NCT00518375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92697770|NCT00518375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697771|NCT02942043|Bevacizumab|bevacizumab|mesh-list
92697772|NCT02942043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697773|NCT02942043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697774|NCT02942043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697775|NCT02942043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697776|NCT02942043|Growth Substances|growth substances|mesh-ancestor
92697777|NCT02942043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697794|NCT00517283|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92697795|NCT00517283|Incretins|incretins|mesh-ancestor
92697796|NCT00517283|Hormones|hormones|mesh-ancestor
92607610|NCT00132821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92607611|NCT00132821|Cholinergic Agents|cholinergic agents|mesh-ancestor
92607612|NCT00132821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607613|NCT00132821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607614|NCT00132821|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92607615|NCT00132821|Antidepressive Agents|antidepressive agents|mesh-ancestor
92607616|NCT00132821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607617|NCT00132821|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92607618|NCT00132821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92697797|NCT00517283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697799|NCT02940912|Emetics|emetics|mesh-ancestor
92697800|NCT02940912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697801|NCT02940912|Autonomic Agents|autonomic agents|mesh-ancestor
92697802|NCT02940912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697803|NCT02940912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697804|NCT02940912|Dopamine Agonists|dopamine agonists|mesh-ancestor
92697805|NCT02940912|Dopamine Agents|dopamine agents|mesh-ancestor
92697806|NCT02940912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697807|NCT02940912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697808|NCT00517322|Ramipril|ramipril|mesh-list
92697809|NCT00517322|Irbesartan|irbesartan|mesh-list
92697810|NCT00517322|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92697811|NCT00517322|Protease Inhibitors|protease inhibitors|mesh-ancestor
92697812|NCT00517322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697813|NCT00517322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697814|NCT00517322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92697815|NCT00517322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92697816|NCT00517322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92697817|NCT02939430|Atropine|atropine|mesh-list
92697818|NCT02939430|Neostigmine|neostigmine|mesh-list
92697819|NCT02939430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92697820|NCT02939430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92697821|NCT02939430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92697822|NCT02939430|Autonomic Agents|autonomic agents|mesh-ancestor
92697823|NCT02939430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697824|NCT02939430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697825|NCT02939430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92697826|NCT02939430|Respiratory System Agents|respiratory system agents|mesh-ancestor
92697827|NCT02939430|Mydriatics|mydriatics|mesh-ancestor
92697828|NCT02939430|Parasympatholytics|parasympatholytics|mesh-ancestor
92697829|NCT02939430|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92697830|NCT02939430|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92697831|NCT02939430|Cholinergic Agents|cholinergic agents|mesh-ancestor
92697832|NCT02939430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697833|NCT02939430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697834|NCT02939430|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92697835|NCT02939430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697836|NCT02939430|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92697837|NCT02940717|Lithium Carbonate|lithium carbonate|mesh-list
92697873|NCT02941068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697874|NCT02941068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92697875|NCT02941068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92697876|NCT02941068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697877|NCT02941068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697878|NCT02941068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92697879|NCT02941068|Hormone Antagonists|hormone antagonists|mesh-ancestor
92697886|NCT02939274|Verteporfin|verteporfin|mesh-list
92697887|NCT02939274|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92697888|NCT02939274|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697889|NCT04694183|Paclitaxel|paclitaxel|mesh-list
92697890|NCT04694183|Antibodies|antibodies|mesh-list
92697891|NCT04694183|Immunoglobulins|immunoglobulins|mesh-list
92607619|NCT00132821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607620|NCT00132821|Dopamine Agents|dopamine agents|mesh-ancestor
92697892|NCT04694183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92697893|NCT04694183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697894|NCT04694183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92697895|NCT04694183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92697896|NCT04694183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92697897|NCT04694183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697898|NCT04694183|Immunologic Factors|immunologic factors|mesh-ancestor
92117756|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697899|NCT04694183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697900|NCT00517946|Cetirizine|cetirizine|mesh-list
92697901|NCT00517946|Pseudoephedrine|pseudoephedrine|mesh-list
92697903|NCT00517946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92697904|NCT00517946|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92697905|NCT00517946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92697906|NCT00517946|Histamine Antagonists|histamine antagonists|mesh-ancestor
92697907|NCT00517946|Histamine Agents|histamine agents|mesh-ancestor
92697908|NCT00517946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697909|NCT00517946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697910|NCT00517946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697911|NCT00517946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92697912|NCT00517946|Autonomic Agents|autonomic agents|mesh-ancestor
92697913|NCT00517946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697914|NCT00517946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92697915|NCT00517946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92697916|NCT00517946|Nasal Decongestants|nasal decongestants|mesh-ancestor
92697917|NCT00517946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92697918|NCT00517946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92697919|NCT00517946|Sympathomimetics|sympathomimetics|mesh-ancestor
92697920|NCT00517946|Adrenergic Agents|adrenergic agents|mesh-ancestor
92697921|NCT04988685|Sirolimus|sirolimus|mesh-list
92697922|NCT04988685|Paclitaxel|paclitaxel|mesh-list
92697923|NCT04988685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92697924|NCT04988685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697925|NCT04988685|Tubulin Modulators|tubulin modulators|mesh-ancestor
92697926|NCT04988685|Antimitotic Agents|antimitotic agents|mesh-ancestor
92697927|NCT04988685|Mitosis Modulators|mitosis modulators|mesh-ancestor
92697928|NCT04988685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697929|NCT04988685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92697930|NCT04988685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697931|NCT04988685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92697932|NCT04988685|Antifungal Agents|antifungal agents|mesh-ancestor
92697933|NCT04988685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697934|NCT04988685|Immunologic Factors|immunologic factors|mesh-ancestor
92697935|NCT04988685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697936|NCT00517985|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92697937|NCT00517985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92371599|NCT01311102|Anesthetics|anesthetics|mesh-ancestor
92697938|NCT00517985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92697939|NCT00517985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92697940|NCT00517985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697941|NCT00517985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697942|NCT00517985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697943|NCT00517985|Analgesics|analgesics|mesh-ancestor
92697944|NCT00517985|Sensory System Agents|sensory system agents|mesh-ancestor
92697970|NCT02939235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697971|NCT02939235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92697972|NCT02939235|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92697973|NCT02939235|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92697974|NCT02939235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92117842|NCT02454348|Vasopressins|vasopressins|mesh-list
92697975|NCT02939235|Purinergic Agents|purinergic agents|mesh-ancestor
92697976|NCT02939235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697977|NCT02939235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697978|NCT02939235|Antiemetics|antiemetics|mesh-ancestor
92697979|NCT02939235|Autonomic Agents|autonomic agents|mesh-ancestor
92697980|NCT02939235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697981|NCT02939235|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92697982|NCT02939235|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92697983|NCT02939235|Dopamine Agents|dopamine agents|mesh-ancestor
92607621|NCT00132821|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92607622|NCT00132821|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92607623|NCT00132821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055184|NCT02105285|Carteolol|carteolol|mesh-list
92697985|NCT00518141|Salicylic Acid|salicylic acid|mesh-list
92697986|NCT00518141|Salicylates|salicylates|mesh-list
92697987|NCT00518141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697988|NCT00518141|Antifungal Agents|antifungal agents|mesh-ancestor
92697989|NCT00518141|Keratolytic Agents|keratolytic agents|mesh-ancestor
92697990|NCT00518141|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697991|NCT00518141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92697992|NCT00518141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92697993|NCT00518141|Analgesics|analgesics|mesh-ancestor
92697994|NCT00518141|Sensory System Agents|sensory system agents|mesh-ancestor
92697995|NCT00518141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698009|NCT02938962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698011|NCT02938962|Coagulants|coagulants|mesh-ancestor
92698012|NCT00519701|Hydroxyurea|hydroxyurea|mesh-list
92698013|NCT00519701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698014|NCT00519701|Antisickling Agents|antisickling agents|mesh-ancestor
92698015|NCT00519701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698016|NCT00519701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698017|NCT00519701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92698018|NCT00519116|Sirolimus|sirolimus|mesh-list
92698019|NCT00519116|Tacrolimus|tacrolimus|mesh-list
92698020|NCT00519116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698021|NCT00519116|Immunologic Factors|immunologic factors|mesh-ancestor
92698022|NCT00519116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698023|NCT00519116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92698024|NCT00519116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698025|NCT00519116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698026|NCT00519116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92698027|NCT00519116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698028|NCT00519116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92698029|NCT00519116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698030|NCT00519116|Antifungal Agents|antifungal agents|mesh-ancestor
92698031|NCT04691076|Fentanyl|fentanyl|mesh-list
92698032|NCT04691076|Propofol|propofol|mesh-list
92698033|NCT04691076|Esketamine|esketamine|mesh-list
92698034|NCT04691076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92698035|NCT04691076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698036|NCT04691076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698037|NCT04691076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92698038|NCT04691076|Anesthetics, General|anesthetics, general|mesh-ancestor
92698039|NCT04691076|Anesthetics|anesthetics|mesh-ancestor
92698040|NCT04691076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92698041|NCT04691076|Narcotics|narcotics|mesh-ancestor
92698042|NCT04691076|Analgesics|analgesics|mesh-ancestor
92698043|NCT04691076|Sensory System Agents|sensory system agents|mesh-ancestor
92698044|NCT04691076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698045|NCT04691076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92698046|NCT04691076|Antidepressive Agents|antidepressive agents|mesh-ancestor
92698047|NCT04691076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92698048|NCT02949206|Thrombin|thrombin|mesh-list
92698049|NCT02949206|Hemostatics|hemostatics|mesh-ancestor
92117907|NCT03244956|Trametinib|trametinib|mesh-list
92698050|NCT02949206|Coagulants|coagulants|mesh-ancestor
92698051|NCT05108454|Micronutrients|micronutrients|mesh-list
92698052|NCT05108454|Trace Elements|trace elements|mesh-list
92698053|NCT05108454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698054|NCT02940561|Methotrexate|methotrexate|mesh-list
92698055|NCT02940561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92698056|NCT02940561|Abortifacient Agents|abortifacient agents|mesh-ancestor
92698057|NCT02940561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92698080|NCT02940405|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92698081|NCT02940405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92698082|NCT02940405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92698083|NCT02940405|Analgesics|analgesics|mesh-ancestor
92698084|NCT02940405|Sensory System Agents|sensory system agents|mesh-ancestor
92698085|NCT02940405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698086|NCT02940405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698087|NCT02940405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698088|NCT02940405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607624|NCT00132860|Azithromycin|azithromycin|mesh-list
92698089|NCT02940405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92698090|NCT02940405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698091|NCT02940405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698092|NCT02940444|Heparin|heparin|mesh-list
92698093|NCT02940444|Anticoagulants|anticoagulants|mesh-ancestor
92698094|NCT02940444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92698095|NCT02940444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92698096|NCT02940444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698097|NCT00520052|Zoledronic Acid|zoledronic acid|mesh-list
92698098|NCT00520052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92698099|NCT00520052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698100|NCT04690647|Dexamethasone|dexamethasone|mesh-list
92698101|NCT04690647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92698102|NCT04690647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698103|NCT04690647|Antiemetics|antiemetics|mesh-ancestor
92698104|NCT04690647|Autonomic Agents|autonomic agents|mesh-ancestor
92698105|NCT04690647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698106|NCT04690647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698107|NCT04690647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698108|NCT04690647|Glucocorticoids|glucocorticoids|mesh-ancestor
92698109|NCT04690647|Hormones|hormones|mesh-ancestor
92698127|NCT00519467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92698128|NCT00519467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698129|NCT00519467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698130|NCT00519467|Leprostatic Agents|leprostatic agents|mesh-ancestor
92698131|NCT00519467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92698132|NCT02940483|Azacitidine|azacitidine|mesh-list
92698133|NCT02940483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698134|NCT02940483|Antimetabolites|antimetabolites|mesh-ancestor
92698135|NCT02940483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698136|NCT02940483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698137|NCT02940483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698138|NCT04974684|Apixaban|apixaban|mesh-list
92698139|NCT04974684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92698140|NCT04974684|Antithrombins|antithrombins|mesh-ancestor
92698141|NCT04974684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92698142|NCT04974684|Protease Inhibitors|protease inhibitors|mesh-ancestor
92698143|NCT04974684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698144|NCT04974684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698145|NCT04974684|Anticoagulants|anticoagulants|mesh-ancestor
92698146|NCT00520091|Celecoxib|celecoxib|mesh-list
92698147|NCT00520091|Irinotecan|irinotecan|mesh-list
92698148|NCT00520091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698149|NCT00520091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92698150|NCT00520091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698151|NCT00520091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698152|NCT00520091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698153|NCT00520091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92698154|NCT00520091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92698155|NCT00520091|Analgesics|analgesics|mesh-ancestor
92698156|NCT00520091|Sensory System Agents|sensory system agents|mesh-ancestor
92698157|NCT00520091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698158|NCT00520091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698159|NCT00520091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698160|NCT00520091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698161|NCT00520091|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92698162|NCT00520091|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92698163|NCT00520169|Ketamine|ketamine|mesh-list
92698164|NCT00520169|Analgesics|analgesics|mesh-ancestor
92698165|NCT00520169|Sensory System Agents|sensory system agents|mesh-ancestor
92698166|NCT00520169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698167|NCT00520169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698172|NCT00520169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698173|NCT00520169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92698174|NCT00520169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92698175|NCT00520169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698176|NCT00520169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698177|NCT00520247|Folic Acid|folic acid|mesh-list
92698178|NCT00520247|Enalapril|enalapril|mesh-list
92698179|NCT00520247|Hematinics|hematinics|mesh-ancestor
92698180|NCT00520247|Vitamin B Complex|vitamin b complex|mesh-ancestor
92698181|NCT00520247|Vitamins|vitamins|mesh-ancestor
92698182|NCT00520247|Micronutrients|micronutrients|mesh-ancestor
92698183|NCT00520247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607625|NCT00132860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92607626|NCT00132860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607627|NCT01244815|Asenapine|asenapine|mesh-list
92607628|NCT01244815|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92698184|NCT00520247|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92698185|NCT00520247|Protease Inhibitors|protease inhibitors|mesh-ancestor
92698186|NCT00520247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698187|NCT00520247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698188|NCT00520247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92698189|NCT02949050|Immunomodulating Agents|immunomodulating agents|mesh-list
92698190|NCT02949050|Immunologic Factors|immunologic factors|mesh-ancestor
92698191|NCT02949050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698192|NCT00520325|Lectins|lectins|mesh-list
92698193|NCT00520325|Agglutinins|agglutinins|mesh-ancestor
92698194|NCT00520325|Immunologic Factors|immunologic factors|mesh-ancestor
92698195|NCT00520325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698196|NCT00520325|Coagulants|coagulants|mesh-ancestor
92698197|NCT00520442|Ibuprofen|ibuprofen|mesh-list
92698198|NCT00520442|Codeine|codeine|mesh-list
92698199|NCT00520442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92698200|NCT00520442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92698201|NCT00520442|Analgesics|analgesics|mesh-ancestor
92698202|NCT00520442|Sensory System Agents|sensory system agents|mesh-ancestor
92698203|NCT00520442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698204|NCT00520442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698205|NCT00520442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698206|NCT00520442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698207|NCT00520442|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92698208|NCT00520442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698209|NCT00520442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698210|NCT00520442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92698211|NCT00520442|Narcotics|narcotics|mesh-ancestor
92698212|NCT00520442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698213|NCT00520442|Antitussive Agents|antitussive agents|mesh-ancestor
92698214|NCT00520442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92698215|NCT02938572|Insulin Aspart|insulin aspart|mesh-list
92698216|NCT02938572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92698217|NCT02938572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698218|NCT02939898|Letrozole|letrozole|mesh-list
92698219|NCT02939898|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92698220|NCT02939898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698221|NCT02939898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92698222|NCT02939898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698223|NCT02939898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698224|NCT02939898|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92698225|NCT02939898|Hormone Antagonists|hormone antagonists|mesh-ancestor
92698226|NCT02939898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698227|NCT02939898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698228|NCT00520754|Levocetirizine|levocetirizine|mesh-list
92698229|NCT00520754|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92698230|NCT00520754|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92698231|NCT00520754|Histamine Antagonists|histamine antagonists|mesh-ancestor
92698232|NCT00520754|Histamine Agents|histamine agents|mesh-ancestor
92698233|NCT00520754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698234|NCT00520754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698235|NCT00520754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698236|NCT02277132|Sildenafil Citrate|sildenafil citrate|mesh-list
92698237|NCT02277132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92698238|NCT02277132|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92698241|NCT02277132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698242|NCT02277132|Urological Agents|urological agents|mesh-ancestor
92698243|NCT00520949|Amoxicillin|amoxicillin|mesh-list
92698244|NCT00520949|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92698245|NCT00520949|Furazolidone|furazolidone|mesh-list
92698246|NCT00520949|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92698247|NCT00520949|Esomeprazole|esomeprazole|mesh-list
92698248|NCT00520949|Bismuth|bismuth|mesh-list
92698249|NCT00520949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92698250|NCT00520949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698251|NCT00520949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92698252|NCT00520949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92607629|NCT01244815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607630|NCT01244815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607631|NCT01244815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698253|NCT00520949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92698254|NCT00520949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698255|NCT00520949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698256|NCT00520949|Antacids|antacids|mesh-ancestor
92698257|NCT00520949|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92698258|NCT00520949|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92698259|NCT00520949|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92698260|NCT00520949|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92698261|NCT00520949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92698262|NCT00520949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92698263|NCT00520949|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92698264|NCT02938260|Metoprolol|metoprolol|mesh-list
92698265|NCT02938260|Diltiazem|diltiazem|mesh-list
92698266|NCT02938260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92698267|NCT02938260|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92698268|NCT02938260|Sympatholytics|sympatholytics|mesh-ancestor
92698269|NCT02938260|Autonomic Agents|autonomic agents|mesh-ancestor
92698270|NCT02938260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698271|NCT02938260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698272|NCT02938260|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92698273|NCT02938260|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92698274|NCT02938260|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92698275|NCT02938260|Adrenergic Agents|adrenergic agents|mesh-ancestor
92118193|NCT00789399|PENTA|penta|mesh-list
92698276|NCT02938260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698277|NCT02938260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698278|NCT02938260|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92698279|NCT02938260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92698280|NCT02938260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92698281|NCT02938260|Vasodilator Agents|vasodilator agents|mesh-ancestor
92698282|NCT02938182|Clopidogrel|clopidogrel|mesh-list
92698283|NCT02938182|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92698284|NCT02938182|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92698285|NCT02938182|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92698286|NCT02938182|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92698287|NCT02938182|Purinergic Agents|purinergic agents|mesh-ancestor
92698288|NCT02938182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698289|NCT02938182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698290|NCT02938182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698291|NCT00521183|Tetrahydrouridine|tetrahydrouridine|mesh-list
92698292|NCT00521183|Antimetabolites|antimetabolites|mesh-ancestor
92698293|NCT00521183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698294|NCT00521612|Sevoflurane|sevoflurane|mesh-list
92698295|NCT00521612|Isoflurane|isoflurane|mesh-list
92698296|NCT00521612|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92698297|NCT00521612|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92698298|NCT00521612|Anesthetics, General|anesthetics, general|mesh-ancestor
92698299|NCT00521612|Anesthetics|anesthetics|mesh-ancestor
92698300|NCT00521612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698301|NCT00521612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698302|NCT00521261|Antibodies|antibodies|mesh-list
92698303|NCT00521261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92698304|NCT00521261|Immunologic Factors|immunologic factors|mesh-ancestor
92698305|NCT00521261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698306|NCT02931591|Metformin|metformin|mesh-list
92698307|NCT02931591|Hormones|hormones|mesh-list
92698308|NCT02931591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92698309|NCT02931591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698317|NCT00521690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698318|NCT00523133|Naltrexone|naltrexone|mesh-list
92698319|NCT00523133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92698320|NCT00523133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92698321|NCT00523133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698322|NCT00523133|Sensory System Agents|sensory system agents|mesh-ancestor
92698323|NCT00523133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698324|NCT02937792|Bupivacaine|bupivacaine|mesh-list
92698325|NCT02937792|Anesthetics, Local|anesthetics, local|mesh-ancestor
92607632|NCT01244815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607633|NCT00132899|Methotrexate|methotrexate|mesh-list
92607634|NCT00132899|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92607635|NCT00132899|Abortifacient Agents|abortifacient agents|mesh-ancestor
92607636|NCT00132899|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92698326|NCT02937792|Anesthetics|anesthetics|mesh-ancestor
92698327|NCT02937792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698328|NCT02937792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698329|NCT02937792|Sensory System Agents|sensory system agents|mesh-ancestor
92698330|NCT02937792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698331|NCT02931474|Tesamorelin|tesamorelin|mesh-list
92698332|NCT02931474|Growth Substances|growth substances|mesh-ancestor
92698333|NCT02931474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698334|NCT02931357|Cetylpyridinium|cetylpyridinium|mesh-list
92698336|NCT02931357|Hyaluronic Acid|hyaluronic acid|mesh-list
92698337|NCT02931357|Anesthetics, Local|anesthetics, local|mesh-ancestor
92698338|NCT02931357|Anesthetics|anesthetics|mesh-ancestor
92698339|NCT02931357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698340|NCT02931357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698341|NCT02931357|Sensory System Agents|sensory system agents|mesh-ancestor
92698342|NCT02931357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698343|NCT02931357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92698344|NCT02931357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92698345|NCT02931357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92698346|NCT02931357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92698347|NCT02931357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698348|NCT02931357|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92698349|NCT02931357|Immunologic Factors|immunologic factors|mesh-ancestor
92698351|NCT02931357|Protective Agents|protective agents|mesh-ancestor
92698352|NCT02931357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92698353|NCT02931357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698354|NCT02937519|Cisplatin|cisplatin|mesh-list
92698355|NCT02937519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698356|NCT00521963|Infliximab|infliximab|mesh-list
92698357|NCT00521963|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92698358|NCT00521963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698359|NCT00521963|Dermatologic Agents|dermatologic agents|mesh-ancestor
92698360|NCT00521963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698361|NCT00521963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698362|NCT02937402|Dimercaprol|dimercaprol|mesh-list
92698363|NCT02937402|Chelating Agents|chelating agents|mesh-ancestor
92698364|NCT02937402|Sequestering Agents|sequestering agents|mesh-ancestor
92698365|NCT02937402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698366|NCT02937363|Thioctic Acid|thioctic acid|mesh-list
92698367|NCT02937363|Antioxidants|antioxidants|mesh-ancestor
92698368|NCT02937363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698369|NCT02937363|Protective Agents|protective agents|mesh-ancestor
92698370|NCT02937363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698371|NCT02937363|Vitamin B Complex|vitamin b complex|mesh-ancestor
92698372|NCT02937363|Vitamins|vitamins|mesh-ancestor
92698373|NCT02937363|Micronutrients|micronutrients|mesh-ancestor
92698374|NCT02948348|Capecitabine|capecitabine|mesh-list
92698375|NCT02948348|Nivolumab|nivolumab|mesh-list
92698376|NCT02948348|Ipilimumab|ipilimumab|mesh-list
92698377|NCT02948348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698378|NCT02948348|Antimetabolites|antimetabolites|mesh-ancestor
92698379|NCT02948348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698395|NCT02931123|Rifaximin|rifaximin|mesh-list
92698396|NCT02931123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92698397|NCT02931123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698398|NCT02931123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698399|NCT02936934|Morphine|morphine|mesh-list
92698400|NCT02936934|Oxycodone|oxycodone|mesh-list
92698401|NCT02936934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92698402|NCT02936934|Narcotics|narcotics|mesh-ancestor
92698403|NCT02936934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698404|NCT02936934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698405|NCT02936934|Analgesics|analgesics|mesh-ancestor
92698406|NCT02936934|Sensory System Agents|sensory system agents|mesh-ancestor
92698407|NCT02936934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698408|NCT00522470|Rosiglitazone|rosiglitazone|mesh-list
92607637|NCT00132899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607638|NCT00132899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92607639|NCT00132899|Antimetabolites|antimetabolites|mesh-ancestor
92698409|NCT00522470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92698410|NCT00522470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698411|NCT00522509|Floxuridine|floxuridine|mesh-list
92698412|NCT00522509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698413|NCT00522509|Antimetabolites|antimetabolites|mesh-ancestor
92698414|NCT00522509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698415|NCT00522509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698416|NCT00522587|Remifentanil|remifentanil|mesh-list
92698417|NCT00522587|Sevoflurane|sevoflurane|mesh-list
92698418|NCT00522587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92698419|NCT00522587|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92698420|NCT00522587|Anesthetics, General|anesthetics, general|mesh-ancestor
92698421|NCT00522587|Anesthetics|anesthetics|mesh-ancestor
92698422|NCT00522587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698423|NCT00522587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698424|NCT00522587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92698425|NCT00522587|Narcotics|narcotics|mesh-ancestor
92698426|NCT00522587|Analgesics|analgesics|mesh-ancestor
92698427|NCT00522587|Sensory System Agents|sensory system agents|mesh-ancestor
92698428|NCT00522587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698430|NCT00522665|Cetuximab|cetuximab|mesh-list
92698431|NCT00522665|Everolimus|everolimus|mesh-list
92698432|NCT00522665|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92698433|NCT00522665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698434|NCT00522665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698435|NCT00522665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698436|NCT00522665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698437|NCT00522665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92698438|NCT00522665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92698439|NCT00522665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92698452|NCT02937012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698453|NCT02937012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92698454|NCT00522782|Budesonide|budesonide|mesh-list
92698455|NCT00522782|Nitric Oxide|nitric oxide|mesh-list
92698456|NCT00522782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698457|NCT00522782|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92698458|NCT00522782|Autonomic Agents|autonomic agents|mesh-ancestor
92698459|NCT00522782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698460|NCT00522782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698461|NCT00522782|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92698462|NCT00522782|Respiratory System Agents|respiratory system agents|mesh-ancestor
92698463|NCT00522782|Glucocorticoids|glucocorticoids|mesh-ancestor
92698464|NCT00522782|Hormones|hormones|mesh-ancestor
92698465|NCT00522782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698466|NCT00522782|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92698467|NCT00522782|Antioxidants|antioxidants|mesh-ancestor
92698468|NCT00522782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698469|NCT00522782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698470|NCT00522782|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92698471|NCT00522782|Vasodilator Agents|vasodilator agents|mesh-ancestor
92698472|NCT00522782|Gasotransmitters|gasotransmitters|mesh-ancestor
92698473|NCT00522782|Protective Agents|protective agents|mesh-ancestor
92698474|NCT00522821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92698475|NCT00522821|Immunoglobulins|immunoglobulins|mesh-list
92698476|NCT00522821|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92698477|NCT00522821|Antibodies|antibodies|mesh-list
92698478|NCT00522821|gamma-Globulins|gamma-globulins|mesh-list
92698479|NCT00522821|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92698480|NCT00522821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698481|NCT00522821|Immunologic Factors|immunologic factors|mesh-ancestor
92698482|NCT00522821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698483|NCT02936895|Vitamin D|vitamin d|mesh-list
92698484|NCT02936895|Cholecalciferol|cholecalciferol|mesh-list
92698485|NCT02936895|Vitamins|vitamins|mesh-ancestor
92698486|NCT02936895|Micronutrients|micronutrients|mesh-ancestor
92698487|NCT02936895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698488|NCT02936895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92698489|NCT02936895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92698490|NCT00522938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92698491|NCT00522938|Tosedostat|tosedostat|mesh-list
92607640|NCT00132899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607641|NCT00132899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607642|NCT00132899|Dermatologic Agents|dermatologic agents|mesh-ancestor
92698492|NCT00522938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698493|NCT00522938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92698494|NCT00522938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698495|NCT00522938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698496|NCT04694105|Dexamethasone|dexamethasone|mesh-list
92698497|NCT04694105|Dexmedetomidine|dexmedetomidine|mesh-list
92698498|NCT04694105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698499|NCT04694105|Antiemetics|antiemetics|mesh-ancestor
92698500|NCT04694105|Autonomic Agents|autonomic agents|mesh-ancestor
92698501|NCT04694105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698504|NCT04694105|Glucocorticoids|glucocorticoids|mesh-ancestor
92698505|NCT04694105|Hormones|hormones|mesh-ancestor
92698506|NCT04694105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698507|NCT04694105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92698508|NCT04694105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698509|NCT04694105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92698510|NCT04694105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698511|NCT04694105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92698512|NCT04694105|Analgesics|analgesics|mesh-ancestor
92698513|NCT04694105|Sensory System Agents|sensory system agents|mesh-ancestor
92698514|NCT04694105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92698515|NCT04694105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92698516|NCT04694105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92698517|NCT04694105|Adrenergic Agents|adrenergic agents|mesh-ancestor
92698518|NCT04694105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698519|NCT04694105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698520|NCT02930733|Bupivacaine|bupivacaine|mesh-list
92698521|NCT02930733|Anesthetics, Local|anesthetics, local|mesh-ancestor
92698522|NCT02930733|Anesthetics|anesthetics|mesh-ancestor
92698523|NCT02930733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698524|NCT02930733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698525|NCT02930733|Sensory System Agents|sensory system agents|mesh-ancestor
92698526|NCT02930733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698527|NCT00523055|Lidocaine|lidocaine|mesh-list
92698528|NCT00523055|Anesthetics, Local|anesthetics, local|mesh-ancestor
92698529|NCT00523055|Anesthetics|anesthetics|mesh-ancestor
92698530|NCT00523055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698531|NCT00523055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698532|NCT00523055|Sensory System Agents|sensory system agents|mesh-ancestor
92698533|NCT00523055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698534|NCT00523055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92698535|NCT00523055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92698536|NCT00523055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92698537|NCT00523055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92698538|NCT00523055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698539|NCT00523289|Bupivacaine|bupivacaine|mesh-list
92698540|NCT00523289|Ropivacaine|ropivacaine|mesh-list
92698541|NCT00523289|Anesthetics, Local|anesthetics, local|mesh-ancestor
92698542|NCT00523289|Anesthetics|anesthetics|mesh-ancestor
92698543|NCT00523289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698544|NCT00523289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698545|NCT00523289|Sensory System Agents|sensory system agents|mesh-ancestor
92698546|NCT00523289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698547|NCT00524381|Etanercept|etanercept|mesh-list
92698548|NCT00524381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92698549|NCT00524381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92698550|NCT00524381|Analgesics|analgesics|mesh-ancestor
92698551|NCT00524381|Sensory System Agents|sensory system agents|mesh-ancestor
92698552|NCT00524381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698553|NCT00524381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698554|NCT00524381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698555|NCT00524381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698556|NCT00524381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698557|NCT00524381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698558|NCT00524381|Immunologic Factors|immunologic factors|mesh-ancestor
92698559|NCT04502667|Vitamin D|vitamin d|mesh-list
92607643|NCT00132899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607644|NCT00132899|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92607645|NCT00132899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92607646|NCT00132899|Immunologic Factors|immunologic factors|mesh-ancestor
92607647|NCT00132899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371687|NCT01318278|Dopamine|dopamine|mesh-list
92014966|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698560|NCT04502667|Cholecalciferol|cholecalciferol|mesh-list
92698561|NCT04502667|Vitamins|vitamins|mesh-ancestor
92698562|NCT04502667|Micronutrients|micronutrients|mesh-ancestor
92698563|NCT04502667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698564|NCT04502667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92698565|NCT04502667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92698566|NCT00524498|Cisplatin|cisplatin|mesh-list
92698567|NCT00524498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698568|NCT00523406|Triamcinolone|triamcinolone|mesh-list
92698569|NCT00523406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698570|NCT00523406|Glucocorticoids|glucocorticoids|mesh-ancestor
92698571|NCT00523406|Hormones|hormones|mesh-ancestor
92698572|NCT00523406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698573|NCT00523406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698590|NCT02936661|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92698591|NCT02936661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92698592|NCT02936661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698594|NCT02936661|Coagulants|coagulants|mesh-ancestor
92698595|NCT02948075|Paclitaxel|paclitaxel|mesh-list
92698596|NCT02948075|Carboplatin|carboplatin|mesh-list
92698597|NCT02948075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92698598|NCT02948075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698599|NCT02948075|Tubulin Modulators|tubulin modulators|mesh-ancestor
92698600|NCT02948075|Antimitotic Agents|antimitotic agents|mesh-ancestor
92698601|NCT02948075|Mitosis Modulators|mitosis modulators|mesh-ancestor
92698602|NCT02948075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698603|NCT02930811|Sildenafil Citrate|sildenafil citrate|mesh-list
92698604|NCT02930811|Vasodilator Agents|vasodilator agents|mesh-ancestor
92698605|NCT02930811|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92698606|NCT02930811|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92698607|NCT02930811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698608|NCT02930811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698609|NCT02930811|Urological Agents|urological agents|mesh-ancestor
92698610|NCT02947880|Bumetanide|bumetanide|mesh-list
92698611|NCT02947880|Diuretics|diuretics|mesh-ancestor
92698612|NCT02947880|Natriuretic Agents|natriuretic agents|mesh-ancestor
92698613|NCT02947880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698614|NCT02947880|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92698615|NCT02947880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92698616|NCT02947880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698617|NCT00523757|Spironolactone|spironolactone|mesh-list
92698618|NCT00523757|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92698619|NCT00523757|Hormone Antagonists|hormone antagonists|mesh-ancestor
92698620|NCT00523757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698621|NCT00523757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698622|NCT00523757|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92698623|NCT00523757|Diuretics|diuretics|mesh-ancestor
92698624|NCT00523757|Natriuretic Agents|natriuretic agents|mesh-ancestor
92698625|NCT00524693|Montelukast|montelukast|mesh-list
92698626|NCT00524693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92698627|NCT00524693|Respiratory System Agents|respiratory system agents|mesh-ancestor
92698628|NCT00524693|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92698629|NCT00524693|Hormone Antagonists|hormone antagonists|mesh-ancestor
92698632|NCT00524693|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92698633|NCT00524693|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92698634|NCT00524693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698635|NCT02931201|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92698636|NCT02931201|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92698637|NCT02931201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698638|NCT02936427|Dexamethasone|dexamethasone|mesh-list
92698639|NCT02936427|Dexamethasone acetate|dexamethasone acetate|mesh-list
92607648|NCT00132899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92607650|NCT00140868|Anticonvulsants|anticonvulsants|mesh-ancestor
92607651|NCT00140868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92607652|NCT00140868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698640|NCT02936427|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92698641|NCT02936427|BB 1101|bb 1101|mesh-list
92698642|NCT02936427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698643|NCT02936427|Antiemetics|antiemetics|mesh-ancestor
92698644|NCT02936427|Autonomic Agents|autonomic agents|mesh-ancestor
92698645|NCT02936427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005266|NCT02330029|Autonomic Agents|autonomic agents|mesh-ancestor
92698646|NCT02936427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698647|NCT02936427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118502|NCT03238092|Androgens|androgens|mesh-ancestor
92698649|NCT02936427|Hormones|hormones|mesh-ancestor
92698650|NCT02936427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698651|NCT02936427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92698652|NCT02936427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698653|NCT02936427|Protease Inhibitors|protease inhibitors|mesh-ancestor
92698654|NCT02936427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698655|NCT02936427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698656|NCT00523913|Rosiglitazone|rosiglitazone|mesh-list
92698657|NCT00523913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92698658|NCT00523913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698659|NCT02947763|Metronidazole|metronidazole|mesh-list
92698660|NCT02947763|Ciprofloxacin|ciprofloxacin|mesh-list
92698661|NCT02947763|Minocycline|minocycline|mesh-list
92698662|NCT02947763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698663|NCT02947763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92698664|NCT02947763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92698665|NCT02947763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92698666|NCT02947763|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92698667|NCT02947763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698668|NCT02947763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698669|NCT02947763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698670|NCT02947763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698671|NCT02947763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92698672|NCT02947763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92698673|NCT00523952|Tacrolimus|tacrolimus|mesh-list
92698674|NCT00523952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698675|NCT00523952|Immunologic Factors|immunologic factors|mesh-ancestor
92698676|NCT00523952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698677|NCT00523952|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92698678|NCT00523952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698679|NCT00523952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698680|NCT00524069|Bevacizumab|bevacizumab|mesh-list
92698681|NCT00524069|Gemcitabine|gemcitabine|mesh-list
92698682|NCT00524069|Capecitabine|capecitabine|mesh-list
92698683|NCT00524069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92698684|NCT00524069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698685|NCT00524069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92698686|NCT00524069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92698687|NCT00524069|Growth Substances|growth substances|mesh-ancestor
92698688|NCT00524069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698689|NCT00524069|Growth Inhibitors|growth inhibitors|mesh-ancestor
92698690|NCT00524069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698691|NCT00524069|Antimetabolites|antimetabolites|mesh-ancestor
92698692|NCT00524069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698693|NCT00524810|Docetaxel|docetaxel|mesh-list
92698694|NCT00524810|Doxorubicin|doxorubicin|mesh-list
92698695|NCT00524810|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92698696|NCT00524810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698697|NCT00524810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92698698|NCT00524810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92698699|NCT00524810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92698726|NCT02935725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698727|NCT02935725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698728|NCT02935725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92698729|NCT02935725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92607653|NCT00140868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607654|NCT00140868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92698730|NCT02935725|Anesthetics, General|anesthetics, general|mesh-ancestor
92698731|NCT02935725|Anesthetics|anesthetics|mesh-ancestor
92698732|NCT02935725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698733|NCT02935725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92698734|NCT02935725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92698735|NCT02935725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698736|NCT02935725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698737|NCT02935764|Leucovorin|leucovorin|mesh-list
92698738|NCT02935764|Fluorouracil|fluorouracil|mesh-list
92698739|NCT02935764|Irinotecan|irinotecan|mesh-list
92698740|NCT02935764|Antimetabolites|antimetabolites|mesh-ancestor
92698741|NCT02935764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698742|NCT02935764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698743|NCT02935764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698744|NCT02935764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698745|NCT02935764|Immunologic Factors|immunologic factors|mesh-ancestor
92698756|NCT02935998|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92698757|NCT02935998|Serotonin Agents|serotonin agents|mesh-ancestor
92698758|NCT02935998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698759|NCT02935998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698760|NCT02935998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698761|NCT02935998|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92698762|NCT02935998|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92698763|NCT02935998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698764|NCT02935998|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92698765|NCT02935998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92698766|NCT02935998|Dopamine Agents|dopamine agents|mesh-ancestor
92698767|NCT02930109|Cytarabine|cytarabine|mesh-list
92698768|NCT02930109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698769|NCT02930109|Antimetabolites|antimetabolites|mesh-ancestor
92698770|NCT02930109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698771|NCT02930109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698772|NCT02930109|Antiviral Agents|antiviral agents|mesh-ancestor
92698773|NCT02930109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698774|NCT02930109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698775|NCT02930109|Immunologic Factors|immunologic factors|mesh-ancestor
92698776|NCT02930109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698777|NCT00524186|Leucovorin|leucovorin|mesh-list
92698778|NCT00524186|Fluorouracil|fluorouracil|mesh-list
92698779|NCT00524186|Irinotecan|irinotecan|mesh-list
92698780|NCT00524186|Sunitinib|sunitinib|mesh-list
92698781|NCT00524186|Calcium|calcium|mesh-list
92698782|NCT00524186|Levoleucovorin|levoleucovorin|mesh-list
92698783|NCT00524186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92698784|NCT00524186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698785|NCT00524186|Antimetabolites|antimetabolites|mesh-ancestor
92698786|NCT00524186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698787|NCT00524186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698788|NCT00524186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698789|NCT00524186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698790|NCT00524186|Immunologic Factors|immunologic factors|mesh-ancestor
92698791|NCT00524186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92698792|NCT00524186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698793|NCT00524186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698794|NCT00524186|Antidotes|antidotes|mesh-ancestor
92698795|NCT00524186|Protective Agents|protective agents|mesh-ancestor
92118664|NCT03247296|Ribavirin|ribavirin|mesh-list
92371714|NCT01324128|Iron|iron|mesh-list
92698796|NCT00524186|Vitamin B Complex|vitamin b complex|mesh-ancestor
92698797|NCT00524186|Vitamins|vitamins|mesh-ancestor
92698799|NCT00524186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92698800|NCT00524186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92698801|NCT00524186|Growth Substances|growth substances|mesh-ancestor
92698802|NCT00524186|Growth Inhibitors|growth inhibitors|mesh-ancestor
92698803|NCT00524186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92698804|NCT00525005|Docetaxel|docetaxel|mesh-list
92698805|NCT00525005|Oxaliplatin|oxaliplatin|mesh-list
92698806|NCT00525005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698807|NCT00525005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92698808|NCT00525005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92698809|NCT00525005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92698810|NCT00525005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607655|NCT00140868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92607656|NCT00140868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014976|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698811|NCT00525200|Docetaxel|docetaxel|mesh-list
92698812|NCT00525200|Cisplatin|cisplatin|mesh-list
92698813|NCT00525200|Fluorouracil|fluorouracil|mesh-list
92698814|NCT00525200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698846|NCT00525239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92698847|NCT00525239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92698848|NCT00525239|Protease Inhibitors|protease inhibitors|mesh-ancestor
92698849|NCT00525239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698850|NCT00525239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698851|NCT00525239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92698852|NCT00525239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92698853|NCT00525239|Antiviral Agents|antiviral agents|mesh-ancestor
92698854|NCT00525239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698855|NCT00525239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92698856|NCT00525239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92698857|NCT00525239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92698858|NCT00525239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92698872|NCT00525278|Levocetirizine|levocetirizine|mesh-list
92698873|NCT00525278|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92698874|NCT00525278|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92698875|NCT00525278|Histamine Antagonists|histamine antagonists|mesh-ancestor
92698876|NCT00525278|Histamine Agents|histamine agents|mesh-ancestor
92698877|NCT00525278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698878|NCT00525278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698879|NCT00525278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698881|NCT02929719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698882|NCT02929719|Antimalarials|antimalarials|mesh-ancestor
92698883|NCT02929719|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92698884|NCT02929719|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92698885|NCT02929719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92698886|NCT02929719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698887|NCT02929719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698888|NCT02929719|Leprostatic Agents|leprostatic agents|mesh-ancestor
92698889|NCT02929719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92698890|NCT04325685|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92698891|NCT04325685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698892|NCT02929524|Ketamine|ketamine|mesh-list
92698893|NCT02929524|Analgesics|analgesics|mesh-ancestor
92698894|NCT02929524|Sensory System Agents|sensory system agents|mesh-ancestor
92698895|NCT02929524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698896|NCT02929524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698897|NCT02929524|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92698898|NCT02929524|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92698899|NCT02929524|Anesthetics, General|anesthetics, general|mesh-ancestor
92698900|NCT02929524|Anesthetics|anesthetics|mesh-ancestor
92698901|NCT02929524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698902|NCT02929524|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92698903|NCT02929524|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92698904|NCT02929524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698905|NCT02929524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698906|NCT00525473|Azathioprine|azathioprine|mesh-list
92698907|NCT00525473|Antimetabolites|antimetabolites|mesh-ancestor
92698908|NCT00525473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698909|NCT00525473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698910|NCT00525473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698911|NCT00525473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698912|NCT00525473|Immunologic Factors|immunologic factors|mesh-ancestor
92698913|NCT00525473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698914|NCT00525473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698915|NCT00526175|Cytarabine|cytarabine|mesh-list
92698916|NCT00526175|Prednisone|prednisone|mesh-list
92698917|NCT00526175|Cyclophosphamide|cyclophosphamide|mesh-list
92698918|NCT00526175|Methotrexate|methotrexate|mesh-list
92698919|NCT00526175|Vincristine|vincristine|mesh-list
92698928|NCT00526175|Alkylating Agents|alkylating agents|mesh-ancestor
92698929|NCT00526175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698930|NCT00526175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698931|NCT00526175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92055966|NCT04676204|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92698932|NCT00526175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92698933|NCT00526175|Glucocorticoids|glucocorticoids|mesh-ancestor
92698934|NCT00526175|Hormones|hormones|mesh-ancestor
92698935|NCT00526175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698936|NCT00526175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92698937|NCT00526175|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92698938|NCT00526175|Abortifacient Agents|abortifacient agents|mesh-ancestor
92698939|NCT00526175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92698940|NCT00526175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698941|NCT00526175|Antimetabolites|antimetabolites|mesh-ancestor
92698942|NCT00526175|Dermatologic Agents|dermatologic agents|mesh-ancestor
92698943|NCT00526175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698944|NCT00526175|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92698945|NCT00526175|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92698946|NCT00526175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92698947|NCT00526175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92698948|NCT00526175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92698949|NCT00526175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92698950|NCT00526175|Antiviral Agents|antiviral agents|mesh-ancestor
92698951|NCT00526175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698952|NCT00526175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92698953|NCT00526175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92698954|NCT00526175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698955|NCT02930031|Acetylcysteine|acetylcysteine|mesh-list
92698956|NCT02930031|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92698957|NCT02930031|Antiviral Agents|antiviral agents|mesh-ancestor
92698958|NCT02930031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698959|NCT02930031|Expectorants|expectorants|mesh-ancestor
92698960|NCT02930031|Respiratory System Agents|respiratory system agents|mesh-ancestor
92698961|NCT02930031|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92698962|NCT02930031|Antioxidants|antioxidants|mesh-ancestor
92698963|NCT02930031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698964|NCT02930031|Protective Agents|protective agents|mesh-ancestor
92698965|NCT02930031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698966|NCT02930031|Antidotes|antidotes|mesh-ancestor
92698967|NCT02929563|Pantoprazole|pantoprazole|mesh-list
92698968|NCT02929563|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92698969|NCT02929563|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698970|NCT02929563|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92698971|NCT02929563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698972|NCT02929563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698973|NCT00525551|Acetylcysteine|acetylcysteine|mesh-list
92698974|NCT00525551|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92698975|NCT00525551|Antiviral Agents|antiviral agents|mesh-ancestor
92698976|NCT00525551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698977|NCT00525551|Expectorants|expectorants|mesh-ancestor
92698978|NCT00525551|Respiratory System Agents|respiratory system agents|mesh-ancestor
92698979|NCT00525551|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92698980|NCT00525551|Antioxidants|antioxidants|mesh-ancestor
92698981|NCT00525551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698982|NCT00525551|Protective Agents|protective agents|mesh-ancestor
92698983|NCT00525551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698984|NCT00525551|Antidotes|antidotes|mesh-ancestor
92698985|NCT04288323|Diethylenetriamine|diethylenetriamine|mesh-list
92698986|NCT04288323|Edetic Acid|edetic acid|mesh-list
92698987|NCT04288323|Pentetic Acid|pentetic acid|mesh-list
92698988|NCT04288323|Antidotes|antidotes|mesh-ancestor
92699000|NCT02946359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92699001|NCT02946359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699002|NCT02946359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92699003|NCT02946359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92699005|NCT02946359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699006|NCT02946359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92699007|NCT02946359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92699008|NCT02946359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699009|NCT02946359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699010|NCT02946437|Midazolam|midazolam|mesh-list
92699011|NCT02946437|Propofol|propofol|mesh-list
92699012|NCT02946437|Sevoflurane|sevoflurane|mesh-list
92699013|NCT02946437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92699014|NCT02946437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699015|NCT02946437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699016|NCT02946437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92699017|NCT02946437|Anesthetics, General|anesthetics, general|mesh-ancestor
92607657|NCT00140868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607658|NCT00140868|GABA Modulators|gaba modulators|mesh-ancestor
92607659|NCT00140868|GABA Agents|gaba agents|mesh-ancestor
92607660|NCT00140868|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92014979|NCT03066427|Growth Substances|growth substances|mesh-ancestor
92699018|NCT02946437|Anesthetics|anesthetics|mesh-ancestor
92699019|NCT02946437|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92699020|NCT02946437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92699021|NCT02946437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92699022|NCT02946437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699023|NCT02946437|GABA Modulators|gaba modulators|mesh-ancestor
92699024|NCT02946437|GABA Agents|gaba agents|mesh-ancestor
92371759|NCT01328964|Hormones|hormones|mesh-ancestor
92699025|NCT02946437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699026|NCT02946437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699027|NCT02946437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92699028|NCT02946437|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92699029|NCT02946632|Metformin|metformin|mesh-list
92699030|NCT02946632|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92699031|NCT02946632|Dapagliflozin|dapagliflozin|mesh-list
92699032|NCT02946632|Glimepiride|glimepiride|mesh-list
92699033|NCT02946632|Saxagliptin|saxagliptin|mesh-list
92699034|NCT02946632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92699035|NCT02946632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699036|NCT02946632|Incretins|incretins|mesh-ancestor
92699037|NCT02946632|Hormones|hormones|mesh-ancestor
92699038|NCT02946632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699039|NCT02946632|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92699040|NCT02946632|Protease Inhibitors|protease inhibitors|mesh-ancestor
92699041|NCT02946632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699042|NCT02946632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699043|NCT02946632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92699044|NCT02946632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92699045|NCT02946632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699046|NCT02946632|Immunologic Factors|immunologic factors|mesh-ancestor
92699047|NCT02929134|Doxycycline|doxycycline|mesh-list
92699048|NCT02929134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699049|NCT02929134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699050|NCT02929134|Antimalarials|antimalarials|mesh-ancestor
92699051|NCT02929134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92699052|NCT02929134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92699053|NCT02929212|Acetaminophen|acetaminophen|mesh-list
92699057|NCT02929212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699058|NCT02929212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699059|NCT02929212|Antipyretics|antipyretics|mesh-ancestor
92699060|NCT02929251|Adalimumab|adalimumab|mesh-list
92699061|NCT02929251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92699062|NCT02929251|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92699063|NCT02929251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699064|NCT02929251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699065|NCT02929095|Midazolam|midazolam|mesh-list
92699066|NCT02929095|Dexmedetomidine|dexmedetomidine|mesh-list
92699067|NCT02929095|Remifentanil|remifentanil|mesh-list
92699068|NCT02929095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92699069|NCT02929095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699070|NCT02929095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699071|NCT02929095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699072|NCT02929095|Analgesics|analgesics|mesh-ancestor
92699073|NCT02929095|Sensory System Agents|sensory system agents|mesh-ancestor
92699074|NCT02929095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699075|NCT02929095|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92699076|NCT02929095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92699077|NCT02929095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92699078|NCT02929095|Adrenergic Agents|adrenergic agents|mesh-ancestor
92699079|NCT02929095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699080|NCT02929095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699081|NCT02929095|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92699082|NCT02929095|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92699083|NCT02929095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92699084|NCT02929095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699085|NCT02929095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92699086|NCT02929095|Anesthetics, General|anesthetics, general|mesh-ancestor
92607661|NCT00140868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92607662|NCT00140868|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92607664|NCT00132938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92607665|NCT00132938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699087|NCT02929095|Anesthetics|anesthetics|mesh-ancestor
92699088|NCT02929095|GABA Modulators|gaba modulators|mesh-ancestor
92699089|NCT02929095|GABA Agents|gaba agents|mesh-ancestor
92699090|NCT02929095|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92699091|NCT02929095|Narcotics|narcotics|mesh-ancestor
92699092|NCT02928861|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92699093|NCT02928861|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92699094|NCT02928861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699095|NCT00525668|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92699096|NCT00525668|Antioxidants|antioxidants|mesh-ancestor
92699097|NCT00525668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699098|NCT00525668|Protective Agents|protective agents|mesh-ancestor
92699099|NCT00525668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699100|NCT00525668|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92699101|NCT00525668|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92699102|NCT00525668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699103|NCT00525668|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92699104|NCT00525707|Tezosentan|tezosentan|mesh-list
92699105|NCT00525707|Vasodilator Agents|vasodilator agents|mesh-ancestor
92699106|NCT00526214|Celecoxib|celecoxib|mesh-list
92699107|NCT00526214|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92699108|NCT00526214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699109|NCT00526214|Analgesics|analgesics|mesh-ancestor
92699110|NCT00526214|Sensory System Agents|sensory system agents|mesh-ancestor
92699111|NCT00526214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699112|NCT00526214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699113|NCT00526214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699114|NCT00526214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699115|NCT00526214|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92699116|NCT00526214|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92699117|NCT00526214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699118|NCT00526214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699119|NCT02928510|Idelalisib|idelalisib|mesh-list
92699120|NCT02928510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699121|NCT02928510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699122|NCT02928510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699123|NCT02946944|Sildenafil Citrate|sildenafil citrate|mesh-list
92699124|NCT02946944|Apixaban|apixaban|mesh-list
92699125|NCT02946944|Vasodilator Agents|vasodilator agents|mesh-ancestor
92699126|NCT02946944|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92699147|NCT02928315|Sensory System Agents|sensory system agents|mesh-ancestor
92699148|NCT02928315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699149|NCT02928315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699150|NCT02928315|Anesthetics|anesthetics|mesh-ancestor
92699151|NCT02928315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699152|NCT02928315|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92699153|NCT02928315|Anticonvulsants|anticonvulsants|mesh-ancestor
92699154|NCT02928315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92699155|NCT02928315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699156|NCT02928315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699157|NCT02928315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699158|NCT02928315|Tocolytic Agents|tocolytic agents|mesh-ancestor
92699159|NCT02928315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92699160|NCT00526409|Cytarabine|cytarabine|mesh-list
92699161|NCT00526409|Prednisolone|prednisolone|mesh-list
92699162|NCT00526409|Cyclophosphamide|cyclophosphamide|mesh-list
92699163|NCT00526409|Methotrexate|methotrexate|mesh-list
92699164|NCT00526409|Vincristine|vincristine|mesh-list
92699165|NCT00526409|Daunorubicin|daunorubicin|mesh-list
92699166|NCT00526409|Asparaginase|asparaginase|mesh-list
92699167|NCT00526409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699168|NCT00526409|Immunologic Factors|immunologic factors|mesh-ancestor
92699169|NCT00526409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699170|NCT00526409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699171|NCT00526409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92699172|NCT00526409|Alkylating Agents|alkylating agents|mesh-ancestor
92607666|NCT02955706|Acetylcarnitine|acetylcarnitine|mesh-list
92607667|NCT02955706|Vitamin B Complex|vitamin b complex|mesh-ancestor
92699173|NCT00526409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699174|NCT00526409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699175|NCT00526409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92699176|NCT00526409|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92699178|NCT00526409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92699179|NCT00526409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699180|NCT00526409|Antimetabolites|antimetabolites|mesh-ancestor
92699181|NCT00526409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92699182|NCT00526409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699183|NCT00526409|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92699194|NCT00526409|Antiviral Agents|antiviral agents|mesh-ancestor
92699195|NCT00526409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699196|NCT00526409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92699197|NCT00526409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92699198|NCT00526409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92699199|NCT00526448|Ribavirin|ribavirin|mesh-list
92699200|NCT00526448|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92699201|NCT00526448|Antimetabolites|antimetabolites|mesh-ancestor
92699202|NCT00526448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699203|NCT00526448|Antiviral Agents|antiviral agents|mesh-ancestor
92699204|NCT00526448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699205|NCT02946671|Nivolumab|nivolumab|mesh-list
92699206|NCT02946671|Mogamulizumab|mogamulizumab|mesh-list
92699207|NCT02946671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92699208|NCT02946671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699209|NCT02946671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92699210|NCT02946671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699211|NCT02927886|Botulinum Toxins|botulinum toxins|mesh-list
92699212|NCT02927886|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92699213|NCT02927886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699214|NCT02927886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699215|NCT02927886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92699216|NCT02927886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699217|NCT02927886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699218|NCT02945280|Apixaban|apixaban|mesh-list
92699219|NCT02945280|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92699220|NCT02945280|Antithrombins|antithrombins|mesh-ancestor
92699221|NCT02945280|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92699222|NCT02945280|Protease Inhibitors|protease inhibitors|mesh-ancestor
92699223|NCT02945280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699224|NCT02945280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699225|NCT02945280|Anticoagulants|anticoagulants|mesh-ancestor
92699226|NCT02945241|Vancomycin|vancomycin|mesh-list
92699227|NCT02945241|Cystatins|cystatins|mesh-list
92699228|NCT02945241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699229|NCT02945241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699230|NCT02945241|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92699231|NCT02945241|Protease Inhibitors|protease inhibitors|mesh-ancestor
92699232|NCT02945241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699233|NCT02945241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699234|NCT00526643|Gemcitabine|gemcitabine|mesh-list
92699235|NCT00526643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699236|NCT00526643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699237|NCT00526643|Antimetabolites|antimetabolites|mesh-ancestor
92699238|NCT00526643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699239|NCT02945163|Tenofovir|tenofovir|mesh-list
92699240|NCT02945163|Lamivudine|lamivudine|mesh-list
92699241|NCT02945163|Efavirenz|efavirenz|mesh-list
92699242|NCT02945163|Antiviral Agents|antiviral agents|mesh-ancestor
92699243|NCT02945163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699244|NCT02945163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92699245|NCT02945163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92699246|NCT02945163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699250|NCT02945163|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92699251|NCT02945163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92699252|NCT02945163|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92699254|NCT02945163|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92699255|NCT02945163|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92699257|NCT00526760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92607668|NCT02955706|Vitamins|vitamins|mesh-ancestor
92607669|NCT02955706|Micronutrients|micronutrients|mesh-ancestor
92607670|NCT02955706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699258|NCT00526760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699259|NCT00526760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699260|NCT00526760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699261|NCT00526760|Analgesics|analgesics|mesh-ancestor
92699262|NCT00526760|Sensory System Agents|sensory system agents|mesh-ancestor
92699263|NCT00526760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699264|NCT00526760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92699265|NCT00526760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92699266|NCT00526760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92699267|NCT00526760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92699268|NCT00526760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699269|NCT00526760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699270|NCT02927379|Dexmedetomidine|dexmedetomidine|mesh-list
92699271|NCT02927379|Ketamine|ketamine|mesh-list
92699272|NCT02927379|Bupivacaine|bupivacaine|mesh-list
92699273|NCT02927379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92699274|NCT02927379|Anesthetics|anesthetics|mesh-ancestor
92699275|NCT02927379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699276|NCT02927379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699277|NCT02927379|Sensory System Agents|sensory system agents|mesh-ancestor
92699278|NCT02927379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699279|NCT02927379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92699280|NCT02927379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699281|NCT02927379|Analgesics|analgesics|mesh-ancestor
92699282|NCT02927379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92699283|NCT02927379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92699284|NCT02927379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92699285|NCT02927379|Adrenergic Agents|adrenergic agents|mesh-ancestor
92699286|NCT02927379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699287|NCT02927379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699288|NCT02927379|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92699289|NCT02927379|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92699290|NCT02927379|Anesthetics, General|anesthetics, general|mesh-ancestor
92699291|NCT02927379|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92699292|NCT02927379|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92699293|NCT00526877|Risperidone|risperidone|mesh-list
92699294|NCT00526877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92699295|NCT00526877|Serotonin Agents|serotonin agents|mesh-ancestor
92699296|NCT00526877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699297|NCT00526877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699298|NCT00526877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699299|NCT00526877|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92699300|NCT00526877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92699301|NCT00526877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699302|NCT00526877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699303|NCT00526877|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92699304|NCT00526877|Dopamine Agents|dopamine agents|mesh-ancestor
92699305|NCT02927496|Doxycycline|doxycycline|mesh-list
92699306|NCT02927496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699307|NCT02927496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699308|NCT02927496|Antimalarials|antimalarials|mesh-ancestor
92699309|NCT02927496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92699310|NCT02927496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92699311|NCT02927535|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92699312|NCT02927535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699313|NCT00527033|Mirabegron|mirabegron|mesh-list
92699314|NCT00527033|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92699315|NCT00527033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92699316|NCT00527033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92699331|NCT02924922|Diuretics|diuretics|mesh-ancestor
92699332|NCT02924922|Natriuretic Agents|natriuretic agents|mesh-ancestor
92699333|NCT02924922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699334|NCT04692896|Lidocaine|lidocaine|mesh-list
92699335|NCT04692896|Anesthetics, Local|anesthetics, local|mesh-ancestor
92699336|NCT04692896|Anesthetics|anesthetics|mesh-ancestor
92699337|NCT04692896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699338|NCT04692896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699339|NCT04692896|Sensory System Agents|sensory system agents|mesh-ancestor
92699340|NCT04692896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607671|NCT02955706|Nootropic Agents|nootropic agents|mesh-ancestor
92607672|NCT01244425|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92607673|NCT01244425|Hemostatics|hemostatics|mesh-ancestor
92607674|NCT01244425|Coagulants|coagulants|mesh-ancestor
92607675|NCT00141063|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92699341|NCT04692896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92699342|NCT04692896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92699343|NCT04692896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92699344|NCT04692896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699345|NCT04692896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699346|NCT00528008|Chlorhexidine|chlorhexidine|mesh-list
92699347|NCT00528008|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92699348|NCT00528008|Povidone-Iodine|povidone-iodine|mesh-list
92699349|NCT00528008|Povidone|povidone|mesh-list
92699350|NCT00528008|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92699351|NCT00528008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699352|NCT00528008|Disinfectants|disinfectants|mesh-ancestor
92699353|NCT00528008|Dermatologic Agents|dermatologic agents|mesh-ancestor
92699354|NCT00528008|Plasma Substitutes|plasma substitutes|mesh-ancestor
92699355|NCT00528008|Blood Substitutes|blood substitutes|mesh-ancestor
92699356|NCT04692740|Chlorambucil|chlorambucil|mesh-list
92699357|NCT04692740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92699358|NCT04692740|Alkylating Agents|alkylating agents|mesh-ancestor
92699359|NCT04692740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699360|NCT04692740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699361|NCT02925000|Vinorelbine|vinorelbine|mesh-list
92699362|NCT02925000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92699363|NCT02925000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699364|NCT02925000|Tubulin Modulators|tubulin modulators|mesh-ancestor
92699365|NCT02925000|Antimitotic Agents|antimitotic agents|mesh-ancestor
92699366|NCT02925000|Mitosis Modulators|mitosis modulators|mesh-ancestor
92699367|NCT02925000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699368|NCT02926989|Plasma-lyte 148|plasma-lyte 148|mesh-list
92699369|NCT02926989|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92699370|NCT02926989|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92699371|NCT02945696|Ropivacaine|ropivacaine|mesh-list
92699372|NCT02945696|Anesthetics, Local|anesthetics, local|mesh-ancestor
92699373|NCT02945696|Anesthetics|anesthetics|mesh-ancestor
92699374|NCT02945696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699375|NCT02945696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699376|NCT02945696|Sensory System Agents|sensory system agents|mesh-ancestor
92699377|NCT02945696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699378|NCT02924766|Prednisone|prednisone|mesh-list
92699379|NCT02924766|Abiraterone Acetate|abiraterone acetate|mesh-list
92699381|NCT02924766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699383|NCT02924766|Hormones|hormones|mesh-ancestor
92699384|NCT02924766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699385|NCT02924766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699386|NCT02924766|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92699387|NCT02924766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699388|NCT02924766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92699389|NCT02924766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699390|NCT02924766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699391|NCT02924766|Hormone Antagonists|hormone antagonists|mesh-ancestor
92699392|NCT02924766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92699393|NCT02924766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92699394|NCT00528281|Pemetrexed|pemetrexed|mesh-list
92699395|NCT00528281|Lapatinib|lapatinib|mesh-list
92699396|NCT00528281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699397|NCT00528281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119261|NCT04348786|Bismuth|bismuth|mesh-list
92699398|NCT00528281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699399|NCT00528281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92699400|NCT00528281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92699401|NCT00528281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92699402|NCT01580501|Sildenafil Citrate|sildenafil citrate|mesh-list
92699404|NCT01580501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92699405|NCT01580501|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92699406|NCT01580501|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92699407|NCT01580501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607676|NCT00141063|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92607677|NCT00141063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607678|NCT00141063|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92699408|NCT01580501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699409|NCT01580501|Urological Agents|urological agents|mesh-ancestor
92699410|NCT02924532|Hormones|hormones|mesh-list
92699411|NCT02924532|Parathyroid Hormone|parathyroid hormone|mesh-list
92699412|NCT02924532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699413|NCT02924532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699414|NCT02924532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699415|NCT00528359|Olanzapine|olanzapine|mesh-list
92699416|NCT00528359|Risperidone|risperidone|mesh-list
92699417|NCT00528359|Aripiprazole|aripiprazole|mesh-list
92699418|NCT00528359|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92699419|NCT00528359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92699420|NCT00528359|Serotonin Agents|serotonin agents|mesh-ancestor
92699421|NCT00528359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699422|NCT00528359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699423|NCT00528359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699424|NCT00528359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92699425|NCT00528359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92699426|NCT00528359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699427|NCT00528359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699428|NCT00528359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92699429|NCT00528359|Dopamine Agents|dopamine agents|mesh-ancestor
92699430|NCT00528359|Antiemetics|antiemetics|mesh-ancestor
92699431|NCT00528359|Autonomic Agents|autonomic agents|mesh-ancestor
92699432|NCT00528359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699433|NCT00528359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92699434|NCT00528359|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92699435|NCT00528359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92699436|NCT00528359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699437|NCT00528359|Antidepressive Agents|antidepressive agents|mesh-ancestor
92699438|NCT00528359|Dopamine Agonists|dopamine agonists|mesh-ancestor
92699439|NCT00528359|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92699440|NCT00528359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92699441|NCT00528359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92699442|NCT00528359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92699443|NCT00527150|Varenicline|varenicline|mesh-list
92699444|NCT00527150|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92699445|NCT00527150|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92699446|NCT00527150|Cholinergic Agents|cholinergic agents|mesh-ancestor
92699447|NCT00527150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699448|NCT00527150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699449|NCT00527150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699450|NCT00527228|Deflazacort|deflazacort|mesh-list
92699460|NCT00527267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699461|NCT02924454|Metoprolol|metoprolol|mesh-list
92699462|NCT02924454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92699463|NCT02924454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92699464|NCT02924454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92699465|NCT02924454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92699466|NCT02924454|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92699467|NCT02924454|Sympatholytics|sympatholytics|mesh-ancestor
92699468|NCT02924454|Autonomic Agents|autonomic agents|mesh-ancestor
92699469|NCT02924454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119339|NCT02040298|Clemastine|clemastine|mesh-list
92699470|NCT02924454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699471|NCT02924454|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92699472|NCT02924454|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92699473|NCT02924454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92699474|NCT02924454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92699475|NCT02924454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699476|NCT02924454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699477|NCT02924454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92699479|NCT02924337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699480|NCT02924337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699481|NCT02924337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607679|NCT00141063|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92607680|NCT00141063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607681|NCT00141063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607682|NCT00141063|Dopamine Agents|dopamine agents|mesh-ancestor
92699482|NCT02924337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92699483|NCT02924337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699484|NCT02924337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699485|NCT02924337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699487|NCT00528515|Desflurane|desflurane|mesh-list
92699488|NCT00528515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92699489|NCT00528515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699490|NCT00528515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699491|NCT00528515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92699492|NCT00528515|Anesthetics, General|anesthetics, general|mesh-ancestor
92699493|NCT00528515|Anesthetics|anesthetics|mesh-ancestor
92699494|NCT00528515|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92699495|NCT02923986|Dasatinib|dasatinib|mesh-list
92699496|NCT02923986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699497|NCT02923986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92699498|NCT02923986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699499|NCT02923986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699500|NCT02926248|Colchicine|colchicine|mesh-list
92699501|NCT02926248|Gout Suppressants|gout suppressants|mesh-ancestor
92699502|NCT02926248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699503|NCT02926248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92699504|NCT02926248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92699505|NCT02926248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92699506|NCT02926248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699507|NCT02926248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699508|NCT00528593|Epoetin Alfa|epoetin alfa|mesh-list
92699509|NCT00528593|Hematinics|hematinics|mesh-ancestor
92699510|NCT02926326|Azithromycin|azithromycin|mesh-list
92699511|NCT02926326|Acumapimod|acumapimod|mesh-list
92699512|NCT02926326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699513|NCT02926326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699514|NCT02926326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92699515|NCT02926326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699535|NCT04691765|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92699536|NCT04691765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699537|NCT04691687|Furosemide|furosemide|mesh-list
92699538|NCT04691687|Diuretics|diuretics|mesh-ancestor
92699539|NCT04691687|Natriuretic Agents|natriuretic agents|mesh-ancestor
92699540|NCT04691687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699541|NCT04691687|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92699542|NCT04691687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119400|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92699543|NCT04691687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699544|NCT04107675|Cyclosporine|cyclosporine|mesh-list
92371899|NCT01340586|Apixaban|apixaban|mesh-list
92699545|NCT04107675|Cyclosporins|cyclosporins|mesh-list
92699546|NCT04107675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699547|NCT04107675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699548|NCT04107675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699549|NCT04107675|Immunologic Factors|immunologic factors|mesh-ancestor
92699550|NCT04107675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699551|NCT04107675|Antifungal Agents|antifungal agents|mesh-ancestor
92699552|NCT04107675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699553|NCT04107675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92699554|NCT04107675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699555|NCT04107675|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92699556|NCT02923869|Bupivacaine|bupivacaine|mesh-list
92699557|NCT02923869|Levobupivacaine|levobupivacaine|mesh-list
92699558|NCT02923869|Anesthetics, Local|anesthetics, local|mesh-ancestor
92699559|NCT02923869|Anesthetics|anesthetics|mesh-ancestor
92699560|NCT02923869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699561|NCT02923869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699562|NCT02923869|Sensory System Agents|sensory system agents|mesh-ancestor
92699563|NCT02923869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699564|NCT02923791|Lenograstim|lenograstim|mesh-list
92699565|NCT02923791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92607683|NCT00141063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607684|NCT01154439|Cytarabine|cytarabine|mesh-list
92607685|NCT01154439|Etoposide|etoposide|mesh-list
92607686|NCT01154439|Mitoxantrone|mitoxantrone|mesh-list
92607687|NCT01154439|Idarubicin|idarubicin|mesh-list
92607688|NCT01154439|Etoposide phosphate|etoposide phosphate|mesh-list
92607689|NCT01154439|Everolimus|everolimus|mesh-list
92607690|NCT01154439|Ifosfamide|ifosfamide|mesh-list
92699566|NCT02923791|Immunologic Factors|immunologic factors|mesh-ancestor
92699567|NCT02923791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699568|NCT00527540|Interferons|interferons|mesh-list
92699573|NCT00527540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699574|NCT00527540|Antiviral Agents|antiviral agents|mesh-ancestor
92699575|NCT00527540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699576|NCT00527540|Antimetabolites|antimetabolites|mesh-ancestor
92699577|NCT00527540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699578|NCT00527540|Immunologic Factors|immunologic factors|mesh-ancestor
92699579|NCT00527540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699580|NCT02926053|Cyclophosphamide|cyclophosphamide|mesh-list
92699581|NCT02926053|Fludarabine|fludarabine|mesh-list
92699582|NCT02926053|Interleukin-2|interleukin-2|mesh-list
92699583|NCT02926053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699584|NCT02926053|Immunologic Factors|immunologic factors|mesh-ancestor
92699585|NCT02926053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699586|NCT02926053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699587|NCT02926053|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92699588|NCT02926053|Alkylating Agents|alkylating agents|mesh-ancestor
92699589|NCT02926053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699590|NCT02926053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699591|NCT02926053|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92699592|NCT02926053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699593|NCT02926053|Analgesics|analgesics|mesh-ancestor
92699594|NCT02926053|Sensory System Agents|sensory system agents|mesh-ancestor
92699595|NCT02926053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699596|NCT00527657|Thalidomide|thalidomide|mesh-list
92699597|NCT00527657|Temozolomide|temozolomide|mesh-list
92699598|NCT00527657|Lomustine|lomustine|mesh-list
92699599|NCT00527657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92699600|NCT00527657|Alkylating Agents|alkylating agents|mesh-ancestor
92699601|NCT00527657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699602|NCT00527657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699603|NCT00527657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699604|NCT00527657|Immunologic Factors|immunologic factors|mesh-ancestor
92699605|NCT00527657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699606|NCT00527657|Leprostatic Agents|leprostatic agents|mesh-ancestor
92699607|NCT00527657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699608|NCT00527657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699609|NCT00527657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92699610|NCT00527657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92699611|NCT00527657|Growth Substances|growth substances|mesh-ancestor
92699612|NCT00527657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92699613|NCT00528983|Azacitidine|azacitidine|mesh-list
92699614|NCT00528983|Cc-486|cc-486|mesh-list
92699615|NCT00528983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699616|NCT00528983|Antimetabolites|antimetabolites|mesh-ancestor
92699617|NCT00528983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699618|NCT00528983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699619|NCT00528983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699620|NCT00529022|Carboplatin|carboplatin|mesh-list
92699621|NCT00529022|Azacitidine|azacitidine|mesh-list
92699622|NCT00529022|Valproic Acid|valproic acid|mesh-list
92699623|NCT00529022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699624|NCT00529022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699625|NCT00529022|Antimetabolites|antimetabolites|mesh-ancestor
92699626|NCT00529022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699627|NCT00529022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699628|NCT00529022|Anticonvulsants|anticonvulsants|mesh-ancestor
92699629|NCT00529022|GABA Agents|gaba agents|mesh-ancestor
92699630|NCT00529022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699631|NCT00529022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699632|NCT00529022|Antimanic Agents|antimanic agents|mesh-ancestor
92699633|NCT00529022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607691|NCT01154439|Carboplatin|carboplatin|mesh-list
92607692|NCT01154439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92699634|NCT00529022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699635|NCT00529022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699636|NCT02923557|Pirarubicin|pirarubicin|mesh-list
92699637|NCT02923557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699638|NCT02925975|Carvedilol|carvedilol|mesh-list
92699639|NCT02925975|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92699640|NCT02925975|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92699641|NCT02925975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92699642|NCT02925975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699643|NCT02925975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699647|NCT02925975|Protective Agents|protective agents|mesh-ancestor
92699648|NCT02925975|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92699649|NCT02925975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699650|NCT02925975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699651|NCT02925975|Vasodilator Agents|vasodilator agents|mesh-ancestor
92699652|NCT02925975|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92699653|NCT02925975|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92699654|NCT02945033|Aspirin|aspirin|mesh-list
92699655|NCT02945033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92699656|NCT02945033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699657|NCT02945033|Analgesics|analgesics|mesh-ancestor
92699658|NCT02945033|Sensory System Agents|sensory system agents|mesh-ancestor
92699659|NCT02945033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699660|NCT02945033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699661|NCT02945033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699662|NCT02945033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699663|NCT02945033|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92371933|NCT01351740|Ritonavir|ritonavir|mesh-list
92699664|NCT02945033|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92699665|NCT02945033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699666|NCT02945033|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92699667|NCT02945033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92699668|NCT02945033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699669|NCT02945033|Antipyretics|antipyretics|mesh-ancestor
92699670|NCT04231968|Ziresovir|ziresovir|mesh-list
92699671|NCT04231968|Antiviral Agents|antiviral agents|mesh-ancestor
92699672|NCT04231968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699673|NCT00529295|Misoprostol|misoprostol|mesh-list
92699674|NCT00529295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92699675|NCT00529295|Abortifacient Agents|abortifacient agents|mesh-ancestor
92699676|NCT00529295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92699677|NCT00529295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699678|NCT00529295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92699679|NCT00529295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92699680|NCT00529295|Oxytocics|oxytocics|mesh-ancestor
92699681|NCT02922933|Entinostat|entinostat|mesh-list
92699682|NCT02922933|Omeprazole|omeprazole|mesh-list
92699683|NCT02922933|Famotidine|famotidine|mesh-list
92699684|NCT02922933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92699685|NCT02922933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92699686|NCT02922933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92699687|NCT02922933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699688|NCT02922933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699689|NCT02922933|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92699690|NCT02922933|Histamine Antagonists|histamine antagonists|mesh-ancestor
92699691|NCT02922933|Histamine Agents|histamine agents|mesh-ancestor
92699692|NCT02922933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699693|NCT02922933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699694|NCT02922933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699695|NCT02922933|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92699696|NCT02945267|Tegafur|tegafur|mesh-list
92699697|NCT02945267|Nimotuzumab|nimotuzumab|mesh-list
92699698|NCT02945267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699699|NCT02945267|Antimetabolites|antimetabolites|mesh-ancestor
92699700|NCT02945267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699701|NCT02945267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699702|NCT02945267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92699703|NCT00529646|APD791|apd791|mesh-list
92699704|NCT00529646|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92699705|NCT00529646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92699706|NCT00529646|Serotonin Agents|serotonin agents|mesh-ancestor
92699707|NCT00529646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607693|NCT01154439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015007|NCT05176821|Esomeprazole|esomeprazole|mesh-list
92699708|NCT00529646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699709|NCT00529646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699710|NCT00527930|Oxaliplatin|oxaliplatin|mesh-list
92699711|NCT00527930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699712|NCT00529841|Hydrocortisone|hydrocortisone|mesh-list
92699713|NCT00529841|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92699714|NCT00529841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699715|NCT00529880|Cytarabine|cytarabine|mesh-list
92699716|NCT00529880|Fludarabine|fludarabine|mesh-list
92699719|NCT00529880|Antimetabolites|antimetabolites|mesh-ancestor
92699720|NCT00529880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699721|NCT00529880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699722|NCT00529880|Immunologic Factors|immunologic factors|mesh-ancestor
92699723|NCT00529880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699724|NCT00529880|Antiviral Agents|antiviral agents|mesh-ancestor
92699725|NCT00529880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699726|NCT02925702|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92699727|NCT02925702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699728|NCT00531089|Rituximab|rituximab|mesh-list
92699729|NCT00531089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92699730|NCT00531089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699731|NCT00531089|Immunologic Factors|immunologic factors|mesh-ancestor
92699732|NCT00531089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699733|NCT00531089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699734|NCT02922699|Omeprazole|omeprazole|mesh-list
92699735|NCT02922699|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92699736|NCT02922699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92699737|NCT02922699|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92699738|NCT02922699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699739|NCT02922699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699740|NCT02922660|Remifentanil|remifentanil|mesh-list
92699741|NCT02922660|Anesthetics|anesthetics|mesh-list
92699742|NCT02922660|Propofol|propofol|mesh-list
92699743|NCT02922660|Desflurane|desflurane|mesh-list
92699744|NCT02922660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699745|NCT02922660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699746|NCT02922660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92699747|NCT02922660|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92699748|NCT02922660|Anesthetics, General|anesthetics, general|mesh-ancestor
92699749|NCT02922660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92699750|NCT02922660|Narcotics|narcotics|mesh-ancestor
92699751|NCT02922660|Analgesics|analgesics|mesh-ancestor
92699752|NCT02922660|Sensory System Agents|sensory system agents|mesh-ancestor
92699753|NCT02922660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699754|NCT02922660|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92699755|NCT02922465|Clopidogrel|clopidogrel|mesh-list
92699756|NCT02922465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92699757|NCT02922465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92699758|NCT02922465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92699759|NCT02922465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92699760|NCT02922465|Purinergic Agents|purinergic agents|mesh-ancestor
92699761|NCT02922465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699762|NCT02922465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699763|NCT02922465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699764|NCT02944292|Propofol|propofol|mesh-list
92699765|NCT02944292|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92699766|NCT02944292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699767|NCT02944292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699768|NCT02944292|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92699769|NCT02944292|Anesthetics, General|anesthetics, general|mesh-ancestor
92699770|NCT02944292|Anesthetics|anesthetics|mesh-ancestor
92699771|NCT02922426|Olanzapine|olanzapine|mesh-list
92699772|NCT02922426|Antiemetics|antiemetics|mesh-ancestor
92699773|NCT02922426|Autonomic Agents|autonomic agents|mesh-ancestor
92699774|NCT02922426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699775|NCT02922426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699776|NCT02922426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92699777|NCT02922426|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92371968|NCT01363050|Ketorolac|ketorolac|mesh-list
92699778|NCT02922426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92699779|NCT02922426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699780|NCT02922426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699781|NCT02922426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92607694|NCT01154439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607695|NCT01154439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607696|NCT01154439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607697|NCT01154439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607698|NCT01154439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699782|NCT02922426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92699783|NCT02922426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699784|NCT02922426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699785|NCT02922426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699786|NCT02922426|Serotonin Agents|serotonin agents|mesh-ancestor
92699787|NCT00531128|Gamma-sitosterol|gamma-sitosterol|mesh-list
92699788|NCT00531128|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92699789|NCT00531128|Antimetabolites|antimetabolites|mesh-ancestor
92699802|NCT00531167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699803|NCT00531167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699804|NCT00531167|Antiviral Agents|antiviral agents|mesh-ancestor
92699805|NCT00531167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699806|NCT00531167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92699807|NCT00531167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92699808|NCT02944214|Febuxostat|febuxostat|mesh-list
92699809|NCT02944214|Benzbromarone|benzbromarone|mesh-list
92699810|NCT02944214|Gout Suppressants|gout suppressants|mesh-ancestor
92699811|NCT02944214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699812|NCT02944214|Uricosuric Agents|uricosuric agents|mesh-ancestor
92699813|NCT02922075|Amoxicillin|amoxicillin|mesh-list
92699814|NCT02922075|Chlorhexidine|chlorhexidine|mesh-list
92699815|NCT02922075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699816|NCT02922075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699817|NCT02922075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92699818|NCT02922075|Disinfectants|disinfectants|mesh-ancestor
92699819|NCT00531245|Oxaliplatin|oxaliplatin|mesh-list
92699820|NCT00531245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699821|NCT02922348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92699822|NCT02922348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92699823|NCT02922348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92699824|NCT02922348|Medroxyprogesterone|medroxyprogesterone|mesh-list
92699825|NCT02922348|Norgestimate|norgestimate|mesh-list
92699826|NCT02922348|Contraceptive Agents|contraceptive agents|mesh-list
92699827|NCT02922348|Contraceptives, Oral|contraceptives, oral|mesh-list
92699828|NCT02922348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92699829|NCT02922348|Hormones|hormones|mesh-list
92699830|NCT02922348|Estradiol|estradiol|mesh-list
92699831|NCT02922348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92699832|NCT02922348|Progestins|progestins|mesh-list
92699833|NCT02922348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699834|NCT02922348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699835|NCT02922348|Estrogens|estrogens|mesh-ancestor
92699836|NCT02922348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92699837|NCT02922348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92699838|NCT02922348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92699839|NCT02922348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92699840|NCT02922348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92699841|NCT00527501|Travoprost|travoprost|mesh-list
92699842|NCT00527501|Brinzolamide|brinzolamide|mesh-list
92699843|NCT00527501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92699844|NCT00527501|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92371981|NCT01363128|Cytarabine|cytarabine|mesh-list
92699845|NCT00527501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699846|NCT00527501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699847|NCT02922387|Varenicline|varenicline|mesh-list
92699848|NCT02922387|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92699849|NCT02922387|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92699850|NCT02922387|Cholinergic Agents|cholinergic agents|mesh-ancestor
92699851|NCT02922387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699852|NCT02922387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699853|NCT02922387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699869|NCT00531362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699870|NCT00531362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92699871|NCT00531362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92699872|NCT00531362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699873|NCT00531362|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92607699|NCT01154439|Antimetabolites|antimetabolites|mesh-ancestor
92607700|NCT01154439|Antiviral Agents|antiviral agents|mesh-ancestor
92607701|NCT01154439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607702|NCT01154439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699874|NCT00531362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92699875|NCT00531362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699876|NCT00531362|Antipyretics|antipyretics|mesh-ancestor
92699877|NCT00531401|Farnesylthiosalicylic acid|farnesylthiosalicylic acid|mesh-list
92699878|NCT00531401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699879|NCT00531401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699880|NCT00531401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699882|NCT00531440|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92699883|NCT00531440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92699884|NCT00531440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699885|NCT00531440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699886|NCT00531440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699887|NCT00531440|Immunologic Factors|immunologic factors|mesh-ancestor
92699888|NCT00531440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699889|NCT00531440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699890|NCT02944526|Ropivacaine|ropivacaine|mesh-list
92699891|NCT02944526|Anesthetics, Local|anesthetics, local|mesh-ancestor
92699892|NCT02944526|Anesthetics|anesthetics|mesh-ancestor
92699893|NCT02944526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699894|NCT02944526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699895|NCT02944526|Sensory System Agents|sensory system agents|mesh-ancestor
92699896|NCT02944526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699897|NCT04000854|Calcium|calcium|mesh-list
92699898|NCT04000854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699899|NCT04000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699900|NCT00530387|Ibuprofen|ibuprofen|mesh-list
92699901|NCT00530387|Diclofenac|diclofenac|mesh-list
92699902|NCT00530387|Ketoprofen|ketoprofen|mesh-list
92699903|NCT00530387|Piroxicam|piroxicam|mesh-list
92699904|NCT00530387|Salicylates|salicylates|mesh-list
92699905|NCT00530387|Etofenamate|etofenamate|mesh-list
92699906|NCT00530387|Sunscreening Agents|sunscreening agents|mesh-list
92699907|NCT00530387|Homosalate|homosalate|mesh-list
92699908|NCT00530387|Octylmethoxycinnamate|octylmethoxycinnamate|mesh-list
92699909|NCT00530387|Benzophenone|benzophenone|mesh-list
92699910|NCT00530387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92699911|NCT00530387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699912|NCT00530387|Analgesics|analgesics|mesh-ancestor
92699913|NCT00530387|Sensory System Agents|sensory system agents|mesh-ancestor
92699925|NCT04689165|Vaccines|vaccines|mesh-list
92699926|NCT04689165|Immunologic Factors|immunologic factors|mesh-ancestor
92699927|NCT04689165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699928|NCT00530582|Progesterone|progesterone|mesh-list
92699929|NCT00530582|Progestins|progestins|mesh-ancestor
92699930|NCT00530582|Hormones|hormones|mesh-ancestor
92371997|NCT01363128|Alkylating Agents|alkylating agents|mesh-ancestor
92699931|NCT00530582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699932|NCT00530582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699933|NCT02944175|Neostigmine|neostigmine|mesh-list
92699934|NCT02944175|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92699935|NCT02944175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699936|NCT02944175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699937|NCT02944175|Cholinergic Agents|cholinergic agents|mesh-ancestor
92699938|NCT02944175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699939|NCT02944175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699940|NCT02944175|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92699941|NCT02944175|Autonomic Agents|autonomic agents|mesh-ancestor
92699942|NCT02944175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699943|NCT02917746|Imiquimod|imiquimod|mesh-list
92699944|NCT02917746|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92699945|NCT02917746|Immunologic Factors|immunologic factors|mesh-ancestor
92699946|NCT02917746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699947|NCT02917746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699948|NCT02917746|Interferon Inducers|interferon inducers|mesh-ancestor
92699949|NCT00531557|Ritonavir|ritonavir|mesh-list
92699950|NCT00531557|Darunavir|darunavir|mesh-list
92699951|NCT00531557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92699952|NCT00531557|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92699953|NCT00531557|Protease Inhibitors|protease inhibitors|mesh-ancestor
92699954|NCT00531557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699955|NCT00531557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607703|NCT01154439|Immunologic Factors|immunologic factors|mesh-ancestor
92607704|NCT01154439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607705|NCT01154439|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92607706|NCT01154439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92699956|NCT00531557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92699957|NCT00531557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92699958|NCT00531557|Antiviral Agents|antiviral agents|mesh-ancestor
92699959|NCT00531557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699960|NCT00531557|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92699961|NCT00531557|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92699962|NCT00531596|Selegiline|selegiline|mesh-list
92699963|NCT00531596|Antidepressive Agents|antidepressive agents|mesh-ancestor
92699964|NCT00531596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92699965|NCT00531596|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92699966|NCT00531596|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92699967|NCT00531596|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92699968|NCT00531596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699969|NCT00531596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699970|NCT00531596|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92699971|NCT00531596|Protective Agents|protective agents|mesh-ancestor
92699972|NCT00531596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699973|NCT02943707|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92699974|NCT02943707|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92699975|NCT02943707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92699976|NCT00531635|Mycophenolic Acid|mycophenolic acid|mesh-list
92699994|NCT00531674|Vitamins|vitamins|mesh-ancestor
92699995|NCT00531674|Micronutrients|micronutrients|mesh-ancestor
92699996|NCT00530972|Ribavirin|ribavirin|mesh-list
92699997|NCT00530972|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92119868|NCT04733937|Caseins|caseins|mesh-list
92699998|NCT00530972|Antimetabolites|antimetabolites|mesh-ancestor
92699999|NCT00530972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700000|NCT00530972|Antiviral Agents|antiviral agents|mesh-ancestor
92700001|NCT00530972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700003|NCT02943317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700004|NCT02943317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700005|NCT02943356|Tadalafil|tadalafil|mesh-list
92700006|NCT02943356|Vasodilator Agents|vasodilator agents|mesh-ancestor
92700007|NCT02943356|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92700008|NCT02943356|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92700009|NCT02943356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700010|NCT02943356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700011|NCT02943356|Urological Agents|urological agents|mesh-ancestor
92700012|NCT02917512|Cyclosporine|cyclosporine|mesh-list
92700013|NCT02917512|Cyclosporins|cyclosporins|mesh-list
92700014|NCT02917512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700015|NCT02917512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700016|NCT02917512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92700017|NCT02917512|Immunologic Factors|immunologic factors|mesh-ancestor
92700018|NCT02917512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700019|NCT02917512|Antifungal Agents|antifungal agents|mesh-ancestor
92700020|NCT02917512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700021|NCT02917512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92700022|NCT02917512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700023|NCT02917512|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92700024|NCT02943902|Vaccines|vaccines|mesh-list
92700025|NCT02943902|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92700026|NCT02943902|Immunologic Factors|immunologic factors|mesh-ancestor
92700027|NCT02943902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700028|NCT00531908|Furosemide|furosemide|mesh-list
92700029|NCT00531908|Diuretics|diuretics|mesh-ancestor
92700030|NCT00531908|Natriuretic Agents|natriuretic agents|mesh-ancestor
92700031|NCT00531908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700032|NCT00531908|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92700033|NCT00531908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92700049|NCT00531791|Glucocorticoids|glucocorticoids|mesh-ancestor
92700050|NCT00531791|Hormones|hormones|mesh-ancestor
92700051|NCT00531791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700052|NCT00531791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700053|NCT00531791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700054|NCT00531791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607708|NCT01154439|Sensory System Agents|sensory system agents|mesh-ancestor
92372045|NCT01371786|Dermatologic Agents|dermatologic agents|mesh-ancestor
92607709|NCT01154439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607710|NCT01154439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92700055|NCT02921178|Omalizumab|omalizumab|mesh-list
92700056|NCT02921178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92700057|NCT02921178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92700058|NCT02921178|Respiratory System Agents|respiratory system agents|mesh-ancestor
92700059|NCT00531986|Lopinavir|lopinavir|mesh-list
92700060|NCT00531986|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92700061|NCT00531986|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92700062|NCT00531986|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700063|NCT00531986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700064|NCT00531986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700065|NCT00531986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92700066|NCT00531986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92700067|NCT00531986|Antiviral Agents|antiviral agents|mesh-ancestor
92700068|NCT00531986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700069|NCT00531986|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92700070|NCT00531986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119933|NCT00183339|Fluoxetine|fluoxetine|mesh-list
92700071|NCT05319899|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92700072|NCT05319899|Choline|choline|mesh-list
92700073|NCT05319899|Omeprazole|omeprazole|mesh-list
92700074|NCT05319899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92700075|NCT05319899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700076|NCT05319899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92700077|NCT05319899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700078|NCT05319899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700079|NCT05319899|Lipotropic Agents|lipotropic agents|mesh-ancestor
92700080|NCT05319899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92700081|NCT05319899|Antimetabolites|antimetabolites|mesh-ancestor
92700082|NCT05319899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92700083|NCT05319899|Nootropic Agents|nootropic agents|mesh-ancestor
92700084|NCT05319899|Chelating Agents|chelating agents|mesh-ancestor
92700085|NCT05319899|Sequestering Agents|sequestering agents|mesh-ancestor
92700086|NCT05319899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92700087|NCT05319899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92700088|NCT05319899|Growth Substances|growth substances|mesh-ancestor
92700089|NCT05319899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700090|NCT05319899|Growth Inhibitors|growth inhibitors|mesh-ancestor
92700091|NCT05319899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700092|NCT02920827|Dapivirine|dapivirine|mesh-list
92700095|NCT02920827|Antiviral Agents|antiviral agents|mesh-ancestor
92700096|NCT02920827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700097|NCT02920905|Lidocaine|lidocaine|mesh-list
92700098|NCT02920905|Atracurium|atracurium|mesh-list
92700099|NCT02920905|Anesthetics, Local|anesthetics, local|mesh-ancestor
92700100|NCT02920905|Anesthetics|anesthetics|mesh-ancestor
92700101|NCT02920905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700102|NCT02920905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700103|NCT02920905|Sensory System Agents|sensory system agents|mesh-ancestor
92700104|NCT02920905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700105|NCT02920905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92700106|NCT02920905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92700107|NCT02920905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92700108|NCT02920905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92700109|NCT02920905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700110|NCT02920905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92700111|NCT02920905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92700112|NCT02920905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92700113|NCT02920905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92700114|NCT02920905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92700115|NCT02920905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92700116|NCT02920905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700117|NCT02917200|Moxifloxacin|moxifloxacin|mesh-list
92700118|NCT02917200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92700119|NCT02917200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700120|NCT02917200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92700121|NCT02917200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92700122|NCT02917200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700123|NCT02917200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607711|NCT01154439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92607712|NCT01154439|Alkylating Agents|alkylating agents|mesh-ancestor
92607713|NCT00133172|Mycophenolic Acid|mycophenolic acid|mesh-list
92700124|NCT02917200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700125|NCT02920515|Leuprolide|leuprolide|mesh-list
92700126|NCT02920515|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92700127|NCT02920515|Fertility Agents|fertility agents|mesh-ancestor
92700128|NCT02920515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92700129|NCT02920515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700130|NCT02920515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700131|NCT02920515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700132|NCT02917005|Palbociclib|palbociclib|mesh-list
92700133|NCT02917005|Exemestane|exemestane|mesh-list
92700134|NCT02917005|Goserelin|goserelin|mesh-list
92700135|NCT02917005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700136|NCT02917005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92700137|NCT02917005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700138|NCT02917005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700139|NCT02917005|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92700140|NCT02917005|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92700141|NCT02917005|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92700142|NCT02917005|Hormone Antagonists|hormone antagonists|mesh-ancestor
92700143|NCT02917005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700144|NCT02917005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120003|NCT02387554|Losartan|losartan|mesh-list
92700145|NCT02917005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700146|NCT02942810|Cefepime|cefepime|mesh-list
92700147|NCT02942810|Cefepime-zidebactam|cefepime-zidebactam|mesh-list
92700148|NCT02942810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92700149|NCT02942810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700150|NCT02920710|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92700151|NCT02920710|Hormones|hormones|mesh-ancestor
92700152|NCT02920710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700153|NCT02920710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700154|NCT02941913|Palonosetron|palonosetron|mesh-list
92700155|NCT02941913|Antiemetics|antiemetics|mesh-ancestor
92700156|NCT02941913|Autonomic Agents|autonomic agents|mesh-ancestor
92700157|NCT02941913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700158|NCT02941913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700159|NCT02941913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700160|NCT02941913|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92700161|NCT02941913|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92700162|NCT02941913|Serotonin Agents|serotonin agents|mesh-ancestor
92700163|NCT02941913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700181|NCT02942732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700183|NCT02942732|Micronutrients|micronutrients|mesh-ancestor
92700184|NCT02942732|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92700185|NCT02942420|Bucillamine|bucillamine|mesh-list
92700186|NCT02942420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92700187|NCT02942420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92700188|NCT02942420|Analgesics|analgesics|mesh-ancestor
92700189|NCT02942420|Sensory System Agents|sensory system agents|mesh-ancestor
92700190|NCT02942420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700191|NCT02942420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700192|NCT02942420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700193|NCT02942420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372080|NCT01380366|Hormones|hormones|mesh-list
92700194|NCT02942420|Antioxidants|antioxidants|mesh-ancestor
92700195|NCT02942420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700196|NCT02942420|Protective Agents|protective agents|mesh-ancestor
92700197|NCT02920359|Leuprolide|leuprolide|mesh-list
92700198|NCT02920359|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92700199|NCT02920359|Fertility Agents|fertility agents|mesh-ancestor
92700200|NCT02920359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92700201|NCT02920359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700202|NCT02920359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700203|NCT02920359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700204|NCT02916654|Iron|iron|mesh-list
92700205|NCT02916654|Trace Elements|trace elements|mesh-ancestor
92700206|NCT02916654|Micronutrients|micronutrients|mesh-ancestor
92700207|NCT02916654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607715|NCT00133172|Tacrolimus|tacrolimus|mesh-list
92607716|NCT00133172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607717|NCT00133172|Glucocorticoids|glucocorticoids|mesh-ancestor
92700208|NCT02941562|Leucovorin|leucovorin|mesh-list
92700209|NCT02941562|Fluorouracil|fluorouracil|mesh-list
92700210|NCT02941562|Oxaliplatin|oxaliplatin|mesh-list
92700211|NCT02941562|Antimetabolites|antimetabolites|mesh-ancestor
92700212|NCT02941562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700213|NCT02941562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92700214|NCT02941562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700215|NCT02941562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92700216|NCT02941562|Immunologic Factors|immunologic factors|mesh-ancestor
92700217|NCT02941562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700218|NCT02941562|Antidotes|antidotes|mesh-ancestor
92700219|NCT02941562|Protective Agents|protective agents|mesh-ancestor
92120084|NCT00094497|Etoposide|etoposide|mesh-list
92700220|NCT02941562|Vitamin B Complex|vitamin b complex|mesh-ancestor
92700221|NCT02941562|Vitamins|vitamins|mesh-ancestor
92700232|NCT02942888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700233|NCT02942888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92700234|NCT02942888|Vasodilator Agents|vasodilator agents|mesh-ancestor
92700236|NCT02916420|Pomalidomide|pomalidomide|mesh-list
92700237|NCT02916420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700238|NCT02916420|Antiemetics|antiemetics|mesh-ancestor
92700239|NCT02916420|Autonomic Agents|autonomic agents|mesh-ancestor
92700240|NCT02916420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700241|NCT02916420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700242|NCT02916420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700243|NCT02916420|Glucocorticoids|glucocorticoids|mesh-ancestor
92700244|NCT02916420|Hormones|hormones|mesh-ancestor
92700245|NCT02916420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700246|NCT02916420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700247|NCT02916420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700248|NCT02916420|Immunologic Factors|immunologic factors|mesh-ancestor
92700249|NCT02916420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92700250|NCT02916420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92700251|NCT02916420|Growth Substances|growth substances|mesh-ancestor
92700252|NCT02916420|Growth Inhibitors|growth inhibitors|mesh-ancestor
92700253|NCT02942381|Hydroxychloroquine|hydroxychloroquine|mesh-list
92700254|NCT02942381|Antimalarials|antimalarials|mesh-ancestor
92700255|NCT02942381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92700256|NCT02942381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92700257|NCT02942381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700258|NCT02942381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700259|NCT02942381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700260|NCT02942381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700261|NCT03458468|Tranexamic Acid|tranexamic acid|mesh-list
92700262|NCT03458468|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92700263|NCT03458468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92700264|NCT03458468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700265|NCT03458468|Hemostatics|hemostatics|mesh-ancestor
92700266|NCT03458468|Coagulants|coagulants|mesh-ancestor
92700267|NCT02942303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92700268|NCT02942303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92700269|NCT02942303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92700270|NCT02942303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700271|NCT02942303|Cholinergic Agents|cholinergic agents|mesh-ancestor
92700272|NCT02942303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700273|NCT02942303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700274|NCT02916381|Anesthetics|anesthetics|mesh-list
92700275|NCT02916381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700276|NCT02916381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700277|NCT02920047|Amlodipine|amlodipine|mesh-list
92700278|NCT02920047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92700279|NCT02920047|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92700280|NCT02920047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92700281|NCT02920047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700282|NCT02920047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92700283|NCT02920047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700284|NCT02920047|Vasodilator Agents|vasodilator agents|mesh-ancestor
92700285|NCT02941016|Evolocumab|evolocumab|mesh-list
92700286|NCT02941016|Alirocumab|alirocumab|mesh-list
92700287|NCT02941016|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92607718|NCT00133172|Hormones|hormones|mesh-ancestor
92607719|NCT00133172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607720|NCT00133172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607721|NCT00133172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700288|NCT02941016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92700300|NCT02941445|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92700301|NCT02941445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92700302|NCT02941445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700303|NCT02941445|Incretins|incretins|mesh-ancestor
92700304|NCT02941445|Hormones|hormones|mesh-ancestor
92700305|NCT02941445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700306|NCT02941445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92700307|NCT02941445|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700308|NCT02941445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700309|NCT02941445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700310|NCT02919501|Vortioxetine|vortioxetine|mesh-list
92700311|NCT02919501|Antidepressive Agents|antidepressive agents|mesh-ancestor
92700312|NCT02919501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92700313|NCT02919501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92700314|NCT02919501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92700315|NCT02919501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700316|NCT02919501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700317|NCT02919501|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92700318|NCT02919501|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92700319|NCT02919501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92700320|NCT02919501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700321|NCT02919501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700322|NCT02919501|Serotonin Agents|serotonin agents|mesh-ancestor
92700323|NCT02919501|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92700324|NCT02919501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92700325|NCT02919501|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92700326|NCT02919501|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92700327|NCT02919579|Esketamine|esketamine|mesh-list
92700328|NCT02919579|Antidepressive Agents|antidepressive agents|mesh-ancestor
92700329|NCT02919579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92700330|NCT02940821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92700331|NCT02940821|Fluorides|fluorides|mesh-list
92700332|NCT02940821|Tin Fluorides|tin fluorides|mesh-list
92700333|NCT02940821|Fluorophosphate|fluorophosphate|mesh-list
92700334|NCT02940821|Cariostatic Agents|cariostatic agents|mesh-ancestor
92700335|NCT02940821|Protective Agents|protective agents|mesh-ancestor
92700336|NCT02940821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700337|NCT02940821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92700338|NCT02940821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700339|NCT02941601|Carboplatin|carboplatin|mesh-list
92700340|NCT02941601|Gemcitabine|gemcitabine|mesh-list
92700341|NCT02941601|Necitumumab|necitumumab|mesh-list
92700342|NCT02941601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700343|NCT02941601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92700344|NCT02941601|Antimetabolites|antimetabolites|mesh-ancestor
92700345|NCT02941601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700346|NCT02941601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700347|NCT03160638|Azithromycin|azithromycin|mesh-list
92700348|NCT03160638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92700349|NCT03160638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700350|NCT02919462|Cisplatin|cisplatin|mesh-list
92700351|NCT02919462|Pemetrexed|pemetrexed|mesh-list
92700352|NCT02919462|Vinorelbine|vinorelbine|mesh-list
92700353|NCT02919462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700355|NCT02919462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700356|NCT02919462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92700357|NCT02919462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92700358|NCT02919462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92700359|NCT02919462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92700360|NCT02919462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92700361|NCT02919462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92700362|NCT02941367|Metformin|metformin|mesh-list
92700363|NCT02941367|Lixisenatide|lixisenatide|mesh-list
92700364|NCT02941367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92700365|NCT02941367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607722|NCT00133172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607723|NCT00133172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92607724|NCT00133172|Immunologic Factors|immunologic factors|mesh-ancestor
92607725|NCT00133172|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92607726|NCT00133172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015032|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92700366|NCT03153150|Warfarin|warfarin|mesh-list
92700367|NCT03153150|Rivaroxaban|rivaroxaban|mesh-list
92700368|NCT03153150|Dabigatran|dabigatran|mesh-list
92700369|NCT03153150|Apixaban|apixaban|mesh-list
92700370|NCT03153150|Edoxaban|edoxaban|mesh-list
92120219|NCT01712009|Analgesics|analgesics|mesh-ancestor
92700371|NCT03153150|Acenocoumarol|acenocoumarol|mesh-list
92700372|NCT03153150|Phenindione|phenindione|mesh-list
92700373|NCT03153150|Anticoagulants|anticoagulants|mesh-ancestor
92700374|NCT03153150|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92700376|NCT03153150|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92700377|NCT03153150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700378|NCT03153150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700379|NCT03153150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700380|NCT02916147|Propofol|propofol|mesh-list
92700381|NCT02916147|Sevoflurane|sevoflurane|mesh-list
92700382|NCT02916147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92700383|NCT02916147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700384|NCT02916147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700385|NCT02916147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92700386|NCT02916147|Anesthetics, General|anesthetics, general|mesh-ancestor
92700387|NCT02916147|Anesthetics|anesthetics|mesh-ancestor
92700388|NCT02916147|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92700389|NCT02916147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92700390|NCT05302388|Diphenhydramine|diphenhydramine|mesh-list
92700391|NCT05302388|Promethazine|promethazine|mesh-list
92700392|NCT05302388|Dexamethasone|dexamethasone|mesh-list
92700393|NCT05302388|Prednisolone|prednisolone|mesh-list
92700394|NCT05302388|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92700395|NCT05302388|Methylprednisolone|methylprednisolone|mesh-list
92700396|NCT05302388|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92700397|NCT05302388|Prednisolone acetate|prednisolone acetate|mesh-list
92700398|NCT05302388|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92700399|NCT05302388|Prednisolone phosphate|prednisolone phosphate|mesh-list
92700400|NCT05302388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700401|NCT05302388|Antiemetics|antiemetics|mesh-ancestor
92700402|NCT05302388|Autonomic Agents|autonomic agents|mesh-ancestor
92700403|NCT05302388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700404|NCT05302388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700405|NCT05302388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700406|NCT05302388|Glucocorticoids|glucocorticoids|mesh-ancestor
92700407|NCT05302388|Hormones|hormones|mesh-ancestor
92700408|NCT05302388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700409|NCT05302388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700410|NCT05302388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700411|NCT05302388|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92700412|NCT05302388|Protective Agents|protective agents|mesh-ancestor
92700413|NCT05302388|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92700414|NCT05302388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92700415|NCT05302388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700416|NCT05302388|Anesthetics, Local|anesthetics, local|mesh-ancestor
92700417|NCT05302388|Anesthetics|anesthetics|mesh-ancestor
92700418|NCT05302388|Sensory System Agents|sensory system agents|mesh-ancestor
92700419|NCT05302388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92700420|NCT05302388|Histamine Antagonists|histamine antagonists|mesh-ancestor
92700421|NCT05302388|Histamine Agents|histamine agents|mesh-ancestor
92700422|NCT05302388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700423|NCT05302388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700424|NCT05302388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92700425|NCT05302388|Antipruritics|antipruritics|mesh-ancestor
92700426|NCT05302388|Dermatologic Agents|dermatologic agents|mesh-ancestor
92700427|NCT02919072|Ropivacaine|ropivacaine|mesh-list
92700428|NCT02919072|Chloroprocaine|chloroprocaine|mesh-list
92700429|NCT02919072|Anesthetics, Local|anesthetics, local|mesh-ancestor
92700430|NCT02919072|Anesthetics|anesthetics|mesh-ancestor
92700431|NCT02919072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700434|NCT02919072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607727|NCT00133172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607728|NCT00133172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92700435|NCT02941328|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92700436|NCT02941328|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92700437|NCT02941328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700438|NCT02941328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700439|NCT02941328|Cholinergic Agents|cholinergic agents|mesh-ancestor
92700440|NCT02941328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700441|NCT02941328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700442|NCT02915796|Lenograstim|lenograstim|mesh-list
92700443|NCT02915796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92700444|NCT02915796|Immunologic Factors|immunologic factors|mesh-ancestor
92700445|NCT02915796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700446|NCT02915250|Insulin Lispro|insulin lispro|mesh-list
92700447|NCT02915250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92700448|NCT02915250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700449|NCT02277041|Misoprostol|misoprostol|mesh-list
92700450|NCT02277041|Carbetocin|carbetocin|mesh-list
92700451|NCT02277041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92700452|NCT02277041|Abortifacient Agents|abortifacient agents|mesh-ancestor
92700453|NCT02277041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92700454|NCT02277041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700455|NCT02277041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92700456|NCT02277041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700457|NCT02277041|Oxytocics|oxytocics|mesh-ancestor
92700458|NCT02915289|Chlorhexidine|chlorhexidine|mesh-list
92700459|NCT02915289|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92700460|NCT02915289|Povidone-Iodine|povidone-iodine|mesh-list
92700461|NCT02915289|Povidone|povidone|mesh-list
92700462|NCT02915289|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92700463|NCT02915289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700464|NCT02915289|Disinfectants|disinfectants|mesh-ancestor
92700465|NCT02915289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92700466|NCT02915289|Plasma Substitutes|plasma substitutes|mesh-ancestor
92700467|NCT02915289|Blood Substitutes|blood substitutes|mesh-ancestor
92700468|NCT02939417|Grape Seed Extract|grape seed extract|mesh-list
92700469|NCT02939417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92700470|NCT02939417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700471|NCT02939417|Antioxidants|antioxidants|mesh-ancestor
92700472|NCT02939417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700473|NCT02939417|Protective Agents|protective agents|mesh-ancestor
92700474|NCT02939417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700475|NCT05034536|Infliximab|infliximab|mesh-list
92700476|NCT05034536|Pembrolizumab|pembrolizumab|mesh-list
92700477|NCT05034536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700478|NCT05034536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700479|NCT05034536|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92700480|NCT05034536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700481|NCT05034536|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92700482|NCT05034536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700483|NCT05034536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92700484|NCT05034536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700485|NCT05034536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700486|NCT02915094|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92700487|NCT02915094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700488|NCT02915172|Capecitabine|capecitabine|mesh-list
92700489|NCT02915172|Lenvatinib|lenvatinib|mesh-list
92700490|NCT02915172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92700491|NCT02915172|Antimetabolites|antimetabolites|mesh-ancestor
92700492|NCT02915172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700493|NCT02915172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700494|NCT02915172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92700495|NCT02915172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700496|NCT02938988|Anti-Infective Agents|anti-infective agents|mesh-list
92700497|NCT02938988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92700498|NCT02938988|Methylene Blue|methylene blue|mesh-list
92700499|NCT02938988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700500|NCT02938988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700501|NCT02915055|Acetaminophen|acetaminophen|mesh-list
92700502|NCT02915055|Ibuprofen|ibuprofen|mesh-list
92700503|NCT02915055|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92700504|NCT02915055|Oxycodone|oxycodone|mesh-list
92700505|NCT02915055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92607729|NCT00133172|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92607730|NCT00133172|Antitubercular Agents|antitubercular agents|mesh-ancestor
92607731|NCT00133172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92700522|NCT01295827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700523|NCT01295827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92700524|NCT01295827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700525|NCT02918760|Gabapentin|gabapentin|mesh-list
92700526|NCT02918760|Analgesics|analgesics|mesh-ancestor
92700527|NCT02918760|Sensory System Agents|sensory system agents|mesh-ancestor
92700528|NCT02918760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700529|NCT02918760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700530|NCT02918760|Anticonvulsants|anticonvulsants|mesh-ancestor
92700531|NCT02918760|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92700532|NCT02918760|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92700533|NCT02918760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700534|NCT02918760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92700535|NCT02918760|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92700536|NCT02918760|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92700537|NCT02918760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700538|NCT02918760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700539|NCT02918760|Antimanic Agents|antimanic agents|mesh-ancestor
92700540|NCT04690751|Cenobamate|cenobamate|mesh-list
92700541|NCT04690751|Anticonvulsants|anticonvulsants|mesh-ancestor
92700542|NCT03458078|Magnesium Sulfate|magnesium sulfate|mesh-list
92700543|NCT03458078|Midazolam|midazolam|mesh-list
92700544|NCT03458078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92700545|NCT03458078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92700546|NCT03458078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700547|NCT03458078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700548|NCT03458078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92700549|NCT03458078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92700550|NCT03458078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92700551|NCT03458078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92700552|NCT03458078|Anesthetics, General|anesthetics, general|mesh-ancestor
92700553|NCT03458078|Anesthetics|anesthetics|mesh-ancestor
92700554|NCT03458078|GABA Modulators|gaba modulators|mesh-ancestor
92700555|NCT03458078|GABA Agents|gaba agents|mesh-ancestor
92700556|NCT03458078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700557|NCT03458078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700558|NCT03458078|Analgesics|analgesics|mesh-ancestor
92700559|NCT03458078|Sensory System Agents|sensory system agents|mesh-ancestor
92700560|NCT03458078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700561|NCT03458078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92700562|NCT03458078|Anticonvulsants|anticonvulsants|mesh-ancestor
92700563|NCT03458078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92700583|NCT02914626|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92700584|NCT02914626|Growth Substances|growth substances|mesh-ancestor
92700585|NCT02914626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700586|NCT02914626|Growth Inhibitors|growth inhibitors|mesh-ancestor
92700587|NCT02914626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700588|NCT02918331|Dexamethasone|dexamethasone|mesh-list
92700589|NCT02918331|Lenalidomide|lenalidomide|mesh-list
92700590|NCT02918331|Daratumumab|daratumumab|mesh-list
92700591|NCT02918331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700592|NCT02918331|Antiemetics|antiemetics|mesh-ancestor
92700593|NCT02918331|Autonomic Agents|autonomic agents|mesh-ancestor
92700594|NCT02918331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700595|NCT02918331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700596|NCT02918331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700597|NCT02918331|Glucocorticoids|glucocorticoids|mesh-ancestor
92700598|NCT02918331|Hormones|hormones|mesh-ancestor
92700599|NCT02918331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700600|NCT02918331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92120439|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700601|NCT02918331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700602|NCT02918331|Immunologic Factors|immunologic factors|mesh-ancestor
92700603|NCT02918331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92700604|NCT02918331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92700605|NCT02918331|Growth Substances|growth substances|mesh-ancestor
92700606|NCT02918331|Growth Inhibitors|growth inhibitors|mesh-ancestor
92700607|NCT02918136|Cortisone|cortisone|mesh-list
92700608|NCT02918136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700609|NCT01294462|Aspirin|aspirin|mesh-list
92700610|NCT01294462|Clopidogrel|clopidogrel|mesh-list
92607732|NCT00133172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607733|NCT00141141|Atorvastatin|atorvastatin|mesh-list
92607734|NCT00141141|Simvastatin|simvastatin|mesh-list
92607735|NCT00141141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92607736|NCT00141141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92057513|NCT01995266|Asunaprevir|asunaprevir|mesh-list
92700611|NCT01294462|Ticagrelor|ticagrelor|mesh-list
92700612|NCT01294462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92700613|NCT01294462|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92700614|NCT01294462|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92700615|NCT01294462|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92700616|NCT01294462|Purinergic Agents|purinergic agents|mesh-ancestor
92700617|NCT01294462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700619|NCT01294462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700620|NCT01294462|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92700621|NCT01294462|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92700622|NCT01294462|Analgesics|analgesics|mesh-ancestor
92700623|NCT01294462|Sensory System Agents|sensory system agents|mesh-ancestor
92700624|NCT01294462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700625|NCT01294462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700626|NCT01294462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700627|NCT01294462|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92700628|NCT01294462|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92700629|NCT01294462|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92700630|NCT01294462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700631|NCT01294462|Antipyretics|antipyretics|mesh-ancestor
92700632|NCT01294423|Dapagliflozin|dapagliflozin|mesh-list
92700633|NCT01294423|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92700634|NCT01294423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700635|NCT01294423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92700636|NCT01294423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700637|NCT02910570|Liraglutide|liraglutide|mesh-list
92700638|NCT02910570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92700639|NCT02910570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700640|NCT02910570|Incretins|incretins|mesh-ancestor
92700641|NCT02910570|Hormones|hormones|mesh-ancestor
92700642|NCT02910570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700643|NCT03077685|Paclitaxel|paclitaxel|mesh-list
92700644|NCT03077685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92700645|NCT03077685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700646|NCT03077685|Tubulin Modulators|tubulin modulators|mesh-ancestor
92700647|NCT03077685|Antimitotic Agents|antimitotic agents|mesh-ancestor
92700648|NCT03077685|Mitosis Modulators|mitosis modulators|mesh-ancestor
92700649|NCT03077685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700650|NCT02910141|Insulin|insulin|mesh-list
92700651|NCT02910141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92700652|NCT02910141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92700653|NCT02910141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700654|NCT04817033|Midazolam|midazolam|mesh-list
92700655|NCT04817033|Dexmedetomidine|dexmedetomidine|mesh-list
92700656|NCT04817033|Anesthetics|anesthetics|mesh-list
92700657|NCT04817033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700658|NCT04817033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700659|NCT04817033|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92700660|NCT04817033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92700661|NCT04817033|Analgesics|analgesics|mesh-ancestor
92700662|NCT04817033|Sensory System Agents|sensory system agents|mesh-ancestor
92700663|NCT04817033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700664|NCT04817033|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92700665|NCT04817033|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92700666|NCT04817033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92700667|NCT04817033|Adrenergic Agents|adrenergic agents|mesh-ancestor
92700668|NCT04817033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700669|NCT04817033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700670|NCT04817033|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92700671|NCT04817033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92700672|NCT04817033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92700673|NCT04817033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92700674|NCT04817033|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92607737|NCT00141141|Antimetabolites|antimetabolites|mesh-ancestor
92607738|NCT00141141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607739|NCT00141141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92607740|NCT00141141|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92607741|NCT00141141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607742|NCT00133250|Heparin|heparin|mesh-list
92057631|NCT05119166|Niacin|niacin|mesh-list
92700675|NCT04817033|Anesthetics, General|anesthetics, general|mesh-ancestor
92700676|NCT04817033|GABA Modulators|gaba modulators|mesh-ancestor
92700677|NCT04817033|GABA Agents|gaba agents|mesh-ancestor
92700678|NCT01292473|Omalizumab|omalizumab|mesh-list
92700679|NCT01292473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92700680|NCT01292473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92700681|NCT01292473|Respiratory System Agents|respiratory system agents|mesh-ancestor
92700682|NCT02938286|Epinephrine|epinephrine|mesh-list
92700683|NCT02938286|Carticaine|carticaine|mesh-list
92700684|NCT02938286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92700685|NCT02938286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92700686|NCT02938286|Adrenergic Agents|adrenergic agents|mesh-ancestor
92700687|NCT02938286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700688|NCT02938286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700689|NCT02938286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700690|NCT02938286|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92700691|NCT02938286|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92700694|NCT02938286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92700695|NCT02938286|Respiratory System Agents|respiratory system agents|mesh-ancestor
92700696|NCT02938286|Mydriatics|mydriatics|mesh-ancestor
92700697|NCT02938286|Sympathomimetics|sympathomimetics|mesh-ancestor
92700698|NCT02938286|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92700699|NCT02938286|Anesthetics, Local|anesthetics, local|mesh-ancestor
92700700|NCT02938286|Anesthetics|anesthetics|mesh-ancestor
92700701|NCT02938286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700702|NCT02938286|Sensory System Agents|sensory system agents|mesh-ancestor
92700703|NCT01292239|Ribavirin|ribavirin|mesh-list
92700704|NCT01292239|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92700705|NCT01292239|Simeprevir|simeprevir|mesh-list
92700706|NCT01292239|Antimetabolites|antimetabolites|mesh-ancestor
92700707|NCT01292239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700708|NCT01292239|Antiviral Agents|antiviral agents|mesh-ancestor
92700709|NCT01292239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700710|NCT01292239|Protease Inhibitors|protease inhibitors|mesh-ancestor
92372200|NCT01404936|Antiviral Agents|antiviral agents|mesh-ancestor
92700711|NCT01292239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700712|NCT05600179|Dexamethasone|dexamethasone|mesh-list
92700713|NCT05600179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700714|NCT05600179|Antiemetics|antiemetics|mesh-ancestor
92700715|NCT05600179|Autonomic Agents|autonomic agents|mesh-ancestor
92700716|NCT05600179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700717|NCT05600179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700718|NCT05600179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700719|NCT05600179|Glucocorticoids|glucocorticoids|mesh-ancestor
92700720|NCT05600179|Hormones|hormones|mesh-ancestor
92700721|NCT05600179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700722|NCT05600179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92700723|NCT05600179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700724|NCT02937662|Cytarabine|cytarabine|mesh-list
92700725|NCT02937662|Cyclophosphamide|cyclophosphamide|mesh-list
92700726|NCT02937662|Idarubicin|idarubicin|mesh-list
92700727|NCT02937662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92700728|NCT02937662|Immunologic Factors|immunologic factors|mesh-ancestor
92700729|NCT02937662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700730|NCT02937662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700731|NCT02937662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92700732|NCT02937662|Alkylating Agents|alkylating agents|mesh-ancestor
92700733|NCT02937662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700734|NCT02937662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700735|NCT02937662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92700736|NCT02937662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92700737|NCT02937662|Antimetabolites|antimetabolites|mesh-ancestor
92700738|NCT02937662|Antiviral Agents|antiviral agents|mesh-ancestor
92700739|NCT02937662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607743|NCT00133250|Calcium heparin|calcium heparin|mesh-list
92607744|NCT00133250|Abciximab|abciximab|mesh-list
92607745|NCT00133250|Anticoagulants|anticoagulants|mesh-ancestor
92607746|NCT00133250|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92607747|NCT00133250|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607748|NCT00133250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607749|NCT00133250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92700740|NCT02937662|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92700741|NCT02937662|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92700742|NCT02937662|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92700743|NCT02937662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700744|NCT01290757|Dabigatran|dabigatran|mesh-list
92700745|NCT01290757|Antithrombins|antithrombins|mesh-ancestor
92700746|NCT01290757|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92700747|NCT01290757|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700748|NCT01290757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700749|NCT01290757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120604|NCT05718232|Lenvatinib|lenvatinib|mesh-list
92700750|NCT01290757|Anticoagulants|anticoagulants|mesh-ancestor
92700751|NCT02937857|Antipyretics|antipyretics|mesh-list
92700752|NCT02937857|Expectorants|expectorants|mesh-list
92700753|NCT02937857|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-list
92700754|NCT02937857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700755|NCT02937857|Respiratory System Agents|respiratory system agents|mesh-ancestor
92700756|NCT04324060|Danazol|danazol|mesh-list
92700757|NCT04324060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92700758|NCT04324060|Hormone Antagonists|hormone antagonists|mesh-ancestor
92700759|NCT04324060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700760|NCT04324060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700761|NCT01290718|Capecitabine|capecitabine|mesh-list
92700762|NCT01290718|Trastuzumab|trastuzumab|mesh-list
92700763|NCT01290718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92700764|NCT01290718|Antimetabolites|antimetabolites|mesh-ancestor
92700765|NCT01290718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700776|NCT02937896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700777|NCT02937896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700778|NCT02937896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700779|NCT02937896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700780|NCT02937896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92700781|NCT02937896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700782|NCT02937896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700783|NCT02937896|Hemostatics|hemostatics|mesh-ancestor
92700784|NCT02937896|Coagulants|coagulants|mesh-ancestor
92700785|NCT02937896|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92700786|NCT02937896|Natriuretic Agents|natriuretic agents|mesh-ancestor
92700787|NCT04688151|Rituximab|rituximab|mesh-list
92700788|NCT04688151|Durvalumab|durvalumab|mesh-list
92700789|NCT04688151|Acalabrutinib|acalabrutinib|mesh-list
92700790|NCT04688151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700791|NCT04688151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700792|NCT04688151|Immunologic Factors|immunologic factors|mesh-ancestor
92700793|NCT04688151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700794|NCT04688151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700795|NCT02937779|Tenofovir|tenofovir|mesh-list
92700796|NCT02937779|Antiviral Agents|antiviral agents|mesh-ancestor
92700797|NCT02937779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700798|NCT02937779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92700799|NCT02937779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92700800|NCT02937779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700801|NCT02937779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700802|NCT02937779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92700803|NCT02937779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92700804|NCT01290679|Ribavirin|ribavirin|mesh-list
92700805|NCT01290679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92700806|NCT01290679|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92700807|NCT01290679|Simeprevir|simeprevir|mesh-list
92700808|NCT01290679|Antimetabolites|antimetabolites|mesh-ancestor
92700809|NCT01290679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700810|NCT01290679|Antiviral Agents|antiviral agents|mesh-ancestor
92607750|NCT00144495|Epoetin Alfa|epoetin alfa|mesh-list
92607751|NCT00144495|Hematinics|hematinics|mesh-ancestor
92607752|NCT00133328|Valsartan|valsartan|mesh-list
92607753|NCT00133328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92607754|NCT00133328|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92700811|NCT01290679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700812|NCT01290679|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700813|NCT01290679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700814|NCT03457389|Cabergoline|cabergoline|mesh-list
92700815|NCT03457389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92700816|NCT03457389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92700817|NCT03457389|Dopamine Agonists|dopamine agonists|mesh-ancestor
92700818|NCT03457389|Dopamine Agents|dopamine agents|mesh-ancestor
92700819|NCT03457389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700820|NCT03457389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700821|NCT03457389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700822|NCT02890186|Remifentanil|remifentanil|mesh-list
92700823|NCT02890186|Propofol|propofol|mesh-list
92700824|NCT02890186|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92700825|NCT02890186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700826|NCT02890186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700827|NCT02890186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92700828|NCT02890186|Anesthetics, General|anesthetics, general|mesh-ancestor
92700829|NCT02890186|Anesthetics|anesthetics|mesh-ancestor
92700830|NCT02890186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92700831|NCT02890186|Narcotics|narcotics|mesh-ancestor
92700832|NCT02890186|Analgesics|analgesics|mesh-ancestor
92700837|NCT02909751|Tocopherols|tocopherols|mesh-list
92700838|NCT02909751|Docetaxel|docetaxel|mesh-list
92700839|NCT02909751|Cyclophosphamide|cyclophosphamide|mesh-list
92700840|NCT02909751|Trastuzumab|trastuzumab|mesh-list
92700841|NCT02909751|Epirubicin|epirubicin|mesh-list
92700842|NCT02909751|Pertuzumab|pertuzumab|mesh-list
92700843|NCT02909751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700844|NCT02909751|Tubulin Modulators|tubulin modulators|mesh-ancestor
92700845|NCT02909751|Antimitotic Agents|antimitotic agents|mesh-ancestor
92700846|NCT02909751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92700847|NCT02909751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700848|NCT02909751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92700849|NCT02909751|Immunologic Factors|immunologic factors|mesh-ancestor
92700850|NCT02909751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700851|NCT02909751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700852|NCT02909751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92700853|NCT02909751|Alkylating Agents|alkylating agents|mesh-ancestor
92700854|NCT02909751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92700855|NCT02909751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700856|NCT02909751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92700857|NCT02909751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92700858|NCT02909751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92700859|NCT02909751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700860|NCT02909751|Antioxidants|antioxidants|mesh-ancestor
92700861|NCT02909751|Protective Agents|protective agents|mesh-ancestor
92700862|NCT02909751|Vitamins|vitamins|mesh-ancestor
92700863|NCT02909751|Micronutrients|micronutrients|mesh-ancestor
92700864|NCT02909712|Pyrimethamine|pyrimethamine|mesh-list
92700865|NCT02909712|Piperaquine|piperaquine|mesh-list
92700866|NCT02909712|Sulfadoxine|sulfadoxine|mesh-list
92700867|NCT02909712|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92700868|NCT02909712|Artenimol|artenimol|mesh-list
92700869|NCT02909712|Antimalarials|antimalarials|mesh-ancestor
92700870|NCT02909712|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92700871|NCT02909712|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92700872|NCT02909712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700873|NCT02909712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92700874|NCT02909712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700875|NCT02909712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700876|NCT02909712|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92700877|NCT02913885|Fluorides|fluorides|mesh-list
92700878|NCT02913885|Fluorides, Topical|fluorides, topical|mesh-list
92700879|NCT02913885|Cariostatic Agents|cariostatic agents|mesh-ancestor
92700880|NCT02913885|Protective Agents|protective agents|mesh-ancestor
92700881|NCT02913885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700882|NCT01290601|Chloroquine|chloroquine|mesh-list
92700883|NCT01290601|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92700884|NCT01290601|Primaquine|primaquine|mesh-list
92700885|NCT01290601|Tafenoquine|tafenoquine|mesh-list
92700886|NCT01290601|Amebicides|amebicides|mesh-ancestor
92700887|NCT01290601|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92700888|NCT01290601|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92700889|NCT01290601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700890|NCT01290601|Antimalarials|antimalarials|mesh-ancestor
92700891|NCT01290601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700892|NCT01290601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92700893|NCT01290601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92700894|NCT01290601|Analgesics|analgesics|mesh-ancestor
92700895|NCT01290601|Sensory System Agents|sensory system agents|mesh-ancestor
92700896|NCT01290601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700897|NCT01290601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700898|NCT01290601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700899|NCT01290601|Filaricides|filaricides|mesh-ancestor
92700900|NCT01290601|Antinematodal Agents|antinematodal agents|mesh-ancestor
92700901|NCT01290601|Anthelmintics|anthelmintics|mesh-ancestor
92700902|NCT02978391|Epinephrine|epinephrine|mesh-list
92700903|NCT02978391|Hemostatics|hemostatics|mesh-list
92700904|NCT02978391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92700905|NCT02978391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92700906|NCT02978391|Adrenergic Agents|adrenergic agents|mesh-ancestor
92700907|NCT02978391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700908|NCT02978391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700911|NCT02978391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92700912|NCT02978391|Autonomic Agents|autonomic agents|mesh-ancestor
92700913|NCT02978391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700914|NCT02978391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92700915|NCT02978391|Respiratory System Agents|respiratory system agents|mesh-ancestor
92700916|NCT02978391|Mydriatics|mydriatics|mesh-ancestor
92700917|NCT02978391|Sympathomimetics|sympathomimetics|mesh-ancestor
92700918|NCT02978391|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92700919|NCT02978391|Coagulants|coagulants|mesh-ancestor
92700920|NCT01290094|Ibandronic Acid|ibandronic acid|mesh-list
92700921|NCT01290094|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92700922|NCT01290094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700923|NCT04688346|Epinephrine|epinephrine|mesh-list
92700924|NCT04688346|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92700925|NCT04688346|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92700926|NCT04688346|Adrenergic Agents|adrenergic agents|mesh-ancestor
92700927|NCT04688346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700928|NCT04688346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700929|NCT04688346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700930|NCT04688346|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92700931|NCT04688346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92700932|NCT04688346|Autonomic Agents|autonomic agents|mesh-ancestor
92700933|NCT04688346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700934|NCT04688346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92700935|NCT04688346|Respiratory System Agents|respiratory system agents|mesh-ancestor
92700936|NCT04688346|Mydriatics|mydriatics|mesh-ancestor
92700937|NCT04688346|Sympathomimetics|sympathomimetics|mesh-ancestor
92700938|NCT04688346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92700940|NCT01289821|Folic Acid|folic acid|mesh-list
92700941|NCT01289821|Oxaliplatin|oxaliplatin|mesh-list
92700942|NCT01289821|Levoleucovorin|levoleucovorin|mesh-list
92700943|NCT01289821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700944|NCT01289821|Antidotes|antidotes|mesh-ancestor
92700945|NCT01289821|Protective Agents|protective agents|mesh-ancestor
92700946|NCT01289821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700947|NCT01289821|Vitamin B Complex|vitamin b complex|mesh-ancestor
92700948|NCT01289821|Vitamins|vitamins|mesh-ancestor
92700949|NCT01289821|Micronutrients|micronutrients|mesh-ancestor
92700950|NCT01289821|Hematinics|hematinics|mesh-ancestor
92700951|NCT02913768|Ondansetron|ondansetron|mesh-list
92700952|NCT02913768|Antiemetics|antiemetics|mesh-ancestor
92700953|NCT02913768|Autonomic Agents|autonomic agents|mesh-ancestor
92700954|NCT02913768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700955|NCT02913768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700956|NCT02913768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700957|NCT02913768|Antipruritics|antipruritics|mesh-ancestor
92700958|NCT02913768|Dermatologic Agents|dermatologic agents|mesh-ancestor
92700959|NCT02913768|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92700960|NCT02913768|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92700961|NCT02913768|Serotonin Agents|serotonin agents|mesh-ancestor
92700962|NCT02913768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92700963|NCT02913768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700964|NCT01289782|Ribavirin|ribavirin|mesh-list
92607755|NCT00133328|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92607756|NCT00133328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607757|NCT00133367|Sirolimus|sirolimus|mesh-list
92607758|NCT00133367|Fludarabine|fludarabine|mesh-list
92607759|NCT00133367|Melphalan|melphalan|mesh-list
92607760|NCT00133367|Tacrolimus|tacrolimus|mesh-list
92700965|NCT01289782|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92700966|NCT01289782|Simeprevir|simeprevir|mesh-list
92700967|NCT01289782|Antimetabolites|antimetabolites|mesh-ancestor
92700968|NCT01289782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372258|NCT01428336|Hormones|hormones|mesh-ancestor
92700969|NCT01289782|Antiviral Agents|antiviral agents|mesh-ancestor
92700970|NCT01289782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700971|NCT01289782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700972|NCT01289782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700973|NCT02913417|Nivolumab|nivolumab|mesh-list
92700974|NCT02913417|Ipilimumab|ipilimumab|mesh-list
92700975|NCT02913417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700976|NCT02913417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700977|NCT02913417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92700978|NCT02913417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700979|NCT02936492|Clobetasol|clobetasol|mesh-list
92700980|NCT02936492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700981|NCT02936492|Glucocorticoids|glucocorticoids|mesh-ancestor
92700982|NCT02936492|Hormones|hormones|mesh-ancestor
92700983|NCT02936492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92700984|NCT02936492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700985|NCT02913573|Bupivacaine|bupivacaine|mesh-list
92701001|NCT02913300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701002|NCT02913300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92701003|NCT02913300|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92701004|NCT02913300|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92701005|NCT02913300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701006|NCT02913300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701007|NCT02936375|Cyclophosphamide|cyclophosphamide|mesh-list
92701008|NCT02936375|Azathioprine|azathioprine|mesh-list
92701009|NCT02936375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701010|NCT02936375|Immunologic Factors|immunologic factors|mesh-ancestor
92701011|NCT02936375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701012|NCT02936375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701013|NCT02936375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92701014|NCT02936375|Alkylating Agents|alkylating agents|mesh-ancestor
92701015|NCT02936375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701016|NCT02936375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701017|NCT02936375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92701018|NCT02936375|Antimetabolites|antimetabolites|mesh-ancestor
92701019|NCT02936375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92701020|NCT02913690|Vitamin E|vitamin e|mesh-list
92701021|NCT02913690|Vitamins|vitamins|mesh-ancestor
92701022|NCT02913690|Micronutrients|micronutrients|mesh-ancestor
92701023|NCT02913690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701024|NCT02913690|Antioxidants|antioxidants|mesh-ancestor
92701025|NCT02913690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701026|NCT02913690|Protective Agents|protective agents|mesh-ancestor
92701027|NCT01289119|Metformin|metformin|mesh-list
92701028|NCT01289119|Pioglitazone|pioglitazone|mesh-list
92701029|NCT01289119|Alogliptin|alogliptin|mesh-list
92701030|NCT01289119|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92701031|NCT01289119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701032|NCT01289119|Incretins|incretins|mesh-ancestor
92701033|NCT01289119|Hormones|hormones|mesh-ancestor
92701034|NCT01289119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701035|NCT01289119|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92701036|NCT01289119|Protease Inhibitors|protease inhibitors|mesh-ancestor
92701037|NCT01289119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701038|NCT01289119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701039|NCT01287832|Vancomycin|vancomycin|mesh-list
92701040|NCT01287832|Daptomycin|daptomycin|mesh-list
92701041|NCT01287832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701042|NCT01287832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701043|NCT02913066|Cisplatin|cisplatin|mesh-list
92701044|NCT02913066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607761|NCT00133367|Thymoglobulin|thymoglobulin|mesh-list
92607762|NCT00133367|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92607763|NCT00133367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701054|NCT02935751|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92701055|NCT02935751|Antithrombins|antithrombins|mesh-ancestor
92701056|NCT02935751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92701057|NCT02935751|Protease Inhibitors|protease inhibitors|mesh-ancestor
92701058|NCT02935751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701059|NCT02935751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701060|NCT02935751|Anticoagulants|anticoagulants|mesh-ancestor
92701062|NCT02935790|Ipilimumab|ipilimumab|mesh-list
92701063|NCT02935790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92701064|NCT02935790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701065|NCT02935790|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92701066|NCT02935790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701067|NCT02912637|Xenon|xenon|mesh-list
92701068|NCT02912637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92701069|NCT02912637|Anesthetics, General|anesthetics, general|mesh-ancestor
92701070|NCT02912637|Anesthetics|anesthetics|mesh-ancestor
92701071|NCT02912637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701072|NCT02912637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701073|NCT02912910|Labetalol|labetalol|mesh-list
92701074|NCT02912910|Nifedipine|nifedipine|mesh-list
92701075|NCT02912910|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92701076|NCT02912910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701077|NCT02912910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701078|NCT02912910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92701079|NCT02912910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701080|NCT02912910|Vasodilator Agents|vasodilator agents|mesh-ancestor
92701081|NCT02912910|Tocolytic Agents|tocolytic agents|mesh-ancestor
92701082|NCT02912910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701083|NCT02912910|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92701084|NCT02912910|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92701085|NCT02912910|Adrenergic Agents|adrenergic agents|mesh-ancestor
92701086|NCT02912910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701087|NCT02912910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92701088|NCT02912910|Sympathomimetics|sympathomimetics|mesh-ancestor
92701089|NCT02912910|Autonomic Agents|autonomic agents|mesh-ancestor
92701090|NCT02912910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701091|NCT02912910|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92701092|NCT02912910|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92701093|NCT02935829|Locust bean gum|locust bean gum|mesh-list
92701094|NCT02935829|Antidiarrheals|antidiarrheals|mesh-ancestor
92701095|NCT02935829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701096|NCT02912676|Methotrexate|methotrexate|mesh-list
92701097|NCT02912676|Mercaptopurine|mercaptopurine|mesh-list
92701098|NCT02912676|Thioguanine|thioguanine|mesh-list
92701099|NCT02912676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92701100|NCT02912676|Abortifacient Agents|abortifacient agents|mesh-ancestor
92701101|NCT02912676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701102|NCT02912676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701103|NCT02912676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92701104|NCT02912676|Antimetabolites|antimetabolites|mesh-ancestor
92701105|NCT02912676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701106|NCT02912676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701107|NCT02912676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701108|NCT02912676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701109|NCT02912676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92701122|NCT02912169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701123|NCT02912520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92701124|NCT02912520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701126|NCT02935959|Dexmedetomidine|dexmedetomidine|mesh-list
92701127|NCT02935959|Ketamine|ketamine|mesh-list
92701128|NCT02935959|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92701129|NCT02935959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701130|NCT02935959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701131|NCT02935959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701132|NCT02935959|Analgesics|analgesics|mesh-ancestor
92701133|NCT02935959|Sensory System Agents|sensory system agents|mesh-ancestor
92701134|NCT02935959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701135|NCT02935959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92701136|NCT02935959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92607764|NCT00133367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607765|NCT00133367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92607766|NCT00133367|Immunologic Factors|immunologic factors|mesh-ancestor
92701137|NCT02935959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92701138|NCT02935959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92701139|NCT02935959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701140|NCT02935959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701141|NCT02935959|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92701142|NCT02935959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92701143|NCT02935959|Anesthetics, General|anesthetics, general|mesh-ancestor
92701144|NCT02935959|Anesthetics|anesthetics|mesh-ancestor
92701145|NCT02935959|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92701146|NCT02935959|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92701147|NCT02935959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92701148|NCT02935959|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92701149|NCT02935959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92701150|NCT02935959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92701151|NCT02935959|GABA Modulators|gaba modulators|mesh-ancestor
92701152|NCT02935959|GABA Agents|gaba agents|mesh-ancestor
92701153|NCT02935322|Chlorhexidine|chlorhexidine|mesh-list
92701154|NCT02935322|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92701155|NCT02935322|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92701156|NCT02935322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701157|NCT02935322|Disinfectants|disinfectants|mesh-ancestor
92701158|NCT02935322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701160|NCT02935647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92701161|NCT02935647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701162|NCT02935647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701163|NCT02935647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92701164|NCT02935647|Anesthetics, General|anesthetics, general|mesh-ancestor
92701165|NCT02935647|Anesthetics|anesthetics|mesh-ancestor
92701166|NCT02912247|Adalimumab|adalimumab|mesh-list
92701167|NCT02912247|Antibodies|antibodies|mesh-list
92701168|NCT02912247|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92701169|NCT02912247|Immunologic Factors|immunologic factors|mesh-ancestor
92701170|NCT02912247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701171|NCT02912247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92701172|NCT02912247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701173|NCT02912247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701174|NCT02935010|Amoxicillin|amoxicillin|mesh-list
92701178|NCT02935010|Potassium Citrate|potassium citrate|mesh-list
92701179|NCT02935010|Esomeprazole|esomeprazole|mesh-list
92701180|NCT02935010|Bismuth|bismuth|mesh-list
92701181|NCT02935010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701182|NCT02935010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701183|NCT02935010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701184|NCT02935010|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92701185|NCT02935010|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92701186|NCT02935010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92701187|NCT02935010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701188|NCT02935010|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92701189|NCT02935010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701190|NCT02935010|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92701191|NCT02935010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92701192|NCT02935010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92701193|NCT02935010|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92701194|NCT02935010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92701195|NCT02935010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92701196|NCT02935010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701197|NCT02935010|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92701198|NCT02935010|Antacids|antacids|mesh-ancestor
92701199|NCT02935010|Diuretics|diuretics|mesh-ancestor
92701200|NCT02935010|Natriuretic Agents|natriuretic agents|mesh-ancestor
92701201|NCT02935010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701202|NCT02935010|Expectorants|expectorants|mesh-ancestor
92701203|NCT02935010|Respiratory System Agents|respiratory system agents|mesh-ancestor
92407691|NCT01446276|Antioxidants|antioxidants|mesh-ancestor
92701204|NCT02935530|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92701205|NCT02935530|Tinzaparin|tinzaparin|mesh-list
92701206|NCT02935530|Dalteparin|dalteparin|mesh-list
92701207|NCT02935530|Argatroban|argatroban|mesh-list
92701208|NCT02935530|Anticoagulants|anticoagulants|mesh-ancestor
92701209|NCT02935530|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92701210|NCT02935530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607767|NCT00133367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607768|NCT00133367|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92607769|NCT00133367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607770|NCT00133367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701211|NCT02935530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701212|NCT02935530|Antithrombins|antithrombins|mesh-ancestor
92701213|NCT02935530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92701214|NCT02935530|Protease Inhibitors|protease inhibitors|mesh-ancestor
92701215|NCT02935530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701216|NCT02935530|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92701217|NCT02934464|Leucovorin|leucovorin|mesh-list
92701218|NCT02934464|Paclitaxel|paclitaxel|mesh-list
92701219|NCT02934464|Ramucirumab|ramucirumab|mesh-list
92701220|NCT02934464|Oxaliplatin|oxaliplatin|mesh-list
92701221|NCT02934464|Levoleucovorin|levoleucovorin|mesh-list
92701222|NCT02934464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92701223|NCT02934464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701224|NCT02934464|Tubulin Modulators|tubulin modulators|mesh-ancestor
92701225|NCT02934464|Antimitotic Agents|antimitotic agents|mesh-ancestor
92701226|NCT02934464|Mitosis Modulators|mitosis modulators|mesh-ancestor
92701227|NCT02934464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701228|NCT02934464|Antidotes|antidotes|mesh-ancestor
92701229|NCT02934464|Protective Agents|protective agents|mesh-ancestor
92701230|NCT02934464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701231|NCT02934464|Vitamin B Complex|vitamin b complex|mesh-ancestor
92701232|NCT02934464|Vitamins|vitamins|mesh-ancestor
92701233|NCT02934464|Micronutrients|micronutrients|mesh-ancestor
92701234|NCT02934035|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92701235|NCT02934035|Fluoxetine|fluoxetine|mesh-list
92701236|NCT02934035|Paroxetine|paroxetine|mesh-list
92701237|NCT02934035|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92701238|NCT02934035|Antidepressive Agents|antidepressive agents|mesh-list
92701239|NCT02934035|Escitalopram|escitalopram|mesh-list
92701240|NCT02934035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92701241|NCT02934035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92701242|NCT02934035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701243|NCT02934035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701244|NCT02934035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701245|NCT02934035|Serotonin Agents|serotonin agents|mesh-ancestor
92701246|NCT02934035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701247|NCT02934035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701248|NCT02934035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92701249|NCT02934035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92701267|NCT02934152|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92701268|NCT02934152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701269|NCT02934152|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92701270|NCT02935335|Menotropins|menotropins|mesh-list
92701271|NCT02935335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92701272|NCT02935335|Fertility Agents|fertility agents|mesh-ancestor
92701273|NCT02935335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701274|NCT02935335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701275|NCT02911662|Cephalexin|cephalexin|mesh-list
92701276|NCT02911662|Nitrofurantoin|nitrofurantoin|mesh-list
92701277|NCT02911662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701278|NCT02911662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701279|NCT02911662|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92701280|NCT02935101|Prednisolone|prednisolone|mesh-list
92701281|NCT02935101|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92701282|NCT02935101|Methylprednisolone|methylprednisolone|mesh-list
92701283|NCT02935101|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92701284|NCT02935101|Prednisolone acetate|prednisolone acetate|mesh-list
92701285|NCT02935101|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92701286|NCT02935101|Prednisolone phosphate|prednisolone phosphate|mesh-list
92701287|NCT02935101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701288|NCT02935101|Glucocorticoids|glucocorticoids|mesh-ancestor
92701289|NCT02935101|Hormones|hormones|mesh-ancestor
92701290|NCT02935101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701291|NCT02935101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701292|NCT02935101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92701294|NCT02935101|Antiemetics|antiemetics|mesh-ancestor
92701295|NCT02935101|Autonomic Agents|autonomic agents|mesh-ancestor
92701296|NCT02935101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607771|NCT00133367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701297|NCT02935101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701298|NCT02935101|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92701299|NCT02935101|Protective Agents|protective agents|mesh-ancestor
92701300|NCT04689971|Vitamins|vitamins|mesh-list
92701301|NCT04689971|Vitamin B Complex|vitamin b complex|mesh-list
92701302|NCT04689971|Micronutrients|micronutrients|mesh-ancestor
92701303|NCT04689971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701304|NCT02934945|Budesonide|budesonide|mesh-list
92701305|NCT02934945|Formoterol Fumarate|formoterol fumarate|mesh-list
92701306|NCT02934945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701307|NCT02934945|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92701308|NCT02934945|Autonomic Agents|autonomic agents|mesh-ancestor
92701319|NCT02934945|Adrenergic Agents|adrenergic agents|mesh-ancestor
92701320|NCT02934945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701321|NCT02934945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701322|NCT02933645|Insulin|insulin|mesh-list
92701323|NCT02933645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92701324|NCT02933645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92701325|NCT02933645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701326|NCT02933684|Cycloserine|cycloserine|mesh-list
92701327|NCT02933684|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92701328|NCT02933684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701329|NCT02933684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92701330|NCT02933684|Antitubercular Agents|antitubercular agents|mesh-ancestor
92701331|NCT02933684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701332|NCT02933684|Antimetabolites|antimetabolites|mesh-ancestor
92701333|NCT02933684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701334|NCT02933333|Molgramostim|molgramostim|mesh-list
92701335|NCT02933333|Lenograstim|lenograstim|mesh-list
92701336|NCT02933333|Sargramostim|sargramostim|mesh-list
92701337|NCT02933333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92701338|NCT02933333|Immunologic Factors|immunologic factors|mesh-ancestor
92701339|NCT02933333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701340|NCT02933333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701341|NCT02670252|Cyclophosphamide|cyclophosphamide|mesh-list
92701342|NCT02670252|Busulfan|busulfan|mesh-list
92701343|NCT02670252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701344|NCT02670252|Immunologic Factors|immunologic factors|mesh-ancestor
92701345|NCT02670252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701346|NCT02670252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701347|NCT02670252|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92701348|NCT02670252|Alkylating Agents|alkylating agents|mesh-ancestor
92701349|NCT02670252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701350|NCT02670252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701351|NCT02670252|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92701352|NCT02934789|Contraceptive Agents|contraceptive agents|mesh-list
92701353|NCT02934789|Contraceptives, Oral|contraceptives, oral|mesh-list
92701354|NCT02934789|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92701355|NCT02934789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701356|NCT02934789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701357|NCT02934789|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92701358|NCT02933099|Dexamethasone|dexamethasone|mesh-list
92701359|NCT02933099|Dexamethasone acetate|dexamethasone acetate|mesh-list
92701360|NCT02933099|Aprepitant|aprepitant|mesh-list
92701361|NCT02933099|Palonosetron|palonosetron|mesh-list
92701362|NCT02933099|BB 1101|bb 1101|mesh-list
92701363|NCT02933099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701364|NCT02933099|Antiemetics|antiemetics|mesh-ancestor
92701365|NCT02933099|Autonomic Agents|autonomic agents|mesh-ancestor
92701366|NCT02933099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701367|NCT02933099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701368|NCT02933099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701369|NCT02933099|Glucocorticoids|glucocorticoids|mesh-ancestor
92701370|NCT02933099|Hormones|hormones|mesh-ancestor
92701371|NCT02933099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701372|NCT02933099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92701391|NCT02911350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92701392|NCT02911350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701393|NCT02911350|Tubulin Modulators|tubulin modulators|mesh-ancestor
92701394|NCT02911350|Antimitotic Agents|antimitotic agents|mesh-ancestor
92701395|NCT02911350|Mitosis Modulators|mitosis modulators|mesh-ancestor
92701396|NCT02911350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701397|NCT02911350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701398|NCT02911350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607772|NCT00133367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92607773|NCT00133367|Antifungal Agents|antifungal agents|mesh-ancestor
92701399|NCT02932397|Propofol|propofol|mesh-list
92701400|NCT02932397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92701401|NCT02932397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701402|NCT02932397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701403|NCT02932397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92701404|NCT02932397|Anesthetics, General|anesthetics, general|mesh-ancestor
92701405|NCT02932397|Anesthetics|anesthetics|mesh-ancestor
92701406|NCT02911272|Oxytocin|oxytocin|mesh-list
92701407|NCT02911272|Oxytocics|oxytocics|mesh-ancestor
92701408|NCT02911272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701409|NCT02911272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701410|NCT02932436|Empagliflozin|empagliflozin|mesh-list
92701411|NCT02932436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92701412|NCT02932436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701413|NCT02932436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92701414|NCT02932436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701415|NCT02932007|Chloroquine|chloroquine|mesh-list
92701416|NCT02932007|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92701417|NCT02932007|Amebicides|amebicides|mesh-ancestor
92701418|NCT02932007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92701419|NCT02932007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92701420|NCT02932007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701421|NCT02932007|Antimalarials|antimalarials|mesh-ancestor
92701422|NCT02932007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701423|NCT02932007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92701424|NCT02932007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701425|NCT02932007|Analgesics|analgesics|mesh-ancestor
92701426|NCT02932007|Sensory System Agents|sensory system agents|mesh-ancestor
92701427|NCT02932007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701428|NCT02932007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701429|NCT02932007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701449|NCT02924987|Growth Inhibitors|growth inhibitors|mesh-ancestor
92701450|NCT02924987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701451|NCT02924909|Paclitaxel|paclitaxel|mesh-list
92701452|NCT02924909|Carboplatin|carboplatin|mesh-list
92701453|NCT02924909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92701454|NCT02924909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701455|NCT02924909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92701456|NCT02924909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92701457|NCT02924909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92701458|NCT02924909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701459|NCT02934321|Erythritol|erythritol|mesh-list
92701460|NCT02934321|Vasodilator Agents|vasodilator agents|mesh-ancestor
92701461|NCT02924753|Cyclophosphamide|cyclophosphamide|mesh-list
92701462|NCT02924753|Fludarabine|fludarabine|mesh-list
92701463|NCT02924753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701464|NCT02924753|Immunologic Factors|immunologic factors|mesh-ancestor
92701465|NCT02924753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701466|NCT02924753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701467|NCT02924753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92701468|NCT02924753|Alkylating Agents|alkylating agents|mesh-ancestor
92701469|NCT02924753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701470|NCT02924753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701471|NCT02924753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92701472|NCT02924675|Pregabalin|pregabalin|mesh-list
92701473|NCT02924675|Analgesics|analgesics|mesh-ancestor
92701474|NCT02924675|Sensory System Agents|sensory system agents|mesh-ancestor
92701475|NCT02924675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701476|NCT02924675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701477|NCT02924675|Anticonvulsants|anticonvulsants|mesh-ancestor
92701478|NCT02924675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92701479|NCT02924675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701480|NCT02924675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701481|NCT02924675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92701482|NCT02924675|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92701483|NCT02924675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92701484|NCT02924675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701485|NCT02924675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92701486|NCT03847545|4-Aminopyridine|4-aminopyridine|mesh-list
92607774|NCT00133367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92607775|NCT00133367|Alkylating Agents|alkylating agents|mesh-ancestor
92607776|NCT00133367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92607777|NCT00141258|Pregabalin|pregabalin|mesh-list
92607778|NCT00141258|Analgesics|analgesics|mesh-ancestor
92701495|NCT02924285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701496|NCT02924285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92701497|NCT02924285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92701498|NCT02924285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92701499|NCT02924285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701500|NCT02924285|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92701501|NCT02924285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92701502|NCT02924285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92701504|NCT01287520|Pemetrexed|pemetrexed|mesh-list
92701505|NCT01287520|Ranitidine|ranitidine|mesh-list
92701506|NCT01287520|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92701507|NCT01287520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701508|NCT01287520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701509|NCT01287520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701510|NCT01287520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92701511|NCT01287520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701512|NCT01287520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92701513|NCT01287520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701514|NCT01287520|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92701515|NCT01287520|Histamine Antagonists|histamine antagonists|mesh-ancestor
92701516|NCT01287520|Histamine Agents|histamine agents|mesh-ancestor
92701517|NCT01287520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701518|NCT01287520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701519|NCT00623740|Hydrocortisone|hydrocortisone|mesh-list
92701520|NCT00623740|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92701521|NCT00623740|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92701522|NCT00623740|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92701523|NCT00623740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701524|NCT02923934|Nivolumab|nivolumab|mesh-list
92701525|NCT02923934|Ipilimumab|ipilimumab|mesh-list
92701526|NCT02923934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92701527|NCT02923934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701528|NCT02923934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92701529|NCT02923934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701530|NCT01287364|Mometasone Furoate|mometasone furoate|mesh-list
92701531|NCT01287364|Ciclesonide|ciclesonide|mesh-list
92701532|NCT01287364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701533|NCT01287364|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701534|NCT01287364|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92701535|NCT01287364|Glucocorticoids|glucocorticoids|mesh-ancestor
92701536|NCT01287364|Hormones|hormones|mesh-ancestor
92701537|NCT01287364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701538|NCT01287364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701539|NCT02889835|Chlorhexidine|chlorhexidine|mesh-list
92701540|NCT02889835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92701541|NCT02889835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701542|NCT02889835|Disinfectants|disinfectants|mesh-ancestor
92701543|NCT02924090|Ketamine|ketamine|mesh-list
92701544|NCT02924090|Etomidate|etomidate|mesh-list
92701545|NCT02924090|Analgesics|analgesics|mesh-ancestor
92701546|NCT02924090|Sensory System Agents|sensory system agents|mesh-ancestor
92701547|NCT02924090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701548|NCT02924090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701549|NCT02924090|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92701550|NCT02924090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92701551|NCT02924090|Anesthetics, General|anesthetics, general|mesh-ancestor
92701561|NCT04137770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701562|NCT04137770|Analgesics|analgesics|mesh-ancestor
92701563|NCT04137770|Sensory System Agents|sensory system agents|mesh-ancestor
92701564|NCT04137770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701565|NCT04137770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701566|NCT04137770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701567|NCT04137770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701568|NCT04137770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92701569|NCT04137770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607779|NCT00141258|Sensory System Agents|sensory system agents|mesh-ancestor
92607780|NCT00141258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607781|NCT00141258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607783|NCT00141258|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92701570|NCT04137770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701571|NCT01286740|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
92701572|NCT01286740|Antiviral Agents|antiviral agents|mesh-ancestor
92701573|NCT01286740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701574|NCT01286740|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92701575|NCT01286740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701576|NCT01286740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701577|NCT01286740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701578|NCT01286740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92701579|NCT01286740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92701580|NCT02923856|Clarithromycin|clarithromycin|mesh-list
92701581|NCT02923856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701582|NCT02923856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701583|NCT02923856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92701584|NCT02923856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701585|NCT02923856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701586|NCT02923856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92701587|NCT02923856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92701588|NCT02934204|Methotrexate|methotrexate|mesh-list
92701589|NCT02934204|Temozolomide|temozolomide|mesh-list
92701590|NCT02934204|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92701591|NCT02934204|Abortifacient Agents|abortifacient agents|mesh-ancestor
92701592|NCT02934204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701593|NCT02934204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701594|NCT02934204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92701595|NCT02934204|Antimetabolites|antimetabolites|mesh-ancestor
92701596|NCT02934204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701597|NCT02934204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701598|NCT02934204|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701599|NCT02934204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701600|NCT02934204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92701601|NCT02934204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701602|NCT02934204|Immunologic Factors|immunologic factors|mesh-ancestor
92701603|NCT02934204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701604|NCT02934204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701605|NCT02934204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92701606|NCT02934204|Alkylating Agents|alkylating agents|mesh-ancestor
92701607|NCT01286077|Bortezomib|bortezomib|mesh-list
92701608|NCT01286077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701609|NCT05590936|Ondansetron|ondansetron|mesh-list
92701610|NCT05590936|Dimenhydrinate|dimenhydrinate|mesh-list
92701611|NCT05590936|Antiemetics|antiemetics|mesh-ancestor
92701612|NCT05590936|Autonomic Agents|autonomic agents|mesh-ancestor
92701613|NCT05590936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701640|NCT02933775|Alkylating Agents|alkylating agents|mesh-ancestor
92701641|NCT02933775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701642|NCT02933775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701643|NCT02933775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92701644|NCT02923583|Abatacept|abatacept|mesh-list
92701645|NCT02923583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92701646|NCT02923583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701647|NCT02923583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92701648|NCT02923583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701649|NCT02923583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701650|NCT02923583|Immunologic Factors|immunologic factors|mesh-ancestor
92701651|NCT02923583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701652|NCT02923583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701653|NCT02933580|JNJ-56136379|jnj-56136379|mesh-list
92701654|NCT02933580|Antiviral Agents|antiviral agents|mesh-ancestor
92701655|NCT02933580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701656|NCT02923388|Vitamins|vitamins|mesh-list
92701657|NCT02923388|Vitamin B 12|vitamin b 12|mesh-list
92701658|NCT02923388|Pyridoxine|pyridoxine|mesh-list
92607784|NCT00141258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607785|NCT00141258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015085|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
92701659|NCT02923388|Vitamin B 6|vitamin b 6|mesh-list
92701660|NCT02923388|Vitamin B Complex|vitamin b complex|mesh-list
92701661|NCT02923388|Micronutrients|micronutrients|mesh-ancestor
92701662|NCT02923388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701677|NCT02933658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92008196|NCT04970303|Methylphenidate|methylphenidate|mesh-list
92701679|NCT02933658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92701680|NCT02933658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92701681|NCT02933853|Insulin|insulin|mesh-list
92701682|NCT02933853|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92701683|NCT02933853|Insulin Aspart|insulin aspart|mesh-list
92701684|NCT02933853|Insulin, Long-Acting|insulin, long-acting|mesh-list
92701685|NCT02933853|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92701686|NCT02933853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92701687|NCT02933853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701688|NCT00532194|Cediranib|cediranib|mesh-list
92701689|NCT00532194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701690|NCT00532194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92701691|NCT00532194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701692|NCT00532194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701693|NCT02665143|Nintedanib|nintedanib|mesh-list
92701694|NCT02665143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701695|NCT02665143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92701696|NCT02665143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701697|NCT02665143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701698|NCT00532272|Letrozole|letrozole|mesh-list
92701699|NCT00532272|Goserelin|goserelin|mesh-list
92701700|NCT00532272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701701|NCT00532272|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92701702|NCT00532272|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92701703|NCT00532272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701704|NCT00532272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701705|NCT00532272|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92701706|NCT00532272|Hormone Antagonists|hormone antagonists|mesh-ancestor
92701707|NCT00532272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701708|NCT00532272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701709|NCT00532272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92701710|NCT02922803|Calcium, Dietary|calcium, dietary|mesh-list
92701711|NCT02922803|Vitamin D|vitamin d|mesh-list
92701712|NCT02922803|Ergocalciferols|ergocalciferols|mesh-list
92701713|NCT02922803|Cholecalciferol|cholecalciferol|mesh-list
92701714|NCT02922803|Vitamins|vitamins|mesh-list
92701715|NCT02922803|Calcium|calcium|mesh-list
92701716|NCT02922803|Micronutrients|micronutrients|mesh-ancestor
92701717|NCT02922803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701718|NCT02922803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92701719|NCT02922803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92701720|NCT02834559|Fluorouracil|fluorouracil|mesh-list
92701732|NCT02834559|Anticoagulants|anticoagulants|mesh-ancestor
92701733|NCT02834559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92701734|NCT02834559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92701735|NCT02922686|Floxacillin|floxacillin|mesh-list
92701736|NCT02922686|Penicillin V|penicillin v|mesh-list
92701737|NCT02922686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701738|NCT02922686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701739|NCT02922491|Vitamin E|vitamin e|mesh-list
92701740|NCT02922491|Vitamins|vitamins|mesh-ancestor
92701741|NCT02922491|Micronutrients|micronutrients|mesh-ancestor
92701742|NCT02922491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701743|NCT02922491|Antioxidants|antioxidants|mesh-ancestor
92701744|NCT02922491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701745|NCT02922491|Protective Agents|protective agents|mesh-ancestor
92701746|NCT02922179|Insulin|insulin|mesh-list
92701747|NCT02922179|Insulin Detemir|insulin detemir|mesh-list
92701748|NCT02922179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92701749|NCT02922179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701750|NCT02921984|Docetaxel|docetaxel|mesh-list
92701751|NCT02921984|Pemetrexed|pemetrexed|mesh-list
92701752|NCT02921984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701753|NCT02921984|Tubulin Modulators|tubulin modulators|mesh-ancestor
92701754|NCT02921984|Antimitotic Agents|antimitotic agents|mesh-ancestor
92701755|NCT02921984|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607786|NCT00141258|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92607787|NCT00141258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92607788|NCT00141258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607789|NCT00141258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607790|NCT00141258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92701756|NCT02921984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701757|NCT02921984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701758|NCT02921984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92701759|NCT02921984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701760|NCT01285609|Paclitaxel|paclitaxel|mesh-list
92701761|NCT01285609|Carboplatin|carboplatin|mesh-list
92701762|NCT01285609|Ipilimumab|ipilimumab|mesh-list
92701763|NCT01285609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92701764|NCT01285609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701765|NCT01285609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92701766|NCT01285609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92701767|NCT01285609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92701768|NCT01285609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701769|NCT01285609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92701770|NCT01285609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92701771|NCT03981341|Bazedoxifene|bazedoxifene|mesh-list
92701772|NCT03981341|Estrogens|estrogens|mesh-list
92701773|NCT03981341|Hormones|hormones|mesh-ancestor
92701774|NCT03981341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701775|NCT03981341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701776|NCT03981341|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92701777|NCT03981341|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92701778|NCT03981341|Hormone Antagonists|hormone antagonists|mesh-ancestor
92701779|NCT03981341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92701780|NCT03924440|Nonoxynol|nonoxynol|mesh-list
92701781|NCT03924440|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92701782|NCT03924440|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92701783|NCT03924440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701784|NCT03924440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92701785|NCT03924440|Contraceptive Agents|contraceptive agents|mesh-ancestor
92701796|NCT01285492|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92701797|NCT01285492|Cholinergic Agents|cholinergic agents|mesh-ancestor
92701798|NCT01285492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701799|NCT01285492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701800|NCT04615143|Tislelizumab|tislelizumab|mesh-list
92701801|NCT04615143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92701802|NCT04615143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701803|NCT01284634|Cannabidiol|cannabidiol|mesh-list
92701804|NCT01284634|Anticonvulsants|anticonvulsants|mesh-ancestor
92701805|NCT02932722|Anesthetics|anesthetics|mesh-list
92701806|NCT02932722|Propofol|propofol|mesh-list
92701807|NCT02932722|Sevoflurane|sevoflurane|mesh-list
92701808|NCT02932722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701809|NCT02932722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701810|NCT02932722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92701811|NCT02932722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92701812|NCT02932722|Anesthetics, General|anesthetics, general|mesh-ancestor
92701813|NCT02932722|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92701814|NCT02932722|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92701815|NCT02932761|Goserelin|goserelin|mesh-list
92701816|NCT02932761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92701817|NCT02932761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701819|NCT01283971|Methotrexate|methotrexate|mesh-list
92701820|NCT01283971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92701821|NCT01283971|Abortifacient Agents|abortifacient agents|mesh-ancestor
92701822|NCT01283971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701823|NCT01283971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701824|NCT01283971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92701825|NCT01283971|Antimetabolites|antimetabolites|mesh-ancestor
92701826|NCT01283971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701827|NCT01283971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701828|NCT01283971|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701829|NCT01283971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607791|NCT00403910|Canrenone|canrenone|mesh-list
92607792|NCT00403910|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92607793|NCT00403910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92607794|NCT00403910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607795|NCT00403910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607796|NCT00403910|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92607797|NCT00403910|Diuretics|diuretics|mesh-ancestor
92607798|NCT00403910|Natriuretic Agents|natriuretic agents|mesh-ancestor
92607799|NCT00141336|Pregabalin|pregabalin|mesh-list
92607800|NCT00141336|Analgesics|analgesics|mesh-ancestor
92701830|NCT01283971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92701831|NCT01283971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701832|NCT01283971|Immunologic Factors|immunologic factors|mesh-ancestor
92701833|NCT01283971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701834|NCT01283971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701835|NCT01283971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92701836|NCT01283971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701837|NCT02921282|Dopamine|dopamine|mesh-list
92701838|NCT02921282|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92701839|NCT02921282|Sympathomimetics|sympathomimetics|mesh-ancestor
92701840|NCT02921282|Autonomic Agents|autonomic agents|mesh-ancestor
92701841|NCT02921282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701842|NCT02921282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701843|NCT02921282|Dopamine Agents|dopamine agents|mesh-ancestor
92701844|NCT02921282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701845|NCT02921282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701846|NCT02921282|Protective Agents|protective agents|mesh-ancestor
92701847|NCT02921360|Aspirin|aspirin|mesh-list
92701848|NCT02921360|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92701849|NCT02921360|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701850|NCT02921360|Analgesics|analgesics|mesh-ancestor
92701851|NCT02921360|Sensory System Agents|sensory system agents|mesh-ancestor
92701861|NCT02921360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701863|NCT02932605|Cannabidiol|cannabidiol|mesh-list
92701864|NCT02932605|Anticonvulsants|anticonvulsants|mesh-ancestor
92701865|NCT02921204|Vitamin D|vitamin d|mesh-list
92701866|NCT02921204|Vitamins|vitamins|mesh-ancestor
92701867|NCT02921204|Micronutrients|micronutrients|mesh-ancestor
92701868|NCT02921204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701869|NCT02921204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92701870|NCT01283581|Vancomycin|vancomycin|mesh-list
92701871|NCT01283581|Linezolid|linezolid|mesh-list
92701872|NCT01283581|Delafloxacin|delafloxacin|mesh-list
92701873|NCT01283581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701874|NCT01283581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701875|NCT01283581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92701876|NCT01283581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701877|NCT01283581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701878|NCT01283542|Pasireotide|pasireotide|mesh-list
92701879|NCT01283542|Hormones|hormones|mesh-ancestor
92701880|NCT01283542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701881|NCT01283542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701882|NCT02932488|Sumatriptan|sumatriptan|mesh-list
92701883|NCT02932488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92701884|NCT02932488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92701885|NCT02932488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92701886|NCT02932488|Serotonin Agents|serotonin agents|mesh-ancestor
92701887|NCT02932488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701888|NCT02932488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701889|NCT02932488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701890|NCT02921165|Aspirin|aspirin|mesh-list
92701891|NCT02921165|Analgesics|analgesics|mesh-list
92121720|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701892|NCT02921165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92701893|NCT02921165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701894|NCT02921165|Sensory System Agents|sensory system agents|mesh-ancestor
92607801|NCT00141336|Sensory System Agents|sensory system agents|mesh-ancestor
92701895|NCT02921165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701896|NCT02921165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701897|NCT02921165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701898|NCT02921165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701899|NCT02921165|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92701900|NCT02921165|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92701901|NCT02921165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701902|NCT02921165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92701903|NCT02921165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92701904|NCT02921165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701905|NCT02921165|Antipyretics|antipyretics|mesh-ancestor
92701906|NCT01283386|Cyclophosphamide|cyclophosphamide|mesh-list
92701907|NCT01283386|Chlorambucil|chlorambucil|mesh-list
92701909|NCT01283386|Fludarabine|fludarabine|mesh-list
92701910|NCT01283386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701911|NCT01283386|Immunologic Factors|immunologic factors|mesh-ancestor
92701912|NCT01283386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701913|NCT01283386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701914|NCT01283386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92701915|NCT01283386|Alkylating Agents|alkylating agents|mesh-ancestor
92701941|NCT01282801|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92701942|NCT01282801|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92701943|NCT01282801|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92701944|NCT01282801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701945|NCT01282801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701946|NCT01282801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701947|NCT01282801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701948|NCT01282801|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92701949|NCT01282801|Antidepressive Agents|antidepressive agents|mesh-ancestor
92701950|NCT01282801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92701951|NCT00532350|Tiotropium Bromide|tiotropium bromide|mesh-list
92701952|NCT00532350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92701953|NCT00532350|Autonomic Agents|autonomic agents|mesh-ancestor
92701954|NCT00532350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701955|NCT00532350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701956|NCT00532350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92701957|NCT00532350|Respiratory System Agents|respiratory system agents|mesh-ancestor
92701958|NCT00532350|Parasympatholytics|parasympatholytics|mesh-ancestor
92701959|NCT00532350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92701960|NCT00532350|Cholinergic Agents|cholinergic agents|mesh-ancestor
92701961|NCT00532350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701962|NCT00532350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701963|NCT02932566|Pirfenidone|pirfenidone|mesh-list
92701964|NCT02932566|Analgesics|analgesics|mesh-ancestor
92701975|NCT00532389|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92701976|NCT00532389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372411|NCT01463202|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92701977|NCT00532389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701978|NCT02932644|Vitamin D|vitamin d|mesh-list
92701979|NCT02932644|Ergocalciferols|ergocalciferols|mesh-list
92701980|NCT02932644|Cholecalciferol|cholecalciferol|mesh-list
92701981|NCT02932644|Vitamins|vitamins|mesh-list
92701982|NCT02932644|Micronutrients|micronutrients|mesh-ancestor
92701983|NCT02932644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701984|NCT02932644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92701985|NCT02932644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92701986|NCT05466708|Dexmedetomidine|dexmedetomidine|mesh-list
92701987|NCT05466708|Ketamine|ketamine|mesh-list
92701988|NCT05466708|Esketamine|esketamine|mesh-list
92701989|NCT05466708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92701990|NCT05466708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701991|NCT05466708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701992|NCT05466708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701993|NCT05466708|Analgesics|analgesics|mesh-ancestor
92701994|NCT05466708|Sensory System Agents|sensory system agents|mesh-ancestor
92701995|NCT05466708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701996|NCT05466708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92701997|NCT05466708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92701998|NCT05466708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92701999|NCT05466708|Adrenergic Agents|adrenergic agents|mesh-ancestor
92702000|NCT05466708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607802|NCT00141336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607803|NCT00141336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607804|NCT00141336|Anticonvulsants|anticonvulsants|mesh-ancestor
92607805|NCT00141336|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92607806|NCT00141336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702001|NCT05466708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702002|NCT05466708|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92702003|NCT05466708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92702004|NCT05466708|Anesthetics, General|anesthetics, general|mesh-ancestor
92702006|NCT05466708|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92702007|NCT05466708|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92702008|NCT05466708|Antidepressive Agents|antidepressive agents|mesh-ancestor
92702009|NCT05466708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702010|NCT02920502|Cholecalciferol|cholecalciferol|mesh-list
92702011|NCT02920502|Vitamin D|vitamin d|mesh-list
92702012|NCT02920502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92702013|NCT02920502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702014|NCT02920502|Vitamins|vitamins|mesh-ancestor
92702015|NCT02920502|Micronutrients|micronutrients|mesh-ancestor
92702016|NCT02920502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92702017|NCT01282216|Vaccines|vaccines|mesh-list
92702018|NCT01282216|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92702019|NCT01282216|Immunologic Factors|immunologic factors|mesh-ancestor
92702020|NCT01282216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702021|NCT01281865|Everolimus|everolimus|mesh-list
92702022|NCT01281865|Imatinib Mesylate|imatinib mesylate|mesh-list
92702023|NCT01281865|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92702024|NCT01281865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702025|NCT01281865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702026|NCT01281865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702027|NCT01281865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702028|NCT01281865|Immunologic Factors|immunologic factors|mesh-ancestor
92702042|NCT02920658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92702043|NCT01281202|Vigabatrin|vigabatrin|mesh-list
92702044|NCT01281202|Anticonvulsants|anticonvulsants|mesh-ancestor
92702045|NCT01281202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702046|NCT01281202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702047|NCT01281202|GABA Agents|gaba agents|mesh-ancestor
92702048|NCT01281202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702049|NCT01281202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702050|NCT01281124|Azacitidine|azacitidine|mesh-list
92702051|NCT01281124|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92702052|NCT01281124|Antimetabolites|antimetabolites|mesh-ancestor
92702053|NCT01281124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702054|NCT01281124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702055|NCT01281124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702056|NCT00623857|Vitamins|vitamins|mesh-list
92702057|NCT00623857|Zinc|zinc|mesh-list
92702058|NCT00623857|Micronutrients|micronutrients|mesh-ancestor
92702059|NCT00623857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702060|NCT00623857|Trace Elements|trace elements|mesh-ancestor
92702061|NCT01280968|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92702062|NCT01280968|Vaccines|vaccines|mesh-list
92702063|NCT01280968|Nicotine|nicotine|mesh-list
92702064|NCT01280968|Immunologic Factors|immunologic factors|mesh-ancestor
92702065|NCT01280968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702066|NCT01280968|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92702067|NCT01280968|Autonomic Agents|autonomic agents|mesh-ancestor
92702068|NCT01280968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702069|NCT01280968|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92702070|NCT01280968|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92702071|NCT01280968|Cholinergic Agents|cholinergic agents|mesh-ancestor
92702072|NCT01280968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702073|NCT01280968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702074|NCT01280968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92702075|NCT01280968|Antacids|antacids|mesh-ancestor
92702076|NCT01280968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702077|NCT02932020|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92702078|NCT02932020|Methylprednisolone|methylprednisolone|mesh-list
92607807|NCT00141336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607808|NCT00141336|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92702079|NCT02932020|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92702080|NCT02932020|Prednisolone|prednisolone|mesh-list
92702081|NCT02932020|Prednisolone acetate|prednisolone acetate|mesh-list
92702082|NCT02932020|Bupivacaine|bupivacaine|mesh-list
92702083|NCT02932020|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92702084|NCT02932020|Prednisolone phosphate|prednisolone phosphate|mesh-list
92702085|NCT02932020|Anesthetics, Local|anesthetics, local|mesh-ancestor
92702086|NCT02932020|Anesthetics|anesthetics|mesh-ancestor
92702087|NCT02932020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702088|NCT02932020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702089|NCT02932020|Sensory System Agents|sensory system agents|mesh-ancestor
92702090|NCT02932020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702091|NCT02932020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702099|NCT02932020|Protective Agents|protective agents|mesh-ancestor
92702100|NCT02932020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92702101|NCT02932020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702102|NCT01280656|Interferons|interferons|mesh-list
92702104|NCT01280656|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92702105|NCT01280656|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92702106|NCT01280656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702107|NCT01280656|Antiviral Agents|antiviral agents|mesh-ancestor
92702108|NCT01280656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702109|NCT01280656|Antimetabolites|antimetabolites|mesh-ancestor
92702110|NCT01280656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702111|NCT03741530|Glyburide|glyburide|mesh-list
92702112|NCT03741530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702113|NCT03741530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702114|NCT01280617|Thymoglobulin|thymoglobulin|mesh-list
92702115|NCT01280617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92702116|NCT01280617|Immunologic Factors|immunologic factors|mesh-ancestor
92702117|NCT01280617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702118|NCT01280617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702119|NCT02932137|Interleukin-2|interleukin-2|mesh-list
92702120|NCT02932137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702121|NCT02932137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92702122|NCT02932137|Analgesics|analgesics|mesh-ancestor
92702123|NCT02932137|Sensory System Agents|sensory system agents|mesh-ancestor
92702124|NCT02932137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702125|NCT02932137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702126|NCT01280266|Amlodipine|amlodipine|mesh-list
92702127|NCT01280266|Udenafil|udenafil|mesh-list
92702128|NCT01280266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92702129|NCT01280266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92702130|NCT01280266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702131|NCT01280266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702132|NCT01280266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92702133|NCT01280266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702134|NCT01280266|Vasodilator Agents|vasodilator agents|mesh-ancestor
92702135|NCT01280266|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92702136|NCT01280266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92702137|NCT01280266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702138|NCT01279447|Bupivacaine|bupivacaine|mesh-list
92702139|NCT01279447|Anesthetics, Local|anesthetics, local|mesh-ancestor
92702140|NCT01279447|Anesthetics|anesthetics|mesh-ancestor
92702141|NCT01279447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702142|NCT01279447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702143|NCT01279447|Sensory System Agents|sensory system agents|mesh-ancestor
92702144|NCT01279447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702145|NCT02932254|Magnesium Sulfate|magnesium sulfate|mesh-list
92702146|NCT02932254|Analgesics|analgesics|mesh-ancestor
92702147|NCT02932254|Sensory System Agents|sensory system agents|mesh-ancestor
92702148|NCT02932254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702149|NCT02932254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702150|NCT02932254|Anesthetics|anesthetics|mesh-ancestor
92702151|NCT02932254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702152|NCT02932254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92702153|NCT02932254|Anticonvulsants|anticonvulsants|mesh-ancestor
92702154|NCT02932254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92607810|NCT00141336|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607811|NCT00141336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607812|NCT00141336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607813|NCT00133406|Vitamin A|vitamin a|mesh-list
92607814|NCT00133406|Glycine|glycine|mesh-list
92015110|NCT05611385|Amphetamine|amphetamine|mesh-list
92702155|NCT02932254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702156|NCT02932254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702157|NCT02932254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92702158|NCT02932254|Tocolytic Agents|tocolytic agents|mesh-ancestor
92702165|NCT02920190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702168|NCT02919878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92702169|NCT02919878|Antimetabolites|antimetabolites|mesh-ancestor
92702170|NCT02919878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702171|NCT02919878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702172|NCT02931786|Ketamine|ketamine|mesh-list
92702173|NCT02931786|Propofol|propofol|mesh-list
92702174|NCT02931786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92372450|NCT01474590|Isotretinoin|isotretinoin|mesh-list
92702175|NCT02931786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702176|NCT02931786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702177|NCT02931786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92702178|NCT02931786|Anesthetics, General|anesthetics, general|mesh-ancestor
92702179|NCT02931786|Anesthetics|anesthetics|mesh-ancestor
92702180|NCT02931786|Analgesics|analgesics|mesh-ancestor
92702181|NCT02931786|Sensory System Agents|sensory system agents|mesh-ancestor
92702182|NCT02931786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702183|NCT02931786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92702184|NCT02931786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92702185|NCT02931786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92702186|NCT02931786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702187|NCT02931786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702188|NCT02919605|Pentamidine|pentamidine|mesh-list
92702189|NCT02919605|Antifungal Agents|antifungal agents|mesh-ancestor
92702190|NCT02919605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702191|NCT02919605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92702192|NCT02919605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92702193|NCT02919605|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92702195|NCT00532428|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92702196|NCT00532428|Hormone Antagonists|hormone antagonists|mesh-ancestor
92702197|NCT00532428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702198|NCT00532428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702199|NCT00532428|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92702200|NCT00532428|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92702201|NCT00532428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92702202|NCT05465733|Pemetrexed|pemetrexed|mesh-list
92702203|NCT05465733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702204|NCT05465733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702205|NCT05465733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702206|NCT05465733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92702207|NCT05465733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92702208|NCT03673787|Atezolizumab|atezolizumab|mesh-list
92702209|NCT03673787|Ipatasertib|ipatasertib|mesh-list
92702210|NCT03673787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92702211|NCT03673787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702212|NCT03673787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92702213|NCT03673787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702214|NCT03673787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702215|NCT03673787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702216|NCT03571802|Simvastatin|simvastatin|mesh-list
92702217|NCT03571802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92702218|NCT03571802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92702219|NCT03571802|Antimetabolites|antimetabolites|mesh-ancestor
92702220|NCT03571802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702221|NCT03571802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92702222|NCT03571802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92702223|NCT03571802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607816|NCT00133406|Micronutrients|micronutrients|mesh-ancestor
92607817|NCT00133406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607818|NCT00133406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607819|NCT00133406|Glycine Agents|glycine agents|mesh-ancestor
92702224|NCT02919332|Deoxyglucose|deoxyglucose|mesh-list
92702225|NCT02919332|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92702226|NCT02919332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92702239|NCT02919371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92702240|NCT02919371|Growth Substances|growth substances|mesh-ancestor
92702241|NCT02919371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702242|NCT02919371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92702243|NCT02919371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702244|NCT02919371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702245|NCT02919371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702246|NCT04736901|Enoxaparin|enoxaparin|mesh-list
92702247|NCT04736901|Rivaroxaban|rivaroxaban|mesh-list
92702248|NCT04736901|Apixaban|apixaban|mesh-list
92702249|NCT04736901|Enoxaparin sodium|enoxaparin sodium|mesh-list
92702250|NCT04736901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92702251|NCT04736901|Antithrombins|antithrombins|mesh-ancestor
92702252|NCT04736901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92702253|NCT04736901|Protease Inhibitors|protease inhibitors|mesh-ancestor
92702254|NCT04736901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702255|NCT04736901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702256|NCT04736901|Anticoagulants|anticoagulants|mesh-ancestor
92702257|NCT04736901|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92702258|NCT04736901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92702259|NCT02919176|Pioglitazone|pioglitazone|mesh-list
92702260|NCT02919176|Mirabegron|mirabegron|mesh-list
92702261|NCT02919176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702262|NCT02919176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702263|NCT02919176|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92702264|NCT02919176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92702265|NCT02919176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92702266|NCT02919176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92702267|NCT02919176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702268|NCT02919176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702269|NCT02919176|Urological Agents|urological agents|mesh-ancestor
92702270|NCT04734678|Infliximab|infliximab|mesh-list
92702271|NCT04734678|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92702272|NCT04734678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702273|NCT04734678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92702274|NCT04734678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702275|NCT04734678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702276|NCT02919059|Dapagliflozin|dapagliflozin|mesh-list
92702277|NCT02919059|Glimepiride|glimepiride|mesh-list
92702278|NCT02919059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92702279|NCT02919059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702280|NCT02919059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702281|NCT02919059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702282|NCT02919059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92702283|NCT02919059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702284|NCT02919059|Immunologic Factors|immunologic factors|mesh-ancestor
92702285|NCT04727775|Remdesivir|remdesivir|mesh-list
92702286|NCT04727775|Favipiravir|favipiravir|mesh-list
92702287|NCT04727775|Antimetabolites|antimetabolites|mesh-ancestor
92702288|NCT04727775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702289|NCT04727775|Antiviral Agents|antiviral agents|mesh-ancestor
92702290|NCT04727775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702291|NCT02918825|Olanzapine|olanzapine|mesh-list
92702304|NCT02918825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702305|NCT02918825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702306|NCT02918825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702307|NCT02918825|Serotonin Agents|serotonin agents|mesh-ancestor
92702308|NCT02918825|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92702309|NCT02918825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92702310|NCT02918825|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92702311|NCT02918825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92702312|NCT02918825|Dopamine Agents|dopamine agents|mesh-ancestor
92702313|NCT02918747|Dexamethasone|dexamethasone|mesh-list
92702314|NCT02918747|Prednisone|prednisone|mesh-list
92702315|NCT02918747|Cyclophosphamide|cyclophosphamide|mesh-list
92607820|NCT00133406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607821|NCT00133445|Vaccines|vaccines|mesh-list
92607822|NCT00133445|Immunologic Factors|immunologic factors|mesh-ancestor
92607823|NCT00133445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702316|NCT02918747|Gemcitabine|gemcitabine|mesh-list
92702317|NCT02918747|Doxorubicin|doxorubicin|mesh-list
92702318|NCT02918747|Oxaliplatin|oxaliplatin|mesh-list
92702319|NCT02918747|Vincristine|vincristine|mesh-list
92702320|NCT02918747|Pegaspargase|pegaspargase|mesh-list
92702321|NCT02918747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702322|NCT02918747|Immunologic Factors|immunologic factors|mesh-ancestor
92702323|NCT02918747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702324|NCT02918747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702325|NCT02918747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92702326|NCT02918747|Alkylating Agents|alkylating agents|mesh-ancestor
92702327|NCT02918747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702328|NCT02918747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702329|NCT02918747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92702330|NCT02918747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702331|NCT02918747|Antiemetics|antiemetics|mesh-ancestor
92702332|NCT02918747|Autonomic Agents|autonomic agents|mesh-ancestor
92702333|NCT02918747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702334|NCT02918747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702335|NCT02918747|Glucocorticoids|glucocorticoids|mesh-ancestor
92702336|NCT02918747|Hormones|hormones|mesh-ancestor
92702337|NCT02918747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702338|NCT02918747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92702339|NCT02918747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92702340|NCT02918747|Antimetabolites|antimetabolites|mesh-ancestor
92702341|NCT02918747|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92702342|NCT02918747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92122177|NCT00224289|Latanoprost|latanoprost|mesh-list
92702343|NCT02918747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92702344|NCT02918747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702345|NCT02918747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92702346|NCT02918747|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702347|NCT02918747|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702348|NCT02918747|Mitosis Modulators|mitosis modulators|mesh-ancestor
92702349|NCT02918708|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92702350|NCT02918708|Immunologic Factors|immunologic factors|mesh-ancestor
92702351|NCT02918708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702352|NCT02918591|Empagliflozin|empagliflozin|mesh-list
92702369|NCT00533520|Growth Inhibitors|growth inhibitors|mesh-ancestor
92702370|NCT00533520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702372|NCT03694262|Atezolizumab|atezolizumab|mesh-list
92702374|NCT03694262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92702375|NCT03694262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702376|NCT03694262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92702377|NCT03694262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92702378|NCT03694262|Growth Substances|growth substances|mesh-ancestor
92702379|NCT03694262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702380|NCT03694262|Growth Inhibitors|growth inhibitors|mesh-ancestor
92702381|NCT03694262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92702382|NCT03694262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702383|NCT03694262|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92702384|NCT03694262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702385|NCT05356104|Exenatide|exenatide|mesh-list
92702386|NCT05356104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702387|NCT05356104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702388|NCT05356104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92702389|NCT05356104|Incretins|incretins|mesh-ancestor
92702390|NCT05356104|Hormones|hormones|mesh-ancestor
92702391|NCT05356104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702392|NCT00533559|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92702393|NCT00533559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702394|NCT03685253|Niacinamide|niacinamide|mesh-list
92702395|NCT03685253|Vitamin B Complex|vitamin b complex|mesh-ancestor
92702396|NCT03685253|Vitamins|vitamins|mesh-ancestor
92702397|NCT03685253|Micronutrients|micronutrients|mesh-ancestor
92702398|NCT03685253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702399|NCT00532220|Ibandronic Acid|ibandronic acid|mesh-list
92607824|NCT00141375|Pregabalin|pregabalin|mesh-list
92607825|NCT00141375|Analgesics|analgesics|mesh-ancestor
92607826|NCT00141375|Sensory System Agents|sensory system agents|mesh-ancestor
92607827|NCT00141375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702400|NCT00532220|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92702401|NCT00532220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702402|NCT00532584|Beclomethasone|beclomethasone|mesh-list
92702403|NCT00532584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702404|NCT00532584|Glucocorticoids|glucocorticoids|mesh-ancestor
92702405|NCT00532584|Hormones|hormones|mesh-ancestor
92702406|NCT00532584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702407|NCT00532584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702408|NCT00532584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92702409|NCT00532584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92702410|NCT04687332|Tryptophan|tryptophan|mesh-list
92702435|NCT00532623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92702436|NCT00532623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702437|NCT00532623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702438|NCT00532623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92702440|NCT05467670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92702441|NCT05467670|Pembrolizumab|pembrolizumab|mesh-list
92702442|NCT05467670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92702443|NCT05467670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702444|NCT05467670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92702445|NCT05467670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92702446|NCT05467670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702447|NCT05467670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702448|NCT05467670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92702449|NCT05467670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92702450|NCT00532662|Ketamine|ketamine|mesh-list
92702451|NCT00532662|Analgesics|analgesics|mesh-ancestor
92702452|NCT00532662|Sensory System Agents|sensory system agents|mesh-ancestor
92702453|NCT00532662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702454|NCT00532662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702455|NCT00532662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92702456|NCT00532662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92702457|NCT00532662|Anesthetics, General|anesthetics, general|mesh-ancestor
92702458|NCT00532662|Anesthetics|anesthetics|mesh-ancestor
92702470|NCT05467436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702472|NCT00533637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92702473|NCT00533637|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92702474|NCT00533637|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92702475|NCT00533637|Histamine Antagonists|histamine antagonists|mesh-ancestor
92702476|NCT00533637|Histamine Agents|histamine agents|mesh-ancestor
92702477|NCT00533637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702478|NCT00533637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702479|NCT00533637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702480|NCT00533676|Oxymetazoline|oxymetazoline|mesh-list
92702481|NCT00533676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92702482|NCT00533676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92702483|NCT00533676|Adrenergic Agents|adrenergic agents|mesh-ancestor
92702484|NCT00533676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702485|NCT00533676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702486|NCT00533676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702487|NCT00533676|Sympathomimetics|sympathomimetics|mesh-ancestor
92702488|NCT00533676|Autonomic Agents|autonomic agents|mesh-ancestor
92702489|NCT00533676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702490|NCT00533676|Nasal Decongestants|nasal decongestants|mesh-ancestor
92702491|NCT00533676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92702492|NCT00533676|Respiratory System Agents|respiratory system agents|mesh-ancestor
92702493|NCT05467319|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92702494|NCT05467319|Hematinics|hematinics|mesh-ancestor
92702495|NCT05466695|Sildenafil Citrate|sildenafil citrate|mesh-list
92702496|NCT05466695|Tadalafil|tadalafil|mesh-list
92702497|NCT05466695|Vasodilator Agents|vasodilator agents|mesh-ancestor
92702498|NCT05466695|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92702499|NCT05466695|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92702500|NCT05466695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702501|NCT05466695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702502|NCT05466695|Urological Agents|urological agents|mesh-ancestor
92607828|NCT00141375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607829|NCT00141375|Anticonvulsants|anticonvulsants|mesh-ancestor
92607830|NCT00141375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92015125|NCT05475041|Hematinics|hematinics|mesh-ancestor
92702503|NCT04484610|Analgesics, Opioid|analgesics, opioid|mesh-list
92702504|NCT04484610|Narcotics|narcotics|mesh-ancestor
92702505|NCT04484610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702506|NCT04484610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702507|NCT04484610|Analgesics|analgesics|mesh-ancestor
92702508|NCT04484610|Sensory System Agents|sensory system agents|mesh-ancestor
92702509|NCT04484610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702510|NCT05321316|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92702511|NCT05321316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92702512|NCT05321316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702513|NCT05466149|Aflutinib|aflutinib|mesh-list
92702514|NCT05466149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702515|NCT05466149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702516|NCT05466149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702517|NCT00532701|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92702518|NCT00532701|Interferon-alpha|interferon-alpha|mesh-list
92702519|NCT00532701|Ribavirin|ribavirin|mesh-list
92702520|NCT00532701|Antiviral Agents|antiviral agents|mesh-ancestor
92702542|NCT00532415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702543|NCT00532415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702545|NCT00532454|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92702546|NCT00532454|Hormone Antagonists|hormone antagonists|mesh-ancestor
92702547|NCT00532454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702548|NCT00532454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702549|NCT00532454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92702550|NCT00532454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702551|NCT00532454|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92702552|NCT00532454|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92702553|NCT00532454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92702554|NCT01275625|Maraviroc|maraviroc|mesh-list
92702555|NCT01275625|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92702556|NCT01275625|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92702557|NCT01275625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702558|NCT01275625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92702559|NCT01275625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92702560|NCT01275625|Antiviral Agents|antiviral agents|mesh-ancestor
92702561|NCT01275625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702562|NCT01275625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92702563|NCT05459792|Lidocaine|lidocaine|mesh-list
92122404|NCT02429232|Hormones|hormones|mesh-ancestor
92702564|NCT05459792|Bupivacaine|bupivacaine|mesh-list
92702565|NCT05459792|Anesthetics, Local|anesthetics, local|mesh-ancestor
92702566|NCT05459792|Anesthetics|anesthetics|mesh-ancestor
92702567|NCT05459792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702568|NCT05459792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702569|NCT05459792|Sensory System Agents|sensory system agents|mesh-ancestor
92702570|NCT05459792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372512|NCT01484340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702581|NCT04686825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702582|NCT04686825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702583|NCT00533988|Anti-Infective Agents|anti-infective agents|mesh-list
92702584|NCT00533988|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92702586|NCT05281185|Coagulants|coagulants|mesh-ancestor
92702587|NCT00532532|Tolperisone|tolperisone|mesh-list
92702588|NCT00532532|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92702589|NCT00532532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702590|NCT00532532|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92702591|NCT00532532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702592|NCT00532571|Coenzyme Q10|coenzyme q10|mesh-list
92702593|NCT00532571|Vitamins|vitamins|mesh-ancestor
92702594|NCT00532571|Micronutrients|micronutrients|mesh-ancestor
92702595|NCT00532571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702596|NCT04322565|Colchicine|colchicine|mesh-list
92702597|NCT04322565|Gout Suppressants|gout suppressants|mesh-ancestor
92702598|NCT04322565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702599|NCT04322565|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702600|NCT04322565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702601|NCT04322565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92607831|NCT00141375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607832|NCT00141375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607833|NCT00141375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92607834|NCT00141375|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92607835|NCT00141375|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92607836|NCT00141375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607837|NCT00141375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015129|NCT02631577|Lenalidomide|lenalidomide|mesh-list
92702602|NCT04322565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702603|NCT04322565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702604|NCT00532688|Acetylcysteine|acetylcysteine|mesh-list
92702605|NCT00532688|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92702606|NCT00532688|Antiviral Agents|antiviral agents|mesh-ancestor
92702607|NCT00532688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702608|NCT00532688|Expectorants|expectorants|mesh-ancestor
92702609|NCT00532688|Respiratory System Agents|respiratory system agents|mesh-ancestor
92702610|NCT00532688|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92702611|NCT00532688|Antioxidants|antioxidants|mesh-ancestor
92702612|NCT00532688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702613|NCT00532688|Protective Agents|protective agents|mesh-ancestor
92702614|NCT00532688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702615|NCT00532688|Antidotes|antidotes|mesh-ancestor
92702616|NCT00534144|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92702617|NCT00534144|Ferric gluconate|ferric gluconate|mesh-list
92702618|NCT00534144|Hematinics|hematinics|mesh-ancestor
92702619|NCT00534183|Haloperidol|haloperidol|mesh-list
92702620|NCT00534183|Olanzapine|olanzapine|mesh-list
92702621|NCT00534183|Risperidone|risperidone|mesh-list
92702622|NCT00534183|Haloperidol decanoate|haloperidol decanoate|mesh-list
92702623|NCT00534183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92702624|NCT00534183|Serotonin Agents|serotonin agents|mesh-ancestor
92702625|NCT00534183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702626|NCT00534183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702627|NCT00534183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702628|NCT00534183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92702629|NCT00534183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702630|NCT00534183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702631|NCT00534183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702632|NCT00534183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92702633|NCT00534183|Dopamine Agents|dopamine agents|mesh-ancestor
92702634|NCT00534183|Antiemetics|antiemetics|mesh-ancestor
92702635|NCT00534183|Autonomic Agents|autonomic agents|mesh-ancestor
92122474|NCT02428764|Carboplatin|carboplatin|mesh-list
92702659|NCT04687449|Analgesics|analgesics|mesh-ancestor
92372526|NCT01495572|Cyclophosphamide|cyclophosphamide|mesh-list
92702660|NCT04687449|Sensory System Agents|sensory system agents|mesh-ancestor
92702661|NCT04687449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702662|NCT04687449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702663|NCT04687449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702664|NCT04687449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702665|NCT04687449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702666|NCT04687449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702667|NCT04687449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702668|NCT05258279|Carboplatin|carboplatin|mesh-list
92702669|NCT05258279|Pembrolizumab|pembrolizumab|mesh-list
92702670|NCT05258279|Pemetrexed|pemetrexed|mesh-list
92702671|NCT05258279|Lenvatinib|lenvatinib|mesh-list
92702672|NCT05258279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702673|NCT05258279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92702674|NCT05258279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92702675|NCT05258279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702676|NCT05258279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702677|NCT05258279|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92702678|NCT05258279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92702679|NCT05258279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702680|NCT00532818|Hydralazine|hydralazine|mesh-list
92702681|NCT00532818|Valproic Acid|valproic acid|mesh-list
92702682|NCT00532818|Anticonvulsants|anticonvulsants|mesh-ancestor
92702698|NCT05209035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607839|NCT00133523|Immunologic Factors|immunologic factors|mesh-ancestor
92607840|NCT00133523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702699|NCT05209035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702700|NCT05209035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92702701|NCT05209035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92702702|NCT05209035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702703|NCT05209035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702704|NCT05209035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702705|NCT05209035|Serotonin Agents|serotonin agents|mesh-ancestor
92702706|NCT05209035|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92702707|NCT05209035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92702708|NCT00534261|Interferons|interferons|mesh-list
92702709|NCT00534261|Interferon-beta|interferon-beta|mesh-list
92702710|NCT00534261|Interferon beta-1a|interferon beta-1a|mesh-list
92122550|NCT04468360|Pregnanolone|pregnanolone|mesh-list
92702711|NCT00534261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702712|NCT00534261|Antiviral Agents|antiviral agents|mesh-ancestor
92702713|NCT00534261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702714|NCT00534261|Immunologic Factors|immunologic factors|mesh-ancestor
92702715|NCT00534261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702716|NCT00534261|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92702717|NCT00532857|Paclitaxel|paclitaxel|mesh-list
92702718|NCT00532857|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92702719|NCT00532857|Gemcitabine|gemcitabine|mesh-list
92702720|NCT00532857|Trastuzumab|trastuzumab|mesh-list
92702721|NCT00532857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92702722|NCT00532857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702723|NCT00532857|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702724|NCT00532857|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702725|NCT00532857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92702726|NCT00532857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702727|NCT00532857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92702728|NCT00532857|Antimetabolites|antimetabolites|mesh-ancestor
92702729|NCT00532857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92702730|NCT05152004|Amoxicillin|amoxicillin|mesh-list
92702731|NCT05152004|Metronidazole|metronidazole|mesh-list
92702732|NCT05152004|Clarithromycin|clarithromycin|mesh-list
92702733|NCT05152004|Rabeprazole|rabeprazole|mesh-list
92702734|NCT05152004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92702735|NCT05152004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702736|NCT05152004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92702737|NCT05152004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92702738|NCT05152004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92702739|NCT05152004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702740|NCT05152004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702741|NCT05152004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92702744|NCT05152004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92372539|NCT01495572|Antiviral Agents|antiviral agents|mesh-ancestor
92702745|NCT05152004|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92702746|NCT05132153|Milrinone|milrinone|mesh-list
92702747|NCT05132153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92702748|NCT05132153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92702749|NCT05132153|Vasodilator Agents|vasodilator agents|mesh-ancestor
92702750|NCT05132153|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92702751|NCT05132153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92702752|NCT05132153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702753|NCT05132153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702754|NCT05132153|Protective Agents|protective agents|mesh-ancestor
92702755|NCT05132153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702756|NCT00534378|Midazolam|midazolam|mesh-list
92702757|NCT00534378|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92702758|NCT00534378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92702759|NCT00534378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702760|NCT00534378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702761|NCT00534378|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92702762|NCT00534378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702763|NCT00534378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702764|NCT00534378|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92702765|NCT00534378|Anesthetics, General|anesthetics, general|mesh-ancestor
92702766|NCT00534378|Anesthetics|anesthetics|mesh-ancestor
92702767|NCT00534378|GABA Modulators|gaba modulators|mesh-ancestor
92702768|NCT00534378|GABA Agents|gaba agents|mesh-ancestor
92702769|NCT00534378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607841|NCT00133562|Glycine|glycine|mesh-list
92607842|NCT00133562|Glycine Agents|glycine agents|mesh-ancestor
92607843|NCT00133562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015135|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92702770|NCT00534378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702771|NCT05131997|Atorvastatin|atorvastatin|mesh-list
92702772|NCT05131997|Ezetimibe|ezetimibe|mesh-list
92702773|NCT05131997|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92702774|NCT05131997|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92702775|NCT05131997|Antimetabolites|antimetabolites|mesh-ancestor
92702776|NCT05131997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702777|NCT05131997|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92702778|NCT05131997|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92702779|NCT05131997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702780|NCT00534456|Darbepoetin alfa|darbepoetin alfa|mesh-list
92702781|NCT00534456|Hematinics|hematinics|mesh-ancestor
92702782|NCT05104229|Aspirin|aspirin|mesh-list
92702783|NCT05104229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92702784|NCT05104229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92702785|NCT05104229|Analgesics|analgesics|mesh-ancestor
92702786|NCT05104229|Sensory System Agents|sensory system agents|mesh-ancestor
92702787|NCT05104229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702788|NCT05104229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702789|NCT05104229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702790|NCT05104229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702791|NCT05104229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92702792|NCT05104229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92702793|NCT05104229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702794|NCT05104229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92702795|NCT05104229|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92702796|NCT05104229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702798|NCT00532961|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92702799|NCT00532961|Tobramycin|tobramycin|mesh-list
92702800|NCT00532961|Dexamethasone|dexamethasone|mesh-list
92702801|NCT00532961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702802|NCT00532961|Antiemetics|antiemetics|mesh-ancestor
92702803|NCT00532961|Autonomic Agents|autonomic agents|mesh-ancestor
92702804|NCT00532961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702805|NCT00532961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702806|NCT00532961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702807|NCT00532961|Glucocorticoids|glucocorticoids|mesh-ancestor
92702808|NCT00532961|Hormones|hormones|mesh-ancestor
92702809|NCT00532961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702810|NCT00532961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92702811|NCT00532961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702812|NCT00532961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92702813|NCT00532961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702814|NCT00532961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92702815|NCT00534573|Amisulpride|amisulpride|mesh-list
92702825|NCT00534573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702826|NCT00534573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92702827|NCT00534573|Antidepressive Agents|antidepressive agents|mesh-ancestor
92702828|NCT00534573|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92702829|NCT00534573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702831|NCT04686890|Tramadol|tramadol|mesh-list
92702832|NCT04686890|Analgesics|analgesics|mesh-list
92702833|NCT04686890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92702834|NCT04686890|Sensory System Agents|sensory system agents|mesh-ancestor
92702835|NCT04686890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702836|NCT04686890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702837|NCT04686890|Antipyretics|antipyretics|mesh-ancestor
92702838|NCT04686890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92702839|NCT04686890|Narcotics|narcotics|mesh-ancestor
92702840|NCT04686890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702841|NCT00533039|Varespladib methyl|varespladib methyl|mesh-list
92702842|NCT00533039|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92702843|NCT00533039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702844|NCT00533039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702845|NCT05103306|Empagliflozin|empagliflozin|mesh-list
92702846|NCT05103306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702847|NCT05103306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607844|NCT00133562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607845|NCT00133562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607846|NCT00404391|Acetaminophen|acetaminophen|mesh-list
92015137|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
92702848|NCT05103306|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92702849|NCT05103306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702850|NCT00534651|Acetaminophen|acetaminophen|mesh-list
92702851|NCT00534651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92702852|NCT00534651|Analgesics|analgesics|mesh-ancestor
92702853|NCT00534651|Sensory System Agents|sensory system agents|mesh-ancestor
92702854|NCT00534651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702855|NCT00534651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702856|NCT00534651|Antipyretics|antipyretics|mesh-ancestor
92702857|NCT05080959|Ropivacaine|ropivacaine|mesh-list
92702858|NCT05080959|Anesthetics, Local|anesthetics, local|mesh-ancestor
92702859|NCT05080959|Anesthetics|anesthetics|mesh-ancestor
92702860|NCT05080959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702861|NCT05080959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702862|NCT05080959|Sensory System Agents|sensory system agents|mesh-ancestor
92702863|NCT05080959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702865|NCT04942730|Cyclophosphamide|cyclophosphamide|mesh-list
92702867|NCT04942730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92702868|NCT04942730|Fludarabine|fludarabine|mesh-list
92702869|NCT04942730|Tacrolimus|tacrolimus|mesh-list
92702870|NCT04942730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702871|NCT04942730|Immunologic Factors|immunologic factors|mesh-ancestor
92702872|NCT04942730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702873|NCT04942730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702874|NCT04942730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92702875|NCT04942730|Alkylating Agents|alkylating agents|mesh-ancestor
92702876|NCT04942730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702877|NCT04942730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702878|NCT04942730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92702879|NCT04942730|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92702880|NCT04942730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702881|NCT04942730|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92702896|NCT04687163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702897|NCT04687163|Antimetabolites|antimetabolites|mesh-ancestor
92702898|NCT04687163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702899|NCT04687163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92702900|NCT04687163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702901|NCT04687163|Immunologic Factors|immunologic factors|mesh-ancestor
92702902|NCT04687163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702903|NCT01270828|Pregabalin|pregabalin|mesh-list
92702904|NCT01270828|Analgesics|analgesics|mesh-ancestor
92702905|NCT01270828|Sensory System Agents|sensory system agents|mesh-ancestor
92702906|NCT01270828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702907|NCT01270828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702908|NCT01270828|Anticonvulsants|anticonvulsants|mesh-ancestor
92702909|NCT01270828|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92702910|NCT01270828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702911|NCT01270828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702912|NCT01270828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92702913|NCT01270828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92702914|NCT01270828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702915|NCT01270828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702916|NCT01270828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702917|NCT00533195|5-Methoxypsoralen|5-methoxypsoralen|mesh-list
92702918|NCT00533195|Methoxsalen|methoxsalen|mesh-list
92702919|NCT00533195|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92702920|NCT00533195|Dermatologic Agents|dermatologic agents|mesh-ancestor
92702921|NCT00533195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702922|NCT03982407|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92702923|NCT03982407|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92702924|NCT03982407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702925|NCT01269385|Rituximab|rituximab|mesh-list
92702926|NCT01269385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92702927|NCT01269385|Alemtuzumab|alemtuzumab|mesh-list
92702928|NCT01269385|Antibodies|antibodies|mesh-list
92702929|NCT01269385|Immunoglobulins|immunoglobulins|mesh-list
92702930|NCT01269385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92702931|NCT01269385|Immunologic Factors|immunologic factors|mesh-ancestor
92702932|NCT01269385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702933|NCT01269385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702934|NCT01269385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92702935|NCT02071862|Paclitaxel|paclitaxel|mesh-list
92702936|NCT02071862|Docetaxel|docetaxel|mesh-list
92702937|NCT02071862|Everolimus|everolimus|mesh-list
92702938|NCT02071862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92702939|NCT02071862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702940|NCT02071862|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702941|NCT02071862|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702942|NCT02071862|Mitosis Modulators|mitosis modulators|mesh-ancestor
92702943|NCT02071862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702944|NCT02071862|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92702945|NCT02071862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702965|NCT02021474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92702966|NCT04959825|Melatonin|melatonin|mesh-list
92702967|NCT04959825|Antioxidants|antioxidants|mesh-ancestor
92702968|NCT04959825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702969|NCT04959825|Protective Agents|protective agents|mesh-ancestor
92702970|NCT04959825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702971|NCT04959825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702972|NCT05471453|Tocotrienols|tocotrienols|mesh-list
92702973|NCT05471453|Vitamin E|vitamin e|mesh-list
92702974|NCT05471453|Tocopherols|tocopherols|mesh-list
92702975|NCT05471453|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92702976|NCT05471453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92702977|NCT05471453|Immunologic Factors|immunologic factors|mesh-ancestor
92702978|NCT05471453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702979|NCT05471453|Antioxidants|antioxidants|mesh-ancestor
92702980|NCT05471453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702981|NCT05471453|Protective Agents|protective agents|mesh-ancestor
92702982|NCT05471453|Vitamins|vitamins|mesh-ancestor
92702983|NCT05471453|Micronutrients|micronutrients|mesh-ancestor
92702984|NCT03457233|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92702985|NCT03457233|Cetrorelix|cetrorelix|mesh-list
92702986|NCT03457233|Menotropins|menotropins|mesh-list
92702987|NCT03457233|Progesterone|progesterone|mesh-list
92702988|NCT03457233|Progestins|progestins|mesh-ancestor
92702989|NCT03457233|Hormones|hormones|mesh-ancestor
92702990|NCT03457233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702991|NCT03457233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702992|NCT03457233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92702993|NCT03457233|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92702994|NCT03457233|Fertility Agents|fertility agents|mesh-ancestor
92702995|NCT03457233|Hormone Antagonists|hormone antagonists|mesh-ancestor
92702996|NCT00535808|Nitroprusside|nitroprusside|mesh-list
92702997|NCT00535808|Nitroglycerin|nitroglycerin|mesh-list
92702998|NCT00535808|Sevoflurane|sevoflurane|mesh-list
92702999|NCT00535808|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92703000|NCT00535808|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92703001|NCT00535808|Anesthetics, General|anesthetics, general|mesh-ancestor
92703002|NCT00535808|Anesthetics|anesthetics|mesh-ancestor
92703003|NCT00535808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703004|NCT00535808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703037|NCT04910100|Nebivolol|nebivolol|mesh-list
92703038|NCT04910100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92703039|NCT04910100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92703040|NCT04910100|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92703041|NCT04910100|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92703042|NCT04910100|Adrenergic Agents|adrenergic agents|mesh-ancestor
92703043|NCT04910100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703044|NCT04910100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703045|NCT04910100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703046|NCT04910100|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703058|NCT01268059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703059|NCT01268059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703060|NCT01267825|Bupivacaine|bupivacaine|mesh-list
92703061|NCT01267825|Anesthetics, Local|anesthetics, local|mesh-ancestor
92703062|NCT01267825|Anesthetics|anesthetics|mesh-ancestor
92703063|NCT01267825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703064|NCT01267825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703065|NCT01267825|Sensory System Agents|sensory system agents|mesh-ancestor
92703066|NCT01267825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607847|NCT00404391|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92607848|NCT00404391|Hydrocodone|hydrocodone|mesh-list
92607849|NCT00404391|Oxycodone|oxycodone|mesh-list
92607850|NCT00404391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703067|NCT00536003|Progesterone|progesterone|mesh-list
92703068|NCT00536003|Progestins|progestins|mesh-ancestor
92703070|NCT00536003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703071|NCT00536003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703072|NCT00533091|Sifalimumab|sifalimumab|mesh-list
92703073|NCT00533091|Immunologic Factors|immunologic factors|mesh-ancestor
92703074|NCT00533091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703075|NCT00536042|Minocycline|minocycline|mesh-list
92703076|NCT00536042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92703077|NCT00536042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703078|NCT01606384|Vasopressins|vasopressins|mesh-list
92703079|NCT01606384|Arginine Vasopressin|arginine vasopressin|mesh-list
92703080|NCT01606384|Hemostatics|hemostatics|mesh-ancestor
92703081|NCT01606384|Coagulants|coagulants|mesh-ancestor
92703082|NCT01606384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92703083|NCT01606384|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92703084|NCT01606384|Natriuretic Agents|natriuretic agents|mesh-ancestor
92703085|NCT01606384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703086|NCT01606462|Oxytocin|oxytocin|mesh-list
92703087|NCT01606462|Oxytocics|oxytocics|mesh-ancestor
92703088|NCT01606462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92703089|NCT01606462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703090|NCT05470595|Atezolizumab|atezolizumab|mesh-list
92703091|NCT05470595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92703092|NCT05470595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703093|NCT05470595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92703094|NCT05470595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703096|NCT01606540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703097|NCT01606540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703098|NCT01606540|Analgesics|analgesics|mesh-ancestor
92703099|NCT01606540|Sensory System Agents|sensory system agents|mesh-ancestor
92703100|NCT01606540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703101|NCT01606540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703102|NCT01606540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703103|NCT01606540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703104|NCT01606540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703105|NCT01606540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703106|NCT01606540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703107|NCT00533169|Tretinoin|tretinoin|mesh-list
92703108|NCT00533169|Isotretinoin|isotretinoin|mesh-list
92703109|NCT00533169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703110|NCT00533169|Keratolytic Agents|keratolytic agents|mesh-ancestor
92703111|NCT00533169|Dermatologic Agents|dermatologic agents|mesh-ancestor
92703112|NCT00593710|Losartan|losartan|mesh-list
92703125|NCT00593710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92703126|NCT00593710|Adrenergic Agents|adrenergic agents|mesh-ancestor
92703127|NCT00593710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703128|NCT04885686|Formaldehyde|formaldehyde|mesh-list
92703129|NCT04885686|Thymol|thymol|mesh-list
92703130|NCT04885686|Dexamethasone|dexamethasone|mesh-list
92703131|NCT04885686|Hydrocortisone|hydrocortisone|mesh-list
92703132|NCT04885686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703133|NCT04885686|Antiemetics|antiemetics|mesh-ancestor
92703134|NCT04885686|Autonomic Agents|autonomic agents|mesh-ancestor
92703135|NCT04885686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703136|NCT04885686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703137|NCT04885686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703138|NCT04885686|Glucocorticoids|glucocorticoids|mesh-ancestor
92703139|NCT04885686|Hormones|hormones|mesh-ancestor
92703140|NCT04885686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703141|NCT04885686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92703142|NCT04885686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703143|NCT04885686|Disinfectants|disinfectants|mesh-ancestor
92703144|NCT04885686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703145|NCT04885686|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92703146|NCT04885686|Antifungal Agents|antifungal agents|mesh-ancestor
92703147|NCT00594217|Progesterone|progesterone|mesh-list
92703148|NCT00594217|Progestins|progestins|mesh-ancestor
92703149|NCT00594217|Hormones|hormones|mesh-ancestor
92607851|NCT00404391|Analgesics|analgesics|mesh-ancestor
92607852|NCT00404391|Sensory System Agents|sensory system agents|mesh-ancestor
92015143|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
92703150|NCT00594217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703151|NCT00594217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703152|NCT00536237|Niacin|niacin|mesh-list
92703153|NCT00536237|Niacinamide|niacinamide|mesh-list
92703154|NCT00536237|Nicotinic Acids|nicotinic acids|mesh-list
92703155|NCT00536237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703156|NCT00536237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703157|NCT00536237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92703158|NCT00536237|Antimetabolites|antimetabolites|mesh-ancestor
92703159|NCT00536237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92703160|NCT00536237|Vasodilator Agents|vasodilator agents|mesh-ancestor
92703161|NCT00536237|Vitamin B Complex|vitamin b complex|mesh-ancestor
92703162|NCT00536237|Vitamins|vitamins|mesh-ancestor
92703163|NCT00536237|Micronutrients|micronutrients|mesh-ancestor
92703164|NCT00533247|Celecoxib|celecoxib|mesh-list
92703165|NCT00533247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703166|NCT00533247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703167|NCT00533247|Analgesics|analgesics|mesh-ancestor
92703168|NCT00533247|Sensory System Agents|sensory system agents|mesh-ancestor
92703169|NCT00533247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703170|NCT00533247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703171|NCT00533247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703172|NCT00533247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703173|NCT00533247|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92703174|NCT00533247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703175|NCT00533247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703193|NCT02690064|Tocopherols|tocopherols|mesh-list
92703194|NCT02690064|Tocotrienols|tocotrienols|mesh-list
92703195|NCT02690064|alpha-Tocopherol|alpha-tocopherol|mesh-list
92703196|NCT02690064|Thioctic Acid|thioctic acid|mesh-list
92703197|NCT02690064|Ubiquinone|ubiquinone|mesh-list
92703198|NCT02690064|Resveratrol|resveratrol|mesh-list
92703199|NCT02690064|Antioxidants|antioxidants|mesh-list
92703200|NCT02690064|Micronutrients|micronutrients|mesh-ancestor
92703201|NCT02690064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703202|NCT02690064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703203|NCT02690064|Protective Agents|protective agents|mesh-ancestor
92703204|NCT02690064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703205|NCT02690064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92703206|NCT02690064|Vitamin B Complex|vitamin b complex|mesh-ancestor
92703207|NCT00594373|Tenofovir|tenofovir|mesh-list
92703208|NCT00594373|Antiviral Agents|antiviral agents|mesh-ancestor
92703209|NCT00594373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703210|NCT00594373|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92703211|NCT00594373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92703212|NCT00594373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703213|NCT00594373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703214|NCT00594373|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92703215|NCT00594373|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92703216|NCT05470166|Lidocaine|lidocaine|mesh-list
92703217|NCT05470166|Anesthetics, Local|anesthetics, local|mesh-ancestor
92703218|NCT05470166|Anesthetics|anesthetics|mesh-ancestor
92703219|NCT05470166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703220|NCT05470166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703221|NCT05470166|Sensory System Agents|sensory system agents|mesh-ancestor
92703222|NCT05470166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703223|NCT05470166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703224|NCT05470166|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92703225|NCT05470166|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92703226|NCT05470166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92703227|NCT05470166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703228|NCT01260142|Propofol|propofol|mesh-list
92703229|NCT01260142|Fospropofol|fospropofol|mesh-list
92703230|NCT01260142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92703231|NCT01260142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703232|NCT01260142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703233|NCT01260142|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92703234|NCT01260142|Anesthetics, General|anesthetics, general|mesh-ancestor
92123080|NCT00361348|Heparin|heparin|mesh-list
92607853|NCT00404391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607854|NCT00404391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607855|NCT00404391|Antipyretics|antipyretics|mesh-ancestor
92607856|NCT00404391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92607857|NCT00404391|Narcotics|narcotics|mesh-ancestor
92015145|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
92703241|NCT05469659|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
92703242|NCT05469659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703243|NCT05469659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703244|NCT05469659|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92703245|NCT05469659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703247|NCT01808820|Vaccines|vaccines|mesh-list
92703248|NCT01808820|Immunologic Factors|immunologic factors|mesh-ancestor
92703249|NCT01808820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703250|NCT01808820|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92703251|NCT01808820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703252|NCT01808820|Interferon Inducers|interferon inducers|mesh-ancestor
92703253|NCT05469386|Methylphenidate|methylphenidate|mesh-list
92703254|NCT05469386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92703255|NCT05469386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703256|NCT05469386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92703257|NCT05469386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92703258|NCT05469386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92703259|NCT05469386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703260|NCT05469386|Dopamine Agents|dopamine agents|mesh-ancestor
92703261|NCT05469386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703262|NCT05469347|Alirocumab|alirocumab|mesh-list
92703263|NCT05469347|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92703264|NCT05469347|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92703265|NCT05469347|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92703266|NCT05469347|Antimetabolites|antimetabolites|mesh-ancestor
92703267|NCT05469347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703268|NCT05469347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92703269|NCT05469347|Protease Inhibitors|protease inhibitors|mesh-ancestor
92703270|NCT05469347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703271|NCT05469347|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92703272|NCT01462890|Paclitaxel|paclitaxel|mesh-list
92703273|NCT01462890|Bevacizumab|bevacizumab|mesh-list
92703274|NCT01462890|Carboplatin|carboplatin|mesh-list
92703275|NCT01462890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92703276|NCT01462890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703277|NCT01462890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703278|NCT01462890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703279|NCT01462890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703280|NCT01462890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703281|NCT01462890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92703282|NCT01462890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92703283|NCT01462890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92703284|NCT01462890|Growth Substances|growth substances|mesh-ancestor
92703285|NCT01462890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703286|NCT01462890|Growth Inhibitors|growth inhibitors|mesh-ancestor
92703287|NCT05469113|Repaglinide|repaglinide|mesh-list
92703288|NCT05469113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703289|NCT05469113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703290|NCT01259713|Amphotericin B|amphotericin b|mesh-list
92703291|NCT01259713|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92703292|NCT01259713|Amebicides|amebicides|mesh-ancestor
92703293|NCT01259713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92703294|NCT01259713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92703295|NCT01259713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372621|NCT01520454|Heparin|heparin|mesh-list
92703296|NCT01259713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92703325|NCT05471427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703326|NCT05471427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703327|NCT05471427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703328|NCT05558449|Midazolam|midazolam|mesh-list
92703329|NCT05558449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92703330|NCT05558449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92607858|NCT00404391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607859|NCT00404391|Antitussive Agents|antitussive agents|mesh-ancestor
92607860|NCT00404391|Respiratory System Agents|respiratory system agents|mesh-ancestor
92703331|NCT05558449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703332|NCT05558449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703333|NCT05558449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92703334|NCT05558449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92703335|NCT05558449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92703336|NCT05558449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92703337|NCT05558449|Anesthetics, General|anesthetics, general|mesh-ancestor
92703338|NCT05558449|Anesthetics|anesthetics|mesh-ancestor
92703339|NCT05558449|GABA Modulators|gaba modulators|mesh-ancestor
92703340|NCT05558449|GABA Agents|gaba agents|mesh-ancestor
92703341|NCT05558449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703342|NCT05558449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703343|NCT04326985|Hyaluronic Acid|hyaluronic acid|mesh-list
92703344|NCT04326985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92703345|NCT04326985|Immunologic Factors|immunologic factors|mesh-ancestor
92703346|NCT04326985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703348|NCT04326985|Protective Agents|protective agents|mesh-ancestor
92703349|NCT00536393|Doxorubicin|doxorubicin|mesh-list
92703350|NCT00536393|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92703351|NCT00536393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92703352|NCT00536393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703353|NCT00536393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92703354|NCT00536393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92703355|NCT00536393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703356|NCT00536393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703357|NCT00595543|Diclofenac|diclofenac|mesh-list
92703358|NCT00595543|Ketorolac|ketorolac|mesh-list
92703359|NCT00595543|Bromfenac|bromfenac|mesh-list
92703360|NCT00595543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703361|NCT00595543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703362|NCT00595543|Analgesics|analgesics|mesh-ancestor
92703363|NCT00595543|Sensory System Agents|sensory system agents|mesh-ancestor
92703364|NCT00595543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703365|NCT00595543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703366|NCT00595543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703367|NCT00595543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703368|NCT00595543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703369|NCT00595543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703370|NCT00595543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703371|NCT04326868|Albendazole|albendazole|mesh-list
92703372|NCT04326868|Mebendazole|mebendazole|mesh-list
92703373|NCT04326868|Benzimidazole|benzimidazole|mesh-list
92703374|NCT04326868|Pyrantel|pyrantel|mesh-list
92703375|NCT04326868|Anthelmintics|anthelmintics|mesh-list
92703376|NCT04326868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92703377|NCT04326868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703378|NCT04326868|Anticestodal Agents|anticestodal agents|mesh-ancestor
92703379|NCT04326868|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92703380|NCT04326868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92703381|NCT04326868|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703382|NCT04326868|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703383|NCT04326868|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703384|NCT04326868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703385|NCT04326868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703386|NCT04326868|Antinematodal Agents|antinematodal agents|mesh-ancestor
92703387|NCT04326868|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92703388|NCT04326868|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92703389|NCT04326868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92703390|NCT04326868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703391|NCT04326868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703392|NCT00595972|Endostar protein|endostar protein|mesh-list
92703393|NCT00595972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92703394|NCT00595972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92703395|NCT00595972|Growth Substances|growth substances|mesh-ancestor
92703396|NCT00595972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703397|NCT00595972|Growth Inhibitors|growth inhibitors|mesh-ancestor
92703398|NCT00595972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703400|NCT00596050|Fentanyl|fentanyl|mesh-list
92703401|NCT00596050|Midazolam|midazolam|mesh-list
92703402|NCT00596050|Ketamine|ketamine|mesh-list
92703403|NCT00596050|Etomidate|etomidate|mesh-list
92607861|NCT00404391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92607862|NCT00404391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92607863|NCT00404391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607865|NCT00144807|Rituximab|rituximab|mesh-list
92607866|NCT00144807|Doxorubicin|doxorubicin|mesh-list
92607867|NCT00144807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92703404|NCT00596050|Anesthetics, Local|anesthetics, local|mesh-ancestor
92703405|NCT00596050|Anesthetics|anesthetics|mesh-ancestor
92703406|NCT00596050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703407|NCT00596050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703408|NCT00596050|Sensory System Agents|sensory system agents|mesh-ancestor
92703409|NCT00596050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703410|NCT00596050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703411|NCT00596050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92703412|NCT00596050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92703413|NCT00596050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92703414|NCT00596050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703415|NCT00596050|Analgesics|analgesics|mesh-ancestor
92703416|NCT00596050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92703417|NCT00596050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92703418|NCT00596050|Anesthetics, General|anesthetics, general|mesh-ancestor
92703419|NCT00596050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92703420|NCT00596050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92703421|NCT00596050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703422|NCT00596050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92703455|NCT00624130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703456|NCT00624130|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92703457|NCT00624130|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92703458|NCT00624130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92703459|NCT00624130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703460|NCT05468450|Polidocanol|polidocanol|mesh-list
92703461|NCT05468450|Sclerosing Solutions|sclerosing solutions|mesh-list
92703462|NCT05468450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92703463|NCT00535860|Teriparatide|teriparatide|mesh-list
92703464|NCT00535860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92703465|NCT00535860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703466|NCT00535860|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92703467|NCT00596479|Lenograstim|lenograstim|mesh-list
92703489|NCT04207957|Olorofim|olorofim|mesh-list
92703490|NCT04207957|Antifungal Agents|antifungal agents|mesh-ancestor
92703491|NCT04207957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703492|NCT00596557|Everolimus|everolimus|mesh-list
92703493|NCT00596557|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92703494|NCT00596557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92372644|NCT01520688|Hormones|hormones|mesh-ancestor
92703495|NCT00596557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703496|NCT00596557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703497|NCT00596557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92703498|NCT00596557|Immunologic Factors|immunologic factors|mesh-ancestor
92703499|NCT00596557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703500|NCT00596557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703501|NCT00596596|Prucalopride|prucalopride|mesh-list
92703502|NCT00596596|Laxatives|laxatives|mesh-ancestor
92703503|NCT00596596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703504|NCT00596596|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92703505|NCT00596596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92703506|NCT00596596|Serotonin Agents|serotonin agents|mesh-ancestor
92703507|NCT00596596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703508|NCT00596596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703509|NCT00596596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703510|NCT05468294|Nivolumab|nivolumab|mesh-list
92703511|NCT05468294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92703512|NCT05468294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703513|NCT05468294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92703514|NCT05468294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703515|NCT05312866|Acetaminophen|acetaminophen|mesh-list
92703516|NCT05312866|Dexamethasone|dexamethasone|mesh-list
92607868|NCT00144807|Immunologic Factors|immunologic factors|mesh-ancestor
92607869|NCT00144807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607870|NCT00144807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92607871|NCT00144807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92607872|NCT00144807|Alkylating Agents|alkylating agents|mesh-ancestor
92703517|NCT05312866|Magnesium Sulfate|magnesium sulfate|mesh-list
92703518|NCT05312866|Fentanyl|fentanyl|mesh-list
92703519|NCT05312866|Bupivacaine|bupivacaine|mesh-list
92703520|NCT05312866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703533|NCT05312866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703534|NCT05312866|Sensory System Agents|sensory system agents|mesh-ancestor
92703535|NCT05312866|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92703536|NCT05312866|Narcotics|narcotics|mesh-ancestor
92703537|NCT05312866|Analgesics|analgesics|mesh-ancestor
92703538|NCT05312866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92703539|NCT05312866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92703540|NCT05312866|Anesthetics, General|anesthetics, general|mesh-ancestor
92703541|NCT05312866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703542|NCT05312866|Antipyretics|antipyretics|mesh-ancestor
92703543|NCT05312866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703544|NCT05312866|Anticonvulsants|anticonvulsants|mesh-ancestor
92703545|NCT05312866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92703546|NCT05312866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92703547|NCT05312866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703548|NCT05312866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92703549|NCT05312866|Tocolytic Agents|tocolytic agents|mesh-ancestor
92703550|NCT05312866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92703551|NCT04326790|Colchicine|colchicine|mesh-list
92703552|NCT04326790|Gout Suppressants|gout suppressants|mesh-ancestor
92703553|NCT04326790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703554|NCT04326790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703555|NCT04326790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703556|NCT04326790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703557|NCT04326790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703558|NCT04326790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703559|NCT00596986|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92703560|NCT00596986|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92703561|NCT00596986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92703562|NCT00596986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92703563|NCT00596986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703564|NCT00596986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703565|NCT00596986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703566|NCT00596986|Analgesics|analgesics|mesh-ancestor
92703567|NCT00596986|Sensory System Agents|sensory system agents|mesh-ancestor
92703568|NCT00596986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703569|NCT00596986|Antidepressive Agents|antidepressive agents|mesh-ancestor
92703570|NCT00596986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92703571|NCT00596986|Dopamine Agents|dopamine agents|mesh-ancestor
92703572|NCT00597064|Prednisone|prednisone|mesh-list
92703573|NCT00597064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703574|NCT00597064|Glucocorticoids|glucocorticoids|mesh-ancestor
92703575|NCT00597064|Hormones|hormones|mesh-ancestor
92703576|NCT00597064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703577|NCT00597064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703578|NCT00597064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92703579|NCT00597064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703580|NCT00597181|Mitomycins|mitomycins|mesh-list
92703581|NCT00597181|Mitomycin|mitomycin|mesh-list
92703582|NCT00597181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92703587|NCT00597181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703588|NCT00597259|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92703589|NCT00597259|Entecavir|entecavir|mesh-list
92703590|NCT00597259|Antiviral Agents|antiviral agents|mesh-ancestor
92703591|NCT00597259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703592|NCT05470764|Amlodipine|amlodipine|mesh-list
92703593|NCT05470764|Perindopril|perindopril|mesh-list
92703594|NCT05470764|Indapamide|indapamide|mesh-list
92703595|NCT05470764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92703596|NCT05470764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92703597|NCT05470764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607873|NCT00144807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607874|NCT00144807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607875|NCT00144807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92607876|NCT00144807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607877|NCT00144807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92703598|NCT05470764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703599|NCT05470764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92703600|NCT05470764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703601|NCT05470764|Vasodilator Agents|vasodilator agents|mesh-ancestor
92703602|NCT05470764|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92703603|NCT05470764|Protease Inhibitors|protease inhibitors|mesh-ancestor
92703604|NCT05470764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703605|NCT05470764|Diuretics|diuretics|mesh-ancestor
92703606|NCT05470764|Natriuretic Agents|natriuretic agents|mesh-ancestor
92703607|NCT05470764|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92703608|NCT00597415|Celecoxib|celecoxib|mesh-list
92703609|NCT00597415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703610|NCT00597415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703611|NCT00597415|Analgesics|analgesics|mesh-ancestor
92703612|NCT00597415|Sensory System Agents|sensory system agents|mesh-ancestor
92703613|NCT00597415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703614|NCT00597415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703615|NCT00597415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703616|NCT00597415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703617|NCT00597415|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92703618|NCT00597415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703619|NCT00597415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703620|NCT00597415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703621|NCT00597688|Chlorhexidine|chlorhexidine|mesh-list
92703622|NCT00597688|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92703623|NCT00597688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703624|NCT00597688|Disinfectants|disinfectants|mesh-ancestor
92703625|NCT05470530|Dexamethasone|dexamethasone|mesh-list
92703626|NCT05470530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703627|NCT05470530|Antiemetics|antiemetics|mesh-ancestor
92703628|NCT05470530|Autonomic Agents|autonomic agents|mesh-ancestor
92703629|NCT05470530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703630|NCT05470530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703631|NCT05470530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703632|NCT05470530|Glucocorticoids|glucocorticoids|mesh-ancestor
92703633|NCT05470530|Hormones|hormones|mesh-ancestor
92703634|NCT05470530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703635|NCT05470530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92703636|NCT05470530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703637|NCT02891980|Vaccines|vaccines|mesh-list
92703638|NCT02891980|Immunologic Factors|immunologic factors|mesh-ancestor
92703639|NCT02891980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703640|NCT05467826|Ribavirin|ribavirin|mesh-list
92703641|NCT05467826|Sofosbuvir|sofosbuvir|mesh-list
92703642|NCT05467826|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92703643|NCT05467826|Velpatasvir|velpatasvir|mesh-list
92703644|NCT05467826|Antimetabolites|antimetabolites|mesh-ancestor
92703645|NCT05467826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703646|NCT05467826|Antiviral Agents|antiviral agents|mesh-ancestor
92703647|NCT05467826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703648|NCT00598156|Bevacizumab|bevacizumab|mesh-list
92703649|NCT00598156|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92703650|NCT00598156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92703651|NCT00598156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703652|NCT00598156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92703657|NCT00598156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92703658|NCT00598156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703659|NCT00598156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703660|NCT00598195|Ketamine|ketamine|mesh-list
92703661|NCT00598195|Analgesics|analgesics|mesh-ancestor
92703662|NCT00598195|Sensory System Agents|sensory system agents|mesh-ancestor
92703663|NCT00598195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607878|NCT00144807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92607879|NCT00144807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607880|NCT00144807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607881|NCT00133640|Cholecalciferol|cholecalciferol|mesh-list
92607883|NCT00133640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92703664|NCT00598195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703665|NCT00598195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92703666|NCT00598195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92703667|NCT00598195|Anesthetics, General|anesthetics, general|mesh-ancestor
92703668|NCT00598195|Anesthetics|anesthetics|mesh-ancestor
92703669|NCT00598195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703670|NCT00598195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92703671|NCT00598195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92703672|NCT00598195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703673|NCT00598195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703674|NCT00598234|Celecoxib|celecoxib|mesh-list
92703675|NCT00598234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703676|NCT00598234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703677|NCT00598234|Analgesics|analgesics|mesh-ancestor
92703678|NCT00598234|Sensory System Agents|sensory system agents|mesh-ancestor
92703679|NCT00598234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703680|NCT00598234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703681|NCT00598234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703682|NCT00598234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703683|NCT00598234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92703684|NCT00598234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703685|NCT00598234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703686|NCT00598234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703687|NCT00598429|Alprostadil|alprostadil|mesh-list
92703688|NCT00598429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92703689|NCT00598429|Vasodilator Agents|vasodilator agents|mesh-ancestor
92703690|NCT00598429|Urological Agents|urological agents|mesh-ancestor
92703692|NCT00598624|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92703693|NCT00598624|Alkylating Agents|alkylating agents|mesh-ancestor
92703694|NCT00598624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703695|NCT00598624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703696|NCT02891785|Antipain|antipain|mesh-list
92703697|NCT02891785|Protease Inhibitors|protease inhibitors|mesh-ancestor
92703698|NCT02891785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703699|NCT02891785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703700|NCT00598858|Prednisone|prednisone|mesh-list
92703701|NCT00598858|Cortisone|cortisone|mesh-list
92703702|NCT00598858|Docetaxel|docetaxel|mesh-list
92703703|NCT00598858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703704|NCT00598858|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703705|NCT00598858|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703706|NCT00598858|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703707|NCT00598858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703708|NCT00598858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703709|NCT00598858|Glucocorticoids|glucocorticoids|mesh-ancestor
92703710|NCT00598858|Hormones|hormones|mesh-ancestor
92703711|NCT00598858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703712|NCT00598858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703713|NCT00598858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92703714|NCT05466305|Cobalt|cobalt|mesh-list
92703715|NCT05466305|Trace Elements|trace elements|mesh-ancestor
92703716|NCT05466305|Micronutrients|micronutrients|mesh-ancestor
92703717|NCT05466305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703718|NCT04207684|Testosterone|testosterone|mesh-list
92703719|NCT04207684|Androgens|androgens|mesh-ancestor
92703720|NCT04207684|Hormones|hormones|mesh-ancestor
92703721|NCT04207684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703722|NCT04207684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703741|NCT02909478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703742|NCT02909478|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92703743|NCT02909478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607884|NCT00133640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607885|NCT00133640|Vitamins|vitamins|mesh-ancestor
92607886|NCT00133640|Micronutrients|micronutrients|mesh-ancestor
92607887|NCT00133640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92607888|NCT01244191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92015173|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
92703744|NCT02909478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703745|NCT02909478|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92703746|NCT02909478|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92703747|NCT02909478|Serotonin Agents|serotonin agents|mesh-ancestor
92703748|NCT00536211|Metformin|metformin|mesh-list
92703749|NCT00536211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703750|NCT00536211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703751|NCT00536705|Montelukast|montelukast|mesh-list
92703752|NCT00536705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92703753|NCT00536705|Respiratory System Agents|respiratory system agents|mesh-ancestor
92703754|NCT00536705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92703755|NCT00536705|Hormone Antagonists|hormone antagonists|mesh-ancestor
92703756|NCT00536705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703757|NCT00536705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703758|NCT00536705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92703759|NCT00536705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92703760|NCT00536705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703761|NCT00624208|Droperidol|droperidol|mesh-list
92703762|NCT00624208|Ondansetron|ondansetron|mesh-list
92703763|NCT00624208|Antiemetics|antiemetics|mesh-ancestor
92703764|NCT00624208|Autonomic Agents|autonomic agents|mesh-ancestor
92703765|NCT00624208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703766|NCT00624208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703767|NCT00624208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703768|NCT00624208|Antipruritics|antipruritics|mesh-ancestor
92703769|NCT00624208|Dermatologic Agents|dermatologic agents|mesh-ancestor
92703770|NCT00624208|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92703771|NCT00624208|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92703772|NCT00624208|Serotonin Agents|serotonin agents|mesh-ancestor
92703773|NCT00624208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703774|NCT00624208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703775|NCT00624208|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92703776|NCT00624208|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92703777|NCT00624208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92703780|NCT00624208|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92703781|NCT00624208|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92703782|NCT00624208|Dopamine Agents|dopamine agents|mesh-ancestor
92703783|NCT00536783|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92703784|NCT00536783|Antidepressive Agents|antidepressive agents|mesh-ancestor
92703785|NCT00536783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92703786|NCT00536783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92703787|NCT00536783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92703788|NCT00536783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703789|NCT00536783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703790|NCT04685642|Aspirin|aspirin|mesh-list
92703791|NCT04685642|Atorvastatin|atorvastatin|mesh-list
92703792|NCT04685642|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703793|NCT04685642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703794|NCT04685642|Analgesics|analgesics|mesh-ancestor
92703795|NCT04685642|Sensory System Agents|sensory system agents|mesh-ancestor
92703796|NCT04685642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703797|NCT04685642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703798|NCT04685642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703799|NCT04685642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703800|NCT04685642|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92703801|NCT04685642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92703802|NCT04685642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703803|NCT04685642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92703804|NCT04685642|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703805|NCT04685642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703806|NCT04685642|Antipyretics|antipyretics|mesh-ancestor
92703807|NCT04685642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92703808|NCT04685642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92015177|NCT02518971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92607889|NCT01244191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607890|NCT01244191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92607891|NCT01244191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607892|NCT01244191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607893|NCT00404508|Hydralazine|hydralazine|mesh-list
92607894|NCT00404508|Valproic Acid|valproic acid|mesh-list
92607895|NCT00404508|Anticonvulsants|anticonvulsants|mesh-ancestor
92607896|NCT00404508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607897|NCT00404508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703809|NCT04685642|Antimetabolites|antimetabolites|mesh-ancestor
92703810|NCT04685642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92703811|NCT04685642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92703812|NCT05312346|Hydroxocobalamin|hydroxocobalamin|mesh-list
92703813|NCT05312346|Vitamin B 12|vitamin b 12|mesh-list
92703814|NCT05312346|Hematinics|hematinics|mesh-ancestor
92703815|NCT05312346|Vitamin B Complex|vitamin b complex|mesh-ancestor
92703816|NCT05312346|Vitamins|vitamins|mesh-ancestor
92703817|NCT05312346|Micronutrients|micronutrients|mesh-ancestor
92703818|NCT05312346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703819|NCT05568563|Ethyl Chloride|ethyl chloride|mesh-list
92703820|NCT05568563|Anesthetics, Local|anesthetics, local|mesh-ancestor
92703821|NCT05568563|Anesthetics|anesthetics|mesh-ancestor
92703822|NCT05568563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703823|NCT05568563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703824|NCT05568563|Sensory System Agents|sensory system agents|mesh-ancestor
92703825|NCT05568563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703826|NCT00536861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92703827|NCT00536861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703828|NCT00536861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92703829|NCT00536861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703830|NCT00536861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703831|NCT05469984|Gentamicins|gentamicins|mesh-list
92703832|NCT05469984|Ampicillin|ampicillin|mesh-list
92703833|NCT05469984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92703834|NCT05469984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703835|NCT05469984|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92703836|NCT05469984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703837|NCT05469984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703838|NCT05312190|Progesterone|progesterone|mesh-list
92703839|NCT05312190|Progestins|progestins|mesh-ancestor
92703840|NCT05312190|Hormones|hormones|mesh-ancestor
92703841|NCT05312190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703842|NCT05312190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703843|NCT00537173|Paclitaxel|paclitaxel|mesh-list
92703844|NCT00537173|Bevacizumab|bevacizumab|mesh-list
92703845|NCT00537173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92703846|NCT00537173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703847|NCT00537173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703848|NCT00537173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703849|NCT00537173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92372737|NCT01537926|Protective Agents|protective agents|mesh-ancestor
92703850|NCT00537173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703876|NCT05469750|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92703877|NCT05469750|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92703878|NCT05469750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703879|NCT05469750|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92703880|NCT05469750|Hormone Antagonists|hormone antagonists|mesh-ancestor
92703881|NCT05469750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703882|NCT05469750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703883|NCT02143830|Cyclophosphamide|cyclophosphamide|mesh-list
92703884|NCT02143830|Busulfan|busulfan|mesh-list
92703885|NCT02143830|Fludarabine|fludarabine|mesh-list
92703886|NCT02143830|Thymoglobulin|thymoglobulin|mesh-list
92703887|NCT02143830|Lenograstim|lenograstim|mesh-list
92703888|NCT02143830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92607898|NCT00404508|GABA Agents|gaba agents|mesh-ancestor
92607899|NCT00404508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607900|NCT00404508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607901|NCT00404508|Antimanic Agents|antimanic agents|mesh-ancestor
92015185|NCT04733963|Bevacizumab|bevacizumab|mesh-list
92703889|NCT02143830|Immunologic Factors|immunologic factors|mesh-ancestor
92703890|NCT02143830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703891|NCT02143830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703892|NCT02143830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92703893|NCT02143830|Alkylating Agents|alkylating agents|mesh-ancestor
92703894|NCT02143830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703895|NCT02143830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703896|NCT02143830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92703897|NCT02143830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92703898|NCT00537251|Insulin Glargine|insulin glargine|mesh-list
92703914|NCT05469204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703915|NCT05469204|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92703916|NCT05469204|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92703917|NCT05469204|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92703918|NCT05469204|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92703919|NCT05469204|Anesthetics, General|anesthetics, general|mesh-ancestor
92703920|NCT05469204|Anesthetics|anesthetics|mesh-ancestor
92703921|NCT05469204|GABA Modulators|gaba modulators|mesh-ancestor
92703922|NCT05469204|GABA Agents|gaba agents|mesh-ancestor
92703923|NCT05469204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703924|NCT05469204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703925|NCT05469204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703926|NCT05469204|Analgesics|analgesics|mesh-ancestor
92703927|NCT05469204|Sensory System Agents|sensory system agents|mesh-ancestor
92703928|NCT05469204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703929|NCT05469204|Antipyretics|antipyretics|mesh-ancestor
92703930|NCT05469204|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703931|NCT05469204|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92703932|NCT05469204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703933|NCT05469204|Protective Agents|protective agents|mesh-ancestor
92703934|NCT05469165|Cyproheptadine|cyproheptadine|mesh-list
92703935|NCT05469165|Antipruritics|antipruritics|mesh-ancestor
92703936|NCT05469165|Dermatologic Agents|dermatologic agents|mesh-ancestor
92703937|NCT05469165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703938|NCT05469165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92703939|NCT05469165|Histamine Antagonists|histamine antagonists|mesh-ancestor
92703940|NCT05469165|Histamine Agents|histamine agents|mesh-ancestor
92703941|NCT05469165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92703942|NCT05469165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703943|NCT05469165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703944|NCT05469165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92703945|NCT05469165|Serotonin Agents|serotonin agents|mesh-ancestor
92703946|NCT05469165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92703948|NCT04319926|Anesthetics, Local|anesthetics, local|mesh-ancestor
92703949|NCT04319926|Anesthetics|anesthetics|mesh-ancestor
92703950|NCT04319926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703951|NCT04319926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703952|NCT04319926|Sensory System Agents|sensory system agents|mesh-ancestor
92703953|NCT04319926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703954|NCT04319926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703955|NCT04319926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92703956|NCT04319926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92703957|NCT04319926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92703958|NCT04319926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703959|NCT01313923|Sirolimus|sirolimus|mesh-list
92703960|NCT01313923|Temsirolimus|temsirolimus|mesh-list
92703961|NCT01313923|MTOR Inhibitors|mtor inhibitors|mesh-list
92703979|NCT01313884|Immunologic Factors|immunologic factors|mesh-ancestor
92703980|NCT01313884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703981|NCT01313884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703982|NCT01313884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92703983|NCT01313884|Alkylating Agents|alkylating agents|mesh-ancestor
92703984|NCT01313884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703985|NCT01313884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703986|NCT01313884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92607902|NCT00404508|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92703987|NCT01313884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92703988|NCT01313884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92703989|NCT01313884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123839|NCT01697969|Analgesics|analgesics|mesh-ancestor
92703990|NCT01313884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703991|NCT01313884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92703992|NCT01313884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92703993|NCT01313884|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703994|NCT01313884|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703995|NCT01313884|Mitosis Modulators|mitosis modulators|mesh-ancestor
92703996|NCT00537524|Vaccines|vaccines|mesh-list
92703997|NCT00537524|Immunologic Factors|immunologic factors|mesh-ancestor
92703998|NCT00537524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703999|NCT00537563|Telithromycin|telithromycin|mesh-list
92704000|NCT00537563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92704001|NCT00537563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704002|NCT00537602|Miglustat|miglustat|mesh-list
92704003|NCT00537602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704004|NCT00537602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704005|NCT00537602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92704006|NCT00537602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92704007|NCT00537602|Antiviral Agents|antiviral agents|mesh-ancestor
92704008|NCT00537602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704009|NCT00537602|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92704010|NCT00537602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704011|NCT00537602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704012|NCT01259284|Atorvastatin|atorvastatin|mesh-list
92704013|NCT01259284|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92704014|NCT01259284|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92704015|NCT01259284|Antimetabolites|antimetabolites|mesh-ancestor
92704016|NCT01259284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704017|NCT01259284|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92704018|NCT01259284|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92372765|NCT01542684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704031|NCT02277171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704033|NCT02277171|Respiratory System Agents|respiratory system agents|mesh-ancestor
92704034|NCT02277171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92704035|NCT02277171|Antioxidants|antioxidants|mesh-ancestor
92704036|NCT02277171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704037|NCT02277171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704038|NCT02277171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92704039|NCT02277171|Vasodilator Agents|vasodilator agents|mesh-ancestor
92704040|NCT02277171|Gasotransmitters|gasotransmitters|mesh-ancestor
92704041|NCT02277171|Protective Agents|protective agents|mesh-ancestor
92704042|NCT00551564|Rosiglitazone|rosiglitazone|mesh-list
92704043|NCT00551564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704044|NCT00551564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704045|NCT05105061|Ketamine|ketamine|mesh-list
92704046|NCT05105061|Analgesics|analgesics|mesh-ancestor
92704047|NCT05105061|Sensory System Agents|sensory system agents|mesh-ancestor
92704048|NCT05105061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704049|NCT05105061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704050|NCT05105061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92704051|NCT05105061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92704052|NCT05105061|Anesthetics, General|anesthetics, general|mesh-ancestor
92704053|NCT05105061|Anesthetics|anesthetics|mesh-ancestor
92704054|NCT05105061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704055|NCT05105061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92704056|NCT05105061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92704057|NCT05105061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704058|NCT05105061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704059|NCT05056584|Glucagon|glucagon|mesh-list
92704060|NCT05056584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704061|NCT05056584|Hormones|hormones|mesh-ancestor
92704062|NCT05056584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704063|NCT05056584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704064|NCT00551954|Acarbose|acarbose|mesh-list
92704065|NCT00551954|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92704067|NCT00551954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704068|NCT00551954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704069|NCT00551954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704070|NCT00552149|Cetuximab|cetuximab|mesh-list
92704071|NCT00552149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607903|NCT00404508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607904|NCT00404508|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607905|NCT00404508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92704072|NCT00552149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704074|NCT05467878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704075|NCT05467878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704076|NCT00536640|Bevacizumab|bevacizumab|mesh-list
92704077|NCT00536640|Gemcitabine|gemcitabine|mesh-list
92704078|NCT00536640|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92704079|NCT00536640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92704080|NCT00536640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704081|NCT00536640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92704093|NCT00552227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704095|NCT01259089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704096|NCT01259089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92704097|NCT01259089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704098|NCT01259089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704099|NCT00552266|Methylphenidate|methylphenidate|mesh-list
92704100|NCT00552266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92372784|NCT01545336|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704101|NCT00552266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704102|NCT00552266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92704103|NCT00552266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92704104|NCT00552266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704105|NCT00552266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704106|NCT00552266|Dopamine Agents|dopamine agents|mesh-ancestor
92704107|NCT00552266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704108|NCT04943757|Cyclophosphamide|cyclophosphamide|mesh-list
92704109|NCT04943757|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92704110|NCT04943757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704111|NCT04943757|Immunologic Factors|immunologic factors|mesh-ancestor
92704112|NCT04943757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704113|NCT04943757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704114|NCT04943757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92704115|NCT04943757|Alkylating Agents|alkylating agents|mesh-ancestor
92704116|NCT04943757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704117|NCT04943757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704118|NCT04943757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92704119|NCT00552461|Rituximab|rituximab|mesh-list
92704120|NCT00552461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92704121|NCT00552461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704122|NCT00552461|Immunologic Factors|immunologic factors|mesh-ancestor
92704123|NCT00552461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704124|NCT00552461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704125|NCT00552500|Valproic Acid|valproic acid|mesh-list
92704126|NCT00552500|Anticonvulsants|anticonvulsants|mesh-ancestor
92704127|NCT00552500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704128|NCT00552500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704129|NCT00552500|GABA Agents|gaba agents|mesh-ancestor
92704130|NCT00552500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704131|NCT00552500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704132|NCT00552500|Antimanic Agents|antimanic agents|mesh-ancestor
92704133|NCT00552500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92704134|NCT00552500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704135|NCT00552500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704136|NCT01258738|Etanercept|etanercept|mesh-list
92704137|NCT01258738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92704139|NCT01258738|Analgesics|analgesics|mesh-ancestor
92704140|NCT01258738|Sensory System Agents|sensory system agents|mesh-ancestor
92704141|NCT01258738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704142|NCT01258738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704160|NCT00552656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704161|NCT00552656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704162|NCT01824537|Vaccines|vaccines|mesh-list
92704163|NCT01824537|Immunologic Factors|immunologic factors|mesh-ancestor
92704164|NCT01824537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704165|NCT04863339|Tranexamic Acid|tranexamic acid|mesh-list
92704166|NCT04863339|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92704167|NCT04863339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92607906|NCT00404508|Vasodilator Agents|vasodilator agents|mesh-ancestor
92607907|NCT00133757|Bupropion|bupropion|mesh-list
92607908|NCT00133757|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92704168|NCT04863339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704169|NCT04863339|Hemostatics|hemostatics|mesh-ancestor
92704170|NCT04863339|Coagulants|coagulants|mesh-ancestor
92704171|NCT04684277|Antidepressive Agents|antidepressive agents|mesh-list
92704172|NCT04684277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704173|NCT00552734|Insulin|insulin|mesh-list
92704174|NCT00552734|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92704175|NCT00552734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704176|NCT00552734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704177|NCT04543682|Iloprost|iloprost|mesh-list
92704178|NCT04543682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92704179|NCT04543682|Vasodilator Agents|vasodilator agents|mesh-ancestor
92372805|NCT01553058|Adalimumab|adalimumab|mesh-list
92704180|NCT04802616|Broncho-Vaxom|broncho-vaxom|mesh-list
92704181|NCT04802616|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92704182|NCT04802616|Immunologic Factors|immunologic factors|mesh-ancestor
92704183|NCT04802616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704184|NCT01258660|Folic Acid|folic acid|mesh-list
92704185|NCT01258660|Vitamin B Complex|vitamin b complex|mesh-list
92704186|NCT01258660|Drospirenone|drospirenone|mesh-list
92704187|NCT01258660|Hematinics|hematinics|mesh-ancestor
92704188|NCT01258660|Vitamins|vitamins|mesh-ancestor
92704189|NCT01258660|Micronutrients|micronutrients|mesh-ancestor
92704190|NCT01258660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704191|NCT01258660|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92704192|NCT01258660|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704193|NCT01258660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704194|NCT01258660|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92704195|NCT01258660|Diuretics|diuretics|mesh-ancestor
92704196|NCT01258660|Natriuretic Agents|natriuretic agents|mesh-ancestor
92704197|NCT04772274|Ustekinumab|ustekinumab|mesh-list
92704198|NCT04772274|Dermatologic Agents|dermatologic agents|mesh-ancestor
92704199|NCT04362527|Milrinone|milrinone|mesh-list
92704200|NCT04362527|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92704201|NCT04362527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92704202|NCT04362527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92704203|NCT04362527|Vasodilator Agents|vasodilator agents|mesh-ancestor
92704221|NCT05567367|Vasodilator Agents|vasodilator agents|mesh-ancestor
92704222|NCT05567367|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92704223|NCT05567367|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92704224|NCT05567367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704225|NCT05567367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704226|NCT05567367|Urological Agents|urological agents|mesh-ancestor
92704228|NCT04656951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704229|NCT04173533|Azacitidine|azacitidine|mesh-list
92704230|NCT04173533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704231|NCT04173533|Antimetabolites|antimetabolites|mesh-ancestor
92704232|NCT04173533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704233|NCT04173533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704234|NCT04173533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704235|NCT01258348|Sunitinib|sunitinib|mesh-list
92704236|NCT01258348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704237|NCT01258348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92704238|NCT01258348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92704239|NCT01258348|Growth Substances|growth substances|mesh-ancestor
92704240|NCT01258348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704241|NCT01258348|Growth Inhibitors|growth inhibitors|mesh-ancestor
92704242|NCT01258348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92704243|NCT01258348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704244|NCT01258348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704245|NCT05136898|Mitomycins|mitomycins|mesh-list
92704246|NCT05136898|Mitomycin|mitomycin|mesh-list
92704247|NCT05136898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92704248|NCT05136898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704249|NCT05136898|Alkylating Agents|alkylating agents|mesh-ancestor
92704250|NCT05136898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704251|NCT05136898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92704252|NCT05136898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704253|NCT01258075|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92704254|NCT01258075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92704255|NCT01258075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92607909|NCT00133757|Antidepressive Agents|antidepressive agents|mesh-ancestor
92607910|NCT00133757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607911|NCT00133757|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92704256|NCT01258075|Antimetabolites|antimetabolites|mesh-ancestor
92704257|NCT01258075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704269|NCT01256671|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92704270|NCT01256671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92704271|NCT01256671|Immunologic Factors|immunologic factors|mesh-ancestor
92704272|NCT01256671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704273|NCT04687566|Memantine|memantine|mesh-list
92704274|NCT04687566|Dextromethorphan|dextromethorphan|mesh-list
92704275|NCT04687566|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92704276|NCT04687566|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92704277|NCT04687566|Dopamine Agents|dopamine agents|mesh-ancestor
92704278|NCT04687566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704279|NCT04687566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704280|NCT04687566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704281|NCT04687566|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92704282|NCT04687566|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92704283|NCT04687566|Antitussive Agents|antitussive agents|mesh-ancestor
92704284|NCT04687566|Respiratory System Agents|respiratory system agents|mesh-ancestor
92704285|NCT01256593|Pregabalin|pregabalin|mesh-list
92704286|NCT01256593|Analgesics|analgesics|mesh-ancestor
92704287|NCT01256593|Sensory System Agents|sensory system agents|mesh-ancestor
92704288|NCT01256593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124127|NCT02423980|Incretins|incretins|mesh-ancestor
92704289|NCT01256593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704290|NCT01256593|Anticonvulsants|anticonvulsants|mesh-ancestor
92704291|NCT01256593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92704292|NCT01256593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704293|NCT01256593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704294|NCT01256593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92704295|NCT01256593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92704296|NCT01256593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92704297|NCT01256593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704298|NCT01256593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704299|NCT01256476|Pravastatin|pravastatin|mesh-list
92704300|NCT01256476|Pitavastatin|pitavastatin|mesh-list
92704301|NCT01256476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92704302|NCT01256476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92704303|NCT01256476|Antimetabolites|antimetabolites|mesh-ancestor
92704304|NCT01256476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704305|NCT01256476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92704306|NCT01256476|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92704307|NCT01256476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704308|NCT05507892|Canagliflozin|canagliflozin|mesh-list
92704309|NCT05507892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92704310|NCT05507892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704311|NCT05507892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704312|NCT05507892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704313|NCT04106999|Dexmedetomidine|dexmedetomidine|mesh-list
92704314|NCT04106999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92704315|NCT04106999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704316|NCT04106999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704317|NCT04106999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92704318|NCT04106999|Analgesics|analgesics|mesh-ancestor
92704319|NCT04106999|Sensory System Agents|sensory system agents|mesh-ancestor
92704320|NCT04106999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704331|NCT05478720|Antimetabolites|antimetabolites|mesh-ancestor
92704332|NCT05478720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704333|NCT05003089|Prednisolone|prednisolone|mesh-list
92704334|NCT05003089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704335|NCT05003089|Glucocorticoids|glucocorticoids|mesh-ancestor
92704336|NCT05003089|Hormones|hormones|mesh-ancestor
92704337|NCT05003089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704338|NCT05003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704339|NCT05003089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92704340|NCT05003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704341|NCT04207021|Curcumin|curcumin|mesh-list
92607912|NCT00133757|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92704342|NCT04207021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92704343|NCT04207021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92704344|NCT04207021|Analgesics|analgesics|mesh-ancestor
92704345|NCT04207021|Sensory System Agents|sensory system agents|mesh-ancestor
92704346|NCT04207021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704347|NCT04207021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704348|NCT04207021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704349|NCT04207021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704350|NCT04207021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704351|NCT04207021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704352|NCT04207021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704353|NCT01255423|Diclofenac|diclofenac|mesh-list
92704354|NCT01255423|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92704355|NCT01255423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92704356|NCT01255423|Analgesics|analgesics|mesh-ancestor
92704357|NCT01255423|Sensory System Agents|sensory system agents|mesh-ancestor
92704358|NCT01255423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704359|NCT01255423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704360|NCT01255423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704361|NCT01255423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704362|NCT01255423|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92704363|NCT01255423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704364|NCT01255423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704365|NCT01255306|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92704366|NCT01255306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92704367|NCT01255306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92704368|NCT01255306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92704369|NCT01255306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92704370|NCT01255306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92704371|NCT01255306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704372|NCT01255306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704373|NCT01255306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704374|NCT01254721|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92704375|NCT01254721|Antidepressive Agents|antidepressive agents|mesh-ancestor
92704376|NCT01254721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704377|NCT01254721|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92704378|NCT01254721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92704379|NCT01254721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704380|NCT01254721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704381|NCT04005053|Acetylcysteine|acetylcysteine|mesh-list
92704393|NCT04003805|Nicotine|nicotine|mesh-list
92704394|NCT04003805|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92704395|NCT04003805|Autonomic Agents|autonomic agents|mesh-ancestor
92704396|NCT04003805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704397|NCT04003805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704398|NCT04003805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92704399|NCT04003805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92704400|NCT04003805|Cholinergic Agents|cholinergic agents|mesh-ancestor
92704401|NCT04003805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704402|NCT04003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704677|NCT01199978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704678|NCT00532116|Selegiline|selegiline|mesh-list
92704679|NCT00532116|Antidepressive Agents|antidepressive agents|mesh-ancestor
92704680|NCT00532116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704681|NCT00532116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92704682|NCT00532116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92704683|NCT00532116|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92704684|NCT00532116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704685|NCT00532116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704686|NCT00532116|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92704687|NCT00532116|Protective Agents|protective agents|mesh-ancestor
92704688|NCT00532116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704689|NCT04283513|Ribavirin|ribavirin|mesh-list
92704690|NCT04283513|Antimetabolites|antimetabolites|mesh-ancestor
92704691|NCT04283513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704692|NCT04283513|Antiviral Agents|antiviral agents|mesh-ancestor
92704693|NCT04283513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704694|NCT01251367|Botulinum Toxins|botulinum toxins|mesh-list
92704695|NCT01251367|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92704696|NCT01251367|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92607913|NCT00133757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607914|NCT00133757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704697|NCT01251367|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92704698|NCT01251367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704699|NCT01251367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704700|NCT01251367|Cholinergic Agents|cholinergic agents|mesh-ancestor
92704701|NCT01251367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704702|NCT01251367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704703|NCT01251367|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92704704|NCT01251367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704705|NCT03910998|Rocuronium|rocuronium|mesh-list
92704706|NCT03910998|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92704707|NCT03910998|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92704708|NCT03910998|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92704403|NCT04842604|Azacitidine|azacitidine|mesh-list
92704404|NCT04842604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704405|NCT04842604|Antimetabolites|antimetabolites|mesh-ancestor
92704406|NCT04842604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704407|NCT04842604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704408|NCT04842604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704409|NCT01254604|Timolol|timolol|mesh-list
92704410|NCT01254604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704411|NCT01254604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92704412|NCT01254604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92704428|NCT03795701|Liraglutide|liraglutide|mesh-list
92704429|NCT03795701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704430|NCT03795701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704431|NCT03795701|Incretins|incretins|mesh-ancestor
92704432|NCT03795701|Hormones|hormones|mesh-ancestor
92704433|NCT03795701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704434|NCT04673578|Celecoxib|celecoxib|mesh-list
92704435|NCT04673578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92704436|NCT04673578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92704437|NCT04673578|Analgesics|analgesics|mesh-ancestor
92704438|NCT04673578|Sensory System Agents|sensory system agents|mesh-ancestor
92704439|NCT04673578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704440|NCT04673578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704441|NCT04673578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704442|NCT04673578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704443|NCT04673578|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92704444|NCT04673578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92704445|NCT04673578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704446|NCT04673578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704447|NCT05414058|Methylphenidate|methylphenidate|mesh-list
92704448|NCT05414058|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92704449|NCT05414058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704450|NCT05414058|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92704451|NCT05414058|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92704452|NCT05414058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704453|NCT05414058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704454|NCT05414058|Dopamine Agents|dopamine agents|mesh-ancestor
92704455|NCT05414058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704456|NCT03757403|Mebendazole|mebendazole|mesh-list
92704457|NCT03757403|Piperazine|piperazine|mesh-list
92704458|NCT03757403|Piperazine citrate|piperazine citrate|mesh-list
92704459|NCT03757403|DMP 777|dmp 777|mesh-list
92704460|NCT03757403|Antinematodal Agents|antinematodal agents|mesh-ancestor
92704461|NCT03757403|Anthelmintics|anthelmintics|mesh-ancestor
92704462|NCT03757403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92704463|NCT03757403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704464|NCT03757403|Tubulin Modulators|tubulin modulators|mesh-ancestor
92704465|NCT03757403|Antimitotic Agents|antimitotic agents|mesh-ancestor
92704466|NCT03757403|Mitosis Modulators|mitosis modulators|mesh-ancestor
92704467|NCT03757403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704468|NCT03757403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704469|NCT03757403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704470|NCT00537342|Immunomodulating Agents|immunomodulating agents|mesh-list
92704471|NCT00537342|Immunologic Factors|immunologic factors|mesh-ancestor
92607916|NCT00133757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607917|NCT00133757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607918|NCT00133757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92607919|NCT00133757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92015199|NCT04222023|Antibodies|antibodies|mesh-list
92704472|NCT00537342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704473|NCT00537420|Sibutramine|sibutramine|mesh-list
92704487|NCT03534284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704488|NCT03534284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704489|NCT03534284|Serotonin Agents|serotonin agents|mesh-ancestor
92704490|NCT03534284|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92704491|NCT03534284|Antidepressive Agents|antidepressive agents|mesh-ancestor
92704492|NCT01254292|Levonorgestrel|levonorgestrel|mesh-list
92704493|NCT01254292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92704494|NCT01254292|Contraceptive Agents|contraceptive agents|mesh-ancestor
92704495|NCT01254292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92704496|NCT01254292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704497|NCT01254292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92704498|NCT01254292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92704499|NCT01254292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92704500|NCT04683458|Paclitaxel|paclitaxel|mesh-list
92704501|NCT04683458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92704502|NCT04683458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92704503|NCT04683458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704504|NCT04683458|Tubulin Modulators|tubulin modulators|mesh-ancestor
92704505|NCT04683458|Antimitotic Agents|antimitotic agents|mesh-ancestor
92704506|NCT04683458|Mitosis Modulators|mitosis modulators|mesh-ancestor
92704507|NCT04683458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704508|NCT01253317|Mecasermin|mecasermin|mesh-list
92704509|NCT01253317|Growth Substances|growth substances|mesh-ancestor
92704510|NCT01253317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704511|NCT00537537|Telbivudine|telbivudine|mesh-list
92704512|NCT00537537|Antiviral Agents|antiviral agents|mesh-ancestor
92704513|NCT00537537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704514|NCT00537537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92704515|NCT00537537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704516|NCT00537537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704517|NCT04319770|Hyaluronic Acid|hyaluronic acid|mesh-list
92704518|NCT04319770|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92704519|NCT04319770|Immunologic Factors|immunologic factors|mesh-ancestor
92704520|NCT04319770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704521|NCT04319770|Viscosupplements|viscosupplements|mesh-ancestor
92704522|NCT04319770|Protective Agents|protective agents|mesh-ancestor
92704523|NCT02722616|Pancrelipase|pancrelipase|mesh-list
92704524|NCT02722616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704525|NCT01253200|Acifluorfen|acifluorfen|mesh-list
92704526|NCT01253200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704527|NCT01253200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704528|NCT04515901|Lidocaine|lidocaine|mesh-list
92704529|NCT04515901|Anesthetics, Local|anesthetics, local|mesh-ancestor
92704530|NCT04515901|Anesthetics|anesthetics|mesh-ancestor
92704531|NCT04515901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704532|NCT04515901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704533|NCT04515901|Sensory System Agents|sensory system agents|mesh-ancestor
92704550|NCT02605421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92704552|NCT02605421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704553|NCT02605421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704554|NCT02605421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92704555|NCT02605421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92704556|NCT02605421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92704557|NCT02605421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92704558|NCT02605421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704559|NCT02605421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92704560|NCT04320589|Dexmedetomidine|dexmedetomidine|mesh-list
92704561|NCT04320589|Anesthetics|anesthetics|mesh-list
92704562|NCT04320589|Anesthetics, General|anesthetics, general|mesh-list
92704563|NCT04320589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92704564|NCT04320589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607920|NCT00133757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607921|NCT00144846|Albuterol|albuterol|mesh-list
92607922|NCT00144846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92607923|NCT00144846|Autonomic Agents|autonomic agents|mesh-ancestor
92607924|NCT00144846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607925|NCT00144846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607926|NCT00144846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92015200|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
92704565|NCT04320589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704566|NCT04320589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92704567|NCT04320589|Analgesics|analgesics|mesh-ancestor
92704568|NCT04320589|Sensory System Agents|sensory system agents|mesh-ancestor
92704569|NCT04320589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704570|NCT04320589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92704571|NCT04320589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92704572|NCT04320589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92704573|NCT04320589|Adrenergic Agents|adrenergic agents|mesh-ancestor
92704574|NCT04320589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704575|NCT04320589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704709|NCT03910998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704710|NCT03910998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704711|NCT04685148|Estradiol|estradiol|mesh-list
92704712|NCT04685148|Estrogens|estrogens|mesh-ancestor
92704713|NCT04685148|Hormones|hormones|mesh-ancestor
92372884|NCT01565616|Busulfan|busulfan|mesh-list
92704714|NCT04685148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704715|NCT04685148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704716|NCT02888548|Botulinum Toxins|botulinum toxins|mesh-list
92704717|NCT02888548|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92704718|NCT02888548|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92704719|NCT02888548|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92704720|NCT02888548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704721|NCT02888548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704722|NCT02888548|Cholinergic Agents|cholinergic agents|mesh-ancestor
92704723|NCT02888548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704733|NCT04246684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704735|NCT04246684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704736|NCT04246684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704737|NCT04246684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704738|NCT04246684|Immunologic Factors|immunologic factors|mesh-ancestor
92704739|NCT04246684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704740|NCT04246684|Antidotes|antidotes|mesh-ancestor
92704741|NCT04246684|Protective Agents|protective agents|mesh-ancestor
92704742|NCT04246684|Vitamin B Complex|vitamin b complex|mesh-ancestor
92704743|NCT04246684|Vitamins|vitamins|mesh-ancestor
92704744|NCT04246684|Micronutrients|micronutrients|mesh-ancestor
92704745|NCT04246684|Hematinics|hematinics|mesh-ancestor
92704746|NCT03883893|Acetaminophen|acetaminophen|mesh-list
92704747|NCT03883893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92704748|NCT03883893|Analgesics|analgesics|mesh-ancestor
92704749|NCT03883893|Sensory System Agents|sensory system agents|mesh-ancestor
92704750|NCT03883893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704751|NCT03883893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704752|NCT03883893|Antipyretics|antipyretics|mesh-ancestor
92704753|NCT00537732|Omeprazole|omeprazole|mesh-list
92704754|NCT00537732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92704755|NCT00537732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704756|NCT00537732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92704757|NCT00537732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704758|NCT00537732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124503|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124504|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
92124506|NCT02409186|Paclitaxel|paclitaxel|mesh-list
92704759|NCT04180436|Rivaroxaban|rivaroxaban|mesh-list
92704760|NCT04180436|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92704761|NCT04180436|Antithrombins|antithrombins|mesh-ancestor
92704762|NCT04180436|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92704763|NCT04180436|Protease Inhibitors|protease inhibitors|mesh-ancestor
92704764|NCT04180436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607927|NCT00144846|Respiratory System Agents|respiratory system agents|mesh-ancestor
92607928|NCT00144846|Tocolytic Agents|tocolytic agents|mesh-ancestor
92607929|NCT00144846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92015208|NCT03066115|Analgesics|analgesics|mesh-ancestor
92704765|NCT04180436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704766|NCT04180436|Anticoagulants|anticoagulants|mesh-ancestor
92704767|NCT01250119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92704768|NCT01250119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704769|NCT01250119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92704770|NCT01250119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704771|NCT01250119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704772|NCT04320277|Ritonavir|ritonavir|mesh-list
92704773|NCT04320277|Lopinavir|lopinavir|mesh-list
92704774|NCT04320277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92704775|NCT04320277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92704776|NCT04320277|Protease Inhibitors|protease inhibitors|mesh-ancestor
92704777|NCT04320277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704778|NCT04320277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704779|NCT04320277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92704780|NCT04320277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92704781|NCT04320277|Antiviral Agents|antiviral agents|mesh-ancestor
92704782|NCT04320277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704783|NCT04320277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92704784|NCT04320277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92704785|NCT01250002|Lidocaine|lidocaine|mesh-list
92704786|NCT01250002|Anesthetics, Local|anesthetics, local|mesh-ancestor
92704787|NCT01250002|Anesthetics|anesthetics|mesh-ancestor
92704788|NCT01250002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372892|NCT01565616|Alkylating Agents|alkylating agents|mesh-ancestor
92704789|NCT01250002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704803|NCT04157153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704804|NCT04157153|Immunologic Factors|immunologic factors|mesh-ancestor
92704805|NCT04157153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704807|NCT05329116|Pentoxifylline|pentoxifylline|mesh-list
92704808|NCT05329116|Anesthetics, Local|anesthetics, local|mesh-ancestor
92704809|NCT05329116|Anesthetics|anesthetics|mesh-ancestor
92704810|NCT05329116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704811|NCT05329116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704812|NCT05329116|Sensory System Agents|sensory system agents|mesh-ancestor
92704813|NCT05329116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704814|NCT05329116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92704815|NCT05329116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92704816|NCT05329116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92704817|NCT05329116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704818|NCT05329116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704819|NCT05329116|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92704820|NCT05329116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704821|NCT05329116|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92704822|NCT05329116|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92704823|NCT05329116|Protective Agents|protective agents|mesh-ancestor
92704824|NCT05329116|Vasodilator Agents|vasodilator agents|mesh-ancestor
92704825|NCT05329116|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92704826|NCT05329116|Antioxidants|antioxidants|mesh-ancestor
92704827|NCT00537888|Fluconazole|fluconazole|mesh-list
92704828|NCT00537888|Antifungal Agents|antifungal agents|mesh-ancestor
92704829|NCT00537888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704830|NCT00537888|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92704831|NCT00537888|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92704832|NCT00537888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704833|NCT00537888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704834|NCT00537888|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92704835|NCT00537888|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704836|NCT00537888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704837|NCT00537888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704838|NCT00537888|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92704839|NCT00537888|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92704840|NCT05264142|Voriconazole|voriconazole|mesh-list
92704841|NCT05264142|Fluvoxamine|fluvoxamine|mesh-list
92704842|NCT05264142|Omeprazole|omeprazole|mesh-list
92704843|NCT05264142|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92607930|NCT00144846|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92607931|NCT00144846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92607932|NCT00144846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92607933|NCT00144846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92607934|NCT00144846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92607935|NCT00144846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607936|NCT00133796|Trastuzumab|trastuzumab|mesh-list
92704844|NCT05264142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704845|NCT05264142|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92704846|NCT05264142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704847|NCT05264142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372909|NCT01566162|Serotonin Agents|serotonin agents|mesh-ancestor
92704867|NCT05264142|Antidepressive Agents|antidepressive agents|mesh-ancestor
92704868|NCT05264142|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92704869|NCT05264142|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92704871|NCT01246960|Fluorouracil|fluorouracil|mesh-list
92704872|NCT01246960|Oxaliplatin|oxaliplatin|mesh-list
92704873|NCT01246960|Ramucirumab|ramucirumab|mesh-list
92704874|NCT01246960|Antimetabolites|antimetabolites|mesh-ancestor
92704875|NCT01246960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704876|NCT01246960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704877|NCT01246960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704878|NCT01246960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704879|NCT01246960|Immunologic Factors|immunologic factors|mesh-ancestor
92704880|NCT01246960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704881|NCT01246960|Antidotes|antidotes|mesh-ancestor
92704882|NCT01246960|Protective Agents|protective agents|mesh-ancestor
92704883|NCT01246960|Vitamin B Complex|vitamin b complex|mesh-ancestor
92704884|NCT01246960|Vitamins|vitamins|mesh-ancestor
92704885|NCT01246960|Micronutrients|micronutrients|mesh-ancestor
92704886|NCT00544986|Anastrozole|anastrozole|mesh-list
92704887|NCT00544986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92704888|NCT00544986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704889|NCT00544986|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92704890|NCT00544986|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92704891|NCT00544986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704892|NCT00544986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704893|NCT00544986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92704894|NCT00544986|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704895|NCT00544986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704896|NCT00544986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704897|NCT03851588|Dolutegravir|dolutegravir|mesh-list
92704898|NCT03851588|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92704910|NCT01244620|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92704911|NCT01244620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92704912|NCT01244620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704913|NCT01244620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704914|NCT01244620|Urological Agents|urological agents|mesh-ancestor
92704915|NCT01244620|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92704916|NCT04319692|Acetic Acid|acetic acid|mesh-list
92704917|NCT04319692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92704918|NCT04319692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704919|NCT00545142|Valproic Acid|valproic acid|mesh-list
92704920|NCT00545142|Aripiprazole|aripiprazole|mesh-list
92704921|NCT00545142|Antidepressive Agents|antidepressive agents|mesh-ancestor
92704922|NCT00545142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704923|NCT00545142|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92704924|NCT00545142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92704925|NCT00545142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704926|NCT00545142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704927|NCT00545142|Dopamine Agonists|dopamine agonists|mesh-ancestor
92704928|NCT00545142|Dopamine Agents|dopamine agents|mesh-ancestor
92704929|NCT00545142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704930|NCT00545142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704931|NCT00545142|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92704932|NCT00545142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92704933|NCT00545142|Serotonin Agents|serotonin agents|mesh-ancestor
92607937|NCT00133796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92607938|NCT00133796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704934|NCT00545142|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92704935|NCT00545142|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92704936|NCT00545142|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92704937|NCT00545142|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92704938|NCT00545142|Anticonvulsants|anticonvulsants|mesh-ancestor
92704939|NCT00545142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704940|NCT00545142|GABA Agents|gaba agents|mesh-ancestor
92704941|NCT00545142|Antimanic Agents|antimanic agents|mesh-ancestor
92704942|NCT01267201|Methylprednisolone|methylprednisolone|mesh-list
92704943|NCT01267201|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92704944|NCT01267201|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92704945|NCT01267201|Prednisolone|prednisolone|mesh-list
92704946|NCT01267201|Prednisolone acetate|prednisolone acetate|mesh-list
92704947|NCT01267201|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92704948|NCT01267201|Prednisolone phosphate|prednisolone phosphate|mesh-list
92704949|NCT01267201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704950|NCT01267201|Antiemetics|antiemetics|mesh-ancestor
92704951|NCT01267201|Autonomic Agents|autonomic agents|mesh-ancestor
92704952|NCT01267201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704953|NCT01267201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704954|NCT01267201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704955|NCT01267201|Glucocorticoids|glucocorticoids|mesh-ancestor
92704956|NCT01267201|Hormones|hormones|mesh-ancestor
92704957|NCT01267201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704958|NCT01267201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92704959|NCT01267201|Protective Agents|protective agents|mesh-ancestor
92704960|NCT01267201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92704961|NCT01267201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704962|NCT03778931|Fulvestrant|fulvestrant|mesh-list
92704963|NCT03778931|Anastrozole|anastrozole|mesh-list
92095930|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704983|NCT03736616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92704984|NCT03736616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704986|NCT03736616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704987|NCT03736616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704988|NCT03736616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92704989|NCT03736616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92704990|NCT03736616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92704991|NCT03736616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704992|NCT03736616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704993|NCT03736616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704994|NCT03736616|Antimetabolites|antimetabolites|mesh-ancestor
92704995|NCT03736616|Antiviral Agents|antiviral agents|mesh-ancestor
92704996|NCT03736616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704997|NCT03736616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372935|NCT01577706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92704998|NCT03736616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92704999|NCT03736616|Alkylating Agents|alkylating agents|mesh-ancestor
92705000|NCT03736616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92705001|NCT03718403|Theophylline|theophylline|mesh-list
92705002|NCT03718403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92705003|NCT03718403|Autonomic Agents|autonomic agents|mesh-ancestor
92705004|NCT03718403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705005|NCT03718403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705006|NCT03718403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92705007|NCT03718403|Respiratory System Agents|respiratory system agents|mesh-ancestor
92705008|NCT03718403|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705009|NCT03718403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705010|NCT03718403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705011|NCT03718403|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705012|NCT03718403|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92705013|NCT03718403|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92705014|NCT03718403|Purinergic Agents|purinergic agents|mesh-ancestor
92705015|NCT03718403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705016|NCT00537966|Ritonavir|ritonavir|mesh-list
92705017|NCT00537966|Darunavir|darunavir|mesh-list
92705018|NCT00537966|Tenofovir|tenofovir|mesh-list
92705019|NCT00537966|Lamivudine|lamivudine|mesh-list
92705020|NCT00537966|Emtricitabine|emtricitabine|mesh-list
92705039|NCT00537966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92705040|NCT00537966|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92607939|NCT00133874|Retapamulin|retapamulin|mesh-list
92607940|NCT00133874|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92607941|NCT00133874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607942|NCT00141414|Pregabalin|pregabalin|mesh-list
92607943|NCT00141414|Analgesics|analgesics|mesh-ancestor
92705041|NCT00537966|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92705043|NCT01266967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705044|NCT01266967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705045|NCT01266967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705046|NCT01266967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705047|NCT03615326|Pembrolizumab|pembrolizumab|mesh-list
92705048|NCT03615326|Capecitabine|capecitabine|mesh-list
92705049|NCT03615326|Oxaliplatin|oxaliplatin|mesh-list
92705050|NCT03615326|Trastuzumab|trastuzumab|mesh-list
92705051|NCT03615326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705052|NCT03615326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92705053|NCT03615326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92705054|NCT03615326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705055|NCT03615326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92705056|NCT03615326|Antimetabolites|antimetabolites|mesh-ancestor
92705057|NCT00538005|Bevacizumab|bevacizumab|mesh-list
92705058|NCT00538005|Oxaliplatin|oxaliplatin|mesh-list
92705059|NCT00538005|Sorafenib|sorafenib|mesh-list
92705060|NCT00538005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92705061|NCT00538005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705062|NCT00538005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92705063|NCT00538005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92705064|NCT00538005|Growth Substances|growth substances|mesh-ancestor
92705065|NCT00538005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705066|NCT00538005|Growth Inhibitors|growth inhibitors|mesh-ancestor
92705067|NCT00538005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705068|NCT00538005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705069|NCT00538005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705070|NCT03610412|Magnesium Oxide|magnesium oxide|mesh-list
92705071|NCT03610412|Antacids|antacids|mesh-ancestor
92705072|NCT03610412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705073|NCT03610412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705074|NCT00538044|Simvastatin|simvastatin|mesh-list
92705075|NCT00538044|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92705076|NCT00538044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92705077|NCT00538044|Antimetabolites|antimetabolites|mesh-ancestor
92096052|NCT04130698|Nicotine|nicotine|mesh-list
92705093|NCT01266460|Immunologic Factors|immunologic factors|mesh-ancestor
92705094|NCT01266460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705095|NCT05119257|Antibodies|antibodies|mesh-list
92705096|NCT05119257|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92705097|NCT05119257|Immunologic Factors|immunologic factors|mesh-ancestor
92705098|NCT05119257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705099|NCT01266265|Treprostinil|treprostinil|mesh-list
92705100|NCT01266265|Bosentan|bosentan|mesh-list
92705101|NCT01266265|Ambrisentan|ambrisentan|mesh-list
92705102|NCT01266265|Epoprostenol|epoprostenol|mesh-list
92705103|NCT01266265|Sildenafil Citrate|sildenafil citrate|mesh-list
92705104|NCT01266265|Tadalafil|tadalafil|mesh-list
92705105|NCT01266265|Iloprost|iloprost|mesh-list
92705106|NCT01266265|Tezosentan|tezosentan|mesh-list
92705107|NCT01266265|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92705108|NCT01266265|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705109|NCT01266265|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705110|NCT01266265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705111|NCT01266265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705112|NCT01266265|Urological Agents|urological agents|mesh-ancestor
92705113|NCT01266265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92705114|NCT01266265|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92705115|NCT01266265|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92705116|NCT03338387|Acipimox|acipimox|mesh-list
92705117|NCT03338387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92705118|NCT03338387|Antimetabolites|antimetabolites|mesh-ancestor
92705119|NCT03338387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705120|NCT03338387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92705121|NCT05112549|Nivolumab|nivolumab|mesh-list
92705122|NCT05112549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92705123|NCT05112549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705124|NCT05112549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92607944|NCT00141414|Sensory System Agents|sensory system agents|mesh-ancestor
92607945|NCT00141414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92607946|NCT00141414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607947|NCT00141414|Anticonvulsants|anticonvulsants|mesh-ancestor
92607948|NCT00141414|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92607949|NCT00141414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705125|NCT05112549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705126|NCT03268382|Doxorubicin|doxorubicin|mesh-list
92372985|NCT05565924|Biguanides|biguanides|mesh-list
92705127|NCT03268382|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92705128|NCT03268382|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92705129|NCT03268382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705130|NCT03268382|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92705131|NCT03268382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92705132|NCT03268382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705133|NCT03268382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705134|NCT01266148|Cyclosporine|cyclosporine|mesh-list
92705135|NCT01266148|Mycophenolic Acid|mycophenolic acid|mesh-list
92705136|NCT01266148|Everolimus|everolimus|mesh-list
92705137|NCT01266148|Cyclosporins|cyclosporins|mesh-list
92705138|NCT01266148|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92705147|NCT01266148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705148|NCT01266148|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92705149|NCT01266148|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92705150|NCT01266148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705151|NCT01266148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705152|NCT01266148|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92705153|NCT01266148|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92705154|NCT01266148|Antitubercular Agents|antitubercular agents|mesh-ancestor
92705155|NCT01266148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705156|NCT00538239|Sirolimus|sirolimus|mesh-list
92705157|NCT00538239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705158|NCT00538239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705159|NCT00538239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92705160|NCT00538239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705161|NCT00538239|Antifungal Agents|antifungal agents|mesh-ancestor
92705162|NCT00538239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705163|NCT00538239|Immunologic Factors|immunologic factors|mesh-ancestor
92705164|NCT00538239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705165|NCT00538317|Tirofiban|tirofiban|mesh-list
92705166|NCT00538317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92705167|NCT00538317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92705168|NCT00538317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705169|NCT00538317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92705170|NCT01265953|Sulforaphane|sulforaphane|mesh-list
92705171|NCT01265953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92705172|NCT01265953|Protective Agents|protective agents|mesh-ancestor
92705173|NCT01265953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705174|NCT01265953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705175|NCT01265875|Secretin|secretin|mesh-list
92705176|NCT01265875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705177|NCT01265875|Hormones|hormones|mesh-ancestor
92705178|NCT01265875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705179|NCT01265875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705180|NCT00538395|Cyclophosphamide|cyclophosphamide|mesh-list
92705181|NCT00538395|Doxorubicin|doxorubicin|mesh-list
92705182|NCT00538395|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92705183|NCT00538395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705184|NCT00538395|Immunologic Factors|immunologic factors|mesh-ancestor
92705185|NCT00538395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705186|NCT00538395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705187|NCT00538395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92705188|NCT00538395|Alkylating Agents|alkylating agents|mesh-ancestor
92373003|NCT05564442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705189|NCT00538395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705190|NCT00538395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705191|NCT00538395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92705192|NCT00538395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92705193|NCT00538395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92705194|NCT00538395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607950|NCT00141414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607951|NCT00141414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92607952|NCT00141414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92607953|NCT00141414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92705195|NCT00538395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705196|NCT01265563|Acetylcysteine|acetylcysteine|mesh-list
92705197|NCT01265563|Silybin|silybin|mesh-list
92705198|NCT01265563|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92705199|NCT01265563|Antiviral Agents|antiviral agents|mesh-ancestor
92705200|NCT01265563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705201|NCT01265563|Expectorants|expectorants|mesh-ancestor
92705202|NCT01265563|Respiratory System Agents|respiratory system agents|mesh-ancestor
92705203|NCT01265563|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92705204|NCT01265563|Antioxidants|antioxidants|mesh-ancestor
92096168|NCT04613453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92705217|NCT01265056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92705218|NCT01265056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92705219|NCT01265056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705220|NCT01265056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92705221|NCT01265056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92705222|NCT01265056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92705223|NCT01265056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705224|NCT01265056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705225|NCT01265056|Antimanic Agents|antimanic agents|mesh-ancestor
92705226|NCT02942498|Vitamins|vitamins|mesh-list
92705227|NCT02942498|Vitamin E|vitamin e|mesh-list
92705228|NCT02942498|Micronutrients|micronutrients|mesh-ancestor
92705229|NCT02942498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705230|NCT02942498|Antioxidants|antioxidants|mesh-ancestor
92705231|NCT02942498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705232|NCT02942498|Protective Agents|protective agents|mesh-ancestor
92705233|NCT00545961|Amoxicillin|amoxicillin|mesh-list
92705234|NCT00545961|Clavulanic Acid|clavulanic acid|mesh-list
92705235|NCT00545961|Clavulanic Acids|clavulanic acids|mesh-list
92705236|NCT00545961|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92705237|NCT00545961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705238|NCT00545961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705239|NCT00545961|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92705240|NCT00545961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705241|NCT00545961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705242|NCT01264939|Omalizumab|omalizumab|mesh-list
92705243|NCT01264939|Diphenhydramine|diphenhydramine|mesh-list
92705244|NCT01264939|Promethazine|promethazine|mesh-list
92705245|NCT01264939|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92705246|NCT01264939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92705247|NCT01264939|Histamine Antagonists|histamine antagonists|mesh-list
92705248|NCT01264939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92705249|NCT01264939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92705250|NCT01264939|Respiratory System Agents|respiratory system agents|mesh-ancestor
92705251|NCT01264939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92705252|NCT01264939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92705253|NCT01264939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705254|NCT01264939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705255|NCT01264939|Anesthetics, Local|anesthetics, local|mesh-ancestor
92705256|NCT01264939|Anesthetics|anesthetics|mesh-ancestor
92705257|NCT01264939|Sensory System Agents|sensory system agents|mesh-ancestor
92705258|NCT01264939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705259|NCT01264939|Antiemetics|antiemetics|mesh-ancestor
92705260|NCT01264939|Autonomic Agents|autonomic agents|mesh-ancestor
92705261|NCT01264939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705262|NCT01264939|Histamine Agents|histamine agents|mesh-ancestor
92705263|NCT01264939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705264|NCT01264939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705265|NCT01264939|Antipruritics|antipruritics|mesh-ancestor
92705266|NCT01264939|Dermatologic Agents|dermatologic agents|mesh-ancestor
92096240|NCT01893827|Naltrexone|naltrexone|mesh-list
92705277|NCT00546039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705278|NCT00546039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705279|NCT00546039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705280|NCT00546039|Phytoestrogens|phytoestrogens|mesh-ancestor
92705281|NCT00546039|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92607954|NCT00141414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92607955|NCT00141414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92607956|NCT00145002|Lenograstim|lenograstim|mesh-list
92705282|NCT00546039|Estrogens|estrogens|mesh-ancestor
92705283|NCT00546039|Hormones|hormones|mesh-ancestor
92125029|NCT02571634|Fentanyl|fentanyl|mesh-list
92705284|NCT00546039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705285|NCT01264081|Lapatinib|lapatinib|mesh-list
92705286|NCT01264081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705287|NCT01264081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705288|NCT01264081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705289|NCT01264081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705290|NCT02711969|Apatinib|apatinib|mesh-list
92705291|NCT02711969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705292|NCT02711969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705293|NCT02711969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705294|NCT02711969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705295|NCT01263925|Pentoxifylline|pentoxifylline|mesh-list
92705296|NCT01263925|Alprostadil|alprostadil|mesh-list
92705297|NCT01263925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705298|NCT01263925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705299|NCT01263925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705300|NCT01263925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92705301|NCT01263925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92705302|NCT01263925|Protective Agents|protective agents|mesh-ancestor
92705303|NCT01263925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705304|NCT01263925|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705305|NCT01263925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92705306|NCT01263925|Antioxidants|antioxidants|mesh-ancestor
92705307|NCT01263925|Urological Agents|urological agents|mesh-ancestor
92705308|NCT04323631|Hydroxychloroquine|hydroxychloroquine|mesh-list
92705309|NCT04323631|Antimalarials|antimalarials|mesh-ancestor
92705310|NCT04323631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92705311|NCT04323631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92705312|NCT04323631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705313|NCT04323631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705314|NCT04323631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705315|NCT04323631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705316|NCT00546234|Tiotropium Bromide|tiotropium bromide|mesh-list
92705317|NCT00546234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92705318|NCT00546234|Autonomic Agents|autonomic agents|mesh-ancestor
92705319|NCT00546234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705320|NCT00546234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705321|NCT00546234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92705322|NCT00546234|Respiratory System Agents|respiratory system agents|mesh-ancestor
92705323|NCT00546234|Parasympatholytics|parasympatholytics|mesh-ancestor
92705324|NCT00546234|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92705325|NCT00546234|Cholinergic Agents|cholinergic agents|mesh-ancestor
92705326|NCT00546234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705327|NCT00546234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705328|NCT01263769|Axitinib|axitinib|mesh-list
92705329|NCT01263769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096297|NCT04415567|Lenvatinib|lenvatinib|mesh-list
92705341|NCT02623439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705342|NCT02623439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92705344|NCT00539331|Carboplatin|carboplatin|mesh-list
92705345|NCT00539331|Cediranib|cediranib|mesh-list
92705346|NCT00539331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92373034|NCT05672472|Sivelestat|sivelestat|mesh-list
92705347|NCT00539331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705348|NCT00539331|Tubulin Modulators|tubulin modulators|mesh-ancestor
92705349|NCT00539331|Antimitotic Agents|antimitotic agents|mesh-ancestor
92705350|NCT00539331|Mitosis Modulators|mitosis modulators|mesh-ancestor
92705351|NCT00539331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705352|NCT00539331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705353|NCT00539331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705354|NCT02236013|Cytarabine|cytarabine|mesh-list
92705355|NCT02236013|Daunorubicin|daunorubicin|mesh-list
92705356|NCT02236013|Idarubicin|idarubicin|mesh-list
92705357|NCT02236013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92705358|NCT02236013|Antimetabolites|antimetabolites|mesh-ancestor
92705359|NCT02236013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705361|NCT02236013|Antiviral Agents|antiviral agents|mesh-ancestor
92705362|NCT02236013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92607957|NCT00145002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92607958|NCT00145002|Immunologic Factors|immunologic factors|mesh-ancestor
92607959|NCT00145002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607961|NCT00141492|Androgens|androgens|mesh-ancestor
92607962|NCT00141492|Hormones|hormones|mesh-ancestor
92705363|NCT02236013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705364|NCT02236013|Immunologic Factors|immunologic factors|mesh-ancestor
92705365|NCT02236013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705366|NCT02236013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92705367|NCT02236013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92705368|NCT02236013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92705369|NCT02236013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705370|NCT00539409|Insulin|insulin|mesh-list
92705371|NCT00539409|Insulin Aspart|insulin aspart|mesh-list
92705372|NCT00539409|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92705373|NCT00539409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705374|NCT00539409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705375|NCT01263691|Vaccines|vaccines|mesh-list
92705376|NCT01263691|Immunologic Factors|immunologic factors|mesh-ancestor
92705377|NCT01263691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705378|NCT02178410|Vitamin D|vitamin d|mesh-list
92705379|NCT02178410|Ergocalciferols|ergocalciferols|mesh-list
92705380|NCT02178410|Cholecalciferol|cholecalciferol|mesh-list
92705381|NCT02178410|Vitamins|vitamins|mesh-list
92705382|NCT02178410|Micronutrients|micronutrients|mesh-ancestor
92705383|NCT02178410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705384|NCT02178410|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92705385|NCT02178410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92705386|NCT00539448|Insulin|insulin|mesh-list
92705387|NCT00539448|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92705388|NCT00539448|Insulin Glargine|insulin glargine|mesh-list
92705389|NCT00539448|Insulin glulisine|insulin glulisine|mesh-list
92705390|NCT00539448|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705391|NCT00539448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705392|NCT05541484|Dapagliflozin|dapagliflozin|mesh-list
92705393|NCT05541484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92096359|NCT03014830|Antimetabolites|antimetabolites|mesh-ancestor
92705407|NCT01715714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92705408|NCT01715714|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92705409|NCT01715714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705410|NCT01540253|Docetaxel|docetaxel|mesh-list
92705411|NCT01540253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705412|NCT01540253|Tubulin Modulators|tubulin modulators|mesh-ancestor
92705413|NCT01540253|Antimitotic Agents|antimitotic agents|mesh-ancestor
92705414|NCT01540253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92705415|NCT01540253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705416|NCT01497392|Gemcitabine|gemcitabine|mesh-list
92705417|NCT01497392|Capecitabine|capecitabine|mesh-list
92705418|NCT01497392|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92705419|NCT01497392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92705420|NCT01497392|Antimetabolites|antimetabolites|mesh-ancestor
92705421|NCT01497392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705422|NCT01497392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705423|NCT01497392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705424|NCT01497392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705425|NCT01310192|Choline|choline|mesh-list
92705426|NCT01310192|Lipotropic Agents|lipotropic agents|mesh-ancestor
92705427|NCT01310192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92705428|NCT01310192|Antimetabolites|antimetabolites|mesh-ancestor
92705429|NCT01310192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705430|NCT01310192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705431|NCT01310192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92705432|NCT01310192|Nootropic Agents|nootropic agents|mesh-ancestor
92705433|NCT00539565|Prednisolone|prednisolone|mesh-list
92705434|NCT00539565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705435|NCT00539565|Glucocorticoids|glucocorticoids|mesh-ancestor
92705436|NCT00539565|Hormones|hormones|mesh-ancestor
92705437|NCT00539565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705438|NCT00539565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705439|NCT00539565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92705440|NCT00539565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607963|NCT00141492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607964|NCT00141492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607965|NCT00141531|Apaziquone|apaziquone|mesh-list
92607966|NCT00141531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705441|NCT00539799|Prednisolone|prednisolone|mesh-list
92705442|NCT00539799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705443|NCT00539799|Glucocorticoids|glucocorticoids|mesh-ancestor
92705444|NCT00539799|Hormones|hormones|mesh-ancestor
92705445|NCT00539799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705446|NCT00539799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705447|NCT00539799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92705448|NCT00539799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705449|NCT00945152|Vancomycin|vancomycin|mesh-list
92705450|NCT00945152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705451|NCT00945152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705452|NCT00546507|Celecoxib|celecoxib|mesh-list
92705453|NCT00546507|Diclofenac|diclofenac|mesh-list
92705454|NCT00546507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92705455|NCT00546507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92705473|NCT00546546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92705475|NCT00546546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705476|NCT00546546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705477|NCT00546546|Dermatologic Agents|dermatologic agents|mesh-ancestor
92705478|NCT00546546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705479|NCT00546546|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92705480|NCT00546546|Immunologic Factors|immunologic factors|mesh-ancestor
92705481|NCT00546546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705482|NCT00546546|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92705483|NCT00659711|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92705484|NCT00659711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705485|NCT00659711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705486|NCT00659711|Incretins|incretins|mesh-ancestor
92705487|NCT00659711|Hormones|hormones|mesh-ancestor
92705488|NCT00659711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705489|NCT00659711|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92705490|NCT00659711|Protease Inhibitors|protease inhibitors|mesh-ancestor
92705491|NCT00659711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373050|NCT05672394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92705492|NCT00659711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705493|NCT02581007|Cyclophosphamide|cyclophosphamide|mesh-list
92705494|NCT02581007|Melphalan|melphalan|mesh-list
92705495|NCT02581007|Fludarabine|fludarabine|mesh-list
92705496|NCT02581007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705497|NCT02581007|Immunologic Factors|immunologic factors|mesh-ancestor
92705498|NCT02581007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705499|NCT02581007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705500|NCT02581007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92705501|NCT02581007|Alkylating Agents|alkylating agents|mesh-ancestor
92705502|NCT02581007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705503|NCT02581007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705504|NCT02581007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92705505|NCT00546741|Metformin|metformin|mesh-list
92705506|NCT00546741|Dapagliflozin|dapagliflozin|mesh-list
92705507|NCT00546741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705508|NCT00546741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705509|NCT00546741|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92125286|NCT02395926|Choline|choline|mesh-list
92096484|NCT04399083|Caffeine|caffeine|mesh-list
92705526|NCT00546936|Ranibizumab|ranibizumab|mesh-list
92705527|NCT00546936|Verteporfin|verteporfin|mesh-list
92705528|NCT00546936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92705529|NCT00546936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92705530|NCT00546936|Growth Substances|growth substances|mesh-ancestor
92705531|NCT00546936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705532|NCT00546936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92705533|NCT00546936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705534|NCT00546936|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92705535|NCT00546936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92705536|NCT02231723|Leucovorin|leucovorin|mesh-list
92705537|NCT02231723|Paclitaxel|paclitaxel|mesh-list
92705538|NCT02231723|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92705539|NCT02231723|Gemcitabine|gemcitabine|mesh-list
92607967|NCT00134069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92607968|NCT00134069|Cetuximab|cetuximab|mesh-list
92607969|NCT00134069|Irinotecan|irinotecan|mesh-list
92705540|NCT02231723|Fluorouracil|fluorouracil|mesh-list
92705541|NCT02231723|Oxaliplatin|oxaliplatin|mesh-list
92705542|NCT02231723|Irinotecan|irinotecan|mesh-list
92705543|NCT02231723|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92705544|NCT02231723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705545|NCT02231723|Tubulin Modulators|tubulin modulators|mesh-ancestor
92705546|NCT02231723|Antimitotic Agents|antimitotic agents|mesh-ancestor
92705547|NCT02231723|Mitosis Modulators|mitosis modulators|mesh-ancestor
92705548|NCT02231723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705549|NCT02231723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92705550|NCT02231723|Antimetabolites|antimetabolites|mesh-ancestor
92705551|NCT02231723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705552|NCT02231723|Immunologic Factors|immunologic factors|mesh-ancestor
92705553|NCT02231723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705554|NCT02231723|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92705555|NCT02231723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92705556|NCT02231723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705557|NCT02231723|Antidotes|antidotes|mesh-ancestor
92705558|NCT02231723|Protective Agents|protective agents|mesh-ancestor
92705559|NCT02231723|Vitamin B Complex|vitamin b complex|mesh-ancestor
92705560|NCT02231723|Vitamins|vitamins|mesh-ancestor
92705561|NCT02231723|Micronutrients|micronutrients|mesh-ancestor
92705562|NCT01263496|Alogliptin|alogliptin|mesh-list
92705563|NCT01263496|Voglibose|voglibose|mesh-list
92705564|NCT01263496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705565|NCT01263496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705566|NCT01263496|Incretins|incretins|mesh-ancestor
92705567|NCT01263496|Hormones|hormones|mesh-ancestor
92705568|NCT01263496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705582|NCT04681937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705584|NCT04681937|Autonomic Agents|autonomic agents|mesh-ancestor
92705585|NCT04681937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705586|NCT04681937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705587|NCT04681937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705588|NCT04681937|Glucocorticoids|glucocorticoids|mesh-ancestor
92705590|NCT04681937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705591|NCT04681937|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92705592|NCT04681937|Protective Agents|protective agents|mesh-ancestor
92705593|NCT04681937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92705594|NCT04681937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705595|NCT04681937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92705596|NCT04681937|Immunologic Factors|immunologic factors|mesh-ancestor
92705597|NCT04681937|Viscosupplements|viscosupplements|mesh-ancestor
92705598|NCT00547053|Amiloride|amiloride|mesh-list
92705599|NCT00547053|Diuretics|diuretics|mesh-ancestor
92705600|NCT00547053|Natriuretic Agents|natriuretic agents|mesh-ancestor
92705601|NCT00547053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705602|NCT00547053|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92705603|NCT00547053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92705604|NCT00547053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705605|NCT00547053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705606|NCT00547053|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92705607|NCT00547053|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92705608|NCT00547092|Sildenafil Citrate|sildenafil citrate|mesh-list
92705609|NCT00547092|Tadalafil|tadalafil|mesh-list
92705610|NCT00547092|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705611|NCT00547092|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92705612|NCT00547092|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705613|NCT00547092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705614|NCT00547092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705615|NCT00547092|Urological Agents|urological agents|mesh-ancestor
92705616|NCT00547131|Temozolomide|temozolomide|mesh-list
92705617|NCT00547131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92705618|NCT00547131|Alkylating Agents|alkylating agents|mesh-ancestor
92705619|NCT00547131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705620|NCT00547131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705621|NCT01964495|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92705622|NCT01964495|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92705623|NCT01964495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705624|NCT01964495|Antitubercular Agents|antitubercular agents|mesh-ancestor
92705625|NCT00547170|Doxycycline|doxycycline|mesh-list
92705626|NCT00547170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705627|NCT00547170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705646|NCT00547287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705647|NCT00547287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705648|NCT00547287|Urological Agents|urological agents|mesh-ancestor
92705649|NCT01263106|Theophylline|theophylline|mesh-list
92705650|NCT01263106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92705651|NCT01263106|Autonomic Agents|autonomic agents|mesh-ancestor
92705652|NCT01263106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705653|NCT01263106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705654|NCT01263106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92705655|NCT01263106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92705656|NCT01263106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705657|NCT01263106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705658|NCT01263106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705659|NCT01263106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705660|NCT01263106|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92705661|NCT01263106|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92705662|NCT01263106|Purinergic Agents|purinergic agents|mesh-ancestor
92705663|NCT01263106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705664|NCT01263028|Ergocalciferols|ergocalciferols|mesh-list
92705665|NCT01263028|Vitamin D|vitamin d|mesh-list
92705666|NCT01263028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92705667|NCT01263028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705668|NCT01263028|Vitamins|vitamins|mesh-ancestor
92705669|NCT01263028|Micronutrients|micronutrients|mesh-ancestor
92705670|NCT01263028|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92705671|NCT00547443|Paclitaxel|paclitaxel|mesh-list
92705672|NCT00547443|Carboplatin|carboplatin|mesh-list
92705673|NCT00547443|Sorafenib|sorafenib|mesh-list
92705674|NCT00547443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92705675|NCT00547443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705676|NCT00547443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92705677|NCT00547443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92705678|NCT00547443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92705679|NCT00547443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705680|NCT00547443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705681|NCT00547443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705682|NCT00547560|Begacestat|begacestat|mesh-list
92705683|NCT00547560|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92705684|NCT00547560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705685|NCT00547560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705707|NCT02908295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92705708|NCT02908295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705710|NCT02908295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705711|NCT02908295|Oxytocics|oxytocics|mesh-ancestor
92705712|NCT03809442|Dexamethasone|dexamethasone|mesh-list
92705713|NCT03809442|Midazolam|midazolam|mesh-list
92705714|NCT03809442|Dexmedetomidine|dexmedetomidine|mesh-list
92705715|NCT03809442|Ketamine|ketamine|mesh-list
92705716|NCT03809442|Tramadol|tramadol|mesh-list
92705717|NCT03809442|Ropivacaine|ropivacaine|mesh-list
92705718|NCT03809442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705719|NCT03809442|Antiemetics|antiemetics|mesh-ancestor
92705720|NCT03809442|Autonomic Agents|autonomic agents|mesh-ancestor
92705721|NCT03809442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705722|NCT03809442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705723|NCT03809442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705724|NCT03809442|Glucocorticoids|glucocorticoids|mesh-ancestor
92705725|NCT03809442|Hormones|hormones|mesh-ancestor
92705726|NCT03809442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705727|NCT03809442|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92705728|NCT03809442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705729|NCT03809442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92705730|NCT03809442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705731|NCT03809442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92705732|NCT03809442|Analgesics|analgesics|mesh-ancestor
92705733|NCT03809442|Sensory System Agents|sensory system agents|mesh-ancestor
92705734|NCT03809442|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92705735|NCT03809442|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92705736|NCT03809442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92705737|NCT03809442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92705738|NCT03809442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705739|NCT03809442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705758|NCT00547989|Ropivacaine|ropivacaine|mesh-list
92607971|NCT00134069|Antibodies|antibodies|mesh-list
92607972|NCT00134069|Immunoglobulins|immunoglobulins|mesh-list
92607973|NCT00134069|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92607974|NCT00134069|Immunologic Factors|immunologic factors|mesh-ancestor
92607975|NCT00134069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705759|NCT00547989|Anesthetics, Local|anesthetics, local|mesh-ancestor
92705760|NCT00547989|Anesthetics|anesthetics|mesh-ancestor
92705761|NCT00547989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705762|NCT00547989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705763|NCT00547989|Sensory System Agents|sensory system agents|mesh-ancestor
92705764|NCT00547989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705765|NCT00534807|Rifampin|rifampin|mesh-list
92705766|NCT00534807|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92705767|NCT00534807|Antitubercular Agents|antitubercular agents|mesh-ancestor
92705768|NCT00534807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705769|NCT00534807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705770|NCT00534807|Leprostatic Agents|leprostatic agents|mesh-ancestor
92705771|NCT00534807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92705772|NCT00534807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705773|NCT00534807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705774|NCT00534807|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92705775|NCT00534807|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92705776|NCT00534807|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92705777|NCT00534807|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92705778|NCT00534807|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92705779|NCT00534807|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92705780|NCT00534846|Toremifene|toremifene|mesh-list
92705781|NCT00534846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92705782|NCT00534846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705783|NCT00534846|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92705784|NCT00534846|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92705785|NCT00534846|Hormone Antagonists|hormone antagonists|mesh-ancestor
92705786|NCT00534846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705787|NCT00534846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705788|NCT00534846|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92705789|NCT00548067|Amlodipine|amlodipine|mesh-list
92705790|NCT00548067|Valsartan|valsartan|mesh-list
92705791|NCT00548067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92705792|NCT00548067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92705793|NCT00548067|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92705794|NCT00548067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705795|NCT00548067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705796|NCT00548067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92705807|NCT02907749|Hormone Antagonists|hormone antagonists|mesh-ancestor
92705808|NCT02907749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125563|NCT02393586|Amoxicillin|amoxicillin|mesh-list
92705810|NCT02907749|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92705811|NCT02907749|Diuretics|diuretics|mesh-ancestor
92705812|NCT02907749|Natriuretic Agents|natriuretic agents|mesh-ancestor
92705813|NCT02907749|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92705814|NCT02907749|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92705815|NCT02907749|Adrenergic Agents|adrenergic agents|mesh-ancestor
92705816|NCT02907749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705817|NCT02907749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705818|NCT02907749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92705819|NCT02907749|Antioxidants|antioxidants|mesh-ancestor
92373117|NCT03729258|Analgesics|analgesics|mesh-ancestor
92705820|NCT02907749|Protective Agents|protective agents|mesh-ancestor
92705821|NCT02907749|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92705822|NCT02907749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705823|NCT02907749|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92705824|NCT02907749|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705825|NCT02907749|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92705826|NCT02907749|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92705828|NCT02907593|Calfactant|calfactant|mesh-list
92705829|NCT02907593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705830|NCT02907593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92607976|NCT00134069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607977|NCT00134069|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92607978|NCT00134069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92607979|NCT00134069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92607980|NCT00134069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92607981|NCT00134069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92607982|NCT00141570|Methyltestosterone|methyltestosterone|mesh-list
92705831|NCT02907593|Autonomic Agents|autonomic agents|mesh-ancestor
92705832|NCT02907593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705833|NCT02907593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705834|NCT02907593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92705835|NCT02907593|Respiratory System Agents|respiratory system agents|mesh-ancestor
92705836|NCT02907593|Glucocorticoids|glucocorticoids|mesh-ancestor
92705837|NCT02907593|Hormones|hormones|mesh-ancestor
92705838|NCT02907593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705839|NCT02907593|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92705840|NCT00548301|Cyclosporine|cyclosporine|mesh-list
92705841|NCT00548301|Cyclosporins|cyclosporins|mesh-list
92705842|NCT00548301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705843|NCT00548301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705844|NCT00548301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705845|NCT00548301|Immunologic Factors|immunologic factors|mesh-ancestor
92705846|NCT00548301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705847|NCT00548301|Antifungal Agents|antifungal agents|mesh-ancestor
92705848|NCT00548301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705849|NCT00548301|Dermatologic Agents|dermatologic agents|mesh-ancestor
92705850|NCT00548301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705851|NCT00548301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92705852|NCT02907710|Endostar protein|endostar protein|mesh-list
92705853|NCT02907710|Endostatins|endostatins|mesh-list
92705854|NCT02907710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92705855|NCT02907710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92705856|NCT02907710|Growth Substances|growth substances|mesh-ancestor
92705857|NCT02907710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705858|NCT02907710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92705859|NCT02907710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705860|NCT03781362|Capecitabine|capecitabine|mesh-list
92705875|NCT04972617|Furosemide|furosemide|mesh-list
92705876|NCT04972617|Diuretics|diuretics|mesh-ancestor
92705877|NCT04972617|Natriuretic Agents|natriuretic agents|mesh-ancestor
92705878|NCT04972617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705879|NCT04972617|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92705880|NCT04972617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705881|NCT04972617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705882|NCT04682210|Bevacizumab|bevacizumab|mesh-list
92705883|NCT04682210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92705884|NCT04682210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705885|NCT04682210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92705886|NCT04682210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92705887|NCT04682210|Growth Substances|growth substances|mesh-ancestor
92705888|NCT04682210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705889|NCT04682210|Growth Inhibitors|growth inhibitors|mesh-ancestor
92705891|NCT04682132|Immunologic Factors|immunologic factors|mesh-ancestor
92373128|NCT03355170|Antiemetics|antiemetics|mesh-ancestor
92705892|NCT04682132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705893|NCT02907554|Cyclosporine|cyclosporine|mesh-list
92705894|NCT02907554|Cyclosporins|cyclosporins|mesh-list
92705895|NCT02907554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705896|NCT02907554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705897|NCT02907554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705898|NCT02907554|Immunologic Factors|immunologic factors|mesh-ancestor
92705899|NCT02907554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705900|NCT02907554|Antifungal Agents|antifungal agents|mesh-ancestor
92705901|NCT02907554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705902|NCT02907554|Dermatologic Agents|dermatologic agents|mesh-ancestor
92705903|NCT02907554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705904|NCT02907554|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92705905|NCT02907632|Metoclopramide|metoclopramide|mesh-list
92062082|NCT00179465|GABA Agents|gaba agents|mesh-ancestor
92705906|NCT02907632|Antiemetics|antiemetics|mesh-ancestor
92705907|NCT02907632|Autonomic Agents|autonomic agents|mesh-ancestor
92705908|NCT02907632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705909|NCT02907632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705910|NCT02907632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92705911|NCT02907632|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92705912|NCT02907632|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92705913|NCT02907632|Dopamine Agents|dopamine agents|mesh-ancestor
92705914|NCT02907632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92705915|NCT02907632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705916|NCT02907437|Minocycline|minocycline|mesh-list
92705917|NCT02907437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705918|NCT02907437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705919|NCT01262872|Vaccines|vaccines|mesh-list
92705920|NCT01262872|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92705921|NCT01262872|Immunologic Factors|immunologic factors|mesh-ancestor
92705932|NCT01262677|Pregabalin|pregabalin|mesh-list
92705933|NCT01262677|Analgesics|analgesics|mesh-ancestor
92705934|NCT01262677|Sensory System Agents|sensory system agents|mesh-ancestor
92705935|NCT01262677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705936|NCT01262677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705937|NCT01262677|Anticonvulsants|anticonvulsants|mesh-ancestor
92705938|NCT01262677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92705939|NCT01262677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92705940|NCT01262677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705941|NCT01262677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92705942|NCT01262677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92705943|NCT01262677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92705944|NCT01262677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705945|NCT01262677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92705946|NCT02899364|Sodium thiosulfate|sodium thiosulfate|mesh-list
92705947|NCT02899364|Antidotes|antidotes|mesh-ancestor
92705948|NCT02899364|Protective Agents|protective agents|mesh-ancestor
92705949|NCT02899364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705950|NCT02899364|Antioxidants|antioxidants|mesh-ancestor
92705951|NCT02899364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705952|NCT02899364|Antitubercular Agents|antitubercular agents|mesh-ancestor
92705953|NCT02899364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92705954|NCT02899364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125707|NCT00367276|Natriuretic Agents|natriuretic agents|mesh-ancestor
92125708|NCT02546986|Pembrolizumab|pembrolizumab|mesh-list
92125709|NCT02546986|Azacitidine|azacitidine|mesh-list
92705955|NCT02899364|Chelating Agents|chelating agents|mesh-ancestor
92705956|NCT02899364|Sequestering Agents|sequestering agents|mesh-ancestor
92705957|NCT04206865|Valsartan|valsartan|mesh-list
92705958|NCT04206865|Vasodilator Agents|vasodilator agents|mesh-list
92705959|NCT04206865|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92705960|NCT04206865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92705961|NCT04206865|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92705962|NCT04206865|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92705963|NCT04206865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705964|NCT00535080|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92705965|NCT00535080|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92705966|NCT00535080|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92705967|NCT00535080|Dermatologic Agents|dermatologic agents|mesh-ancestor
92705968|NCT01262638|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92705969|NCT01262638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92705970|NCT01262638|Antimetabolites|antimetabolites|mesh-ancestor
92705971|NCT01262638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705972|NCT01262638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92705973|NCT01262638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705974|NCT01262638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705975|NCT01262638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705976|NCT00535119|Paclitaxel|paclitaxel|mesh-list
92705977|NCT00535119|Carboplatin|carboplatin|mesh-list
92705978|NCT00535119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92705979|NCT00535119|Veliparib|veliparib|mesh-list
92705980|NCT00535119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92705981|NCT00535119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705982|NCT00535119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706010|NCT04207450|Glutaral|glutaral|mesh-list
92706011|NCT04207450|Disinfectants|disinfectants|mesh-ancestor
92607984|NCT00141570|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
92706012|NCT04207450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706013|NCT04070443|Imatinib Mesylate|imatinib mesylate|mesh-list
92706014|NCT04070443|Ponatinib|ponatinib|mesh-list
92706015|NCT04070443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706016|NCT04070443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706017|NCT04070443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706018|NCT04070443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706019|NCT04043494|Cytarabine|cytarabine|mesh-list
92706020|NCT04043494|Dexamethasone|dexamethasone|mesh-list
92706021|NCT04043494|Prednisone|prednisone|mesh-list
92706022|NCT04043494|Prednisolone|prednisolone|mesh-list
92706023|NCT04043494|Cyclophosphamide|cyclophosphamide|mesh-list
92706024|NCT04043494|Ifosfamide|ifosfamide|mesh-list
92706025|NCT04043494|Doxorubicin|doxorubicin|mesh-list
92706026|NCT04043494|Methotrexate|methotrexate|mesh-list
92706027|NCT04043494|Vincristine|vincristine|mesh-list
92706028|NCT04043494|Daunorubicin|daunorubicin|mesh-list
92706029|NCT04043494|Asparaginase|asparaginase|mesh-list
92706030|NCT04043494|Mercaptopurine|mercaptopurine|mesh-list
92706031|NCT04043494|Thioguanine|thioguanine|mesh-list
92706032|NCT04043494|Pegaspargase|pegaspargase|mesh-list
92706033|NCT04043494|Vindesine|vindesine|mesh-list
92097013|NCT00638157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706046|NCT04043494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706047|NCT04043494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92706048|NCT04043494|Glucocorticoids|glucocorticoids|mesh-ancestor
92706049|NCT04043494|Hormones|hormones|mesh-ancestor
92706050|NCT04043494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706051|NCT04043494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92706052|NCT04043494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92706053|NCT04043494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92706054|NCT04043494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92706055|NCT04043494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706056|NCT04043494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92706057|NCT04043494|Abortifacient Agents|abortifacient agents|mesh-ancestor
92706058|NCT04043494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706059|NCT04043494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92706060|NCT04043494|Antimetabolites|antimetabolites|mesh-ancestor
92706061|NCT04043494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92706062|NCT04043494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92706063|NCT04043494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706064|NCT04043494|Antiviral Agents|antiviral agents|mesh-ancestor
92706065|NCT04043494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706066|NCT04043494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92706067|NCT04043494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706068|NCT04043494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706069|NCT04043494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706070|NCT02899286|BCT-100|bct-100|mesh-list
92706071|NCT02899286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706072|NCT04322422|Montelukast|montelukast|mesh-list
92706073|NCT04322422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92706074|NCT04322422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92706075|NCT04322422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92706076|NCT04322422|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706077|NCT04322422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706078|NCT04322422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706079|NCT04322422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92706080|NCT04322422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92706081|NCT04322422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706082|NCT02899169|Tretinoin|tretinoin|mesh-list
92706083|NCT02899169|Hydroxyurea|hydroxyurea|mesh-list
92706084|NCT02899169|Arsenic Trioxide|arsenic trioxide|mesh-list
92706085|NCT02899169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706086|NCT02899169|Keratolytic Agents|keratolytic agents|mesh-ancestor
92706087|NCT02899169|Dermatologic Agents|dermatologic agents|mesh-ancestor
92706088|NCT02899169|Antisickling Agents|antisickling agents|mesh-ancestor
92706089|NCT02899169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706090|NCT02899169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706091|NCT02899169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706092|NCT00548964|Ketamine|ketamine|mesh-list
92706093|NCT00548964|Lithium Carbonate|lithium carbonate|mesh-list
92706094|NCT00548964|Analgesics|analgesics|mesh-ancestor
92097063|NCT01082380|Crizotinib|crizotinib|mesh-list
92706105|NCT00548964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706106|NCT00548964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706107|NCT00548964|Antidepressive Agents|antidepressive agents|mesh-ancestor
92607985|NCT00141570|Testosterone|testosterone|mesh-list
92607986|NCT00141570|Testosterone undecanoate|testosterone undecanoate|mesh-list
92607987|NCT00141570|Testosterone enanthate|testosterone enanthate|mesh-list
92607988|NCT00141570|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92607989|NCT00141570|Hormones|hormones|mesh-ancestor
92015258|NCT01364649|Vortioxetine|vortioxetine|mesh-list
92706108|NCT00548964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92706109|NCT00548964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706110|NCT00548964|Antimanic Agents|antimanic agents|mesh-ancestor
92706111|NCT00548964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92706112|NCT00535353|Irinotecan|irinotecan|mesh-list
92706113|NCT00535353|Olaparib|olaparib|mesh-list
92706114|NCT00535353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92706115|NCT00535353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92706116|NCT00535353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706117|NCT00535353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706118|NCT00535353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706119|NCT00535353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92706120|NCT02898779|Primaquine|primaquine|mesh-list
92706121|NCT02898779|Antimalarials|antimalarials|mesh-ancestor
92706122|NCT02898779|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92706123|NCT02898779|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92706124|NCT02898779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706125|NCT00549120|Propranolol|propranolol|mesh-list
92706126|NCT00549120|Albuterol|albuterol|mesh-list
92706127|NCT00549120|Ipratropium|ipratropium|mesh-list
92706128|NCT00549120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92706129|NCT00549120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92706130|NCT00549120|Adrenergic Agents|adrenergic agents|mesh-ancestor
92706131|NCT00549120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706132|NCT00549120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706133|NCT00549120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706134|NCT00549120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92706135|NCT00549120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92706136|NCT00549120|Vasodilator Agents|vasodilator agents|mesh-ancestor
92706137|NCT00549120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92706138|NCT00549120|Autonomic Agents|autonomic agents|mesh-ancestor
92706139|NCT00549120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706140|NCT00549120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92706141|NCT00549120|Respiratory System Agents|respiratory system agents|mesh-ancestor
92706142|NCT00549120|Tocolytic Agents|tocolytic agents|mesh-ancestor
92706143|NCT00549120|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706144|NCT00549120|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92706145|NCT00549120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92706146|NCT00549120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92706147|NCT00549120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92706148|NCT00549120|Cholinergic Agents|cholinergic agents|mesh-ancestor
92706149|NCT04680884|Antifungal Agents|antifungal agents|mesh-list
92706150|NCT04680884|Clotrimazole|clotrimazole|mesh-list
92706151|NCT04680884|Miconazole|miconazole|mesh-list
92706152|NCT04680884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706153|NCT04680884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92706154|NCT04680884|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92706155|NCT04680884|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92706156|NCT04680884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706157|NCT04680884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706158|NCT04680884|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92706176|NCT00535509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706177|NCT00535509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706178|NCT01262365|Epratuzumab|epratuzumab|mesh-list
92706179|NCT01262365|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706180|NCT01262365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706181|NCT03244176|Avelumab|avelumab|mesh-list
92706182|NCT03244176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706183|NCT03244176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706184|NCT00535665|Vaccines|vaccines|mesh-list
92706185|NCT00535665|Immunologic Factors|immunologic factors|mesh-ancestor
92706186|NCT00535665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706187|NCT03971110|Goserelin|goserelin|mesh-list
92706188|NCT03971110|Bicalutamide|bicalutamide|mesh-list
92706189|NCT03971110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92607990|NCT00141570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92607991|NCT00141570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92607992|NCT00141570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92607993|NCT00141570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706190|NCT03971110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706191|NCT03971110|Androgen Antagonists|androgen antagonists|mesh-ancestor
92706192|NCT03971110|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706193|NCT03971110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706194|NCT03971110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706195|NCT01262287|Dutasteride|dutasteride|mesh-list
92706196|NCT01262287|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92706197|NCT01262287|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92706198|NCT01262287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706199|NCT01262287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706200|NCT01262287|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706201|NCT01262287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706202|NCT01262287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706203|NCT01262092|Buprenorphine|buprenorphine|mesh-list
92706204|NCT01262092|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92706205|NCT01262092|Narcotics|narcotics|mesh-ancestor
92706206|NCT01262092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706207|NCT01262092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706208|NCT01262092|Analgesics|analgesics|mesh-ancestor
92706209|NCT01262092|Sensory System Agents|sensory system agents|mesh-ancestor
92706210|NCT01262092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706211|NCT01262092|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92706212|NCT03898180|Pembrolizumab|pembrolizumab|mesh-list
92706213|NCT03898180|Lenvatinib|lenvatinib|mesh-list
92706214|NCT03898180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706242|NCT03088410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706243|NCT03088410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706244|NCT03088410|Antiviral Agents|antiviral agents|mesh-ancestor
92706245|NCT03088410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706246|NCT03088410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92706247|NCT03088410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92706248|NCT03088410|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92706249|NCT03088410|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92706251|NCT02897765|Poly ICLC|poly iclc|mesh-list
92706252|NCT02897765|Immunologic Factors|immunologic factors|mesh-ancestor
92706253|NCT02897765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706254|NCT02897765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126021|NCT02686164|Anesthetics|anesthetics|mesh-ancestor
92706255|NCT02897765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706256|NCT02897765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92706257|NCT02897765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706258|NCT02897765|Interferon Inducers|interferon inducers|mesh-ancestor
92706275|NCT04321642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706276|NCT02897219|Ipragliflozin|ipragliflozin|mesh-list
92706277|NCT02897219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92706278|NCT02897219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706279|NCT02897219|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92706280|NCT02897219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706281|NCT04321720|Mechlorethamine|mechlorethamine|mesh-list
92706282|NCT04321720|Alkylating Agents|alkylating agents|mesh-ancestor
92706283|NCT04321720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706284|NCT04321720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706285|NCT04321720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706286|NCT04321837|Vitamin D|vitamin d|mesh-list
92706287|NCT04321837|Cholecalciferol|cholecalciferol|mesh-list
92706288|NCT04321837|Ibandronic Acid|ibandronic acid|mesh-list
92706289|NCT04321837|Vitamins|vitamins|mesh-ancestor
92706290|NCT04321837|Micronutrients|micronutrients|mesh-ancestor
92706291|NCT04321837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706292|NCT04321837|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92706293|NCT04321837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92706294|NCT02896829|Imatinib Mesylate|imatinib mesylate|mesh-list
92706295|NCT02896829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92607995|NCT00141570|Androgens|androgens|mesh-ancestor
92607996|NCT00134147|Insulin|insulin|mesh-list
92607997|NCT00134147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92607998|NCT00134147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706296|NCT02896829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706297|NCT02896829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706298|NCT02896829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706299|NCT00549666|Moxifloxacin|moxifloxacin|mesh-list
92706300|NCT00549666|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92706301|NCT00549666|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92706302|NCT00549666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92706303|NCT00549666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92706304|NCT00549666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706305|NCT00549666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706306|NCT00549666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92706307|NCT00549666|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92706308|NCT00549666|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92706309|NCT00549666|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92706310|NCT00549666|Adrenergic Agents|adrenergic agents|mesh-ancestor
92706311|NCT00549666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706312|NCT00549666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706313|NCT00549666|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92706314|NCT00549666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92706315|NCT00549666|Serotonin Agents|serotonin agents|mesh-ancestor
92706316|NCT00549666|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92706325|NCT00549666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92706326|NCT00549666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706327|NCT00549666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92706328|NCT00549666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92706329|NCT00549666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706330|NCT00549666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706331|NCT04680923|Bupivacaine|bupivacaine|mesh-list
92706332|NCT04680923|Anesthetics, Local|anesthetics, local|mesh-ancestor
92706333|NCT04680923|Anesthetics|anesthetics|mesh-ancestor
92706334|NCT04680923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706335|NCT04680923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706336|NCT04680923|Sensory System Agents|sensory system agents|mesh-ancestor
92706337|NCT04680923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706338|NCT00551538|Insulin Glargine|insulin glargine|mesh-list
92706339|NCT00551538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92706340|NCT00551538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706341|NCT03694522|Bemarituzumab|bemarituzumab|mesh-list
92706342|NCT03694522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706343|NCT03694522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706344|NCT04891419|Lidocaine|lidocaine|mesh-list
92706345|NCT04891419|Anesthetics, Local|anesthetics, local|mesh-ancestor
92706346|NCT04891419|Anesthetics|anesthetics|mesh-ancestor
92706347|NCT04891419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706348|NCT04891419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706349|NCT04891419|Sensory System Agents|sensory system agents|mesh-ancestor
92706350|NCT04891419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706351|NCT04891419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92706352|NCT04891419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92706353|NCT04891419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92706354|NCT04891419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92706355|NCT04891419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706356|NCT00551577|Carboplatin|carboplatin|mesh-list
92706357|NCT00551577|Docetaxel|docetaxel|mesh-list
92706358|NCT00551577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706359|NCT00551577|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706360|NCT00551577|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706361|NCT00551577|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706362|NCT00551577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706363|NCT04207723|Paroxetine|paroxetine|mesh-list
92706364|NCT04207723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92706365|NCT04207723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92706366|NCT04207723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92607999|NCT00403988|Oxaliplatin|oxaliplatin|mesh-list
92608000|NCT00403988|Vinorelbine|vinorelbine|mesh-list
92608001|NCT00403988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015270|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92706367|NCT04207723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706368|NCT04207723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706369|NCT04207723|Serotonin Agents|serotonin agents|mesh-ancestor
92706370|NCT04207723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706371|NCT04207723|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92706372|NCT04207723|Antidepressive Agents|antidepressive agents|mesh-ancestor
92706373|NCT04207723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92706374|NCT04207723|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92706375|NCT04207723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92706376|NCT04207723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706377|NCT04321096|Camostat|camostat|mesh-list
92706378|NCT04321096|Protease Inhibitors|protease inhibitors|mesh-ancestor
92706379|NCT04321096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706380|NCT04321096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097341|NCT01047358|Exemestane|exemestane|mesh-list
92706387|NCT03556696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706388|NCT03556696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92706389|NCT03556696|Anesthetics, General|anesthetics, general|mesh-ancestor
92706390|NCT03556696|Anesthetics|anesthetics|mesh-ancestor
92706391|NCT03556696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92706392|NCT03556696|Narcotics|narcotics|mesh-ancestor
92706393|NCT03556696|Analgesics|analgesics|mesh-ancestor
92706394|NCT03556696|Sensory System Agents|sensory system agents|mesh-ancestor
92706395|NCT03556696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706396|NCT04320706|Oxytocin|oxytocin|mesh-list
92706397|NCT04320706|Oxytocics|oxytocics|mesh-ancestor
92706398|NCT04320706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706399|NCT04320706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706400|NCT03482479|Naltrexone|naltrexone|mesh-list
92706401|NCT03482479|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92706402|NCT03482479|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92706403|NCT03482479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706404|NCT03482479|Sensory System Agents|sensory system agents|mesh-ancestor
92706405|NCT03482479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706406|NCT00553709|Nicotine|nicotine|mesh-list
92706407|NCT00553709|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92706408|NCT00553709|Autonomic Agents|autonomic agents|mesh-ancestor
92706409|NCT00553709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706410|NCT00553709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706411|NCT00553709|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92706412|NCT00553709|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92706413|NCT00553709|Cholinergic Agents|cholinergic agents|mesh-ancestor
92706414|NCT00553709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706415|NCT00553709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706416|NCT00551733|Paclitaxel|paclitaxel|mesh-list
92706417|NCT00551733|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92706418|NCT00551733|Carboplatin|carboplatin|mesh-list
92706419|NCT00551733|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92706420|NCT00551733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92706421|NCT00551733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706422|NCT00551733|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706423|NCT00551733|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706424|NCT00551733|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706425|NCT00551733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706426|NCT02896205|Mycophenolic Acid|mycophenolic acid|mesh-list
92706427|NCT02896205|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92706428|NCT02896205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706429|NCT02896205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92706430|NCT02896205|Antitubercular Agents|antitubercular agents|mesh-ancestor
92706431|NCT02896205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92706432|NCT02896205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706433|NCT02896205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706434|NCT02896205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706435|NCT04922424|Atorvastatin|atorvastatin|mesh-list
92706436|NCT04922424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92706437|NCT04922424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92706438|NCT04922424|Antimetabolites|antimetabolites|mesh-ancestor
92373209|NCT04508166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92706439|NCT04922424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608002|NCT00403988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92608003|NCT00403988|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706440|NCT04922424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92706441|NCT04922424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92706442|NCT04922424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706443|NCT00553748|Alovudine|alovudine|mesh-list
92706444|NCT00553748|Antiviral Agents|antiviral agents|mesh-ancestor
92706445|NCT00553748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706447|NCT00551850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706448|NCT00551850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706449|NCT00551850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706450|NCT00551850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706451|NCT00550095|Valsartan|valsartan|mesh-list
92706463|NCT00551889|Alkylating Agents|alkylating agents|mesh-ancestor
92706464|NCT00551889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706465|NCT00551889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706466|NCT00551889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92706467|NCT00551889|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92706468|NCT00551889|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92706469|NCT00551889|Analgesics|analgesics|mesh-ancestor
92706470|NCT00551889|Sensory System Agents|sensory system agents|mesh-ancestor
92706471|NCT00551889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706472|NCT00551889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92706473|NCT00551889|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92706474|NCT00551889|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92706475|NCT00551889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706476|NCT03455764|Trametinib|trametinib|mesh-list
92706477|NCT03455764|Dabrafenib|dabrafenib|mesh-list
92706478|NCT03455764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706479|NCT03455764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706480|NCT03455764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706481|NCT03455764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706482|NCT04902495|Pemetrexed|pemetrexed|mesh-list
92706483|NCT04902495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706484|NCT04902495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706485|NCT04902495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706486|NCT04902495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92706487|NCT04902495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706488|NCT03433183|Sirolimus|sirolimus|mesh-list
92706489|NCT03433183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92706490|NCT03433183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706491|NCT03433183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92706492|NCT03433183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706493|NCT03433183|Antifungal Agents|antifungal agents|mesh-ancestor
92706494|NCT03433183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706495|NCT03433183|Immunologic Factors|immunologic factors|mesh-ancestor
92706496|NCT03433183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706497|NCT02895659|Norepinephrine|norepinephrine|mesh-list
92706498|NCT02895659|Epinephrine|epinephrine|mesh-list
92706499|NCT02895659|Racepinephrine|racepinephrine|mesh-list
92706500|NCT02895659|Epinephryl borate|epinephryl borate|mesh-list
92706501|NCT02895659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92706502|NCT02895659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92706503|NCT02895659|Adrenergic Agents|adrenergic agents|mesh-ancestor
92706504|NCT02895659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706505|NCT02895659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706506|NCT02895659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706507|NCT02895659|Sympathomimetics|sympathomimetics|mesh-ancestor
92706508|NCT02895659|Autonomic Agents|autonomic agents|mesh-ancestor
92706509|NCT02895659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706510|NCT02895659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92706511|NCT02895659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92706512|NCT02895659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92706513|NCT02895659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92706532|NCT03391882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706534|NCT00550329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92706535|NCT00550329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706536|NCT00550485|Escitalopram|escitalopram|mesh-list
92706537|NCT00550485|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92706538|NCT00550485|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92706539|NCT00550485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608004|NCT00403988|Antimitotic Agents|antimitotic agents|mesh-ancestor
92608005|NCT00403988|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608006|NCT00403988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608007|NCT00134186|Motexafin gadolinium|motexafin gadolinium|mesh-list
92706540|NCT00550485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706541|NCT00550485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706542|NCT00550485|Serotonin Agents|serotonin agents|mesh-ancestor
92706543|NCT00550485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706544|NCT00550563|Cholecalciferol|cholecalciferol|mesh-list
92706545|NCT00550563|Vitamin D|vitamin d|mesh-list
92706546|NCT00550563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92706547|NCT00550563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706548|NCT00550563|Vitamins|vitamins|mesh-ancestor
92706549|NCT00550563|Micronutrients|micronutrients|mesh-ancestor
92706550|NCT00550563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92706551|NCT02895191|Urinastatin|urinastatin|mesh-list
92706552|NCT02895191|Trypsin Inhibitors|trypsin inhibitors|mesh-list
92706553|NCT02895191|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92706554|NCT02895191|Protease Inhibitors|protease inhibitors|mesh-ancestor
92706555|NCT02895191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706556|NCT02895191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706557|NCT04680650|Anesthetics|anesthetics|mesh-list
92706558|NCT04680650|Propofol|propofol|mesh-list
92706559|NCT04680650|Sevoflurane|sevoflurane|mesh-list
92706560|NCT04680650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706561|NCT04680650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706562|NCT04680650|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92706563|NCT04680650|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92706564|NCT04680650|Anesthetics, General|anesthetics, general|mesh-ancestor
92706565|NCT04680650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92706566|NCT04680650|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92706567|NCT02895113|Aspirin|aspirin|mesh-list
92706568|NCT02895113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92706569|NCT02895113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92706570|NCT02895113|Analgesics|analgesics|mesh-ancestor
92706579|NCT02895113|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92706580|NCT02895113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92706581|NCT02895113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706582|NCT02895113|Antipyretics|antipyretics|mesh-ancestor
92706583|NCT00552630|Penicillamine|penicillamine|mesh-list
92706584|NCT00552630|Antidotes|antidotes|mesh-ancestor
92706585|NCT00552630|Protective Agents|protective agents|mesh-ancestor
92706586|NCT00552630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706587|NCT00552630|Chelating Agents|chelating agents|mesh-ancestor
92706588|NCT00552630|Sequestering Agents|sequestering agents|mesh-ancestor
92706589|NCT00552630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706590|NCT00552630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706591|NCT02894957|Varenicline|varenicline|mesh-list
92706592|NCT02894957|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92706593|NCT02894957|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92706594|NCT02894957|Cholinergic Agents|cholinergic agents|mesh-ancestor
92706595|NCT02894957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373236|NCT03624270|Vitamins|vitamins|mesh-ancestor
92706596|NCT02894957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706597|NCT02894957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706598|NCT00550992|Leucovorin|leucovorin|mesh-list
92706599|NCT00550992|Cytarabine|cytarabine|mesh-list
92706600|NCT00550992|Cyclosporine|cyclosporine|mesh-list
92706601|NCT00550992|Prednisone|prednisone|mesh-list
92706602|NCT00550992|Prednisolone|prednisolone|mesh-list
92706603|NCT00550992|Hydrocortisone|hydrocortisone|mesh-list
92706604|NCT00550992|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92706605|NCT00550992|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92706606|NCT00550992|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92706607|NCT00550992|Cyclophosphamide|cyclophosphamide|mesh-list
92706608|NCT00550992|Melphalan|melphalan|mesh-list
92706609|NCT00550992|Busulfan|busulfan|mesh-list
92706610|NCT00550992|Methotrexate|methotrexate|mesh-list
92706611|NCT00550992|Etoposide|etoposide|mesh-list
92706612|NCT00550992|Vincristine|vincristine|mesh-list
92706613|NCT00550992|Daunorubicin|daunorubicin|mesh-list
92706614|NCT00550992|Asparaginase|asparaginase|mesh-list
92706615|NCT00550992|Mitoxantrone|mitoxantrone|mesh-list
92706616|NCT00550992|Mercaptopurine|mercaptopurine|mesh-list
92706617|NCT00550992|Pegaspargase|pegaspargase|mesh-list
92706618|NCT00550992|Thioguanine|thioguanine|mesh-list
92706619|NCT00550992|Cyclosporins|cyclosporins|mesh-list
92608008|NCT00134186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608009|NCT00134186|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92608010|NCT00134186|Dermatologic Agents|dermatologic agents|mesh-ancestor
92608011|NCT00141648|Prednisolone|prednisolone|mesh-list
92608012|NCT00141648|Cyclophosphamide|cyclophosphamide|mesh-list
92608013|NCT00141648|Doxorubicin|doxorubicin|mesh-list
92608014|NCT00141648|Vincristine|vincristine|mesh-list
92608015|NCT00141648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608016|NCT00141648|Immunologic Factors|immunologic factors|mesh-ancestor
92015278|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
92706620|NCT00550992|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92706621|NCT00550992|Levoleucovorin|levoleucovorin|mesh-list
92706622|NCT00550992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706623|NCT00550992|Immunologic Factors|immunologic factors|mesh-ancestor
92706624|NCT00550992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706625|NCT00550992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126390|NCT05339542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92126391|NCT05339542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92706626|NCT00550992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92126396|NCT05339542|Antiemetics|antiemetics|mesh-ancestor
92706627|NCT00550992|Alkylating Agents|alkylating agents|mesh-ancestor
92706628|NCT00550992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706629|NCT00550992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706630|NCT00550992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92706631|NCT00550992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92706632|NCT00550992|Glucocorticoids|glucocorticoids|mesh-ancestor
92706634|NCT00550992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706635|NCT00550992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92706636|NCT00550992|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92706637|NCT00550992|Abortifacient Agents|abortifacient agents|mesh-ancestor
92706646|NCT00550992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92706647|NCT00550992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92706648|NCT00550992|Antiviral Agents|antiviral agents|mesh-ancestor
92706649|NCT00550992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706650|NCT00550992|Antidotes|antidotes|mesh-ancestor
92706651|NCT00550992|Protective Agents|protective agents|mesh-ancestor
92706652|NCT00550992|Vitamin B Complex|vitamin b complex|mesh-ancestor
92706653|NCT00550992|Vitamins|vitamins|mesh-ancestor
92706654|NCT00550992|Micronutrients|micronutrients|mesh-ancestor
92706655|NCT00550992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706656|NCT00550992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706657|NCT00550992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706658|NCT00550992|Antifungal Agents|antifungal agents|mesh-ancestor
92706659|NCT00550992|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92706660|NCT00550992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373250|NCT03455088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706661|NCT00550992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92706662|NCT00550992|Analgesics|analgesics|mesh-ancestor
92706663|NCT00550992|Sensory System Agents|sensory system agents|mesh-ancestor
92706664|NCT02895074|Proxymetacaine|proxymetacaine|mesh-list
92706665|NCT02895074|Tropicamide|tropicamide|mesh-list
92706666|NCT02895074|Mydriatics|mydriatics|mesh-ancestor
92706667|NCT02895074|Autonomic Agents|autonomic agents|mesh-ancestor
92706668|NCT02895074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706669|NCT02895074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706670|NCT02895074|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92706671|NCT02895074|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92706672|NCT02895074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92706673|NCT02895074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706674|NCT02895074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706675|NCT02895074|Anesthetics, Local|anesthetics, local|mesh-ancestor
92706676|NCT02895074|Anesthetics|anesthetics|mesh-ancestor
92706677|NCT02895074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706678|NCT02895074|Sensory System Agents|sensory system agents|mesh-ancestor
92706679|NCT02894918|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92706680|NCT02894918|Antiviral Agents|antiviral agents|mesh-ancestor
92706681|NCT02894918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706682|NCT00551109|SA 4503|sa 4503|mesh-list
92706683|NCT00551109|Nootropic Agents|nootropic agents|mesh-ancestor
92608017|NCT00141648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608018|NCT00141648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608019|NCT00141648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92608020|NCT00141648|Alkylating Agents|alkylating agents|mesh-ancestor
92608021|NCT00141648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706684|NCT00551265|Cyclophosphamide|cyclophosphamide|mesh-list
92706685|NCT00551265|Oregovomab|oregovomab|mesh-list
92706686|NCT00551265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92706687|NCT00551265|Antibodies|antibodies|mesh-list
92706688|NCT00551265|Immunoglobulins|immunoglobulins|mesh-list
92706689|NCT00551265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92706690|NCT00551265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706691|NCT00551265|Immunologic Factors|immunologic factors|mesh-ancestor
92706692|NCT00551265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706693|NCT00551265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706694|NCT00551265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706695|NCT00551265|Alkylating Agents|alkylating agents|mesh-ancestor
92706696|NCT00551265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706697|NCT00551265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706698|NCT00551265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92706699|NCT02894606|Thymoglobulin|thymoglobulin|mesh-list
92706700|NCT02894606|Basiliximab|basiliximab|mesh-list
92706701|NCT02894606|Immunologic Factors|immunologic factors|mesh-ancestor
92706702|NCT02894606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706703|NCT02894606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706704|NCT00551343|Exenatide|exenatide|mesh-list
92706705|NCT00551343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92706706|NCT00551343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706724|NCT02894645|Cytarabine|cytarabine|mesh-list
92706725|NCT02894645|Dexamethasone|dexamethasone|mesh-list
92706726|NCT02894645|Prednisolone|prednisolone|mesh-list
92706727|NCT02894645|Cyclophosphamide|cyclophosphamide|mesh-list
92706728|NCT02894645|Doxorubicin|doxorubicin|mesh-list
92706729|NCT02894645|Methotrexate|methotrexate|mesh-list
92706730|NCT02894645|Fludarabine|fludarabine|mesh-list
92706731|NCT02894645|Vincristine|vincristine|mesh-list
92706732|NCT02894645|Daunorubicin|daunorubicin|mesh-list
92706733|NCT02894645|Asparaginase|asparaginase|mesh-list
92706734|NCT02894645|Mercaptopurine|mercaptopurine|mesh-list
92706735|NCT02894645|Thioguanine|thioguanine|mesh-list
92706736|NCT02894645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706737|NCT02894645|Immunologic Factors|immunologic factors|mesh-ancestor
92706738|NCT02894645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706739|NCT02894645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706740|NCT02894645|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706741|NCT02894645|Alkylating Agents|alkylating agents|mesh-ancestor
92706742|NCT02894645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706743|NCT02894645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706744|NCT02894645|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92706745|NCT02894645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92706746|NCT02894645|Antiemetics|antiemetics|mesh-ancestor
92706747|NCT02894645|Autonomic Agents|autonomic agents|mesh-ancestor
92706748|NCT02894645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706749|NCT02894645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92706750|NCT02894645|Glucocorticoids|glucocorticoids|mesh-ancestor
92706751|NCT02894645|Hormones|hormones|mesh-ancestor
92706752|NCT02894645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706753|NCT02894645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92706754|NCT02894645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92706755|NCT02894645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92706756|NCT02894645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92706757|NCT02894645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706758|NCT02894645|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92706759|NCT02894645|Abortifacient Agents|abortifacient agents|mesh-ancestor
92706760|NCT02894645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706761|NCT02894645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92706762|NCT02894645|Antimetabolites|antimetabolites|mesh-ancestor
92706763|NCT02894645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92706774|NCT00552747|Antimetabolites|antimetabolites|mesh-ancestor
92706775|NCT00552747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706776|NCT00552747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92608023|NCT00141648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92608024|NCT00141648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92015290|NCT02588261|Gefitinib|gefitinib|mesh-list
92706777|NCT05427617|Fulvestrant|fulvestrant|mesh-list
92706778|NCT05427617|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92706779|NCT05427617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92706780|NCT05427617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126540|NCT01566149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92706781|NCT05427617|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92706782|NCT05427617|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92706783|NCT05427617|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706784|NCT05427617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706785|NCT05427617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706786|NCT05427617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706787|NCT05427617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706788|NCT05427500|Bupivacaine|bupivacaine|mesh-list
92706789|NCT05427500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92706790|NCT05427500|Anesthetics|anesthetics|mesh-ancestor
92706791|NCT05427500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706792|NCT05427500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706793|NCT05427500|Sensory System Agents|sensory system agents|mesh-ancestor
92706794|NCT05427500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706795|NCT05427383|Paclitaxel|paclitaxel|mesh-list
92706796|NCT05427383|Docetaxel|docetaxel|mesh-list
92706797|NCT05427383|Irinotecan|irinotecan|mesh-list
92706798|NCT05427383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92706799|NCT05427383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706800|NCT05427383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706801|NCT05427383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706802|NCT05427383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706803|NCT05427383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373259|NCT03355560|Nivolumab|nivolumab|mesh-list
92706804|NCT05427383|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92706805|NCT05427383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92706806|NCT05427383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706807|NCT05427305|Bevacizumab|bevacizumab|mesh-list
92706808|NCT05427305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706809|NCT05427305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706810|NCT05427305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92706811|NCT05427305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92706812|NCT05427305|Growth Substances|growth substances|mesh-ancestor
92706813|NCT05427305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706814|NCT05427305|Growth Inhibitors|growth inhibitors|mesh-ancestor
92706815|NCT01099449|Oxaliplatin|oxaliplatin|mesh-list
92706816|NCT01099449|Magnesium Sulfate|magnesium sulfate|mesh-list
92706817|NCT01099449|Calcium|calcium|mesh-list
92706818|NCT01099449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92706819|NCT01099449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706820|NCT01099449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706821|NCT01099449|Analgesics|analgesics|mesh-ancestor
92706822|NCT01099449|Sensory System Agents|sensory system agents|mesh-ancestor
92706823|NCT01099449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706824|NCT01099449|Anesthetics|anesthetics|mesh-ancestor
92706825|NCT01099449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706826|NCT01099449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92706827|NCT01099449|Anticonvulsants|anticonvulsants|mesh-ancestor
92706844|NCT01234402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92706846|NCT01234402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706847|NCT01234402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706848|NCT01260922|Donepezil|donepezil|mesh-list
92706849|NCT01260922|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92706850|NCT01260922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706851|NCT01260922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706852|NCT01260922|Cholinergic Agents|cholinergic agents|mesh-ancestor
92706853|NCT01260922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706854|NCT01260922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706855|NCT01260922|Nootropic Agents|nootropic agents|mesh-ancestor
92706857|NCT01212094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706858|NCT01212094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706859|NCT01212094|Immunologic Factors|immunologic factors|mesh-ancestor
92608025|NCT00141648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92608026|NCT00141648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608027|NCT00141648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706860|NCT01212094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706861|NCT01212094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706862|NCT04369794|BCG Vaccine|bcg vaccine|mesh-list
92706863|NCT04369794|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92706864|NCT04369794|Immunologic Factors|immunologic factors|mesh-ancestor
92706865|NCT04369794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706866|NCT05409885|Anesthetics|anesthetics|mesh-list
92706867|NCT05409885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706868|NCT05409885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706869|NCT00552864|Ropivacaine|ropivacaine|mesh-list
92706870|NCT00552864|Levobupivacaine|levobupivacaine|mesh-list
92706871|NCT00552864|Anesthetics, Local|anesthetics, local|mesh-ancestor
92706872|NCT00552864|Anesthetics|anesthetics|mesh-ancestor
92706873|NCT00552864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706874|NCT00552864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706875|NCT00552864|Sensory System Agents|sensory system agents|mesh-ancestor
92706876|NCT00552864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706877|NCT01211665|Methylprednisolone|methylprednisolone|mesh-list
92706878|NCT01211665|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92706879|NCT01211665|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92706880|NCT01211665|Prednisolone|prednisolone|mesh-list
92706881|NCT01211665|Prednisolone acetate|prednisolone acetate|mesh-list
92706882|NCT01211665|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92706883|NCT01211665|Prednisolone phosphate|prednisolone phosphate|mesh-list
92706884|NCT01211665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92706885|NCT01211665|Antiemetics|antiemetics|mesh-ancestor
92706886|NCT01211665|Autonomic Agents|autonomic agents|mesh-ancestor
92706887|NCT01211665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706903|NCT04401176|Sensory System Agents|sensory system agents|mesh-ancestor
92706904|NCT04401176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706905|NCT04401176|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92706906|NCT04401176|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92706907|NCT04401176|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92706908|NCT04401176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92706909|NCT04401176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706910|NCT04401176|Anticoagulants|anticoagulants|mesh-ancestor
92706911|NCT04401176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92706912|NCT04401176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92706913|NCT01232491|Insulin Detemir|insulin detemir|mesh-list
92706914|NCT01232491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92706915|NCT01232491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706916|NCT04335305|Pembrolizumab|pembrolizumab|mesh-list
92706917|NCT04335305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706918|NCT04335305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706919|NCT04335305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92706920|NCT04335305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706921|NCT04288089|Palbociclib|palbociclib|mesh-list
92706922|NCT04288089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706923|NCT04288089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706924|NCT04288089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706925|NCT04288089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706926|NCT05371899|Chiauranib|chiauranib|mesh-list
92706927|NCT05371899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706928|NCT05371899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706929|NCT05371899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706930|NCT05371899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706931|NCT04152980|Pentoxifylline|pentoxifylline|mesh-list
92706932|NCT04152980|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92706933|NCT04152980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706934|NCT04152980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706935|NCT04152980|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92706936|NCT04152980|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92706937|NCT04152980|Protective Agents|protective agents|mesh-ancestor
92706938|NCT04152980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706939|NCT04152980|Vasodilator Agents|vasodilator agents|mesh-ancestor
92706940|NCT04152980|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92706941|NCT04152980|Antioxidants|antioxidants|mesh-ancestor
92706942|NCT01232452|Pemetrexed|pemetrexed|mesh-list
92608028|NCT00141648|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92608030|NCT00141648|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706943|NCT01232452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706944|NCT01232452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706945|NCT01232452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706946|NCT01232452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92097910|NCT01143766|Anticonvulsants|anticonvulsants|mesh-ancestor
92706955|NCT05345613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92706956|NCT05345613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92706957|NCT05345613|Adrenergic Agents|adrenergic agents|mesh-ancestor
92706958|NCT05345613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706959|NCT05345613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706960|NCT05345613|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92706961|NCT05345613|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92706962|NCT05345613|Autonomic Agents|autonomic agents|mesh-ancestor
92706963|NCT05345613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706964|NCT05345613|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92706965|NCT05345613|Respiratory System Agents|respiratory system agents|mesh-ancestor
92706966|NCT05345613|Mydriatics|mydriatics|mesh-ancestor
92706967|NCT05345613|Sympathomimetics|sympathomimetics|mesh-ancestor
92706968|NCT05345613|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92706969|NCT01211197|Metformin|metformin|mesh-list
92706970|NCT01211197|Empagliflozin|empagliflozin|mesh-list
92706971|NCT01211197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92706972|NCT01211197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706973|NCT01211197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92706974|NCT01211197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706975|NCT00553137|Fluconazole|fluconazole|mesh-list
92706976|NCT00553137|Antifungal Agents|antifungal agents|mesh-ancestor
92706977|NCT00553137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706978|NCT00553137|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92373287|NCT01608672|Botulinum Toxins|botulinum toxins|mesh-list
92706979|NCT00553137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92706980|NCT00553137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706981|NCT00553137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706982|NCT00553137|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92706983|NCT00553137|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706984|NCT00553137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706985|NCT00553137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706986|NCT00553137|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92706987|NCT00553137|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92706988|NCT04090775|Cyclophosphamide|cyclophosphamide|mesh-list
92706989|NCT04090775|Nivolumab|nivolumab|mesh-list
92706990|NCT04090775|Ipilimumab|ipilimumab|mesh-list
92706991|NCT04090775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706992|NCT04090775|Immunologic Factors|immunologic factors|mesh-ancestor
92706993|NCT04090775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706994|NCT04090775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706995|NCT04090775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706996|NCT04090775|Alkylating Agents|alkylating agents|mesh-ancestor
92706997|NCT04090775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706998|NCT04090775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706999|NCT04090775|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92707000|NCT04090775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707001|NCT04090775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92707002|NCT01232296|Sorafenib|sorafenib|mesh-list
92707003|NCT01232296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707004|NCT01232296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707005|NCT01232296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707006|NCT01232296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707007|NCT04041011|Fluzoparib|fluzoparib|mesh-list
92707008|NCT04041011|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92707009|NCT04041011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707010|NCT04041011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707011|NCT04041011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707040|NCT04116528|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92707041|NCT04116528|Anesthetics, General|anesthetics, general|mesh-ancestor
92707042|NCT04116528|Anesthetics|anesthetics|mesh-ancestor
92707043|NCT04116528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608031|NCT00141648|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608032|NCT00141648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608033|NCT00141648|Glucocorticoids|glucocorticoids|mesh-ancestor
92707044|NCT04116528|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92707045|NCT04116528|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92707046|NCT04116528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707047|NCT04116528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707048|NCT04116528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92707049|NCT04116528|Narcotics|narcotics|mesh-ancestor
92707050|NCT04116528|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92707051|NCT05288907|Lidocaine|lidocaine|mesh-list
92707052|NCT05288907|Anesthetics, Local|anesthetics, local|mesh-ancestor
92707053|NCT05288907|Anesthetics|anesthetics|mesh-ancestor
92098035|NCT03461718|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92707069|NCT03911336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707070|NCT03911336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707072|NCT03911336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707073|NCT03911336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707074|NCT03911336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92707075|NCT03911336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707076|NCT03911336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707077|NCT03850535|Cytarabine|cytarabine|mesh-list
92707078|NCT03850535|Daunorubicin|daunorubicin|mesh-list
92707079|NCT03850535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707080|NCT03850535|Antimetabolites|antimetabolites|mesh-ancestor
92707081|NCT03850535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707082|NCT03850535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707083|NCT03850535|Antiviral Agents|antiviral agents|mesh-ancestor
92707084|NCT03850535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707085|NCT03850535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707086|NCT03850535|Immunologic Factors|immunologic factors|mesh-ancestor
92707087|NCT03850535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707088|NCT03850535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92707089|NCT03850535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92707090|NCT03850535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707091|NCT03850535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707092|NCT03850301|Etifoxine|etifoxine|mesh-list
92707093|NCT03850301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92707094|NCT03850301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92707095|NCT03850301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707096|NCT03850301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707097|NCT03850301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92707098|NCT05255367|Phenol|phenol|mesh-list
92707099|NCT05255367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92707100|NCT05255367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707101|NCT05255367|Disinfectants|disinfectants|mesh-ancestor
92707102|NCT05255367|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92707103|NCT05255367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92707104|NCT04017936|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92707105|NCT04017936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707106|NCT03653000|Anesthetics|anesthetics|mesh-list
92707107|NCT03653000|Anesthetics, Local|anesthetics, local|mesh-list
92707108|NCT03653000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707109|NCT03653000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707110|NCT03653000|Sensory System Agents|sensory system agents|mesh-ancestor
92707122|NCT03639389|Narcotics|narcotics|mesh-ancestor
92707123|NCT05172531|Cisatracurium|cisatracurium|mesh-list
92707124|NCT05172531|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92707125|NCT05172531|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92707126|NCT05172531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707127|NCT05172531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707128|NCT03570983|Cytarabine|cytarabine|mesh-list
92707129|NCT03570983|Etoposide|etoposide|mesh-list
92707130|NCT03570983|Melphalan|melphalan|mesh-list
92707131|NCT03570983|Carmustine|carmustine|mesh-list
92707132|NCT03570983|Allopurinol|allopurinol|mesh-list
92707133|NCT03570983|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707134|NCT03570983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707135|NCT03570983|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92707136|NCT03570983|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707137|NCT03570983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707138|NCT03570983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707139|NCT03570983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608034|NCT00141648|Hormones|hormones|mesh-ancestor
92608035|NCT00141648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608036|NCT00141648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608037|NCT00134420|Clonidine|clonidine|mesh-list
92608038|NCT00134420|Mitogens|mitogens|mesh-list
92707140|NCT03570983|Antimetabolites|antimetabolites|mesh-ancestor
92707141|NCT03570983|Antiviral Agents|antiviral agents|mesh-ancestor
92707142|NCT03570983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707143|NCT03570983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707144|NCT03570983|Immunologic Factors|immunologic factors|mesh-ancestor
92707145|NCT03570983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707146|NCT03570983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92707147|NCT03570983|Alkylating Agents|alkylating agents|mesh-ancestor
92707148|NCT03570983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92707149|NCT03570983|Gout Suppressants|gout suppressants|mesh-ancestor
92707150|NCT03570983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707151|NCT03570983|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92707152|NCT03570983|Antioxidants|antioxidants|mesh-ancestor
92707153|NCT03570983|Protective Agents|protective agents|mesh-ancestor
92707154|NCT03540758|Niacin|niacin|mesh-list
92707155|NCT03540758|Nicotinic Acids|nicotinic acids|mesh-list
92707156|NCT03540758|Niacinamide|niacinamide|mesh-list
92707157|NCT03540758|Diazoxide|diazoxide|mesh-list
92707158|NCT03540758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92707159|NCT03540758|Antimetabolites|antimetabolites|mesh-ancestor
92707160|NCT03540758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707161|NCT03540758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92707162|NCT03540758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92707163|NCT03540758|Vitamin B Complex|vitamin b complex|mesh-ancestor
92707164|NCT03540758|Vitamins|vitamins|mesh-ancestor
92707165|NCT03540758|Micronutrients|micronutrients|mesh-ancestor
92707166|NCT03540758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707167|NCT03540758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92707168|NCT03187379|Bupivacaine|bupivacaine|mesh-list
92707169|NCT03187379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92707170|NCT03187379|Anesthetics|anesthetics|mesh-ancestor
92707171|NCT03187379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707172|NCT03187379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707173|NCT03187379|Sensory System Agents|sensory system agents|mesh-ancestor
92707174|NCT03187379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707175|NCT03182231|Exenatide|exenatide|mesh-list
92707176|NCT03182231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707177|NCT03182231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707178|NCT03182231|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92707199|NCT02837042|Pembrolizumab|pembrolizumab|mesh-list
92707200|NCT02837042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707201|NCT02837042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707202|NCT02837042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92707203|NCT02837042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707204|NCT05098470|Metformin|metformin|mesh-list
92707205|NCT05098470|Insulin Glargine|insulin glargine|mesh-list
92707206|NCT05098470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707207|NCT05098470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707208|NCT02710643|Ofatumumab|ofatumumab|mesh-list
92707209|NCT02710643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707210|NCT05093205|Midazolam|midazolam|mesh-list
92707211|NCT05093205|Atorvastatin|atorvastatin|mesh-list
92707212|NCT05093205|Levonorgestrel|levonorgestrel|mesh-list
92707213|NCT05093205|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92707214|NCT05093205|Estradiol|estradiol|mesh-list
92707215|NCT05093205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92707216|NCT05093205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92707217|NCT05093205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707218|NCT05093205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707219|NCT05093205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92707220|NCT05093205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92707221|NCT05093205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92707222|NCT05093205|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92707223|NCT05093205|Anesthetics, General|anesthetics, general|mesh-ancestor
92707224|NCT05093205|Anesthetics|anesthetics|mesh-ancestor
92707225|NCT05093205|GABA Modulators|gaba modulators|mesh-ancestor
92707226|NCT05093205|GABA Agents|gaba agents|mesh-ancestor
92707227|NCT05093205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707228|NCT05093205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707229|NCT05093205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92707230|NCT05093205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92707231|NCT05093205|Antimetabolites|antimetabolites|mesh-ancestor
92707232|NCT05093205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92707233|NCT05093205|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92707234|NCT05093205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707247|NCT02623751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707248|NCT02623751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92707249|NCT02623751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92707250|NCT02623751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707251|NCT02623751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707252|NCT02623751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92707253|NCT02623751|Hormone Antagonists|hormone antagonists|mesh-ancestor
92707254|NCT02623751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707255|NCT02623751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707256|NCT02623751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92707258|NCT02469155|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92707259|NCT02469155|Serotonin Agents|serotonin agents|mesh-ancestor
92707260|NCT02469155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707261|NCT02469155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707262|NCT02469155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707263|NCT02469155|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92707264|NCT02469155|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92707265|NCT02469155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707266|NCT02469155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92707267|NCT02469155|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92707268|NCT02469155|Dopamine Agents|dopamine agents|mesh-ancestor
92707269|NCT02465606|Triamcinolone|triamcinolone|mesh-list
92707270|NCT02465606|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92707271|NCT02465606|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92707272|NCT02465606|Hydrocortisone|hydrocortisone|mesh-list
92707273|NCT02465606|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92707274|NCT02465606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707275|NCT02465606|Glucocorticoids|glucocorticoids|mesh-ancestor
92707276|NCT02465606|Hormones|hormones|mesh-ancestor
92707277|NCT02465606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707278|NCT02465606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707279|NCT02465606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707280|NCT02465606|Immunologic Factors|immunologic factors|mesh-ancestor
92707281|NCT02465606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707282|NCT02465606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707283|NCT05080530|Vitamin D|vitamin d|mesh-list
92707284|NCT05080530|Cholecalciferol|cholecalciferol|mesh-list
92707285|NCT05080530|Vitamins|vitamins|mesh-ancestor
92707286|NCT05080530|Micronutrients|micronutrients|mesh-ancestor
92707287|NCT05080530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707288|NCT05080530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92707289|NCT05080530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92707290|NCT00554177|Mifepristone|mifepristone|mesh-list
92707291|NCT00554177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92707292|NCT00554177|Abortifacient Agents|abortifacient agents|mesh-ancestor
92707293|NCT00554177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92707294|NCT00554177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707295|NCT00554177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92707296|NCT00554177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92707313|NCT05073627|Antithrombins|antithrombins|mesh-ancestor
92707314|NCT05073627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92707315|NCT05073627|Protease Inhibitors|protease inhibitors|mesh-ancestor
92707316|NCT05073627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707317|NCT05073627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707318|NCT05073627|Anticoagulants|anticoagulants|mesh-ancestor
92707319|NCT05073627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92707320|NCT05073627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707321|NCT04678739|Remdesivir|remdesivir|mesh-list
92707322|NCT04678739|Antimetabolites|antimetabolites|mesh-ancestor
92707323|NCT04678739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707324|NCT04678739|Antiviral Agents|antiviral agents|mesh-ancestor
92707325|NCT04678739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707326|NCT03368196|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92707327|NCT03368196|Immunoconjugates|immunoconjugates|mesh-ancestor
92707328|NCT03368196|Immunologic Factors|immunologic factors|mesh-ancestor
92707329|NCT03368196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707330|NCT03230565|Ropivacaine|ropivacaine|mesh-list
92608039|NCT00134420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608040|NCT00134420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608041|NCT00134420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063253|NCT01703091|Docetaxel|docetaxel|mesh-list
92707331|NCT03230565|Anesthetics, Local|anesthetics, local|mesh-ancestor
92707332|NCT03230565|Anesthetics|anesthetics|mesh-ancestor
92707333|NCT03230565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707334|NCT03230565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707335|NCT03230565|Sensory System Agents|sensory system agents|mesh-ancestor
92707336|NCT03230565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707337|NCT02389985|Paclitaxel|paclitaxel|mesh-list
92707338|NCT02389985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707339|NCT02389985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707340|NCT02389985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92707341|NCT02389985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92707342|NCT02389985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707343|NCT02389985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707344|NCT03147612|Cytarabine|cytarabine|mesh-list
92707345|NCT03147612|Cyclophosphamide|cyclophosphamide|mesh-list
92707346|NCT03147612|Rituximab|rituximab|mesh-list
92707347|NCT03147612|Methotrexate|methotrexate|mesh-list
92707348|NCT03147612|Vincristine|vincristine|mesh-list
92707349|NCT03147612|Blinatumomab|blinatumomab|mesh-list
92707350|NCT03147612|Ponatinib|ponatinib|mesh-list
92707351|NCT03147612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92707352|NCT03147612|Muromonab-CD3|muromonab-cd3|mesh-list
92707353|NCT03147612|Antibodies|antibodies|mesh-list
92707367|NCT03147612|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92707369|NCT03147612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92707370|NCT03147612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707371|NCT03147612|Antimetabolites|antimetabolites|mesh-ancestor
92707372|NCT03147612|Dermatologic Agents|dermatologic agents|mesh-ancestor
92707373|NCT03147612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707374|NCT03147612|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92707375|NCT03147612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92707376|NCT03147612|Antiviral Agents|antiviral agents|mesh-ancestor
92707377|NCT03147612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707378|NCT03147612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92707379|NCT03147612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707381|NCT03147612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92707382|NCT03147612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707383|NCT03147612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707384|NCT02377895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92707385|NCT02365649|Upadacitinib|upadacitinib|mesh-list
92707386|NCT02365649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92707387|NCT02365649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707388|NCT02365649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707389|NCT02365649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707390|NCT02365649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707391|NCT03455075|Levonorgestrel|levonorgestrel|mesh-list
92707392|NCT03455075|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92707393|NCT03455075|Contraceptive Agents|contraceptive agents|mesh-ancestor
92707394|NCT03455075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92707395|NCT03455075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707396|NCT03455075|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92707397|NCT03455075|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92707398|NCT03455075|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92707399|NCT05007132|Trifluridine|trifluridine|mesh-list
92707400|NCT05007132|Bevacizumab|bevacizumab|mesh-list
92707401|NCT05007132|Panitumumab|panitumumab|mesh-list
92707402|NCT05007132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707403|NCT05007132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707404|NCT05007132|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92707405|NCT05007132|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92707406|NCT05007132|Growth Substances|growth substances|mesh-ancestor
92707407|NCT05007132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707408|NCT05007132|Growth Inhibitors|growth inhibitors|mesh-ancestor
92707409|NCT05007132|Antimetabolites|antimetabolites|mesh-ancestor
92707410|NCT05007132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707411|NCT05007132|Antiviral Agents|antiviral agents|mesh-ancestor
92707412|NCT05007132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707413|NCT04684017|Carboplatin|carboplatin|mesh-list
92608042|NCT00134420|Analgesics|analgesics|mesh-ancestor
92608043|NCT00134420|Sensory System Agents|sensory system agents|mesh-ancestor
92608044|NCT00134420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608045|NCT00134420|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92608046|NCT00134420|Sympatholytics|sympatholytics|mesh-ancestor
92707414|NCT04684017|Etoposide|etoposide|mesh-list
92707415|NCT04684017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707439|NCT00554528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92707440|NCT00554528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707441|NCT00554528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707442|NCT04683198|Carboplatin|carboplatin|mesh-list
92707443|NCT04683198|Etoposide|etoposide|mesh-list
92707444|NCT04683198|Apatinib|apatinib|mesh-list
92707445|NCT04683198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707446|NCT04683198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707447|NCT04683198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92707448|NCT04683198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707449|NCT04683198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707450|NCT04683198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707451|NCT04683198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707452|NCT03075423|Nivolumab|nivolumab|mesh-list
92707453|NCT03075423|Ipilimumab|ipilimumab|mesh-list
92707454|NCT03075423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707455|NCT03075423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707456|NCT03075423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92707457|NCT03075423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707458|NCT02342249|Oseltamivir|oseltamivir|mesh-list
92707459|NCT02342249|Antiviral Agents|antiviral agents|mesh-ancestor
92707460|NCT02342249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707461|NCT02342249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707462|NCT02342249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707463|NCT02339129|Ibuprofen|ibuprofen|mesh-list
92098437|NCT03130218|Peppermint oil|peppermint oil|mesh-list
92707476|NCT02884206|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92707478|NCT02884206|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92707479|NCT02884206|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92707480|NCT02884206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707481|NCT04961541|Vaccines|vaccines|mesh-list
92707482|NCT04961541|Immunologic Factors|immunologic factors|mesh-ancestor
92707483|NCT04961541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707484|NCT02326454|Talaporfin|talaporfin|mesh-list
92707485|NCT02326454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707486|NCT02326454|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92707487|NCT02326454|Dermatologic Agents|dermatologic agents|mesh-ancestor
92707488|NCT02871219|Lenalidomide|lenalidomide|mesh-list
92707489|NCT02871219|Obinutuzumab|obinutuzumab|mesh-list
92707490|NCT02871219|Immunologic Factors|immunologic factors|mesh-ancestor
92707491|NCT02871219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707492|NCT02871219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92707493|NCT02871219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92707494|NCT02871219|Growth Substances|growth substances|mesh-ancestor
92707495|NCT02871219|Growth Inhibitors|growth inhibitors|mesh-ancestor
92707496|NCT02871219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707497|NCT02871219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707498|NCT02324309|Insulin Lispro|insulin lispro|mesh-list
92707499|NCT02324309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707500|NCT02324309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707501|NCT02306291|Cytarabine|cytarabine|mesh-list
92707502|NCT02306291|Etoposide|etoposide|mesh-list
92707503|NCT02306291|Mitoxantrone|mitoxantrone|mesh-list
92707504|NCT02306291|Idarubicin|idarubicin|mesh-list
92707505|NCT02306291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707506|NCT02306291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707507|NCT02306291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92707508|NCT02306291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707509|NCT02306291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707510|NCT02306291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707511|NCT02306291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707512|NCT02306291|Antimetabolites|antimetabolites|mesh-ancestor
92608047|NCT00134420|Autonomic Agents|autonomic agents|mesh-ancestor
92608048|NCT00134420|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92608049|NCT00134420|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92608050|NCT00134420|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92608051|NCT00134420|Adrenergic Agents|adrenergic agents|mesh-ancestor
92608052|NCT00134420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608053|NCT00141804|Sirolimus|sirolimus|mesh-list
92608054|NCT00141804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92608055|NCT00141804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608056|NCT00141804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92608057|NCT00141804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015307|NCT04426487|Progestins|progestins|mesh-ancestor
92707513|NCT02306291|Antiviral Agents|antiviral agents|mesh-ancestor
92707514|NCT02306291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707515|NCT02306291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707516|NCT02306291|Immunologic Factors|immunologic factors|mesh-ancestor
92707517|NCT02306291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707518|NCT02306291|Analgesics|analgesics|mesh-ancestor
92707519|NCT02306291|Sensory System Agents|sensory system agents|mesh-ancestor
92707520|NCT02306291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707521|NCT02306291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92707522|NCT02302079|Ranibizumab|ranibizumab|mesh-list
92707523|NCT02302079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92098491|NCT05684172|Tenecteplase|tenecteplase|mesh-list
92707541|NCT04678076|Analgesics|analgesics|mesh-ancestor
92707542|NCT04678076|Sensory System Agents|sensory system agents|mesh-ancestor
92707543|NCT04678076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707544|NCT04678076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707545|NCT04678076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707546|NCT04678076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707547|NCT04678076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92707548|NCT04678076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707549|NCT04678076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707550|NCT02257619|Docetaxel|docetaxel|mesh-list
92373368|NCT01620216|Growth Substances|growth substances|mesh-ancestor
92707551|NCT02257619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707552|NCT02257619|Tubulin Modulators|tubulin modulators|mesh-ancestor
92707553|NCT02257619|Antimitotic Agents|antimitotic agents|mesh-ancestor
92707554|NCT02257619|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707555|NCT02257619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707556|NCT04891302|Clevudine|clevudine|mesh-list
92707557|NCT04891302|Antiviral Agents|antiviral agents|mesh-ancestor
92707558|NCT04891302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707559|NCT04857645|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92707560|NCT04857645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707561|NCT04857645|Antimetabolites|antimetabolites|mesh-ancestor
92707562|NCT04857645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707563|NCT04857645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707564|NCT02224235|Aspirin|aspirin|mesh-list
92707565|NCT02224235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92707566|NCT02224235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92707567|NCT02224235|Analgesics|analgesics|mesh-ancestor
92707568|NCT02224235|Sensory System Agents|sensory system agents|mesh-ancestor
92707569|NCT02224235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707570|NCT02224235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707571|NCT02224235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707572|NCT02224235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707573|NCT02224235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92707574|NCT02224235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92707575|NCT02224235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707576|NCT02224235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92098550|NCT03848754|Immunologic Factors|immunologic factors|mesh-ancestor
92707611|NCT02529852|Growth Substances|growth substances|mesh-ancestor
92707612|NCT02529852|Growth Inhibitors|growth inhibitors|mesh-ancestor
92608058|NCT00141804|Antifungal Agents|antifungal agents|mesh-ancestor
92608059|NCT00141804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608060|NCT00141804|Immunologic Factors|immunologic factors|mesh-ancestor
92608061|NCT00141804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608062|NCT00134498|Atorvastatin|atorvastatin|mesh-list
92608063|NCT00134498|Torcetrapib|torcetrapib|mesh-list
92608064|NCT00134498|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92608065|NCT00134498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92707613|NCT02529852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707614|NCT02221232|Ethanol|ethanol|mesh-list
92707615|NCT02221232|Chlorhexidine|chlorhexidine|mesh-list
92707616|NCT02221232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92707617|NCT02221232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92707618|NCT02221232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098608|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707652|NCT01962636|Antifungal Agents|antifungal agents|mesh-ancestor
92707653|NCT01962636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707654|NCT01962636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92707655|NCT01962636|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92707656|NCT01231321|Adalimumab|adalimumab|mesh-list
92707657|NCT01231321|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92707658|NCT01231321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707659|NCT01231321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707660|NCT01722240|Liraglutide|liraglutide|mesh-list
92098650|NCT03443778|Dexamethasone|dexamethasone|mesh-list
92707676|NCT01210144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707678|NCT01210144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92707680|NCT01209949|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92707681|NCT01209949|Dermatologic Agents|dermatologic agents|mesh-ancestor
92707682|NCT01209949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92707683|NCT01209949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92707684|NCT01209949|Analgesics|analgesics|mesh-ancestor
92707685|NCT01209949|Sensory System Agents|sensory system agents|mesh-ancestor
92707686|NCT01209949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707687|NCT01209949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707688|NCT01209949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707689|NCT01209949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707690|NCT04831593|Anesthetics|anesthetics|mesh-list
92707691|NCT04831593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707692|NCT04831593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707693|NCT04667897|Ranibizumab|ranibizumab|mesh-list
92707694|NCT04667897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92707695|NCT04667897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92707696|NCT04667897|Growth Substances|growth substances|mesh-ancestor
92707697|NCT04667897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707698|NCT04667897|Growth Inhibitors|growth inhibitors|mesh-ancestor
92707699|NCT04667897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707700|NCT01209832|Midazolam|midazolam|mesh-list
92707701|NCT01209832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92707702|NCT01209832|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92707703|NCT01209832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707704|NCT01209832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707705|NCT01209832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92707706|NCT01209832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92707707|NCT01209832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92707708|NCT01209832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92707709|NCT01209832|Anesthetics, General|anesthetics, general|mesh-ancestor
92707710|NCT01209832|Anesthetics|anesthetics|mesh-ancestor
92707711|NCT01209832|GABA Modulators|gaba modulators|mesh-ancestor
92707712|NCT01209832|GABA Agents|gaba agents|mesh-ancestor
92707713|NCT01209832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707714|NCT01209832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707715|NCT04667819|Hyaluronic Acid|hyaluronic acid|mesh-list
92707716|NCT04667819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92707717|NCT04667819|Immunologic Factors|immunologic factors|mesh-ancestor
92707718|NCT04667819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707719|NCT04667819|Viscosupplements|viscosupplements|mesh-ancestor
92707720|NCT04667819|Protective Agents|protective agents|mesh-ancestor
92707748|NCT04667624|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92015326|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92608066|NCT00134498|Antimetabolites|antimetabolites|mesh-ancestor
92608067|NCT00134498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608068|NCT00134498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92608069|NCT00134498|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92608070|NCT00134498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608071|NCT00141843|Factor VIII|factor viii|mesh-list
92608072|NCT00141843|Coagulants|coagulants|mesh-ancestor
92608073|NCT00141882|Memantine|memantine|mesh-list
92608074|NCT00141882|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92707749|NCT04667624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92707750|NCT04667624|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92707751|NCT04667624|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92707752|NCT04667624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707753|NCT04667351|Fluorouracil|fluorouracil|mesh-list
92707754|NCT04667351|Antimetabolites|antimetabolites|mesh-ancestor
92707755|NCT04667351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707756|NCT04667351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707757|NCT04667351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707758|NCT04667351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707759|NCT04667351|Immunologic Factors|immunologic factors|mesh-ancestor
92707760|NCT04667351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707761|NCT01230814|Metronidazole|metronidazole|mesh-list
92707762|NCT01230814|Miconazole|miconazole|mesh-list
92707763|NCT01230814|Clotrimazole|clotrimazole|mesh-list
92707764|NCT01230814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707765|NCT01230814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92707786|NCT01230307|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92707788|NCT01209598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707789|NCT01209598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707790|NCT01209598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707791|NCT01209598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707792|NCT00556634|Efavirenz|efavirenz|mesh-list
92707793|NCT00556634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92707794|NCT00556634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92707795|NCT00556634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707796|NCT00556634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707797|NCT00556634|Antiviral Agents|antiviral agents|mesh-ancestor
92707798|NCT00556634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707799|NCT00556634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92707800|NCT00556634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92707801|NCT00556634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92707802|NCT00556634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92707803|NCT00556634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92707804|NCT00556634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92707805|NCT01209520|Paclitaxel|paclitaxel|mesh-list
92707806|NCT01209520|Vinorelbine|vinorelbine|mesh-list
92707807|NCT01209520|Docetaxel|docetaxel|mesh-list
92707808|NCT01209520|Cisplatin|cisplatin|mesh-list
92707809|NCT01209520|Carboplatin|carboplatin|mesh-list
92707810|NCT01209520|Pemetrexed|pemetrexed|mesh-list
92707811|NCT01209520|Azacitidine|azacitidine|mesh-list
92707812|NCT01209520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707813|NCT01209520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707814|NCT01209520|Tubulin Modulators|tubulin modulators|mesh-ancestor
92707815|NCT01209520|Antimitotic Agents|antimitotic agents|mesh-ancestor
92707816|NCT01209520|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707834|NCT04784754|Antioxidants|antioxidants|mesh-ancestor
92707835|NCT04784754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707836|NCT04784754|Protective Agents|protective agents|mesh-ancestor
92707837|NCT04784754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707838|NCT04784754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707839|NCT04666805|Tamoxifen|tamoxifen|mesh-list
92707840|NCT04666805|Toremifene|toremifene|mesh-list
92707841|NCT04666805|Letrozole|letrozole|mesh-list
92608075|NCT00141882|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92608076|NCT00141882|Dopamine Agents|dopamine agents|mesh-ancestor
92608077|NCT00141882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608078|NCT00141882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608079|NCT00141882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707842|NCT04666805|Anastrozole|anastrozole|mesh-list
92707843|NCT04666805|Exemestane|exemestane|mesh-list
92707844|NCT04666805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707845|NCT04666805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92707846|NCT04666805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92707847|NCT04666805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707848|NCT04666805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707849|NCT04666805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92707850|NCT04666805|Hormone Antagonists|hormone antagonists|mesh-ancestor
92707851|NCT04666805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707852|NCT04666805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707853|NCT04666805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92707854|NCT04666805|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92707855|NCT04666805|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92707856|NCT04666805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92707857|NCT04766853|Dexamethasone|dexamethasone|mesh-list
92707858|NCT04766853|Hyaluronic Acid|hyaluronic acid|mesh-list
92707859|NCT04766853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707860|NCT04766853|Antiemetics|antiemetics|mesh-ancestor
92707861|NCT04766853|Autonomic Agents|autonomic agents|mesh-ancestor
92707862|NCT04766853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707863|NCT04766853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707864|NCT04766853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92707865|NCT04766853|Glucocorticoids|glucocorticoids|mesh-ancestor
92707866|NCT04766853|Hormones|hormones|mesh-ancestor
92707867|NCT04766853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707868|NCT04766853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92707869|NCT04766853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707870|NCT04766853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92707871|NCT04766853|Immunologic Factors|immunologic factors|mesh-ancestor
92707872|NCT04766853|Viscosupplements|viscosupplements|mesh-ancestor
92707873|NCT04766853|Protective Agents|protective agents|mesh-ancestor
92707894|NCT04665986|Tubulin Modulators|tubulin modulators|mesh-ancestor
92707895|NCT04665986|Antimitotic Agents|antimitotic agents|mesh-ancestor
92707896|NCT04665986|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707897|NCT04665986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707898|NCT04665986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707899|NCT04638309|Azacitidine|azacitidine|mesh-list
92707900|NCT04638309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707901|NCT04638309|Antimetabolites|antimetabolites|mesh-ancestor
92707902|NCT04638309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707903|NCT04638309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707904|NCT04638309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707906|NCT04665830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92707907|NCT04665830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92707908|NCT04665830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92707909|NCT04665830|Antimetabolites|antimetabolites|mesh-ancestor
92707910|NCT04665830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707911|NCT04665830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92707912|NCT04665830|Protease Inhibitors|protease inhibitors|mesh-ancestor
92707913|NCT04665830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707914|NCT04665830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92707915|NCT04683237|Liraglutide|liraglutide|mesh-list
92707916|NCT04683237|Megestrol|megestrol|mesh-list
92707917|NCT04683237|Megestrol Acetate|megestrol acetate|mesh-list
92707918|NCT04683237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707919|NCT04683237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707920|NCT04683237|Incretins|incretins|mesh-ancestor
92707921|NCT04683237|Hormones|hormones|mesh-ancestor
92707922|NCT04683237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707923|NCT04683237|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92707924|NCT04683237|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92707925|NCT04683237|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92608080|NCT00141882|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92608082|NCT00152295|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92608083|NCT00152295|Estrogens|estrogens|mesh-ancestor
92608084|NCT00152295|Hormones|hormones|mesh-ancestor
92608085|NCT00152295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608086|NCT00152295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608087|NCT00152373|Levetiracetam|levetiracetam|mesh-list
92608088|NCT00152373|Anticonvulsants|anticonvulsants|mesh-ancestor
92707926|NCT04683237|Contraceptive Agents|contraceptive agents|mesh-ancestor
92707927|NCT04683237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92707928|NCT04683237|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92707929|NCT04683237|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92707930|NCT04683237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92707931|NCT04683237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707932|NCT04683237|Appetite Stimulants|appetite stimulants|mesh-ancestor
92098905|NCT01212952|Autonomic Agents|autonomic agents|mesh-ancestor
92707951|NCT04664894|Sofosbuvir|sofosbuvir|mesh-list
92707952|NCT04664894|Velpatasvir|velpatasvir|mesh-list
92707953|NCT04664894|Antimetabolites|antimetabolites|mesh-ancestor
92707954|NCT04664894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707955|NCT04664894|Antiviral Agents|antiviral agents|mesh-ancestor
92707956|NCT04664894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707957|NCT00557102|Leucovorin|leucovorin|mesh-list
92707958|NCT00557102|Fluorouracil|fluorouracil|mesh-list
92707959|NCT00557102|Irinotecan|irinotecan|mesh-list
92707960|NCT00557102|Cetuximab|cetuximab|mesh-list
92707961|NCT00557102|Calcium|calcium|mesh-list
92707962|NCT00557102|Levoleucovorin|levoleucovorin|mesh-list
92707963|NCT00557102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92707964|NCT00557102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707965|NCT00557102|Antimetabolites|antimetabolites|mesh-ancestor
92707966|NCT00557102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707967|NCT00557102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707968|NCT00557102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707969|NCT00557102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707970|NCT00557102|Immunologic Factors|immunologic factors|mesh-ancestor
92707971|NCT00557102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92707972|NCT00557102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707973|NCT00557102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707974|NCT00557102|Antidotes|antidotes|mesh-ancestor
92707975|NCT00557102|Protective Agents|protective agents|mesh-ancestor
92707976|NCT00557102|Vitamin B Complex|vitamin b complex|mesh-ancestor
92707977|NCT00557102|Vitamins|vitamins|mesh-ancestor
92707978|NCT00557102|Micronutrients|micronutrients|mesh-ancestor
92707979|NCT00557102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707980|NCT04682691|Erythromycin|erythromycin|mesh-list
92707981|NCT04682691|Erythromycin Estolate|erythromycin estolate|mesh-list
92707982|NCT04682691|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92707983|NCT04682691|Erythromycin stearate|erythromycin stearate|mesh-list
92707984|NCT04682691|Metoclopramide|metoclopramide|mesh-list
92707985|NCT04682691|Antiemetics|antiemetics|mesh-ancestor
92707986|NCT04682691|Autonomic Agents|autonomic agents|mesh-ancestor
92707987|NCT04682691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707988|NCT04682691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707989|NCT04682691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098962|NCT03449940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92708005|NCT04663763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708006|NCT04663763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92708008|NCT04663763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708009|NCT04663763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708010|NCT04351737|Dexamethasone|dexamethasone|mesh-list
92708011|NCT04351737|Prednisolone|prednisolone|mesh-list
92708012|NCT04351737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92708013|NCT04351737|Methylprednisolone|methylprednisolone|mesh-list
92708014|NCT04351737|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92708015|NCT04351737|Prednisolone acetate|prednisolone acetate|mesh-list
92708016|NCT04351737|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92608089|NCT00152373|Nootropic Agents|nootropic agents|mesh-ancestor
92608090|NCT00134654|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92608091|NCT00134654|Estrogens|estrogens|mesh-ancestor
92608092|NCT00134654|Hormones|hormones|mesh-ancestor
92608093|NCT00134654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608094|NCT00134654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608095|NCT00141960|Famotidine|famotidine|mesh-list
92708017|NCT04351737|Prednisolone phosphate|prednisolone phosphate|mesh-list
92708018|NCT04351737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708019|NCT04351737|Antiemetics|antiemetics|mesh-ancestor
92708020|NCT04351737|Autonomic Agents|autonomic agents|mesh-ancestor
92373447|NCT01639872|GABA Agents|gaba agents|mesh-ancestor
92708021|NCT04351737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708022|NCT04351737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708023|NCT04351737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92708024|NCT04351737|Glucocorticoids|glucocorticoids|mesh-ancestor
92708025|NCT04351737|Hormones|hormones|mesh-ancestor
92708026|NCT04351737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708027|NCT04351737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708028|NCT04351737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708029|NCT04351737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92708030|NCT04351737|Protective Agents|protective agents|mesh-ancestor
92708031|NCT04347915|Clevudine|clevudine|mesh-list
92708032|NCT04347915|Antiviral Agents|antiviral agents|mesh-ancestor
92708033|NCT04347915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708034|NCT04185051|Aticaprant|aticaprant|mesh-list
92708035|NCT04185051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92708036|NCT04185051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708037|NCT04185051|Sensory System Agents|sensory system agents|mesh-ancestor
92708038|NCT04185051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708039|NCT04662788|Antibodies|antibodies|mesh-list
92708040|NCT04662788|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92708041|NCT04662788|Immunologic Factors|immunologic factors|mesh-ancestor
92708042|NCT04662788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708043|NCT04662866|Metformin|metformin|mesh-list
92708044|NCT04662866|Pioglitazone|pioglitazone|mesh-list
92708045|NCT04662866|Empagliflozin|empagliflozin|mesh-list
92708046|NCT04662866|Linagliptin|linagliptin|mesh-list
92708047|NCT04662866|Biguanides|biguanides|mesh-list
92708048|NCT04662866|Protease Inhibitors|protease inhibitors|mesh-list
92708049|NCT04662866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92708050|NCT04662866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708051|NCT04662866|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92708059|NCT04662476|Cholecalciferol|cholecalciferol|mesh-list
92708060|NCT04662476|Vitamins|vitamins|mesh-ancestor
92708061|NCT04662476|Micronutrients|micronutrients|mesh-ancestor
92708062|NCT04662476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708063|NCT04662476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92708064|NCT04662476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92708065|NCT03986424|Memantine|memantine|mesh-list
92708066|NCT03986424|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92708067|NCT03986424|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92708068|NCT03986424|Dopamine Agents|dopamine agents|mesh-ancestor
92708069|NCT03986424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708070|NCT03986424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708071|NCT03986424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708072|NCT03986424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92708073|NCT03986424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92708074|NCT03918252|Nivolumab|nivolumab|mesh-list
92708075|NCT03918252|Ipilimumab|ipilimumab|mesh-list
92708076|NCT03918252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708077|NCT03918252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708078|NCT03918252|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92708079|NCT03918252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708080|NCT04662125|Acetaminophen|acetaminophen|mesh-list
92708081|NCT04662125|Prednisolone|prednisolone|mesh-list
92708082|NCT04662125|Pregabalin|pregabalin|mesh-list
92708083|NCT04662125|Caffeine|caffeine|mesh-list
92708084|NCT04662125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708085|NCT04662125|Glucocorticoids|glucocorticoids|mesh-ancestor
92708086|NCT04662125|Hormones|hormones|mesh-ancestor
92373453|NCT01640340|Antiemetics|antiemetics|mesh-ancestor
92708087|NCT04662125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608096|NCT00141960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92608097|NCT00141960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92608098|NCT00141960|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92608099|NCT00141960|Histamine Antagonists|histamine antagonists|mesh-ancestor
92608100|NCT00141960|Histamine Agents|histamine agents|mesh-ancestor
92608101|NCT00141960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608102|NCT00141960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608103|NCT00141960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708088|NCT04662125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708089|NCT04662125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708090|NCT04662125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708091|NCT04662125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708092|NCT04662125|Analgesics|analgesics|mesh-ancestor
92708093|NCT04662125|Sensory System Agents|sensory system agents|mesh-ancestor
92708094|NCT04662125|Anticonvulsants|anticonvulsants|mesh-ancestor
92708095|NCT04662125|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92708096|NCT04662125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708097|NCT04662125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708098|NCT04662125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92708099|NCT04662125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92708100|NCT04662125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92708101|NCT04662125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708102|NCT04662125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708103|NCT04662125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708104|NCT04662125|Antipyretics|antipyretics|mesh-ancestor
92708105|NCT04662125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92708106|NCT04662125|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92708107|NCT04662125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708108|NCT04662125|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92708109|NCT04662125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92708110|NCT04662125|Purinergic Agents|purinergic agents|mesh-ancestor
92708111|NCT04662125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708112|NCT00557180|Beclomethasone|beclomethasone|mesh-list
92708113|NCT00557180|Bromides|bromides|mesh-list
92708114|NCT00557180|Tiotropium Bromide|tiotropium bromide|mesh-list
92708115|NCT00557180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92708134|NCT00557180|Hormones|hormones|mesh-ancestor
92708135|NCT00557180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708136|NCT00557219|Fenoldopam|fenoldopam|mesh-list
92708137|NCT00557219|Ketanserin|ketanserin|mesh-list
92708138|NCT00557219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92708139|NCT00557219|Vasodilator Agents|vasodilator agents|mesh-ancestor
92708140|NCT00557219|Dopamine Agonists|dopamine agonists|mesh-ancestor
92708141|NCT00557219|Dopamine Agents|dopamine agents|mesh-ancestor
92708142|NCT00557219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708143|NCT00557219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708144|NCT00557219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708145|NCT00557219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92708146|NCT00557219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92708147|NCT00557219|Serotonin Agents|serotonin agents|mesh-ancestor
92708148|NCT00539877|Irinotecan|irinotecan|mesh-list
92373471|NCT01641120|Interferons|interferons|mesh-list
92708149|NCT00539877|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92708150|NCT00539877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92708151|NCT00539877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708152|NCT00539877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708153|NCT00539877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708154|NCT03798405|Analgesics|analgesics|mesh-list
92708155|NCT03798405|Narcotics|narcotics|mesh-list
92708156|NCT03798405|Sensory System Agents|sensory system agents|mesh-ancestor
92708157|NCT03798405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708158|NCT03798405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708159|NCT03798405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708160|NCT04661696|Paclitaxel|paclitaxel|mesh-list
92708161|NCT04661696|Carboplatin|carboplatin|mesh-list
92708162|NCT04661696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92708163|NCT04661696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608104|NCT00134693|Prednisolone|prednisolone|mesh-list
92608105|NCT00134693|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92608106|NCT00134693|Methylprednisolone|methylprednisolone|mesh-list
92608107|NCT00134693|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92608108|NCT00134693|Prednisolone acetate|prednisolone acetate|mesh-list
92608109|NCT00134693|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92608110|NCT00134693|Prednisolone phosphate|prednisolone phosphate|mesh-list
92608111|NCT00134693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608112|NCT00134693|Glucocorticoids|glucocorticoids|mesh-ancestor
92608113|NCT00134693|Hormones|hormones|mesh-ancestor
92015363|NCT04982367|Sirolimus|sirolimus|mesh-list
92708164|NCT04661696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92708165|NCT04661696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92708166|NCT04661696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92708167|NCT04661696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708168|NCT03776136|Pembrolizumab|pembrolizumab|mesh-list
92708169|NCT03776136|Lenvatinib|lenvatinib|mesh-list
92708170|NCT03776136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708171|NCT03776136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708194|NCT03689946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708195|NCT03689946|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92708196|NCT03689946|Protease Inhibitors|protease inhibitors|mesh-ancestor
92708197|NCT03689946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708198|NCT03689946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92708200|NCT04660916|Dermatologic Agents|dermatologic agents|mesh-ancestor
92708201|NCT00540150|Immunomodulating Agents|immunomodulating agents|mesh-list
92708202|NCT00540150|Immunologic Factors|immunologic factors|mesh-ancestor
92708203|NCT00540150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708204|NCT01208233|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1H)-one|3-(4-(2-hydroxyethyl)piperazin-1-yl)-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido(3,4-b)pyrazin-2(1h)-one|mesh-list
92708205|NCT01208233|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92708206|NCT01208233|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92708207|NCT01208233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708208|NCT01208233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708209|NCT04660565|Prednisone|prednisone|mesh-list
92708210|NCT04660565|Belimumab|belimumab|mesh-list
92708211|NCT04660565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708212|NCT04660565|Glucocorticoids|glucocorticoids|mesh-ancestor
92708213|NCT04660565|Hormones|hormones|mesh-ancestor
92708214|NCT04660565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708215|NCT04660565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708216|NCT04660565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708217|NCT04660565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708218|NCT04660565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92708219|NCT04660565|Immunologic Factors|immunologic factors|mesh-ancestor
92708220|NCT04319341|Autoantibodies|autoantibodies|mesh-list
92708221|NCT04319341|Immunologic Factors|immunologic factors|mesh-ancestor
92708222|NCT04319341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708223|NCT05420935|Immunoglobulin G|immunoglobulin g|mesh-list
92708224|NCT05420935|Immunoglobulin E|immunoglobulin e|mesh-list
92099206|NCT04788420|Sorafenib|sorafenib|mesh-list
92708233|NCT01208038|Hormones|hormones|mesh-ancestor
92708234|NCT01208038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708235|NCT01208038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708236|NCT01208038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708237|NCT01208038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708238|NCT01208038|Anabolic Agents|anabolic agents|mesh-ancestor
92708239|NCT04659785|Apatinib|apatinib|mesh-list
92708240|NCT04659785|Fluzoparib|fluzoparib|mesh-list
92708241|NCT04659785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708242|NCT04659785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92708243|NCT04659785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708244|NCT04659785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708245|NCT04659785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92708246|NCT01207687|Bevacizumab|bevacizumab|mesh-list
92015372|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608114|NCT00134693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608115|NCT00134693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608117|NCT00134693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608118|NCT00134693|Antiemetics|antiemetics|mesh-ancestor
92608119|NCT00134693|Autonomic Agents|autonomic agents|mesh-ancestor
92608120|NCT00134693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608121|NCT00134693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92608122|NCT00134693|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92608123|NCT00134693|Protective Agents|protective agents|mesh-ancestor
92708247|NCT01207687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92708248|NCT01207687|Antibodies|antibodies|mesh-list
92708249|NCT01207687|Immunoglobulins|immunoglobulins|mesh-list
92708250|NCT01207687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92708251|NCT01207687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708252|NCT01207687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92708253|NCT01207687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92708254|NCT01207687|Growth Substances|growth substances|mesh-ancestor
92708255|NCT01207687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708256|NCT01207687|Growth Inhibitors|growth inhibitors|mesh-ancestor
92708257|NCT01207687|Immunologic Factors|immunologic factors|mesh-ancestor
92708258|NCT01207453|Milnacipran|milnacipran|mesh-list
92708259|NCT01207453|Levomilnacipran|levomilnacipran|mesh-list
92708260|NCT01207453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92708261|NCT01207453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92708262|NCT01207453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708263|NCT01207453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708264|NCT01207453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708265|NCT01207453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708266|NCT01207453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708267|NCT01207453|Analgesics|analgesics|mesh-ancestor
92708268|NCT01207453|Sensory System Agents|sensory system agents|mesh-ancestor
92708269|NCT01207453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708270|NCT01207453|Antidepressive Agents|antidepressive agents|mesh-ancestor
92708271|NCT01207453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708272|NCT00540345|Interferons|interferons|mesh-list
92708273|NCT00540345|Ribavirin|ribavirin|mesh-list
92708274|NCT00540345|Interferon-alpha|interferon-alpha|mesh-list
92708275|NCT00540345|Interferon alpha-2|interferon alpha-2|mesh-list
92708276|NCT00540345|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92128048|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708277|NCT00540345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708278|NCT00540345|Antiviral Agents|antiviral agents|mesh-ancestor
92708279|NCT00540345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708280|NCT00540345|Antimetabolites|antimetabolites|mesh-ancestor
92708281|NCT00540345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708282|NCT00540345|Immunologic Factors|immunologic factors|mesh-ancestor
92708283|NCT00540345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708284|NCT01207414|Iloperidone|iloperidone|mesh-list
92708285|NCT01207414|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92373504|NCT01644396|Adalimumab|adalimumab|mesh-list
92708286|NCT01207414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92708287|NCT01207414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708288|NCT01207414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708289|NCT01207414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708290|NCT00540384|Darbepoetin alfa|darbepoetin alfa|mesh-list
92099252|NCT01238536|Hormones|hormones|mesh-ancestor
92708303|NCT04659551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708304|NCT04659551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708305|NCT04659551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92708306|NCT04659551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708307|NCT04659551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92708308|NCT04659551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92708309|NCT04659551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92708310|NCT04659551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608124|NCT00152412|Levocetirizine|levocetirizine|mesh-list
92608125|NCT00152412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92608126|NCT00152412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92608127|NCT00152412|Histamine Antagonists|histamine antagonists|mesh-ancestor
92608128|NCT00152412|Histamine Agents|histamine agents|mesh-ancestor
92608129|NCT00152412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608130|NCT00152412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608131|NCT00152412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708312|NCT04659551|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92708313|NCT04659551|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92708314|NCT04659551|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92708315|NCT04659551|Hormone Antagonists|hormone antagonists|mesh-ancestor
92708316|NCT04659551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708317|NCT04659551|Luteolytic Agents|luteolytic agents|mesh-ancestor
92708318|NCT04659551|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92708319|NCT04659551|Contraceptive Agents|contraceptive agents|mesh-ancestor
92708320|NCT04659551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92708321|NCT04659551|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92708322|NCT04659551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708323|NCT01206517|Asenapine|asenapine|mesh-list
92708324|NCT01206517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92708325|NCT01206517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92708326|NCT01206517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708327|NCT01206517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708328|NCT01206517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708329|NCT01206439|Nebivolol|nebivolol|mesh-list
92708330|NCT01206439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92708331|NCT01206439|Vasodilator Agents|vasodilator agents|mesh-ancestor
92708332|NCT01206439|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92708333|NCT01206439|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92708334|NCT01206439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92708335|NCT01206439|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708336|NCT01206439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708337|NCT01206439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708338|NCT01206439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708339|NCT01206322|Insulin|insulin|mesh-list
92708340|NCT01206322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92708341|NCT01206322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708342|NCT00540501|Oseltamivir|oseltamivir|mesh-list
92708343|NCT00540501|Zanamivir|zanamivir|mesh-list
92708344|NCT00540501|Antiviral Agents|antiviral agents|mesh-ancestor
92708345|NCT00540501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708346|NCT00540501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708347|NCT00540501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708348|NCT00557453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92708349|NCT00557453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92708350|NCT00557453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708351|NCT00557453|Antitubercular Agents|antitubercular agents|mesh-ancestor
92708352|NCT01207102|Paclitaxel|paclitaxel|mesh-list
92708353|NCT01207102|Carboplatin|carboplatin|mesh-list
92708354|NCT01207102|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92708370|NCT04658732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708371|NCT04658732|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92708372|NCT04658732|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92708373|NCT04658732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92708374|NCT04658732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708375|NCT04658732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708376|NCT04658732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708377|NCT04658732|Anticonvulsants|anticonvulsants|mesh-ancestor
92708378|NCT04658732|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92708379|NCT04658732|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92708380|NCT04658732|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708381|NCT04658732|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92708382|NCT04658732|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92708383|NCT04658732|Antimanic Agents|antimanic agents|mesh-ancestor
92708384|NCT04658732|GABA Modulators|gaba modulators|mesh-ancestor
92015389|NCT05031975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608132|NCT00142038|Docetaxel|docetaxel|mesh-list
92608133|NCT00142038|Capecitabine|capecitabine|mesh-list
92608134|NCT00142038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608135|NCT00142038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608136|NCT00142038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92608137|NCT00142038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608138|NCT00142038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608139|NCT00142038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92708385|NCT04658732|GABA Agents|gaba agents|mesh-ancestor
92708386|NCT00540696|Darbepoetin alfa|darbepoetin alfa|mesh-list
92708387|NCT00540696|Hematinics|hematinics|mesh-ancestor
92708388|NCT04658420|Ketamine|ketamine|mesh-list
92708389|NCT04658420|Analgesics|analgesics|mesh-ancestor
92708390|NCT04658420|Sensory System Agents|sensory system agents|mesh-ancestor
92708391|NCT04658420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708392|NCT04658420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708393|NCT04658420|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92708394|NCT04658420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92708395|NCT04658420|Anesthetics, General|anesthetics, general|mesh-ancestor
92708396|NCT04658420|Anesthetics|anesthetics|mesh-ancestor
92708397|NCT04658420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708398|NCT04658420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92708399|NCT04658420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92708400|NCT04658420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708401|NCT04658420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708402|NCT00540891|Alfuzosin|alfuzosin|mesh-list
92708403|NCT00540891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92708404|NCT00540891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92708405|NCT00540891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92708406|NCT00540891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708407|NCT00540891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708408|NCT00540891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708409|NCT00540891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708410|NCT00540891|Urological Agents|urological agents|mesh-ancestor
92708411|NCT04658225|Chlorhexidine|chlorhexidine|mesh-list
92708429|NCT00541008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92708431|NCT00541008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708433|NCT00541047|Goserelin|goserelin|mesh-list
92708434|NCT00541047|Bicalutamide|bicalutamide|mesh-list
92708435|NCT00541047|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92708436|NCT00541047|Fertility Agents|fertility agents|mesh-ancestor
92708437|NCT00541047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92708438|NCT00541047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708439|NCT00541047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708440|NCT00541047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708441|NCT00541047|Androgen Antagonists|androgen antagonists|mesh-ancestor
92708442|NCT00541047|Hormone Antagonists|hormone antagonists|mesh-ancestor
92708443|NCT00541047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708444|NCT00541086|Tamoxifen|tamoxifen|mesh-list
92708445|NCT00541086|Letrozole|letrozole|mesh-list
92708446|NCT00541086|Anastrozole|anastrozole|mesh-list
92708447|NCT00541086|Exemestane|exemestane|mesh-list
92708448|NCT00541086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708449|NCT00541086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708450|NCT00541086|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92708451|NCT00541086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92708452|NCT00541086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708453|NCT00541086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92708454|NCT00541086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92708455|NCT00541086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708456|NCT00541086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708457|NCT00541086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708458|NCT00541086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92708459|NCT00541086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92608140|NCT00142038|Antimetabolites|antimetabolites|mesh-ancestor
92608141|NCT00134810|Botulinum Toxins|botulinum toxins|mesh-list
92608142|NCT00134810|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92608143|NCT00134810|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92608144|NCT00134810|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92064109|NCT01866657|Mydriatics|mydriatics|mesh-ancestor
92708460|NCT00541086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92708461|NCT04657484|Prednisolone|prednisolone|mesh-list
92708462|NCT04657484|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92708463|NCT04657484|Methylprednisolone|methylprednisolone|mesh-list
92708464|NCT04657484|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92708465|NCT04657484|Prednisolone acetate|prednisolone acetate|mesh-list
92708466|NCT04657484|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92708467|NCT04657484|Prednisolone phosphate|prednisolone phosphate|mesh-list
92708477|NCT04657484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708478|NCT04657484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92708479|NCT04657484|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92708480|NCT04657484|Protective Agents|protective agents|mesh-ancestor
92708481|NCT00541125|Leucovorin|leucovorin|mesh-list
92708482|NCT00541125|Bevacizumab|bevacizumab|mesh-list
92708483|NCT00541125|Fluorouracil|fluorouracil|mesh-list
92708484|NCT00541125|Irinotecan|irinotecan|mesh-list
92708485|NCT00541125|Calcium|calcium|mesh-list
92708486|NCT00541125|Levoleucovorin|levoleucovorin|mesh-list
92708487|NCT00541125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708488|NCT00541125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708489|NCT00541125|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92708490|NCT00541125|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92708491|NCT00541125|Growth Substances|growth substances|mesh-ancestor
92708492|NCT00541125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708493|NCT00541125|Growth Inhibitors|growth inhibitors|mesh-ancestor
92708494|NCT00541125|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92708495|NCT00541125|Antimetabolites|antimetabolites|mesh-ancestor
92708496|NCT00541125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708497|NCT00541125|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92708498|NCT00541125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92708499|NCT00541125|Immunologic Factors|immunologic factors|mesh-ancestor
92708500|NCT00541125|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92708501|NCT00541125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92708502|NCT00541125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708503|NCT00541125|Antidotes|antidotes|mesh-ancestor
92708504|NCT00541125|Protective Agents|protective agents|mesh-ancestor
92708505|NCT00541125|Vitamin B Complex|vitamin b complex|mesh-ancestor
92708507|NCT00541125|Micronutrients|micronutrients|mesh-ancestor
92708508|NCT00541164|Ubiquinone|ubiquinone|mesh-list
92708509|NCT00541164|Coenzyme Q10|coenzyme q10|mesh-list
92708510|NCT00541164|Micronutrients|micronutrients|mesh-ancestor
92708511|NCT00541164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708512|NCT00541164|Vitamins|vitamins|mesh-ancestor
92708513|NCT00541281|Prednisone|prednisone|mesh-list
92708514|NCT00541281|Docetaxel|docetaxel|mesh-list
92708515|NCT00541281|Estramustine|estramustine|mesh-list
92708516|NCT00541281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708517|NCT00541281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92708518|NCT00541281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92708519|NCT00541281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92708520|NCT00541281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708521|NCT00541281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708522|NCT00541281|Glucocorticoids|glucocorticoids|mesh-ancestor
92708523|NCT00541281|Hormones|hormones|mesh-ancestor
92708524|NCT00541281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708525|NCT00541281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708526|NCT00541281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708527|NCT00541281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92708528|NCT00541281|Alkylating Agents|alkylating agents|mesh-ancestor
92708529|NCT00541320|2-(5-chlorothien-2-yl)-N-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|2-(5-chlorothien-2-yl)-n-(1-(1-methyl-2-(morpholin-4-yl)-2-oxoethyl)-2-oxopyrrolidin-3-yl)ethenesulfonamide|mesh-list
92708530|NCT00541320|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92708531|NCT00541320|Antithrombins|antithrombins|mesh-ancestor
92708532|NCT00541320|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92708533|NCT00541320|Protease Inhibitors|protease inhibitors|mesh-ancestor
92708534|NCT00541320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608145|NCT00134810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608146|NCT00134810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608147|NCT00134810|Cholinergic Agents|cholinergic agents|mesh-ancestor
92608148|NCT00134810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608149|NCT00134810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608150|NCT00134810|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92608151|NCT00134810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608152|NCT02964455|Docetaxel|docetaxel|mesh-list
92608153|NCT02964455|Nedaplatin|nedaplatin|mesh-list
92608154|NCT02964455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708545|NCT04657172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708546|NCT04657172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708548|NCT03199794|Coagulants|coagulants|mesh-ancestor
92708549|NCT00541359|Bortezomib|bortezomib|mesh-list
92708550|NCT00541359|Topotecan|topotecan|mesh-list
92708551|NCT00541359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708552|NCT00541359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92708553|NCT00541359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92708554|NCT00541359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708555|NCT00541359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708556|NCT03096249|Oxytocin|oxytocin|mesh-list
92708557|NCT03096249|Oxytocics|oxytocics|mesh-ancestor
92708558|NCT03096249|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92708559|NCT03096249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708560|NCT04656665|Aspirin|aspirin|mesh-list
92708561|NCT04656665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92708562|NCT04656665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708563|NCT04656665|Analgesics|analgesics|mesh-ancestor
92708564|NCT04656665|Sensory System Agents|sensory system agents|mesh-ancestor
92708565|NCT04656665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708566|NCT04656665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708567|NCT04656665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708568|NCT04656665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708569|NCT04656665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92708570|NCT04656665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92708571|NCT04656665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708572|NCT04656665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92708573|NCT04656665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92708574|NCT04656665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708575|NCT04656665|Antipyretics|antipyretics|mesh-ancestor
92708576|NCT03014622|Botulinum Toxins|botulinum toxins|mesh-list
92128346|NCT02383212|Pemetrexed|pemetrexed|mesh-list
92708577|NCT03014622|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92708578|NCT03014622|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92708579|NCT03014622|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92708580|NCT03014622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708581|NCT03014622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708582|NCT03014622|Cholinergic Agents|cholinergic agents|mesh-ancestor
92708583|NCT03014622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708584|NCT03014622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708585|NCT03014622|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92708586|NCT03014622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708587|NCT04655807|Adalimumab|adalimumab|mesh-list
92708588|NCT04655807|Ustekinumab|ustekinumab|mesh-list
92708589|NCT04655807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92708590|NCT04655807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708591|NCT04655807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708592|NCT04655807|Dermatologic Agents|dermatologic agents|mesh-ancestor
92708593|NCT04655417|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
92708594|NCT04655417|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92708595|NCT04655417|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92708596|NCT00541515|Insulin|insulin|mesh-list
92708597|NCT00541515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92708598|NCT00541515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708599|NCT04655729|Infliximab|infliximab|mesh-list
92708618|NCT00541554|Serotonin Agents|serotonin agents|mesh-ancestor
92608155|NCT02964455|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608156|NCT02964455|Antimitotic Agents|antimitotic agents|mesh-ancestor
92608157|NCT02964455|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608158|NCT02964455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608159|NCT00142155|Rituximab|rituximab|mesh-list
92608160|NCT00142155|Antibodies|antibodies|mesh-list
92608161|NCT00142155|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92608162|NCT00142155|Immunologic Factors|immunologic factors|mesh-ancestor
92608163|NCT00142155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608164|NCT00142155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92608165|NCT00142155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708619|NCT00541554|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92708620|NCT00541554|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92708621|NCT00541554|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92708622|NCT00541554|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92708623|NCT04655183|Niraparib|niraparib|mesh-list
92708624|NCT04655183|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92708625|NCT04655183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708626|NCT04655183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708627|NCT04655183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708628|NCT00541710|Genistein|genistein|mesh-list
92708629|NCT00541710|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92708630|NCT00541710|Protective Agents|protective agents|mesh-ancestor
92708631|NCT00541710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708632|NCT00541710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708633|NCT00541710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92708634|NCT00541710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708635|NCT00541710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708636|NCT00541710|Phytoestrogens|phytoestrogens|mesh-ancestor
92708637|NCT00541710|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92708638|NCT00541710|Estrogens|estrogens|mesh-ancestor
92708639|NCT00541710|Hormones|hormones|mesh-ancestor
92708640|NCT00541710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708641|NCT04654676|Vildagliptin|vildagliptin|mesh-list
92708642|NCT04654676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92708643|NCT04654676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708644|NCT04654676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92708645|NCT04654676|Protease Inhibitors|protease inhibitors|mesh-ancestor
92708646|NCT04654676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708647|NCT04654676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708648|NCT00541905|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92708649|NCT00541905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92373548|NCT01652976|Leucovorin|leucovorin|mesh-list
92708650|NCT00541905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708651|NCT00541905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708652|NCT00541905|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92708653|NCT00541905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708681|NCT01205581|Vaccines|vaccines|mesh-list
92708682|NCT01205581|Immunologic Factors|immunologic factors|mesh-ancestor
92708683|NCT01205581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708684|NCT00542139|Betamethasone|betamethasone|mesh-list
92708685|NCT00542139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708686|NCT00542139|Glucocorticoids|glucocorticoids|mesh-ancestor
92708687|NCT00542139|Hormones|hormones|mesh-ancestor
92708688|NCT00542139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708689|NCT00542139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708690|NCT00542139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92708691|NCT00542139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92708692|NCT02499354|Iron|iron|mesh-list
92708693|NCT02499354|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92708694|NCT02499354|Trace Elements|trace elements|mesh-ancestor
92708695|NCT02499354|Micronutrients|micronutrients|mesh-ancestor
92708696|NCT02499354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708697|NCT02499354|Hematinics|hematinics|mesh-ancestor
92608166|NCT00142155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608167|NCT00152490|Certolizumab Pegol|certolizumab pegol|mesh-list
92608168|NCT00152490|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92608169|NCT00152490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608170|NCT00152490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92708698|NCT02499354|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92708699|NCT02499354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92708700|NCT00542295|Mebeverine|mebeverine|mesh-list
92708720|NCT02293980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92708721|NCT02293980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708722|NCT04653506|Acetaminophen|acetaminophen|mesh-list
92708723|NCT04653506|Ibuprofen|ibuprofen|mesh-list
92708724|NCT04653506|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92708725|NCT04653506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708726|NCT04653506|Analgesics|analgesics|mesh-ancestor
92708727|NCT04653506|Sensory System Agents|sensory system agents|mesh-ancestor
92708728|NCT04653506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708729|NCT04653506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708730|NCT04653506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708731|NCT04653506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708732|NCT04653506|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92708733|NCT04653506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708734|NCT04653506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708735|NCT04653506|Antipyretics|antipyretics|mesh-ancestor
92708736|NCT00542412|Riluzole|riluzole|mesh-list
92708737|NCT00542412|Anticonvulsants|anticonvulsants|mesh-ancestor
92708738|NCT00542412|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92708739|NCT00542412|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92708740|NCT00542412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708741|NCT00542412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708742|NCT00542412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708743|NCT00542412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92708744|NCT00542412|Protective Agents|protective agents|mesh-ancestor
92708745|NCT04653623|Tranexamic Acid|tranexamic acid|mesh-list
92708746|NCT04653623|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92373566|NCT01656252|Cytarabine|cytarabine|mesh-list
92708747|NCT04653623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92708748|NCT04653623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708749|NCT04653623|Hemostatics|hemostatics|mesh-ancestor
92708750|NCT04653623|Coagulants|coagulants|mesh-ancestor
92708751|NCT00542568|Epoetin Alfa|epoetin alfa|mesh-list
92708752|NCT00542568|Hematinics|hematinics|mesh-ancestor
92708753|NCT04653779|Metformin|metformin|mesh-list
92708754|NCT04653779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92708755|NCT04653779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708767|NCT04685031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708768|NCT04685031|Glucocorticoids|glucocorticoids|mesh-ancestor
92708769|NCT04685031|Hormones|hormones|mesh-ancestor
92708770|NCT04685031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708771|NCT04685031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708772|NCT00542763|Mycophenolic Acid|mycophenolic acid|mesh-list
92708773|NCT00542763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92708774|NCT00542763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708775|NCT00542763|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92708776|NCT00542763|Antitubercular Agents|antitubercular agents|mesh-ancestor
92708777|NCT00542763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92708778|NCT00542763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708779|NCT00542763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708780|NCT00542763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708781|NCT01854684|Temoporfin|temoporfin|mesh-list
92708782|NCT01854684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708783|NCT01854684|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92708784|NCT01854684|Dermatologic Agents|dermatologic agents|mesh-ancestor
92708785|NCT00542802|Carbamazepine|carbamazepine|mesh-list
92708786|NCT00542802|Levetiracetam|levetiracetam|mesh-list
92708787|NCT00542802|Anticonvulsants|anticonvulsants|mesh-ancestor
92708788|NCT00542802|Nootropic Agents|nootropic agents|mesh-ancestor
92708789|NCT00542802|Antimanic Agents|antimanic agents|mesh-ancestor
92708790|NCT00542802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92708791|NCT00542802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708792|NCT00542802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015427|NCT04216797|GABA Modulators|gaba modulators|mesh-ancestor
92608171|NCT00152490|Immunologic Factors|immunologic factors|mesh-ancestor
92608172|NCT00152490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608173|NCT00152490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608175|NCT00134888|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92608176|NCT00134888|Naloxone|naloxone|mesh-list
92608177|NCT00134888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92608178|NCT00134888|Narcotics|narcotics|mesh-ancestor
92608179|NCT00134888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608180|NCT00134888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608181|NCT00134888|Analgesics|analgesics|mesh-ancestor
92608182|NCT00134888|Sensory System Agents|sensory system agents|mesh-ancestor
92608183|NCT00134888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608184|NCT00134888|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92608185|NCT00134966|Levodopa|levodopa|mesh-list
92608186|NCT00134966|Carbidopa|carbidopa|mesh-list
92608187|NCT00134966|Entacapone|entacapone|mesh-list
92608188|NCT00134966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92608189|NCT00134966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92708793|NCT00542802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708794|NCT00542802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708795|NCT00542802|Analgesics|analgesics|mesh-ancestor
92708796|NCT00542802|Sensory System Agents|sensory system agents|mesh-ancestor
92708797|NCT00542802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708798|NCT00542802|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92708799|NCT00542802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708800|NCT00542802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708801|NCT00542802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92708802|NCT00542802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92708803|NCT04652648|Hydroxychloroquine|hydroxychloroquine|mesh-list
92708804|NCT04652648|Antimalarials|antimalarials|mesh-ancestor
92708805|NCT04652648|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92708806|NCT04652648|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92708807|NCT04652648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708808|NCT04652648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708809|NCT04652648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708810|NCT04652648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708811|NCT00542841|Hydrocortisone|hydrocortisone|mesh-list
92708812|NCT00542841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708813|NCT04652765|Bicalutamide|bicalutamide|mesh-list
92708814|NCT04652765|Camostat|camostat|mesh-list
92708815|NCT04652765|Androgen Antagonists|androgen antagonists|mesh-ancestor
92708816|NCT04652765|Hormone Antagonists|hormone antagonists|mesh-ancestor
92708817|NCT04652765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708818|NCT04652765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708819|NCT04652765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708835|NCT00543114|Immunologic Factors|immunologic factors|mesh-ancestor
92708836|NCT00543114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708837|NCT00543114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708838|NCT00543114|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92708839|NCT00543114|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92708840|NCT00543114|Growth Substances|growth substances|mesh-ancestor
92708841|NCT00543114|Growth Inhibitors|growth inhibitors|mesh-ancestor
92708842|NCT03454724|Sirolimus|sirolimus|mesh-list
92708843|NCT03454724|Everolimus|everolimus|mesh-list
92708844|NCT03454724|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92708845|NCT03454724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92608190|NCT00134966|Dopamine Agents|dopamine agents|mesh-ancestor
92608191|NCT00134966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015444|NCT04033237|Nicotine|nicotine|mesh-list
92708846|NCT03454724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708847|NCT03454724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708848|NCT03454724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92708849|NCT03454724|Immunologic Factors|immunologic factors|mesh-ancestor
92708850|NCT03454724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708851|NCT03454724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708852|NCT03454724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92708853|NCT03454724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708854|NCT03454724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92708855|NCT03454724|Antifungal Agents|antifungal agents|mesh-ancestor
92708856|NCT01014546|Vitamins|vitamins|mesh-list
92708857|NCT01014546|Ascorbic Acid|ascorbic acid|mesh-list
92708858|NCT01014546|Arsenic Trioxide|arsenic trioxide|mesh-list
92708859|NCT01014546|Micronutrients|micronutrients|mesh-ancestor
92708860|NCT01014546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708861|NCT01014546|Antioxidants|antioxidants|mesh-ancestor
92708862|NCT01014546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708863|NCT01014546|Protective Agents|protective agents|mesh-ancestor
92708864|NCT01014546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708865|NCT00543231|Oblimersen|oblimersen|mesh-list
92708866|NCT00543231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708867|NCT00557843|Bupivacaine|bupivacaine|mesh-list
92708868|NCT00557843|Anesthetics, Local|anesthetics, local|mesh-ancestor
92708869|NCT00557843|Anesthetics|anesthetics|mesh-ancestor
92708870|NCT00557843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708871|NCT00557843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708872|NCT00557843|Sensory System Agents|sensory system agents|mesh-ancestor
92708873|NCT00557843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708874|NCT04651556|Acetaminophen|acetaminophen|mesh-list
92708875|NCT04651556|Ketorolac|ketorolac|mesh-list
92708876|NCT04651556|Magnesium Sulfate|magnesium sulfate|mesh-list
92708877|NCT04651556|Bupivacaine|bupivacaine|mesh-list
92708878|NCT04651556|Anesthetics, Local|anesthetics, local|mesh-ancestor
92708879|NCT04651556|Anesthetics|anesthetics|mesh-ancestor
92708880|NCT04651556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708881|NCT04651556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708882|NCT04651556|Sensory System Agents|sensory system agents|mesh-ancestor
92708896|NCT04651556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708897|NCT04651556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92708898|NCT04651556|Tocolytic Agents|tocolytic agents|mesh-ancestor
92708899|NCT04651556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92708900|NCT04651049|Propranolol|propranolol|mesh-list
92708901|NCT04651049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92708902|NCT04651049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92708903|NCT04651049|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708904|NCT04651049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708905|NCT04651049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708906|NCT04651049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708907|NCT04651049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92708908|NCT04651049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92708909|NCT04651049|Vasodilator Agents|vasodilator agents|mesh-ancestor
92708910|NCT04651205|Thiamine|thiamine|mesh-list
92708911|NCT04651205|Vitamins|vitamins|mesh-ancestor
92708912|NCT04651205|Micronutrients|micronutrients|mesh-ancestor
92708913|NCT04651205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708914|NCT04651205|Vitamin B Complex|vitamin b complex|mesh-ancestor
92708915|NCT03456648|Apixaban|apixaban|mesh-list
92708916|NCT03456648|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92708917|NCT03456648|Antithrombins|antithrombins|mesh-ancestor
92708918|NCT03456648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92708919|NCT03456648|Protease Inhibitors|protease inhibitors|mesh-ancestor
92708920|NCT03456648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708921|NCT03456648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708922|NCT03456648|Anticoagulants|anticoagulants|mesh-ancestor
92708923|NCT00557921|Aspirin|aspirin|mesh-list
92708924|NCT00557921|Omeprazole|omeprazole|mesh-list
92708925|NCT00557921|Clopidogrel|clopidogrel|mesh-list
92708926|NCT00557921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92708927|NCT00557921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708928|NCT00557921|Analgesics|analgesics|mesh-ancestor
92708929|NCT00557921|Sensory System Agents|sensory system agents|mesh-ancestor
92708930|NCT00557921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608192|NCT00134966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608193|NCT00134966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608194|NCT00134966|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92608195|NCT00134966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708931|NCT00557921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708932|NCT00557921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708933|NCT00557921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708934|NCT00557921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92708935|NCT00557921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92708936|NCT00557921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708937|NCT00557921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92708938|NCT00557921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92708939|NCT00557921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708940|NCT00557921|Antipyretics|antipyretics|mesh-ancestor
92708941|NCT00557921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92708942|NCT00557921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92708943|NCT00557921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92708960|NCT02352558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708961|NCT02352558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708962|NCT02352558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708963|NCT02352558|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92708965|NCT02352558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708966|NCT02324283|Propofol|propofol|mesh-list
92708967|NCT02324283|Desflurane|desflurane|mesh-list
92708968|NCT02324283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92708969|NCT02324283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708970|NCT02324283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708971|NCT02324283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92708972|NCT02324283|Anesthetics, General|anesthetics, general|mesh-ancestor
92708973|NCT02324283|Anesthetics|anesthetics|mesh-ancestor
92708974|NCT02324283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92708975|NCT00557960|Amphetamine|amphetamine|mesh-list
92708976|NCT00557960|Adderall|adderall|mesh-list
92708977|NCT00557960|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92708978|NCT00557960|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92708979|NCT00557960|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92708980|NCT00557960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708981|NCT00557960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708982|NCT00557960|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708983|NCT00557960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708984|NCT00557960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708985|NCT00557960|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92708986|NCT00557960|Sympathomimetics|sympathomimetics|mesh-ancestor
92708987|NCT00557960|Autonomic Agents|autonomic agents|mesh-ancestor
92708988|NCT00557960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708989|NCT00557960|Dopamine Agents|dopamine agents|mesh-ancestor
92708990|NCT00557960|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92708991|NCT00558077|Metformin|metformin|mesh-list
92708992|NCT00558077|Clomiphene|clomiphene|mesh-list
92708993|NCT00558077|Enclomiphene|enclomiphene|mesh-list
92708994|NCT00558077|Zuclomiphene|zuclomiphene|mesh-list
92708995|NCT00558077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92708996|NCT00558077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708997|NCT00558077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92708998|NCT00558077|Hormone Antagonists|hormone antagonists|mesh-ancestor
92708999|NCT00558077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709000|NCT00558077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92709001|NCT00558077|Fertility Agents|fertility agents|mesh-ancestor
92709002|NCT00558077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709003|NCT00558077|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92709016|NCT05077254|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92709018|NCT05077254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92709019|NCT05077254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709020|NCT00543504|Bevacizumab|bevacizumab|mesh-list
92709021|NCT00543504|Trastuzumab|trastuzumab|mesh-list
92709022|NCT00543504|Cetuximab|cetuximab|mesh-list
92709023|NCT00543504|Sunitinib|sunitinib|mesh-list
92608196|NCT00134966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92064547|NCT04140448|Ranibizumab|ranibizumab|mesh-list
92709024|NCT00543504|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92709025|NCT00543504|Sorafenib|sorafenib|mesh-list
92709026|NCT00543504|Lapatinib|lapatinib|mesh-list
92709027|NCT00543504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92709028|NCT00543504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709029|NCT00543504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92709030|NCT00543504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92709031|NCT00543504|Growth Substances|growth substances|mesh-ancestor
92709032|NCT00543504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709033|NCT00543504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92709034|NCT00543504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709035|NCT00543504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709036|NCT00543504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709038|NCT00543933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92709039|NCT00543933|Autonomic Agents|autonomic agents|mesh-ancestor
92709040|NCT00543933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709041|NCT00543933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709042|NCT00543933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92709043|NCT00543933|Respiratory System Agents|respiratory system agents|mesh-ancestor
92709044|NCT00543933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92709045|NCT00543933|Antioxidants|antioxidants|mesh-ancestor
92709046|NCT00543933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709047|NCT00543933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709048|NCT00543933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92709049|NCT00543933|Vasodilator Agents|vasodilator agents|mesh-ancestor
92709050|NCT00543933|Gasotransmitters|gasotransmitters|mesh-ancestor
92709051|NCT00543933|Protective Agents|protective agents|mesh-ancestor
92709052|NCT00544011|Bevacizumab|bevacizumab|mesh-list
92709053|NCT00544011|Fluorouracil|fluorouracil|mesh-list
92709054|NCT00544011|Capecitabine|capecitabine|mesh-list
92709055|NCT00544011|Irinotecan|irinotecan|mesh-list
92709056|NCT00544011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92709057|NCT00544011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709058|NCT00544011|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92709059|NCT00544011|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92709060|NCT00544011|Growth Substances|growth substances|mesh-ancestor
92709061|NCT00544011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709062|NCT00544011|Growth Inhibitors|growth inhibitors|mesh-ancestor
92709063|NCT00544011|Antimetabolites|antimetabolites|mesh-ancestor
92709064|NCT00544011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709065|NCT00544011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709066|NCT00544011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709067|NCT00544011|Immunologic Factors|immunologic factors|mesh-ancestor
92709083|NCT04649723|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92709084|NCT04649723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92709085|NCT04649723|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92709086|NCT04649723|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92709087|NCT04649723|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92709088|NCT04649723|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92709089|NCT02909088|Ecopipam|ecopipam|mesh-list
92709090|NCT02909088|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92709091|NCT02909088|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92709092|NCT02909088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709093|NCT02909088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709094|NCT02909088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709095|NCT02909088|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92709096|NCT02909088|Dopamine Agents|dopamine agents|mesh-ancestor
92709097|NCT02909088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709098|NCT02909088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709099|NCT04649645|Nicotine|nicotine|mesh-list
92709100|NCT04649645|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92709101|NCT04649645|Autonomic Agents|autonomic agents|mesh-ancestor
92709102|NCT04649645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709103|NCT04649645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709104|NCT04649645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92709105|NCT04649645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92709106|NCT04649645|Cholinergic Agents|cholinergic agents|mesh-ancestor
92709107|NCT04649645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709108|NCT04649645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709109|NCT00544128|Ritonavir|ritonavir|mesh-list
92608197|NCT00135005|Imatinib Mesylate|imatinib mesylate|mesh-list
92608198|NCT00135005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608199|NCT00135005|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709110|NCT00544128|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92709111|NCT00544128|Tenofovir|tenofovir|mesh-list
92709112|NCT00544128|Lamivudine|lamivudine|mesh-list
92709113|NCT00544128|Emtricitabine|emtricitabine|mesh-list
92709114|NCT00544128|Abacavir|abacavir|mesh-list
92709115|NCT00544128|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92709116|NCT00544128|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92709117|NCT00544128|Protease Inhibitors|protease inhibitors|mesh-ancestor
92709118|NCT00544128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709119|NCT00544128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709120|NCT00544128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92709121|NCT00544128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92709122|NCT00544128|Antiviral Agents|antiviral agents|mesh-ancestor
92709123|NCT00544128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709124|NCT00544128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92709125|NCT00544128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92709126|NCT00544128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92709127|NCT00544128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92709152|NCT01239745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709153|NCT01239472|Everolimus|everolimus|mesh-list
92709154|NCT01239472|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92709155|NCT01239472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709156|NCT01239472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709157|NCT01239472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709158|NCT01239472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709159|NCT01239472|Immunologic Factors|immunologic factors|mesh-ancestor
92709160|NCT01239472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709161|NCT01239472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709162|NCT00544284|Temozolomide|temozolomide|mesh-list
92709163|NCT00544284|Bortezomib|bortezomib|mesh-list
92709164|NCT00544284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92709165|NCT00544284|Alkylating Agents|alkylating agents|mesh-ancestor
92709166|NCT00544284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709167|NCT00544284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709168|NCT02888275|Dexmedetomidine|dexmedetomidine|mesh-list
92709169|NCT02888275|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92709170|NCT02888275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709171|NCT02888275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709172|NCT02888275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92709173|NCT02888275|Analgesics|analgesics|mesh-ancestor
92709174|NCT02888275|Sensory System Agents|sensory system agents|mesh-ancestor
92709175|NCT02888275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709176|NCT02888275|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92709177|NCT02888275|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92709178|NCT02888275|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92709213|NCT02909049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709214|NCT02909049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92709215|NCT02909049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92709235|NCT01229449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709236|NCT01229449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709237|NCT01229449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92709238|NCT01229449|Narcotics|narcotics|mesh-ancestor
92709239|NCT01229449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709240|NCT01229449|Antitussive Agents|antitussive agents|mesh-ancestor
92709241|NCT01229449|Respiratory System Agents|respiratory system agents|mesh-ancestor
92709242|NCT01238575|Guanfacine|guanfacine|mesh-list
92709243|NCT01238575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92709244|NCT01238575|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92709245|NCT01238575|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92709246|NCT01238575|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92709247|NCT01238575|Adrenergic Agents|adrenergic agents|mesh-ancestor
92709248|NCT01238575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709249|NCT01238575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709250|NCT01238575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709251|NCT01237951|Dexamethasone|dexamethasone|mesh-list
92709252|NCT01237951|Gemcitabine|gemcitabine|mesh-list
92709253|NCT01237951|Melphalan|melphalan|mesh-list
92709254|NCT01237951|Busulfan|busulfan|mesh-list
92709255|NCT01237951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608200|NCT00135005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709256|NCT01237951|Antiemetics|antiemetics|mesh-ancestor
92709257|NCT01237951|Autonomic Agents|autonomic agents|mesh-ancestor
92709258|NCT01237951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709259|NCT01237951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709260|NCT01237951|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709261|NCT01237951|Glucocorticoids|glucocorticoids|mesh-ancestor
92709262|NCT01237951|Hormones|hormones|mesh-ancestor
92709263|NCT01237951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709264|NCT01237951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709265|NCT01237951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709266|NCT01237951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709267|NCT01237951|Antimetabolites|antimetabolites|mesh-ancestor
92709268|NCT01237951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709269|NCT01237951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92709270|NCT01237951|Alkylating Agents|alkylating agents|mesh-ancestor
92709271|NCT01237951|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92709272|NCT01237951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709273|NCT01237951|Immunologic Factors|immunologic factors|mesh-ancestor
92709287|NCT00544362|Immunologic Factors|immunologic factors|mesh-ancestor
92709288|NCT00544362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709289|NCT00544362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92709290|NCT01239394|Ofatumumab|ofatumumab|mesh-list
92709291|NCT01239394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709292|NCT00553293|Hormones|hormones|mesh-list
92709293|NCT00553293|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92709294|NCT00553293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709295|NCT00553293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709296|NCT04648358|Dexamethasone|dexamethasone|mesh-list
92709297|NCT04648358|Bupivacaine|bupivacaine|mesh-list
92709298|NCT04648358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709299|NCT04648358|Antiemetics|antiemetics|mesh-ancestor
92709300|NCT04648358|Autonomic Agents|autonomic agents|mesh-ancestor
92709301|NCT04648358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709302|NCT04648358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709303|NCT04648358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709304|NCT04648358|Glucocorticoids|glucocorticoids|mesh-ancestor
92709305|NCT04648358|Hormones|hormones|mesh-ancestor
92709306|NCT04648358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709307|NCT04648358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709308|NCT04648358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709309|NCT04648358|Anesthetics, Local|anesthetics, local|mesh-ancestor
92709310|NCT04648358|Anesthetics|anesthetics|mesh-ancestor
92709311|NCT04648358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709312|NCT04648358|Sensory System Agents|sensory system agents|mesh-ancestor
92709313|NCT00544518|Metformin|metformin|mesh-list
92709314|NCT00544518|Benfluorex|benfluorex|mesh-list
92709315|NCT00544518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92709316|NCT00544518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709317|NCT00544518|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92709318|NCT00544518|Antimetabolites|antimetabolites|mesh-ancestor
92709319|NCT00544518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709320|NCT00544518|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92709321|NCT00544518|Appetite Depressants|appetite depressants|mesh-ancestor
92709322|NCT00544518|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92709323|NCT02908698|Prednisone|prednisone|mesh-list
92709324|NCT02908698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709325|NCT02908698|Glucocorticoids|glucocorticoids|mesh-ancestor
92709326|NCT02908698|Hormones|hormones|mesh-ancestor
92709327|NCT02908698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709328|NCT02908698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709329|NCT02908698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709330|NCT02908698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709331|NCT00544596|Acetic Acid|acetic acid|mesh-list
92709332|NCT00544596|Etoposide|etoposide|mesh-list
92709333|NCT00544596|Etoposide phosphate|etoposide phosphate|mesh-list
92709335|NCT00544596|Gossypol acetic acid|gossypol acetic acid|mesh-list
92709336|NCT00544596|Gossypol|gossypol|mesh-list
92709337|NCT00544596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709338|NCT00544596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92709339|NCT00544596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92709349|NCT00544596|Protective Agents|protective agents|mesh-ancestor
92709350|NCT00544596|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92709351|NCT00544596|Contraceptive Agents|contraceptive agents|mesh-ancestor
92608201|NCT00135005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608202|NCT00142233|N-Methylaspartate|n-methylaspartate|mesh-list
92608203|NCT00142233|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92608204|NCT00142233|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92608205|NCT00142233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709352|NCT00544596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709353|NCT00544596|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92709354|NCT00544596|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92709355|NCT00544596|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92709357|NCT02908191|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92709358|NCT02908191|Entecavir|entecavir|mesh-list
92709359|NCT02908191|Antiviral Agents|antiviral agents|mesh-ancestor
92709360|NCT02908191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709361|NCT02908191|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92709362|NCT02908191|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92709363|NCT02908191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709364|NCT02908191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709365|NCT02908191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92709366|NCT02908191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92709367|NCT00544791|Melatonin|melatonin|mesh-list
92709368|NCT00544791|Antioxidants|antioxidants|mesh-ancestor
92709369|NCT00544791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709370|NCT00544791|Protective Agents|protective agents|mesh-ancestor
92709371|NCT00544791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709372|NCT00544791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709373|NCT04647773|Pregabalin|pregabalin|mesh-list
92709374|NCT04647773|Analgesics|analgesics|mesh-ancestor
92709375|NCT04647773|Sensory System Agents|sensory system agents|mesh-ancestor
92709376|NCT04647773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709377|NCT04647773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709378|NCT04647773|Anticonvulsants|anticonvulsants|mesh-ancestor
92709379|NCT04647773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92709380|NCT04647773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709381|NCT04647773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709382|NCT04647773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92709383|NCT04647773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92709384|NCT04647773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92709385|NCT04647773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709386|NCT04647773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709387|NCT01237678|Carboplatin|carboplatin|mesh-list
92709388|NCT01237678|Etoposide|etoposide|mesh-list
92709389|NCT01237678|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
92709390|NCT01237678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709391|NCT01237678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92709392|NCT01237678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92709393|NCT01237678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92709394|NCT01237678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709395|NCT01237678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709396|NCT01237678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92709397|NCT01237678|Immunotoxins|immunotoxins|mesh-ancestor
92709398|NCT01237678|Immunoconjugates|immunoconjugates|mesh-ancestor
92709399|NCT01237678|Immunologic Factors|immunologic factors|mesh-ancestor
92709400|NCT01237678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709401|NCT04647461|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92709402|NCT04647461|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92709403|NCT04647461|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92709427|NCT01237327|Exemestane|exemestane|mesh-list
92709428|NCT01237327|Megestrol|megestrol|mesh-list
92709429|NCT01237327|Megestrol Acetate|megestrol acetate|mesh-list
92709430|NCT01237327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709431|NCT01237327|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92709432|NCT01237327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92709433|NCT01237327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709434|NCT01237327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709435|NCT01237327|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92709436|NCT01237327|Hormone Antagonists|hormone antagonists|mesh-ancestor
92709437|NCT01237327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709438|NCT01237327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608206|NCT00142233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608207|NCT00142233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608208|NCT00135083|Insulin glulisine|insulin glulisine|mesh-list
92709439|NCT01237327|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92709440|NCT01237327|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92709441|NCT01237327|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92709442|NCT01237327|Contraceptive Agents|contraceptive agents|mesh-ancestor
92709443|NCT01237327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709444|NCT01237327|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92709445|NCT01237327|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92709446|NCT01237327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709447|NCT01237327|Appetite Stimulants|appetite stimulants|mesh-ancestor
92709448|NCT01237327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92709449|NCT02907021|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92709450|NCT02907021|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92709470|NCT04647344|Paclitaxel|paclitaxel|mesh-list
92709471|NCT04647344|Carboplatin|carboplatin|mesh-list
92709472|NCT04647344|Pemetrexed|pemetrexed|mesh-list
92709473|NCT04647344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92709474|NCT04647344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709475|NCT04647344|Tubulin Modulators|tubulin modulators|mesh-ancestor
92709476|NCT04647344|Antimitotic Agents|antimitotic agents|mesh-ancestor
92709477|NCT04647344|Mitosis Modulators|mitosis modulators|mesh-ancestor
92709478|NCT04647344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129240|NCT00344175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709480|NCT04647344|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92709481|NCT04647344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92709482|NCT02906748|Parathyroid Hormone|parathyroid hormone|mesh-list
92709483|NCT02906748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92709484|NCT02906748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709485|NCT02907957|Anesthetics|anesthetics|mesh-list
92709486|NCT02907957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709487|NCT02907957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709488|NCT04646876|Magnesium Sulfate|magnesium sulfate|mesh-list
92709489|NCT04646876|Analgesics|analgesics|mesh-ancestor
92709490|NCT04646876|Sensory System Agents|sensory system agents|mesh-ancestor
92709491|NCT04646876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709492|NCT04646876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709493|NCT04646876|Anesthetics|anesthetics|mesh-ancestor
92709494|NCT04646876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709495|NCT04646876|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92709496|NCT04646876|Anticonvulsants|anticonvulsants|mesh-ancestor
92709497|NCT04646876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92709498|NCT04646876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709499|NCT04646876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709500|NCT04646876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92709501|NCT04646876|Tocolytic Agents|tocolytic agents|mesh-ancestor
92709502|NCT04646876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709503|NCT02908035|Sirolimus|sirolimus|mesh-list
92709504|NCT02908035|Temsirolimus|temsirolimus|mesh-list
92709505|NCT02908035|MTOR Inhibitors|mtor inhibitors|mesh-list
92709515|NCT02908035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92709516|NCT02908035|Antifungal Agents|antifungal agents|mesh-ancestor
92709517|NCT04646759|Capecitabine|capecitabine|mesh-list
92709518|NCT04646759|Fulvestrant|fulvestrant|mesh-list
92709519|NCT04646759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709520|NCT04646759|Antimetabolites|antimetabolites|mesh-ancestor
92709521|NCT04646759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709522|NCT04646759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709523|NCT04646759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709524|NCT04646759|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92709525|NCT04646759|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92709526|NCT04646759|Hormone Antagonists|hormone antagonists|mesh-ancestor
92709527|NCT04646759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709528|NCT04646759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709529|NCT02906514|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92709530|NCT02906514|Plasma Substitutes|plasma substitutes|mesh-ancestor
92709531|NCT02906514|Blood Substitutes|blood substitutes|mesh-ancestor
92709532|NCT04646135|Lorazepam|lorazepam|mesh-list
92709533|NCT04646135|Anticonvulsants|anticonvulsants|mesh-ancestor
92608209|NCT00135083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608210|NCT00135083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608211|NCT04725357|Meloxicam|meloxicam|mesh-list
92608212|NCT04725357|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608213|NCT04725357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608214|NCT04725357|Analgesics|analgesics|mesh-ancestor
92015460|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92709534|NCT04646135|Antiemetics|antiemetics|mesh-ancestor
92709535|NCT04646135|Autonomic Agents|autonomic agents|mesh-ancestor
92709536|NCT04646135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709537|NCT04646135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709538|NCT04646135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709539|NCT04646135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92709540|NCT04646135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709541|NCT04646135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92709542|NCT04646135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92709543|NCT04646135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709544|NCT04646135|GABA Modulators|gaba modulators|mesh-ancestor
92709545|NCT04646135|GABA Agents|gaba agents|mesh-ancestor
92709546|NCT04646135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709547|NCT04646135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709548|NCT02906553|Nitroglycerin|nitroglycerin|mesh-list
92709549|NCT02906553|Vasodilator Agents|vasodilator agents|mesh-ancestor
92709550|NCT04682184|Propranolol|propranolol|mesh-list
92709551|NCT04682184|Pseudoephedrine|pseudoephedrine|mesh-list
92709552|NCT04682184|Ephedrine|ephedrine|mesh-list
92709553|NCT04682184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92709554|NCT04682184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92709556|NCT04682184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709557|NCT04682184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709558|NCT04682184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709559|NCT04682184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92709560|NCT04682184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92709561|NCT04682184|Vasodilator Agents|vasodilator agents|mesh-ancestor
92709562|NCT04682184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92709563|NCT04682184|Autonomic Agents|autonomic agents|mesh-ancestor
92709564|NCT04682184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709565|NCT04682184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92709566|NCT04682184|Respiratory System Agents|respiratory system agents|mesh-ancestor
92709567|NCT04682184|Nasal Decongestants|nasal decongestants|mesh-ancestor
92709568|NCT04682184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92709569|NCT04682184|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92709570|NCT04682184|Sympathomimetics|sympathomimetics|mesh-ancestor
92709571|NCT04645940|Rabeprazole|rabeprazole|mesh-list
92709596|NCT00558662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92709597|NCT00558662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92709598|NCT00558662|Coccidiostats|coccidiostats|mesh-ancestor
92709599|NCT00558662|Proton Ionophores|proton ionophores|mesh-ancestor
92709600|NCT00558662|Uncoupling Agents|uncoupling agents|mesh-ancestor
92709601|NCT00558662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709602|NCT00558662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709603|NCT00558662|Ionophores|ionophores|mesh-ancestor
92709604|NCT00558662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709605|NCT00558662|Sodium Ionophores|sodium ionophores|mesh-ancestor
92709606|NCT02905890|Norethindrone|norethindrone|mesh-list
92709607|NCT02905890|Norethindrone enanthate|norethindrone enanthate|mesh-list
92709608|NCT02905890|Norethindrone Acetate|norethindrone acetate|mesh-list
92709609|NCT02905890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92709610|NCT02905890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92709611|NCT02905890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92709612|NCT02905890|Contraceptive Agents|contraceptive agents|mesh-ancestor
92709613|NCT02905890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709614|NCT02905890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709615|NCT02905890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92709616|NCT02905890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92709617|NCT02906163|Gefitinib|gefitinib|mesh-list
92709618|NCT02906163|Afatinib|afatinib|mesh-list
92709619|NCT02906163|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92709620|NCT02906163|Thymalfasin|thymalfasin|mesh-list
92709621|NCT02906163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608215|NCT04725357|Sensory System Agents|sensory system agents|mesh-ancestor
92608216|NCT04725357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608217|NCT04725357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608218|NCT04725357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709634|NCT04645745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709635|NCT02905695|Levobupivacaine|levobupivacaine|mesh-list
92709636|NCT02905695|Anesthetics, Local|anesthetics, local|mesh-ancestor
92709637|NCT02905695|Anesthetics|anesthetics|mesh-ancestor
92709638|NCT02905695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709639|NCT02905695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709640|NCT02905695|Sensory System Agents|sensory system agents|mesh-ancestor
92709641|NCT02905695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709642|NCT00558818|Clevudine|clevudine|mesh-list
92709643|NCT00558818|Antiviral Agents|antiviral agents|mesh-ancestor
92709644|NCT00558818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709645|NCT04644341|Respiratory System Agents|respiratory system agents|mesh-list
92709646|NCT04681911|Paclitaxel|paclitaxel|mesh-list
92709647|NCT04681911|Vinorelbine|vinorelbine|mesh-list
92709648|NCT04681911|Carboplatin|carboplatin|mesh-list
92709649|NCT04681911|Gemcitabine|gemcitabine|mesh-list
92709650|NCT04681911|Capecitabine|capecitabine|mesh-list
92709651|NCT04681911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92709652|NCT04681911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709653|NCT04681911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92709654|NCT04681911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92709655|NCT04681911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92709656|NCT04681911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709657|NCT04681911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709658|NCT04681911|Antimetabolites|antimetabolites|mesh-ancestor
92709659|NCT02905539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92709660|NCT02905539|Hematinics|hematinics|mesh-ancestor
92709661|NCT02905734|Nicotine|nicotine|mesh-list
92709662|NCT02905734|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92709663|NCT02905734|Autonomic Agents|autonomic agents|mesh-ancestor
92709664|NCT02905734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709665|NCT02905734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709666|NCT02905734|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92709667|NCT02905734|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92709668|NCT02905734|Cholinergic Agents|cholinergic agents|mesh-ancestor
92709669|NCT02905734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709670|NCT02905734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709671|NCT04644185|Myeloma Proteins|myeloma proteins|mesh-list
92709672|NCT04644185|Paraproteins|paraproteins|mesh-list
92709673|NCT04644185|Immunologic Factors|immunologic factors|mesh-ancestor
92709674|NCT04644185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709675|NCT02905461|Contraceptive Agents|contraceptive agents|mesh-list
92709676|NCT02905461|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92709677|NCT02905461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709678|NCT02905305|Dexamethasone|dexamethasone|mesh-list
92709679|NCT02905305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709680|NCT02905305|Antiemetics|antiemetics|mesh-ancestor
92709681|NCT02905305|Autonomic Agents|autonomic agents|mesh-ancestor
92709682|NCT02905305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709683|NCT02905305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709684|NCT02905305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709685|NCT02905305|Glucocorticoids|glucocorticoids|mesh-ancestor
92709686|NCT02905305|Hormones|hormones|mesh-ancestor
92709687|NCT02905305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709699|NCT02899182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709700|NCT02905227|Zolmitriptan|zolmitriptan|mesh-list
92709701|NCT02905227|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92709702|NCT02905227|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92709703|NCT02905227|Serotonin Agents|serotonin agents|mesh-ancestor
92709704|NCT02905227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709705|NCT02905227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709706|NCT02905227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709708|NCT04643483|Certolizumab Pegol|certolizumab pegol|mesh-list
92709709|NCT04643483|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92709710|NCT04643483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709711|NCT04643483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92709712|NCT04643483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709713|NCT04643483|Immunologic Factors|immunologic factors|mesh-ancestor
92608219|NCT04725357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608220|NCT04725357|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92709714|NCT04643483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709715|NCT00559052|Pancrelipase|pancrelipase|mesh-list
92709716|NCT00559052|Pancreatin|pancreatin|mesh-list
92709717|NCT00559052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709718|NCT02899104|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92709719|NCT02899104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709720|NCT04643132|Ketamine|ketamine|mesh-list
92709721|NCT04643132|Esketamine|esketamine|mesh-list
92709722|NCT04643132|Analgesics|analgesics|mesh-ancestor
92709723|NCT04643132|Sensory System Agents|sensory system agents|mesh-ancestor
92709724|NCT04643132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709725|NCT04643132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709726|NCT04643132|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92709727|NCT04643132|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92709728|NCT04643132|Anesthetics, General|anesthetics, general|mesh-ancestor
92709729|NCT04643132|Anesthetics|anesthetics|mesh-ancestor
92709730|NCT04643132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709731|NCT04643132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92709732|NCT04643132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92709733|NCT04643132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709734|NCT04643132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709735|NCT04643132|Antidepressive Agents|antidepressive agents|mesh-ancestor
92709736|NCT04643132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709737|NCT02899143|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92709738|NCT02899143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709739|NCT02899026|Prednisone|prednisone|mesh-list
92709740|NCT02899026|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92709741|NCT02899026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709742|NCT02899026|Glucocorticoids|glucocorticoids|mesh-ancestor
92709743|NCT02899026|Hormones|hormones|mesh-ancestor
92709744|NCT02899026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709745|NCT02899026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709746|NCT02899026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709747|NCT02899026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709748|NCT02899026|Immunologic Factors|immunologic factors|mesh-ancestor
92709749|NCT00559169|Verapamil|verapamil|mesh-list
92709750|NCT00559169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92709751|NCT00559169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92709752|NCT00559169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709768|NCT04642547|Lenvatinib|lenvatinib|mesh-list
92709769|NCT04642547|Gefitinib|gefitinib|mesh-list
92709770|NCT04642547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709771|NCT04642547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709772|NCT04642547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709773|NCT04642547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709774|NCT02898792|Remifentanil|remifentanil|mesh-list
92709775|NCT02898792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92709776|NCT02898792|Narcotics|narcotics|mesh-ancestor
92709777|NCT02898792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709778|NCT02898792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709779|NCT02898792|Analgesics|analgesics|mesh-ancestor
92709780|NCT02898792|Sensory System Agents|sensory system agents|mesh-ancestor
92709781|NCT02898792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709782|NCT04642391|Cosyntropin|cosyntropin|mesh-list
92709783|NCT04642391|Hormones|hormones|mesh-ancestor
92709784|NCT04642391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709785|NCT04642391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709786|NCT02904564|Fluorouracil|fluorouracil|mesh-list
92709787|NCT02904564|Antimetabolites|antimetabolites|mesh-ancestor
92709788|NCT02904564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709789|NCT02904564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709790|NCT02904564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709791|NCT02904564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709792|NCT02904564|Immunologic Factors|immunologic factors|mesh-ancestor
92709793|NCT02904564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709794|NCT04642001|Listerine|listerine|mesh-list
92709795|NCT04642001|Sodium Fluoride|sodium fluoride|mesh-list
92709796|NCT04642001|Cariostatic Agents|cariostatic agents|mesh-ancestor
92709797|NCT04642001|Protective Agents|protective agents|mesh-ancestor
92709798|NCT04642001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709799|NCT04642001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92709800|NCT04642001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608221|NCT04725357|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608222|NCT04725357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608223|NCT04725357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709802|NCT00559286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92709803|NCT00559286|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92709804|NCT00559286|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92709805|NCT00559286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709806|NCT04640870|Afatinib|afatinib|mesh-list
92709807|NCT04640870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709808|NCT04640870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709809|NCT04640870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709810|NCT04640870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709825|NCT02897934|Sensory System Agents|sensory system agents|mesh-ancestor
92709826|NCT02897934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709827|NCT04640129|Interferons|interferons|mesh-list
92709828|NCT04640129|Tenofovir|tenofovir|mesh-list
92709829|NCT04640129|Interferon-alpha|interferon-alpha|mesh-list
92709830|NCT04640129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709831|NCT04640129|Antiviral Agents|antiviral agents|mesh-ancestor
92709832|NCT04640129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709833|NCT04640129|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92709834|NCT04640129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92709835|NCT04640129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709836|NCT04640129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709837|NCT04640129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92709838|NCT04640129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92709839|NCT04640129|Immunologic Factors|immunologic factors|mesh-ancestor
92709840|NCT04640129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709841|NCT02898012|Bevacizumab|bevacizumab|mesh-list
92709842|NCT02898012|Temozolomide|temozolomide|mesh-list
92709843|NCT02898012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129616|NCT05800288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129617|NCT05800288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129618|NCT05800288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92129619|NCT05800288|Anesthetics, General|anesthetics, general|mesh-ancestor
92129620|NCT05800288|Anesthetics|anesthetics|mesh-ancestor
92129631|NCT05800106|Sunitinib|sunitinib|mesh-list
92129632|NCT05800106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129633|NCT05800106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92129634|NCT05800106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129635|NCT05800106|Growth Substances|growth substances|mesh-ancestor
92709844|NCT02898012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709845|NCT02898012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92709846|NCT02898012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92709847|NCT02898012|Growth Substances|growth substances|mesh-ancestor
92709848|NCT02898012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709849|NCT02898012|Growth Inhibitors|growth inhibitors|mesh-ancestor
92709850|NCT02898012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92709851|NCT02898012|Alkylating Agents|alkylating agents|mesh-ancestor
92709852|NCT02898012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709853|NCT04640324|Vitamin D|vitamin d|mesh-list
92709854|NCT04640324|Vitamins|vitamins|mesh-list
92709855|NCT04640324|Vitamin E|vitamin e|mesh-list
92709856|NCT04640324|Silybin|silybin|mesh-list
92709857|NCT04640324|Micronutrients|micronutrients|mesh-ancestor
92709858|NCT04640324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709859|NCT04640324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92709860|NCT04640324|Antioxidants|antioxidants|mesh-ancestor
92709861|NCT04640324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709865|NCT04640285|Menthol|menthol|mesh-list
92709866|NCT04640285|Nicotine|nicotine|mesh-list
92709867|NCT04640285|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92709868|NCT04640285|Autonomic Agents|autonomic agents|mesh-ancestor
92709869|NCT04640285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709870|NCT04640285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709871|NCT04640285|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92709872|NCT04640285|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92709873|NCT04640285|Cholinergic Agents|cholinergic agents|mesh-ancestor
92709874|NCT04640285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709875|NCT04640285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608225|NCT00135122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92608226|NCT00135122|Methylprednisolone|methylprednisolone|mesh-list
92709876|NCT04640285|Antipruritics|antipruritics|mesh-ancestor
92709877|NCT04640285|Dermatologic Agents|dermatologic agents|mesh-ancestor
92709878|NCT00559481|Ketoconazole|ketoconazole|mesh-list
92709879|NCT00559481|Dexamethasone|dexamethasone|mesh-list
92709880|NCT00559481|Hydrocortisone|hydrocortisone|mesh-list
92709881|NCT00559481|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92709882|NCT00559481|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92709883|NCT00559481|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92709884|NCT00559481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709885|NCT00559481|Antiemetics|antiemetics|mesh-ancestor
92709886|NCT00559481|Autonomic Agents|autonomic agents|mesh-ancestor
92709887|NCT00559481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709888|NCT00559481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709889|NCT00559481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709890|NCT00559481|Glucocorticoids|glucocorticoids|mesh-ancestor
92709891|NCT00559481|Hormones|hormones|mesh-ancestor
92709892|NCT00559481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92709893|NCT00559481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709894|NCT00559481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709895|NCT00559481|Antifungal Agents|antifungal agents|mesh-ancestor
92709896|NCT00559481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709897|NCT00559481|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92709898|NCT00559481|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92709899|NCT00559481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709900|NCT00559481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709901|NCT00559481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92709902|NCT00559481|Hormone Antagonists|hormone antagonists|mesh-ancestor
92709903|NCT00559481|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92709904|NCT02897856|Midazolam|midazolam|mesh-list
92709905|NCT02897856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92709906|NCT02897856|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373792|NCT05463354|Vaccines|vaccines|mesh-list
92709907|NCT02897856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709908|NCT02897856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709909|NCT02897856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92709910|NCT02897856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92709911|NCT02897856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709912|NCT02897856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92709913|NCT02897856|Anesthetics, General|anesthetics, general|mesh-ancestor
92709914|NCT02897856|Anesthetics|anesthetics|mesh-ancestor
92709915|NCT02897856|GABA Modulators|gaba modulators|mesh-ancestor
92709916|NCT02897856|GABA Agents|gaba agents|mesh-ancestor
92709917|NCT02897856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709918|NCT02897856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709919|NCT01236118|Ixekizumab|ixekizumab|mesh-list
92709920|NCT01236118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92709921|NCT04206631|Doxycycline|doxycycline|mesh-list
92709922|NCT04206631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92709923|NCT04206631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709924|NCT04206631|Antimalarials|antimalarials|mesh-ancestor
92709925|NCT04206631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92709926|NCT04206631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92709927|NCT04639817|Levofloxacin|levofloxacin|mesh-list
92709928|NCT04639817|Trimethoprim|trimethoprim|mesh-list
92709929|NCT04639817|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92709930|NCT04639817|Sulfamethoxazole|sulfamethoxazole|mesh-list
92709931|NCT04639817|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92709932|NCT04639817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709933|NCT04639817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92709934|NCT04639817|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92709937|NCT04639817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709938|NCT04639817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709939|NCT04639817|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92709940|NCT04639817|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92709941|NCT04639817|Antimalarials|antimalarials|mesh-ancestor
92709942|NCT04639817|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92709943|NCT04639817|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92709944|NCT04639817|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92709945|NCT04639817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92709946|NCT04639817|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92709947|NCT01236001|Lacosamide|lacosamide|mesh-list
92608227|NCT00135122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92608228|NCT00135122|Prednisolone acetate|prednisolone acetate|mesh-list
92709948|NCT01236001|Anticonvulsants|anticonvulsants|mesh-ancestor
92709949|NCT01236001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92709950|NCT01236001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92709951|NCT01236001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709952|NCT01236001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709953|NCT02897466|Anti-Infective Agents|anti-infective agents|mesh-list
92709954|NCT02897466|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92709955|NCT01229254|Amiodarone|amiodarone|mesh-list
92709956|NCT01229254|Betrixaban|betrixaban|mesh-list
92709957|NCT01229254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92709958|NCT01229254|Vasodilator Agents|vasodilator agents|mesh-ancestor
92709959|NCT01229254|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92709960|NCT01229254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709961|NCT01229254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709962|NCT01229254|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92709963|NCT01229254|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92709964|NCT01229254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92709965|NCT01229254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709966|NCT01229254|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92709967|NCT01229254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92709968|NCT01229254|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92709969|NCT01229254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92709970|NCT01229254|Antithrombins|antithrombins|mesh-ancestor
92709971|NCT01229254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92709972|NCT01229254|Protease Inhibitors|protease inhibitors|mesh-ancestor
92709973|NCT01229254|Anticoagulants|anticoagulants|mesh-ancestor
92709974|NCT04639232|Probenecid|probenecid|mesh-list
92709975|NCT04639232|Uricosuric Agents|uricosuric agents|mesh-ancestor
92709976|NCT04639232|Gout Suppressants|gout suppressants|mesh-ancestor
92709977|NCT04639232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92709978|NCT01235728|Calcitriol|calcitriol|mesh-list
92709979|NCT01235728|MK 0873|mk 0873|mesh-list
92709980|NCT01235728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92709981|NCT01235728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709982|NCT01235728|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92709983|NCT01235728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92709984|NCT01235728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709985|NCT01235728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92709986|NCT01235728|Vitamins|vitamins|mesh-ancestor
92709987|NCT01235728|Micronutrients|micronutrients|mesh-ancestor
92709988|NCT01235728|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92709989|NCT01235728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92709990|NCT01235728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92709991|NCT01235728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709992|NCT00559676|Leucovorin|leucovorin|mesh-list
92709993|NCT00559676|Fluorouracil|fluorouracil|mesh-list
92709994|NCT00559676|Capecitabine|capecitabine|mesh-list
92709995|NCT00559676|Oxaliplatin|oxaliplatin|mesh-list
92709996|NCT00559676|Irinotecan|irinotecan|mesh-list
92709997|NCT00559676|Calcium|calcium|mesh-list
92709998|NCT00559676|Levoleucovorin|levoleucovorin|mesh-list
92709999|NCT00559676|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92710000|NCT00559676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710001|NCT00559676|Antimetabolites|antimetabolites|mesh-ancestor
92710002|NCT00559676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710003|NCT00559676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92710004|NCT00559676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710005|NCT00559676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710006|NCT00559676|Immunologic Factors|immunologic factors|mesh-ancestor
92710007|NCT00559676|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92710011|NCT00559676|Protective Agents|protective agents|mesh-ancestor
92710012|NCT00559676|Vitamin B Complex|vitamin b complex|mesh-ancestor
92710013|NCT00559676|Vitamins|vitamins|mesh-ancestor
92710014|NCT00559676|Micronutrients|micronutrients|mesh-ancestor
92710015|NCT04639271|Trastuzumab|trastuzumab|mesh-list
92710016|NCT04639271|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92710017|NCT04639271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710018|NCT04639271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710019|NCT04681053|Ivermectin|ivermectin|mesh-list
92710020|NCT04681053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92710021|NCT04681053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710022|NCT04639193|Acetazolamide|acetazolamide|mesh-list
92608229|NCT00135122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92608230|NCT00135122|Prednisolone phosphate|prednisolone phosphate|mesh-list
92608231|NCT00135122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710023|NCT04639193|Eszopiclone|eszopiclone|mesh-list
92710024|NCT04639193|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92710025|NCT04639193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92710026|NCT04639193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92710027|NCT04639193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710028|NCT04639193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710029|NCT04639193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710030|NCT04639193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710031|NCT04639193|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92710032|NCT04639193|Antidepressive Agents|antidepressive agents|mesh-ancestor
92710033|NCT04639193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92710034|NCT04639193|Anticonvulsants|anticonvulsants|mesh-ancestor
92710035|NCT04639193|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92710036|NCT04639193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710037|NCT04639193|Diuretics|diuretics|mesh-ancestor
92710038|NCT04639193|Natriuretic Agents|natriuretic agents|mesh-ancestor
92710039|NCT04639193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92710040|NCT04639193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710041|NCT01235689|Prednisone|prednisone|mesh-list
92710042|NCT01235689|Adalimumab|adalimumab|mesh-list
92710043|NCT01235689|Azathioprine|azathioprine|mesh-list
92710044|NCT01235689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710045|NCT01235689|Glucocorticoids|glucocorticoids|mesh-ancestor
92710046|NCT01235689|Hormones|hormones|mesh-ancestor
92710047|NCT01235689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710048|NCT01235689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710049|NCT01235689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92710050|NCT01235689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710051|NCT01235689|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92710052|NCT01235689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710053|NCT01235689|Antimetabolites|antimetabolites|mesh-ancestor
92710054|NCT01235689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710055|NCT01235689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92710056|NCT01235689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710057|NCT01235689|Immunologic Factors|immunologic factors|mesh-ancestor
92710058|NCT04638686|Lamivudine|lamivudine|mesh-list
92710059|NCT04638686|Dolutegravir|dolutegravir|mesh-list
92710060|NCT04638686|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92710061|NCT04638686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92710062|NCT04638686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710063|NCT04638686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710064|NCT04638686|Antiviral Agents|antiviral agents|mesh-ancestor
92710065|NCT04638686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710066|NCT04638686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92710067|NCT04638686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92129864|NCT05702333|Simendan|simendan|mesh-list
92710068|NCT04638686|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92710069|NCT04638686|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92710070|NCT04680819|Propolis|propolis|mesh-list
92710071|NCT04680819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710072|NCT02896842|Imatinib Mesylate|imatinib mesylate|mesh-list
92710073|NCT02896842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710074|NCT02896842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92710075|NCT02896842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710076|NCT02896842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710077|NCT00559715|Bevacizumab|bevacizumab|mesh-list
92710078|NCT00559715|Ranibizumab|ranibizumab|mesh-list
92710079|NCT00559715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710084|NCT00559715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710085|NCT00559715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92710086|NCT02896803|Fluorouracil|fluorouracil|mesh-list
92710087|NCT02896803|Oxaliplatin|oxaliplatin|mesh-list
92710088|NCT02896803|Antimetabolites|antimetabolites|mesh-ancestor
92710089|NCT02896803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710090|NCT02896803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92710091|NCT02896803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710092|NCT02896803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608233|NCT00135122|Hormones|hormones|mesh-ancestor
92608234|NCT00135122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608235|NCT00135122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710093|NCT02896803|Immunologic Factors|immunologic factors|mesh-ancestor
92710094|NCT02896803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710095|NCT02897037|Heparin|heparin|mesh-list
92710096|NCT02897037|Bivalirudin|bivalirudin|mesh-list
92710097|NCT02897037|Anticoagulants|anticoagulants|mesh-ancestor
92710098|NCT02897037|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92710099|NCT02897037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92710100|NCT02897037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710101|NCT02897037|Antithrombins|antithrombins|mesh-ancestor
92710102|NCT02897037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92710103|NCT02897037|Protease Inhibitors|protease inhibitors|mesh-ancestor
92710104|NCT02897037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710105|NCT00553683|Cyclophosphamide|cyclophosphamide|mesh-list
92710106|NCT00553683|Poly ICLC|poly iclc|mesh-list
92710107|NCT00553683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710108|NCT00553683|Immunologic Factors|immunologic factors|mesh-ancestor
92710109|NCT00553683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710110|NCT00553683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710111|NCT00553683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92710112|NCT00553683|Alkylating Agents|alkylating agents|mesh-ancestor
92710113|NCT00553683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710114|NCT00553683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710115|NCT00553683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92710116|NCT00553683|Interferon Inducers|interferon inducers|mesh-ancestor
92710117|NCT01229176|Vaccines|vaccines|mesh-list
92710118|NCT01229176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92710119|NCT01229176|Immunologic Factors|immunologic factors|mesh-ancestor
92710120|NCT01229176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710121|NCT01228747|Levetiracetam|levetiracetam|mesh-list
92710122|NCT01228747|Anticonvulsants|anticonvulsants|mesh-ancestor
92710123|NCT01228747|Nootropic Agents|nootropic agents|mesh-ancestor
92710124|NCT02896413|Dexmedetomidine|dexmedetomidine|mesh-list
92710125|NCT02896413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92710126|NCT02896413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710127|NCT02896413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710128|NCT02896413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710129|NCT02896413|Analgesics|analgesics|mesh-ancestor
92710130|NCT02896413|Sensory System Agents|sensory system agents|mesh-ancestor
92710131|NCT02896413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710132|NCT02896413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92710133|NCT02896413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92710134|NCT02896413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92710135|NCT02896413|Adrenergic Agents|adrenergic agents|mesh-ancestor
92710136|NCT02896413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710137|NCT02896413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710138|NCT00553722|Eplerenone|eplerenone|mesh-list
92710139|NCT00553722|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92710140|NCT00553722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92710141|NCT00553722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710142|NCT00553722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710143|NCT00553722|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92710144|NCT00553722|Diuretics|diuretics|mesh-ancestor
92710145|NCT00553722|Natriuretic Agents|natriuretic agents|mesh-ancestor
92710146|NCT00553722|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92710147|NCT01235338|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92710148|NCT01235338|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92710149|NCT01235338|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92710160|NCT01235338|Dopamine Agents|dopamine agents|mesh-ancestor
92710161|NCT01234675|Milnacipran|milnacipran|mesh-list
92710162|NCT01234675|Levomilnacipran|levomilnacipran|mesh-list
92710163|NCT01234675|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92710164|NCT01234675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92710165|NCT01234675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710166|NCT01234675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710167|NCT01234675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710168|NCT01234675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608236|NCT00135122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608237|NCT00135122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608238|NCT00135122|Antiemetics|antiemetics|mesh-ancestor
92608239|NCT00135122|Autonomic Agents|autonomic agents|mesh-ancestor
92608240|NCT00135122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608241|NCT00135122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015487|NCT05165251|Amlodipine|amlodipine|mesh-list
92710169|NCT01234675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710170|NCT01234675|Analgesics|analgesics|mesh-ancestor
92710171|NCT01234675|Sensory System Agents|sensory system agents|mesh-ancestor
92710172|NCT01234675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710173|NCT01234675|Antidepressive Agents|antidepressive agents|mesh-ancestor
92710174|NCT01234675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92710175|NCT02896101|Pimecrolimus|pimecrolimus|mesh-list
92710176|NCT02896101|Tacrolimus|tacrolimus|mesh-list
92710177|NCT02896101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92710178|NCT02896101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710179|NCT02896101|Analgesics|analgesics|mesh-ancestor
92710180|NCT02896101|Sensory System Agents|sensory system agents|mesh-ancestor
92710181|NCT02896101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710182|NCT02896101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710183|NCT02896101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710184|NCT02896101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710185|NCT02896101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92710186|NCT02896101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710187|NCT02896101|Immunologic Factors|immunologic factors|mesh-ancestor
92710188|NCT02896101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92710189|NCT02896101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710190|NCT02896101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710191|NCT02896023|Menotropins|menotropins|mesh-list
92710192|NCT02896023|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92710193|NCT02896023|Fertility Agents|fertility agents|mesh-ancestor
92710194|NCT02896023|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92710195|NCT02896023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710196|NCT04637633|Lubricant Eye Drops|lubricant eye drops|mesh-list
92710197|NCT04637633|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92710198|NCT04637633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92710199|NCT01228318|Zoledronic Acid|zoledronic acid|mesh-list
92710200|NCT01228318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92710201|NCT01228318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710202|NCT02895672|Exenatide|exenatide|mesh-list
92710203|NCT02895672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710204|NCT02895672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710205|NCT02895672|Incretins|incretins|mesh-ancestor
92710206|NCT02895672|Hormones|hormones|mesh-ancestor
92710207|NCT02895672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710208|NCT02895672|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92710209|NCT01227967|Ribavirin|ribavirin|mesh-list
92710210|NCT01227967|Oseltamivir|oseltamivir|mesh-list
92710211|NCT01227967|Amantadine|amantadine|mesh-list
92129988|NCT05353283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710217|NCT01227967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92710218|NCT01227967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92710219|NCT01227967|Dopamine Agents|dopamine agents|mesh-ancestor
92710220|NCT01227967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710221|NCT01227967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710222|NCT01227967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710223|NCT01227967|Analgesics|analgesics|mesh-ancestor
92710224|NCT01227967|Sensory System Agents|sensory system agents|mesh-ancestor
92710225|NCT01227967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710226|NCT00560144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92710227|NCT00560144|Immunologic Factors|immunologic factors|mesh-ancestor
92373865|NCT01309074|Anticonvulsants|anticonvulsants|mesh-ancestor
92710228|NCT00560144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710230|NCT04637204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710231|NCT04637204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92710232|NCT04637204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710233|NCT04637204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710234|NCT04637360|Calcitriol|calcitriol|mesh-list
92710235|NCT04637360|Cinacalcet|cinacalcet|mesh-list
92710236|NCT04637360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608242|NCT00135122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92608243|NCT00135122|Protective Agents|protective agents|mesh-ancestor
92608244|NCT00142350|Fluorouracil|fluorouracil|mesh-list
92608245|NCT00142350|Irinotecan|irinotecan|mesh-list
92608246|NCT00142350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608247|NCT00142350|Antimetabolites|antimetabolites|mesh-ancestor
92710237|NCT04637360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710238|NCT04637360|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92710239|NCT04637360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710240|NCT04637360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710241|NCT04637360|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92710242|NCT04637360|Vitamins|vitamins|mesh-ancestor
92710243|NCT04637360|Micronutrients|micronutrients|mesh-ancestor
92710244|NCT04637360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92710245|NCT04637360|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92710246|NCT04637360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92710247|NCT04637360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710248|NCT04317703|Metformin|metformin|mesh-list
92710249|NCT04317703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710250|NCT04317703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710251|NCT00560222|Lactoferrin|lactoferrin|mesh-list
92710252|NCT00560222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710253|NCT04317508|Benzocaine|benzocaine|mesh-list
92710254|NCT04317508|Anesthetics, Local|anesthetics, local|mesh-ancestor
92710255|NCT04317508|Anesthetics|anesthetics|mesh-ancestor
92710256|NCT04317508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710257|NCT04317508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710258|NCT04317508|Sensory System Agents|sensory system agents|mesh-ancestor
92710259|NCT04317508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710260|NCT00560300|Vitamin D|vitamin d|mesh-list
92710261|NCT00560300|Cholecalciferol|cholecalciferol|mesh-list
92710262|NCT00560300|Calcitriol|calcitriol|mesh-list
92710263|NCT00560300|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92710264|NCT00560300|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92710265|NCT00560300|Calcium Carbonate|calcium carbonate|mesh-list
92710266|NCT00560300|Calcium|calcium|mesh-list
92710267|NCT00560300|Sevelamer|sevelamer|mesh-list
92710268|NCT00560300|Vitamins|vitamins|mesh-ancestor
92710269|NCT00560300|Micronutrients|micronutrients|mesh-ancestor
92710270|NCT00560300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710271|NCT00560300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92710272|NCT00560300|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92710273|NCT00560300|Antacids|antacids|mesh-ancestor
92710274|NCT00560300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710275|NCT00560300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710276|NCT00560300|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92710277|NCT00560300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710278|NCT00560300|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92710279|NCT00560300|Chelating Agents|chelating agents|mesh-ancestor
92710280|NCT00560300|Sequestering Agents|sequestering agents|mesh-ancestor
92710281|NCT02904369|Tenofovir|tenofovir|mesh-list
92710286|NCT02904369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92710287|NCT02904369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710288|NCT02904369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710289|NCT02904369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92710290|NCT02904369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92130068|NCT04929626|Albuterol|albuterol|mesh-list
92710291|NCT00560378|Tacrolimus|tacrolimus|mesh-list
92710292|NCT00560378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710294|NCT00560378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710295|NCT00560378|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92710296|NCT00560378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710297|NCT00560378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710298|NCT02895321|Listerine|listerine|mesh-list
92710299|NCT02895321|Sodium Fluoride|sodium fluoride|mesh-list
92710300|NCT02895321|Cariostatic Agents|cariostatic agents|mesh-ancestor
92710301|NCT02895321|Protective Agents|protective agents|mesh-ancestor
92710302|NCT02895321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710303|NCT02895321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92710304|NCT02895321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710305|NCT02894892|Esomeprazole|esomeprazole|mesh-list
92710306|NCT02894892|Bismuth|bismuth|mesh-list
92608248|NCT00142350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608249|NCT00142350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608250|NCT00142350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710307|NCT02894892|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92710308|NCT02894892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710309|NCT02894892|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92710310|NCT02894892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710311|NCT02894892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710312|NCT02894892|Antacids|antacids|mesh-ancestor
92710313|NCT04635566|Mebeverine|mebeverine|mesh-list
92710314|NCT04635566|Alverine|alverine|mesh-list
92710315|NCT04635566|Anticonvulsants|anticonvulsants|mesh-ancestor
92710316|NCT04635566|Parasympatholytics|parasympatholytics|mesh-ancestor
92710317|NCT04635566|Autonomic Agents|autonomic agents|mesh-ancestor
92710318|NCT04635566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710319|NCT04635566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710320|NCT04635293|Simendan|simendan|mesh-list
92710321|NCT04635293|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92710322|NCT04635293|Vasodilator Agents|vasodilator agents|mesh-ancestor
92710323|NCT04635293|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92710324|NCT04635293|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92710325|NCT04635293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710326|NCT04635293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710327|NCT04635293|Protective Agents|protective agents|mesh-ancestor
92710328|NCT04635293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710329|NCT01227889|Dacarbazine|dacarbazine|mesh-list
92710330|NCT01227889|Dabrafenib|dabrafenib|mesh-list
92710331|NCT01227889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92710332|NCT01227889|Alkylating Agents|alkylating agents|mesh-ancestor
92710333|NCT01227889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710334|NCT01227889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710335|NCT01227889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92710336|NCT01227889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710337|NCT02888392|Psyllium|psyllium|mesh-list
92710338|NCT02888392|Cathartics|cathartics|mesh-ancestor
92710339|NCT02888392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710340|NCT00624676|Salicylic Acid|salicylic acid|mesh-list
92710341|NCT00624676|Benzoic Acid|benzoic acid|mesh-list
92710342|NCT00624676|Salicylates|salicylates|mesh-list
92710343|NCT00624676|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92710344|NCT00624676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92710345|NCT00624676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710346|NCT00624676|Antifungal Agents|antifungal agents|mesh-ancestor
92710347|NCT00624676|Keratolytic Agents|keratolytic agents|mesh-ancestor
92710348|NCT00624676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92710349|NCT00624676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710350|NCT00624676|Analgesics|analgesics|mesh-ancestor
92710351|NCT00624676|Sensory System Agents|sensory system agents|mesh-ancestor
92710352|NCT00624676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710353|NCT00624676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710354|NCT00624676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710355|NCT00624676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710365|NCT05655715|Nivolumab|nivolumab|mesh-list
92710366|NCT05655715|Ipilimumab|ipilimumab|mesh-list
92130137|NCT04733118|Immunotoxins|immunotoxins|mesh-ancestor
92710367|NCT05655715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710368|NCT05655715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710369|NCT05655715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92710370|NCT05655715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710371|NCT04317235|Ropivacaine|ropivacaine|mesh-list
92710372|NCT04317235|Anesthetics, Local|anesthetics, local|mesh-ancestor
92710373|NCT04317235|Anesthetics|anesthetics|mesh-ancestor
92710374|NCT04317235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710375|NCT04317235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710376|NCT04317235|Sensory System Agents|sensory system agents|mesh-ancestor
92710377|NCT04317235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710378|NCT00560690|Metformin|metformin|mesh-list
92710379|NCT00560690|Interferons|interferons|mesh-list
92710380|NCT00560690|Ribavirin|ribavirin|mesh-list
92710381|NCT00560690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710382|NCT00560690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710383|NCT00560690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710384|NCT00560690|Antiviral Agents|antiviral agents|mesh-ancestor
92710385|NCT00560690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065676|NCT03774394|Clopidogrel|clopidogrel|mesh-list
92710386|NCT00560690|Antimetabolites|antimetabolites|mesh-ancestor
92710387|NCT00560690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710388|NCT01227421|Nitazoxanide|nitazoxanide|mesh-list
92710389|NCT01227421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92710390|NCT01227421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710391|NCT02903901|Melatonin|melatonin|mesh-list
92710392|NCT02903901|Antioxidants|antioxidants|mesh-ancestor
92710393|NCT02903901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710394|NCT02903901|Protective Agents|protective agents|mesh-ancestor
92710395|NCT02903901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710396|NCT02903901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710397|NCT04634981|Anesthetics|anesthetics|mesh-list
92710398|NCT04634981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710399|NCT04634981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710400|NCT00553449|Rabeprazole|rabeprazole|mesh-list
92710401|NCT00553449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92710402|NCT00553449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710403|NCT00553449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92710404|NCT00553449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710405|NCT00553449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710406|NCT05655130|Dexamethasone|dexamethasone|mesh-list
92710407|NCT05655130|Methylprednisolone|methylprednisolone|mesh-list
92710408|NCT05655130|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92710409|NCT05655130|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92710410|NCT05655130|Prednisolone|prednisolone|mesh-list
92710411|NCT05655130|Prednisolone acetate|prednisolone acetate|mesh-list
92710412|NCT05655130|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92710413|NCT05655130|Prednisolone phosphate|prednisolone phosphate|mesh-list
92710414|NCT05655130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710415|NCT05655130|Antiemetics|antiemetics|mesh-ancestor
92710416|NCT05655130|Autonomic Agents|autonomic agents|mesh-ancestor
92710417|NCT05655130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710418|NCT05655130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710419|NCT05655130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710420|NCT05655130|Glucocorticoids|glucocorticoids|mesh-ancestor
92710421|NCT05655130|Hormones|hormones|mesh-ancestor
92710432|NCT04633850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710433|NCT04633850|Antiemetics|antiemetics|mesh-ancestor
92710434|NCT04633850|Autonomic Agents|autonomic agents|mesh-ancestor
92710435|NCT04633850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710436|NCT04633850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710437|NCT04633850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710438|NCT04633850|Glucocorticoids|glucocorticoids|mesh-ancestor
92710439|NCT04633850|Hormones|hormones|mesh-ancestor
92710440|NCT04633850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710441|NCT04633850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92710442|NCT04633850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710443|NCT04633850|Anesthetics, Local|anesthetics, local|mesh-ancestor
92710444|NCT04633850|Anesthetics|anesthetics|mesh-ancestor
92710445|NCT04633850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710446|NCT04633850|Sensory System Agents|sensory system agents|mesh-ancestor
92710447|NCT04633733|Tacrolimus|tacrolimus|mesh-list
92710448|NCT04633733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710449|NCT04633733|Immunologic Factors|immunologic factors|mesh-ancestor
92710450|NCT04633733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710451|NCT04633733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92710452|NCT04633733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710453|NCT04633733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710454|NCT05427942|Adalimumab|adalimumab|mesh-list
92710455|NCT05427942|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92710456|NCT05427942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710457|NCT05427942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710458|NCT05427903|Epinephrine|epinephrine|mesh-list
92710459|NCT05427903|Anesthetics|anesthetics|mesh-list
92710460|NCT05427903|Carticaine|carticaine|mesh-list
92710461|NCT05427903|Anesthetics, Local|anesthetics, local|mesh-list
92710462|NCT05427903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710463|NCT05427903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710464|NCT05427903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92710465|NCT05427903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92710466|NCT05427903|Adrenergic Agents|adrenergic agents|mesh-ancestor
92710467|NCT05427903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608252|NCT00142350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608253|NCT00142350|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92608254|NCT00142350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608255|NCT00142350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608256|NCT00135317|Darbepoetin alfa|darbepoetin alfa|mesh-list
92608257|NCT00135317|Hematinics|hematinics|mesh-ancestor
92608258|NCT00152646|Clopidogrel|clopidogrel|mesh-list
92608259|NCT00152646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92608260|NCT00152646|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92608261|NCT00152646|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92608262|NCT00152646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92608263|NCT00152646|Purinergic Agents|purinergic agents|mesh-ancestor
92608264|NCT00152646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608265|NCT00152646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608266|NCT00152646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710468|NCT05427903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710469|NCT05427903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92710470|NCT05427903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92710471|NCT05427903|Autonomic Agents|autonomic agents|mesh-ancestor
92710472|NCT05427903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710473|NCT05427903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92710474|NCT05427903|Respiratory System Agents|respiratory system agents|mesh-ancestor
92710475|NCT05427903|Mydriatics|mydriatics|mesh-ancestor
92710476|NCT05427903|Sympathomimetics|sympathomimetics|mesh-ancestor
92710477|NCT05427903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92710478|NCT05427903|Sensory System Agents|sensory system agents|mesh-ancestor
92710479|NCT05427747|Meropenem|meropenem|mesh-list
92710480|NCT05427747|Cefotaxime|cefotaxime|mesh-list
92710481|NCT05427747|Cefoxitin|cefoxitin|mesh-list
92710482|NCT05427747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92710483|NCT05427747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710484|NCT00445406|Bevacizumab|bevacizumab|mesh-list
92710485|NCT00445406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710486|NCT00445406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710487|NCT00445406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92710503|NCT02903004|Doxorubicin|doxorubicin|mesh-list
92710504|NCT02903004|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92710505|NCT02903004|Topotecan|topotecan|mesh-list
92710506|NCT02903004|Trabectedin|trabectedin|mesh-list
92710507|NCT02903004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92710508|NCT02903004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710509|NCT02903004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92710510|NCT02903004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92710511|NCT02903004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92710512|NCT02903004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710513|NCT02903004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92710514|NCT02903004|Antimetabolites|antimetabolites|mesh-ancestor
92710515|NCT02903004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92710516|NCT02903004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92710517|NCT02903004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92710518|NCT02903004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710519|NCT02903004|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92710520|NCT02903004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92710521|NCT02903004|Alkylating Agents|alkylating agents|mesh-ancestor
92710522|NCT05427084|Canagliflozin|canagliflozin|mesh-list
92710523|NCT05427084|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92710524|NCT05427084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710525|NCT05427084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608267|NCT00135434|Ritonavir|ritonavir|mesh-list
92608268|NCT00135434|Lopinavir|lopinavir|mesh-list
92608269|NCT00135434|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92608270|NCT00135434|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92608271|NCT00135434|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92608272|NCT00135434|Protease Inhibitors|protease inhibitors|mesh-ancestor
92608273|NCT00135434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015511|NCT05023473|Analgesics|analgesics|mesh-ancestor
92710526|NCT05427084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710527|NCT00445796|Artesunate|artesunate|mesh-list
92710528|NCT00445796|Amodiaquine|amodiaquine|mesh-list
92710529|NCT00445796|Antimalarials|antimalarials|mesh-ancestor
92710530|NCT00445796|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92710531|NCT00445796|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92710532|NCT00445796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710533|NCT00445796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710534|NCT00445796|Antiviral Agents|antiviral agents|mesh-ancestor
92710535|NCT00445796|Schistosomicides|schistosomicides|mesh-ancestor
92710536|NCT00445796|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92710537|NCT00445796|Anthelmintics|anthelmintics|mesh-ancestor
92710538|NCT01225822|Enoxaparin|enoxaparin|mesh-list
92710539|NCT01225822|Dabigatran|dabigatran|mesh-list
92710540|NCT01225822|Anticoagulants|anticoagulants|mesh-ancestor
92710541|NCT01225822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92710542|NCT01225822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92710543|NCT01225822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710544|NCT01225822|Antithrombins|antithrombins|mesh-ancestor
92710545|NCT01225822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92710546|NCT01225822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92710547|NCT01225822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710548|NCT00445874|Ketotifen|ketotifen|mesh-list
92710549|NCT00445874|Antipruritics|antipruritics|mesh-ancestor
92710550|NCT00445874|Dermatologic Agents|dermatologic agents|mesh-ancestor
92710551|NCT00445874|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92710567|NCT01225549|Respiratory System Agents|respiratory system agents|mesh-ancestor
92710569|NCT01225549|Hormones|hormones|mesh-ancestor
92710570|NCT01225549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710571|NCT05469685|Amoxicillin|amoxicillin|mesh-list
92710572|NCT05469685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92710573|NCT05469685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710574|NCT02956772|Arsenic Trioxide|arsenic trioxide|mesh-list
92710575|NCT02956772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710576|NCT00446069|Morphine|morphine|mesh-list
92710577|NCT00446069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92710578|NCT00446069|Narcotics|narcotics|mesh-ancestor
92373913|NCT01721460|Analgesics|analgesics|mesh-ancestor
92710579|NCT00446069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710580|NCT00446069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710581|NCT00446069|Analgesics|analgesics|mesh-ancestor
92710582|NCT00446069|Sensory System Agents|sensory system agents|mesh-ancestor
92710583|NCT00446069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710584|NCT02902653|Misoprostol|misoprostol|mesh-list
92710585|NCT02902653|Dinoprostone|dinoprostone|mesh-list
92710586|NCT02902653|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92710587|NCT02902653|Abortifacient Agents|abortifacient agents|mesh-ancestor
92710588|NCT02902653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92710589|NCT02902653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710590|NCT02902653|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92710591|NCT02902653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710592|NCT02902653|Oxytocics|oxytocics|mesh-ancestor
92710593|NCT00446303|Azacitidine|azacitidine|mesh-list
92710594|NCT00446303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92710595|NCT00446303|Antimetabolites|antimetabolites|mesh-ancestor
92710596|NCT00446303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710597|NCT00446303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710598|NCT00446303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710599|NCT01223404|Mecamylamine|mecamylamine|mesh-list
92710600|NCT01223404|Nicotine|nicotine|mesh-list
92710601|NCT01223404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92710602|NCT01223404|Autonomic Agents|autonomic agents|mesh-ancestor
92710603|NCT01223404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710604|NCT01223404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710605|NCT01223404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92608274|NCT00135434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608275|NCT00135434|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92608276|NCT00135434|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92608277|NCT00135434|Antiviral Agents|antiviral agents|mesh-ancestor
92608278|NCT00135434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608279|NCT00135434|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92608280|NCT00135434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92608281|NCT00135473|Insulin|insulin|mesh-list
92608282|NCT00135473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92608283|NCT00135473|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92608284|NCT00135473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608285|NCT00135473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608286|NCT00135473|Plasma Substitutes|plasma substitutes|mesh-ancestor
92608287|NCT00135473|Blood Substitutes|blood substitutes|mesh-ancestor
92608288|NCT00142428|Cetuximab|cetuximab|mesh-list
92608289|NCT00142428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92608290|NCT00142428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608291|NCT00135551|Benidipine|benidipine|mesh-list
92608292|NCT00135551|Diuretics|diuretics|mesh-list
92608293|NCT00135551|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92710606|NCT01223404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92710607|NCT01223404|Cholinergic Agents|cholinergic agents|mesh-ancestor
92710608|NCT01223404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373924|NCT01722318|Enzyme Activators|enzyme activators|mesh-ancestor
92710609|NCT01223404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710610|NCT01223404|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92710627|NCT00446420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710629|NCT00446420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92710630|NCT00446420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92710631|NCT00446420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92710632|NCT00446420|GABA Modulators|gaba modulators|mesh-ancestor
92710633|NCT00446420|GABA Agents|gaba agents|mesh-ancestor
92710634|NCT00446420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710635|NCT00446420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710636|NCT00446537|Methylphenidate|methylphenidate|mesh-list
92710637|NCT00446537|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92710638|NCT00446537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710639|NCT00446537|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92710640|NCT00446537|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92710641|NCT00446537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710642|NCT00446537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710643|NCT00446537|Dopamine Agents|dopamine agents|mesh-ancestor
92710644|NCT00446537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710645|NCT00446576|Epoetin Alfa|epoetin alfa|mesh-list
92710646|NCT00446576|Hematinics|hematinics|mesh-ancestor
92710647|NCT02902302|Ibuprofen|ibuprofen|mesh-list
92710648|NCT02902302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92710649|NCT02902302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710650|NCT02902302|Analgesics|analgesics|mesh-ancestor
92710651|NCT02902302|Sensory System Agents|sensory system agents|mesh-ancestor
92710652|NCT02902302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710653|NCT02902302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710654|NCT02902302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710655|NCT02902302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710656|NCT02902302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608294|NCT00135551|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92015537|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
92710657|NCT02902302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710658|NCT02902302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710659|NCT01223365|Hydrocodone|hydrocodone|mesh-list
92710660|NCT01223365|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92710661|NCT01223365|Narcotics|narcotics|mesh-ancestor
92710662|NCT01223365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710663|NCT01223365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710664|NCT01223365|Analgesics|analgesics|mesh-ancestor
92710665|NCT01223365|Sensory System Agents|sensory system agents|mesh-ancestor
92710666|NCT01223365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710667|NCT01223365|Antitussive Agents|antitussive agents|mesh-ancestor
92710668|NCT01223365|Respiratory System Agents|respiratory system agents|mesh-ancestor
92710669|NCT02956811|Dapagliflozin|dapagliflozin|mesh-list
92710670|NCT02956811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92710673|NCT02956811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710674|NCT04319419|Micronutrients|micronutrients|mesh-list
92130448|NCT03856671|Neomycin|neomycin|mesh-list
92710675|NCT04319419|Trace Elements|trace elements|mesh-list
92710676|NCT04319419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710677|NCT05657704|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92710678|NCT05657704|Tramadol|tramadol|mesh-list
92710679|NCT05657704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92710680|NCT05657704|Narcotics|narcotics|mesh-ancestor
92710681|NCT05657704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710682|NCT05657704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710683|NCT05657704|Analgesics|analgesics|mesh-ancestor
92710684|NCT05657704|Sensory System Agents|sensory system agents|mesh-ancestor
92710685|NCT05657704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710686|NCT05657704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92710687|NCT05657704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710688|NCT05657704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710689|NCT05657704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710690|NCT00446771|Mannitol|mannitol|mesh-list
92710691|NCT00446771|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92710692|NCT00446771|Diuretics|diuretics|mesh-ancestor
92710693|NCT00446771|Natriuretic Agents|natriuretic agents|mesh-ancestor
92710694|NCT00446771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710695|NCT04317157|Caffeine|caffeine|mesh-list
92710696|NCT04317157|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92710697|NCT04317157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710698|NCT04317157|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92710699|NCT04317157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710700|NCT04317157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710701|NCT04317157|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92710702|NCT04317157|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92710703|NCT04317157|Purinergic Agents|purinergic agents|mesh-ancestor
92710704|NCT04317157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710705|NCT04317079|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92710706|NCT04317079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710707|NCT04317079|Antioxidants|antioxidants|mesh-ancestor
92710708|NCT04317079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710709|NCT04317079|Protective Agents|protective agents|mesh-ancestor
92710710|NCT04317079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710711|NCT04317079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92710712|NCT03277430|Tacrolimus|tacrolimus|mesh-list
92710713|NCT03277430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710714|NCT03277430|Immunologic Factors|immunologic factors|mesh-ancestor
92710715|NCT03277430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710716|NCT03277430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92710717|NCT03277430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710718|NCT03277430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710719|NCT04699214|Endostar protein|endostar protein|mesh-list
92710720|NCT04699214|Endostatins|endostatins|mesh-list
92710721|NCT04699214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92710722|NCT04699214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92710723|NCT04699214|Growth Substances|growth substances|mesh-ancestor
92710724|NCT04699214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710725|NCT04699214|Growth Inhibitors|growth inhibitors|mesh-ancestor
92710726|NCT04699214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710727|NCT02902380|Dexmedetomidine|dexmedetomidine|mesh-list
92710728|NCT02902380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92608296|NCT00135551|Natriuretic Agents|natriuretic agents|mesh-ancestor
92608297|NCT00135551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710729|NCT02902380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710730|NCT02902380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710731|NCT02902380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92710732|NCT02902380|Analgesics|analgesics|mesh-ancestor
92710733|NCT02902380|Sensory System Agents|sensory system agents|mesh-ancestor
92710734|NCT02902380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710735|NCT02902380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92710736|NCT02902380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92710737|NCT02902380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92710738|NCT02902380|Adrenergic Agents|adrenergic agents|mesh-ancestor
92710739|NCT02902380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710740|NCT02902380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710741|NCT01221727|Denosumab|denosumab|mesh-list
92710745|NCT01221727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710746|NCT01221727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710747|NCT01221727|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92710748|NCT01221727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92130518|NCT03289234|Edaravone|edaravone|mesh-list
92710749|NCT01221727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92710750|NCT01221727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92710751|NCT01221727|Anesthetics, General|anesthetics, general|mesh-ancestor
92710752|NCT01221727|Anesthetics|anesthetics|mesh-ancestor
92710753|NCT01221727|GABA Modulators|gaba modulators|mesh-ancestor
92710754|NCT01221727|GABA Agents|gaba agents|mesh-ancestor
92710755|NCT01221727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710756|NCT01221727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710757|NCT01221727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92710758|NCT01221181|Eculizumab|eculizumab|mesh-list
92710759|NCT01221181|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92710760|NCT01221181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710761|NCT01221181|Immunologic Factors|immunologic factors|mesh-ancestor
92710762|NCT01221181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710763|NCT03277079|Ezetimibe|ezetimibe|mesh-list
92710764|NCT03277079|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92710765|NCT03277079|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92710766|NCT03277079|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92710767|NCT03277079|Antimetabolites|antimetabolites|mesh-ancestor
92710768|NCT03277079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710769|NCT03277079|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92710770|NCT03277079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710771|NCT01220557|Insulin|insulin|mesh-list
92710772|NCT01220557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710773|NCT01220557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710774|NCT04317001|Modafinil|modafinil|mesh-list
92710775|NCT04317001|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92710776|NCT04317001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710777|NCT04317001|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92710778|NCT04317001|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92710779|NCT04317001|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92710780|NCT04317001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710781|NCT05426499|Fluconazole|fluconazole|mesh-list
92710782|NCT05426499|Isavuconazole|isavuconazole|mesh-list
92710783|NCT05426499|Anidulafungin|anidulafungin|mesh-list
92710784|NCT05426499|Meropenem|meropenem|mesh-list
92710785|NCT05426499|Cefotaxime|cefotaxime|mesh-list
92710786|NCT05426499|Cefoxitin|cefoxitin|mesh-list
92710787|NCT05426499|Antifungal Agents|antifungal agents|mesh-ancestor
92710788|NCT05426499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710789|NCT05426499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92710790|NCT05426499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92710791|NCT05426499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710792|NCT05426499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710793|NCT05426499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92710794|NCT05426499|Hormone Antagonists|hormone antagonists|mesh-ancestor
92710795|NCT05426499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710796|NCT05426499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710797|NCT05426499|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92608298|NCT00135551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608299|NCT00135551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608300|NCT00135551|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92608301|NCT00135551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92608302|NCT00135551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608303|NCT00135551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92710798|NCT05426499|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92710799|NCT05426499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92710801|NCT00446810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92710802|NCT00446810|Immunologic Factors|immunologic factors|mesh-ancestor
92710803|NCT00446810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710804|NCT00446810|Chelating Agents|chelating agents|mesh-ancestor
92710805|NCT00446810|Sequestering Agents|sequestering agents|mesh-ancestor
92710806|NCT00446810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710807|NCT01220167|Ondansetron|ondansetron|mesh-list
92710808|NCT01220167|Antiemetics|antiemetics|mesh-ancestor
92710809|NCT01220167|Autonomic Agents|autonomic agents|mesh-ancestor
92710810|NCT01220167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710811|NCT01220167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710812|NCT01220167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710835|NCT00447356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710836|NCT00447356|Immunologic Factors|immunologic factors|mesh-ancestor
92710837|NCT00447356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710838|NCT05425875|Dimercaprol|dimercaprol|mesh-list
92710839|NCT05425875|Chelating Agents|chelating agents|mesh-ancestor
92710840|NCT05425875|Sequestering Agents|sequestering agents|mesh-ancestor
92710841|NCT05425875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710842|NCT00447473|Ketoconazole|ketoconazole|mesh-list
92710843|NCT00447473|Mitoxantrone|mitoxantrone|mesh-list
92710844|NCT00447473|Analgesics|analgesics|mesh-ancestor
92710845|NCT00447473|Sensory System Agents|sensory system agents|mesh-ancestor
92710846|NCT00447473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710847|NCT00447473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710848|NCT00447473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710849|NCT00447473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92710850|NCT00447473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92710851|NCT00447473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710852|NCT00447473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710853|NCT00447473|Antifungal Agents|antifungal agents|mesh-ancestor
92710854|NCT00447473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710855|NCT00447473|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92710856|NCT00447473|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92710857|NCT00447473|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92710858|NCT00447473|Hormone Antagonists|hormone antagonists|mesh-ancestor
92710859|NCT00447473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710860|NCT00447473|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92710861|NCT00553488|Insulin|insulin|mesh-list
92710862|NCT00553488|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92710863|NCT00553488|Insulin Lispro|insulin lispro|mesh-list
92710864|NCT00553488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710865|NCT00553488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710866|NCT03455322|Octreotide|octreotide|mesh-list
92710874|NCT03455322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710875|NCT03455322|Sympathomimetics|sympathomimetics|mesh-ancestor
92710876|NCT03455322|Autonomic Agents|autonomic agents|mesh-ancestor
92710877|NCT03455322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710878|NCT03455322|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92710879|NCT03455322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710880|NCT03455322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92710881|NCT03455322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710882|NCT03455322|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92710883|NCT05425368|Fluorides|fluorides|mesh-list
92710884|NCT05425368|Cariostatic Agents|cariostatic agents|mesh-ancestor
92710885|NCT05425368|Protective Agents|protective agents|mesh-ancestor
92710886|NCT05425368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710887|NCT00447863|Levonorgestrel|levonorgestrel|mesh-list
92710888|NCT00447863|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92608304|NCT00135551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608305|NCT00135551|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608306|NCT00152724|Aspirin|aspirin|mesh-list
92710889|NCT00447863|Estradiol|estradiol|mesh-list
92710890|NCT00447863|Estrogens|estrogens|mesh-ancestor
92710891|NCT00447863|Hormones|hormones|mesh-ancestor
92710892|NCT00447863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710893|NCT00447863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710894|NCT00447863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92710895|NCT00447863|Contraceptive Agents|contraceptive agents|mesh-ancestor
92710896|NCT00447863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92710897|NCT00447863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92710898|NCT00447863|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92130670|NCT02375100|Acetaminophen|acetaminophen|mesh-list
92710900|NCT00447863|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92710901|NCT00448097|Docetaxel|docetaxel|mesh-list
92710902|NCT00448097|Cetuximab|cetuximab|mesh-list
92710903|NCT00448097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710904|NCT00448097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92710905|NCT00448097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92710906|NCT00448097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92710907|NCT00448097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710908|NCT00448097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710909|NCT00448214|Warfarin|warfarin|mesh-list
92710910|NCT00448214|Anticoagulants|anticoagulants|mesh-ancestor
92710911|NCT00448253|Immunoglobulins|immunoglobulins|mesh-list
92710912|NCT00448253|Immunologic Factors|immunologic factors|mesh-ancestor
92710913|NCT00448253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710914|NCT00448292|Naluzotan|naluzotan|mesh-list
92710915|NCT00448292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92710916|NCT00448292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92710917|NCT00448292|Serotonin Agents|serotonin agents|mesh-ancestor
92710918|NCT00448292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710919|NCT00448292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710920|NCT00448292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710921|NCT02901561|Misoprostol|misoprostol|mesh-list
92710922|NCT02901561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92710923|NCT02901561|Abortifacient Agents|abortifacient agents|mesh-ancestor
92710924|NCT02901561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92710925|NCT02901561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710926|NCT02901561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92710927|NCT02901561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92710928|NCT02901561|Oxytocics|oxytocics|mesh-ancestor
92710929|NCT00448409|Sargramostim|sargramostim|mesh-list
92710930|NCT00448409|Immunologic Factors|immunologic factors|mesh-ancestor
92710931|NCT00448409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710932|NCT02901366|Dotinurad|dotinurad|mesh-list
92710933|NCT02901366|Uricosuric Agents|uricosuric agents|mesh-ancestor
92710934|NCT02901366|Gout Suppressants|gout suppressants|mesh-ancestor
92710935|NCT02901366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710936|NCT03276689|Pregabalin|pregabalin|mesh-list
92710939|NCT03276689|Sensory System Agents|sensory system agents|mesh-ancestor
92710940|NCT03276689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710941|NCT03276689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710942|NCT03276689|Anticonvulsants|anticonvulsants|mesh-ancestor
92710943|NCT03276689|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92710944|NCT03276689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710945|NCT03276689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710946|NCT03276689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92710947|NCT03276689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92710948|NCT03276689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92710949|NCT03276689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710950|NCT03276689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92710951|NCT03276689|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92710952|NCT03276689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92710953|NCT03276689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710954|NCT03276689|Antidepressive Agents|antidepressive agents|mesh-ancestor
92710955|NCT03276689|Dopamine Agents|dopamine agents|mesh-ancestor
92710956|NCT01220128|Paclitaxel|paclitaxel|mesh-list
92710957|NCT01220128|Docetaxel|docetaxel|mesh-list
92710958|NCT01220128|Cyclophosphamide|cyclophosphamide|mesh-list
92710959|NCT01220128|Carboplatin|carboplatin|mesh-list
92710960|NCT01220128|Doxorubicin|doxorubicin|mesh-list
92608307|NCT00152724|Celecoxib|celecoxib|mesh-list
92608308|NCT00152724|Indomethacin|indomethacin|mesh-list
92608309|NCT00152724|Nitroprusside|nitroprusside|mesh-list
92608310|NCT00152724|Acetylcholine|acetylcholine|mesh-list
92608311|NCT00152724|Capsaicin|capsaicin|mesh-list
92608312|NCT00152724|Clopidogrel|clopidogrel|mesh-list
92608313|NCT00152724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608314|NCT00152724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608315|NCT00152724|Analgesics|analgesics|mesh-ancestor
92710961|NCT01220128|Fluorouracil|fluorouracil|mesh-list
92710962|NCT01220128|Trastuzumab|trastuzumab|mesh-list
92710963|NCT01220128|Epirubicin|epirubicin|mesh-list
92710964|NCT01220128|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92710965|NCT01220128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92710966|NCT01220128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710967|NCT01220128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92710968|NCT01220128|Antimitotic Agents|antimitotic agents|mesh-ancestor
92710969|NCT01220128|Mitosis Modulators|mitosis modulators|mesh-ancestor
92710970|NCT01220128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710971|NCT01220128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92710972|NCT01220128|Immunologic Factors|immunologic factors|mesh-ancestor
92710973|NCT01220128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710974|NCT01220128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710975|NCT01220128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92710976|NCT01220128|Alkylating Agents|alkylating agents|mesh-ancestor
92710977|NCT01220128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92710978|NCT01220128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92710979|NCT01220128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92710980|NCT01220128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92710981|NCT01220128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710982|NCT01220128|Antimetabolites|antimetabolites|mesh-ancestor
92710983|NCT01220128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92710984|NCT01220128|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710985|NCT01220128|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92710986|NCT01220128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92710987|NCT01220128|Hormone Antagonists|hormone antagonists|mesh-ancestor
92710988|NCT01220128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710989|NCT04698941|Paclitaxel|paclitaxel|mesh-list
92710990|NCT04698941|Simvastatin|simvastatin|mesh-list
92710991|NCT04698941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92710992|NCT04698941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710993|NCT04698941|Tubulin Modulators|tubulin modulators|mesh-ancestor
92710994|NCT04698941|Antimitotic Agents|antimitotic agents|mesh-ancestor
92710995|NCT04698941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92710996|NCT04698941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710997|NCT04698941|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92710998|NCT04698941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92710999|NCT04698941|Antimetabolites|antimetabolites|mesh-ancestor
92711000|NCT04698941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92711001|NCT04698941|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92711002|NCT04698941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711003|NCT02901288|Levofloxacin|levofloxacin|mesh-list
92711004|NCT02901288|Rifampin|rifampin|mesh-list
92711005|NCT02901288|Isoniazid|isoniazid|mesh-list
92711006|NCT02901288|Pyrazinamide|pyrazinamide|mesh-list
92711007|NCT02901288|Ethambutol|ethambutol|mesh-list
92711008|NCT02901288|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92711009|NCT02901288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711010|NCT02901288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711020|NCT02901288|Leprostatic Agents|leprostatic agents|mesh-ancestor
92711021|NCT02901288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92711022|NCT02901288|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92711023|NCT02901288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92711024|NCT02901288|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92711025|NCT02901288|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92711026|NCT02901288|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92711027|NCT02901288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92608316|NCT00152724|Sensory System Agents|sensory system agents|mesh-ancestor
92608317|NCT00152724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608318|NCT00152724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711028|NCT02901288|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92711029|NCT02901288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92711030|NCT02901288|Antimetabolites|antimetabolites|mesh-ancestor
92711031|NCT02901288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92711032|NCT00448643|Cisplatin|cisplatin|mesh-list
92711033|NCT00448643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711034|NCT05424393|Etanercept|etanercept|mesh-list
92711035|NCT05424393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711036|NCT05424393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711037|NCT05424393|Analgesics|analgesics|mesh-ancestor
92711038|NCT05424393|Sensory System Agents|sensory system agents|mesh-ancestor
92711039|NCT05424393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711040|NCT05424393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711041|NCT05424393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711042|NCT05424393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711043|NCT05424393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711044|NCT05424393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711045|NCT05424393|Immunologic Factors|immunologic factors|mesh-ancestor
92711046|NCT00448838|Gemcitabine|gemcitabine|mesh-list
92711047|NCT00448838|Oxaliplatin|oxaliplatin|mesh-list
92711048|NCT00448838|Cetuximab|cetuximab|mesh-list
92130832|NCT04505280|Lidocaine|lidocaine|mesh-list
92711049|NCT00448838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711050|NCT00448838|Antimetabolites|antimetabolites|mesh-ancestor
92711051|NCT00448838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711052|NCT00448838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711053|NCT00448838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711054|NCT01219933|Methylprednisolone|methylprednisolone|mesh-list
92711055|NCT01219933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92711056|NCT01219933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92711057|NCT01219933|Prednisolone|prednisolone|mesh-list
92711058|NCT01219933|Prednisolone acetate|prednisolone acetate|mesh-list
92711059|NCT01219933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92711060|NCT01219933|Prednisolone phosphate|prednisolone phosphate|mesh-list
92711061|NCT01219933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711062|NCT01219933|Antiemetics|antiemetics|mesh-ancestor
92711063|NCT01219933|Autonomic Agents|autonomic agents|mesh-ancestor
92711064|NCT01219933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711065|NCT01219933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711066|NCT01219933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711067|NCT01219933|Glucocorticoids|glucocorticoids|mesh-ancestor
92711068|NCT01219933|Hormones|hormones|mesh-ancestor
92711069|NCT01219933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711070|NCT01219933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92711071|NCT01219933|Protective Agents|protective agents|mesh-ancestor
92711072|NCT01219933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92711073|NCT01219933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711084|NCT05368441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711085|NCT05368441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92711086|NCT05368441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92711087|NCT05368441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92711088|NCT05368441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92711089|NCT05368441|Anesthetics, General|anesthetics, general|mesh-ancestor
92711090|NCT05368441|Anesthetics|anesthetics|mesh-ancestor
92711091|NCT05368441|GABA Modulators|gaba modulators|mesh-ancestor
92711092|NCT05368441|GABA Agents|gaba agents|mesh-ancestor
92711093|NCT05368441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711094|NCT05368441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711095|NCT05468359|Cyclophosphamide|cyclophosphamide|mesh-list
92711096|NCT05468359|Bevacizumab|bevacizumab|mesh-list
92711097|NCT05468359|Sorafenib|sorafenib|mesh-list
92711098|NCT05468359|Atezolizumab|atezolizumab|mesh-list
92711099|NCT05468359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711100|NCT05468359|Immunologic Factors|immunologic factors|mesh-ancestor
92711101|NCT05468359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711102|NCT05468359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711103|NCT05468359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92711104|NCT05468359|Alkylating Agents|alkylating agents|mesh-ancestor
92711105|NCT05468359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711106|NCT05468359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711107|NCT05468359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92711108|NCT05468359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711109|NCT05468359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711110|NCT05468359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711111|NCT05468359|Growth Substances|growth substances|mesh-ancestor
92711112|NCT05468359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711113|NCT05468359|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92711114|NCT05468359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711115|NCT05468359|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92711116|NCT04316845|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92711117|NCT04316845|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92711118|NCT04316845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711119|NCT01218802|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92711120|NCT01218802|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92711121|NCT01218802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92711122|NCT01218802|Antimetabolites|antimetabolites|mesh-ancestor
92711123|NCT01218802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130899|NCT02881086|Hormones|hormones|mesh-ancestor
92711124|NCT01218802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92711125|NCT01218802|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92711126|NCT01218802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711127|NCT02887222|Bupivacaine|bupivacaine|mesh-list
92711128|NCT02887222|Anesthetics, Local|anesthetics, local|mesh-ancestor
92711129|NCT02887222|Anesthetics|anesthetics|mesh-ancestor
92711130|NCT02887222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711131|NCT02887222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711132|NCT02887222|Sensory System Agents|sensory system agents|mesh-ancestor
92711133|NCT02887222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711134|NCT01218646|Vaccines|vaccines|mesh-list
92711135|NCT01218646|Immunologic Factors|immunologic factors|mesh-ancestor
92711136|NCT01218646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711137|NCT00449423|Acipimox|acipimox|mesh-list
92711138|NCT00449423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92711139|NCT00449423|Antimetabolites|antimetabolites|mesh-ancestor
92711141|NCT00449423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92711142|NCT00449501|Budesonide|budesonide|mesh-list
92711143|NCT00449501|Formoterol Fumarate|formoterol fumarate|mesh-list
92711144|NCT00449501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711145|NCT00449501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92711146|NCT00449501|Autonomic Agents|autonomic agents|mesh-ancestor
92711147|NCT00449501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711148|NCT00449501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711149|NCT00449501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92711150|NCT00449501|Respiratory System Agents|respiratory system agents|mesh-ancestor
92711151|NCT00449501|Glucocorticoids|glucocorticoids|mesh-ancestor
92711152|NCT00449501|Hormones|hormones|mesh-ancestor
92711153|NCT00449501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711154|NCT00449501|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92711155|NCT00449501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92711156|NCT00449501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92711157|NCT00449501|Adrenergic Agents|adrenergic agents|mesh-ancestor
92711158|NCT00449501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711159|NCT00449501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711160|NCT02900820|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92711161|NCT02900820|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92711162|NCT02900820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711163|NCT02900820|Antitubercular Agents|antitubercular agents|mesh-ancestor
92711164|NCT01188772|Sofosbuvir|sofosbuvir|mesh-list
92711165|NCT01188772|Antiviral Agents|antiviral agents|mesh-ancestor
92711166|NCT01188772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711167|NCT01188655|Etanercept|etanercept|mesh-list
92711168|NCT01188655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711169|NCT01188655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711170|NCT01188655|Analgesics|analgesics|mesh-ancestor
92711171|NCT01188655|Sensory System Agents|sensory system agents|mesh-ancestor
92711172|NCT01188655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711173|NCT01188655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711174|NCT01188655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711175|NCT01188655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711176|NCT01188655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711177|NCT01188655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711178|NCT01188655|Immunologic Factors|immunologic factors|mesh-ancestor
92711179|NCT00449618|Aspirin|aspirin|mesh-list
92711180|NCT00449618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711181|NCT00449618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608319|NCT00152724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608320|NCT00152724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608321|NCT00152724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92608322|NCT00152724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015561|NCT05019885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92711182|NCT00449618|Analgesics|analgesics|mesh-ancestor
92711183|NCT00449618|Sensory System Agents|sensory system agents|mesh-ancestor
92711184|NCT00449618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711185|NCT00449618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711186|NCT00449618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711187|NCT00449618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711188|NCT00449618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92711189|NCT00449618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92711190|NCT00449618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711191|NCT00449618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92711192|NCT00449618|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92711193|NCT00449618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711194|NCT00449618|Antipyretics|antipyretics|mesh-ancestor
92711195|NCT01188538|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92711196|NCT01188538|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92130972|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92711197|NCT01188538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711199|NCT01188538|Sensory System Agents|sensory system agents|mesh-ancestor
92711200|NCT01188538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711201|NCT01188538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711202|NCT01188538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711203|NCT01188538|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711204|NCT01188538|Dermatologic Agents|dermatologic agents|mesh-ancestor
92711205|NCT00449657|Paclitaxel|paclitaxel|mesh-list
92711206|NCT00449657|Carboplatin|carboplatin|mesh-list
92711207|NCT00449657|Gemcitabine|gemcitabine|mesh-list
92711208|NCT00449657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92711209|NCT00449657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711210|NCT00449657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92711211|NCT00449657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92711212|NCT00449657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92711217|NCT04318444|Antimalarials|antimalarials|mesh-ancestor
92711218|NCT04318444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92711219|NCT04318444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92711220|NCT04318444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711221|NCT04318444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711222|NCT04318444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711223|NCT04318444|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711224|NCT03276143|Enoxaparin|enoxaparin|mesh-list
92711225|NCT03276143|Apixaban|apixaban|mesh-list
92711226|NCT03276143|Anticoagulants|anticoagulants|mesh-ancestor
92711227|NCT03276143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92711228|NCT03276143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92711229|NCT03276143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711230|NCT03276143|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92711231|NCT03276143|Antithrombins|antithrombins|mesh-ancestor
92711232|NCT03276143|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92711233|NCT03276143|Protease Inhibitors|protease inhibitors|mesh-ancestor
92711234|NCT03276143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711235|NCT00449774|Lamotrigine|lamotrigine|mesh-list
92711236|NCT00449774|Anticonvulsants|anticonvulsants|mesh-list
92711237|NCT00449774|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92711238|NCT00449774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92711239|NCT00449774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711240|NCT00449774|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92711241|NCT00449774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711242|NCT00449774|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92711243|NCT00449774|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92711244|NCT00449774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711245|NCT00449774|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92711246|NCT00449774|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92711247|NCT02900742|Gemcitabine|gemcitabine|mesh-list
92711248|NCT02900742|Docetaxel|docetaxel|mesh-list
92711249|NCT02900742|Pemetrexed|pemetrexed|mesh-list
92711250|NCT02900742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608323|NCT00152724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608324|NCT00152724|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92608325|NCT00152724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608326|NCT00152724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711251|NCT02900742|Antimetabolites|antimetabolites|mesh-ancestor
92711252|NCT02900742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711253|NCT02900742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711254|NCT02900742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92711255|NCT02900742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92711256|NCT02900742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92711257|NCT02900742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711258|NCT02900742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92711259|NCT02900742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92711260|NCT00449813|Pantoprazole|pantoprazole|mesh-list
92711261|NCT00449813|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92711262|NCT00449813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711263|NCT00449813|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92711264|NCT00449813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711265|NCT00449813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711266|NCT01218100|Lisinopril|lisinopril|mesh-list
92711267|NCT01218100|Nebivolol|nebivolol|mesh-list
92711268|NCT01218100|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92711269|NCT01218100|Protease Inhibitors|protease inhibitors|mesh-ancestor
92711270|NCT01218100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131048|NCT01523275|Mitomycins|mitomycins|mesh-list
92711271|NCT01218100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711272|NCT01218100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92711273|NCT01218100|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92711274|NCT01218100|Protective Agents|protective agents|mesh-ancestor
92711275|NCT01218100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711276|NCT01218100|Vasodilator Agents|vasodilator agents|mesh-ancestor
92711277|NCT01218100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92711278|NCT01218100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92711279|NCT01218100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92711280|NCT01218100|Adrenergic Agents|adrenergic agents|mesh-ancestor
92711281|NCT01218100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711282|NCT00450008|Thalidomide|thalidomide|mesh-list
92711283|NCT00450008|Docetaxel|docetaxel|mesh-list
92711304|NCT00450086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711305|NCT00450086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92711306|NCT00450086|Autonomic Agents|autonomic agents|mesh-ancestor
92711307|NCT00450086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711308|NCT00450086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711309|NCT00450086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92711310|NCT00450086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92711311|NCT00450086|Glucocorticoids|glucocorticoids|mesh-ancestor
92711312|NCT00450086|Hormones|hormones|mesh-ancestor
92711313|NCT00450086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711314|NCT00450086|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711315|NCT00450086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711316|NCT00450086|Analgesics|analgesics|mesh-ancestor
92711317|NCT00450086|Sensory System Agents|sensory system agents|mesh-ancestor
92711318|NCT00450086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711319|NCT05422911|Abiraterone Acetate|abiraterone acetate|mesh-list
92711320|NCT05422911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711321|NCT05422911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92711322|NCT05422911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711323|NCT05422911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711324|NCT05422911|Hormone Antagonists|hormone antagonists|mesh-ancestor
92711325|NCT05422911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711326|NCT05422911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711327|NCT05422911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92711328|NCT00450164|Nadolol|nadolol|mesh-list
92711329|NCT00450164|Prazosin|prazosin|mesh-list
92711330|NCT00450164|Isosorbide|isosorbide|mesh-list
92711331|NCT00450164|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92711332|NCT00450164|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92711333|NCT00450164|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92711334|NCT00450164|Diuretics|diuretics|mesh-ancestor
92711335|NCT00450164|Natriuretic Agents|natriuretic agents|mesh-ancestor
92608327|NCT00152724|Antipyretics|antipyretics|mesh-ancestor
92066536|NCT05684848|Resveratrol|resveratrol|mesh-list
92711336|NCT00450164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711337|NCT00450164|Vasodilator Agents|vasodilator agents|mesh-ancestor
92711338|NCT00450164|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92711362|NCT02900430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711363|NCT02900430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711364|NCT02900430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92711365|NCT02900430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92711366|NCT00450203|Bevacizumab|bevacizumab|mesh-list
92711367|NCT00450203|Capecitabine|capecitabine|mesh-list
92711369|NCT00450203|Lapatinib|lapatinib|mesh-list
92711370|NCT00450203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711371|NCT00450203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711372|NCT00450203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711373|NCT00450203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711374|NCT00450203|Growth Substances|growth substances|mesh-ancestor
92711375|NCT00450203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711376|NCT00450203|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711377|NCT00450203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711378|NCT00450203|Antimetabolites|antimetabolites|mesh-ancestor
92711379|NCT00450203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711380|NCT00450203|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92711381|NCT00450203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92711382|NCT00450203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92711383|NCT00450203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711384|NCT00450203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92711385|NCT00450281|Antibodies|antibodies|mesh-list
92711386|NCT00450281|Immunologic Factors|immunologic factors|mesh-ancestor
92711387|NCT00450281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711390|NCT04699097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711392|NCT04698746|Anesthetics, Local|anesthetics, local|mesh-list
92711393|NCT04698746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711394|NCT04698746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711395|NCT04698746|Sensory System Agents|sensory system agents|mesh-ancestor
92711396|NCT04698746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711397|NCT00450320|Sirolimus|sirolimus|mesh-list
92711398|NCT00450320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711399|NCT00450320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711400|NCT00450320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92711401|NCT00450320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711402|NCT00450320|Antifungal Agents|antifungal agents|mesh-ancestor
92711403|NCT00450320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711404|NCT00450320|Immunologic Factors|immunologic factors|mesh-ancestor
92711405|NCT00450320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711406|NCT00450398|polysaccharide-K|polysaccharide-k|mesh-list
92711407|NCT00450398|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92711408|NCT00450398|Immunologic Factors|immunologic factors|mesh-ancestor
92711409|NCT00450398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711410|NCT00450398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92711411|NCT00450398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711412|NCT00450398|Antiviral Agents|antiviral agents|mesh-ancestor
92711413|NCT00450398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711414|NCT00450398|Interferon Inducers|interferon inducers|mesh-ancestor
92711415|NCT00450398|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92711416|NCT00450398|Protective Agents|protective agents|mesh-ancestor
92711417|NCT00450515|Capecitabine|capecitabine|mesh-list
92711418|NCT00450515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711419|NCT00450515|Antimetabolites|antimetabolites|mesh-ancestor
92711420|NCT00450515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711421|NCT00450515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711422|NCT00450827|Bevacizumab|bevacizumab|mesh-list
92711423|NCT00450827|Antibodies|antibodies|mesh-list
92711424|NCT00450827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92711425|NCT00450827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711426|NCT00450827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711427|NCT00450827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711428|NCT00450827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711429|NCT00450827|Growth Substances|growth substances|mesh-ancestor
92711430|NCT00450827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711431|NCT00450827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711432|NCT00450827|Immunologic Factors|immunologic factors|mesh-ancestor
92711433|NCT00450944|Immunotoxins|immunotoxins|mesh-list
92608328|NCT00152724|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92711434|NCT00450944|Immunoconjugates|immunoconjugates|mesh-ancestor
92711435|NCT00450944|Immunologic Factors|immunologic factors|mesh-ancestor
92711436|NCT00450944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711437|NCT00451061|Tamsulosin|tamsulosin|mesh-list
92711438|NCT00451061|Alfuzosin|alfuzosin|mesh-list
92711439|NCT00451061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92711440|NCT00451061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92711441|NCT00451061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92711442|NCT00451061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92711443|NCT00451061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711444|NCT00451061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711445|NCT00451061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711446|NCT00451061|Urological Agents|urological agents|mesh-ancestor
92711447|NCT02931383|Liraglutide|liraglutide|mesh-list
92711448|NCT02931383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92711449|NCT02931383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711450|NCT02931383|Incretins|incretins|mesh-ancestor
92711451|NCT02931383|Hormones|hormones|mesh-ancestor
92711452|NCT02931383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711453|NCT04341441|Hydroxychloroquine|hydroxychloroquine|mesh-list
92711454|NCT04341441|Antimalarials|antimalarials|mesh-ancestor
92711455|NCT04341441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92711456|NCT04341441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92711457|NCT04341441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711458|NCT04341441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711459|NCT04341441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711460|NCT04341441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711461|NCT01187953|Tacrolimus|tacrolimus|mesh-list
92711466|NCT01187953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711467|NCT01187953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711468|NCT02900157|Durvalumab|durvalumab|mesh-list
92711469|NCT02900157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711470|NCT02900157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711471|NCT04262817|Nicotine|nicotine|mesh-list
92711472|NCT04262817|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92711473|NCT04262817|Autonomic Agents|autonomic agents|mesh-ancestor
92711474|NCT04262817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711475|NCT04262817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711476|NCT04262817|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92711477|NCT04262817|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92711478|NCT04262817|Cholinergic Agents|cholinergic agents|mesh-ancestor
92711479|NCT04262817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711480|NCT04262817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711481|NCT02931188|Anacetrapib|anacetrapib|mesh-list
92711482|NCT02931188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92711483|NCT02931188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92711484|NCT02931188|Antimetabolites|antimetabolites|mesh-ancestor
92711485|NCT02931188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711486|NCT02931188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92711487|NCT01217944|Ranibizumab|ranibizumab|mesh-list
92711488|NCT01217944|Verteporfin|verteporfin|mesh-list
92711489|NCT01217944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711490|NCT01217944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711491|NCT01217944|Growth Substances|growth substances|mesh-ancestor
92711492|NCT01217944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711493|NCT01217944|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711494|NCT01217944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711495|NCT01217944|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92711496|NCT01217944|Dermatologic Agents|dermatologic agents|mesh-ancestor
92131274|NCT01522651|Dronedarone|dronedarone|mesh-list
92711498|NCT04689815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711499|NCT01187446|Vorinostat|vorinostat|mesh-list
92711500|NCT01187446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711501|NCT01187446|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92711502|NCT01187446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711503|NCT01187446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711504|NCT02931071|Plerixafor|plerixafor|mesh-list
92711505|NCT02931071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92711506|NCT02931071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92711507|NCT02931071|Antiviral Agents|antiviral agents|mesh-ancestor
92711508|NCT02931071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711509|NCT01187407|Serotonin|serotonin|mesh-list
92608329|NCT00152724|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92608330|NCT00152724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92608331|NCT00152724|Purinergic Agents|purinergic agents|mesh-ancestor
92608332|NCT00152724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711510|NCT01187407|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92711511|NCT01187407|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92711512|NCT01187407|Serotonin Agents|serotonin agents|mesh-ancestor
92711513|NCT01187407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711514|NCT01187407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711515|NCT01187407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711516|NCT01187407|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92711517|NCT01187407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92711518|NCT01186939|Azacitidine|azacitidine|mesh-list
92711519|NCT01186939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711520|NCT01186939|Antimetabolites|antimetabolites|mesh-ancestor
92711521|NCT01186939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711522|NCT01186939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711523|NCT01186939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711524|NCT04447040|Acetaminophen|acetaminophen|mesh-list
92711525|NCT04447040|Naproxen|naproxen|mesh-list
92711526|NCT04447040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711527|NCT04447040|Analgesics|analgesics|mesh-ancestor
92711528|NCT04447040|Sensory System Agents|sensory system agents|mesh-ancestor
92711529|NCT04447040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711530|NCT04447040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711531|NCT04447040|Antipyretics|antipyretics|mesh-ancestor
92711532|NCT04447040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711549|NCT02930954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711550|NCT02930954|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711551|NCT02930954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711552|NCT02930954|Antimetabolites|antimetabolites|mesh-ancestor
92711553|NCT02930954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711554|NCT02930954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711555|NCT02930954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92711556|NCT02930954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92711557|NCT02930954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92711558|NCT04117659|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92711559|NCT04117659|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92711560|NCT04117659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711561|NCT04117659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711562|NCT02930057|Betamethasone|betamethasone|mesh-list
92711563|NCT02930057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711564|NCT02930057|Glucocorticoids|glucocorticoids|mesh-ancestor
92711566|NCT02930057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711567|NCT02930057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711568|NCT02930057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92711569|NCT02930057|Respiratory System Agents|respiratory system agents|mesh-ancestor
92711570|NCT02929901|Caffeine|caffeine|mesh-list
92711571|NCT02929901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92711572|NCT02929901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711573|NCT02929901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92711574|NCT02929901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711575|NCT02929901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711576|NCT02929901|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92711577|NCT02929901|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92711578|NCT02929901|Purinergic Agents|purinergic agents|mesh-ancestor
92711579|NCT02929901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711580|NCT02929706|Azathioprine|azathioprine|mesh-list
92711581|NCT02929706|Antimetabolites|antimetabolites|mesh-ancestor
92711582|NCT02929706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711583|NCT02929706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711584|NCT02929706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711585|NCT02929706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711586|NCT02929706|Immunologic Factors|immunologic factors|mesh-ancestor
92711587|NCT02929706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711588|NCT02929706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711589|NCT03993132|Empagliflozin|empagliflozin|mesh-list
92608333|NCT00152724|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92608334|NCT00152724|Antipruritics|antipruritics|mesh-ancestor
92608335|NCT00152724|Dermatologic Agents|dermatologic agents|mesh-ancestor
92608336|NCT00152724|Gout Suppressants|gout suppressants|mesh-ancestor
92711593|NCT03993132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711594|NCT03993132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92711595|NCT03993132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711596|NCT03993132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711597|NCT03993132|Hormones|hormones|mesh-ancestor
92711598|NCT03993132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711599|NCT03993132|Incretins|incretins|mesh-ancestor
92711600|NCT00553878|Dutasteride|dutasteride|mesh-list
92711601|NCT00553878|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92711602|NCT00553878|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92711603|NCT00553878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711604|NCT00553878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711605|NCT00553878|Hormone Antagonists|hormone antagonists|mesh-ancestor
92711606|NCT00553878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711607|NCT00553878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711608|NCT00624325|Interferons|interferons|mesh-list
92711609|NCT00624325|Interferon-alpha|interferon-alpha|mesh-list
92711610|NCT00624325|Interferon alpha-2|interferon alpha-2|mesh-list
92711611|NCT00624325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711612|NCT00624325|Antiviral Agents|antiviral agents|mesh-ancestor
92711613|NCT00624325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711614|NCT00624325|Immunologic Factors|immunologic factors|mesh-ancestor
92711615|NCT00624325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711616|NCT04689893|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92711617|NCT04689893|Chelating Agents|chelating agents|mesh-ancestor
92711618|NCT04689893|Sequestering Agents|sequestering agents|mesh-ancestor
92711619|NCT04689893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711620|NCT05184192|Gabapentin|gabapentin|mesh-list
92711621|NCT05184192|Analgesics|analgesics|mesh-ancestor
92711622|NCT05184192|Sensory System Agents|sensory system agents|mesh-ancestor
92711623|NCT05184192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711624|NCT05184192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711625|NCT05184192|Anticonvulsants|anticonvulsants|mesh-ancestor
92711626|NCT05184192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92711627|NCT05184192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92711628|NCT05184192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711629|NCT05184192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92711630|NCT05184192|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92711631|NCT05184192|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92711632|NCT05184192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711633|NCT05184192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711634|NCT05184192|Antimanic Agents|antimanic agents|mesh-ancestor
92711635|NCT02929121|Doxycycline|doxycycline|mesh-list
92711636|NCT02929121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711637|NCT02929121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711638|NCT02929121|Antimalarials|antimalarials|mesh-ancestor
92711639|NCT02929121|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92711640|NCT02929121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92711641|NCT02929394|Trabectedin|trabectedin|mesh-list
92711642|NCT02929394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92711643|NCT02929394|Alkylating Agents|alkylating agents|mesh-ancestor
92711644|NCT02929394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711645|NCT02929394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711647|NCT02929316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711648|NCT05134974|Phentolamine|phentolamine|mesh-list
92711649|NCT05134974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92711650|NCT05134974|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92711651|NCT05134974|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92711652|NCT05134974|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92711653|NCT05134974|Adrenergic Agents|adrenergic agents|mesh-ancestor
92711654|NCT05134974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711655|NCT05134974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711656|NCT05134974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711657|NCT05134974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92711658|NCT02928965|Minocycline|minocycline|mesh-list
92608337|NCT00152724|Tocolytic Agents|tocolytic agents|mesh-ancestor
92608338|NCT00152724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92608339|NCT00152724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92608340|NCT00152724|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608341|NCT00152724|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92711659|NCT02928965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711660|NCT02928965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711661|NCT02928692|Minocycline|minocycline|mesh-list
92711662|NCT02928692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711666|NCT04679142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711667|NCT04679142|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92711668|NCT04679142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711669|NCT04679142|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92711670|NCT04679142|GABA Agonists|gaba agonists|mesh-ancestor
92711671|NCT04679142|GABA Agents|gaba agents|mesh-ancestor
92711672|NCT04679142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711673|NCT04679142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711674|NCT02928419|Lenalidomide|lenalidomide|mesh-list
92711675|NCT02928419|Immunologic Factors|immunologic factors|mesh-ancestor
92711676|NCT02928419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711677|NCT02928419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711678|NCT02928419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711679|NCT02928419|Growth Substances|growth substances|mesh-ancestor
92711680|NCT02928419|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711681|NCT02928419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711682|NCT02928614|Liraglutide|liraglutide|mesh-list
92711683|NCT02928614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92711684|NCT02928614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711685|NCT02928614|Incretins|incretins|mesh-ancestor
92711686|NCT02928614|Hormones|hormones|mesh-ancestor
92711687|NCT02928614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711688|NCT03685500|Emtricitabine|emtricitabine|mesh-list
92711689|NCT03685500|Darunavir|darunavir|mesh-list
92711690|NCT03685500|Cobicistat|cobicistat|mesh-list
92711691|NCT03685500|Antiviral Agents|antiviral agents|mesh-ancestor
92711692|NCT03685500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711693|NCT03685500|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92711694|NCT03685500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92711695|NCT03685500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711696|NCT03685500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711697|NCT03685500|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92711698|NCT03685500|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92711699|NCT03685500|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92711700|NCT03685500|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92711701|NCT03685500|Protease Inhibitors|protease inhibitors|mesh-ancestor
92711702|NCT03685500|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92711703|NCT03685500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92711704|NCT02928575|Temozolomide|temozolomide|mesh-list
92711705|NCT02928575|Sunitinib|sunitinib|mesh-list
92711706|NCT02928575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92711707|NCT02928575|Alkylating Agents|alkylating agents|mesh-ancestor
92711708|NCT02928575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711709|NCT02928575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711710|NCT02928575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711711|NCT02928575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711712|NCT02928575|Growth Substances|growth substances|mesh-ancestor
92711713|NCT02928575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711714|NCT02928575|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711715|NCT02928575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92711716|NCT02928575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711717|NCT02927951|Pregabalin|pregabalin|mesh-list
92711718|NCT02927951|Analgesics|analgesics|mesh-ancestor
92711719|NCT02927951|Sensory System Agents|sensory system agents|mesh-ancestor
92711720|NCT02927951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711721|NCT02927951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711722|NCT02927951|Anticonvulsants|anticonvulsants|mesh-ancestor
92711723|NCT02927951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92711724|NCT02927951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92711725|NCT02927951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711726|NCT02927951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608342|NCT00152724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92608343|NCT00152724|Cholinergic Agents|cholinergic agents|mesh-ancestor
92608344|NCT00135668|Nitroprusside|nitroprusside|mesh-list
92608345|NCT00135668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92711727|NCT02927951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92711728|NCT02927951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92711729|NCT02927951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711730|NCT02927951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92711731|NCT02927405|Gabapentin|gabapentin|mesh-list
92711732|NCT02927405|Analgesics|analgesics|mesh-ancestor
92711733|NCT02927405|Sensory System Agents|sensory system agents|mesh-ancestor
92711734|NCT02927405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711751|NCT05005299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711752|NCT05005299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711753|NCT05005299|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92711754|NCT05005299|Alkylating Agents|alkylating agents|mesh-ancestor
92711755|NCT05005299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711756|NCT05005299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711757|NCT05005299|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92374174|NCT01746264|Vitamin D|vitamin d|mesh-list
92711758|NCT02927444|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92711759|NCT02927444|Immunologic Factors|immunologic factors|mesh-ancestor
92711760|NCT02927444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711762|NCT02927522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92711763|NCT02927522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711764|NCT02927522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711765|NCT02927522|Cholinergic Agents|cholinergic agents|mesh-ancestor
92711766|NCT02927522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711767|NCT02927522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711768|NCT02927522|Nootropic Agents|nootropic agents|mesh-ancestor
92711769|NCT02926976|Valproic Acid|valproic acid|mesh-list
92711770|NCT02926976|Risperidone|risperidone|mesh-list
92711771|NCT02926976|Aripiprazole|aripiprazole|mesh-list
92711772|NCT02926976|Clozapine|clozapine|mesh-list
92711773|NCT02926976|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92711774|NCT02926976|Serotonin Agents|serotonin agents|mesh-ancestor
92711775|NCT02926976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711776|NCT02926976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711777|NCT02926976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711778|NCT02926976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92711779|NCT02926976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92711780|NCT02926976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711781|NCT02926976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92711782|NCT02926976|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92711783|NCT02926976|Dopamine Agents|dopamine agents|mesh-ancestor
92711784|NCT02926976|Antidepressive Agents|antidepressive agents|mesh-ancestor
92711785|NCT02926976|Dopamine Agonists|dopamine agonists|mesh-ancestor
92711786|NCT02926976|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92711787|NCT02926976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92711788|NCT02926976|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92711789|NCT02926976|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92711790|NCT02926976|Anticonvulsants|anticonvulsants|mesh-ancestor
92711791|NCT02926976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131579|NCT02352168|Hormones|hormones|mesh-ancestor
92711808|NCT04680195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711809|NCT04864431|Vitamin D|vitamin d|mesh-list
92711810|NCT04864431|Cholecalciferol|cholecalciferol|mesh-list
92711811|NCT04864431|Vitamins|vitamins|mesh-ancestor
92711812|NCT04864431|Micronutrients|micronutrients|mesh-ancestor
92711813|NCT04864431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711814|NCT04864431|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92711815|NCT04864431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92711816|NCT00553995|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92711817|NCT00553995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711818|NCT00553995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711819|NCT00553995|Analgesics|analgesics|mesh-ancestor
92711820|NCT00553995|Sensory System Agents|sensory system agents|mesh-ancestor
92711821|NCT00553995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711822|NCT00553995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711823|NCT00553995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711824|NCT00553995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711825|NCT04798287|Adalimumab|adalimumab|mesh-list
92711826|NCT04798287|Infliximab|infliximab|mesh-list
92608346|NCT00135668|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608347|NCT00135668|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92608348|NCT00135668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608349|NCT00152802|Vaccines|vaccines|mesh-list
92608350|NCT00152802|Immunologic Factors|immunologic factors|mesh-ancestor
92711827|NCT04798287|Golimumab|golimumab|mesh-list
92711828|NCT04798287|Certolizumab Pegol|certolizumab pegol|mesh-list
92711829|NCT04798287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92711830|NCT04798287|Etanercept|etanercept|mesh-list
92711831|NCT04798287|Tofacitinib|tofacitinib|mesh-list
92711832|NCT04798287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711833|NCT04798287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711834|NCT04798287|Dermatologic Agents|dermatologic agents|mesh-ancestor
92711835|NCT04798287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711836|NCT04798287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711837|NCT04798287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711838|NCT04798287|Analgesics|analgesics|mesh-ancestor
92711839|NCT04798287|Sensory System Agents|sensory system agents|mesh-ancestor
92711840|NCT04798287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711841|NCT04798287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711842|NCT04798287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711843|NCT04798287|Immunologic Factors|immunologic factors|mesh-ancestor
92711844|NCT04798287|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92711845|NCT04798287|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92711846|NCT04798287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711847|NCT04798287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711848|NCT04689191|Vaccines|vaccines|mesh-list
92711849|NCT04689191|Immunologic Factors|immunologic factors|mesh-ancestor
92711850|NCT04689191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711851|NCT02925299|Insulin|insulin|mesh-list
92711852|NCT02925299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92711853|NCT02925299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711854|NCT02925416|Oritavancin|oritavancin|mesh-list
92711855|NCT02925416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711874|NCT02917967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92711875|NCT02917967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711876|NCT02917967|Cholinergic Agents|cholinergic agents|mesh-ancestor
92711877|NCT02917967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711878|NCT02917967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711879|NCT04485273|Anesthetics|anesthetics|mesh-list
92711880|NCT04485273|Sevoflurane|sevoflurane|mesh-list
92711881|NCT04485273|Bupivacaine|bupivacaine|mesh-list
92711882|NCT04485273|Anesthetics, Local|anesthetics, local|mesh-list
92711883|NCT04485273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92711884|NCT04485273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711885|NCT04485273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711886|NCT04485273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92711887|NCT04485273|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92711888|NCT04485273|Anesthetics, General|anesthetics, general|mesh-ancestor
92711889|NCT04485273|Sensory System Agents|sensory system agents|mesh-ancestor
92711890|NCT04485273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711891|NCT02205528|Metformin|metformin|mesh-list
92711892|NCT02205528|Liraglutide|liraglutide|mesh-list
92711893|NCT02205528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92711894|NCT02205528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711895|NCT02205528|Incretins|incretins|mesh-ancestor
92711896|NCT02205528|Hormones|hormones|mesh-ancestor
92711897|NCT02205528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711898|NCT03532022|Dexamethasone|dexamethasone|mesh-list
92711899|NCT03532022|Prednisone|prednisone|mesh-list
92711900|NCT03532022|Prednisolone|prednisolone|mesh-list
92711901|NCT03532022|Hydrocortisone|hydrocortisone|mesh-list
92711902|NCT03532022|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92711903|NCT03532022|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92711904|NCT03532022|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92711905|NCT03532022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711906|NCT03532022|Antiemetics|antiemetics|mesh-ancestor
92711907|NCT03532022|Autonomic Agents|autonomic agents|mesh-ancestor
92711908|NCT03532022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711909|NCT03532022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711910|NCT03532022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711914|NCT03532022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608351|NCT00152802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711915|NCT03532022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711916|NCT02200380|Plerixafor|plerixafor|mesh-list
92711917|NCT02200380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92711918|NCT02200380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92711919|NCT02200380|Antiviral Agents|antiviral agents|mesh-ancestor
92711920|NCT02200380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711921|NCT02191878|TKM-080301|tkm-080301|mesh-list
92711922|NCT02191878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92711923|NCT02191878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711924|NCT02191878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711925|NCT02160678|Tazarotene|tazarotene|mesh-list
92711926|NCT02160678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92711927|NCT02160678|Keratolytic Agents|keratolytic agents|mesh-ancestor
92711928|NCT02153502|Quinidine|quinidine|mesh-list
92711929|NCT02153502|Quinidine gluconate|quinidine gluconate|mesh-list
92711930|NCT02153502|Dextromethorphan|dextromethorphan|mesh-list
92711931|NCT02153502|Antitussive Agents|antitussive agents|mesh-ancestor
92711932|NCT02153502|Respiratory System Agents|respiratory system agents|mesh-ancestor
92711933|NCT02153502|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92711934|NCT02153502|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92711935|NCT02153502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711936|NCT02153502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711937|NCT02153502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711938|NCT02153502|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92711939|NCT02153502|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92711940|NCT02153502|Adrenergic Agents|adrenergic agents|mesh-ancestor
92711941|NCT02153502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92711942|NCT02153502|Antimalarials|antimalarials|mesh-ancestor
92711943|NCT02153502|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92711944|NCT02153502|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92711945|NCT02153502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711946|NCT02153502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711947|NCT02153502|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92711948|NCT02153502|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92711949|NCT02153502|Cholinergic Agents|cholinergic agents|mesh-ancestor
92711950|NCT02153502|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92711951|NCT02153502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92711952|NCT02153502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92711953|NCT02153502|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92711954|NCT02153502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92711955|NCT02130687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92711956|NCT02130687|Aprepitant|aprepitant|mesh-list
92711957|NCT02130687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92711958|NCT02130687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711959|NCT02130687|Incretins|incretins|mesh-ancestor
92711960|NCT02130687|Hormones|hormones|mesh-ancestor
92711961|NCT02130687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711962|NCT02130687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92711963|NCT02130687|Protease Inhibitors|protease inhibitors|mesh-ancestor
92711964|NCT02130687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711965|NCT02130687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711966|NCT02130687|Antiemetics|antiemetics|mesh-ancestor
92711967|NCT02130687|Autonomic Agents|autonomic agents|mesh-ancestor
92711968|NCT02130687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711969|NCT02130687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92711970|NCT02130687|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92711971|NCT02130687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711972|NCT01228656|Mometasone Furoate|mometasone furoate|mesh-list
92711973|NCT01228656|Salicylic Acid|salicylic acid|mesh-list
92711974|NCT01228656|Salicylates|salicylates|mesh-list
92711975|NCT01228656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711976|NCT01228656|Dermatologic Agents|dermatologic agents|mesh-ancestor
92711977|NCT01228656|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92711978|NCT01228656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711979|NCT01228656|Antifungal Agents|antifungal agents|mesh-ancestor
92711980|NCT01228656|Keratolytic Agents|keratolytic agents|mesh-ancestor
92711981|NCT01228656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92711982|NCT01228656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92711986|NCT01228656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711987|NCT01228656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711988|NCT01228656|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92711989|NCT01228656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608353|NCT00135746|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92608354|NCT00135746|Autonomic Agents|autonomic agents|mesh-ancestor
92711990|NCT01228656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711991|NCT02128113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92711992|NCT02128113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92711993|NCT02125266|Methotrexate|methotrexate|mesh-list
92711994|NCT02125266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92711995|NCT02125266|Abortifacient Agents|abortifacient agents|mesh-ancestor
92711996|NCT02125266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92711997|NCT02125266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711998|NCT02125266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711999|NCT02125266|Antimetabolites|antimetabolites|mesh-ancestor
92712000|NCT02125266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712001|NCT02125266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712002|NCT02125266|Dermatologic Agents|dermatologic agents|mesh-ancestor
92712003|NCT02125266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712004|NCT02125266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92712005|NCT02125266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712006|NCT02125266|Immunologic Factors|immunologic factors|mesh-ancestor
92712007|NCT02125266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712008|NCT02125266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92712009|NCT02116998|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92712010|NCT02116998|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92712011|NCT02116998|Immunologic Factors|immunologic factors|mesh-ancestor
92712012|NCT02116998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712014|NCT02116998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712015|NCT02116998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712016|NCT02110368|Methyltestosterone|methyltestosterone|mesh-list
92712017|NCT02110368|Testosterone|testosterone|mesh-list
92712018|NCT02110368|Testosterone undecanoate|testosterone undecanoate|mesh-list
92712019|NCT02110368|Testosterone enanthate|testosterone enanthate|mesh-list
92712020|NCT02110368|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92712021|NCT02110368|Androgens|androgens|mesh-ancestor
92712022|NCT02110368|Hormones|hormones|mesh-ancestor
92712023|NCT02110368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712024|NCT02110368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712025|NCT02110368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712026|NCT02110368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712027|NCT02110368|Anabolic Agents|anabolic agents|mesh-ancestor
92712028|NCT02916485|Sirolimus|sirolimus|mesh-list
92712029|NCT02916485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92712030|NCT02916485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712031|NCT02916485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92712032|NCT02916485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712033|NCT02916485|Antifungal Agents|antifungal agents|mesh-ancestor
92712034|NCT02916485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712035|NCT02916485|Immunologic Factors|immunologic factors|mesh-ancestor
92712036|NCT02916485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712037|NCT01709214|Oxycodone|oxycodone|mesh-list
92712038|NCT01709214|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92712039|NCT01709214|Narcotics|narcotics|mesh-ancestor
92712040|NCT01709214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712041|NCT01709214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712042|NCT01709214|Analgesics|analgesics|mesh-ancestor
92712043|NCT01709214|Sensory System Agents|sensory system agents|mesh-ancestor
92712044|NCT01709214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712045|NCT02916602|Losartan|losartan|mesh-list
92712046|NCT02916602|Amlodipine|amlodipine|mesh-list
92712047|NCT02916602|Chlorthalidone|chlorthalidone|mesh-list
92712048|NCT02916602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92712049|NCT02916602|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92712050|NCT02916602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712051|NCT02916602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712052|NCT02916602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92712053|NCT02916602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712054|NCT02916602|Vasodilator Agents|vasodilator agents|mesh-ancestor
92712072|NCT02106546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712073|NCT02106546|Tubulin Modulators|tubulin modulators|mesh-ancestor
92712074|NCT02106546|Antimitotic Agents|antimitotic agents|mesh-ancestor
92712075|NCT02106546|Mitosis Modulators|mitosis modulators|mesh-ancestor
92712076|NCT02106546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608355|NCT00135746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608356|NCT00135746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608357|NCT00135746|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92608358|NCT00135746|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92712077|NCT02106546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92712078|NCT02106546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712079|NCT02916173|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92712080|NCT02916173|Hormones|hormones|mesh-list
92712081|NCT02916173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712082|NCT02916173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712083|NCT02916173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712084|NCT02916134|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92712085|NCT02916134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712086|NCT02104245|Ciprofloxacin|ciprofloxacin|mesh-list
92712087|NCT02104245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92712088|NCT02104245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712089|NCT02104245|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92712090|NCT02104245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92712091|NCT02104245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131874|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
92712092|NCT02104245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712093|NCT02104245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712094|NCT02104245|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92712095|NCT02104245|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92712096|NCT01699737|Glimepiride|glimepiride|mesh-list
92712097|NCT01699737|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92712098|NCT01699737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712099|NCT01699737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712100|NCT01699737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712101|NCT01699737|Immunologic Factors|immunologic factors|mesh-ancestor
92712103|NCT04688723|Clopidogrel|clopidogrel|mesh-list
92712104|NCT04688723|Ticagrelor|ticagrelor|mesh-list
92712105|NCT04688723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92712106|NCT04688723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92712107|NCT04688723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92712108|NCT04688723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92712109|NCT04688723|Purinergic Agents|purinergic agents|mesh-ancestor
92712110|NCT04688723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712111|NCT04688723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712123|NCT01699464|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92712124|NCT01699464|Adrenergic Agents|adrenergic agents|mesh-ancestor
92712125|NCT01699464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712126|NCT01699464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712127|NCT01699464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92712128|NCT01699464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92712129|NCT04688645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92712130|NCT02104050|Dapansutrile|dapansutrile|mesh-list
92712131|NCT02104050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712132|NCT01694277|Sunitinib|sunitinib|mesh-list
92712133|NCT01694277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712134|NCT01694277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712135|NCT01694277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712136|NCT01694277|Growth Substances|growth substances|mesh-ancestor
92712137|NCT01694277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712138|NCT01694277|Growth Inhibitors|growth inhibitors|mesh-ancestor
92374231|NCT01758432|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92712139|NCT01694277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92712140|NCT01694277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712141|NCT01694277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712142|NCT01669980|Vancomycin|vancomycin|mesh-list
92712143|NCT01669980|Ceftriaxone|ceftriaxone|mesh-list
92712144|NCT01669980|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92712145|NCT01669980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92712146|NCT01669980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712147|NCT02915666|Trametinib|trametinib|mesh-list
92712148|NCT02915666|Dabrafenib|dabrafenib|mesh-list
92712149|NCT02915666|Digoxin|digoxin|mesh-list
92712150|NCT02915666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712151|NCT02915666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92712152|NCT02915666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712153|NCT02915666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608359|NCT00135746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92608360|NCT00135746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608361|NCT00135746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712154|NCT02915666|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92712155|NCT02915666|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92712156|NCT02915666|Protective Agents|protective agents|mesh-ancestor
92712157|NCT02915666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712158|NCT02092935|Vancomycin|vancomycin|mesh-list
92712159|NCT02092935|Ridinilazole|ridinilazole|mesh-list
92712160|NCT02092935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92712161|NCT02092935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712162|NCT01666977|Carboplatin|carboplatin|mesh-list
92712163|NCT01666977|Pemetrexed|pemetrexed|mesh-list
92712164|NCT01666977|Trebananib|trebananib|mesh-list
92712165|NCT01666977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712166|NCT01666977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712167|NCT01666977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712168|NCT01666977|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92712169|NCT01666977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92712170|NCT01666977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712171|NCT01666977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712173|NCT01666977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712174|NCT01666977|Growth Inhibitors|growth inhibitors|mesh-ancestor
92712175|NCT02915354|Etanercept|etanercept|mesh-list
92712176|NCT02915354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92712177|NCT02915354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92712178|NCT02915354|Analgesics|analgesics|mesh-ancestor
92712180|NCT02915354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712181|NCT02915354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712182|NCT02915354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712183|NCT02915354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712184|NCT02915354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712185|NCT02915354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712186|NCT02915354|Immunologic Factors|immunologic factors|mesh-ancestor
92712188|NCT01661634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92712189|NCT01661634|Autonomic Agents|autonomic agents|mesh-ancestor
92712190|NCT01661634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712191|NCT01661634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712192|NCT01661634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92712193|NCT01661634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92712194|NCT01661634|Diuretics|diuretics|mesh-ancestor
92712195|NCT01661634|Natriuretic Agents|natriuretic agents|mesh-ancestor
92712196|NCT01661166|Fesoterodine|fesoterodine|mesh-list
92712197|NCT01661166|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92712198|NCT01661166|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92712199|NCT01661166|Cholinergic Agents|cholinergic agents|mesh-ancestor
92712200|NCT01661166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712201|NCT01661166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712202|NCT01661166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712203|NCT01661166|Urological Agents|urological agents|mesh-ancestor
92712204|NCT02915042|Dexmedetomidine|dexmedetomidine|mesh-list
92712205|NCT02915042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92712206|NCT02915042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712207|NCT02915042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712208|NCT02915042|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92712209|NCT02915042|Analgesics|analgesics|mesh-ancestor
92712210|NCT02915042|Sensory System Agents|sensory system agents|mesh-ancestor
92712211|NCT02915042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712212|NCT02915042|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92712213|NCT02915042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92712214|NCT02915042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92712215|NCT02915042|Adrenergic Agents|adrenergic agents|mesh-ancestor
92712216|NCT02915042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712217|NCT02915042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712218|NCT01658826|Valacyclovir|valacyclovir|mesh-list
92712219|NCT01658826|Pritelivir|pritelivir|mesh-list
92712220|NCT01658826|Antiviral Agents|antiviral agents|mesh-ancestor
92712221|NCT01658826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712222|NCT01658826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712223|NCT01658826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712224|NCT02092077|Hormones|hormones|mesh-list
92608362|NCT00135785|Bupropion|bupropion|mesh-list
92608363|NCT00135785|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92608364|NCT00135785|Antidepressive Agents|antidepressive agents|mesh-ancestor
92712225|NCT02092077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712226|NCT02092077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712227|NCT02914886|Insulin|insulin|mesh-list
92712228|NCT02914886|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92712229|NCT02914886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712230|NCT02914886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712231|NCT01643226|Riboflavin|riboflavin|mesh-list
92712232|NCT01643226|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92712233|NCT01643226|Vitamin B Complex|vitamin b complex|mesh-ancestor
92712234|NCT01643226|Vitamins|vitamins|mesh-ancestor
92712235|NCT01643226|Micronutrients|micronutrients|mesh-ancestor
92712236|NCT01643226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712237|NCT01643226|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92712238|NCT01643226|Dermatologic Agents|dermatologic agents|mesh-ancestor
92712239|NCT02914652|Albuterol|albuterol|mesh-list
92712240|NCT02914652|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92712241|NCT02914652|Autonomic Agents|autonomic agents|mesh-ancestor
92712242|NCT02914652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712243|NCT02914652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712244|NCT02914652|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92712245|NCT02914652|Respiratory System Agents|respiratory system agents|mesh-ancestor
92712246|NCT02914652|Tocolytic Agents|tocolytic agents|mesh-ancestor
92712247|NCT02914652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712248|NCT02914652|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92712249|NCT02914652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92712250|NCT02914652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92712251|NCT02914652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92712252|NCT02914652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712255|NCT02081118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712256|NCT02081118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712257|NCT02081118|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92712258|NCT02081118|Incretins|incretins|mesh-ancestor
92712259|NCT02081118|Hormones|hormones|mesh-ancestor
92712260|NCT02081118|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712261|NCT02077881|Paclitaxel|paclitaxel|mesh-list
92712262|NCT02077881|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92712263|NCT02077881|Gemcitabine|gemcitabine|mesh-list
92712264|NCT02077881|Tryptophan|tryptophan|mesh-list
92712265|NCT02077881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92712266|NCT02077881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712267|NCT02077881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92712268|NCT02077881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92712269|NCT02077881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92712270|NCT02077881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712271|NCT02077881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92712272|NCT02077881|Antimetabolites|antimetabolites|mesh-ancestor
92712273|NCT02077881|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92712274|NCT02077881|Antidepressive Agents|antidepressive agents|mesh-ancestor
92712275|NCT02077881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92712276|NCT01632228|Bevacizumab|bevacizumab|mesh-list
92712277|NCT01632228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92712278|NCT01632228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712279|NCT01632228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712280|NCT01632228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712281|NCT01632228|Growth Substances|growth substances|mesh-ancestor
92712282|NCT01632228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712283|NCT01632228|Growth Inhibitors|growth inhibitors|mesh-ancestor
92712284|NCT01628094|Ritonavir|ritonavir|mesh-list
92712285|NCT01628094|Ribavirin|ribavirin|mesh-list
92712286|NCT01628094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92712287|NCT01628094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92712288|NCT01628094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92712289|NCT01628094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712290|NCT01628094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712291|NCT01628094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92712292|NCT01628094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92712293|NCT01628094|Antiviral Agents|antiviral agents|mesh-ancestor
92712294|NCT01628094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712295|NCT01628094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92608365|NCT00135785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92608366|NCT00135785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92608367|NCT00135785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92712296|NCT01628094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92712297|NCT01628094|Antimetabolites|antimetabolites|mesh-ancestor
92712298|NCT02073123|Pembrolizumab|pembrolizumab|mesh-list
92712299|NCT02073123|Nivolumab|nivolumab|mesh-list
92712300|NCT02073123|Ipilimumab|ipilimumab|mesh-list
92712301|NCT02073123|Tryptophan|tryptophan|mesh-list
92712302|NCT02073123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92712303|NCT02073123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712304|NCT02073123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92712305|NCT02073123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712306|NCT02073123|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92712307|NCT02073123|Antidepressive Agents|antidepressive agents|mesh-ancestor
92712308|NCT02073123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92712309|NCT02914145|Piperaquine|piperaquine|mesh-list
92712310|NCT02914145|Artenimol|artenimol|mesh-list
92712311|NCT02914145|Antimalarials|antimalarials|mesh-ancestor
92712312|NCT02914145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92712313|NCT02914145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92712314|NCT02914145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712315|NCT02914028|Acetaminophen|acetaminophen|mesh-list
92712316|NCT02914028|Tramadol|tramadol|mesh-list
92712317|NCT02914028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92712318|NCT02914028|Analgesics|analgesics|mesh-ancestor
92712319|NCT02914028|Sensory System Agents|sensory system agents|mesh-ancestor
92712320|NCT02914028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712321|NCT02914028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712322|NCT02914028|Antipyretics|antipyretics|mesh-ancestor
92712323|NCT02914028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92712324|NCT02914028|Narcotics|narcotics|mesh-ancestor
92712325|NCT02914028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712326|NCT02064426|Epoetin Alfa|epoetin alfa|mesh-list
92712327|NCT02064426|Hematinics|hematinics|mesh-ancestor
92712344|NCT00585507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712345|NCT00585507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712346|NCT00585507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92712347|NCT00585507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92712348|NCT00585507|Hormone Antagonists|hormone antagonists|mesh-ancestor
92712349|NCT00585507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712350|NCT00585507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712351|NCT02063685|Prednisone|prednisone|mesh-list
92712352|NCT02063685|Cyclophosphamide|cyclophosphamide|mesh-list
92712353|NCT02063685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92712354|NCT02063685|Rituximab|rituximab|mesh-list
92712355|NCT02063685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92712356|NCT02063685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712357|NCT02063685|Immunologic Factors|immunologic factors|mesh-ancestor
92712358|NCT02063685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712359|NCT02063685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712360|NCT02063685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92712361|NCT02063685|Alkylating Agents|alkylating agents|mesh-ancestor
92712362|NCT02063685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712363|NCT02063685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712364|NCT02063685|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92712365|NCT02063685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92712366|NCT02063685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712367|NCT02063685|Glucocorticoids|glucocorticoids|mesh-ancestor
92712368|NCT02063685|Hormones|hormones|mesh-ancestor
92712369|NCT02063685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712370|NCT02063685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712371|NCT02063295|CKD732|ckd732|mesh-list
92712372|NCT02063295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712373|NCT02063295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712374|NCT02063295|Growth Substances|growth substances|mesh-ancestor
92712375|NCT02063295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712376|NCT02063295|Growth Inhibitors|growth inhibitors|mesh-ancestor
92712377|NCT02063295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712378|NCT02057172|Liraglutide|liraglutide|mesh-list
92712379|NCT02057172|Exenatide|exenatide|mesh-list
92712380|NCT02057172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712381|NCT02057172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608368|NCT00135785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608369|NCT00135785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712382|NCT02057172|Incretins|incretins|mesh-ancestor
92712383|NCT02057172|Hormones|hormones|mesh-ancestor
92712384|NCT02057172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712385|NCT02057172|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92712386|NCT02894307|Rivaroxaban|rivaroxaban|mesh-list
92712387|NCT02894307|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92712388|NCT02894307|Antithrombins|antithrombins|mesh-ancestor
92712395|NCT02052648|Temozolomide|temozolomide|mesh-list
92374279|NCT01766076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92712397|NCT02052648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92712398|NCT02052648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712399|NCT02052648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712400|NCT02052648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712401|NCT02052648|Growth Substances|growth substances|mesh-ancestor
92712402|NCT02052648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712403|NCT02052648|Growth Inhibitors|growth inhibitors|mesh-ancestor
92712404|NCT02052648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92712405|NCT02052648|Alkylating Agents|alkylating agents|mesh-ancestor
92712406|NCT02052648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712407|NCT02052648|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92712408|NCT02052648|Antidepressive Agents|antidepressive agents|mesh-ancestor
92712409|NCT02052648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92712410|NCT01186744|Tofacitinib|tofacitinib|mesh-list
92712411|NCT01186744|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92712412|NCT01186744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92712413|NCT01186744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712414|NCT01186744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712415|NCT02044341|Benzocaine|benzocaine|mesh-list
92712416|NCT02044341|Glycerol|glycerol|mesh-list
92712417|NCT02044341|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92712418|NCT02044341|Protective Agents|protective agents|mesh-ancestor
92712419|NCT02044341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712420|NCT02044341|Anesthetics, Local|anesthetics, local|mesh-ancestor
92712421|NCT02044341|Anesthetics|anesthetics|mesh-ancestor
92712422|NCT02044341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712423|NCT02044341|Sensory System Agents|sensory system agents|mesh-ancestor
92712424|NCT02044341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712425|NCT00555399|Temozolomide|temozolomide|mesh-list
92712426|NCT00555399|Vorinostat|vorinostat|mesh-list
92712427|NCT00555399|Isotretinoin|isotretinoin|mesh-list
92712428|NCT00555399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92712429|NCT00555399|Alkylating Agents|alkylating agents|mesh-ancestor
92712430|NCT00555399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712431|NCT00555399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712432|NCT00555399|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92712433|NCT00555399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712434|NCT00555399|Dermatologic Agents|dermatologic agents|mesh-ancestor
92712435|NCT02912663|Magnesium Sulfate|magnesium sulfate|mesh-list
92712436|NCT02912663|Verapamil|verapamil|mesh-list
92712437|NCT02912663|Analgesics|analgesics|mesh-ancestor
92712438|NCT02912663|Sensory System Agents|sensory system agents|mesh-ancestor
92712439|NCT02912663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712440|NCT02912663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712441|NCT02912663|Anesthetics|anesthetics|mesh-ancestor
92712442|NCT02912663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712443|NCT02912663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92712444|NCT02912663|Anticonvulsants|anticonvulsants|mesh-ancestor
92712445|NCT02912663|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92712446|NCT02912663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712447|NCT02912663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712448|NCT02912663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92712449|NCT02912663|Tocolytic Agents|tocolytic agents|mesh-ancestor
92712450|NCT02912663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712451|NCT02912663|Vasodilator Agents|vasodilator agents|mesh-ancestor
92712452|NCT02894151|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92712453|NCT02894151|Medroxyprogesterone|medroxyprogesterone|mesh-list
92712454|NCT02894151|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92712455|NCT02894151|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92712456|NCT02894151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92712460|NCT02894151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92608370|NCT00135785|Dopamine Agents|dopamine agents|mesh-ancestor
92608371|NCT00135785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015609|NCT01670539|Hormones|hormones|mesh-ancestor
92712461|NCT02894151|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92712462|NCT02894151|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92712463|NCT02894151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712465|NCT02912702|Dexamethasone|dexamethasone|mesh-list
92712466|NCT02912702|Methylprednisolone|methylprednisolone|mesh-list
92712467|NCT02912702|Doxorubicin|doxorubicin|mesh-list
92712468|NCT02912702|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92712469|NCT02912702|Etoposide|etoposide|mesh-list
92712470|NCT02912702|Etoposide phosphate|etoposide phosphate|mesh-list
92712471|NCT02912702|Pegaspargase|pegaspargase|mesh-list
92712472|NCT02912702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712473|NCT02912702|Antiemetics|antiemetics|mesh-ancestor
92712474|NCT02912702|Autonomic Agents|autonomic agents|mesh-ancestor
92712475|NCT02912702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712476|NCT02912702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712477|NCT02912702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712478|NCT02912702|Glucocorticoids|glucocorticoids|mesh-ancestor
92712479|NCT02912702|Hormones|hormones|mesh-ancestor
92712480|NCT02912702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712481|NCT02912702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712482|NCT02912702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712483|NCT02912702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92712484|NCT02912702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92712485|NCT02912702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92712486|NCT02912702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712487|NCT02912702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712488|NCT02912702|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92712489|NCT02912702|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92712490|NCT02912702|Protective Agents|protective agents|mesh-ancestor
92712491|NCT02010333|Benzyl Alcohol|benzyl alcohol|mesh-list
92712492|NCT02010333|Anesthetics, Local|anesthetics, local|mesh-ancestor
92712493|NCT02010333|Anesthetics|anesthetics|mesh-ancestor
92712494|NCT02010333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712495|NCT02010333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712496|NCT02010333|Sensory System Agents|sensory system agents|mesh-ancestor
92712497|NCT02010333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712498|NCT02008344|Favipiravir|favipiravir|mesh-list
92712499|NCT02008344|Antiviral Agents|antiviral agents|mesh-ancestor
92712500|NCT02008344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712501|NCT02912156|Voriconazole|voriconazole|mesh-list
92712502|NCT02912156|Antifungal Agents|antifungal agents|mesh-ancestor
92712503|NCT02912156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712504|NCT02912156|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92712505|NCT02912156|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92712506|NCT02912156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712507|NCT02912156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712508|NCT02912156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92712509|NCT02912156|Hormone Antagonists|hormone antagonists|mesh-ancestor
92712510|NCT02912156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712511|NCT02912156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712512|NCT02912156|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92712513|NCT03455049|Andrographolide|andrographolide|mesh-list
92712514|NCT03455049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712515|NCT03455049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92374315|NCT01769586|Anesthetics|anesthetics|mesh-ancestor
92712516|NCT03455049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92712517|NCT03455049|Analgesics|analgesics|mesh-ancestor
92712518|NCT03455049|Sensory System Agents|sensory system agents|mesh-ancestor
92712519|NCT03455049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712520|NCT03455049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712521|NCT03455049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712522|NCT03455049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92712523|NCT03455049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92712524|NCT03455049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712525|NCT03455049|Antiviral Agents|antiviral agents|mesh-ancestor
92712526|NCT03455049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92712530|NCT02912234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712531|NCT02912234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92712532|NCT02912234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608372|NCT00135785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067629|NCT03614494|Analgesics|analgesics|mesh-ancestor
92712533|NCT02912234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712534|NCT02912234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92712535|NCT02912234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92712536|NCT02912234|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92712537|NCT02912234|Antithrombins|antithrombins|mesh-ancestor
92712538|NCT02912234|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92712539|NCT02912234|Protease Inhibitors|protease inhibitors|mesh-ancestor
92712540|NCT02912234|Anticoagulants|anticoagulants|mesh-ancestor
92712541|NCT04676139|Fluoxetine|fluoxetine|mesh-list
92712542|NCT04676139|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92712543|NCT04676139|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92712544|NCT04676139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712545|NCT04676139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712546|NCT04676139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712547|NCT04676139|Serotonin Agents|serotonin agents|mesh-ancestor
92712548|NCT04676139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712549|NCT04676139|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92712550|NCT04676139|Antidepressive Agents|antidepressive agents|mesh-ancestor
92712551|NCT04676139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92712552|NCT04676139|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92712553|NCT04676139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92712554|NCT04676139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712555|NCT01999764|Retinol acetate|retinol acetate|mesh-list
92712556|NCT01999764|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92712557|NCT01999764|Immunologic Factors|immunologic factors|mesh-ancestor
92712558|NCT01999764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712559|NCT01999764|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92712560|NCT01999764|Protective Agents|protective agents|mesh-ancestor
92712561|NCT01999764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712562|NCT02911961|Acetaminophen|acetaminophen|mesh-list
92712563|NCT02911961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92712564|NCT02911961|Analgesics|analgesics|mesh-ancestor
92712565|NCT02911961|Sensory System Agents|sensory system agents|mesh-ancestor
92712566|NCT02911961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712567|NCT02911961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712568|NCT02911961|Antipyretics|antipyretics|mesh-ancestor
92712569|NCT01998828|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92712570|NCT01998828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92712571|NCT01998828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712572|NCT01998828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712573|NCT04676061|Norethindrone|norethindrone|mesh-list
92712574|NCT04676061|Norethindrone Acetate|norethindrone acetate|mesh-list
92712575|NCT04676061|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92712576|NCT04676061|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92712577|NCT04676061|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92712578|NCT04676061|Contraceptive Agents|contraceptive agents|mesh-ancestor
92712579|NCT04676061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712580|NCT04676061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712581|NCT04676061|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92712582|NCT04676061|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92712583|NCT04675944|Treprostinil|treprostinil|mesh-list
92712584|NCT04675944|Zamicastat|zamicastat|mesh-list
92712585|NCT04675944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92712586|NCT04675944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712587|NCT04675944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712588|NCT02911766|Chlorhexidine|chlorhexidine|mesh-list
92712589|NCT02911766|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92712590|NCT02911766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92712591|NCT02911766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712592|NCT02911766|Disinfectants|disinfectants|mesh-ancestor
92712593|NCT02911766|Dermatologic Agents|dermatologic agents|mesh-ancestor
92712594|NCT01993641|Azacitidine|azacitidine|mesh-list
92712595|NCT01993641|Decitabine|decitabine|mesh-list
92712596|NCT01993641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92712597|NCT01993641|Antimetabolites|antimetabolites|mesh-ancestor
92712606|NCT02911298|Metronidazole|metronidazole|mesh-list
92712607|NCT02911298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712608|NCT02911298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92712609|NCT02911298|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92608373|NCT00135785|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92712610|NCT02911298|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92712611|NCT01983306|Dolcanatide|dolcanatide|mesh-list
92712612|NCT01983306|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92712613|NCT01983306|Enzyme Activators|enzyme activators|mesh-ancestor
92712614|NCT01983306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712615|NCT01983306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712616|NCT01982175|Alemtuzumab|alemtuzumab|mesh-list
92712617|NCT01982175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92712618|NCT01982175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712619|NCT01975818|Epoetin Alfa|epoetin alfa|mesh-list
92712620|NCT01975818|Hematinics|hematinics|mesh-ancestor
92712622|NCT01973049|Asunaprevir|asunaprevir|mesh-list
92712623|NCT01973049|Antimetabolites|antimetabolites|mesh-ancestor
92712624|NCT01973049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712625|NCT01973049|Antiviral Agents|antiviral agents|mesh-ancestor
92712626|NCT01973049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712627|NCT01973049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92712628|NCT01973049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712629|NCT01185964|Doxorubicin|doxorubicin|mesh-list
92712630|NCT01185964|Olaratumab|olaratumab|mesh-list
92712631|NCT01185964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92712632|NCT01185964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712633|NCT01185964|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92712634|NCT01185964|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92712635|NCT01185964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712636|NCT01185964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712637|NCT01972854|Riboflavin|riboflavin|mesh-list
92712638|NCT01972854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92712639|NCT01972854|Vitamin B Complex|vitamin b complex|mesh-ancestor
92712640|NCT01972854|Vitamins|vitamins|mesh-ancestor
92712641|NCT01972854|Micronutrients|micronutrients|mesh-ancestor
92374350|NCT01783470|Mirabegron|mirabegron|mesh-list
92712642|NCT01972854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712643|NCT01972854|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92712644|NCT01972854|Dermatologic Agents|dermatologic agents|mesh-ancestor
92712645|NCT02550470|Sevoflurane|sevoflurane|mesh-list
92712646|NCT02550470|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92712647|NCT02550470|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92712648|NCT02550470|Anesthetics, General|anesthetics, general|mesh-ancestor
92712649|NCT02550470|Anesthetics|anesthetics|mesh-ancestor
92712650|NCT02550470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712651|NCT02550470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712652|NCT02910518|Insulin|insulin|mesh-list
92712653|NCT02910518|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92712654|NCT02910518|Insulin Aspart|insulin aspart|mesh-list
92712655|NCT02910518|Insulin glulisine|insulin glulisine|mesh-list
92712656|NCT02910518|Insulin, Isophane|insulin, isophane|mesh-list
92712657|NCT02910518|Isophane Insulin, Human|isophane insulin, human|mesh-list
92712658|NCT02910518|Isophane insulin, beef|isophane insulin, beef|mesh-list
92712659|NCT02910518|Heparin|heparin|mesh-list
92712660|NCT02910518|Calcium heparin|calcium heparin|mesh-list
92712661|NCT02910518|Glucagon|glucagon|mesh-list
92712662|NCT02910518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712663|NCT02910518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712664|NCT02910518|Anticoagulants|anticoagulants|mesh-ancestor
92712665|NCT02910518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92712666|NCT02910518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92712667|NCT02910518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712670|NCT02910518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712672|NCT01217437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92712673|NCT01217437|Irinotecan|irinotecan|mesh-list
92712674|NCT01217437|Temozolomide|temozolomide|mesh-list
92712675|NCT01217437|Camptothecin|camptothecin|mesh-list
92712676|NCT01217437|Endothelial Growth Factors|endothelial growth factors|mesh-list
92712677|NCT01217437|Antibodies|antibodies|mesh-list
92712678|NCT01217437|Immunoglobulins|immunoglobulins|mesh-list
92712679|NCT01217437|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92712680|NCT01217437|Immunoglobulin G|immunoglobulin g|mesh-list
92712681|NCT01217437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712682|NCT01217437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712683|NCT01217437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712684|NCT01217437|Growth Substances|growth substances|mesh-ancestor
92712685|NCT01217437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712686|NCT01217437|Growth Inhibitors|growth inhibitors|mesh-ancestor
92712687|NCT01217437|Immunologic Factors|immunologic factors|mesh-ancestor
92712688|NCT01217437|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92712689|NCT01217437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608374|NCT00135785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92608375|NCT00135785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608377|NCT00159081|Risperidone|risperidone|mesh-list
92608378|NCT00159081|Haloperidol decanoate|haloperidol decanoate|mesh-list
92608379|NCT00159081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92608380|NCT00159081|Serotonin Agents|serotonin agents|mesh-ancestor
92712690|NCT01217437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712691|NCT01217437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712692|NCT01217437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92712693|NCT01217437|Alkylating Agents|alkylating agents|mesh-ancestor
92712694|NCT01217437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92712695|NCT00624364|Metformin|metformin|mesh-list
92712696|NCT00624364|Insulin Aspart|insulin aspart|mesh-list
92712697|NCT00624364|Biphasic Insulins|biphasic insulins|mesh-list
92712698|NCT00624364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712699|NCT00624364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712700|NCT02910596|Bethanechol|bethanechol|mesh-list
92712701|NCT02910596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92712702|NCT02910596|Autonomic Agents|autonomic agents|mesh-ancestor
92712703|NCT02910596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712704|NCT02910596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712705|NCT02910596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92712706|NCT02910596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92712707|NCT02910596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92712708|NCT02910596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712709|NCT02910596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712710|NCT04316377|Hydroxychloroquine|hydroxychloroquine|mesh-list
92712711|NCT04316377|Antimalarials|antimalarials|mesh-ancestor
92712712|NCT04316377|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92712713|NCT04316377|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92712714|NCT04316377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712715|NCT04316377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712716|NCT04316377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712717|NCT04316377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712718|NCT02886988|Botulinum Toxins|botulinum toxins|mesh-list
92712719|NCT02886988|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92712720|NCT02886988|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92712721|NCT02886988|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92712722|NCT02886988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712723|NCT02886988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712724|NCT02886988|Cholinergic Agents|cholinergic agents|mesh-ancestor
92712725|NCT02886988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712726|NCT02886988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712727|NCT02886988|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92712728|NCT02886988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712730|NCT04676997|Cyclophosphamide|cyclophosphamide|mesh-list
92712731|NCT04676997|Epirubicin|epirubicin|mesh-list
92712732|NCT04676997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92712733|NCT04676997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712734|NCT04676997|Tubulin Modulators|tubulin modulators|mesh-ancestor
92712735|NCT04676997|Antimitotic Agents|antimitotic agents|mesh-ancestor
92712736|NCT04676997|Mitosis Modulators|mitosis modulators|mesh-ancestor
92712737|NCT04676997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712738|NCT04676997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712739|NCT04676997|Immunologic Factors|immunologic factors|mesh-ancestor
92712740|NCT04676997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712741|NCT04676997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712744|NCT04676997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92712745|NCT04676997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92712746|NCT04676997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92712747|NCT04676997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92712748|NCT04676997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712749|NCT02910206|Sufentanil|sufentanil|mesh-list
92712750|NCT02910206|Propofol|propofol|mesh-list
92712751|NCT02910206|Etomidate|etomidate|mesh-list
92712752|NCT02910206|Cisatracurium|cisatracurium|mesh-list
92712753|NCT02910206|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92712754|NCT02910206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608381|NCT00159081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608382|NCT00159081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608383|NCT00159081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712755|NCT02910206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712756|NCT02910206|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92712757|NCT02910206|Anesthetics, General|anesthetics, general|mesh-ancestor
92712758|NCT02910206|Anesthetics|anesthetics|mesh-ancestor
92712759|NCT02910206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92712760|NCT02910206|Narcotics|narcotics|mesh-ancestor
92712761|NCT02910206|Analgesics|analgesics|mesh-ancestor
92712762|NCT02910206|Sensory System Agents|sensory system agents|mesh-ancestor
92712763|NCT02910206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712764|NCT02910206|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92712765|NCT02910206|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92024842|NCT04277845|Dexamethasone|dexamethasone|mesh-list
92712766|NCT02910206|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92712767|NCT04675086|Antiviral Agents|antiviral agents|mesh-list
92712768|NCT04675086|Remdesivir|remdesivir|mesh-list
92712769|NCT04675086|Protease Inhibitors|protease inhibitors|mesh-list
92712770|NCT04675086|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92712771|NCT04675086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712772|NCT04675086|Antimetabolites|antimetabolites|mesh-ancestor
92712773|NCT04675086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712774|NCT04675086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712775|NCT04675086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92712776|NCT04675086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92712778|NCT02909972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92712779|NCT02909972|Antimetabolites|antimetabolites|mesh-ancestor
92712780|NCT02909972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712781|NCT02909972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712782|NCT02909972|Antiviral Agents|antiviral agents|mesh-ancestor
92712783|NCT02909972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712784|NCT02909972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712785|NCT02909972|Immunologic Factors|immunologic factors|mesh-ancestor
92712786|NCT02909972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712787|NCT00555594|Bevacizumab|bevacizumab|mesh-list
92712788|NCT00555594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92712789|NCT00555594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712790|NCT00555594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92712791|NCT00555594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92712792|NCT00555594|Growth Substances|growth substances|mesh-ancestor
92712793|NCT00555594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712794|NCT00555594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92712795|NCT02910050|Letrozole|letrozole|mesh-list
92712796|NCT02910050|Anastrozole|anastrozole|mesh-list
92712797|NCT02910050|Exemestane|exemestane|mesh-list
92712798|NCT02910050|Bicalutamide|bicalutamide|mesh-list
92712799|NCT02910050|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92712800|NCT02910050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712801|NCT02910050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92712802|NCT02910050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712803|NCT02910050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712804|NCT02910050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92712805|NCT02910050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92712806|NCT02910050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712807|NCT02910050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712808|NCT02910050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712809|NCT02910050|Androgen Antagonists|androgen antagonists|mesh-ancestor
92712810|NCT02909933|Metformin|metformin|mesh-list
92712811|NCT02909933|Liraglutide|liraglutide|mesh-list
92712812|NCT02909933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92712813|NCT02909933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712814|NCT02909933|Incretins|incretins|mesh-ancestor
92712815|NCT02909933|Hormones|hormones|mesh-ancestor
92712816|NCT02909933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712821|NCT02910245|Glucocorticoids|glucocorticoids|mesh-ancestor
92712823|NCT02910245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712824|NCT02910245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712825|NCT02910245|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712826|NCT02910245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712827|NCT02910245|Antimetabolites|antimetabolites|mesh-ancestor
92608384|NCT00159081|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92608385|NCT00159081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608386|NCT00159081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067942|NCT05887609|Maytansine|maytansine|mesh-list
92712828|NCT02910245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712829|NCT02910245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92712830|NCT02910245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712831|NCT02910245|Immunologic Factors|immunologic factors|mesh-ancestor
92712832|NCT02910245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92712833|NCT02910245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374385|NCT01785186|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92712834|NCT02910245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92712835|NCT02910245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92712836|NCT02910245|Analgesics|analgesics|mesh-ancestor
92712837|NCT02910245|Sensory System Agents|sensory system agents|mesh-ancestor
92712838|NCT02910245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712839|NCT02910245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712840|NCT01185340|Serotonin|serotonin|mesh-list
92712841|NCT01185340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92712842|NCT01185340|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92712843|NCT01185340|Serotonin Agents|serotonin agents|mesh-ancestor
92712844|NCT01185340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712845|NCT01185340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712846|NCT01185340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712847|NCT01185340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92712848|NCT01185340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712849|NCT01959282|Niacinamide|niacinamide|mesh-list
92712850|NCT01959282|Peficitinib|peficitinib|mesh-list
92712851|NCT01959282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712852|NCT01959282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712853|NCT01959282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712854|NCT01959282|Immunologic Factors|immunologic factors|mesh-ancestor
92712855|NCT01959282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712856|NCT01959282|Vitamin B Complex|vitamin b complex|mesh-ancestor
92712857|NCT01959282|Vitamins|vitamins|mesh-ancestor
92712858|NCT01959282|Micronutrients|micronutrients|mesh-ancestor
92712859|NCT01185301|Adalimumab|adalimumab|mesh-list
92712860|NCT01185301|Methotrexate|methotrexate|mesh-list
92712861|NCT01185301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92712862|NCT01185301|Abortifacient Agents|abortifacient agents|mesh-ancestor
92712863|NCT01185301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712864|NCT01185301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712865|NCT01185301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92712866|NCT01185301|Antimetabolites|antimetabolites|mesh-ancestor
92712867|NCT01185301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712868|NCT01185301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712869|NCT01185301|Dermatologic Agents|dermatologic agents|mesh-ancestor
92712870|NCT01185301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712871|NCT01185301|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92712872|NCT01185301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712873|NCT01185301|Immunologic Factors|immunologic factors|mesh-ancestor
92712874|NCT01185301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712875|NCT01185301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92712876|NCT01185301|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92712877|NCT01185301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712878|NCT01216072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92712879|NCT01216072|Interferon beta-1b|interferon beta-1b|mesh-list
92712880|NCT01216072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92712881|NCT01216072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712882|NCT01216072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92712883|NCT01216072|Immunologic Factors|immunologic factors|mesh-ancestor
92712884|NCT01216072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712885|NCT01216072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92712886|NCT01940991|Botulinum Toxins|botulinum toxins|mesh-list
92712898|NCT02909465|Ketamine|ketamine|mesh-list
92712899|NCT02909465|Haloperidol|haloperidol|mesh-list
92712900|NCT02909465|Haloperidol decanoate|haloperidol decanoate|mesh-list
92712901|NCT02909465|Analgesics|analgesics|mesh-ancestor
92712902|NCT02909465|Sensory System Agents|sensory system agents|mesh-ancestor
92712903|NCT02909465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712904|NCT02909465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608388|NCT00159081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92608389|NCT00159081|Dopamine Agents|dopamine agents|mesh-ancestor
92608390|NCT00159081|Antiemetics|antiemetics|mesh-ancestor
92608391|NCT00159081|Autonomic Agents|autonomic agents|mesh-ancestor
92712905|NCT02909465|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92712906|NCT02909465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92712907|NCT02909465|Anesthetics, General|anesthetics, general|mesh-ancestor
92712908|NCT02909465|Anesthetics|anesthetics|mesh-ancestor
92712909|NCT02909465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712910|NCT02909465|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92712911|NCT02909465|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92712912|NCT02909465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712913|NCT02909465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712914|NCT02909465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92712915|NCT02909465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92712916|NCT02909465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92712917|NCT02909465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92712918|NCT02909465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92712919|NCT02909465|GABA Modulators|gaba modulators|mesh-ancestor
92712920|NCT02909465|GABA Agents|gaba agents|mesh-ancestor
92712921|NCT02909465|Antiemetics|antiemetics|mesh-ancestor
92712922|NCT02909465|Autonomic Agents|autonomic agents|mesh-ancestor
92712923|NCT02909465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712924|NCT02909465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92712925|NCT02909465|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92712926|NCT02909465|Dopamine Agents|dopamine agents|mesh-ancestor
92712927|NCT02909465|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92712929|NCT04312555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92712930|NCT04312555|Vasodilator Agents|vasodilator agents|mesh-ancestor
92712931|NCT04312555|Urological Agents|urological agents|mesh-ancestor
92712932|NCT01184989|Dabigatran|dabigatran|mesh-list
92712933|NCT01184989|Antithrombins|antithrombins|mesh-ancestor
92712934|NCT01184989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92712935|NCT01184989|Protease Inhibitors|protease inhibitors|mesh-ancestor
92712936|NCT01184989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712937|NCT01184989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712938|NCT01184989|Anticoagulants|anticoagulants|mesh-ancestor
92712939|NCT04674423|Tenofovir|tenofovir|mesh-list
92712940|NCT04674423|Antiviral Agents|antiviral agents|mesh-ancestor
92712941|NCT04674423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92712942|NCT04674423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92712943|NCT04674423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92712944|NCT04674423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374415|NCT01790490|Ketamine|ketamine|mesh-list
92712945|NCT04674423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712946|NCT04674423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92712947|NCT04674423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92712948|NCT00555867|Anastrozole|anastrozole|mesh-list
92712949|NCT00555867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712950|NCT00555867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712951|NCT00555867|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92712961|NCT00555984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92712962|NCT00555984|Anesthetics|anesthetics|mesh-list
92712963|NCT00555984|Sevoflurane|sevoflurane|mesh-list
92712964|NCT00555984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92712965|NCT00555984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712966|NCT00555984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712967|NCT00555984|Anesthetics, General|anesthetics, general|mesh-ancestor
92712968|NCT00555984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92712969|NCT00555984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92712970|NCT00555984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92712971|NCT00555984|Narcotics|narcotics|mesh-ancestor
92712972|NCT00555984|Analgesics|analgesics|mesh-ancestor
92712973|NCT00555984|Sensory System Agents|sensory system agents|mesh-ancestor
92712974|NCT00555984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712975|NCT03457337|Gefitinib|gefitinib|mesh-list
92712976|NCT03457337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712977|NCT03457337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92712978|NCT03457337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712979|NCT03457337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712980|NCT02274779|Leuprolide|leuprolide|mesh-list
92712981|NCT02274779|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92712982|NCT02274779|Fertility Agents|fertility agents|mesh-ancestor
92608392|NCT00159081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608393|NCT00159081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92608394|NCT00159081|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92608395|NCT00152841|Vitamin E|vitamin e|mesh-list
92608396|NCT00152841|Vitamins|vitamins|mesh-ancestor
92712983|NCT02274779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712984|NCT02274779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712985|NCT02274779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92712986|NCT02274779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712987|NCT01908738|Lidocaine|lidocaine|mesh-list
92712988|NCT01908738|Anesthetics, Local|anesthetics, local|mesh-ancestor
92712989|NCT01908738|Anesthetics|anesthetics|mesh-ancestor
92712990|NCT01908738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92712991|NCT01908738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712992|NCT01908738|Sensory System Agents|sensory system agents|mesh-ancestor
92712993|NCT01908738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712994|NCT01908738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92712995|NCT01908738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92712996|NCT01908738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92712997|NCT01908738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712998|NCT01908738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713000|NCT04673955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713001|NCT04673955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713002|NCT01904409|Rifaximin|rifaximin|mesh-list
92713003|NCT01904409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92713004|NCT01904409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713005|NCT01904409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713006|NCT01902381|Thioctic Acid|thioctic acid|mesh-list
92713007|NCT01902381|Antioxidants|antioxidants|mesh-ancestor
92713008|NCT01902381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713009|NCT01902381|Protective Agents|protective agents|mesh-ancestor
92713010|NCT01902381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713011|NCT01902381|Vitamin B Complex|vitamin b complex|mesh-ancestor
92713012|NCT01902381|Vitamins|vitamins|mesh-ancestor
92713013|NCT01902381|Micronutrients|micronutrients|mesh-ancestor
92713014|NCT04673799|Denosumab|denosumab|mesh-list
92713015|NCT04673799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92713016|NCT04673799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713017|NCT04673487|Immunoglobulin G|immunoglobulin g|mesh-list
92713021|NCT01215955|Insulin Lispro|insulin lispro|mesh-list
92713022|NCT01215955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713023|NCT01215955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713024|NCT05194592|Dapagliflozin|dapagliflozin|mesh-list
92713025|NCT05194592|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92713026|NCT05194592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713027|NCT05194592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713028|NCT05194592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713029|NCT01871415|Metformin|metformin|mesh-list
92713030|NCT01871415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713031|NCT01871415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713032|NCT05189717|Everolimus|everolimus|mesh-list
92713033|NCT05189717|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92713034|NCT05189717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713035|NCT05189717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713036|NCT05189717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713037|NCT05189717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713038|NCT05189717|Immunologic Factors|immunologic factors|mesh-ancestor
92713039|NCT05189717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713040|NCT05189717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713041|NCT05182463|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92713042|NCT05182463|Antiviral Agents|antiviral agents|mesh-ancestor
92713043|NCT05182463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713044|NCT02277197|Cetuximab|cetuximab|mesh-list
92713045|NCT02277197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713046|NCT02277197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713047|NCT00555087|Methyltestosterone|methyltestosterone|mesh-list
92713048|NCT00555087|Testosterone|testosterone|mesh-list
92713049|NCT00555087|Testosterone undecanoate|testosterone undecanoate|mesh-list
92713050|NCT00555087|Testosterone enanthate|testosterone enanthate|mesh-list
92713051|NCT00555087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92713052|NCT00555087|Androgens|androgens|mesh-ancestor
92608397|NCT00152841|Micronutrients|micronutrients|mesh-ancestor
92608398|NCT00152841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608399|NCT00152841|Antioxidants|antioxidants|mesh-ancestor
92015633|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713054|NCT00555087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713055|NCT00555087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713056|NCT00555087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92713057|NCT00555087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713058|NCT00555087|Anabolic Agents|anabolic agents|mesh-ancestor
92713059|NCT04673214|Acetaminophen|acetaminophen|mesh-list
92713060|NCT04673214|Azithromycin|azithromycin|mesh-list
92713061|NCT04673214|Ivermectin|ivermectin|mesh-list
92713062|NCT04673214|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92713063|NCT04673214|Analgesics|analgesics|mesh-ancestor
92713064|NCT04673214|Sensory System Agents|sensory system agents|mesh-ancestor
92713065|NCT04673214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713066|NCT04673214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713067|NCT04673214|Antipyretics|antipyretics|mesh-ancestor
92713068|NCT04673214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92713069|NCT04673214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713070|NCT04673214|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92713071|NCT00556023|Gemcitabine|gemcitabine|mesh-list
92713072|NCT00556023|Tremelimumab|tremelimumab|mesh-list
92713073|NCT00556023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92132851|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
92713075|NCT00556023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713076|NCT00556023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713077|NCT05011214|Ketamine|ketamine|mesh-list
92713078|NCT05011214|Sevoflurane|sevoflurane|mesh-list
92713079|NCT05011214|Esketamine|esketamine|mesh-list
92713080|NCT05011214|Analgesics|analgesics|mesh-ancestor
92713081|NCT05011214|Sensory System Agents|sensory system agents|mesh-ancestor
92713082|NCT05011214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713083|NCT05011214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713084|NCT05011214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92713085|NCT05011214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713086|NCT05011214|Anesthetics, General|anesthetics, general|mesh-ancestor
92713087|NCT05011214|Anesthetics|anesthetics|mesh-ancestor
92713088|NCT05011214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713089|NCT05011214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92713090|NCT05011214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92713091|NCT05011214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713104|NCT04676763|Histamine Agents|histamine agents|mesh-ancestor
92713105|NCT04676763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713106|NCT04676763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713107|NCT04676763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713108|NCT04672707|Bromhexine|bromhexine|mesh-list
92713109|NCT04672707|Expectorants|expectorants|mesh-ancestor
92713110|NCT04672707|Respiratory System Agents|respiratory system agents|mesh-ancestor
92713111|NCT04932083|Fentanyl|fentanyl|mesh-list
92713112|NCT04932083|Midazolam|midazolam|mesh-list
92713113|NCT04932083|Nalbuphine|nalbuphine|mesh-list
92713114|NCT04932083|Bupivacaine|bupivacaine|mesh-list
92713115|NCT04932083|Anesthetics, Local|anesthetics, local|mesh-ancestor
92713116|NCT04932083|Anesthetics|anesthetics|mesh-ancestor
92713117|NCT04932083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713118|NCT04932083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713119|NCT04932083|Sensory System Agents|sensory system agents|mesh-ancestor
92713120|NCT04932083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713121|NCT04932083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92713122|NCT04932083|Narcotics|narcotics|mesh-ancestor
92713123|NCT04932083|Analgesics|analgesics|mesh-ancestor
92713124|NCT04932083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92713125|NCT04932083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713126|NCT04932083|Anesthetics, General|anesthetics, general|mesh-ancestor
92713127|NCT04932083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713128|NCT04932083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92713129|NCT04932083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92713130|NCT04932083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92713131|NCT04932083|GABA Modulators|gaba modulators|mesh-ancestor
92713132|NCT04932083|GABA Agents|gaba agents|mesh-ancestor
92713133|NCT04932083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713134|NCT04932083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608400|NCT00152841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608401|NCT00152841|Protective Agents|protective agents|mesh-ancestor
92713135|NCT01825980|Ritonavir|ritonavir|mesh-list
92713136|NCT01825980|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92713137|NCT01825980|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92713138|NCT01825980|Protease Inhibitors|protease inhibitors|mesh-ancestor
92713139|NCT01825980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713140|NCT01825980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374486|NCT01797822|Hormones|hormones|mesh-ancestor
92713141|NCT01825980|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92713142|NCT01825980|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92713143|NCT01825980|Antiviral Agents|antiviral agents|mesh-ancestor
92713144|NCT01825980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713145|NCT01825980|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92713146|NCT01825980|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92713147|NCT04672317|Immunomodulating Agents|immunomodulating agents|mesh-list
92713148|NCT04672317|Immunologic Factors|immunologic factors|mesh-ancestor
92713149|NCT04672317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713150|NCT04790045|Venetoclax|venetoclax|mesh-list
92713151|NCT04790045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713152|NCT01655225|Pemetrexed|pemetrexed|mesh-list
92713153|NCT01655225|Letrozole|letrozole|mesh-list
92713154|NCT01655225|Fulvestrant|fulvestrant|mesh-list
92713155|NCT01655225|Midazolam|midazolam|mesh-list
92713156|NCT01655225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713157|NCT01655225|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92713158|NCT01655225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713162|NCT01655225|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92713163|NCT01655225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92713164|NCT01655225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713165|NCT01655225|Anesthetics, General|anesthetics, general|mesh-ancestor
92713166|NCT01655225|Anesthetics|anesthetics|mesh-ancestor
92713167|NCT01655225|GABA Modulators|gaba modulators|mesh-ancestor
92713168|NCT01655225|GABA Agents|gaba agents|mesh-ancestor
92713169|NCT01655225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713170|NCT01655225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713171|NCT01655225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713172|NCT01655225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92713173|NCT01655225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92713174|NCT01655225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92713175|NCT01655225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92713176|NCT01655225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92713177|NCT01655225|Hormone Antagonists|hormone antagonists|mesh-ancestor
92713178|NCT01655225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713179|NCT01655225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92713180|NCT01655225|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92713181|NCT01818921|CKD732|ckd732|mesh-list
92713182|NCT01818921|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92713183|NCT01818921|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92713184|NCT01818921|Growth Substances|growth substances|mesh-ancestor
92713185|NCT01818921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713186|NCT01818921|Growth Inhibitors|growth inhibitors|mesh-ancestor
92713187|NCT01818921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713188|NCT01810575|Alprostadil|alprostadil|mesh-list
92713189|NCT01810575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92713190|NCT01810575|Vasodilator Agents|vasodilator agents|mesh-ancestor
92713191|NCT01810575|Urological Agents|urological agents|mesh-ancestor
92713192|NCT01785771|Exenatide|exenatide|mesh-list
92713193|NCT01785771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713194|NCT01785771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713195|NCT01785771|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92713196|NCT01785771|Incretins|incretins|mesh-ancestor
92713197|NCT01785771|Hormones|hormones|mesh-ancestor
92713198|NCT01785771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713199|NCT01784874|Vaccines|vaccines|mesh-list
92713200|NCT01784874|Immunologic Factors|immunologic factors|mesh-ancestor
92713201|NCT01784874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713202|NCT04607252|Metformin|metformin|mesh-list
92713203|NCT04607252|Megestrol|megestrol|mesh-list
92713204|NCT04607252|Megestrol Acetate|megestrol acetate|mesh-list
92713205|NCT04607252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713206|NCT04607252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713207|NCT04607252|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92713208|NCT04607252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92713209|NCT04607252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92608402|NCT00159120|Antipsychotic Agents|antipsychotic agents|mesh-list
92608403|NCT00159120|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608404|NCT00159120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713210|NCT04607252|Contraceptive Agents|contraceptive agents|mesh-ancestor
92713211|NCT04607252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92713212|NCT04607252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92713213|NCT04607252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92713214|NCT04607252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92713215|NCT04607252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713216|NCT04607252|Appetite Stimulants|appetite stimulants|mesh-ancestor
92713217|NCT04607252|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92713218|NCT01782729|Tacrolimus|tacrolimus|mesh-list
92713219|NCT01782729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713220|NCT01782729|Immunologic Factors|immunologic factors|mesh-ancestor
92713221|NCT01782729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713222|NCT01782729|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92713223|NCT01782729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713224|NCT01782729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133004|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
92713225|NCT01780428|Acetaminophen|acetaminophen|mesh-list
92713226|NCT01780428|Promethazine|promethazine|mesh-list
92713227|NCT01780428|Diphenhydramine|diphenhydramine|mesh-list
92713228|NCT01780428|Hydrocodone|hydrocodone|mesh-list
92713229|NCT01780428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92713230|NCT01780428|Analgesics|analgesics|mesh-ancestor
92713262|NCT04573556|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92713263|NCT04573556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713264|NCT04573556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713265|NCT04573556|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92713266|NCT04573556|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713267|NCT04573556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713268|NCT04573556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713269|NCT04671108|Hyaluronic Acid|hyaluronic acid|mesh-list
92713270|NCT04671108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92713271|NCT04671108|Immunologic Factors|immunologic factors|mesh-ancestor
92713272|NCT04671108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713273|NCT04671108|Viscosupplements|viscosupplements|mesh-ancestor
92713274|NCT04671108|Protective Agents|protective agents|mesh-ancestor
92713280|NCT01779453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713281|NCT01779453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92713282|NCT01779453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92713283|NCT01779453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713284|NCT01779453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713285|NCT01779453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713286|NCT01776606|Botulinum Toxins|botulinum toxins|mesh-list
92713287|NCT01776606|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92713288|NCT01776606|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92713289|NCT01776606|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92713290|NCT01776606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92713291|NCT01776606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713292|NCT01776606|Cholinergic Agents|cholinergic agents|mesh-ancestor
92713293|NCT01776606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713294|NCT01776606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713295|NCT01776606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92713296|NCT01776606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713298|NCT04567160|Sevoflurane|sevoflurane|mesh-list
92713299|NCT04567160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713300|NCT04567160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713301|NCT04567160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713302|NCT04567160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713303|NCT04567160|Anesthetics, General|anesthetics, general|mesh-ancestor
92713304|NCT04567160|Anesthetics|anesthetics|mesh-ancestor
92713305|NCT04567160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92713306|NCT04567160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92713307|NCT01774578|Gemcitabine|gemcitabine|mesh-list
92713309|NCT01774578|Pemetrexed|pemetrexed|mesh-list
92713310|NCT01774578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92713311|NCT01774578|Antimetabolites|antimetabolites|mesh-ancestor
92713312|NCT01774578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713313|NCT01774578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608405|NCT00159120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608406|NCT00159120|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92608407|NCT00159159|Cyclosporine|cyclosporine|mesh-list
92713314|NCT01774578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92713315|NCT01774578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92713316|NCT01774578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92713317|NCT01774578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713318|NCT01774578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92713319|NCT01774578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92713320|NCT04543994|Remestemcel-l|remestemcel-l|mesh-list
92713321|NCT04543994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713322|NCT04543994|Antiviral Agents|antiviral agents|mesh-ancestor
92713323|NCT04543994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713324|NCT04670601|Flurbiprofen|flurbiprofen|mesh-list
92713325|NCT04670601|Analgesics|analgesics|mesh-ancestor
92713326|NCT04670601|Sensory System Agents|sensory system agents|mesh-ancestor
92713327|NCT04670601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713328|NCT04670601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713329|NCT04670601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92713330|NCT04670601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92713331|NCT04670601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713332|NCT04670601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713333|NCT04670601|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92713334|NCT04670601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713335|NCT04670601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713336|NCT04670913|Apatinib|apatinib|mesh-list
92713337|NCT04670913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713338|NCT04670913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713339|NCT04670913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713340|NCT04670913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713341|NCT04671069|Clopidogrel|clopidogrel|mesh-list
92713342|NCT04671069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92713343|NCT04671069|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92713352|NCT04322123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92713353|NCT04322123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713354|NCT04322123|Antimalarials|antimalarials|mesh-ancestor
92713355|NCT04322123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92713356|NCT04322123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92713357|NCT04322123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713358|NCT04322123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713359|NCT04322123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713360|NCT04259138|Vedolizumab|vedolizumab|mesh-list
92713361|NCT04259138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713362|NCT01741155|Docetaxel|docetaxel|mesh-list
92713363|NCT01741155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713364|NCT01741155|Tubulin Modulators|tubulin modulators|mesh-ancestor
92713365|NCT01741155|Antimitotic Agents|antimitotic agents|mesh-ancestor
92713366|NCT01741155|Mitosis Modulators|mitosis modulators|mesh-ancestor
92713367|NCT01741155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713368|NCT04244630|Antioxidants|antioxidants|mesh-list
92713369|NCT04244630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713370|NCT04244630|Protective Agents|protective agents|mesh-ancestor
92713371|NCT04244630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713372|NCT04239053|Bupivacaine|bupivacaine|mesh-list
92713373|NCT04239053|Anesthetics, Local|anesthetics, local|mesh-ancestor
92713374|NCT04239053|Anesthetics|anesthetics|mesh-ancestor
92713375|NCT04239053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133150|NCT04409431|Autonomic Agents|autonomic agents|mesh-ancestor
92713376|NCT04239053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713377|NCT04239053|Sensory System Agents|sensory system agents|mesh-ancestor
92713378|NCT04239053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713379|NCT01718145|Ribavirin|ribavirin|mesh-list
92713380|NCT01718145|Asunaprevir|asunaprevir|mesh-list
92713381|NCT01718145|Antimetabolites|antimetabolites|mesh-ancestor
92713382|NCT01718145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713383|NCT01718145|Antiviral Agents|antiviral agents|mesh-ancestor
92713384|NCT01718145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713385|NCT01718145|Protease Inhibitors|protease inhibitors|mesh-ancestor
92713386|NCT01718145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713387|NCT00556257|Cyclosporine|cyclosporine|mesh-list
92713388|NCT00556257|Cyclosporins|cyclosporins|mesh-list
92713389|NCT00556257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374496|NCT01809054|Analgesics|analgesics|mesh-ancestor
92713390|NCT00556257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713391|NCT00556257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713392|NCT00556257|Immunologic Factors|immunologic factors|mesh-ancestor
92713393|NCT00556257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713394|NCT00556257|Antifungal Agents|antifungal agents|mesh-ancestor
92713395|NCT00556257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713396|NCT00556257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92713397|NCT00556257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713398|NCT00556257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92713400|NCT01712451|Xhance|xhance|mesh-list
92713401|NCT01712451|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92713402|NCT01712451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713403|NCT01712451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92713404|NCT01712451|Autonomic Agents|autonomic agents|mesh-ancestor
92713405|NCT01712451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713406|NCT01712451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713407|NCT01712451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92713408|NCT01712451|Respiratory System Agents|respiratory system agents|mesh-ancestor
92713409|NCT01712451|Dermatologic Agents|dermatologic agents|mesh-ancestor
92713410|NCT01712451|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92713430|NCT04669821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713431|NCT04669821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713432|NCT04669821|Anesthetics, General|anesthetics, general|mesh-ancestor
92713433|NCT04669821|Anesthetics|anesthetics|mesh-ancestor
92713434|NCT00532025|Sorafenib|sorafenib|mesh-list
92713435|NCT00532025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713436|NCT00532025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713437|NCT00532025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713438|NCT00532025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713439|NCT04669392|Ethanol|ethanol|mesh-list
92713440|NCT04669392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92713441|NCT04669392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713442|NCT04669392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713443|NCT04669392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713444|NCT00532142|Triamcinolone|triamcinolone|mesh-list
92713445|NCT00532142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713446|NCT00532142|Glucocorticoids|glucocorticoids|mesh-ancestor
92713447|NCT00532142|Hormones|hormones|mesh-ancestor
92713448|NCT00532142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713449|NCT00532142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713450|NCT00533312|Niacin|niacin|mesh-list
92713451|NCT00533312|Niacinamide|niacinamide|mesh-list
92713452|NCT00533312|Nicotinic Acids|nicotinic acids|mesh-list
92713453|NCT00533312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92713454|NCT00533312|Antimetabolites|antimetabolites|mesh-ancestor
92713455|NCT00533312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713456|NCT00533312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92713457|NCT00533312|Vasodilator Agents|vasodilator agents|mesh-ancestor
92713458|NCT00533312|Vitamin B Complex|vitamin b complex|mesh-ancestor
92713459|NCT00533312|Vitamins|vitamins|mesh-ancestor
92713460|NCT00533312|Micronutrients|micronutrients|mesh-ancestor
92713461|NCT00533312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713462|NCT00533390|Efavirenz|efavirenz|mesh-list
92713463|NCT00533390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92713464|NCT00533390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92713465|NCT00533390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713475|NCT00556296|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92713476|NCT00556296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92713477|NCT00556296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713478|NCT00556296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92713479|NCT00556296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92713480|NCT00556296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92713481|NCT00556296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713482|NCT00556296|Dopamine Agents|dopamine agents|mesh-ancestor
92713483|NCT00556296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713484|NCT04668456|Lidocaine|lidocaine|mesh-list
92713485|NCT04668456|Dexmedetomidine|dexmedetomidine|mesh-list
92713486|NCT04668456|Anesthetics, Local|anesthetics, local|mesh-ancestor
92713487|NCT04668456|Anesthetics|anesthetics|mesh-ancestor
92713488|NCT04668456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713489|NCT04668456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407924|NCT01447797|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92713490|NCT04668456|Sensory System Agents|sensory system agents|mesh-ancestor
92713491|NCT04668456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713492|NCT04668456|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92713493|NCT04668456|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92608408|NCT00159159|Cyclosporins|cyclosporins|mesh-list
92608409|NCT00159159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608410|NCT00159159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608411|NCT00159159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015645|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
92713494|NCT04668456|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92713495|NCT04668456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92713496|NCT04668456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713497|NCT04668456|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713498|NCT04668456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92713499|NCT04668456|Analgesics|analgesics|mesh-ancestor
92713500|NCT04668456|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92713501|NCT04668456|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92713502|NCT04668456|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92713503|NCT04668456|Adrenergic Agents|adrenergic agents|mesh-ancestor
92713504|NCT04668456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713505|NCT04693169|Choline|choline|mesh-list
92713506|NCT04693169|Lipotropic Agents|lipotropic agents|mesh-ancestor
92713507|NCT04693169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92713508|NCT04693169|Antimetabolites|antimetabolites|mesh-ancestor
92713509|NCT04693169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713510|NCT04693169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713511|NCT04693169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92713512|NCT04693169|Nootropic Agents|nootropic agents|mesh-ancestor
92713513|NCT04668417|Vaccines|vaccines|mesh-list
92713514|NCT04668417|Immunologic Factors|immunologic factors|mesh-ancestor
92713515|NCT04668417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713516|NCT00556413|Leucovorin|leucovorin|mesh-list
92713517|NCT00556413|Fluorouracil|fluorouracil|mesh-list
92713518|NCT00556413|Oxaliplatin|oxaliplatin|mesh-list
92713519|NCT00556413|Irinotecan|irinotecan|mesh-list
92713520|NCT00556413|Cetuximab|cetuximab|mesh-list
92713521|NCT00556413|Calcium|calcium|mesh-list
92713522|NCT00556413|Levoleucovorin|levoleucovorin|mesh-list
92713523|NCT00556413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92713524|NCT00556413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133309|NCT00427557|Rituximab|rituximab|mesh-list
92713525|NCT00556413|Antimetabolites|antimetabolites|mesh-ancestor
92713526|NCT00556413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713527|NCT00556413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92713531|NCT00556413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92713533|NCT00556413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713534|NCT00556413|Antidotes|antidotes|mesh-ancestor
92713535|NCT00556413|Protective Agents|protective agents|mesh-ancestor
92713536|NCT00556413|Vitamin B Complex|vitamin b complex|mesh-ancestor
92713538|NCT00556413|Micronutrients|micronutrients|mesh-ancestor
92713539|NCT00556413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713540|NCT04668690|Mitoxantrone|mitoxantrone|mesh-list
92713541|NCT04668690|Analgesics|analgesics|mesh-ancestor
92713542|NCT04668690|Sensory System Agents|sensory system agents|mesh-ancestor
92713543|NCT04668690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713544|NCT04668690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713545|NCT04668690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713546|NCT04668690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92713547|NCT04668690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92713548|NCT04668690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713549|NCT04668690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713550|NCT00533585|Paclitaxel|paclitaxel|mesh-list
92713551|NCT00533585|Bevacizumab|bevacizumab|mesh-list
92713552|NCT00533585|Carboplatin|carboplatin|mesh-list
92713553|NCT00533585|Sorafenib|sorafenib|mesh-list
92713554|NCT00533585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92713555|NCT00533585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713556|NCT00533585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92713557|NCT00533585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92713558|NCT00533585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92713559|NCT00533585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713560|NCT00533585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713561|NCT00533585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92713562|NCT00533585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92713563|NCT00533585|Growth Substances|growth substances|mesh-ancestor
92713564|NCT00533585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608412|NCT00159159|Immunologic Factors|immunologic factors|mesh-ancestor
92608413|NCT00159159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608414|NCT00159159|Antifungal Agents|antifungal agents|mesh-ancestor
92608415|NCT00159159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713565|NCT00533585|Growth Inhibitors|growth inhibitors|mesh-ancestor
92713566|NCT00533585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713567|NCT00533585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713568|NCT00533624|Mycophenolic Acid|mycophenolic acid|mesh-list
92713569|NCT00533624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92713570|NCT00533624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713571|NCT00533624|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92713572|NCT00533624|Antitubercular Agents|antitubercular agents|mesh-ancestor
92713573|NCT00533624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92713574|NCT00533624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713575|NCT00533624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713576|NCT00533624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713577|NCT04562441|Avelumab|avelumab|mesh-list
92713578|NCT04562441|Axitinib|axitinib|mesh-list
92713579|NCT04562441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713580|NCT04562441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713581|NCT04562441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713582|NCT04562441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713583|NCT04562441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713584|NCT04659057|Lidocaine|lidocaine|mesh-list
92713585|NCT04659057|Dexmedetomidine|dexmedetomidine|mesh-list
92713586|NCT04659057|Anesthetics, Local|anesthetics, local|mesh-ancestor
92713587|NCT04659057|Anesthetics|anesthetics|mesh-ancestor
92713588|NCT04659057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713589|NCT04659057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713590|NCT04659057|Sensory System Agents|sensory system agents|mesh-ancestor
92713591|NCT04659057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713592|NCT04659057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92713593|NCT04659057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92713594|NCT04659057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92713595|NCT04659057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92713596|NCT04659057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713597|NCT04659057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713598|NCT04659057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92713599|NCT04659057|Analgesics|analgesics|mesh-ancestor
92713601|NCT04659057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92713602|NCT04659057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92713603|NCT04659057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92713604|NCT04659057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713605|NCT04547153|Docetaxel|docetaxel|mesh-list
92713606|NCT04547153|Fluorouracil|fluorouracil|mesh-list
92713607|NCT04547153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713608|NCT04547153|Tubulin Modulators|tubulin modulators|mesh-ancestor
92713609|NCT04547153|Antimitotic Agents|antimitotic agents|mesh-ancestor
92713610|NCT04547153|Mitosis Modulators|mitosis modulators|mesh-ancestor
92713611|NCT04547153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713612|NCT04547153|Antimetabolites|antimetabolites|mesh-ancestor
92713613|NCT04547153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92713614|NCT04547153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713615|NCT04547153|Immunologic Factors|immunologic factors|mesh-ancestor
92713616|NCT04547153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713617|NCT00533741|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92713618|NCT00533741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92713619|NCT00533741|Immunologic Factors|immunologic factors|mesh-ancestor
92713620|NCT00533741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713621|NCT00533741|Antacids|antacids|mesh-ancestor
92713622|NCT00533741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713623|NCT00533741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713624|NCT00533858|Losartan|losartan|mesh-list
92713625|NCT00533858|Lacidipine|lacidipine|mesh-list
92713626|NCT00533858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92713627|NCT00533858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92713628|NCT00533858|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92713629|NCT00533858|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92713630|NCT00533858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713631|NCT00533858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92608416|NCT00159159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92608417|NCT00159159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015650|NCT03064633|Analgesics|analgesics|mesh-ancestor
92713632|NCT00533858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92713633|NCT00533858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92713634|NCT00533858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713635|NCT04658355|Chlorhexidine|chlorhexidine|mesh-list
92713636|NCT04658355|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92713637|NCT04658355|Povidone-Iodine|povidone-iodine|mesh-list
92713638|NCT04658355|Povidone|povidone|mesh-list
92713639|NCT04658355|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92713640|NCT04658355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713641|NCT04658355|Disinfectants|disinfectants|mesh-ancestor
92713642|NCT04658355|Dermatologic Agents|dermatologic agents|mesh-ancestor
92713643|NCT04658355|Plasma Substitutes|plasma substitutes|mesh-ancestor
92713644|NCT04658355|Blood Substitutes|blood substitutes|mesh-ancestor
92713645|NCT00533936|Paclitaxel|paclitaxel|mesh-list
92713646|NCT00533936|Cyclophosphamide|cyclophosphamide|mesh-list
92713647|NCT00533936|Doxorubicin|doxorubicin|mesh-list
92713648|NCT00533936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92713649|NCT00533936|Fluorouracil|fluorouracil|mesh-list
92713650|NCT00533936|Trastuzumab|trastuzumab|mesh-list
92713651|NCT00533936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92713652|NCT00533936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713653|NCT00533936|Tubulin Modulators|tubulin modulators|mesh-ancestor
92713654|NCT00533936|Antimitotic Agents|antimitotic agents|mesh-ancestor
92713655|NCT00533936|Mitosis Modulators|mitosis modulators|mesh-ancestor
92713656|NCT00533936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713657|NCT00533936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713658|NCT00533936|Immunologic Factors|immunologic factors|mesh-ancestor
92713659|NCT00533936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713660|NCT00533936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713661|NCT00533936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92713662|NCT00533936|Alkylating Agents|alkylating agents|mesh-ancestor
92713663|NCT00533936|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92713664|NCT00533936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92713665|NCT00533936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92713666|NCT00533936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92713667|NCT00533936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713668|NCT00533936|Antimetabolites|antimetabolites|mesh-ancestor
92713669|NCT00533936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92713670|NCT00533936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713671|NCT00557544|Ketoprofen|ketoprofen|mesh-list
92713672|NCT00557544|Metoclopramide|metoclopramide|mesh-list
92713673|NCT00557544|Antiemetics|antiemetics|mesh-ancestor
92713674|NCT00557544|Autonomic Agents|autonomic agents|mesh-ancestor
92713694|NCT04667910|Growth Substances|growth substances|mesh-ancestor
92713695|NCT04667910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713696|NCT04667910|Growth Inhibitors|growth inhibitors|mesh-ancestor
92713697|NCT04667910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713698|NCT00556608|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92713699|NCT00556608|Hyaluronic Acid|hyaluronic acid|mesh-list
92713700|NCT00556608|Hylan|hylan|mesh-list
92713701|NCT00556608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92713702|NCT00556608|Immunologic Factors|immunologic factors|mesh-ancestor
92713703|NCT00556608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713704|NCT00556608|Viscosupplements|viscosupplements|mesh-ancestor
92713705|NCT00556608|Protective Agents|protective agents|mesh-ancestor
92713706|NCT00534287|Moxifloxacin|moxifloxacin|mesh-list
92713707|NCT00534287|Meropenem|meropenem|mesh-list
92713708|NCT00534287|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92713709|NCT00534287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92713710|NCT00534287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713711|NCT00534287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92713712|NCT00534287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92713713|NCT00534287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713714|NCT00534287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713715|NCT00534287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713716|NCT00534287|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92713717|NCT00534287|Contraceptive Agents|contraceptive agents|mesh-ancestor
92713718|NCT00534287|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92713719|NCT00534287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713720|NCT00534287|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92713721|NCT00534287|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92608418|NCT00159159|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92608420|NCT00135824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92608421|NCT00135824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92713722|NCT00534287|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92713723|NCT04168502|Gemtuzumab|gemtuzumab|mesh-list
92713724|NCT04168502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713725|NCT04168502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713726|NCT04168502|Immunotoxins|immunotoxins|mesh-ancestor
92713727|NCT04168502|Immunoconjugates|immunoconjugates|mesh-ancestor
92713731|NCT01215916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713732|NCT01215916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713733|NCT01215916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713734|NCT01215916|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92713735|NCT01215916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92713736|NCT01184872|Vancomycin|vancomycin|mesh-list
92713737|NCT01184872|Daptomycin|daptomycin|mesh-list
92713738|NCT01184872|Penicillins|penicillins|mesh-list
92713739|NCT01184872|Floxacillin|floxacillin|mesh-list
92713740|NCT01184872|Cloxacillin|cloxacillin|mesh-list
92713741|NCT01184872|Oxacillin|oxacillin|mesh-list
92713742|NCT01184872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92713743|NCT01184872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713744|NCT01215721|Solifenacin Succinate|solifenacin succinate|mesh-list
92713745|NCT01215721|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92713746|NCT01215721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92713747|NCT01215721|Cholinergic Agents|cholinergic agents|mesh-ancestor
92713748|NCT01215721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713749|NCT01215721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713750|NCT01215721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713751|NCT01215721|Urological Agents|urological agents|mesh-ancestor
92713752|NCT04666623|Esketamine|esketamine|mesh-list
92713753|NCT04666623|Antidepressive Agents|antidepressive agents|mesh-ancestor
92713754|NCT04666623|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92713755|NCT00534677|Octreotide|octreotide|mesh-list
92713756|NCT00534677|Terlipressin|terlipressin|mesh-list
92713757|NCT00534677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713758|NCT00534677|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92713759|NCT00534677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713760|NCT00534677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92713761|NCT00534677|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92713762|NCT00556959|Clonidine|clonidine|mesh-list
92713763|NCT00556959|Analgesics|analgesics|mesh-ancestor
92713764|NCT00556959|Sensory System Agents|sensory system agents|mesh-ancestor
92713765|NCT00556959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713766|NCT00556959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713767|NCT00556959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92713768|NCT00556959|Sympatholytics|sympatholytics|mesh-ancestor
92713769|NCT00556959|Autonomic Agents|autonomic agents|mesh-ancestor
92713770|NCT00556959|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92713771|NCT00556959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92713772|NCT00556959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92713773|NCT00556959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92713774|NCT00556959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713775|NCT00556959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713776|NCT01184326|Everolimus|everolimus|mesh-list
92713777|NCT01184326|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92713778|NCT01184326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713779|NCT01184326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713780|NCT01184326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713781|NCT01184326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713782|NCT01184326|Immunologic Factors|immunologic factors|mesh-ancestor
92713783|NCT01184326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713784|NCT01184326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713785|NCT01215253|Ranolazine|ranolazine|mesh-list
92713786|NCT01215253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92713787|NCT01215253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374519|NCT01810692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92713788|NCT01215253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713789|NCT01184053|Arsenic Trioxide|arsenic trioxide|mesh-list
92713790|NCT01184053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713791|NCT03813875|Fentanyl|fentanyl|mesh-list
92713792|NCT03813875|Midazolam|midazolam|mesh-list
92713793|NCT03813875|Alfentanil|alfentanil|mesh-list
92713794|NCT03813875|Propofol|propofol|mesh-list
92713795|NCT03813875|Sevoflurane|sevoflurane|mesh-list
92608422|NCT00135824|Plasma Substitutes|plasma substitutes|mesh-ancestor
92608423|NCT00135824|Blood Substitutes|blood substitutes|mesh-ancestor
92608424|NCT00135863|Tinzaparin|tinzaparin|mesh-list
92713796|NCT03813875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713797|NCT03813875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713798|NCT03813875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713799|NCT03813875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713800|NCT03813875|Anesthetics, General|anesthetics, general|mesh-ancestor
92713801|NCT03813875|Anesthetics|anesthetics|mesh-ancestor
92713802|NCT03813875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92713804|NCT03813875|Analgesics|analgesics|mesh-ancestor
92713805|NCT03813875|Sensory System Agents|sensory system agents|mesh-ancestor
92713806|NCT03813875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713807|NCT03813875|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92713808|NCT03813875|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92713809|NCT03813875|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92713810|NCT03813875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92713811|NCT03813875|GABA Modulators|gaba modulators|mesh-ancestor
92713812|NCT03813875|GABA Agents|gaba agents|mesh-ancestor
92713813|NCT03813875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713814|NCT03813875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713815|NCT03813875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92713816|NCT03813875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92713817|NCT01183858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92713818|NCT01183858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713819|NCT01183858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713820|NCT01183858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713821|NCT01183858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713822|NCT05449522|Vitamin D|vitamin d|mesh-list
92713823|NCT05449522|Vitamins|vitamins|mesh-ancestor
92713824|NCT05449522|Micronutrients|micronutrients|mesh-ancestor
92713825|NCT05449522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713826|NCT05449522|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92713827|NCT04665609|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92713828|NCT03737981|Venetoclax|venetoclax|mesh-list
92713829|NCT03737981|Obinutuzumab|obinutuzumab|mesh-list
92713830|NCT03737981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713831|NCT03737981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713833|NCT04665141|Benralizumab|benralizumab|mesh-list
92713834|NCT04665141|Reslizumab|reslizumab|mesh-list
92713835|NCT04665141|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92713836|NCT04665141|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92713837|NCT04665141|Respiratory System Agents|respiratory system agents|mesh-ancestor
92713838|NCT04665063|Cyclophosphamide|cyclophosphamide|mesh-list
92713839|NCT04665063|Fludarabine|fludarabine|mesh-list
92713840|NCT04665063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713841|NCT04665063|Immunologic Factors|immunologic factors|mesh-ancestor
92713842|NCT04665063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713843|NCT04665063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713844|NCT04665063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92713845|NCT04665063|Alkylating Agents|alkylating agents|mesh-ancestor
92713846|NCT04665063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713847|NCT04665063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713848|NCT04665063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92713849|NCT04664595|Propofol|propofol|mesh-list
92713850|NCT04664595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713851|NCT04664595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713852|NCT04664595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713853|NCT04664595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92713854|NCT04664595|Anesthetics, General|anesthetics, general|mesh-ancestor
92713855|NCT04664595|Anesthetics|anesthetics|mesh-ancestor
92713856|NCT01215175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92713857|NCT01215175|Immunologic Factors|immunologic factors|mesh-ancestor
92713858|NCT01215175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713859|NCT03580148|Cortisone|cortisone|mesh-list
92713860|NCT03580148|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92713861|NCT03580148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713862|NCT04664517|Anesthetics|anesthetics|mesh-list
92713863|NCT04664517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713864|NCT04664517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713865|NCT05335915|Nicotine|nicotine|mesh-list
92713866|NCT05335915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92713867|NCT05335915|Autonomic Agents|autonomic agents|mesh-ancestor
92713868|NCT05335915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713869|NCT05335915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713870|NCT05335915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92713871|NCT05335915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92713872|NCT05335915|Cholinergic Agents|cholinergic agents|mesh-ancestor
92713873|NCT05335915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713874|NCT05335915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713875|NCT01215097|Linagliptin|linagliptin|mesh-list
92713876|NCT01215097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92713877|NCT01215097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713878|NCT01215097|Incretins|incretins|mesh-ancestor
92713879|NCT01215097|Hormones|hormones|mesh-ancestor
92713881|NCT01215097|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92713882|NCT01215097|Protease Inhibitors|protease inhibitors|mesh-ancestor
92713883|NCT01215097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713884|NCT01215097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713886|NCT03527576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713887|NCT03527576|Antiemetics|antiemetics|mesh-ancestor
92713888|NCT03527576|Autonomic Agents|autonomic agents|mesh-ancestor
92713889|NCT03527576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713890|NCT03527576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713891|NCT03527576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713892|NCT03527576|Glucocorticoids|glucocorticoids|mesh-ancestor
92713893|NCT03527576|Hormones|hormones|mesh-ancestor
92713894|NCT03527576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713895|NCT03527576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92713896|NCT03527576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713897|NCT04664010|Vitamins|vitamins|mesh-list
92713898|NCT04664010|Ascorbic Acid|ascorbic acid|mesh-list
92713899|NCT04664010|Interferons|interferons|mesh-list
92713900|NCT04664010|Ribavirin|ribavirin|mesh-list
92713901|NCT04664010|Interferon-alpha|interferon-alpha|mesh-list
92713902|NCT04664010|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92713903|NCT04664010|Micronutrients|micronutrients|mesh-ancestor
92713904|NCT04664010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713905|NCT04664010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713906|NCT04664010|Antiviral Agents|antiviral agents|mesh-ancestor
92713907|NCT04664010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713908|NCT04664010|Antimetabolites|antimetabolites|mesh-ancestor
92713909|NCT04664010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713910|NCT04664010|Immunologic Factors|immunologic factors|mesh-ancestor
92713911|NCT04664010|Antioxidants|antioxidants|mesh-ancestor
92713912|NCT04664010|Protective Agents|protective agents|mesh-ancestor
92713913|NCT04664127|Valacyclovir|valacyclovir|mesh-list
92713914|NCT04664127|Antiviral Agents|antiviral agents|mesh-ancestor
92713915|NCT04664127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713916|NCT04664088|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92713917|NCT04664088|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92713918|NCT04664088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92713919|NCT04664088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92713920|NCT04664088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713921|NCT04664088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713922|NCT04664088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713923|NCT04664088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92713924|NCT04664088|Antidepressive Agents|antidepressive agents|mesh-ancestor
92713925|NCT04664088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92713926|NCT04664244|Nimotuzumab|nimotuzumab|mesh-list
92713927|NCT04664244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713928|NCT04664244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713929|NCT04663386|Budesonide|budesonide|mesh-list
92713930|NCT04663386|Formoterol Fumarate|formoterol fumarate|mesh-list
92374532|NCT01813734|Ponatinib|ponatinib|mesh-list
92713931|NCT04663386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713932|NCT04663386|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92713933|NCT04663386|Autonomic Agents|autonomic agents|mesh-ancestor
92713934|NCT04663386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713935|NCT04663386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713936|NCT04663386|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92713937|NCT04663386|Respiratory System Agents|respiratory system agents|mesh-ancestor
92713938|NCT04663386|Glucocorticoids|glucocorticoids|mesh-ancestor
92713939|NCT04663386|Hormones|hormones|mesh-ancestor
92713940|NCT04663386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713941|NCT04663386|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92713942|NCT04663386|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92713943|NCT04663386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92608427|NCT00135863|Anticoagulants|anticoagulants|mesh-ancestor
92608428|NCT00135863|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92608429|NCT00135863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92608430|NCT00135863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608431|NCT00135902|Progesterone|progesterone|mesh-list
92713944|NCT04663386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92713945|NCT04663386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713946|NCT04663386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713947|NCT03504488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92713948|NCT03504488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713949|NCT03504488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713950|NCT03504488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713953|NCT04663269|Antiemetics|antiemetics|mesh-ancestor
92713954|NCT04663269|Autonomic Agents|autonomic agents|mesh-ancestor
92713955|NCT04663269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713956|NCT04663269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713957|NCT04663269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713958|NCT04663269|Glucocorticoids|glucocorticoids|mesh-ancestor
92713959|NCT04663269|Hormones|hormones|mesh-ancestor
92713960|NCT04663269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713961|NCT04663269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92713962|NCT04663269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713963|NCT03312738|Everolimus|everolimus|mesh-list
92713964|NCT03312738|Exemestane|exemestane|mesh-list
92713965|NCT03312738|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92713966|NCT03312738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713967|NCT03312738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713968|NCT03312738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713969|NCT03312738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713970|NCT03312738|Immunologic Factors|immunologic factors|mesh-ancestor
92713971|NCT03312738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713972|NCT03312738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713973|NCT03312738|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92713974|NCT03312738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92713975|NCT03312738|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92713976|NCT03312738|Hormone Antagonists|hormone antagonists|mesh-ancestor
92713977|NCT03312738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713978|NCT03303339|Cytarabine|cytarabine|mesh-list
92713980|NCT03303339|Onvansertib|onvansertib|mesh-list
92713981|NCT03303339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92713982|NCT03303339|Antimetabolites|antimetabolites|mesh-ancestor
92713983|NCT03303339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713984|NCT03303339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713985|NCT03303339|Antiviral Agents|antiviral agents|mesh-ancestor
92713986|NCT03303339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713987|NCT03303339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713988|NCT03303339|Immunologic Factors|immunologic factors|mesh-ancestor
92713989|NCT03303339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713990|NCT03303339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713991|NCT03303339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713992|NCT03422471|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92713993|NCT03422471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713994|NCT03299946|Nivolumab|nivolumab|mesh-list
92713995|NCT03299946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713996|NCT03299946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713997|NCT03299946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92713998|NCT03299946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713999|NCT00535340|Amibegron|amibegron|mesh-list
92714000|NCT00535340|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92714001|NCT00535340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92714002|NCT00535340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92714003|NCT00535340|Adrenergic Agents|adrenergic agents|mesh-ancestor
92714004|NCT00535340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714005|NCT00535340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714006|NCT00535340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714007|NCT00535340|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92608432|NCT00135902|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92608433|NCT00135902|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92608434|NCT00135902|Progestins|progestins|mesh-ancestor
92608435|NCT00135902|Hormones|hormones|mesh-ancestor
92015663|NCT02589665|Analgesics|analgesics|mesh-ancestor
92714008|NCT00535379|Sunitinib|sunitinib|mesh-list
92714009|NCT00535379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714010|NCT00535379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92714011|NCT00535379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92714012|NCT00535379|Growth Substances|growth substances|mesh-ancestor
92714013|NCT00535379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714014|NCT00535379|Growth Inhibitors|growth inhibitors|mesh-ancestor
92714015|NCT00535379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92714016|NCT00535379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714017|NCT00535379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714018|NCT00535418|Letrozole|letrozole|mesh-list
92714019|NCT00535418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714020|NCT00535418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92714021|NCT00535418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92714022|NCT00535418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714023|NCT00535418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714033|NCT04679064|Topotecan|topotecan|mesh-list
92714034|NCT04679064|Niraparib|niraparib|mesh-list
92714035|NCT04679064|Dostarlimab|dostarlimab|mesh-list
92714036|NCT04679064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92714037|NCT04679064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714038|NCT04679064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92714039|NCT04679064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92714040|NCT04679064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92714041|NCT04679064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714042|NCT04679064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714043|NCT04679064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92714044|NCT04679064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92714045|NCT04679064|Growth Substances|growth substances|mesh-ancestor
92714046|NCT04679064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714047|NCT04679064|Growth Inhibitors|growth inhibitors|mesh-ancestor
92714048|NCT04679064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92714049|NCT04679064|Antimetabolites|antimetabolites|mesh-ancestor
92714050|NCT04679064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92714051|NCT04679064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92714052|NCT04679064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92714053|NCT04679064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714054|NCT04679064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92714055|NCT04679064|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92714056|NCT01183780|Leucovorin|leucovorin|mesh-list
92714057|NCT01183780|Folic Acid|folic acid|mesh-list
92714058|NCT01183780|Fluorouracil|fluorouracil|mesh-list
92714059|NCT01183780|Irinotecan|irinotecan|mesh-list
92714060|NCT01183780|Ramucirumab|ramucirumab|mesh-list
92714061|NCT01183780|Levoleucovorin|levoleucovorin|mesh-list
92714062|NCT01183780|Antimetabolites|antimetabolites|mesh-ancestor
92714063|NCT01183780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714064|NCT01183780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92714065|NCT01183780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714066|NCT01183780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714067|NCT01183780|Immunologic Factors|immunologic factors|mesh-ancestor
92714068|NCT01183780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714069|NCT01183780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92714070|NCT01183780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92714071|NCT01183780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714072|NCT01183780|Antidotes|antidotes|mesh-ancestor
92714073|NCT01183780|Protective Agents|protective agents|mesh-ancestor
92714074|NCT01183780|Vitamin B Complex|vitamin b complex|mesh-ancestor
92714075|NCT01183780|Vitamins|vitamins|mesh-ancestor
92714076|NCT01183780|Micronutrients|micronutrients|mesh-ancestor
92714077|NCT01183780|Hematinics|hematinics|mesh-ancestor
92714078|NCT04679103|Eculizumab|eculizumab|mesh-list
92714079|NCT04679103|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92714080|NCT04679103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714081|NCT04679103|Immunologic Factors|immunologic factors|mesh-ancestor
92714082|NCT04679103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714083|NCT00535574|Bexarotene|bexarotene|mesh-list
92714084|NCT00535574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682800|NCT00438113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92714085|NCT04678830|Leronlimab|leronlimab|mesh-list
92714086|NCT04678830|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92714087|NCT04678830|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92714088|NCT04678830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714089|NCT04678830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92714090|NCT04678830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92714091|NCT04678830|Antiviral Agents|antiviral agents|mesh-ancestor
92714092|NCT04678830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714123|NCT01183390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714125|NCT02887807|Cyclosporins|cyclosporins|mesh-list
92714126|NCT02887807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714127|NCT02887807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714128|NCT02887807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714129|NCT02887807|Immunologic Factors|immunologic factors|mesh-ancestor
92714130|NCT02887807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714131|NCT02887807|Antifungal Agents|antifungal agents|mesh-ancestor
92714132|NCT02887807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714133|NCT02887807|Dermatologic Agents|dermatologic agents|mesh-ancestor
92714134|NCT02887807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714138|NCT04663035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714139|NCT03098589|Lenalidomide|lenalidomide|mesh-list
92714140|NCT03098589|Immunologic Factors|immunologic factors|mesh-ancestor
92714141|NCT03098589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714142|NCT03098589|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92714143|NCT03098589|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92714144|NCT03098589|Growth Substances|growth substances|mesh-ancestor
92714145|NCT03098589|Growth Inhibitors|growth inhibitors|mesh-ancestor
92714146|NCT03098589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714147|NCT04662177|Dexmedetomidine|dexmedetomidine|mesh-list
92714148|NCT04662177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92714149|NCT04662177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714150|NCT04662177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714151|NCT04662177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714152|NCT04662177|Analgesics|analgesics|mesh-ancestor
92714153|NCT04662177|Sensory System Agents|sensory system agents|mesh-ancestor
92714154|NCT04662177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714155|NCT04662177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92714156|NCT04662177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92714157|NCT04662177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92714158|NCT04662177|Adrenergic Agents|adrenergic agents|mesh-ancestor
92714159|NCT04662177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714160|NCT04662177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714161|NCT03026517|Phenformin|phenformin|mesh-list
92714162|NCT03026517|Trametinib|trametinib|mesh-list
92714163|NCT03026517|Dabrafenib|dabrafenib|mesh-list
92714164|NCT03026517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714165|NCT03026517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92714166|NCT03026517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714167|NCT03026517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714168|NCT03026517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92714169|NCT03026517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714170|NCT00537953|Miltefosine|miltefosine|mesh-list
92714171|NCT00537953|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92714172|NCT00537953|Antifungal Agents|antifungal agents|mesh-ancestor
92714173|NCT00537953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714174|NCT00537953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714175|NCT00537953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92714176|NCT00537953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92714177|NCT04662138|Antiviral Agents|antiviral agents|mesh-list
92714178|NCT04662138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714179|NCT05226299|Capsaicin|capsaicin|mesh-list
92714180|NCT05226299|Antipruritics|antipruritics|mesh-ancestor
92714181|NCT05226299|Dermatologic Agents|dermatologic agents|mesh-ancestor
92714182|NCT05226299|Sensory System Agents|sensory system agents|mesh-ancestor
92714183|NCT05226299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714184|NCT05226299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714185|NCT00557232|Bevacizumab|bevacizumab|mesh-list
92714186|NCT00557232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714187|NCT00557232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714188|NCT00557232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92714189|NCT00557232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92714190|NCT00557232|Growth Substances|growth substances|mesh-ancestor
92714191|NCT00557232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608436|NCT00135902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608437|NCT00135902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608438|NCT00135902|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92608439|NCT00135902|Hormone Antagonists|hormone antagonists|mesh-ancestor
92714192|NCT00557232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92714193|NCT02797119|Tranexamic Acid|tranexamic acid|mesh-list
92714194|NCT02797119|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92714195|NCT02797119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92714196|NCT02797119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714197|NCT02797119|Hemostatics|hemostatics|mesh-ancestor
92714198|NCT02797119|Coagulants|coagulants|mesh-ancestor
92714199|NCT05161208|Varenicline|varenicline|mesh-list
92714200|NCT05161208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92714201|NCT05161208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92714202|NCT05161208|Cholinergic Agents|cholinergic agents|mesh-ancestor
92714203|NCT05161208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714204|NCT05161208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714205|NCT05161208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714207|NCT00538070|Glycine Agents|glycine agents|mesh-ancestor
92714208|NCT00538070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714225|NCT05110391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92714226|NCT05110391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714227|NCT00538187|Bortezomib|bortezomib|mesh-list
92714228|NCT00538187|Obatoclax|obatoclax|mesh-list
92714229|NCT00538187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714230|NCT00538187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714231|NCT00538187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714232|NCT04661709|Aspirin|aspirin|mesh-list
92714233|NCT04661709|Metoprolol|metoprolol|mesh-list
92714234|NCT04661709|Isosorbide|isosorbide|mesh-list
92714235|NCT04661709|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92714236|NCT04661709|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92714237|NCT04661709|Nitroglycerin|nitroglycerin|mesh-list
92714238|NCT04661709|Trimetazidine|trimetazidine|mesh-list
92714239|NCT04661709|Clopidogrel|clopidogrel|mesh-list
92714240|NCT04661709|Atorvastatin|atorvastatin|mesh-list
92714241|NCT04661709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714242|NCT04661709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714243|NCT04661709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714244|NCT04661709|Analgesics|analgesics|mesh-ancestor
92714245|NCT04661709|Sensory System Agents|sensory system agents|mesh-ancestor
92714246|NCT04661709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714247|NCT04661709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714248|NCT04661709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714249|NCT04661709|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92714250|NCT04661709|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92714251|NCT04661709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714252|NCT04661709|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92714253|NCT04661709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92714254|NCT04661709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714255|NCT04661709|Antipyretics|antipyretics|mesh-ancestor
92714256|NCT04661709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92714257|NCT04661709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92714258|NCT04661709|Antimetabolites|antimetabolites|mesh-ancestor
92714259|NCT04661709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92714260|NCT04661709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92714261|NCT04661709|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92714262|NCT04661709|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92714263|NCT04661709|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92714264|NCT04661709|Purinergic Agents|purinergic agents|mesh-ancestor
92714265|NCT04661709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714266|NCT04661709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92714267|NCT04661709|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92714276|NCT04661709|Natriuretic Agents|natriuretic agents|mesh-ancestor
92714277|NCT04661709|Vasodilator Agents|vasodilator agents|mesh-ancestor
92714278|NCT04661709|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92714279|NCT02466867|Naftifine|naftifine|mesh-list
92714280|NCT02466867|Antifungal Agents|antifungal agents|mesh-ancestor
92714281|NCT02466867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134048|NCT04079257|Eculizumab|eculizumab|mesh-list
92714282|NCT00538265|Mycophenolic Acid|mycophenolic acid|mesh-list
92714283|NCT00538265|Tacrolimus|tacrolimus|mesh-list
92608440|NCT00135941|Insulin|insulin|mesh-list
92608441|NCT00135941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92714284|NCT00538265|Thymoglobulin|thymoglobulin|mesh-list
92714285|NCT00538265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714286|NCT00538265|Immunologic Factors|immunologic factors|mesh-ancestor
92714287|NCT00538265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714288|NCT00538265|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92714289|NCT00538265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714290|NCT00538265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714291|NCT00538265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92714292|NCT00538265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714293|NCT00538265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92714294|NCT00538265|Antitubercular Agents|antitubercular agents|mesh-ancestor
92714295|NCT00538265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92714296|NCT00538265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714297|NCT02462811|Acetaminophen|acetaminophen|mesh-list
92714298|NCT02462811|Promethazine|promethazine|mesh-list
92714299|NCT02462811|Diphenhydramine|diphenhydramine|mesh-list
92714300|NCT02462811|Hydrocodone|hydrocodone|mesh-list
92714301|NCT02462811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714302|NCT02462811|Analgesics|analgesics|mesh-ancestor
92714303|NCT02462811|Sensory System Agents|sensory system agents|mesh-ancestor
92714304|NCT02462811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714305|NCT02462811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714306|NCT02462811|Antipyretics|antipyretics|mesh-ancestor
92714307|NCT02462811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92714308|NCT02462811|Narcotics|narcotics|mesh-ancestor
92714309|NCT02462811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714310|NCT02462811|Antitussive Agents|antitussive agents|mesh-ancestor
92714311|NCT02462811|Respiratory System Agents|respiratory system agents|mesh-ancestor
92714312|NCT02462811|Antipruritics|antipruritics|mesh-ancestor
92714313|NCT02462811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92714314|NCT02462811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92714315|NCT02462811|Histamine Antagonists|histamine antagonists|mesh-ancestor
92714316|NCT02462811|Histamine Agents|histamine agents|mesh-ancestor
92714317|NCT02462811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714318|NCT02462811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714319|NCT02462811|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92714320|NCT02462811|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92714321|NCT02462811|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92714322|NCT02462811|Anesthetics, Local|anesthetics, local|mesh-ancestor
92714323|NCT02462811|Anesthetics|anesthetics|mesh-ancestor
92714324|NCT02462811|Antiemetics|antiemetics|mesh-ancestor
92714325|NCT02462811|Autonomic Agents|autonomic agents|mesh-ancestor
92714326|NCT02462811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92714327|NCT00538382|Artesunate|artesunate|mesh-list
92714328|NCT00538382|Antimalarials|antimalarials|mesh-ancestor
92714329|NCT00538382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92714330|NCT00538382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92714331|NCT00538382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714332|NCT00538382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714333|NCT00538382|Antiviral Agents|antiviral agents|mesh-ancestor
92714334|NCT00538382|Schistosomicides|schistosomicides|mesh-ancestor
92714335|NCT00538382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92714336|NCT00538382|Anthelmintics|anthelmintics|mesh-ancestor
92714337|NCT00538421|Propofol|propofol|mesh-list
92714338|NCT00538421|Sevoflurane|sevoflurane|mesh-list
92714340|NCT00538421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714341|NCT00538421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714342|NCT00538421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92714343|NCT00538421|Anesthetics, General|anesthetics, general|mesh-ancestor
92714344|NCT00538421|Anesthetics|anesthetics|mesh-ancestor
92714345|NCT00538421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92714346|NCT00538421|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92714347|NCT04661475|Dexmedetomidine|dexmedetomidine|mesh-list
92714348|NCT04661475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92714349|NCT04661475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714350|NCT04661475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714351|NCT04661475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714352|NCT04661475|Analgesics|analgesics|mesh-ancestor
92714353|NCT04661475|Sensory System Agents|sensory system agents|mesh-ancestor
92714354|NCT04661475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714355|NCT04661475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92714356|NCT04661475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92714357|NCT04661475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92714358|NCT04661475|Adrenergic Agents|adrenergic agents|mesh-ancestor
92608443|NCT00135941|Insulin glulisine|insulin glulisine|mesh-list
92608444|NCT00135941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608445|NCT00135941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608446|NCT00152919|Meloxicam|meloxicam|mesh-list
92608447|NCT00152919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608448|NCT00152919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608449|NCT00152919|Analgesics|analgesics|mesh-ancestor
92608450|NCT00152919|Sensory System Agents|sensory system agents|mesh-ancestor
92608451|NCT00152919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608452|NCT00152919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714359|NCT04661475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714360|NCT04661475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714361|NCT00538499|Fentanyl|fentanyl|mesh-list
92714362|NCT00538499|Bupivacaine|bupivacaine|mesh-list
92714363|NCT00538499|Anesthetics, Local|anesthetics, local|mesh-ancestor
92714364|NCT00538499|Anesthetics|anesthetics|mesh-ancestor
92714365|NCT00538499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714366|NCT00538499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714367|NCT00538499|Sensory System Agents|sensory system agents|mesh-ancestor
92714368|NCT00538499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714369|NCT00538499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92714370|NCT00538499|Narcotics|narcotics|mesh-ancestor
92714371|NCT00538499|Analgesics|analgesics|mesh-ancestor
92714372|NCT00538499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92714373|NCT00538499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92714374|NCT00538499|Anesthetics, General|anesthetics, general|mesh-ancestor
92714375|NCT00538538|Ranibizumab|ranibizumab|mesh-list
92714376|NCT00538538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92714377|NCT00538538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92714378|NCT00538538|Growth Substances|growth substances|mesh-ancestor
92714379|NCT00538538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714380|NCT00538538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92714381|NCT00538538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714382|NCT00554346|Etoricoxib|etoricoxib|mesh-list
92714383|NCT00554346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714384|NCT00554346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714385|NCT00554346|Analgesics|analgesics|mesh-ancestor
92714386|NCT00554346|Sensory System Agents|sensory system agents|mesh-ancestor
92714387|NCT00554346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714388|NCT00554346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714389|NCT00554346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714390|NCT00554346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714391|NCT00554346|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92714392|NCT00554346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92714393|NCT00554346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714394|NCT00554346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714395|NCT00538655|Modafinil|modafinil|mesh-list
92714396|NCT00538655|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92714397|NCT00538655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714398|NCT00538655|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92714399|NCT00538655|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92714400|NCT00538655|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92714401|NCT00538655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714402|NCT00538694|Daptomycin|daptomycin|mesh-list
92714403|NCT00538694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92714404|NCT00538694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714405|NCT02436096|Cyclobenzaprine|cyclobenzaprine|mesh-list
92714406|NCT02436096|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92714407|NCT02436096|Antidepressive Agents|antidepressive agents|mesh-ancestor
92714408|NCT02436096|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714409|NCT02436096|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92714410|NCT02436096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608454|NCT00152919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608455|NCT00152919|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92608456|NCT00152919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608457|NCT00152919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608458|NCT00152919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608459|NCT00406146|Artesunate|artesunate|mesh-list
92714411|NCT02436096|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92714413|NCT02436096|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92374543|NCT01818414|Abortifacient Agents|abortifacient agents|mesh-ancestor
92714414|NCT02436096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714415|NCT00538811|Interferons|interferons|mesh-list
92714416|NCT00538811|Ribavirin|ribavirin|mesh-list
92714417|NCT00538811|Interferon-alpha|interferon-alpha|mesh-list
92714418|NCT00538811|Interferon alpha-2|interferon alpha-2|mesh-list
92714419|NCT00538811|Interferon-gamma|interferon-gamma|mesh-list
92714420|NCT00538811|Amantadine|amantadine|mesh-list
92714421|NCT00538811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714422|NCT00538811|Antiviral Agents|antiviral agents|mesh-ancestor
92714423|NCT00538811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714424|NCT00538811|Antimetabolites|antimetabolites|mesh-ancestor
92714425|NCT00538811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714426|NCT00538811|Immunologic Factors|immunologic factors|mesh-ancestor
92714427|NCT00538811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714428|NCT00538811|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92714429|NCT00538811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92714430|NCT00538811|Dopamine Agents|dopamine agents|mesh-ancestor
92714431|NCT00538811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714432|NCT00538811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714433|NCT00538811|Analgesics|analgesics|mesh-ancestor
92714434|NCT00538811|Sensory System Agents|sensory system agents|mesh-ancestor
92714435|NCT00538811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714436|NCT04660773|Pregabalin|pregabalin|mesh-list
92714437|NCT04660773|Analgesics|analgesics|mesh-ancestor
92714438|NCT04660773|Sensory System Agents|sensory system agents|mesh-ancestor
92714439|NCT04660773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714440|NCT04660773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714441|NCT04660773|Anticonvulsants|anticonvulsants|mesh-ancestor
92714442|NCT04660773|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92714443|NCT04660773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714444|NCT04660773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714445|NCT04660773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714446|NCT04660773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92714447|NCT04660773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92714448|NCT04660773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714449|NCT04660773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714450|NCT00538889|Citalopram|citalopram|mesh-list
92714451|NCT00538889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92714452|NCT00538889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92714453|NCT00538889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714454|NCT00538889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714455|NCT00538889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714456|NCT00538889|Serotonin Agents|serotonin agents|mesh-ancestor
92714457|NCT00538889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714458|NCT00538889|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92714459|NCT00538889|Antidepressive Agents|antidepressive agents|mesh-ancestor
92714460|NCT00538889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714461|NCT02413827|Ipilimumab|ipilimumab|mesh-list
92714462|NCT02413827|Poly ICLC|poly iclc|mesh-list
92714463|NCT02413827|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92714464|NCT02413827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714465|NCT02413827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714466|NCT02413827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92714467|NCT02413827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714468|NCT02413827|Interferon Inducers|interferon inducers|mesh-ancestor
92714469|NCT02413827|Immunologic Factors|immunologic factors|mesh-ancestor
92714470|NCT02413827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714471|NCT00538967|Doxycycline|doxycycline|mesh-list
92714472|NCT00538967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92714473|NCT00538967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714474|NCT00538967|Antimalarials|antimalarials|mesh-ancestor
92714475|NCT00538967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92714476|NCT00538967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92714477|NCT00539123|Buprenorphine|buprenorphine|mesh-list
92714478|NCT00539123|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92714479|NCT00539123|Narcotics|narcotics|mesh-ancestor
92714480|NCT00539123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714481|NCT00539123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714482|NCT00539123|Analgesics|analgesics|mesh-ancestor
92714483|NCT00539123|Sensory System Agents|sensory system agents|mesh-ancestor
92714484|NCT00539123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714485|NCT00539123|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92714487|NCT02382510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92714489|NCT02382510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714490|NCT02382510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714491|NCT02382510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92714492|NCT02382510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92714493|NCT02382510|Parasympatholytics|parasympatholytics|mesh-ancestor
92714494|NCT02382510|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92714495|NCT02382510|Cholinergic Agents|cholinergic agents|mesh-ancestor
92714496|NCT02382510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714497|NCT02382510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714498|NCT00539396|Insulin|insulin|mesh-list
92714499|NCT00539396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92714500|NCT00539396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714501|NCT00539435|Insulin|insulin|mesh-list
92714502|NCT00539435|Insulin Aspart|insulin aspart|mesh-list
92714503|NCT00539435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92714504|NCT00539435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714505|NCT00539630|Docetaxel|docetaxel|mesh-list
92714506|NCT00539630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714507|NCT00539630|Tubulin Modulators|tubulin modulators|mesh-ancestor
92714508|NCT00539630|Antimitotic Agents|antimitotic agents|mesh-ancestor
92714509|NCT00539630|Mitosis Modulators|mitosis modulators|mesh-ancestor
92714510|NCT00539630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714511|NCT04660461|Lansoprazole|lansoprazole|mesh-list
92714512|NCT04660461|Dexlansoprazole|dexlansoprazole|mesh-list
92714513|NCT04660461|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92714514|NCT04660461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92714515|NCT04660461|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92714516|NCT04660461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714517|NCT04660461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714519|NCT00539669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714520|NCT00539669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92714521|NCT00539669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92714522|NCT00539669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92714523|NCT00539669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714524|NCT00554424|Lidocaine|lidocaine|mesh-list
92714525|NCT00554424|Anesthetics, Local|anesthetics, local|mesh-ancestor
92714526|NCT00554424|Anesthetics|anesthetics|mesh-ancestor
92714527|NCT00554424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714528|NCT00554424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714529|NCT00554424|Sensory System Agents|sensory system agents|mesh-ancestor
92714530|NCT00554424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714531|NCT00554424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92714532|NCT00554424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92714533|NCT00554424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92714534|NCT00554424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714535|NCT00554424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714536|NCT04660305|Insulin Aspart|insulin aspart|mesh-list
92714537|NCT04660305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92714538|NCT04660305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714539|NCT00554502|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92714540|NCT00554502|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92714541|NCT00554502|Immunologic Factors|immunologic factors|mesh-ancestor
92714542|NCT00554502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714543|NCT00554502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92714544|NCT00554502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714545|NCT00554502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714546|NCT00539786|Rabeprazole|rabeprazole|mesh-list
92714547|NCT00539786|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92714548|NCT00539786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92714549|NCT00539786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92608460|NCT00406146|Lumefantrine|lumefantrine|mesh-list
92608461|NCT00406146|Artemether|artemether|mesh-list
92608462|NCT00406146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92608463|NCT00406146|Amodiaquine|amodiaquine|mesh-list
92608464|NCT00406146|Antimalarials|antimalarials|mesh-ancestor
92608465|NCT00406146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92608466|NCT00406146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92714550|NCT00539786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714551|NCT00539786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714552|NCT00540098|Paroxetine|paroxetine|mesh-list
92714553|NCT00540098|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92714554|NCT00540098|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92714555|NCT00540098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714556|NCT00540098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714557|NCT00540098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714558|NCT00540098|Serotonin Agents|serotonin agents|mesh-ancestor
92714560|NCT00540098|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92714562|NCT00540098|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714563|NCT00540098|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92714564|NCT00540098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92714565|NCT00540098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714566|NCT00540137|Ritonavir|ritonavir|mesh-list
92714567|NCT00540137|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92714568|NCT00540137|Nevirapine|nevirapine|mesh-list
92714569|NCT00540137|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92714570|NCT00540137|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92714571|NCT00540137|Protease Inhibitors|protease inhibitors|mesh-ancestor
92714572|NCT00540137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714573|NCT00540137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714574|NCT00540137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92714575|NCT00540137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92714576|NCT00540137|Antiviral Agents|antiviral agents|mesh-ancestor
92714577|NCT00540137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714578|NCT00540137|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92714579|NCT00540137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92714580|NCT00540137|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92714581|NCT00540137|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92714582|NCT00540137|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92714583|NCT00540137|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92714585|NCT04660110|Artenimol|artenimol|mesh-list
92714586|NCT04660110|Antimalarials|antimalarials|mesh-ancestor
92714587|NCT04660110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92714588|NCT04660110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92714589|NCT04660110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714590|NCT02339064|Apomorphine|apomorphine|mesh-list
92714591|NCT02339064|Emetics|emetics|mesh-ancestor
92714592|NCT02339064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714593|NCT02339064|Autonomic Agents|autonomic agents|mesh-ancestor
92714594|NCT02339064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714595|NCT02339064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92714596|NCT02339064|Dopamine Agonists|dopamine agonists|mesh-ancestor
92714597|NCT02339064|Dopamine Agents|dopamine agents|mesh-ancestor
92714598|NCT02339064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714599|NCT02339064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714600|NCT02336685|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92714601|NCT02336685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714602|NCT02336685|Immunologic Factors|immunologic factors|mesh-ancestor
92714603|NCT00540410|Artesunate|artesunate|mesh-list
92714604|NCT00540410|Lumefantrine|lumefantrine|mesh-list
92714605|NCT00540410|Amodiaquine|amodiaquine|mesh-list
92714606|NCT00540410|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92714607|NCT00540410|Antimalarials|antimalarials|mesh-ancestor
92714608|NCT00540410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92714609|NCT00540410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92714610|NCT00540410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714611|NCT00540410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714612|NCT00540410|Antiviral Agents|antiviral agents|mesh-ancestor
92714613|NCT00540410|Schistosomicides|schistosomicides|mesh-ancestor
92714614|NCT00540410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92608467|NCT00406146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608468|NCT00406146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608469|NCT00406146|Antiviral Agents|antiviral agents|mesh-ancestor
92608470|NCT00406146|Schistosomicides|schistosomicides|mesh-ancestor
92608471|NCT00406146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92608472|NCT00406146|Anthelmintics|anthelmintics|mesh-ancestor
92714615|NCT00540410|Anthelmintics|anthelmintics|mesh-ancestor
92714616|NCT00540527|Plasminogen|plasminogen|mesh-list
92714617|NCT00540527|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92714618|NCT00540527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92714619|NCT00540527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92714620|NCT00540527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714621|NCT00540605|Tenofovir|tenofovir|mesh-list
92714622|NCT00540605|Antiviral Agents|antiviral agents|mesh-ancestor
92714623|NCT00540605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714624|NCT00540605|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92714625|NCT00540605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92714626|NCT00540605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714627|NCT00540605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714628|NCT00540605|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92714629|NCT00540605|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92714630|NCT04659915|Metformin|metformin|mesh-list
92714631|NCT04659915|Prednisone|prednisone|mesh-list
92714632|NCT04659915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92714633|NCT04659915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714637|NCT04659915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92714638|NCT04659915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92714639|NCT04659915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714640|NCT00557427|Fluoxetine|fluoxetine|mesh-list
92714641|NCT00557427|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92714642|NCT00557427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92714643|NCT00557427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714644|NCT00557427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714645|NCT00557427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714646|NCT00557427|Serotonin Agents|serotonin agents|mesh-ancestor
92714647|NCT00557427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714648|NCT00557427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92714649|NCT00557427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92714650|NCT00557427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714651|NCT00557427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92714652|NCT00557427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92714653|NCT00557427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714654|NCT00540800|Docetaxel|docetaxel|mesh-list
92714655|NCT00540800|Capecitabine|capecitabine|mesh-list
92714656|NCT00540800|Epirubicin|epirubicin|mesh-list
92714657|NCT00540800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714658|NCT00540800|Tubulin Modulators|tubulin modulators|mesh-ancestor
92714659|NCT00540800|Antimitotic Agents|antimitotic agents|mesh-ancestor
92714660|NCT00540800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92714661|NCT00540800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714662|NCT00540800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92714663|NCT00540800|Antimetabolites|antimetabolites|mesh-ancestor
92714664|NCT00540800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92714665|NCT00540800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92714666|NCT00540800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92714667|NCT00540800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714669|NCT00540956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92714670|NCT00540956|Antimetabolites|antimetabolites|mesh-ancestor
92714671|NCT00540956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714672|NCT00540956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714673|NCT00540956|Antiviral Agents|antiviral agents|mesh-ancestor
92714674|NCT00540956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714675|NCT00540956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714676|NCT00540956|Immunologic Factors|immunologic factors|mesh-ancestor
92714677|NCT00540956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714678|NCT00541073|Vitamin B 12|vitamin b 12|mesh-list
92714679|NCT00541073|Hydroxocobalamin|hydroxocobalamin|mesh-list
92714680|NCT00541073|Pemetrexed|pemetrexed|mesh-list
92714681|NCT00541073|Vitamins|vitamins|mesh-ancestor
92608473|NCT00136058|Alendronate|alendronate|mesh-list
92069777|NCT04410081|Lazertinib|lazertinib|mesh-list
92714682|NCT00541073|Micronutrients|micronutrients|mesh-ancestor
92714683|NCT00541073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714684|NCT00541073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714685|NCT00541073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714686|NCT00541073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714687|NCT00541073|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92714688|NCT00541073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92714689|NCT00541073|Vitamin B Complex|vitamin b complex|mesh-ancestor
92714690|NCT00541073|Hematinics|hematinics|mesh-ancestor
92714691|NCT00541112|Leucovorin|leucovorin|mesh-list
92714692|NCT00541112|Fluorouracil|fluorouracil|mesh-list
92714693|NCT00541112|Capecitabine|capecitabine|mesh-list
92714694|NCT00541112|Oxaliplatin|oxaliplatin|mesh-list
92714695|NCT00541112|Cetuximab|cetuximab|mesh-list
92714696|NCT00541112|Calcium|calcium|mesh-list
92714697|NCT00541112|Levoleucovorin|levoleucovorin|mesh-list
92714698|NCT00541112|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714699|NCT00541112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714700|NCT00541112|Antimetabolites|antimetabolites|mesh-ancestor
92714701|NCT00541112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714702|NCT00541112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92714703|NCT00541112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714704|NCT00541112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714705|NCT00541112|Immunologic Factors|immunologic factors|mesh-ancestor
92714706|NCT00541112|Antidotes|antidotes|mesh-ancestor
92714707|NCT00541112|Protective Agents|protective agents|mesh-ancestor
92714712|NCT04659525|Ezetimibe|ezetimibe|mesh-list
92714713|NCT04659525|Evolocumab|evolocumab|mesh-list
92714714|NCT04659525|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92714715|NCT04659525|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92714716|NCT04659525|Antimetabolites|antimetabolites|mesh-ancestor
92714717|NCT04659525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714718|NCT04659525|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92714719|NCT04659525|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92714720|NCT04659525|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92714721|NCT04659525|Protease Inhibitors|protease inhibitors|mesh-ancestor
92714722|NCT04659525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714723|NCT02333643|Digoxin|digoxin|mesh-list
92714724|NCT02333643|Furosemide|furosemide|mesh-list
92134499|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92134500|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
92714725|NCT02333643|Diuretics|diuretics|mesh-ancestor
92134501|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
92134502|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134503|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92134504|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92134505|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714726|NCT02333643|Natriuretic Agents|natriuretic agents|mesh-ancestor
92714727|NCT02333643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714728|NCT02333643|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92714729|NCT02333643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714730|NCT02333643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714731|NCT02333643|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92714732|NCT02333643|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92714733|NCT02333643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714734|NCT02333643|Protective Agents|protective agents|mesh-ancestor
92714735|NCT00541463|Nelfinavir|nelfinavir|mesh-list
92714736|NCT00541463|Indinavir|indinavir|mesh-list
92714737|NCT00541463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714738|NCT00541463|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92714739|NCT00541463|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92714740|NCT00541463|Protease Inhibitors|protease inhibitors|mesh-ancestor
92714741|NCT00541463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714742|NCT00541463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92714743|NCT00541463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92714744|NCT00541463|Antiviral Agents|antiviral agents|mesh-ancestor
92714745|NCT00541463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714746|NCT02324985|Ibuprofen|ibuprofen|mesh-list
92714747|NCT02324985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714748|NCT02324985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714749|NCT02324985|Analgesics|analgesics|mesh-ancestor
92714750|NCT02324985|Sensory System Agents|sensory system agents|mesh-ancestor
92714751|NCT02324985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714752|NCT02324985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608474|NCT00136058|Risedronic Acid|risedronic acid|mesh-list
92608475|NCT00136058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92608476|NCT00136058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608477|NCT00136058|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92608478|NCT00136058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608479|NCT00136058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608480|NCT00136058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608481|NCT00152958|Pramipexole|pramipexole|mesh-list
92608482|NCT00152958|Antioxidants|antioxidants|mesh-ancestor
92714753|NCT02324985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714754|NCT02324985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714755|NCT02324985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92714756|NCT02324985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714757|NCT02324985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714758|NCT04659642|Fentanyl|fentanyl|mesh-list
92714759|NCT04659642|Dexmedetomidine|dexmedetomidine|mesh-list
92714760|NCT04659642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92714761|NCT04659642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714762|NCT04659642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714763|NCT04659642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714764|NCT04659642|Analgesics|analgesics|mesh-ancestor
92714765|NCT04659642|Sensory System Agents|sensory system agents|mesh-ancestor
92714766|NCT04659642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714767|NCT04659642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92714768|NCT04659642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92714769|NCT04659642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92714770|NCT04659642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92714771|NCT04659642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714772|NCT04659642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714776|NCT04659642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92714777|NCT04659642|Anesthetics, General|anesthetics, general|mesh-ancestor
92714778|NCT04659642|Anesthetics|anesthetics|mesh-ancestor
92714779|NCT00541736|Nitroglycerin|nitroglycerin|mesh-list
92714780|NCT00541736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92714781|NCT00541814|Cyclosporine|cyclosporine|mesh-list
92714782|NCT00541814|Cyclosporins|cyclosporins|mesh-list
92714783|NCT00541814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714784|NCT00541814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714785|NCT00541814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92714786|NCT00541814|Immunologic Factors|immunologic factors|mesh-ancestor
92714787|NCT00541814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714788|NCT00541814|Antifungal Agents|antifungal agents|mesh-ancestor
92714789|NCT00541814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714790|NCT00541814|Dermatologic Agents|dermatologic agents|mesh-ancestor
92714791|NCT00541814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714792|NCT00541814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92714793|NCT00541853|Candesartan|candesartan|mesh-list
92714794|NCT00541853|Candesartan cilexetil|candesartan cilexetil|mesh-list
92714795|NCT00541853|Cilnidipine|cilnidipine|mesh-list
92714796|NCT00541853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92714797|NCT00541853|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92714798|NCT00541853|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92714799|NCT00541853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714800|NCT00541853|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92714801|NCT00541853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714802|NCT00541853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714803|NCT00541853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714804|NCT02301234|Celecoxib|celecoxib|mesh-list
92714805|NCT02301234|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92714806|NCT02301234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714807|NCT02301234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714808|NCT02301234|Analgesics|analgesics|mesh-ancestor
92714809|NCT02301234|Sensory System Agents|sensory system agents|mesh-ancestor
92714810|NCT02301234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608483|NCT00152958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608485|NCT00152958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608486|NCT00152958|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92015714|NCT04426097|Iodine|iodine|mesh-list
92714811|NCT02301234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714812|NCT02301234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714813|NCT02301234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714814|NCT02301234|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92714815|NCT02301234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92714816|NCT02301234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714817|NCT02301234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714818|NCT02301234|Immunologic Factors|immunologic factors|mesh-ancestor
92714819|NCT02300142|Vaccines|vaccines|mesh-list
92714820|NCT02300142|Immunologic Factors|immunologic factors|mesh-ancestor
92714821|NCT02300142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714822|NCT01214668|Doxorubicin|doxorubicin|mesh-list
92714823|NCT01214668|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92714824|NCT01214668|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92714825|NCT01214668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714826|NCT01214668|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92714827|NCT01214668|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92714828|NCT01214668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714829|NCT01214668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714830|NCT00542126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92714831|NCT00542126|Luteolytic Agents|luteolytic agents|mesh-ancestor
92714832|NCT00542126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92714833|NCT00542126|Contraceptive Agents|contraceptive agents|mesh-ancestor
92714834|NCT00542126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92714835|NCT00542126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714836|NCT00542126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92714837|NCT00542126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92714838|NCT00542126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714839|NCT00542165|Alfuzosin|alfuzosin|mesh-list
92714840|NCT00542165|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92714841|NCT00542165|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92714842|NCT00542165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92714843|NCT00542165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92714844|NCT00542165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714854|NCT00542243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92714855|NCT00542243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714856|NCT00542243|Urological Agents|urological agents|mesh-ancestor
92714857|NCT00542399|Insulin Detemir|insulin detemir|mesh-list
92714858|NCT00542399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92714859|NCT00542399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714860|NCT00542555|Naproxen|naproxen|mesh-list
92714861|NCT00542555|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92714862|NCT00542555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714863|NCT00542555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714864|NCT00542555|Analgesics|analgesics|mesh-ancestor
92714865|NCT00542555|Sensory System Agents|sensory system agents|mesh-ancestor
92714866|NCT00542555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714867|NCT00542555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714868|NCT00542555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714869|NCT00542555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714870|NCT00542555|Gout Suppressants|gout suppressants|mesh-ancestor
92714871|NCT00542555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92714872|NCT00542555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714873|NCT00542555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714874|NCT00542555|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92714875|NCT00542711|Curcumin|curcumin|mesh-list
92714876|NCT00542711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714877|NCT00542711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714878|NCT00542711|Analgesics|analgesics|mesh-ancestor
92714879|NCT00542711|Sensory System Agents|sensory system agents|mesh-ancestor
92714880|NCT00542711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714881|NCT00542711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714882|NCT00542711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608487|NCT00152958|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92608488|NCT00152958|Dopamine Agonists|dopamine agonists|mesh-ancestor
92714883|NCT00542711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714884|NCT00542711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714885|NCT00542711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714886|NCT00542711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714887|NCT00542984|Teriparatide|teriparatide|mesh-list
92714888|NCT00542984|Calcitonin|calcitonin|mesh-list
92714889|NCT00542984|Salmon calcitonin|salmon calcitonin|mesh-list
92714890|NCT00542984|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92714891|NCT00542984|Katacalcin|katacalcin|mesh-list
92374574|NCT01821378|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92714892|NCT00542984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714893|NCT00542984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714894|NCT00542984|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92714895|NCT00542984|Vasodilator Agents|vasodilator agents|mesh-ancestor
92714896|NCT02257983|Ubiquinone|ubiquinone|mesh-list
92714897|NCT02257983|Micronutrients|micronutrients|mesh-ancestor
92714898|NCT02257983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714899|NCT00543023|Teriparatide|teriparatide|mesh-list
92714900|NCT00543023|Calcitonin|calcitonin|mesh-list
92714901|NCT00543023|Salmon calcitonin|salmon calcitonin|mesh-list
92714902|NCT00543023|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92714903|NCT00543023|Katacalcin|katacalcin|mesh-list
92714904|NCT00543023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714905|NCT00543023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714906|NCT00543023|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92714907|NCT00543023|Vasodilator Agents|vasodilator agents|mesh-ancestor
92714908|NCT04648917|Caffeic acid|caffeic acid|mesh-list
92714910|NCT04648917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714911|NCT04648917|Protective Agents|protective agents|mesh-ancestor
92714912|NCT04648917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714914|NCT00543179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714915|NCT00543218|Teriparatide|teriparatide|mesh-list
92714916|NCT00543218|Calcitonin|calcitonin|mesh-list
92714917|NCT00543218|Salmon calcitonin|salmon calcitonin|mesh-list
92714918|NCT00543218|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92714919|NCT00543218|Katacalcin|katacalcin|mesh-list
92714920|NCT00543218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92714921|NCT00543218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714922|NCT00543218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92714923|NCT00543218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92714924|NCT02252835|Colchicine|colchicine|mesh-list
92714925|NCT02252835|Febuxostat|febuxostat|mesh-list
92714926|NCT02252835|Gout Suppressants|gout suppressants|mesh-ancestor
92714927|NCT02252835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714928|NCT02252835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92714929|NCT02252835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92714930|NCT02252835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92714931|NCT02252835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714932|NCT02252835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714933|NCT03456752|Dexamethasone|dexamethasone|mesh-list
92714934|NCT03456752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714935|NCT03456752|Antiemetics|antiemetics|mesh-ancestor
92714936|NCT03456752|Autonomic Agents|autonomic agents|mesh-ancestor
92714937|NCT03456752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714938|NCT03456752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714939|NCT03456752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92714940|NCT03456752|Glucocorticoids|glucocorticoids|mesh-ancestor
92714941|NCT03456752|Hormones|hormones|mesh-ancestor
92714942|NCT03456752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92714943|NCT03456752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92714944|NCT03456752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714945|NCT03456713|Mirikizumab|mirikizumab|mesh-list
92714946|NCT03456713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92714947|NCT03456713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92714948|NCT03456713|Analgesics|analgesics|mesh-ancestor
92714949|NCT03456713|Sensory System Agents|sensory system agents|mesh-ancestor
92714950|NCT03456713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714951|NCT03456713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714952|NCT03456713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714953|NCT03456713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714954|NCT03456713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92714955|NCT03456713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92714956|NCT04648137|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92608489|NCT00152958|Dopamine Agents|dopamine agents|mesh-ancestor
92608490|NCT00152958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608491|NCT00136175|Paclitaxel|paclitaxel|mesh-list
92608492|NCT00136175|Carboplatin|carboplatin|mesh-list
92608493|NCT00136175|Gemcitabine|gemcitabine|mesh-list
92608494|NCT00136175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92608495|NCT00136175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608496|NCT00136175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608497|NCT00136175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92608498|NCT00136175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92374577|NCT01821378|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92608499|NCT00136175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608500|NCT00136175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608501|NCT00136175|Antimetabolites|antimetabolites|mesh-ancestor
92608502|NCT00152997|Pramipexole|pramipexole|mesh-list
92608503|NCT00152997|Antioxidants|antioxidants|mesh-ancestor
92608504|NCT00152997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070110|NCT00985192|Everolimus|everolimus|mesh-list
92714957|NCT04648137|Hallucinogens|hallucinogens|mesh-ancestor
92714958|NCT04648137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714959|NCT04648137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714960|NCT04648137|Serotonin Agents|serotonin agents|mesh-ancestor
92714961|NCT04648137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92714962|NCT04648137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714963|NCT04648137|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92714964|NCT04648137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92714965|NCT04648137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92714966|NCT04648137|Adrenergic Agents|adrenergic agents|mesh-ancestor
92714967|NCT04648332|Bupivacaine|bupivacaine|mesh-list
92714968|NCT04648332|Anesthetics, Local|anesthetics, local|mesh-ancestor
92714969|NCT04648332|Anesthetics|anesthetics|mesh-ancestor
92714970|NCT04648332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714971|NCT04648332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714972|NCT04648332|Sensory System Agents|sensory system agents|mesh-ancestor
92714973|NCT04648332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714974|NCT00543335|Sorafenib|sorafenib|mesh-list
92714975|NCT00543335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714976|NCT00543335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92714977|NCT00543335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714978|NCT00543335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714979|NCT00543413|Enalapril|enalapril|mesh-list
92714980|NCT00543413|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92714981|NCT00543413|Protease Inhibitors|protease inhibitors|mesh-ancestor
92714982|NCT00543413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714992|NCT00543608|Vancomycin|vancomycin|mesh-list
92714993|NCT00543608|Iclaprim|iclaprim|mesh-list
92714994|NCT00543608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92714995|NCT00543608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714996|NCT00543608|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92714997|NCT00543608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714998|NCT00543608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714999|NCT00554775|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92715000|NCT00554775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715001|NCT00554775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715002|NCT00554775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715003|NCT00554775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715004|NCT00543647|Fenofibrate|fenofibrate|mesh-list
92715005|NCT00543647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92715006|NCT00543647|Antimetabolites|antimetabolites|mesh-ancestor
92715007|NCT00543647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608505|NCT00152997|Protective Agents|protective agents|mesh-ancestor
92608506|NCT00152997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608507|NCT00152997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92608508|NCT00152997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92608509|NCT00152997|Dopamine Agonists|dopamine agonists|mesh-ancestor
92015734|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
92715008|NCT00543647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92715009|NCT04647669|Interferons|interferons|mesh-list
92715010|NCT04647669|Interferon-beta|interferon-beta|mesh-list
92715011|NCT04647669|Interferon beta-1a|interferon beta-1a|mesh-list
92715012|NCT04647669|Remdesivir|remdesivir|mesh-list
92715013|NCT04647669|Acalabrutinib|acalabrutinib|mesh-list
92715014|NCT04647669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715015|NCT04647669|Antiviral Agents|antiviral agents|mesh-ancestor
92715016|NCT04647669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715017|NCT04647669|Immunologic Factors|immunologic factors|mesh-ancestor
92715018|NCT04647669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715019|NCT04647669|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92715020|NCT04647669|Antimetabolites|antimetabolites|mesh-ancestor
92715021|NCT04647669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715022|NCT00543686|Fluticasone|fluticasone|mesh-list
92715023|NCT00543686|Montelukast|montelukast|mesh-list
92715024|NCT00543686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715025|NCT00543686|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92715026|NCT00543686|Autonomic Agents|autonomic agents|mesh-ancestor
92374580|NCT01822548|Vildagliptin|vildagliptin|mesh-list
92715027|NCT00543686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715028|NCT00543686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715029|NCT00543686|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92715030|NCT00543686|Respiratory System Agents|respiratory system agents|mesh-ancestor
92715031|NCT00543686|Dermatologic Agents|dermatologic agents|mesh-ancestor
92715032|NCT00543686|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92715033|NCT00543686|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92715034|NCT00543686|Hormone Antagonists|hormone antagonists|mesh-ancestor
92715035|NCT00543686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715036|NCT00543686|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92715037|NCT00543686|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92715038|NCT00543686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715040|NCT00543842|Capecitabine|capecitabine|mesh-list
92715041|NCT00543842|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92715042|NCT00543842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715043|NCT00543842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715044|NCT00543842|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715045|NCT00543842|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715046|NCT00543842|Growth Substances|growth substances|mesh-ancestor
92715047|NCT00543842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715051|NCT00543842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715053|NCT00543842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715054|NCT04638816|Lidocaine|lidocaine|mesh-list
92715055|NCT04638816|Hyaluronic Acid|hyaluronic acid|mesh-list
92715056|NCT04638816|Anesthetics, Local|anesthetics, local|mesh-ancestor
92715057|NCT04638816|Anesthetics|anesthetics|mesh-ancestor
92715058|NCT04638816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715059|NCT04638816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715060|NCT04638816|Sensory System Agents|sensory system agents|mesh-ancestor
92715061|NCT04638816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715062|NCT04638816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92715063|NCT04638816|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92715064|NCT04638816|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92715065|NCT04638816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92715066|NCT04638816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715067|NCT04638816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92715068|NCT04638816|Immunologic Factors|immunologic factors|mesh-ancestor
92715069|NCT04638816|Viscosupplements|viscosupplements|mesh-ancestor
92715070|NCT04638816|Protective Agents|protective agents|mesh-ancestor
92715071|NCT00543959|Pioglitazone|pioglitazone|mesh-list
92715072|NCT00543959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92715073|NCT00543959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715074|NCT00544037|Interferons|interferons|mesh-list
92715075|NCT00544037|Interferon-beta|interferon-beta|mesh-list
92608510|NCT00152997|Dopamine Agents|dopamine agents|mesh-ancestor
92715076|NCT00544037|Interferon beta-1b|interferon beta-1b|mesh-list
92715077|NCT00544037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715078|NCT00544037|Antiviral Agents|antiviral agents|mesh-ancestor
92715079|NCT00544037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715080|NCT00544037|Immunologic Factors|immunologic factors|mesh-ancestor
92715081|NCT00544037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715082|NCT00544037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92715083|NCT00544154|Certolizumab Pegol|certolizumab pegol|mesh-list
92715084|NCT00544154|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92715085|NCT00544154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715086|NCT00544154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715087|NCT00544154|Immunologic Factors|immunologic factors|mesh-ancestor
92715088|NCT00544154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715089|NCT00544154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715090|NCT04638582|Paclitaxel|paclitaxel|mesh-list
92715091|NCT04638582|Carboplatin|carboplatin|mesh-list
92715092|NCT04638582|Pembrolizumab|pembrolizumab|mesh-list
92715093|NCT04638582|Pemetrexed|pemetrexed|mesh-list
92715094|NCT04638582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92715095|NCT04638582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715096|NCT04638582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92715097|NCT04638582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92715098|NCT04638582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92715099|NCT04638582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715100|NCT04638582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715101|NCT04638582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715102|NCT04638582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715103|NCT04638582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92715104|NCT04638582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92715106|NCT00544193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715107|NCT00544193|Antimetabolites|antimetabolites|mesh-ancestor
92715108|NCT00544193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715109|NCT00544193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715110|NCT00544232|Paclitaxel|paclitaxel|mesh-list
92715111|NCT00544232|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92715112|NCT00544232|Cyclophosphamide|cyclophosphamide|mesh-list
92715113|NCT00544232|Methotrexate|methotrexate|mesh-list
92715114|NCT00544232|Epirubicin|epirubicin|mesh-list
92715115|NCT00544232|Darbepoetin alfa|darbepoetin alfa|mesh-list
92715116|NCT00544232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92715117|NCT00544232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715118|NCT00544232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92715119|NCT00544232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92715120|NCT00544232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92715124|NCT00544232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715125|NCT00544232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715126|NCT00544232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92715127|NCT00544232|Alkylating Agents|alkylating agents|mesh-ancestor
92715128|NCT00544232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92715129|NCT00544232|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92715130|NCT00544232|Abortifacient Agents|abortifacient agents|mesh-ancestor
92715131|NCT00544232|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92715132|NCT00544232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715133|NCT00544232|Antimetabolites|antimetabolites|mesh-ancestor
92715134|NCT00544232|Dermatologic Agents|dermatologic agents|mesh-ancestor
92715135|NCT00544232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715136|NCT00544232|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92715137|NCT00544232|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92715138|NCT00544232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92715139|NCT00544232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92715140|NCT00544232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715141|NCT00544232|Hematinics|hematinics|mesh-ancestor
92715142|NCT01191268|Insulin|insulin|mesh-list
92715143|NCT01191268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92715144|NCT01191268|Insulin Glargine|insulin glargine|mesh-list
92715145|NCT01191268|Insulin Lispro|insulin lispro|mesh-list
92715146|NCT01191268|Dulaglutide|dulaglutide|mesh-list
92715147|NCT01191268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92715148|NCT01191268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715149|NCT04647552|Hydrocortisone|hydrocortisone|mesh-list
92715150|NCT04647552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715151|NCT00544349|Leucovorin|leucovorin|mesh-list
92715152|NCT00544349|Fluorouracil|fluorouracil|mesh-list
92715153|NCT00544349|Oxaliplatin|oxaliplatin|mesh-list
92715154|NCT00544349|Cetuximab|cetuximab|mesh-list
92715155|NCT00544349|Calcium|calcium|mesh-list
92715156|NCT00544349|Levoleucovorin|levoleucovorin|mesh-list
92608511|NCT00152997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608512|NCT00136292|Daptomycin|daptomycin|mesh-list
92715157|NCT00544349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92715158|NCT00544349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715159|NCT00544349|Antimetabolites|antimetabolites|mesh-ancestor
92715160|NCT00544349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715161|NCT00544349|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715162|NCT00544349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715163|NCT00544349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715164|NCT00544349|Immunologic Factors|immunologic factors|mesh-ancestor
92715165|NCT00544349|Antidotes|antidotes|mesh-ancestor
92715166|NCT00544349|Protective Agents|protective agents|mesh-ancestor
92715167|NCT00544349|Vitamin B Complex|vitamin b complex|mesh-ancestor
92715168|NCT00544349|Vitamins|vitamins|mesh-ancestor
92715169|NCT00544349|Micronutrients|micronutrients|mesh-ancestor
92715170|NCT00544349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715171|NCT01191190|Ofatumumab|ofatumumab|mesh-list
92715172|NCT01191190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715173|NCT00544388|Levocetirizine|levocetirizine|mesh-list
92715174|NCT00544388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92715175|NCT00544388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92715176|NCT00544388|Histamine Antagonists|histamine antagonists|mesh-ancestor
92715177|NCT00544388|Histamine Agents|histamine agents|mesh-ancestor
92715178|NCT00544388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715179|NCT00544388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715180|NCT00544388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715182|NCT00544505|Fluorouracil|fluorouracil|mesh-list
92715183|NCT00544505|Epirubicin|epirubicin|mesh-list
92715184|NCT00544505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715185|NCT00544505|Immunologic Factors|immunologic factors|mesh-ancestor
92715186|NCT00544505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715187|NCT00544505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715188|NCT00544505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92715189|NCT00544505|Alkylating Agents|alkylating agents|mesh-ancestor
92715190|NCT00544505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715191|NCT00544505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715192|NCT00544505|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92715193|NCT00544505|Antimetabolites|antimetabolites|mesh-ancestor
92715194|NCT00544505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715204|NCT00544700|Growth Substances|growth substances|mesh-ancestor
92715205|NCT00544700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715206|NCT00544700|Growth Inhibitors|growth inhibitors|mesh-ancestor
92715207|NCT05824481|Lenvatinib|lenvatinib|mesh-list
92715208|NCT05824481|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92715209|NCT05824481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715210|NCT05824481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715211|NCT05824481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715212|NCT05824481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715213|NCT05824468|Lenvatinib|lenvatinib|mesh-list
92715214|NCT05824468|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92715215|NCT05824468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715216|NCT05824468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715217|NCT05824468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715218|NCT05824468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715219|NCT05824455|Irinotecan|irinotecan|mesh-list
92715220|NCT05824455|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92715221|NCT05824455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715222|NCT05824455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715223|NCT05824455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715224|NCT05824455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715225|NCT05824390|Rituximab|rituximab|mesh-list
92715226|NCT05824390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715227|NCT05824390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715228|NCT05824390|Immunologic Factors|immunologic factors|mesh-ancestor
92715229|NCT05824390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715230|NCT05824390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715231|NCT05824312|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92715232|NCT05824312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715233|NCT05824312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715234|NCT05824312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715235|NCT05824156|Streptococcal polysaccharide type III group B|streptococcal polysaccharide type iii group b|mesh-list
92608513|NCT00136292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92715236|NCT05824156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715237|NCT05823883|Metformin|metformin|mesh-list
92715238|NCT05823883|Empagliflozin|empagliflozin|mesh-list
92715239|NCT05823883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92715240|NCT05823883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715241|NCT05823883|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92715242|NCT05823883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715243|NCT05823870|Metformin|metformin|mesh-list
92715244|NCT05823870|Empagliflozin|empagliflozin|mesh-list
92715245|NCT05823870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92715246|NCT05823870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715247|NCT05823870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92715248|NCT05823870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715249|NCT05823701|Azacitidine|azacitidine|mesh-list
92715250|NCT05823701|Mitoxantrone|mitoxantrone|mesh-list
92715251|NCT05823701|Obinutuzumab|obinutuzumab|mesh-list
92135029|NCT04082767|Midazolam|midazolam|mesh-list
92715252|NCT05823701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715253|NCT05823701|Antimetabolites|antimetabolites|mesh-ancestor
92715254|NCT05823701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715255|NCT05823701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715256|NCT05823701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715257|NCT05823701|Analgesics|analgesics|mesh-ancestor
92715262|NCT05823701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715263|NCT05823701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715265|NCT05823623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92715266|NCT05823623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715267|NCT05823623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92715268|NCT05823623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92715269|NCT05823623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92715270|NCT05823623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715271|NCT05823480|Azacitidine|azacitidine|mesh-list
92715272|NCT05823480|Magrolimab|magrolimab|mesh-list
92715273|NCT05823480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715274|NCT05823480|Antimetabolites|antimetabolites|mesh-ancestor
92715275|NCT05823480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715276|NCT05823480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715277|NCT05823480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715278|NCT05823480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715279|NCT05823168|Anticonvulsants|anticonvulsants|mesh-list
92715280|NCT05823155|Penicillins|penicillins|mesh-list
92715281|NCT05823155|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92715282|NCT05823155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715283|NCT05822882|Anesthetics|anesthetics|mesh-list
92715284|NCT05822882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715285|NCT05822882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715286|NCT05822713|Amisulpride|amisulpride|mesh-list
92715287|NCT05822713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92715288|NCT05822713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92715289|NCT05822713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715290|NCT05822713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715291|NCT05822713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92715292|NCT05822713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92715293|NCT05822713|Dopamine Agents|dopamine agents|mesh-ancestor
92715294|NCT05822713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715295|NCT05822713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715296|NCT05822713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92715297|NCT05822713|Antidepressive Agents|antidepressive agents|mesh-ancestor
92715298|NCT05822674|Metformin|metformin|mesh-list
92715299|NCT05822674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92715300|NCT05822674|Empagliflozin|empagliflozin|mesh-list
92715301|NCT05822674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92715302|NCT05822674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715303|NCT05822674|Incretins|incretins|mesh-ancestor
92715304|NCT05822674|Hormones|hormones|mesh-ancestor
92715305|NCT05822674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715306|NCT05822674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92715307|NCT05822674|Protease Inhibitors|protease inhibitors|mesh-ancestor
92715308|NCT05822674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715309|NCT05822674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608514|NCT00136292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608515|NCT00153075|Fenoterol|fenoterol|mesh-list
92715310|NCT05822674|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92715311|NCT05820451|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92715312|NCT05817474|Lidocaine|lidocaine|mesh-list
92715313|NCT05817474|Tranexamic Acid|tranexamic acid|mesh-list
92715314|NCT05817474|Anesthetics, Local|anesthetics, local|mesh-ancestor
92715315|NCT05817474|Anesthetics|anesthetics|mesh-ancestor
92715316|NCT05817474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715317|NCT05817474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715318|NCT05817474|Sensory System Agents|sensory system agents|mesh-ancestor
92715319|NCT05817474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715320|NCT05817474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92715321|NCT05817474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92715322|NCT05817474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92715323|NCT05817474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92715324|NCT05817474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715325|NCT05817474|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92715329|NCT05824338|Bupivacaine|bupivacaine|mesh-list
92715330|NCT05824338|Ropivacaine|ropivacaine|mesh-list
92715331|NCT05824338|Anesthetics|anesthetics|mesh-list
92715332|NCT05824338|Anesthetics, Local|anesthetics, local|mesh-ancestor
92715333|NCT05824338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715334|NCT05824338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715335|NCT05824338|Sensory System Agents|sensory system agents|mesh-ancestor
92715336|NCT05824338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715337|NCT05794503|Neostigmine|neostigmine|mesh-list
92715338|NCT05794503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92715339|NCT05794503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715340|NCT05794503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715341|NCT05794503|Cholinergic Agents|cholinergic agents|mesh-ancestor
92715342|NCT05794503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715343|NCT05794503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715344|NCT05794503|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92715345|NCT05794503|Autonomic Agents|autonomic agents|mesh-ancestor
92715346|NCT05794503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715347|NCT05780567|Tamoxifen|tamoxifen|mesh-list
92715348|NCT05780567|Letrozole|letrozole|mesh-list
92715349|NCT05780567|Anastrozole|anastrozole|mesh-list
92715350|NCT05780567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715351|NCT05780567|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92715352|NCT05780567|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92715353|NCT05780567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715354|NCT05780567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715355|NCT05780567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92715356|NCT05780567|Hormone Antagonists|hormone antagonists|mesh-ancestor
92715357|NCT05780567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715358|NCT05780567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715359|NCT05780567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715360|NCT05780567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92715361|NCT05780567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92715362|NCT05780567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92715363|NCT05751629|Bevacizumab|bevacizumab|mesh-list
92715364|NCT05751629|Niraparib|niraparib|mesh-list
92715365|NCT05751629|Dostarlimab|dostarlimab|mesh-list
92715366|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715367|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715368|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715369|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715370|NCT05751629|Growth Substances|growth substances|mesh-ancestor
92715371|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715372|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
92715373|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92715374|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715375|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715376|NCT05746273|Nicotine|nicotine|mesh-list
92715377|NCT05746273|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92715378|NCT05746273|Autonomic Agents|autonomic agents|mesh-ancestor
92715379|NCT05746273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715380|NCT05746273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715381|NCT05746273|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92715382|NCT05746273|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92682801|NCT00438113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92715383|NCT05746273|Cholinergic Agents|cholinergic agents|mesh-ancestor
92715384|NCT05746273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715385|NCT05746273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715386|NCT05736640|Denosumab|denosumab|mesh-list
92715387|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92715388|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715389|NCT05728294|Ropivacaine|ropivacaine|mesh-list
92715390|NCT05728294|Anesthetics, Local|anesthetics, local|mesh-ancestor
92715391|NCT05728294|Anesthetics|anesthetics|mesh-ancestor
92715392|NCT05728294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715393|NCT05728294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715394|NCT05728294|Sensory System Agents|sensory system agents|mesh-ancestor
92715395|NCT05728294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715396|NCT05726916|Eculizumab|eculizumab|mesh-list
92715397|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92715407|NCT05704829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715409|NCT05685004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92715410|NCT05685004|Alkylating Agents|alkylating agents|mesh-ancestor
92715411|NCT05685004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715412|NCT05685004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715413|NCT05681572|Midazolam|midazolam|mesh-list
92715414|NCT05681572|Dexmedetomidine|dexmedetomidine|mesh-list
92715415|NCT05681572|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92715416|NCT05681572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715417|NCT05681572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715418|NCT05681572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92715419|NCT05681572|Analgesics|analgesics|mesh-ancestor
92715420|NCT05681572|Sensory System Agents|sensory system agents|mesh-ancestor
92715421|NCT05681572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715422|NCT05681572|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92715423|NCT05681572|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92715424|NCT05681572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92715425|NCT05681572|Adrenergic Agents|adrenergic agents|mesh-ancestor
92715426|NCT05681572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715427|NCT05681572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715428|NCT05681572|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92715429|NCT05681572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92715430|NCT05681572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92715431|NCT05681572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92715432|NCT05681572|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92715433|NCT05681572|Anesthetics, General|anesthetics, general|mesh-ancestor
92715434|NCT05681572|Anesthetics|anesthetics|mesh-ancestor
92715435|NCT05681572|GABA Modulators|gaba modulators|mesh-ancestor
92715436|NCT05681572|GABA Agents|gaba agents|mesh-ancestor
92715437|NCT05671757|Daratumumab|daratumumab|mesh-list
92715438|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92715439|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715440|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
92715441|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715442|NCT05608252|Fulvestrant|fulvestrant|mesh-list
92715443|NCT05608252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715444|NCT05608252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715445|NCT05608252|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92715446|NCT05608252|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92715447|NCT05608252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92715448|NCT05608252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715449|NCT05608252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715450|NCT05564221|Omalizumab|omalizumab|mesh-list
92715451|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92715452|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92715453|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
92715454|NCT05491200|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92715455|NCT05491200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92715456|NCT05490888|Terlipressin|terlipressin|mesh-list
92715457|NCT05490888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92715458|NCT05490888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92715459|NCT05410301|Bevacizumab|bevacizumab|mesh-list
92715460|NCT05410301|Lomustine|lomustine|mesh-list
92715461|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715462|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715463|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715465|NCT05410301|Growth Substances|growth substances|mesh-ancestor
92715466|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608516|NCT00153075|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
92608517|NCT00153075|Ipratropium|ipratropium|mesh-list
92608518|NCT00153075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92608519|NCT00153075|Autonomic Agents|autonomic agents|mesh-ancestor
92608520|NCT00153075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608521|NCT00153075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608522|NCT00153075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92608523|NCT00153075|Respiratory System Agents|respiratory system agents|mesh-ancestor
92608524|NCT00153075|Sympathomimetics|sympathomimetics|mesh-ancestor
92608525|NCT00153075|Tocolytic Agents|tocolytic agents|mesh-ancestor
92715467|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
92715468|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92715469|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
92715470|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715471|NCT05297578|Vaccines|vaccines|mesh-list
92135249|NCT01458275|Hormones|hormones|mesh-ancestor
92715472|NCT05297578|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92715473|NCT05297578|Immunologic Factors|immunologic factors|mesh-ancestor
92715474|NCT05297578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715475|NCT05293249|Methylprednisolone|methylprednisolone|mesh-list
92715476|NCT05293249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92715477|NCT05293249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92715478|NCT05293249|Prednisolone|prednisolone|mesh-list
92715479|NCT05293249|Prednisolone acetate|prednisolone acetate|mesh-list
92715480|NCT05293249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92715481|NCT05293249|Prednisolone phosphate|prednisolone phosphate|mesh-list
92715482|NCT05293249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715483|NCT05293249|Antiemetics|antiemetics|mesh-ancestor
92715484|NCT05293249|Autonomic Agents|autonomic agents|mesh-ancestor
92715485|NCT05293249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715486|NCT05293249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715487|NCT05293249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715488|NCT05293249|Glucocorticoids|glucocorticoids|mesh-ancestor
92715489|NCT05293249|Hormones|hormones|mesh-ancestor
92715490|NCT05293249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715491|NCT05293249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92715492|NCT05293249|Protective Agents|protective agents|mesh-ancestor
92715493|NCT05293249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715494|NCT05293249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715495|NCT05180474|Antibodies|antibodies|mesh-list
92715496|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92715497|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
92715498|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715499|NCT05172934|Tenecteplase|tenecteplase|mesh-list
92715500|NCT05172934|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92715501|NCT05172934|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92715502|NCT05172934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715503|NCT05171816|Olaparib|olaparib|mesh-list
92715504|NCT05171816|Abiraterone Acetate|abiraterone acetate|mesh-list
92715505|NCT05171816|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92715506|NCT05171816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715507|NCT05171816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715508|NCT05171816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715509|NCT05171816|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92715510|NCT05171816|Hormone Antagonists|hormone antagonists|mesh-ancestor
92715511|NCT05171816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715512|NCT05171816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715513|NCT05171816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92715514|NCT05126966|Ranibizumab|ranibizumab|mesh-list
92715515|NCT05126966|Aflibercept|aflibercept|mesh-list
92715516|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715517|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715518|NCT05126966|Growth Substances|growth substances|mesh-ancestor
92715519|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015755|NCT04278755|Drospirenone|drospirenone|mesh-list
92608526|NCT00153075|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92608527|NCT00153075|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92608528|NCT00153075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92608529|NCT00153075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92608530|NCT00153075|Adrenergic Agents|adrenergic agents|mesh-ancestor
92608531|NCT00153075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608532|NCT00153075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715520|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
92715521|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715522|NCT05126784|Denosumab|denosumab|mesh-list
92715523|NCT05126784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92715524|NCT05126784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715525|NCT05065294|Psilocybin|psilocybin|mesh-list
92715526|NCT05065294|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92715527|NCT05065294|Hallucinogens|hallucinogens|mesh-ancestor
92715528|NCT05065294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715529|NCT05065294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92715530|NCT05065294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92715531|NCT05065294|Serotonin Agents|serotonin agents|mesh-ancestor
92715532|NCT05065294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715533|NCT05065294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715534|NCT05065294|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92715535|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
92715540|NCT05058287|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92715541|NCT05058287|Prednisolone phosphate|prednisolone phosphate|mesh-list
92715542|NCT05058287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715543|NCT05058287|Antiemetics|antiemetics|mesh-ancestor
92715544|NCT05058287|Autonomic Agents|autonomic agents|mesh-ancestor
92715545|NCT05058287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715546|NCT05058287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715547|NCT05058287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715548|NCT05058287|Glucocorticoids|glucocorticoids|mesh-ancestor
92715549|NCT05058287|Hormones|hormones|mesh-ancestor
92715550|NCT05058287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715551|NCT05058287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92715552|NCT05058287|Protective Agents|protective agents|mesh-ancestor
92715553|NCT05058287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715554|NCT05058287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715555|NCT04968899|Dexamethasone|dexamethasone|mesh-list
92715556|NCT04968899|Immunoglobulins|immunoglobulins|mesh-list
92715557|NCT04968899|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92715558|NCT04968899|Antibodies|antibodies|mesh-list
92715559|NCT04968899|gamma-Globulins|gamma-globulins|mesh-list
92715560|NCT04968899|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92715561|NCT04968899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715562|NCT04968899|Antiemetics|antiemetics|mesh-ancestor
92715563|NCT04968899|Autonomic Agents|autonomic agents|mesh-ancestor
92715564|NCT04968899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715565|NCT04968899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715566|NCT04968899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715567|NCT04968899|Glucocorticoids|glucocorticoids|mesh-ancestor
92715568|NCT04968899|Hormones|hormones|mesh-ancestor
92715569|NCT04968899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715570|NCT04968899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715571|NCT04968899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715572|NCT04968899|Immunologic Factors|immunologic factors|mesh-ancestor
92715573|NCT04965818|Futibatinib|futibatinib|mesh-list
92715574|NCT04965818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715575|NCT04952597|Tislelizumab|tislelizumab|mesh-list
92715576|NCT04952597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715577|NCT04952597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715578|NCT04943224|Trametinib|trametinib|mesh-list
92715579|NCT04943224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715580|NCT04943224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715581|NCT04943224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715582|NCT04943224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608533|NCT00153075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92608534|NCT00153075|Cholinergic Agents|cholinergic agents|mesh-ancestor
92608535|NCT00159471|Gemcitabine|gemcitabine|mesh-list
92608536|NCT00159471|Capecitabine|capecitabine|mesh-list
92608537|NCT00159471|Docetaxel|docetaxel|mesh-list
92715583|NCT04943211|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92715584|NCT04943211|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92715585|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715586|NCT04943198|Vemurafenib|vemurafenib|mesh-list
92715587|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715588|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715589|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715590|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715591|NCT04941105|Evolocumab|evolocumab|mesh-list
92715592|NCT04941105|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92715593|NCT04941105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92715594|NCT04941105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92715595|NCT04941105|Antimetabolites|antimetabolites|mesh-ancestor
92715596|NCT04941105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715597|NCT04941105|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92715598|NCT04941105|Protease Inhibitors|protease inhibitors|mesh-ancestor
92715599|NCT04941105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715600|NCT04941105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92715601|NCT04933695|Sotorasib|sotorasib|mesh-list
92715602|NCT04933695|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715603|NCT04933695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715604|NCT04933695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715605|NCT04933695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715606|NCT04873102|Danazol|danazol|mesh-list
92715607|NCT04873102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92715613|NCT04860141|Sensory System Agents|sensory system agents|mesh-ancestor
92715614|NCT04860141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715615|NCT04860141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715616|NCT04860141|Anticonvulsants|anticonvulsants|mesh-ancestor
92715617|NCT04860141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92715618|NCT04860141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92715619|NCT04860141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715620|NCT04860141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92715621|NCT04860141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92715622|NCT04860141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92715623|NCT04860141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715624|NCT04860141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715625|NCT04860141|Antimanic Agents|antimanic agents|mesh-ancestor
92715627|NCT04823156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92715628|NCT04823156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715629|NCT04813653|Cyclosporine|cyclosporine|mesh-list
92715630|NCT04813653|Dexamethasone|dexamethasone|mesh-list
92715631|NCT04813653|Cyclosporins|cyclosporins|mesh-list
92715632|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715633|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
92715634|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
92715635|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715636|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715637|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715638|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
92715639|NCT04813653|Hormones|hormones|mesh-ancestor
92715640|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715641|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715642|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715643|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715644|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715645|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715646|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
92715647|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
92715648|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715649|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
92715650|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715651|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92715652|NCT04803747|Tranexamic Acid|tranexamic acid|mesh-list
92715653|NCT04803747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92715654|NCT04803747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92608538|NCT00159471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608539|NCT00159471|Antimetabolites|antimetabolites|mesh-ancestor
92608540|NCT00159471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715655|NCT04803747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715656|NCT04803747|Hemostatics|hemostatics|mesh-ancestor
92715657|NCT04803747|Coagulants|coagulants|mesh-ancestor
92715658|NCT04790474|Dexamethasone|dexamethasone|mesh-list
92715659|NCT04790474|Pomalidomide|pomalidomide|mesh-list
92715660|NCT04790474|Ixazomib|ixazomib|mesh-list
92715661|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715662|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
92715663|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
92715664|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715665|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715666|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715667|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
92715668|NCT04790474|Hormones|hormones|mesh-ancestor
92715669|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715670|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92715671|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715672|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
92715673|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715674|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715675|NCT04790474|Growth Substances|growth substances|mesh-ancestor
92715676|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
92715677|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
92715678|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715683|NCT04778410|Azacitidine|azacitidine|mesh-list
92715684|NCT04778410|Venetoclax|venetoclax|mesh-list
92715685|NCT04778410|Cc-486|cc-486|mesh-list
92715686|NCT04778410|Magrolimab|magrolimab|mesh-list
92715687|NCT04778410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92715688|NCT04778410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715689|NCT04778410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92715690|NCT04778410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715691|NCT04778410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715692|NCT04778410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715693|NCT04778410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715694|NCT04778410|Antimetabolites|antimetabolites|mesh-ancestor
92715695|NCT04778410|Antiviral Agents|antiviral agents|mesh-ancestor
92374600|NCT01825512|Deferasirox|deferasirox|mesh-list
92715696|NCT04778410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135477|NCT01468207|Adalimumab|adalimumab|mesh-list
92715697|NCT04778410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715698|NCT04778410|Immunologic Factors|immunologic factors|mesh-ancestor
92715699|NCT04778410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715700|NCT04778410|Analgesics|analgesics|mesh-ancestor
92715701|NCT04778410|Sensory System Agents|sensory system agents|mesh-ancestor
92715702|NCT04778410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715703|NCT04778410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715704|NCT04767594|Palbociclib|palbociclib|mesh-list
92715705|NCT04767594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715706|NCT04767594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715707|NCT04767594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715708|NCT04767594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715709|NCT04743570|Methylnaltrexone|methylnaltrexone|mesh-list
92715710|NCT04743570|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92715711|NCT04743570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715712|NCT04743570|Sensory System Agents|sensory system agents|mesh-ancestor
92715713|NCT04743570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715714|NCT04718025|Aspirin|aspirin|mesh-list
92715715|NCT04718025|Ticagrelor|ticagrelor|mesh-list
92715716|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92715717|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92715718|NCT04718025|Analgesics|analgesics|mesh-ancestor
92715719|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
92715720|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715721|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715722|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715723|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715724|NCT04718025|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92715725|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92715726|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608541|NCT00159471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608542|NCT00159471|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608543|NCT00159471|Antimitotic Agents|antimitotic agents|mesh-ancestor
92608544|NCT00159471|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608545|NCT00136370|Chlorhexidine|chlorhexidine|mesh-list
92608546|NCT00136370|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92608547|NCT00136370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715727|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92715728|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92715729|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715730|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
92715731|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92715732|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92715733|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92715734|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
92715735|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715736|NCT04666948|Vancomycin|vancomycin|mesh-list
92715737|NCT04666948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92715738|NCT04666948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715739|NCT04642430|Rivaroxaban|rivaroxaban|mesh-list
92715740|NCT04642430|Apixaban|apixaban|mesh-list
92715741|NCT04642430|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92715742|NCT04642430|Antithrombins|antithrombins|mesh-ancestor
92715743|NCT04642430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92715744|NCT04642430|Protease Inhibitors|protease inhibitors|mesh-ancestor
92715745|NCT04642430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715746|NCT04642430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715747|NCT04642430|Anticoagulants|anticoagulants|mesh-ancestor
92715748|NCT04609176|Apatinib|apatinib|mesh-list
92715749|NCT04609176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715750|NCT04609176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715754|NCT04593940|Cenicriviroc|cenicriviroc|mesh-list
92715755|NCT04593940|Infliximab|infliximab|mesh-list
92715756|NCT04593940|Abatacept|abatacept|mesh-list
92715757|NCT04593940|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92715758|NCT04593940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715759|NCT04593940|Dermatologic Agents|dermatologic agents|mesh-ancestor
92715760|NCT04593940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715761|NCT04593940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715762|NCT04593940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92374603|NCT01825512|Chelating Agents|chelating agents|mesh-ancestor
92715763|NCT04593940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715764|NCT04593940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715765|NCT04593940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715766|NCT04593940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715767|NCT04593940|Immunologic Factors|immunologic factors|mesh-ancestor
92715768|NCT04593940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715769|NCT04593940|Antimetabolites|antimetabolites|mesh-ancestor
92715770|NCT04593940|Antiviral Agents|antiviral agents|mesh-ancestor
92715771|NCT04593940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715772|NCT04593940|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92715773|NCT04593940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92715774|NCT04593940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92715775|NCT04562090|Mirabegron|mirabegron|mesh-list
92715776|NCT04562090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92715777|NCT04562090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92715778|NCT04562090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92715779|NCT04562090|Adrenergic Agents|adrenergic agents|mesh-ancestor
92715780|NCT04562090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715781|NCT04562090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715782|NCT04562090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715783|NCT04562090|Urological Agents|urological agents|mesh-ancestor
92715784|NCT04557189|Ondansetron|ondansetron|mesh-list
92715785|NCT04557189|Antiemetics|antiemetics|mesh-ancestor
92715786|NCT04557189|Autonomic Agents|autonomic agents|mesh-ancestor
92715787|NCT04557189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715788|NCT04557189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715789|NCT04557189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715790|NCT04557189|Antipruritics|antipruritics|mesh-ancestor
92715791|NCT04557189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92715792|NCT04557189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92608548|NCT00136370|Disinfectants|disinfectants|mesh-ancestor
92608549|NCT00159510|Nitric Oxide|nitric oxide|mesh-list
92608550|NCT00159510|Methylene Blue|methylene blue|mesh-list
92015778|NCT04277975|Analgesics|analgesics|mesh-ancestor
92715793|NCT04557189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92715794|NCT04557189|Serotonin Agents|serotonin agents|mesh-ancestor
92715795|NCT04557189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715796|NCT04557189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715797|NCT04530838|Vaccines|vaccines|mesh-list
92715798|NCT04530838|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92715799|NCT04530838|Immunologic Factors|immunologic factors|mesh-ancestor
92715800|NCT04530838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715801|NCT04442919|Morphine|morphine|mesh-list
92715802|NCT04442919|Methoxyflurane|methoxyflurane|mesh-list
92715803|NCT04442919|Ticagrelor|ticagrelor|mesh-list
92715804|NCT04442919|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92715805|NCT04442919|Narcotics|narcotics|mesh-ancestor
92715806|NCT04442919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715807|NCT04442919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715808|NCT04442919|Analgesics|analgesics|mesh-ancestor
92715809|NCT04442919|Sensory System Agents|sensory system agents|mesh-ancestor
92715810|NCT04442919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715811|NCT04442919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92715812|NCT04442919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92715813|NCT04442919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92715814|NCT04442919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92715815|NCT04442919|Purinergic Agents|purinergic agents|mesh-ancestor
92715816|NCT04442919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715817|NCT04442919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715818|NCT04442919|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92715819|NCT04442919|Anesthetics, General|anesthetics, general|mesh-ancestor
92715820|NCT04442919|Anesthetics|anesthetics|mesh-ancestor
92715821|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
92715822|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715829|NCT04424901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715830|NCT04424901|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92715831|NCT04424901|Vasodilator Agents|vasodilator agents|mesh-ancestor
92715832|NCT04415060|Sevoflurane|sevoflurane|mesh-list
92715833|NCT04415060|Isoflurane|isoflurane|mesh-list
92715834|NCT04415060|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92715835|NCT04415060|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92715836|NCT04415060|Anesthetics, General|anesthetics, general|mesh-ancestor
92715837|NCT04415060|Anesthetics|anesthetics|mesh-ancestor
92715838|NCT04415060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715839|NCT04415060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715840|NCT04410445|Nivolumab|nivolumab|mesh-list
92715841|NCT04410445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715842|NCT04410445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715843|NCT04410445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715844|NCT04410445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715845|NCT04408664|Cromolyn Sodium|cromolyn sodium|mesh-list
92715846|NCT04408664|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92715847|NCT04408664|Immunologic Factors|immunologic factors|mesh-ancestor
92715848|NCT04408664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715849|NCT04408664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92715850|NCT04408664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715851|NCT04408664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92715852|NCT04408664|Respiratory System Agents|respiratory system agents|mesh-ancestor
92715853|NCT04381091|Idebenone|idebenone|mesh-list
92715854|NCT04381091|Antioxidants|antioxidants|mesh-ancestor
92715855|NCT04381091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715856|NCT04381091|Protective Agents|protective agents|mesh-ancestor
92715857|NCT04381091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715858|NCT04293562|Cytarabine|cytarabine|mesh-list
92715859|NCT04293562|Deoxyglucose|deoxyglucose|mesh-list
92715860|NCT04293562|Hydrocortisone|hydrocortisone|mesh-list
92715861|NCT04293562|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92715862|NCT04293562|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92715863|NCT04293562|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92715864|NCT04293562|Methotrexate|methotrexate|mesh-list
92715865|NCT04293562|Etoposide|etoposide|mesh-list
92715866|NCT04293562|Etoposide phosphate|etoposide phosphate|mesh-list
92715867|NCT04293562|Daunorubicin|daunorubicin|mesh-list
92608551|NCT00159510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92608552|NCT00159510|Autonomic Agents|autonomic agents|mesh-ancestor
92608553|NCT00159510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608554|NCT00159510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608555|NCT00159510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92608556|NCT00159510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92608557|NCT00159510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92608558|NCT00159510|Antioxidants|antioxidants|mesh-ancestor
92715868|NCT04293562|Asparaginase|asparaginase|mesh-list
92715869|NCT04293562|Mitoxantrone|mitoxantrone|mesh-list
92715870|NCT04293562|Podophyllotoxin|podophyllotoxin|mesh-list
92715871|NCT04293562|Gemtuzumab|gemtuzumab|mesh-list
92715872|NCT04293562|Dexrazoxane|dexrazoxane|mesh-list
92715873|NCT04293562|Razoxane|razoxane|mesh-list
92715874|NCT04293562|Calicheamicins|calicheamicins|mesh-list
92715875|NCT04293562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92715876|NCT04293562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92715877|NCT04293562|Abortifacient Agents|abortifacient agents|mesh-ancestor
92715878|NCT04293562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92715879|NCT04293562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715880|NCT04293562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715881|NCT04293562|Antimetabolites|antimetabolites|mesh-ancestor
92715882|NCT04293562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715883|NCT04293562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715884|NCT04293562|Dermatologic Agents|dermatologic agents|mesh-ancestor
92715885|NCT04293562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715886|NCT04293562|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92715887|NCT04293562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715888|NCT04293562|Immunologic Factors|immunologic factors|mesh-ancestor
92715889|NCT04293562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715890|NCT04293562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92715891|NCT04293562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92715892|NCT04293562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92715902|NCT04293562|Keratolytic Agents|keratolytic agents|mesh-ancestor
92715903|NCT04293562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92715904|NCT04293562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92715905|NCT04293562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92715906|NCT04293562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715907|NCT04293562|Immunotoxins|immunotoxins|mesh-ancestor
92715908|NCT04293562|Immunoconjugates|immunoconjugates|mesh-ancestor
92715909|NCT04293562|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92715910|NCT04293562|Protective Agents|protective agents|mesh-ancestor
92715911|NCT04225312|Natalizumab|natalizumab|mesh-list
92715912|NCT04225312|Immunologic Factors|immunologic factors|mesh-ancestor
92715913|NCT04225312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715914|NCT04209205|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92715915|NCT04209205|Immunologic Factors|immunologic factors|mesh-ancestor
92715916|NCT04209205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715917|NCT04156347|Topotecan|topotecan|mesh-list
92715918|NCT04156347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92715919|NCT04156347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715920|NCT04156347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715921|NCT04156347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715922|NCT04156347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715923|NCT04129086|Ketamine|ketamine|mesh-list
92715924|NCT04129086|Analgesics|analgesics|mesh-ancestor
92715925|NCT04129086|Sensory System Agents|sensory system agents|mesh-ancestor
92715926|NCT04129086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715927|NCT04129086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715928|NCT04129086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92715929|NCT04129086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92715931|NCT04129086|Anesthetics|anesthetics|mesh-ancestor
92715932|NCT04129086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715933|NCT04129086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92715934|NCT04129086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92715935|NCT04129086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92715936|NCT04129086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715937|NCT04062448|Rituximab|rituximab|mesh-list
92608559|NCT00159510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608560|NCT00159510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608561|NCT00159510|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92608562|NCT00159510|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608563|NCT00159510|Gasotransmitters|gasotransmitters|mesh-ancestor
92608564|NCT00159510|Protective Agents|protective agents|mesh-ancestor
92608565|NCT00159510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608566|NCT00136409|Imatinib Mesylate|imatinib mesylate|mesh-list
92608567|NCT00136409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608568|NCT00136409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92608569|NCT00136409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608570|NCT00136409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608571|NCT00153114|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92608572|NCT00153114|Laxatives|laxatives|mesh-ancestor
92608573|NCT00153114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92715938|NCT04062448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715939|NCT04062448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715940|NCT04062448|Immunologic Factors|immunologic factors|mesh-ancestor
92715941|NCT04062448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715942|NCT04062448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92715943|NCT04003285|Pregnanolone|pregnanolone|mesh-list
92715944|NCT04003285|Anesthetics|anesthetics|mesh-ancestor
92715945|NCT04003285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92715946|NCT04003285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715947|NCT04000555|Vancomycin|vancomycin|mesh-list
92715948|NCT04000555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92715949|NCT04000555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715950|NCT03994393|Durvalumab|durvalumab|mesh-list
92715951|NCT03994393|Tremelimumab|tremelimumab|mesh-list
92715952|NCT03994393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715953|NCT03994393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715954|NCT03961438|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
92715955|NCT03961438|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92715956|NCT03961438|Immunologic Factors|immunologic factors|mesh-ancestor
92715957|NCT03961438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715958|NCT03933163|Resveratrol|resveratrol|mesh-list
92715959|NCT03933163|Antioxidants|antioxidants|mesh-ancestor
92715960|NCT03933163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715962|NCT03933163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715963|NCT03933163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715964|NCT03933163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92715965|NCT03829501|Atezolizumab|atezolizumab|mesh-list
92715966|NCT03829501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715967|NCT03829501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715968|NCT03829501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715969|NCT03829501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715970|NCT03798639|Nivolumab|nivolumab|mesh-list
92715971|NCT03798639|Ipilimumab|ipilimumab|mesh-list
92715972|NCT03798639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715973|NCT03798639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715974|NCT03798639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715975|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715976|NCT03774901|Avelumab|avelumab|mesh-list
92715977|NCT03774901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715978|NCT03774901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715979|NCT03762018|Bevacizumab|bevacizumab|mesh-list
92715980|NCT03762018|Atezolizumab|atezolizumab|mesh-list
92715981|NCT03762018|Carboplatin|carboplatin|mesh-list
92715982|NCT03762018|Pemetrexed|pemetrexed|mesh-list
92715983|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92608575|NCT00136448|Interleukin-2|interleukin-2|mesh-list
92608576|NCT00136448|Daunorubicin|daunorubicin|mesh-list
92608577|NCT00136448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608578|NCT00136448|Antimetabolites|antimetabolites|mesh-ancestor
92715984|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715985|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715986|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715987|NCT03762018|Growth Substances|growth substances|mesh-ancestor
92715988|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715989|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
92715990|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715991|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715992|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92715993|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92715994|NCT03762018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715995|NCT03737643|Paclitaxel|paclitaxel|mesh-list
92715996|NCT03737643|Bevacizumab|bevacizumab|mesh-list
92715997|NCT03737643|Carboplatin|carboplatin|mesh-list
92715998|NCT03737643|Durvalumab|durvalumab|mesh-list
92715999|NCT03737643|Olaparib|olaparib|mesh-list
92716000|NCT03737643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92716001|NCT03737643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92135776|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92716003|NCT03737643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92716004|NCT03737643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716005|NCT03737643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716006|NCT03737643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716007|NCT03737643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716008|NCT03737643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716009|NCT03737643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716010|NCT03737643|Growth Substances|growth substances|mesh-ancestor
92716011|NCT03737643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716012|NCT03737643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716013|NCT03737643|Immunologic Factors|immunologic factors|mesh-ancestor
92716014|NCT03737643|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92716015|NCT03737643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716016|NCT03456882|RNS60|rns60|mesh-list
92716017|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92716018|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92716019|NCT03456882|Analgesics|analgesics|mesh-ancestor
92716020|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
92716021|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716022|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716023|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716024|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716025|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92716026|NCT03433807|Idebenone|idebenone|mesh-list
92716027|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
92716028|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716029|NCT03433807|Protective Agents|protective agents|mesh-ancestor
92716030|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716031|NCT03416179|Cytarabine|cytarabine|mesh-list
92716032|NCT03416179|Azacitidine|azacitidine|mesh-list
92716033|NCT03416179|Daunorubicin|daunorubicin|mesh-list
92716034|NCT03416179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716035|NCT03416179|Antimetabolites|antimetabolites|mesh-ancestor
92716038|NCT03416179|Antiviral Agents|antiviral agents|mesh-ancestor
92716039|NCT03416179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716040|NCT03416179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716041|NCT03416179|Immunologic Factors|immunologic factors|mesh-ancestor
92716042|NCT03416179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716043|NCT03416179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716044|NCT03416179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92716045|NCT03416179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92716046|NCT03416179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716047|NCT03313544|Nivolumab|nivolumab|mesh-list
92716048|NCT03313544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716049|NCT03313544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716050|NCT03313544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92716051|NCT03313544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716052|NCT03309150|Paclitaxel|paclitaxel|mesh-list
92608579|NCT00136448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608580|NCT00136448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608581|NCT00136448|Antiviral Agents|antiviral agents|mesh-ancestor
92608582|NCT00136448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716053|NCT03309150|Carboplatin|carboplatin|mesh-list
92716054|NCT03309150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92716055|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716056|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
92716057|NCT03309150|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716058|NCT03309150|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716059|NCT03309150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716060|NCT03266783|Rivaroxaban|rivaroxaban|mesh-list
92716062|NCT03266783|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92716063|NCT03266783|Antithrombins|antithrombins|mesh-ancestor
92716064|NCT03266783|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92716065|NCT03266783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92716066|NCT03266783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716067|NCT03266783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716068|NCT03266783|Anticoagulants|anticoagulants|mesh-ancestor
92716069|NCT03251859|Ticagrelor|ticagrelor|mesh-list
92716070|NCT03251859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92716071|NCT03251859|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92716072|NCT03251859|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92716073|NCT03251859|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92716074|NCT03251859|Purinergic Agents|purinergic agents|mesh-ancestor
92716075|NCT03251859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716076|NCT03251859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716077|NCT03251859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716078|NCT03186638|Ibuprofen|ibuprofen|mesh-list
92716079|NCT03186638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92716080|NCT03186638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92716081|NCT03186638|Analgesics|analgesics|mesh-ancestor
92716082|NCT03186638|Sensory System Agents|sensory system agents|mesh-ancestor
92716083|NCT03186638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716084|NCT03186638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716085|NCT03186638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716086|NCT03186638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716087|NCT03186638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92716088|NCT03186638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716089|NCT03186638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716090|NCT02918409|Tobramycin|tobramycin|mesh-list
92716091|NCT02918409|Colistin|colistin|mesh-list
92716092|NCT02918409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92716093|NCT02918409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716094|NCT02859792|Riluzole|riluzole|mesh-list
92716095|NCT02859792|Anticonvulsants|anticonvulsants|mesh-ancestor
92716096|NCT02859792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92716097|NCT02859792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92716098|NCT02859792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716099|NCT02859792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716100|NCT02859792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716101|NCT02859792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92716102|NCT02859792|Protective Agents|protective agents|mesh-ancestor
92716103|NCT02852213|Dopa Decarboxylase|dopa decarboxylase|mesh-list
92716104|NCT02852213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92716105|NCT02852213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92716106|NCT02793466|Durvalumab|durvalumab|mesh-list
92716107|NCT02793466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92716111|NCT02793466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716113|NCT02774005|Antioxidants|antioxidants|mesh-ancestor
92716114|NCT02774005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716115|NCT02774005|Protective Agents|protective agents|mesh-ancestor
92716116|NCT02774005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716117|NCT02700828|Hydrocortisone|hydrocortisone|mesh-list
92716118|NCT02700828|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92716119|NCT02700828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716120|NCT02695771|Gemcitabine|gemcitabine|mesh-list
92716121|NCT02695771|Mitomycins|mitomycins|mesh-list
92716122|NCT02695771|Mitomycin|mitomycin|mesh-list
92716123|NCT02695771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92608583|NCT00136448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608584|NCT00136448|Immunologic Factors|immunologic factors|mesh-ancestor
92608585|NCT00136448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716124|NCT02695771|Antimetabolites|antimetabolites|mesh-ancestor
92716125|NCT02695771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716126|NCT02695771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716127|NCT02695771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92716128|NCT02695771|Alkylating Agents|alkylating agents|mesh-ancestor
92716129|NCT02695771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92716130|NCT02695771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716131|NCT02293954|Antibodies|antibodies|mesh-list
92716132|NCT02293954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92716133|NCT02293954|Immunologic Factors|immunologic factors|mesh-ancestor
92716134|NCT02293954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716135|NCT02259621|Paclitaxel|paclitaxel|mesh-list
92716136|NCT02259621|Carboplatin|carboplatin|mesh-list
92716137|NCT02259621|Nivolumab|nivolumab|mesh-list
92716138|NCT02259621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92716139|NCT02259621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716140|NCT02259621|Tubulin Modulators|tubulin modulators|mesh-ancestor
92716141|NCT02259621|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716142|NCT02259621|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716143|NCT02259621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716144|NCT02259621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716145|NCT02259621|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92716146|NCT02190305|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92716147|NCT02190305|Immunologic Factors|immunologic factors|mesh-ancestor
92716148|NCT02190305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716149|NCT01941641|Capecitabine|capecitabine|mesh-list
92716150|NCT01941641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716151|NCT01941641|Antimetabolites|antimetabolites|mesh-ancestor
92716152|NCT01941641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716153|NCT01941641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716154|NCT01804634|Cyclophosphamide|cyclophosphamide|mesh-list
92716155|NCT01804634|Melphalan|melphalan|mesh-list
92716156|NCT01804634|Fludarabine|fludarabine|mesh-list
92716157|NCT01804634|Tacrolimus|tacrolimus|mesh-list
92716158|NCT01804634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716159|NCT01804634|Immunologic Factors|immunologic factors|mesh-ancestor
92716160|NCT01804634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716161|NCT01804634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716162|NCT01804634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92716163|NCT01804634|Alkylating Agents|alkylating agents|mesh-ancestor
92716164|NCT01804634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716165|NCT01804634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716166|NCT01804634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92716167|NCT01804634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92716168|NCT01804634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716169|NCT01792934|Bevacizumab|bevacizumab|mesh-list
92716170|NCT01792934|Irinotecan|irinotecan|mesh-list
92716171|NCT01792934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716172|NCT01792934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716173|NCT01792934|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716174|NCT01792934|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716175|NCT01792934|Growth Substances|growth substances|mesh-ancestor
92716176|NCT01792934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716177|NCT01792934|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716178|NCT01792934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92716179|NCT01792934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716192|NCT01653223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92716193|NCT01653223|Antimetabolites|antimetabolites|mesh-ancestor
92716194|NCT01653223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716195|NCT01653223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92716196|NCT01653223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92716197|NCT01653223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716199|NCT01549587|Cetylpyridinium|cetylpyridinium|mesh-list
92716200|NCT01549587|Fluorides|fluorides|mesh-list
92716201|NCT01549587|Sodium Fluoride|sodium fluoride|mesh-list
92716202|NCT01549587|Tin Fluorides|tin fluorides|mesh-list
92716203|NCT01549587|Cariostatic Agents|cariostatic agents|mesh-ancestor
92716204|NCT01549587|Protective Agents|protective agents|mesh-ancestor
92716205|NCT01549587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608586|NCT00136448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608587|NCT00136448|Analgesics|analgesics|mesh-ancestor
92608588|NCT00136448|Sensory System Agents|sensory system agents|mesh-ancestor
92608589|NCT00136448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608590|NCT00136448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92608591|NCT00136448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92608592|NCT00136448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608593|NCT00136448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608594|NCT00153153|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92608595|NCT00153153|Laxatives|laxatives|mesh-ancestor
92608596|NCT00153153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92608597|NCT00136487|Celecoxib|celecoxib|mesh-list
92608598|NCT00136487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608599|NCT00136487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608600|NCT00136487|Analgesics|analgesics|mesh-ancestor
92608601|NCT00136487|Sensory System Agents|sensory system agents|mesh-ancestor
92608602|NCT00136487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608603|NCT00136487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608604|NCT00136487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608605|NCT00136487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608606|NCT00136487|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92608607|NCT00136487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608608|NCT00136487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608609|NCT00136487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608610|NCT00153192|Dronabinol|dronabinol|mesh-list
92608611|NCT00153192|Hallucinogens|hallucinogens|mesh-ancestor
92716206|NCT01549587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92716207|NCT01549587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716208|NCT01356290|Cytarabine|cytarabine|mesh-list
92716209|NCT01356290|Thalidomide|thalidomide|mesh-list
92716210|NCT01356290|Celecoxib|celecoxib|mesh-list
92716211|NCT01356290|Cyclophosphamide|cyclophosphamide|mesh-list
92716212|NCT01356290|Bevacizumab|bevacizumab|mesh-list
92716213|NCT01356290|Etoposide|etoposide|mesh-list
92716214|NCT01356290|Etoposide phosphate|etoposide phosphate|mesh-list
92716215|NCT01356290|Fenofibric acid|fenofibric acid|mesh-list
92716216|NCT01356290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716217|NCT01356290|Immunologic Factors|immunologic factors|mesh-ancestor
92716218|NCT01356290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716219|NCT01356290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716220|NCT01356290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92716221|NCT01356290|Alkylating Agents|alkylating agents|mesh-ancestor
92716222|NCT01356290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716223|NCT01356290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716224|NCT01356290|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92716225|NCT01356290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716226|NCT01356290|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716227|NCT01356290|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716228|NCT01356290|Growth Substances|growth substances|mesh-ancestor
92716229|NCT01356290|Growth Inhibitors|growth inhibitors|mesh-ancestor
92608612|NCT00153192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608613|NCT00153192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92716230|NCT01356290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92716231|NCT01356290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92716232|NCT01356290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716233|NCT01356290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716234|NCT01356290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716235|NCT01356290|Antimetabolites|antimetabolites|mesh-ancestor
92716236|NCT01356290|Antiviral Agents|antiviral agents|mesh-ancestor
92716237|NCT01356290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716238|NCT01356290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92716239|NCT01356290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92716240|NCT01356290|Analgesics|analgesics|mesh-ancestor
92716241|NCT01356290|Sensory System Agents|sensory system agents|mesh-ancestor
92716242|NCT01356290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716243|NCT01356290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716247|NCT01356290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92716248|NCT01356290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92716249|NCT01356290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92716250|NCT01356290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92716251|NCT01047540|Pritelivir|pritelivir|mesh-list
92716252|NCT01047540|Antiviral Agents|antiviral agents|mesh-ancestor
92716253|NCT01047540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716254|NCT01047540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716255|NCT01047540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716256|NCT00521222|Fluticasone|fluticasone|mesh-list
92716258|NCT00521222|Albuterol|albuterol|mesh-list
92716259|NCT00521222|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92716260|NCT00521222|Ipratropium|ipratropium|mesh-list
92716261|NCT00521222|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92716262|NCT00521222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716263|NCT00521222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92716264|NCT00521222|Autonomic Agents|autonomic agents|mesh-ancestor
92716265|NCT00521222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716266|NCT00521222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716267|NCT00521222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92716268|NCT00521222|Respiratory System Agents|respiratory system agents|mesh-ancestor
92716269|NCT00521222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92716270|NCT00521222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92716271|NCT00521222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92716272|NCT00521222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92716273|NCT00521222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92716274|NCT00521222|Adrenergic Agents|adrenergic agents|mesh-ancestor
92716275|NCT00521222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716276|NCT00521222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716277|NCT00521222|Tocolytic Agents|tocolytic agents|mesh-ancestor
92716278|NCT00521222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92716279|NCT00521222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92716280|NCT00521222|Cholinergic Agents|cholinergic agents|mesh-ancestor
92716281|NCT00521222|Glucocorticoids|glucocorticoids|mesh-ancestor
92716282|NCT00521222|Hormones|hormones|mesh-ancestor
92716283|NCT00521222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716284|NCT00521222|Sympathomimetics|sympathomimetics|mesh-ancestor
92716285|NCT00545012|Levetiracetam|levetiracetam|mesh-list
92716286|NCT00545012|Anticonvulsants|anticonvulsants|mesh-ancestor
92716287|NCT00545012|Nootropic Agents|nootropic agents|mesh-ancestor
92716288|NCT00545090|Ibandronic Acid|ibandronic acid|mesh-list
92716289|NCT00545090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716290|NCT00545090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716291|NCT00545207|Ibandronic Acid|ibandronic acid|mesh-list
92716292|NCT00545207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716293|NCT00545207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716294|NCT00545246|Docetaxel|docetaxel|mesh-list
92716295|NCT00545246|Aflibercept|aflibercept|mesh-list
92716296|NCT00545246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716297|NCT00545246|Tubulin Modulators|tubulin modulators|mesh-ancestor
92716298|NCT00545246|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716299|NCT00545246|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716300|NCT00545246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716301|NCT00545246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716302|NCT00545246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716303|NCT00545246|Growth Substances|growth substances|mesh-ancestor
92136084|NCT04767295|Paclitaxel|paclitaxel|mesh-list
92608614|NCT00153192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608615|NCT00153192|Analgesics|analgesics|mesh-ancestor
92608616|NCT00153192|Sensory System Agents|sensory system agents|mesh-ancestor
92608617|NCT00153192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608618|NCT00153192|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92015839|NCT04426955|Tubulin Modulators|tubulin modulators|mesh-ancestor
92716304|NCT00545246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716305|NCT00545246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716307|NCT03456401|Sunitinib|sunitinib|mesh-list
92716308|NCT03456401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716309|NCT03456401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92716310|NCT03456401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716311|NCT03456401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716312|NCT03456401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716313|NCT03456401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716314|NCT03456401|Growth Substances|growth substances|mesh-ancestor
92716315|NCT03456401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716316|NCT03456401|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716317|NCT00545480|Ibandronic Acid|ibandronic acid|mesh-list
92716319|NCT00545480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716320|NCT04646694|Ketamine|ketamine|mesh-list
92716321|NCT04646694|Analgesics|analgesics|mesh-ancestor
92716322|NCT04646694|Sensory System Agents|sensory system agents|mesh-ancestor
92716323|NCT04646694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716324|NCT04646694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716325|NCT04646694|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92716326|NCT04646694|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92716327|NCT04646694|Anesthetics, General|anesthetics, general|mesh-ancestor
92716328|NCT04646694|Anesthetics|anesthetics|mesh-ancestor
92716329|NCT04646694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716330|NCT04646694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92716331|NCT04646694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92716332|NCT04646694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716333|NCT04646694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716334|NCT00545519|Thymoglobulin|thymoglobulin|mesh-list
92716335|NCT00545519|Immunologic Factors|immunologic factors|mesh-ancestor
92716336|NCT00545519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716337|NCT00545519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716338|NCT00545558|Tenofovir|tenofovir|mesh-list
92716339|NCT00545558|Emtricitabine|emtricitabine|mesh-list
92716340|NCT00545558|Efavirenz|efavirenz|mesh-list
92716341|NCT00545558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92716342|NCT00545558|Antiviral Agents|antiviral agents|mesh-ancestor
92716343|NCT00545558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716344|NCT00545558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92716345|NCT00545558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92716346|NCT00545558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716347|NCT00545558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716348|NCT00545558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92716349|NCT00545558|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92716350|NCT00545558|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92716351|NCT00545558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92716352|NCT00545558|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92716353|NCT00545558|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92716354|NCT00545558|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92716355|NCT00545558|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92716356|NCT04684667|Propranolol|propranolol|mesh-list
92716357|NCT04684667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92716358|NCT04684667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92716359|NCT04684667|Adrenergic Agents|adrenergic agents|mesh-ancestor
92716360|NCT04684667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716361|NCT04684667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716362|NCT04684667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716363|NCT04684667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92716364|NCT04684667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92716365|NCT04684667|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716366|NCT00545675|Valproic Acid|valproic acid|mesh-list
92608619|NCT00153192|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92608620|NCT00153192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608621|NCT00153192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608622|NCT00153192|Hormones|hormones|mesh-ancestor
92716367|NCT00545675|Aripiprazole|aripiprazole|mesh-list
92716368|NCT00545675|Antidepressive Agents|antidepressive agents|mesh-ancestor
92716369|NCT00545675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92716370|NCT00545675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92716371|NCT00545675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92716372|NCT00545675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716373|NCT00545675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716374|NCT00545675|Dopamine Agonists|dopamine agonists|mesh-ancestor
92716375|NCT00545675|Dopamine Agents|dopamine agents|mesh-ancestor
92716376|NCT00545675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716377|NCT00545675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716378|NCT00545675|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92716379|NCT00545675|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92716380|NCT00545675|Serotonin Agents|serotonin agents|mesh-ancestor
92716381|NCT00545675|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92716382|NCT00545675|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92716383|NCT00545675|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92716384|NCT00545675|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92716385|NCT00545675|Anticonvulsants|anticonvulsants|mesh-ancestor
92716386|NCT00545675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716387|NCT00545675|GABA Agents|gaba agents|mesh-ancestor
92716388|NCT00545675|Antimanic Agents|antimanic agents|mesh-ancestor
92716389|NCT00545831|Taurolidine|taurolidine|mesh-list
92716390|NCT00545831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716391|NCT00545831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92716392|NCT00545831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716394|NCT00545870|Ranibizumab|ranibizumab|mesh-list
92716395|NCT00545870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716396|NCT00545870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716397|NCT00545870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716398|NCT00545870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716399|NCT00545870|Growth Substances|growth substances|mesh-ancestor
92716400|NCT00545870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716401|NCT00545870|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716402|NCT00545909|Ibandronic Acid|ibandronic acid|mesh-list
92716403|NCT00545909|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716404|NCT00545909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716406|NCT04645914|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92716407|NCT04645914|Autonomic Agents|autonomic agents|mesh-ancestor
92716408|NCT04645914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716409|NCT04645914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716410|NCT04645914|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92716411|NCT04645914|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92716412|NCT04645914|Cholinergic Agents|cholinergic agents|mesh-ancestor
92716413|NCT04645914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716414|NCT04645914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716415|NCT00546065|Esomeprazole|esomeprazole|mesh-list
92716416|NCT00546065|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92716417|NCT00546065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92716418|NCT00546065|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92716419|NCT00546065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716420|NCT00546065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716421|NCT00546143|Omalizumab|omalizumab|mesh-list
92716422|NCT00546143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92716423|NCT00546143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92716424|NCT00546143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92716425|NCT00546143|Respiratory System Agents|respiratory system agents|mesh-ancestor
92716426|NCT00546143|Immunologic Factors|immunologic factors|mesh-ancestor
92716427|NCT00546143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716428|NCT00560079|Allopurinol|allopurinol|mesh-list
92716429|NCT00560079|Dipyridamole|dipyridamole|mesh-list
92716430|NCT00560079|Antimetabolites|antimetabolites|mesh-ancestor
92716431|NCT00560079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716432|NCT00560079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716433|NCT00560079|Gout Suppressants|gout suppressants|mesh-ancestor
92716434|NCT00560079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716435|NCT00560079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92608623|NCT00153192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608624|NCT00136526|Docetaxel|docetaxel|mesh-list
92608625|NCT00136526|Fosfestrol|fosfestrol|mesh-list
92608626|NCT00136526|Diethylstilbestrol|diethylstilbestrol|mesh-list
92608627|NCT00136526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608628|NCT00136526|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608629|NCT00136526|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716436|NCT00560079|Antioxidants|antioxidants|mesh-ancestor
92716437|NCT00560079|Protective Agents|protective agents|mesh-ancestor
92716438|NCT00560079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716439|NCT00560079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92716440|NCT00560079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92716441|NCT00560079|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716442|NCT00560118|Fotemustine|fotemustine|mesh-list
92716443|NCT00560118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716444|NCT00546494|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92716445|NCT00546494|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92716446|NCT00546494|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92716447|NCT00546494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92716448|NCT00546494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716449|NCT00546494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716450|NCT00546494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716451|NCT00546494|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92716452|NCT00546494|Antidepressive Agents|antidepressive agents|mesh-ancestor
92716453|NCT00546494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92716455|NCT00546533|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92716456|NCT00546533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92716457|NCT00546533|Analgesics|analgesics|mesh-ancestor
92716458|NCT00546533|Sensory System Agents|sensory system agents|mesh-ancestor
92716459|NCT00546533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716460|NCT00546533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716461|NCT00546533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716462|NCT00546533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716463|NCT00546533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92716464|NCT00546533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716487|NCT00546923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92716488|NCT00546923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716490|NCT00546923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716491|NCT00546923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92716492|NCT00546923|Antidepressive Agents|antidepressive agents|mesh-ancestor
92716493|NCT00546923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92716494|NCT00547001|Estradiol|estradiol|mesh-list
92716495|NCT00547001|Estrogens|estrogens|mesh-ancestor
92716496|NCT00547001|Hormones|hormones|mesh-ancestor
92716497|NCT00547001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716498|NCT00547001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716499|NCT00547352|Sildenafil Citrate|sildenafil citrate|mesh-list
92716500|NCT00547352|Tadalafil|tadalafil|mesh-list
92716501|NCT00547352|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716502|NCT00547352|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92716503|NCT00547352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92716504|NCT00547352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716505|NCT00547352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716506|NCT00547352|Urological Agents|urological agents|mesh-ancestor
92716507|NCT00547508|Tadalafil|tadalafil|mesh-list
92716508|NCT00547508|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716509|NCT00547508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92716510|NCT00547508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92716511|NCT00547508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716512|NCT00547508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716513|NCT00547508|Urological Agents|urological agents|mesh-ancestor
92716514|NCT00560274|Ribavirin|ribavirin|mesh-list
92716531|NCT00547547|Protective Agents|protective agents|mesh-ancestor
92716532|NCT00547547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716533|NCT00547547|Trace Elements|trace elements|mesh-ancestor
92716534|NCT00547547|Micronutrients|micronutrients|mesh-ancestor
92608630|NCT00136526|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682802|NCT00438113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92716536|NCT00547625|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716537|NCT00547625|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92716538|NCT00547625|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92716539|NCT00547625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716540|NCT00547625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716541|NCT00547625|Urological Agents|urological agents|mesh-ancestor
92716542|NCT00547664|Morphine|morphine|mesh-list
92716543|NCT00547664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92716544|NCT00547664|Narcotics|narcotics|mesh-ancestor
92716545|NCT00547664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716546|NCT00547664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716547|NCT00547664|Analgesics|analgesics|mesh-ancestor
92716548|NCT00547664|Sensory System Agents|sensory system agents|mesh-ancestor
92716549|NCT00547664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716550|NCT00560430|Telmisartan|telmisartan|mesh-list
92716551|NCT00560430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92716552|NCT00560430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92716553|NCT00560430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92716554|NCT00560430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716555|NCT00560547|Epoetin Alfa|epoetin alfa|mesh-list
92374634|NCT01834404|Topiramate|topiramate|mesh-list
92716556|NCT00560547|Hematinics|hematinics|mesh-ancestor
92716557|NCT04636125|Doxycycline|doxycycline|mesh-list
92716558|NCT04636125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92716559|NCT04636125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716560|NCT04636125|Antimalarials|antimalarials|mesh-ancestor
92716561|NCT04636125|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92716562|NCT04636125|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92716563|NCT04684628|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92716564|NCT04684628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92716565|NCT04684628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716566|NCT04636242|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92716567|NCT04636242|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92716568|NCT04636242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92716569|NCT00548288|Pamidronate|pamidronate|mesh-list
92716570|NCT00548288|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716571|NCT00548288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716572|NCT04644354|Nifedipine|nifedipine|mesh-list
92716573|NCT04644354|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92716574|NCT04644354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92716577|NCT04644354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716578|NCT04644354|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716579|NCT04644354|Tocolytic Agents|tocolytic agents|mesh-ancestor
92716580|NCT04644354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92716581|NCT00548483|Dexamethasone|dexamethasone|mesh-list
92716582|NCT00548483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716583|NCT00548483|Antiemetics|antiemetics|mesh-ancestor
92716584|NCT00548483|Autonomic Agents|autonomic agents|mesh-ancestor
92716585|NCT00548483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716586|NCT00548483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716587|NCT00548483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92716588|NCT00548483|Glucocorticoids|glucocorticoids|mesh-ancestor
92716589|NCT00548483|Hormones|hormones|mesh-ancestor
92716590|NCT00548483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716591|NCT00548483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92716592|NCT00548483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716593|NCT04635852|Fentanyl|fentanyl|mesh-list
92716594|NCT04635852|Morphine|morphine|mesh-list
92716595|NCT04635852|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92716596|NCT04635852|Narcotics|narcotics|mesh-ancestor
92716597|NCT04635852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716598|NCT04635852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716599|NCT04635852|Analgesics|analgesics|mesh-ancestor
92136375|NCT03912909|Empagliflozin|empagliflozin|mesh-list
92716600|NCT04635852|Sensory System Agents|sensory system agents|mesh-ancestor
92716601|NCT04635852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716602|NCT04635852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92716603|NCT04635852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92716604|NCT04635852|Anesthetics, General|anesthetics, general|mesh-ancestor
92716605|NCT04635852|Anesthetics|anesthetics|mesh-ancestor
92716606|NCT00548561|Dexrazoxane|dexrazoxane|mesh-list
92716607|NCT00548561|Razoxane|razoxane|mesh-list
92716608|NCT00548561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716609|NCT00548561|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92608631|NCT00136526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608632|NCT00136526|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92716610|NCT00548561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92716611|NCT00548561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716612|NCT00548561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716613|NCT00548561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716614|NCT00548561|Protective Agents|protective agents|mesh-ancestor
92716615|NCT00548561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716616|NCT00548561|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716617|NCT00548561|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716618|NCT04635696|Ethyl Chloride|ethyl chloride|mesh-list
92716619|NCT04635696|Anesthetics, Local|anesthetics, local|mesh-ancestor
92716620|NCT04635696|Anesthetics|anesthetics|mesh-ancestor
92716621|NCT04635696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716622|NCT04635696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716623|NCT04635696|Sensory System Agents|sensory system agents|mesh-ancestor
92716624|NCT04635696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716625|NCT00548678|Aspirin|aspirin|mesh-list
92716626|NCT00548678|Diclofenac|diclofenac|mesh-list
92716627|NCT00548678|Ketorolac|ketorolac|mesh-list
92716628|NCT00548678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92716629|NCT00548678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92716630|NCT00548678|Analgesics|analgesics|mesh-ancestor
92716631|NCT00548678|Sensory System Agents|sensory system agents|mesh-ancestor
92716632|NCT00548678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716633|NCT00548678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716634|NCT00548678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716635|NCT00548678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716636|NCT00548678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92716637|NCT00548678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92716638|NCT00548678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716639|NCT00548678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92716640|NCT00548678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92716641|NCT00548678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716642|NCT00548678|Antipyretics|antipyretics|mesh-ancestor
92716643|NCT00548834|Certolizumab Pegol|certolizumab pegol|mesh-list
92716644|NCT00548834|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92716645|NCT00548834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716646|NCT00548834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716663|NCT00560586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92716664|NCT00560586|Glucocorticoids|glucocorticoids|mesh-ancestor
92716665|NCT00560586|Hormones|hormones|mesh-ancestor
92716666|NCT00560586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716667|NCT00549068|Risedronic Acid|risedronic acid|mesh-list
92716668|NCT00549068|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92716669|NCT00549068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92716670|NCT00549068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716671|NCT00549068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92716672|NCT00549068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716673|NCT00549068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716674|NCT00549107|Simendan|simendan|mesh-list
92716675|NCT00549107|Milrinone|milrinone|mesh-list
92716676|NCT00549107|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92716677|NCT00549107|Vasodilator Agents|vasodilator agents|mesh-ancestor
92716678|NCT00549107|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92716679|NCT00549107|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92716680|NCT00549107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716681|NCT00549107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716682|NCT00549107|Protective Agents|protective agents|mesh-ancestor
92716683|NCT00549107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716684|NCT00549107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92716685|NCT00549146|Fluticasone|fluticasone|mesh-list
92716686|NCT00549146|Xhance|xhance|mesh-list
92716687|NCT00549146|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92716688|NCT00549146|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92716689|NCT00549146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716690|NCT00549146|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92716691|NCT00549146|Autonomic Agents|autonomic agents|mesh-ancestor
92716692|NCT00549146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716693|NCT00549146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716694|NCT00549146|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92608633|NCT00136526|Estrogens|estrogens|mesh-ancestor
92608634|NCT00136526|Hormones|hormones|mesh-ancestor
92682803|NCT00438113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92716695|NCT00549146|Respiratory System Agents|respiratory system agents|mesh-ancestor
92716696|NCT00549146|Dermatologic Agents|dermatologic agents|mesh-ancestor
92716697|NCT00549146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92716698|NCT00549146|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92716699|NCT00549146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92716700|NCT00549146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92716701|NCT00549146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92716702|NCT00549146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716703|NCT00549146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716711|NCT00549341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716712|NCT00549341|Cholinergic Agents|cholinergic agents|mesh-ancestor
92716713|NCT00549341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716714|NCT00549341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716715|NCT00549419|Dobutamine|dobutamine|mesh-list
92716716|NCT00549419|Norepinephrine|norepinephrine|mesh-list
92716717|NCT00549419|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92716718|NCT00549419|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92716719|NCT00549419|Adrenergic Agents|adrenergic agents|mesh-ancestor
92716720|NCT00549419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716721|NCT00549419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716722|NCT00549419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716723|NCT00549419|Sympathomimetics|sympathomimetics|mesh-ancestor
92716724|NCT00549419|Autonomic Agents|autonomic agents|mesh-ancestor
92716725|NCT00549419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716726|NCT00549419|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92716727|NCT00549419|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92716728|NCT00549419|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92716729|NCT00549419|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92716730|NCT00549419|Protective Agents|protective agents|mesh-ancestor
92716731|NCT04643691|Losartan|losartan|mesh-list
92716732|NCT04643691|Spironolactone|spironolactone|mesh-list
92716733|NCT04643691|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92716734|NCT04643691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92716735|NCT04643691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92716736|NCT04643691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92716737|NCT04643691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716738|NCT04643691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92716739|NCT04643691|Hormone Antagonists|hormone antagonists|mesh-ancestor
92716740|NCT04643691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716741|NCT04643691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716742|NCT04643691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92716743|NCT04643691|Diuretics|diuretics|mesh-ancestor
92716744|NCT04643691|Natriuretic Agents|natriuretic agents|mesh-ancestor
92716745|NCT03455972|Immunomodulating Agents|immunomodulating agents|mesh-list
92716746|NCT03455972|Immunologic Factors|immunologic factors|mesh-ancestor
92136552|NCT01572038|Paclitaxel|paclitaxel|mesh-list
92716747|NCT03455972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716748|NCT00549536|Calcium, Dietary|calcium, dietary|mesh-list
92716749|NCT00549536|Calcium|calcium|mesh-list
92716750|NCT00549536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92716751|NCT00549536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716752|NCT00549536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716753|NCT00549614|Acipimox|acipimox|mesh-list
92716754|NCT00549614|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92716755|NCT00549614|Antimetabolites|antimetabolites|mesh-ancestor
92716756|NCT00549614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716757|NCT00549614|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92716758|NCT04923542|Hormones|hormones|mesh-list
92716759|NCT04923542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716760|NCT04923542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716761|NCT00559026|Dacarbazine|dacarbazine|mesh-list
92716762|NCT00559026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92716763|NCT00559026|Alkylating Agents|alkylating agents|mesh-ancestor
92716764|NCT00559026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716765|NCT00559026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716766|NCT00549887|Insulin|insulin|mesh-list
92716767|NCT00549887|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92716768|NCT00549887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608635|NCT00136526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608636|NCT00136526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608637|NCT00136526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92716771|NCT00549926|Pravastatin|pravastatin|mesh-list
92716772|NCT00549926|Pitavastatin|pitavastatin|mesh-list
92716773|NCT00549926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92716774|NCT00549926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92716775|NCT00549926|Antimetabolites|antimetabolites|mesh-ancestor
92716776|NCT00549926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716777|NCT00549926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92716778|NCT00549926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92716779|NCT00549926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716780|NCT00549965|Risedronic Acid|risedronic acid|mesh-list
92716781|NCT00549965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92716782|NCT00549965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374642|NCT01834404|Sympathomimetics|sympathomimetics|mesh-ancestor
92716783|NCT00549965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716784|NCT00549965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92716785|NCT00549965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716786|NCT00549965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716787|NCT00550004|Gemcitabine|gemcitabine|mesh-list
92716788|NCT00550004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716789|NCT00550004|Antimetabolites|antimetabolites|mesh-ancestor
92716790|NCT00550004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716791|NCT00550004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716792|NCT04634721|Bupivacaine|bupivacaine|mesh-list
92716793|NCT04634721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92716794|NCT04634721|Anesthetics|anesthetics|mesh-ancestor
92716795|NCT04634721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716796|NCT04634721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716797|NCT04634721|Sensory System Agents|sensory system agents|mesh-ancestor
92716798|NCT04634721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716799|NCT00550160|Artesunate|artesunate|mesh-list
92716800|NCT00550160|Amodiaquine|amodiaquine|mesh-list
92716801|NCT00550160|Antimalarials|antimalarials|mesh-ancestor
92716802|NCT00550160|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92716803|NCT00550160|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92716804|NCT00550160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716805|NCT00550160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716806|NCT00550160|Antiviral Agents|antiviral agents|mesh-ancestor
92716807|NCT00550160|Schistosomicides|schistosomicides|mesh-ancestor
92716808|NCT00550160|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92716809|NCT00550160|Anthelmintics|anthelmintics|mesh-ancestor
92716810|NCT00550199|Gemcitabine|gemcitabine|mesh-list
92716811|NCT00550199|Panobinostat|panobinostat|mesh-list
92716812|NCT00550199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716813|NCT00550199|Antimetabolites|antimetabolites|mesh-ancestor
92716814|NCT00550199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716815|NCT00550199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716816|NCT00550199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92716817|NCT00550199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716818|NCT04643301|Liraglutide|liraglutide|mesh-list
92716819|NCT04643301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92716820|NCT04643301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716821|NCT04643301|Incretins|incretins|mesh-ancestor
92716822|NCT04643301|Hormones|hormones|mesh-ancestor
92716823|NCT04643301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716824|NCT00550433|Bazedoxifene|bazedoxifene|mesh-list
92716825|NCT00550433|Estrogens|estrogens|mesh-list
92716826|NCT00550433|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92716827|NCT00550433|Hormones|hormones|mesh-ancestor
92716828|NCT00550433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716829|NCT00550433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716830|NCT00550433|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92716831|NCT00550433|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92716832|NCT00550433|Hormone Antagonists|hormone antagonists|mesh-ancestor
92716833|NCT00550433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716834|NCT04642989|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92716835|NCT04642989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716836|NCT04634058|Antibodies|antibodies|mesh-list
92716837|NCT04634058|Immunoglobulins|immunoglobulins|mesh-list
92608639|NCT00136565|Cyclophosphamide|cyclophosphamide|mesh-list
92608640|NCT00136565|Doxorubicin|doxorubicin|mesh-list
92608641|NCT00136565|Bortezomib|bortezomib|mesh-list
92608642|NCT00136565|Bleomycin|bleomycin|mesh-list
92608643|NCT00136565|Vindesine|vindesine|mesh-list
92716838|NCT04634058|Immunologic Factors|immunologic factors|mesh-ancestor
92716839|NCT04634058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716840|NCT00550628|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92716841|NCT00550628|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92716842|NCT00550628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716844|NCT00560820|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92716845|NCT00560820|Chelating Agents|chelating agents|mesh-ancestor
92716846|NCT00560820|Sequestering Agents|sequestering agents|mesh-ancestor
92716847|NCT00560820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716848|NCT00550784|Paclitaxel|paclitaxel|mesh-list
92716849|NCT00550784|Cyclophosphamide|cyclophosphamide|mesh-list
92716850|NCT00550784|Melphalan|melphalan|mesh-list
92716851|NCT00550784|Topotecan|topotecan|mesh-list
92716852|NCT00550784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92716853|NCT00550784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716854|NCT00550784|Tubulin Modulators|tubulin modulators|mesh-ancestor
92716855|NCT00550784|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716856|NCT00550784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716857|NCT00550784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716858|NCT00550784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716859|NCT00550784|Immunologic Factors|immunologic factors|mesh-ancestor
92716860|NCT00550784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716861|NCT00550784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716862|NCT00550784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92716863|NCT00550784|Alkylating Agents|alkylating agents|mesh-ancestor
92716864|NCT00550784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92716865|NCT00550784|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92716866|NCT00550784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716867|NCT00550784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716868|NCT00550901|Dexrazoxane|dexrazoxane|mesh-list
92716869|NCT00550901|Razoxane|razoxane|mesh-list
92716870|NCT00550901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716871|NCT00550901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92716872|NCT00550901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92716873|NCT00550901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716874|NCT00550901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716875|NCT00550901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716876|NCT00550901|Protective Agents|protective agents|mesh-ancestor
92716877|NCT00550901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716878|NCT00550901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92716879|NCT00550901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92716880|NCT04633746|Endostatins|endostatins|mesh-list
92716881|NCT04633746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716882|NCT04633746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716883|NCT04633746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716884|NCT04633746|Growth Substances|growth substances|mesh-ancestor
92716885|NCT04633746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716886|NCT04633746|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716887|NCT00551018|Tenofovir|tenofovir|mesh-list
92716888|NCT00551018|Emtricitabine|emtricitabine|mesh-list
92716889|NCT00551018|Antiviral Agents|antiviral agents|mesh-ancestor
92716890|NCT00551018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716891|NCT00551018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92716892|NCT00551018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92716893|NCT00551018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716894|NCT00551018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716895|NCT00551018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92716896|NCT00551018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92716897|NCT00551096|Gemcitabine|gemcitabine|mesh-list
92716898|NCT00551096|Capecitabine|capecitabine|mesh-list
92716899|NCT00551096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716900|NCT00551096|Antimetabolites|antimetabolites|mesh-ancestor
92716901|NCT00551096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716902|NCT00551096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716903|NCT00551252|Gemcitabine|gemcitabine|mesh-list
92716904|NCT00551252|Imatinib Mesylate|imatinib mesylate|mesh-list
92608644|NCT00136565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608645|NCT00136565|Immunologic Factors|immunologic factors|mesh-ancestor
92608646|NCT00136565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608647|NCT00136565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608648|NCT00136565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92608649|NCT00136565|Alkylating Agents|alkylating agents|mesh-ancestor
92608650|NCT00136565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608651|NCT00136565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608652|NCT00136565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92608653|NCT00136565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92608654|NCT00136565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92608655|NCT00136565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608656|NCT00136565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608657|NCT00136565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608658|NCT00136565|Glucocorticoids|glucocorticoids|mesh-ancestor
92608659|NCT00136565|Hormones|hormones|mesh-ancestor
92608660|NCT00136565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716905|NCT00551252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716906|NCT00551252|Antimetabolites|antimetabolites|mesh-ancestor
92716907|NCT00551252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374648|NCT01835262|Ketamine|ketamine|mesh-list
92716908|NCT00551252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716909|NCT00551252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92716910|NCT00551252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716911|NCT01125761|Clemastine|clemastine|mesh-list
92716912|NCT01125761|Dexamethasone|dexamethasone|mesh-list
92716913|NCT01125761|Dexamethasone acetate|dexamethasone acetate|mesh-list
92716914|NCT01125761|BB 1101|bb 1101|mesh-list
92716915|NCT01125761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716916|NCT01125761|Antiemetics|antiemetics|mesh-ancestor
92716917|NCT01125761|Autonomic Agents|autonomic agents|mesh-ancestor
92716921|NCT01125761|Glucocorticoids|glucocorticoids|mesh-ancestor
92716922|NCT01125761|Hormones|hormones|mesh-ancestor
92716923|NCT01125761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716924|NCT01125761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92716925|NCT01125761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716926|NCT01125761|Protease Inhibitors|protease inhibitors|mesh-ancestor
92716927|NCT01125761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716928|NCT01125761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716929|NCT01125761|Antipruritics|antipruritics|mesh-ancestor
92716930|NCT01125761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92716931|NCT01125761|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92716932|NCT01125761|Histamine Antagonists|histamine antagonists|mesh-ancestor
92716933|NCT01125761|Histamine Agents|histamine agents|mesh-ancestor
92716934|NCT01125761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716935|NCT01125761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92716936|NCT00871013|Thalidomide|thalidomide|mesh-list
92716937|NCT00871013|Dexamethasone|dexamethasone|mesh-list
92716938|NCT00871013|Cyclophosphamide|cyclophosphamide|mesh-list
92716939|NCT00871013|Melphalan|melphalan|mesh-list
92716940|NCT00871013|Doxorubicin|doxorubicin|mesh-list
92716941|NCT00871013|Etoposide|etoposide|mesh-list
92716942|NCT00871013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92716943|NCT00871013|Bortezomib|bortezomib|mesh-list
92716944|NCT00871013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92716945|NCT00871013|Immunologic Factors|immunologic factors|mesh-ancestor
92716946|NCT00871013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716947|NCT00871013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716948|NCT00871013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92716949|NCT00871013|Alkylating Agents|alkylating agents|mesh-ancestor
92608661|NCT00136565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608662|NCT00136565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92608663|NCT00136565|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608664|NCT00136565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92608665|NCT00136565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608666|NCT00159627|Rolofylline|rolofylline|mesh-list
92608667|NCT00159627|Diuretics|diuretics|mesh-ancestor
92716950|NCT00871013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716951|NCT00871013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716952|NCT00871013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92716953|NCT00871013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716954|NCT00871013|Antiemetics|antiemetics|mesh-ancestor
92716955|NCT00871013|Autonomic Agents|autonomic agents|mesh-ancestor
92716956|NCT00871013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716957|NCT00871013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92716958|NCT00871013|Glucocorticoids|glucocorticoids|mesh-ancestor
92716959|NCT00871013|Hormones|hormones|mesh-ancestor
92716960|NCT00871013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716961|NCT00871013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92716962|NCT00871013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92716963|NCT00871013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92716964|NCT00871013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716965|NCT00871013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716966|NCT00871013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92716967|NCT00871013|Leprostatic Agents|leprostatic agents|mesh-ancestor
92716968|NCT00871013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92716969|NCT00871013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716970|NCT00871013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92716971|NCT00871013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92716972|NCT00871013|Growth Substances|growth substances|mesh-ancestor
92716973|NCT00871013|Growth Inhibitors|growth inhibitors|mesh-ancestor
92716974|NCT04641780|Brexpiprazole|brexpiprazole|mesh-list
92716975|NCT04641780|Serotonin Agents|serotonin agents|mesh-ancestor
92716976|NCT04641780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716977|NCT04641780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716978|NCT04641780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716979|NCT04641780|Dopamine Agonists|dopamine agonists|mesh-ancestor
92716980|NCT04641780|Dopamine Agents|dopamine agents|mesh-ancestor
92716981|NCT05408312|Vaccines|vaccines|mesh-list
92716982|NCT05408312|Immunologic Factors|immunologic factors|mesh-ancestor
92716983|NCT05408312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716984|NCT00559338|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92716985|NCT00559338|Natriuretic Agents|natriuretic agents|mesh-ancestor
92716986|NCT00559338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716987|NCT05340374|177Lu-PSMA-617|177lu-psma-617|mesh-list
92716988|NCT05340374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92716989|NCT05340374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716994|NCT00553124|Vitamin E|vitamin e|mesh-list
92716995|NCT00553124|Selenium|selenium|mesh-list
92716996|NCT00553124|Vitamins|vitamins|mesh-ancestor
92716997|NCT00553124|Micronutrients|micronutrients|mesh-ancestor
92716998|NCT00553124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716999|NCT00553124|Antioxidants|antioxidants|mesh-ancestor
92717000|NCT00553124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717001|NCT00553124|Protective Agents|protective agents|mesh-ancestor
92717002|NCT00553124|Trace Elements|trace elements|mesh-ancestor
92717003|NCT04640181|Enoxaparin|enoxaparin|mesh-list
92717004|NCT04640181|Rivaroxaban|rivaroxaban|mesh-list
92717005|NCT04640181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92717006|NCT04640181|Antithrombins|antithrombins|mesh-ancestor
92717007|NCT04640181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92717008|NCT04640181|Protease Inhibitors|protease inhibitors|mesh-ancestor
92717009|NCT04640181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717010|NCT04640181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717011|NCT04640181|Anticoagulants|anticoagulants|mesh-ancestor
92717012|NCT04640181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92717013|NCT04640181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717014|NCT00559455|Leucovorin|leucovorin|mesh-list
92717015|NCT00559455|Fluorouracil|fluorouracil|mesh-list
92717016|NCT00559455|Oxaliplatin|oxaliplatin|mesh-list
92608668|NCT00159627|Natriuretic Agents|natriuretic agents|mesh-ancestor
92608669|NCT00159627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608670|NCT00159666|Pregabalin|pregabalin|mesh-list
92608671|NCT00159666|Analgesics|analgesics|mesh-ancestor
92608672|NCT00159666|Sensory System Agents|sensory system agents|mesh-ancestor
92015891|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
92717017|NCT00559455|Antimetabolites|antimetabolites|mesh-ancestor
92717018|NCT00559455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717019|NCT00559455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92717020|NCT00559455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717021|NCT00559455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717022|NCT00559455|Immunologic Factors|immunologic factors|mesh-ancestor
92717023|NCT00559455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717024|NCT00559455|Antidotes|antidotes|mesh-ancestor
92717025|NCT00559455|Protective Agents|protective agents|mesh-ancestor
92717026|NCT00559455|Vitamin B Complex|vitamin b complex|mesh-ancestor
92717027|NCT00559455|Vitamins|vitamins|mesh-ancestor
92717028|NCT00559455|Micronutrients|micronutrients|mesh-ancestor
92717029|NCT00559494|Minocycline|minocycline|mesh-list
92717030|NCT00559494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92717031|NCT00559494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717032|NCT05209412|Aspirin|aspirin|mesh-list
92717033|NCT05209412|Paclitaxel|paclitaxel|mesh-list
92717034|NCT05209412|Clopidogrel|clopidogrel|mesh-list
92717035|NCT05209412|Ticagrelor|ticagrelor|mesh-list
92717036|NCT05209412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92717037|NCT05209412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717038|NCT05209412|Tubulin Modulators|tubulin modulators|mesh-ancestor
92717039|NCT05209412|Antimitotic Agents|antimitotic agents|mesh-ancestor
92717040|NCT05209412|Mitosis Modulators|mitosis modulators|mesh-ancestor
92717041|NCT05209412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717042|NCT05209412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717043|NCT05209412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717044|NCT05209412|Analgesics|analgesics|mesh-ancestor
92717045|NCT05209412|Sensory System Agents|sensory system agents|mesh-ancestor
92717046|NCT05209412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717047|NCT05209412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717048|NCT05209412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717049|NCT05209412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717050|NCT05209412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92136835|NCT01443923|Ribavirin|ribavirin|mesh-list
92717051|NCT05209412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717052|NCT05209412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92717053|NCT05209412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717054|NCT05209412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717055|NCT05209412|Antipyretics|antipyretics|mesh-ancestor
92717056|NCT05209412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92717057|NCT05209412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92717058|NCT05209412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92717059|NCT05209412|Purinergic Agents|purinergic agents|mesh-ancestor
92717060|NCT05209412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717061|NCT05186675|Epinephrine|epinephrine|mesh-list
92717062|NCT05186675|Racepinephrine|racepinephrine|mesh-list
92717069|NCT05186675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717071|NCT05186675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92717072|NCT05186675|Autonomic Agents|autonomic agents|mesh-ancestor
92717073|NCT05186675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717074|NCT05186675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92717075|NCT05186675|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717076|NCT05186675|Mydriatics|mydriatics|mesh-ancestor
92717077|NCT05186675|Sympathomimetics|sympathomimetics|mesh-ancestor
92717078|NCT05186675|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92717079|NCT05172791|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92717080|NCT05172791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717081|NCT04639362|Venetoclax|venetoclax|mesh-list
92717082|NCT04639362|Obinutuzumab|obinutuzumab|mesh-list
92717083|NCT04639362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717084|NCT04639362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92717085|NCT04639284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92717086|NCT04639284|Antibodies|antibodies|mesh-list
92717087|NCT04639284|Immunologic Factors|immunologic factors|mesh-ancestor
92717088|NCT04639284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608673|NCT00159666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608674|NCT00159666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608675|NCT00159666|Anticonvulsants|anticonvulsants|mesh-ancestor
92608676|NCT00159666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92717089|NCT04639284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92717090|NCT04639284|Growth Substances|growth substances|mesh-ancestor
92717091|NCT04639284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92717092|NCT04639284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717093|NCT00559689|Budesonide|budesonide|mesh-list
92717094|NCT00559689|Beclomethasone|beclomethasone|mesh-list
92717095|NCT00559689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717096|NCT00559689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92717097|NCT00559689|Autonomic Agents|autonomic agents|mesh-ancestor
92717098|NCT00559689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717099|NCT00559689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717100|NCT00559689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92717101|NCT00559689|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717102|NCT00559689|Glucocorticoids|glucocorticoids|mesh-ancestor
92717103|NCT00559689|Hormones|hormones|mesh-ancestor
92717104|NCT00559689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717105|NCT04629027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92717106|NCT04629027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717107|NCT04629027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92717108|NCT04629027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717109|NCT00561288|Acetaminophen|acetaminophen|mesh-list
92717110|NCT00561288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717111|NCT00561288|Analgesics|analgesics|mesh-ancestor
92717112|NCT00561288|Sensory System Agents|sensory system agents|mesh-ancestor
92717113|NCT00561288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717114|NCT00561288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717115|NCT00561288|Antipyretics|antipyretics|mesh-ancestor
92717116|NCT00561327|Losartan|losartan|mesh-list
92717117|NCT00561327|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92717118|NCT00561327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92717119|NCT00561327|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92717120|NCT00561327|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92717121|NCT00561327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717122|NCT00561522|Capecitabine|capecitabine|mesh-list
92717123|NCT00561522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92717124|NCT00561522|Antimetabolites|antimetabolites|mesh-ancestor
92717125|NCT00561522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136901|NCT00574587|Paclitaxel|paclitaxel|mesh-list
92717126|NCT00561522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717127|NCT03454620|Irinotecan|irinotecan|mesh-list
92717128|NCT03454620|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92717129|NCT03454620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92717141|NCT04628559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717142|NCT04628559|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92717144|NCT04628559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717145|NCT04628559|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717146|NCT04628559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717147|NCT04628559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717148|NCT04628559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92717149|NCT04628559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92717150|NCT04628559|Anesthetics, General|anesthetics, general|mesh-ancestor
92717151|NCT04628559|Anesthetics|anesthetics|mesh-ancestor
92717152|NCT04628559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92717153|NCT04628559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92717154|NCT04683341|Tenofovir|tenofovir|mesh-list
92717155|NCT04683341|Antiviral Agents|antiviral agents|mesh-ancestor
92717156|NCT04683341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717157|NCT04683341|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92717158|NCT04683341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92717159|NCT04683341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717160|NCT04683341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717161|NCT04683341|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92717162|NCT04683341|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92717163|NCT04628676|Epinephrine|epinephrine|mesh-list
92717164|NCT04628676|Tranylcypromine|tranylcypromine|mesh-list
92717165|NCT04628676|Tranexamic Acid|tranexamic acid|mesh-list
92608677|NCT00159666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608678|NCT00159666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608679|NCT00159666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92717166|NCT04628676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92717167|NCT04628676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717168|NCT04628676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717169|NCT04628676|Hemostatics|hemostatics|mesh-ancestor
92717170|NCT04628676|Coagulants|coagulants|mesh-ancestor
92717171|NCT04628676|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717172|NCT04628676|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717173|NCT04628676|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717174|NCT04628676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717175|NCT04628676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717176|NCT04628676|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92717177|NCT04628676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92717178|NCT04628676|Autonomic Agents|autonomic agents|mesh-ancestor
92717179|NCT04628676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717180|NCT04628676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92717181|NCT04628676|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717182|NCT04628676|Mydriatics|mydriatics|mesh-ancestor
92717183|NCT04628676|Sympathomimetics|sympathomimetics|mesh-ancestor
92717184|NCT04628676|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92717185|NCT04628676|Antidepressive Agents|antidepressive agents|mesh-ancestor
92717186|NCT04628676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717187|NCT04628676|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92717188|NCT04628676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717189|NCT04628676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92717190|NCT04628676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92717191|NCT04628676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717192|NCT04628325|Furosemide|furosemide|mesh-list
92717195|NCT04628325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717196|NCT04628325|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92717197|NCT04628325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717198|NCT04628325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717199|NCT04657497|Camostat|camostat|mesh-list
92717200|NCT04657497|Protease Inhibitors|protease inhibitors|mesh-ancestor
92717201|NCT04657497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717202|NCT04657497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717203|NCT04657497|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92717204|NCT04657497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92717206|NCT01214434|Dermatologic Agents|dermatologic agents|mesh-ancestor
92717207|NCT04971356|Aspirin|aspirin|mesh-list
92717208|NCT04971356|Ticagrelor|ticagrelor|mesh-list
92717209|NCT04971356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717210|NCT04971356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717211|NCT04971356|Analgesics|analgesics|mesh-ancestor
92717212|NCT04971356|Sensory System Agents|sensory system agents|mesh-ancestor
92717213|NCT04971356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717214|NCT04971356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717215|NCT04971356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717216|NCT04971356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717217|NCT04971356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92717218|NCT04971356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717219|NCT04971356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717220|NCT04971356|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92717221|NCT04971356|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717222|NCT04971356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717223|NCT04971356|Antipyretics|antipyretics|mesh-ancestor
92717224|NCT04971356|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92717225|NCT04971356|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92717226|NCT04971356|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92717227|NCT04971356|Purinergic Agents|purinergic agents|mesh-ancestor
92717228|NCT04971356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717229|NCT01214395|Tea Tree Oil|tea tree oil|mesh-list
92717230|NCT01214395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92717231|NCT01214395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717232|NCT01214239|Linagliptin|linagliptin|mesh-list
92717233|NCT01214239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608680|NCT00159666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92608681|NCT00159666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608682|NCT00159666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608683|NCT00159666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717234|NCT01214239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717236|NCT01214239|Hormones|hormones|mesh-ancestor
92717237|NCT01214239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717238|NCT01214239|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92717239|NCT01214239|Protease Inhibitors|protease inhibitors|mesh-ancestor
92717240|NCT01214239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717241|NCT01214239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717242|NCT01214044|Dexetimide|dexetimide|mesh-list
92717243|NCT01214044|Citalopram|citalopram|mesh-list
92717244|NCT01214044|Escitalopram|escitalopram|mesh-list
92717245|NCT01214044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92717246|NCT01214044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92717247|NCT01214044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717248|NCT01214044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717249|NCT01214044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717250|NCT01214044|Serotonin Agents|serotonin agents|mesh-ancestor
92717251|NCT01214044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717252|NCT01214044|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92717253|NCT01214044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92717254|NCT01214044|Parasympatholytics|parasympatholytics|mesh-ancestor
92717255|NCT01214044|Autonomic Agents|autonomic agents|mesh-ancestor
92717256|NCT01214044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717257|NCT01214044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92717258|NCT01214044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92717259|NCT01214044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92717260|NCT01214044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92717261|NCT01214044|Antidepressive Agents|antidepressive agents|mesh-ancestor
92717262|NCT01214044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717263|NCT01213966|Artefenomel|artefenomel|mesh-list
92717264|NCT01213966|Antimalarials|antimalarials|mesh-ancestor
92717265|NCT01213966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92717269|NCT01213264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717270|NCT01213264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717272|NCT04657107|Esketamine|esketamine|mesh-list
92717273|NCT04657107|Analgesics|analgesics|mesh-ancestor
92717274|NCT04657107|Sensory System Agents|sensory system agents|mesh-ancestor
92717275|NCT04657107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717276|NCT04657107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717277|NCT04657107|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92717278|NCT04657107|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92717279|NCT04657107|Anesthetics, General|anesthetics, general|mesh-ancestor
92717281|NCT04657107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717282|NCT04657107|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92717283|NCT04657107|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92717284|NCT04657107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374656|NCT01835262|Anesthetics, General|anesthetics, general|mesh-ancestor
92717285|NCT04657107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717286|NCT04657107|Antidepressive Agents|antidepressive agents|mesh-ancestor
92717287|NCT04657107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717288|NCT00561717|Cetirizine|cetirizine|mesh-list
92717289|NCT00561717|Loratadine|loratadine|mesh-list
92717290|NCT00561717|Azelastine|azelastine|mesh-list
92717291|NCT00561717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92717292|NCT00561717|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92717293|NCT00561717|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92717294|NCT00561717|Histamine Antagonists|histamine antagonists|mesh-ancestor
92717295|NCT00561717|Histamine Agents|histamine agents|mesh-ancestor
92717296|NCT00561717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717297|NCT00561717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717298|NCT00561717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717299|NCT00561717|Antipruritics|antipruritics|mesh-ancestor
92717300|NCT00561717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92717301|NCT00561717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92717302|NCT00561717|Autonomic Agents|autonomic agents|mesh-ancestor
92717303|NCT00561717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717304|NCT00561717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92608684|NCT00153270|Valproic Acid|valproic acid|mesh-list
92608685|NCT00153270|Anticonvulsants|anticonvulsants|mesh-ancestor
92608686|NCT00153270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015905|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717305|NCT00561717|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717306|NCT00561717|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92717307|NCT00561717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717308|NCT00561756|Vaccines|vaccines|mesh-list
92717309|NCT00561756|Immunologic Factors|immunologic factors|mesh-ancestor
92717310|NCT00561756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717311|NCT04863950|Lomustine|lomustine|mesh-list
92717312|NCT04863950|Imipramine|imipramine|mesh-list
92717313|NCT04863950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92717314|NCT04863950|Alkylating Agents|alkylating agents|mesh-ancestor
92717315|NCT04863950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717316|NCT04863950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717317|NCT04863950|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92717318|NCT04863950|Antidepressive Agents|antidepressive agents|mesh-ancestor
92717319|NCT04863950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717320|NCT04863950|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92717321|NCT04863950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92717322|NCT04863950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717323|NCT04863950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717324|NCT04863950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717325|NCT04863950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717326|NCT04824911|Aspirin|aspirin|mesh-list
92717327|NCT04824911|Clopidogrel|clopidogrel|mesh-list
92717328|NCT04824911|Atorvastatin|atorvastatin|mesh-list
92717329|NCT04824911|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92717330|NCT04824911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717331|NCT04824911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717332|NCT04824911|Analgesics|analgesics|mesh-ancestor
92717333|NCT04824911|Sensory System Agents|sensory system agents|mesh-ancestor
92717334|NCT04824911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717335|NCT04824911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717336|NCT04824911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717337|NCT04824911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717338|NCT04824911|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92717342|NCT04824911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717343|NCT04824911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717344|NCT04824911|Antipyretics|antipyretics|mesh-ancestor
92717345|NCT04824911|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92717346|NCT04824911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92717347|NCT04824911|Antimetabolites|antimetabolites|mesh-ancestor
92717348|NCT04824911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92717349|NCT04824911|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92717350|NCT04824911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92717351|NCT04824911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92717353|NCT04824911|Purinergic Agents|purinergic agents|mesh-ancestor
92717354|NCT04824911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717355|NCT04683146|Chlorhexidine|chlorhexidine|mesh-list
92717356|NCT04683146|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92717357|NCT04683146|Propranolol|propranolol|mesh-list
92717358|NCT04683146|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92717359|NCT04683146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717360|NCT04683146|Disinfectants|disinfectants|mesh-ancestor
92717361|NCT04683146|Dermatologic Agents|dermatologic agents|mesh-ancestor
92717362|NCT04683146|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92717363|NCT04683146|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92717364|NCT04683146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717365|NCT04683146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717366|NCT04683146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717367|NCT04683146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717368|NCT04683146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92717369|NCT04683146|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92717370|NCT04683146|Vasodilator Agents|vasodilator agents|mesh-ancestor
92717371|NCT04816877|Analgesics, Opioid|analgesics, opioid|mesh-list
92717372|NCT04816877|Narcotics|narcotics|mesh-ancestor
92717373|NCT04816877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717374|NCT04816877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717375|NCT04816877|Analgesics|analgesics|mesh-ancestor
92717376|NCT04816877|Sensory System Agents|sensory system agents|mesh-ancestor
92608687|NCT00153270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608688|NCT00153270|GABA Agents|gaba agents|mesh-ancestor
92608689|NCT00153270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717377|NCT04816877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717378|NCT04800302|Morphine|morphine|mesh-list
92717379|NCT04800302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92717380|NCT04800302|Narcotics|narcotics|mesh-ancestor
92717381|NCT04800302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717382|NCT04800302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717383|NCT04800302|Analgesics|analgesics|mesh-ancestor
92717384|NCT04800302|Sensory System Agents|sensory system agents|mesh-ancestor
92717385|NCT04800302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717386|NCT04711304|Hyaluronic Acid|hyaluronic acid|mesh-list
92717387|NCT04711304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92717388|NCT04711304|Immunologic Factors|immunologic factors|mesh-ancestor
92717389|NCT04711304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717390|NCT04711304|Viscosupplements|viscosupplements|mesh-ancestor
92717391|NCT04711304|Protective Agents|protective agents|mesh-ancestor
92717392|NCT04710719|Triamcinolone|triamcinolone|mesh-list
92717393|NCT04710719|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92717394|NCT04710719|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92717395|NCT04710719|Fluorouracil|fluorouracil|mesh-list
92717396|NCT04710719|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92717397|NCT04710719|Antimetabolites|antimetabolites|mesh-ancestor
92717398|NCT04710719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717399|NCT04710719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92717400|NCT04710719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717401|NCT04710719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717402|NCT04710719|Immunologic Factors|immunologic factors|mesh-ancestor
92717403|NCT04710719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717404|NCT04710719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717405|NCT04710719|Glucocorticoids|glucocorticoids|mesh-ancestor
92717406|NCT04710719|Hormones|hormones|mesh-ancestor
92717407|NCT04710719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717408|NCT04710719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717409|NCT04627779|Flurbiprofen|flurbiprofen|mesh-list
92717410|NCT04627779|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92717411|NCT04627779|Analgesics|analgesics|mesh-ancestor
92717424|NCT04537598|Narcotics|narcotics|mesh-ancestor
92717425|NCT04537598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717426|NCT04537598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717428|NCT04537598|Sensory System Agents|sensory system agents|mesh-ancestor
92717429|NCT04537598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717430|NCT04627467|Chloroquine|chloroquine|mesh-list
92717431|NCT04627467|Amebicides|amebicides|mesh-ancestor
92717432|NCT04627467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92717433|NCT04627467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92717434|NCT04627467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717435|NCT04627467|Antimalarials|antimalarials|mesh-ancestor
92717436|NCT04627467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717437|NCT04627623|Antibodies|antibodies|mesh-list
92717438|NCT04627623|Immunoglobulin G|immunoglobulin g|mesh-list
92717439|NCT04627623|Immunologic Factors|immunologic factors|mesh-ancestor
92717440|NCT04627623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717441|NCT04656249|Lenvatinib|lenvatinib|mesh-list
92717442|NCT04656249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407925|NCT01447797|Antimetabolites|antimetabolites|mesh-ancestor
92717443|NCT04656249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92717444|NCT04656249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717445|NCT04656249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717446|NCT04481555|Azithromycin|azithromycin|mesh-list
92717447|NCT04481555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92717448|NCT04481555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717449|NCT04682795|Insulin|insulin|mesh-list
92717450|NCT04682795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92717451|NCT04682795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717452|NCT04655664|Vitamin D|vitamin d|mesh-list
92717453|NCT04655664|Ergocalciferols|ergocalciferols|mesh-list
92717454|NCT04655664|Cholecalciferol|cholecalciferol|mesh-list
92717455|NCT04655664|Vitamins|vitamins|mesh-list
92717456|NCT04655664|Micronutrients|micronutrients|mesh-ancestor
92717457|NCT04655664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717458|NCT04655664|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92717459|NCT04655664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92717460|NCT04655508|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92608690|NCT00153270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608691|NCT00153270|Antimanic Agents|antimanic agents|mesh-ancestor
92608692|NCT00153270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608693|NCT00153270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608694|NCT00153270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92608695|NCT00159705|Pregabalin|pregabalin|mesh-list
92717461|NCT04655508|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92717462|NCT04655508|Autonomic Agents|autonomic agents|mesh-ancestor
92717463|NCT04655508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717464|NCT04655508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717465|NCT04655508|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92717466|NCT04655508|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717467|NCT04655508|Glucocorticoids|glucocorticoids|mesh-ancestor
92717468|NCT04655508|Hormones|hormones|mesh-ancestor
92717469|NCT04655508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717470|NCT04655508|Sympathomimetics|sympathomimetics|mesh-ancestor
92717471|NCT04655040|Caffeine|caffeine|mesh-list
92717472|NCT04655040|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92717473|NCT04655040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717474|NCT04655040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92717475|NCT04655040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717508|NCT04626414|Hematinics|hematinics|mesh-ancestor
92717509|NCT04654416|Colchicine|colchicine|mesh-list
92717510|NCT04654416|Gout Suppressants|gout suppressants|mesh-ancestor
92717511|NCT04654416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717512|NCT04654416|Tubulin Modulators|tubulin modulators|mesh-ancestor
92717513|NCT04654416|Antimitotic Agents|antimitotic agents|mesh-ancestor
92717514|NCT04654416|Mitosis Modulators|mitosis modulators|mesh-ancestor
92717515|NCT04654416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717516|NCT04654416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717522|NCT02906150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717523|NCT02906150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717524|NCT02906150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92717525|NCT02906150|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92717526|NCT02906150|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92717527|NCT02906150|Immunologic Factors|immunologic factors|mesh-ancestor
92717528|NCT02906150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717529|NCT00561990|Nimotuzumab|nimotuzumab|mesh-list
92717530|NCT00561990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92717531|NCT00561990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717532|NCT02905994|Cytarabine|cytarabine|mesh-list
92717533|NCT02905994|Idarubicin|idarubicin|mesh-list
92717534|NCT02905994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92717535|NCT02905994|Antimetabolites|antimetabolites|mesh-ancestor
92717536|NCT02905994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717537|NCT02905994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717538|NCT02905994|Antiviral Agents|antiviral agents|mesh-ancestor
92717539|NCT02905994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717540|NCT02905994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717541|NCT02905994|Immunologic Factors|immunologic factors|mesh-ancestor
92717542|NCT02905994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717543|NCT02905994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92717544|NCT02905994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92717545|NCT02905994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92717546|NCT02905994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717547|NCT02905682|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92717548|NCT02905682|Hemostatics|hemostatics|mesh-ancestor
92717549|NCT02905682|Coagulants|coagulants|mesh-ancestor
92717550|NCT02905682|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92717551|NCT02905682|Natriuretic Agents|natriuretic agents|mesh-ancestor
92717552|NCT02905682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717553|NCT04626258|Fluconazole|fluconazole|mesh-list
92717554|NCT04626258|Antifungal Agents|antifungal agents|mesh-ancestor
92717555|NCT04626258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717556|NCT04626258|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92717557|NCT04626258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92717558|NCT04626258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717559|NCT04626258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717560|NCT04626258|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92717561|NCT04626258|Hormone Antagonists|hormone antagonists|mesh-ancestor
92717562|NCT04626258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717563|NCT04626258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717564|NCT04626258|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92717565|NCT04626258|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92717566|NCT04681820|Flumatinib|flumatinib|mesh-list
92717567|NCT04681820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92717568|NCT04681820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717569|NCT04681820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717570|NCT04626063|Acetaminophen|acetaminophen|mesh-list
92717571|NCT04626063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92717572|NCT04626063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92717573|NCT04626063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717574|NCT04626063|Analgesics|analgesics|mesh-ancestor
92717575|NCT04626063|Sensory System Agents|sensory system agents|mesh-ancestor
92717576|NCT04626063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717577|NCT04626063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717578|NCT04626063|Antipyretics|antipyretics|mesh-ancestor
92717579|NCT04626063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717580|NCT04625985|Metformin|metformin|mesh-list
92717581|NCT04625985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92717582|NCT04625985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717583|NCT02905760|Furosemide|furosemide|mesh-list
92717584|NCT02905760|Diuretics|diuretics|mesh-list
92717585|NCT02905760|Natriuretic Agents|natriuretic agents|mesh-ancestor
92717586|NCT02905760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717587|NCT02905760|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92717592|NCT02905526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717593|NCT04654182|Chlorhexidine|chlorhexidine|mesh-list
92717594|NCT04654182|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92717595|NCT04654182|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92717596|NCT04654182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717597|NCT04654182|Disinfectants|disinfectants|mesh-ancestor
92717598|NCT04654182|Dermatologic Agents|dermatologic agents|mesh-ancestor
92717599|NCT04654026|Aspirin|aspirin|mesh-list
92717600|NCT04654026|Clopidogrel|clopidogrel|mesh-list
92717601|NCT04654026|Ticagrelor|ticagrelor|mesh-list
92717602|NCT04654026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717603|NCT04654026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717604|NCT04654026|Analgesics|analgesics|mesh-ancestor
92717605|NCT04654026|Sensory System Agents|sensory system agents|mesh-ancestor
92717606|NCT04654026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717607|NCT04654026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717608|NCT04654026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717609|NCT04654026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717610|NCT04654026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92717611|NCT04654026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717612|NCT04654026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717613|NCT04654026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92717614|NCT04654026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717615|NCT04654026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717616|NCT04654026|Antipyretics|antipyretics|mesh-ancestor
92717617|NCT04654026|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92717618|NCT04654026|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92717619|NCT04654026|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92717620|NCT04654026|Purinergic Agents|purinergic agents|mesh-ancestor
92717621|NCT04654026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717622|NCT04625595|Methyldopa|methyldopa|mesh-list
92717623|NCT04625595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92717624|NCT04625595|Sympatholytics|sympatholytics|mesh-ancestor
92717625|NCT04625595|Autonomic Agents|autonomic agents|mesh-ancestor
92717626|NCT04625595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717627|NCT04625595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717628|NCT04625595|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92717629|NCT04625595|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717630|NCT04625595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717631|NCT04625595|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717632|NCT04625595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717633|NCT04625595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717634|NCT02905058|Ketoprofen|ketoprofen|mesh-list
92717635|NCT02905058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717636|NCT02905058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717637|NCT02905058|Analgesics|analgesics|mesh-ancestor
92608697|NCT00159705|Sensory System Agents|sensory system agents|mesh-ancestor
92608698|NCT00159705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608699|NCT00159705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608700|NCT00159705|Anticonvulsants|anticonvulsants|mesh-ancestor
92608701|NCT00159705|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92608702|NCT00159705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717638|NCT02905058|Sensory System Agents|sensory system agents|mesh-ancestor
92717639|NCT02905058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717640|NCT02905058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717641|NCT02905058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717642|NCT02905058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717643|NCT02905058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717644|NCT02905058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717645|NCT02905058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717647|NCT04653792|Analgesics|analgesics|mesh-ancestor
92717648|NCT04653792|Sensory System Agents|sensory system agents|mesh-ancestor
92717649|NCT04653792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717650|NCT04653792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717652|NCT04653792|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92717653|NCT04653792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717654|NCT04653792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717655|NCT04653792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92717656|NCT04653792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92717657|NCT04653792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92717659|NCT04653792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717660|NCT00557700|Bromides|bromides|mesh-list
92717661|NCT00557700|Tiotropium Bromide|tiotropium bromide|mesh-list
92717662|NCT00557700|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92717663|NCT00557700|Autonomic Agents|autonomic agents|mesh-ancestor
92717664|NCT00557700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717665|NCT00557700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717666|NCT00557700|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92717667|NCT00557700|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717668|NCT00557700|Parasympatholytics|parasympatholytics|mesh-ancestor
92717669|NCT00557700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92717670|NCT00557700|Cholinergic Agents|cholinergic agents|mesh-ancestor
92717671|NCT00557700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717672|NCT00557700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717673|NCT00557700|Anticonvulsants|anticonvulsants|mesh-ancestor
92717674|NCT00557739|Mometasone Furoate|mometasone furoate|mesh-list
92717675|NCT00557739|Nortriptyline|nortriptyline|mesh-list
92717676|NCT00557739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717677|NCT00557739|Dermatologic Agents|dermatologic agents|mesh-ancestor
92717678|NCT00557739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92717679|NCT00557739|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92717680|NCT00557739|Antidepressive Agents|antidepressive agents|mesh-ancestor
92717681|NCT00557739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717682|NCT00557739|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92717683|NCT00557739|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92717684|NCT00557739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717685|NCT00557739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717686|NCT00557739|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717687|NCT00557739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717688|NCT00557739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717689|NCT02903888|Levonorgestrel|levonorgestrel|mesh-list
92717690|NCT02903888|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92717691|NCT02903888|Contraceptive Agents|contraceptive agents|mesh-ancestor
92717692|NCT02903888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92717693|NCT02903888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717694|NCT02903888|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92717695|NCT02903888|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92717696|NCT02903888|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92717697|NCT04624269|Hydroxychloroquine|hydroxychloroquine|mesh-list
92717698|NCT04624269|Antimalarials|antimalarials|mesh-ancestor
92717699|NCT04624269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92717700|NCT04624269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92608703|NCT00159705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608704|NCT00159705|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608705|NCT00159705|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92717701|NCT04624269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717702|NCT04624269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717703|NCT04624269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717704|NCT04624269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717705|NCT04652739|Prednisolone|prednisolone|mesh-list
92717707|NCT04652739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717708|NCT04652739|Glucocorticoids|glucocorticoids|mesh-ancestor
92717709|NCT04652739|Hormones|hormones|mesh-ancestor
92717710|NCT04652739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717711|NCT04652739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717712|NCT04652739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92717713|NCT04652739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717714|NCT04652739|Protective Agents|protective agents|mesh-ancestor
92717715|NCT04652739|Antioxidants|antioxidants|mesh-ancestor
92717716|NCT04652739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717717|NCT04652739|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92717718|NCT04652739|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92717719|NCT02903498|Tegafur|tegafur|mesh-list
92717720|NCT02903498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92717721|NCT02903498|Antimetabolites|antimetabolites|mesh-ancestor
92717722|NCT02903498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717723|NCT02903498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717724|NCT04652427|Dexmedetomidine|dexmedetomidine|mesh-list
92717725|NCT04652427|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92717726|NCT04652427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717727|NCT04652427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717728|NCT04652427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717729|NCT04652427|Analgesics|analgesics|mesh-ancestor
92717730|NCT04652427|Sensory System Agents|sensory system agents|mesh-ancestor
92717733|NCT04652427|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717734|NCT04652427|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717735|NCT04652427|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717736|NCT04652427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717737|NCT04652427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717738|NCT04623879|Ivacaftor|ivacaftor|mesh-list
92717739|NCT04623879|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92717740|NCT04623879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717741|NCT04623879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717742|NCT00562068|Prednisolone|prednisolone|mesh-list
92717743|NCT00562068|Cyclophosphamide|cyclophosphamide|mesh-list
92717744|NCT00562068|Doxorubicin|doxorubicin|mesh-list
92717745|NCT00562068|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92717746|NCT00562068|Vincristine|vincristine|mesh-list
92717747|NCT00562068|Alemtuzumab|alemtuzumab|mesh-list
92717748|NCT00562068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717749|NCT00562068|Immunologic Factors|immunologic factors|mesh-ancestor
92717750|NCT00562068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717751|NCT00562068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717752|NCT00562068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92717753|NCT00562068|Alkylating Agents|alkylating agents|mesh-ancestor
92717754|NCT00562068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717755|NCT00562068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717756|NCT00562068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92717757|NCT00562068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92717758|NCT00562068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92717759|NCT00562068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92717760|NCT00562068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717761|NCT00562068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92717762|NCT00562068|Tubulin Modulators|tubulin modulators|mesh-ancestor
92717763|NCT00562068|Antimitotic Agents|antimitotic agents|mesh-ancestor
92717764|NCT00562068|Mitosis Modulators|mitosis modulators|mesh-ancestor
92717765|NCT00562068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717766|NCT00562068|Glucocorticoids|glucocorticoids|mesh-ancestor
92717767|NCT00562068|Hormones|hormones|mesh-ancestor
92717768|NCT00562068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92717769|NCT00562068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608706|NCT00159705|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608707|NCT00159705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608708|NCT00159705|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92608709|NCT00136994|Ziprasidone|ziprasidone|mesh-list
92608710|NCT00136994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92608711|NCT00136994|Serotonin Agents|serotonin agents|mesh-ancestor
92608712|NCT00136994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682804|NCT00438113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717770|NCT00562068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92717771|NCT00562185|Carboplatin|carboplatin|mesh-list
92717772|NCT00562185|Doxorubicin|doxorubicin|mesh-list
92717773|NCT00562185|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92717774|NCT00562185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717775|NCT00562185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92717776|NCT00562185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92717777|NCT00562185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92717778|NCT00562185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717779|NCT00562185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717780|NCT00562224|Abexinostat|abexinostat|mesh-list
92717781|NCT00562224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92717782|NCT00562224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717783|NCT00562224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717784|NCT02903069|Temozolomide|temozolomide|mesh-list
92717785|NCT02903069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92717786|NCT02903069|Alkylating Agents|alkylating agents|mesh-ancestor
92717787|NCT02903069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717788|NCT02903069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717789|NCT04623840|Tadalafil|tadalafil|mesh-list
92717790|NCT04623840|Vasodilator Agents|vasodilator agents|mesh-ancestor
92717791|NCT04623840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92717792|NCT04623840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92717793|NCT04623840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717794|NCT04623840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717795|NCT04623840|Urological Agents|urological agents|mesh-ancestor
92717796|NCT02902640|Trimethoprim|trimethoprim|mesh-list
92717797|NCT02902640|Sulfamethoxazole|sulfamethoxazole|mesh-list
92717798|NCT02902640|Phenylpropanolamine|phenylpropanolamine|mesh-list
92717799|NCT02902640|Guaifenesin|guaifenesin|mesh-list
92717800|NCT02902640|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92717801|NCT02902640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92717806|NCT02902640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92717807|NCT02902640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717808|NCT02902640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717809|NCT02902640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92717810|NCT02902640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92717811|NCT02902640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92717812|NCT02902640|Expectorants|expectorants|mesh-ancestor
92717813|NCT02902640|Respiratory System Agents|respiratory system agents|mesh-ancestor
92717814|NCT02902640|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717815|NCT02902640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717816|NCT02902640|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717817|NCT02902640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717818|NCT02902640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717819|NCT02902640|Appetite Depressants|appetite depressants|mesh-ancestor
92717820|NCT02902640|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92717821|NCT02902640|Sympathomimetics|sympathomimetics|mesh-ancestor
92717822|NCT02902640|Autonomic Agents|autonomic agents|mesh-ancestor
92717823|NCT02902640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717824|NCT02902640|Nasal Decongestants|nasal decongestants|mesh-ancestor
92717825|NCT02902640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92717826|NCT04624893|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92717827|NCT04624893|Immunoconjugates|immunoconjugates|mesh-list
92717828|NCT04624893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92717829|NCT04624893|Immunologic Factors|immunologic factors|mesh-ancestor
92717830|NCT04624893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717831|NCT02902523|Tenofovir|tenofovir|mesh-list
92717832|NCT02902523|Antiviral Agents|antiviral agents|mesh-ancestor
92608713|NCT00136994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608714|NCT00136994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608715|NCT00136994|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92717833|NCT02902523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717834|NCT02902523|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92717835|NCT02902523|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92717836|NCT02902523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717837|NCT02902523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717838|NCT02902523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92717839|NCT02902523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92717840|NCT02902289|Ibuprofen|ibuprofen|mesh-list
92717841|NCT02902289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717842|NCT02902289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717843|NCT02902289|Analgesics|analgesics|mesh-ancestor
92717844|NCT02902289|Sensory System Agents|sensory system agents|mesh-ancestor
92717845|NCT02902289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717846|NCT02902289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717847|NCT02902289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717848|NCT02902289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717849|NCT02902289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717850|NCT02902289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717851|NCT02902289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717852|NCT02902133|Acetazolamide|acetazolamide|mesh-list
92717853|NCT02902133|Anticonvulsants|anticonvulsants|mesh-ancestor
92717854|NCT02902133|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92717855|NCT02902133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717856|NCT02902133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717857|NCT02902133|Diuretics|diuretics|mesh-ancestor
92717858|NCT02902133|Natriuretic Agents|natriuretic agents|mesh-ancestor
92717859|NCT02902133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717860|NCT04623021|Nafamostat|nafamostat|mesh-list
92717861|NCT04623021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717862|NCT04623021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717863|NCT04623021|Analgesics|analgesics|mesh-ancestor
92717864|NCT04623021|Sensory System Agents|sensory system agents|mesh-ancestor
92717865|NCT04623021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717866|NCT04623021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717867|NCT04623021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717868|NCT04623021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717869|NCT04623021|Anticoagulants|anticoagulants|mesh-ancestor
92717870|NCT04623021|Protease Inhibitors|protease inhibitors|mesh-ancestor
92412994|NCT01455350|Lidocaine|lidocaine|mesh-list
92412995|NCT01455350|Anesthetics, Local|anesthetics, local|mesh-ancestor
92412996|NCT01455350|Anesthetics|anesthetics|mesh-ancestor
92412999|NCT01455350|Sensory System Agents|sensory system agents|mesh-ancestor
92413000|NCT01455350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413001|NCT01455350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413002|NCT01455350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92413003|NCT01455350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92413004|NCT01455350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413005|NCT01455350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413006|NCT01455636|Micronutrients|micronutrients|mesh-list
92413007|NCT01455636|Trace Elements|trace elements|mesh-list
92413008|NCT01455636|Hand Sanitizers|hand sanitizers|mesh-list
92413009|NCT01455636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413010|NCT01455636|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92413011|NCT01455636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413012|NCT01455636|Disinfectants|disinfectants|mesh-ancestor
92413013|NCT01456078|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92413014|NCT01456078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92413015|NCT01456078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413016|NCT01456507|Naltrexone|naltrexone|mesh-list
92413017|NCT01456507|Oxycodone|oxycodone|mesh-list
92413018|NCT01456507|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92413019|NCT01456507|Narcotics|narcotics|mesh-ancestor
92413020|NCT01456507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413021|NCT01456507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413022|NCT01456507|Analgesics|analgesics|mesh-ancestor
92413023|NCT01456507|Sensory System Agents|sensory system agents|mesh-ancestor
92413024|NCT01456507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413025|NCT01456507|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92608716|NCT00136994|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608717|NCT00136994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608718|NCT00136994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986407|NCT03112577|Xhance|xhance|mesh-list
92608719|NCT00136994|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92608720|NCT00136994|Dopamine Agents|dopamine agents|mesh-ancestor
92608721|NCT00137033|Celecoxib|celecoxib|mesh-list
92413026|NCT01456507|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92413027|NCT01456585|Gemcitabine|gemcitabine|mesh-list
92413028|NCT01456585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92413029|NCT01456585|Antimetabolites|antimetabolites|mesh-ancestor
92413030|NCT01456585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413031|NCT01456585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413032|NCT01456650|Glyburide|glyburide|mesh-list
92413033|NCT01456650|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413034|NCT01456650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413035|NCT01457040|Etoposide|etoposide|mesh-list
92413036|NCT01457040|Etoposide phosphate|etoposide phosphate|mesh-list
92413037|NCT01457040|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92413038|NCT01457040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413039|NCT01457040|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92413040|NCT01457040|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413041|NCT01457040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413042|NCT01457040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413043|NCT01457508|Edetic Acid|edetic acid|mesh-list
92413044|NCT01457508|Pentetic Acid|pentetic acid|mesh-list
92413045|NCT01457508|Antidotes|antidotes|mesh-ancestor
92413046|NCT01457508|Protective Agents|protective agents|mesh-ancestor
92413047|NCT01457508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413048|NCT01457508|Chelating Agents|chelating agents|mesh-ancestor
92413049|NCT01457508|Sequestering Agents|sequestering agents|mesh-ancestor
92413050|NCT01457508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413051|NCT01457508|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92413052|NCT01457508|Anticoagulants|anticoagulants|mesh-ancestor
92413053|NCT01457508|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92413054|NCT01458431|Anesthetics|anesthetics|mesh-list
92413055|NCT01458431|Levobupivacaine|levobupivacaine|mesh-list
92413056|NCT01458431|Anesthetics, Local|anesthetics, local|mesh-list
92413057|NCT01458431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413058|NCT01458431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413059|NCT01458431|Sensory System Agents|sensory system agents|mesh-ancestor
92413060|NCT01458431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413061|NCT01458808|Dialysis Solutions|dialysis solutions|mesh-list
92413062|NCT01458808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92413063|NCT01459445|Metformin|metformin|mesh-list
92413064|NCT01459445|Drospirenone|drospirenone|mesh-list
92413065|NCT01459445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92413066|NCT01459445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413067|NCT01459445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413068|NCT01459445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92413069|NCT01459445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92413073|NCT01459445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92413076|NCT01459445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413077|NCT01459445|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92413078|NCT01459445|Hormone Antagonists|hormone antagonists|mesh-ancestor
92413079|NCT01459445|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92413080|NCT01459445|Diuretics|diuretics|mesh-ancestor
92413081|NCT01459445|Natriuretic Agents|natriuretic agents|mesh-ancestor
92413082|NCT01460030|Cinacalcet|cinacalcet|mesh-list
92413083|NCT01460030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413084|NCT01460030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413085|NCT01460030|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92413086|NCT01460030|Hormone Antagonists|hormone antagonists|mesh-ancestor
92413087|NCT01460030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413088|NCT01460069|Liraglutide|liraglutide|mesh-list
92413089|NCT01460069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413090|NCT01460069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413091|NCT01460069|Incretins|incretins|mesh-ancestor
92413092|NCT01460069|Hormones|hormones|mesh-ancestor
92608722|NCT00137033|Naproxen|naproxen|mesh-list
92608723|NCT00137033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608724|NCT00137033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608725|NCT00137033|Analgesics|analgesics|mesh-ancestor
92608726|NCT00137033|Sensory System Agents|sensory system agents|mesh-ancestor
92608727|NCT00137033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413093|NCT01460069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413094|NCT01460134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92413095|NCT01460134|Immunologic Factors|immunologic factors|mesh-ancestor
92413096|NCT01460134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413097|NCT01460212|Fluvoxamine|fluvoxamine|mesh-list
92413098|NCT01460212|Citalopram|citalopram|mesh-list
92413099|NCT01460212|Fluoxetine|fluoxetine|mesh-list
92413100|NCT01460212|Paroxetine|paroxetine|mesh-list
92413101|NCT01460212|Sertraline|sertraline|mesh-list
92413102|NCT01460212|Antidepressive Agents|antidepressive agents|mesh-list
92413103|NCT01460212|Escitalopram|escitalopram|mesh-list
92413104|NCT01460212|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92413105|NCT01460212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92413106|NCT01460212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413107|NCT01460212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413108|NCT01460212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413109|NCT01460212|Serotonin Agents|serotonin agents|mesh-ancestor
92413110|NCT01460212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413111|NCT01460212|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92413112|NCT01460212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92413113|NCT01460212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92413114|NCT01460212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92413115|NCT01460212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413116|NCT01460212|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92413117|NCT01460212|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92413118|NCT01460212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413119|NCT01460212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92413120|NCT01460212|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92413121|NCT01460355|Botulinum Toxins|botulinum toxins|mesh-list
92413122|NCT01460355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92413123|NCT01460355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92413124|NCT01460355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92413125|NCT01460355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413126|NCT01460355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413127|NCT01460355|Cholinergic Agents|cholinergic agents|mesh-ancestor
92413128|NCT01460355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413129|NCT01460355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413130|NCT01460355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92413131|NCT01460355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413132|NCT01460420|Lenalidomide|lenalidomide|mesh-list
92413133|NCT01460420|Bortezomib|bortezomib|mesh-list
92413134|NCT01460420|Immunologic Factors|immunologic factors|mesh-ancestor
92413135|NCT01460420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413136|NCT01460420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92413137|NCT01460420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92413138|NCT01460420|Growth Substances|growth substances|mesh-ancestor
92413139|NCT01460420|Growth Inhibitors|growth inhibitors|mesh-ancestor
92413140|NCT01460420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413152|NCT01460537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92413153|NCT01460537|Antimetabolites|antimetabolites|mesh-ancestor
92413154|NCT01460537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413155|NCT01460563|Magnesium Sulfate|magnesium sulfate|mesh-list
92413156|NCT01460563|Analgesics|analgesics|mesh-ancestor
92413157|NCT01460563|Sensory System Agents|sensory system agents|mesh-ancestor
92413158|NCT01460563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413159|NCT01460563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413160|NCT01460563|Anesthetics|anesthetics|mesh-ancestor
92413161|NCT01460563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413162|NCT01460563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413163|NCT01460563|Anticonvulsants|anticonvulsants|mesh-ancestor
92413164|NCT01460563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92413165|NCT01460563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92608728|NCT00137033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015944|NCT05554211|Coagulants|coagulants|mesh-ancestor
92413166|NCT01460563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413167|NCT01460563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413168|NCT01460563|Tocolytic Agents|tocolytic agents|mesh-ancestor
92413169|NCT01460563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92413170|NCT01460602|Rituximab|rituximab|mesh-list
92413171|NCT01460602|Bortezomib|bortezomib|mesh-list
92413172|NCT01460602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92413173|NCT01460602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413174|NCT01460602|Immunologic Factors|immunologic factors|mesh-ancestor
92413175|NCT01460602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413176|NCT01460602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92413177|NCT01460615|Hydrocortisone|hydrocortisone|mesh-list
92413178|NCT01460615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413179|NCT01460667|Acetaminophen|acetaminophen|mesh-list
92413180|NCT01460667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92413181|NCT01460667|Analgesics|analgesics|mesh-ancestor
92413182|NCT01460667|Sensory System Agents|sensory system agents|mesh-ancestor
92413183|NCT01460667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413184|NCT01460667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413185|NCT01460667|Antipyretics|antipyretics|mesh-ancestor
92413186|NCT01460693|Imatinib Mesylate|imatinib mesylate|mesh-list
92413187|NCT01460693|Dasatinib|dasatinib|mesh-list
92413188|NCT01460693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413189|NCT01460693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413190|NCT01460693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413191|NCT01460693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413192|NCT01460706|Edotreotide|edotreotide|mesh-list
92413193|NCT01460706|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92413194|NCT01460706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413195|NCT01460797|Metformin|metformin|mesh-list
92413196|NCT01460797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413197|NCT01460797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413198|NCT01460836|Tobramycin|tobramycin|mesh-list
92413199|NCT01460836|Aztreonam|aztreonam|mesh-list
92413200|NCT01460836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413201|NCT01460836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413202|NCT01460888|Olaparib|olaparib|mesh-list
92413203|NCT01460888|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92413204|NCT01460888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413209|NCT01460979|MTOR Inhibitors|mtor inhibitors|mesh-list
92413210|NCT01460979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413211|NCT01460979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413212|NCT01460979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413213|NCT01460979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413214|NCT01460979|Immunologic Factors|immunologic factors|mesh-ancestor
92413215|NCT01460979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413216|NCT01460979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413217|NCT01460979|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413218|NCT01460979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413219|NCT01460979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92413220|NCT01460979|Antifungal Agents|antifungal agents|mesh-ancestor
92413221|NCT01461018|Immunoglobulins|immunoglobulins|mesh-list
92413222|NCT01461018|Antibodies|antibodies|mesh-list
92413223|NCT01461018|gamma-Globulins|gamma-globulins|mesh-list
92413224|NCT01461018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92413225|NCT01461018|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92413226|NCT01461018|Immunologic Factors|immunologic factors|mesh-ancestor
92413227|NCT01461018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413228|NCT01461031|Nefopam|nefopam|mesh-list
92413229|NCT01461031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92413230|NCT01461031|Analgesics|analgesics|mesh-ancestor
92413231|NCT01461031|Sensory System Agents|sensory system agents|mesh-ancestor
92413232|NCT01461031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413233|NCT01461031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413234|NCT01461174|Memantine|memantine|mesh-list
92413235|NCT01461174|Modafinil|modafinil|mesh-list
92413236|NCT01461174|Donepezil|donepezil|mesh-list
92413237|NCT01461174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92413238|NCT01461174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413239|NCT01461174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413240|NCT01461174|Cholinergic Agents|cholinergic agents|mesh-ancestor
92608730|NCT00137033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608731|NCT00137033|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92608732|NCT00137033|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608733|NCT00137033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073169|NCT01895998|Albuterol|albuterol|mesh-list
92413241|NCT01461174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413242|NCT01461174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413243|NCT01461174|Nootropic Agents|nootropic agents|mesh-ancestor
92413244|NCT01461174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92413245|NCT01461174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92413246|NCT01461174|Dopamine Agents|dopamine agents|mesh-ancestor
92413247|NCT01461174|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92413248|NCT01461174|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92413249|NCT01461174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92413250|NCT01461174|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92413251|NCT01461174|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92413252|NCT01461174|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92413253|NCT01461460|Moxifloxacin|moxifloxacin|mesh-list
92413254|NCT01461460|Tedizolid phosphate|tedizolid phosphate|mesh-list
92413255|NCT01461460|Tedizolid|tedizolid|mesh-list
92413256|NCT01461460|Oxazolidinones|oxazolidinones|mesh-list
92413257|NCT01461460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413258|NCT01461460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413259|NCT01461460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92413260|NCT01461460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413261|NCT01461460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413262|NCT01461460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413263|NCT01461460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413264|NCT01461460|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92413265|NCT01461577|Insulin Glargine|insulin glargine|mesh-list
92413266|NCT01461577|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413267|NCT01461577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413268|NCT01461616|Insulin|insulin|mesh-list
92413269|NCT01461616|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92413270|NCT01461616|Insulin Glargine|insulin glargine|mesh-list
92413271|NCT01461616|Insulin Detemir|insulin detemir|mesh-list
92413272|NCT01461616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413273|NCT01461616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413274|NCT01461746|Docetaxel|docetaxel|mesh-list
92413275|NCT01461746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413276|NCT01461746|Tubulin Modulators|tubulin modulators|mesh-ancestor
92413277|NCT01461746|Antimitotic Agents|antimitotic agents|mesh-ancestor
92413281|NCT01461759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413282|NCT01461772|Carboplatin|carboplatin|mesh-list
92413283|NCT01461772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413284|NCT01461876|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92413285|NCT01461876|Antiviral Agents|antiviral agents|mesh-ancestor
92413286|NCT01461876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413287|NCT01462006|Sirolimus|sirolimus|mesh-list
92413288|NCT01462006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413289|NCT01462006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413290|NCT01462006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92413291|NCT01462006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413292|NCT01462006|Antifungal Agents|antifungal agents|mesh-ancestor
92413293|NCT01462006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413294|NCT01462006|Immunologic Factors|immunologic factors|mesh-ancestor
92413295|NCT01462006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413296|NCT01462058|Vitamin D|vitamin d|mesh-list
92413297|NCT01462058|Cholecalciferol|cholecalciferol|mesh-list
92413298|NCT01462058|Vitamins|vitamins|mesh-ancestor
92413299|NCT01462058|Micronutrients|micronutrients|mesh-ancestor
92413300|NCT01462058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413301|NCT01462058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92413302|NCT01462058|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413303|NCT01462149|Carboplatin|carboplatin|mesh-list
92413304|NCT01462149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413305|NCT01462214|Everolimus|everolimus|mesh-list
92413306|NCT01462214|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92413307|NCT01462214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413308|NCT01462214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413309|NCT01462214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413310|NCT01462214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413311|NCT01462214|Immunologic Factors|immunologic factors|mesh-ancestor
92608734|NCT00137033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608735|NCT00137033|Gout Suppressants|gout suppressants|mesh-ancestor
92608736|NCT00137072|Sildenafil Citrate|sildenafil citrate|mesh-list
92413312|NCT01462214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413313|NCT01462214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413314|NCT01462422|Misoprostol|misoprostol|mesh-list
92413315|NCT01462422|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92413316|NCT01462422|Abortifacient Agents|abortifacient agents|mesh-ancestor
92413317|NCT01462422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92413318|NCT01462422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413319|NCT01462422|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92413320|NCT01462422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92413321|NCT01462422|Oxytocics|oxytocics|mesh-ancestor
92413322|NCT01462474|Cisplatin|cisplatin|mesh-list
92413323|NCT01462474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413324|NCT01462487|Zanamivir|zanamivir|mesh-list
92413325|NCT01462487|Antiviral Agents|antiviral agents|mesh-ancestor
92413326|NCT01462487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413327|NCT01462487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413328|NCT01462487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413329|NCT01462500|Miltefosine|miltefosine|mesh-list
92413330|NCT01462500|Antifungal Agents|antifungal agents|mesh-ancestor
92413331|NCT01462500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413332|NCT01462500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413333|NCT01462500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92413334|NCT01462500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92413335|NCT01462617|Nemiralisib|nemiralisib|mesh-list
92413336|NCT01462617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413337|NCT01462617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413338|NCT01462617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413339|NCT01462669|Ezogabine|ezogabine|mesh-list
92413340|NCT01462669|Anticonvulsants|anticonvulsants|mesh-ancestor
92413341|NCT01462669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413342|NCT01462669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413343|NCT01462903|Immunomodulating Agents|immunomodulating agents|mesh-list
92413344|NCT01462903|Immunologic Factors|immunologic factors|mesh-ancestor
92413345|NCT01462903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413346|NCT01462968|Heparin|heparin|mesh-list
92413347|NCT01462968|Anticoagulants|anticoagulants|mesh-ancestor
92413348|NCT01462968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92413349|NCT01462968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92413350|NCT01462968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413351|NCT01463046|Cytarabine|cytarabine|mesh-list
92413357|NCT01463046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413358|NCT01463046|Antiviral Agents|antiviral agents|mesh-ancestor
92413359|NCT01463046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413360|NCT01463046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413361|NCT01463046|Immunologic Factors|immunologic factors|mesh-ancestor
92413362|NCT01463046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413363|NCT01463046|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92413364|NCT01463046|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92413365|NCT01463046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413366|NCT01463046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413367|NCT01463046|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92413368|NCT01463150|Clopidogrel|clopidogrel|mesh-list
92413369|NCT01463150|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92413370|NCT01463150|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92413371|NCT01463150|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92413372|NCT01463150|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92413373|NCT01463150|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92413374|NCT01463150|Purinergic Agents|purinergic agents|mesh-ancestor
92413375|NCT01463150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413376|NCT01463150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413377|NCT01463150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413378|NCT01463163|Ticagrelor|ticagrelor|mesh-list
92413379|NCT01463163|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92413380|NCT01463163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92413381|NCT01463163|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92413382|NCT01463163|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92413383|NCT01463163|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92413384|NCT01463163|Purinergic Agents|purinergic agents|mesh-ancestor
92608737|NCT00137072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374694|NCT01843920|Hormones|hormones|mesh-ancestor
92608738|NCT00137072|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608739|NCT00137072|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92608740|NCT00137072|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92608741|NCT00137072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413385|NCT01463163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413386|NCT01463163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413387|NCT01463163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413388|NCT01463215|Ambroxol|ambroxol|mesh-list
92413389|NCT01463215|Expectorants|expectorants|mesh-ancestor
92413390|NCT01463215|Respiratory System Agents|respiratory system agents|mesh-ancestor
92413391|NCT01463228|Metformin|metformin|mesh-list
92413392|NCT01463228|Canagliflozin|canagliflozin|mesh-list
92413393|NCT01463228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413394|NCT01463228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413395|NCT01463228|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92413396|NCT01463228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413397|NCT01463280|Lidocaine|lidocaine|mesh-list
92413398|NCT01463280|Anesthetics, Local|anesthetics, local|mesh-ancestor
92413399|NCT01463280|Anesthetics|anesthetics|mesh-ancestor
92413400|NCT01463280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413401|NCT01463280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413402|NCT01463280|Sensory System Agents|sensory system agents|mesh-ancestor
92413403|NCT01463280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413404|NCT01463280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413405|NCT01463280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92413406|NCT01463280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92413407|NCT01463280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413408|NCT01463280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413409|NCT01463332|Dexmedetomidine|dexmedetomidine|mesh-list
92413410|NCT01463332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92413411|NCT01463332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413412|NCT01463332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413413|NCT01463332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92413414|NCT01463332|Analgesics|analgesics|mesh-ancestor
92413415|NCT01463332|Sensory System Agents|sensory system agents|mesh-ancestor
92413416|NCT01463332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413417|NCT01463332|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92413418|NCT01463332|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92413421|NCT01463332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413422|NCT01463332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413423|NCT01463371|Azithromycin|azithromycin|mesh-list
92413424|NCT01463371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413425|NCT01463371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413427|NCT01463592|Interferons|interferons|mesh-list
92413428|NCT01463592|Ribavirin|ribavirin|mesh-list
92413429|NCT01463592|Interferon-alpha|interferon-alpha|mesh-list
92413430|NCT01463592|Interferon alpha-2|interferon alpha-2|mesh-list
92413431|NCT01463592|Cadexomer iodine|cadexomer iodine|mesh-list
92413432|NCT01463592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413433|NCT01463592|Antiviral Agents|antiviral agents|mesh-ancestor
92413434|NCT01463592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413435|NCT01463592|Antimetabolites|antimetabolites|mesh-ancestor
92413436|NCT01463592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413437|NCT01463592|Immunologic Factors|immunologic factors|mesh-ancestor
92413438|NCT01463592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413439|NCT01463592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92413440|NCT01463592|Trace Elements|trace elements|mesh-ancestor
92413441|NCT01463592|Micronutrients|micronutrients|mesh-ancestor
92413442|NCT01463605|Nimotuzumab|nimotuzumab|mesh-list
92413443|NCT01463605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92413444|NCT01463605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413445|NCT01463735|Vitamin E|vitamin e|mesh-list
92413447|NCT01463735|Micronutrients|micronutrients|mesh-ancestor
92413448|NCT01463735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413449|NCT01463735|Antioxidants|antioxidants|mesh-ancestor
92413450|NCT01463735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413451|NCT01463735|Protective Agents|protective agents|mesh-ancestor
92608742|NCT00137072|Urological Agents|urological agents|mesh-ancestor
92608743|NCT04724538|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
92608744|NCT04724538|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92608745|NCT04724538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413452|NCT01463774|Metformin|metformin|mesh-list
92413453|NCT01463774|Canagliflozin|canagliflozin|mesh-list
92413454|NCT01463774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413455|NCT01463774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413456|NCT01463774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92413457|NCT01463774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413458|NCT01463813|Vitamin D|vitamin d|mesh-list
92413459|NCT01463813|Ergocalciferols|ergocalciferols|mesh-list
92413460|NCT01463813|Cholecalciferol|cholecalciferol|mesh-list
92413461|NCT01463813|Vitamins|vitamins|mesh-list
92413462|NCT01463813|Micronutrients|micronutrients|mesh-ancestor
92413463|NCT01463813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413464|NCT01463813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92413465|NCT01463813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413466|NCT01463852|Vincristine|vincristine|mesh-list
92413467|NCT01463852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92413468|NCT01463852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413469|NCT01463852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92413470|NCT01463852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92413471|NCT01463852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92413472|NCT01463852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413473|NCT01463865|Ropivacaine|ropivacaine|mesh-list
92413474|NCT01463865|Anesthetics, Local|anesthetics, local|mesh-ancestor
92413475|NCT01463865|Anesthetics|anesthetics|mesh-ancestor
92413476|NCT01463865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413477|NCT01463865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413478|NCT01463865|Sensory System Agents|sensory system agents|mesh-ancestor
92413479|NCT01463865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413480|NCT01463956|Interferons|interferons|mesh-list
92413481|NCT01463956|Ribavirin|ribavirin|mesh-list
92413482|NCT01463956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413483|NCT01463956|Antiviral Agents|antiviral agents|mesh-ancestor
92413484|NCT01463956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413485|NCT01463956|Antimetabolites|antimetabolites|mesh-ancestor
92413486|NCT01463956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413487|NCT01464008|Interferons|interferons|mesh-list
92413488|NCT01464008|Ribavirin|ribavirin|mesh-list
92413489|NCT01464008|Interferon-alpha|interferon-alpha|mesh-list
92413490|NCT01464008|Interferon alpha-2|interferon alpha-2|mesh-list
92413491|NCT01464008|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92413492|NCT01464008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413493|NCT01464008|Antiviral Agents|antiviral agents|mesh-ancestor
92413494|NCT01464008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413495|NCT01464008|Antimetabolites|antimetabolites|mesh-ancestor
92413508|NCT01464060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413509|NCT01464060|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92413510|NCT01464060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92413511|NCT01464099|Insulin|insulin|mesh-list
92413512|NCT01464099|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92413513|NCT01464099|Insulin Aspart|insulin aspart|mesh-list
92413514|NCT01464099|Insulin, Long-Acting|insulin, long-acting|mesh-list
92413515|NCT01464099|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92413516|NCT01464099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413517|NCT01464099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413518|NCT01464112|Dexamethasone|dexamethasone|mesh-list
92413519|NCT01464112|Bortezomib|bortezomib|mesh-list
92413520|NCT01464112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413521|NCT01464112|Antiemetics|antiemetics|mesh-ancestor
92413522|NCT01464112|Autonomic Agents|autonomic agents|mesh-ancestor
92413523|NCT01464112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413524|NCT01464112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413525|NCT01464112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92413526|NCT01464112|Glucocorticoids|glucocorticoids|mesh-ancestor
92413528|NCT01464112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413529|NCT01464112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92413530|NCT01464112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413531|NCT01464125|Azithromycin|azithromycin|mesh-list
92608746|NCT00159900|Sildenafil Citrate|sildenafil citrate|mesh-list
92608747|NCT00159900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413532|NCT01464125|Fosmidomycin|fosmidomycin|mesh-list
92413533|NCT01464125|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413534|NCT01464125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413535|NCT01464138|Clindamycin|clindamycin|mesh-list
92413536|NCT01464138|Clindamycin palmitate|clindamycin palmitate|mesh-list
92413537|NCT01464138|Clindamycin phosphate|clindamycin phosphate|mesh-list
92413538|NCT01464138|Fosmidomycin|fosmidomycin|mesh-list
92413539|NCT01464138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413540|NCT01464138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413541|NCT01464138|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92413542|NCT01464138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413543|NCT01464138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413544|NCT01464242|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92413545|NCT01464242|Pentoxifylline|pentoxifylline|mesh-list
92413546|NCT01464242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92413547|NCT01464242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413548|NCT01464242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413549|NCT01464242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92413550|NCT01464242|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92413551|NCT01464242|Protective Agents|protective agents|mesh-ancestor
92413552|NCT01464242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413553|NCT01464242|Vasodilator Agents|vasodilator agents|mesh-ancestor
92413554|NCT01464242|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92413555|NCT01464242|Antioxidants|antioxidants|mesh-ancestor
92413556|NCT01464242|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92413557|NCT01464242|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92374910|NCT05228574|Amiloride|amiloride|mesh-list
92413558|NCT01464242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413559|NCT01464281|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92413560|NCT01464281|Antiviral Agents|antiviral agents|mesh-ancestor
92413563|NCT01464450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92413564|NCT01464450|Antithrombins|antithrombins|mesh-ancestor
92413565|NCT01464450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92413566|NCT01464450|Protease Inhibitors|protease inhibitors|mesh-ancestor
92413567|NCT01464450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413568|NCT01464450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413569|NCT01464450|Anticoagulants|anticoagulants|mesh-ancestor
92413570|NCT01464476|Azimilide|azimilide|mesh-list
92413571|NCT01464476|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413572|NCT01464476|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92413573|NCT01464476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413574|NCT01464476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413575|NCT01464476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413576|NCT01464476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413577|NCT01464489|Atropine|atropine|mesh-list
92413578|NCT01464489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92413579|NCT01464489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413580|NCT01464489|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92413581|NCT01464489|Autonomic Agents|autonomic agents|mesh-ancestor
92413582|NCT01464489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413583|NCT01464489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413584|NCT01464489|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92413585|NCT01464489|Respiratory System Agents|respiratory system agents|mesh-ancestor
92413586|NCT01464489|Mydriatics|mydriatics|mesh-ancestor
92375197|NCT01890642|Lidocaine|lidocaine|mesh-list
92413587|NCT01464489|Parasympatholytics|parasympatholytics|mesh-ancestor
92413588|NCT01464489|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92413589|NCT01464489|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92413590|NCT01464489|Cholinergic Agents|cholinergic agents|mesh-ancestor
92413591|NCT01464489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413592|NCT01464489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413593|NCT01466608|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92413594|NCT01466608|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92138248|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
92413595|NCT01466608|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92413596|NCT01466608|Antimetabolites|antimetabolites|mesh-ancestor
92413597|NCT01466608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413598|NCT01466608|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92413599|NCT01466608|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92413600|NCT01466608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413601|NCT01466712|Beclomethasone|beclomethasone|mesh-list
92413602|NCT01466712|Formoterol Fumarate|formoterol fumarate|mesh-list
92608748|NCT00159900|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608749|NCT00159900|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92608750|NCT00159900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92608751|NCT00159900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413603|NCT01466712|Tiotropium Bromide|tiotropium bromide|mesh-list
92413604|NCT01466712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92413605|NCT01466712|Autonomic Agents|autonomic agents|mesh-ancestor
92375387|NCT01942668|Hormones|hormones|mesh-ancestor
92413606|NCT01466712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413607|NCT01466712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413608|NCT01466712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92413609|NCT01466712|Respiratory System Agents|respiratory system agents|mesh-ancestor
92413610|NCT01466712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92413611|NCT01466712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92413612|NCT01466712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92413613|NCT01466712|Adrenergic Agents|adrenergic agents|mesh-ancestor
92413614|NCT01466712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413615|NCT01466712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413616|NCT01466712|Parasympatholytics|parasympatholytics|mesh-ancestor
92413617|NCT01466712|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92413618|NCT01466712|Cholinergic Agents|cholinergic agents|mesh-ancestor
92413619|NCT01466712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413620|NCT01466712|Glucocorticoids|glucocorticoids|mesh-ancestor
92413622|NCT01466712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413623|NCT01466829|Hormones|hormones|mesh-list
92413624|NCT01466829|Parathyroid Hormone|parathyroid hormone|mesh-list
92375615|NCT05574894|Hormones|hormones|mesh-list
92413625|NCT01466829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413626|NCT01466829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413627|NCT01466829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413628|NCT01466855|Topotecan|topotecan|mesh-list
92375659|NCT05242692|Dexmedetomidine|dexmedetomidine|mesh-list
92413629|NCT01466855|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92413630|NCT01466855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413631|NCT01466855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413643|NCT01466959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92413644|NCT01466959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413645|NCT01466959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413646|NCT01466959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92413647|NCT01466959|Immunologic Factors|immunologic factors|mesh-ancestor
92413648|NCT01466959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413649|NCT01466959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92413650|NCT01466959|Protective Agents|protective agents|mesh-ancestor
92413651|NCT01466959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413652|NCT01467011|Mycophenolic Acid|mycophenolic acid|mesh-list
92413653|NCT01467011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92413654|NCT01467011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413655|NCT01467011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92413656|NCT01467011|Antitubercular Agents|antitubercular agents|mesh-ancestor
92413657|NCT01467011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413658|NCT01467011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413659|NCT01467011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413660|NCT01467011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413661|NCT01467115|Leucovorin|leucovorin|mesh-list
92413662|NCT01467115|Docetaxel|docetaxel|mesh-list
92413663|NCT01467115|Fluorouracil|fluorouracil|mesh-list
92413664|NCT01467115|Cetuximab|cetuximab|mesh-list
92413665|NCT01467115|Epoetin Alfa|epoetin alfa|mesh-list
92413666|NCT01467115|Levoleucovorin|levoleucovorin|mesh-list
92375868|NCT01688076|Botulinum Toxins|botulinum toxins|mesh-list
92413667|NCT01467115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413668|NCT01467115|Tubulin Modulators|tubulin modulators|mesh-ancestor
92413669|NCT01467115|Antimitotic Agents|antimitotic agents|mesh-ancestor
92413670|NCT01467115|Mitosis Modulators|mitosis modulators|mesh-ancestor
92413671|NCT01467115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413672|NCT01467115|Antimetabolites|antimetabolites|mesh-ancestor
92413673|NCT01467115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92413674|NCT01467115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413675|NCT01467115|Immunologic Factors|immunologic factors|mesh-ancestor
92413676|NCT01467115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413677|NCT01467115|Antidotes|antidotes|mesh-ancestor
92413678|NCT01467115|Protective Agents|protective agents|mesh-ancestor
92413679|NCT01467115|Vitamin B Complex|vitamin b complex|mesh-ancestor
92413680|NCT01467115|Vitamins|vitamins|mesh-ancestor
92413681|NCT01467115|Micronutrients|micronutrients|mesh-ancestor
92608752|NCT00159900|Urological Agents|urological agents|mesh-ancestor
92608753|NCT00159978|Alovudine|alovudine|mesh-list
92608754|NCT00159978|Antiviral Agents|antiviral agents|mesh-ancestor
92608755|NCT00159978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413682|NCT01467115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92413683|NCT01467115|Hematinics|hematinics|mesh-ancestor
92413684|NCT01467141|Insulin|insulin|mesh-list
92413685|NCT01467141|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92413686|NCT01467141|Insulin Aspart|insulin aspart|mesh-list
92413687|NCT01467141|Isophane Insulin, Human|isophane insulin, human|mesh-list
92413688|NCT01467141|Insulin, Isophane|insulin, isophane|mesh-list
92413689|NCT01467141|Isophane insulin, beef|isophane insulin, beef|mesh-list
92413690|NCT01467141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413691|NCT01467141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413692|NCT01467219|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92376140|NCT02024724|Anesthetics|anesthetics|mesh-ancestor
92413693|NCT01467219|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92413694|NCT01467219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376224|NCT02036424|Hormones|hormones|mesh-ancestor
92413695|NCT01467232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92413696|NCT01467258|Amantadine|amantadine|mesh-list
92413697|NCT01467258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92413698|NCT01467258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92413705|NCT01467258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92413706|NCT01467258|Analgesics|analgesics|mesh-ancestor
92413707|NCT01467258|Sensory System Agents|sensory system agents|mesh-ancestor
92413708|NCT01467258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413709|NCT01467297|Levofloxacin|levofloxacin|mesh-list
92413710|NCT01467297|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92413711|NCT01467297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413712|NCT01467297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413713|NCT01467297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92413714|NCT01467297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413715|NCT01467297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413716|NCT01467297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413717|NCT01467297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413718|NCT01467297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92413719|NCT01467297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92413720|NCT01467310|Trametinib|trametinib|mesh-list
92413721|NCT01467310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413722|NCT01467310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413723|NCT01467310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413724|NCT01467310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413725|NCT01467323|Insulin|insulin|mesh-list
92413726|NCT01467323|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92413727|NCT01467323|Insulin Aspart|insulin aspart|mesh-list
92413728|NCT01467323|Biphasic Insulins|biphasic insulins|mesh-list
92413729|NCT01467323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92376634|NCT02214420|Ribavirin|ribavirin|mesh-list
92413730|NCT01467323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413731|NCT01467362|Desonide|desonide|mesh-list
92413732|NCT01467362|V0034CR|v0034cr|mesh-list
92413733|NCT01467362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413734|NCT01467362|Emollients|emollients|mesh-ancestor
92413735|NCT01467362|Dermatologic Agents|dermatologic agents|mesh-ancestor
92413736|NCT01467375|Insulin Aspart|insulin aspart|mesh-list
92413737|NCT01467375|Biphasic Insulins|biphasic insulins|mesh-list
92413738|NCT01467375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413739|NCT01467375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413740|NCT01467401|Insulin|insulin|mesh-list
92413741|NCT01467401|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92413742|NCT01467401|Insulin Aspart|insulin aspart|mesh-list
92413743|NCT01467401|Biphasic Insulins|biphasic insulins|mesh-list
92413744|NCT01467401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413745|NCT01467401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413746|NCT01467414|Insulin|insulin|mesh-list
92138391|NCT01436305|Alemtuzumab|alemtuzumab|mesh-list
92413747|NCT01467414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413748|NCT01467414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413749|NCT01467518|Dolutegravir|dolutegravir|mesh-list
92413750|NCT01467518|Methadone|methadone|mesh-list
92413751|NCT01467518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92413752|NCT01467518|Narcotics|narcotics|mesh-ancestor
92413753|NCT01467518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413754|NCT01467518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413755|NCT01467518|Analgesics|analgesics|mesh-ancestor
92413756|NCT01467518|Sensory System Agents|sensory system agents|mesh-ancestor
92413757|NCT01467518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413758|NCT01467518|Antitussive Agents|antitussive agents|mesh-ancestor
92608756|NCT00137345|Sirolimus|sirolimus|mesh-list
92608757|NCT00137345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92608758|NCT00137345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608759|NCT00137345|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92608760|NCT00137345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608761|NCT00137345|Antifungal Agents|antifungal agents|mesh-ancestor
92377118|NCT02330094|Antimanic Agents|antimanic agents|mesh-ancestor
92413759|NCT01467518|Respiratory System Agents|respiratory system agents|mesh-ancestor
92413760|NCT01467518|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92413761|NCT01467518|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92413762|NCT01467518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413763|NCT01467518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413764|NCT01467518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92413765|NCT01467518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92413766|NCT01467518|Antiviral Agents|antiviral agents|mesh-ancestor
92413767|NCT01467518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413768|NCT01467531|Dolutegravir|dolutegravir|mesh-list
92413769|NCT01467531|Cabotegravir|cabotegravir|mesh-list
92413776|NCT01467531|Antiviral Agents|antiviral agents|mesh-ancestor
92377267|NCT02384070|Antipyretics|antipyretics|mesh-ancestor
92413777|NCT01467531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413778|NCT01467596|Lidocaine|lidocaine|mesh-list
92413779|NCT01467596|Levobupivacaine|levobupivacaine|mesh-list
92413780|NCT01467596|Anesthetics, Local|anesthetics, local|mesh-ancestor
92413781|NCT01467596|Anesthetics|anesthetics|mesh-ancestor
92413782|NCT01467596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92413783|NCT01467596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413784|NCT01467596|Sensory System Agents|sensory system agents|mesh-ancestor
92413785|NCT01467596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413786|NCT01467596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413787|NCT01467596|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92413788|NCT01467596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92413789|NCT01467596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413790|NCT01467596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413791|NCT01467648|Doripenem|doripenem|mesh-list
92413792|NCT01467648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413793|NCT01467648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413794|NCT01467687|Verapamil|verapamil|mesh-list
92413795|NCT01467687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92413796|NCT01467687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92413797|NCT01467687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413798|NCT01467687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413799|NCT01467687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413800|NCT01467687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413801|NCT01467687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92413802|NCT01467804|Sertraline|sertraline|mesh-list
92413803|NCT01467804|Antidepressive Agents|antidepressive agents|mesh-ancestor
92413804|NCT01467804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92413805|NCT01467804|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92413806|NCT01467804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92413807|NCT01467804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413808|NCT01467804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413809|NCT01467804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413810|NCT01467804|Serotonin Agents|serotonin agents|mesh-ancestor
92413811|NCT01467804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413812|NCT01467921|Oxaliplatin|oxaliplatin|mesh-list
92413813|NCT01467921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413814|NCT01467986|Sirolimus|sirolimus|mesh-list
92413815|NCT01467986|Irinotecan|irinotecan|mesh-list
92413816|NCT01467986|Temozolomide|temozolomide|mesh-list
92413817|NCT01467986|Dasatinib|dasatinib|mesh-list
92413818|NCT01467986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92413819|NCT01467986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413820|NCT01467986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378270|NCT02663622|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92413821|NCT01467986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413822|NCT01467986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413823|NCT01467986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92413824|NCT01467986|Alkylating Agents|alkylating agents|mesh-ancestor
92413825|NCT01467986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413826|NCT01467986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413827|NCT01467986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92608762|NCT00137345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608763|NCT00137345|Immunologic Factors|immunologic factors|mesh-ancestor
92608764|NCT00137345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608765|NCT00137462|Atorvastatin|atorvastatin|mesh-list
92608766|NCT00137462|Torcetrapib|torcetrapib|mesh-list
92608767|NCT00137462|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92413828|NCT01467986|Antifungal Agents|antifungal agents|mesh-ancestor
92413829|NCT01467986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413830|NCT01467986|Immunologic Factors|immunologic factors|mesh-ancestor
92413831|NCT01467986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413832|NCT01467986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413833|NCT01468025|Naproxen|naproxen|mesh-list
92413834|NCT01468025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92413835|NCT01468025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92413836|NCT01468025|Analgesics|analgesics|mesh-ancestor
92413837|NCT01468025|Sensory System Agents|sensory system agents|mesh-ancestor
92413844|NCT01468025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413845|NCT01468025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413847|NCT01468038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92413848|NCT01468038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92413849|NCT01468038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378775|NCT02525718|Glucocorticoids|glucocorticoids|mesh-ancestor
92413850|NCT01468038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413851|NCT01468038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92413852|NCT01468038|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92413853|NCT01468038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92378921|NCT02553798|Cholinergic Agents|cholinergic agents|mesh-ancestor
92413854|NCT01468038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413855|NCT01468038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413856|NCT01468038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413857|NCT01468038|Serotonin Agents|serotonin agents|mesh-ancestor
92413858|NCT01468038|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92413859|NCT01468038|Antidepressive Agents|antidepressive agents|mesh-ancestor
92413860|NCT01468051|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92413861|NCT01468051|Vaccines|vaccines|mesh-list
92413862|NCT01468051|Immunologic Factors|immunologic factors|mesh-ancestor
92413863|NCT01468051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413864|NCT01468051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92413865|NCT01468051|Antacids|antacids|mesh-ancestor
92413866|NCT01468051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413867|NCT01468051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92413868|NCT01468155|Dabigatran|dabigatran|mesh-list
92413869|NCT01468155|Antithrombins|antithrombins|mesh-ancestor
92413870|NCT01468155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92413871|NCT01468155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92379214|NCT03376698|Colchicine|colchicine|mesh-list
92413872|NCT01468155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413873|NCT01468155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413874|NCT01468155|Anticoagulants|anticoagulants|mesh-ancestor
92413875|NCT01468259|Droxidopa|droxidopa|mesh-list
92379283|NCT05697276|Lidocaine|lidocaine|mesh-list
92413876|NCT01468259|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92413877|NCT01468259|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92413878|NCT01468272|Beclomethasone|beclomethasone|mesh-list
92413879|NCT01468272|Formoterol Fumarate|formoterol fumarate|mesh-list
92413880|NCT01468272|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92413881|NCT01468272|Autonomic Agents|autonomic agents|mesh-ancestor
92413882|NCT01468272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413883|NCT01468272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413884|NCT01468272|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92413885|NCT01468272|Respiratory System Agents|respiratory system agents|mesh-ancestor
92413886|NCT01468272|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92413887|NCT01468272|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92413888|NCT01468272|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92413889|NCT01468272|Adrenergic Agents|adrenergic agents|mesh-ancestor
92413890|NCT01468272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413891|NCT01468272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413892|NCT01468272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413893|NCT01468272|Glucocorticoids|glucocorticoids|mesh-ancestor
92413894|NCT01468272|Hormones|hormones|mesh-ancestor
92413895|NCT01468272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413896|NCT01468285|Betahistine|betahistine|mesh-list
92413897|NCT01468285|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608768|NCT00137462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92608769|NCT00137462|Antimetabolites|antimetabolites|mesh-ancestor
92608770|NCT00137462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413898|NCT01468285|Histamine Agonists|histamine agonists|mesh-ancestor
92413899|NCT01468285|Histamine Agents|histamine agents|mesh-ancestor
92413900|NCT01468285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413901|NCT01468285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413902|NCT01468285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413904|NCT01468389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92413905|NCT01468389|Antimetabolites|antimetabolites|mesh-ancestor
92413909|NCT01468415|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92413910|NCT01468415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413911|NCT01468415|Disinfectants|disinfectants|mesh-ancestor
92413912|NCT01468415|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92413913|NCT01468415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92413914|NCT01468441|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92413915|NCT01468441|Cetrorelix|cetrorelix|mesh-list
92413916|NCT01468441|Luteolytic Agents|luteolytic agents|mesh-ancestor
92413917|NCT01468441|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92413918|NCT01468441|Contraceptive Agents|contraceptive agents|mesh-ancestor
92413919|NCT01468441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92413920|NCT01468441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413921|NCT01468441|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92413922|NCT01468441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92413923|NCT01468441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413924|NCT01468441|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92413925|NCT01468441|Fertility Agents|fertility agents|mesh-ancestor
92413926|NCT01468441|Hormone Antagonists|hormone antagonists|mesh-ancestor
92413927|NCT01468441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413928|NCT01468480|Calcium, Dietary|calcium, dietary|mesh-list
92413929|NCT01468480|Calcium|calcium|mesh-list
92413930|NCT01468480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92413931|NCT01468480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413932|NCT01468480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92413933|NCT01468519|Insulin|insulin|mesh-list
92413934|NCT01468519|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92413935|NCT01468519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92413936|NCT01468519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413937|NCT01468545|Iloprost|iloprost|mesh-list
92413938|NCT01468545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92413939|NCT01468545|Vasodilator Agents|vasodilator agents|mesh-ancestor
92413940|NCT01468571|Spironolactone|spironolactone|mesh-list
92413941|NCT01468571|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92413942|NCT01468571|Hormone Antagonists|hormone antagonists|mesh-ancestor
92413943|NCT01468571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413944|NCT01468571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413945|NCT01468571|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92413946|NCT01468571|Diuretics|diuretics|mesh-ancestor
92413947|NCT01468571|Natriuretic Agents|natriuretic agents|mesh-ancestor
92413948|NCT01468610|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92413949|NCT01468610|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92413950|NCT01468610|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92413951|NCT01468610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92413952|NCT01468610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413953|NCT01468610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413954|NCT01468610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413955|NCT01468610|Antidepressive Agents|antidepressive agents|mesh-ancestor
92413956|NCT01468610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92413957|NCT01468688|Imatinib Mesylate|imatinib mesylate|mesh-list
92413958|NCT01468688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413959|NCT01468688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413960|NCT01468688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413961|NCT01468688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413962|NCT01468714|Ketoconazole|ketoconazole|mesh-list
92413963|NCT01468714|Antifungal Agents|antifungal agents|mesh-ancestor
92413964|NCT01468714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413965|NCT01468714|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92413966|NCT01468714|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92413967|NCT01468714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608771|NCT00137462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92608772|NCT00137462|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92608773|NCT00137462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608774|NCT00153543|Vaccines|vaccines|mesh-list
92413968|NCT01468714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413969|NCT01468714|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92413970|NCT01468714|Hormone Antagonists|hormone antagonists|mesh-ancestor
92413971|NCT01468714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92413972|NCT01468714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413973|NCT01468714|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92413974|NCT01468740|Prednisone|prednisone|mesh-list
92413977|NCT01468740|Doxorubicin|doxorubicin|mesh-list
92413979|NCT01468740|Vincristine|vincristine|mesh-list
92413980|NCT01468740|Bleomycin|bleomycin|mesh-list
92413981|NCT01468740|Vinblastine|vinblastine|mesh-list
92413982|NCT01468740|Procarbazine|procarbazine|mesh-list
92413983|NCT01468740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92413984|NCT01468740|Immunologic Factors|immunologic factors|mesh-ancestor
92413985|NCT01468740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413986|NCT01468740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92413987|NCT01468740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92413988|NCT01468740|Alkylating Agents|alkylating agents|mesh-ancestor
92413989|NCT01468740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413990|NCT01468740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413991|NCT01468740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92413992|NCT01468740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92413993|NCT01468740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92413994|NCT01468740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92413995|NCT01468740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413996|NCT01468740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413997|NCT01468740|Glucocorticoids|glucocorticoids|mesh-ancestor
92413998|NCT01468740|Hormones|hormones|mesh-ancestor
92380363|NCT02905578|Paclitaxel|paclitaxel|mesh-list
92413999|NCT01468740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414000|NCT01468740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92414001|NCT01468740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92414002|NCT01468740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92414003|NCT01468740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92414004|NCT01468740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92414005|NCT01469143|Insulin|insulin|mesh-list
92414006|NCT01469143|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92414007|NCT01469143|Insulin Aspart|insulin aspart|mesh-list
92414008|NCT01469143|Insulin, Long-Acting|insulin, long-acting|mesh-list
92414009|NCT01469143|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92414010|NCT01469143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414011|NCT01469143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414012|NCT01469169|Iloprost|iloprost|mesh-list
92380640|NCT05348148|Histamine Agents|histamine agents|mesh-ancestor
92380712|NCT02529930|Immunologic Factors|immunologic factors|mesh-ancestor
92414013|NCT01469169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92414014|NCT01469169|Vasodilator Agents|vasodilator agents|mesh-ancestor
92414015|NCT01469338|Prednisone|prednisone|mesh-list
92414016|NCT01469338|Octreotide|octreotide|mesh-list
92414017|NCT01469338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414018|NCT01469338|Glucocorticoids|glucocorticoids|mesh-ancestor
92414019|NCT01469338|Hormones|hormones|mesh-ancestor
92414020|NCT01469338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414021|NCT01469338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414022|NCT01469338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92414023|NCT01469338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414024|NCT01469338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414025|NCT01469351|Liraglutide|liraglutide|mesh-list
92414026|NCT01469351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414027|NCT01469351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414028|NCT01469351|Incretins|incretins|mesh-ancestor
92414029|NCT01469351|Hormones|hormones|mesh-ancestor
92414030|NCT01469351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414031|NCT01469416|Clopidogrel|clopidogrel|mesh-list
92414032|NCT01469416|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92414033|NCT01469416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92414034|NCT01469416|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92414035|NCT01469416|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92381081|NCT02913924|Clonazepam|clonazepam|mesh-list
92414036|NCT01469416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92414037|NCT01469416|Purinergic Agents|purinergic agents|mesh-ancestor
92414038|NCT01469416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381142|NCT02953860|Fulvestrant|fulvestrant|mesh-list
92414039|NCT01469416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414040|NCT01469416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414041|NCT01469416|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92414042|NCT01469416|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92414043|NCT01469416|Antimetabolites|antimetabolites|mesh-ancestor
92414044|NCT01469416|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92414045|NCT01469416|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92414046|NCT01469416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414047|NCT01469468|Simvastatin|simvastatin|mesh-list
92414048|NCT01469468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92414052|NCT01469468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92414053|NCT01469468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92414054|NCT01469468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414055|NCT01469481|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
92414056|NCT01469481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414057|NCT01469481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414058|NCT01469507|Hyaluronic Acid|hyaluronic acid|mesh-list
92414059|NCT01469507|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92414060|NCT01469507|Immunologic Factors|immunologic factors|mesh-ancestor
92381355|NCT03041298|Chelating Agents|chelating agents|mesh-ancestor
92414061|NCT01469507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414062|NCT01469507|Viscosupplements|viscosupplements|mesh-ancestor
92414063|NCT01469507|Protective Agents|protective agents|mesh-ancestor
92414065|NCT01469520|Zidovudine|zidovudine|mesh-list
92414066|NCT01469520|Nevirapine|nevirapine|mesh-list
92414067|NCT01469520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92414068|NCT01469520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92414069|NCT01469520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414070|NCT01469520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414071|NCT01469520|Antiviral Agents|antiviral agents|mesh-ancestor
92414072|NCT01469520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414073|NCT01469520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92414074|NCT01469520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92414075|NCT01469520|Antimetabolites|antimetabolites|mesh-ancestor
92414076|NCT01469520|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92414077|NCT01469520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92414078|NCT01469559|Insulin|insulin|mesh-list
92414079|NCT01469559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414080|NCT01469559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414081|NCT01469572|Everolimus|everolimus|mesh-list
92414082|NCT01469572|Pasireotide|pasireotide|mesh-list
92414083|NCT01469572|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92414084|NCT01469572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414085|NCT01469572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414086|NCT01469572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414087|NCT01469572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414088|NCT01469572|Immunologic Factors|immunologic factors|mesh-ancestor
92414089|NCT01469572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414090|NCT01469572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414091|NCT01469572|Hormones|hormones|mesh-ancestor
92381695|NCT01463670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414092|NCT01469572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414093|NCT01469598|Gemcitabine|gemcitabine|mesh-list
92414094|NCT01469598|Docetaxel|docetaxel|mesh-list
92414095|NCT01469598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414096|NCT01469598|Antimetabolites|antimetabolites|mesh-ancestor
92414097|NCT01469598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414098|NCT01469598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414099|NCT01469598|Tubulin Modulators|tubulin modulators|mesh-ancestor
92414100|NCT01469598|Antimitotic Agents|antimitotic agents|mesh-ancestor
92414101|NCT01469598|Mitosis Modulators|mitosis modulators|mesh-ancestor
92414102|NCT01469624|Pentoxifylline|pentoxifylline|mesh-list
92414103|NCT01469624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92414104|NCT01469624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414105|NCT01469624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414106|NCT01469624|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92414107|NCT01469624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92414108|NCT01469624|Protective Agents|protective agents|mesh-ancestor
92414109|NCT01469624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414110|NCT01469624|Vasodilator Agents|vasodilator agents|mesh-ancestor
92414111|NCT01469624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92414112|NCT01469624|Antioxidants|antioxidants|mesh-ancestor
92414113|NCT01469650|Vitamin D|vitamin d|mesh-list
92414114|NCT01469650|Ergocalciferols|ergocalciferols|mesh-list
92608775|NCT00153543|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92608776|NCT00153543|Immunologic Factors|immunologic factors|mesh-ancestor
92382051|NCT03541356|Carbidopa|carbidopa|mesh-list
92608777|NCT00153543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608779|NCT00137501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92414115|NCT01469650|Cholecalciferol|cholecalciferol|mesh-list
92414116|NCT01469650|Vitamins|vitamins|mesh-list
92414117|NCT01469650|Micronutrients|micronutrients|mesh-ancestor
92414118|NCT01469650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414119|NCT01469650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92414133|NCT01469884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414135|NCT01469884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414136|NCT01469884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92414137|NCT01469884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414138|NCT01469884|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92414139|NCT01469884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414140|NCT01469884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414141|NCT01469975|Edetic Acid|edetic acid|mesh-list
92414142|NCT01469975|Pentetic Acid|pentetic acid|mesh-list
92414143|NCT01469975|Antidotes|antidotes|mesh-ancestor
92414144|NCT01469975|Protective Agents|protective agents|mesh-ancestor
92414145|NCT01469975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414146|NCT01469975|Chelating Agents|chelating agents|mesh-ancestor
92414147|NCT01469975|Sequestering Agents|sequestering agents|mesh-ancestor
92414148|NCT01469975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414149|NCT01469975|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92414150|NCT01469975|Anticoagulants|anticoagulants|mesh-ancestor
92414151|NCT01469975|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92414152|NCT01469988|Testosterone|testosterone|mesh-list
92414153|NCT01469988|Androgens|androgens|mesh-ancestor
92414154|NCT01469988|Hormones|hormones|mesh-ancestor
92382625|NCT01878786|Mycophenolic Acid|mycophenolic acid|mesh-list
92382778|NCT01350258|Fludarabine|fludarabine|mesh-list
92382850|NCT01151904|Latanoprost|latanoprost|mesh-list
92414155|NCT01469988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414156|NCT01469988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414157|NCT01470040|Aspirin|aspirin|mesh-list
92382922|NCT00875394|Protease Inhibitors|protease inhibitors|mesh-ancestor
92414158|NCT01470040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92414159|NCT01470040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92414160|NCT01470040|Analgesics|analgesics|mesh-ancestor
92414161|NCT01470040|Sensory System Agents|sensory system agents|mesh-ancestor
92414162|NCT01470040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414163|NCT01470040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414164|NCT01470040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414165|NCT01470040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414166|NCT01470040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92414167|NCT01470040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92414168|NCT01470040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383063|NCT00570258|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92383130|NCT04100772|Vaccines|vaccines|mesh-list
92414169|NCT01470040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92414170|NCT01470040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92414171|NCT01470040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414172|NCT01470040|Antipyretics|antipyretics|mesh-ancestor
92383290|NCT00074724|Dobutamine|dobutamine|mesh-list
92414173|NCT01470053|Mometasone Furoate|mometasone furoate|mesh-list
92414174|NCT01470053|Azelastine|azelastine|mesh-list
92383355|NCT00000138|Acyclovir|acyclovir|mesh-list
92414175|NCT01470053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414176|NCT01470053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92414177|NCT01470053|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92414178|NCT01470053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92414179|NCT01470053|Autonomic Agents|autonomic agents|mesh-ancestor
92383501|NCT00000276|Dopamine Agents|dopamine agents|mesh-ancestor
92414180|NCT01470053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414181|NCT01470053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414182|NCT01470053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92414183|NCT01470053|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383643|NCT00000444|Nicotine|nicotine|mesh-list
92414186|NCT01470053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414187|NCT01470053|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92414188|NCT01470053|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92414189|NCT01470053|Histamine Antagonists|histamine antagonists|mesh-ancestor
92414190|NCT01470053|Histamine Agents|histamine agents|mesh-ancestor
92414191|NCT01470053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414192|NCT01470092|Tibolone|tibolone|mesh-list
92414193|NCT01470092|Androgen Antagonists|androgen antagonists|mesh-ancestor
92414194|NCT01470092|Hormone Antagonists|hormone antagonists|mesh-ancestor
92383936|NCT00000918|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92414195|NCT01470092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92608780|NCT00137501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92384086|NCT00001104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608781|NCT00137501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414196|NCT01470092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414197|NCT01470092|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92414198|NCT01470092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92414199|NCT01470092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414200|NCT01470092|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92414201|NCT01470092|Anabolic Agents|anabolic agents|mesh-ancestor
92414203|NCT01470157|Ketamine|ketamine|mesh-list
92384236|NCT00001812|Nystatin|nystatin|mesh-list
92414204|NCT01470157|Analgesics|analgesics|mesh-ancestor
92414205|NCT01470157|Sensory System Agents|sensory system agents|mesh-ancestor
92414206|NCT01470157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414207|NCT01470157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414208|NCT01470157|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92414209|NCT01470157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92414210|NCT01470157|Anesthetics, General|anesthetics, general|mesh-ancestor
92414211|NCT01470157|Anesthetics|anesthetics|mesh-ancestor
92414212|NCT01470157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92384303|NCT00001968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92384373|NCT00002052|Amoxicillin|amoxicillin|mesh-list
92414213|NCT01470157|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92414214|NCT01470157|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92414215|NCT01470157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414216|NCT01470157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414217|NCT01470209|Everolimus|everolimus|mesh-list
92414218|NCT01470209|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92414219|NCT01470209|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414220|NCT01470209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384523|NCT00002154|Antioxidants|antioxidants|mesh-ancestor
92414221|NCT01470209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414222|NCT01470209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414223|NCT01470209|Immunologic Factors|immunologic factors|mesh-ancestor
92384585|NCT00002184|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384663|NCT00002220|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92414224|NCT01470209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414225|NCT01470209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414226|NCT01470326|Bazedoxifene|bazedoxifene|mesh-list
92414227|NCT01470326|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92414228|NCT01470326|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92414229|NCT01470326|Hormone Antagonists|hormone antagonists|mesh-ancestor
92414230|NCT01470326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414231|NCT01470326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414232|NCT01470326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92414233|NCT01470339|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92414234|NCT01470339|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92414235|NCT01470339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92414236|NCT01470339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92414237|NCT01470339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414238|NCT01470339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414239|NCT01470339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414240|NCT01470339|Analgesics|analgesics|mesh-ancestor
92414241|NCT01470339|Sensory System Agents|sensory system agents|mesh-ancestor
92414242|NCT01470339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414243|NCT01470339|Antidepressive Agents|antidepressive agents|mesh-ancestor
92414244|NCT01470339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92414245|NCT01470339|Dopamine Agents|dopamine agents|mesh-ancestor
92414246|NCT01470352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92414247|NCT01470352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92414248|NCT01470352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92414249|NCT01470352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92414250|NCT01470352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414251|NCT01470352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414252|NCT01470352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414270|NCT01470495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414271|NCT01470495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414272|NCT01470690|Omeprazole|omeprazole|mesh-list
92414273|NCT01470690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92414274|NCT01470690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414275|NCT01470690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92414276|NCT01470690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414277|NCT01470690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414278|NCT01470742|Capecitabine|capecitabine|mesh-list
92608782|NCT00137501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608783|NCT00137501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608784|NCT00137501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92608785|NCT00137501|Tocolytic Agents|tocolytic agents|mesh-ancestor
92414279|NCT01470742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414280|NCT01470742|Antimetabolites|antimetabolites|mesh-ancestor
92414281|NCT01470742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414282|NCT01470742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414283|NCT01470794|Flucytosine|flucytosine|mesh-list
92414284|NCT01470794|Antifungal Agents|antifungal agents|mesh-ancestor
92414285|NCT01470794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414286|NCT01470794|Antimetabolites|antimetabolites|mesh-ancestor
92414287|NCT01470794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414288|NCT01470807|Pancrelipase|pancrelipase|mesh-list
92414289|NCT01470807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414290|NCT01470937|Acarbose|acarbose|mesh-list
92414291|NCT01470937|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92414292|NCT01470937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414293|NCT01470937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414294|NCT01470937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414295|NCT01470937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414296|NCT01471067|Mycophenolic Acid|mycophenolic acid|mesh-list
92414297|NCT01471067|Rituximab|rituximab|mesh-list
92414298|NCT01471067|Fludarabine|fludarabine|mesh-list
92414299|NCT01471067|Fludarabine phosphate|fludarabine phosphate|mesh-list
92414300|NCT01471067|Melphalan|melphalan|mesh-list
92414301|NCT01471067|Busulfan|busulfan|mesh-list
92414302|NCT01471067|Clofarabine|clofarabine|mesh-list
92414303|NCT01471067|Tacrolimus|tacrolimus|mesh-list
92414304|NCT01471067|Thymoglobulin|thymoglobulin|mesh-list
92414305|NCT01471067|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92414306|NCT01471067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414307|NCT01471067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414308|NCT01471067|Immunologic Factors|immunologic factors|mesh-ancestor
92414309|NCT01471067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414310|NCT01471067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414311|NCT01471067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414312|NCT01471067|Antimetabolites|antimetabolites|mesh-ancestor
92414313|NCT01471067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414317|NCT01471067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414318|NCT01471067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92414319|NCT01471067|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92414320|NCT01471067|Antitubercular Agents|antitubercular agents|mesh-ancestor
92414321|NCT01471067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92414322|NCT01471067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92414323|NCT01471067|Alkylating Agents|alkylating agents|mesh-ancestor
92414324|NCT01471067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92414325|NCT01471132|Paclitaxel|paclitaxel|mesh-list
92414326|NCT01471132|Oxaliplatin|oxaliplatin|mesh-list
92414327|NCT01471132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92414328|NCT01471132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414329|NCT01471132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92414330|NCT01471132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92414331|NCT01471132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92414332|NCT01471132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414333|NCT01471145|Naltrexone|naltrexone|mesh-list
92414334|NCT01471145|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92414335|NCT01471145|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92414336|NCT01471145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414337|NCT01471145|Sensory System Agents|sensory system agents|mesh-ancestor
92414338|NCT01471145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414339|NCT01471158|Timolol|timolol|mesh-list
92414340|NCT01471158|Dorzolamide|dorzolamide|mesh-list
92414341|NCT01471158|Maleic acid|maleic acid|mesh-list
92414342|NCT01471158|Brinzolamide|brinzolamide|mesh-list
92414343|NCT01471158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384959|NCT00002424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414344|NCT01471158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717871|NCT04623021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414345|NCT01471158|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92414346|NCT01471158|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92414347|NCT01471158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92414348|NCT01471158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608786|NCT00137501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92608788|NCT00153660|Celecoxib|celecoxib|mesh-list
92414349|NCT01471158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414350|NCT01471158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92414351|NCT01471158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92414352|NCT01471158|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92414353|NCT01471184|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92414354|NCT01471184|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92414355|NCT01471262|Liver Extracts|liver extracts|mesh-list
92414356|NCT01471262|Hematinics|hematinics|mesh-ancestor
92414357|NCT01471275|Metformin|metformin|mesh-list
92414358|NCT01471275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414359|NCT01471275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414360|NCT01471418|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92414361|NCT01471418|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92414362|NCT01471418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414363|NCT01471470|Bevacizumab|bevacizumab|mesh-list
92414364|NCT01471470|Docetaxel|docetaxel|mesh-list
92414365|NCT01471470|Capecitabine|capecitabine|mesh-list
92414366|NCT01471470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414367|NCT01471470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414368|NCT01471470|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92414369|NCT01471470|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92414370|NCT01471470|Growth Substances|growth substances|mesh-ancestor
92414371|NCT01471470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414372|NCT01471470|Growth Inhibitors|growth inhibitors|mesh-ancestor
92414373|NCT01471470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92414374|NCT01471470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92414375|NCT01471470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92414376|NCT01471470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414377|NCT01471470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414378|NCT01471470|Antimetabolites|antimetabolites|mesh-ancestor
92414379|NCT01471535|Interferons|interferons|mesh-list
92414380|NCT01471535|Interferon-alpha|interferon-alpha|mesh-list
92414381|NCT01471535|Interferon alpha-2|interferon alpha-2|mesh-list
92414382|NCT01471535|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92414383|NCT01471535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414384|NCT01471535|Antiviral Agents|antiviral agents|mesh-ancestor
92414385|NCT01471535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414386|NCT01471535|Immunologic Factors|immunologic factors|mesh-ancestor
92414416|NCT01471704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414418|NCT01471704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414419|NCT01471704|Vasodilator Agents|vasodilator agents|mesh-ancestor
92414421|NCT01471730|Hemostatics|hemostatics|mesh-ancestor
92414422|NCT01471730|Coagulants|coagulants|mesh-ancestor
92414423|NCT01471808|Metformin|metformin|mesh-list
92414424|NCT01471808|Pioglitazone|pioglitazone|mesh-list
92414425|NCT01471808|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92414426|NCT01471808|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414427|NCT01471808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414428|NCT01471808|Incretins|incretins|mesh-ancestor
92414429|NCT01471808|Hormones|hormones|mesh-ancestor
92414430|NCT01471808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414458|NCT01471886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414459|NCT01471886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414460|NCT01471886|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92414461|NCT01471886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414462|NCT01471886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414463|NCT01471886|Gout Suppressants|gout suppressants|mesh-ancestor
92414464|NCT01471899|Ketorolac|ketorolac|mesh-list
92414465|NCT01471899|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92414466|NCT01471899|Naproxen|naproxen|mesh-list
92414467|NCT01471899|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92414468|NCT01471899|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92414469|NCT01471899|Analgesics|analgesics|mesh-ancestor
92414470|NCT01471899|Sensory System Agents|sensory system agents|mesh-ancestor
92414471|NCT01471899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414472|NCT01471899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414473|NCT01471899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414474|NCT01471899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414475|NCT01471899|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92414476|NCT01471899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414477|NCT01471899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608789|NCT00153660|Naproxen|naproxen|mesh-list
92608790|NCT00153660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608791|NCT00153660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608792|NCT00153660|Analgesics|analgesics|mesh-ancestor
92333821|NCT00004177|Antibodies|antibodies|mesh-list
92608793|NCT00153660|Sensory System Agents|sensory system agents|mesh-ancestor
92608794|NCT00153660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608795|NCT00153660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608796|NCT00153660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016002|NCT02629159|Adalimumab|adalimumab|mesh-list
92414478|NCT01471899|Gout Suppressants|gout suppressants|mesh-ancestor
92414479|NCT01471925|Esomeprazole|esomeprazole|mesh-list
92414491|NCT01471990|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
92414492|NCT01471990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92139139|NCT03139422|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92414493|NCT01471990|Vasodilator Agents|vasodilator agents|mesh-ancestor
92414494|NCT01471990|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92414495|NCT01471990|Protective Agents|protective agents|mesh-ancestor
92414496|NCT01471990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414497|NCT01471990|Growth Substances|growth substances|mesh-ancestor
92414498|NCT01471990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414499|NCT01471990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414500|NCT01472016|Docetaxel|docetaxel|mesh-list
92414501|NCT01472016|Cetuximab|cetuximab|mesh-list
92414502|NCT01472016|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92414503|NCT01472016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414504|NCT01472016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92414505|NCT01472016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92414506|NCT01472016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92414507|NCT01472016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414508|NCT01472016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414509|NCT01472016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414510|NCT01472016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414511|NCT01472029|Leucovorin|leucovorin|mesh-list
92414512|NCT01472029|Docetaxel|docetaxel|mesh-list
92414513|NCT01472029|Oxaliplatin|oxaliplatin|mesh-list
92414514|NCT01472029|Trastuzumab|trastuzumab|mesh-list
92414515|NCT01472029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414516|NCT01472029|Tubulin Modulators|tubulin modulators|mesh-ancestor
92414517|NCT01472029|Antimitotic Agents|antimitotic agents|mesh-ancestor
92414518|NCT01472029|Mitosis Modulators|mitosis modulators|mesh-ancestor
92414519|NCT01472029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414520|NCT01472029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414521|NCT01472029|Antidotes|antidotes|mesh-ancestor
92414522|NCT01472029|Protective Agents|protective agents|mesh-ancestor
92414523|NCT01472029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414524|NCT01472029|Vitamin B Complex|vitamin b complex|mesh-ancestor
92414525|NCT01472029|Vitamins|vitamins|mesh-ancestor
92414526|NCT01472029|Micronutrients|micronutrients|mesh-ancestor
92414527|NCT01472055|Fludarabine|fludarabine|mesh-list
92414528|NCT01472055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414529|NCT01472146|Doxorubicin|doxorubicin|mesh-list
92414530|NCT01472146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414531|NCT01472146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92414532|NCT01472146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92414533|NCT01472146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92414534|NCT01472146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414535|NCT01472146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414536|NCT01472263|Pentoxifylline|pentoxifylline|mesh-list
92414537|NCT01472263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92414538|NCT01472263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414539|NCT01472263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414540|NCT01472263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92414541|NCT01472263|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92414545|NCT01472263|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92414546|NCT01472263|Antioxidants|antioxidants|mesh-ancestor
92414547|NCT01472315|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92016011|NCT05548985|Midodrine|midodrine|mesh-list
92608797|NCT00153660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608798|NCT00153660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92608799|NCT00153660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608800|NCT00153660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608801|NCT00153660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608802|NCT00153660|Gout Suppressants|gout suppressants|mesh-ancestor
92608803|NCT00137657|Trimethoprim|trimethoprim|mesh-list
92608804|NCT00137657|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92608805|NCT00137657|Sulfamethoxazole|sulfamethoxazole|mesh-list
92608806|NCT00137657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92608807|NCT00137657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608808|NCT00137657|Antimalarials|antimalarials|mesh-ancestor
92608809|NCT00137657|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92608810|NCT00137657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92608811|NCT00137657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92608812|NCT00137657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608813|NCT00137657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608814|NCT00137657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92608815|NCT00137657|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92608816|NCT00137657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92608817|NCT00137657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92608818|NCT00153699|Topiramate|topiramate|mesh-list
92608819|NCT00153699|Anticonvulsants|anticonvulsants|mesh-ancestor
92608820|NCT00153699|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608821|NCT00153699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608822|NCT00160290|Lactulose|lactulose|mesh-list
92608823|NCT00160290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92608824|NCT00137735|Gabapentin|gabapentin|mesh-list
92608825|NCT00137735|Analgesics|analgesics|mesh-ancestor
92608826|NCT00137735|Sensory System Agents|sensory system agents|mesh-ancestor
92016038|NCT05552807|Paclitaxel|paclitaxel|mesh-list
92414548|NCT01472315|Medroxyprogesterone|medroxyprogesterone|mesh-list
92414549|NCT01472315|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92414550|NCT01472315|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92414551|NCT01472315|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92414552|NCT01472315|Contraceptive Agents|contraceptive agents|mesh-ancestor
92385094|NCT00002496|Cobalt|cobalt|mesh-list
92414553|NCT01472315|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92414554|NCT01472315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414555|NCT01472315|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92414556|NCT01472315|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92414557|NCT01472315|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92414558|NCT01472315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92608827|NCT00137735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608828|NCT00137735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608830|NCT00137735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92608831|NCT00137735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608832|NCT00137735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92414559|NCT01472315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414560|NCT01472406|Pancrelipase|pancrelipase|mesh-list
92414561|NCT01472406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414562|NCT01472497|Pioglitazone|pioglitazone|mesh-list
92414563|NCT01472497|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414564|NCT01472497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414565|NCT01472510|Ranibizumab|ranibizumab|mesh-list
92414566|NCT01472510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92414567|NCT01472510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92139219|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
92414568|NCT01472510|Growth Substances|growth substances|mesh-ancestor
92414569|NCT01472510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414570|NCT01472510|Growth Inhibitors|growth inhibitors|mesh-ancestor
92414571|NCT01472510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414572|NCT01472640|Liraglutide|liraglutide|mesh-list
92414573|NCT01472640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414574|NCT01472640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414575|NCT01472640|Incretins|incretins|mesh-ancestor
92414576|NCT01472640|Hormones|hormones|mesh-ancestor
92414577|NCT01472640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414578|NCT01472653|Cetuximab|cetuximab|mesh-list
92414579|NCT01472653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414580|NCT01472653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414581|NCT01472666|Caseins|caseins|mesh-list
92414582|NCT01472666|Chelating Agents|chelating agents|mesh-ancestor
92414583|NCT01472666|Sequestering Agents|sequestering agents|mesh-ancestor
92414584|NCT01472666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414585|NCT01472731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92414586|NCT01472731|Immunologic Factors|immunologic factors|mesh-ancestor
92414587|NCT01472731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414588|NCT01472770|Gemcitabine|gemcitabine|mesh-list
92414589|NCT01472770|Capecitabine|capecitabine|mesh-list
92414590|NCT01472770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414591|NCT01472770|Antimetabolites|antimetabolites|mesh-ancestor
92414592|NCT01472770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414593|NCT01472770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414594|NCT01472783|Veliparib|veliparib|mesh-list
92414595|NCT01472783|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92414596|NCT01472783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414597|NCT01472783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414598|NCT01472783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414599|NCT01472796|Vitamin D|vitamin d|mesh-list
92414600|NCT01472796|Cholecalciferol|cholecalciferol|mesh-list
92414601|NCT01472796|Vitamins|vitamins|mesh-ancestor
92414602|NCT01472796|Micronutrients|micronutrients|mesh-ancestor
92414603|NCT01472796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414604|NCT01472796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92414605|NCT01472796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414606|NCT01472900|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92414607|NCT01472900|Dermatologic Agents|dermatologic agents|mesh-ancestor
92414608|NCT01472913|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92414609|NCT01472913|Hemostatics|hemostatics|mesh-ancestor
92414610|NCT01472913|Coagulants|coagulants|mesh-ancestor
92414611|NCT01472926|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92414612|NCT01472926|Plasminogen|plasminogen|mesh-list
92414613|NCT01472926|Tenecteplase|tenecteplase|mesh-list
92414614|NCT01472926|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92414620|NCT01472978|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92414621|NCT01472978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92414622|NCT01473043|Axitinib|axitinib|mesh-list
92414623|NCT01473043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414624|NCT01473043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414625|NCT01473043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414626|NCT01473043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414627|NCT01473069|Ketoconazole|ketoconazole|mesh-list
92608833|NCT00137735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92608834|NCT00137735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92414628|NCT01473069|Antifungal Agents|antifungal agents|mesh-ancestor
92414629|NCT01473069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414630|NCT01473069|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92414631|NCT01473069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92414632|NCT01473069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414633|NCT01473069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414634|NCT01473069|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92414635|NCT01473069|Hormone Antagonists|hormone antagonists|mesh-ancestor
92414636|NCT01473069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414637|NCT01473069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414638|NCT01473069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92414639|NCT01473147|Exenatide|exenatide|mesh-list
92414640|NCT01473147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414641|NCT01473147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414642|NCT01473147|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92414643|NCT01473147|Incretins|incretins|mesh-ancestor
92414644|NCT01473147|Hormones|hormones|mesh-ancestor
92414645|NCT01473147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414646|NCT01473173|Esomeprazole|esomeprazole|mesh-list
92414647|NCT01473173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92414648|NCT01473173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414649|NCT01473173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92414650|NCT01473173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414651|NCT01473173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414652|NCT01473251|Bevacizumab|bevacizumab|mesh-list
92414653|NCT01473251|Ranibizumab|ranibizumab|mesh-list
92414654|NCT01473251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414655|NCT01473251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414656|NCT01473251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92414657|NCT01473251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92414658|NCT01473251|Growth Substances|growth substances|mesh-ancestor
92414659|NCT01473251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414660|NCT01473251|Growth Inhibitors|growth inhibitors|mesh-ancestor
92414661|NCT01473277|Triamcinolone|triamcinolone|mesh-list
92414662|NCT01473277|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92414663|NCT01473277|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92414664|NCT01473277|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92414665|NCT01473277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92414666|NCT01473277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414667|NCT01473277|Glucocorticoids|glucocorticoids|mesh-ancestor
92414668|NCT01473277|Hormones|hormones|mesh-ancestor
92414669|NCT01473277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414670|NCT01473277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414671|NCT01473277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414672|NCT01473277|Immunologic Factors|immunologic factors|mesh-ancestor
92414673|NCT01473277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414674|NCT01473277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414675|NCT01473277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92414676|NCT01473277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92414677|NCT01473277|Cholinergic Agents|cholinergic agents|mesh-ancestor
92414678|NCT01473277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414679|NCT01473303|Leucovorin|leucovorin|mesh-list
92414680|NCT01473303|Fluorouracil|fluorouracil|mesh-list
92414681|NCT01473303|Oxaliplatin|oxaliplatin|mesh-list
92414682|NCT01473303|Irinotecan|irinotecan|mesh-list
92414683|NCT01473303|Calcium|calcium|mesh-list
92414684|NCT01473303|Levoleucovorin|levoleucovorin|mesh-list
92414685|NCT01473303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414687|NCT01473303|Antimetabolites|antimetabolites|mesh-ancestor
92414688|NCT01473303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414689|NCT01473303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414690|NCT01473303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414691|NCT01473303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414692|NCT01473303|Immunologic Factors|immunologic factors|mesh-ancestor
92414693|NCT01473303|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92414694|NCT01473303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92414695|NCT01473303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414696|NCT01473303|Antidotes|antidotes|mesh-ancestor
92414697|NCT01473303|Protective Agents|protective agents|mesh-ancestor
92414698|NCT01473303|Vitamin B Complex|vitamin b complex|mesh-ancestor
92608835|NCT00137735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92608836|NCT00137735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016047|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
92414699|NCT01473303|Vitamins|vitamins|mesh-ancestor
92414700|NCT01473303|Micronutrients|micronutrients|mesh-ancestor
92414701|NCT01473316|Ketoconazole|ketoconazole|mesh-list
92414702|NCT01473316|Antifungal Agents|antifungal agents|mesh-ancestor
92414703|NCT01473316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414704|NCT01473316|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92414705|NCT01473316|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92414706|NCT01473316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414707|NCT01473316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414708|NCT01473316|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92414709|NCT01473316|Hormone Antagonists|hormone antagonists|mesh-ancestor
92414710|NCT01473316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414711|NCT01473316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414712|NCT01473316|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92414713|NCT01473472|Tenofovir|tenofovir|mesh-list
92414714|NCT01473472|Emtricitabine|emtricitabine|mesh-list
92414715|NCT01473472|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92414716|NCT01473472|Antiviral Agents|antiviral agents|mesh-ancestor
92139382|NCT00665457|Antimetabolites|antimetabolites|mesh-ancestor
92414717|NCT01473472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414718|NCT01473472|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92414719|NCT01473472|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92414720|NCT01473472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414721|NCT01473472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414722|NCT01473472|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92414723|NCT01473472|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92414724|NCT01473537|Calcium|calcium|mesh-list
92414725|NCT01473537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414726|NCT01473537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414727|NCT01473797|Cladribine|cladribine|mesh-list
92414728|NCT01473797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414729|NCT01473797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414730|NCT01473797|Immunologic Factors|immunologic factors|mesh-ancestor
92414731|NCT01473797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414732|NCT01473810|Endocine|endocine|mesh-list
92414733|NCT01473810|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92414734|NCT01473810|Immunologic Factors|immunologic factors|mesh-ancestor
92414735|NCT01473810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414736|NCT01473901|Temozolomide|temozolomide|mesh-list
92414737|NCT01473901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92414738|NCT01473901|Alkylating Agents|alkylating agents|mesh-ancestor
92414739|NCT01473901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414740|NCT01473901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414741|NCT01473914|Vitamins|vitamins|mesh-list
92414742|NCT01473914|Vitamin E|vitamin e|mesh-list
92414743|NCT01473914|Tocopherols|tocopherols|mesh-list
92414744|NCT01473914|Tocotrienols|tocotrienols|mesh-list
92414745|NCT01473914|alpha-Tocopherol|alpha-tocopherol|mesh-list
92414746|NCT01473914|Zinc|zinc|mesh-list
92414747|NCT01473914|Selenium|selenium|mesh-list
92414748|NCT01473914|Micronutrients|micronutrients|mesh-ancestor
92414749|NCT01473914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414750|NCT01473914|Trace Elements|trace elements|mesh-ancestor
92414751|NCT01473914|Antioxidants|antioxidants|mesh-ancestor
92414752|NCT01473914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414753|NCT01473914|Protective Agents|protective agents|mesh-ancestor
92414754|NCT01474174|Vaccines|vaccines|mesh-list
92414755|NCT01474174|Immunologic Factors|immunologic factors|mesh-ancestor
92414756|NCT01474174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414757|NCT01474187|Capecitabine|capecitabine|mesh-list
92414758|NCT01474187|Irinotecan|irinotecan|mesh-list
92414785|NCT01474330|Growth Substances|growth substances|mesh-ancestor
92414786|NCT01474330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92414787|NCT01474330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414789|NCT01474382|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92414790|NCT01474382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92414791|NCT01474382|Adrenergic Agents|adrenergic agents|mesh-ancestor
92414792|NCT01474382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414793|NCT01474382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414794|NCT01474382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608837|NCT00137735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608838|NCT00137735|Antimanic Agents|antimanic agents|mesh-ancestor
92608839|NCT00137774|Bevacizumab|bevacizumab|mesh-list
92414795|NCT01474382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92414796|NCT01474460|Vitamin K|vitamin k|mesh-list
92414797|NCT01474460|Vitamin K 1|vitamin k 1|mesh-list
92414798|NCT01474460|Vitamins|vitamins|mesh-ancestor
92414799|NCT01474460|Micronutrients|micronutrients|mesh-ancestor
92414800|NCT01474460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414801|NCT01474460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92414802|NCT01474460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92414803|NCT01474460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414804|NCT01474460|Hemostatics|hemostatics|mesh-ancestor
92414805|NCT01474460|Coagulants|coagulants|mesh-ancestor
92414806|NCT01474473|Calpastatin|calpastatin|mesh-list
92414807|NCT01474473|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92414813|NCT01474499|Glycerol|glycerol|mesh-list
92414814|NCT01474499|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92385248|NCT00002568|Paclitaxel|paclitaxel|mesh-list
92414815|NCT01474499|Protective Agents|protective agents|mesh-ancestor
92414816|NCT01474499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414817|NCT01474499|Cathartics|cathartics|mesh-ancestor
92414818|NCT01474499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414819|NCT01474499|Antidiarrheals|antidiarrheals|mesh-ancestor
92414820|NCT01474642|Capecitabine|capecitabine|mesh-list
92414821|NCT01474642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414822|NCT01474642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414823|NCT01474642|Antimetabolites|antimetabolites|mesh-ancestor
92414824|NCT01474642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414825|NCT01474902|Enoxaparin|enoxaparin|mesh-list
92414826|NCT01474902|Anticoagulants|anticoagulants|mesh-ancestor
92414827|NCT01474902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92414828|NCT01474902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92414829|NCT01474902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414830|NCT01474967|Metformin|metformin|mesh-list
92414831|NCT01474967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92414832|NCT01474967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414833|NCT01475006|AMG 595|amg 595|mesh-list
92414834|NCT01475006|Immunoconjugates|immunoconjugates|mesh-ancestor
92414835|NCT01475006|Immunologic Factors|immunologic factors|mesh-ancestor
92414836|NCT01475006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414837|NCT01475019|Orlistat|orlistat|mesh-list
92414838|NCT01475019|Sibutramine|sibutramine|mesh-list
92414839|NCT01475019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414840|NCT01475019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414841|NCT01475019|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92414842|NCT01475019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92414843|NCT01475019|Antidepressive Agents|antidepressive agents|mesh-ancestor
92414844|NCT01475019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92414845|NCT01475019|Appetite Depressants|appetite depressants|mesh-ancestor
92414846|NCT01475032|Beclomethasone|beclomethasone|mesh-list
92414847|NCT01475032|Formoterol Fumarate|formoterol fumarate|mesh-list
92414848|NCT01475032|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92414849|NCT01475032|Autonomic Agents|autonomic agents|mesh-ancestor
92414850|NCT01475032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414851|NCT01475032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414852|NCT01475032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92414853|NCT01475032|Respiratory System Agents|respiratory system agents|mesh-ancestor
92414854|NCT01475032|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92414855|NCT01475032|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92414856|NCT01475032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92414857|NCT01475032|Adrenergic Agents|adrenergic agents|mesh-ancestor
92414858|NCT01475032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414859|NCT01475032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414860|NCT01475032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414861|NCT01475032|Glucocorticoids|glucocorticoids|mesh-ancestor
92414862|NCT01475032|Hormones|hormones|mesh-ancestor
92414863|NCT01475032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414864|NCT01475227|Zinc|zinc|mesh-list
92414865|NCT01475227|Zinc Sulfate|zinc sulfate|mesh-list
92414866|NCT01475227|Trace Elements|trace elements|mesh-ancestor
92414867|NCT01475227|Micronutrients|micronutrients|mesh-ancestor
92414868|NCT01475227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414869|NCT01475227|Astringents|astringents|mesh-ancestor
92414870|NCT01475227|Dermatologic Agents|dermatologic agents|mesh-ancestor
92414871|NCT01475266|Apaziquone|apaziquone|mesh-list
92608840|NCT00137774|Temozolomide|temozolomide|mesh-list
92608841|NCT00137774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414872|NCT01475266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414873|NCT01475279|Warfarin|warfarin|mesh-list
92414874|NCT01475279|Anticoagulants|anticoagulants|mesh-ancestor
92414875|NCT01475318|Letrozole|letrozole|mesh-list
92414876|NCT01475318|Misoprostol|misoprostol|mesh-list
92414877|NCT01475318|Mifepristone|mifepristone|mesh-list
92414878|NCT01475318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414879|NCT01475318|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92414880|NCT01475318|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92414881|NCT01475318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414885|NCT01475318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414886|NCT01475318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414887|NCT01475318|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92414888|NCT01475318|Abortifacient Agents|abortifacient agents|mesh-ancestor
92414889|NCT01475318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92414890|NCT01475318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92414891|NCT01475318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414893|NCT01475318|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92414894|NCT01475318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92414895|NCT01475318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92414896|NCT01475318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92414897|NCT01475318|Contraceptive Agents|contraceptive agents|mesh-ancestor
92414898|NCT01475318|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92414899|NCT01475318|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92414900|NCT01475318|Luteolytic Agents|luteolytic agents|mesh-ancestor
92414901|NCT01475318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92414902|NCT01475318|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92414903|NCT01475552|Abciximab|abciximab|mesh-list
92414904|NCT01475552|Clopidogrel|clopidogrel|mesh-list
92414905|NCT01475552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414906|NCT01475552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414907|NCT01475552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92414908|NCT01475552|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92414909|NCT01475552|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92414910|NCT01475552|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92414911|NCT01475552|Purinergic Agents|purinergic agents|mesh-ancestor
92414912|NCT01475552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414913|NCT01475552|Anticoagulants|anticoagulants|mesh-ancestor
92414914|NCT01475578|Ergoloid Mesylates|ergoloid mesylates|mesh-list
92414915|NCT01475578|Dihydroergotoxine|dihydroergotoxine|mesh-list
92414916|NCT01475578|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92414917|NCT01475578|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92414918|NCT01475578|Adrenergic Agents|adrenergic agents|mesh-ancestor
92414919|NCT01475578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414920|NCT01475578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414921|NCT01475578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414922|NCT01475578|Vasodilator Agents|vasodilator agents|mesh-ancestor
92414923|NCT01475578|Nootropic Agents|nootropic agents|mesh-ancestor
92414924|NCT01475578|Dopamine Agonists|dopamine agonists|mesh-ancestor
92414925|NCT01475578|Dopamine Agents|dopamine agents|mesh-ancestor
92414926|NCT01475617|Calcium, Dietary|calcium, dietary|mesh-list
92414927|NCT01475617|Vitamin B 12|vitamin b 12|mesh-list
92414928|NCT01475617|Hydroxocobalamin|hydroxocobalamin|mesh-list
92414929|NCT01475617|Calcium|calcium|mesh-list
92414930|NCT01475617|Vitamins|vitamins|mesh-ancestor
92414931|NCT01475617|Micronutrients|micronutrients|mesh-ancestor
92414932|NCT01475617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414933|NCT01475617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414934|NCT01475617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92414935|NCT01475617|Vitamin B Complex|vitamin b complex|mesh-ancestor
92414936|NCT01475617|Hematinics|hematinics|mesh-ancestor
92414937|NCT01475656|Levetiracetam|levetiracetam|mesh-list
92414938|NCT01475656|Anticonvulsants|anticonvulsants|mesh-ancestor
92414939|NCT01475656|Nootropic Agents|nootropic agents|mesh-ancestor
92414940|NCT01475708|Doxycycline|doxycycline|mesh-list
92414941|NCT01475708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92414942|NCT01475708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414943|NCT01475708|Antimalarials|antimalarials|mesh-ancestor
92414944|NCT01475708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92414945|NCT01475708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92414946|NCT01475760|Chitosan|chitosan|mesh-list
92139592|NCT04351230|Maytansine|maytansine|mesh-list
92414947|NCT01475760|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92608843|NCT00137774|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92016054|NCT05699993|Itraconazole|itraconazole|mesh-list
92414948|NCT01475760|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92414949|NCT01475760|Antimetabolites|antimetabolites|mesh-ancestor
92414950|NCT01475760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414951|NCT01475760|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92414952|NCT01475760|Chelating Agents|chelating agents|mesh-ancestor
92414963|NCT01475877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92414964|NCT01475877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414965|NCT01475890|Vitamin D|vitamin d|mesh-list
92414966|NCT01475890|Cholecalciferol|cholecalciferol|mesh-list
92414967|NCT01475890|Vitamins|vitamins|mesh-ancestor
92414968|NCT01475890|Micronutrients|micronutrients|mesh-ancestor
92414969|NCT01475890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414970|NCT01475890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92414971|NCT01475890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414972|NCT01476007|Vitamins|vitamins|mesh-list
92414973|NCT01476007|Hydroxocobalamin|hydroxocobalamin|mesh-list
92414974|NCT01476007|Vitamin B 12|vitamin b 12|mesh-list
92414975|NCT01476007|Vitamin B Complex|vitamin b complex|mesh-list
92414976|NCT01476007|Micronutrients|micronutrients|mesh-ancestor
92414977|NCT01476007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414978|NCT01476007|Hematinics|hematinics|mesh-ancestor
92414979|NCT01476124|Morphine|morphine|mesh-list
92414980|NCT01476124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92414981|NCT01476124|Narcotics|narcotics|mesh-ancestor
92414982|NCT01476124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92414983|NCT01476124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414984|NCT01476124|Analgesics|analgesics|mesh-ancestor
92414985|NCT01476124|Sensory System Agents|sensory system agents|mesh-ancestor
92414986|NCT01476124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414987|NCT01476137|Trametinib|trametinib|mesh-list
92414988|NCT01476137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414989|NCT01476137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414990|NCT01476137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414991|NCT01476137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414992|NCT01476176|Acetaminophen|acetaminophen|mesh-list
92414993|NCT01476176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92414994|NCT01476176|Analgesics|analgesics|mesh-ancestor
92414995|NCT01476176|Sensory System Agents|sensory system agents|mesh-ancestor
92414996|NCT01476176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414997|NCT01476176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414998|NCT01476176|Antipyretics|antipyretics|mesh-ancestor
92414999|NCT01476189|Acetaminophen|acetaminophen|mesh-list
92415000|NCT01476189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415001|NCT01476189|Analgesics|analgesics|mesh-ancestor
92415002|NCT01476189|Sensory System Agents|sensory system agents|mesh-ancestor
92415003|NCT01476189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415004|NCT01476189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415005|NCT01476189|Antipyretics|antipyretics|mesh-ancestor
92415006|NCT01476215|Acetaminophen|acetaminophen|mesh-list
92415007|NCT01476215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415008|NCT01476215|Analgesics|analgesics|mesh-ancestor
92415009|NCT01476215|Sensory System Agents|sensory system agents|mesh-ancestor
92415010|NCT01476215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415011|NCT01476215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415012|NCT01476215|Antipyretics|antipyretics|mesh-ancestor
92415013|NCT01476280|Palonosetron|palonosetron|mesh-list
92415014|NCT01476280|Ramosetron|ramosetron|mesh-list
92415015|NCT01476280|Antiemetics|antiemetics|mesh-ancestor
92415016|NCT01476280|Autonomic Agents|autonomic agents|mesh-ancestor
92415017|NCT01476280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415018|NCT01476280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415019|NCT01476280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415020|NCT01476280|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92415021|NCT01476280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92415022|NCT01476280|Serotonin Agents|serotonin agents|mesh-ancestor
92415023|NCT01476280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415042|NCT01476410|Antibodies|antibodies|mesh-list
92415043|NCT01476410|Immunoglobulins|immunoglobulins|mesh-list
92415044|NCT01476410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92415045|NCT01476410|Immunoconjugates|immunoconjugates|mesh-list
92415046|NCT01476410|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92415047|NCT01476410|Immunologic Factors|immunologic factors|mesh-ancestor
92415048|NCT01476410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608844|NCT00137774|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92608845|NCT00137774|Growth Substances|growth substances|mesh-ancestor
92415049|NCT01476410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92415050|NCT01476410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415051|NCT01476410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92415052|NCT01476410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92415053|NCT01476410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415054|NCT01476410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415055|NCT01476410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92415057|NCT01476410|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92415058|NCT01476410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92415059|NCT01476410|Alkylating Agents|alkylating agents|mesh-ancestor
92415060|NCT01476410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92415061|NCT01476410|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415062|NCT01476410|Antimitotic Agents|antimitotic agents|mesh-ancestor
92415063|NCT01476410|Mitosis Modulators|mitosis modulators|mesh-ancestor
92415064|NCT01476488|Tacrolimus|tacrolimus|mesh-list
92415065|NCT01476488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92415066|NCT01476488|Immunologic Factors|immunologic factors|mesh-ancestor
92415067|NCT01476488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415068|NCT01476488|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92415069|NCT01476488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415070|NCT01476488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415071|NCT01476592|Resveratrol|resveratrol|mesh-list
92415072|NCT01476592|Antioxidants|antioxidants|mesh-ancestor
92415073|NCT01476592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415074|NCT01476592|Protective Agents|protective agents|mesh-ancestor
92415075|NCT01476592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415076|NCT01476592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415077|NCT01476592|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92415078|NCT01476605|Sodium Morrhuate|sodium morrhuate|mesh-list
92415079|NCT01476605|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92415080|NCT01476605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92415081|NCT01476683|Racecadotril|racecadotril|mesh-list
92415082|NCT01476683|Thiorphan|thiorphan|mesh-list
92415083|NCT01476683|Antidiarrheals|antidiarrheals|mesh-ancestor
92415095|NCT01476774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415097|NCT01476800|Ketoconazole|ketoconazole|mesh-list
92415098|NCT01476800|Mirabegron|mirabegron|mesh-list
92415099|NCT01476800|Antifungal Agents|antifungal agents|mesh-ancestor
92139743|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
92415100|NCT01476800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415101|NCT01476800|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92415102|NCT01476800|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415103|NCT01476800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415104|NCT01476800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415105|NCT01476800|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92415106|NCT01476800|Hormone Antagonists|hormone antagonists|mesh-ancestor
92385312|NCT00002586|Protective Agents|protective agents|mesh-ancestor
92415107|NCT01476800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415108|NCT01476800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415109|NCT01476800|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92415110|NCT01476800|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92415111|NCT01476800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92415112|NCT01476800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92415113|NCT01476800|Adrenergic Agents|adrenergic agents|mesh-ancestor
92415114|NCT01476800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415115|NCT01476800|Urological Agents|urological agents|mesh-ancestor
92415116|NCT01476813|Glycopyrrolate|glycopyrrolate|mesh-list
92415117|NCT01476813|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92415118|NCT01476813|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92415119|NCT01476813|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92415120|NCT01476813|Cholinergic Agents|cholinergic agents|mesh-ancestor
92415121|NCT01476813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415122|NCT01476813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415123|NCT01476813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415124|NCT01477021|Cyclophosphamide|cyclophosphamide|mesh-list
92415125|NCT01477021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92415126|NCT01477021|Immunologic Factors|immunologic factors|mesh-ancestor
92415127|NCT01477021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415128|NCT01477021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608846|NCT00137774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608847|NCT00137774|Growth Inhibitors|growth inhibitors|mesh-ancestor
92415129|NCT01477021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92415130|NCT01477021|Alkylating Agents|alkylating agents|mesh-ancestor
92415131|NCT01477021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415132|NCT01477021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415133|NCT01477021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92415134|NCT01477034|Vitamin D|vitamin d|mesh-list
92415135|NCT01477034|Ergocalciferols|ergocalciferols|mesh-list
92415136|NCT01477034|Cholecalciferol|cholecalciferol|mesh-list
92415137|NCT01477034|Vitamins|vitamins|mesh-list
92415138|NCT01477034|Micronutrients|micronutrients|mesh-ancestor
92415139|NCT01477034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415140|NCT01477034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92415141|NCT01477034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415142|NCT01477060|Metformin|metformin|mesh-list
92415143|NCT01477060|Lapatinib|lapatinib|mesh-list
92415144|NCT01477060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92415145|NCT01477060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415148|NCT01477060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415149|NCT01477060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415150|NCT01477073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92415152|NCT01477073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415153|NCT01477073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415154|NCT01477112|Beta Carotene|beta carotene|mesh-list
92415155|NCT01477112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415156|NCT01477112|Provitamins|provitamins|mesh-ancestor
92415157|NCT01477112|Vitamins|vitamins|mesh-ancestor
92415158|NCT01477112|Micronutrients|micronutrients|mesh-ancestor
92415159|NCT01477151|Anesthetics|anesthetics|mesh-list
92415160|NCT01477151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415161|NCT01477151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415162|NCT01477190|Morphine|morphine|mesh-list
92415163|NCT01477190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92415164|NCT01477190|Narcotics|narcotics|mesh-ancestor
92415165|NCT01477190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415166|NCT01477190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415167|NCT01477190|Analgesics|analgesics|mesh-ancestor
92415168|NCT01477190|Sensory System Agents|sensory system agents|mesh-ancestor
92415169|NCT01477190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415170|NCT01477203|Escitalopram|escitalopram|mesh-list
92415171|NCT01477203|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92415172|NCT01477203|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92415173|NCT01477203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415174|NCT01477203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415175|NCT01477203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415177|NCT01477203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415178|NCT01477242|Ondansetron|ondansetron|mesh-list
92415179|NCT01477242|Antiemetics|antiemetics|mesh-ancestor
92415180|NCT01477242|Autonomic Agents|autonomic agents|mesh-ancestor
92415181|NCT01477242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415182|NCT01477242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415183|NCT01477242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415184|NCT01477242|Antipruritics|antipruritics|mesh-ancestor
92415185|NCT01477242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92415186|NCT01477242|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92415187|NCT01477242|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92415188|NCT01477242|Serotonin Agents|serotonin agents|mesh-ancestor
92415189|NCT01477242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415190|NCT01477242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415191|NCT01477268|Sertraline|sertraline|mesh-list
92415192|NCT01477268|Antidepressive Agents|antidepressive agents|mesh-list
92415193|NCT01477268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92415194|NCT01477268|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92415195|NCT01477268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92415196|NCT01477268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415197|NCT01477268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415198|NCT01477268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415199|NCT01477268|Serotonin Agents|serotonin agents|mesh-ancestor
92415200|NCT01477268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415201|NCT01477294|Caffeine|caffeine|mesh-list
92608848|NCT00137774|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92608849|NCT00137774|Alkylating Agents|alkylating agents|mesh-ancestor
92608850|NCT00137774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608851|NCT00160329|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92608852|NCT00160329|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92608853|NCT00160329|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92415202|NCT01477294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92415203|NCT01477294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415204|NCT01477294|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92415205|NCT01477294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415206|NCT01477294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415207|NCT01477294|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92415208|NCT01477294|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92415209|NCT01477294|Purinergic Agents|purinergic agents|mesh-ancestor
92415210|NCT01477294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415211|NCT01477385|Fluorides|fluorides|mesh-list
92415212|NCT01477385|Cariostatic Agents|cariostatic agents|mesh-ancestor
92415213|NCT01477385|Protective Agents|protective agents|mesh-ancestor
92415214|NCT01477385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415215|NCT01477411|Digoxin|digoxin|mesh-list
92415216|NCT01477411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92415217|NCT01477411|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92385355|NCT00002598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92415229|NCT01477489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415230|NCT01477489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415232|NCT01477580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92415233|NCT01477580|Immunologic Factors|immunologic factors|mesh-ancestor
92415234|NCT01477580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415235|NCT01477580|Antacids|antacids|mesh-ancestor
92385506|NCT00002676|Dexamethasone|dexamethasone|mesh-list
92415236|NCT01477580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415237|NCT01477580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415238|NCT01477606|Cytarabine|cytarabine|mesh-list
92385679|NCT00002718|Hormones|hormones|mesh-ancestor
92415239|NCT01477606|Daunorubicin|daunorubicin|mesh-list
92415240|NCT01477606|Midostaurin|midostaurin|mesh-list
92415241|NCT01477606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92415242|NCT01477606|Antimetabolites|antimetabolites|mesh-ancestor
92415243|NCT01477606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415244|NCT01477606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415245|NCT01477606|Antiviral Agents|antiviral agents|mesh-ancestor
92415246|NCT01477606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415247|NCT01477606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92415248|NCT01477606|Immunologic Factors|immunologic factors|mesh-ancestor
92139898|NCT01795131|Vitamins|vitamins|mesh-ancestor
92415249|NCT01477606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415250|NCT01477606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92415251|NCT01477606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92415252|NCT01477606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92415253|NCT01477606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415254|NCT01477606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92415255|NCT01477632|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92385815|NCT00002790|Cyclosporine|cyclosporine|mesh-list
92415256|NCT01477632|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92415258|NCT01477632|Norethindrone Acetate|norethindrone acetate|mesh-list
92415259|NCT01477632|Estradiol|estradiol|mesh-list
92415260|NCT01477632|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92415261|NCT01477632|Estrogens|estrogens|mesh-ancestor
92415262|NCT01477632|Hormones|hormones|mesh-ancestor
92415263|NCT01477632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415264|NCT01477632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415265|NCT01477632|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92385866|NCT05751252|Ganirelix|ganirelix|mesh-list
92415266|NCT01477632|Contraceptive Agents|contraceptive agents|mesh-ancestor
92415267|NCT01477632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92415268|NCT01477632|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92415269|NCT01477632|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92415270|NCT01477632|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92386003|NCT04836780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415271|NCT01477632|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92415272|NCT01477736|Oxybutynin|oxybutynin|mesh-list
92415273|NCT01477736|Botulinum Toxins|botulinum toxins|mesh-list
92415274|NCT01477736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92415275|NCT01477736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92608854|NCT00160329|Protease Inhibitors|protease inhibitors|mesh-ancestor
92608855|NCT00160329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608856|NCT00160329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608857|NCT00160329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92415276|NCT01477736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92415277|NCT01477736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415278|NCT01477736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415279|NCT01477736|Cholinergic Agents|cholinergic agents|mesh-ancestor
92415280|NCT01477736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415286|NCT01477736|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92415287|NCT01477736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92415288|NCT01477736|Urological Agents|urological agents|mesh-ancestor
92415289|NCT01477801|Cholecalciferol|cholecalciferol|mesh-list
92415290|NCT01477801|Vitamin D|vitamin d|mesh-list
92415291|NCT01477801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415292|NCT01477801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415293|NCT01477801|Vitamins|vitamins|mesh-ancestor
92415294|NCT01477801|Micronutrients|micronutrients|mesh-ancestor
92386326|NCT00002802|Cobalt|cobalt|mesh-list
92415295|NCT01477801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92415296|NCT01477840|Misoprostol|misoprostol|mesh-list
92415297|NCT01477840|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92415298|NCT01477840|Abortifacient Agents|abortifacient agents|mesh-ancestor
92415299|NCT01477840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92415300|NCT01477840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415301|NCT01477840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92415302|NCT01477840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415303|NCT01477840|Oxytocics|oxytocics|mesh-ancestor
92415304|NCT01477931|Bupropion|bupropion|mesh-list
92415305|NCT01477931|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92415306|NCT01477931|Antidepressive Agents|antidepressive agents|mesh-ancestor
92415307|NCT01477931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92415308|NCT01477931|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92415309|NCT01477931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92415310|NCT01477931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415311|NCT01477931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415312|NCT01477931|Dopamine Agents|dopamine agents|mesh-ancestor
92415313|NCT01477931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415314|NCT01477931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415315|NCT01477931|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92415316|NCT01477931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415317|NCT01477931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415318|NCT01477983|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92415319|NCT01477983|Flecainide|flecainide|mesh-list
92415320|NCT01477983|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92415321|NCT01477983|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92139973|NCT01400503|Siltuximab|siltuximab|mesh-list
92415322|NCT01477983|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415323|NCT01477983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415324|NCT01478022|Ibuprofen|ibuprofen|mesh-list
92415325|NCT01478022|Isosorbide|isosorbide|mesh-list
92415326|NCT01478022|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92415327|NCT01478022|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92415328|NCT01478022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92415329|NCT01478022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415330|NCT01478022|Analgesics|analgesics|mesh-ancestor
92415331|NCT01478022|Sensory System Agents|sensory system agents|mesh-ancestor
92415332|NCT01478022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387164|NCT00003558|Vitamins|vitamins|mesh-ancestor
92415333|NCT01478022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415334|NCT01478022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415335|NCT01478022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387233|NCT00003606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415336|NCT01478022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92415337|NCT01478022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415338|NCT01478022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415339|NCT01478022|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92415340|NCT01478022|Diuretics|diuretics|mesh-ancestor
92415341|NCT01478022|Natriuretic Agents|natriuretic agents|mesh-ancestor
92415342|NCT01478022|Vasodilator Agents|vasodilator agents|mesh-ancestor
92415343|NCT01478022|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92415344|NCT01478074|Cytarabine|cytarabine|mesh-list
92415345|NCT01478074|Fludarabine|fludarabine|mesh-list
92387453|NCT00003852|Paclitaxel|paclitaxel|mesh-list
92387521|NCT00003888|Antimetabolites|antimetabolites|mesh-ancestor
92608858|NCT00160329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92608859|NCT00160329|Antiviral Agents|antiviral agents|mesh-ancestor
92608860|NCT00160329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608861|NCT00137813|Bevacizumab|bevacizumab|mesh-list
92415346|NCT01478074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415347|NCT01478074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92415348|NCT01478074|Antimetabolites|antimetabolites|mesh-ancestor
92387677|NCT00003996|Etoposide|etoposide|mesh-list
92415349|NCT01478074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415353|NCT01478074|Antiviral Agents|antiviral agents|mesh-ancestor
92415354|NCT01478074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415355|NCT01478165|Palonosetron|palonosetron|mesh-list
92415356|NCT01478165|Anesthetics|anesthetics|mesh-list
92415357|NCT01478165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415358|NCT01478165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415359|NCT01478165|Antiemetics|antiemetics|mesh-ancestor
92415360|NCT01478165|Autonomic Agents|autonomic agents|mesh-ancestor
92415361|NCT01478165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387822|NCT00004128|Busulfan|busulfan|mesh-list
92415362|NCT01478165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415363|NCT01478165|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92415364|NCT01478165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92387890|NCT00004188|Melphalan|melphalan|mesh-list
92415365|NCT01478165|Serotonin Agents|serotonin agents|mesh-ancestor
92415366|NCT01478165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415367|NCT01478165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415368|NCT01478230|Nicotine|nicotine|mesh-list
92415369|NCT01478230|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92415370|NCT01478230|Autonomic Agents|autonomic agents|mesh-ancestor
92415371|NCT01478230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415372|NCT01478230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415373|NCT01478230|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92415374|NCT01478230|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92415375|NCT01478230|Cholinergic Agents|cholinergic agents|mesh-ancestor
92415376|NCT01478230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415377|NCT01478230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415378|NCT01478282|Rivaroxaban|rivaroxaban|mesh-list
92415379|NCT01478282|Dabigatran|dabigatran|mesh-list
92415380|NCT01478282|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92415381|NCT01478282|Antithrombins|antithrombins|mesh-ancestor
92388330|NCT00004728|Analgesics|analgesics|mesh-ancestor
92415382|NCT01478282|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92415383|NCT01478282|Protease Inhibitors|protease inhibitors|mesh-ancestor
92415384|NCT01478282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415385|NCT01478282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415386|NCT01478282|Anticoagulants|anticoagulants|mesh-ancestor
92415387|NCT01478308|Metformin|metformin|mesh-list
92415388|NCT01478308|Prednisone|prednisone|mesh-list
92415389|NCT01478308|Docetaxel|docetaxel|mesh-list
92388564|NCT00005022|Etoposide|etoposide|mesh-list
92415390|NCT01478308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92415391|NCT01478308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415392|NCT01478308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415393|NCT01478308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415394|NCT01478308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92415395|NCT01478308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388775|NCT00005796|Vincristine|vincristine|mesh-list
92415396|NCT01478308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415397|NCT01478308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415398|NCT01478308|Glucocorticoids|glucocorticoids|mesh-ancestor
92415399|NCT01478308|Hormones|hormones|mesh-ancestor
92388848|NCT00355524|Ritonavir|ritonavir|mesh-list
92415400|NCT01478308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415401|NCT01478308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92415402|NCT01478386|Hyaluronic Acid|hyaluronic acid|mesh-list
92415403|NCT01478386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92415404|NCT01478386|Immunologic Factors|immunologic factors|mesh-ancestor
92415405|NCT01478386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415406|NCT01478386|Viscosupplements|viscosupplements|mesh-ancestor
92415407|NCT01478386|Protective Agents|protective agents|mesh-ancestor
92415408|NCT01478490|Metoprolol|metoprolol|mesh-list
92415409|NCT01478490|Mirabegron|mirabegron|mesh-list
92415410|NCT01478490|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92415411|NCT01478490|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92415412|NCT01478490|Sympatholytics|sympatholytics|mesh-ancestor
92415413|NCT01478490|Autonomic Agents|autonomic agents|mesh-ancestor
92415414|NCT01478490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415415|NCT01478490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415416|NCT01478490|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92415417|NCT01478490|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92608862|NCT00137813|Docetaxel|docetaxel|mesh-list
92608863|NCT00137813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92415418|NCT01478490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92415419|NCT01478490|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389213|NCT00361686|Analgesics|analgesics|mesh-ancestor
92415420|NCT01478490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389284|NCT00363090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415421|NCT01478490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415422|NCT01478490|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92415434|NCT01478503|Urological Agents|urological agents|mesh-ancestor
92415435|NCT01478529|Mirabegron|mirabegron|mesh-list
92415436|NCT01478529|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92415437|NCT01478529|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92415438|NCT01478529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92415439|NCT01478529|Adrenergic Agents|adrenergic agents|mesh-ancestor
92415440|NCT01478529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415441|NCT01478529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415442|NCT01478529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415443|NCT01478529|Urological Agents|urological agents|mesh-ancestor
92415444|NCT01478568|Desipramine|desipramine|mesh-list
92415445|NCT01478568|Mirabegron|mirabegron|mesh-list
92415446|NCT01478568|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92415447|NCT01478568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92415448|NCT01478568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92415449|NCT01478568|Adrenergic Agents|adrenergic agents|mesh-ancestor
92415450|NCT01478568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415451|NCT01478568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415452|NCT01478568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415453|NCT01478568|Urological Agents|urological agents|mesh-ancestor
92415454|NCT01478568|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92415455|NCT01478568|Antidepressive Agents|antidepressive agents|mesh-ancestor
92415456|NCT01478568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92415457|NCT01478568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415458|NCT01478568|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92389860|NCT00378612|Sirolimus|sirolimus|mesh-list
92415459|NCT01478568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92415460|NCT01478568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415461|NCT01478607|Capsaicin|capsaicin|mesh-list
92390006|NCT00383526|Vaccines|vaccines|mesh-list
92415462|NCT01478607|Antipruritics|antipruritics|mesh-ancestor
92415463|NCT01478607|Dermatologic Agents|dermatologic agents|mesh-ancestor
92415464|NCT01478607|Sensory System Agents|sensory system agents|mesh-ancestor
92415465|NCT01478607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140118|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92140119|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140120|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140121|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92140122|NCT01399723|Amoxicillin|amoxicillin|mesh-list
92140130|NCT04771962|Desflurane|desflurane|mesh-list
92415466|NCT01478607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415468|NCT01478633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92415469|NCT01478633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415470|NCT01478633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415471|NCT01478633|Cholinergic Agents|cholinergic agents|mesh-ancestor
92415472|NCT01478633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415473|NCT01478633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415474|NCT01478633|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92415475|NCT01478633|Autonomic Agents|autonomic agents|mesh-ancestor
92415476|NCT01478633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415477|NCT01478633|Nootropic Agents|nootropic agents|mesh-ancestor
92415478|NCT01478685|Paclitaxel|paclitaxel|mesh-list
92415479|NCT01478685|Carboplatin|carboplatin|mesh-list
92415480|NCT01478685|Azacitidine|azacitidine|mesh-list
92415481|NCT01478685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92415494|NCT01478724|Sequestering Agents|sequestering agents|mesh-ancestor
92415495|NCT01478724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415496|NCT01478737|Dexamethasone|dexamethasone|mesh-list
92415497|NCT01478737|Dexamethasone acetate|dexamethasone acetate|mesh-list
92415498|NCT01478737|BB 1101|bb 1101|mesh-list
92415499|NCT01478737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415500|NCT01478737|Antiemetics|antiemetics|mesh-ancestor
92415501|NCT01478737|Autonomic Agents|autonomic agents|mesh-ancestor
92415502|NCT01478737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415503|NCT01478737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415504|NCT01478737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415505|NCT01478737|Glucocorticoids|glucocorticoids|mesh-ancestor
92415506|NCT01478737|Hormones|hormones|mesh-ancestor
92608864|NCT00137813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608865|NCT00137813|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92608866|NCT00137813|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92608867|NCT00137813|Growth Substances|growth substances|mesh-ancestor
92016072|NCT05552651|Paclitaxel|paclitaxel|mesh-list
92415507|NCT01478737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415508|NCT01478737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92415509|NCT01478737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415510|NCT01478737|Protease Inhibitors|protease inhibitors|mesh-ancestor
92415511|NCT01478737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415512|NCT01478737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415513|NCT01478997|Acetaminophen|acetaminophen|mesh-list
92415514|NCT01478997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415515|NCT01478997|Analgesics|analgesics|mesh-ancestor
92415516|NCT01478997|Sensory System Agents|sensory system agents|mesh-ancestor
92415517|NCT01478997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415518|NCT01478997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415519|NCT01478997|Antipyretics|antipyretics|mesh-ancestor
92415520|NCT01479023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92415521|NCT01479023|Immunologic Factors|immunologic factors|mesh-ancestor
92415522|NCT01479023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415523|NCT01479036|Docetaxel|docetaxel|mesh-list
92415524|NCT01479036|Epirubicin|epirubicin|mesh-list
92415525|NCT01479036|Endostatins|endostatins|mesh-list
92415526|NCT01479036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415527|NCT01479036|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415528|NCT01479036|Antimitotic Agents|antimitotic agents|mesh-ancestor
92391160|NCT03217734|Adalimumab|adalimumab|mesh-list
92415529|NCT01479036|Mitosis Modulators|mitosis modulators|mesh-ancestor
92415530|NCT01479036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415531|NCT01479036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92415532|NCT01479036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92415533|NCT01479036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92415534|NCT01479036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415535|NCT01479036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92415536|NCT01479036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92391348|NCT01831674|Metformin|metformin|mesh-list
92415537|NCT01479036|Growth Substances|growth substances|mesh-ancestor
92415538|NCT01479036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415539|NCT01479036|Growth Inhibitors|growth inhibitors|mesh-ancestor
92415540|NCT01479088|Cinacalcet|cinacalcet|mesh-list
92391419|NCT01836120|Antimetabolites|antimetabolites|mesh-ancestor
92415541|NCT01479088|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415542|NCT01479088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415543|NCT01479088|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92415544|NCT01479088|Hormone Antagonists|hormone antagonists|mesh-ancestor
92391566|NCT01836432|Antidotes|antidotes|mesh-ancestor
92415545|NCT01479088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415575|NCT01479296|Vaccines|vaccines|mesh-list
92415576|NCT01479296|Immunologic Factors|immunologic factors|mesh-ancestor
92415577|NCT01479296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415578|NCT01479361|Atovaquone|atovaquone|mesh-list
92415579|NCT01479361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415580|NCT01479361|Antimalarials|antimalarials|mesh-ancestor
92415581|NCT01479361|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92415582|NCT01479361|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92415583|NCT01479361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415584|NCT01479361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415585|NCT01479504|Cisplatin|cisplatin|mesh-list
92415586|NCT01479504|Docetaxel|docetaxel|mesh-list
92415587|NCT01479504|Nedaplatin|nedaplatin|mesh-list
92415588|NCT01479504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415589|NCT01479504|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415590|NCT01479504|Antimitotic Agents|antimitotic agents|mesh-ancestor
92415591|NCT01479504|Mitosis Modulators|mitosis modulators|mesh-ancestor
92415592|NCT01479504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415593|NCT01479556|Pregabalin|pregabalin|mesh-list
92415594|NCT01479556|Analgesics|analgesics|mesh-ancestor
92415595|NCT01479556|Sensory System Agents|sensory system agents|mesh-ancestor
92415596|NCT01479556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415633|NCT01479751|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92415637|NCT01479751|Anticonvulsants|anticonvulsants|mesh-ancestor
92415638|NCT01479751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92415639|NCT01479751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415640|NCT01479751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92608868|NCT00137813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608869|NCT00137813|Growth Inhibitors|growth inhibitors|mesh-ancestor
92608870|NCT00137813|Tubulin Modulators|tubulin modulators|mesh-ancestor
92392172|NCT02242266|Tiotropium Bromide|tiotropium bromide|mesh-list
92608871|NCT00137813|Antimitotic Agents|antimitotic agents|mesh-ancestor
92415641|NCT01479751|Tocolytic Agents|tocolytic agents|mesh-ancestor
92415642|NCT01479751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92415643|NCT01479751|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92415644|NCT01479751|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92415645|NCT01479751|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92415646|NCT01479881|Cyclosporine|cyclosporine|mesh-list
92415647|NCT01479881|Simeprevir|simeprevir|mesh-list
92415648|NCT01479881|Tacrolimus|tacrolimus|mesh-list
92415649|NCT01479881|Cyclosporins|cyclosporins|mesh-list
92415650|NCT01479881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92415651|NCT01479881|Immunologic Factors|immunologic factors|mesh-ancestor
92392399|NCT02248506|Clotrimazole|clotrimazole|mesh-list
92415652|NCT01479881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415653|NCT01479881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92415654|NCT01479881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415655|NCT01479881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415656|NCT01479881|Antifungal Agents|antifungal agents|mesh-ancestor
92415657|NCT01479881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415658|NCT01479881|Dermatologic Agents|dermatologic agents|mesh-ancestor
92415659|NCT01479881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92415660|NCT01479881|Antiviral Agents|antiviral agents|mesh-ancestor
92415661|NCT01479881|Protease Inhibitors|protease inhibitors|mesh-ancestor
92415662|NCT01479920|Fluoxetine|fluoxetine|mesh-list
92415663|NCT01479920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92415664|NCT01479920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92392820|NCT05444556|Antitussive Agents|antitussive agents|mesh-ancestor
92415665|NCT01479920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415666|NCT01479920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415667|NCT01479920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415668|NCT01479920|Serotonin Agents|serotonin agents|mesh-ancestor
92393042|NCT05767229|Adrenergic Agents|adrenergic agents|mesh-ancestor
92415669|NCT01479920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393118|NCT05631028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92415670|NCT01479920|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92415671|NCT01479920|Antidepressive Agents|antidepressive agents|mesh-ancestor
92415672|NCT01479920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92415673|NCT01479920|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92415674|NCT01479920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415675|NCT01479920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415676|NCT01479933|Vitamin D|vitamin d|mesh-list
92415677|NCT01479933|Ergocalciferols|ergocalciferols|mesh-list
92415678|NCT01479933|Cholecalciferol|cholecalciferol|mesh-list
92415679|NCT01479933|Vitamins|vitamins|mesh-list
92415680|NCT01479933|Micronutrients|micronutrients|mesh-ancestor
92415681|NCT01479933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415682|NCT01479933|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92415683|NCT01479933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415684|NCT01480050|Temozolomide|temozolomide|mesh-list
92415685|NCT01480050|Mibefradil|mibefradil|mesh-list
92415686|NCT01480050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92415687|NCT01480050|Alkylating Agents|alkylating agents|mesh-ancestor
92393400|NCT05019638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393480|NCT04677959|Albuterol|albuterol|mesh-list
92415688|NCT01480050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415689|NCT01480050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140353|NCT02076997|Methotrexate|methotrexate|mesh-list
92393556|NCT04512105|Venetoclax|venetoclax|mesh-list
92415690|NCT01480050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92415691|NCT01480050|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92415692|NCT01480050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92393619|NCT04469959|Levodopa|levodopa|mesh-list
92415693|NCT01480050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415694|NCT01480050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415695|NCT01480050|Vasodilator Agents|vasodilator agents|mesh-ancestor
92415696|NCT01480050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92393768|NCT03965689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415697|NCT01480050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415698|NCT01480050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415699|NCT01480063|4-Aminopyridine|4-aminopyridine|mesh-list
92415700|NCT01480063|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92415701|NCT01480063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415702|NCT01480063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393849|NCT03785587|Bromides|bromides|mesh-list
92415705|NCT01480141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92415706|NCT01480141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393918|NCT03426904|Leucovorin|leucovorin|mesh-list
92608872|NCT00137813|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608873|NCT00137813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608874|NCT00137852|Celecoxib|celecoxib|mesh-list
92608875|NCT00137852|Irinotecan|irinotecan|mesh-list
92608876|NCT00137852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415707|NCT01480141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415708|NCT01480323|Aldesleukin|aldesleukin|mesh-list
92415709|NCT01480323|Ipilimumab|ipilimumab|mesh-list
92415710|NCT01480323|Interleukin-2|interleukin-2|mesh-list
92415711|NCT01480323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92415712|NCT01480323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415713|NCT01480323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92415714|NCT01480323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415715|NCT01480323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415716|NCT01480323|Analgesics|analgesics|mesh-ancestor
92415717|NCT01480323|Sensory System Agents|sensory system agents|mesh-ancestor
92415718|NCT01480323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415719|NCT01480323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415720|NCT01480323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92415721|NCT01480323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92415722|NCT01480323|Antiviral Agents|antiviral agents|mesh-ancestor
92415723|NCT01480323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415724|NCT01480336|Amiodarone|amiodarone|mesh-list
92415725|NCT01480336|Ranolazine|ranolazine|mesh-list
92415726|NCT01480336|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92415727|NCT01480336|Vasodilator Agents|vasodilator agents|mesh-ancestor
92415728|NCT01480336|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92415729|NCT01480336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415730|NCT01480336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415731|NCT01480336|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92415732|NCT01480336|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92415733|NCT01480336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415734|NCT01480336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415735|NCT01480336|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92415736|NCT01480336|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92415737|NCT01480336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92415738|NCT01480492|Telbivudine|telbivudine|mesh-list
92415739|NCT01480492|Antiviral Agents|antiviral agents|mesh-ancestor
92415740|NCT01480492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415741|NCT01480492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92415742|NCT01480492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415743|NCT01480492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415744|NCT01480531|Clevidipine|clevidipine|mesh-list
92415745|NCT01480531|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92415746|NCT01480531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394422|NCT01384682|Antiviral Agents|antiviral agents|mesh-ancestor
92415747|NCT01480531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415748|NCT01480531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415749|NCT01480531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415750|NCT01480609|Ezogabine|ezogabine|mesh-list
92415751|NCT01480609|Anticonvulsants|anticonvulsants|mesh-ancestor
92415752|NCT01480609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415753|NCT01480609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415754|NCT01480687|Ciprofibrate|ciprofibrate|mesh-list
92415755|NCT01480687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92415756|NCT01480687|Antimetabolites|antimetabolites|mesh-ancestor
92415757|NCT01480687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415758|NCT01480687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92415759|NCT01480713|Raltegravir Potassium|raltegravir potassium|mesh-list
92415760|NCT01480713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92140431|NCT01270191|Exenatide|exenatide|mesh-list
92415761|NCT01480713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92415762|NCT01480713|Antiviral Agents|antiviral agents|mesh-ancestor
92415763|NCT01480713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415764|NCT01480713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92415765|NCT01480713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92415766|NCT01480713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415767|NCT01480713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415768|NCT01480752|Lornoxicam|lornoxicam|mesh-list
92608877|NCT00137852|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92608878|NCT00137852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92608879|NCT00137852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075554|NCT05766358|Tirzepatide|tirzepatide|mesh-list
92415769|NCT01480752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92415770|NCT01480752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415771|NCT01480752|Analgesics|analgesics|mesh-ancestor
92415772|NCT01480752|Sensory System Agents|sensory system agents|mesh-ancestor
92415773|NCT01480752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415779|NCT01480765|Analgesics|analgesics|mesh-ancestor
92415780|NCT01480765|Sensory System Agents|sensory system agents|mesh-ancestor
92415781|NCT01480765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415782|NCT01480765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415783|NCT01480765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92415784|NCT01480765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92415785|NCT01480765|Anesthetics, General|anesthetics, general|mesh-ancestor
92415786|NCT01480765|Anesthetics|anesthetics|mesh-ancestor
92415787|NCT01480765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415788|NCT01480765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92415789|NCT01480765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92415790|NCT01480765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415791|NCT01480765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415792|NCT01480765|Anticonvulsants|anticonvulsants|mesh-ancestor
92415793|NCT01480765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92415794|NCT01480765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415795|NCT01480765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415796|NCT01480765|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92415797|NCT01480765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92415798|NCT01480765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92415799|NCT01480778|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92415800|NCT01480778|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92415801|NCT01480778|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92415802|NCT01480778|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92415803|NCT01480778|Contraceptive Agents|contraceptive agents|mesh-ancestor
92415804|NCT01480778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92415805|NCT01480778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415806|NCT01480778|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92415807|NCT01480778|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92415808|NCT01480778|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92415809|NCT01480778|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92415810|NCT01480778|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92394476|NCT01385228|Prednisone|prednisone|mesh-list
92415811|NCT01480778|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92415812|NCT01480791|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92415813|NCT01480791|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92415814|NCT01480791|Diuretics|diuretics|mesh-ancestor
92415815|NCT01480791|Natriuretic Agents|natriuretic agents|mesh-ancestor
92415816|NCT01480791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415817|NCT01480791|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92415818|NCT01480791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415819|NCT01480791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415820|NCT01480817|Sorafenib|sorafenib|mesh-list
92415821|NCT01480817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415822|NCT01480817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92415823|NCT01480817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415824|NCT01480817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415825|NCT01480869|Calcium, Dietary|calcium, dietary|mesh-list
92415826|NCT01480869|Cholecalciferol|cholecalciferol|mesh-list
92415827|NCT01480869|Vitamin D|vitamin d|mesh-list
92415828|NCT01480869|Calcium|calcium|mesh-list
92415829|NCT01480869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415830|NCT01480869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415831|NCT01480869|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92415832|NCT01480869|Vitamins|vitamins|mesh-ancestor
92415833|NCT01480869|Micronutrients|micronutrients|mesh-ancestor
92415835|NCT01480986|Octreotide|octreotide|mesh-list
92415836|NCT01480986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415837|NCT01480986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92415838|NCT01480986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92415839|NCT01480986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608880|NCT00137852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608881|NCT00137852|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92415840|NCT01480986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415841|NCT01480986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415842|NCT01480986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92415864|NCT01481194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415866|NCT01481194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92415867|NCT01481194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92415868|NCT01481194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92415869|NCT01481194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415870|NCT01481194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92415871|NCT01481194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92415872|NCT01481194|Growth Substances|growth substances|mesh-ancestor
92415873|NCT01481194|Growth Inhibitors|growth inhibitors|mesh-ancestor
92415874|NCT01481233|Colchicine|colchicine|mesh-list
92415875|NCT01481233|Gout Suppressants|gout suppressants|mesh-ancestor
92415876|NCT01481233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92415877|NCT01481233|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415878|NCT01481233|Antimitotic Agents|antimitotic agents|mesh-ancestor
92415879|NCT01481233|Mitosis Modulators|mitosis modulators|mesh-ancestor
92415880|NCT01481233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415881|NCT01481233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415882|NCT01481259|Pemetrexed|pemetrexed|mesh-list
92415883|NCT01481259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415884|NCT01481259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415885|NCT01481259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415886|NCT01481259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92415887|NCT01481259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92415888|NCT01481311|Bromides|bromides|mesh-list
92415889|NCT01481311|Anticonvulsants|anticonvulsants|mesh-ancestor
92415890|NCT01481350|Sildenafil Citrate|sildenafil citrate|mesh-list
92415891|NCT01481350|Vasodilator Agents|vasodilator agents|mesh-ancestor
92415892|NCT01481350|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92415893|NCT01481350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92415894|NCT01481350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415895|NCT01481350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415896|NCT01481350|Urological Agents|urological agents|mesh-ancestor
92415897|NCT01481389|Theobromine|theobromine|mesh-list
92415898|NCT01481389|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92415899|NCT01481389|Autonomic Agents|autonomic agents|mesh-ancestor
92415901|NCT01481389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415902|NCT01481389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92415903|NCT01481389|Respiratory System Agents|respiratory system agents|mesh-ancestor
92415905|NCT01481454|Vaccines|vaccines|mesh-list
92415906|NCT01481454|Immunologic Factors|immunologic factors|mesh-ancestor
92415907|NCT01481454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415908|NCT01481519|Povidone-Iodine|povidone-iodine|mesh-list
92415909|NCT01481519|Dexamethasone|dexamethasone|mesh-list
92415910|NCT01481519|Dexamethasone acetate|dexamethasone acetate|mesh-list
92415911|NCT01481519|Povidone|povidone|mesh-list
92415912|NCT01481519|Lubricant Eye Drops|lubricant eye drops|mesh-list
92415913|NCT01481519|BB 1101|bb 1101|mesh-list
92415914|NCT01481519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415915|NCT01481519|Antiemetics|antiemetics|mesh-ancestor
92415916|NCT01481519|Autonomic Agents|autonomic agents|mesh-ancestor
92415917|NCT01481519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415918|NCT01481519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415919|NCT01481519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415920|NCT01481519|Glucocorticoids|glucocorticoids|mesh-ancestor
92415921|NCT01481519|Hormones|hormones|mesh-ancestor
92415922|NCT01481519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92415923|NCT01481519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92415924|NCT01481519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415925|NCT01481519|Protease Inhibitors|protease inhibitors|mesh-ancestor
92415926|NCT01481519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415927|NCT01481519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415928|NCT01481519|Plasma Substitutes|plasma substitutes|mesh-ancestor
92415929|NCT01481519|Blood Substitutes|blood substitutes|mesh-ancestor
92415930|NCT01481519|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92415931|NCT01481519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415932|NCT01481519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92608882|NCT00137852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608883|NCT00137852|Analgesics|analgesics|mesh-ancestor
92608884|NCT00137852|Sensory System Agents|sensory system agents|mesh-ancestor
92608885|NCT00137852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608886|NCT00137852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415933|NCT01481519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92415934|NCT01481532|Histamine Antagonists|histamine antagonists|mesh-list
92415935|NCT01481532|Histamine Agents|histamine agents|mesh-ancestor
92415936|NCT01481532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415937|NCT01481532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415938|NCT01481532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415939|NCT01481610|Diclofenac|diclofenac|mesh-list
92415940|NCT01481610|Lumiracoxib|lumiracoxib|mesh-list
92415941|NCT01481610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92415942|NCT01481610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92415943|NCT01481610|Analgesics|analgesics|mesh-ancestor
92415944|NCT01481610|Sensory System Agents|sensory system agents|mesh-ancestor
92415945|NCT01481610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415946|NCT01481610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415947|NCT01481610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415948|NCT01481610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92415949|NCT01481610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92415950|NCT01481610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415951|NCT01481610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415952|NCT01481610|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92415953|NCT01481701|Oxaliplatin|oxaliplatin|mesh-list
92415954|NCT01481701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415955|NCT01481714|Picosulfate sodium|picosulfate sodium|mesh-list
92415956|NCT01481714|Magnesium Oxide|magnesium oxide|mesh-list
92415957|NCT01481714|Sodium Citrate|sodium citrate|mesh-list
92415958|NCT01481714|Citric Acid|citric acid|mesh-list
92415959|NCT01481714|Anticoagulants|anticoagulants|mesh-ancestor
92415960|NCT01481714|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92415961|NCT01481714|Chelating Agents|chelating agents|mesh-ancestor
92415962|NCT01481714|Sequestering Agents|sequestering agents|mesh-ancestor
92415963|NCT01481714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415964|NCT01481714|Cathartics|cathartics|mesh-ancestor
92415965|NCT01481714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415966|NCT01481714|Antacids|antacids|mesh-ancestor
92415967|NCT01481831|Palonosetron|palonosetron|mesh-list
92415968|NCT01481831|Antiemetics|antiemetics|mesh-ancestor
92415969|NCT01481831|Autonomic Agents|autonomic agents|mesh-ancestor
92415970|NCT01481831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415971|NCT01481831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415972|NCT01481831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415973|NCT01481831|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92415974|NCT01481831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92415987|NCT01481844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92415988|NCT01481844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415989|NCT01481844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92415990|NCT01481844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92415991|NCT01481844|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92415992|NCT01481844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415993|NCT01481844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415994|NCT01481844|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92415995|NCT01481844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415996|NCT01481844|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92415997|NCT01481844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415998|NCT01481844|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92415999|NCT01481844|Antacids|antacids|mesh-ancestor
92416000|NCT01481844|Alkylating Agents|alkylating agents|mesh-ancestor
92416001|NCT01481844|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92416002|NCT01481844|Antidiarrheals|antidiarrheals|mesh-ancestor
92416003|NCT01481870|Sorafenib|sorafenib|mesh-list
92416004|NCT01481870|Sunitinib|sunitinib|mesh-list
92416005|NCT01481870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416006|NCT01481870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416007|NCT01481870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416008|NCT01481870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416009|NCT01481870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92416010|NCT01481870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92416011|NCT01481870|Growth Substances|growth substances|mesh-ancestor
92416012|NCT01481870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416013|NCT01481870|Growth Inhibitors|growth inhibitors|mesh-ancestor
92416014|NCT01481883|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92416015|NCT01481883|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92416016|NCT01481883|Hormone Antagonists|hormone antagonists|mesh-ancestor
92416017|NCT01481883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416018|NCT01481883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416019|NCT01481883|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92416020|NCT01481883|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92416021|NCT01481883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92416022|NCT01482052|Vaccines|vaccines|mesh-list
92416023|NCT01482052|Immunologic Factors|immunologic factors|mesh-ancestor
92416024|NCT01482052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416025|NCT01482104|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92416026|NCT01482104|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92416027|NCT01482104|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92416028|NCT01482104|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416029|NCT01482117|Cilostazol|cilostazol|mesh-list
92416030|NCT01482117|Clopidogrel|clopidogrel|mesh-list
92416031|NCT01482117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92416032|NCT01482117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92416033|NCT01482117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92416034|NCT01482117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92416035|NCT01482117|Purinergic Agents|purinergic agents|mesh-ancestor
92416036|NCT01482117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416037|NCT01482117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416038|NCT01482117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416039|NCT01482117|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92416048|NCT01482117|Protective Agents|protective agents|mesh-ancestor
92416049|NCT01482117|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92416050|NCT01482117|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92416051|NCT01482117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416052|NCT01482156|Everolimus|everolimus|mesh-list
92416053|NCT01482156|Dactolisib|dactolisib|mesh-list
92416054|NCT01482156|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92416055|NCT01482156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416056|NCT01482156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416057|NCT01482156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416058|NCT01482156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416059|NCT01482156|Immunologic Factors|immunologic factors|mesh-ancestor
92416060|NCT01482156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416061|NCT01482156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416062|NCT01482299|Everolimus|everolimus|mesh-list
92416063|NCT01482299|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92416064|NCT01482299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416065|NCT01482299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416066|NCT01482299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416067|NCT01482299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416068|NCT01482299|Immunologic Factors|immunologic factors|mesh-ancestor
92416069|NCT01482299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416070|NCT01482299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416071|NCT01482338|Drospirenone|drospirenone|mesh-list
92416072|NCT01482338|Desogestrel|desogestrel|mesh-list
92416073|NCT01482338|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92416074|NCT01482338|Hormone Antagonists|hormone antagonists|mesh-ancestor
92416075|NCT01482338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416076|NCT01482338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416077|NCT01482338|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92416078|NCT01482338|Diuretics|diuretics|mesh-ancestor
92416079|NCT01482338|Natriuretic Agents|natriuretic agents|mesh-ancestor
92416080|NCT01482338|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92416081|NCT01482338|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92416082|NCT01482338|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92416083|NCT01482338|Contraceptive Agents|contraceptive agents|mesh-ancestor
92416084|NCT01482338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92416085|NCT01482338|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92416086|NCT01482338|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92416087|NCT01482338|Progestins|progestins|mesh-ancestor
92416088|NCT01482338|Hormones|hormones|mesh-ancestor
92416089|NCT01482377|Cetuximab|cetuximab|mesh-list
92416090|NCT01482377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92608887|NCT00137852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608888|NCT00137852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608889|NCT00137852|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92608890|NCT00137852|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608891|NCT00160407|Orlistat|orlistat|mesh-list
92416091|NCT01482377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92416092|NCT01482377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416093|NCT01482377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416094|NCT01482377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416095|NCT01482377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416096|NCT01482416|Estrogens|estrogens|mesh-list
92416097|NCT01482416|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92416098|NCT01482416|Hormones|hormones|mesh-ancestor
92416099|NCT01482416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416100|NCT01482416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416101|NCT01482442|Sorafenib|sorafenib|mesh-list
92416102|NCT01482442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416103|NCT01482442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416104|NCT01482442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416105|NCT01482442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416106|NCT01482468|Palonosetron|palonosetron|mesh-list
92416114|NCT01482468|Serotonin Agents|serotonin agents|mesh-ancestor
92416115|NCT01482468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416116|NCT01482468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416117|NCT01482559|Dopamine|dopamine|mesh-list
92416118|NCT01482559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92416119|NCT01482559|Sympathomimetics|sympathomimetics|mesh-ancestor
92416120|NCT01482559|Autonomic Agents|autonomic agents|mesh-ancestor
92416121|NCT01482559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416122|NCT01482559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416123|NCT01482559|Dopamine Agents|dopamine agents|mesh-ancestor
92416124|NCT01482559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416125|NCT01482559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416126|NCT01482559|Protective Agents|protective agents|mesh-ancestor
92416127|NCT01482624|Hyaluronic Acid|hyaluronic acid|mesh-list
92416128|NCT01482624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92416129|NCT01482624|Immunologic Factors|immunologic factors|mesh-ancestor
92416130|NCT01482624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416131|NCT01482624|Viscosupplements|viscosupplements|mesh-ancestor
92416132|NCT01482624|Protective Agents|protective agents|mesh-ancestor
92416133|NCT01482728|Dasatinib|dasatinib|mesh-list
92416134|NCT01482728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416135|NCT01482728|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416136|NCT01482728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416137|NCT01482728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416138|NCT01482754|Rituximab|rituximab|mesh-list
92416139|NCT01482754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92416140|NCT01482754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416141|NCT01482754|Immunologic Factors|immunologic factors|mesh-ancestor
92416142|NCT01482754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416143|NCT01482754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92416144|NCT01482897|Prednisolone|prednisolone|mesh-list
92416145|NCT01482897|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92416146|NCT01482897|Methylprednisolone|methylprednisolone|mesh-list
92416147|NCT01482897|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92416148|NCT01482897|Prednisolone acetate|prednisolone acetate|mesh-list
92416149|NCT01482897|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92416150|NCT01482897|Prednisolone phosphate|prednisolone phosphate|mesh-list
92416151|NCT01482897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416152|NCT01482897|Glucocorticoids|glucocorticoids|mesh-ancestor
92416153|NCT01482897|Hormones|hormones|mesh-ancestor
92416154|NCT01482897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416155|NCT01482897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416156|NCT01482897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92416157|NCT01482897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416158|NCT01482897|Antiemetics|antiemetics|mesh-ancestor
92416159|NCT01482897|Autonomic Agents|autonomic agents|mesh-ancestor
92416160|NCT01482897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416161|NCT01482897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416162|NCT01482897|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92608892|NCT00160407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608893|NCT00160407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416163|NCT01482897|Protective Agents|protective agents|mesh-ancestor
92416165|NCT01482936|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92416166|NCT01482936|Narcotics|narcotics|mesh-ancestor
92416167|NCT01482936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416168|NCT01482936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416169|NCT01482936|Analgesics|analgesics|mesh-ancestor
92416170|NCT01482936|Sensory System Agents|sensory system agents|mesh-ancestor
92416171|NCT01482936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416172|NCT01483014|Imatinib Mesylate|imatinib mesylate|mesh-list
92416173|NCT01483014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416174|NCT01483014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416175|NCT01483014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416185|NCT01483053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416186|NCT01483053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92416187|NCT01483053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416188|NCT01483248|Interferons|interferons|mesh-list
92416189|NCT01483248|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92416190|NCT01483248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416191|NCT01483248|Antiviral Agents|antiviral agents|mesh-ancestor
92416192|NCT01483248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416193|NCT01483248|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92416194|NCT01483248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416195|NCT01483274|Vaccines|vaccines|mesh-list
92416196|NCT01483274|Immunologic Factors|immunologic factors|mesh-ancestor
92416197|NCT01483274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416198|NCT01483300|Cisplatin|cisplatin|mesh-list
92416199|NCT01483300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416200|NCT01483365|Progesterone|progesterone|mesh-list
92416201|NCT01483365|Progestins|progestins|mesh-ancestor
92416202|NCT01483365|Hormones|hormones|mesh-ancestor
92416203|NCT01483365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416204|NCT01483365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416205|NCT01483508|Proanthocyanidin|proanthocyanidin|mesh-list
92416206|NCT01483508|Procyanidin|procyanidin|mesh-list
92416207|NCT01483508|Antioxidants|antioxidants|mesh-ancestor
92416208|NCT01483508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416209|NCT01483508|Protective Agents|protective agents|mesh-ancestor
92416210|NCT01483508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416211|NCT01483508|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92416212|NCT01483508|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92416213|NCT01483508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416214|NCT01483638|Axitinib|axitinib|mesh-list
92416215|NCT01483638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416216|NCT01483638|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416217|NCT01483638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416218|NCT01483638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416219|NCT01483729|Ritonavir|ritonavir|mesh-list
92416220|NCT01483729|Lactams|lactams|mesh-list
92416221|NCT01483729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92416222|NCT01483729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92416223|NCT01483729|Protease Inhibitors|protease inhibitors|mesh-ancestor
92416224|NCT01483729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416225|NCT01483729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416226|NCT01483729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92416227|NCT01483729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92416228|NCT01483729|Antiviral Agents|antiviral agents|mesh-ancestor
92416229|NCT01483729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416230|NCT01483729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92416231|NCT01483729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92416232|NCT01483729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416233|NCT01483781|Canagliflozin|canagliflozin|mesh-list
92416234|NCT01483781|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92416235|NCT01483781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416236|NCT01483781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416237|NCT01483781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416238|NCT01483859|Liver Extracts|liver extracts|mesh-list
92416239|NCT01483859|Hematinics|hematinics|mesh-ancestor
92416240|NCT01483911|Gontivimab|gontivimab|mesh-list
92416248|NCT01484080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92416249|NCT01484080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416250|NCT01484080|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608894|NCT00160407|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92608895|NCT00160407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92608896|NCT00153933|Lenalidomide|lenalidomide|mesh-list
92416251|NCT01484080|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416252|NCT01484080|Mitosis Modulators|mitosis modulators|mesh-ancestor
92416253|NCT01484080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416254|NCT01484145|Terbinafine|terbinafine|mesh-list
92416255|NCT01484145|Antifungal Agents|antifungal agents|mesh-ancestor
92416256|NCT01484145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416257|NCT01484145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416258|NCT01484145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416259|NCT01484171|Idarubicin|idarubicin|mesh-list
92416260|NCT01484171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92416261|NCT01484171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416262|NCT01484171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92416263|NCT01484171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92416264|NCT01484171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416265|NCT01484171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416266|NCT01484184|Levodopa|levodopa|mesh-list
92416267|NCT01484184|Buspirone|buspirone|mesh-list
92416268|NCT01484184|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92416269|NCT01484184|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92416270|NCT01484184|Dopamine Agents|dopamine agents|mesh-ancestor
92416271|NCT01484184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416272|NCT01484184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416273|NCT01484184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416274|NCT01484184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92416275|NCT01484184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92416276|NCT01484184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416277|NCT01484184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92416278|NCT01484184|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92416279|NCT01484184|Serotonin Agents|serotonin agents|mesh-ancestor
92416280|NCT01484262|Liraglutide|liraglutide|mesh-list
92416281|NCT01484262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416282|NCT01484262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416283|NCT01484262|Incretins|incretins|mesh-ancestor
92416284|NCT01484262|Hormones|hormones|mesh-ancestor
92416285|NCT01484262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416286|NCT01484327|Carvedilol|carvedilol|mesh-list
92416287|NCT01484327|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92416288|NCT01484327|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92416289|NCT01484327|Adrenergic Agents|adrenergic agents|mesh-ancestor
92416290|NCT01484327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416291|NCT01484327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416292|NCT01484327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416293|NCT01484327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92416294|NCT01484327|Antioxidants|antioxidants|mesh-ancestor
92416295|NCT01484327|Protective Agents|protective agents|mesh-ancestor
92416296|NCT01484327|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92416297|NCT01484327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92416298|NCT01484327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92416299|NCT01484327|Vasodilator Agents|vasodilator agents|mesh-ancestor
92416300|NCT01484327|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92416301|NCT01484327|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92416302|NCT01484457|Pancrelipase|pancrelipase|mesh-list
92416303|NCT01484457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416304|NCT01484600|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92416305|NCT01484600|Immunologic Factors|immunologic factors|mesh-ancestor
92416306|NCT01484600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416307|NCT01484613|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92416308|NCT01484613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92416317|NCT01484717|Autonomic Agents|autonomic agents|mesh-ancestor
92416318|NCT01484717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416319|NCT01484717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416320|NCT01484717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92416321|NCT01484717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92416322|NCT01484717|Cholinergic Agents|cholinergic agents|mesh-ancestor
92416323|NCT01484717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416324|NCT01484717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416326|NCT01484756|Trace Elements|trace elements|mesh-list
92608898|NCT00153933|Immunologic Factors|immunologic factors|mesh-ancestor
92608899|NCT00153933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608900|NCT00153933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92416327|NCT01484756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416328|NCT01484964|Peficitinib|peficitinib|mesh-list
92416329|NCT01484964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416330|NCT01484964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416331|NCT01484964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416332|NCT01484964|Immunologic Factors|immunologic factors|mesh-ancestor
92416333|NCT01484964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416334|NCT01484990|Levodopa|levodopa|mesh-list
92416335|NCT01484990|Carbidopa|carbidopa|mesh-list
92416336|NCT01484990|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92416337|NCT01484990|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92416338|NCT01484990|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92416339|NCT01484990|Dopamine Agents|dopamine agents|mesh-ancestor
92416340|NCT01484990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416341|NCT01484990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416342|NCT01484990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416343|NCT01484990|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92416344|NCT01484990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416345|NCT01484990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92416346|NCT01484990|Immunologic Factors|immunologic factors|mesh-ancestor
92416347|NCT01484990|Dopamine Agonists|dopamine agonists|mesh-ancestor
92416348|NCT01485003|Natalizumab|natalizumab|mesh-list
92416349|NCT01485003|Immunologic Factors|immunologic factors|mesh-ancestor
92416350|NCT01485003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416351|NCT01485068|Paclitaxel|paclitaxel|mesh-list
92416352|NCT01485068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92416353|NCT01485068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416354|NCT01485068|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416355|NCT01485068|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416356|NCT01485068|Mitosis Modulators|mitosis modulators|mesh-ancestor
92394510|NCT01385683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416357|NCT01485068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416358|NCT01485081|Paclitaxel|paclitaxel|mesh-list
92416359|NCT01485081|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92416360|NCT01485081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416361|NCT01485081|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416362|NCT01485081|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416363|NCT01485081|Mitosis Modulators|mitosis modulators|mesh-ancestor
92416364|NCT01485081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416365|NCT01485146|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92416366|NCT01485146|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92416367|NCT01485146|Antimetabolites|antimetabolites|mesh-ancestor
92416368|NCT01485146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416369|NCT01485146|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92416370|NCT01485146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416371|NCT01485146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416372|NCT01485146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416373|NCT01485185|Gabapentin|gabapentin|mesh-list
92416374|NCT01485185|Donepezil|donepezil|mesh-list
92416385|NCT01485185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92416386|NCT01485185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416387|NCT01485185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416388|NCT01485185|Antimanic Agents|antimanic agents|mesh-ancestor
92416389|NCT01485185|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92416390|NCT01485185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416391|NCT01485185|Cholinergic Agents|cholinergic agents|mesh-ancestor
92416392|NCT01485185|Nootropic Agents|nootropic agents|mesh-ancestor
92416393|NCT01485198|Acetaminophen|acetaminophen|mesh-list
92416394|NCT01485198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92416395|NCT01485198|Analgesics|analgesics|mesh-ancestor
92416396|NCT01485198|Sensory System Agents|sensory system agents|mesh-ancestor
92416397|NCT01485198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416398|NCT01485198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416399|NCT01485198|Antipyretics|antipyretics|mesh-ancestor
92416400|NCT01485211|Riboflavin|riboflavin|mesh-list
92416401|NCT01485211|Vitamin B Complex|vitamin b complex|mesh-ancestor
92416402|NCT01485211|Vitamins|vitamins|mesh-ancestor
92416403|NCT01485211|Micronutrients|micronutrients|mesh-ancestor
92416404|NCT01485211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416405|NCT01485211|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92608901|NCT00153933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92608902|NCT00153933|Growth Substances|growth substances|mesh-ancestor
92608903|NCT00153933|Growth Inhibitors|growth inhibitors|mesh-ancestor
92608904|NCT00153933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076234|NCT04696523|Xenon|xenon|mesh-list
92416406|NCT01485211|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416407|NCT01485224|Thalidomide|thalidomide|mesh-list
92416408|NCT01485224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416409|NCT01485224|Immunologic Factors|immunologic factors|mesh-ancestor
92416410|NCT01485224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416411|NCT01485224|Leprostatic Agents|leprostatic agents|mesh-ancestor
92416412|NCT01485224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416413|NCT01485224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416414|NCT01485224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92416415|NCT01485224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92416416|NCT01485224|Growth Substances|growth substances|mesh-ancestor
92416417|NCT01485224|Growth Inhibitors|growth inhibitors|mesh-ancestor
92416418|NCT01485224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416419|NCT01485315|Mannitol|mannitol|mesh-list
92416420|NCT01485315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92416421|NCT01485315|Diuretics|diuretics|mesh-ancestor
92416422|NCT01485315|Natriuretic Agents|natriuretic agents|mesh-ancestor
92416423|NCT01485315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416424|NCT01485367|Adapalene|adapalene|mesh-list
92416425|NCT01485367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92416426|NCT01485367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92416427|NCT01485367|Analgesics|analgesics|mesh-ancestor
92416428|NCT01485367|Sensory System Agents|sensory system agents|mesh-ancestor
92416429|NCT01485367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416430|NCT01485367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416431|NCT01485367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416432|NCT01485367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92416433|NCT01485367|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416434|NCT01485406|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92416435|NCT01485406|Immunologic Factors|immunologic factors|mesh-ancestor
92416436|NCT01485406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416437|NCT01485445|Fluticasone|fluticasone|mesh-list
92416438|NCT01485445|Xhance|xhance|mesh-list
92416439|NCT01485445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416440|NCT01485445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92416441|NCT01485445|Autonomic Agents|autonomic agents|mesh-ancestor
92416444|NCT01485445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92416445|NCT01485445|Respiratory System Agents|respiratory system agents|mesh-ancestor
92416446|NCT01485445|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416447|NCT01485445|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92416448|NCT01485562|Misoprostol|misoprostol|mesh-list
92416449|NCT01485562|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92416450|NCT01485562|Abortifacient Agents|abortifacient agents|mesh-ancestor
92416451|NCT01485562|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92416452|NCT01485562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416453|NCT01485562|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92416454|NCT01485562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416455|NCT01485562|Oxytocics|oxytocics|mesh-ancestor
92416456|NCT01485653|Mepivacaine|mepivacaine|mesh-list
92416457|NCT01485653|Anesthetics, Local|anesthetics, local|mesh-ancestor
92416458|NCT01485653|Anesthetics|anesthetics|mesh-ancestor
92416459|NCT01485653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416460|NCT01485653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416461|NCT01485653|Sensory System Agents|sensory system agents|mesh-ancestor
92416462|NCT01485653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416463|NCT01485679|Deoxyglucose|deoxyglucose|mesh-list
92416464|NCT01485679|Antimetabolites|antimetabolites|mesh-ancestor
92416465|NCT01485679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416466|NCT01485679|Antiviral Agents|antiviral agents|mesh-ancestor
92416467|NCT01485679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416468|NCT01485692|Promethazine|promethazine|mesh-list
92416469|NCT01485692|Diphenhydramine|diphenhydramine|mesh-list
92416471|NCT01485692|Haloperidol|haloperidol|mesh-list
92416472|NCT01485692|Olanzapine|olanzapine|mesh-list
92416473|NCT01485692|Haloperidol decanoate|haloperidol decanoate|mesh-list
92416474|NCT01485692|Ziprasidone|ziprasidone|mesh-list
92416475|NCT01485692|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92416476|NCT01485692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92608905|NCT00138164|Denileukin diftitox|denileukin diftitox|mesh-list
92608906|NCT00138164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608907|NCT00153972|Levodopa|levodopa|mesh-list
92608908|NCT00153972|Cabergoline|cabergoline|mesh-list
92608909|NCT00153972|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92608910|NCT00153972|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92608911|NCT00153972|Dopamine Agents|dopamine agents|mesh-ancestor
92416477|NCT01485692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416478|NCT01485692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416479|NCT01485692|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92416480|NCT01485692|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92416481|NCT01485692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92416482|NCT01485692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92416483|NCT01485692|Anesthetics, General|anesthetics, general|mesh-ancestor
92416484|NCT01485692|Anesthetics|anesthetics|mesh-ancestor
92416485|NCT01485692|GABA Modulators|gaba modulators|mesh-ancestor
92416486|NCT01485692|GABA Agents|gaba agents|mesh-ancestor
92416487|NCT01485692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416488|NCT01485692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416489|NCT01485692|Antiemetics|antiemetics|mesh-ancestor
92416490|NCT01485692|Autonomic Agents|autonomic agents|mesh-ancestor
92416491|NCT01485692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416492|NCT01485692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416493|NCT01485692|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92416494|NCT01485692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92416495|NCT01485692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92416496|NCT01485692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92416497|NCT01485692|Serotonin Agents|serotonin agents|mesh-ancestor
92416498|NCT01485692|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92416499|NCT01485692|Dopamine Agents|dopamine agents|mesh-ancestor
92416500|NCT01485692|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92416501|NCT01485692|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92416502|NCT01485692|Antipruritics|antipruritics|mesh-ancestor
92416503|NCT01485692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416504|NCT01485692|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92416505|NCT01485692|Histamine Antagonists|histamine antagonists|mesh-ancestor
92416506|NCT01485692|Histamine Agents|histamine agents|mesh-ancestor
92416507|NCT01485692|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92416508|NCT01485692|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92416509|NCT01485692|Anesthetics, Local|anesthetics, local|mesh-ancestor
92416510|NCT01485692|Sensory System Agents|sensory system agents|mesh-ancestor
92416511|NCT01485718|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92416512|NCT01485718|Cathartics|cathartics|mesh-ancestor
92141179|NCT01272609|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92416513|NCT01485718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416514|NCT01485731|Nelfinavir|nelfinavir|mesh-list
92416515|NCT01485731|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92416531|NCT01485744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92416532|NCT01485744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416533|NCT01485744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416535|NCT01485744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416536|NCT01485744|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92416537|NCT01485744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92416538|NCT01485744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416539|NCT01485744|Antidotes|antidotes|mesh-ancestor
92416540|NCT01485744|Protective Agents|protective agents|mesh-ancestor
92416541|NCT01485744|Vitamin B Complex|vitamin b complex|mesh-ancestor
92416542|NCT01485744|Vitamins|vitamins|mesh-ancestor
92416543|NCT01485744|Micronutrients|micronutrients|mesh-ancestor
92416544|NCT01485822|Travoprost|travoprost|mesh-list
92416545|NCT01485822|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92416546|NCT01485822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92416547|NCT01485822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92416548|NCT01485835|Dexamethasone|dexamethasone|mesh-list
92416549|NCT01485835|Bortezomib|bortezomib|mesh-list
92416550|NCT01485835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416551|NCT01485835|Antiemetics|antiemetics|mesh-ancestor
92416552|NCT01485835|Autonomic Agents|autonomic agents|mesh-ancestor
92416553|NCT01485835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416554|NCT01485835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416555|NCT01485835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416556|NCT01485835|Glucocorticoids|glucocorticoids|mesh-ancestor
92608912|NCT00153972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92608913|NCT00153972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416557|NCT01485835|Hormones|hormones|mesh-ancestor
92416558|NCT01485835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416559|NCT01485835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92416560|NCT01485835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416561|NCT01485848|Paclitaxel|paclitaxel|mesh-list
92416562|NCT01485848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92416563|NCT01485848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416564|NCT01485848|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416565|NCT01485848|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416566|NCT01485848|Mitosis Modulators|mitosis modulators|mesh-ancestor
92416567|NCT01485848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416568|NCT01485926|Carboplatin|carboplatin|mesh-list
92416569|NCT01485926|Docetaxel|docetaxel|mesh-list
92416570|NCT01485926|Trastuzumab|trastuzumab|mesh-list
92416571|NCT01485926|Lapatinib|lapatinib|mesh-list
92416572|NCT01485926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416573|NCT01485926|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416574|NCT01485926|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416575|NCT01485926|Mitosis Modulators|mitosis modulators|mesh-ancestor
92416576|NCT01485926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416577|NCT01485926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92416578|NCT01485926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416579|NCT01485926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416580|NCT01485939|Lidocaine|lidocaine|mesh-list
92416584|NCT01485939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416585|NCT01485939|Sensory System Agents|sensory system agents|mesh-ancestor
92416586|NCT01485939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416587|NCT01485939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92416588|NCT01485939|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92416589|NCT01485939|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92416590|NCT01485939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92416591|NCT01485939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416593|NCT01485978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92416594|NCT01485978|Protease Inhibitors|protease inhibitors|mesh-ancestor
92416595|NCT01485978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416596|NCT01485978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416597|NCT01485978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92416599|NCT01486004|Antiviral Agents|antiviral agents|mesh-ancestor
92416600|NCT01486004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416601|NCT01486004|Protease Inhibitors|protease inhibitors|mesh-ancestor
92416602|NCT01486004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416603|NCT01486004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416604|NCT01486017|Peficitinib|peficitinib|mesh-list
92416605|NCT01486017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416606|NCT01486017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416607|NCT01486017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416608|NCT01486017|Immunologic Factors|immunologic factors|mesh-ancestor
92416609|NCT01486017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416610|NCT01486082|Amoxicillin|amoxicillin|mesh-list
92416611|NCT01486082|Clarithromycin|clarithromycin|mesh-list
92416612|NCT01486082|Omeprazole|omeprazole|mesh-list
92416613|NCT01486082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416614|NCT01486082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416615|NCT01486082|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92416616|NCT01486082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416617|NCT01486082|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92416618|NCT01486082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416619|NCT01486082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416620|NCT01486082|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92416621|NCT01486082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92416622|NCT01486082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92416623|NCT01485809|Gefitinib|gefitinib|mesh-list
92416624|NCT01485809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416625|NCT01485809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416626|NCT01485809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416627|NCT01485809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416628|NCT01486251|Axitinib|axitinib|mesh-list
92416629|NCT01486251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016122|NCT05541419|Hormones|hormones|mesh-ancestor
92608914|NCT00153972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608915|NCT00153972|Dopamine Agonists|dopamine agonists|mesh-ancestor
92608916|NCT00160485|Glyburide|glyburide|mesh-list
92608917|NCT00160485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92608918|NCT00160485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608919|NCT00404183|Acetaminophen|acetaminophen|mesh-list
92608920|NCT00404183|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92608921|NCT00404183|Hydrocodone|hydrocodone|mesh-list
92608922|NCT00404183|Oxycodone|oxycodone|mesh-list
92608923|NCT00404183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608924|NCT00404183|Analgesics|analgesics|mesh-ancestor
92608925|NCT00404183|Sensory System Agents|sensory system agents|mesh-ancestor
92608926|NCT00404183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608927|NCT00404183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608928|NCT00404183|Antipyretics|antipyretics|mesh-ancestor
92416630|NCT01486251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416631|NCT01486251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416632|NCT01486251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416633|NCT01486381|Insulin Aspart|insulin aspart|mesh-list
92416634|NCT01486381|Biphasic Insulins|biphasic insulins|mesh-list
92416635|NCT01486381|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92416636|NCT01486381|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416637|NCT01486381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416638|NCT01486433|Aspirin|aspirin|mesh-list
92416639|NCT01486433|Simvastatin|simvastatin|mesh-list
92416640|NCT01486433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92416641|NCT01486433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92416642|NCT01486433|Analgesics|analgesics|mesh-ancestor
92416643|NCT01486433|Sensory System Agents|sensory system agents|mesh-ancestor
92416644|NCT01486433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416645|NCT01486433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416646|NCT01486433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416647|NCT01486433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92416648|NCT01486433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92416649|NCT01486433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92416650|NCT01486433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416652|NCT01486433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92416653|NCT01486433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416654|NCT01486433|Antipyretics|antipyretics|mesh-ancestor
92416655|NCT01486433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92416656|NCT01486433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92416657|NCT01486433|Antimetabolites|antimetabolites|mesh-ancestor
92416658|NCT01486433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92416659|NCT01486433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92416660|NCT01486459|Lithium Carbonate|lithium carbonate|mesh-list
92416661|NCT01486459|Antidepressive Agents|antidepressive agents|mesh-ancestor
92416662|NCT01486459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92416663|NCT01486459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416664|NCT01486459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416665|NCT01486459|Antimanic Agents|antimanic agents|mesh-ancestor
92416666|NCT01486459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92416667|NCT01486459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416668|NCT01486459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416669|NCT01486485|Nafamostat|nafamostat|mesh-list
92416670|NCT01486485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92416671|NCT01486485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92416672|NCT01486485|Analgesics|analgesics|mesh-ancestor
92416673|NCT01486485|Sensory System Agents|sensory system agents|mesh-ancestor
92608929|NCT00404183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92608930|NCT00404183|Narcotics|narcotics|mesh-ancestor
92608931|NCT00404183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608932|NCT00404183|Antitussive Agents|antitussive agents|mesh-ancestor
92416674|NCT01486485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416675|NCT01486485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416676|NCT01486485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416677|NCT01486485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92416678|NCT01486485|Anticoagulants|anticoagulants|mesh-ancestor
92416679|NCT01486485|Protease Inhibitors|protease inhibitors|mesh-ancestor
92416680|NCT01486485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416681|NCT01486485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416682|NCT01486485|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92416683|NCT01486485|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92416684|NCT01486485|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92416685|NCT01486485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416686|NCT01486485|Immunologic Factors|immunologic factors|mesh-ancestor
92416687|NCT01486511|Liver Extracts|liver extracts|mesh-list
92416688|NCT01486511|Hematinics|hematinics|mesh-ancestor
92416689|NCT01486550|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92416690|NCT01486550|Plasma Substitutes|plasma substitutes|mesh-ancestor
92416691|NCT01486550|Blood Substitutes|blood substitutes|mesh-ancestor
92416692|NCT01486563|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92416693|NCT01486563|Plasma Substitutes|plasma substitutes|mesh-ancestor
92416694|NCT01486563|Blood Substitutes|blood substitutes|mesh-ancestor
92416695|NCT01486576|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92416696|NCT01486576|Plasma Substitutes|plasma substitutes|mesh-ancestor
92416697|NCT01486576|Blood Substitutes|blood substitutes|mesh-ancestor
92416698|NCT01486602|Paclitaxel|paclitaxel|mesh-list
92416699|NCT01486602|Carboplatin|carboplatin|mesh-list
92416700|NCT01486602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92416701|NCT01486602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416702|NCT01486602|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416703|NCT01486602|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416704|NCT01486602|Mitosis Modulators|mitosis modulators|mesh-ancestor
92416705|NCT01486602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416706|NCT01486706|Gabapentin|gabapentin|mesh-list
92416707|NCT01486706|Solifenacin Succinate|solifenacin succinate|mesh-list
92416708|NCT01486706|Analgesics|analgesics|mesh-ancestor
92416709|NCT01486706|Sensory System Agents|sensory system agents|mesh-ancestor
92416710|NCT01486706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416711|NCT01486706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416712|NCT01486706|Anticonvulsants|anticonvulsants|mesh-ancestor
92416713|NCT01486706|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92416714|NCT01486706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92416715|NCT01486706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416716|NCT01486706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92416717|NCT01486706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92416718|NCT01486706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92416719|NCT01486706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416720|NCT01486706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416721|NCT01486706|Antimanic Agents|antimanic agents|mesh-ancestor
92416722|NCT01486706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92416723|NCT01486706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92416724|NCT01486706|Cholinergic Agents|cholinergic agents|mesh-ancestor
92416727|NCT01486823|Immunologic Factors|immunologic factors|mesh-ancestor
92416728|NCT01486823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416729|NCT01486862|Insulin Aspart|insulin aspart|mesh-list
92416730|NCT01486862|Biphasic Insulins|biphasic insulins|mesh-list
92416731|NCT01486862|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92416732|NCT01486862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416733|NCT01486862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416734|NCT01486875|Insulin Aspart|insulin aspart|mesh-list
92416735|NCT01486875|Biphasic Insulins|biphasic insulins|mesh-list
92416736|NCT01486875|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92416737|NCT01486875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416738|NCT01486875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141406|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
92416739|NCT01486888|Insulin|insulin|mesh-list
92416740|NCT01486888|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92608933|NCT00404183|Respiratory System Agents|respiratory system agents|mesh-ancestor
92608934|NCT00404183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608935|NCT00404183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608936|NCT00404183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608937|NCT00154011|Rosiglitazone|rosiglitazone|mesh-list
92416741|NCT01486888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416742|NCT01486888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416743|NCT01486901|Insulin|insulin|mesh-list
92416744|NCT01486901|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92416745|NCT01486901|Isophane Insulin, Human|isophane insulin, human|mesh-list
92416746|NCT01486901|Insulin, Isophane|insulin, isophane|mesh-list
92416747|NCT01486901|Isophane insulin, beef|isophane insulin, beef|mesh-list
92416748|NCT01486901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416749|NCT01486901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416750|NCT01486914|Insulin Aspart|insulin aspart|mesh-list
92416751|NCT01486914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416752|NCT01486914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416753|NCT01486940|Insulin|insulin|mesh-list
92416754|NCT01486940|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92416755|NCT01486940|Insulin Aspart|insulin aspart|mesh-list
92416756|NCT01486940|Insulin Detemir|insulin detemir|mesh-list
92416757|NCT01486940|Isophane Insulin, Human|isophane insulin, human|mesh-list
92416758|NCT01486940|Insulin, Isophane|insulin, isophane|mesh-list
92416759|NCT01486940|Isophane insulin, beef|isophane insulin, beef|mesh-list
92416760|NCT01486940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416761|NCT01486940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416762|NCT01486953|Sevoflurane|sevoflurane|mesh-list
92416763|NCT01486953|Desflurane|desflurane|mesh-list
92416764|NCT01486953|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92416765|NCT01486953|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92416766|NCT01486953|Anesthetics, General|anesthetics, general|mesh-ancestor
92416767|NCT01486953|Anesthetics|anesthetics|mesh-ancestor
92416768|NCT01486953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416769|NCT01486953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416770|NCT01486979|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92416771|NCT01486979|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92416772|NCT01486979|Estradiol|estradiol|mesh-list
92416773|NCT01486979|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92416774|NCT01486979|Estrogens|estrogens|mesh-ancestor
92416775|NCT01486979|Hormones|hormones|mesh-ancestor
92416776|NCT01486979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416777|NCT01486979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416778|NCT01486979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92416779|NCT01486979|Contraceptive Agents|contraceptive agents|mesh-ancestor
92416780|NCT01486979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92416781|NCT01486979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92416782|NCT01486992|Nimotuzumab|nimotuzumab|mesh-list
92416783|NCT01486992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92416784|NCT01486992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416785|NCT01487096|Teriflunomide|teriflunomide|mesh-list
92416786|NCT01487096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92416787|NCT01487096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92416788|NCT01487096|Analgesics|analgesics|mesh-ancestor
92416789|NCT01487096|Sensory System Agents|sensory system agents|mesh-ancestor
92416790|NCT01487096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416791|NCT01487096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416792|NCT01487096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92416793|NCT01487096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92416794|NCT01487096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416795|NCT01487096|Immunologic Factors|immunologic factors|mesh-ancestor
92416796|NCT01487135|Moxifloxacin|moxifloxacin|mesh-list
92416797|NCT01487135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416798|NCT01487135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416802|NCT01487135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416803|NCT01487135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416804|NCT01487226|Paclitaxel|paclitaxel|mesh-list
92416805|NCT01487226|Cisplatin|cisplatin|mesh-list
92416806|NCT01487226|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92416807|NCT01487226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416808|NCT01487226|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416809|NCT01487226|Antimitotic Agents|antimitotic agents|mesh-ancestor
92416810|NCT01487226|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608939|NCT00154011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608940|NCT00404222|Acetaminophen|acetaminophen|mesh-list
92608941|NCT00404222|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92416811|NCT01487226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416812|NCT01487278|Misoprostol|misoprostol|mesh-list
92141476|NCT03592069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92416813|NCT01487278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92416814|NCT01487278|Abortifacient Agents|abortifacient agents|mesh-ancestor
92416815|NCT01487278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92416816|NCT01487278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416817|NCT01487278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92416818|NCT01487278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416819|NCT01487278|Oxytocics|oxytocics|mesh-ancestor
92416820|NCT01487304|Hormones|hormones|mesh-list
92416821|NCT01487304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92416822|NCT01487304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416823|NCT01487317|Rivastigmine|rivastigmine|mesh-list
92416824|NCT01487317|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92416825|NCT01487317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416826|NCT01487317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416827|NCT01487317|Cholinergic Agents|cholinergic agents|mesh-ancestor
92416828|NCT01487317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416829|NCT01487317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416830|NCT01487317|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92394564|NCT01386086|Serotonin Agents|serotonin agents|mesh-ancestor
92416831|NCT01487317|Protective Agents|protective agents|mesh-ancestor
92416832|NCT01487369|Insulin Aspart|insulin aspart|mesh-list
92416833|NCT01487369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416834|NCT01487369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416835|NCT01487382|Insulin Aspart|insulin aspart|mesh-list
92416836|NCT01487382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416837|NCT01487382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416838|NCT01487395|Donepezil|donepezil|mesh-list
92416839|NCT01487395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92416840|NCT01487395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416841|NCT01487395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416842|NCT01487395|Cholinergic Agents|cholinergic agents|mesh-ancestor
92416843|NCT01487395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416844|NCT01487395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416845|NCT01487395|Nootropic Agents|nootropic agents|mesh-ancestor
92416846|NCT01487408|Insulin Aspart|insulin aspart|mesh-list
92416847|NCT01487408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416848|NCT01487408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416849|NCT01487421|Insulin|insulin|mesh-list
92416850|NCT01487421|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92416851|NCT01487421|Insulin Aspart|insulin aspart|mesh-list
92416852|NCT01487421|Insulin Detemir|insulin detemir|mesh-list
92416853|NCT01487421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416854|NCT01487421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416855|NCT01487512|Hydromorphone|hydromorphone|mesh-list
92416856|NCT01487512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92416857|NCT01487512|Narcotics|narcotics|mesh-ancestor
92416858|NCT01487512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416859|NCT01487512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416860|NCT01487512|Analgesics|analgesics|mesh-ancestor
92416861|NCT01487512|Sensory System Agents|sensory system agents|mesh-ancestor
92416862|NCT01487512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416863|NCT01487564|Hydromorphone|hydromorphone|mesh-list
92416864|NCT01487564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92416865|NCT01487564|Narcotics|narcotics|mesh-ancestor
92416866|NCT01487564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416867|NCT01487564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416868|NCT01487564|Analgesics|analgesics|mesh-ancestor
92416869|NCT01487564|Sensory System Agents|sensory system agents|mesh-ancestor
92416870|NCT01487564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416875|NCT01487629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92416876|NCT01487629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92416877|NCT01487629|Growth Substances|growth substances|mesh-ancestor
92416878|NCT01487629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416879|NCT01487629|Growth Inhibitors|growth inhibitors|mesh-ancestor
92416880|NCT01487785|Gemcitabine|gemcitabine|mesh-list
92608942|NCT00404222|Hydrocodone|hydrocodone|mesh-list
92608943|NCT00404222|Oxycodone|oxycodone|mesh-list
92608944|NCT00404222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608945|NCT00404222|Analgesics|analgesics|mesh-ancestor
92416881|NCT01487785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92416882|NCT01487785|Antimetabolites|antimetabolites|mesh-ancestor
92416883|NCT01487785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416884|NCT01487785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416885|NCT01487798|Insulin|insulin|mesh-list
92416886|NCT01487798|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92416887|NCT01487798|Insulin Aspart|insulin aspart|mesh-list
92416888|NCT01487798|Biphasic Insulins|biphasic insulins|mesh-list
92416889|NCT01487798|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92416890|NCT01487798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141551|NCT04585854|Purinergic Agents|purinergic agents|mesh-ancestor
92416891|NCT01487798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416892|NCT01487811|Insulin Aspart|insulin aspart|mesh-list
92416893|NCT01487811|Biphasic Insulins|biphasic insulins|mesh-list
92416894|NCT01487811|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92416895|NCT01487811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416896|NCT01487811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416897|NCT01487993|Metformin|metformin|mesh-list
92416898|NCT01487993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92416899|NCT01487993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416900|NCT01488136|Diazoxide|diazoxide|mesh-list
92416901|NCT01488136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92416902|NCT01488136|Vasodilator Agents|vasodilator agents|mesh-ancestor
92416903|NCT01488201|Brodalumab|brodalumab|mesh-list
92416904|NCT01488201|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416905|NCT01488227|Vitamin D|vitamin d|mesh-list
92416906|NCT01488227|Ergocalciferols|ergocalciferols|mesh-list
92416907|NCT01488227|Cholecalciferol|cholecalciferol|mesh-list
92416908|NCT01488227|Vitamins|vitamins|mesh-list
92416909|NCT01488227|Micronutrients|micronutrients|mesh-ancestor
92416910|NCT01488227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416911|NCT01488227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92416912|NCT01488227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92416913|NCT01488253|Sirolimus|sirolimus|mesh-list
92416914|NCT01488253|Temsirolimus|temsirolimus|mesh-list
92416915|NCT01488253|MTOR Inhibitors|mtor inhibitors|mesh-list
92416916|NCT01488253|Tacrolimus|tacrolimus|mesh-list
92416917|NCT01488253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416918|NCT01488253|Immunologic Factors|immunologic factors|mesh-ancestor
92416919|NCT01488253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416920|NCT01488253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92416921|NCT01488253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416922|NCT01488253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416923|NCT01488253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416924|NCT01488253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416925|NCT01488253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92416926|NCT01488253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416927|NCT01488253|Antifungal Agents|antifungal agents|mesh-ancestor
92416928|NCT01488253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416929|NCT01488266|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92416930|NCT01488266|Milnacipran|milnacipran|mesh-list
92416931|NCT01488266|Aripiprazole|aripiprazole|mesh-list
92416932|NCT01488266|Mirtazapine|mirtazapine|mesh-list
92416933|NCT01488266|Bupropion|bupropion|mesh-list
92416934|NCT01488266|Fluoxetine|fluoxetine|mesh-list
92416935|NCT01488266|Paroxetine|paroxetine|mesh-list
92416936|NCT01488266|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92416937|NCT01488266|Sertraline|sertraline|mesh-list
92416938|NCT01488266|Antidepressive Agents|antidepressive agents|mesh-list
92416939|NCT01488266|Escitalopram|escitalopram|mesh-list
92416940|NCT01488266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92416941|NCT01488266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92416942|NCT01488266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92416943|NCT01488266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416945|NCT01488266|Serotonin Agents|serotonin agents|mesh-ancestor
92416946|NCT01488266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416947|NCT01488266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416948|NCT01488266|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92416949|NCT01488266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92416950|NCT01488266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92608946|NCT00404222|Sensory System Agents|sensory system agents|mesh-ancestor
92608947|NCT00404222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608948|NCT00404222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608949|NCT00404222|Antipyretics|antipyretics|mesh-ancestor
92608950|NCT00404222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92416951|NCT01488266|Dopamine Agents|dopamine agents|mesh-ancestor
92416952|NCT01488266|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92416953|NCT01488266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92416954|NCT01488266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416955|NCT01488266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92416956|NCT01488266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92416957|NCT01488266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416958|NCT01488266|Dopamine Agonists|dopamine agonists|mesh-ancestor
92416959|NCT01488266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91938002|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
92416960|NCT01488266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92416961|NCT01488266|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92141625|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416962|NCT01488266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92416963|NCT01488266|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92416964|NCT01488266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92416965|NCT01488266|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92416966|NCT01488266|Analgesics|analgesics|mesh-ancestor
92416967|NCT01488266|Sensory System Agents|sensory system agents|mesh-ancestor
92416968|NCT01488266|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92416969|NCT01488266|Histamine Antagonists|histamine antagonists|mesh-ancestor
92416970|NCT01488266|Histamine Agents|histamine agents|mesh-ancestor
92416971|NCT01488266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92416972|NCT01488266|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92416973|NCT01488266|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92416974|NCT01488266|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92416975|NCT01488266|Adrenergic Agents|adrenergic agents|mesh-ancestor
92416976|NCT01488266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92416977|NCT01488266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92416978|NCT01488305|Micronutrients|micronutrients|mesh-list
92416979|NCT01488305|Trace Elements|trace elements|mesh-list
92416980|NCT01488305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416981|NCT01488344|Nintedanib|nintedanib|mesh-list
92416982|NCT01488344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416983|NCT01488344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92416984|NCT01488344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416985|NCT01488344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416986|NCT01488396|Cyclosporine|cyclosporine|mesh-list
92416987|NCT01488396|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92416988|NCT01488396|Cyclosporins|cyclosporins|mesh-list
92416989|NCT01488396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416990|NCT01488396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416991|NCT01488396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92416992|NCT01488396|Immunologic Factors|immunologic factors|mesh-ancestor
92416993|NCT01488396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416994|NCT01488396|Antifungal Agents|antifungal agents|mesh-ancestor
92416995|NCT01488396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416996|NCT01488396|Dermatologic Agents|dermatologic agents|mesh-ancestor
92416997|NCT01488396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92416998|NCT01488396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92416999|NCT01488396|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92417000|NCT01488526|Tenofovir|tenofovir|mesh-list
92417001|NCT01488526|Antiviral Agents|antiviral agents|mesh-ancestor
92417002|NCT01488526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417003|NCT01488526|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92417004|NCT01488526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92417005|NCT01488526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417006|NCT01488526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417007|NCT01488526|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92417008|NCT01488526|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92417009|NCT01488552|Metformin|metformin|mesh-list
92417010|NCT01488552|Paclitaxel|paclitaxel|mesh-list
92417011|NCT01488552|Gemcitabine|gemcitabine|mesh-list
92417012|NCT01488552|Folfirinox|folfirinox|mesh-list
92417013|NCT01488552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92417014|NCT01488552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608951|NCT00404222|Narcotics|narcotics|mesh-ancestor
92608952|NCT00404222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92608953|NCT00404222|Antitussive Agents|antitussive agents|mesh-ancestor
92608954|NCT00404222|Respiratory System Agents|respiratory system agents|mesh-ancestor
92417015|NCT01488552|Tubulin Modulators|tubulin modulators|mesh-ancestor
92417016|NCT01488552|Antimitotic Agents|antimitotic agents|mesh-ancestor
92417026|NCT01488565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417027|NCT01488565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417028|NCT01488565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417029|NCT01488656|Vitamin D|vitamin d|mesh-list
92417030|NCT01488656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92417031|NCT01488656|Antioxidants|antioxidants|mesh-list
92417032|NCT01488656|Vitamins|vitamins|mesh-ancestor
92417033|NCT01488656|Micronutrients|micronutrients|mesh-ancestor
92417034|NCT01488656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417035|NCT01488656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92417036|NCT01488656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417037|NCT01488656|Protective Agents|protective agents|mesh-ancestor
92417038|NCT01488734|Vitamin D|vitamin d|mesh-list
92141698|NCT05102058|Dexmedetomidine|dexmedetomidine|mesh-list
92417039|NCT01488734|Ergocalciferols|ergocalciferols|mesh-list
92417040|NCT01488734|Cholecalciferol|cholecalciferol|mesh-list
92417041|NCT01488734|Vitamins|vitamins|mesh-list
92417042|NCT01488734|Micronutrients|micronutrients|mesh-ancestor
92417043|NCT01488734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417044|NCT01488734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92417045|NCT01488734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92417046|NCT01488773|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92417047|NCT01488773|Montelukast|montelukast|mesh-list
92417048|NCT01488773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92417049|NCT01488773|Autonomic Agents|autonomic agents|mesh-ancestor
92417050|NCT01488773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417051|NCT01488773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417052|NCT01488773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92417053|NCT01488773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92417054|NCT01488773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92417055|NCT01488773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92417056|NCT01488773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92417057|NCT01488773|Adrenergic Agents|adrenergic agents|mesh-ancestor
92417058|NCT01488773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417059|NCT01488773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417060|NCT01488773|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92417061|NCT01488773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92417062|NCT01488773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92417063|NCT01488773|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92417064|NCT01488773|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92417065|NCT01488838|Cisplatin|cisplatin|mesh-list
92417066|NCT01488838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417067|NCT01488955|Fosfomycin|fosfomycin|mesh-list
92417068|NCT01488955|Ibuprofen|ibuprofen|mesh-list
92417069|NCT01488955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417070|NCT01488955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417071|NCT01488955|Analgesics|analgesics|mesh-ancestor
92417072|NCT01488955|Sensory System Agents|sensory system agents|mesh-ancestor
92417073|NCT01488955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417074|NCT01488955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417075|NCT01488955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417076|NCT01488955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417077|NCT01488955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92417078|NCT01488955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417079|NCT01488955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417080|NCT01488955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92417093|NCT01489072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417094|NCT01489072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417096|NCT01489072|Sensory System Agents|sensory system agents|mesh-ancestor
92417097|NCT01489072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417098|NCT01489124|Imipenem|imipenem|mesh-list
92417099|NCT01489124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92417100|NCT01489124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92608955|NCT00404222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92608956|NCT00404222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608957|NCT00404222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608958|NCT00160602|Certolizumab Pegol|certolizumab pegol|mesh-list
92016150|NCT05541185|Analgesics|analgesics|mesh-ancestor
92417101|NCT01489137|Remifentanil|remifentanil|mesh-list
92417102|NCT01489137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92417103|NCT01489137|Narcotics|narcotics|mesh-ancestor
92417104|NCT01489137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417105|NCT01489137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417106|NCT01489137|Analgesics|analgesics|mesh-ancestor
92417107|NCT01489137|Sensory System Agents|sensory system agents|mesh-ancestor
92417108|NCT01489137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417109|NCT01489202|Cobalt|cobalt|mesh-list
92417110|NCT01489202|Chromium|chromium|mesh-list
92417111|NCT01489202|Everolimus|everolimus|mesh-list
92417112|NCT01489202|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92417113|NCT01489202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92417114|NCT01489202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417115|NCT01489202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141772|NCT03964051|Omalizumab|omalizumab|mesh-list
92394586|NCT01386177|Adrenergic Agents|adrenergic agents|mesh-ancestor
92417116|NCT01489202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417117|NCT01489202|Immunologic Factors|immunologic factors|mesh-ancestor
92417118|NCT01489202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417119|NCT01489202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417120|NCT01489202|Trace Elements|trace elements|mesh-ancestor
92417121|NCT01489202|Micronutrients|micronutrients|mesh-ancestor
92417123|NCT01489228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417124|NCT01489228|Immunologic Factors|immunologic factors|mesh-ancestor
92417125|NCT01489228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417126|NCT01489228|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92417127|NCT01489228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92417128|NCT01489228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92417129|NCT01489228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417130|NCT01489319|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92417131|NCT01489319|Sodium Salicylate|sodium salicylate|mesh-list
92417132|NCT01489319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417133|NCT01489319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417134|NCT01489319|Analgesics|analgesics|mesh-ancestor
92417135|NCT01489319|Sensory System Agents|sensory system agents|mesh-ancestor
92417136|NCT01489319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417137|NCT01489319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417138|NCT01489319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417139|NCT01489319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417140|NCT01489319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92417141|NCT01489319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417142|NCT01489319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417143|NCT01489371|Doxorubicin|doxorubicin|mesh-list
92417144|NCT01489371|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92417147|NCT01489371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417148|NCT01489371|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92417149|NCT01489371|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92417150|NCT01489371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417151|NCT01489371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417152|NCT01489371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92417153|NCT01489371|Immunologic Factors|immunologic factors|mesh-ancestor
92417154|NCT01489371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417155|NCT01489371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92417156|NCT01489371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92417157|NCT01489371|Growth Substances|growth substances|mesh-ancestor
92417158|NCT01489371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92417159|NCT01489410|Ethanol|ethanol|mesh-list
92417160|NCT01489410|Doxorubicin|doxorubicin|mesh-list
92417161|NCT01489410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92417162|NCT01489410|Ethiodized Oil|ethiodized oil|mesh-list
92417163|NCT01489410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92417164|NCT01489410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417165|NCT01489410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92417166|NCT01489410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92417167|NCT01489410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417168|NCT01489410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608959|NCT00160602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92608960|NCT00160602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92608961|NCT00160602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92608962|NCT00160602|Immunologic Factors|immunologic factors|mesh-ancestor
92608963|NCT00160602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076946|NCT03301506|Seladelpar|seladelpar|mesh-list
92417169|NCT01489410|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92417170|NCT01489410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417171|NCT01489410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417172|NCT01489410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417173|NCT01489488|Riociguat|riociguat|mesh-list
92417174|NCT01489488|Enzyme Activators|enzyme activators|mesh-ancestor
92417175|NCT01489488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417176|NCT01489566|Fluorouracil|fluorouracil|mesh-list
92417177|NCT01489566|Mitomycins|mitomycins|mesh-list
92417178|NCT01489566|Mitomycin|mitomycin|mesh-list
92417179|NCT01489566|Antimetabolites|antimetabolites|mesh-ancestor
92417180|NCT01489566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417181|NCT01489566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417182|NCT01489566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417183|NCT01489566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417184|NCT01489566|Immunologic Factors|immunologic factors|mesh-ancestor
92417185|NCT01489566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417186|NCT01489566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92417187|NCT01489566|Alkylating Agents|alkylating agents|mesh-ancestor
92417188|NCT01489566|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92417189|NCT01489566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141847|NCT04616274|Venetoclax|venetoclax|mesh-list
92417191|NCT01489592|Antioxidants|antioxidants|mesh-ancestor
92417192|NCT01489592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417193|NCT01489592|Protective Agents|protective agents|mesh-ancestor
92417194|NCT01489592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417195|NCT01489631|Sufentanil|sufentanil|mesh-list
92417196|NCT01489631|Gabapentin|gabapentin|mesh-list
92417197|NCT01489631|Bupivacaine|bupivacaine|mesh-list
92417198|NCT01489631|Ropivacaine|ropivacaine|mesh-list
92417199|NCT01489631|Anesthetics, Local|anesthetics, local|mesh-ancestor
92417200|NCT01489631|Anesthetics|anesthetics|mesh-ancestor
92417201|NCT01489631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417202|NCT01489631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417203|NCT01489631|Sensory System Agents|sensory system agents|mesh-ancestor
92417204|NCT01489631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417205|NCT01489631|Analgesics|analgesics|mesh-ancestor
92417206|NCT01489631|Anticonvulsants|anticonvulsants|mesh-ancestor
92417207|NCT01489631|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92417208|NCT01489631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92417209|NCT01489631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92417210|NCT01489631|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92417211|NCT01489631|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92417212|NCT01489631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417213|NCT01489631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417214|NCT01489631|Antimanic Agents|antimanic agents|mesh-ancestor
92417215|NCT01489631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92417216|NCT01489631|Narcotics|narcotics|mesh-ancestor
92417217|NCT01489631|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92417218|NCT01489631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92417231|NCT01489683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92417232|NCT01489683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92417233|NCT01489683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92417234|NCT01489683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417235|NCT01489683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417236|NCT01489696|Tamsulosin|tamsulosin|mesh-list
92417237|NCT01489696|Mirabegron|mirabegron|mesh-list
92417238|NCT01489696|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92417239|NCT01489696|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92417240|NCT01489696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92417241|NCT01489696|Adrenergic Agents|adrenergic agents|mesh-ancestor
92417242|NCT01489696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417243|NCT01489696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92608965|NCT00138242|Carboplatin|carboplatin|mesh-list
92608966|NCT00138242|Docetaxel|docetaxel|mesh-list
92608967|NCT00138242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92608968|NCT00138242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92608969|NCT00138242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077010|NCT03112590|Paclitaxel|paclitaxel|mesh-list
92417244|NCT01489696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417245|NCT01489696|Urological Agents|urological agents|mesh-ancestor
92417246|NCT01489696|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92417247|NCT01489696|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92417248|NCT01489696|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92417249|NCT01489709|Solifenacin Succinate|solifenacin succinate|mesh-list
92417250|NCT01489709|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92417251|NCT01489709|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92417252|NCT01489709|Cholinergic Agents|cholinergic agents|mesh-ancestor
92417253|NCT01489709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417254|NCT01489709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417255|NCT01489709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417256|NCT01489709|Urological Agents|urological agents|mesh-ancestor
92417257|NCT01489852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92417258|NCT01489852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92417259|NCT01489852|Estradiol|estradiol|mesh-list
92417260|NCT01489852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92417261|NCT01489852|Estrogens|estrogens|mesh-ancestor
92417262|NCT01489852|Hormones|hormones|mesh-ancestor
92417263|NCT01489852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141924|NCT04198363|Antacids|antacids|mesh-ancestor
92417264|NCT01489852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417265|NCT01489852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92417266|NCT01489852|Contraceptive Agents|contraceptive agents|mesh-ancestor
92417267|NCT01489852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92417268|NCT01489852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92417269|NCT01489865|Fluorouracil|fluorouracil|mesh-list
92417270|NCT01489865|Veliparib|veliparib|mesh-list
92417271|NCT01489865|Antimetabolites|antimetabolites|mesh-ancestor
92417272|NCT01489865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417273|NCT01489865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417274|NCT01489865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417275|NCT01489865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417276|NCT01489865|Immunologic Factors|immunologic factors|mesh-ancestor
92417277|NCT01489865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417278|NCT01489865|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92417279|NCT01489865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417280|NCT01489904|Botulinum Toxins|botulinum toxins|mesh-list
92417283|NCT01489904|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92417284|NCT01489904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417285|NCT01489904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417286|NCT01489904|Cholinergic Agents|cholinergic agents|mesh-ancestor
92417287|NCT01489904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417288|NCT01489904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417289|NCT01489904|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92417290|NCT01489904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417291|NCT01489917|Heparin|heparin|mesh-list
92417292|NCT01489917|Hemostatics|hemostatics|mesh-list
92417293|NCT01489917|Anticoagulants|anticoagulants|mesh-ancestor
92417294|NCT01489917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92417295|NCT01489917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92417296|NCT01489917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417297|NCT01489917|Coagulants|coagulants|mesh-ancestor
92417298|NCT01489943|Pioglitazone|pioglitazone|mesh-list
92417299|NCT01489943|Midazolam|midazolam|mesh-list
92417300|NCT01489943|Omeprazole|omeprazole|mesh-list
92417301|NCT01489943|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92417302|NCT01489943|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92417303|NCT01489943|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92417304|NCT01489943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417305|NCT01489943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417306|NCT01489943|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92417307|NCT01489943|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92608970|NCT00138242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92608971|NCT00138242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417308|NCT01489943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92417309|NCT01489943|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92417310|NCT01489943|Anesthetics, General|anesthetics, general|mesh-ancestor
92417311|NCT01489943|Anesthetics|anesthetics|mesh-ancestor
92417312|NCT01489943|GABA Modulators|gaba modulators|mesh-ancestor
92417313|NCT01489943|GABA Agents|gaba agents|mesh-ancestor
92417314|NCT01489943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417315|NCT01489943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417316|NCT01489943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92417317|NCT01489943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92417318|NCT01489943|Antimetabolites|antimetabolites|mesh-ancestor
92417319|NCT01489943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92417320|NCT01489943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92417321|NCT01489943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417322|NCT01489943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417323|NCT01489943|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92417324|NCT01489943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92417325|NCT01489943|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92417326|NCT01489982|Zopiclone|zopiclone|mesh-list
92417327|NCT01489982|Doxepin|doxepin|mesh-list
92417328|NCT01489982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92417329|NCT01489982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417330|NCT01489982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417331|NCT01489982|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92417332|NCT01489982|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92417333|NCT01489982|Antidepressive Agents|antidepressive agents|mesh-ancestor
92417334|NCT01489982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92417335|NCT01489982|Histamine Antagonists|histamine antagonists|mesh-ancestor
92417336|NCT01489982|Histamine Agents|histamine agents|mesh-ancestor
92417337|NCT01489982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717874|NCT04623021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92142018|NCT00751179|Bromides|bromides|mesh-list
92417338|NCT01489982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417339|NCT01489995|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
92417340|NCT01489995|Antiviral Agents|antiviral agents|mesh-ancestor
92417341|NCT01489995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417342|NCT01489995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417343|NCT01489995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417344|NCT01490047|Etanercept|etanercept|mesh-list
92417345|NCT01490047|Doxorubicin|doxorubicin|mesh-list
92417346|NCT01490047|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92417347|NCT01490047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92417348|NCT01490047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417349|NCT01490047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92417350|NCT01490047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92417351|NCT01490047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417352|NCT01490047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417358|NCT01490047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417359|NCT01490047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417360|NCT01490047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417361|NCT01490047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92417362|NCT01490047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417363|NCT01490047|Immunologic Factors|immunologic factors|mesh-ancestor
92417364|NCT01490099|Insulin Detemir|insulin detemir|mesh-list
92417365|NCT01490099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417366|NCT01490099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417367|NCT01490112|Insulin Aspart|insulin aspart|mesh-list
92417368|NCT01490112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417369|NCT01490112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417370|NCT01490203|Edetic Acid|edetic acid|mesh-list
92417371|NCT01490203|Pentetic Acid|pentetic acid|mesh-list
92417372|NCT01490203|Antidotes|antidotes|mesh-ancestor
92417373|NCT01490203|Protective Agents|protective agents|mesh-ancestor
92417374|NCT01490203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417375|NCT01490203|Chelating Agents|chelating agents|mesh-ancestor
92417376|NCT01490203|Sequestering Agents|sequestering agents|mesh-ancestor
92417377|NCT01490203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417378|NCT01490203|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92417379|NCT01490203|Anticoagulants|anticoagulants|mesh-ancestor
92417380|NCT01490203|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92608973|NCT00154050|Candesartan cilexetil|candesartan cilexetil|mesh-list
92608975|NCT00154050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92608976|NCT00154050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92608977|NCT00154050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92608978|NCT00154050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417381|NCT01490216|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92417382|NCT01490216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92417383|NCT01490216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417384|NCT01490216|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92417385|NCT01490216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92417386|NCT01490216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417387|NCT01490216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417388|NCT01490216|Dopamine Agents|dopamine agents|mesh-ancestor
92417389|NCT01490216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417390|NCT01490229|Ezetimibe|ezetimibe|mesh-list
92417391|NCT01490229|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92417392|NCT01490229|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92417393|NCT01490229|Antimetabolites|antimetabolites|mesh-ancestor
92417394|NCT01490229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417395|NCT01490229|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92417396|NCT01490255|Amlodipine|amlodipine|mesh-list
92417397|NCT01490255|Ranolazine|ranolazine|mesh-list
92417398|NCT01490255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92417399|NCT01490255|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92417400|NCT01490255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417401|NCT01490255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417402|NCT01490255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92417403|NCT01490255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417404|NCT01490255|Vasodilator Agents|vasodilator agents|mesh-ancestor
92394593|NCT01386229|Analgesics|analgesics|mesh-ancestor
92417405|NCT01490255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92417406|NCT01490268|Sufentanil|sufentanil|mesh-list
92417407|NCT01490268|Dsuvia|dsuvia|mesh-list
92417408|NCT01490268|Hydromorphone|hydromorphone|mesh-list
92417409|NCT01490268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92417410|NCT01490268|Narcotics|narcotics|mesh-ancestor
92417411|NCT01490268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417412|NCT01490268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417413|NCT01490268|Analgesics|analgesics|mesh-ancestor
92417414|NCT01490268|Sensory System Agents|sensory system agents|mesh-ancestor
92417415|NCT01490268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417416|NCT01490268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92417417|NCT01490268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92417418|NCT01490268|Anesthetics, General|anesthetics, general|mesh-ancestor
92417419|NCT01490268|Anesthetics|anesthetics|mesh-ancestor
92417420|NCT01490333|Vitamin D|vitamin d|mesh-list
92417421|NCT01490333|Cholecalciferol|cholecalciferol|mesh-list
92417422|NCT01490333|Vitamins|vitamins|mesh-ancestor
92417423|NCT01490333|Micronutrients|micronutrients|mesh-ancestor
92417427|NCT01490346|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92417428|NCT01490346|Antiviral Agents|antiviral agents|mesh-ancestor
92417429|NCT01490346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417430|NCT01490398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92417431|NCT01490398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92417432|NCT01490398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92417433|NCT01490398|Antimetabolites|antimetabolites|mesh-ancestor
92417434|NCT01490398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417435|NCT01490398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92417436|NCT01490398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92417437|NCT01490398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417438|NCT01490411|Immunomodulating Agents|immunomodulating agents|mesh-list
92417439|NCT01490411|Immunologic Factors|immunologic factors|mesh-list
92417440|NCT01490411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417441|NCT01490437|Dexamethasone|dexamethasone|mesh-list
92417442|NCT01490437|Pemetrexed|pemetrexed|mesh-list
92417443|NCT01490437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417444|NCT01490437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417445|NCT01490437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417446|NCT01490437|Antiemetics|antiemetics|mesh-ancestor
92608979|NCT00154050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92608980|NCT00154050|Protease Inhibitors|protease inhibitors|mesh-ancestor
92608981|NCT00154050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608982|NCT00154089|Masoprocol|masoprocol|mesh-list
92608983|NCT00154089|Antioxidants|antioxidants|mesh-ancestor
92608984|NCT00154089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417447|NCT01490437|Autonomic Agents|autonomic agents|mesh-ancestor
92417448|NCT01490437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417449|NCT01490437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92417450|NCT01490437|Glucocorticoids|glucocorticoids|mesh-ancestor
92417451|NCT01490437|Hormones|hormones|mesh-ancestor
92417452|NCT01490437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92417453|NCT01490437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92417454|NCT01490437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417455|NCT01490437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417456|NCT01490437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92417457|NCT01490437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92417458|NCT01490476|Everolimus|everolimus|mesh-list
92417459|NCT01490476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417460|NCT01490476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417461|NCT01490476|Immunologic Factors|immunologic factors|mesh-ancestor
92417462|NCT01490476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417463|NCT01490476|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92417464|NCT01490476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92417465|NCT01490476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417466|NCT01490476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417467|NCT01490567|Donepezil|donepezil|mesh-list
92417468|NCT01490567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92417469|NCT01490567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417470|NCT01490567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417471|NCT01490567|Cholinergic Agents|cholinergic agents|mesh-ancestor
92417472|NCT01490567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417473|NCT01490567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417474|NCT01490567|Nootropic Agents|nootropic agents|mesh-ancestor
92417475|NCT01490658|Metformin|metformin|mesh-list
92417476|NCT01490658|Repaglinide|repaglinide|mesh-list
92417477|NCT01490658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417478|NCT01490658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417479|NCT01490671|Tenofovir|tenofovir|mesh-list
92417480|NCT01490671|Antiviral Agents|antiviral agents|mesh-ancestor
92417481|NCT01490671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417482|NCT01490671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92417483|NCT01490671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92417484|NCT01490671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417485|NCT01490671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417486|NCT01490671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92417487|NCT01490671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92417488|NCT01490749|Carboplatin|carboplatin|mesh-list
92417490|NCT01490749|Oxaliplatin|oxaliplatin|mesh-list
92417491|NCT01490749|Everolimus|everolimus|mesh-list
92417492|NCT01490749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417493|NCT01490749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417494|NCT01490749|Antimetabolites|antimetabolites|mesh-ancestor
92417495|NCT01490749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417497|NCT01490749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92417498|NCT01490749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417499|NCT01490749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417500|NCT01490749|Immunologic Factors|immunologic factors|mesh-ancestor
92417501|NCT01490749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417502|NCT01490762|Insulin|insulin|mesh-list
92417503|NCT01490762|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92417504|NCT01490762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417505|NCT01490762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417506|NCT01490905|Ibuprofen|ibuprofen|mesh-list
92417507|NCT01490905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417508|NCT01490905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417509|NCT01490905|Analgesics|analgesics|mesh-ancestor
92417510|NCT01490905|Sensory System Agents|sensory system agents|mesh-ancestor
92417511|NCT01490905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608985|NCT00154089|Protective Agents|protective agents|mesh-ancestor
92608986|NCT00154089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92608987|NCT00154089|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92608988|NCT00154089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92608989|NCT00154089|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92608990|NCT00154089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417512|NCT01490905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417513|NCT01490905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417514|NCT01490905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417515|NCT01490905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92417516|NCT01490905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417517|NCT01490905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417519|NCT01490944|Folic Acid|folic acid|mesh-list
92417520|NCT01490944|Vitamin B 12|vitamin b 12|mesh-list
92417521|NCT01490944|Hydroxocobalamin|hydroxocobalamin|mesh-list
92417522|NCT01490944|Vitamin B Complex|vitamin b complex|mesh-list
92417523|NCT01490944|Trace Elements|trace elements|mesh-ancestor
92417524|NCT01490944|Micronutrients|micronutrients|mesh-ancestor
92417525|NCT01490944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417526|NCT01490944|Hematinics|hematinics|mesh-ancestor
92417527|NCT01490944|Vitamins|vitamins|mesh-ancestor
92417528|NCT01490996|Curcumin|curcumin|mesh-list
92417529|NCT01490996|Capecitabine|capecitabine|mesh-list
92417530|NCT01490996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417531|NCT01490996|Antimetabolites|antimetabolites|mesh-ancestor
92417532|NCT01490996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417533|NCT01490996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417534|NCT01490996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417535|NCT01490996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417536|NCT01490996|Analgesics|analgesics|mesh-ancestor
92417537|NCT01490996|Sensory System Agents|sensory system agents|mesh-ancestor
92417538|NCT01490996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417539|NCT01490996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417540|NCT01490996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417541|NCT01490996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417542|NCT01490996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417543|NCT01491009|Midazolam|midazolam|mesh-list
92417544|NCT01491009|Remifentanil|remifentanil|mesh-list
92417545|NCT01491009|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92417546|NCT01491009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92417547|NCT01491009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417548|NCT01491009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417549|NCT01491009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92417550|NCT01491009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92417551|NCT01491009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92417552|NCT01491009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92417553|NCT01491009|Anesthetics, General|anesthetics, general|mesh-ancestor
92417554|NCT01491009|Anesthetics|anesthetics|mesh-ancestor
92417555|NCT01491009|GABA Modulators|gaba modulators|mesh-ancestor
92417556|NCT01491009|GABA Agents|gaba agents|mesh-ancestor
92417557|NCT01491009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417558|NCT01491009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417559|NCT01491009|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92417560|NCT01491009|Narcotics|narcotics|mesh-ancestor
92417561|NCT01491009|Analgesics|analgesics|mesh-ancestor
92417562|NCT01491009|Sensory System Agents|sensory system agents|mesh-ancestor
92417563|NCT01491009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417564|NCT01491048|Tacrine|tacrine|mesh-list
92417565|NCT01491048|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92417566|NCT01491048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417567|NCT01491048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417568|NCT01491048|Cholinergic Agents|cholinergic agents|mesh-ancestor
92417569|NCT01491048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417570|NCT01491048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417571|NCT01491048|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92417572|NCT01491048|Autonomic Agents|autonomic agents|mesh-ancestor
92417583|NCT01491100|Antiviral Agents|antiviral agents|mesh-ancestor
92417584|NCT01491100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417585|NCT01491100|Immunologic Factors|immunologic factors|mesh-ancestor
92608991|NCT00154089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92608992|NCT00154089|Analgesics|analgesics|mesh-ancestor
92608993|NCT00154089|Sensory System Agents|sensory system agents|mesh-ancestor
92608994|NCT00154089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92608995|NCT00154089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417586|NCT01491100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417587|NCT01491100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92417589|NCT01491139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417590|NCT01491139|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92417591|NCT01491139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417592|NCT01491139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417593|NCT01491191|Palmidrol|palmidrol|mesh-list
92417594|NCT01491191|Analgesics|analgesics|mesh-ancestor
92417595|NCT01491191|Sensory System Agents|sensory system agents|mesh-ancestor
92417596|NCT01491191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417597|NCT01491191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417598|NCT01491191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417599|NCT01491191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417600|NCT01491191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417601|NCT01491191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417602|NCT01491191|Antiviral Agents|antiviral agents|mesh-ancestor
92417603|NCT01491191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417604|NCT01491191|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92417605|NCT01491191|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92417606|NCT01491191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417607|NCT01491191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417608|NCT01491191|Hormones|hormones|mesh-ancestor
92417609|NCT01491191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92417610|NCT01491204|Paclitaxel|paclitaxel|mesh-list
92417611|NCT01491204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92417612|NCT01491204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417613|NCT01491204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92417614|NCT01491204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92417615|NCT01491204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92417616|NCT01491204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417617|NCT01491217|Paclitaxel|paclitaxel|mesh-list
92417618|NCT01491217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92417619|NCT01491217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417620|NCT01491217|Tubulin Modulators|tubulin modulators|mesh-ancestor
92417621|NCT01491217|Antimitotic Agents|antimitotic agents|mesh-ancestor
92417622|NCT01491217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92417623|NCT01491217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417624|NCT01491256|Atorvastatin|atorvastatin|mesh-list
92417625|NCT01491256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92417626|NCT01491256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92417627|NCT01491256|Antimetabolites|antimetabolites|mesh-ancestor
92417628|NCT01491256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417629|NCT01491256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92417630|NCT01491256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92417631|NCT01491256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417632|NCT01491295|Tenofovir|tenofovir|mesh-list
92417633|NCT01491295|Lamivudine|lamivudine|mesh-list
92417634|NCT01491295|Adefovir|adefovir|mesh-list
92417635|NCT01491295|Antiviral Agents|antiviral agents|mesh-ancestor
92417636|NCT01491295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417637|NCT01491295|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92417663|NCT01491503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92417664|NCT01491503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417665|NCT01491503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92417666|NCT01491503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92417667|NCT01491503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417668|NCT01491503|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92417670|NCT01491503|Histamine Antagonists|histamine antagonists|mesh-ancestor
92417671|NCT01491503|Histamine Agents|histamine agents|mesh-ancestor
92417672|NCT01491503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417673|NCT01491503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92608996|NCT00154089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92608997|NCT00138359|Niclosamide|niclosamide|mesh-list
92608998|NCT00138359|Anticestodal Agents|anticestodal agents|mesh-ancestor
92608999|NCT00138359|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92077413|NCT00082706|Leucovorin|leucovorin|mesh-list
92417674|NCT01491711|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92417675|NCT01491711|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92417676|NCT01491711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92417677|NCT01491711|Dermatologic Agents|dermatologic agents|mesh-ancestor
92417678|NCT01491867|Travoprost|travoprost|mesh-list
92417679|NCT01491867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92417680|NCT01492062|Pancrelipase|pancrelipase|mesh-list
92417681|NCT01492062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92417682|NCT01492114|Resveratrol|resveratrol|mesh-list
92417683|NCT01492114|Antioxidants|antioxidants|mesh-ancestor
92417684|NCT01492114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417685|NCT01492114|Protective Agents|protective agents|mesh-ancestor
92417687|NCT01492114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417688|NCT01492114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92417690|NCT01492153|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92417691|NCT01492153|Isophane Insulin, Human|isophane insulin, human|mesh-list
92417692|NCT01492153|Insulin, Isophane|insulin, isophane|mesh-list
92417693|NCT01492153|Isophane insulin, beef|isophane insulin, beef|mesh-list
92417694|NCT01492153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417695|NCT01492153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417696|NCT01492166|Insulin|insulin|mesh-list
92417697|NCT01492166|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92417698|NCT01492166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417699|NCT01492166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417700|NCT01492179|Lidocaine|lidocaine|mesh-list
92417701|NCT01492179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92417702|NCT01492179|Anesthetics|anesthetics|mesh-ancestor
92417703|NCT01492179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417704|NCT01492179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417705|NCT01492179|Sensory System Agents|sensory system agents|mesh-ancestor
92417706|NCT01492179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417707|NCT01492179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92417708|NCT01492179|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92417709|NCT01492179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92417710|NCT01492179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417711|NCT01492179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417712|NCT01492205|Insulin|insulin|mesh-list
92417713|NCT01492205|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92142374|NCT00723099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394609|NCT01386242|Antiviral Agents|antiviral agents|mesh-ancestor
92417714|NCT01492205|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417715|NCT01492205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417716|NCT01492218|Insulin|insulin|mesh-list
92417717|NCT01492218|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92417718|NCT01492218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417719|NCT01492218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417720|NCT01492387|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92417721|NCT01492387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417722|NCT01492504|Asunaprevir|asunaprevir|mesh-list
92417723|NCT01492504|Protease Inhibitors|protease inhibitors|mesh-ancestor
92417724|NCT01492504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417725|NCT01492504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417726|NCT01492543|Tegafur|tegafur|mesh-list
92417727|NCT01492543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417728|NCT01492543|Antimetabolites|antimetabolites|mesh-ancestor
92417729|NCT01492543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417730|NCT01492543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417731|NCT01492556|Etoposide|etoposide|mesh-list
92417732|NCT01492556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92417733|NCT01492556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417734|NCT01492556|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92417735|NCT01492556|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92417736|NCT01492556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417737|NCT01492556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417738|NCT01492608|Magnesium Sulfate|magnesium sulfate|mesh-list
92417739|NCT01492608|Analgesics|analgesics|mesh-ancestor
92417740|NCT01492608|Sensory System Agents|sensory system agents|mesh-ancestor
92417741|NCT01492608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417742|NCT01492608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417743|NCT01492608|Anesthetics|anesthetics|mesh-ancestor
92417744|NCT01492608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417745|NCT01492608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92417746|NCT01492608|Anticonvulsants|anticonvulsants|mesh-ancestor
92417747|NCT01492608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92417748|NCT01492608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417749|NCT01492608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417750|NCT01492608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92417751|NCT01492608|Tocolytic Agents|tocolytic agents|mesh-ancestor
92417752|NCT01492608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92417753|NCT01492621|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92417754|NCT01492621|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92417755|NCT01492621|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92417756|NCT01492621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417761|NCT01492621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92417762|NCT01492712|Propofol|propofol|mesh-list
92417763|NCT01492712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92417764|NCT01492712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417765|NCT01492712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417766|NCT01492712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92417767|NCT01492712|Anesthetics, General|anesthetics, general|mesh-ancestor
92417768|NCT01492712|Anesthetics|anesthetics|mesh-ancestor
92417769|NCT01492725|Plasminogen|plasminogen|mesh-list
92417770|NCT01492725|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92417771|NCT01492725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92417772|NCT01492725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92417773|NCT01492725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417774|NCT01492881|Doxorubicin|doxorubicin|mesh-list
92417775|NCT01492881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92417776|NCT01492881|Bortezomib|bortezomib|mesh-list
92417777|NCT01492881|Vorinostat|vorinostat|mesh-list
92417778|NCT01492881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92417779|NCT01492881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417780|NCT01492881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92417781|NCT01492881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92417782|NCT01492881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417783|NCT01492881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417784|NCT01492881|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92417785|NCT01492894|Cyclosporine|cyclosporine|mesh-list
92417786|NCT01492894|Sirolimus|sirolimus|mesh-list
92417787|NCT01492894|Tacrolimus|tacrolimus|mesh-list
92417788|NCT01492894|Cyclosporins|cyclosporins|mesh-list
92417789|NCT01492894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417790|NCT01492894|Immunologic Factors|immunologic factors|mesh-ancestor
92417791|NCT01492894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417792|NCT01492894|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92417793|NCT01492894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417794|NCT01492894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417795|NCT01492894|Antifungal Agents|antifungal agents|mesh-ancestor
92417796|NCT01492894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417797|NCT01492894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92417798|NCT01492894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417799|NCT01492894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92417800|NCT01492894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92417801|NCT01492894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417802|NCT01492920|Acetylcarnitine|acetylcarnitine|mesh-list
92417803|NCT01492920|Vitamin B Complex|vitamin b complex|mesh-ancestor
92417804|NCT01492920|Vitamins|vitamins|mesh-ancestor
92417805|NCT01492920|Micronutrients|micronutrients|mesh-ancestor
92417806|NCT01492920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417807|NCT01492920|Nootropic Agents|nootropic agents|mesh-ancestor
92417808|NCT01492959|Insulin|insulin|mesh-list
92417809|NCT01492959|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92417810|NCT01492959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417811|NCT01492959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417812|NCT01492985|Vaccines|vaccines|mesh-list
92417813|NCT01492985|Immunologic Factors|immunologic factors|mesh-ancestor
92417814|NCT01492985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417815|NCT01493050|Calcium Carbonate|calcium carbonate|mesh-list
92417816|NCT01493050|Calcium|calcium|mesh-list
92417817|NCT01493050|Sevelamer|sevelamer|mesh-list
92417818|NCT01493050|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92417819|NCT01493050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417820|NCT01493050|Antacids|antacids|mesh-ancestor
92609001|NCT00138359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92609002|NCT00138359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417821|NCT01493050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417822|NCT01493050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92417823|NCT01493050|Chelating Agents|chelating agents|mesh-ancestor
92417824|NCT01493050|Sequestering Agents|sequestering agents|mesh-ancestor
92417825|NCT01493102|Vasopressins|vasopressins|mesh-list
92417826|NCT01493102|Arginine Vasopressin|arginine vasopressin|mesh-list
92417827|NCT01493102|Norepinephrine|norepinephrine|mesh-list
92417828|NCT01493102|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92417829|NCT01493102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92417831|NCT01493102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417832|NCT01493102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417833|NCT01493102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417835|NCT01493102|Autonomic Agents|autonomic agents|mesh-ancestor
92417836|NCT01493102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417837|NCT01493102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92417838|NCT01493102|Hemostatics|hemostatics|mesh-ancestor
92417839|NCT01493102|Coagulants|coagulants|mesh-ancestor
92417840|NCT01493102|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92417841|NCT01493102|Natriuretic Agents|natriuretic agents|mesh-ancestor
92417842|NCT01493115|Insulin|insulin|mesh-list
92417843|NCT01493115|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92417844|NCT01493115|Insulin Glargine|insulin glargine|mesh-list
92417845|NCT01493115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417846|NCT01493115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417847|NCT01493154|Cyclophosphamide|cyclophosphamide|mesh-list
92417848|NCT01493154|Vaccines|vaccines|mesh-list
92417849|NCT01493154|Immunologic Factors|immunologic factors|mesh-ancestor
92417850|NCT01493154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417851|NCT01493154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92417852|NCT01493154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417853|NCT01493154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92417854|NCT01493154|Alkylating Agents|alkylating agents|mesh-ancestor
92417855|NCT01493154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417856|NCT01493154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417857|NCT01493154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92417858|NCT01493310|Paclitaxel|paclitaxel|mesh-list
92417859|NCT01493310|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92417860|NCT01493310|Mifepristone|mifepristone|mesh-list
92417861|NCT01493310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92417862|NCT01493310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417863|NCT01493310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92417864|NCT01493310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92417865|NCT01493310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92417866|NCT01493310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417867|NCT01493310|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92417868|NCT01493310|Abortifacient Agents|abortifacient agents|mesh-ancestor
92417869|NCT01493310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92417870|NCT01493310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417871|NCT01493310|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92417872|NCT01493310|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92417873|NCT01493310|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92417874|NCT01493310|Contraceptive Agents|contraceptive agents|mesh-ancestor
92417875|NCT01493310|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92417876|NCT01493310|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92417877|NCT01493310|Hormone Antagonists|hormone antagonists|mesh-ancestor
92417878|NCT01493310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92417879|NCT01493310|Luteolytic Agents|luteolytic agents|mesh-ancestor
92417880|NCT01493310|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92417881|NCT01493310|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92417882|NCT01493336|Capecitabine|capecitabine|mesh-list
92417883|NCT01493336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417884|NCT01493336|Antimetabolites|antimetabolites|mesh-ancestor
92417885|NCT01493336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417886|NCT01493336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417887|NCT01493388|Insulin|insulin|mesh-list
92417888|NCT01493388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417889|NCT01493388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417890|NCT01493440|Atosiban|atosiban|mesh-list
92417891|NCT01493440|Hormone Antagonists|hormone antagonists|mesh-ancestor
92417892|NCT01493440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609003|NCT00138359|Antinematodal Agents|antinematodal agents|mesh-ancestor
92609004|NCT00154128|Salicylic Acid|salicylic acid|mesh-list
92609005|NCT00154128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016193|NCT04964505|Antimetabolites|antimetabolites|mesh-ancestor
92417893|NCT01493440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417894|NCT01493440|Tocolytic Agents|tocolytic agents|mesh-ancestor
92417895|NCT01493440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92417896|NCT01493479|Rituximab|rituximab|mesh-list
92417897|NCT01493479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92417898|NCT01493479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417899|NCT01493479|Immunologic Factors|immunologic factors|mesh-ancestor
92417900|NCT01493479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417901|NCT01493479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417902|NCT01493570|BI 409306|bi 409306|mesh-list
92417936|NCT01493843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417938|NCT01493843|Antimitotic Agents|antimitotic agents|mesh-ancestor
92417939|NCT01493843|Mitosis Modulators|mitosis modulators|mesh-ancestor
92142621|NCT04149067|Hormones|hormones|mesh-ancestor
92417940|NCT01493843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417941|NCT01493843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92417942|NCT01493843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92417943|NCT01493843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92417944|NCT01493843|Growth Substances|growth substances|mesh-ancestor
92417945|NCT01493843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417948|NCT01493856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92417949|NCT01493856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92417950|NCT01493856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92417951|NCT01493856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417952|NCT01493973|Epoetin Alfa|epoetin alfa|mesh-list
92417953|NCT01493973|Hematinics|hematinics|mesh-ancestor
92417954|NCT01493986|Ropivacaine|ropivacaine|mesh-list
92417955|NCT01493986|Anesthetics, Local|anesthetics, local|mesh-ancestor
92417956|NCT01493986|Anesthetics|anesthetics|mesh-ancestor
92417957|NCT01493986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417958|NCT01493986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417959|NCT01493986|Sensory System Agents|sensory system agents|mesh-ancestor
92417960|NCT01493986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417961|NCT01493999|Clopidogrel|clopidogrel|mesh-list
92417962|NCT01493999|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92417963|NCT01493999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92417964|NCT01493999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92417965|NCT01493999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92417966|NCT01493999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92417967|NCT01493999|Purinergic Agents|purinergic agents|mesh-ancestor
92417968|NCT01493999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417969|NCT01493999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417970|NCT01493999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417971|NCT01494012|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92417972|NCT01494012|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92417973|NCT01494012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417974|NCT01494090|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92417975|NCT01494090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92417976|NCT01494090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92417977|NCT01494090|Antimetabolites|antimetabolites|mesh-ancestor
92417978|NCT01494090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417979|NCT01494090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92417980|NCT01494090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92417981|NCT01494090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417982|NCT01494155|Hydroxychloroquine|hydroxychloroquine|mesh-list
92417983|NCT01494155|Capecitabine|capecitabine|mesh-list
92417984|NCT01494155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417985|NCT01494155|Antimetabolites|antimetabolites|mesh-ancestor
92417986|NCT01494155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417987|NCT01494155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417988|NCT01494155|Antimalarials|antimalarials|mesh-ancestor
92417989|NCT01494155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92417990|NCT01494155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92417991|NCT01494155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417992|NCT01494155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417993|NCT01494155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609006|NCT00154128|Antifungal Agents|antifungal agents|mesh-ancestor
92609007|NCT00154128|Keratolytic Agents|keratolytic agents|mesh-ancestor
92609008|NCT00154128|Dermatologic Agents|dermatologic agents|mesh-ancestor
92609009|NCT00154167|Phentolamine|phentolamine|mesh-list
92609010|NCT00154167|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92016197|NCT04981093|Dexamethasone|dexamethasone|mesh-list
92417994|NCT01494259|Epinephrine|epinephrine|mesh-list
92417995|NCT01494259|Bupivacaine|bupivacaine|mesh-list
92417996|NCT01494259|Anesthetics, Local|anesthetics, local|mesh-ancestor
92417997|NCT01494259|Anesthetics|anesthetics|mesh-ancestor
92417998|NCT01494259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417999|NCT01494259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418000|NCT01494259|Sensory System Agents|sensory system agents|mesh-ancestor
92418001|NCT01494259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418002|NCT01494259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92418003|NCT01494259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92418004|NCT01494259|Adrenergic Agents|adrenergic agents|mesh-ancestor
92418005|NCT01494259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418006|NCT01494259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418007|NCT01494259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92418008|NCT01494259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92418009|NCT01494259|Autonomic Agents|autonomic agents|mesh-ancestor
92418010|NCT01494259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92418011|NCT01494259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142686|NCT04917588|Lidocaine|lidocaine|mesh-list
92418012|NCT01494259|Mydriatics|mydriatics|mesh-ancestor
92418013|NCT01494259|Sympathomimetics|sympathomimetics|mesh-ancestor
92418014|NCT01494259|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92418015|NCT01494311|Lidocaine|lidocaine|mesh-list
92418016|NCT01494311|Tetracaine|tetracaine|mesh-list
92418017|NCT01494311|Anesthetics, Local|anesthetics, local|mesh-ancestor
92418033|NCT01494363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418034|NCT01494363|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92418035|NCT01494363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418036|NCT01494363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418037|NCT01494363|Immunologic Factors|immunologic factors|mesh-ancestor
92418038|NCT01494363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418039|NCT01494363|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92418040|NCT01494363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92418041|NCT01494363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418042|NCT01494363|Antidotes|antidotes|mesh-ancestor
92418043|NCT01494363|Protective Agents|protective agents|mesh-ancestor
92418044|NCT01494363|Vitamin B Complex|vitamin b complex|mesh-ancestor
92418045|NCT01494363|Vitamins|vitamins|mesh-ancestor
92418046|NCT01494363|Micronutrients|micronutrients|mesh-ancestor
92418047|NCT01494402|Aspirin|aspirin|mesh-list
92418048|NCT01494402|Esomeprazole|esomeprazole|mesh-list
92418049|NCT01494402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92418050|NCT01494402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92418051|NCT01494402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92418052|NCT01494402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418053|NCT01494402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418054|NCT01494402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418055|NCT01494402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418056|NCT01494402|Analgesics|analgesics|mesh-ancestor
92418057|NCT01494402|Sensory System Agents|sensory system agents|mesh-ancestor
92418058|NCT01494402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418059|NCT01494402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418060|NCT01494402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418061|NCT01494402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418062|NCT01494402|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92418063|NCT01494402|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92418064|NCT01494402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418065|NCT01494402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92418066|NCT01494402|Antipyretics|antipyretics|mesh-ancestor
92418067|NCT01494415|Paclitaxel|paclitaxel|mesh-list
92418068|NCT01494415|Carboplatin|carboplatin|mesh-list
92418069|NCT01494415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92418070|NCT01494415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418071|NCT01494415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92418072|NCT01494415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92418073|NCT01494415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92609011|NCT00154167|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92609012|NCT00154167|Adrenergic Agents|adrenergic agents|mesh-ancestor
92609013|NCT00154167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609014|NCT00154167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609015|NCT00154167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609016|NCT00154167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92609017|NCT00138515|Vildagliptin|vildagliptin|mesh-list
92609018|NCT00138515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609019|NCT00138515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418074|NCT01494415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418075|NCT01494597|Cyclosporine|cyclosporine|mesh-list
92418076|NCT01494597|Isavuconazole|isavuconazole|mesh-list
92418077|NCT01494597|Cyclosporins|cyclosporins|mesh-list
92418078|NCT01494597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418081|NCT01494597|Immunologic Factors|immunologic factors|mesh-ancestor
92418082|NCT01494597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418083|NCT01494597|Antifungal Agents|antifungal agents|mesh-ancestor
92418084|NCT01494597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418085|NCT01494597|Dermatologic Agents|dermatologic agents|mesh-ancestor
92418086|NCT01494597|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418087|NCT01494597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92418088|NCT01494636|Lidocaine|lidocaine|mesh-list
92418090|NCT01494636|Anesthetics, Local|anesthetics, local|mesh-ancestor
92418091|NCT01494636|Anesthetics|anesthetics|mesh-ancestor
92418092|NCT01494636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418093|NCT01494636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418094|NCT01494636|Sensory System Agents|sensory system agents|mesh-ancestor
92418095|NCT01494636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418096|NCT01494636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92418097|NCT01494636|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92418098|NCT01494636|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92418099|NCT01494636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418100|NCT01494636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418101|NCT01494688|Paclitaxel|paclitaxel|mesh-list
92418102|NCT01494688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92418103|NCT01494688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418104|NCT01494688|Tubulin Modulators|tubulin modulators|mesh-ancestor
92418105|NCT01494688|Antimitotic Agents|antimitotic agents|mesh-ancestor
92418106|NCT01494688|Mitosis Modulators|mitosis modulators|mesh-ancestor
92418107|NCT01494688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418108|NCT01494714|Petrolatum|petrolatum|mesh-list
92418109|NCT01494714|Emollients|emollients|mesh-ancestor
92418110|NCT01494714|Dermatologic Agents|dermatologic agents|mesh-ancestor
92418111|NCT01494727|Amlodipine|amlodipine|mesh-list
92418112|NCT01494727|Valsartan|valsartan|mesh-list
92418113|NCT01494727|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92418114|NCT01494727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92418115|NCT01494727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92418116|NCT01494727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418117|NCT01494727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418118|NCT01494727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92418119|NCT01494727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418120|NCT01494727|Vasodilator Agents|vasodilator agents|mesh-ancestor
92418121|NCT01494727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92418122|NCT01494727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92418123|NCT01494740|Vaccines|vaccines|mesh-list
92418124|NCT01494740|Immunologic Factors|immunologic factors|mesh-ancestor
92418125|NCT01494740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418126|NCT01494805|Ranibizumab|ranibizumab|mesh-list
92418127|NCT01494805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418128|NCT01494805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418129|NCT01494805|Growth Substances|growth substances|mesh-ancestor
92418130|NCT01494805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418131|NCT01494805|Growth Inhibitors|growth inhibitors|mesh-ancestor
92609020|NCT00138515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92609021|NCT00138515|Protease Inhibitors|protease inhibitors|mesh-ancestor
92609022|NCT00138515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609023|NCT00138515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609024|NCT00154206|Mycophenolic Acid|mycophenolic acid|mesh-list
92609025|NCT00154206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92609026|NCT00154206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609027|NCT00154206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92609028|NCT00154206|Antitubercular Agents|antitubercular agents|mesh-ancestor
92609029|NCT00154206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609030|NCT00154206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609031|NCT00154206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609032|NCT00154206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609033|NCT00138554|Pioglitazone|pioglitazone|mesh-list
92609034|NCT00138554|Vildagliptin|vildagliptin|mesh-list
92609035|NCT00138554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609036|NCT00138554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609037|NCT00138554|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92609038|NCT00138554|Protease Inhibitors|protease inhibitors|mesh-ancestor
92418132|NCT01494805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418133|NCT01494857|Adalimumab|adalimumab|mesh-list
92418134|NCT01494857|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92418135|NCT01494857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418136|NCT01494857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418137|NCT01495026|Tamsulosin|tamsulosin|mesh-list
92418138|NCT01495026|Dutasteride|dutasteride|mesh-list
92418139|NCT01495026|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92418140|NCT01495026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92418141|NCT01495026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92418142|NCT01495026|Adrenergic Agents|adrenergic agents|mesh-ancestor
92418143|NCT01495026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418144|NCT01495026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418145|NCT01495026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418146|NCT01495026|Urological Agents|urological agents|mesh-ancestor
92418147|NCT01495026|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92418148|NCT01495026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92418149|NCT01495026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418150|NCT01495026|Hormone Antagonists|hormone antagonists|mesh-ancestor
92418152|NCT01495039|Nystatin|nystatin|mesh-list
92418153|NCT01495039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418154|NCT01495039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418155|NCT01495039|Antifungal Agents|antifungal agents|mesh-ancestor
92418156|NCT01495039|Ionophores|ionophores|mesh-ancestor
92418157|NCT01495039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418158|NCT01495039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418159|NCT01495104|Valproic Acid|valproic acid|mesh-list
92418160|NCT01495104|Anticonvulsants|anticonvulsants|mesh-ancestor
92418161|NCT01495104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418162|NCT01495104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418163|NCT01495104|GABA Agents|gaba agents|mesh-ancestor
92418164|NCT01495104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418165|NCT01495104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418166|NCT01495104|Antimanic Agents|antimanic agents|mesh-ancestor
92609039|NCT00138554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609040|NCT00138554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609042|NCT00138593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609043|NCT00138593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609044|NCT00138593|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92609045|NCT00138593|Protease Inhibitors|protease inhibitors|mesh-ancestor
92609046|NCT00138593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609047|NCT00138593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016232|NCT02513823|Vitamin D|vitamin d|mesh-list
92418167|NCT01495104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92418168|NCT01495104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418169|NCT01495104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92418171|NCT01495117|Chlorhexidine|chlorhexidine|mesh-list
92418172|NCT01495117|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92418173|NCT01495117|Povidone-Iodine|povidone-iodine|mesh-list
92418174|NCT01495117|Povidone|povidone|mesh-list
92418175|NCT01495117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92418176|NCT01495117|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92418177|NCT01495117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418178|NCT01495117|Disinfectants|disinfectants|mesh-ancestor
92418179|NCT01495117|Dermatologic Agents|dermatologic agents|mesh-ancestor
92418180|NCT01495117|Trace Elements|trace elements|mesh-ancestor
92418181|NCT01495117|Micronutrients|micronutrients|mesh-ancestor
92418182|NCT01495117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418183|NCT01495117|Plasma Substitutes|plasma substitutes|mesh-ancestor
92418184|NCT01495117|Blood Substitutes|blood substitutes|mesh-ancestor
92418185|NCT01495156|Antipsychotic Agents|antipsychotic agents|mesh-list
92418186|NCT01495156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92418187|NCT01495156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92418188|NCT01495156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418189|NCT01495156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418190|NCT01495169|Iloperidone|iloperidone|mesh-list
92418191|NCT01495169|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92418192|NCT01495169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92418193|NCT01495169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418194|NCT01495169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418195|NCT01495169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92418196|NCT01495195|Selegiline|selegiline|mesh-list
92418197|NCT01495195|Donepezil|donepezil|mesh-list
92418198|NCT01495195|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92418199|NCT01495195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418200|NCT01495195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418201|NCT01495195|Cholinergic Agents|cholinergic agents|mesh-ancestor
92418202|NCT01495195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418203|NCT01495195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418204|NCT01495195|Nootropic Agents|nootropic agents|mesh-ancestor
92418205|NCT01495195|Antidepressive Agents|antidepressive agents|mesh-ancestor
92418206|NCT01495195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92418207|NCT01495195|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92418208|NCT01495195|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92418209|NCT01495195|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92418210|NCT01495195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92418211|NCT01495195|Protective Agents|protective agents|mesh-ancestor
92418212|NCT01495208|Aflibercept|aflibercept|mesh-list
92418213|NCT01495208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418214|NCT01495208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418215|NCT01495208|Growth Substances|growth substances|mesh-ancestor
92418216|NCT01495208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418217|NCT01495208|Growth Inhibitors|growth inhibitors|mesh-ancestor
92418218|NCT01495208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418219|NCT01495260|Vitamin E|vitamin e|mesh-list
92418220|NCT01495260|Thioctic Acid|thioctic acid|mesh-list
92418221|NCT01495260|Acetylcysteine|acetylcysteine|mesh-list
92418222|NCT01495260|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92418223|NCT01495260|Vitamins|vitamins|mesh-ancestor
92418224|NCT01495260|Micronutrients|micronutrients|mesh-ancestor
92609048|NCT00154245|Mycophenolic Acid|mycophenolic acid|mesh-list
92609049|NCT00154245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92609050|NCT00154245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609051|NCT00154245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92609052|NCT00154245|Antitubercular Agents|antitubercular agents|mesh-ancestor
92609053|NCT00154245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609054|NCT00154245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609055|NCT00154245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609056|NCT00154245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609057|NCT00138632|Vatalanib|vatalanib|mesh-list
92609058|NCT00138632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92609059|NCT00138632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609060|NCT00138632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609061|NCT00160875|Irinotecan|irinotecan|mesh-list
92609062|NCT00160875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609063|NCT00160875|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92418225|NCT01495260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418226|NCT01495260|Antiviral Agents|antiviral agents|mesh-ancestor
92418227|NCT01495260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418243|NCT01495338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418244|NCT01495338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418245|NCT01495338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418246|NCT01495338|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92418247|NCT01495338|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92418248|NCT01495338|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92418249|NCT01495338|Histamine Antagonists|histamine antagonists|mesh-ancestor
92418250|NCT01495338|Histamine Agents|histamine agents|mesh-ancestor
92418251|NCT01495338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418252|NCT01495338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418253|NCT01495351|Bortezomib|bortezomib|mesh-list
92418254|NCT01495351|Veliparib|veliparib|mesh-list
92418255|NCT01495351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418256|NCT01495351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92418257|NCT01495351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418258|NCT01495351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418259|NCT01495377|Remifentanil|remifentanil|mesh-list
92418260|NCT01495377|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92418261|NCT01495377|Narcotics|narcotics|mesh-ancestor
92418262|NCT01495377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418263|NCT01495377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418264|NCT01495377|Analgesics|analgesics|mesh-ancestor
92418265|NCT01495377|Sensory System Agents|sensory system agents|mesh-ancestor
92418266|NCT01495377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418267|NCT01495468|Hormones|hormones|mesh-list
92418268|NCT01495468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418269|NCT01495468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418270|NCT01495520|Ranolazine|ranolazine|mesh-list
92418271|NCT01495520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92418272|NCT01495520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418273|NCT01495520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418274|NCT01495624|Dexamethasone|dexamethasone|mesh-list
92418275|NCT01495624|Dexamethasone acetate|dexamethasone acetate|mesh-list
92418276|NCT01495624|Ropivacaine|ropivacaine|mesh-list
92418277|NCT01495624|Anesthetics|anesthetics|mesh-list
92418278|NCT01495624|BB 1101|bb 1101|mesh-list
92418279|NCT01495624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418280|NCT01495624|Antiemetics|antiemetics|mesh-ancestor
92418281|NCT01495624|Autonomic Agents|autonomic agents|mesh-ancestor
92609064|NCT00160875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92609065|NCT00160875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609066|NCT00160875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609067|NCT00138710|Letrozole|letrozole|mesh-list
92609068|NCT00138710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609069|NCT00138710|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92609070|NCT00138710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92609071|NCT00138710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609072|NCT00138710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609073|NCT00138710|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92609074|NCT00138710|Hormone Antagonists|hormone antagonists|mesh-ancestor
92609075|NCT00138710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609076|NCT00138710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609077|NCT01243762|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92609078|NCT01243762|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92418282|NCT01495624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418283|NCT01495624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418284|NCT01495624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92418285|NCT01495624|Glucocorticoids|glucocorticoids|mesh-ancestor
92418286|NCT01495624|Hormones|hormones|mesh-ancestor
92418287|NCT01495624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418288|NCT01495624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92418295|NCT01495624|Sensory System Agents|sensory system agents|mesh-ancestor
92418296|NCT01495715|Idebenone|idebenone|mesh-list
92418297|NCT01495715|Antioxidants|antioxidants|mesh-ancestor
92418298|NCT01495715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418299|NCT01495715|Protective Agents|protective agents|mesh-ancestor
92418300|NCT01495715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418301|NCT01495806|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92418302|NCT01495806|Cathartics|cathartics|mesh-ancestor
92418303|NCT01495806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92418304|NCT01495845|Clopidogrel|clopidogrel|mesh-list
92418305|NCT01495845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418306|NCT01495845|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92418307|NCT01495845|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92418308|NCT01495845|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92418309|NCT01495845|Purinergic Agents|purinergic agents|mesh-ancestor
92418310|NCT01495845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418311|NCT01495845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418312|NCT01495845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142982|NCT04726878|Acetaminophen|acetaminophen|mesh-list
92418313|NCT01495884|Lapatinib|lapatinib|mesh-list
92418314|NCT01495884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418315|NCT01495884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418316|NCT01495884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418317|NCT01495884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418318|NCT01495910|Abiraterone Acetate|abiraterone acetate|mesh-list
92418319|NCT01495910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418320|NCT01495910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92418321|NCT01495910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418322|NCT01495910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418323|NCT01495910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92609079|NCT01243762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609080|NCT01243762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609081|NCT00154323|Oxcarbazepine|oxcarbazepine|mesh-list
92609082|NCT00154323|Anticonvulsants|anticonvulsants|mesh-ancestor
92609083|NCT00154323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92609084|NCT00154323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92609085|NCT00154323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609086|NCT00154323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609087|NCT00154323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92334119|NCT00004237|Analgesics|analgesics|mesh-ancestor
92609089|NCT00138866|Risedronic Acid|risedronic acid|mesh-list
92609090|NCT00138866|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92609091|NCT00138866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609092|NCT00138866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609093|NCT00138866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92016281|NCT03063073|Analgesics|analgesics|mesh-ancestor
92418324|NCT01495910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418325|NCT01495910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418326|NCT01495910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92418327|NCT01495949|Thiopental|thiopental|mesh-list
92418328|NCT01495949|Etomidate|etomidate|mesh-list
92418329|NCT01495949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92418330|NCT01495949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418331|NCT01495949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418332|NCT01495949|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92418333|NCT01495949|Anesthetics, General|anesthetics, general|mesh-ancestor
92418334|NCT01495949|Anesthetics|anesthetics|mesh-ancestor
92418335|NCT01495949|Anticonvulsants|anticonvulsants|mesh-ancestor
92418336|NCT01495949|GABA Modulators|gaba modulators|mesh-ancestor
92418337|NCT01495949|GABA Agents|gaba agents|mesh-ancestor
92418338|NCT01495949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418339|NCT01495949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418340|NCT01495962|Botulinum Toxins|botulinum toxins|mesh-list
92418341|NCT01495962|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92418342|NCT01495962|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92418343|NCT01495962|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92394636|NCT01386346|Capecitabine|capecitabine|mesh-list
92418344|NCT01495962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418345|NCT01495962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418346|NCT01495962|Cholinergic Agents|cholinergic agents|mesh-ancestor
92418347|NCT01495962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418348|NCT01495962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418349|NCT01495962|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92418350|NCT01495962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418351|NCT01496105|Lidocaine|lidocaine|mesh-list
92418352|NCT01496105|Anesthetics, Local|anesthetics, local|mesh-ancestor
92418353|NCT01496105|Anesthetics|anesthetics|mesh-ancestor
92418354|NCT01496105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418358|NCT01496105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92418359|NCT01496105|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92418360|NCT01496105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92418361|NCT01496105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418362|NCT01496105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418363|NCT01496196|Tranexamic Acid|tranexamic acid|mesh-list
92418364|NCT01496196|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92609094|NCT00138866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609095|NCT00138866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92609096|NCT00154362|Oxcarbazepine|oxcarbazepine|mesh-list
92609097|NCT00154362|Anticonvulsants|anticonvulsants|mesh-ancestor
92609098|NCT00154362|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92609099|NCT00154362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92418365|NCT01496196|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92418366|NCT01496196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418367|NCT01496196|Hemostatics|hemostatics|mesh-ancestor
92418368|NCT01496196|Coagulants|coagulants|mesh-ancestor
92418369|NCT01496261|Aspirin|aspirin|mesh-list
92418370|NCT01496261|Clopidogrel|clopidogrel|mesh-list
92418371|NCT01496261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418372|NCT01496261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418373|NCT01496261|Analgesics|analgesics|mesh-ancestor
92418374|NCT01496261|Sensory System Agents|sensory system agents|mesh-ancestor
92418375|NCT01496261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418376|NCT01496261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418377|NCT01496261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418378|NCT01496261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418379|NCT01496261|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92418380|NCT01496261|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92418381|NCT01496261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418382|NCT01496261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418383|NCT01496261|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92418384|NCT01496261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418385|NCT01496261|Antipyretics|antipyretics|mesh-ancestor
92418386|NCT01496261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92418387|NCT01496261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92418388|NCT01496261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92418389|NCT01496261|Purinergic Agents|purinergic agents|mesh-ancestor
92418390|NCT01496261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418391|NCT01496326|Ibuprofen|ibuprofen|mesh-list
92418392|NCT01496326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418393|NCT01496326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418394|NCT01496326|Analgesics|analgesics|mesh-ancestor
92418395|NCT01496326|Sensory System Agents|sensory system agents|mesh-ancestor
92418396|NCT01496326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418397|NCT01496326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418398|NCT01496326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418399|NCT01496326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418400|NCT01496326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92418401|NCT01496326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418402|NCT01496326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418403|NCT01496417|Abatacept|abatacept|mesh-list
92418404|NCT01496417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92418405|NCT01496417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418406|NCT01496417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92418407|NCT01496417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418408|NCT01496417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418409|NCT01496417|Immunologic Factors|immunologic factors|mesh-ancestor
92418410|NCT01496417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418411|NCT01496417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418412|NCT01496443|Glimepiride|glimepiride|mesh-list
92418413|NCT01496443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92418414|NCT01496443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418415|NCT01496443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418416|NCT01496443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418417|NCT01496443|Immunologic Factors|immunologic factors|mesh-ancestor
92418418|NCT01496521|Aspirin|aspirin|mesh-list
92418419|NCT01496521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418420|NCT01496521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418421|NCT01496521|Analgesics|analgesics|mesh-ancestor
92418422|NCT01496521|Sensory System Agents|sensory system agents|mesh-ancestor
92418423|NCT01496521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418440|NCT01496690|Analgesics|analgesics|mesh-ancestor
92418441|NCT01496690|Sensory System Agents|sensory system agents|mesh-ancestor
92609100|NCT00154362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609101|NCT00154362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609102|NCT00154362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92609103|NCT00154362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92609104|NCT00161031|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92609105|NCT00161031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92609106|NCT00161031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92609107|NCT00161031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016300|NCT02476617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92418442|NCT01496690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418443|NCT01496690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418444|NCT01496690|Anticonvulsants|anticonvulsants|mesh-ancestor
92418445|NCT01496690|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92418446|NCT01496690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418447|NCT01496690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418448|NCT01496690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92418449|NCT01496690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92418450|NCT01496690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92418451|NCT01496690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418452|NCT01496690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92418454|NCT01496742|Bevacizumab|bevacizumab|mesh-list
92418455|NCT01496742|Carboplatin|carboplatin|mesh-list
92418456|NCT01496742|Pemetrexed|pemetrexed|mesh-list
92418457|NCT01496742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92418458|NCT01496742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418459|NCT01496742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92418460|NCT01496742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92418461|NCT01496742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92418462|NCT01496742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418463|NCT01496742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92418464|NCT01496742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418465|NCT01496742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418466|NCT01496742|Growth Substances|growth substances|mesh-ancestor
92418467|NCT01496742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418468|NCT01496742|Growth Inhibitors|growth inhibitors|mesh-ancestor
92418469|NCT01496742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418470|NCT01496742|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92418471|NCT01496742|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92418473|NCT01496911|Levocetirizine|levocetirizine|mesh-list
92418474|NCT01496911|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92418475|NCT01496911|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92418476|NCT01496911|Histamine Antagonists|histamine antagonists|mesh-ancestor
92418477|NCT01496911|Histamine Agents|histamine agents|mesh-ancestor
92418478|NCT01496911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418479|NCT01496911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418480|NCT01496911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418481|NCT01496911|Antipruritics|antipruritics|mesh-ancestor
92418482|NCT01496911|Dermatologic Agents|dermatologic agents|mesh-ancestor
92418483|NCT01496989|Interleukin-12|interleukin-12|mesh-list
92418487|NCT01496989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418488|NCT01496989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418489|NCT01496989|Growth Substances|growth substances|mesh-ancestor
92418490|NCT01496989|Growth Inhibitors|growth inhibitors|mesh-ancestor
92418491|NCT01496989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418492|NCT01497002|Cytarabine|cytarabine|mesh-list
92418493|NCT01497002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92418494|NCT01497002|Antimetabolites|antimetabolites|mesh-ancestor
92418495|NCT01497002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418496|NCT01497002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418497|NCT01497002|Antiviral Agents|antiviral agents|mesh-ancestor
92418498|NCT01497002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609108|NCT00161031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609109|NCT00161031|Adrenergic Agents|adrenergic agents|mesh-ancestor
92609110|NCT00161031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609111|NCT00161031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609112|NCT00154401|Liraglutide|liraglutide|mesh-list
92609113|NCT00154401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609114|NCT00154401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609115|NCT00154401|Incretins|incretins|mesh-ancestor
92609116|NCT00154401|Hormones|hormones|mesh-ancestor
92609117|NCT00154401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609118|NCT00138944|Eplerenone|eplerenone|mesh-list
92609119|NCT00138944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92609120|NCT00138944|Hormone Antagonists|hormone antagonists|mesh-ancestor
92418499|NCT01497002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418500|NCT01497002|Immunologic Factors|immunologic factors|mesh-ancestor
92418501|NCT01497002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418502|NCT01497041|Docetaxel|docetaxel|mesh-list
92418503|NCT01497041|Oxaliplatin|oxaliplatin|mesh-list
92418504|NCT01497041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418505|NCT01497041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92418506|NCT01497041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92418507|NCT01497041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92418508|NCT01497041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418509|NCT01497093|Thalidomide|thalidomide|mesh-list
92418510|NCT01497093|Dexamethasone|dexamethasone|mesh-list
92418511|NCT01497093|Bortezomib|bortezomib|mesh-list
92418512|NCT01497093|Pomalidomide|pomalidomide|mesh-list
92418513|NCT01497093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418514|NCT01497093|Antiemetics|antiemetics|mesh-ancestor
92418515|NCT01497093|Autonomic Agents|autonomic agents|mesh-ancestor
92418516|NCT01497093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418517|NCT01497093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418518|NCT01497093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92418519|NCT01497093|Glucocorticoids|glucocorticoids|mesh-ancestor
92418520|NCT01497093|Hormones|hormones|mesh-ancestor
92418521|NCT01497093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418522|NCT01497093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92418523|NCT01497093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418524|NCT01497093|Immunologic Factors|immunologic factors|mesh-ancestor
92418525|NCT01497093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418526|NCT01497093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418527|NCT01497093|Growth Substances|growth substances|mesh-ancestor
92418528|NCT01497093|Growth Inhibitors|growth inhibitors|mesh-ancestor
92418529|NCT01497093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418530|NCT01497093|Leprostatic Agents|leprostatic agents|mesh-ancestor
92418531|NCT01497093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418532|NCT01497093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418533|NCT01497132|Vitamin D|vitamin d|mesh-list
92418534|NCT01497132|Cholecalciferol|cholecalciferol|mesh-list
92418535|NCT01497132|Vitamins|vitamins|mesh-ancestor
92418536|NCT01497132|Micronutrients|micronutrients|mesh-ancestor
92418537|NCT01497132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418538|NCT01497132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92418539|NCT01497132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92418541|NCT01497145|Hematinics|hematinics|mesh-ancestor
92418542|NCT01497288|Fentanyl|fentanyl|mesh-list
92418543|NCT01497288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92418544|NCT01497288|Narcotics|narcotics|mesh-ancestor
92418545|NCT01497288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418546|NCT01497288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418547|NCT01497288|Analgesics|analgesics|mesh-ancestor
92394648|NCT01386372|Tolvaptan|tolvaptan|mesh-list
92418548|NCT01497288|Sensory System Agents|sensory system agents|mesh-ancestor
92418549|NCT01497288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609121|NCT00138944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609122|NCT00138944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609123|NCT00138944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92016329|NCT03064165|Epinephrine|epinephrine|mesh-list
92418550|NCT01497288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92418551|NCT01497288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92418552|NCT01497288|Anesthetics, General|anesthetics, general|mesh-ancestor
92418553|NCT01497288|Anesthetics|anesthetics|mesh-ancestor
92418554|NCT01497327|Sofosbuvir|sofosbuvir|mesh-list
92418555|NCT01497327|Antiviral Agents|antiviral agents|mesh-ancestor
92418556|NCT01497327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418557|NCT01497431|Selenium|selenium|mesh-list
92418558|NCT01497431|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
92418559|NCT01497431|Antioxidants|antioxidants|mesh-ancestor
92418561|NCT01497431|Protective Agents|protective agents|mesh-ancestor
92418562|NCT01497431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418563|NCT01497431|Trace Elements|trace elements|mesh-ancestor
92418564|NCT01497431|Micronutrients|micronutrients|mesh-ancestor
92418565|NCT01497431|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92418566|NCT01497431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418567|NCT01497444|Sorafenib|sorafenib|mesh-list
92418568|NCT01497444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418569|NCT01497444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418570|NCT01497444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418571|NCT01497444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418572|NCT01497470|Paclitaxel|paclitaxel|mesh-list
92418573|NCT01497470|Carboplatin|carboplatin|mesh-list
92418574|NCT01497470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92418575|NCT01497470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418576|NCT01497470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92418577|NCT01497470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92418578|NCT01497470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92418579|NCT01497470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418580|NCT01497483|Cyclosporine|cyclosporine|mesh-list
92418581|NCT01497483|Pravastatin|pravastatin|mesh-list
92418582|NCT01497483|Cyclosporins|cyclosporins|mesh-list
92418583|NCT01497483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418584|NCT01497483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418585|NCT01497483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418586|NCT01497483|Immunologic Factors|immunologic factors|mesh-ancestor
92418587|NCT01497483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418588|NCT01497483|Antifungal Agents|antifungal agents|mesh-ancestor
92418589|NCT01497483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418590|NCT01497483|Dermatologic Agents|dermatologic agents|mesh-ancestor
92418591|NCT01497483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418592|NCT01497483|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92418593|NCT01497483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92418594|NCT01497483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92418595|NCT01497483|Antimetabolites|antimetabolites|mesh-ancestor
92418596|NCT01497483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92418597|NCT01497483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92418598|NCT01497522|Vildagliptin|vildagliptin|mesh-list
92418599|NCT01497522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418600|NCT01497522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418601|NCT01497522|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92418602|NCT01497522|Protease Inhibitors|protease inhibitors|mesh-ancestor
92418603|NCT01497522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418604|NCT01497522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418605|NCT01497535|Insulin|insulin|mesh-list
92418606|NCT01497535|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92418607|NCT01497535|Insulin Glargine|insulin glargine|mesh-list
92418608|NCT01497535|Insulin Detemir|insulin detemir|mesh-list
92418609|NCT01497535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418610|NCT01497535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418611|NCT01497548|Methylphenidate|methylphenidate|mesh-list
92418612|NCT01497548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92418613|NCT01497548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418614|NCT01497548|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92418615|NCT01497548|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92418616|NCT01497548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016330|NCT03064165|Bupivacaine|bupivacaine|mesh-list
92609125|NCT00138944|Natriuretic Agents|natriuretic agents|mesh-ancestor
92609126|NCT00138944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92609127|NCT00161070|Aspirin|aspirin|mesh-list
92609128|NCT00161070|Dipyridamole|dipyridamole|mesh-list
92609129|NCT00161070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92609130|NCT00161070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609131|NCT00161070|Analgesics|analgesics|mesh-ancestor
92609132|NCT00161070|Sensory System Agents|sensory system agents|mesh-ancestor
92016332|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
92418617|NCT01497548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418618|NCT01497548|Dopamine Agents|dopamine agents|mesh-ancestor
92418619|NCT01497548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418620|NCT01497561|Insulin|insulin|mesh-list
92418621|NCT01497561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92418622|NCT01497561|Insulin Detemir|insulin detemir|mesh-list
92418623|NCT01497561|Isophane Insulin, Human|isophane insulin, human|mesh-list
92418624|NCT01497561|Insulin, Isophane|insulin, isophane|mesh-list
92418625|NCT01497561|Isophane insulin, beef|isophane insulin, beef|mesh-list
92418626|NCT01497561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418627|NCT01497561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418628|NCT01497574|Insulin|insulin|mesh-list
92418629|NCT01497574|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92418630|NCT01497574|Insulin Glargine|insulin glargine|mesh-list
92418631|NCT01497574|Insulin Detemir|insulin detemir|mesh-list
92418632|NCT01497574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418633|NCT01497574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418634|NCT01497587|Insulin Detemir|insulin detemir|mesh-list
92418635|NCT01497587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418636|NCT01497587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418637|NCT01497600|Insulin|insulin|mesh-list
92418638|NCT01497600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92418639|NCT01497600|Insulin Detemir|insulin detemir|mesh-list
92418640|NCT01497600|Isophane Insulin, Human|isophane insulin, human|mesh-list
92418641|NCT01497600|Insulin, Isophane|insulin, isophane|mesh-list
92418642|NCT01497600|Isophane insulin, beef|isophane insulin, beef|mesh-list
92418643|NCT01497600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418644|NCT01497600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418645|NCT01497626|Bortezomib|bortezomib|mesh-list
92418646|NCT01497626|Lapatinib|lapatinib|mesh-list
92418647|NCT01497626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418648|NCT01497626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418649|NCT01497626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418650|NCT01497626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418651|NCT01497652|Rasagiline|rasagiline|mesh-list
92418652|NCT01497652|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92418653|NCT01497652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418654|NCT01497652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418655|NCT01497652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92418656|NCT01497652|Protective Agents|protective agents|mesh-ancestor
92418657|NCT01497652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418658|NCT01497717|Adalimumab|adalimumab|mesh-list
92418659|NCT01497717|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92418660|NCT01497717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418661|NCT01497717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418662|NCT01497873|Topotecan|topotecan|mesh-list
92418663|NCT01497873|Belotecan|belotecan|mesh-list
92418664|NCT01497873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92418665|NCT01497873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92418666|NCT01497873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418667|NCT01497873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418668|NCT01497873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418669|NCT01497912|Atorvastatin|atorvastatin|mesh-list
92418670|NCT01497912|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92418671|NCT01497912|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92418672|NCT01497912|Antimetabolites|antimetabolites|mesh-ancestor
92418673|NCT01497912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418674|NCT01497912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92609133|NCT00161070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609134|NCT00161070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609135|NCT00161070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609136|NCT00161070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609137|NCT00161070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92609138|NCT00161070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92609139|NCT00161070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609140|NCT00161070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418675|NCT01497912|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92418676|NCT01497912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418678|NCT01497977|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92418679|NCT01497977|Estrogens|estrogens|mesh-ancestor
92418680|NCT01497977|Hormones|hormones|mesh-ancestor
92418681|NCT01497977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418682|NCT01497977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418683|NCT01497990|Ertapenem|ertapenem|mesh-list
92418684|NCT01497990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418685|NCT01497990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418686|NCT01498003|Tirofiban|tirofiban|mesh-list
92418687|NCT01498003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92418688|NCT01498003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717875|NCT04623021|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92418689|NCT01498003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418690|NCT01498003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418692|NCT01498016|Alkylating Agents|alkylating agents|mesh-ancestor
92418693|NCT01498016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418694|NCT01498016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418695|NCT01498016|Immunologic Factors|immunologic factors|mesh-ancestor
92418696|NCT01498016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418697|NCT01498016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92418698|NCT01498016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418699|NCT01498016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92418700|NCT01498081|Tiotropium Bromide|tiotropium bromide|mesh-list
92418701|NCT01498081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92418702|NCT01498081|Autonomic Agents|autonomic agents|mesh-ancestor
92418703|NCT01498081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418704|NCT01498081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418705|NCT01498081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92418706|NCT01498081|Respiratory System Agents|respiratory system agents|mesh-ancestor
92418707|NCT01498081|Parasympatholytics|parasympatholytics|mesh-ancestor
92418708|NCT01498081|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92418710|NCT01498081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418711|NCT01498081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418713|NCT01498380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92418714|NCT01498380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418715|NCT01498380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418716|NCT01498380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418717|NCT01498380|Analgesics|analgesics|mesh-ancestor
92418718|NCT01498380|Sensory System Agents|sensory system agents|mesh-ancestor
92418719|NCT01498380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418720|NCT01498380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92418721|NCT01498380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92418722|NCT01498380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92418723|NCT01498380|Adrenergic Agents|adrenergic agents|mesh-ancestor
92418724|NCT01498380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418725|NCT01498380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418726|NCT01498406|Vitamin D|vitamin d|mesh-list
92418727|NCT01498406|Ergocalciferols|ergocalciferols|mesh-list
92418728|NCT01498406|Cholecalciferol|cholecalciferol|mesh-list
92418729|NCT01498406|Vitamins|vitamins|mesh-list
92418730|NCT01498406|Micronutrients|micronutrients|mesh-ancestor
92418731|NCT01498406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418732|NCT01498406|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92609141|NCT00161070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92609142|NCT00161070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609143|NCT00161070|Antipyretics|antipyretics|mesh-ancestor
92418733|NCT01498406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92418734|NCT01498523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92418735|NCT01498562|Gefitinib|gefitinib|mesh-list
92418736|NCT01498562|Nimotuzumab|nimotuzumab|mesh-list
92418737|NCT01498562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418738|NCT01498562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418739|NCT01498562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418740|NCT01498562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418741|NCT01498562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92418742|NCT01498718|Vaccines|vaccines|mesh-list
92418743|NCT01498718|Immunologic Factors|immunologic factors|mesh-ancestor
92418744|NCT01498718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418745|NCT01498783|Fluorouracil|fluorouracil|mesh-list
92418746|NCT01498783|Antimetabolites|antimetabolites|mesh-ancestor
92418747|NCT01498783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418748|NCT01498783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92418749|NCT01498783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418750|NCT01498783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418751|NCT01498783|Immunologic Factors|immunologic factors|mesh-ancestor
92418752|NCT01498783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418753|NCT01498796|Ketorolac|ketorolac|mesh-list
92418754|NCT01498796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418755|NCT01498796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418756|NCT01498796|Analgesics|analgesics|mesh-ancestor
92418757|NCT01498796|Sensory System Agents|sensory system agents|mesh-ancestor
92418758|NCT01498796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418759|NCT01498796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418760|NCT01498796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418761|NCT01498796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418762|NCT01498796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92418763|NCT01498796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418764|NCT01498796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418766|NCT01498809|Sympathomimetics|sympathomimetics|mesh-ancestor
92418767|NCT01498809|Autonomic Agents|autonomic agents|mesh-ancestor
92418768|NCT01498809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418769|NCT01498809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418770|NCT01498809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92418771|NCT01498809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92418772|NCT01498809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92418773|NCT01498809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92418774|NCT01498809|Adrenergic Agents|adrenergic agents|mesh-ancestor
92418775|NCT01498809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418776|NCT01498809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418777|NCT01498835|Sunitinib|sunitinib|mesh-list
92418778|NCT01498835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418779|NCT01498835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418780|NCT01498835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418781|NCT01498835|Growth Substances|growth substances|mesh-ancestor
92418786|NCT01498835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418787|NCT01498861|Dolutegravir|dolutegravir|mesh-list
92418788|NCT01498861|Moxifloxacin|moxifloxacin|mesh-list
92418789|NCT01498861|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92418790|NCT01498861|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92418791|NCT01498861|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92418792|NCT01498861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418793|NCT01498861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418794|NCT01498861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92418795|NCT01498861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92418796|NCT01498861|Antiviral Agents|antiviral agents|mesh-ancestor
92418797|NCT01498861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418798|NCT01498861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418799|NCT01498861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92418800|NCT01498861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92418801|NCT01498861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418802|NCT01498861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92418803|NCT01498861|Contraceptive Agents|contraceptive agents|mesh-ancestor
92418804|NCT01498861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609144|NCT00161070|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92609145|NCT00161070|Vasodilator Agents|vasodilator agents|mesh-ancestor
92609146|NCT00138983|Vitamin D|vitamin d|mesh-list
92418805|NCT01498861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418806|NCT01498861|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92394662|NCT01386567|Methyltestosterone|methyltestosterone|mesh-list
92418807|NCT01498861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92418808|NCT01498861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92418809|NCT01498900|Repaglinide|repaglinide|mesh-list
92418810|NCT01498900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418811|NCT01498900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418812|NCT01498913|Repaglinide|repaglinide|mesh-list
92418813|NCT01498913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418814|NCT01498913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418815|NCT01498926|Insulin|insulin|mesh-list
92418816|NCT01498926|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92418817|NCT01498926|Insulin Detemir|insulin detemir|mesh-list
92418818|NCT01498926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418819|NCT01498926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418820|NCT01498939|Insulin Detemir|insulin detemir|mesh-list
92418821|NCT01498939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418822|NCT01498939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418823|NCT01499004|Tofacitinib|tofacitinib|mesh-list
92418824|NCT01499004|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92418825|NCT01499004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418826|NCT01499004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418827|NCT01499004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418828|NCT01499069|Solifenacin Succinate|solifenacin succinate|mesh-list
92418829|NCT01499069|Fesoterodine|fesoterodine|mesh-list
92418830|NCT01499069|Propiverine|propiverine|mesh-list
92418831|NCT01499069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92418832|NCT01499069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92418833|NCT01499069|Cholinergic Agents|cholinergic agents|mesh-ancestor
92418834|NCT01499069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418835|NCT01499069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418836|NCT01499069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418837|NCT01499069|Urological Agents|urological agents|mesh-ancestor
92418838|NCT01499069|Parasympatholytics|parasympatholytics|mesh-ancestor
92418839|NCT01499069|Autonomic Agents|autonomic agents|mesh-ancestor
92418840|NCT01499069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418841|NCT01499108|Liraglutide|liraglutide|mesh-list
92418842|NCT01499108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92418843|NCT01499108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418844|NCT01499108|Incretins|incretins|mesh-ancestor
92418846|NCT01499108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418847|NCT01499121|Sunitinib|sunitinib|mesh-list
92418848|NCT01499121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418849|NCT01499121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92418850|NCT01499121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92418851|NCT01499121|Growth Substances|growth substances|mesh-ancestor
92418852|NCT01499121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418853|NCT01499121|Growth Inhibitors|growth inhibitors|mesh-ancestor
92418864|NCT01499251|Macitentan|macitentan|mesh-list
92418865|NCT01499251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92418866|NCT01499251|Alkylating Agents|alkylating agents|mesh-ancestor
92418867|NCT01499251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418868|NCT01499251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418869|NCT01499251|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92418870|NCT01499251|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92418871|NCT01499251|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92418872|NCT01499407|Abciximab|abciximab|mesh-list
92418873|NCT01499407|Anticoagulants|anticoagulants|mesh-ancestor
92418874|NCT01499407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418875|NCT01499433|Caspofungin|caspofungin|mesh-list
92418876|NCT01499433|Antifungal Agents|antifungal agents|mesh-ancestor
92418877|NCT01499433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418878|NCT01499433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418879|NCT01499433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418880|NCT01499446|Fluticasone|fluticasone|mesh-list
92418881|NCT01499446|Xhance|xhance|mesh-list
92418882|NCT01499446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418883|NCT01499446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92418884|NCT01499446|Autonomic Agents|autonomic agents|mesh-ancestor
92418885|NCT01499446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609148|NCT00138983|Alfacalcidol|alfacalcidol|mesh-list
92609149|NCT00138983|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92609150|NCT00138983|Vitamins|vitamins|mesh-ancestor
92418886|NCT01499446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418887|NCT01499446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92418888|NCT01499446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92418889|NCT01499446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92418890|NCT01499446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92418891|NCT01499485|Acetazolamide|acetazolamide|mesh-list
92418892|NCT01499485|Anticonvulsants|anticonvulsants|mesh-ancestor
92418893|NCT01499485|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92418894|NCT01499485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418895|NCT01499485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418896|NCT01499485|Diuretics|diuretics|mesh-ancestor
92418897|NCT01499485|Natriuretic Agents|natriuretic agents|mesh-ancestor
92418898|NCT01499485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418899|NCT01499589|Anesthetics|anesthetics|mesh-list
92418900|NCT01499589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418901|NCT01499589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418902|NCT01499602|Norethindrone|norethindrone|mesh-list
92418903|NCT01499602|Norethindrone Acetate|norethindrone acetate|mesh-list
92418904|NCT01499602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92418905|NCT01499602|Contraceptive Agents|contraceptive agents|mesh-ancestor
92418906|NCT01499602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92418907|NCT01499602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418908|NCT01499602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92418909|NCT01499602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92418910|NCT01499602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92418911|NCT01499602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92418912|NCT01499641|Methylprednisolone|methylprednisolone|mesh-list
92418913|NCT01499641|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92418914|NCT01499641|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92418915|NCT01499641|Prednisolone|prednisolone|mesh-list
92418916|NCT01499641|Prednisolone acetate|prednisolone acetate|mesh-list
92418917|NCT01499641|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92418918|NCT01499641|Prednisolone phosphate|prednisolone phosphate|mesh-list
92418919|NCT01499641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418951|NCT01499771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92418952|NCT01499771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92418953|NCT01499771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418954|NCT01499875|Penicillin V|penicillin v|mesh-list
92418955|NCT01499875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418956|NCT01499875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418957|NCT01500005|Vitamin D|vitamin d|mesh-list
92418958|NCT01500005|Vitamins|vitamins|mesh-ancestor
92418959|NCT01500005|Micronutrients|micronutrients|mesh-ancestor
92418960|NCT01500005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418961|NCT01500005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92418962|NCT01500018|Phentermine|phentermine|mesh-list
92418963|NCT01500018|Ketamine|ketamine|mesh-list
92418966|NCT01500018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418967|NCT01500018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418968|NCT01500018|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92418969|NCT01500018|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92418970|NCT01500018|Anesthetics, General|anesthetics, general|mesh-ancestor
92418972|NCT01500018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418973|NCT01500018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92418974|NCT01500018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92418975|NCT01500018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92418976|NCT01500018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418977|NCT01500018|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92418978|NCT01500018|Appetite Depressants|appetite depressants|mesh-ancestor
92418979|NCT01500018|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92418980|NCT01500018|Sympathomimetics|sympathomimetics|mesh-ancestor
92418981|NCT01500018|Autonomic Agents|autonomic agents|mesh-ancestor
92418982|NCT01500018|Adrenergic Agents|adrenergic agents|mesh-ancestor
92418983|NCT01500070|Everolimus|everolimus|mesh-list
92418984|NCT01500070|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92418985|NCT01500070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418986|NCT01500070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418987|NCT01500070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609151|NCT00138983|Micronutrients|micronutrients|mesh-ancestor
92609152|NCT00138983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609153|NCT00138983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92609154|NCT01243177|Lacosamide|lacosamide|mesh-list
92609155|NCT01243177|Carbamazepine|carbamazepine|mesh-list
92418988|NCT01500070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418989|NCT01500070|Immunologic Factors|immunologic factors|mesh-ancestor
92418990|NCT01500070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418991|NCT01500070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418992|NCT01500161|Cytarabine|cytarabine|mesh-list
92418993|NCT01500161|Fludarabine|fludarabine|mesh-list
92418994|NCT01500161|Etoposide|etoposide|mesh-list
92418995|NCT01500161|Melphalan|melphalan|mesh-list
92418996|NCT01500161|Busulfan|busulfan|mesh-list
92418997|NCT01500161|Carmustine|carmustine|mesh-list
92418998|NCT01500161|Clofarabine|clofarabine|mesh-list
92418999|NCT01500161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419000|NCT01500161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419001|NCT01500161|Antimetabolites|antimetabolites|mesh-ancestor
92419002|NCT01500161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419003|NCT01500161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419004|NCT01500161|Immunologic Factors|immunologic factors|mesh-ancestor
92419005|NCT01500161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419006|NCT01500161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92419007|NCT01500161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92419008|NCT01500161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419009|NCT01500161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419010|NCT01500161|Antiviral Agents|antiviral agents|mesh-ancestor
92419011|NCT01500161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419012|NCT01500161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92419013|NCT01500161|Alkylating Agents|alkylating agents|mesh-ancestor
92419014|NCT01500161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92419015|NCT01500408|Interferons|interferons|mesh-list
92419016|NCT01500408|Interferon-beta|interferon-beta|mesh-list
92419017|NCT01500408|Interferon beta-1a|interferon beta-1a|mesh-list
92419018|NCT01500408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419019|NCT01500408|Antiviral Agents|antiviral agents|mesh-ancestor
92419020|NCT01500408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419021|NCT01500408|Immunologic Factors|immunologic factors|mesh-ancestor
92419022|NCT01500408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419023|NCT01500408|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92419024|NCT01500473|Desogestrel|desogestrel|mesh-list
92419025|NCT01500473|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92419026|NCT01500473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92419027|NCT01500473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92419028|NCT01500473|Contraceptive Agents|contraceptive agents|mesh-ancestor
92419029|NCT01500473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92419030|NCT01500473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419031|NCT01500473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92419032|NCT01500473|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92419033|NCT01500473|Progestins|progestins|mesh-ancestor
92419034|NCT01500473|Hormones|hormones|mesh-ancestor
92419035|NCT01500473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419036|NCT01500538|Vorinostat|vorinostat|mesh-list
92419037|NCT01500538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419040|NCT01500538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419041|NCT01500577|Nimesulide|nimesulide|mesh-list
92419042|NCT01500577|Simvastatin|simvastatin|mesh-list
92419043|NCT01500577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92419044|NCT01500577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92419045|NCT01500577|Antimetabolites|antimetabolites|mesh-ancestor
92419046|NCT01500577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419047|NCT01500577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92419048|NCT01500577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92419049|NCT01500577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419050|NCT01500577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92419051|NCT01500577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92419052|NCT01500577|Analgesics|analgesics|mesh-ancestor
92419053|NCT01500577|Sensory System Agents|sensory system agents|mesh-ancestor
92419054|NCT01500577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419055|NCT01500577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016356|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92609156|NCT01243177|Anticonvulsants|anticonvulsants|mesh-ancestor
92609157|NCT01243177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92609158|NCT01243177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92609159|NCT01243177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609160|NCT01243177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609161|NCT01243177|Antimanic Agents|antimanic agents|mesh-ancestor
92609162|NCT01243177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92078735|NCT00333814|BB 1101|bb 1101|mesh-list
92419056|NCT01500577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419057|NCT01500577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419058|NCT01500577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92419059|NCT01500590|Ramipril|ramipril|mesh-list
92419060|NCT01500590|Irbesartan|irbesartan|mesh-list
92419061|NCT01500590|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92419062|NCT01500590|Protease Inhibitors|protease inhibitors|mesh-ancestor
92419063|NCT01500590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419064|NCT01500590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419065|NCT01500590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92419066|NCT01500590|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92419067|NCT01500590|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92419068|NCT01500785|Vitamin B 12|vitamin b 12|mesh-list
92419069|NCT01500785|Hydroxocobalamin|hydroxocobalamin|mesh-list
92419070|NCT01500785|Simendan|simendan|mesh-list
92419071|NCT01500785|Vitamins|vitamins|mesh-ancestor
92419072|NCT01500785|Micronutrients|micronutrients|mesh-ancestor
92419073|NCT01500785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419074|NCT01500785|Vitamin B Complex|vitamin b complex|mesh-ancestor
92419075|NCT01500785|Hematinics|hematinics|mesh-ancestor
92419076|NCT01500785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92419077|NCT01500785|Vasodilator Agents|vasodilator agents|mesh-ancestor
92419078|NCT01500785|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92419079|NCT01500785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92419080|NCT01500785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419081|NCT01500785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419082|NCT01500785|Protective Agents|protective agents|mesh-ancestor
92419083|NCT01500824|Crizotinib|crizotinib|mesh-list
92419084|NCT01500824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419085|NCT01500824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92419086|NCT01500824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419087|NCT01500824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419088|NCT01500837|Levofloxacin|levofloxacin|mesh-list
92419089|NCT01500837|Ofloxacin|ofloxacin|mesh-list
92419090|NCT01500837|Rifampin|rifampin|mesh-list
92419091|NCT01500837|Clindamycin|clindamycin|mesh-list
92419092|NCT01500837|Clindamycin palmitate|clindamycin palmitate|mesh-list
92419093|NCT01500837|Clindamycin phosphate|clindamycin phosphate|mesh-list
92419094|NCT01500837|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92419095|NCT01500837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419096|NCT01500837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419097|NCT01500837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92419098|NCT01500837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419099|NCT01500837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419100|NCT01500837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419101|NCT01500837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419102|NCT01500837|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92419103|NCT01500837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92419104|NCT01500837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92419105|NCT01500837|Antitubercular Agents|antitubercular agents|mesh-ancestor
92419106|NCT01500837|Leprostatic Agents|leprostatic agents|mesh-ancestor
92419107|NCT01500837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92419108|NCT01500837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92419109|NCT01500837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92419122|NCT01500850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92419123|NCT01500850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609163|NCT01243177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609164|NCT01243177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609165|NCT01243177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92609166|NCT01243177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609167|NCT01243177|Analgesics|analgesics|mesh-ancestor
92419124|NCT01500863|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92419125|NCT01500863|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92419126|NCT01500863|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92419128|NCT01500863|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92419129|NCT01500863|Progesterone|progesterone|mesh-list
92419130|NCT01500863|Estrogens|estrogens|mesh-ancestor
92419131|NCT01500863|Hormones|hormones|mesh-ancestor
92419132|NCT01500863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394683|NCT01386567|Anabolic Agents|anabolic agents|mesh-ancestor
92419133|NCT01500863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419134|NCT01500863|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92419135|NCT01500863|Contraceptive Agents|contraceptive agents|mesh-ancestor
92419136|NCT01500863|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92143815|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419137|NCT01500863|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92419138|NCT01500863|Progestins|progestins|mesh-ancestor
92419139|NCT01500863|Luteolytic Agents|luteolytic agents|mesh-ancestor
92419140|NCT01500863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92419141|NCT01500863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419142|NCT01500915|Ranibizumab|ranibizumab|mesh-list
92419143|NCT01500915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92419144|NCT01500915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92419145|NCT01500915|Growth Substances|growth substances|mesh-ancestor
92419146|NCT01500915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419147|NCT01500915|Growth Inhibitors|growth inhibitors|mesh-ancestor
92419148|NCT01500915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419149|NCT01500928|Insulin|insulin|mesh-list
92419150|NCT01500928|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92419151|NCT01500928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419152|NCT01500980|Chloroquine|chloroquine|mesh-list
92419153|NCT01500980|Primaquine|primaquine|mesh-list
92419154|NCT01500980|Amebicides|amebicides|mesh-ancestor
92419155|NCT01500980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92419156|NCT01500980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92419157|NCT01500980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419158|NCT01500980|Antimalarials|antimalarials|mesh-ancestor
92419159|NCT01500980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419160|NCT01500993|Fluorouracil|fluorouracil|mesh-list
92419161|NCT01500993|Capecitabine|capecitabine|mesh-list
92419162|NCT01500993|Antimetabolites|antimetabolites|mesh-ancestor
92419163|NCT01500993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419164|NCT01500993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419165|NCT01500993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419166|NCT01500993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419167|NCT01500993|Immunologic Factors|immunologic factors|mesh-ancestor
92419168|NCT01500993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419169|NCT01501032|Pancrelipase|pancrelipase|mesh-list
92419170|NCT01501032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419171|NCT01501084|Exenatide|exenatide|mesh-list
92419172|NCT01501084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92419173|NCT01501084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419178|NCT01501123|Midazolam|midazolam|mesh-list
92419179|NCT01501123|Haloperidol|haloperidol|mesh-list
92419180|NCT01501123|Haloperidol decanoate|haloperidol decanoate|mesh-list
92419181|NCT01501123|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92419182|NCT01501123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92419183|NCT01501123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419184|NCT01501123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419185|NCT01501123|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92419186|NCT01501123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419187|NCT01501123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419188|NCT01501123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92419189|NCT01501123|Anesthetics, General|anesthetics, general|mesh-ancestor
92419190|NCT01501123|Anesthetics|anesthetics|mesh-ancestor
92419191|NCT01501123|GABA Modulators|gaba modulators|mesh-ancestor
92419192|NCT01501123|GABA Agents|gaba agents|mesh-ancestor
92419193|NCT01501123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419194|NCT01501123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419195|NCT01501123|Antiemetics|antiemetics|mesh-ancestor
92609169|NCT01243177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078866|NCT01490697|Antimetabolites|antimetabolites|mesh-ancestor
92419196|NCT01501123|Autonomic Agents|autonomic agents|mesh-ancestor
92419197|NCT01501123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419198|NCT01501123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419199|NCT01501123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92419200|NCT01501123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92419201|NCT01501123|Dopamine Agents|dopamine agents|mesh-ancestor
92419202|NCT01501123|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92419203|NCT01501136|Dexamethasone|dexamethasone|mesh-list
92419204|NCT01501136|Dexamethasone acetate|dexamethasone acetate|mesh-list
92419205|NCT01501136|Cisplatin|cisplatin|mesh-list
92419206|NCT01501136|Gemcitabine|gemcitabine|mesh-list
92419207|NCT01501136|Etoposide|etoposide|mesh-list
92419208|NCT01501136|Etoposide phosphate|etoposide phosphate|mesh-list
92419209|NCT01501136|Ifosfamide|ifosfamide|mesh-list
92419210|NCT01501136|Isophosphamide mustard|isophosphamide mustard|mesh-list
92419211|NCT01501136|Pegaspargase|pegaspargase|mesh-list
92419212|NCT01501136|Asparaginase|asparaginase|mesh-list
92419213|NCT01501136|BB 1101|bb 1101|mesh-list
92419214|NCT01501136|Mesna|mesna|mesh-list
92419215|NCT01501136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419216|NCT01501136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419217|NCT01501136|Antiemetics|antiemetics|mesh-ancestor
92419218|NCT01501136|Autonomic Agents|autonomic agents|mesh-ancestor
92419219|NCT01501136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419220|NCT01501136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419221|NCT01501136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419222|NCT01501136|Glucocorticoids|glucocorticoids|mesh-ancestor
92419223|NCT01501136|Hormones|hormones|mesh-ancestor
92419224|NCT01501136|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419225|NCT01501136|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92419226|NCT01501136|Protease Inhibitors|protease inhibitors|mesh-ancestor
92419227|NCT01501136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419228|NCT01501136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419229|NCT01501136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419230|NCT01501136|Antimetabolites|antimetabolites|mesh-ancestor
92419231|NCT01501136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92419232|NCT01501136|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92419233|NCT01501136|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419234|NCT01501136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92419235|NCT01501136|Alkylating Agents|alkylating agents|mesh-ancestor
92419236|NCT01501136|Protective Agents|protective agents|mesh-ancestor
92419237|NCT01501149|Dexamethasone|dexamethasone|mesh-list
92419238|NCT01501149|Gemcitabine|gemcitabine|mesh-list
92419239|NCT01501149|Etoposide|etoposide|mesh-list
92419240|NCT01501149|Pegaspargase|pegaspargase|mesh-list
92419241|NCT01501149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419242|NCT01501149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419243|NCT01501149|Antiemetics|antiemetics|mesh-ancestor
92419244|NCT01501149|Autonomic Agents|autonomic agents|mesh-ancestor
92419245|NCT01501149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419246|NCT01501149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419247|NCT01501149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419248|NCT01501149|Glucocorticoids|glucocorticoids|mesh-ancestor
92419249|NCT01501149|Hormones|hormones|mesh-ancestor
92419261|NCT01501214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419262|NCT01501214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419264|NCT01501214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92419265|NCT01501253|Amlodipine|amlodipine|mesh-list
92419266|NCT01501253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92419267|NCT01501253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92419268|NCT01501253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419269|NCT01501253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419270|NCT01501253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92419271|NCT01501253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419272|NCT01501253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92419273|NCT01501344|Calcium|calcium|mesh-list
92419274|NCT01501344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92419275|NCT01501344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419276|NCT01501370|Dexamethasone|dexamethasone|mesh-list
92419277|NCT01501370|Dexamethasone acetate|dexamethasone acetate|mesh-list
92419278|NCT01501370|Lenalidomide|lenalidomide|mesh-list
92419279|NCT01501370|Vorinostat|vorinostat|mesh-list
92609170|NCT01243177|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92609171|NCT01243177|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92609172|NCT00154440|Amoxicillin|amoxicillin|mesh-list
92609173|NCT00154440|Metronidazole|metronidazole|mesh-list
92609174|NCT00154440|Clarithromycin|clarithromycin|mesh-list
92419281|NCT01501370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419282|NCT01501370|Antiemetics|antiemetics|mesh-ancestor
92419283|NCT01501370|Autonomic Agents|autonomic agents|mesh-ancestor
92419284|NCT01501370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419285|NCT01501370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419286|NCT01501370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419287|NCT01501370|Glucocorticoids|glucocorticoids|mesh-ancestor
92419288|NCT01501370|Hormones|hormones|mesh-ancestor
92419289|NCT01501370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419290|NCT01501370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92419291|NCT01501370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419292|NCT01501370|Protease Inhibitors|protease inhibitors|mesh-ancestor
92419293|NCT01501370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419294|NCT01501370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419295|NCT01501370|Immunologic Factors|immunologic factors|mesh-ancestor
92419296|NCT01501370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92419297|NCT01501370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92419298|NCT01501370|Growth Substances|growth substances|mesh-ancestor
92419299|NCT01501370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92419300|NCT01501370|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92419301|NCT01501396|Megestrol|megestrol|mesh-list
92419302|NCT01501396|Megestrol Acetate|megestrol acetate|mesh-list
92419303|NCT01501396|Mirtazapine|mirtazapine|mesh-list
92419304|NCT01501396|Antidepressive Agents|antidepressive agents|mesh-ancestor
92419305|NCT01501396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419306|NCT01501396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92419307|NCT01501396|Histamine Antagonists|histamine antagonists|mesh-ancestor
92419308|NCT01501396|Histamine Agents|histamine agents|mesh-ancestor
92419309|NCT01501396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419310|NCT01501396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419330|NCT01501396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92419331|NCT01501396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419332|NCT01501396|Appetite Stimulants|appetite stimulants|mesh-ancestor
92419333|NCT01501396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92419334|NCT01501422|Estrogens|estrogens|mesh-list
92419335|NCT01501422|Hormones|hormones|mesh-ancestor
92419336|NCT01501422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419337|NCT01501422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419338|NCT01501435|Fenofibric acid|fenofibric acid|mesh-list
92419339|NCT01501435|Fenofibrate|fenofibrate|mesh-list
92419340|NCT01501435|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92419341|NCT01501435|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92419342|NCT01501435|Antimetabolites|antimetabolites|mesh-ancestor
92419343|NCT01501435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419344|NCT01501435|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92419345|NCT01501448|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92419346|NCT01501448|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92419347|NCT01501448|Levonorgestrel|levonorgestrel|mesh-list
92419348|NCT01501448|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92419349|NCT01501448|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92419350|NCT01501448|Estradiol|estradiol|mesh-list
92419351|NCT01501448|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92419352|NCT01501448|Estrogens|estrogens|mesh-ancestor
92419353|NCT01501448|Hormones|hormones|mesh-ancestor
92419354|NCT01501448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419355|NCT01501448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419356|NCT01501448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92419357|NCT01501448|Contraceptive Agents|contraceptive agents|mesh-ancestor
92419358|NCT01501448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92419359|NCT01501448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92419360|NCT01501448|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92419361|NCT01501448|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92419362|NCT01501448|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92419363|NCT01501448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92609175|NCT00154440|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92609176|NCT00154440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609177|NCT00154440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609178|NCT00154440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92609179|NCT00154440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92419380|NCT01501500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419381|NCT01501500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419382|NCT01501500|Cholinergic Agents|cholinergic agents|mesh-ancestor
92419383|NCT01501500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419384|NCT01501591|Hydroxyzine|hydroxyzine|mesh-list
92419385|NCT01501591|Antipruritics|antipruritics|mesh-ancestor
92419386|NCT01501591|Dermatologic Agents|dermatologic agents|mesh-ancestor
92419387|NCT01501591|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92419388|NCT01501591|Histamine Antagonists|histamine antagonists|mesh-ancestor
92419389|NCT01501591|Histamine Agents|histamine agents|mesh-ancestor
92419390|NCT01501591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394693|NCT01386580|Trastuzumab|trastuzumab|mesh-list
92419391|NCT01501591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419392|NCT01501591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419393|NCT01501669|Capecitabine|capecitabine|mesh-list
92419394|NCT01501669|Irinotecan|irinotecan|mesh-list
92419395|NCT01501669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419396|NCT01501669|Antimetabolites|antimetabolites|mesh-ancestor
92419397|NCT01501669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419398|NCT01501669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419399|NCT01501669|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92419400|NCT01501669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419401|NCT01501669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419402|NCT01501695|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
92419403|NCT01501695|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92419404|NCT01501695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419405|NCT01501695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419406|NCT01501695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419407|NCT01501695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419408|NCT01501695|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92419409|NCT01501695|Dopamine Agents|dopamine agents|mesh-ancestor
92419410|NCT01501695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419411|NCT01501695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419412|NCT01501708|Voriconazole|voriconazole|mesh-list
92419413|NCT01501708|Amphotericin B|amphotericin b|mesh-list
92419414|NCT01501708|Caspofungin|caspofungin|mesh-list
92419415|NCT01501708|Antifungal Agents|antifungal agents|mesh-ancestor
92419416|NCT01501708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419417|NCT01501708|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92419418|NCT01501708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92419419|NCT01501708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419420|NCT01501708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419423|NCT01501708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419424|NCT01501708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419425|NCT01501708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92419426|NCT01501708|Amebicides|amebicides|mesh-ancestor
92419427|NCT01501708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92419428|NCT01501708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92419429|NCT01501708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419430|NCT01501747|Acetaminophen|acetaminophen|mesh-list
92419431|NCT01501747|Cephalexin|cephalexin|mesh-list
92419432|NCT01501747|Ibuprofen|ibuprofen|mesh-list
92419433|NCT01501747|Caffeine|caffeine|mesh-list
92419434|NCT01501747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92419435|NCT01501747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92419436|NCT01501747|Analgesics|analgesics|mesh-ancestor
92419437|NCT01501747|Sensory System Agents|sensory system agents|mesh-ancestor
92419438|NCT01501747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144124|NCT02467153|Vitamin D|vitamin d|mesh-list
92419439|NCT01501747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419440|NCT01501747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419441|NCT01501747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419442|NCT01501747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92419443|NCT01501747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419444|NCT01501747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419445|NCT01501747|Antipyretics|antipyretics|mesh-ancestor
92609181|NCT00154440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016377|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92419446|NCT01501747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92419447|NCT01501747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92419448|NCT01501747|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92419449|NCT01501747|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92419450|NCT01501747|Purinergic Agents|purinergic agents|mesh-ancestor
92419451|NCT01501747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419452|NCT01501747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419453|NCT01501747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419454|NCT01501760|Bevacizumab|bevacizumab|mesh-list
92419455|NCT01501760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92419456|NCT01501760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419457|NCT01501760|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92419458|NCT01501760|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92419459|NCT01501760|Growth Substances|growth substances|mesh-ancestor
92394697|NCT01386580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419460|NCT01501760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419461|NCT01501760|Growth Inhibitors|growth inhibitors|mesh-ancestor
92419462|NCT01501786|Ketamine|ketamine|mesh-list
92419463|NCT01501786|Propofol|propofol|mesh-list
92419464|NCT01501786|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92419465|NCT01501786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419466|NCT01501786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419467|NCT01501786|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92419468|NCT01501786|Anesthetics, General|anesthetics, general|mesh-ancestor
92419469|NCT01501786|Anesthetics|anesthetics|mesh-ancestor
92419470|NCT01501786|Analgesics|analgesics|mesh-ancestor
92419471|NCT01501786|Sensory System Agents|sensory system agents|mesh-ancestor
92419472|NCT01501786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419473|NCT01501786|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92419474|NCT01501786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92419475|NCT01501786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92419476|NCT01501786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419477|NCT01501786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419478|NCT01501799|Adapalene|adapalene|mesh-list
92419479|NCT01501799|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92419480|NCT01501799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92419481|NCT01501799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92419482|NCT01501799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92419483|NCT01501799|Analgesics|analgesics|mesh-ancestor
92419484|NCT01501799|Sensory System Agents|sensory system agents|mesh-ancestor
92419485|NCT01501799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419486|NCT01501799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419487|NCT01501799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419488|NCT01501799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419489|NCT01501890|Algestone|algestone|mesh-list
92419490|NCT01501890|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92419491|NCT01501890|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92419492|NCT01501890|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92419495|NCT01501890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419496|NCT01501890|Progestins|progestins|mesh-ancestor
92419497|NCT01501890|Hormones|hormones|mesh-ancestor
92419498|NCT01501890|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92419499|NCT01501890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92419500|NCT01501890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92419501|NCT01501890|Contraceptive Agents|contraceptive agents|mesh-ancestor
92419502|NCT01501890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92419503|NCT01501890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92419504|NCT01501890|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92419505|NCT01501916|Vitamin D|vitamin d|mesh-list
92419506|NCT01501916|Cholecalciferol|cholecalciferol|mesh-list
92419507|NCT01501916|Vitamins|vitamins|mesh-ancestor
92419508|NCT01501916|Micronutrients|micronutrients|mesh-ancestor
92419509|NCT01501916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419510|NCT01501916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92419511|NCT01501916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92419512|NCT01501942|Glycine|glycine|mesh-list
92419513|NCT01501942|Glycine Agents|glycine agents|mesh-ancestor
92419514|NCT01501942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419515|NCT01501942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419516|NCT01501942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016380|NCT03791593|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92419517|NCT01501968|Ascorbic Acid|ascorbic acid|mesh-list
92419518|NCT01501968|Colistin|colistin|mesh-list
92419519|NCT01501968|Vitamins|vitamins|mesh-ancestor
92419520|NCT01501968|Micronutrients|micronutrients|mesh-ancestor
92419521|NCT01501968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419522|NCT01501968|Antioxidants|antioxidants|mesh-ancestor
92419523|NCT01501968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419524|NCT01501968|Protective Agents|protective agents|mesh-ancestor
92419525|NCT01501968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419526|NCT01501968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419527|NCT01502020|Imiquimod|imiquimod|mesh-list
92419528|NCT01502020|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92419529|NCT01502020|Immunologic Factors|immunologic factors|mesh-ancestor
92419530|NCT01502020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419531|NCT01502020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419532|NCT01502020|Interferon Inducers|interferon inducers|mesh-ancestor
92419533|NCT01502046|Dronabinol|dronabinol|mesh-list
92419534|NCT01502046|Cannabidiol|cannabidiol|mesh-list
92419535|NCT01502046|Anticonvulsants|anticonvulsants|mesh-ancestor
92419536|NCT01502046|Hallucinogens|hallucinogens|mesh-ancestor
92419537|NCT01502046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419538|NCT01502046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419539|NCT01502046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92419540|NCT01502046|Analgesics|analgesics|mesh-ancestor
92419541|NCT01502046|Sensory System Agents|sensory system agents|mesh-ancestor
92419542|NCT01502046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419543|NCT01502046|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92419544|NCT01502046|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92419545|NCT01502046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419546|NCT01502046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419547|NCT01502046|Hormones|hormones|mesh-ancestor
92419548|NCT01502046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419549|NCT01502202|Pemetrexed|pemetrexed|mesh-list
92419550|NCT01502202|Gefitinib|gefitinib|mesh-list
92419551|NCT01502202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419552|NCT01502202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419553|NCT01502202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419554|NCT01502202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92419555|NCT01502202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92419556|NCT01502202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92419557|NCT01502241|Temozolomide|temozolomide|mesh-list
92419558|NCT01502241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92419559|NCT01502241|Alkylating Agents|alkylating agents|mesh-ancestor
92419560|NCT01502241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419561|NCT01502241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419562|NCT01502267|Bortezomib|bortezomib|mesh-list
92419563|NCT01502267|Rituximab|rituximab|mesh-list
92419564|NCT01502267|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92419565|NCT01502267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419568|NCT01502267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419570|NCT01502280|Ascorbic Acid|ascorbic acid|mesh-list
92419571|NCT01502280|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92419572|NCT01502280|Antioxidants|antioxidants|mesh-ancestor
92419573|NCT01502280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419574|NCT01502280|Protective Agents|protective agents|mesh-ancestor
92419575|NCT01502280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419576|NCT01502280|Vitamins|vitamins|mesh-ancestor
92419577|NCT01502280|Micronutrients|micronutrients|mesh-ancestor
92419578|NCT01502280|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92419579|NCT01502280|Dermatologic Agents|dermatologic agents|mesh-ancestor
92419580|NCT01502358|Vaccines|vaccines|mesh-list
92419581|NCT01502358|Immunologic Factors|immunologic factors|mesh-ancestor
92419582|NCT01502358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419583|NCT01502592|Ipilimumab|ipilimumab|mesh-list
92419584|NCT01502592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92419585|NCT01502592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419586|NCT01502592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92419587|NCT01502592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419588|NCT01502605|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92419589|NCT01502605|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92419590|NCT01502605|Dermatologic Agents|dermatologic agents|mesh-ancestor
92419591|NCT01502696|Interferon alpha-2|interferon alpha-2|mesh-list
92419592|NCT01502696|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92419593|NCT01502696|Antiviral Agents|antiviral agents|mesh-ancestor
92609182|NCT00154440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609183|NCT00154440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92609184|NCT00154440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92609185|NCT00139061|Atorvastatin|atorvastatin|mesh-list
92609186|NCT00139061|Torcetrapib|torcetrapib|mesh-list
92016384|NCT03064243|Apatinib|apatinib|mesh-list
92419594|NCT01502696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419595|NCT01502696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419596|NCT01502774|Cyclosporine|cyclosporine|mesh-list
92419597|NCT01502774|Cyclosporins|cyclosporins|mesh-list
92419598|NCT01502774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419599|NCT01502774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419600|NCT01502774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419601|NCT01502774|Immunologic Factors|immunologic factors|mesh-ancestor
92419602|NCT01502774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419603|NCT01502774|Antifungal Agents|antifungal agents|mesh-ancestor
92419604|NCT01502774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419605|NCT01502774|Dermatologic Agents|dermatologic agents|mesh-ancestor
92419606|NCT01502774|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419607|NCT01502774|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92419608|NCT01502800|Beta-lapachone|beta-lapachone|mesh-list
92419609|NCT01502800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419610|NCT01502800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92419611|NCT01502800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92419612|NCT01502800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419613|NCT01502800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419614|NCT01502800|Antiviral Agents|antiviral agents|mesh-ancestor
92419615|NCT01502878|Cefpodoxime|cefpodoxime|mesh-list
92419616|NCT01502878|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
92419617|NCT01502878|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419618|NCT01502878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419619|NCT01502904|Sirolimus|sirolimus|mesh-list
92419620|NCT01502904|Pravastatin|pravastatin|mesh-list
92419621|NCT01502904|Pitavastatin|pitavastatin|mesh-list
92419622|NCT01502904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419623|NCT01502904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419624|NCT01502904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92419625|NCT01502904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419626|NCT01502904|Antifungal Agents|antifungal agents|mesh-ancestor
92419627|NCT01502904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419628|NCT01502904|Immunologic Factors|immunologic factors|mesh-ancestor
92419629|NCT01502904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419630|NCT01502904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419631|NCT01502904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419632|NCT01502904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92419633|NCT01502904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92419634|NCT01502904|Antimetabolites|antimetabolites|mesh-ancestor
92419635|NCT01502904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92419636|NCT01502904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92419637|NCT01502943|Atorvastatin|atorvastatin|mesh-list
92419638|NCT01502943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419650|NCT01503008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419652|NCT01503008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419653|NCT01503008|Protease Inhibitors|protease inhibitors|mesh-ancestor
92419654|NCT01503060|Lidocaine|lidocaine|mesh-list
92419655|NCT01503060|Anesthetics, Local|anesthetics, local|mesh-ancestor
92419656|NCT01503060|Anesthetics|anesthetics|mesh-ancestor
92419657|NCT01503060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419658|NCT01503060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419659|NCT01503060|Sensory System Agents|sensory system agents|mesh-ancestor
92419660|NCT01503060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419661|NCT01503060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92419662|NCT01503060|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92419663|NCT01503060|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92144335|NCT01675999|Leucovorin|leucovorin|mesh-list
92419664|NCT01503060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419665|NCT01503060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419666|NCT01503216|Vitamin D|vitamin d|mesh-list
92609188|NCT00139061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92419667|NCT01503216|Cholecalciferol|cholecalciferol|mesh-list
92419668|NCT01503216|Ergocalciferols|ergocalciferols|mesh-list
92419669|NCT01503216|Vitamins|vitamins|mesh-ancestor
92419670|NCT01503216|Micronutrients|micronutrients|mesh-ancestor
92419671|NCT01503216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419672|NCT01503216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92419673|NCT01503216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92419674|NCT01503242|Cyclosporine|cyclosporine|mesh-list
92419675|NCT01503242|Mycophenolic Acid|mycophenolic acid|mesh-list
92419676|NCT01503242|Fludarabine|fludarabine|mesh-list
92419677|NCT01503242|Fludarabine phosphate|fludarabine phosphate|mesh-list
92419678|NCT01503242|Antibodies|antibodies|mesh-list
92419679|NCT01503242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92419680|NCT01503242|Cyclosporins|cyclosporins|mesh-list
92419681|NCT01503242|Immunologic Factors|immunologic factors|mesh-ancestor
92419682|NCT01503242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419683|NCT01503242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419684|NCT01503242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419685|NCT01503242|Antimetabolites|antimetabolites|mesh-ancestor
92419686|NCT01503242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419687|NCT01503242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419688|NCT01503242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419689|NCT01503242|Antifungal Agents|antifungal agents|mesh-ancestor
92419690|NCT01503242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419691|NCT01503242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92419692|NCT01503242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419693|NCT01503242|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92419694|NCT01503242|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92419695|NCT01503242|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92419696|NCT01503242|Antitubercular Agents|antitubercular agents|mesh-ancestor
92419697|NCT01503242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92419698|NCT01503359|Glycine|glycine|mesh-list
92419699|NCT01503359|Glycine Agents|glycine agents|mesh-ancestor
92419700|NCT01503359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419701|NCT01503359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419712|NCT01503385|Celecoxib|celecoxib|mesh-list
92419713|NCT01503385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92419714|NCT01503385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92419715|NCT01503385|Analgesics|analgesics|mesh-ancestor
92419716|NCT01503385|Sensory System Agents|sensory system agents|mesh-ancestor
92419717|NCT01503385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419718|NCT01503385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419719|NCT01503385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419720|NCT01503385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419721|NCT01503385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92419722|NCT01503385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92419723|NCT01503385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419724|NCT01503385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419725|NCT01503398|Olanzapine|olanzapine|mesh-list
92419726|NCT01503398|Antiemetics|antiemetics|mesh-ancestor
92419727|NCT01503398|Autonomic Agents|autonomic agents|mesh-ancestor
92419728|NCT01503398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419729|NCT01503398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419730|NCT01503398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419731|NCT01503398|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92419732|NCT01503398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419733|NCT01503398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419734|NCT01503398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419735|NCT01503398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92419736|NCT01503398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92419737|NCT01503398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419738|NCT01503398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144414|NCT04747015|Oxytocin|oxytocin|mesh-list
92419739|NCT01503398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419740|NCT01503398|Serotonin Agents|serotonin agents|mesh-ancestor
92419741|NCT01503424|Olanzapine|olanzapine|mesh-list
92419742|NCT01503424|Antiemetics|antiemetics|mesh-ancestor
92419743|NCT01503424|Autonomic Agents|autonomic agents|mesh-ancestor
92419744|NCT01503424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419745|NCT01503424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419746|NCT01503424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419747|NCT01503424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92609189|NCT00139061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92609190|NCT00139061|Antimetabolites|antimetabolites|mesh-ancestor
92609191|NCT00139061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609192|NCT00139061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92016389|NCT03765619|Aspirin|aspirin|mesh-list
92419748|NCT01503424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419749|NCT01503424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419750|NCT01503424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419751|NCT01503424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92419752|NCT01503424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92419753|NCT01503424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419754|NCT01503424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419755|NCT01503424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419756|NCT01503424|Serotonin Agents|serotonin agents|mesh-ancestor
92419757|NCT01503437|Olanzapine|olanzapine|mesh-list
92419758|NCT01503437|Antiemetics|antiemetics|mesh-ancestor
92419759|NCT01503437|Autonomic Agents|autonomic agents|mesh-ancestor
92419760|NCT01503437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419761|NCT01503437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419762|NCT01503437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419763|NCT01503437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92419764|NCT01503437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419765|NCT01503437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419766|NCT01503437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419786|NCT01503450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419787|NCT01503450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419788|NCT01503450|Serotonin Agents|serotonin agents|mesh-ancestor
92419789|NCT01503502|Imatinib Mesylate|imatinib mesylate|mesh-list
92419790|NCT01503502|Flumatinib|flumatinib|mesh-list
92419791|NCT01503502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419792|NCT01503502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92419793|NCT01503502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419794|NCT01503502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419795|NCT01503580|Solifenacin Succinate|solifenacin succinate|mesh-list
92419796|NCT01503580|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92419797|NCT01503580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92419798|NCT01503580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92419799|NCT01503580|Cholinergic Agents|cholinergic agents|mesh-ancestor
92419800|NCT01503580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419801|NCT01503580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419802|NCT01503580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419803|NCT01503580|Urological Agents|urological agents|mesh-ancestor
92419804|NCT01503593|Calcium|calcium|mesh-list
92419805|NCT01503593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92419806|NCT01503593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419807|NCT01503658|Aspirin|aspirin|mesh-list
92419808|NCT01503658|Clopidogrel|clopidogrel|mesh-list
92419809|NCT01503658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92419810|NCT01503658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92419811|NCT01503658|Analgesics|analgesics|mesh-ancestor
92419812|NCT01503658|Sensory System Agents|sensory system agents|mesh-ancestor
92419813|NCT01503658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419814|NCT01503658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419815|NCT01503658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419816|NCT01503658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419817|NCT01503658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92419818|NCT01503658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92419819|NCT01503658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419830|NCT01503671|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92419831|NCT01503671|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92419833|NCT01503671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419834|NCT01503671|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92419835|NCT01503671|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92419836|NCT01503671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419837|NCT01503736|Citric Acid|citric acid|mesh-list
92419838|NCT01503736|Sodium Citrate|sodium citrate|mesh-list
92419839|NCT01503736|Ferric Compounds|ferric compounds|mesh-list
92419840|NCT01503736|Anticoagulants|anticoagulants|mesh-ancestor
92419841|NCT01503736|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92609193|NCT00139061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92609194|NCT00139061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609195|NCT00139100|Anti-Infective Agents|anti-infective agents|mesh-list
92609196|NCT00139100|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92609197|NCT04705584|Cyclosporine|cyclosporine|mesh-list
92419842|NCT01503736|Chelating Agents|chelating agents|mesh-ancestor
92419843|NCT01503736|Sequestering Agents|sequestering agents|mesh-ancestor
92419844|NCT01503736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419845|NCT01503736|Hematinics|hematinics|mesh-ancestor
92419846|NCT01503788|Midazolam|midazolam|mesh-list
92419847|NCT01503788|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92419848|NCT01503788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92419849|NCT01503788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419850|NCT01503788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419851|NCT01503788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92419852|NCT01503788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419853|NCT01503788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419854|NCT01503788|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92419855|NCT01503788|Anesthetics, General|anesthetics, general|mesh-ancestor
92419856|NCT01503788|Anesthetics|anesthetics|mesh-ancestor
92419857|NCT01503788|GABA Modulators|gaba modulators|mesh-ancestor
92419858|NCT01503788|GABA Agents|gaba agents|mesh-ancestor
92419859|NCT01503788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419860|NCT01503788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419861|NCT01503801|Nitric Oxide|nitric oxide|mesh-list
92419862|NCT01503801|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-list
92419863|NCT01503801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92419864|NCT01503801|Autonomic Agents|autonomic agents|mesh-ancestor
92419865|NCT01503801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419866|NCT01503801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419867|NCT01503801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92419868|NCT01503801|Respiratory System Agents|respiratory system agents|mesh-ancestor
92419869|NCT01503801|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92419870|NCT01503801|Antioxidants|antioxidants|mesh-ancestor
92419871|NCT01503801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419872|NCT01503801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419873|NCT01503801|Vasodilator Agents|vasodilator agents|mesh-ancestor
92419874|NCT01503801|Gasotransmitters|gasotransmitters|mesh-ancestor
92419875|NCT01503801|Protective Agents|protective agents|mesh-ancestor
92419876|NCT01503905|Tamoxifen|tamoxifen|mesh-list
92419877|NCT01503905|Cyclophosphamide|cyclophosphamide|mesh-list
92419878|NCT01503905|Docetaxel|docetaxel|mesh-list
92419879|NCT01503905|Trastuzumab|trastuzumab|mesh-list
92419880|NCT01503905|Epirubicin|epirubicin|mesh-list
92419881|NCT01503905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419882|NCT01503905|Immunologic Factors|immunologic factors|mesh-ancestor
92419883|NCT01503905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419884|NCT01503905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419885|NCT01503905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92419902|NCT01503905|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92419903|NCT01503905|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92419904|NCT01503905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92419905|NCT01503918|Valacyclovir|valacyclovir|mesh-list
92419906|NCT01503918|Valganciclovir|valganciclovir|mesh-list
92419907|NCT01503918|Acyclovir|acyclovir|mesh-list
92419908|NCT01503918|Ganciclovir|ganciclovir|mesh-list
92419909|NCT01503918|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92419910|NCT01503918|Antiviral Agents|antiviral agents|mesh-ancestor
92419911|NCT01503918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92419912|NCT01503918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92419913|NCT01503918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419914|NCT01503918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419915|NCT01503983|Capecitabine|capecitabine|mesh-list
92419916|NCT01503983|Oxaliplatin|oxaliplatin|mesh-list
92419917|NCT01503983|Trastuzumab|trastuzumab|mesh-list
92419918|NCT01503983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419919|NCT01503983|Antimetabolites|antimetabolites|mesh-ancestor
92419920|NCT01503983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419921|NCT01503983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419922|NCT01503983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92419923|NCT01504074|Triamcinolone|triamcinolone|mesh-list
92419924|NCT01504074|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92609198|NCT04705584|Prednisolone|prednisolone|mesh-list
92609199|NCT04705584|Cyclosporins|cyclosporins|mesh-list
92609200|NCT04705584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419925|NCT01504074|Levobunolol|levobunolol|mesh-list
92419926|NCT01504074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92419927|NCT01504074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92419928|NCT01504074|Glucocorticoids|glucocorticoids|mesh-ancestor
92419929|NCT01504074|Hormones|hormones|mesh-ancestor
92419930|NCT01504074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419931|NCT01504074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419932|NCT01504074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419933|NCT01504074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419934|NCT01504074|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92419935|NCT01504074|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92419936|NCT01504074|Adrenergic Agents|adrenergic agents|mesh-ancestor
92419937|NCT01504074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419938|NCT01504074|Sympatholytics|sympatholytics|mesh-ancestor
92419939|NCT01504074|Autonomic Agents|autonomic agents|mesh-ancestor
92419940|NCT01504126|Propranolol|propranolol|mesh-list
92419941|NCT01504126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92419942|NCT01504126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92419945|NCT01504126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419946|NCT01504126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419948|NCT01504126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92419949|NCT01504126|Vasodilator Agents|vasodilator agents|mesh-ancestor
92419950|NCT01504139|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92419951|NCT01504139|Estradiol|estradiol|mesh-list
92419952|NCT01504139|Progesterone|progesterone|mesh-list
92419953|NCT01504139|Estrogens|estrogens|mesh-ancestor
92419954|NCT01504139|Hormones|hormones|mesh-ancestor
92419955|NCT01504139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419956|NCT01504139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419957|NCT01504139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92419958|NCT01504139|Progestins|progestins|mesh-ancestor
92419959|NCT01504178|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92419960|NCT01504178|Levodopa|levodopa|mesh-list
92419961|NCT01504178|Apomorphine|apomorphine|mesh-list
92419962|NCT01504178|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92419963|NCT01504178|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92419964|NCT01504178|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92419965|NCT01504178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419966|NCT01504178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419967|NCT01504178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419968|NCT01504178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419969|NCT01504178|Analgesics|analgesics|mesh-ancestor
92419970|NCT01504178|Sensory System Agents|sensory system agents|mesh-ancestor
92419971|NCT01504178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419972|NCT01504178|Antidepressive Agents|antidepressive agents|mesh-ancestor
92419973|NCT01504178|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419974|NCT01504178|Dopamine Agents|dopamine agents|mesh-ancestor
92419975|NCT01504178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92419976|NCT01504178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92419977|NCT01504178|Emetics|emetics|mesh-ancestor
92419978|NCT01504178|Autonomic Agents|autonomic agents|mesh-ancestor
92419979|NCT01504178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419980|NCT01504178|Dopamine Agonists|dopamine agonists|mesh-ancestor
92419981|NCT01504256|Leucovorin|leucovorin|mesh-list
92419982|NCT01504256|Docetaxel|docetaxel|mesh-list
92419983|NCT01504256|Fluorouracil|fluorouracil|mesh-list
92419984|NCT01504256|Oxaliplatin|oxaliplatin|mesh-list
92419985|NCT01504256|Catumaxomab|catumaxomab|mesh-list
92419986|NCT01504256|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92419987|NCT01504256|Levoleucovorin|levoleucovorin|mesh-list
92419988|NCT01504256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419989|NCT01504256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92419990|NCT01504256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92419991|NCT01504256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92419992|NCT01504256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419993|NCT01504256|Antimetabolites|antimetabolites|mesh-ancestor
92419994|NCT01504256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419995|NCT01504256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92419996|NCT01504256|Immunologic Factors|immunologic factors|mesh-ancestor
92419997|NCT01504256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419998|NCT01504256|Antidotes|antidotes|mesh-ancestor
92419999|NCT01504256|Protective Agents|protective agents|mesh-ancestor
92609201|NCT04705584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609202|NCT04705584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92609203|NCT04705584|Immunologic Factors|immunologic factors|mesh-ancestor
92609204|NCT04705584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609205|NCT04705584|Antifungal Agents|antifungal agents|mesh-ancestor
92420000|NCT01504256|Vitamin B Complex|vitamin b complex|mesh-ancestor
92420002|NCT01504256|Micronutrients|micronutrients|mesh-ancestor
92420003|NCT01504256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420004|NCT01504282|Mitomycins|mitomycins|mesh-list
92420005|NCT01504282|Mitomycin|mitomycin|mesh-list
92420006|NCT01504282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92420007|NCT01504282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420008|NCT01504282|Alkylating Agents|alkylating agents|mesh-ancestor
92420009|NCT01504282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420010|NCT01504282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92420011|NCT01504282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420012|NCT01504295|Metadoxine|metadoxine|mesh-list
92420013|NCT01504295|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92420014|NCT01504321|Moxonidine|moxonidine|mesh-list
92420015|NCT01504321|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420016|NCT01504334|Pirfenidone|pirfenidone|mesh-list
92420017|NCT01504334|Analgesics|analgesics|mesh-ancestor
92420018|NCT01504334|Sensory System Agents|sensory system agents|mesh-ancestor
92420026|NCT01504347|Vaccines|vaccines|mesh-list
92420027|NCT01504347|Immunologic Factors|immunologic factors|mesh-ancestor
92420028|NCT01504347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420029|NCT01504386|Ropivacaine|ropivacaine|mesh-list
92420030|NCT01504386|Anesthetics, Local|anesthetics, local|mesh-ancestor
92420031|NCT01504386|Anesthetics|anesthetics|mesh-ancestor
92420032|NCT01504386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420033|NCT01504386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420034|NCT01504386|Sensory System Agents|sensory system agents|mesh-ancestor
92420035|NCT01504386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420036|NCT01504490|Bexarotene|bexarotene|mesh-list
92420037|NCT01504490|Efatutazone|efatutazone|mesh-list
92420038|NCT01504490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144716|NCT02651220|Adapalene|adapalene|mesh-list
92420039|NCT01504503|Donepezil|donepezil|mesh-list
92420040|NCT01504503|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92420041|NCT01504503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420042|NCT01504503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420044|NCT01504503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420045|NCT01504503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420046|NCT01504503|Nootropic Agents|nootropic agents|mesh-ancestor
92420047|NCT01504516|Donepezil|donepezil|mesh-list
92420048|NCT01504516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92420049|NCT01504516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420050|NCT01504516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420051|NCT01504516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420052|NCT01504516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420053|NCT01504516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420054|NCT01504516|Nootropic Agents|nootropic agents|mesh-ancestor
92420055|NCT01504542|Vaccines|vaccines|mesh-list
92420056|NCT01504542|Immunologic Factors|immunologic factors|mesh-ancestor
92394741|NCT01386658|Icatibant|icatibant|mesh-list
92420057|NCT01504542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420058|NCT01504581|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92420059|NCT01504581|Antiviral Agents|antiviral agents|mesh-ancestor
92420060|NCT01504581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420061|NCT01504620|Insulin|insulin|mesh-list
92420062|NCT01504620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420063|NCT01504620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420064|NCT01504646|Lyprinol|lyprinol|mesh-list
92420065|NCT01504646|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92420066|NCT01504646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92420067|NCT01504646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420068|NCT01504646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420069|NCT01504659|Ketamine|ketamine|mesh-list
92420070|NCT01504659|Analgesics|analgesics|mesh-ancestor
92420071|NCT01504659|Sensory System Agents|sensory system agents|mesh-ancestor
92420072|NCT01504659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420073|NCT01504659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609206|NCT04705584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609207|NCT04705584|Dermatologic Agents|dermatologic agents|mesh-ancestor
92609208|NCT04705584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609209|NCT04705584|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92609210|NCT04705584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92420074|NCT01504659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92420075|NCT01504659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92420076|NCT01504659|Anesthetics, General|anesthetics, general|mesh-ancestor
92420078|NCT01504659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420079|NCT01504659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92420080|NCT01504659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92420081|NCT01504659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420082|NCT01504659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420083|NCT01504724|Bevacizumab|bevacizumab|mesh-list
92420084|NCT01504724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420085|NCT01504724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420086|NCT01504724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420089|NCT01504724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420090|NCT01504724|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420091|NCT01504776|Bortezomib|bortezomib|mesh-list
92420092|NCT01504776|Panobinostat|panobinostat|mesh-list
92420093|NCT01504776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420094|NCT01504776|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92420095|NCT01504776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420096|NCT01504776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420097|NCT01504828|Ramipril|ramipril|mesh-list
92420098|NCT01504828|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92420099|NCT01504828|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420100|NCT01504828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420101|NCT01504828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420102|NCT01504828|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420103|NCT01504906|Cyclosporine|cyclosporine|mesh-list
92420104|NCT01504906|Ticagrelor|ticagrelor|mesh-list
92420105|NCT01504906|Cyclosporins|cyclosporins|mesh-list
92420106|NCT01504906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420107|NCT01504906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420108|NCT01504906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92420109|NCT01504906|Immunologic Factors|immunologic factors|mesh-ancestor
92420110|NCT01504906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420111|NCT01504906|Antifungal Agents|antifungal agents|mesh-ancestor
92420112|NCT01504906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420113|NCT01504906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92420114|NCT01504906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92420115|NCT01504906|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92420116|NCT01504906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92420117|NCT01504906|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92420118|NCT01504906|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92420119|NCT01504906|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92420120|NCT01504906|Purinergic Agents|purinergic agents|mesh-ancestor
92420121|NCT01504906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420122|NCT01504984|Imatinib Mesylate|imatinib mesylate|mesh-list
92420123|NCT01504984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420124|NCT01504984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420125|NCT01504984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420126|NCT01504984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420128|NCT01505049|Immunologic Factors|immunologic factors|mesh-ancestor
92420129|NCT01505049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420130|NCT01505088|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92420131|NCT01505088|Dexamethasone|dexamethasone|mesh-list
92420132|NCT01505088|Prednisolone|prednisolone|mesh-list
92420133|NCT01505088|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92420134|NCT01505088|Methylprednisolone|methylprednisolone|mesh-list
92420135|NCT01505088|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92420136|NCT01505088|Prednisolone acetate|prednisolone acetate|mesh-list
92420137|NCT01505088|Citric Acid|citric acid|mesh-list
92420138|NCT01505088|Sodium Citrate|sodium citrate|mesh-list
92420139|NCT01505088|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92420140|NCT01505088|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92420141|NCT01505088|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92609211|NCT04705584|Glucocorticoids|glucocorticoids|mesh-ancestor
92609212|NCT04705584|Hormones|hormones|mesh-ancestor
92609213|NCT04705584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420142|NCT01505088|Prednisolone phosphate|prednisolone phosphate|mesh-list
92420143|NCT01505088|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92420144|NCT01505088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92420145|NCT01505088|Antiemetics|antiemetics|mesh-ancestor
92420146|NCT01505088|Autonomic Agents|autonomic agents|mesh-ancestor
92420147|NCT01505088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420148|NCT01505088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420149|NCT01505088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420150|NCT01505088|Glucocorticoids|glucocorticoids|mesh-ancestor
92420151|NCT01505088|Hormones|hormones|mesh-ancestor
92420152|NCT01505088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420153|NCT01505088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92420154|NCT01505088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420155|NCT01505088|Anticoagulants|anticoagulants|mesh-ancestor
92420156|NCT01505088|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92420157|NCT01505088|Chelating Agents|chelating agents|mesh-ancestor
92420158|NCT01505088|Sequestering Agents|sequestering agents|mesh-ancestor
92420159|NCT01505088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420160|NCT01505088|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92420191|NCT01505231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420192|NCT01505231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420193|NCT01505231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420194|NCT01505231|Sympathomimetics|sympathomimetics|mesh-ancestor
92420195|NCT01505231|Autonomic Agents|autonomic agents|mesh-ancestor
92420196|NCT01505231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420197|NCT01505231|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92420198|NCT01505231|Hemostatics|hemostatics|mesh-ancestor
92420199|NCT01505231|Coagulants|coagulants|mesh-ancestor
92420200|NCT01505231|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92420201|NCT01505231|Natriuretic Agents|natriuretic agents|mesh-ancestor
92420203|NCT01505283|Sufentanil|sufentanil|mesh-list
92420204|NCT01505283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92420205|NCT01505283|Anesthetics|anesthetics|mesh-ancestor
92420206|NCT01505283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420207|NCT01505283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420208|NCT01505283|Sensory System Agents|sensory system agents|mesh-ancestor
92420209|NCT01505283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420210|NCT01505283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92420211|NCT01505283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92420212|NCT01505283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92420213|NCT01505283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92420214|NCT01505283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420215|NCT01505283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92420217|NCT01505283|Analgesics|analgesics|mesh-ancestor
92420218|NCT01505283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92420219|NCT01505283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92420220|NCT01505283|Anesthetics, General|anesthetics, general|mesh-ancestor
92420221|NCT01505296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92420222|NCT01505413|Gemcitabine|gemcitabine|mesh-list
92420223|NCT01505413|Oxaliplatin|oxaliplatin|mesh-list
92420224|NCT01505413|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92420225|NCT01505413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92420226|NCT01505413|Antimetabolites|antimetabolites|mesh-ancestor
92420227|NCT01505413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420228|NCT01505413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420229|NCT01505413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420230|NCT01505413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420231|NCT01505426|Metformin|metformin|mesh-list
92420232|NCT01505426|Ipragliflozin|ipragliflozin|mesh-list
92420233|NCT01505426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420234|NCT01505426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420235|NCT01505426|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92420236|NCT01505426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420237|NCT01505439|Solifenacin Succinate|solifenacin succinate|mesh-list
92420238|NCT01505439|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92420239|NCT01505439|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92420240|NCT01505439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420241|NCT01505439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609214|NCT04705584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92420242|NCT01505439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420243|NCT01505439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420244|NCT01505439|Urological Agents|urological agents|mesh-ancestor
92420245|NCT01505504|Mirtazapine|mirtazapine|mesh-list
92420246|NCT01505504|Antidepressive Agents|antidepressive agents|mesh-ancestor
92420247|NCT01505504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92420248|NCT01505504|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420249|NCT01505504|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420250|NCT01505504|Histamine Agents|histamine agents|mesh-ancestor
92420251|NCT01505504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420252|NCT01505504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420253|NCT01505504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420254|NCT01505504|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92420255|NCT01505504|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92420256|NCT01505504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420257|NCT01505504|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92420258|NCT01505504|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92420259|NCT01505504|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92420260|NCT01505504|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420261|NCT01505504|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92420262|NCT01505504|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92420263|NCT01505504|Serotonin Agents|serotonin agents|mesh-ancestor
92420264|NCT01505504|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92420265|NCT01505777|Mosapride|mosapride|mesh-list
92420266|NCT01505777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420267|NCT01505777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92420268|NCT01505777|Serotonin Agents|serotonin agents|mesh-ancestor
92420269|NCT01505777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420270|NCT01505777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420271|NCT01505777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420272|NCT01505790|Clopidogrel|clopidogrel|mesh-list
92420273|NCT01505790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92420274|NCT01505790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92420275|NCT01505790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92420276|NCT01505790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92420277|NCT01505790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92420278|NCT01505790|Purinergic Agents|purinergic agents|mesh-ancestor
92420279|NCT01505790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420280|NCT01505790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420311|NCT01505998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420313|NCT01505998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92420314|NCT01505998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420315|NCT01505998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420316|NCT01506011|Amlodipine|amlodipine|mesh-list
92420317|NCT01506011|Benazepril|benazepril|mesh-list
92420318|NCT01506011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420319|NCT01506011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92420320|NCT01506011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92420321|NCT01506011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420322|NCT01506011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92420324|NCT01506011|Vasodilator Agents|vasodilator agents|mesh-ancestor
92420325|NCT01506011|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92420326|NCT01506011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420327|NCT01506011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420328|NCT01506024|Tacrine|tacrine|mesh-list
92420329|NCT01506024|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92420330|NCT01506024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420331|NCT01506024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420332|NCT01506024|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420333|NCT01506024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420334|NCT01506024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420335|NCT01506024|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92420336|NCT01506024|Autonomic Agents|autonomic agents|mesh-ancestor
92420337|NCT01506024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420338|NCT01506024|Nootropic Agents|nootropic agents|mesh-ancestor
92420339|NCT01506037|Desloratadine|desloratadine|mesh-list
92420340|NCT01506037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92420341|NCT01506037|Cholinergic Agents|cholinergic agents|mesh-ancestor
92609217|NCT00139217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92420342|NCT01506037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420343|NCT01506037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420344|NCT01506037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420345|NCT01506037|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92420346|NCT01506037|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420347|NCT01506037|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420348|NCT01506037|Histamine Agents|histamine agents|mesh-ancestor
92420349|NCT01506050|Desloratadine|desloratadine|mesh-list
92420350|NCT01506050|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92420351|NCT01506050|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420352|NCT01506050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420353|NCT01506050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420354|NCT01506050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420355|NCT01506050|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92420356|NCT01506050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420357|NCT01506050|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420358|NCT01506050|Histamine Agents|histamine agents|mesh-ancestor
92420359|NCT01506063|Levocetirizine|levocetirizine|mesh-list
92420360|NCT01506063|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92420361|NCT01506063|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420362|NCT01506063|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420363|NCT01506063|Histamine Agents|histamine agents|mesh-ancestor
92420364|NCT01506063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420365|NCT01506063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420366|NCT01506063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420367|NCT01506076|Levocetirizine|levocetirizine|mesh-list
92420368|NCT01506076|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92420369|NCT01506076|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420370|NCT01506076|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420371|NCT01506076|Histamine Agents|histamine agents|mesh-ancestor
92420372|NCT01506076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420373|NCT01506076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420374|NCT01506076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420375|NCT01506115|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92420376|NCT01506115|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92420377|NCT01506115|Trioxsalen|trioxsalen|mesh-list
92420378|NCT01506115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420379|NCT01506115|Dermatologic Agents|dermatologic agents|mesh-ancestor
92420380|NCT01506115|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92420381|NCT01506167|Leucovorin|leucovorin|mesh-list
92420382|NCT01506167|Folic Acid|folic acid|mesh-list
92420383|NCT01506167|Bevacizumab|bevacizumab|mesh-list
92420384|NCT01506167|Fluorouracil|fluorouracil|mesh-list
92420385|NCT01506167|Capecitabine|capecitabine|mesh-list
92420386|NCT01506167|Oxaliplatin|oxaliplatin|mesh-list
92420387|NCT01506167|Irinotecan|irinotecan|mesh-list
92420388|NCT01506167|Levoleucovorin|levoleucovorin|mesh-list
92420389|NCT01506167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420390|NCT01506167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420391|NCT01506167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420392|NCT01506167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420393|NCT01506167|Growth Substances|growth substances|mesh-ancestor
92420394|NCT01506167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420395|NCT01506167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420396|NCT01506167|Antimetabolites|antimetabolites|mesh-ancestor
92420404|NCT01506167|Antidotes|antidotes|mesh-ancestor
92420405|NCT01506167|Protective Agents|protective agents|mesh-ancestor
92420406|NCT01506167|Vitamin B Complex|vitamin b complex|mesh-ancestor
92420407|NCT01506167|Vitamins|vitamins|mesh-ancestor
92420408|NCT01506167|Micronutrients|micronutrients|mesh-ancestor
92420409|NCT01506167|Hematinics|hematinics|mesh-ancestor
92420410|NCT01506336|Sunitinib|sunitinib|mesh-list
92420411|NCT01506336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420412|NCT01506336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420413|NCT01506336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420414|NCT01506336|Growth Substances|growth substances|mesh-ancestor
92420415|NCT01506336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420416|NCT01506336|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420417|NCT01506336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420418|NCT01506336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420419|NCT01506336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420421|NCT01506388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92609218|NCT00139217|Autonomic Agents|autonomic agents|mesh-ancestor
92609219|NCT00139217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609220|NCT00139217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609221|NCT00139217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92609222|NCT00139217|Respiratory System Agents|respiratory system agents|mesh-ancestor
92420422|NCT01506388|Abortifacient Agents|abortifacient agents|mesh-ancestor
92420423|NCT01506388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92420424|NCT01506388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420425|NCT01506388|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92420426|NCT01506388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420428|NCT01506414|Rituximab|rituximab|mesh-list
92420429|NCT01506414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420430|NCT01506414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420431|NCT01506414|Immunologic Factors|immunologic factors|mesh-ancestor
92420432|NCT01506414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420433|NCT01506414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92420434|NCT01506505|Aspirin|aspirin|mesh-list
92420435|NCT01506505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92420436|NCT01506505|Lisinopril|lisinopril|mesh-list
92420437|NCT01506505|Simvastatin|simvastatin|mesh-list
92420438|NCT01506505|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92420439|NCT01506505|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92420440|NCT01506505|Antimetabolites|antimetabolites|mesh-ancestor
92420441|NCT01506505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420442|NCT01506505|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92420443|NCT01506505|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92420444|NCT01506505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420445|NCT01506505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420446|NCT01506505|Diuretics|diuretics|mesh-ancestor
92420447|NCT01506505|Natriuretic Agents|natriuretic agents|mesh-ancestor
92420448|NCT01506505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420449|NCT01506505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92420450|NCT01506505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92420451|NCT01506505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92420452|NCT01506505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92420453|NCT01506505|Analgesics|analgesics|mesh-ancestor
92420454|NCT01506505|Sensory System Agents|sensory system agents|mesh-ancestor
92420455|NCT01506505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420456|NCT01506505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92420457|NCT01506505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92420458|NCT01506505|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92420459|NCT01506505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92420460|NCT01506505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92420461|NCT01506505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92420462|NCT01506505|Antipyretics|antipyretics|mesh-ancestor
92420463|NCT01506505|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92420464|NCT01506505|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420465|NCT01506505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92420466|NCT01506505|Protective Agents|protective agents|mesh-ancestor
92420468|NCT01506544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420469|NCT01506544|Antisickling Agents|antisickling agents|mesh-ancestor
92420470|NCT01506544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420471|NCT01506544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420472|NCT01506544|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92420473|NCT01506557|Cholecalciferol|cholecalciferol|mesh-list
92420474|NCT01506557|Vitamin D|vitamin d|mesh-list
92420475|NCT01506557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92420476|NCT01506557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420477|NCT01506557|Vitamins|vitamins|mesh-ancestor
92420478|NCT01506557|Micronutrients|micronutrients|mesh-ancestor
92420479|NCT01506557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92420480|NCT01506570|Vaccines|vaccines|mesh-list
92420481|NCT01506570|Immunologic Factors|immunologic factors|mesh-ancestor
92420482|NCT01506570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420483|NCT01506622|Fentanyl|fentanyl|mesh-list
92420484|NCT01506622|Propofol|propofol|mesh-list
92420485|NCT01506622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92420486|NCT01506622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420487|NCT01506622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609223|NCT00139217|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92609224|NCT00139217|Antioxidants|antioxidants|mesh-ancestor
92609225|NCT00139217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609226|NCT00139217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080032|NCT00457366|Lorazepam|lorazepam|mesh-list
92420488|NCT01506622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92420489|NCT01506622|Anesthetics, General|anesthetics, general|mesh-ancestor
92420490|NCT01506622|Anesthetics|anesthetics|mesh-ancestor
92420491|NCT01506622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92420492|NCT01506622|Narcotics|narcotics|mesh-ancestor
92420493|NCT01506622|Analgesics|analgesics|mesh-ancestor
92420494|NCT01506622|Sensory System Agents|sensory system agents|mesh-ancestor
92420495|NCT01506622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420496|NCT01506622|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92420497|NCT01506635|Timolol|timolol|mesh-list
92420498|NCT01506635|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92420499|NCT01506635|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92420500|NCT01506635|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420501|NCT01506635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420502|NCT01506635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420503|NCT01506635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420504|NCT01506635|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92420505|NCT01506635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420506|NCT01506713|Clopidogrel|clopidogrel|mesh-list
92420507|NCT01506713|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92420508|NCT01506713|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92420509|NCT01506713|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92420510|NCT01506713|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92420511|NCT01506713|Purinergic Agents|purinergic agents|mesh-ancestor
92420512|NCT01506713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420513|NCT01506713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420514|NCT01506713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420515|NCT01506739|Donepezil|donepezil|mesh-list
92420516|NCT01506739|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92420517|NCT01506739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420518|NCT01506739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420519|NCT01506739|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420520|NCT01506739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420521|NCT01506739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420522|NCT01506739|Nootropic Agents|nootropic agents|mesh-ancestor
92420523|NCT01506752|Donepezil|donepezil|mesh-list
92420524|NCT01506752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92420525|NCT01506752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420526|NCT01506752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420527|NCT01506752|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420528|NCT01506752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420529|NCT01506752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420530|NCT01506752|Nootropic Agents|nootropic agents|mesh-ancestor
92420531|NCT01506765|Acetylcysteine|acetylcysteine|mesh-list
92420532|NCT01506765|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92420533|NCT01506765|Antiviral Agents|antiviral agents|mesh-ancestor
92420534|NCT01506765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420535|NCT01506765|Expectorants|expectorants|mesh-ancestor
92420536|NCT01506765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92420537|NCT01506765|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92420538|NCT01506765|Antioxidants|antioxidants|mesh-ancestor
92420539|NCT01506765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420540|NCT01506765|Protective Agents|protective agents|mesh-ancestor
92420561|NCT01506791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92420562|NCT01506791|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92420563|NCT01506791|Sympathomimetics|sympathomimetics|mesh-ancestor
92420564|NCT01506791|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420565|NCT01506804|Methylprednisolone|methylprednisolone|mesh-list
92420566|NCT01506804|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92420567|NCT01506804|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92420568|NCT01506804|Prednisolone|prednisolone|mesh-list
92420569|NCT01506804|Prednisolone acetate|prednisolone acetate|mesh-list
92420570|NCT01506804|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92420571|NCT01506804|Prednisolone phosphate|prednisolone phosphate|mesh-list
92420572|NCT01506804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609227|NCT00139217|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92609228|NCT00139217|Vasodilator Agents|vasodilator agents|mesh-ancestor
92609229|NCT00139217|Gasotransmitters|gasotransmitters|mesh-ancestor
92609230|NCT00139217|Protective Agents|protective agents|mesh-ancestor
92609231|NCT00161226|Levonorgestrel|levonorgestrel|mesh-list
92609232|NCT00161226|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92420573|NCT01506804|Antiemetics|antiemetics|mesh-ancestor
92420574|NCT01506804|Autonomic Agents|autonomic agents|mesh-ancestor
92420575|NCT01506804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420576|NCT01506804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420577|NCT01506804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420578|NCT01506804|Glucocorticoids|glucocorticoids|mesh-ancestor
92420579|NCT01506804|Hormones|hormones|mesh-ancestor
92420580|NCT01506804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420581|NCT01506804|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92420582|NCT01506804|Protective Agents|protective agents|mesh-ancestor
92420583|NCT01506804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92420584|NCT01506804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420585|NCT01506895|Darapladib|darapladib|mesh-list
92420586|NCT01506895|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92420587|NCT01506895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420588|NCT01506895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420589|NCT01506921|Ketamine|ketamine|mesh-list
92420590|NCT01506921|Esketamine|esketamine|mesh-list
92420591|NCT01506921|Analgesics|analgesics|mesh-ancestor
92420592|NCT01506921|Sensory System Agents|sensory system agents|mesh-ancestor
92420593|NCT01506921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420594|NCT01506921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420595|NCT01506921|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92420596|NCT01506921|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92420605|NCT01506921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92420607|NCT01507064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420608|NCT01507064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420609|NCT01507064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420610|NCT01507064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420611|NCT01507077|CKD732|ckd732|mesh-list
92420612|NCT01507077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420613|NCT01507077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420614|NCT01507077|Growth Substances|growth substances|mesh-ancestor
92420615|NCT01507077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420616|NCT01507077|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420617|NCT01507077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420618|NCT01507194|Ondansetron|ondansetron|mesh-list
92420619|NCT01507194|Vestipitant|vestipitant|mesh-list
92420620|NCT01507194|Antiemetics|antiemetics|mesh-ancestor
92420621|NCT01507194|Autonomic Agents|autonomic agents|mesh-ancestor
92420622|NCT01507194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420623|NCT01507194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420624|NCT01507194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420625|NCT01507194|Antipruritics|antipruritics|mesh-ancestor
92420626|NCT01507194|Dermatologic Agents|dermatologic agents|mesh-ancestor
92420627|NCT01507194|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92420628|NCT01507194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92420629|NCT01507194|Serotonin Agents|serotonin agents|mesh-ancestor
92420630|NCT01507194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034865|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
92420631|NCT01507194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420632|NCT01507194|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92420633|NCT01507272|Liraglutide|liraglutide|mesh-list
92420634|NCT01507272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420635|NCT01507272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420636|NCT01507272|Incretins|incretins|mesh-ancestor
92420637|NCT01507272|Hormones|hormones|mesh-ancestor
92420638|NCT01507272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420639|NCT01507285|Liraglutide|liraglutide|mesh-list
92420640|NCT01507285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420641|NCT01507285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420642|NCT01507285|Incretins|incretins|mesh-ancestor
92420644|NCT01507285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420645|NCT01507311|Liraglutide|liraglutide|mesh-list
92609233|NCT00161226|Contraceptive Agents|contraceptive agents|mesh-ancestor
92609234|NCT00161226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609235|NCT00161226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609236|NCT00161226|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92420646|NCT01507311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420647|NCT01507311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420648|NCT01507311|Incretins|incretins|mesh-ancestor
92420649|NCT01507311|Hormones|hormones|mesh-ancestor
92420650|NCT01507311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420651|NCT01507337|Liraglutide|liraglutide|mesh-list
92420652|NCT01507337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420653|NCT01507337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420654|NCT01507337|Incretins|incretins|mesh-ancestor
92420655|NCT01507337|Hormones|hormones|mesh-ancestor
92420656|NCT01507337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420657|NCT01507363|Gabapentin|gabapentin|mesh-list
92420658|NCT01507363|Analgesics|analgesics|mesh-ancestor
92420659|NCT01507363|Sensory System Agents|sensory system agents|mesh-ancestor
92420660|NCT01507363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420661|NCT01507363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420662|NCT01507363|Anticonvulsants|anticonvulsants|mesh-ancestor
92420663|NCT01507363|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92420668|NCT01507363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92420669|NCT01507363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420670|NCT01507363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420671|NCT01507363|Antimanic Agents|antimanic agents|mesh-ancestor
92420672|NCT01507376|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92420673|NCT01507376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92420674|NCT01507376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420675|NCT01507389|Liraglutide|liraglutide|mesh-list
92420676|NCT01507389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420677|NCT01507389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420678|NCT01507389|Incretins|incretins|mesh-ancestor
92420679|NCT01507389|Hormones|hormones|mesh-ancestor
92420680|NCT01507389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420681|NCT01507428|Deoxyglucose|deoxyglucose|mesh-list
92420682|NCT01507428|Misonidazole|misonidazole|mesh-list
92420683|NCT01507428|Paclitaxel|paclitaxel|mesh-list
92420684|NCT01507428|Carboplatin|carboplatin|mesh-list
92420685|NCT01507428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92420686|NCT01507428|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92420687|NCT01507428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92420688|NCT01507428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420689|NCT01507428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92420690|NCT01507428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92420691|NCT01507428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92420692|NCT01507428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420693|NCT01507428|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92420694|NCT01507428|Antimetabolites|antimetabolites|mesh-ancestor
92420695|NCT01507428|Antiviral Agents|antiviral agents|mesh-ancestor
92420696|NCT01507428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420697|NCT01507428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92420698|NCT01507428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92420699|NCT01507454|Estradiol|estradiol|mesh-list
92420700|NCT01507454|Estrogens|estrogens|mesh-ancestor
92420701|NCT01507454|Hormones|hormones|mesh-ancestor
92420702|NCT01507454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420703|NCT01507454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420704|NCT01507467|Nimorazole|nimorazole|mesh-list
92420705|NCT01507467|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92420706|NCT01507467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92420707|NCT01507467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92420708|NCT01507467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420709|NCT01507480|Bevacizumab|bevacizumab|mesh-list
92420710|NCT01507480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420711|NCT01507480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420712|NCT01507480|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420713|NCT01507480|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420714|NCT01507480|Growth Substances|growth substances|mesh-ancestor
92420715|NCT01507480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420716|NCT01507480|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420717|NCT01507519|Sirolimus|sirolimus|mesh-list
92420718|NCT01507519|Temsirolimus|temsirolimus|mesh-list
92609237|NCT00161226|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92609238|NCT00161226|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92609240|NCT00139256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609241|NCT00139256|Glucocorticoids|glucocorticoids|mesh-ancestor
92609242|NCT00139256|Hormones|hormones|mesh-ancestor
92420719|NCT01507519|MTOR Inhibitors|mtor inhibitors|mesh-list
92420720|NCT01507519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92420721|NCT01507519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420722|NCT01507519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92420723|NCT01507519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420724|NCT01507519|Antifungal Agents|antifungal agents|mesh-ancestor
92420725|NCT01507519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92420726|NCT01507519|Immunologic Factors|immunologic factors|mesh-ancestor
92420727|NCT01507519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420728|NCT01507519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420729|NCT01507519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420730|NCT01507519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420731|NCT01507558|Dexamethasone|dexamethasone|mesh-list
92420732|NCT01507558|Dexamethasone acetate|dexamethasone acetate|mesh-list
92420733|NCT01507558|BB 1101|bb 1101|mesh-list
92420734|NCT01507558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92420735|NCT01507558|Antiemetics|antiemetics|mesh-ancestor
92420736|NCT01507558|Autonomic Agents|autonomic agents|mesh-ancestor
92420743|NCT01507558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92420744|NCT01507558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420745|NCT01507558|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420746|NCT01507558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420747|NCT01507558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420748|NCT01507571|Psychotropic Drugs|psychotropic drugs|mesh-list
92420749|NCT01507597|Glucagon|glucagon|mesh-list
92420750|NCT01507597|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92420751|NCT01507597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420752|NCT01507597|Hormones|hormones|mesh-ancestor
92420753|NCT01507597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420754|NCT01507597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420755|NCT01507597|Incretins|incretins|mesh-ancestor
92420756|NCT01507701|Clonidine|clonidine|mesh-list
92420757|NCT01507701|Analgesics|analgesics|mesh-ancestor
92420758|NCT01507701|Sensory System Agents|sensory system agents|mesh-ancestor
92420759|NCT01507701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420760|NCT01507701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420761|NCT01507701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420762|NCT01507701|Sympatholytics|sympatholytics|mesh-ancestor
92420763|NCT01507701|Autonomic Agents|autonomic agents|mesh-ancestor
92420764|NCT01507701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92420765|NCT01507701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92394791|NCT01386996|Hormones|hormones|mesh-ancestor
92420766|NCT01507701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92420767|NCT01507701|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420768|NCT01507701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420769|NCT01507701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420770|NCT01507727|Tolvaptan|tolvaptan|mesh-list
92420771|NCT01507727|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92420772|NCT01507727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420773|NCT01507727|Natriuretic Agents|natriuretic agents|mesh-ancestor
92420774|NCT01507727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420775|NCT01507740|Bevacizumab|bevacizumab|mesh-list
92420776|NCT01507740|Sorafenib|sorafenib|mesh-list
92420777|NCT01507740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420778|NCT01507740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420779|NCT01507740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420780|NCT01507740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420781|NCT01507740|Growth Substances|growth substances|mesh-ancestor
92420782|NCT01507740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420783|NCT01507740|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420784|NCT01507740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420785|NCT01507740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420786|NCT01507740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420787|NCT01507792|Loratadine|loratadine|mesh-list
92420788|NCT01507792|Omeprazole|omeprazole|mesh-list
92420789|NCT01507792|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92420790|NCT01507792|Histamine|histamine|mesh-list
92609243|NCT00139256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609245|NCT00139256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92420791|NCT01507792|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92420792|NCT01507792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420793|NCT01507792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420794|NCT01507792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420795|NCT01507792|Antipruritics|antipruritics|mesh-ancestor
92420796|NCT01507792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92420797|NCT01507792|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92420798|NCT01507792|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92420799|NCT01507792|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420800|NCT01507792|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420801|NCT01507792|Histamine Agents|histamine agents|mesh-ancestor
92420802|NCT01507792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420803|NCT01507792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420804|NCT01507792|Histamine Agonists|histamine agonists|mesh-ancestor
92420815|NCT01507974|Clavulanic Acid|clavulanic acid|mesh-list
92420816|NCT01507974|Cephalexin|cephalexin|mesh-list
92420817|NCT01507974|Cefuroxime|cefuroxime|mesh-list
92420818|NCT01507974|Nitrofurantoin|nitrofurantoin|mesh-list
92420819|NCT01507974|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92420820|NCT01507974|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92420821|NCT01507974|Trimethoprim|trimethoprim|mesh-list
92420822|NCT01507974|Sulfamethoxazole|sulfamethoxazole|mesh-list
92420823|NCT01507974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420824|NCT01507974|Antitubercular Agents|antitubercular agents|mesh-ancestor
92420825|NCT01507974|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92420826|NCT01507974|Antimalarials|antimalarials|mesh-ancestor
92420827|NCT01507974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92420828|NCT01507974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92420829|NCT01507974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92420830|NCT01507974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420831|NCT01507974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420832|NCT01507974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92420833|NCT01507974|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92420834|NCT01507974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92420835|NCT01507974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92420836|NCT01508000|Bevacizumab|bevacizumab|mesh-list
92420837|NCT01508000|Panitumumab|panitumumab|mesh-list
92420838|NCT01508000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420839|NCT01508000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420840|NCT01508000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420841|NCT01508000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420842|NCT01508000|Growth Substances|growth substances|mesh-ancestor
92420843|NCT01508000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420844|NCT01508000|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420845|NCT01508104|Everolimus|everolimus|mesh-list
92420846|NCT01508104|Dactolisib|dactolisib|mesh-list
92420847|NCT01508104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92420848|NCT01508104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420849|NCT01508104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420850|NCT01508104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420851|NCT01508104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92420852|NCT01508104|Immunologic Factors|immunologic factors|mesh-ancestor
92420853|NCT01508104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420854|NCT01508104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420855|NCT01507610|Sumatriptan|sumatriptan|mesh-list
92420856|NCT01507610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92420857|NCT01507610|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92420858|NCT01507610|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92420859|NCT01507610|Serotonin Agents|serotonin agents|mesh-ancestor
92420860|NCT01507610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420861|NCT01507610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420862|NCT01507610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420863|NCT01508143|Misoprostol|misoprostol|mesh-list
92420864|NCT01508143|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92420865|NCT01508143|Abortifacient Agents|abortifacient agents|mesh-ancestor
92420866|NCT01508143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92145550|NCT03513445|Epinephrine|epinephrine|mesh-list
92609246|NCT00139256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92609247|NCT00161304|Methyltestosterone|methyltestosterone|mesh-list
92609248|NCT00161304|Testosterone|testosterone|mesh-list
92609249|NCT00161304|Testosterone undecanoate|testosterone undecanoate|mesh-list
92609250|NCT00161304|Testosterone enanthate|testosterone enanthate|mesh-list
92609251|NCT00161304|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92609252|NCT00161304|Androgens|androgens|mesh-ancestor
92420867|NCT01508143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420868|NCT01508143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92420869|NCT01508143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420871|NCT01508182|Metformin|metformin|mesh-list
92420876|NCT01508182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420877|NCT01508195|Metformin|metformin|mesh-list
92420878|NCT01508195|Canagliflozin|canagliflozin|mesh-list
92420879|NCT01508195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420880|NCT01508195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420881|NCT01508195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92420882|NCT01508195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420883|NCT01508221|Vitamin E|vitamin e|mesh-list
92420884|NCT01508221|Pentoxifylline|pentoxifylline|mesh-list
92420885|NCT01508221|Vitamins|vitamins|mesh-ancestor
92420886|NCT01508221|Micronutrients|micronutrients|mesh-ancestor
92420887|NCT01508221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420888|NCT01508221|Antioxidants|antioxidants|mesh-ancestor
92420889|NCT01508221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420890|NCT01508221|Protective Agents|protective agents|mesh-ancestor
92420891|NCT01508221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92420892|NCT01508221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420893|NCT01508221|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92420894|NCT01508221|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92420895|NCT01508221|Vasodilator Agents|vasodilator agents|mesh-ancestor
92420896|NCT01508221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92420897|NCT01508260|Furosemide|furosemide|mesh-list
92420898|NCT01508260|Diuretics|diuretics|mesh-ancestor
92420899|NCT01508260|Natriuretic Agents|natriuretic agents|mesh-ancestor
92420900|NCT01508260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420901|NCT01508260|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92420902|NCT01508260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92420903|NCT01508260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420904|NCT01508286|Ribavirin|ribavirin|mesh-list
92420905|NCT01508286|Antimetabolites|antimetabolites|mesh-ancestor
92420906|NCT01508286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420907|NCT01508286|Antiviral Agents|antiviral agents|mesh-ancestor
92420908|NCT01508286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420909|NCT01508364|Sorafenib|sorafenib|mesh-list
92420910|NCT01508364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420911|NCT01508364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420912|NCT01508364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420913|NCT01508364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420914|NCT01508429|Misoprostol|misoprostol|mesh-list
92420915|NCT01508429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92420916|NCT01508429|Abortifacient Agents|abortifacient agents|mesh-ancestor
92420917|NCT01508429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92420918|NCT01508429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420919|NCT01508429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92420920|NCT01508429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420921|NCT01508429|Oxytocics|oxytocics|mesh-ancestor
92420922|NCT01508468|Rituximab|rituximab|mesh-list
92420923|NCT01508468|Angiotensin II|angiotensin ii|mesh-list
92420924|NCT01508468|Giapreza|giapreza|mesh-list
92420925|NCT01508468|Calcium|calcium|mesh-list
92420926|NCT01508468|Diuretics|diuretics|mesh-list
92420927|NCT01508468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92420928|NCT01508468|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92420929|NCT01508468|Angiotensinogen|angiotensinogen|mesh-list
92420930|NCT01508468|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92420931|NCT01508468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420932|NCT01508468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420933|NCT01508468|Immunologic Factors|immunologic factors|mesh-ancestor
92420934|NCT01508468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609253|NCT00161304|Hormones|hormones|mesh-ancestor
92609254|NCT00161304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609255|NCT00161304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609256|NCT00161304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92420935|NCT01508468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92420936|NCT01508468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92420937|NCT01508468|Natriuretic Agents|natriuretic agents|mesh-ancestor
92420938|NCT01508468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92420939|NCT01508468|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420940|NCT01508468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420941|NCT01508468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420942|NCT01508468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92420946|NCT01508468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420948|NCT01508494|Galantamine|galantamine|mesh-list
92420949|NCT01508494|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92420950|NCT01508494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420951|NCT01508494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420952|NCT01508494|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420953|NCT01508494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420954|NCT01508494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420955|NCT01508494|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92420956|NCT01508494|Autonomic Agents|autonomic agents|mesh-ancestor
92420957|NCT01508494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420958|NCT01508494|Nootropic Agents|nootropic agents|mesh-ancestor
92420959|NCT01508572|Bevacizumab|bevacizumab|mesh-list
92420960|NCT01508572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92420961|NCT01508572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420962|NCT01508572|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92420963|NCT01508572|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420964|NCT01508572|Growth Substances|growth substances|mesh-ancestor
92420965|NCT01508572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420966|NCT01508572|Growth Inhibitors|growth inhibitors|mesh-ancestor
92420967|NCT01508611|Fluorides|fluorides|mesh-list
92420968|NCT01508611|Cariostatic Agents|cariostatic agents|mesh-ancestor
92420969|NCT01508611|Protective Agents|protective agents|mesh-ancestor
92420970|NCT01508611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420971|NCT01508637|Terazosin|terazosin|mesh-list
92420972|NCT01508637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92420973|NCT01508637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92420974|NCT01508637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92420975|NCT01508637|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420976|NCT01508637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420977|NCT01508637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420978|NCT01508637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420979|NCT01508637|Urological Agents|urological agents|mesh-ancestor
92420980|NCT01508663|Everolimus|everolimus|mesh-list
92394811|NCT01387087|Peficitinib|peficitinib|mesh-list
92420981|NCT01508663|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92420982|NCT01508663|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92420983|NCT01508663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92420984|NCT01508663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420985|NCT01508663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420986|NCT01508663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92420987|NCT01508663|Immunologic Factors|immunologic factors|mesh-ancestor
92420988|NCT01508663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420989|NCT01508663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420990|NCT01508663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420991|NCT01508741|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92420992|NCT01508741|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92420993|NCT01508741|Dermatologic Agents|dermatologic agents|mesh-ancestor
92420994|NCT01508806|Liraglutide|liraglutide|mesh-list
92420995|NCT01508806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420996|NCT01508806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420997|NCT01508806|Incretins|incretins|mesh-ancestor
92420998|NCT01508806|Hormones|hormones|mesh-ancestor
92420999|NCT01508806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421000|NCT01508845|Vitamin D|vitamin d|mesh-list
92421001|NCT01508845|Ergocalciferols|ergocalciferols|mesh-list
92421002|NCT01508845|Cholecalciferol|cholecalciferol|mesh-list
92421003|NCT01508845|Vitamins|vitamins|mesh-list
92609257|NCT00161304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609258|NCT00161304|Anabolic Agents|anabolic agents|mesh-ancestor
92421004|NCT01508845|Micronutrients|micronutrients|mesh-ancestor
92421005|NCT01508845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421006|NCT01508845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92421007|NCT01508845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92421008|NCT01508858|Liraglutide|liraglutide|mesh-list
92421009|NCT01508858|Levonorgestrel|levonorgestrel|mesh-list
92421010|NCT01508858|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92421011|NCT01508858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421012|NCT01508858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421013|NCT01508858|Incretins|incretins|mesh-ancestor
92421014|NCT01508858|Hormones|hormones|mesh-ancestor
92421016|NCT01508858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92421017|NCT01508858|Contraceptive Agents|contraceptive agents|mesh-ancestor
92421018|NCT01508858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92421019|NCT01508858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92421020|NCT01508858|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92421021|NCT01508858|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92421022|NCT01508858|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92421023|NCT01508858|Estrogens|estrogens|mesh-ancestor
92421024|NCT01508884|Imiquimod|imiquimod|mesh-list
92421025|NCT01508884|Vaccines|vaccines|mesh-list
92421026|NCT01508884|Immunologic Factors|immunologic factors|mesh-ancestor
92421027|NCT01508884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421028|NCT01508884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92421029|NCT01508884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421030|NCT01508884|Interferon Inducers|interferon inducers|mesh-ancestor
92421031|NCT01508897|Liraglutide|liraglutide|mesh-list
92421032|NCT01508897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421033|NCT01508897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421034|NCT01508897|Incretins|incretins|mesh-ancestor
92421035|NCT01508897|Hormones|hormones|mesh-ancestor
92421036|NCT01508897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421037|NCT01508923|Liraglutide|liraglutide|mesh-list
92421038|NCT01508923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421039|NCT01508923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421040|NCT01508923|Incretins|incretins|mesh-ancestor
92421041|NCT01508923|Hormones|hormones|mesh-ancestor
92421042|NCT01508923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421043|NCT01508949|Liraglutide|liraglutide|mesh-list
92421044|NCT01508949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421045|NCT01508949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421046|NCT01508949|Incretins|incretins|mesh-ancestor
92421047|NCT01508949|Hormones|hormones|mesh-ancestor
92421048|NCT01508949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421049|NCT01509001|Metformin|metformin|mesh-list
92421050|NCT01509001|Glimepiride|glimepiride|mesh-list
92421051|NCT01509001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421052|NCT01509001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421053|NCT01509001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421054|NCT01509001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421055|NCT01509001|Immunologic Factors|immunologic factors|mesh-ancestor
92421056|NCT01509131|Bisacodyl|bisacodyl|mesh-list
92421057|NCT01509131|Cathartics|cathartics|mesh-ancestor
92421058|NCT01509131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421059|NCT01509131|Laxatives|laxatives|mesh-ancestor
92421060|NCT01509144|Vaccines|vaccines|mesh-list
92421061|NCT01509144|Immunologic Factors|immunologic factors|mesh-ancestor
92421062|NCT01509144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421063|NCT01509209|Pseudoephedrine|pseudoephedrine|mesh-list
92421064|NCT01509209|Ephedrine|ephedrine|mesh-list
92421065|NCT01509209|Levocetirizine|levocetirizine|mesh-list
92421066|NCT01509209|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92421067|NCT01509209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92421068|NCT01509209|Histamine Antagonists|histamine antagonists|mesh-ancestor
92421069|NCT01509209|Histamine Agents|histamine agents|mesh-ancestor
92421070|NCT01509209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421071|NCT01509209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421072|NCT01509209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421073|NCT01509209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92421074|NCT01509209|Autonomic Agents|autonomic agents|mesh-ancestor
92421075|NCT01509209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421076|NCT01509209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92421077|NCT01509209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92421078|NCT01509209|Nasal Decongestants|nasal decongestants|mesh-ancestor
92609259|NCT01242748|Goserelin|goserelin|mesh-list
92609260|NCT01242748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92609261|NCT01242748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609262|NCT00139373|Donepezil|donepezil|mesh-list
92421079|NCT01509209|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92421080|NCT01509209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92421081|NCT01509209|Sympathomimetics|sympathomimetics|mesh-ancestor
92421082|NCT01509209|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421083|NCT01509261|Lansoprazole|lansoprazole|mesh-list
92421084|NCT01509261|Dexlansoprazole|dexlansoprazole|mesh-list
92421085|NCT01509261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92421086|NCT01509261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421087|NCT01509261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92421088|NCT01509261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421102|NCT01509300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421103|NCT01509300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421104|NCT01509300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92421105|NCT01509300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92421106|NCT01509300|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92421107|NCT01509300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421108|NCT01509300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92421109|NCT01509300|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92421110|NCT01509300|Antitubercular Agents|antitubercular agents|mesh-ancestor
92421111|NCT01509300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92421112|NCT01509300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421114|NCT01509365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92421115|NCT01509365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92421116|NCT01509365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92421117|NCT01509365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92421118|NCT01509365|Purinergic Agents|purinergic agents|mesh-ancestor
92421119|NCT01509365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421120|NCT01509365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421121|NCT01509365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421122|NCT01509391|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92421123|NCT01509391|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92421124|NCT01509391|Immunologic Factors|immunologic factors|mesh-ancestor
92421125|NCT01509391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421126|NCT01509469|Caseins|caseins|mesh-list
92421127|NCT01509469|Chelating Agents|chelating agents|mesh-ancestor
92421128|NCT01509469|Sequestering Agents|sequestering agents|mesh-ancestor
92421129|NCT01509469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421130|NCT01509521|Phenylephrine|phenylephrine|mesh-list
92421131|NCT01509521|Oxymetazoline|oxymetazoline|mesh-list
92421132|NCT01509521|Ephedrine|ephedrine|mesh-list
92421133|NCT01509521|Pseudoephedrine|pseudoephedrine|mesh-list
92421134|NCT01509521|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92421135|NCT01509521|Mydriatics|mydriatics|mesh-ancestor
92421136|NCT01509521|Autonomic Agents|autonomic agents|mesh-ancestor
92421137|NCT01509521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421138|NCT01509521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421139|NCT01509521|Sympathomimetics|sympathomimetics|mesh-ancestor
92421140|NCT01509521|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92421141|NCT01509521|Nasal Decongestants|nasal decongestants|mesh-ancestor
92421142|NCT01509521|Respiratory System Agents|respiratory system agents|mesh-ancestor
92421143|NCT01509521|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92421144|NCT01509521|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92421145|NCT01509521|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92421146|NCT01509521|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421147|NCT01509521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421148|NCT01509521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421154|NCT01509560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92421155|NCT01509560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92421156|NCT01509560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421157|NCT01509560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421158|NCT01509560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421159|NCT01509560|Immunologic Factors|immunologic factors|mesh-ancestor
92421160|NCT01509560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421161|NCT01509560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421162|NCT01509599|Methyl salicylate|methyl salicylate|mesh-list
92421163|NCT01509599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92421164|NCT01509742|Liraglutide|liraglutide|mesh-list
92609263|NCT00139373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92080671|NCT01452789|Morphine|morphine|mesh-list
92421165|NCT01509742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421166|NCT01509742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421167|NCT01509742|Incretins|incretins|mesh-ancestor
92421168|NCT01509742|Hormones|hormones|mesh-ancestor
92421169|NCT01509742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421170|NCT01509755|Liraglutide|liraglutide|mesh-list
92421171|NCT01509755|Glimepiride|glimepiride|mesh-list
92421172|NCT01509755|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421173|NCT01509755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421174|NCT01509755|Incretins|incretins|mesh-ancestor
92421175|NCT01509755|Hormones|hormones|mesh-ancestor
92421176|NCT01509755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421177|NCT01509755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421178|NCT01509755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421179|NCT01509755|Immunologic Factors|immunologic factors|mesh-ancestor
92421180|NCT01509911|Gemcitabine|gemcitabine|mesh-list
92421181|NCT01509911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92421182|NCT01509911|Antimetabolites|antimetabolites|mesh-ancestor
92421183|NCT01509911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421184|NCT01509911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421185|NCT01509976|Triclosan|triclosan|mesh-list
92421186|NCT01509976|Triclocarban|triclocarban|mesh-list
92421187|NCT01509976|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92421188|NCT01509976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421189|NCT01509976|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92421190|NCT01509976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92421191|NCT01509976|Antimetabolites|antimetabolites|mesh-ancestor
92421192|NCT01509976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421193|NCT01509976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92421194|NCT01510015|Risperidone|risperidone|mesh-list
92421195|NCT01510015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92421196|NCT01510015|Serotonin Agents|serotonin agents|mesh-ancestor
92421197|NCT01510015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421198|NCT01510015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421199|NCT01510015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421200|NCT01510015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92421201|NCT01510015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92421202|NCT01510015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421203|NCT01510015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92421204|NCT01510015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92421205|NCT01510015|Dopamine Agents|dopamine agents|mesh-ancestor
92421206|NCT01510093|Insulin Aspart|insulin aspart|mesh-list
92421207|NCT01510093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421208|NCT01510093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421209|NCT01510132|Timolol|timolol|mesh-list
92421210|NCT01510132|Travoprost|travoprost|mesh-list
92421211|NCT01510132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92421212|NCT01510132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92421213|NCT01510132|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421214|NCT01510132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421215|NCT01510132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421216|NCT01510132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421217|NCT01510132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421218|NCT01510132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92421219|NCT01510171|Ticagrelor|ticagrelor|mesh-list
92421229|NCT01510288|Ipilimumab|ipilimumab|mesh-list
92421230|NCT01510288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92421231|NCT01510288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421232|NCT01510288|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92421233|NCT01510288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421234|NCT01510366|Vaccines|vaccines|mesh-list
92421235|NCT01510366|Immunologic Factors|immunologic factors|mesh-ancestor
92421236|NCT01510366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421237|NCT01510431|Remestemcel-l|remestemcel-l|mesh-list
92421238|NCT01510431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421239|NCT01510431|Antiviral Agents|antiviral agents|mesh-ancestor
92421240|NCT01510431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421241|NCT01510509|Everolimus|everolimus|mesh-list
92421242|NCT01510509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92421243|NCT01510509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92421244|NCT01510509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421245|NCT01510509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609264|NCT00139373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609265|NCT00139373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421246|NCT01510509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421247|NCT01510509|Immunologic Factors|immunologic factors|mesh-ancestor
92421248|NCT01510509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421249|NCT01510509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421251|NCT01510522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421252|NCT01510522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421253|NCT01510548|Adalimumab|adalimumab|mesh-list
92421254|NCT01510548|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92421255|NCT01510548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421256|NCT01510548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92421257|NCT01510561|Gemcitabine|gemcitabine|mesh-list
92421258|NCT01510561|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92421259|NCT01510561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92421260|NCT01510561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92421261|NCT01510561|Antimetabolites|antimetabolites|mesh-ancestor
92421262|NCT01510561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421263|NCT01510561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421264|NCT01510561|Chelating Agents|chelating agents|mesh-ancestor
92421265|NCT01510561|Sequestering Agents|sequestering agents|mesh-ancestor
92421266|NCT01510561|Immunologic Factors|immunologic factors|mesh-ancestor
92421267|NCT01510561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421268|NCT01510574|Misoprostol|misoprostol|mesh-list
92421269|NCT01510574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92421270|NCT01510574|Abortifacient Agents|abortifacient agents|mesh-ancestor
92421271|NCT01510574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92421272|NCT01510574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421273|NCT01510574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92421274|NCT01510574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421275|NCT01510574|Oxytocics|oxytocics|mesh-ancestor
92421276|NCT01510613|Dexamethasone|dexamethasone|mesh-list
92421277|NCT01510613|Pomalidomide|pomalidomide|mesh-list
92421278|NCT01510613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421279|NCT01510613|Antiemetics|antiemetics|mesh-ancestor
92421280|NCT01510613|Autonomic Agents|autonomic agents|mesh-ancestor
92421281|NCT01510613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421282|NCT01510613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421283|NCT01510613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421284|NCT01510613|Glucocorticoids|glucocorticoids|mesh-ancestor
92421297|NCT01510626|Respiratory System Agents|respiratory system agents|mesh-ancestor
92421298|NCT01510665|Magnesium citrate|magnesium citrate|mesh-list
92421299|NCT01510665|Cathartics|cathartics|mesh-ancestor
92421300|NCT01510665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421301|NCT01510795|Spironolactone|spironolactone|mesh-list
92421302|NCT01510795|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92421303|NCT01510795|Hormone Antagonists|hormone antagonists|mesh-ancestor
92421304|NCT01510795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421305|NCT01510795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421306|NCT01510795|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92421307|NCT01510795|Diuretics|diuretics|mesh-ancestor
92421308|NCT01510795|Natriuretic Agents|natriuretic agents|mesh-ancestor
92421309|NCT01510847|Testosterone undecanoate|testosterone undecanoate|mesh-list
92421310|NCT01510847|Androgens|androgens|mesh-ancestor
92421311|NCT01510847|Hormones|hormones|mesh-ancestor
92421312|NCT01510847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421313|NCT01510847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421314|NCT01510860|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92421315|NCT01510860|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92421316|NCT01510860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421317|NCT01510977|Bisacodyl|bisacodyl|mesh-list
92421318|NCT01510977|Cathartics|cathartics|mesh-ancestor
92421319|NCT01510977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421320|NCT01510977|Laxatives|laxatives|mesh-ancestor
92421321|NCT01510990|Gefitinib|gefitinib|mesh-list
92421322|NCT01510990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421323|NCT01510990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92421324|NCT01510990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421325|NCT01510990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421326|NCT01511003|Tacrolimus|tacrolimus|mesh-list
92421327|NCT01511003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421328|NCT01511003|Immunologic Factors|immunologic factors|mesh-ancestor
92609266|NCT00139373|Cholinergic Agents|cholinergic agents|mesh-ancestor
92609267|NCT00139373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421329|NCT01511003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421330|NCT01511003|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92421331|NCT01511003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421332|NCT01511003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421333|NCT01511029|Moxifloxacin|moxifloxacin|mesh-list
92421334|NCT01511029|Pramipexole|pramipexole|mesh-list
92421335|NCT01511029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92421336|NCT01511029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421337|NCT01511029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92421338|NCT01511029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92421339|NCT01511029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421340|NCT01511029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421341|NCT01511029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421342|NCT01511029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421343|NCT01511029|Antioxidants|antioxidants|mesh-ancestor
92421344|NCT01511029|Protective Agents|protective agents|mesh-ancestor
92421345|NCT01511029|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92421346|NCT01511029|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92421347|NCT01511029|Dopamine Agonists|dopamine agonists|mesh-ancestor
92421351|NCT01511146|Oxaliplatin|oxaliplatin|mesh-list
92421352|NCT01511146|Mitomycins|mitomycins|mesh-list
92421353|NCT01511146|Mitomycin|mitomycin|mesh-list
92421354|NCT01511146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92421355|NCT01511146|Antimetabolites|antimetabolites|mesh-ancestor
92421356|NCT01511146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421357|NCT01511146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421358|NCT01511146|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92421359|NCT01511146|Alkylating Agents|alkylating agents|mesh-ancestor
92421360|NCT01511146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92421361|NCT01511146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421362|NCT01511159|Insulin|insulin|mesh-list
92421363|NCT01511159|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92421364|NCT01511159|Liraglutide|liraglutide|mesh-list
92421365|NCT01511159|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421366|NCT01511159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421367|NCT01511159|Incretins|incretins|mesh-ancestor
92421368|NCT01511159|Hormones|hormones|mesh-ancestor
92421369|NCT01511159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421370|NCT01511172|Metformin|metformin|mesh-list
92421371|NCT01511172|Liraglutide|liraglutide|mesh-list
92421372|NCT01511172|Glimepiride|glimepiride|mesh-list
92394832|NCT01387295|Capecitabine|capecitabine|mesh-list
92421373|NCT01511172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421374|NCT01511172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421375|NCT01511172|Incretins|incretins|mesh-ancestor
92421376|NCT01511172|Hormones|hormones|mesh-ancestor
92421377|NCT01511172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421378|NCT01511172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421379|NCT01511172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421380|NCT01511172|Immunologic Factors|immunologic factors|mesh-ancestor
92421381|NCT01511185|Liraglutide|liraglutide|mesh-list
92421382|NCT01511185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421383|NCT01511185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421384|NCT01511185|Incretins|incretins|mesh-ancestor
92421385|NCT01511185|Hormones|hormones|mesh-ancestor
92421386|NCT01511185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421387|NCT01511198|Metformin|metformin|mesh-list
92421388|NCT01511198|Liraglutide|liraglutide|mesh-list
92421389|NCT01511198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421390|NCT01511198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421391|NCT01511198|Incretins|incretins|mesh-ancestor
92421392|NCT01511198|Hormones|hormones|mesh-ancestor
92421393|NCT01511198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421394|NCT01511211|Dexamethasone|dexamethasone|mesh-list
92421395|NCT01511211|Ropivacaine|ropivacaine|mesh-list
92421396|NCT01511211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421398|NCT01511211|Autonomic Agents|autonomic agents|mesh-ancestor
92421399|NCT01511211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421400|NCT01511211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421401|NCT01511211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421402|NCT01511211|Glucocorticoids|glucocorticoids|mesh-ancestor
92421403|NCT01511211|Hormones|hormones|mesh-ancestor
92421404|NCT01511211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421405|NCT01511211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92609268|NCT00139373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609269|NCT00139373|Nootropic Agents|nootropic agents|mesh-ancestor
92609270|NCT00161421|Leuprolide|leuprolide|mesh-list
92609271|NCT00161421|Testosterone|testosterone|mesh-list
92609272|NCT00161421|Dutasteride|dutasteride|mesh-list
92609273|NCT00161421|Androgens|androgens|mesh-ancestor
92421406|NCT01511211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421407|NCT01511211|Anesthetics, Local|anesthetics, local|mesh-ancestor
92421408|NCT01511211|Anesthetics|anesthetics|mesh-ancestor
92421409|NCT01511211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421410|NCT01511211|Sensory System Agents|sensory system agents|mesh-ancestor
92421411|NCT01511237|Lamivudine|lamivudine|mesh-list
92421412|NCT01511237|Zidovudine|zidovudine|mesh-list
92421413|NCT01511237|Nevirapine|nevirapine|mesh-list
92421414|NCT01511237|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92421415|NCT01511237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92421416|NCT01511237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421417|NCT01511237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421418|NCT01511237|Antiviral Agents|antiviral agents|mesh-ancestor
92421419|NCT01511237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421420|NCT01511237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92421421|NCT01511237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92421422|NCT01511237|Antimetabolites|antimetabolites|mesh-ancestor
92421423|NCT01511237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92421427|NCT01511263|Diuretics|diuretics|mesh-list
92421428|NCT01511263|Natriuretic Agents|natriuretic agents|mesh-ancestor
92421429|NCT01511263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421430|NCT01511263|Vasodilator Agents|vasodilator agents|mesh-ancestor
92421431|NCT01511263|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92421432|NCT01511263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92421433|NCT01511263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421434|NCT01511263|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92421435|NCT01511263|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92421436|NCT01511263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92421437|NCT01511263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421438|NCT01511263|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92421439|NCT01511263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92421440|NCT01511263|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92421441|NCT01511289|Imatinib Mesylate|imatinib mesylate|mesh-list
92421442|NCT01511289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421443|NCT01511289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92421444|NCT01511289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421445|NCT01511289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421446|NCT01511302|Budesonide|budesonide|mesh-list
92421447|NCT01511302|RNS60|rns60|mesh-list
92421448|NCT01511302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421449|NCT01511302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92421450|NCT01511302|Autonomic Agents|autonomic agents|mesh-ancestor
92421451|NCT01511302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421452|NCT01511302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421453|NCT01511302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92421454|NCT01511302|Respiratory System Agents|respiratory system agents|mesh-ancestor
92421455|NCT01511302|Glucocorticoids|glucocorticoids|mesh-ancestor
92421456|NCT01511302|Hormones|hormones|mesh-ancestor
92421457|NCT01511302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421458|NCT01511302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92421459|NCT01511302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421460|NCT01511302|Analgesics|analgesics|mesh-ancestor
92421461|NCT01511302|Sensory System Agents|sensory system agents|mesh-ancestor
92421462|NCT01511302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92421463|NCT01511302|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92421464|NCT01511367|Fluticasone|fluticasone|mesh-list
92421465|NCT01511367|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92421466|NCT01511367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92421467|NCT01511367|Autonomic Agents|autonomic agents|mesh-ancestor
92421468|NCT01511367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146148|NCT00087685|Everolimus|everolimus|mesh-list
92421469|NCT01511367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421470|NCT01511367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92421471|NCT01511367|Respiratory System Agents|respiratory system agents|mesh-ancestor
92609274|NCT00161421|Hormones|hormones|mesh-ancestor
92609275|NCT00161421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609276|NCT00161421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609277|NCT00161421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080993|NCT00497770|Pemetrexed|pemetrexed|mesh-list
92421472|NCT01511367|Glucocorticoids|glucocorticoids|mesh-ancestor
92421474|NCT01511367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421475|NCT01511367|Sympathomimetics|sympathomimetics|mesh-ancestor
92421476|NCT01511367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421477|NCT01511367|Dermatologic Agents|dermatologic agents|mesh-ancestor
92421478|NCT01511367|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92421479|NCT01511471|Ticagrelor|ticagrelor|mesh-list
92421480|NCT01511471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92421481|NCT01511471|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92421482|NCT01511471|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92421483|NCT01511471|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92421484|NCT01511471|Purinergic Agents|purinergic agents|mesh-ancestor
92421485|NCT01511471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421486|NCT01511471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421487|NCT01511471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421488|NCT01511562|Cytarabine|cytarabine|mesh-list
92421489|NCT01511562|Etoposide|etoposide|mesh-list
92421490|NCT01511562|Thiotepa|thiotepa|mesh-list
92421491|NCT01511562|Carmustine|carmustine|mesh-list
92421492|NCT01511562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92421493|NCT01511562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421494|NCT01511562|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92421518|NCT01511692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421519|NCT01511692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421520|NCT01511692|Immunologic Factors|immunologic factors|mesh-ancestor
92421521|NCT01511705|Ondansetron|ondansetron|mesh-list
92421522|NCT01511705|Antiemetics|antiemetics|mesh-ancestor
92421523|NCT01511705|Autonomic Agents|autonomic agents|mesh-ancestor
92421524|NCT01511705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421525|NCT01511705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421526|NCT01511705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421527|NCT01511705|Antipruritics|antipruritics|mesh-ancestor
92421528|NCT01511705|Dermatologic Agents|dermatologic agents|mesh-ancestor
92421529|NCT01511705|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92421530|NCT01511705|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92421531|NCT01511705|Serotonin Agents|serotonin agents|mesh-ancestor
92421532|NCT01511705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421533|NCT01511705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421534|NCT01511718|Ondansetron|ondansetron|mesh-list
92421535|NCT01511718|Antiemetics|antiemetics|mesh-ancestor
92421536|NCT01511718|Autonomic Agents|autonomic agents|mesh-ancestor
92421537|NCT01511718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421538|NCT01511718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421539|NCT01511718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421540|NCT01511718|Antipruritics|antipruritics|mesh-ancestor
92421541|NCT01511718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92421542|NCT01511718|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92421543|NCT01511718|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92421544|NCT01511718|Serotonin Agents|serotonin agents|mesh-ancestor
92421545|NCT01511718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421546|NCT01511718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421550|NCT01511731|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92421551|NCT01511731|Histamine Antagonists|histamine antagonists|mesh-ancestor
92421553|NCT01511731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421554|NCT01511731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421555|NCT01511731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421556|NCT01511757|Fluconazole|fluconazole|mesh-list
92421557|NCT01511757|Antifungal Agents|antifungal agents|mesh-ancestor
92421558|NCT01511757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421559|NCT01511757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92421560|NCT01511757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92421561|NCT01511757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421562|NCT01511757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609278|NCT00161421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609279|NCT00161421|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92609280|NCT00161421|Fertility Agents|fertility agents|mesh-ancestor
92421563|NCT01511757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92421564|NCT01511757|Hormone Antagonists|hormone antagonists|mesh-ancestor
92421565|NCT01511757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421566|NCT01511757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421567|NCT01511757|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92421568|NCT01511757|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92421569|NCT01511770|Fluconazole|fluconazole|mesh-list
92421570|NCT01511770|Antifungal Agents|antifungal agents|mesh-ancestor
92421571|NCT01511770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421572|NCT01511770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92421573|NCT01511770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92421574|NCT01511770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421575|NCT01511770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421576|NCT01511770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92421577|NCT01511770|Hormone Antagonists|hormone antagonists|mesh-ancestor
92421578|NCT01511770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421579|NCT01511770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421580|NCT01511770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92421581|NCT01511770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92421582|NCT01511822|Inositol|inositol|mesh-list
92421583|NCT01511822|Drospirenone|drospirenone|mesh-list
92421584|NCT01511822|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92421585|NCT01511822|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92421586|NCT01511822|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92421587|NCT01511822|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92421588|NCT01511822|Estradiol|estradiol|mesh-list
92421589|NCT01511822|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92421590|NCT01511822|Estrogens|estrogens|mesh-ancestor
92421591|NCT01511822|Hormones|hormones|mesh-ancestor
92421592|NCT01511822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421593|NCT01511822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421594|NCT01511822|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92421595|NCT01511822|Contraceptive Agents|contraceptive agents|mesh-ancestor
92421596|NCT01511822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92421597|NCT01511822|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92421598|NCT01511822|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92421599|NCT01511822|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92421600|NCT01511822|Vitamin B Complex|vitamin b complex|mesh-ancestor
92421601|NCT01511822|Vitamins|vitamins|mesh-ancestor
92421602|NCT01511822|Micronutrients|micronutrients|mesh-ancestor
92421603|NCT01511822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92421604|NCT01511822|Hormone Antagonists|hormone antagonists|mesh-ancestor
92421605|NCT01511822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92421606|NCT01511822|Diuretics|diuretics|mesh-ancestor
92421607|NCT01511822|Natriuretic Agents|natriuretic agents|mesh-ancestor
92421608|NCT01511835|Folic Acid|folic acid|mesh-list
92421609|NCT01511835|Vitamin B Complex|vitamin b complex|mesh-list
92421610|NCT01511835|Inositol|inositol|mesh-list
92421611|NCT01511835|Hematinics|hematinics|mesh-ancestor
92421612|NCT01511835|Vitamins|vitamins|mesh-ancestor
92421613|NCT01511835|Micronutrients|micronutrients|mesh-ancestor
92421614|NCT01511835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421615|NCT01511848|Deferasirox|deferasirox|mesh-list
92421616|NCT01511848|Deferiprone|deferiprone|mesh-list
92421617|NCT01511848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92421620|NCT01511848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421623|NCT01511874|Fertility Agents|fertility agents|mesh-ancestor
92421624|NCT01511874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92421625|NCT01511874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421626|NCT01511874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92421627|NCT01511874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421628|NCT01511887|Ibuprofen|ibuprofen|mesh-list
92421629|NCT01511887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92421630|NCT01511887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421631|NCT01511887|Analgesics|analgesics|mesh-ancestor
92421632|NCT01511887|Sensory System Agents|sensory system agents|mesh-ancestor
92421633|NCT01511887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421634|NCT01511887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609281|NCT00161421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609282|NCT00161421|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92609283|NCT00161421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92421635|NCT01511887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421636|NCT01511887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92421637|NCT01511887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92421638|NCT01511887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421639|NCT01511887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421640|NCT01511991|Sevoflurane|sevoflurane|mesh-list
92421641|NCT01511991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92421642|NCT01511991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92421643|NCT01511991|Anesthetics, General|anesthetics, general|mesh-ancestor
92421644|NCT01511991|Anesthetics|anesthetics|mesh-ancestor
92421645|NCT01511991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421646|NCT01511991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421647|NCT01512004|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92421648|NCT01512004|Propiverine|propiverine|mesh-list
92421649|NCT01512004|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92421650|NCT01512004|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92421651|NCT01512004|Cholinergic Agents|cholinergic agents|mesh-ancestor
92421652|NCT01512004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421653|NCT01512004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421654|NCT01512004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421655|NCT01512004|Urological Agents|urological agents|mesh-ancestor
92421656|NCT01512004|Parasympatholytics|parasympatholytics|mesh-ancestor
92421657|NCT01512004|Autonomic Agents|autonomic agents|mesh-ancestor
92421658|NCT01512004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421659|NCT01512017|Petrolatum|petrolatum|mesh-list
92421660|NCT01512017|Emollients|emollients|mesh-ancestor
92421661|NCT01512017|Dermatologic Agents|dermatologic agents|mesh-ancestor
92421662|NCT01512147|Dexmedetomidine|dexmedetomidine|mesh-list
92421663|NCT01512147|Propofol|propofol|mesh-list
92421664|NCT01512147|Isoflurane|isoflurane|mesh-list
92421665|NCT01512147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92421666|NCT01512147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421667|NCT01512147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421668|NCT01512147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421669|NCT01512147|Analgesics|analgesics|mesh-ancestor
92421670|NCT01512147|Sensory System Agents|sensory system agents|mesh-ancestor
92421671|NCT01512147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421672|NCT01512147|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92421673|NCT01512147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92421674|NCT01512147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92421675|NCT01512147|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421676|NCT01512147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421677|NCT01512147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421678|NCT01512147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92421679|NCT01512147|Anesthetics, General|anesthetics, general|mesh-ancestor
92421680|NCT01512147|Anesthetics|anesthetics|mesh-ancestor
92421681|NCT01512147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92421682|NCT01512173|Propranolol|propranolol|mesh-list
92421683|NCT01512173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92421684|NCT01512173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92421685|NCT01512173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421686|NCT01512173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421687|NCT01512173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421688|NCT01512173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421689|NCT01512173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421690|NCT01512173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92421701|NCT01512199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421702|NCT01512199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92421704|NCT01512199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421705|NCT01512355|Dexmedetomidine|dexmedetomidine|mesh-list
92421706|NCT01512355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92421707|NCT01512355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421708|NCT01512355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421709|NCT01512355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421710|NCT01512355|Analgesics|analgesics|mesh-ancestor
92421711|NCT01512355|Sensory System Agents|sensory system agents|mesh-ancestor
92421712|NCT01512355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609284|NCT00161421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609285|NCT00161421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609286|NCT00161421|Hormone Antagonists|hormone antagonists|mesh-ancestor
92609287|NCT00139568|Tegaserod|tegaserod|mesh-list
92609288|NCT00139568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92421713|NCT01512355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92421714|NCT01512355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92421715|NCT01512355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92421716|NCT01512355|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421717|NCT01512355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421718|NCT01512355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421719|NCT01512459|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92421720|NCT01512459|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92421721|NCT01512459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92421722|NCT01512459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92421723|NCT01512459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421724|NCT01512459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421725|NCT01512459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421726|NCT01512459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92421727|NCT01512459|Antidepressive Agents|antidepressive agents|mesh-ancestor
92421728|NCT01512459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92421729|NCT01512485|Clopidogrel|clopidogrel|mesh-list
92421730|NCT01512485|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92421731|NCT01512485|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92421732|NCT01512485|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92421733|NCT01512485|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92421734|NCT01512485|Purinergic Agents|purinergic agents|mesh-ancestor
92421735|NCT01512485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421736|NCT01512485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421737|NCT01512485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421738|NCT01512511|Nitrous Oxide|nitrous oxide|mesh-list
92421739|NCT01512511|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92421740|NCT01512511|Anesthetics, General|anesthetics, general|mesh-ancestor
92421741|NCT01512511|Anesthetics|anesthetics|mesh-ancestor
92421742|NCT01512511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421743|NCT01512511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421744|NCT01512511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421745|NCT01512511|Analgesics|analgesics|mesh-ancestor
92421746|NCT01512511|Sensory System Agents|sensory system agents|mesh-ancestor
92421747|NCT01512511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421748|NCT01512537|Vitamin D|vitamin d|mesh-list
92421749|NCT01512537|Ergocalciferols|ergocalciferols|mesh-list
92421750|NCT01512537|Cholecalciferol|cholecalciferol|mesh-list
92421751|NCT01512537|Vitamins|vitamins|mesh-list
92421752|NCT01512537|Micronutrients|micronutrients|mesh-ancestor
92421753|NCT01512537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421770|NCT01512862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421771|NCT01512862|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92421773|NCT01512862|Micronutrients|micronutrients|mesh-ancestor
92421774|NCT01512862|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92421775|NCT01512901|Betamethasone|betamethasone|mesh-list
92421776|NCT01512901|Betamethasone Valerate|betamethasone valerate|mesh-list
92421777|NCT01512901|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92421778|NCT01512901|Betamethasone benzoate|betamethasone benzoate|mesh-list
92421779|NCT01512901|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92421780|NCT01512901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421781|NCT01512901|Glucocorticoids|glucocorticoids|mesh-ancestor
92421782|NCT01512901|Hormones|hormones|mesh-ancestor
92421783|NCT01512901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421784|NCT01512901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421785|NCT01512901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92421786|NCT01512901|Respiratory System Agents|respiratory system agents|mesh-ancestor
92421787|NCT01512914|Ropivacaine|ropivacaine|mesh-list
92421788|NCT01512914|Anesthetics, Local|anesthetics, local|mesh-ancestor
92421789|NCT01512914|Anesthetics|anesthetics|mesh-ancestor
92421790|NCT01512914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421791|NCT01512914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609289|NCT00139568|Serotonin Agents|serotonin agents|mesh-ancestor
92609290|NCT00139568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609291|NCT00139568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609292|NCT00139568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421792|NCT01512914|Sensory System Agents|sensory system agents|mesh-ancestor
92421793|NCT01512914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421794|NCT01512953|Lansoprazole|lansoprazole|mesh-list
92421795|NCT01512953|Dexlansoprazole|dexlansoprazole|mesh-list
92421796|NCT01512953|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92421797|NCT01512953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421798|NCT01512953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92421799|NCT01512953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421800|NCT01512953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421801|NCT01512966|Aflibercept|aflibercept|mesh-list
92421802|NCT01512966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92421803|NCT01512966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92421804|NCT01512966|Growth Substances|growth substances|mesh-ancestor
92421805|NCT01512966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421806|NCT01512966|Growth Inhibitors|growth inhibitors|mesh-ancestor
92421807|NCT01512966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394875|NCT01387880|Everolimus|everolimus|mesh-list
92421808|NCT01513044|Mycophenolic Acid|mycophenolic acid|mesh-list
92421809|NCT01513044|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92421810|NCT01513044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421811|NCT01513044|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92421824|NCT01513057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421825|NCT01513057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421827|NCT01513070|Isosorbide|isosorbide|mesh-list
92421828|NCT01513070|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92421829|NCT01513070|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92421830|NCT01513070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92421831|NCT01513070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421832|NCT01513070|Analgesics|analgesics|mesh-ancestor
92421833|NCT01513070|Sensory System Agents|sensory system agents|mesh-ancestor
92421834|NCT01513070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421835|NCT01513070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421836|NCT01513070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92421837|NCT01513070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92421838|NCT01513070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92421839|NCT01513070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92421840|NCT01513070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421841|NCT01513070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92421842|NCT01513070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92421843|NCT01513070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421844|NCT01513070|Antipyretics|antipyretics|mesh-ancestor
92421845|NCT01513070|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92421846|NCT01513070|Diuretics|diuretics|mesh-ancestor
92421847|NCT01513070|Natriuretic Agents|natriuretic agents|mesh-ancestor
92421848|NCT01513070|Vasodilator Agents|vasodilator agents|mesh-ancestor
92421849|NCT01513070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92421850|NCT01513083|Trastuzumab|trastuzumab|mesh-list
92421851|NCT01513083|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92421852|NCT01513083|Maytansine|maytansine|mesh-list
92421853|NCT01513083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92421854|NCT01513083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421855|NCT01513083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92421856|NCT01513083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92421857|NCT01513083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92421858|NCT01513083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92421859|NCT01513083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421860|NCT01513083|Immunotoxins|immunotoxins|mesh-ancestor
92421861|NCT01513083|Immunoconjugates|immunoconjugates|mesh-ancestor
92421862|NCT01513083|Immunologic Factors|immunologic factors|mesh-ancestor
92421863|NCT01513083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421864|NCT01513174|Olaparib|olaparib|mesh-list
92421865|NCT01513174|Gefitinib|gefitinib|mesh-list
92421866|NCT01513174|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92421867|NCT01513174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421868|NCT01513174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421869|NCT01513174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609295|NCT00139646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92609296|NCT00139646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609297|NCT00139646|Analgesics|analgesics|mesh-ancestor
92081372|NCT00555880|Midodrine|midodrine|mesh-list
92421870|NCT01513174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92421871|NCT01513200|Heparin|heparin|mesh-list
92421872|NCT01513200|Calcium heparin|calcium heparin|mesh-list
92421873|NCT01513200|Anticoagulants|anticoagulants|mesh-ancestor
92421874|NCT01513200|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92421890|NCT01513564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92421891|NCT01513564|Narcotics|narcotics|mesh-ancestor
92421892|NCT01513564|Analgesics|analgesics|mesh-ancestor
92421893|NCT01513564|Sensory System Agents|sensory system agents|mesh-ancestor
92421894|NCT01513564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421895|NCT01513603|Cytarabine|cytarabine|mesh-list
92421896|NCT01513603|Mitoxantrone|mitoxantrone|mesh-list
92421897|NCT01513603|Cladribine|cladribine|mesh-list
92421898|NCT01513603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92421899|NCT01513603|Antimetabolites|antimetabolites|mesh-ancestor
92421900|NCT01513603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421901|NCT01513603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421902|NCT01513603|Antiviral Agents|antiviral agents|mesh-ancestor
92421903|NCT01513603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421904|NCT01513603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421905|NCT01513603|Immunologic Factors|immunologic factors|mesh-ancestor
92421906|NCT01513603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421907|NCT01513603|Analgesics|analgesics|mesh-ancestor
92421908|NCT01513603|Sensory System Agents|sensory system agents|mesh-ancestor
92421909|NCT01513603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421910|NCT01513603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92421911|NCT01513603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92421912|NCT01513603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421913|NCT01513668|Acetaminophen|acetaminophen|mesh-list
92146590|NCT01677949|Alkylating Agents|alkylating agents|mesh-ancestor
92421914|NCT01513668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421915|NCT01513668|Analgesics|analgesics|mesh-ancestor
92421916|NCT01513668|Sensory System Agents|sensory system agents|mesh-ancestor
92421917|NCT01513668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421918|NCT01513668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421919|NCT01513668|Antipyretics|antipyretics|mesh-ancestor
92421920|NCT01513681|Lamotrigine|lamotrigine|mesh-list
92421921|NCT01513681|Anticonvulsants|anticonvulsants|mesh-ancestor
92421922|NCT01513681|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92421923|NCT01513681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92421924|NCT01513681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421925|NCT01513681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92421926|NCT01513681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421927|NCT01513681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92421928|NCT01513681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92421929|NCT01513681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421930|NCT01513681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92421931|NCT01513681|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92421932|NCT01513720|Lamotrigine|lamotrigine|mesh-list
92421933|NCT01513720|Anticonvulsants|anticonvulsants|mesh-ancestor
92421934|NCT01513720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92421943|NCT01513720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92421944|NCT01513772|Dexmedetomidine|dexmedetomidine|mesh-list
92421945|NCT01513772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92421946|NCT01513772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421947|NCT01513772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421948|NCT01513772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92421949|NCT01513772|Analgesics|analgesics|mesh-ancestor
92421950|NCT01513772|Sensory System Agents|sensory system agents|mesh-ancestor
92421951|NCT01513772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421952|NCT01513772|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92421953|NCT01513772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92421954|NCT01513772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92421955|NCT01513772|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421956|NCT01513772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421957|NCT01513772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421958|NCT01513785|Amoxicillin|amoxicillin|mesh-list
92609298|NCT00139646|Sensory System Agents|sensory system agents|mesh-ancestor
92609299|NCT00139646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081443|NCT05559268|Denosumab|denosumab|mesh-list
92421959|NCT01513785|Rabeprazole|rabeprazole|mesh-list
92421960|NCT01513785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92421961|NCT01513785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421962|NCT01513785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92421963|NCT01513785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421964|NCT01513785|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92421965|NCT01513785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421966|NCT01513785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421967|NCT01513811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92421968|NCT01513863|Metronidazole|metronidazole|mesh-list
92421969|NCT01513863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421970|NCT01513863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92421971|NCT01513863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92421972|NCT01513863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92421973|NCT01513941|Interferons|interferons|mesh-list
92421974|NCT01513941|Ribavirin|ribavirin|mesh-list
92421975|NCT01513941|Interferon-alpha|interferon-alpha|mesh-list
92421976|NCT01513941|Interferon alpha-2|interferon alpha-2|mesh-list
92421977|NCT01513941|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92421978|NCT01513941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421979|NCT01513941|Antiviral Agents|antiviral agents|mesh-ancestor
92421980|NCT01513941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421981|NCT01513941|Antimetabolites|antimetabolites|mesh-ancestor
92421982|NCT01513941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421983|NCT01513941|Immunologic Factors|immunologic factors|mesh-ancestor
92421984|NCT01513941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421985|NCT01514019|Acebutolol|acebutolol|mesh-list
92421986|NCT01514019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92421987|NCT01514019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92421988|NCT01514019|Sympathomimetics|sympathomimetics|mesh-ancestor
92421989|NCT01514019|Autonomic Agents|autonomic agents|mesh-ancestor
92421990|NCT01514019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92421991|NCT01514019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421992|NCT01514019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92421993|NCT01514019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92421994|NCT01514019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92421995|NCT01514019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92421996|NCT01514019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421997|NCT01514019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421998|NCT01514110|Paclitaxel|paclitaxel|mesh-list
92421999|NCT01514110|Carboplatin|carboplatin|mesh-list
92422000|NCT01514110|Everolimus|everolimus|mesh-list
92422032|NCT01514175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422033|NCT01514175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422034|NCT01514188|Doxorubicin|doxorubicin|mesh-list
92422035|NCT01514188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92422036|NCT01514188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422037|NCT01514188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422038|NCT01514188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422039|NCT01514188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422040|NCT01514188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422041|NCT01514227|Aspirin|aspirin|mesh-list
92422042|NCT01514227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92422043|NCT01514227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422048|NCT01514227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422049|NCT01514227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422050|NCT01514227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92422051|NCT01514227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422052|NCT01514227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422053|NCT01514227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92422054|NCT01514227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92422055|NCT01514227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422056|NCT01514227|Antipyretics|antipyretics|mesh-ancestor
92422057|NCT01514266|Curcumin|curcumin|mesh-list
92422058|NCT01514266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92422059|NCT01514266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422060|NCT01514266|Analgesics|analgesics|mesh-ancestor
92422061|NCT01514266|Sensory System Agents|sensory system agents|mesh-ancestor
92422062|NCT01514266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422063|NCT01514266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609300|NCT00139646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609301|NCT00139646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609302|NCT00139646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609303|NCT00139646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92422064|NCT01514266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422065|NCT01514266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422066|NCT01514266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422067|NCT01514266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422068|NCT01514266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422069|NCT01514409|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92422070|NCT01514409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92422071|NCT01514409|Antidepressive Agents|antidepressive agents|mesh-ancestor
92422072|NCT01514409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92422073|NCT01514487|Liraglutide|liraglutide|mesh-list
92422074|NCT01514487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422075|NCT01514487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422076|NCT01514487|Incretins|incretins|mesh-ancestor
92422077|NCT01514487|Hormones|hormones|mesh-ancestor
92422078|NCT01514487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422079|NCT01514695|Fentanyl|fentanyl|mesh-list
92422080|NCT01514695|Midazolam|midazolam|mesh-list
92422081|NCT01514695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92422082|NCT01514695|Narcotics|narcotics|mesh-ancestor
92422083|NCT01514695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422084|NCT01514695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422085|NCT01514695|Analgesics|analgesics|mesh-ancestor
92422086|NCT01514695|Sensory System Agents|sensory system agents|mesh-ancestor
92422087|NCT01514695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422088|NCT01514695|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92422089|NCT01514695|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92422090|NCT01514695|Anesthetics, General|anesthetics, general|mesh-ancestor
92422091|NCT01514695|Anesthetics|anesthetics|mesh-ancestor
92422092|NCT01514695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92422093|NCT01514695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92422094|NCT01514695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92422095|NCT01514695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92422096|NCT01514695|GABA Modulators|gaba modulators|mesh-ancestor
92422097|NCT01514695|GABA Agents|gaba agents|mesh-ancestor
92422098|NCT01514695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422099|NCT01514695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422100|NCT01514721|Timolol|timolol|mesh-list
92422101|NCT01514721|Travoprost|travoprost|mesh-list
92422102|NCT01514721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422103|NCT01514721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92422104|NCT01514721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92422105|NCT01514721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92422106|NCT01514721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422107|NCT01514721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422108|NCT01514721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92422109|NCT01514721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92422110|NCT01514812|Digoxin|digoxin|mesh-list
92422111|NCT01514812|Darexaban|darexaban|mesh-list
92422112|NCT01514812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92422113|NCT01514812|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92422114|NCT01514812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422115|NCT01514812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422117|NCT01514812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422118|NCT01514812|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92422119|NCT01514812|Antithrombins|antithrombins|mesh-ancestor
92422120|NCT01514812|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92422121|NCT01514812|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422122|NCT01514812|Anticoagulants|anticoagulants|mesh-ancestor
92422124|NCT01514825|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92422125|NCT01514825|Antithrombins|antithrombins|mesh-ancestor
92422126|NCT01514825|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92422127|NCT01514825|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422128|NCT01514825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422129|NCT01514825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422130|NCT01514825|Anticoagulants|anticoagulants|mesh-ancestor
92422131|NCT01514838|Acarbose|acarbose|mesh-list
92422132|NCT01514838|Ipragliflozin|ipragliflozin|mesh-list
92422133|NCT01514838|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92609304|NCT00139646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609305|NCT00139646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609306|NCT00139646|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92609307|NCT00406302|Docetaxel|docetaxel|mesh-list
92609308|NCT00406302|Oxaliplatin|oxaliplatin|mesh-list
92609309|NCT00406302|Cetuximab|cetuximab|mesh-list
92609310|NCT00406302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422134|NCT01514838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422135|NCT01514838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422136|NCT01514838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422137|NCT01514838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422138|NCT01514838|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92422139|NCT01514851|Calcium Carbonate|calcium carbonate|mesh-list
92422140|NCT01514851|Calcium|calcium|mesh-list
92717876|NCT04623021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422141|NCT01514851|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92422142|NCT01514851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422143|NCT01514851|Antacids|antacids|mesh-ancestor
92422144|NCT01514851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422145|NCT01514851|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92422146|NCT01514929|Moxifloxacin|moxifloxacin|mesh-list
92422147|NCT01514929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422148|NCT01514929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422149|NCT01514929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422150|NCT01514929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422151|NCT01514929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422152|NCT01514929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422153|NCT01514929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422154|NCT01514942|Folic Acid|folic acid|mesh-list
92422155|NCT01514942|Vitamin B Complex|vitamin b complex|mesh-list
92422156|NCT01514942|Hydroxocobalamin|hydroxocobalamin|mesh-list
92422157|NCT01514942|Vitamin B 12|vitamin b 12|mesh-list
92422158|NCT01514942|Inositol|inositol|mesh-list
92422159|NCT01514942|Manganese|manganese|mesh-list
92422160|NCT01514942|Hematinics|hematinics|mesh-ancestor
92422161|NCT01514942|Vitamins|vitamins|mesh-ancestor
92422162|NCT01514942|Micronutrients|micronutrients|mesh-ancestor
92422163|NCT01514942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422164|NCT01514942|Trace Elements|trace elements|mesh-ancestor
92422165|NCT01514968|Cyclosporine|cyclosporine|mesh-list
92422166|NCT01514968|Ritonavir|ritonavir|mesh-list
92422167|NCT01514968|Cyclosporins|cyclosporins|mesh-list
92422168|NCT01514968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422169|NCT01514968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422170|NCT01514968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422171|NCT01514968|Immunologic Factors|immunologic factors|mesh-ancestor
92422172|NCT01514968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422173|NCT01514968|Antifungal Agents|antifungal agents|mesh-ancestor
92422174|NCT01514968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422175|NCT01514968|Dermatologic Agents|dermatologic agents|mesh-ancestor
92422176|NCT01514968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422177|NCT01514968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92422178|NCT01514968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92422179|NCT01514968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92422180|NCT01514968|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422181|NCT01514968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92422182|NCT01514968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92422183|NCT01514968|Antiviral Agents|antiviral agents|mesh-ancestor
92422184|NCT01514968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92422185|NCT01514968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92422186|NCT01514981|Mogamulizumab|mogamulizumab|mesh-list
92422187|NCT01514981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422188|NCT01515020|Vancomycin|vancomycin|mesh-list
92422189|NCT01515020|Daptomycin|daptomycin|mesh-list
92422190|NCT01515020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422191|NCT01515020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422206|NCT01515228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422207|NCT01515228|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92422208|NCT01515228|Autonomic Agents|autonomic agents|mesh-ancestor
92422209|NCT01515228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422210|NCT01515228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92609311|NCT00406302|Tubulin Modulators|tubulin modulators|mesh-ancestor
92609312|NCT00406302|Antimitotic Agents|antimitotic agents|mesh-ancestor
92609313|NCT00406302|Mitosis Modulators|mitosis modulators|mesh-ancestor
92609314|NCT00406302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609315|NCT00406302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016491|NCT03063541|Analgesics|analgesics|mesh-ancestor
92422211|NCT01515228|Respiratory System Agents|respiratory system agents|mesh-ancestor
92422212|NCT01515228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92422213|NCT01515228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422214|NCT01515228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92422215|NCT01515228|Vasodilator Agents|vasodilator agents|mesh-ancestor
92422216|NCT01515228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92422217|NCT01515228|Protective Agents|protective agents|mesh-ancestor
92422218|NCT01515228|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92422219|NCT01515228|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92422220|NCT01515371|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92422221|NCT01515371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92422222|NCT01515371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422223|NCT01515371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422224|NCT01515371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92422225|NCT01515371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92422226|NCT01515371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422227|NCT01515371|Cholinergic Agents|cholinergic agents|mesh-ancestor
92422228|NCT01515371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422230|NCT01515397|Plasma Substitutes|plasma substitutes|mesh-ancestor
92422231|NCT01515397|Blood Substitutes|blood substitutes|mesh-ancestor
92422232|NCT01515553|Liraglutide|liraglutide|mesh-list
92422233|NCT01515553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422234|NCT01515553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422235|NCT01515553|Incretins|incretins|mesh-ancestor
92422237|NCT01515553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422238|NCT01515579|Liraglutide|liraglutide|mesh-list
92422239|NCT01515579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422240|NCT01515579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422241|NCT01515579|Incretins|incretins|mesh-ancestor
92422242|NCT01515579|Hormones|hormones|mesh-ancestor
92422243|NCT01515579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422244|NCT01515592|Liraglutide|liraglutide|mesh-list
92422245|NCT01515592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422246|NCT01515592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422247|NCT01515592|Incretins|incretins|mesh-ancestor
92422248|NCT01515592|Hormones|hormones|mesh-ancestor
92422249|NCT01515592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422250|NCT01515683|Anesthetics|anesthetics|mesh-list
92422251|NCT01515683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422252|NCT01515683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422253|NCT01515774|Pramipexole|pramipexole|mesh-list
92422254|NCT01515774|Antioxidants|antioxidants|mesh-ancestor
92422261|NCT01515774|Dopamine Agents|dopamine agents|mesh-ancestor
92422262|NCT01515774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422263|NCT01515813|Tenofovir|tenofovir|mesh-list
92422264|NCT01515813|Emtricitabine|emtricitabine|mesh-list
92422265|NCT01515813|Efavirenz|efavirenz|mesh-list
92422266|NCT01515813|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92422267|NCT01515813|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92422268|NCT01515813|Pravastatin|pravastatin|mesh-list
92422269|NCT01515813|Antiviral Agents|antiviral agents|mesh-ancestor
92422270|NCT01515813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422271|NCT01515813|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92422272|NCT01515813|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92422273|NCT01515813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422274|NCT01515813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422275|NCT01515813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92422276|NCT01515813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92422277|NCT01515813|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92422278|NCT01515813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92609316|NCT00139685|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92609317|NCT00139685|Contraceptive Agents|contraceptive agents|mesh-list
92609318|NCT00139685|Medroxyprogesterone|medroxyprogesterone|mesh-list
92609319|NCT00139685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609320|NCT00139685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609321|NCT00139685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92609322|NCT00139685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92422279|NCT01515813|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92422280|NCT01515813|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92422281|NCT01515813|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92408079|NCT01448642|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92422282|NCT01515813|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92422283|NCT01515813|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92422284|NCT01515813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92422285|NCT01515813|Antimetabolites|antimetabolites|mesh-ancestor
92422286|NCT01515813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92422287|NCT01515813|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92422288|NCT01515826|Moxifloxacin|moxifloxacin|mesh-list
92422289|NCT01515826|Dexamethasone|dexamethasone|mesh-list
92422290|NCT01515826|Dexamethasone acetate|dexamethasone acetate|mesh-list
92422291|NCT01515826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92422292|NCT01515826|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92422293|NCT01515826|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92422294|NCT01515826|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92422296|NCT01515826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422297|NCT01515826|Antiemetics|antiemetics|mesh-ancestor
92422298|NCT01515826|Autonomic Agents|autonomic agents|mesh-ancestor
92422299|NCT01515826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422300|NCT01515826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422301|NCT01515826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92422302|NCT01515826|Glucocorticoids|glucocorticoids|mesh-ancestor
92422303|NCT01515826|Hormones|hormones|mesh-ancestor
92422304|NCT01515826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422305|NCT01515826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92422306|NCT01515826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422307|NCT01515826|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422308|NCT01515826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422309|NCT01515826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422310|NCT01515826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422311|NCT01515826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422312|NCT01515826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422313|NCT01515826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422314|NCT01515826|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92422315|NCT01515826|Contraceptive Agents|contraceptive agents|mesh-ancestor
92422316|NCT01515826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92422317|NCT01515826|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92422318|NCT01515826|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92422319|NCT01515826|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92422320|NCT01515839|Thioctic Acid|thioctic acid|mesh-list
92422323|NCT01515839|Vinpocetine|vinpocetine|mesh-list
92422324|NCT01515839|Huperzine A|huperzine a|mesh-list
92422325|NCT01515839|Antioxidants|antioxidants|mesh-ancestor
92422326|NCT01515839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422327|NCT01515839|Protective Agents|protective agents|mesh-ancestor
92422328|NCT01515839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422329|NCT01515839|Vitamin B Complex|vitamin b complex|mesh-ancestor
92422330|NCT01515839|Vitamins|vitamins|mesh-ancestor
92422331|NCT01515839|Micronutrients|micronutrients|mesh-ancestor
92422332|NCT01515839|Nootropic Agents|nootropic agents|mesh-ancestor
92422333|NCT01515839|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92422334|NCT01515839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422335|NCT01515839|Cholinergic Agents|cholinergic agents|mesh-ancestor
92422336|NCT01515839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422337|NCT01515839|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92422338|NCT01515839|Antiviral Agents|antiviral agents|mesh-ancestor
92422339|NCT01515839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422340|NCT01515839|Expectorants|expectorants|mesh-ancestor
92609323|NCT00139685|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92609324|NCT00139685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92422341|NCT01515839|Respiratory System Agents|respiratory system agents|mesh-ancestor
92422342|NCT01515839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92422343|NCT01515839|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92422344|NCT01515839|Vasodilator Agents|vasodilator agents|mesh-ancestor
92422345|NCT01515852|Anesthetics|anesthetics|mesh-list
92422346|NCT01515852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422347|NCT01515852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422348|NCT01515917|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92422349|NCT01515917|Nootropic Agents|nootropic agents|mesh-ancestor
92422350|NCT01515969|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92422351|NCT01515969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422352|NCT01515969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92422353|NCT01515969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422354|NCT01515969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422355|NCT01516060|Efavirenz|efavirenz|mesh-list
92422356|NCT01516060|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92422357|NCT01516060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92422358|NCT01516060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422359|NCT01516060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422360|NCT01516060|Antiviral Agents|antiviral agents|mesh-ancestor
92422361|NCT01516060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422362|NCT01516060|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92422363|NCT01516060|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92422364|NCT01516060|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92717877|NCT04623021|Immunologic Factors|immunologic factors|mesh-ancestor
92147043|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
92422365|NCT01516060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92422366|NCT01516060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92422367|NCT01516060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92422368|NCT01516138|Insulin|insulin|mesh-list
92422369|NCT01516138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422370|NCT01516138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422371|NCT01516255|Liraglutide|liraglutide|mesh-list
92422372|NCT01516255|Moxifloxacin|moxifloxacin|mesh-list
92422373|NCT01516255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422374|NCT01516255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422375|NCT01516255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422376|NCT01516255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422377|NCT01516255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422378|NCT01516255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422379|NCT01516255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422380|NCT01516255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422381|NCT01516255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422382|NCT01516255|Incretins|incretins|mesh-ancestor
92422383|NCT01516255|Hormones|hormones|mesh-ancestor
92422384|NCT01516255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422385|NCT01514903|Sildenafil Citrate|sildenafil citrate|mesh-list
92422386|NCT01514903|Vasodilator Agents|vasodilator agents|mesh-ancestor
92422387|NCT01514903|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92422388|NCT01514903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92422389|NCT01514903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422390|NCT01514903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422391|NCT01514903|Urological Agents|urological agents|mesh-ancestor
92422406|NCT01516372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92422407|NCT01516372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92422408|NCT01516450|Belimumab|belimumab|mesh-list
92422409|NCT01516450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422410|NCT01516450|Immunologic Factors|immunologic factors|mesh-ancestor
92422411|NCT01516450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422412|NCT01516463|Bacitracin|bacitracin|mesh-list
92422413|NCT01516463|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92422414|NCT01516463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422415|NCT01516463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422416|NCT01516554|Methyltestosterone|methyltestosterone|mesh-list
92422417|NCT01516554|Testosterone|testosterone|mesh-list
92422418|NCT01516554|Testosterone undecanoate|testosterone undecanoate|mesh-list
92422419|NCT01516554|Testosterone enanthate|testosterone enanthate|mesh-list
92609325|NCT00139685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609326|NCT00139685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92422420|NCT01516554|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92422421|NCT01516554|Androgens|androgens|mesh-ancestor
92422422|NCT01516554|Hormones|hormones|mesh-ancestor
92422423|NCT01516554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422424|NCT01516554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422425|NCT01516554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92422426|NCT01516554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422427|NCT01516554|Anabolic Agents|anabolic agents|mesh-ancestor
92422428|NCT01516567|Cyclophosphamide|cyclophosphamide|mesh-list
92422429|NCT01516567|Rituximab|rituximab|mesh-list
92422430|NCT01516567|Doxorubicin|doxorubicin|mesh-list
92422431|NCT01516567|Etoposide|etoposide|mesh-list
92422432|NCT01516567|Vincristine|vincristine|mesh-list
92422433|NCT01516567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422434|NCT01516567|Immunologic Factors|immunologic factors|mesh-ancestor
92422435|NCT01516567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422436|NCT01516567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422437|NCT01516567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92422438|NCT01516567|Alkylating Agents|alkylating agents|mesh-ancestor
92422439|NCT01516567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422440|NCT01516567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422441|NCT01516567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92422442|NCT01516567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92422443|NCT01516567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92422444|NCT01516567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422445|NCT01516567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422446|NCT01516567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422447|NCT01516567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92422448|NCT01516567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422449|NCT01516567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422450|NCT01516567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422452|NCT01516580|Cyclophosphamide|cyclophosphamide|mesh-list
92422474|NCT01516580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92422475|NCT01516580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92422476|NCT01516580|Antimetabolites|antimetabolites|mesh-ancestor
92422477|NCT01516580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92422478|NCT01516580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92422479|NCT01516580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92422480|NCT01516580|Antiviral Agents|antiviral agents|mesh-ancestor
92422481|NCT01516580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422482|NCT01516580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92422483|NCT01516580|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422484|NCT01516580|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422485|NCT01516580|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422486|NCT01516710|Liver Extracts|liver extracts|mesh-list
92422487|NCT01516710|Hematinics|hematinics|mesh-ancestor
92422488|NCT01516723|Sirolimus|sirolimus|mesh-list
92422489|NCT01516723|Everolimus|everolimus|mesh-list
92422490|NCT01516723|MTOR Inhibitors|mtor inhibitors|mesh-list
92422491|NCT01516723|Temsirolimus|temsirolimus|mesh-list
92422492|NCT01516723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92422493|NCT01516723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422494|NCT01516723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422495|NCT01516723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422496|NCT01516723|Immunologic Factors|immunologic factors|mesh-ancestor
92422497|NCT01516723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422498|NCT01516723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422499|NCT01516723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422500|NCT01516723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422501|NCT01516723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92422502|NCT01516723|Antifungal Agents|antifungal agents|mesh-ancestor
92422503|NCT01516762|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92422504|NCT01516762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422505|NCT01516814|Heparin|heparin|mesh-list
92422506|NCT01516814|Calcium heparin|calcium heparin|mesh-list
92422507|NCT01516814|Warfarin|warfarin|mesh-list
92422508|NCT01516814|Rivaroxaban|rivaroxaban|mesh-list
92422534|NCT01516866|Cariostatic Agents|cariostatic agents|mesh-ancestor
92422535|NCT01516866|Protective Agents|protective agents|mesh-ancestor
92422536|NCT01516866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422537|NCT01516866|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92422538|NCT01516866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422539|NCT01516996|Docetaxel|docetaxel|mesh-list
92609328|NCT00139685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92609330|NCT00406341|Glucocorticoids|glucocorticoids|mesh-ancestor
92422540|NCT01516996|Nimotuzumab|nimotuzumab|mesh-list
92422541|NCT01516996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422542|NCT01516996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422543|NCT01516996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422544|NCT01516996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422545|NCT01516996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422546|NCT01516996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92422547|NCT01517009|Docetaxel|docetaxel|mesh-list
92422548|NCT01517009|Capecitabine|capecitabine|mesh-list
92422549|NCT01517009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422550|NCT01517009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422551|NCT01517009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422552|NCT01517009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422553|NCT01517009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422554|NCT01517009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92422555|NCT01517009|Antimetabolites|antimetabolites|mesh-ancestor
92422556|NCT01517022|Nicotine|nicotine|mesh-list
92422557|NCT01517022|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92422558|NCT01517022|Autonomic Agents|autonomic agents|mesh-ancestor
92422559|NCT01517022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422560|NCT01517022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422561|NCT01517022|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92422575|NCT01517308|Antiviral Agents|antiviral agents|mesh-ancestor
92422576|NCT01517308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422577|NCT01517308|Antimetabolites|antimetabolites|mesh-ancestor
92422578|NCT01517308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422579|NCT01517308|Immunologic Factors|immunologic factors|mesh-ancestor
92422580|NCT01517308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422581|NCT01517321|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92422582|NCT01517321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422583|NCT01517321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422584|NCT01517321|Incretins|incretins|mesh-ancestor
92422585|NCT01517321|Hormones|hormones|mesh-ancestor
92422586|NCT01517321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422587|NCT01517321|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92147266|NCT01401647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92422588|NCT01517321|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422589|NCT01517321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422590|NCT01517321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422591|NCT01517334|Minocycline|minocycline|mesh-list
92422592|NCT01517334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422593|NCT01517334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422594|NCT01517347|Interleukin-2|interleukin-2|mesh-list
92422595|NCT01517347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422596|NCT01517347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422597|NCT01517347|Analgesics|analgesics|mesh-ancestor
92422598|NCT01517347|Sensory System Agents|sensory system agents|mesh-ancestor
92422599|NCT01517347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422600|NCT01517347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422601|NCT01517360|Oxytocin|oxytocin|mesh-list
92422602|NCT01517360|Oxytocics|oxytocics|mesh-ancestor
92422603|NCT01517360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92422604|NCT01517360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422605|NCT01517399|Vitamin K|vitamin k|mesh-list
92422606|NCT01517399|Digoxin|digoxin|mesh-list
92422607|NCT01517399|Midazolam|midazolam|mesh-list
92422608|NCT01517399|Caffeine|caffeine|mesh-list
92422609|NCT01517399|Omeprazole|omeprazole|mesh-list
92422610|NCT01517399|Warfarin|warfarin|mesh-list
92422611|NCT01517399|Vitamins|vitamins|mesh-ancestor
92422612|NCT01517399|Micronutrients|micronutrients|mesh-ancestor
92422613|NCT01517399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422614|NCT01517399|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92422615|NCT01517399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92422616|NCT01517399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422617|NCT01517399|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92422618|NCT01517399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92422619|NCT01517399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92422620|NCT01517399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92422621|NCT01517399|Anesthetics, General|anesthetics, general|mesh-ancestor
92422622|NCT01517399|Anesthetics|anesthetics|mesh-ancestor
92422623|NCT01517399|GABA Modulators|gaba modulators|mesh-ancestor
92609331|NCT00406341|Hormones|hormones|mesh-ancestor
92609332|NCT00406341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016510|NCT03490513|Anastrozole|anastrozole|mesh-list
92422624|NCT01517399|GABA Agents|gaba agents|mesh-ancestor
92422625|NCT01517399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422626|NCT01517399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422645|NCT01517490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92422646|NCT01517490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422647|NCT01517490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422648|NCT01517555|Acetaminophen|acetaminophen|mesh-list
92422649|NCT01517555|Liraglutide|liraglutide|mesh-list
92422650|NCT01517555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422651|NCT01517555|Analgesics|analgesics|mesh-ancestor
92422652|NCT01517555|Sensory System Agents|sensory system agents|mesh-ancestor
92422653|NCT01517555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422654|NCT01517555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422655|NCT01517555|Antipyretics|antipyretics|mesh-ancestor
92422656|NCT01517555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422657|NCT01517555|Incretins|incretins|mesh-ancestor
92422658|NCT01517555|Hormones|hormones|mesh-ancestor
92422659|NCT01517555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422660|NCT01517568|Liraglutide|liraglutide|mesh-list
92422661|NCT01517568|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422662|NCT01517568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422663|NCT01517568|Incretins|incretins|mesh-ancestor
92422664|NCT01517568|Hormones|hormones|mesh-ancestor
92422665|NCT01517568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422666|NCT01517607|Mesalamine|mesalamine|mesh-list
92422667|NCT01517607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92147345|NCT03084601|Calcium|calcium|mesh-list
92422668|NCT01517607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422669|NCT01517607|Analgesics|analgesics|mesh-ancestor
92422670|NCT01517607|Sensory System Agents|sensory system agents|mesh-ancestor
92422671|NCT01517607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422673|NCT01517607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422674|NCT01517607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422675|NCT01517724|Bortezomib|bortezomib|mesh-list
92422676|NCT01517724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422677|NCT01517815|Tazobactam|tazobactam|mesh-list
92422678|NCT01517815|Piperacillin|piperacillin|mesh-list
92422679|NCT01517815|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92422680|NCT01517815|Doripenem|doripenem|mesh-list
92422681|NCT01517815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422682|NCT01517815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422683|NCT01517815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92422684|NCT01517815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422685|NCT01517815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422686|NCT01517828|Midazolam|midazolam|mesh-list
92422687|NCT01517828|Ketamine|ketamine|mesh-list
92422690|NCT01517828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422691|NCT01517828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422692|NCT01517828|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92422693|NCT01517828|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92422694|NCT01517828|Anesthetics, General|anesthetics, general|mesh-ancestor
92422696|NCT01517828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422697|NCT01517828|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92422698|NCT01517828|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92422699|NCT01517828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422700|NCT01517828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422701|NCT01517828|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92422702|NCT01517828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92422703|NCT01517828|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92422704|NCT01517828|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92422705|NCT01517828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92422706|NCT01517828|GABA Modulators|gaba modulators|mesh-ancestor
92422707|NCT01517828|GABA Agents|gaba agents|mesh-ancestor
92422708|NCT01517854|Sildenafil Citrate|sildenafil citrate|mesh-list
92422709|NCT01517854|Vasodilator Agents|vasodilator agents|mesh-ancestor
92422710|NCT01517854|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92422711|NCT01517854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92422712|NCT01517854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422713|NCT01517854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422714|NCT01517854|Urological Agents|urological agents|mesh-ancestor
92609333|NCT00406341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609334|NCT00139724|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92609335|NCT00139724|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92609336|NCT00139724|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92422715|NCT01517932|Dexmedetomidine|dexmedetomidine|mesh-list
92422716|NCT01517932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92422717|NCT01517932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422718|NCT01517932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422719|NCT01517932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422720|NCT01517932|Analgesics|analgesics|mesh-ancestor
92422721|NCT01517932|Sensory System Agents|sensory system agents|mesh-ancestor
92422722|NCT01517932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422723|NCT01517932|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92422724|NCT01517932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92422725|NCT01517932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92422726|NCT01517932|Adrenergic Agents|adrenergic agents|mesh-ancestor
92422727|NCT01517932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422728|NCT01517932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422729|NCT01517997|Paclitaxel|paclitaxel|mesh-list
92422730|NCT01517997|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92422731|NCT01517997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422732|NCT01517997|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422733|NCT01517997|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422734|NCT01517997|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422735|NCT01517997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422736|NCT01518062|Estrogens|estrogens|mesh-list
92422737|NCT01518062|Hormones|hormones|mesh-ancestor
92422738|NCT01518062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422739|NCT01518062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422740|NCT01518101|Metformin|metformin|mesh-list
92422741|NCT01518101|Liraglutide|liraglutide|mesh-list
92422742|NCT01518101|Vildagliptin|vildagliptin|mesh-list
92422743|NCT01518101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422744|NCT01518101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422745|NCT01518101|Incretins|incretins|mesh-ancestor
92422746|NCT01518101|Hormones|hormones|mesh-ancestor
92422747|NCT01518101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422748|NCT01518101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92422749|NCT01518101|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422750|NCT01518101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422751|NCT01518101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422752|NCT01516944|Capecitabine|capecitabine|mesh-list
92422753|NCT01516944|Tegafur|tegafur|mesh-list
92422754|NCT01516944|Oxaliplatin|oxaliplatin|mesh-list
92422755|NCT01516944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92422756|NCT01516944|Antimetabolites|antimetabolites|mesh-ancestor
92422757|NCT01516944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422758|NCT01516944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422759|NCT01518166|Liraglutide|liraglutide|mesh-list
92422765|NCT01518166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92422766|NCT01518166|Antimetabolites|antimetabolites|mesh-ancestor
92422767|NCT01518166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422768|NCT01518166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92422769|NCT01518166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92422770|NCT01518166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422771|NCT01518166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422772|NCT01518166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422773|NCT01518166|Incretins|incretins|mesh-ancestor
92422774|NCT01518166|Hormones|hormones|mesh-ancestor
92422775|NCT01518166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422776|NCT01518166|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92422777|NCT01518166|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92422778|NCT01518166|Protective Agents|protective agents|mesh-ancestor
92422779|NCT01518166|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92422780|NCT01518166|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422781|NCT01518166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92422782|NCT01518166|Antifungal Agents|antifungal agents|mesh-ancestor
92422783|NCT01518166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422784|NCT01518231|Aspirin|aspirin|mesh-list
92422785|NCT01518231|Edaravone|edaravone|mesh-list
92422786|NCT01518231|Warfarin|warfarin|mesh-list
92609337|NCT00139724|Cholinergic Agents|cholinergic agents|mesh-ancestor
92609338|NCT00139724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609339|NCT00139724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016515|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422787|NCT01518231|Atorvastatin|atorvastatin|mesh-list
92422788|NCT01518231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92422789|NCT01518231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422790|NCT01518231|Analgesics|analgesics|mesh-ancestor
92422791|NCT01518231|Sensory System Agents|sensory system agents|mesh-ancestor
92422792|NCT01518231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422793|NCT01518231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422794|NCT01518231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422795|NCT01518231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422796|NCT01518231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92422797|NCT01518231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422798|NCT01518231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422799|NCT01518231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92422800|NCT01518231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92422801|NCT01518231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422802|NCT01518231|Antipyretics|antipyretics|mesh-ancestor
92422803|NCT01518231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92422804|NCT01518231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92422805|NCT01518231|Antimetabolites|antimetabolites|mesh-ancestor
92422806|NCT01518231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92422807|NCT01518231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92422808|NCT01518231|Anticoagulants|anticoagulants|mesh-ancestor
92422809|NCT01518231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92422810|NCT01518231|Antioxidants|antioxidants|mesh-ancestor
92422811|NCT01518231|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92422812|NCT01518231|Protective Agents|protective agents|mesh-ancestor
92422813|NCT01518413|Irinotecan|irinotecan|mesh-list
92422814|NCT01518413|Sorafenib|sorafenib|mesh-list
92422815|NCT01518413|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92422816|NCT01518413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422817|NCT01518413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422818|NCT01518413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422819|NCT01518413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422820|NCT01518413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92422821|NCT01518465|Dexamethasone|dexamethasone|mesh-list
92422822|NCT01518465|Lenalidomide|lenalidomide|mesh-list
92422823|NCT01518465|Dalteparin|dalteparin|mesh-list
92422824|NCT01518465|Tinzaparin|tinzaparin|mesh-list
92422825|NCT01518465|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92422826|NCT01518465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422827|NCT01518465|Antiemetics|antiemetics|mesh-ancestor
92422828|NCT01518465|Autonomic Agents|autonomic agents|mesh-ancestor
92422829|NCT01518465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422830|NCT01518465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422831|NCT01518465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92422832|NCT01518465|Glucocorticoids|glucocorticoids|mesh-ancestor
92422833|NCT01518465|Hormones|hormones|mesh-ancestor
92422836|NCT01518465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422837|NCT01518465|Immunologic Factors|immunologic factors|mesh-ancestor
92422838|NCT01518465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92422839|NCT01518465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92422840|NCT01518465|Growth Substances|growth substances|mesh-ancestor
92422841|NCT01518465|Growth Inhibitors|growth inhibitors|mesh-ancestor
92422842|NCT01518465|Anticoagulants|anticoagulants|mesh-ancestor
92422843|NCT01518465|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92422844|NCT01518465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422845|NCT01518465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422846|NCT01518569|Urinastatin|urinastatin|mesh-list
92422847|NCT01518569|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92422848|NCT01518569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92422849|NCT01518569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422850|NCT01518569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422851|NCT01518569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422852|NCT01518595|Bosentan|bosentan|mesh-list
92422853|NCT01518595|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92422854|NCT01518595|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92422855|NCT01518595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422856|NCT01518608|Alfentanil|alfentanil|mesh-list
92609341|NCT00139724|Urological Agents|urological agents|mesh-ancestor
92609342|NCT00161577|Ketorolac|ketorolac|mesh-list
92609343|NCT00161577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92422857|NCT01518608|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92422858|NCT01518608|Narcotics|narcotics|mesh-ancestor
92422859|NCT01518608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422860|NCT01518608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422861|NCT01518608|Analgesics|analgesics|mesh-ancestor
92422862|NCT01518608|Sensory System Agents|sensory system agents|mesh-ancestor
92422863|NCT01518608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012898|NCT04814381|Ketamine|ketamine|mesh-list
92422864|NCT01518608|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92422865|NCT01518608|Anesthetics, General|anesthetics, general|mesh-ancestor
92422866|NCT01518608|Anesthetics|anesthetics|mesh-ancestor
92422867|NCT01518621|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92422868|NCT01518621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422869|NCT01518621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92422870|NCT01518621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422871|NCT01518621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422872|NCT01518634|Imipramine|imipramine|mesh-list
92422873|NCT01518634|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92422874|NCT01518634|Antidepressive Agents|antidepressive agents|mesh-ancestor
92422875|NCT01518634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92422876|NCT01518634|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92422877|NCT01518634|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92422878|NCT01518634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92422879|NCT01518634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422880|NCT01518634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92422881|NCT01518634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422882|NCT01518634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422883|NCT01518712|Metformin|metformin|mesh-list
92422884|NCT01518712|Canagliflozin|canagliflozin|mesh-list
92422885|NCT01518712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422886|NCT01518712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422887|NCT01518712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92422888|NCT01518712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422889|NCT01518725|Vitamin D|vitamin d|mesh-list
92422890|NCT01518725|Cholecalciferol|cholecalciferol|mesh-list
92422891|NCT01518725|Vitamins|vitamins|mesh-ancestor
92422892|NCT01518725|Micronutrients|micronutrients|mesh-ancestor
92422893|NCT01518725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422894|NCT01518725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92422895|NCT01518725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92422896|NCT01518790|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92422897|NCT01518790|Laxatives|laxatives|mesh-ancestor
92422898|NCT01518790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92422899|NCT01518855|Amlodipine|amlodipine|mesh-list
92422900|NCT01518855|Nifedipine|nifedipine|mesh-list
92422901|NCT01518855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92422902|NCT01518855|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92422903|NCT01518855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92422904|NCT01518855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422906|NCT01518855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422908|NCT01518855|Tocolytic Agents|tocolytic agents|mesh-ancestor
92422909|NCT01518855|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92422910|NCT01518933|Silybin|silybin|mesh-list
92422911|NCT01518933|Silymarin|silymarin|mesh-list
92422912|NCT01518933|Antioxidants|antioxidants|mesh-ancestor
92422913|NCT01518933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422914|NCT01518933|Protective Agents|protective agents|mesh-ancestor
92422915|NCT01518933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422916|NCT01518933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92422917|NCT01518933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422918|NCT01518959|Cholecalciferol|cholecalciferol|mesh-list
92422919|NCT01518959|Vitamin D|vitamin d|mesh-list
92422920|NCT01518959|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92422921|NCT01518959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422922|NCT01518959|Vitamins|vitamins|mesh-ancestor
92422923|NCT01518959|Micronutrients|micronutrients|mesh-ancestor
92422924|NCT01518959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92422925|NCT01518998|Amlodipine|amlodipine|mesh-list
92609344|NCT00161577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609345|NCT00161577|Analgesics|analgesics|mesh-ancestor
92422926|NCT01518998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92422927|NCT01518998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92422928|NCT01518998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92422929|NCT01518998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422930|NCT01518998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92422931|NCT01518998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422932|NCT01518998|Vasodilator Agents|vasodilator agents|mesh-ancestor
92422933|NCT01519011|Azacitidine|azacitidine|mesh-list
92422934|NCT01519011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92422935|NCT01519011|Antimetabolites|antimetabolites|mesh-ancestor
92422936|NCT01519011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422937|NCT01519011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422938|NCT01519011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422939|NCT01519037|Cinacalcet|cinacalcet|mesh-list
92422940|NCT01519037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92422941|NCT01519037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422942|NCT01519037|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92422943|NCT01519037|Hormone Antagonists|hormone antagonists|mesh-ancestor
92422944|NCT01519037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422945|NCT01519076|Coal Tar|coal tar|mesh-list
92422946|NCT01519076|Keratolytic Agents|keratolytic agents|mesh-ancestor
92422947|NCT01519076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92422948|NCT01519102|Hormones|hormones|mesh-list
92422949|NCT01519102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422950|NCT01519102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422951|NCT01519128|Rilpivirine|rilpivirine|mesh-list
92422952|NCT01519128|Digoxin|digoxin|mesh-list
92422953|NCT01519128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92422954|NCT01519128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92422955|NCT01519128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422956|NCT01519128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422957|NCT01519128|Protective Agents|protective agents|mesh-ancestor
92422958|NCT01519128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422959|NCT01519128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92422960|NCT01519128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92422961|NCT01519128|Antiviral Agents|antiviral agents|mesh-ancestor
92422962|NCT01519128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422963|NCT01519128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92422964|NCT01519128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92422965|NCT01519154|Ketamine|ketamine|mesh-list
92422966|NCT01519154|Propofol|propofol|mesh-list
92422967|NCT01519154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92422968|NCT01519154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92422969|NCT01519154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422970|NCT01519154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92422971|NCT01519154|Anesthetics, General|anesthetics, general|mesh-ancestor
92422973|NCT01519154|Analgesics|analgesics|mesh-ancestor
92422974|NCT01519154|Sensory System Agents|sensory system agents|mesh-ancestor
92422975|NCT01519154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422976|NCT01519154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92422977|NCT01519154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92422979|NCT01519154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422980|NCT01519154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422982|NCT01519297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92422983|NCT01519297|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92422984|NCT01519297|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92422985|NCT01519297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422986|NCT01519310|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92422987|NCT01519310|Metronidazole|metronidazole|mesh-list
92422988|NCT01519310|Ciprofloxacin|ciprofloxacin|mesh-list
92422989|NCT01519310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422990|NCT01519310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92422991|NCT01519310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92422992|NCT01519310|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422993|NCT01519310|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422994|NCT01519310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422995|NCT01519310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422996|NCT01519310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422997|NCT01519310|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92609346|NCT00161577|Sensory System Agents|sensory system agents|mesh-ancestor
92609347|NCT00161577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609348|NCT00161577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609349|NCT00161577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609350|NCT00161577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609351|NCT00161577|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92422998|NCT01519310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92423000|NCT01519336|Darunavir|darunavir|mesh-list
92423001|NCT01519336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92423002|NCT01519336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92423003|NCT01519336|Protease Inhibitors|protease inhibitors|mesh-ancestor
92423004|NCT01519336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423005|NCT01519336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423006|NCT01519336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92423007|NCT01519336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92423008|NCT01519336|Antiviral Agents|antiviral agents|mesh-ancestor
92423009|NCT01519336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423010|NCT01519336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92423011|NCT01519336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92423012|NCT01519401|Drospirenone|drospirenone|mesh-list
92423013|NCT01519401|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92423014|NCT01519401|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92423015|NCT01519401|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92423016|NCT01519401|Estradiol|estradiol|mesh-list
92423017|NCT01519401|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92423018|NCT01519401|Estrogens|estrogens|mesh-ancestor
92423019|NCT01519401|Hormones|hormones|mesh-ancestor
92423020|NCT01519401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423021|NCT01519401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423022|NCT01519401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92423023|NCT01519401|Contraceptive Agents|contraceptive agents|mesh-ancestor
92423024|NCT01519401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92423025|NCT01519401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92423026|NCT01519401|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92423027|NCT01519401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92423028|NCT01519401|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92423029|NCT01519401|Hormone Antagonists|hormone antagonists|mesh-ancestor
92423030|NCT01519401|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92423031|NCT01519401|Diuretics|diuretics|mesh-ancestor
92423032|NCT01519401|Natriuretic Agents|natriuretic agents|mesh-ancestor
92423033|NCT01519544|Acetazolamide|acetazolamide|mesh-list
92423034|NCT01519544|Temazepam|temazepam|mesh-list
92423035|NCT01519544|Anticonvulsants|anticonvulsants|mesh-ancestor
92423036|NCT01519544|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92423037|NCT01519544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423038|NCT01519544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423039|NCT01519544|Diuretics|diuretics|mesh-ancestor
92423040|NCT01519544|Natriuretic Agents|natriuretic agents|mesh-ancestor
92423041|NCT01519544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423042|NCT01519544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92423043|NCT01519544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423044|NCT01519544|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92147714|NCT00775671|Metoprolol|metoprolol|mesh-list
92423045|NCT01519544|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92423046|NCT01519544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92423047|NCT01519544|GABA Modulators|gaba modulators|mesh-ancestor
92423048|NCT01519544|GABA Agents|gaba agents|mesh-ancestor
92423049|NCT01519544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423050|NCT01519687|Tofisopam|tofisopam|mesh-list
92423080|NCT01519986|Cholecalciferol|cholecalciferol|mesh-list
92423081|NCT01519986|Vitamins|vitamins|mesh-ancestor
92423082|NCT01519986|Micronutrients|micronutrients|mesh-ancestor
92423083|NCT01519986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423084|NCT01519986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92423085|NCT01519986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92423086|NCT01520012|Esomeprazole|esomeprazole|mesh-list
92423087|NCT01520012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92423088|NCT01520012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423089|NCT01520012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92609352|NCT00161577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609353|NCT00161577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609354|NCT00404261|Fluticasone|fluticasone|mesh-list
92609355|NCT00404261|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92423090|NCT01520012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423091|NCT01520012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423092|NCT01520025|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92423093|NCT01520025|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92423094|NCT01520025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394956|NCT01388322|Anticoagulants|anticoagulants|mesh-ancestor
92423095|NCT01520077|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92423096|NCT01520077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92423097|NCT01520077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92423098|NCT01520077|Antimetabolites|antimetabolites|mesh-ancestor
92423100|NCT01520077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92423101|NCT01520103|Everolimus|everolimus|mesh-list
92423102|NCT01520103|Vinorelbine|vinorelbine|mesh-list
92423103|NCT01520103|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92423104|NCT01520103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92423105|NCT01520103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423106|NCT01520103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423107|NCT01520103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423108|NCT01520103|Immunologic Factors|immunologic factors|mesh-ancestor
92423109|NCT01520103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423110|NCT01520103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423111|NCT01520103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92423112|NCT01520103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92423113|NCT01520103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92423114|NCT01520103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92423115|NCT01520116|Timolol|timolol|mesh-list
92423116|NCT01520116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92423117|NCT01520116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92423118|NCT01520116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92423119|NCT01520116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423120|NCT01520116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423121|NCT01520116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423122|NCT01520116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423123|NCT01520116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92423124|NCT01520181|Lactams|lactams|mesh-list
92423125|NCT01520181|beta-Lactams|beta-lactams|mesh-list
92423126|NCT01520181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92423127|NCT01520181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423128|NCT01520285|Felodipine|felodipine|mesh-list
92423129|NCT01520285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423130|NCT01520285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92423131|NCT01520285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92423132|NCT01520285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423133|NCT01520285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423134|NCT01520285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92423135|NCT01520285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423136|NCT01520285|Vasodilator Agents|vasodilator agents|mesh-ancestor
92423137|NCT01520298|Acetaminophen|acetaminophen|mesh-list
92423138|NCT01520298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423139|NCT01520298|Analgesics|analgesics|mesh-ancestor
92423140|NCT01520298|Sensory System Agents|sensory system agents|mesh-ancestor
92423141|NCT01520298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423142|NCT01520298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423143|NCT01520298|Antipyretics|antipyretics|mesh-ancestor
92423144|NCT01520350|Aripiprazole|aripiprazole|mesh-list
92423145|NCT01520350|Antidepressive Agents|antidepressive agents|mesh-ancestor
92423146|NCT01520350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92423147|NCT01520350|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92423148|NCT01520350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92423149|NCT01520350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423150|NCT01520350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423151|NCT01520350|Dopamine Agonists|dopamine agonists|mesh-ancestor
92423152|NCT01520350|Dopamine Agents|dopamine agents|mesh-ancestor
92423153|NCT01520350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423154|NCT01520350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423155|NCT01520350|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92423156|NCT01520350|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92609356|NCT00404261|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92609357|NCT00404261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609358|NCT00404261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92423157|NCT01520350|Serotonin Agents|serotonin agents|mesh-ancestor
92423158|NCT01520350|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92423159|NCT01520350|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92423160|NCT01520350|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92423161|NCT01520350|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92423162|NCT01520389|Irinotecan|irinotecan|mesh-list
92423163|NCT01520389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92423164|NCT01520389|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92423165|NCT01520389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92423166|NCT01520389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423167|NCT01520389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423168|NCT01520389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423169|NCT01520389|Immunologic Factors|immunologic factors|mesh-ancestor
92423170|NCT01520389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423171|NCT01520415|Lidocaine|lidocaine|mesh-list
92423182|NCT01520415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147861|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92147862|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92147863|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92147864|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92147865|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92147866|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92147867|NCT04608201|Nicotine|nicotine|mesh-list
92147868|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92147869|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
92147870|NCT04608201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147871|NCT04608201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423183|NCT01520415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423184|NCT01520441|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92423185|NCT01520441|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92423186|NCT01520441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423187|NCT01520441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423188|NCT01520441|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92423189|NCT01520441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423190|NCT01520441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423191|NCT01520441|Cholinergic Agents|cholinergic agents|mesh-ancestor
92423192|NCT01520441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423193|NCT01520467|Anastrozole|anastrozole|mesh-list
92423194|NCT01520467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92423195|NCT01520467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423196|NCT01520467|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92423197|NCT01520467|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92423198|NCT01520467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423199|NCT01520467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423200|NCT01520467|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92423201|NCT01520467|Hormone Antagonists|hormone antagonists|mesh-ancestor
92423202|NCT01520467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423203|NCT01520467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423204|NCT01520584|Vitamins|vitamins|mesh-list
92423205|NCT01520584|Micronutrients|micronutrients|mesh-ancestor
92423206|NCT01520584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423207|NCT01520753|Insulin|insulin|mesh-list
92423208|NCT01520753|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92423209|NCT01520753|Insulin Aspart|insulin aspart|mesh-list
92423210|NCT01520753|Insulin, Long-Acting|insulin, long-acting|mesh-list
92423211|NCT01520753|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92423212|NCT01520753|Biphasic Insulins|biphasic insulins|mesh-list
92423213|NCT01520753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423214|NCT01520753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423215|NCT01520766|Methamphetamine|methamphetamine|mesh-list
92423216|NCT01520766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92423217|NCT01520766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423218|NCT01520766|Sympathomimetics|sympathomimetics|mesh-ancestor
92423219|NCT01520766|Autonomic Agents|autonomic agents|mesh-ancestor
92423220|NCT01520766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423221|NCT01520766|Dopamine Agents|dopamine agents|mesh-ancestor
92609359|NCT00404261|Autonomic Agents|autonomic agents|mesh-ancestor
92609360|NCT00404261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082808|NCT01876381|Tolvaptan|tolvaptan|mesh-list
92423222|NCT01520766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423240|NCT01520818|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92423241|NCT01520818|Biphasic Insulins|biphasic insulins|mesh-list
92423242|NCT01520818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423243|NCT01520818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423244|NCT01520831|Insulin|insulin|mesh-list
92423245|NCT01520831|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92423246|NCT01520831|Insulin Aspart|insulin aspart|mesh-list
92423247|NCT01520831|Insulin, Long-Acting|insulin, long-acting|mesh-list
92423248|NCT01520831|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92423249|NCT01520831|Biphasic Insulins|biphasic insulins|mesh-list
92423250|NCT01520831|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92423251|NCT01520831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423252|NCT01520831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423253|NCT01520896|Ketoconazole|ketoconazole|mesh-list
92423254|NCT01520896|Naloxegol|naloxegol|mesh-list
92423255|NCT01520896|Antifungal Agents|antifungal agents|mesh-ancestor
92423256|NCT01520896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423257|NCT01520896|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92423258|NCT01520896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92423259|NCT01520896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423260|NCT01520896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423261|NCT01520896|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92423262|NCT01520896|Hormone Antagonists|hormone antagonists|mesh-ancestor
92423263|NCT01520896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423264|NCT01520896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423265|NCT01520896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92423266|NCT01520896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92423267|NCT01520896|Sensory System Agents|sensory system agents|mesh-ancestor
92423268|NCT01520896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423269|NCT01521130|Levetiracetam|levetiracetam|mesh-list
92423270|NCT01521130|Anticonvulsants|anticonvulsants|mesh-ancestor
92423271|NCT01521130|Nootropic Agents|nootropic agents|mesh-ancestor
92423272|NCT01521299|Hydroxyurea|hydroxyurea|mesh-list
92423273|NCT01521299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423274|NCT01521299|Antisickling Agents|antisickling agents|mesh-ancestor
92423275|NCT01521299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423276|NCT01521299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423277|NCT01521299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92423278|NCT01521312|Saxagliptin|saxagliptin|mesh-list
92423279|NCT01521312|Incretins|incretins|mesh-ancestor
92423288|NCT01521325|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92423289|NCT01521325|Immunologic Factors|immunologic factors|mesh-ancestor
92423290|NCT01521325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423291|NCT01521377|Moxifloxacin|moxifloxacin|mesh-list
92423292|NCT01521377|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92423293|NCT01521377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92423294|NCT01521377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423295|NCT01521377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92423296|NCT01521377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92423297|NCT01521377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423298|NCT01521377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423299|NCT01521377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423300|NCT01521377|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92423301|NCT01521377|Contraceptive Agents|contraceptive agents|mesh-ancestor
92423302|NCT01521377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92423303|NCT01521377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423304|NCT01521377|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92423305|NCT01521377|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92423306|NCT01521377|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92423307|NCT01521455|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92423308|NCT01521455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92423309|NCT01521455|Autonomic Agents|autonomic agents|mesh-ancestor
92423310|NCT01521455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423311|NCT01521455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423312|NCT01521455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92423313|NCT01521455|Respiratory System Agents|respiratory system agents|mesh-ancestor
92609361|NCT00404261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016534|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
92423314|NCT01521455|Glucocorticoids|glucocorticoids|mesh-ancestor
92423315|NCT01521455|Hormones|hormones|mesh-ancestor
92394972|NCT01388517|Micronutrients|micronutrients|mesh-ancestor
92423316|NCT01521455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423317|NCT01521455|Sympathomimetics|sympathomimetics|mesh-ancestor
92423318|NCT01521481|Anesthetics|anesthetics|mesh-list
92423319|NCT01521481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423320|NCT01521481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423321|NCT01521520|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92423322|NCT01521520|Hematinics|hematinics|mesh-ancestor
92423323|NCT01521520|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92423324|NCT01521520|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92423325|NCT01521572|Albuterol|albuterol|mesh-list
92423326|NCT01521572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92423327|NCT01521572|Autonomic Agents|autonomic agents|mesh-ancestor
92423328|NCT01521572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423329|NCT01521572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423330|NCT01521572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92423331|NCT01521572|Respiratory System Agents|respiratory system agents|mesh-ancestor
92423332|NCT01521572|Tocolytic Agents|tocolytic agents|mesh-ancestor
92423333|NCT01521572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92423334|NCT01521572|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92423335|NCT01521572|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92423336|NCT01521572|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92423337|NCT01521572|Adrenergic Agents|adrenergic agents|mesh-ancestor
92423338|NCT01521572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423339|NCT01521572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423340|NCT01521624|Metformin|metformin|mesh-list
92423341|NCT01521624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423342|NCT01521624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423343|NCT01521689|Rituximab|rituximab|mesh-list
92423347|NCT01521689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423348|NCT01521689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92423349|NCT01521767|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92423350|NCT01521767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92423351|NCT01521767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92423352|NCT01521767|Cholinergic Agents|cholinergic agents|mesh-ancestor
92423353|NCT01521767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423354|NCT01521767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423355|NCT01521767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423356|NCT01521767|Urological Agents|urological agents|mesh-ancestor
92423357|NCT01521793|Retinol acetate|retinol acetate|mesh-list
92423358|NCT01521793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92423359|NCT01521793|Immunologic Factors|immunologic factors|mesh-ancestor
92423360|NCT01521793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423361|NCT01521793|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92423362|NCT01521793|Protective Agents|protective agents|mesh-ancestor
92423363|NCT01521793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423364|NCT01521819|Ranibizumab|ranibizumab|mesh-list
92423365|NCT01521819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92423366|NCT01521819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92423367|NCT01521819|Growth Substances|growth substances|mesh-ancestor
92423368|NCT01521819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423369|NCT01521819|Growth Inhibitors|growth inhibitors|mesh-ancestor
92423370|NCT01521819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423371|NCT01521936|Vitamin D|vitamin d|mesh-list
92423372|NCT01521936|Ergocalciferols|ergocalciferols|mesh-list
92423373|NCT01521936|Cholecalciferol|cholecalciferol|mesh-list
92423374|NCT01521936|Vitamins|vitamins|mesh-list
92423375|NCT01521936|Micronutrients|micronutrients|mesh-ancestor
92423376|NCT01521936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423377|NCT01521936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92423378|NCT01521936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92423379|NCT01521962|Alogliptin|alogliptin|mesh-list
92423380|NCT01521962|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423381|NCT01521962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423382|NCT01521962|Incretins|incretins|mesh-ancestor
92423383|NCT01521962|Hormones|hormones|mesh-ancestor
92423384|NCT01521962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423385|NCT01521962|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92423386|NCT01521962|Protease Inhibitors|protease inhibitors|mesh-ancestor
92423387|NCT01521962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609362|NCT00404261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92609363|NCT00404261|Respiratory System Agents|respiratory system agents|mesh-ancestor
92609364|NCT00404261|Dermatologic Agents|dermatologic agents|mesh-ancestor
92609365|NCT00404261|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92609366|NCT00404261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92082955|NCT03597555|Anesthetics|anesthetics|mesh-ancestor
92423388|NCT01521962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423389|NCT01521975|Adefovir|adefovir|mesh-list
92423390|NCT01521975|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92423391|NCT01521975|Telbivudine|telbivudine|mesh-list
92423392|NCT01521975|Antiviral Agents|antiviral agents|mesh-ancestor
92423393|NCT01521975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423394|NCT01521975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92423395|NCT01521975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92423396|NCT01521975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423397|NCT01521975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423398|NCT01522040|Magnesium Sulfate|magnesium sulfate|mesh-list
92423399|NCT01522040|Analgesics|analgesics|mesh-ancestor
92423400|NCT01522040|Sensory System Agents|sensory system agents|mesh-ancestor
92423401|NCT01522040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423402|NCT01522040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423403|NCT01522040|Anesthetics|anesthetics|mesh-ancestor
92423404|NCT01522040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423405|NCT01522040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423406|NCT01522040|Anticonvulsants|anticonvulsants|mesh-ancestor
92423407|NCT01522040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92423408|NCT01522040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423409|NCT01522040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423410|NCT01522040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92423411|NCT01522040|Tocolytic Agents|tocolytic agents|mesh-ancestor
92423412|NCT01522040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92423413|NCT01522092|Escitalopram|escitalopram|mesh-list
92423414|NCT01522092|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92423417|NCT01522092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423418|NCT01522092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423419|NCT01522092|Serotonin Agents|serotonin agents|mesh-ancestor
92423420|NCT01522092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423421|NCT01522105|Daptomycin|daptomycin|mesh-list
92423422|NCT01522105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92423423|NCT01522105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423424|NCT01522326|Ibuprofen|ibuprofen|mesh-list
92423425|NCT01522326|Metoclopramide|metoclopramide|mesh-list
92423426|NCT01522326|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92423427|NCT01522326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423428|NCT01522326|Analgesics|analgesics|mesh-ancestor
92423429|NCT01522326|Sensory System Agents|sensory system agents|mesh-ancestor
92423430|NCT01522326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423431|NCT01522326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423432|NCT01522326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423433|NCT01522326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92423434|NCT01522326|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92423435|NCT01522326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423436|NCT01522326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423437|NCT01522326|Antiemetics|antiemetics|mesh-ancestor
92423438|NCT01522326|Autonomic Agents|autonomic agents|mesh-ancestor
92423439|NCT01522326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423440|NCT01522326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92423441|NCT01522326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92423442|NCT01522326|Dopamine Agents|dopamine agents|mesh-ancestor
92423443|NCT01522326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423444|NCT01522378|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92423445|NCT01522378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423446|NCT01522378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423447|NCT01522378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423448|NCT01522378|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92423449|NCT01522534|Morphine|morphine|mesh-list
92423450|NCT01522534|Mepivacaine|mepivacaine|mesh-list
92423451|NCT01522534|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92423452|NCT01522534|Narcotics|narcotics|mesh-ancestor
92609367|NCT00404261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92609368|NCT00404261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92609369|NCT00404261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92609370|NCT00404261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609371|NCT00404261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423453|NCT01522534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423454|NCT01522534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423455|NCT01522534|Analgesics|analgesics|mesh-ancestor
92423456|NCT01522534|Sensory System Agents|sensory system agents|mesh-ancestor
92423457|NCT01522534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423458|NCT01522534|Anesthetics, Local|anesthetics, local|mesh-ancestor
92423459|NCT01522534|Anesthetics|anesthetics|mesh-ancestor
92423460|NCT01522547|Pomalidomide|pomalidomide|mesh-list
92423461|NCT01522547|Immunologic Factors|immunologic factors|mesh-ancestor
92423462|NCT01522547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423463|NCT01522547|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92423464|NCT01522547|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92423465|NCT01522547|Growth Substances|growth substances|mesh-ancestor
92423466|NCT01522547|Growth Inhibitors|growth inhibitors|mesh-ancestor
92423467|NCT01522547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423468|NCT01522612|Leucovorin|leucovorin|mesh-list
92423469|NCT01522612|Fluorouracil|fluorouracil|mesh-list
92423470|NCT01522612|Cetuximab|cetuximab|mesh-list
92423471|NCT01522612|Antimetabolites|antimetabolites|mesh-ancestor
92423472|NCT01522612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423473|NCT01522612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92423474|NCT01522612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423475|NCT01522612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423476|NCT01522612|Immunologic Factors|immunologic factors|mesh-ancestor
92423477|NCT01522612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423478|NCT01522612|Antidotes|antidotes|mesh-ancestor
92423479|NCT01522612|Protective Agents|protective agents|mesh-ancestor
92423480|NCT01522612|Vitamin B Complex|vitamin b complex|mesh-ancestor
92423482|NCT01522612|Micronutrients|micronutrients|mesh-ancestor
92423483|NCT01522612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92423484|NCT01522625|Tenofovir|tenofovir|mesh-list
92423485|NCT01522625|Antiviral Agents|antiviral agents|mesh-ancestor
92423486|NCT01522625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423487|NCT01522625|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92423488|NCT01522625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92423489|NCT01522625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423499|NCT01522729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423500|NCT01522729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423501|NCT01522729|Analgesics|analgesics|mesh-ancestor
92423502|NCT01522729|Sensory System Agents|sensory system agents|mesh-ancestor
92423503|NCT01522729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423504|NCT01522729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92423505|NCT01522729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92423506|NCT01522729|Anesthetics, General|anesthetics, general|mesh-ancestor
92423507|NCT01522729|Anesthetics|anesthetics|mesh-ancestor
92423509|NCT01522820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92423510|NCT01522820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423511|NCT01522820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92423512|NCT01522820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423513|NCT01522820|Antifungal Agents|antifungal agents|mesh-ancestor
92423514|NCT01522820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423515|NCT01522820|Immunologic Factors|immunologic factors|mesh-ancestor
92423516|NCT01522820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423517|NCT01522846|Heparin|heparin|mesh-list
92423518|NCT01522846|Anticoagulants|anticoagulants|mesh-ancestor
92423519|NCT01522846|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92423520|NCT01522846|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92423521|NCT01522846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423522|NCT01522872|Dexamethasone|dexamethasone|mesh-list
92423523|NCT01522872|Dexamethasone acetate|dexamethasone acetate|mesh-list
92423524|NCT01522872|Bortezomib|bortezomib|mesh-list
92423525|NCT01522872|Pomalidomide|pomalidomide|mesh-list
92423526|NCT01522872|Phosphoramide Mustards|phosphoramide mustards|mesh-list
92423527|NCT01522872|BB 1101|bb 1101|mesh-list
92423528|NCT01522872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423529|NCT01522872|Antiemetics|antiemetics|mesh-ancestor
92423530|NCT01522872|Autonomic Agents|autonomic agents|mesh-ancestor
92609372|NCT00404261|Glucocorticoids|glucocorticoids|mesh-ancestor
92609373|NCT00404261|Hormones|hormones|mesh-ancestor
92016544|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92394985|NCT01388517|Dermatologic Agents|dermatologic agents|mesh-ancestor
92423531|NCT01522872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423532|NCT01522872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423533|NCT01522872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423534|NCT01522872|Glucocorticoids|glucocorticoids|mesh-ancestor
92423535|NCT01522872|Hormones|hormones|mesh-ancestor
92423536|NCT01522872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423537|NCT01522872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92423538|NCT01522872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423539|NCT01522872|Protease Inhibitors|protease inhibitors|mesh-ancestor
92423540|NCT01522872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423541|NCT01522872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423542|NCT01522872|Immunologic Factors|immunologic factors|mesh-ancestor
92423543|NCT01522872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92423544|NCT01522872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92423545|NCT01522872|Growth Substances|growth substances|mesh-ancestor
92423546|NCT01522872|Growth Inhibitors|growth inhibitors|mesh-ancestor
92423547|NCT01522872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92423548|NCT01522872|Alkylating Agents|alkylating agents|mesh-ancestor
92423549|NCT01522989|Fluorouracil|fluorouracil|mesh-list
92423550|NCT01522989|Oxaliplatin|oxaliplatin|mesh-list
92423551|NCT01522989|Palbociclib|palbociclib|mesh-list
92423552|NCT01522989|Antimetabolites|antimetabolites|mesh-ancestor
92423553|NCT01522989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423554|NCT01522989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92423555|NCT01522989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423556|NCT01522989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423557|NCT01522989|Immunologic Factors|immunologic factors|mesh-ancestor
92423559|NCT01522989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92423561|NCT01523002|Artesunate|artesunate|mesh-list
92423562|NCT01523002|Pyronaridine|pyronaridine|mesh-list
92423563|NCT01523002|Metoprolol|metoprolol|mesh-list
92423564|NCT01523002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423565|NCT01523002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92423566|NCT01523002|Sympatholytics|sympatholytics|mesh-ancestor
92423567|NCT01523002|Autonomic Agents|autonomic agents|mesh-ancestor
92423568|NCT01523002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423569|NCT01523002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423570|NCT01523002|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92423571|NCT01523002|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92423572|NCT01523002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92423573|NCT01523002|Adrenergic Agents|adrenergic agents|mesh-ancestor
92423574|NCT01523002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423575|NCT01523002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423576|NCT01523002|Antimalarials|antimalarials|mesh-ancestor
92423577|NCT01523002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92423578|NCT01523002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92423579|NCT01523002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423580|NCT01523002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423581|NCT01523002|Antiviral Agents|antiviral agents|mesh-ancestor
92423582|NCT01523002|Schistosomicides|schistosomicides|mesh-ancestor
92423583|NCT01523002|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92423584|NCT01523002|Anthelmintics|anthelmintics|mesh-ancestor
92423585|NCT01523015|Docetaxel|docetaxel|mesh-list
92423586|NCT01523015|Fluorouracil|fluorouracil|mesh-list
92423587|NCT01523015|Oxaliplatin|oxaliplatin|mesh-list
92423588|NCT01523015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423589|NCT01523015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92423590|NCT01523015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92423591|NCT01523015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92423592|NCT01523015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423593|NCT01523015|Antimetabolites|antimetabolites|mesh-ancestor
92423594|NCT01523015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92423595|NCT01523015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423596|NCT01523015|Immunologic Factors|immunologic factors|mesh-ancestor
92423597|NCT01523015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423598|NCT01523041|Insulin|insulin|mesh-list
92423599|NCT01523041|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92423600|NCT01523041|Insulin Aspart|insulin aspart|mesh-list
92423601|NCT01523041|Insulin, Long-Acting|insulin, long-acting|mesh-list
92423602|NCT01523041|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92423603|NCT01523041|Biphasic Insulins|biphasic insulins|mesh-list
92609374|NCT00404261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609375|NCT00404261|Sympathomimetics|sympathomimetics|mesh-ancestor
92609376|NCT00406380|Bevacizumab|bevacizumab|mesh-list
92423604|NCT01523041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423605|NCT01523041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423606|NCT01523054|Metoprolol|metoprolol|mesh-list
92423607|NCT01523054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423608|NCT01523054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92423609|NCT01523054|Sympatholytics|sympatholytics|mesh-ancestor
92423610|NCT01523054|Autonomic Agents|autonomic agents|mesh-ancestor
92423611|NCT01523054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423612|NCT01523054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423613|NCT01523054|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92423614|NCT01523054|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92423615|NCT01523054|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92423616|NCT01523054|Adrenergic Agents|adrenergic agents|mesh-ancestor
92423617|NCT01523054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423618|NCT01523054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423619|NCT01523067|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
92423620|NCT01523067|Vasodilator Agents|vasodilator agents|mesh-ancestor
92423621|NCT01523080|Acetaminophen|acetaminophen|mesh-list
92423622|NCT01523080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423623|NCT01523080|Analgesics|analgesics|mesh-ancestor
92423624|NCT01523080|Sensory System Agents|sensory system agents|mesh-ancestor
92423625|NCT01523080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423626|NCT01523080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423627|NCT01523080|Antipyretics|antipyretics|mesh-ancestor
92423628|NCT01523093|Ondansetron|ondansetron|mesh-list
92423629|NCT01523093|Antiemetics|antiemetics|mesh-ancestor
92423630|NCT01523093|Autonomic Agents|autonomic agents|mesh-ancestor
92423631|NCT01523093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423632|NCT01523093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423638|NCT01523093|Serotonin Agents|serotonin agents|mesh-ancestor
92423639|NCT01523093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423640|NCT01523093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423641|NCT01523119|Ondansetron|ondansetron|mesh-list
92423642|NCT01523119|Antiemetics|antiemetics|mesh-ancestor
92423643|NCT01523119|Autonomic Agents|autonomic agents|mesh-ancestor
92423644|NCT01523119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423645|NCT01523119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423646|NCT01523119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423647|NCT01523119|Antipruritics|antipruritics|mesh-ancestor
92423648|NCT01523119|Dermatologic Agents|dermatologic agents|mesh-ancestor
92423649|NCT01523119|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92423650|NCT01523119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92423651|NCT01523119|Serotonin Agents|serotonin agents|mesh-ancestor
92423652|NCT01523119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423653|NCT01523119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423654|NCT01523236|Mometasone Furoate|mometasone furoate|mesh-list
92423655|NCT01523236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423656|NCT01523236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92423657|NCT01523236|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92423658|NCT01523314|Dexamethasone|dexamethasone|mesh-list
92423659|NCT01523314|Bevacizumab|bevacizumab|mesh-list
92423660|NCT01523314|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92423661|NCT01523314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423662|NCT01523314|Antiemetics|antiemetics|mesh-ancestor
92423663|NCT01523314|Autonomic Agents|autonomic agents|mesh-ancestor
92423664|NCT01523314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423665|NCT01523314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423666|NCT01523314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423667|NCT01523314|Glucocorticoids|glucocorticoids|mesh-ancestor
92423668|NCT01523314|Hormones|hormones|mesh-ancestor
92423669|NCT01523314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423670|NCT01523314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92423671|NCT01523314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423672|NCT01523314|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92423673|NCT01523314|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92423674|NCT01523314|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92423675|NCT01523314|Growth Substances|growth substances|mesh-ancestor
92423676|NCT01523314|Growth Inhibitors|growth inhibitors|mesh-ancestor
92423677|NCT01523314|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92609377|NCT00406380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92609378|NCT00406380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609379|NCT00406380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92423679|NCT01523327|Antioxidants|antioxidants|mesh-ancestor
92423680|NCT01523327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423681|NCT01523327|Protective Agents|protective agents|mesh-ancestor
92423682|NCT01523327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423683|NCT01523379|Parecoxib|parecoxib|mesh-list
92423684|NCT01523379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92423685|NCT01523379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92423686|NCT01523379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423687|NCT01523379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423688|NCT01523379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92423689|NCT01523379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423690|NCT01523379|Analgesics|analgesics|mesh-ancestor
92423691|NCT01523379|Sensory System Agents|sensory system agents|mesh-ancestor
92423692|NCT01523379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423693|NCT01523379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423694|NCT01523379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423695|NCT01523379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92423696|NCT01523418|Rivaroxaban|rivaroxaban|mesh-list
92423697|NCT01523418|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92423698|NCT01523418|Antithrombins|antithrombins|mesh-ancestor
92423699|NCT01523418|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92423700|NCT01523418|Protease Inhibitors|protease inhibitors|mesh-ancestor
92423701|NCT01523418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423702|NCT01523418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423705|NCT01523431|Fluorouracil|fluorouracil|mesh-list
92423707|NCT01523431|Antimetabolites|antimetabolites|mesh-ancestor
92148390|NCT03300427|Valsartan|valsartan|mesh-list
92423708|NCT01523431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423709|NCT01523431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92423710|NCT01523431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423711|NCT01523431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423712|NCT01523431|Immunologic Factors|immunologic factors|mesh-ancestor
92423713|NCT01523431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423714|NCT01523431|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92423715|NCT01523431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92423716|NCT01523431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423718|NCT01523431|Protective Agents|protective agents|mesh-ancestor
92423719|NCT01523431|Vitamin B Complex|vitamin b complex|mesh-ancestor
92423720|NCT01523431|Vitamins|vitamins|mesh-ancestor
92423721|NCT01523431|Micronutrients|micronutrients|mesh-ancestor
92423722|NCT01523483|Progesterone|progesterone|mesh-list
92423723|NCT01523483|Progestins|progestins|mesh-ancestor
92423724|NCT01523483|Hormones|hormones|mesh-ancestor
92423725|NCT01523483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423726|NCT01523483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423727|NCT01523548|Carbon Monoxide|carbon monoxide|mesh-list
92423728|NCT01523548|Antimetabolites|antimetabolites|mesh-ancestor
92423729|NCT01523548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423730|NCT01523548|Gasotransmitters|gasotransmitters|mesh-ancestor
92423731|NCT01523548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423732|NCT01523548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423733|NCT01523574|Calcium, Dietary|calcium, dietary|mesh-list
92423734|NCT01523574|Vitamin E|vitamin e|mesh-list
92423735|NCT01523574|Oxaliplatin|oxaliplatin|mesh-list
92423736|NCT01523574|Magnesium Sulfate|magnesium sulfate|mesh-list
92423737|NCT01523574|Calcium|calcium|mesh-list
92423738|NCT01523574|Vitamins|vitamins|mesh-ancestor
92423739|NCT01523574|Micronutrients|micronutrients|mesh-ancestor
92423740|NCT01523574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423741|NCT01523574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92423742|NCT01523574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92423743|NCT01523574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423744|NCT01523574|Analgesics|analgesics|mesh-ancestor
92423745|NCT01523574|Sensory System Agents|sensory system agents|mesh-ancestor
92423746|NCT01523574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423747|NCT01523574|Anesthetics|anesthetics|mesh-ancestor
92423748|NCT01523574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423749|NCT01523574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423750|NCT01523574|Anticonvulsants|anticonvulsants|mesh-ancestor
92609380|NCT00406380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92609381|NCT00406380|Growth Substances|growth substances|mesh-ancestor
92609382|NCT00406380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609383|NCT00406380|Growth Inhibitors|growth inhibitors|mesh-ancestor
92423751|NCT01523574|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92423752|NCT01523574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423753|NCT01523574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423754|NCT01523574|Tocolytic Agents|tocolytic agents|mesh-ancestor
92423755|NCT01523574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92423756|NCT01523574|Antioxidants|antioxidants|mesh-ancestor
92423757|NCT01523574|Protective Agents|protective agents|mesh-ancestor
92423758|NCT01523639|Metformin|metformin|mesh-list
92423759|NCT01523639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423760|NCT01523639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423761|NCT01523678|Paclitaxel|paclitaxel|mesh-list
92423762|NCT01523678|Carboplatin|carboplatin|mesh-list
92423763|NCT01523678|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92423764|NCT01523678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423765|NCT01523678|Tubulin Modulators|tubulin modulators|mesh-ancestor
92423766|NCT01523678|Antimitotic Agents|antimitotic agents|mesh-ancestor
92423767|NCT01523678|Mitosis Modulators|mitosis modulators|mesh-ancestor
92423768|NCT01523678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423769|NCT01523847|Doxorubicin|doxorubicin|mesh-list
92423770|NCT01523847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92423771|NCT01523847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423772|NCT01523847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92423773|NCT01523847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92423774|NCT01523847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423775|NCT01523847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423776|NCT01523860|Rituximab|rituximab|mesh-list
92423777|NCT01523860|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92423778|NCT01523860|Mitoxantrone|mitoxantrone|mesh-list
92423788|NCT01523860|Sensory System Agents|sensory system agents|mesh-ancestor
92423789|NCT01523860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423790|NCT01523860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92423791|NCT01523860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92423792|NCT01523860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423793|NCT01524068|Rituximab|rituximab|mesh-list
92423794|NCT01524068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92423795|NCT01524068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423796|NCT01524068|Immunologic Factors|immunologic factors|mesh-ancestor
92423797|NCT01524068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423798|NCT01524068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92423799|NCT01524081|Amoxicillin|amoxicillin|mesh-list
92423800|NCT01524081|Metronidazole|metronidazole|mesh-list
92423801|NCT01524081|Clavulanic Acids|clavulanic acids|mesh-list
92423802|NCT01524081|Clavulanic Acid|clavulanic acid|mesh-list
92423803|NCT01524081|Cefuroxime|cefuroxime|mesh-list
92423804|NCT01524081|Cefuroxime axetil|cefuroxime axetil|mesh-list
92423805|NCT01524081|Fluconazole|fluconazole|mesh-list
92423806|NCT01524081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92423807|NCT01524081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92423808|NCT01524081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423809|NCT01524081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92423810|NCT01524081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92423811|NCT01524081|Antifungal Agents|antifungal agents|mesh-ancestor
92395007|NCT01388595|Autonomic Agents|autonomic agents|mesh-ancestor
92423812|NCT01524081|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92423813|NCT01524081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92423814|NCT01524081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423815|NCT01524081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423816|NCT01524081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92423817|NCT01524081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92423818|NCT01524081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423819|NCT01524081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423820|NCT01524081|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92423821|NCT01524081|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92423822|NCT01524081|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92423823|NCT01524094|Leucovorin|leucovorin|mesh-list
92423824|NCT01524094|Fluorouracil|fluorouracil|mesh-list
92423825|NCT01524094|Oxaliplatin|oxaliplatin|mesh-list
92423826|NCT01524094|Levoleucovorin|levoleucovorin|mesh-list
92423827|NCT01524094|Antimetabolites|antimetabolites|mesh-ancestor
92609384|NCT00406497|Difluprednate|difluprednate|mesh-list
92609385|NCT00406497|Glucocorticoids|glucocorticoids|mesh-ancestor
92609386|NCT00406497|Hormones|hormones|mesh-ancestor
92609387|NCT00406497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609388|NCT00406497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609389|NCT00161655|Etanercept|etanercept|mesh-list
92609390|NCT00161655|Methotrexate|methotrexate|mesh-list
92423828|NCT01524094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423829|NCT01524094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92423830|NCT01524094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423831|NCT01524094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423832|NCT01524094|Immunologic Factors|immunologic factors|mesh-ancestor
92423833|NCT01524094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423834|NCT01524094|Antidotes|antidotes|mesh-ancestor
92423835|NCT01524094|Protective Agents|protective agents|mesh-ancestor
92423836|NCT01524094|Vitamin B Complex|vitamin b complex|mesh-ancestor
92423837|NCT01524094|Vitamins|vitamins|mesh-ancestor
92423838|NCT01524094|Micronutrients|micronutrients|mesh-ancestor
92423839|NCT01524237|Ketamine|ketamine|mesh-list
92423840|NCT01524237|Analgesics|analgesics|mesh-ancestor
92423841|NCT01524237|Sensory System Agents|sensory system agents|mesh-ancestor
92423842|NCT01524237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423843|NCT01524237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423844|NCT01524237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92423848|NCT01524237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423849|NCT01524237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92423850|NCT01524237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92423851|NCT01524237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423852|NCT01524237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423853|NCT01524315|Vitamins|vitamins|mesh-list
92423854|NCT01524315|Thiamine|thiamine|mesh-list
92423855|NCT01524315|Vitamin B Complex|vitamin b complex|mesh-list
92423856|NCT01524315|Micronutrients|micronutrients|mesh-ancestor
92423857|NCT01524315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423858|NCT01524354|Anesthetics|anesthetics|mesh-list
92423859|NCT01524354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423860|NCT01524354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423861|NCT01524367|Dexmedetomidine|dexmedetomidine|mesh-list
92423862|NCT01524367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92423863|NCT01524367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423864|NCT01524367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423865|NCT01524367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423866|NCT01524367|Analgesics|analgesics|mesh-ancestor
92423867|NCT01524367|Sensory System Agents|sensory system agents|mesh-ancestor
92423868|NCT01524367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423869|NCT01524367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92423870|NCT01524367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92423871|NCT01524367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92423872|NCT01524367|Adrenergic Agents|adrenergic agents|mesh-ancestor
92423873|NCT01524367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423874|NCT01524367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423875|NCT01524432|Clotrimazole|clotrimazole|mesh-list
92423876|NCT01524432|Miconazole|miconazole|mesh-list
92423877|NCT01524432|Antifungal Agents|antifungal agents|mesh-list
92423878|NCT01524432|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92423879|NCT01524432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423880|NCT01524432|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92423881|NCT01524432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92423882|NCT01524432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423883|NCT01524432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423884|NCT01524432|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92423885|NCT01524432|Hormone Antagonists|hormone antagonists|mesh-ancestor
92423886|NCT01524432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423887|NCT01524432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423888|NCT01524432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92423889|NCT01524432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92423890|NCT01524445|Bortezomib|bortezomib|mesh-list
92609391|NCT00161655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92609392|NCT00161655|Abortifacient Agents|abortifacient agents|mesh-ancestor
92609393|NCT00161655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609394|NCT00161655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609395|NCT00161655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92609396|NCT00161655|Antimetabolites|antimetabolites|mesh-ancestor
92016563|NCT04977427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92423891|NCT01524445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423892|NCT01524497|Trazodone|trazodone|mesh-list
92423893|NCT01524497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92423894|NCT01524497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92423895|NCT01524497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423896|NCT01524497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423897|NCT01524497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92423898|NCT01524497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92423899|NCT01524497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92423900|NCT01524497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423901|NCT01524497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423902|NCT01524497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423903|NCT01524497|Serotonin Agents|serotonin agents|mesh-ancestor
92423904|NCT01524497|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92423905|NCT01524497|Antidepressive Agents|antidepressive agents|mesh-ancestor
92423906|NCT01524575|Gemcitabine|gemcitabine|mesh-list
92423907|NCT01524575|Oxaliplatin|oxaliplatin|mesh-list
92423908|NCT01524575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92423909|NCT01524575|Antimetabolites|antimetabolites|mesh-ancestor
92423910|NCT01524575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423911|NCT01524575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423912|NCT01524601|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92423913|NCT01524601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92423914|NCT01524601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92423916|NCT01524601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423917|NCT01524601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92423918|NCT01524601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92423919|NCT01524601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423920|NCT01524653|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92423921|NCT01524653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92423922|NCT01524653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92423923|NCT01524653|Antimetabolites|antimetabolites|mesh-ancestor
92423924|NCT01524653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423925|NCT01524653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92423926|NCT01524653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92395034|NCT01388660|Clopidogrel|clopidogrel|mesh-list
92423927|NCT01524653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423928|NCT01524705|Insulin|insulin|mesh-list
92423929|NCT01524705|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92423930|NCT01524705|Metformin|metformin|mesh-list
92423931|NCT01524705|Insulin Glargine|insulin glargine|mesh-list
92423933|NCT01524705|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92423934|NCT01524705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423935|NCT01524705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423936|NCT01524705|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92423937|NCT01524705|Incretins|incretins|mesh-ancestor
92423938|NCT01524705|Hormones|hormones|mesh-ancestor
92423939|NCT01524705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423940|NCT01524731|Dexamethasone|dexamethasone|mesh-list
92423941|NCT01524731|Dexamethasone acetate|dexamethasone acetate|mesh-list
92423942|NCT01524731|BB 1101|bb 1101|mesh-list
92423943|NCT01524731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423944|NCT01524731|Antiemetics|antiemetics|mesh-ancestor
92423945|NCT01524731|Autonomic Agents|autonomic agents|mesh-ancestor
92423946|NCT01524731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423947|NCT01524731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423948|NCT01524731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423949|NCT01524731|Glucocorticoids|glucocorticoids|mesh-ancestor
92423950|NCT01524731|Hormones|hormones|mesh-ancestor
92423951|NCT01524731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609397|NCT00161655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609398|NCT00161655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609399|NCT00161655|Dermatologic Agents|dermatologic agents|mesh-ancestor
92609400|NCT00161655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083526|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92423952|NCT01524731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92423953|NCT01524731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423954|NCT01524731|Protease Inhibitors|protease inhibitors|mesh-ancestor
92423955|NCT01524731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423956|NCT01524731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423957|NCT01524744|Pimecrolimus|pimecrolimus|mesh-list
92423958|NCT01524744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92423959|NCT01524744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423960|NCT01524744|Analgesics|analgesics|mesh-ancestor
92423961|NCT01524744|Sensory System Agents|sensory system agents|mesh-ancestor
92423962|NCT01524744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423963|NCT01524744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423964|NCT01524744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92423965|NCT01524744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92423966|NCT01524744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92423967|NCT01524744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92423968|NCT01524744|Immunologic Factors|immunologic factors|mesh-ancestor
92423969|NCT01524744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92423970|NCT01524744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423971|NCT01524744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423972|NCT01524757|Pantoprazole|pantoprazole|mesh-list
92423973|NCT01524757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92423974|NCT01524757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423975|NCT01524757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92423976|NCT01524757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423977|NCT01524757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423978|NCT01524809|Insulin|insulin|mesh-list
92423979|NCT01524809|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92423980|NCT01524809|Insulin Aspart|insulin aspart|mesh-list
92423981|NCT01524809|Insulin, Long-Acting|insulin, long-acting|mesh-list
92423982|NCT01524809|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92423983|NCT01524809|Biphasic Insulins|biphasic insulins|mesh-list
92423984|NCT01524809|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92423985|NCT01524809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92395043|NCT01388738|Cerebrolysin|cerebrolysin|mesh-list
92423986|NCT01524809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423987|NCT01524861|Thioctic Acid|thioctic acid|mesh-list
92423988|NCT01524861|Acetylcarnitine|acetylcarnitine|mesh-list
92423989|NCT01524861|Antioxidants|antioxidants|mesh-ancestor
92424013|NCT01524939|Immunoglobulin G|immunoglobulin g|mesh-list
92424014|NCT01524939|Immunologic Factors|immunologic factors|mesh-ancestor
92424015|NCT01524939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424016|NCT01525004|Vaccines|vaccines|mesh-list
92424017|NCT01525004|Immunologic Factors|immunologic factors|mesh-ancestor
92424018|NCT01525004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424019|NCT01525043|Naproxen|naproxen|mesh-list
92424020|NCT01525043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92424021|NCT01525043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92424022|NCT01525043|Analgesics|analgesics|mesh-ancestor
92424023|NCT01525043|Sensory System Agents|sensory system agents|mesh-ancestor
92424024|NCT01525043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424025|NCT01525043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424026|NCT01525043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424027|NCT01525043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424028|NCT01525043|Gout Suppressants|gout suppressants|mesh-ancestor
92424029|NCT01525043|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92424030|NCT01525043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424031|NCT01525043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424032|NCT01525290|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92424033|NCT01525290|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92424034|NCT01525290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92424035|NCT01525290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424036|NCT01525537|Sufentanil|sufentanil|mesh-list
92424038|NCT01525537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92424039|NCT01525537|Narcotics|narcotics|mesh-ancestor
92609402|NCT00161655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92609403|NCT00161655|Immunologic Factors|immunologic factors|mesh-ancestor
92424040|NCT01525537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424041|NCT01525537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424044|NCT01525537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424045|NCT01525537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92424046|NCT01525537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92424047|NCT01525537|Anesthetics, General|anesthetics, general|mesh-ancestor
92424048|NCT01525537|Anesthetics|anesthetics|mesh-ancestor
92424049|NCT01525680|Hydrocortisone|hydrocortisone|mesh-list
92424050|NCT01525680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424051|NCT01525706|Ethanol|ethanol|mesh-list
92424052|NCT01525706|Paclitaxel|paclitaxel|mesh-list
92424053|NCT01525706|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92395050|NCT01388842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92424054|NCT01525706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92424055|NCT01525706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424056|NCT01525706|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424057|NCT01525706|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424058|NCT01525706|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424059|NCT01525706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424060|NCT01525706|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92424061|NCT01525706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424062|NCT01525706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424063|NCT01525706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424064|NCT01525719|Everolimus|everolimus|mesh-list
92424065|NCT01525719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92424066|NCT01525719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92424067|NCT01525719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424068|NCT01525719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424069|NCT01525719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424070|NCT01525719|Immunologic Factors|immunologic factors|mesh-ancestor
92424071|NCT01525719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424072|NCT01525719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424073|NCT01525771|Cisplatin|cisplatin|mesh-list
92424074|NCT01525771|Docetaxel|docetaxel|mesh-list
92424075|NCT01525771|Capecitabine|capecitabine|mesh-list
92424076|NCT01525771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424077|NCT01525771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424078|NCT01525771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424079|NCT01525771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424080|NCT01525771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424081|NCT01525771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92424082|NCT01525771|Antimetabolites|antimetabolites|mesh-ancestor
92424084|NCT01525823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424085|NCT01525823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424086|NCT01525836|Rituximab|rituximab|mesh-list
92424087|NCT01525836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92424088|NCT01525836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424089|NCT01525836|Immunologic Factors|immunologic factors|mesh-ancestor
92424090|NCT01525836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424091|NCT01525836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424092|NCT01525888|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92424093|NCT01525888|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92424094|NCT01525888|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92424095|NCT01525888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424096|NCT01525888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92424097|NCT01525914|Dutasteride|dutasteride|mesh-list
92424098|NCT01525914|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92424099|NCT01525914|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92424100|NCT01525914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395081|NCT01389063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92424101|NCT01525914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424102|NCT01525914|Hormone Antagonists|hormone antagonists|mesh-ancestor
92424103|NCT01525914|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424104|NCT01525914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424105|NCT01526005|Nicotine|nicotine|mesh-list
92424106|NCT01526005|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92424107|NCT01526005|Autonomic Agents|autonomic agents|mesh-ancestor
92424108|NCT01526005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424109|NCT01526005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424110|NCT01526005|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92609404|NCT00161655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609405|NCT00161655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92609406|NCT00161655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92609407|NCT00161655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609408|NCT00161655|Analgesics|analgesics|mesh-ancestor
92609409|NCT00161655|Sensory System Agents|sensory system agents|mesh-ancestor
92609410|NCT00161655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609411|NCT00161655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609412|NCT00161655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92609413|NCT00161733|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92424111|NCT01526005|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92424112|NCT01526005|Cholinergic Agents|cholinergic agents|mesh-ancestor
92424113|NCT01526005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424114|NCT01526005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424115|NCT01526070|Aflibercept|aflibercept|mesh-list
92424116|NCT01526070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92424117|NCT01526070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92424118|NCT01526070|Growth Substances|growth substances|mesh-ancestor
92424119|NCT01526070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424120|NCT01526070|Growth Inhibitors|growth inhibitors|mesh-ancestor
92424121|NCT01526070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424122|NCT01526083|Lacosamide|lacosamide|mesh-list
92424123|NCT01526083|Warfarin|warfarin|mesh-list
92424124|NCT01526083|Anticoagulants|anticoagulants|mesh-ancestor
92424125|NCT01526083|Anticonvulsants|anticonvulsants|mesh-ancestor
92424126|NCT01526083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92424127|NCT01526083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92424128|NCT01526083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424129|NCT01526083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424130|NCT01526122|Aspirin|aspirin|mesh-list
92424131|NCT01526122|Clopidogrel|clopidogrel|mesh-list
92424132|NCT01526122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92424133|NCT01526122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92424134|NCT01526122|Analgesics|analgesics|mesh-ancestor
92424135|NCT01526122|Sensory System Agents|sensory system agents|mesh-ancestor
92424136|NCT01526122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424137|NCT01526122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424138|NCT01526122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424139|NCT01526122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395107|NCT01389206|Macitentan|macitentan|mesh-list
92424140|NCT01526122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92424141|NCT01526122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92424142|NCT01526122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424143|NCT01526122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92424144|NCT01526122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92424145|NCT01526122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424146|NCT01526122|Antipyretics|antipyretics|mesh-ancestor
92424147|NCT01526122|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92424148|NCT01526122|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92424149|NCT01526122|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92424150|NCT01526122|Purinergic Agents|purinergic agents|mesh-ancestor
92424151|NCT01526122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424152|NCT01526161|Fluticasone|fluticasone|mesh-list
92424154|NCT01526161|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92424155|NCT01526161|Montelukast|montelukast|mesh-list
92424156|NCT01526161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424157|NCT01526161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92424158|NCT01526161|Autonomic Agents|autonomic agents|mesh-ancestor
92424159|NCT01526161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424160|NCT01526161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424161|NCT01526161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92424162|NCT01526161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92424163|NCT01526161|Dermatologic Agents|dermatologic agents|mesh-ancestor
92424164|NCT01526161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92424165|NCT01526161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92424166|NCT01526161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92424167|NCT01526161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92424168|NCT01526161|Adrenergic Agents|adrenergic agents|mesh-ancestor
92424169|NCT01526161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424170|NCT01526161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424171|NCT01526161|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92424172|NCT01526161|Hormone Antagonists|hormone antagonists|mesh-ancestor
92424173|NCT01526161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424174|NCT01526161|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92424175|NCT01526161|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92424176|NCT01526174|Golimumab|golimumab|mesh-list
92424177|NCT01526174|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92424178|NCT01526174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424179|NCT01526174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424180|NCT01526174|Immunologic Factors|immunologic factors|mesh-ancestor
92424181|NCT01526174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424182|NCT01526278|Alendronate|alendronate|mesh-list
92424183|NCT01526278|Calcitriol|calcitriol|mesh-list
92424184|NCT01526278|Maxmarvil|maxmarvil|mesh-list
92424185|NCT01526278|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92424186|NCT01526278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424187|NCT01526278|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92424188|NCT01526278|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92424189|NCT01526278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424199|NCT01526317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92424200|NCT01526317|Antimetabolites|antimetabolites|mesh-ancestor
92424201|NCT01526317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424202|NCT01526317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92424203|NCT01526317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92424204|NCT01526317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424206|NCT01526369|Trastuzumab|trastuzumab|mesh-list
92424207|NCT01526369|Lapatinib|lapatinib|mesh-list
92424208|NCT01526369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92424209|NCT01526369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424210|NCT01526369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424211|NCT01526369|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424212|NCT01526369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424213|NCT01526369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424214|NCT01526369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92424215|NCT01526369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92424216|NCT01526369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424217|NCT01526395|Propofol|propofol|mesh-list
92424218|NCT01526395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92424219|NCT01526395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424220|NCT01526395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424221|NCT01526395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92424222|NCT01526395|Anesthetics, General|anesthetics, general|mesh-ancestor
92424223|NCT01526395|Anesthetics|anesthetics|mesh-ancestor
92424224|NCT01526460|Atorvastatin|atorvastatin|mesh-list
92424225|NCT01526460|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92424226|NCT01526460|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92424227|NCT01526460|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92424228|NCT01526460|Antimetabolites|antimetabolites|mesh-ancestor
92424229|NCT01526460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424230|NCT01526460|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92424231|NCT01526460|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92424232|NCT01526460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424233|NCT01526499|Cyclophosphamide|cyclophosphamide|mesh-list
92424235|NCT01526499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424236|NCT01526499|Immunologic Factors|immunologic factors|mesh-ancestor
92424237|NCT01526499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424238|NCT01526499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424239|NCT01526499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92424240|NCT01526499|Alkylating Agents|alkylating agents|mesh-ancestor
92424241|NCT01526499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424242|NCT01526499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424243|NCT01526499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92424244|NCT01526499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424245|NCT01526499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424246|NCT01526499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424247|NCT01526525|Acetaminophen|acetaminophen|mesh-list
92424248|NCT01526525|Parecoxib|parecoxib|mesh-list
92424249|NCT01526525|Ketamine|ketamine|mesh-list
92424250|NCT01526525|Morphine|morphine|mesh-list
92424251|NCT01526525|Tramadol|tramadol|mesh-list
92609414|NCT00161733|Hemostatics|hemostatics|mesh-ancestor
92609415|NCT00161733|Coagulants|coagulants|mesh-ancestor
92609416|NCT00139841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92609417|NCT00139841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92609418|NCT00139841|Alkylating Agents|alkylating agents|mesh-ancestor
92016585|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
92424252|NCT01526525|Analgesics|analgesics|mesh-ancestor
92424253|NCT01526525|Sensory System Agents|sensory system agents|mesh-ancestor
92424254|NCT01526525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424255|NCT01526525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424256|NCT01526525|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92424257|NCT01526525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92424260|NCT01526525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424261|NCT01526525|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92424262|NCT01526525|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92424263|NCT01526525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424264|NCT01526525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424265|NCT01526525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92424267|NCT01526525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92424268|NCT01526525|Antipyretics|antipyretics|mesh-ancestor
92424269|NCT01526525|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92424270|NCT01526525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92424271|NCT01526525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424272|NCT01526525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92424273|NCT01526525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424274|NCT01526525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424275|NCT01526564|Acetylcarnitine|acetylcarnitine|mesh-list
92424276|NCT01526564|Vitamin B Complex|vitamin b complex|mesh-ancestor
92424277|NCT01526564|Vitamins|vitamins|mesh-ancestor
92424278|NCT01526564|Micronutrients|micronutrients|mesh-ancestor
92424279|NCT01526564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424280|NCT01526564|Nootropic Agents|nootropic agents|mesh-ancestor
92424281|NCT01526616|Metformin|metformin|mesh-list
92424282|NCT01526616|Spironolactone|spironolactone|mesh-list
92424283|NCT01526616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424284|NCT01526616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424285|NCT01526616|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92424286|NCT01526616|Hormone Antagonists|hormone antagonists|mesh-ancestor
92424287|NCT01526616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424288|NCT01526616|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92424289|NCT01526616|Diuretics|diuretics|mesh-ancestor
92424290|NCT01526616|Natriuretic Agents|natriuretic agents|mesh-ancestor
92424291|NCT01526694|Thalidomide|thalidomide|mesh-list
92424292|NCT01526694|Dexamethasone|dexamethasone|mesh-list
92424293|NCT01526694|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92424294|NCT01526694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424295|NCT01526694|Antiemetics|antiemetics|mesh-ancestor
92424296|NCT01526694|Autonomic Agents|autonomic agents|mesh-ancestor
92424297|NCT01526694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424298|NCT01526694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424299|NCT01526694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92424300|NCT01526694|Glucocorticoids|glucocorticoids|mesh-ancestor
92424301|NCT01526694|Hormones|hormones|mesh-ancestor
92424302|NCT01526694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424303|NCT01526694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92424304|NCT01526694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424305|NCT01526694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92424306|NCT01526694|Alkylating Agents|alkylating agents|mesh-ancestor
92424307|NCT01526694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424308|NCT01526694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424309|NCT01526694|Immunologic Factors|immunologic factors|mesh-ancestor
92424310|NCT01526694|Leprostatic Agents|leprostatic agents|mesh-ancestor
92424311|NCT01526694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424312|NCT01526694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424313|NCT01526694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92424314|NCT01526694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92424315|NCT01526694|Growth Substances|growth substances|mesh-ancestor
92424316|NCT01526694|Growth Inhibitors|growth inhibitors|mesh-ancestor
92424317|NCT01526837|Bevacizumab|bevacizumab|mesh-list
92609419|NCT00139841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609420|NCT00139841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609421|NCT00139880|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92609422|NCT00139880|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92609423|NCT00139880|Immunologic Factors|immunologic factors|mesh-ancestor
92609424|NCT00139880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016590|NCT03061981|Metformin|metformin|mesh-list
92424318|NCT01526837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92424319|NCT01526837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424320|NCT01526837|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92424321|NCT01526837|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92424322|NCT01526837|Growth Substances|growth substances|mesh-ancestor
92424323|NCT01526837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424324|NCT01526837|Growth Inhibitors|growth inhibitors|mesh-ancestor
92424325|NCT01526850|Cyclosporine|cyclosporine|mesh-list
92424326|NCT01526850|Cyclosporins|cyclosporins|mesh-list
92424327|NCT01526850|Glucocorticoids|glucocorticoids|mesh-list
92424328|NCT01526850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424329|NCT01526850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424330|NCT01526850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424332|NCT01526850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424333|NCT01526850|Antifungal Agents|antifungal agents|mesh-ancestor
92424334|NCT01526850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424335|NCT01526850|Dermatologic Agents|dermatologic agents|mesh-ancestor
92424336|NCT01526850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424337|NCT01526850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92424338|NCT01526850|Hormones|hormones|mesh-ancestor
92424339|NCT01526850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424340|NCT01526876|Clevidipine|clevidipine|mesh-list
92424341|NCT01526876|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92424342|NCT01526876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424343|NCT01526876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424344|NCT01526876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92424345|NCT01526876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424346|NCT01526941|Insulin|insulin|mesh-list
92424347|NCT01526941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92424348|NCT01526941|Insulin Aspart|insulin aspart|mesh-list
92424349|NCT01526941|Insulin, Long-Acting|insulin, long-acting|mesh-list
92424350|NCT01526941|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92424351|NCT01526941|Biphasic Insulins|biphasic insulins|mesh-list
92424352|NCT01526941|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92424353|NCT01526941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424354|NCT01526941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424355|NCT01526980|Insulin|insulin|mesh-list
92424356|NCT01526980|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92424357|NCT01526980|Insulin Aspart|insulin aspart|mesh-list
92424358|NCT01526980|Insulin, Long-Acting|insulin, long-acting|mesh-list
92424359|NCT01526980|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92424360|NCT01526980|Biphasic Insulins|biphasic insulins|mesh-list
92424361|NCT01526980|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92424362|NCT01526980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424363|NCT01526980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424364|NCT01527019|Cephalosporins|cephalosporins|mesh-list
92424365|NCT01527019|Norfloxacin|norfloxacin|mesh-list
92424366|NCT01527019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424367|NCT01527019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424368|NCT01527019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92424369|NCT01527019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92424370|NCT01527019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424371|NCT01527019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424372|NCT01527019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424373|NCT01527019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92424374|NCT01527019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92424375|NCT01527032|Thalidomide|thalidomide|mesh-list
92424376|NCT01527032|Dexamethasone|dexamethasone|mesh-list
92609425|NCT00139880|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92609426|NCT00139880|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92609427|NCT00139880|Dopamine Agonists|dopamine agonists|mesh-ancestor
92609428|NCT00139880|Dopamine Agents|dopamine agents|mesh-ancestor
92609429|NCT00139880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609430|NCT00139880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609431|NCT04724187|Misoprostol|misoprostol|mesh-list
92609432|NCT04724187|Oxytocin|oxytocin|mesh-list
92609433|NCT04724187|Oxytocics|oxytocics|mesh-ancestor
92609434|NCT04724187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609435|NCT04724187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609436|NCT04724187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92609437|NCT04724187|Abortifacient Agents|abortifacient agents|mesh-ancestor
92609438|NCT04724187|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92609439|NCT04724187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92609440|NCT04727021|Rivaroxaban|rivaroxaban|mesh-list
92609441|NCT04727021|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92609442|NCT04727021|Antithrombins|antithrombins|mesh-ancestor
92609443|NCT04727021|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92609444|NCT04727021|Protease Inhibitors|protease inhibitors|mesh-ancestor
92609445|NCT04727021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609446|NCT04727021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609447|NCT04727021|Anticoagulants|anticoagulants|mesh-ancestor
92609448|NCT04724226|Apatinib|apatinib|mesh-list
92609449|NCT04724226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609450|NCT04724226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92609451|NCT04724226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609452|NCT04724226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609453|NCT04724343|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92609454|NCT04724343|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92609455|NCT04724343|Cetrorelix|cetrorelix|mesh-list
92334500|NCT00004981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609457|NCT04724343|Luteolytic Agents|luteolytic agents|mesh-ancestor
92609458|NCT04724343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92609459|NCT04724343|Contraceptive Agents|contraceptive agents|mesh-ancestor
92609460|NCT04724343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92016593|NCT02510001|Crizotinib|crizotinib|mesh-list
92424377|NCT01527032|Melphalan|melphalan|mesh-list
92424378|NCT01527032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424379|NCT01527032|Antiemetics|antiemetics|mesh-ancestor
92149062|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92609461|NCT04724343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609462|NCT04724343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92609463|NCT04724343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92609464|NCT04724343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609465|NCT04724343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92609466|NCT04724343|Fertility Agents|fertility agents|mesh-ancestor
92609467|NCT04724343|Hormone Antagonists|hormone antagonists|mesh-ancestor
92609468|NCT04724343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016630|NCT02474199|Acetaminophen|acetaminophen|mesh-list
92424380|NCT01527032|Autonomic Agents|autonomic agents|mesh-ancestor
92424381|NCT01527032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424382|NCT01527032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424383|NCT01527032|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92424384|NCT01527032|Glucocorticoids|glucocorticoids|mesh-ancestor
92424385|NCT01527032|Hormones|hormones|mesh-ancestor
92424386|NCT01527032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424387|NCT01527032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92424388|NCT01527032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424389|NCT01527032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92424390|NCT01527032|Alkylating Agents|alkylating agents|mesh-ancestor
92424391|NCT01527032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424392|NCT01527032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92424393|NCT01527032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424394|NCT01527032|Immunologic Factors|immunologic factors|mesh-ancestor
92424395|NCT01527032|Leprostatic Agents|leprostatic agents|mesh-ancestor
92424396|NCT01527032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424397|NCT01527032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424398|NCT01527032|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92424399|NCT01527032|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92424400|NCT01527032|Growth Substances|growth substances|mesh-ancestor
92424401|NCT01527032|Growth Inhibitors|growth inhibitors|mesh-ancestor
92424404|NCT01527097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92424405|NCT01527097|Antimetabolites|antimetabolites|mesh-ancestor
92424406|NCT01527097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424407|NCT01527097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92424408|NCT01527097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92424409|NCT01527097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424410|NCT01527279|Antazoline|antazoline|mesh-list
92424411|NCT01527279|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92424412|NCT01527279|Histamine Antagonists|histamine antagonists|mesh-ancestor
92424413|NCT01527279|Histamine Agents|histamine agents|mesh-ancestor
92424414|NCT01527279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424415|NCT01527279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424416|NCT01527279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424417|NCT01527279|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92424418|NCT01527305|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92424419|NCT01527305|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92424420|NCT01527305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424421|NCT01527305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424422|NCT01527305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424423|NCT01527305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424424|NCT01527305|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92424425|NCT01527305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92424426|NCT01527305|Serotonin Agents|serotonin agents|mesh-ancestor
92424427|NCT01527305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424428|NCT01527305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424429|NCT01527305|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92424430|NCT01527305|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92424431|NCT01527305|Dopamine Agents|dopamine agents|mesh-ancestor
92424432|NCT01527318|Clofibric Acid|clofibric acid|mesh-list
92424433|NCT01527318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92424434|NCT01527318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92424435|NCT01527318|Antimetabolites|antimetabolites|mesh-ancestor
92609470|NCT00140075|Epirubicin|epirubicin|mesh-list
92609471|NCT00140075|Taxane|taxane|mesh-list
92609472|NCT00140075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92609473|NCT00140075|Immunologic Factors|immunologic factors|mesh-ancestor
92609474|NCT00140075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609475|NCT00140075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609476|NCT00140075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92609477|NCT00140075|Alkylating Agents|alkylating agents|mesh-ancestor
92609478|NCT00140075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609479|NCT00140075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609480|NCT00140075|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92395269|NCT01389791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92609481|NCT00140075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92609482|NCT00140075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92424436|NCT01527318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424437|NCT01527318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92424438|NCT01527422|Prednisone|prednisone|mesh-list
92424439|NCT01527422|Cyclophosphamide|cyclophosphamide|mesh-list
92424440|NCT01527422|Doxorubicin|doxorubicin|mesh-list
92424441|NCT01527422|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92424442|NCT01527422|Vincristine|vincristine|mesh-list
92424443|NCT01527422|Sargramostim|sargramostim|mesh-list
92424444|NCT01527422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424445|NCT01527422|Immunologic Factors|immunologic factors|mesh-ancestor
92424446|NCT01527422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424447|NCT01527422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424448|NCT01527422|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92424449|NCT01527422|Alkylating Agents|alkylating agents|mesh-ancestor
92424450|NCT01527422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424451|NCT01527422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424452|NCT01527422|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92149140|NCT00842751|Finasteride|finasteride|mesh-list
92424453|NCT01527422|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92424454|NCT01527422|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92424455|NCT01527422|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92424456|NCT01527422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424457|NCT01527422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424459|NCT01527422|Hormones|hormones|mesh-ancestor
92424460|NCT01527422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424461|NCT01527422|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92424462|NCT01527422|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92424463|NCT01527422|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424464|NCT01527422|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424465|NCT01527422|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424466|NCT01527448|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92424467|NCT01527448|Antidepressive Agents|antidepressive agents|mesh-ancestor
92424468|NCT01527448|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424469|NCT01527448|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92424470|NCT01527448|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424471|NCT01527448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424472|NCT01527448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424473|NCT01527474|Escitalopram|escitalopram|mesh-list
92424474|NCT01527474|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92424484|NCT01527539|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424485|NCT01527539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424486|NCT01527552|Insulin Aspart|insulin aspart|mesh-list
92424487|NCT01527552|Biphasic Insulins|biphasic insulins|mesh-list
92424488|NCT01527552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424489|NCT01527552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424490|NCT01527565|Insulin Aspart|insulin aspart|mesh-list
92424491|NCT01527565|Biphasic Insulins|biphasic insulins|mesh-list
92424492|NCT01527565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609483|NCT00140075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92609484|NCT00140075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609485|NCT00140114|Misoprostol|misoprostol|mesh-list
92609486|NCT00140114|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92609487|NCT00140114|Abortifacient Agents|abortifacient agents|mesh-ancestor
92609488|NCT00140114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609489|NCT00140114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609490|NCT00140114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92609491|NCT00140114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92609492|NCT00140114|Oxytocics|oxytocics|mesh-ancestor
92609493|NCT00140153|Testosterone|testosterone|mesh-list
92609494|NCT00140153|Androgens|androgens|mesh-ancestor
92424493|NCT01527565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424494|NCT01527630|Insulin Aspart|insulin aspart|mesh-list
92424495|NCT01527630|Biphasic Insulins|biphasic insulins|mesh-list
92424496|NCT01527630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424497|NCT01527630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424498|NCT01527643|Insulin Aspart|insulin aspart|mesh-list
92424499|NCT01527643|Biphasic Insulins|biphasic insulins|mesh-list
92424500|NCT01527643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424501|NCT01527643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424502|NCT01527656|Insulin Aspart|insulin aspart|mesh-list
92424503|NCT01527656|Biphasic Insulins|biphasic insulins|mesh-list
92424504|NCT01527656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424505|NCT01527656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424506|NCT01527669|Lovastatin|lovastatin|mesh-list
92424507|NCT01527669|L 647318|l 647318|mesh-list
92424508|NCT01527669|Dihydromevinolin|dihydromevinolin|mesh-list
92424509|NCT01527669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92424510|NCT01527669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92424511|NCT01527669|Antimetabolites|antimetabolites|mesh-ancestor
92424512|NCT01527669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424513|NCT01527669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92424514|NCT01527669|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92424515|NCT01527669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424516|NCT01527734|Tetrodotoxin|tetrodotoxin|mesh-list
92424517|NCT01527734|Anesthetics, Local|anesthetics, local|mesh-ancestor
92424518|NCT01527734|Anesthetics|anesthetics|mesh-ancestor
92424519|NCT01527734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424520|NCT01527734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424521|NCT01527734|Sensory System Agents|sensory system agents|mesh-ancestor
92424522|NCT01527734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424523|NCT01527734|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92424524|NCT01527734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424525|NCT01527734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424526|NCT01527786|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92424527|NCT01527786|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92424528|NCT01527786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92424529|NCT01527786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395322|NCT01390324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424530|NCT01527786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424531|NCT01527786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424532|NCT01527786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424533|NCT01527786|Antidepressive Agents|antidepressive agents|mesh-ancestor
92424534|NCT01527786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424535|NCT01527864|Paclitaxel|paclitaxel|mesh-list
92424536|NCT01527864|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92424537|NCT01527864|Carboplatin|carboplatin|mesh-list
92424538|NCT01527864|Endostatins|endostatins|mesh-list
92424542|NCT01527864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424543|NCT01527864|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424544|NCT01527864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424545|NCT01527864|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92424546|NCT01527864|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92424547|NCT01527864|Growth Substances|growth substances|mesh-ancestor
92609495|NCT00140153|Hormones|hormones|mesh-ancestor
92016664|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92424548|NCT01527864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424549|NCT01527864|Growth Inhibitors|growth inhibitors|mesh-ancestor
92424550|NCT01527890|Fentanyl|fentanyl|mesh-list
92424551|NCT01527890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92424552|NCT01527890|Narcotics|narcotics|mesh-ancestor
92424553|NCT01527890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424554|NCT01527890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424555|NCT01527890|Analgesics|analgesics|mesh-ancestor
92424556|NCT01527890|Sensory System Agents|sensory system agents|mesh-ancestor
92424557|NCT01527890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424558|NCT01527890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92424559|NCT01527890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92424560|NCT01527890|Anesthetics, General|anesthetics, general|mesh-ancestor
92424561|NCT01527890|Anesthetics|anesthetics|mesh-ancestor
92424562|NCT01527903|Midazolam|midazolam|mesh-list
92424563|NCT01527903|Propofol|propofol|mesh-list
92424564|NCT01527903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92424565|NCT01527903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424566|NCT01527903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424567|NCT01527903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92424568|NCT01527903|Anesthetics, General|anesthetics, general|mesh-ancestor
92424569|NCT01527903|Anesthetics|anesthetics|mesh-ancestor
92424570|NCT01527903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92424571|NCT01527903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92424572|NCT01527903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424573|NCT01527903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424574|NCT01527903|GABA Modulators|gaba modulators|mesh-ancestor
92424575|NCT01527903|GABA Agents|gaba agents|mesh-ancestor
92424576|NCT01527903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424577|NCT01527903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424578|NCT01527968|Tranexamic Acid|tranexamic acid|mesh-list
92424579|NCT01527968|Aminocaproic Acid|aminocaproic acid|mesh-list
92424580|NCT01527968|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92424581|NCT01527968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92424582|NCT01527968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424583|NCT01527968|Hemostatics|hemostatics|mesh-ancestor
92424584|NCT01527968|Coagulants|coagulants|mesh-ancestor
92424585|NCT01527994|Aprepitant|aprepitant|mesh-list
92424586|NCT01527994|Antiemetics|antiemetics|mesh-ancestor
92424587|NCT01527994|Autonomic Agents|autonomic agents|mesh-ancestor
92424588|NCT01527994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424589|NCT01527994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424590|NCT01527994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92424591|NCT01527994|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92424592|NCT01527994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424593|NCT01527994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424594|NCT01528007|Naltrexone|naltrexone|mesh-list
92424595|NCT01528007|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92424596|NCT01528007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92424597|NCT01528007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424598|NCT01528007|Sensory System Agents|sensory system agents|mesh-ancestor
92424599|NCT01528007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424600|NCT01528137|Lactoferrin|lactoferrin|mesh-list
92424601|NCT01528137|Talactoferrin alfa|talactoferrin alfa|mesh-list
92424602|NCT01528137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424603|NCT01528137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424604|NCT01528163|Methotrexate|methotrexate|mesh-list
92424605|NCT01528163|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92424606|NCT01528163|Abortifacient Agents|abortifacient agents|mesh-ancestor
92424607|NCT01528163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92424608|NCT01528163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424609|NCT01528163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92424610|NCT01528163|Antimetabolites|antimetabolites|mesh-ancestor
92424611|NCT01528163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424630|NCT01528371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424631|NCT01528371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424632|NCT01528371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92424633|NCT01528371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424634|NCT01528371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424635|NCT01528371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92424636|NCT01528371|Anesthetics, General|anesthetics, general|mesh-ancestor
92424638|NCT01528371|GABA Modulators|gaba modulators|mesh-ancestor
92424639|NCT01528371|GABA Agents|gaba agents|mesh-ancestor
92609496|NCT00140153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609497|NCT00140153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424640|NCT01528371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424641|NCT01528371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424642|NCT01528501|Panobinostat|panobinostat|mesh-list
92424643|NCT01528501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424644|NCT01528501|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92424645|NCT01528501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424646|NCT01528501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424647|NCT01528540|Pregabalin|pregabalin|mesh-list
92424648|NCT01528540|Antioxidants|antioxidants|mesh-list
92424649|NCT01528540|Analgesics|analgesics|mesh-ancestor
92424650|NCT01528540|Sensory System Agents|sensory system agents|mesh-ancestor
92424651|NCT01528540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424652|NCT01528540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424653|NCT01528540|Anticonvulsants|anticonvulsants|mesh-ancestor
92424654|NCT01528540|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92424655|NCT01528540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424656|NCT01528540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424657|NCT01528540|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92424658|NCT01528540|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92424659|NCT01528540|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424660|NCT01528540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424661|NCT01528540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424662|NCT01528540|Protective Agents|protective agents|mesh-ancestor
92424663|NCT01528618|Cisplatin|cisplatin|mesh-list
92424664|NCT01528618|Gemcitabine|gemcitabine|mesh-list
92424665|NCT01528618|Fluorouracil|fluorouracil|mesh-list
92424666|NCT01528618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424667|NCT01528618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92424668|NCT01528618|Antimetabolites|antimetabolites|mesh-ancestor
92424669|NCT01528618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424671|NCT01528618|Immunologic Factors|immunologic factors|mesh-ancestor
92424672|NCT01528618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424673|NCT01528644|Calcium, Dietary|calcium, dietary|mesh-list
92424674|NCT01528644|Iron|iron|mesh-list
92424675|NCT01528644|Ferrous gluconate|ferrous gluconate|mesh-list
92424676|NCT01528644|Calcium|calcium|mesh-list
92424677|NCT01528644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92149361|NCT00876915|Anticoagulants|anticoagulants|mesh-ancestor
92424678|NCT01528644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424679|NCT01528644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92424680|NCT01528644|Trace Elements|trace elements|mesh-ancestor
92424681|NCT01528644|Micronutrients|micronutrients|mesh-ancestor
92424683|NCT01528722|Bupivacaine|bupivacaine|mesh-list
92424684|NCT01528722|Anesthetics, Local|anesthetics, local|mesh-ancestor
92424685|NCT01528722|Anesthetics|anesthetics|mesh-ancestor
92424686|NCT01528722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424687|NCT01528722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424688|NCT01528722|Sensory System Agents|sensory system agents|mesh-ancestor
92424689|NCT01528722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424690|NCT01528800|Vitamin K|vitamin k|mesh-list
92424691|NCT01528800|Vitamin K 1|vitamin k 1|mesh-list
92424692|NCT01528800|Vitamins|vitamins|mesh-ancestor
92424693|NCT01528800|Micronutrients|micronutrients|mesh-ancestor
92424694|NCT01528800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424695|NCT01528800|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92424696|NCT01528800|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92424697|NCT01528800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424698|NCT01528800|Hemostatics|hemostatics|mesh-ancestor
92424699|NCT01528800|Coagulants|coagulants|mesh-ancestor
92424700|NCT01528813|Amorolfine|amorolfine|mesh-list
92424701|NCT01528813|Antifungal Agents|antifungal agents|mesh-ancestor
92424702|NCT01528813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424703|NCT01528826|Oxaliplatin|oxaliplatin|mesh-list
92424704|NCT01528826|Vinorelbine|vinorelbine|mesh-list
92424705|NCT01528826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424706|NCT01528826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92424707|NCT01528826|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424708|NCT01528826|Antimitotic Agents|antimitotic agents|mesh-ancestor
92424709|NCT01528826|Mitosis Modulators|mitosis modulators|mesh-ancestor
92424710|NCT01528826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424711|NCT01528852|Chlorhexidine|chlorhexidine|mesh-list
92609498|NCT00140309|Moxifloxacin|moxifloxacin|mesh-list
92609499|NCT00140309|Rifampin|rifampin|mesh-list
92609500|NCT00140309|Isoniazid|isoniazid|mesh-list
92609501|NCT00140309|Pyrazinamide|pyrazinamide|mesh-list
92609502|NCT00140309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609503|NCT00140309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424712|NCT01528852|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92424713|NCT01528852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92424714|NCT01528852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424715|NCT01528852|Disinfectants|disinfectants|mesh-ancestor
92424716|NCT01528852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92424717|NCT01528865|Tenofovir|tenofovir|mesh-list
92424718|NCT01528865|Lamivudine|lamivudine|mesh-list
92424719|NCT01528865|Antiviral Agents|antiviral agents|mesh-ancestor
92424720|NCT01528865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424721|NCT01528865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92424722|NCT01528865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92424723|NCT01528865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424724|NCT01528865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424725|NCT01528865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92424726|NCT01528865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92424727|NCT01528930|Amikacin|amikacin|mesh-list
92424728|NCT01528930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424729|NCT01528930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424730|NCT01528943|Epoprostenol|epoprostenol|mesh-list
92424731|NCT01528943|Tezosentan|tezosentan|mesh-list
92424732|NCT01528943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92424733|NCT01528943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92424734|NCT01528943|Vasodilator Agents|vasodilator agents|mesh-ancestor
92424735|NCT01529073|Nitazoxanide|nitazoxanide|mesh-list
92424736|NCT01529073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92424737|NCT01529073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424738|NCT01529125|Lamivudine|lamivudine|mesh-list
92424739|NCT01529125|Zidovudine|zidovudine|mesh-list
92424740|NCT01529125|Nevirapine|nevirapine|mesh-list
92424741|NCT01529125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92424742|NCT01529125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92424743|NCT01529125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424744|NCT01529125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424745|NCT01529125|Antiviral Agents|antiviral agents|mesh-ancestor
92424746|NCT01529125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424747|NCT01529125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92424749|NCT01529125|Antimetabolites|antimetabolites|mesh-ancestor
92424750|NCT01529125|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92424751|NCT01529125|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92424753|NCT01529138|Temsirolimus|temsirolimus|mesh-list
92424754|NCT01529138|MTOR Inhibitors|mtor inhibitors|mesh-list
92424755|NCT01529138|Axitinib|axitinib|mesh-list
92424756|NCT01529138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92424758|NCT01529138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424759|NCT01529138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424760|NCT01529138|Immunologic Factors|immunologic factors|mesh-ancestor
92424761|NCT01529138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424762|NCT01529138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424763|NCT01529138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424764|NCT01529138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424765|NCT01529138|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92424766|NCT01529138|Antifungal Agents|antifungal agents|mesh-ancestor
92424767|NCT01529164|Leucovorin|leucovorin|mesh-list
92424768|NCT01529164|Fluorouracil|fluorouracil|mesh-list
92424769|NCT01529164|Oxaliplatin|oxaliplatin|mesh-list
92424770|NCT01529164|Endostar protein|endostar protein|mesh-list
92424771|NCT01529164|Endostatins|endostatins|mesh-list
92424772|NCT01529164|Antimetabolites|antimetabolites|mesh-ancestor
92424773|NCT01529164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424774|NCT01529164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92424775|NCT01529164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424776|NCT01529164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424777|NCT01529164|Immunologic Factors|immunologic factors|mesh-ancestor
92424778|NCT01529164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424779|NCT01529164|Antidotes|antidotes|mesh-ancestor
92424780|NCT01529164|Protective Agents|protective agents|mesh-ancestor
92424781|NCT01529164|Vitamin B Complex|vitamin b complex|mesh-ancestor
92424782|NCT01529164|Vitamins|vitamins|mesh-ancestor
92609504|NCT00140309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92609505|NCT00140309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92609506|NCT00140309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609507|NCT00140309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609508|NCT00140309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609509|NCT00140309|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92609510|NCT00140309|Antitubercular Agents|antitubercular agents|mesh-ancestor
92609511|NCT00140309|Leprostatic Agents|leprostatic agents|mesh-ancestor
92609512|NCT00140309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92609513|NCT00140309|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92609514|NCT00140309|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92609515|NCT00140309|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92609516|NCT00140309|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92609517|NCT00140309|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92609518|NCT00140309|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92424783|NCT01529164|Micronutrients|micronutrients|mesh-ancestor
92424784|NCT01529164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92424785|NCT01529164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92424786|NCT01529164|Growth Substances|growth substances|mesh-ancestor
92424787|NCT01529164|Growth Inhibitors|growth inhibitors|mesh-ancestor
92424789|NCT01529177|Citric Acid|citric acid|mesh-list
92424790|NCT01529177|Sodium Citrate|sodium citrate|mesh-list
92424791|NCT01529177|Clomiphene|clomiphene|mesh-list
92424792|NCT01529177|Enclomiphene|enclomiphene|mesh-list
92424793|NCT01529177|Zuclomiphene|zuclomiphene|mesh-list
92424794|NCT01529177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424795|NCT01529177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424796|NCT01529177|Anticoagulants|anticoagulants|mesh-ancestor
92424797|NCT01529177|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92424798|NCT01529177|Chelating Agents|chelating agents|mesh-ancestor
92424799|NCT01529177|Sequestering Agents|sequestering agents|mesh-ancestor
92424800|NCT01529177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424801|NCT01529177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92424802|NCT01529177|Hormone Antagonists|hormone antagonists|mesh-ancestor
92424803|NCT01529177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424804|NCT01529177|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92424805|NCT01529177|Fertility Agents|fertility agents|mesh-ancestor
92424806|NCT01529177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92424807|NCT01529177|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92424808|NCT01529177|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92424809|NCT01529190|Pregabalin|pregabalin|mesh-list
92424810|NCT01529190|Analgesics|analgesics|mesh-ancestor
92424811|NCT01529190|Sensory System Agents|sensory system agents|mesh-ancestor
92424812|NCT01529190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424813|NCT01529190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424814|NCT01529190|Anticonvulsants|anticonvulsants|mesh-ancestor
92424815|NCT01529190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92424816|NCT01529190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424817|NCT01529190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424818|NCT01529190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92424819|NCT01529190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92424820|NCT01529190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424821|NCT01529190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424822|NCT01529190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424823|NCT01529229|Prednisolone|prednisolone|mesh-list
92424824|NCT01529229|Betamethasone|betamethasone|mesh-list
92609519|NCT00140309|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92609520|NCT00140309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92609521|NCT00140309|Antimetabolites|antimetabolites|mesh-ancestor
92609522|NCT00140309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92609523|NCT00161811|Vaccines|vaccines|mesh-list
92609524|NCT00161811|Immunologic Factors|immunologic factors|mesh-ancestor
92609525|NCT00161811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609526|NCT01240135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92609527|NCT00140348|Immunomodulating Agents|immunomodulating agents|mesh-list
92424826|NCT01529229|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92424827|NCT01529229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424828|NCT01529229|Glucocorticoids|glucocorticoids|mesh-ancestor
92424829|NCT01529229|Hormones|hormones|mesh-ancestor
92424830|NCT01529229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424831|NCT01529229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424832|NCT01529229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92424833|NCT01529229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424834|NCT01529229|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92424835|NCT01529229|Respiratory System Agents|respiratory system agents|mesh-ancestor
92424836|NCT01529229|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92424837|NCT01529229|Cholinergic Agents|cholinergic agents|mesh-ancestor
92424838|NCT01529229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424839|NCT01529229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424840|NCT01529229|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92424841|NCT01529229|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92424842|NCT01529229|Histamine Antagonists|histamine antagonists|mesh-ancestor
92424844|NCT01529242|Prednisolone|prednisolone|mesh-list
92424845|NCT01529242|Betamethasone|betamethasone|mesh-list
92424846|NCT01529242|Desloratadine|desloratadine|mesh-list
92424847|NCT01529242|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92424848|NCT01529242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424849|NCT01529242|Glucocorticoids|glucocorticoids|mesh-ancestor
92424850|NCT01529242|Hormones|hormones|mesh-ancestor
92424851|NCT01529242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424852|NCT01529242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424853|NCT01529242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92424854|NCT01529242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424855|NCT01529242|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92424856|NCT01529242|Respiratory System Agents|respiratory system agents|mesh-ancestor
92424857|NCT01529242|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92424858|NCT01529242|Cholinergic Agents|cholinergic agents|mesh-ancestor
92424859|NCT01529242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424860|NCT01529242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424861|NCT01529242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92424862|NCT01529242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92424863|NCT01529242|Histamine Antagonists|histamine antagonists|mesh-ancestor
92424864|NCT01529242|Histamine Agents|histamine agents|mesh-ancestor
92424865|NCT01529255|Telbivudine|telbivudine|mesh-list
92424866|NCT01529255|Antiviral Agents|antiviral agents|mesh-ancestor
92424867|NCT01529255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424868|NCT01529255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92424869|NCT01529255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424870|NCT01529255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424871|NCT01529294|Iloperidone|iloperidone|mesh-list
92424872|NCT01529294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92424873|NCT01529294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424874|NCT01529294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424875|NCT01529294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424876|NCT01529294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424877|NCT01529320|Methylprednisolone|methylprednisolone|mesh-list
92424878|NCT01529320|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92424879|NCT01529320|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92424880|NCT01529320|Prednisolone|prednisolone|mesh-list
92424881|NCT01529320|Prednisolone acetate|prednisolone acetate|mesh-list
92424882|NCT01529320|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
92334576|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92609529|NCT00140348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609531|NCT01240759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609532|NCT01240759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609533|NCT01241734|Lenalidomide|lenalidomide|mesh-list
92609534|NCT01241734|Immunologic Factors|immunologic factors|mesh-ancestor
92424883|NCT01529320|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92424884|NCT01529320|Prednisolone phosphate|prednisolone phosphate|mesh-list
92424885|NCT01529320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92424886|NCT01529320|Antiemetics|antiemetics|mesh-ancestor
92424887|NCT01529320|Autonomic Agents|autonomic agents|mesh-ancestor
92424888|NCT01529320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424889|NCT01529320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424890|NCT01529320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92424891|NCT01529320|Glucocorticoids|glucocorticoids|mesh-ancestor
92424892|NCT01529320|Hormones|hormones|mesh-ancestor
92424893|NCT01529320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424894|NCT01529320|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92424895|NCT01529320|Protective Agents|protective agents|mesh-ancestor
92424896|NCT01529320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92424897|NCT01529320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424898|NCT01529437|Immunomodulating Agents|immunomodulating agents|mesh-list
92424909|NCT01529476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424910|NCT01529476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424911|NCT01529476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92424912|NCT01529476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92424913|NCT01529528|Anagliptin|anagliptin|mesh-list
92424914|NCT01529528|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92424915|NCT01529528|Protease Inhibitors|protease inhibitors|mesh-ancestor
92424916|NCT01529528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424917|NCT01529528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424918|NCT01529528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424919|NCT01529528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424920|NCT01529541|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92424921|NCT01529541|Anagliptin|anagliptin|mesh-list
92424922|NCT01529541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424923|NCT01529541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424924|NCT01529541|Incretins|incretins|mesh-ancestor
92424925|NCT01529541|Hormones|hormones|mesh-ancestor
92424926|NCT01529541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92424927|NCT01529541|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92424928|NCT01529541|Protease Inhibitors|protease inhibitors|mesh-ancestor
92424929|NCT01529541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424930|NCT01529541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424931|NCT01529554|Everolimus|everolimus|mesh-list
92424932|NCT01529554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92424933|NCT01529554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92424934|NCT01529554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424935|NCT01529554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424936|NCT01529554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424937|NCT01529554|Immunologic Factors|immunologic factors|mesh-ancestor
92424938|NCT01529554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424939|NCT01529554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424940|NCT01529619|Rivastigmine|rivastigmine|mesh-list
92424941|NCT01529619|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92424942|NCT01529619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424943|NCT01529619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424944|NCT01529619|Cholinergic Agents|cholinergic agents|mesh-ancestor
92424945|NCT01529619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424946|NCT01529619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424947|NCT01529619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92424948|NCT01529619|Protective Agents|protective agents|mesh-ancestor
92424949|NCT01529710|Praziquantel|praziquantel|mesh-list
92424950|NCT01529710|Anthelmintics|anthelmintics|mesh-ancestor
92424951|NCT01529710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92424952|NCT01529710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609535|NCT01241734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609536|NCT01241734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92609537|NCT01241734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92609538|NCT01241734|Growth Substances|growth substances|mesh-ancestor
92609539|NCT01241734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016705|NCT02504541|Androgens|androgens|mesh-ancestor
92424953|NCT01529788|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92424954|NCT01529788|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92424955|NCT01529788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92424956|NCT01529788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424957|NCT01529788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424958|NCT01529788|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92424959|NCT01529788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424960|NCT01529788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424961|NCT01529788|Cholinergic Agents|cholinergic agents|mesh-ancestor
92424962|NCT01529788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424964|NCT01529892|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92424965|NCT01529892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424967|NCT01529892|Autonomic Agents|autonomic agents|mesh-ancestor
92424968|NCT01529892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424969|NCT01529892|Dopamine Agents|dopamine agents|mesh-ancestor
92424970|NCT01529892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395427|NCT01390896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92424971|NCT01529892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424972|NCT01529892|Adrenergic Agents|adrenergic agents|mesh-ancestor
92424973|NCT01529892|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92424974|NCT01529892|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92424975|NCT01529892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424976|NCT01529892|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92424977|NCT01529957|Nemonoxacin|nemonoxacin|mesh-list
92424978|NCT01529957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424979|NCT01529957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424980|NCT01530022|Lacosamide|lacosamide|mesh-list
92424981|NCT01530022|Carbamazepine|carbamazepine|mesh-list
92424982|NCT01530022|Anticonvulsants|anticonvulsants|mesh-ancestor
92424983|NCT01530022|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92424984|NCT01530022|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92424985|NCT01530022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424986|NCT01530022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424987|NCT01530022|Antimanic Agents|antimanic agents|mesh-ancestor
92424988|NCT01530022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92424989|NCT01530022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92424990|NCT01530022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424991|NCT01530022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92424992|NCT01530022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92424993|NCT01530022|Analgesics|analgesics|mesh-ancestor
92424994|NCT01530022|Sensory System Agents|sensory system agents|mesh-ancestor
92424995|NCT01530022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92424996|NCT01530022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92424997|NCT01530022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92424998|NCT01530048|Insulin Aspart|insulin aspart|mesh-list
92424999|NCT01530048|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92425000|NCT01530048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425001|NCT01530126|Becaplermin|becaplermin|mesh-list
92425002|NCT01530126|Anticoagulants|anticoagulants|mesh-ancestor
92425003|NCT01530126|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92425004|NCT01530126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92425005|NCT01530126|Growth Substances|growth substances|mesh-ancestor
92425006|NCT01530126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425007|NCT01530152|Lidocaine|lidocaine|mesh-list
92425008|NCT01530152|Anesthetics, Local|anesthetics, local|mesh-ancestor
92425009|NCT01530152|Anesthetics|anesthetics|mesh-ancestor
92425010|NCT01530152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425011|NCT01530152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425012|NCT01530152|Sensory System Agents|sensory system agents|mesh-ancestor
92425013|NCT01530152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425014|NCT01530152|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92425015|NCT01530152|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92609540|NCT01241734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425016|NCT01530152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92425017|NCT01530152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92425018|NCT01530152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425019|NCT01530217|Ibuprofen|ibuprofen|mesh-list
92425020|NCT01530217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425021|NCT01530217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425022|NCT01530217|Analgesics|analgesics|mesh-ancestor
92425023|NCT01530217|Sensory System Agents|sensory system agents|mesh-ancestor
92425024|NCT01530217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425025|NCT01530217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425026|NCT01530217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425027|NCT01530217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425028|NCT01530217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92425029|NCT01530217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425030|NCT01530217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425031|NCT01530230|Oxytocin|oxytocin|mesh-list
92425032|NCT01530230|Oxytocics|oxytocics|mesh-ancestor
92425033|NCT01530230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92425034|NCT01530230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425042|NCT01530308|Haloperidol|haloperidol|mesh-list
92425043|NCT01530308|Haloperidol decanoate|haloperidol decanoate|mesh-list
92425044|NCT01530308|Antipsychotic Agents|antipsychotic agents|mesh-list
92425045|NCT01530308|Dopamine Antagonists|dopamine antagonists|mesh-list
92425046|NCT01530308|Antiemetics|antiemetics|mesh-ancestor
92425047|NCT01530308|Autonomic Agents|autonomic agents|mesh-ancestor
92425048|NCT01530308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425049|NCT01530308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425050|NCT01530308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425051|NCT01530308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92425052|NCT01530308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425053|NCT01530308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92425054|NCT01530308|Dopamine Agents|dopamine agents|mesh-ancestor
92425055|NCT01530308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425056|NCT01530308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425057|NCT01530308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92425058|NCT01530308|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92425059|NCT01530308|Sympathomimetics|sympathomimetics|mesh-ancestor
92425060|NCT01530308|Protective Agents|protective agents|mesh-ancestor
92425061|NCT01530386|Lacosamide|lacosamide|mesh-list
92425062|NCT01530386|Anticonvulsants|anticonvulsants|mesh-ancestor
92425063|NCT01530386|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92425064|NCT01530386|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92425065|NCT01530386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92425066|NCT01530386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425067|NCT01530438|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92425068|NCT01530438|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92425069|NCT01530438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425070|NCT01530451|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92425071|NCT01530451|Hemostatics|hemostatics|mesh-ancestor
92425072|NCT01530451|Coagulants|coagulants|mesh-ancestor
92425073|NCT01530451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92425074|NCT01530451|Natriuretic Agents|natriuretic agents|mesh-ancestor
92425075|NCT01530451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425076|NCT01530490|Cabergoline|cabergoline|mesh-list
92425077|NCT01530490|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92425078|NCT01530490|Plasma Substitutes|plasma substitutes|mesh-ancestor
92425079|NCT01530490|Blood Substitutes|blood substitutes|mesh-ancestor
92425080|NCT01530490|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92425081|NCT01530490|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92425082|NCT01530490|Dopamine Agonists|dopamine agonists|mesh-ancestor
92425083|NCT01530490|Dopamine Agents|dopamine agents|mesh-ancestor
92425084|NCT01530490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425085|NCT01530490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425086|NCT01530490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425087|NCT01530503|Capecitabine|capecitabine|mesh-list
92425088|NCT01530503|Mitomycins|mitomycins|mesh-list
92425089|NCT01530503|Mitomycin|mitomycin|mesh-list
92425090|NCT01530503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92425091|NCT01530503|Antimetabolites|antimetabolites|mesh-ancestor
92425092|NCT01530503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425093|NCT01530503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425094|NCT01530503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92425095|NCT01530503|Alkylating Agents|alkylating agents|mesh-ancestor
92609541|NCT00140387|Immunomodulating Agents|immunomodulating agents|mesh-list
92609542|NCT00140387|Immunologic Factors|immunologic factors|mesh-ancestor
92609543|NCT00140387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609544|NCT00504634|Bortezomib|bortezomib|mesh-list
92609545|NCT00504634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609546|NCT00140465|Clopidogrel|clopidogrel|mesh-list
92609547|NCT00140465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92609548|NCT00140465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92609549|NCT00140465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92425096|NCT01530503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92425097|NCT01530503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425098|NCT01530542|Oxycodone|oxycodone|mesh-list
92425099|NCT01530542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92425100|NCT01530542|Narcotics|narcotics|mesh-ancestor
92425101|NCT01530542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425102|NCT01530542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425103|NCT01530542|Analgesics|analgesics|mesh-ancestor
92425104|NCT01530542|Sensory System Agents|sensory system agents|mesh-ancestor
92425121|NCT01530607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425122|NCT01530607|Immunologic Factors|immunologic factors|mesh-ancestor
92425123|NCT01530607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425124|NCT01530607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425125|NCT01530607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92425126|NCT01530607|Alkylating Agents|alkylating agents|mesh-ancestor
92425127|NCT01530607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425128|NCT01530607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425129|NCT01530607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92425130|NCT01530607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92425131|NCT01530620|Propiverine|propiverine|mesh-list
92425132|NCT01530620|Parasympatholytics|parasympatholytics|mesh-ancestor
92425133|NCT01530620|Autonomic Agents|autonomic agents|mesh-ancestor
92425134|NCT01530620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425135|NCT01530620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425136|NCT01530620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92425137|NCT01530620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92425138|NCT01530620|Cholinergic Agents|cholinergic agents|mesh-ancestor
92425139|NCT01530620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425140|NCT01530620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425141|NCT01530620|Urological Agents|urological agents|mesh-ancestor
92425142|NCT01530698|Vaccines|vaccines|mesh-list
92425143|NCT01530698|Immunologic Factors|immunologic factors|mesh-ancestor
92425144|NCT01530698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425145|NCT01530711|Terlipressin|terlipressin|mesh-list
92425146|NCT01530711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92425147|NCT01530711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92425148|NCT01530737|Antithrombins|antithrombins|mesh-list
92425149|NCT01530737|Antithrombin III|antithrombin iii|mesh-list
92425150|NCT01530737|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92425151|NCT01530737|Protease Inhibitors|protease inhibitors|mesh-ancestor
92425152|NCT01530737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425153|NCT01530737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425154|NCT01530737|Anticoagulants|anticoagulants|mesh-ancestor
92425155|NCT01530763|Amoxicillin|amoxicillin|mesh-list
92425156|NCT01530763|Ceftriaxone|ceftriaxone|mesh-list
92425157|NCT01530763|Clavulanic Acid|clavulanic acid|mesh-list
92425158|NCT01530763|Clavulanic Acids|clavulanic acids|mesh-list
92425159|NCT01530763|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92425160|NCT01530763|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92425161|NCT01530763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425162|NCT01530763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425163|NCT01530763|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92425164|NCT01530763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425168|NCT01530815|Anesthetics|anesthetics|mesh-ancestor
92425169|NCT01530815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425170|NCT01530815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425171|NCT01530815|Sensory System Agents|sensory system agents|mesh-ancestor
92609550|NCT00140465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92609551|NCT00140465|Purinergic Agents|purinergic agents|mesh-ancestor
92425172|NCT01530815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425173|NCT01530984|Ipilimumab|ipilimumab|mesh-list
92425174|NCT01530984|Sargramostim|sargramostim|mesh-list
92425175|NCT01530984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92425176|NCT01530984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425177|NCT01530984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92425178|NCT01530984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425179|NCT01530984|Immunologic Factors|immunologic factors|mesh-ancestor
92425180|NCT01530984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425181|NCT01531049|Nicotine|nicotine|mesh-list
92425182|NCT01531049|Varenicline|varenicline|mesh-list
92425183|NCT01531049|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92425184|NCT01531049|Autonomic Agents|autonomic agents|mesh-ancestor
92425185|NCT01531049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425186|NCT01531049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425187|NCT01531049|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92425188|NCT01531049|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92425189|NCT01531049|Cholinergic Agents|cholinergic agents|mesh-ancestor
92425190|NCT01531049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425191|NCT01531049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425192|NCT01531114|Ticagrelor|ticagrelor|mesh-list
92425193|NCT01531114|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92425194|NCT01531114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92425195|NCT01531114|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92425196|NCT01531114|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92425197|NCT01531114|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92425198|NCT01531114|Purinergic Agents|purinergic agents|mesh-ancestor
92425199|NCT01531114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425200|NCT01531114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425201|NCT01531114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425202|NCT01531140|Bisacodyl|bisacodyl|mesh-list
92425203|NCT01531140|Senna Extract|senna extract|mesh-list
92425204|NCT01531140|Sennosides|sennosides|mesh-list
92425205|NCT01531140|Cathartics|cathartics|mesh-ancestor
92425206|NCT01531140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425207|NCT01531140|Laxatives|laxatives|mesh-ancestor
92425208|NCT01531166|Interferons|interferons|mesh-list
92425209|NCT01531166|Interferon-alpha|interferon-alpha|mesh-list
92425210|NCT01531166|Interferon alpha-2|interferon alpha-2|mesh-list
92425211|NCT01531166|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92425212|NCT01531166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425213|NCT01531166|Antiviral Agents|antiviral agents|mesh-ancestor
92425214|NCT01531166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425215|NCT01531166|Immunologic Factors|immunologic factors|mesh-ancestor
92425216|NCT01531166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425217|NCT01531192|Nystatin|nystatin|mesh-list
92425218|NCT01531192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425219|NCT01531192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425220|NCT01531192|Antifungal Agents|antifungal agents|mesh-ancestor
92425221|NCT01531192|Ionophores|ionophores|mesh-ancestor
92425222|NCT01531192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92425223|NCT01531192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425224|NCT01531218|Azithromycin|azithromycin|mesh-list
92425225|NCT01531218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425226|NCT01531218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425227|NCT01531244|Dactinomycin|dactinomycin|mesh-list
92425228|NCT01531244|Cactinomycin|cactinomycin|mesh-list
92425229|NCT01531244|Melphalan|melphalan|mesh-list
92425230|NCT01531244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92425231|NCT01531244|Alkylating Agents|alkylating agents|mesh-ancestor
92425232|NCT01531244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425233|NCT01531244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425234|NCT01531244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92425235|NCT01531244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425236|NCT01531244|Immunologic Factors|immunologic factors|mesh-ancestor
92425237|NCT01531244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425246|NCT01531309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425247|NCT01531309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425249|NCT01531322|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92425250|NCT01531322|Immunologic Factors|immunologic factors|mesh-ancestor
92425251|NCT01531322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425252|NCT01531361|Sorafenib|sorafenib|mesh-list
92609553|NCT00140465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609554|NCT00140465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609555|NCT00504673|Insulin|insulin|mesh-list
92609556|NCT00504673|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92425253|NCT01531361|Vemurafenib|vemurafenib|mesh-list
92425254|NCT01531361|Crizotinib|crizotinib|mesh-list
92425255|NCT01531361|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92425256|NCT01531361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425257|NCT01531361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92425258|NCT01531361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425259|NCT01531361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425260|NCT01531452|Oxaliplatin|oxaliplatin|mesh-list
92425261|NCT01531452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425262|NCT01531517|Pantothenic Acid|pantothenic acid|mesh-list
92425263|NCT01531517|Propolis|propolis|mesh-list
92425264|NCT01531517|Vitamin B Complex|vitamin b complex|mesh-ancestor
92425265|NCT01531517|Vitamins|vitamins|mesh-ancestor
92425266|NCT01531517|Micronutrients|micronutrients|mesh-ancestor
92425267|NCT01531517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425268|NCT01531517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425269|NCT01531569|Secoisolariciresinol|secoisolariciresinol|mesh-list
92425270|NCT01531569|Phytoestrogens|phytoestrogens|mesh-ancestor
92425271|NCT01531569|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92425272|NCT01531569|Estrogens|estrogens|mesh-ancestor
92425273|NCT01531569|Hormones|hormones|mesh-ancestor
92425274|NCT01531569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92425275|NCT01531569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425276|NCT01531595|Bevacizumab|bevacizumab|mesh-list
92425277|NCT01531595|Oxaliplatin|oxaliplatin|mesh-list
92425278|NCT01531595|Irinotecan|irinotecan|mesh-list
92425279|NCT01531595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92425280|NCT01531595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149982|NCT00882895|Prednisolone|prednisolone|mesh-list
92425281|NCT01531595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92425282|NCT01531595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92425283|NCT01531595|Growth Substances|growth substances|mesh-ancestor
92425284|NCT01531595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425285|NCT01531595|Growth Inhibitors|growth inhibitors|mesh-ancestor
92425286|NCT01531595|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92425287|NCT01531595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92425288|NCT01531595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425289|NCT01531595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425291|NCT01531647|Raltegravir Potassium|raltegravir potassium|mesh-list
92425292|NCT01531647|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92425293|NCT01531647|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92425294|NCT01531647|Protease Inhibitors|protease inhibitors|mesh-ancestor
92425295|NCT01531647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425296|NCT01531647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425297|NCT01531647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92425298|NCT01531647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92425299|NCT01531647|Antiviral Agents|antiviral agents|mesh-ancestor
92425300|NCT01531647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425301|NCT01531647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92425302|NCT01531647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92425303|NCT01531647|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92425304|NCT01531647|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92425326|NCT01531777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92425327|NCT01531777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425328|NCT01531777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425329|NCT01531790|Carboplatin|carboplatin|mesh-list
92425330|NCT01531790|Pemetrexed|pemetrexed|mesh-list
92425331|NCT01531790|Endostar protein|endostar protein|mesh-list
92425332|NCT01531790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425333|NCT01531790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425334|NCT01531790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425335|NCT01531790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92425336|NCT01531790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92425337|NCT01531790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92425338|NCT01531790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92609557|NCT00504673|Insulin Aspart|insulin aspart|mesh-list
92609558|NCT00504673|Insulin Detemir|insulin detemir|mesh-list
92609559|NCT00504673|Isophane Insulin, Human|isophane insulin, human|mesh-list
92609560|NCT00504673|Insulin, Isophane|insulin, isophane|mesh-list
92425339|NCT01531790|Growth Substances|growth substances|mesh-ancestor
92425340|NCT01531790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425341|NCT01531790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92425342|NCT01531829|Heparin|heparin|mesh-list
92425343|NCT01531829|Plasminogen|plasminogen|mesh-list
92425344|NCT01531829|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92425345|NCT01531829|Tinzaparin|tinzaparin|mesh-list
92425346|NCT01531829|Dalteparin|dalteparin|mesh-list
92425347|NCT01531829|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92425348|NCT01531829|Nadroparin|nadroparin|mesh-list
92425349|NCT01531829|Anticoagulants|anticoagulants|mesh-ancestor
92425350|NCT01531829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92425351|NCT01531829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92425352|NCT01531829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425353|NCT01531842|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92425354|NCT01531842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425355|NCT01531855|Insulin|insulin|mesh-list
92425356|NCT01531855|Insulin Lispro|insulin lispro|mesh-list
92425357|NCT01531855|Insulin, Short-Acting|insulin, short-acting|mesh-list
92150040|NCT01494506|Antidotes|antidotes|mesh-ancestor
92425358|NCT01531855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92425359|NCT01531855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425360|NCT01531920|Ethanol|ethanol|mesh-list
92425363|NCT01531920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425364|NCT01531920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425365|NCT01532011|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92425366|NCT01532011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425367|NCT01532011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92425368|NCT01532011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425369|NCT01532011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425370|NCT01532076|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92425372|NCT01532076|Coagulants|coagulants|mesh-ancestor
92425373|NCT01532102|Antiviral Agents|antiviral agents|mesh-list
92425374|NCT01532102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425375|NCT01532115|Moxifloxacin|moxifloxacin|mesh-list
92425376|NCT01532115|Opicapone|opicapone|mesh-list
92425377|NCT01532115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425378|NCT01532115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425379|NCT01532115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92425380|NCT01532115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92425381|NCT01532115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425382|NCT01532115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425383|NCT01532115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425384|NCT01532115|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92425385|NCT01532115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92425386|NCT01532115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92425387|NCT01532154|4-Aminopyridine|4-aminopyridine|mesh-list
92425388|NCT01532154|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92425389|NCT01532154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92425390|NCT01532154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425391|NCT01532232|Varenicline|varenicline|mesh-list
92425392|NCT01532232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92425393|NCT01532232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92425394|NCT01532232|Cholinergic Agents|cholinergic agents|mesh-ancestor
92425395|NCT01532232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425396|NCT01532232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425397|NCT01532232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425398|NCT01532297|Dialysis Solutions|dialysis solutions|mesh-list
92425399|NCT01532297|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92425400|NCT01532336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92425401|NCT01532466|Rocuronium|rocuronium|mesh-list
92425402|NCT01532466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92425403|NCT01532466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92425404|NCT01532466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92425405|NCT01532466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425406|NCT01532466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425407|NCT01532544|Heparin|heparin|mesh-list
92425408|NCT01532544|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92425409|NCT01532544|Tinzaparin|tinzaparin|mesh-list
92425410|NCT01532544|Dalteparin|dalteparin|mesh-list
92609561|NCT00504673|Isophane insulin, beef|isophane insulin, beef|mesh-list
92609562|NCT00504673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92084918|NCT00655642|Promethazine|promethazine|mesh-list
92425411|NCT01532544|Eptifibatide|eptifibatide|mesh-list
92425412|NCT01532544|Anticoagulants|anticoagulants|mesh-ancestor
92425413|NCT01532544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92425414|NCT01532544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92425415|NCT01532544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425416|NCT01532544|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92425417|NCT01532674|Anti-Infective Agents|anti-infective agents|mesh-list
92425418|NCT01532674|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92425419|NCT01532726|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92425420|NCT01532726|Anticonvulsants|anticonvulsants|mesh-ancestor
92425421|NCT01532726|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92425422|NCT01532726|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92425423|NCT01532726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92425424|NCT01532726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425425|NCT01532804|Bevacizumab|bevacizumab|mesh-list
92425426|NCT01532804|Oxaliplatin|oxaliplatin|mesh-list
92425427|NCT01532804|Raltitrexed|raltitrexed|mesh-list
92425428|NCT01532804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92425429|NCT01532804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425430|NCT01532804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92425431|NCT01532804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92425432|NCT01532804|Growth Substances|growth substances|mesh-ancestor
92425435|NCT01532804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92425436|NCT01532804|Antimetabolites|antimetabolites|mesh-ancestor
92425437|NCT01532804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425438|NCT01532804|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92425439|NCT01532804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425440|NCT01532843|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92425441|NCT01532843|Antiviral Agents|antiviral agents|mesh-ancestor
92425442|NCT01532843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425444|NCT01532856|Dexamethasone|dexamethasone|mesh-list
92425445|NCT01532856|Dexamethasone acetate|dexamethasone acetate|mesh-list
92425447|NCT01532856|Cyclophosphamide|cyclophosphamide|mesh-list
92425448|NCT01532856|Melphalan|melphalan|mesh-list
92425449|NCT01532856|BB 1101|bb 1101|mesh-list
92425450|NCT01532856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425451|NCT01532856|Immunologic Factors|immunologic factors|mesh-ancestor
92425452|NCT01532856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425453|NCT01532856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425454|NCT01532856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92425455|NCT01532856|Alkylating Agents|alkylating agents|mesh-ancestor
92425456|NCT01532856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425457|NCT01532856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425458|NCT01532856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92425459|NCT01532856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425460|NCT01532856|Antiemetics|antiemetics|mesh-ancestor
92425461|NCT01532856|Autonomic Agents|autonomic agents|mesh-ancestor
92425462|NCT01532856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425463|NCT01532856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425464|NCT01532856|Glucocorticoids|glucocorticoids|mesh-ancestor
92425465|NCT01532856|Hormones|hormones|mesh-ancestor
92425466|NCT01532856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92425467|NCT01532856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92425468|NCT01532856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92425469|NCT01532856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425470|NCT01532856|Leprostatic Agents|leprostatic agents|mesh-ancestor
92425471|NCT01532856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425472|NCT01532856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425473|NCT01532856|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92425474|NCT01532856|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92425475|NCT01532856|Growth Substances|growth substances|mesh-ancestor
92425476|NCT01532856|Growth Inhibitors|growth inhibitors|mesh-ancestor
92425477|NCT01532895|Hydromorphone|hydromorphone|mesh-list
92425478|NCT01532895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92425479|NCT01532895|Narcotics|narcotics|mesh-ancestor
92425480|NCT01532895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425481|NCT01532895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425482|NCT01532895|Analgesics|analgesics|mesh-ancestor
92425483|NCT01532895|Sensory System Agents|sensory system agents|mesh-ancestor
92425484|NCT01532895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609563|NCT00504673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425485|NCT01532960|Poly ICLC|poly iclc|mesh-list
92425486|NCT01532960|Interferon Inducers|interferon inducers|mesh-ancestor
92425487|NCT01532960|Immunologic Factors|immunologic factors|mesh-ancestor
92425488|NCT01532960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425489|NCT01533090|Bisacodyl|bisacodyl|mesh-list
92425490|NCT01533090|Cathartics|cathartics|mesh-ancestor
92425491|NCT01533090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425492|NCT01533090|Laxatives|laxatives|mesh-ancestor
92425493|NCT01533129|Testosterone|testosterone|mesh-list
92425494|NCT01533129|Androgens|androgens|mesh-ancestor
92425495|NCT01533129|Hormones|hormones|mesh-ancestor
92425496|NCT01533129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92425497|NCT01533129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425498|NCT01533155|Quinidine|quinidine|mesh-list
92425499|NCT01533155|Quinidine gluconate|quinidine gluconate|mesh-list
92425500|NCT01533155|Morphine|morphine|mesh-list
92425501|NCT01533155|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92150194|NCT03218631|Oxandrolone|oxandrolone|mesh-list
92150195|NCT03218631|Androgens|androgens|mesh-ancestor
92150196|NCT03218631|Hormones|hormones|mesh-ancestor
92150197|NCT03218631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150198|NCT03218631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150199|NCT03218631|Anabolic Agents|anabolic agents|mesh-ancestor
92150200|NCT03451045|Dronabinol|dronabinol|mesh-list
92425502|NCT01533155|Narcotics|narcotics|mesh-ancestor
92425511|NCT01533155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425512|NCT01533155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425513|NCT01533155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92425515|NCT01533155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92425516|NCT01533155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92425517|NCT01533155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425518|NCT01533155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425519|NCT01533155|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92425520|NCT01533155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92425521|NCT01533155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92425522|NCT01533155|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92425523|NCT01533155|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92425524|NCT01533155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92425525|NCT01533155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92425526|NCT01533155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92425527|NCT01533220|Pheniramine|pheniramine|mesh-list
92425528|NCT01533220|Naphazoline|naphazoline|mesh-list
92425529|NCT01533220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425530|NCT01533220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92425531|NCT01533220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92425532|NCT01533220|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425533|NCT01533220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425534|NCT01533220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425535|NCT01533220|Nasal Decongestants|nasal decongestants|mesh-ancestor
92425536|NCT01533220|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92425537|NCT01533220|Respiratory System Agents|respiratory system agents|mesh-ancestor
92425538|NCT01533220|Antipruritics|antipruritics|mesh-ancestor
92425539|NCT01533220|Dermatologic Agents|dermatologic agents|mesh-ancestor
92425540|NCT01533220|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92425541|NCT01533220|Histamine Antagonists|histamine antagonists|mesh-ancestor
92425542|NCT01533220|Histamine Agents|histamine agents|mesh-ancestor
92425543|NCT01533220|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92425544|NCT01533272|Tenofovir|tenofovir|mesh-list
92425545|NCT01533272|Emtricitabine|emtricitabine|mesh-list
92425546|NCT01533272|Lopinavir|lopinavir|mesh-list
92425547|NCT01533272|Maraviroc|maraviroc|mesh-list
92425548|NCT01533272|Antiviral Agents|antiviral agents|mesh-ancestor
92425549|NCT01533272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425550|NCT01533272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92425551|NCT01533272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92425552|NCT01533272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425553|NCT01533272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425554|NCT01533272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92425555|NCT01533272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92425556|NCT01533272|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92425557|NCT01533272|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92425558|NCT01533272|Protease Inhibitors|protease inhibitors|mesh-ancestor
92425559|NCT01533272|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92425560|NCT01533272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92425561|NCT01533272|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92609564|NCT01247701|Cyclophosphamide|cyclophosphamide|mesh-list
92609565|NCT01247701|Busulfan|busulfan|mesh-list
92609566|NCT01247701|Fludarabine|fludarabine|mesh-list
92609567|NCT01247701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016733|NCT02961361|Ropivacaine|ropivacaine|mesh-list
92425562|NCT01533272|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92425563|NCT01533272|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92425564|NCT01533324|Leucovorin|leucovorin|mesh-list
92425565|NCT01533324|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92425566|NCT01533324|Antidotes|antidotes|mesh-ancestor
92425567|NCT01533324|Protective Agents|protective agents|mesh-ancestor
92395526|NCT01391403|Artemisinins|artemisinins|mesh-list
92425568|NCT01533324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425569|NCT01533324|Vitamin B Complex|vitamin b complex|mesh-ancestor
92425570|NCT01533324|Vitamins|vitamins|mesh-ancestor
92425585|NCT01533389|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92425587|NCT01533389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92425588|NCT01533389|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425589|NCT01533389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425590|NCT01533389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425591|NCT01533389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425592|NCT01533389|Urological Agents|urological agents|mesh-ancestor
92425593|NCT01533441|Vitamin K|vitamin k|mesh-list
92425594|NCT01533441|Vitamin K 2|vitamin k 2|mesh-list
92425595|NCT01533441|Vitamin K 1|vitamin k 1|mesh-list
92425596|NCT01533441|Vitamins|vitamins|mesh-ancestor
92425597|NCT01533441|Micronutrients|micronutrients|mesh-ancestor
92425598|NCT01533441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425599|NCT01533441|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92425600|NCT01533441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92425601|NCT01533441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425602|NCT01533441|Hemostatics|hemostatics|mesh-ancestor
92425603|NCT01533441|Coagulants|coagulants|mesh-ancestor
92425604|NCT01533506|Stiripentol|stiripentol|mesh-list
92425605|NCT01533506|Anticonvulsants|anticonvulsants|mesh-ancestor
92425606|NCT01533545|Epinephrine|epinephrine|mesh-list
92425607|NCT01533545|Mepivacaine|mepivacaine|mesh-list
92425608|NCT01533545|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92425609|NCT01533545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92425610|NCT01533545|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425611|NCT01533545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425612|NCT01533545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425613|NCT01533545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425614|NCT01533545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92425615|NCT01533545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92425616|NCT01533545|Autonomic Agents|autonomic agents|mesh-ancestor
92425617|NCT01533545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425618|NCT01533545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92425619|NCT01533545|Respiratory System Agents|respiratory system agents|mesh-ancestor
92425620|NCT01533545|Mydriatics|mydriatics|mesh-ancestor
92425621|NCT01533545|Sympathomimetics|sympathomimetics|mesh-ancestor
92425622|NCT01533545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92425623|NCT01533545|Anesthetics, Local|anesthetics, local|mesh-ancestor
92425624|NCT01533545|Anesthetics|anesthetics|mesh-ancestor
92425625|NCT01533545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425626|NCT01533545|Sensory System Agents|sensory system agents|mesh-ancestor
92425627|NCT01533558|Caspofungin|caspofungin|mesh-list
92425628|NCT01533558|Antifungal Agents|antifungal agents|mesh-ancestor
92425629|NCT01533558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425630|NCT01533558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425631|NCT01533558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425632|NCT01533662|Phenylephrine|phenylephrine|mesh-list
92425645|NCT01533662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92425646|NCT01533662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425647|NCT01533662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425648|NCT01533662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425649|NCT01533662|Protective Agents|protective agents|mesh-ancestor
92425650|NCT01533675|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92425651|NCT01533675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92425652|NCT01533675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425653|NCT01533740|Leucovorin|leucovorin|mesh-list
92425654|NCT01533740|Folic Acid|folic acid|mesh-list
92425655|NCT01533740|Bevacizumab|bevacizumab|mesh-list
92425656|NCT01533740|Fluorouracil|fluorouracil|mesh-list
92425657|NCT01533740|Irinotecan|irinotecan|mesh-list
92425658|NCT01533740|Levoleucovorin|levoleucovorin|mesh-list
92609568|NCT01247701|Immunologic Factors|immunologic factors|mesh-ancestor
92609569|NCT01247701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609570|NCT01247701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425659|NCT01533740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92425660|NCT01533740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425661|NCT01533740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92425662|NCT01533740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92425663|NCT01533740|Growth Substances|growth substances|mesh-ancestor
92425664|NCT01533740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425665|NCT01533740|Growth Inhibitors|growth inhibitors|mesh-ancestor
92425666|NCT01533740|Antimetabolites|antimetabolites|mesh-ancestor
92425667|NCT01533740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425668|NCT01533740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92425669|NCT01533740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425670|NCT01533740|Immunologic Factors|immunologic factors|mesh-ancestor
92425671|NCT01533740|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92425672|NCT01533740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92425673|NCT01533740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425674|NCT01533740|Antidotes|antidotes|mesh-ancestor
92425675|NCT01533740|Protective Agents|protective agents|mesh-ancestor
92425676|NCT01533740|Vitamin B Complex|vitamin b complex|mesh-ancestor
92425677|NCT01533740|Vitamins|vitamins|mesh-ancestor
92425678|NCT01533740|Micronutrients|micronutrients|mesh-ancestor
92425679|NCT01533740|Hematinics|hematinics|mesh-ancestor
92425680|NCT01533818|Amoxicillin|amoxicillin|mesh-list
92425681|NCT01533818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425682|NCT01533818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425683|NCT01533870|Rifampin|rifampin|mesh-list
92425684|NCT01533870|Naloxegol|naloxegol|mesh-list
92425685|NCT01533870|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92425686|NCT01533870|Antitubercular Agents|antitubercular agents|mesh-ancestor
92425687|NCT01533870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425688|NCT01533870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425689|NCT01533870|Leprostatic Agents|leprostatic agents|mesh-ancestor
92425690|NCT01533870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92425691|NCT01533870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425692|NCT01533870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425693|NCT01533870|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92425694|NCT01533870|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92425695|NCT01533870|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92425696|NCT01533870|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92425697|NCT01533870|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92425699|NCT01533870|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92395567|NCT01391715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425700|NCT01533870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425701|NCT01533870|Sensory System Agents|sensory system agents|mesh-ancestor
92425702|NCT01533870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425704|NCT01534026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425705|NCT01534026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425706|NCT01534026|Analgesics|analgesics|mesh-ancestor
92425707|NCT01534026|Sensory System Agents|sensory system agents|mesh-ancestor
92425708|NCT01534026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425709|NCT01534026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425710|NCT01534026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425711|NCT01534026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425712|NCT01534026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92425713|NCT01534026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92425714|NCT01534026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425715|NCT01534026|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92425716|NCT01534026|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92425717|NCT01534026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425718|NCT01534026|Antipyretics|antipyretics|mesh-ancestor
92425719|NCT01534169|Dexamethasone|dexamethasone|mesh-list
92425720|NCT01534169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425721|NCT01534169|Antiemetics|antiemetics|mesh-ancestor
92425722|NCT01534169|Autonomic Agents|autonomic agents|mesh-ancestor
92425723|NCT01534169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425724|NCT01534169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425725|NCT01534169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425726|NCT01534169|Glucocorticoids|glucocorticoids|mesh-ancestor
92425727|NCT01534169|Hormones|hormones|mesh-ancestor
92425728|NCT01534169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609571|NCT01247701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92609573|NCT01247701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609574|NCT01247701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425729|NCT01534169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92425730|NCT01534169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425731|NCT01534247|Metronidazole|metronidazole|mesh-list
92425732|NCT01534247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425733|NCT01534247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425734|NCT01534247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92425735|NCT01534247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92425736|NCT01534312|Mesalamine|mesalamine|mesh-list
92425737|NCT01534312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425738|NCT01534312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425739|NCT01534312|Analgesics|analgesics|mesh-ancestor
92425740|NCT01534312|Sensory System Agents|sensory system agents|mesh-ancestor
92425741|NCT01534312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425742|NCT01534312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425743|NCT01534312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425744|NCT01534312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425745|NCT01534442|Atropine|atropine|mesh-list
92425746|NCT01534442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92425747|NCT01534442|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92425748|NCT01534442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92425749|NCT01534442|Autonomic Agents|autonomic agents|mesh-ancestor
92425750|NCT01534442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425751|NCT01534442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425752|NCT01534442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395596|NCT01392144|Antioxidants|antioxidants|mesh-ancestor
92425753|NCT01534442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92425754|NCT01534442|Mydriatics|mydriatics|mesh-ancestor
92425755|NCT01534442|Parasympatholytics|parasympatholytics|mesh-ancestor
92425756|NCT01534442|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92425757|NCT01534442|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92425758|NCT01534442|Cholinergic Agents|cholinergic agents|mesh-ancestor
92425759|NCT01534442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425760|NCT01534442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425761|NCT01534455|Lapatinib|lapatinib|mesh-list
92425762|NCT01534455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425763|NCT01534455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92425764|NCT01534455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425765|NCT01534455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425766|NCT01534494|Psilocybin|psilocybin|mesh-list
92425767|NCT01534494|Hallucinogens|hallucinogens|mesh-ancestor
92425768|NCT01534494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425769|NCT01534494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92425770|NCT01534546|Capecitabine|capecitabine|mesh-list
92425771|NCT01534546|Oxaliplatin|oxaliplatin|mesh-list
92425775|NCT01534546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425776|NCT01534585|Paclitaxel|paclitaxel|mesh-list
92425777|NCT01534585|Mitogens|mitogens|mesh-list
92425778|NCT01534585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92425779|NCT01534585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425780|NCT01534585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92425781|NCT01534585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92425782|NCT01534585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92425783|NCT01534585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425784|NCT01534702|Cytarabine|cytarabine|mesh-list
92425785|NCT01534702|Clofarabine|clofarabine|mesh-list
92425786|NCT01534702|Idarubicin|idarubicin|mesh-list
92425787|NCT01534702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92425788|NCT01534702|Antimetabolites|antimetabolites|mesh-ancestor
92425789|NCT01534702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425790|NCT01534702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425791|NCT01534702|Antiviral Agents|antiviral agents|mesh-ancestor
92425792|NCT01534702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425793|NCT01534702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425794|NCT01534702|Immunologic Factors|immunologic factors|mesh-ancestor
92425795|NCT01534702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425796|NCT01534702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92425797|NCT01534702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92425798|NCT01534702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92609575|NCT01247701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92609576|NCT00140543|Mycophenolic Acid|mycophenolic acid|mesh-list
92609577|NCT00140543|Sirolimus|sirolimus|mesh-list
92425799|NCT01534702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425800|NCT01534754|Mesalamine|mesalamine|mesh-list
92425801|NCT01534754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425802|NCT01534754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425803|NCT01534754|Analgesics|analgesics|mesh-ancestor
92425804|NCT01534754|Sensory System Agents|sensory system agents|mesh-ancestor
92425805|NCT01534754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425806|NCT01534754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425807|NCT01534754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425809|NCT01534806|Ketorolac|ketorolac|mesh-list
92425810|NCT01534806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425811|NCT01534806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425812|NCT01534806|Analgesics|analgesics|mesh-ancestor
92425813|NCT01534806|Sensory System Agents|sensory system agents|mesh-ancestor
92425814|NCT01534806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425815|NCT01534806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425816|NCT01534806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425817|NCT01534806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425818|NCT01534806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92425819|NCT01534806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425820|NCT01534806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425821|NCT01534845|Temozolomide|temozolomide|mesh-list
92425822|NCT01534845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92425823|NCT01534845|Alkylating Agents|alkylating agents|mesh-ancestor
92425824|NCT01534845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425825|NCT01534845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425826|NCT01534858|Polihexanide|polihexanide|mesh-list
92425827|NCT01534858|Betaine|betaine|mesh-list
92425828|NCT01534858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92425829|NCT01534858|Lipotropic Agents|lipotropic agents|mesh-ancestor
92425830|NCT01534858|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92425831|NCT01534858|Antimetabolites|antimetabolites|mesh-ancestor
92425832|NCT01534858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425833|NCT01534858|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92425834|NCT01534858|Disinfectants|disinfectants|mesh-ancestor
92425835|NCT01534858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425836|NCT01534884|Rituximab|rituximab|mesh-list
92425837|NCT01534884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92425838|NCT01534884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425839|NCT01534884|Immunologic Factors|immunologic factors|mesh-ancestor
92425840|NCT01534884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425841|NCT01534884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425842|NCT01534949|Rituximab|rituximab|mesh-list
92425843|NCT01534949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92425844|NCT01534949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425857|NCT01535027|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92425859|NCT01535079|Ibuprofen|ibuprofen|mesh-list
92425860|NCT01535079|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425861|NCT01535079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425862|NCT01535079|Analgesics|analgesics|mesh-ancestor
92425863|NCT01535079|Sensory System Agents|sensory system agents|mesh-ancestor
92425864|NCT01535079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425865|NCT01535079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425866|NCT01535079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425867|NCT01535079|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395657|NCT01392534|Telmisartan|telmisartan|mesh-list
92425868|NCT01535079|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92425869|NCT01535079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425870|NCT01535079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425871|NCT01535092|Silybin|silybin|mesh-list
92425872|NCT01535092|Protective Agents|protective agents|mesh-ancestor
92425873|NCT01535092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425874|NCT01535092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92425875|NCT01535092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425876|NCT01535157|Ketoconazole|ketoconazole|mesh-list
92425877|NCT01535157|Fenretinide|fenretinide|mesh-list
92425878|NCT01535157|Retinamide|retinamide|mesh-list
92425879|NCT01535157|Antifungal Agents|antifungal agents|mesh-ancestor
92425880|NCT01535157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150563|NCT01839981|Thioctic Acid|thioctic acid|mesh-list
92425881|NCT01535157|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92609578|NCT00140543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92016743|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92425882|NCT01535157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92425883|NCT01535157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425884|NCT01535157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425885|NCT01535157|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92425886|NCT01535157|Hormone Antagonists|hormone antagonists|mesh-ancestor
92425887|NCT01535157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92425888|NCT01535157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425889|NCT01535157|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92425890|NCT01535157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425891|NCT01535157|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92425892|NCT01535157|Protective Agents|protective agents|mesh-ancestor
92425893|NCT01535170|Lactoferrin|lactoferrin|mesh-list
92425894|NCT01535170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425895|NCT01535183|Irinotecan|irinotecan|mesh-list
92425896|NCT01535183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92425897|NCT01535183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92425898|NCT01535183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425899|NCT01535183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425900|NCT01535183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425901|NCT01535417|Celecoxib|celecoxib|mesh-list
92425902|NCT01535417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92425903|NCT01535417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92425907|NCT01535417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425908|NCT01535417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92425909|NCT01535417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425910|NCT01535417|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92425911|NCT01535417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92425912|NCT01535417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425913|NCT01535417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425914|NCT01535469|Fluconazole|fluconazole|mesh-list
92425915|NCT01535469|Antifungal Agents|antifungal agents|mesh-ancestor
92425916|NCT01535469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425917|NCT01535469|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92425918|NCT01535469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92425919|NCT01535469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425920|NCT01535469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425921|NCT01535469|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92425922|NCT01535469|Hormone Antagonists|hormone antagonists|mesh-ancestor
92425923|NCT01535469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92425924|NCT01535469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425925|NCT01535469|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92425926|NCT01535469|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92425927|NCT01535495|Propranolol|propranolol|mesh-list
92425928|NCT01535495|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92425929|NCT01535495|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92425930|NCT01535495|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425931|NCT01535495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425932|NCT01535495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425933|NCT01535495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425934|NCT01535495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92425935|NCT01535495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92425936|NCT01535495|Vasodilator Agents|vasodilator agents|mesh-ancestor
92425937|NCT01535547|Isavuconazole|isavuconazole|mesh-list
92425938|NCT01535547|Tacrolimus|tacrolimus|mesh-list
92425939|NCT01535547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425940|NCT01535547|Immunologic Factors|immunologic factors|mesh-ancestor
92425941|NCT01535547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425942|NCT01535547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92425943|NCT01535547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425944|NCT01535547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425945|NCT01535547|Antifungal Agents|antifungal agents|mesh-ancestor
92425946|NCT01535547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425947|NCT01535612|Insulin|insulin|mesh-list
92425948|NCT01535612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92425949|NCT01535612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425950|NCT01535677|Metformin|metformin|mesh-list
92609580|NCT00140543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92609581|NCT00140543|Antitubercular Agents|antitubercular agents|mesh-ancestor
92609582|NCT00140543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609583|NCT00140543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425951|NCT01535677|Dapagliflozin|dapagliflozin|mesh-list
92425952|NCT01535677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92425953|NCT01535677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425954|NCT01535677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92425955|NCT01535677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425956|NCT01535690|Methylene Blue|methylene blue|mesh-list
92425957|NCT01535690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425958|NCT01535690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425959|NCT01535768|Travoprost|travoprost|mesh-list
92425960|NCT01535768|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92425961|NCT01535768|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92425962|NCT01535768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92425963|NCT01535768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92425964|NCT01535768|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92425965|NCT01535768|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92425966|NCT01535768|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92425967|NCT01535768|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425968|NCT01535768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425969|NCT01535768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425970|NCT01535768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425971|NCT01535781|Tranexamic Acid|tranexamic acid|mesh-list
92425972|NCT01535781|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92425973|NCT01535781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92425974|NCT01535781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425976|NCT01535781|Coagulants|coagulants|mesh-ancestor
92425977|NCT01535820|Ortho Evra|ortho evra|mesh-list
92425978|NCT01535820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92425979|NCT01535820|Contraceptive Agents|contraceptive agents|mesh-ancestor
92425980|NCT01535820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92425981|NCT01535820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425982|NCT01535859|Cabergoline|cabergoline|mesh-list
92425983|NCT01535859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92425984|NCT01535859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92425985|NCT01535859|Dopamine Agonists|dopamine agonists|mesh-ancestor
92425986|NCT01535859|Dopamine Agents|dopamine agents|mesh-ancestor
92425987|NCT01535859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425988|NCT01535859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425989|NCT01535859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425990|NCT01535872|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92425991|NCT01535872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92425992|NCT01535872|Immunologic Factors|immunologic factors|mesh-ancestor
92425993|NCT01535872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425994|NCT01535989|Sirolimus|sirolimus|mesh-list
92425995|NCT01535989|Temsirolimus|temsirolimus|mesh-list
92425996|NCT01535989|MTOR Inhibitors|mtor inhibitors|mesh-list
92425997|NCT01535989|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92425998|NCT01535989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92425999|NCT01535989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426000|NCT01535989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426001|NCT01535989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426002|NCT01535989|Immunologic Factors|immunologic factors|mesh-ancestor
92426003|NCT01535989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426004|NCT01535989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426005|NCT01535989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426006|NCT01535989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426007|NCT01535989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426008|NCT01535989|Antifungal Agents|antifungal agents|mesh-ancestor
92426009|NCT01535989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92426010|NCT01535989|Immunotoxins|immunotoxins|mesh-ancestor
92426011|NCT01535989|Immunoconjugates|immunoconjugates|mesh-ancestor
92426012|NCT01536002|Propofol|propofol|mesh-list
92426013|NCT01536002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92426014|NCT01536002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426015|NCT01536002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426016|NCT01536002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92426017|NCT01536002|Anesthetics, General|anesthetics, general|mesh-ancestor
92609584|NCT00140543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609585|NCT00140543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426019|NCT01536028|Insulin|insulin|mesh-list
92426020|NCT01536028|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92426021|NCT01536028|Insulin Aspart|insulin aspart|mesh-list
92426022|NCT01536028|Insulin, Long-Acting|insulin, long-acting|mesh-list
92426023|NCT01536028|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92426024|NCT01536028|Biphasic Insulins|biphasic insulins|mesh-list
92426025|NCT01536028|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426026|NCT01536028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426027|NCT01536028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426028|NCT01536054|Sirolimus|sirolimus|mesh-list
92426029|NCT01536054|Sargramostim|sargramostim|mesh-list
92426030|NCT01536054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426031|NCT01536054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426032|NCT01536054|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426033|NCT01536054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426034|NCT01536054|Antifungal Agents|antifungal agents|mesh-ancestor
92426035|NCT01536054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426036|NCT01536054|Immunologic Factors|immunologic factors|mesh-ancestor
92426037|NCT01536054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426038|NCT01536132|Simendan|simendan|mesh-list
92426039|NCT01536132|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92426040|NCT01536132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92426041|NCT01536132|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92426042|NCT01536132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92426043|NCT01536132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426044|NCT01536132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426045|NCT01536132|Protective Agents|protective agents|mesh-ancestor
92426046|NCT01536132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426047|NCT01536158|Acetaminophen|acetaminophen|mesh-list
92426048|NCT01536158|Ibuprofen|ibuprofen|mesh-list
92426059|NCT01536158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426060|NCT01536158|Antipyretics|antipyretics|mesh-ancestor
92426062|NCT01536223|Docetaxel|docetaxel|mesh-list
92426063|NCT01536223|Fluorouracil|fluorouracil|mesh-list
92426064|NCT01536223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426065|NCT01536223|Tubulin Modulators|tubulin modulators|mesh-ancestor
92426066|NCT01536223|Antimitotic Agents|antimitotic agents|mesh-ancestor
92426067|NCT01536223|Mitosis Modulators|mitosis modulators|mesh-ancestor
92426068|NCT01536223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426069|NCT01536223|Antimetabolites|antimetabolites|mesh-ancestor
92426070|NCT01536223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426071|NCT01536223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426072|NCT01536223|Immunologic Factors|immunologic factors|mesh-ancestor
92426073|NCT01536223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426074|NCT01536249|Pramipexole|pramipexole|mesh-list
92426075|NCT01536249|Cimetidine|cimetidine|mesh-list
92426076|NCT01536249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92426077|NCT01536249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426078|NCT01536249|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92426079|NCT01536249|Histamine Antagonists|histamine antagonists|mesh-ancestor
92426080|NCT01536249|Histamine Agents|histamine agents|mesh-ancestor
92426081|NCT01536249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426082|NCT01536249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426083|NCT01536249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426084|NCT01536249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92426085|NCT01536249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92426086|NCT01536249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426087|NCT01536249|Antioxidants|antioxidants|mesh-ancestor
92426088|NCT01536249|Protective Agents|protective agents|mesh-ancestor
92395728|NCT01392833|Prednisolone|prednisolone|mesh-list
92426089|NCT01536249|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92426090|NCT01536249|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92426091|NCT01536249|Dopamine Agonists|dopamine agonists|mesh-ancestor
92426092|NCT01536249|Dopamine Agents|dopamine agents|mesh-ancestor
92426093|NCT01536301|Morphine|morphine|mesh-list
92426094|NCT01536301|Oxycodone|oxycodone|mesh-list
92426095|NCT01536301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92426096|NCT01536301|Narcotics|narcotics|mesh-ancestor
92426097|NCT01536301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426098|NCT01536301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150788|NCT00795522|Cholinergic Agents|cholinergic agents|mesh-ancestor
92426099|NCT01536301|Analgesics|analgesics|mesh-ancestor
92609586|NCT00140543|Antifungal Agents|antifungal agents|mesh-ancestor
92609587|NCT00140543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085578|NCT00721162|Ramucirumab|ramucirumab|mesh-list
92426100|NCT01536301|Sensory System Agents|sensory system agents|mesh-ancestor
92426101|NCT01536301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426102|NCT01536314|Memantine|memantine|mesh-list
92426103|NCT01536314|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92426104|NCT01536314|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92426105|NCT01536314|Dopamine Agents|dopamine agents|mesh-ancestor
92426106|NCT01536314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426107|NCT01536314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426108|NCT01536314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426109|NCT01536314|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92426110|NCT01536314|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92426111|NCT01536353|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92426112|NCT01536353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92426116|NCT01536431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426118|NCT01536470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92426119|NCT01536470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92426120|NCT01536470|Adrenergic Agents|adrenergic agents|mesh-ancestor
92426121|NCT01536470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426122|NCT01536470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426123|NCT01536470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426124|NCT01536470|Sympathomimetics|sympathomimetics|mesh-ancestor
92426125|NCT01536470|Autonomic Agents|autonomic agents|mesh-ancestor
92426126|NCT01536470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426127|NCT01536470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92426128|NCT01536600|Insulin Aspart|insulin aspart|mesh-list
92426129|NCT01536600|Biphasic Insulins|biphasic insulins|mesh-list
92426130|NCT01536600|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426131|NCT01536600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426132|NCT01536600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426133|NCT01536613|Insulin Aspart|insulin aspart|mesh-list
92426134|NCT01536613|Biphasic Insulins|biphasic insulins|mesh-list
92426135|NCT01536613|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426136|NCT01536613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426137|NCT01536613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426138|NCT01536626|Insulin Aspart|insulin aspart|mesh-list
92426139|NCT01536626|Biphasic Insulins|biphasic insulins|mesh-list
92426140|NCT01536626|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426141|NCT01536626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426142|NCT01536626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426143|NCT01536639|Insulin Aspart|insulin aspart|mesh-list
92426144|NCT01536639|Biphasic Insulins|biphasic insulins|mesh-list
92426145|NCT01536639|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426146|NCT01536639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426147|NCT01536639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426148|NCT01536652|Insulin Aspart|insulin aspart|mesh-list
92426149|NCT01536652|Biphasic Insulins|biphasic insulins|mesh-list
92426150|NCT01536652|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426151|NCT01536652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426152|NCT01536652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426153|NCT01536665|Liraglutide|liraglutide|mesh-list
92426154|NCT01536665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426155|NCT01536665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426156|NCT01536665|Incretins|incretins|mesh-ancestor
92426157|NCT01536665|Hormones|hormones|mesh-ancestor
92426158|NCT01536665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426159|NCT01536691|Ondansetron|ondansetron|mesh-list
92426160|NCT01536691|Aprepitant|aprepitant|mesh-list
92426161|NCT01536691|Fosaprepitant|fosaprepitant|mesh-list
92426162|NCT01536691|Ramosetron|ramosetron|mesh-list
92426163|NCT01536691|Antiemetics|antiemetics|mesh-ancestor
92426164|NCT01536691|Autonomic Agents|autonomic agents|mesh-ancestor
92426165|NCT01536691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426166|NCT01536691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426167|NCT01536691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426168|NCT01536691|Antipruritics|antipruritics|mesh-ancestor
92426169|NCT01536691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92426170|NCT01536691|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92609589|NCT00140543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609590|NCT00154791|Gemcitabine|gemcitabine|mesh-list
92609591|NCT00154791|Oxaliplatin|oxaliplatin|mesh-list
92609592|NCT00154791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426171|NCT01536691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92426172|NCT01536691|Serotonin Agents|serotonin agents|mesh-ancestor
92426173|NCT01536691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426174|NCT01536691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426175|NCT01536691|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92426176|NCT01536717|Carticaine|carticaine|mesh-list
92426177|NCT01536717|Anesthetics, Local|anesthetics, local|mesh-ancestor
92426178|NCT01536717|Anesthetics|anesthetics|mesh-ancestor
92426179|NCT01536717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426180|NCT01536717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426181|NCT01536717|Sensory System Agents|sensory system agents|mesh-ancestor
92426182|NCT01536717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426183|NCT01536743|Palbociclib|palbociclib|mesh-list
92426199|NCT01537055|Ofloxacin|ofloxacin|mesh-list
92426200|NCT01537055|Lansoprazole|lansoprazole|mesh-list
92426201|NCT01537055|Dexlansoprazole|dexlansoprazole|mesh-list
92426202|NCT01537055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426203|NCT01537055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395773|NCT01393080|Nimotuzumab|nimotuzumab|mesh-list
92426204|NCT01537055|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92426205|NCT01537055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92426206|NCT01537055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92426207|NCT01537055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426208|NCT01537055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426209|NCT01537055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426210|NCT01537055|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92426211|NCT01537055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92426212|NCT01537055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92426213|NCT01537055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426214|NCT01537055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92426215|NCT01537094|Vitamins|vitamins|mesh-list
92426216|NCT01537094|Ascorbic Acid|ascorbic acid|mesh-list
92426217|NCT01537094|Micronutrients|micronutrients|mesh-ancestor
92426218|NCT01537094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426219|NCT01537094|Antioxidants|antioxidants|mesh-ancestor
92426220|NCT01537094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426221|NCT01537094|Protective Agents|protective agents|mesh-ancestor
92426222|NCT01537107|Sirolimus|sirolimus|mesh-list
92426223|NCT01537107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92426224|NCT01537107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426225|NCT01537107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426226|NCT01537107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426227|NCT01537107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426228|NCT01537107|Antifungal Agents|antifungal agents|mesh-ancestor
92426229|NCT01537107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426230|NCT01537107|Immunologic Factors|immunologic factors|mesh-ancestor
92426231|NCT01537107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426232|NCT01537107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426233|NCT01537107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92426234|NCT01537146|Ropivacaine|ropivacaine|mesh-list
92426235|NCT01537146|Anesthetics, Local|anesthetics, local|mesh-ancestor
92426236|NCT01537146|Anesthetics|anesthetics|mesh-ancestor
92426237|NCT01537146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426238|NCT01537146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426239|NCT01537146|Sensory System Agents|sensory system agents|mesh-ancestor
92426240|NCT01537146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426241|NCT01537250|Levofloxacin|levofloxacin|mesh-list
92426242|NCT01537250|Ofloxacin|ofloxacin|mesh-list
92426243|NCT01537250|Nemonoxacin|nemonoxacin|mesh-list
92426244|NCT01537250|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92426253|NCT01537250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92426255|NCT01537354|Beractant|beractant|mesh-list
92426256|NCT01537354|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92426257|NCT01537354|Respiratory System Agents|respiratory system agents|mesh-ancestor
92426258|NCT01537380|Cefazolin|cefazolin|mesh-list
92426259|NCT01537380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426260|NCT01537380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609593|NCT00154791|Antimetabolites|antimetabolites|mesh-ancestor
92609594|NCT00154791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609595|NCT00154791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609596|NCT00140582|Rituximab|rituximab|mesh-list
92609597|NCT00140582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92609598|NCT00140582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609599|NCT00140582|Immunologic Factors|immunologic factors|mesh-ancestor
92609600|NCT00140582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426261|NCT01537471|Meclizine|meclizine|mesh-list
92426262|NCT01537471|Dimenhydrinate|dimenhydrinate|mesh-list
92426263|NCT01537471|Antiemetics|antiemetics|mesh-ancestor
92426264|NCT01537471|Autonomic Agents|autonomic agents|mesh-ancestor
92426265|NCT01537471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426266|NCT01537471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426267|NCT01537471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426268|NCT01537471|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92426269|NCT01537471|Histamine Antagonists|histamine antagonists|mesh-ancestor
92426270|NCT01537471|Histamine Agents|histamine agents|mesh-ancestor
92426271|NCT01537471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426272|NCT01537471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426273|NCT01537471|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92426274|NCT01537471|Cholinergic Agents|cholinergic agents|mesh-ancestor
92426275|NCT01537471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92426276|NCT01537575|Immunoglobulins|immunoglobulins|mesh-list
92426277|NCT01537575|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92426278|NCT01537575|Antibodies|antibodies|mesh-list
92426279|NCT01537575|gamma-Globulins|gamma-globulins|mesh-list
92426280|NCT01537575|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92426281|NCT01537575|Immunologic Factors|immunologic factors|mesh-ancestor
92426282|NCT01537575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426283|NCT01537640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92426284|NCT01537640|Immunologic Factors|immunologic factors|mesh-ancestor
92426285|NCT01537640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426286|NCT01537744|Azacitidine|azacitidine|mesh-list
92426287|NCT01537744|Romidepsin|romidepsin|mesh-list
92426288|NCT01537744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426289|NCT01537744|Antimetabolites|antimetabolites|mesh-ancestor
92426290|NCT01537744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426291|NCT01537744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426292|NCT01537744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426293|NCT01537744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426294|NCT01537744|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92426295|NCT01537770|Lidocaine|lidocaine|mesh-list
92426296|NCT01537770|Anesthetics, Local|anesthetics, local|mesh-ancestor
92426297|NCT01537770|Anesthetics|anesthetics|mesh-ancestor
92426298|NCT01537770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426299|NCT01537770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426300|NCT01537770|Sensory System Agents|sensory system agents|mesh-ancestor
92426301|NCT01537770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426302|NCT01537770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92426303|NCT01537770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92426304|NCT01537770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92426305|NCT01537770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92426306|NCT01537770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426307|NCT01537809|Vitamin D|vitamin d|mesh-list
92426308|NCT01537809|Ergocalciferols|ergocalciferols|mesh-list
92426309|NCT01537809|Cholecalciferol|cholecalciferol|mesh-list
92426310|NCT01537809|Vitamins|vitamins|mesh-list
92426311|NCT01537809|Micronutrients|micronutrients|mesh-ancestor
92426313|NCT01537809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92426314|NCT01537809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92426316|NCT01537861|Dexamethasone|dexamethasone|mesh-list
92426317|NCT01537861|Cyclophosphamide|cyclophosphamide|mesh-list
92426318|NCT01537861|Lenalidomide|lenalidomide|mesh-list
92426319|NCT01537861|Bortezomib|bortezomib|mesh-list
92426320|NCT01537861|Pomalidomide|pomalidomide|mesh-list
92426321|NCT01537861|Lenograstim|lenograstim|mesh-list
92426322|NCT01537861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426323|NCT01537861|Immunologic Factors|immunologic factors|mesh-ancestor
92426324|NCT01537861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426325|NCT01537861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426326|NCT01537861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92426327|NCT01537861|Alkylating Agents|alkylating agents|mesh-ancestor
92426328|NCT01537861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426329|NCT01537861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426330|NCT01537861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92426331|NCT01537861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426332|NCT01537861|Antiemetics|antiemetics|mesh-ancestor
92426333|NCT01537861|Autonomic Agents|autonomic agents|mesh-ancestor
92426334|NCT01537861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426335|NCT01537861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426336|NCT01537861|Glucocorticoids|glucocorticoids|mesh-ancestor
92426338|NCT01537861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426339|NCT01537861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92426340|NCT01537861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92426341|NCT01537861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92426342|NCT01537861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92426343|NCT01537861|Growth Substances|growth substances|mesh-ancestor
92426344|NCT01537861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92426345|NCT01537861|Leprostatic Agents|leprostatic agents|mesh-ancestor
92426346|NCT01537861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426347|NCT01537861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426348|NCT01538095|Trebananib|trebananib|mesh-list
92426349|NCT01538095|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92426350|NCT01538095|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92426351|NCT01538095|Growth Substances|growth substances|mesh-ancestor
92426352|NCT01538095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426353|NCT01538095|Growth Inhibitors|growth inhibitors|mesh-ancestor
92426354|NCT01538095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426355|NCT01538108|Paclitaxel|paclitaxel|mesh-list
92426356|NCT01538108|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92426357|NCT01538108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426358|NCT01538108|Tubulin Modulators|tubulin modulators|mesh-ancestor
92426359|NCT01538108|Antimitotic Agents|antimitotic agents|mesh-ancestor
92426360|NCT01538108|Mitosis Modulators|mitosis modulators|mesh-ancestor
92426361|NCT01538108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426362|NCT01538225|Nabiximols|nabiximols|mesh-list
92426363|NCT01538225|Analgesics|analgesics|mesh-ancestor
92426364|NCT01538225|Sensory System Agents|sensory system agents|mesh-ancestor
92426365|NCT01538225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426366|NCT01538225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426367|NCT01538316|Genistein|genistein|mesh-list
92426368|NCT01538316|Quercetin|quercetin|mesh-list
92426369|NCT01538316|Antioxidants|antioxidants|mesh-ancestor
92426370|NCT01538316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426371|NCT01538316|Protective Agents|protective agents|mesh-ancestor
92426372|NCT01538316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426373|NCT01538316|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92426374|NCT01538316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426375|NCT01538316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426376|NCT01538316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426377|NCT01538316|Phytoestrogens|phytoestrogens|mesh-ancestor
92426378|NCT01538316|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92426379|NCT01538316|Estrogens|estrogens|mesh-ancestor
92426380|NCT01538316|Hormones|hormones|mesh-ancestor
92426381|NCT01538316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426382|NCT01538329|Amantadine|amantadine|mesh-list
92426383|NCT01538329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92426384|NCT01538329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92426385|NCT01538329|Antiviral Agents|antiviral agents|mesh-ancestor
92426386|NCT01538329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426387|NCT01538329|Dopamine Agents|dopamine agents|mesh-ancestor
92426397|NCT01538381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426398|NCT01538381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426399|NCT01538381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426400|NCT01538394|Nicotine|nicotine|mesh-list
92426401|NCT01538394|Varenicline|varenicline|mesh-list
92426402|NCT01538394|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92426403|NCT01538394|Autonomic Agents|autonomic agents|mesh-ancestor
92426404|NCT01538394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426405|NCT01538394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426406|NCT01538394|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92426407|NCT01538394|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92334669|NCT00005575|Imipramine|imipramine|mesh-list
92609603|NCT00154869|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92609604|NCT00154869|Antimetabolites|antimetabolites|mesh-ancestor
92016760|NCT02426281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92426408|NCT01538394|Cholinergic Agents|cholinergic agents|mesh-ancestor
92426409|NCT01538394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426410|NCT01538394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426411|NCT01538446|Clopidogrel|clopidogrel|mesh-list
92426412|NCT01538446|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92426413|NCT01538446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92426414|NCT01538446|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92426415|NCT01538446|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92426416|NCT01538446|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92426417|NCT01538446|Purinergic Agents|purinergic agents|mesh-ancestor
92426418|NCT01538446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426419|NCT01538446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426420|NCT01538446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426421|NCT01538459|Dexamethasone|dexamethasone|mesh-list
92426422|NCT01538459|Bupivacaine|bupivacaine|mesh-list
92426423|NCT01538459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426424|NCT01538459|Antiemetics|antiemetics|mesh-ancestor
92426425|NCT01538459|Autonomic Agents|autonomic agents|mesh-ancestor
92426426|NCT01538459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426427|NCT01538459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426428|NCT01538459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426429|NCT01538459|Glucocorticoids|glucocorticoids|mesh-ancestor
92426430|NCT01538459|Hormones|hormones|mesh-ancestor
92426431|NCT01538459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426432|NCT01538459|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92426433|NCT01538459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426434|NCT01538459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92426435|NCT01538459|Anesthetics|anesthetics|mesh-ancestor
92426436|NCT01538459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426437|NCT01538459|Sensory System Agents|sensory system agents|mesh-ancestor
92426438|NCT01538485|Cholecalciferol|cholecalciferol|mesh-list
92426439|NCT01538485|Vitamin D|vitamin d|mesh-list
92426440|NCT01538485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92426441|NCT01538485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426442|NCT01538485|Vitamins|vitamins|mesh-ancestor
92426443|NCT01538485|Micronutrients|micronutrients|mesh-ancestor
92426444|NCT01538485|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92426445|NCT01538511|Insulin|insulin|mesh-list
92426446|NCT01538511|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92426447|NCT01538511|Insulin Aspart|insulin aspart|mesh-list
92426448|NCT01538511|Insulin, Long-Acting|insulin, long-acting|mesh-list
92426449|NCT01538511|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92426450|NCT01538511|Biphasic Insulins|biphasic insulins|mesh-list
92426451|NCT01538511|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92426452|NCT01538511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426457|NCT01538537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426458|NCT01538537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426459|NCT01538563|ON 01910|on 01910|mesh-list
92426460|NCT01538563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426461|NCT01538563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426462|NCT01538563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426463|NCT01538563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426464|NCT01538576|Insulin Aspart|insulin aspart|mesh-list
92426465|NCT01538576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92395835|NCT01393340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92426466|NCT01538576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426467|NCT01538589|Insulin Aspart|insulin aspart|mesh-list
92426468|NCT01538589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426469|NCT01538589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426470|NCT01538641|Rituximab|rituximab|mesh-list
92426471|NCT01538641|Gemcitabine|gemcitabine|mesh-list
92426472|NCT01538641|Oxaliplatin|oxaliplatin|mesh-list
92426473|NCT01538641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92426474|NCT01538641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426475|NCT01538641|Immunologic Factors|immunologic factors|mesh-ancestor
92426476|NCT01538641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426477|NCT01538641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609605|NCT00154869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609606|NCT00154869|Antiviral Agents|antiviral agents|mesh-ancestor
92609607|NCT00154869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609608|NCT00140660|Rituximab|rituximab|mesh-list
92609609|NCT00140660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92609610|NCT00140660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426478|NCT01538641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426479|NCT01538641|Antimetabolites|antimetabolites|mesh-ancestor
92426480|NCT01538641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426481|NCT01538667|Ciprofloxacin|ciprofloxacin|mesh-list
92426482|NCT01538667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426483|NCT01538667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426484|NCT01538667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92426485|NCT01538667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92426486|NCT01538667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426487|NCT01538667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426488|NCT01538667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426489|NCT01538667|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92426490|NCT01538667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92426491|NCT01538693|Cyproheptadine|cyproheptadine|mesh-list
92426492|NCT01538693|Dexetimide|dexetimide|mesh-list
92426493|NCT01538693|Citalopram|citalopram|mesh-list
92426494|NCT01538693|Escitalopram|escitalopram|mesh-list
92426495|NCT01538693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92426496|NCT01538693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92426497|NCT01538693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92426498|NCT01538693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426499|NCT01538693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426500|NCT01538693|Serotonin Agents|serotonin agents|mesh-ancestor
92426501|NCT01538693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426502|NCT01538693|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92426503|NCT01538693|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92426504|NCT01538693|Parasympatholytics|parasympatholytics|mesh-ancestor
92426505|NCT01538693|Autonomic Agents|autonomic agents|mesh-ancestor
92426506|NCT01538693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426507|NCT01538693|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92426508|NCT01538693|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92426509|NCT01538693|Cholinergic Agents|cholinergic agents|mesh-ancestor
92426510|NCT01538693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92426511|NCT01538693|Antidepressive Agents|antidepressive agents|mesh-ancestor
92426512|NCT01538693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92426513|NCT01538693|Antipruritics|antipruritics|mesh-ancestor
92426514|NCT01538693|Dermatologic Agents|dermatologic agents|mesh-ancestor
92426515|NCT01538693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426516|NCT01538693|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92426517|NCT01538693|Histamine Antagonists|histamine antagonists|mesh-ancestor
92426518|NCT01538693|Histamine Agents|histamine agents|mesh-ancestor
92426519|NCT01538693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92426520|NCT01538693|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92426521|NCT01538732|Alitretinoin|alitretinoin|mesh-list
92426522|NCT01538732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426523|NCT01538732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92426538|NCT01538849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426539|NCT01538849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92426540|NCT01538849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395844|NCT01393548|Mydriatics|mydriatics|mesh-ancestor
92426541|NCT01538849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426542|NCT01538875|Labetalol|labetalol|mesh-list
92426543|NCT01538875|Hydralazine|hydralazine|mesh-list
92426544|NCT01538875|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92426545|NCT01538875|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92426546|NCT01538875|Adrenergic Agents|adrenergic agents|mesh-ancestor
92426547|NCT01538875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426548|NCT01538875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426549|NCT01538875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426550|NCT01538875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92426551|NCT01538875|Sympathomimetics|sympathomimetics|mesh-ancestor
92426552|NCT01538875|Autonomic Agents|autonomic agents|mesh-ancestor
92426553|NCT01538875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609611|NCT00140660|Immunologic Factors|immunologic factors|mesh-ancestor
92426554|NCT01538875|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92426555|NCT01538875|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92426556|NCT01538875|Vasodilator Agents|vasodilator agents|mesh-ancestor
92426557|NCT01538901|Imiquimod|imiquimod|mesh-list
92426558|NCT01538901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92426559|NCT01538901|Immunologic Factors|immunologic factors|mesh-ancestor
92426560|NCT01538901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426561|NCT01538901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426562|NCT01538901|Interferon Inducers|interferon inducers|mesh-ancestor
92426563|NCT01538927|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92426564|NCT01538927|Hemostatics|hemostatics|mesh-ancestor
92426565|NCT01538927|Coagulants|coagulants|mesh-ancestor
92426566|NCT01538940|Vaccines|vaccines|mesh-list
92426567|NCT01538940|Immunologic Factors|immunologic factors|mesh-ancestor
92426568|NCT01538940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426569|NCT01538953|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92426570|NCT01538953|Disinfectants|disinfectants|mesh-list
92426572|NCT01538953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426573|NCT01539018|Sorafenib|sorafenib|mesh-list
92426574|NCT01539018|Tegafur|tegafur|mesh-list
92426575|NCT01539018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426576|NCT01539018|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426577|NCT01539018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426578|NCT01539018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426579|NCT01539018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426580|NCT01539018|Antimetabolites|antimetabolites|mesh-ancestor
92426581|NCT01539044|Atropine|atropine|mesh-list
92426582|NCT01539044|Neostigmine|neostigmine|mesh-list
92426583|NCT01539044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92426584|NCT01539044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92426585|NCT01539044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92426586|NCT01539044|Autonomic Agents|autonomic agents|mesh-ancestor
92426587|NCT01539044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426608|NCT01539174|Immunologic Factors|immunologic factors|mesh-ancestor
92426609|NCT01539174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426610|NCT01539174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426611|NCT01539174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92426612|NCT01539174|Alkylating Agents|alkylating agents|mesh-ancestor
92426613|NCT01539174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426614|NCT01539174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426615|NCT01539174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92426616|NCT01539174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92426617|NCT01539174|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426618|NCT01539174|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92426619|NCT01539174|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92426620|NCT01539174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426621|NCT01539174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426622|NCT01539174|Glucocorticoids|glucocorticoids|mesh-ancestor
92426623|NCT01539174|Hormones|hormones|mesh-ancestor
92426624|NCT01539174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426625|NCT01539174|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92426626|NCT01539174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92426627|NCT01539174|Tubulin Modulators|tubulin modulators|mesh-ancestor
92426628|NCT01539174|Antimitotic Agents|antimitotic agents|mesh-ancestor
92426629|NCT01539174|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151316|NCT05061732|Rabeprazole|rabeprazole|mesh-list
92426630|NCT01539265|Silodosin|silodosin|mesh-list
92426631|NCT01539265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92426632|NCT01539265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92426633|NCT01539265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92426634|NCT01539265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92426635|NCT01539265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426636|NCT01539265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426637|NCT01539265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426638|NCT01539265|Urological Agents|urological agents|mesh-ancestor
92426639|NCT01539330|Voriconazole|voriconazole|mesh-list
92426640|NCT01539330|Antifungal Agents|antifungal agents|mesh-ancestor
92426641|NCT01539330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426642|NCT01539330|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92426648|NCT01539330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426649|NCT01539330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426650|NCT01539330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92609612|NCT00140660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426651|NCT01539343|Anti-Infective Agents|anti-infective agents|mesh-list
92426652|NCT01539343|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92426654|NCT01539408|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92426655|NCT01539408|Abortifacient Agents|abortifacient agents|mesh-ancestor
92426656|NCT01539408|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92426657|NCT01539408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426658|NCT01539408|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92426659|NCT01539408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426660|NCT01539408|Oxytocics|oxytocics|mesh-ancestor
92426661|NCT01539473|Tedizolid phosphate|tedizolid phosphate|mesh-list
92426662|NCT01539473|Tedizolid|tedizolid|mesh-list
92426663|NCT01539473|Tyramine|tyramine|mesh-list
92426664|NCT01539473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426665|NCT01539473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426666|NCT01539473|Sympathomimetics|sympathomimetics|mesh-ancestor
92426667|NCT01539473|Autonomic Agents|autonomic agents|mesh-ancestor
92426668|NCT01539473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426669|NCT01539473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426670|NCT01539473|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92426671|NCT01539473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92426672|NCT01539473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92426673|NCT01539473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426674|NCT01539473|Adrenergic Agents|adrenergic agents|mesh-ancestor
92426675|NCT01539473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426676|NCT01539564|Minocycline|minocycline|mesh-list
92426677|NCT01539564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426678|NCT01539564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426679|NCT01539577|Dexamethasone|dexamethasone|mesh-list
92426680|NCT01539577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426681|NCT01539577|Antiemetics|antiemetics|mesh-ancestor
92426682|NCT01539577|Autonomic Agents|autonomic agents|mesh-ancestor
92426683|NCT01539577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426684|NCT01539577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426685|NCT01539577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426686|NCT01539577|Glucocorticoids|glucocorticoids|mesh-ancestor
92426687|NCT01539577|Hormones|hormones|mesh-ancestor
92426688|NCT01539577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426689|NCT01539577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92426690|NCT01539577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426691|NCT01539603|Sirolimus|sirolimus|mesh-list
92426692|NCT01539603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426693|NCT01539603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426694|NCT01539603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426695|NCT01539603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426696|NCT01539603|Antifungal Agents|antifungal agents|mesh-ancestor
92426697|NCT01539603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426698|NCT01539603|Immunologic Factors|immunologic factors|mesh-ancestor
92426699|NCT01539603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426700|NCT01539616|Fenofibrate|fenofibrate|mesh-list
92426701|NCT01539616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92426702|NCT01539616|Antimetabolites|antimetabolites|mesh-ancestor
92426703|NCT01539616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426704|NCT01539616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92426705|NCT01539655|Omeprazole|omeprazole|mesh-list
92426706|NCT01539655|Ranitidine|ranitidine|mesh-list
92426707|NCT01539655|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92426708|NCT01539655|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92426709|NCT01539655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426710|NCT01539655|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92426711|NCT01539655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426737|NCT01539720|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92426738|NCT01539720|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92426739|NCT01539720|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92426740|NCT01539733|Haloperidol|haloperidol|mesh-list
92426741|NCT01539733|Olanzapine|olanzapine|mesh-list
92426742|NCT01539733|Haloperidol decanoate|haloperidol decanoate|mesh-list
92426743|NCT01539733|Antiemetics|antiemetics|mesh-ancestor
92426744|NCT01539733|Autonomic Agents|autonomic agents|mesh-ancestor
92426745|NCT01539733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426746|NCT01539733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426747|NCT01539733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426748|NCT01539733|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92426749|NCT01539733|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92426750|NCT01539733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609613|NCT00140660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609615|NCT00162006|Antibodies|antibodies|mesh-list
92609616|NCT00162006|gamma-Globulins|gamma-globulins|mesh-list
92609617|NCT00162006|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92609618|NCT00162006|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92609619|NCT00162006|Immunologic Factors|immunologic factors|mesh-ancestor
92426751|NCT01539733|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92426752|NCT01539733|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92426753|NCT01539733|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92426754|NCT01539733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92426755|NCT01539733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426756|NCT01539733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426757|NCT01539733|Serotonin Agents|serotonin agents|mesh-ancestor
92426758|NCT01539733|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92426759|NCT01539733|Dopamine Agents|dopamine agents|mesh-ancestor
92426769|NCT01539902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426771|NCT01539902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92426772|NCT01540032|Salicylates|salicylates|mesh-list
92426773|NCT01540032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92426774|NCT01540032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92426775|NCT01540032|Analgesics|analgesics|mesh-ancestor
92426776|NCT01540032|Sensory System Agents|sensory system agents|mesh-ancestor
92426777|NCT01540032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426778|NCT01540032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426779|NCT01540032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426780|NCT01540032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426781|NCT01540032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92426782|NCT01540032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426783|NCT01540032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426784|NCT01540084|Propofol|propofol|mesh-list
92426785|NCT01540084|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92426786|NCT01540084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426787|NCT01540084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426788|NCT01540084|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92426789|NCT01540084|Anesthetics, General|anesthetics, general|mesh-ancestor
92426790|NCT01540084|Anesthetics|anesthetics|mesh-ancestor
92426791|NCT01540110|Cyclophosphamide|cyclophosphamide|mesh-list
92426792|NCT01540110|Docetaxel|docetaxel|mesh-list
92426793|NCT01540110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426794|NCT01540110|Immunologic Factors|immunologic factors|mesh-ancestor
92426795|NCT01540110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426796|NCT01540110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426797|NCT01540110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92426798|NCT01540110|Alkylating Agents|alkylating agents|mesh-ancestor
92426799|NCT01540110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426800|NCT01540110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426801|NCT01540110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92426802|NCT01540110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92426803|NCT01540110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92426804|NCT01540110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92426805|NCT01540136|Nedaplatin|nedaplatin|mesh-list
92426806|NCT01540136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426807|NCT01540240|Zidovudine|zidovudine|mesh-list
92426808|NCT01540240|Antimetabolites|antimetabolites|mesh-ancestor
92426809|NCT01540240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426810|NCT01540240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92426811|NCT01540240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92426812|NCT01540240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426813|NCT01540240|Antiviral Agents|antiviral agents|mesh-ancestor
92426814|NCT01540240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426815|NCT01540240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92426816|NCT01540240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92426817|NCT01540435|Bevacizumab|bevacizumab|mesh-list
92426818|NCT01540435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92426819|NCT01540435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426820|NCT01540435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92426821|NCT01540435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92609620|NCT00162006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609621|NCT00162045|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92609622|NCT00162045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92609623|NCT00162045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609625|NCT02964572|Glimepiride|glimepiride|mesh-list
92609626|NCT02964572|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92426822|NCT01540435|Growth Substances|growth substances|mesh-ancestor
92426823|NCT01540435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426824|NCT01540435|Growth Inhibitors|growth inhibitors|mesh-ancestor
92426835|NCT01540500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426836|NCT01540500|Serotonin Agents|serotonin agents|mesh-ancestor
92426837|NCT01540500|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92426838|NCT01540500|Antidepressive Agents|antidepressive agents|mesh-ancestor
92426839|NCT01540500|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92426840|NCT01540500|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92426841|NCT01540500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426842|NCT01540500|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92426843|NCT01540526|Axitinib|axitinib|mesh-list
92426844|NCT01540526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426845|NCT01540526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426846|NCT01540526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426847|NCT01540526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426848|NCT01540591|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92426849|NCT01540591|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92426850|NCT01540591|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92426851|NCT01540591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92151542|NCT01720563|Tegafur|tegafur|mesh-list
92426853|NCT01540682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92426854|NCT01540682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426855|NCT01540708|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92426856|NCT01540708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92426857|NCT01540708|Autonomic Agents|autonomic agents|mesh-ancestor
92426858|NCT01540708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426859|NCT01540708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426860|NCT01540708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92426861|NCT01540708|Respiratory System Agents|respiratory system agents|mesh-ancestor
92426862|NCT01540708|Glucocorticoids|glucocorticoids|mesh-ancestor
92426863|NCT01540708|Hormones|hormones|mesh-ancestor
92426864|NCT01540708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426865|NCT01540708|Sympathomimetics|sympathomimetics|mesh-ancestor
92426866|NCT01540721|Acetaminophen|acetaminophen|mesh-list
92426867|NCT01540721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92426868|NCT01540721|Analgesics|analgesics|mesh-ancestor
92426869|NCT01540721|Sensory System Agents|sensory system agents|mesh-ancestor
92426870|NCT01540721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426871|NCT01540721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426872|NCT01540721|Antipyretics|antipyretics|mesh-ancestor
92426873|NCT01540734|Acetaminophen|acetaminophen|mesh-list
92426874|NCT01540734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92426875|NCT01540734|Analgesics|analgesics|mesh-ancestor
92426876|NCT01540734|Sensory System Agents|sensory system agents|mesh-ancestor
92426877|NCT01540734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426878|NCT01540734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426879|NCT01540734|Antipyretics|antipyretics|mesh-ancestor
92426880|NCT01540747|Folic Acid|folic acid|mesh-list
92426881|NCT01540747|Vitamin B Complex|vitamin b complex|mesh-list
92426882|NCT01540747|Inositol|inositol|mesh-list
92426883|NCT01540747|Melatonin|melatonin|mesh-list
92426884|NCT01540747|Antioxidants|antioxidants|mesh-ancestor
92426885|NCT01540747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426886|NCT01540747|Protective Agents|protective agents|mesh-ancestor
92426887|NCT01540747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426888|NCT01540747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426890|NCT01540747|Vitamins|vitamins|mesh-ancestor
92426891|NCT01540747|Micronutrients|micronutrients|mesh-ancestor
92426892|NCT01540812|Cytarabine|cytarabine|mesh-list
92609627|NCT02964572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609628|NCT02964572|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609629|NCT02964572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609630|NCT02964572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92609631|NCT02964572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92609632|NCT02964572|Immunologic Factors|immunologic factors|mesh-ancestor
92426894|NCT01540812|Dexamethasone acetate|dexamethasone acetate|mesh-list
92426895|NCT01540812|Prednisone|prednisone|mesh-list
92426896|NCT01540812|Hydrocortisone|hydrocortisone|mesh-list
92426897|NCT01540812|Fludarabine|fludarabine|mesh-list
92426898|NCT01540812|Vincristine|vincristine|mesh-list
92426899|NCT01540812|Daunorubicin|daunorubicin|mesh-list
92426900|NCT01540812|Idarubicin|idarubicin|mesh-list
92426901|NCT01540812|Methotrexate|methotrexate|mesh-list
92426902|NCT01540812|Pegaspargase|pegaspargase|mesh-list
92426903|NCT01540812|Asparaginase|asparaginase|mesh-list
92426904|NCT01540812|BB 1101|bb 1101|mesh-list
92426905|NCT01540812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426906|NCT01540812|Antiemetics|antiemetics|mesh-ancestor
92426907|NCT01540812|Autonomic Agents|autonomic agents|mesh-ancestor
92426908|NCT01540812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426909|NCT01540812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426910|NCT01540812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426911|NCT01540812|Glucocorticoids|glucocorticoids|mesh-ancestor
92426912|NCT01540812|Hormones|hormones|mesh-ancestor
92426913|NCT01540812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92426914|NCT01540812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92426915|NCT01540812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426916|NCT01540812|Protease Inhibitors|protease inhibitors|mesh-ancestor
92426917|NCT01540812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426918|NCT01540812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426919|NCT01540812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426920|NCT01540812|Antimetabolites|antimetabolites|mesh-ancestor
92426921|NCT01540812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426922|NCT01540812|Immunologic Factors|immunologic factors|mesh-ancestor
92426923|NCT01540812|Antiviral Agents|antiviral agents|mesh-ancestor
92426924|NCT01540812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426925|NCT01540812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92426926|NCT01540812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92426927|NCT01540812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92426928|NCT01540812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92426929|NCT01540812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92426930|NCT01540812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92426932|NCT01540812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92426933|NCT01540812|Abortifacient Agents|abortifacient agents|mesh-ancestor
92426934|NCT01540812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92426935|NCT01540812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92426936|NCT01540812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92426937|NCT01540812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426938|NCT01540812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92426939|NCT01540877|Anesthetics|anesthetics|mesh-list
92426940|NCT01540877|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92426941|NCT01540877|Anesthetics, Local|anesthetics, local|mesh-list
92426942|NCT01540877|Capsaicin|capsaicin|mesh-list
92426943|NCT01540877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426944|NCT01540877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426945|NCT01540877|Sensory System Agents|sensory system agents|mesh-ancestor
92426946|NCT01540877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426947|NCT01540877|Antipruritics|antipruritics|mesh-ancestor
92426948|NCT01540877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92426949|NCT01540877|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92426950|NCT01541059|Ropivacaine|ropivacaine|mesh-list
92426951|NCT01541059|Anesthetics, Local|anesthetics, local|mesh-ancestor
92426952|NCT01541059|Anesthetics|anesthetics|mesh-ancestor
92426953|NCT01541059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426954|NCT01541059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426955|NCT01541059|Sensory System Agents|sensory system agents|mesh-ancestor
92426956|NCT01541059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426957|NCT01541072|Lenograstim|lenograstim|mesh-list
92426958|NCT01541072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92609633|NCT00162201|Abatacept|abatacept|mesh-list
92609634|NCT00162201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92609635|NCT00162201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609636|NCT00162201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92609637|NCT00162201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609638|NCT00162201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016792|NCT02448381|Hypericin|hypericin|mesh-list
92426959|NCT01541072|Immunologic Factors|immunologic factors|mesh-ancestor
92426960|NCT01541072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426961|NCT01541124|Morphine|morphine|mesh-list
92426962|NCT01541124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92426963|NCT01541124|Narcotics|narcotics|mesh-ancestor
92426964|NCT01541124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426965|NCT01541124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426966|NCT01541124|Analgesics|analgesics|mesh-ancestor
92426988|NCT01541189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426989|NCT01541267|Telmisartan|telmisartan|mesh-list
92426990|NCT01541267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92426991|NCT01541267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92426992|NCT01541267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92426993|NCT01541267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426994|NCT01541280|Azacitidine|azacitidine|mesh-list
92426995|NCT01541280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92426996|NCT01541280|Antimetabolites|antimetabolites|mesh-ancestor
92426997|NCT01541280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426998|NCT01541280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426999|NCT01541280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427000|NCT01541293|Lidocaine|lidocaine|mesh-list
92427001|NCT01541293|Anesthetics, Local|anesthetics, local|mesh-ancestor
92427002|NCT01541293|Anesthetics|anesthetics|mesh-ancestor
92427003|NCT01541293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151702|NCT00635089|Reslizumab|reslizumab|mesh-list
92427004|NCT01541293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427005|NCT01541293|Sensory System Agents|sensory system agents|mesh-ancestor
92427006|NCT01541293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427007|NCT01541293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427008|NCT01541293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92427009|NCT01541293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92427010|NCT01541293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427011|NCT01541293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427012|NCT01541332|Dexamethasone|dexamethasone|mesh-list
92427013|NCT01541332|Doxorubicin|doxorubicin|mesh-list
92427014|NCT01541332|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92427015|NCT01541332|Pomalidomide|pomalidomide|mesh-list
92427016|NCT01541332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427017|NCT01541332|Antiemetics|antiemetics|mesh-ancestor
92427018|NCT01541332|Autonomic Agents|autonomic agents|mesh-ancestor
92427041|NCT01541436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427042|NCT01541436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427043|NCT01541475|Dexetimide|dexetimide|mesh-list
92427044|NCT01541475|Citalopram|citalopram|mesh-list
92427045|NCT01541475|Bupropion|bupropion|mesh-list
92427046|NCT01541475|Escitalopram|escitalopram|mesh-list
92427047|NCT01541475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92427048|NCT01541475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92427049|NCT01541475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427050|NCT01541475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427051|NCT01541475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427052|NCT01541475|Serotonin Agents|serotonin agents|mesh-ancestor
92427053|NCT01541475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427054|NCT01541475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92427055|NCT01541475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92427056|NCT01541475|Parasympatholytics|parasympatholytics|mesh-ancestor
92427057|NCT01541475|Autonomic Agents|autonomic agents|mesh-ancestor
92427058|NCT01541475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427059|NCT01541475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92427060|NCT01541475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92609639|NCT00162201|Immunologic Factors|immunologic factors|mesh-ancestor
92609640|NCT00162201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609641|NCT00162201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609642|NCT01248247|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92609643|NCT01248247|Sorafenib|sorafenib|mesh-list
92609644|NCT01248247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609645|NCT01248247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92609646|NCT01248247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016800|NCT02448381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92427061|NCT01541475|Cholinergic Agents|cholinergic agents|mesh-ancestor
92427062|NCT01541475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92427063|NCT01541475|Antidepressive Agents|antidepressive agents|mesh-ancestor
92427064|NCT01541475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92427065|NCT01541475|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92427066|NCT01541475|Dopamine Agents|dopamine agents|mesh-ancestor
92427067|NCT01541475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92427068|NCT01541475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92427069|NCT01541475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427070|NCT01541605|Methylphenidate|methylphenidate|mesh-list
92427074|NCT01541605|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92427075|NCT01541605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427076|NCT01541605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427077|NCT01541605|Dopamine Agents|dopamine agents|mesh-ancestor
92427078|NCT01541605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427079|NCT01541631|Albendazole|albendazole|mesh-list
92427080|NCT01541631|Praziquantel|praziquantel|mesh-list
92427081|NCT01541631|Anthelmintics|anthelmintics|mesh-ancestor
92427082|NCT01541631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92427083|NCT01541631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427084|NCT01541631|Anticestodal Agents|anticestodal agents|mesh-ancestor
92427085|NCT01541631|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92427086|NCT01541631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92427087|NCT01541631|Tubulin Modulators|tubulin modulators|mesh-ancestor
92427088|NCT01541631|Antimitotic Agents|antimitotic agents|mesh-ancestor
92427089|NCT01541631|Mitosis Modulators|mitosis modulators|mesh-ancestor
92427090|NCT01541631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427091|NCT01541631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427092|NCT01541670|Antibodies|antibodies|mesh-list
92427093|NCT01541670|Immunologic Factors|immunologic factors|mesh-ancestor
92427094|NCT01541670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427095|NCT01541683|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92427096|NCT01541904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92427097|NCT01541904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92427098|NCT01541085|Ritonavir|ritonavir|mesh-list
92427099|NCT01541085|Darunavir|darunavir|mesh-list
92427100|NCT01541085|Efavirenz|efavirenz|mesh-list
92427101|NCT01541085|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92427102|NCT01541085|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92427103|NCT01541085|Protease Inhibitors|protease inhibitors|mesh-ancestor
92427104|NCT01541085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427105|NCT01541085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427106|NCT01541085|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92427107|NCT01541085|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92427108|NCT01541085|Antiviral Agents|antiviral agents|mesh-ancestor
92427109|NCT01541085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427110|NCT01541085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92427111|NCT01541085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92427112|NCT01541085|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92427113|NCT01541085|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92427114|NCT01541085|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92427115|NCT01541085|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92427116|NCT01541085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92427117|NCT01541085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92427118|NCT01541085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92427119|NCT01541943|Losartan|losartan|mesh-list
92427120|NCT01541943|Atorvastatin|atorvastatin|mesh-list
92609647|NCT01248247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609648|NCT00140894|Rofecoxib|rofecoxib|mesh-list
92427121|NCT01541943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92427122|NCT01541943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92427123|NCT01541943|Antimetabolites|antimetabolites|mesh-ancestor
92427124|NCT01541943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427125|NCT01541943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92427126|NCT01541943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92427127|NCT01541943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427128|NCT01541943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427129|NCT01541943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92427130|NCT01541943|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92427131|NCT01541943|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92427132|NCT01541956|Metformin|metformin|mesh-list
92427133|NCT01541956|Vildagliptin|vildagliptin|mesh-list
92427134|NCT01541956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427135|NCT01541956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427136|NCT01541956|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92427137|NCT01541956|Protease Inhibitors|protease inhibitors|mesh-ancestor
92427138|NCT01541956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427139|NCT01541956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427140|NCT01542047|Carboplatin|carboplatin|mesh-list
92427144|NCT01542060|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92427145|NCT01542060|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427146|NCT01542060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427147|NCT01542099|Remifentanil|remifentanil|mesh-list
92427148|NCT01542099|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427149|NCT01542099|Narcotics|narcotics|mesh-ancestor
92427150|NCT01542099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427151|NCT01542099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427152|NCT01542099|Analgesics|analgesics|mesh-ancestor
92427153|NCT01542099|Sensory System Agents|sensory system agents|mesh-ancestor
92427154|NCT01542099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427155|NCT01542138|Niacinamide|niacinamide|mesh-list
92427157|NCT01542138|Nicotinic Acids|nicotinic acids|mesh-list
92427158|NCT01542138|Desonide|desonide|mesh-list
92427159|NCT01542138|Vitamin B Complex|vitamin b complex|mesh-ancestor
92427160|NCT01542138|Vitamins|vitamins|mesh-ancestor
92427161|NCT01542138|Micronutrients|micronutrients|mesh-ancestor
92395907|NCT01393795|Sensory System Agents|sensory system agents|mesh-ancestor
92427162|NCT01542138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427163|NCT01542138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92427164|NCT01542138|Antimetabolites|antimetabolites|mesh-ancestor
92427165|NCT01542138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427166|NCT01542138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92427167|NCT01542138|Vasodilator Agents|vasodilator agents|mesh-ancestor
92427168|NCT01542138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427169|NCT01542190|Ketorolac|ketorolac|mesh-list
92427170|NCT01542190|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92427171|NCT01542190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92427172|NCT01542190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92427173|NCT01542190|Analgesics|analgesics|mesh-ancestor
92427174|NCT01542190|Sensory System Agents|sensory system agents|mesh-ancestor
92427175|NCT01542190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427176|NCT01542190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427177|NCT01542190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427178|NCT01542190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427179|NCT01542190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92427180|NCT01542190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427181|NCT01542190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427182|NCT01542242|Liraglutide|liraglutide|mesh-list
92427183|NCT01542242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427184|NCT01542242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427185|NCT01542242|Incretins|incretins|mesh-ancestor
92427186|NCT01542242|Hormones|hormones|mesh-ancestor
92427187|NCT01542242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427188|NCT01542268|Pentoxifylline|pentoxifylline|mesh-list
92427189|NCT01542268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92427190|NCT01542268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427191|NCT01542268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427192|NCT01542268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92427193|NCT01542268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92427194|NCT01542268|Protective Agents|protective agents|mesh-ancestor
92609649|NCT00140894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609650|NCT00140894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609651|NCT00140894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609652|NCT00140894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92609653|NCT00140894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92609654|NCT00140894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609655|NCT00140894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92609656|NCT00140894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609657|NCT00140894|Analgesics|analgesics|mesh-ancestor
92609658|NCT00140894|Sensory System Agents|sensory system agents|mesh-ancestor
92609659|NCT00140894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609660|NCT00140894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609661|NCT00155064|Losartan|losartan|mesh-list
92609662|NCT00155064|Captopril|captopril|mesh-list
92609663|NCT00155064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92609664|NCT00155064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92609665|NCT00155064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92609666|NCT00155064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92609667|NCT00155064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609668|NCT00155064|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92609669|NCT00155064|Protease Inhibitors|protease inhibitors|mesh-ancestor
92609670|NCT00155064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609671|NCT02483260|Ribavirin|ribavirin|mesh-list
92609672|NCT02483260|Antimetabolites|antimetabolites|mesh-ancestor
92427195|NCT01542268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427196|NCT01542268|Vasodilator Agents|vasodilator agents|mesh-ancestor
92427197|NCT01542268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92427198|NCT01542268|Antioxidants|antioxidants|mesh-ancestor
92427199|NCT01542294|Oxaliplatin|oxaliplatin|mesh-list
92427200|NCT01542294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427201|NCT01542424|Insulin|insulin|mesh-list
92427202|NCT01542424|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92427203|NCT01542424|Insulin Aspart|insulin aspart|mesh-list
92427204|NCT01542424|Insulin Detemir|insulin detemir|mesh-list
92427205|NCT01542424|Biphasic Insulins|biphasic insulins|mesh-list
92427206|NCT01542424|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92395919|NCT01393925|Analgesics|analgesics|mesh-ancestor
92427207|NCT01542424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427208|NCT01542424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427209|NCT01542437|Afatinib|afatinib|mesh-list
92427210|NCT01542437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427211|NCT01542437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92427212|NCT01542437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427213|NCT01542437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427214|NCT01542450|Insulin|insulin|mesh-list
92427217|NCT01542450|Isophane Insulin, Human|isophane insulin, human|mesh-list
92427218|NCT01542450|Insulin, Isophane|insulin, isophane|mesh-list
92427219|NCT01542450|Isophane insulin, beef|isophane insulin, beef|mesh-list
92427220|NCT01542450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427221|NCT01542450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427222|NCT01542463|Insulin Detemir|insulin detemir|mesh-list
92609673|NCT02483260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609674|NCT02483260|Antiviral Agents|antiviral agents|mesh-ancestor
92609675|NCT02483260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609676|NCT00140933|Diclofenac|diclofenac|mesh-list
92334735|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
92609678|NCT00140933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92609679|NCT00140933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609680|NCT00140933|Analgesics|analgesics|mesh-ancestor
92609681|NCT00140933|Sensory System Agents|sensory system agents|mesh-ancestor
92427223|NCT01542463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427224|NCT01542463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427225|NCT01542476|Insulin Detemir|insulin detemir|mesh-list
92427226|NCT01542476|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427227|NCT01542476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427228|NCT01542489|Insulin|insulin|mesh-list
92427229|NCT01542489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92427230|NCT01542489|Insulin Aspart|insulin aspart|mesh-list
92427231|NCT01542489|Insulin Detemir|insulin detemir|mesh-list
92427232|NCT01542489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427233|NCT01542489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427234|NCT01542697|Magnesium Sulfate|magnesium sulfate|mesh-list
92427235|NCT01542697|Analgesics|analgesics|mesh-ancestor
92427236|NCT01542697|Sensory System Agents|sensory system agents|mesh-ancestor
92427237|NCT01542697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427238|NCT01542697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427239|NCT01542697|Anesthetics|anesthetics|mesh-ancestor
92427240|NCT01542697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427241|NCT01542697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427242|NCT01542697|Anticonvulsants|anticonvulsants|mesh-ancestor
92427243|NCT01542697|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92427244|NCT01542697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427245|NCT01542697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427246|NCT01542697|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92427247|NCT01542697|Tocolytic Agents|tocolytic agents|mesh-ancestor
92427248|NCT01542697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92427249|NCT01542710|Timolol|timolol|mesh-list
92427250|NCT01542710|Bimatoprost|bimatoprost|mesh-list
92427251|NCT01542710|Travoprost|travoprost|mesh-list
92427252|NCT01542710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92427253|NCT01542710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92427254|NCT01542710|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427255|NCT01542710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427256|NCT01542710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427257|NCT01542710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427258|NCT01542710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427259|NCT01542710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92427260|NCT01542723|Nadroparin|nadroparin|mesh-list
92427261|NCT01542723|Anticoagulants|anticoagulants|mesh-ancestor
92427262|NCT01542723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92427263|NCT01542723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92427264|NCT01542723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427265|NCT01542762|Nadroparin|nadroparin|mesh-list
92427266|NCT01542762|Anticoagulants|anticoagulants|mesh-ancestor
92427267|NCT01542762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92427268|NCT01542762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92427269|NCT01542762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427270|NCT01542801|Ciprofloxacin|ciprofloxacin|mesh-list
92427271|NCT01542801|Norfloxacin|norfloxacin|mesh-list
92427272|NCT01542801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92427273|NCT01542801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427274|NCT01542801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92427275|NCT01542801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92427276|NCT01542801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427277|NCT01542801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427278|NCT01542801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427279|NCT01542801|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92609682|NCT00140933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609683|NCT00140933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609684|NCT00140933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609685|NCT00140933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92609686|NCT00140933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92427280|NCT01542801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92427282|NCT01542827|Sensory System Agents|sensory system agents|mesh-ancestor
92427283|NCT01542827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427284|NCT01542827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427285|NCT01542918|Rituximab|rituximab|mesh-list
92427286|NCT01542918|Lenalidomide|lenalidomide|mesh-list
92427287|NCT01542918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92427288|NCT01542918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427294|NCT01542918|Growth Substances|growth substances|mesh-ancestor
92427295|NCT01542918|Growth Inhibitors|growth inhibitors|mesh-ancestor
92427296|NCT01543035|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92427297|NCT01543035|Antiviral Agents|antiviral agents|mesh-ancestor
92427298|NCT01543035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427299|NCT01543061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92427300|NCT01543061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92427301|NCT01543139|Valproic Acid|valproic acid|mesh-list
92151992|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92427302|NCT01543139|Anticonvulsants|anticonvulsants|mesh-ancestor
92427303|NCT01543139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427304|NCT01543139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427305|NCT01543139|GABA Agents|gaba agents|mesh-ancestor
92427306|NCT01543139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427307|NCT01543139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427308|NCT01543139|Antimanic Agents|antimanic agents|mesh-ancestor
92427309|NCT01543139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92427310|NCT01543139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427311|NCT01543139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92427312|NCT01543165|Ketorolac|ketorolac|mesh-list
92427313|NCT01543165|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92427314|NCT01543165|Morphine|morphine|mesh-list
92427315|NCT01543165|Analgesics|analgesics|mesh-list
92427316|NCT01543165|Nefopam|nefopam|mesh-list
92427317|NCT01543165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427318|NCT01543165|Narcotics|narcotics|mesh-ancestor
92427319|NCT01543165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427320|NCT01543165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427321|NCT01543165|Sensory System Agents|sensory system agents|mesh-ancestor
92427322|NCT01543165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427323|NCT01543165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92427324|NCT01543165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92427325|NCT01543165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427326|NCT01543165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427327|NCT01543165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92427328|NCT01543165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427329|NCT01543165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427330|NCT01543321|Tetrabenazine|tetrabenazine|mesh-list
92427331|NCT01543321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92427332|NCT01543321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92427333|NCT01543321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427334|NCT01543321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427335|NCT01543321|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427336|NCT01543321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427337|NCT01543321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427338|NCT01543347|Temocillin|temocillin|mesh-list
92427339|NCT01543347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92427340|NCT01543347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427341|NCT01543386|Curcumin|curcumin|mesh-list
92427342|NCT01543386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92427343|NCT01543386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92427344|NCT01543386|Analgesics|analgesics|mesh-ancestor
92427345|NCT01543386|Sensory System Agents|sensory system agents|mesh-ancestor
92427346|NCT01543386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427347|NCT01543386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427348|NCT01543386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609687|NCT00140933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609688|NCT00140933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609689|NCT00140933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92427349|NCT01543386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427350|NCT01543386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427351|NCT01543386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427352|NCT01543386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427353|NCT01543399|Tibolone|tibolone|mesh-list
92427354|NCT01543399|Androgen Antagonists|androgen antagonists|mesh-ancestor
92427355|NCT01543399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92427356|NCT01543399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427357|NCT01543399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427360|NCT01543399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427361|NCT01543399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92427362|NCT01543399|Anabolic Agents|anabolic agents|mesh-ancestor
92427363|NCT01543399|Hormones|hormones|mesh-ancestor
92427364|NCT01543464|Temozolomide|temozolomide|mesh-list
92427365|NCT01543464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92427366|NCT01543464|Alkylating Agents|alkylating agents|mesh-ancestor
92427367|NCT01543464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427368|NCT01543464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427369|NCT01543555|Atorvastatin|atorvastatin|mesh-list
92427370|NCT01543555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92427371|NCT01543555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92427372|NCT01543555|Antimetabolites|antimetabolites|mesh-ancestor
92427373|NCT01543555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427374|NCT01543555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92427375|NCT01543555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92427376|NCT01543555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152072|NCT01045161|Bromides|bromides|mesh-list
92427378|NCT01543724|Antidepressive Agents|antidepressive agents|mesh-ancestor
92427379|NCT01543724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92427380|NCT01543724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427381|NCT01543724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427382|NCT01543724|Antimanic Agents|antimanic agents|mesh-ancestor
92427383|NCT01543724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92427384|NCT01543724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427385|NCT01543724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427386|NCT01543737|Hyaluronic Acid|hyaluronic acid|mesh-list
92427387|NCT01543737|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92427388|NCT01543737|Immunologic Factors|immunologic factors|mesh-ancestor
92427389|NCT01543737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427390|NCT01543737|Viscosupplements|viscosupplements|mesh-ancestor
92427391|NCT01543737|Protective Agents|protective agents|mesh-ancestor
92427392|NCT01543750|4-Aminopyridine|4-aminopyridine|mesh-list
92427393|NCT01543750|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92427394|NCT01543750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427395|NCT01543750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427396|NCT01543906|Retinol acetate|retinol acetate|mesh-list
92427397|NCT01543906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92427398|NCT01543906|Immunologic Factors|immunologic factors|mesh-ancestor
92427399|NCT01543906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427400|NCT01543906|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92427401|NCT01543906|Protective Agents|protective agents|mesh-ancestor
92427402|NCT01543906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427403|NCT01543932|Clopidogrel|clopidogrel|mesh-list
92427404|NCT01543932|Ticagrelor|ticagrelor|mesh-list
92427405|NCT01543932|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92427406|NCT01543932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92427407|NCT01543932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92427408|NCT01543932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92427409|NCT01543932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92427410|NCT01543932|Purinergic Agents|purinergic agents|mesh-ancestor
92427411|NCT01543932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408080|NCT01448642|Antimetabolites|antimetabolites|mesh-ancestor
92427412|NCT01543932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427413|NCT01543932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427414|NCT01543945|Dexamethasone|dexamethasone|mesh-list
92427415|NCT01543945|Dexamethasone acetate|dexamethasone acetate|mesh-list
92427416|NCT01543945|Ondansetron|ondansetron|mesh-list
92427417|NCT01543945|Antiemetics|antiemetics|mesh-list
92609690|NCT04515628|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92609691|NCT04515628|Branebrutinib|branebrutinib|mesh-list
92609692|NCT04515628|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92609693|NCT04515628|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92609694|NCT04515628|Antimetabolites|antimetabolites|mesh-ancestor
92016849|NCT05536271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427418|NCT01543945|Dimenhydrinate|dimenhydrinate|mesh-list
92427419|NCT01543945|BB 1101|bb 1101|mesh-list
92427420|NCT01543945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427421|NCT01543945|Autonomic Agents|autonomic agents|mesh-ancestor
92427422|NCT01543945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427423|NCT01543945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427424|NCT01543945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92427425|NCT01543945|Glucocorticoids|glucocorticoids|mesh-ancestor
92427426|NCT01543945|Hormones|hormones|mesh-ancestor
92427427|NCT01543945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427428|NCT01543945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92427429|NCT01543945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427430|NCT01543945|Protease Inhibitors|protease inhibitors|mesh-ancestor
92427445|NCT01543971|Immunologic Factors|immunologic factors|mesh-ancestor
92427446|NCT01543971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427447|NCT01543971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92427448|NCT01543971|Vasodilator Agents|vasodilator agents|mesh-ancestor
92427449|NCT01544140|Midazolam|midazolam|mesh-list
92427450|NCT01544140|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92427451|NCT01544140|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92427452|NCT01544140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427453|NCT01544140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427454|NCT01544140|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92427455|NCT01544140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92427456|NCT01544140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92427457|NCT01544140|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92427458|NCT01544140|Anesthetics, General|anesthetics, general|mesh-ancestor
92427459|NCT01544140|Anesthetics|anesthetics|mesh-ancestor
92427460|NCT01544140|GABA Modulators|gaba modulators|mesh-ancestor
92427461|NCT01544140|GABA Agents|gaba agents|mesh-ancestor
92427462|NCT01544140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427463|NCT01544140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427464|NCT01544192|Tocopherols|tocopherols|mesh-list
92427465|NCT01544192|Vitamin E|vitamin e|mesh-list
92427466|NCT01544192|Tocotrienols|tocotrienols|mesh-list
92427467|NCT01544192|alpha-Tocopherol|alpha-tocopherol|mesh-list
92427468|NCT01544192|Antioxidants|antioxidants|mesh-list
92427469|NCT01544192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427470|NCT01544192|Protective Agents|protective agents|mesh-ancestor
92427471|NCT01544192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427472|NCT01544192|Vitamins|vitamins|mesh-ancestor
92427473|NCT01544192|Micronutrients|micronutrients|mesh-ancestor
92427474|NCT01544283|Triamcinolone|triamcinolone|mesh-list
92427475|NCT01544283|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92427476|NCT01544283|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92427477|NCT01544283|Lidocaine|lidocaine|mesh-list
92427478|NCT01544283|Tetracaine|tetracaine|mesh-list
92427479|NCT01544283|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92427480|NCT01544283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92427481|NCT01544283|Anesthetics|anesthetics|mesh-ancestor
92427482|NCT01544283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427483|NCT01544283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427484|NCT01544283|Sensory System Agents|sensory system agents|mesh-ancestor
92427485|NCT01544283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427486|NCT01544283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427487|NCT01544283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92427488|NCT01544283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92427489|NCT01544283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427490|NCT01544283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427491|NCT01544283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427492|NCT01544283|Glucocorticoids|glucocorticoids|mesh-ancestor
92427493|NCT01544283|Hormones|hormones|mesh-ancestor
92427496|NCT01544283|Immunologic Factors|immunologic factors|mesh-ancestor
92427497|NCT01544283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427498|NCT01544439|Salicylic Acid|salicylic acid|mesh-list
92427499|NCT01544439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609695|NCT04515628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609697|NCT04515628|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92609698|NCT04515628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427500|NCT01544439|Antifungal Agents|antifungal agents|mesh-ancestor
92427501|NCT01544439|Keratolytic Agents|keratolytic agents|mesh-ancestor
92427502|NCT01544439|Dermatologic Agents|dermatologic agents|mesh-ancestor
92427503|NCT01544504|Norepinephrine|norepinephrine|mesh-list
92427504|NCT01544504|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92427505|NCT01544504|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92427506|NCT01544504|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427507|NCT01544504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427508|NCT01544504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427509|NCT01544504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427510|NCT01544504|Sympathomimetics|sympathomimetics|mesh-ancestor
92427511|NCT01544504|Autonomic Agents|autonomic agents|mesh-ancestor
92427512|NCT01544504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427513|NCT01544504|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92427514|NCT01544517|Amoxicillin|amoxicillin|mesh-list
92427515|NCT01544517|Levofloxacin|levofloxacin|mesh-list
92427516|NCT01544517|Tinidazole|tinidazole|mesh-list
92427517|NCT01544517|Esomeprazole|esomeprazole|mesh-list
92427518|NCT01544517|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92427519|NCT01544517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92427520|NCT01544517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427521|NCT01544517|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92427522|NCT01544517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92427523|NCT01544517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427524|NCT01544517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427525|NCT01544517|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92427526|NCT01544517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92427527|NCT01544517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92427528|NCT01544517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427529|NCT01544517|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92427530|NCT01544517|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92427532|NCT01544517|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92427533|NCT01544517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92427534|NCT01544517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92427535|NCT01544634|Beclomethasone|beclomethasone|mesh-list
92427536|NCT01544634|Propranolol|propranolol|mesh-list
92427537|NCT01544634|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92427538|NCT01544634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92427539|NCT01544634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427540|NCT01544634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427541|NCT01544634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427542|NCT01544634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427543|NCT01544634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427544|NCT01544634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92427545|NCT01544634|Vasodilator Agents|vasodilator agents|mesh-ancestor
92427546|NCT01544634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427547|NCT01544634|Glucocorticoids|glucocorticoids|mesh-ancestor
92427548|NCT01544634|Hormones|hormones|mesh-ancestor
92427549|NCT01544634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427550|NCT01544634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92427551|NCT01544634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92427552|NCT01544673|Linezolid|linezolid|mesh-list
92427553|NCT01544673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92427554|NCT01544673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427555|NCT01544673|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92427556|NCT01544673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427557|NCT01544673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427558|NCT01544725|Ketamine|ketamine|mesh-list
92427559|NCT01544725|Propofol|propofol|mesh-list
92427560|NCT01544725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92427561|NCT01544725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427562|NCT01544725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427563|NCT01544725|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92427564|NCT01544725|Anesthetics, General|anesthetics, general|mesh-ancestor
92427565|NCT01544725|Anesthetics|anesthetics|mesh-ancestor
92427566|NCT01544725|Analgesics|analgesics|mesh-ancestor
92609699|NCT04515628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92609701|NCT00407043|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92609702|NCT00141011|Ancrod|ancrod|mesh-list
92609703|NCT00141011|Anticoagulants|anticoagulants|mesh-ancestor
92427567|NCT01544725|Sensory System Agents|sensory system agents|mesh-ancestor
92427582|NCT01544751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92427583|NCT01544751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92427584|NCT01544751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427585|NCT01544829|Theobromine|theobromine|mesh-list
92427586|NCT01544829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92427587|NCT01544829|Autonomic Agents|autonomic agents|mesh-ancestor
92427588|NCT01544829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427589|NCT01544829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427590|NCT01544829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92427591|NCT01544829|Respiratory System Agents|respiratory system agents|mesh-ancestor
92427592|NCT01544829|Vasodilator Agents|vasodilator agents|mesh-ancestor
92427593|NCT01544842|Triamcinolone|triamcinolone|mesh-list
92427594|NCT01544842|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92427595|NCT01544842|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92427596|NCT01544842|Tacrolimus|tacrolimus|mesh-list
92427597|NCT01544842|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92427598|NCT01544842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92427599|NCT01544842|Immunologic Factors|immunologic factors|mesh-ancestor
92427600|NCT01544842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427601|NCT01544842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92427602|NCT01544842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427603|NCT01544842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427604|NCT01544842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427605|NCT01544842|Glucocorticoids|glucocorticoids|mesh-ancestor
92427607|NCT01544842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427608|NCT01544881|Insulin|insulin|mesh-list
92427609|NCT01544881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427610|NCT01544881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427611|NCT01544894|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92427612|NCT01544894|Strontium ranelate|strontium ranelate|mesh-list
92427613|NCT01544894|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92427614|NCT01544894|Hormone Antagonists|hormone antagonists|mesh-ancestor
92427615|NCT01544894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427616|NCT01544894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427617|NCT01544894|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92427618|NCT01544894|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92427619|NCT01544894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92427620|NCT01544907|Paclitaxel|paclitaxel|mesh-list
92427621|NCT01544907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92427622|NCT01544907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427623|NCT01544907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92427624|NCT01544907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92427625|NCT01544907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92427626|NCT01544907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427628|NCT01544959|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92427630|NCT01544959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427631|NCT01544959|Narcotics|narcotics|mesh-ancestor
92427632|NCT01544959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427633|NCT01544959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427634|NCT01544959|Analgesics|analgesics|mesh-ancestor
92427635|NCT01544959|Sensory System Agents|sensory system agents|mesh-ancestor
92427636|NCT01544959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427637|NCT01544959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92427638|NCT01544959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92427639|NCT01544959|Anesthetics, General|anesthetics, general|mesh-ancestor
92427640|NCT01544959|Anesthetics|anesthetics|mesh-ancestor
92427641|NCT01544959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92427642|NCT01544959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427643|NCT01544959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427644|NCT01544959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427645|NCT01544959|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92427646|NCT01544972|Acetaminophen|acetaminophen|mesh-list
92427647|NCT01544972|Ibuprofen|ibuprofen|mesh-list
92427648|NCT01544972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92427649|NCT01544972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92427650|NCT01544972|Analgesics|analgesics|mesh-ancestor
92427651|NCT01544972|Sensory System Agents|sensory system agents|mesh-ancestor
92427652|NCT01544972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427653|NCT01544972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427654|NCT01544972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427655|NCT01544972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427656|NCT01544972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92427657|NCT01544972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427658|NCT01544972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427659|NCT01544972|Antipyretics|antipyretics|mesh-ancestor
92427660|NCT01545024|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92427661|NCT01545024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427662|NCT01545024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427663|NCT01545024|Incretins|incretins|mesh-ancestor
92427664|NCT01545024|Hormones|hormones|mesh-ancestor
92427665|NCT01545024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427666|NCT01545024|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92427667|NCT01545024|Protease Inhibitors|protease inhibitors|mesh-ancestor
92427668|NCT01545024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427669|NCT01545024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427670|NCT01545284|Acitretin|acitretin|mesh-list
92427671|NCT01545284|Keratolytic Agents|keratolytic agents|mesh-ancestor
92427672|NCT01545284|Dermatologic Agents|dermatologic agents|mesh-ancestor
92427673|NCT01545297|Dexmedetomidine|dexmedetomidine|mesh-list
92427674|NCT01545297|Remifentanil|remifentanil|mesh-list
92427675|NCT01545297|Propofol|propofol|mesh-list
92427676|NCT01545297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92427677|NCT01545297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427678|NCT01545297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427679|NCT01545297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92427681|NCT01545297|Sensory System Agents|sensory system agents|mesh-ancestor
92427682|NCT01545297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427683|NCT01545297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92427684|NCT01545297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92427685|NCT01545297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92427686|NCT01545297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427687|NCT01545297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427688|NCT01545297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427689|NCT01545297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92427690|NCT01545297|Anesthetics, General|anesthetics, general|mesh-ancestor
92427691|NCT01545297|Anesthetics|anesthetics|mesh-ancestor
92427692|NCT01545297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427693|NCT01545297|Narcotics|narcotics|mesh-ancestor
92427694|NCT01545427|Imatinib Mesylate|imatinib mesylate|mesh-list
92427695|NCT01545427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427696|NCT01545427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92427697|NCT01545427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427698|NCT01545427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427699|NCT01545440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92427700|NCT01545440|Immunologic Factors|immunologic factors|mesh-ancestor
92427701|NCT01545440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427718|NCT01545778|Sensory System Agents|sensory system agents|mesh-ancestor
92427719|NCT01545778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427720|NCT01545778|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92427721|NCT01545778|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92427722|NCT01545778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427723|NCT01545778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427724|NCT01545778|Adrenergic Agents|adrenergic agents|mesh-ancestor
92427725|NCT01545778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427726|NCT01545791|Insulin Detemir|insulin detemir|mesh-list
92427727|NCT01545791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427728|NCT01545791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427729|NCT01545804|Lenalidomide|lenalidomide|mesh-list
92427730|NCT01545804|Immunologic Factors|immunologic factors|mesh-ancestor
92427731|NCT01545804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427732|NCT01545804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92427733|NCT01545804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92427734|NCT01545804|Growth Substances|growth substances|mesh-ancestor
92427735|NCT01545804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92427736|NCT01545804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609705|NCT00141011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92609706|NCT00141011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427738|NCT01545830|Cholecalciferol|cholecalciferol|mesh-list
92427739|NCT01545830|Vitamins|vitamins|mesh-ancestor
92427740|NCT01545830|Micronutrients|micronutrients|mesh-ancestor
92427741|NCT01545830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427742|NCT01545830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92427743|NCT01545830|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92427744|NCT01545856|Levodopa|levodopa|mesh-list
92427745|NCT01545856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92427746|NCT01545856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92427747|NCT01545856|Dopamine Agents|dopamine agents|mesh-ancestor
92427748|NCT01545856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427749|NCT01545856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427750|NCT01545856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427751|NCT01545947|Azacitidine|azacitidine|mesh-list
92427752|NCT01545947|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92427753|NCT01545947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92427754|NCT01545947|Antimetabolites|antimetabolites|mesh-ancestor
92427755|NCT01545947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427756|NCT01545947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427757|NCT01545947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427758|NCT01545947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92427759|NCT01546051|BCI-838|bci-838|mesh-list
92427760|NCT01546051|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92427761|NCT01546051|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92427762|NCT01546051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427763|NCT01546051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427765|NCT01546090|Alprazolam|alprazolam|mesh-list
92427766|NCT01546090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92427767|NCT01546090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427768|NCT01546090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427769|NCT01546090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92427770|NCT01546090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92427771|NCT01546090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92427772|NCT01546090|GABA Modulators|gaba modulators|mesh-ancestor
92427773|NCT01546090|GABA Agents|gaba agents|mesh-ancestor
92427774|NCT01546090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427775|NCT01546090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427776|NCT01546103|Vitamin D|vitamin d|mesh-list
92427777|NCT01546103|Ergocalciferols|ergocalciferols|mesh-list
92427778|NCT01546103|Cholecalciferol|cholecalciferol|mesh-list
92427779|NCT01546103|Vitamins|vitamins|mesh-list
92427780|NCT01546103|Micronutrients|micronutrients|mesh-ancestor
92427781|NCT01546103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427782|NCT01546103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92427783|NCT01546103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92427784|NCT01546116|Lamivudine|lamivudine|mesh-list
92427785|NCT01546116|Adefovir|adefovir|mesh-list
92427786|NCT01546116|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92427787|NCT01546116|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92427788|NCT01546116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92427789|NCT01546116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427790|NCT01546116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427791|NCT01546116|Antiviral Agents|antiviral agents|mesh-ancestor
92427792|NCT01546116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427793|NCT01546116|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92427794|NCT01546116|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92427795|NCT01546389|Chloroquine|chloroquine|mesh-list
92427796|NCT01546389|Amebicides|amebicides|mesh-ancestor
92427797|NCT01546389|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92427798|NCT01546389|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92427799|NCT01546389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427800|NCT01546389|Antimalarials|antimalarials|mesh-ancestor
92427801|NCT01546389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427802|NCT01546558|Metformin|metformin|mesh-list
92427803|NCT01546558|Ranolazine|ranolazine|mesh-list
92427804|NCT01546558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427805|NCT01546558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427806|NCT01546558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92427807|NCT01546558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427808|NCT01546558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427809|NCT01546597|Metformin|metformin|mesh-list
92609707|NCT00504946|Cholecalciferol|cholecalciferol|mesh-list
92609708|NCT00504946|Vitamin D|vitamin d|mesh-list
92609709|NCT00504946|Prednisone|prednisone|mesh-list
92609710|NCT00504946|Budesonide|budesonide|mesh-list
92609711|NCT00504946|Montelukast|montelukast|mesh-list
92427810|NCT01546597|Ranolazine|ranolazine|mesh-list
92427811|NCT01546597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427812|NCT01546597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427813|NCT01546597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92427814|NCT01546597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92427815|NCT01546597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427816|NCT01546701|Morphine|morphine|mesh-list
92427817|NCT01546701|Buprenorphine|buprenorphine|mesh-list
92427818|NCT01546701|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427819|NCT01546701|Narcotics|narcotics|mesh-ancestor
92427820|NCT01546701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427821|NCT01546701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427822|NCT01546701|Analgesics|analgesics|mesh-ancestor
92427823|NCT01546701|Sensory System Agents|sensory system agents|mesh-ancestor
92427824|NCT01546701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427825|NCT01546701|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92427826|NCT01546896|Alprazolam|alprazolam|mesh-list
92427827|NCT01546896|Buspirone|buspirone|mesh-list
92427828|NCT01546896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92427829|NCT01546896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427830|NCT01546896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427831|NCT01546896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92427832|NCT01546896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92427833|NCT01546896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92427834|NCT01546896|GABA Modulators|gaba modulators|mesh-ancestor
92427835|NCT01546896|GABA Agents|gaba agents|mesh-ancestor
92427836|NCT01546896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427837|NCT01546896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427838|NCT01546896|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92427849|NCT01546961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427850|NCT01546961|Antimalarials|antimalarials|mesh-ancestor
92427851|NCT01546961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427852|NCT01547091|Antirheumatic Agents|antirheumatic agents|mesh-list
92427853|NCT01547104|Glimepiride|glimepiride|mesh-list
92427854|NCT01547104|Linagliptin|linagliptin|mesh-list
92427855|NCT01547104|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92427856|NCT01547104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427857|NCT01547104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427858|NCT01547104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92427859|NCT01547104|Immunologic Factors|immunologic factors|mesh-ancestor
92427860|NCT01547104|Incretins|incretins|mesh-ancestor
92427861|NCT01547104|Hormones|hormones|mesh-ancestor
92427862|NCT01547104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427863|NCT01547104|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92427864|NCT01547104|Protease Inhibitors|protease inhibitors|mesh-ancestor
92427865|NCT01547104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427866|NCT01547104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427867|NCT01547143|Cyclosporine|cyclosporine|mesh-list
92427868|NCT01547143|Dexamethasone|dexamethasone|mesh-list
92427869|NCT01547143|Etoposide|etoposide|mesh-list
92427870|NCT01547143|Cyclosporins|cyclosporins|mesh-list
92427871|NCT01547143|gamma-Globulins|gamma-globulins|mesh-list
92427872|NCT01547143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92427873|NCT01547143|Antiemetics|antiemetics|mesh-ancestor
92427874|NCT01547143|Autonomic Agents|autonomic agents|mesh-ancestor
92427875|NCT01547143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427876|NCT01547143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427877|NCT01547143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92427878|NCT01547143|Glucocorticoids|glucocorticoids|mesh-ancestor
92427879|NCT01547143|Hormones|hormones|mesh-ancestor
92427880|NCT01547143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427881|NCT01547143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92427882|NCT01547143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427883|NCT01547143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427884|NCT01547143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427885|NCT01547143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92427886|NCT01547143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92427887|NCT01547143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92427888|NCT01547143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92609713|NCT00504946|Glucocorticoids|glucocorticoids|mesh-ancestor
92609714|NCT00504946|Hormones|hormones|mesh-ancestor
92609715|NCT00504946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609716|NCT00504946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609717|NCT00504946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92427889|NCT01547143|Immunologic Factors|immunologic factors|mesh-ancestor
92427890|NCT01547143|Antifungal Agents|antifungal agents|mesh-ancestor
92427891|NCT01547143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427892|NCT01547143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92427893|NCT01547143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427894|NCT01547143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92427895|NCT01547169|Insulin|insulin|mesh-list
92427896|NCT01547169|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92427897|NCT01547169|Insulin Detemir|insulin detemir|mesh-list
92427898|NCT01547169|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427899|NCT01547169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427900|NCT01547221|Clotrimazole|clotrimazole|mesh-list
92427901|NCT01547221|Miconazole|miconazole|mesh-list
92427902|NCT01547221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92427903|NCT01547221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427904|NCT01547221|Antifungal Agents|antifungal agents|mesh-ancestor
92427905|NCT01547221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92427906|NCT01547221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92427909|NCT01547221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92427910|NCT01547221|Hormone Antagonists|hormone antagonists|mesh-ancestor
92427911|NCT01547221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427912|NCT01547221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427913|NCT01547221|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92427914|NCT01547221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92427915|NCT01547312|Interferons|interferons|mesh-list
92427916|NCT01547312|Ribavirin|ribavirin|mesh-list
92427917|NCT01547312|Grazoprevir|grazoprevir|mesh-list
92427918|NCT01547312|Liver Extracts|liver extracts|mesh-list
92427919|NCT01547312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427920|NCT01547312|Antiviral Agents|antiviral agents|mesh-ancestor
92427921|NCT01547312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427922|NCT01547312|Antimetabolites|antimetabolites|mesh-ancestor
92427923|NCT01547312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427924|NCT01547312|Hematinics|hematinics|mesh-ancestor
92427925|NCT01547325|Doxycycline|doxycycline|mesh-list
92427926|NCT01547325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92427927|NCT01547325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427928|NCT01547325|Antimalarials|antimalarials|mesh-ancestor
92427929|NCT01547325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92427930|NCT01547325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92427931|NCT01547377|Zinc|zinc|mesh-list
92427932|NCT01547377|Selenium|selenium|mesh-list
92427933|NCT01547377|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92427934|NCT01547377|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92427935|NCT01547377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92427936|NCT01547377|Antimetabolites|antimetabolites|mesh-ancestor
92427937|NCT01547377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427938|NCT01547377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92427939|NCT01547377|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92427940|NCT01547377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427941|NCT01547377|Trace Elements|trace elements|mesh-ancestor
92427942|NCT01547377|Micronutrients|micronutrients|mesh-ancestor
92427943|NCT01547377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427944|NCT01547377|Antioxidants|antioxidants|mesh-ancestor
92427945|NCT01547377|Protective Agents|protective agents|mesh-ancestor
92427946|NCT01547416|Fentanyl|fentanyl|mesh-list
92427947|NCT01547416|Ropivacaine|ropivacaine|mesh-list
92427948|NCT01547416|Anesthetics, Local|anesthetics, local|mesh-ancestor
92427949|NCT01547416|Anesthetics|anesthetics|mesh-ancestor
92427950|NCT01547416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427951|NCT01547416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427952|NCT01547416|Sensory System Agents|sensory system agents|mesh-ancestor
92427953|NCT01547416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427954|NCT01547416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427955|NCT01547416|Narcotics|narcotics|mesh-ancestor
92609718|NCT00504946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609719|NCT00504946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92427957|NCT01547416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92427958|NCT01547416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92427959|NCT01547416|Anesthetics, General|anesthetics, general|mesh-ancestor
92427960|NCT01547455|Atorvastatin|atorvastatin|mesh-list
92427961|NCT01547455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92427962|NCT01547455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92427963|NCT01547455|Antimetabolites|antimetabolites|mesh-ancestor
92427964|NCT01547455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427965|NCT01547455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92427966|NCT01547455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92427967|NCT01547455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427968|NCT01547494|Vitamins|vitamins|mesh-list
92427969|NCT01547494|Micronutrients|micronutrients|mesh-ancestor
92427970|NCT01547494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427971|NCT01547520|Meperidine|meperidine|mesh-list
92427972|NCT01547520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427973|NCT01547520|Narcotics|narcotics|mesh-ancestor
92427974|NCT01547520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427975|NCT01547520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427976|NCT01547520|Analgesics|analgesics|mesh-ancestor
92427977|NCT01547520|Sensory System Agents|sensory system agents|mesh-ancestor
92427978|NCT01547520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427979|NCT01547520|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92427980|NCT01547546|GDC-0084|gdc-0084|mesh-list
92427981|NCT01547546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427985|NCT01547559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92427986|NCT01547559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427987|NCT01548001|Methotrexate|methotrexate|mesh-list
92427988|NCT01548001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92427989|NCT01548001|Abortifacient Agents|abortifacient agents|mesh-ancestor
92427990|NCT01548001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92427991|NCT01548001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427992|NCT01548001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92427993|NCT01548001|Antimetabolites|antimetabolites|mesh-ancestor
92427994|NCT01548001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427995|NCT01548001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427996|NCT01548001|Dermatologic Agents|dermatologic agents|mesh-ancestor
92427997|NCT01548001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427998|NCT01548001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92427999|NCT01548001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428000|NCT01548001|Immunologic Factors|immunologic factors|mesh-ancestor
92428001|NCT01548001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428002|NCT01548001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92428003|NCT01548027|Anesthetics|anesthetics|mesh-list
92428004|NCT01548027|Anesthetics, Local|anesthetics, local|mesh-list
92428005|NCT01548027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428006|NCT01548027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428007|NCT01548027|Sensory System Agents|sensory system agents|mesh-ancestor
92428008|NCT01548027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428009|NCT01548066|Valproic Acid|valproic acid|mesh-list
92428010|NCT01548066|Anticonvulsants|anticonvulsants|mesh-ancestor
92428011|NCT01548066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428012|NCT01548066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428013|NCT01548066|GABA Agents|gaba agents|mesh-ancestor
92428014|NCT01548066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428015|NCT01548066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428016|NCT01548066|Antimanic Agents|antimanic agents|mesh-ancestor
92428017|NCT01548066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92428018|NCT01548066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428019|NCT01548066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92428020|NCT01548079|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92428021|NCT01548079|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92428022|NCT01548079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428023|NCT01548118|Vaccines|vaccines|mesh-list
92428024|NCT01548118|Immunologic Factors|immunologic factors|mesh-ancestor
92428025|NCT01548118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428026|NCT01548144|Pemetrexed|pemetrexed|mesh-list
92428027|NCT01548144|Crizotinib|crizotinib|mesh-list
92428028|NCT01548144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428029|NCT01548144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428030|NCT01548144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609720|NCT00504946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92609721|NCT00504946|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92087363|NCT00757822|Hormones|hormones|mesh-ancestor
92428031|NCT01548144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92428032|NCT01548144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92428033|NCT01548144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428034|NCT01548157|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92428035|NCT01548157|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92428036|NCT01548157|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92428037|NCT01548157|Antimetabolites|antimetabolites|mesh-ancestor
92428038|NCT01548157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428039|NCT01548157|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92428040|NCT01548157|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92428041|NCT01548157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428042|NCT01548170|Ketoconazole|ketoconazole|mesh-list
92428043|NCT01548170|Sunitinib|sunitinib|mesh-list
92428044|NCT01548170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428045|NCT01548170|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428046|NCT01548170|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428047|NCT01548170|Growth Substances|growth substances|mesh-ancestor
92428048|NCT01548170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428049|NCT01548170|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428050|NCT01548170|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428051|NCT01548170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428052|NCT01548170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428053|NCT01548170|Antifungal Agents|antifungal agents|mesh-ancestor
92428054|NCT01548170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428058|NCT01548170|Hormone Antagonists|hormone antagonists|mesh-ancestor
92428059|NCT01548170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428060|NCT01548170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92428061|NCT01548209|Dexmedetomidine|dexmedetomidine|mesh-list
92428062|NCT01548209|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92428063|NCT01548209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428064|NCT01548209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428065|NCT01548209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428066|NCT01548209|Analgesics|analgesics|mesh-ancestor
92428067|NCT01548209|Sensory System Agents|sensory system agents|mesh-ancestor
92428068|NCT01548209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428069|NCT01548209|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92428070|NCT01548209|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92428071|NCT01548209|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92428072|NCT01548209|Adrenergic Agents|adrenergic agents|mesh-ancestor
92428073|NCT01548209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428074|NCT01548209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428075|NCT01548235|Insulin Aspart|insulin aspart|mesh-list
92428076|NCT01548235|Biphasic Insulins|biphasic insulins|mesh-list
92428077|NCT01548235|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92428078|NCT01548235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428079|NCT01548235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428081|NCT01548248|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92428082|NCT01548248|Insulin Aspart|insulin aspart|mesh-list
92428083|NCT01548248|Insulin Detemir|insulin detemir|mesh-list
92428084|NCT01548248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428085|NCT01548248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428086|NCT01548274|Sarpogrelate|sarpogrelate|mesh-list
92428087|NCT01548274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92428088|NCT01548274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92428089|NCT01548274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428090|NCT01548274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92428091|NCT01548274|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92428092|NCT01548274|Serotonin Agents|serotonin agents|mesh-ancestor
92428093|NCT01548274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428094|NCT01548274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428095|NCT01548326|Atorvastatin|atorvastatin|mesh-list
92428096|NCT01548326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92428097|NCT01548326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92428098|NCT01548326|Antimetabolites|antimetabolites|mesh-ancestor
92428099|NCT01548326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609723|NCT00504946|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92609724|NCT00504946|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92609725|NCT00504946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428100|NCT01548326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92428101|NCT01548326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92428102|NCT01548326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428103|NCT01548482|Sirolimus|sirolimus|mesh-list
92428104|NCT01548482|Temsirolimus|temsirolimus|mesh-list
92428105|NCT01548482|Trebananib|trebananib|mesh-list
92428106|NCT01548482|MTOR Inhibitors|mtor inhibitors|mesh-list
92428107|NCT01548482|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428108|NCT01548482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428109|NCT01548482|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92428110|NCT01548482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428111|NCT01548482|Antifungal Agents|antifungal agents|mesh-ancestor
92428112|NCT01548482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428113|NCT01548482|Immunologic Factors|immunologic factors|mesh-ancestor
92428114|NCT01548482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428115|NCT01548482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428116|NCT01548482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428117|NCT01548482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428118|NCT01548482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428119|NCT01548482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428120|NCT01548482|Growth Substances|growth substances|mesh-ancestor
92428121|NCT01548482|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428122|NCT01548521|Oxytocin|oxytocin|mesh-list
92428123|NCT01548521|Oxytocics|oxytocics|mesh-ancestor
92428124|NCT01548521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92428127|NCT01548560|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92428128|NCT01548560|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92428129|NCT01548560|Antiviral Agents|antiviral agents|mesh-ancestor
92428130|NCT01548560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428131|NCT01548612|Nitroprusside|nitroprusside|mesh-list
92428132|NCT01548612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428133|NCT01548612|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428134|NCT01548612|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92428135|NCT01548612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428136|NCT01548677|Trastuzumab|trastuzumab|mesh-list
92428137|NCT01548677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92428138|NCT01548677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428139|NCT01548703|BCI-838|bci-838|mesh-list
92428140|NCT01548703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92428141|NCT01548703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92428142|NCT01548703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428143|NCT01548703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428144|NCT01548703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428145|NCT01548794|Lidocaine|lidocaine|mesh-list
92428146|NCT01548794|Bupivacaine|bupivacaine|mesh-list
92428147|NCT01548794|Anesthetics|anesthetics|mesh-list
92428148|NCT01548794|Anesthetics, Local|anesthetics, local|mesh-ancestor
92428149|NCT01548794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428150|NCT01548794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428151|NCT01548794|Sensory System Agents|sensory system agents|mesh-ancestor
92428152|NCT01548794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428153|NCT01548794|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92428154|NCT01548794|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92428155|NCT01548794|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92428156|NCT01548794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92428157|NCT01548794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428158|NCT01548807|Everolimus|everolimus|mesh-list
92428159|NCT01548807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92428160|NCT01548807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428161|NCT01548807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428162|NCT01548807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428163|NCT01548807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428164|NCT01548807|Immunologic Factors|immunologic factors|mesh-ancestor
92428165|NCT01548807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428166|NCT01548807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428167|NCT01548859|Midazolam|midazolam|mesh-list
92428168|NCT01548859|Sevoflurane|sevoflurane|mesh-list
92609726|NCT00504946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92609727|NCT00504946|Autonomic Agents|autonomic agents|mesh-ancestor
92609728|NCT00504946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609729|NCT00504946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92609731|NCT00504946|Micronutrients|micronutrients|mesh-ancestor
92609732|NCT00504946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92609733|NCT00141050|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92609734|NCT00141050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92609735|NCT00141050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609736|NCT00141050|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92609737|NCT00141050|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92428169|NCT01548859|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92428170|NCT01548859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92428171|NCT01548859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428172|NCT01548859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428173|NCT01548859|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92428174|NCT01548859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92428175|NCT01548859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92428176|NCT01548859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92428177|NCT01548859|Anesthetics, General|anesthetics, general|mesh-ancestor
92428178|NCT01548859|Anesthetics|anesthetics|mesh-ancestor
92428179|NCT01548859|GABA Modulators|gaba modulators|mesh-ancestor
92428180|NCT01548859|GABA Agents|gaba agents|mesh-ancestor
92428181|NCT01548859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428182|NCT01548859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428183|NCT01548859|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92428184|NCT01548859|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92428185|NCT01548872|Cardioplegic Solutions|cardioplegic solutions|mesh-list
92428186|NCT01548872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92428187|NCT01548911|Gemtuzumab|gemtuzumab|mesh-list
92428188|NCT01548911|Calicheamicins|calicheamicins|mesh-list
92428189|NCT01548911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92428190|NCT01548911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428191|NCT01548911|Immunotoxins|immunotoxins|mesh-ancestor
92428192|NCT01548911|Immunoconjugates|immunoconjugates|mesh-ancestor
92428193|NCT01548911|Immunologic Factors|immunologic factors|mesh-ancestor
92428194|NCT01548911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428195|NCT01548911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92428196|NCT01548924|Paclitaxel|paclitaxel|mesh-list
92428197|NCT01548924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92428198|NCT01548924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428202|NCT01548924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428203|NCT01548950|Bosentan|bosentan|mesh-list
92428204|NCT01548950|Sildenafil Citrate|sildenafil citrate|mesh-list
92428205|NCT01548950|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428206|NCT01548950|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92428207|NCT01548950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92428208|NCT01548950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428209|NCT01548950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428210|NCT01548950|Urological Agents|urological agents|mesh-ancestor
92040724|NCT05024552|Cytarabine|cytarabine|mesh-list
92428211|NCT01548950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428212|NCT01548950|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92428213|NCT01549093|Carboplatin|carboplatin|mesh-list
92428214|NCT01549093|Gemcitabine|gemcitabine|mesh-list
92428215|NCT01549093|Endostar protein|endostar protein|mesh-list
92428216|NCT01549093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428217|NCT01549093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92428218|NCT01549093|Antimetabolites|antimetabolites|mesh-ancestor
92428219|NCT01549093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428220|NCT01549093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92609738|NCT00141050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609739|NCT00141050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609740|NCT00141050|Dopamine Agents|dopamine agents|mesh-ancestor
92609741|NCT00141050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428221|NCT01549093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428222|NCT01549093|Growth Substances|growth substances|mesh-ancestor
92428223|NCT01549093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428224|NCT01549093|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428225|NCT01549158|Torsemide|torsemide|mesh-list
92428226|NCT01549158|Furosemide|furosemide|mesh-list
92428227|NCT01549158|Diuretics|diuretics|mesh-ancestor
92428228|NCT01549158|Natriuretic Agents|natriuretic agents|mesh-ancestor
92428229|NCT01549158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428230|NCT01549158|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92428231|NCT01549158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92428232|NCT01549158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428233|NCT01549158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428234|NCT01549171|Iloprost|iloprost|mesh-list
92428235|NCT01549171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92428236|NCT01549171|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428237|NCT01549236|Benzonidazole|benzonidazole|mesh-list
92428238|NCT01549236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428239|NCT01549236|Immunologic Factors|immunologic factors|mesh-ancestor
92428240|NCT01549236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428241|NCT01549236|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92428242|NCT01549236|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92428243|NCT01549236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92428244|NCT01549236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428245|NCT01549301|Lenograstim|lenograstim|mesh-list
92428246|NCT01549301|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92428247|NCT01549301|Immunologic Factors|immunologic factors|mesh-ancestor
92428248|NCT01549301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428249|NCT01549418|Aspirin|aspirin|mesh-list
92428250|NCT01549418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92428251|NCT01549418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428252|NCT01549418|Analgesics|analgesics|mesh-ancestor
92428253|NCT01549418|Sensory System Agents|sensory system agents|mesh-ancestor
92428254|NCT01549418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428255|NCT01549418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428256|NCT01549418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428257|NCT01549418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428258|NCT01549418|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92428259|NCT01549418|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92428260|NCT01549418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428261|NCT01549418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92428262|NCT01549418|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92428263|NCT01549418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428264|NCT01549418|Antipyretics|antipyretics|mesh-ancestor
92428265|NCT01549431|Dexamethasone|dexamethasone|mesh-list
92428266|NCT01549431|Panobinostat|panobinostat|mesh-list
92428267|NCT01549431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428268|NCT01549431|Antiemetics|antiemetics|mesh-ancestor
92428269|NCT01549431|Autonomic Agents|autonomic agents|mesh-ancestor
92428270|NCT01549431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428271|NCT01549431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428275|NCT01549431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428277|NCT01549431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428278|NCT01549431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92152975|NCT02240199|Lidocaine|lidocaine|mesh-list
92428279|NCT01549431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428280|NCT01549431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428281|NCT01549496|Amlodipine|amlodipine|mesh-list
92428282|NCT01549496|Diltiazem|diltiazem|mesh-list
92428283|NCT01549496|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428284|NCT01549496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92428285|NCT01549496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92428286|NCT01549496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428287|NCT01549496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92428288|NCT01549496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428289|NCT01549496|Vasodilator Agents|vasodilator agents|mesh-ancestor
92609742|NCT04511416|Metformin|metformin|mesh-list
92609743|NCT04511416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609744|NCT04511416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016900|NCT02581163|Ribavirin|ribavirin|mesh-list
92428290|NCT01549548|Ponatinib|ponatinib|mesh-list
92428291|NCT01549548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428292|NCT01549548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428293|NCT01549548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428294|NCT01549548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428295|NCT01549574|Crizotinib|crizotinib|mesh-list
92428296|NCT01549574|Esomeprazole|esomeprazole|mesh-list
92428297|NCT01549574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92428298|NCT01549574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428299|NCT01549574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92428300|NCT01549574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428301|NCT01549574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428302|NCT01549574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428303|NCT01549574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428304|NCT01549600|Psyllium|psyllium|mesh-list
92428305|NCT01549600|Cathartics|cathartics|mesh-ancestor
92428306|NCT01549600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428307|NCT01549691|Alprazolam|alprazolam|mesh-list
92428308|NCT01549691|Zopiclone|zopiclone|mesh-list
92428309|NCT01549691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92428310|NCT01549691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428311|NCT01549691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428312|NCT01549691|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92428313|NCT01549691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92428314|NCT01549691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92428315|NCT01549691|GABA Modulators|gaba modulators|mesh-ancestor
92428316|NCT01549691|GABA Agents|gaba agents|mesh-ancestor
92428317|NCT01549691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428318|NCT01549691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428319|NCT01549704|Ropivacaine|ropivacaine|mesh-list
92428320|NCT01549704|Anesthetics, Local|anesthetics, local|mesh-ancestor
92428321|NCT01549704|Anesthetics|anesthetics|mesh-ancestor
92428322|NCT01549704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428323|NCT01549704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428324|NCT01549704|Sensory System Agents|sensory system agents|mesh-ancestor
92428325|NCT01549704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428326|NCT01549743|Celecoxib|celecoxib|mesh-list
92428327|NCT01549743|Rebamipide|rebamipide|mesh-list
92428328|NCT01549743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92428329|NCT01549743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428330|NCT01549743|Analgesics|analgesics|mesh-ancestor
92428331|NCT01549743|Sensory System Agents|sensory system agents|mesh-ancestor
92428332|NCT01549743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428333|NCT01549743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428334|NCT01549743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428335|NCT01549743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428336|NCT01549743|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92428337|NCT01549743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92428338|NCT01549743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428339|NCT01549743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428340|NCT01549743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92428341|NCT01549743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428342|NCT01549743|Antioxidants|antioxidants|mesh-ancestor
92153046|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
92428352|NCT01549847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92428353|NCT01549847|Protective Agents|protective agents|mesh-ancestor
92428354|NCT01549847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428356|NCT01549938|Cholecalciferol|cholecalciferol|mesh-list
92428357|NCT01549938|Vitamin D|vitamin d|mesh-list
92428358|NCT01549938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92428359|NCT01549938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428360|NCT01549938|Vitamins|vitamins|mesh-ancestor
92428361|NCT01549938|Micronutrients|micronutrients|mesh-ancestor
92428362|NCT01549938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92428363|NCT01549990|Sevoflurane|sevoflurane|mesh-list
92428364|NCT01549990|Desflurane|desflurane|mesh-list
92428365|NCT01549990|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92428366|NCT01549990|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92428367|NCT01549990|Anesthetics, General|anesthetics, general|mesh-ancestor
92428368|NCT01549990|Anesthetics|anesthetics|mesh-ancestor
92609745|NCT00407082|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92609746|NCT00407082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92609747|NCT00407082|Glucocorticoids|glucocorticoids|mesh-ancestor
92609748|NCT00407082|Hormones|hormones|mesh-ancestor
92428369|NCT01549990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428370|NCT01549990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428371|NCT01550055|Irinotecan|irinotecan|mesh-list
92428372|NCT01550055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92428373|NCT01550055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92428374|NCT01550055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428375|NCT01550055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428376|NCT01550055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428377|NCT01550107|Allopurinol|allopurinol|mesh-list
92428378|NCT01550107|Antimetabolites|antimetabolites|mesh-ancestor
92428379|NCT01550107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428380|NCT01550107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428381|NCT01550107|Gout Suppressants|gout suppressants|mesh-ancestor
92428382|NCT01550107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428383|NCT01550107|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92428384|NCT01550107|Antioxidants|antioxidants|mesh-ancestor
92428385|NCT01550107|Protective Agents|protective agents|mesh-ancestor
92428386|NCT01550107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428387|NCT01550146|Dexamethasone|dexamethasone|mesh-list
92428388|NCT01550146|Dexamethasone acetate|dexamethasone acetate|mesh-list
92428389|NCT01550146|BB 1101|bb 1101|mesh-list
92428390|NCT01550146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428391|NCT01550146|Antiemetics|antiemetics|mesh-ancestor
92428392|NCT01550146|Autonomic Agents|autonomic agents|mesh-ancestor
92428393|NCT01550146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428394|NCT01550146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428395|NCT01550146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428396|NCT01550146|Glucocorticoids|glucocorticoids|mesh-ancestor
92428397|NCT01550146|Hormones|hormones|mesh-ancestor
92428398|NCT01550146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428399|NCT01550146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92428400|NCT01550146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428401|NCT01550146|Protease Inhibitors|protease inhibitors|mesh-ancestor
92428402|NCT01550146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428403|NCT01550146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428404|NCT01550302|Bupivacaine|bupivacaine|mesh-list
92428405|NCT01550302|Anesthetics, Local|anesthetics, local|mesh-ancestor
92428406|NCT01550302|Anesthetics|anesthetics|mesh-ancestor
92428407|NCT01550302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428408|NCT01550302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428409|NCT01550302|Sensory System Agents|sensory system agents|mesh-ancestor
92428432|NCT01550419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428433|NCT01550419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92428434|NCT01550419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92428435|NCT01550419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428436|NCT01550445|Prednisolone|prednisolone|mesh-list
92428437|NCT01550445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428438|NCT01550445|Glucocorticoids|glucocorticoids|mesh-ancestor
92428439|NCT01550445|Hormones|hormones|mesh-ancestor
92428440|NCT01550445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428441|NCT01550445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428442|NCT01550445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92428443|NCT01550445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428444|NCT01550640|Remifentanil|remifentanil|mesh-list
92428445|NCT01550640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92428446|NCT01550640|Narcotics|narcotics|mesh-ancestor
92428447|NCT01550640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428448|NCT01550640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428449|NCT01550640|Analgesics|analgesics|mesh-ancestor
92428450|NCT01550640|Sensory System Agents|sensory system agents|mesh-ancestor
92428451|NCT01550640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428452|NCT01550653|Liraglutide|liraglutide|mesh-list
92428453|NCT01550653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428454|NCT01550653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428455|NCT01550653|Incretins|incretins|mesh-ancestor
92428456|NCT01550653|Hormones|hormones|mesh-ancestor
92428457|NCT01550653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428458|NCT01550770|Propofol|propofol|mesh-list
92609749|NCT00407082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609750|NCT00407082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609752|NCT00141089|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92609753|NCT00141089|Serotonin Agents|serotonin agents|mesh-ancestor
92609754|NCT00141089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609755|NCT00141089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428459|NCT01550770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92428460|NCT01550770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428461|NCT01550770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428462|NCT01550770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92428463|NCT01550770|Anesthetics, General|anesthetics, general|mesh-ancestor
92428464|NCT01550770|Anesthetics|anesthetics|mesh-ancestor
92428465|NCT01550848|Gemcitabine|gemcitabine|mesh-list
92428466|NCT01550848|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92428470|NCT01550848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428472|NCT01550900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428473|NCT01550900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428474|NCT01550926|Orlistat|orlistat|mesh-list
92428475|NCT01550926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428476|NCT01550926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428477|NCT01550926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92428478|NCT01550926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92428479|NCT01551004|REP 3123|rep 3123|mesh-list
92428480|NCT01551004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428481|NCT01551004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428482|NCT01551069|Hydroxychloroquine|hydroxychloroquine|mesh-list
92428483|NCT01551069|Antimalarials|antimalarials|mesh-ancestor
92428484|NCT01551069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92428485|NCT01551069|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92428486|NCT01551069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428487|NCT01551069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428488|NCT01551069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428489|NCT01551069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428490|NCT01550458|Mibefradil|mibefradil|mesh-list
92428491|NCT01550458|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428492|NCT01550458|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92428493|NCT01550458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92428494|NCT01550458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428495|NCT01550458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92428496|NCT01550458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428497|NCT01550458|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428498|NCT01550458|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92428499|NCT01550458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92428500|NCT01550458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428501|NCT01551147|Montelukast|montelukast|mesh-list
92428502|NCT01551147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92428503|NCT01551147|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153198|NCT04374279|Bicalutamide|bicalutamide|mesh-list
92428504|NCT01551147|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92428505|NCT01551147|Hormone Antagonists|hormone antagonists|mesh-ancestor
92428506|NCT01551147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428507|NCT01551147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428508|NCT01551147|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92428509|NCT01551147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92428510|NCT01551147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428511|NCT01551225|Escitalopram|escitalopram|mesh-list
92428512|NCT01551225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92428513|NCT01551225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92428514|NCT01551225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92428515|NCT01551225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428516|NCT01551225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428517|NCT01551225|Serotonin Agents|serotonin agents|mesh-ancestor
92428518|NCT01551225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428519|NCT01551290|Infliximab|infliximab|mesh-list
92609756|NCT00141089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609757|NCT00407121|Bevacizumab|bevacizumab|mesh-list
92428520|NCT01551290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92428521|NCT01551290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428522|NCT01551290|Dermatologic Agents|dermatologic agents|mesh-ancestor
92428523|NCT01551290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428524|NCT01551290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428525|NCT01551329|Ketamine|ketamine|mesh-list
92428526|NCT01551329|Analgesics|analgesics|mesh-ancestor
92428527|NCT01551329|Sensory System Agents|sensory system agents|mesh-ancestor
92428528|NCT01551329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428529|NCT01551329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428530|NCT01551329|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92428531|NCT01551329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92428532|NCT01551329|Anesthetics, General|anesthetics, general|mesh-ancestor
92428533|NCT01551329|Anesthetics|anesthetics|mesh-ancestor
92428534|NCT01551329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428545|NCT01551368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428547|NCT01551394|Gentamicins|gentamicins|mesh-list
92428548|NCT01551394|Meropenem|meropenem|mesh-list
92428549|NCT01551394|Ampicillin|ampicillin|mesh-list
92428550|NCT01551394|Cefotaxime|cefotaxime|mesh-list
92428551|NCT01551394|Cefoxitin|cefoxitin|mesh-list
92428552|NCT01551394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428553|NCT01551394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428554|NCT01551394|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92428555|NCT01551394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428556|NCT01551394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428557|NCT01551459|Sunitinib|sunitinib|mesh-list
92428558|NCT01551459|Dacarbazine|dacarbazine|mesh-list
92428559|NCT01551459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428560|NCT01551459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428561|NCT01551459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428562|NCT01551459|Growth Substances|growth substances|mesh-ancestor
92428563|NCT01551459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428564|NCT01551459|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428565|NCT01551459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428566|NCT01551459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428567|NCT01551459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428568|NCT01551459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92428569|NCT01551459|Alkylating Agents|alkylating agents|mesh-ancestor
92428570|NCT01551485|Zolpidem|zolpidem|mesh-list
92428571|NCT01551485|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92428572|NCT01551485|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92428573|NCT01551485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396014|NCT01394445|Cholinergic Agents|cholinergic agents|mesh-ancestor
92428574|NCT01551485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428575|NCT01551485|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92428576|NCT01551485|GABA Agonists|gaba agonists|mesh-ancestor
92428577|NCT01551485|GABA Agents|gaba agents|mesh-ancestor
92428578|NCT01551485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428579|NCT01551485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428580|NCT01551511|Dronabinol|dronabinol|mesh-list
92428581|NCT01551511|Hallucinogens|hallucinogens|mesh-ancestor
92428582|NCT01551511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428583|NCT01551511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92428584|NCT01551511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428585|NCT01551511|Analgesics|analgesics|mesh-ancestor
92428586|NCT01551511|Sensory System Agents|sensory system agents|mesh-ancestor
92428587|NCT01551511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428588|NCT01551511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92428589|NCT01551511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92428590|NCT01551511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428591|NCT01551511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428592|NCT01551511|Hormones|hormones|mesh-ancestor
92428593|NCT01551511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428594|NCT01551589|Docetaxel|docetaxel|mesh-list
92428595|NCT01551589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428596|NCT01551589|Tubulin Modulators|tubulin modulators|mesh-ancestor
92428598|NCT01551589|Mitosis Modulators|mitosis modulators|mesh-ancestor
92428599|NCT01551589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428600|NCT01551615|Metformin|metformin|mesh-list
92428601|NCT01551615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428602|NCT01551615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428603|NCT01551628|BCT-100|bct-100|mesh-list
92609758|NCT00407121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92609759|NCT00407121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016917|NCT05591417|BB 1101|bb 1101|mesh-list
92428604|NCT01551628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428605|NCT01551641|Thalidomide|thalidomide|mesh-list
92428606|NCT01551641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428607|NCT01551641|Immunologic Factors|immunologic factors|mesh-ancestor
92428608|NCT01551641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428609|NCT01551641|Leprostatic Agents|leprostatic agents|mesh-ancestor
92428610|NCT01551641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428611|NCT01551641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428612|NCT01551641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428613|NCT01551641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428614|NCT01551641|Growth Substances|growth substances|mesh-ancestor
92428615|NCT01551641|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428616|NCT01551641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428617|NCT01551667|Antibodies|antibodies|mesh-list
92428618|NCT01551667|Immunologic Factors|immunologic factors|mesh-ancestor
92428619|NCT01551667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428620|NCT01551680|Iniparib|iniparib|mesh-list
92428621|NCT01551680|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92428622|NCT01551680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428623|NCT01551680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428624|NCT01551680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428625|NCT01551719|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92428626|NCT01551719|Vancomycin|vancomycin|mesh-list
92428627|NCT01551719|Linezolid|linezolid|mesh-list
92428628|NCT01551719|Daptomycin|daptomycin|mesh-list
92428629|NCT01551719|Penicillins|penicillins|mesh-list
92428630|NCT01551719|Tigecycline|tigecycline|mesh-list
92428631|NCT01551719|Cephalosporins|cephalosporins|mesh-list
92428632|NCT01551719|Teicoplanin|teicoplanin|mesh-list
92428633|NCT01551719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428634|NCT01551719|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92428635|NCT01551719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428636|NCT01551719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428637|NCT01551797|Acetaminophen|acetaminophen|mesh-list
92428638|NCT01551797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428639|NCT01551797|Analgesics|analgesics|mesh-ancestor
92428640|NCT01551797|Sensory System Agents|sensory system agents|mesh-ancestor
92428641|NCT01551797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428642|NCT01551797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428643|NCT01551797|Antipyretics|antipyretics|mesh-ancestor
92428644|NCT01551810|Vaccines|vaccines|mesh-list
92428645|NCT01551810|Immunologic Factors|immunologic factors|mesh-ancestor
92428646|NCT01551810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428647|NCT01551823|Vaccines|vaccines|mesh-list
92428648|NCT01551823|Immunologic Factors|immunologic factors|mesh-ancestor
92428649|NCT01551823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428650|NCT01551836|Acetaminophen|acetaminophen|mesh-list
92153349|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92153350|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92153357|NCT03402087|Vitamins|vitamins|mesh-ancestor
92428651|NCT01551836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428652|NCT01551836|Analgesics|analgesics|mesh-ancestor
92428653|NCT01551836|Sensory System Agents|sensory system agents|mesh-ancestor
92428654|NCT01551836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428655|NCT01551836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428656|NCT01551836|Antipyretics|antipyretics|mesh-ancestor
92428657|NCT01552005|Saxagliptin|saxagliptin|mesh-list
92428658|NCT01552005|Incretins|incretins|mesh-ancestor
92428659|NCT01552005|Hormones|hormones|mesh-ancestor
92428660|NCT01552005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428661|NCT01552005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428662|NCT01552005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92428663|NCT01552005|Protease Inhibitors|protease inhibitors|mesh-ancestor
92428664|NCT01552005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428665|NCT01552005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428666|NCT01552005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428667|NCT01552018|Saxagliptin|saxagliptin|mesh-list
92428668|NCT01552018|Incretins|incretins|mesh-ancestor
92428669|NCT01552018|Hormones|hormones|mesh-ancestor
92428670|NCT01552018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428675|NCT01552018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087974|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92428676|NCT01552018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428678|NCT01552044|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92428679|NCT01552044|Hormone Antagonists|hormone antagonists|mesh-ancestor
92428680|NCT01552044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428681|NCT01552044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428682|NCT01552044|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92428683|NCT01552044|Diuretics|diuretics|mesh-ancestor
92428684|NCT01552044|Natriuretic Agents|natriuretic agents|mesh-ancestor
92428685|NCT01552122|Vitamin D|vitamin d|mesh-list
92428686|NCT01552122|Cholecalciferol|cholecalciferol|mesh-list
92428687|NCT01552122|Alendronate|alendronate|mesh-list
92428688|NCT01552122|Calcium Carbonate|calcium carbonate|mesh-list
92428689|NCT01552122|Calcium|calcium|mesh-list
92428690|NCT01552122|Vitamins|vitamins|mesh-ancestor
92428691|NCT01552122|Micronutrients|micronutrients|mesh-ancestor
92428692|NCT01552122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428693|NCT01552122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92428694|NCT01552122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92428695|NCT01552122|Antacids|antacids|mesh-ancestor
92428696|NCT01552122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428697|NCT01552122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428698|NCT01552148|Morphine|morphine|mesh-list
92428699|NCT01552148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92428700|NCT01552148|Narcotics|narcotics|mesh-ancestor
92428701|NCT01552148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428702|NCT01552148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428703|NCT01552148|Analgesics|analgesics|mesh-ancestor
92428704|NCT01552148|Sensory System Agents|sensory system agents|mesh-ancestor
92428705|NCT01552148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428706|NCT01552187|Colchicine|colchicine|mesh-list
92428707|NCT01552187|Gout Suppressants|gout suppressants|mesh-ancestor
92428708|NCT01552187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428709|NCT01552187|Tubulin Modulators|tubulin modulators|mesh-ancestor
92428710|NCT01552187|Antimitotic Agents|antimitotic agents|mesh-ancestor
92428711|NCT01552187|Mitosis Modulators|mitosis modulators|mesh-ancestor
92428712|NCT01552187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428713|NCT01552187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428714|NCT01552330|Artesunate|artesunate|mesh-list
92428715|NCT01552330|Primaquine|primaquine|mesh-list
92428716|NCT01552330|Pyronaridine|pyronaridine|mesh-list
92428717|NCT01552330|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92428718|NCT01552330|Antimalarials|antimalarials|mesh-ancestor
92428719|NCT01552330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92428720|NCT01552330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153429|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
92153430|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153431|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153432|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92153433|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92153434|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153436|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428721|NCT01552330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428722|NCT01552330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428723|NCT01552330|Antiviral Agents|antiviral agents|mesh-ancestor
92428724|NCT01552330|Schistosomicides|schistosomicides|mesh-ancestor
92428725|NCT01552330|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92428726|NCT01552330|Anthelmintics|anthelmintics|mesh-ancestor
92428727|NCT01552629|Cyclosporine|cyclosporine|mesh-list
92428728|NCT01552629|Cyclosporins|cyclosporins|mesh-list
92428729|NCT01552629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428730|NCT01552629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428731|NCT01552629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428732|NCT01552629|Immunologic Factors|immunologic factors|mesh-ancestor
92428733|NCT01552629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428734|NCT01552629|Antifungal Agents|antifungal agents|mesh-ancestor
92428735|NCT01552629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428739|NCT01552668|Fidaxomicin|fidaxomicin|mesh-list
92428740|NCT01552668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428741|NCT01552668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428742|NCT01552798|Aspirin|aspirin|mesh-list
92428743|NCT01552798|Acetaminophen|acetaminophen|mesh-list
92428744|NCT01552798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92428745|NCT01552798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428746|NCT01552798|Analgesics|analgesics|mesh-ancestor
92428747|NCT01552798|Sensory System Agents|sensory system agents|mesh-ancestor
92428748|NCT01552798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609761|NCT00407121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92609762|NCT00407121|Growth Substances|growth substances|mesh-ancestor
92609763|NCT00407121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609764|NCT00407121|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428749|NCT01552798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428750|NCT01552798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428751|NCT01552798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428752|NCT01552798|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92428753|NCT01552798|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92428754|NCT01552798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428755|NCT01552798|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92428756|NCT01552798|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92428757|NCT01552798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428758|NCT01552798|Antipyretics|antipyretics|mesh-ancestor
92428759|NCT01552837|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92428760|NCT01552837|Antidepressive Agents|antidepressive agents|mesh-ancestor
92428761|NCT01552837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92428762|NCT01552837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92428763|NCT01552837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92428764|NCT01552837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428765|NCT01552837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428766|NCT01552850|Oxycodone|oxycodone|mesh-list
92428767|NCT01552850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92428768|NCT01552850|Narcotics|narcotics|mesh-ancestor
92428769|NCT01552850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428770|NCT01552850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428771|NCT01552850|Analgesics|analgesics|mesh-ancestor
92428772|NCT01552850|Sensory System Agents|sensory system agents|mesh-ancestor
92428773|NCT01552850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428774|NCT01552863|Oxycodone|oxycodone|mesh-list
92428775|NCT01552863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92428776|NCT01552863|Narcotics|narcotics|mesh-ancestor
92428777|NCT01552863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428778|NCT01552863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428779|NCT01552863|Analgesics|analgesics|mesh-ancestor
92428780|NCT01552863|Sensory System Agents|sensory system agents|mesh-ancestor
92428781|NCT01552863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428782|NCT01552967|Capecitabine|capecitabine|mesh-list
92428783|NCT01552967|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92428784|NCT01552967|Antimetabolites|antimetabolites|mesh-ancestor
92428785|NCT01552967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428786|NCT01552967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428787|NCT01552980|Oxaliplatin|oxaliplatin|mesh-list
92428788|NCT01552980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428789|NCT01552993|Acetaminophen|acetaminophen|mesh-list
92428790|NCT01552993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92428791|NCT01552993|Analgesics|analgesics|mesh-ancestor
92428792|NCT01552993|Sensory System Agents|sensory system agents|mesh-ancestor
92153499|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92428793|NCT01552993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428794|NCT01552993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428795|NCT01552993|Antipyretics|antipyretics|mesh-ancestor
92428796|NCT01553006|Cefditoren|cefditoren|mesh-list
92428797|NCT01553006|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
92428798|NCT01553006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428799|NCT01553006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428800|NCT01553019|Gemcitabine|gemcitabine|mesh-list
92428801|NCT01553019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92428802|NCT01553019|Antimetabolites|antimetabolites|mesh-ancestor
92428803|NCT01553019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428804|NCT01553019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428805|NCT01553123|Ulipristal acetate|ulipristal acetate|mesh-list
92428806|NCT01553123|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92428807|NCT01553123|Contraceptive Agents|contraceptive agents|mesh-ancestor
92428808|NCT01553123|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92428827|NCT01553357|Growth Substances|growth substances|mesh-ancestor
92428828|NCT01553357|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428829|NCT01553435|Dextromethorphan|dextromethorphan|mesh-list
92428830|NCT01553435|Antitussive Agents|antitussive agents|mesh-ancestor
92428831|NCT01553435|Respiratory System Agents|respiratory system agents|mesh-ancestor
92428832|NCT01553435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92428833|NCT01553435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92428834|NCT01553435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428835|NCT01553435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428836|NCT01553435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428837|NCT01553500|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92428838|NCT01553500|Cathartics|cathartics|mesh-ancestor
92428839|NCT01553500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428840|NCT01553617|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92428841|NCT01553617|Plasma Substitutes|plasma substitutes|mesh-ancestor
92428842|NCT01553617|Blood Substitutes|blood substitutes|mesh-ancestor
92428843|NCT01553721|Udenafil|udenafil|mesh-list
92428844|NCT01553721|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92428845|NCT01553721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92428846|NCT01553721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428847|NCT01553721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428848|NCT01553773|Estradiol|estradiol|mesh-list
92428849|NCT01553773|Estrogens|estrogens|mesh-ancestor
92428850|NCT01553773|Hormones|hormones|mesh-ancestor
92428851|NCT01553773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428852|NCT01553773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428853|NCT01553786|Lenalidomide|lenalidomide|mesh-list
92428854|NCT01553786|Immunologic Factors|immunologic factors|mesh-ancestor
92428855|NCT01553786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428856|NCT01553786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428857|NCT01553786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428858|NCT01553786|Growth Substances|growth substances|mesh-ancestor
92428859|NCT01553786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428860|NCT01553786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428861|NCT01553903|Tamoxifen|tamoxifen|mesh-list
92428862|NCT01553903|Letrozole|letrozole|mesh-list
92428863|NCT01553903|Anastrozole|anastrozole|mesh-list
92428864|NCT01553903|Exemestane|exemestane|mesh-list
92428865|NCT01553903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428866|NCT01553903|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92428869|NCT01553903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428871|NCT01553903|Hormone Antagonists|hormone antagonists|mesh-ancestor
92428872|NCT01553903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428873|NCT01553903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428874|NCT01553903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92428875|NCT01553903|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92428876|NCT01553903|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92428877|NCT01553903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92428878|NCT01553942|Pemetrexed|pemetrexed|mesh-list
92428879|NCT01553942|Afatinib|afatinib|mesh-list
92428880|NCT01553942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428881|NCT01553942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428882|NCT01553942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428883|NCT01553942|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92428884|NCT01553942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92428885|NCT01553942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92428886|NCT01553981|Tadalafil|tadalafil|mesh-list
92428887|NCT01553981|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428888|NCT01553981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92428889|NCT01553981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92428890|NCT01553981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428891|NCT01553981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428892|NCT01553981|Urological Agents|urological agents|mesh-ancestor
92428893|NCT01554059|Bevacizumab|bevacizumab|mesh-list
92428894|NCT01554059|Oxaliplatin|oxaliplatin|mesh-list
92428895|NCT01554059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92428896|NCT01554059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428897|NCT01554059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428898|NCT01554059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428899|NCT01554059|Growth Substances|growth substances|mesh-ancestor
92428900|NCT01554059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428901|NCT01554059|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428902|NCT01554111|Picosulfate sodium|picosulfate sodium|mesh-list
92428903|NCT01554111|Cathartics|cathartics|mesh-ancestor
92428904|NCT01554111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428905|NCT01554124|Meropenem|meropenem|mesh-list
92428906|NCT01554124|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428907|NCT01554124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609766|NCT00141167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92609767|NCT00141167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92609768|NCT00141167|Cholinergic Agents|cholinergic agents|mesh-ancestor
92609769|NCT00141167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428908|NCT01554254|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92428909|NCT01554254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428910|NCT01554254|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428911|NCT01554345|Vitamin E|vitamin e|mesh-list
92428912|NCT01554345|Selenium|selenium|mesh-list
92428913|NCT01554345|Vitamins|vitamins|mesh-ancestor
92428914|NCT01554345|Micronutrients|micronutrients|mesh-ancestor
92428915|NCT01554345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428916|NCT01554345|Antioxidants|antioxidants|mesh-ancestor
92428917|NCT01554345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428918|NCT01554345|Protective Agents|protective agents|mesh-ancestor
92428919|NCT01554345|Trace Elements|trace elements|mesh-ancestor
92428920|NCT01554397|Cisplatin|cisplatin|mesh-list
92428921|NCT01554397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428922|NCT01554540|Treprostinil|treprostinil|mesh-list
92428923|NCT01554540|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92396062|NCT01394679|Deoxyglucose|deoxyglucose|mesh-list
92428924|NCT01554592|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92428925|NCT01554592|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92428926|NCT01554592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92428927|NCT01554592|Antimetabolites|antimetabolites|mesh-ancestor
92428928|NCT01554592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428929|NCT01554592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428930|NCT01554592|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92428931|NCT01554631|Acarbose|acarbose|mesh-list
92428932|NCT01554631|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92428933|NCT01554631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428934|NCT01554631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428935|NCT01554631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92428936|NCT01554631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428939|NCT01554657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428940|NCT01554657|Antitubercular Agents|antitubercular agents|mesh-ancestor
92428942|NCT01554813|Immunologic Factors|immunologic factors|mesh-ancestor
92428943|NCT01554813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428944|NCT01554826|Vaccines|vaccines|mesh-list
92428945|NCT01554826|Immunologic Factors|immunologic factors|mesh-ancestor
92428946|NCT01554826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428947|NCT01554852|Thalidomide|thalidomide|mesh-list
92428948|NCT01554852|Dexamethasone|dexamethasone|mesh-list
92428949|NCT01554852|Dexamethasone acetate|dexamethasone acetate|mesh-list
92428950|NCT01554852|Cyclophosphamide|cyclophosphamide|mesh-list
92428951|NCT01554852|Melphalan|melphalan|mesh-list
92428952|NCT01554852|Lenalidomide|lenalidomide|mesh-list
92428953|NCT01554852|Bortezomib|bortezomib|mesh-list
92428954|NCT01554852|Vorinostat|vorinostat|mesh-list
92428955|NCT01554852|BB 1101|bb 1101|mesh-list
92428956|NCT01554852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92428957|NCT01554852|Immunologic Factors|immunologic factors|mesh-ancestor
92428958|NCT01554852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428959|NCT01554852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428960|NCT01554852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92428961|NCT01554852|Alkylating Agents|alkylating agents|mesh-ancestor
92428962|NCT01554852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428963|NCT01554852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428964|NCT01554852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92428965|NCT01554852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428966|NCT01554852|Antiemetics|antiemetics|mesh-ancestor
92428967|NCT01554852|Autonomic Agents|autonomic agents|mesh-ancestor
92428968|NCT01554852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428969|NCT01554852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428970|NCT01554852|Glucocorticoids|glucocorticoids|mesh-ancestor
92428971|NCT01554852|Hormones|hormones|mesh-ancestor
92428972|NCT01554852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428973|NCT01554852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92428974|NCT01554852|Protease Inhibitors|protease inhibitors|mesh-ancestor
92428975|NCT01554852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428976|NCT01554852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428977|NCT01554852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428978|NCT01554852|Growth Substances|growth substances|mesh-ancestor
92428979|NCT01554852|Growth Inhibitors|growth inhibitors|mesh-ancestor
92428980|NCT01554852|Leprostatic Agents|leprostatic agents|mesh-ancestor
92609770|NCT00141167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609771|NCT00141167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609772|NCT00141206|Varenicline|varenicline|mesh-list
92609773|NCT00141206|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92609774|NCT00141206|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92609775|NCT00141206|Cholinergic Agents|cholinergic agents|mesh-ancestor
92609776|NCT00141206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609777|NCT00141206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609778|NCT00141206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609779|NCT00141245|Pregabalin|pregabalin|mesh-list
92428981|NCT01554852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92428982|NCT01554852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92428983|NCT01554852|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92428984|NCT01554930|Methylprednisolone|methylprednisolone|mesh-list
92428985|NCT01554930|Mannitol|mannitol|mesh-list
92428986|NCT01554930|Immunoglobulins|immunoglobulins|mesh-list
92428987|NCT01554930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428988|NCT01554930|Antiemetics|antiemetics|mesh-ancestor
92428989|NCT01554930|Autonomic Agents|autonomic agents|mesh-ancestor
92428990|NCT01554930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396065|NCT01394679|Antiviral Agents|antiviral agents|mesh-ancestor
92428991|NCT01554930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428992|NCT01554930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428993|NCT01554930|Glucocorticoids|glucocorticoids|mesh-ancestor
92428994|NCT01554930|Hormones|hormones|mesh-ancestor
92428995|NCT01554930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428996|NCT01554930|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92428997|NCT01554930|Protective Agents|protective agents|mesh-ancestor
92428998|NCT01554930|Immunologic Factors|immunologic factors|mesh-ancestor
92428999|NCT01554930|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92429000|NCT01554930|Diuretics|diuretics|mesh-ancestor
92429001|NCT01554930|Natriuretic Agents|natriuretic agents|mesh-ancestor
92429002|NCT01554969|Capecitabine|capecitabine|mesh-list
92429003|NCT01554969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429004|NCT01554969|Antimetabolites|antimetabolites|mesh-ancestor
92429005|NCT01554969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429006|NCT01554969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429007|NCT01554995|Linezolid|linezolid|mesh-list
92429008|NCT01554995|Delpazolid|delpazolid|mesh-list
92429009|NCT01554995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92429010|NCT01554995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429011|NCT01554995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92429012|NCT01554995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429014|NCT01555008|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92429015|NCT01555008|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92429016|NCT01555008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429018|NCT01555008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429019|NCT01555060|Ferrous gluconate|ferrous gluconate|mesh-list
92429020|NCT01555060|Hematinics|hematinics|mesh-ancestor
92429021|NCT01555099|Budesonide|budesonide|mesh-list
92429022|NCT01555099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429023|NCT01555099|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92429024|NCT01555099|Autonomic Agents|autonomic agents|mesh-ancestor
92429025|NCT01555099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429026|NCT01555099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429027|NCT01555099|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92429028|NCT01555099|Respiratory System Agents|respiratory system agents|mesh-ancestor
92429029|NCT01555099|Glucocorticoids|glucocorticoids|mesh-ancestor
92429030|NCT01555099|Hormones|hormones|mesh-ancestor
92429031|NCT01555099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429032|NCT01555112|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92429033|NCT01555112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92429034|NCT01555112|Immunologic Factors|immunologic factors|mesh-ancestor
92429035|NCT01555112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609781|NCT00141245|Sensory System Agents|sensory system agents|mesh-ancestor
92609782|NCT00141245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609783|NCT00141245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609784|NCT00141245|Anticonvulsants|anticonvulsants|mesh-ancestor
92429036|NCT01555112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429037|NCT01555112|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92429038|NCT01555112|Protective Agents|protective agents|mesh-ancestor
92429039|NCT01555112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92429040|NCT01555112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92429041|NCT01555112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429042|NCT01555112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429043|NCT01555112|Antiviral Agents|antiviral agents|mesh-ancestor
92429044|NCT01555112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429045|NCT01555190|Folic Acid|folic acid|mesh-list
92429046|NCT01555190|Inositol|inositol|mesh-list
92429047|NCT01555190|Hematinics|hematinics|mesh-ancestor
92429048|NCT01555190|Vitamin B Complex|vitamin b complex|mesh-ancestor
92429049|NCT01555190|Vitamins|vitamins|mesh-ancestor
92429050|NCT01555190|Micronutrients|micronutrients|mesh-ancestor
92429051|NCT01555190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429052|NCT01555216|Ropivacaine|ropivacaine|mesh-list
92429053|NCT01555216|Anesthetics, Local|anesthetics, local|mesh-ancestor
92429054|NCT01555216|Anesthetics|anesthetics|mesh-ancestor
92429055|NCT01555216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429056|NCT01555216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396067|NCT01394731|Acetaminophen|acetaminophen|mesh-list
92429057|NCT01555216|Sensory System Agents|sensory system agents|mesh-ancestor
92429058|NCT01555216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429059|NCT01555398|Fenofibric acid|fenofibric acid|mesh-list
92429060|NCT01555398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92429061|NCT01555398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92429062|NCT01555398|Antimetabolites|antimetabolites|mesh-ancestor
92429063|NCT01555398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429064|NCT01555398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92429065|NCT01555476|Ibuprofen|ibuprofen|mesh-list
92429066|NCT01555476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92429067|NCT01555476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92429068|NCT01555476|Analgesics|analgesics|mesh-ancestor
92429069|NCT01555476|Sensory System Agents|sensory system agents|mesh-ancestor
92429070|NCT01555476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429071|NCT01555476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429072|NCT01555476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429073|NCT01555476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429074|NCT01555476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92429075|NCT01555476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429076|NCT01555476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429077|NCT01555580|Molgramostim|molgramostim|mesh-list
92429078|NCT01555580|Sargramostim|sargramostim|mesh-list
92429079|NCT01555580|Immunologic Factors|immunologic factors|mesh-ancestor
92429080|NCT01555580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429081|NCT01555580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429082|NCT01555632|Atorvastatin|atorvastatin|mesh-list
92429083|NCT01555632|Calcium|calcium|mesh-list
92429086|NCT01555632|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92429088|NCT01555632|Antimetabolites|antimetabolites|mesh-ancestor
92429089|NCT01555632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429090|NCT01555632|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92429091|NCT01555632|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92429092|NCT01555632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429093|NCT01555658|Heparin|heparin|mesh-list
92429094|NCT01555658|Bivalirudin|bivalirudin|mesh-list
92429095|NCT01555658|Anticoagulants|anticoagulants|mesh-ancestor
92429096|NCT01555658|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92153797|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92429097|NCT01555658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92429098|NCT01555658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429099|NCT01555658|Antithrombins|antithrombins|mesh-ancestor
92429100|NCT01555658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92429101|NCT01555658|Protease Inhibitors|protease inhibitors|mesh-ancestor
92429102|NCT01555658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429103|NCT01555710|Carboplatin|carboplatin|mesh-list
92609785|NCT00141245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92609786|NCT00141245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609787|NCT00141245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609788|NCT00141245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429105|NCT01555710|Isophosphamide mustard|isophosphamide mustard|mesh-list
92429106|NCT01555710|Ifosfamide|ifosfamide|mesh-list
92429107|NCT01555710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429108|NCT01555710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92429109|NCT01555710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92429110|NCT01555710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92429111|NCT01555710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429112|NCT01555710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429113|NCT01555710|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92429114|NCT01555710|Alkylating Agents|alkylating agents|mesh-ancestor
92429115|NCT01555788|Pancrelipase|pancrelipase|mesh-list
92429116|NCT01555788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429117|NCT01555814|Amisulpride|amisulpride|mesh-list
92429118|NCT01555814|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92429119|NCT01555814|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92429120|NCT01555814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92429121|NCT01555814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429122|NCT01555814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92429123|NCT01555814|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92429124|NCT01555814|Dopamine Agents|dopamine agents|mesh-ancestor
92429125|NCT01555814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429126|NCT01555814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429127|NCT01555814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92429128|NCT01555814|Antidepressive Agents|antidepressive agents|mesh-ancestor
92429129|NCT01555853|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92429130|NCT01555853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429131|NCT01555866|Isavuconazole|isavuconazole|mesh-list
92429132|NCT01555866|Antifungal Agents|antifungal agents|mesh-ancestor
92429133|NCT01555866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429134|NCT01555879|Abatacept|abatacept|mesh-list
92429135|NCT01555879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92429136|NCT01555879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429137|NCT01555879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92429138|NCT01555879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429139|NCT01555879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92429140|NCT01555879|Immunologic Factors|immunologic factors|mesh-ancestor
92429141|NCT01555879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429142|NCT01555879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429143|NCT01555918|Isavuconazole|isavuconazole|mesh-list
92429144|NCT01555918|Antifungal Agents|antifungal agents|mesh-ancestor
92429145|NCT01555918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429146|NCT01555970|Acetylcysteine|acetylcysteine|mesh-list
92429147|NCT01555970|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92429148|NCT01555970|Antiviral Agents|antiviral agents|mesh-ancestor
92429149|NCT01555970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429150|NCT01555970|Expectorants|expectorants|mesh-ancestor
92429151|NCT01555970|Respiratory System Agents|respiratory system agents|mesh-ancestor
92429152|NCT01555970|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92429153|NCT01555970|Antioxidants|antioxidants|mesh-ancestor
92429154|NCT01555970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429166|NCT01556191|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92429167|NCT01556191|Fulvestrant|fulvestrant|mesh-list
92429168|NCT01556191|Gefitinib|gefitinib|mesh-list
92429169|NCT01556191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429170|NCT01556191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92429171|NCT01556191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429172|NCT01556191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429173|NCT01556191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92429174|NCT01556191|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92429175|NCT01556191|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92429176|NCT01556191|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429177|NCT01556191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429178|NCT01556191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429179|NCT01556321|Caffeine|caffeine|mesh-list
92609789|NCT00141245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92609790|NCT00141245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088453|NCT01747915|Analgesics|analgesics|mesh-ancestor
92429180|NCT01556321|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92429181|NCT01556321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429182|NCT01556321|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92429183|NCT01556321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429184|NCT01556321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429185|NCT01556321|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92429186|NCT01556321|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92429187|NCT01556321|Purinergic Agents|purinergic agents|mesh-ancestor
92429188|NCT01556321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429189|NCT01556334|Azithromycin|azithromycin|mesh-list
92429190|NCT01556334|Erythromycin|erythromycin|mesh-list
92429191|NCT01556334|Erythromycin Estolate|erythromycin estolate|mesh-list
92429192|NCT01556334|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92429193|NCT01556334|Erythromycin stearate|erythromycin stearate|mesh-list
92429194|NCT01556334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92429195|NCT01556334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429196|NCT01556334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429197|NCT01556334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92429198|NCT01556334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429199|NCT01556334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429200|NCT01556477|Lenalidomide|lenalidomide|mesh-list
92429201|NCT01556477|Azacitidine|azacitidine|mesh-list
92429202|NCT01556477|Immunologic Factors|immunologic factors|mesh-ancestor
92429203|NCT01556477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429204|NCT01556477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92429205|NCT01556477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92429206|NCT01556477|Growth Substances|growth substances|mesh-ancestor
92429207|NCT01556477|Growth Inhibitors|growth inhibitors|mesh-ancestor
92429208|NCT01556477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429209|NCT01556477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429210|NCT01556477|Antimetabolites|antimetabolites|mesh-ancestor
92429211|NCT01556477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429212|NCT01556477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429213|NCT01556529|Unithiol|unithiol|mesh-list
92429214|NCT01556529|Antidotes|antidotes|mesh-ancestor
92429215|NCT01556529|Protective Agents|protective agents|mesh-ancestor
92429216|NCT01556529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429217|NCT01556529|Chelating Agents|chelating agents|mesh-ancestor
92429218|NCT01556529|Sequestering Agents|sequestering agents|mesh-ancestor
92429221|NCT01556542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92429222|NCT01556542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429223|NCT01556542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92429224|NCT01556542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92429225|NCT01556542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92429226|NCT01556542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429227|NCT05847660|Cetrorelix|cetrorelix|mesh-list
92429228|NCT05847660|Progesterone|progesterone|mesh-list
92429229|NCT05847660|Dydrogesterone|dydrogesterone|mesh-list
92429230|NCT05847660|Progestins|progestins|mesh-ancestor
92429231|NCT05847660|Hormones|hormones|mesh-ancestor
92429232|NCT05847660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429233|NCT05847660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429234|NCT05847660|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92429235|NCT05847660|Fertility Agents|fertility agents|mesh-ancestor
92429236|NCT05847660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92429237|NCT05847660|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429238|NCT05847413|Verapamil|verapamil|mesh-list
92429239|NCT05847413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92429240|NCT05847413|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92429241|NCT05847413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429242|NCT05847413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429243|NCT05847413|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429244|NCT05847413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429245|NCT05847413|Vasodilator Agents|vasodilator agents|mesh-ancestor
92429246|NCT05847322|Azithromycin|azithromycin|mesh-list
92429247|NCT05847322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92429248|NCT05847322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429249|NCT05847257|Ubiquinone|ubiquinone|mesh-list
92429250|NCT05847257|Coenzyme Q10|coenzyme q10|mesh-list
92429251|NCT05847257|Letrozole|letrozole|mesh-list
92609791|NCT00141245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609793|NCT00141362|Pregabalin|pregabalin|mesh-list
92609794|NCT00141362|Analgesics|analgesics|mesh-ancestor
92609795|NCT00141362|Sensory System Agents|sensory system agents|mesh-ancestor
92429252|NCT05847257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429253|NCT05847257|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92429254|NCT05847257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92429255|NCT05847257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429256|NCT05847257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429257|NCT05847257|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92429258|NCT05847257|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429259|NCT05847257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429260|NCT05847257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429261|NCT05847257|Micronutrients|micronutrients|mesh-ancestor
92429262|NCT05847257|Vitamins|vitamins|mesh-ancestor
92429263|NCT05847244|Metformin|metformin|mesh-list
92429264|NCT05847244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92429265|NCT05847244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429266|NCT05847205|Hirudins|hirudins|mesh-list
92429267|NCT05847205|Antithrombins|antithrombins|mesh-ancestor
92429268|NCT05847205|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92429269|NCT05847205|Protease Inhibitors|protease inhibitors|mesh-ancestor
92429270|NCT05847205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429271|NCT05847205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429272|NCT05847205|Anticoagulants|anticoagulants|mesh-ancestor
92429273|NCT05847205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92429274|NCT05847205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92429275|NCT05847088|Dexamethasone|dexamethasone|mesh-list
92429276|NCT05847088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429277|NCT05847088|Antiemetics|antiemetics|mesh-ancestor
92429278|NCT05847088|Autonomic Agents|autonomic agents|mesh-ancestor
92429279|NCT05847088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429280|NCT05847088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429281|NCT05847088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92429282|NCT05847088|Glucocorticoids|glucocorticoids|mesh-ancestor
92429283|NCT05847088|Hormones|hormones|mesh-ancestor
92429284|NCT05847088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429285|NCT05847088|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92429286|NCT05847088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429287|NCT05847049|Nepafenac|nepafenac|mesh-list
92429288|NCT05847049|Aflibercept|aflibercept|mesh-list
92429289|NCT05847049|Eplerenone|eplerenone|mesh-list
92429290|NCT05847049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92429291|NCT05847049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92429292|NCT05847049|Growth Substances|growth substances|mesh-ancestor
92429297|NCT05847049|Hormone Antagonists|hormone antagonists|mesh-ancestor
92429298|NCT05847049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92429299|NCT05847049|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92429300|NCT05847049|Diuretics|diuretics|mesh-ancestor
92429301|NCT05847049|Natriuretic Agents|natriuretic agents|mesh-ancestor
92429302|NCT05847049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92429303|NCT05847049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92429304|NCT05847049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92429305|NCT05847049|Analgesics|analgesics|mesh-ancestor
92429306|NCT05847049|Sensory System Agents|sensory system agents|mesh-ancestor
92429307|NCT05847049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429308|NCT05847049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92429309|NCT05847049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92429310|NCT05846880|Vitamin D|vitamin d|mesh-list
92429311|NCT05846880|Ergocalciferols|ergocalciferols|mesh-list
92429312|NCT05846880|Cholecalciferol|cholecalciferol|mesh-list
92429313|NCT05846880|Vitamins|vitamins|mesh-list
92429314|NCT05846880|Lenalidomide|lenalidomide|mesh-list
92429315|NCT05846880|Micronutrients|micronutrients|mesh-ancestor
92429316|NCT05846880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429317|NCT05846880|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92429318|NCT05846880|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429319|NCT05846880|Immunologic Factors|immunologic factors|mesh-ancestor
92429320|NCT05846880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92429321|NCT05846880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92429322|NCT05846880|Growth Substances|growth substances|mesh-ancestor
92609796|NCT00141362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609797|NCT00141362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609798|NCT00141362|Anticonvulsants|anticonvulsants|mesh-ancestor
92609799|NCT00141362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92609800|NCT00141362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609801|NCT00141362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429323|NCT05846880|Growth Inhibitors|growth inhibitors|mesh-ancestor
92429324|NCT05846880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429325|NCT05846867|Leucovorin|leucovorin|mesh-list
92429326|NCT05846867|Fluorouracil|fluorouracil|mesh-list
92429327|NCT05846867|Oxaliplatin|oxaliplatin|mesh-list
92429328|NCT05846867|Irinotecan|irinotecan|mesh-list
92429329|NCT05846867|Calcium|calcium|mesh-list
92429330|NCT05846867|Levoleucovorin|levoleucovorin|mesh-list
92429331|NCT05846867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429332|NCT05846867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429333|NCT05846867|Antimetabolites|antimetabolites|mesh-ancestor
92429334|NCT05846867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429335|NCT05846867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92429336|NCT05846867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429337|NCT05846867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92429338|NCT05846867|Immunologic Factors|immunologic factors|mesh-ancestor
92429339|NCT05846867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92429340|NCT05846867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92429341|NCT05846867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429342|NCT05846867|Antidotes|antidotes|mesh-ancestor
92429343|NCT05846867|Protective Agents|protective agents|mesh-ancestor
92429344|NCT05846867|Vitamin B Complex|vitamin b complex|mesh-ancestor
92429345|NCT05846867|Vitamins|vitamins|mesh-ancestor
92429346|NCT05846867|Micronutrients|micronutrients|mesh-ancestor
92429347|NCT05845736|Antihypertensive Agents|antihypertensive agents|mesh-list
92429348|NCT05840744|Antithrombins|antithrombins|mesh-list
92429349|NCT05840744|Thrombin|thrombin|mesh-list
92429350|NCT05840744|Hemostatics|hemostatics|mesh-ancestor
92429351|NCT05840744|Coagulants|coagulants|mesh-ancestor
92429352|NCT05840744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92429353|NCT05840744|Protease Inhibitors|protease inhibitors|mesh-ancestor
92429354|NCT05840744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92429355|NCT05840744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429356|NCT05840744|Anticoagulants|anticoagulants|mesh-ancestor
92429357|NCT05840692|Escitalopram|escitalopram|mesh-list
92429358|NCT05840692|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92429359|NCT05840692|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92429360|NCT05840692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429361|NCT05840692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429362|NCT05840692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429363|NCT05840692|Serotonin Agents|serotonin agents|mesh-ancestor
92429364|NCT05840692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429368|NCT05840640|Immunologic Factors|immunologic factors|mesh-ancestor
92429369|NCT05840640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429370|NCT05840588|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92429371|NCT05840588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92429373|NCT05840536|Furosemide|furosemide|mesh-list
92429374|NCT05840536|Diuretics|diuretics|mesh-ancestor
92429375|NCT05840536|Natriuretic Agents|natriuretic agents|mesh-ancestor
92429376|NCT05840536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429377|NCT05840536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92429378|NCT05840536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92429379|NCT05840536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429380|NCT05840536|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92429381|NCT05840536|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92429382|NCT05840406|Acetaminophen|acetaminophen|mesh-list
92429383|NCT05840406|Ibuprofen|ibuprofen|mesh-list
92429384|NCT05840406|Ketoprofen|ketoprofen|mesh-list
92429385|NCT05840406|Dexmedetomidine|dexmedetomidine|mesh-list
92429386|NCT05840406|Tramadol|tramadol|mesh-list
92429387|NCT05840406|Levobupivacaine|levobupivacaine|mesh-list
92429388|NCT05840406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92429389|NCT05840406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609802|NCT00141362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92609803|NCT00141362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92609804|NCT00141362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92609805|NCT00141362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609806|NCT00141362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92609807|NCT00155259|Docetaxel|docetaxel|mesh-list
92609808|NCT00155259|Capecitabine|capecitabine|mesh-list
92429390|NCT05840406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429391|NCT05840406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92429392|NCT05840406|Analgesics|analgesics|mesh-ancestor
92429393|NCT05840406|Sensory System Agents|sensory system agents|mesh-ancestor
92429394|NCT05840406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92429395|NCT05840406|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92429396|NCT05840406|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92429397|NCT05840406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92429398|NCT05840406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92429399|NCT05840406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92429400|NCT05840406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154096|NCT04024865|Antiemetics|antiemetics|mesh-ancestor
92717884|NCT02901977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92717885|NCT02901977|Protease Inhibitors|protease inhibitors|mesh-ancestor
92717886|NCT02901977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717887|NCT02901977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717888|NCT02901977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92717889|NCT02901977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92717890|NCT02901977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92717891|NCT02901977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92717892|NCT02901977|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717893|NCT02901977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717894|NCT02901977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717895|NCT00553553|Morphine|morphine|mesh-list
92717896|NCT00553553|Remifentanil|remifentanil|mesh-list
92717897|NCT00553553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92717898|NCT00553553|Narcotics|narcotics|mesh-ancestor
92717899|NCT00553553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717900|NCT00553553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717901|NCT00553553|Analgesics|analgesics|mesh-ancestor
92717902|NCT00553553|Sensory System Agents|sensory system agents|mesh-ancestor
92717903|NCT00553553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717904|NCT04622982|Vitamin D|vitamin d|mesh-list
92717905|NCT04622982|Vitamins|vitamins|mesh-ancestor
92717906|NCT04622982|Micronutrients|micronutrients|mesh-ancestor
92717907|NCT04622982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717908|NCT04622982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92717909|NCT04622202|Pregabalin|pregabalin|mesh-list
92717910|NCT04622202|Analgesics|analgesics|mesh-ancestor
92717911|NCT04622202|Sensory System Agents|sensory system agents|mesh-ancestor
92717912|NCT04622202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717913|NCT04622202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717914|NCT04622202|Anticonvulsants|anticonvulsants|mesh-ancestor
92717915|NCT04622202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92717916|NCT04622202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717917|NCT04622202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717918|NCT04622202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92717930|NCT02901587|Antidepressive Agents|antidepressive agents|mesh-ancestor
92717931|NCT02901587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717932|NCT02901587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92717933|NCT02901587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92717934|NCT02901587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717935|NCT02901587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717936|NCT04622397|Tranexamic Acid|tranexamic acid|mesh-list
92717937|NCT04622397|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92717938|NCT04622397|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717939|NCT04622397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717940|NCT04622397|Hemostatics|hemostatics|mesh-ancestor
92717941|NCT04622397|Coagulants|coagulants|mesh-ancestor
92717942|NCT02901353|Sirolimus|sirolimus|mesh-list
92717943|NCT02901353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609809|NCT00155259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609810|NCT00155259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92609811|NCT00155259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92088727|NCT01702987|Vitamins|vitamins|mesh-ancestor
92717944|NCT02901353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717945|NCT02901353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92717946|NCT02901353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717947|NCT02901353|Antifungal Agents|antifungal agents|mesh-ancestor
92717948|NCT02901353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717949|NCT02901353|Immunologic Factors|immunologic factors|mesh-ancestor
92717950|NCT02901353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717951|NCT04621461|Zinc Sulfate|zinc sulfate|mesh-list
92717952|NCT04621461|Astringents|astringents|mesh-ancestor
92717953|NCT04621461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717954|NCT04621461|Dermatologic Agents|dermatologic agents|mesh-ancestor
92717955|NCT02901236|Antifibrotic Agents|antifibrotic agents|mesh-list
92717956|NCT02901236|Bevacizumab|bevacizumab|mesh-list
92717957|NCT02901236|Mitomycins|mitomycins|mesh-list
92717958|NCT02901236|Mitomycin|mitomycin|mesh-list
92717959|NCT02901236|Antimetabolites|antimetabolites|mesh-list
92717960|NCT02901236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92717961|NCT02901236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717962|NCT02901236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92717963|NCT02901236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92717964|NCT02901236|Growth Substances|growth substances|mesh-ancestor
92717965|NCT02901236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717966|NCT02901236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92717967|NCT02901236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92717968|NCT02901236|Alkylating Agents|alkylating agents|mesh-ancestor
92717969|NCT02901236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717970|NCT02901236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92717971|NCT02901236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717972|NCT02901236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717973|NCT04621617|Midodrine|midodrine|mesh-list
92717974|NCT04621617|Sympathomimetics|sympathomimetics|mesh-ancestor
92717975|NCT04621617|Autonomic Agents|autonomic agents|mesh-ancestor
92717976|NCT04621617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717977|NCT04621617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717978|NCT04621617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92717979|NCT04621617|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92717980|NCT04621617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717981|NCT04621617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717982|NCT04621617|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717983|NCT04621617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717992|NCT01212757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717994|NCT01212757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717995|NCT01212757|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92717996|NCT01212757|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92717997|NCT01212757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717998|NCT01212757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717999|NCT01212757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718000|NCT01212757|Immunologic Factors|immunologic factors|mesh-ancestor
92718001|NCT01212757|Leprostatic Agents|leprostatic agents|mesh-ancestor
92718002|NCT01212757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718003|NCT01212757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718004|NCT01212757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92718005|NCT01212757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92718006|NCT01212757|Growth Substances|growth substances|mesh-ancestor
92718007|NCT01212757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92718008|NCT01212757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718009|NCT00562419|Irinotecan|irinotecan|mesh-list
92718010|NCT00562419|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92718011|NCT00562419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92718012|NCT00562419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718013|NCT00562419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718014|NCT00562419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718015|NCT00562458|Anastrozole|anastrozole|mesh-list
92718016|NCT00562458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92718017|NCT00562458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718018|NCT00562458|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92718019|NCT00562458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92718020|NCT00562458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609812|NCT00155259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92609813|NCT00155259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609814|NCT00155259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92609815|NCT00155259|Antimetabolites|antimetabolites|mesh-ancestor
92609816|NCT04518124|Propranolol|propranolol|mesh-list
92609817|NCT04518124|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92016967|NCT05678933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718021|NCT00562458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718022|NCT00562458|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92718023|NCT00562458|Hormone Antagonists|hormone antagonists|mesh-ancestor
92718024|NCT00562458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718025|NCT00562458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718026|NCT02900729|Losartan|losartan|mesh-list
92718027|NCT02900729|Amlodipine|amlodipine|mesh-list
92718028|NCT02900729|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92718029|NCT02900729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718030|NCT02900729|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92718031|NCT02900729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322304|NCT00002108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92718032|NCT02900729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718033|NCT02900729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92718034|NCT02900729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718035|NCT02900729|Vasodilator Agents|vasodilator agents|mesh-ancestor
92718036|NCT02900729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92718037|NCT02900729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92718038|NCT02900729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92718039|NCT02900729|Diuretics|diuretics|mesh-ancestor
92718040|NCT02900729|Natriuretic Agents|natriuretic agents|mesh-ancestor
92718041|NCT02900729|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92718042|NCT04621227|Midazolam|midazolam|mesh-list
92718043|NCT04621227|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92718044|NCT04621227|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92718045|NCT04621227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92718046|NCT04621227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718058|NCT04621227|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92718059|NCT04621227|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92718060|NCT04621227|Antimetabolites|antimetabolites|mesh-ancestor
92718061|NCT04621227|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92718062|NCT04621227|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92718063|NCT04621227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718064|NCT01190410|Certolizumab Pegol|certolizumab pegol|mesh-list
92718065|NCT01190410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92718066|NCT01190410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718067|NCT01190410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718068|NCT01190410|Immunologic Factors|immunologic factors|mesh-ancestor
92718069|NCT01190410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718070|NCT01190410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718071|NCT01190254|Asenapine|asenapine|mesh-list
92718072|NCT01190254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92718073|NCT01190254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92718074|NCT01190254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718075|NCT01190254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718076|NCT01190254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92718077|NCT04620954|Nivolumab|nivolumab|mesh-list
92718078|NCT04620954|Oregovomab|oregovomab|mesh-list
92718079|NCT04620954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718080|NCT04620954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718081|NCT04620954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92718082|NCT04620954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718083|NCT00562692|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92718084|NCT00562692|Natriuretic Agents|natriuretic agents|mesh-ancestor
92718085|NCT00562692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718086|NCT04621110|Fentanyl|fentanyl|mesh-list
92718087|NCT04621110|Midazolam|midazolam|mesh-list
92718088|NCT04621110|Dexmedetomidine|dexmedetomidine|mesh-list
92718089|NCT04621110|Ketamine|ketamine|mesh-list
92718090|NCT04621110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92609818|NCT04518124|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92609819|NCT04518124|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088859|NCT01737931|Hormones|hormones|mesh-ancestor
92718091|NCT04621110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718092|NCT04621110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718093|NCT04621110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718094|NCT04621110|Analgesics|analgesics|mesh-ancestor
92718095|NCT04621110|Sensory System Agents|sensory system agents|mesh-ancestor
92718096|NCT04621110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718097|NCT04621110|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92718098|NCT04621110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92718099|NCT04621110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718100|NCT04621110|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718101|NCT04621110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718102|NCT04621110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718103|NCT04621110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92718104|NCT04621110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92718105|NCT04621110|Anesthetics, General|anesthetics, general|mesh-ancestor
92405288|NCT01435837|Caffeine|caffeine|mesh-list
92718106|NCT04621110|Anesthetics|anesthetics|mesh-ancestor
92718107|NCT04621110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92718108|NCT04621110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92718109|NCT04621110|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92718110|NCT04621110|Narcotics|narcotics|mesh-ancestor
92718124|NCT04620720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92718125|NCT04620720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718126|NCT04620720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92718127|NCT04620720|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92718128|NCT04620720|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92718129|NCT04620720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718130|NCT04620720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718131|NCT04620720|Antimanic Agents|antimanic agents|mesh-ancestor
92718132|NCT02900417|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92718133|NCT02900417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92718134|NCT02900417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718135|NCT02900417|Incretins|incretins|mesh-ancestor
92718136|NCT02900417|Hormones|hormones|mesh-ancestor
92718137|NCT02900417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718138|NCT02900417|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92718139|NCT02900417|Protease Inhibitors|protease inhibitors|mesh-ancestor
92718140|NCT02900417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718141|NCT02900417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718142|NCT04620837|Tislelizumab|tislelizumab|mesh-list
92718143|NCT04620837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718144|NCT04620837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718145|NCT04620018|Amoxicillin|amoxicillin|mesh-list
92718146|NCT04620018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718147|NCT04620018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718148|NCT02900105|Letrozole|letrozole|mesh-list
92718149|NCT02900105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718150|NCT02900105|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92718151|NCT02900105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92718152|NCT02900105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718153|NCT02900105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718154|NCT02900105|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92718155|NCT02900105|Hormone Antagonists|hormone antagonists|mesh-ancestor
92718156|NCT02900105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718157|NCT02900105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718158|NCT04620213|Phentolamine|phentolamine|mesh-list
92718159|NCT04620213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92718160|NCT04620213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92718161|NCT04620213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92718162|NCT04620213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92718163|NCT04620213|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718164|NCT04620213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718165|NCT04620213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718166|NCT04620213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718167|NCT04620213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718168|NCT04619862|Gabapentin|gabapentin|mesh-list
92718169|NCT04619862|Analgesics|analgesics|mesh-ancestor
92718170|NCT04619862|Sensory System Agents|sensory system agents|mesh-ancestor
92609820|NCT04518124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609821|NCT04518124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609822|NCT04518124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609823|NCT04518124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92609824|NCT04518124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92609825|NCT04518124|Vasodilator Agents|vasodilator agents|mesh-ancestor
92609826|NCT00141401|Pregabalin|pregabalin|mesh-list
92718171|NCT04619862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718172|NCT04619862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718173|NCT04619862|Anticonvulsants|anticonvulsants|mesh-ancestor
92718182|NCT04619862|Antimanic Agents|antimanic agents|mesh-ancestor
92718184|NCT01190839|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92718185|NCT01190839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718186|NCT01190839|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718187|NCT01190839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718188|NCT01190839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718189|NCT00562770|Valacyclovir|valacyclovir|mesh-list
92718190|NCT00562770|Valganciclovir|valganciclovir|mesh-list
92718191|NCT00562770|Antiviral Agents|antiviral agents|mesh-ancestor
92718192|NCT00562770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718193|NCT05424692|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92718194|NCT05424692|Fluorouracil|fluorouracil|mesh-list
92718195|NCT05424692|Oxaliplatin|oxaliplatin|mesh-list
92718196|NCT05424692|Irinotecan|irinotecan|mesh-list
92718197|NCT05424692|Cetuximab|cetuximab|mesh-list
92718198|NCT05424692|Antimetabolites|antimetabolites|mesh-ancestor
92718199|NCT05424692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718200|NCT05424692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718201|NCT05424692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718202|NCT05424692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718203|NCT05424692|Immunologic Factors|immunologic factors|mesh-ancestor
92718204|NCT05424692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718205|NCT05424692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92718206|NCT05424692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92718207|NCT05424692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718208|NCT05424692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718209|NCT05424692|Vitamin B Complex|vitamin b complex|mesh-ancestor
92718210|NCT05424692|Vitamins|vitamins|mesh-ancestor
92718211|NCT05424692|Micronutrients|micronutrients|mesh-ancestor
92718212|NCT04618965|Dexmedetomidine|dexmedetomidine|mesh-list
92718213|NCT04618965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92718214|NCT04618965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718215|NCT04618965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718216|NCT04618965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718217|NCT04618965|Analgesics|analgesics|mesh-ancestor
92718218|NCT04618965|Sensory System Agents|sensory system agents|mesh-ancestor
92718219|NCT04618965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718220|NCT04618965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92718221|NCT04618965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92718222|NCT04618965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718223|NCT04618965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718224|NCT04618965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718225|NCT04618965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718226|NCT01190449|Ofatumumab|ofatumumab|mesh-list
92718227|NCT01190449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718228|NCT00562809|Irbesartan|irbesartan|mesh-list
92718229|NCT00562809|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718230|NCT00562809|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92718231|NCT00562809|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92718232|NCT00562809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718233|NCT01190098|Lacosamide|lacosamide|mesh-list
92718234|NCT01190098|Anticonvulsants|anticonvulsants|mesh-ancestor
92718235|NCT01190098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92718236|NCT01190098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92718237|NCT01190098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92718238|NCT01190098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718239|NCT05312593|Chlorhexidine|chlorhexidine|mesh-list
92718251|NCT02885740|Analgesics|analgesics|mesh-ancestor
92609828|NCT00141401|Sensory System Agents|sensory system agents|mesh-ancestor
92718252|NCT02885740|Sensory System Agents|sensory system agents|mesh-ancestor
92718253|NCT02885740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718254|NCT02885740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718255|NCT02885740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92718256|NCT02885740|Vasodilator Agents|vasodilator agents|mesh-ancestor
92718257|NCT02885740|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92718258|NCT02885740|Purinergic Agonists|purinergic agonists|mesh-ancestor
92718259|NCT02885740|Purinergic Agents|purinergic agents|mesh-ancestor
92718260|NCT02885740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718261|NCT02885740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718262|NCT05309785|Canagliflozin|canagliflozin|mesh-list
92718263|NCT05309785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92718264|NCT05309785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718265|NCT05309785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92718266|NCT05309785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718267|NCT01190020|Lubiprostone|lubiprostone|mesh-list
92718268|NCT01190020|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92718269|NCT01190020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92718270|NCT01190020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718271|NCT01189435|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92718272|NCT01189435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718273|NCT01189435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92718274|NCT01189435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718275|NCT01189435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718277|NCT01165996|Azacitidine|azacitidine|mesh-list
92718278|NCT01165996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718279|NCT01165996|Antimetabolites|antimetabolites|mesh-ancestor
92718280|NCT01165996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718281|NCT01165996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718282|NCT01165996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718283|NCT04619433|Carboplatin|carboplatin|mesh-list
92718284|NCT04619433|Pemetrexed|pemetrexed|mesh-list
92718285|NCT04619433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718286|NCT04619433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718287|NCT04619433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718288|NCT04619433|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92718289|NCT04619433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92718290|NCT04619160|Propofol|propofol|mesh-list
92718291|NCT04619160|Sevoflurane|sevoflurane|mesh-list
92718292|NCT04619160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92718293|NCT04619160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718294|NCT04619160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718295|NCT04619160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92718296|NCT04619160|Anesthetics, General|anesthetics, general|mesh-ancestor
92718297|NCT04619160|Anesthetics|anesthetics|mesh-ancestor
92718298|NCT04619160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92718299|NCT04619160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92718300|NCT01165684|Insulin|insulin|mesh-list
92718301|NCT01165684|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92718302|NCT01165684|Insulin Aspart|insulin aspart|mesh-list
92718303|NCT01165684|Insulin, Long-Acting|insulin, long-acting|mesh-list
92718305|NCT01165684|Insulin Detemir|insulin detemir|mesh-list
92718306|NCT01165684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92718307|NCT01165684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718308|NCT01189201|Linagliptin|linagliptin|mesh-list
92718309|NCT01189201|Empagliflozin|empagliflozin|mesh-list
92718310|NCT01189201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92718311|NCT01189201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718312|NCT01189201|Incretins|incretins|mesh-ancestor
92718313|NCT01189201|Hormones|hormones|mesh-ancestor
92718314|NCT01189201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718315|NCT01189201|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92718316|NCT01189201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92718317|NCT01189201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718318|NCT01189201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718319|NCT01189201|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92718320|NCT01188811|Thioctic Acid|thioctic acid|mesh-list
92718321|NCT01188811|Antioxidants|antioxidants|mesh-ancestor
92718322|NCT01188811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609829|NCT00141401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016984|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718323|NCT01188811|Protective Agents|protective agents|mesh-ancestor
92718324|NCT01188811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718325|NCT01188811|Vitamin B Complex|vitamin b complex|mesh-ancestor
92718327|NCT01188811|Micronutrients|micronutrients|mesh-ancestor
92322305|NCT00002108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718328|NCT01183234|Methylphenidate|methylphenidate|mesh-list
92718329|NCT01183234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92718330|NCT01183234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718331|NCT01183234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92718332|NCT01183234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92718333|NCT01183234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92718334|NCT01183234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718335|NCT01183234|Dopamine Agents|dopamine agents|mesh-ancestor
92718336|NCT01183234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718338|NCT04618497|Methoxyflurane|methoxyflurane|mesh-list
92718339|NCT04618497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92718340|NCT04618497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718341|NCT04618497|Analgesics|analgesics|mesh-ancestor
92718342|NCT04618497|Sensory System Agents|sensory system agents|mesh-ancestor
92718343|NCT04618497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718344|NCT04618497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718345|NCT04618497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718346|NCT04618497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718347|NCT04618497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92718348|NCT04618497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718349|NCT04618497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718350|NCT04618497|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92718351|NCT04618497|Anesthetics, General|anesthetics, general|mesh-ancestor
92718352|NCT04618497|Anesthetics|anesthetics|mesh-ancestor
92718353|NCT04618497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718354|NCT04618575|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92718355|NCT04618575|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92718356|NCT04618575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718357|NCT04618536|Sunscreening Agents|sunscreening agents|mesh-list
92718358|NCT04618536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92718359|NCT04618536|Protective Agents|protective agents|mesh-ancestor
92718360|NCT04618536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718361|NCT04618536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718362|NCT04651959|Favipiravir|favipiravir|mesh-list
92718363|NCT04651959|Antiviral Agents|antiviral agents|mesh-ancestor
92718364|NCT04651959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718365|NCT01165216|Paclitaxel|paclitaxel|mesh-list
92718366|NCT01165216|Carboplatin|carboplatin|mesh-list
92718367|NCT01165216|Ipilimumab|ipilimumab|mesh-list
92718368|NCT01165216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92718369|NCT01165216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718370|NCT01165216|Tubulin Modulators|tubulin modulators|mesh-ancestor
92718371|NCT01165216|Antimitotic Agents|antimitotic agents|mesh-ancestor
92718372|NCT01165216|Mitosis Modulators|mitosis modulators|mesh-ancestor
92718373|NCT01165216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718374|NCT01165216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718375|NCT01165216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92718376|NCT04652115|Defibrotide|defibrotide|mesh-list
92718394|NCT04618146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92718395|NCT04618146|Narcotics|narcotics|mesh-ancestor
92718396|NCT04618146|Analgesics|analgesics|mesh-ancestor
92718397|NCT04651842|Insulin|insulin|mesh-list
92718398|NCT04651842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92718399|NCT04651842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718400|NCT05421962|Fentanyl|fentanyl|mesh-list
92718401|NCT05421962|Ketamine|ketamine|mesh-list
92718402|NCT05421962|Analgesics|analgesics|mesh-ancestor
92718403|NCT05421962|Sensory System Agents|sensory system agents|mesh-ancestor
92718404|NCT05421962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718405|NCT05421962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718406|NCT05421962|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92718407|NCT05421962|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92718408|NCT05421962|Anesthetics, General|anesthetics, general|mesh-ancestor
92718409|NCT05421962|Anesthetics|anesthetics|mesh-ancestor
92718410|NCT05421962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718411|NCT05421962|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92609830|NCT00141401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609831|NCT00141401|Anticonvulsants|anticonvulsants|mesh-ancestor
92609832|NCT00141401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92609833|NCT00141401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609834|NCT00141401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609835|NCT00141401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92718412|NCT05421962|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92718413|NCT05421962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718414|NCT05421962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718415|NCT05421962|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92718416|NCT05421962|Narcotics|narcotics|mesh-ancestor
92718417|NCT05421962|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92718418|NCT00557817|Darbepoetin alfa|darbepoetin alfa|mesh-list
92718419|NCT00557817|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92718420|NCT00557817|Hematinics|hematinics|mesh-ancestor
92718421|NCT05419583|Aspirin|aspirin|mesh-list
92718422|NCT05419583|Warfarin|warfarin|mesh-list
92718423|NCT05419583|Apixaban|apixaban|mesh-list
92718424|NCT05419583|Anticoagulants|anticoagulants|mesh-list
92718425|NCT05419583|Edoxaban|edoxaban|mesh-list
92718426|NCT05419583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92718427|NCT05419583|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92718428|NCT05419583|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92718429|NCT05419583|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718430|NCT05419583|Analgesics|analgesics|mesh-ancestor
92718431|NCT05419583|Sensory System Agents|sensory system agents|mesh-ancestor
92718432|NCT05419583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718433|NCT05419583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718434|NCT05419583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718435|NCT05419583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718436|NCT05419583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92718439|NCT05419583|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92718440|NCT05419583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718441|NCT05419583|Antipyretics|antipyretics|mesh-ancestor
92718442|NCT05419583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92718443|NCT05419583|Antithrombins|antithrombins|mesh-ancestor
92718444|NCT05419583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92718445|NCT05419583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92396117|NCT01394835|Protease Inhibitors|protease inhibitors|mesh-ancestor
92718446|NCT05419583|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92718447|NCT05419583|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92718448|NCT05419583|Antimetabolites|antimetabolites|mesh-ancestor
92718449|NCT05419583|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92718450|NCT05387408|Analgesics, Opioid|analgesics, opioid|mesh-list
92718451|NCT05387408|Narcotics|narcotics|mesh-ancestor
92718452|NCT05387408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718453|NCT05387408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718454|NCT05387408|Analgesics|analgesics|mesh-ancestor
92718455|NCT05387408|Sensory System Agents|sensory system agents|mesh-ancestor
92718456|NCT05387408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718457|NCT05376761|Dexmedetomidine|dexmedetomidine|mesh-list
92718458|NCT05376761|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92718459|NCT05376761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718460|NCT05376761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718461|NCT05376761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718462|NCT05376761|Analgesics|analgesics|mesh-ancestor
92718463|NCT05376761|Sensory System Agents|sensory system agents|mesh-ancestor
92718464|NCT05376761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718465|NCT05376761|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92718466|NCT05376761|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92718467|NCT05376761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718468|NCT05376761|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718469|NCT05376761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718470|NCT05376761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718471|NCT04617561|Methylprednisolone|methylprednisolone|mesh-list
92718472|NCT04617561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92718473|NCT04617561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92718474|NCT04617561|Prednisolone|prednisolone|mesh-list
92609836|NCT00141401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92609837|NCT00141401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92609838|NCT00141401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609839|NCT00141401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92718475|NCT04617561|Prednisolone acetate|prednisolone acetate|mesh-list
92718476|NCT04617561|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92718477|NCT04617561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92718478|NCT04617561|Prednisolone phosphate|prednisolone phosphate|mesh-list
92718479|NCT04617561|Glucocorticoids|glucocorticoids|mesh-list
92718480|NCT04617561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718481|NCT04617561|Antiemetics|antiemetics|mesh-ancestor
92718482|NCT04617561|Autonomic Agents|autonomic agents|mesh-ancestor
92718483|NCT04617561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718484|NCT04617561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718485|NCT04617561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718486|NCT04617561|Hormones|hormones|mesh-ancestor
92718487|NCT04617561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718488|NCT04617561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92718489|NCT04617561|Protective Agents|protective agents|mesh-ancestor
92718490|NCT04617561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92718491|NCT04617561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718492|NCT04617561|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92718493|NCT04617483|Vaccines|vaccines|mesh-list
92718494|NCT04617483|Immunologic Factors|immunologic factors|mesh-ancestor
92718495|NCT04617483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718496|NCT04617249|Anesthetics|anesthetics|mesh-list
92718497|NCT04617249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718498|NCT04617249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718499|NCT05349383|Antineoplastic Agents|antineoplastic agents|mesh-list
92718500|NCT05349383|Antibodies|antibodies|mesh-list
92718501|NCT05349383|Immunoglobulins|immunoglobulins|mesh-list
92718502|NCT05349383|Immunoconjugates|immunoconjugates|mesh-list
92718503|NCT05349383|Immunomodulating Agents|immunomodulating agents|mesh-list
92718504|NCT05349383|Immunologic Factors|immunologic factors|mesh-ancestor
92718505|NCT05349383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718506|NCT04617171|Benralizumab|benralizumab|mesh-list
92718507|NCT04617171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92718508|NCT04617171|Respiratory System Agents|respiratory system agents|mesh-ancestor
92718509|NCT00557934|Dobutamine|dobutamine|mesh-list
92718510|NCT00557934|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92718512|NCT00557934|Autonomic Agents|autonomic agents|mesh-ancestor
92718513|NCT00557934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718514|NCT00557934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718515|NCT00557934|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92718516|NCT00557934|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92718517|NCT00557934|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718518|NCT00557934|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718519|NCT00557934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718520|NCT00557934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718521|NCT00557934|Protective Agents|protective agents|mesh-ancestor
92718522|NCT00558051|Vaccines|vaccines|mesh-list
92718523|NCT00558051|Immunologic Factors|immunologic factors|mesh-ancestor
92718524|NCT00558051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718525|NCT00558090|Morphine|morphine|mesh-list
92718526|NCT00558090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92718527|NCT00558090|Narcotics|narcotics|mesh-ancestor
92718528|NCT00558090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718529|NCT00558090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718530|NCT00558090|Analgesics|analgesics|mesh-ancestor
92718531|NCT00558090|Sensory System Agents|sensory system agents|mesh-ancestor
92718532|NCT00558090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718533|NCT04617015|Bromides|bromides|mesh-list
92718534|NCT04617015|Ipratropium|ipratropium|mesh-list
92718535|NCT04617015|Anticonvulsants|anticonvulsants|mesh-ancestor
92718536|NCT04617015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92718537|NCT04617015|Autonomic Agents|autonomic agents|mesh-ancestor
92718538|NCT04617015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718539|NCT04617015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718540|NCT04617015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92718541|NCT04617015|Respiratory System Agents|respiratory system agents|mesh-ancestor
92718542|NCT04617015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92718543|NCT04617015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92718544|NCT04617015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609840|NCT00505102|Everolimus|everolimus|mesh-list
92609841|NCT00505102|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92016996|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718545|NCT04617015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718546|NCT04650828|Tenofovir|tenofovir|mesh-list
92718547|NCT04650828|Antiviral Agents|antiviral agents|mesh-ancestor
92718548|NCT04650828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718549|NCT04650828|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92718550|NCT04650828|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92718551|NCT04650828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718552|NCT04650828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718553|NCT04650828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92405736|NCT05387525|Diclofenac|diclofenac|mesh-list
92718554|NCT04650828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92718555|NCT04650555|Genistein|genistein|mesh-list
92718556|NCT04650555|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92718557|NCT04650555|Protective Agents|protective agents|mesh-ancestor
92718558|NCT04650555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718559|NCT04650555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718560|NCT04650555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92718561|NCT04650555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718562|NCT04650555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718563|NCT04650555|Phytoestrogens|phytoestrogens|mesh-ancestor
92718564|NCT04650555|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92718565|NCT04650555|Estrogens|estrogens|mesh-ancestor
92718567|NCT04650555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718568|NCT05181683|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92718569|NCT05181683|Antiviral Agents|antiviral agents|mesh-ancestor
92718570|NCT05181683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718571|NCT04650321|Ocrelizumab|ocrelizumab|mesh-list
92718572|NCT04650321|Immunologic Factors|immunologic factors|mesh-ancestor
92718573|NCT04650321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718574|NCT05153525|Cisatracurium|cisatracurium|mesh-list
92718575|NCT05153525|Atracurium|atracurium|mesh-list
92718576|NCT05153525|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92718577|NCT05153525|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92718578|NCT05153525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718579|NCT05153525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718580|NCT05153525|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92718581|NCT05153525|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92718582|NCT05153525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92718583|NCT05153525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92718584|NCT05153525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718588|NCT04649892|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92718589|NCT04649892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718590|NCT04649892|Sensory System Agents|sensory system agents|mesh-ancestor
92718591|NCT04649892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718592|NCT05125796|Acetaminophen|acetaminophen|mesh-list
92718593|NCT05125796|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92718594|NCT05125796|Ketoprofen|ketoprofen|mesh-list
92718595|NCT05125796|Lidocaine|lidocaine|mesh-list
92718596|NCT05125796|Anesthetics, Local|anesthetics, local|mesh-ancestor
92718597|NCT05125796|Anesthetics|anesthetics|mesh-ancestor
92718598|NCT05125796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718599|NCT05125796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718600|NCT05125796|Sensory System Agents|sensory system agents|mesh-ancestor
92718601|NCT05125796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718602|NCT05125796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92718603|NCT05125796|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92718604|NCT05125796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92718605|NCT05125796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92718606|NCT05125796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718607|NCT05125796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718608|NCT05125796|Analgesics|analgesics|mesh-ancestor
92718609|NCT05125796|Antipyretics|antipyretics|mesh-ancestor
92718610|NCT05125796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92718611|NCT05125796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718612|NCT05125796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718613|NCT05125796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92718614|NCT05125796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718615|NCT04616859|Ethanol|ethanol|mesh-list
92718616|NCT04616859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92609842|NCT00505102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92609843|NCT00505102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016997|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718617|NCT04616859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718618|NCT04616859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718619|NCT04616859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718620|NCT04616586|Siltuximab|siltuximab|mesh-list
92718621|NCT04616586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718622|NCT04616352|Cefuroxime|cefuroxime|mesh-list
92718623|NCT04616352|Cefuroxime axetil|cefuroxime axetil|mesh-list
92718624|NCT04616352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718625|NCT04616352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718626|NCT00553943|Cytarabine|cytarabine|mesh-list
92718627|NCT00553943|Rituximab|rituximab|mesh-list
92718628|NCT00553943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718629|NCT00553943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405812|NCT05111431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92718630|NCT00553943|Immunologic Factors|immunologic factors|mesh-ancestor
92718631|NCT00553943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718632|NCT00553943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718633|NCT00553943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718634|NCT00553943|Antimetabolites|antimetabolites|mesh-ancestor
92718635|NCT00553943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718636|NCT00553943|Antiviral Agents|antiviral agents|mesh-ancestor
92718637|NCT00553943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718638|NCT00553943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718639|NCT00563160|Carboplatin|carboplatin|mesh-list
92718640|NCT00563160|Gemcitabine|gemcitabine|mesh-list
92718641|NCT00563160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718642|NCT00563160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718643|NCT00563160|Antimetabolites|antimetabolites|mesh-ancestor
92718644|NCT00563160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718646|NCT00563238|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92718647|NCT00563238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718648|NCT00563238|Sympatholytics|sympatholytics|mesh-ancestor
92718649|NCT00563238|Autonomic Agents|autonomic agents|mesh-ancestor
92718650|NCT00563238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718651|NCT00563238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718652|NCT00563238|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92718653|NCT00563238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92718654|NCT00563238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92718655|NCT00563238|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042710|NCT02308124|Midodrine|midodrine|mesh-list
92718656|NCT00563238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718657|NCT00563238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718659|NCT04679558|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92718660|NCT04679558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718661|NCT04679558|Disinfectants|disinfectants|mesh-ancestor
92718662|NCT04934228|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92718663|NCT04934228|Clonidine|clonidine|mesh-list
92718664|NCT04934228|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718665|NCT04934228|Diuretics|diuretics|mesh-ancestor
92718666|NCT04934228|Natriuretic Agents|natriuretic agents|mesh-ancestor
92718667|NCT04934228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718668|NCT04934228|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92718669|NCT04934228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92718670|NCT04934228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718671|NCT04934228|Analgesics|analgesics|mesh-ancestor
92718672|NCT04934228|Sensory System Agents|sensory system agents|mesh-ancestor
92718673|NCT04934228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718674|NCT04934228|Sympatholytics|sympatholytics|mesh-ancestor
92718675|NCT04934228|Autonomic Agents|autonomic agents|mesh-ancestor
92718676|NCT04934228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92718677|NCT04934228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92718678|NCT04934228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718679|NCT04934228|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718680|NCT04934228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718681|NCT03454503|Imatinib Mesylate|imatinib mesylate|mesh-list
92718682|NCT03454503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718683|NCT03454503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92718684|NCT03454503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718685|NCT03454503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718686|NCT04616391|Insulin|insulin|mesh-list
92609844|NCT00505102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609845|NCT00505102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92609846|NCT00505102|Immunologic Factors|immunologic factors|mesh-ancestor
92609847|NCT00505102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609848|NCT00505102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718687|NCT04616391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92718688|NCT04616391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718689|NCT04890236|Tisagenlecleucel|tisagenlecleucel|mesh-list
92718690|NCT04890236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718691|NCT04890236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718692|NCT04615962|Mometasone Furoate|mometasone furoate|mesh-list
92718693|NCT04615962|Hydrocortisone|hydrocortisone|mesh-list
92718694|NCT04615962|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92718695|NCT04615962|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92718696|NCT04615962|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92718697|NCT04615962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718698|NCT04615962|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718699|NCT04615962|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92718700|NCT04881929|Docetaxel|docetaxel|mesh-list
92718701|NCT04881929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718702|NCT04881929|Tubulin Modulators|tubulin modulators|mesh-ancestor
92718703|NCT04881929|Antimitotic Agents|antimitotic agents|mesh-ancestor
92718704|NCT04881929|Mitosis Modulators|mitosis modulators|mesh-ancestor
92718705|NCT04881929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718706|NCT04615767|Inositol|inositol|mesh-list
92718707|NCT04615767|Vitamin B Complex|vitamin b complex|mesh-ancestor
92718708|NCT04615767|Vitamins|vitamins|mesh-ancestor
92718709|NCT04615767|Micronutrients|micronutrients|mesh-ancestor
92718710|NCT04615767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718711|NCT04615611|Albuterol|albuterol|mesh-list
92718712|NCT04615611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92718713|NCT04615611|Autonomic Agents|autonomic agents|mesh-ancestor
92718714|NCT04615611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718715|NCT04615611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718716|NCT04615611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92718717|NCT04615611|Respiratory System Agents|respiratory system agents|mesh-ancestor
92718718|NCT04615611|Tocolytic Agents|tocolytic agents|mesh-ancestor
92718719|NCT04615611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92718720|NCT04615611|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92718721|NCT04615611|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92718722|NCT04615611|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718723|NCT04615611|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718724|NCT04615611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718725|NCT04615611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718726|NCT04615728|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92718727|NCT04615728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718728|NCT04725812|Eculizumab|eculizumab|mesh-list
92718729|NCT04725812|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92718730|NCT04725812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718731|NCT04725812|Immunologic Factors|immunologic factors|mesh-ancestor
92718734|NCT04713371|Pembrolizumab|pembrolizumab|mesh-list
92718735|NCT04713371|Ipilimumab|ipilimumab|mesh-list
92718736|NCT04713371|Sargramostim|sargramostim|mesh-list
92718737|NCT04713371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718738|NCT04713371|Immunologic Factors|immunologic factors|mesh-ancestor
92718739|NCT04713371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718740|NCT04713371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718741|NCT04713371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92718742|NCT04713371|Alkylating Agents|alkylating agents|mesh-ancestor
92718743|NCT04713371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718744|NCT04713371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718745|NCT04713371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92718746|NCT04713371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718747|NCT04713371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92718748|NCT04683614|Norepinephrine|norepinephrine|mesh-list
92718749|NCT04683614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92718750|NCT04683614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92718751|NCT04683614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718752|NCT04683614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609849|NCT00404378|Ketoconazole|ketoconazole|mesh-list
92609850|NCT00404378|Casopitant|casopitant|mesh-list
92609851|NCT00404378|Antifungal Agents|antifungal agents|mesh-ancestor
92609852|NCT00404378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609853|NCT00404378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92609854|NCT00404378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92718753|NCT04683614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718754|NCT04683614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718755|NCT04683614|Sympathomimetics|sympathomimetics|mesh-ancestor
92718756|NCT04683614|Autonomic Agents|autonomic agents|mesh-ancestor
92718757|NCT04683614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718758|NCT04683614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92718759|NCT04613895|Fexuprazan|fexuprazan|mesh-list
92718760|NCT04613895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718761|NCT04613700|Secretin|secretin|mesh-list
92718762|NCT04613700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718763|NCT04613700|Hormones|hormones|mesh-ancestor
92718764|NCT04613700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718765|NCT04613700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718766|NCT04675151|Phentolamine|phentolamine|mesh-list
92718767|NCT04675151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92718768|NCT04675151|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92718769|NCT04675151|Pilocarpine|pilocarpine|mesh-list
92718770|NCT04675151|Miotics|miotics|mesh-ancestor
92718771|NCT04675151|Autonomic Agents|autonomic agents|mesh-ancestor
92718772|NCT04675151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718773|NCT04675151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718774|NCT04675151|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92718775|NCT04675151|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92718776|NCT04675151|Cholinergic Agents|cholinergic agents|mesh-ancestor
92718777|NCT04675151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718778|NCT04675151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718779|NCT04675151|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92718780|NCT04675151|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92718781|NCT04675151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718782|NCT04675151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718783|NCT00563355|Epoetin Alfa|epoetin alfa|mesh-list
92718784|NCT00563355|Hematinics|hematinics|mesh-ancestor
92718785|NCT00563394|Ofloxacin|ofloxacin|mesh-list
92718786|NCT00563394|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92718787|NCT00563394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718788|NCT00563394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718789|NCT00563394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92718790|NCT00563394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92718791|NCT00563394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718792|NCT00563394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718793|NCT00563394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718794|NCT00563394|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92718795|NCT00563394|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92718796|NCT00563433|Ofloxacin|ofloxacin|mesh-list
92718797|NCT00563433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92718798|NCT00563433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718799|NCT00563433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718800|NCT00563433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92718801|NCT00563433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92718802|NCT00563433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718803|NCT00563433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718804|NCT00563433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718817|NCT00563472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92718818|NCT00563472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92718819|NCT00563472|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92718820|NCT04679597|Capecitabine|capecitabine|mesh-list
92718821|NCT04679597|Oxaliplatin|oxaliplatin|mesh-list
92718822|NCT04679597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718823|NCT04679597|Antimetabolites|antimetabolites|mesh-ancestor
92718824|NCT04679597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718825|NCT04679597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718826|NCT04615910|Exenatide|exenatide|mesh-list
92718827|NCT04615910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92609855|NCT00404378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609856|NCT00404378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609857|NCT00404378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92609858|NCT00404378|Hormone Antagonists|hormone antagonists|mesh-ancestor
92718828|NCT04615910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718829|NCT04615910|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92718830|NCT04615910|Incretins|incretins|mesh-ancestor
92718831|NCT04615910|Hormones|hormones|mesh-ancestor
92718832|NCT04615910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718833|NCT04609397|Hemay005|hemay005|mesh-list
92718834|NCT04609397|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718835|NCT04609397|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92718836|NCT04609397|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92718837|NCT04609397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718838|NCT04609397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718839|NCT04587947|Valsartan|valsartan|mesh-list
92718840|NCT04587947|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92718841|NCT04587947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92718842|NCT04587947|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92718843|NCT04587947|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92718844|NCT04587947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718845|NCT04612998|Atropine|atropine|mesh-list
92718846|NCT04612998|Ephedrine|ephedrine|mesh-list
92718847|NCT04612998|Metoclopramide|metoclopramide|mesh-list
92718848|NCT04612998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92718849|NCT04612998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92718850|NCT04612998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92718851|NCT04612998|Autonomic Agents|autonomic agents|mesh-ancestor
92718852|NCT04612998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718853|NCT04612998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718854|NCT04612998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92718855|NCT04612998|Respiratory System Agents|respiratory system agents|mesh-ancestor
92718856|NCT04612998|Mydriatics|mydriatics|mesh-ancestor
92718857|NCT04612998|Parasympatholytics|parasympatholytics|mesh-ancestor
92718858|NCT04612998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92718859|NCT04612998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92718860|NCT04612998|Cholinergic Agents|cholinergic agents|mesh-ancestor
92718861|NCT04612998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718862|NCT04612998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718863|NCT04612998|Antiemetics|antiemetics|mesh-ancestor
92718864|NCT04612998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718865|NCT04612998|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92718866|NCT04612998|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92718883|NCT00563589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718884|NCT00563589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718885|NCT00563589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718886|NCT00563589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92718887|NCT00563589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718888|NCT00563589|Immunologic Factors|immunologic factors|mesh-ancestor
92718889|NCT00563589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92718890|NCT00563589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92718891|NCT00563589|Antifungal Agents|antifungal agents|mesh-ancestor
92718892|NCT00563589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718893|NCT00563589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92718894|NCT00563589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92718895|NCT00563589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92718896|NCT00563589|Antitubercular Agents|antitubercular agents|mesh-ancestor
92718897|NCT00563589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92718898|NCT04612803|Histamine Antagonists|histamine antagonists|mesh-list
92718899|NCT04612803|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92718900|NCT04612803|Histamine Agents|histamine agents|mesh-ancestor
92718901|NCT04612803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718902|NCT04612803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718903|NCT04612803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718905|NCT02204345|Carboplatin|carboplatin|mesh-list
92718906|NCT02204345|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92718907|NCT02204345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718908|NCT02204345|Tubulin Modulators|tubulin modulators|mesh-ancestor
92718909|NCT02204345|Antimitotic Agents|antimitotic agents|mesh-ancestor
92609859|NCT00404378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609860|NCT00404378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718910|NCT02204345|Mitosis Modulators|mitosis modulators|mesh-ancestor
92718911|NCT02204345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718912|NCT02187302|Bevacizumab|bevacizumab|mesh-list
92718913|NCT02187302|Sunitinib|sunitinib|mesh-list
92718914|NCT02187302|Everolimus|everolimus|mesh-list
92718915|NCT02187302|Sorafenib|sorafenib|mesh-list
92718916|NCT02187302|Axitinib|axitinib|mesh-list
92718917|NCT02187302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718918|NCT02187302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718919|NCT02187302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92718920|NCT02187302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92718921|NCT02187302|Growth Substances|growth substances|mesh-ancestor
92718922|NCT02187302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718923|NCT02187302|Growth Inhibitors|growth inhibitors|mesh-ancestor
92718924|NCT02187302|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92718925|NCT02187302|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92718926|NCT02187302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718931|NCT02179151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92718932|NCT02179151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92718933|NCT02179151|Growth Substances|growth substances|mesh-ancestor
92718934|NCT02179151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718935|NCT02179151|Growth Inhibitors|growth inhibitors|mesh-ancestor
92718936|NCT02179151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718937|NCT02160665|Tazarotene|tazarotene|mesh-list
92718938|NCT02160665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718939|NCT02160665|Keratolytic Agents|keratolytic agents|mesh-ancestor
92718940|NCT02138630|Capsaicin|capsaicin|mesh-list
92718941|NCT02138630|Antipruritics|antipruritics|mesh-ancestor
92718942|NCT02138630|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718943|NCT02138630|Sensory System Agents|sensory system agents|mesh-ancestor
92718944|NCT02138630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718945|NCT02138630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718946|NCT02137343|Capecitabine|capecitabine|mesh-list
92718947|NCT02137343|Rilotumumab|rilotumumab|mesh-list
92718948|NCT02137343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718949|NCT02137343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718950|NCT02137343|Antimetabolites|antimetabolites|mesh-ancestor
92718951|NCT02137343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718952|NCT02137343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92718953|NCT02125253|Mometasone Furoate|mometasone furoate|mesh-list
92718954|NCT02125253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718955|NCT02125253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92718956|NCT02125253|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92718957|NCT02114060|Vaccines|vaccines|mesh-list
92718958|NCT02114060|Immunologic Factors|immunologic factors|mesh-ancestor
92718959|NCT02114060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718960|NCT00560898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92718961|NCT02104388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92718962|NCT02104388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92718963|NCT04633044|Betaine|betaine|mesh-list
92718964|NCT04633044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92718965|NCT04633044|Lipotropic Agents|lipotropic agents|mesh-ancestor
92718966|NCT04633044|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92718967|NCT04633044|Antimetabolites|antimetabolites|mesh-ancestor
92718968|NCT04633044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718969|NCT04633044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92718970|NCT04611438|Cannabidiol|cannabidiol|mesh-list
92718971|NCT04611438|Anticonvulsants|anticonvulsants|mesh-ancestor
92718972|NCT00563823|Vatalanib|vatalanib|mesh-list
92718973|NCT00563823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92718974|NCT00563823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718975|NCT00563823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718976|NCT00563862|Fluorouracil|fluorouracil|mesh-list
92718977|NCT00563862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718978|NCT00563862|Antimetabolites|antimetabolites|mesh-ancestor
92718979|NCT00563862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718980|NCT00563862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718981|NCT00563862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718982|NCT00563862|Immunologic Factors|immunologic factors|mesh-ancestor
92718983|NCT00563862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718984|NCT04611711|Decitabine|decitabine|mesh-list
92718985|NCT04611711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92609861|NCT00404378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92609862|NCT00404378|Antiemetics|antiemetics|mesh-ancestor
92609863|NCT00404378|Autonomic Agents|autonomic agents|mesh-ancestor
92609864|NCT00404378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017015|NCT05697029|Tetrandrine|tetrandrine|mesh-list
92718986|NCT04611711|Antimetabolites|antimetabolites|mesh-ancestor
92718987|NCT04611711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718988|NCT04611711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718989|NCT04611711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718990|NCT04632537|BCG Vaccine|bcg vaccine|mesh-list
92718991|NCT04632537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92718992|NCT04632537|Immunologic Factors|immunologic factors|mesh-ancestor
92718993|NCT04632537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718994|NCT02092922|Filanesib|filanesib|mesh-list
92718995|NCT02092922|Lenograstim|lenograstim|mesh-list
92718996|NCT02092922|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92718997|NCT02092922|Immunologic Factors|immunologic factors|mesh-ancestor
92718998|NCT02092922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718999|NCT02092922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92719012|NCT02083289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92719013|NCT02081300|Methyltestosterone|methyltestosterone|mesh-list
92719014|NCT02081300|Testosterone|testosterone|mesh-list
92719015|NCT02081300|Testosterone undecanoate|testosterone undecanoate|mesh-list
92719016|NCT02081300|Testosterone enanthate|testosterone enanthate|mesh-list
92719017|NCT02081300|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92719018|NCT02081300|Androgens|androgens|mesh-ancestor
92719020|NCT02081300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719021|NCT02081300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719022|NCT02081300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719023|NCT02081300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719024|NCT02081300|Anabolic Agents|anabolic agents|mesh-ancestor
92719025|NCT02074007|Benzocaine|benzocaine|mesh-list
92719026|NCT02074007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719027|NCT02074007|Anesthetics, Local|anesthetics, local|mesh-ancestor
92719028|NCT02074007|Anesthetics|anesthetics|mesh-ancestor
92719029|NCT02074007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719030|NCT02074007|Sensory System Agents|sensory system agents|mesh-ancestor
92719031|NCT02074007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719032|NCT02072954|Asenapine|asenapine|mesh-list
92719033|NCT02072954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92719034|NCT02072954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92719035|NCT02072954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719036|NCT02072954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719037|NCT02072954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92719038|NCT00554918|Zoledronic Acid|zoledronic acid|mesh-list
92719039|NCT00554918|Prednisolone|prednisolone|mesh-list
92719040|NCT00554918|Docetaxel|docetaxel|mesh-list
92719041|NCT00554918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396142|NCT01394887|Metformin|metformin|mesh-list
92719042|NCT00554918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92719043|NCT00554918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92719044|NCT00554918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92719045|NCT00554918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719046|NCT00554918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719047|NCT00554918|Glucocorticoids|glucocorticoids|mesh-ancestor
92719048|NCT00554918|Hormones|hormones|mesh-ancestor
92719049|NCT00554918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719050|NCT00554918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719051|NCT00554918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719052|NCT00554918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92719053|NCT04631874|Varenicline|varenicline|mesh-list
92719054|NCT04631874|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92719055|NCT04631874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92719056|NCT04631874|Cholinergic Agents|cholinergic agents|mesh-ancestor
92719057|NCT04631874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719058|NCT04631874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719059|NCT04631874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719060|NCT02057315|Ketoprofen|ketoprofen|mesh-list
92719061|NCT02057315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719062|NCT02057315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719066|NCT02057315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609865|NCT00404378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92609866|NCT00404378|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92609867|NCT00404378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609868|NCT04511728|Propofol|propofol|mesh-list
92609869|NCT04511728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92719067|NCT02057315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719068|NCT02057315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719069|NCT02057315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92719070|NCT02057315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719071|NCT02057315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719072|NCT02047214|Bevacizumab|bevacizumab|mesh-list
92719073|NCT02047214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719074|NCT02047214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719075|NCT02047214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92719076|NCT02047214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92719077|NCT02047214|Growth Substances|growth substances|mesh-ancestor
92719078|NCT02047214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719079|NCT02047214|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719080|NCT02046395|Amlodipine|amlodipine|mesh-list
92719081|NCT02046395|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92719082|NCT02046395|Hydralazine|hydralazine|mesh-list
92719083|NCT02046395|Terazosin|terazosin|mesh-list
92719084|NCT02046395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92719085|NCT02046395|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92719086|NCT02046395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719087|NCT02046395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719088|NCT02046395|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92719089|NCT02046395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719090|NCT02046395|Vasodilator Agents|vasodilator agents|mesh-ancestor
92719091|NCT02046395|Diuretics|diuretics|mesh-ancestor
92719092|NCT02046395|Natriuretic Agents|natriuretic agents|mesh-ancestor
92719093|NCT02046395|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92719094|NCT02046395|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92719095|NCT02046395|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92719096|NCT02046395|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92719097|NCT02046395|Adrenergic Agents|adrenergic agents|mesh-ancestor
92719098|NCT02046395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719099|NCT02046395|Urological Agents|urological agents|mesh-ancestor
92719100|NCT02032277|Paclitaxel|paclitaxel|mesh-list
92719101|NCT02032277|Cyclophosphamide|cyclophosphamide|mesh-list
92719102|NCT02032277|Carboplatin|carboplatin|mesh-list
92719103|NCT02032277|Doxorubicin|doxorubicin|mesh-list
92719104|NCT02032277|Veliparib|veliparib|mesh-list
92719105|NCT02032277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92719106|NCT02032277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719107|NCT02032277|Tubulin Modulators|tubulin modulators|mesh-ancestor
92719108|NCT02032277|Antimitotic Agents|antimitotic agents|mesh-ancestor
92719109|NCT02032277|Mitosis Modulators|mitosis modulators|mesh-ancestor
92719110|NCT02032277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719111|NCT02032277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719112|NCT02032277|Immunologic Factors|immunologic factors|mesh-ancestor
92719113|NCT02032277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719114|NCT02032277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719115|NCT02032277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92719116|NCT02032277|Alkylating Agents|alkylating agents|mesh-ancestor
92719117|NCT02032277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92719118|NCT02032277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92719119|NCT02032277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92719120|NCT02032277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92719121|NCT02032277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719122|NCT02032277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92719123|NCT00560976|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92719124|NCT00560976|Ferric gluconate|ferric gluconate|mesh-list
92719125|NCT00560976|Hematinics|hematinics|mesh-ancestor
92719126|NCT02026349|Favipiravir|favipiravir|mesh-list
92719127|NCT02026349|Antiviral Agents|antiviral agents|mesh-ancestor
92719128|NCT02026349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719129|NCT04611126|Cyclophosphamide|cyclophosphamide|mesh-list
92719130|NCT04611126|Nivolumab|nivolumab|mesh-list
92719131|NCT04611126|Fludarabine|fludarabine|mesh-list
92719132|NCT04611126|Fludarabine phosphate|fludarabine phosphate|mesh-list
92609870|NCT04511728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609871|NCT04511728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609872|NCT04511728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92609873|NCT04511728|Anesthetics, General|anesthetics, general|mesh-ancestor
92609874|NCT04511728|Anesthetics|anesthetics|mesh-ancestor
92609875|NCT00162318|Cetuximab|cetuximab|mesh-list
92609876|NCT00162318|Gefitinib|gefitinib|mesh-list
92609877|NCT00162318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719133|NCT04611126|Ipilimumab|ipilimumab|mesh-list
92719134|NCT04611126|Relatlimab|relatlimab|mesh-list
92719135|NCT04611126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719136|NCT04611126|Immunologic Factors|immunologic factors|mesh-ancestor
92719137|NCT04611126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719139|NCT04611126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92719140|NCT04611126|Alkylating Agents|alkylating agents|mesh-ancestor
92719141|NCT04611126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719142|NCT04611126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719143|NCT04611126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92719144|NCT04611126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719145|NCT04611126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92719146|NCT04611126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719147|NCT04611126|Antimetabolites|antimetabolites|mesh-ancestor
92719148|NCT02026232|Hydroxychloroquine|hydroxychloroquine|mesh-list
92719149|NCT02026232|Antimalarials|antimalarials|mesh-ancestor
92719150|NCT02026232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92719151|NCT02026232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92719152|NCT02026232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719153|NCT02026232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719154|NCT02026232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719155|NCT02026232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719156|NCT04611165|Nivolumab|nivolumab|mesh-list
92719157|NCT04611165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719158|NCT04611165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719159|NCT04611165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92719160|NCT04611165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719161|NCT02014649|Laninamivir|laninamivir|mesh-list
92719162|NCT02014649|Zanamivir|zanamivir|mesh-list
92719163|NCT02014649|Antiviral Agents|antiviral agents|mesh-ancestor
92719164|NCT02014649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719165|NCT02014649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719166|NCT02014649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719167|NCT02014142|Latanoprost|latanoprost|mesh-list
92719168|NCT02014142|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92719169|NCT02014142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92719170|NCT04610580|Choline|choline|mesh-list
92719171|NCT04610580|Lipotropic Agents|lipotropic agents|mesh-ancestor
92719172|NCT04610580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92719173|NCT04610580|Antimetabolites|antimetabolites|mesh-ancestor
92719174|NCT04610580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719175|NCT04610580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719176|NCT04610580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92719177|NCT04610580|Nootropic Agents|nootropic agents|mesh-ancestor
92719178|NCT04631250|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92719179|NCT04631250|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92719180|NCT04631250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92719181|NCT01998035|Azacitidine|azacitidine|mesh-list
92719182|NCT01998035|Romidepsin|romidepsin|mesh-list
92719183|NCT01998035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719184|NCT01998035|Antimetabolites|antimetabolites|mesh-ancestor
92719185|NCT01998035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719186|NCT01998035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719187|NCT01998035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719188|NCT01998035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92719189|NCT01998035|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92719190|NCT04611243|Vaccines|vaccines|mesh-list
92719191|NCT04611243|Immunologic Factors|immunologic factors|mesh-ancestor
92719192|NCT04611243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719193|NCT00564057|Candesartan|candesartan|mesh-list
92719194|NCT00564057|Candesartan cilexetil|candesartan cilexetil|mesh-list
92609878|NCT00162318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089953|NCT02151448|Interferons|interferons|mesh-list
92719195|NCT00564057|Lercanidipine|lercanidipine|mesh-list
92719196|NCT00564057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92719197|NCT00564057|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92719198|NCT00564057|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92719199|NCT00564057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719200|NCT00564057|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92719201|NCT00564057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719202|NCT00564057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92719203|NCT00564057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719204|NCT04610541|Remdesivir|remdesivir|mesh-list
92719205|NCT04610541|Antimetabolites|antimetabolites|mesh-ancestor
92719206|NCT04610541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719207|NCT04610541|Antiviral Agents|antiviral agents|mesh-ancestor
92719208|NCT04610541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719209|NCT04677335|Lovastatin|lovastatin|mesh-list
92719210|NCT04677335|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92719216|NCT04677335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719217|NCT04630548|Copper|copper|mesh-list
92719218|NCT04630548|Trace Elements|trace elements|mesh-ancestor
92719219|NCT04630548|Micronutrients|micronutrients|mesh-ancestor
92719220|NCT04630548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719221|NCT01975610|Spebrutinib|spebrutinib|mesh-list
92719222|NCT01975610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92719223|NCT01975610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719224|NCT01975610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719225|NCT01969838|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92719226|NCT01969838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92719227|NCT01969838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719228|NCT01969838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719229|NCT01967810|Bevacizumab|bevacizumab|mesh-list
92719230|NCT01967810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719231|NCT01967810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719232|NCT01967810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92719233|NCT01967810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92719234|NCT01967810|Growth Substances|growth substances|mesh-ancestor
92719235|NCT01967810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719236|NCT01967810|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719238|NCT01165138|Xhance|xhance|mesh-list
92719239|NCT01165138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719240|NCT01165138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92719241|NCT01165138|Autonomic Agents|autonomic agents|mesh-ancestor
92719242|NCT01165138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719243|NCT01165138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719244|NCT01165138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92719245|NCT01165138|Respiratory System Agents|respiratory system agents|mesh-ancestor
92719246|NCT01165138|Dermatologic Agents|dermatologic agents|mesh-ancestor
92719247|NCT01165138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92719248|NCT00561054|Cetuximab|cetuximab|mesh-list
92719249|NCT00561054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719250|NCT00561054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719251|NCT04206358|Molgramostim|molgramostim|mesh-list
92719252|NCT04206358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719253|NCT00561093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92719254|NCT00561093|Pentoxifylline|pentoxifylline|mesh-list
92719255|NCT00561093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92719256|NCT00561093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719257|NCT00561093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719258|NCT00561093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92719259|NCT00561093|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92719260|NCT00561093|Protective Agents|protective agents|mesh-ancestor
92719261|NCT00561093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719262|NCT00561093|Vasodilator Agents|vasodilator agents|mesh-ancestor
92719263|NCT00561093|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92719264|NCT00561093|Antioxidants|antioxidants|mesh-ancestor
92719265|NCT01960010|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92719266|NCT01960010|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92719267|NCT01165021|Folic Acid|folic acid|mesh-list
92719268|NCT01165021|Vitamin B 12|vitamin b 12|mesh-list
92719269|NCT01165021|Dexamethasone|dexamethasone|mesh-list
92719270|NCT01165021|Pemetrexed|pemetrexed|mesh-list
92719271|NCT01165021|Vitamins|vitamins|mesh-ancestor
92609879|NCT00162318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92609880|NCT00162318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017032|NCT02627677|Ponatinib|ponatinib|mesh-list
92719272|NCT01165021|Micronutrients|micronutrients|mesh-ancestor
92719273|NCT01165021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719274|NCT01165021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719275|NCT01165021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719276|NCT01165021|Antiemetics|antiemetics|mesh-ancestor
92719277|NCT01165021|Autonomic Agents|autonomic agents|mesh-ancestor
92719278|NCT01165021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719279|NCT01165021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719280|NCT01165021|Glucocorticoids|glucocorticoids|mesh-ancestor
92719281|NCT01165021|Hormones|hormones|mesh-ancestor
92719283|NCT01165021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719285|NCT01165021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719286|NCT01165021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92719287|NCT01165021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92719288|NCT01165021|Hematinics|hematinics|mesh-ancestor
92719289|NCT01165021|Vitamin B Complex|vitamin b complex|mesh-ancestor
92719290|NCT00561132|Vanadyl sulfate|vanadyl sulfate|mesh-list
92719291|NCT00561132|Magnesium Oxide|magnesium oxide|mesh-list
92719292|NCT00561132|Antacids|antacids|mesh-ancestor
92719293|NCT00561132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719294|NCT00561132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719295|NCT00561132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92719296|NCT00561132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719297|NCT01956812|Gemcitabine|gemcitabine|mesh-list
92719298|NCT01956812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719299|NCT01956812|Antimetabolites|antimetabolites|mesh-ancestor
92719300|NCT01956812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719301|NCT01956812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719302|NCT01952990|Phenylephrine|phenylephrine|mesh-list
92719303|NCT01952990|Oxymetazoline|oxymetazoline|mesh-list
92719304|NCT01952990|Tetracaine|tetracaine|mesh-list
92406488|NCT01439152|Immunoconjugates|immunoconjugates|mesh-list
92719305|NCT01952990|Anesthetics, Local|anesthetics, local|mesh-ancestor
92719306|NCT01952990|Anesthetics|anesthetics|mesh-ancestor
92719307|NCT01952990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719308|NCT01952990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719309|NCT01952990|Sensory System Agents|sensory system agents|mesh-ancestor
92719310|NCT01952990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719311|NCT01952990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92719312|NCT01952990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92719313|NCT01952990|Adrenergic Agents|adrenergic agents|mesh-ancestor
92719314|NCT01952990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719315|NCT01952990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719316|NCT01952990|Sympathomimetics|sympathomimetics|mesh-ancestor
92719317|NCT01952990|Autonomic Agents|autonomic agents|mesh-ancestor
92719318|NCT01952990|Nasal Decongestants|nasal decongestants|mesh-ancestor
92719319|NCT01952990|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92719320|NCT01952990|Respiratory System Agents|respiratory system agents|mesh-ancestor
92719321|NCT01952990|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92719322|NCT01952990|Mydriatics|mydriatics|mesh-ancestor
92719323|NCT01952990|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92719324|NCT01952990|Protective Agents|protective agents|mesh-ancestor
92719325|NCT04314310|Tenoxicam|tenoxicam|mesh-list
92719326|NCT04314310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719327|NCT04314310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719328|NCT04314310|Analgesics|analgesics|mesh-ancestor
92719329|NCT04314310|Sensory System Agents|sensory system agents|mesh-ancestor
92719330|NCT04314310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719331|NCT04314310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719332|NCT04314310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719333|NCT04314310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719334|NCT04314310|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92719335|NCT04314310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719336|NCT04314310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719337|NCT04610307|Anesthetics|anesthetics|mesh-list
92719338|NCT04610307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719339|NCT04610307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719340|NCT04610502|Immunoglobulins|immunoglobulins|mesh-list
92719341|NCT04610502|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92719342|NCT04610502|Antibodies|antibodies|mesh-list
92609881|NCT00162318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609882|NCT00404417|Botulinum Toxins|botulinum toxins|mesh-list
92609883|NCT00404417|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92609884|NCT00404417|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92609885|NCT00404417|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92609886|NCT00404417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719343|NCT04610502|Immunologic Factors|immunologic factors|mesh-ancestor
92719344|NCT04610502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719345|NCT01164475|Plerixafor|plerixafor|mesh-list
92719346|NCT01164475|Lenograstim|lenograstim|mesh-list
92719347|NCT01164475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92719348|NCT01164475|Immunologic Factors|immunologic factors|mesh-ancestor
92719349|NCT01164475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719350|NCT01164475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92719351|NCT01164475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92719352|NCT01164475|Antiviral Agents|antiviral agents|mesh-ancestor
92719353|NCT01164475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719366|NCT01941836|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92719367|NCT01941836|Ezetimibe|ezetimibe|mesh-list
92719368|NCT01941836|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92719369|NCT01941836|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92719370|NCT01941836|Antimetabolites|antimetabolites|mesh-ancestor
92719371|NCT01941836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719372|NCT01941836|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92719373|NCT01941836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719374|NCT01941836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92719375|NCT01941836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719376|NCT04629885|Oxytocin|oxytocin|mesh-list
92719377|NCT04629885|Oxytocics|oxytocics|mesh-ancestor
92719378|NCT04629885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92719379|NCT04629885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719380|NCT01163851|Bococizumab|bococizumab|mesh-list
92719381|NCT01163851|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92406568|NCT01439984|Clomipramine|clomipramine|mesh-list
92719382|NCT01163851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92719383|NCT01163851|Antimetabolites|antimetabolites|mesh-ancestor
92719384|NCT01163851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719385|NCT01163851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92719386|NCT01917383|Timolol|timolol|mesh-list
92719387|NCT01917383|Latanoprost|latanoprost|mesh-list
92719388|NCT01917383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92719389|NCT01917383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92719390|NCT01917383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92719391|NCT01917383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719392|NCT01917383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719393|NCT01917383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719394|NCT01917383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92719395|NCT01917383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92719396|NCT01917383|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92719397|NCT01917383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92719398|NCT01163617|Adalimumab|adalimumab|mesh-list
92719399|NCT01163617|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92719400|NCT01163617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719401|NCT01163617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719402|NCT01911767|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92719403|NCT01911767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92719404|NCT01911767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719405|NCT01911767|Immunologic Factors|immunologic factors|mesh-ancestor
92719406|NCT01911767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719407|NCT04629846|Docetaxel|docetaxel|mesh-list
92719408|NCT04629846|Trastuzumab|trastuzumab|mesh-list
92719409|NCT04629846|Pertuzumab|pertuzumab|mesh-list
92719410|NCT04629846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719411|NCT04629846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92719412|NCT04629846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92719413|NCT04629846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92719414|NCT04629846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719415|NCT04629846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719423|NCT01909427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609887|NCT00404417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609888|NCT00404417|Cholinergic Agents|cholinergic agents|mesh-ancestor
92609889|NCT00404417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609890|NCT00404417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090203|NCT01908803|Hormones|hormones|mesh-ancestor
92719424|NCT01909427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719425|NCT01909427|Dermatologic Agents|dermatologic agents|mesh-ancestor
92719426|NCT01909427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719427|NCT01909427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92719428|NCT01909427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719429|NCT01909427|Immunologic Factors|immunologic factors|mesh-ancestor
92719430|NCT01909427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719431|NCT01909427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92719432|NCT04629573|Anesthetics|anesthetics|mesh-list
92719433|NCT04629573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719434|NCT04629573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719435|NCT00564174|Aspirin|aspirin|mesh-list
92719436|NCT00564174|Heparin|heparin|mesh-list
92719437|NCT00564174|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92719438|NCT00564174|Tinzaparin|tinzaparin|mesh-list
92719439|NCT00564174|Dalteparin|dalteparin|mesh-list
92719440|NCT00564174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719441|NCT00564174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719442|NCT00564174|Analgesics|analgesics|mesh-ancestor
92719443|NCT00564174|Sensory System Agents|sensory system agents|mesh-ancestor
92719444|NCT00564174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719445|NCT00564174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719446|NCT00564174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719447|NCT00564174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719448|NCT00564174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92719449|NCT00564174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92719450|NCT00564174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719451|NCT00564174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92719452|NCT00564174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92719453|NCT00564174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719454|NCT00564174|Antipyretics|antipyretics|mesh-ancestor
92719455|NCT00564174|Anticoagulants|anticoagulants|mesh-ancestor
92719456|NCT01163266|Vortioxetine|vortioxetine|mesh-list
92719457|NCT01163266|Antidepressive Agents|antidepressive agents|mesh-ancestor
92719459|NCT01163266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92719460|NCT01163266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92719461|NCT01163266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719462|NCT01163266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719463|NCT01163266|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92719464|NCT01163266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92719465|NCT01163266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719466|NCT01163266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719467|NCT01163266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719468|NCT01163266|Serotonin Agents|serotonin agents|mesh-ancestor
92719469|NCT01163266|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92719470|NCT01163266|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92719471|NCT01163266|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92719472|NCT01163266|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92719473|NCT01873703|Azacitidine|azacitidine|mesh-list
92719474|NCT01873703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719475|NCT01873703|Antimetabolites|antimetabolites|mesh-ancestor
92719476|NCT01873703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719477|NCT01873703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719478|NCT01873703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719479|NCT01870505|Letrozole|letrozole|mesh-list
92719480|NCT01870505|Exemestane|exemestane|mesh-list
92719481|NCT01870505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719482|NCT01870505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92719483|NCT01870505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92719495|NCT00564213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92719496|NCT00564213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719497|NCT00564213|Alkylating Agents|alkylating agents|mesh-ancestor
92719498|NCT00564213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609891|NCT00404417|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92609892|NCT00404417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609893|NCT04519762|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92609894|NCT04519762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719499|NCT00564213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92719500|NCT00564213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719501|NCT01861847|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92719502|NCT01861847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92719503|NCT01861847|Immunologic Factors|immunologic factors|mesh-ancestor
92719504|NCT01861847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719505|NCT00564252|Finasteride|finasteride|mesh-list
92719506|NCT00564252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92719507|NCT00564252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92719508|NCT00564252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719509|NCT00564252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719510|NCT00564252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92719511|NCT00564252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719512|NCT00564252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719513|NCT00564252|Urological Agents|urological agents|mesh-ancestor
92719515|NCT04629144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719516|NCT04629144|Immunologic Factors|immunologic factors|mesh-ancestor
92719517|NCT04629144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719518|NCT04609488|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92719519|NCT04609488|Respiratory System Agents|respiratory system agents|mesh-ancestor
92719520|NCT01847573|Halofuginone|halofuginone|mesh-list
92719521|NCT01847573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719522|NCT01847573|Coccidiostats|coccidiostats|mesh-ancestor
92719523|NCT01847573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92719524|NCT01847573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92719525|NCT01847573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719526|NCT01847573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92719527|NCT01847573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719528|NCT01847573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406714|NCT01440790|Vitamins|vitamins|mesh-list
92719529|NCT01847573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92719530|NCT01847573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92719531|NCT01847573|Growth Substances|growth substances|mesh-ancestor
92719532|NCT01847573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719533|NCT01847573|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719534|NCT04609254|Acetaminophen|acetaminophen|mesh-list
92719535|NCT04609254|Ibuprofen|ibuprofen|mesh-list
92719536|NCT04609254|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92719537|NCT04609254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719538|NCT04609254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719539|NCT04609254|Analgesics|analgesics|mesh-ancestor
92719540|NCT04609254|Sensory System Agents|sensory system agents|mesh-ancestor
92719541|NCT04609254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719542|NCT04609254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719543|NCT04609254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719544|NCT04609254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719560|NCT01846481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719561|NCT01846481|Dopamine Agents|dopamine agents|mesh-ancestor
92719562|NCT01846481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719564|NCT04609293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719565|NCT04609293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92719566|NCT04609293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719567|NCT04609293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719568|NCT04676789|Pegaspargase|pegaspargase|mesh-list
92719569|NCT04676789|Antibodies|antibodies|mesh-list
92719570|NCT04676789|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92719571|NCT04676789|Immunologic Factors|immunologic factors|mesh-ancestor
92719572|NCT04676789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719573|NCT04676789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719574|NCT01811576|Hormones|hormones|mesh-list
92719575|NCT01811576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719576|NCT01811576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719577|NCT01811498|Bevacizumab|bevacizumab|mesh-list
92719578|NCT01811498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719579|NCT01811498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334953|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609895|NCT00162357|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92609896|NCT00162357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92609897|NCT00162357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609899|NCT00404456|Antioxidants|antioxidants|mesh-ancestor
92609900|NCT00404456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609901|NCT00404456|Protective Agents|protective agents|mesh-ancestor
92719580|NCT01811498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92719581|NCT01811498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92719582|NCT01811498|Growth Substances|growth substances|mesh-ancestor
92719583|NCT01811498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719584|NCT01811498|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719585|NCT01804829|Immunoglobulins|immunoglobulins|mesh-list
92719586|NCT01804829|Antibodies|antibodies|mesh-list
92719587|NCT01804829|gamma-Globulins|gamma-globulins|mesh-list
92719588|NCT01804829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92719589|NCT01804829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92719590|NCT01804829|Immunoglobulin G|immunoglobulin g|mesh-list
92719591|NCT01804829|Immunologic Factors|immunologic factors|mesh-ancestor
92719592|NCT01804829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719593|NCT00565422|Escitalopram|escitalopram|mesh-list
92719594|NCT00565422|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92719595|NCT00565422|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92719596|NCT00565422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719597|NCT00565422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719598|NCT00565422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719599|NCT00565422|Serotonin Agents|serotonin agents|mesh-ancestor
92719600|NCT00565422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719601|NCT01802723|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92719602|NCT01802723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92719624|NCT01780844|Mycophenolic Acid|mycophenolic acid|mesh-list
92719625|NCT01780844|Prednisone|prednisone|mesh-list
92719626|NCT01780844|Tacrolimus|tacrolimus|mesh-list
92719627|NCT01780844|Basiliximab|basiliximab|mesh-list
92719628|NCT01780844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719629|NCT01780844|Glucocorticoids|glucocorticoids|mesh-ancestor
92719630|NCT01780844|Hormones|hormones|mesh-ancestor
92719631|NCT01780844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408234|NCT01449344|Antimetabolites|antimetabolites|mesh-ancestor
92719632|NCT01780844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719633|NCT01780844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719634|NCT01780844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719635|NCT01780844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719636|NCT01780844|Immunologic Factors|immunologic factors|mesh-ancestor
92719637|NCT01780844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92719638|NCT01780844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719639|NCT01780844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719640|NCT01780844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92719641|NCT01780844|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92719642|NCT01780844|Antitubercular Agents|antitubercular agents|mesh-ancestor
92719643|NCT01780844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92719644|NCT01780844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719645|NCT01779947|Estradiol|estradiol|mesh-list
92719646|NCT01779947|Estrogens|estrogens|mesh-ancestor
92719647|NCT01779947|Hormones|hormones|mesh-ancestor
92719648|NCT01779947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719649|NCT01779947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719650|NCT00564408|Carbachol|carbachol|mesh-list
92719651|NCT00564408|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92719652|NCT00564408|Miotics|miotics|mesh-ancestor
92719653|NCT00564408|Autonomic Agents|autonomic agents|mesh-ancestor
92719654|NCT00564408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719655|NCT00564408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719656|NCT00564408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92719658|NCT00564408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719659|NCT00564408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719660|NCT00564408|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92609902|NCT00404456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609903|NCT00404456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609904|NCT00404534|Amoxicillin|amoxicillin|mesh-list
92609905|NCT00404534|Clarithromycin|clarithromycin|mesh-list
92609906|NCT00404534|Omeprazole|omeprazole|mesh-list
92609907|NCT00404534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090395|NCT05311228|Azithromycin|azithromycin|mesh-list
92719661|NCT00564408|Analgesics|analgesics|mesh-ancestor
92719662|NCT00564408|Sensory System Agents|sensory system agents|mesh-ancestor
92719663|NCT00564408|Protective Agents|protective agents|mesh-ancestor
92719664|NCT01773785|Docetaxel|docetaxel|mesh-list
92719665|NCT01773785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719666|NCT01773785|Tubulin Modulators|tubulin modulators|mesh-ancestor
92719667|NCT01773785|Antimitotic Agents|antimitotic agents|mesh-ancestor
92719668|NCT01773785|Mitosis Modulators|mitosis modulators|mesh-ancestor
92719669|NCT01773785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719670|NCT01758458|Interferons|interferons|mesh-list
92719671|NCT01758458|Aldesleukin|aldesleukin|mesh-list
92719672|NCT01758458|Interferon-beta|interferon-beta|mesh-list
92719673|NCT01758458|Interleukin-2|interleukin-2|mesh-list
92719674|NCT01758458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406884|NCT01441804|Ribavirin|ribavirin|mesh-list
92719675|NCT01758458|Antiviral Agents|antiviral agents|mesh-ancestor
92719676|NCT01758458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719677|NCT01758458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719678|NCT01758458|Analgesics|analgesics|mesh-ancestor
92719679|NCT01758458|Sensory System Agents|sensory system agents|mesh-ancestor
92719680|NCT01758458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719681|NCT01758458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719682|NCT01758458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92719683|NCT01758458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92719684|NCT01758458|Immunologic Factors|immunologic factors|mesh-ancestor
92719686|NCT04608981|Diclofenac|diclofenac|mesh-list
92719687|NCT04608981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719688|NCT04608981|Glucocorticoids|glucocorticoids|mesh-ancestor
92719689|NCT04608981|Hormones|hormones|mesh-ancestor
92719690|NCT04608981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719691|NCT04608981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719692|NCT04608981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719693|NCT04608981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719694|NCT04608981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719695|NCT04608981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719696|NCT04608981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719697|NCT04608981|Analgesics|analgesics|mesh-ancestor
92719698|NCT04608981|Sensory System Agents|sensory system agents|mesh-ancestor
92719699|NCT04608981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719700|NCT04608981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92719701|NCT04608981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719702|NCT04608981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719703|NCT01737905|Epinephrine|epinephrine|mesh-list
92719704|NCT01737905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92719705|NCT01737905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92719706|NCT01737905|Adrenergic Agents|adrenergic agents|mesh-ancestor
92719707|NCT01737905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719708|NCT01737905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719709|NCT01737905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719710|NCT01737905|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92719711|NCT01737905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92719712|NCT01737905|Autonomic Agents|autonomic agents|mesh-ancestor
92719713|NCT01737905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719714|NCT01737905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92719715|NCT01737905|Respiratory System Agents|respiratory system agents|mesh-ancestor
92719716|NCT01737905|Mydriatics|mydriatics|mesh-ancestor
92719717|NCT01737905|Sympathomimetics|sympathomimetics|mesh-ancestor
92719718|NCT01737905|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92719719|NCT01730027|Montelukast|montelukast|mesh-list
92719720|NCT01730027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92719721|NCT01730027|Respiratory System Agents|respiratory system agents|mesh-ancestor
92719722|NCT01730027|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92719723|NCT01730027|Hormone Antagonists|hormone antagonists|mesh-ancestor
92609909|NCT00404534|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92609910|NCT00404534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92609911|NCT00404534|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92719724|NCT01730027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719725|NCT01730027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719726|NCT01730027|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92719727|NCT01730027|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92719728|NCT01730027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719729|NCT04608669|Acetaminophen|acetaminophen|mesh-list
92719730|NCT04608669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719733|NCT04608669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719734|NCT04608669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719736|NCT00555230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92719737|NCT00555230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92719738|NCT00555230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92719739|NCT00555230|Antimetabolites|antimetabolites|mesh-ancestor
92719740|NCT00555230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719741|NCT00555230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92719742|NCT00555230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92719743|NCT00555230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719744|NCT04600089|Ketamine|ketamine|mesh-list
92719745|NCT04600089|Analgesics|analgesics|mesh-ancestor
92719746|NCT04600089|Sensory System Agents|sensory system agents|mesh-ancestor
92719747|NCT04600089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719748|NCT04600089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719749|NCT04600089|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92719750|NCT04600089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92406934|NCT01441986|Analgesics|analgesics|mesh-ancestor
92719751|NCT04600089|Anesthetics, General|anesthetics, general|mesh-ancestor
92719752|NCT04600089|Anesthetics|anesthetics|mesh-ancestor
92719753|NCT04600089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719754|NCT04600089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92719755|NCT04600089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92719756|NCT04600089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719757|NCT04600089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719758|NCT01704365|Vaccines|vaccines|mesh-list
92719759|NCT01704365|Immunologic Factors|immunologic factors|mesh-ancestor
92396197|NCT01395199|Vasodilator Agents|vasodilator agents|mesh-ancestor
92719760|NCT01704365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719761|NCT01698281|Dexamethasone|dexamethasone|mesh-list
92719762|NCT01698281|Doxorubicin|doxorubicin|mesh-list
92719763|NCT01698281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719764|NCT01698281|Antiemetics|antiemetics|mesh-ancestor
92719765|NCT01698281|Autonomic Agents|autonomic agents|mesh-ancestor
92719766|NCT01698281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719767|NCT01698281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719768|NCT01698281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719769|NCT01698281|Glucocorticoids|glucocorticoids|mesh-ancestor
92719770|NCT01698281|Hormones|hormones|mesh-ancestor
92719771|NCT01698281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719772|NCT01698281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719773|NCT01698281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719774|NCT01698281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92719775|NCT01698281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92719776|NCT01698281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92719777|NCT01698281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719778|NCT01698281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719779|NCT00565461|Vaccines|vaccines|mesh-list
92719780|NCT00565461|Immunologic Factors|immunologic factors|mesh-ancestor
92719781|NCT00565461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719782|NCT01858883|Paclitaxel|paclitaxel|mesh-list
92719783|NCT01858883|Gemcitabine|gemcitabine|mesh-list
92719784|NCT01858883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92719785|NCT01858883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719786|NCT01858883|Tubulin Modulators|tubulin modulators|mesh-ancestor
92719787|NCT01858883|Antimitotic Agents|antimitotic agents|mesh-ancestor
92719788|NCT01858883|Mitosis Modulators|mitosis modulators|mesh-ancestor
92719789|NCT01858883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719790|NCT01858883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92609912|NCT00404534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609913|NCT00404534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609914|NCT00404534|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92719791|NCT01858883|Antimetabolites|antimetabolites|mesh-ancestor
92719792|NCT01697072|Cisplatin|cisplatin|mesh-list
92719793|NCT01697072|Capecitabine|capecitabine|mesh-list
92719794|NCT01697072|Epirubicin|epirubicin|mesh-list
92719795|NCT01697072|Rilotumumab|rilotumumab|mesh-list
92719796|NCT01697072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719797|NCT01697072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719798|NCT01697072|Antimetabolites|antimetabolites|mesh-ancestor
92719799|NCT01697072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719800|NCT01697072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92719801|NCT01697072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92719802|NCT01697072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92719804|NCT01697072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719806|NCT00565500|Celecoxib|celecoxib|mesh-list
92719807|NCT00565500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719808|NCT00565500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719809|NCT00565500|Analgesics|analgesics|mesh-ancestor
92719810|NCT00565500|Sensory System Agents|sensory system agents|mesh-ancestor
92719811|NCT00565500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719812|NCT00565500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719813|NCT00565500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719814|NCT00565500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719815|NCT00565500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92719816|NCT00565500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719817|NCT00565500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719818|NCT00565500|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92719819|NCT04608084|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92719820|NCT04608084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92719821|NCT01691846|Metformin|metformin|mesh-list
92719822|NCT01691846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92719823|NCT01691846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719824|NCT01658501|Metformin|metformin|mesh-list
92719825|NCT01658501|Liraglutide|liraglutide|mesh-list
92719826|NCT01658501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92719827|NCT01658501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719828|NCT01658501|Incretins|incretins|mesh-ancestor
92719829|NCT01658501|Hormones|hormones|mesh-ancestor
92719830|NCT01658501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719831|NCT01651871|Cetirizine|cetirizine|mesh-list
92719832|NCT01651871|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92719833|NCT01651871|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92719834|NCT01651871|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92719835|NCT01651871|Histamine Antagonists|histamine antagonists|mesh-ancestor
92719836|NCT01651871|Histamine Agents|histamine agents|mesh-ancestor
92719837|NCT01651871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719838|NCT01651871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719839|NCT01651871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719840|NCT04608006|Fentanyl|fentanyl|mesh-list
92719841|NCT04608006|Bupivacaine|bupivacaine|mesh-list
92719842|NCT04608006|Anesthetics, Local|anesthetics, local|mesh-ancestor
92719843|NCT04608006|Anesthetics|anesthetics|mesh-ancestor
92719844|NCT04608006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719845|NCT04608006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719846|NCT04608006|Sensory System Agents|sensory system agents|mesh-ancestor
92719847|NCT04608006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719848|NCT04608006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92719849|NCT04608006|Narcotics|narcotics|mesh-ancestor
92719850|NCT04608006|Analgesics|analgesics|mesh-ancestor
92719851|NCT04608006|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92719852|NCT04608006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92719853|NCT04608006|Anesthetics, General|anesthetics, general|mesh-ancestor
92719854|NCT04599621|Uric Acid|uric acid|mesh-list
92719855|NCT04599621|Antioxidants|antioxidants|mesh-ancestor
92719856|NCT04599621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719857|NCT04599621|Protective Agents|protective agents|mesh-ancestor
92719858|NCT04599621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719859|NCT00564525|Amitriptyline|amitriptyline|mesh-list
92719860|NCT00564525|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92719861|NCT00564525|Antidepressive Agents|antidepressive agents|mesh-ancestor
92719862|NCT00564525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92719863|NCT00564525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719864|NCT00564525|Analgesics|analgesics|mesh-ancestor
92719865|NCT00564525|Sensory System Agents|sensory system agents|mesh-ancestor
92719866|NCT00564525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719867|NCT00564525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719868|NCT00564525|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92719869|NCT00564525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92719870|NCT00564525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719871|NCT00564525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719872|NCT00564525|Adrenergic Agents|adrenergic agents|mesh-ancestor
92719873|NCT00564525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719874|NCT04607733|Mirikizumab|mirikizumab|mesh-list
92719875|NCT04607733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92719876|NCT04607733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92719889|NCT01632137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719890|NCT01632137|Protective Agents|protective agents|mesh-ancestor
92719891|NCT01632137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719892|NCT01632137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719893|NCT00565539|Interferons|interferons|mesh-list
92719894|NCT00565539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719895|NCT00565539|Antiviral Agents|antiviral agents|mesh-ancestor
92719896|NCT00565539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92719897|NCT04599699|Androgens|androgens|mesh-list
92719898|NCT04599699|Hormones|hormones|mesh-ancestor
92719899|NCT04599699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719900|NCT04599699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719901|NCT01563731|Antihypertensive Agents|antihypertensive agents|mesh-list
92719902|NCT01563731|Calcium Channel Blockers|calcium channel blockers|mesh-list
92719904|NCT01563731|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92719905|NCT01563731|Simvastatin|simvastatin|mesh-list
92719906|NCT01563731|Pravastatin|pravastatin|mesh-list
92719907|NCT01563731|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92719908|NCT01563731|Diuretics|diuretics|mesh-list
92719909|NCT01563731|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92719910|NCT01563731|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92719911|NCT01563731|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92719912|NCT01563731|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92719913|NCT01563731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92719914|NCT01563731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719915|NCT01563731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92719916|NCT01563731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92719917|NCT01563731|Antimetabolites|antimetabolites|mesh-ancestor
92719918|NCT01563731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719919|NCT01563731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92719920|NCT01563731|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92719921|NCT01563731|Natriuretic Agents|natriuretic agents|mesh-ancestor
92719922|NCT01563731|Protease Inhibitors|protease inhibitors|mesh-ancestor
92719923|NCT01563731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719924|NCT01563731|Hormone Antagonists|hormone antagonists|mesh-ancestor
92719925|NCT01563731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719926|NCT01563731|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92719927|NCT01516346|Hydralazine|hydralazine|mesh-list
92719928|NCT01516346|Isosorbide|isosorbide|mesh-list
92719929|NCT01516346|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92719930|NCT01516346|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92719931|NCT01516346|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92719932|NCT01516346|Diuretics|diuretics|mesh-ancestor
92719933|NCT01516346|Natriuretic Agents|natriuretic agents|mesh-ancestor
92719934|NCT01516346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719935|NCT01516346|Vasodilator Agents|vasodilator agents|mesh-ancestor
92719936|NCT01516346|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92719937|NCT01516346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719938|NCT01516346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92719939|NCT01303796|Decitabine|decitabine|mesh-list
92719940|NCT01303796|Sapacitabine|sapacitabine|mesh-list
92719941|NCT01303796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719943|NCT01303796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719945|NCT01303796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719946|NCT04598880|Magnesium citrate|magnesium citrate|mesh-list
92719947|NCT04598880|Picosulfate sodium|picosulfate sodium|mesh-list
92719948|NCT04598880|Cathartics|cathartics|mesh-ancestor
92719949|NCT04598880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719950|NCT00564564|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92609915|NCT00404534|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92017065|NCT05041907|Ritonavir|ritonavir|mesh-list
92719951|NCT00564564|Clomipramine|clomipramine|mesh-list
92719952|NCT00564564|Antidepressive Agents|antidepressive agents|mesh-ancestor
92719953|NCT00564564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92719954|NCT00564564|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92719955|NCT00564564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92719956|NCT00564564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719957|NCT00564564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719958|NCT00564564|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92719959|NCT00564564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92719960|NCT00564564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92719961|NCT00564564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719962|NCT00564564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719963|NCT00564564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719964|NCT00564564|Serotonin Agents|serotonin agents|mesh-ancestor
92719965|NCT02894138|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92719966|NCT02894138|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92719967|NCT02894138|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92719968|NCT02894138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719969|NCT00565656|Bevacizumab|bevacizumab|mesh-list
92719970|NCT00565656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719971|NCT00565656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719972|NCT00565656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92719973|NCT00565656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92407163|NCT01443065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92719974|NCT00565656|Growth Substances|growth substances|mesh-ancestor
92719975|NCT00565656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719976|NCT00565656|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719977|NCT00564603|Dexamethasone|dexamethasone|mesh-list
92719978|NCT00564603|Dexamethasone acetate|dexamethasone acetate|mesh-list
92719979|NCT00564603|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92719980|NCT00564603|BB 1101|bb 1101|mesh-list
92719981|NCT00564603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719982|NCT00564603|Antiemetics|antiemetics|mesh-ancestor
92719983|NCT00564603|Autonomic Agents|autonomic agents|mesh-ancestor
92719984|NCT00564603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719985|NCT00564603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719986|NCT00564603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719987|NCT00564603|Glucocorticoids|glucocorticoids|mesh-ancestor
92719988|NCT00564603|Hormones|hormones|mesh-ancestor
92719989|NCT00564603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719990|NCT00564603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92719991|NCT00564603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719992|NCT00564603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92719993|NCT00564603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719994|NCT00564603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719995|NCT00555347|Modafinil|modafinil|mesh-list
92719996|NCT00555347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92719997|NCT00555347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719998|NCT00555347|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92719999|NCT00555347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92720000|NCT00555347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92720001|NCT00555347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720002|NCT00564642|Acetylcysteine|acetylcysteine|mesh-list
92720003|NCT00564642|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92720004|NCT00564642|Antiviral Agents|antiviral agents|mesh-ancestor
92720005|NCT00564642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720006|NCT00564642|Expectorants|expectorants|mesh-ancestor
92720007|NCT00564642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92720008|NCT00564642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92720009|NCT00564642|Antioxidants|antioxidants|mesh-ancestor
92720010|NCT00564642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720011|NCT00564642|Protective Agents|protective agents|mesh-ancestor
92720012|NCT00564642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720028|NCT04675697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720029|NCT04675697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720030|NCT04675697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92720031|NCT04675697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92720032|NCT04675697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609916|NCT00404534|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92609917|NCT00505258|Ceftobiprole|ceftobiprole|mesh-list
92609918|NCT00505258|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92609919|NCT00505258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92609920|NCT00505258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609921|NCT00162396|Albuterol|albuterol|mesh-list
92609922|NCT00162396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92609923|NCT00162396|Autonomic Agents|autonomic agents|mesh-ancestor
92609924|NCT00162396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609925|NCT00162396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609926|NCT00162396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92609927|NCT00162396|Respiratory System Agents|respiratory system agents|mesh-ancestor
92609928|NCT00162396|Tocolytic Agents|tocolytic agents|mesh-ancestor
92609929|NCT00162396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92609930|NCT00162396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92609931|NCT00162396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92609932|NCT00162396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92017067|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
92720033|NCT04675697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720034|NCT04606836|Bupivacaine|bupivacaine|mesh-list
92720035|NCT04606836|Anesthetics, Local|anesthetics, local|mesh-ancestor
92720036|NCT04606836|Anesthetics|anesthetics|mesh-ancestor
92720037|NCT04606836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720038|NCT04606836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720039|NCT04606836|Sensory System Agents|sensory system agents|mesh-ancestor
92720040|NCT04606836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720041|NCT01163149|Immunoglobulin G|immunoglobulin g|mesh-list
92720042|NCT01163149|Immunologic Factors|immunologic factors|mesh-ancestor
92720043|NCT01163149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720044|NCT04676126|Dorzolamide|dorzolamide|mesh-list
92720045|NCT04676126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720046|NCT04676126|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92720047|NCT04676126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720048|NCT04676126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720049|NCT04675619|Pirfenidone|pirfenidone|mesh-list
92720050|NCT04675619|Analgesics|analgesics|mesh-ancestor
92720051|NCT04675619|Sensory System Agents|sensory system agents|mesh-ancestor
92720052|NCT04675619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720053|NCT04675619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720054|NCT04675619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92720055|NCT04675619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720056|NCT04675619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720057|NCT04675619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720058|NCT04675619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720059|NCT05305300|Vaccines|vaccines|mesh-list
92720060|NCT05305300|Somatomedin B|somatomedin b|mesh-list
92720061|NCT05305300|Immunologic Factors|immunologic factors|mesh-ancestor
92720062|NCT05305300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720063|NCT05305300|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92720064|NCT05305300|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92720065|NCT05305300|Protease Inhibitors|protease inhibitors|mesh-ancestor
92720066|NCT05305300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720067|NCT05305300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720068|NCT04187755|Ceftazidime|ceftazidime|mesh-list
92720069|NCT04187755|Cefepime|cefepime|mesh-list
92720070|NCT04187755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92720071|NCT04187755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609933|NCT00162396|Adrenergic Agents|adrenergic agents|mesh-ancestor
92609934|NCT00162396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92609935|NCT00162396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609936|NCT00162435|Warfarin|warfarin|mesh-list
92609937|NCT00162435|Anticoagulants|anticoagulants|mesh-ancestor
92609938|NCT04518982|Lenalidomide|lenalidomide|mesh-list
92609939|NCT04518982|Immunologic Factors|immunologic factors|mesh-ancestor
92609940|NCT04518982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609941|NCT04518982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92609942|NCT04518982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92609943|NCT04518982|Growth Substances|growth substances|mesh-ancestor
92609944|NCT04518982|Growth Inhibitors|growth inhibitors|mesh-ancestor
92609945|NCT04518982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720072|NCT00555542|Rituximab|rituximab|mesh-list
92720074|NCT00555542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720076|NCT00555542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720077|NCT00555542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720078|NCT04606563|Losartan|losartan|mesh-list
92720079|NCT04606563|Valsartan|valsartan|mesh-list
92720080|NCT04606563|Telmisartan|telmisartan|mesh-list
92720081|NCT04606563|Candesartan|candesartan|mesh-list
92720082|NCT04606563|Candesartan cilexetil|candesartan cilexetil|mesh-list
92720083|NCT04606563|Olmesartan|olmesartan|mesh-list
92720084|NCT04606563|Irbesartan|irbesartan|mesh-list
92720085|NCT04606563|Eprosartan|eprosartan|mesh-list
92720086|NCT04606563|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92720087|NCT04606563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720088|NCT04606563|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92720089|NCT04606563|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92720090|NCT04606563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720091|NCT04606563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720092|NCT04606563|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92720093|NCT00565968|Sorafenib|sorafenib|mesh-list
92720094|NCT00565968|Melphalan|melphalan|mesh-list
92720095|NCT00565968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720096|NCT00565968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92720097|NCT00565968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720098|NCT00565968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720099|NCT00565968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92720100|NCT00565968|Alkylating Agents|alkylating agents|mesh-ancestor
92720101|NCT00565968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92720102|NCT00565968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720103|NCT00565968|Immunologic Factors|immunologic factors|mesh-ancestor
92720104|NCT00565968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720105|NCT01162486|Rifampin|rifampin|mesh-list
92720106|NCT01162486|Rifapentine|rifapentine|mesh-list
92720107|NCT01162486|Midazolam|midazolam|mesh-list
92720108|NCT01162486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92720109|NCT01162486|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92720110|NCT01162486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720111|NCT01162486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720112|NCT01162486|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92720113|NCT01162486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92720114|NCT01162486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720115|NCT01162486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92720116|NCT01162486|Anesthetics, General|anesthetics, general|mesh-ancestor
92720117|NCT01162486|Anesthetics|anesthetics|mesh-ancestor
92720118|NCT01162486|GABA Modulators|gaba modulators|mesh-ancestor
92720119|NCT01162486|GABA Agents|gaba agents|mesh-ancestor
92720120|NCT01162486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720121|NCT01162486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720122|NCT01162486|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92720123|NCT01162486|Antitubercular Agents|antitubercular agents|mesh-ancestor
92609946|NCT00155376|Morphine|morphine|mesh-list
92609947|NCT00155376|Glucagon|glucagon|mesh-list
92609948|NCT00155376|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92609949|NCT00155376|Narcotics|narcotics|mesh-ancestor
92609950|NCT00155376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609951|NCT00155376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090950|NCT04380220|Protein C|protein c|mesh-list
92720124|NCT01162486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92720125|NCT01162486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720126|NCT01162486|Leprostatic Agents|leprostatic agents|mesh-ancestor
92720127|NCT01162486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92720128|NCT01162486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720129|NCT01162486|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92720130|NCT01162486|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92720131|NCT01162486|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92720132|NCT01162486|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92720133|NCT01162486|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92720134|NCT01162486|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92720135|NCT01162135|Digoxin|digoxin|mesh-list
92720136|NCT01162135|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720137|NCT01162135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92720138|NCT01162135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720139|NCT01162135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720140|NCT01162135|Protective Agents|protective agents|mesh-ancestor
92720141|NCT01162135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720142|NCT00555776|Gabapentin|gabapentin|mesh-list
92720143|NCT00555776|Analgesics|analgesics|mesh-ancestor
92720144|NCT00555776|Sensory System Agents|sensory system agents|mesh-ancestor
92720145|NCT00555776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720146|NCT00555776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720150|NCT00555776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720151|NCT00555776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720152|NCT00555776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92720153|NCT00555776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92720154|NCT00555776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720155|NCT00555776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720156|NCT00555776|Antimanic Agents|antimanic agents|mesh-ancestor
92720157|NCT01161628|Rituximab|rituximab|mesh-list
92720158|NCT01161628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92720159|NCT01161628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720160|NCT01161628|Immunologic Factors|immunologic factors|mesh-ancestor
92720161|NCT01161628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720162|NCT01161628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720163|NCT04314505|Analgesics, Opioid|analgesics, opioid|mesh-list
92720164|NCT04314505|Narcotics|narcotics|mesh-ancestor
92720165|NCT04314505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720166|NCT04314505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720167|NCT04314505|Analgesics|analgesics|mesh-ancestor
92720168|NCT04314505|Sensory System Agents|sensory system agents|mesh-ancestor
92720169|NCT04314505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720170|NCT02885545|Anticoagulants|anticoagulants|mesh-list
92720171|NCT01161472|Alprazolam|alprazolam|mesh-list
92720172|NCT01161472|Fesoterodine|fesoterodine|mesh-list
92720173|NCT01161472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92720174|NCT01161472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720175|NCT01161472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720176|NCT01161472|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92720177|NCT01161472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92720178|NCT01161472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720179|NCT01161472|GABA Modulators|gaba modulators|mesh-ancestor
92720180|NCT01161472|GABA Agents|gaba agents|mesh-ancestor
92720181|NCT01161472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720182|NCT01161472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720183|NCT01161472|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92720184|NCT01161472|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92720185|NCT01161472|Cholinergic Agents|cholinergic agents|mesh-ancestor
92720186|NCT01161472|Urological Agents|urological agents|mesh-ancestor
92720187|NCT04675385|Hyaluronic Acid|hyaluronic acid|mesh-list
92720188|NCT04675385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92609952|NCT00155376|Analgesics|analgesics|mesh-ancestor
92609953|NCT00155376|Sensory System Agents|sensory system agents|mesh-ancestor
92609954|NCT00155376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92609955|NCT00155376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92609956|NCT00155376|Hormones|hormones|mesh-ancestor
92017100|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720189|NCT04675385|Immunologic Factors|immunologic factors|mesh-ancestor
92720190|NCT04675385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720191|NCT04675385|Viscosupplements|viscosupplements|mesh-ancestor
92720192|NCT04675385|Protective Agents|protective agents|mesh-ancestor
92720193|NCT04598061|Dexmedetomidine|dexmedetomidine|mesh-list
92720194|NCT04598061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92720195|NCT04598061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720196|NCT04598061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720197|NCT04598061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720198|NCT04598061|Analgesics|analgesics|mesh-ancestor
92720199|NCT04598061|Sensory System Agents|sensory system agents|mesh-ancestor
92720200|NCT04598061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720201|NCT04598061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92720202|NCT04598061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92720203|NCT04598061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92720204|NCT04598061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720205|NCT04598061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720206|NCT04598061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720207|NCT04674956|Paclitaxel|paclitaxel|mesh-list
92720208|NCT04674956|Gemcitabine|gemcitabine|mesh-list
92720209|NCT04674956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720210|NCT04674956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720211|NCT04674956|Tubulin Modulators|tubulin modulators|mesh-ancestor
92720212|NCT04674956|Antimitotic Agents|antimitotic agents|mesh-ancestor
92720213|NCT04674956|Mitosis Modulators|mitosis modulators|mesh-ancestor
92720214|NCT04674956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720215|NCT04674956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720216|NCT04674956|Antimetabolites|antimetabolites|mesh-ancestor
92720217|NCT00564720|Gemcitabine|gemcitabine|mesh-list
92720218|NCT00564720|Oxaliplatin|oxaliplatin|mesh-list
92720219|NCT00564720|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92720222|NCT00564720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720223|NCT00564720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720224|NCT00564720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92720226|NCT01160770|Clobazam|clobazam|mesh-list
92720227|NCT01160770|Anticonvulsants|anticonvulsants|mesh-ancestor
92720228|NCT01160770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92720229|NCT01160770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92720230|NCT01160770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720231|NCT01160770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720232|NCT01160770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720233|NCT01160770|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92720234|NCT01160770|GABA Agonists|gaba agonists|mesh-ancestor
92720235|NCT01160770|GABA Agents|gaba agents|mesh-ancestor
92720236|NCT01160770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720237|NCT01160770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720238|NCT04632758|Crizotinib|crizotinib|mesh-list
92720239|NCT04632758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720240|NCT04632758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92720241|NCT04632758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720242|NCT04632758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720243|NCT00566046|Levetiracetam|levetiracetam|mesh-list
92720244|NCT00566046|Anticonvulsants|anticonvulsants|mesh-ancestor
92720245|NCT00566046|Nootropic Agents|nootropic agents|mesh-ancestor
92720246|NCT01160614|Oxycodone|oxycodone|mesh-list
92720247|NCT01160614|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92720248|NCT01160614|Narcotics|narcotics|mesh-ancestor
92720249|NCT01160614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720250|NCT01160614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720251|NCT01160614|Analgesics|analgesics|mesh-ancestor
92720252|NCT01160614|Sensory System Agents|sensory system agents|mesh-ancestor
92720253|NCT01160614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720254|NCT00566124|Insulin|insulin|mesh-list
92720255|NCT00566124|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92720256|NCT00566124|Insulin Glargine|insulin glargine|mesh-list
92609957|NCT00155376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609958|NCT00141557|Methyltestosterone|methyltestosterone|mesh-list
92609959|NCT00141557|Estrogens|estrogens|mesh-list
92609960|NCT00141557|Estrogens, Esterified (USP)|estrogens, esterified (usp)|mesh-list
92609961|NCT00141557|Estrone|estrone|mesh-list
92609962|NCT00141557|Testosterone|testosterone|mesh-list
92609963|NCT00141557|Testosterone undecanoate|testosterone undecanoate|mesh-list
92720257|NCT00566124|Insulin Detemir|insulin detemir|mesh-list
92720258|NCT00566124|Isophane Insulin, Human|isophane insulin, human|mesh-list
92720259|NCT00566124|Insulin, Isophane|insulin, isophane|mesh-list
92720260|NCT00566124|Isophane insulin, beef|isophane insulin, beef|mesh-list
92720261|NCT00566124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720262|NCT00566124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720263|NCT01159912|Fluticasone|fluticasone|mesh-list
92720264|NCT01159912|Xhance|xhance|mesh-list
92720265|NCT01159912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720266|NCT01159912|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92720267|NCT01159912|Autonomic Agents|autonomic agents|mesh-ancestor
92720268|NCT01159912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720269|NCT01159912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720270|NCT01159912|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92720271|NCT01159912|Respiratory System Agents|respiratory system agents|mesh-ancestor
92720272|NCT01159912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92720273|NCT01159912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92720274|NCT04606212|Losartan|losartan|mesh-list
92720275|NCT04606212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720276|NCT04606212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720277|NCT04606212|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92720278|NCT04606212|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92720279|NCT04606212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720280|NCT04606017|Calcium Carbonate|calcium carbonate|mesh-list
92720281|NCT04606017|Antacids|antacids|mesh-ancestor
92720282|NCT04606017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720283|NCT04606017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92720284|NCT04631822|Dexamethasone|dexamethasone|mesh-list
92720285|NCT04631822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720286|NCT04631822|Antiemetics|antiemetics|mesh-ancestor
92720287|NCT04631822|Autonomic Agents|autonomic agents|mesh-ancestor
92720288|NCT04631822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720289|NCT04631822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720290|NCT04631822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92720291|NCT04631822|Glucocorticoids|glucocorticoids|mesh-ancestor
92720292|NCT04631822|Hormones|hormones|mesh-ancestor
92720293|NCT04631822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720297|NCT04605705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92720298|NCT04605705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720299|NCT04605705|Analgesics|analgesics|mesh-ancestor
92720300|NCT04605705|Sensory System Agents|sensory system agents|mesh-ancestor
92720301|NCT04605705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720302|NCT04605705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720303|NCT04605705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720304|NCT04605705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720305|NCT00560924|Estradiol|estradiol|mesh-list
92720306|NCT00560924|Estrogens|estrogens|mesh-ancestor
92720307|NCT00560924|Hormones|hormones|mesh-ancestor
92720308|NCT00560924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720309|NCT00560924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720310|NCT00560963|Everolimus|everolimus|mesh-list
92720311|NCT00560963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92720312|NCT00560963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92720313|NCT00560963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720314|NCT00560963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720315|NCT00560963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720316|NCT00560963|Immunologic Factors|immunologic factors|mesh-ancestor
92720317|NCT00560963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720318|NCT00560963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720319|NCT01159600|Empagliflozin|empagliflozin|mesh-list
92720320|NCT01159600|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92609964|NCT00141557|Testosterone enanthate|testosterone enanthate|mesh-list
92609965|NCT00141557|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92609966|NCT00141557|Hormones|hormones|mesh-ancestor
92017111|NCT05674253|Analgesics|analgesics|mesh-ancestor
92720321|NCT01159600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720322|NCT01159600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720323|NCT01159600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720324|NCT04631627|Aspirin|aspirin|mesh-list
92720325|NCT04631627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92720326|NCT04631627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720327|NCT04631627|Analgesics|analgesics|mesh-ancestor
92720328|NCT04631627|Sensory System Agents|sensory system agents|mesh-ancestor
92720329|NCT04631627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720330|NCT04631627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720331|NCT04631627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720332|NCT04631627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720333|NCT04631627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92720334|NCT04631627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92720335|NCT04631627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720336|NCT04631627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92720337|NCT04631627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92720338|NCT04631627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720339|NCT04631627|Antipyretics|antipyretics|mesh-ancestor
92720340|NCT04314193|Prednisolone|prednisolone|mesh-list
92720341|NCT04314193|Methotrexate|methotrexate|mesh-list
92720342|NCT04314193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92720343|NCT04314193|Abortifacient Agents|abortifacient agents|mesh-ancestor
92720344|NCT04314193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92720345|NCT04314193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720346|NCT04314193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720347|NCT04314193|Antimetabolites|antimetabolites|mesh-ancestor
92720348|NCT04314193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720349|NCT04314193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720350|NCT04314193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92720351|NCT04314193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720352|NCT04314193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92720353|NCT04314193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720354|NCT04314193|Immunologic Factors|immunologic factors|mesh-ancestor
92720355|NCT04314193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720356|NCT04314193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92720357|NCT04314193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720358|NCT04314193|Glucocorticoids|glucocorticoids|mesh-ancestor
92720359|NCT04314193|Hormones|hormones|mesh-ancestor
92720360|NCT04314193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720361|NCT04314193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92720362|NCT01159171|Bevacizumab|bevacizumab|mesh-list
92720363|NCT01159171|Capecitabine|capecitabine|mesh-list
92720364|NCT01159171|Oxaliplatin|oxaliplatin|mesh-list
92720369|NCT01159171|Growth Substances|growth substances|mesh-ancestor
92720370|NCT01159171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720371|NCT01159171|Growth Inhibitors|growth inhibitors|mesh-ancestor
92720372|NCT01159171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720373|NCT01159171|Antimetabolites|antimetabolites|mesh-ancestor
92720374|NCT01159171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720375|NCT04631315|Prednisolone|prednisolone|mesh-list
92720376|NCT04631315|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92720377|NCT04631315|Methylprednisolone|methylprednisolone|mesh-list
92720378|NCT04631315|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92720379|NCT04631315|Prednisolone acetate|prednisolone acetate|mesh-list
92720380|NCT04631315|Phenylephrine|phenylephrine|mesh-list
92720381|NCT04631315|Oxymetazoline|oxymetazoline|mesh-list
92720382|NCT04631315|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92720383|NCT04631315|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92720384|NCT04631315|Prednisolone phosphate|prednisolone phosphate|mesh-list
92720385|NCT04631315|Difluprednate|difluprednate|mesh-list
92720386|NCT04631315|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92720387|NCT04631315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720388|NCT04631315|Glucocorticoids|glucocorticoids|mesh-ancestor
92720389|NCT04631315|Hormones|hormones|mesh-ancestor
92720390|NCT04631315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720391|NCT04631315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720392|NCT04631315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92609967|NCT00141557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92609968|NCT00141557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609969|NCT00141557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92720393|NCT04631315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720394|NCT04631315|Antiemetics|antiemetics|mesh-ancestor
92720395|NCT04631315|Autonomic Agents|autonomic agents|mesh-ancestor
92720396|NCT04631315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720397|NCT04631315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92720398|NCT04631315|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92720399|NCT04631315|Protective Agents|protective agents|mesh-ancestor
92720400|NCT04631315|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92720401|NCT04631315|Mydriatics|mydriatics|mesh-ancestor
92720402|NCT04631315|Sympathomimetics|sympathomimetics|mesh-ancestor
92720403|NCT04631315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92720404|NCT04631315|Nasal Decongestants|nasal decongestants|mesh-ancestor
92720405|NCT04631315|Respiratory System Agents|respiratory system agents|mesh-ancestor
92720406|NCT04631315|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92720407|NCT04631315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92720408|NCT04631315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92720409|NCT04631315|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720410|NCT04631315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720411|NCT04631315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720412|NCT04597203|Hydroquinone|hydroquinone|mesh-list
92720413|NCT04597203|Antioxidants|antioxidants|mesh-ancestor
92720414|NCT04597203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720415|NCT04597203|Protective Agents|protective agents|mesh-ancestor
92720416|NCT04597203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720417|NCT04597203|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92720419|NCT01158118|Sargramostim|sargramostim|mesh-list
92720420|NCT01158118|Immunologic Factors|immunologic factors|mesh-ancestor
92720421|NCT01158118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720422|NCT01158118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92720423|NCT01158118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92720424|NCT01158118|Antiviral Agents|antiviral agents|mesh-ancestor
92720425|NCT01158118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720427|NCT02885311|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92720428|NCT02885311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92720429|NCT02885311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720430|NCT02885311|Sensory System Agents|sensory system agents|mesh-ancestor
92720431|NCT02885311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720432|NCT00566241|Mecasermin|mecasermin|mesh-list
92720433|NCT00566241|Growth Substances|growth substances|mesh-ancestor
92720434|NCT00566241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720435|NCT00561119|Paclitaxel|paclitaxel|mesh-list
92720436|NCT00561119|Gemcitabine|gemcitabine|mesh-list
92720437|NCT00561119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720447|NCT00561197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720448|NCT00561197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92720449|NCT00561197|Contraceptive Agents|contraceptive agents|mesh-ancestor
92720450|NCT00561197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92720451|NCT00561197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720452|NCT00561197|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92720453|NCT00561197|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92720454|NCT00561197|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92720456|NCT00564993|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92720457|NCT00564993|Sympathomimetics|sympathomimetics|mesh-ancestor
92720458|NCT00564993|Autonomic Agents|autonomic agents|mesh-ancestor
92720459|NCT00564993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720460|NCT00564993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720461|NCT00564993|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92720462|NCT00564993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92720463|NCT00564993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92720464|NCT00564993|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720465|NCT00564993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720466|NCT00564993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720467|NCT00564993|Protective Agents|protective agents|mesh-ancestor
92720468|NCT04595916|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92720469|NCT04595916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92720470|NCT04595916|Antimetabolites|antimetabolites|mesh-ancestor
92335035|NCT00004807|Topiramate|topiramate|mesh-list
92609970|NCT00141557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92609971|NCT00141557|Anabolic Agents|anabolic agents|mesh-ancestor
92609972|NCT00141557|Androgens|androgens|mesh-ancestor
92091364|NCT01836016|Xhance|xhance|mesh-list
92720471|NCT04595916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720472|NCT04595916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92720473|NCT04604886|Dobutamine|dobutamine|mesh-list
92720474|NCT04604886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92720475|NCT04604886|Sympathomimetics|sympathomimetics|mesh-ancestor
92720476|NCT04604886|Autonomic Agents|autonomic agents|mesh-ancestor
92720477|NCT04604886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720478|NCT04604886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720479|NCT04604886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92720480|NCT04604886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92720481|NCT04604886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92720482|NCT04604886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720483|NCT04604886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720484|NCT04604886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720485|NCT04604886|Protective Agents|protective agents|mesh-ancestor
92720486|NCT04595877|Dipyrone|dipyrone|mesh-list
92720487|NCT04595877|Endorphins|endorphins|mesh-list
92720488|NCT04595877|beta-Endorphin|beta-endorphin|mesh-list
92720489|NCT04595877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92720490|NCT04595877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720491|NCT04595877|Analgesics|analgesics|mesh-ancestor
92720492|NCT04595877|Sensory System Agents|sensory system agents|mesh-ancestor
92720493|NCT04595877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720494|NCT04595877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720495|NCT04595877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720496|NCT04595877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720497|NCT04595877|Antipyretics|antipyretics|mesh-ancestor
92720498|NCT04595877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720499|NCT04595877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407697|NCT01446328|Olanzapine|olanzapine|mesh-list
92720500|NCT00561509|Antidepressive Agents|antidepressive agents|mesh-list
92720501|NCT00561509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720523|NCT00566553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720524|NCT01157182|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92720525|NCT01157182|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92720527|NCT01157182|Norethindrone Acetate|norethindrone acetate|mesh-list
92720528|NCT01157182|Estradiol|estradiol|mesh-list
92720529|NCT01157182|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92720530|NCT01157182|Estrogens|estrogens|mesh-ancestor
92720531|NCT01157182|Hormones|hormones|mesh-ancestor
92720532|NCT01157182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720533|NCT01157182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720534|NCT01157182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92720535|NCT01157182|Contraceptive Agents|contraceptive agents|mesh-ancestor
92720536|NCT01157182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92720537|NCT01157182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92720538|NCT01157182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92720539|NCT01157182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92720540|NCT01157182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92720541|NCT01157065|Ranibizumab|ranibizumab|mesh-list
92720542|NCT01157065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92720543|NCT01157065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92720544|NCT01157065|Growth Substances|growth substances|mesh-ancestor
92720545|NCT01157065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720546|NCT01157065|Growth Inhibitors|growth inhibitors|mesh-ancestor
92720547|NCT01157065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720548|NCT00566592|Ethanol|ethanol|mesh-list
92720549|NCT00566592|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92720550|NCT00566592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720551|NCT00566592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720552|NCT00566592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720553|NCT01156792|Montelukast|montelukast|mesh-list
92720554|NCT01156792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92720555|NCT01156792|Respiratory System Agents|respiratory system agents|mesh-ancestor
92720556|NCT01156792|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92720557|NCT01156792|Hormone Antagonists|hormone antagonists|mesh-ancestor
92720567|NCT04628624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609974|NCT00162474|Warfarin|warfarin|mesh-list
92609975|NCT00162474|Anticoagulants|anticoagulants|mesh-ancestor
92609976|NCT00162474|Anticonvulsants|anticonvulsants|mesh-ancestor
92609977|NCT00162474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92720569|NCT04628624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720570|NCT04604028|Cyclophosphamide|cyclophosphamide|mesh-list
92720571|NCT04604028|Lenalidomide|lenalidomide|mesh-list
92720572|NCT04604028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720573|NCT04604028|Immunologic Factors|immunologic factors|mesh-ancestor
92720574|NCT04604028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720575|NCT04604028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720576|NCT04604028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92720577|NCT04604028|Alkylating Agents|alkylating agents|mesh-ancestor
92720578|NCT04604028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720579|NCT04604028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720580|NCT04604028|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92720581|NCT04604028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92720582|NCT04604028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92720583|NCT04604028|Growth Substances|growth substances|mesh-ancestor
92720584|NCT04604028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92720585|NCT01156480|Hydrocortisone|hydrocortisone|mesh-list
92720586|NCT01156480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720587|NCT00561587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92720588|NCT00561587|Antidepressive Agents|antidepressive agents|mesh-ancestor
92720589|NCT00561587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720590|NCT00561587|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92720591|NCT00561587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92720592|NCT00561587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720593|NCT00561587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720594|NCT01156363|Epoetin Alfa|epoetin alfa|mesh-list
92720595|NCT01156363|Hematinics|hematinics|mesh-ancestor
92720596|NCT02884921|Acetaminophen|acetaminophen|mesh-list
92720597|NCT02884921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720598|NCT02884921|Analgesics|analgesics|mesh-ancestor
92720599|NCT02884921|Sensory System Agents|sensory system agents|mesh-ancestor
92720600|NCT02884921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720601|NCT02884921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720602|NCT02884921|Antipyretics|antipyretics|mesh-ancestor
92720603|NCT00561704|Losartan|losartan|mesh-list
92720604|NCT00561704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720605|NCT00561704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720606|NCT00561704|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92720607|NCT00561704|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92720608|NCT00561704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720609|NCT01156051|Guanfacine|guanfacine|mesh-list
92720610|NCT01156051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720611|NCT01156051|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92720612|NCT01156051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92720613|NCT01156051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92720614|NCT01156051|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720615|NCT01156051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720616|NCT01156051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720617|NCT01156051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720618|NCT04595409|Ustekinumab|ustekinumab|mesh-list
92720619|NCT04595409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92720620|NCT04628000|Vitamin D|vitamin d|mesh-list
92720624|NCT04628000|Micronutrients|micronutrients|mesh-ancestor
92720625|NCT04628000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720626|NCT04628000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92720627|NCT04628000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92720628|NCT01155661|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
92720629|NCT01155661|Serotonin|serotonin|mesh-list
92720630|NCT01155661|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92720631|NCT01155661|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92720632|NCT01155661|Serotonin Agents|serotonin agents|mesh-ancestor
92720633|NCT01155661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720634|NCT01155661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720635|NCT01155661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720636|NCT01155661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92609978|NCT00162474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92609979|NCT00162474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92609980|NCT00162474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609981|NCT00162474|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92609982|NCT00162474|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92609983|NCT04518553|Antiviral Agents|antiviral agents|mesh-list
92720637|NCT01155661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92720638|NCT01155661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92720639|NCT01155661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720640|NCT01155661|Disinfectants|disinfectants|mesh-ancestor
92720641|NCT00565188|Adenosine|adenosine|mesh-list
92720642|NCT00565188|Analgesics|analgesics|mesh-ancestor
92720643|NCT00565188|Sensory System Agents|sensory system agents|mesh-ancestor
92720644|NCT00565188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720645|NCT00565188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720646|NCT00565188|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720647|NCT00565188|Vasodilator Agents|vasodilator agents|mesh-ancestor
92407841|NCT01447095|Epoprostenol|epoprostenol|mesh-list
92720648|NCT00565188|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92720649|NCT00565188|Purinergic Agonists|purinergic agonists|mesh-ancestor
92720650|NCT00565188|Purinergic Agents|purinergic agents|mesh-ancestor
92720651|NCT00565188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720652|NCT00565188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720653|NCT04603833|Docetaxel|docetaxel|mesh-list
92720654|NCT04603833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720655|NCT04603833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92720656|NCT04603833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92720657|NCT04603833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92720658|NCT04603833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720659|NCT04603872|Dasatinib|dasatinib|mesh-list
92720660|NCT04603872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720661|NCT04603872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92720662|NCT04603872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720663|NCT04603872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720664|NCT04603794|Chlorhexidine|chlorhexidine|mesh-list
92720665|NCT04603794|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92720666|NCT04603794|Povidone-Iodine|povidone-iodine|mesh-list
92720667|NCT04603794|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92720668|NCT04603794|Povidone|povidone|mesh-list
92720669|NCT04603794|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92720670|NCT04603794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720671|NCT04603794|Disinfectants|disinfectants|mesh-ancestor
92720672|NCT04603794|Dermatologic Agents|dermatologic agents|mesh-ancestor
92720673|NCT04603794|Plasma Substitutes|plasma substitutes|mesh-ancestor
92720674|NCT04603794|Blood Substitutes|blood substitutes|mesh-ancestor
92720675|NCT01155583|Dexamethasone|dexamethasone|mesh-list
92720676|NCT01155583|Lenalidomide|lenalidomide|mesh-list
92720677|NCT01155583|Azacitidine|azacitidine|mesh-list
92720678|NCT01155583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720679|NCT01155583|Antiemetics|antiemetics|mesh-ancestor
92720680|NCT01155583|Autonomic Agents|autonomic agents|mesh-ancestor
92720681|NCT01155583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720682|NCT01155583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720683|NCT01155583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92720684|NCT01155583|Glucocorticoids|glucocorticoids|mesh-ancestor
92720685|NCT01155583|Hormones|hormones|mesh-ancestor
92720686|NCT01155583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720687|NCT01155583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92720688|NCT01155583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720689|NCT01155583|Immunologic Factors|immunologic factors|mesh-ancestor
92720690|NCT01155583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92720691|NCT01155583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92720692|NCT01155583|Growth Substances|growth substances|mesh-ancestor
92720693|NCT01155583|Growth Inhibitors|growth inhibitors|mesh-ancestor
92720696|NCT01155583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720698|NCT04603131|Vaccines|vaccines|mesh-list
92720699|NCT04603131|Immunologic Factors|immunologic factors|mesh-ancestor
92720700|NCT04603131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720701|NCT04627181|Hydroxocobalamin|hydroxocobalamin|mesh-list
92017128|NCT02500641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92609984|NCT04518553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92609986|NCT00505336|Atorvastatin|atorvastatin|mesh-list
92609987|NCT00505336|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92609988|NCT00505336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92609989|NCT00505336|Antimetabolites|antimetabolites|mesh-ancestor
92609990|NCT00505336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92609991|NCT00505336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92017133|NCT02500641|Analgesics|analgesics|mesh-ancestor
92720702|NCT04627181|Vitamin B 12|vitamin b 12|mesh-list
92720703|NCT04627181|Hematinics|hematinics|mesh-ancestor
92720704|NCT04627181|Vitamin B Complex|vitamin b complex|mesh-ancestor
92720705|NCT04627181|Vitamins|vitamins|mesh-ancestor
92720706|NCT04627181|Micronutrients|micronutrients|mesh-ancestor
92720707|NCT04627181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720708|NCT04626752|Cyclophosphamide|cyclophosphamide|mesh-list
92720709|NCT04626752|Fludarabine|fludarabine|mesh-list
92720710|NCT04626752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720711|NCT04626752|Immunologic Factors|immunologic factors|mesh-ancestor
92720712|NCT04626752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720713|NCT04626752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720714|NCT04626752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92720715|NCT04626752|Alkylating Agents|alkylating agents|mesh-ancestor
92720716|NCT04626752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720717|NCT04626752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720718|NCT04626752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92720719|NCT01155466|Rasagiline|rasagiline|mesh-list
92720720|NCT01155466|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92720721|NCT01155466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720722|NCT01155466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407913|NCT01447589|Antiviral Agents|antiviral agents|mesh-ancestor
92720723|NCT01155466|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92720724|NCT01155466|Protective Agents|protective agents|mesh-ancestor
92720725|NCT01155466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720726|NCT00561899|Piperaquine|piperaquine|mesh-list
92720727|NCT00561899|Amodiaquine|amodiaquine|mesh-list
92720728|NCT00561899|Artenimol|artenimol|mesh-list
92720729|NCT00561899|Antimalarials|antimalarials|mesh-ancestor
92720730|NCT00561899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92720731|NCT00561899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92720732|NCT00561899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720733|NCT01155388|Ferrous fumarate|ferrous fumarate|mesh-list
92720734|NCT01155388|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92720735|NCT01155388|Hematinics|hematinics|mesh-ancestor
92720736|NCT01155388|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92720737|NCT01155388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92720738|NCT01155388|Trace Elements|trace elements|mesh-ancestor
92720739|NCT01155388|Micronutrients|micronutrients|mesh-ancestor
92720740|NCT01155388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720741|NCT00565227|Docetaxel|docetaxel|mesh-list
92720742|NCT00565227|Vorinostat|vorinostat|mesh-list
92720743|NCT00565227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720744|NCT00565227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92720745|NCT00565227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92720746|NCT00565227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92720747|NCT00565227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720748|NCT00565227|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92720749|NCT00565227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720750|NCT04602273|Azacitidine|azacitidine|mesh-list
92720751|NCT04602273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720752|NCT04602273|Antimetabolites|antimetabolites|mesh-ancestor
92720753|NCT04602273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720754|NCT04602273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720755|NCT04602273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720756|NCT04313764|Bupivacaine|bupivacaine|mesh-list
92720757|NCT04313764|Anesthetics, Local|anesthetics, local|mesh-ancestor
92720758|NCT04313764|Anesthetics|anesthetics|mesh-ancestor
92720759|NCT04313764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92609992|NCT00505336|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92609993|NCT00505336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92609994|NCT00505336|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92609995|NCT00505336|Hormone Antagonists|hormone antagonists|mesh-ancestor
92396255|NCT01395589|Vitamin D|vitamin d|mesh-list
92609996|NCT00505336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720760|NCT04313764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720761|NCT04313764|Sensory System Agents|sensory system agents|mesh-ancestor
92720762|NCT04313764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720763|NCT04626089|Metformin|metformin|mesh-list
92720764|NCT04626089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720765|NCT04626089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720766|NCT04601688|Dexamethasone|dexamethasone|mesh-list
92720767|NCT04601688|Bevacizumab|bevacizumab|mesh-list
92720770|NCT04601688|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92720771|NCT04601688|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92720772|NCT04601688|Growth Substances|growth substances|mesh-ancestor
92720773|NCT04601688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720774|NCT04601688|Growth Inhibitors|growth inhibitors|mesh-ancestor
92720775|NCT04601688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720776|NCT04601688|Antiemetics|antiemetics|mesh-ancestor
92720777|NCT04601688|Autonomic Agents|autonomic agents|mesh-ancestor
92720778|NCT04601688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720779|NCT04601688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92720780|NCT04601688|Glucocorticoids|glucocorticoids|mesh-ancestor
92720781|NCT04601688|Hormones|hormones|mesh-ancestor
92720782|NCT04601688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720783|NCT04601688|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92720784|NCT01154452|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92720785|NCT01154452|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92720786|NCT01154452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720787|NCT01154452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720788|NCT04313452|Insulin|insulin|mesh-list
92720789|NCT04313452|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720790|NCT04313452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720791|NCT01154218|Crizotinib|crizotinib|mesh-list
92720792|NCT01154218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720793|NCT01154218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92720794|NCT01154218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720795|NCT01154218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720796|NCT04601142|Methylprednisolone|methylprednisolone|mesh-list
92720797|NCT04601142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92407987|NCT01448239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720798|NCT04601142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92720800|NCT04601142|Prednisolone acetate|prednisolone acetate|mesh-list
92720801|NCT04601142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92720802|NCT04601142|Prednisolone phosphate|prednisolone phosphate|mesh-list
92720803|NCT04601142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720804|NCT04601142|Antiemetics|antiemetics|mesh-ancestor
92720805|NCT04601142|Autonomic Agents|autonomic agents|mesh-ancestor
92720806|NCT04601142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720807|NCT04601142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720808|NCT04601142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92720809|NCT04601142|Glucocorticoids|glucocorticoids|mesh-ancestor
92720810|NCT04601142|Hormones|hormones|mesh-ancestor
92720811|NCT04601142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720812|NCT04601142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92720813|NCT04601142|Protective Agents|protective agents|mesh-ancestor
92720814|NCT04601142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92720815|NCT04601142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720816|NCT04625543|Paclitaxel|paclitaxel|mesh-list
92720817|NCT04625543|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92720818|NCT04625543|Cisplatin|cisplatin|mesh-list
92720819|NCT04625543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720820|NCT04625543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720821|NCT04625543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92720822|NCT04625543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92609997|NCT00505336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92609998|NCT00505336|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92609999|NCT00505336|Diuretics|diuretics|mesh-ancestor
92610000|NCT00505336|Natriuretic Agents|natriuretic agents|mesh-ancestor
92720823|NCT04625543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92720824|NCT04625543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720825|NCT04601259|Salicylic Acid|salicylic acid|mesh-list
92720826|NCT04601259|Salicylates|salicylates|mesh-list
92720827|NCT04601259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396257|NCT01395589|Micronutrients|micronutrients|mesh-ancestor
92720828|NCT04601259|Antifungal Agents|antifungal agents|mesh-ancestor
92720829|NCT04601259|Keratolytic Agents|keratolytic agents|mesh-ancestor
92720830|NCT04601259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92720831|NCT04601259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92720832|NCT04601259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720833|NCT04601259|Analgesics|analgesics|mesh-ancestor
92720834|NCT04601259|Sensory System Agents|sensory system agents|mesh-ancestor
92720835|NCT04601259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720836|NCT04601259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720837|NCT04601259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720838|NCT04601259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720855|NCT04625426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720856|NCT04625114|Gabexate|gabexate|mesh-list
92720857|NCT04625114|Camostat|camostat|mesh-list
92720858|NCT04625114|Protease Inhibitors|protease inhibitors|mesh-ancestor
92720859|NCT04625114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720860|NCT04625114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720861|NCT04625114|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92720862|NCT04625114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92720863|NCT04625114|Anticoagulants|anticoagulants|mesh-ancestor
92720864|NCT00567099|Aripiprazole|aripiprazole|mesh-list
92720865|NCT00567099|Antidepressive Agents|antidepressive agents|mesh-ancestor
92720866|NCT00567099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720867|NCT00567099|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92720868|NCT00567099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92720869|NCT00567099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720870|NCT00567099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720871|NCT00567099|Dopamine Agonists|dopamine agonists|mesh-ancestor
92720872|NCT00567099|Dopamine Agents|dopamine agents|mesh-ancestor
92720873|NCT00567099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720874|NCT00567099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720875|NCT00567099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92720876|NCT00567099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92720877|NCT00567099|Serotonin Agents|serotonin agents|mesh-ancestor
92720878|NCT00567099|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92720879|NCT00567099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92720880|NCT00567099|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92720881|NCT00567099|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92720882|NCT00567177|Cyclosporine|cyclosporine|mesh-list
92720883|NCT00567177|Cyclosporins|cyclosporins|mesh-list
92720884|NCT00567177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720885|NCT00567177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720886|NCT00567177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720887|NCT00567177|Immunologic Factors|immunologic factors|mesh-ancestor
92720888|NCT00567177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720889|NCT00567177|Antifungal Agents|antifungal agents|mesh-ancestor
92720890|NCT00567177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720891|NCT00567177|Dermatologic Agents|dermatologic agents|mesh-ancestor
92720892|NCT00567177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720893|NCT00567177|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92720894|NCT00567216|Nadolol|nadolol|mesh-list
92720895|NCT00567216|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92720896|NCT00567216|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92720897|NCT00567216|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720898|NCT00567216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720909|NCT00562055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92720910|NCT00562055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92720911|NCT00562055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720912|NCT00562055|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720913|NCT00562055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720914|NCT00562055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610001|NCT00505336|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92610002|NCT04518202|Lidocaine|lidocaine|mesh-list
92610003|NCT04518202|Anesthetics, Local|anesthetics, local|mesh-ancestor
92610004|NCT04518202|Anesthetics|anesthetics|mesh-ancestor
92610005|NCT04518202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610006|NCT04518202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720915|NCT00562055|Antidepressive Agents|antidepressive agents|mesh-ancestor
92720916|NCT00562055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92720917|NCT04624217|Paclitaxel|paclitaxel|mesh-list
92720918|NCT04624217|Gemcitabine|gemcitabine|mesh-list
92720919|NCT04624217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720920|NCT04624217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720921|NCT04624217|Tubulin Modulators|tubulin modulators|mesh-ancestor
92720922|NCT04624217|Antimitotic Agents|antimitotic agents|mesh-ancestor
92720923|NCT04624217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92720924|NCT04624217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720925|NCT04624217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720926|NCT04624217|Antimetabolites|antimetabolites|mesh-ancestor
92720927|NCT04623866|Valsartan|valsartan|mesh-list
92720928|NCT04623866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720929|NCT04623866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92720930|NCT04623866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92720931|NCT04623866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720932|NCT00567372|Bevacizumab|bevacizumab|mesh-list
92720933|NCT00567372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92720934|NCT00567372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720935|NCT00567372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92720936|NCT00567372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92720937|NCT00567372|Growth Substances|growth substances|mesh-ancestor
92720938|NCT00567372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720939|NCT00567372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92720940|NCT00562133|Insulin|insulin|mesh-list
92720941|NCT00562133|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92720942|NCT00562133|Insulin glulisine|insulin glulisine|mesh-list
92720943|NCT00562133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720944|NCT00562133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720945|NCT00567411|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92720946|NCT00567411|Apraclonidine|apraclonidine|mesh-list
92720947|NCT00567411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720948|NCT00567411|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92720949|NCT00567411|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92720950|NCT00567411|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92720951|NCT00567411|Adrenergic Agents|adrenergic agents|mesh-ancestor
92720952|NCT00567411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720953|NCT00567411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720954|NCT00567411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720956|NCT00562172|Insulin Glargine|insulin glargine|mesh-list
92720957|NCT00562172|Glimepiride|glimepiride|mesh-list
92720958|NCT00562172|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720959|NCT00562172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720960|NCT00562172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720961|NCT00562172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92720962|NCT00562172|Immunologic Factors|immunologic factors|mesh-ancestor
92720963|NCT00567450|Ropivacaine|ropivacaine|mesh-list
92720976|NCT00567528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720977|NCT00567528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720978|NCT00567528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92720979|NCT00567528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92720980|NCT00567528|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92720981|NCT00567528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720982|NCT00567528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720983|NCT00567606|Risedronic Acid|risedronic acid|mesh-list
92720984|NCT00567606|Calcium|calcium|mesh-list
92720985|NCT00567606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92720986|NCT00567606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720987|NCT00567606|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92720988|NCT00567606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92720989|NCT00567606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610007|NCT04518202|Sensory System Agents|sensory system agents|mesh-ancestor
92396268|NCT01395654|Rifampin|rifampin|mesh-list
92610008|NCT04518202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610009|NCT04518202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92610010|NCT04518202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92720990|NCT00567606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92720991|NCT04590612|Levodopa|levodopa|mesh-list
92720992|NCT04590612|Carbidopa|carbidopa|mesh-list
92720993|NCT04590612|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92720994|NCT04590612|Citalopram|citalopram|mesh-list
92720995|NCT04590612|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92720996|NCT04590612|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92720997|NCT04590612|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92720998|NCT04590612|Dopamine Agents|dopamine agents|mesh-ancestor
92720999|NCT04590612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721000|NCT04590612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721001|NCT04590612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721002|NCT04590612|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92721003|NCT04590612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721004|NCT04590612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92721005|NCT04590612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92721006|NCT04590612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721007|NCT04590612|Serotonin Agents|serotonin agents|mesh-ancestor
92721008|NCT04590612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92721009|NCT04590612|Antidepressive Agents|antidepressive agents|mesh-ancestor
92721010|NCT04590612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721011|NCT04590612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92721012|NCT04590612|Immunologic Factors|immunologic factors|mesh-ancestor
92721013|NCT04590612|Dopamine Agonists|dopamine agonists|mesh-ancestor
92721014|NCT00562250|Dapagliflozin|dapagliflozin|mesh-list
92721015|NCT00562250|Glimepiride|glimepiride|mesh-list
92721016|NCT00562250|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92721017|NCT00562250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721018|NCT00562250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721019|NCT00562250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721020|NCT00562250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92721021|NCT00562250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721022|NCT00562250|Immunologic Factors|immunologic factors|mesh-ancestor
92721023|NCT00562289|Aspirin|aspirin|mesh-list
92721024|NCT00562289|Dipyridamole|dipyridamole|mesh-list
92721025|NCT00562289|Rivaroxaban|rivaroxaban|mesh-list
92721035|NCT00562289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721036|NCT00562289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721037|NCT00562289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721038|NCT00562289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92721039|NCT00562289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92721040|NCT00562289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721041|NCT00562289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92721042|NCT00562289|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92721043|NCT00562289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721044|NCT00562289|Antipyretics|antipyretics|mesh-ancestor
92721045|NCT00562289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92721046|NCT00562289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92721047|NCT00562289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92721048|NCT00562289|Purinergic Agents|purinergic agents|mesh-ancestor
92721049|NCT00562289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721050|NCT00562289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92721051|NCT00562289|Antithrombins|antithrombins|mesh-ancestor
92721052|NCT00562289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92721053|NCT00562289|Protease Inhibitors|protease inhibitors|mesh-ancestor
92721054|NCT00562289|Anticoagulants|anticoagulants|mesh-ancestor
92721055|NCT00562289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92721056|NCT00562289|Vasodilator Agents|vasodilator agents|mesh-ancestor
92721057|NCT04313218|Misoprostol|misoprostol|mesh-list
92721058|NCT04313218|Carbetocin|carbetocin|mesh-list
92396277|NCT01395654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721059|NCT04313218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92721060|NCT04313218|Abortifacient Agents|abortifacient agents|mesh-ancestor
92721061|NCT04313218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92721062|NCT04313218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610011|NCT04518202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92610012|NCT04518202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017154|NCT04973293|Growth Substances|growth substances|mesh-ancestor
92721063|NCT04313218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92721064|NCT04313218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721065|NCT04313218|Oxytocics|oxytocics|mesh-ancestor
92721066|NCT00624871|Ascorbic Acid|ascorbic acid|mesh-list
92721067|NCT00624871|Ibuprofen|ibuprofen|mesh-list
92721068|NCT00624871|Vitamins|vitamins|mesh-ancestor
92721069|NCT00624871|Micronutrients|micronutrients|mesh-ancestor
92721070|NCT00624871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721071|NCT00624871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92721072|NCT00624871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92721073|NCT00624871|Analgesics|analgesics|mesh-ancestor
92721074|NCT00624871|Sensory System Agents|sensory system agents|mesh-ancestor
92721075|NCT00624871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721076|NCT00624871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721077|NCT00624871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721078|NCT00624871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92721079|NCT00624871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721080|NCT00624871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721081|NCT00624871|Antioxidants|antioxidants|mesh-ancestor
92721082|NCT00624871|Protective Agents|protective agents|mesh-ancestor
92721083|NCT01153984|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92721084|NCT01153984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721085|NCT01153984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721086|NCT01153984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721087|NCT01153984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721088|NCT04590183|Prednisolone|prednisolone|mesh-list
92721089|NCT04590183|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92721090|NCT04590183|Methylprednisolone|methylprednisolone|mesh-list
92721091|NCT04590183|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92721092|NCT04590183|Prednisolone acetate|prednisolone acetate|mesh-list
92721093|NCT04590183|Tacrolimus|tacrolimus|mesh-list
92721094|NCT04590183|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92721106|NCT04590183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92721107|NCT04590183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721108|NCT04590183|Antiemetics|antiemetics|mesh-ancestor
92721109|NCT04590183|Autonomic Agents|autonomic agents|mesh-ancestor
92721110|NCT04590183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721111|NCT04590183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721112|NCT04590183|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92721113|NCT04590183|Protective Agents|protective agents|mesh-ancestor
92721114|NCT04622618|Gabapentin|gabapentin|mesh-list
92721115|NCT04622618|Analgesics|analgesics|mesh-ancestor
92721116|NCT04622618|Sensory System Agents|sensory system agents|mesh-ancestor
92721117|NCT04622618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721118|NCT04622618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721119|NCT04622618|Anticonvulsants|anticonvulsants|mesh-ancestor
92721120|NCT04622618|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92721121|NCT04622618|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92721122|NCT04622618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721123|NCT04622618|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721124|NCT04622618|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92721125|NCT04622618|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92721126|NCT04622618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396286|NCT01395654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92721127|NCT04622618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721128|NCT04622618|Antimanic Agents|antimanic agents|mesh-ancestor
92721129|NCT04622891|Azithromycin|azithromycin|mesh-list
92721130|NCT04622891|Clarithromycin|clarithromycin|mesh-list
92721131|NCT04622891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92721132|NCT04622891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721133|NCT04622891|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92721134|NCT04622891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721135|NCT04622891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721136|NCT04622891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92721137|NCT04622891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92721138|NCT04622579|Rituximab|rituximab|mesh-list
92721139|NCT04622579|Lenalidomide|lenalidomide|mesh-list
92721140|NCT04622579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721141|NCT04622579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721142|NCT04622579|Immunologic Factors|immunologic factors|mesh-ancestor
92721143|NCT04622579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610013|NCT04518202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610014|NCT04517890|Lidocaine|lidocaine|mesh-list
92721144|NCT04622579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721145|NCT04622579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92721146|NCT04622579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721147|NCT04622579|Growth Substances|growth substances|mesh-ancestor
92721148|NCT04622579|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721149|NCT01153009|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92721150|NCT01153009|Vortioxetine|vortioxetine|mesh-list
92721151|NCT01153009|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92721152|NCT01153009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92721153|NCT01153009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721154|NCT01153009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721163|NCT01153009|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92721164|NCT01153009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92721165|NCT01153009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721166|NCT01153009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92721167|NCT01153009|Serotonin Agents|serotonin agents|mesh-ancestor
92721168|NCT01153009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92721169|NCT01153009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92721170|NCT01153009|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92721171|NCT01153009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92721173|NCT04622111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721174|NCT04622111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721175|NCT04622033|Brodalumab|brodalumab|mesh-list
92721176|NCT04622033|Dermatologic Agents|dermatologic agents|mesh-ancestor
92721177|NCT01152580|Melatonin|melatonin|mesh-list
92721178|NCT01152580|Antioxidants|antioxidants|mesh-ancestor
92721179|NCT01152580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721180|NCT01152580|Protective Agents|protective agents|mesh-ancestor
92721181|NCT01152580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721182|NCT01152580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721183|NCT04621799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92721184|NCT04621799|Hemostatics|hemostatics|mesh-ancestor
92721185|NCT04621799|Coagulants|coagulants|mesh-ancestor
92721186|NCT04621370|Capecitabine|capecitabine|mesh-list
92721187|NCT04621370|Durvalumab|durvalumab|mesh-list
92721188|NCT04621370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92721189|NCT04621370|Antimetabolites|antimetabolites|mesh-ancestor
92721190|NCT04621370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721191|NCT04621370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721192|NCT04621370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721193|NCT04589130|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
92721194|NCT04589130|Naltrexone|naltrexone|mesh-list
92721195|NCT04589130|Bupropion|bupropion|mesh-list
92721196|NCT04589130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92721197|NCT04589130|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92721198|NCT04589130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721199|NCT04589130|Sensory System Agents|sensory system agents|mesh-ancestor
92721200|NCT04589130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721201|NCT04589130|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92721202|NCT04589130|Antidepressive Agents|antidepressive agents|mesh-ancestor
92396302|NCT01395667|Vitamins|vitamins|mesh-ancestor
92721203|NCT04589130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721204|NCT04589130|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92721205|NCT04589130|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92721206|NCT04589130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721207|NCT04589130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721208|NCT04589130|Dopamine Agents|dopamine agents|mesh-ancestor
92721209|NCT04589130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721210|NCT04589130|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92721211|NCT04589130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92721212|NCT04589130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721213|NCT04589130|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92721214|NCT04621487|Amoxicillin|amoxicillin|mesh-list
92721215|NCT04621487|Metronidazole|metronidazole|mesh-list
92721216|NCT04621487|Clarithromycin|clarithromycin|mesh-list
92721217|NCT04621487|Pantoprazole|pantoprazole|mesh-list
92721218|NCT04621487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92721219|NCT04621487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721220|NCT04621487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92721221|NCT04621487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92610015|NCT04517890|Anesthetics, Local|anesthetics, local|mesh-ancestor
92610016|NCT04517890|Anesthetics|anesthetics|mesh-ancestor
92610017|NCT04517890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721222|NCT04621487|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92721224|NCT04621487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721225|NCT04621487|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92721226|NCT04621487|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92721227|NCT04621487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92721228|NCT04621487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721229|NCT04621487|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92721231|NCT01152190|Vasodilator Agents|vasodilator agents|mesh-ancestor
92721232|NCT01152190|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92721233|NCT01152190|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92721234|NCT01152190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721235|NCT01152190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721236|NCT01152190|Urological Agents|urological agents|mesh-ancestor
92721237|NCT04621565|Hydrocortisone|hydrocortisone|mesh-list
92721238|NCT04621565|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92721239|NCT04621565|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92721240|NCT04621565|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92721241|NCT04621565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721242|NCT01151410|Enalapril|enalapril|mesh-list
92721243|NCT01151410|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92721244|NCT01151410|Protease Inhibitors|protease inhibitors|mesh-ancestor
92721245|NCT01151410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721246|NCT01151410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721247|NCT01151410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92721248|NCT00562406|Ranibizumab|ranibizumab|mesh-list
92721249|NCT00562406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92721250|NCT00562406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721251|NCT00562406|Growth Substances|growth substances|mesh-ancestor
92721252|NCT00562406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721253|NCT00562406|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721254|NCT00562406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721255|NCT04621409|Anti-Infective Agents|anti-infective agents|mesh-list
92721256|NCT04621409|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92721258|NCT04588935|Perindopril|perindopril|mesh-list
92721259|NCT04588935|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92721260|NCT04588935|Sympatholytics|sympatholytics|mesh-ancestor
92721261|NCT04588935|Autonomic Agents|autonomic agents|mesh-ancestor
92721262|NCT04588935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721263|NCT04588935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396308|NCT01395849|Fluticasone|fluticasone|mesh-list
92721264|NCT04588935|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92721265|NCT04588935|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92721266|NCT04588935|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92721267|NCT04588935|Adrenergic Agents|adrenergic agents|mesh-ancestor
92721268|NCT04588935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721269|NCT04588935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721270|NCT04588935|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92721271|NCT04588935|Protease Inhibitors|protease inhibitors|mesh-ancestor
92721272|NCT04588935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721273|NCT00562523|Sorafenib|sorafenib|mesh-list
92721274|NCT00562523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721275|NCT00562523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721276|NCT00562523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721277|NCT00562523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721278|NCT00562640|Cyclophosphamide|cyclophosphamide|mesh-list
92721279|NCT00562640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721280|NCT00562640|Immunologic Factors|immunologic factors|mesh-ancestor
92721281|NCT00562640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721282|NCT00562640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721283|NCT00562640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92721284|NCT00562640|Alkylating Agents|alkylating agents|mesh-ancestor
92721285|NCT00562640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721286|NCT00562640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721287|NCT00562640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92721288|NCT04649697|Clobetasol|clobetasol|mesh-list
92721289|NCT04649697|Rebamipide|rebamipide|mesh-list
92721290|NCT04649697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721291|NCT04649697|Glucocorticoids|glucocorticoids|mesh-ancestor
92610018|NCT04517890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610019|NCT04517890|Sensory System Agents|sensory system agents|mesh-ancestor
92721292|NCT04649697|Hormones|hormones|mesh-ancestor
92721293|NCT04649697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721294|NCT04649697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721295|NCT04649697|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92721299|NCT04649697|Protective Agents|protective agents|mesh-ancestor
92721300|NCT04649697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721301|NCT04649502|Metformin|metformin|mesh-list
92721302|NCT04649502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721303|NCT04649502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721304|NCT04621253|Dipyrone|dipyrone|mesh-list
92721305|NCT04621253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92721306|NCT04621253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92721307|NCT04621253|Analgesics|analgesics|mesh-ancestor
92721308|NCT04621253|Sensory System Agents|sensory system agents|mesh-ancestor
92721309|NCT04621253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721310|NCT04621253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721311|NCT04621253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721312|NCT04621253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721313|NCT04621253|Antipyretics|antipyretics|mesh-ancestor
92721314|NCT00567762|Tacrolimus|tacrolimus|mesh-list
92721315|NCT00567762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721316|NCT00567762|Immunologic Factors|immunologic factors|mesh-ancestor
92721317|NCT00567762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721318|NCT00567762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92408518|NCT05964114|Vancomycin|vancomycin|mesh-list
92721319|NCT00567762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721320|NCT00567762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721321|NCT04620785|Methylene Blue|methylene blue|mesh-list
92721322|NCT04620785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396317|NCT01395849|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721323|NCT04620785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721324|NCT04620590|Dapagliflozin|dapagliflozin|mesh-list
92721325|NCT04620590|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92721326|NCT04620590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721327|NCT04620590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721328|NCT04620590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721329|NCT04691063|Carboplatin|carboplatin|mesh-list
92721330|NCT04691063|Etoposide|etoposide|mesh-list
92721331|NCT04691063|Etoposide phosphate|etoposide phosphate|mesh-list
92721332|NCT04691063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721333|NCT04691063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92721334|NCT04691063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92721335|NCT04691063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92721336|NCT04691063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721337|NCT04691063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721338|NCT01151215|Anastrozole|anastrozole|mesh-list
92721339|NCT01151215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92721340|NCT01151215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721341|NCT01151215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92721342|NCT01151215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92721343|NCT01151215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721344|NCT01151215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721345|NCT01151215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92721346|NCT01151215|Hormone Antagonists|hormone antagonists|mesh-ancestor
92721347|NCT01151215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721348|NCT01151215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721349|NCT04588389|Lidocaine|lidocaine|mesh-list
92721350|NCT04588389|Ropivacaine|ropivacaine|mesh-list
92721351|NCT04588389|Anesthetics, Local|anesthetics, local|mesh-ancestor
92721352|NCT04588389|Anesthetics|anesthetics|mesh-ancestor
92721353|NCT04588389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721354|NCT04588389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721355|NCT04588389|Sensory System Agents|sensory system agents|mesh-ancestor
92721356|NCT04588389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721357|NCT04588389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92721358|NCT04588389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92721359|NCT04588389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92721360|NCT04588389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721361|NCT04588389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721362|NCT00637234|Oxcarbazepine|oxcarbazepine|mesh-list
92721363|NCT00637234|Anticonvulsants|anticonvulsants|mesh-ancestor
92721364|NCT00637234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92721367|NCT00637234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721368|NCT00637234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92721369|NCT00637234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92721370|NCT04588194|Dexamethasone|dexamethasone|mesh-list
92721371|NCT04588194|Rituximab|rituximab|mesh-list
92721372|NCT04588194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721373|NCT04588194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721374|NCT04588194|Immunologic Factors|immunologic factors|mesh-ancestor
92721375|NCT04588194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721376|NCT04588194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721377|NCT04588194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721378|NCT04588194|Antiemetics|antiemetics|mesh-ancestor
92721379|NCT04588194|Autonomic Agents|autonomic agents|mesh-ancestor
92721380|NCT04588194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721381|NCT04588194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721382|NCT04588194|Glucocorticoids|glucocorticoids|mesh-ancestor
92721383|NCT04588194|Hormones|hormones|mesh-ancestor
92721384|NCT04588194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721385|NCT04588194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92721386|NCT02940314|Solifenacin Succinate|solifenacin succinate|mesh-list
92721387|NCT02940314|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92721388|NCT02940314|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92721389|NCT02940314|Cholinergic Agents|cholinergic agents|mesh-ancestor
92721390|NCT02940314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721391|NCT02940314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721392|NCT02940314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721393|NCT02940314|Urological Agents|urological agents|mesh-ancestor
92721394|NCT04581213|Anesthetics|anesthetics|mesh-list
92721395|NCT04581213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721396|NCT04581213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721397|NCT01151137|Dronedarone|dronedarone|mesh-list
92721398|NCT01151137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92721399|NCT01151098|Buprenorphine|buprenorphine|mesh-list
92721400|NCT01151098|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92721401|NCT01151098|Narcotics|narcotics|mesh-ancestor
92721402|NCT01151098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721403|NCT01151098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721404|NCT01151098|Analgesics|analgesics|mesh-ancestor
92721405|NCT01151098|Sensory System Agents|sensory system agents|mesh-ancestor
92721406|NCT01151098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721407|NCT01151098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92721408|NCT04587843|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
92721409|NCT04587843|Naltrexone|naltrexone|mesh-list
92721410|NCT04587843|Bupropion|bupropion|mesh-list
92721411|NCT04587843|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92721412|NCT04587843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92721413|NCT04587843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721414|NCT04587843|Sensory System Agents|sensory system agents|mesh-ancestor
92721415|NCT04587843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721416|NCT04587843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92721417|NCT04587843|Antidepressive Agents|antidepressive agents|mesh-ancestor
92721418|NCT04587843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721419|NCT04587843|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92721420|NCT04587843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92721421|NCT04587843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721422|NCT04587843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721423|NCT04587843|Dopamine Agents|dopamine agents|mesh-ancestor
92721424|NCT04587843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721425|NCT04587843|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92721426|NCT04587843|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92721427|NCT04587843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721428|NCT04587843|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92721429|NCT04619303|Dexamethasone|dexamethasone|mesh-list
92721430|NCT04619303|Bevacizumab|bevacizumab|mesh-list
92721431|NCT04619303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721432|NCT04619303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721433|NCT04619303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92610021|NCT04517890|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92610022|NCT04517890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92610023|NCT04517890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92721434|NCT04619303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721435|NCT04619303|Growth Substances|growth substances|mesh-ancestor
92721446|NCT04619303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92721447|NCT04619537|Docetaxel|docetaxel|mesh-list
92721448|NCT04619537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721449|NCT04619537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92721450|NCT04619537|Antimitotic Agents|antimitotic agents|mesh-ancestor
92721451|NCT04619537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92721452|NCT04619537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721453|NCT04619381|Clopidogrel|clopidogrel|mesh-list
92721454|NCT04619381|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92721455|NCT04619381|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92721456|NCT04619381|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92721457|NCT04619381|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92721458|NCT04619381|Purinergic Agents|purinergic agents|mesh-ancestor
92721459|NCT04619381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721460|NCT04619381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721461|NCT04619381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721462|NCT00568503|Bromides|bromides|mesh-list
92721463|NCT00568503|Tiotropium Bromide|tiotropium bromide|mesh-list
92721464|NCT00568503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92721465|NCT00568503|Autonomic Agents|autonomic agents|mesh-ancestor
92721466|NCT00568503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721467|NCT00568503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721468|NCT00568503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92721469|NCT00568503|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721470|NCT00568503|Parasympatholytics|parasympatholytics|mesh-ancestor
92721471|NCT00568503|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92721472|NCT00568503|Cholinergic Agents|cholinergic agents|mesh-ancestor
92721473|NCT00568503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721474|NCT00568503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721475|NCT00568503|Anticonvulsants|anticonvulsants|mesh-ancestor
92721476|NCT00568542|Epoetin Alfa|epoetin alfa|mesh-list
92721477|NCT00568542|Hematinics|hematinics|mesh-ancestor
92721478|NCT00562835|Thiamine|thiamine|mesh-list
92721479|NCT00562835|Methylprednisolone|methylprednisolone|mesh-list
92721480|NCT00562835|Vitamins|vitamins|mesh-ancestor
92721481|NCT00562835|Micronutrients|micronutrients|mesh-ancestor
92721482|NCT00562835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721483|NCT00562835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721484|NCT00562835|Antiemetics|antiemetics|mesh-ancestor
92721485|NCT00562835|Autonomic Agents|autonomic agents|mesh-ancestor
92721486|NCT00562835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721487|NCT00562835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721488|NCT00562835|Glucocorticoids|glucocorticoids|mesh-ancestor
92721489|NCT00562835|Hormones|hormones|mesh-ancestor
92721490|NCT00562835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721491|NCT00562835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92721492|NCT00562835|Protective Agents|protective agents|mesh-ancestor
92721493|NCT00562835|Vitamin B Complex|vitamin b complex|mesh-ancestor
92721494|NCT00568737|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92721495|NCT00568737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721496|NCT04587141|Ferric gluconate|ferric gluconate|mesh-list
92721497|NCT04587141|Hematinics|hematinics|mesh-ancestor
92721498|NCT04586790|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92721499|NCT04586790|Epinephrine|epinephrine|mesh-list
92721500|NCT04586790|Racepinephrine|racepinephrine|mesh-list
92721501|NCT04586790|Midodrine|midodrine|mesh-list
92721502|NCT04586790|Norepinephrine|norepinephrine|mesh-list
92721506|NCT04586790|Adrenergic Agents|adrenergic agents|mesh-ancestor
92721507|NCT04586790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721508|NCT04586790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721509|NCT04586790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721510|NCT04586790|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92721511|NCT04586790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92721512|NCT04586790|Autonomic Agents|autonomic agents|mesh-ancestor
92721513|NCT04586790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721514|NCT04586790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92721515|NCT04586790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721516|NCT04586790|Mydriatics|mydriatics|mesh-ancestor
92610024|NCT04517890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610025|NCT04517890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610027|NCT00141596|Furosemide|furosemide|mesh-list
92610028|NCT00141596|Diuretics|diuretics|mesh-ancestor
92721517|NCT04586790|Sympathomimetics|sympathomimetics|mesh-ancestor
92721518|NCT04586790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92721519|NCT04586790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92721520|NCT04586790|Hemostatics|hemostatics|mesh-ancestor
92721521|NCT04586790|Coagulants|coagulants|mesh-ancestor
92721522|NCT04586790|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92721523|NCT04586790|Natriuretic Agents|natriuretic agents|mesh-ancestor
92721524|NCT00568815|Rituximab|rituximab|mesh-list
92721525|NCT00568815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721526|NCT00568815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396349|NCT01395862|Hormones|hormones|mesh-ancestor
92721527|NCT00568815|Immunologic Factors|immunologic factors|mesh-ancestor
92721528|NCT00568815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721529|NCT00568815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721530|NCT00568893|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92721531|NCT00568893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721532|NCT00568971|Docetaxel|docetaxel|mesh-list
92721533|NCT00568971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721534|NCT00568971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92721535|NCT00568971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92721536|NCT00568971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92721537|NCT00568971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721538|NCT00562913|Sorafenib|sorafenib|mesh-list
92721539|NCT00562913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721540|NCT00562913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721541|NCT00562913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721542|NCT00562913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721543|NCT00569088|Mannitol|mannitol|mesh-list
92721544|NCT00569088|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92721545|NCT00569088|Diuretics|diuretics|mesh-ancestor
92721546|NCT00569088|Natriuretic Agents|natriuretic agents|mesh-ancestor
92721547|NCT00569088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721548|NCT00569244|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92721549|NCT00569244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92721550|NCT00569244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721551|NCT04586361|Hyaluronic Acid|hyaluronic acid|mesh-list
92721552|NCT04586361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92721553|NCT04586361|Immunologic Factors|immunologic factors|mesh-ancestor
92721554|NCT04586361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721555|NCT04586361|Viscosupplements|viscosupplements|mesh-ancestor
92721556|NCT04586361|Protective Agents|protective agents|mesh-ancestor
92721557|NCT04618952|Calcium|calcium|mesh-list
92721558|NCT04618952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92721559|NCT04618952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721560|NCT04619069|Hormones|hormones|mesh-list
92721561|NCT04619069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721562|NCT04619069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721563|NCT04585932|Leuprolide|leuprolide|mesh-list
92721564|NCT04585932|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92721565|NCT04585932|Fertility Agents|fertility agents|mesh-ancestor
92721566|NCT04585932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92721567|NCT04585932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721568|NCT04585932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92721569|NCT04585932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721570|NCT00569400|Insulin|insulin|mesh-list
92721571|NCT00569400|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92721572|NCT00569400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721573|NCT00569400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721574|NCT04618367|Lenvatinib|lenvatinib|mesh-list
92721575|NCT04618367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721577|NCT04618367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721578|NCT04618367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721579|NCT00562952|Telmisartan|telmisartan|mesh-list
92721580|NCT00562952|Bisoprolol|bisoprolol|mesh-list
92721581|NCT00562952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92721582|NCT00562952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92721583|NCT00562952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92610029|NCT00141596|Natriuretic Agents|natriuretic agents|mesh-ancestor
92610030|NCT00141596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610031|NCT00141596|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92610032|NCT00141596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721584|NCT00562952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721585|NCT00562952|Sympatholytics|sympatholytics|mesh-ancestor
92721586|NCT00562952|Autonomic Agents|autonomic agents|mesh-ancestor
92721587|NCT00562952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721588|NCT00562952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721589|NCT00562952|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92721590|NCT00562952|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92721591|NCT00562952|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92721592|NCT00562952|Adrenergic Agents|adrenergic agents|mesh-ancestor
92721593|NCT00562952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721594|NCT05035316|Aspirin|aspirin|mesh-list
92721595|NCT05035316|Calcium|calcium|mesh-list
92721596|NCT05035316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92721597|NCT05035316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396377|NCT01395927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721598|NCT05035316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92396430|NCT01396304|Calcium|calcium|mesh-list
92721599|NCT05035316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92721600|NCT05035316|Analgesics|analgesics|mesh-ancestor
92721601|NCT05035316|Sensory System Agents|sensory system agents|mesh-ancestor
92721602|NCT05035316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721603|NCT05035316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721604|NCT05035316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721605|NCT05035316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92721606|NCT05035316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92721607|NCT05035316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396511|NCT01397019|Leucovorin|leucovorin|mesh-list
92721608|NCT05035316|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92721609|NCT05035316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92721610|NCT05035316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721611|NCT05035316|Antipyretics|antipyretics|mesh-ancestor
92721612|NCT04618601|Spironolactone|spironolactone|mesh-list
92721613|NCT04618601|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92721614|NCT04618601|Hormone Antagonists|hormone antagonists|mesh-ancestor
92721615|NCT04618601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721616|NCT04618601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721617|NCT04618601|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92721618|NCT04618601|Diuretics|diuretics|mesh-ancestor
92721619|NCT04618601|Natriuretic Agents|natriuretic agents|mesh-ancestor
92721620|NCT00567918|Tacrolimus|tacrolimus|mesh-list
92721621|NCT00567918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721622|NCT00567918|Immunologic Factors|immunologic factors|mesh-ancestor
92721623|NCT00567918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396640|NCT04965870|Trifluridine|trifluridine|mesh-list
92721624|NCT00567918|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92721625|NCT00567918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721626|NCT00567918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721627|NCT00569712|Budesonide|budesonide|mesh-list
92721628|NCT00569712|Formoterol Fumarate|formoterol fumarate|mesh-list
92721629|NCT00569712|Dimercaprol|dimercaprol|mesh-list
92721630|NCT00569712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721631|NCT00569712|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92721632|NCT00569712|Autonomic Agents|autonomic agents|mesh-ancestor
92721633|NCT00569712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721634|NCT00569712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721635|NCT00569712|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92721636|NCT00569712|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721637|NCT00569712|Glucocorticoids|glucocorticoids|mesh-ancestor
92721638|NCT00569712|Hormones|hormones|mesh-ancestor
92721639|NCT00569712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721640|NCT00569712|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92721641|NCT00569712|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92721642|NCT00569712|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92721643|NCT00569712|Adrenergic Agents|adrenergic agents|mesh-ancestor
92721644|NCT00569712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721645|NCT00569712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721646|NCT00569712|Chelating Agents|chelating agents|mesh-ancestor
92610033|NCT00141596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721654|NCT00569751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721655|NCT00569790|Bevacizumab|bevacizumab|mesh-list
92721656|NCT00569790|Irinotecan|irinotecan|mesh-list
92721657|NCT00569790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721658|NCT00569790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721659|NCT00569790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92721660|NCT00569790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721661|NCT00569790|Growth Substances|growth substances|mesh-ancestor
92721662|NCT00569790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721663|NCT00569790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721664|NCT00569790|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92721665|NCT00569790|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92721666|NCT00569790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721667|NCT00569790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721668|NCT00567957|Remifentanil|remifentanil|mesh-list
92721669|NCT00567957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92721670|NCT00567957|Narcotics|narcotics|mesh-ancestor
92721671|NCT00567957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721672|NCT00567957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721673|NCT00567957|Analgesics|analgesics|mesh-ancestor
92721674|NCT00567957|Sensory System Agents|sensory system agents|mesh-ancestor
92721675|NCT00567957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721676|NCT02940002|Betamethasone|betamethasone|mesh-list
92721677|NCT02940002|Clobetasol|clobetasol|mesh-list
92721678|NCT02940002|Calcipotriene|calcipotriene|mesh-list
92721679|NCT02940002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721680|NCT02940002|Glucocorticoids|glucocorticoids|mesh-ancestor
92721681|NCT02940002|Hormones|hormones|mesh-ancestor
92721682|NCT02940002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721683|NCT02940002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721684|NCT02940002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92721685|NCT02940002|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721686|NCT02940002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92721687|NCT04618328|Tretinoin|tretinoin|mesh-list
92721688|NCT04618328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721689|NCT04618328|Keratolytic Agents|keratolytic agents|mesh-ancestor
92721690|NCT04618328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92721692|NCT04617782|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92721693|NCT04617782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721694|NCT04617782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721695|NCT04617782|Cholinergic Agents|cholinergic agents|mesh-ancestor
92721696|NCT04617782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721697|NCT04617782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721698|NCT04617782|Nootropic Agents|nootropic agents|mesh-ancestor
92721699|NCT00569985|Cyclophosphamide|cyclophosphamide|mesh-list
92721700|NCT00569985|Carmustine|carmustine|mesh-list
92721701|NCT00569985|Etoposide|etoposide|mesh-list
92721702|NCT00569985|Etoposide phosphate|etoposide phosphate|mesh-list
92721703|NCT00569985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721704|NCT00569985|Immunologic Factors|immunologic factors|mesh-ancestor
92721705|NCT00569985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721706|NCT00569985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721707|NCT00569985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92721708|NCT00569985|Alkylating Agents|alkylating agents|mesh-ancestor
92721709|NCT00569985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721710|NCT00569985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721711|NCT00569985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92721712|NCT00569985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92721713|NCT00569985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92721714|NCT00569985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92721715|NCT00569985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721716|NCT04617626|Azithromycin|azithromycin|mesh-list
92721723|NCT00570180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721725|NCT02939846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721726|NCT02939846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721727|NCT02939846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721728|NCT02939846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721729|NCT02939495|Sildenafil Citrate|sildenafil citrate|mesh-list
92721730|NCT02939495|Vasodilator Agents|vasodilator agents|mesh-ancestor
92721731|NCT02939495|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92721732|NCT02939495|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92721733|NCT02939495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610034|NCT00141596|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92610035|NCT00141596|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92610036|NCT00141596|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92610037|NCT00141596|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92721734|NCT02939495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721735|NCT02939495|Urological Agents|urological agents|mesh-ancestor
92721736|NCT00570219|Valproic Acid|valproic acid|mesh-list
92721737|NCT00570219|Anticonvulsants|anticonvulsants|mesh-ancestor
92721738|NCT00570219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721739|NCT00570219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721740|NCT00570219|GABA Agents|gaba agents|mesh-ancestor
92721741|NCT00570219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721742|NCT00570219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721743|NCT00570219|Antimanic Agents|antimanic agents|mesh-ancestor
92721744|NCT00570219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92721745|NCT00570219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721746|NCT00570219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721747|NCT00570375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92721748|NCT00570375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721749|NCT00570375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721750|NCT00570375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721751|NCT00570375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721752|NCT00568074|Repaglinide|repaglinide|mesh-list
92721753|NCT00568074|Acarbose|acarbose|mesh-list
92721754|NCT00568074|Gliquidone|gliquidone|mesh-list
92721755|NCT00568074|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721756|NCT00568074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721757|NCT00568074|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92721758|NCT00568074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721759|NCT00568074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721760|NCT00568113|Acetylcysteine|acetylcysteine|mesh-list
92721761|NCT00568113|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92721762|NCT00568113|Antiviral Agents|antiviral agents|mesh-ancestor
92721763|NCT00568113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721764|NCT00568113|Expectorants|expectorants|mesh-ancestor
92721765|NCT00568113|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721766|NCT00568113|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92721767|NCT00568113|Antioxidants|antioxidants|mesh-ancestor
92721768|NCT00568113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721769|NCT00568113|Protective Agents|protective agents|mesh-ancestor
92721770|NCT00568113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721771|NCT00568113|Antidotes|antidotes|mesh-ancestor
92721772|NCT00568152|Aspirin|aspirin|mesh-list
92721773|NCT00568152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92721774|NCT00568152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92721775|NCT00568152|Analgesics|analgesics|mesh-ancestor
92721776|NCT00568152|Sensory System Agents|sensory system agents|mesh-ancestor
92721777|NCT00568152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721778|NCT00568152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721779|NCT00568152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721780|NCT00568152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92721781|NCT00568152|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92721782|NCT00568152|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92721783|NCT00568152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721784|NCT00568152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92721785|NCT00568152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92721786|NCT00568152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721790|NCT04610879|Anticonvulsants|anticonvulsants|mesh-ancestor
92721791|NCT04610879|Nootropic Agents|nootropic agents|mesh-ancestor
92721792|NCT04610879|Antimanic Agents|antimanic agents|mesh-ancestor
92721793|NCT04610879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92721794|NCT04610879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721795|NCT04610879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721796|NCT04610879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721797|NCT04610879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92721798|NCT04610879|Analgesics|analgesics|mesh-ancestor
92721799|NCT04610879|Sensory System Agents|sensory system agents|mesh-ancestor
92721800|NCT04610879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721801|NCT04610879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92721802|NCT04610879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610038|NCT02275663|Cytarabine|cytarabine|mesh-list
92610039|NCT02275663|Fludarabine|fludarabine|mesh-list
92610040|NCT02275663|Azacitidine|azacitidine|mesh-list
92610041|NCT02275663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017183|NCT04972045|Curcumin|curcumin|mesh-list
92721803|NCT04610879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721804|NCT04610879|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92721805|NCT04610879|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92721806|NCT00570648|Hyaluronic Acid|hyaluronic acid|mesh-list
92721807|NCT00570648|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92721808|NCT00570648|Immunologic Factors|immunologic factors|mesh-ancestor
92721809|NCT00570648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721810|NCT00570648|Viscosupplements|viscosupplements|mesh-ancestor
92721811|NCT00570648|Protective Agents|protective agents|mesh-ancestor
92721812|NCT00570726|Ranibizumab|ranibizumab|mesh-list
92721813|NCT00570726|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92721814|NCT00570726|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721815|NCT00570726|Growth Substances|growth substances|mesh-ancestor
92721816|NCT00570726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721817|NCT00570726|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721818|NCT00570726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721819|NCT00570843|Lubricant Eye Drops|lubricant eye drops|mesh-list
92721820|NCT00570843|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92721821|NCT00570843|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92721822|NCT00563069|Midazolam|midazolam|mesh-list
92721823|NCT00563069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92721824|NCT00563069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92721825|NCT00563069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721826|NCT00563069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721827|NCT00563069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92721828|NCT00563069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92721829|NCT00563069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721830|NCT00563069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92721831|NCT00563069|Anesthetics, General|anesthetics, general|mesh-ancestor
92721832|NCT00563069|Anesthetics|anesthetics|mesh-ancestor
92721833|NCT00563069|GABA Modulators|gaba modulators|mesh-ancestor
92721834|NCT00563069|GABA Agents|gaba agents|mesh-ancestor
92721835|NCT00563069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721836|NCT00563069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721837|NCT04580355|Amoxicillin|amoxicillin|mesh-list
92721838|NCT04580355|Metronidazole|metronidazole|mesh-list
92721839|NCT04580355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92721840|NCT04580355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721841|NCT04580355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92721842|NCT04580355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92721843|NCT00563108|Basiliximab|basiliximab|mesh-list
92721844|NCT00563108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721845|NCT00563108|Immunologic Factors|immunologic factors|mesh-ancestor
92396852|NCT05274139|Antiviral Agents|antiviral agents|mesh-ancestor
92721846|NCT00563108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721847|NCT00570882|Sunitinib|sunitinib|mesh-list
92721848|NCT00570882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721849|NCT00570882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92721850|NCT00570882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721851|NCT00570882|Growth Substances|growth substances|mesh-ancestor
92721852|NCT00570882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721853|NCT00570882|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721854|NCT00570882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721855|NCT00570882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721856|NCT00570882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721857|NCT00563147|Sirolimus|sirolimus|mesh-list
92721858|NCT00563147|Temsirolimus|temsirolimus|mesh-list
92721859|NCT00563147|MTOR Inhibitors|mtor inhibitors|mesh-list
92721860|NCT00563147|Tivozanib|tivozanib|mesh-list
92721861|NCT00563147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721866|NCT00563147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721867|NCT00563147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721868|NCT00563147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92721869|NCT00563147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721870|NCT00563147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92721871|NCT00563147|Antifungal Agents|antifungal agents|mesh-ancestor
92721872|NCT00570999|Mitogens|mitogens|mesh-list
92721873|NCT00570999|Mitosis Modulators|mitosis modulators|mesh-ancestor
92721874|NCT00570999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721875|NCT04616261|Formoterol Fumarate|formoterol fumarate|mesh-list
92610042|NCT02275663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610044|NCT02275663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017186|NCT04972045|Analgesics|analgesics|mesh-ancestor
92721876|NCT04616261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92721877|NCT04616261|Autonomic Agents|autonomic agents|mesh-ancestor
92721878|NCT04616261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721879|NCT04616261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721880|NCT04616261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92721881|NCT04616261|Respiratory System Agents|respiratory system agents|mesh-ancestor
92721882|NCT04616261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92721883|NCT04616261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92721884|NCT04616261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92721885|NCT04616261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92721886|NCT04616261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721887|NCT04616261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721888|NCT00563225|Insulin Glargine|insulin glargine|mesh-list
92721889|NCT00563225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721890|NCT00563225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721891|NCT00571116|Arsenic Trioxide|arsenic trioxide|mesh-list
92721892|NCT00571116|Disulfiram|disulfiram|mesh-list
92721893|NCT00571116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721894|NCT00571116|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92721895|NCT00571116|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92721896|NCT00571116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721897|NCT00571116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721898|NCT00571155|Levetiracetam|levetiracetam|mesh-list
92721899|NCT00571155|Anticonvulsants|anticonvulsants|mesh-ancestor
92721900|NCT00571155|Nootropic Agents|nootropic agents|mesh-ancestor
92721901|NCT04615481|Metronidazole|metronidazole|mesh-list
92721902|NCT04615481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721903|NCT04615481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92721904|NCT04615481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92721905|NCT04615481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92721906|NCT04614584|Mirtazapine|mirtazapine|mesh-list
92721907|NCT04614584|Methamphetamine|methamphetamine|mesh-list
92721908|NCT04614584|Antidepressive Agents|antidepressive agents|mesh-ancestor
92721909|NCT04614584|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721910|NCT04614584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92721911|NCT04614584|Histamine Antagonists|histamine antagonists|mesh-ancestor
92721912|NCT04614584|Histamine Agents|histamine agents|mesh-ancestor
92721913|NCT04614584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721914|NCT04614584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721915|NCT04614584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721916|NCT04614584|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92721917|NCT04614584|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92721918|NCT04614584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721919|NCT04614584|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92721920|NCT04614584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92721921|NCT04614584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92721922|NCT04614584|Adrenergic Agents|adrenergic agents|mesh-ancestor
92721923|NCT04614584|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92721924|NCT04614584|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92721925|NCT04614584|Serotonin Agents|serotonin agents|mesh-ancestor
92721926|NCT04614584|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92721927|NCT04614584|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92721928|NCT04614584|Sympathomimetics|sympathomimetics|mesh-ancestor
92721929|NCT04614584|Autonomic Agents|autonomic agents|mesh-ancestor
92721930|NCT04614584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721931|NCT04614584|Dopamine Agents|dopamine agents|mesh-ancestor
92721933|NCT04614584|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92721934|NCT04614584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721935|NCT04614584|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92721937|NCT00563303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721938|NCT00571506|Pioglitazone|pioglitazone|mesh-list
92721939|NCT00571506|Rosiglitazone|rosiglitazone|mesh-list
92721940|NCT00571506|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92721941|NCT00571506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721942|NCT04613609|Nicotine|nicotine|mesh-list
92721943|NCT04613609|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92721944|NCT04613609|Autonomic Agents|autonomic agents|mesh-ancestor
92721945|NCT04613609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610045|NCT02275663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610046|NCT02275663|Immunologic Factors|immunologic factors|mesh-ancestor
92017187|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
92721946|NCT04613609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721947|NCT04613609|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92721948|NCT04613609|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92721949|NCT04613609|Cholinergic Agents|cholinergic agents|mesh-ancestor
92721950|NCT04613609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721951|NCT04613609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721952|NCT00571740|Leucovorin|leucovorin|mesh-list
92721953|NCT00571740|Bevacizumab|bevacizumab|mesh-list
92721954|NCT00571740|Cetuximab|cetuximab|mesh-list
92721955|NCT00571740|Fluorouracil|fluorouracil|mesh-list
92721956|NCT00571740|Oxaliplatin|oxaliplatin|mesh-list
92721957|NCT00571740|Calcium|calcium|mesh-list
92721958|NCT00571740|Levoleucovorin|levoleucovorin|mesh-list
92721959|NCT00571740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92721960|NCT00571740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721961|NCT00571740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92721962|NCT00571740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92721963|NCT00571740|Growth Substances|growth substances|mesh-ancestor
92721964|NCT00571740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721965|NCT00571740|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721966|NCT00571740|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92721967|NCT00571740|Antimetabolites|antimetabolites|mesh-ancestor
92721968|NCT00571740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721969|NCT00571740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92721970|NCT00571740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721971|NCT00571740|Immunologic Factors|immunologic factors|mesh-ancestor
92721972|NCT00571740|Antidotes|antidotes|mesh-ancestor
92721973|NCT00571740|Protective Agents|protective agents|mesh-ancestor
92721974|NCT00571740|Vitamin B Complex|vitamin b complex|mesh-ancestor
92721975|NCT00571740|Vitamins|vitamins|mesh-ancestor
92721976|NCT00571740|Micronutrients|micronutrients|mesh-ancestor
92721977|NCT00563342|Ethanol|ethanol|mesh-list
92721978|NCT00563342|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92721979|NCT00563342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721980|NCT00563342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92721981|NCT00563342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721982|NCT04583046|Iloprost|iloprost|mesh-list
92721983|NCT04583046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92721984|NCT04583046|Vasodilator Agents|vasodilator agents|mesh-ancestor
92721985|NCT04582929|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92721986|NCT04582929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92721987|NCT04582929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721988|NCT04582929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721989|NCT04582929|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92721990|NCT04582929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721991|NCT04582929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721992|NCT04582929|Cholinergic Agents|cholinergic agents|mesh-ancestor
92721993|NCT04582929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721994|NCT04613726|Ondansetron|ondansetron|mesh-list
92721995|NCT04613726|Granisetron|granisetron|mesh-list
92721996|NCT04613726|Antiemetics|antiemetics|mesh-ancestor
92721997|NCT04613726|Autonomic Agents|autonomic agents|mesh-ancestor
92721998|NCT04613726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721999|NCT04613726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722000|NCT04613726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722001|NCT04613726|Antipruritics|antipruritics|mesh-ancestor
92722002|NCT04613726|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722003|NCT04613726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92722004|NCT04613726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92722005|NCT04613726|Serotonin Agents|serotonin agents|mesh-ancestor
92722006|NCT04613726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722010|NCT04613804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92722011|NCT04613804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722012|NCT04613102|Cannabidiol|cannabidiol|mesh-list
92722013|NCT04613102|Anticonvulsants|anticonvulsants|mesh-ancestor
92722014|NCT04613219|Tofacitinib|tofacitinib|mesh-list
92722015|NCT04613219|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92722016|NCT04613219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92722017|NCT04613219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722018|NCT04613219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722019|NCT00563615|Tegaserod|tegaserod|mesh-list
92610047|NCT02275663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610048|NCT02275663|Antiviral Agents|antiviral agents|mesh-ancestor
92610049|NCT02275663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610050|NCT02275663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610051|NCT02275702|Dexamethasone|dexamethasone|mesh-list
92722020|NCT00563615|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92722021|NCT00563615|Serotonin Agents|serotonin agents|mesh-ancestor
92722022|NCT00563615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722023|NCT00563615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722024|NCT00563615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722025|NCT00563654|Alfuzosin|alfuzosin|mesh-list
92722026|NCT00563654|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92722027|NCT00563654|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92722028|NCT00563654|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92722029|NCT00563654|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722030|NCT00563654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722031|NCT00563654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722032|NCT00563654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722033|NCT00563654|Urological Agents|urological agents|mesh-ancestor
92722034|NCT04613180|Montelukast|montelukast|mesh-list
92722035|NCT04613180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722036|NCT04613180|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722037|NCT04613180|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92722038|NCT04613180|Hormone Antagonists|hormone antagonists|mesh-ancestor
92722039|NCT04613180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722040|NCT04613180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722041|NCT04613180|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92722042|NCT04613180|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92722043|NCT04613180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722044|NCT00571935|Insulin|insulin|mesh-list
92722045|NCT00571935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92722046|NCT00571935|Insulin Aspart|insulin aspart|mesh-list
92722047|NCT00571935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92722048|NCT00571935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722049|NCT00572013|Rituximab|rituximab|mesh-list
92722050|NCT00572013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92722051|NCT00572013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722052|NCT00572013|Immunologic Factors|immunologic factors|mesh-ancestor
92722053|NCT00572013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722054|NCT00572013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722055|NCT04612634|Vaccines|vaccines|mesh-list
92722056|NCT04612634|Immunologic Factors|immunologic factors|mesh-ancestor
92722057|NCT04612634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722058|NCT04612556|Vaccines|vaccines|mesh-list
92722059|NCT04612556|Immunologic Factors|immunologic factors|mesh-ancestor
92722060|NCT04612556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722061|NCT04580199|Ethanol|ethanol|mesh-list
92722062|NCT04580199|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92722063|NCT04580199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722064|NCT04580199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722065|NCT04580199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722066|NCT00568347|Fluticasone|fluticasone|mesh-list
92722068|NCT00568347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92722069|NCT00568347|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92722070|NCT00568347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722071|NCT00568347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92722072|NCT00568347|Autonomic Agents|autonomic agents|mesh-ancestor
92722073|NCT00568347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722074|NCT00568347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722075|NCT00568347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722076|NCT00568347|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722079|NCT00568347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92722080|NCT00568347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92722081|NCT00568347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92722082|NCT00568347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722083|NCT00568347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722084|NCT00568347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722085|NCT00568347|Glucocorticoids|glucocorticoids|mesh-ancestor
92722086|NCT00568347|Hormones|hormones|mesh-ancestor
92610052|NCT02275702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92610053|NCT02275702|Antiemetics|antiemetics|mesh-ancestor
92610054|NCT02275702|Autonomic Agents|autonomic agents|mesh-ancestor
92610055|NCT02275702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017193|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722087|NCT00568347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722088|NCT00568347|Sympathomimetics|sympathomimetics|mesh-ancestor
92722089|NCT04611971|Belimumab|belimumab|mesh-list
92722090|NCT04611971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722091|NCT04611971|Immunologic Factors|immunologic factors|mesh-ancestor
92722092|NCT04611971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722093|NCT00572208|Gabapentin|gabapentin|mesh-list
92722094|NCT00572208|Analgesics|analgesics|mesh-ancestor
92722095|NCT00572208|Sensory System Agents|sensory system agents|mesh-ancestor
92722096|NCT00572208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722097|NCT00572208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722098|NCT00572208|Anticonvulsants|anticonvulsants|mesh-ancestor
92722099|NCT00572208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92722100|NCT00572208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92722101|NCT00572208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722102|NCT00572208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92722103|NCT00572208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92722104|NCT00572208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92722105|NCT00572208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722106|NCT00572208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722107|NCT00572208|Antimanic Agents|antimanic agents|mesh-ancestor
92722108|NCT00572364|Olaparib|olaparib|mesh-list
92722109|NCT00572364|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92722110|NCT00572364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722111|NCT00572364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722112|NCT00572364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722113|NCT00563771|Rasburicase|rasburicase|mesh-list
92722114|NCT00563771|Gout Suppressants|gout suppressants|mesh-ancestor
92722115|NCT00563771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722116|NCT04582032|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92722117|NCT04582032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92722118|NCT04582032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92722119|NCT04582032|Analgesics|analgesics|mesh-ancestor
92722120|NCT04582032|Sensory System Agents|sensory system agents|mesh-ancestor
92722121|NCT04582032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722122|NCT04582032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722123|NCT04582032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722124|NCT04582032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722125|NCT00563849|Leflunomide|leflunomide|mesh-list
92722126|NCT00563849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722127|NCT00563849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722128|NCT00563849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722129|NCT00563849|Immunologic Factors|immunologic factors|mesh-ancestor
92722130|NCT00563849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722131|NCT04581876|Paclitaxel|paclitaxel|mesh-list
92722132|NCT04581876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92722133|NCT04581876|Raltitrexed|raltitrexed|mesh-list
92722134|NCT04581876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722135|NCT04581876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722136|NCT04581876|Tubulin Modulators|tubulin modulators|mesh-ancestor
92722137|NCT04581876|Antimitotic Agents|antimitotic agents|mesh-ancestor
92722138|NCT04581876|Mitosis Modulators|mitosis modulators|mesh-ancestor
92722139|NCT04581876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722140|NCT04581876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92722142|NCT04581876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92722143|NCT04581876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722144|NCT00563927|Fluorouracil|fluorouracil|mesh-list
92722145|NCT00563927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722146|NCT00563927|Antimetabolites|antimetabolites|mesh-ancestor
92722147|NCT00563927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722148|NCT00563927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92722149|NCT00563927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722153|NCT01150123|Immunologic Factors|immunologic factors|mesh-ancestor
92722154|NCT01150123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610056|NCT02275702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610057|NCT02275702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92093117|NCT03604653|Cisplatin|cisplatin|mesh-list
92722155|NCT00572559|Vancomycin|vancomycin|mesh-list
92722156|NCT00572559|Linezolid|linezolid|mesh-list
92722157|NCT00572559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92722158|NCT00572559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722159|NCT00572559|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92722160|NCT00572559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722161|NCT00572559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722162|NCT04611464|Misoprostol|misoprostol|mesh-list
92722163|NCT04611464|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92722164|NCT04611464|Abortifacient Agents|abortifacient agents|mesh-ancestor
92722165|NCT04611464|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92722166|NCT04611464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722167|NCT04611464|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92722168|NCT04611464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722169|NCT04611464|Oxytocics|oxytocics|mesh-ancestor
92722170|NCT04611776|Paclitaxel|paclitaxel|mesh-list
92722171|NCT04611776|Carboplatin|carboplatin|mesh-list
92722172|NCT04611776|Gemcitabine|gemcitabine|mesh-list
92722173|NCT04611776|Pemetrexed|pemetrexed|mesh-list
92722174|NCT04611776|Atezolizumab|atezolizumab|mesh-list
92722175|NCT04611776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722176|NCT04611776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722177|NCT04611776|Tubulin Modulators|tubulin modulators|mesh-ancestor
92722178|NCT04611776|Antimitotic Agents|antimitotic agents|mesh-ancestor
92722179|NCT04611776|Mitosis Modulators|mitosis modulators|mesh-ancestor
92722180|NCT04611776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722181|NCT04611776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92722182|NCT04611776|Antimetabolites|antimetabolites|mesh-ancestor
92722183|NCT04611776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396889|NCT05273398|Diazepam|diazepam|mesh-list
92722184|NCT04611776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92722185|NCT04611776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92722186|NCT04611776|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92722187|NCT04611776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92722188|NCT00572637|Delanzomib|delanzomib|mesh-list
92722189|NCT00572637|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
92722190|NCT00572637|Protease Inhibitors|protease inhibitors|mesh-ancestor
92722191|NCT00572637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722192|NCT00572637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722193|NCT01149655|Aripiprazole|aripiprazole|mesh-list
92722194|NCT01149655|Antidepressive Agents|antidepressive agents|mesh-ancestor
92722195|NCT01149655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92722196|NCT01149655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92722197|NCT01149655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92722198|NCT01149655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722199|NCT01149655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722200|NCT01149655|Dopamine Agonists|dopamine agonists|mesh-ancestor
92722201|NCT01149655|Dopamine Agents|dopamine agents|mesh-ancestor
92722202|NCT01149655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722203|NCT01149655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722204|NCT01149655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92722205|NCT01149655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92722206|NCT01149655|Serotonin Agents|serotonin agents|mesh-ancestor
92722207|NCT01149655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92722208|NCT01149655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92722209|NCT01149655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92722210|NCT01149655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92722211|NCT00575406|Prednisolone|prednisolone|mesh-list
92722212|NCT00575406|Cyclophosphamide|cyclophosphamide|mesh-list
92722213|NCT00575406|Rituximab|rituximab|mesh-list
92722214|NCT00575406|Doxorubicin|doxorubicin|mesh-list
92722215|NCT00575406|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92722216|NCT00575406|Vincristine|vincristine|mesh-list
92722217|NCT00575406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722218|NCT00575406|Immunologic Factors|immunologic factors|mesh-ancestor
92722219|NCT00575406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722220|NCT00575406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722221|NCT00575406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92722222|NCT00575406|Alkylating Agents|alkylating agents|mesh-ancestor
92722225|NCT00575406|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92722226|NCT00575406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610058|NCT02275702|Glucocorticoids|glucocorticoids|mesh-ancestor
92610059|NCT02275702|Hormones|hormones|mesh-ancestor
92610060|NCT02275702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610061|NCT02275702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92610062|NCT02275702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722227|NCT00575406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92722228|NCT00575406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92722229|NCT00575406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92722230|NCT00575406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722231|NCT00575406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722232|NCT00575406|Glucocorticoids|glucocorticoids|mesh-ancestor
92722233|NCT00575406|Hormones|hormones|mesh-ancestor
92722234|NCT00575406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722235|NCT00575406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92722236|NCT00575406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722237|NCT00575406|Tubulin Modulators|tubulin modulators|mesh-ancestor
92722238|NCT00575406|Antimitotic Agents|antimitotic agents|mesh-ancestor
92722239|NCT00575406|Mitosis Modulators|mitosis modulators|mesh-ancestor
92722240|NCT01149538|Choline|choline|mesh-list
92722241|NCT01149538|Lipotropic Agents|lipotropic agents|mesh-ancestor
92722242|NCT01149538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92722243|NCT01149538|Antimetabolites|antimetabolites|mesh-ancestor
92722244|NCT01149538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722245|NCT01149538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722246|NCT01149538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92722247|NCT01149538|Nootropic Agents|nootropic agents|mesh-ancestor
92722248|NCT01149460|Valacyclovir|valacyclovir|mesh-list
92722249|NCT01149460|Antiviral Agents|antiviral agents|mesh-ancestor
92722250|NCT01149460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722251|NCT00575523|Atropine|atropine|mesh-list
92722252|NCT00575523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92722253|NCT00575523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92722254|NCT00575523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92722255|NCT00575523|Autonomic Agents|autonomic agents|mesh-ancestor
92722256|NCT00575523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722257|NCT00575523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722258|NCT00575523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722259|NCT00575523|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722260|NCT00575523|Mydriatics|mydriatics|mesh-ancestor
92722261|NCT00575523|Parasympatholytics|parasympatholytics|mesh-ancestor
92722262|NCT00575523|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92722263|NCT00575523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92722264|NCT00575523|Cholinergic Agents|cholinergic agents|mesh-ancestor
92722265|NCT00575523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722266|NCT00575523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722267|NCT01149421|Dulaglutide|dulaglutide|mesh-list
92722268|NCT01149421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92722269|NCT01149421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722270|NCT00575601|Simvastatin|simvastatin|mesh-list
92722271|NCT00575601|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92722272|NCT00575601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92722273|NCT00575601|Antimetabolites|antimetabolites|mesh-ancestor
92722274|NCT00575601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722275|NCT00575601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92722276|NCT00575601|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92722277|NCT00575601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722278|NCT04600271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92722279|NCT04600271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92722280|NCT04600271|Norepinephrine|norepinephrine|mesh-list
92722281|NCT04600271|Analgesics|analgesics|mesh-list
92722282|NCT04600271|Diuretics|diuretics|mesh-list
92722283|NCT04600271|Sensory System Agents|sensory system agents|mesh-ancestor
92722284|NCT04600271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722285|NCT04600271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722286|NCT04600271|Natriuretic Agents|natriuretic agents|mesh-ancestor
92722287|NCT04600271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92722288|NCT04600271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92408604|NCT05963139|Anesthetics|anesthetics|mesh-ancestor
92722289|NCT04600271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722290|NCT04600271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610064|NCT04518163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92610065|NCT04518163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92610066|NCT04518163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610067|NCT04518163|Hemostatics|hemostatics|mesh-ancestor
92722291|NCT04600271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722292|NCT04600271|Sympathomimetics|sympathomimetics|mesh-ancestor
92722293|NCT04600271|Autonomic Agents|autonomic agents|mesh-ancestor
92722294|NCT04600271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92722297|NCT00575640|Hydralazine|hydralazine|mesh-list
92722298|NCT00575640|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92722299|NCT00575640|Vasodilator Agents|vasodilator agents|mesh-ancestor
92722300|NCT04599959|Hydrocortisone|hydrocortisone|mesh-list
92722301|NCT04599959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722302|NCT04579731|Lactitol|lactitol|mesh-list
92722303|NCT04579731|Cathartics|cathartics|mesh-ancestor
92722304|NCT04579731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722305|NCT00565487|Capecitabine|capecitabine|mesh-list
92722306|NCT00565487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92722307|NCT00565487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92722308|NCT00565487|Antimetabolites|antimetabolites|mesh-ancestor
92722309|NCT00565487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722310|NCT00565487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722311|NCT00565487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92722312|NCT00565487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722313|NCT04600115|Adenosine|adenosine|mesh-list
92722314|NCT04600115|Regadenoson|regadenoson|mesh-list
92722315|NCT04600115|Analgesics|analgesics|mesh-ancestor
92722316|NCT04600115|Sensory System Agents|sensory system agents|mesh-ancestor
92396902|NCT05273398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92722317|NCT04600115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722318|NCT04600115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722319|NCT04600115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92722320|NCT04600115|Vasodilator Agents|vasodilator agents|mesh-ancestor
92722321|NCT04600115|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92722322|NCT04600115|Purinergic Agonists|purinergic agonists|mesh-ancestor
92722323|NCT04600115|Purinergic Agents|purinergic agents|mesh-ancestor
92722324|NCT04600115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722325|NCT04600115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722326|NCT04600115|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92722327|NCT04600037|Pregabalin|pregabalin|mesh-list
92722328|NCT04600037|Analgesics|analgesics|mesh-ancestor
92722329|NCT04600037|Sensory System Agents|sensory system agents|mesh-ancestor
92722330|NCT04600037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722331|NCT04600037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722332|NCT04600037|Anticonvulsants|anticonvulsants|mesh-ancestor
92722333|NCT04600037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92722334|NCT04600037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92722335|NCT04600037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722336|NCT04600037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92722337|NCT04600037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92722338|NCT04600037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92722339|NCT04600037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722340|NCT04600037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92722341|NCT00575796|Vinblastine|vinblastine|mesh-list
92722342|NCT00575796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722343|NCT00575796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722344|NCT00575796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92722345|NCT00575796|Antimitotic Agents|antimitotic agents|mesh-ancestor
92722346|NCT00575796|Mitosis Modulators|mitosis modulators|mesh-ancestor
92722347|NCT00575796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722348|NCT00575835|Vitamin D|vitamin d|mesh-list
92722349|NCT00575835|Ergocalciferols|ergocalciferols|mesh-list
92722350|NCT00575835|Cholecalciferol|cholecalciferol|mesh-list
92722351|NCT00575835|Vitamins|vitamins|mesh-list
92722352|NCT00575835|Micronutrients|micronutrients|mesh-ancestor
92722353|NCT00575835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722354|NCT00575835|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92722355|NCT00575835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92722356|NCT00573222|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92722357|NCT00573222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92610068|NCT04518163|Coagulants|coagulants|mesh-ancestor
92610069|NCT04517227|Durvalumab|durvalumab|mesh-list
92610070|NCT04517227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017210|NCT04971577|Simvastatin|simvastatin|mesh-list
92722358|NCT00573222|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722359|NCT00575874|Pioglitazone|pioglitazone|mesh-list
92722360|NCT00575874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92722361|NCT00575874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722362|NCT03454217|Oxycodone|oxycodone|mesh-list
92722363|NCT03454217|Tramadol|tramadol|mesh-list
92722364|NCT03454217|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92722365|NCT03454217|Narcotics|narcotics|mesh-ancestor
92722366|NCT03454217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722367|NCT03454217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722371|NCT00575913|Alfuzosin|alfuzosin|mesh-list
92722372|NCT00575913|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92722373|NCT00575913|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92722374|NCT00575913|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92722375|NCT00575913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722376|NCT00575913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722377|NCT00575913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722378|NCT00575913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722379|NCT00575913|Urological Agents|urological agents|mesh-ancestor
92722380|NCT04579302|Bupivacaine|bupivacaine|mesh-list
92722381|NCT04579302|Anesthetics, Local|anesthetics, local|mesh-ancestor
92722382|NCT04579302|Anesthetics|anesthetics|mesh-ancestor
92722383|NCT04579302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722384|NCT04579302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722385|NCT04579302|Sensory System Agents|sensory system agents|mesh-ancestor
92722386|NCT04579302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722387|NCT00565682|Etoricoxib|etoricoxib|mesh-list
92722388|NCT00565682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92722389|NCT00565682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92722390|NCT00565682|Analgesics|analgesics|mesh-ancestor
92722391|NCT00565682|Sensory System Agents|sensory system agents|mesh-ancestor
92722392|NCT00565682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722393|NCT00565682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722394|NCT00565682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722395|NCT00565682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722396|NCT00565682|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92722397|NCT00565682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92722398|NCT00565682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722399|NCT00565682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722400|NCT00575952|Paclitaxel|paclitaxel|mesh-list
92722401|NCT00575952|Doxorubicin|doxorubicin|mesh-list
92722402|NCT00575952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92722403|NCT00575952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722404|NCT00575952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722405|NCT00575952|Tubulin Modulators|tubulin modulators|mesh-ancestor
92722406|NCT00575952|Antimitotic Agents|antimitotic agents|mesh-ancestor
92722407|NCT00575952|Mitosis Modulators|mitosis modulators|mesh-ancestor
92722408|NCT00575952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722409|NCT00575952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92722410|NCT00575952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92722411|NCT00575952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92722412|NCT00575952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722413|NCT00573417|Modafinil|modafinil|mesh-list
92722414|NCT00573417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92722415|NCT00573417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722416|NCT00573417|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92722417|NCT00573417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92722418|NCT00573417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92722419|NCT00573417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722420|NCT00573495|BIRC5 protein, human|birc5 protein, human|mesh-list
92722421|NCT00573495|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92722422|NCT00573495|Protease Inhibitors|protease inhibitors|mesh-ancestor
92722423|NCT00573495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722424|NCT00573495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722425|NCT00565955|Montelukast|montelukast|mesh-list
92722426|NCT00565955|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92610071|NCT04517227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610072|NCT00141713|Etanercept|etanercept|mesh-list
92017211|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92722427|NCT00565955|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722428|NCT00565955|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92722429|NCT00565955|Hormone Antagonists|hormone antagonists|mesh-ancestor
92722430|NCT00565955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722431|NCT00565955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722432|NCT00565955|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92722433|NCT00565955|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92722434|NCT00565955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722435|NCT04598594|Nicotine|nicotine|mesh-list
92722439|NCT04598594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722441|NCT04598594|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92722442|NCT04598594|Cholinergic Agents|cholinergic agents|mesh-ancestor
92722443|NCT04598594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722444|NCT04598594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722445|NCT00576069|Fluticasone|fluticasone|mesh-list
92722446|NCT00576069|Mometasone Furoate|mometasone furoate|mesh-list
92722447|NCT00576069|Prednisone|prednisone|mesh-list
92722448|NCT00576069|Budesonide|budesonide|mesh-list
92722449|NCT00576069|Formoterol Fumarate|formoterol fumarate|mesh-list
92722450|NCT00576069|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92722451|NCT00576069|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92722452|NCT00576069|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92722453|NCT00576069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722454|NCT00576069|Glucocorticoids|glucocorticoids|mesh-ancestor
92722455|NCT00576069|Hormones|hormones|mesh-ancestor
92722456|NCT00576069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722457|NCT00576069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722458|NCT00576069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92722459|NCT00576069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722460|NCT00576069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92722461|NCT00576069|Autonomic Agents|autonomic agents|mesh-ancestor
92722462|NCT00576069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722463|NCT00576069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722464|NCT00576069|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722465|NCT00576069|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722466|NCT00576069|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92722467|NCT00576069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92722468|NCT00576069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92722469|NCT00576069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92722470|NCT00576069|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722471|NCT00576069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722472|NCT00576069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722473|NCT00576069|Sympathomimetics|sympathomimetics|mesh-ancestor
92722474|NCT00573690|Carboplatin|carboplatin|mesh-list
92722475|NCT00573690|Etoposide|etoposide|mesh-list
92722476|NCT00573690|Pemetrexed|pemetrexed|mesh-list
92722477|NCT00573690|Sorafenib|sorafenib|mesh-list
92722478|NCT00573690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722479|NCT00573690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722480|NCT00573690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92722481|NCT00573690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92722482|NCT00573690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722483|NCT00573690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722484|NCT00573690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92722485|NCT00573690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92722486|NCT00573690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92722487|NCT00576225|Paclitaxel|paclitaxel|mesh-list
92722488|NCT00576225|Carboplatin|carboplatin|mesh-list
92722489|NCT00576225|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92722490|NCT00576225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92722491|NCT00576225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722492|NCT00576225|Tubulin Modulators|tubulin modulators|mesh-ancestor
92722493|NCT00576225|Antimitotic Agents|antimitotic agents|mesh-ancestor
92722494|NCT00576225|Mitosis Modulators|mitosis modulators|mesh-ancestor
92722495|NCT00576225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722496|NCT04597931|Zoledronic Acid|zoledronic acid|mesh-list
92722497|NCT04597931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92610073|NCT00141713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92610074|NCT00141713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92610075|NCT00141713|Analgesics|analgesics|mesh-ancestor
92610076|NCT00141713|Sensory System Agents|sensory system agents|mesh-ancestor
92610077|NCT00141713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722498|NCT04597931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722499|NCT00576459|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92722500|NCT00576459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396935|NCT05271370|Leronlimab|leronlimab|mesh-list
92722501|NCT00576459|Glucocorticoids|glucocorticoids|mesh-ancestor
92722502|NCT00576459|Hormones|hormones|mesh-ancestor
92722503|NCT00576459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722504|NCT00576459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722505|NCT04597775|Hydroxychloroquine|hydroxychloroquine|mesh-list
92722506|NCT04597775|Antimalarials|antimalarials|mesh-ancestor
92722511|NCT04597775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722512|NCT04597775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722513|NCT00573885|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92722515|NCT00573885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722516|NCT00573885|Protective Agents|protective agents|mesh-ancestor
92722517|NCT00573885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722518|NCT00573885|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92722519|NCT00573885|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92722520|NCT00573885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722521|NCT00573885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92722522|NCT04597424|Doxycycline|doxycycline|mesh-list
92722523|NCT04597424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92722524|NCT04597424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722525|NCT04597424|Antimalarials|antimalarials|mesh-ancestor
92722526|NCT04597424|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92722527|NCT04597424|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92722528|NCT00573924|Lansoprazole|lansoprazole|mesh-list
92722529|NCT00573924|Dexlansoprazole|dexlansoprazole|mesh-list
92722530|NCT00573924|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92722531|NCT00573924|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92722532|NCT00573924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722533|NCT00573924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722534|NCT00573924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722535|NCT00573963|Ropivacaine|ropivacaine|mesh-list
92722536|NCT00573963|Anesthetics, Local|anesthetics, local|mesh-ancestor
92722537|NCT00573963|Anesthetics|anesthetics|mesh-ancestor
92722538|NCT00573963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722539|NCT00573963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722540|NCT00573963|Sensory System Agents|sensory system agents|mesh-ancestor
92722541|NCT00573963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722542|NCT00576615|Propofol|propofol|mesh-list
92722543|NCT00576615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92722544|NCT00576615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722545|NCT00576615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722546|NCT00576615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92722547|NCT00576615|Anesthetics, General|anesthetics, general|mesh-ancestor
92722548|NCT00576615|Anesthetics|anesthetics|mesh-ancestor
92722549|NCT00574041|Interferons|interferons|mesh-list
92722550|NCT00574041|Interferon-beta|interferon-beta|mesh-list
92722551|NCT00574041|Interferon beta-1a|interferon beta-1a|mesh-list
92722552|NCT00574041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722553|NCT00574041|Antiviral Agents|antiviral agents|mesh-ancestor
92722554|NCT00574041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722555|NCT00574041|Immunologic Factors|immunologic factors|mesh-ancestor
92722556|NCT00574041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722557|NCT00574041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92722558|NCT00566267|Simvastatin|simvastatin|mesh-list
92722559|NCT00566267|Ezetimibe|ezetimibe|mesh-list
92722560|NCT00566267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92722561|NCT00566267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92722562|NCT00566267|Antimetabolites|antimetabolites|mesh-ancestor
92722563|NCT00566267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722564|NCT00566267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92722565|NCT00566267|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92722566|NCT00566267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722567|NCT00574353|Misonidazole|misonidazole|mesh-list
92610078|NCT00141713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610079|NCT00141713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722568|NCT00574353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722569|NCT00574353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92722570|NCT00574353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92722571|NCT00574353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722572|NCT04596839|Remdesivir|remdesivir|mesh-list
92722573|NCT04596839|Antimetabolites|antimetabolites|mesh-ancestor
92722574|NCT04596839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722575|NCT04596839|Antiviral Agents|antiviral agents|mesh-ancestor
92722576|NCT04596839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722577|NCT00574470|Infliximab|infliximab|mesh-list
92722578|NCT00574470|Daclizumab|daclizumab|mesh-list
92722579|NCT00574470|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92722580|NCT00574470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722584|NCT00574470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722585|NCT00574470|Immunologic Factors|immunologic factors|mesh-ancestor
92722586|NCT00574470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722587|NCT00577161|Vidarabine|vidarabine|mesh-list
92722588|NCT00577161|Rituximab|rituximab|mesh-list
92722589|NCT00577161|Fludarabine|fludarabine|mesh-list
92722590|NCT00577161|Fludarabine phosphate|fludarabine phosphate|mesh-list
92722591|NCT00577161|Pixantrone|pixantrone|mesh-list
92722592|NCT00577161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92722593|NCT00577161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722594|NCT00577161|Immunologic Factors|immunologic factors|mesh-ancestor
92722595|NCT00577161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722596|NCT00577161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722597|NCT00577161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92722598|NCT00577161|Antimetabolites|antimetabolites|mesh-ancestor
92722599|NCT00577161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722600|NCT00577161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722601|NCT00577161|Antiviral Agents|antiviral agents|mesh-ancestor
92722602|NCT00577161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722603|NCT00577161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92722604|NCT00577161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92722605|NCT00577161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722606|NCT00574509|Tositumomab I-131|tositumomab i-131|mesh-list
92722607|NCT00574509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722608|NCT04596488|Efavirenz|efavirenz|mesh-list
92722609|NCT04596488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92722610|NCT04596488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92722611|NCT04596488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722612|NCT04596488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722613|NCT04596488|Antiviral Agents|antiviral agents|mesh-ancestor
92722614|NCT04596488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722615|NCT04596488|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92722616|NCT04596488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92722617|NCT04596488|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92722618|NCT04596488|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92722619|NCT04596488|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92722620|NCT04596488|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92722621|NCT04595942|Fludrocortisone|fludrocortisone|mesh-list
92722622|NCT04595942|Midodrine|midodrine|mesh-list
92722623|NCT04595942|Sympathomimetics|sympathomimetics|mesh-ancestor
92722624|NCT04595942|Autonomic Agents|autonomic agents|mesh-ancestor
92722625|NCT04595942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722626|NCT04595942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722627|NCT04595942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92722628|NCT04595942|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92722629|NCT04595942|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92722630|NCT04595942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92722631|NCT04595942|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722632|NCT04595942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722633|NCT04595942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722634|NCT04595942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722635|NCT00566384|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92722636|NCT00566384|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92722637|NCT00566384|Immunologic Factors|immunologic factors|mesh-ancestor
92722638|NCT00566384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722639|NCT00574743|Mycophenolic Acid|mycophenolic acid|mesh-list
92610081|NCT00141713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610082|NCT00141713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610083|NCT00141713|Immunologic Factors|immunologic factors|mesh-ancestor
92610085|NCT04517188|Povidone-Iodine|povidone-iodine|mesh-list
92610086|NCT04517188|Povidone|povidone|mesh-list
92610087|NCT04517188|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92610088|NCT04517188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722640|NCT00574743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92722641|NCT00574743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722642|NCT00574743|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92722643|NCT00574743|Antitubercular Agents|antitubercular agents|mesh-ancestor
92722644|NCT00574743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92722645|NCT00574743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722646|NCT00574743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722647|NCT00574743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722648|NCT04595825|Antibodies|antibodies|mesh-list
92722649|NCT04595825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92722650|NCT04595825|Immunologic Factors|immunologic factors|mesh-ancestor
92722651|NCT04595825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722653|NCT04595318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92722654|NCT04595318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92722655|NCT04595318|Cholinergic Agents|cholinergic agents|mesh-ancestor
92722656|NCT04595318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722657|NCT04595318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722658|NCT04595318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722659|NCT00577668|Thalidomide|thalidomide|mesh-list
92722660|NCT00577668|Dexamethasone|dexamethasone|mesh-list
92722661|NCT00577668|Melphalan|melphalan|mesh-list
92722662|NCT00577668|Bortezomib|bortezomib|mesh-list
92722663|NCT00577668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722664|NCT00577668|Antiemetics|antiemetics|mesh-ancestor
92722665|NCT00577668|Autonomic Agents|autonomic agents|mesh-ancestor
92722666|NCT00577668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722667|NCT00577668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722668|NCT00577668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722669|NCT00577668|Glucocorticoids|glucocorticoids|mesh-ancestor
92722670|NCT00577668|Hormones|hormones|mesh-ancestor
92722671|NCT00577668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722672|NCT00577668|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92722673|NCT00577668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722674|NCT00577668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92722675|NCT00577668|Alkylating Agents|alkylating agents|mesh-ancestor
92722676|NCT00577668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722677|NCT00577668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92722678|NCT00577668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722679|NCT00577668|Immunologic Factors|immunologic factors|mesh-ancestor
92722680|NCT00577668|Leprostatic Agents|leprostatic agents|mesh-ancestor
92722681|NCT00577668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92722682|NCT00577668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722683|NCT00577668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92722684|NCT00577668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92722685|NCT00577668|Growth Substances|growth substances|mesh-ancestor
92722686|NCT00577668|Growth Inhibitors|growth inhibitors|mesh-ancestor
92722687|NCT01147744|Fluticasone|fluticasone|mesh-list
92722688|NCT01147744|Xhance|xhance|mesh-list
92722689|NCT01147744|Montelukast|montelukast|mesh-list
92722690|NCT01147744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722691|NCT01147744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92722692|NCT01147744|Autonomic Agents|autonomic agents|mesh-ancestor
92722693|NCT01147744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722694|NCT01147744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722695|NCT01147744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722696|NCT01147744|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722697|NCT01147744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722698|NCT01147744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92722699|NCT01147744|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92722700|NCT01147744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92722701|NCT01147744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722702|NCT01147744|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92722703|NCT01147744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92722704|NCT01147744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722705|NCT04313374|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92722706|NCT04313374|Morphine|morphine|mesh-list
92722707|NCT04313374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92722708|NCT04313374|Narcotics|narcotics|mesh-ancestor
92722709|NCT04313374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92722710|NCT04313374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722711|NCT04313374|Analgesics|analgesics|mesh-ancestor
92722712|NCT04313374|Sensory System Agents|sensory system agents|mesh-ancestor
92722713|NCT04313374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722714|NCT04313374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92722715|NCT04313374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92722716|NCT04313374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722717|NCT04313374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722718|NCT04313335|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92722719|NCT04313335|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92722720|NCT04313335|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92722721|NCT04313335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92722722|NCT04313335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722732|NCT00577980|Androgens|androgens|mesh-ancestor
92722733|NCT00577980|Hormones|hormones|mesh-ancestor
92722734|NCT00577980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722735|NCT00577980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722736|NCT04594343|Disulfiram|disulfiram|mesh-list
92722737|NCT04594343|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92722738|NCT04594343|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92722739|NCT04594343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722740|NCT04594343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722741|NCT01147393|Epratuzumab|epratuzumab|mesh-list
92722742|NCT01147393|Veltuzumab|veltuzumab|mesh-list
92722743|NCT01147393|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92722744|NCT01147393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92722745|NCT01147393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722746|NCT01147393|Chelating Agents|chelating agents|mesh-ancestor
92722747|NCT01147393|Sequestering Agents|sequestering agents|mesh-ancestor
92722748|NCT01147393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722749|NCT00578097|Botulinum Toxins|botulinum toxins|mesh-list
92722750|NCT00578097|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92722751|NCT00578097|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92722752|NCT00578097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92722753|NCT00578097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92722754|NCT00578097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722755|NCT00578097|Cholinergic Agents|cholinergic agents|mesh-ancestor
92722756|NCT00578097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722757|NCT00578097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722758|NCT00578097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92722759|NCT00578097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722760|NCT00578370|Cyclosporine|cyclosporine|mesh-list
92722761|NCT00578370|Betamethasone|betamethasone|mesh-list
92722762|NCT00578370|Calcipotriene|calcipotriene|mesh-list
92722763|NCT00578370|Cyclosporins|cyclosporins|mesh-list
92722764|NCT00578370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722765|NCT00578370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722766|NCT00578370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92722767|NCT00578370|Immunologic Factors|immunologic factors|mesh-ancestor
92722768|NCT00578370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722769|NCT00578370|Antifungal Agents|antifungal agents|mesh-ancestor
92722770|NCT00578370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722771|NCT00578370|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722772|NCT00578370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722773|NCT00578370|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92722774|NCT00578370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722775|NCT00578370|Glucocorticoids|glucocorticoids|mesh-ancestor
92722776|NCT00578370|Hormones|hormones|mesh-ancestor
92722777|NCT00578370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722778|NCT00578370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722779|NCT00578370|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722780|NCT04593836|Peppermint oil|peppermint oil|mesh-list
92722781|NCT04593836|Menthol|menthol|mesh-list
92610089|NCT04517188|Trace Elements|trace elements|mesh-ancestor
92610090|NCT04517188|Micronutrients|micronutrients|mesh-ancestor
92610091|NCT04517188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610092|NCT04517188|Plasma Substitutes|plasma substitutes|mesh-ancestor
92610093|NCT04517188|Blood Substitutes|blood substitutes|mesh-ancestor
92610094|NCT00162552|Pentoxifylline|pentoxifylline|mesh-list
92610095|NCT00162552|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92610096|NCT00162552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722782|NCT04593836|Antipruritics|antipruritics|mesh-ancestor
92722783|NCT04593836|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722784|NCT04593836|Antiemetics|antiemetics|mesh-ancestor
92722785|NCT04593836|Autonomic Agents|autonomic agents|mesh-ancestor
92722786|NCT04593836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722787|NCT04593836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722788|NCT04593836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722789|NCT04593836|Parasympatholytics|parasympatholytics|mesh-ancestor
92722790|NCT04593524|Vitamin D|vitamin d|mesh-list
92722791|NCT04593524|Vitamins|vitamins|mesh-ancestor
92722792|NCT04593524|Micronutrients|micronutrients|mesh-ancestor
92722793|NCT04593524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722794|NCT04593524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92722795|NCT00578526|Sunitinib|sunitinib|mesh-list
92722796|NCT00578526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722797|NCT00578526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92722798|NCT00578526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92722799|NCT00578526|Growth Substances|growth substances|mesh-ancestor
92722800|NCT00578526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722801|NCT00578526|Growth Inhibitors|growth inhibitors|mesh-ancestor
92722802|NCT00578526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92722803|NCT00578526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722804|NCT00578526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722805|NCT04593446|Picosulfate sodium|picosulfate sodium|mesh-list
92722806|NCT04593446|Cathartics|cathartics|mesh-ancestor
92722807|NCT04593446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722809|NCT00566891|Clopidogrel|clopidogrel|mesh-list
92722810|NCT00566891|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92722811|NCT00566891|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92722812|NCT00566891|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92722813|NCT00566891|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92722814|NCT00566891|Purinergic Agents|purinergic agents|mesh-ancestor
92722815|NCT00566891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722816|NCT00566891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722817|NCT00566891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722818|NCT00566891|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92722819|NCT00566891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92722820|NCT00578760|Aspirin|aspirin|mesh-list
92722821|NCT00578760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92722822|NCT00578760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92722823|NCT00578760|Analgesics|analgesics|mesh-ancestor
92722824|NCT00578760|Sensory System Agents|sensory system agents|mesh-ancestor
92722825|NCT00578760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722826|NCT00578760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722827|NCT00578760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722828|NCT00578760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722829|NCT00578760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92722830|NCT00578760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92722831|NCT00578760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722832|NCT00578760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92722833|NCT00578760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92722834|NCT00578760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722835|NCT00578760|Antipyretics|antipyretics|mesh-ancestor
92722836|NCT04592822|Dabigatran|dabigatran|mesh-list
92722837|NCT04592822|Antithrombins|antithrombins|mesh-ancestor
92722838|NCT04592822|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92722839|NCT04592822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92722840|NCT04592822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722841|NCT04592822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722842|NCT04592822|Anticoagulants|anticoagulants|mesh-ancestor
92610097|NCT00162552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610098|NCT00162552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92722843|NCT00567047|Vildagliptin|vildagliptin|mesh-list
92722844|NCT00567047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92722845|NCT00567047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722846|NCT00567047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92722847|NCT00567047|Protease Inhibitors|protease inhibitors|mesh-ancestor
92722848|NCT00567047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722849|NCT00567047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722850|NCT04592666|Carboplatin|carboplatin|mesh-list
92722852|NCT04592666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722853|NCT04592666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722854|NCT04592666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722855|NCT04592666|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92722856|NCT04592666|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92722857|NCT04593056|Warfarin|warfarin|mesh-list
92722858|NCT04593056|Rivaroxaban|rivaroxaban|mesh-list
92722859|NCT04593056|Anticoagulants|anticoagulants|mesh-ancestor
92722860|NCT04593056|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92722861|NCT04593056|Antithrombins|antithrombins|mesh-ancestor
92722862|NCT04593056|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92722863|NCT04593056|Protease Inhibitors|protease inhibitors|mesh-ancestor
92722864|NCT04593056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722865|NCT04593056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722869|NCT04592198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722870|NCT04592198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722871|NCT04592198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722872|NCT04592198|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92722873|NCT04592198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92722874|NCT04592198|Serotonin Agents|serotonin agents|mesh-ancestor
92722875|NCT04592198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722876|NCT04592198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722877|NCT04592081|Dexamethasone|dexamethasone|mesh-list
92722878|NCT04592081|Dexamethasone acetate|dexamethasone acetate|mesh-list
92722880|NCT04592081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92722881|NCT04592081|Antiemetics|antiemetics|mesh-ancestor
92722883|NCT04592081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722884|NCT04592081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722885|NCT04592081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722886|NCT04592081|Glucocorticoids|glucocorticoids|mesh-ancestor
92722887|NCT04592081|Hormones|hormones|mesh-ancestor
92722888|NCT04592081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92722889|NCT04592081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92722890|NCT04592081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722891|NCT04592081|Protease Inhibitors|protease inhibitors|mesh-ancestor
92722892|NCT04592081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722893|NCT04592081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722894|NCT04591847|Vitamin D|vitamin d|mesh-list
92722895|NCT04591847|Ergocalciferols|ergocalciferols|mesh-list
92722896|NCT04591847|Vitamins|vitamins|mesh-ancestor
92722897|NCT04591847|Micronutrients|micronutrients|mesh-ancestor
92722898|NCT04591847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722899|NCT04591847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92722900|NCT04591847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92722901|NCT04591535|Levodopa|levodopa|mesh-list
92722902|NCT04591535|Carbidopa|carbidopa|mesh-list
92722903|NCT04591535|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92722904|NCT04591535|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92722905|NCT04591535|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92722906|NCT04591535|Dopamine Agents|dopamine agents|mesh-ancestor
92722907|NCT04591535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722908|NCT04591535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722909|NCT04591535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722910|NCT04591535|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92722911|NCT04591535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722912|NCT04591535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92722913|NCT04591535|Immunologic Factors|immunologic factors|mesh-ancestor
92722914|NCT04591535|Dopamine Agonists|dopamine agonists|mesh-ancestor
92722915|NCT00580242|Lenalidomide|lenalidomide|mesh-list
92722916|NCT00580242|Bortezomib|bortezomib|mesh-list
92610099|NCT00162552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92610100|NCT00162552|Protective Agents|protective agents|mesh-ancestor
92610101|NCT00162552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722917|NCT00580242|Immunologic Factors|immunologic factors|mesh-ancestor
92722918|NCT00580242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722919|NCT00580242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92722920|NCT00580242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92722921|NCT00580242|Growth Substances|growth substances|mesh-ancestor
92722922|NCT00580242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92722923|NCT00580242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722924|NCT04591457|Insulin|insulin|mesh-list
92722925|NCT04591457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92722926|NCT04591457|Insulin Glargine|insulin glargine|mesh-list
92722927|NCT04591457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92722928|NCT04591457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722929|NCT00580320|Bortezomib|bortezomib|mesh-list
92722930|NCT00580320|Dacarbazine|dacarbazine|mesh-list
92722931|NCT00580320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722932|NCT00580320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92722933|NCT00580320|Alkylating Agents|alkylating agents|mesh-ancestor
92722934|NCT00580320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722935|NCT00580359|Capecitabine|capecitabine|mesh-list
92722936|NCT00580359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92722937|NCT00580359|Antimetabolites|antimetabolites|mesh-ancestor
92722938|NCT00580359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722942|NCT00580437|Sympathomimetics|sympathomimetics|mesh-ancestor
92722943|NCT00580437|Autonomic Agents|autonomic agents|mesh-ancestor
92722944|NCT00580437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722945|NCT00580437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722946|NCT00580437|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92722947|NCT00580437|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92722948|NCT00580437|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92722949|NCT00580437|Adrenergic Agents|adrenergic agents|mesh-ancestor
92722950|NCT00580437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722951|NCT00580437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722952|NCT00580437|Protective Agents|protective agents|mesh-ancestor
92722954|NCT00580827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92722955|NCT00580827|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92722956|NCT00580827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722957|NCT00580827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722958|NCT00580905|Adenosine|adenosine|mesh-list
92722959|NCT00580905|Nitroprusside|nitroprusside|mesh-list
92722960|NCT00580905|Analgesics|analgesics|mesh-ancestor
92722961|NCT00580905|Sensory System Agents|sensory system agents|mesh-ancestor
92722962|NCT00580905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722963|NCT00580905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722964|NCT00580905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92722965|NCT00580905|Vasodilator Agents|vasodilator agents|mesh-ancestor
92722966|NCT00580905|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92722967|NCT00580905|Purinergic Agonists|purinergic agonists|mesh-ancestor
92722968|NCT00580905|Purinergic Agents|purinergic agents|mesh-ancestor
92722969|NCT00580905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722970|NCT00580905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722971|NCT00580905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92722972|NCT00580905|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92722973|NCT04590638|Epinephrine|epinephrine|mesh-list
92722974|NCT04590638|Racepinephrine|racepinephrine|mesh-list
92722975|NCT04590638|Epinephryl borate|epinephryl borate|mesh-list
92722976|NCT04590638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92722977|NCT04590638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92722978|NCT04590638|Adrenergic Agents|adrenergic agents|mesh-ancestor
92610102|NCT00162552|Vasodilator Agents|vasodilator agents|mesh-ancestor
92610103|NCT00162552|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92610104|NCT00162552|Antioxidants|antioxidants|mesh-ancestor
92610105|NCT04516681|Ascorbic Acid|ascorbic acid|mesh-list
92610106|NCT04516681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610107|NCT04516681|Vitamins|vitamins|mesh-ancestor
92610108|NCT04516681|Micronutrients|micronutrients|mesh-ancestor
92722979|NCT04590638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722980|NCT04590638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722981|NCT04590638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722982|NCT04590638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92722983|NCT04590638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92722984|NCT04590638|Autonomic Agents|autonomic agents|mesh-ancestor
92396979|NCT05271058|BB 1101|bb 1101|mesh-list
92722985|NCT04590638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722986|NCT04590638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92722987|NCT04590638|Respiratory System Agents|respiratory system agents|mesh-ancestor
92722988|NCT04590638|Mydriatics|mydriatics|mesh-ancestor
92722989|NCT04590638|Sympathomimetics|sympathomimetics|mesh-ancestor
92722990|NCT04590638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92722991|NCT00567554|Paclitaxel|paclitaxel|mesh-list
92722992|NCT00567554|Docetaxel|docetaxel|mesh-list
92722993|NCT00567554|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92722994|NCT00567554|Cyclophosphamide|cyclophosphamide|mesh-list
92722995|NCT00567554|Bevacizumab|bevacizumab|mesh-list
92722996|NCT00567554|Trastuzumab|trastuzumab|mesh-list
92722997|NCT00567554|Everolimus|everolimus|mesh-list
92722998|NCT00567554|Epirubicin|epirubicin|mesh-list
92722999|NCT00567554|Lapatinib|lapatinib|mesh-list
92723000|NCT00567554|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92723001|NCT00567554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723002|NCT00567554|Tubulin Modulators|tubulin modulators|mesh-ancestor
92723003|NCT00567554|Antimitotic Agents|antimitotic agents|mesh-ancestor
92723010|NCT00567554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92723011|NCT00567554|Alkylating Agents|alkylating agents|mesh-ancestor
92723012|NCT00567554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92723013|NCT00567554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92723014|NCT00567554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92723015|NCT00567554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92723016|NCT00567554|Growth Substances|growth substances|mesh-ancestor
92723017|NCT00567554|Growth Inhibitors|growth inhibitors|mesh-ancestor
92723018|NCT00567554|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92723019|NCT00567554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92723020|NCT00567554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723021|NCT00567554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92723022|NCT00567554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92723023|NCT00567554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92723024|NCT00581139|Midazolam|midazolam|mesh-list
92723025|NCT00581139|Anesthetics|anesthetics|mesh-ancestor
92723026|NCT00581139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723027|NCT00581139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723028|NCT00581139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92723029|NCT00581139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92723030|NCT00581139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92723031|NCT00581139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723032|NCT00581139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723033|NCT00581139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92723034|NCT00581139|Anesthetics, General|anesthetics, general|mesh-ancestor
92723035|NCT00581139|GABA Modulators|gaba modulators|mesh-ancestor
92723036|NCT00581139|GABA Agents|gaba agents|mesh-ancestor
92723037|NCT00581139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723038|NCT00581139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723039|NCT04590482|Letrozole|letrozole|mesh-list
92723040|NCT04590482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723041|NCT04590482|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92723042|NCT04590482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92723043|NCT04590482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723044|NCT04590482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723045|NCT04590482|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92723046|NCT04590482|Hormone Antagonists|hormone antagonists|mesh-ancestor
92723047|NCT04590482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610109|NCT04516681|Antioxidants|antioxidants|mesh-ancestor
92610110|NCT04516681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610111|NCT04516681|Protective Agents|protective agents|mesh-ancestor
92610112|NCT00141791|Etanercept|etanercept|mesh-list
92610113|NCT00141791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723048|NCT04590482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723049|NCT00581217|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92723050|NCT00581217|Laxatives|laxatives|mesh-ancestor
92723051|NCT00581217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723052|NCT00567710|Risperidone|risperidone|mesh-list
92723053|NCT00567710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92723054|NCT00567710|Serotonin Agents|serotonin agents|mesh-ancestor
92723055|NCT00567710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723056|NCT00567710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723057|NCT00567710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723058|NCT00567710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92723059|NCT00567710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723060|NCT00567710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723061|NCT00567710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723062|NCT00567710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92723063|NCT00567710|Dopamine Agents|dopamine agents|mesh-ancestor
92723064|NCT04589429|Morphine|morphine|mesh-list
92723065|NCT04589429|Nalbuphine|nalbuphine|mesh-list
92723066|NCT04589429|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92723067|NCT04589429|Narcotics|narcotics|mesh-ancestor
92723068|NCT04589429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723069|NCT04589429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723070|NCT04589429|Analgesics|analgesics|mesh-ancestor
92723071|NCT04589429|Sensory System Agents|sensory system agents|mesh-ancestor
92723073|NCT04589390|Selexipag|selexipag|mesh-list
92723074|NCT04589390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92723075|NCT04577040|Tadalafil|tadalafil|mesh-list
92723076|NCT04577040|Vasodilator Agents|vasodilator agents|mesh-ancestor
92723077|NCT04577040|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92723078|NCT04577040|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92723079|NCT04577040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723080|NCT04577040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723081|NCT04577040|Urological Agents|urological agents|mesh-ancestor
92723082|NCT04589234|Gemcitabine|gemcitabine|mesh-list
92723083|NCT04589234|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92723084|NCT04589234|Folfirinox|folfirinox|mesh-list
92723085|NCT04589234|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92723086|NCT04589234|Antimetabolites|antimetabolites|mesh-ancestor
92723087|NCT04589234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723088|NCT04589234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723089|NCT03453177|Fosfomycin|fosfomycin|mesh-list
92723090|NCT03453177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723091|NCT03453177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723092|NCT04594629|Nitroglycerin|nitroglycerin|mesh-list
92723093|NCT04594629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92723094|NCT04588532|Doxepin|doxepin|mesh-list
92723095|NCT04588532|Histamine|histamine|mesh-list
92723096|NCT04588532|Histamine Agonists|histamine agonists|mesh-ancestor
92723097|NCT04588532|Histamine Agents|histamine agents|mesh-ancestor
92723098|NCT04588532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723099|NCT04588532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723100|NCT04588532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723101|NCT04588532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92723102|NCT04588532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92723103|NCT04588532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723104|NCT04588532|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92723105|NCT04588532|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723106|NCT04588532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723107|NCT04588532|Histamine Antagonists|histamine antagonists|mesh-ancestor
92723108|NCT04577430|Dexmedetomidine|dexmedetomidine|mesh-list
92723109|NCT04577430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92723110|NCT04577430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723111|NCT04577430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610114|NCT00141791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92610115|NCT00141791|Analgesics|analgesics|mesh-ancestor
92610116|NCT00141791|Sensory System Agents|sensory system agents|mesh-ancestor
92094271|NCT03090880|Tinzaparin|tinzaparin|mesh-list
92723112|NCT04577430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723113|NCT04577430|Analgesics|analgesics|mesh-ancestor
92723114|NCT04577430|Sensory System Agents|sensory system agents|mesh-ancestor
92723115|NCT04577430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723116|NCT04577430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92723117|NCT04577430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92723118|NCT04577430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92723119|NCT04577430|Adrenergic Agents|adrenergic agents|mesh-ancestor
92723120|NCT04577430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723121|NCT04577430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723122|NCT00567788|Bimatoprost|bimatoprost|mesh-list
92723123|NCT00567788|Latanoprost|latanoprost|mesh-list
92723124|NCT00567788|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92723125|NCT00567788|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92723126|NCT00567788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92723127|NCT00581607|Bosentan|bosentan|mesh-list
92723128|NCT00581607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92723129|NCT00581607|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92723130|NCT00581607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723131|NCT00581685|Celecoxib|celecoxib|mesh-list
92723132|NCT00581685|Pregabalin|pregabalin|mesh-list
92723133|NCT00581685|Analgesics|analgesics|mesh-ancestor
92723134|NCT00581685|Sensory System Agents|sensory system agents|mesh-ancestor
92723135|NCT00581685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723136|NCT00581685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723137|NCT00581685|Anticonvulsants|anticonvulsants|mesh-ancestor
92723138|NCT00581685|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92723139|NCT00581685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723140|NCT00581685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723141|NCT00581685|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92723142|NCT00581685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92723148|NCT00581685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723149|NCT00581685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723150|NCT00581685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92723151|NCT00581685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723152|NCT00581685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723154|NCT04588220|Melatonin|melatonin|mesh-list
92723155|NCT04588220|Antioxidants|antioxidants|mesh-ancestor
92723156|NCT04588220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723157|NCT04588220|Protective Agents|protective agents|mesh-ancestor
92723158|NCT04588220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723159|NCT04588220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723160|NCT04588220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92723161|NCT04588220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92723162|NCT04586543|Docetaxel|docetaxel|mesh-list
92723163|NCT04586543|Selegiline|selegiline|mesh-list
92723164|NCT04586543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723165|NCT04586543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92723166|NCT04586543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92723167|NCT04586543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723168|NCT04586543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723169|NCT04586543|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723170|NCT04586543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723171|NCT04586543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92723172|NCT04586543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92723173|NCT04586543|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92723174|NCT04586543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723175|NCT04586543|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92723176|NCT04586543|Protective Agents|protective agents|mesh-ancestor
92723177|NCT04586543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723178|NCT04586465|Carboplatin|carboplatin|mesh-list
92723179|NCT04586465|Gemcitabine|gemcitabine|mesh-list
92723180|NCT04586465|Pembrolizumab|pembrolizumab|mesh-list
92723181|NCT04586465|Pemetrexed|pemetrexed|mesh-list
92723182|NCT04586465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723183|NCT04586465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92723184|NCT04586465|Antimetabolites|antimetabolites|mesh-ancestor
92723185|NCT04586465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610118|NCT00141791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610119|NCT00141791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92610120|NCT00141791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92610121|NCT00141791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723186|NCT04586465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92723187|NCT04586465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92723188|NCT04586465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723189|NCT04586465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92723190|NCT04586465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92723191|NCT00566865|Gemfibrozil|gemfibrozil|mesh-list
92396997|NCT05271045|Vitamin D|vitamin d|mesh-list
92723192|NCT00566865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92723193|NCT00566865|Antimetabolites|antimetabolites|mesh-ancestor
92723194|NCT00566865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723195|NCT00566865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92723196|NCT00566865|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92723197|NCT00566865|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92723198|NCT00566865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723199|NCT04585997|Omalizumab|omalizumab|mesh-list
92723200|NCT04585997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92723201|NCT04585997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92723202|NCT04585997|Respiratory System Agents|respiratory system agents|mesh-ancestor
92723203|NCT04593108|Letrozole|letrozole|mesh-list
92723204|NCT04593108|Misoprostol|misoprostol|mesh-list
92723205|NCT04593108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723206|NCT04593108|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92723207|NCT04593108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92723208|NCT04593108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723209|NCT04593108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723210|NCT04593108|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92723211|NCT04593108|Hormone Antagonists|hormone antagonists|mesh-ancestor
92723213|NCT04593108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723214|NCT04593108|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92723215|NCT04593108|Abortifacient Agents|abortifacient agents|mesh-ancestor
92723216|NCT04593108|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92723217|NCT04593108|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92723218|NCT04593108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723219|NCT04593108|Oxytocics|oxytocics|mesh-ancestor
92723221|NCT04585334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723222|NCT04585334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723223|NCT04585334|Analgesics|analgesics|mesh-ancestor
92723224|NCT04585334|Sensory System Agents|sensory system agents|mesh-ancestor
92723225|NCT04585334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723226|NCT04585334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723227|NCT04585334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723228|NCT04585334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723229|NCT04585334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723230|NCT04585334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723231|NCT04585334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723232|NCT04585412|Palonosetron|palonosetron|mesh-list
92723233|NCT04585412|Antiemetics|antiemetics|mesh-ancestor
92723234|NCT04585412|Autonomic Agents|autonomic agents|mesh-ancestor
92723235|NCT04585412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723236|NCT04585412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723237|NCT04585412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723238|NCT04585412|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92723239|NCT04585412|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92723240|NCT04585412|Serotonin Agents|serotonin agents|mesh-ancestor
92723241|NCT04585412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723242|NCT04585412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723243|NCT00567866|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92723244|NCT00567866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723245|NCT00567866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723246|NCT00567866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92723247|NCT00567866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723248|NCT00567866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723249|NCT00567866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723250|NCT00567983|Cyclosporine|cyclosporine|mesh-list
92610122|NCT00141791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610123|NCT00141791|Immunologic Factors|immunologic factors|mesh-ancestor
92610124|NCT04516603|4-Aminopyridine|4-aminopyridine|mesh-list
92610125|NCT04516603|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92723251|NCT00567983|Cyclosporins|cyclosporins|mesh-list
92723252|NCT00567983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723253|NCT00567983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723254|NCT00567983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92723255|NCT00567983|Immunologic Factors|immunologic factors|mesh-ancestor
92723256|NCT00567983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723257|NCT00567983|Antifungal Agents|antifungal agents|mesh-ancestor
92723258|NCT00567983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723259|NCT00567983|Dermatologic Agents|dermatologic agents|mesh-ancestor
92723260|NCT00567983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723261|NCT00567983|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92723262|NCT00582582|Vitamin D|vitamin d|mesh-list
92723263|NCT00582582|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92723264|NCT00582582|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92723265|NCT00582582|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92723266|NCT00582582|Docetaxel|docetaxel|mesh-list
92723267|NCT00582582|Vitamins|vitamins|mesh-ancestor
92723268|NCT00582582|Micronutrients|micronutrients|mesh-ancestor
92723269|NCT00582582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723270|NCT00582582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723271|NCT00582582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92723272|NCT00582582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92723273|NCT00582582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723274|NCT00582582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723275|NCT00582582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92723276|NCT00566904|Aspirin|aspirin|mesh-list
92723277|NCT00566904|Lidocaine|lidocaine|mesh-list
92723278|NCT00566904|Anesthetics, Local|anesthetics, local|mesh-list
92723279|NCT00566904|Anesthetics|anesthetics|mesh-list
92723280|NCT00566904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723281|NCT00566904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723282|NCT00566904|Sensory System Agents|sensory system agents|mesh-ancestor
92723283|NCT00566904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723286|NCT00566904|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92723287|NCT00566904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723288|NCT00566904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723289|NCT00566904|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723290|NCT00566904|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723291|NCT00566904|Analgesics|analgesics|mesh-ancestor
92723292|NCT00566904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723293|NCT00566904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723294|NCT00566904|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92723295|NCT00566904|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92723296|NCT00566904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92723297|NCT00566904|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723298|NCT00566904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723299|NCT00566904|Antipyretics|antipyretics|mesh-ancestor
92723300|NCT04584983|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92723301|NCT04584983|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92723302|NCT04584983|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92723303|NCT04584983|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92723304|NCT04584515|Itraconazole|itraconazole|mesh-list
92723305|NCT04584515|Rifampin|rifampin|mesh-list
92723306|NCT04584515|Antifungal Agents|antifungal agents|mesh-ancestor
92723307|NCT04584515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723308|NCT04584515|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92723309|NCT04584515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92723310|NCT04584515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723311|NCT04584515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723312|NCT04584515|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92723313|NCT04584515|Hormone Antagonists|hormone antagonists|mesh-ancestor
92723314|NCT04584515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723315|NCT04584515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723316|NCT04584515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92723317|NCT04584515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92610126|NCT04516603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610127|NCT04516603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610128|NCT00162591|Remifentanil|remifentanil|mesh-list
92610129|NCT00162591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92610130|NCT00162591|Narcotics|narcotics|mesh-ancestor
92610131|NCT00162591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610132|NCT00162591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610133|NCT00162591|Analgesics|analgesics|mesh-ancestor
92610134|NCT00162591|Sensory System Agents|sensory system agents|mesh-ancestor
92610135|NCT00162591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610136|NCT00505492|Paclitaxel|paclitaxel|mesh-list
92610137|NCT00505492|Cisplatin|cisplatin|mesh-list
92610138|NCT00505492|Carboplatin|carboplatin|mesh-list
92610139|NCT00505492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92610140|NCT00505492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610141|NCT00505492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92723318|NCT04584515|Antitubercular Agents|antitubercular agents|mesh-ancestor
92723319|NCT04584515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723320|NCT04584515|Leprostatic Agents|leprostatic agents|mesh-ancestor
92723321|NCT04584515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92723322|NCT04584515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92723323|NCT04584515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92723324|NCT04584515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92723325|NCT04584515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92723326|NCT04584515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92723327|NCT04584515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92723328|NCT04584710|Dactolisib|dactolisib|mesh-list
92723329|NCT04584710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723330|NCT04584671|Xenon|xenon|mesh-list
92723331|NCT04584671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92723332|NCT04584671|Anesthetics, General|anesthetics, general|mesh-ancestor
92723333|NCT04584671|Anesthetics|anesthetics|mesh-ancestor
92723334|NCT04584671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723335|NCT04584671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723336|NCT04584008|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92723337|NCT04584008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723338|NCT04584008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723339|NCT04584008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723340|NCT04592211|Paclitaxel|paclitaxel|mesh-list
92723341|NCT04592211|Pembrolizumab|pembrolizumab|mesh-list
92723342|NCT04592211|Olaparib|olaparib|mesh-list
92723343|NCT04592211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92723344|NCT04592211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723345|NCT04592211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92723346|NCT04592211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92723347|NCT04592211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723348|NCT04592211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723349|NCT04592211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92723350|NCT04592211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92723351|NCT04592211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92723360|NCT04576143|Cyclophosphamide|cyclophosphamide|mesh-list
92723361|NCT04576143|Epirubicin|epirubicin|mesh-list
92723362|NCT04576143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92723363|NCT04576143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723364|NCT04576143|Tubulin Modulators|tubulin modulators|mesh-ancestor
92723365|NCT04576143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92723366|NCT04576143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723367|NCT04576143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610143|NCT00505492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723368|NCT04576143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92723369|NCT04576143|Immunologic Factors|immunologic factors|mesh-ancestor
92723370|NCT04576143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723371|NCT04576143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723372|NCT04576143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92723373|NCT04576143|Alkylating Agents|alkylating agents|mesh-ancestor
92723374|NCT04576143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92723375|NCT04576143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92723376|NCT04576143|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92723377|NCT04576143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92723378|NCT04576143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723379|NCT04583267|Tenofovir|tenofovir|mesh-list
92723380|NCT04583267|Emtricitabine|emtricitabine|mesh-list
92723381|NCT04583267|Antiviral Agents|antiviral agents|mesh-ancestor
92723382|NCT04583267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723383|NCT04583267|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92723384|NCT04583267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92723385|NCT04583267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723386|NCT04583267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723387|NCT04583267|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92723388|NCT04583267|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92723389|NCT04583111|Domperidone|domperidone|mesh-list
92723390|NCT04583111|Sulpiride|sulpiride|mesh-list
92723391|NCT04583111|Antiemetics|antiemetics|mesh-ancestor
92723392|NCT04583111|Autonomic Agents|autonomic agents|mesh-ancestor
92723393|NCT04583111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723394|NCT04583111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723395|NCT04583111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723396|NCT04583111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92723397|NCT04583111|Dopamine Agents|dopamine agents|mesh-ancestor
92723398|NCT04583111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723399|NCT04583111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723400|NCT04583111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92723401|NCT04583111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723402|NCT04583111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723403|NCT04583111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723404|NCT04583111|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92723405|NCT04583111|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723406|NCT01146613|Varenicline|varenicline|mesh-list
92723407|NCT01146613|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92723408|NCT01146613|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92723409|NCT01146613|Cholinergic Agents|cholinergic agents|mesh-ancestor
92723410|NCT01146613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723411|NCT01146613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723412|NCT01146613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723413|NCT01145755|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92723417|NCT01145755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723418|NCT01145755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723419|NCT01145755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723420|NCT01145755|Analgesics|analgesics|mesh-ancestor
92723421|NCT01145755|Sensory System Agents|sensory system agents|mesh-ancestor
92723422|NCT01145755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723423|NCT01145755|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723424|NCT01145755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723425|NCT01145755|Dopamine Agents|dopamine agents|mesh-ancestor
92723426|NCT04591743|Nicotine|nicotine|mesh-list
92723427|NCT04591743|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92723428|NCT04591743|Autonomic Agents|autonomic agents|mesh-ancestor
92723429|NCT04591743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723430|NCT04591743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723431|NCT04591743|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92723432|NCT04591743|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92723433|NCT04591743|Cholinergic Agents|cholinergic agents|mesh-ancestor
92723434|NCT04591743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723435|NCT04591743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723436|NCT00567060|Piracetam|piracetam|mesh-list
92610144|NCT00505492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610146|NCT00141830|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92610147|NCT00141830|Abortifacient Agents|abortifacient agents|mesh-ancestor
92610148|NCT00141830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92610149|NCT00141830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094640|NCT03020680|Ubiquinone|ubiquinone|mesh-list
92723437|NCT00567060|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92723438|NCT00567060|Protective Agents|protective agents|mesh-ancestor
92723439|NCT00567060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723440|NCT00567060|Nootropic Agents|nootropic agents|mesh-ancestor
92723441|NCT00568217|Acetaminophen|acetaminophen|mesh-list
92723442|NCT00568217|Ibuprofen|ibuprofen|mesh-list
92723443|NCT00568217|Diclofenac|diclofenac|mesh-list
92723444|NCT00568217|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723445|NCT00568217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723446|NCT00568217|Analgesics|analgesics|mesh-ancestor
92723447|NCT00568217|Sensory System Agents|sensory system agents|mesh-ancestor
92723448|NCT00568217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723449|NCT00568217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723450|NCT00568217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723451|NCT00568217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723452|NCT00568217|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723453|NCT00568217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723454|NCT00568217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397021|NCT05270434|Sensory System Agents|sensory system agents|mesh-ancestor
92723456|NCT00583323|Atropine sulfate-diphenoxylate hydrochloride drug combination|atropine sulfate-diphenoxylate hydrochloride drug combination|mesh-list
92723457|NCT00583323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723458|NCT04582604|Decitabine|decitabine|mesh-list
92723459|NCT04582604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92723460|NCT04582604|Antimetabolites|antimetabolites|mesh-ancestor
92723461|NCT04582604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723462|NCT04582604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723463|NCT04582604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723464|NCT00590928|Esomeprazole|esomeprazole|mesh-list
92723465|NCT00590928|Ranitidine|ranitidine|mesh-list
92723466|NCT00590928|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92723467|NCT00590928|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92723468|NCT00590928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723469|NCT00590928|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92723470|NCT00590928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723471|NCT00590928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723472|NCT00590928|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92723473|NCT00590928|Histamine Antagonists|histamine antagonists|mesh-ancestor
92723474|NCT00590928|Histamine Agents|histamine agents|mesh-ancestor
92723475|NCT00590928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723476|NCT00590928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723477|NCT01145482|Insulin|insulin|mesh-list
92723478|NCT01145482|Insulin Aspart|insulin aspart|mesh-list
92723479|NCT01145482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92723480|NCT01145482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723481|NCT00568295|Acetaminophen|acetaminophen|mesh-list
92723482|NCT00568295|Rofecoxib|rofecoxib|mesh-list
92723483|NCT00568295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723484|NCT00568295|Analgesics|analgesics|mesh-ancestor
92723489|NCT00568295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92723490|NCT00568295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723491|NCT00568295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723492|NCT00568295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723493|NCT00568295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723494|NCT00568295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723495|NCT00568295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723496|NCT00591162|Tetracycline|tetracycline|mesh-list
92723497|NCT00591162|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723498|NCT00591162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723499|NCT00591162|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92723500|NCT00591162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610150|NCT00141830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610151|NCT00141830|Antimetabolites|antimetabolites|mesh-ancestor
92610152|NCT00141830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610153|NCT00141830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610154|NCT00141830|Dermatologic Agents|dermatologic agents|mesh-ancestor
92723501|NCT00591162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723502|NCT00583518|Hormones|hormones|mesh-list
92723503|NCT00583518|Parathyroid Hormone|parathyroid hormone|mesh-list
92723504|NCT00583518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723505|NCT00583518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723506|NCT00583518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92723507|NCT04582136|Sirolimus|sirolimus|mesh-list
92723508|NCT04582136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723509|NCT04582136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723510|NCT04582136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92723511|NCT04582136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723512|NCT04582136|Antifungal Agents|antifungal agents|mesh-ancestor
92723513|NCT04582136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92723514|NCT04582136|Immunologic Factors|immunologic factors|mesh-ancestor
92723515|NCT04582136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723516|NCT00591201|Infliximab|infliximab|mesh-list
92723517|NCT00591201|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92723518|NCT00591201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723519|NCT00591201|Dermatologic Agents|dermatologic agents|mesh-ancestor
92723520|NCT00591201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723521|NCT00591201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723522|NCT04582097|Ramipril|ramipril|mesh-list
92723523|NCT04582097|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92723524|NCT04582097|Protease Inhibitors|protease inhibitors|mesh-ancestor
92723525|NCT04582097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723526|NCT04582097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723527|NCT04582097|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92723528|NCT00591357|Loperamide|loperamide|mesh-list
92723529|NCT00591357|Antidiarrheals|antidiarrheals|mesh-list
92723530|NCT00591357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723531|NCT04575675|Dapagliflozin|dapagliflozin|mesh-list
92723532|NCT04575675|Valsartan|valsartan|mesh-list
92723533|NCT04575675|Carvedilol|carvedilol|mesh-list
92723534|NCT04575675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92723535|NCT04575675|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92723536|NCT04575675|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92723537|NCT04575675|Mineralocorticoids|mineralocorticoids|mesh-list
92723538|NCT04575675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92723539|NCT04575675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723540|NCT04575675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92723541|NCT04575675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723542|NCT04575675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92723543|NCT04575675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92723544|NCT04575675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92723545|NCT04575675|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92723549|NCT04575675|Protective Agents|protective agents|mesh-ancestor
92723550|NCT04575675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92723551|NCT04575675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723552|NCT04575675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92723553|NCT04575675|Vasodilator Agents|vasodilator agents|mesh-ancestor
92723554|NCT04575675|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92723555|NCT04575675|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92723556|NCT04575675|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610155|NCT00141830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723557|NCT04575675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723558|NCT04575675|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92723559|NCT04575675|Diuretics|diuretics|mesh-ancestor
92723560|NCT04575675|Natriuretic Agents|natriuretic agents|mesh-ancestor
92723561|NCT04575675|Hormones|hormones|mesh-ancestor
92723562|NCT00568412|Pimecrolimus|pimecrolimus|mesh-list
92723563|NCT00568412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723564|NCT00568412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723565|NCT00568412|Analgesics|analgesics|mesh-ancestor
92723566|NCT00568412|Sensory System Agents|sensory system agents|mesh-ancestor
92723567|NCT00568412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723568|NCT00568412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723569|NCT00568412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723570|NCT00568412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723571|NCT00568412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92723572|NCT00568412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92723573|NCT00568412|Immunologic Factors|immunologic factors|mesh-ancestor
92723574|NCT00568412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92723575|NCT00568412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723576|NCT00568412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723577|NCT00568529|Capecitabine|capecitabine|mesh-list
92723578|NCT00568529|Oxaliplatin|oxaliplatin|mesh-list
92723579|NCT00568529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92723580|NCT00568529|Antimetabolites|antimetabolites|mesh-ancestor
92723581|NCT00568529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723582|NCT00568529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723583|NCT00568568|Hormones|hormones|mesh-list
92723584|NCT00568568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723585|NCT00568568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723586|NCT04575558|Azithromycin|azithromycin|mesh-list
92723587|NCT04575558|Hydroxychloroquine|hydroxychloroquine|mesh-list
92723588|NCT04575558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723589|NCT04575558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723590|NCT04575558|Antimalarials|antimalarials|mesh-ancestor
92723591|NCT04575558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92723592|NCT04575558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92723593|NCT04575558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723594|NCT04575558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723595|NCT04575558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723597|NCT00568763|Immunologic Factors|immunologic factors|mesh-ancestor
92723598|NCT00568763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723599|NCT00568841|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92723600|NCT00568841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723601|NCT00568841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92723602|NCT00568841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723603|NCT00568841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723604|NCT00583869|Pregabalin|pregabalin|mesh-list
92723605|NCT00583869|Analgesics|analgesics|mesh-ancestor
92723606|NCT00583869|Sensory System Agents|sensory system agents|mesh-ancestor
92723607|NCT00583869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723608|NCT00583869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723609|NCT00583869|Anticonvulsants|anticonvulsants|mesh-ancestor
92723610|NCT00583869|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92723611|NCT00583869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723612|NCT00583869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723613|NCT00583869|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92723614|NCT00583869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92723615|NCT00583869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723616|NCT00583869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723621|NCT00568880|Antimalarials|antimalarials|mesh-ancestor
92723622|NCT00568880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92723623|NCT00568880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92723624|NCT00568880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723625|NCT00568880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723626|NCT00568880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723627|NCT00568880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723628|NCT03451695|Morphine|morphine|mesh-list
92723629|NCT03451695|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92723630|NCT03451695|Narcotics|narcotics|mesh-ancestor
92723631|NCT03451695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723632|NCT03451695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610156|NCT00141830|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92610157|NCT00141830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610158|NCT00141830|Immunologic Factors|immunologic factors|mesh-ancestor
92610159|NCT00141830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92610160|NCT00141830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92610161|NCT04516174|Dexmedetomidine|dexmedetomidine|mesh-list
92723633|NCT03451695|Analgesics|analgesics|mesh-ancestor
92723634|NCT03451695|Sensory System Agents|sensory system agents|mesh-ancestor
92723635|NCT03451695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723636|NCT00569465|Acetylcysteine|acetylcysteine|mesh-list
92723637|NCT00569465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92723638|NCT00569465|Antiviral Agents|antiviral agents|mesh-ancestor
92723639|NCT00569465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723640|NCT00569465|Expectorants|expectorants|mesh-ancestor
92723641|NCT00569465|Respiratory System Agents|respiratory system agents|mesh-ancestor
92723642|NCT00569465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92723643|NCT00569465|Antioxidants|antioxidants|mesh-ancestor
92723644|NCT00569465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723645|NCT00569465|Protective Agents|protective agents|mesh-ancestor
92723646|NCT00569465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723647|NCT00569465|Antidotes|antidotes|mesh-ancestor
92723648|NCT00583986|Albuterol|albuterol|mesh-list
92723649|NCT00583986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92723650|NCT00583986|Autonomic Agents|autonomic agents|mesh-ancestor
92723651|NCT00583986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723652|NCT00583986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723653|NCT00583986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92723654|NCT00583986|Respiratory System Agents|respiratory system agents|mesh-ancestor
92723655|NCT00583986|Tocolytic Agents|tocolytic agents|mesh-ancestor
92723656|NCT00583986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92723657|NCT00583986|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92723658|NCT00583986|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92723659|NCT00583986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92723660|NCT00583986|Adrenergic Agents|adrenergic agents|mesh-ancestor
92723661|NCT00583986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723662|NCT00583986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723663|NCT00569621|Moxaverine|moxaverine|mesh-list
92723664|NCT00569621|Parasympatholytics|parasympatholytics|mesh-ancestor
92723665|NCT00569621|Autonomic Agents|autonomic agents|mesh-ancestor
92723666|NCT00569621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723667|NCT00569621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723668|NCT00569699|Bevacizumab|bevacizumab|mesh-list
92723669|NCT00569699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92723670|NCT00569699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723671|NCT00569699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92723672|NCT00569699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92723673|NCT00569699|Growth Substances|growth substances|mesh-ancestor
92723674|NCT00569699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723675|NCT00569699|Growth Inhibitors|growth inhibitors|mesh-ancestor
92723677|NCT00569816|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92723678|NCT00569816|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92723679|NCT00569816|Anesthetics, General|anesthetics, general|mesh-ancestor
92723680|NCT00569816|Anesthetics|anesthetics|mesh-ancestor
92723681|NCT00569816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723682|NCT00569816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723683|NCT00570050|Insulin|insulin|mesh-list
92723684|NCT00570050|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92723685|NCT00570050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92723686|NCT00570050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723687|NCT00570245|Nitric Oxide|nitric oxide|mesh-list
92723688|NCT00570245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92723689|NCT00570245|Autonomic Agents|autonomic agents|mesh-ancestor
92723690|NCT00570245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723694|NCT00570245|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92723695|NCT00570245|Antioxidants|antioxidants|mesh-ancestor
92723696|NCT00570245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723697|NCT00570245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723698|NCT00570245|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92723699|NCT00570245|Vasodilator Agents|vasodilator agents|mesh-ancestor
92610162|NCT04516174|Ropivacaine|ropivacaine|mesh-list
92610163|NCT04516174|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92610164|NCT04516174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610165|NCT04516174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610166|NCT04516174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92610167|NCT04516174|Analgesics|analgesics|mesh-ancestor
92094998|NCT03083691|Nivolumab|nivolumab|mesh-list
92723700|NCT00570245|Gasotransmitters|gasotransmitters|mesh-ancestor
92723701|NCT00570245|Protective Agents|protective agents|mesh-ancestor
92723702|NCT00570284|Panobinostat|panobinostat|mesh-list
92723703|NCT00570284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723704|NCT00570284|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92723705|NCT00570284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723706|NCT00570284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723707|NCT00570440|Levonorgestrel|levonorgestrel|mesh-list
92723708|NCT00570440|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92723709|NCT00570440|Contraceptive Agents|contraceptive agents|mesh-list
92723710|NCT00570440|Contraceptives, Oral|contraceptives, oral|mesh-list
92723711|NCT00570440|Estradiol|estradiol|mesh-list
92723712|NCT00570440|Estrogens|estrogens|mesh-ancestor
92723713|NCT00570440|Hormones|hormones|mesh-ancestor
92723714|NCT00570440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723715|NCT00570440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723716|NCT00570440|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92723717|NCT00570440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92723718|NCT00570440|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92723719|NCT00570440|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92723720|NCT00570440|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92723721|NCT00570479|Anecortave|anecortave|mesh-list
92723722|NCT00570479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92723723|NCT00570479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92723724|NCT00570479|Growth Substances|growth substances|mesh-ancestor
92723725|NCT00570479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723726|NCT00570479|Growth Inhibitors|growth inhibitors|mesh-ancestor
92723727|NCT00570479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723728|NCT00584298|Octreotide|octreotide|mesh-list
92723729|NCT00584298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723730|NCT00584298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92723731|NCT00584298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723732|NCT00584376|Pregabalin|pregabalin|mesh-list
92723733|NCT00584376|Analgesics|analgesics|mesh-ancestor
92723734|NCT00584376|Sensory System Agents|sensory system agents|mesh-ancestor
92723735|NCT00584376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723736|NCT00584376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723737|NCT00584376|Anticonvulsants|anticonvulsants|mesh-ancestor
92723738|NCT00584376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92723739|NCT00584376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723740|NCT00584376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723741|NCT00584376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92723742|NCT00584376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92723743|NCT00584376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723744|NCT00584376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723745|NCT00584376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723746|NCT00570830|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92723747|NCT00570830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723748|NCT00570830|Glucocorticoids|glucocorticoids|mesh-ancestor
92723749|NCT00570830|Hormones|hormones|mesh-ancestor
92723750|NCT00570830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723751|NCT00570830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723752|NCT00584493|Tremelimumab|tremelimumab|mesh-list
92723753|NCT00584493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723754|NCT04580342|Propranolol|propranolol|mesh-list
92723755|NCT04580342|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92723756|NCT04580342|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92723757|NCT04580342|Adrenergic Agents|adrenergic agents|mesh-ancestor
92723758|NCT04580342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723759|NCT04580342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723760|NCT04580342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610168|NCT04516174|Sensory System Agents|sensory system agents|mesh-ancestor
92610169|NCT04516174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723761|NCT04580342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92723768|NCT00571142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92723769|NCT00571142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92723770|NCT00571142|Growth Substances|growth substances|mesh-ancestor
92723771|NCT00571142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723772|NCT00571142|Growth Inhibitors|growth inhibitors|mesh-ancestor
92723773|NCT00571142|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92723774|NCT00571142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723775|NCT00571142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92723776|NCT00571142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723777|NCT00571142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723779|NCT00571142|GABA Agents|gaba agents|mesh-ancestor
92723780|NCT00571142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723781|NCT00571142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723782|NCT00584532|Genistein|genistein|mesh-list
92723783|NCT00584532|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92723784|NCT00584532|Protective Agents|protective agents|mesh-ancestor
92723785|NCT00584532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723786|NCT00584532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723787|NCT00584532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92723788|NCT00584532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723789|NCT00584532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723790|NCT00584532|Phytoestrogens|phytoestrogens|mesh-ancestor
92723791|NCT00584532|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92723792|NCT00584532|Estrogens|estrogens|mesh-ancestor
92723793|NCT00584532|Hormones|hormones|mesh-ancestor
92723794|NCT00584532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723795|NCT00584571|Dexetimide|dexetimide|mesh-list
92723796|NCT00584571|Citalopram|citalopram|mesh-list
92723797|NCT00584571|Escitalopram|escitalopram|mesh-list
92723798|NCT00584571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92723799|NCT00584571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92723800|NCT00584571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723801|NCT00584571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723802|NCT00584571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723803|NCT00584571|Serotonin Agents|serotonin agents|mesh-ancestor
92723804|NCT00584571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723805|NCT00584571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92723806|NCT00584571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92723807|NCT00584571|Parasympatholytics|parasympatholytics|mesh-ancestor
92723808|NCT00584571|Autonomic Agents|autonomic agents|mesh-ancestor
92723809|NCT00584571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723810|NCT00584571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92723811|NCT00584571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92723812|NCT00584571|Cholinergic Agents|cholinergic agents|mesh-ancestor
92723813|NCT00584571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92723814|NCT00584571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723815|NCT00584571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723816|NCT03451500|Levodopa|levodopa|mesh-list
92723817|NCT03451500|Carbidopa|carbidopa|mesh-list
92723818|NCT03451500|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92723819|NCT03451500|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92723820|NCT03451500|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92723821|NCT03451500|Dopamine Agents|dopamine agents|mesh-ancestor
92723822|NCT03451500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723823|NCT03451500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723824|NCT03451500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723825|NCT03451500|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92723826|NCT03451500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723827|NCT03451500|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92723828|NCT03451500|Immunologic Factors|immunologic factors|mesh-ancestor
92723829|NCT03451500|Dopamine Agonists|dopamine agonists|mesh-ancestor
92723830|NCT00584610|Copper|copper|mesh-list
92723834|NCT00584610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92723835|NCT00584610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723836|NCT00584610|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92723837|NCT00584610|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92723838|NCT00584610|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92723839|NCT00584610|Trace Elements|trace elements|mesh-ancestor
92610170|NCT04516174|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92610171|NCT04516174|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92610172|NCT04516174|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92723840|NCT00584610|Micronutrients|micronutrients|mesh-ancestor
92723841|NCT00571298|Sodium thiosulfate|sodium thiosulfate|mesh-list
92723842|NCT00571298|Gemcitabine|gemcitabine|mesh-list
92723843|NCT00571298|Amifostine|amifostine|mesh-list
92723844|NCT00571298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723845|NCT00571298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92723846|NCT00571298|Antimetabolites|antimetabolites|mesh-ancestor
92723847|NCT00571298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723848|NCT00571298|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92723849|NCT00571298|Protective Agents|protective agents|mesh-ancestor
92723850|NCT00571298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723851|NCT00571298|Antidotes|antidotes|mesh-ancestor
92723852|NCT00571298|Antioxidants|antioxidants|mesh-ancestor
92723853|NCT00571298|Antitubercular Agents|antitubercular agents|mesh-ancestor
92723854|NCT00571298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723855|NCT00571298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723856|NCT00571298|Chelating Agents|chelating agents|mesh-ancestor
92723857|NCT00571298|Sequestering Agents|sequestering agents|mesh-ancestor
92723858|NCT00571337|Infliximab|infliximab|mesh-list
92723859|NCT00571337|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92723860|NCT00571337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723861|NCT00571337|Dermatologic Agents|dermatologic agents|mesh-ancestor
92723862|NCT00571337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723863|NCT00571337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723864|NCT04575519|Aspirin|aspirin|mesh-list
92723865|NCT04575519|Ibuprofen|ibuprofen|mesh-list
92397055|NCT05269654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723866|NCT04575519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723867|NCT04575519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723868|NCT04575519|Analgesics|analgesics|mesh-ancestor
92723869|NCT04575519|Sensory System Agents|sensory system agents|mesh-ancestor
92723870|NCT04575519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723871|NCT04575519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723872|NCT04575519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723873|NCT04575519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723874|NCT04575519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723875|NCT04575519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723876|NCT04575519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723877|NCT04575519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92723878|NCT04575519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92723879|NCT04575519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92723880|NCT04575519|Antipyretics|antipyretics|mesh-ancestor
92723881|NCT04573803|Phenytoin|phenytoin|mesh-list
92723882|NCT04573803|Levetiracetam|levetiracetam|mesh-list
92723883|NCT04573803|Anticonvulsants|anticonvulsants|mesh-ancestor
92723884|NCT04573803|Nootropic Agents|nootropic agents|mesh-ancestor
92723885|NCT04573803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92723886|NCT04573803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92723887|NCT04573803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723888|NCT04573803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723889|NCT04573803|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92723890|NCT04573803|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92723891|NCT00584688|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92723892|NCT00584688|Antidepressive Agents|antidepressive agents|mesh-ancestor
92723893|NCT00584688|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723894|NCT00584688|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92723895|NCT00584688|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723896|NCT00584688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723897|NCT00584688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723898|NCT04573686|Epoetin Alfa|epoetin alfa|mesh-list
92723899|NCT04573686|Hematinics|hematinics|mesh-ancestor
92723900|NCT01143337|Methotrexate|methotrexate|mesh-list
92723901|NCT01143337|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92723902|NCT01143337|Abortifacient Agents|abortifacient agents|mesh-ancestor
92723906|NCT01143337|Antimetabolites|antimetabolites|mesh-ancestor
92723907|NCT01143337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723908|NCT01143337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723909|NCT01143337|Dermatologic Agents|dermatologic agents|mesh-ancestor
92723910|NCT01143337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610173|NCT04516174|Adrenergic Agents|adrenergic agents|mesh-ancestor
92610174|NCT04516174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610175|NCT04516174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610176|NCT04516174|Anesthetics, Local|anesthetics, local|mesh-ancestor
92610177|NCT04516174|Anesthetics|anesthetics|mesh-ancestor
92723911|NCT01143337|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92723912|NCT01143337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92723913|NCT01143337|Immunologic Factors|immunologic factors|mesh-ancestor
92723914|NCT01143337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723915|NCT01143337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92723916|NCT04313023|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
92723917|NCT04313023|Respiratory System Agents|respiratory system agents|mesh-ancestor
92723918|NCT02883595|Thymalfasin|thymalfasin|mesh-list
92723919|NCT02883595|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92723920|NCT02883595|Immunologic Factors|immunologic factors|mesh-ancestor
92723921|NCT02883595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723922|NCT01143259|Alvimopan|alvimopan|mesh-list
92723923|NCT01143259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723924|NCT00571805|Varenicline|varenicline|mesh-list
92723925|NCT00571805|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92723926|NCT00571805|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92723927|NCT00571805|Cholinergic Agents|cholinergic agents|mesh-ancestor
92723928|NCT00571805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723929|NCT00571805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723930|NCT00571805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723931|NCT02883556|Pembrolizumab|pembrolizumab|mesh-list
92723932|NCT02883556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92723933|NCT02883556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723934|NCT02883556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92723935|NCT02883556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723936|NCT00585000|Tremelimumab|tremelimumab|mesh-list
92723937|NCT00585000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723938|NCT00572078|Sorafenib|sorafenib|mesh-list
92723939|NCT00572078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723940|NCT00572078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92723941|NCT00572078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723942|NCT00572078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723943|NCT00572312|Atorvastatin|atorvastatin|mesh-list
92723944|NCT00572312|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92723945|NCT00572312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92723946|NCT00572312|Antimetabolites|antimetabolites|mesh-ancestor
92723947|NCT00572312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723948|NCT00572312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92723949|NCT00572312|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92723950|NCT00572312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723951|NCT00585156|Celecoxib|celecoxib|mesh-list
92723952|NCT00585156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723953|NCT00585156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723954|NCT00585156|Analgesics|analgesics|mesh-ancestor
92723955|NCT00585156|Sensory System Agents|sensory system agents|mesh-ancestor
92723956|NCT00585156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723957|NCT00585156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723958|NCT00585156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92723959|NCT00585156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723960|NCT00585156|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92723961|NCT00585156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92723962|NCT00585156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723963|NCT00585156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723964|NCT01142596|Asenapine|asenapine|mesh-list
92723965|NCT01142596|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92723966|NCT01142596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723967|NCT01142596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723968|NCT01142596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723969|NCT01142596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723970|NCT00572390|Estrogens|estrogens|mesh-list
92723971|NCT00572390|Hormones|hormones|mesh-ancestor
92723972|NCT00572390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723975|NCT01142128|Pancrelipase|pancrelipase|mesh-list
92723976|NCT01142128|Pancreatin|pancreatin|mesh-list
92610178|NCT04515979|Pembrolizumab|pembrolizumab|mesh-list
92610179|NCT04515979|Vactosertib|vactosertib|mesh-list
92610180|NCT04515979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610181|NCT04515979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610182|NCT04515979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92723977|NCT01142128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92723978|NCT01142128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92723979|NCT01142128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92723980|NCT01142128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723981|NCT01142128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723983|NCT04572867|Natriuretic Agents|natriuretic agents|mesh-ancestor
92723984|NCT04572867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723985|NCT01142089|Rifamycins|rifamycins|mesh-list
92723986|NCT01142089|Rifamycin SV|rifamycin sv|mesh-list
92723987|NCT01142089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92723988|NCT01142089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723989|NCT01142089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723990|NCT00572663|Acetylcysteine|acetylcysteine|mesh-list
92723991|NCT00572663|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92723992|NCT00572663|Antiviral Agents|antiviral agents|mesh-ancestor
92723993|NCT00572663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92723994|NCT00572663|Expectorants|expectorants|mesh-ancestor
92723995|NCT00572663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92723996|NCT00572663|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92723997|NCT00572663|Antioxidants|antioxidants|mesh-ancestor
92723998|NCT00572663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723999|NCT00572663|Protective Agents|protective agents|mesh-ancestor
92724000|NCT00572663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724001|NCT00572663|Antidotes|antidotes|mesh-ancestor
92724002|NCT01140880|Tenofovir|tenofovir|mesh-list
92724003|NCT01140880|Emtricitabine|emtricitabine|mesh-list
92724004|NCT01140880|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92724005|NCT01140880|Antiviral Agents|antiviral agents|mesh-ancestor
92724006|NCT01140880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724007|NCT01140880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92724008|NCT01140880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92724009|NCT01140880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724010|NCT01140880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724011|NCT01140880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92724012|NCT01140880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92724013|NCT00572741|Cod Liver Oil|cod liver oil|mesh-list
92724014|NCT00572741|Vitamins|vitamins|mesh-ancestor
92724015|NCT00572741|Micronutrients|micronutrients|mesh-ancestor
92724016|NCT00572741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724017|NCT00572819|Misoprostol|misoprostol|mesh-list
92724018|NCT00572819|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92724019|NCT00572819|Abortifacient Agents|abortifacient agents|mesh-ancestor
92724020|NCT00572819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92724021|NCT00572819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724022|NCT00572819|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92724023|NCT00572819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724024|NCT00572819|Oxytocics|oxytocics|mesh-ancestor
92724025|NCT03451110|Fluconazole|fluconazole|mesh-list
92724026|NCT03451110|Lemborexant|lemborexant|mesh-list
92724027|NCT03451110|Famotidine|famotidine|mesh-list
92724028|NCT03451110|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92724029|NCT03451110|Antifungal Agents|antifungal agents|mesh-ancestor
92724030|NCT03451110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724031|NCT03451110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92724032|NCT03451110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92724033|NCT03451110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724034|NCT03451110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724035|NCT03451110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92724036|NCT03451110|Hormone Antagonists|hormone antagonists|mesh-ancestor
92724037|NCT03451110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724038|NCT03451110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724039|NCT03451110|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92724040|NCT03451110|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92610183|NCT04515979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610184|NCT04515979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724042|NCT03451110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724043|NCT03451110|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92724044|NCT03451110|Histamine Antagonists|histamine antagonists|mesh-ancestor
92724045|NCT03451110|Histamine Agents|histamine agents|mesh-ancestor
92724050|NCT03451110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724051|NCT03451110|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92724052|NCT03451110|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92724053|NCT03451110|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92724054|NCT03451110|Contraceptive Agents|contraceptive agents|mesh-ancestor
92724055|NCT03451110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92724056|NCT03451110|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92724057|NCT03451110|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92724058|NCT03451110|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92724059|NCT03451110|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92724060|NCT00585741|Alovudine|alovudine|mesh-list
92724061|NCT00585741|Antiviral Agents|antiviral agents|mesh-ancestor
92724062|NCT00585741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724063|NCT03450798|Anesthetics|anesthetics|mesh-list
92724064|NCT03450798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724065|NCT03450798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724066|NCT00573326|Imatinib Mesylate|imatinib mesylate|mesh-list
92724067|NCT00573326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724068|NCT00573326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724069|NCT00573326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724070|NCT00573326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724071|NCT01140061|MK 0873|mk 0873|mesh-list
92724072|NCT01140061|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92724073|NCT01140061|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92724074|NCT01140061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724075|NCT01140061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724076|NCT04312750|Lidocaine|lidocaine|mesh-list
92724077|NCT04312750|Anesthetics, Local|anesthetics, local|mesh-ancestor
92724078|NCT04312750|Anesthetics|anesthetics|mesh-ancestor
92724079|NCT04312750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724080|NCT04312750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724081|NCT04312750|Sensory System Agents|sensory system agents|mesh-ancestor
92724082|NCT04312750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724083|NCT04312750|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92724084|NCT04312750|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92724085|NCT04312750|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92724086|NCT04312750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92724087|NCT04312750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724088|NCT00573404|Sunitinib|sunitinib|mesh-list
92724089|NCT00573404|Imatinib Mesylate|imatinib mesylate|mesh-list
92724090|NCT00573404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724091|NCT00573404|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92724092|NCT00573404|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92724093|NCT00573404|Growth Substances|growth substances|mesh-ancestor
92724094|NCT00573404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724095|NCT00573404|Growth Inhibitors|growth inhibitors|mesh-ancestor
92724096|NCT00573404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724097|NCT00573404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724098|NCT00573404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724099|NCT01139125|Cysteamine|cysteamine|mesh-list
92724100|NCT01139125|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92724101|NCT01139125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724102|NCT01139047|Metronidazole|metronidazole|mesh-list
92724103|NCT01139047|Azelaic acid|azelaic acid|mesh-list
92724104|NCT01139047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724105|NCT01139047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724106|NCT01139047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92724107|NCT01139047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92724108|NCT01139047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724109|NCT01139047|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724110|NCT01139008|Metronidazole|metronidazole|mesh-list
92724111|NCT01139008|Azelaic acid|azelaic acid|mesh-list
92724112|NCT01139008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724113|NCT01139008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92610186|NCT00505531|Diphenhydramine|diphenhydramine|mesh-list
92610187|NCT00505531|Tramadol|tramadol|mesh-list
92724114|NCT01139008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92724115|NCT01139008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92724123|NCT00573599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724124|NCT00573599|Anesthetics, Local|anesthetics, local|mesh-ancestor
92724125|NCT00573599|Anesthetics|anesthetics|mesh-ancestor
92724126|NCT00573599|Sensory System Agents|sensory system agents|mesh-ancestor
92724127|NCT00573599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724128|NCT00573599|Antiemetics|antiemetics|mesh-ancestor
92724129|NCT00573599|Autonomic Agents|autonomic agents|mesh-ancestor
92724130|NCT00573599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724131|NCT00573599|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92724132|NCT00573599|Histamine Antagonists|histamine antagonists|mesh-ancestor
92724133|NCT00573599|Histamine Agents|histamine agents|mesh-ancestor
92724134|NCT00573599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724135|NCT00573599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724136|NCT00573599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92724137|NCT00573599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92724138|NCT00573599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92724139|NCT00573599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92724140|NCT00573599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92724141|NCT00573599|Dopamine Agents|dopamine agents|mesh-ancestor
92724142|NCT04572516|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92724143|NCT04572516|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92724144|NCT04572516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92724145|NCT04572516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724146|NCT04572516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724147|NCT04572516|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92724148|NCT04572516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92724149|NCT04572516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724150|NCT04572516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92724151|NCT04572516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724152|NCT00573638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92724153|NCT00573638|Latanoprost|latanoprost|mesh-list
92724154|NCT00573638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92724155|NCT01138657|Prednisone|prednisone|mesh-list
92724156|NCT01138657|Adalimumab|adalimumab|mesh-list
92724157|NCT01138657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724158|NCT01138657|Glucocorticoids|glucocorticoids|mesh-ancestor
92724159|NCT01138657|Hormones|hormones|mesh-ancestor
92724160|NCT01138657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724161|NCT01138657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724162|NCT01138657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724163|NCT01138657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724164|NCT01138657|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92724165|NCT01138657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724166|NCT01138501|Factor VIII|factor viii|mesh-list
92724167|NCT01138501|Coagulants|coagulants|mesh-ancestor
92724168|NCT01138150|Naproxen|naproxen|mesh-list
92724169|NCT01138150|Sumatriptan|sumatriptan|mesh-list
92724170|NCT01138150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92724171|NCT01138150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724172|NCT01138150|Analgesics|analgesics|mesh-ancestor
92724173|NCT01138150|Sensory System Agents|sensory system agents|mesh-ancestor
92724174|NCT01138150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724175|NCT01138150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724176|NCT01138150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724177|NCT01138150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724178|NCT01138150|Gout Suppressants|gout suppressants|mesh-ancestor
92724179|NCT01138150|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92724180|NCT01138150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724181|NCT01138150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724182|NCT01138150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92724183|NCT01138150|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92724184|NCT01138150|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92724187|NCT00586092|Bevacizumab|bevacizumab|mesh-list
92724188|NCT00586092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724189|NCT00586092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724191|NCT00586092|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92724192|NCT00586092|Growth Substances|growth substances|mesh-ancestor
92724193|NCT00586092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610188|NCT00505531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92610189|NCT00505531|Narcotics|narcotics|mesh-ancestor
92724194|NCT00586092|Growth Inhibitors|growth inhibitors|mesh-ancestor
92724195|NCT01137955|Rifaximin|rifaximin|mesh-list
92724196|NCT01137955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724197|NCT01137955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724198|NCT01137955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724199|NCT00573950|Cilostazol|cilostazol|mesh-list
92724200|NCT00573950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92724201|NCT00573950|Autonomic Agents|autonomic agents|mesh-ancestor
92724202|NCT00573950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724203|NCT00573950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724204|NCT00573950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92724205|NCT00573950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92724206|NCT00573950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92724207|NCT00573950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92724208|NCT00573950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724209|NCT00573950|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92724210|NCT00573950|Vasodilator Agents|vasodilator agents|mesh-ancestor
92724211|NCT00573950|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92724212|NCT00573950|Protective Agents|protective agents|mesh-ancestor
92397090|NCT05248724|Analgesics|analgesics|mesh-ancestor
92724213|NCT00573950|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92724214|NCT00573950|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92724215|NCT00573950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724216|NCT00586131|Citric Acid|citric acid|mesh-list
92724217|NCT00586131|Sodium Citrate|sodium citrate|mesh-list
92724218|NCT00586131|Anticoagulants|anticoagulants|mesh-ancestor
92724219|NCT00586131|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92724220|NCT00586131|Chelating Agents|chelating agents|mesh-ancestor
92724221|NCT00586131|Sequestering Agents|sequestering agents|mesh-ancestor
92724222|NCT00586131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724223|NCT00586287|Phenprocoumon|phenprocoumon|mesh-list
92724224|NCT00586287|Anticoagulants|anticoagulants|mesh-ancestor
92724225|NCT00586365|Naproxen|naproxen|mesh-list
92724226|NCT00586365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92724227|NCT00586365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724228|NCT00586365|Analgesics|analgesics|mesh-ancestor
92724229|NCT00586365|Sensory System Agents|sensory system agents|mesh-ancestor
92724230|NCT00586365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724231|NCT00586365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724232|NCT00586365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724233|NCT00586365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724234|NCT00586365|Gout Suppressants|gout suppressants|mesh-ancestor
92724235|NCT00586365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92724236|NCT00586365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724237|NCT00586365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724238|NCT00574652|Aldesleukin|aldesleukin|mesh-list
92724239|NCT00574652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724240|NCT00574652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92724241|NCT00574652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92724242|NCT00574652|Antiviral Agents|antiviral agents|mesh-ancestor
92724243|NCT00574652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724244|NCT00574730|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92724245|NCT00574730|Rituximab|rituximab|mesh-list
92724246|NCT00574730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724247|NCT00574730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724248|NCT00574730|Immunologic Factors|immunologic factors|mesh-ancestor
92724249|NCT00574730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724250|NCT00574730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724251|NCT00574730|Antiviral Agents|antiviral agents|mesh-ancestor
92724252|NCT00574730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724253|NCT00574769|Bevacizumab|bevacizumab|mesh-list
92724254|NCT00574769|Docetaxel|docetaxel|mesh-list
92724255|NCT00574769|Everolimus|everolimus|mesh-list
92724256|NCT00574769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724257|NCT00574769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724258|NCT00574769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92724259|NCT00574769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92724267|NCT00574769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92724268|NCT00574769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724269|NCT00574769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724270|NCT00574769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724271|NCT00574769|Immunologic Factors|immunologic factors|mesh-ancestor
92724272|NCT00586443|Bevacizumab|bevacizumab|mesh-list
92724273|NCT00586443|Panitumumab|panitumumab|mesh-list
92724274|NCT00586443|Everolimus|everolimus|mesh-list
92610190|NCT00505531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610191|NCT00505531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610192|NCT00505531|Analgesics|analgesics|mesh-ancestor
92610193|NCT00505531|Sensory System Agents|sensory system agents|mesh-ancestor
92724275|NCT00586443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724276|NCT00586443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724277|NCT00586443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92724278|NCT00586443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92724279|NCT00586443|Growth Substances|growth substances|mesh-ancestor
92724280|NCT00586443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724281|NCT00586443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92724282|NCT00586443|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92724283|NCT00586443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724284|NCT00586443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724285|NCT00586443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724286|NCT00586443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724287|NCT00586443|Immunologic Factors|immunologic factors|mesh-ancestor
92724288|NCT00574925|Esomeprazole|esomeprazole|mesh-list
92724289|NCT00574925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92724290|NCT00574925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724291|NCT00574925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92724292|NCT00574925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724293|NCT00574925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724294|NCT00586560|Cyclophosphamide|cyclophosphamide|mesh-list
92724295|NCT00586560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724296|NCT00586560|Immunologic Factors|immunologic factors|mesh-ancestor
92724297|NCT00586560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724298|NCT00586560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724299|NCT00586560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724300|NCT00586560|Alkylating Agents|alkylating agents|mesh-ancestor
92724301|NCT00586560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724302|NCT00586560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724303|NCT00586560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92724304|NCT00574964|Temozolomide|temozolomide|mesh-list
92724305|NCT00574964|Carmustine|carmustine|mesh-list
92724306|NCT00574964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724307|NCT00574964|Alkylating Agents|alkylating agents|mesh-ancestor
92724308|NCT00574964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724309|NCT00574964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724310|NCT03450057|Daratumumab|daratumumab|mesh-list
92724311|NCT03450057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724312|NCT01137682|Octreotide|octreotide|mesh-list
92724313|NCT01137682|Lanreotide|lanreotide|mesh-list
92724314|NCT01137682|Pasireotide|pasireotide|mesh-list
92724315|NCT01137682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724316|NCT01137682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724317|NCT01137682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724318|NCT01137682|Hormones|hormones|mesh-ancestor
92724319|NCT01137682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724320|NCT01137682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724321|NCT00586794|Sildenafil Citrate|sildenafil citrate|mesh-list
92724322|NCT00586794|Vasodilator Agents|vasodilator agents|mesh-ancestor
92724323|NCT00586794|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92724324|NCT00586794|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92724325|NCT00586794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724326|NCT00586794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724327|NCT00586794|Urological Agents|urological agents|mesh-ancestor
92724332|NCT00575354|Isoflurane|isoflurane|mesh-list
92724333|NCT00575354|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92724334|NCT00575354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92724335|NCT00575354|Anesthetics, General|anesthetics, general|mesh-ancestor
92724336|NCT00575354|Anesthetics|anesthetics|mesh-ancestor
92724337|NCT00575354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724338|NCT00575354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724339|NCT00586911|Betaine|betaine|mesh-list
92724340|NCT00586911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724341|NCT00586911|Lipotropic Agents|lipotropic agents|mesh-ancestor
92724342|NCT00586911|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92724343|NCT00586911|Antimetabolites|antimetabolites|mesh-ancestor
92724344|NCT00586911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017324|NCT04314167|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92610194|NCT00505531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610195|NCT00505531|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92610196|NCT00505531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92610197|NCT00505531|Anesthetics, Local|anesthetics, local|mesh-ancestor
92610198|NCT00505531|Anesthetics|anesthetics|mesh-ancestor
92610199|NCT00505531|Antiemetics|antiemetics|mesh-ancestor
92610200|NCT00505531|Autonomic Agents|autonomic agents|mesh-ancestor
92610201|NCT00505531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610202|NCT00505531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92610203|NCT00505531|Histamine Antagonists|histamine antagonists|mesh-ancestor
92610204|NCT00505531|Histamine Agents|histamine agents|mesh-ancestor
92610205|NCT00505531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610206|NCT00505531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610207|NCT00505531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92724345|NCT00586911|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92724346|NCT00575393|Gold Sodium Thiomalate|gold sodium thiomalate|mesh-list
92724347|NCT00575393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724348|NCT00575549|Dobutamine|dobutamine|mesh-list
92724349|NCT00575549|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92724350|NCT00575549|Sympathomimetics|sympathomimetics|mesh-ancestor
92724351|NCT00575549|Autonomic Agents|autonomic agents|mesh-ancestor
92724352|NCT00575549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724353|NCT00575549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724354|NCT00575549|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92724355|NCT00575549|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92724356|NCT00575549|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92724357|NCT00575549|Adrenergic Agents|adrenergic agents|mesh-ancestor
92724358|NCT00575549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724359|NCT00575549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724360|NCT00575549|Protective Agents|protective agents|mesh-ancestor
92724361|NCT03453684|Vancomycin|vancomycin|mesh-list
92724362|NCT03453684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724363|NCT03453684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724364|NCT00575627|Interferons|interferons|mesh-list
92724365|NCT00575627|Ribavirin|ribavirin|mesh-list
92724366|NCT00575627|Interferon-alpha|interferon-alpha|mesh-list
92724367|NCT00575627|Interferon alpha-2|interferon alpha-2|mesh-list
92724368|NCT00575627|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92724369|NCT00575627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724370|NCT00575627|Antiviral Agents|antiviral agents|mesh-ancestor
92724371|NCT00575627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724372|NCT00575627|Antimetabolites|antimetabolites|mesh-ancestor
92724373|NCT00575627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724374|NCT00575627|Immunologic Factors|immunologic factors|mesh-ancestor
92724375|NCT00575627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724376|NCT00555854|Benzocaine|benzocaine|mesh-list
92724377|NCT00555854|Anesthetics, Local|anesthetics, local|mesh-ancestor
92724378|NCT00555854|Anesthetics|anesthetics|mesh-ancestor
92724379|NCT00555854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724380|NCT00555854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724381|NCT00555854|Sensory System Agents|sensory system agents|mesh-ancestor
92724382|NCT00555854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724383|NCT04674332|Insulin, Long-Acting|insulin, long-acting|mesh-list
92724384|NCT04674332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92724385|NCT04674332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724386|NCT00587145|Docetaxel|docetaxel|mesh-list
92724387|NCT00587145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724388|NCT00587145|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724389|NCT00587145|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724390|NCT00587145|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724391|NCT00587145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610208|NCT00141908|Castor Oil|castor oil|mesh-list
92610209|NCT00141908|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92610210|NCT00141908|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92610211|NCT00141908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92610212|NCT00141908|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610213|NCT00141908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610214|NCT00141908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724392|NCT04674176|Rifaximin|rifaximin|mesh-list
92724393|NCT04674176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724394|NCT04674176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724395|NCT04674176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724396|NCT04674527|Temozolomide|temozolomide|mesh-list
92724397|NCT04674527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724398|NCT04674527|Alkylating Agents|alkylating agents|mesh-ancestor
92724399|NCT04674527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724401|NCT00199836|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92724402|NCT00199836|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92724403|NCT00199836|Immunologic Factors|immunologic factors|mesh-ancestor
92724404|NCT00199836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724406|NCT00199797|Fluorouracil|fluorouracil|mesh-list
92724407|NCT00199797|Oxaliplatin|oxaliplatin|mesh-list
92724408|NCT00199797|Antimetabolites|antimetabolites|mesh-ancestor
92724409|NCT00199797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724410|NCT00199797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724411|NCT00199797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724412|NCT00199797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724413|NCT00199797|Immunologic Factors|immunologic factors|mesh-ancestor
92724414|NCT00199797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724415|NCT00199797|Antidotes|antidotes|mesh-ancestor
92724416|NCT00199797|Protective Agents|protective agents|mesh-ancestor
92724417|NCT00199797|Vitamin B Complex|vitamin b complex|mesh-ancestor
92724418|NCT00199797|Vitamins|vitamins|mesh-ancestor
92724419|NCT00199797|Micronutrients|micronutrients|mesh-ancestor
92724420|NCT01137604|Bevacizumab|bevacizumab|mesh-list
92724421|NCT01137604|Lenvatinib|lenvatinib|mesh-list
92724422|NCT01137604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724423|NCT01137604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724424|NCT01137604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92724425|NCT01137604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92724426|NCT01137604|Growth Substances|growth substances|mesh-ancestor
92724427|NCT01137604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724428|NCT01137604|Growth Inhibitors|growth inhibitors|mesh-ancestor
92724429|NCT01137604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724430|NCT01137604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724431|NCT01137604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724432|NCT03454919|Palbociclib|palbociclib|mesh-list
92724433|NCT03454919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724434|NCT03454919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724435|NCT03454919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724436|NCT03454919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724437|NCT00198822|Vitamin A|vitamin a|mesh-list
92724438|NCT00198822|Beta Carotene|beta carotene|mesh-list
92724439|NCT00198822|Carotenoids|carotenoids|mesh-list
92724440|NCT00198822|Vitamins|vitamins|mesh-ancestor
92724441|NCT00198822|Micronutrients|micronutrients|mesh-ancestor
92724442|NCT00198822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724443|NCT00198822|Antioxidants|antioxidants|mesh-ancestor
92724444|NCT00198822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724445|NCT00198822|Protective Agents|protective agents|mesh-ancestor
92724446|NCT00198822|Provitamins|provitamins|mesh-ancestor
92724447|NCT05214976|Paclitaxel|paclitaxel|mesh-list
92724448|NCT05214976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92724449|NCT05214976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724450|NCT05214976|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724451|NCT05214976|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724452|NCT05214976|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724453|NCT05214976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724454|NCT05204134|Insulin|insulin|mesh-list
92724455|NCT05204134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92610215|NCT00141908|Progestins|progestins|mesh-ancestor
92610216|NCT00141908|Hormones|hormones|mesh-ancestor
92724456|NCT05204134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724457|NCT05181436|Chrysarobin|chrysarobin|mesh-list
92724458|NCT05181436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92724459|NCT05181436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724460|NCT05181436|Analgesics|analgesics|mesh-ancestor
92724461|NCT05181436|Sensory System Agents|sensory system agents|mesh-ancestor
92724462|NCT05181436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724463|NCT05181436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724464|NCT05181436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724465|NCT05181436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724466|NCT01137292|Voriconazole|voriconazole|mesh-list
92724467|NCT01137292|Antifungal Agents|antifungal agents|mesh-ancestor
92724468|NCT01137292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724469|NCT01137292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92724470|NCT01137292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92724471|NCT01137292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724472|NCT01137292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724473|NCT01137292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92724474|NCT01137292|Hormone Antagonists|hormone antagonists|mesh-ancestor
92724477|NCT01137292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92724478|NCT02883478|Riboflavin|riboflavin|mesh-list
92724479|NCT02883478|Vitamin B Complex|vitamin b complex|mesh-ancestor
92724480|NCT02883478|Vitamins|vitamins|mesh-ancestor
92724481|NCT02883478|Micronutrients|micronutrients|mesh-ancestor
92724482|NCT02883478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724483|NCT02883478|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92724484|NCT02883478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724485|NCT00197145|Aplaviroc|aplaviroc|mesh-list
92724486|NCT00197145|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92724487|NCT00197145|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92724488|NCT00197145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724489|NCT00197145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92724490|NCT00197145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92724491|NCT00197145|Antiviral Agents|antiviral agents|mesh-ancestor
92724492|NCT00197145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724493|NCT04674137|Histamine|histamine|mesh-list
92724494|NCT04674137|Glutarimide|glutarimide|mesh-list
92724495|NCT04674137|Histamine Agonists|histamine agonists|mesh-ancestor
92724496|NCT04674137|Histamine Agents|histamine agents|mesh-ancestor
92724497|NCT04674137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724498|NCT04674137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724499|NCT04674137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724500|NCT04674137|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92724501|NCT04674137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724502|NCT04312438|Caseins|caseins|mesh-list
92724503|NCT04312438|Chelating Agents|chelating agents|mesh-ancestor
92724504|NCT04312438|Sequestering Agents|sequestering agents|mesh-ancestor
92724505|NCT04312438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724506|NCT04312360|Metronidazole|metronidazole|mesh-list
92724507|NCT04312360|Fosfomycin|fosfomycin|mesh-list
92724508|NCT04312360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724509|NCT04312360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724510|NCT04312360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92724511|NCT04312360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92724512|NCT00197106|Fluticasone|fluticasone|mesh-list
92724513|NCT00197106|Xhance|xhance|mesh-list
92724514|NCT00197106|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92724515|NCT00197106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724516|NCT00197106|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92724517|NCT00197106|Autonomic Agents|autonomic agents|mesh-ancestor
92724518|NCT00197106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724519|NCT00197106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724520|NCT00197106|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92724521|NCT00197106|Respiratory System Agents|respiratory system agents|mesh-ancestor
92724522|NCT00197106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724523|NCT00197106|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92724524|NCT00197106|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92724525|NCT00197106|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92724526|NCT00197106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92724527|NCT00197106|Adrenergic Agents|adrenergic agents|mesh-ancestor
92724528|NCT00197106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724529|NCT00197106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724530|NCT01136746|Insulin|insulin|mesh-list
92610217|NCT00141908|Cathartics|cathartics|mesh-ancestor
92610218|NCT00141908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610219|NCT00162669|Bevacizumab|bevacizumab|mesh-list
92610220|NCT00162669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610221|NCT00162669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610222|NCT00162669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92610223|NCT00162669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92610224|NCT00162669|Growth Substances|growth substances|mesh-ancestor
92610225|NCT00162669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610226|NCT00162669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92610227|NCT00141947|Bexarotene|bexarotene|mesh-list
92610228|NCT00141947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610229|NCT04514770|Misoprostol|misoprostol|mesh-list
92610230|NCT04514770|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92610231|NCT04514770|Abortifacient Agents|abortifacient agents|mesh-ancestor
92610232|NCT04514770|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92610233|NCT04514770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610234|NCT04514770|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92610235|NCT04514770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610236|NCT04514770|Oxytocics|oxytocics|mesh-ancestor
92610237|NCT00141986|Vitamin D|vitamin d|mesh-list
92610238|NCT00141986|Ergocalciferols|ergocalciferols|mesh-list
92610239|NCT00141986|Cholecalciferol|cholecalciferol|mesh-list
92610240|NCT00141986|Vitamins|vitamins|mesh-list
92610241|NCT00141986|Micronutrients|micronutrients|mesh-ancestor
92610242|NCT00141986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610243|NCT00141986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92610244|NCT00141986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610245|NCT04514731|Magnesium Sulfate|magnesium sulfate|mesh-list
92724531|NCT01136746|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92724532|NCT01136746|Insulin Glargine|insulin glargine|mesh-list
92724533|NCT01136746|Insulin Lispro|insulin lispro|mesh-list
92724534|NCT01136746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92724535|NCT01136746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724536|NCT01136356|Morphine|morphine|mesh-list
92724537|NCT01136356|Buprenorphine|buprenorphine|mesh-list
92724538|NCT01136356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92724539|NCT01136356|Narcotics|narcotics|mesh-ancestor
92724540|NCT01136356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724541|NCT01136356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724542|NCT01136356|Analgesics|analgesics|mesh-ancestor
92724543|NCT01136356|Sensory System Agents|sensory system agents|mesh-ancestor
92724544|NCT01136356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724545|NCT01136356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92724546|NCT00587379|Atorvastatin|atorvastatin|mesh-list
92724547|NCT00587379|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92724548|NCT00587379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92724549|NCT00587379|Antimetabolites|antimetabolites|mesh-ancestor
92610247|NCT04514731|Sensory System Agents|sensory system agents|mesh-ancestor
92610248|NCT04514731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724552|NCT00587379|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92724553|NCT00587379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724554|NCT04673396|Norcantharidin|norcantharidin|mesh-list
92724555|NCT04673396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724556|NCT04673396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724557|NCT04673396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724558|NCT00637390|Alemtuzumab|alemtuzumab|mesh-list
92724559|NCT00637390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724560|NCT00637390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724561|NCT00196326|Levonorgestrel|levonorgestrel|mesh-list
92724562|NCT00196326|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92724563|NCT00196326|Estradiol|estradiol|mesh-list
92724564|NCT00196326|Estrogens|estrogens|mesh-ancestor
92724565|NCT00196326|Hormones|hormones|mesh-ancestor
92724566|NCT00196326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724567|NCT00196326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724568|NCT00196326|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92724569|NCT00196326|Contraceptive Agents|contraceptive agents|mesh-ancestor
92724570|NCT00196326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92724571|NCT00196326|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92724572|NCT00196326|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92724573|NCT00196326|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92724574|NCT00196326|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92724575|NCT00587496|Aspirin|aspirin|mesh-list
92724576|NCT00587496|Valacyclovir|valacyclovir|mesh-list
92724577|NCT00587496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92724578|NCT00587496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724579|NCT00587496|Analgesics|analgesics|mesh-ancestor
92724580|NCT00587496|Sensory System Agents|sensory system agents|mesh-ancestor
92724581|NCT00587496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724582|NCT00587496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724583|NCT00587496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724584|NCT00587496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724585|NCT00587496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92724586|NCT00587496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92724587|NCT00587496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724588|NCT00587496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92724589|NCT00587496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92724590|NCT00587496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724591|NCT00587496|Antipyretics|antipyretics|mesh-ancestor
92724592|NCT00587496|Antiviral Agents|antiviral agents|mesh-ancestor
92724593|NCT00587496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724594|NCT00195663|Adalimumab|adalimumab|mesh-list
92724595|NCT00195663|Methotrexate|methotrexate|mesh-list
92724596|NCT00195663|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92724597|NCT00195663|Abortifacient Agents|abortifacient agents|mesh-ancestor
92724598|NCT00195663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92724599|NCT00195663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724600|NCT00195663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724601|NCT00195663|Antimetabolites|antimetabolites|mesh-ancestor
92724602|NCT00195663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724603|NCT00195663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724604|NCT00195663|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724605|NCT00195663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724606|NCT00195663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92724607|NCT00195663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724608|NCT00195663|Immunologic Factors|immunologic factors|mesh-ancestor
92724609|NCT00195663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724610|NCT00195663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92724611|NCT00195663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92724612|NCT00195663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724613|NCT01135498|Bevacizumab|bevacizumab|mesh-list
92724614|NCT01135498|Capecitabine|capecitabine|mesh-list
92724615|NCT01135498|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92724616|NCT01135498|Oxaliplatin|oxaliplatin|mesh-list
92724617|NCT01135498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724618|NCT01135498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724619|NCT01135498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92724620|NCT01135498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92017371|NCT05645705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610249|NCT04514731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610251|NCT04514731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610252|NCT04514731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92610253|NCT04514731|Anticonvulsants|anticonvulsants|mesh-ancestor
92610254|NCT04514731|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610255|NCT04514731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610256|NCT04514731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610257|NCT04514731|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610258|NCT04514731|Tocolytic Agents|tocolytic agents|mesh-ancestor
92017372|NCT02445339|Naltrexone|naltrexone|mesh-list
92724621|NCT01135498|Growth Substances|growth substances|mesh-ancestor
92724624|NCT01135498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724626|NCT01135498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724627|NCT01135498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92724628|NCT01135498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724629|NCT04610567|Methotrexate|methotrexate|mesh-list
92724630|NCT04610567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92724631|NCT04610567|Abortifacient Agents|abortifacient agents|mesh-ancestor
92724632|NCT04610567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92724633|NCT04610567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724634|NCT04610567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724635|NCT04610567|Antimetabolites|antimetabolites|mesh-ancestor
92724636|NCT04610567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724637|NCT04610567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724638|NCT04610567|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724639|NCT04610567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724640|NCT04610567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92724641|NCT04610567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724642|NCT04610567|Immunologic Factors|immunologic factors|mesh-ancestor
92724643|NCT04610567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724644|NCT04610567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92724645|NCT02883439|Fluticasone|fluticasone|mesh-list
92724646|NCT02883439|Xhance|xhance|mesh-list
92724647|NCT02883439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724648|NCT02883439|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92724649|NCT02883439|Autonomic Agents|autonomic agents|mesh-ancestor
92724650|NCT02883439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724651|NCT02883439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724652|NCT02883439|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92724653|NCT02883439|Respiratory System Agents|respiratory system agents|mesh-ancestor
92724654|NCT02883439|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724655|NCT02883439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92724656|NCT00195507|Etanercept|etanercept|mesh-list
92724657|NCT00195507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92724658|NCT00195507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724659|NCT00195507|Analgesics|analgesics|mesh-ancestor
92724660|NCT00195507|Sensory System Agents|sensory system agents|mesh-ancestor
92724661|NCT00195507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724662|NCT00195507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724663|NCT00195507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724664|NCT00195507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724665|NCT00195507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724666|NCT00195507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724667|NCT00195507|Immunologic Factors|immunologic factors|mesh-ancestor
92724668|NCT00195429|Sirolimus|sirolimus|mesh-list
92724669|NCT00195429|Prednisone|prednisone|mesh-list
92724670|NCT00195429|Tacrolimus|tacrolimus|mesh-list
92724671|NCT00195429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724672|NCT00195429|Glucocorticoids|glucocorticoids|mesh-ancestor
92724673|NCT00195429|Hormones|hormones|mesh-ancestor
92610259|NCT04514731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92610260|NCT04514419|Docetaxel|docetaxel|mesh-list
92610261|NCT04514419|Trastuzumab|trastuzumab|mesh-list
92610262|NCT04514419|Pertuzumab|pertuzumab|mesh-list
92610263|NCT04514419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610264|NCT04514419|Tubulin Modulators|tubulin modulators|mesh-ancestor
92610265|NCT04514419|Antimitotic Agents|antimitotic agents|mesh-ancestor
92610266|NCT04514419|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724674|NCT00195429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724675|NCT00195429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724676|NCT00195429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724677|NCT00195429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724678|NCT00195429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724679|NCT00195429|Immunologic Factors|immunologic factors|mesh-ancestor
92724680|NCT00195429|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92724681|NCT00195429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724682|NCT00195429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724683|NCT00195429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724684|NCT00195429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724685|NCT00195429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92724686|NCT00195429|Antifungal Agents|antifungal agents|mesh-ancestor
92724687|NCT00195351|Metronidazole|metronidazole|mesh-list
92724688|NCT00195351|Ceftriaxone|ceftriaxone|mesh-list
92724689|NCT00195351|Tigecycline|tigecycline|mesh-list
92724690|NCT00195351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724691|NCT00195351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724692|NCT00195351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92724693|NCT00195351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92724694|NCT00195351|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92397154|NCT05162118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724696|NCT00195351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724698|NCT04609748|Cannabidiol|cannabidiol|mesh-list
92724699|NCT04609748|Anticonvulsants|anticonvulsants|mesh-ancestor
92724700|NCT04609748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92724701|NCT04609748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724702|NCT04609748|Analgesics|analgesics|mesh-ancestor
92724703|NCT04609748|Sensory System Agents|sensory system agents|mesh-ancestor
92724704|NCT04609748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724705|NCT04609748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724706|NCT04609748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724707|NCT04609748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724708|NCT04609748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92724709|NCT04609748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724710|NCT04609748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724711|NCT00195273|Cyclosporine|cyclosporine|mesh-list
92724712|NCT00195273|Sirolimus|sirolimus|mesh-list
92724713|NCT00195273|Mycophenolic Acid|mycophenolic acid|mesh-list
92724714|NCT00195273|Cyclosporins|cyclosporins|mesh-list
92724715|NCT00195273|Daclizumab|daclizumab|mesh-list
92724716|NCT00195273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724717|NCT00195273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724718|NCT00195273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724719|NCT00195273|Immunologic Factors|immunologic factors|mesh-ancestor
92724720|NCT00195273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724721|NCT00195273|Antifungal Agents|antifungal agents|mesh-ancestor
92724722|NCT00195273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724723|NCT00195273|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724724|NCT00195273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724725|NCT00195273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92724726|NCT00195273|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92724727|NCT00195273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724728|NCT00195273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92724729|NCT00195273|Antitubercular Agents|antitubercular agents|mesh-ancestor
92724730|NCT00195273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92724731|NCT00564200|Dexamethasone|dexamethasone|mesh-list
92724732|NCT00564200|Fludarabine|fludarabine|mesh-list
92724733|NCT00564200|Bortezomib|bortezomib|mesh-list
92724734|NCT00564200|Melphalan|melphalan|mesh-list
92724735|NCT00564200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724736|NCT00564200|Antiemetics|antiemetics|mesh-ancestor
92724737|NCT00564200|Autonomic Agents|autonomic agents|mesh-ancestor
92610267|NCT04514419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610268|NCT04514419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610269|NCT00142025|Oxcarbazepine|oxcarbazepine|mesh-list
92610270|NCT00142025|Anticonvulsants|anticonvulsants|mesh-ancestor
92610271|NCT00142025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92610272|NCT00142025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92610273|NCT00142025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610274|NCT00142025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610275|NCT00142025|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92610276|NCT00142025|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92724738|NCT00564200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724739|NCT00564200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724740|NCT00564200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724741|NCT00564200|Glucocorticoids|glucocorticoids|mesh-ancestor
92724742|NCT00564200|Hormones|hormones|mesh-ancestor
92724743|NCT00564200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724744|NCT00564200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724745|NCT00564200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724746|NCT00564200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724747|NCT00564200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724748|NCT00564200|Immunologic Factors|immunologic factors|mesh-ancestor
92724749|NCT00564200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724750|NCT00564200|Alkylating Agents|alkylating agents|mesh-ancestor
92724751|NCT00564200|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92724752|NCT00193479|Prednisone|prednisone|mesh-list
92724753|NCT00193479|Cyclophosphamide|cyclophosphamide|mesh-list
92724754|NCT00193479|Rituximab|rituximab|mesh-list
92724755|NCT00193479|Vincristine|vincristine|mesh-list
92397161|NCT05142267|Naloxone|naloxone|mesh-list
92724756|NCT00193479|Mitoxantrone|mitoxantrone|mesh-list
92724757|NCT00193479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724758|NCT00193479|Immunologic Factors|immunologic factors|mesh-ancestor
92724759|NCT00193479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724760|NCT00193479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724761|NCT00193479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724762|NCT00193479|Alkylating Agents|alkylating agents|mesh-ancestor
92724763|NCT00193479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724764|NCT00193479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724765|NCT00193479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92724766|NCT00193479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724767|NCT00193479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724768|NCT00193479|Glucocorticoids|glucocorticoids|mesh-ancestor
92724769|NCT00193479|Hormones|hormones|mesh-ancestor
92724773|NCT00193479|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724774|NCT00193479|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724775|NCT00193479|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724777|NCT00193479|Sensory System Agents|sensory system agents|mesh-ancestor
92724778|NCT00193479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724779|NCT00193479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92724780|NCT00193479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92724781|NCT00193479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724782|NCT00193206|Paclitaxel|paclitaxel|mesh-list
92724783|NCT00193206|Gemcitabine|gemcitabine|mesh-list
92724784|NCT00193206|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92724785|NCT00193206|Epirubicin|epirubicin|mesh-list
92724786|NCT00193206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92724787|NCT00193206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724788|NCT00193206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724789|NCT00193206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724790|NCT00193206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724791|NCT00193206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724792|NCT00193206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724793|NCT00193206|Antimetabolites|antimetabolites|mesh-ancestor
92610277|NCT02275897|Methamphetamine|methamphetamine|mesh-list
92610278|NCT02275897|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92724794|NCT00193206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92724795|NCT00193206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92724796|NCT00193206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92724797|NCT00193206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724798|NCT00193050|Gemcitabine|gemcitabine|mesh-list
92724799|NCT00193050|Docetaxel|docetaxel|mesh-list
92724800|NCT00193050|Epirubicin|epirubicin|mesh-list
92724801|NCT00193050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724802|NCT00193050|Antimetabolites|antimetabolites|mesh-ancestor
92724803|NCT00193050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724804|NCT00193050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724805|NCT00193050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724806|NCT00193050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724807|NCT00193050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724808|NCT00193050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92724809|NCT00193050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92724810|NCT00193050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92724811|NCT00193050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724812|NCT04608734|Midazolam|midazolam|mesh-list
92724813|NCT04608734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92724814|NCT04608734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92724815|NCT04608734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724816|NCT04608734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724817|NCT04608734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92724818|NCT04608734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92724819|NCT04608734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92724820|NCT04608734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92724821|NCT04608734|Anesthetics, General|anesthetics, general|mesh-ancestor
92724822|NCT04608734|Anesthetics|anesthetics|mesh-ancestor
92724823|NCT04608734|GABA Modulators|gaba modulators|mesh-ancestor
92724824|NCT04608734|GABA Agents|gaba agents|mesh-ancestor
92724825|NCT04608734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724826|NCT04608734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724827|NCT00192075|Leucovorin|leucovorin|mesh-list
92724828|NCT00192075|Folic Acid|folic acid|mesh-list
92724829|NCT00192075|Gemcitabine|gemcitabine|mesh-list
92724830|NCT00192075|Oxaliplatin|oxaliplatin|mesh-list
92724831|NCT00192075|Levoleucovorin|levoleucovorin|mesh-list
92724832|NCT00192075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724833|NCT00192075|Antimetabolites|antimetabolites|mesh-ancestor
92724834|NCT00192075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724835|NCT00192075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724836|NCT00192075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724837|NCT00192075|Antidotes|antidotes|mesh-ancestor
92724838|NCT00192075|Protective Agents|protective agents|mesh-ancestor
92724839|NCT00192075|Vitamin B Complex|vitamin b complex|mesh-ancestor
92724840|NCT00192075|Vitamins|vitamins|mesh-ancestor
92724841|NCT00192075|Micronutrients|micronutrients|mesh-ancestor
92724853|NCT00191724|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92724854|NCT00191724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724855|NCT00191724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92724856|NCT00191646|Paclitaxel|paclitaxel|mesh-list
92724857|NCT00191646|Carboplatin|carboplatin|mesh-list
92724858|NCT00191646|Gemcitabine|gemcitabine|mesh-list
92724859|NCT00191646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92724860|NCT00191646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724861|NCT00191646|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724862|NCT00191646|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724863|NCT00191646|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724864|NCT00191646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724865|NCT00191646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724866|NCT00191646|Antimetabolites|antimetabolites|mesh-ancestor
92724867|NCT00191451|Carboplatin|carboplatin|mesh-list
92724868|NCT00191451|Gemcitabine|gemcitabine|mesh-list
92724869|NCT00191451|Trastuzumab|trastuzumab|mesh-list
92724870|NCT00191451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724871|NCT00191451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724872|NCT00191451|Antimetabolites|antimetabolites|mesh-ancestor
92724873|NCT00191451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724874|NCT00191451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610279|NCT02275897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610280|NCT02275897|Sympathomimetics|sympathomimetics|mesh-ancestor
92610281|NCT02275897|Autonomic Agents|autonomic agents|mesh-ancestor
92724875|NCT00191334|Gemcitabine|gemcitabine|mesh-list
92724876|NCT00191334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724877|NCT00191334|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724878|NCT00191334|Antimetabolites|antimetabolites|mesh-ancestor
92724879|NCT00191334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724880|NCT00191139|Cisplatin|cisplatin|mesh-list
92724881|NCT00191139|Gemcitabine|gemcitabine|mesh-list
92724882|NCT00191139|Docetaxel|docetaxel|mesh-list
92724883|NCT00191139|Etoposide|etoposide|mesh-list
92724884|NCT00191139|Etoposide phosphate|etoposide phosphate|mesh-list
92724885|NCT00191139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724886|NCT00191139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724887|NCT00191139|Antimetabolites|antimetabolites|mesh-ancestor
92724888|NCT00191139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724889|NCT00191139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724890|NCT00191139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724891|NCT00191139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724892|NCT00191139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92724893|NCT00191139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92724894|NCT00191139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92724895|NCT00191139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724896|NCT00564512|Cyclophosphamide|cyclophosphamide|mesh-list
92724897|NCT00564512|Rituximab|rituximab|mesh-list
92724898|NCT00564512|Fludarabine|fludarabine|mesh-list
92724899|NCT00564512|Alemtuzumab|alemtuzumab|mesh-list
92724900|NCT00564512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724901|NCT00564512|Immunologic Factors|immunologic factors|mesh-ancestor
92724902|NCT00564512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724903|NCT00564512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724904|NCT00564512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724905|NCT00564512|Alkylating Agents|alkylating agents|mesh-ancestor
92724906|NCT00564512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724907|NCT00564512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724912|NCT00564551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92724913|NCT00564551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724914|NCT00564551|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92724915|NCT00190983|Pemetrexed|pemetrexed|mesh-list
92724916|NCT00190983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724917|NCT00190983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724918|NCT00190983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724919|NCT00190983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92724920|NCT00190983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92724921|NCT00190749|Olanzapine|olanzapine|mesh-list
92724922|NCT00190749|Risperidone|risperidone|mesh-list
92724923|NCT00190749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92724924|NCT00190749|Serotonin Agents|serotonin agents|mesh-ancestor
92724925|NCT00190749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724926|NCT00190749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724927|NCT00190749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724928|NCT00190749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92724929|NCT00190749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92724930|NCT00190749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724931|NCT00190749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92724932|NCT00190749|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92724933|NCT00190749|Dopamine Agents|dopamine agents|mesh-ancestor
92724934|NCT00190749|Antiemetics|antiemetics|mesh-ancestor
92724935|NCT00190749|Autonomic Agents|autonomic agents|mesh-ancestor
92724936|NCT00190749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724937|NCT00190749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92724938|NCT00190749|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92724939|NCT00190749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92724940|NCT00190749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92724941|NCT04607447|Dexamethasone|dexamethasone|mesh-list
92724942|NCT04607447|Atorvastatin|atorvastatin|mesh-list
92724943|NCT04607447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92724944|NCT04607447|Antiemetics|antiemetics|mesh-ancestor
92724945|NCT04607447|Autonomic Agents|autonomic agents|mesh-ancestor
92724946|NCT04607447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724947|NCT04607447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724948|NCT04607447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610282|NCT02275897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610283|NCT02275897|Dopamine Agents|dopamine agents|mesh-ancestor
92610284|NCT02275897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724949|NCT04607447|Glucocorticoids|glucocorticoids|mesh-ancestor
92724950|NCT04607447|Hormones|hormones|mesh-ancestor
92724951|NCT04607447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724952|NCT04607447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724953|NCT04607447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724954|NCT04607447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92724955|NCT04607447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92724956|NCT04607447|Antimetabolites|antimetabolites|mesh-ancestor
92724957|NCT04607447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724958|NCT04607447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92724959|NCT04607447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92724960|NCT04607447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724961|NCT00190671|Cyclophosphamide|cyclophosphamide|mesh-list
92724962|NCT00190671|Pemetrexed|pemetrexed|mesh-list
92724963|NCT00190671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92724964|NCT00190671|Immunologic Factors|immunologic factors|mesh-ancestor
92724965|NCT00190671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724966|NCT00190671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92724967|NCT00190671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92724968|NCT00190671|Alkylating Agents|alkylating agents|mesh-ancestor
92724969|NCT00190671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724970|NCT00190671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724971|NCT00190671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92724972|NCT00190671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724973|NCT00190671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92724974|NCT00190671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92724975|NCT04607525|Dexmedetomidine|dexmedetomidine|mesh-list
92724976|NCT04607525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92724977|NCT04607525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724979|NCT04607525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92724980|NCT04607525|Analgesics|analgesics|mesh-ancestor
92724981|NCT04607525|Sensory System Agents|sensory system agents|mesh-ancestor
92724982|NCT04607525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92724983|NCT04607525|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92724984|NCT04607525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92724985|NCT04607525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92724986|NCT04607525|Adrenergic Agents|adrenergic agents|mesh-ancestor
92724987|NCT04607525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724988|NCT04607525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724989|NCT00198276|Bleomycin|bleomycin|mesh-list
92724990|NCT00198276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92724991|NCT00198276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724992|NCT04607642|Manganese|manganese|mesh-list
92724993|NCT04607642|Trace Elements|trace elements|mesh-ancestor
92724994|NCT04607642|Micronutrients|micronutrients|mesh-ancestor
92724995|NCT04607642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724996|NCT00588003|Anastrozole|anastrozole|mesh-list
92724997|NCT00588003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724998|NCT00588003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724999|NCT00588003|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92725000|NCT00588003|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92725001|NCT00588003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725002|NCT00588003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725003|NCT00588003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92725004|NCT00588003|Hormone Antagonists|hormone antagonists|mesh-ancestor
92725005|NCT00588003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725006|NCT00588003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725007|NCT04607057|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-list
92725008|NCT04607057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92725009|NCT00564590|Melatonin|melatonin|mesh-list
92725010|NCT00564590|Omeprazole|omeprazole|mesh-list
92725011|NCT00564590|Antioxidants|antioxidants|mesh-ancestor
92725012|NCT00564590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725013|NCT00564590|Protective Agents|protective agents|mesh-ancestor
92725014|NCT00564590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725015|NCT00564590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725016|NCT00564590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92610285|NCT02275897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610286|NCT02275897|Adrenergic Agents|adrenergic agents|mesh-ancestor
92610287|NCT02275897|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92610288|NCT02275897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725017|NCT00564590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725018|NCT00564590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92725019|NCT00564590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725020|NCT00564668|Insulin Aspart|insulin aspart|mesh-list
92725021|NCT00564668|Biphasic Insulins|biphasic insulins|mesh-list
92725022|NCT00564668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92725023|NCT00564668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725024|NCT00564707|Botulinum Toxins|botulinum toxins|mesh-list
92725025|NCT00564707|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92725026|NCT00564707|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92725027|NCT00564707|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92725028|NCT00564707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725029|NCT00564707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725030|NCT00564707|Cholinergic Agents|cholinergic agents|mesh-ancestor
92725031|NCT00564707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725032|NCT00564707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725033|NCT00564707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92725034|NCT00564707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725035|NCT04574778|Acetaminophen|acetaminophen|mesh-list
92725036|NCT04574778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92725037|NCT04574778|Analgesics|analgesics|mesh-ancestor
92725038|NCT04574778|Sensory System Agents|sensory system agents|mesh-ancestor
92725039|NCT04574778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725040|NCT04574778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725041|NCT04574778|Antipyretics|antipyretics|mesh-ancestor
92725042|NCT04606082|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92725043|NCT04606082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92725044|NCT04606082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725045|NCT04605770|Pemetrexed|pemetrexed|mesh-list
92725046|NCT04605770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725047|NCT04605770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725048|NCT04605770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725049|NCT04605770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92725050|NCT04605770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92725053|NCT04605887|Vasodilator Agents|vasodilator agents|mesh-ancestor
92725055|NCT04605419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92725056|NCT04605419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725057|NCT04605575|Vinorelbine|vinorelbine|mesh-list
92725058|NCT04605575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92725059|NCT04605575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725060|NCT04605575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92725061|NCT04605575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92725062|NCT04605575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92725063|NCT04605575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725064|NCT00589134|Ganirelix|ganirelix|mesh-list
92725065|NCT00589134|Hormone Antagonists|hormone antagonists|mesh-ancestor
92725066|NCT00589134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725067|NCT00589134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725068|NCT00589251|Penicillins|penicillins|mesh-list
92725069|NCT00589251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92725070|NCT00589251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725071|NCT00564824|Caffeine|caffeine|mesh-list
92725072|NCT00564824|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92725073|NCT00564824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725074|NCT00564824|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92725075|NCT00564824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725076|NCT00564824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725077|NCT00564824|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92725078|NCT00564824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92725079|NCT00564824|Purinergic Agents|purinergic agents|mesh-ancestor
92725080|NCT00564824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725081|NCT00589485|Cobalt|cobalt|mesh-list
92725082|NCT00589485|Trace Elements|trace elements|mesh-ancestor
92725083|NCT00589485|Micronutrients|micronutrients|mesh-ancestor
92610289|NCT02275897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610290|NCT02275897|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92725084|NCT00589485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725085|NCT00564941|Deferasirox|deferasirox|mesh-list
92725086|NCT00564941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92725087|NCT00564941|Chelating Agents|chelating agents|mesh-ancestor
92725088|NCT00564941|Sequestering Agents|sequestering agents|mesh-ancestor
92725089|NCT00564941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725090|NCT04605107|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92725091|NCT04605107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92725092|NCT04605107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725093|NCT00589953|Epoetin Alfa|epoetin alfa|mesh-list
92725094|NCT00589953|Hematinics|hematinics|mesh-ancestor
92725095|NCT00589992|Ibutilide|ibutilide|mesh-list
92725096|NCT00589992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92725097|NCT00590070|Adenosine|adenosine|mesh-list
92725099|NCT00590070|Analgesics|analgesics|mesh-ancestor
92725100|NCT00590070|Sensory System Agents|sensory system agents|mesh-ancestor
92725101|NCT00590070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725102|NCT00590070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725103|NCT00590070|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92725104|NCT00590070|Vasodilator Agents|vasodilator agents|mesh-ancestor
92725105|NCT00590070|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92725106|NCT00590070|Purinergic Agonists|purinergic agonists|mesh-ancestor
92725107|NCT00590070|Purinergic Agents|purinergic agents|mesh-ancestor
92725108|NCT00590070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725109|NCT00590070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725110|NCT00590070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92725111|NCT00590070|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92725112|NCT00565019|Triamcinolone|triamcinolone|mesh-list
92725113|NCT00565019|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92725114|NCT00565019|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92725115|NCT00565019|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92725116|NCT00565019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725117|NCT00565019|Glucocorticoids|glucocorticoids|mesh-ancestor
92725118|NCT00565019|Hormones|hormones|mesh-ancestor
92725119|NCT00565019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725120|NCT00565019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725121|NCT00565019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725122|NCT00565019|Immunologic Factors|immunologic factors|mesh-ancestor
92725123|NCT00565019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725125|NCT00565097|Lanreotide|lanreotide|mesh-list
92725126|NCT00565097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725127|NCT04604756|Losartan|losartan|mesh-list
92725128|NCT04604756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92725129|NCT04604756|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92725130|NCT04604756|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92725131|NCT04604756|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92725132|NCT04604756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725133|NCT00590343|Vatalanib|vatalanib|mesh-list
92725134|NCT00590343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92725135|NCT00590343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725136|NCT00590343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725137|NCT04604678|Metformin|metformin|mesh-list
92725138|NCT04604678|Naltrexone|naltrexone|mesh-list
92725139|NCT04604678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92725140|NCT04604678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725141|NCT04604678|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92725142|NCT04604678|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92725143|NCT04604678|Sensory System Agents|sensory system agents|mesh-ancestor
92725144|NCT04604678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725145|NCT04604327|Bemiparin|bemiparin|mesh-list
92725146|NCT04604327|Anticoagulants|anticoagulants|mesh-ancestor
92725147|NCT00590694|Ranibizumab|ranibizumab|mesh-list
92725148|NCT00590694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725149|NCT00590694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725150|NCT00590694|Growth Substances|growth substances|mesh-ancestor
92725151|NCT00590694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725152|NCT00590694|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725153|NCT00590694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725154|NCT00565175|Famotidine|famotidine|mesh-list
92725155|NCT00565175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92725156|NCT00565175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610292|NCT00162786|Antipruritics|antipruritics|mesh-ancestor
92610293|NCT00162786|Dermatologic Agents|dermatologic agents|mesh-ancestor
92725157|NCT00565175|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92725158|NCT00565175|Histamine Antagonists|histamine antagonists|mesh-ancestor
92725159|NCT00565175|Histamine Agents|histamine agents|mesh-ancestor
92725160|NCT00565175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725161|NCT00565175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725162|NCT00565175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725163|NCT00477165|Citalopram|citalopram|mesh-list
92725164|NCT00477165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92725165|NCT00477165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725166|NCT00477165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725167|NCT00477165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725168|NCT00477165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725169|NCT00477165|Serotonin Agents|serotonin agents|mesh-ancestor
92725170|NCT00477165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725171|NCT00477165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92725172|NCT00477165|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725173|NCT00477165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725174|NCT04604054|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92725175|NCT04604054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92725176|NCT04604054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725177|NCT00476229|Rituximab|rituximab|mesh-list
92725178|NCT00476229|Thymoglobulin|thymoglobulin|mesh-list
92725179|NCT00476229|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92725180|NCT00476229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725181|NCT00476229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725182|NCT00476229|Immunologic Factors|immunologic factors|mesh-ancestor
92725183|NCT00476229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725184|NCT00476229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92725185|NCT00476229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725186|NCT04603976|Erenumab|erenumab|mesh-list
92725187|NCT04603976|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92725188|NCT04603976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725189|NCT04603976|Analgesics|analgesics|mesh-ancestor
92725190|NCT04603976|Sensory System Agents|sensory system agents|mesh-ancestor
92725191|NCT04603976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725192|NCT04603976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725193|NCT00476151|Ketamine|ketamine|mesh-list
92725194|NCT00476151|Amitriptyline|amitriptyline|mesh-list
92725195|NCT00476151|Analgesics|analgesics|mesh-ancestor
92725200|NCT00476151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92725201|NCT00476151|Anesthetics, General|anesthetics, general|mesh-ancestor
92725202|NCT00476151|Anesthetics|anesthetics|mesh-ancestor
92725203|NCT00476151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725204|NCT00476151|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92725205|NCT00476151|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92725206|NCT00476151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725207|NCT00476151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725208|NCT00476151|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92725209|NCT00476151|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725210|NCT00476151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725211|NCT00476151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92725212|NCT00476151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92725213|NCT00476151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725214|NCT00476151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725215|NCT00476151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92725216|NCT04603664|Cystatins|cystatins|mesh-list
92725217|NCT04603664|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92725218|NCT04603664|Protease Inhibitors|protease inhibitors|mesh-ancestor
92725219|NCT04603664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725220|NCT04603664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725221|NCT00474903|Aspirin|aspirin|mesh-list
92725222|NCT00474903|Esomeprazole|esomeprazole|mesh-list
92725223|NCT00474903|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92725224|NCT00474903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725225|NCT00474903|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92725226|NCT00474903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725227|NCT00474903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610294|NCT00162786|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92610295|NCT00162786|Histamine Antagonists|histamine antagonists|mesh-ancestor
92610296|NCT00162786|Histamine Agents|histamine agents|mesh-ancestor
92610297|NCT00162786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610298|NCT00162786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610299|NCT00162786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725228|NCT00474903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92725229|NCT00474903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92725230|NCT00474903|Analgesics|analgesics|mesh-ancestor
92725231|NCT00474903|Sensory System Agents|sensory system agents|mesh-ancestor
92725232|NCT00474903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725233|NCT00474903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725234|NCT00474903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725235|NCT00474903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92725236|NCT00474903|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92725237|NCT00474903|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92725238|NCT00474903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92725239|NCT00474903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92725240|NCT00474903|Antipyretics|antipyretics|mesh-ancestor
92725241|NCT01134055|Ranibizumab|ranibizumab|mesh-list
92725242|NCT01134055|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92725243|NCT01134055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725244|NCT01134055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725245|NCT01134055|Growth Substances|growth substances|mesh-ancestor
92725246|NCT01134055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725247|NCT01134055|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725248|NCT01134055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725249|NCT01134055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92725250|NCT00474708|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92725251|NCT00474708|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92725252|NCT00474708|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725253|NCT00474708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725254|NCT00474708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725255|NCT00474708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725256|NCT00474708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725257|NCT00474708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92725258|NCT00474708|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725259|NCT00474708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725260|NCT00474240|Atorvastatin|atorvastatin|mesh-list
92725261|NCT00474240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92725262|NCT00474240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92725263|NCT00474240|Antimetabolites|antimetabolites|mesh-ancestor
92725265|NCT00474240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92725266|NCT00474240|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92725267|NCT00474240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725269|NCT00473889|Carboplatin|carboplatin|mesh-list
92725270|NCT00473889|Vorinostat|vorinostat|mesh-list
92725271|NCT00473889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92725272|NCT00473889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725273|NCT00473889|Tubulin Modulators|tubulin modulators|mesh-ancestor
92725274|NCT00473889|Antimitotic Agents|antimitotic agents|mesh-ancestor
92725275|NCT00473889|Mitosis Modulators|mitosis modulators|mesh-ancestor
92725276|NCT00473889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725277|NCT00473889|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92725278|NCT00473889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725279|NCT00565214|Vitamins|vitamins|mesh-list
92725280|NCT00565214|Vitamin E|vitamin e|mesh-list
92725281|NCT00565214|Selenium|selenium|mesh-list
92725282|NCT00565214|Micronutrients|micronutrients|mesh-ancestor
92725283|NCT00565214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725284|NCT00565214|Antioxidants|antioxidants|mesh-ancestor
92725285|NCT00565214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725286|NCT00565214|Protective Agents|protective agents|mesh-ancestor
92725287|NCT00565214|Trace Elements|trace elements|mesh-ancestor
92725288|NCT00565253|Nitric Oxide|nitric oxide|mesh-list
92725289|NCT00565253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92725290|NCT00565253|Autonomic Agents|autonomic agents|mesh-ancestor
92725291|NCT00565253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610300|NCT00142181|Alemtuzumab|alemtuzumab|mesh-list
92610301|NCT00142181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610302|NCT00142181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610303|NCT00505804|Dexmedetomidine|dexmedetomidine|mesh-list
92610304|NCT00505804|Haloperidol|haloperidol|mesh-list
92610305|NCT00505804|Haloperidol decanoate|haloperidol decanoate|mesh-list
92610306|NCT00505804|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92725292|NCT00565253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725293|NCT00565253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92725294|NCT00565253|Respiratory System Agents|respiratory system agents|mesh-ancestor
92725295|NCT00565253|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92725296|NCT00565253|Antioxidants|antioxidants|mesh-ancestor
92725297|NCT00565253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725298|NCT00565253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725299|NCT00565253|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92725300|NCT00565253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92725301|NCT00565253|Gasotransmitters|gasotransmitters|mesh-ancestor
92725302|NCT00565253|Protective Agents|protective agents|mesh-ancestor
92725303|NCT02277600|Darunavir|darunavir|mesh-list
92725304|NCT02277600|Cobicistat|cobicistat|mesh-list
92725305|NCT02277600|Fostemsavir|fostemsavir|mesh-list
92725306|NCT02277600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92725307|NCT02277600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92725308|NCT02277600|Protease Inhibitors|protease inhibitors|mesh-ancestor
92725309|NCT02277600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725310|NCT02277600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725311|NCT02277600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92725312|NCT02277600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92725313|NCT02277600|Antiviral Agents|antiviral agents|mesh-ancestor
92725314|NCT02277600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725315|NCT02277600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92725316|NCT02277600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92725317|NCT02277600|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92725318|NCT02277600|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92725319|NCT04602143|Testosterone|testosterone|mesh-list
92725320|NCT04602143|Androgens|androgens|mesh-ancestor
92725321|NCT04602143|Hormones|hormones|mesh-ancestor
92725322|NCT04602143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725323|NCT04602143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725324|NCT02277678|Morphine|morphine|mesh-list
92725325|NCT02277678|Oxycodone|oxycodone|mesh-list
92725326|NCT02277678|Analgesics, Opioid|analgesics, opioid|mesh-list
92725327|NCT02277678|Narcotics|narcotics|mesh-ancestor
92725328|NCT02277678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725329|NCT02277678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725330|NCT02277678|Analgesics|analgesics|mesh-ancestor
92725331|NCT02277678|Sensory System Agents|sensory system agents|mesh-ancestor
92725332|NCT02277678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725333|NCT02277717|Trastuzumab|trastuzumab|mesh-list
92725334|NCT02277717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725335|NCT02277717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725336|NCT04601675|Dexamethasone|dexamethasone|mesh-list
92725337|NCT04601675|Ranibizumab|ranibizumab|mesh-list
92725338|NCT04601675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725339|NCT04601675|Antiemetics|antiemetics|mesh-ancestor
92725344|NCT04601675|Glucocorticoids|glucocorticoids|mesh-ancestor
92725345|NCT04601675|Hormones|hormones|mesh-ancestor
92725346|NCT04601675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725347|NCT04601675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92725348|NCT04601675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725349|NCT04601675|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725350|NCT04601675|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725351|NCT04601675|Growth Substances|growth substances|mesh-ancestor
92725352|NCT04601675|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725353|NCT00565292|Anacetrapib|anacetrapib|mesh-list
92725354|NCT00565292|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92725355|NCT00565292|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92725356|NCT00565292|Antimetabolites|antimetabolites|mesh-ancestor
92725357|NCT00565292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725358|NCT00565292|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92610307|NCT00505804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610308|NCT00505804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725359|NCT01580865|Mycophenolic Acid|mycophenolic acid|mesh-list
92725360|NCT01580865|Tacrolimus|tacrolimus|mesh-list
92725361|NCT01580865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725362|NCT01580865|Immunologic Factors|immunologic factors|mesh-ancestor
92725363|NCT01580865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725364|NCT01580865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92725365|NCT01580865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725366|NCT01580865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725367|NCT01580865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92725368|NCT01580865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725369|NCT01580865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92725370|NCT01580865|Antitubercular Agents|antitubercular agents|mesh-ancestor
92725371|NCT01580865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92725372|NCT01580865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725373|NCT00473694|Glycopyrrolate|glycopyrrolate|mesh-list
92725374|NCT00473694|Rocuronium|rocuronium|mesh-list
92725375|NCT00473694|Vecuronium Bromide|vecuronium bromide|mesh-list
92725376|NCT00473694|Neostigmine|neostigmine|mesh-list
92725377|NCT00473694|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92725378|NCT00473694|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92725379|NCT00473694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92725380|NCT00473694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725381|NCT00473694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725382|NCT00473694|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92725383|NCT00473694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725384|NCT00473694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725385|NCT00473694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92725386|NCT00473694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725387|NCT00473694|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92725388|NCT00473694|Autonomic Agents|autonomic agents|mesh-ancestor
92725389|NCT00473694|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92725390|NCT00473694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92725391|NCT00473694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92725392|NCT00473694|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92725393|NCT04601324|Fluticasone|fluticasone|mesh-list
92725394|NCT04601324|Xhance|xhance|mesh-list
92725395|NCT04601324|Azelastine|azelastine|mesh-list
92725396|NCT04601324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725397|NCT04601324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92725398|NCT04601324|Autonomic Agents|autonomic agents|mesh-ancestor
92725399|NCT04601324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725400|NCT04601324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725401|NCT04601324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92725402|NCT04601324|Respiratory System Agents|respiratory system agents|mesh-ancestor
92725403|NCT04601324|Dermatologic Agents|dermatologic agents|mesh-ancestor
92725404|NCT04601324|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92725405|NCT04601324|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92725406|NCT04601324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725407|NCT04601324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725408|NCT04601324|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92725409|NCT04601324|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92725410|NCT04601324|Histamine Antagonists|histamine antagonists|mesh-ancestor
92397254|NCT05064137|Protective Agents|protective agents|mesh-ancestor
92725414|NCT00565331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725416|NCT00565331|Immunologic Factors|immunologic factors|mesh-ancestor
92725417|NCT00565331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725418|NCT00565331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92725419|NCT00473655|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92725420|NCT00473655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92725421|NCT00473655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92725422|NCT00473655|Antimetabolites|antimetabolites|mesh-ancestor
92725423|NCT00473655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725424|NCT00473655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92725425|NCT00473655|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92725426|NCT00473655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725427|NCT00582920|Zoledronic Acid|zoledronic acid|mesh-list
92725428|NCT00582920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92725429|NCT00582920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725430|NCT00473382|Ranibizumab|ranibizumab|mesh-list
92725431|NCT00473382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725432|NCT00473382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92610309|NCT00505804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92610310|NCT00505804|Analgesics|analgesics|mesh-ancestor
92610311|NCT00505804|Sensory System Agents|sensory system agents|mesh-ancestor
92610312|NCT00505804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725433|NCT00473382|Growth Substances|growth substances|mesh-ancestor
92725434|NCT00473382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725435|NCT00473382|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725436|NCT00473382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725437|NCT04576364|Magnesium Sulfate|magnesium sulfate|mesh-list
92725438|NCT04576364|Analgesics|analgesics|mesh-ancestor
92725439|NCT04576364|Sensory System Agents|sensory system agents|mesh-ancestor
92725440|NCT04576364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725441|NCT04576364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725442|NCT04576364|Anesthetics|anesthetics|mesh-ancestor
92725443|NCT04576364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725444|NCT04576364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92725445|NCT04576364|Anticonvulsants|anticonvulsants|mesh-ancestor
92725446|NCT04576364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92725447|NCT04576364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725448|NCT04576364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725449|NCT04576364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92725450|NCT04576364|Tocolytic Agents|tocolytic agents|mesh-ancestor
92725451|NCT04576364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92725452|NCT02210325|Azithromycin|azithromycin|mesh-list
92725453|NCT02210325|Ceftriaxone|ceftriaxone|mesh-list
92725454|NCT02210325|Solithromycin|solithromycin|mesh-list
92725455|NCT02210325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92725456|NCT02210325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725457|NCT00473265|Teriparatide|teriparatide|mesh-list
92725458|NCT00473265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92725459|NCT00473265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725460|NCT00473265|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92725461|NCT00472641|Ziprasidone|ziprasidone|mesh-list
92725462|NCT00472641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92725467|NCT00472641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92725468|NCT00472641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92725469|NCT00472641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725470|NCT00472641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725471|NCT00472641|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92725472|NCT00472641|Dopamine Agents|dopamine agents|mesh-ancestor
92725473|NCT04576208|Antidiarrheals|antidiarrheals|mesh-list
92725474|NCT04576208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725475|NCT04571151|Halobetasol|halobetasol|mesh-list
92725476|NCT04571151|Calcipotriene|calcipotriene|mesh-list
92725477|NCT04571151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92725478|NCT04571151|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92725479|NCT01133977|Lenvatinib|lenvatinib|mesh-list
92725480|NCT01133977|Dacarbazine|dacarbazine|mesh-list
92397264|NCT05052528|Immunoglobulins|immunoglobulins|mesh-list
92725481|NCT01133977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725482|NCT01133977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92725483|NCT01133977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610313|NCT00505804|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92610314|NCT00505804|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92725484|NCT01133977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725485|NCT01133977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92725486|NCT01133977|Alkylating Agents|alkylating agents|mesh-ancestor
92725487|NCT00583193|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92725488|NCT00583193|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92725489|NCT00583193|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725490|NCT00583193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725491|NCT00583193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725492|NCT00583193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725493|NCT00583193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725494|NCT00583193|Analgesics|analgesics|mesh-ancestor
92725495|NCT00583193|Sensory System Agents|sensory system agents|mesh-ancestor
92725496|NCT00583193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725497|NCT00583193|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725498|NCT00583193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725499|NCT00583193|Dopamine Agents|dopamine agents|mesh-ancestor
92725500|NCT01133821|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92725501|NCT01133821|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725502|NCT01133821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725503|NCT01133821|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92725504|NCT01133821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92725505|NCT01133821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725506|NCT01133821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725507|NCT00583271|Ethanol|ethanol|mesh-list
92725508|NCT00583271|Triamcinolone|triamcinolone|mesh-list
92725509|NCT00583271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725510|NCT00583271|Glucocorticoids|glucocorticoids|mesh-ancestor
92725511|NCT00583271|Hormones|hormones|mesh-ancestor
92725512|NCT00583271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725513|NCT00583271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725514|NCT00583271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92725515|NCT00583271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725516|NCT00583271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725517|NCT00583349|Paclitaxel|paclitaxel|mesh-list
92725518|NCT00583349|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92725519|NCT00583349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725520|NCT00583349|Tubulin Modulators|tubulin modulators|mesh-ancestor
92725521|NCT00583349|Antimitotic Agents|antimitotic agents|mesh-ancestor
92725522|NCT00583349|Mitosis Modulators|mitosis modulators|mesh-ancestor
92725523|NCT00583349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725524|NCT01133665|Lenalidomide|lenalidomide|mesh-list
92725525|NCT01133665|Cetuximab|cetuximab|mesh-list
92725526|NCT01133665|Immunologic Factors|immunologic factors|mesh-ancestor
92725527|NCT01133665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725528|NCT01133665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725529|NCT01133665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725530|NCT01133665|Growth Substances|growth substances|mesh-ancestor
92725531|NCT01133665|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725532|NCT01133665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725539|NCT00583427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92725540|NCT00583427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92725541|NCT00583427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92725542|NCT00583427|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92725543|NCT00583427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725544|NCT01133626|Prednisone|prednisone|mesh-list
92725545|NCT01133626|Beclomethasone|beclomethasone|mesh-list
92725546|NCT01133626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725547|NCT01133626|Glucocorticoids|glucocorticoids|mesh-ancestor
92725548|NCT01133626|Hormones|hormones|mesh-ancestor
92725549|NCT01133626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725550|NCT01133626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725551|NCT01133626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92725552|NCT01133626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725553|NCT01133626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92725554|NCT01133626|Respiratory System Agents|respiratory system agents|mesh-ancestor
92725555|NCT01133392|Insulin|insulin|mesh-list
92725556|NCT01133392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92725557|NCT01133392|Insulin Lispro|insulin lispro|mesh-list
92610316|NCT00505804|Adrenergic Agents|adrenergic agents|mesh-ancestor
92610317|NCT00505804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610318|NCT00505804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610319|NCT00505804|Antiemetics|antiemetics|mesh-ancestor
92610320|NCT00505804|Autonomic Agents|autonomic agents|mesh-ancestor
92610321|NCT00505804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725558|NCT01133392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92725559|NCT01133392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725560|NCT00471354|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92725561|NCT00471354|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92725562|NCT00471354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725563|NCT00471354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725564|NCT00471354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725565|NCT00471354|Adrenergic Agents|adrenergic agents|mesh-ancestor
92725566|NCT00471354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725567|NCT00471354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725568|NCT02882893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92725569|NCT02882893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92725570|NCT02882893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92725571|NCT02882893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725572|NCT02882893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725573|NCT02882893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92725574|NCT02882893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725575|NCT02882893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725576|NCT02882893|Cholinergic Agents|cholinergic agents|mesh-ancestor
92725577|NCT02882893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725578|NCT02210364|Capecitabine|capecitabine|mesh-list
92725579|NCT02210364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92725580|NCT02210364|Antimetabolites|antimetabolites|mesh-ancestor
92725581|NCT02210364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725582|NCT02210364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725583|NCT00471315|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92725584|NCT00471315|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92725585|NCT00471315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725586|NCT00471315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725587|NCT00471315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725588|NCT00471315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725589|NCT00471315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725590|NCT00471315|Analgesics|analgesics|mesh-ancestor
92725591|NCT00471315|Sensory System Agents|sensory system agents|mesh-ancestor
92725592|NCT00471315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725593|NCT00471315|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725594|NCT00471315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725595|NCT00471315|Dopamine Agents|dopamine agents|mesh-ancestor
92725596|NCT00471237|Alendronate|alendronate|mesh-list
92725597|NCT00471237|Teriparatide|teriparatide|mesh-list
92725598|NCT00471237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92725600|NCT00471237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92725602|NCT04570683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725603|NCT04570683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725604|NCT04570683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92725605|NCT04570683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725606|NCT04570449|Fluoxetine|fluoxetine|mesh-list
92725607|NCT04570449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92725608|NCT04570449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725609|NCT04570449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725610|NCT04570449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725611|NCT04570449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725612|NCT04570449|Serotonin Agents|serotonin agents|mesh-ancestor
92725613|NCT04570449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725614|NCT04570449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92725615|NCT04570449|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725616|NCT04570449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725617|NCT04570449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92610322|NCT00505804|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92610323|NCT00505804|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610324|NCT00505804|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92610325|NCT00505804|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92610326|NCT00505804|Dopamine Agents|dopamine agents|mesh-ancestor
92610327|NCT00505804|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92610329|NCT00505843|Carbidopa|carbidopa|mesh-list
92610330|NCT00505843|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92725618|NCT04570449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92725619|NCT04570449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725620|NCT00470847|Trastuzumab|trastuzumab|mesh-list
92725621|NCT00470847|Lapatinib|lapatinib|mesh-list
92725622|NCT00470847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725623|NCT00470847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725624|NCT00470847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92725625|NCT00470847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725626|NCT00470847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725627|NCT00584090|Solifenacin Succinate|solifenacin succinate|mesh-list
92725628|NCT00584090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92725629|NCT00584090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92725630|NCT00584090|Cholinergic Agents|cholinergic agents|mesh-ancestor
92725631|NCT00584090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725632|NCT00584090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725633|NCT00584090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725634|NCT00584090|Urological Agents|urological agents|mesh-ancestor
92725635|NCT00584168|Dexamethasone|dexamethasone|mesh-list
92725636|NCT00584168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725637|NCT00584168|Antiemetics|antiemetics|mesh-ancestor
92725638|NCT00584168|Autonomic Agents|autonomic agents|mesh-ancestor
92725639|NCT00584168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725640|NCT00584168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725641|NCT00584168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725642|NCT00584168|Glucocorticoids|glucocorticoids|mesh-ancestor
92725643|NCT00584168|Hormones|hormones|mesh-ancestor
92725644|NCT00584168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725645|NCT00584168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92725646|NCT00584168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725647|NCT00470535|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92725648|NCT00470535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725649|NCT00470535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92725650|NCT00470535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725651|NCT00470535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725652|NCT01133275|Prednisone|prednisone|mesh-list
92725653|NCT01133275|Lenalidomide|lenalidomide|mesh-list
92725654|NCT01133275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725655|NCT01133275|Glucocorticoids|glucocorticoids|mesh-ancestor
92725656|NCT01133275|Hormones|hormones|mesh-ancestor
92725657|NCT01133275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725658|NCT01133275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725659|NCT01133275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92725660|NCT01133275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725661|NCT01133275|Immunologic Factors|immunologic factors|mesh-ancestor
92725662|NCT01133275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725663|NCT01133275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725664|NCT01133275|Growth Substances|growth substances|mesh-ancestor
92725665|NCT01133275|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725666|NCT00470184|Capecitabine|capecitabine|mesh-list
92725667|NCT00470184|Oxaliplatin|oxaliplatin|mesh-list
92725668|NCT00470184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92725669|NCT00470184|Antimetabolites|antimetabolites|mesh-ancestor
92725673|NCT04570254|Vitamin E|vitamin e|mesh-list
92725674|NCT04570254|Acetylcysteine|acetylcysteine|mesh-list
92725675|NCT04570254|Pentoxifylline|pentoxifylline|mesh-list
92725676|NCT04570254|Melatonin|melatonin|mesh-list
92725677|NCT04570254|Antioxidants|antioxidants|mesh-list
92725678|NCT04570254|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92725679|NCT04570254|Micronutrients|micronutrients|mesh-ancestor
92725680|NCT04570254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610331|NCT00505843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92610332|NCT00505843|Dopamine Agents|dopamine agents|mesh-ancestor
92610333|NCT00505843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017446|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
92725681|NCT04570254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725682|NCT04570254|Protective Agents|protective agents|mesh-ancestor
92725683|NCT04570254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725684|NCT04570254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92725685|NCT04570254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725686|NCT04570254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92725687|NCT04570254|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92725688|NCT04570254|Vasodilator Agents|vasodilator agents|mesh-ancestor
92725689|NCT04570254|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92725690|NCT04570254|Antiviral Agents|antiviral agents|mesh-ancestor
92725691|NCT04570254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725692|NCT04570254|Expectorants|expectorants|mesh-ancestor
92725693|NCT04570254|Respiratory System Agents|respiratory system agents|mesh-ancestor
92725694|NCT04570254|Antidotes|antidotes|mesh-ancestor
92725695|NCT00470067|Carboplatin|carboplatin|mesh-list
92725696|NCT00470067|Doxorubicin|doxorubicin|mesh-list
92725697|NCT00470067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92725698|NCT00470067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725699|NCT00470067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92725700|NCT00470067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92725701|NCT00470067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92725702|NCT00470067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725703|NCT00470067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725704|NCT00584636|Budesonide|budesonide|mesh-list
92725705|NCT00584636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725706|NCT00584636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92725707|NCT00584636|Autonomic Agents|autonomic agents|mesh-ancestor
92725708|NCT00584636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725709|NCT00584636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725710|NCT00584636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92725711|NCT00584636|Respiratory System Agents|respiratory system agents|mesh-ancestor
92725712|NCT00584636|Glucocorticoids|glucocorticoids|mesh-ancestor
92725713|NCT00584636|Hormones|hormones|mesh-ancestor
92725714|NCT00584636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725715|NCT00479817|Paclitaxel|paclitaxel|mesh-list
92725716|NCT00479817|Trebananib|trebananib|mesh-list
92725717|NCT00479817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92725718|NCT00479817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725719|NCT00479817|Tubulin Modulators|tubulin modulators|mesh-ancestor
92725720|NCT00479817|Antimitotic Agents|antimitotic agents|mesh-ancestor
92725721|NCT00479817|Mitosis Modulators|mitosis modulators|mesh-ancestor
92725722|NCT00479817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725723|NCT00479817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725724|NCT00479817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725725|NCT00479817|Growth Substances|growth substances|mesh-ancestor
92725726|NCT00479817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725727|NCT00479817|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725728|NCT04575194|Liraglutide|liraglutide|mesh-list
92725729|NCT04575194|Naltrexone|naltrexone|mesh-list
92725730|NCT04575194|Bupropion|bupropion|mesh-list
92725731|NCT04575194|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92408618|NCT05963087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725732|NCT04575194|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92725733|NCT04575194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725734|NCT04575194|Sensory System Agents|sensory system agents|mesh-ancestor
92725751|NCT04575194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725753|NCT00478179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92725754|NCT00478179|Anesthetics|anesthetics|mesh-ancestor
92725755|NCT00478179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610334|NCT00505843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610335|NCT00505843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610336|NCT00505843|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92725756|NCT00478179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725757|NCT00478179|Sensory System Agents|sensory system agents|mesh-ancestor
92397288|NCT05051150|Autonomic Agents|autonomic agents|mesh-ancestor
92725758|NCT00478179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725759|NCT00585143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92725760|NCT00585143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92725761|NCT00585143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92725762|NCT00585143|Antimetabolites|antimetabolites|mesh-ancestor
92725763|NCT00585143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725764|NCT00585143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92725765|NCT00585143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92725766|NCT00585143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725767|NCT00585260|Mannitol|mannitol|mesh-list
92725768|NCT00585260|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92725769|NCT00585260|Diuretics|diuretics|mesh-ancestor
92725770|NCT00585260|Natriuretic Agents|natriuretic agents|mesh-ancestor
92725771|NCT00585260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725772|NCT00475020|Fludarabine|fludarabine|mesh-list
92725773|NCT00475020|Fludarabine phosphate|fludarabine phosphate|mesh-list
92725774|NCT00475020|Busulfan|busulfan|mesh-list
92725775|NCT00475020|Thymoglobulin|thymoglobulin|mesh-list
92725776|NCT00475020|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92725777|NCT00475020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725778|NCT00475020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92725779|NCT00475020|Antimetabolites|antimetabolites|mesh-ancestor
92725780|NCT00475020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725781|NCT00475020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725782|NCT00475020|Immunologic Factors|immunologic factors|mesh-ancestor
92725783|NCT00475020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725784|NCT00475020|Alkylating Agents|alkylating agents|mesh-ancestor
92725785|NCT00475020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92725786|NCT00475020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92725787|NCT00585455|Sertraline|sertraline|mesh-list
92725788|NCT00585455|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725789|NCT00585455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725790|NCT00585455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92725793|NCT00585455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725794|NCT00585455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725795|NCT00585455|Serotonin Agents|serotonin agents|mesh-ancestor
92725796|NCT00585455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725797|NCT01083966|Bevacizumab|bevacizumab|mesh-list
92725798|NCT01083966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725799|NCT01083966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725800|NCT01083966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92725801|NCT01083966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92725802|NCT01083966|Growth Substances|growth substances|mesh-ancestor
92725803|NCT01083966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725804|NCT01083966|Growth Inhibitors|growth inhibitors|mesh-ancestor
92725805|NCT01132807|Prednisone|prednisone|mesh-list
92725806|NCT01132807|Cyclophosphamide|cyclophosphamide|mesh-list
92725808|NCT01132807|Doxorubicin|doxorubicin|mesh-list
92725809|NCT01132807|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92725810|NCT01132807|Etoposide|etoposide|mesh-list
92725811|NCT01132807|Bleomycin|bleomycin|mesh-list
92725812|NCT01132807|Vinblastine|vinblastine|mesh-list
92725813|NCT01132807|Etoposide phosphate|etoposide phosphate|mesh-list
92725814|NCT01132807|Procarbazine|procarbazine|mesh-list
92725815|NCT01132807|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92725816|NCT01132807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725817|NCT01132807|Immunologic Factors|immunologic factors|mesh-ancestor
92725818|NCT01132807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725819|NCT01132807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92725820|NCT01132807|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92725821|NCT01132807|Alkylating Agents|alkylating agents|mesh-ancestor
92725822|NCT01132807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725823|NCT01132807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725824|NCT01132807|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92725825|NCT01132807|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92610337|NCT00505843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610338|NCT00505882|Pramlintide|pramlintide|mesh-list
92397295|NCT05045313|Probenecid|probenecid|mesh-list
92610339|NCT00505882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92610340|NCT00505882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610341|NCT00142337|Zidovudine|zidovudine|mesh-list
92725826|NCT01132807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92725827|NCT01132807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92725828|NCT01132807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725829|NCT01132807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725830|NCT01132807|Glucocorticoids|glucocorticoids|mesh-ancestor
92725831|NCT01132807|Hormones|hormones|mesh-ancestor
92725832|NCT01132807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725833|NCT01132807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92725834|NCT01132807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92725835|NCT01132807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92725836|NCT01132807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92725837|NCT01132807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92725838|NCT01132807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92725839|NCT04569513|Parathyroid Hormone|parathyroid hormone|mesh-list
92725840|NCT04569513|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92725841|NCT04569513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725842|NCT01089543|Rabeprazole|rabeprazole|mesh-list
92725843|NCT01089543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92725844|NCT01089543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725845|NCT01089543|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92725846|NCT01089543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725847|NCT01089543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725848|NCT04569630|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92725849|NCT04569630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725850|NCT01089504|Phenobarbital|phenobarbital|mesh-list
92725851|NCT01089504|Anticonvulsants|anticonvulsants|mesh-ancestor
92725852|NCT01089504|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92725853|NCT01089504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725854|NCT01089504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725855|NCT01089504|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92725856|NCT01089504|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92725857|NCT01089504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725858|NCT01089504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725859|NCT01089504|GABA Modulators|gaba modulators|mesh-ancestor
92725860|NCT01089504|GABA Agents|gaba agents|mesh-ancestor
92725861|NCT01089504|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92725862|NCT01089504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92725865|NCT03452696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92725866|NCT03452696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725868|NCT01088997|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92725869|NCT01088997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92725870|NCT01088997|Vasodilator Agents|vasodilator agents|mesh-ancestor
92725871|NCT01088997|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92725872|NCT01088997|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92725873|NCT01088997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725874|NCT01088997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725875|NCT01088997|Protective Agents|protective agents|mesh-ancestor
92725876|NCT01088997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725877|NCT00586118|Propofol|propofol|mesh-list
92725878|NCT00586118|Sevoflurane|sevoflurane|mesh-list
92725879|NCT00586118|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92725880|NCT00586118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725881|NCT00586118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725882|NCT00586118|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92725883|NCT00586118|Anesthetics, General|anesthetics, general|mesh-ancestor
92725884|NCT00586118|Anesthetics|anesthetics|mesh-ancestor
92725885|NCT00586118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92725886|NCT00586118|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92725887|NCT01088529|Prednisone|prednisone|mesh-list
92725888|NCT01088529|Leuprolide|leuprolide|mesh-list
92725889|NCT01088529|Goserelin|goserelin|mesh-list
92725890|NCT01088529|Abiraterone Acetate|abiraterone acetate|mesh-list
92725891|NCT01088529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725892|NCT01088529|Glucocorticoids|glucocorticoids|mesh-ancestor
92725893|NCT01088529|Hormones|hormones|mesh-ancestor
92610342|NCT00142337|Didanosine|didanosine|mesh-list
92610343|NCT00142337|Antimetabolites|antimetabolites|mesh-ancestor
92610344|NCT00142337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610345|NCT00142337|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92610346|NCT00142337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92725894|NCT01088529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725895|NCT01088529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725896|NCT01088529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92725897|NCT01088529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725898|NCT01088529|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92725899|NCT01088529|Fertility Agents|fertility agents|mesh-ancestor
92725900|NCT01088529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92725901|NCT01088529|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92725902|NCT01088529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725903|NCT01088529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725904|NCT01088529|Hormone Antagonists|hormone antagonists|mesh-ancestor
92725905|NCT01088529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92725906|NCT00586274|Fludarabine|fludarabine|mesh-list
92725907|NCT00586274|Alemtuzumab|alemtuzumab|mesh-list
92725908|NCT00586274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725909|NCT00586274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725910|NCT00586430|Lorazepam|lorazepam|mesh-list
92725911|NCT00586430|Anticonvulsants|anticonvulsants|mesh-ancestor
92725912|NCT00586430|Antiemetics|antiemetics|mesh-ancestor
92725913|NCT00586430|Autonomic Agents|autonomic agents|mesh-ancestor
92725914|NCT00586430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725915|NCT00586430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725916|NCT00586430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725917|NCT00586430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92725918|NCT00586430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725919|NCT00586430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92725920|NCT00586430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92725921|NCT00586430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725922|NCT00586430|GABA Modulators|gaba modulators|mesh-ancestor
92725923|NCT00586430|GABA Agents|gaba agents|mesh-ancestor
92725924|NCT00586430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725925|NCT00586430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725926|NCT04569279|Warfarin|warfarin|mesh-list
92725927|NCT04569279|Rivaroxaban|rivaroxaban|mesh-list
92725928|NCT04569279|Anticoagulants|anticoagulants|mesh-ancestor
92725929|NCT04569279|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92725930|NCT04569279|Antithrombins|antithrombins|mesh-ancestor
92725931|NCT04569279|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92725932|NCT04569279|Protease Inhibitors|protease inhibitors|mesh-ancestor
92725933|NCT04569279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725934|NCT04569279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725935|NCT04312204|Carboplatin|carboplatin|mesh-list
92725936|NCT04312204|Gemcitabine|gemcitabine|mesh-list
92725939|NCT04312204|Antimetabolites|antimetabolites|mesh-ancestor
92725940|NCT04312204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725941|NCT04312282|Itraconazole|itraconazole|mesh-list
92725942|NCT04312282|Rifampin|rifampin|mesh-list
92725943|NCT04312282|Antifungal Agents|antifungal agents|mesh-ancestor
92725944|NCT04312282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92725945|NCT04312282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92725946|NCT04312282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92725947|NCT04312282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92725948|NCT04312282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725949|NCT04312282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92725950|NCT04312282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92725951|NCT04312282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725952|NCT04312282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725953|NCT04312282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92725954|NCT04312282|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92725955|NCT04312282|Antitubercular Agents|antitubercular agents|mesh-ancestor
92725956|NCT04312282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92725957|NCT04312282|Leprostatic Agents|leprostatic agents|mesh-ancestor
92725958|NCT04312282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92610347|NCT00142337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610349|NCT00142337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610350|NCT00142337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92610351|NCT00142337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92610352|NCT00162864|Montelukast|montelukast|mesh-list
92610353|NCT00162864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92610354|NCT00162864|Respiratory System Agents|respiratory system agents|mesh-ancestor
92610355|NCT00162864|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92610356|NCT00162864|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610357|NCT00162864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610358|NCT00162864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610359|NCT00162864|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92610360|NCT00162864|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92610361|NCT00162864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610363|NCT04512313|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92610364|NCT04512313|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92725959|NCT04312282|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92725960|NCT04312282|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92725961|NCT04312282|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92725962|NCT04312282|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92725963|NCT04312282|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92725964|NCT04312282|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92725965|NCT01087905|Nicotine|nicotine|mesh-list
92725966|NCT01087905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92725967|NCT01087905|Autonomic Agents|autonomic agents|mesh-ancestor
92725968|NCT01087905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725969|NCT01087905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725970|NCT01087905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92725971|NCT01087905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92725972|NCT01087905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92725973|NCT01087905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725974|NCT01087905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725975|NCT01087788|Certolizumab Pegol|certolizumab pegol|mesh-list
92725976|NCT01087788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92725977|NCT01087788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92725978|NCT01087788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92725979|NCT01087788|Immunologic Factors|immunologic factors|mesh-ancestor
92725980|NCT01087788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725981|NCT01087788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92725982|NCT00586976|Ropivacaine|ropivacaine|mesh-list
92725983|NCT00586976|Anesthetics, Local|anesthetics, local|mesh-ancestor
92725984|NCT00586976|Anesthetics|anesthetics|mesh-ancestor
92725985|NCT00586976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92725986|NCT00586976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725987|NCT00586976|Sensory System Agents|sensory system agents|mesh-ancestor
92725988|NCT00586976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725989|NCT00587015|Immunotoxin HA22|immunotoxin ha22|mesh-list
92725990|NCT00587015|Immunotoxins|immunotoxins|mesh-ancestor
92725991|NCT00587015|Immunoconjugates|immunoconjugates|mesh-ancestor
92725992|NCT00587015|Immunologic Factors|immunologic factors|mesh-ancestor
92725993|NCT00587015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725994|NCT00587015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725995|NCT04568772|Atovaquone|atovaquone|mesh-list
92725996|NCT04568772|Proguanil|proguanil|mesh-list
92610366|NCT04512313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017480|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92725997|NCT04568772|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92725998|NCT04568772|Esomeprazole|esomeprazole|mesh-list
92725999|NCT04568772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92726000|NCT04568772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726001|NCT04568772|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92726002|NCT04568772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726003|NCT04568772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726004|NCT04568772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726005|NCT04568772|Antimalarials|antimalarials|mesh-ancestor
92726006|NCT04568772|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92726007|NCT04568772|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92726008|NCT04568772|Antimetabolites|antimetabolites|mesh-ancestor
92726010|NCT04575389|Antioxidants|antioxidants|mesh-ancestor
92726011|NCT04575389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726012|NCT04575389|Protective Agents|protective agents|mesh-ancestor
92726013|NCT04575389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726014|NCT01086150|Lidocaine|lidocaine|mesh-list
92726015|NCT01086150|Anesthetics, Local|anesthetics, local|mesh-ancestor
92726016|NCT01086150|Anesthetics|anesthetics|mesh-ancestor
92726017|NCT01086150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726018|NCT01086150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726019|NCT01086150|Sensory System Agents|sensory system agents|mesh-ancestor
92726020|NCT01086150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726021|NCT01086150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92726022|NCT01086150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92726023|NCT01086150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92726024|NCT01086150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726025|NCT01086150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726026|NCT00587249|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92726027|NCT00587249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92726028|NCT00587249|Immunologic Factors|immunologic factors|mesh-ancestor
92726029|NCT00587249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726030|NCT00587249|Antacids|antacids|mesh-ancestor
92726031|NCT00587249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726032|NCT00587249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726034|NCT00587327|Hormone Antagonists|hormone antagonists|mesh-ancestor
92726035|NCT00587327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726036|NCT00587327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726037|NCT00587327|Tocolytic Agents|tocolytic agents|mesh-ancestor
92726038|NCT00587327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726039|NCT00587444|Heparin|heparin|mesh-list
92726040|NCT00587444|Calcium heparin|calcium heparin|mesh-list
92726041|NCT00587444|Anticoagulants|anticoagulants|mesh-ancestor
92726042|NCT00587444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92726043|NCT00587444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92726044|NCT00587444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726045|NCT02278302|Ethanol|ethanol|mesh-list
92726046|NCT02278302|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92726047|NCT02278302|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92726048|NCT02278302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726049|NCT02278302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726050|NCT02278302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726051|NCT02278302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726052|NCT00587717|Simvastatin|simvastatin|mesh-list
92726053|NCT00587717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92726054|NCT00587717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92726055|NCT00587717|Antimetabolites|antimetabolites|mesh-ancestor
92726056|NCT00587717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726057|NCT00587717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92726058|NCT00587717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92726059|NCT00587717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726060|NCT01085136|Afatinib|afatinib|mesh-list
92726061|NCT01085136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726062|NCT01085136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92726063|NCT01085136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726064|NCT01085136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726065|NCT00587873|Leucovorin|leucovorin|mesh-list
92610367|NCT04512313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610369|NCT00142493|Dexmedetomidine|dexmedetomidine|mesh-list
92610370|NCT00142493|Thiopental|thiopental|mesh-list
92610371|NCT00142493|Propofol|propofol|mesh-list
92726066|NCT00587873|Methotrexate|methotrexate|mesh-list
92726067|NCT00587873|Thioguanine|thioguanine|mesh-list
92726068|NCT00587873|Calcium|calcium|mesh-list
92726069|NCT00587873|Levoleucovorin|levoleucovorin|mesh-list
92726070|NCT00587873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92726071|NCT00587873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726072|NCT00587873|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92726073|NCT00587873|Abortifacient Agents|abortifacient agents|mesh-ancestor
92726074|NCT00587873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726075|NCT00587873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726076|NCT00587873|Antimetabolites|antimetabolites|mesh-ancestor
92726077|NCT00587873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726078|NCT00587873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726079|NCT00587873|Dermatologic Agents|dermatologic agents|mesh-ancestor
92726080|NCT00587873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726081|NCT00587873|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92726084|NCT00587873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726085|NCT00587873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92726086|NCT00587873|Antidotes|antidotes|mesh-ancestor
92726087|NCT00587873|Protective Agents|protective agents|mesh-ancestor
92726088|NCT00587873|Vitamin B Complex|vitamin b complex|mesh-ancestor
92726089|NCT00587873|Vitamins|vitamins|mesh-ancestor
92726090|NCT00587873|Micronutrients|micronutrients|mesh-ancestor
92726091|NCT01084707|Nicotine|nicotine|mesh-list
92726092|NCT01084707|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92726093|NCT01084707|Autonomic Agents|autonomic agents|mesh-ancestor
92726094|NCT01084707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726095|NCT01084707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726096|NCT01084707|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92726097|NCT01084707|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92726098|NCT01084707|Cholinergic Agents|cholinergic agents|mesh-ancestor
92726099|NCT01084707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726100|NCT01084707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726101|NCT02210598|Oxytocin|oxytocin|mesh-list
92726102|NCT02210598|Oxytocics|oxytocics|mesh-ancestor
92726103|NCT02210598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726104|NCT02210598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726105|NCT04574960|Carboplatin|carboplatin|mesh-list
92726106|NCT04574960|Gemcitabine|gemcitabine|mesh-list
92726107|NCT04574960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726108|NCT04574960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726109|NCT04574960|Antimetabolites|antimetabolites|mesh-ancestor
92726110|NCT04574960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726111|NCT03452657|Ranibizumab|ranibizumab|mesh-list
92726112|NCT03452657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92726113|NCT03452657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92726114|NCT03452657|Growth Substances|growth substances|mesh-ancestor
92726115|NCT03452657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726116|NCT03452657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92726117|NCT03452657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726118|NCT03452501|Infliximab|infliximab|mesh-list
92726119|NCT03452501|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92726120|NCT03452501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92610373|NCT00142493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610374|NCT00142493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610375|NCT00142493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92610376|NCT00142493|Analgesics|analgesics|mesh-ancestor
92610377|NCT00142493|Sensory System Agents|sensory system agents|mesh-ancestor
92610378|NCT00142493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726121|NCT03452501|Dermatologic Agents|dermatologic agents|mesh-ancestor
92726122|NCT03452501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726123|NCT03452501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726124|NCT00588302|Moexipril|moexipril|mesh-list
92726125|NCT00588302|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92726126|NCT00588302|Protease Inhibitors|protease inhibitors|mesh-ancestor
92726127|NCT00588302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726128|NCT00588302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726129|NCT00588302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92726130|NCT01084005|Linagliptin|linagliptin|mesh-list
92726131|NCT01084005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92726132|NCT01084005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726133|NCT01084005|Incretins|incretins|mesh-ancestor
92726134|NCT01084005|Hormones|hormones|mesh-ancestor
92726135|NCT01084005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726136|NCT01084005|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92726137|NCT01084005|Protease Inhibitors|protease inhibitors|mesh-ancestor
92726138|NCT01084005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726139|NCT01084005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726140|NCT01083810|Ritonavir|ritonavir|mesh-list
92726141|NCT01083810|Lopinavir|lopinavir|mesh-list
92726143|NCT01083810|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92726145|NCT01083810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726146|NCT01083810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726147|NCT01083810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92726148|NCT01083810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92726149|NCT01083810|Antiviral Agents|antiviral agents|mesh-ancestor
92726150|NCT01083810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726151|NCT01083810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92726152|NCT01083810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92726153|NCT00588926|Remifentanil|remifentanil|mesh-list
92726154|NCT00588926|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92726155|NCT00588926|Narcotics|narcotics|mesh-ancestor
92726156|NCT00588926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726157|NCT00588926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726158|NCT00588926|Analgesics|analgesics|mesh-ancestor
92726159|NCT00588926|Sensory System Agents|sensory system agents|mesh-ancestor
92726160|NCT00588926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726161|NCT00589082|Daunorubicin|daunorubicin|mesh-list
92726162|NCT00589082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92726163|NCT00589082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726164|NCT00589082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92726165|NCT00589082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92726166|NCT00589082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726167|NCT00589082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726168|NCT00589238|Paclitaxel|paclitaxel|mesh-list
92726169|NCT00589238|Cyclophosphamide|cyclophosphamide|mesh-list
92726170|NCT00589238|Carboplatin|carboplatin|mesh-list
92726171|NCT00589238|Doxorubicin|doxorubicin|mesh-list
92726172|NCT00589238|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92726173|NCT00589238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92726174|NCT00589238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726175|NCT00589238|Tubulin Modulators|tubulin modulators|mesh-ancestor
92726176|NCT00589238|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726177|NCT00589238|Mitosis Modulators|mitosis modulators|mesh-ancestor
92726178|NCT00589238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726179|NCT00589238|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726180|NCT00589238|Immunologic Factors|immunologic factors|mesh-ancestor
92726181|NCT00589238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726182|NCT00589238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92610379|NCT00142493|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92610380|NCT00142493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92610381|NCT00142493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92610382|NCT00142493|Adrenergic Agents|adrenergic agents|mesh-ancestor
92610383|NCT00142493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017490|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
92726183|NCT00589238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92726184|NCT00589238|Alkylating Agents|alkylating agents|mesh-ancestor
92726185|NCT00589238|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92726186|NCT00589238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92726187|NCT00589238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92726188|NCT00589238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92726189|NCT00589238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726190|NCT00589394|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92726191|NCT00589394|Immunologic Factors|immunologic factors|mesh-ancestor
92726192|NCT00589394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726193|NCT01083576|Gentamicins|gentamicins|mesh-list
92726194|NCT01083576|Paromomycin|paromomycin|mesh-list
92726195|NCT01083576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92726196|NCT01083576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726197|NCT01083576|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92726198|NCT01083576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726199|NCT01083576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726200|NCT01083576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92726201|NCT01083576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92726202|NCT04568265|Entecavir|entecavir|mesh-list
92726203|NCT04568265|Antiviral Agents|antiviral agents|mesh-ancestor
92726204|NCT04568265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726205|NCT04568304|Carboplatin|carboplatin|mesh-list
92726206|NCT04568304|Gemcitabine|gemcitabine|mesh-list
92726207|NCT04568304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726208|NCT04568304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726209|NCT04568304|Antimetabolites|antimetabolites|mesh-ancestor
92726210|NCT04568304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726211|NCT01082640|Febuxostat|febuxostat|mesh-list
92726212|NCT01082640|Gout Suppressants|gout suppressants|mesh-ancestor
92726213|NCT01082640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726214|NCT00589862|Clopidogrel|clopidogrel|mesh-list
92726215|NCT00589862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726244|NCT00590174|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726245|NCT00590174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726246|NCT00590174|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92726247|NCT00590174|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92726248|NCT00590174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726249|NCT00590174|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726250|NCT00590174|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92726251|NCT00590174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726252|NCT00590174|Antipyretics|antipyretics|mesh-ancestor
92726253|NCT00590174|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92726254|NCT00590174|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92726255|NCT00590174|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92726256|NCT00590174|Purinergic Agents|purinergic agents|mesh-ancestor
92726257|NCT00590174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726258|NCT00590213|Bicalutamide|bicalutamide|mesh-list
92726262|NCT00590213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726263|NCT00590213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726264|NCT00590408|Ubiquinone|ubiquinone|mesh-list
92726265|NCT00590408|Coenzyme Q10|coenzyme q10|mesh-list
92726266|NCT00590408|Micronutrients|micronutrients|mesh-ancestor
92726267|NCT00590408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726268|NCT00590408|Vitamins|vitamins|mesh-ancestor
92726269|NCT00590447|Rituximab|rituximab|mesh-list
92726270|NCT00590447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92726271|NCT00590447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726272|NCT00590447|Immunologic Factors|immunologic factors|mesh-ancestor
92726273|NCT00590447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726274|NCT00590447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726275|NCT01081626|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92726276|NCT01081626|Hormones|hormones|mesh-ancestor
92610384|NCT00142493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610385|NCT00142493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92610386|NCT00142493|Anesthetics, General|anesthetics, general|mesh-ancestor
92726277|NCT01081626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726278|NCT01081626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726279|NCT01080768|Amlodipine|amlodipine|mesh-list
92726280|NCT01080768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92726281|NCT01080768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92726282|NCT01080768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726283|NCT01080768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726284|NCT01080768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92726285|NCT01080768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726286|NCT01080768|Vasodilator Agents|vasodilator agents|mesh-ancestor
92726287|NCT03452345|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92726288|NCT03452345|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92726289|NCT03452345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726290|NCT03452345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726291|NCT03452345|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92726292|NCT03452345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726293|NCT03452345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397344|NCT04870333|Sotrovimab|sotrovimab|mesh-list
92726294|NCT03452345|Cholinergic Agents|cholinergic agents|mesh-ancestor
92726295|NCT03452345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726296|NCT03452306|Metformin|metformin|mesh-list
92726297|NCT03452306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92726298|NCT03452306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726299|NCT01080300|Gabapentin|gabapentin|mesh-list
92726300|NCT01080300|Analgesics|analgesics|mesh-ancestor
92726301|NCT01080300|Sensory System Agents|sensory system agents|mesh-ancestor
92726302|NCT01080300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726303|NCT01080300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726304|NCT01080300|Anticonvulsants|anticonvulsants|mesh-ancestor
92726305|NCT01080300|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92726306|NCT01080300|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92726307|NCT01080300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726308|NCT01080300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92726309|NCT01080300|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92726310|NCT01080300|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92726311|NCT01080300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726312|NCT01080300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726313|NCT01080300|Antimanic Agents|antimanic agents|mesh-ancestor
92726314|NCT02210715|Raltegravir Potassium|raltegravir potassium|mesh-list
92726315|NCT02210715|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92726316|NCT02210715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92726317|NCT02210715|Antiviral Agents|antiviral agents|mesh-ancestor
92726318|NCT02210715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726319|NCT02210715|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92726320|NCT02210715|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92726321|NCT02210715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726322|NCT02210715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726323|NCT00590603|Ascorbic Acid|ascorbic acid|mesh-list
92726324|NCT00590603|Bortezomib|bortezomib|mesh-list
92726325|NCT00590603|Arsenic Trioxide|arsenic trioxide|mesh-list
92726326|NCT00590603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726327|NCT00590603|Antioxidants|antioxidants|mesh-ancestor
92726328|NCT00590603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726329|NCT00590603|Protective Agents|protective agents|mesh-ancestor
92726333|NCT01085097|Mycophenolic Acid|mycophenolic acid|mesh-list
92726335|NCT01085097|Methylprednisolone|methylprednisolone|mesh-list
92726336|NCT01085097|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92726337|NCT01085097|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92726338|NCT01085097|Prednisolone|prednisolone|mesh-list
92726339|NCT01085097|Prednisolone acetate|prednisolone acetate|mesh-list
92726340|NCT01085097|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92726341|NCT01085097|Prednisolone phosphate|prednisolone phosphate|mesh-list
92726342|NCT01085097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726343|NCT01085097|Glucocorticoids|glucocorticoids|mesh-ancestor
92726344|NCT01085097|Hormones|hormones|mesh-ancestor
92726345|NCT01085097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726346|NCT01085097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610388|NCT00142493|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92610389|NCT00142493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92610390|NCT00142493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610391|NCT00142493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92726347|NCT01085097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92726348|NCT01085097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726349|NCT01085097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92726350|NCT01085097|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92726351|NCT01085097|Antitubercular Agents|antitubercular agents|mesh-ancestor
92726352|NCT01085097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92726353|NCT01085097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726354|NCT01085097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726355|NCT01085097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726356|NCT01085097|Antiemetics|antiemetics|mesh-ancestor
92726357|NCT01085097|Autonomic Agents|autonomic agents|mesh-ancestor
92726358|NCT01085097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726359|NCT01085097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726360|NCT01085097|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92726361|NCT01085097|Protective Agents|protective agents|mesh-ancestor
92726362|NCT00590837|Lomustine|lomustine|mesh-list
92726363|NCT00590837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92726364|NCT00590837|Alkylating Agents|alkylating agents|mesh-ancestor
92726365|NCT00590837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726366|NCT00590837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726367|NCT01086267|Cetuximab|cetuximab|mesh-list
92726368|NCT01086267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92726369|NCT01086267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726370|NCT00590915|Asparaginase|asparaginase|mesh-list
92726371|NCT00590915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726372|NCT04567290|Ticagrelor|ticagrelor|mesh-list
92726373|NCT04567290|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726374|NCT04567290|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92726375|NCT04567290|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92726376|NCT04567290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92726377|NCT04567290|Purinergic Agents|purinergic agents|mesh-ancestor
92726378|NCT04567290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726379|NCT04567290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726380|NCT04567290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726381|NCT01084161|Morphine|morphine|mesh-list
92726382|NCT01084161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92726383|NCT01084161|Narcotics|narcotics|mesh-ancestor
92726384|NCT01084161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726385|NCT01084161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726386|NCT01084161|Analgesics|analgesics|mesh-ancestor
92726387|NCT01084161|Sensory System Agents|sensory system agents|mesh-ancestor
92726388|NCT01084161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726389|NCT01083615|Prednisone|prednisone|mesh-list
92726390|NCT01083615|Docetaxel|docetaxel|mesh-list
92726391|NCT01083615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726392|NCT01083615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92726393|NCT01083615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726394|NCT01083615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92726395|NCT01083615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726396|NCT01083615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726397|NCT01083615|Glucocorticoids|glucocorticoids|mesh-ancestor
92726398|NCT01083615|Hormones|hormones|mesh-ancestor
92726399|NCT01083615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726400|NCT01083615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726401|NCT01083615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92726407|NCT00591188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726409|NCT00591188|Antiviral Agents|antiviral agents|mesh-ancestor
92726410|NCT00591188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726411|NCT00591188|Immunologic Factors|immunologic factors|mesh-ancestor
92726412|NCT00591188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726413|NCT00591383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92726414|NCT00591383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726415|NCT00591383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92726416|NCT00591383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610392|NCT00142493|GABA Modulators|gaba modulators|mesh-ancestor
92610393|NCT00142493|GABA Agents|gaba agents|mesh-ancestor
92726417|NCT00591383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726418|NCT01081782|Ceralifimod|ceralifimod|mesh-list
92726419|NCT01081782|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92726420|NCT01081782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726421|NCT01081782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726422|NCT01081782|Immunologic Factors|immunologic factors|mesh-ancestor
92726423|NCT01081782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726424|NCT01080222|Ribavirin|ribavirin|mesh-list
92726425|NCT01080222|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92726426|NCT01080222|Antimetabolites|antimetabolites|mesh-ancestor
92726427|NCT01080222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726428|NCT01080222|Antiviral Agents|antiviral agents|mesh-ancestor
92726429|NCT01080222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726430|NCT03452267|Metformin|metformin|mesh-list
92726431|NCT03452267|Pioglitazone|pioglitazone|mesh-list
92726432|NCT03452267|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92726433|NCT03452267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726434|NCT01088802|Carboplatin|carboplatin|mesh-list
92726435|NCT01088802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726436|NCT03451682|Procyanidin|procyanidin|mesh-list
92726437|NCT03451682|Antioxidants|antioxidants|mesh-ancestor
92726438|NCT03451682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726439|NCT03451682|Protective Agents|protective agents|mesh-ancestor
92726440|NCT03451682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726441|NCT02210754|Menthol|menthol|mesh-list
92726442|NCT02210754|Nicotine|nicotine|mesh-list
92726443|NCT02210754|Glycerol|glycerol|mesh-list
92726444|NCT02210754|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92726445|NCT02210754|Autonomic Agents|autonomic agents|mesh-ancestor
92726446|NCT02210754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726447|NCT02210754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726448|NCT02210754|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92726449|NCT02210754|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92726450|NCT02210754|Cholinergic Agents|cholinergic agents|mesh-ancestor
92726451|NCT02210754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726452|NCT02210754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726453|NCT02210754|Antipruritics|antipruritics|mesh-ancestor
92726454|NCT02210754|Dermatologic Agents|dermatologic agents|mesh-ancestor
92726455|NCT02210754|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92726456|NCT02210754|Protective Agents|protective agents|mesh-ancestor
92726457|NCT04574141|Melatonin|melatonin|mesh-list
92726458|NCT04574141|Antioxidants|antioxidants|mesh-ancestor
92726459|NCT04574141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726460|NCT04574141|Protective Agents|protective agents|mesh-ancestor
92726461|NCT04574141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726462|NCT04574141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726463|NCT04998981|Fenofibrate|fenofibrate|mesh-list
92726464|NCT04998981|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92726465|NCT04998981|Antimetabolites|antimetabolites|mesh-ancestor
92726466|NCT04998981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726467|NCT04998981|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92726468|NCT04573049|Simendan|simendan|mesh-list
92726469|NCT04573049|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92726470|NCT04573049|Vasodilator Agents|vasodilator agents|mesh-ancestor
92726471|NCT04573049|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92726474|NCT04573049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726475|NCT04573049|Protective Agents|protective agents|mesh-ancestor
92726476|NCT04573049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726477|NCT04572698|Endothelial Growth Factors|endothelial growth factors|mesh-list
92726478|NCT04572698|Growth Substances|growth substances|mesh-ancestor
92726479|NCT04572698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726480|NCT04572542|Paclitaxel|paclitaxel|mesh-list
92726481|NCT04572542|Apatinib|apatinib|mesh-list
92726482|NCT04572542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92726483|NCT04572542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726484|NCT04572542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92726485|NCT04572542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726486|NCT04572542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92726487|NCT04572542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726488|NCT04572542|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92726489|NCT04572542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726490|NCT04991103|Dexamethasone|dexamethasone|mesh-list
92610395|NCT04511923|Heparin|heparin|mesh-list
92610396|NCT04511923|Anticoagulants|anticoagulants|mesh-ancestor
92726491|NCT04991103|Lenalidomide|lenalidomide|mesh-list
92726492|NCT04991103|Bortezomib|bortezomib|mesh-list
92726493|NCT04991103|Daratumumab|daratumumab|mesh-list
92726494|NCT04991103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726495|NCT04991103|Antiemetics|antiemetics|mesh-ancestor
92726496|NCT04991103|Autonomic Agents|autonomic agents|mesh-ancestor
92726497|NCT04991103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726498|NCT04991103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726499|NCT04991103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726500|NCT04991103|Glucocorticoids|glucocorticoids|mesh-ancestor
92726501|NCT04991103|Hormones|hormones|mesh-ancestor
92726502|NCT04991103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726503|NCT04991103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92726504|NCT04991103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726505|NCT04991103|Immunologic Factors|immunologic factors|mesh-ancestor
92726506|NCT04991103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92726507|NCT04991103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92726508|NCT04991103|Growth Substances|growth substances|mesh-ancestor
92726509|NCT04991103|Growth Inhibitors|growth inhibitors|mesh-ancestor
92726510|NCT04572620|Rituximab|rituximab|mesh-list
92726511|NCT04572620|Abatacept|abatacept|mesh-list
92726512|NCT04572620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92726513|NCT04572620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726514|NCT04572620|Immunologic Factors|immunologic factors|mesh-ancestor
92726515|NCT04572620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726516|NCT04572620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726517|NCT04572620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92726518|NCT04572620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726519|NCT04572620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726520|NCT03451019|Sevelamer|sevelamer|mesh-list
92726521|NCT03451019|Chelating Agents|chelating agents|mesh-ancestor
92726522|NCT03451019|Sequestering Agents|sequestering agents|mesh-ancestor
92726523|NCT03451019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726524|NCT03450863|Insulin Aspart|insulin aspart|mesh-list
92726525|NCT03450863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92726526|NCT03450863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726527|NCT02211066|Clopidogrel|clopidogrel|mesh-list
92726528|NCT02211066|Ticagrelor|ticagrelor|mesh-list
92726529|NCT02211066|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726530|NCT02211066|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92726531|NCT02211066|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92726532|NCT02211066|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92726533|NCT02211066|Purinergic Agents|purinergic agents|mesh-ancestor
92726534|NCT02211066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726535|NCT02211066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726536|NCT02211066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726537|NCT03450317|Aspirin|aspirin|mesh-list
92726538|NCT03450317|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92726539|NCT03450317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92726540|NCT03450317|Analgesics|analgesics|mesh-ancestor
92726541|NCT03450317|Sensory System Agents|sensory system agents|mesh-ancestor
92726542|NCT03450317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726543|NCT03450317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726544|NCT03450317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726545|NCT03450317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726546|NCT03450317|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92726547|NCT03450317|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92726548|NCT03450317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726549|NCT03450317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726550|NCT03450317|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92726551|NCT03450317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726553|NCT04565496|Pembrolizumab|pembrolizumab|mesh-list
92726554|NCT04565496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92726555|NCT04565496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726556|NCT04565496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92726557|NCT04565496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726558|NCT03450161|Fentanyl|fentanyl|mesh-list
92726559|NCT03450161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92610397|NCT04511923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92610398|NCT04511923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92017508|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92726560|NCT03450161|Narcotics|narcotics|mesh-ancestor
92726561|NCT03450161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726562|NCT03450161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726563|NCT03450161|Analgesics|analgesics|mesh-ancestor
92726564|NCT03450161|Sensory System Agents|sensory system agents|mesh-ancestor
92726565|NCT03450161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726566|NCT03450161|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92726567|NCT03450161|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92726568|NCT03450161|Anesthetics, General|anesthetics, general|mesh-ancestor
92726569|NCT03450161|Anesthetics|anesthetics|mesh-ancestor
92726570|NCT04565184|Artesunate|artesunate|mesh-list
92726571|NCT04565184|Lumefantrine|lumefantrine|mesh-list
92726572|NCT04565184|Artemether|artemether|mesh-list
92726573|NCT04565184|Amodiaquine|amodiaquine|mesh-list
92726574|NCT04565184|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92726575|NCT04565184|Amodiaquine, artesunate drug combination|amodiaquine, artesunate drug combination|mesh-list
92726576|NCT04565184|Antimalarials|antimalarials|mesh-ancestor
92726577|NCT04565184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92726578|NCT04565184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92726579|NCT04565184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726580|NCT04565184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726581|NCT04565184|Antiviral Agents|antiviral agents|mesh-ancestor
92726582|NCT04565184|Schistosomicides|schistosomicides|mesh-ancestor
92726583|NCT04565184|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92726584|NCT04565184|Anthelmintics|anthelmintics|mesh-ancestor
92726585|NCT03452579|Bevacizumab|bevacizumab|mesh-list
92726586|NCT03452579|Nivolumab|nivolumab|mesh-list
92726587|NCT03452579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92726588|NCT03452579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726589|NCT03452579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92726590|NCT03452579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92726591|NCT03452579|Growth Substances|growth substances|mesh-ancestor
92726592|NCT03452579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726593|NCT03452579|Growth Inhibitors|growth inhibitors|mesh-ancestor
92726594|NCT03452579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92726595|NCT03452579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726596|NCT04997850|Lenvatinib|lenvatinib|mesh-list
92726597|NCT04997850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726598|NCT04997850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92726599|NCT04997850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726600|NCT04997850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726601|NCT03450629|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92726602|NCT03450629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92726603|NCT03450629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92726604|NCT03450629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92726605|NCT03450629|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92726606|NCT03450629|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92726607|NCT03450629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92726608|NCT03450629|Adrenergic Agents|adrenergic agents|mesh-ancestor
92726609|NCT03450629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726610|NCT03450629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726611|NCT03450629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726612|NCT03456947|Pregabalin|pregabalin|mesh-list
92726613|NCT03456947|Analgesics|analgesics|mesh-ancestor
92726614|NCT03456947|Sensory System Agents|sensory system agents|mesh-ancestor
92726615|NCT03456947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726616|NCT03456947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726617|NCT03456947|Anticonvulsants|anticonvulsants|mesh-ancestor
92726618|NCT03456947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92726620|NCT03456947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726621|NCT03456947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92726622|NCT03456947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92726623|NCT03456947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92726624|NCT03456947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726625|NCT03456947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92726626|NCT03456791|Protease Inhibitors|protease inhibitors|mesh-list
92726627|NCT03456791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726628|NCT03456791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726629|NCT04564638|Cyclosporine|cyclosporine|mesh-list
92610399|NCT04511923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610400|NCT04511611|Rivaroxaban|rivaroxaban|mesh-list
92610401|NCT04511611|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92610402|NCT04511611|Antithrombins|antithrombins|mesh-ancestor
92610403|NCT04511611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92726630|NCT04564638|Cyclosporins|cyclosporins|mesh-list
92726631|NCT04564638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726632|NCT04564638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726633|NCT04564638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726634|NCT04564638|Immunologic Factors|immunologic factors|mesh-ancestor
92726635|NCT04564638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726636|NCT04564638|Antifungal Agents|antifungal agents|mesh-ancestor
92726637|NCT04564638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726638|NCT04564638|Dermatologic Agents|dermatologic agents|mesh-ancestor
92726639|NCT04564638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726640|NCT04564638|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92726642|NCT04564326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92726643|NCT04564326|Narcotics|narcotics|mesh-ancestor
92726644|NCT04564326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726645|NCT04564326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726646|NCT04564326|Analgesics|analgesics|mesh-ancestor
92726647|NCT04564326|Sensory System Agents|sensory system agents|mesh-ancestor
92726648|NCT04564326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726649|NCT04564326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92726650|NCT04564326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92726651|NCT04564326|Anesthetics, General|anesthetics, general|mesh-ancestor
92726652|NCT04564326|Anesthetics|anesthetics|mesh-ancestor
92726653|NCT03453164|Nivolumab|nivolumab|mesh-list
92726654|NCT03453164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92726655|NCT03453164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726656|NCT03453164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92726657|NCT03453164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726658|NCT03450434|Histamine|histamine|mesh-list
92726659|NCT03450434|Glutarimide|glutarimide|mesh-list
92726660|NCT03450434|Histamine Agonists|histamine agonists|mesh-ancestor
92726661|NCT03450434|Histamine Agents|histamine agents|mesh-ancestor
92726662|NCT03450434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726663|NCT03450434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726664|NCT03450434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726665|NCT03450434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92726666|NCT03450434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726667|NCT00198029|Hylan|hylan|mesh-list
92726668|NCT00198029|Viscosupplements|viscosupplements|mesh-ancestor
92726669|NCT00198029|Protective Agents|protective agents|mesh-ancestor
92726670|NCT00198029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726671|NCT02215122|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92726672|NCT02215122|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92726673|NCT02215122|Autonomic Agents|autonomic agents|mesh-ancestor
92726674|NCT02215122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726675|NCT02215122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726676|NCT02215122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92726677|NCT02215122|Respiratory System Agents|respiratory system agents|mesh-ancestor
92726678|NCT02215122|Glucocorticoids|glucocorticoids|mesh-ancestor
92726679|NCT02215122|Hormones|hormones|mesh-ancestor
92726680|NCT02215122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726681|NCT02215122|Sympathomimetics|sympathomimetics|mesh-ancestor
92726682|NCT00196976|Edetic Acid|edetic acid|mesh-list
92726683|NCT00196976|Vaccines|vaccines|mesh-list
92726684|NCT00196976|Pentetic Acid|pentetic acid|mesh-list
92726685|NCT00196976|Immunologic Factors|immunologic factors|mesh-ancestor
92726686|NCT00196976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726687|NCT00196976|Antidotes|antidotes|mesh-ancestor
92726688|NCT00196976|Protective Agents|protective agents|mesh-ancestor
92726689|NCT00196976|Chelating Agents|chelating agents|mesh-ancestor
92726690|NCT00196976|Sequestering Agents|sequestering agents|mesh-ancestor
92726691|NCT00196976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726692|NCT00196976|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92726720|NCT04563780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726722|NCT04560894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610404|NCT04511611|Protease Inhibitors|protease inhibitors|mesh-ancestor
92610405|NCT04511611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610406|NCT04511611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610407|NCT04511611|Anticoagulants|anticoagulants|mesh-ancestor
92726723|NCT04560894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92726724|NCT04560894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397388|NCT04760912|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92726725|NCT04560894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726726|NCT04560465|Tranexamic Acid|tranexamic acid|mesh-list
92726727|NCT04560465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92726728|NCT04560465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92726729|NCT04560465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726730|NCT04560465|Hemostatics|hemostatics|mesh-ancestor
92726731|NCT04560465|Coagulants|coagulants|mesh-ancestor
92726732|NCT00195494|Etanercept|etanercept|mesh-list
92726733|NCT00195494|Methotrexate|methotrexate|mesh-list
92726734|NCT00195494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92726735|NCT00195494|Abortifacient Agents|abortifacient agents|mesh-ancestor
92726736|NCT00195494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726737|NCT00195494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726738|NCT00195494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726739|NCT00195494|Antimetabolites|antimetabolites|mesh-ancestor
92726740|NCT00195494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726942|NCT00190775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92726943|NCT00190775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726944|NCT00190775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726946|NCT00198263|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92726947|NCT00198263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726948|NCT00198107|Cycloserine|cycloserine|mesh-list
92726949|NCT00198107|Aripiprazole|aripiprazole|mesh-list
92726950|NCT00198107|Antidepressive Agents|antidepressive agents|mesh-ancestor
92726951|NCT00198107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92726952|NCT00198107|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92726953|NCT00198107|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92726954|NCT00198107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726955|NCT00198107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726956|NCT00198107|Dopamine Agonists|dopamine agonists|mesh-ancestor
92726957|NCT00198107|Dopamine Agents|dopamine agents|mesh-ancestor
92726958|NCT00198107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726959|NCT00198107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726960|NCT00198107|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92726961|NCT00198107|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92726962|NCT00198107|Serotonin Agents|serotonin agents|mesh-ancestor
92726963|NCT00198107|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92726993|NCT00177164|Olanzapine|olanzapine|mesh-list
92726994|NCT00177164|Risperidone|risperidone|mesh-list
92726995|NCT00177164|Aripiprazole|aripiprazole|mesh-list
92726996|NCT00177164|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92726997|NCT00177164|Ziprasidone|ziprasidone|mesh-list
92726998|NCT00177164|Antipsychotic Agents|antipsychotic agents|mesh-list
92726999|NCT00177164|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92727000|NCT00177164|Serotonin Agents|serotonin agents|mesh-ancestor
92727001|NCT00177164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727002|NCT00177164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727003|NCT00177164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727004|NCT00177164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92727005|NCT00177164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727006|NCT00177164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92727007|NCT00177164|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92727008|NCT00177164|Dopamine Agents|dopamine agents|mesh-ancestor
92727009|NCT00177164|Antiemetics|antiemetics|mesh-ancestor
92727010|NCT00177164|Autonomic Agents|autonomic agents|mesh-ancestor
92727011|NCT00177164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727404|NCT04556136|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92727405|NCT00471887|Tremelimumab|tremelimumab|mesh-list
92727406|NCT00471887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727407|NCT04556058|Perindopril|perindopril|mesh-list
92727408|NCT04556058|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92727409|NCT04556058|Protease Inhibitors|protease inhibitors|mesh-ancestor
92727410|NCT04556058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610409|NCT04511299|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92610410|NCT04511299|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92610411|NCT04511299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92610412|NCT00142571|Gemcitabine|gemcitabine|mesh-list
92610413|NCT00142571|Docetaxel|docetaxel|mesh-list
92727411|NCT04556058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727412|NCT04556058|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92727413|NCT00470834|Bicalutamide|bicalutamide|mesh-list
92727414|NCT00470834|Dutasteride|dutasteride|mesh-list
92727415|NCT00470834|Androgen Antagonists|androgen antagonists|mesh-ancestor
92727416|NCT00470834|Hormone Antagonists|hormone antagonists|mesh-ancestor
92727417|NCT00470834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727418|NCT00470834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727419|NCT00470834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727420|NCT00470834|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92727421|NCT00470834|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92727422|NCT00470834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727423|NCT00470834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727424|NCT00470366|Paclitaxel|paclitaxel|mesh-list
92727425|NCT00470366|Ifosfamide|ifosfamide|mesh-list
92727690|NCT04553328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727692|NCT04553328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727693|NCT01085591|Vancomycin|vancomycin|mesh-list
92727694|NCT01085591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727695|NCT01085591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727696|NCT04552977|Temozolomide|temozolomide|mesh-list
92727697|NCT04552977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727698|NCT04552977|Alkylating Agents|alkylating agents|mesh-ancestor
92727699|NCT04552977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727700|NCT04552977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727770|NCT04552431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727771|NCT04552431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727772|NCT04552431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92727773|NCT04552431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92727774|NCT04552431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727775|NCT04552431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727776|NCT04552431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727777|NCT04552431|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92727778|NCT04552431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92727779|NCT04552431|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92727780|NCT04552431|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92727781|NCT04552431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92727782|NCT04552431|Adrenergic Agents|adrenergic agents|mesh-ancestor
92727930|NCT00177216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727932|NCT00177216|Serotonin Agents|serotonin agents|mesh-ancestor
92727933|NCT00177216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727934|NCT00177216|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92727935|NCT00177216|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92727936|NCT00177216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727937|NCT00177216|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92727938|NCT00177216|GABA Agonists|gaba agonists|mesh-ancestor
92728024|NCT00171951|Pasireotide|pasireotide|mesh-list
92728025|NCT00171951|Hormones|hormones|mesh-ancestor
92728026|NCT00171951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728027|NCT00171951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728028|NCT01080131|Triamcinolone|triamcinolone|mesh-list
92728029|NCT01080131|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92728030|NCT01080131|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92728031|NCT01080131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92728032|NCT01080131|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92728033|NCT01080131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728119|NCT04550793|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92728120|NCT04550793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728121|NCT04550793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728122|NCT04550793|Cholinergic Agents|cholinergic agents|mesh-ancestor
92728340|NCT04541823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92610414|NCT00142571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610415|NCT00142571|Antimetabolites|antimetabolites|mesh-ancestor
92728341|NCT00556361|Ketamine|ketamine|mesh-list
92728342|NCT00556361|Analgesics|analgesics|mesh-ancestor
92728343|NCT00556361|Sensory System Agents|sensory system agents|mesh-ancestor
92728344|NCT00556361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728345|NCT00556361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728346|NCT00556361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92728347|NCT00556361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92728348|NCT00556361|Anesthetics, General|anesthetics, general|mesh-ancestor
92728349|NCT00556361|Anesthetics|anesthetics|mesh-ancestor
92728350|NCT00556361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728351|NCT00556361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92728352|NCT00556361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92728353|NCT00556361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728354|NCT00556361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728355|NCT04571606|Bupivacaine|bupivacaine|mesh-list
92728356|NCT04571606|Anesthetics, Local|anesthetics, local|mesh-ancestor
92728357|NCT04571606|Anesthetics|anesthetics|mesh-ancestor
92728358|NCT04571606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728359|NCT04571606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728360|NCT04571606|Sensory System Agents|sensory system agents|mesh-ancestor
92728361|NCT04571606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728362|NCT02210117|Bevacizumab|bevacizumab|mesh-list
92728363|NCT02210117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92728364|NCT02210117|Nivolumab|nivolumab|mesh-list
92728365|NCT02210117|Ipilimumab|ipilimumab|mesh-list
92728366|NCT02210117|Endothelial Growth Factors|endothelial growth factors|mesh-list
92728367|NCT02210117|Antibodies|antibodies|mesh-list
92728368|NCT02210117|Immunoglobulins|immunoglobulins|mesh-list
92728369|NCT02210117|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92728370|NCT02210117|Immunoglobulin G|immunoglobulin g|mesh-list
92728371|NCT02210117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728372|NCT02210117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92728373|NCT02210117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92728374|NCT02210117|Growth Substances|growth substances|mesh-ancestor
92728375|NCT02210117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728376|NCT02210117|Growth Inhibitors|growth inhibitors|mesh-ancestor
92728377|NCT02210117|Immunologic Factors|immunologic factors|mesh-ancestor
92728378|NCT02210117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92728379|NCT02210117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728380|NCT04541277|Cytarabine|cytarabine|mesh-list
92728381|NCT04541277|Azacitidine|azacitidine|mesh-list
92728382|NCT04541277|Decitabine|decitabine|mesh-list
92728383|NCT04541277|Tislelizumab|tislelizumab|mesh-list
92728384|NCT04541277|Idarubicin|idarubicin|mesh-list
92728385|NCT04541277|Lenograstim|lenograstim|mesh-list
92728386|NCT04541277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728387|NCT04541277|Antimetabolites|antimetabolites|mesh-ancestor
92728388|NCT04541277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728389|NCT04541277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728390|NCT04541277|Antiviral Agents|antiviral agents|mesh-ancestor
92728391|NCT04541277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728392|NCT04541277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728393|NCT04541277|Immunologic Factors|immunologic factors|mesh-ancestor
92728394|NCT04541277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729181|NCT01121926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729182|NCT01121926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729183|NCT01121926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729184|NCT01121926|Serotonin Agents|serotonin agents|mesh-ancestor
92729185|NCT01121926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92729186|NCT01121926|Antidepressive Agents|antidepressive agents|mesh-ancestor
92729187|NCT00577421|Risedronic Acid|risedronic acid|mesh-list
92729188|NCT00577421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92729189|NCT00577421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729190|NCT00577421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729191|NCT00577421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729192|NCT00577421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729193|NCT00577421|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92729194|NCT00577694|Clofarabine|clofarabine|mesh-list
92729195|NCT00577694|Gemtuzumab|gemtuzumab|mesh-list
92729196|NCT00577694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92729197|NCT00577694|Antimetabolites|antimetabolites|mesh-ancestor
92610416|NCT00142571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610417|NCT00142571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610418|NCT00142571|Tubulin Modulators|tubulin modulators|mesh-ancestor
92729198|NCT00577694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729199|NCT00577694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729200|NCT00577694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92729201|NCT00577694|Immunotoxins|immunotoxins|mesh-ancestor
92729202|NCT00577694|Immunoconjugates|immunoconjugates|mesh-ancestor
92729203|NCT00577694|Immunologic Factors|immunologic factors|mesh-ancestor
92729204|NCT00577694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729205|NCT04537533|Tranexamic Acid|tranexamic acid|mesh-list
92729206|NCT04537533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92729207|NCT04537533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92729208|NCT04537533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729209|NCT04537533|Hemostatics|hemostatics|mesh-ancestor
92729210|NCT04537533|Coagulants|coagulants|mesh-ancestor
92729211|NCT02216058|Sirolimus|sirolimus|mesh-list
92729212|NCT02216058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729213|NCT02216058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729214|NCT02216058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92729215|NCT02216058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729216|NCT02216058|Antifungal Agents|antifungal agents|mesh-ancestor
92729217|NCT02216058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92729218|NCT02216058|Immunologic Factors|immunologic factors|mesh-ancestor
92729219|NCT02216058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729220|NCT00577850|Alendronate|alendronate|mesh-list
92729221|NCT00577850|Risedronic Acid|risedronic acid|mesh-list
92729222|NCT00577850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92729230|NCT00577967|Sensory System Agents|sensory system agents|mesh-ancestor
92729231|NCT00577967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729232|NCT00577967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729233|NCT00577967|Anticonvulsants|anticonvulsants|mesh-ancestor
92729234|NCT00577967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92729235|NCT00577967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92729236|NCT00577967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729237|NCT00577967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92729238|NCT00577967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92729239|NCT00577967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92729240|NCT00577967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729241|NCT00577967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729242|NCT00577967|Antimanic Agents|antimanic agents|mesh-ancestor
92729243|NCT00578201|Cetuximab|cetuximab|mesh-list
92729244|NCT00578201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92729245|NCT00578201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729246|NCT04544319|Dapagliflozin|dapagliflozin|mesh-list
92729247|NCT04544319|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92729248|NCT04544319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729249|NCT04544319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92729250|NCT04544319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729251|NCT04578470|Vitamin D|vitamin d|mesh-list
92729252|NCT04578470|Vitamins|vitamins|mesh-ancestor
92729253|NCT04578470|Micronutrients|micronutrients|mesh-ancestor
92397435|NCT04580381|Natalizumab|natalizumab|mesh-list
92729254|NCT04578470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729255|NCT04578470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92729256|NCT00578435|Cyclophosphamide|cyclophosphamide|mesh-list
92729257|NCT00578435|Busulfan|busulfan|mesh-list
92729258|NCT00578435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92729259|NCT00578435|Immunologic Factors|immunologic factors|mesh-ancestor
92729260|NCT00578435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729261|NCT00578435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729262|NCT00578435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92729263|NCT00578435|Alkylating Agents|alkylating agents|mesh-ancestor
92729264|NCT00578435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729265|NCT00578435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729266|NCT00578435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92729267|NCT04537065|Mydriatics|mydriatics|mesh-list
92729268|NCT04537065|Autonomic Agents|autonomic agents|mesh-ancestor
92729269|NCT04537065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729270|NCT04537065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729271|NCT04544163|Lidocaine|lidocaine|mesh-list
92610419|NCT00142571|Antimitotic Agents|antimitotic agents|mesh-ancestor
92610420|NCT00142571|Mitosis Modulators|mitosis modulators|mesh-ancestor
92729272|NCT04544163|Magnesium Sulfate|magnesium sulfate|mesh-list
92729273|NCT04544163|Fentanyl|fentanyl|mesh-list
92729274|NCT04544163|Anesthetics, Local|anesthetics, local|mesh-ancestor
92729275|NCT04544163|Anesthetics|anesthetics|mesh-ancestor
92729276|NCT04544163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729277|NCT04544163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729278|NCT04544163|Sensory System Agents|sensory system agents|mesh-ancestor
92729279|NCT04544163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729280|NCT04544163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92729281|NCT04544163|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92729282|NCT04544163|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92729283|NCT04544163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729284|NCT04544163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729285|NCT04544163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92729286|NCT04544163|Narcotics|narcotics|mesh-ancestor
92729287|NCT04544163|Analgesics|analgesics|mesh-ancestor
92729288|NCT04544163|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92729290|NCT04544163|Anesthetics, General|anesthetics, general|mesh-ancestor
92729291|NCT04544163|Anticonvulsants|anticonvulsants|mesh-ancestor
92729292|NCT04544163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92729293|NCT04544163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729294|NCT04544163|Tocolytic Agents|tocolytic agents|mesh-ancestor
92729295|NCT04544163|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729296|NCT04543851|Carbon Fiber|carbon fiber|mesh-list
92729297|NCT04543851|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92729298|NCT04543851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729299|NCT00578591|Rituximab|rituximab|mesh-list
92729300|NCT00578591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92729301|NCT00578591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729302|NCT00578591|Immunologic Factors|immunologic factors|mesh-ancestor
92729303|NCT00578591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729304|NCT00578591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729305|NCT04536948|Methyl salicylate|methyl salicylate|mesh-list
92729306|NCT04536948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729307|NCT04543890|Etoposide|etoposide|mesh-list
92729308|NCT04543890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729309|NCT04543890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92729310|NCT04543890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92729311|NCT04543890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92729312|NCT04543890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729313|NCT04543890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729314|NCT04536831|Vitamin D|vitamin d|mesh-list
92729315|NCT04536831|Ergocalciferols|ergocalciferols|mesh-list
92729316|NCT04536831|Cholecalciferol|cholecalciferol|mesh-list
92729317|NCT04536831|Vitamins|vitamins|mesh-list
92729318|NCT04536831|Micronutrients|micronutrients|mesh-ancestor
92729319|NCT04536831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729320|NCT04536831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92729321|NCT04536831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729322|NCT02214966|Telmisartan|telmisartan|mesh-list
92729323|NCT02214966|Ramipril|ramipril|mesh-list
92729324|NCT02214966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729325|NCT02214966|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92729326|NCT02214966|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92729327|NCT02214966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729328|NCT02214966|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92729329|NCT02214966|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729330|NCT02214966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729331|NCT04536558|Olanzapine|olanzapine|mesh-list
92729332|NCT04536558|Fosaprepitant|fosaprepitant|mesh-list
92729333|NCT04536558|Aprepitant|aprepitant|mesh-list
92729334|NCT04536558|Antiemetics|antiemetics|mesh-ancestor
92729335|NCT04536558|Autonomic Agents|autonomic agents|mesh-ancestor
92729336|NCT04536558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729337|NCT04536558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729338|NCT04536558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729339|NCT04536558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92729340|NCT04536558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92729341|NCT04536558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729342|NCT04536558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92729343|NCT04536558|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92729344|NCT04536558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92610422|NCT00142610|Vitamin E|vitamin e|mesh-list
92610423|NCT00142610|Micronutrients|micronutrients|mesh-ancestor
92610424|NCT00142610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610425|NCT00142610|Antioxidants|antioxidants|mesh-ancestor
92610426|NCT00142610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610427|NCT00142610|Protective Agents|protective agents|mesh-ancestor
92729345|NCT04536558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729346|NCT04536558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729347|NCT04536558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729348|NCT04536558|Serotonin Agents|serotonin agents|mesh-ancestor
92729349|NCT04536558|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92729350|NCT04557137|Somatostatin|somatostatin|mesh-list
92729351|NCT04557137|Hormones|hormones|mesh-ancestor
92729352|NCT04557137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729353|NCT04557137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729354|NCT04536675|Bromides|bromides|mesh-list
92729355|NCT04536675|Anticonvulsants|anticonvulsants|mesh-ancestor
92729356|NCT04536363|Alprostadil|alprostadil|mesh-list
92729357|NCT04536363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92729358|NCT04536363|Vasodilator Agents|vasodilator agents|mesh-ancestor
92729359|NCT04536363|Urological Agents|urological agents|mesh-ancestor
92729360|NCT00578825|Ritonavir|ritonavir|mesh-list
92729361|NCT00578825|Lopinavir|lopinavir|mesh-list
92729362|NCT00578825|Ribavirin|ribavirin|mesh-list
92729363|NCT00578825|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92729365|NCT00578825|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729366|NCT00578825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729367|NCT00578825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729368|NCT00578825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92729369|NCT00578825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92729370|NCT00578825|Antiviral Agents|antiviral agents|mesh-ancestor
92729371|NCT00578825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729372|NCT00578825|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92729373|NCT00578825|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92729374|NCT00578825|Antimetabolites|antimetabolites|mesh-ancestor
92729376|NCT04536129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729377|NCT04556708|Chlorhexidine|chlorhexidine|mesh-list
92729378|NCT04556708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92729379|NCT04556708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729380|NCT04556708|Disinfectants|disinfectants|mesh-ancestor
92729381|NCT04535973|Hormones|hormones|mesh-list
92729382|NCT04535973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729383|NCT04535973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729384|NCT04536051|Acetaminophen|acetaminophen|mesh-list
92729385|NCT04536051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92729386|NCT04536051|Analgesics|analgesics|mesh-ancestor
92729387|NCT04536051|Sensory System Agents|sensory system agents|mesh-ancestor
92729388|NCT04536051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729389|NCT04536051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729390|NCT04536051|Antipyretics|antipyretics|mesh-ancestor
92729391|NCT02215005|Telmisartan|telmisartan|mesh-list
92729392|NCT02215005|Ramipril|ramipril|mesh-list
92729393|NCT02215005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729394|NCT02215005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92729395|NCT02215005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92729396|NCT02215005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729397|NCT02215005|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92729398|NCT02215005|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729399|NCT02215005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729400|NCT02215044|Gemcitabine|gemcitabine|mesh-list
92729401|NCT02215044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92729402|NCT02215044|Antimetabolites|antimetabolites|mesh-ancestor
92729403|NCT02215044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729404|NCT02215044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729405|NCT04556279|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92729406|NCT04556279|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610428|NCT04510870|Ferric Compounds|ferric compounds|mesh-list
92610429|NCT04510870|Hematinics|hematinics|mesh-ancestor
92610430|NCT00406575|Methocarbamol|methocarbamol|mesh-list
92610431|NCT00406575|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92610432|NCT00406575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610433|NCT00406575|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92610434|NCT00406575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610435|NCT02275975|Fluconazole|fluconazole|mesh-list
92610436|NCT02275975|Antifungal Agents|antifungal agents|mesh-ancestor
92610437|NCT02275975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610438|NCT02275975|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92610439|NCT02275975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92610440|NCT02275975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610441|NCT02275975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610442|NCT02275975|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92610443|NCT02275975|Hormone Antagonists|hormone antagonists|mesh-ancestor
92729407|NCT04556279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729408|NCT04556279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729409|NCT04556279|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92729410|NCT04556279|Diuretics|diuretics|mesh-ancestor
92729411|NCT04556279|Natriuretic Agents|natriuretic agents|mesh-ancestor
92729412|NCT02216331|Rifampin|rifampin|mesh-list
92729413|NCT02216331|Rifapentine|rifapentine|mesh-list
92729414|NCT02216331|Bedaquiline|bedaquiline|mesh-list
92729415|NCT02216331|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92729416|NCT02216331|Antitubercular Agents|antitubercular agents|mesh-ancestor
92729417|NCT02216331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729418|NCT02216331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729419|NCT02216331|Leprostatic Agents|leprostatic agents|mesh-ancestor
92729420|NCT02216331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92729421|NCT02216331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729422|NCT02216331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729423|NCT02216331|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92729424|NCT02216331|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92729425|NCT02216331|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92729426|NCT02216331|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92729427|NCT02216331|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92729428|NCT02216331|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92729429|NCT04535817|Omalizumab|omalizumab|mesh-list
92729430|NCT04535817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92729431|NCT04535817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92729432|NCT04535817|Respiratory System Agents|respiratory system agents|mesh-ancestor
92729433|NCT04578236|Tretinoin|tretinoin|mesh-list
92729434|NCT04578236|Captopril|captopril|mesh-list
92729435|NCT04578236|Isotretinoin|isotretinoin|mesh-list
92729438|NCT04578236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729439|NCT04578236|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92729440|NCT04578236|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729441|NCT04578236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729442|NCT04578236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729443|NCT04578236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729444|NCT04542759|Besifloxacin|besifloxacin|mesh-list
92729445|NCT04542759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92729446|NCT04542759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92729447|NCT04542759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729448|NCT04542759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729449|NCT04542759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92729450|NCT04542759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92017549|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92610444|NCT02275975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610445|NCT02275975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610446|NCT02275975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92610447|NCT02275975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92610448|NCT02276092|Anti-Infective Agents|anti-infective agents|mesh-list
92610449|NCT02276092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92610450|NCT00142727|Analgesics, Opioid|analgesics, opioid|mesh-list
92610452|NCT00142727|Narcotic Antagonists|narcotic antagonists|mesh-list
92610453|NCT00142727|Narcotics|narcotics|mesh-ancestor
92610454|NCT00142727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610455|NCT00142727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610456|NCT00142727|Analgesics|analgesics|mesh-ancestor
92729451|NCT04542759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729452|NCT04542759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729453|NCT04542759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729454|NCT04542213|Insulin|insulin|mesh-list
92729455|NCT04542213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92729456|NCT04542213|Linagliptin|linagliptin|mesh-list
92729457|NCT04542213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92729458|NCT04542213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729459|NCT04542213|Incretins|incretins|mesh-ancestor
92729460|NCT04542213|Hormones|hormones|mesh-ancestor
92729461|NCT04542213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729462|NCT04542213|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92729463|NCT04542213|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729464|NCT04542213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729465|NCT04542213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729466|NCT04542252|Cyclosporine|cyclosporine|mesh-list
92729467|NCT04542252|Cyclosporins|cyclosporins|mesh-list
92729468|NCT04542252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729469|NCT04542252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729470|NCT04542252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92729471|NCT04542252|Immunologic Factors|immunologic factors|mesh-ancestor
92729472|NCT04542252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729473|NCT04542252|Antifungal Agents|antifungal agents|mesh-ancestor
92729474|NCT04542252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729475|NCT04542252|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729476|NCT04542252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729477|NCT04542252|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92729478|NCT04555694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92729479|NCT04555694|Cyclosporine|cyclosporine|mesh-list
92729480|NCT04555694|Dexamethasone|dexamethasone|mesh-list
92729481|NCT04555694|Cyclosporins|cyclosporins|mesh-list
92729482|NCT04555694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729483|NCT04555694|Antiemetics|antiemetics|mesh-ancestor
92729484|NCT04555694|Autonomic Agents|autonomic agents|mesh-ancestor
92729485|NCT04555694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729486|NCT04555694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729487|NCT04555694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729488|NCT04555694|Glucocorticoids|glucocorticoids|mesh-ancestor
92729489|NCT04555694|Hormones|hormones|mesh-ancestor
92729490|NCT04555694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729491|NCT04555694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92729492|NCT04555694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729493|NCT04555694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729494|NCT04555694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729495|NCT04555694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92729496|NCT04555694|Immunologic Factors|immunologic factors|mesh-ancestor
92610457|NCT00142727|Sensory System Agents|sensory system agents|mesh-ancestor
92610458|NCT00142727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610459|NCT00142727|Antitussive Agents|antitussive agents|mesh-ancestor
92610460|NCT00142727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92610462|NCT04510402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92610463|NCT04510402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610464|NCT00506194|Gliclazide|gliclazide|mesh-list
92610465|NCT00506194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92610466|NCT00506194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610467|NCT00404573|Cariprazine|cariprazine|mesh-list
92610468|NCT00404573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92610469|NCT00404573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610470|NCT00404573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610471|NCT00404573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729497|NCT04555694|Antifungal Agents|antifungal agents|mesh-ancestor
92729498|NCT04555694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729499|NCT04555694|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729500|NCT04555694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729501|NCT04555694|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92729502|NCT04555694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92729503|NCT04532775|Methylprednisolone|methylprednisolone|mesh-list
92729504|NCT04532775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92729505|NCT04532775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92729506|NCT04532775|Prednisolone|prednisolone|mesh-list
92729507|NCT04532775|Prednisolone acetate|prednisolone acetate|mesh-list
92729508|NCT04532775|Magnesium Sulfate|magnesium sulfate|mesh-list
92729515|NCT04532775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729516|NCT04532775|Sensory System Agents|sensory system agents|mesh-ancestor
92729517|NCT04532775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729518|NCT04532775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729519|NCT04532775|Antiemetics|antiemetics|mesh-ancestor
92729520|NCT04532775|Autonomic Agents|autonomic agents|mesh-ancestor
92729521|NCT04532775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729522|NCT04532775|Glucocorticoids|glucocorticoids|mesh-ancestor
92729523|NCT04532775|Hormones|hormones|mesh-ancestor
92729524|NCT04532775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729525|NCT04532775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92729526|NCT04532775|Protective Agents|protective agents|mesh-ancestor
92729527|NCT04532775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92729528|NCT04532775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729529|NCT04532775|Analgesics|analgesics|mesh-ancestor
92729530|NCT04532775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92729531|NCT04532775|Anticonvulsants|anticonvulsants|mesh-ancestor
92729532|NCT04532775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92729533|NCT04532775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729534|NCT04532775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729535|NCT04532775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729536|NCT04532775|Tocolytic Agents|tocolytic agents|mesh-ancestor
92729537|NCT04532775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729538|NCT00579644|Minocycline|minocycline|mesh-list
92729539|NCT00579644|Methotrexate|methotrexate|mesh-list
92729540|NCT00579644|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92729541|NCT00579644|Abortifacient Agents|abortifacient agents|mesh-ancestor
92729542|NCT00579644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729543|NCT00579644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729544|NCT00579644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92729545|NCT00579644|Antimetabolites|antimetabolites|mesh-ancestor
92729546|NCT00579644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729547|NCT00579644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610472|NCT00404573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92610473|NCT00506272|Insulin|insulin|mesh-list
92610474|NCT00506272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92610475|NCT00506272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729548|NCT00579644|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729549|NCT00579644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729550|NCT00579644|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92729551|NCT00579644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92729552|NCT00579644|Immunologic Factors|immunologic factors|mesh-ancestor
92729553|NCT00579644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729554|NCT00579644|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92729555|NCT00579644|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729556|NCT00579644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729557|NCT04578158|Quercetin|quercetin|mesh-list
92729558|NCT04578158|Antioxidants|antioxidants|mesh-ancestor
92729559|NCT04578158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729560|NCT04578158|Protective Agents|protective agents|mesh-ancestor
92729561|NCT04578158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729562|NCT04532736|Mometasone Furoate|mometasone furoate|mesh-list
92729563|NCT04532736|Methylprednisolone|methylprednisolone|mesh-list
92729564|NCT04532736|Methotrexate|methotrexate|mesh-list
92729565|NCT04532736|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92729566|NCT04532736|Abortifacient Agents|abortifacient agents|mesh-ancestor
92729567|NCT04532736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729568|NCT04532736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729569|NCT04532736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92729570|NCT04532736|Antimetabolites|antimetabolites|mesh-ancestor
92397521|NCT04245644|Analgesics|analgesics|mesh-ancestor
92729571|NCT04532736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729572|NCT04532736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729573|NCT04532736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729574|NCT04532736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729575|NCT04532736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92729576|NCT04532736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92729577|NCT04532736|Immunologic Factors|immunologic factors|mesh-ancestor
92729580|NCT04532736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729581|NCT04532736|Antiemetics|antiemetics|mesh-ancestor
92729582|NCT04532736|Autonomic Agents|autonomic agents|mesh-ancestor
92729583|NCT04532736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729584|NCT04532736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729585|NCT04532736|Glucocorticoids|glucocorticoids|mesh-ancestor
92729586|NCT04532736|Hormones|hormones|mesh-ancestor
92729587|NCT04532736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729588|NCT04532736|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92729589|NCT04532736|Protective Agents|protective agents|mesh-ancestor
92729590|NCT04532736|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92729591|NCT04555733|Lemborexant|lemborexant|mesh-list
92729592|NCT04555733|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92729593|NCT04555733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729594|NCT04555733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729595|NCT04555733|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92729596|NCT04555733|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92729597|NCT04555733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729598|NCT04555733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729599|NCT02216994|Mineral Oil|mineral oil|mesh-list
92729600|NCT02216994|Lactulose|lactulose|mesh-list
92729601|NCT02216994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729602|NCT02216994|Emollients|emollients|mesh-ancestor
92729603|NCT02216994|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729604|NCT02212613|Brexpiprazole|brexpiprazole|mesh-list
92729605|NCT02212613|Serotonin Agents|serotonin agents|mesh-ancestor
92729606|NCT02212613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729607|NCT02212613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729608|NCT02212613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729609|NCT02212613|Dopamine Agonists|dopamine agonists|mesh-ancestor
92729610|NCT02212613|Dopamine Agents|dopamine agents|mesh-ancestor
92729612|NCT02217189|Astringents|astringents|mesh-ancestor
92729613|NCT02217189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729614|NCT02217189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729615|NCT00579956|Meropenem|meropenem|mesh-list
92729616|NCT00579956|Ceftazidime|ceftazidime|mesh-list
92729617|NCT00579956|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729618|NCT00579956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610476|NCT00506311|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92610477|NCT00506311|Hemostatics|hemostatics|mesh-ancestor
92610478|NCT00506311|Coagulants|coagulants|mesh-ancestor
92610479|NCT04519645|Lacosamide|lacosamide|mesh-list
92610480|NCT04519645|Anticonvulsants|anticonvulsants|mesh-ancestor
92610481|NCT04519645|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92729619|NCT04555304|Paclitaxel|paclitaxel|mesh-list
92729620|NCT04555304|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92729621|NCT04555304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92729622|NCT04555304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729623|NCT04555304|Tubulin Modulators|tubulin modulators|mesh-ancestor
92729624|NCT04555304|Antimitotic Agents|antimitotic agents|mesh-ancestor
92729625|NCT04555304|Mitosis Modulators|mitosis modulators|mesh-ancestor
92729626|NCT04555304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729627|NCT04531800|Mitogens|mitogens|mesh-list
92729628|NCT04531800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92729629|NCT04531800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729630|NCT00579995|Acetylcysteine|acetylcysteine|mesh-list
92729631|NCT00579995|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92729632|NCT00579995|Antiviral Agents|antiviral agents|mesh-ancestor
92729633|NCT00579995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729634|NCT00579995|Expectorants|expectorants|mesh-ancestor
92729635|NCT00579995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92729636|NCT00579995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92729637|NCT00579995|Antioxidants|antioxidants|mesh-ancestor
92729638|NCT00579995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729639|NCT00579995|Protective Agents|protective agents|mesh-ancestor
92729640|NCT00579995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729641|NCT00579995|Antidotes|antidotes|mesh-ancestor
92729642|NCT04531371|Dexmedetomidine|dexmedetomidine|mesh-list
92729643|NCT04531371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92729644|NCT04531371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729645|NCT04531371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729646|NCT04531371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92729647|NCT04531371|Analgesics|analgesics|mesh-ancestor
92729648|NCT04531371|Sensory System Agents|sensory system agents|mesh-ancestor
92729649|NCT04531371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729650|NCT04531371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92729651|NCT04531371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92729655|NCT04531371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729656|NCT00580112|Dexamethasone|dexamethasone|mesh-list
92729657|NCT00580112|Trabectedin|trabectedin|mesh-list
92729658|NCT00580112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729659|NCT00580112|Antiemetics|antiemetics|mesh-ancestor
92729660|NCT00580112|Autonomic Agents|autonomic agents|mesh-ancestor
92729661|NCT00580112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729662|NCT00580112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729663|NCT00580112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729664|NCT00580112|Glucocorticoids|glucocorticoids|mesh-ancestor
92729666|NCT00580112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729667|NCT00580112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92729668|NCT00580112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729669|NCT00580112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92729670|NCT00580112|Alkylating Agents|alkylating agents|mesh-ancestor
92729671|NCT00580112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729672|NCT04531332|Linezolid|linezolid|mesh-list
92729673|NCT04531332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729674|NCT04531332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729675|NCT04531332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92729676|NCT04531332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729677|NCT04531332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729678|NCT04530864|Dexamethasone|dexamethasone|mesh-list
92729679|NCT04530864|Dexamethasone acetate|dexamethasone acetate|mesh-list
92729680|NCT04530864|BB 1101|bb 1101|mesh-list
92729681|NCT04530864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729682|NCT04530864|Antiemetics|antiemetics|mesh-ancestor
92729683|NCT04530864|Autonomic Agents|autonomic agents|mesh-ancestor
92729684|NCT04530864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729685|NCT04530864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610482|NCT04519645|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92610483|NCT04519645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610484|NCT04519645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017584|NCT04948567|Analgesics|analgesics|mesh-ancestor
92729686|NCT04530864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397562|NCT04074512|Copper|copper|mesh-list
92729687|NCT04530864|Glucocorticoids|glucocorticoids|mesh-ancestor
92729688|NCT04530864|Hormones|hormones|mesh-ancestor
92729689|NCT04530864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729690|NCT04530864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92729691|NCT04530864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729692|NCT04530864|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729693|NCT04530864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729694|NCT04530864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729695|NCT00580190|Alprazolam|alprazolam|mesh-list
92729696|NCT00580190|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92729697|NCT00580190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729698|NCT00580190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729699|NCT00580190|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92729700|NCT00580190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92729701|NCT00580190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92729702|NCT00580190|GABA Modulators|gaba modulators|mesh-ancestor
92729703|NCT00580190|GABA Agents|gaba agents|mesh-ancestor
92729704|NCT00580190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729705|NCT00580190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729706|NCT04530903|Clonidine|clonidine|mesh-list
92729707|NCT04530903|Levobupivacaine|levobupivacaine|mesh-list
92729708|NCT04530903|Analgesics|analgesics|mesh-ancestor
92729709|NCT04530903|Sensory System Agents|sensory system agents|mesh-ancestor
92729710|NCT04530903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729711|NCT04530903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729712|NCT04530903|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729713|NCT04530903|Sympatholytics|sympatholytics|mesh-ancestor
92729714|NCT04530903|Autonomic Agents|autonomic agents|mesh-ancestor
92729715|NCT04530903|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92729716|NCT04530903|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92729717|NCT04530903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92729718|NCT04530903|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729719|NCT04530903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729720|NCT04530903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729721|NCT04530903|Anesthetics, Local|anesthetics, local|mesh-ancestor
92729722|NCT04530903|Anesthetics|anesthetics|mesh-ancestor
92729728|NCT04554680|Dabrafenib|dabrafenib|mesh-list
92729729|NCT04554680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729730|NCT04554680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92729731|NCT04554680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729732|NCT04554680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729733|NCT00580424|Norethindrone|norethindrone|mesh-list
92729734|NCT00580424|Norethindrone Acetate|norethindrone acetate|mesh-list
92729735|NCT00580424|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92729736|NCT00580424|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92729737|NCT00580424|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92729738|NCT00580424|Contraceptive Agents|contraceptive agents|mesh-ancestor
92729739|NCT00580424|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729740|NCT00580424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729741|NCT00580424|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92729742|NCT00580424|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92729743|NCT01121575|Crizotinib|crizotinib|mesh-list
92729744|NCT01121575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729745|NCT01121575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92729746|NCT01121575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729747|NCT01121575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729748|NCT00625573|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92729749|NCT00625573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729750|NCT04205851|Gimsilumab|gimsilumab|mesh-list
92729751|NCT04205851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729752|NCT04205851|Antiviral Agents|antiviral agents|mesh-ancestor
92729753|NCT04205851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729754|NCT02882113|Tacrolimus|tacrolimus|mesh-list
92729755|NCT02882113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610485|NCT00406731|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92610486|NCT00406731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610487|NCT00406731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610488|NCT00142844|Naltrexone|naltrexone|mesh-list
92610489|NCT00142844|Disulfiram|disulfiram|mesh-list
92610490|NCT00142844|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92729756|NCT02882113|Immunologic Factors|immunologic factors|mesh-ancestor
92729757|NCT02882113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729758|NCT02882113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92729759|NCT02882113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729760|NCT02882113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729761|NCT04530045|Piperacillin|piperacillin|mesh-list
92729762|NCT04530045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729763|NCT04530045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729764|NCT01121536|Modafinil|modafinil|mesh-list
92729765|NCT01121536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92729766|NCT01121536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729767|NCT01121536|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92729768|NCT01121536|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92729769|NCT01121536|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92729770|NCT01121536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729771|NCT00580619|Methyldopa|methyldopa|mesh-list
92729772|NCT00580619|Trimethaphan|trimethaphan|mesh-list
92729773|NCT00580619|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
92729774|NCT00580619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729775|NCT00580619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729776|NCT00580619|Sympatholytics|sympatholytics|mesh-ancestor
92729777|NCT00580619|Autonomic Agents|autonomic agents|mesh-ancestor
92729778|NCT00580619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729779|NCT00580619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729780|NCT00580619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92729781|NCT00580619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92729782|NCT00580619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92729783|NCT00580619|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729784|NCT00580619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729785|NCT00580619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92729786|NCT00580619|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92729787|NCT00580619|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92729788|NCT00580619|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92729789|NCT00580619|Cholinergic Agents|cholinergic agents|mesh-ancestor
92729790|NCT00580619|Vasodilator Agents|vasodilator agents|mesh-ancestor
92729791|NCT04554524|Paclitaxel|paclitaxel|mesh-list
92729792|NCT04554524|Pembrolizumab|pembrolizumab|mesh-list
92729794|NCT04554524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729795|NCT04554524|Tubulin Modulators|tubulin modulators|mesh-ancestor
92729796|NCT04554524|Antimitotic Agents|antimitotic agents|mesh-ancestor
92729797|NCT04554524|Mitosis Modulators|mitosis modulators|mesh-ancestor
92729798|NCT04554524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729799|NCT04554524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92729800|NCT04554524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92729801|NCT02212652|Vitamin D|vitamin d|mesh-list
92729802|NCT02212652|Ergocalciferols|ergocalciferols|mesh-list
92729803|NCT02212652|Cholecalciferol|cholecalciferol|mesh-list
92729804|NCT02212652|Vitamins|vitamins|mesh-list
92729805|NCT02212652|Micronutrients|micronutrients|mesh-ancestor
92729806|NCT02212652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729807|NCT02212652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92729808|NCT02212652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729809|NCT02212769|Losartan|losartan|mesh-list
92729810|NCT02212769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92729811|NCT02212769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729812|NCT02212769|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92729813|NCT02212769|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92729814|NCT02212769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729815|NCT02212808|Anti-Infective Agents|anti-infective agents|mesh-list
92729816|NCT02212808|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92729817|NCT02217852|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92729818|NCT02217852|Captopril|captopril|mesh-list
92729819|NCT02217852|Antihypertensive Agents|antihypertensive agents|mesh-list
92610491|NCT00142844|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92610492|NCT00142844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610493|NCT00142844|Sensory System Agents|sensory system agents|mesh-ancestor
92729820|NCT02217852|Nitrendipine|nitrendipine|mesh-list
92729821|NCT02217852|Diuretics|diuretics|mesh-ancestor
92729822|NCT02217852|Natriuretic Agents|natriuretic agents|mesh-ancestor
92729823|NCT02217852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729824|NCT02217852|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92729825|NCT02217852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729826|NCT02217852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729827|NCT02217852|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92729828|NCT02217852|Protease Inhibitors|protease inhibitors|mesh-ancestor
92729829|NCT02217852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729830|NCT02217852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92729831|NCT02217852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729832|NCT02217852|Vasodilator Agents|vasodilator agents|mesh-ancestor
92729834|NCT02217930|Levonadifloxacin|levonadifloxacin|mesh-list
92729835|NCT02217930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729836|NCT02217930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729837|NCT02217930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92729838|NCT02217930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92729839|NCT02217930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729840|NCT02217930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729841|NCT02217930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729842|NCT02217930|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92729843|NCT04577846|Cephalexin|cephalexin|mesh-list
92729844|NCT04577846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729845|NCT04577846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729846|NCT04529811|Rifaximin|rifaximin|mesh-list
92729847|NCT04529811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729848|NCT04529811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729849|NCT04529811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729850|NCT02218047|Interferons|interferons|mesh-list
92729851|NCT02218047|Interferon-alpha|interferon-alpha|mesh-list
92729852|NCT02218047|Interferon alpha-2|interferon alpha-2|mesh-list
92729853|NCT02218047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729854|NCT02218047|Antiviral Agents|antiviral agents|mesh-ancestor
92729855|NCT02218047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729856|NCT02218047|Immunologic Factors|immunologic factors|mesh-ancestor
92729857|NCT02218047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729858|NCT00580814|Methylphenidate|methylphenidate|mesh-list
92729859|NCT00580814|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92729860|NCT00580814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729861|NCT00580814|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92729862|NCT00580814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92729863|NCT00580814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729864|NCT00580814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729865|NCT00580814|Dopamine Agents|dopamine agents|mesh-ancestor
92729866|NCT00580814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729869|NCT01120600|Calcium Carbonate|calcium carbonate|mesh-list
92729870|NCT01120600|Calcium|calcium|mesh-list
92729871|NCT01120600|Vitamins|vitamins|mesh-ancestor
92729872|NCT01120600|Micronutrients|micronutrients|mesh-ancestor
92729873|NCT01120600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729874|NCT01120600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729875|NCT01120600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92729876|NCT01120600|Antacids|antacids|mesh-ancestor
92729877|NCT01120600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729878|NCT01120600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729879|NCT04577885|Rifampin|rifampin|mesh-list
92729880|NCT04577885|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92729881|NCT04577885|Antitubercular Agents|antitubercular agents|mesh-ancestor
92729882|NCT04577885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729883|NCT04577885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729884|NCT04577885|Leprostatic Agents|leprostatic agents|mesh-ancestor
92729885|NCT04577885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92729886|NCT04577885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729887|NCT04577885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729888|NCT04577885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92610494|NCT00142844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335557|NCT02116530|Dexamethasone|dexamethasone|mesh-list
92610495|NCT00142844|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92610496|NCT00142844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610497|NCT00142844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610498|NCT00163137|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92610499|NCT00163137|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92610500|NCT00163137|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610501|NCT00163137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610502|NCT00163137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729889|NCT04577885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92729890|NCT04577885|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92729891|NCT04577885|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92729892|NCT04577885|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92729893|NCT04577885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92729894|NCT00580931|Niacinamide|niacinamide|mesh-list
92729895|NCT00580931|Niacin|niacin|mesh-list
92729896|NCT00580931|Nicotinic Acids|nicotinic acids|mesh-list
92729897|NCT00580931|Vitamin B Complex|vitamin b complex|mesh-ancestor
92729898|NCT00580931|Vitamins|vitamins|mesh-ancestor
92729899|NCT00580931|Micronutrients|micronutrients|mesh-ancestor
92729900|NCT00580931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729901|NCT00580931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92729902|NCT00580931|Antimetabolites|antimetabolites|mesh-ancestor
92729903|NCT00580931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729904|NCT00580931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92729905|NCT00580931|Vasodilator Agents|vasodilator agents|mesh-ancestor
92729906|NCT01120093|Bromides|bromides|mesh-list
92729907|NCT01120093|Formoterol Fumarate|formoterol fumarate|mesh-list
92729908|NCT01120093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92729909|NCT01120093|Autonomic Agents|autonomic agents|mesh-ancestor
92729910|NCT01120093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729911|NCT01120093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729912|NCT01120093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92729913|NCT01120093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92729914|NCT01120093|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92729915|NCT01120093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92729916|NCT01120093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92729917|NCT01120093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729918|NCT01120093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729919|NCT01120093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729920|NCT01120093|Anticonvulsants|anticonvulsants|mesh-ancestor
92729921|NCT00581009|Lithium Carbonate|lithium carbonate|mesh-list
92729922|NCT00581009|Sertraline|sertraline|mesh-list
92729923|NCT00581009|Antidepressive Agents|antidepressive agents|mesh-ancestor
92729924|NCT00581009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92729925|NCT00581009|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92729926|NCT00581009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92729927|NCT00581009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729928|NCT00581009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729929|NCT00581009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729930|NCT00581009|Serotonin Agents|serotonin agents|mesh-ancestor
92729931|NCT00581009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729932|NCT00581009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729933|NCT00581009|Antimanic Agents|antimanic agents|mesh-ancestor
92729934|NCT00581009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92729935|NCT00581009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729936|NCT02218359|Amikacin|amikacin|mesh-list
92729937|NCT02218359|Fosfomycin|fosfomycin|mesh-list
92729938|NCT02218359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92729939|NCT02218359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92729940|NCT02218359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729951|NCT02218398|Autonomic Agents|autonomic agents|mesh-ancestor
92729952|NCT02218398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729953|NCT02218398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729954|NCT02218398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92729955|NCT02218398|Respiratory System Agents|respiratory system agents|mesh-ancestor
92729956|NCT02218398|Tocolytic Agents|tocolytic agents|mesh-ancestor
92729957|NCT02218398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729958|NCT02218398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92729959|NCT02218398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92729960|NCT02218398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92729961|NCT02218398|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729962|NCT02218398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729963|NCT02218398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729964|NCT02218671|Brotizolam|brotizolam|mesh-list
92729965|NCT02218671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92729966|NCT02218671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729967|NCT02218671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729968|NCT01119937|Glycopyrrolate|glycopyrrolate|mesh-list
92729969|NCT01119937|Tiotropium Bromide|tiotropium bromide|mesh-list
92729970|NCT01119937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92729971|NCT01119937|Autonomic Agents|autonomic agents|mesh-ancestor
92729972|NCT01119937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729973|NCT01119937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729974|NCT01119937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92729975|NCT01119937|Respiratory System Agents|respiratory system agents|mesh-ancestor
92729976|NCT01119937|Parasympatholytics|parasympatholytics|mesh-ancestor
92729977|NCT01119937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92729978|NCT01119937|Cholinergic Agents|cholinergic agents|mesh-ancestor
92729979|NCT01119937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729980|NCT01119937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729981|NCT01119937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92729982|NCT01119937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92729983|NCT01119898|Diclofenac|diclofenac|mesh-list
92729984|NCT01119898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92729985|NCT01119898|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92729986|NCT01119898|Analgesics|analgesics|mesh-ancestor
92729987|NCT01119898|Sensory System Agents|sensory system agents|mesh-ancestor
92729988|NCT01119898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729989|NCT01119898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729990|NCT01119898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729991|NCT01119898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729992|NCT01119898|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92729993|NCT01119898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729994|NCT01119898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729995|NCT01119859|Adalimumab|adalimumab|mesh-list
92729996|NCT01119859|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92729997|NCT01119859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729998|NCT01119859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729999|NCT02278926|Insulin|insulin|mesh-list
92730000|NCT02278926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92730001|NCT02278926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730002|NCT01119703|Vaccines|vaccines|mesh-list
92730003|NCT01119703|Immunologic Factors|immunologic factors|mesh-ancestor
92730004|NCT01119703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730005|NCT02882230|Dolutegravir|dolutegravir|mesh-list
92730009|NCT02882230|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92730010|NCT02882230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730011|NCT02882230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730012|NCT02882230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92730013|NCT02882230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92730014|NCT02882230|Antiviral Agents|antiviral agents|mesh-ancestor
92730015|NCT02882230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730016|NCT02882230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92730017|NCT02882230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92730018|NCT01119625|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92730019|NCT01119625|Immunologic Factors|immunologic factors|mesh-ancestor
92730020|NCT01119625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730021|NCT02218827|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92730022|NCT02218827|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92730023|NCT02881762|Maraviroc|maraviroc|mesh-list
92730024|NCT02881762|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92610503|NCT00163137|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92610504|NCT00163137|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92610505|NCT00163137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92610506|NCT00142883|Pregabalin|pregabalin|mesh-list
92730025|NCT02881762|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92730026|NCT02881762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730027|NCT02881762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92730028|NCT02881762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92730029|NCT02881762|Antiviral Agents|antiviral agents|mesh-ancestor
92730030|NCT02881762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730031|NCT02881762|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92730032|NCT04561947|Mitogens|mitogens|mesh-list
92730033|NCT04561947|Mitosis Modulators|mitosis modulators|mesh-ancestor
92730034|NCT04561947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730035|NCT01118962|Lacosamide|lacosamide|mesh-list
92730036|NCT01118962|Anticonvulsants|anticonvulsants|mesh-ancestor
92730037|NCT01118962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92730038|NCT01118962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92730039|NCT01118962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730040|NCT01118962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730041|NCT00581165|Etanercept|etanercept|mesh-list
92730042|NCT00581165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92730043|NCT00581165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730044|NCT00581165|Analgesics|analgesics|mesh-ancestor
92730045|NCT00581165|Sensory System Agents|sensory system agents|mesh-ancestor
92730046|NCT00581165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730047|NCT00581165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730048|NCT00581165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730049|NCT00581165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730050|NCT00581165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730051|NCT00581165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92730052|NCT00581165|Immunologic Factors|immunologic factors|mesh-ancestor
92730053|NCT05092984|Spironolactone|spironolactone|mesh-list
92730054|NCT05092984|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92730055|NCT05092984|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730056|NCT05092984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730057|NCT05092984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730058|NCT05092984|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92730059|NCT05092984|Diuretics|diuretics|mesh-ancestor
92730060|NCT05092984|Natriuretic Agents|natriuretic agents|mesh-ancestor
92730061|NCT02213159|Dexmedetomidine|dexmedetomidine|mesh-list
92730062|NCT02213159|Morphine|morphine|mesh-list
92730063|NCT02213159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92730064|NCT02213159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730065|NCT02213159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730066|NCT02213159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730067|NCT02213159|Analgesics|analgesics|mesh-ancestor
92730068|NCT02213159|Sensory System Agents|sensory system agents|mesh-ancestor
92730069|NCT02213159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730070|NCT02213159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92730071|NCT02213159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92730072|NCT02213159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92730073|NCT02213159|Adrenergic Agents|adrenergic agents|mesh-ancestor
92730074|NCT02213159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730075|NCT02213159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730076|NCT02213159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92730080|NCT02219100|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92730081|NCT02219100|Abortifacient Agents|abortifacient agents|mesh-ancestor
92730082|NCT02219100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92730083|NCT02219100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730084|NCT02219100|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92730085|NCT02219100|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92730086|NCT02219100|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92730087|NCT02219100|Contraceptive Agents|contraceptive agents|mesh-ancestor
92730088|NCT02219100|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92730089|NCT02219100|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92730090|NCT02219100|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730091|NCT02219100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610507|NCT00142883|Analgesics|analgesics|mesh-ancestor
92610508|NCT00142883|Sensory System Agents|sensory system agents|mesh-ancestor
92610509|NCT00142883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017611|NCT04419181|Immunotoxins|immunotoxins|mesh-ancestor
92730092|NCT02219100|Luteolytic Agents|luteolytic agents|mesh-ancestor
92730093|NCT02219100|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92730094|NCT02219100|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92730095|NCT01118377|Capecitabine|capecitabine|mesh-list
92730096|NCT01118377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92730097|NCT01118377|Antimetabolites|antimetabolites|mesh-ancestor
92730098|NCT01118377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730099|NCT01118377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730100|NCT02219178|Dexamethasone|dexamethasone|mesh-list
92730101|NCT02219178|Lenalidomide|lenalidomide|mesh-list
92730103|NCT02219178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730104|NCT02219178|Antiemetics|antiemetics|mesh-ancestor
92730105|NCT02219178|Autonomic Agents|autonomic agents|mesh-ancestor
92730106|NCT02219178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730107|NCT02219178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730108|NCT02219178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730109|NCT02219178|Glucocorticoids|glucocorticoids|mesh-ancestor
92730110|NCT02219178|Hormones|hormones|mesh-ancestor
92730111|NCT02219178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730112|NCT02219178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92730113|NCT02219178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730114|NCT02219178|Immunologic Factors|immunologic factors|mesh-ancestor
92730115|NCT02219178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92730116|NCT02219178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92730117|NCT02219178|Growth Substances|growth substances|mesh-ancestor
92730118|NCT02219178|Growth Inhibitors|growth inhibitors|mesh-ancestor
92730119|NCT02213315|Mavrilimumab|mavrilimumab|mesh-list
92730120|NCT02213315|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92730121|NCT02213315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730122|NCT02213315|Immunologic Factors|immunologic factors|mesh-ancestor
92730123|NCT02213315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730124|NCT02219217|Dolutegravir|dolutegravir|mesh-list
92730125|NCT02219217|Cobicistat|cobicistat|mesh-list
92730126|NCT02219217|Elvitegravir|elvitegravir|mesh-list
92730127|NCT02219217|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92730128|NCT02219217|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92730129|NCT02219217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730130|NCT02219217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730131|NCT02219217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92730132|NCT02219217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92730133|NCT02219217|Antiviral Agents|antiviral agents|mesh-ancestor
92730134|NCT02219217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730135|NCT02219217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92730136|NCT02219217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92730138|NCT04577378|Tretinoin|tretinoin|mesh-list
92730139|NCT04577378|Isotretinoin|isotretinoin|mesh-list
92730140|NCT04577378|Antifungal Agents|antifungal agents|mesh-ancestor
92730141|NCT04577378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730142|NCT04577378|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92730143|NCT04577378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92730144|NCT04577378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730145|NCT04577378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730146|NCT04577378|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92730147|NCT04577378|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730148|NCT04577378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730149|NCT04577378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730150|NCT04577378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92730151|NCT04577378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730153|NCT04577378|Dermatologic Agents|dermatologic agents|mesh-ancestor
92730154|NCT02219412|Aspirin|aspirin|mesh-list
92730155|NCT02219412|Ticagrelor|ticagrelor|mesh-list
92730156|NCT02219412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92730157|NCT02219412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730158|NCT02219412|Analgesics|analgesics|mesh-ancestor
92730159|NCT02219412|Sensory System Agents|sensory system agents|mesh-ancestor
92730160|NCT02219412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730161|NCT02219412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610510|NCT00142883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610511|NCT00142883|Anticonvulsants|anticonvulsants|mesh-ancestor
92610512|NCT00142883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610513|NCT00142883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730162|NCT02219412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730163|NCT02219412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730164|NCT02219412|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92730165|NCT02219412|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92730166|NCT02219412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730167|NCT02219412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92730168|NCT02219412|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92730169|NCT02219412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730170|NCT02219412|Antipyretics|antipyretics|mesh-ancestor
92730171|NCT02219412|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92730172|NCT02219412|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92730173|NCT02219412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92730174|NCT02219412|Purinergic Agents|purinergic agents|mesh-ancestor
92730175|NCT02219412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730176|NCT04577027|Travoprost|travoprost|mesh-list
92730177|NCT04577027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92730178|NCT02211690|Tenofovir|tenofovir|mesh-list
92730179|NCT02211690|Emtricitabine|emtricitabine|mesh-list
92730180|NCT02211690|Dolutegravir|dolutegravir|mesh-list
92730181|NCT02211690|Antiviral Agents|antiviral agents|mesh-ancestor
92730182|NCT02211690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730183|NCT02211690|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92730184|NCT02211690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92730185|NCT02211690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730186|NCT02211690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730187|NCT02211690|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92730188|NCT02211690|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92730189|NCT02211690|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92730190|NCT02211690|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92730191|NCT04553393|Decitabine|decitabine|mesh-list
92730192|NCT04553393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92730193|NCT04553393|Antimetabolites|antimetabolites|mesh-ancestor
92730194|NCT04553393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730195|NCT04553393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730196|NCT04553393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730197|NCT02211846|Mirabegron|mirabegron|mesh-list
92730198|NCT02211846|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92730199|NCT02211846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92730200|NCT02211846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92730201|NCT02211846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92730202|NCT02211846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730203|NCT02211846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730204|NCT02211846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730206|NCT02219646|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92730207|NCT02219646|Vasodilator Agents|vasodilator agents|mesh-ancestor
92730208|NCT02219646|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92730209|NCT02219646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92730210|NCT02219646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730211|NCT02219646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730212|NCT02219646|Urological Agents|urological agents|mesh-ancestor
92730213|NCT04553510|Bevacizumab|bevacizumab|mesh-list
92730214|NCT04553510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92730215|NCT04553510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730216|NCT04553510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92730217|NCT04553510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92730218|NCT04553510|Growth Substances|growth substances|mesh-ancestor
92730219|NCT04553510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730220|NCT04553510|Growth Inhibitors|growth inhibitors|mesh-ancestor
92730221|NCT03453281|Aflibercept|aflibercept|mesh-list
92730222|NCT03453281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92730223|NCT03453281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92730224|NCT03453281|Growth Substances|growth substances|mesh-ancestor
92730226|NCT03453281|Growth Inhibitors|growth inhibitors|mesh-ancestor
92730227|NCT03453281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730228|NCT01642134|Aspirin|aspirin|mesh-list
92730229|NCT01642134|Clopidogrel|clopidogrel|mesh-list
92017619|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92730230|NCT01642134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92730231|NCT01642134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730232|NCT01642134|Analgesics|analgesics|mesh-ancestor
92730233|NCT01642134|Sensory System Agents|sensory system agents|mesh-ancestor
92730234|NCT01642134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730235|NCT01642134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730236|NCT01642134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730237|NCT01642134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730238|NCT01642134|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92730239|NCT01642134|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92730240|NCT01642134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730241|NCT01642134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92730242|NCT01642134|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92730243|NCT01642134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730244|NCT01642134|Antipyretics|antipyretics|mesh-ancestor
92730245|NCT01642134|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92730246|NCT01642134|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92730247|NCT01642134|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92730248|NCT01642134|Purinergic Agents|purinergic agents|mesh-ancestor
92730249|NCT01642134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730250|NCT00581789|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92730251|NCT00581789|Sunitinib|sunitinib|mesh-list
92730252|NCT00581789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730253|NCT00581789|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92730254|NCT00581789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730255|NCT00581789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730256|NCT00581789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92730257|NCT00581789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92730258|NCT00581789|Growth Substances|growth substances|mesh-ancestor
92730259|NCT00581789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730260|NCT00581789|Growth Inhibitors|growth inhibitors|mesh-ancestor
92730261|NCT02213588|Antioxidants|antioxidants|mesh-list
92730262|NCT02213588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730263|NCT02213588|Protective Agents|protective agents|mesh-ancestor
92730264|NCT02213588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730265|NCT01642524|Dextrans|dextrans|mesh-list
92730266|NCT01642524|Anticoagulants|anticoagulants|mesh-ancestor
92730267|NCT01642524|Plasma Substitutes|plasma substitutes|mesh-ancestor
92730268|NCT01642524|Blood Substitutes|blood substitutes|mesh-ancestor
92730269|NCT02213783|Imipenem|imipenem|mesh-list
92730270|NCT02213783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92730271|NCT02213783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730272|NCT04552613|Carboplatin|carboplatin|mesh-list
92730273|NCT04552613|Pemetrexed|pemetrexed|mesh-list
92730274|NCT04552613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730275|NCT04552613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730276|NCT04552613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730277|NCT04552613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92730278|NCT04552613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92730279|NCT01117987|Imatinib Mesylate|imatinib mesylate|mesh-list
92730280|NCT01117987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730281|NCT01117987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92730282|NCT01117987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730283|NCT01117987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730284|NCT02219490|Ritonavir|ritonavir|mesh-list
92730285|NCT02219490|Ribavirin|ribavirin|mesh-list
92730286|NCT02219490|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92730287|NCT02219490|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92730288|NCT02219490|Protease Inhibitors|protease inhibitors|mesh-ancestor
92730289|NCT02219490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730290|NCT02219490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730291|NCT02219490|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92730292|NCT02219490|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92730293|NCT02219490|Antiviral Agents|antiviral agents|mesh-ancestor
92730294|NCT02219490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730295|NCT02219490|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92730296|NCT02219490|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92730297|NCT02219490|Antimetabolites|antimetabolites|mesh-ancestor
92730300|NCT01117051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730301|NCT01117051|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92730302|NCT01117051|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92610514|NCT00142883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610515|NCT00142883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610516|NCT00142883|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92610517|NCT00142883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92017620|NCT04946929|Tinzaparin|tinzaparin|mesh-list
92730303|NCT01117051|Serotonin Agents|serotonin agents|mesh-ancestor
92730304|NCT01117051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730305|NCT01117051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730306|NCT01117051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730307|NCT02211417|Evening primrose oil|evening primrose oil|mesh-list
92730308|NCT02211417|Mineral Oil|mineral oil|mesh-list
92730309|NCT02211417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92730310|NCT02211417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730311|NCT02211417|Analgesics|analgesics|mesh-ancestor
92730312|NCT02211417|Sensory System Agents|sensory system agents|mesh-ancestor
92730313|NCT02211417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730314|NCT02211417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730315|NCT02211417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730316|NCT02211417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730317|NCT02211417|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92730318|NCT02211417|Antimetabolites|antimetabolites|mesh-ancestor
92730319|NCT02211417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730320|NCT02211417|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92730321|NCT02211417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92730322|NCT02211417|Emollients|emollients|mesh-ancestor
92730323|NCT02279121|Taurolidine|taurolidine|mesh-list
92730324|NCT02279121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92730325|NCT02279121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730326|NCT02279121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92730327|NCT02279121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730328|NCT02218164|Interferons|interferons|mesh-list
92730329|NCT02218164|Interferon-alpha|interferon-alpha|mesh-list
92730330|NCT02218164|Interferon alpha-2|interferon alpha-2|mesh-list
92730331|NCT02218164|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92730332|NCT02218164|Fluorouracil|fluorouracil|mesh-list
92730333|NCT02218164|Capecitabine|capecitabine|mesh-list
92730334|NCT02218164|Antimetabolites|antimetabolites|mesh-ancestor
92730335|NCT02218164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730336|NCT02218164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92730337|NCT02218164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730338|NCT02218164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92730339|NCT02218164|Immunologic Factors|immunologic factors|mesh-ancestor
92730340|NCT02218164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730341|NCT02218164|Antiviral Agents|antiviral agents|mesh-ancestor
92730342|NCT02218164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730343|NCT04552067|Enoxaparin|enoxaparin|mesh-list
92730344|NCT04552067|Anticoagulants|anticoagulants|mesh-ancestor
92730345|NCT04552067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92730346|NCT04552067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92730347|NCT04552067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730348|NCT01643187|Vitamins|vitamins|mesh-list
92730349|NCT01643187|Micronutrients|micronutrients|mesh-ancestor
92730350|NCT01643187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730351|NCT01643265|Caseins|caseins|mesh-list
92730352|NCT01643265|Chelating Agents|chelating agents|mesh-ancestor
92730353|NCT01643265|Sequestering Agents|sequestering agents|mesh-ancestor
92730354|NCT01643265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730355|NCT04551833|Levobupivacaine|levobupivacaine|mesh-list
92730356|NCT04551833|Anesthetics, Local|anesthetics, local|mesh-ancestor
92730357|NCT04551833|Anesthetics|anesthetics|mesh-ancestor
92730358|NCT04551833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730359|NCT04551833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730360|NCT04551833|Sensory System Agents|sensory system agents|mesh-ancestor
92730361|NCT04551833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730362|NCT04551755|Doxycycline|doxycycline|mesh-list
92730363|NCT04551755|Ivermectin|ivermectin|mesh-list
92730364|NCT04551755|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92730365|NCT04551755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730366|NCT04551755|Antimalarials|antimalarials|mesh-ancestor
92730367|NCT04551755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92610518|NCT00142883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610519|NCT00142883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92610520|NCT04517851|Elotuzumab|elotuzumab|mesh-list
92730368|NCT04551755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92730369|NCT01643499|Leucovorin|leucovorin|mesh-list
92730370|NCT01643499|Fluorouracil|fluorouracil|mesh-list
92730371|NCT01643499|Oxaliplatin|oxaliplatin|mesh-list
92730372|NCT01643499|Irinotecan|irinotecan|mesh-list
92730373|NCT01643499|Calcium|calcium|mesh-list
92730376|NCT01643499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730377|NCT01643499|Antimetabolites|antimetabolites|mesh-ancestor
92730378|NCT01643499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730379|NCT01643499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92730380|NCT01643499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730381|NCT01643499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92730382|NCT01643499|Immunologic Factors|immunologic factors|mesh-ancestor
92730383|NCT01643499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92730384|NCT01643499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92730385|NCT01643499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730386|NCT01643499|Antidotes|antidotes|mesh-ancestor
92730387|NCT01643499|Protective Agents|protective agents|mesh-ancestor
92730388|NCT01643499|Vitamin B Complex|vitamin b complex|mesh-ancestor
92730389|NCT01643499|Vitamins|vitamins|mesh-ancestor
92730390|NCT01643499|Micronutrients|micronutrients|mesh-ancestor
92730391|NCT01117012|Ivacaftor|ivacaftor|mesh-list
92730392|NCT01117012|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92730393|NCT01117012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730394|NCT01117012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730395|NCT01116739|Fluorides|fluorides|mesh-list
92730396|NCT01116739|Fluorides, Topical|fluorides, topical|mesh-list
92730397|NCT01116739|Cariostatic Agents|cariostatic agents|mesh-ancestor
92730398|NCT01116739|Protective Agents|protective agents|mesh-ancestor
92730399|NCT01116739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730400|NCT01640496|Vitamin D|vitamin d|mesh-list
92730401|NCT01640496|Cholecalciferol|cholecalciferol|mesh-list
92730402|NCT01640496|Vitamins|vitamins|mesh-ancestor
92730403|NCT01640496|Micronutrients|micronutrients|mesh-ancestor
92730404|NCT01640496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730405|NCT01640496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92730406|NCT01640496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730407|NCT04551248|Vaccines|vaccines|mesh-list
92730408|NCT04551248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92730409|NCT04551248|Immunologic Factors|immunologic factors|mesh-ancestor
92730410|NCT04551248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730411|NCT01640535|Cetirizine|cetirizine|mesh-list
92730412|NCT01640535|Montelukast|montelukast|mesh-list
92730413|NCT01640535|Levocetirizine|levocetirizine|mesh-list
92730414|NCT01640535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92730415|NCT01640535|Respiratory System Agents|respiratory system agents|mesh-ancestor
92730416|NCT01640535|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92730417|NCT01640535|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730418|NCT01640535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730419|NCT01640535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730420|NCT01640535|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92730421|NCT01640535|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92730422|NCT01640535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730423|NCT01640535|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92730424|NCT01640535|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92730425|NCT01640535|Histamine Antagonists|histamine antagonists|mesh-ancestor
92730426|NCT01640535|Histamine Agents|histamine agents|mesh-ancestor
92730427|NCT01640535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730429|NCT04550936|Isavuconazole|isavuconazole|mesh-list
92730430|NCT04550936|Antifungal Agents|antifungal agents|mesh-ancestor
92730431|NCT04550936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730432|NCT04550858|Rebamipide|rebamipide|mesh-list
92730433|NCT04550858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92730434|NCT04550858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730435|NCT04550858|Antioxidants|antioxidants|mesh-ancestor
92730436|NCT04550858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730437|NCT04550858|Protective Agents|protective agents|mesh-ancestor
92730438|NCT04550858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730439|NCT04550858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730440|NCT01640574|Chloroquine|chloroquine|mesh-list
92730441|NCT01640574|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92610522|NCT04515238|Venetoclax|venetoclax|mesh-list
92610523|NCT04515238|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92730442|NCT01640574|Piperaquine|piperaquine|mesh-list
92730443|NCT01640574|Artenimol|artenimol|mesh-list
92730444|NCT01640574|Artemisinins|artemisinins|mesh-list
92730445|NCT01640574|Amebicides|amebicides|mesh-ancestor
92730446|NCT01640574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92730447|NCT01640574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92730448|NCT01640574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730449|NCT01640574|Antimalarials|antimalarials|mesh-ancestor
92730453|NCT01640574|Analgesics|analgesics|mesh-ancestor
92730454|NCT01640574|Sensory System Agents|sensory system agents|mesh-ancestor
92730455|NCT01640574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730456|NCT01640574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730457|NCT01640574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730458|NCT01640574|Filaricides|filaricides|mesh-ancestor
92730459|NCT01640574|Antinematodal Agents|antinematodal agents|mesh-ancestor
92730460|NCT01640574|Anthelmintics|anthelmintics|mesh-ancestor
92730461|NCT01116427|Abatacept|abatacept|mesh-list
92730462|NCT01116427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92730463|NCT01116427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730464|NCT01116427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92730465|NCT01116427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730466|NCT01116427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92730467|NCT01116427|Immunologic Factors|immunologic factors|mesh-ancestor
92730468|NCT01116427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730469|NCT01116427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730470|NCT04529226|Haloperidol|haloperidol|mesh-list
92730471|NCT04529226|Pimozide|pimozide|mesh-list
92730472|NCT04529226|Olanzapine|olanzapine|mesh-list
92730473|NCT04529226|Risperidone|risperidone|mesh-list
92730474|NCT04529226|Haloperidol decanoate|haloperidol decanoate|mesh-list
92730475|NCT04529226|Clozapine|clozapine|mesh-list
92730476|NCT04529226|Amisulpride|amisulpride|mesh-list
92730477|NCT04529226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92730478|NCT04529226|Serotonin Agents|serotonin agents|mesh-ancestor
92730479|NCT04529226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730480|NCT04529226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730481|NCT04529226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730482|NCT04529226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92730483|NCT04529226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92730484|NCT04529226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730485|NCT04529226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92730486|NCT04529226|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92730487|NCT04529226|Dopamine Agents|dopamine agents|mesh-ancestor
92397654|NCT03758170|Hormones|hormones|mesh-ancestor
92730488|NCT04529226|Antiemetics|antiemetics|mesh-ancestor
92730489|NCT04529226|Autonomic Agents|autonomic agents|mesh-ancestor
92730490|NCT04529226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730491|NCT04529226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730492|NCT04529226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92730493|NCT04529226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92730494|NCT04529226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730495|NCT04529226|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92730496|NCT04529226|GABA Antagonists|gaba antagonists|mesh-ancestor
92730497|NCT04529226|GABA Agents|gaba agents|mesh-ancestor
92730498|NCT04529226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92730499|NCT04529226|Antidepressive Agents|antidepressive agents|mesh-ancestor
92730500|NCT04310683|Hormones|hormones|mesh-list
92730501|NCT04310683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730502|NCT04310683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730503|NCT04550702|Mirabegron|mirabegron|mesh-list
92730504|NCT04550702|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92730505|NCT04550702|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92730506|NCT04550702|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92730507|NCT04550702|Adrenergic Agents|adrenergic agents|mesh-ancestor
92730508|NCT04550702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730509|NCT04550702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730510|NCT04550702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730511|NCT04550702|Urological Agents|urological agents|mesh-ancestor
92730512|NCT01116232|Sirolimus|sirolimus|mesh-list
92730513|NCT01116232|Rituximab|rituximab|mesh-list
92730514|NCT01116232|Tacrolimus|tacrolimus|mesh-list
92730515|NCT01116232|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92610524|NCT04515238|Obinutuzumab|obinutuzumab|mesh-list
92610525|NCT04515238|Zanubrutinib|zanubrutinib|mesh-list
92610526|NCT04515238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610527|NCT04515238|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92610528|NCT04515238|Alkylating Agents|alkylating agents|mesh-ancestor
92610529|NCT04515238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610530|NCT04515238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610531|NCT04515238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92610532|NCT04515238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610533|NCT00142961|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92610534|NCT00142961|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92610535|NCT00142961|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92017635|NCT03058237|Baclofen|baclofen|mesh-list
92730516|NCT01116232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92730517|NCT01116232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730518|NCT01116232|Immunologic Factors|immunologic factors|mesh-ancestor
92730519|NCT01116232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730520|NCT01116232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730521|NCT01116232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92730525|NCT01116232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92730526|NCT01116232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730527|NCT01116232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92730528|NCT01116232|Antifungal Agents|antifungal agents|mesh-ancestor
92730529|NCT02214095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92730530|NCT04550351|Vaccines|vaccines|mesh-list
92730531|NCT04550351|Immunologic Factors|immunologic factors|mesh-ancestor
92730532|NCT04550351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730533|NCT01640691|Vaccines|vaccines|mesh-list
92730534|NCT01640691|Immunologic Factors|immunologic factors|mesh-ancestor
92730535|NCT01640691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730536|NCT01643889|Moxifloxacin|moxifloxacin|mesh-list
92730537|NCT01643889|Domperidone|domperidone|mesh-list
92730538|NCT01643889|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92730539|NCT01643889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730540|NCT01643889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92730541|NCT01643889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92730542|NCT01643889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730543|NCT01643889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730544|NCT01643889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730545|NCT01643889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730546|NCT01643889|Antiemetics|antiemetics|mesh-ancestor
92730547|NCT01643889|Autonomic Agents|autonomic agents|mesh-ancestor
92730548|NCT01643889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730549|NCT01643889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730550|NCT01643889|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92730551|NCT01643889|Dopamine Agents|dopamine agents|mesh-ancestor
92730552|NCT01643889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730553|NCT04550078|Calcium, Dietary|calcium, dietary|mesh-list
92730554|NCT04550078|Calcium Carbonate|calcium carbonate|mesh-list
92730555|NCT04550078|Calcium|calcium|mesh-list
92730556|NCT04550078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730557|NCT04550078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730558|NCT04550078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92730559|NCT04550078|Antacids|antacids|mesh-ancestor
92730560|NCT04550078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730561|NCT04550078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730562|NCT01205035|Ranibizumab|ranibizumab|mesh-list
92730563|NCT01205035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92730564|NCT01205035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92730565|NCT01205035|Growth Substances|growth substances|mesh-ancestor
92730566|NCT01205035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610536|NCT00142961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610537|NCT00142961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610538|NCT00142961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92610539|NCT00142961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610540|NCT00142961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730567|NCT01205035|Growth Inhibitors|growth inhibitors|mesh-ancestor
92730568|NCT01205035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730569|NCT04549844|Bupivacaine|bupivacaine|mesh-list
92730570|NCT04549844|Anesthetics, Local|anesthetics, local|mesh-ancestor
92730571|NCT04549844|Anesthetics|anesthetics|mesh-ancestor
92730572|NCT04549844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730573|NCT04549844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730574|NCT04549844|Sensory System Agents|sensory system agents|mesh-ancestor
92730575|NCT04549844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730576|NCT01644084|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92730577|NCT01644084|Plasma Substitutes|plasma substitutes|mesh-ancestor
92730578|NCT01644084|Blood Substitutes|blood substitutes|mesh-ancestor
92730579|NCT01204918|Riluzole|riluzole|mesh-list
92730580|NCT01204918|Anticonvulsants|anticonvulsants|mesh-ancestor
92730581|NCT01204918|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92730582|NCT01204918|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92730583|NCT01204918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730584|NCT01204918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730585|NCT01204918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730586|NCT01204918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92730587|NCT01204918|Protective Agents|protective agents|mesh-ancestor
92730588|NCT04528797|Methylprednisolone|methylprednisolone|mesh-list
92730589|NCT04528797|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92730590|NCT04528797|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92730591|NCT04528797|Prednisolone|prednisolone|mesh-list
92730592|NCT04528797|Prednisolone acetate|prednisolone acetate|mesh-list
92730593|NCT04528797|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92730599|NCT04528797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730600|NCT04528797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92730601|NCT04528797|Glucocorticoids|glucocorticoids|mesh-ancestor
92730602|NCT04528797|Hormones|hormones|mesh-ancestor
92730603|NCT04528797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730604|NCT04528797|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92730605|NCT04528797|Protective Agents|protective agents|mesh-ancestor
92730606|NCT04528797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92730607|NCT04528797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730608|NCT00624481|Teriparatide|teriparatide|mesh-list
92730609|NCT00624481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730610|NCT00624481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730611|NCT00624481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92730612|NCT04529187|Midazolam|midazolam|mesh-list
92730613|NCT04529187|Dexmedetomidine|dexmedetomidine|mesh-list
92730614|NCT04529187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92730615|NCT04529187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730616|NCT04529187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397667|NCT03704285|Propofol|propofol|mesh-list
92730617|NCT04529187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730618|NCT04529187|Analgesics|analgesics|mesh-ancestor
92730619|NCT04529187|Sensory System Agents|sensory system agents|mesh-ancestor
92730620|NCT04529187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730621|NCT04529187|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92730622|NCT04529187|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92730623|NCT04529187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92730624|NCT04529187|Adrenergic Agents|adrenergic agents|mesh-ancestor
92730625|NCT04529187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730626|NCT04529187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730627|NCT04529187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92730628|NCT04529187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92730629|NCT04529187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92730630|NCT04529187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92730631|NCT04529187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92730632|NCT04529187|Anesthetics, General|anesthetics, general|mesh-ancestor
92730633|NCT04529187|Anesthetics|anesthetics|mesh-ancestor
92730634|NCT04529187|GABA Modulators|gaba modulators|mesh-ancestor
92610541|NCT00163254|Abciximab|abciximab|mesh-list
92610542|NCT00163254|Anticoagulants|anticoagulants|mesh-ancestor
92730635|NCT04529187|GABA Agents|gaba agents|mesh-ancestor
92730636|NCT04549415|Metformin|metformin|mesh-list
92730637|NCT04549415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92730638|NCT04549415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730639|NCT02214368|Propofol|propofol|mesh-list
92730640|NCT02214368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92730641|NCT02214368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730642|NCT02214368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730643|NCT02214368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92730644|NCT02214368|Anesthetics, General|anesthetics, general|mesh-ancestor
92730645|NCT02214368|Anesthetics|anesthetics|mesh-ancestor
92730646|NCT01204294|Metformin|metformin|mesh-list
92730647|NCT01204294|Linagliptin|linagliptin|mesh-list
92730648|NCT01204294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92730649|NCT01204294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730650|NCT01204294|Incretins|incretins|mesh-ancestor
92730651|NCT01204294|Hormones|hormones|mesh-ancestor
92730652|NCT01204294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730653|NCT01204294|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92730654|NCT01204294|Protease Inhibitors|protease inhibitors|mesh-ancestor
92730655|NCT01204294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730656|NCT01204294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730657|NCT01182181|Anastrozole|anastrozole|mesh-list
92730658|NCT01182181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92730659|NCT01182181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730660|NCT01182181|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92730661|NCT01182181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92730662|NCT01182181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730663|NCT01182181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730664|NCT01182181|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92730667|NCT01182181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730670|NCT01181986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730671|NCT01181986|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92730672|NCT01181986|Incretins|incretins|mesh-ancestor
92730673|NCT01181986|Hormones|hormones|mesh-ancestor
92730674|NCT01181986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730675|NCT04315909|Vitamin E|vitamin e|mesh-list
92730676|NCT04315909|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92730677|NCT04315909|Vitamins|vitamins|mesh-ancestor
92730678|NCT04315909|Micronutrients|micronutrients|mesh-ancestor
92730679|NCT04315909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730680|NCT04315909|Antioxidants|antioxidants|mesh-ancestor
92730681|NCT04315909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730682|NCT04315909|Protective Agents|protective agents|mesh-ancestor
92730683|NCT04315909|Hemostatics|hemostatics|mesh-ancestor
92730684|NCT04315909|Coagulants|coagulants|mesh-ancestor
92730685|NCT01181167|Enoxaparin|enoxaparin|mesh-list
92730686|NCT01181167|Enoxaparin sodium|enoxaparin sodium|mesh-list
92730687|NCT01181167|Edoxaban|edoxaban|mesh-list
92730688|NCT01181167|Anticoagulants|anticoagulants|mesh-ancestor
92730689|NCT01181167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92730690|NCT01181167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92730691|NCT01181167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730692|NCT01181167|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92730693|NCT01181167|Antithrombins|antithrombins|mesh-ancestor
92730694|NCT01181167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92730695|NCT01181167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92730696|NCT01181167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730697|NCT04548557|Immunoglobulins|immunoglobulins|mesh-list
92730698|NCT04548557|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92730699|NCT04548557|Antibodies|antibodies|mesh-list
92730700|NCT04548557|gamma-Globulins|gamma-globulins|mesh-list
92730701|NCT04548557|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92730702|NCT04548557|Immunologic Factors|immunologic factors|mesh-ancestor
92730703|NCT04548557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730704|NCT01181128|Factor VIII|factor viii|mesh-list
92730705|NCT01181128|Coagulants|coagulants|mesh-ancestor
92730706|NCT04548401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92730707|NCT04548284|Glucocorticoids|glucocorticoids|mesh-list
92730708|NCT04548284|Hormones|hormones|mesh-ancestor
92730709|NCT04548284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730710|NCT04548284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730711|NCT04547894|TMC-310911|tmc-310911|mesh-list
92730712|NCT04547894|Protease Inhibitors|protease inhibitors|mesh-ancestor
92730713|NCT04547894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610543|NCT00163254|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92610545|NCT00143000|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92610546|NCT00143000|Antimetabolites|antimetabolites|mesh-ancestor
92610547|NCT00143000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017652|NCT04410991|Teriflunomide|teriflunomide|mesh-list
92730714|NCT04547894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730715|NCT01641315|Immunoglobulins|immunoglobulins|mesh-list
92730716|NCT01641315|Immunologic Factors|immunologic factors|mesh-ancestor
92730717|NCT01641315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730718|NCT01644825|Paclitaxel|paclitaxel|mesh-list
92730719|NCT01644825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92730720|NCT01644825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730721|NCT01644825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92730722|NCT01644825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92730723|NCT01644825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92730724|NCT01644825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730725|NCT01644864|Ropivacaine|ropivacaine|mesh-list
92730726|NCT01644864|Anesthetics, Local|anesthetics, local|mesh-ancestor
92730727|NCT01644864|Anesthetics|anesthetics|mesh-ancestor
92730728|NCT01644864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730729|NCT01644864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730730|NCT01644864|Sensory System Agents|sensory system agents|mesh-ancestor
92730731|NCT01644864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730733|NCT04547855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92730734|NCT04547855|Alkylating Agents|alkylating agents|mesh-ancestor
92730735|NCT04547855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730736|NCT04547855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730737|NCT01641510|Clopidogrel|clopidogrel|mesh-list
92730738|NCT01641510|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92730739|NCT01641510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92730743|NCT01641510|Purinergic Agents|purinergic agents|mesh-ancestor
92730744|NCT01641510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730745|NCT01641510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730746|NCT01641510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730747|NCT04547621|Temozolomide|temozolomide|mesh-list
92730748|NCT04547621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92730749|NCT04547621|Alkylating Agents|alkylating agents|mesh-ancestor
92730750|NCT04547621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730751|NCT04547621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730752|NCT01641549|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92730753|NCT01641549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92730754|NCT01641549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730755|NCT04547348|Denosumab|denosumab|mesh-list
92730756|NCT04547348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92730757|NCT04547348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730758|NCT04547426|Nicotine|nicotine|mesh-list
92730759|NCT04547426|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92730760|NCT04547426|Autonomic Agents|autonomic agents|mesh-ancestor
92730761|NCT04547426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730762|NCT04547426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730763|NCT04547426|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92730764|NCT04547426|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92730765|NCT04547426|Cholinergic Agents|cholinergic agents|mesh-ancestor
92730766|NCT04547426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730767|NCT04547426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730768|NCT01641666|Ribavirin|ribavirin|mesh-list
92730769|NCT01641666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92730770|NCT01641666|Interferon-alpha|interferon-alpha|mesh-list
92730771|NCT01641666|Antimetabolites|antimetabolites|mesh-ancestor
92730772|NCT01641666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730773|NCT01641666|Antiviral Agents|antiviral agents|mesh-ancestor
92730774|NCT01641666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730775|NCT01641666|Immunologic Factors|immunologic factors|mesh-ancestor
92730776|NCT01641666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730777|NCT01203787|Sorafenib|sorafenib|mesh-list
92730778|NCT01203787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610548|NCT00143000|Antiviral Agents|antiviral agents|mesh-ancestor
92610549|NCT00143000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610550|NCT04514029|Dexamethasone|dexamethasone|mesh-list
92610551|NCT04514029|Simvastatin|simvastatin|mesh-list
92610552|NCT04514029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730779|NCT01203787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92730780|NCT01203787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730781|NCT01203787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730782|NCT04547504|Pembrolizumab|pembrolizumab|mesh-list
92730783|NCT04547504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92730784|NCT04547504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730785|NCT04547504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397722|NCT03360214|Bupivacaine|bupivacaine|mesh-list
92730786|NCT04547504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730787|NCT01645254|Antimalarials|antimalarials|mesh-list
92730788|NCT01645254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92730789|NCT01645254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92730790|NCT01645254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730791|NCT01181011|Amlodipine|amlodipine|mesh-list
92730792|NCT01181011|Telmisartan|telmisartan|mesh-list
92730793|NCT01181011|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92730794|NCT01181011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92730795|NCT01181011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92730796|NCT01181011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730797|NCT01181011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730798|NCT01181011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730799|NCT01181011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730800|NCT01181011|Vasodilator Agents|vasodilator agents|mesh-ancestor
92730801|NCT01181011|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92730802|NCT01181011|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92730803|NCT01641783|Paclitaxel|paclitaxel|mesh-list
92730804|NCT01641783|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92730805|NCT01641783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92730806|NCT01641783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730807|NCT01641783|Tubulin Modulators|tubulin modulators|mesh-ancestor
92730810|NCT01641783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730811|NCT02214602|Doxorubicin|doxorubicin|mesh-list
92730812|NCT02214602|Epirubicin|epirubicin|mesh-list
92730813|NCT02214602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92730814|NCT02214602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730815|NCT02214602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92730816|NCT02214602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92730817|NCT02214602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730818|NCT02214602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730819|NCT01646580|Ciclopirox|ciclopirox|mesh-list
92730820|NCT01646580|Antifungal Agents|antifungal agents|mesh-ancestor
92730821|NCT01646580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730822|NCT04546802|Grazoprevir|grazoprevir|mesh-list
92730823|NCT04546802|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92730824|NCT04546802|Antiviral Agents|antiviral agents|mesh-ancestor
92730825|NCT04546802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730826|NCT01580033|Vaccines|vaccines|mesh-list
92730827|NCT01580033|Immunologic Factors|immunologic factors|mesh-ancestor
92730828|NCT01580033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730829|NCT04546373|Niraparib|niraparib|mesh-list
92730830|NCT04546373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92730831|NCT04546373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730832|NCT04546373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730833|NCT04546373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730834|NCT01645410|Atorvastatin|atorvastatin|mesh-list
92730835|NCT01645410|Calcium|calcium|mesh-list
92730836|NCT01645410|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730837|NCT01645410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730838|NCT01645410|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92730839|NCT01645410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92730840|NCT01645410|Antimetabolites|antimetabolites|mesh-ancestor
92730841|NCT01645410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730842|NCT01645410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92730843|NCT01645410|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92610553|NCT04514029|Antiemetics|antiemetics|mesh-ancestor
92610554|NCT04514029|Autonomic Agents|autonomic agents|mesh-ancestor
92730844|NCT01645410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730845|NCT04546334|Magnesium Sulfate|magnesium sulfate|mesh-list
92730846|NCT04546334|Analgesics|analgesics|mesh-ancestor
92730847|NCT04546334|Sensory System Agents|sensory system agents|mesh-ancestor
92730848|NCT04546334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730849|NCT04546334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730850|NCT04546334|Anesthetics|anesthetics|mesh-ancestor
92730851|NCT04546334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730852|NCT04546334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92730853|NCT04546334|Anticonvulsants|anticonvulsants|mesh-ancestor
92730854|NCT04546334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92730855|NCT04546334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730856|NCT04546334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730857|NCT04546334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730858|NCT04546334|Tocolytic Agents|tocolytic agents|mesh-ancestor
92730859|NCT04546334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92730860|NCT04546256|Fluticasone|fluticasone|mesh-list
92730862|NCT04546256|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92730863|NCT04546256|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92730864|NCT04546256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730865|NCT04546256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92730866|NCT04546256|Autonomic Agents|autonomic agents|mesh-ancestor
92730867|NCT04546256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730868|NCT04546256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730869|NCT04546256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92730870|NCT04546256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92730871|NCT04546256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92730872|NCT04546256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92730873|NCT04546256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92730874|NCT04546256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92730875|NCT04546256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92730876|NCT04546256|Adrenergic Agents|adrenergic agents|mesh-ancestor
92730877|NCT04546256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730878|NCT04546256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730879|NCT04546256|Glucocorticoids|glucocorticoids|mesh-ancestor
92730901|NCT02214680|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92730902|NCT02214680|Adrenergic Agents|adrenergic agents|mesh-ancestor
92730903|NCT02214680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730904|NCT02214680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730905|NCT02214680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730906|NCT02214680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92730907|NCT02214680|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92730908|NCT02214680|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92730909|NCT02214680|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92730910|NCT02214680|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92730911|NCT02756208|Vaccines|vaccines|mesh-list
92730912|NCT02756208|Immunologic Factors|immunologic factors|mesh-ancestor
92730913|NCT02756208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730914|NCT04545788|Linezolid|linezolid|mesh-list
92730915|NCT04545788|Cycloserine|cycloserine|mesh-list
92730916|NCT04545788|Bedaquiline|bedaquiline|mesh-list
92730917|NCT04545788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92730918|NCT04545788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730919|NCT04545788|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92730920|NCT04545788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730921|NCT04545788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730922|NCT04545788|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92730923|NCT04545788|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92730924|NCT04545788|Antitubercular Agents|antitubercular agents|mesh-ancestor
92730925|NCT04545788|Antimetabolites|antimetabolites|mesh-ancestor
92730926|NCT02756013|Paclitaxel|paclitaxel|mesh-list
92730927|NCT02756013|Carboplatin|carboplatin|mesh-list
92730928|NCT02756013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92730929|NCT02756013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730930|NCT02756013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92730931|NCT02756013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92730932|NCT02756013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92730941|NCT01680042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92730942|NCT04545710|Osimertinib|osimertinib|mesh-list
92730943|NCT04545710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730944|NCT04545710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92610555|NCT04514029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610556|NCT04514029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610557|NCT04514029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610559|NCT04514029|Hormones|hormones|mesh-ancestor
92730945|NCT04545710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730946|NCT04545710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730947|NCT01646229|Polymyxins|polymyxins|mesh-list
92730948|NCT01646229|Polymyxin B|polymyxin b|mesh-list
92730949|NCT01646229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92730950|NCT01646229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730951|NCT01680081|Adenosine|adenosine|mesh-list
92730952|NCT01680081|Analgesics|analgesics|mesh-ancestor
92730953|NCT01680081|Sensory System Agents|sensory system agents|mesh-ancestor
92730954|NCT01680081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730955|NCT01680081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730956|NCT01680081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92730957|NCT01680081|Vasodilator Agents|vasodilator agents|mesh-ancestor
92730958|NCT01680081|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92730959|NCT01680081|Purinergic Agonists|purinergic agonists|mesh-ancestor
92730960|NCT01680081|Purinergic Agents|purinergic agents|mesh-ancestor
92730961|NCT01680081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92730962|NCT01680081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730963|NCT01646307|Atorvastatin|atorvastatin|mesh-list
92730964|NCT01646307|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92730965|NCT01646307|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92730966|NCT01646307|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92730967|NCT01646307|Antimetabolites|antimetabolites|mesh-ancestor
92730968|NCT01646307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730969|NCT01646307|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92730970|NCT01646307|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92730971|NCT01646307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730972|NCT04544969|Cisplatin|cisplatin|mesh-list
92730973|NCT04544969|Gemcitabine|gemcitabine|mesh-list
92730974|NCT04544969|Docetaxel|docetaxel|mesh-list
92730975|NCT04544969|Fluorouracil|fluorouracil|mesh-list
92730976|NCT04544969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92730977|NCT04544969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92730978|NCT04544969|Antimetabolites|antimetabolites|mesh-ancestor
92730979|NCT04544969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730980|NCT04544969|Tubulin Modulators|tubulin modulators|mesh-ancestor
92730981|NCT04544969|Antimitotic Agents|antimitotic agents|mesh-ancestor
92730982|NCT04544969|Mitosis Modulators|mitosis modulators|mesh-ancestor
92730983|NCT04544969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92730984|NCT04544969|Immunologic Factors|immunologic factors|mesh-ancestor
92730985|NCT04544969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730986|NCT04541732|Anesthetics|anesthetics|mesh-list
92730987|NCT04541732|Propofol|propofol|mesh-list
92730988|NCT04541732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730989|NCT04541732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730990|NCT04541732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92730991|NCT04541732|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92730992|NCT04541732|Anesthetics, General|anesthetics, general|mesh-ancestor
92730993|NCT01680471|Midazolam|midazolam|mesh-list
92730994|NCT01680471|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92730995|NCT01680471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92730996|NCT01680471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92730997|NCT01680471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730998|NCT01680471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92731001|NCT01680471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92731002|NCT01680471|Anesthetics, General|anesthetics, general|mesh-ancestor
92731003|NCT01680471|Anesthetics|anesthetics|mesh-ancestor
92731004|NCT01680471|GABA Modulators|gaba modulators|mesh-ancestor
92731005|NCT01680471|GABA Agents|gaba agents|mesh-ancestor
92731006|NCT01680471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731007|NCT01680471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731008|NCT02279316|Vitamin D|vitamin d|mesh-list
92731009|NCT02279316|Cholecalciferol|cholecalciferol|mesh-list
92731010|NCT02279316|Vitamins|vitamins|mesh-ancestor
92731011|NCT02279316|Micronutrients|micronutrients|mesh-ancestor
92731012|NCT02279316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731013|NCT02279316|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92610560|NCT04514029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731014|NCT02279316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731015|NCT04544306|Anti-Infective Agents|anti-infective agents|mesh-list
92731016|NCT04544306|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92731018|NCT04544228|Bupivacaine|bupivacaine|mesh-list
92731019|NCT04544228|Neostigmine|neostigmine|mesh-list
92731020|NCT04544228|Anesthetics, Local|anesthetics, local|mesh-ancestor
92731021|NCT04544228|Anesthetics|anesthetics|mesh-ancestor
92731022|NCT04544228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731023|NCT04544228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731024|NCT04544228|Sensory System Agents|sensory system agents|mesh-ancestor
92731025|NCT04544228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731026|NCT04544228|Analgesics|analgesics|mesh-ancestor
92731027|NCT04544228|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92731028|NCT04544228|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92731029|NCT04544228|Anesthetics, General|anesthetics, general|mesh-ancestor
92731030|NCT04544228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92731031|NCT04544228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92731032|NCT04544228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731033|NCT04544228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731034|NCT04544228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92731035|NCT04544228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731036|NCT04544228|Cholinergic Agents|cholinergic agents|mesh-ancestor
92731037|NCT04544228|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92731038|NCT04544228|Autonomic Agents|autonomic agents|mesh-ancestor
92731039|NCT01646736|Cyclophosphamide|cyclophosphamide|mesh-list
92731040|NCT01646736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731041|NCT01646736|Immunologic Factors|immunologic factors|mesh-ancestor
92731042|NCT01646736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731043|NCT01646736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731044|NCT01646736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92731045|NCT01646736|Alkylating Agents|alkylating agents|mesh-ancestor
92731046|NCT01646736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731047|NCT01646736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731048|NCT01646736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92731049|NCT04542005|Albuterol|albuterol|mesh-list
92731050|NCT04542005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92731051|NCT04542005|Autonomic Agents|autonomic agents|mesh-ancestor
92731052|NCT04542005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731053|NCT04542005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731054|NCT04542005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92731055|NCT04542005|Respiratory System Agents|respiratory system agents|mesh-ancestor
92731056|NCT04542005|Tocolytic Agents|tocolytic agents|mesh-ancestor
92731057|NCT04542005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92731058|NCT04542005|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92731059|NCT04542005|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92731060|NCT04542005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92731061|NCT04542005|Adrenergic Agents|adrenergic agents|mesh-ancestor
92731062|NCT04542005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731063|NCT04542005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731064|NCT01646775|Fentanyl|fentanyl|mesh-list
92731065|NCT01646775|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92731066|NCT01646775|Narcotics|narcotics|mesh-ancestor
92731067|NCT01646775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731068|NCT01646775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731069|NCT01646775|Analgesics|analgesics|mesh-ancestor
92731070|NCT01646775|Sensory System Agents|sensory system agents|mesh-ancestor
92731071|NCT01646775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731077|NCT01646853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731078|NCT01646853|Antimetabolites|antimetabolites|mesh-ancestor
92731079|NCT01646853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731080|NCT01646853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92731081|NCT01646853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731082|NCT01646853|Immunologic Factors|immunologic factors|mesh-ancestor
92731083|NCT01646853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731084|NCT01647165|Dexamethasone|dexamethasone|mesh-list
92731085|NCT01647165|Lenalidomide|lenalidomide|mesh-list
92731086|NCT01647165|Bortezomib|bortezomib|mesh-list
92731087|NCT01647165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92610562|NCT04514029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731088|NCT01647165|Antiemetics|antiemetics|mesh-ancestor
92731089|NCT01647165|Autonomic Agents|autonomic agents|mesh-ancestor
92731090|NCT01647165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731091|NCT01647165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731092|NCT01647165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731093|NCT01647165|Glucocorticoids|glucocorticoids|mesh-ancestor
92731094|NCT01647165|Hormones|hormones|mesh-ancestor
92731095|NCT01647165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731096|NCT01647165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92731097|NCT01647165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731098|NCT01647165|Immunologic Factors|immunologic factors|mesh-ancestor
92731099|NCT01647165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92731100|NCT01647165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92731101|NCT01647165|Growth Substances|growth substances|mesh-ancestor
92731102|NCT01647165|Growth Inhibitors|growth inhibitors|mesh-ancestor
92731103|NCT01681134|Tacrolimus|tacrolimus|mesh-list
92731104|NCT01681134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731105|NCT01681134|Immunologic Factors|immunologic factors|mesh-ancestor
92731106|NCT01681134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731107|NCT01681134|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92731108|NCT01681134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731109|NCT01681134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731110|NCT04543916|Irinotecan|irinotecan|mesh-list
92731111|NCT04543916|Venetoclax|venetoclax|mesh-list
92731112|NCT04543916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92731113|NCT04543916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92731114|NCT04543916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731115|NCT04543916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731116|NCT04543916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731117|NCT04541147|Dexamethasone|dexamethasone|mesh-list
92731118|NCT04541147|Analgesics|analgesics|mesh-list
92731119|NCT04541147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731120|NCT04541147|Antiemetics|antiemetics|mesh-ancestor
92731121|NCT04541147|Autonomic Agents|autonomic agents|mesh-ancestor
92731122|NCT04541147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731123|NCT04541147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731124|NCT04541147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731125|NCT04541147|Glucocorticoids|glucocorticoids|mesh-ancestor
92731126|NCT04541147|Hormones|hormones|mesh-ancestor
92731127|NCT04541147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731128|NCT04541147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92731129|NCT04541147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731130|NCT04541147|Sensory System Agents|sensory system agents|mesh-ancestor
92731131|NCT04541303|Tranexamic Acid|tranexamic acid|mesh-list
92731132|NCT04541303|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92731133|NCT04541303|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92731134|NCT04541303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731135|NCT04541303|Hemostatics|hemostatics|mesh-ancestor
92731136|NCT04541303|Coagulants|coagulants|mesh-ancestor
92731137|NCT02214992|Telmisartan|telmisartan|mesh-list
92731138|NCT02214992|Ramipril|ramipril|mesh-list
92731139|NCT02214992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92731140|NCT02214992|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92731141|NCT02214992|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92731142|NCT02214992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731145|NCT02214992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731146|NCT04528095|Clozapine|clozapine|mesh-list
92731147|NCT04528095|Amisulpride|amisulpride|mesh-list
92731148|NCT04528095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92731149|NCT04528095|Serotonin Agents|serotonin agents|mesh-ancestor
92731150|NCT04528095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731151|NCT04528095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731152|NCT04528095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731153|NCT04528095|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92731154|NCT04528095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92731155|NCT04528095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731156|NCT04528095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731157|NCT04528095|GABA Antagonists|gaba antagonists|mesh-ancestor
92731158|NCT04528095|GABA Agents|gaba agents|mesh-ancestor
92731159|NCT04528095|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92731160|NCT04528095|Dopamine Agents|dopamine agents|mesh-ancestor
92610563|NCT04514029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92610564|NCT04514029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92610565|NCT04514029|Antimetabolites|antimetabolites|mesh-ancestor
92731161|NCT04528095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92731162|NCT04528095|Antidepressive Agents|antidepressive agents|mesh-ancestor
92731163|NCT04528056|Sulfasalazine|sulfasalazine|mesh-list
92731164|NCT04528056|Ambrisentan|ambrisentan|mesh-list
92731165|NCT04528056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731166|NCT04528056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92731167|NCT04528056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92731168|NCT04528056|Analgesics|analgesics|mesh-ancestor
92731169|NCT04528056|Sensory System Agents|sensory system agents|mesh-ancestor
92731170|NCT04528056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731171|NCT04528056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731172|NCT04528056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731173|NCT04528056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731174|NCT04528056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731175|NCT04528056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92731176|NCT04543565|Tenofovir|tenofovir|mesh-list
92731178|NCT04543565|Antiviral Agents|antiviral agents|mesh-ancestor
92731179|NCT04543565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731180|NCT04543565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92731181|NCT04543565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92731182|NCT04543565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731183|NCT04543565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731184|NCT04543565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92731185|NCT04543565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92731186|NCT01647555|Cetuximab|cetuximab|mesh-list
92731187|NCT01647555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92731188|NCT01647555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731189|NCT04543370|Deflazacort|deflazacort|mesh-list
92731190|NCT04543370|Midazolam|midazolam|mesh-list
92731191|NCT04543370|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92731192|NCT04543370|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92731193|NCT04543370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731194|NCT04543370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731195|NCT04543370|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92731196|NCT04543370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92731197|NCT04543370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731198|NCT04543370|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92731199|NCT04543370|Anesthetics, General|anesthetics, general|mesh-ancestor
92731200|NCT04543370|Anesthetics|anesthetics|mesh-ancestor
92731201|NCT04543370|GABA Modulators|gaba modulators|mesh-ancestor
92731202|NCT04543370|GABA Agents|gaba agents|mesh-ancestor
92731203|NCT04543370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731204|NCT04543370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731205|NCT04543370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731206|NCT04543370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731207|NCT04543370|Immunologic Factors|immunologic factors|mesh-ancestor
92731208|NCT01681563|Cyclophosphamide|cyclophosphamide|mesh-list
92731209|NCT01681563|Ofatumumab|ofatumumab|mesh-list
92731210|NCT01681563|Pentostatin|pentostatin|mesh-list
92731211|NCT01681563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731212|NCT01681563|Immunologic Factors|immunologic factors|mesh-ancestor
92731213|NCT01681563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731214|NCT01681563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731215|NCT01681563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92731216|NCT01681563|Alkylating Agents|alkylating agents|mesh-ancestor
92731217|NCT01681563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731219|NCT01681563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92731220|NCT01681563|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92731221|NCT01681563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731222|NCT01681680|Metformin|metformin|mesh-list
92731223|NCT01681680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92731224|NCT01681680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731225|NCT01647633|Calcium|calcium|mesh-list
92731226|NCT01647633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731227|NCT01647633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731228|NCT01647672|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92731229|NCT01647672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731230|NCT01647984|Vitamins|vitamins|mesh-list
92731231|NCT01647984|Vitamin E|vitamin e|mesh-list
92731232|NCT01647984|Vitamin B Complex|vitamin b complex|mesh-list
92731233|NCT01647984|Micronutrients|micronutrients|mesh-ancestor
92610566|NCT04514029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335633|NCT02070744|Ivacaftor|ivacaftor|mesh-list
92731234|NCT01647984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731235|NCT01647984|Antioxidants|antioxidants|mesh-ancestor
92731236|NCT01647984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731237|NCT01647984|Protective Agents|protective agents|mesh-ancestor
92731238|NCT02215382|Atropine|atropine|mesh-list
92731239|NCT02215382|Neostigmine|neostigmine|mesh-list
92731240|NCT02215382|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92731241|NCT02215382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92731242|NCT02215382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92731243|NCT02215382|Autonomic Agents|autonomic agents|mesh-ancestor
92731244|NCT02215382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731245|NCT02215382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731246|NCT02215382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92731247|NCT02215382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92731248|NCT02215382|Mydriatics|mydriatics|mesh-ancestor
92731249|NCT02215382|Parasympatholytics|parasympatholytics|mesh-ancestor
92731250|NCT02215382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92731251|NCT02215382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92731252|NCT02215382|Cholinergic Agents|cholinergic agents|mesh-ancestor
92731253|NCT02215382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731254|NCT02215382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731255|NCT02215382|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92731256|NCT02215382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731257|NCT02215382|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92731258|NCT01682109|Valacyclovir|valacyclovir|mesh-list
92731259|NCT01682109|Antiviral Agents|antiviral agents|mesh-ancestor
92731260|NCT01682109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731261|NCT02215148|Tolvaptan|tolvaptan|mesh-list
92731262|NCT02215148|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92731263|NCT02215148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731264|NCT02215148|Natriuretic Agents|natriuretic agents|mesh-ancestor
92731265|NCT02215148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731266|NCT01682343|Calcium|calcium|mesh-list
92731267|NCT01682343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731268|NCT01682343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731269|NCT01648257|Cabotegravir|cabotegravir|mesh-list
92731270|NCT01648257|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92731271|NCT01648257|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92731272|NCT01648257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731273|NCT01648257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731274|NCT01648257|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92731275|NCT01648257|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92731276|NCT01648257|Antiviral Agents|antiviral agents|mesh-ancestor
92731277|NCT01648257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731278|NCT02215460|Chlorhexidine|chlorhexidine|mesh-list
92731279|NCT02215460|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92731280|NCT02215460|Azithromycin|azithromycin|mesh-list
92731281|NCT02215460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92731282|NCT02215460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731283|NCT02215460|Disinfectants|disinfectants|mesh-ancestor
92731284|NCT02215460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92731285|NCT02215460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92731286|NCT02215499|Sodium Oxybate|sodium oxybate|mesh-list
92731287|NCT02215499|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92731288|NCT02215499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92731289|NCT02215499|Anesthetics, General|anesthetics, general|mesh-ancestor
92731290|NCT02215499|Anesthetics|anesthetics|mesh-ancestor
92731291|NCT02215499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731292|NCT02215499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731295|NCT01648608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92731296|NCT01648608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92731297|NCT01648608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731298|NCT01648608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731299|NCT01648608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92731300|NCT01648608|Hormone Antagonists|hormone antagonists|mesh-ancestor
92731301|NCT01648608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731302|NCT01648608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731303|NCT02215538|Methylphenidate|methylphenidate|mesh-list
92731304|NCT02215538|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92610567|NCT04514029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92610568|NCT04514029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92731305|NCT02215538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731306|NCT02215538|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92731307|NCT02215538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92731308|NCT02215538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731309|NCT02215538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731310|NCT02215538|Dopamine Agents|dopamine agents|mesh-ancestor
92731311|NCT02215538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731312|NCT01682421|Dexamethasone|dexamethasone|mesh-list
92731313|NCT01682421|Dexamethasone acetate|dexamethasone acetate|mesh-list
92731315|NCT01682421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731316|NCT01682421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731317|NCT01682421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731318|NCT01682421|Antiemetics|antiemetics|mesh-ancestor
92731319|NCT01682421|Autonomic Agents|autonomic agents|mesh-ancestor
92731320|NCT01682421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731321|NCT01682421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731322|NCT01682421|Glucocorticoids|glucocorticoids|mesh-ancestor
92731323|NCT01682421|Hormones|hormones|mesh-ancestor
92731324|NCT01682421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731325|NCT01682421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92731326|NCT01682421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731327|NCT01682421|Protease Inhibitors|protease inhibitors|mesh-ancestor
92731328|NCT01682421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731329|NCT01682499|Calcium, Dietary|calcium, dietary|mesh-list
92731330|NCT01682499|Magnesium Sulfate|magnesium sulfate|mesh-list
92731331|NCT01682499|Calcium|calcium|mesh-list
92731332|NCT01682499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731333|NCT01682499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731334|NCT01682499|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92731335|NCT01682499|Analgesics|analgesics|mesh-ancestor
92731336|NCT01682499|Sensory System Agents|sensory system agents|mesh-ancestor
92731337|NCT01682499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731338|NCT01682499|Anesthetics|anesthetics|mesh-ancestor
92731339|NCT01682499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731340|NCT01682499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92731341|NCT01682499|Anticonvulsants|anticonvulsants|mesh-ancestor
92731342|NCT01682499|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92731343|NCT01682499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731344|NCT01682499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731345|NCT01682499|Tocolytic Agents|tocolytic agents|mesh-ancestor
92731346|NCT01682499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92731347|NCT04540055|Anesthetics|anesthetics|mesh-list
92731348|NCT04540055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731349|NCT04540055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731350|NCT01180660|Lidocaine|lidocaine|mesh-list
92731351|NCT01180660|Anesthetics, Local|anesthetics, local|mesh-ancestor
92731352|NCT01180660|Anesthetics|anesthetics|mesh-ancestor
92731353|NCT01180660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731354|NCT01180660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731355|NCT01180660|Sensory System Agents|sensory system agents|mesh-ancestor
92731356|NCT01180660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731357|NCT01180660|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92731358|NCT01180660|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92731359|NCT01180660|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92731360|NCT01180660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731361|NCT01180660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731362|NCT01648881|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92731365|NCT01202227|Pregabalin|pregabalin|mesh-list
92731366|NCT01202227|Analgesics|analgesics|mesh-ancestor
92731367|NCT01202227|Sensory System Agents|sensory system agents|mesh-ancestor
92731368|NCT01202227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731369|NCT01202227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731370|NCT01202227|Anticonvulsants|anticonvulsants|mesh-ancestor
92731371|NCT01202227|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92731372|NCT01202227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731373|NCT01202227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610569|NCT04514029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610570|NCT02590393|Nicotine|nicotine|mesh-list
92610571|NCT02590393|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92610572|NCT02590393|Autonomic Agents|autonomic agents|mesh-ancestor
92731374|NCT01202227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731375|NCT01202227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92731376|NCT01202227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92731377|NCT01202227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731378|NCT01202227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731379|NCT01682733|Botulinum Toxins|botulinum toxins|mesh-list
92731380|NCT01682733|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92397817|NCT03180294|Antidepressive Agents|antidepressive agents|mesh-ancestor
92731381|NCT01682733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731382|NCT01682733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731383|NCT01682733|Cholinergic Agents|cholinergic agents|mesh-ancestor
92731384|NCT01682733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731385|NCT01682733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731386|NCT04539314|Dexmedetomidine|dexmedetomidine|mesh-list
92731387|NCT04539314|Bupivacaine|bupivacaine|mesh-list
92731388|NCT04539314|Anesthetics, Local|anesthetics, local|mesh-ancestor
92731389|NCT04539314|Anesthetics|anesthetics|mesh-ancestor
92731390|NCT04539314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731391|NCT04539314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731392|NCT04539314|Sensory System Agents|sensory system agents|mesh-ancestor
92731393|NCT04539314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731394|NCT04539314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92731395|NCT04539314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92731396|NCT04539314|Analgesics|analgesics|mesh-ancestor
92731397|NCT04539314|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92731398|NCT04539314|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92731399|NCT04539314|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92731400|NCT04539314|Adrenergic Agents|adrenergic agents|mesh-ancestor
92731401|NCT04539314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731402|NCT04539314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731403|NCT01682772|Olaparib|olaparib|mesh-list
92731404|NCT01682772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92731405|NCT01682772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731406|NCT01682772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731407|NCT01682772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731408|NCT01649037|Terlipressin|terlipressin|mesh-list
92731409|NCT01649037|Epinephrine|epinephrine|mesh-list
92731410|NCT01649037|Racepinephrine|racepinephrine|mesh-list
92731411|NCT01649037|Norepinephrine|norepinephrine|mesh-list
92731412|NCT01649037|Epinephryl borate|epinephryl borate|mesh-list
92731413|NCT01649037|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92731414|NCT01649037|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92731415|NCT01649037|Adrenergic Agents|adrenergic agents|mesh-ancestor
92731416|NCT01649037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731417|NCT01649037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731418|NCT01649037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731419|NCT01649037|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92731420|NCT01649037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92731421|NCT01649037|Autonomic Agents|autonomic agents|mesh-ancestor
92731422|NCT01649037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731423|NCT01649037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92731424|NCT01649037|Respiratory System Agents|respiratory system agents|mesh-ancestor
92731425|NCT01649037|Mydriatics|mydriatics|mesh-ancestor
92731426|NCT01649037|Sympathomimetics|sympathomimetics|mesh-ancestor
92731427|NCT01649037|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92731428|NCT01649037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92731429|NCT04539119|Tenofovir|tenofovir|mesh-list
92731430|NCT04539119|Entecavir|entecavir|mesh-list
92731431|NCT04539119|Antiviral Agents|antiviral agents|mesh-ancestor
92731432|NCT04539119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731433|NCT04539119|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92731439|NCT02279511|Adenosine|adenosine|mesh-list
92731440|NCT02279511|Analgesics|analgesics|mesh-ancestor
92731441|NCT02279511|Sensory System Agents|sensory system agents|mesh-ancestor
92731442|NCT02279511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731443|NCT02279511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731444|NCT02279511|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92731445|NCT02279511|Vasodilator Agents|vasodilator agents|mesh-ancestor
92610573|NCT02590393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610574|NCT02590393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610575|NCT02590393|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92610576|NCT02590393|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92731446|NCT02279511|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92731447|NCT02279511|Purinergic Agonists|purinergic agonists|mesh-ancestor
92731448|NCT02279511|Purinergic Agents|purinergic agents|mesh-ancestor
92731449|NCT02279511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731450|NCT02279511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731451|NCT02279628|Morphine|morphine|mesh-list
92731452|NCT02279628|Ropivacaine|ropivacaine|mesh-list
92731453|NCT02279628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92731454|NCT02279628|Narcotics|narcotics|mesh-ancestor
92731455|NCT02279628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731456|NCT02279628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731457|NCT02279628|Analgesics|analgesics|mesh-ancestor
92731458|NCT02279628|Sensory System Agents|sensory system agents|mesh-ancestor
92731459|NCT02279628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731460|NCT02279628|Anesthetics, Local|anesthetics, local|mesh-ancestor
92731461|NCT02279628|Anesthetics|anesthetics|mesh-ancestor
92731462|NCT04542629|Trace Elements|trace elements|mesh-list
92731463|NCT04542629|Rituximab|rituximab|mesh-list
92731464|NCT04542629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92731465|NCT04542629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731466|NCT04542629|Immunologic Factors|immunologic factors|mesh-ancestor
92731467|NCT04542629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731468|NCT04542629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731469|NCT04542629|Micronutrients|micronutrients|mesh-ancestor
92731470|NCT01683006|Rocuronium|rocuronium|mesh-list
92731471|NCT01683006|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92731472|NCT01683006|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92731473|NCT01683006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92731474|NCT01683006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731475|NCT01683006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731476|NCT01683162|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92731477|NCT01683162|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92731478|NCT01683162|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92731479|NCT01683162|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92731480|NCT02215733|Telmisartan|telmisartan|mesh-list
92731481|NCT02215733|Diuretics|diuretics|mesh-list
92731482|NCT02215733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92731483|NCT02215733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92731484|NCT02215733|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92731485|NCT02215733|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92731486|NCT02215733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731487|NCT02215733|Natriuretic Agents|natriuretic agents|mesh-ancestor
92731488|NCT02215733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731489|NCT02215733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92731490|NCT02215733|Adrenergic Agents|adrenergic agents|mesh-ancestor
92731491|NCT02215733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731492|NCT01202188|Glycopyrrolate|glycopyrrolate|mesh-list
92731493|NCT01202188|Tiotropium Bromide|tiotropium bromide|mesh-list
92731494|NCT01202188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92731495|NCT01202188|Autonomic Agents|autonomic agents|mesh-ancestor
92731496|NCT01202188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731497|NCT01202188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731498|NCT01202188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92731499|NCT01202188|Respiratory System Agents|respiratory system agents|mesh-ancestor
92731500|NCT01202188|Parasympatholytics|parasympatholytics|mesh-ancestor
92731501|NCT01202188|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92731502|NCT01202188|Cholinergic Agents|cholinergic agents|mesh-ancestor
92731505|NCT01202188|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92731506|NCT01202188|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92731507|NCT01179919|Oseltamivir|oseltamivir|mesh-list
92731508|NCT01179919|Antiviral Agents|antiviral agents|mesh-ancestor
92731509|NCT01179919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731510|NCT01179919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731511|NCT01179919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731512|NCT01201798|Prednisolone|prednisolone|mesh-list
92731513|NCT01201798|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92610577|NCT02590393|Cholinergic Agents|cholinergic agents|mesh-ancestor
92610578|NCT02590393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610579|NCT02590393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610580|NCT00506506|Acetylcysteine|acetylcysteine|mesh-list
92731514|NCT01201798|Methylprednisolone|methylprednisolone|mesh-list
92731515|NCT01201798|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92731516|NCT01201798|Prednisolone acetate|prednisolone acetate|mesh-list
92731517|NCT01201798|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92731518|NCT01201798|Prednisolone phosphate|prednisolone phosphate|mesh-list
92731519|NCT01201798|Difluprednate|difluprednate|mesh-list
92731520|NCT01201798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731521|NCT01201798|Glucocorticoids|glucocorticoids|mesh-ancestor
92731522|NCT01201798|Hormones|hormones|mesh-ancestor
92731523|NCT01201798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731524|NCT01201798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731525|NCT01201798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92731526|NCT01201798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731527|NCT01201798|Antiemetics|antiemetics|mesh-ancestor
92731528|NCT01201798|Autonomic Agents|autonomic agents|mesh-ancestor
92731529|NCT01201798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731530|NCT01201798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731531|NCT01201798|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92731532|NCT01201798|Protective Agents|protective agents|mesh-ancestor
92731533|NCT01201759|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92731534|NCT01201759|Sodium Salicylate|sodium salicylate|mesh-list
92731535|NCT01201759|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92731536|NCT01201759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92731537|NCT01201759|Analgesics|analgesics|mesh-ancestor
92731538|NCT01201759|Sensory System Agents|sensory system agents|mesh-ancestor
92731539|NCT01201759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731540|NCT01201759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731541|NCT01201759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731542|NCT01201759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731543|NCT01201759|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92731544|NCT01201759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731545|NCT01201759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731546|NCT04532684|Pregabalin|pregabalin|mesh-list
92731547|NCT04532684|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92731548|NCT04532684|Analgesics|analgesics|mesh-ancestor
92731549|NCT04532684|Sensory System Agents|sensory system agents|mesh-ancestor
92731550|NCT04532684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731551|NCT04532684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731552|NCT04532684|Anticonvulsants|anticonvulsants|mesh-ancestor
92731553|NCT04532684|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92731554|NCT04532684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731555|NCT04532684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731556|NCT04532684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92731557|NCT04532684|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92731558|NCT04532684|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92731559|NCT04532684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731560|NCT04532684|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731561|NCT04532684|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92731562|NCT04532684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92731563|NCT04532684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731564|NCT04532684|Antidepressive Agents|antidepressive agents|mesh-ancestor
92731565|NCT04532684|Dopamine Agents|dopamine agents|mesh-ancestor
92731566|NCT01649466|Insulin|insulin|mesh-list
92731567|NCT01649466|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92731568|NCT01649466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92731569|NCT01649466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731570|NCT01200589|Rituximab|rituximab|mesh-list
92731571|NCT01200589|Ofatumumab|ofatumumab|mesh-list
92731572|NCT01200589|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92731573|NCT01200589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92731574|NCT01200589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731580|NCT01683552|Aprepitant|aprepitant|mesh-list
92731581|NCT01683552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731582|NCT01683552|Glucocorticoids|glucocorticoids|mesh-ancestor
92731583|NCT01683552|Hormones|hormones|mesh-ancestor
92731584|NCT01683552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610581|NCT00506506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92610583|NCT00506506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731585|NCT01683552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731586|NCT01683552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92731587|NCT01683552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731588|NCT01683552|Antiemetics|antiemetics|mesh-ancestor
92731589|NCT01683552|Autonomic Agents|autonomic agents|mesh-ancestor
92731590|NCT01683552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731591|NCT01683552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731592|NCT01683552|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92731593|NCT01683552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731594|NCT01683552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731595|NCT01683552|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92731596|NCT01683552|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92731597|NCT01683552|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92731598|NCT01683552|Histamine Antagonists|histamine antagonists|mesh-ancestor
92731599|NCT01683552|Histamine Agents|histamine agents|mesh-ancestor
92731600|NCT01649544|Amiodarone|amiodarone|mesh-list
92731601|NCT01649544|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92731602|NCT01649544|Vasodilator Agents|vasodilator agents|mesh-ancestor
92731603|NCT01649544|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92731604|NCT01649544|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731605|NCT01649544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731606|NCT01649544|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92731607|NCT01649544|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92731608|NCT01649544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92731609|NCT01649544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731610|NCT01649544|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92731611|NCT01649544|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92731612|NCT01649544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92731613|NCT04528290|Ozanimod|ozanimod|mesh-list
92731614|NCT04528290|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92731615|NCT04528290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731616|NCT04528290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731617|NCT04528290|Immunologic Factors|immunologic factors|mesh-ancestor
92731618|NCT04528290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731619|NCT01179334|Sildenafil Citrate|sildenafil citrate|mesh-list
92731620|NCT01179334|Riociguat|riociguat|mesh-list
92731621|NCT01179334|Vasodilator Agents|vasodilator agents|mesh-ancestor
92731622|NCT01179334|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92731623|NCT01179334|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92731624|NCT01179334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731625|NCT01179334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731626|NCT01179334|Urological Agents|urological agents|mesh-ancestor
92731627|NCT01179334|Enzyme Activators|enzyme activators|mesh-ancestor
92731628|NCT01649622|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92397869|NCT03061643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731629|NCT01649622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92731630|NCT01649622|Alkylating Agents|alkylating agents|mesh-ancestor
92731631|NCT01649622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731632|NCT01649622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731633|NCT01683747|Tranexamic Acid|tranexamic acid|mesh-list
92731634|NCT01683747|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92731635|NCT01683747|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92731636|NCT01683747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731637|NCT01683747|Hemostatics|hemostatics|mesh-ancestor
92731638|NCT01683747|Coagulants|coagulants|mesh-ancestor
92731639|NCT01178671|Mirtazapine|mirtazapine|mesh-list
92731640|NCT01178671|Sertraline|sertraline|mesh-list
92731641|NCT01178671|Antidepressive Agents|antidepressive agents|mesh-ancestor
92731642|NCT01178671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731643|NCT01178671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92731644|NCT01178671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92731645|NCT01178671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731646|NCT01178671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731648|NCT01178671|Serotonin Agents|serotonin agents|mesh-ancestor
92731649|NCT01178671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731650|NCT01178671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92731651|NCT01178671|Histamine Antagonists|histamine antagonists|mesh-ancestor
92610584|NCT00506506|Expectorants|expectorants|mesh-ancestor
92610585|NCT00506506|Respiratory System Agents|respiratory system agents|mesh-ancestor
92610586|NCT00506506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92610587|NCT00506506|Antioxidants|antioxidants|mesh-ancestor
92610588|NCT00506506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017689|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
92731652|NCT01178671|Histamine Agents|histamine agents|mesh-ancestor
92731653|NCT01178671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92731654|NCT01178671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92731655|NCT01178671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731656|NCT01178671|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92731657|NCT01178671|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92731658|NCT01178671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92731659|NCT01178671|Adrenergic Agents|adrenergic agents|mesh-ancestor
92731660|NCT01178671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92731661|NCT01178671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92731662|NCT01178671|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92731663|NCT04532060|Anti-Infective Agents|anti-infective agents|mesh-list
92731664|NCT04532060|Nystatin|nystatin|mesh-list
92731665|NCT04532060|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92731666|NCT04532060|Antifungal Agents|antifungal agents|mesh-ancestor
92731667|NCT04532060|Ionophores|ionophores|mesh-ancestor
92731668|NCT04532060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92731669|NCT04532060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731670|NCT01649739|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92731671|NCT01649739|Vasodilator Agents|vasodilator agents|mesh-ancestor
92731672|NCT01649739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92731673|NCT01649739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92731674|NCT01649739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731675|NCT01649739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731676|NCT01649739|Urological Agents|urological agents|mesh-ancestor
92731677|NCT04532333|Heparin|heparin|mesh-list
92731678|NCT04532333|Bivalirudin|bivalirudin|mesh-list
92731679|NCT04532333|Anticoagulants|anticoagulants|mesh-ancestor
92731680|NCT04532333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92731681|NCT04532333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92731682|NCT04532333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731683|NCT04532333|Antithrombins|antithrombins|mesh-ancestor
92731684|NCT04532333|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92731685|NCT04532333|Protease Inhibitors|protease inhibitors|mesh-ancestor
92731686|NCT04532333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731687|NCT01649895|Cycloserine|cycloserine|mesh-list
92731688|NCT01649895|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92397878|NCT03055390|Antiemetics|antiemetics|mesh-ancestor
92731689|NCT01649895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731690|NCT01649895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92731691|NCT01649895|Antitubercular Agents|antitubercular agents|mesh-ancestor
92731692|NCT01649895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92731693|NCT01649895|Antimetabolites|antimetabolites|mesh-ancestor
92731694|NCT01649895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731695|NCT01649505|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92731696|NCT01649505|Hemostatics|hemostatics|mesh-ancestor
92731697|NCT01649505|Coagulants|coagulants|mesh-ancestor
92731698|NCT01178086|Rituximab|rituximab|mesh-list
92731699|NCT01178086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92731700|NCT01178086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731701|NCT01178086|Immunologic Factors|immunologic factors|mesh-ancestor
92731702|NCT01178086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731703|NCT01178086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731704|NCT04531865|Mycophenolic Acid|mycophenolic acid|mesh-list
92731705|NCT04531865|Rituximab|rituximab|mesh-list
92731706|NCT04531865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92731707|NCT04531865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731708|NCT04531865|Immunologic Factors|immunologic factors|mesh-ancestor
92731709|NCT04531865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731710|NCT04531865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731711|NCT04531865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92731712|NCT04531865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92731713|NCT04531865|Antitubercular Agents|antitubercular agents|mesh-ancestor
92610589|NCT00506506|Protective Agents|protective agents|mesh-ancestor
92610590|NCT00506506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610591|NCT00506506|Antidotes|antidotes|mesh-ancestor
92610592|NCT02594254|Anti-Infective Agents|anti-infective agents|mesh-list
92610593|NCT02594254|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92610594|NCT00163332|Ciclesonide|ciclesonide|mesh-list
92610595|NCT00163332|Glucocorticoids|glucocorticoids|mesh-ancestor
92731714|NCT04531865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92731715|NCT04531865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731716|NCT04531865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731717|NCT04531865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731719|NCT01643070|Oxaliplatin|oxaliplatin|mesh-list
92731720|NCT01643070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92731721|NCT01643070|Antimetabolites|antimetabolites|mesh-ancestor
92731722|NCT01643070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731723|NCT01643070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731724|NCT01684059|Zinc Sulfate|zinc sulfate|mesh-list
92731725|NCT01684059|Astringents|astringents|mesh-ancestor
92731726|NCT01684059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731727|NCT01684059|Dermatologic Agents|dermatologic agents|mesh-ancestor
92731728|NCT04531748|Toremifene|toremifene|mesh-list
92731729|NCT04531748|Melatonin|melatonin|mesh-list
92731730|NCT04531748|Antioxidants|antioxidants|mesh-ancestor
92731731|NCT04531748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731732|NCT04531748|Protective Agents|protective agents|mesh-ancestor
92731733|NCT04531748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731734|NCT04531748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731735|NCT04531748|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92731736|NCT04531748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731737|NCT04531748|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92731738|NCT04531748|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92731739|NCT04531748|Hormone Antagonists|hormone antagonists|mesh-ancestor
92731740|NCT04531748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731741|NCT04531748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92731742|NCT01177813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92731743|NCT01177813|Empagliflozin|empagliflozin|mesh-list
92731744|NCT01177813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92731745|NCT01177813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731746|NCT01177813|Incretins|incretins|mesh-ancestor
92731747|NCT01177813|Hormones|hormones|mesh-ancestor
92731748|NCT01177813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397886|NCT03055390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731749|NCT01177813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92731750|NCT01177813|Protease Inhibitors|protease inhibitors|mesh-ancestor
92731751|NCT01177813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731752|NCT01177813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731753|NCT01177813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92731754|NCT04315831|Buprenorphine|buprenorphine|mesh-list
92731755|NCT04315831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92731756|NCT04315831|Narcotics|narcotics|mesh-ancestor
92731757|NCT04315831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731758|NCT04315831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731759|NCT04315831|Analgesics|analgesics|mesh-ancestor
92731760|NCT04315831|Sensory System Agents|sensory system agents|mesh-ancestor
92731761|NCT04315831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731762|NCT04315831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92731763|NCT02216045|Ribavirin|ribavirin|mesh-list
92731764|NCT02216045|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92731765|NCT02216045|Interferon-alpha|interferon-alpha|mesh-list
92731766|NCT02216045|Antimetabolites|antimetabolites|mesh-ancestor
92731767|NCT02216045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731768|NCT02216045|Antiviral Agents|antiviral agents|mesh-ancestor
92731769|NCT02216045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731770|NCT02216045|Immunologic Factors|immunologic factors|mesh-ancestor
92731771|NCT02216045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731772|NCT01684371|Tea Tree Oil|tea tree oil|mesh-list
92731773|NCT01684371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92731774|NCT01684371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92731775|NCT01684371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610596|NCT00163332|Hormones|hormones|mesh-ancestor
92610597|NCT00163332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610598|NCT00163332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610599|NCT00163332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92610600|NCT00163371|Ciclesonide|ciclesonide|mesh-list
92731776|NCT04531397|Dapagliflozin|dapagliflozin|mesh-list
92731777|NCT04531397|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92731778|NCT04531397|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92731779|NCT04531397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731780|NCT04531397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92731781|NCT04531397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731782|NCT04531397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92731783|NCT04531397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731784|NCT04531475|Lansoprazole|lansoprazole|mesh-list
92731785|NCT04531475|Dexlansoprazole|dexlansoprazole|mesh-list
92731786|NCT04531475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92731787|NCT04531475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731788|NCT04531475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92731789|NCT04531475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731793|NCT01684449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92731794|NCT01684449|Antimetabolites|antimetabolites|mesh-ancestor
92731795|NCT01684449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731796|NCT01684449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731797|NCT01684449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92731798|NCT01684449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731799|NCT01684449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92731800|NCT01684449|Antifungal Agents|antifungal agents|mesh-ancestor
92731801|NCT01684449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92731802|NCT01684449|Immunologic Factors|immunologic factors|mesh-ancestor
92731803|NCT01684449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731804|NCT04537403|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92731805|NCT04537403|Chelating Agents|chelating agents|mesh-ancestor
92731806|NCT04537403|Sequestering Agents|sequestering agents|mesh-ancestor
92731807|NCT04537403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731808|NCT01684683|Theophylline|theophylline|mesh-list
92731809|NCT01684683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92731810|NCT01684683|Autonomic Agents|autonomic agents|mesh-ancestor
92731811|NCT01684683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731812|NCT01684683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731813|NCT01684683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92731814|NCT01684683|Respiratory System Agents|respiratory system agents|mesh-ancestor
92731815|NCT01684683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92731816|NCT01684683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731817|NCT01684683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731818|NCT01684683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92731819|NCT01684683|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92731820|NCT01684683|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92731821|NCT01684683|Purinergic Agents|purinergic agents|mesh-ancestor
92731822|NCT01684683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731823|NCT01684800|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92731824|NCT01684800|Hemostatics|hemostatics|mesh-ancestor
92731825|NCT01684800|Coagulants|coagulants|mesh-ancestor
92731826|NCT01684800|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92731827|NCT01684800|Natriuretic Agents|natriuretic agents|mesh-ancestor
92731828|NCT01684800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731829|NCT04531163|Acetylcysteine|acetylcysteine|mesh-list
92731830|NCT04531163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92731831|NCT04531163|Antiviral Agents|antiviral agents|mesh-ancestor
92731832|NCT04531163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731833|NCT04531163|Expectorants|expectorants|mesh-ancestor
92731834|NCT04531163|Respiratory System Agents|respiratory system agents|mesh-ancestor
92731835|NCT04531163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92731836|NCT04531163|Antioxidants|antioxidants|mesh-ancestor
92731837|NCT04531163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731838|NCT04531163|Protective Agents|protective agents|mesh-ancestor
92731839|NCT04531163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731840|NCT04531163|Antidotes|antidotes|mesh-ancestor
92731841|NCT01684995|Nicotine|nicotine|mesh-list
92731842|NCT01684995|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92610601|NCT00163371|Glucocorticoids|glucocorticoids|mesh-ancestor
92610602|NCT00163371|Hormones|hormones|mesh-ancestor
92610603|NCT00163371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610604|NCT00163371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610605|NCT00163371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92610606|NCT00143156|Pregabalin|pregabalin|mesh-list
92610607|NCT00143156|Analgesics|analgesics|mesh-ancestor
92731844|NCT01684995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731845|NCT01684995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731846|NCT01684995|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92731847|NCT01684995|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92731848|NCT01684995|Cholinergic Agents|cholinergic agents|mesh-ancestor
92731849|NCT01684995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731850|NCT01684995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731851|NCT01685502|Acarbose|acarbose|mesh-list
92731852|NCT01685502|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92731853|NCT01685502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731854|NCT01685502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731855|NCT01685502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92731856|NCT01685502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731857|NCT04527276|Chlorhexidine|chlorhexidine|mesh-list
92731858|NCT04527276|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92731859|NCT04527276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731860|NCT04527276|Disinfectants|disinfectants|mesh-ancestor
92731861|NCT01200355|Posaconazole|posaconazole|mesh-list
92731862|NCT01200355|Micafungin|micafungin|mesh-list
92731865|NCT01200355|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92731866|NCT01200355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92731867|NCT01200355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92731868|NCT01200355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92731869|NCT01200355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92731870|NCT01200355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731871|NCT01200355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731872|NCT01200355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92731873|NCT01200355|Hormone Antagonists|hormone antagonists|mesh-ancestor
92731874|NCT01200355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731875|NCT01200355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731876|NCT04527666|Anticoagulants|anticoagulants|mesh-list
92731877|NCT04530500|Androgens|androgens|mesh-list
92731878|NCT04530500|Hormones|hormones|mesh-ancestor
92731879|NCT04530500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731880|NCT04530500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731881|NCT01685658|Acetaminophen|acetaminophen|mesh-list
92731882|NCT01685658|Ketoprofen|ketoprofen|mesh-list
92731883|NCT01685658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92731884|NCT01685658|Analgesics|analgesics|mesh-ancestor
92731885|NCT01685658|Sensory System Agents|sensory system agents|mesh-ancestor
92731886|NCT01685658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731887|NCT01685658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731888|NCT01685658|Antipyretics|antipyretics|mesh-ancestor
92731889|NCT01685658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92731890|NCT01685658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731891|NCT01685658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731892|NCT01685658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92731893|NCT01685658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731894|NCT01685658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731895|NCT04530578|Heparin|heparin|mesh-list
92731896|NCT04530578|Calcium heparin|calcium heparin|mesh-list
92731897|NCT04530578|Enoxaparin|enoxaparin|mesh-list
92731898|NCT04530578|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92731899|NCT04530578|Tinzaparin|tinzaparin|mesh-list
92731900|NCT04530578|Dalteparin|dalteparin|mesh-list
92731901|NCT04530578|Anticoagulants|anticoagulants|mesh-ancestor
92731902|NCT04530578|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92731903|NCT04530578|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92731904|NCT04530578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731905|NCT01685853|Bisacodyl|bisacodyl|mesh-list
92731906|NCT01685853|Cathartics|cathartics|mesh-ancestor
92731907|NCT01685853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92610608|NCT00143156|Sensory System Agents|sensory system agents|mesh-ancestor
92610609|NCT00143156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610610|NCT00143156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610611|NCT00143156|Anticonvulsants|anticonvulsants|mesh-ancestor
92731908|NCT01685853|Laxatives|laxatives|mesh-ancestor
92731909|NCT04530422|Azithromycin|azithromycin|mesh-list
92731910|NCT04530422|Hydroxychloroquine|hydroxychloroquine|mesh-list
92731911|NCT04530422|Sofosbuvir|sofosbuvir|mesh-list
92731912|NCT04530422|Oseltamivir|oseltamivir|mesh-list
92731913|NCT04530422|Ledipasvir|ledipasvir|mesh-list
92731914|NCT04530422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92731915|NCT04530422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731916|NCT04530422|Antimalarials|antimalarials|mesh-ancestor
92731917|NCT04530422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92731918|NCT04530422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92731919|NCT04530422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731920|NCT04530422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731922|NCT04530422|Antiviral Agents|antiviral agents|mesh-ancestor
92731923|NCT02887573|Mosapride|mosapride|mesh-list
92731924|NCT02887573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731925|NCT02887573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731926|NCT02887573|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92731927|NCT02887573|Serotonin Agents|serotonin agents|mesh-ancestor
92731928|NCT02887573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731929|NCT02887573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731930|NCT01685892|Venetoclax|venetoclax|mesh-list
92731931|NCT01685892|Obinutuzumab|obinutuzumab|mesh-list
92731932|NCT01685892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731933|NCT01685892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92731934|NCT02887534|Tizanidine|tizanidine|mesh-list
92731935|NCT02887534|Analgesics|analgesics|mesh-ancestor
92731936|NCT02887534|Sensory System Agents|sensory system agents|mesh-ancestor
92731937|NCT02887534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731938|NCT02887534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731939|NCT02887534|Anticonvulsants|anticonvulsants|mesh-ancestor
92731942|NCT02887534|Parasympatholytics|parasympatholytics|mesh-ancestor
92731943|NCT02887534|Autonomic Agents|autonomic agents|mesh-ancestor
92731944|NCT02887534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92731945|NCT02887534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92731946|NCT02887534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92731947|NCT02887534|Adrenergic Agents|adrenergic agents|mesh-ancestor
92731948|NCT02887534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731949|NCT02887534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731950|NCT01685931|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92731951|NCT01685931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92731952|NCT01685931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92731953|NCT01685931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731954|NCT01685931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731955|NCT01685931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731956|NCT01685931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92731957|NCT01685931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92731958|NCT01685931|Serotonin Agents|serotonin agents|mesh-ancestor
92731959|NCT01685931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731960|NCT01685931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731961|NCT01685931|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92731962|NCT01685931|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92731963|NCT01685931|Dopamine Agents|dopamine agents|mesh-ancestor
92731964|NCT01685970|Picosulfate sodium|picosulfate sodium|mesh-list
92731965|NCT01685970|Cathartics|cathartics|mesh-ancestor
92731966|NCT01685970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731967|NCT04530617|Camostat|camostat|mesh-list
92731968|NCT04530617|Protease Inhibitors|protease inhibitors|mesh-ancestor
92731969|NCT04530617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731970|NCT04530617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731971|NCT04530617|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92731972|NCT04530617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92731973|NCT01686009|Ketamine|ketamine|mesh-list
92731974|NCT01686009|Analgesics|analgesics|mesh-ancestor
92731975|NCT01686009|Sensory System Agents|sensory system agents|mesh-ancestor
92731976|NCT01686009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731977|NCT01686009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731978|NCT01686009|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92610612|NCT00143156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610613|NCT00143156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610614|NCT00143156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610615|NCT00143156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610616|NCT00143156|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92610617|NCT00143156|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610618|NCT00143156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610619|NCT00143156|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731979|NCT01686009|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92731980|NCT01686009|Anesthetics, General|anesthetics, general|mesh-ancestor
92731981|NCT01686009|Anesthetics|anesthetics|mesh-ancestor
92731982|NCT01686009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92731983|NCT01686009|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92731984|NCT01686009|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92731985|NCT01686009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731986|NCT01686009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731987|NCT04536662|Dexamethasone|dexamethasone|mesh-list
92731988|NCT04536662|Prednisone|prednisone|mesh-list
92731989|NCT04536662|Hydrocortisone|hydrocortisone|mesh-list
92731990|NCT04536662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92731991|NCT04536662|Antiemetics|antiemetics|mesh-ancestor
92731992|NCT04536662|Autonomic Agents|autonomic agents|mesh-ancestor
92731993|NCT04536662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92731994|NCT04536662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731995|NCT04536662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92731996|NCT04536662|Glucocorticoids|glucocorticoids|mesh-ancestor
92731997|NCT04536662|Hormones|hormones|mesh-ancestor
92731998|NCT04536662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92731999|NCT04536662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732000|NCT04536662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732001|NCT01686321|Rituximab|rituximab|mesh-list
92732002|NCT01686321|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92732003|NCT01686321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92732004|NCT01686321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732005|NCT01686321|Immunologic Factors|immunologic factors|mesh-ancestor
92732006|NCT01686321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732007|NCT01686321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732008|NCT01686321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92732009|NCT01686321|Alkylating Agents|alkylating agents|mesh-ancestor
92732010|NCT01686321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732011|NCT01199731|Etravirine|etravirine|mesh-list
92732015|NCT01199731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732017|NCT01199731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732018|NCT01686555|Venetoclax|venetoclax|mesh-list
92732019|NCT01686555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732020|NCT01686711|Pioglitazone|pioglitazone|mesh-list
92732021|NCT01686711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732022|NCT01686711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732023|NCT01686789|Interferons|interferons|mesh-list
92732024|NCT01686789|Interferon-alpha|interferon-alpha|mesh-list
92732025|NCT01686789|Interferon alpha-2|interferon alpha-2|mesh-list
92732026|NCT01686789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92732027|NCT01686789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732028|NCT01686789|Antiviral Agents|antiviral agents|mesh-ancestor
92732029|NCT01686789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732030|NCT01686789|Immunologic Factors|immunologic factors|mesh-ancestor
92732031|NCT01686789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732032|NCT02217683|Nitric Oxide|nitric oxide|mesh-list
92732033|NCT02217683|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92732034|NCT02217683|Autonomic Agents|autonomic agents|mesh-ancestor
92732035|NCT02217683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732036|NCT02217683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732037|NCT02217683|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92610620|NCT00163410|Ciclesonide|ciclesonide|mesh-list
92610621|NCT00163410|Glucocorticoids|glucocorticoids|mesh-ancestor
92610622|NCT00163410|Hormones|hormones|mesh-ancestor
92610623|NCT00163410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610624|NCT00163410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610625|NCT00163410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92610626|NCT00143195|Amlodipine|amlodipine|mesh-list
92732038|NCT02217683|Respiratory System Agents|respiratory system agents|mesh-ancestor
92732039|NCT02217683|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92732040|NCT02217683|Antioxidants|antioxidants|mesh-ancestor
92732041|NCT02217683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732042|NCT02217683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732043|NCT02217683|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92732044|NCT02217683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92732045|NCT02217683|Gasotransmitters|gasotransmitters|mesh-ancestor
92732046|NCT02217683|Protective Agents|protective agents|mesh-ancestor
92732047|NCT02217722|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92732048|NCT02217722|Amoxicillin|amoxicillin|mesh-list
92732049|NCT02217722|Metronidazole|metronidazole|mesh-list
92732050|NCT02217722|Doxycycline|doxycycline|mesh-list
92732051|NCT02217722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732052|NCT02217722|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92732053|NCT02217722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732054|NCT02217722|Antimalarials|antimalarials|mesh-ancestor
92732055|NCT02217839|Octreotide|octreotide|mesh-list
92732056|NCT02217839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732057|NCT02217839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732058|NCT02217839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732059|NCT01687062|Fe(III)-EDTA|fe(iii)-edta|mesh-list
92732060|NCT01687062|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92732061|NCT01687062|Chelating Agents|chelating agents|mesh-ancestor
92732062|NCT01687062|Sequestering Agents|sequestering agents|mesh-ancestor
92732063|NCT01687062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732064|NCT02217956|Bevacizumab|bevacizumab|mesh-list
92732065|NCT02217956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92732066|NCT02217956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397919|NCT03011775|Vasodilator Agents|vasodilator agents|mesh-list
92732067|NCT02217956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92732068|NCT02217956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92732070|NCT02217956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732071|NCT02217956|Growth Inhibitors|growth inhibitors|mesh-ancestor
92732072|NCT01687140|Cycloserine|cycloserine|mesh-list
92732073|NCT01687140|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92732074|NCT01687140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732075|NCT01687140|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92732076|NCT01687140|Antitubercular Agents|antitubercular agents|mesh-ancestor
92732077|NCT01687140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92732078|NCT01687140|Antimetabolites|antimetabolites|mesh-ancestor
92732079|NCT01687140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732080|NCT04535960|Liraglutide|liraglutide|mesh-list
92732081|NCT04535960|Empagliflozin|empagliflozin|mesh-list
92732082|NCT04535960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732083|NCT04535960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732084|NCT04535960|Incretins|incretins|mesh-ancestor
92732089|NCT04536428|Hemostatics|hemostatics|mesh-list
92732090|NCT04536428|Coagulants|coagulants|mesh-ancestor
92732091|NCT01687374|Hormones|hormones|mesh-list
92732092|NCT01687374|Parathyroid Hormone|parathyroid hormone|mesh-list
92732093|NCT01687374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732094|NCT01687374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732095|NCT01687374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92732096|NCT04530188|Propofol|propofol|mesh-list
92732097|NCT04530188|Sevoflurane|sevoflurane|mesh-list
92732098|NCT04530188|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92732099|NCT04530188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732100|NCT04530188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732101|NCT04530188|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92732102|NCT04530188|Anesthetics, General|anesthetics, general|mesh-ancestor
92732103|NCT04530188|Anesthetics|anesthetics|mesh-ancestor
92732104|NCT04530188|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92610627|NCT00143195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92732105|NCT04530188|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92732106|NCT01687491|Enoxaparin|enoxaparin|mesh-list
92732107|NCT01687491|Anticoagulants|anticoagulants|mesh-ancestor
92732108|NCT01687491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92732109|NCT01687491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92732110|NCT01687491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732111|NCT04530227|Paclitaxel|paclitaxel|mesh-list
92732112|NCT04530227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92732113|NCT04530227|Pemetrexed|pemetrexed|mesh-list
92732114|NCT04530227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92732115|NCT04530227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732116|NCT04530227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92732117|NCT04530227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92732118|NCT04530227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92732119|NCT04530227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732120|NCT04530227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732121|NCT04530227|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92732122|NCT04530227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92732123|NCT01199263|Paclitaxel|paclitaxel|mesh-list
92732124|NCT01199263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92732125|NCT01199263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92732126|NCT01199263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732127|NCT01199263|Tubulin Modulators|tubulin modulators|mesh-ancestor
92732128|NCT01199263|Antimitotic Agents|antimitotic agents|mesh-ancestor
92732129|NCT01199263|Mitosis Modulators|mitosis modulators|mesh-ancestor
92732130|NCT01199263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732131|NCT02218034|Nicotinic Acids|nicotinic acids|mesh-list
92732132|NCT02218034|Tazarotene|tazarotene|mesh-list
92732133|NCT02218034|Dermatologic Agents|dermatologic agents|mesh-ancestor
92732134|NCT02218034|Keratolytic Agents|keratolytic agents|mesh-ancestor
92732135|NCT02218034|Vitamin B Complex|vitamin b complex|mesh-ancestor
92732136|NCT02218034|Vitamins|vitamins|mesh-ancestor
92732137|NCT02218034|Micronutrients|micronutrients|mesh-ancestor
92732138|NCT02218034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732139|NCT01688154|Proanthocyanidin|proanthocyanidin|mesh-list
92732140|NCT01688154|Procyanidin|procyanidin|mesh-list
92732141|NCT01688154|Antioxidants|antioxidants|mesh-ancestor
92732142|NCT01688154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732143|NCT01688154|Protective Agents|protective agents|mesh-ancestor
92732144|NCT01688154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732145|NCT01688154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92732146|NCT01688154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732147|NCT01688154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732148|NCT01688349|Glucocorticoids|glucocorticoids|mesh-list
92732149|NCT01688349|Hormones|hormones|mesh-ancestor
92732150|NCT01688349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732151|NCT01688349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732152|NCT05138484|Chlorhexidine|chlorhexidine|mesh-list
92732153|NCT05138484|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92732154|NCT05138484|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92732176|NCT04529525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732178|NCT02216409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92732179|NCT02216409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732180|NCT05126121|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92732181|NCT05126121|Amoxicillin|amoxicillin|mesh-list
92732182|NCT05126121|Clarithromycin|clarithromycin|mesh-list
92732183|NCT05126121|Levofloxacin|levofloxacin|mesh-list
92732184|NCT05126121|Ofloxacin|ofloxacin|mesh-list
92732185|NCT05126121|Tetracycline|tetracycline|mesh-list
92732186|NCT05126121|Tinidazole|tinidazole|mesh-list
92732187|NCT05126121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92732188|NCT05126121|Furazolidone|furazolidone|mesh-list
92732189|NCT05126121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732190|NCT05126121|Antitubercular Agents|antitubercular agents|mesh-ancestor
92732191|NCT05126121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92732192|NCT05126121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732193|NCT05126121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732194|NCT05126121|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92732195|NCT05126121|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92732196|NCT05126121|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92732197|NCT05126121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92732198|NCT05126121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92732199|NCT05126121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610628|NCT00143195|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610629|NCT00143195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017733|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732200|NCT05126121|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92732201|NCT05126121|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92732202|NCT05126121|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92732204|NCT05126121|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732205|NCT05126121|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92732206|NCT05126121|Alkylating Agents|alkylating agents|mesh-ancestor
92732207|NCT02218658|Brotizolam|brotizolam|mesh-list
92732208|NCT02218658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92732209|NCT02218658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732211|NCT01199068|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92732213|NCT01199068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732214|NCT01199068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92732215|NCT01199068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732216|NCT01199068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732217|NCT01198873|Dronedarone|dronedarone|mesh-list
92732218|NCT01198873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92732220|NCT01198795|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92732221|NCT01198795|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92732222|NCT01198795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92732223|NCT01198795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732224|NCT01198795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732225|NCT01198795|Serotonin Agents|serotonin agents|mesh-ancestor
92732226|NCT01198795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732227|NCT02278913|Insulin|insulin|mesh-list
92732228|NCT02278913|Insulin Glargine|insulin glargine|mesh-list
92732229|NCT02278913|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92732230|NCT02278913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732231|NCT02278913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732232|NCT02216513|Deferoxamine|deferoxamine|mesh-list
92732233|NCT02216513|Siderophores|siderophores|mesh-ancestor
92732234|NCT02216513|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92732235|NCT02216513|Chelating Agents|chelating agents|mesh-ancestor
92732236|NCT02216513|Sequestering Agents|sequestering agents|mesh-ancestor
92732237|NCT02216513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732238|NCT02218775|Aticaprant|aticaprant|mesh-list
92732239|NCT02218775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92732240|NCT02218775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732241|NCT02218775|Sensory System Agents|sensory system agents|mesh-ancestor
92732242|NCT02218775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732243|NCT02216552|Resveratrol|resveratrol|mesh-list
92732244|NCT02216552|Antioxidants|antioxidants|mesh-ancestor
92732245|NCT02216552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732246|NCT02216552|Protective Agents|protective agents|mesh-ancestor
92732247|NCT02216552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732248|NCT02216552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732249|NCT02216552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92732250|NCT01198756|Vaccines|vaccines|mesh-list
92732251|NCT01198756|Immunologic Factors|immunologic factors|mesh-ancestor
92732252|NCT01198756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732253|NCT02216487|Irinotecan|irinotecan|mesh-list
92732254|NCT02216487|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92732255|NCT02216487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92732256|NCT02216487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732257|NCT02216487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732258|NCT02216487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732259|NCT02218814|Bupivacaine|bupivacaine|mesh-list
92732260|NCT02218814|Anesthetics, Local|anesthetics, local|mesh-ancestor
92732261|NCT02218814|Anesthetics|anesthetics|mesh-ancestor
92732262|NCT02218814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732263|NCT02218814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732264|NCT02218814|Sensory System Agents|sensory system agents|mesh-ancestor
92732265|NCT02218814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732266|NCT02216565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92732267|NCT02216565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92732268|NCT02216565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92732269|NCT02216565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610630|NCT00143195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610631|NCT00143195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610632|NCT00143195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610633|NCT00143195|Vasodilator Agents|vasodilator agents|mesh-ancestor
92610634|NCT00163449|Ciclesonide|ciclesonide|mesh-list
92732270|NCT04534803|BCG Vaccine|bcg vaccine|mesh-list
92732271|NCT04534803|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92732272|NCT04534803|Immunologic Factors|immunologic factors|mesh-ancestor
92732273|NCT04534803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732274|NCT01198132|Vitamin D|vitamin d|mesh-list
92732275|NCT01198132|Ergocalciferols|ergocalciferols|mesh-list
92732276|NCT01198132|Cholecalciferol|cholecalciferol|mesh-list
92732277|NCT01198132|Vitamins|vitamins|mesh-list
92732278|NCT01198132|Interferons|interferons|mesh-list
92732279|NCT01198132|Interferon-beta|interferon-beta|mesh-list
92732280|NCT01198132|Interferon beta-1a|interferon beta-1a|mesh-list
92732281|NCT01198132|Micronutrients|micronutrients|mesh-ancestor
92732282|NCT01198132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732283|NCT01198132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92732285|NCT01198132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732286|NCT01198132|Antiviral Agents|antiviral agents|mesh-ancestor
92732287|NCT01198132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732288|NCT01198132|Immunologic Factors|immunologic factors|mesh-ancestor
92732289|NCT01198132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92732290|NCT02219165|Immunoglobulins|immunoglobulins|mesh-list
92732291|NCT02219165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92732292|NCT02219165|Antibodies|antibodies|mesh-list
92732293|NCT02219165|Immunologic Factors|immunologic factors|mesh-ancestor
92732294|NCT02219165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732295|NCT04534725|Interferons|interferons|mesh-list
92732296|NCT04534725|Interferon-alpha|interferon-alpha|mesh-list
92732297|NCT04534725|Lenzilumab|lenzilumab|mesh-list
92732298|NCT04534725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732299|NCT04534725|Antiviral Agents|antiviral agents|mesh-ancestor
92732300|NCT04534725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732301|NCT04534725|Immunologic Factors|immunologic factors|mesh-ancestor
92732302|NCT04534725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732303|NCT04534725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732304|NCT04534478|Prednisone|prednisone|mesh-list
92732305|NCT04534478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732306|NCT04534478|Glucocorticoids|glucocorticoids|mesh-ancestor
92732307|NCT04534478|Hormones|hormones|mesh-ancestor
92732308|NCT04534478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732309|NCT04534478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732310|NCT04534478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732311|NCT04534478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732312|NCT02216669|Imidazole|imidazole|mesh-list
92732313|NCT02216669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732314|NCT02216669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732315|NCT03772158|Cetirizine|cetirizine|mesh-list
92732316|NCT03772158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92732317|NCT03772158|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92732318|NCT03772158|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92732319|NCT03772158|Histamine Antagonists|histamine antagonists|mesh-ancestor
92732320|NCT03772158|Histamine Agents|histamine agents|mesh-ancestor
92732321|NCT03772158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732322|NCT03772158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732323|NCT03772158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732324|NCT01196416|Cisplatin|cisplatin|mesh-list
92732325|NCT01196416|Temozolomide|temozolomide|mesh-list
92732326|NCT01196416|Vinblastine|vinblastine|mesh-list
92732327|NCT01196416|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92732328|NCT01196416|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92732329|NCT01196416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732330|NCT01196416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92732331|NCT01196416|Alkylating Agents|alkylating agents|mesh-ancestor
92732332|NCT01196416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732333|NCT01196416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92610635|NCT00163449|Glucocorticoids|glucocorticoids|mesh-ancestor
92610636|NCT00163449|Hormones|hormones|mesh-ancestor
92610637|NCT00163449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610638|NCT00163449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610639|NCT00163449|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92610640|NCT00143234|Amlodipine|amlodipine|mesh-list
92732334|NCT01196416|Tubulin Modulators|tubulin modulators|mesh-ancestor
92732335|NCT01196416|Antimitotic Agents|antimitotic agents|mesh-ancestor
92732336|NCT01196416|Mitosis Modulators|mitosis modulators|mesh-ancestor
92732337|NCT01196416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732338|NCT01196104|Insulin|insulin|mesh-list
92732339|NCT01196104|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92732340|NCT01196104|Insulin Glargine|insulin glargine|mesh-list
92732341|NCT01196104|Insulin Aspart|insulin aspart|mesh-list
92732342|NCT01196104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732343|NCT01196104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732344|NCT04534322|Dexamethasone|dexamethasone|mesh-list
92732345|NCT04534322|Melphalan|melphalan|mesh-list
92732346|NCT04534322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732347|NCT04534322|Antiemetics|antiemetics|mesh-ancestor
92732348|NCT04534322|Autonomic Agents|autonomic agents|mesh-ancestor
92732349|NCT04534322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732350|NCT04534322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732351|NCT04534322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732352|NCT04534322|Glucocorticoids|glucocorticoids|mesh-ancestor
92732353|NCT04534322|Hormones|hormones|mesh-ancestor
92732354|NCT04534322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732355|NCT04534322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732356|NCT04534322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732359|NCT04534322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732360|NCT04534322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92732361|NCT04534322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732362|NCT04534322|Immunologic Factors|immunologic factors|mesh-ancestor
92732363|NCT02219672|Ritonavir|ritonavir|mesh-list
92732364|NCT02219672|Lopinavir|lopinavir|mesh-list
92732365|NCT02219672|Tenofovir|tenofovir|mesh-list
92732366|NCT02219672|Lamivudine|lamivudine|mesh-list
92732367|NCT02219672|Raltegravir Potassium|raltegravir potassium|mesh-list
92732368|NCT02219672|Triptolide|triptolide|mesh-list
92732369|NCT02219672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92732370|NCT02219672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92732371|NCT02219672|Protease Inhibitors|protease inhibitors|mesh-ancestor
92732372|NCT02219672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732373|NCT02219672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732374|NCT02219672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92732375|NCT02219672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92732376|NCT02219672|Antiviral Agents|antiviral agents|mesh-ancestor
92732377|NCT02219672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732378|NCT02219672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92732379|NCT02219672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92732380|NCT02219672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92732381|NCT02219672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92732382|NCT02219672|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92732383|NCT02219672|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92732384|NCT02219672|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92732385|NCT02219672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732386|NCT02219672|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92732387|NCT02219672|Contraceptive Agents|contraceptive agents|mesh-ancestor
92732388|NCT02219672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92732389|NCT02219672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732390|NCT02219672|Immunologic Factors|immunologic factors|mesh-ancestor
92732391|NCT02219672|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92732392|NCT02219672|Alkylating Agents|alkylating agents|mesh-ancestor
92732393|NCT02219672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732394|NCT03113955|Epirubicin|epirubicin|mesh-list
92732395|NCT03113955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92732396|NCT03113955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732397|NCT03113955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92732398|NCT03113955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92732399|NCT03113955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335706|NCT02083380|Piperaquine|piperaquine|mesh-list
92610641|NCT00143234|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92610642|NCT00143234|Atorvastatin|atorvastatin|mesh-list
92610643|NCT00143234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92732400|NCT03113955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732401|NCT02219750|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92732402|NCT02219750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732403|NCT02219750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732404|NCT04534452|Phenylephrine|phenylephrine|mesh-list
92732405|NCT04534452|Oxymetazoline|oxymetazoline|mesh-list
92732406|NCT04534452|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92732407|NCT04534452|Mydriatics|mydriatics|mesh-ancestor
92732408|NCT04534452|Autonomic Agents|autonomic agents|mesh-ancestor
92732409|NCT04534452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732410|NCT04534452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732411|NCT04534452|Sympathomimetics|sympathomimetics|mesh-ancestor
92732412|NCT04534452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92732413|NCT04534452|Nasal Decongestants|nasal decongestants|mesh-ancestor
92732414|NCT04534452|Respiratory System Agents|respiratory system agents|mesh-ancestor
92732415|NCT04534452|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92732416|NCT04534452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92732417|NCT04534452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92732418|NCT04534452|Adrenergic Agents|adrenergic agents|mesh-ancestor
92732419|NCT04534452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732420|NCT04534452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732421|NCT04534452|Protective Agents|protective agents|mesh-ancestor
92732422|NCT02219789|Fulvestrant|fulvestrant|mesh-list
92732423|NCT02219789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92397964|NCT02924480|Lidocaine|lidocaine|mesh-list
92732424|NCT02219789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732425|NCT02219789|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92732426|NCT02219789|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92732427|NCT02219789|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327601|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732435|NCT04533867|Autonomic Agents|autonomic agents|mesh-ancestor
92732436|NCT04533867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732437|NCT04533867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732438|NCT04533867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732439|NCT04533867|Antipruritics|antipruritics|mesh-ancestor
92732440|NCT04533867|Dermatologic Agents|dermatologic agents|mesh-ancestor
92732441|NCT04533867|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92732442|NCT04533867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92732443|NCT04533867|Serotonin Agents|serotonin agents|mesh-ancestor
92732444|NCT04533867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732445|NCT04533867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732446|NCT02219867|Ketamine|ketamine|mesh-list
92732447|NCT02219867|Analgesics|analgesics|mesh-ancestor
92732448|NCT02219867|Sensory System Agents|sensory system agents|mesh-ancestor
92732449|NCT02219867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732450|NCT02219867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732451|NCT02219867|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92732452|NCT02219867|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92732453|NCT02219867|Anesthetics, General|anesthetics, general|mesh-ancestor
92732454|NCT02219867|Anesthetics|anesthetics|mesh-ancestor
92732455|NCT02219867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732456|NCT02219867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92732457|NCT02219867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92732458|NCT02219867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732459|NCT02219867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732460|NCT04533906|Povidone-Iodine|povidone-iodine|mesh-list
92732461|NCT04533906|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92732462|NCT04533906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732463|NCT02219906|Resveratrol|resveratrol|mesh-list
92732464|NCT02219906|Antioxidants|antioxidants|mesh-ancestor
92732465|NCT02219906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732466|NCT02219906|Protective Agents|protective agents|mesh-ancestor
92732467|NCT02219906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732468|NCT02219906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732469|NCT02219906|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92732470|NCT04533243|Fentanyl|fentanyl|mesh-list
92732471|NCT04533243|Morphine|morphine|mesh-list
92610644|NCT00143234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92610645|NCT00143234|Antimetabolites|antimetabolites|mesh-ancestor
92610646|NCT00143234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732472|NCT04533243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92732473|NCT04533243|Narcotics|narcotics|mesh-ancestor
92732474|NCT04533243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732475|NCT04533243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732476|NCT04533243|Analgesics|analgesics|mesh-ancestor
92732477|NCT04533243|Sensory System Agents|sensory system agents|mesh-ancestor
92732478|NCT04533243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732479|NCT04533243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92732480|NCT04533243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92732481|NCT04533243|Anesthetics, General|anesthetics, general|mesh-ancestor
92732482|NCT04533243|Anesthetics|anesthetics|mesh-ancestor
92732483|NCT04533321|Afatinib|afatinib|mesh-list
92732484|NCT04533321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732485|NCT04533321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92732486|NCT04533321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732487|NCT04533321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732488|NCT01195831|Calcipotriene|calcipotriene|mesh-list
92732489|NCT01195831|Dermatologic Agents|dermatologic agents|mesh-ancestor
92732490|NCT01195675|Empagliflozin|empagliflozin|mesh-list
92732491|NCT01195675|Moxifloxacin|moxifloxacin|mesh-list
92397976|NCT02924064|Metformin|metformin|mesh-list
92732492|NCT01195675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92732493|NCT01195675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732494|NCT01195675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92732495|NCT01195675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92732498|NCT01195675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732499|NCT01195675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732500|NCT01195675|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92732501|NCT01195675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732502|NCT04532931|Acetaminophen|acetaminophen|mesh-list
92732503|NCT04532931|Sofosbuvir|sofosbuvir|mesh-list
92732504|NCT04532931|Artesunate|artesunate|mesh-list
92732505|NCT04532931|Favipiravir|favipiravir|mesh-list
92732506|NCT04532931|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92732507|NCT04532931|Amodiaquine|amodiaquine|mesh-list
92732508|NCT04532931|Nitazoxanide|nitazoxanide|mesh-list
92732509|NCT04532931|Pyronaridine|pyronaridine|mesh-list
92732510|NCT04532931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92732511|NCT04532931|Analgesics|analgesics|mesh-ancestor
92732512|NCT04532931|Sensory System Agents|sensory system agents|mesh-ancestor
92732513|NCT04532931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732514|NCT04532931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732515|NCT04532931|Antipyretics|antipyretics|mesh-ancestor
92732516|NCT04532931|Antiviral Agents|antiviral agents|mesh-ancestor
92732517|NCT04532931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732518|NCT04532931|Antimalarials|antimalarials|mesh-ancestor
92732519|NCT04532931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92732520|NCT04532931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732521|NCT04532931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732522|NCT04532931|Schistosomicides|schistosomicides|mesh-ancestor
92732523|NCT04532931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92732524|NCT04532931|Anthelmintics|anthelmintics|mesh-ancestor
92732525|NCT01195363|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92732526|NCT01195363|Antidepressive Agents|antidepressive agents|mesh-ancestor
92732527|NCT01195363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92732528|NCT01195363|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92732529|NCT01195363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92732530|NCT01195363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732531|NCT01195363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732532|NCT01195090|Pioglitazone|pioglitazone|mesh-list
92732533|NCT01195090|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92732534|NCT01195090|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732535|NCT01195090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732536|NCT01195090|Incretins|incretins|mesh-ancestor
92732537|NCT01195090|Hormones|hormones|mesh-ancestor
92732538|NCT01195090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732539|NCT01195090|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92732540|NCT01195090|Protease Inhibitors|protease inhibitors|mesh-ancestor
92732541|NCT01195090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732542|NCT01195090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732543|NCT02213081|Ulipristal acetate|ulipristal acetate|mesh-list
92732544|NCT02213081|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92610647|NCT00143234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92610648|NCT00143234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92732545|NCT02213081|Contraceptive Agents|contraceptive agents|mesh-ancestor
92732546|NCT02213081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92732547|NCT02213081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732548|NCT02213081|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92732549|NCT02213627|Menotropins|menotropins|mesh-list
92732550|NCT02213627|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92732551|NCT02213627|Fertility Agents|fertility agents|mesh-ancestor
92732552|NCT02213627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92732553|NCT02213627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732554|NCT02216799|Insulin|insulin|mesh-list
92732555|NCT02216799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92732556|NCT02216799|Insulin Glargine|insulin glargine|mesh-list
92732557|NCT02216799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732558|NCT02216799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732559|NCT02216877|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92732560|NCT02216877|Antacids|antacids|mesh-ancestor
92732561|NCT02216877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732562|NCT02216877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732563|NCT02214563|Vitamin D|vitamin d|mesh-list
92732564|NCT02214563|Ergocalciferols|ergocalciferols|mesh-list
92732565|NCT02214563|Cholecalciferol|cholecalciferol|mesh-list
92732566|NCT02214563|Vitamins|vitamins|mesh-list
92732567|NCT02214563|Micronutrients|micronutrients|mesh-ancestor
92732568|NCT02214563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732569|NCT02214563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92327602|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732573|NCT01194973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732574|NCT01194973|Immunologic Factors|immunologic factors|mesh-ancestor
92732575|NCT01194973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732576|NCT02218619|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92732577|NCT02218619|Antiviral Agents|antiviral agents|mesh-ancestor
92732578|NCT02218619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732579|NCT02218619|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92732580|NCT02218619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732581|NCT02218697|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92732582|NCT02218697|Immunologic Factors|immunologic factors|mesh-ancestor
92732583|NCT02218697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732584|NCT02216747|Prednisone|prednisone|mesh-list
92732585|NCT02216747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732586|NCT02216747|Glucocorticoids|glucocorticoids|mesh-ancestor
92732587|NCT02216747|Hormones|hormones|mesh-ancestor
92732588|NCT02216747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732589|NCT02216747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732590|NCT02216747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732591|NCT02216747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732592|NCT02216786|Everolimus|everolimus|mesh-list
92732593|NCT02216786|Fulvestrant|fulvestrant|mesh-list
92732594|NCT02216786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92732595|NCT02216786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92732596|NCT02216786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732597|NCT02216786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732598|NCT02216786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732599|NCT02216786|Immunologic Factors|immunologic factors|mesh-ancestor
92732600|NCT02216786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732601|NCT02216786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732602|NCT02216786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732603|NCT02216786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92732604|NCT02216786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92732605|NCT02216786|Hormone Antagonists|hormone antagonists|mesh-ancestor
92732606|NCT02216786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732607|NCT02279147|Neostigmine|neostigmine|mesh-list
92732608|NCT02279147|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92732609|NCT02279147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732610|NCT02279147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732611|NCT02279147|Cholinergic Agents|cholinergic agents|mesh-ancestor
92732612|NCT02279147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732613|NCT02279147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732614|NCT02279147|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92732615|NCT02279147|Autonomic Agents|autonomic agents|mesh-ancestor
92610649|NCT00143234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610650|NCT00143234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92732616|NCT02279147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732617|NCT02279186|Tranexamic Acid|tranexamic acid|mesh-list
92732618|NCT02279186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92732619|NCT02279186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92732620|NCT02279186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732621|NCT02279186|Hemostatics|hemostatics|mesh-ancestor
92732622|NCT02279186|Coagulants|coagulants|mesh-ancestor
92732624|NCT01177540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92732625|NCT01177540|Antimetabolites|antimetabolites|mesh-ancestor
92732626|NCT01177540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732627|NCT01177540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732628|NCT01177540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732629|NCT01177384|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92732630|NCT01177384|Glimepiride|glimepiride|mesh-list
92732631|NCT01177384|Acarbose|acarbose|mesh-list
92732632|NCT01177384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732633|NCT01177384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732634|NCT01177384|Incretins|incretins|mesh-ancestor
92732635|NCT01177384|Hormones|hormones|mesh-ancestor
92732636|NCT01177384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732637|NCT01177384|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92732638|NCT01177384|Protease Inhibitors|protease inhibitors|mesh-ancestor
92732639|NCT01177384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732643|NCT01177384|Immunologic Factors|immunologic factors|mesh-ancestor
92732644|NCT01177384|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92732645|NCT01640093|Abiraterone Acetate|abiraterone acetate|mesh-list
92732646|NCT01640093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732647|NCT01640093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92732648|NCT01640093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732649|NCT01640093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732650|NCT01640093|Hormone Antagonists|hormone antagonists|mesh-ancestor
92732651|NCT01640093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732652|NCT01640093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732653|NCT01640093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92732654|NCT01194154|Epoetin Alfa|epoetin alfa|mesh-list
92732655|NCT01194154|Hematinics|hematinics|mesh-ancestor
92732656|NCT01640210|Insulin|insulin|mesh-list
92732657|NCT01640210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732658|NCT01640210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732659|NCT01640405|Bevacizumab|bevacizumab|mesh-list
92732660|NCT01640405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92732661|NCT01640405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732662|NCT01640405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92732663|NCT01640405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92732664|NCT01640405|Growth Substances|growth substances|mesh-ancestor
92732665|NCT01640405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732666|NCT01640405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92732667|NCT01640444|Bevacizumab|bevacizumab|mesh-list
92732668|NCT01640444|Cetuximab|cetuximab|mesh-list
92732669|NCT01640444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92732670|NCT01640444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732671|NCT01640444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92732672|NCT01640444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92732673|NCT01640444|Growth Substances|growth substances|mesh-ancestor
92732674|NCT01640444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732675|NCT01640444|Growth Inhibitors|growth inhibitors|mesh-ancestor
92732676|NCT01642433|Prazosin|prazosin|mesh-list
92732677|NCT01642433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92732678|NCT01642433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92732679|NCT01642433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92732680|NCT01642433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92732681|NCT01642433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92732682|NCT01642433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732683|NCT01642433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732684|NCT01642433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732685|NCT01642472|Ulipristal acetate|ulipristal acetate|mesh-list
92732686|NCT01642472|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92732687|NCT01642472|Contraceptive Agents|contraceptive agents|mesh-ancestor
92732688|NCT01642472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92610651|NCT00143234|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610652|NCT00143234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610653|NCT00143234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610654|NCT00143234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732689|NCT01642472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732690|NCT01642472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92732691|NCT01640639|Thalidomide|thalidomide|mesh-list
92732692|NCT01640639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732693|NCT01640639|Immunologic Factors|immunologic factors|mesh-ancestor
92732694|NCT01640639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732695|NCT01640639|Leprostatic Agents|leprostatic agents|mesh-ancestor
92732696|NCT01640639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92732697|NCT01640639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732698|NCT01640639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92397994|NCT02873819|Sargramostim|sargramostim|mesh-list
92732699|NCT01640639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92732700|NCT01640639|Growth Substances|growth substances|mesh-ancestor
92732701|NCT01640639|Growth Inhibitors|growth inhibitors|mesh-ancestor
92732702|NCT01640639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732703|NCT01642667|Saruplase|saruplase|mesh-list
92732704|NCT01642667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92732705|NCT01642667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92732706|NCT01642667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732707|NCT01642745|Mannitol|mannitol|mesh-list
92732708|NCT01642745|Methacholine Chloride|methacholine chloride|mesh-list
92732709|NCT01642745|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92732710|NCT01642745|Diuretics|diuretics|mesh-ancestor
92732714|NCT01642745|Autonomic Agents|autonomic agents|mesh-ancestor
92732715|NCT01642745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732716|NCT01642745|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92732717|NCT01642745|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92732718|NCT01642745|Respiratory System Agents|respiratory system agents|mesh-ancestor
92732719|NCT01642745|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92732720|NCT01642745|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92732721|NCT01642745|Cholinergic Agents|cholinergic agents|mesh-ancestor
92732722|NCT01642745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732723|NCT01642745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732725|NCT01640990|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92732726|NCT01640990|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92732727|NCT01640990|Purinergic Agonists|purinergic agonists|mesh-ancestor
92732728|NCT01640990|Purinergic Agents|purinergic agents|mesh-ancestor
92732729|NCT01640990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732730|NCT01640990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732731|NCT01640990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732732|NCT01642862|Simvastatin|simvastatin|mesh-list
92732733|NCT01642862|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92732734|NCT01642862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92732735|NCT01642862|Antimetabolites|antimetabolites|mesh-ancestor
92732736|NCT01642862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732737|NCT01642862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92732738|NCT01642862|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92732739|NCT01642862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732740|NCT01642940|Ticagrelor|ticagrelor|mesh-list
92322306|NCT00002108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732741|NCT01642940|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92732742|NCT01642940|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92732743|NCT01642940|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92732744|NCT01642940|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92732745|NCT01642940|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92732746|NCT01642940|Purinergic Agents|purinergic agents|mesh-ancestor
92732747|NCT01642940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732748|NCT01642940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732749|NCT01642940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732750|NCT04497519|Hydroxychloroquine|hydroxychloroquine|mesh-list
92732751|NCT04497519|Antimalarials|antimalarials|mesh-ancestor
92732752|NCT04497519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92732753|NCT04497519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732754|NCT04497519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732755|NCT04497519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610655|NCT00143234|Vasodilator Agents|vasodilator agents|mesh-ancestor
92732756|NCT04497519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732757|NCT04497519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732759|NCT01641224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92732760|NCT01641224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92732761|NCT01641224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732762|NCT01641224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92732763|NCT01641224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732764|NCT01641224|Parasympatholytics|parasympatholytics|mesh-ancestor
92732765|NCT01641224|Autonomic Agents|autonomic agents|mesh-ancestor
92732766|NCT01641224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732767|NCT01643135|Tranylcypromine|tranylcypromine|mesh-list
92732768|NCT01643135|Tranexamic Acid|tranexamic acid|mesh-list
92732769|NCT01643135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92397997|NCT02873819|Immunologic Factors|immunologic factors|mesh-ancestor
92732770|NCT01643135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92732771|NCT01643135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732772|NCT01643135|Hemostatics|hemostatics|mesh-ancestor
92732773|NCT01643135|Coagulants|coagulants|mesh-ancestor
92732774|NCT01643135|Antidepressive Agents|antidepressive agents|mesh-ancestor
92732775|NCT01643135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92732776|NCT01643135|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92732777|NCT01643135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732778|NCT01643135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92732779|NCT01643135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92732781|NCT01643135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732782|NCT01641419|Dexamethasone|dexamethasone|mesh-list
92732783|NCT01641419|Dexamethasone acetate|dexamethasone acetate|mesh-list
92732784|NCT01641419|BB 1101|bb 1101|mesh-list
92732785|NCT01641419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732786|NCT01641419|Antiemetics|antiemetics|mesh-ancestor
92732787|NCT01641419|Autonomic Agents|autonomic agents|mesh-ancestor
92732788|NCT01641419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732789|NCT01641419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732790|NCT01641419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732791|NCT01641419|Glucocorticoids|glucocorticoids|mesh-ancestor
92732792|NCT01641419|Hormones|hormones|mesh-ancestor
92732793|NCT01641419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732794|NCT01641419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732795|NCT01641419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732796|NCT01641419|Protease Inhibitors|protease inhibitors|mesh-ancestor
92732797|NCT01641419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732798|NCT01641419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732799|NCT01643252|Riboflavin|riboflavin|mesh-list
92732800|NCT01643252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92732801|NCT01643252|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92732802|NCT01643252|Vitamin B Complex|vitamin b complex|mesh-ancestor
92732803|NCT01643252|Vitamins|vitamins|mesh-ancestor
92732804|NCT01643252|Micronutrients|micronutrients|mesh-ancestor
92732805|NCT01643252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732806|NCT01643252|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92732807|NCT01643252|Dermatologic Agents|dermatologic agents|mesh-ancestor
92732808|NCT01641458|Capecitabine|capecitabine|mesh-list
92732809|NCT01641458|Fluorouracil|fluorouracil|mesh-list
92732810|NCT01641458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92732811|NCT01641458|Antimetabolites|antimetabolites|mesh-ancestor
92732812|NCT01641458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732813|NCT01641458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732814|NCT01641458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732815|NCT01641458|Immunologic Factors|immunologic factors|mesh-ancestor
92322307|NCT00002108|Antiviral Agents|antiviral agents|mesh-ancestor
92732816|NCT01641458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732817|NCT01641536|Entecavir|entecavir|mesh-list
92732818|NCT01641536|Antiviral Agents|antiviral agents|mesh-ancestor
92732819|NCT01641536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732820|NCT01641575|Gemcitabine|gemcitabine|mesh-list
92732821|NCT01641575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732822|NCT01641575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92732823|NCT01641575|Antimetabolites|antimetabolites|mesh-ancestor
92732824|NCT01641575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732825|NCT01643447|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92732826|NCT01643447|Urinastatin|urinastatin|mesh-list
92732827|NCT01643447|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92732828|NCT01643447|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92732829|NCT01643447|Protease Inhibitors|protease inhibitors|mesh-ancestor
92610656|NCT00163488|Ciclesonide|ciclesonide|mesh-list
92610657|NCT00163488|Glucocorticoids|glucocorticoids|mesh-ancestor
92610658|NCT00163488|Hormones|hormones|mesh-ancestor
92610659|NCT00163488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610660|NCT00163488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610661|NCT00163488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92610662|NCT00143351|Ziprasidone|ziprasidone|mesh-list
92610663|NCT00143351|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92732830|NCT01643447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732831|NCT01643447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732832|NCT01643447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732833|NCT01643603|Dasatinib|dasatinib|mesh-list
92732834|NCT01643603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732835|NCT01643603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92732836|NCT01643603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732837|NCT01643603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732838|NCT02754011|Capecitabine|capecitabine|mesh-list
92732839|NCT02754011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92732840|NCT02754011|Antimetabolites|antimetabolites|mesh-ancestor
92732841|NCT02754011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732842|NCT02754011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732843|NCT02755844|Metformin|metformin|mesh-list
92732844|NCT02755844|Cyclophosphamide|cyclophosphamide|mesh-list
92732845|NCT02755844|Olaparib|olaparib|mesh-list
92732846|NCT02755844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732847|NCT02755844|Immunologic Factors|immunologic factors|mesh-ancestor
92732848|NCT02755844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732849|NCT02755844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732850|NCT02755844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92732851|NCT02755844|Alkylating Agents|alkylating agents|mesh-ancestor
92732852|NCT02755844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732853|NCT02755844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732856|NCT02755844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92732858|NCT02756897|Venetoclax|venetoclax|mesh-list
92732859|NCT02756897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732860|NCT01601106|Prednisolone|prednisolone|mesh-list
92732861|NCT01601106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732862|NCT01601106|Glucocorticoids|glucocorticoids|mesh-ancestor
92732863|NCT01601106|Hormones|hormones|mesh-ancestor
92732864|NCT01601106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732865|NCT01601106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732866|NCT01601106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92732867|NCT01601106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732868|NCT02750540|Tenofovir|tenofovir|mesh-list
92732869|NCT02750540|Antiviral Agents|antiviral agents|mesh-ancestor
92732870|NCT02750540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732871|NCT02750540|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92732872|NCT02750540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92732873|NCT02750540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732874|NCT02750540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732875|NCT02750540|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92732876|NCT02750540|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92732877|NCT01601184|Temozolomide|temozolomide|mesh-list
92732878|NCT01601184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92732879|NCT01601184|Alkylating Agents|alkylating agents|mesh-ancestor
92732880|NCT01601184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732881|NCT01601184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92732882|NCT01643759|Buprenorphine|buprenorphine|mesh-list
92732883|NCT01643759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92732884|NCT01643759|Narcotics|narcotics|mesh-ancestor
92732885|NCT01643759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732886|NCT01643759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732887|NCT01643759|Analgesics|analgesics|mesh-ancestor
92732888|NCT01643759|Sensory System Agents|sensory system agents|mesh-ancestor
92732889|NCT01643759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732890|NCT01643759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92732891|NCT04488237|Vitamin D|vitamin d|mesh-list
92732893|NCT04488237|Micronutrients|micronutrients|mesh-ancestor
92732894|NCT04488237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732895|NCT04488237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92732896|NCT04528628|Norepinephrine|norepinephrine|mesh-list
92732897|NCT04528628|Serotonin|serotonin|mesh-list
92732898|NCT04528628|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92732899|NCT04528628|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
92732900|NCT04528628|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92732901|NCT04528628|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92732902|NCT04528628|Adrenergic Agents|adrenergic agents|mesh-ancestor
92732903|NCT04528628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732904|NCT04528628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732905|NCT04528628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732906|NCT04528628|Sympathomimetics|sympathomimetics|mesh-ancestor
92732907|NCT04528628|Autonomic Agents|autonomic agents|mesh-ancestor
92732908|NCT04528628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732909|NCT04528628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92732910|NCT04528628|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92732911|NCT04528628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92732912|NCT04528628|Serotonin Agents|serotonin agents|mesh-ancestor
92732913|NCT04528628|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92732914|NCT01641341|Nitazoxanide|nitazoxanide|mesh-list
92732915|NCT01641341|Pancrelipase|pancrelipase|mesh-list
92732916|NCT01641341|Pancreatin|pancreatin|mesh-list
92732917|NCT01641341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732918|NCT01641341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732919|NCT01641341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92732920|NCT01680107|Cycloserine|cycloserine|mesh-list
92732921|NCT01680107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92732922|NCT01680107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732923|NCT01680107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92732924|NCT01680107|Antitubercular Agents|antitubercular agents|mesh-ancestor
92732925|NCT01680107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92732926|NCT01680107|Antimetabolites|antimetabolites|mesh-ancestor
92732930|NCT01680146|Sequestering Agents|sequestering agents|mesh-ancestor
92732931|NCT01680146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732933|NCT01680185|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92732934|NCT01680185|Insulin Lispro|insulin lispro|mesh-list
92732935|NCT01680185|Isophane Insulin, Human|isophane insulin, human|mesh-list
92732936|NCT01680185|Insulin, Isophane|insulin, isophane|mesh-list
92732937|NCT01680185|Isophane insulin, beef|isophane insulin, beef|mesh-list
92732938|NCT01680185|Insulin, Short-Acting|insulin, short-acting|mesh-list
92732939|NCT01680185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732940|NCT01680185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732941|NCT01680263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92732942|NCT01680263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92732943|NCT01680263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92732944|NCT01680263|Analgesics|analgesics|mesh-ancestor
92732945|NCT01680263|Sensory System Agents|sensory system agents|mesh-ancestor
92732946|NCT01680263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732947|NCT01680263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732948|NCT01680263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732949|NCT01601730|Dexetimide|dexetimide|mesh-list
92732950|NCT01601730|Modafinil|modafinil|mesh-list
92732951|NCT01601730|Citalopram|citalopram|mesh-list
92732952|NCT01601730|Escitalopram|escitalopram|mesh-list
92732953|NCT01601730|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92732954|NCT01601730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92732955|NCT01601730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92732956|NCT01601730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732957|NCT01601730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732958|NCT01601730|Serotonin Agents|serotonin agents|mesh-ancestor
92732959|NCT01601730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732960|NCT01601730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92732961|NCT01601730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92732962|NCT01601730|Parasympatholytics|parasympatholytics|mesh-ancestor
92732963|NCT01601730|Autonomic Agents|autonomic agents|mesh-ancestor
92732964|NCT01601730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732965|NCT01601730|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92732966|NCT01601730|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92732967|NCT01601730|Cholinergic Agents|cholinergic agents|mesh-ancestor
92732968|NCT01601730|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92732969|NCT01601730|Antidepressive Agents|antidepressive agents|mesh-ancestor
92732970|NCT01601730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92610665|NCT00143351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610666|NCT00143351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610667|NCT00143351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732971|NCT01601730|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92732972|NCT01601730|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92732973|NCT01601730|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92732974|NCT01601730|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92732976|NCT01644071|Citalopram|citalopram|mesh-list
92732977|NCT01644071|Escitalopram|escitalopram|mesh-list
92732978|NCT01644071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92732979|NCT01644071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92732980|NCT01644071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92732981|NCT01644071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732982|NCT01644071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92732983|NCT01644071|Serotonin Agents|serotonin agents|mesh-ancestor
92732984|NCT01644071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732985|NCT01644071|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92732986|NCT01644071|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92732987|NCT01644071|Parasympatholytics|parasympatholytics|mesh-ancestor
92732988|NCT01644071|Autonomic Agents|autonomic agents|mesh-ancestor
92732989|NCT01644071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732990|NCT01644071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92732991|NCT01644071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92732992|NCT01644071|Cholinergic Agents|cholinergic agents|mesh-ancestor
92732993|NCT01644071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92732994|NCT01644071|Antidepressive Agents|antidepressive agents|mesh-ancestor
92732995|NCT01644071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92732996|NCT01680536|Maraviroc|maraviroc|mesh-list
92732997|NCT01680536|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92732998|NCT01680536|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92733000|NCT01680536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92733001|NCT01680536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92733002|NCT01680536|Antiviral Agents|antiviral agents|mesh-ancestor
92733003|NCT01680536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733004|NCT01680536|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92733005|NCT01602003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92733006|NCT01602003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92733007|NCT01602003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733008|NCT01602003|Incretins|incretins|mesh-ancestor
92733009|NCT01602003|Hormones|hormones|mesh-ancestor
92733010|NCT01602003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733011|NCT01602003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92733012|NCT01602003|Protease Inhibitors|protease inhibitors|mesh-ancestor
92733013|NCT01602003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733014|NCT01602003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733015|NCT01193920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92733016|NCT01193920|Vaccines|vaccines|mesh-list
92733017|NCT01193920|Immunologic Factors|immunologic factors|mesh-ancestor
92733018|NCT01193920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733019|NCT01644773|Dasatinib|dasatinib|mesh-list
92733020|NCT01644773|Crizotinib|crizotinib|mesh-list
92733021|NCT01644773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733022|NCT01644773|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92733023|NCT01644773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733024|NCT01644773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733025|NCT01602588|Hydroxychloroquine|hydroxychloroquine|mesh-list
92733026|NCT01602588|Antimalarials|antimalarials|mesh-ancestor
92733027|NCT01602588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92733028|NCT01602588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92733029|NCT01602588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733030|NCT01602588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733031|NCT01602588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733032|NCT01602588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733033|NCT01681550|Incretins|incretins|mesh-list
92733034|NCT01681550|Hormones|hormones|mesh-ancestor
92733035|NCT01681550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733036|NCT01681550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733037|NCT01645085|Mannitol|mannitol|mesh-list
92610668|NCT00143351|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92610669|NCT00143351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610670|NCT00143351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610671|NCT00143351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92733038|NCT01645085|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92733039|NCT01645085|Diuretics|diuretics|mesh-ancestor
92733040|NCT01645085|Natriuretic Agents|natriuretic agents|mesh-ancestor
92733041|NCT01645085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733042|NCT01645124|Hydroxyurea|hydroxyurea|mesh-list
92014956|NCT05613491|Insulin|insulin|mesh-list
92733043|NCT01645124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733044|NCT01645124|Antisickling Agents|antisickling agents|mesh-ancestor
92733045|NCT01645124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733046|NCT01645124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733047|NCT01645124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92733048|NCT01602861|Spironolactone|spironolactone|mesh-list
92733049|NCT01602861|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92733050|NCT01602861|Hormone Antagonists|hormone antagonists|mesh-ancestor
92733051|NCT01602861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733052|NCT01602861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733053|NCT01602861|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92733054|NCT01602861|Diuretics|diuretics|mesh-ancestor
92733055|NCT01602861|Natriuretic Agents|natriuretic agents|mesh-ancestor
92733057|NCT01681667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92733058|NCT01681667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733059|NCT01681667|Analgesics|analgesics|mesh-ancestor
92733060|NCT01681667|Sensory System Agents|sensory system agents|mesh-ancestor
92733061|NCT01681667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733062|NCT01681667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733063|NCT01681667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733064|NCT01681667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733065|NCT01681667|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92733066|NCT01681667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733067|NCT01681667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733068|NCT01600365|Ganciclovir|ganciclovir|mesh-list
92733069|NCT01600365|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92733070|NCT01600365|Lubricant Eye Drops|lubricant eye drops|mesh-list
92733071|NCT01600365|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92733072|NCT01600365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92733076|NCT01600365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733077|NCT01600365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733078|NCT01602900|Rolipram|rolipram|mesh-list
92733079|NCT01602900|Antidepressive Agents|antidepressive agents|mesh-ancestor
92733080|NCT01602900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92733081|NCT01602900|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92733082|NCT01602900|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92733083|NCT01602900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733084|NCT01602900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733085|NCT01645241|Ganirelix|ganirelix|mesh-list
92733086|NCT01645241|Hormone Antagonists|hormone antagonists|mesh-ancestor
92733087|NCT01645241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733088|NCT01645241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733089|NCT01602939|Cladribine|cladribine|mesh-list
92733090|NCT01602939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733091|NCT01602939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92733092|NCT01602939|Immunologic Factors|immunologic factors|mesh-ancestor
92733093|NCT01602939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733094|NCT01600404|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92733095|NCT01600404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92733096|NCT01600404|Cholinergic Agents|cholinergic agents|mesh-ancestor
92733097|NCT01600404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733098|NCT01600404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733099|NCT01600404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733100|NCT01603134|Allopurinol|allopurinol|mesh-list
92733101|NCT01603134|Antimetabolites|antimetabolites|mesh-ancestor
92733102|NCT01603134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733103|NCT01603134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733104|NCT01603134|Gout Suppressants|gout suppressants|mesh-ancestor
92733105|NCT01603134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733106|NCT01603134|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92610673|NCT00143351|Dopamine Agents|dopamine agents|mesh-ancestor
92610674|NCT00163605|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92610675|NCT00163605|Thrombin|thrombin|mesh-list
92610676|NCT00163605|Calcium|calcium|mesh-list
92017769|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733107|NCT01603134|Antioxidants|antioxidants|mesh-ancestor
92733108|NCT01603134|Protective Agents|protective agents|mesh-ancestor
92733109|NCT01603134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733110|NCT01603173|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92733111|NCT01603173|Antidepressive Agents|antidepressive agents|mesh-ancestor
92733112|NCT01603173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92733113|NCT01603173|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92733114|NCT01603173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92733115|NCT01603173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733116|NCT01603173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733117|NCT01603212|Interferons|interferons|mesh-list
92733118|NCT01603212|Interferon-alpha|interferon-alpha|mesh-list
92733119|NCT01603212|Interferon alpha-2|interferon alpha-2|mesh-list
92733120|NCT01603212|Aldesleukin|aldesleukin|mesh-list
92733121|NCT01603212|Interleukin-2|interleukin-2|mesh-list
92733122|NCT01603212|Vemurafenib|vemurafenib|mesh-list
92733123|NCT01603212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733124|NCT01603212|Antiviral Agents|antiviral agents|mesh-ancestor
92733125|NCT01603212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733126|NCT01603212|Immunologic Factors|immunologic factors|mesh-ancestor
92733127|NCT01603212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733128|NCT01603212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733129|NCT01603212|Analgesics|analgesics|mesh-ancestor
92733130|NCT01603212|Sensory System Agents|sensory system agents|mesh-ancestor
92733131|NCT01603212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733132|NCT01603212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92733133|NCT01603212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92733134|NCT01603212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92733135|NCT01603212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733136|NCT01603212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733137|NCT01645748|Cisplatin|cisplatin|mesh-list
92733138|NCT01645748|Docetaxel|docetaxel|mesh-list
92733139|NCT01645748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733140|NCT01645748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733141|NCT01645748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92733142|NCT01645748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733143|NCT01645748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733144|NCT02484924|Clopidogrel|clopidogrel|mesh-list
92733146|NCT02484924|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92733147|NCT02484924|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92733148|NCT02484924|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92733149|NCT02484924|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92733150|NCT02484924|Purinergic Agents|purinergic agents|mesh-ancestor
92733151|NCT02484924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733152|NCT02484924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733153|NCT02484924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733154|NCT01645826|Diltiazem|diltiazem|mesh-list
92733155|NCT01645826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92733156|NCT01645826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92733157|NCT01645826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92733158|NCT01645826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733159|NCT01645826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92733160|NCT01645826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733161|NCT01645826|Vasodilator Agents|vasodilator agents|mesh-ancestor
92733162|NCT01607034|Pramipexole|pramipexole|mesh-list
92733163|NCT01607034|Antioxidants|antioxidants|mesh-ancestor
92733164|NCT01607034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733165|NCT01607034|Protective Agents|protective agents|mesh-ancestor
92733166|NCT01607034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733167|NCT01607034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92733168|NCT01607034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92733169|NCT01607034|Dopamine Agonists|dopamine agonists|mesh-ancestor
92733170|NCT01607034|Dopamine Agents|dopamine agents|mesh-ancestor
92733171|NCT01607034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610677|NCT00163605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610678|NCT00163605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610679|NCT00163605|Hemostatics|hemostatics|mesh-ancestor
92610680|NCT00163605|Coagulants|coagulants|mesh-ancestor
92610681|NCT02598583|Ravulizumab|ravulizumab|mesh-list
92610682|NCT02598583|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92610683|NCT02598583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92733172|NCT01603251|Ivermectin|ivermectin|mesh-list
92733173|NCT01603251|Lumefantrine|lumefantrine|mesh-list
92733174|NCT01603251|Artemether|artemether|mesh-list
92733175|NCT01603251|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92733176|NCT01603251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92733177|NCT01603251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733178|NCT01603251|Antimalarials|antimalarials|mesh-ancestor
92733179|NCT01603251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92733180|NCT01646294|Mirabegron|mirabegron|mesh-list
92733181|NCT01646294|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92733182|NCT01646294|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92733183|NCT01646294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733184|NCT01646294|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733185|NCT01646294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733186|NCT01646294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733187|NCT01646294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733188|NCT01646294|Urological Agents|urological agents|mesh-ancestor
92733189|NCT01603758|Ezetimibe|ezetimibe|mesh-list
92733190|NCT01603758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92733191|NCT01603758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92733192|NCT01603758|Antimetabolites|antimetabolites|mesh-ancestor
92733193|NCT01603758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733194|NCT01603758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92733195|NCT01177228|Vedolizumab|vedolizumab|mesh-list
92733196|NCT01177228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733197|NCT02279342|Febuxostat|febuxostat|mesh-list
92733198|NCT02279342|Gout Suppressants|gout suppressants|mesh-ancestor
92733199|NCT02279342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733200|NCT01607307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92733201|NCT02279381|Chlorhexidine|chlorhexidine|mesh-list
92733202|NCT02279381|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92733203|NCT02279381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733204|NCT02279381|Disinfectants|disinfectants|mesh-ancestor
92733205|NCT01646567|Betamethasone|betamethasone|mesh-list
92733206|NCT01646567|Betamethasone Valerate|betamethasone valerate|mesh-list
92733207|NCT01646567|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92733208|NCT01646567|Betamethasone benzoate|betamethasone benzoate|mesh-list
92733209|NCT01646567|Calcipotriene|calcipotriene|mesh-list
92733210|NCT01646567|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92733211|NCT01646567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733212|NCT01646567|Glucocorticoids|glucocorticoids|mesh-ancestor
92733213|NCT01646567|Hormones|hormones|mesh-ancestor
92733214|NCT01646567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733215|NCT01646567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733216|NCT01646567|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92733217|NCT01646567|Respiratory System Agents|respiratory system agents|mesh-ancestor
92733218|NCT01646567|Dermatologic Agents|dermatologic agents|mesh-ancestor
92733219|NCT01681979|Fluticasone|fluticasone|mesh-list
92733223|NCT01681979|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92733224|NCT01681979|Autonomic Agents|autonomic agents|mesh-ancestor
92733225|NCT01681979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733226|NCT01681979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733227|NCT01681979|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92733228|NCT01681979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92733229|NCT01681979|Dermatologic Agents|dermatologic agents|mesh-ancestor
92733230|NCT01681979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92733231|NCT01681979|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92733232|NCT01681979|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92733233|NCT01681979|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733234|NCT01681979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733235|NCT01681979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733236|NCT01681979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733237|NCT01646684|Pasireotide|pasireotide|mesh-list
92733238|NCT01646684|Hormones|hormones|mesh-ancestor
92733239|NCT01646684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733240|NCT01646684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733241|NCT01607580|Methylprednisolone|methylprednisolone|mesh-list
92733242|NCT01607580|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92733243|NCT01607580|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92733244|NCT01607580|Prednisolone|prednisolone|mesh-list
92733245|NCT01607580|Prednisolone acetate|prednisolone acetate|mesh-list
92733246|NCT01607580|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92733247|NCT01607580|Prednisolone phosphate|prednisolone phosphate|mesh-list
92733248|NCT01607580|Glucocorticoids|glucocorticoids|mesh-list
92733249|NCT01607580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733250|NCT01607580|Antiemetics|antiemetics|mesh-ancestor
92733251|NCT01607580|Autonomic Agents|autonomic agents|mesh-ancestor
92733252|NCT01607580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733253|NCT01607580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733254|NCT01607580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733255|NCT01607580|Hormones|hormones|mesh-ancestor
92733256|NCT01607580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733257|NCT01607580|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92733258|NCT01607580|Protective Agents|protective agents|mesh-ancestor
92733259|NCT01607580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92733260|NCT01607580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733261|NCT01647152|Ustekinumab|ustekinumab|mesh-list
92733262|NCT01647152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92733263|NCT01604187|Fentanyl|fentanyl|mesh-list
92733264|NCT01604187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92733266|NCT01604187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733267|NCT01604187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733268|NCT01604187|Analgesics|analgesics|mesh-ancestor
92733269|NCT01604187|Sensory System Agents|sensory system agents|mesh-ancestor
92733270|NCT01604187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733271|NCT01604187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92733272|NCT01604187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92733273|NCT01604187|Anesthetics, General|anesthetics, general|mesh-ancestor
92733274|NCT01604187|Anesthetics|anesthetics|mesh-ancestor
92733275|NCT01604382|Remifentanil|remifentanil|mesh-list
92733276|NCT01604382|Bupivacaine|bupivacaine|mesh-list
92733277|NCT01604382|Anesthetics|anesthetics|mesh-list
92733278|NCT01604382|Propofol|propofol|mesh-list
92733279|NCT01604382|Anesthetics, Local|anesthetics, local|mesh-ancestor
92733280|NCT01604382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733281|NCT01604382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733282|NCT01604382|Sensory System Agents|sensory system agents|mesh-ancestor
92733283|NCT01604382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733284|NCT01604382|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92733285|NCT01604382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92733286|NCT01604382|Anesthetics, General|anesthetics, general|mesh-ancestor
92733287|NCT01604382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92733288|NCT01604382|Narcotics|narcotics|mesh-ancestor
92733289|NCT01604382|Analgesics|analgesics|mesh-ancestor
92733290|NCT01682408|Mannitol|mannitol|mesh-list
92733291|NCT01682408|Ranitidine|ranitidine|mesh-list
92733292|NCT01682408|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92733293|NCT01682408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92733294|NCT01682408|Diuretics|diuretics|mesh-ancestor
92733295|NCT01682408|Natriuretic Agents|natriuretic agents|mesh-ancestor
92733298|NCT01682408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733299|NCT01682408|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92733300|NCT01682408|Histamine Antagonists|histamine antagonists|mesh-ancestor
92733301|NCT01682408|Histamine Agents|histamine agents|mesh-ancestor
92733302|NCT01682408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733303|NCT01682408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733304|NCT01607970|Oxytocin|oxytocin|mesh-list
92733305|NCT01607970|Oxytocics|oxytocics|mesh-ancestor
92733306|NCT01607970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92733307|NCT01607970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733308|NCT01608009|Paclitaxel|paclitaxel|mesh-list
92733309|NCT01608009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92733310|NCT01608009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733311|NCT01608009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733312|NCT01608009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92733313|NCT01608009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398036|NCT02719314|Methylprednisolone|methylprednisolone|mesh-list
92610685|NCT02598583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610686|NCT00143429|Latanoprost|latanoprost|mesh-list
92733314|NCT01608009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733315|NCT01647347|Povidone-Iodine|povidone-iodine|mesh-list
92733316|NCT01647347|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92733317|NCT01647347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733318|NCT01604031|Lenalidomide|lenalidomide|mesh-list
92733319|NCT01604031|Immunologic Factors|immunologic factors|mesh-ancestor
92733320|NCT01604031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733321|NCT01604031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92733322|NCT01604031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92733323|NCT01604031|Growth Substances|growth substances|mesh-ancestor
92733324|NCT01604031|Growth Inhibitors|growth inhibitors|mesh-ancestor
92733325|NCT01604031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733326|NCT01682564|Candesartan cilexetil|candesartan cilexetil|mesh-list
92733327|NCT01682564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92733328|NCT01682564|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92733329|NCT01682564|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92733330|NCT01682564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733331|NCT01608360|Lidocaine|lidocaine|mesh-list
92733332|NCT01608360|Anesthetics, Local|anesthetics, local|mesh-ancestor
92733333|NCT01608360|Anesthetics|anesthetics|mesh-ancestor
92733334|NCT01608360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733335|NCT01608360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733336|NCT01608360|Sensory System Agents|sensory system agents|mesh-ancestor
92733337|NCT01608360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733338|NCT01608360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92322308|NCT00002108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733339|NCT01608360|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92733340|NCT01608360|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92733341|NCT01608360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92733342|NCT01608360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733343|NCT01647659|Trametinib|trametinib|mesh-list
92733344|NCT01647659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733345|NCT01647659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92733346|NCT01647659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733347|NCT01647659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733348|NCT01604811|Tamsulosin|tamsulosin|mesh-list
92733349|NCT01604811|Saw palmetto extract|saw palmetto extract|mesh-list
92733350|NCT01604811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92733351|NCT01604811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92733352|NCT01604811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92733353|NCT01604811|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733354|NCT01604811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733355|NCT01604811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733356|NCT01604811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733357|NCT01604811|Urological Agents|urological agents|mesh-ancestor
92733358|NCT01683032|Methylphenidate|methylphenidate|mesh-list
92733359|NCT01683032|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92733360|NCT01683032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733361|NCT01683032|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92733362|NCT01683032|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92733363|NCT01683032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92327603|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92733364|NCT01683032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733366|NCT01683032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733367|NCT01604928|Mirabegron|mirabegron|mesh-list
92733368|NCT01604928|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92733369|NCT01604928|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92733370|NCT01604928|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92733371|NCT01604928|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733372|NCT01604928|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733373|NCT01604928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733374|NCT01604928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733375|NCT01604928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733376|NCT01604928|Urological Agents|urological agents|mesh-ancestor
92733377|NCT01604928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92733378|NCT01604928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92733379|NCT01604928|Cholinergic Agents|cholinergic agents|mesh-ancestor
92610687|NCT00143429|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92610688|NCT00143429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92610689|NCT02598895|Carboplatin|carboplatin|mesh-list
92610690|NCT02598895|Docetaxel|docetaxel|mesh-list
92610691|NCT02598895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733380|NCT01683149|Sorafenib|sorafenib|mesh-list
92733381|NCT01683149|Topotecan|topotecan|mesh-list
92733382|NCT01683149|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
92733383|NCT01683149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733384|NCT01683149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92733385|NCT01683149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733386|NCT01683149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733387|NCT01683149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92733388|NCT01608555|Tobramycin|tobramycin|mesh-list
92733389|NCT01608555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92733390|NCT01608555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733391|NCT01605084|Ritonavir|ritonavir|mesh-list
92733392|NCT01605084|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92733393|NCT01605084|Darunavir|darunavir|mesh-list
92733394|NCT01605084|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92733395|NCT01605084|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92733396|NCT01605084|Protease Inhibitors|protease inhibitors|mesh-ancestor
92733397|NCT01605084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733398|NCT01605084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733399|NCT01605084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92733400|NCT01605084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92733401|NCT01605084|Antiviral Agents|antiviral agents|mesh-ancestor
92733402|NCT01605084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733403|NCT01605084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92733404|NCT01605084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92733405|NCT01647893|Bivalirudin|bivalirudin|mesh-list
92733406|NCT01647893|Antithrombins|antithrombins|mesh-ancestor
92733407|NCT01647893|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92733408|NCT01647893|Protease Inhibitors|protease inhibitors|mesh-ancestor
92733409|NCT01647893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733410|NCT01647893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733411|NCT01647893|Anticoagulants|anticoagulants|mesh-ancestor
92733412|NCT01648010|Mitomycins|mitomycins|mesh-list
92322309|NCT00002108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92733413|NCT01648010|Mitomycin|mitomycin|mesh-list
92733414|NCT01648010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92733415|NCT01648010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733416|NCT01648010|Alkylating Agents|alkylating agents|mesh-ancestor
92733417|NCT01648010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733418|NCT01648010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92733419|NCT01648010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733420|NCT01605318|Irinotecan|irinotecan|mesh-list
92733421|NCT01605318|Labetuzumab|labetuzumab|mesh-list
92733422|NCT01605318|Immunoconjugates|immunoconjugates|mesh-list
92733423|NCT01605318|Immunologic Factors|immunologic factors|mesh-ancestor
92733424|NCT01605318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733425|NCT01605318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92733426|NCT01605318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92733427|NCT01605318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733428|NCT01605318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733429|NCT01605318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733430|NCT01605318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92733431|NCT01608711|Gemcitabine|gemcitabine|mesh-list
92733432|NCT01608711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92733433|NCT01608711|Antimetabolites|antimetabolites|mesh-ancestor
92733434|NCT01608711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733435|NCT01608711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733436|NCT01605357|Mannitol|mannitol|mesh-list
92733437|NCT01605357|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92733440|NCT01605357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733441|NCT01648127|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92733442|NCT01648127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92733443|NCT01648127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733444|NCT01608750|Folic Acid|folic acid|mesh-list
92733445|NCT01608750|Hematinics|hematinics|mesh-ancestor
92733446|NCT01608750|Vitamin B Complex|vitamin b complex|mesh-ancestor
92733447|NCT01608750|Vitamins|vitamins|mesh-ancestor
92733448|NCT01608750|Micronutrients|micronutrients|mesh-ancestor
92610693|NCT02598895|Antimitotic Agents|antimitotic agents|mesh-ancestor
92610694|NCT02598895|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733449|NCT01608750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733450|NCT01605513|Interferons|interferons|mesh-list
92733451|NCT01605513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733452|NCT01605513|Antiviral Agents|antiviral agents|mesh-ancestor
92733453|NCT01605513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733454|NCT04528277|Isoniazid|isoniazid|mesh-list
92733455|NCT04528277|Rifapentine|rifapentine|mesh-list
92733456|NCT04528277|Antitubercular Agents|antitubercular agents|mesh-ancestor
92733457|NCT04528277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92733458|NCT04528277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733459|NCT04528277|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92733460|NCT04528277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92733461|NCT04528277|Antimetabolites|antimetabolites|mesh-ancestor
92733462|NCT04528277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733463|NCT04528277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92733464|NCT04528277|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92733465|NCT04528277|Leprostatic Agents|leprostatic agents|mesh-ancestor
92733466|NCT01683656|Niacin|niacin|mesh-list
92733467|NCT01683656|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92733468|NCT01683656|Antimetabolites|antimetabolites|mesh-ancestor
92733469|NCT01683656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733470|NCT01683656|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92733471|NCT01683656|Vasodilator Agents|vasodilator agents|mesh-ancestor
92733472|NCT01683656|Vitamin B Complex|vitamin b complex|mesh-ancestor
92733473|NCT01683656|Vitamins|vitamins|mesh-ancestor
92733474|NCT01683656|Micronutrients|micronutrients|mesh-ancestor
92733475|NCT01683656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733476|NCT01605864|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92733477|NCT01605864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92733478|NCT01605864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733479|NCT01608945|Hydrocortisone|hydrocortisone|mesh-list
92733480|NCT01608945|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92733481|NCT01608945|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92733482|NCT01608945|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92733483|NCT01608945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733484|NCT01608984|Sufentanil|sufentanil|mesh-list
92733485|NCT01608984|Isoflurane|isoflurane|mesh-list
92733486|NCT01608984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92733487|NCT01608984|Narcotics|narcotics|mesh-ancestor
92733488|NCT01608984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733489|NCT01608984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733490|NCT01608984|Analgesics|analgesics|mesh-ancestor
92733491|NCT01608984|Sensory System Agents|sensory system agents|mesh-ancestor
92733492|NCT01608984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733493|NCT01608984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92733494|NCT01608984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92733495|NCT01608984|Anesthetics, General|anesthetics, general|mesh-ancestor
92733496|NCT01608984|Anesthetics|anesthetics|mesh-ancestor
92733497|NCT01608984|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92733498|NCT01648517|Carboplatin|carboplatin|mesh-list
92733499|NCT01648517|Gemcitabine|gemcitabine|mesh-list
92733500|NCT01648517|Docetaxel|docetaxel|mesh-list
92733501|NCT01648517|Vinorelbine|vinorelbine|mesh-list
92733502|NCT01648517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733503|NCT01648517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92733504|NCT01648517|Antimetabolites|antimetabolites|mesh-ancestor
92733505|NCT01648517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733506|NCT01648517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733507|NCT01648517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92733508|NCT01648517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733509|NCT01648517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92733510|NCT01609101|Cobalt|cobalt|mesh-list
92733511|NCT01609101|Trace Elements|trace elements|mesh-ancestor
92733512|NCT01609101|Micronutrients|micronutrients|mesh-ancestor
92733513|NCT01609101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733514|NCT01648556|Prednisone|prednisone|mesh-list
92733515|NCT01648556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733518|NCT01648556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733519|NCT01648556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733520|NCT01648556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92733522|NCT01648595|Fentanyl|fentanyl|mesh-list
92733523|NCT01648595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92610695|NCT02598895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610696|NCT05147272|Gemcitabine|gemcitabine|mesh-list
92017791|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
92733524|NCT01648595|Narcotics|narcotics|mesh-ancestor
92733525|NCT01648595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733526|NCT01648595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733527|NCT01648595|Analgesics|analgesics|mesh-ancestor
92733528|NCT01648595|Sensory System Agents|sensory system agents|mesh-ancestor
92733529|NCT01648595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733530|NCT01648595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92733531|NCT01648595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92733532|NCT01648595|Anesthetics, General|anesthetics, general|mesh-ancestor
92733533|NCT01648595|Anesthetics|anesthetics|mesh-ancestor
92733534|NCT01648634|Nebivolol|nebivolol|mesh-list
92733535|NCT01648634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92733536|NCT01648634|Vasodilator Agents|vasodilator agents|mesh-ancestor
92733537|NCT01648634|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92733538|NCT01648634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92733539|NCT01648634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733540|NCT01648634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733541|NCT01648634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733542|NCT01648634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733543|NCT01648634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733544|NCT01606059|Acetaminophen|acetaminophen|mesh-list
92733545|NCT01606059|Tramadol|tramadol|mesh-list
92733546|NCT01606059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733547|NCT01606059|Analgesics|analgesics|mesh-ancestor
92733548|NCT01606059|Sensory System Agents|sensory system agents|mesh-ancestor
92733549|NCT01606059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733550|NCT01606059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733551|NCT01606059|Antipyretics|antipyretics|mesh-ancestor
92733552|NCT01606059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92733553|NCT01606059|Narcotics|narcotics|mesh-ancestor
92733554|NCT01606059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733555|NCT01648712|Heparin|heparin|mesh-list
92733556|NCT01648712|Anticoagulants|anticoagulants|mesh-ancestor
92733557|NCT01648712|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92733558|NCT01648712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92733559|NCT01648712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733560|NCT01688544|Benzimidazole|benzimidazole|mesh-list
92733561|NCT01688544|Anthelmintics|anthelmintics|mesh-ancestor
92733562|NCT01688544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92733563|NCT01688544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322310|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92733564|NCT01688583|Fentanyl|fentanyl|mesh-list
92733565|NCT01688583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92733566|NCT01688583|Narcotics|narcotics|mesh-ancestor
92733567|NCT01688583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733568|NCT01688583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733569|NCT01688583|Analgesics|analgesics|mesh-ancestor
92733570|NCT01688583|Sensory System Agents|sensory system agents|mesh-ancestor
92733571|NCT01688583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733572|NCT01688583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92733573|NCT01688583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92733574|NCT01688583|Anesthetics, General|anesthetics, general|mesh-ancestor
92733575|NCT01688583|Anesthetics|anesthetics|mesh-ancestor
92733576|NCT01648829|Atorvastatin|atorvastatin|mesh-list
92733577|NCT01648829|Pitavastatin|pitavastatin|mesh-list
92733578|NCT01648829|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92733579|NCT01648829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92733580|NCT01648829|Antimetabolites|antimetabolites|mesh-ancestor
92733581|NCT01648829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733582|NCT01648829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92733583|NCT01648829|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92733584|NCT01648829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733585|NCT01688700|Paclitaxel|paclitaxel|mesh-list
92733586|NCT01688700|Nimotuzumab|nimotuzumab|mesh-list
92733587|NCT01688700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92733588|NCT01688700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733589|NCT01688700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733593|NCT01688700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92733594|NCT01684085|Lorazepam|lorazepam|mesh-list
92733595|NCT01684085|Anticonvulsants|anticonvulsants|mesh-ancestor
92733596|NCT01684085|Antiemetics|antiemetics|mesh-ancestor
92610697|NCT05147272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610699|NCT05147272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610700|NCT05147272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733597|NCT01684085|Autonomic Agents|autonomic agents|mesh-ancestor
92733598|NCT01684085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733599|NCT01684085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733600|NCT01684085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733601|NCT01684085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92733602|NCT01684085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733603|NCT01684085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92733604|NCT01684085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92733605|NCT01684085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92733606|NCT01684085|GABA Modulators|gaba modulators|mesh-ancestor
92733607|NCT01684085|GABA Agents|gaba agents|mesh-ancestor
92733608|NCT01684085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733609|NCT01684085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733610|NCT01684241|Vaccines|vaccines|mesh-list
92733611|NCT01684241|Immunologic Factors|immunologic factors|mesh-ancestor
92733612|NCT01684241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733613|NCT01688934|Naproxen|naproxen|mesh-list
92733614|NCT01688934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92733615|NCT01688934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733616|NCT01688934|Analgesics|analgesics|mesh-ancestor
92733617|NCT01688934|Sensory System Agents|sensory system agents|mesh-ancestor
92733618|NCT01688934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733619|NCT01688934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733620|NCT01688934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733621|NCT01688934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733622|NCT01688934|Gout Suppressants|gout suppressants|mesh-ancestor
92733623|NCT01688934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92733624|NCT01688934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733625|NCT01688934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733626|NCT01684319|Caseins|caseins|mesh-list
92733627|NCT01684319|Chelating Agents|chelating agents|mesh-ancestor
92733628|NCT01684319|Sequestering Agents|sequestering agents|mesh-ancestor
92733629|NCT01684319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733630|NCT02279576|Paclitaxel|paclitaxel|mesh-list
92733631|NCT02279576|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92733632|NCT02279576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92733633|NCT02279576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733634|NCT02279576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733635|NCT02279576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92733636|NCT02279576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733637|NCT02279576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733638|NCT02279615|Tamsulosin|tamsulosin|mesh-list
92733639|NCT02279615|Mirabegron|mirabegron|mesh-list
92733640|NCT02279615|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92733641|NCT02279615|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92733642|NCT02279615|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92322311|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
92733643|NCT02279615|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733644|NCT02279615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733645|NCT02279615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733646|NCT02279615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733647|NCT02279615|Urological Agents|urological agents|mesh-ancestor
92733648|NCT02279615|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92733649|NCT02279615|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92733650|NCT02279615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733651|NCT01689051|Glucagon|glucagon|mesh-list
92733652|NCT01689051|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92733653|NCT01689051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733654|NCT01689051|Hormones|hormones|mesh-ancestor
92733655|NCT01689051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733656|NCT01689051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733657|NCT01689051|Incretins|incretins|mesh-ancestor
92733658|NCT01689090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
92733659|NCT01689090|Citric Acid|citric acid|mesh-list
92733660|NCT01689090|Sodium Citrate|sodium citrate|mesh-list
92733664|NCT01689090|Chelating Agents|chelating agents|mesh-ancestor
92610702|NCT00143546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92610703|NCT00143546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92610704|NCT00143546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017798|NCT04941625|Cystatins|cystatins|mesh-list
92733665|NCT01689090|Sequestering Agents|sequestering agents|mesh-ancestor
92733666|NCT01689090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733667|NCT01689090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92733668|NCT01689090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733669|NCT01689090|Analgesics|analgesics|mesh-ancestor
92733670|NCT01689090|Sensory System Agents|sensory system agents|mesh-ancestor
92733671|NCT01689090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733672|NCT01689090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733673|NCT01689090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733674|NCT01689090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733675|NCT01689090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733676|NCT01689129|Insulin|insulin|mesh-list
92733677|NCT01689129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92733678|NCT01689129|Insulin Glargine|insulin glargine|mesh-list
92733679|NCT01689129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92733680|NCT01689129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733681|NCT01689285|Valacyclovir|valacyclovir|mesh-list
92733682|NCT01689285|Antiviral Agents|antiviral agents|mesh-ancestor
92733683|NCT01689285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733684|NCT01606527|Ibuprofen|ibuprofen|mesh-list
92733685|NCT01606527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92733686|NCT01606527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733687|NCT01606527|Analgesics|analgesics|mesh-ancestor
92733688|NCT01606527|Sensory System Agents|sensory system agents|mesh-ancestor
92733689|NCT01606527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733690|NCT01606527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733691|NCT01606527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733692|NCT01606527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733693|NCT01606527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92733694|NCT01606527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733695|NCT01606527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733696|NCT01609335|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92733697|NCT01609335|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92733698|NCT01609335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733699|NCT01609413|Calcium Carbonate|calcium carbonate|mesh-list
92733700|NCT01609413|Antacids|antacids|mesh-ancestor
92733701|NCT01609413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733702|NCT01609413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733703|NCT02279966|Vortioxetine|vortioxetine|mesh-list
92733704|NCT02279966|Paroxetine|paroxetine|mesh-list
92733705|NCT02279966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92733706|NCT02279966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92733707|NCT02279966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92733708|NCT02279966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733709|NCT02279966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733710|NCT02279966|Serotonin Agents|serotonin agents|mesh-ancestor
92733711|NCT02279966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733712|NCT02279966|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92733713|NCT02279966|Antidepressive Agents|antidepressive agents|mesh-ancestor
92733714|NCT02279966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92733715|NCT02279966|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92733716|NCT02279966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92733717|NCT02279966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733718|NCT02279966|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92733719|NCT02279966|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92733720|NCT02279966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733721|NCT02279966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92733722|NCT02279966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92733723|NCT02279966|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92733724|NCT02279966|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92733726|NCT01684787|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92733727|NCT01684787|Interferon-alpha|interferon-alpha|mesh-list
92733728|NCT01684787|Antimetabolites|antimetabolites|mesh-ancestor
92610705|NCT00143546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92610706|NCT00155883|Leucovorin|leucovorin|mesh-list
92610707|NCT00155883|Fluorouracil|fluorouracil|mesh-list
92610708|NCT00155883|Antimetabolites|antimetabolites|mesh-ancestor
92610709|NCT00155883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733729|NCT01684787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733730|NCT01684787|Antiviral Agents|antiviral agents|mesh-ancestor
92327604|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
92733735|NCT01649258|Fosaprepitant|fosaprepitant|mesh-list
92733736|NCT01649258|Aprepitant|aprepitant|mesh-list
92733737|NCT01649258|Antiemetics|antiemetics|mesh-ancestor
92733738|NCT01649258|Autonomic Agents|autonomic agents|mesh-ancestor
92733739|NCT01649258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733740|NCT01649258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733741|NCT01649258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92733742|NCT01649258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92733743|NCT01649258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92733744|NCT01649258|Serotonin Agents|serotonin agents|mesh-ancestor
92733745|NCT01649258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733746|NCT01649258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733747|NCT01649258|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92733748|NCT01649336|Paclitaxel|paclitaxel|mesh-list
92733749|NCT01649336|Antimitotic Agents|antimitotic agents|mesh-list
92733750|NCT01649336|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92733751|NCT01649336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733752|NCT01649336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733753|NCT01649336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733754|NCT01649336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733755|NCT01609491|Phenylephrine|phenylephrine|mesh-list
92733756|NCT01609491|Oxymetazoline|oxymetazoline|mesh-list
92733757|NCT01609491|Norepinephrine|norepinephrine|mesh-list
92733758|NCT01609491|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92733759|NCT01609491|Mydriatics|mydriatics|mesh-ancestor
92733760|NCT01609491|Autonomic Agents|autonomic agents|mesh-ancestor
92733761|NCT01609491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733762|NCT01609491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733763|NCT01609491|Sympathomimetics|sympathomimetics|mesh-ancestor
92733764|NCT01609491|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92733765|NCT01609491|Nasal Decongestants|nasal decongestants|mesh-ancestor
92733766|NCT01609491|Respiratory System Agents|respiratory system agents|mesh-ancestor
92733767|NCT01609491|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92733768|NCT01609491|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92733769|NCT01609491|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733770|NCT01609491|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733771|NCT01609491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733772|NCT01609491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733773|NCT01609491|Protective Agents|protective agents|mesh-ancestor
92733774|NCT01606878|Cyclophosphamide|cyclophosphamide|mesh-list
92733775|NCT01606878|Doxorubicin|doxorubicin|mesh-list
92733776|NCT01606878|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92733777|NCT01606878|Vincristine|vincristine|mesh-list
92733778|NCT01606878|Topotecan|topotecan|mesh-list
92733779|NCT01606878|Crizotinib|crizotinib|mesh-list
92733780|NCT01606878|Dexrazoxane|dexrazoxane|mesh-list
92733781|NCT01606878|Razoxane|razoxane|mesh-list
92733782|NCT01606878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92733783|NCT01606878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92733784|NCT01606878|Immunologic Factors|immunologic factors|mesh-ancestor
92733785|NCT01606878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733786|NCT01606878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733787|NCT01606878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92733788|NCT01606878|Alkylating Agents|alkylating agents|mesh-ancestor
92733789|NCT01606878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733790|NCT01606878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733791|NCT01606878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92733792|NCT01606878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92733793|NCT01606878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92733794|NCT01606878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92733795|NCT01606878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733796|NCT01606878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92610710|NCT00155883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92733797|NCT01606878|Tubulin Modulators|tubulin modulators|mesh-ancestor
92733798|NCT01606878|Antimitotic Agents|antimitotic agents|mesh-ancestor
92733799|NCT01606878|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733800|NCT01606878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92733801|NCT01606878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92733802|NCT01606878|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92733804|NCT01684865|Rituximab|rituximab|mesh-list
92733805|NCT01684865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92733806|NCT01684865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733807|NCT01684865|Immunologic Factors|immunologic factors|mesh-ancestor
92733808|NCT01684865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733809|NCT01684865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733810|NCT01580163|Methadone|methadone|mesh-list
92733811|NCT01580163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92733812|NCT01580163|Narcotics|narcotics|mesh-ancestor
92733813|NCT01580163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733814|NCT01580163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733815|NCT01580163|Analgesics|analgesics|mesh-ancestor
92733816|NCT01580163|Sensory System Agents|sensory system agents|mesh-ancestor
92733817|NCT01580163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733818|NCT01580163|Antitussive Agents|antitussive agents|mesh-ancestor
92733819|NCT01580163|Respiratory System Agents|respiratory system agents|mesh-ancestor
92733820|NCT01609647|Clopidogrel|clopidogrel|mesh-list
92733821|NCT01609647|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92733822|NCT01609647|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92733823|NCT01609647|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92733824|NCT01609647|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92733825|NCT01609647|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92733826|NCT01609647|Purinergic Agents|purinergic agents|mesh-ancestor
92733827|NCT01609647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733828|NCT01609647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733829|NCT01609647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733830|NCT01580202|Lamivudine|lamivudine|mesh-list
92733831|NCT01580202|Entecavir|entecavir|mesh-list
92733832|NCT01580202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92733833|NCT01580202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92733834|NCT01580202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733835|NCT01580202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733836|NCT01580202|Antiviral Agents|antiviral agents|mesh-ancestor
92733837|NCT01580202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733838|NCT01580202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92733839|NCT01580202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92733840|NCT01649570|Insulin Aspart|insulin aspart|mesh-list
92733841|NCT01649570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92733842|NCT01649570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733843|NCT01609881|Ketorolac|ketorolac|mesh-list
92733844|NCT01609881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92733845|NCT01609881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92733846|NCT01609881|Analgesics|analgesics|mesh-ancestor
92733847|NCT01609881|Sensory System Agents|sensory system agents|mesh-ancestor
92733848|NCT01609881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733849|NCT01609881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733850|NCT01609881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733851|NCT01609881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733852|NCT01609881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92733853|NCT01609881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733854|NCT01609881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733855|NCT01609959|Valsartan|valsartan|mesh-list
92733856|NCT01609959|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92733857|NCT01609959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92733858|NCT01609959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92733859|NCT01609959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92733860|NCT01609959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733861|NCT01609998|Vaccines|vaccines|mesh-list
92733862|NCT01609998|Immunologic Factors|immunologic factors|mesh-ancestor
92733863|NCT01609998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733864|NCT01606098|Bevacizumab|bevacizumab|mesh-list
92322312|NCT00381134|Losartan|losartan|mesh-list
92733865|NCT01606098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92733867|NCT01606098|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92733868|NCT01606098|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92733869|NCT01606098|Growth Substances|growth substances|mesh-ancestor
92610711|NCT00155883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610712|NCT00155883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610713|NCT00155883|Immunologic Factors|immunologic factors|mesh-ancestor
92017807|NCT04922047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733870|NCT01606098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733871|NCT01606098|Growth Inhibitors|growth inhibitors|mesh-ancestor
92733872|NCT01649921|Interferons|interferons|mesh-list
92733873|NCT01649921|Interferon-gamma|interferon-gamma|mesh-list
92733874|NCT01649921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733875|NCT01649921|Antiviral Agents|antiviral agents|mesh-ancestor
92733876|NCT01649921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733880|NCT01605162|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2H)-one|10-((4-hydroxypiperidin-1-yl)methyl)chromeno(4,3,2-de)phthalazin-3(2h)-one|mesh-list
92733881|NCT01605162|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92733882|NCT01605162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733883|NCT01605162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733884|NCT01605162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733885|NCT01649999|Peficitinib|peficitinib|mesh-list
92733886|NCT01649999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733887|NCT01649999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733888|NCT01649999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92733889|NCT01649999|Immunologic Factors|immunologic factors|mesh-ancestor
92733890|NCT01649999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733891|NCT01604889|Ipilimumab|ipilimumab|mesh-list
92733892|NCT01604889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92733893|NCT01604889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733894|NCT01604889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92733895|NCT01604889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733896|NCT01685762|Metformin|metformin|mesh-list
92733897|NCT01685762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92733898|NCT01685762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733899|NCT01602822|Ritonavir|ritonavir|mesh-list
92733900|NCT01602822|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92733901|NCT01602822|Tenofovir|tenofovir|mesh-list
92733902|NCT01602822|Emtricitabine|emtricitabine|mesh-list
92733903|NCT01602822|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92733904|NCT01602822|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92733905|NCT01602822|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92733906|NCT01602822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92733907|NCT01602822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398111|NCT02656550|Immunologic Factors|immunologic factors|mesh-ancestor
92733908|NCT01602822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733909|NCT01602822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92733910|NCT01602822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92733911|NCT01602822|Antiviral Agents|antiviral agents|mesh-ancestor
92733912|NCT01602822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733913|NCT01602822|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92733914|NCT01602822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92733915|NCT01602822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92733916|NCT01602822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92733917|NCT02273154|Buspirone|buspirone|mesh-list
92733918|NCT02273154|Paroxetine|paroxetine|mesh-list
92733919|NCT02273154|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92733920|NCT02273154|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92733921|NCT02273154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92733922|NCT02273154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733923|NCT02273154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733924|NCT02273154|Serotonin Agents|serotonin agents|mesh-ancestor
92733925|NCT02273154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733926|NCT02273154|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92733927|NCT02273154|Antidepressive Agents|antidepressive agents|mesh-ancestor
92733928|NCT02273154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92733929|NCT02273154|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92733930|NCT02273154|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92733931|NCT02273154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92733932|NCT02273154|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92733933|NCT02273154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92733934|NCT02273154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733935|NCT02273154|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92610714|NCT00155883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610716|NCT00155883|Protective Agents|protective agents|mesh-ancestor
92610717|NCT00155883|Vitamin B Complex|vitamin b complex|mesh-ancestor
92733936|NCT01602393|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
92733937|NCT01602393|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92733939|NCT01602393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733940|NCT01645787|4-Aminopyridine|4-aminopyridine|mesh-list
92733941|NCT01645787|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92733942|NCT01645787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92733943|NCT01645787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733944|NCT02270034|Crizotinib|crizotinib|mesh-list
92733948|NCT02270034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733949|NCT02273271|Alovudine|alovudine|mesh-list
92733950|NCT02273271|Antiviral Agents|antiviral agents|mesh-ancestor
92733951|NCT02273271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733952|NCT02270307|Cyclophosphamide|cyclophosphamide|mesh-list
92733953|NCT02270307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92733954|NCT02270307|Immunologic Factors|immunologic factors|mesh-ancestor
92733955|NCT02270307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733956|NCT02270307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92733957|NCT02270307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92733958|NCT02270307|Alkylating Agents|alkylating agents|mesh-ancestor
92733959|NCT02270307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733960|NCT02270307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733961|NCT02270307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92733962|NCT02270424|Fluticasone|fluticasone|mesh-list
92733963|NCT02270424|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92733964|NCT02270424|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92733965|NCT02270424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733966|NCT02270424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92733967|NCT02270424|Autonomic Agents|autonomic agents|mesh-ancestor
92733968|NCT02270424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733969|NCT02270424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733970|NCT02270424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92733971|NCT02270424|Respiratory System Agents|respiratory system agents|mesh-ancestor
92733972|NCT02270424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92733973|NCT02270424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92733974|NCT02270424|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92733975|NCT02270424|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92733976|NCT02270424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92733977|NCT02270424|Adrenergic Agents|adrenergic agents|mesh-ancestor
92733978|NCT02270424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92733979|NCT02270424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733980|NCT02270424|Glucocorticoids|glucocorticoids|mesh-ancestor
92733981|NCT02270424|Hormones|hormones|mesh-ancestor
92733982|NCT02270424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733983|NCT02270424|Sympathomimetics|sympathomimetics|mesh-ancestor
92733984|NCT01686347|Ropivacaine|ropivacaine|mesh-list
92733985|NCT01686347|Anesthetics, Local|anesthetics, local|mesh-ancestor
92733986|NCT01686347|Anesthetics|anesthetics|mesh-ancestor
92733987|NCT01686347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92733988|NCT01686347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733989|NCT01686347|Sensory System Agents|sensory system agents|mesh-ancestor
92733990|NCT01686347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92733991|NCT05140655|Fulvestrant|fulvestrant|mesh-list
92733992|NCT05140655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92733993|NCT05140655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733994|NCT05140655|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92733995|NCT05140655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92733996|NCT05140655|Hormone Antagonists|hormone antagonists|mesh-ancestor
92733997|NCT05140655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92733998|NCT05140655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733999|NCT01688570|Cyproheptadine|cyproheptadine|mesh-list
92734000|NCT01688570|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92734001|NCT01688570|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92734002|NCT01688570|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92610718|NCT00155883|Vitamins|vitamins|mesh-ancestor
92610719|NCT00155883|Micronutrients|micronutrients|mesh-ancestor
92610720|NCT00506545|Rolapitant|rolapitant|mesh-list
92610721|NCT00506545|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92610722|NCT00506545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734003|NCT01688570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92734004|NCT01688570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734005|NCT01688570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734006|NCT01688570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734007|NCT01688570|Analgesics|analgesics|mesh-ancestor
92734008|NCT01688570|Sensory System Agents|sensory system agents|mesh-ancestor
92734009|NCT01688570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734010|NCT01688570|Antidepressive Agents|antidepressive agents|mesh-ancestor
92734011|NCT01688570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92734012|NCT01688570|Dopamine Agents|dopamine agents|mesh-ancestor
92734013|NCT01688570|Antipruritics|antipruritics|mesh-ancestor
92734014|NCT01688570|Dermatologic Agents|dermatologic agents|mesh-ancestor
92734016|NCT01688570|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92734017|NCT01688570|Histamine Antagonists|histamine antagonists|mesh-ancestor
92734018|NCT01688570|Histamine Agents|histamine agents|mesh-ancestor
92734019|NCT01688570|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92734020|NCT01688570|Serotonin Agents|serotonin agents|mesh-ancestor
92734021|NCT01688570|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92734022|NCT01686464|Valacyclovir|valacyclovir|mesh-list
92734023|NCT01686464|Prednisone|prednisone|mesh-list
92734024|NCT01686464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734025|NCT01686464|Glucocorticoids|glucocorticoids|mesh-ancestor
92734026|NCT01686464|Hormones|hormones|mesh-ancestor
92734027|NCT01686464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734028|NCT01686464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734029|NCT01686464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92734030|NCT01686464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734031|NCT01686464|Antiviral Agents|antiviral agents|mesh-ancestor
92734032|NCT01686464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734033|NCT02270970|Belimumab|belimumab|mesh-list
92734034|NCT02270970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734035|NCT02270970|Immunologic Factors|immunologic factors|mesh-ancestor
92734036|NCT02270970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734037|NCT01688648|Lidocaine|lidocaine|mesh-list
92734038|NCT01688648|Dexmedetomidine|dexmedetomidine|mesh-list
92734039|NCT01688648|Anesthetics, Local|anesthetics, local|mesh-ancestor
92734040|NCT01688648|Anesthetics|anesthetics|mesh-ancestor
92734041|NCT01688648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734042|NCT01688648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734043|NCT01688648|Sensory System Agents|sensory system agents|mesh-ancestor
92734044|NCT01688648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734045|NCT01688648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92734046|NCT01688648|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92734047|NCT01688648|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92734048|NCT01688648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92734049|NCT01688648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734050|NCT01688648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92734051|NCT01688648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734052|NCT01688648|Analgesics|analgesics|mesh-ancestor
92734053|NCT01688648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92734054|NCT01688648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92734055|NCT01688648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92734056|NCT01688648|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734057|NCT01688648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734058|NCT01686659|Chrysarobin|chrysarobin|mesh-list
92734059|NCT01686659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92734060|NCT01686659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734061|NCT01686659|Analgesics|analgesics|mesh-ancestor
92734062|NCT01686659|Sensory System Agents|sensory system agents|mesh-ancestor
92734063|NCT01686659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734064|NCT01686659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734065|NCT01686659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734066|NCT01686659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734067|NCT02271126|Heparin|heparin|mesh-list
92734068|NCT02271126|Thromboplastin|thromboplastin|mesh-list
92734069|NCT02271126|Anticoagulants|anticoagulants|mesh-ancestor
92734070|NCT02271126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92610723|NCT00506545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610724|NCT00506545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610725|NCT04696393|Mitapivat|mitapivat|mesh-list
92734071|NCT02271126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92734072|NCT02271126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734073|NCT02271126|Hemostatics|hemostatics|mesh-ancestor
92734074|NCT02271126|Coagulants|coagulants|mesh-ancestor
92734075|NCT02271165|Immunoglobulins|immunoglobulins|mesh-list
92734076|NCT02271165|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92734077|NCT02271165|Antibodies|antibodies|mesh-list
92734078|NCT02271165|Immunologic Factors|immunologic factors|mesh-ancestor
92734079|NCT02271165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734080|NCT02271204|Ibandronic Acid|ibandronic acid|mesh-list
92734081|NCT02271204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92734082|NCT02271204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734084|NCT02271282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92734085|NCT02271282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734086|NCT02271282|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92734087|NCT02271282|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92734088|NCT02271282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327605|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92734093|NCT01688960|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92734094|NCT01688960|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92734095|NCT01688960|Growth Substances|growth substances|mesh-ancestor
92734096|NCT01688960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734097|NCT01688960|Growth Inhibitors|growth inhibitors|mesh-ancestor
92734098|NCT01688960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734099|NCT02271360|Cabergoline|cabergoline|mesh-list
92734100|NCT02271360|Calcium Dobesilate|calcium dobesilate|mesh-list
92734101|NCT02271360|Calcium|calcium|mesh-list
92734102|NCT02271360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92734103|NCT02271360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734104|NCT02271360|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92734105|NCT02271360|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92734106|NCT02271360|Dopamine Agonists|dopamine agonists|mesh-ancestor
92734107|NCT02271360|Dopamine Agents|dopamine agents|mesh-ancestor
92734108|NCT02271360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734109|NCT02271360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734110|NCT02271360|Hemostatics|hemostatics|mesh-ancestor
92734111|NCT02271360|Coagulants|coagulants|mesh-ancestor
92734112|NCT01687049|Red yeast rice|red yeast rice|mesh-list
92734113|NCT01687049|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92734114|NCT01687049|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92734115|NCT01687049|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92734116|NCT01687049|Antimetabolites|antimetabolites|mesh-ancestor
92734117|NCT01687049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734118|NCT01687049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734119|NCT01687049|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92734120|NCT02271399|Aspirin|aspirin|mesh-list
92734121|NCT02271399|Rivaroxaban|rivaroxaban|mesh-list
92734122|NCT02271399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92734123|NCT02271399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734124|NCT02271399|Analgesics|analgesics|mesh-ancestor
92734125|NCT02271399|Sensory System Agents|sensory system agents|mesh-ancestor
92734126|NCT02271399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734127|NCT02271399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734128|NCT02271399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734129|NCT02271399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734130|NCT02271399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92734131|NCT02271399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92734132|NCT02271399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734133|NCT02271399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92734134|NCT02271399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92734135|NCT02271399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734136|NCT02271399|Antipyretics|antipyretics|mesh-ancestor
92734137|NCT02271399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92734138|NCT02271399|Antithrombins|antithrombins|mesh-ancestor
92734139|NCT02271399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92734140|NCT02271399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92734141|NCT02271399|Anticoagulants|anticoagulants|mesh-ancestor
92734142|NCT02271438|Moxifloxacin|moxifloxacin|mesh-list
92610726|NCT04696393|Enzyme Activators|enzyme activators|mesh-ancestor
92610727|NCT04696393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610728|NCT05143723|Hormones|hormones|mesh-list
92017820|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734143|NCT02271438|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92734144|NCT02271438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92734145|NCT02271438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734146|NCT02271438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92734147|NCT02271438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92734148|NCT02271438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734149|NCT02271438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734150|NCT02271438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734151|NCT02271438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92734152|NCT02271438|Contraceptive Agents|contraceptive agents|mesh-ancestor
92734153|NCT02271438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92734154|NCT02271438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734155|NCT02271438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92734156|NCT02271438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92734157|NCT02271438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92734162|NCT01687127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734164|NCT01687127|Vitamins|vitamins|mesh-ancestor
92734165|NCT01687127|Micronutrients|micronutrients|mesh-ancestor
92734166|NCT02271555|Remifentanil|remifentanil|mesh-list
92734167|NCT02271555|Sevoflurane|sevoflurane|mesh-list
92734168|NCT02271555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92734169|NCT02271555|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92734170|NCT02271555|Anesthetics, General|anesthetics, general|mesh-ancestor
92734171|NCT02271555|Anesthetics|anesthetics|mesh-ancestor
92734172|NCT02271555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734173|NCT02271555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734174|NCT02271555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92734175|NCT02271555|Narcotics|narcotics|mesh-ancestor
92734176|NCT02271555|Analgesics|analgesics|mesh-ancestor
92734177|NCT02271555|Sensory System Agents|sensory system agents|mesh-ancestor
92734178|NCT02271555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734179|NCT01687205|Tenofovir|tenofovir|mesh-list
92734180|NCT01687205|Antiviral Agents|antiviral agents|mesh-ancestor
92734181|NCT01687205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734182|NCT01687205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92734183|NCT01687205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92734184|NCT01687205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734185|NCT01687205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734186|NCT01687205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92734187|NCT01687205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92734188|NCT01689116|Moxifloxacin|moxifloxacin|mesh-list
92734189|NCT01689116|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92734190|NCT01689116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92734191|NCT01689116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734192|NCT01689116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92734193|NCT01689116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92734194|NCT01689116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734195|NCT01689116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734196|NCT01689116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734197|NCT01689116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92734198|NCT01689116|Contraceptive Agents|contraceptive agents|mesh-ancestor
92734199|NCT01689116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92734200|NCT01689116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734201|NCT01689116|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92734202|NCT01689116|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92734203|NCT01689116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92734204|NCT01689194|genexol-PM|genexol-pm|mesh-list
92734205|NCT01689194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734206|NCT01689194|Tubulin Modulators|tubulin modulators|mesh-ancestor
92734207|NCT01689194|Antimitotic Agents|antimitotic agents|mesh-ancestor
92734208|NCT01689194|Mitosis Modulators|mitosis modulators|mesh-ancestor
92734209|NCT01689194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734210|NCT01687439|Vinorelbine|vinorelbine|mesh-list
92734211|NCT01687439|Endostar protein|endostar protein|mesh-list
92734212|NCT01687439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734213|NCT01687439|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92610729|NCT05143723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92610730|NCT05143723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734214|NCT01687439|Tubulin Modulators|tubulin modulators|mesh-ancestor
92734215|NCT01687439|Antimitotic Agents|antimitotic agents|mesh-ancestor
92734216|NCT01687439|Mitosis Modulators|mitosis modulators|mesh-ancestor
92734217|NCT01687439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734218|NCT01687439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92734219|NCT01687439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92734220|NCT01687439|Growth Substances|growth substances|mesh-ancestor
92734221|NCT01687439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734222|NCT01687439|Growth Inhibitors|growth inhibitors|mesh-ancestor
92734223|NCT01588704|Bevacizumab|bevacizumab|mesh-list
92734224|NCT01588704|Pemetrexed|pemetrexed|mesh-list
92734225|NCT01588704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92734226|NCT01588704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734227|NCT01588704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92734228|NCT01588704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92322313|NCT00381134|Spironolactone|spironolactone|mesh-list
92734229|NCT01588704|Growth Substances|growth substances|mesh-ancestor
92734233|NCT01588704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734234|NCT01588704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92734235|NCT01588704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92734236|NCT01588743|Insulin Aspart|insulin aspart|mesh-list
92734237|NCT01588743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92734238|NCT01588743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734239|NCT01689311|Alprostadil|alprostadil|mesh-list
92734240|NCT01689311|Misoprostol|misoprostol|mesh-list
92734241|NCT01689311|Oxytocin|oxytocin|mesh-list
92734242|NCT01689311|Ergonovine|ergonovine|mesh-list
92734243|NCT01689311|Dinoprost|dinoprost|mesh-list
92734244|NCT01689311|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
92734245|NCT01689311|Oxytocics|oxytocics|mesh-ancestor
92734246|NCT01689311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92734247|NCT01689311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734248|NCT01689311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92734249|NCT01689311|Abortifacient Agents|abortifacient agents|mesh-ancestor
92734250|NCT01689311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92734251|NCT01689311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734252|NCT01689311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92734253|NCT01689311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92734254|NCT01689311|Urological Agents|urological agents|mesh-ancestor
92734255|NCT01588782|Ketoconazole|ketoconazole|mesh-list
92734256|NCT01588782|Antifungal Agents|antifungal agents|mesh-ancestor
92734257|NCT01588782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734258|NCT01588782|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92734259|NCT01588782|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92734260|NCT01588782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734261|NCT01588782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734262|NCT01588782|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92734263|NCT01588782|Hormone Antagonists|hormone antagonists|mesh-ancestor
92734264|NCT01588782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734265|NCT01588782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734266|NCT01588782|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92734267|NCT02272101|Vitamin D|vitamin d|mesh-list
92734268|NCT02272101|Vitamins|vitamins|mesh-ancestor
92734269|NCT02272101|Micronutrients|micronutrients|mesh-ancestor
92734270|NCT02272101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734271|NCT02272101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92734272|NCT02278133|Cetuximab|cetuximab|mesh-list
92734273|NCT02278133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92734274|NCT02278133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734275|NCT01687868|Dexmedetomidine|dexmedetomidine|mesh-list
92734276|NCT01687868|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92734277|NCT01687868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734278|NCT01687868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734279|NCT01687868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734280|NCT01687868|Analgesics|analgesics|mesh-ancestor
92734281|NCT01687868|Sensory System Agents|sensory system agents|mesh-ancestor
92734282|NCT01687868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734283|NCT01687868|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92734284|NCT01687868|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92610731|NCT00143624|Rosiglitazone|rosiglitazone|mesh-list
92610732|NCT00143624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92610733|NCT00143624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610734|NCT05142865|Carboplatin|carboplatin|mesh-list
92734285|NCT01687868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92734286|NCT01687868|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734287|NCT01687868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734288|NCT01687868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734289|NCT01688024|Mitomycins|mitomycins|mesh-list
92734290|NCT01688024|Mitomycin|mitomycin|mesh-list
92734291|NCT01688024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92734292|NCT01688024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734293|NCT01688024|Alkylating Agents|alkylating agents|mesh-ancestor
92734294|NCT01688024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734295|NCT01688024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92734296|NCT01688024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734297|NCT01689623|Simeprevir|simeprevir|mesh-list
92734298|NCT01689623|Atorvastatin|atorvastatin|mesh-list
92734299|NCT01689623|Simvastatin|simvastatin|mesh-list
92734300|NCT01689623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92734301|NCT01689623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92734303|NCT01689623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734305|NCT01689623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92734306|NCT01689623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734307|NCT01689623|Antiviral Agents|antiviral agents|mesh-ancestor
92734308|NCT01689623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734309|NCT01689623|Protease Inhibitors|protease inhibitors|mesh-ancestor
92734310|NCT04055142|Cidofovir|cidofovir|mesh-list
92734311|NCT04055142|Antiviral Agents|antiviral agents|mesh-ancestor
92734312|NCT04055142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734313|NCT04055142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734314|NCT04055142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734315|NCT02272647|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92734316|NCT02272647|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92734317|NCT02272647|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92734318|NCT02272647|Medroxyprogesterone|medroxyprogesterone|mesh-list
92734319|NCT02272647|Estradiol|estradiol|mesh-list
92734320|NCT02272647|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92734321|NCT02272647|Progesterone|progesterone|mesh-list
92734322|NCT02272647|Estrogens|estrogens|mesh-ancestor
92734323|NCT02272647|Hormones|hormones|mesh-ancestor
92734324|NCT02272647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734325|NCT02272647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734326|NCT02272647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92734327|NCT02272647|Contraceptive Agents|contraceptive agents|mesh-ancestor
92734328|NCT02272647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92734329|NCT02272647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92734330|NCT02272647|Progestins|progestins|mesh-ancestor
92734331|NCT02272647|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92734332|NCT02272647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92734333|NCT02272647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92734334|NCT02272647|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92734335|NCT02272647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92734336|NCT02272647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734337|NCT02272764|Itraconazole|itraconazole|mesh-list
92734338|NCT02272764|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92734339|NCT02272764|Antifungal Agents|antifungal agents|mesh-ancestor
92734340|NCT02272764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734341|NCT02272764|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92734342|NCT02272764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92734343|NCT02272764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734344|NCT02272764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734345|NCT02272764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92734346|NCT02272764|Hormone Antagonists|hormone antagonists|mesh-ancestor
92734347|NCT02272764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734348|NCT02272764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734349|NCT02272764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92734350|NCT01689896|Testosterone|testosterone|mesh-list
92734351|NCT01689896|Androgens|androgens|mesh-ancestor
92734352|NCT01689896|Hormones|hormones|mesh-ancestor
92610735|NCT05142865|Etoposide|etoposide|mesh-list
92610736|NCT05142865|Apatinib|apatinib|mesh-list
92017830|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734353|NCT01689896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734354|NCT01689896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734355|NCT01316094|Ipragliflozin|ipragliflozin|mesh-list
92734356|NCT01316094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92734357|NCT01316094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734358|NCT01316094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92734359|NCT01316094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734360|NCT01689935|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92734361|NCT01689935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92734362|NCT01689935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92734363|NCT01316133|Tacrolimus|tacrolimus|mesh-list
92734364|NCT01316133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734365|NCT01316133|Immunologic Factors|immunologic factors|mesh-ancestor
92734366|NCT01316133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734367|NCT01316133|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92734368|NCT01316133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734369|NCT01316133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734370|NCT05654064|Fentanyl|fentanyl|mesh-list
92734371|NCT05654064|Dexmedetomidine|dexmedetomidine|mesh-list
92734372|NCT05654064|Remifentanil|remifentanil|mesh-list
92734373|NCT05654064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92734378|NCT05654064|Sensory System Agents|sensory system agents|mesh-ancestor
92734379|NCT05654064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734380|NCT05654064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92734381|NCT05654064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92734382|NCT05654064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92734383|NCT05654064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734384|NCT05654064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734385|NCT05654064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734386|NCT05654064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92734387|NCT05654064|Narcotics|narcotics|mesh-ancestor
92734388|NCT05654064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92734389|NCT05654064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92734390|NCT05654064|Anesthetics, General|anesthetics, general|mesh-ancestor
92734391|NCT05654064|Anesthetics|anesthetics|mesh-ancestor
92734392|NCT01687985|Laxatives|laxatives|mesh-list
92734393|NCT01687985|Cathartics|cathartics|mesh-list
92734394|NCT01687985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734395|NCT01686620|Insulin Lispro|insulin lispro|mesh-list
92734396|NCT01686620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92734397|NCT01686620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734398|NCT01685255|Tamoxifen|tamoxifen|mesh-list
92734399|NCT01685255|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92734400|NCT01685255|Hormone Antagonists|hormone antagonists|mesh-ancestor
92734401|NCT01685255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734402|NCT01685255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734403|NCT01685255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92734404|NCT01685255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734405|NCT01685255|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92734406|NCT01685255|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92734407|NCT01685255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92734408|NCT01680965|Ofatumumab|ofatumumab|mesh-list
92734409|NCT01680965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734410|NCT02272998|Ponatinib|ponatinib|mesh-list
92734411|NCT02272998|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92734412|NCT02272998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92734413|NCT02272998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734414|NCT02272998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734415|NCT02272998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734416|NCT01683188|Vemurafenib|vemurafenib|mesh-list
92734417|NCT01683188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734418|NCT01683188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92734419|NCT01683188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734420|NCT01683188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734421|NCT01339923|Vaccines|vaccines|mesh-list
92734422|NCT01339923|Immunologic Factors|immunologic factors|mesh-ancestor
92734423|NCT01339923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734424|NCT04417088|Carboplatin|carboplatin|mesh-list
92734425|NCT04417088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398190|NCT02427581|Poly I-C|poly i-c|mesh-list
92610737|NCT05142865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610738|NCT05142865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92610739|NCT05142865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92610740|NCT05142865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92017831|NCT04930471|Metformin|metformin|mesh-list
92734426|NCT01380093|Naltrexone|naltrexone|mesh-list
92734427|NCT01380093|Morphine|morphine|mesh-list
92734428|NCT01380093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92734429|NCT01380093|Narcotics|narcotics|mesh-ancestor
92734430|NCT01380093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734431|NCT01380093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734432|NCT01380093|Analgesics|analgesics|mesh-ancestor
92734433|NCT01380093|Sensory System Agents|sensory system agents|mesh-ancestor
92734434|NCT01380093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734435|NCT01380093|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92734436|NCT01380093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92734437|NCT01379937|Vaccines|vaccines|mesh-list
92734438|NCT01379937|Immunologic Factors|immunologic factors|mesh-ancestor
92734439|NCT01379937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734440|NCT04820972|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92734441|NCT03558854|Aspirin|aspirin|mesh-list
92734442|NCT03558854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92734443|NCT03558854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734444|NCT03558854|Analgesics|analgesics|mesh-ancestor
92734449|NCT03558854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734450|NCT03558854|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92734451|NCT03558854|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92734452|NCT03558854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734453|NCT03558854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92734454|NCT03558854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92734456|NCT03558854|Antipyretics|antipyretics|mesh-ancestor
92734457|NCT01335477|Nintedanib|nintedanib|mesh-list
92734458|NCT01335477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734459|NCT01335477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92734460|NCT01335477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734461|NCT01335477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734462|NCT03389438|Immunomodulating Agents|immunomodulating agents|mesh-list
92734463|NCT03389438|Immunologic Factors|immunologic factors|mesh-ancestor
92734464|NCT03389438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734465|NCT01371747|Losartan|losartan|mesh-list
92734466|NCT01371747|Spironolactone|spironolactone|mesh-list
92734467|NCT01371747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92734468|NCT01371747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92734469|NCT01371747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92734470|NCT01371747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92734471|NCT01371747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734472|NCT01371747|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92734473|NCT01371747|Hormone Antagonists|hormone antagonists|mesh-ancestor
92734474|NCT01371747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734475|NCT01371747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734476|NCT01371747|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92734477|NCT01371747|Diuretics|diuretics|mesh-ancestor
92734478|NCT01371747|Natriuretic Agents|natriuretic agents|mesh-ancestor
92734479|NCT01335399|Dexamethasone|dexamethasone|mesh-list
92734480|NCT01335399|Dexamethasone acetate|dexamethasone acetate|mesh-list
92734481|NCT01335399|Lenalidomide|lenalidomide|mesh-list
92734482|NCT01335399|Elotuzumab|elotuzumab|mesh-list
92734483|NCT01335399|BB 1101|bb 1101|mesh-list
92734484|NCT01335399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734485|NCT01335399|Antiemetics|antiemetics|mesh-ancestor
92734486|NCT01335399|Autonomic Agents|autonomic agents|mesh-ancestor
92734487|NCT01335399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734488|NCT01335399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734489|NCT01335399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734490|NCT01335399|Glucocorticoids|glucocorticoids|mesh-ancestor
92734491|NCT01335399|Hormones|hormones|mesh-ancestor
92734492|NCT01335399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734493|NCT01335399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92734494|NCT01335399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734495|NCT01335399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92610741|NCT05142865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610742|NCT05142865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610743|NCT05142865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92610744|NCT00143702|Riboflavin|riboflavin|mesh-list
92734496|NCT01335399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734497|NCT01335399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734498|NCT01335399|Immunologic Factors|immunologic factors|mesh-ancestor
92734499|NCT01335399|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92734500|NCT01335399|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92734501|NCT01335399|Growth Substances|growth substances|mesh-ancestor
92734502|NCT01335399|Growth Inhibitors|growth inhibitors|mesh-ancestor
92734503|NCT04825262|Tacrolimus|tacrolimus|mesh-list
92734504|NCT04825262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734505|NCT04825262|Immunologic Factors|immunologic factors|mesh-ancestor
92734506|NCT04825262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734507|NCT04825262|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92734508|NCT04825262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734509|NCT04825262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734510|NCT01335009|Antibodies|antibodies|mesh-list
92734511|NCT01335009|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92734512|NCT01335009|Immunologic Factors|immunologic factors|mesh-ancestor
92734513|NCT01335009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734514|NCT01332630|Diphenhydramine|diphenhydramine|mesh-list
92734515|NCT01332630|Dexamethasone|dexamethasone|mesh-list
92734517|NCT01332630|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92734518|NCT01332630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734519|NCT01332630|Antiemetics|antiemetics|mesh-ancestor
92734520|NCT01332630|Autonomic Agents|autonomic agents|mesh-ancestor
92734521|NCT01332630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734522|NCT01332630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734523|NCT01332630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734524|NCT01332630|Glucocorticoids|glucocorticoids|mesh-ancestor
92734525|NCT01332630|Hormones|hormones|mesh-ancestor
92734526|NCT01332630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734527|NCT01332630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92734528|NCT01332630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734529|NCT01332630|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92734530|NCT01332630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92734531|NCT01332630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734532|NCT01332630|Anesthetics, Local|anesthetics, local|mesh-ancestor
92734533|NCT01332630|Anesthetics|anesthetics|mesh-ancestor
92734534|NCT01332630|Sensory System Agents|sensory system agents|mesh-ancestor
92734535|NCT01332630|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92734536|NCT01332630|Histamine Antagonists|histamine antagonists|mesh-ancestor
92734537|NCT01332630|Histamine Agents|histamine agents|mesh-ancestor
92734538|NCT01332630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734539|NCT01332630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734540|NCT01332630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92734541|NCT01332630|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92734542|NCT01332630|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92734543|NCT01366209|Pirfenidone|pirfenidone|mesh-list
92734544|NCT01366209|Analgesics|analgesics|mesh-ancestor
92734545|NCT01366209|Sensory System Agents|sensory system agents|mesh-ancestor
92734546|NCT01366209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734547|NCT01366209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734548|NCT01366209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92734549|NCT01366209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734550|NCT01366209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734551|NCT01366209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734552|NCT01366209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734553|NCT01365507|Insulin|insulin|mesh-list
92734554|NCT01365507|Insulin Aspart|insulin aspart|mesh-list
92734555|NCT01365507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92734556|NCT01365507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734557|NCT02995694|Estradiol|estradiol|mesh-list
92734558|NCT02995694|Estrogens|estrogens|mesh-ancestor
92734559|NCT02995694|Hormones|hormones|mesh-ancestor
92734560|NCT02995694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734561|NCT02995694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734562|NCT01365468|Everolimus|everolimus|mesh-list
92734563|NCT01365468|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92610746|NCT00143702|Abacavir|abacavir|mesh-list
92610747|NCT00143702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92610748|NCT00143702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92734564|NCT01365468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92734565|NCT01365468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734566|NCT01365468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734567|NCT01365468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734568|NCT01365468|Immunologic Factors|immunologic factors|mesh-ancestor
92734569|NCT01365468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734570|NCT01365468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734571|NCT04827836|Povidone-Iodine|povidone-iodine|mesh-list
92734572|NCT04827836|Povidone|povidone|mesh-list
92734573|NCT04827836|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92734574|NCT04827836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92734575|NCT04827836|Plasma Substitutes|plasma substitutes|mesh-ancestor
92734576|NCT04827836|Blood Substitutes|blood substitutes|mesh-ancestor
92734577|NCT04827836|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92734578|NCT04827836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734579|NCT01357980|Botulinum Toxins|botulinum toxins|mesh-list
92734580|NCT01357980|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92734581|NCT01357980|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92734582|NCT01357980|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92734583|NCT01357980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92734584|NCT01357980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734585|NCT01357980|Cholinergic Agents|cholinergic agents|mesh-ancestor
92734586|NCT01357980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734587|NCT01357980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734588|NCT01357980|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92734589|NCT01357980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734595|NCT01332318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734596|NCT01332318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734597|NCT01332318|Anticonvulsants|anticonvulsants|mesh-ancestor
92734598|NCT01332318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92734599|NCT01332318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92734600|NCT01332318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734601|NCT01332318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92734602|NCT01332318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92734603|NCT01332318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92734604|NCT01332318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734605|NCT01332318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734606|NCT01332318|Antimanic Agents|antimanic agents|mesh-ancestor
92734607|NCT01332318|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92734608|NCT01332318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92734609|NCT01332318|Anesthetics, Local|anesthetics, local|mesh-ancestor
92734610|NCT01332318|Anesthetics|anesthetics|mesh-ancestor
92734611|NCT01332318|Antiemetics|antiemetics|mesh-ancestor
92734612|NCT01332318|Autonomic Agents|autonomic agents|mesh-ancestor
92734613|NCT01332318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734614|NCT01332318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92734615|NCT01332318|Histamine Antagonists|histamine antagonists|mesh-ancestor
92734616|NCT01332318|Histamine Agents|histamine agents|mesh-ancestor
92734617|NCT01332318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92734618|NCT01332318|Antipruritics|antipruritics|mesh-ancestor
92734619|NCT01332318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92734620|NCT04828226|Clonidine|clonidine|mesh-list
92734621|NCT04828226|Analgesics|analgesics|mesh-ancestor
92734622|NCT04828226|Sensory System Agents|sensory system agents|mesh-ancestor
92734623|NCT04828226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734624|NCT04828226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734625|NCT04828226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92734626|NCT04828226|Sympatholytics|sympatholytics|mesh-ancestor
92734627|NCT04828226|Autonomic Agents|autonomic agents|mesh-ancestor
92734628|NCT04828226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92734629|NCT04828226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92734630|NCT04828226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92734631|NCT04828226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734632|NCT04828226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734633|NCT04828226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734634|NCT01331109|Milnacipran|milnacipran|mesh-list
92734635|NCT01331109|Levomilnacipran|levomilnacipran|mesh-list
92610749|NCT00143702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610750|NCT00143702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610751|NCT00143702|Antiviral Agents|antiviral agents|mesh-ancestor
92734636|NCT01331109|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92734637|NCT01331109|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92734638|NCT01331109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92734639|NCT01331109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734640|NCT01331109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734641|NCT01331109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734642|NCT01331109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734643|NCT01331109|Analgesics|analgesics|mesh-ancestor
92734644|NCT01331109|Sensory System Agents|sensory system agents|mesh-ancestor
92734645|NCT01331109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734646|NCT01331109|Antidepressive Agents|antidepressive agents|mesh-ancestor
92734647|NCT01331109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92734648|NCT01357161|Paclitaxel|paclitaxel|mesh-list
92734649|NCT01357161|Carboplatin|carboplatin|mesh-list
92734650|NCT01357161|Adavosertib|adavosertib|mesh-list
92734651|NCT01357161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92734652|NCT01357161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734653|NCT01357161|Tubulin Modulators|tubulin modulators|mesh-ancestor
92734654|NCT01357161|Antimitotic Agents|antimitotic agents|mesh-ancestor
92734655|NCT01357161|Mitosis Modulators|mitosis modulators|mesh-ancestor
92734656|NCT01357161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734657|NCT01357161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734658|NCT01351350|Paclitaxel|paclitaxel|mesh-list
92734659|NCT01351350|Trastuzumab|trastuzumab|mesh-list
92734660|NCT01351350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92734661|NCT01351350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734668|NCT02271503|Carbidopa|carbidopa|mesh-list
92734669|NCT02271503|Levodopa|levodopa|mesh-list
92734670|NCT02271503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92734671|NCT02271503|Immunologic Factors|immunologic factors|mesh-ancestor
92734672|NCT02271503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734673|NCT02271503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92734674|NCT02271503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92734675|NCT02271503|Dopamine Agonists|dopamine agonists|mesh-ancestor
92734676|NCT02271503|Dopamine Agents|dopamine agents|mesh-ancestor
92734677|NCT02271503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734678|NCT02271503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734679|NCT02271503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92734680|NCT02271503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734681|NCT01350804|Abatacept|abatacept|mesh-list
92734682|NCT01350804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92734683|NCT01350804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734684|NCT01350804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92734685|NCT01350804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734686|NCT01350804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734687|NCT01350804|Immunologic Factors|immunologic factors|mesh-ancestor
92734688|NCT01350804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734689|NCT01350804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734690|NCT02270957|Abatacept|abatacept|mesh-list
92734691|NCT02270957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92734692|NCT02270957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734693|NCT02270957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92734694|NCT02270957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734695|NCT02270957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734696|NCT02270957|Immunologic Factors|immunologic factors|mesh-ancestor
92734697|NCT02270957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734698|NCT02270957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734699|NCT01348542|Trazodone|trazodone|mesh-list
92734700|NCT01348542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92734701|NCT01348542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92734702|NCT01348542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734703|NCT01348542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734704|NCT01348542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92734705|NCT01348542|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92734706|NCT01348542|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92734707|NCT01348542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610752|NCT00143702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610753|NCT00143702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92610754|NCT00143702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92734708|NCT01348542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734709|NCT01348542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734710|NCT01348542|Serotonin Agents|serotonin agents|mesh-ancestor
92734711|NCT01348542|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92734712|NCT01348542|Antidepressive Agents|antidepressive agents|mesh-ancestor
92734713|NCT01346592|Vaccines|vaccines|mesh-list
92734714|NCT01346592|Immunologic Factors|immunologic factors|mesh-ancestor
92734715|NCT01346592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734716|NCT01193335|Vaccines|vaccines|mesh-list
92734717|NCT01193335|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92734718|NCT01193335|Immunologic Factors|immunologic factors|mesh-ancestor
92734719|NCT01193335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734720|NCT02893995|Treprostinil|treprostinil|mesh-list
92734721|NCT02893995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92734722|NCT01342887|Cyclosporine|cyclosporine|mesh-list
92734723|NCT01342887|Etoposide|etoposide|mesh-list
92734724|NCT01342887|Mitoxantrone|mitoxantrone|mesh-list
92734725|NCT01342887|Etoposide phosphate|etoposide phosphate|mesh-list
92734726|NCT01342887|Pravastatin|pravastatin|mesh-list
92734727|NCT01342887|Cyclosporins|cyclosporins|mesh-list
92734728|NCT01342887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92734731|NCT01342887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92734732|NCT01342887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734733|NCT01342887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734734|NCT01342887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734735|NCT01342887|Immunologic Factors|immunologic factors|mesh-ancestor
92734736|NCT01342887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734737|NCT01342887|Antifungal Agents|antifungal agents|mesh-ancestor
92734738|NCT01342887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734739|NCT01342887|Dermatologic Agents|dermatologic agents|mesh-ancestor
92734740|NCT01342887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734741|NCT01342887|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92734742|NCT01342887|Analgesics|analgesics|mesh-ancestor
92734743|NCT01342887|Sensory System Agents|sensory system agents|mesh-ancestor
92734744|NCT01342887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734745|NCT01342887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92734746|NCT01342887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92734747|NCT01342887|Antimetabolites|antimetabolites|mesh-ancestor
92734748|NCT01342887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92734749|NCT01342887|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92734750|NCT04445415|Antibodies|antibodies|mesh-list
92734751|NCT04445415|Immunologic Factors|immunologic factors|mesh-ancestor
92734752|NCT04445415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734754|NCT01342341|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92734755|NCT01342341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734756|NCT01342341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92734757|NCT01342341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734758|NCT01340664|Metformin|metformin|mesh-list
92734759|NCT01340664|Canagliflozin|canagliflozin|mesh-list
92734760|NCT01340664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92734761|NCT01340664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734762|NCT01340664|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92734763|NCT01340664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734764|NCT01340625|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92734765|NCT01340625|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92734766|NCT01340625|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92734767|NCT01340625|Norethindrone|norethindrone|mesh-list
92734768|NCT01340625|Norethindrone Acetate|norethindrone acetate|mesh-list
92734769|NCT01340625|Estradiol|estradiol|mesh-list
92734770|NCT01340625|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92734771|NCT01340625|Estrogens|estrogens|mesh-ancestor
92734772|NCT01340625|Hormones|hormones|mesh-ancestor
92734773|NCT01340625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734774|NCT01340625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734775|NCT01340625|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92734776|NCT01340625|Contraceptive Agents|contraceptive agents|mesh-ancestor
92734777|NCT01340625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92734778|NCT01340625|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92734779|NCT01340625|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92734780|NCT01340625|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92610755|NCT00143702|Vitamin B Complex|vitamin b complex|mesh-ancestor
92610757|NCT00143702|Micronutrients|micronutrients|mesh-ancestor
92610758|NCT00143702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017850|NCT04940689|Analgesics|analgesics|mesh-ancestor
92734781|NCT01340625|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92734782|NCT04823468|Cisplatin|cisplatin|mesh-list
92734783|NCT04823468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734784|NCT01340196|Tenofovir|tenofovir|mesh-list
92734785|NCT01340196|Antiviral Agents|antiviral agents|mesh-ancestor
92734786|NCT01340196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734787|NCT01340196|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92734788|NCT01340196|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92734789|NCT01340196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734790|NCT01340196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734791|NCT01340196|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92734792|NCT01340196|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92734793|NCT02893332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92734794|NCT02893332|Gefitinib|gefitinib|mesh-list
92734795|NCT02893332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734796|NCT02893332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92734797|NCT02893332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734798|NCT02893332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734799|NCT04328493|Chloroquine|chloroquine|mesh-list
92734800|NCT04328493|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92734801|NCT04328493|Amebicides|amebicides|mesh-ancestor
92734802|NCT04328493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92734806|NCT04328493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734807|NCT04328493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92734808|NCT04328493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734809|NCT04328493|Analgesics|analgesics|mesh-ancestor
92734810|NCT04328493|Sensory System Agents|sensory system agents|mesh-ancestor
92734811|NCT04328493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734812|NCT04328493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734813|NCT04328493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734814|NCT04328493|Filaricides|filaricides|mesh-ancestor
92734815|NCT04328493|Antinematodal Agents|antinematodal agents|mesh-ancestor
92734816|NCT04328493|Anthelmintics|anthelmintics|mesh-ancestor
92734818|NCT04396587|Oxycodone|oxycodone|mesh-list
92734819|NCT04396587|Hydromorphone|hydromorphone|mesh-list
92734820|NCT04396587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92734821|NCT04396587|Narcotics|narcotics|mesh-ancestor
92734822|NCT04396587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734823|NCT04396587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734824|NCT04396587|Analgesics|analgesics|mesh-ancestor
92734825|NCT04396587|Sensory System Agents|sensory system agents|mesh-ancestor
92734826|NCT04396587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734827|NCT04396587|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92734828|NCT04396587|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92734829|NCT04396587|Anesthetics, General|anesthetics, general|mesh-ancestor
92734830|NCT04396587|Anesthetics|anesthetics|mesh-ancestor
92734831|NCT05139524|Immunoglobulin G|immunoglobulin g|mesh-list
92734832|NCT05139524|Immunologic Factors|immunologic factors|mesh-ancestor
92734833|NCT05139524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734834|NCT01327599|Timolol|timolol|mesh-list
92734835|NCT01327599|Travoprost|travoprost|mesh-list
92734836|NCT01327599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92734837|NCT01327599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92734838|NCT01327599|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92734839|NCT01327599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92734840|NCT01327599|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734841|NCT01327599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734842|NCT01327599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734843|NCT01327599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734844|NCT01327599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92734845|NCT01327599|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92734846|NCT01193257|Prednisone|prednisone|mesh-list
92734847|NCT01193257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734848|NCT01193257|Glucocorticoids|glucocorticoids|mesh-ancestor
92734849|NCT01193257|Hormones|hormones|mesh-ancestor
92734850|NCT01193257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734851|NCT01193257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734852|NCT01193257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92610759|NCT00143702|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92610760|NCT00143702|Dermatologic Agents|dermatologic agents|mesh-ancestor
92610761|NCT00156078|Pregabalin|pregabalin|mesh-list
92610762|NCT00156078|Analgesics|analgesics|mesh-ancestor
92610763|NCT00156078|Sensory System Agents|sensory system agents|mesh-ancestor
92734853|NCT01193257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734854|NCT02893371|Lamotrigine|lamotrigine|mesh-list
92734855|NCT02893371|Carbamazepine|carbamazepine|mesh-list
92734856|NCT02893371|Oxcarbazepine|oxcarbazepine|mesh-list
92734857|NCT02893371|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92734858|NCT02893371|Valproic Acid|valproic acid|mesh-list
92734859|NCT02893371|Haloperidol|haloperidol|mesh-list
92734860|NCT02893371|Olanzapine|olanzapine|mesh-list
92734861|NCT02893371|Risperidone|risperidone|mesh-list
92734862|NCT02893371|Aripiprazole|aripiprazole|mesh-list
92734863|NCT02893371|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92734864|NCT02893371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92734865|NCT02893371|Ziprasidone|ziprasidone|mesh-list
92734866|NCT02893371|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92734867|NCT02893371|Clozapine|clozapine|mesh-list
92734868|NCT02893371|Asenapine|asenapine|mesh-list
92734869|NCT02893371|Perphenazine|perphenazine|mesh-list
92734870|NCT02893371|Lithium Carbonate|lithium carbonate|mesh-list
92734871|NCT02893371|Mirtazapine|mirtazapine|mesh-list
92734872|NCT02893371|Fluvoxamine|fluvoxamine|mesh-list
92734873|NCT02893371|Doxepin|doxepin|mesh-list
92734874|NCT02893371|Citalopram|citalopram|mesh-list
92734875|NCT02893371|Bupropion|bupropion|mesh-list
92734876|NCT02893371|Sertraline|sertraline|mesh-list
92734877|NCT02893371|Fluoxetine|fluoxetine|mesh-list
92734878|NCT02893371|Paroxetine|paroxetine|mesh-list
92734879|NCT02893371|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92734880|NCT02893371|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92734881|NCT02893371|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92734885|NCT02893371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92734886|NCT02893371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734887|NCT02893371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734888|NCT02893371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92734889|NCT02893371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92734890|NCT02893371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734891|NCT02893371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92734892|NCT02893371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92734893|NCT02893371|Dopamine Agents|dopamine agents|mesh-ancestor
92734894|NCT02893371|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92734895|NCT02893371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92734896|NCT02893371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92734897|NCT02893371|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92734898|NCT02893371|Autonomic Agents|autonomic agents|mesh-ancestor
92734899|NCT02893371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734900|NCT02893371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92734901|NCT02893371|Antidepressive Agents|antidepressive agents|mesh-ancestor
92734902|NCT02893371|Antiemetics|antiemetics|mesh-ancestor
92734903|NCT02893371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734904|NCT02893371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92734905|NCT02893371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92734906|NCT02893371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92734907|NCT02893371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734908|NCT02893371|Dopamine Agonists|dopamine agonists|mesh-ancestor
92734909|NCT02893371|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92734910|NCT02893371|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92734911|NCT02893371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92734912|NCT02893371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92734913|NCT02893371|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92734914|NCT02893371|Analgesics|analgesics|mesh-ancestor
92734915|NCT02893371|Sensory System Agents|sensory system agents|mesh-ancestor
92734916|NCT02893371|Antimanic Agents|antimanic agents|mesh-ancestor
92734917|NCT02893371|Anticonvulsants|anticonvulsants|mesh-ancestor
92734918|NCT02893371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92734919|NCT02893371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92734920|NCT02893371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92734921|NCT02893371|GABA Agents|gaba agents|mesh-ancestor
92734922|NCT02893371|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92734923|NCT02893371|Histamine Antagonists|histamine antagonists|mesh-ancestor
92734924|NCT02893371|Histamine Agents|histamine agents|mesh-ancestor
92734925|NCT02893371|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92610764|NCT00156078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610765|NCT00156078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610766|NCT00156078|Anticonvulsants|anticonvulsants|mesh-ancestor
92610767|NCT00156078|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92610768|NCT00156078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92610769|NCT00156078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734926|NCT02893371|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92734927|NCT02893371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92734928|NCT02893371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92734929|NCT02893371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92734930|NCT02893371|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92734931|NCT02893371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734932|NCT02893371|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92734933|NCT02893371|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92734934|NCT02893371|GABA Antagonists|gaba antagonists|mesh-ancestor
92734935|NCT02893371|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92734936|NCT02893371|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92734937|NCT02893371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92734938|NCT02893371|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92734939|NCT02893371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92734940|NCT02893371|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92734941|NCT05138978|Listerine|listerine|mesh-list
92734942|NCT05138978|Sodium Fluoride|sodium fluoride|mesh-list
92734943|NCT05138978|Cariostatic Agents|cariostatic agents|mesh-ancestor
92734944|NCT05138978|Protective Agents|protective agents|mesh-ancestor
92734945|NCT05138978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734946|NCT05138978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92734947|NCT05138978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734948|NCT05138861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92734949|NCT05138861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92734950|NCT02893176|Macitentan|macitentan|mesh-list
92734951|NCT02893176|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92734954|NCT02893176|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92734955|NCT01193218|Empagliflozin|empagliflozin|mesh-list
92734956|NCT01193218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92734957|NCT01193218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734958|NCT01193218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92734959|NCT01193218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734960|NCT01193101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92734961|NCT01193101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92734962|NCT01193101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734963|NCT04328805|Ibuprofen|ibuprofen|mesh-list
92734964|NCT04328805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92734965|NCT04328805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734966|NCT04328805|Analgesics|analgesics|mesh-ancestor
92734967|NCT04328805|Sensory System Agents|sensory system agents|mesh-ancestor
92734968|NCT04328805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734969|NCT04328805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734970|NCT04328805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734971|NCT04328805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92734972|NCT04328805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92734973|NCT04328805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734974|NCT04328805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734975|NCT04329000|Esomeprazole|esomeprazole|mesh-list
92734976|NCT04329000|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92734977|NCT04329000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734978|NCT04329000|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92734979|NCT04329000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734980|NCT04329000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734981|NCT01192399|Eculizumab|eculizumab|mesh-list
92734982|NCT01192399|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92734983|NCT01192399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92734984|NCT01192399|Immunologic Factors|immunologic factors|mesh-ancestor
92610770|NCT00156078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92734985|NCT01192399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734987|NCT04389294|Immunologic Factors|immunologic factors|mesh-ancestor
92734988|NCT04389294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734989|NCT01176916|Exemestane|exemestane|mesh-list
92734990|NCT01176916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734991|NCT01176916|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92734992|NCT01176916|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92734993|NCT01176916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734994|NCT01176916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734995|NCT01176916|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92734996|NCT01176916|Hormone Antagonists|hormone antagonists|mesh-ancestor
92734997|NCT01176916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734998|NCT01176916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734999|NCT05382091|Naltrexone|naltrexone|mesh-list
92735000|NCT05382091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92735001|NCT05382091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92735002|NCT05382091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735003|NCT05382091|Sensory System Agents|sensory system agents|mesh-ancestor
92735004|NCT05382091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735005|NCT02894268|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92735006|NCT02894268|Doxycycline|doxycycline|mesh-list
92735007|NCT02894268|Furazolidone|furazolidone|mesh-list
92735008|NCT02894268|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92735009|NCT02894268|Esomeprazole|esomeprazole|mesh-list
92735010|NCT02894268|Bismuth|bismuth|mesh-list
92735011|NCT02894268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735012|NCT02894268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92735013|NCT02894268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735014|NCT02894268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92735015|NCT02894268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735016|NCT02894268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735017|NCT02894268|Antimalarials|antimalarials|mesh-ancestor
92735018|NCT02894268|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92735019|NCT02894268|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92735020|NCT02894268|Antacids|antacids|mesh-ancestor
92735021|NCT02894268|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92735025|NCT01600625|Minocycline|minocycline|mesh-list
92735026|NCT01600625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735027|NCT01600625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735028|NCT01600742|Vorinostat|vorinostat|mesh-list
92735029|NCT01600742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735030|NCT01600742|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92735031|NCT01600742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735032|NCT01600742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735033|NCT01327482|Raltegravir Potassium|raltegravir potassium|mesh-list
92735034|NCT01327482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92735035|NCT01327482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92735036|NCT01327482|Antiviral Agents|antiviral agents|mesh-ancestor
92735037|NCT01327482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735038|NCT01327482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92735039|NCT01327482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92735040|NCT01327482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735041|NCT01327482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735042|NCT02893488|Lamivudine|lamivudine|mesh-list
92735043|NCT02893488|Dolutegravir|dolutegravir|mesh-list
92735044|NCT02893488|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92735045|NCT02893488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92735046|NCT02893488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735047|NCT02893488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735048|NCT02893488|Antiviral Agents|antiviral agents|mesh-ancestor
92735049|NCT02893488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735050|NCT02893488|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92735051|NCT02893488|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92735052|NCT02893488|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92735053|NCT02893488|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92735054|NCT04328883|Aspirin|aspirin|mesh-list
92735055|NCT04328883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92735056|NCT04328883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92735057|NCT04328883|Analgesics|analgesics|mesh-ancestor
92735058|NCT04328883|Sensory System Agents|sensory system agents|mesh-ancestor
92610772|NCT00156078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610773|NCT00156078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610774|NCT00156078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735059|NCT04328883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735060|NCT04328883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735061|NCT04328883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735062|NCT04328883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735063|NCT04328883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92735064|NCT04328883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92735065|NCT04328883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735066|NCT04328883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92735067|NCT04328883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92735068|NCT04328883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735069|NCT04328883|Antipyretics|antipyretics|mesh-ancestor
92735070|NCT01600235|Phenylephrine|phenylephrine|mesh-list
92735071|NCT01600235|Oxymetazoline|oxymetazoline|mesh-list
92735072|NCT01600235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92735073|NCT01600235|Mydriatics|mydriatics|mesh-ancestor
92735074|NCT01600235|Autonomic Agents|autonomic agents|mesh-ancestor
92735075|NCT01600235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735076|NCT01600235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735077|NCT01600235|Sympathomimetics|sympathomimetics|mesh-ancestor
92735078|NCT01600235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92735079|NCT01600235|Nasal Decongestants|nasal decongestants|mesh-ancestor
92735080|NCT01600235|Respiratory System Agents|respiratory system agents|mesh-ancestor
92735081|NCT01600235|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92735082|NCT01600235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92735083|NCT01600235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92735084|NCT01600235|Adrenergic Agents|adrenergic agents|mesh-ancestor
92735085|NCT01600235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735086|NCT01600235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735087|NCT01600235|Protective Agents|protective agents|mesh-ancestor
92735088|NCT02893254|Adalimumab|adalimumab|mesh-list
92735089|NCT02893254|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92735090|NCT02893254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735091|NCT02893254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735092|NCT00592137|Calcium, Dietary|calcium, dietary|mesh-list
92735093|NCT00592137|Calcium|calcium|mesh-list
92735094|NCT00592137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735095|NCT00592137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735096|NCT00592137|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92735097|NCT04455776|Propofol|propofol|mesh-list
92735098|NCT04455776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92735099|NCT04455776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735100|NCT04455776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735101|NCT04455776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92735102|NCT04455776|Anesthetics, General|anesthetics, general|mesh-ancestor
92735103|NCT04455776|Anesthetics|anesthetics|mesh-ancestor
92735104|NCT04135092|Aldesleukin|aldesleukin|mesh-list
92735105|NCT04135092|Cyclophosphamide|cyclophosphamide|mesh-list
92735106|NCT04135092|Pembrolizumab|pembrolizumab|mesh-list
92735107|NCT04135092|Fludarabine|fludarabine|mesh-list
92735108|NCT04135092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92735109|NCT04135092|Immunologic Factors|immunologic factors|mesh-ancestor
92735110|NCT04135092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735111|NCT04135092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735112|NCT04135092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92735113|NCT04135092|Alkylating Agents|alkylating agents|mesh-ancestor
92735114|NCT04135092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735115|NCT04135092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735116|NCT04135092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92735117|NCT04135092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92735118|NCT04135092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92735119|NCT04135092|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92735120|NCT04135092|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92735121|NCT04135092|Antiviral Agents|antiviral agents|mesh-ancestor
92735122|NCT04135092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735123|NCT00592215|Misoprostol|misoprostol|mesh-list
92735124|NCT00592215|Mifepristone|mifepristone|mesh-list
92735125|NCT00592215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92610776|NCT00506623|Irinotecan|irinotecan|mesh-list
92610777|NCT00506623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610778|NCT00506623|Antimetabolites|antimetabolites|mesh-ancestor
92735126|NCT00592215|Abortifacient Agents|abortifacient agents|mesh-ancestor
92735127|NCT00592215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735128|NCT00592215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735129|NCT00592215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92735130|NCT00592215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735131|NCT00592215|Oxytocics|oxytocics|mesh-ancestor
92735132|NCT00592215|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92735133|NCT00592215|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92735134|NCT00592215|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92735135|NCT00592215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92735136|NCT00592215|Contraceptive Agents|contraceptive agents|mesh-ancestor
92735137|NCT00592215|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92735138|NCT00592215|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92735139|NCT00592215|Hormone Antagonists|hormone antagonists|mesh-ancestor
92735140|NCT00592215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735141|NCT00592215|Luteolytic Agents|luteolytic agents|mesh-ancestor
92735142|NCT00592215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92735143|NCT00592215|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92735144|NCT00592332|Alprazolam|alprazolam|mesh-list
92735145|NCT00592332|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92735146|NCT00592332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735147|NCT00592332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735148|NCT00592332|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92735149|NCT00592332|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92735150|NCT00592332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735151|NCT00592332|GABA Modulators|gaba modulators|mesh-ancestor
92735152|NCT00592332|GABA Agents|gaba agents|mesh-ancestor
92735153|NCT00592332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735154|NCT00592332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735155|NCT04477382|Tretinoin|tretinoin|mesh-list
92735156|NCT04477382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735157|NCT04477382|Keratolytic Agents|keratolytic agents|mesh-ancestor
92735158|NCT04477382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92735159|NCT01600274|Dienogest|dienogest|mesh-list
92735160|NCT01600274|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92735161|NCT01600274|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92735162|NCT01600274|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92735163|NCT01600274|Estradiol|estradiol|mesh-list
92735164|NCT01600274|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92735165|NCT01600274|Nandrolone|nandrolone|mesh-list
92735166|NCT01600274|Estrogens|estrogens|mesh-ancestor
92735167|NCT01600274|Hormones|hormones|mesh-ancestor
92735168|NCT01600274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735172|NCT01600274|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735173|NCT01600274|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92735174|NCT01600274|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92735175|NCT01600274|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92735176|NCT01600274|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92735177|NCT01600274|Hormone Antagonists|hormone antagonists|mesh-ancestor
92735178|NCT01600274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92735179|NCT01600274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735180|NCT01600274|Androgens|androgens|mesh-ancestor
92735181|NCT01600274|Anabolic Agents|anabolic agents|mesh-ancestor
92735182|NCT01176565|Nicardipine|nicardipine|mesh-list
92735183|NCT01176565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92735184|NCT01176565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92735185|NCT01176565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735186|NCT01176565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735187|NCT01176565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92398245|NCT02293109|Glucocorticoids|glucocorticoids|mesh-ancestor
92735188|NCT01176565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735189|NCT01176565|Vasodilator Agents|vasodilator agents|mesh-ancestor
92735190|NCT04374123|Antibodies|antibodies|mesh-list
92735191|NCT04374123|Immunoglobulin M|immunoglobulin m|mesh-list
92735192|NCT04374123|Immunologic Factors|immunologic factors|mesh-ancestor
92735193|NCT04374123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735194|NCT01113541|Ziprasidone|ziprasidone|mesh-list
92610779|NCT00506623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610780|NCT00506623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735195|NCT01113541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92735196|NCT01113541|Serotonin Agents|serotonin agents|mesh-ancestor
92735197|NCT01113541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735198|NCT01113541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735199|NCT01113541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735200|NCT01113541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92735201|NCT01113541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92322314|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92735202|NCT01113541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735204|NCT01113541|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92735205|NCT01113541|Dopamine Agents|dopamine agents|mesh-ancestor
92735206|NCT00591708|Calcium, Dietary|calcium, dietary|mesh-list
92735207|NCT00591708|Citric Acid|citric acid|mesh-list
92735208|NCT00591708|Sodium Citrate|sodium citrate|mesh-list
92735210|NCT00591708|Calcium citrate malate|calcium citrate malate|mesh-list
92735211|NCT00591708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735212|NCT00591708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735213|NCT00591708|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92735214|NCT00591708|Anticoagulants|anticoagulants|mesh-ancestor
92735215|NCT00591708|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92735216|NCT00591708|Chelating Agents|chelating agents|mesh-ancestor
92735217|NCT00591708|Sequestering Agents|sequestering agents|mesh-ancestor
92735218|NCT00591708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735219|NCT01176058|Fluconazole|fluconazole|mesh-list
92735220|NCT01176058|Anidulafungin|anidulafungin|mesh-list
92735221|NCT01176058|Antifungal Agents|antifungal agents|mesh-ancestor
92735222|NCT01176058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735223|NCT01176058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92735224|NCT01176058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92735225|NCT01176058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735226|NCT01176058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735227|NCT01176058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92735228|NCT01176058|Hormone Antagonists|hormone antagonists|mesh-ancestor
92735229|NCT01176058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735230|NCT01176058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735231|NCT01176058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92735232|NCT01176058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92735233|NCT04328766|Fexuprazan|fexuprazan|mesh-list
92735234|NCT04328766|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735235|NCT02273765|Tenofovir|tenofovir|mesh-list
92735236|NCT02273765|Lamivudine|lamivudine|mesh-list
92735237|NCT02273765|Efavirenz|efavirenz|mesh-list
92735238|NCT02273765|Raltegravir Potassium|raltegravir potassium|mesh-list
92735239|NCT02273765|Antiviral Agents|antiviral agents|mesh-ancestor
92735240|NCT02273765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735242|NCT02273765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92735243|NCT02273765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735244|NCT02273765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735245|NCT02273765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92735246|NCT02273765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92735247|NCT02273765|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92735248|NCT02273765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92735249|NCT02273765|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92398263|NCT02293109|Antidotes|antidotes|mesh-ancestor
92735250|NCT02273765|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92735251|NCT02273765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92735252|NCT02273765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92735253|NCT02273765|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92735254|NCT02273765|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92735255|NCT01607333|Lamotrigine|lamotrigine|mesh-list
92735256|NCT01607333|Anticonvulsants|anticonvulsants|mesh-ancestor
92735257|NCT01607333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92735258|NCT01607333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735259|NCT01607333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735260|NCT01607333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735261|NCT01607333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735262|NCT01607333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92735263|NCT01607333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92735264|NCT01607333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735265|NCT01607333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735266|NCT01607333|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92735267|NCT01601093|Sulbactam|sulbactam|mesh-list
92735268|NCT01601093|Cefoperazone|cefoperazone|mesh-list
92735269|NCT01601093|Sulperazone|sulperazone|mesh-list
92735270|NCT01601093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735271|NCT01601093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735272|NCT01601093|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92735273|NCT01601093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735274|NCT01601093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735275|NCT01601093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92735276|NCT04367688|Tenofovir|tenofovir|mesh-list
92735277|NCT04367688|Emtricitabine|emtricitabine|mesh-list
92735278|NCT04367688|Antiviral Agents|antiviral agents|mesh-ancestor
92735279|NCT04367688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735280|NCT04367688|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92735281|NCT04367688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92735282|NCT04367688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735283|NCT04367688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735284|NCT04367688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92735285|NCT04367688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92735286|NCT02485418|Propofol|propofol|mesh-list
92735287|NCT02485418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92735288|NCT02485418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735289|NCT02485418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735290|NCT02485418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92735291|NCT02485418|Anesthetics, General|anesthetics, general|mesh-ancestor
92735292|NCT02485418|Anesthetics|anesthetics|mesh-ancestor
92735293|NCT04366830|Remestemcel-l|remestemcel-l|mesh-list
92735294|NCT04366830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735295|NCT04366830|Antiviral Agents|antiviral agents|mesh-ancestor
92735296|NCT04366830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735297|NCT01175824|Insulin|insulin|mesh-list
92735298|NCT01175824|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92735299|NCT01175824|Insulin Glargine|insulin glargine|mesh-list
92735300|NCT01175824|Insulin Lispro|insulin lispro|mesh-list
92735301|NCT01175824|Protamines|protamines|mesh-list
92735302|NCT01175824|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735303|NCT01175824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735304|NCT01175824|Heparin Antagonists|heparin antagonists|mesh-ancestor
92735305|NCT01175824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735306|NCT01175824|Coagulants|coagulants|mesh-ancestor
92735307|NCT01175707|Vancomycin|vancomycin|mesh-list
92735308|NCT01175707|Daptomycin|daptomycin|mesh-list
92735309|NCT01175707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735310|NCT01175707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735312|NCT01112059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735313|NCT01112059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735315|NCT01112059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92735316|NCT01112059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92735317|NCT01175668|Clonidine|clonidine|mesh-list
92735318|NCT01175668|Phenobarbital|phenobarbital|mesh-list
92735319|NCT01175668|Analgesics|analgesics|mesh-ancestor
92735320|NCT01175668|Sensory System Agents|sensory system agents|mesh-ancestor
92735321|NCT01175668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735322|NCT01175668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735323|NCT01175668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92735324|NCT01175668|Sympatholytics|sympatholytics|mesh-ancestor
92735325|NCT01175668|Autonomic Agents|autonomic agents|mesh-ancestor
92735326|NCT01175668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92735327|NCT01175668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92735328|NCT01175668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92735329|NCT01175668|Adrenergic Agents|adrenergic agents|mesh-ancestor
92735330|NCT01175668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735331|NCT01175668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735332|NCT01175668|Anticonvulsants|anticonvulsants|mesh-ancestor
92735333|NCT01175668|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92735334|NCT01175668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735335|NCT01175668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92735336|NCT01175668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92610781|NCT00506623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92735337|NCT01175668|GABA Modulators|gaba modulators|mesh-ancestor
92735338|NCT01175668|GABA Agents|gaba agents|mesh-ancestor
92735339|NCT01175668|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92735340|NCT01175668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92735341|NCT01175668|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92735342|NCT01601327|Methyltestosterone|methyltestosterone|mesh-list
92735343|NCT01601327|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92735344|NCT01601327|Testosterone|testosterone|mesh-list
92735345|NCT01601327|Testosterone undecanoate|testosterone undecanoate|mesh-list
92735346|NCT01601327|Testosterone enanthate|testosterone enanthate|mesh-list
92735347|NCT01601327|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92735348|NCT01601327|Androgens|androgens|mesh-ancestor
92735350|NCT01601327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735351|NCT01601327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735352|NCT01601327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92735353|NCT01601327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735354|NCT01601327|Anabolic Agents|anabolic agents|mesh-ancestor
92735355|NCT01601327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735356|NCT01601366|Contraceptive Agents|contraceptive agents|mesh-list
92735357|NCT01601366|Contraceptives, Oral|contraceptives, oral|mesh-list
92735358|NCT01601366|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92735359|NCT01601366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735360|NCT01601366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735361|NCT01601366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92735362|NCT01607762|Olanzapine|olanzapine|mesh-list
92735363|NCT01607762|Risperidone|risperidone|mesh-list
92735364|NCT01607762|Aripiprazole|aripiprazole|mesh-list
92735365|NCT01607762|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92735366|NCT01607762|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92735367|NCT01607762|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92735368|NCT01607762|Serotonin Agents|serotonin agents|mesh-ancestor
92735369|NCT01607762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735370|NCT01607762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735371|NCT01607762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735372|NCT01607762|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92735373|NCT01607762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92735374|NCT01607762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735375|NCT01607762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735376|NCT01607762|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92735377|NCT01607762|Dopamine Agents|dopamine agents|mesh-ancestor
92735378|NCT01607762|Antiemetics|antiemetics|mesh-ancestor
92735379|NCT01607762|Autonomic Agents|autonomic agents|mesh-ancestor
92735380|NCT01607762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735381|NCT01607762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735382|NCT01607762|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92735383|NCT01607762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92735384|NCT01607762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735385|NCT01607762|Antidepressive Agents|antidepressive agents|mesh-ancestor
92735387|NCT01607762|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92735388|NCT01607762|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92735389|NCT01607762|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92735390|NCT01607762|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92735391|NCT04327947|Hyaluronic Acid|hyaluronic acid|mesh-list
92735392|NCT04327947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92735393|NCT04327947|Immunologic Factors|immunologic factors|mesh-ancestor
92735394|NCT04327947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735395|NCT04327947|Viscosupplements|viscosupplements|mesh-ancestor
92735396|NCT04327947|Protective Agents|protective agents|mesh-ancestor
92735397|NCT01607918|Amoxicillin|amoxicillin|mesh-list
92735398|NCT01607918|Metronidazole|metronidazole|mesh-list
92735399|NCT01607918|Clarithromycin|clarithromycin|mesh-list
92735400|NCT01607918|Lansoprazole|lansoprazole|mesh-list
92735401|NCT01607918|Dexlansoprazole|dexlansoprazole|mesh-list
92735402|NCT01607918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735403|NCT01607918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735404|NCT01607918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92735405|NCT01607918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92735406|NCT01607918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92735407|NCT01607918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735408|NCT01607918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735409|NCT01607918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92735410|NCT01607918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92735411|NCT01607918|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92610782|NCT00506623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92610784|NCT00143741|Atorvastatin|atorvastatin|mesh-list
92610785|NCT00143741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92610786|NCT00143741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92017875|NCT04940845|Denosumab|denosumab|mesh-list
92735412|NCT01607918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735413|NCT01607918|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92735414|NCT01607996|Anesthetics|anesthetics|mesh-list
92735415|NCT01607996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735416|NCT01607996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735417|NCT01601561|Insulin|insulin|mesh-list
92735418|NCT01601561|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92735419|NCT01601561|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735420|NCT01601561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735421|NCT01601795|Sevoflurane|sevoflurane|mesh-list
92735422|NCT01601795|Isoflurane|isoflurane|mesh-list
92735423|NCT01601795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92735424|NCT01601795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92735425|NCT01601795|Anesthetics, General|anesthetics, general|mesh-ancestor
92735426|NCT01601795|Anesthetics|anesthetics|mesh-ancestor
92735427|NCT01601795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735428|NCT01601795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735429|NCT01601912|Dexetimide|dexetimide|mesh-list
92735430|NCT01601912|Citalopram|citalopram|mesh-list
92735431|NCT01601912|Escitalopram|escitalopram|mesh-list
92735432|NCT01601912|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92735433|NCT01601912|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92735434|NCT01601912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92735435|NCT01601912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735436|NCT01601912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735437|NCT01601912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735438|NCT01601912|Serotonin Agents|serotonin agents|mesh-ancestor
92735439|NCT01601912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735440|NCT01601912|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92398297|NCT01940809|Nivolumab|nivolumab|mesh-list
92735441|NCT01601912|Antidepressive Agents|antidepressive agents|mesh-ancestor
92735442|NCT01601912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735443|NCT01601912|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92735444|NCT01601912|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92735445|NCT01601912|Parasympatholytics|parasympatholytics|mesh-ancestor
92735446|NCT01601912|Autonomic Agents|autonomic agents|mesh-ancestor
92735447|NCT01601912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735448|NCT01601912|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92735449|NCT01601912|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92735450|NCT01601912|Cholinergic Agents|cholinergic agents|mesh-ancestor
92735451|NCT01601912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92735452|NCT01601912|Adrenergic Agents|adrenergic agents|mesh-ancestor
92735453|NCT01111825|Sirolimus|sirolimus|mesh-list
92735454|NCT01111825|Temsirolimus|temsirolimus|mesh-list
92735455|NCT01111825|MTOR Inhibitors|mtor inhibitors|mesh-list
92735456|NCT01111825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92735457|NCT01111825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735458|NCT01111825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735459|NCT01111825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92735460|NCT01111825|Immunologic Factors|immunologic factors|mesh-ancestor
92735463|NCT01111825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735464|NCT01111825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735465|NCT01111825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92735466|NCT01111825|Antifungal Agents|antifungal agents|mesh-ancestor
92735468|NCT01175590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735469|NCT01175590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735470|NCT01175590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92735471|NCT01175590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92735472|NCT01175590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735473|NCT01175590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735474|NCT01175590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735475|NCT01175473|Metformin|metformin|mesh-list
92735476|NCT01175473|Liraglutide|liraglutide|mesh-list
92735477|NCT01175473|Lixisenatide|lixisenatide|mesh-list
92735478|NCT01175473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735479|NCT01175473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610787|NCT00143741|Antimetabolites|antimetabolites|mesh-ancestor
92610788|NCT00143741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610789|NCT00143741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92610790|NCT00143741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92610791|NCT00143741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735480|NCT01175473|Incretins|incretins|mesh-ancestor
92735481|NCT01175473|Hormones|hormones|mesh-ancestor
92735482|NCT01175473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735483|NCT01111552|Aripiprazole|aripiprazole|mesh-list
92735484|NCT01111552|Escitalopram|escitalopram|mesh-list
92735485|NCT01111552|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92735486|NCT01111552|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92735487|NCT01111552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735488|NCT01111552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735489|NCT01111552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735490|NCT01111552|Serotonin Agents|serotonin agents|mesh-ancestor
92735491|NCT01111552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735492|NCT01111552|Antidepressive Agents|antidepressive agents|mesh-ancestor
92735493|NCT01111552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735494|NCT01111552|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92735495|NCT01111552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92735496|NCT01111552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735497|NCT01111552|Dopamine Agonists|dopamine agonists|mesh-ancestor
92735498|NCT01111552|Dopamine Agents|dopamine agents|mesh-ancestor
92735499|NCT01111552|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92735501|NCT01111552|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92735502|NCT01111552|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92735503|NCT01111552|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92735504|NCT01111552|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92735505|NCT01602185|Memantine|memantine|mesh-list
92735506|NCT01602185|Dextromethorphan|dextromethorphan|mesh-list
92735507|NCT01602185|Antitussive Agents|antitussive agents|mesh-list
92735508|NCT01602185|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92735509|NCT01602185|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92735510|NCT01602185|Dopamine Agents|dopamine agents|mesh-ancestor
92408235|NCT01449344|Antiviral Agents|antiviral agents|mesh-ancestor
92735511|NCT01602185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735512|NCT01602185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735513|NCT01602185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735514|NCT01602185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92735515|NCT01602185|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92735516|NCT01602185|Respiratory System Agents|respiratory system agents|mesh-ancestor
92735517|NCT01602302|Adalimumab|adalimumab|mesh-list
92735518|NCT01602302|Infliximab|infliximab|mesh-list
92735519|NCT01602302|Golimumab|golimumab|mesh-list
92735520|NCT01602302|Certolizumab Pegol|certolizumab pegol|mesh-list
92735521|NCT01602302|Etanercept|etanercept|mesh-list
92735522|NCT01602302|Abatacept|abatacept|mesh-list
92735523|NCT01602302|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92735524|NCT01602302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735525|NCT01602302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735526|NCT01602302|Dermatologic Agents|dermatologic agents|mesh-ancestor
92735527|NCT01602302|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735528|NCT01602302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92735529|NCT01602302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92735530|NCT01602302|Analgesics|analgesics|mesh-ancestor
92735531|NCT01602302|Sensory System Agents|sensory system agents|mesh-ancestor
92735532|NCT01602302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735533|NCT01602302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735534|NCT01602302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92735537|NCT01602302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735538|NCT01602302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92735539|NCT01602302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735540|NCT02893722|Oxytocin|oxytocin|mesh-list
92735541|NCT02893722|Atosiban|atosiban|mesh-list
92735542|NCT02893722|Oxytocics|oxytocics|mesh-ancestor
92735543|NCT02893722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735544|NCT02893722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735545|NCT02893722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92610792|NCT00143780|Vaccines|vaccines|mesh-list
92735546|NCT02893722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735547|NCT02893722|Tocolytic Agents|tocolytic agents|mesh-ancestor
92735548|NCT01608269|Lamivudine|lamivudine|mesh-list
92735549|NCT01608269|Abacavir|abacavir|mesh-list
92735550|NCT01608269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92735551|NCT01608269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92735552|NCT01608269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735553|NCT01608269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735554|NCT01608269|Antiviral Agents|antiviral agents|mesh-ancestor
92735555|NCT01608269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735556|NCT01608269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92735557|NCT01608269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92735558|NCT01608347|Folic Acid|folic acid|mesh-list
92735559|NCT01608347|Vitamin B Complex|vitamin b complex|mesh-list
92735560|NCT01608347|Hematinics|hematinics|mesh-ancestor
92735561|NCT01608347|Vitamins|vitamins|mesh-ancestor
92735562|NCT01608347|Micronutrients|micronutrients|mesh-ancestor
92735563|NCT01608347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735564|NCT04405284|Disinfectants|disinfectants|mesh-list
92735565|NCT04405284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735566|NCT01608464|Cisplatin|cisplatin|mesh-list
92735567|NCT01608464|Docetaxel|docetaxel|mesh-list
92735568|NCT01608464|Fluorouracil|fluorouracil|mesh-list
92735569|NCT01608464|Irinotecan|irinotecan|mesh-list
92735570|NCT01608464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735571|NCT01608464|Tubulin Modulators|tubulin modulators|mesh-ancestor
92735572|NCT01608464|Antimitotic Agents|antimitotic agents|mesh-ancestor
92735573|NCT01608464|Mitosis Modulators|mitosis modulators|mesh-ancestor
92735574|NCT01608464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735575|NCT01608464|Antimetabolites|antimetabolites|mesh-ancestor
92398306|NCT01940809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735576|NCT01608464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92735577|NCT01608464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92735579|NCT01608464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735580|NCT01608464|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92735581|NCT01608464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92735582|NCT01608464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735583|NCT01608698|Drospirenone|drospirenone|mesh-list
92735584|NCT01608698|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92735585|NCT01608698|Chlormadinone Acetate|chlormadinone acetate|mesh-list
92735586|NCT01608698|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92735587|NCT01608698|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92735588|NCT01608698|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92735589|NCT01608698|Contraceptive Agents|contraceptive agents|mesh-ancestor
92735590|NCT01608698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735591|NCT01608698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735592|NCT01608698|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92735593|NCT01608698|Estrogens|estrogens|mesh-ancestor
92735594|NCT01608698|Hormones|hormones|mesh-ancestor
92735595|NCT01608698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735596|NCT01608698|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92735597|NCT01608698|Hormone Antagonists|hormone antagonists|mesh-ancestor
92735598|NCT01608698|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92735599|NCT01608698|Diuretics|diuretics|mesh-ancestor
92735600|NCT01608698|Natriuretic Agents|natriuretic agents|mesh-ancestor
92735601|NCT01608698|Androgen Antagonists|androgen antagonists|mesh-ancestor
92735602|NCT01608698|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92735603|NCT04310254|Edetic Acid|edetic acid|mesh-list
92735604|NCT04310254|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92735605|NCT04310254|Pentetic Acid|pentetic acid|mesh-list
92735606|NCT04310254|Anticoagulants|anticoagulants|mesh-ancestor
92735607|NCT04310254|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92735608|NCT04310254|Chelating Agents|chelating agents|mesh-ancestor
92735609|NCT04310254|Sequestering Agents|sequestering agents|mesh-ancestor
92735610|NCT04310254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735613|NCT04310254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735614|NCT04310254|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92735615|NCT01603511|Charcoal|charcoal|mesh-list
92735616|NCT01603511|Antidotes|antidotes|mesh-ancestor
92735617|NCT01603511|Protective Agents|protective agents|mesh-ancestor
92735618|NCT01603511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735619|NCT01603745|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92735620|NCT01603745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735621|NCT01603745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735622|NCT01174186|Adalimumab|adalimumab|mesh-list
92610793|NCT00143780|Immunologic Factors|immunologic factors|mesh-ancestor
92610794|NCT00143780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610796|NCT02276365|Empagliflozin|empagliflozin|mesh-list
92610797|NCT02276365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735623|NCT01174186|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92735624|NCT01174186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735625|NCT01174186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735626|NCT01609049|Ribavirin|ribavirin|mesh-list
92735627|NCT01609049|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92735628|NCT01609049|Antimetabolites|antimetabolites|mesh-ancestor
92735629|NCT01609049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735630|NCT01609049|Antiviral Agents|antiviral agents|mesh-ancestor
92735631|NCT01609049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735632|NCT01609088|Erythritol|erythritol|mesh-list
92735633|NCT01609088|Vasodilator Agents|vasodilator agents|mesh-ancestor
92735634|NCT01609127|Capecitabine|capecitabine|mesh-list
92735635|NCT01609127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92735636|NCT01609127|Antimetabolites|antimetabolites|mesh-ancestor
92735637|NCT01609127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735638|NCT01609127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735639|NCT01609166|Allopurinol|allopurinol|mesh-list
92735640|NCT01609166|Antimetabolites|antimetabolites|mesh-ancestor
92735641|NCT01609166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735642|NCT01609166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735643|NCT01609166|Gout Suppressants|gout suppressants|mesh-ancestor
92735644|NCT01609166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735645|NCT01609166|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92735646|NCT01609166|Antioxidants|antioxidants|mesh-ancestor
92735647|NCT01609166|Protective Agents|protective agents|mesh-ancestor
92398319|NCT01740297|Ipilimumab|ipilimumab|mesh-list
92735648|NCT01609166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735649|NCT01609205|Adalimumab|adalimumab|mesh-list
92735650|NCT01609205|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92735651|NCT01609205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735652|NCT01609205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735654|NCT01604057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735655|NCT01604057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735656|NCT01604057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92735657|NCT00592566|Dexamethasone|dexamethasone|mesh-list
92735658|NCT00592566|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92735659|NCT00592566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92735660|NCT00592566|Antiemetics|antiemetics|mesh-ancestor
92735661|NCT00592566|Autonomic Agents|autonomic agents|mesh-ancestor
92735662|NCT00592566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735663|NCT00592566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735664|NCT00592566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735665|NCT00592566|Glucocorticoids|glucocorticoids|mesh-ancestor
92735666|NCT00592566|Hormones|hormones|mesh-ancestor
92735667|NCT00592566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735668|NCT00592566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92735669|NCT00592566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735670|NCT00592566|Hemostatics|hemostatics|mesh-ancestor
92735671|NCT00592566|Coagulants|coagulants|mesh-ancestor
92735672|NCT00592566|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92735673|NCT00592566|Natriuretic Agents|natriuretic agents|mesh-ancestor
92735674|NCT01111123|Halobetasol|halobetasol|mesh-list
92735675|NCT01111123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92735676|NCT01604330|Baclofen|baclofen|mesh-list
92735677|NCT01604330|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92735678|NCT01604330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735679|NCT01604330|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92735680|NCT01604330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735681|NCT01604330|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92735682|NCT01604330|GABA Agonists|gaba agonists|mesh-ancestor
92735683|NCT01604330|GABA Agents|gaba agents|mesh-ancestor
92735684|NCT01604330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735685|NCT01604330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735689|NCT00622830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735690|NCT01173679|Rituximab|rituximab|mesh-list
92735691|NCT01173679|Fludarabine|fludarabine|mesh-list
92610798|NCT02276365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610799|NCT02276365|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92610800|NCT02276365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735692|NCT01173679|Dasatinib|dasatinib|mesh-list
92735693|NCT01173679|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92735694|NCT01173679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735695|NCT01173679|Immunologic Factors|immunologic factors|mesh-ancestor
92735696|NCT01173679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735697|NCT01173679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92735698|NCT01173679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735699|NCT01173679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92735700|NCT01173679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735701|NCT02881528|Metformin|metformin|mesh-list
92735702|NCT02881528|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735703|NCT02881528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735704|NCT01609439|Vitamin D|vitamin d|mesh-list
92735705|NCT01609439|Vitamins|vitamins|mesh-ancestor
92735706|NCT01609439|Micronutrients|micronutrients|mesh-ancestor
92735707|NCT01609439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735708|NCT01609439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92735709|NCT01110382|Amoxicillin|amoxicillin|mesh-list
92735710|NCT01110382|Meropenem|meropenem|mesh-list
92735711|NCT01110382|Clavulanic Acid|clavulanic acid|mesh-list
92735712|NCT01110382|Clavulanic Acids|clavulanic acids|mesh-list
92735713|NCT01110382|Doripenem|doripenem|mesh-list
92735714|NCT01110382|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92735715|NCT01110382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735716|NCT01110382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735717|NCT01110382|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92735718|NCT01110382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735719|NCT01110382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735720|NCT00592917|Cholecalciferol|cholecalciferol|mesh-list
92735721|NCT00592917|Vitamin D|vitamin d|mesh-list
92735722|NCT00592917|Calcium Carbonate|calcium carbonate|mesh-list
92735723|NCT00592917|Calcium|calcium|mesh-list
92735724|NCT00592917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735725|NCT00592917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735726|NCT00592917|Vitamins|vitamins|mesh-ancestor
92735727|NCT00592917|Micronutrients|micronutrients|mesh-ancestor
92735728|NCT00592917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92735729|NCT00592917|Antacids|antacids|mesh-ancestor
92735730|NCT00592917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735731|NCT00592917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735732|NCT01609517|Bupivacaine|bupivacaine|mesh-list
92735733|NCT01609517|Anesthetics|anesthetics|mesh-list
92735734|NCT01609517|Anesthetics, Local|anesthetics, local|mesh-ancestor
92735735|NCT01609517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735736|NCT01609517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735737|NCT01609517|Sensory System Agents|sensory system agents|mesh-ancestor
92735738|NCT01609517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735739|NCT05265325|Epoetin Alfa|epoetin alfa|mesh-list
92735740|NCT05265325|Hematinics|hematinics|mesh-ancestor
92735741|NCT00593151|Interferons|interferons|mesh-list
92735742|NCT00593151|Interferon-alpha|interferon-alpha|mesh-list
92735743|NCT00593151|Interferon alpha-2|interferon alpha-2|mesh-list
92735744|NCT00593151|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92735745|NCT00593151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735746|NCT00593151|Antiviral Agents|antiviral agents|mesh-ancestor
92735747|NCT00593151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735748|NCT00593151|Immunologic Factors|immunologic factors|mesh-ancestor
92735749|NCT00593151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735750|NCT02489006|Olaparib|olaparib|mesh-list
92735751|NCT02489006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92735752|NCT02489006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735753|NCT02489006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735754|NCT02489006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735755|NCT01173601|Serotonin|serotonin|mesh-list
92735756|NCT01173601|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92735757|NCT01173601|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92735758|NCT01173601|Serotonin Agents|serotonin agents|mesh-ancestor
92735759|NCT01173601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327606|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92610801|NCT05145634|Anticoagulants|anticoagulants|mesh-list
92610802|NCT00143975|Cytarabine|cytarabine|mesh-list
92610803|NCT00143975|Mitoxantrone|mitoxantrone|mesh-list
92610804|NCT00143975|Gemtuzumab|gemtuzumab|mesh-list
92610805|NCT00143975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610806|NCT00143975|Antimetabolites|antimetabolites|mesh-ancestor
92735763|NCT01173601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735764|NCT01609673|Everolimus|everolimus|mesh-list
92735765|NCT01609673|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92735766|NCT01609673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92735767|NCT01609673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735768|NCT01609673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735769|NCT01609673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92735770|NCT01609673|Immunologic Factors|immunologic factors|mesh-ancestor
92735771|NCT01609673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735772|NCT01609673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735773|NCT01173055|Milnacipran|milnacipran|mesh-list
92735774|NCT01173055|Levomilnacipran|levomilnacipran|mesh-list
92735775|NCT01173055|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92735776|NCT01173055|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92735777|NCT01173055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735778|NCT01173055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735779|NCT01173055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735780|NCT01173055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735781|NCT01173055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92735782|NCT01173055|Analgesics|analgesics|mesh-ancestor
92735783|NCT01173055|Sensory System Agents|sensory system agents|mesh-ancestor
92735784|NCT01173055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735785|NCT01173055|Antidepressive Agents|antidepressive agents|mesh-ancestor
92735786|NCT01173055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735787|NCT00593502|Oseltamivir|oseltamivir|mesh-list
92735788|NCT00593502|Antiviral Agents|antiviral agents|mesh-ancestor
92735789|NCT00593502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735790|NCT00593502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735791|NCT00593502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735792|NCT01609907|Valsartan|valsartan|mesh-list
92735793|NCT01609907|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92735794|NCT01609907|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92735795|NCT01609907|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92735796|NCT01609907|Antimetabolites|antimetabolites|mesh-ancestor
92735797|NCT01609907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735798|NCT01609907|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92735799|NCT01609907|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92735800|NCT01609907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735801|NCT01609907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92735802|NCT01609907|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92735803|NCT01609907|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92735804|NCT00593580|Cholecalciferol|cholecalciferol|mesh-list
92735805|NCT00593580|Vitamin D|vitamin d|mesh-list
92735806|NCT00593580|Alendronate|alendronate|mesh-list
92735807|NCT00593580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735808|NCT00593580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735809|NCT00593580|Vitamins|vitamins|mesh-ancestor
92735810|NCT00593580|Micronutrients|micronutrients|mesh-ancestor
92735811|NCT00593580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92735812|NCT04327011|Flucytosine|flucytosine|mesh-list
92735813|NCT04327011|Antifungal Agents|antifungal agents|mesh-ancestor
92735814|NCT04327011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735815|NCT04327011|Antimetabolites|antimetabolites|mesh-ancestor
92735816|NCT04327011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735817|NCT00593619|Iron|iron|mesh-list
92735818|NCT00593619|Dextrans|dextrans|mesh-list
92735819|NCT00593619|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92735820|NCT00593619|Iron-Dextran Complex|iron-dextran complex|mesh-list
92735821|NCT00593619|Trace Elements|trace elements|mesh-ancestor
92735822|NCT00593619|Micronutrients|micronutrients|mesh-ancestor
92735823|NCT00593619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735824|NCT00593619|Hematinics|hematinics|mesh-ancestor
92735825|NCT00593619|Anticoagulants|anticoagulants|mesh-ancestor
92735826|NCT00593619|Plasma Substitutes|plasma substitutes|mesh-ancestor
92735827|NCT00593619|Blood Substitutes|blood substitutes|mesh-ancestor
92735828|NCT00593658|Pentoxifylline|pentoxifylline|mesh-list
92610807|NCT00143975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610808|NCT00143975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610809|NCT00143975|Antiviral Agents|antiviral agents|mesh-ancestor
92610810|NCT00143975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735829|NCT00593658|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92735830|NCT00593658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735833|NCT00593658|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92735834|NCT00593658|Protective Agents|protective agents|mesh-ancestor
92735835|NCT00593658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735836|NCT00593658|Vasodilator Agents|vasodilator agents|mesh-ancestor
92735837|NCT00593658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92735838|NCT00593658|Antioxidants|antioxidants|mesh-ancestor
92735839|NCT00593697|Docetaxel|docetaxel|mesh-list
92735840|NCT00593697|Trastuzumab|trastuzumab|mesh-list
92735841|NCT00593697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735842|NCT00593697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92735843|NCT00593697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92735844|NCT00593697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92735845|NCT00593697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735846|NCT00593697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92735847|NCT01601522|Ranitidine|ranitidine|mesh-list
92735848|NCT01601522|Desloratadine|desloratadine|mesh-list
92735849|NCT01601522|Histamine Antagonists|histamine antagonists|mesh-list
92735850|NCT01601522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92735851|NCT01601522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92735852|NCT01601522|Cholinergic Agents|cholinergic agents|mesh-ancestor
92735853|NCT01601522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735854|NCT01601522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735855|NCT01601522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735856|NCT01601522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92735857|NCT01601522|Histamine Agents|histamine agents|mesh-ancestor
92735858|NCT01601522|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92735859|NCT01601522|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92735860|NCT01601522|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92735861|NCT00593853|Methylphenidate|methylphenidate|mesh-list
92735862|NCT00593853|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92735863|NCT00593853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735864|NCT00593853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92735865|NCT00593853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92735866|NCT00593853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735867|NCT00593853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735868|NCT00593853|Dopamine Agents|dopamine agents|mesh-ancestor
92735869|NCT00593853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735870|NCT01607294|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92735871|NCT01607294|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92735872|NCT01607294|Antimetabolites|antimetabolites|mesh-ancestor
92735873|NCT01607294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735874|NCT01607294|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92735875|NCT01607294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735876|NCT01607294|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735877|NCT01607294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735878|NCT00594087|Eszopiclone|eszopiclone|mesh-list
92735879|NCT00594087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92735880|NCT00594087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735881|NCT00594087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735882|NCT00594126|Imetelstat|imetelstat|mesh-list
92735883|NCT00594126|Motesanib diphosphate|motesanib diphosphate|mesh-list
92735884|NCT00594126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735885|NCT00594126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735886|NCT00594126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92735887|NCT01605344|Leucovorin|leucovorin|mesh-list
92735888|NCT01605344|Fluorouracil|fluorouracil|mesh-list
92735889|NCT01605344|Irinotecan|irinotecan|mesh-list
92735890|NCT01605344|Atorvastatin|atorvastatin|mesh-list
92735891|NCT01605344|Antimetabolites|antimetabolites|mesh-ancestor
92735892|NCT01605344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735893|NCT01605344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92735894|NCT01605344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735895|NCT01605344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610811|NCT00143975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610812|NCT00143975|Immunologic Factors|immunologic factors|mesh-ancestor
92610813|NCT00143975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610814|NCT00143975|Analgesics|analgesics|mesh-ancestor
92610815|NCT00143975|Sensory System Agents|sensory system agents|mesh-ancestor
92735896|NCT01605344|Immunologic Factors|immunologic factors|mesh-ancestor
92735897|NCT01605344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735898|NCT01605344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92735899|NCT01605344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92735900|NCT01605344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735901|NCT01605344|Antidotes|antidotes|mesh-ancestor
92735906|NCT01605344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92735907|NCT01605344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92735908|NCT01605344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92735909|NCT01605344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92735910|NCT00593463|Cycloserine|cycloserine|mesh-list
92735911|NCT00593463|Verapamil|verapamil|mesh-list
92735912|NCT00593463|Diltiazem|diltiazem|mesh-list
92735913|NCT00593463|Isradipine|isradipine|mesh-list
92735914|NCT00593463|Nifedipine|nifedipine|mesh-list
92735915|NCT00593463|Gabapentin|gabapentin|mesh-list
92735916|NCT00593463|Naloxone|naloxone|mesh-list
92735917|NCT00593463|Analgesics|analgesics|mesh-ancestor
92735918|NCT00593463|Sensory System Agents|sensory system agents|mesh-ancestor
92735919|NCT00593463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92735920|NCT00593463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735921|NCT00593463|Anticonvulsants|anticonvulsants|mesh-ancestor
92735922|NCT00593463|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92735923|NCT00593463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92735924|NCT00593463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735925|NCT00593463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92735926|NCT00593463|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92735927|NCT00593463|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92735928|NCT00593463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92735929|NCT00593463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735930|NCT00593463|Antimanic Agents|antimanic agents|mesh-ancestor
92735931|NCT00593463|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92735932|NCT00593463|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92735933|NCT00593463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92735934|NCT00593463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735935|NCT00593463|Vasodilator Agents|vasodilator agents|mesh-ancestor
92735936|NCT00593463|Tocolytic Agents|tocolytic agents|mesh-ancestor
92735937|NCT00593463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92735938|NCT00593463|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92735939|NCT00593463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735940|NCT00593463|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92735941|NCT00593463|Antitubercular Agents|antitubercular agents|mesh-ancestor
92735942|NCT00593463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92735943|NCT00593463|Antimetabolites|antimetabolites|mesh-ancestor
92735944|NCT00593463|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92735945|NCT00593463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92735946|NCT00592410|Insulin|insulin|mesh-list
92735947|NCT00592410|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92735948|NCT00592410|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735949|NCT00592410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735950|NCT04328064|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92735951|NCT04328064|Calcium|calcium|mesh-list
92735952|NCT04328064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92735953|NCT04328064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735954|NCT04328064|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92735955|NCT04328064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92735956|NCT04328064|Antimetabolites|antimetabolites|mesh-ancestor
92735957|NCT04328064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735958|NCT04328064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92735959|NCT04328064|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92610816|NCT00143975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610817|NCT00143975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92610818|NCT00143975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92735960|NCT04328064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735961|NCT01605734|Sorafenib|sorafenib|mesh-list
92735962|NCT01605734|Chlorotrianisene|chlorotrianisene|mesh-list
92735963|NCT01605734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735964|NCT01605734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92735965|NCT01605734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735966|NCT01605734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735967|NCT01605734|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92735968|NCT01605734|Estrogens|estrogens|mesh-ancestor
92735970|NCT01605734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92735972|NCT01605734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92735973|NCT01605773|Glyburide|glyburide|mesh-list
92735974|NCT01605773|Repaglinide|repaglinide|mesh-list
92735975|NCT01605773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735976|NCT01605773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735977|NCT00592527|Insulin Detemir|insulin detemir|mesh-list
92735978|NCT00592527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92735979|NCT00592527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735980|NCT00594555|Cytarabine|cytarabine|mesh-list
92735981|NCT00594555|Imatinib Mesylate|imatinib mesylate|mesh-list
92735982|NCT00594555|Cladribine|cladribine|mesh-list
92735983|NCT00594555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92735984|NCT00594555|Antimetabolites|antimetabolites|mesh-ancestor
92735985|NCT00594555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735986|NCT00594555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735987|NCT00594555|Antiviral Agents|antiviral agents|mesh-ancestor
92735988|NCT00594555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92735989|NCT00594555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92735990|NCT00594555|Immunologic Factors|immunologic factors|mesh-ancestor
92735991|NCT00594555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735992|NCT00594555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92735993|NCT00594555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735994|NCT01605929|Mepivacaine|mepivacaine|mesh-list
92735995|NCT01605929|Anesthetics, Local|anesthetics, local|mesh-ancestor
92735996|NCT01605929|Anesthetics|anesthetics|mesh-ancestor
92735997|NCT01605929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92735998|NCT01605929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735999|NCT01605929|Sensory System Agents|sensory system agents|mesh-ancestor
92736000|NCT01605929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736001|NCT02270606|Calcium, Dietary|calcium, dietary|mesh-list
92736002|NCT02270606|Leucovorin|leucovorin|mesh-list
92736003|NCT02270606|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92736004|NCT02270606|Tetrahydrofolates|tetrahydrofolates|mesh-list
92736006|NCT02270606|Oxaliplatin|oxaliplatin|mesh-list
92736007|NCT02270606|Calcium|calcium|mesh-list
92736008|NCT02270606|Levoleucovorin|levoleucovorin|mesh-list
92736009|NCT02270606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92736010|NCT02270606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736011|NCT02270606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92736012|NCT02270606|Antimetabolites|antimetabolites|mesh-ancestor
92736013|NCT02270606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017907|NCT04939675|Lamotrigine|lamotrigine|mesh-list
92736014|NCT02270606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92736015|NCT02270606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736016|NCT02270606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736017|NCT02270606|Immunologic Factors|immunologic factors|mesh-ancestor
92736018|NCT02270606|Antidotes|antidotes|mesh-ancestor
92736019|NCT02270606|Protective Agents|protective agents|mesh-ancestor
92736020|NCT02270606|Vitamin B Complex|vitamin b complex|mesh-ancestor
92736021|NCT02270606|Vitamins|vitamins|mesh-ancestor
92736022|NCT02270606|Micronutrients|micronutrients|mesh-ancestor
92736023|NCT00594633|Donepezil|donepezil|mesh-list
92736024|NCT00594633|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92736025|NCT00594633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327607|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92736041|NCT01606046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736042|NCT01606046|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92736043|NCT02892942|Cetrorelix|cetrorelix|mesh-list
92736044|NCT02892942|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92736045|NCT02892942|Fertility Agents|fertility agents|mesh-ancestor
92736046|NCT02892942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92736047|NCT02892942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736048|NCT02892942|Hormone Antagonists|hormone antagonists|mesh-ancestor
92736049|NCT02892942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736050|NCT00594867|Aspirin|aspirin|mesh-list
92736051|NCT00594867|Acetaminophen|acetaminophen|mesh-list
92736052|NCT00594867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92736053|NCT00594867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92736054|NCT00594867|Analgesics|analgesics|mesh-ancestor
92736055|NCT00594867|Sensory System Agents|sensory system agents|mesh-ancestor
92736056|NCT00594867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736057|NCT00594867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736058|NCT00594867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736059|NCT00594867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736060|NCT00594867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92736061|NCT00594867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92736062|NCT00594867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736063|NCT00594867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92736064|NCT00594867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92736065|NCT00594867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736066|NCT00594867|Antipyretics|antipyretics|mesh-ancestor
92736067|NCT01606241|Cyclophosphamide|cyclophosphamide|mesh-list
92736068|NCT01606241|Vaccines|vaccines|mesh-list
92736071|NCT01606241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736072|NCT01606241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736073|NCT01606241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92736074|NCT01606241|Alkylating Agents|alkylating agents|mesh-ancestor
92736075|NCT01606241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736076|NCT01606241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736077|NCT01606241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92736078|NCT02270918|Apixaban|apixaban|mesh-list
92736079|NCT02270918|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92736080|NCT02270918|Antithrombins|antithrombins|mesh-ancestor
92736081|NCT02270918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92736082|NCT02270918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736083|NCT02270918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736084|NCT02270918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736085|NCT02270918|Anticoagulants|anticoagulants|mesh-ancestor
92736086|NCT02270996|Anti-Infective Agents|anti-infective agents|mesh-list
92736087|NCT02270996|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92610819|NCT00143975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610820|NCT00143975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92610821|NCT00143975|Immunotoxins|immunotoxins|mesh-ancestor
92017908|NCT04939675|Zonisamide|zonisamide|mesh-list
92736088|NCT00595140|Octreotide|octreotide|mesh-list
92736089|NCT00595140|Dopamine|dopamine|mesh-list
92736090|NCT00595140|Cabergoline|cabergoline|mesh-list
92736091|NCT00595140|Somatostatin|somatostatin|mesh-list
92736092|NCT00595140|Dopamine Agonists|dopamine agonists|mesh-list
92736093|NCT00595140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736094|NCT00595140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92736095|NCT00595140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736096|NCT00595140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92736097|NCT00595140|Sympathomimetics|sympathomimetics|mesh-ancestor
92736098|NCT00595140|Autonomic Agents|autonomic agents|mesh-ancestor
92736099|NCT00595140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736100|NCT00595140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736101|NCT00595140|Dopamine Agents|dopamine agents|mesh-ancestor
92736102|NCT00595140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736103|NCT00595140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736104|NCT00595140|Protective Agents|protective agents|mesh-ancestor
92736105|NCT00595140|Hormones|hormones|mesh-ancestor
92736106|NCT00595140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736107|NCT00595140|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92736108|NCT00595140|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92736109|NCT02271035|Hyaluronic Acid|hyaluronic acid|mesh-list
92736110|NCT02271035|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92736111|NCT02271035|Immunologic Factors|immunologic factors|mesh-ancestor
92736112|NCT02271035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736113|NCT02271035|Viscosupplements|viscosupplements|mesh-ancestor
92736114|NCT02271035|Protective Agents|protective agents|mesh-ancestor
92736115|NCT01606358|Carboplatin|carboplatin|mesh-list
92736116|NCT01606358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736117|NCT02271113|Enoxaparin|enoxaparin|mesh-list
92736118|NCT02271113|Enoxaparin sodium|enoxaparin sodium|mesh-list
92736119|NCT02271113|Anticoagulants|anticoagulants|mesh-ancestor
92736120|NCT02271113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92736121|NCT02271113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92736122|NCT02271113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736123|NCT02271191|Nicardipine|nicardipine|mesh-list
92736124|NCT02271191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92736125|NCT02271191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92736126|NCT02271191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736127|NCT02271191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736128|NCT02271191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92736129|NCT02271191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736130|NCT02271191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92736131|NCT00595374|Insulin|insulin|mesh-list
92736132|NCT00595374|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92736133|NCT00595374|Insulin Aspart|insulin aspart|mesh-list
92736134|NCT00595374|Insulin Detemir|insulin detemir|mesh-list
92736135|NCT00595374|Isophane Insulin, Human|isophane insulin, human|mesh-list
92736136|NCT00595374|Insulin, Isophane|insulin, isophane|mesh-list
92736137|NCT00595374|Isophane insulin, beef|isophane insulin, beef|mesh-list
92736138|NCT00595374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736139|NCT00595374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736140|NCT00595569|Insulin|insulin|mesh-list
92736141|NCT00595569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736142|NCT00595569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736143|NCT02271347|Brincidofovir|brincidofovir|mesh-list
92736162|NCT01172938|Leprostatic Agents|leprostatic agents|mesh-ancestor
92736163|NCT01172938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92736164|NCT01172938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736165|NCT01172938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92736166|NCT01172938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92736167|NCT01172938|Growth Substances|growth substances|mesh-ancestor
92736168|NCT01172938|Growth Inhibitors|growth inhibitors|mesh-ancestor
92736169|NCT01172938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736170|NCT02271464|Cyclophosphamide|cyclophosphamide|mesh-list
92736171|NCT02271464|Bevacizumab|bevacizumab|mesh-list
92736172|NCT02271464|Capecitabine|capecitabine|mesh-list
92736173|NCT02271464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736174|NCT02271464|Immunologic Factors|immunologic factors|mesh-ancestor
92736175|NCT02271464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610822|NCT00143975|Immunoconjugates|immunoconjugates|mesh-ancestor
92610823|NCT00156312|Docetaxel|docetaxel|mesh-list
92610824|NCT00156312|Capecitabine|capecitabine|mesh-list
92610825|NCT00156312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610826|NCT00156312|Tubulin Modulators|tubulin modulators|mesh-ancestor
92610827|NCT00156312|Antimitotic Agents|antimitotic agents|mesh-ancestor
92610828|NCT00156312|Mitosis Modulators|mitosis modulators|mesh-ancestor
92610829|NCT00156312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736176|NCT02271464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736177|NCT02271464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92736178|NCT02271464|Alkylating Agents|alkylating agents|mesh-ancestor
92736179|NCT02271464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736180|NCT02271464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736181|NCT02271464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92736182|NCT02271464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736183|NCT02271464|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92736184|NCT02271464|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92736185|NCT02271464|Growth Substances|growth substances|mesh-ancestor
92736186|NCT02271464|Growth Inhibitors|growth inhibitors|mesh-ancestor
92736187|NCT02271464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92736188|NCT02271464|Antimetabolites|antimetabolites|mesh-ancestor
92736189|NCT04326894|Methotrexate|methotrexate|mesh-list
92736190|NCT04326894|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92736191|NCT04326894|Abortifacient Agents|abortifacient agents|mesh-ancestor
92736192|NCT04326894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92736193|NCT04326894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736194|NCT04326894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92736195|NCT04326894|Antimetabolites|antimetabolites|mesh-ancestor
92736196|NCT04326894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736197|NCT04326894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736198|NCT04326894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92736199|NCT04326894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736207|NCT02271542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736209|NCT02271542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92736210|NCT02271542|Anesthetics, General|anesthetics, general|mesh-ancestor
92736211|NCT02271542|Anesthetics|anesthetics|mesh-ancestor
92736212|NCT01109992|Regadenoson|regadenoson|mesh-list
92736213|NCT01109992|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92736214|NCT01109992|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92736215|NCT01109992|Purinergic Agonists|purinergic agonists|mesh-ancestor
92736216|NCT01109992|Purinergic Agents|purinergic agents|mesh-ancestor
92736217|NCT01109992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736218|NCT01109992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736219|NCT01109992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736220|NCT02892357|Omeprazole|omeprazole|mesh-list
92736221|NCT02892357|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92736222|NCT02892357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736223|NCT02892357|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92736224|NCT02892357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736225|NCT02892357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736226|NCT01109524|Cetuximab|cetuximab|mesh-list
92736227|NCT01109524|Vinorelbine|vinorelbine|mesh-list
92736228|NCT01109524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736229|NCT01109524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736230|NCT01109524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92736231|NCT01109524|Tubulin Modulators|tubulin modulators|mesh-ancestor
92736232|NCT01109524|Antimitotic Agents|antimitotic agents|mesh-ancestor
92736233|NCT01109524|Mitosis Modulators|mitosis modulators|mesh-ancestor
92736234|NCT01109524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736235|NCT01109173|Nepafenac|nepafenac|mesh-list
92736236|NCT01109173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92736237|NCT01109173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92736238|NCT01109173|Analgesics|analgesics|mesh-ancestor
92736239|NCT01109173|Sensory System Agents|sensory system agents|mesh-ancestor
92736240|NCT01109173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736241|NCT01109173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610830|NCT00156312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610831|NCT00156312|Antimetabolites|antimetabolites|mesh-ancestor
92610832|NCT00506701|Tadalafil|tadalafil|mesh-list
92610833|NCT00506701|Vasodilator Agents|vasodilator agents|mesh-ancestor
92017917|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92736242|NCT01109173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736243|NCT01109173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736244|NCT02271971|Vitamin D|vitamin d|mesh-list
92736245|NCT02271971|Cholecalciferol|cholecalciferol|mesh-list
92736246|NCT02271971|Vitamins|vitamins|mesh-ancestor
92736247|NCT02271971|Micronutrients|micronutrients|mesh-ancestor
92736248|NCT02271971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736249|NCT02271971|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92736250|NCT02271971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92736251|NCT01172821|Tiotropium Bromide|tiotropium bromide|mesh-list
92736252|NCT01172821|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92736253|NCT01172821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92736254|NCT01172821|Autonomic Agents|autonomic agents|mesh-ancestor
92736255|NCT01172821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736256|NCT01172821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736257|NCT01172821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92736258|NCT01172821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92736259|NCT01172821|Parasympatholytics|parasympatholytics|mesh-ancestor
92736260|NCT01172821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92736261|NCT01172821|Cholinergic Agents|cholinergic agents|mesh-ancestor
92736262|NCT01172821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736263|NCT01172821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736264|NCT01172821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92736265|NCT01172821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92736266|NCT01172821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92736267|NCT01172821|Adrenergic Agents|adrenergic agents|mesh-ancestor
92736269|NCT01172275|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92736270|NCT01172275|Antiviral Agents|antiviral agents|mesh-ancestor
92736271|NCT01172275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736272|NCT01172275|Expectorants|expectorants|mesh-ancestor
92736273|NCT01172275|Respiratory System Agents|respiratory system agents|mesh-ancestor
92736274|NCT01172275|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92736275|NCT01172275|Antioxidants|antioxidants|mesh-ancestor
92736276|NCT01172275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736277|NCT01172275|Protective Agents|protective agents|mesh-ancestor
92736278|NCT01172275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736279|NCT01172275|Antidotes|antidotes|mesh-ancestor
92736280|NCT05034952|Acetaminophen|acetaminophen|mesh-list
92736281|NCT05034952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92736282|NCT05034952|Analgesics|analgesics|mesh-ancestor
92736283|NCT05034952|Sensory System Agents|sensory system agents|mesh-ancestor
92736284|NCT05034952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736285|NCT05034952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736286|NCT05034952|Antipyretics|antipyretics|mesh-ancestor
92736287|NCT00596037|Hormones|hormones|mesh-list
92736288|NCT00596037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736289|NCT00596037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736290|NCT02273102|Tretinoin|tretinoin|mesh-list
92736291|NCT02273102|Tranylcypromine|tranylcypromine|mesh-list
92736292|NCT02273102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736293|NCT02273102|Keratolytic Agents|keratolytic agents|mesh-ancestor
92736294|NCT02273102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92736295|NCT02273102|Antidepressive Agents|antidepressive agents|mesh-ancestor
92736296|NCT02273102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92736297|NCT02273102|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92736298|NCT02273102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736299|NCT02273102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736300|NCT02273102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92736301|NCT02273102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610834|NCT00506701|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92610835|NCT00506701|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92610836|NCT00506701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610837|NCT00506701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610838|NCT00506701|Urological Agents|urological agents|mesh-ancestor
92736302|NCT02273102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736303|NCT02273102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736304|NCT02272478|Decitabine|decitabine|mesh-list
92736305|NCT02272478|Gemtuzumab|gemtuzumab|mesh-list
92736306|NCT02272478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92736307|NCT02272478|Antimetabolites|antimetabolites|mesh-ancestor
92736308|NCT02272478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736309|NCT02272478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736310|NCT02272478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736311|NCT02272478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736312|NCT02272478|Immunotoxins|immunotoxins|mesh-ancestor
92736313|NCT02272478|Immunoconjugates|immunoconjugates|mesh-ancestor
92736314|NCT02272478|Immunologic Factors|immunologic factors|mesh-ancestor
92736315|NCT02272478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736316|NCT02272517|Vortioxetine|vortioxetine|mesh-list
92736317|NCT02272517|Escitalopram|escitalopram|mesh-list
92736318|NCT02272517|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92736319|NCT02272517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92736320|NCT02272517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736321|NCT02272517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736322|NCT02272517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736323|NCT02272517|Serotonin Agents|serotonin agents|mesh-ancestor
92736324|NCT02272517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736325|NCT02272517|Antidepressive Agents|antidepressive agents|mesh-ancestor
92736326|NCT02272517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92736327|NCT02272517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92736328|NCT02272517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92736329|NCT02272517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736330|NCT02272517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92736331|NCT02272517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92736332|NCT02272517|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92736333|NCT02272517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92736336|NCT02272829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736337|NCT02272829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736339|NCT02272829|Sensory System Agents|sensory system agents|mesh-ancestor
92736340|NCT02272829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736341|NCT00596115|Pramipexole|pramipexole|mesh-list
92736342|NCT00596115|Antioxidants|antioxidants|mesh-ancestor
92736343|NCT00596115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736344|NCT00596115|Protective Agents|protective agents|mesh-ancestor
92736345|NCT00596115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736346|NCT00596115|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92736347|NCT00596115|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92736348|NCT00596115|Dopamine Agonists|dopamine agonists|mesh-ancestor
92736349|NCT00596115|Dopamine Agents|dopamine agents|mesh-ancestor
92736350|NCT00596115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736351|NCT02272868|Rifaximin|rifaximin|mesh-list
92736352|NCT02272868|Omeprazole|omeprazole|mesh-list
92736353|NCT02272868|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92736354|NCT02272868|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92736355|NCT02272868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736356|NCT02272868|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92736357|NCT02272868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736358|NCT02272868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736359|NCT02272868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92736360|NCT02272868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736361|NCT02272868|Laxatives|laxatives|mesh-ancestor
92736362|NCT02273453|Oxazepam|oxazepam|mesh-list
92736363|NCT02273453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92736364|NCT02273453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736365|NCT02273453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736366|NCT02273453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92736367|NCT02273453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610840|NCT05147857|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92610841|NCT05147857|Abortifacient Agents|abortifacient agents|mesh-ancestor
92736368|NCT02273453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92736369|NCT02273453|GABA Modulators|gaba modulators|mesh-ancestor
92736370|NCT02273453|GABA Agents|gaba agents|mesh-ancestor
92736371|NCT02273453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736372|NCT02273453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736373|NCT01108510|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92736374|NCT01108510|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92736375|NCT01108510|Cobicistat|cobicistat|mesh-list
92736376|NCT01108510|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92398359|NCT01595620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736377|NCT01108510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92736378|NCT01108510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736379|NCT01108510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736380|NCT01108510|Antiviral Agents|antiviral agents|mesh-ancestor
92736381|NCT01108510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736382|NCT01108510|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92736383|NCT01108510|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92736384|NCT01108510|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92736385|NCT01108510|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92736386|NCT01108510|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736387|NCT01108510|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92736388|NCT01108510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92736389|NCT02273258|Insulin|insulin|mesh-list
92736390|NCT02273258|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92736391|NCT02273258|Insulin Lispro|insulin lispro|mesh-list
92736392|NCT02273258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736393|NCT02273258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736394|NCT05015686|Vaccines|vaccines|mesh-list
92736395|NCT05015686|Immunologic Factors|immunologic factors|mesh-ancestor
92736396|NCT05015686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736397|NCT04327245|Tagatose|tagatose|mesh-list
92736398|NCT04327245|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92736399|NCT04327245|Chelating Agents|chelating agents|mesh-ancestor
92736400|NCT04327245|Sequestering Agents|sequestering agents|mesh-ancestor
92736401|NCT04327245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736402|NCT01588769|Immunomodulating Agents|immunomodulating agents|mesh-list
92736403|NCT01588769|Immunologic Factors|immunologic factors|mesh-ancestor
92736404|NCT01588769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736405|NCT04327401|Dexamethasone|dexamethasone|mesh-list
92736406|NCT04327401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736407|NCT04327401|Antiemetics|antiemetics|mesh-ancestor
92736410|NCT04327401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736411|NCT04327401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736412|NCT04327401|Glucocorticoids|glucocorticoids|mesh-ancestor
92736413|NCT04327401|Hormones|hormones|mesh-ancestor
92736414|NCT04327401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736415|NCT04327401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92736416|NCT04327401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736417|NCT01340027|Solifenacin Succinate|solifenacin succinate|mesh-list
92736418|NCT01340027|Mirabegron|mirabegron|mesh-list
92736419|NCT01340027|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92736420|NCT01340027|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92736421|NCT01340027|Cholinergic Agents|cholinergic agents|mesh-ancestor
92736422|NCT01340027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736423|NCT01340027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736424|NCT01340027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736425|NCT01340027|Urological Agents|urological agents|mesh-ancestor
92736426|NCT01340027|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92736427|NCT01340027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92736428|NCT01340027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92736429|NCT01340027|Adrenergic Agents|adrenergic agents|mesh-ancestor
92736430|NCT01107925|Clopidogrel|clopidogrel|mesh-list
92736431|NCT01107925|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92610842|NCT05147857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92610843|NCT05147857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610844|NCT05147857|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92610845|NCT05147857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736432|NCT01107925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92736433|NCT01107925|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92736434|NCT01107925|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92736435|NCT01107925|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92736436|NCT01107925|Purinergic Agents|purinergic agents|mesh-ancestor
92736437|NCT01107925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736438|NCT01107925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736439|NCT01107925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736440|NCT04310293|Hormones|hormones|mesh-list
92736441|NCT04310293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736442|NCT04310293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736443|NCT01339559|Brivaracetam|brivaracetam|mesh-list
92736444|NCT01339559|Anticonvulsants|anticonvulsants|mesh-ancestor
92736445|NCT01588847|Sufentanil|sufentanil|mesh-list
92736446|NCT01588847|Bupivacaine|bupivacaine|mesh-list
92736447|NCT01588847|Anesthetics|anesthetics|mesh-list
92736448|NCT01588847|Propofol|propofol|mesh-list
92736449|NCT01588847|Sevoflurane|sevoflurane|mesh-list
92736450|NCT01588847|Rocuronium|rocuronium|mesh-list
92736451|NCT01588847|Anesthetics, Local|anesthetics, local|mesh-ancestor
92736452|NCT01588847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736453|NCT01588847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736454|NCT01588847|Sensory System Agents|sensory system agents|mesh-ancestor
92736455|NCT01588847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736456|NCT01588847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92736457|NCT01588847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92736458|NCT01588847|Anesthetics, General|anesthetics, general|mesh-ancestor
92736459|NCT01588847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92736460|NCT01588847|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92736461|NCT01588847|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92736462|NCT01588847|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92736463|NCT01588847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92736464|NCT01588847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92736465|NCT01588847|Narcotics|narcotics|mesh-ancestor
92736466|NCT01588847|Analgesics|analgesics|mesh-ancestor
92736467|NCT01588847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92736468|NCT00107900|Edoxaban|edoxaban|mesh-list
92736469|NCT00107900|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92736470|NCT00107900|Antithrombins|antithrombins|mesh-ancestor
92736471|NCT00107900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92736472|NCT00107900|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736473|NCT00107900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736476|NCT00107315|Bevacizumab|bevacizumab|mesh-list
92736477|NCT00107315|Capecitabine|capecitabine|mesh-list
92736478|NCT00107315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736479|NCT00107315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736480|NCT00107315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92736481|NCT00107315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92736482|NCT00107315|Growth Substances|growth substances|mesh-ancestor
92736483|NCT00107315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736484|NCT00107315|Growth Inhibitors|growth inhibitors|mesh-ancestor
92736485|NCT00107315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92736486|NCT00107315|Antimetabolites|antimetabolites|mesh-ancestor
92736487|NCT00107315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736488|NCT01335971|Sulforaphane|sulforaphane|mesh-list
92736489|NCT01335971|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92736490|NCT01335971|Protective Agents|protective agents|mesh-ancestor
92736491|NCT01335971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736492|NCT01335971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736493|NCT00107276|Cyclophosphamide|cyclophosphamide|mesh-list
92736494|NCT00107276|Capecitabine|capecitabine|mesh-list
92736495|NCT00107276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736496|NCT00107276|Immunologic Factors|immunologic factors|mesh-ancestor
92736497|NCT00107276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736498|NCT00107276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736499|NCT00107276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92736500|NCT00107276|Alkylating Agents|alkylating agents|mesh-ancestor
92610847|NCT00144053|Paclitaxel|paclitaxel|mesh-list
92610848|NCT00144053|Vindesine|vindesine|mesh-list
92610849|NCT00144053|Carboplatin|carboplatin|mesh-list
92610850|NCT00144053|Irinotecan|irinotecan|mesh-list
92736501|NCT00107276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736502|NCT00107276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736503|NCT00107276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92736504|NCT00107276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92736505|NCT00107276|Antimetabolites|antimetabolites|mesh-ancestor
92736507|NCT01335698|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92736508|NCT01335698|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92736509|NCT01335698|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92736510|NCT01335698|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736511|NCT01335698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736512|NCT01335698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736513|NCT01335698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92736514|NCT01335698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92736515|NCT01335698|Antiviral Agents|antiviral agents|mesh-ancestor
92736516|NCT01335698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736517|NCT01335698|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92736518|NCT01335698|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92736519|NCT00107198|Prednisone|prednisone|mesh-list
92736520|NCT00107198|Cortisone|cortisone|mesh-list
92736521|NCT00107198|Cyclophosphamide|cyclophosphamide|mesh-list
92736522|NCT00107198|Doxorubicin|doxorubicin|mesh-list
92736523|NCT00107198|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92736524|NCT00107198|Vincristine|vincristine|mesh-list
92736525|NCT00107198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736526|NCT00107198|Immunologic Factors|immunologic factors|mesh-ancestor
92736527|NCT00107198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736528|NCT00107198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736529|NCT00107198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92736530|NCT00107198|Alkylating Agents|alkylating agents|mesh-ancestor
92736531|NCT00107198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736532|NCT00107198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736533|NCT00107198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92736534|NCT00107198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92736535|NCT00107198|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92736536|NCT00107198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92736537|NCT00107198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736538|NCT00107198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736539|NCT00107198|Glucocorticoids|glucocorticoids|mesh-ancestor
92736540|NCT00107198|Hormones|hormones|mesh-ancestor
92736541|NCT00107198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736542|NCT00107198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92736543|NCT00107198|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92736544|NCT00107198|Tubulin Modulators|tubulin modulators|mesh-ancestor
92736545|NCT00107198|Antimitotic Agents|antimitotic agents|mesh-ancestor
92736549|NCT00107120|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92736550|NCT00107120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736551|NCT00107120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736552|NCT00107120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736553|NCT00107120|Serotonin Agents|serotonin agents|mesh-ancestor
92736554|NCT00107120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736555|NCT01335464|Nintedanib|nintedanib|mesh-list
92736556|NCT01335464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736557|NCT01335464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92736558|NCT01335464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736559|NCT01335464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736560|NCT00106184|Rituximab|rituximab|mesh-list
92736561|NCT00106184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736562|NCT00106184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736563|NCT00106184|Immunologic Factors|immunologic factors|mesh-ancestor
92736564|NCT00106184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736565|NCT00106184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736566|NCT00598923|Topiramate|topiramate|mesh-list
92736567|NCT00598923|Phenytoin|phenytoin|mesh-list
92736568|NCT00598923|Anticonvulsants|anticonvulsants|mesh-ancestor
92736569|NCT00598923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736570|NCT00598923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736571|NCT00598923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92398389|NCT01513187|Interferons|interferons|mesh-list
92610851|NCT00144053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92610852|NCT00144053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610853|NCT00144053|Tubulin Modulators|tubulin modulators|mesh-ancestor
92610854|NCT00144053|Antimitotic Agents|antimitotic agents|mesh-ancestor
92610855|NCT00144053|Mitosis Modulators|mitosis modulators|mesh-ancestor
92736572|NCT00598923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92736573|NCT00598923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736574|NCT00598923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736575|NCT00598923|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92736576|NCT00598923|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92736577|NCT02892318|Atezolizumab|atezolizumab|mesh-list
92736578|NCT02892318|Guadecitabine|guadecitabine|mesh-list
92736579|NCT02892318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92736580|NCT02892318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736581|NCT02892318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736582|NCT02892318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736583|NCT01334918|Regadenoson|regadenoson|mesh-list
92736584|NCT01334918|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92736585|NCT01334918|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92736586|NCT01334918|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92736587|NCT01334918|Purinergic Agonists|purinergic agonists|mesh-ancestor
92736588|NCT01334918|Purinergic Agents|purinergic agents|mesh-ancestor
92736589|NCT01334918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736590|NCT01334918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736591|NCT01334918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736592|NCT01334918|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92736593|NCT00598962|Azithromycin|azithromycin|mesh-list
92736594|NCT00598962|Rifampin|rifampin|mesh-list
92736595|NCT00598962|Rifabutin|rifabutin|mesh-list
92736596|NCT00598962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92736597|NCT00598962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736598|NCT00598962|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92736599|NCT00598962|Antitubercular Agents|antitubercular agents|mesh-ancestor
92736600|NCT00598962|Leprostatic Agents|leprostatic agents|mesh-ancestor
92736601|NCT00598962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92736602|NCT00598962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736603|NCT00598962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736604|NCT00598962|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92736605|NCT00598962|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92736606|NCT00598962|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92736607|NCT00598962|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92736608|NCT00598962|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92736609|NCT00598962|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92736610|NCT01332968|Prednisone|prednisone|mesh-list
92736611|NCT01332968|Cyclophosphamide|cyclophosphamide|mesh-list
92736612|NCT01332968|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92736613|NCT01332968|Rituximab|rituximab|mesh-list
92736614|NCT01332968|Doxorubicin|doxorubicin|mesh-list
92736615|NCT01332968|Vincristine|vincristine|mesh-list
92736616|NCT01332968|Obinutuzumab|obinutuzumab|mesh-list
92736622|NCT01332968|Alkylating Agents|alkylating agents|mesh-ancestor
92736623|NCT01332968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736624|NCT01332968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736625|NCT01332968|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92736626|NCT01332968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736627|NCT01332968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92736628|NCT01332968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92736629|NCT01332968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92736630|NCT01332968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736631|NCT01332968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736632|NCT01332968|Glucocorticoids|glucocorticoids|mesh-ancestor
92736633|NCT01332968|Hormones|hormones|mesh-ancestor
92736634|NCT01332968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736635|NCT01332968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92736636|NCT01332968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92736637|NCT01332968|Tubulin Modulators|tubulin modulators|mesh-ancestor
92736638|NCT01332968|Antimitotic Agents|antimitotic agents|mesh-ancestor
92736639|NCT01332968|Mitosis Modulators|mitosis modulators|mesh-ancestor
92610856|NCT00144053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610857|NCT00144053|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92610858|NCT00144053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92610859|NCT00144053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610860|NCT05147194|Trimetazidine|trimetazidine|mesh-list
92736640|NCT00599079|Azithromycin|azithromycin|mesh-list
92736641|NCT00599079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92736642|NCT00599079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736643|NCT00599235|Hydralazine|hydralazine|mesh-list
92736644|NCT00599235|Sildenafil Citrate|sildenafil citrate|mesh-list
92736645|NCT00599235|Vasodilator Agents|vasodilator agents|mesh-ancestor
92736646|NCT00599235|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92736647|NCT00599235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92736648|NCT00599235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736649|NCT00599235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736650|NCT00599235|Urological Agents|urological agents|mesh-ancestor
92736651|NCT00599235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92736653|NCT00599274|Interferon-beta|interferon-beta|mesh-list
92736654|NCT00599274|Interferon beta-1a|interferon beta-1a|mesh-list
92736655|NCT00599274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736656|NCT00599274|Antiviral Agents|antiviral agents|mesh-ancestor
92736657|NCT00599274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736658|NCT00599274|Immunologic Factors|immunologic factors|mesh-ancestor
92736659|NCT00599274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736660|NCT00599274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92736661|NCT01332227|Ritonavir|ritonavir|mesh-list
92736662|NCT01332227|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92736663|NCT01332227|Tenofovir|tenofovir|mesh-list
92736664|NCT01332227|Emtricitabine|emtricitabine|mesh-list
92736665|NCT01332227|Raltegravir Potassium|raltegravir potassium|mesh-list
92736666|NCT01332227|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92736667|NCT01332227|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92736668|NCT01332227|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736669|NCT01332227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736670|NCT01332227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736671|NCT01332227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92736672|NCT01332227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92736673|NCT01332227|Antiviral Agents|antiviral agents|mesh-ancestor
92736674|NCT01332227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736675|NCT01332227|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92736676|NCT01332227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92736677|NCT01332227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92736678|NCT01332227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92736679|NCT01332227|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92736680|NCT01332227|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92736681|NCT01332149|Pregabalin|pregabalin|mesh-list
92736682|NCT01332149|Analgesics|analgesics|mesh-ancestor
92736683|NCT01332149|Sensory System Agents|sensory system agents|mesh-ancestor
92736684|NCT01332149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736685|NCT01332149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736686|NCT01332149|Anticonvulsants|anticonvulsants|mesh-ancestor
92736689|NCT01332149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736690|NCT01332149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92736691|NCT01332149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92736692|NCT01332149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92736693|NCT01332149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736694|NCT01332149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92736696|NCT01326702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92736697|NCT01326702|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92736698|NCT01326702|Veliparib|veliparib|mesh-list
92736699|NCT01326702|Antibodies|antibodies|mesh-list
92736700|NCT01326702|Immunoglobulins|immunoglobulins|mesh-list
92736701|NCT01326702|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92736702|NCT01326702|Immunologic Factors|immunologic factors|mesh-ancestor
92736703|NCT01326702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736704|NCT01326702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736705|NCT01326702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736706|NCT01326702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92736707|NCT01326702|Alkylating Agents|alkylating agents|mesh-ancestor
92610862|NCT00144131|Darbepoetin alfa|darbepoetin alfa|mesh-list
92610863|NCT00144131|Hematinics|hematinics|mesh-ancestor
92610864|NCT00144209|Levodopa|levodopa|mesh-list
92610865|NCT00144209|Pramipexole|pramipexole|mesh-list
92610866|NCT00144209|Benserazide|benserazide|mesh-list
92736708|NCT01326702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015126|NCT05611307|Hormones|hormones|mesh-list
92736709|NCT01326702|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92736710|NCT01326702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736711|NCT00599625|Pravastatin|pravastatin|mesh-list
92736712|NCT00599625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92736713|NCT00599625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92736714|NCT00599625|Antimetabolites|antimetabolites|mesh-ancestor
92736715|NCT00599625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736716|NCT00599625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92736717|NCT00599625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92736718|NCT00599625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736719|NCT05650697|Cannabidiol|cannabidiol|mesh-list
92736720|NCT05650697|Anticonvulsants|anticonvulsants|mesh-ancestor
92736721|NCT05649878|Methylprednisolone|methylprednisolone|mesh-list
92736722|NCT05649878|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92736723|NCT05649878|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92736724|NCT05649878|Prednisolone|prednisolone|mesh-list
92736725|NCT05649878|Prednisolone acetate|prednisolone acetate|mesh-list
92736726|NCT05649878|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92736727|NCT05649878|Prednisolone phosphate|prednisolone phosphate|mesh-list
92736728|NCT05649878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736729|NCT05649878|Antiemetics|antiemetics|mesh-ancestor
92736730|NCT05649878|Autonomic Agents|autonomic agents|mesh-ancestor
92736731|NCT05649878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736732|NCT05649878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736733|NCT05649878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736734|NCT05649878|Glucocorticoids|glucocorticoids|mesh-ancestor
92736735|NCT05649878|Hormones|hormones|mesh-ancestor
92736736|NCT05649878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736737|NCT05649878|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92736738|NCT05649878|Protective Agents|protective agents|mesh-ancestor
92736739|NCT05649878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92736740|NCT05649878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736741|NCT01327703|Pancreatin|pancreatin|mesh-list
92736742|NCT01327703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736743|NCT01380080|Efavirenz|efavirenz|mesh-list
92736744|NCT01380080|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92736745|NCT01380080|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92736746|NCT01380080|Rifampin|rifampin|mesh-list
92736747|NCT01380080|Isoniazid|isoniazid|mesh-list
92736748|NCT01380080|Pyrazinamide|pyrazinamide|mesh-list
92736749|NCT01380080|Ethambutol|ethambutol|mesh-list
92736750|NCT01380080|Isoniazid, pyrazinamide, rifampin drug combination|isoniazid, pyrazinamide, rifampin drug combination|mesh-list
92736751|NCT01380080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92736752|NCT01380080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92736753|NCT01380080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736754|NCT01380080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736755|NCT01380080|Antiviral Agents|antiviral agents|mesh-ancestor
92736756|NCT01380080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736757|NCT01380080|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92736759|NCT01380080|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92736760|NCT01380080|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92736761|NCT01380080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92736762|NCT01380080|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92736763|NCT01380080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92736764|NCT01380080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92736765|NCT01380080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92736766|NCT01380080|Antitubercular Agents|antitubercular agents|mesh-ancestor
92736767|NCT01380080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92736768|NCT01380080|Leprostatic Agents|leprostatic agents|mesh-ancestor
92736769|NCT01380080|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92736770|NCT01380080|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92736771|NCT01380080|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92610867|NCT00144209|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92610868|NCT00144209|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92610869|NCT00144209|Dopamine Agents|dopamine agents|mesh-ancestor
92610870|NCT00144209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736772|NCT01380080|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92736773|NCT01380080|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92736774|NCT01380080|Antimetabolites|antimetabolites|mesh-ancestor
92736775|NCT01380080|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92736776|NCT01379573|Hydroxychloroquine|hydroxychloroquine|mesh-list
92736777|NCT01379573|Antimalarials|antimalarials|mesh-ancestor
92736778|NCT01379573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92736779|NCT01379573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92736780|NCT01379573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736781|NCT01379573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736782|NCT01379573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736783|NCT01379573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736784|NCT01371851|Doxazosin|doxazosin|mesh-list
92736785|NCT01371851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92736786|NCT01371851|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92736787|NCT01371851|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92736788|NCT01371851|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92736789|NCT01371851|Adrenergic Agents|adrenergic agents|mesh-ancestor
92736790|NCT01371851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736791|NCT01371851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736792|NCT01371851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736793|NCT01371734|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92736794|NCT01371734|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92736795|NCT01371734|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92736796|NCT01371734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736797|NCT01371734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736798|NCT01371734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736799|NCT01371734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736800|NCT01371734|Antidepressive Agents|antidepressive agents|mesh-ancestor
92736801|NCT01371734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92736803|NCT04328870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736804|NCT04328870|Oxytocics|oxytocics|mesh-ancestor
92736805|NCT04328870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92736806|NCT00591617|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92736807|NCT00591617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92736808|NCT00591617|Narcotics|narcotics|mesh-ancestor
92736809|NCT00591617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736810|NCT00591617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736811|NCT00591617|Analgesics|analgesics|mesh-ancestor
92736812|NCT00591617|Sensory System Agents|sensory system agents|mesh-ancestor
92736813|NCT00591617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736814|NCT00591617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92736815|NCT01357889|rGLP-1 protein|rglp-1 protein|mesh-list
92736816|NCT01357889|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92736817|NCT01357889|Incretins|incretins|mesh-ancestor
92736818|NCT01357889|Hormones|hormones|mesh-ancestor
92736819|NCT01357889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736820|NCT01357889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736821|NCT01357655|Dasatinib|dasatinib|mesh-list
92736822|NCT01357655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736823|NCT01357655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92736824|NCT01357655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736825|NCT01357655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736826|NCT01357616|Timolol|timolol|mesh-list
92736827|NCT01357616|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92736828|NCT01357616|Brinzolamide|brinzolamide|mesh-list
92736829|NCT01357616|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92736833|NCT01357616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736834|NCT01357616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736835|NCT01357616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736836|NCT01357616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92736837|NCT01357616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92736838|NCT01357616|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92736839|NCT01357616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736840|NCT01351025|Atorvastatin|atorvastatin|mesh-list
92610871|NCT00144209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610872|NCT00144209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610873|NCT00144209|Antioxidants|antioxidants|mesh-ancestor
92610874|NCT00144209|Protective Agents|protective agents|mesh-ancestor
92610875|NCT00144209|Dopamine Agonists|dopamine agonists|mesh-ancestor
92610876|NCT00144209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736841|NCT01351025|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92736842|NCT01351025|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92736843|NCT01351025|Antimetabolites|antimetabolites|mesh-ancestor
92736844|NCT01351025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736845|NCT01351025|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92736846|NCT01351025|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92736847|NCT01351025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736848|NCT01348763|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92736849|NCT01348763|Maraviroc|maraviroc|mesh-list
92736850|NCT01348763|Darunavir|darunavir|mesh-list
92736851|NCT01348763|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92736852|NCT01348763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92736853|NCT01348763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736854|NCT01348763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736855|NCT01348763|Antiviral Agents|antiviral agents|mesh-ancestor
92736856|NCT01348763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736857|NCT01348763|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92736858|NCT01348763|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92736859|NCT01348763|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92736860|NCT01348763|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92736861|NCT01348763|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92736862|NCT01348763|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92736863|NCT01348763|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92736864|NCT01348763|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736865|NCT01346540|Nintedanib|nintedanib|mesh-list
92736866|NCT01346540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736867|NCT01346540|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92736868|NCT01346540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736869|NCT01346540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736870|NCT01342913|Fluticasone|fluticasone|mesh-list
92736871|NCT01342913|Xhance|xhance|mesh-list
92736872|NCT01342913|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92736873|NCT01342913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736874|NCT01342913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92736875|NCT01342913|Autonomic Agents|autonomic agents|mesh-ancestor
92736876|NCT01342913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736877|NCT01342913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736878|NCT01342913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92736879|NCT01342913|Respiratory System Agents|respiratory system agents|mesh-ancestor
92736880|NCT01342913|Dermatologic Agents|dermatologic agents|mesh-ancestor
92736881|NCT01342913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92736882|NCT01342913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92736883|NCT01342913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92736884|NCT01342913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92736885|NCT01342913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92736886|NCT01342913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398430|NCT00962988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736887|NCT01342913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736888|NCT01342796|Vaccines|vaccines|mesh-list
92736889|NCT01342796|Immunologic Factors|immunologic factors|mesh-ancestor
92736890|NCT01342796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736891|NCT01342640|Epoetin Alfa|epoetin alfa|mesh-list
92736892|NCT01342640|Hematinics|hematinics|mesh-ancestor
92736893|NCT01342484|Linagliptin|linagliptin|mesh-list
92736894|NCT01342484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736895|NCT01342484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736896|NCT01342484|Incretins|incretins|mesh-ancestor
92736897|NCT01342484|Hormones|hormones|mesh-ancestor
92736898|NCT01342484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736899|NCT01342484|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92736900|NCT01342484|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736903|NCT01342445|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92736904|NCT01342445|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92610878|NCT05149339|Vitamin D|vitamin d|mesh-list
92610879|NCT05149339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92610880|NCT05149339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610881|NCT05149339|Vitamins|vitamins|mesh-ancestor
92610882|NCT05149339|Micronutrients|micronutrients|mesh-ancestor
92736905|NCT01342445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736906|NCT01342445|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92736907|NCT01342445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92736908|NCT01342445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736909|NCT01342445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736910|NCT01342445|Dopamine Agents|dopamine agents|mesh-ancestor
92736911|NCT01342445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736912|NCT01342211|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92736913|NCT01342211|Bococizumab|bococizumab|mesh-list
92736914|NCT01342211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92736915|NCT01342211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92736916|NCT01342211|Antimetabolites|antimetabolites|mesh-ancestor
92736917|NCT01342211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736918|NCT01342211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736919|NCT01342211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92736920|NCT01342094|Timolol|timolol|mesh-list
92736921|NCT01342094|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92736922|NCT01342094|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92736923|NCT01342094|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92736924|NCT01342094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92736925|NCT01342094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92736926|NCT01342094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736927|NCT01342094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736928|NCT01342094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736929|NCT01342094|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92736930|NCT01342094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92736931|NCT01340768|Metformin|metformin|mesh-list
92736932|NCT01340768|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92736933|NCT01340768|Glimepiride|glimepiride|mesh-list
92736934|NCT01340768|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736935|NCT01340768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736936|NCT01340768|Incretins|incretins|mesh-ancestor
92736937|NCT01340768|Hormones|hormones|mesh-ancestor
92736938|NCT01340768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92736939|NCT01340768|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92736940|NCT01340768|Protease Inhibitors|protease inhibitors|mesh-ancestor
92736941|NCT01340768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736942|NCT01340768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736944|NCT01340768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736945|NCT01340768|Immunologic Factors|immunologic factors|mesh-ancestor
92736946|NCT01340300|Metformin|metformin|mesh-list
92736947|NCT01340300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92736948|NCT01340300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736949|NCT01107535|Palivizumab|palivizumab|mesh-list
92736950|NCT01107535|Antibodies|antibodies|mesh-list
92736951|NCT01107535|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92736952|NCT01107535|Immunologic Factors|immunologic factors|mesh-ancestor
92736953|NCT01107535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736954|NCT01107535|Antiviral Agents|antiviral agents|mesh-ancestor
92736955|NCT01107535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736956|NCT02880943|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92736957|NCT02880943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736958|NCT04207632|Botulinum Toxins|botulinum toxins|mesh-list
92736959|NCT04207632|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92736960|NCT04207632|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92736961|NCT04207632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92736962|NCT04207632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736963|NCT04207632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736964|NCT04207632|Cholinergic Agents|cholinergic agents|mesh-ancestor
92736965|NCT04207632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736966|NCT04207632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736967|NCT04207632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92736968|NCT04207632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017962|NCT04938037|Prednisolone|prednisolone|mesh-list
92736969|NCT00598338|Prucalopride|prucalopride|mesh-list
92736970|NCT00598338|Laxatives|laxatives|mesh-ancestor
92736971|NCT00598338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736972|NCT00598338|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92736977|NCT00598338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736978|NCT00598572|Deferoxamine|deferoxamine|mesh-list
92736979|NCT00598572|Siderophores|siderophores|mesh-ancestor
92736980|NCT00598572|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92736981|NCT00598572|Chelating Agents|chelating agents|mesh-ancestor
92736982|NCT00598572|Sequestering Agents|sequestering agents|mesh-ancestor
92736983|NCT00598572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736984|NCT00599820|Bevacizumab|bevacizumab|mesh-list
92736985|NCT00599820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92736986|NCT00599820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92736987|NCT00599820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92736988|NCT00599820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92736989|NCT00599820|Growth Substances|growth substances|mesh-ancestor
92736990|NCT00599820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736991|NCT00599820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92736992|NCT00599898|Nifedipine|nifedipine|mesh-list
92736993|NCT00599898|Atosiban|atosiban|mesh-list
92736994|NCT00599898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92736995|NCT00599898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736996|NCT00599898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736997|NCT00599898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92736998|NCT00599898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736999|NCT00599898|Vasodilator Agents|vasodilator agents|mesh-ancestor
92737000|NCT00599898|Tocolytic Agents|tocolytic agents|mesh-ancestor
92737001|NCT00599898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737002|NCT00599898|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737003|NCT00599898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737004|NCT00600054|Nimotuzumab|nimotuzumab|mesh-list
92737005|NCT00600054|Antibodies|antibodies|mesh-list
92737006|NCT00600054|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92737007|NCT00600054|Immunologic Factors|immunologic factors|mesh-ancestor
92737008|NCT00600054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737009|NCT00600054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92737010|NCT00600054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737011|NCT00600210|Bevacizumab|bevacizumab|mesh-list
92737012|NCT00600210|Carboplatin|carboplatin|mesh-list
92737013|NCT00600210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92737014|NCT00600210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737015|NCT00600210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737016|NCT00600210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737017|NCT00600210|Growth Substances|growth substances|mesh-ancestor
92737018|NCT00600210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737019|NCT00600210|Growth Inhibitors|growth inhibitors|mesh-ancestor
92737020|NCT00600366|Insulin Aspart|insulin aspart|mesh-list
92737021|NCT00600366|Biphasic Insulins|biphasic insulins|mesh-list
92737022|NCT00600366|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92737023|NCT00600366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92737024|NCT00600366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737025|NCT01326546|Entecavir|entecavir|mesh-list
92737026|NCT01326546|Antiviral Agents|antiviral agents|mesh-ancestor
92737027|NCT01326546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737028|NCT00600600|Tigecycline|tigecycline|mesh-list
92737029|NCT00600600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737030|NCT00600600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737031|NCT00600600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92737032|NCT00600600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737033|NCT00600600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737034|NCT00623064|Gemcitabine|gemcitabine|mesh-list
92737035|NCT00623064|Lapatinib|lapatinib|mesh-list
92737036|NCT00623064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737037|NCT00623064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92737038|NCT00623064|Antimetabolites|antimetabolites|mesh-ancestor
92737039|NCT00623064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737040|NCT00623064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92737041|NCT00623064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737042|NCT00623220|Nitrous Oxide|nitrous oxide|mesh-list
92737044|NCT00623220|Anesthetics, General|anesthetics, general|mesh-ancestor
92737045|NCT00623220|Anesthetics|anesthetics|mesh-ancestor
92737046|NCT00623220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610883|NCT05149339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92610884|NCT00144248|Nevirapine|nevirapine|mesh-list
92610885|NCT00144248|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92610886|NCT00144248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92610887|NCT00144248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610888|NCT00144248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610889|NCT00144248|Antiviral Agents|antiviral agents|mesh-ancestor
92610890|NCT00144248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610891|NCT00144248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92017964|NCT04938037|Bupivacaine|bupivacaine|mesh-list
92737047|NCT00623220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737048|NCT00623220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92737049|NCT00623220|Analgesics|analgesics|mesh-ancestor
92737050|NCT00623220|Sensory System Agents|sensory system agents|mesh-ancestor
92737051|NCT00623220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737052|NCT00600912|SMOFlipid|smoflipid|mesh-list
92737053|NCT00600912|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92737054|NCT00600912|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92737055|NCT00600912|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92737056|NCT00600990|Vestipitant|vestipitant|mesh-list
92737057|NCT00600990|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92737058|NCT00600990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737059|NCT00600990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737060|NCT00600990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737061|NCT00601302|Amlodipine|amlodipine|mesh-list
92737062|NCT00601302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737063|NCT00601302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92737064|NCT00601302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737065|NCT00601302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737066|NCT00601302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92737067|NCT00601302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737068|NCT00601302|Vasodilator Agents|vasodilator agents|mesh-ancestor
92737069|NCT00601536|Lithium Carbonate|lithium carbonate|mesh-list
92737070|NCT00601536|Antidepressive Agents|antidepressive agents|mesh-ancestor
92737071|NCT00601536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92737072|NCT00601536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737073|NCT00601536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737074|NCT00601536|Antimanic Agents|antimanic agents|mesh-ancestor
92737075|NCT00601536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92737076|NCT00601536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737077|NCT00601536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737078|NCT00601614|Temozolomide|temozolomide|mesh-list
92737079|NCT00601614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92737080|NCT00601614|Alkylating Agents|alkylating agents|mesh-ancestor
92737081|NCT00601614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737082|NCT00601614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737083|NCT00601692|Docetaxel|docetaxel|mesh-list
92737085|NCT00601692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737086|NCT00601692|Tubulin Modulators|tubulin modulators|mesh-ancestor
92737087|NCT00601692|Antimitotic Agents|antimitotic agents|mesh-ancestor
92737088|NCT00601692|Mitosis Modulators|mitosis modulators|mesh-ancestor
92737089|NCT00601692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737090|NCT00601692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92737091|NCT00601692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92737092|NCT00601692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737093|NCT00602004|Losartan|losartan|mesh-list
92737094|NCT00602004|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737095|NCT00602004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92610892|NCT00144248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92610893|NCT00144248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92610894|NCT00144248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92610895|NCT00148005|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92610896|NCT00148005|Cholinergic Agents|cholinergic agents|mesh-ancestor
92610897|NCT00148005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017973|NCT04938037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737096|NCT00602004|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92737097|NCT00602004|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92737098|NCT00602004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737099|NCT00602082|Capecitabine|capecitabine|mesh-list
92737100|NCT00602082|Streptozocin|streptozocin|mesh-list
92737101|NCT00602082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737102|NCT00602082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92737103|NCT00602082|Antimetabolites|antimetabolites|mesh-ancestor
92737104|NCT00602082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737105|NCT00602082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92737106|NCT04327752|Dermatologic Agents|dermatologic agents|mesh-list
92737107|NCT01171963|Vaccines|vaccines|mesh-list
92737108|NCT01171963|Immunologic Factors|immunologic factors|mesh-ancestor
92737109|NCT01171963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737110|NCT01171183|Carvedilol|carvedilol|mesh-list
92737114|NCT01171183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737115|NCT01171183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737116|NCT01171183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737117|NCT01171183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737118|NCT01171183|Antioxidants|antioxidants|mesh-ancestor
92737119|NCT01171183|Protective Agents|protective agents|mesh-ancestor
92737120|NCT01171183|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92737121|NCT01171183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737122|NCT01171183|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92737123|NCT01171183|Vasodilator Agents|vasodilator agents|mesh-ancestor
92737124|NCT01171183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92737125|NCT01171183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92737126|NCT01169779|Metformin|metformin|mesh-list
92737127|NCT01169779|Lixisenatide|lixisenatide|mesh-list
92737128|NCT01169779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92737129|NCT01169779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737130|NCT01169701|Mycophenolic Acid|mycophenolic acid|mesh-list
92737131|NCT01169701|Everolimus|everolimus|mesh-list
92737132|NCT01169701|Tacrolimus|tacrolimus|mesh-list
92737133|NCT01169701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92737134|NCT01169701|Immunologic Factors|immunologic factors|mesh-ancestor
92737135|NCT01169701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737136|NCT01169701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92737137|NCT01169701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737138|NCT01169701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737139|NCT01169701|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92737140|NCT01169701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92737141|NCT01169701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737142|NCT01169701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92737143|NCT01169701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92737144|NCT01169701|Antitubercular Agents|antitubercular agents|mesh-ancestor
92737145|NCT01169701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737146|NCT01169701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737147|NCT01167907|Ropivacaine|ropivacaine|mesh-list
92737148|NCT01167907|Anesthetics, Local|anesthetics, local|mesh-ancestor
92737149|NCT01167907|Anesthetics|anesthetics|mesh-ancestor
92737150|NCT01167907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737151|NCT01167907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737152|NCT01167907|Sensory System Agents|sensory system agents|mesh-ancestor
92737153|NCT01167907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737154|NCT01115491|Bevacizumab|bevacizumab|mesh-list
92737155|NCT01115491|Temozolomide|temozolomide|mesh-list
92737156|NCT01115491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92737157|NCT01115491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610898|NCT00148005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610899|NCT00148005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610901|NCT00144287|Tipranavir|tipranavir|mesh-list
92610902|NCT00144287|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92610903|NCT00144287|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92610904|NCT00144287|Protease Inhibitors|protease inhibitors|mesh-ancestor
92610905|NCT00144287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610906|NCT00144287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610907|NCT00144287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92610908|NCT00144287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92610909|NCT00144287|Antiviral Agents|antiviral agents|mesh-ancestor
92610910|NCT00144287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610911|NCT00144287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92610912|NCT00144287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92610913|NCT00144326|Bromides|bromides|mesh-list
92737158|NCT01115491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737159|NCT01115491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737160|NCT01115491|Growth Substances|growth substances|mesh-ancestor
92737161|NCT01115491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737162|NCT01115491|Growth Inhibitors|growth inhibitors|mesh-ancestor
92737163|NCT01115491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92737164|NCT01115491|Alkylating Agents|alkylating agents|mesh-ancestor
92737165|NCT01115491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737166|NCT01113931|Doxycycline|doxycycline|mesh-list
92737167|NCT01113931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737168|NCT01113931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737169|NCT01113931|Antimalarials|antimalarials|mesh-ancestor
92737170|NCT01113931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92737171|NCT01113931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92737172|NCT02881177|Oxytocin|oxytocin|mesh-list
92737173|NCT02881177|Oxytocics|oxytocics|mesh-ancestor
92737174|NCT02881177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737175|NCT02881177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737176|NCT02880787|Rocuronium|rocuronium|mesh-list
92737177|NCT02880787|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92737178|NCT02880787|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92737179|NCT02880787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92737180|NCT02880787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737181|NCT02880787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737186|NCT01106677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737187|NCT01106677|Incretins|incretins|mesh-ancestor
92737188|NCT01106677|Hormones|hormones|mesh-ancestor
92737189|NCT01106677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737190|NCT01106677|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92737191|NCT01106677|Protease Inhibitors|protease inhibitors|mesh-ancestor
92737192|NCT01106677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737193|NCT01106677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737194|NCT01106677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92737195|NCT04309357|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92737196|NCT04309357|Plasminogen|plasminogen|mesh-list
92737197|NCT04309357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92737198|NCT04309357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92737199|NCT04309357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737200|NCT04985929|Sildenafil Citrate|sildenafil citrate|mesh-list
92737201|NCT04985929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92737202|NCT04985929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92610914|NCT00144326|Tiotropium Bromide|tiotropium bromide|mesh-list
92610915|NCT00144326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92610916|NCT00144326|Autonomic Agents|autonomic agents|mesh-ancestor
92610917|NCT00144326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92610918|NCT00144326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610919|NCT00144326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92610920|NCT00144326|Respiratory System Agents|respiratory system agents|mesh-ancestor
92610921|NCT00144326|Parasympatholytics|parasympatholytics|mesh-ancestor
92737203|NCT04985929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92737204|NCT04985929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737205|NCT04985929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737206|NCT04985929|Urological Agents|urological agents|mesh-ancestor
92737207|NCT04308343|Methotrexate|methotrexate|mesh-list
92737208|NCT04308343|Letrozole|letrozole|mesh-list
92737209|NCT04308343|Cetrorelix|cetrorelix|mesh-list
92737210|NCT04308343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92737211|NCT04308343|Abortifacient Agents|abortifacient agents|mesh-ancestor
92737212|NCT04308343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737213|NCT04308343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737214|NCT04308343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92737215|NCT04308343|Antimetabolites|antimetabolites|mesh-ancestor
92737216|NCT04308343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737217|NCT04308343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737218|NCT04308343|Dermatologic Agents|dermatologic agents|mesh-ancestor
92737219|NCT04308343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737220|NCT04308343|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92737221|NCT04308343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92737222|NCT04308343|Immunologic Factors|immunologic factors|mesh-ancestor
92737223|NCT04308343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737224|NCT04308343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92737225|NCT04308343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92737226|NCT04308343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92737227|NCT04308343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92737228|NCT04308343|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737229|NCT04308343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737230|NCT04308343|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92737231|NCT04308343|Fertility Agents|fertility agents|mesh-ancestor
92737232|NCT01099579|Ritonavir|ritonavir|mesh-list
92737233|NCT01099579|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92737234|NCT01099579|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92737235|NCT01099579|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92737236|NCT01099579|Protease Inhibitors|protease inhibitors|mesh-ancestor
92737237|NCT01099579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737238|NCT01099579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737239|NCT01099579|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92737240|NCT01099579|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92737241|NCT01099579|Antiviral Agents|antiviral agents|mesh-ancestor
92737242|NCT01099579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737243|NCT01099579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92737244|NCT01099579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92737245|NCT01103713|Azithromycin|azithromycin|mesh-list
92737246|NCT01103713|Chloroquine|chloroquine|mesh-list
92737247|NCT01103713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737248|NCT01103713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737249|NCT01103713|Amebicides|amebicides|mesh-ancestor
92737250|NCT01103713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92737251|NCT01103713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92737252|NCT01103713|Antimalarials|antimalarials|mesh-ancestor
92737253|NCT01103713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737256|NCT01103245|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737257|NCT01103245|Diuretics|diuretics|mesh-ancestor
92737258|NCT01103245|Natriuretic Agents|natriuretic agents|mesh-ancestor
92737259|NCT01103245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737260|NCT01103245|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92737261|NCT01103245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737262|NCT01103245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610922|NCT00144326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92610923|NCT00144326|Cholinergic Agents|cholinergic agents|mesh-ancestor
92610924|NCT00144326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610925|NCT00144326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610926|NCT00144326|Anticonvulsants|anticonvulsants|mesh-ancestor
92737263|NCT01103245|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92737264|NCT01103245|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737265|NCT01103245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737266|NCT01103245|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92737267|NCT02878837|Midazolam|midazolam|mesh-list
92737268|NCT02878837|Dexmedetomidine|dexmedetomidine|mesh-list
92737269|NCT02878837|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92737270|NCT02878837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737271|NCT02878837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737272|NCT02878837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92737273|NCT02878837|Analgesics|analgesics|mesh-ancestor
92737274|NCT02878837|Sensory System Agents|sensory system agents|mesh-ancestor
92737275|NCT02878837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737276|NCT02878837|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92737277|NCT02878837|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92737278|NCT02878837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92737279|NCT02878837|Adrenergic Agents|adrenergic agents|mesh-ancestor
92737280|NCT02878837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737281|NCT02878837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737282|NCT02878837|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92737283|NCT02878837|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92737284|NCT02878837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92737285|NCT02878837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92737286|NCT02878837|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92737287|NCT02878837|Anesthetics, General|anesthetics, general|mesh-ancestor
92737288|NCT02878837|Anesthetics|anesthetics|mesh-ancestor
92737289|NCT02878837|GABA Modulators|gaba modulators|mesh-ancestor
92737290|NCT02878837|GABA Agents|gaba agents|mesh-ancestor
92737291|NCT02880007|Cisplatin|cisplatin|mesh-list
92737292|NCT02880007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737293|NCT04982029|Cannabidiol|cannabidiol|mesh-list
92737294|NCT04982029|Anticonvulsants|anticonvulsants|mesh-ancestor
92737295|NCT02880085|Lidocaine|lidocaine|mesh-list
92737296|NCT02880085|Anesthetics, Local|anesthetics, local|mesh-list
92737297|NCT02880085|Anesthetics|anesthetics|mesh-list
92737298|NCT02880085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737299|NCT02880085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737300|NCT02880085|Sensory System Agents|sensory system agents|mesh-ancestor
92737301|NCT02880085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737302|NCT02880085|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737303|NCT02880085|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92737304|NCT02880085|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92737305|NCT02880085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737306|NCT02880085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737307|NCT01098097|Ribavirin|ribavirin|mesh-list
92737308|NCT01098097|Antimetabolites|antimetabolites|mesh-ancestor
92737309|NCT01098097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737310|NCT01098097|Antiviral Agents|antiviral agents|mesh-ancestor
92737311|NCT01098097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737312|NCT04407572|Vitamin D|vitamin d|mesh-list
92737313|NCT04407572|Vitamins|vitamins|mesh-list
92737314|NCT04407572|Vitamin B 12|vitamin b 12|mesh-list
92737315|NCT04407572|Hydroxocobalamin|hydroxocobalamin|mesh-list
92737316|NCT04407572|Micronutrients|micronutrients|mesh-ancestor
92737317|NCT04407572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737318|NCT04407572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92737319|NCT04407572|Vitamin B Complex|vitamin b complex|mesh-ancestor
92737320|NCT04407572|Hematinics|hematinics|mesh-ancestor
92737321|NCT04328636|Magnesium Sulfate|magnesium sulfate|mesh-list
92737322|NCT04328636|Analgesics|analgesics|mesh-ancestor
92737323|NCT04328636|Sensory System Agents|sensory system agents|mesh-ancestor
92737324|NCT04328636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737325|NCT04328636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737326|NCT04328636|Anesthetics|anesthetics|mesh-ancestor
92737327|NCT04328636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610927|NCT02954692|Metformin|metformin|mesh-list
92610928|NCT02954692|Insulin Glargine|insulin glargine|mesh-list
92610929|NCT02954692|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92610930|NCT02954692|Meglitinide|meglitinide|mesh-list
92610931|NCT02954692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92610932|NCT02954692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92018009|NCT04936711|Bupivacaine|bupivacaine|mesh-list
92737331|NCT04328636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737332|NCT04328636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737333|NCT04328636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92737334|NCT04328636|Tocolytic Agents|tocolytic agents|mesh-ancestor
92737335|NCT04328636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737336|NCT02893826|Nimodipine|nimodipine|mesh-list
92737337|NCT02893826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737338|NCT02893826|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92737339|NCT02893826|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737340|NCT02893826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737341|NCT02893826|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92737342|NCT02893826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737343|NCT02893826|Vasodilator Agents|vasodilator agents|mesh-ancestor
92737344|NCT02893280|Aspirin|aspirin|mesh-list
92737345|NCT02893280|Enoxaparin|enoxaparin|mesh-list
92737346|NCT02893280|Streptokinase|streptokinase|mesh-list
92737347|NCT02893280|Clopidogrel|clopidogrel|mesh-list
92737348|NCT02893280|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92737349|NCT02893280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92737350|NCT02893280|Analgesics|analgesics|mesh-ancestor
92737351|NCT02893280|Sensory System Agents|sensory system agents|mesh-ancestor
92737352|NCT02893280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737353|NCT02893280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737354|NCT02893280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737355|NCT02893280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737356|NCT02893280|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92737357|NCT02893280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92737358|NCT02893280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737359|NCT02893280|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92737360|NCT02893280|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92737361|NCT02893280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737362|NCT02893280|Antipyretics|antipyretics|mesh-ancestor
92737363|NCT02893280|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92737364|NCT02893280|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92737365|NCT02893280|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92737366|NCT02893280|Purinergic Agents|purinergic agents|mesh-ancestor
92737367|NCT02893280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737368|NCT02893280|Anticoagulants|anticoagulants|mesh-ancestor
92737369|NCT04390802|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92737370|NCT04390802|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92737371|NCT04390802|Dermatologic Agents|dermatologic agents|mesh-ancestor
92737372|NCT04328480|Colchicine|colchicine|mesh-list
92737373|NCT04328480|Gout Suppressants|gout suppressants|mesh-ancestor
92737374|NCT04328480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737375|NCT04328480|Tubulin Modulators|tubulin modulators|mesh-ancestor
92737376|NCT04328480|Antimitotic Agents|antimitotic agents|mesh-ancestor
92737377|NCT04328480|Mitosis Modulators|mitosis modulators|mesh-ancestor
92737378|NCT04328480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737379|NCT04328480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737380|NCT00592280|Pancrelipase|pancrelipase|mesh-list
92737381|NCT00592280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92737382|NCT02893124|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92737383|NCT02893124|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92737384|NCT02893124|Antiviral Agents|antiviral agents|mesh-ancestor
92737385|NCT02893124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737386|NCT02892812|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92737387|NCT02892812|Immunologic Factors|immunologic factors|mesh-ancestor
92737388|NCT02892812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737389|NCT00592670|Fluoxetine|fluoxetine|mesh-list
92737390|NCT00592670|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92737391|NCT00592670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92610933|NCT02954692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610934|NCT02954692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610935|NCT02954692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610936|NCT00506935|Vigabatrin|vigabatrin|mesh-list
92610937|NCT00506935|Anticonvulsants|anticonvulsants|mesh-ancestor
92610938|NCT00506935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610939|NCT00506935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610940|NCT00506935|GABA Agents|gaba agents|mesh-ancestor
92610941|NCT00506935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336005|NCT02020512|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92018011|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
92737392|NCT00592670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737393|NCT00592670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737394|NCT00592670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737395|NCT00592670|Serotonin Agents|serotonin agents|mesh-ancestor
92737396|NCT00592670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737397|NCT00592670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92737405|NCT04327232|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737406|NCT04327232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737407|NCT04327232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737408|NCT04327232|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92737409|NCT04327232|Diuretics|diuretics|mesh-ancestor
92737410|NCT04327232|Natriuretic Agents|natriuretic agents|mesh-ancestor
92737411|NCT00593138|Methylphenidate|methylphenidate|mesh-list
92737412|NCT00593138|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92737413|NCT00593138|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92737414|NCT00593138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737415|NCT00593138|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92737416|NCT00593138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92737417|NCT00593138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737418|NCT00593138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737419|NCT00593138|Dopamine Agents|dopamine agents|mesh-ancestor
92737420|NCT00593138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737421|NCT00593294|Drospirenone|drospirenone|mesh-list
92737422|NCT00593294|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92737423|NCT00593294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737424|NCT00593294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92737425|NCT00593294|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737426|NCT00593294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737427|NCT00593294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92737428|NCT00593294|Diuretics|diuretics|mesh-ancestor
92737429|NCT00593294|Natriuretic Agents|natriuretic agents|mesh-ancestor
92737430|NCT00593294|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92737431|NCT00593294|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92737432|NCT00593294|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92737433|NCT00593294|Contraceptive Agents|contraceptive agents|mesh-ancestor
92737434|NCT00593294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737435|NCT00593294|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92737436|NCT00593294|Estrogens|estrogens|mesh-ancestor
92737437|NCT00593294|Hormones|hormones|mesh-ancestor
92737438|NCT00593996|Vitamin D|vitamin d|mesh-list
92737439|NCT00593996|Ergocalciferols|ergocalciferols|mesh-list
92737440|NCT00593996|Vitamins|vitamins|mesh-ancestor
92737441|NCT00593996|Micronutrients|micronutrients|mesh-ancestor
92737442|NCT00593996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737443|NCT00593996|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92737444|NCT00593996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92737445|NCT00594542|Lidocaine|lidocaine|mesh-list
92737446|NCT00594542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92737447|NCT00594542|Anesthetics|anesthetics|mesh-ancestor
92737448|NCT00594542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737449|NCT00594542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610942|NCT00506935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610943|NCT00144365|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92610944|NCT00144365|Antiviral Agents|antiviral agents|mesh-ancestor
92610945|NCT00144365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610947|NCT00506974|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92610948|NCT00506974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92610949|NCT00506974|Anesthetics, General|anesthetics, general|mesh-ancestor
92610950|NCT00506974|Anesthetics|anesthetics|mesh-ancestor
92610951|NCT00506974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737450|NCT00594542|Sensory System Agents|sensory system agents|mesh-ancestor
92737451|NCT00594542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737452|NCT00594542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737453|NCT00594542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92737454|NCT00594542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92737455|NCT00594542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737456|NCT00594542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737457|NCT00595322|Bevacizumab|bevacizumab|mesh-list
92737458|NCT00595322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92737459|NCT00595322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737460|NCT00595322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737461|NCT00595322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737462|NCT00595322|Growth Substances|growth substances|mesh-ancestor
92737466|NCT00596336|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92737467|NCT00596336|Immunologic Factors|immunologic factors|mesh-ancestor
92737468|NCT00596336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737469|NCT00596336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737470|NCT00596336|Interferon Inducers|interferon inducers|mesh-ancestor
92737471|NCT00596414|Midazolam|midazolam|mesh-list
92737472|NCT00596414|Meperidine|meperidine|mesh-list
92737473|NCT00596414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92737474|NCT00596414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92737475|NCT00596414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737476|NCT00596414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737477|NCT00596414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92737478|NCT00596414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92737479|NCT00596414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92737480|NCT00596414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92737481|NCT00596414|Anesthetics, General|anesthetics, general|mesh-ancestor
92737482|NCT00596414|Anesthetics|anesthetics|mesh-ancestor
92737483|NCT00596414|GABA Modulators|gaba modulators|mesh-ancestor
92737484|NCT00596414|GABA Agents|gaba agents|mesh-ancestor
92737485|NCT00596414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737486|NCT00596414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737487|NCT00596414|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92737488|NCT00596414|Narcotics|narcotics|mesh-ancestor
92737489|NCT00596414|Analgesics|analgesics|mesh-ancestor
92737490|NCT00596414|Sensory System Agents|sensory system agents|mesh-ancestor
92737491|NCT00596414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737492|NCT00596648|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92737493|NCT00596648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737494|NCT00596648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92737495|NCT00596648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737496|NCT00596648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737497|NCT00596804|Veltuzumab|veltuzumab|mesh-list
92737498|NCT00596804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737499|NCT00622934|Epoetin Alfa|epoetin alfa|mesh-list
92737500|NCT00622934|Hematinics|hematinics|mesh-ancestor
92737501|NCT00597662|Icodextrin|icodextrin|mesh-list
92737502|NCT00597662|Dialysis Solutions|dialysis solutions|mesh-ancestor
92737503|NCT00597662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92737504|NCT00598052|Escitalopram|escitalopram|mesh-list
92737505|NCT00598052|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92737506|NCT00598052|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92737507|NCT00598052|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737508|NCT00598052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737509|NCT00598052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610952|NCT00506974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610953|NCT00156546|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92610954|NCT00156546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610955|NCT00507052|Acetylcysteine|acetylcysteine|mesh-list
92610956|NCT00507052|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92610957|NCT00507052|Antiviral Agents|antiviral agents|mesh-ancestor
92018034|NCT04927039|Iloprost|iloprost|mesh-list
92737510|NCT00598052|Serotonin Agents|serotonin agents|mesh-ancestor
92737511|NCT00598052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737512|NCT04326296|Lenalidomide|lenalidomide|mesh-list
92737513|NCT04326296|Antibodies|antibodies|mesh-list
92737514|NCT04326296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92737515|NCT04326296|Immunologic Factors|immunologic factors|mesh-ancestor
92737516|NCT04326296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737517|NCT04326296|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737518|NCT04326296|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737519|NCT04326296|Growth Substances|growth substances|mesh-ancestor
92737520|NCT04326296|Growth Inhibitors|growth inhibitors|mesh-ancestor
92737521|NCT04326296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737522|NCT00598676|Sirolimus|sirolimus|mesh-list
92737523|NCT00598676|Everolimus|everolimus|mesh-list
92737524|NCT00598676|MTOR Inhibitors|mtor inhibitors|mesh-list
92737525|NCT00598676|Temsirolimus|temsirolimus|mesh-list
92737526|NCT00598676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92737527|NCT00598676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327608|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92737530|NCT00598676|Immunologic Factors|immunologic factors|mesh-ancestor
92737531|NCT00598676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737532|NCT00598676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737533|NCT00598676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737534|NCT00598676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737535|NCT00598676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92737536|NCT00598676|Antifungal Agents|antifungal agents|mesh-ancestor
92737538|NCT00599222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737539|NCT00599222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737540|NCT00599222|Growth Substances|growth substances|mesh-ancestor
92737541|NCT00599222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737542|NCT00599222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92737543|NCT00599222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737544|NCT00599534|Montelukast|montelukast|mesh-list
92737545|NCT00599534|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92737546|NCT00599534|Respiratory System Agents|respiratory system agents|mesh-ancestor
92737547|NCT00599534|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92737548|NCT00599534|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737549|NCT00599534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737550|NCT00599534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737551|NCT00599534|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92737552|NCT00599534|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92737553|NCT00599534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737554|NCT00600158|Lidocaine|lidocaine|mesh-list
92737555|NCT00600158|Hydromorphone|hydromorphone|mesh-list
92737556|NCT00600158|Bupivacaine|bupivacaine|mesh-list
92737557|NCT00600158|Anesthetics, Local|anesthetics, local|mesh-ancestor
92737558|NCT00600158|Anesthetics|anesthetics|mesh-ancestor
92737559|NCT00600158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737560|NCT00600158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737561|NCT00600158|Sensory System Agents|sensory system agents|mesh-ancestor
92737562|NCT00600158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737563|NCT00600158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737564|NCT00600158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92610958|NCT00507052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92610960|NCT00507052|Respiratory System Agents|respiratory system agents|mesh-ancestor
92610961|NCT00507052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92610962|NCT00507052|Antioxidants|antioxidants|mesh-ancestor
92610963|NCT00507052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610964|NCT00507052|Protective Agents|protective agents|mesh-ancestor
92610965|NCT00507052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610966|NCT00507052|Antidotes|antidotes|mesh-ancestor
92610967|NCT00507091|Leucovorin|leucovorin|mesh-list
92610968|NCT00507091|Fluorouracil|fluorouracil|mesh-list
92737565|NCT00600158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92737566|NCT00600158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737567|NCT00600158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737568|NCT00600158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92737569|NCT00600158|Narcotics|narcotics|mesh-ancestor
92737570|NCT00600158|Analgesics|analgesics|mesh-ancestor
92737571|NCT04325984|Dexamethasone|dexamethasone|mesh-list
92737572|NCT04325984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737573|NCT04325984|Antiemetics|antiemetics|mesh-ancestor
92737574|NCT04325984|Autonomic Agents|autonomic agents|mesh-ancestor
92737575|NCT04325984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737576|NCT04325984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737577|NCT04325984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92737578|NCT04325984|Glucocorticoids|glucocorticoids|mesh-ancestor
92737579|NCT04325984|Hormones|hormones|mesh-ancestor
92737580|NCT04325984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737581|NCT04325984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92737582|NCT04325984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737583|NCT00600548|Miltefosine|miltefosine|mesh-list
92737584|NCT00600548|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92737585|NCT00600548|Antifungal Agents|antifungal agents|mesh-ancestor
92737586|NCT00600548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737587|NCT00600548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737588|NCT00600548|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92737589|NCT00600548|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92737590|NCT00600626|Insulin|insulin|mesh-list
92737591|NCT00600626|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92737592|NCT00600626|Insulin Aspart|insulin aspart|mesh-list
92737593|NCT00600626|Insulin, Long-Acting|insulin, long-acting|mesh-list
92737594|NCT00600626|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92737595|NCT00600626|Biphasic Insulins|biphasic insulins|mesh-list
92737596|NCT00600626|Isophane Insulin, Human|isophane insulin, human|mesh-list
92737597|NCT00600626|Insulin, Isophane|insulin, isophane|mesh-list
92737598|NCT00600626|Isophane insulin, beef|isophane insulin, beef|mesh-list
92737599|NCT00600626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92737613|NCT00601328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92737614|NCT00601328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737615|NCT00601328|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92737616|NCT00601328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737617|NCT00601328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737618|NCT00601328|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92737619|NCT00601328|Vitamins|vitamins|mesh-ancestor
92737620|NCT00601328|Micronutrients|micronutrients|mesh-ancestor
92737621|NCT00601328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92737622|NCT00601562|Zidovudine|zidovudine|mesh-list
92737623|NCT00601562|Antimetabolites|antimetabolites|mesh-ancestor
92737624|NCT00601562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737625|NCT00601562|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92737626|NCT00601562|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92737627|NCT00601562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737628|NCT00601562|Antiviral Agents|antiviral agents|mesh-ancestor
92737629|NCT00601562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737630|NCT00601562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92737631|NCT00601562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92737632|NCT00601874|Pilocarpine|pilocarpine|mesh-list
92610969|NCT00507091|Irinotecan|irinotecan|mesh-list
92610970|NCT00507091|Antimetabolites|antimetabolites|mesh-ancestor
92610971|NCT00507091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610972|NCT00507091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92610973|NCT00507091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92610974|NCT00507091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92610975|NCT00507091|Immunologic Factors|immunologic factors|mesh-ancestor
92610976|NCT00507091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610977|NCT00507091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92737633|NCT00601874|Miotics|miotics|mesh-ancestor
92737634|NCT00601874|Autonomic Agents|autonomic agents|mesh-ancestor
92737635|NCT00601874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737636|NCT00601874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737637|NCT00601874|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92737638|NCT00601874|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92737639|NCT00601874|Cholinergic Agents|cholinergic agents|mesh-ancestor
92737640|NCT00601874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737641|NCT00601874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737642|NCT01326026|Insulin|insulin|mesh-list
92737643|NCT01326026|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92737644|NCT01326026|Insulin, Long-Acting|insulin, long-acting|mesh-list
92737645|NCT01326026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92737646|NCT01326026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737647|NCT01097629|Suvorexant|suvorexant|mesh-list
92737648|NCT01097629|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92737649|NCT01097629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92737650|NCT01097629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737651|NCT01097629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737652|NCT01097629|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92737653|NCT01097629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737654|NCT01097629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737655|NCT04308031|Digoxin|digoxin|mesh-list
92737656|NCT04308031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737657|NCT04308031|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92737658|NCT04308031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737659|NCT04308031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737660|NCT04308031|Protective Agents|protective agents|mesh-ancestor
92737661|NCT04308031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737662|NCT01096849|Levofloxacin|levofloxacin|mesh-list
92737663|NCT01096849|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92737677|NCT01324388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737678|NCT01324388|Sympatholytics|sympatholytics|mesh-ancestor
92737679|NCT01324388|Autonomic Agents|autonomic agents|mesh-ancestor
92737680|NCT01324388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737681|NCT01324388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737682|NCT01324388|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92737683|NCT01324388|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92737684|NCT01324388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92737685|NCT01324388|Adrenergic Agents|adrenergic agents|mesh-ancestor
92737686|NCT01324388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737687|NCT01324388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737688|NCT01324388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92737689|NCT01324388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92737690|NCT01324388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737691|NCT01324388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92737692|NCT01324388|Protective Agents|protective agents|mesh-ancestor
92737693|NCT01324388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92737694|NCT02878681|Ranibizumab|ranibizumab|mesh-list
92737695|NCT02878681|Aflibercept|aflibercept|mesh-list
92737696|NCT02878681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737697|NCT02878681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737698|NCT02878681|Growth Substances|growth substances|mesh-ancestor
92737699|NCT02878681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737700|NCT02878681|Growth Inhibitors|growth inhibitors|mesh-ancestor
92610978|NCT00507091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92610979|NCT00507091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92610980|NCT00507091|Antidotes|antidotes|mesh-ancestor
92610981|NCT00507091|Protective Agents|protective agents|mesh-ancestor
92610982|NCT00507091|Vitamin B Complex|vitamin b complex|mesh-ancestor
92610983|NCT00507091|Vitamins|vitamins|mesh-ancestor
92610984|NCT00507091|Micronutrients|micronutrients|mesh-ancestor
92610985|NCT05148910|Copper|copper|mesh-list
92610986|NCT05148910|Trace Elements|trace elements|mesh-ancestor
92018061|NCT04935541|Narcotics|narcotics|mesh-ancestor
92737701|NCT02878681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737702|NCT01324310|Ketoconazole|ketoconazole|mesh-list
92737703|NCT01324310|Romidepsin|romidepsin|mesh-list
92737704|NCT01324310|Antifungal Agents|antifungal agents|mesh-ancestor
92737705|NCT01324310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737706|NCT01324310|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92737707|NCT01324310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92737708|NCT01324310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737709|NCT01324310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737710|NCT01324310|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92737711|NCT01324310|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737712|NCT01324310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737713|NCT01324310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737714|NCT01324310|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92737715|NCT01324310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92737716|NCT01324310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737717|NCT01324310|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92737718|NCT01102231|Cetuximab|cetuximab|mesh-list
92737719|NCT01102231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92737720|NCT01102231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737721|NCT01095835|Interferons|interferons|mesh-list
92737722|NCT01095835|Lamivudine|lamivudine|mesh-list
92737723|NCT01095835|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92737724|NCT01095835|Interferon-alpha|interferon-alpha|mesh-list
92737727|NCT01095835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737728|NCT01095835|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92737729|NCT01095835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92737730|NCT01095835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737731|NCT01095835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737732|NCT01095835|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92737733|NCT01095835|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92737734|NCT01095835|Immunologic Factors|immunologic factors|mesh-ancestor
92737735|NCT01095835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737736|NCT04908865|Belimumab|belimumab|mesh-list
92737737|NCT04908865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92737738|NCT04908865|Immunologic Factors|immunologic factors|mesh-ancestor
92737739|NCT04908865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737740|NCT01324232|Quinidine|quinidine|mesh-list
92737741|NCT01324232|Dextromethorphan|dextromethorphan|mesh-list
92737742|NCT01324232|Antitussive Agents|antitussive agents|mesh-ancestor
92737743|NCT01324232|Respiratory System Agents|respiratory system agents|mesh-ancestor
92737744|NCT01324232|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92737745|NCT01324232|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92737746|NCT01324232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737747|NCT01324232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737748|NCT01324232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737750|NCT01324232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92737751|NCT01324232|Adrenergic Agents|adrenergic agents|mesh-ancestor
92737752|NCT01324232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737753|NCT01324232|Antimalarials|antimalarials|mesh-ancestor
92737754|NCT01324232|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92737755|NCT01324232|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92737756|NCT01324232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737757|NCT01324232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737758|NCT01324232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92737759|NCT01324232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92737760|NCT01324232|Cholinergic Agents|cholinergic agents|mesh-ancestor
92610987|NCT05148910|Micronutrients|micronutrients|mesh-ancestor
92610988|NCT05148910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610989|NCT00148083|Risperidone|risperidone|mesh-list
92610990|NCT00148083|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92610991|NCT00148083|Serotonin Agents|serotonin agents|mesh-ancestor
92610992|NCT00148083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92610993|NCT00148083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92610994|NCT00148083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92610995|NCT00148083|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92737761|NCT01324232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92737762|NCT01324232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92737763|NCT01324232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737764|NCT01324232|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92737765|NCT01324232|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92737766|NCT02878291|Vaccines|vaccines|mesh-list
92737767|NCT02878291|Immunologic Factors|immunologic factors|mesh-ancestor
92737768|NCT02878291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737769|NCT05350891|Immunomodulating Agents|immunomodulating agents|mesh-list
92737770|NCT05350891|Immunologic Factors|immunologic factors|mesh-ancestor
92737771|NCT05350891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737772|NCT01323920|Methotrexate|methotrexate|mesh-list
92737773|NCT01323920|Bortezomib|bortezomib|mesh-list
92737774|NCT01323920|Tacrolimus|tacrolimus|mesh-list
92737775|NCT01323920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92737776|NCT01323920|Abortifacient Agents|abortifacient agents|mesh-ancestor
92737777|NCT01323920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737778|NCT01323920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737779|NCT01323920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92737780|NCT01323920|Antimetabolites|antimetabolites|mesh-ancestor
92737781|NCT01323920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737782|NCT01323920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737783|NCT01323920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92737784|NCT01323920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737785|NCT01323920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92737786|NCT01323920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92737787|NCT01323920|Immunologic Factors|immunologic factors|mesh-ancestor
92737788|NCT01323920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737789|NCT01323920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92737790|NCT01323920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92737791|NCT01093885|Ambrisentan|ambrisentan|mesh-list
92737792|NCT01093885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737793|NCT00597597|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92737794|NCT00597597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737795|NCT00597597|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92737796|NCT00597597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737797|NCT00597597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737798|NCT02891967|Z 350|z 350|mesh-list
92737800|NCT02891967|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92737801|NCT02891967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737802|NCT02891967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737803|NCT02891967|Hormone Antagonists|hormone antagonists|mesh-ancestor
92737804|NCT02891967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737805|NCT02891967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737806|NCT00598377|Cosyntropin|cosyntropin|mesh-list
92737807|NCT00598377|Hormones|hormones|mesh-ancestor
92737808|NCT00598377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737809|NCT00598377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737810|NCT00598533|Sirolimus|sirolimus|mesh-list
92737811|NCT00598533|Probucol|probucol|mesh-list
92737812|NCT00598533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737813|NCT00598533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737814|NCT00598533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92737815|NCT00598533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737816|NCT00598533|Antifungal Agents|antifungal agents|mesh-ancestor
92610996|NCT00148083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92610997|NCT00148083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92610998|NCT00148083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92610999|NCT00148083|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92611000|NCT00148083|Dopamine Agents|dopamine agents|mesh-ancestor
92611001|NCT05148442|Azacitidine|azacitidine|mesh-list
92611002|NCT05148442|Decitabine|decitabine|mesh-list
92611003|NCT05148442|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92611004|NCT05148442|Antimetabolites|antimetabolites|mesh-ancestor
92611005|NCT05148442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611006|NCT05148442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611007|NCT05148442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611008|NCT05148403|Glyburide|glyburide|mesh-list
92737817|NCT00598533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92737818|NCT00598533|Immunologic Factors|immunologic factors|mesh-ancestor
92737819|NCT00598533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737820|NCT00598533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737822|NCT00598533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92737823|NCT00598533|Antimetabolites|antimetabolites|mesh-ancestor
92737824|NCT00598533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92737825|NCT00598533|Antioxidants|antioxidants|mesh-ancestor
92737826|NCT00598533|Protective Agents|protective agents|mesh-ancestor
92737827|NCT00599937|Tretinoin|tretinoin|mesh-list
92737828|NCT00599937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737829|NCT00599937|Keratolytic Agents|keratolytic agents|mesh-ancestor
92737830|NCT00599937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92737831|NCT00600093|Amantadine|amantadine|mesh-list
92737832|NCT00600093|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92737833|NCT00600093|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92737834|NCT00600093|Antiviral Agents|antiviral agents|mesh-ancestor
92737835|NCT00600093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737836|NCT00600093|Dopamine Agents|dopamine agents|mesh-ancestor
92737837|NCT00600093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737838|NCT00600093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737839|NCT00600093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737840|NCT00600093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92737841|NCT00600093|Analgesics|analgesics|mesh-ancestor
92737842|NCT00600093|Sensory System Agents|sensory system agents|mesh-ancestor
92737843|NCT00600093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737844|NCT00600249|Docetaxel|docetaxel|mesh-list
92737845|NCT00600249|Cetuximab|cetuximab|mesh-list
92737846|NCT00600249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737847|NCT00600249|Tubulin Modulators|tubulin modulators|mesh-ancestor
92737848|NCT00600249|Antimitotic Agents|antimitotic agents|mesh-ancestor
92737849|NCT00600249|Mitosis Modulators|mitosis modulators|mesh-ancestor
92737850|NCT00600249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737851|NCT00600249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92737852|NCT00600405|Ibuprofen|ibuprofen|mesh-list
92737853|NCT00600405|Oxycodone|oxycodone|mesh-list
92737854|NCT00600405|Tamsulosin|tamsulosin|mesh-list
92737855|NCT00600405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92737856|NCT00600405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92737857|NCT00600405|Analgesics|analgesics|mesh-ancestor
92737858|NCT00600405|Sensory System Agents|sensory system agents|mesh-ancestor
92737859|NCT00600405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737860|NCT00600405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737861|NCT00600405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737862|NCT00600405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737863|NCT00600405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92737864|NCT00600405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737865|NCT00600405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737866|NCT00600405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92737867|NCT00600405|Narcotics|narcotics|mesh-ancestor
92737868|NCT00600405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92611009|NCT05148403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92611010|NCT05148403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611011|NCT05148208|Dialysis Solutions|dialysis solutions|mesh-list
92611012|NCT05148208|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92611013|NCT05148169|Sulforaphane|sulforaphane|mesh-list
92611014|NCT05148169|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92611015|NCT05148169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92611016|NCT05148169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018084|NCT04916899|Isoniazid|isoniazid|mesh-list
92737869|NCT00600405|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92737870|NCT00600405|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92737871|NCT00600405|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92737872|NCT00600405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92737873|NCT00600405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737885|NCT00600639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737886|NCT00600639|Antitubercular Agents|antitubercular agents|mesh-ancestor
92737887|NCT00600639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737888|NCT00600639|Glucocorticoids|glucocorticoids|mesh-ancestor
92737889|NCT00600639|Hormones|hormones|mesh-ancestor
92737890|NCT00600639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92737891|NCT00600639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737892|NCT00600639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92737893|NCT00600639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737894|NCT00600639|Antiemetics|antiemetics|mesh-ancestor
92737895|NCT00600639|Autonomic Agents|autonomic agents|mesh-ancestor
92737896|NCT00600639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737898|NCT00600639|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92737899|NCT00600639|Protective Agents|protective agents|mesh-ancestor
92737900|NCT00600639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92737901|NCT00600639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92737902|NCT00600639|Respiratory System Agents|respiratory system agents|mesh-ancestor
92737903|NCT00600639|Tocolytic Agents|tocolytic agents|mesh-ancestor
92737904|NCT00600639|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92737905|NCT00600639|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92737906|NCT00600639|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92737907|NCT00600639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92737908|NCT00600639|Adrenergic Agents|adrenergic agents|mesh-ancestor
92737909|NCT00600639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737910|NCT00600639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737911|NCT00600873|Pramipexole|pramipexole|mesh-list
92737912|NCT00600873|Antioxidants|antioxidants|mesh-ancestor
92737913|NCT00600873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737914|NCT00600873|Protective Agents|protective agents|mesh-ancestor
92737915|NCT00600873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737916|NCT00600873|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92737917|NCT00600873|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92737918|NCT00600873|Dopamine Agonists|dopamine agonists|mesh-ancestor
92737919|NCT00600873|Dopamine Agents|dopamine agents|mesh-ancestor
92737920|NCT00600873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737921|NCT00598611|Loratadine|loratadine|mesh-list
92737922|NCT00598611|Desloratadine|desloratadine|mesh-list
92737923|NCT00598611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92737924|NCT00598611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92737925|NCT00598611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737926|NCT00598611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737927|NCT00598611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737928|NCT00598611|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92737929|NCT00598611|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92737930|NCT00598611|Histamine Antagonists|histamine antagonists|mesh-ancestor
92737931|NCT00598611|Histamine Agents|histamine agents|mesh-ancestor
92737932|NCT00598611|Antipruritics|antipruritics|mesh-ancestor
92737933|NCT00598611|Dermatologic Agents|dermatologic agents|mesh-ancestor
92737934|NCT00598611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92737935|NCT04325724|Dermatologic Agents|dermatologic agents|mesh-list
92737936|NCT04325490|Hydrocortisone|hydrocortisone|mesh-list
92611017|NCT05148169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611018|NCT05148169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611019|NCT05148169|Serotonin Agents|serotonin agents|mesh-ancestor
92611020|NCT05148169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611021|NCT05148169|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92611022|NCT05148169|Protective Agents|protective agents|mesh-ancestor
92611023|NCT05148169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611025|NCT00144482|Hematinics|hematinics|mesh-ancestor
92611026|NCT05148754|Elsulfavirine|elsulfavirine|mesh-list
92611027|NCT05148754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92737937|NCT04325490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737938|NCT00601575|Lithium Carbonate|lithium carbonate|mesh-list
92737939|NCT00601575|Antidepressive Agents|antidepressive agents|mesh-ancestor
92737940|NCT00601575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92737942|NCT00601575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737944|NCT00601575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92737945|NCT00601575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737946|NCT00601575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737947|NCT00601887|Meloxicam|meloxicam|mesh-list
92737948|NCT00601887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92737949|NCT00601887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92737950|NCT00601887|Analgesics|analgesics|mesh-ancestor
92737951|NCT00601887|Sensory System Agents|sensory system agents|mesh-ancestor
92737952|NCT00601887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737953|NCT00601887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737954|NCT00601887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92737955|NCT00601887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92737956|NCT00601887|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92737957|NCT00601887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92737958|NCT00601887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737959|NCT00601887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737960|NCT01325493|Ketamine|ketamine|mesh-list
92737961|NCT01325493|Analgesics|analgesics|mesh-ancestor
92737962|NCT01325493|Sensory System Agents|sensory system agents|mesh-ancestor
92737963|NCT01325493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92737964|NCT01325493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737965|NCT01325493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92737966|NCT01325493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92737967|NCT01325493|Anesthetics, General|anesthetics, general|mesh-ancestor
92737968|NCT01325493|Anesthetics|anesthetics|mesh-ancestor
92737969|NCT01325493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92737971|NCT01325493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92737972|NCT01325493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737973|NCT01325493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737974|NCT01325337|Bimatoprost|bimatoprost|mesh-list
92737975|NCT01325337|Minoxidil|minoxidil|mesh-list
92737976|NCT01325337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92737977|NCT01325337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92737978|NCT01325337|Vasodilator Agents|vasodilator agents|mesh-ancestor
92737979|NCT01324947|Pomalidomide|pomalidomide|mesh-list
92737980|NCT01324947|Immunologic Factors|immunologic factors|mesh-ancestor
92737981|NCT01324947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737982|NCT01324947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737983|NCT01324947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92737984|NCT01324947|Growth Substances|growth substances|mesh-ancestor
92737985|NCT01324947|Growth Inhibitors|growth inhibitors|mesh-ancestor
92737986|NCT01324947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737987|NCT01101841|Paroxetine|paroxetine|mesh-list
92737988|NCT01101841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92737989|NCT01101841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92737990|NCT01101841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92737991|NCT01101841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611028|NCT05148754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92611029|NCT05148754|Antiviral Agents|antiviral agents|mesh-ancestor
92611030|NCT05148754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611031|NCT00404729|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92611032|NCT00404729|Nootropic Agents|nootropic agents|mesh-ancestor
92611033|NCT05146687|Bevacizumab|bevacizumab|mesh-list
92611034|NCT05146687|Ranibizumab|ranibizumab|mesh-list
92611035|NCT05146687|Aflibercept|aflibercept|mesh-list
92611036|NCT05146687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611037|NCT05146687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611038|NCT05146687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92737992|NCT01101841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92737993|NCT01101841|Serotonin Agents|serotonin agents|mesh-ancestor
92737994|NCT01101841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737995|NCT01101841|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92737996|NCT01101841|Antidepressive Agents|antidepressive agents|mesh-ancestor
92737997|NCT01101841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92737998|NCT01101841|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92737999|NCT01101841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92738000|NCT01101841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738001|NCT02877511|Sunscreening Agents|sunscreening agents|mesh-list
92738002|NCT02877511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92738003|NCT02877511|Protective Agents|protective agents|mesh-ancestor
92738004|NCT02877511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738005|NCT02877511|Dermatologic Agents|dermatologic agents|mesh-ancestor
92738006|NCT01324323|Rifampin|rifampin|mesh-list
92738007|NCT01324323|Romidepsin|romidepsin|mesh-list
92738008|NCT01324323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92738009|NCT01324323|Antitubercular Agents|antitubercular agents|mesh-ancestor
92738010|NCT01324323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92738011|NCT01324323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738012|NCT01324323|Leprostatic Agents|leprostatic agents|mesh-ancestor
92738013|NCT01324323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92738016|NCT01324323|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92738017|NCT01324323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92738018|NCT01324323|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92738019|NCT01324323|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92738020|NCT01324323|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92738021|NCT01324323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92738022|NCT01324323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92738023|NCT01324323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738024|NCT01324323|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92738025|NCT05344963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92738026|NCT05344963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738027|NCT05344963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738028|NCT05344963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738029|NCT02879227|Cisplatin|cisplatin|mesh-list
92738030|NCT02879227|Oxaliplatin|oxaliplatin|mesh-list
92738031|NCT02879227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738032|NCT01323582|Azithromycin|azithromycin|mesh-list
92738033|NCT01323582|Erythromycin|erythromycin|mesh-list
92738034|NCT01323582|Erythromycin Estolate|erythromycin estolate|mesh-list
92738035|NCT01323582|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92738036|NCT01323582|Erythromycin stearate|erythromycin stearate|mesh-list
92738037|NCT01323582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92738038|NCT01323582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738039|NCT01323582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738040|NCT01323582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92738041|NCT01323582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738042|NCT01323582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738043|NCT05367765|Imatinib Mesylate|imatinib mesylate|mesh-list
92738044|NCT05367765|Flumatinib|flumatinib|mesh-list
92738045|NCT05367765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738046|NCT05367765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92611039|NCT05146687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92611040|NCT05146687|Growth Substances|growth substances|mesh-ancestor
92611041|NCT05146687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611042|NCT05146687|Growth Inhibitors|growth inhibitors|mesh-ancestor
92611043|NCT05141422|Efavirenz|efavirenz|mesh-list
92611044|NCT05141422|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92611045|NCT05141422|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92611046|NCT05141422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611047|NCT05141422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611048|NCT05141422|Antiviral Agents|antiviral agents|mesh-ancestor
92611049|NCT05141422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611050|NCT05141422|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92611051|NCT05141422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92738047|NCT05367765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738048|NCT05367765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738049|NCT01323621|Fluticasone|fluticasone|mesh-list
92738051|NCT01323621|Albuterol|albuterol|mesh-list
92738052|NCT01323621|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92738053|NCT01323621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738054|NCT01323621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92738055|NCT01323621|Autonomic Agents|autonomic agents|mesh-ancestor
92738056|NCT01323621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738057|NCT01323621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738058|NCT01323621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92738059|NCT01323621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92738060|NCT01323621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92738061|NCT01323621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92738062|NCT01323621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92738063|NCT01323621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92738064|NCT01323621|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92738065|NCT01323621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92738066|NCT01323621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738067|NCT01323621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738068|NCT01323621|Tocolytic Agents|tocolytic agents|mesh-ancestor
92738069|NCT01323621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92738070|NCT05645289|Alendronate|alendronate|mesh-list
92738071|NCT05645289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92738072|NCT05645289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738073|NCT01320033|Doxycycline|doxycycline|mesh-list
92738074|NCT01320033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92738075|NCT01320033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738076|NCT01320033|Antimalarials|antimalarials|mesh-ancestor
92738077|NCT01320033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92738078|NCT01320033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92738079|NCT05644743|Gemcitabine|gemcitabine|mesh-list
92738080|NCT05644743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738081|NCT05644743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92738082|NCT05644743|Antimetabolites|antimetabolites|mesh-ancestor
92738083|NCT05644743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738084|NCT01317615|Paclitaxel|paclitaxel|mesh-list
92738085|NCT01317615|Carboplatin|carboplatin|mesh-list
92738088|NCT01317615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738089|NCT01317615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92738090|NCT01317615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92738091|NCT01317615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92738092|NCT01317615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738093|NCT01317615|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92738094|NCT01317615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738095|NCT01317615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738096|NCT01317615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611052|NCT05141422|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92611053|NCT05141422|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92611054|NCT05141422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92611055|NCT05141422|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92611056|NCT05148637|Lidocaine|lidocaine|mesh-list
92611057|NCT05148637|Fentanyl|fentanyl|mesh-list
92611058|NCT05148637|Anesthetics|anesthetics|mesh-list
92611059|NCT05148637|Sevoflurane|sevoflurane|mesh-list
92611060|NCT05148637|Desflurane|desflurane|mesh-list
92611061|NCT05148637|Anesthetics, Local|anesthetics, local|mesh-ancestor
92611062|NCT05148637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738097|NCT01317615|Immunologic Factors|immunologic factors|mesh-ancestor
92738098|NCT01317615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738099|NCT01078675|Calcium, Dietary|calcium, dietary|mesh-list
92738100|NCT01078675|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92738102|NCT01078675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92738103|NCT01078675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738104|NCT01078675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92738105|NCT01078675|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92738106|NCT01078675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92738107|NCT01078675|Antimetabolites|antimetabolites|mesh-ancestor
92738108|NCT01078675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738109|NCT01078675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92738110|NCT01078675|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92738111|NCT01078675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738112|NCT01100437|Naltrexone|naltrexone|mesh-list
92738113|NCT01100437|Morphine|morphine|mesh-list
92738114|NCT01100437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92738115|NCT01100437|Narcotics|narcotics|mesh-ancestor
92738116|NCT01100437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738117|NCT01100437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738119|NCT01100437|Sensory System Agents|sensory system agents|mesh-ancestor
92738120|NCT01100437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738121|NCT01100437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92738122|NCT01100437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92738123|NCT01322490|Molgramostim|molgramostim|mesh-list
92738124|NCT01322490|Sargramostim|sargramostim|mesh-list
92738125|NCT01322490|Immunologic Factors|immunologic factors|mesh-ancestor
92738126|NCT01322490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738127|NCT01322490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738128|NCT01314261|Interferons|interferons|mesh-list
92738129|NCT01314261|Ribavirin|ribavirin|mesh-list
92738130|NCT01314261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738131|NCT01314261|Antiviral Agents|antiviral agents|mesh-ancestor
92738132|NCT01314261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738133|NCT01314261|Antimetabolites|antimetabolites|mesh-ancestor
92738134|NCT01314261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738135|NCT02891616|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92738136|NCT02891616|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92738137|NCT02891616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738138|NCT05661357|Disitamab vedotin|disitamab vedotin|mesh-list
92738139|NCT05661357|Immunoconjugates|immunoconjugates|mesh-ancestor
92738140|NCT05661357|Immunologic Factors|immunologic factors|mesh-ancestor
92738141|NCT05661357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738142|NCT01321710|Acetaminophen|acetaminophen|mesh-list
92738143|NCT01321710|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738144|NCT01321710|Analgesics|analgesics|mesh-ancestor
92738145|NCT01321710|Sensory System Agents|sensory system agents|mesh-ancestor
92738146|NCT01321710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738147|NCT01321710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738148|NCT01321710|Antipyretics|antipyretics|mesh-ancestor
92738149|NCT01321008|Prednisone|prednisone|mesh-list
92738150|NCT01321008|Cyclophosphamide|cyclophosphamide|mesh-list
92738151|NCT01321008|Doxorubicin|doxorubicin|mesh-list
92738152|NCT01321008|Vincristine|vincristine|mesh-list
92738153|NCT01321008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611063|NCT05148637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611065|NCT05148637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611066|NCT05148637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92738154|NCT01321008|Immunologic Factors|immunologic factors|mesh-ancestor
92738155|NCT01321008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738156|NCT01321008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738157|NCT01321008|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92738158|NCT01321008|Alkylating Agents|alkylating agents|mesh-ancestor
92738159|NCT01321008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738160|NCT01321008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738163|NCT01321008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92738164|NCT01321008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92738165|NCT01321008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738166|NCT01321008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738167|NCT01321008|Glucocorticoids|glucocorticoids|mesh-ancestor
92738168|NCT01321008|Hormones|hormones|mesh-ancestor
92738169|NCT01321008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398534|NCT01397500|Testosterone|testosterone|mesh-list
92738170|NCT01321008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738171|NCT01321008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92738172|NCT01321008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92738173|NCT01321008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92738174|NCT01321008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92738175|NCT01323530|Capecitabine|capecitabine|mesh-list
92738176|NCT01323530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92738177|NCT01323530|Antimetabolites|antimetabolites|mesh-ancestor
92738178|NCT01323530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738179|NCT01323530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738180|NCT01313637|Bromides|bromides|mesh-list
92738181|NCT01313637|Anticonvulsants|anticonvulsants|mesh-ancestor
92738182|NCT01320722|Vitamin D|vitamin d|mesh-list
92738183|NCT01320722|Ergocalciferols|ergocalciferols|mesh-list
92738184|NCT01320722|Cholecalciferol|cholecalciferol|mesh-list
92738185|NCT01320722|Vitamins|vitamins|mesh-list
92738186|NCT01320722|Allopurinol|allopurinol|mesh-list
92738187|NCT01320722|Probenecid|probenecid|mesh-list
92738188|NCT01320722|Micronutrients|micronutrients|mesh-ancestor
92738189|NCT01320722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738190|NCT01320722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92738191|NCT01320722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92738192|NCT01320722|Antimetabolites|antimetabolites|mesh-ancestor
92738193|NCT01320722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738194|NCT01320722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738196|NCT01320722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738197|NCT01320722|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92738198|NCT01320722|Antioxidants|antioxidants|mesh-ancestor
92738199|NCT01320722|Protective Agents|protective agents|mesh-ancestor
92738200|NCT01320722|Uricosuric Agents|uricosuric agents|mesh-ancestor
92738201|NCT01313559|Everolimus|everolimus|mesh-list
92738202|NCT01313559|Pasireotide|pasireotide|mesh-list
92738203|NCT01313559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92738204|NCT01313559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738205|NCT01313559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738206|NCT01313559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738207|NCT01313559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92738208|NCT01313559|Immunologic Factors|immunologic factors|mesh-ancestor
92738209|NCT01313559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738210|NCT01313559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738211|NCT01313559|Hormones|hormones|mesh-ancestor
92738212|NCT01313559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738213|NCT05661279|Acetaminophen|acetaminophen|mesh-list
92738214|NCT05661279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738215|NCT05661279|Analgesics|analgesics|mesh-ancestor
92738216|NCT05661279|Sensory System Agents|sensory system agents|mesh-ancestor
92738217|NCT05661279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738218|NCT05661279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738219|NCT05661279|Antipyretics|antipyretics|mesh-ancestor
92738220|NCT02890875|Ethanol|ethanol|mesh-list
92738221|NCT02890875|Heparin|heparin|mesh-list
92738222|NCT02890875|Anticoagulants|anticoagulants|mesh-ancestor
92738223|NCT02890875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92738224|NCT02890875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92611067|NCT05148637|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92611068|NCT05148637|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92611069|NCT05148637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611070|NCT05148637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611071|NCT05148637|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92611072|NCT05148637|Narcotics|narcotics|mesh-ancestor
92611073|NCT05148637|Analgesics|analgesics|mesh-ancestor
92738225|NCT02890875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738226|NCT02890875|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92738227|NCT02890875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738228|NCT02890875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738229|NCT02890875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738230|NCT01312467|Metformin|metformin|mesh-list
92738231|NCT01312467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738232|NCT01312467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738233|NCT01310127|Nepafenac|nepafenac|mesh-list
92738234|NCT01310127|Bromfenac|bromfenac|mesh-list
92738235|NCT01310127|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92738236|NCT01310127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92738238|NCT01310127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738240|NCT01310127|Sensory System Agents|sensory system agents|mesh-ancestor
92738241|NCT01310127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738242|NCT01310127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738243|NCT01310127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738244|NCT01310127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738245|NCT01318902|Dexamethasone|dexamethasone|mesh-list
92738246|NCT01318902|Ixazomib|ixazomib|mesh-list
92738247|NCT01318902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738248|NCT01318902|Antiemetics|antiemetics|mesh-ancestor
92738249|NCT01318902|Autonomic Agents|autonomic agents|mesh-ancestor
92738250|NCT01318902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738251|NCT01318902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738252|NCT01318902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738253|NCT01318902|Glucocorticoids|glucocorticoids|mesh-ancestor
92738254|NCT01318902|Hormones|hormones|mesh-ancestor
92738255|NCT01318902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738256|NCT01318902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738257|NCT01318902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738258|NCT01318902|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738259|NCT01318902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738260|NCT01318902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738261|NCT01313858|Golimumab|golimumab|mesh-list
92738262|NCT01313858|Methotrexate|methotrexate|mesh-list
92738263|NCT01313858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92738264|NCT01313858|Abortifacient Agents|abortifacient agents|mesh-ancestor
92738265|NCT01313858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92738266|NCT01313858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738267|NCT01313858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92738268|NCT01313858|Antimetabolites|antimetabolites|mesh-ancestor
92738269|NCT01313858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738270|NCT01313858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738271|NCT01313858|Dermatologic Agents|dermatologic agents|mesh-ancestor
92738272|NCT01313858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738273|NCT01313858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92738274|NCT01313858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92738275|NCT01313858|Immunologic Factors|immunologic factors|mesh-ancestor
92738276|NCT01313858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738277|NCT01313858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92738278|NCT01313858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92738279|NCT01313858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738280|NCT01313780|Oxycodone|oxycodone|mesh-list
92738281|NCT01313780|Naloxone|naloxone|mesh-list
92738282|NCT01313780|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92738283|NCT01313780|Narcotics|narcotics|mesh-ancestor
92738284|NCT01313780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738285|NCT01313780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738286|NCT01313780|Analgesics|analgesics|mesh-ancestor
92611074|NCT05148637|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92611075|NCT05148637|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92611077|NCT05148637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92611078|NCT05148637|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92738287|NCT01313780|Sensory System Agents|sensory system agents|mesh-ancestor
92738288|NCT01313780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738289|NCT01313780|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92738290|NCT01090453|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92738291|NCT01090453|Immunologic Factors|immunologic factors|mesh-ancestor
92738292|NCT01090453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738293|NCT01170364|Sibutramine|sibutramine|mesh-list
92738294|NCT01170364|Antidepressive Agents|antidepressive agents|mesh-ancestor
92738295|NCT01170364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92738296|NCT01170364|Appetite Depressants|appetite depressants|mesh-ancestor
92738297|NCT01170364|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92738298|NCT01170208|Insulin|insulin|mesh-list
92738299|NCT01170208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738300|NCT01170208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738301|NCT02891018|Paclitaxel|paclitaxel|mesh-list
92738302|NCT02891018|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92738303|NCT02891018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92738304|NCT02891018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738305|NCT02891018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92738306|NCT02891018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92738307|NCT02891018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398536|NCT01397500|Hormones|hormones|mesh-ancestor
92738308|NCT02891018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738309|NCT01169350|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92738311|NCT01169350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738312|NCT01169038|Azithromycin|azithromycin|mesh-list
92738313|NCT01169038|Rifampin|rifampin|mesh-list
92738314|NCT01169038|Ethambutol|ethambutol|mesh-list
92738315|NCT01169038|Levofloxacin|levofloxacin|mesh-list
92738316|NCT01169038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92738317|NCT01169038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738318|NCT01169038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92738319|NCT01169038|Antitubercular Agents|antitubercular agents|mesh-ancestor
92738320|NCT01169038|Leprostatic Agents|leprostatic agents|mesh-ancestor
92738321|NCT01169038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92738322|NCT01169038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738323|NCT01169038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738324|NCT01169038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92738325|NCT01169038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92738326|NCT01169038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92738327|NCT01169038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92738328|NCT01169038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92738329|NCT01169038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92738330|NCT01169038|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92738331|NCT01169038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92738332|NCT01169038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92738333|NCT01169038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738334|NCT01169038|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92738335|NCT01169038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92738336|NCT00624754|Budesonide|budesonide|mesh-list
92738337|NCT00624754|Formoterol Fumarate|formoterol fumarate|mesh-list
92738338|NCT00624754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738339|NCT00624754|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92738340|NCT00624754|Autonomic Agents|autonomic agents|mesh-ancestor
92738341|NCT00624754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738342|NCT00624754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738343|NCT00624754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92738344|NCT00624754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92738345|NCT00624754|Glucocorticoids|glucocorticoids|mesh-ancestor
92738347|NCT00624754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738348|NCT00624754|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92738349|NCT00624754|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92738350|NCT00624754|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92018156|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
92611080|NCT00148278|Epinephrine|epinephrine|mesh-list
92611081|NCT00148278|Norepinephrine|norepinephrine|mesh-list
92611082|NCT00148278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92611083|NCT00148278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92611084|NCT00148278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92611085|NCT00148278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611086|NCT00148278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611087|NCT00148278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611088|NCT00148278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92738351|NCT00624754|Adrenergic Agents|adrenergic agents|mesh-ancestor
92738352|NCT00624754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738353|NCT00624754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738354|NCT01114828|Tolvaptan|tolvaptan|mesh-list
92738355|NCT01114828|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92738356|NCT01114828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738357|NCT01114828|Natriuretic Agents|natriuretic agents|mesh-ancestor
92738358|NCT01114828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738359|NCT01313312|Botulinum Toxins|botulinum toxins|mesh-list
92738360|NCT01313312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92738361|NCT01313312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92738362|NCT01313312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92738363|NCT01313312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92738364|NCT01313312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738365|NCT01313312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92738366|NCT01313312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738367|NCT01313312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738368|NCT01313312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92738369|NCT01313312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738370|NCT01114672|Ergocalciferols|ergocalciferols|mesh-list
92738371|NCT01114672|Vitamin D|vitamin d|mesh-list
92738372|NCT01114672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92738373|NCT01114672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738374|NCT01114672|Vitamins|vitamins|mesh-ancestor
92738375|NCT01114672|Micronutrients|micronutrients|mesh-ancestor
92738376|NCT01114672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92738377|NCT01114516|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92738378|NCT01114516|Clindamycin|clindamycin|mesh-list
92738379|NCT01114516|Clindamycin palmitate|clindamycin palmitate|mesh-list
92738380|NCT01114516|Clindamycin phosphate|clindamycin phosphate|mesh-list
92738381|NCT01114516|Cefazolin|cefazolin|mesh-list
92738382|NCT01114516|Indomethacin|indomethacin|mesh-list
92738383|NCT01114516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738384|NCT01114516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92738385|NCT01114516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738386|NCT01114516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738387|NCT01114516|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92738388|NCT01114516|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738389|NCT01114516|Analgesics|analgesics|mesh-ancestor
92738390|NCT01114516|Sensory System Agents|sensory system agents|mesh-ancestor
92738391|NCT01114516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738392|NCT01114516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738393|NCT01114516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738394|NCT01114516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738395|NCT01114516|Gout Suppressants|gout suppressants|mesh-ancestor
92738396|NCT01114516|Tocolytic Agents|tocolytic agents|mesh-ancestor
92738397|NCT01114516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92738398|NCT01114516|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92738399|NCT01313078|Asparaginase|asparaginase|mesh-list
92738400|NCT01313078|Pegaspargase|pegaspargase|mesh-list
92738401|NCT01313078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738402|NCT01114360|Melatonin|melatonin|mesh-list
92738403|NCT01114360|Antioxidants|antioxidants|mesh-ancestor
92611089|NCT00148278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92611091|NCT00148278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611092|NCT00148278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92611093|NCT00148278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92336154|NCT02057250|Analgesics|analgesics|mesh-ancestor
92611094|NCT00148278|Mydriatics|mydriatics|mesh-ancestor
92611095|NCT00148278|Sympathomimetics|sympathomimetics|mesh-ancestor
92611096|NCT00148278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92611097|NCT00148278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92611098|NCT00148278|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92611099|NCT00148278|Protective Agents|protective agents|mesh-ancestor
92611100|NCT05594849|Budesonide|budesonide|mesh-list
92738404|NCT01114360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738405|NCT01114360|Protective Agents|protective agents|mesh-ancestor
92738406|NCT01114360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738407|NCT01114360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738408|NCT01310036|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92738409|NCT01310036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738410|NCT01310036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738411|NCT01310036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738412|NCT01310036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738413|NCT01075321|Lenalidomide|lenalidomide|mesh-list
92738414|NCT01075321|Everolimus|everolimus|mesh-list
92738415|NCT01075321|Immunologic Factors|immunologic factors|mesh-ancestor
92738416|NCT01075321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738418|NCT01075321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92738419|NCT01075321|Growth Substances|growth substances|mesh-ancestor
92738420|NCT01075321|Growth Inhibitors|growth inhibitors|mesh-ancestor
92738421|NCT01075321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738422|NCT01075321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92738423|NCT01075321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738424|NCT01075321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738425|NCT01075321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398542|NCT01397513|Analgesics|analgesics|mesh-ancestor
92738426|NCT01075321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92738427|NCT01114204|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92738428|NCT01114204|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92738429|NCT01114204|Hematinics|hematinics|mesh-ancestor
92738430|NCT01114204|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92738431|NCT01114204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92738432|NCT01075243|Acetaminophen|acetaminophen|mesh-list
92738433|NCT01075243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738434|NCT01075243|Analgesics|analgesics|mesh-ancestor
92738435|NCT01075243|Sensory System Agents|sensory system agents|mesh-ancestor
92738436|NCT01075243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738437|NCT01075243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738438|NCT01075243|Antipyretics|antipyretics|mesh-ancestor
92738439|NCT01078441|Dexamethasone|dexamethasone|mesh-list
92738440|NCT01078441|Cyclophosphamide|cyclophosphamide|mesh-list
92738441|NCT01078441|Doxorubicin|doxorubicin|mesh-list
92738442|NCT01078441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92738443|NCT01078441|Bortezomib|bortezomib|mesh-list
92738444|NCT01078441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92738445|NCT01078441|Immunologic Factors|immunologic factors|mesh-ancestor
92738446|NCT01078441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738447|NCT01078441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738448|NCT01078441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92738449|NCT01078441|Alkylating Agents|alkylating agents|mesh-ancestor
92738450|NCT01078441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738451|NCT01078441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738452|NCT01078441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92738453|NCT01078441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738454|NCT01078441|Antiemetics|antiemetics|mesh-ancestor
92611101|NCT05594849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611102|NCT05594849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92611103|NCT05594849|Autonomic Agents|autonomic agents|mesh-ancestor
92611104|NCT05594849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611105|NCT05594849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611106|NCT05594849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92611107|NCT05594849|Respiratory System Agents|respiratory system agents|mesh-ancestor
92611108|NCT05594849|Glucocorticoids|glucocorticoids|mesh-ancestor
92611109|NCT05594849|Hormones|hormones|mesh-ancestor
92682805|NCT00438113|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92738455|NCT01078441|Autonomic Agents|autonomic agents|mesh-ancestor
92738456|NCT01078441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738457|NCT01078441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738462|NCT01078441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92738463|NCT01078441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92738464|NCT01078441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92738465|NCT01078441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738466|NCT00626665|Tadalafil|tadalafil|mesh-list
92738467|NCT00626665|Vasodilator Agents|vasodilator agents|mesh-ancestor
92738468|NCT00626665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92738469|NCT00626665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92738470|NCT00626665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738471|NCT00626665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738472|NCT00626665|Urological Agents|urological agents|mesh-ancestor
92738473|NCT01090063|Ustekinumab|ustekinumab|mesh-list
92738474|NCT01090063|Dermatologic Agents|dermatologic agents|mesh-ancestor
92738475|NCT01306214|Empagliflozin|empagliflozin|mesh-list
92738476|NCT01306214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92738477|NCT01306214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738478|NCT01306214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738479|NCT01306214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738480|NCT00623402|Interferons|interferons|mesh-list
92738481|NCT00623402|Sorafenib|sorafenib|mesh-list
92738482|NCT00623402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738483|NCT00623402|Antiviral Agents|antiviral agents|mesh-ancestor
92738484|NCT00623402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738485|NCT00623402|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738486|NCT00623402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738487|NCT00623402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738488|NCT01077739|Leucovorin|leucovorin|mesh-list
92738489|NCT01077739|Bevacizumab|bevacizumab|mesh-list
92738490|NCT01077739|Fluorouracil|fluorouracil|mesh-list
92738491|NCT01077739|Capecitabine|capecitabine|mesh-list
92738492|NCT01077739|Oxaliplatin|oxaliplatin|mesh-list
92738493|NCT01077739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92738494|NCT01077739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738495|NCT01077739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92738496|NCT01077739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92738497|NCT01077739|Growth Substances|growth substances|mesh-ancestor
92738498|NCT01077739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738499|NCT01077739|Growth Inhibitors|growth inhibitors|mesh-ancestor
92738501|NCT01077739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738502|NCT01077739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92738503|NCT01077739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92738504|NCT01077739|Immunologic Factors|immunologic factors|mesh-ancestor
92738505|NCT01077739|Antidotes|antidotes|mesh-ancestor
92738506|NCT01077739|Protective Agents|protective agents|mesh-ancestor
92738507|NCT01077739|Vitamin B Complex|vitamin b complex|mesh-ancestor
92738508|NCT01077739|Vitamins|vitamins|mesh-ancestor
92738509|NCT01077739|Micronutrients|micronutrients|mesh-ancestor
92738510|NCT01306058|Sorafenib|sorafenib|mesh-list
92738511|NCT01306058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738512|NCT01306058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738513|NCT01306058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738514|NCT01306058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738515|NCT00626509|Sunitinib|sunitinib|mesh-list
92611110|NCT05594849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92611112|NCT00507247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611113|NCT00507247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611114|NCT00507286|Alprostadil|alprostadil|mesh-list
92611115|NCT00507286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92611116|NCT00507286|Vasodilator Agents|vasodilator agents|mesh-ancestor
92611117|NCT00507286|Urological Agents|urological agents|mesh-ancestor
92738516|NCT00626509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738517|NCT00626509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92738518|NCT00626509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92738519|NCT00626509|Growth Substances|growth substances|mesh-ancestor
92738520|NCT00626509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738521|NCT00626509|Growth Inhibitors|growth inhibitors|mesh-ancestor
92738522|NCT00626509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738523|NCT00626509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738524|NCT00626509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738525|NCT02877901|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92738526|NCT02877901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92738527|NCT02877901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92738528|NCT02877901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92738529|NCT02877901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738534|NCT04306159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738535|NCT04306159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738536|NCT01305200|Calcium|calcium|mesh-list
92738537|NCT01305200|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92738538|NCT01305200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738539|NCT01304498|Vaccines|vaccines|mesh-list
92738540|NCT01304498|Immunologic Factors|immunologic factors|mesh-ancestor
92738541|NCT01304498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738542|NCT01074931|Ritonavir|ritonavir|mesh-list
92738543|NCT01074931|Lopinavir|lopinavir|mesh-list
92738544|NCT01074931|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92738545|NCT01074931|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92738546|NCT01074931|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738547|NCT01074931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738548|NCT01074931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738549|NCT01074931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92738550|NCT01074931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92738551|NCT01074931|Antiviral Agents|antiviral agents|mesh-ancestor
92738552|NCT01074931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738553|NCT01074931|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92738554|NCT01074931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92738555|NCT04774159|Colchicine|colchicine|mesh-list
92738556|NCT04774159|Gout Suppressants|gout suppressants|mesh-ancestor
92738557|NCT04774159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738558|NCT04774159|Tubulin Modulators|tubulin modulators|mesh-ancestor
92738559|NCT04774159|Antimitotic Agents|antimitotic agents|mesh-ancestor
92738560|NCT04774159|Mitosis Modulators|mitosis modulators|mesh-ancestor
92738561|NCT04774159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738562|NCT04774159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738563|NCT01303172|Gemcitabine|gemcitabine|mesh-list
92738564|NCT01303172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92738565|NCT01303172|Antimetabolites|antimetabolites|mesh-ancestor
92738566|NCT01303172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738567|NCT01303172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738568|NCT01302938|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92738569|NCT01302938|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92738570|NCT01302938|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92738571|NCT01302938|Cholinergic Agents|cholinergic agents|mesh-ancestor
92738572|NCT01302938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738573|NCT01302938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738574|NCT01302938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738575|NCT01302938|Urological Agents|urological agents|mesh-ancestor
92738576|NCT01076647|Insulin|insulin|mesh-list
92738577|NCT01076647|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92018195|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
92611118|NCT05143762|Acetaminophen|acetaminophen|mesh-list
92611119|NCT05143762|Dexamethasone|dexamethasone|mesh-list
92611120|NCT05143762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611121|NCT05143762|Antiemetics|antiemetics|mesh-ancestor
92611122|NCT05143762|Autonomic Agents|autonomic agents|mesh-ancestor
92611123|NCT05143762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611124|NCT05143762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611125|NCT05143762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611126|NCT05143762|Glucocorticoids|glucocorticoids|mesh-ancestor
92611127|NCT05143762|Hormones|hormones|mesh-ancestor
92611128|NCT05143762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92611129|NCT05143762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92611130|NCT05143762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611131|NCT05143762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611132|NCT05143762|Analgesics|analgesics|mesh-ancestor
92611133|NCT05143762|Sensory System Agents|sensory system agents|mesh-ancestor
92611134|NCT05143762|Antipyretics|antipyretics|mesh-ancestor
92611135|NCT00148356|Paclitaxel|paclitaxel|mesh-list
92738578|NCT01076647|Insulin Glargine|insulin glargine|mesh-list
92738579|NCT01076647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738580|NCT01076647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738581|NCT04306081|Evolocumab|evolocumab|mesh-list
92738582|NCT04306081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92738583|NCT04306081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92738584|NCT04306081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92738585|NCT04306081|Antimetabolites|antimetabolites|mesh-ancestor
92738586|NCT04306081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738587|NCT04306081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92738588|NCT04306081|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738589|NCT04306081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738590|NCT04306081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92738591|NCT01074307|Bisoprolol|bisoprolol|mesh-list
92738592|NCT01074307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92738593|NCT01074307|Sympatholytics|sympatholytics|mesh-ancestor
92738594|NCT01074307|Autonomic Agents|autonomic agents|mesh-ancestor
92738595|NCT01074307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738596|NCT01074307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738597|NCT01074307|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92738598|NCT01074307|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92738599|NCT01074307|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92738600|NCT01074307|Adrenergic Agents|adrenergic agents|mesh-ancestor
92738604|NCT01076335|Leuprolide|leuprolide|mesh-list
92738605|NCT01076335|Goserelin|goserelin|mesh-list
92738606|NCT01076335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738607|NCT01076335|Tubulin Modulators|tubulin modulators|mesh-ancestor
92738608|NCT01076335|Antimitotic Agents|antimitotic agents|mesh-ancestor
92738609|NCT01076335|Mitosis Modulators|mitosis modulators|mesh-ancestor
92738610|NCT01076335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738611|NCT01076335|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92738612|NCT01076335|Fertility Agents|fertility agents|mesh-ancestor
92738613|NCT01076335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92738614|NCT01076335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738615|NCT01076335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738616|NCT01309737|Tofacitinib|tofacitinib|mesh-list
92738617|NCT01309737|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92738618|NCT01309737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738619|NCT01309737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611136|NCT00148356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92611137|NCT00148356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738620|NCT01309737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738621|NCT01074229|Ropivacaine|ropivacaine|mesh-list
92738622|NCT01074229|Anesthetics, Local|anesthetics, local|mesh-ancestor
92738623|NCT01074229|Anesthetics|anesthetics|mesh-ancestor
92738624|NCT01074229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738625|NCT01074229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738626|NCT01074229|Sensory System Agents|sensory system agents|mesh-ancestor
92738627|NCT01074229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738628|NCT01106014|Selexipag|selexipag|mesh-list
92738629|NCT01106014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92738630|NCT01105936|Acetaminophen|acetaminophen|mesh-list
92738631|NCT01105936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738632|NCT01105936|Analgesics|analgesics|mesh-ancestor
92738633|NCT01105936|Sensory System Agents|sensory system agents|mesh-ancestor
92738634|NCT01105936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738635|NCT01105936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738636|NCT01105936|Antipyretics|antipyretics|mesh-ancestor
92738637|NCT01309659|Iron|iron|mesh-list
92738638|NCT01309659|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92738639|NCT01309659|Trace Elements|trace elements|mesh-ancestor
92738640|NCT01309659|Micronutrients|micronutrients|mesh-ancestor
92738641|NCT01309659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738642|NCT01309659|Hematinics|hematinics|mesh-ancestor
92738643|NCT04989166|Curcumin|curcumin|mesh-list
92738644|NCT04989166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92738645|NCT04989166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738646|NCT04989166|Analgesics|analgesics|mesh-ancestor
92738647|NCT04989166|Sensory System Agents|sensory system agents|mesh-ancestor
92738648|NCT04989166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738649|NCT04989166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738650|NCT04989166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738651|NCT04989166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92738652|NCT04989166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738653|NCT04989166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738654|NCT04989166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738655|NCT05320705|Dexmedetomidine|dexmedetomidine|mesh-list
92738656|NCT05320705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92738657|NCT05320705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738658|NCT05320705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738659|NCT05320705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738660|NCT05320705|Analgesics|analgesics|mesh-ancestor
92738661|NCT05320705|Sensory System Agents|sensory system agents|mesh-ancestor
92738662|NCT05320705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738663|NCT05320705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92738664|NCT05320705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92738665|NCT05320705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92738666|NCT05320705|Adrenergic Agents|adrenergic agents|mesh-ancestor
92738667|NCT05320705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738668|NCT05320705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738669|NCT01104766|Aripiprazole|aripiprazole|mesh-list
92738670|NCT01104766|Cariprazine|cariprazine|mesh-list
92738671|NCT01104766|Antidepressive Agents|antidepressive agents|mesh-ancestor
92738672|NCT01104766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92738673|NCT01104766|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92738678|NCT01104766|Dopamine Agents|dopamine agents|mesh-ancestor
92738679|NCT01104766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738680|NCT01104766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738681|NCT01104766|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92738682|NCT01104766|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92738683|NCT01104766|Serotonin Agents|serotonin agents|mesh-ancestor
92738684|NCT01104766|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92738685|NCT01104766|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92738686|NCT01104766|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92738687|NCT01104766|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92738688|NCT02880280|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92738689|NCT02880280|Menotropins|menotropins|mesh-list
92738690|NCT02880280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92738691|NCT02880280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738692|NCT02880280|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92738693|NCT02880280|Fertility Agents|fertility agents|mesh-ancestor
92738694|NCT04862455|Pembrolizumab|pembrolizumab|mesh-list
92611138|NCT00148356|Tubulin Modulators|tubulin modulators|mesh-ancestor
92611139|NCT00148356|Antimitotic Agents|antimitotic agents|mesh-ancestor
92611140|NCT00148356|Mitosis Modulators|mitosis modulators|mesh-ancestor
92611141|NCT00148356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611142|NCT00424281|PENTA|penta|mesh-list
92611143|NCT00424281|Fondaparinux|fondaparinux|mesh-list
92611144|NCT00424281|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92738695|NCT04862455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92738696|NCT04862455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738697|NCT04862455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92738698|NCT04862455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738699|NCT01104376|Efavirenz|efavirenz|mesh-list
92738700|NCT01104376|Voriconazole|voriconazole|mesh-list
92738701|NCT01104376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92738702|NCT01104376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92738703|NCT01104376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738704|NCT01104376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738705|NCT01104376|Antiviral Agents|antiviral agents|mesh-ancestor
92738706|NCT01104376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738707|NCT01104376|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92738708|NCT01104376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92738709|NCT01104376|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92738710|NCT01104376|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92738711|NCT01104376|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92738712|NCT01104376|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92738713|NCT01104376|Antifungal Agents|antifungal agents|mesh-ancestor
92738714|NCT01104376|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92738715|NCT01104376|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92738716|NCT01104376|Hormone Antagonists|hormone antagonists|mesh-ancestor
92738717|NCT01104376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738718|NCT01104376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738719|NCT01104376|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92738720|NCT02875873|Methamphetamine|methamphetamine|mesh-list
92738721|NCT02875873|Plasma-lyte 148|plasma-lyte 148|mesh-list
92738722|NCT02875873|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92738723|NCT02875873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738724|NCT02875873|Sympathomimetics|sympathomimetics|mesh-ancestor
92738725|NCT02875873|Autonomic Agents|autonomic agents|mesh-ancestor
92738726|NCT02875873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738727|NCT02875873|Dopamine Agents|dopamine agents|mesh-ancestor
92738728|NCT02875873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738729|NCT02875873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738730|NCT02875873|Adrenergic Agents|adrenergic agents|mesh-ancestor
92738731|NCT02875873|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92738732|NCT02875873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92738733|NCT02875873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92738734|NCT02875873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92738735|NCT02875873|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92738736|NCT02875873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92738737|NCT01072357|Bevacizumab|bevacizumab|mesh-list
92738738|NCT01072357|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92738739|NCT01072357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92738740|NCT01072357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738742|NCT01072357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92738744|NCT01072357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738745|NCT01072357|Growth Inhibitors|growth inhibitors|mesh-ancestor
92738746|NCT01072357|Laxatives|laxatives|mesh-ancestor
92738747|NCT01072357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738748|NCT01072201|Triclosan|triclosan|mesh-list
92738749|NCT01072201|Fluorides|fluorides|mesh-list
92738750|NCT01072201|Cariostatic Agents|cariostatic agents|mesh-ancestor
92738751|NCT01072201|Protective Agents|protective agents|mesh-ancestor
92738752|NCT01072201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398565|NCT01397994|Atenolol|atenolol|mesh-list
92738753|NCT01072201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92738754|NCT01072201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738755|NCT01072201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92611145|NCT00424281|Antithrombins|antithrombins|mesh-ancestor
92611146|NCT00424281|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92611147|NCT00424281|Protease Inhibitors|protease inhibitors|mesh-ancestor
92611148|NCT00424281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611149|NCT00424281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611150|NCT00424281|Anticoagulants|anticoagulants|mesh-ancestor
92611151|NCT00424281|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92738756|NCT01072201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92738757|NCT01072201|Antimetabolites|antimetabolites|mesh-ancestor
92738758|NCT01072201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738759|NCT01072201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92738760|NCT02893709|Omeprazole|omeprazole|mesh-list
92738761|NCT02893709|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92738762|NCT02893709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738763|NCT02893709|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92738764|NCT02893709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738765|NCT02893709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738766|NCT04972396|Metformin|metformin|mesh-list
92738767|NCT04972396|Digoxin|digoxin|mesh-list
92738768|NCT04972396|Warfarin|warfarin|mesh-list
92738769|NCT04972396|Atorvastatin|atorvastatin|mesh-list
92738770|NCT04972396|Levonorgestrel|levonorgestrel|mesh-list
92738771|NCT04972396|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92738772|NCT04972396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738773|NCT04972396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738774|NCT04972396|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92738775|NCT04972396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92738776|NCT04972396|Antimetabolites|antimetabolites|mesh-ancestor
92738777|NCT04972396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738778|NCT04972396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92738779|NCT04972396|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92738780|NCT04972396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738781|NCT04972396|Anticoagulants|anticoagulants|mesh-ancestor
92738782|NCT04972396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92738783|NCT04972396|Contraceptive Agents|contraceptive agents|mesh-ancestor
92738784|NCT04972396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92738785|NCT04972396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92738786|NCT04972396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92738787|NCT04972396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92738788|NCT04972396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92738789|NCT04972396|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92738790|NCT04972396|Protective Agents|protective agents|mesh-ancestor
92738791|NCT04972396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92738792|NCT04972396|Estrogens|estrogens|mesh-ancestor
92738793|NCT04972396|Hormones|hormones|mesh-ancestor
92738794|NCT04972396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738795|NCT01089361|Ketamine|ketamine|mesh-list
92738796|NCT01089361|Analgesics|analgesics|mesh-ancestor
92738797|NCT01089361|Sensory System Agents|sensory system agents|mesh-ancestor
92738798|NCT01089361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738799|NCT01089361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738800|NCT01089361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92738801|NCT01089361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92738802|NCT01089361|Anesthetics, General|anesthetics, general|mesh-ancestor
92738803|NCT01089361|Anesthetics|anesthetics|mesh-ancestor
92738804|NCT01089361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738805|NCT01089361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92738806|NCT01089361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92738807|NCT01089361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738808|NCT01089361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738809|NCT01102972|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92738810|NCT01102972|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92738811|NCT01102972|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92738812|NCT01102972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92738814|NCT01102972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738815|NCT01102972|Antiviral Agents|antiviral agents|mesh-ancestor
92611153|NCT00148395|Carboplatin|carboplatin|mesh-list
92611154|NCT00148395|Gemcitabine|gemcitabine|mesh-list
92611155|NCT00148395|Ifosfamide|ifosfamide|mesh-list
92611156|NCT00148395|Mitomycins|mitomycins|mesh-list
92611157|NCT00148395|Mitomycin|mitomycin|mesh-list
92611158|NCT00148395|Vinorelbine|vinorelbine|mesh-list
92611159|NCT00148395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611160|NCT00148395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92738816|NCT01102972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738817|NCT01102972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92738818|NCT01102972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92738819|NCT01102972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92738820|NCT01102972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92738821|NCT01102972|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738822|NCT04328753|Chlorhexidine|chlorhexidine|mesh-list
92738823|NCT04328753|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92738824|NCT04328753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738825|NCT04328753|Disinfectants|disinfectants|mesh-ancestor
92738827|NCT01087489|Anesthetics, Local|anesthetics, local|mesh-ancestor
92738828|NCT01087489|Anesthetics|anesthetics|mesh-ancestor
92738829|NCT01087489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738830|NCT01087489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738831|NCT01087489|Sensory System Agents|sensory system agents|mesh-ancestor
92738832|NCT01087489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738833|NCT01087489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92738834|NCT01087489|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92738835|NCT01087489|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92738836|NCT01087489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92738837|NCT01087489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738838|NCT04306627|Amlodipine|amlodipine|mesh-list
92738839|NCT04306627|Perindopril|perindopril|mesh-list
92738840|NCT04306627|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92738841|NCT04306627|Atorvastatin|atorvastatin|mesh-list
92738842|NCT04306627|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92738843|NCT04306627|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92738844|NCT04306627|Antimetabolites|antimetabolites|mesh-ancestor
92738845|NCT04306627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738846|NCT04306627|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92738847|NCT04306627|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92738848|NCT04306627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738849|NCT04306627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92738850|NCT04306627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92738851|NCT04306627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92738852|NCT04306627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92738853|NCT04306627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738854|NCT04306627|Vasodilator Agents|vasodilator agents|mesh-ancestor
92738855|NCT04306627|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92738856|NCT04306627|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738857|NCT04306471|Evolocumab|evolocumab|mesh-list
92738858|NCT04306471|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92738859|NCT04306471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92738860|NCT04306471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92738861|NCT04306471|Antimetabolites|antimetabolites|mesh-ancestor
92738862|NCT04306471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738863|NCT04306471|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92738864|NCT04306471|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738865|NCT04306471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738866|NCT04306471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92738867|NCT04296253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92738868|NCT04296253|Mitogens|mitogens|mesh-list
92738869|NCT04296253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92738870|NCT04296253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738871|NCT01082965|Donepezil|donepezil|mesh-list
92738872|NCT01082965|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92018228|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92611161|NCT00148395|Antimetabolites|antimetabolites|mesh-ancestor
92611162|NCT00148395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611163|NCT00148395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92611164|NCT00148395|Alkylating Agents|alkylating agents|mesh-ancestor
92611165|NCT00148395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92611166|NCT00148395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92611167|NCT00148395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611168|NCT00148395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92611169|NCT00148395|Tubulin Modulators|tubulin modulators|mesh-ancestor
92611170|NCT00148395|Antimitotic Agents|antimitotic agents|mesh-ancestor
92611171|NCT00148395|Mitosis Modulators|mitosis modulators|mesh-ancestor
92611172|NCT02276677|Oxytocin|oxytocin|mesh-list
92611173|NCT02276677|Oxytocics|oxytocics|mesh-ancestor
92611174|NCT02276677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92611175|NCT02276677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611176|NCT05141344|Melatonin|melatonin|mesh-list
92738873|NCT01082965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738874|NCT01082965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738875|NCT01082965|Cholinergic Agents|cholinergic agents|mesh-ancestor
92738876|NCT01082965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738877|NCT01082965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738878|NCT01082965|Nootropic Agents|nootropic agents|mesh-ancestor
92738879|NCT01102426|Dexamethasone|dexamethasone|mesh-list
92738880|NCT01102426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738881|NCT01102426|Antiemetics|antiemetics|mesh-ancestor
92738882|NCT01102426|Autonomic Agents|autonomic agents|mesh-ancestor
92738883|NCT01102426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738884|NCT01102426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738890|NCT01102426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738892|NCT04308850|Vitamins|vitamins|mesh-ancestor
92738893|NCT04308850|Micronutrients|micronutrients|mesh-ancestor
92738894|NCT04308850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738895|NCT04308850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92738896|NCT01101334|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92738897|NCT01101334|Efatutazone|efatutazone|mesh-list
92738898|NCT01101334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738899|NCT01101334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92738900|NCT01101334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738901|NCT01101334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738902|NCT01327547|Maraviroc|maraviroc|mesh-list
92738903|NCT01327547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92738904|NCT01327547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92738905|NCT01327547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738906|NCT01327547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92738907|NCT01327547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92738908|NCT01327547|Antiviral Agents|antiviral agents|mesh-ancestor
92738909|NCT01327547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738910|NCT01327547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92738911|NCT01308567|Prednisone|prednisone|mesh-list
92738912|NCT01308567|Docetaxel|docetaxel|mesh-list
92738913|NCT01308567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738914|NCT01308567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92738915|NCT01308567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92738916|NCT01308567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92738917|NCT01308567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738918|NCT01308567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738919|NCT01308567|Glucocorticoids|glucocorticoids|mesh-ancestor
92611177|NCT05141344|Antioxidants|antioxidants|mesh-ancestor
92611178|NCT05141344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611179|NCT05141344|Protective Agents|protective agents|mesh-ancestor
92611180|NCT05141344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611181|NCT05141344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92611182|NCT00156858|Busulfan|busulfan|mesh-list
92611183|NCT00156858|Alkylating Agents|alkylating agents|mesh-ancestor
92738920|NCT01308567|Hormones|hormones|mesh-ancestor
92738921|NCT01308567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738922|NCT01308567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738923|NCT01308567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738924|NCT00592241|Insulin|insulin|mesh-list
92738925|NCT00592241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92738926|NCT00592241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92738927|NCT00592241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738928|NCT02890719|Ribavirin|ribavirin|mesh-list
92738929|NCT02890719|Grazoprevir|grazoprevir|mesh-list
92738930|NCT02890719|Antimetabolites|antimetabolites|mesh-ancestor
92738931|NCT02890719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738932|NCT02890719|Antiviral Agents|antiviral agents|mesh-ancestor
92738933|NCT02890719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738934|NCT04325061|Dexamethasone|dexamethasone|mesh-list
92738935|NCT04325061|Dexamethasone acetate|dexamethasone acetate|mesh-list
92738936|NCT04325061|BB 1101|bb 1101|mesh-list
92738937|NCT04325061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738938|NCT04325061|Antiemetics|antiemetics|mesh-ancestor
92738939|NCT04325061|Autonomic Agents|autonomic agents|mesh-ancestor
92738940|NCT04325061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738941|NCT04325061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738942|NCT04325061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738943|NCT04325061|Glucocorticoids|glucocorticoids|mesh-ancestor
92738944|NCT04325061|Hormones|hormones|mesh-ancestor
92738945|NCT04325061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738946|NCT04325061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738947|NCT04325061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738948|NCT04325061|Protease Inhibitors|protease inhibitors|mesh-ancestor
92738949|NCT04325061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738950|NCT04325061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738951|NCT01307319|Beclomethasone|beclomethasone|mesh-list
92738952|NCT01307319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738953|NCT01307319|Glucocorticoids|glucocorticoids|mesh-ancestor
92738954|NCT01307319|Hormones|hormones|mesh-ancestor
92738955|NCT01307319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738957|NCT01307319|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92738958|NCT01307319|Respiratory System Agents|respiratory system agents|mesh-ancestor
92738959|NCT04365725|Remdesivir|remdesivir|mesh-list
92738960|NCT04365725|Antimetabolites|antimetabolites|mesh-ancestor
92738961|NCT04365725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738962|NCT04365725|Antiviral Agents|antiviral agents|mesh-ancestor
92738963|NCT04365725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92738964|NCT01080391|Dexamethasone|dexamethasone|mesh-list
92738965|NCT01080391|Lenalidomide|lenalidomide|mesh-list
92738966|NCT01080391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92738967|NCT01080391|Antiemetics|antiemetics|mesh-ancestor
92738968|NCT01080391|Autonomic Agents|autonomic agents|mesh-ancestor
92738969|NCT01080391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738970|NCT01080391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738971|NCT01080391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92738972|NCT01080391|Glucocorticoids|glucocorticoids|mesh-ancestor
92738973|NCT01080391|Hormones|hormones|mesh-ancestor
92738974|NCT01080391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738975|NCT01080391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738976|NCT01080391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92738977|NCT01080391|Immunologic Factors|immunologic factors|mesh-ancestor
92738978|NCT01080391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92738979|NCT01080391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92738980|NCT01080391|Growth Substances|growth substances|mesh-ancestor
92611184|NCT00156858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611185|NCT00156858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611186|NCT00156858|Immunologic Factors|immunologic factors|mesh-ancestor
92611187|NCT00156858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611188|NCT00156858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92611189|NCT00156858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611190|NCT00156858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92611192|NCT03451825|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92738981|NCT01080391|Growth Inhibitors|growth inhibitors|mesh-ancestor
92738982|NCT01070329|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92738983|NCT01070329|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92738984|NCT01070329|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92738985|NCT01070329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92738986|NCT01070329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738987|NCT01070329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738988|NCT01070329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738989|NCT01070329|Analgesics|analgesics|mesh-ancestor
92738990|NCT01070329|Sensory System Agents|sensory system agents|mesh-ancestor
92738991|NCT01070329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92738992|NCT01070329|Antidepressive Agents|antidepressive agents|mesh-ancestor
92738993|NCT01070329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92738994|NCT01070329|Dopamine Agents|dopamine agents|mesh-ancestor
92738995|NCT04327427|Aspirin|aspirin|mesh-list
92738996|NCT04327427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92738997|NCT04327427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92738998|NCT04327427|Analgesics|analgesics|mesh-ancestor
92738999|NCT04327427|Sensory System Agents|sensory system agents|mesh-ancestor
92739000|NCT04327427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739001|NCT04327427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739002|NCT04327427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739003|NCT04327427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739004|NCT04327427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92739005|NCT04327427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92739006|NCT04327427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739007|NCT04327427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92739008|NCT04327427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92739009|NCT04327427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739010|NCT04327427|Antipyretics|antipyretics|mesh-ancestor
92739011|NCT02875717|Aspirin|aspirin|mesh-list
92739012|NCT02875717|Heparin|heparin|mesh-list
92739013|NCT02875717|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92739014|NCT02875717|Tinzaparin|tinzaparin|mesh-list
92739015|NCT02875717|Dalteparin|dalteparin|mesh-list
92739016|NCT02875717|Anticoagulants|anticoagulants|mesh-ancestor
92739017|NCT02875717|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92739018|NCT02875717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92739019|NCT02875717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739020|NCT02875717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92739021|NCT02875717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92739022|NCT02875717|Analgesics|analgesics|mesh-ancestor
92739023|NCT02875717|Sensory System Agents|sensory system agents|mesh-ancestor
92739024|NCT02875717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739025|NCT02875717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739026|NCT02875717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739027|NCT02875717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739030|NCT02875717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739031|NCT02875717|Antipyretics|antipyretics|mesh-ancestor
92739032|NCT04334837|Copper|copper|mesh-list
92739033|NCT04334837|Trace Elements|trace elements|mesh-ancestor
92739034|NCT04334837|Micronutrients|micronutrients|mesh-ancestor
92739035|NCT04334837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739036|NCT00593099|Bupropion|bupropion|mesh-list
92739037|NCT00593099|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92611193|NCT03451825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611194|NCT03451825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611195|NCT03451825|Immunologic Factors|immunologic factors|mesh-ancestor
92611196|NCT03451825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611197|NCT00156897|Orlistat|orlistat|mesh-list
92611198|NCT00156897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611199|NCT00156897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611200|NCT00156897|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92611201|NCT00156897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92611202|NCT03459859|Cytarabine|cytarabine|mesh-list
92611203|NCT03459859|Pevonedistat|pevonedistat|mesh-list
92611204|NCT03459859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739038|NCT00593099|Antidepressive Agents|antidepressive agents|mesh-ancestor
92739039|NCT00593099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92739040|NCT00593099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92739041|NCT00593099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92739042|NCT00593099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92739043|NCT00593099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739044|NCT00593099|Dopamine Agents|dopamine agents|mesh-ancestor
92739045|NCT00593099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739046|NCT00593099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739047|NCT00593099|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92739048|NCT00593099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92739049|NCT00593099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739050|NCT00593177|Parathyroid Hormone|parathyroid hormone|mesh-list
92739051|NCT00593177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92739052|NCT00593177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739053|NCT00593255|Insulin|insulin|mesh-list
92739054|NCT00593255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92739055|NCT00593255|Insulin Aspart|insulin aspart|mesh-list
92739056|NCT00593255|Isophane Insulin, Human|isophane insulin, human|mesh-list
92739057|NCT00593255|Insulin, Isophane|insulin, isophane|mesh-list
92739058|NCT00593255|Isophane insulin, beef|isophane insulin, beef|mesh-list
92739059|NCT00593255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739060|NCT00593255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739061|NCT00593801|Epoetin Alfa|epoetin alfa|mesh-list
92739062|NCT00593801|Hematinics|hematinics|mesh-ancestor
92739063|NCT00593879|Mecamylamine|mecamylamine|mesh-list
92739064|NCT00593879|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739065|NCT00593879|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92739066|NCT00593879|Autonomic Agents|autonomic agents|mesh-ancestor
92739067|NCT00593879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739068|NCT00593879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739069|NCT00593879|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92739070|NCT00593879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92739071|NCT00593879|Cholinergic Agents|cholinergic agents|mesh-ancestor
92739072|NCT00593879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739073|NCT00593879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739074|NCT00594191|Simvastatin|simvastatin|mesh-list
92739075|NCT00594191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92739076|NCT00594191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92739077|NCT00594191|Antimetabolites|antimetabolites|mesh-ancestor
92739078|NCT00594191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739079|NCT00594191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92739080|NCT00594191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92739081|NCT00594191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739082|NCT00594269|Risperidone|risperidone|mesh-list
92739083|NCT00594269|Citalopram|citalopram|mesh-list
92739084|NCT00594269|Sertraline|sertraline|mesh-list
92739085|NCT00594269|Paroxetine|paroxetine|mesh-list
92739086|NCT00594269|Escitalopram|escitalopram|mesh-list
92739087|NCT00594269|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92739088|NCT00594269|Serotonin Agents|serotonin agents|mesh-ancestor
92611205|NCT03459859|Antimetabolites|antimetabolites|mesh-ancestor
92611206|NCT03459859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611207|NCT03459859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611208|NCT03459859|Antiviral Agents|antiviral agents|mesh-ancestor
92611209|NCT03459859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611210|NCT03459859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611211|NCT03459859|Immunologic Factors|immunologic factors|mesh-ancestor
92611212|NCT03459859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611213|NCT03459859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611214|NCT05594459|Analgesics|analgesics|mesh-list
92611215|NCT05594459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611216|NCT05594459|Sensory System Agents|sensory system agents|mesh-ancestor
92018270|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
92739089|NCT00594269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739090|NCT00594269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739091|NCT00594269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739092|NCT00594269|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92739093|NCT00594269|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92739094|NCT00594269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739095|NCT00594269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92739096|NCT00594269|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92739097|NCT00594269|Dopamine Agents|dopamine agents|mesh-ancestor
92739098|NCT00594269|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92739099|NCT00594269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92739100|NCT00594269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92739116|NCT04326959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739117|NCT04326959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739119|NCT04326959|Immunologic Factors|immunologic factors|mesh-ancestor
92739120|NCT04326959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739121|NCT04326959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739122|NCT00594737|Memantine|memantine|mesh-list
92739123|NCT00594737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92739124|NCT00594737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92739125|NCT00594737|Dopamine Agents|dopamine agents|mesh-ancestor
92739126|NCT00594737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739127|NCT00594737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739128|NCT00594737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739129|NCT00594737|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92739130|NCT00594737|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92739131|NCT00595049|Bosentan|bosentan|mesh-list
92739132|NCT00595049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739133|NCT00595049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92739134|NCT00595049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739135|NCT00595985|Sorafenib|sorafenib|mesh-list
92739136|NCT00595985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739137|NCT00595985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739138|NCT00595985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739139|NCT00595985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739140|NCT00596063|Insulin|insulin|mesh-list
92739141|NCT00596063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739142|NCT00596063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739143|NCT00596219|Celecoxib|celecoxib|mesh-list
92739144|NCT00596219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92739145|NCT00596219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92739146|NCT00596219|Analgesics|analgesics|mesh-ancestor
92739147|NCT00596219|Sensory System Agents|sensory system agents|mesh-ancestor
92739148|NCT00596219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739149|NCT00596219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739150|NCT00596219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018280|NCT02495883|Ethanol|ethanol|mesh-list
92611217|NCT05594459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611218|NCT00507403|Infliximab|infliximab|mesh-list
92611219|NCT00507403|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92611220|NCT00507403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611221|NCT00507403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611222|NCT00507403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611223|NCT00507403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611224|NCT00156975|Capecitabine|capecitabine|mesh-list
92611225|NCT00156975|Oxaliplatin|oxaliplatin|mesh-list
92739151|NCT00596219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739152|NCT00596219|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92739153|NCT00596219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92739154|NCT00596219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739155|NCT00596219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739156|NCT00596297|Bevacizumab|bevacizumab|mesh-list
92327609|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739157|NCT00596297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92739159|NCT00596297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739160|NCT00596297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92739161|NCT00596297|Growth Substances|growth substances|mesh-ancestor
92739162|NCT00596297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739163|NCT00596297|Growth Inhibitors|growth inhibitors|mesh-ancestor
92739164|NCT00596375|Lidocaine|lidocaine|mesh-list
92739165|NCT00596375|Anesthetics, Local|anesthetics, local|mesh-ancestor
92739166|NCT00596375|Anesthetics|anesthetics|mesh-ancestor
92739167|NCT00596375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739168|NCT00596375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739169|NCT00596375|Sensory System Agents|sensory system agents|mesh-ancestor
92739170|NCT00596375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739171|NCT00596375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92739172|NCT00596375|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92739173|NCT00596375|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92739174|NCT00596375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92739175|NCT00596375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739176|NCT00596531|Acamprosate|acamprosate|mesh-list
92739177|NCT00596531|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92739178|NCT00596609|Morphine|morphine|mesh-list
92739179|NCT00596609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92739180|NCT00596609|Narcotics|narcotics|mesh-ancestor
92739181|NCT00596609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739182|NCT00596609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739183|NCT00596609|Analgesics|analgesics|mesh-ancestor
92739184|NCT00596609|Sensory System Agents|sensory system agents|mesh-ancestor
92739185|NCT00596609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739186|NCT04326803|Vaccines|vaccines|mesh-list
92739187|NCT04326803|Immunologic Factors|immunologic factors|mesh-ancestor
92739188|NCT04326803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739189|NCT00597233|Insulin|insulin|mesh-list
92739190|NCT00597233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92739191|NCT00597233|Insulin Aspart|insulin aspart|mesh-list
92739192|NCT00597233|Isophane Insulin, Human|isophane insulin, human|mesh-list
92739193|NCT00597233|Insulin, Isophane|insulin, isophane|mesh-list
92739194|NCT00597233|Isophane insulin, beef|isophane insulin, beef|mesh-list
92739195|NCT00597233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739196|NCT00597233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739197|NCT01064401|Interferons|interferons|mesh-list
92739198|NCT01064401|Interferon-beta|interferon-beta|mesh-list
92739199|NCT01064401|Interferon beta-1a|interferon beta-1a|mesh-list
92739200|NCT01064401|Daclizumab|daclizumab|mesh-list
92739201|NCT01064401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739202|NCT01064401|Antiviral Agents|antiviral agents|mesh-ancestor
92739203|NCT01064401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739204|NCT01064401|Immunologic Factors|immunologic factors|mesh-ancestor
92739205|NCT01064401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739206|NCT01064401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92739207|NCT01064401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739208|NCT00597389|Propranolol|propranolol|mesh-list
92611227|NCT00156975|Antimetabolites|antimetabolites|mesh-ancestor
92611228|NCT00156975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018290|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
92739209|NCT00597389|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92739210|NCT00597389|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92739211|NCT00597389|Adrenergic Agents|adrenergic agents|mesh-ancestor
92739212|NCT00597389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739213|NCT00597389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739214|NCT00597389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739215|NCT00597389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92739216|NCT00597389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739217|NCT00597389|Vasodilator Agents|vasodilator agents|mesh-ancestor
92739218|NCT01306617|Ritonavir|ritonavir|mesh-list
92739219|NCT01306617|Ribavirin|ribavirin|mesh-list
92739220|NCT01306617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92739221|NCT01306617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92739222|NCT01306617|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739223|NCT01306617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739224|NCT01306617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739225|NCT01306617|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92739226|NCT01306617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92739227|NCT01306617|Antiviral Agents|antiviral agents|mesh-ancestor
92739228|NCT01306617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739229|NCT01306617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92739230|NCT01306617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92739231|NCT01306617|Antimetabolites|antimetabolites|mesh-ancestor
92739232|NCT00597623|Adalimumab|adalimumab|mesh-list
92739235|NCT00597623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739236|NCT00597857|Hydrocortisone|hydrocortisone|mesh-list
92739237|NCT00597857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739239|NCT00627133|Anticonvulsants|anticonvulsants|mesh-ancestor
92739240|NCT00627133|Nootropic Agents|nootropic agents|mesh-ancestor
92739241|NCT00598013|Pioglitazone|pioglitazone|mesh-list
92739242|NCT00598013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739243|NCT00598013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739244|NCT04303429|Capecitabine|capecitabine|mesh-list
92739245|NCT04303429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739246|NCT04303429|Antimetabolites|antimetabolites|mesh-ancestor
92739247|NCT04303429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739248|NCT04303429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739249|NCT00598091|Gemcitabine|gemcitabine|mesh-list
92739250|NCT00598091|Dasatinib|dasatinib|mesh-list
92739251|NCT00598091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739252|NCT00598091|Antimetabolites|antimetabolites|mesh-ancestor
92739253|NCT00598091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739254|NCT00598091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739255|NCT00598091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739256|NCT00598091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739257|NCT00623415|Flupirtine|flupirtine|mesh-list
92739258|NCT00623415|Analgesics|analgesics|mesh-ancestor
92739259|NCT00623415|Sensory System Agents|sensory system agents|mesh-ancestor
92739260|NCT00623415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739261|NCT00623415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739262|NCT04326725|Hydroxychloroquine|hydroxychloroquine|mesh-list
92739263|NCT04326725|Antimalarials|antimalarials|mesh-ancestor
92739264|NCT04326725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92739265|NCT04326725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92739266|NCT04326725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739267|NCT04326725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739268|NCT04326725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739269|NCT04326725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739270|NCT01038427|Mometasone Furoate|mometasone furoate|mesh-list
92739271|NCT01038427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739272|NCT01038427|Dermatologic Agents|dermatologic agents|mesh-ancestor
92739273|NCT01038427|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92739274|NCT00598169|Dexamethasone|dexamethasone|mesh-list
92739275|NCT00598169|Rituximab|rituximab|mesh-list
92739276|NCT00598169|Carboplatin|carboplatin|mesh-list
92739277|NCT00598169|Etoposide|etoposide|mesh-list
92739278|NCT00598169|Bortezomib|bortezomib|mesh-list
92739279|NCT00598169|Ifosfamide|ifosfamide|mesh-list
92739280|NCT00598169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611229|NCT00156975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611230|NCT05594381|Oxaliplatin|oxaliplatin|mesh-list
92611231|NCT05594381|Tegafur|tegafur|mesh-list
92611232|NCT05594381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611233|NCT05594381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92611234|NCT05594381|Antimetabolites|antimetabolites|mesh-ancestor
92611235|NCT05594381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611236|NCT00148473|Misoprostol|misoprostol|mesh-list
92739281|NCT00598169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739282|NCT00598169|Immunologic Factors|immunologic factors|mesh-ancestor
92739283|NCT00598169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739284|NCT00598169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739285|NCT00598169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739286|NCT00598169|Antiemetics|antiemetics|mesh-ancestor
92739287|NCT00598169|Autonomic Agents|autonomic agents|mesh-ancestor
92739288|NCT00598169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739289|NCT00598169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92739290|NCT00598169|Glucocorticoids|glucocorticoids|mesh-ancestor
92739291|NCT00598169|Hormones|hormones|mesh-ancestor
92739292|NCT00598169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739293|NCT00598169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92739294|NCT00598169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92739295|NCT00598169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92739296|NCT00598169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739297|NCT00598169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739298|NCT00598169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739299|NCT00598169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92739300|NCT00598169|Alkylating Agents|alkylating agents|mesh-ancestor
92739301|NCT00598247|Paclitaxel|paclitaxel|mesh-list
92739302|NCT00598247|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92739303|NCT00598247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92739304|NCT00598247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739305|NCT00598247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92739306|NCT00598247|Antimitotic Agents|antimitotic agents|mesh-ancestor
92739307|NCT00598247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92327610|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
92739310|NCT00598403|Cefditoren|cefditoren|mesh-list
92739311|NCT00598403|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
92739312|NCT00598403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92739313|NCT00598403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739314|NCT00598403|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92739315|NCT00598403|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739316|NCT00598403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739317|NCT00598403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739318|NCT00598403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739319|NCT00598403|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92739320|NCT00598403|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92739321|NCT00598637|Everolimus|everolimus|mesh-list
92739322|NCT00598637|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92739323|NCT00598637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739324|NCT00598637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739325|NCT00598637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739326|NCT00598637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739327|NCT00598637|Immunologic Factors|immunologic factors|mesh-ancestor
92739328|NCT00598637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739329|NCT00598637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739330|NCT00598715|Sirolimus|sirolimus|mesh-list
92739331|NCT00598715|Paclitaxel|paclitaxel|mesh-list
92739332|NCT00598715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92739333|NCT00598715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739334|NCT00598715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92739335|NCT00598715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92739336|NCT00598715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92739337|NCT00598715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739338|NCT00598715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92739339|NCT00598715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739340|NCT00598715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92611237|NCT00148473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92611238|NCT00148473|Abortifacient Agents|abortifacient agents|mesh-ancestor
92611239|NCT00148473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92739341|NCT00598715|Antifungal Agents|antifungal agents|mesh-ancestor
92739342|NCT00598715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739343|NCT00598715|Immunologic Factors|immunologic factors|mesh-ancestor
92739344|NCT00598715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739345|NCT00598793|Insulin|insulin|mesh-list
92739346|NCT00598793|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92739347|NCT00598793|Metformin|metformin|mesh-list
92739348|NCT00598793|Insulin Glargine|insulin glargine|mesh-list
92739349|NCT00598793|Pioglitazone|pioglitazone|mesh-list
92739350|NCT00598793|Insulin Aspart|insulin aspart|mesh-list
92739351|NCT00598793|Biphasic Insulins|biphasic insulins|mesh-list
92739352|NCT00598793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739353|NCT00598793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739354|NCT01326845|Deferasirox|deferasirox|mesh-list
92739355|NCT01326845|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92739356|NCT01326845|Chelating Agents|chelating agents|mesh-ancestor
92739357|NCT01326845|Sequestering Agents|sequestering agents|mesh-ancestor
92739358|NCT01326845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739359|NCT01062763|Spironolactone|spironolactone|mesh-list
92739360|NCT01062763|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92739361|NCT01062763|Hormone Antagonists|hormone antagonists|mesh-ancestor
92739362|NCT01062763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739363|NCT01062763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739364|NCT01062763|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92739365|NCT01062763|Diuretics|diuretics|mesh-ancestor
92739366|NCT01062763|Natriuretic Agents|natriuretic agents|mesh-ancestor
92739367|NCT00599417|Broncho-Vaxom|broncho-vaxom|mesh-list
92739368|NCT00599417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92739369|NCT00599417|Immunologic Factors|immunologic factors|mesh-ancestor
92739370|NCT00599417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739371|NCT00599573|Ondansetron|ondansetron|mesh-list
92739372|NCT00599573|Antiemetics|antiemetics|mesh-ancestor
92739373|NCT00599573|Autonomic Agents|autonomic agents|mesh-ancestor
92739374|NCT00599573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739375|NCT00599573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739376|NCT00599573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92739377|NCT00599573|Antipruritics|antipruritics|mesh-ancestor
92739378|NCT00599573|Dermatologic Agents|dermatologic agents|mesh-ancestor
92739379|NCT00599573|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92739380|NCT00599573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92739381|NCT00599573|Serotonin Agents|serotonin agents|mesh-ancestor
92739384|NCT00599651|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92739385|NCT00599651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92739386|NCT01048099|Trastuzumab|trastuzumab|mesh-list
92739388|NCT01048099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92739389|NCT01048099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739390|NCT00599807|Vitamin D|vitamin d|mesh-list
92739391|NCT00599807|Cholecalciferol|cholecalciferol|mesh-list
92739392|NCT00599807|Vitamins|vitamins|mesh-ancestor
92739393|NCT00599807|Micronutrients|micronutrients|mesh-ancestor
92739394|NCT00599807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739395|NCT00599807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92739396|NCT00599807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92739397|NCT00599885|Valsartan|valsartan|mesh-list
92739398|NCT00599885|Telmisartan|telmisartan|mesh-list
92739399|NCT00599885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739400|NCT00599885|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92739401|NCT00599885|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92739402|NCT00599885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739403|NCT01303965|Sirolimus|sirolimus|mesh-list
92739404|NCT01303965|Lenalidomide|lenalidomide|mesh-list
92739405|NCT01303965|Tacrolimus|tacrolimus|mesh-list
92739406|NCT01303965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739407|NCT01303965|Immunologic Factors|immunologic factors|mesh-ancestor
92739408|NCT01303965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739409|NCT01303965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92739410|NCT01303965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739411|NCT01303965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739412|NCT01303965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739413|NCT01303965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92611240|NCT00148473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611241|NCT00148473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92611242|NCT00148473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92739414|NCT01303965|Growth Substances|growth substances|mesh-ancestor
92739415|NCT01303965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92739416|NCT01303965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739417|NCT01303965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92739418|NCT01303965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739419|NCT01303965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92739420|NCT01303965|Antifungal Agents|antifungal agents|mesh-ancestor
92739421|NCT00600041|Pantoprazole|pantoprazole|mesh-list
92739422|NCT00600041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92739423|NCT00600041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92739424|NCT00600041|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92739425|NCT00600041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739426|NCT00600041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739427|NCT01045993|Analgesics|analgesics|mesh-list
92739428|NCT01045993|Sensory System Agents|sensory system agents|mesh-ancestor
92739429|NCT01045993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739430|NCT01045993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739431|NCT00600509|Levetiracetam|levetiracetam|mesh-list
92739432|NCT00600509|Anticonvulsants|anticonvulsants|mesh-ancestor
92739433|NCT00600509|Nootropic Agents|nootropic agents|mesh-ancestor
92739434|NCT01326533|Hydroxychloroquine|hydroxychloroquine|mesh-list
92739435|NCT01326533|Antimalarials|antimalarials|mesh-ancestor
92739436|NCT01326533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92739437|NCT01326533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92739438|NCT01326533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739439|NCT01326533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739440|NCT01326533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739441|NCT01326533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739442|NCT00600587|Carboplatin|carboplatin|mesh-list
92739443|NCT00600587|Gemcitabine|gemcitabine|mesh-list
92739444|NCT00600587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92739445|NCT00600587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739446|NCT00600587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739447|NCT00600587|Antimetabolites|antimetabolites|mesh-ancestor
92739448|NCT00600587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739449|NCT00600587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739450|NCT00600587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739451|NCT01045447|Insulin|insulin|mesh-list
92739452|NCT01045447|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92739453|NCT01045447|Insulin Glargine|insulin glargine|mesh-list
92739454|NCT01045447|Insulin Aspart|insulin aspart|mesh-list
92739455|NCT01045447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739461|NCT00623207|Autonomic Agents|autonomic agents|mesh-ancestor
92739462|NCT00623207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739463|NCT00623207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739464|NCT00623207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92739465|NCT00623207|Respiratory System Agents|respiratory system agents|mesh-ancestor
92739466|NCT00623207|Mydriatics|mydriatics|mesh-ancestor
92739467|NCT00623207|Parasympatholytics|parasympatholytics|mesh-ancestor
92739468|NCT00623207|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92739469|NCT00623207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92739470|NCT00623207|Cholinergic Agents|cholinergic agents|mesh-ancestor
92739471|NCT00623207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739472|NCT00623207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739473|NCT00600977|Doxorubicin|doxorubicin|mesh-list
92739474|NCT00600977|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92739475|NCT00600977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92739476|NCT00600977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739477|NCT00600977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92739478|NCT00600977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739479|NCT00600977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739480|NCT00600977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739481|NCT00601211|Pilocarpine|pilocarpine|mesh-list
92739482|NCT00601211|Miotics|miotics|mesh-ancestor
92739483|NCT00601211|Autonomic Agents|autonomic agents|mesh-ancestor
92739484|NCT00601211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739485|NCT00601211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739486|NCT00601211|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92739487|NCT00601211|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92739488|NCT00601211|Cholinergic Agents|cholinergic agents|mesh-ancestor
92739489|NCT00601211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739490|NCT00601211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739491|NCT00601289|Temozolomide|temozolomide|mesh-list
92739492|NCT00601289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92739493|NCT00601289|Alkylating Agents|alkylating agents|mesh-ancestor
92739494|NCT00601289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739495|NCT00601289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739496|NCT00601913|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92739497|NCT00601913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739498|NCT00601913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739499|NCT00601913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739500|NCT00601913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739501|NCT00601991|Aflibercept|aflibercept|mesh-list
92739502|NCT00601991|Endothelial Growth Factors|endothelial growth factors|mesh-list
92739503|NCT00601991|Growth Substances|growth substances|mesh-ancestor
92739504|NCT00601991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739505|NCT00601991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739506|NCT00601991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92739507|NCT00601991|Growth Inhibitors|growth inhibitors|mesh-ancestor
92739508|NCT00601991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739509|NCT01301391|Maleic acid|maleic acid|mesh-list
92739510|NCT01301391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739511|NCT01301391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739512|NCT04325633|Naproxen|naproxen|mesh-list
92739513|NCT04325633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92739514|NCT04325633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92739515|NCT04325633|Analgesics|analgesics|mesh-ancestor
92739516|NCT04325633|Sensory System Agents|sensory system agents|mesh-ancestor
92739517|NCT04325633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739518|NCT04325633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739519|NCT04325633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739520|NCT04325633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739521|NCT04325633|Gout Suppressants|gout suppressants|mesh-ancestor
92739522|NCT04325633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92739523|NCT04325633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739524|NCT04325633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739526|NCT05643651|Vitamin K|vitamin k|mesh-list
92739527|NCT05643651|Warfarin|warfarin|mesh-list
92739528|NCT05643651|Rivaroxaban|rivaroxaban|mesh-list
92739529|NCT05643651|Clopidogrel|clopidogrel|mesh-list
92739530|NCT05643651|Vitamins|vitamins|mesh-ancestor
92739531|NCT05643651|Micronutrients|micronutrients|mesh-ancestor
92739532|NCT05643651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739533|NCT05643651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92739534|NCT05643651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92739535|NCT05643651|Analgesics|analgesics|mesh-ancestor
92739536|NCT05643651|Sensory System Agents|sensory system agents|mesh-ancestor
92151794|NCT04759729|Vitamins|vitamins|mesh-list
92739537|NCT05643651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739538|NCT05643651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739539|NCT05643651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739540|NCT05643651|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92739541|NCT05643651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92739542|NCT05643651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739543|NCT05643651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92739544|NCT05643651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92739545|NCT05643651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739546|NCT05643651|Antipyretics|antipyretics|mesh-ancestor
92739547|NCT05643651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92739548|NCT05643651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92739549|NCT05643651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92739550|NCT05643651|Purinergic Agents|purinergic agents|mesh-ancestor
92739551|NCT05643651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739552|NCT05643651|Anticoagulants|anticoagulants|mesh-ancestor
92739553|NCT05643651|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92739554|NCT05643651|Antithrombins|antithrombins|mesh-ancestor
92739555|NCT05643651|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92739556|NCT05643651|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739557|NCT05643651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92739558|NCT05643651|Hemostatics|hemostatics|mesh-ancestor
92739559|NCT05643651|Coagulants|coagulants|mesh-ancestor
92739560|NCT01061359|Epirubicin|epirubicin|mesh-list
92739561|NCT01061359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92739562|NCT01061359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739563|NCT01061359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92611245|NCT00507637|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92611246|NCT00507637|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92611247|NCT00507637|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92336319|NCT02006706|Antiemetics|antiemetics|mesh-ancestor
92611248|NCT00507637|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92739564|NCT01061359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739565|NCT01061359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739566|NCT01061359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739567|NCT05643417|Bevacizumab|bevacizumab|mesh-list
92739568|NCT05643417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92739569|NCT05643417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739570|NCT05643417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739571|NCT05643417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92739572|NCT05643417|Growth Substances|growth substances|mesh-ancestor
92739573|NCT05643417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739574|NCT05643417|Growth Inhibitors|growth inhibitors|mesh-ancestor
92739575|NCT04303741|Apatinib|apatinib|mesh-list
92739576|NCT04303741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739577|NCT04303741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739578|NCT04303741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739579|NCT04303741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739580|NCT00626977|Clonidine|clonidine|mesh-list
92739581|NCT00626977|Ropivacaine|ropivacaine|mesh-list
92739582|NCT00626977|Anesthetics, Local|anesthetics, local|mesh-ancestor
92739583|NCT00626977|Anesthetics|anesthetics|mesh-ancestor
92739584|NCT00626977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739585|NCT00626977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739586|NCT00626977|Sensory System Agents|sensory system agents|mesh-ancestor
92739587|NCT00626977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739588|NCT00626977|Analgesics|analgesics|mesh-ancestor
92739589|NCT00626977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739590|NCT00626977|Sympatholytics|sympatholytics|mesh-ancestor
92739591|NCT00626977|Autonomic Agents|autonomic agents|mesh-ancestor
92739592|NCT00626977|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92739593|NCT00626977|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92739594|NCT00626977|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92739595|NCT00626977|Adrenergic Agents|adrenergic agents|mesh-ancestor
92739596|NCT00626977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739597|NCT00626977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739598|NCT04303819|Exenatide|exenatide|mesh-list
92739599|NCT04303819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739600|NCT04303819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739602|NCT04303819|Incretins|incretins|mesh-ancestor
92739604|NCT04303819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739605|NCT01301079|Ketamine|ketamine|mesh-list
92739606|NCT01301079|Analgesics|analgesics|mesh-ancestor
92739607|NCT01301079|Sensory System Agents|sensory system agents|mesh-ancestor
92739608|NCT01301079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739609|NCT01301079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739610|NCT01301079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92739611|NCT01301079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92739612|NCT01301079|Anesthetics, General|anesthetics, general|mesh-ancestor
92739613|NCT01301079|Anesthetics|anesthetics|mesh-ancestor
92739614|NCT01301079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739615|NCT01301079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92739616|NCT01301079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92739617|NCT01301079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739618|NCT01301079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739619|NCT05271721|Dexamethasone|dexamethasone|mesh-list
92739620|NCT05271721|Dexamethasone acetate|dexamethasone acetate|mesh-list
92739621|NCT05271721|BB 1101|bb 1101|mesh-list
92739622|NCT05271721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739623|NCT05271721|Antiemetics|antiemetics|mesh-ancestor
92739624|NCT05271721|Autonomic Agents|autonomic agents|mesh-ancestor
92739625|NCT05271721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739626|NCT05271721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739627|NCT05271721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92739628|NCT05271721|Glucocorticoids|glucocorticoids|mesh-ancestor
92739629|NCT05271721|Hormones|hormones|mesh-ancestor
92611249|NCT00507637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611250|NCT00507637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611252|NCT00507637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739630|NCT05271721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739631|NCT05271721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92739632|NCT05271721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739633|NCT05271721|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739634|NCT05271721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739635|NCT05271721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739636|NCT01301001|Gabapentin|gabapentin|mesh-list
92739637|NCT01301001|Analgesics|analgesics|mesh-ancestor
92739638|NCT01301001|Sensory System Agents|sensory system agents|mesh-ancestor
92739639|NCT01301001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739640|NCT01301001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739641|NCT01301001|Anticonvulsants|anticonvulsants|mesh-ancestor
92739642|NCT01301001|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92739643|NCT01301001|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92739644|NCT01301001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739645|NCT01301001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92739646|NCT01301001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92739647|NCT01301001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92739648|NCT01301001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739649|NCT01301001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739650|NCT01301001|Antimanic Agents|antimanic agents|mesh-ancestor
92739651|NCT01035463|Cytarabine|cytarabine|mesh-list
92739652|NCT01035463|Rituximab|rituximab|mesh-list
92739653|NCT01035463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92739654|NCT01035463|Etoposide|etoposide|mesh-list
92739655|NCT01035463|Lenalidomide|lenalidomide|mesh-list
92739656|NCT01035463|Etoposide phosphate|etoposide phosphate|mesh-list
92739657|NCT01035463|Melphalan|melphalan|mesh-list
92739658|NCT01035463|Mechlorethamine|mechlorethamine|mesh-list
92739659|NCT01035463|Carmustine|carmustine|mesh-list
92739660|NCT01035463|Podophyllotoxin|podophyllotoxin|mesh-list
92739661|NCT01035463|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92739662|NCT01035463|Antibodies|antibodies|mesh-list
92739663|NCT01035463|Immunoglobulins|immunoglobulins|mesh-list
92739664|NCT01035463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92739665|NCT01035463|Immunologic Factors|immunologic factors|mesh-ancestor
92739666|NCT01035463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739667|NCT01035463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739668|NCT01035463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739669|NCT01035463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92739670|NCT01035463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92739671|NCT01035463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739672|NCT01035463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739673|NCT01035463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739674|NCT01035463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739675|NCT01035463|Antimetabolites|antimetabolites|mesh-ancestor
92739679|NCT01035463|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739680|NCT01035463|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92739681|NCT01035463|Growth Substances|growth substances|mesh-ancestor
92739682|NCT01035463|Growth Inhibitors|growth inhibitors|mesh-ancestor
92739683|NCT01035463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92739684|NCT01035463|Alkylating Agents|alkylating agents|mesh-ancestor
92739685|NCT01035463|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92739686|NCT01035463|Keratolytic Agents|keratolytic agents|mesh-ancestor
92739687|NCT01035463|Dermatologic Agents|dermatologic agents|mesh-ancestor
92739688|NCT01035463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92739689|NCT01035463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92739690|NCT01035463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92739691|NCT01300923|Acamprosate|acamprosate|mesh-list
92739692|NCT01300923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92739693|NCT01300767|Contact Lens Solutions|contact lens solutions|mesh-list
92739694|NCT01300767|Disinfectants|disinfectants|mesh-ancestor
92739695|NCT01300767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739696|NCT02890173|Eplerenone|eplerenone|mesh-list
92739697|NCT02890173|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92739698|NCT02890173|Hormone Antagonists|hormone antagonists|mesh-ancestor
92018316|NCT04913779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739699|NCT02890173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739700|NCT02890173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739701|NCT02890173|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92739702|NCT02890173|Diuretics|diuretics|mesh-ancestor
92739703|NCT02890173|Natriuretic Agents|natriuretic agents|mesh-ancestor
92739704|NCT02890173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739705|NCT01300455|Suvorexant|suvorexant|mesh-list
92739706|NCT01300455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92739707|NCT01300455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92739708|NCT01300455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739709|NCT01300455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739710|NCT01300455|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92739711|NCT01300455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739712|NCT01300455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739713|NCT01101178|Oxycodone|oxycodone|mesh-list
92739714|NCT01101178|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92739715|NCT01101178|Narcotics|narcotics|mesh-ancestor
92739716|NCT01101178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739717|NCT01101178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739718|NCT01101178|Analgesics|analgesics|mesh-ancestor
92739719|NCT01101178|Sensory System Agents|sensory system agents|mesh-ancestor
92739720|NCT01101178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739721|NCT05637645|Bupivacaine|bupivacaine|mesh-list
92739722|NCT05637645|Anesthetics, Local|anesthetics, local|mesh-ancestor
92739723|NCT05637645|Anesthetics|anesthetics|mesh-ancestor
92739724|NCT05637645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739725|NCT05637645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739726|NCT05637645|Sensory System Agents|sensory system agents|mesh-ancestor
92739727|NCT05637645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739728|NCT01101022|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92739729|NCT01101022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92739730|NCT01101022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739731|NCT01101022|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92739732|NCT01101022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92739733|NCT01101022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92739734|NCT01101022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739735|NCT01101022|Dopamine Agents|dopamine agents|mesh-ancestor
92739736|NCT01101022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739737|NCT02879110|Sulforaphane|sulforaphane|mesh-list
92739738|NCT02879110|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92739739|NCT02879110|Protective Agents|protective agents|mesh-ancestor
92739740|NCT02879110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739741|NCT02879110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739742|NCT04207515|Anesthetics|anesthetics|mesh-list
92739743|NCT04207515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739744|NCT04207515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739745|NCT01100944|Cyclophosphamide|cyclophosphamide|mesh-list
92739746|NCT01100944|Doxorubicin|doxorubicin|mesh-list
92739748|NCT01100944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739749|NCT01100944|Immunologic Factors|immunologic factors|mesh-ancestor
92739750|NCT01100944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739751|NCT01100944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739752|NCT01100944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92739753|NCT01100944|Alkylating Agents|alkylating agents|mesh-ancestor
92739754|NCT01100944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739755|NCT01100944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611253|NCT00507637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611254|NCT00507637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92611255|NCT00507637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739756|NCT01100944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92739757|NCT01100944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92739758|NCT01100944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92739759|NCT01100944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739760|NCT01100944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739761|NCT01100944|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92739763|NCT01100320|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92739764|NCT01100320|Narcotics|narcotics|mesh-ancestor
92739765|NCT01100320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739766|NCT01100320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739767|NCT01100320|Analgesics|analgesics|mesh-ancestor
92739768|NCT01100320|Sensory System Agents|sensory system agents|mesh-ancestor
92739769|NCT01100320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739770|NCT04309708|Nimodipine|nimodipine|mesh-list
92739771|NCT04309708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739772|NCT04309708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92739773|NCT04309708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92739774|NCT04309708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739775|NCT04309708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92739776|NCT04309708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739777|NCT04309708|Vasodilator Agents|vasodilator agents|mesh-ancestor
92739778|NCT01100086|Oxycodone|oxycodone|mesh-list
92739779|NCT01100086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92739780|NCT01100086|Narcotics|narcotics|mesh-ancestor
92739781|NCT01100086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739782|NCT01100086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739783|NCT01100086|Analgesics|analgesics|mesh-ancestor
92739784|NCT01100086|Sensory System Agents|sensory system agents|mesh-ancestor
92739785|NCT01100086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739786|NCT01297959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92739787|NCT00626080|Insulin|insulin|mesh-list
92739788|NCT00626080|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92739789|NCT00626080|Insulin Detemir|insulin detemir|mesh-list
92739790|NCT00626080|Isophane Insulin, Human|isophane insulin, human|mesh-list
92739791|NCT00626080|Insulin, Isophane|insulin, isophane|mesh-list
92739792|NCT00626080|Isophane insulin, beef|isophane insulin, beef|mesh-list
92739793|NCT00626080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739794|NCT00626080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739795|NCT04309240|Rivaroxaban|rivaroxaban|mesh-list
92739796|NCT04309240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92739797|NCT04309240|Antithrombins|antithrombins|mesh-ancestor
92739798|NCT04309240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92739799|NCT04309240|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739800|NCT04309240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327611|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739803|NCT01035229|Everolimus|everolimus|mesh-list
92739804|NCT01035229|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92739805|NCT01035229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739806|NCT01035229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739807|NCT01035229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739808|NCT01035229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739809|NCT01035229|Immunologic Factors|immunologic factors|mesh-ancestor
92739810|NCT01035229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739811|NCT01035229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739812|NCT01059799|Insulin|insulin|mesh-list
92739813|NCT01059799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92739814|NCT01059799|Insulin Glargine|insulin glargine|mesh-list
92739815|NCT01059799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92739816|NCT01059799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739817|NCT04301869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92739818|NCT04301869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739819|NCT04301479|Hydrocortisone|hydrocortisone|mesh-list
92739820|NCT04301479|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92739821|NCT04301479|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92739822|NCT04301479|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92739823|NCT04301479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739825|NCT01106092|Immunologic Factors|immunologic factors|mesh-ancestor
92739826|NCT01106092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611256|NCT05594342|Dobutamine|dobutamine|mesh-list
92611257|NCT05594342|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92611258|NCT05594342|Sympathomimetics|sympathomimetics|mesh-ancestor
92611259|NCT05594342|Autonomic Agents|autonomic agents|mesh-ancestor
92018322|NCT03054259|Rituximab|rituximab|mesh-list
92739827|NCT04307290|Dexmedetomidine|dexmedetomidine|mesh-list
92739828|NCT04307290|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92739829|NCT04307290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739830|NCT04307290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739831|NCT04307290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92739832|NCT04307290|Analgesics|analgesics|mesh-ancestor
92739833|NCT04307290|Sensory System Agents|sensory system agents|mesh-ancestor
92739834|NCT04307290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739835|NCT04307290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92739836|NCT04307290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92739837|NCT04307290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92739838|NCT04307290|Adrenergic Agents|adrenergic agents|mesh-ancestor
92739839|NCT04307290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739840|NCT04307290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739841|NCT01325207|Trastuzumab|trastuzumab|mesh-list
92739842|NCT01325207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92739843|NCT01325207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739844|NCT01324349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92739845|NCT01324349|Hemostatics|hemostatics|mesh-list
92739846|NCT01324349|Coagulants|coagulants|mesh-ancestor
92739847|NCT01095250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92739848|NCT01095250|Immunologic Factors|immunologic factors|mesh-ancestor
92739849|NCT01095250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739850|NCT01095094|Ritonavir|ritonavir|mesh-list
92739851|NCT01095094|Lopinavir|lopinavir|mesh-list
92739852|NCT01095094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92739853|NCT01095094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92739854|NCT01095094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739855|NCT01095094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739856|NCT01095094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739857|NCT01095094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92739858|NCT01095094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92739859|NCT01095094|Antiviral Agents|antiviral agents|mesh-ancestor
92739860|NCT01095094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739861|NCT01095094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92739862|NCT01095094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92739863|NCT00623285|Pregabalin|pregabalin|mesh-list
92739864|NCT00623285|Analgesics|analgesics|mesh-ancestor
92739865|NCT00623285|Sensory System Agents|sensory system agents|mesh-ancestor
92739866|NCT00623285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92739867|NCT00623285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739868|NCT00623285|Anticonvulsants|anticonvulsants|mesh-ancestor
92739869|NCT00623285|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92739870|NCT00623285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92739871|NCT00623285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739872|NCT00623285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92739876|NCT00623285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92739877|NCT01097044|Afamelanotide|afamelanotide|mesh-list
92739878|NCT01097044|Dermatologic Agents|dermatologic agents|mesh-ancestor
92739879|NCT01322009|Acetylcysteine|acetylcysteine|mesh-list
92739880|NCT01322009|Probenecid|probenecid|mesh-list
92739881|NCT01322009|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92739882|NCT01322009|Antiviral Agents|antiviral agents|mesh-ancestor
92739883|NCT01322009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739884|NCT01322009|Expectorants|expectorants|mesh-ancestor
92739885|NCT01322009|Respiratory System Agents|respiratory system agents|mesh-ancestor
92739886|NCT01322009|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92398650|NCT01398202|Vitamins|vitamins|mesh-ancestor
92739887|NCT01322009|Antioxidants|antioxidants|mesh-ancestor
92739888|NCT01322009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739889|NCT01322009|Protective Agents|protective agents|mesh-ancestor
92739890|NCT01322009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739891|NCT01322009|Antidotes|antidotes|mesh-ancestor
92739892|NCT01322009|Uricosuric Agents|uricosuric agents|mesh-ancestor
92739893|NCT01322009|Gout Suppressants|gout suppressants|mesh-ancestor
92739894|NCT01322009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739895|NCT01320683|Leucovorin|leucovorin|mesh-list
92739896|NCT01320683|Bevacizumab|bevacizumab|mesh-list
92739897|NCT01320683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92611260|NCT05594342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611261|NCT05594342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739899|NCT01320683|Oxaliplatin|oxaliplatin|mesh-list
92739900|NCT01320683|Irinotecan|irinotecan|mesh-list
92739901|NCT01320683|Antibodies|antibodies|mesh-list
92739902|NCT01320683|Immunoglobulins|immunoglobulins|mesh-list
92739903|NCT01320683|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92739904|NCT01320683|Levoleucovorin|levoleucovorin|mesh-list
92739905|NCT01320683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739906|NCT01320683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92739907|NCT01320683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92739908|NCT01320683|Growth Substances|growth substances|mesh-ancestor
92739909|NCT01320683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739910|NCT01320683|Growth Inhibitors|growth inhibitors|mesh-ancestor
92739911|NCT01320683|Immunologic Factors|immunologic factors|mesh-ancestor
92739912|NCT01320683|Antimetabolites|antimetabolites|mesh-ancestor
92739913|NCT01320683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739914|NCT01320683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92739915|NCT01320683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739916|NCT01320683|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92739917|NCT01320683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92739918|NCT01320683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739919|NCT01320683|Antidotes|antidotes|mesh-ancestor
92739920|NCT01320683|Protective Agents|protective agents|mesh-ancestor
92739921|NCT01320683|Vitamin B Complex|vitamin b complex|mesh-ancestor
92739922|NCT01320683|Vitamins|vitamins|mesh-ancestor
92739923|NCT01320683|Micronutrients|micronutrients|mesh-ancestor
92739924|NCT01320293|Adalimumab|adalimumab|mesh-list
92739925|NCT01320293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92739926|NCT01320293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739927|NCT01320293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92739928|NCT01318811|Heparin|heparin|mesh-list
92739929|NCT01318811|Calcium heparin|calcium heparin|mesh-list
92739930|NCT01318811|Anticoagulants|anticoagulants|mesh-ancestor
92739931|NCT01318811|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92739932|NCT01318811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92739933|NCT01318811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739934|NCT05644769|Lisinopril|lisinopril|mesh-list
92739935|NCT05644769|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92739936|NCT05644769|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739937|NCT05644769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739938|NCT05644769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739939|NCT05644769|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92739940|NCT05644769|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92739941|NCT05644769|Protective Agents|protective agents|mesh-ancestor
92739942|NCT05644769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739943|NCT05644691|Emollients|emollients|mesh-list
92739944|NCT05644691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92739945|NCT01093846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92739946|NCT01093846|Immunologic Factors|immunologic factors|mesh-ancestor
92739947|NCT01093846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739948|NCT01093534|Solifenacin Succinate|solifenacin succinate|mesh-list
92739949|NCT01093534|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92739953|NCT01093534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739954|NCT01093534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739955|NCT01093534|Urological Agents|urological agents|mesh-ancestor
92739956|NCT01314911|Oseltamivir|oseltamivir|mesh-list
92739957|NCT01314911|Antiviral Agents|antiviral agents|mesh-ancestor
92739958|NCT01314911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739959|NCT01314911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739960|NCT01314911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739961|NCT01093222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92739962|NCT01093222|Sorafenib|sorafenib|mesh-list
92739963|NCT01093222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739964|NCT01093222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92739965|NCT01093222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739966|NCT01093222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739967|NCT02878018|Hormones|hormones|mesh-list
92739968|NCT02878018|Adrenergic Agents|adrenergic agents|mesh-list
92739969|NCT02878018|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92739970|NCT02878018|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92739971|NCT02878018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739972|NCT02878018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611262|NCT05594342|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92611263|NCT05594342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92611264|NCT05594342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92739973|NCT02878018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739974|NCT02878018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739975|NCT02878018|Immunologic Factors|immunologic factors|mesh-ancestor
92739976|NCT02878018|Protease Inhibitors|protease inhibitors|mesh-ancestor
92739977|NCT02878018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739978|NCT01313663|Pemetrexed|pemetrexed|mesh-list
92739979|NCT01313663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739980|NCT01313663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739981|NCT01313663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739982|NCT01313663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92739983|NCT01313663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92739984|NCT01092832|Voriconazole|voriconazole|mesh-list
92739985|NCT01092832|Antifungal Agents|antifungal agents|mesh-ancestor
92739986|NCT01092832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739987|NCT01092832|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92739988|NCT01092832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92739989|NCT01092832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739990|NCT01092832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739991|NCT01092832|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92739992|NCT01092832|Hormone Antagonists|hormone antagonists|mesh-ancestor
92739993|NCT01092832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92739994|NCT01092832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739995|NCT01092832|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92739996|NCT02878564|Praziquantel|praziquantel|mesh-list
92739997|NCT02878564|Anthelmintics|anthelmintics|mesh-ancestor
92739998|NCT02878564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92739999|NCT02878564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740000|NCT04308070|Hemostatics|hemostatics|mesh-list
92740001|NCT04308070|Coagulants|coagulants|mesh-ancestor
92740002|NCT01313273|Ascorbic Acid|ascorbic acid|mesh-list
92740003|NCT01313273|Methyltestosterone|methyltestosterone|mesh-list
92740004|NCT01313273|Lanreotide|lanreotide|mesh-list
92740005|NCT01313273|Androgens|androgens|mesh-list
92740006|NCT01313273|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92740007|NCT01313273|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92740008|NCT01313273|Androgen Antagonists|androgen antagonists|mesh-list
92740009|NCT01313273|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
92740010|NCT01313273|Hormones|hormones|mesh-ancestor
92740011|NCT01313273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740012|NCT01313273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740013|NCT01313273|Antioxidants|antioxidants|mesh-ancestor
92740014|NCT01313273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740015|NCT01313273|Protective Agents|protective agents|mesh-ancestor
92740016|NCT01313273|Vitamins|vitamins|mesh-ancestor
92740017|NCT01313273|Micronutrients|micronutrients|mesh-ancestor
92740018|NCT01313273|Estrogens|estrogens|mesh-ancestor
92740019|NCT01313273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92740020|NCT01313273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740024|NCT01091974|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92740025|NCT01091974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740026|NCT01091974|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92740027|NCT01091974|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92740028|NCT01091974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92740029|NCT01091974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740030|NCT01313117|Thioctic Acid|thioctic acid|mesh-list
92740031|NCT01313117|Antioxidants|antioxidants|mesh-ancestor
92740032|NCT01313117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740033|NCT01313117|Protective Agents|protective agents|mesh-ancestor
92740034|NCT01313117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740035|NCT01313117|Vitamin B Complex|vitamin b complex|mesh-ancestor
92740036|NCT01313117|Vitamins|vitamins|mesh-ancestor
92740037|NCT01313117|Micronutrients|micronutrients|mesh-ancestor
92740038|NCT01091662|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92740039|NCT01091662|Anticonvulsants|anticonvulsants|mesh-ancestor
92740040|NCT01091662|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92740041|NCT01091662|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92740042|NCT01091662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611266|NCT05594342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682806|NCT00438113|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92740043|NCT01091662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740044|NCT01312961|Fluticasone|fluticasone|mesh-list
92740045|NCT01312961|Xhance|xhance|mesh-list
92740046|NCT01312961|Albuterol|albuterol|mesh-list
92740047|NCT01312961|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92740048|NCT01312961|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92740050|NCT01312961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740051|NCT01312961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92740052|NCT01312961|Autonomic Agents|autonomic agents|mesh-ancestor
92740053|NCT01312961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740054|NCT01312961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740055|NCT01312961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740056|NCT01312961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740057|NCT01312961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740058|NCT01312961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92740059|NCT01312961|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92740060|NCT01312961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92740061|NCT01312961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92740062|NCT01312961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92740063|NCT01312961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740064|NCT01312961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740065|NCT01312961|Tocolytic Agents|tocolytic agents|mesh-ancestor
92740066|NCT01312961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740067|NCT01312961|Immunologic Factors|immunologic factors|mesh-ancestor
92740068|NCT01312961|Glucocorticoids|glucocorticoids|mesh-ancestor
92740069|NCT01312961|Hormones|hormones|mesh-ancestor
92740070|NCT01312961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740071|NCT01312961|Sympathomimetics|sympathomimetics|mesh-ancestor
92740072|NCT00626158|Gemcitabine|gemcitabine|mesh-list
92740073|NCT00626158|Capecitabine|capecitabine|mesh-list
92740074|NCT00626158|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92740075|NCT00626158|Antimetabolites|antimetabolites|mesh-ancestor
92740076|NCT00626158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740077|NCT00626158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740078|NCT01310777|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92740079|NCT01310777|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92740080|NCT01310777|Brinzolamide|brinzolamide|mesh-list
92740081|NCT01310777|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92740082|NCT01310777|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92740083|NCT01310777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92740084|NCT01310777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92740085|NCT01310777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92740086|NCT01310777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92740087|NCT01310777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740088|NCT01310777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740089|NCT01310777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740090|NCT01310777|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92740091|NCT01310777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740092|NCT01309997|Rituximab|rituximab|mesh-list
92740099|NCT01309997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92740100|NCT01309997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740101|NCT01309997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740102|NCT01309841|Naloxegol|naloxegol|mesh-list
92740103|NCT01309841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92740104|NCT01309841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740105|NCT01309841|Sensory System Agents|sensory system agents|mesh-ancestor
92740106|NCT01309841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740107|NCT01308749|Oxytocin|oxytocin|mesh-list
92740108|NCT01308749|Oxytocics|oxytocics|mesh-ancestor
92740109|NCT01308749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740110|NCT01308749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740111|NCT01307891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92740112|NCT01307891|Paclitaxel|paclitaxel|mesh-list
92740113|NCT01307891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740114|NCT01307891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92740115|NCT01307891|Tubulin Modulators|tubulin modulators|mesh-ancestor
92740116|NCT01307891|Antimitotic Agents|antimitotic agents|mesh-ancestor
92740117|NCT01307891|Mitosis Modulators|mitosis modulators|mesh-ancestor
92682807|NCT00438113|Urological Agents|urological agents|mesh-ancestor
92682808|NCT00438152|Ritonavir|ritonavir|mesh-list
92740118|NCT01307891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740119|NCT05644301|Minocycline|minocycline|mesh-list
92740120|NCT05644301|Celecoxib|celecoxib|mesh-list
92740121|NCT05644301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92740122|NCT05644301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740123|NCT05644301|Analgesics|analgesics|mesh-ancestor
92740124|NCT05644301|Sensory System Agents|sensory system agents|mesh-ancestor
92740125|NCT05644301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740126|NCT05644301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740127|NCT05644301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740128|NCT05644301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740129|NCT05644301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92740130|NCT05644301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92740131|NCT05644301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740132|NCT05644301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740133|NCT05644301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740134|NCT05644301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740135|NCT02890745|Empagliflozin|empagliflozin|mesh-list
92740136|NCT02890745|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92740137|NCT02890745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740138|NCT02890745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92740139|NCT02890745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740140|NCT01307579|Fluconazole|fluconazole|mesh-list
92740141|NCT01307579|Caspofungin|caspofungin|mesh-list
92740142|NCT01307579|Antifungal Agents|antifungal agents|mesh-ancestor
92740143|NCT01307579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740144|NCT01307579|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92740145|NCT01307579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740146|NCT01307579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740147|NCT01307579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740148|NCT01307579|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92740149|NCT01307579|Hormone Antagonists|hormone antagonists|mesh-ancestor
92740150|NCT01307579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740151|NCT01307579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740152|NCT01307579|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92740153|NCT01307579|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92740155|NCT01057693|Analgesics|analgesics|mesh-ancestor
92740156|NCT01057693|Sensory System Agents|sensory system agents|mesh-ancestor
92740157|NCT01057693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740158|NCT01057693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740159|NCT01057693|Anticonvulsants|anticonvulsants|mesh-ancestor
92740165|NCT01057693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92740166|NCT01057693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740167|NCT01057693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92740168|NCT04325009|Atorvastatin|atorvastatin|mesh-list
92740169|NCT04325009|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92740170|NCT04325009|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92740171|NCT04325009|Antimetabolites|antimetabolites|mesh-ancestor
92740172|NCT04325009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740173|NCT04325009|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92740174|NCT04325009|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92740175|NCT04325009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740176|NCT01034137|Methotrexate|methotrexate|mesh-list
92740177|NCT01034137|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92740178|NCT01034137|Abortifacient Agents|abortifacient agents|mesh-ancestor
92740179|NCT01034137|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740180|NCT01034137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740181|NCT01034137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92740182|NCT01034137|Antimetabolites|antimetabolites|mesh-ancestor
92740183|NCT01034137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740184|NCT01034137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740185|NCT01034137|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740186|NCT01034137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740187|NCT01034137|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92740188|NCT01034137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740189|NCT01034137|Immunologic Factors|immunologic factors|mesh-ancestor
92740190|NCT01034137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611267|NCT05594342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611268|NCT05594342|Protective Agents|protective agents|mesh-ancestor
92611269|NCT00157053|Factor VIII|factor viii|mesh-list
92611270|NCT00157053|Coagulants|coagulants|mesh-ancestor
92740192|NCT04302805|Thymoglobulin|thymoglobulin|mesh-list
92740193|NCT04302805|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92740194|NCT04302805|Immunologic Factors|immunologic factors|mesh-ancestor
92740195|NCT04302805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740196|NCT04302805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740197|NCT01056289|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92740198|NCT01056289|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92740199|NCT01056289|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92740200|NCT01056289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92740201|NCT01056289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740202|NCT01056289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740203|NCT01056289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740204|NCT01056289|Antidepressive Agents|antidepressive agents|mesh-ancestor
92740205|NCT01056289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92740206|NCT02875093|Cytarabine|cytarabine|mesh-list
92740207|NCT02875093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92740208|NCT02875093|Antimetabolites|antimetabolites|mesh-ancestor
92740209|NCT02875093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740210|NCT02875093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740211|NCT02875093|Antiviral Agents|antiviral agents|mesh-ancestor
92740212|NCT02875093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740213|NCT02875093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740214|NCT02875093|Immunologic Factors|immunologic factors|mesh-ancestor
92740215|NCT02875093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740216|NCT01033825|Ciclesonide|ciclesonide|mesh-list
92740217|NCT01033825|Dexamethasone|dexamethasone|mesh-list
92740218|NCT01033825|Dexamethasone acetate|dexamethasone acetate|mesh-list
92740219|NCT01033825|BB 1101|bb 1101|mesh-list
92740220|NCT01033825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740221|NCT01033825|Antiemetics|antiemetics|mesh-ancestor
92740222|NCT01033825|Autonomic Agents|autonomic agents|mesh-ancestor
92740223|NCT01033825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740224|NCT01033825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740225|NCT01033825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740226|NCT01033825|Glucocorticoids|glucocorticoids|mesh-ancestor
92740227|NCT01033825|Hormones|hormones|mesh-ancestor
92740230|NCT01033825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740232|NCT01033825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740233|NCT01033825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740234|NCT01033825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92740235|NCT01033747|Deferasirox|deferasirox|mesh-list
92740236|NCT01033747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92740237|NCT01033747|Chelating Agents|chelating agents|mesh-ancestor
92740238|NCT01033747|Sequestering Agents|sequestering agents|mesh-ancestor
92740239|NCT01033747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740240|NCT02875015|Lidocaine|lidocaine|mesh-list
92740241|NCT02875015|Bupivacaine|bupivacaine|mesh-list
92740242|NCT02875015|Anesthetics, Local|anesthetics, local|mesh-ancestor
92740243|NCT02875015|Anesthetics|anesthetics|mesh-ancestor
92740244|NCT02875015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740245|NCT02875015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740246|NCT02875015|Sensory System Agents|sensory system agents|mesh-ancestor
92740247|NCT02875015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740248|NCT02875015|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92740249|NCT02875015|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92740250|NCT02875015|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92740251|NCT02875015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063175|NCT04414995|Acetaminophen|acetaminophen|mesh-list
92740252|NCT02875015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740253|NCT01091428|Paclitaxel|paclitaxel|mesh-list
92740254|NCT01091428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92740255|NCT01091428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740256|NCT01091428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92740257|NCT01091428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92740258|NCT01091428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92740259|NCT01091428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740260|NCT01096342|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
92611272|NCT00507793|Sirolimus|sirolimus|mesh-list
92611273|NCT00507793|Cyclosporins|cyclosporins|mesh-list
92611274|NCT00507793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740261|NCT01096342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92740262|NCT01096342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740263|NCT01096342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740264|NCT01096186|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92740265|NCT01096186|Carbidopa|carbidopa|mesh-list
92740266|NCT01096186|Levodopa|levodopa|mesh-list
92740267|NCT01096186|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92740268|NCT01096186|Immunologic Factors|immunologic factors|mesh-ancestor
92740269|NCT01096186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740270|NCT01096186|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92740271|NCT01096186|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92740272|NCT01096186|Dopamine Agonists|dopamine agonists|mesh-ancestor
92740273|NCT01096186|Dopamine Agents|dopamine agents|mesh-ancestor
92740274|NCT01096186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740275|NCT01096186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740276|NCT01096186|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92740277|NCT01096186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740278|NCT01032889|Deoxycholic Acid|deoxycholic acid|mesh-list
92740279|NCT01032889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92740280|NCT01032889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740281|NCT01049503|Fluorides|fluorides|mesh-list
92740282|NCT01049503|Cariostatic Agents|cariostatic agents|mesh-ancestor
92740283|NCT01049503|Protective Agents|protective agents|mesh-ancestor
92740284|NCT01049503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740285|NCT04302649|Dialysis Solutions|dialysis solutions|mesh-list
92740286|NCT04302649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92740287|NCT04301557|Capecitabine|capecitabine|mesh-list
92740288|NCT04301557|Oxaliplatin|oxaliplatin|mesh-list
92740289|NCT04301557|Antibodies|antibodies|mesh-list
92740290|NCT04301557|Immunologic Factors|immunologic factors|mesh-ancestor
92740291|NCT04301557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740292|NCT04301557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92740293|NCT04301557|Antimetabolites|antimetabolites|mesh-ancestor
92740294|NCT04301557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740295|NCT04301557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740296|NCT02874313|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92740297|NCT02874313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740301|NCT01029535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740302|NCT01029535|Viscosupplements|viscosupplements|mesh-ancestor
92740303|NCT01029535|Protective Agents|protective agents|mesh-ancestor
92740304|NCT04301323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92740305|NCT04301323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92740306|NCT01028053|Flutemetamol|flutemetamol|mesh-list
92740307|NCT01028053|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92740308|NCT01028053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740309|NCT01023217|Lamivudine|lamivudine|mesh-list
92740310|NCT01023217|Adefovir|adefovir|mesh-list
92740311|NCT01023217|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92740312|NCT01023217|Entecavir|entecavir|mesh-list
92740313|NCT01023217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92740314|NCT01023217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92740315|NCT01023217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740316|NCT01023217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740317|NCT01023217|Antiviral Agents|antiviral agents|mesh-ancestor
92740318|NCT01023217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740319|NCT01023217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92740320|NCT01023217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92750781|NCT05935202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740321|NCT01095796|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92740322|NCT01095796|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92740323|NCT01095796|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92740324|NCT01095796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92740325|NCT01095796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611275|NCT00507793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682809|NCT00438152|Lopinavir|lopinavir|mesh-list
92740326|NCT01095796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740327|NCT01095796|Antiviral Agents|antiviral agents|mesh-ancestor
92740328|NCT01095796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740329|NCT01095796|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92740330|NCT01095796|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92740331|NCT01023061|Prednisone|prednisone|mesh-list
92740332|NCT01023061|Leuprolide|leuprolide|mesh-list
92740333|NCT01023061|Goserelin|goserelin|mesh-list
92740334|NCT01023061|Abiraterone Acetate|abiraterone acetate|mesh-list
92740335|NCT01023061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740336|NCT01023061|Glucocorticoids|glucocorticoids|mesh-ancestor
92740337|NCT01023061|Hormones|hormones|mesh-ancestor
92740338|NCT01023061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740339|NCT01023061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740340|NCT01023061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92740341|NCT01023061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740342|NCT01023061|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92740343|NCT01023061|Fertility Agents|fertility agents|mesh-ancestor
92740344|NCT01023061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740345|NCT01023061|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92740346|NCT01023061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740347|NCT01023061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740348|NCT01023061|Hormone Antagonists|hormone antagonists|mesh-ancestor
92740349|NCT01023061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740350|NCT01027897|Doripenem|doripenem|mesh-list
92740351|NCT01027897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740352|NCT01027897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740353|NCT01027351|Vaccines|vaccines|mesh-list
92740354|NCT01027351|Immunologic Factors|immunologic factors|mesh-ancestor
92740355|NCT01027351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740356|NCT05661045|Anesthetics|anesthetics|mesh-list
92740357|NCT05661045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740358|NCT05661045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740360|NCT01294683|Niacinamide|niacinamide|mesh-list
92740361|NCT01294683|Nicotinic Acids|nicotinic acids|mesh-list
92740362|NCT01294683|Simvastatin|simvastatin|mesh-list
92740363|NCT01294683|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92740364|NCT01294683|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92740365|NCT01294683|Antimetabolites|antimetabolites|mesh-ancestor
92740366|NCT01294683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740367|NCT01294683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92740368|NCT01294683|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92740369|NCT01294683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740370|NCT01294683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92740371|NCT01294683|Vitamin B Complex|vitamin b complex|mesh-ancestor
92740372|NCT01294683|Vitamins|vitamins|mesh-ancestor
92740373|NCT01294683|Micronutrients|micronutrients|mesh-ancestor
92740374|NCT01294683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740375|NCT01294449|Cytarabine|cytarabine|mesh-list
92740376|NCT01294449|Dexamethasone|dexamethasone|mesh-list
92740377|NCT01294449|Methotrexate|methotrexate|mesh-list
92740378|NCT01294449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92740379|NCT01294449|Antimetabolites|antimetabolites|mesh-ancestor
92740380|NCT01294449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740381|NCT01294449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740382|NCT01294449|Antiviral Agents|antiviral agents|mesh-ancestor
92740383|NCT01294449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740384|NCT01294449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740385|NCT01294449|Immunologic Factors|immunologic factors|mesh-ancestor
92740386|NCT01294449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740387|NCT01294449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740388|NCT01294449|Antiemetics|antiemetics|mesh-ancestor
92740389|NCT01294449|Autonomic Agents|autonomic agents|mesh-ancestor
92740390|NCT01294449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740391|NCT01294449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611276|NCT00507793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740392|NCT01294449|Glucocorticoids|glucocorticoids|mesh-ancestor
92740393|NCT01294449|Hormones|hormones|mesh-ancestor
92740394|NCT01294449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740395|NCT01294449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92740396|NCT01294449|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92740397|NCT01294449|Abortifacient Agents|abortifacient agents|mesh-ancestor
92740398|NCT01294449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740399|NCT01294449|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740400|NCT01294449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740401|NCT01294449|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92740402|NCT01294449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740403|NCT01294449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92740404|NCT01293123|Tenofovir|tenofovir|mesh-list
92740405|NCT01293123|Emtricitabine|emtricitabine|mesh-list
92740406|NCT01293123|Efavirenz|efavirenz|mesh-list
92740407|NCT01293123|Raltegravir Potassium|raltegravir potassium|mesh-list
92740408|NCT01293123|Antiviral Agents|antiviral agents|mesh-ancestor
92740409|NCT01293123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740410|NCT01293123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92740411|NCT01293123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92740412|NCT01293123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740413|NCT01293123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740414|NCT01293123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92740415|NCT01293123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92740416|NCT01293123|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92740417|NCT01293123|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740418|NCT01293123|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92740419|NCT01293123|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92740420|NCT01293123|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92740421|NCT01293123|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92740422|NCT01293123|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92740423|NCT01293123|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92740424|NCT01292187|Calcitonin|calcitonin|mesh-list
92740425|NCT01292187|Salmon calcitonin|salmon calcitonin|mesh-list
92740426|NCT01292187|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92740427|NCT01292187|Katacalcin|katacalcin|mesh-list
92740428|NCT01292187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92740430|NCT01292187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92740431|NCT01292187|Vasodilator Agents|vasodilator agents|mesh-ancestor
92740432|NCT01026493|Temozolomide|temozolomide|mesh-list
92740433|NCT01026493|Veliparib|veliparib|mesh-list
92740434|NCT01026493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92740435|NCT01026493|Alkylating Agents|alkylating agents|mesh-ancestor
92740436|NCT01026493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740437|NCT01026493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740438|NCT01026493|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92740439|NCT01026493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740440|NCT01291173|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92740441|NCT01291173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92740442|NCT01291173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740443|NCT01291173|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92740444|NCT01291173|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92740445|NCT01291173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92740446|NCT01291173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740447|NCT01291173|Dopamine Agents|dopamine agents|mesh-ancestor
92740448|NCT01291173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740449|NCT01291017|Palbociclib|palbociclib|mesh-list
92740450|NCT01291017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740451|NCT01291017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92740452|NCT01291017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740453|NCT01291017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740454|NCT01290315|Dextrans|dextrans|mesh-list
92740455|NCT01290315|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92063396|NCT04027192|Midazolam|midazolam|mesh-list
92611277|NCT00507793|Immunologic Factors|immunologic factors|mesh-ancestor
92611278|NCT00507793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611279|NCT00507793|Antifungal Agents|antifungal agents|mesh-ancestor
92611280|NCT00507793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740456|NCT01290315|Iron-Dextran Complex|iron-dextran complex|mesh-list
92740457|NCT01290315|Hematinics|hematinics|mesh-ancestor
92740458|NCT01290315|Anticoagulants|anticoagulants|mesh-ancestor
92740459|NCT01290315|Plasma Substitutes|plasma substitutes|mesh-ancestor
92740460|NCT01290315|Blood Substitutes|blood substitutes|mesh-ancestor
92740461|NCT01289847|gamma-Globulins|gamma-globulins|mesh-list
92740462|NCT01289847|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92740463|NCT01289847|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92740464|NCT01289847|Immunologic Factors|immunologic factors|mesh-ancestor
92740465|NCT01289847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740466|NCT01021813|Suvorexant|suvorexant|mesh-list
92740467|NCT01021813|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92740468|NCT01021813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92740469|NCT01021813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740470|NCT01021813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740471|NCT01021813|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92740472|NCT01021813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740473|NCT01021813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740474|NCT01025635|Azelaic acid|azelaic acid|mesh-list
92740475|NCT01025635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740476|NCT01025635|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740477|NCT01021423|Lenalidomide|lenalidomide|mesh-list
92740478|NCT01021423|Immunologic Factors|immunologic factors|mesh-ancestor
92740479|NCT01021423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740480|NCT01021423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92740481|NCT01021423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92740482|NCT01021423|Growth Substances|growth substances|mesh-ancestor
92740483|NCT01021423|Growth Inhibitors|growth inhibitors|mesh-ancestor
92740484|NCT01021423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740485|NCT01020877|Metronidazole|metronidazole|mesh-list
92740486|NCT01020877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740487|NCT01020877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740488|NCT01020877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92740489|NCT01020877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92740490|NCT01020799|Escitalopram|escitalopram|mesh-list
92740491|NCT01020799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92740492|NCT01020799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92740493|NCT01020799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92740494|NCT01020799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740495|NCT01020799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740496|NCT01020799|Serotonin Agents|serotonin agents|mesh-ancestor
92740497|NCT01020799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740498|NCT02872597|Dexamethasone|dexamethasone|mesh-list
92740499|NCT02872597|Prednisone|prednisone|mesh-list
92740500|NCT02872597|Methylprednisolone|methylprednisolone|mesh-list
92740507|NCT02872597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740508|NCT02872597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740509|NCT02872597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740510|NCT02872597|Glucocorticoids|glucocorticoids|mesh-ancestor
92740511|NCT02872597|Hormones|hormones|mesh-ancestor
92740512|NCT02872597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740513|NCT02872597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92740514|NCT02872597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740515|NCT02872597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740516|NCT02872597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92740517|NCT02872597|Protective Agents|protective agents|mesh-ancestor
92740518|NCT02872597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92740519|NCT02872597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740520|NCT02872597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740521|NCT02872597|Tocolytic Agents|tocolytic agents|mesh-ancestor
92740522|NCT02872597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740523|NCT02872597|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92740524|NCT02872597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92740525|NCT02872597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92740526|NCT02872597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92740527|NCT02872597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740528|NCT02872597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92611281|NCT00507793|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611282|NCT00507793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611283|NCT00507793|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92611284|NCT00507793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611285|NCT00507793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92740529|NCT02872597|Cholinergic Agents|cholinergic agents|mesh-ancestor
92740530|NCT02873065|Amoxicillin|amoxicillin|mesh-list
92740531|NCT02873065|Clarithromycin|clarithromycin|mesh-list
92740532|NCT02873065|Potassium Citrate|potassium citrate|mesh-list
92740533|NCT02873065|Bismuth|bismuth|mesh-list
92740534|NCT02873065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740535|NCT02873065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740536|NCT02873065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740537|NCT02873065|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92740538|NCT02873065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740539|NCT02873065|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92740540|NCT02873065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740541|NCT02873065|Antacids|antacids|mesh-ancestor
92740542|NCT02873065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740543|NCT02873065|Diuretics|diuretics|mesh-ancestor
92740544|NCT02873065|Natriuretic Agents|natriuretic agents|mesh-ancestor
92740545|NCT02873065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740546|NCT02873065|Expectorants|expectorants|mesh-ancestor
92740547|NCT02873065|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740548|NCT00628225|Bupropion|bupropion|mesh-list
92740549|NCT00628225|Nicotine|nicotine|mesh-list
92740550|NCT00628225|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92740551|NCT00628225|Autonomic Agents|autonomic agents|mesh-ancestor
92740552|NCT00628225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740553|NCT00628225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740554|NCT00628225|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92740555|NCT00628225|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92740556|NCT00628225|Cholinergic Agents|cholinergic agents|mesh-ancestor
92740557|NCT00628225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740558|NCT00628225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740559|NCT00628225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92740560|NCT00628225|Antidepressive Agents|antidepressive agents|mesh-ancestor
92740561|NCT00628225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92740562|NCT00628225|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92740563|NCT00628225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92740564|NCT00628225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92740565|NCT00628225|Dopamine Agents|dopamine agents|mesh-ancestor
92740566|NCT00628225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92740567|NCT00628225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740568|NCT00628225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740569|NCT01014013|Ceftriaxone|ceftriaxone|mesh-list
92740570|NCT01014013|Ertapenem|ertapenem|mesh-list
92740571|NCT01014013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740574|NCT01013701|Xhance|xhance|mesh-list
92740575|NCT01013701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740576|NCT01013701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92740577|NCT01013701|Autonomic Agents|autonomic agents|mesh-ancestor
92740578|NCT01013701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740579|NCT01013701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740580|NCT01013701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740581|NCT01013701|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740582|NCT01013701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740583|NCT01013701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92740584|NCT01020019|Lofexidine|lofexidine|mesh-list
92740585|NCT01020019|Dronabinol|dronabinol|mesh-list
92740586|NCT01020019|Hallucinogens|hallucinogens|mesh-ancestor
92740587|NCT01020019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740588|NCT01020019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92740589|NCT01020019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740590|NCT01020019|Analgesics|analgesics|mesh-ancestor
92740591|NCT01020019|Sensory System Agents|sensory system agents|mesh-ancestor
92740592|NCT01020019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740593|NCT01020019|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92740594|NCT01020019|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92740595|NCT01020019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750782|NCT05935059|Pregabalin|pregabalin|mesh-list
92740596|NCT01020019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611286|NCT00507793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611287|NCT00507832|Hydrocortisone|hydrocortisone|mesh-list
92611288|NCT00507832|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92611289|NCT00507832|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92611290|NCT00507832|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92611291|NCT00507832|Pimecrolimus|pimecrolimus|mesh-list
92611292|NCT00507832|Tacrolimus|tacrolimus|mesh-list
92611293|NCT00507832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611294|NCT00507832|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611295|NCT00507832|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611296|NCT00507832|Analgesics|analgesics|mesh-ancestor
92611297|NCT00507832|Sensory System Agents|sensory system agents|mesh-ancestor
92611298|NCT00507832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611299|NCT00507832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018355|NCT03053869|Diazepam|diazepam|mesh-list
92740597|NCT01020019|Hormones|hormones|mesh-ancestor
92740598|NCT01020019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740599|NCT01020019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92740600|NCT01020019|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92740601|NCT01020019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92740602|NCT01020019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92740603|NCT01020019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92740604|NCT01020019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92740605|NCT00627835|Cisplatin|cisplatin|mesh-list
92740606|NCT00627835|Sorafenib|sorafenib|mesh-list
92740607|NCT00627835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740608|NCT00627835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92740609|NCT00627835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740610|NCT00627835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740611|NCT01019317|Cytarabine|cytarabine|mesh-list
92740612|NCT01019317|Fludarabine|fludarabine|mesh-list
92740613|NCT01019317|Fludarabine phosphate|fludarabine phosphate|mesh-list
92740614|NCT01019317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740615|NCT01019317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92740616|NCT01019317|Antimetabolites|antimetabolites|mesh-ancestor
92740617|NCT01019317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740618|NCT01019317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740619|NCT01019317|Immunologic Factors|immunologic factors|mesh-ancestor
92740620|NCT01019317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740622|NCT01019317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740623|NCT02877238|Sevoflurane|sevoflurane|mesh-list
92740624|NCT02877238|Anesthetics|anesthetics|mesh-ancestor
92740625|NCT02877238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740626|NCT02877238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740627|NCT02877238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92740628|NCT02877238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92740629|NCT02877238|Anesthetics, General|anesthetics, general|mesh-ancestor
92740630|NCT01288911|Bicalutamide|bicalutamide|mesh-list
92740631|NCT01288911|Androgen Antagonists|androgen antagonists|mesh-ancestor
92740632|NCT01288911|Hormone Antagonists|hormone antagonists|mesh-ancestor
92740633|NCT01288911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740634|NCT01288911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740635|NCT01288911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740636|NCT01288443|Atorvastatin|atorvastatin|mesh-list
92740637|NCT01288443|Alirocumab|alirocumab|mesh-list
92740638|NCT01288443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92740639|NCT01288443|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92740640|NCT01288443|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92740641|NCT01288443|Antimetabolites|antimetabolites|mesh-ancestor
92611300|NCT00507832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611301|NCT00507832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740642|NCT01288443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740643|NCT01288443|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92740644|NCT01288443|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92740645|NCT01288443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740649|NCT01288443|Immunologic Factors|immunologic factors|mesh-ancestor
92740650|NCT01288443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740651|NCT01288209|Ribavirin|ribavirin|mesh-list
92740652|NCT01288209|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92740653|NCT01288209|Simeprevir|simeprevir|mesh-list
92740654|NCT01288209|Antimetabolites|antimetabolites|mesh-ancestor
92740655|NCT01288209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740656|NCT01288209|Antiviral Agents|antiviral agents|mesh-ancestor
92740657|NCT01288209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740658|NCT01288209|Protease Inhibitors|protease inhibitors|mesh-ancestor
92740659|NCT01288209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740660|NCT01287195|Omeprazole|omeprazole|mesh-list
92740661|NCT01287195|Muromonab-CD3|muromonab-cd3|mesh-list
92740662|NCT01287195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92740663|NCT01287195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740664|NCT01287195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92740665|NCT01287195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740666|NCT01287195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740667|NCT01287195|Immunologic Factors|immunologic factors|mesh-ancestor
92740668|NCT01287195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740669|NCT01287195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740670|NCT01287117|Omalizumab|omalizumab|mesh-list
92740671|NCT01287117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92740672|NCT01287117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740673|NCT01287117|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740674|NCT01287039|Reslizumab|reslizumab|mesh-list
92740675|NCT01287039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740676|NCT01287039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740677|NCT05572203|Caseins|caseins|mesh-list
92740678|NCT05572203|Chelating Agents|chelating agents|mesh-ancestor
92740679|NCT05572203|Sequestering Agents|sequestering agents|mesh-ancestor
92740680|NCT05572203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740681|NCT01285401|Interferons|interferons|mesh-list
92740682|NCT01285401|Interferon-beta|interferon-beta|mesh-list
92740683|NCT01285401|Interferon beta-1a|interferon beta-1a|mesh-list
92740684|NCT01285401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740685|NCT01285401|Antiviral Agents|antiviral agents|mesh-ancestor
92740686|NCT01285401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740687|NCT01285401|Immunologic Factors|immunologic factors|mesh-ancestor
92740688|NCT01285401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740689|NCT01285401|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92740690|NCT01285323|Reslizumab|reslizumab|mesh-list
92740691|NCT01285323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740692|NCT01285323|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740693|NCT01284621|Empagliflozin|empagliflozin|mesh-list
92740694|NCT01284621|Ramipril|ramipril|mesh-list
92740695|NCT01284621|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92740696|NCT01284621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92740697|NCT01284621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740698|NCT01284621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740699|NCT01284621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92740700|NCT01284621|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92740701|NCT01284621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92740702|NCT01284621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740704|NCT01283139|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92740705|NCT01283139|Immunologic Factors|immunologic factors|mesh-ancestor
92740706|NCT01283139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740707|NCT01281969|Immunoglobulins|immunoglobulins|mesh-list
92740708|NCT01281969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92740709|NCT01281969|Antibodies|antibodies|mesh-list
92740710|NCT01281969|gamma-Globulins|gamma-globulins|mesh-list
92740711|NCT01281969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92740712|NCT01281969|Immunologic Factors|immunologic factors|mesh-ancestor
92740713|NCT01281969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740714|NCT01281813|Ritonavir|ritonavir|mesh-list
92740715|NCT01281813|Darunavir|darunavir|mesh-list
92740716|NCT01281813|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92740717|NCT01281813|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92611302|NCT00507832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611303|NCT00507832|Immunologic Factors|immunologic factors|mesh-ancestor
92611304|NCT00507832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92611305|NCT00507832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611306|NCT00507832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740718|NCT01281813|Protease Inhibitors|protease inhibitors|mesh-ancestor
92740719|NCT01281813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740720|NCT01281813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740724|NCT01281813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740725|NCT01281813|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92740726|NCT01281813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740728|NCT01090414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740729|NCT01090414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740730|NCT01090414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740731|NCT01090102|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92740732|NCT01090102|Mesalamine|mesalamine|mesh-list
92740733|NCT01090102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92740734|NCT01090102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740735|NCT01090102|Analgesics|analgesics|mesh-ancestor
92740736|NCT01090102|Sensory System Agents|sensory system agents|mesh-ancestor
92740737|NCT01090102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740738|NCT01090102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740739|NCT01090102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740740|NCT01090102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740741|NCT01090102|Antitubercular Agents|antitubercular agents|mesh-ancestor
92740742|NCT01090102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740743|NCT01090102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740744|NCT01281189|Pramipexole|pramipexole|mesh-list
92740745|NCT01281189|Antioxidants|antioxidants|mesh-ancestor
92740746|NCT01281189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740747|NCT01281189|Protective Agents|protective agents|mesh-ancestor
92740748|NCT01281189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740749|NCT01281189|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92740750|NCT01281189|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92740751|NCT01281189|Dopamine Agonists|dopamine agonists|mesh-ancestor
92740752|NCT01281189|Dopamine Agents|dopamine agents|mesh-ancestor
92740753|NCT01281189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740754|NCT04306666|Anesthetics|anesthetics|mesh-list
92740755|NCT04306666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740756|NCT04306666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740757|NCT01280955|Plerixafor|plerixafor|mesh-list
92740758|NCT01280955|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92740759|NCT01280955|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92740760|NCT01280955|Antiviral Agents|antiviral agents|mesh-ancestor
92740761|NCT01280955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740762|NCT01280721|Tolvaptan|tolvaptan|mesh-list
92740763|NCT01280721|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92740764|NCT01280721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740765|NCT01280721|Natriuretic Agents|natriuretic agents|mesh-ancestor
92740766|NCT01280721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740767|NCT01087762|Certolizumab Pegol|certolizumab pegol|mesh-list
92740768|NCT01087762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92740769|NCT01087762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740770|NCT01087762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740771|NCT01087762|Immunologic Factors|immunologic factors|mesh-ancestor
92740772|NCT01087762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740773|NCT01087762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740774|NCT04306354|Oxytocin|oxytocin|mesh-list
92740775|NCT04306354|Oxytocics|oxytocics|mesh-ancestor
92740776|NCT04306354|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740777|NCT04306354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740778|NCT04306276|Dienogest|dienogest|mesh-list
92740779|NCT04306276|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92740780|NCT04306276|Contraceptive Agents|contraceptive agents|mesh-ancestor
92740781|NCT04306276|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740782|NCT04306276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740783|NCT04306276|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92740784|NCT04306276|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92611307|NCT00507949|Megestrol|megestrol|mesh-list
92611308|NCT00507949|Megestrol Acetate|megestrol acetate|mesh-list
92611309|NCT00507949|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92740785|NCT04306276|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92740786|NCT04306276|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92740787|NCT04306276|Hormone Antagonists|hormone antagonists|mesh-ancestor
92740788|NCT04306276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740789|NCT04306276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92740790|NCT04306276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740791|NCT01078168|Acitretin|acitretin|mesh-list
92740792|NCT01078168|Keratolytic Agents|keratolytic agents|mesh-ancestor
92740795|NCT01086358|Sumatriptan|sumatriptan|mesh-list
92740796|NCT01086358|Naratriptan|naratriptan|mesh-list
92740797|NCT01086358|Zolmitriptan|zolmitriptan|mesh-list
92740798|NCT01086358|Rizatriptan|rizatriptan|mesh-list
92740799|NCT01086358|Eletriptan|eletriptan|mesh-list
92740800|NCT01086358|Almotriptan|almotriptan|mesh-list
92740801|NCT01086358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92740802|NCT01086358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740803|NCT01086358|Analgesics|analgesics|mesh-ancestor
92740804|NCT01086358|Sensory System Agents|sensory system agents|mesh-ancestor
92740805|NCT01086358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740806|NCT01086358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740807|NCT01086358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740808|NCT01086358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740809|NCT01086358|Gout Suppressants|gout suppressants|mesh-ancestor
92740810|NCT01086358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92740811|NCT01086358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740812|NCT01086358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740813|NCT01086358|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92740814|NCT01086358|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92740815|NCT01086358|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92740816|NCT01086358|Serotonin Agents|serotonin agents|mesh-ancestor
92740817|NCT01086358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740818|NCT01277601|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92740819|NCT01277601|Antiviral Agents|antiviral agents|mesh-ancestor
92740820|NCT01277601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740821|NCT01277523|Tiotropium Bromide|tiotropium bromide|mesh-list
92740822|NCT01277523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92740823|NCT01277523|Autonomic Agents|autonomic agents|mesh-ancestor
92740824|NCT01277523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740825|NCT01277523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740826|NCT01277523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740827|NCT01277523|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740828|NCT01277523|Parasympatholytics|parasympatholytics|mesh-ancestor
92740829|NCT01277523|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92740830|NCT01277523|Cholinergic Agents|cholinergic agents|mesh-ancestor
92740831|NCT01277523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740832|NCT01277523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740833|NCT01081834|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92740834|NCT01081834|Canagliflozin|canagliflozin|mesh-list
92740835|NCT01081834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92740836|NCT01081834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740837|NCT01081834|Incretins|incretins|mesh-ancestor
92740838|NCT01081834|Hormones|hormones|mesh-ancestor
92740839|NCT01081834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740840|NCT01081834|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92740841|NCT01081834|Protease Inhibitors|protease inhibitors|mesh-ancestor
92740842|NCT01081834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740843|NCT01081834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740844|NCT01081834|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92740845|NCT01079962|Atenolol|atenolol|mesh-list
92740846|NCT01079962|Bisoprolol|bisoprolol|mesh-list
92740847|NCT01079962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92740848|NCT01079962|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92740849|NCT01079962|Sympatholytics|sympatholytics|mesh-ancestor
92740850|NCT01079962|Autonomic Agents|autonomic agents|mesh-ancestor
92740851|NCT01079962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740852|NCT01079962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740853|NCT01079962|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92740854|NCT01079962|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92740855|NCT01079962|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92611310|NCT00507949|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92611311|NCT00507949|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92611312|NCT00507949|Contraceptive Agents|contraceptive agents|mesh-ancestor
92740856|NCT01079962|Adrenergic Agents|adrenergic agents|mesh-ancestor
92740857|NCT01079962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740858|NCT01079962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740859|NCT01274637|Dalteparin|dalteparin|mesh-list
92740860|NCT01274637|Tinzaparin|tinzaparin|mesh-list
92740861|NCT01274637|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92740862|NCT01274637|Anticoagulants|anticoagulants|mesh-ancestor
92740863|NCT01274637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92740864|NCT01274637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92740865|NCT01274637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740866|NCT01079806|Entecavir|entecavir|mesh-list
92740869|NCT02876770|Melatonin|melatonin|mesh-list
92740870|NCT02876770|Antioxidants|antioxidants|mesh-ancestor
92740871|NCT02876770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740872|NCT02876770|Protective Agents|protective agents|mesh-ancestor
92740873|NCT02876770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740874|NCT02876770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740875|NCT01077622|Ofatumumab|ofatumumab|mesh-list
92740876|NCT01077622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740877|NCT01313676|Fluticasone|fluticasone|mesh-list
92740879|NCT01313676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740880|NCT01313676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92740881|NCT01313676|Autonomic Agents|autonomic agents|mesh-ancestor
92740882|NCT01313676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740883|NCT01313676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740884|NCT01313676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92740885|NCT01313676|Respiratory System Agents|respiratory system agents|mesh-ancestor
92740886|NCT01313676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740887|NCT01313676|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92740888|NCT00623376|Dronabinol|dronabinol|mesh-list
92740889|NCT00623376|Nabilone|nabilone|mesh-list
92740890|NCT00623376|Antiemetics|antiemetics|mesh-ancestor
92740891|NCT00623376|Autonomic Agents|autonomic agents|mesh-ancestor
92740892|NCT00623376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740893|NCT00623376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740894|NCT00623376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740895|NCT00623376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92740896|NCT00623376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92740897|NCT00623376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740898|NCT00623376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92740899|NCT00623376|Hallucinogens|hallucinogens|mesh-ancestor
92740900|NCT00623376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740901|NCT00623376|Analgesics|analgesics|mesh-ancestor
92740902|NCT00623376|Sensory System Agents|sensory system agents|mesh-ancestor
92740903|NCT00623376|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92740904|NCT00623376|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92740905|NCT00623376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740906|NCT00623376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740907|NCT00623376|Hormones|hormones|mesh-ancestor
92740908|NCT00623376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740909|NCT01313286|Globalagliatin|globalagliatin|mesh-list
92740910|NCT01313286|Enzyme Activators|enzyme activators|mesh-ancestor
92740911|NCT01313286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740912|NCT01313208|Etanercept|etanercept|mesh-list
92740913|NCT01313208|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92740914|NCT01313208|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740915|NCT01313208|Analgesics|analgesics|mesh-ancestor
92740916|NCT01313208|Sensory System Agents|sensory system agents|mesh-ancestor
92740917|NCT01313208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740918|NCT01313208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740919|NCT01313208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740920|NCT01313208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740921|NCT01313208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92740922|NCT01313208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92740923|NCT01313208|Immunologic Factors|immunologic factors|mesh-ancestor
92740925|NCT01075984|Antifungal Agents|antifungal agents|mesh-ancestor
92740926|NCT01075984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740927|NCT01075984|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92740928|NCT01075984|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92740929|NCT01075984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92611313|NCT00507949|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92740930|NCT01075984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92740931|NCT01075984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92740932|NCT01075984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740933|NCT01075984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740934|NCT01075984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92740935|NCT01075984|Hormone Antagonists|hormone antagonists|mesh-ancestor
92740936|NCT01075984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740937|NCT01075984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740938|NCT01024231|Nivolumab|nivolumab|mesh-list
92740939|NCT01024231|Ipilimumab|ipilimumab|mesh-list
92740940|NCT01024231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92740943|NCT01024231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740945|NCT01012999|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92740946|NCT01012999|Narcotics|narcotics|mesh-ancestor
92740947|NCT01012999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92740948|NCT01012999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740949|NCT01012999|Analgesics|analgesics|mesh-ancestor
92740950|NCT01012999|Sensory System Agents|sensory system agents|mesh-ancestor
92740951|NCT01012999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740952|NCT01012999|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92740953|NCT01012999|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92740954|NCT01012999|Anesthetics, General|anesthetics, general|mesh-ancestor
92740955|NCT01012999|Anesthetics|anesthetics|mesh-ancestor
92740956|NCT00637663|Lamivudine|lamivudine|mesh-list
92740957|NCT00637663|Entecavir|entecavir|mesh-list
92740958|NCT00637663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92740959|NCT00637663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92740960|NCT00637663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740961|NCT00637663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740962|NCT00637663|Antiviral Agents|antiviral agents|mesh-ancestor
92740963|NCT00637663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740964|NCT00637663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92740965|NCT00637663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92740966|NCT01016977|Nicotinic Acids|nicotinic acids|mesh-list
92740967|NCT01016977|Clindamycin|clindamycin|mesh-list
92740968|NCT01016977|Clindamycin palmitate|clindamycin palmitate|mesh-list
92740969|NCT01016977|Clindamycin phosphate|clindamycin phosphate|mesh-list
92740970|NCT01016977|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92740971|NCT01016977|Tazarotene|tazarotene|mesh-list
92740972|NCT01016977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92740973|NCT01016977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740974|NCT01016977|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92740975|NCT01016977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92740976|NCT01016977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740977|NCT01016977|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740978|NCT01016977|Keratolytic Agents|keratolytic agents|mesh-ancestor
92740979|NCT01016977|Vitamin B Complex|vitamin b complex|mesh-ancestor
92740980|NCT01016977|Vitamins|vitamins|mesh-ancestor
92740981|NCT01016977|Micronutrients|micronutrients|mesh-ancestor
92740982|NCT01016977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740983|NCT02871661|Amitriptyline|amitriptyline|mesh-list
92740984|NCT02871661|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92740985|NCT02871661|Antidepressive Agents|antidepressive agents|mesh-ancestor
92740986|NCT02871661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92740987|NCT02871661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92740988|NCT02871661|Analgesics|analgesics|mesh-ancestor
92740989|NCT02871661|Sensory System Agents|sensory system agents|mesh-ancestor
92740990|NCT02871661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92740991|NCT02871661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740992|NCT02871661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92740993|NCT02871661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92740994|NCT02871661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611314|NCT00507949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740995|NCT02871661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740996|NCT02871661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92740997|NCT02871661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740998|NCT01012765|Tiotropium Bromide|tiotropium bromide|mesh-list
92740999|NCT01012765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92741000|NCT01012765|Autonomic Agents|autonomic agents|mesh-ancestor
92741001|NCT01012765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741002|NCT01012765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741003|NCT01012765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92741007|NCT01012765|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741008|NCT01012765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741009|NCT01012765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741010|NCT00628459|Micronutrients|micronutrients|mesh-list
92741011|NCT00628459|Trace Elements|trace elements|mesh-list
92741012|NCT00628459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741013|NCT00627913|Anesthetics|anesthetics|mesh-list
92741014|NCT00627913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741015|NCT00627913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741016|NCT00627991|Valsartan|valsartan|mesh-list
92741017|NCT00627991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92741018|NCT00627991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92741019|NCT00627991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92741020|NCT00627991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741021|NCT01006291|Insulin|insulin|mesh-list
92741022|NCT01006291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92741023|NCT01006291|Insulin Glargine|insulin glargine|mesh-list
92741024|NCT01006291|Insulin, Long-Acting|insulin, long-acting|mesh-list
92741025|NCT01006291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92741026|NCT01006291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741027|NCT04296175|Paclitaxel|paclitaxel|mesh-list
92741028|NCT04296175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92741029|NCT04296175|Carboplatin|carboplatin|mesh-list
92741030|NCT04296175|Epirubicin|epirubicin|mesh-list
92741031|NCT04296175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92741032|NCT04296175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741033|NCT04296175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92741034|NCT04296175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92741035|NCT04296175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92741036|NCT04296175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741037|NCT04296175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92741038|NCT04296175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92741039|NCT04296175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92741040|NCT04296175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741041|NCT02871349|Propranolol|propranolol|mesh-list
92741042|NCT02871349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92741043|NCT02871349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92741044|NCT02871349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92741045|NCT02871349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741046|NCT02871349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741047|NCT02871349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741048|NCT02871349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92741049|NCT02871349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92741050|NCT02871349|Vasodilator Agents|vasodilator agents|mesh-ancestor
92741051|NCT01012609|Irinotecan|irinotecan|mesh-list
92741052|NCT01012609|Cetuximab|cetuximab|mesh-list
92741053|NCT01012609|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92741054|NCT01012609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92741055|NCT01012609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741056|NCT01012609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741057|NCT01012609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741058|NCT01012609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741059|NCT04297501|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92741060|NCT04297501|Antiviral Agents|antiviral agents|mesh-ancestor
92741061|NCT04297501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741062|NCT01012219|Aspirin|aspirin|mesh-list
92741064|NCT01012219|Clopidogrel|clopidogrel|mesh-list
92741065|NCT01012219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92741066|NCT01012219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741067|NCT01012219|Analgesics|analgesics|mesh-ancestor
92741068|NCT01012219|Sensory System Agents|sensory system agents|mesh-ancestor
92741069|NCT01012219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741070|NCT01012219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611315|NCT00507949|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92611316|NCT00507949|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92611317|NCT00507949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92611318|NCT00507949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741071|NCT01012219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741072|NCT01012219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741073|NCT01012219|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92741074|NCT01012219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92741075|NCT01012219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741076|NCT01012219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92741079|NCT01012219|Antipyretics|antipyretics|mesh-ancestor
92741080|NCT01012219|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92741081|NCT01012219|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92741082|NCT01012219|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92741083|NCT01012219|Purinergic Agents|purinergic agents|mesh-ancestor
92741084|NCT01012219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741085|NCT01012219|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92741086|NCT01012219|Antimetabolites|antimetabolites|mesh-ancestor
92741087|NCT01012219|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92741088|NCT01012219|Vasodilator Agents|vasodilator agents|mesh-ancestor
92741089|NCT01012219|Vitamin B Complex|vitamin b complex|mesh-ancestor
92741091|NCT01012219|Micronutrients|micronutrients|mesh-ancestor
92741092|NCT01011907|Varenicline|varenicline|mesh-list
92741093|NCT01011907|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92741094|NCT01011907|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92741095|NCT01011907|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741096|NCT01011907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741097|NCT01011907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741098|NCT01011907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741100|NCT01011673|Metoclopramide|metoclopramide|mesh-list
92741101|NCT01011673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92741102|NCT01011673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741103|NCT01011673|Analgesics|analgesics|mesh-ancestor
92741104|NCT01011673|Sensory System Agents|sensory system agents|mesh-ancestor
92741105|NCT01011673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741106|NCT01011673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741107|NCT01011673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741108|NCT01011673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741109|NCT01011673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92741110|NCT01011673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741111|NCT01011673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741112|NCT01011673|Antiemetics|antiemetics|mesh-ancestor
92741113|NCT01011673|Autonomic Agents|autonomic agents|mesh-ancestor
92741114|NCT01011673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92741115|NCT01011673|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92741116|NCT01011673|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92741117|NCT01011673|Dopamine Agents|dopamine agents|mesh-ancestor
92741118|NCT01011673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741119|NCT01311648|Factor VIII|factor viii|mesh-list
92741120|NCT01311648|Coagulants|coagulants|mesh-ancestor
92741121|NCT01011439|Maleic acid|maleic acid|mesh-list
92741122|NCT01011439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741123|NCT01011439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741124|NCT04406857|Capecitabine|capecitabine|mesh-list
92741125|NCT04406857|Ropidoxuridine|ropidoxuridine|mesh-list
92741126|NCT04406857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92741127|NCT04406857|Antimetabolites|antimetabolites|mesh-ancestor
92741128|NCT04406857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741129|NCT04406857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741130|NCT01311024|Vaccines|vaccines|mesh-list
92741131|NCT01311024|Immunologic Factors|immunologic factors|mesh-ancestor
92741132|NCT01311024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741133|NCT02871193|Dexamethasone|dexamethasone|mesh-list
92741134|NCT02871193|Ropivacaine|ropivacaine|mesh-list
92741135|NCT02871193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741136|NCT02871193|Antiemetics|antiemetics|mesh-ancestor
92741137|NCT02871193|Autonomic Agents|autonomic agents|mesh-ancestor
92741138|NCT02871193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741139|NCT02871193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741141|NCT02871193|Glucocorticoids|glucocorticoids|mesh-ancestor
92741142|NCT02871193|Hormones|hormones|mesh-ancestor
92611319|NCT00507949|Appetite Stimulants|appetite stimulants|mesh-ancestor
92611320|NCT00507949|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92611321|NCT00148551|Triamcinolone|triamcinolone|mesh-list
92611322|NCT00148551|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92611323|NCT00148551|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92611324|NCT00148551|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92611325|NCT00148551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611326|NCT00148551|Glucocorticoids|glucocorticoids|mesh-ancestor
92611327|NCT00148551|Hormones|hormones|mesh-ancestor
92611328|NCT00148551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741143|NCT02871193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741144|NCT02871193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92741145|NCT02871193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741146|NCT02871193|Anesthetics, Local|anesthetics, local|mesh-ancestor
92741147|NCT02871193|Anesthetics|anesthetics|mesh-ancestor
92741148|NCT02871193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741149|NCT02871193|Sensory System Agents|sensory system agents|mesh-ancestor
92741150|NCT01310868|Carmustine|carmustine|mesh-list
92741151|NCT01310868|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92741152|NCT01310868|Levulinic acid|levulinic acid|mesh-list
92741157|NCT01310868|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92741158|NCT01310868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92741159|NCT01310868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741160|NCT01273155|Belinostat|belinostat|mesh-list
92741161|NCT01273155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741162|NCT01273155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92741163|NCT01273155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741164|NCT01273155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741165|NCT05557851|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
92741166|NCT05557851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92741167|NCT05557851|Alkylating Agents|alkylating agents|mesh-ancestor
92741168|NCT05557851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741169|NCT05557851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741170|NCT01005901|Glycopyrrolate|glycopyrrolate|mesh-list
92741171|NCT01005901|Bromides|bromides|mesh-list
92741172|NCT01005901|Anticonvulsants|anticonvulsants|mesh-ancestor
92741173|NCT01005901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92741174|NCT01005901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92741175|NCT01005901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92741176|NCT01005901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741177|NCT01005901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741178|NCT01005901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741179|NCT01005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741180|NCT02889549|Clopidogrel|clopidogrel|mesh-list
92741181|NCT02889549|Ticagrelor|ticagrelor|mesh-list
92741182|NCT02889549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92741183|NCT02889549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92741184|NCT02889549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92741185|NCT02889549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92741186|NCT02889549|Purinergic Agents|purinergic agents|mesh-ancestor
92741187|NCT02889549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741188|NCT02889549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741189|NCT02889549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741190|NCT05549037|Immunomodulating Agents|immunomodulating agents|mesh-list
92741191|NCT05549037|Immunologic Factors|immunologic factors|mesh-ancestor
92741192|NCT05549037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741193|NCT01309386|Morphine|morphine|mesh-list
92741194|NCT01309386|Tapentadol|tapentadol|mesh-list
92741195|NCT01309386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92741196|NCT01309386|Narcotics|narcotics|mesh-ancestor
92741197|NCT01309386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741198|NCT01309386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741199|NCT01309386|Analgesics|analgesics|mesh-ancestor
92741200|NCT01309386|Sensory System Agents|sensory system agents|mesh-ancestor
92750783|NCT05935059|Anticonvulsants|anticonvulsants|mesh-list
92611329|NCT00148551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611330|NCT00148551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611331|NCT00148551|Immunologic Factors|immunologic factors|mesh-ancestor
92741201|NCT01309386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741202|NCT01309386|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92741203|NCT01309386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92741204|NCT01309386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92741205|NCT01309386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741206|NCT01309386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92741207|NCT01309386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741208|NCT04295317|Capecitabine|capecitabine|mesh-list
92741209|NCT04295317|Antibodies|antibodies|mesh-list
92741210|NCT04295317|Antibodies, Blocking|antibodies, blocking|mesh-list
92741211|NCT04295317|Immunologic Factors|immunologic factors|mesh-ancestor
92741212|NCT04295317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741213|NCT04295317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92741214|NCT04295317|Antimetabolites|antimetabolites|mesh-ancestor
92741215|NCT04295317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741216|NCT04295317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741217|NCT01266603|Aldesleukin|aldesleukin|mesh-list
92741218|NCT01266603|Interleukin-2|interleukin-2|mesh-list
92741219|NCT01266603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741220|NCT01266603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741221|NCT01266603|Analgesics|analgesics|mesh-ancestor
92741223|NCT01266603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741224|NCT01266603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741225|NCT01266603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92741226|NCT01266603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92741227|NCT01266603|Antiviral Agents|antiviral agents|mesh-ancestor
92741228|NCT01266603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741230|NCT04295551|Lopinavir|lopinavir|mesh-list
92741231|NCT04295551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92741232|NCT04295551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92741233|NCT04295551|Protease Inhibitors|protease inhibitors|mesh-ancestor
92741234|NCT04295551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741235|NCT04295551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741236|NCT04295551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92741237|NCT04295551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92741238|NCT04295551|Antiviral Agents|antiviral agents|mesh-ancestor
92741239|NCT04295551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741240|NCT04295551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92741241|NCT04295551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92741242|NCT01266291|Vigabatrin|vigabatrin|mesh-list
92741243|NCT01266291|Anticonvulsants|anticonvulsants|mesh-ancestor
92741244|NCT01266291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741245|NCT01266291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741246|NCT01266291|GABA Agents|gaba agents|mesh-ancestor
92741247|NCT01266291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741248|NCT01266291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741249|NCT01004263|Rizatriptan|rizatriptan|mesh-list
92741250|NCT01004263|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92741251|NCT01004263|Serotonin Agents|serotonin agents|mesh-ancestor
92741252|NCT01004263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741253|NCT01004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741254|NCT01004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741255|NCT01265823|Adalimumab|adalimumab|mesh-list
92741256|NCT01265823|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92741257|NCT01265823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741258|NCT01265823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741259|NCT01004185|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92741260|NCT01004185|Mesalamine|mesalamine|mesh-list
92741261|NCT01004185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92741262|NCT01004185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741263|NCT01004185|Analgesics|analgesics|mesh-ancestor
92741264|NCT01004185|Sensory System Agents|sensory system agents|mesh-ancestor
92741265|NCT01004185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741266|NCT01004185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741267|NCT01004185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741268|NCT01004185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741269|NCT01004185|Antitubercular Agents|antitubercular agents|mesh-ancestor
92741270|NCT01004185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92741271|NCT01004185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741272|NCT01265511|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92741273|NCT01265511|Antiviral Agents|antiviral agents|mesh-ancestor
92741274|NCT01265511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741275|NCT01264965|Acetaminophen|acetaminophen|mesh-list
92741276|NCT01264965|Oxycodone|oxycodone|mesh-list
92741277|NCT01264965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741278|NCT01264965|Analgesics|analgesics|mesh-ancestor
92741279|NCT01264965|Sensory System Agents|sensory system agents|mesh-ancestor
92741280|NCT01264965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741281|NCT01264965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741282|NCT01264965|Antipyretics|antipyretics|mesh-ancestor
92741283|NCT01264965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92741284|NCT01264965|Narcotics|narcotics|mesh-ancestor
92741285|NCT01264965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741286|NCT01264887|Tapentadol|tapentadol|mesh-list
92741287|NCT01264887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92322315|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92741288|NCT01264887|Narcotics|narcotics|mesh-ancestor
92741289|NCT01264887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741290|NCT01264887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741291|NCT01264887|Analgesics|analgesics|mesh-ancestor
92741292|NCT01264887|Sensory System Agents|sensory system agents|mesh-ancestor
92741293|NCT01264887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741294|NCT01264887|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92741295|NCT01264887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92741299|NCT01264887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741300|NCT01011283|Azacitidine|azacitidine|mesh-list
92741301|NCT01011283|Decitabine|decitabine|mesh-list
92741302|NCT01011283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92741303|NCT01011283|Antimetabolites|antimetabolites|mesh-ancestor
92741304|NCT01011283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741305|NCT01011283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741306|NCT01011283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741307|NCT01263483|Inositol|inositol|mesh-list
92741308|NCT01263483|Alogliptin|alogliptin|mesh-list
92741309|NCT01263483|Voglibose|voglibose|mesh-list
92741310|NCT01263483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92741311|NCT01263483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741312|NCT01263483|Incretins|incretins|mesh-ancestor
92741313|NCT01263483|Hormones|hormones|mesh-ancestor
92741314|NCT01263483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741315|NCT01263483|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92741316|NCT01263483|Protease Inhibitors|protease inhibitors|mesh-ancestor
92741317|NCT01263483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741318|NCT01263483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741319|NCT01263483|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92741320|NCT01263483|Vitamin B Complex|vitamin b complex|mesh-ancestor
92741321|NCT01263483|Vitamins|vitamins|mesh-ancestor
92741322|NCT01263483|Micronutrients|micronutrients|mesh-ancestor
92741323|NCT01011049|Vaccines|vaccines|mesh-list
92741324|NCT01011049|Immunologic Factors|immunologic factors|mesh-ancestor
92741325|NCT01011049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741326|NCT01263093|Clopidogrel|clopidogrel|mesh-list
92741327|NCT01263093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92741328|NCT01263093|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92741329|NCT01263093|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92741330|NCT01263093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92741331|NCT01263093|Purinergic Agents|purinergic agents|mesh-ancestor
92741332|NCT01263093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741333|NCT01263093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741334|NCT01263093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741335|NCT01010971|Ciclesonide|ciclesonide|mesh-list
92741336|NCT01010971|Glucocorticoids|glucocorticoids|mesh-ancestor
92741337|NCT01010971|Hormones|hormones|mesh-ancestor
92741338|NCT01010971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741339|NCT01010971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741340|NCT01010971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92741341|NCT01306656|Vitamin D|vitamin d|mesh-list
92741342|NCT01306656|Ergocalciferols|ergocalciferols|mesh-list
92741343|NCT01306656|Cholecalciferol|cholecalciferol|mesh-list
92741344|NCT01306656|Vitamins|vitamins|mesh-list
92741345|NCT01306656|Micronutrients|micronutrients|mesh-ancestor
92741346|NCT01306656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741347|NCT01306656|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92741348|NCT01306656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92741349|NCT01003639|Aspirin|aspirin|mesh-list
92741350|NCT01003639|Acetaminophen|acetaminophen|mesh-list
92611333|NCT00148551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611334|NCT05594186|Tranexamic Acid|tranexamic acid|mesh-list
92741351|NCT01003639|Ibuprofen|ibuprofen|mesh-list
92741352|NCT01003639|Naproxen|naproxen|mesh-list
92741353|NCT01003639|Acetazolamide|acetazolamide|mesh-list
92741354|NCT01003639|Codeine|codeine|mesh-list
92741355|NCT01003639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92741356|NCT01003639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741357|NCT01003639|Analgesics|analgesics|mesh-ancestor
92741358|NCT01003639|Sensory System Agents|sensory system agents|mesh-ancestor
92741359|NCT01003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741360|NCT01003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741361|NCT01003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741362|NCT01003639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741363|NCT01003639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92741365|NCT01003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741366|NCT01003639|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92741367|NCT01003639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92741368|NCT01003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741369|NCT01003639|Antipyretics|antipyretics|mesh-ancestor
92741371|NCT01003639|Anticonvulsants|anticonvulsants|mesh-ancestor
92741372|NCT01003639|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92741374|NCT01003639|Natriuretic Agents|natriuretic agents|mesh-ancestor
92741375|NCT01003639|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92741376|NCT01003639|Narcotics|narcotics|mesh-ancestor
92741377|NCT01003639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741378|NCT01003639|Antitussive Agents|antitussive agents|mesh-ancestor
92741379|NCT01003639|Respiratory System Agents|respiratory system agents|mesh-ancestor
92741380|NCT01003249|Baclofen|baclofen|mesh-list
92741381|NCT01003249|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92741382|NCT01003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741383|NCT01003249|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92741384|NCT01003249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741385|NCT01003249|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92741386|NCT01003249|GABA Agonists|gaba agonists|mesh-ancestor
92741387|NCT01003249|GABA Agents|gaba agents|mesh-ancestor
92741388|NCT01003249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741389|NCT01003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741390|NCT04297033|Lovastatin|lovastatin|mesh-list
92741391|NCT04297033|L 647318|l 647318|mesh-list
92741392|NCT04297033|Dihydromevinolin|dihydromevinolin|mesh-list
92741393|NCT04297033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92741394|NCT04297033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92741395|NCT04297033|Antimetabolites|antimetabolites|mesh-ancestor
92741396|NCT04297033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741397|NCT04297033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92741398|NCT04297033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92741399|NCT04297033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741400|NCT04294537|Anesthetics|anesthetics|mesh-list
92741401|NCT04294537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741402|NCT04294537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741403|NCT04295629|Anesthetics|anesthetics|mesh-list
92741404|NCT04295629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741405|NCT04295629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741406|NCT01306032|Cyclophosphamide|cyclophosphamide|mesh-list
92741407|NCT01306032|Veliparib|veliparib|mesh-list
92741408|NCT01306032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741409|NCT01306032|Immunologic Factors|immunologic factors|mesh-ancestor
92741410|NCT01306032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741411|NCT01306032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741412|NCT01306032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92741413|NCT01306032|Alkylating Agents|alkylating agents|mesh-ancestor
92741414|NCT01306032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741415|NCT01306032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741416|NCT01306032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92741417|NCT01306032|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92741418|NCT01306032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741419|NCT01263015|Lamivudine|lamivudine|mesh-list
92741420|NCT01263015|Abacavir|abacavir|mesh-list
92741421|NCT01263015|Dideoxynucleosides|dideoxynucleosides|mesh-list
92741422|NCT01263015|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92741423|NCT01263015|Dolutegravir|dolutegravir|mesh-list
92741424|NCT01263015|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92741425|NCT01263015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92741426|NCT01263015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741427|NCT01263015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741428|NCT01263015|Antiviral Agents|antiviral agents|mesh-ancestor
92741429|NCT01263015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741430|NCT01263015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92741431|NCT01263015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92741432|NCT01263015|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92741433|NCT01263015|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92741434|NCT01263015|Antimetabolites|antimetabolites|mesh-ancestor
92741435|NCT04322955|Nivolumab|nivolumab|mesh-list
92741436|NCT04322955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741437|NCT04322955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741438|NCT04322955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92741439|NCT04322955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741441|NCT04322175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92741442|NCT04322175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741443|NCT04322175|Analgesics|analgesics|mesh-ancestor
92741446|NCT04322175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741447|NCT04322175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741448|NCT04322175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741449|NCT04322175|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92741450|NCT04322175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92741451|NCT04322175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741452|NCT04322175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741453|NCT04321785|Caffeine|caffeine|mesh-list
92741454|NCT04321785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92741455|NCT04321785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741456|NCT04321785|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92741457|NCT04321785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741458|NCT04321785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741459|NCT04321785|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92741460|NCT04321785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92741461|NCT04321785|Purinergic Agents|purinergic agents|mesh-ancestor
92741462|NCT04321785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741463|NCT01305408|Modafinil|modafinil|mesh-list
92741464|NCT01305408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92741465|NCT01305408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741466|NCT01305408|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92741467|NCT01305408|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92741468|NCT01305408|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92741469|NCT01305408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741470|NCT01261611|Botulinum Toxins|botulinum toxins|mesh-list
92741471|NCT01261611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92741472|NCT01261611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92741473|NCT01261611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92741474|NCT01261611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92741475|NCT01261611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741476|NCT01261611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741477|NCT01261611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741478|NCT01261611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741479|NCT01261611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92741480|NCT01261611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741481|NCT04207125|Psychotropic Drugs|psychotropic drugs|mesh-list
92741482|NCT04320693|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92741483|NCT04320693|Immunoconjugates|immunoconjugates|mesh-ancestor
92741484|NCT04320693|Immunologic Factors|immunologic factors|mesh-ancestor
92741485|NCT04320693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741486|NCT00624039|Pilocarpine|pilocarpine|mesh-list
92741487|NCT00624039|Miotics|miotics|mesh-ancestor
92741488|NCT00624039|Autonomic Agents|autonomic agents|mesh-ancestor
92750784|NCT05935059|Tianeptine|tianeptine|mesh-list
92741489|NCT00624039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741490|NCT00624039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741491|NCT00624039|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92741492|NCT00624039|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92741493|NCT00624039|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741494|NCT00624039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741495|NCT00624039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741496|NCT01304706|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92611336|NCT05594186|Contraceptive Agents|contraceptive agents|mesh-list
92611337|NCT05594186|Contraceptives, Oral|contraceptives, oral|mesh-list
92611338|NCT05594186|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92611339|NCT05594186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92611340|NCT05594186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92611341|NCT05594186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741497|NCT01304706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741498|NCT01304706|Glucocorticoids|glucocorticoids|mesh-ancestor
92741499|NCT01304706|Hormones|hormones|mesh-ancestor
92741500|NCT01304706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741501|NCT01304706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741502|NCT05661240|Docetaxel|docetaxel|mesh-list
92741503|NCT05661240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741504|NCT05661240|Tubulin Modulators|tubulin modulators|mesh-ancestor
92741505|NCT05661240|Antimitotic Agents|antimitotic agents|mesh-ancestor
92741506|NCT05661240|Mitosis Modulators|mitosis modulators|mesh-ancestor
92741507|NCT05661240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741508|NCT05464719|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92741509|NCT05464719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741510|NCT05464719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741511|NCT02889003|Pioglitazone|pioglitazone|mesh-list
92741512|NCT02889003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92741514|NCT01008553|Fentanyl|fentanyl|mesh-list
92741515|NCT01008553|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92741516|NCT01008553|Narcotics|narcotics|mesh-ancestor
92741517|NCT01008553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741518|NCT01008553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741519|NCT01008553|Analgesics|analgesics|mesh-ancestor
92741520|NCT01008553|Sensory System Agents|sensory system agents|mesh-ancestor
92741521|NCT01008553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741522|NCT01008553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92741523|NCT01008553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92741524|NCT01008553|Anesthetics, General|anesthetics, general|mesh-ancestor
92741525|NCT01008553|Anesthetics|anesthetics|mesh-ancestor
92741526|NCT05226663|Fluorides|fluorides|mesh-list
92741527|NCT05226663|Cariostatic Agents|cariostatic agents|mesh-ancestor
92741528|NCT05226663|Protective Agents|protective agents|mesh-ancestor
92741529|NCT05226663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741530|NCT05141877|Anesthetics|anesthetics|mesh-list
92741531|NCT05141877|Propofol|propofol|mesh-list
92741532|NCT05141877|Sevoflurane|sevoflurane|mesh-list
92741533|NCT05141877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741534|NCT05141877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741535|NCT05141877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92741536|NCT05141877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92741537|NCT05141877|Anesthetics, General|anesthetics, general|mesh-ancestor
92741538|NCT05141877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92741539|NCT05141877|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92741540|NCT04901169|Angiotensin II|angiotensin ii|mesh-list
92741541|NCT04901169|Giapreza|giapreza|mesh-list
92741542|NCT04901169|Angiotensinogen|angiotensinogen|mesh-list
92741543|NCT04901169|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92741544|NCT04901169|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92741545|NCT04901169|Protease Inhibitors|protease inhibitors|mesh-ancestor
92741546|NCT04901169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741547|NCT04901169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741548|NCT04479267|Prednisone|prednisone|mesh-list
92741549|NCT04479267|Methylprednisolone|methylprednisolone|mesh-list
92741550|NCT04479267|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92741551|NCT04479267|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92741552|NCT04479267|Prednisolone|prednisolone|mesh-list
92741553|NCT04479267|Prednisolone acetate|prednisolone acetate|mesh-list
92741554|NCT04479267|Hydrocortisone|hydrocortisone|mesh-list
92741555|NCT04479267|Cortisone|cortisone|mesh-list
92741556|NCT04479267|Cyclophosphamide|cyclophosphamide|mesh-list
92741557|NCT04479267|Rituximab|rituximab|mesh-list
92741558|NCT04479267|Doxorubicin|doxorubicin|mesh-list
92741559|NCT04479267|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92741560|NCT04479267|Antibodies|antibodies|mesh-list
92741561|NCT04479267|Immunoglobulins|immunoglobulins|mesh-list
92611342|NCT05594186|Hemostatics|hemostatics|mesh-ancestor
92611343|NCT05594186|Coagulants|coagulants|mesh-ancestor
92611344|NCT05594186|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92611345|NCT05594186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92741562|NCT04479267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92741563|NCT04479267|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92741564|NCT04479267|Prednisolone phosphate|prednisolone phosphate|mesh-list
92741565|NCT04479267|Immunoconjugates|immunoconjugates|mesh-list
92741566|NCT04479267|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92741567|NCT04479267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741568|NCT04479267|Immunologic Factors|immunologic factors|mesh-ancestor
92741569|NCT04479267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741570|NCT04479267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741571|NCT04479267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92741572|NCT04479267|Alkylating Agents|alkylating agents|mesh-ancestor
92741573|NCT04479267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741574|NCT04479267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741575|NCT04479267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92741576|NCT04479267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741577|NCT04479267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92741578|NCT04479267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92741579|NCT04479267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92741580|NCT04479267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741581|NCT04479267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741582|NCT04479267|Glucocorticoids|glucocorticoids|mesh-ancestor
92741583|NCT04479267|Hormones|hormones|mesh-ancestor
92741584|NCT04479267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741585|NCT04479267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92741586|NCT04479267|Antiemetics|antiemetics|mesh-ancestor
92741587|NCT04479267|Autonomic Agents|autonomic agents|mesh-ancestor
92741588|NCT04479267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741589|NCT04479267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92741593|NCT04439799|Testosterone|testosterone|mesh-list
92741594|NCT04439799|Testosterone undecanoate|testosterone undecanoate|mesh-list
92741595|NCT04439799|Testosterone enanthate|testosterone enanthate|mesh-list
92741596|NCT04439799|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92741597|NCT04439799|Androgens|androgens|mesh-ancestor
92741599|NCT04439799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741600|NCT04439799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741601|NCT04439799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92741602|NCT04439799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741603|NCT04439799|Anabolic Agents|anabolic agents|mesh-ancestor
92741604|NCT04021017|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92741605|NCT04021017|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92741606|NCT04021017|Estradiol|estradiol|mesh-list
92741607|NCT04021017|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92741608|NCT04021017|Estrogens|estrogens|mesh-ancestor
92741609|NCT04021017|Hormones|hormones|mesh-ancestor
92741610|NCT04021017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741611|NCT04021017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741612|NCT04021017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92741613|NCT04021017|Contraceptive Agents|contraceptive agents|mesh-ancestor
92741614|NCT04021017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92741615|NCT04021017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92741616|NCT03916185|Vaccines|vaccines|mesh-list
92741617|NCT03916185|Immunologic Factors|immunologic factors|mesh-ancestor
92741618|NCT03916185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741619|NCT03764553|Leucovorin|leucovorin|mesh-list
92741620|NCT03764553|Carboplatin|carboplatin|mesh-list
92741621|NCT03764553|Fluorouracil|fluorouracil|mesh-list
92741622|NCT03764553|Capecitabine|capecitabine|mesh-list
92741623|NCT03764553|Oxaliplatin|oxaliplatin|mesh-list
92741624|NCT03764553|Irinotecan|irinotecan|mesh-list
92741625|NCT03764553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741626|NCT03764553|Antimetabolites|antimetabolites|mesh-ancestor
92741627|NCT03764553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741628|NCT03764553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92741629|NCT03764553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741630|NCT03764553|Immunologic Factors|immunologic factors|mesh-ancestor
92741631|NCT03764553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741632|NCT03764553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92741633|NCT03764553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92018412|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
92611346|NCT05594186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611347|NCT05594186|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92611348|NCT05594186|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92611349|NCT00157092|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92611350|NCT00157092|Protein C Inhibitor|protein c inhibitor|mesh-list
92611351|NCT00157092|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92611352|NCT00157092|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92611353|NCT00157092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92741634|NCT03764553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741635|NCT03764553|Antidotes|antidotes|mesh-ancestor
92741636|NCT03764553|Protective Agents|protective agents|mesh-ancestor
92741637|NCT03764553|Vitamin B Complex|vitamin b complex|mesh-ancestor
92741638|NCT03764553|Vitamins|vitamins|mesh-ancestor
92741639|NCT03764553|Micronutrients|micronutrients|mesh-ancestor
92741640|NCT04320225|Dexamethasone|dexamethasone|mesh-list
92741641|NCT04320225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741642|NCT04320225|Antiemetics|antiemetics|mesh-ancestor
92741643|NCT04320225|Autonomic Agents|autonomic agents|mesh-ancestor
92741644|NCT04320225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741645|NCT04320225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741646|NCT04320225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92741647|NCT04320225|Glucocorticoids|glucocorticoids|mesh-ancestor
92741648|NCT04320225|Hormones|hormones|mesh-ancestor
92741649|NCT04320225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741650|NCT04320225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92741651|NCT04320225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741652|NCT03221751|Prazosin|prazosin|mesh-list
92741653|NCT03221751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92741654|NCT03221751|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92741655|NCT03221751|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92741656|NCT03221751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92741657|NCT03221751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92741658|NCT03221751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741659|NCT03221751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741660|NCT03221751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741661|NCT03219177|Analgesics, Opioid|analgesics, opioid|mesh-list
92741662|NCT03219177|Narcotics|narcotics|mesh-ancestor
92741663|NCT03219177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741664|NCT03219177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741668|NCT01302834|Cetuximab|cetuximab|mesh-list
92741669|NCT01302834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741670|NCT01302834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741671|NCT02866071|Ketamine|ketamine|mesh-list
92741672|NCT02866071|Analgesics|analgesics|mesh-ancestor
92741673|NCT02866071|Sensory System Agents|sensory system agents|mesh-ancestor
92741674|NCT02866071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741675|NCT02866071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741676|NCT02866071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92741677|NCT02866071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92741678|NCT02866071|Anesthetics, General|anesthetics, general|mesh-ancestor
92741679|NCT02866071|Anesthetics|anesthetics|mesh-ancestor
92741680|NCT02866071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741681|NCT02866071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92741682|NCT02866071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92741683|NCT02866071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741684|NCT02866071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741685|NCT05507775|Digoxin|digoxin|mesh-list
92741686|NCT05507775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92741687|NCT05507775|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92741688|NCT05507775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741689|NCT05507775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741690|NCT05507775|Protective Agents|protective agents|mesh-ancestor
92741691|NCT05507775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741692|NCT02890602|Prednisolone|prednisolone|mesh-list
92741693|NCT02890602|Cyclophosphamide|cyclophosphamide|mesh-list
92611354|NCT00157092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741694|NCT02890602|Vincristine|vincristine|mesh-list
92741695|NCT02890602|Darbepoetin alfa|darbepoetin alfa|mesh-list
92741696|NCT02890602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741697|NCT02890602|Immunologic Factors|immunologic factors|mesh-ancestor
92741698|NCT02890602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741699|NCT02890602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741700|NCT02890602|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92741701|NCT02890602|Alkylating Agents|alkylating agents|mesh-ancestor
92741702|NCT02890602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741703|NCT02890602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741704|NCT02890602|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92741705|NCT02890602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92741706|NCT02890602|Tubulin Modulators|tubulin modulators|mesh-ancestor
92741707|NCT02890602|Antimitotic Agents|antimitotic agents|mesh-ancestor
92741708|NCT02890602|Mitosis Modulators|mitosis modulators|mesh-ancestor
92741709|NCT02890602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741710|NCT02890602|Glucocorticoids|glucocorticoids|mesh-ancestor
92741711|NCT02890602|Hormones|hormones|mesh-ancestor
92741712|NCT02890602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741713|NCT02890602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92741714|NCT02890602|Hematinics|hematinics|mesh-ancestor
92741715|NCT01259115|Ketoconazole|ketoconazole|mesh-list
92741716|NCT01259115|Buprenorphine|buprenorphine|mesh-list
92741717|NCT01259115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92741718|NCT01259115|Narcotics|narcotics|mesh-ancestor
92741719|NCT01259115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741720|NCT01259115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741721|NCT01259115|Analgesics|analgesics|mesh-ancestor
92741722|NCT01259115|Sensory System Agents|sensory system agents|mesh-ancestor
92741723|NCT01259115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741724|NCT01259115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92741725|NCT01259115|Antifungal Agents|antifungal agents|mesh-ancestor
92741726|NCT01259115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741727|NCT01259115|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92741728|NCT01259115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92741729|NCT01259115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741730|NCT01259115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741731|NCT01259115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92741732|NCT01259115|Hormone Antagonists|hormone antagonists|mesh-ancestor
92741733|NCT01259115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741734|NCT01259115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92741735|NCT01302054|Fesoterodine|fesoterodine|mesh-list
92741738|NCT01302054|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741739|NCT01302054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741740|NCT01302054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741741|NCT01302054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741742|NCT01302054|Urological Agents|urological agents|mesh-ancestor
92741743|NCT05642910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92741744|NCT05642910|Antiviral Agents|antiviral agents|mesh-ancestor
92741745|NCT05642910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741746|NCT01300650|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92741747|NCT01300650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741748|NCT01300572|Cyclosporine|cyclosporine|mesh-list
92741749|NCT01300572|Mycophenolic Acid|mycophenolic acid|mesh-list
92741750|NCT01300572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92741751|NCT01300572|Fludarabine|fludarabine|mesh-list
92741752|NCT01300572|Fludarabine phosphate|fludarabine phosphate|mesh-list
92741753|NCT01300572|Antibodies|antibodies|mesh-list
92741754|NCT01300572|Immunoglobulins|immunoglobulins|mesh-list
92741755|NCT01300572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92741756|NCT01300572|Cyclosporins|cyclosporins|mesh-list
92741757|NCT01300572|Immunologic Factors|immunologic factors|mesh-ancestor
92741758|NCT01300572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741759|NCT01300572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741760|NCT01300572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92741761|NCT01300572|Antimetabolites|antimetabolites|mesh-ancestor
92741762|NCT01300572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741763|NCT01300572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741764|NCT01300572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741765|NCT01300572|Antifungal Agents|antifungal agents|mesh-ancestor
92741766|NCT01300572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741767|NCT01300572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92682810|NCT00438152|Saquinavir|saquinavir|mesh-list
92682811|NCT00438152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92741768|NCT01300572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741769|NCT01300572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92741770|NCT01300572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92741771|NCT01300572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92741772|NCT01300572|Antitubercular Agents|antitubercular agents|mesh-ancestor
92741773|NCT01300572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92741774|NCT01077154|Denosumab|denosumab|mesh-list
92741775|NCT01077154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92741776|NCT01077154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741777|NCT01258101|Ribavirin|ribavirin|mesh-list
92741778|NCT01258101|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92741779|NCT01258101|Interferon-alpha|interferon-alpha|mesh-list
92741780|NCT01258101|Antimetabolites|antimetabolites|mesh-ancestor
92741781|NCT01258101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741782|NCT01258101|Antiviral Agents|antiviral agents|mesh-ancestor
92741783|NCT01258101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741784|NCT01258101|Immunologic Factors|immunologic factors|mesh-ancestor
92741785|NCT01258101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741786|NCT05640804|Dasatinib|dasatinib|mesh-list
92741787|NCT05640804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741788|NCT05640804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92741789|NCT05640804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741790|NCT05640804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741791|NCT00623688|Imidacloprid|imidacloprid|mesh-list
92741792|NCT00623688|Cholinergic Agents|cholinergic agents|mesh-ancestor
92741793|NCT00623688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741794|NCT00623688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741795|NCT00623688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741796|NCT01300260|Dulaglutide|dulaglutide|mesh-list
92741797|NCT01300260|Glucagon|glucagon|mesh-list
92741798|NCT01300260|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92741799|NCT01300260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92741800|NCT01300260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741801|NCT01300260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92741802|NCT01300260|Hormones|hormones|mesh-ancestor
92741803|NCT01300260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741804|NCT01300260|Incretins|incretins|mesh-ancestor
92741805|NCT01256385|Sirolimus|sirolimus|mesh-list
92741806|NCT01256385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92741807|NCT01256385|Cetuximab|cetuximab|mesh-list
92741808|NCT01256385|Temsirolimus|temsirolimus|mesh-list
92741809|NCT01256385|MTOR Inhibitors|mtor inhibitors|mesh-list
92741824|NCT00637182|Anastrozole|anastrozole|mesh-list
92741825|NCT00637182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92741826|NCT00637182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741827|NCT00637182|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92741828|NCT00637182|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92741829|NCT00637182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741830|NCT00637182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741831|NCT00637182|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92741832|NCT00637182|Hormone Antagonists|hormone antagonists|mesh-ancestor
92741833|NCT00637182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741834|NCT00637182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741835|NCT01298778|Acetaminophen|acetaminophen|mesh-list
92741836|NCT01298778|Morphine|morphine|mesh-list
92741837|NCT01298778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92741838|NCT01298778|Analgesics|analgesics|mesh-ancestor
92741839|NCT01298778|Sensory System Agents|sensory system agents|mesh-ancestor
92741840|NCT01298778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741841|NCT01298778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741842|NCT01298778|Antipyretics|antipyretics|mesh-ancestor
92741843|NCT01298778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92741844|NCT01298778|Narcotics|narcotics|mesh-ancestor
92741845|NCT01298778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741846|NCT01298700|Bimatoprost|bimatoprost|mesh-list
92741847|NCT01298700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92741848|NCT01298700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92741849|NCT01298700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92741850|NCT01297920|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92741851|NCT01297920|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92741852|NCT01297920|Brinzolamide|brinzolamide|mesh-list
92741853|NCT01297920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92741854|NCT01297920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92611355|NCT00157092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611356|NCT00148590|Memantine|memantine|mesh-list
92611357|NCT00148590|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92611358|NCT00148590|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92741855|NCT01297920|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92741856|NCT01297920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92741857|NCT01297920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92741858|NCT01297920|Adrenergic Agents|adrenergic agents|mesh-ancestor
92741859|NCT01297920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741860|NCT01297920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741861|NCT01297920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741862|NCT01297920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92741863|NCT01297920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741864|NCT01255761|Certolizumab Pegol|certolizumab pegol|mesh-list
92741865|NCT01255761|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92741866|NCT01255761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741867|NCT01255761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741868|NCT01255761|Immunologic Factors|immunologic factors|mesh-ancestor
92741869|NCT01255761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741870|NCT01255761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741875|NCT01297062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92741877|NCT01297062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741878|NCT01297062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741879|NCT01297062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741880|NCT01297062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741881|NCT01297062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92741882|NCT01297062|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92741883|NCT01297062|Incretins|incretins|mesh-ancestor
92741884|NCT01297062|Hormones|hormones|mesh-ancestor
92741885|NCT01297062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741886|NCT01296672|Finasteride|finasteride|mesh-list
92741887|NCT01296672|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92741889|NCT01296672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741890|NCT01296672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741891|NCT01296672|Hormone Antagonists|hormone antagonists|mesh-ancestor
92741892|NCT01296672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741893|NCT01296672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741894|NCT01296672|Urological Agents|urological agents|mesh-ancestor
92741895|NCT01254669|Vaccines|vaccines|mesh-list
92741896|NCT01254669|Immunologic Factors|immunologic factors|mesh-ancestor
92741897|NCT01254669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741898|NCT04324476|Bevacizumab|bevacizumab|mesh-list
92741899|NCT04324476|Capecitabine|capecitabine|mesh-list
92741900|NCT04324476|Oxaliplatin|oxaliplatin|mesh-list
92741901|NCT04324476|Irinotecan|irinotecan|mesh-list
92741902|NCT04324476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741903|NCT04324476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741904|NCT04324476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92741905|NCT04324476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92741906|NCT04324476|Growth Substances|growth substances|mesh-ancestor
92741907|NCT04324476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741908|NCT04324476|Growth Inhibitors|growth inhibitors|mesh-ancestor
92741909|NCT04324476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92741910|NCT04324476|Antimetabolites|antimetabolites|mesh-ancestor
92741911|NCT04324476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741912|NCT04324476|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92741913|NCT04324476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92741914|NCT04324476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741915|NCT01295814|Adalimumab|adalimumab|mesh-list
92741916|NCT01295814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92741917|NCT01295814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92741918|NCT01295814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92741919|NCT01254045|Oxytocin|oxytocin|mesh-list
92741920|NCT01254045|Oxytocics|oxytocics|mesh-ancestor
92741921|NCT01254045|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92741922|NCT01254045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741923|NCT01075282|Metformin|metformin|mesh-list
92741924|NCT01075282|Insulin Glargine|insulin glargine|mesh-list
92741925|NCT01075282|Glimepiride|glimepiride|mesh-list
92741926|NCT01075282|Dulaglutide|dulaglutide|mesh-list
92611359|NCT00148590|Dopamine Agents|dopamine agents|mesh-ancestor
92611360|NCT00148590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741927|NCT01075282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92741928|NCT01075282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741929|NCT01075282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92741930|NCT01075282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741931|NCT01075282|Immunologic Factors|immunologic factors|mesh-ancestor
92741932|NCT04324086|Calcium, Dietary|calcium, dietary|mesh-list
92741933|NCT04324086|Calcium|calcium|mesh-list
92741934|NCT04324086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92741935|NCT04324086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741936|NCT04324086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92741937|NCT01295034|Vitamin D|vitamin d|mesh-list
92741938|NCT01295034|Ergocalciferols|ergocalciferols|mesh-list
92741939|NCT01295034|Cholecalciferol|cholecalciferol|mesh-list
92741940|NCT01295034|Vitamins|vitamins|mesh-list
92741941|NCT01295034|Micronutrients|micronutrients|mesh-ancestor
92741942|NCT01295034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741943|NCT01295034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92741945|NCT01253421|Amisulpride|amisulpride|mesh-list
92741946|NCT01253421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92741947|NCT01253421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92741948|NCT01253421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741949|NCT01253421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741950|NCT01253421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92741951|NCT01253421|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92741952|NCT01253421|Dopamine Agents|dopamine agents|mesh-ancestor
92741953|NCT01253421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741954|NCT01253421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741955|NCT01253421|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92741956|NCT01253421|Antidepressive Agents|antidepressive agents|mesh-ancestor
92741957|NCT01077076|Omeprazole|omeprazole|mesh-list
92741958|NCT01077076|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92741959|NCT01077076|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92741960|NCT01077076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92741961|NCT01077076|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92741962|NCT01077076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741963|NCT01077076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741964|NCT02876224|Bevacizumab|bevacizumab|mesh-list
92741965|NCT02876224|Atezolizumab|atezolizumab|mesh-list
92741966|NCT02876224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92741967|NCT02876224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741968|NCT02876224|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92741969|NCT02876224|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92741970|NCT02876224|Growth Substances|growth substances|mesh-ancestor
92741971|NCT02876224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741972|NCT02876224|Growth Inhibitors|growth inhibitors|mesh-ancestor
92741973|NCT02876224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92741974|NCT02876224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741975|NCT01294644|Deoxycholic Acid|deoxycholic acid|mesh-list
92741976|NCT01294644|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92741977|NCT01294644|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92741978|NCT01253265|Ixekizumab|ixekizumab|mesh-list
92741979|NCT01253265|Dermatologic Agents|dermatologic agents|mesh-ancestor
92741980|NCT01293006|Suvorexant|suvorexant|mesh-list
92741981|NCT01293006|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92741982|NCT01293006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92741983|NCT01293006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92741984|NCT01293006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741985|NCT01293006|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92741986|NCT01293006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92741987|NCT01293006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741988|NCT01253187|Tetrahydrofolates|tetrahydrofolates|mesh-list
92741989|NCT01253187|Drospirenone|drospirenone|mesh-list
92741990|NCT01253187|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92741991|NCT01253187|Hormone Antagonists|hormone antagonists|mesh-ancestor
92741992|NCT01253187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92741993|NCT01253187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741994|NCT01253187|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92741995|NCT01253187|Diuretics|diuretics|mesh-ancestor
92741996|NCT01253187|Natriuretic Agents|natriuretic agents|mesh-ancestor
92741997|NCT01253187|Vitamin B Complex|vitamin b complex|mesh-ancestor
92611361|NCT00148590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611362|NCT00148590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741998|NCT01253187|Vitamins|vitamins|mesh-ancestor
92741999|NCT01253187|Micronutrients|micronutrients|mesh-ancestor
92742000|NCT01252563|Amlodipine|amlodipine|mesh-list
92742001|NCT01252563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92742002|NCT01252563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92742003|NCT01252563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742004|NCT01252563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742005|NCT01252563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92742006|NCT01252563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742007|NCT01252563|Vasodilator Agents|vasodilator agents|mesh-ancestor
92742008|NCT01292226|Cyclosporine|cyclosporine|mesh-list
92742009|NCT01292226|Mycophenolic Acid|mycophenolic acid|mesh-list
92742010|NCT01292226|Antibodies|antibodies|mesh-list
92742011|NCT01292226|Cyclosporins|cyclosporins|mesh-list
92742012|NCT01292226|Immunologic Factors|immunologic factors|mesh-ancestor
92742013|NCT01292226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742014|NCT01292226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742015|NCT01292226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742022|NCT01292226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92742023|NCT01292226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742024|NCT01292226|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92742025|NCT01292226|Antitubercular Agents|antitubercular agents|mesh-ancestor
92742026|NCT01292226|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742027|NCT01075048|Irinotecan|irinotecan|mesh-list
92742028|NCT01075048|Cetuximab|cetuximab|mesh-list
92742029|NCT01075048|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92742030|NCT01075048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92742031|NCT01075048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742032|NCT01075048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742033|NCT01075048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742034|NCT01075048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742035|NCT01252251|Everolimus|everolimus|mesh-list
92742036|NCT01252251|Pasireotide|pasireotide|mesh-list
92742037|NCT01252251|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92742038|NCT01252251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742039|NCT01252251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742040|NCT01252251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742041|NCT01252251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742042|NCT01252251|Immunologic Factors|immunologic factors|mesh-ancestor
92742043|NCT01252251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742044|NCT01252251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742045|NCT01252251|Hormones|hormones|mesh-ancestor
92742046|NCT01252251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742047|NCT02888301|Clofarabine|clofarabine|mesh-list
92742048|NCT02888301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92742049|NCT02888301|Antimetabolites|antimetabolites|mesh-ancestor
92742050|NCT02888301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742051|NCT02888301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742052|NCT00624273|Sildenafil Citrate|sildenafil citrate|mesh-list
92742053|NCT00624273|Vasodilator Agents|vasodilator agents|mesh-ancestor
92742054|NCT00624273|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92742055|NCT00624273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92742056|NCT00624273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742057|NCT00624273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742058|NCT00624273|Urological Agents|urological agents|mesh-ancestor
92742059|NCT04305964|Silicon|silicon|mesh-list
92742060|NCT04305964|Trace Elements|trace elements|mesh-ancestor
92742061|NCT04305964|Micronutrients|micronutrients|mesh-ancestor
92742062|NCT04305964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742063|NCT04306042|Pembrolizumab|pembrolizumab|mesh-list
92742064|NCT04306042|Nivolumab|nivolumab|mesh-list
92742065|NCT04306042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742066|NCT04306042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742067|NCT04306042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92742068|NCT04306042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742069|NCT01074502|Apremilast|apremilast|mesh-list
92742070|NCT01074502|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92742071|NCT01074502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742072|NCT01074502|Analgesics|analgesics|mesh-ancestor
92611363|NCT00148590|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92611364|NCT00148590|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92611365|NCT02954068|Oxytocin|oxytocin|mesh-list
92611366|NCT02954068|Oxytocics|oxytocics|mesh-ancestor
92742073|NCT01074502|Sensory System Agents|sensory system agents|mesh-ancestor
92742074|NCT01074502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742075|NCT01074502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742076|NCT01074502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742077|NCT01074502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742078|NCT01074502|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92742079|NCT01074502|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92742080|NCT01074502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742081|NCT01074502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742082|NCT04303312|Benzydamine|benzydamine|mesh-list
92742083|NCT04303312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742087|NCT01285908|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742088|NCT01285908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742089|NCT01285908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742090|NCT01285908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742091|NCT01285908|Sympathomimetics|sympathomimetics|mesh-ancestor
92742092|NCT01285908|Autonomic Agents|autonomic agents|mesh-ancestor
92742093|NCT01285908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742094|NCT01285908|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92742095|NCT01074268|Insulin|insulin|mesh-list
92742096|NCT01074268|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92742097|NCT01074268|Insulin Aspart|insulin aspart|mesh-list
92742098|NCT01074268|Insulin Detemir|insulin detemir|mesh-list
92742099|NCT01074268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742100|NCT01074268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742101|NCT01074190|Fentanyl|fentanyl|mesh-list
92742102|NCT01074190|Bupivacaine|bupivacaine|mesh-list
92742103|NCT01074190|Anesthetics, Local|anesthetics, local|mesh-ancestor
92742104|NCT01074190|Anesthetics|anesthetics|mesh-ancestor
92742105|NCT01074190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742106|NCT01074190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742107|NCT01074190|Sensory System Agents|sensory system agents|mesh-ancestor
92742108|NCT01074190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742109|NCT01074190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92742110|NCT01074190|Narcotics|narcotics|mesh-ancestor
92742111|NCT01074190|Analgesics|analgesics|mesh-ancestor
92742112|NCT01074190|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92742113|NCT01074190|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92742114|NCT01074190|Anesthetics, General|anesthetics, general|mesh-ancestor
92742116|NCT01073566|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92742117|NCT01073566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742118|NCT01073566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742119|NCT01072396|Tiotropium Bromide|tiotropium bromide|mesh-list
92742120|NCT01072396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92742121|NCT01072396|Autonomic Agents|autonomic agents|mesh-ancestor
92742122|NCT01072396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742123|NCT01072396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742124|NCT01072396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92742125|NCT01072396|Respiratory System Agents|respiratory system agents|mesh-ancestor
92742126|NCT01072396|Parasympatholytics|parasympatholytics|mesh-ancestor
92742127|NCT01072396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92742128|NCT01072396|Cholinergic Agents|cholinergic agents|mesh-ancestor
92742129|NCT01072396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742130|NCT01072396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742131|NCT01045096|Dexlansoprazole|dexlansoprazole|mesh-list
92742132|NCT01045096|Lansoprazole|lansoprazole|mesh-list
92742133|NCT01045096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92742134|NCT01045096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92742135|NCT01045096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92398797|NCT01399346|Insulin|insulin|mesh-list
92742136|NCT01045096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742137|NCT01045096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742138|NCT02876146|Albendazole|albendazole|mesh-list
92742139|NCT02876146|Benzimidazole|benzimidazole|mesh-list
92742140|NCT02876146|Anthelmintics|anthelmintics|mesh-ancestor
92742141|NCT02876146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92742142|NCT02876146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742143|NCT02876146|Anticestodal Agents|anticestodal agents|mesh-ancestor
92742144|NCT02876146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92611368|NCT02954068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611369|NCT00157131|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92611370|NCT00157131|Hemostatics|hemostatics|mesh-ancestor
92611371|NCT00157131|Coagulants|coagulants|mesh-ancestor
92611372|NCT02954029|Hemostatics|hemostatics|mesh-list
92742145|NCT02876146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92742146|NCT02876146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742147|NCT02876146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742148|NCT02876146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92742149|NCT02876146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742150|NCT02876146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742151|NCT02874586|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92742152|NCT02874586|Immunologic Factors|immunologic factors|mesh-ancestor
92742153|NCT02874586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742154|NCT02875756|Ivermectin|ivermectin|mesh-list
92742155|NCT02875756|Selamectin|selamectin|mesh-list
92742156|NCT02875756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92742157|NCT02875756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742158|NCT02874820|Idazoxan|idazoxan|mesh-list
92742167|NCT04305028|Rivaroxaban|rivaroxaban|mesh-list
92742168|NCT04305028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92742169|NCT04305028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742170|NCT04305028|Analgesics|analgesics|mesh-ancestor
92742171|NCT04305028|Sensory System Agents|sensory system agents|mesh-ancestor
92742172|NCT04305028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742173|NCT04305028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742174|NCT04305028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742175|NCT04305028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742176|NCT04305028|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92742177|NCT04305028|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92742178|NCT04305028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742179|NCT04305028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92742180|NCT04305028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92742181|NCT04305028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742182|NCT04305028|Antipyretics|antipyretics|mesh-ancestor
92742183|NCT04305028|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92742184|NCT04305028|Antithrombins|antithrombins|mesh-ancestor
92742185|NCT04305028|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92742187|NCT04305028|Anticoagulants|anticoagulants|mesh-ancestor
92742188|NCT04304794|Antithyroid Agents|antithyroid agents|mesh-list
92742189|NCT04304794|Hormone Antagonists|hormone antagonists|mesh-ancestor
92742190|NCT04304794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742191|NCT04304794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742192|NCT02874664|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92742193|NCT02874664|Immunoconjugates|immunoconjugates|mesh-ancestor
92742194|NCT02874664|Immunologic Factors|immunologic factors|mesh-ancestor
92742195|NCT02874664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742196|NCT01284114|Renin Inhibitors|renin inhibitors|mesh-list
92742197|NCT01284114|Protease Inhibitors|protease inhibitors|mesh-ancestor
92742198|NCT01284114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742199|NCT01284114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742200|NCT01283334|Carboplatin|carboplatin|mesh-list
92742201|NCT01283334|Cetuximab|cetuximab|mesh-list
92742202|NCT01283334|Everolimus|everolimus|mesh-list
92742203|NCT01283334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742204|NCT01283334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742205|NCT01283334|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92742206|NCT01283334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742207|NCT01283334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742208|NCT01283334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742209|NCT01283334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742210|NCT01283334|Immunologic Factors|immunologic factors|mesh-ancestor
92742211|NCT01283334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742212|NCT04304716|Anesthetics|anesthetics|mesh-list
92742213|NCT04304716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742214|NCT04304716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742215|NCT01282476|Rituximab|rituximab|mesh-list
92742216|NCT01282476|Panobinostat|panobinostat|mesh-list
92742217|NCT01282476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611373|NCT02954029|Coagulants|coagulants|mesh-ancestor
92611374|NCT00508456|Temozolomide|temozolomide|mesh-list
92611375|NCT00508456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92611376|NCT00508456|Alkylating Agents|alkylating agents|mesh-ancestor
92018434|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92742218|NCT01282476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742219|NCT01282476|Immunologic Factors|immunologic factors|mesh-ancestor
92742220|NCT01282476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742221|NCT01282476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742222|NCT01282476|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92742223|NCT01282476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327612|NCT00003086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742227|NCT02889822|Vasodilator Agents|vasodilator agents|mesh-ancestor
92742228|NCT02889822|Urological Agents|urological agents|mesh-ancestor
92742229|NCT01282164|Insulin|insulin|mesh-list
92742230|NCT01282164|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92742231|NCT01282164|Glucagon|glucagon|mesh-list
92742232|NCT01282164|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92742233|NCT01282164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742234|NCT01282164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742235|NCT01282164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92742236|NCT01282164|Hormones|hormones|mesh-ancestor
92742237|NCT01282164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742238|NCT01282164|Incretins|incretins|mesh-ancestor
92742239|NCT01250379|Bevacizumab|bevacizumab|mesh-list
92742240|NCT01250379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742241|NCT01250379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742242|NCT01250379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92742243|NCT01250379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92742244|NCT01250379|Growth Substances|growth substances|mesh-ancestor
92742245|NCT01250379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742246|NCT01250379|Growth Inhibitors|growth inhibitors|mesh-ancestor
92742247|NCT01072630|Modafinil|modafinil|mesh-list
92742248|NCT01072630|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92742249|NCT01072630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742250|NCT01072630|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92742251|NCT01072630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92742252|NCT01072630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92742253|NCT01072630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742254|NCT04302532|Ubiquinone|ubiquinone|mesh-list
92742255|NCT04302532|Coenzyme Q10|coenzyme q10|mesh-list
92742256|NCT04302532|Clomiphene|clomiphene|mesh-list
92742257|NCT04302532|Enclomiphene|enclomiphene|mesh-list
92742258|NCT04302532|Zuclomiphene|zuclomiphene|mesh-list
92742259|NCT04302532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92742260|NCT04302532|Hormone Antagonists|hormone antagonists|mesh-ancestor
92742261|NCT04302532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742262|NCT04302532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742263|NCT04302532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92742264|NCT04302532|Fertility Agents|fertility agents|mesh-ancestor
92742265|NCT04302532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92742266|NCT04302532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92742267|NCT04302532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92742268|NCT04302532|Micronutrients|micronutrients|mesh-ancestor
92742269|NCT04302532|Vitamins|vitamins|mesh-ancestor
92742270|NCT01281306|Valsartan|valsartan|mesh-list
92742271|NCT01281306|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92742272|NCT01281306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92742273|NCT01281306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92742274|NCT01281306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92742275|NCT01281306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742276|NCT04304560|Dapagliflozin|dapagliflozin|mesh-list
92750785|NCT05935059|Antidepressive Agents|antidepressive agents|mesh-list
92742277|NCT04304560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92742278|NCT04304560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742279|NCT04304560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742280|NCT04304560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742281|NCT04643470|Zanubrutinib|zanubrutinib|mesh-list
92742282|NCT04643470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742283|NCT04643470|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92611377|NCT00508456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611378|NCT00508456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611379|NCT00508495|Acetaminophen|acetaminophen|mesh-list
92018439|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
92742284|NCT04643470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742285|NCT04643470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742286|NCT01250145|Teriparatide|teriparatide|mesh-list
92742287|NCT01250145|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92742288|NCT01250145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742289|NCT01250145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92742291|NCT04319601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742292|NCT04319601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742293|NCT04319601|Immunologic Factors|immunologic factors|mesh-ancestor
92742296|NCT04640896|Lidocaine|lidocaine|mesh-list
92742297|NCT04640896|Bupivacaine|bupivacaine|mesh-list
92742298|NCT04640896|Anesthetics, Local|anesthetics, local|mesh-ancestor
92742299|NCT04640896|Anesthetics|anesthetics|mesh-ancestor
92742300|NCT04640896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742301|NCT04640896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742302|NCT04640896|Sensory System Agents|sensory system agents|mesh-ancestor
92742303|NCT04640896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742304|NCT04640896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92742305|NCT04640896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92742306|NCT04640896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92742307|NCT04640896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742308|NCT04640896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742309|NCT01273818|Gentamicins|gentamicins|mesh-list
92742310|NCT01273818|Cefazolin|cefazolin|mesh-list
92742311|NCT01273818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742312|NCT01273818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742313|NCT01273818|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92742314|NCT01273818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742315|NCT01273818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742316|NCT01037218|Udenafil|udenafil|mesh-list
92742317|NCT01037218|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92742318|NCT01037218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92742319|NCT01037218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742320|NCT01037218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742321|NCT01038856|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92742322|NCT01038856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742323|NCT01038856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742324|NCT01038856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742325|NCT01038856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742326|NCT01269918|Dexmedetomidine|dexmedetomidine|mesh-list
92742327|NCT01269918|Remifentanil|remifentanil|mesh-list
92742328|NCT01269918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92742329|NCT01269918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742330|NCT01269918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742331|NCT01269918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742332|NCT01269918|Analgesics|analgesics|mesh-ancestor
92742333|NCT01269918|Sensory System Agents|sensory system agents|mesh-ancestor
92742334|NCT01269918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742335|NCT01269918|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92742336|NCT01269918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92742337|NCT01269918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92742338|NCT01269918|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742339|NCT01269918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742340|NCT01269918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742341|NCT01269918|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92742342|NCT01269918|Narcotics|narcotics|mesh-ancestor
92742343|NCT01036594|Ketoconazole|ketoconazole|mesh-list
92742344|NCT01036594|Dexamethasone|dexamethasone|mesh-list
92742345|NCT01036594|Dexamethasone acetate|dexamethasone acetate|mesh-list
92742346|NCT01036594|Hydrocortisone|hydrocortisone|mesh-list
92742347|NCT01036594|BB 1101|bb 1101|mesh-list
92742348|NCT01036594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742349|NCT01036594|Antiemetics|antiemetics|mesh-ancestor
92742350|NCT01036594|Autonomic Agents|autonomic agents|mesh-ancestor
92611380|NCT00508495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92611381|NCT00508495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742351|NCT01036594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742352|NCT01036594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742353|NCT01036594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92742354|NCT01036594|Glucocorticoids|glucocorticoids|mesh-ancestor
92742355|NCT01036594|Hormones|hormones|mesh-ancestor
92742356|NCT01036594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742357|NCT01036594|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92742358|NCT01036594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742359|NCT01036594|Protease Inhibitors|protease inhibitors|mesh-ancestor
92742360|NCT01036594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742361|NCT01036594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742362|NCT01036594|Antifungal Agents|antifungal agents|mesh-ancestor
92742363|NCT01036594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742364|NCT01036594|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92742366|NCT01036594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92742368|NCT01036594|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92742369|NCT04301908|Interferons|interferons|mesh-list
92742370|NCT04301908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742371|NCT04301908|Antiviral Agents|antiviral agents|mesh-ancestor
92742372|NCT04301908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742373|NCT04304248|Paclitaxel|paclitaxel|mesh-list
92742374|NCT04304248|Carboplatin|carboplatin|mesh-list
92742375|NCT04304248|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92742376|NCT04304248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92742377|NCT04304248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742378|NCT04304248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742379|NCT04304248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742380|NCT04304248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92742381|NCT04304248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742382|NCT01268046|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92742383|NCT01268046|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92742384|NCT01268046|Estradiol|estradiol|mesh-list
92742385|NCT01268046|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92742386|NCT01268046|Estrogens|estrogens|mesh-list
92742387|NCT01268046|Hormones|hormones|mesh-ancestor
92742388|NCT01268046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742389|NCT01268046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742390|NCT01268046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92742391|NCT01268046|Contraceptive Agents|contraceptive agents|mesh-ancestor
92742392|NCT01268046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92742393|NCT01268046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92742394|NCT04732000|Acetylcysteine|acetylcysteine|mesh-list
92742395|NCT04732000|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92742396|NCT04732000|Antiviral Agents|antiviral agents|mesh-ancestor
92742397|NCT04732000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742398|NCT04732000|Expectorants|expectorants|mesh-ancestor
92742399|NCT04732000|Respiratory System Agents|respiratory system agents|mesh-ancestor
92742400|NCT04732000|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92742401|NCT04732000|Antioxidants|antioxidants|mesh-ancestor
92742402|NCT04732000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742403|NCT04732000|Protective Agents|protective agents|mesh-ancestor
92742404|NCT04732000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742405|NCT04732000|Antidotes|antidotes|mesh-ancestor
92742406|NCT01267266|Hydrocortisone|hydrocortisone|mesh-list
92742407|NCT01267266|Saracatinib|saracatinib|mesh-list
92742408|NCT01267266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742409|NCT01267266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742410|NCT01267266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742411|NCT01267266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742412|NCT01034176|Levofloxacin|levofloxacin|mesh-list
92742413|NCT01034176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92398818|NCT01399463|Paclitaxel|paclitaxel|mesh-list
92742414|NCT01034176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742415|NCT01034176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742416|NCT01034176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92742417|NCT01034176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92742418|NCT01034176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742419|NCT01034176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742420|NCT01034176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742421|NCT01034176|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92742422|NCT01034176|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92611383|NCT00508495|Sensory System Agents|sensory system agents|mesh-ancestor
92611384|NCT00508495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611385|NCT00508495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611386|NCT00508495|Antipyretics|antipyretics|mesh-ancestor
92611387|NCT00508690|Metronidazole|metronidazole|mesh-list
92611388|NCT00508690|Kanamycin|kanamycin|mesh-list
92611389|NCT00508690|Cefmetazole|cefmetazole|mesh-list
92611390|NCT00508690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611391|NCT00508690|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742423|NCT02889432|Melatonin|melatonin|mesh-list
92742424|NCT02889432|Antioxidants|antioxidants|mesh-ancestor
92742425|NCT02889432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742426|NCT02889432|Protective Agents|protective agents|mesh-ancestor
92742427|NCT02889432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742428|NCT02889432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742429|NCT01033942|Tenofovir|tenofovir|mesh-list
92742430|NCT01033942|Emtricitabine|emtricitabine|mesh-list
92742431|NCT01033942|Antiviral Agents|antiviral agents|mesh-ancestor
92742432|NCT01033942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742433|NCT01033942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92742434|NCT01033942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92742435|NCT01033942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742436|NCT01033942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742437|NCT01033942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92742439|NCT01062256|Phenylpropanolamine|phenylpropanolamine|mesh-list
92742440|NCT01062256|Guaifenesin|guaifenesin|mesh-list
92742441|NCT01062256|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92742442|NCT01062256|Expectorants|expectorants|mesh-ancestor
92742443|NCT01062256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92742444|NCT01062256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92742445|NCT01062256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92742446|NCT01062256|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742447|NCT01062256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742448|NCT01062256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742449|NCT01062256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742450|NCT01062256|Appetite Depressants|appetite depressants|mesh-ancestor
92742451|NCT01062256|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92742452|NCT01062256|Sympathomimetics|sympathomimetics|mesh-ancestor
92742453|NCT01062256|Autonomic Agents|autonomic agents|mesh-ancestor
92742454|NCT01062256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742455|NCT01062256|Nasal Decongestants|nasal decongestants|mesh-ancestor
92742456|NCT01062256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92742457|NCT01029886|Liraglutide|liraglutide|mesh-list
92742458|NCT01029886|Exenatide|exenatide|mesh-list
92742459|NCT01029886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742460|NCT01029886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742461|NCT01029886|Incretins|incretins|mesh-ancestor
92742462|NCT01029886|Hormones|hormones|mesh-ancestor
92742463|NCT01029886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742464|NCT01029886|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92742465|NCT01244061|Varenicline|varenicline|mesh-list
92742466|NCT01244061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92742467|NCT01244061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92742468|NCT01244061|Cholinergic Agents|cholinergic agents|mesh-ancestor
92742469|NCT01244061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742470|NCT01244061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742471|NCT01244061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742472|NCT01243671|Adalimumab|adalimumab|mesh-list
92742473|NCT01243671|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92742474|NCT01243671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742475|NCT01243671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742476|NCT01240785|Metformin|metformin|mesh-list
92742477|NCT01240785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742478|NCT01240785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742479|NCT01266876|Alirocumab|alirocumab|mesh-list
92742480|NCT01266876|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92018454|NCT03053167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611392|NCT00508690|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92611393|NCT00508690|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92611394|NCT00508690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92611395|NCT00508690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611396|NCT00508690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611397|NCT00148707|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92611398|NCT00148707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611399|NCT02953522|Folic Acid|folic acid|mesh-list
92611400|NCT02953522|Vitamin B Complex|vitamin b complex|mesh-list
92742481|NCT01266876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92742482|NCT01266876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92742483|NCT01266876|Antimetabolites|antimetabolites|mesh-ancestor
92742484|NCT01266876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742485|NCT01266876|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92742486|NCT01266876|Protease Inhibitors|protease inhibitors|mesh-ancestor
92742487|NCT01266876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742488|NCT01266876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92742489|NCT01033240|Sorafenib|sorafenib|mesh-list
92742490|NCT01033240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742491|NCT01033240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742492|NCT01033240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742493|NCT01033240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742494|NCT01032382|Gentamicins|gentamicins|mesh-list
92742495|NCT01032382|Paromomycin|paromomycin|mesh-list
92742496|NCT01032382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742497|NCT01032382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742498|NCT01032382|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92742499|NCT01032382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742500|NCT01032382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742501|NCT01032382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92742502|NCT01032382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92742503|NCT01029652|Triamcinolone|triamcinolone|mesh-list
92742504|NCT01029652|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92742505|NCT01029652|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92742506|NCT01029652|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92742507|NCT01029652|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92742508|NCT01029652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742509|NCT01029652|Glucocorticoids|glucocorticoids|mesh-ancestor
92742510|NCT01029652|Hormones|hormones|mesh-ancestor
92742511|NCT01029652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742512|NCT01029652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742516|NCT01029652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742517|NCT01029340|Factor VIII|factor viii|mesh-list
92742518|NCT01029340|Coagulants|coagulants|mesh-ancestor
92742519|NCT01265550|Baclofen|baclofen|mesh-list
92742520|NCT01265550|Desipramine|desipramine|mesh-list
92742521|NCT01265550|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92742522|NCT01265550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742523|NCT01265550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92742524|NCT01265550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742525|NCT01265550|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92742526|NCT01265550|GABA Agonists|gaba agonists|mesh-ancestor
92742527|NCT01265550|GABA Agents|gaba agents|mesh-ancestor
92742528|NCT01265550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742529|NCT01265550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742530|NCT01265550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92742531|NCT01265550|Antidepressive Agents|antidepressive agents|mesh-ancestor
92742532|NCT01265550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92742533|NCT01265550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742534|NCT01265550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92742535|NCT01265550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92742536|NCT01265550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742537|NCT01265550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742538|NCT01265394|Flutemetamol|flutemetamol|mesh-list
92611401|NCT02953522|Hematinics|hematinics|mesh-ancestor
92611402|NCT02953522|Vitamins|vitamins|mesh-ancestor
92611403|NCT02953522|Micronutrients|micronutrients|mesh-ancestor
92611404|NCT02953522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611405|NCT00148746|Cyclosporine|cyclosporine|mesh-list
92611406|NCT00148746|Prednisolone|prednisolone|mesh-list
92742539|NCT01265394|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92742540|NCT01265394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742541|NCT01029262|Lenalidomide|lenalidomide|mesh-list
92742542|NCT01029262|Immunologic Factors|immunologic factors|mesh-ancestor
92742543|NCT01029262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742544|NCT01029262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92742545|NCT01029262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92742546|NCT01029262|Growth Substances|growth substances|mesh-ancestor
92742547|NCT01029262|Growth Inhibitors|growth inhibitors|mesh-ancestor
92742548|NCT01029262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742549|NCT01061710|Varenicline|varenicline|mesh-list
92742550|NCT01061710|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92742551|NCT01061710|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92742552|NCT01061710|Cholinergic Agents|cholinergic agents|mesh-ancestor
92742553|NCT01061710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742554|NCT01061710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742555|NCT01061710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742556|NCT01028014|Pseudoephedrine|pseudoephedrine|mesh-list
92742557|NCT01028014|Ephedrine|ephedrine|mesh-list
92742558|NCT01028014|Cyclobenzaprine|cyclobenzaprine|mesh-list
92742559|NCT01028014|Imipramine|imipramine|mesh-list
92742560|NCT01028014|Tamsulosin|tamsulosin|mesh-list
92742561|NCT01028014|Solifenacin Succinate|solifenacin succinate|mesh-list
92742562|NCT01028014|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92742563|NCT01028014|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92742564|NCT01028014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92742565|NCT01028014|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742566|NCT01028014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742567|NCT01028014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742568|NCT01028014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742569|NCT01028014|Urological Agents|urological agents|mesh-ancestor
92742570|NCT01028014|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92742571|NCT01028014|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92742572|NCT01028014|Cholinergic Agents|cholinergic agents|mesh-ancestor
92742573|NCT01028014|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92742574|NCT01028014|Autonomic Agents|autonomic agents|mesh-ancestor
92742575|NCT01028014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742576|NCT01028014|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92742577|NCT01028014|Respiratory System Agents|respiratory system agents|mesh-ancestor
92742578|NCT01028014|Nasal Decongestants|nasal decongestants|mesh-ancestor
92742579|NCT01028014|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92742580|NCT01028014|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92742581|NCT01028014|Sympathomimetics|sympathomimetics|mesh-ancestor
92742582|NCT01028014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92742583|NCT01028014|Antidepressive Agents|antidepressive agents|mesh-ancestor
92742584|NCT01028014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92742588|NCT01028014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742589|NCT01028014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92742590|NCT01028014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92742591|NCT01028014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742592|NCT01264770|Adalimumab|adalimumab|mesh-list
92742593|NCT01264770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92742594|NCT01264770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742595|NCT01264770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742596|NCT02873650|Dabrafenib|dabrafenib|mesh-list
92742597|NCT02873650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742598|NCT02873650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742599|NCT02873650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742600|NCT02873650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742601|NCT01302080|Sertraline|sertraline|mesh-list
92742602|NCT01302080|Antidepressive Agents|antidepressive agents|mesh-ancestor
92742603|NCT01302080|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92742604|NCT01302080|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92611407|NCT00148746|Pimecrolimus|pimecrolimus|mesh-list
92742605|NCT01302080|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92742606|NCT01302080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750786|NCT05935059|Analgesics|analgesics|mesh-ancestor
92742607|NCT01302080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742608|NCT01302080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742609|NCT01302080|Serotonin Agents|serotonin agents|mesh-ancestor
92742610|NCT01302080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742611|NCT01032070|Etoposide|etoposide|mesh-list
92742612|NCT01032070|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92742613|NCT01032070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92742614|NCT01032070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742615|NCT01032070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92742616|NCT01032070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92742617|NCT01032070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742618|NCT01032070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742619|NCT01032070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742620|NCT01237899|Eplerenone|eplerenone|mesh-list
92742621|NCT01237899|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92742622|NCT01237899|Hormone Antagonists|hormone antagonists|mesh-ancestor
92742623|NCT01237899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742624|NCT01237899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742625|NCT01237899|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92742626|NCT01237899|Diuretics|diuretics|mesh-ancestor
92742627|NCT01237899|Natriuretic Agents|natriuretic agents|mesh-ancestor
92742628|NCT01237899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92742629|NCT01263444|Timolol|timolol|mesh-list
92742630|NCT01263444|Bimatoprost|bimatoprost|mesh-list
92742631|NCT01263444|Travoprost|travoprost|mesh-list
92742632|NCT01263444|Latanoprost|latanoprost|mesh-list
92742633|NCT01263444|Brinzolamide|brinzolamide|mesh-list
92742634|NCT01263444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92742635|NCT01263444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92742636|NCT01263444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742637|NCT01263444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742638|NCT01263444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742639|NCT01263444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742640|NCT01263444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92742641|NCT01263444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92742642|NCT01263444|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92742643|NCT01263444|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92742644|NCT01263444|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92742645|NCT01263444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742646|NCT01031836|Sifalimumab|sifalimumab|mesh-list
92742647|NCT01031836|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92742648|NCT01031836|Immunologic Factors|immunologic factors|mesh-ancestor
92742649|NCT01031836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742650|NCT01237587|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92742651|NCT01237587|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92742652|NCT01237587|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92742653|NCT01237587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742654|NCT01237587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742659|NCT01237587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742660|NCT01237587|Antidepressive Agents|antidepressive agents|mesh-ancestor
92742661|NCT01237587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92742662|NCT01237587|Dopamine Agents|dopamine agents|mesh-ancestor
92742663|NCT01031680|Dapagliflozin|dapagliflozin|mesh-list
92742664|NCT01031680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92742665|NCT01031680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742666|NCT01031680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92742667|NCT01031680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742668|NCT01031446|Paclitaxel|paclitaxel|mesh-list
92742669|NCT01031446|Everolimus|everolimus|mesh-list
92742670|NCT01031446|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92742671|NCT01031446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742672|NCT01031446|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742673|NCT01031446|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742674|NCT01031446|Mitosis Modulators|mitosis modulators|mesh-ancestor
92742675|NCT01031446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742676|NCT01031446|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92742677|NCT01031446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92742678|NCT01031446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742679|NCT01031446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611408|NCT00148746|Prednicarbate|prednicarbate|mesh-list
92611410|NCT00148746|Cyclosporins|cyclosporins|mesh-list
92742680|NCT01031446|Immunologic Factors|immunologic factors|mesh-ancestor
92742681|NCT01031446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742682|NCT01030900|Prednisone|prednisone|mesh-list
92742683|NCT01030900|Cyclophosphamide|cyclophosphamide|mesh-list
92742684|NCT01030900|Rituximab|rituximab|mesh-list
92742685|NCT01030900|Doxorubicin|doxorubicin|mesh-list
92742686|NCT01030900|Etoposide|etoposide|mesh-list
92742687|NCT01030900|Vincristine|vincristine|mesh-list
92742688|NCT01030900|Alemtuzumab|alemtuzumab|mesh-list
92742689|NCT01030900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742690|NCT01030900|Immunologic Factors|immunologic factors|mesh-ancestor
92742691|NCT01030900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742692|NCT01030900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742693|NCT01030900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92742694|NCT01030900|Alkylating Agents|alkylating agents|mesh-ancestor
92742695|NCT01030900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742696|NCT01030900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742697|NCT01030900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92742698|NCT01030900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742699|NCT01030900|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92742700|NCT01030900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92742701|NCT01030900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92742702|NCT01030900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742703|NCT01030900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742704|NCT01030900|Glucocorticoids|glucocorticoids|mesh-ancestor
92742705|NCT01030900|Hormones|hormones|mesh-ancestor
92742706|NCT01030900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742707|NCT01030900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92742708|NCT01030900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92742709|NCT01030900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742710|NCT01030900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742711|NCT01030900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92742712|NCT01030822|Vaccines|vaccines|mesh-list
92742713|NCT01030822|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92742714|NCT01030822|Immunologic Factors|immunologic factors|mesh-ancestor
92742715|NCT01030822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742716|NCT01026454|Valacyclovir|valacyclovir|mesh-list
92742717|NCT01026454|Acyclovir|acyclovir|mesh-list
92742718|NCT01026454|Antiviral Agents|antiviral agents|mesh-ancestor
92742719|NCT01026454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742720|NCT01026220|Prednisone|prednisone|mesh-list
92742721|NCT01026220|Cyclophosphamide|cyclophosphamide|mesh-list
92742722|NCT01026220|Ifosfamide|ifosfamide|mesh-list
92742723|NCT01026220|Doxorubicin|doxorubicin|mesh-list
92742724|NCT01026220|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92742725|NCT01026220|Etoposide|etoposide|mesh-list
92742726|NCT01026220|Vincristine|vincristine|mesh-list
92742727|NCT01026220|Vinorelbine|vinorelbine|mesh-list
92742728|NCT01026220|Bleomycin|bleomycin|mesh-list
92742732|NCT01026220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742733|NCT01026220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742734|NCT01026220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92742735|NCT01026220|Alkylating Agents|alkylating agents|mesh-ancestor
92742736|NCT01026220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742737|NCT01026220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742738|NCT01026220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92742739|NCT01026220|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92742740|NCT01026220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92742741|NCT01026220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92742742|NCT01026220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742743|NCT01026220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742744|NCT01026220|Glucocorticoids|glucocorticoids|mesh-ancestor
92742745|NCT01026220|Hormones|hormones|mesh-ancestor
92742746|NCT01026220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742747|NCT01026220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92742748|NCT01026220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92742749|NCT01026220|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742750|NCT01026220|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742751|NCT01026220|Mitosis Modulators|mitosis modulators|mesh-ancestor
92742752|NCT01026142|Capecitabine|capecitabine|mesh-list
92742753|NCT01026142|Trastuzumab|trastuzumab|mesh-list
92742754|NCT01026142|Pertuzumab|pertuzumab|mesh-list
92742755|NCT01026142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92611411|NCT00148746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742756|NCT01026142|Antimetabolites|antimetabolites|mesh-ancestor
92742757|NCT01026142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742758|NCT01026142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742759|NCT01026142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742760|NCT01030666|Chlorhexidine|chlorhexidine|mesh-list
92742761|NCT01030666|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92742762|NCT01030666|Doxycycline|doxycycline|mesh-list
92742763|NCT01030666|Ibuprofen|ibuprofen|mesh-list
92742764|NCT01030666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92742765|NCT01030666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742766|NCT01030666|Analgesics|analgesics|mesh-ancestor
92742767|NCT01030666|Sensory System Agents|sensory system agents|mesh-ancestor
92742768|NCT01030666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742769|NCT01030666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742770|NCT01030666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92742771|NCT01030666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742772|NCT01030666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92742773|NCT01030666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742774|NCT01030666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742775|NCT01030666|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92742776|NCT01030666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742777|NCT01030666|Disinfectants|disinfectants|mesh-ancestor
92742778|NCT01030666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92742779|NCT01030666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742780|NCT01030666|Antimalarials|antimalarials|mesh-ancestor
92742781|NCT01030666|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92742782|NCT01030666|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92742783|NCT01023256|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92742784|NCT01023256|Immunologic Factors|immunologic factors|mesh-ancestor
92742785|NCT01023256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742786|NCT01058668|Cariprazine|cariprazine|mesh-list
92742787|NCT01058668|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92742788|NCT01058668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92742789|NCT01058668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742790|NCT01058668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742791|NCT01058668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92742792|NCT00623558|Docetaxel|docetaxel|mesh-list
92742793|NCT00623558|Cetuximab|cetuximab|mesh-list
92742794|NCT00623558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742795|NCT00623558|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742796|NCT00623558|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742797|NCT00623558|Mitosis Modulators|mitosis modulators|mesh-ancestor
92742798|NCT00623558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742799|NCT00623558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742800|NCT01301066|Pravastatin|pravastatin|mesh-list
92742805|NCT01301066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742806|NCT01301066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92742807|NCT01301066|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92742808|NCT01301066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742809|NCT01022398|Vitamin D|vitamin d|mesh-list
92742810|NCT01022398|Cholecalciferol|cholecalciferol|mesh-list
92742811|NCT01022398|Vitamins|vitamins|mesh-ancestor
92742812|NCT01022398|Micronutrients|micronutrients|mesh-ancestor
92742813|NCT01022398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742814|NCT01022398|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92742815|NCT01022398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92742816|NCT05642624|Amphotericin B|amphotericin b|mesh-list
92742817|NCT05642624|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92742818|NCT05642624|Deoxycholic Acid|deoxycholic acid|mesh-list
92742819|NCT05642624|Amebicides|amebicides|mesh-ancestor
92742820|NCT05642624|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92742821|NCT05642624|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92742822|NCT05642624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742823|NCT05642624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742824|NCT05642624|Antifungal Agents|antifungal agents|mesh-ancestor
92742825|NCT05642624|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92742826|NCT05642624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92742827|NCT04324346|Paclitaxel|paclitaxel|mesh-list
92742828|NCT04324346|Docetaxel|docetaxel|mesh-list
92742829|NCT04324346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92742830|NCT04324346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742831|NCT04324346|Tubulin Modulators|tubulin modulators|mesh-ancestor
92742832|NCT04324346|Antimitotic Agents|antimitotic agents|mesh-ancestor
92742833|NCT04324346|Mitosis Modulators|mitosis modulators|mesh-ancestor
92611412|NCT00148746|Immunologic Factors|immunologic factors|mesh-ancestor
92611413|NCT00148746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611414|NCT00148746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92611415|NCT00148746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742834|NCT04324346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742835|NCT04300114|Fluzoparib|fluzoparib|mesh-list
92742836|NCT04300114|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92742837|NCT04300114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742838|NCT04300114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742839|NCT04300114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742840|NCT02890238|Sildenafil Citrate|sildenafil citrate|mesh-list
92742841|NCT02890238|Citric Acid|citric acid|mesh-list
92742842|NCT02890238|Sodium Citrate|sodium citrate|mesh-list
92742843|NCT02890238|Clomiphene|clomiphene|mesh-list
92742844|NCT02890238|Enclomiphene|enclomiphene|mesh-list
92742845|NCT02890238|Zuclomiphene|zuclomiphene|mesh-list
92742846|NCT02890238|Anticoagulants|anticoagulants|mesh-ancestor
92742847|NCT02890238|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92742848|NCT02890238|Chelating Agents|chelating agents|mesh-ancestor
92742849|NCT02890238|Sequestering Agents|sequestering agents|mesh-ancestor
92742850|NCT02890238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742851|NCT02890238|Vasodilator Agents|vasodilator agents|mesh-ancestor
92742852|NCT02890238|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92742853|NCT02890238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92742854|NCT02890238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742855|NCT02890238|Urological Agents|urological agents|mesh-ancestor
92742856|NCT02890238|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92742857|NCT02890238|Hormone Antagonists|hormone antagonists|mesh-ancestor
92742858|NCT02890238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92742859|NCT02890238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742860|NCT02890238|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92742861|NCT02890238|Fertility Agents|fertility agents|mesh-ancestor
92742862|NCT02890238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92742863|NCT02890238|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92742864|NCT02890238|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92742865|NCT00627796|Lanreotide|lanreotide|mesh-list
92742866|NCT00627796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742867|NCT01299896|Bupropion|bupropion|mesh-list
92742868|NCT01299896|Nicotine|nicotine|mesh-list
92742869|NCT01299896|Varenicline|varenicline|mesh-list
92742870|NCT01299896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92742871|NCT01299896|Autonomic Agents|autonomic agents|mesh-ancestor
92742872|NCT01299896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742873|NCT01299896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742875|NCT01299896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92742876|NCT01299896|Cholinergic Agents|cholinergic agents|mesh-ancestor
92742877|NCT01299896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742878|NCT01299896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742879|NCT01299896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92742880|NCT01299896|Antidepressive Agents|antidepressive agents|mesh-ancestor
92742881|NCT01299896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92742882|NCT01299896|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92742883|NCT01299896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92742884|NCT01299896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742885|NCT01299896|Dopamine Agents|dopamine agents|mesh-ancestor
92742886|NCT01299896|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92742887|NCT01299896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92742888|NCT01299896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742889|NCT01299584|Remifentanil|remifentanil|mesh-list
92742890|NCT01299584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92742891|NCT01299584|Narcotics|narcotics|mesh-ancestor
92742892|NCT01299584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742893|NCT01299584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742894|NCT01299584|Analgesics|analgesics|mesh-ancestor
92742895|NCT01299584|Sensory System Agents|sensory system agents|mesh-ancestor
92742896|NCT01299584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742897|NCT01236573|Cyclophosphamide|cyclophosphamide|mesh-list
92742898|NCT01236573|Fludarabine|fludarabine|mesh-list
92742899|NCT01236573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742900|NCT01236573|Immunologic Factors|immunologic factors|mesh-ancestor
92611416|NCT00148746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611418|NCT00148746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611419|NCT00148746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611420|NCT00148746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742901|NCT01236573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742902|NCT01236573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742903|NCT01236573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92742904|NCT01236573|Alkylating Agents|alkylating agents|mesh-ancestor
92742905|NCT01236573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742906|NCT01236573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742907|NCT01236573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92742908|NCT04323228|Antioxidants|antioxidants|mesh-list
92742909|NCT04323228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742910|NCT04323228|Protective Agents|protective agents|mesh-ancestor
92742911|NCT04323228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742912|NCT04322760|Lidocaine|lidocaine|mesh-list
92742913|NCT04322760|Dexmedetomidine|dexmedetomidine|mesh-list
92742914|NCT04322760|Bupivacaine|bupivacaine|mesh-list
92742915|NCT04322760|Anesthetics, Local|anesthetics, local|mesh-ancestor
92742916|NCT04322760|Anesthetics|anesthetics|mesh-ancestor
92742917|NCT04322760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92742918|NCT04322760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742919|NCT04322760|Sensory System Agents|sensory system agents|mesh-ancestor
92742920|NCT04322760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92742921|NCT04322760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92742922|NCT04322760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92742923|NCT04322760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92742924|NCT04322760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742925|NCT04322760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742926|NCT04322760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92742927|NCT04322760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92742928|NCT04322760|Analgesics|analgesics|mesh-ancestor
92742929|NCT04322760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92742930|NCT04322760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92742931|NCT04322760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92742932|NCT04322760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742933|NCT04322760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742935|NCT04322214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92742936|NCT04322214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92742937|NCT04322214|Antiviral Agents|antiviral agents|mesh-ancestor
92742938|NCT04322214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742939|NCT04322214|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92742940|NCT04322214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92742941|NCT04322214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742942|NCT04322214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742943|NCT01057810|Ipilimumab|ipilimumab|mesh-list
92742944|NCT01057810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92742945|NCT01057810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92742946|NCT01057810|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92742948|NCT01262352|Ivacaftor|ivacaftor|mesh-list
92742949|NCT01262352|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92742950|NCT01262352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742951|NCT01262352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742952|NCT01299272|Serotonin|serotonin|mesh-list
92742953|NCT01299272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92742954|NCT01299272|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92742955|NCT01299272|Serotonin Agents|serotonin agents|mesh-ancestor
92742956|NCT01299272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742957|NCT01299272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742958|NCT01299272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742959|NCT01299272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92742960|NCT01299272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92742961|NCT01299116|Contraceptive Agents|contraceptive agents|mesh-list
92742962|NCT01299116|Etonogestrel|etonogestrel|mesh-list
92742963|NCT01299116|Contraceptives, Oral|contraceptives, oral|mesh-list
92742964|NCT01299116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92742965|NCT01299116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742966|NCT01299116|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92742967|NCT01299116|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92742968|NCT04207398|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92742969|NCT04207398|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92742970|NCT04207398|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742971|NCT04207398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742972|NCT04207398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742973|NCT04207398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742974|NCT01299038|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92742975|NCT01299038|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92742976|NCT01299038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92742977|NCT01299038|Antimetabolites|antimetabolites|mesh-ancestor
92742978|NCT01299038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742979|NCT01299038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92742980|NCT01299038|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92742981|NCT01299038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742982|NCT04321278|Azithromycin|azithromycin|mesh-list
92742983|NCT04321278|Hydroxychloroquine|hydroxychloroquine|mesh-list
92742984|NCT04321278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92742985|NCT04321278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742986|NCT04321278|Antimalarials|antimalarials|mesh-ancestor
92742987|NCT04321278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92742988|NCT04321278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92742989|NCT04321278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742990|NCT04321278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742991|NCT04321278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742992|NCT01261338|Sucrose polyester|sucrose polyester|mesh-list
92742993|NCT01261338|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92742994|NCT01261338|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92742995|NCT01261338|Antimetabolites|antimetabolites|mesh-ancestor
92742996|NCT01261338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742997|NCT01261338|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92742998|NCT01260948|Donepezil|donepezil|mesh-list
92742999|NCT01260948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92743000|NCT01260948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743001|NCT01260948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743002|NCT01260948|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743003|NCT01260948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743004|NCT01260948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743005|NCT01260948|Nootropic Agents|nootropic agents|mesh-ancestor
92743006|NCT01025284|Lenograstim|lenograstim|mesh-list
92743007|NCT01025284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92743008|NCT01025284|Immunologic Factors|immunologic factors|mesh-ancestor
92743009|NCT01025284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743010|NCT02873026|Triamcinolone|triamcinolone|mesh-list
92743011|NCT02873026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92743012|NCT02873026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92743013|NCT02873026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92743014|NCT02873026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743015|NCT02873026|Glucocorticoids|glucocorticoids|mesh-ancestor
92743016|NCT02873026|Hormones|hormones|mesh-ancestor
92743017|NCT02873026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743019|NCT02873026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743020|NCT02873026|Immunologic Factors|immunologic factors|mesh-ancestor
92743021|NCT02873026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743022|NCT02873026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743023|NCT01056718|Nebivolol|nebivolol|mesh-list
92743024|NCT01056718|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92743025|NCT01056718|Vasodilator Agents|vasodilator agents|mesh-ancestor
92743026|NCT01056718|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92743027|NCT01056718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92743028|NCT01056718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92743029|NCT01056718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92743030|NCT01056718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743031|NCT01056718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743032|NCT01056718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743033|NCT01298570|Leucovorin|leucovorin|mesh-list
92743034|NCT01298570|Fluorouracil|fluorouracil|mesh-list
92743035|NCT01298570|Irinotecan|irinotecan|mesh-list
92743036|NCT01298570|Levoleucovorin|levoleucovorin|mesh-list
92743037|NCT01298570|Antimetabolites|antimetabolites|mesh-ancestor
92743038|NCT01298570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611421|NCT00148746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611422|NCT00148746|Glucocorticoids|glucocorticoids|mesh-ancestor
92611423|NCT00148746|Hormones|hormones|mesh-ancestor
92743039|NCT01298570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743040|NCT01298570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743041|NCT01298570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743042|NCT01298570|Immunologic Factors|immunologic factors|mesh-ancestor
92743043|NCT01298570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743044|NCT01298570|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92743045|NCT01298570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92743046|NCT01298570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743047|NCT01298570|Antidotes|antidotes|mesh-ancestor
92743048|NCT01298570|Protective Agents|protective agents|mesh-ancestor
92743049|NCT01298570|Vitamin B Complex|vitamin b complex|mesh-ancestor
92743050|NCT01298570|Vitamins|vitamins|mesh-ancestor
92743051|NCT01298570|Micronutrients|micronutrients|mesh-ancestor
92743052|NCT01259856|Aspirin|aspirin|mesh-list
92743053|NCT01259856|Interferons|interferons|mesh-list
92743054|NCT01259856|Interferon-alpha|interferon-alpha|mesh-list
92743055|NCT01259856|Interferon alpha-2|interferon alpha-2|mesh-list
92743056|NCT01259856|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92743057|NCT01259856|Hydroxyurea|hydroxyurea|mesh-list
92743058|NCT01259856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743059|NCT01259856|Antiviral Agents|antiviral agents|mesh-ancestor
92743060|NCT01259856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743061|NCT01259856|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92743062|NCT01259856|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92743063|NCT01259856|Analgesics|analgesics|mesh-ancestor
92743064|NCT01259856|Sensory System Agents|sensory system agents|mesh-ancestor
92743065|NCT01259856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743066|NCT01259856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743067|NCT01259856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743068|NCT01259856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743069|NCT01259856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92743070|NCT01259856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92743071|NCT01259856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743072|NCT01259856|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92743073|NCT01259856|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92743074|NCT01259856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743075|NCT01259856|Antipyretics|antipyretics|mesh-ancestor
92743076|NCT01259856|Immunologic Factors|immunologic factors|mesh-ancestor
92743077|NCT01259856|Antisickling Agents|antisickling agents|mesh-ancestor
92743078|NCT01259856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92743079|NCT00624000|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92743080|NCT00624000|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92743081|NCT00624000|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92743082|NCT00624000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743083|NCT01259466|Nicotine|nicotine|mesh-list
92743084|NCT01259466|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92743085|NCT01259466|Autonomic Agents|autonomic agents|mesh-ancestor
92743086|NCT01259466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743087|NCT01259466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743088|NCT01259466|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92743089|NCT01259466|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92743090|NCT01259466|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743091|NCT01259466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743092|NCT01259466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743097|NCT01259388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743098|NCT01259388|Antimanic Agents|antimanic agents|mesh-ancestor
92743099|NCT01259388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92743100|NCT01259388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743101|NCT01259388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743102|NCT05525910|Ritonavir|ritonavir|mesh-list
92743103|NCT05525910|Nirmatrelvir|nirmatrelvir|mesh-list
92743104|NCT05525910|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92743105|NCT05525910|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92743106|NCT05525910|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92743107|NCT05525910|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743108|NCT05525910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743109|NCT05525910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743110|NCT05525910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92743111|NCT05525910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92743112|NCT05525910|Antiviral Agents|antiviral agents|mesh-ancestor
92611424|NCT00148746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92611425|NCT00148746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92611426|NCT00148746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743113|NCT05525910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743114|NCT05525910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92743115|NCT05525910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92743116|NCT00624078|Antivenins|antivenins|mesh-list
92743117|NCT00624078|Immunologic Factors|immunologic factors|mesh-ancestor
92743118|NCT00624078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743119|NCT05286528|Imatinib Mesylate|imatinib mesylate|mesh-list
92743120|NCT05286528|Dasatinib|dasatinib|mesh-list
92743121|NCT05286528|Ponatinib|ponatinib|mesh-list
92743122|NCT05286528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743123|NCT05286528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743124|NCT05286528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743125|NCT05286528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743126|NCT01297244|Tivozanib|tivozanib|mesh-list
92743127|NCT01297244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743128|NCT01297244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743129|NCT01297244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743130|NCT04752696|Leucovorin|leucovorin|mesh-list
92743131|NCT04752696|Fluorouracil|fluorouracil|mesh-list
92743132|NCT04752696|Irinotecan|irinotecan|mesh-list
92743133|NCT04752696|Onvansertib|onvansertib|mesh-list
92743134|NCT04752696|Antimetabolites|antimetabolites|mesh-ancestor
92743135|NCT04752696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743136|NCT04752696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743137|NCT04752696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743138|NCT04752696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743139|NCT04752696|Immunologic Factors|immunologic factors|mesh-ancestor
92743140|NCT04752696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743141|NCT04752696|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92743142|NCT04752696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92743143|NCT04752696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743144|NCT04752696|Antidotes|antidotes|mesh-ancestor
92743145|NCT04752696|Protective Agents|protective agents|mesh-ancestor
92743146|NCT04752696|Vitamin B Complex|vitamin b complex|mesh-ancestor
92743147|NCT04752696|Vitamins|vitamins|mesh-ancestor
92743148|NCT04752696|Micronutrients|micronutrients|mesh-ancestor
92743149|NCT04752696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743150|NCT04554732|Mitogens|mitogens|mesh-list
92743151|NCT04554732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92743152|NCT04554732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743153|NCT04481256|Paclitaxel|paclitaxel|mesh-list
92743154|NCT04481256|Carboplatin|carboplatin|mesh-list
92743155|NCT04481256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92743156|NCT04481256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743157|NCT04481256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92743158|NCT04481256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92743159|NCT04481256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92743160|NCT04481256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743161|NCT04387110|Ocrelizumab|ocrelizumab|mesh-list
92743162|NCT04387110|Immunologic Factors|immunologic factors|mesh-ancestor
92743163|NCT04387110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743164|NCT03434418|Osimertinib|osimertinib|mesh-list
92743165|NCT03434418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743168|NCT03434418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743169|NCT03377478|Sofosbuvir|sofosbuvir|mesh-list
92743170|NCT03377478|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92743171|NCT03377478|Velpatasvir|velpatasvir|mesh-list
92743172|NCT03377478|Antiviral Agents|antiviral agents|mesh-ancestor
92743173|NCT03377478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743174|NCT03181932|Vancomycin|vancomycin|mesh-list
92743175|NCT03181932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92743176|NCT03181932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743177|NCT02583672|Acetylcysteine|acetylcysteine|mesh-list
92743178|NCT02583672|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92743179|NCT02583672|Antiviral Agents|antiviral agents|mesh-ancestor
92743180|NCT02583672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743181|NCT02583672|Expectorants|expectorants|mesh-ancestor
92743182|NCT02583672|Respiratory System Agents|respiratory system agents|mesh-ancestor
92743183|NCT02583672|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92743184|NCT02583672|Antioxidants|antioxidants|mesh-ancestor
92611427|NCT00148746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611428|NCT00148746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611429|NCT00148746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611430|NCT00148746|Analgesics|analgesics|mesh-ancestor
92743185|NCT02583672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743186|NCT02583672|Protective Agents|protective agents|mesh-ancestor
92743187|NCT02583672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743188|NCT02583672|Antidotes|antidotes|mesh-ancestor
92743189|NCT02888730|Tobramycin|tobramycin|mesh-list
92743190|NCT02888730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92743191|NCT02888730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743192|NCT01696734|Domperidone|domperidone|mesh-list
92743193|NCT01696734|Antiemetics|antiemetics|mesh-ancestor
92743194|NCT01696734|Autonomic Agents|autonomic agents|mesh-ancestor
92743195|NCT01696734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743196|NCT01696734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743197|NCT01696734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743198|NCT01696734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92743199|NCT01696734|Dopamine Agents|dopamine agents|mesh-ancestor
92743200|NCT01696734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743201|NCT01696734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743202|NCT01598298|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92743203|NCT01598298|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92743204|NCT01598298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92743205|NCT01598298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92743206|NCT01598298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743207|NCT01598298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743208|NCT01598298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743209|NCT01598298|Analgesics|analgesics|mesh-ancestor
92743210|NCT01598298|Sensory System Agents|sensory system agents|mesh-ancestor
92743211|NCT01598298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743212|NCT01598298|Antidepressive Agents|antidepressive agents|mesh-ancestor
92743213|NCT01598298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743214|NCT01598298|Dopamine Agents|dopamine agents|mesh-ancestor
92743215|NCT02888652|Clopidogrel|clopidogrel|mesh-list
92743216|NCT02888652|Ticagrelor|ticagrelor|mesh-list
92743217|NCT02888652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92743218|NCT02888652|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92743219|NCT02888652|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92743220|NCT02888652|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92743221|NCT02888652|Purinergic Agents|purinergic agents|mesh-ancestor
92743222|NCT02888652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743223|NCT02888652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743224|NCT02888652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743225|NCT01235949|Acetaminophen|acetaminophen|mesh-list
92743226|NCT01235949|Ibuprofen|ibuprofen|mesh-list
92743227|NCT01235949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92743228|NCT01235949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92743229|NCT01235949|Analgesics|analgesics|mesh-ancestor
92743230|NCT01235949|Sensory System Agents|sensory system agents|mesh-ancestor
92743231|NCT01235949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743232|NCT01235949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743233|NCT01235949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743234|NCT01235949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743235|NCT01235949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92743236|NCT01235949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743237|NCT01235949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743238|NCT01235949|Antipyretics|antipyretics|mesh-ancestor
92743240|NCT00691158|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92743241|NCT00691158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743242|NCT00691158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743243|NCT00691158|Appetite Depressants|appetite depressants|mesh-ancestor
92743244|NCT00691158|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92743245|NCT00691158|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92743246|NCT00691158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743247|NCT01235793|Temozolomide|temozolomide|mesh-list
92743248|NCT01235793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92743249|NCT01235793|Alkylating Agents|alkylating agents|mesh-ancestor
92611431|NCT00148746|Sensory System Agents|sensory system agents|mesh-ancestor
92611433|NCT00148785|Indinavir|indinavir|mesh-list
92611434|NCT00148785|Fosamprenavir|fosamprenavir|mesh-list
92611435|NCT00148785|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92743250|NCT01235793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743251|NCT01235793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743253|NCT05601648|Hallucinogens|hallucinogens|mesh-ancestor
92743254|NCT05601648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743255|NCT05601648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743256|NCT01235715|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92743257|NCT01235715|Hemostatics|hemostatics|mesh-ancestor
92743258|NCT01235715|Coagulants|coagulants|mesh-ancestor
92743259|NCT01235403|Lacosamide|lacosamide|mesh-list
92743260|NCT01235403|Anticonvulsants|anticonvulsants|mesh-ancestor
92743261|NCT01235403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92743262|NCT01235403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92743263|NCT01235403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92743264|NCT01235403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743265|NCT01024036|Siltuximab|siltuximab|mesh-list
92743266|NCT01024036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743267|NCT01234467|Rituximab|rituximab|mesh-list
92743268|NCT01234467|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92743269|NCT01234467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743270|NCT01234467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743271|NCT01234467|Immunologic Factors|immunologic factors|mesh-ancestor
92743272|NCT01234467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743273|NCT01234467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743274|NCT01234467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92743275|NCT01234467|Alkylating Agents|alkylating agents|mesh-ancestor
92743276|NCT01234467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743277|NCT01233999|Botulinum Toxins|botulinum toxins|mesh-list
92743278|NCT01233999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92743279|NCT01233999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92743280|NCT01233999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92743281|NCT01233999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92743282|NCT01233999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743283|NCT01233999|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743284|NCT01233999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743285|NCT01233999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743286|NCT01233999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92743287|NCT01233999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743288|NCT01233687|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92743289|NCT01233687|Rilotumumab|rilotumumab|mesh-list
92743290|NCT01233687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743291|NCT01233687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743292|NCT01233687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743293|NCT01233687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743294|NCT01233687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743295|NCT01233609|Valproic Acid|valproic acid|mesh-list
92743296|NCT01233609|Anticonvulsants|anticonvulsants|mesh-ancestor
92743297|NCT01233609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743298|NCT01233609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743299|NCT01233609|GABA Agents|gaba agents|mesh-ancestor
92743300|NCT01233609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743301|NCT01233609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743302|NCT01233609|Antimanic Agents|antimanic agents|mesh-ancestor
92743303|NCT01233609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92743304|NCT01233609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743305|NCT01233609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743306|NCT01232283|Apremilast|apremilast|mesh-list
92743307|NCT01232283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92743308|NCT01232283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92743309|NCT01232283|Analgesics|analgesics|mesh-ancestor
92743310|NCT01232283|Sensory System Agents|sensory system agents|mesh-ancestor
92743311|NCT01232283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743324|NCT01232127|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92743325|NCT01232127|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92743326|NCT01232127|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743327|NCT01232127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611436|NCT00148785|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92611437|NCT00148785|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743328|NCT01232127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743329|NCT01232127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92743330|NCT01232127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92743331|NCT01232127|Antiviral Agents|antiviral agents|mesh-ancestor
92743332|NCT01232127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743333|NCT01232127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92743334|NCT01232127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92743335|NCT01232127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92743336|NCT01232127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92743337|NCT01232127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743338|NCT01232127|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92743339|NCT01232127|Histamine Antagonists|histamine antagonists|mesh-ancestor
92743340|NCT01232127|Histamine Agents|histamine agents|mesh-ancestor
92743341|NCT01232127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743342|NCT01232127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743343|NCT01258608|Sorafenib|sorafenib|mesh-list
92743344|NCT01258608|Mapatumumab|mapatumumab|mesh-list
92743345|NCT01258608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743346|NCT01258608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743347|NCT01258608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743348|NCT01258608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743349|NCT01231659|Everolimus|everolimus|mesh-list
92743350|NCT01231659|Letrozole|letrozole|mesh-list
92743351|NCT01231659|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92743352|NCT01231659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743353|NCT01231659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743354|NCT01231659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743355|NCT01231659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743356|NCT01231659|Immunologic Factors|immunologic factors|mesh-ancestor
92743357|NCT01231659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743358|NCT01231659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743359|NCT01231659|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92743360|NCT01231659|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92743361|NCT01231659|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92743362|NCT01231659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92743363|NCT01231659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743364|NCT02875288|Bupivacaine|bupivacaine|mesh-list
92743365|NCT02875288|Anesthetics, Local|anesthetics, local|mesh-ancestor
92743366|NCT02875288|Anesthetics|anesthetics|mesh-ancestor
92743367|NCT02875288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743368|NCT02875288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743369|NCT02875288|Sensory System Agents|sensory system agents|mesh-ancestor
92743370|NCT02875288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743371|NCT01054222|Fesoterodine|fesoterodine|mesh-list
92743372|NCT01054222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92743373|NCT01054222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92743374|NCT01054222|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743377|NCT01054222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743379|NCT01052428|Metoprolol|metoprolol|mesh-list
92743380|NCT01052428|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92743381|NCT01052428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92743382|NCT01052428|Sympatholytics|sympatholytics|mesh-ancestor
92743383|NCT01052428|Autonomic Agents|autonomic agents|mesh-ancestor
92743384|NCT01052428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743385|NCT01052428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743386|NCT01052428|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92743387|NCT01052428|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92743388|NCT01052428|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92743389|NCT01052428|Adrenergic Agents|adrenergic agents|mesh-ancestor
92743390|NCT01052428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743391|NCT01052428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743392|NCT01052272|Allopurinol|allopurinol|mesh-list
92743393|NCT01052272|Candesartan|candesartan|mesh-list
92743394|NCT01052272|Candesartan cilexetil|candesartan cilexetil|mesh-list
92743395|NCT01052272|Ramipril|ramipril|mesh-list
92743396|NCT01052272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92743397|NCT01052272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92743398|NCT01052272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92611438|NCT00148785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611439|NCT00148785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611440|NCT00148785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92611441|NCT00148785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92611442|NCT00148785|Antiviral Agents|antiviral agents|mesh-ancestor
92743399|NCT01052272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743400|NCT01052272|Antimetabolites|antimetabolites|mesh-ancestor
92743401|NCT01052272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743402|NCT01052272|Gout Suppressants|gout suppressants|mesh-ancestor
92743403|NCT01052272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743404|NCT01052272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92743405|NCT01052272|Antioxidants|antioxidants|mesh-ancestor
92743406|NCT01052272|Protective Agents|protective agents|mesh-ancestor
92743407|NCT01052272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743408|NCT01052272|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92743409|NCT01052272|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743410|NCT01257204|Interferons|interferons|mesh-list
92743411|NCT01257204|Ribavirin|ribavirin|mesh-list
92743412|NCT01257204|Interferon-alpha|interferon-alpha|mesh-list
92743413|NCT01257204|Interferon alpha-2|interferon alpha-2|mesh-list
92743414|NCT01257204|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92743415|NCT01257204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743416|NCT01257204|Antiviral Agents|antiviral agents|mesh-ancestor
92743417|NCT01257204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743418|NCT01257204|Antimetabolites|antimetabolites|mesh-ancestor
92743419|NCT01257204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743420|NCT01257204|Immunologic Factors|immunologic factors|mesh-ancestor
92743421|NCT01257204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743422|NCT01231581|Gemcitabine|gemcitabine|mesh-list
92743423|NCT01231581|Trametinib|trametinib|mesh-list
92743424|NCT01231581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743425|NCT01231581|Antimetabolites|antimetabolites|mesh-ancestor
92743426|NCT01231581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743427|NCT01231581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743428|NCT01231581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743429|NCT01231581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743430|NCT01050634|Exemestane|exemestane|mesh-list
92743431|NCT01050634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743432|NCT01050634|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92743433|NCT01050634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92743434|NCT01050634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743435|NCT01050634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743436|NCT01050634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92743437|NCT01050634|Hormone Antagonists|hormone antagonists|mesh-ancestor
92743438|NCT01050634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743439|NCT01050634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743440|NCT01020526|Pregabalin|pregabalin|mesh-list
92743441|NCT01020526|Analgesics|analgesics|mesh-ancestor
92743442|NCT01020526|Sensory System Agents|sensory system agents|mesh-ancestor
92743443|NCT01020526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743444|NCT01020526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743445|NCT01020526|Anticonvulsants|anticonvulsants|mesh-ancestor
92743446|NCT01020526|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92743447|NCT01020526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92743450|NCT01020526|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92743451|NCT01020526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92743452|NCT01020526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743453|NCT01020526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743454|NCT01020448|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92743455|NCT01020448|Luteolytic Agents|luteolytic agents|mesh-ancestor
92743456|NCT01020448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92743457|NCT01020448|Contraceptive Agents|contraceptive agents|mesh-ancestor
92743458|NCT01020448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066357|NCT03083704|Enoxaparin|enoxaparin|mesh-list
92743459|NCT01020448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743460|NCT01020448|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92743461|NCT01020448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92743462|NCT01020448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743463|NCT04286230|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92743464|NCT04286230|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92743465|NCT04286230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743466|NCT04286230|Antitubercular Agents|antitubercular agents|mesh-ancestor
92743467|NCT01256658|Lumefantrine|lumefantrine|mesh-list
92743468|NCT01256658|Artemether|artemether|mesh-list
92743469|NCT01256658|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92743470|NCT01256658|Antimalarials|antimalarials|mesh-ancestor
92743471|NCT01256658|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92743472|NCT01256658|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92743473|NCT01256658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743474|NCT01256190|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92743475|NCT01256190|Fibrin Foam|fibrin foam|mesh-list
92743476|NCT01256190|Hemostatics|hemostatics|mesh-ancestor
92743477|NCT01256190|Coagulants|coagulants|mesh-ancestor
92743478|NCT02888574|Oxytocin|oxytocin|mesh-list
92743479|NCT02888574|Oxytocics|oxytocics|mesh-ancestor
92743480|NCT02888574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92743481|NCT02888574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743482|NCT01231503|Vaccines|vaccines|mesh-list
92743483|NCT01231503|Immunologic Factors|immunologic factors|mesh-ancestor
92743484|NCT01231503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743485|NCT01228071|Testosterone|testosterone|mesh-list
92743486|NCT01228071|Androgens|androgens|mesh-ancestor
92743487|NCT01228071|Hormones|hormones|mesh-ancestor
92743488|NCT01228071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743489|NCT01228071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743490|NCT04319289|Vitamin D|vitamin d|mesh-list
92743491|NCT04319289|Ergocalciferols|ergocalciferols|mesh-list
92743492|NCT04319289|Cholecalciferol|cholecalciferol|mesh-list
92743493|NCT04319289|Vitamins|vitamins|mesh-list
92743494|NCT04319289|Micronutrients|micronutrients|mesh-ancestor
92743495|NCT04319289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743496|NCT04319289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92743497|NCT04319289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92743498|NCT01008475|Irinotecan|irinotecan|mesh-list
92743499|NCT01008475|Cetuximab|cetuximab|mesh-list
92743500|NCT01008475|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92743501|NCT01008475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92743502|NCT01008475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743503|NCT01008475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743504|NCT01008475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743505|NCT01008475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743506|NCT01226745|Ceralifimod|ceralifimod|mesh-list
92743507|NCT01226745|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92743508|NCT01226745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743509|NCT01226745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743510|NCT01226745|Immunologic Factors|immunologic factors|mesh-ancestor
92743511|NCT01226745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743512|NCT01226511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92743513|NCT01226511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92743514|NCT01226511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92743515|NCT01226511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92743516|NCT01226511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743517|NCT01226511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743518|NCT01226511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743519|NCT01226511|Analgesics|analgesics|mesh-ancestor
92743520|NCT01226511|Sensory System Agents|sensory system agents|mesh-ancestor
92743521|NCT01226511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743522|NCT01226511|Antidepressive Agents|antidepressive agents|mesh-ancestor
92743523|NCT01226511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743524|NCT01226511|Dopamine Agents|dopamine agents|mesh-ancestor
92743525|NCT01226043|Insulin Glargine|insulin glargine|mesh-list
92743526|NCT01226043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743527|NCT01226043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743528|NCT01001377|Cetuximab|cetuximab|mesh-list
92743529|NCT01001377|Panitumumab|panitumumab|mesh-list
92743530|NCT01001377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743531|NCT01001377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743532|NCT01225887|Nintedanib|nintedanib|mesh-list
92743533|NCT01225887|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92743534|NCT01225887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743535|NCT01225887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743536|NCT01225887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743537|NCT01225887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743538|NCT01296932|BI 836826|bi 836826|mesh-list
92743539|NCT01296932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743540|NCT01296932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611443|NCT00148785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611444|NCT00148785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92611445|NCT00148785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92743541|NCT01296698|Nicotine|nicotine|mesh-list
92743542|NCT01296698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92743543|NCT01296698|Autonomic Agents|autonomic agents|mesh-ancestor
92743544|NCT01296698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743545|NCT01296698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743546|NCT01296698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92743547|NCT01296698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92743548|NCT01296698|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743549|NCT01296698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743550|NCT01296698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743551|NCT01001221|Gemcitabine|gemcitabine|mesh-list
92743552|NCT01001221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743553|NCT01001221|Antimetabolites|antimetabolites|mesh-ancestor
92743554|NCT01001221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743555|NCT01001221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743556|NCT01296152|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92743557|NCT01296152|Medroxyprogesterone|medroxyprogesterone|mesh-list
92743558|NCT01296152|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92743559|NCT01296152|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92743560|NCT01296152|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92743561|NCT01296152|Contraceptive Agents|contraceptive agents|mesh-ancestor
92743562|NCT01296152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92743563|NCT01296152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743564|NCT01296152|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92743565|NCT01296152|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92743566|NCT01296152|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92743567|NCT01296152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92743568|NCT01296152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743569|NCT01002547|Vitamins|vitamins|mesh-list
92743570|NCT01002547|Vitamin E|vitamin e|mesh-list
92743571|NCT01002547|Tocopherols|tocopherols|mesh-list
92743572|NCT01002547|Tocotrienols|tocotrienols|mesh-list
92743573|NCT01002547|alpha-Tocopherol|alpha-tocopherol|mesh-list
92743574|NCT01002547|Pioglitazone|pioglitazone|mesh-list
92743575|NCT01002547|Micronutrients|micronutrients|mesh-ancestor
92743576|NCT01002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743577|NCT01002547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743578|NCT01002547|Antioxidants|antioxidants|mesh-ancestor
92743579|NCT01002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743580|NCT01002547|Protective Agents|protective agents|mesh-ancestor
92743581|NCT04295161|Abiraterone Acetate|abiraterone acetate|mesh-list
92743582|NCT04295161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743583|NCT04295161|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92743584|NCT04295161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743585|NCT04295161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743586|NCT04295161|Hormone Antagonists|hormone antagonists|mesh-ancestor
92743587|NCT04295161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743588|NCT04295161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743589|NCT04295161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92743590|NCT04325659|Lofexidine|lofexidine|mesh-list
92743591|NCT04325659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92743592|NCT04325659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92743593|NCT04325659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743618|NCT00998335|Insulin Aspart|insulin aspart|mesh-list
92743619|NCT00998335|Insulin, Long-Acting|insulin, long-acting|mesh-list
92743620|NCT00998335|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92743621|NCT00998335|Insulin Detemir|insulin detemir|mesh-list
92743622|NCT00998335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743623|NCT00998335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743624|NCT02871505|Penicillins|penicillins|mesh-list
92743625|NCT02871505|Penicillin G|penicillin g|mesh-list
92743626|NCT02871505|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92743627|NCT02871505|Penicillin G Procaine|penicillin g procaine|mesh-list
92743628|NCT02871505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92743629|NCT02871505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743630|NCT01294670|Etoposide|etoposide|mesh-list
92743631|NCT01294670|Vorinostat|vorinostat|mesh-list
92743632|NCT01294670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92743633|NCT01294670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743634|NCT01294670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92743635|NCT01294670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92743636|NCT01294670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743637|NCT01294670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743638|NCT01294670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92743639|NCT01006603|Glimepiride|glimepiride|mesh-list
92743640|NCT01006603|Saxagliptin|saxagliptin|mesh-list
92743641|NCT01006603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92743642|NCT01006603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743643|NCT01006603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743644|NCT01006603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743645|NCT01006603|Immunologic Factors|immunologic factors|mesh-ancestor
92743646|NCT01006603|Incretins|incretins|mesh-ancestor
92743650|NCT01006603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743651|NCT01006603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743652|NCT01006603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743653|NCT00997321|Ketamine|ketamine|mesh-list
92743654|NCT00997321|Propofol|propofol|mesh-list
92743655|NCT00997321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92743656|NCT00997321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743657|NCT00997321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743658|NCT00997321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92743659|NCT00997321|Anesthetics, General|anesthetics, general|mesh-ancestor
92743660|NCT00997321|Anesthetics|anesthetics|mesh-ancestor
92743661|NCT00997321|Analgesics|analgesics|mesh-ancestor
92743662|NCT00997321|Sensory System Agents|sensory system agents|mesh-ancestor
92743663|NCT00997321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743664|NCT00997321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92743665|NCT00997321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92743666|NCT00997321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92743667|NCT00997321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743668|NCT00997321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743669|NCT01294592|Tamsulosin|tamsulosin|mesh-list
92743670|NCT01294592|Dutasteride|dutasteride|mesh-list
92743671|NCT01294592|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92743672|NCT01294592|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92743673|NCT01294592|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92743674|NCT01294592|Adrenergic Agents|adrenergic agents|mesh-ancestor
92743675|NCT01294592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743676|NCT01294592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743677|NCT01294592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743678|NCT01294592|Urological Agents|urological agents|mesh-ancestor
92743679|NCT01294592|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92743680|NCT01294592|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92743681|NCT01294592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743682|NCT01294592|Hormone Antagonists|hormone antagonists|mesh-ancestor
92743683|NCT01294592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743684|NCT00997243|Azacitidine|azacitidine|mesh-list
92743685|NCT00997243|Lintuzumab|lintuzumab|mesh-list
92743686|NCT00997243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743687|NCT00997243|Antimetabolites|antimetabolites|mesh-ancestor
92743688|NCT00997243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743689|NCT00997243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743690|NCT00997243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743691|NCT00997243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743692|NCT02869321|Fentanyl|fentanyl|mesh-list
92743693|NCT02869321|Morphine|morphine|mesh-list
92743694|NCT02869321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92743695|NCT02869321|Narcotics|narcotics|mesh-ancestor
92743696|NCT02869321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743697|NCT02869321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743698|NCT02869321|Analgesics|analgesics|mesh-ancestor
92743699|NCT02869321|Sensory System Agents|sensory system agents|mesh-ancestor
92743700|NCT02869321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743701|NCT02869321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92743702|NCT02869321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92743703|NCT02869321|Anesthetics, General|anesthetics, general|mesh-ancestor
92743704|NCT02869321|Anesthetics|anesthetics|mesh-ancestor
92743705|NCT01294436|Dapagliflozin|dapagliflozin|mesh-list
92743706|NCT01294436|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92743707|NCT01294436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743708|NCT01294436|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743709|NCT01294436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611447|NCT00148824|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92611448|NCT00148824|Immunologic Factors|immunologic factors|mesh-ancestor
92611449|NCT00148824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743710|NCT01294358|Gemcitabine|gemcitabine|mesh-list
92743711|NCT01294358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743712|NCT01294358|Antimetabolites|antimetabolites|mesh-ancestor
92743713|NCT01294358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743714|NCT01294358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743715|NCT01224639|Vaccines|vaccines|mesh-list
92743716|NCT01224639|Immunologic Factors|immunologic factors|mesh-ancestor
92743721|NCT01293968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92743722|NCT01293968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92743723|NCT01293968|Analgesics|analgesics|mesh-ancestor
92743724|NCT01293968|Sensory System Agents|sensory system agents|mesh-ancestor
92743725|NCT01293968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743726|NCT01293968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743727|NCT01293968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743728|NCT01293968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743729|NCT01293968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92743730|NCT01293968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743731|NCT01293968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743732|NCT01293968|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92743733|NCT01293968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92743734|NCT01293968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743735|NCT01293968|Anesthetics, Local|anesthetics, local|mesh-ancestor
92743736|NCT01293968|Anesthetics|anesthetics|mesh-ancestor
92743737|NCT01293968|Antiemetics|antiemetics|mesh-ancestor
92743738|NCT01293968|Autonomic Agents|autonomic agents|mesh-ancestor
92743739|NCT01293968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743740|NCT01293968|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92743741|NCT01293968|Histamine Antagonists|histamine antagonists|mesh-ancestor
92743742|NCT01293968|Histamine Agents|histamine agents|mesh-ancestor
92743743|NCT01293968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743744|NCT01293968|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92743745|NCT01293968|Antipruritics|antipruritics|mesh-ancestor
92743746|NCT01293968|Dermatologic Agents|dermatologic agents|mesh-ancestor
92743748|NCT01293032|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92743749|NCT01293032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743750|NCT01293032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92743751|NCT01293032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92743752|NCT01293032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743753|NCT01293032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743754|NCT01293032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92743755|NCT01293032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743756|NCT01293032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92743757|NCT01293032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92743758|NCT01293032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92743759|NCT01293032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92743760|NCT01293032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743762|NCT01224171|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743763|NCT01223937|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92743764|NCT01223937|Hemostatics|hemostatics|mesh-ancestor
92743765|NCT01223937|Coagulants|coagulants|mesh-ancestor
92743766|NCT01223937|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92743767|NCT01223937|Natriuretic Agents|natriuretic agents|mesh-ancestor
92743768|NCT01223937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743769|NCT01223235|Bevacizumab|bevacizumab|mesh-list
92743770|NCT01223235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743771|NCT01223235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743772|NCT01223235|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92743773|NCT01223235|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92743774|NCT01223235|Growth Substances|growth substances|mesh-ancestor
92743775|NCT01223235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743776|NCT01223235|Growth Inhibitors|growth inhibitors|mesh-ancestor
92743777|NCT00993967|Idebenone|idebenone|mesh-list
92743778|NCT00993967|Antioxidants|antioxidants|mesh-ancestor
92743779|NCT00993967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743780|NCT00993967|Protective Agents|protective agents|mesh-ancestor
92743781|NCT00993967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743782|NCT04204603|CKD-506|ckd-506|mesh-list
92743783|NCT04204603|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92743784|NCT04204603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743785|NCT04204603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743786|NCT01222533|Tiotropium Bromide|tiotropium bromide|mesh-list
92743787|NCT01222533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92743788|NCT01222533|Autonomic Agents|autonomic agents|mesh-ancestor
92743790|NCT01222533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743792|NCT01222533|Respiratory System Agents|respiratory system agents|mesh-ancestor
92743793|NCT01222533|Parasympatholytics|parasympatholytics|mesh-ancestor
92743794|NCT01222533|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92743795|NCT01222533|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743796|NCT01222533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743797|NCT01222533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743798|NCT01221753|Carboplatin|carboplatin|mesh-list
92743799|NCT01221753|Docetaxel|docetaxel|mesh-list
92743800|NCT01221753|Fluorouracil|fluorouracil|mesh-list
92743801|NCT01221753|Cetuximab|cetuximab|mesh-list
92743802|NCT01221753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743803|NCT01221753|Tubulin Modulators|tubulin modulators|mesh-ancestor
92743804|NCT01221753|Antimitotic Agents|antimitotic agents|mesh-ancestor
92743805|NCT01221753|Mitosis Modulators|mitosis modulators|mesh-ancestor
92743806|NCT01221753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743807|NCT01221753|Antimetabolites|antimetabolites|mesh-ancestor
92743808|NCT01221753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92743809|NCT01221753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743810|NCT01221753|Immunologic Factors|immunologic factors|mesh-ancestor
92743811|NCT01221753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743812|NCT01221753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743813|NCT02888223|Factor VIII|factor viii|mesh-list
92743814|NCT02888223|Coagulants|coagulants|mesh-ancestor
92743815|NCT01014988|Zanamivir|zanamivir|mesh-list
92743816|NCT01014988|Antiviral Agents|antiviral agents|mesh-ancestor
92743817|NCT01014988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743818|NCT01014988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743819|NCT01014988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743820|NCT01019980|Acetaminophen|acetaminophen|mesh-list
92743821|NCT01019980|Diclofenac|diclofenac|mesh-list
92743822|NCT01019980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92743823|NCT01019980|Analgesics|analgesics|mesh-ancestor
92743824|NCT01019980|Sensory System Agents|sensory system agents|mesh-ancestor
92743825|NCT01019980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743826|NCT01019980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743827|NCT01019980|Antipyretics|antipyretics|mesh-ancestor
92743828|NCT01019980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92743829|NCT01019980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743830|NCT01019980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743831|NCT01019980|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92743832|NCT01019980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743833|NCT01019980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743834|NCT00993499|Sirolimus|sirolimus|mesh-list
92743835|NCT00993499|Afatinib|afatinib|mesh-list
92743836|NCT00993499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92743837|NCT00993499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743838|NCT00993499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92743839|NCT00993499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743840|NCT00993499|Antifungal Agents|antifungal agents|mesh-ancestor
92743841|NCT00993499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92743842|NCT00993499|Immunologic Factors|immunologic factors|mesh-ancestor
92743843|NCT00993499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743844|NCT00993499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743845|NCT00993499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743846|NCT00993499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743847|NCT01014442|Mycophenolic Acid|mycophenolic acid|mesh-list
92743848|NCT01014442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92743849|NCT01014442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743850|NCT01014442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92743851|NCT01014442|Antitubercular Agents|antitubercular agents|mesh-ancestor
92743852|NCT01014442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92743853|NCT01014442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743854|NCT01014442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743855|NCT01014442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743856|NCT00996307|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92611451|NCT00466570|Gatifloxacin|gatifloxacin|mesh-list
92611452|NCT00466570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611453|NCT00466570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611454|NCT00466570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92611455|NCT00466570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92611456|NCT00466570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743857|NCT00996307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92743858|NCT00996307|Immunologic Factors|immunologic factors|mesh-ancestor
92743859|NCT00996307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743860|NCT02869165|Estrogens|estrogens|mesh-list
92743861|NCT02869165|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92743862|NCT02869165|Hormones|hormones|mesh-ancestor
92743867|NCT01219959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92743868|NCT00993421|Sibutramine|sibutramine|mesh-list
92743869|NCT00993421|Metoprolol|metoprolol|mesh-list
92743870|NCT00993421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92743871|NCT00993421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92743872|NCT00993421|Sympatholytics|sympatholytics|mesh-ancestor
92743873|NCT00993421|Autonomic Agents|autonomic agents|mesh-ancestor
92743874|NCT00993421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743875|NCT00993421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743876|NCT00993421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92743877|NCT00993421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92743878|NCT00993421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92743879|NCT00993421|Adrenergic Agents|adrenergic agents|mesh-ancestor
92743880|NCT00993421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743881|NCT00993421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743882|NCT00993421|Antidepressive Agents|antidepressive agents|mesh-ancestor
92743883|NCT00993421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743884|NCT00993421|Appetite Depressants|appetite depressants|mesh-ancestor
92743885|NCT00993421|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92743886|NCT01014208|Rituximab|rituximab|mesh-list
92743887|NCT01014208|Ofatumumab|ofatumumab|mesh-list
92743888|NCT01014208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92743889|NCT01014208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743890|NCT01014208|Immunologic Factors|immunologic factors|mesh-ancestor
92743891|NCT01014208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743892|NCT01014208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743893|NCT04205578|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92743894|NCT04205578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92743895|NCT04205578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92743896|NCT04205578|Protective Agents|protective agents|mesh-ancestor
92743897|NCT04205578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743898|NCT00991939|Dexamethasone|dexamethasone|mesh-list
92743899|NCT00991939|Prednisone|prednisone|mesh-list
92743900|NCT00991939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743901|NCT00991939|Antiemetics|antiemetics|mesh-ancestor
92743902|NCT00991939|Autonomic Agents|autonomic agents|mesh-ancestor
92743903|NCT00991939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743904|NCT00991939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743905|NCT00991939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743906|NCT00991939|Glucocorticoids|glucocorticoids|mesh-ancestor
92743907|NCT00991939|Hormones|hormones|mesh-ancestor
92743908|NCT00991939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743909|NCT00991939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92398907|NCT01400256|Valsartan|valsartan|mesh-list
92743910|NCT00991939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743911|NCT02868385|Praziquantel|praziquantel|mesh-list
92743912|NCT02868385|Anthelmintics|anthelmintics|mesh-ancestor
92743913|NCT02868385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92743914|NCT02868385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743915|NCT00993265|Acetylcysteine|acetylcysteine|mesh-list
92743916|NCT00993265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92743917|NCT00993265|Antiviral Agents|antiviral agents|mesh-ancestor
92743918|NCT00993265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743919|NCT00993265|Expectorants|expectorants|mesh-ancestor
92743920|NCT00993265|Respiratory System Agents|respiratory system agents|mesh-ancestor
92743921|NCT00993265|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92743922|NCT00993265|Antioxidants|antioxidants|mesh-ancestor
92743923|NCT00993265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743924|NCT00993265|Protective Agents|protective agents|mesh-ancestor
92682812|NCT00438152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92743925|NCT00993265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743926|NCT00993265|Antidotes|antidotes|mesh-ancestor
92743927|NCT00993031|Ritonavir|ritonavir|mesh-list
92743928|NCT00993031|Lopinavir|lopinavir|mesh-list
92743929|NCT00993031|Lamivudine|lamivudine|mesh-list
92743930|NCT00993031|Zidovudine|zidovudine|mesh-list
92743931|NCT00993031|Efavirenz|efavirenz|mesh-list
92743932|NCT00993031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92743933|NCT00993031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92743934|NCT00993031|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743935|NCT00993031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743938|NCT00993031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92743940|NCT00993031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743941|NCT00993031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92743942|NCT00993031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92743943|NCT00993031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92743944|NCT00993031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92743945|NCT00993031|Antimetabolites|antimetabolites|mesh-ancestor
92743946|NCT00993031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92743947|NCT00993031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92743948|NCT00993031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92743949|NCT00993031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92743950|NCT00993031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92743951|NCT01010776|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92743952|NCT01010776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92743953|NCT01010776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92743954|NCT01010776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92743955|NCT01010776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743956|NCT01010776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743957|NCT01010776|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92743958|NCT01010776|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92743959|NCT01010776|Serotonin Agents|serotonin agents|mesh-ancestor
92743960|NCT01010776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743961|NCT01010776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743962|NCT01010776|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92743963|NCT01010776|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92743964|NCT01010776|Dopamine Agents|dopamine agents|mesh-ancestor
92743965|NCT04291729|Interferons|interferons|mesh-list
92743966|NCT04291729|Ritonavir|ritonavir|mesh-list
92743967|NCT04291729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743968|NCT04291729|Antiviral Agents|antiviral agents|mesh-ancestor
92743969|NCT04291729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92743970|NCT04291729|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92743971|NCT04291729|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92743972|NCT04291729|Protease Inhibitors|protease inhibitors|mesh-ancestor
92743973|NCT04291729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743974|NCT04291729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743975|NCT04291729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92743976|NCT04291729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92743977|NCT04291729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92743978|NCT04291729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92743979|NCT02868931|Insulin|insulin|mesh-list
92743980|NCT02868931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92743981|NCT02868931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743982|NCT01018810|Interleukin-23|interleukin-23|mesh-list
92743983|NCT01018810|Antibodies|antibodies|mesh-list
92743984|NCT01018810|Immunoglobulins|immunoglobulins|mesh-list
92743985|NCT01018810|Immunologic Factors|immunologic factors|mesh-ancestor
92743986|NCT01018810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743987|NCT01018810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92743988|NCT01018810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92743989|NCT01018810|Growth Substances|growth substances|mesh-ancestor
92743990|NCT01018810|Growth Inhibitors|growth inhibitors|mesh-ancestor
92743991|NCT01018810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92743992|NCT02867917|Psyllium|psyllium|mesh-list
92743993|NCT02867917|Cathartics|cathartics|mesh-ancestor
92743994|NCT02867917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743995|NCT01018732|Lactitol|lactitol|mesh-list
92743996|NCT01018732|Cathartics|cathartics|mesh-ancestor
92743997|NCT01018732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92743998|NCT01218867|Aldesleukin|aldesleukin|mesh-list
92743999|NCT01218867|Cyclophosphamide|cyclophosphamide|mesh-list
92744000|NCT01218867|Fludarabine|fludarabine|mesh-list
92744001|NCT01218867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92744002|NCT01218867|Immunologic Factors|immunologic factors|mesh-ancestor
92611457|NCT00466570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611458|NCT00466570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611459|NCT00466570|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92611460|NCT00466570|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92744003|NCT01218867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744004|NCT01218867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744005|NCT01218867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92744006|NCT01218867|Alkylating Agents|alkylating agents|mesh-ancestor
92744007|NCT01218867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744011|NCT01218867|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92744012|NCT01218867|Antiviral Agents|antiviral agents|mesh-ancestor
92744013|NCT01218867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744014|NCT01018264|Solifenacin Succinate|solifenacin succinate|mesh-list
92744015|NCT01018264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92744016|NCT01018264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92744017|NCT01018264|Cholinergic Agents|cholinergic agents|mesh-ancestor
92744018|NCT01018264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744019|NCT01018264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744020|NCT01018264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744021|NCT01018264|Urological Agents|urological agents|mesh-ancestor
92744022|NCT01018186|Fluticasone|fluticasone|mesh-list
92744023|NCT01018186|Xhance|xhance|mesh-list
92744024|NCT01018186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744025|NCT01018186|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92744026|NCT01018186|Autonomic Agents|autonomic agents|mesh-ancestor
92744027|NCT01018186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744028|NCT01018186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744029|NCT01018186|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92744030|NCT01018186|Respiratory System Agents|respiratory system agents|mesh-ancestor
92744031|NCT01018186|Dermatologic Agents|dermatologic agents|mesh-ancestor
92744032|NCT01018186|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92744033|NCT00992407|Risperidone|risperidone|mesh-list
92744034|NCT00992407|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92744035|NCT00992407|Serotonin Agents|serotonin agents|mesh-ancestor
92744036|NCT00992407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744037|NCT00992407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744038|NCT00992407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744039|NCT00992407|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92744040|NCT00992407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92744041|NCT00992407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744042|NCT00992407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92744043|NCT00992407|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92744044|NCT00992407|Dopamine Agents|dopamine agents|mesh-ancestor
92744045|NCT00986245|Ropinirole|ropinirole|mesh-list
92744046|NCT00986245|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92744047|NCT00986245|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92744048|NCT00986245|Dopamine Agonists|dopamine agonists|mesh-ancestor
92744049|NCT00986245|Dopamine Agents|dopamine agents|mesh-ancestor
92744050|NCT00986245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744051|NCT00986245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744052|NCT00986245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744053|NCT00989833|Budesonide|budesonide|mesh-list
92744054|NCT00989833|Terbutaline|terbutaline|mesh-list
92744055|NCT00989833|Formoterol Fumarate|formoterol fumarate|mesh-list
92744056|NCT00989833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744057|NCT00989833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92744058|NCT00989833|Autonomic Agents|autonomic agents|mesh-ancestor
92744059|NCT00989833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744060|NCT00989833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744061|NCT00989833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92744062|NCT00989833|Respiratory System Agents|respiratory system agents|mesh-ancestor
92744063|NCT00989833|Glucocorticoids|glucocorticoids|mesh-ancestor
92744064|NCT00989833|Hormones|hormones|mesh-ancestor
92744065|NCT00989833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744066|NCT00989833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92744067|NCT00989833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92744068|NCT00989833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92744069|NCT00989833|Adrenergic Agents|adrenergic agents|mesh-ancestor
92744070|NCT00989833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744071|NCT00989833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611461|NCT00466609|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92611462|NCT00466609|Fluoxetine|fluoxetine|mesh-list
92611463|NCT00466609|Clomipramine|clomipramine|mesh-list
92744072|NCT00989833|Sympathomimetics|sympathomimetics|mesh-ancestor
92744073|NCT00989833|Tocolytic Agents|tocolytic agents|mesh-ancestor
92744074|NCT00989833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92744075|NCT04292119|Crizotinib|crizotinib|mesh-list
92744076|NCT04292119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744077|NCT04292119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744078|NCT04292119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744079|NCT04292119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744080|NCT01218477|Dasatinib|dasatinib|mesh-list
92744084|NCT01218477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744085|NCT01218009|Albuterol|albuterol|mesh-list
92744086|NCT01218009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92744087|NCT01218009|Autonomic Agents|autonomic agents|mesh-ancestor
92744088|NCT01218009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744089|NCT01218009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744090|NCT01218009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92744091|NCT01218009|Respiratory System Agents|respiratory system agents|mesh-ancestor
92744092|NCT01218009|Tocolytic Agents|tocolytic agents|mesh-ancestor
92744093|NCT01218009|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92744094|NCT01218009|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92744095|NCT01218009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92744096|NCT01218009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92744097|NCT01218009|Adrenergic Agents|adrenergic agents|mesh-ancestor
92744098|NCT01218009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744099|NCT01218009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744100|NCT02868151|Ascorbic Acid|ascorbic acid|mesh-list
92744101|NCT02868151|Vitamins|vitamins|mesh-ancestor
92744102|NCT02868151|Micronutrients|micronutrients|mesh-ancestor
92744103|NCT02868151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744104|NCT02868151|Antioxidants|antioxidants|mesh-ancestor
92744105|NCT02868151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744106|NCT02868151|Protective Agents|protective agents|mesh-ancestor
92744107|NCT01217307|Metformin|metformin|mesh-list
92744108|NCT01217307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92744109|NCT01217307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744110|NCT02868073|Vaccines|vaccines|mesh-list
92744111|NCT02868073|Immunologic Factors|immunologic factors|mesh-ancestor
92744112|NCT02868073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744113|NCT01013740|Capecitabine|capecitabine|mesh-list
92744114|NCT01013740|Vinorelbine|vinorelbine|mesh-list
92744115|NCT01013740|Lapatinib|lapatinib|mesh-list
92744116|NCT01013740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92744117|NCT01013740|Antimetabolites|antimetabolites|mesh-ancestor
92744118|NCT01013740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744119|NCT01013740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744120|NCT01013740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92744121|NCT01013740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92744122|NCT01013740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92744123|NCT01013740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92744124|NCT01013740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744125|NCT01013740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744126|NCT01217073|Metformin|metformin|mesh-list
92744127|NCT01217073|Pioglitazone|pioglitazone|mesh-list
92744128|NCT01217073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92744129|NCT01217073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744130|NCT00985621|Oxycodone|oxycodone|mesh-list
92744132|NCT00985621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92744133|NCT00985621|Narcotics|narcotics|mesh-ancestor
92744134|NCT00985621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744135|NCT00985621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744136|NCT00985621|Analgesics|analgesics|mesh-ancestor
92744137|NCT00985621|Sensory System Agents|sensory system agents|mesh-ancestor
92744138|NCT00985621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744139|NCT01215981|Vaccines|vaccines|mesh-list
92744140|NCT01215981|Immunologic Factors|immunologic factors|mesh-ancestor
92744141|NCT01215981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744142|NCT01215435|Insulin|insulin|mesh-list
92744143|NCT01215435|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92744144|NCT01215435|Insulin Aspart|insulin aspart|mesh-list
92744145|NCT01215435|Insulin, Long-Acting|insulin, long-acting|mesh-list
92744146|NCT01215435|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92744147|NCT01215435|Biphasic Insulins|biphasic insulins|mesh-list
92611464|NCT00466609|Antidepressive Agents|antidepressive agents|mesh-ancestor
92611465|NCT00466609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92611466|NCT00466609|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92611467|NCT00466609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92682813|NCT00438152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92744148|NCT01215435|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92744149|NCT01215435|Insulin, Isophane|insulin, isophane|mesh-list
92744150|NCT01215435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92744151|NCT01215435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744153|NCT01215357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92744154|NCT01215357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92327613|NCT00003086|Analgesics|analgesics|mesh-ancestor
92744161|NCT01215357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744163|NCT01017874|Gefitinib|gefitinib|mesh-list
92744164|NCT01017874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744165|NCT01017874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744166|NCT01017874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744167|NCT01017874|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92744168|NCT01017874|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92744169|NCT01017874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744170|NCT00627952|Amlodipine|amlodipine|mesh-list
92744171|NCT00627952|Manidipine|manidipine|mesh-list
92744172|NCT00627952|Delapril|delapril|mesh-list
92744173|NCT00627952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92744174|NCT00627952|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92744175|NCT00627952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744176|NCT00627952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744177|NCT00627952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744178|NCT00627952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744179|NCT00627952|Vasodilator Agents|vasodilator agents|mesh-ancestor
92744180|NCT00627952|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92744181|NCT00627952|Protease Inhibitors|protease inhibitors|mesh-ancestor
92744182|NCT00627952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744183|NCT01009840|Bortezomib|bortezomib|mesh-list
92744184|NCT01009840|Busulfan|busulfan|mesh-list
92744185|NCT01009840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744186|NCT01009840|Alkylating Agents|alkylating agents|mesh-ancestor
92744187|NCT01009840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744188|NCT01009840|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92744189|NCT01009840|Immunologic Factors|immunologic factors|mesh-ancestor
92744190|NCT01009840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744191|NCT01009840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92744192|NCT01009840|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92744193|NCT04420936|Benzocaine|benzocaine|mesh-list
92744194|NCT04420936|Anesthetics, Local|anesthetics, local|mesh-ancestor
92744195|NCT04420936|Anesthetics|anesthetics|mesh-ancestor
92744196|NCT04420936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744197|NCT04420936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744198|NCT04420936|Sensory System Agents|sensory system agents|mesh-ancestor
92398926|NCT01400464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744199|NCT04420936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744200|NCT02872090|Glycopyrrolate|glycopyrrolate|mesh-list
92744201|NCT02872090|Tiotropium Bromide|tiotropium bromide|mesh-list
92744202|NCT02872090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92744203|NCT02872090|Autonomic Agents|autonomic agents|mesh-ancestor
92744204|NCT02872090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744205|NCT02872090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744206|NCT02872090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92744207|NCT02872090|Respiratory System Agents|respiratory system agents|mesh-ancestor
92744208|NCT02872090|Parasympatholytics|parasympatholytics|mesh-ancestor
92744209|NCT02872090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92744210|NCT02872090|Cholinergic Agents|cholinergic agents|mesh-ancestor
92744211|NCT02872090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744212|NCT02872090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744213|NCT02872090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92744214|NCT02872090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92744215|NCT00982657|Sunitinib|sunitinib|mesh-list
92744216|NCT00982657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744217|NCT00982657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92744218|NCT00982657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92744219|NCT00982657|Growth Substances|growth substances|mesh-ancestor
92744220|NCT00982657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744221|NCT00982657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92744223|NCT00982657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744224|NCT00982657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744226|NCT02867839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744227|NCT02867293|Anesthetics|anesthetics|mesh-list
92744228|NCT02867293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744229|NCT02867293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744230|NCT01005316|Mycophenolic Acid|mycophenolic acid|mesh-list
92744231|NCT01005316|Prednisone|prednisone|mesh-list
92744232|NCT01005316|Tacrolimus|tacrolimus|mesh-list
92744233|NCT01005316|Immunoglobulins|immunoglobulins|mesh-list
92744234|NCT01005316|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92744235|NCT01005316|Antibodies|antibodies|mesh-list
92744236|NCT01005316|gamma-Globulins|gamma-globulins|mesh-list
92744237|NCT01005316|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92744238|NCT01005316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744239|NCT01005316|Glucocorticoids|glucocorticoids|mesh-ancestor
92744240|NCT01005316|Hormones|hormones|mesh-ancestor
92744241|NCT01005316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744242|NCT01005316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744243|NCT01005316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92744244|NCT01005316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744245|NCT01005316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92744246|NCT01005316|Immunologic Factors|immunologic factors|mesh-ancestor
92744247|NCT01005316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92744248|NCT01005316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744249|NCT01005316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744250|NCT01005316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92744251|NCT01005316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92744252|NCT01005316|Antitubercular Agents|antitubercular agents|mesh-ancestor
92744253|NCT01005316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92744254|NCT01005316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744255|NCT00988429|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92744256|NCT00988429|Anticonvulsants|anticonvulsants|mesh-ancestor
92744257|NCT00988429|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92744258|NCT00988429|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92744259|NCT00988429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744260|NCT00988429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744261|NCT01008904|Magnesium Oxide|magnesium oxide|mesh-list
92744262|NCT01008904|Antacids|antacids|mesh-ancestor
92744263|NCT01008904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744264|NCT01008904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92744265|NCT04290793|Cyclophosphamide|cyclophosphamide|mesh-list
92744266|NCT04290793|Trastuzumab|trastuzumab|mesh-list
92744267|NCT04290793|Epirubicin|epirubicin|mesh-list
92744268|NCT04290793|Taxane|taxane|mesh-list
92744269|NCT04290793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92744270|NCT04290793|Immunologic Factors|immunologic factors|mesh-ancestor
92744271|NCT04290793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744272|NCT04290793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744273|NCT04290793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92744274|NCT04290793|Alkylating Agents|alkylating agents|mesh-ancestor
92744275|NCT04290793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744276|NCT04290793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744277|NCT04290793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92744278|NCT04290793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744279|NCT04290793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92744280|NCT04290793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92744281|NCT04290793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92744282|NCT04290793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744283|NCT01004614|Amlodipine|amlodipine|mesh-list
92744284|NCT01004614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92744285|NCT01004614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92744286|NCT01004614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744287|NCT01004614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744288|NCT01004614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744289|NCT01004614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744290|NCT01004614|Vasodilator Agents|vasodilator agents|mesh-ancestor
92744291|NCT04297462|Oseltamivir|oseltamivir|mesh-list
92744292|NCT04297462|Antiviral Agents|antiviral agents|mesh-ancestor
92744293|NCT04297462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611468|NCT00466609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92611469|NCT00466609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611470|NCT00466609|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92744294|NCT04297462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744296|NCT00981409|Heparin|heparin|mesh-list
92744297|NCT00981409|Calcium heparin|calcium heparin|mesh-list
92744298|NCT00981409|PENTA|penta|mesh-list
92744299|NCT00981409|Fondaparinux|fondaparinux|mesh-list
92744300|NCT00981409|Anticoagulants|anticoagulants|mesh-ancestor
92744301|NCT00981409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92744302|NCT00981409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92744303|NCT00981409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744304|NCT00981409|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92744305|NCT00981409|Antithrombins|antithrombins|mesh-ancestor
92744306|NCT00981409|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92744307|NCT00981409|Protease Inhibitors|protease inhibitors|mesh-ancestor
92744308|NCT00981409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744309|NCT04297072|Rivaroxaban|rivaroxaban|mesh-list
92744310|NCT04297072|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92744311|NCT04297072|Antithrombins|antithrombins|mesh-ancestor
92744312|NCT04297072|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92744313|NCT04297072|Protease Inhibitors|protease inhibitors|mesh-ancestor
92744314|NCT04297072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744315|NCT04297072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744316|NCT04297072|Anticoagulants|anticoagulants|mesh-ancestor
92744317|NCT01008748|Nicotine|nicotine|mesh-list
92744318|NCT01008748|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92744319|NCT01008748|Autonomic Agents|autonomic agents|mesh-ancestor
92744320|NCT01008748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744321|NCT01008748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744322|NCT01008748|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92744323|NCT01008748|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92744324|NCT01008748|Cholinergic Agents|cholinergic agents|mesh-ancestor
92744325|NCT01008748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744326|NCT01008748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744327|NCT00628732|Cyclophosphamide|cyclophosphamide|mesh-list
92744328|NCT00628732|Topotecan|topotecan|mesh-list
92744329|NCT00628732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92744330|NCT00628732|Immunologic Factors|immunologic factors|mesh-ancestor
92744331|NCT00628732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744332|NCT00628732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744333|NCT00628732|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92744334|NCT00628732|Alkylating Agents|alkylating agents|mesh-ancestor
92744335|NCT00628732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744336|NCT00628732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744337|NCT00628732|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92744338|NCT00628732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92744339|NCT00628732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92744340|NCT00628732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744341|NCT04131829|Fluoxetine|fluoxetine|mesh-list
92744342|NCT04131829|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92744343|NCT04131829|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92744344|NCT04131829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744345|NCT04131829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744346|NCT04131829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744347|NCT04131829|Serotonin Agents|serotonin agents|mesh-ancestor
92744348|NCT04131829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744349|NCT04131829|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92744350|NCT04131829|Antidepressive Agents|antidepressive agents|mesh-ancestor
92744351|NCT04131829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92744352|NCT04131829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92744353|NCT04131829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92744354|NCT04131829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744355|NCT04205344|Bupivacaine|bupivacaine|mesh-list
92744356|NCT04205344|Anesthetics, Local|anesthetics, local|mesh-ancestor
92744357|NCT04205344|Anesthetics|anesthetics|mesh-ancestor
92744358|NCT04205344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744359|NCT04205344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744360|NCT04205344|Sensory System Agents|sensory system agents|mesh-ancestor
92744361|NCT04205344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611471|NCT00466609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92611472|NCT00466609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744362|NCT00629317|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92744363|NCT00629317|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92744364|NCT00629317|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92744365|NCT00629317|Dermatologic Agents|dermatologic agents|mesh-ancestor
92744367|NCT00978757|Analgesics|analgesics|mesh-ancestor
92744368|NCT00978757|Sensory System Agents|sensory system agents|mesh-ancestor
92744369|NCT00978757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744370|NCT00978757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744371|NCT00978757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92744372|NCT00978757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92744373|NCT00978757|Anesthetics, General|anesthetics, general|mesh-ancestor
92744375|NCT00978757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744376|NCT00978757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92744377|NCT00978757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92744378|NCT00978757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744379|NCT00978757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744380|NCT01214421|Tolvaptan|tolvaptan|mesh-list
92744381|NCT01214421|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92744382|NCT01214421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744383|NCT01214421|Natriuretic Agents|natriuretic agents|mesh-ancestor
92744384|NCT01214421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744385|NCT01214187|Carbon Monoxide|carbon monoxide|mesh-list
92744386|NCT01214187|Antimetabolites|antimetabolites|mesh-ancestor
92744387|NCT01214187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744388|NCT01214187|Gasotransmitters|gasotransmitters|mesh-ancestor
92744389|NCT01214187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744390|NCT01214187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744391|NCT02866903|Bevacizumab|bevacizumab|mesh-list
92744392|NCT02866903|Oxaliplatin|oxaliplatin|mesh-list
92744393|NCT02866903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744394|NCT02866903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744395|NCT02866903|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92744396|NCT02866903|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92744397|NCT02866903|Growth Substances|growth substances|mesh-ancestor
92744398|NCT02866903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744399|NCT02866903|Growth Inhibitors|growth inhibitors|mesh-ancestor
92744400|NCT03945019|Infliximab|infliximab|mesh-list
92744401|NCT03945019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92744402|NCT03945019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744403|NCT03945019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92744404|NCT03945019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92744405|NCT03945019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744406|NCT01003990|Ritonavir|ritonavir|mesh-list
92744407|NCT01003990|Lopinavir|lopinavir|mesh-list
92744408|NCT01003990|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92744409|NCT01003990|Tenofovir|tenofovir|mesh-list
92744410|NCT01003990|Emtricitabine|emtricitabine|mesh-list
92744411|NCT01003990|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92744412|NCT01003990|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92744413|NCT01003990|Protease Inhibitors|protease inhibitors|mesh-ancestor
92744414|NCT01003990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744415|NCT01003990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744416|NCT01003990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92744417|NCT01003990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92744418|NCT01003990|Antiviral Agents|antiviral agents|mesh-ancestor
92744419|NCT01003990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744420|NCT01003990|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92744421|NCT01003990|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92744422|NCT01003990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92744423|NCT01003990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92744424|NCT01002820|Ganaxolone|ganaxolone|mesh-list
92744425|NCT01002820|Neurosteroids|neurosteroids|mesh-ancestor
92744426|NCT01002820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744427|NCT01002820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744428|NCT01002820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744429|NCT01002820|GABA Modulators|gaba modulators|mesh-ancestor
92744431|NCT01012258|Cetuximab|cetuximab|mesh-list
92744432|NCT01012258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744433|NCT01012258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611473|NCT00466609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336525|NCT01989546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682814|NCT00438152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744434|NCT00628810|Leucovorin|leucovorin|mesh-list
92744435|NCT00628810|Bevacizumab|bevacizumab|mesh-list
92744436|NCT00628810|Fluorouracil|fluorouracil|mesh-list
92744437|NCT00628810|Irinotecan|irinotecan|mesh-list
92744438|NCT00628810|Calcium|calcium|mesh-list
92744439|NCT00628810|Levoleucovorin|levoleucovorin|mesh-list
92744440|NCT00628810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744441|NCT00628810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744442|NCT00628810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92744443|NCT00628810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92744444|NCT00628810|Growth Substances|growth substances|mesh-ancestor
92744448|NCT00628810|Antimetabolites|antimetabolites|mesh-ancestor
92744449|NCT00628810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744450|NCT00628810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92744451|NCT00628810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92744452|NCT00628810|Immunologic Factors|immunologic factors|mesh-ancestor
92744453|NCT00628810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92744454|NCT00628810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92744455|NCT00628810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744456|NCT00628810|Antidotes|antidotes|mesh-ancestor
92744457|NCT00628810|Protective Agents|protective agents|mesh-ancestor
92744458|NCT00628810|Vitamin B Complex|vitamin b complex|mesh-ancestor
92744459|NCT00628810|Vitamins|vitamins|mesh-ancestor
92744460|NCT00628810|Micronutrients|micronutrients|mesh-ancestor
92744461|NCT00975481|Alprazolam|alprazolam|mesh-list
92744462|NCT00975481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92744463|NCT00975481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744464|NCT00975481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744465|NCT00975481|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92744466|NCT00975481|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92744467|NCT00975481|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92744468|NCT00975481|GABA Modulators|gaba modulators|mesh-ancestor
92744469|NCT00975481|GABA Agents|gaba agents|mesh-ancestor
92744470|NCT00975481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744471|NCT00975481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744472|NCT01011868|Empagliflozin|empagliflozin|mesh-list
92744473|NCT01011868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92744474|NCT01011868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744475|NCT01011868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92744476|NCT01011868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744477|NCT04290013|Tranexamic Acid|tranexamic acid|mesh-list
92744478|NCT04290013|Norethindrone|norethindrone|mesh-list
92744479|NCT04290013|Norethindrone Acetate|norethindrone acetate|mesh-list
92744480|NCT04290013|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92744481|NCT04290013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92744482|NCT04290013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744483|NCT04290013|Hemostatics|hemostatics|mesh-ancestor
92744484|NCT04290013|Coagulants|coagulants|mesh-ancestor
92744485|NCT04290013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92744486|NCT04290013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92744487|NCT04290013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92744488|NCT04290013|Contraceptive Agents|contraceptive agents|mesh-ancestor
92744489|NCT04290013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92744490|NCT04290013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744491|NCT04290013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92744492|NCT04290013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92744493|NCT04288999|Capecitabine|capecitabine|mesh-list
92744494|NCT04288999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92744495|NCT04288999|Antimetabolites|antimetabolites|mesh-ancestor
92744496|NCT04288999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744497|NCT04288999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744498|NCT01213173|Metoprolol|metoprolol|mesh-list
92744499|NCT01213173|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92744500|NCT01213173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92744501|NCT01213173|Sympatholytics|sympatholytics|mesh-ancestor
92744502|NCT01213173|Autonomic Agents|autonomic agents|mesh-ancestor
92744503|NCT01213173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744504|NCT01213173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744505|NCT01213173|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92611474|NCT00466609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611476|NCT00466609|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92611477|NCT00466609|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92611478|NCT00466609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92611479|NCT00466609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611480|NCT00466609|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92611481|NCT00157326|Tadalafil|tadalafil|mesh-list
92611482|NCT00157326|Vasodilator Agents|vasodilator agents|mesh-ancestor
92611483|NCT00157326|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92611484|NCT00157326|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92611485|NCT00157326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611486|NCT00157326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611487|NCT00157326|Urological Agents|urological agents|mesh-ancestor
92611488|NCT00466843|Prednisone|prednisone|mesh-list
92611489|NCT00466843|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92611490|NCT00466843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611491|NCT00466843|Glucocorticoids|glucocorticoids|mesh-ancestor
92611492|NCT00466843|Hormones|hormones|mesh-ancestor
92611493|NCT00466843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92611494|NCT00466843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611495|NCT00466843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92611496|NCT00466843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611497|NCT00466843|Immunologic Factors|immunologic factors|mesh-ancestor
92611498|NCT00466843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92611499|NCT00148863|Interferons|interferons|mesh-list
92611500|NCT00148863|Ribavirin|ribavirin|mesh-list
92611501|NCT00148863|Interferon-alpha|interferon-alpha|mesh-list
92611502|NCT00148863|Interferon alpha-2|interferon alpha-2|mesh-list
92611503|NCT00148863|Interferon-gamma|interferon-gamma|mesh-list
92744506|NCT01213173|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92744507|NCT01213173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92744508|NCT01213173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92744509|NCT01213173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744510|NCT01213173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744511|NCT04095715|Hemostatics|hemostatics|mesh-list
92744512|NCT04095715|Coagulants|coagulants|mesh-ancestor
92744513|NCT02866435|Potassium phosphate|potassium phosphate|mesh-list
92744514|NCT02866435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744515|NCT02866435|Cariostatic Agents|cariostatic agents|mesh-ancestor
92744543|NCT04288765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744544|NCT04288765|Immunologic Factors|immunologic factors|mesh-ancestor
92744545|NCT04288765|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92744546|NCT04288765|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92744547|NCT04288765|Growth Substances|growth substances|mesh-ancestor
92744548|NCT04288765|Growth Inhibitors|growth inhibitors|mesh-ancestor
92018548|NCT04900129|Salicylates|salicylates|mesh-list
92611504|NCT00148863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92611505|NCT00148863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611506|NCT00148863|Antiviral Agents|antiviral agents|mesh-ancestor
92611507|NCT00148863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611508|NCT00148863|Antimetabolites|antimetabolites|mesh-ancestor
92611509|NCT00148863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611510|NCT00148863|Immunologic Factors|immunologic factors|mesh-ancestor
92611511|NCT00148863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018550|NCT04900129|Menthol|menthol|mesh-list
92744549|NCT01211535|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92744550|NCT02863861|Dexmedetomidine|dexmedetomidine|mesh-list
92744551|NCT02863861|Ketamine|ketamine|mesh-list
92744552|NCT02863861|Propofol|propofol|mesh-list
92744553|NCT02863861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92744554|NCT02863861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744555|NCT02863861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744556|NCT02863861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92744557|NCT02863861|Analgesics|analgesics|mesh-ancestor
92744558|NCT02863861|Sensory System Agents|sensory system agents|mesh-ancestor
92744559|NCT02863861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744560|NCT02863861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92744561|NCT02863861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92744562|NCT02863861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92744563|NCT02863861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92744564|NCT02863861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744588|NCT01011556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744590|NCT01211145|Oxazolidinones|oxazolidinones|mesh-list
92744591|NCT01211145|Zolmitriptan|zolmitriptan|mesh-list
92744592|NCT01211145|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92744593|NCT01211145|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92744594|NCT01211145|Serotonin Agents|serotonin agents|mesh-ancestor
92744595|NCT01211145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744596|NCT01211145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744597|NCT01211145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744598|NCT01211145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744599|NCT01211145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92744600|NCT01211145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744601|NCT00977665|Rasagiline|rasagiline|mesh-list
92744602|NCT00977665|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92744603|NCT00977665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744604|NCT00977665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744605|NCT00977665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92744606|NCT00977665|Protective Agents|protective agents|mesh-ancestor
92744607|NCT00977665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744608|NCT04298008|Durvalumab|durvalumab|mesh-list
92744609|NCT04298008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744610|NCT04298008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744611|NCT00628342|Esomeprazole|esomeprazole|mesh-list
92744612|NCT00628342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92744613|NCT00628342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92744614|NCT00628342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92744618|NCT01210443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92744619|NCT01210443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744620|NCT04287361|Clonazepam|clonazepam|mesh-list
92744621|NCT04287361|Anticonvulsants|anticonvulsants|mesh-ancestor
92744622|NCT04287361|GABA Modulators|gaba modulators|mesh-ancestor
92744623|NCT04287361|GABA Agents|gaba agents|mesh-ancestor
92744624|NCT04287361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744625|NCT04287361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744626|NCT04287361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744627|NCT00624429|Budesonide|budesonide|mesh-list
92744628|NCT00624429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744629|NCT00624429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92744630|NCT00624429|Autonomic Agents|autonomic agents|mesh-ancestor
92611512|NCT00466999|Misoprostol|misoprostol|mesh-list
92611513|NCT00466999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92611514|NCT00466999|Abortifacient Agents|abortifacient agents|mesh-ancestor
92611515|NCT00466999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92611516|NCT00466999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744631|NCT00624429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744632|NCT00624429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744633|NCT00624429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92744634|NCT00624429|Respiratory System Agents|respiratory system agents|mesh-ancestor
92744635|NCT00624429|Glucocorticoids|glucocorticoids|mesh-ancestor
92744636|NCT00624429|Hormones|hormones|mesh-ancestor
92744637|NCT00624429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744638|NCT01001572|Amlodipine|amlodipine|mesh-list
92744639|NCT01001572|Valsartan|valsartan|mesh-list
92744640|NCT01001572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92744641|NCT01001572|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92744642|NCT01001572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744643|NCT01001572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744644|NCT01001572|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744645|NCT01001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744646|NCT01001572|Vasodilator Agents|vasodilator agents|mesh-ancestor
92744647|NCT01001572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92744648|NCT01001572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92744649|NCT04287205|Dydrogesterone|dydrogesterone|mesh-list
92744650|NCT04287205|Progestins|progestins|mesh-ancestor
92744651|NCT04287205|Hormones|hormones|mesh-ancestor
92744652|NCT04287205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744653|NCT04287205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744654|NCT00628576|Heparin|heparin|mesh-list
92744655|NCT00628576|Calcium heparin|calcium heparin|mesh-list
92744656|NCT00628576|Tinzaparin|tinzaparin|mesh-list
92744657|NCT00628576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92744658|NCT00628576|Dalteparin|dalteparin|mesh-list
92744659|NCT00628576|Anticoagulants|anticoagulants|mesh-ancestor
92744660|NCT00628576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92744661|NCT00628576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92744662|NCT00628576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744663|NCT01208337|Alemtuzumab|alemtuzumab|mesh-list
92744664|NCT01208337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744665|NCT01208337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744666|NCT04370548|Clindamycin|clindamycin|mesh-list
92744667|NCT04370548|Clindamycin palmitate|clindamycin palmitate|mesh-list
92744668|NCT04370548|Clindamycin phosphate|clindamycin phosphate|mesh-list
92744669|NCT04370548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92744670|NCT04370548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744671|NCT04370548|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92744672|NCT04370548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744673|NCT04370548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744674|NCT01208181|Etoricoxib|etoricoxib|mesh-list
92744675|NCT01208181|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92744676|NCT01208181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92744677|NCT01208181|Analgesics|analgesics|mesh-ancestor
92744678|NCT01208181|Sensory System Agents|sensory system agents|mesh-ancestor
92744679|NCT01208181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744680|NCT01208181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744681|NCT01208181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744682|NCT01208181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744683|NCT01208181|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92744684|NCT01208181|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92744685|NCT01208181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744687|NCT01208103|Bevacizumab|bevacizumab|mesh-list
92744688|NCT01208103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92744689|NCT01208103|Capecitabine|capecitabine|mesh-list
92744690|NCT01208103|Oxaliplatin|oxaliplatin|mesh-list
92744691|NCT01208103|Endothelial Growth Factors|endothelial growth factors|mesh-list
92744692|NCT01208103|Antibodies|antibodies|mesh-list
92744693|NCT01208103|Immunoglobulins|immunoglobulins|mesh-list
92744694|NCT01208103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92744695|NCT01208103|Immunoglobulin G|immunoglobulin g|mesh-list
92744696|NCT01208103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611517|NCT00466999|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92611518|NCT00466999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611519|NCT00466999|Oxytocics|oxytocics|mesh-ancestor
92611520|NCT00467116|Gemcitabine|gemcitabine|mesh-list
92611521|NCT00467116|Cetuximab|cetuximab|mesh-list
92611522|NCT00467116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92744697|NCT01208103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92744698|NCT01208103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92744699|NCT01208103|Growth Substances|growth substances|mesh-ancestor
92744700|NCT01208103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744701|NCT01208103|Growth Inhibitors|growth inhibitors|mesh-ancestor
92744702|NCT01208103|Immunologic Factors|immunologic factors|mesh-ancestor
92744703|NCT01208103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92744704|NCT01208103|Antimetabolites|antimetabolites|mesh-ancestor
92744705|NCT01208103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744706|NCT01206777|Rituximab|rituximab|mesh-list
92744707|NCT01206777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744708|NCT01206777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744709|NCT01206777|Immunologic Factors|immunologic factors|mesh-ancestor
92744710|NCT01206777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744711|NCT01206777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744712|NCT01001494|Bromides|bromides|mesh-list
92744713|NCT01001494|Anticonvulsants|anticonvulsants|mesh-ancestor
92744714|NCT01205685|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92744715|NCT01205685|Letrozole|letrozole|mesh-list
92744716|NCT01205685|Goserelin|goserelin|mesh-list
92744717|NCT01205685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744718|NCT01205685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744719|NCT01205685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744720|NCT01205685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744721|NCT01205685|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92744722|NCT01205685|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92744723|NCT01205685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92744724|NCT01205685|Hormone Antagonists|hormone antagonists|mesh-ancestor
92744725|NCT01205685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744726|NCT01205685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744727|NCT01205685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92744728|NCT01205529|Procainamide|procainamide|mesh-list
92744729|NCT01205529|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92744730|NCT01205529|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92744731|NCT01205529|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92744732|NCT01205529|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744733|NCT01205529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744734|NCT04294966|Dronabinol|dronabinol|mesh-list
92744735|NCT04294966|Hallucinogens|hallucinogens|mesh-ancestor
92744736|NCT04294966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744737|NCT04294966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92744738|NCT04294966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92744739|NCT04294966|Analgesics|analgesics|mesh-ancestor
92744740|NCT04294966|Sensory System Agents|sensory system agents|mesh-ancestor
92744741|NCT04294966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744742|NCT04294966|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92744743|NCT04294966|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92744744|NCT04294966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744745|NCT04294966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744746|NCT04294966|Hormones|hormones|mesh-ancestor
92744747|NCT04294966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744748|NCT01205451|Botulinum Toxins|botulinum toxins|mesh-list
92744749|NCT01205451|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92744750|NCT01205451|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92744751|NCT01205451|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92744752|NCT01205451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744753|NCT01205451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744754|NCT01205451|Cholinergic Agents|cholinergic agents|mesh-ancestor
92744755|NCT01205451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744756|NCT01205451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744757|NCT01205451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92744760|NCT04294732|Anesthetics, Local|anesthetics, local|mesh-ancestor
92611523|NCT00467116|Antimetabolites|antimetabolites|mesh-ancestor
92611524|NCT00467116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611525|NCT00467116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611526|NCT00467116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611527|NCT00157482|Simvastatin|simvastatin|mesh-list
92611528|NCT00157482|Ezetimibe|ezetimibe|mesh-list
92611529|NCT00157482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92744762|NCT04294732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744763|NCT04294732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744764|NCT04294732|Sensory System Agents|sensory system agents|mesh-ancestor
92744765|NCT04294732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744766|NCT02887677|Dapagliflozin|dapagliflozin|mesh-list
92744767|NCT02887677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92744768|NCT02887677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744769|NCT02887677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92744770|NCT02887677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744771|NCT01001104|Dulaglutide|dulaglutide|mesh-list
92744772|NCT01001104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92744773|NCT01001104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744774|NCT04204954|Ciprofloxacin|ciprofloxacin|mesh-list
92744775|NCT04204954|Tea Tree Oil|tea tree oil|mesh-list
92744776|NCT04204954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92744777|NCT04204954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744778|NCT04204954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92744779|NCT04204954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92744780|NCT04204954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744781|NCT04204954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744782|NCT04204954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744783|NCT04204954|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92744784|NCT04204954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92744785|NCT04204954|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92744786|NCT01204671|Vaccines|vaccines|mesh-list
92744787|NCT01204671|Immunologic Factors|immunologic factors|mesh-ancestor
92744788|NCT01204671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744789|NCT01202955|Tolcapone|tolcapone|mesh-list
92744790|NCT01202955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92744791|NCT01202955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92744792|NCT01202955|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92744793|NCT01202955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744794|NCT01202955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744795|NCT01202877|Azacitidine|azacitidine|mesh-list
92744796|NCT01202877|Midostaurin|midostaurin|mesh-list
92744797|NCT01202877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92744798|NCT01202877|Antimetabolites|antimetabolites|mesh-ancestor
92744799|NCT01202877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744800|NCT01202877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744801|NCT01202877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744802|NCT01202877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744804|NCT01202409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744805|NCT01202409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744806|NCT01202175|Nebivolol|nebivolol|mesh-list
92744807|NCT01202175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92744808|NCT01202175|Vasodilator Agents|vasodilator agents|mesh-ancestor
92744809|NCT01202175|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92744810|NCT01202175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92744811|NCT01202175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92744812|NCT01202175|Adrenergic Agents|adrenergic agents|mesh-ancestor
92744813|NCT01202175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744814|NCT01202175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744815|NCT01202175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744816|NCT01201785|Aspirin|aspirin|mesh-list
92744817|NCT01201785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92744818|NCT01201785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92744819|NCT01201785|Analgesics|analgesics|mesh-ancestor
92744820|NCT01201785|Sensory System Agents|sensory system agents|mesh-ancestor
92611530|NCT00157482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92611531|NCT00157482|Antimetabolites|antimetabolites|mesh-ancestor
92611532|NCT00157482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744821|NCT01201785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744822|NCT01201785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744823|NCT01201785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744824|NCT01201785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744825|NCT01201785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92744826|NCT01201785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92744827|NCT01201785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744828|NCT01201785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92744831|NCT01201785|Antipyretics|antipyretics|mesh-ancestor
92744832|NCT01200069|Ibuprofen|ibuprofen|mesh-list
92744833|NCT01200069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92744834|NCT01200069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92744835|NCT01200069|Analgesics|analgesics|mesh-ancestor
92744836|NCT01200069|Sensory System Agents|sensory system agents|mesh-ancestor
92398959|NCT01400646|Hemostatics|hemostatics|mesh-ancestor
92744837|NCT01200069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744838|NCT01200069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744839|NCT01200069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744840|NCT01200069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744841|NCT01200069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92744842|NCT01200069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744843|NCT01200069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744844|NCT01199289|Brodalumab|brodalumab|mesh-list
92744845|NCT01199289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92744846|NCT01199055|Paclitaxel|paclitaxel|mesh-list
92744847|NCT01199055|Carboplatin|carboplatin|mesh-list
92744848|NCT01199055|Efatutazone|efatutazone|mesh-list
92744849|NCT01199055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92744850|NCT01199055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744851|NCT01199055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92744852|NCT01199055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92744853|NCT01199055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92744854|NCT01199055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744855|NCT01198587|Zinc Sulfate|zinc sulfate|mesh-list
92744856|NCT01198587|Astringents|astringents|mesh-ancestor
92744857|NCT01198587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744858|NCT01198587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92744859|NCT01198509|Vancomycin|vancomycin|mesh-list
92744860|NCT01198509|Doxycycline|doxycycline|mesh-list
92744861|NCT01198509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92744862|NCT01198509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744863|NCT01198509|Antimalarials|antimalarials|mesh-ancestor
92744864|NCT01198509|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92744865|NCT01198509|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92744866|NCT01198275|Amiodarone|amiodarone|mesh-list
92744867|NCT01198275|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92744868|NCT01198275|Vasodilator Agents|vasodilator agents|mesh-ancestor
92744869|NCT01198275|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92744870|NCT01198275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744871|NCT01198275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744872|NCT01198275|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92744873|NCT01198275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92744874|NCT01198275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92744875|NCT01198275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744876|NCT01198275|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92744877|NCT01198275|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92744878|NCT01198275|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92744879|NCT01197417|Magnesium Sulfate|magnesium sulfate|mesh-list
92744880|NCT01197417|Analgesics|analgesics|mesh-ancestor
92744881|NCT01197417|Sensory System Agents|sensory system agents|mesh-ancestor
92744882|NCT01197417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744883|NCT01197417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744884|NCT01197417|Anesthetics|anesthetics|mesh-ancestor
92744885|NCT01197417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744886|NCT01197417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92744887|NCT01197417|Anticonvulsants|anticonvulsants|mesh-ancestor
92744888|NCT01197417|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92744889|NCT01197417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744890|NCT01197417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611533|NCT00157482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92611534|NCT00157482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92611535|NCT00157482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611537|NCT00467194|Bevacizumab|bevacizumab|mesh-list
92611538|NCT00467194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92611539|NCT00467194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744891|NCT01197417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744892|NCT01197417|Tocolytic Agents|tocolytic agents|mesh-ancestor
92744893|NCT01197417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92744894|NCT00977431|Temozolomide|temozolomide|mesh-list
92744895|NCT00977431|Afatinib|afatinib|mesh-list
92744896|NCT00977431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92744897|NCT00977431|Alkylating Agents|alkylating agents|mesh-ancestor
92744898|NCT00977431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744899|NCT00977431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744900|NCT00977431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744901|NCT00977431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744903|NCT04290169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92744904|NCT04290169|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92744905|NCT04290169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92744906|NCT04290169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744907|NCT04290169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744908|NCT04290169|Cholinergic Agents|cholinergic agents|mesh-ancestor
92744909|NCT04290169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744910|NCT04290169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744911|NCT04290169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92744912|NCT04290169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744913|NCT02864095|Epinephrine|epinephrine|mesh-list
92744914|NCT02864095|Tranexamic Acid|tranexamic acid|mesh-list
92744915|NCT02864095|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92744916|NCT02864095|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92744917|NCT02864095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744918|NCT02864095|Hemostatics|hemostatics|mesh-ancestor
92744919|NCT02864095|Coagulants|coagulants|mesh-ancestor
92744920|NCT02864095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92744921|NCT02864095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92744922|NCT02864095|Adrenergic Agents|adrenergic agents|mesh-ancestor
92744923|NCT02864095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744924|NCT02864095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744925|NCT02864095|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92744926|NCT02864095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92744927|NCT02864095|Autonomic Agents|autonomic agents|mesh-ancestor
92744928|NCT02864095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744929|NCT02864095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92744930|NCT02864095|Respiratory System Agents|respiratory system agents|mesh-ancestor
92744931|NCT02864095|Mydriatics|mydriatics|mesh-ancestor
92744932|NCT02864095|Sympathomimetics|sympathomimetics|mesh-ancestor
92744933|NCT02864095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92744934|NCT00977197|Pregabalin|pregabalin|mesh-list
92744935|NCT00977197|Analgesics|analgesics|mesh-ancestor
92744936|NCT00977197|Sensory System Agents|sensory system agents|mesh-ancestor
92744937|NCT00977197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744938|NCT00977197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744939|NCT00977197|Anticonvulsants|anticonvulsants|mesh-ancestor
92744940|NCT00977197|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92744941|NCT00977197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92744942|NCT00977197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744943|NCT00977197|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744944|NCT00977197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92744945|NCT00977197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92744946|NCT00977197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744947|NCT00977197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92744948|NCT04288219|Nifedipine|nifedipine|mesh-list
92744949|NCT04288219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92744950|NCT04288219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611540|NCT00467194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92611541|NCT00467194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92611542|NCT00467194|Growth Substances|growth substances|mesh-ancestor
92018582|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92744951|NCT04288219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744952|NCT04288219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744953|NCT04288219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744954|NCT04288219|Vasodilator Agents|vasodilator agents|mesh-ancestor
92744956|NCT04288219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92744957|NCT00974233|Rituximab|rituximab|mesh-list
92744958|NCT00974233|Lenalidomide|lenalidomide|mesh-list
92744959|NCT00974233|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92744960|NCT00974233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92744961|NCT00974233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744962|NCT00974233|Immunologic Factors|immunologic factors|mesh-ancestor
92744963|NCT00974233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744964|NCT00974233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744965|NCT00974233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92744966|NCT00974233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92051302|NCT02162771|Prednisone|prednisone|mesh-list
92744967|NCT00974233|Growth Substances|growth substances|mesh-ancestor
92744968|NCT00974233|Growth Inhibitors|growth inhibitors|mesh-ancestor
92744969|NCT00974233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92744970|NCT00974233|Alkylating Agents|alkylating agents|mesh-ancestor
92744971|NCT00974233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744972|NCT00972595|Ondansetron|ondansetron|mesh-list
92744973|NCT00972595|Antiemetics|antiemetics|mesh-ancestor
92744974|NCT00972595|Autonomic Agents|autonomic agents|mesh-ancestor
92744975|NCT00972595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744978|NCT00972595|Antipruritics|antipruritics|mesh-ancestor
92744979|NCT00972595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92744980|NCT00972595|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92744981|NCT00972595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92744982|NCT00972595|Serotonin Agents|serotonin agents|mesh-ancestor
92744983|NCT00972595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744984|NCT00972595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744985|NCT01196091|Antimalarials|antimalarials|mesh-list
92744986|NCT01196091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92744987|NCT01196091|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92744988|NCT01196091|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92744989|NCT01196091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92744990|NCT01196091|Analgesics|analgesics|mesh-ancestor
92744991|NCT01196091|Sensory System Agents|sensory system agents|mesh-ancestor
92744992|NCT01196091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744993|NCT01196091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744994|NCT01196091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92744995|NCT01196091|Immunologic Factors|immunologic factors|mesh-ancestor
92744996|NCT01196091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92744997|NCT01196091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92744998|NCT01196091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745000|NCT00972283|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92745001|NCT00972283|Insulin Glargine|insulin glargine|mesh-list
92745002|NCT00972283|Insulin Aspart|insulin aspart|mesh-list
92745003|NCT00972283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92745004|NCT00972283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745005|NCT05366049|Acetaminophen|acetaminophen|mesh-list
92745006|NCT05366049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745007|NCT05366049|Analgesics|analgesics|mesh-ancestor
92745008|NCT05366049|Sensory System Agents|sensory system agents|mesh-ancestor
92745009|NCT05366049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745010|NCT05366049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745011|NCT05366049|Antipyretics|antipyretics|mesh-ancestor
92745012|NCT00969709|Milnacipran|milnacipran|mesh-list
92745013|NCT00969709|Levomilnacipran|levomilnacipran|mesh-list
92745014|NCT00969709|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92745015|NCT00969709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92745016|NCT00969709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92745017|NCT00969709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745018|NCT00969709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745019|NCT00969709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745020|NCT00969709|Antidepressive Agents|antidepressive agents|mesh-ancestor
92611543|NCT00467194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611544|NCT00467194|Growth Inhibitors|growth inhibitors|mesh-ancestor
92745021|NCT00969709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92745022|NCT00969709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745023|NCT00969709|Analgesics|analgesics|mesh-ancestor
92745024|NCT00969709|Sensory System Agents|sensory system agents|mesh-ancestor
92745025|NCT00969709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745026|NCT01193517|Capecitabine|capecitabine|mesh-list
92745027|NCT01193517|Azacitidine|azacitidine|mesh-list
92745029|NCT01193517|Oxaliplatin|oxaliplatin|mesh-list
92745030|NCT01193517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92745031|NCT01193517|Antimetabolites|antimetabolites|mesh-ancestor
92745032|NCT01193517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745033|NCT01193517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745034|NCT01193517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745035|NCT02863705|Timolol|timolol|mesh-list
92745036|NCT02863705|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92745037|NCT02863705|Bimatoprost|bimatoprost|mesh-list
92745038|NCT02863705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92745039|NCT02863705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92745040|NCT02863705|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92151795|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
92745041|NCT02863705|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92745042|NCT02863705|Adrenergic Agents|adrenergic agents|mesh-ancestor
92745043|NCT02863705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745044|NCT02863705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745045|NCT02863705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745046|NCT02863705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92745047|NCT02863705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92745048|NCT02863705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92745053|NCT01193283|Cyclosporins|cyclosporins|mesh-list
92745054|NCT01193283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745055|NCT01193283|Immunologic Factors|immunologic factors|mesh-ancestor
92745056|NCT01193283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745057|NCT01193283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745058|NCT01193283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92745059|NCT01193283|Alkylating Agents|alkylating agents|mesh-ancestor
92745060|NCT01193283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745061|NCT01193283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745062|NCT01193283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92745063|NCT01193283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745064|NCT01193283|Antifungal Agents|antifungal agents|mesh-ancestor
92745065|NCT01193283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745066|NCT01193283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92745067|NCT01193283|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92745068|NCT02863471|Gemcitabine|gemcitabine|mesh-list
92745069|NCT02863471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92745070|NCT02863471|Antimetabolites|antimetabolites|mesh-ancestor
92745071|NCT02863471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745072|NCT02863471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745073|NCT01193127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92745074|NCT01193127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92745075|NCT01193127|Mydriatics|mydriatics|mesh-list
92745076|NCT01193127|Autonomic Agents|autonomic agents|mesh-ancestor
92745077|NCT01193127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745078|NCT01193127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745079|NCT01192815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92745080|NCT01192815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745081|NCT01192815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92745082|NCT01192815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745083|NCT01192815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745084|NCT01192191|Fluticasone|fluticasone|mesh-list
92745086|NCT01192191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745087|NCT01192191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92745088|NCT01192191|Autonomic Agents|autonomic agents|mesh-ancestor
92745089|NCT01192191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745090|NCT01192191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745091|NCT01192191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92745092|NCT01192191|Respiratory System Agents|respiratory system agents|mesh-ancestor
92745093|NCT01192191|Dermatologic Agents|dermatologic agents|mesh-ancestor
92745094|NCT01192191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92745095|NCT01307267|Rituximab|rituximab|mesh-list
92745096|NCT01307267|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92611545|NCT00467194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611546|NCT00467194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745097|NCT01307267|Immunoglobulin G|immunoglobulin g|mesh-list
92745098|NCT01307267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745099|NCT01307267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745100|NCT01307267|Immunologic Factors|immunologic factors|mesh-ancestor
92745101|NCT01307267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745102|NCT01307267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745103|NCT01307111|Misoprostol|misoprostol|mesh-list
92745104|NCT01307111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92745105|NCT01307111|Abortifacient Agents|abortifacient agents|mesh-ancestor
92745106|NCT01307111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92745107|NCT01307111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745108|NCT01307111|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92745109|NCT01307111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745110|NCT01307111|Oxytocics|oxytocics|mesh-ancestor
92745111|NCT01191801|Cytarabine|cytarabine|mesh-list
92745112|NCT01191801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92745113|NCT01191801|Antimetabolites|antimetabolites|mesh-ancestor
92398972|NCT01400685|Immunologic Factors|immunologic factors|mesh-ancestor
92745114|NCT01191801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745115|NCT01191801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745116|NCT01191801|Antiviral Agents|antiviral agents|mesh-ancestor
92745117|NCT01191801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745118|NCT01191801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745119|NCT01191801|Immunologic Factors|immunologic factors|mesh-ancestor
92745120|NCT01191801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745123|NCT01306643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745124|NCT01306643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745125|NCT05656833|Cysteamine|cysteamine|mesh-list
92745126|NCT05656833|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92745127|NCT05656833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745128|NCT01306331|Nonoxynol|nonoxynol|mesh-list
92745129|NCT01306331|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92745130|NCT01306331|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92745131|NCT01306331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745132|NCT01306331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92745133|NCT01306331|Contraceptive Agents|contraceptive agents|mesh-ancestor
92745134|NCT01306331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92745135|NCT01306331|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92745136|NCT00624663|Rivastigmine|rivastigmine|mesh-list
92745137|NCT00624663|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92745138|NCT00624663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745139|NCT00624663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745140|NCT00624663|Cholinergic Agents|cholinergic agents|mesh-ancestor
92745141|NCT00624663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745142|NCT00624663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745143|NCT00624663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92745144|NCT00624663|Protective Agents|protective agents|mesh-ancestor
92745145|NCT02890823|Cholecalciferol|cholecalciferol|mesh-list
92745146|NCT02890823|Vitamin D|vitamin d|mesh-list
92745147|NCT02890823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92745148|NCT02890823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745149|NCT02890823|Vitamins|vitamins|mesh-ancestor
92745150|NCT02890823|Micronutrients|micronutrients|mesh-ancestor
92745151|NCT02890823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92745152|NCT02887443|Midazolam|midazolam|mesh-list
92745153|NCT02887443|Idebenone|idebenone|mesh-list
92745154|NCT02887443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92745155|NCT02887443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92745156|NCT02887443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745157|NCT02887443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745158|NCT02887443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92745159|NCT02887443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92745160|NCT02887443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92745161|NCT02887443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92745162|NCT02887443|Anesthetics, General|anesthetics, general|mesh-ancestor
92745163|NCT02887443|Anesthetics|anesthetics|mesh-ancestor
92745164|NCT02887443|GABA Modulators|gaba modulators|mesh-ancestor
92745165|NCT02887443|GABA Agents|gaba agents|mesh-ancestor
92745166|NCT02887443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745167|NCT02887443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745168|NCT02887443|Antioxidants|antioxidants|mesh-ancestor
92745169|NCT02887443|Protective Agents|protective agents|mesh-ancestor
92611547|NCT00467194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92745170|NCT05359263|Dapagliflozin|dapagliflozin|mesh-list
92745171|NCT05359263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92745172|NCT05359263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745173|NCT05359263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92745174|NCT05359263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745175|NCT01305941|Trastuzumab|trastuzumab|mesh-list
92745176|NCT01305941|Everolimus|everolimus|mesh-list
92745177|NCT01305941|Vinorelbine|vinorelbine|mesh-list
92745178|NCT01305941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745179|NCT01305941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745180|NCT01305941|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92745181|NCT01305941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92745182|NCT01305941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745183|NCT01305941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745184|NCT01305941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745185|NCT01305941|Immunologic Factors|immunologic factors|mesh-ancestor
92745186|NCT01305941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745187|NCT01305941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92745188|NCT01305941|Tubulin Modulators|tubulin modulators|mesh-ancestor
92745189|NCT01305941|Antimitotic Agents|antimitotic agents|mesh-ancestor
92745190|NCT01305941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92745191|NCT05658549|Acetylcysteine|acetylcysteine|mesh-list
92745192|NCT05658549|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92745193|NCT05658549|Antiviral Agents|antiviral agents|mesh-ancestor
92745194|NCT05658549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745195|NCT05658549|Expectorants|expectorants|mesh-ancestor
92745199|NCT05658549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745200|NCT05658549|Protective Agents|protective agents|mesh-ancestor
92745201|NCT05658549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745202|NCT05658549|Antidotes|antidotes|mesh-ancestor
92745203|NCT02887365|Tegafur|tegafur|mesh-list
92745204|NCT02887365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92745205|NCT02887365|Antimetabolites|antimetabolites|mesh-ancestor
92745206|NCT02887365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745207|NCT02887365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745208|NCT05658159|Vitamin D|vitamin d|mesh-list
92745209|NCT05658159|Ergocalciferols|ergocalciferols|mesh-list
92745210|NCT05658159|Cholecalciferol|cholecalciferol|mesh-list
92745211|NCT05658159|Vitamins|vitamins|mesh-list
92745212|NCT05658159|Micronutrients|micronutrients|mesh-ancestor
92745213|NCT05658159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745214|NCT05658159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92745215|NCT05658159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92745216|NCT01305239|Exemestane|exemestane|mesh-list
92745217|NCT01305239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745218|NCT01305239|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92745219|NCT01305239|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92745220|NCT01305239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745221|NCT01305239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745222|NCT01305239|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92745223|NCT01305239|Hormone Antagonists|hormone antagonists|mesh-ancestor
92745224|NCT01305239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745225|NCT01305239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745226|NCT04317183|Miconazole|miconazole|mesh-list
92745227|NCT04317183|Antifungal Agents|antifungal agents|mesh-ancestor
92745228|NCT04317183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745229|NCT04317183|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92745230|NCT04317183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92745231|NCT04317183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745232|NCT04317183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745233|NCT04317183|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92745234|NCT04317183|Hormone Antagonists|hormone antagonists|mesh-ancestor
92745235|NCT04317183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745236|NCT04317183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745237|NCT04317183|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92745238|NCT04317183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92745239|NCT01194219|Apremilast|apremilast|mesh-list
92745240|NCT01194219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92745241|NCT01194219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745242|NCT01194219|Analgesics|analgesics|mesh-ancestor
92745243|NCT01194219|Sensory System Agents|sensory system agents|mesh-ancestor
92611548|NCT00467194|Antifungal Agents|antifungal agents|mesh-ancestor
92336610|NCT01945242|Alogliptin|alogliptin|mesh-list
92611549|NCT00467194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745244|NCT01194219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745245|NCT01194219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745246|NCT01194219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745247|NCT01194219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745248|NCT01194219|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92745249|NCT01194219|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92745250|NCT01194219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745251|NCT01194219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745252|NCT01304693|Ranibizumab|ranibizumab|mesh-list
92745253|NCT01304693|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92745254|NCT01304693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92745255|NCT01304693|Growth Substances|growth substances|mesh-ancestor
92745256|NCT01304693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745257|NCT01304693|Growth Inhibitors|growth inhibitors|mesh-ancestor
92745258|NCT01304693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745259|NCT01304147|Ketamine|ketamine|mesh-list
92745260|NCT01304147|Analgesics|analgesics|mesh-ancestor
92745261|NCT01304147|Sensory System Agents|sensory system agents|mesh-ancestor
92745262|NCT01304147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745263|NCT01304147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745264|NCT01304147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92745265|NCT01304147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92745268|NCT01304147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745269|NCT01304147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92745270|NCT01304147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92745272|NCT01304147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745273|NCT05661227|Dexmedetomidine|dexmedetomidine|mesh-list
92745274|NCT05661227|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92745275|NCT05661227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745276|NCT05661227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745277|NCT05661227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745278|NCT05661227|Analgesics|analgesics|mesh-ancestor
92745279|NCT05661227|Sensory System Agents|sensory system agents|mesh-ancestor
92745280|NCT05661227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745281|NCT05661227|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92745282|NCT05661227|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92745283|NCT05661227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92745284|NCT05661227|Adrenergic Agents|adrenergic agents|mesh-ancestor
92745285|NCT05661227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745286|NCT05661227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745287|NCT01303445|Omeprazole|omeprazole|mesh-list
92745288|NCT01303445|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
92745289|NCT01303445|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92745290|NCT01303445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745291|NCT01303445|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92745292|NCT01303445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745293|NCT01303445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745294|NCT01303445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92745295|NCT01188681|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92745296|NCT01188681|Immunoglobulin G|immunoglobulin g|mesh-list
92745297|NCT01188681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92745298|NCT01188681|Alkylating Agents|alkylating agents|mesh-ancestor
92745299|NCT01188681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745300|NCT01188681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745301|NCT01188681|Immunologic Factors|immunologic factors|mesh-ancestor
92745302|NCT01188681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745303|NCT01302899|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92745304|NCT01302899|Ramipril|ramipril|mesh-list
92745305|NCT01302899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92745306|NCT01302899|Diuretics|diuretics|mesh-ancestor
92745307|NCT01302899|Natriuretic Agents|natriuretic agents|mesh-ancestor
92745308|NCT01302899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745309|NCT01302899|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92745310|NCT01302899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92745311|NCT01302899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745312|NCT01302899|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92611551|NCT00148902|Docetaxel|docetaxel|mesh-list
92611552|NCT00148902|Lapatinib|lapatinib|mesh-list
92611553|NCT00148902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611554|NCT00148902|Tubulin Modulators|tubulin modulators|mesh-ancestor
92611555|NCT00148902|Antimitotic Agents|antimitotic agents|mesh-ancestor
92611556|NCT00148902|Mitosis Modulators|mitosis modulators|mesh-ancestor
92745313|NCT01302899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92745314|NCT01302899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745315|NCT01187901|Sulindac|sulindac|mesh-list
92745316|NCT01187901|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92745317|NCT01187901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745318|NCT01187901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92745319|NCT01187901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745320|NCT01187901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745321|NCT01187901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92745322|NCT01187901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745323|NCT01187901|Analgesics|analgesics|mesh-ancestor
92745324|NCT01187901|Sensory System Agents|sensory system agents|mesh-ancestor
92745325|NCT01187901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745326|NCT01187901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745327|NCT01187901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745328|NCT01187901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745329|NCT01187901|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92745330|NCT01302119|Tavaborole|tavaborole|mesh-list
92745331|NCT01302119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92745332|NCT01302119|Antifungal Agents|antifungal agents|mesh-ancestor
92745333|NCT01302119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745334|NCT05927922|Ibuprofen|ibuprofen|mesh-list
92745335|NCT05927922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92745338|NCT05927922|Sensory System Agents|sensory system agents|mesh-ancestor
92745339|NCT05927922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745340|NCT05927922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745341|NCT05927922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745342|NCT05927922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745343|NCT05927922|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92745344|NCT05927922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745345|NCT05927922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745346|NCT05927857|Trifluridine|trifluridine|mesh-list
92745347|NCT05927857|Ramucirumab|ramucirumab|mesh-list
92745348|NCT05927857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745349|NCT05927857|Antimetabolites|antimetabolites|mesh-ancestor
92745350|NCT05927857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745351|NCT05927857|Antiviral Agents|antiviral agents|mesh-ancestor
92745352|NCT05927857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745353|NCT05927831|Grape Seed Extract|grape seed extract|mesh-list
92745354|NCT05927831|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92745355|NCT05927831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745356|NCT05927831|Antioxidants|antioxidants|mesh-ancestor
92745357|NCT05927831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745358|NCT05927831|Protective Agents|protective agents|mesh-ancestor
92745359|NCT05927831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745360|NCT05927818|Charcoal|charcoal|mesh-list
92745361|NCT05927818|Antidotes|antidotes|mesh-ancestor
92745362|NCT05927818|Protective Agents|protective agents|mesh-ancestor
92745363|NCT05927818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745364|NCT05927649|Moxifloxacin|moxifloxacin|mesh-list
92745365|NCT05927649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745366|NCT05927649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745367|NCT05927649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92745368|NCT05927649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92745369|NCT05927649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745370|NCT05927649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745371|NCT05927649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745372|NCT05927428|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92745373|NCT05927428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92745374|NCT05927259|Acetylcysteine|acetylcysteine|mesh-list
92745375|NCT05927259|Atropine|atropine|mesh-list
92745376|NCT05927259|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92745377|NCT05927259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92611557|NCT00148902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611558|NCT00148902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92611559|NCT00148902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611560|NCT05507645|Saruplase|saruplase|mesh-list
92745378|NCT05927259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92745379|NCT05927259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92745380|NCT05927259|Autonomic Agents|autonomic agents|mesh-ancestor
92745381|NCT05927259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745382|NCT05927259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745383|NCT05927259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92745384|NCT05927259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92745385|NCT05927259|Mydriatics|mydriatics|mesh-ancestor
92745386|NCT05927259|Parasympatholytics|parasympatholytics|mesh-ancestor
92745387|NCT05927259|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92745388|NCT05927259|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92745389|NCT05927259|Cholinergic Agents|cholinergic agents|mesh-ancestor
92745390|NCT05927259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745391|NCT05927259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745392|NCT05927259|Antiviral Agents|antiviral agents|mesh-ancestor
92745393|NCT05927259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745394|NCT05927259|Expectorants|expectorants|mesh-ancestor
92745395|NCT05927259|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92745396|NCT05927259|Antioxidants|antioxidants|mesh-ancestor
92745397|NCT05927259|Protective Agents|protective agents|mesh-ancestor
92745398|NCT05927259|Antidotes|antidotes|mesh-ancestor
92745399|NCT05927155|Tiotropium Bromide|tiotropium bromide|mesh-list
92745400|NCT05927155|Olodaterol|olodaterol|mesh-list
92745401|NCT05927155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92745402|NCT05927155|Autonomic Agents|autonomic agents|mesh-ancestor
92745403|NCT05927155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745404|NCT05927155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745405|NCT05927155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92745406|NCT05927155|Respiratory System Agents|respiratory system agents|mesh-ancestor
92745407|NCT05927155|Parasympatholytics|parasympatholytics|mesh-ancestor
92745408|NCT05927155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92745409|NCT05927155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92745412|NCT05927142|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92745413|NCT05927142|Durvalumab|durvalumab|mesh-list
92745414|NCT05927142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745415|NCT05927142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745416|NCT05927142|Antiviral Agents|antiviral agents|mesh-ancestor
92745417|NCT05927142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745418|NCT05927129|Antidepressive Agents|antidepressive agents|mesh-list
92745419|NCT05927129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92745420|NCT05926895|Betamethasone|betamethasone|mesh-list
92745421|NCT05926895|Betamethasone Valerate|betamethasone valerate|mesh-list
92745422|NCT05926895|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92745423|NCT05926895|Betamethasone benzoate|betamethasone benzoate|mesh-list
92745424|NCT05926895|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
92745425|NCT05926895|Prilocaine|prilocaine|mesh-list
92745426|NCT05926895|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92745427|NCT05926895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745428|NCT05926895|Glucocorticoids|glucocorticoids|mesh-ancestor
92745429|NCT05926895|Hormones|hormones|mesh-ancestor
92745430|NCT05926895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745431|NCT05926895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745432|NCT05926895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92745433|NCT05926895|Respiratory System Agents|respiratory system agents|mesh-ancestor
92745434|NCT05926895|Anesthetics, Local|anesthetics, local|mesh-ancestor
92745435|NCT05926895|Anesthetics|anesthetics|mesh-ancestor
92745436|NCT05926895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745437|NCT05926895|Sensory System Agents|sensory system agents|mesh-ancestor
92745438|NCT05926895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745439|NCT05926882|Apremilast|apremilast|mesh-list
92745440|NCT05926882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92745441|NCT05926882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745442|NCT05926882|Analgesics|analgesics|mesh-ancestor
92745443|NCT05926882|Sensory System Agents|sensory system agents|mesh-ancestor
92745444|NCT05926882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745445|NCT05926882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611561|NCT05507645|Anticoagulants|anticoagulants|mesh-list
92611562|NCT05507645|Clopidogrel|clopidogrel|mesh-list
92611563|NCT05507645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018602|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
92745446|NCT05926882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745447|NCT05926882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745448|NCT05926882|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92745449|NCT05926882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92745450|NCT05926882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745451|NCT05926882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745452|NCT05926869|Clindamycin|clindamycin|mesh-list
92745453|NCT05926869|Clindamycin palmitate|clindamycin palmitate|mesh-list
92745454|NCT05926869|Clindamycin phosphate|clindamycin phosphate|mesh-list
92745455|NCT05926869|Dapsone|dapsone|mesh-list
92745456|NCT05926869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745457|NCT05926869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745458|NCT05926869|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92745459|NCT05926869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745460|NCT05926869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745461|NCT05926869|Antimalarials|antimalarials|mesh-ancestor
92745462|NCT05926869|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92745463|NCT05926869|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92745464|NCT05926869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92745465|NCT05926869|Leprostatic Agents|leprostatic agents|mesh-ancestor
92745466|NCT05926804|Amoxicillin|amoxicillin|mesh-list
92745467|NCT05926804|Metronidazole|metronidazole|mesh-list
92745468|NCT05926804|Clarithromycin|clarithromycin|mesh-list
92745469|NCT05926804|Lansoprazole|lansoprazole|mesh-list
92745470|NCT05926804|Dexlansoprazole|dexlansoprazole|mesh-list
92745471|NCT05926804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745472|NCT05926804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745473|NCT05926804|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92745474|NCT05926804|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92745475|NCT05926804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92745476|NCT05926804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745477|NCT05926804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745478|NCT05926804|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92745479|NCT05926804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92745480|NCT05926804|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92745481|NCT05926804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745486|NCT05926570|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92745487|NCT05926570|Hormone Antagonists|hormone antagonists|mesh-ancestor
92745488|NCT05926570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745490|NCT05926466|Bedaquiline|bedaquiline|mesh-list
92745491|NCT05926466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745492|NCT05926466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745493|NCT05926466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92745494|NCT05926466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92745495|NCT05926466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745496|NCT05926466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745497|NCT05926466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745498|NCT05926466|Antitubercular Agents|antitubercular agents|mesh-ancestor
92745499|NCT05926440|Vaccines|vaccines|mesh-list
92745500|NCT05926440|Somatomedin B|somatomedin b|mesh-list
92745501|NCT05926440|Immunologic Factors|immunologic factors|mesh-ancestor
92745502|NCT05926440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745503|NCT05926440|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92745504|NCT05926440|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92745505|NCT05926440|Protease Inhibitors|protease inhibitors|mesh-ancestor
92745506|NCT05926440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745507|NCT05926440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745508|NCT05926427|Rituximab|rituximab|mesh-list
92745509|NCT05926427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745510|NCT05926427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745511|NCT05926427|Immunologic Factors|immunologic factors|mesh-ancestor
92745512|NCT05926427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745513|NCT05926427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745514|NCT05926271|Clopidogrel|clopidogrel|mesh-list
92745515|NCT05926271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92745516|NCT05926271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92745517|NCT05926271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92745518|NCT05926271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92611565|NCT05507645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92611566|NCT05507645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611567|NCT05507645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92611568|NCT05507645|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92745519|NCT05926271|Purinergic Agents|purinergic agents|mesh-ancestor
92745520|NCT05926271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745521|NCT05926271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745522|NCT05926271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745523|NCT05926258|Chloroprocaine|chloroprocaine|mesh-list
92745524|NCT05926258|Benoxinate|benoxinate|mesh-list
92745525|NCT05926258|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92745526|NCT05926258|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92745527|NCT05926258|Anesthetics, Local|anesthetics, local|mesh-ancestor
92745528|NCT05926258|Anesthetics|anesthetics|mesh-ancestor
92745529|NCT05926258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745530|NCT05926258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745531|NCT05926258|Sensory System Agents|sensory system agents|mesh-ancestor
92745532|NCT05926258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745533|NCT05926245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92745534|NCT05926206|Folfirinox|folfirinox|mesh-list
92745535|NCT05926206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745536|NCT05926180|Digoxin|digoxin|mesh-list
92745537|NCT05926180|Midazolam|midazolam|mesh-list
92745538|NCT05926180|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92745539|NCT05926180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92745540|NCT05926180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92745541|NCT05926180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745542|NCT05926180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745543|NCT05926180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92745544|NCT05926180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92745545|NCT05926180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92745546|NCT05926180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92745547|NCT05926180|Anesthetics, General|anesthetics, general|mesh-ancestor
92745549|NCT05926180|GABA Modulators|gaba modulators|mesh-ancestor
92745550|NCT05926180|GABA Agents|gaba agents|mesh-ancestor
92745551|NCT05926180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745552|NCT05926180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745553|NCT05926180|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92745554|NCT05926180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92745557|NCT05926180|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92745559|NCT05926180|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92745560|NCT05926180|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92745561|NCT05926180|Protective Agents|protective agents|mesh-ancestor
92745562|NCT05926128|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92745563|NCT05926128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92745564|NCT05926128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745565|NCT05926128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745566|NCT05924152|Adagrasib|adagrasib|mesh-list
92745567|NCT05924152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745568|NCT05922176|Immunomodulating Agents|immunomodulating agents|mesh-list
92745569|NCT05922176|Immunologic Factors|immunologic factors|mesh-list
92745570|NCT05922176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745571|NCT05920967|Dexamethasone|dexamethasone|mesh-list
92745572|NCT05920967|Dexamethasone acetate|dexamethasone acetate|mesh-list
92745573|NCT05920967|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92745574|NCT05920967|BB 1101|bb 1101|mesh-list
92745575|NCT05920967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745576|NCT05920967|Antiemetics|antiemetics|mesh-ancestor
92745577|NCT05920967|Autonomic Agents|autonomic agents|mesh-ancestor
92745578|NCT05920967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745579|NCT05920967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745580|NCT05920967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745581|NCT05920967|Glucocorticoids|glucocorticoids|mesh-ancestor
92745582|NCT05920967|Hormones|hormones|mesh-ancestor
92745583|NCT05920967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745584|NCT05920967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92745585|NCT05920967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745586|NCT05920967|Protease Inhibitors|protease inhibitors|mesh-ancestor
92611569|NCT05507645|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92611570|NCT05507645|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92611571|NCT05507645|Purinergic Agents|purinergic agents|mesh-ancestor
92611572|NCT05507645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611573|NCT03271918|Cabergoline|cabergoline|mesh-list
92611574|NCT03271918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92611575|NCT03271918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92611576|NCT03271918|Dopamine Agonists|dopamine agonists|mesh-ancestor
92611577|NCT03271918|Dopamine Agents|dopamine agents|mesh-ancestor
92611578|NCT03271918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611579|NCT03271918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611580|NCT03271918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611581|NCT00467467|Alfuzosin|alfuzosin|mesh-list
92611582|NCT00467467|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92745587|NCT05920967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745588|NCT05920967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745589|NCT05920798|Pembrolizumab|pembrolizumab|mesh-list
92745590|NCT05920798|Vaccines|vaccines|mesh-list
92745591|NCT05920798|Immunologic Factors|immunologic factors|mesh-ancestor
92745592|NCT05920798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745593|NCT05920798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745594|NCT05920798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745595|NCT05920798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92745596|NCT05920798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745597|NCT05914467|Teicoplanin|teicoplanin|mesh-list
92745598|NCT05914467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745599|NCT05914467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745600|NCT05880862|Mirabegron|mirabegron|mesh-list
92745601|NCT05880862|Trospium chloride|trospium chloride|mesh-list
92745602|NCT05880862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92745603|NCT05880862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92745604|NCT05880862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92745605|NCT05880862|Adrenergic Agents|adrenergic agents|mesh-ancestor
92745606|NCT05880862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745607|NCT05880862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745608|NCT05880862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745609|NCT05880862|Urological Agents|urological agents|mesh-ancestor
92745610|NCT05880862|Parasympatholytics|parasympatholytics|mesh-ancestor
92745611|NCT05880862|Autonomic Agents|autonomic agents|mesh-ancestor
92745612|NCT05880862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745613|NCT05880862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92745614|NCT05880862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92745615|NCT05880862|Cholinergic Agents|cholinergic agents|mesh-ancestor
92745616|NCT05876182|Vancomycin|vancomycin|mesh-list
92745617|NCT05876182|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745618|NCT05876182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745619|NCT05864417|Sunscreening Agents|sunscreening agents|mesh-list
92745620|NCT05864417|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92745621|NCT05864417|Protective Agents|protective agents|mesh-ancestor
92745622|NCT05864417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745623|NCT05864417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92745624|NCT05835011|Decitabine|decitabine|mesh-list
92745625|NCT05835011|Magrolimab|magrolimab|mesh-list
92745626|NCT05835011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92745627|NCT05835011|Antimetabolites|antimetabolites|mesh-ancestor
92745641|NCT05798481|Expectorants|expectorants|mesh-ancestor
92745642|NCT05798481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92745643|NCT05798481|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92745644|NCT05798481|Antioxidants|antioxidants|mesh-ancestor
92745645|NCT05798481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745646|NCT05798481|Protective Agents|protective agents|mesh-ancestor
92611583|NCT00467467|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92611584|NCT00467467|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92745647|NCT05798481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745649|NCT05790486|Nicotine|nicotine|mesh-list
92745650|NCT05790486|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92745651|NCT05790486|Autonomic Agents|autonomic agents|mesh-ancestor
92745652|NCT05790486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745653|NCT05790486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745654|NCT05790486|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92745655|NCT05790486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92745656|NCT05790486|Cholinergic Agents|cholinergic agents|mesh-ancestor
92745657|NCT05790486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745658|NCT05790486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745659|NCT05789069|Tislelizumab|tislelizumab|mesh-list
92745660|NCT05789069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745661|NCT05789069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745662|NCT05737628|Rituximab|rituximab|mesh-list
92745663|NCT05737628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745664|NCT05737628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745665|NCT05737628|Immunologic Factors|immunologic factors|mesh-ancestor
92745666|NCT05737628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745667|NCT05737628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745668|NCT05736341|Midazolam|midazolam|mesh-list
92745669|NCT05736341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92745670|NCT05736341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92745671|NCT05736341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745672|NCT05736341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745673|NCT05736341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92745674|NCT05736341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92745675|NCT05736341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92745676|NCT05736341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92745677|NCT05736341|Anesthetics, General|anesthetics, general|mesh-ancestor
92745678|NCT05736341|Anesthetics|anesthetics|mesh-ancestor
92745679|NCT05736341|GABA Modulators|gaba modulators|mesh-ancestor
92745680|NCT05736341|GABA Agents|gaba agents|mesh-ancestor
92745681|NCT05736341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745682|NCT05736341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745683|NCT05696080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92745684|NCT05696080|Immunologic Factors|immunologic factors|mesh-ancestor
92745685|NCT05696080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745686|NCT05691010|Paclitaxel|paclitaxel|mesh-list
92745687|NCT05691010|Carboplatin|carboplatin|mesh-list
92745688|NCT05691010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92745689|NCT05691010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745690|NCT05691010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92745691|NCT05691010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92745694|NCT05690984|Dexamethasone|dexamethasone|mesh-list
92745695|NCT05690984|Lenalidomide|lenalidomide|mesh-list
92745696|NCT05690984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745697|NCT05690984|Antiemetics|antiemetics|mesh-ancestor
92745698|NCT05690984|Autonomic Agents|autonomic agents|mesh-ancestor
92745699|NCT05690984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745700|NCT05690984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745701|NCT05690984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745702|NCT05690984|Glucocorticoids|glucocorticoids|mesh-ancestor
92745703|NCT05690984|Hormones|hormones|mesh-ancestor
92745704|NCT05690984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745705|NCT05690984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92745706|NCT05690984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745707|NCT05690984|Immunologic Factors|immunologic factors|mesh-ancestor
92745708|NCT05690984|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92745709|NCT05690984|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92745710|NCT05690984|Growth Substances|growth substances|mesh-ancestor
92745711|NCT05690984|Growth Inhibitors|growth inhibitors|mesh-ancestor
92745712|NCT05688332|Metformin|metformin|mesh-list
92745713|NCT05688332|Glyburide|glyburide|mesh-list
92745714|NCT05688332|Voglibose|voglibose|mesh-list
92745715|NCT05688332|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92745716|NCT05688332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745717|NCT05688332|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92745718|NCT05688332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745719|NCT05688332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745720|NCT05679401|Cyclophosphamide|cyclophosphamide|mesh-list
92611585|NCT00467467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92611586|NCT00467467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611587|NCT00467467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611588|NCT00467467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745721|NCT05679401|Glucocorticoids|glucocorticoids|mesh-list
92745722|NCT05679401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745723|NCT05679401|Immunologic Factors|immunologic factors|mesh-ancestor
92745724|NCT05679401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745725|NCT05679401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745726|NCT05679401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92745727|NCT05679401|Alkylating Agents|alkylating agents|mesh-ancestor
92745728|NCT05679401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745729|NCT05679401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745730|NCT05679401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92745732|NCT05679401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745733|NCT05645536|Tamoxifen|tamoxifen|mesh-list
92745734|NCT05645536|Letrozole|letrozole|mesh-list
92745735|NCT05645536|Anastrozole|anastrozole|mesh-list
92745736|NCT05645536|Exemestane|exemestane|mesh-list
92745737|NCT05645536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745738|NCT05645536|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92745739|NCT05645536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92745740|NCT05645536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745741|NCT05645536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745742|NCT05645536|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92745743|NCT05645536|Hormone Antagonists|hormone antagonists|mesh-ancestor
92745744|NCT05645536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745745|NCT05645536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745746|NCT05645536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92745747|NCT05645536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92745748|NCT05645536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92745749|NCT05645536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92745750|NCT05642962|Pancrelipase|pancrelipase|mesh-list
92745751|NCT05642962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745752|NCT05641142|Anticoagulants|anticoagulants|mesh-list
92745753|NCT05617313|Pembrolizumab|pembrolizumab|mesh-list
92745754|NCT05617313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745755|NCT05617313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745756|NCT05617313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92745757|NCT05617313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745758|NCT05605509|Gemcitabine|gemcitabine|mesh-list
92745759|NCT05605509|Trastuzumab|trastuzumab|mesh-list
92745760|NCT05605509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92745761|NCT05605509|Antimetabolites|antimetabolites|mesh-ancestor
92745762|NCT05605509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745763|NCT05605509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745767|NCT05601492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92745768|NCT05601492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745769|NCT05601492|Analgesics|analgesics|mesh-ancestor
92745770|NCT05601492|Sensory System Agents|sensory system agents|mesh-ancestor
92745771|NCT05601492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745772|NCT05601492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745773|NCT05601492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745774|NCT05601492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745775|NCT05601492|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92745776|NCT05601492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92745777|NCT05601492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745778|NCT05601492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745779|NCT05601492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745780|NCT05601492|Immunologic Factors|immunologic factors|mesh-ancestor
92745781|NCT05601492|Leprostatic Agents|leprostatic agents|mesh-ancestor
92745782|NCT05601492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745783|NCT05601492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745784|NCT05601492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92745785|NCT05601492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92745786|NCT05601492|Growth Substances|growth substances|mesh-ancestor
92611589|NCT00467467|Urological Agents|urological agents|mesh-ancestor
92611590|NCT00406887|Difluprednate|difluprednate|mesh-list
92611591|NCT00406887|Glucocorticoids|glucocorticoids|mesh-ancestor
92611592|NCT00406887|Hormones|hormones|mesh-ancestor
92611593|NCT00406887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018614|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92745787|NCT05601492|Growth Inhibitors|growth inhibitors|mesh-ancestor
92745788|NCT05601492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745789|NCT05597735|Tecovirimat|tecovirimat|mesh-list
92745790|NCT05597735|Antiviral Agents|antiviral agents|mesh-ancestor
92745791|NCT05597735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745792|NCT05589363|Bupivacaine|bupivacaine|mesh-list
92745793|NCT05589363|Anesthetics, Local|anesthetics, local|mesh-ancestor
92745794|NCT05589363|Anesthetics|anesthetics|mesh-ancestor
92745795|NCT05589363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745796|NCT05589363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745797|NCT05589363|Sensory System Agents|sensory system agents|mesh-ancestor
92745798|NCT05589363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745799|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
92745800|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92745801|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745802|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745803|NCT05583708|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92745804|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745805|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92745806|NCT05582434|Clindamycin|clindamycin|mesh-list
92745807|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
92745808|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
92745809|NCT05582434|Adapalene|adapalene|mesh-list
92745810|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92745811|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745812|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745813|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92745814|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745815|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745816|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
92745817|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92745818|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745819|NCT05582434|Analgesics|analgesics|mesh-ancestor
92745820|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
92745821|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745822|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745823|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745824|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745825|NCT05554133|Proflavine|proflavine|mesh-list
92745826|NCT05554133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92745827|NCT05554133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745828|NCT05549661|Onvansertib|onvansertib|mesh-list
92745829|NCT05549661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92745830|NCT05549661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745831|NCT05549661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745832|NCT05528588|Furosemide|furosemide|mesh-list
92745833|NCT05528588|Diuretics|diuretics|mesh-ancestor
92745834|NCT05528588|Natriuretic Agents|natriuretic agents|mesh-ancestor
92745835|NCT05528588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745838|NCT05528588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745840|NCT05518877|Analgesics|analgesics|mesh-ancestor
92745841|NCT05518877|Sensory System Agents|sensory system agents|mesh-ancestor
92745842|NCT05518877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745843|NCT05518877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745844|NCT05518877|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92745845|NCT05518877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92745846|NCT05518877|Anesthetics, General|anesthetics, general|mesh-ancestor
92745847|NCT05518877|Anesthetics|anesthetics|mesh-ancestor
92745848|NCT05518877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92745849|NCT05518877|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92745850|NCT05518877|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92745851|NCT05518877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745852|NCT05518877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611594|NCT00406887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611596|NCT00467506|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92611597|NCT00467506|Immunologic Factors|immunologic factors|mesh-ancestor
92611598|NCT00467506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745853|NCT05488431|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92745854|NCT05488431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92745855|NCT05488431|Antimetabolites|antimetabolites|mesh-ancestor
92745856|NCT05488431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745857|NCT05488431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92745858|NCT05488431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745859|NCT05488431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92745860|NCT05488431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745861|NCT05468489|Carboplatin|carboplatin|mesh-list
92745862|NCT05468489|Etoposide|etoposide|mesh-list
92745863|NCT05468489|Etoposide phosphate|etoposide phosphate|mesh-list
92745864|NCT05468489|Atezolizumab|atezolizumab|mesh-list
92745865|NCT05468489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745866|NCT05468489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92745867|NCT05468489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92745868|NCT05468489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92745869|NCT05468489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745870|NCT05468489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745871|NCT05468489|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92745872|NCT05468489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745873|NCT05465954|Pembrolizumab|pembrolizumab|mesh-list
92745874|NCT05465954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745875|NCT05465954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745876|NCT05465954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92745877|NCT05465954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745878|NCT05435235|Dapagliflozin|dapagliflozin|mesh-list
92745879|NCT05435235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92745880|NCT05435235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745881|NCT05435235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92745882|NCT05435235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745883|NCT05434663|Granisetron|granisetron|mesh-list
92745884|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
92745885|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
92745886|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745887|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745888|NCT05434663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745889|NCT05434663|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92745890|NCT05434663|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92745891|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
92745892|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745893|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745894|NCT05421858|Fluconazole|fluconazole|mesh-list
92745895|NCT05421858|Caspofungin|caspofungin|mesh-list
92745896|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
92745897|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745898|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92745899|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92745900|NCT05421858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745901|NCT05421858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745902|NCT05421858|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92745903|NCT05421858|Hormone Antagonists|hormone antagonists|mesh-ancestor
92745912|NCT05394350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745913|NCT05394350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92745914|NCT05394350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745915|NCT05394337|Atezolizumab|atezolizumab|mesh-list
92745917|NCT05394337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745918|NCT05394337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745919|NCT05394337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745920|NCT05392946|Dexamethasone|dexamethasone|mesh-list
92745921|NCT05392946|Dexamethasone acetate|dexamethasone acetate|mesh-list
92745922|NCT05392946|Bortezomib|bortezomib|mesh-list
92745923|NCT05392946|Daratumumab|daratumumab|mesh-list
92745924|NCT05392946|Ichthammol|ichthammol|mesh-list
92611599|NCT00467545|Telbivudine|telbivudine|mesh-list
92611600|NCT00467545|Antiviral Agents|antiviral agents|mesh-ancestor
92611601|NCT00467545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611602|NCT00467545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92611603|NCT00467545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611604|NCT00467545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611605|NCT00467662|Acyclovir|acyclovir|mesh-list
92611606|NCT00467662|Docosanol|docosanol|mesh-list
92611607|NCT00467662|Antiviral Agents|antiviral agents|mesh-ancestor
92611608|NCT00467662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611609|NCT05497310|Tretinoin|tretinoin|mesh-list
92745925|NCT05392946|BB 1101|bb 1101|mesh-list
92745926|NCT05392946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745927|NCT05392946|Antiemetics|antiemetics|mesh-ancestor
92745928|NCT05392946|Autonomic Agents|autonomic agents|mesh-ancestor
92745929|NCT05392946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92745930|NCT05392946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745931|NCT05392946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92745932|NCT05392946|Glucocorticoids|glucocorticoids|mesh-ancestor
92745933|NCT05392946|Hormones|hormones|mesh-ancestor
92745934|NCT05392946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745935|NCT05392946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92745936|NCT05392946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745937|NCT05392946|Protease Inhibitors|protease inhibitors|mesh-ancestor
92745938|NCT05392946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745939|NCT05392946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745940|NCT05392946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92745941|NCT05389423|Prednisone|prednisone|mesh-list
92745942|NCT05389423|Cyclophosphamide|cyclophosphamide|mesh-list
92745943|NCT05389423|Rituximab|rituximab|mesh-list
92745944|NCT05389423|Doxorubicin|doxorubicin|mesh-list
92745945|NCT05389423|Etoposide|etoposide|mesh-list
92745946|NCT05389423|Vincristine|vincristine|mesh-list
92745947|NCT05389423|Pomalidomide|pomalidomide|mesh-list
92745948|NCT05389423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92745949|NCT05389423|Immunologic Factors|immunologic factors|mesh-ancestor
92745950|NCT05389423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745951|NCT05389423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92745952|NCT05389423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92745953|NCT05389423|Alkylating Agents|alkylating agents|mesh-ancestor
92745954|NCT05389423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745955|NCT05389423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745956|NCT05389423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92745957|NCT05389423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745958|NCT05389423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92745959|NCT05389423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92745960|NCT05389423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92745961|NCT05389423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745962|NCT05389423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92745963|NCT05389423|Glucocorticoids|glucocorticoids|mesh-ancestor
92745964|NCT05389423|Hormones|hormones|mesh-ancestor
92745965|NCT05389423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745966|NCT05389423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92745967|NCT05389423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92745968|NCT05389423|Tubulin Modulators|tubulin modulators|mesh-ancestor
92745969|NCT05389423|Antimitotic Agents|antimitotic agents|mesh-ancestor
92745970|NCT05389423|Mitosis Modulators|mitosis modulators|mesh-ancestor
92745971|NCT05389423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92745972|NCT05389423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92745973|NCT05389423|Growth Substances|growth substances|mesh-ancestor
92745974|NCT05389423|Growth Inhibitors|growth inhibitors|mesh-ancestor
92745975|NCT05382208|Doxycycline|doxycycline|mesh-list
92745976|NCT05382208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92745977|NCT05382208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745978|NCT05382208|Antimalarials|antimalarials|mesh-ancestor
92745979|NCT05382208|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92611610|NCT05497310|Arsenic Trioxide|arsenic trioxide|mesh-list
92611611|NCT05497310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611612|NCT05497310|Keratolytic Agents|keratolytic agents|mesh-ancestor
92611613|NCT05497310|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611614|NCT00467935|Ranibizumab|ranibizumab|mesh-list
92745980|NCT05382208|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92745981|NCT05374603|Durvalumab|durvalumab|mesh-list
92745982|NCT05374603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745983|NCT05374603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745984|NCT05356936|Vitamin D|vitamin d|mesh-list
92745985|NCT05356936|Cholecalciferol|cholecalciferol|mesh-list
92745986|NCT05356936|Vitamins|vitamins|mesh-list
92745987|NCT05356936|Vitamin K|vitamin k|mesh-list
92745988|NCT05356936|Vitamin K 2|vitamin k 2|mesh-list
92745989|NCT05356936|Micronutrients|micronutrients|mesh-ancestor
92745990|NCT05356936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745991|NCT05356936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92745992|NCT05356936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92745993|NCT05356936|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92745994|NCT05356936|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92745995|NCT05356936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745996|NCT05356936|Hemostatics|hemostatics|mesh-ancestor
92745997|NCT05356936|Coagulants|coagulants|mesh-ancestor
92745998|NCT05354453|Phenethyl isothiocyanate|phenethyl isothiocyanate|mesh-list
92745999|NCT05354453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746000|NCT05354453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746001|NCT05354453|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92746002|NCT05354453|Protective Agents|protective agents|mesh-ancestor
92746003|NCT05354453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746004|NCT05354453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746005|NCT05339256|Buprenorphine|buprenorphine|mesh-list
92746006|NCT05339256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92746007|NCT05339256|Narcotics|narcotics|mesh-ancestor
92746008|NCT05339256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92746009|NCT05339256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746010|NCT05339256|Analgesics|analgesics|mesh-ancestor
92746011|NCT05339256|Sensory System Agents|sensory system agents|mesh-ancestor
92746012|NCT05339256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746013|NCT05339256|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92746014|NCT05323812|Edaravone|edaravone|mesh-list
92746015|NCT05323812|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92746016|NCT05323812|Antioxidants|antioxidants|mesh-ancestor
92746017|NCT05323812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746018|NCT05323812|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92746019|NCT05323812|Protective Agents|protective agents|mesh-ancestor
92746020|NCT05323812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746021|NCT05322577|Nivolumab|nivolumab|mesh-list
92746022|NCT05322577|Bemarituzumab|bemarituzumab|mesh-list
92746023|NCT05322577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746024|NCT05322577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746025|NCT05322577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746026|NCT05322577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746027|NCT05321420|Pirfenidone|pirfenidone|mesh-list
92746028|NCT05321420|Analgesics|analgesics|mesh-ancestor
92746029|NCT05321420|Sensory System Agents|sensory system agents|mesh-ancestor
92746030|NCT05321420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746031|NCT05321420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746032|NCT05321420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92746033|NCT05321420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92746034|NCT05321420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746035|NCT05321420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746036|NCT05321420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746037|NCT05273567|Guanfacine|guanfacine|mesh-list
92746038|NCT05273567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92746039|NCT05273567|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92746040|NCT05273567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92746041|NCT05273567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92746042|NCT05273567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92746043|NCT05273567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92746044|NCT05273567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611615|NCT00467935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92746045|NCT05273567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746050|NCT05267600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746051|NCT05267600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746052|NCT05267600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92746053|NCT05267600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746054|NCT05264974|Vaccines|vaccines|mesh-list
92746055|NCT05264974|Immunologic Factors|immunologic factors|mesh-ancestor
92746056|NCT05264974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746057|NCT05186974|Carboplatin|carboplatin|mesh-list
92746058|NCT05186974|Pembrolizumab|pembrolizumab|mesh-list
92746059|NCT05186974|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92746060|NCT05186974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746061|NCT05186974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746062|NCT05186974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746063|NCT05186974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746064|NCT05186974|Immunoconjugates|immunoconjugates|mesh-ancestor
92746065|NCT05186974|Immunologic Factors|immunologic factors|mesh-ancestor
92746066|NCT05186974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746067|NCT05170009|Oseltamivir|oseltamivir|mesh-list
92746068|NCT05170009|Baloxavir|baloxavir|mesh-list
92746069|NCT05170009|Antiviral Agents|antiviral agents|mesh-ancestor
92746070|NCT05170009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746071|NCT05170009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746072|NCT05170009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746073|NCT05166421|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92746074|NCT05166421|Antiviral Agents|antiviral agents|mesh-ancestor
92746075|NCT05166421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746076|NCT05153239|Irinotecan|irinotecan|mesh-list
92746077|NCT05153239|Topotecan|topotecan|mesh-list
92746078|NCT05153239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92746079|NCT05153239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92746080|NCT05153239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746081|NCT05153239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746082|NCT05153239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746083|NCT05111353|Poly ICLC|poly iclc|mesh-list
92746084|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
92746085|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
92746086|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746087|NCT05109442|Atezolizumab|atezolizumab|mesh-list
92746088|NCT05109442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746089|NCT05109442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746090|NCT05109442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746091|NCT05109442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746092|NCT05061550|Paclitaxel|paclitaxel|mesh-list
92746093|NCT05061550|Cisplatin|cisplatin|mesh-list
92746094|NCT05061550|Carboplatin|carboplatin|mesh-list
92746095|NCT05061550|Pemetrexed|pemetrexed|mesh-list
92746096|NCT05061550|Durvalumab|durvalumab|mesh-list
92746097|NCT05061550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746098|NCT05061550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746099|NCT05061550|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746100|NCT05061550|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746101|NCT05061550|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746102|NCT05061550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746103|NCT05061550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746104|NCT05061550|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92746105|NCT05061550|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92746106|NCT05061550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746107|NCT05053087|Ropivacaine|ropivacaine|mesh-list
92746108|NCT05053087|Anesthetics, Local|anesthetics, local|mesh-ancestor
92746109|NCT05053087|Anesthetics|anesthetics|mesh-ancestor
92746110|NCT05053087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92746111|NCT05053087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746112|NCT05053087|Sensory System Agents|sensory system agents|mesh-ancestor
92746113|NCT05053087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746114|NCT05050942|Octreotide|octreotide|mesh-list
92746115|NCT05050942|Lanreotide|lanreotide|mesh-list
92746116|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92746117|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92746118|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746124|NCT05000216|Methotrexate|methotrexate|mesh-list
92746126|NCT05000216|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92746127|NCT05000216|Immunologic Factors|immunologic factors|mesh-ancestor
92611616|NCT00467935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92611617|NCT00467935|Growth Substances|growth substances|mesh-ancestor
92611618|NCT00467935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611619|NCT00467935|Growth Inhibitors|growth inhibitors|mesh-ancestor
92611620|NCT00467935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018640|NCT02492763|Metformin|metformin|mesh-list
92746128|NCT05000216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746129|NCT05000216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92746130|NCT05000216|Abortifacient Agents|abortifacient agents|mesh-ancestor
92746131|NCT05000216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92746132|NCT05000216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746133|NCT05000216|Antimetabolites|antimetabolites|mesh-ancestor
92746134|NCT05000216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746135|NCT05000216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746136|NCT05000216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92746137|NCT05000216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746138|NCT05000216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92746139|NCT05000216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746140|NCT05000216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92746141|NCT05000216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92746142|NCT05000216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92746143|NCT05000216|Antitubercular Agents|antitubercular agents|mesh-ancestor
92746144|NCT05000216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92746145|NCT05000216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746146|NCT04983966|Desflurane|desflurane|mesh-list
92746147|NCT04983966|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92746148|NCT04983966|Anesthetics, General|anesthetics, general|mesh-ancestor
92746149|NCT04983966|Anesthetics|anesthetics|mesh-ancestor
92746150|NCT04983966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92746151|NCT04983966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746152|NCT04972942|Daratumumab|daratumumab|mesh-list
92746153|NCT04972942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746154|NCT04964128|Insulin|insulin|mesh-list
92746155|NCT04964128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92746156|NCT04964128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746157|NCT04953910|Decitabine|decitabine|mesh-list
92746158|NCT04953910|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92746159|NCT04953910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746160|NCT04953910|Antimetabolites|antimetabolites|mesh-ancestor
92746161|NCT04953910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746162|NCT04953910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746163|NCT04953910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746164|NCT04953897|Decitabine|decitabine|mesh-list
92746165|NCT04953897|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92746166|NCT04953897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746167|NCT04953897|Antimetabolites|antimetabolites|mesh-ancestor
92746168|NCT04953897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746169|NCT04953897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746170|NCT04953897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746171|NCT04949256|Calcium, Dietary|calcium, dietary|mesh-list
92746172|NCT04949256|Leucovorin|leucovorin|mesh-list
92746173|NCT04949256|Paclitaxel|paclitaxel|mesh-list
92746174|NCT04949256|Pembrolizumab|pembrolizumab|mesh-list
92746175|NCT04949256|Oxaliplatin|oxaliplatin|mesh-list
92746176|NCT04949256|Lenvatinib|lenvatinib|mesh-list
92746177|NCT04949256|Calcium|calcium|mesh-list
92746178|NCT04949256|Levoleucovorin|levoleucovorin|mesh-list
92746179|NCT04949256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746180|NCT04949256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746181|NCT04949256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746182|NCT04949256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746183|NCT04949256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746184|NCT04949256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746185|NCT04949256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746186|NCT04949256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746187|NCT04949256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92746188|NCT04949256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611622|NCT00149019|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92611623|NCT00149019|Immunologic Factors|immunologic factors|mesh-ancestor
92746192|NCT04949256|Vitamin B Complex|vitamin b complex|mesh-ancestor
92746194|NCT04949256|Micronutrients|micronutrients|mesh-ancestor
92746195|NCT04949256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746196|NCT04949256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746197|NCT04931017|Metformin|metformin|mesh-list
92746198|NCT04931017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92746199|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746200|NCT04925479|Niacinamide|niacinamide|mesh-list
92746201|NCT04925479|Vitamin B Complex|vitamin b complex|mesh-ancestor
92746202|NCT04925479|Vitamins|vitamins|mesh-ancestor
92746203|NCT04925479|Micronutrients|micronutrients|mesh-ancestor
92746204|NCT04925479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746205|NCT04917406|Dexamethasone|dexamethasone|mesh-list
92746206|NCT04917406|Lidocaine|lidocaine|mesh-list
92746207|NCT04917406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746208|NCT04917406|Antiemetics|antiemetics|mesh-ancestor
92746209|NCT04917406|Autonomic Agents|autonomic agents|mesh-ancestor
92746210|NCT04917406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746211|NCT04917406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746212|NCT04917406|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92746213|NCT04917406|Glucocorticoids|glucocorticoids|mesh-ancestor
92746214|NCT04917406|Hormones|hormones|mesh-ancestor
92746215|NCT04917406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746216|NCT04917406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92746217|NCT04917406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746218|NCT04917406|Anesthetics, Local|anesthetics, local|mesh-ancestor
92746219|NCT04917406|Anesthetics|anesthetics|mesh-ancestor
92746220|NCT04917406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92746221|NCT04917406|Sensory System Agents|sensory system agents|mesh-ancestor
92746222|NCT04917406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92746223|NCT04917406|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92746224|NCT04917406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92746225|NCT04917406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92746226|NCT04917406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746228|NCT04867785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92746229|NCT04867785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746230|NCT04840589|Nivolumab|nivolumab|mesh-list
92746231|NCT04840589|Ipilimumab|ipilimumab|mesh-list
92746232|NCT04840589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746233|NCT04840589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746234|NCT04840589|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746235|NCT04840589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746236|NCT04837196|Pembrolizumab|pembrolizumab|mesh-list
92746237|NCT04837196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746238|NCT04837196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746239|NCT04837196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746240|NCT04837196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746241|NCT04812912|Hormones|hormones|mesh-list
92746242|NCT04812912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746243|NCT04812912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746244|NCT04785820|Nivolumab|nivolumab|mesh-list
92746245|NCT04785820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746246|NCT04785820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746247|NCT04785820|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746248|NCT04785820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746249|NCT04767061|Propranolol|propranolol|mesh-list
92746250|NCT04767061|Metoprolol|metoprolol|mesh-list
92746251|NCT04767061|Atenolol|atenolol|mesh-list
92746252|NCT04767061|Sotalol|sotalol|mesh-list
92746253|NCT04767061|Nadolol|nadolol|mesh-list
92746254|NCT04767061|Acebutolol|acebutolol|mesh-list
92746255|NCT04767061|Carvedilol|carvedilol|mesh-list
92746256|NCT04767061|Nebivolol|nebivolol|mesh-list
92746257|NCT04767061|Bisoprolol|bisoprolol|mesh-list
92746258|NCT04767061|Labetalol|labetalol|mesh-list
92746259|NCT04767061|Pindolol|pindolol|mesh-list
92746260|NCT04767061|Betaxolol|betaxolol|mesh-list
92746261|NCT04767061|Penbutolol|penbutolol|mesh-list
92746262|NCT04767061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92746263|NCT04767061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92746264|NCT04767061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92746267|NCT04767061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746268|NCT04767061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92746269|NCT04767061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92611624|NCT00149019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611625|NCT00468091|Atropine|atropine|mesh-list
92611626|NCT00468091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92746271|NCT04767061|Sympatholytics|sympatholytics|mesh-ancestor
92746272|NCT04767061|Autonomic Agents|autonomic agents|mesh-ancestor
92746273|NCT04767061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746274|NCT04767061|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92746275|NCT04767061|Antioxidants|antioxidants|mesh-ancestor
92746276|NCT04767061|Protective Agents|protective agents|mesh-ancestor
92746277|NCT04767061|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92746278|NCT04767061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92746279|NCT04767061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92746280|NCT04767061|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92746281|NCT04767061|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92746282|NCT04767061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92746283|NCT04767061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92746284|NCT04767061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92746285|NCT04767061|Sympathomimetics|sympathomimetics|mesh-ancestor
92746286|NCT04767061|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92746287|NCT04767061|Serotonin Agents|serotonin agents|mesh-ancestor
92746288|NCT04761302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92746289|NCT04740671|Ranibizumab|ranibizumab|mesh-list
92746290|NCT04740671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92746291|NCT04740671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92746292|NCT04740671|Growth Substances|growth substances|mesh-ancestor
92746293|NCT04740671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746294|NCT04740671|Growth Inhibitors|growth inhibitors|mesh-ancestor
92746295|NCT04740671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746296|NCT04706507|Ganciclovir|ganciclovir|mesh-list
92746297|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92746298|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
92746299|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746300|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92746301|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746302|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746303|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
92746304|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746305|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746306|NCT04691375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746307|NCT04691375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746308|NCT04688320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92746309|NCT04688320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92746310|NCT04688320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92746311|NCT04688320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746312|NCT04666038|Rituximab|rituximab|mesh-list
92746313|NCT04666038|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92746314|NCT04666038|Idelalisib|idelalisib|mesh-list
92746315|NCT04666038|Pirtobrutinib|pirtobrutinib|mesh-list
92746316|NCT04666038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746317|NCT04666038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746318|NCT04666038|Immunologic Factors|immunologic factors|mesh-ancestor
92746319|NCT04666038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746320|NCT04666038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746321|NCT04666038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746322|NCT04666038|Alkylating Agents|alkylating agents|mesh-ancestor
92746323|NCT04666038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746324|NCT04666038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746325|NCT04666038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746326|NCT04657081|Decitabine|decitabine|mesh-list
92746327|NCT04657081|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92746328|NCT04657081|Venetoclax|venetoclax|mesh-list
92746329|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746330|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
92746331|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746332|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746333|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746334|NCT04630158|Lubricant Eye Drops|lubricant eye drops|mesh-list
92746338|NCT04617535|Antiviral Agents|antiviral agents|mesh-ancestor
92746339|NCT04617535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746340|NCT04613518|Deucravacitinib|deucravacitinib|mesh-list
92746341|NCT04613518|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611627|NCT00468091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92611628|NCT00468091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92611629|NCT00468091|Autonomic Agents|autonomic agents|mesh-ancestor
92611630|NCT00468091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611631|NCT00468091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611632|NCT00468091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92746342|NCT04613518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746343|NCT04613518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746344|NCT04613518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746345|NCT04592913|Durvalumab|durvalumab|mesh-list
92746346|NCT04592913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746347|NCT04592913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746348|NCT04539964|Antirheumatic Agents|antirheumatic agents|mesh-list
92746349|NCT04511039|Trifluridine|trifluridine|mesh-list
92746350|NCT04511039|Talazoparib|talazoparib|mesh-list
92746351|NCT04511039|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746352|NCT04511039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746353|NCT04511039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746354|NCT04511039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746355|NCT04511039|Antimetabolites|antimetabolites|mesh-ancestor
92746356|NCT04511039|Antiviral Agents|antiviral agents|mesh-ancestor
92746357|NCT04511039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746358|NCT04466917|Paclitaxel|paclitaxel|mesh-list
92746359|NCT04466917|Bevacizumab|bevacizumab|mesh-list
92746360|NCT04466917|Carboplatin|carboplatin|mesh-list
92746361|NCT04466917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746362|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746363|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746364|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746365|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746366|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746367|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746368|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92746369|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92746370|NCT04466917|Growth Substances|growth substances|mesh-ancestor
92746371|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746372|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
92746373|NCT04462471|Vemurafenib|vemurafenib|mesh-list
92746374|NCT04462471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746375|NCT04462471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746376|NCT04462471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746377|NCT04462471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746378|NCT04388163|Gentian Violet|gentian violet|mesh-list
92746379|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92746380|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746381|NCT04370483|Leflunomide|leflunomide|mesh-list
92746382|NCT04370483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746383|NCT04370483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746384|NCT04370483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746385|NCT04370483|Immunologic Factors|immunologic factors|mesh-ancestor
92746386|NCT04370483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746387|NCT04339777|Mycophenolic Acid|mycophenolic acid|mesh-list
92746388|NCT04339777|Cyclophosphamide|cyclophosphamide|mesh-list
92746389|NCT04339777|Busulfan|busulfan|mesh-list
92746390|NCT04339777|Fludarabine|fludarabine|mesh-list
92746391|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
92746392|NCT04339777|Tacrolimus|tacrolimus|mesh-list
92746393|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746394|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
92746395|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746396|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746397|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746398|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
92746399|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746400|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746401|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746402|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92746403|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746404|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92611633|NCT00468091|Respiratory System Agents|respiratory system agents|mesh-ancestor
92611634|NCT00468091|Mydriatics|mydriatics|mesh-ancestor
92611635|NCT00468091|Parasympatholytics|parasympatholytics|mesh-ancestor
92611636|NCT00468091|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92746405|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92746406|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
92746408|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746409|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746410|NCT04337970|Axitinib|axitinib|mesh-list
92746411|NCT04337970|Talazoparib|talazoparib|mesh-list
92746412|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746413|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746414|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746415|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746416|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746417|NCT04297254|Lenvatinib|lenvatinib|mesh-list
92746418|NCT04297254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746419|NCT04297254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746420|NCT04297254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746421|NCT04297254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746422|NCT04283656|Tenofovir|tenofovir|mesh-list
92746423|NCT04283656|Lamivudine|lamivudine|mesh-list
92746424|NCT04283656|Spironolactone|spironolactone|mesh-list
92746425|NCT04283656|Estradiol|estradiol|mesh-list
92746426|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
92746427|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746428|NCT04283656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92746429|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92746430|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746431|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746432|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92746433|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92746434|NCT04283656|Estrogens|estrogens|mesh-ancestor
92746435|NCT04283656|Hormones|hormones|mesh-ancestor
92746436|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746437|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746438|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92746439|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
92746440|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92746441|NCT04283656|Diuretics|diuretics|mesh-ancestor
92746442|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
92746443|NCT04275999|Ivermectin|ivermectin|mesh-list
92746444|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92746445|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746447|NCT04268277|Pembrolizumab|pembrolizumab|mesh-list
92746448|NCT04268277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746449|NCT04268277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746450|NCT04268277|Immunologic Factors|immunologic factors|mesh-ancestor
92746451|NCT04268277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746452|NCT04268277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746453|NCT04268277|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746454|NCT04268277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746455|NCT04238624|Trametinib|trametinib|mesh-list
92746456|NCT04238624|Dabrafenib|dabrafenib|mesh-list
92746457|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746458|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746459|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746460|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746461|NCT04212013|Rituximab|rituximab|mesh-list
92746462|NCT04212013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746463|NCT04212013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746464|NCT04212013|Immunologic Factors|immunologic factors|mesh-ancestor
92746465|NCT04212013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746466|NCT04212013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746467|NCT04207931|Fluocinonide|fluocinonide|mesh-list
92746468|NCT04207931|Triamcinolone|triamcinolone|mesh-list
92746469|NCT04207931|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92746470|NCT04207931|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92746471|NCT04207931|Betamethasone|betamethasone|mesh-list
92746472|NCT04207931|Betamethasone Valerate|betamethasone valerate|mesh-list
92746473|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92746474|NCT04207931|Betamethasone benzoate|betamethasone benzoate|mesh-list
92611637|NCT00468091|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92611638|NCT00468091|Cholinergic Agents|cholinergic agents|mesh-ancestor
92611639|NCT00468091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611640|NCT00468091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611641|NCT00468364|Insulin|insulin|mesh-list
92611642|NCT00468364|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92611643|NCT00468364|Insulin Glargine|insulin glargine|mesh-list
92611644|NCT00468364|Insulin, Isophane|insulin, isophane|mesh-list
92018655|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
92746475|NCT04207931|Clobetasol|clobetasol|mesh-list
92746476|NCT04207931|Minoxidil|minoxidil|mesh-list
92746477|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92746478|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92746479|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746480|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
92746481|NCT04207931|Hormones|hormones|mesh-ancestor
92746482|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746484|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746485|NCT04207931|Immunologic Factors|immunologic factors|mesh-ancestor
92746486|NCT04207931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746487|NCT04207931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746488|NCT04207931|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92746489|NCT04207931|Respiratory System Agents|respiratory system agents|mesh-ancestor
92746490|NCT04207931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92746491|NCT04207931|Vasodilator Agents|vasodilator agents|mesh-ancestor
92746492|NCT04207931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92746493|NCT04170283|Tislelizumab|tislelizumab|mesh-list
92746494|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
92746495|NCT04170283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746496|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746497|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746498|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746499|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746500|NCT04161755|Atezolizumab|atezolizumab|mesh-list
92746501|NCT04161755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746502|NCT04161755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746503|NCT04161755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746504|NCT04161755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746505|NCT04153136|Valsartan|valsartan|mesh-list
92746506|NCT04153136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92746507|NCT04153136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92746508|NCT04153136|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92746509|NCT04153136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92746510|NCT04153136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746511|NCT04128072|Mogamulizumab|mogamulizumab|mesh-list
92746512|NCT04128072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746513|NCT04106414|Nivolumab|nivolumab|mesh-list
92746514|NCT04106414|Linrodostat|linrodostat|mesh-list
92746515|NCT04106414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746516|NCT04106414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746517|NCT04106414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746518|NCT04106414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746519|NCT04106414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746521|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92746522|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
92746523|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746524|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746525|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92746526|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92746527|NCT04063267|Cholinergic Agents|cholinergic agents|mesh-ancestor
92746528|NCT04063267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92746529|NCT04063267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746530|NCT04047914|Anti-Infective Agents|anti-infective agents|mesh-list
92746531|NCT04047914|Mupirocin|mupirocin|mesh-list
92611645|NCT00468364|Isophane Insulin, Human|isophane insulin, human|mesh-list
92611647|NCT00468364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92746532|NCT04047914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92746533|NCT04047914|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92746534|NCT04047914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746535|NCT04047914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746536|NCT04042753|Nivolumab|nivolumab|mesh-list
92746537|NCT04042753|Ipilimumab|ipilimumab|mesh-list
92746538|NCT04042753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746539|NCT04042753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746540|NCT04042753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746541|NCT04042753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746542|NCT03999710|Durvalumab|durvalumab|mesh-list
92746543|NCT03999710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746544|NCT03999710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746545|NCT03995355|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92746546|NCT03995355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92746547|NCT03945591|Cyclophosphamide|cyclophosphamide|mesh-list
92746548|NCT03945591|Bortezomib|bortezomib|mesh-list
92746549|NCT03945591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746550|NCT03945591|Immunologic Factors|immunologic factors|mesh-ancestor
92746551|NCT03945591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746552|NCT03945591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746553|NCT03945591|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746554|NCT03945591|Alkylating Agents|alkylating agents|mesh-ancestor
92746557|NCT03945591|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746558|NCT03942211|Selexipag|selexipag|mesh-list
92746559|NCT03942211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92746560|NCT03933397|Morphine|morphine|mesh-list
92746561|NCT03933397|Hydromorphone|hydromorphone|mesh-list
92746562|NCT03933397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92746563|NCT03933397|Narcotics|narcotics|mesh-ancestor
92746564|NCT03933397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92746565|NCT03933397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746566|NCT03933397|Analgesics|analgesics|mesh-ancestor
92746567|NCT03933397|Sensory System Agents|sensory system agents|mesh-ancestor
92746568|NCT03933397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746569|NCT03925090|Cisplatin|cisplatin|mesh-list
92746570|NCT03925090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746571|NCT03919266|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92746572|NCT03919266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746573|NCT03829436|Nivolumab|nivolumab|mesh-list
92746574|NCT03829436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746575|NCT03829436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746576|NCT03829436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746577|NCT03829436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746578|NCT03819296|Prednisone|prednisone|mesh-list
92746579|NCT03819296|Infliximab|infliximab|mesh-list
92746580|NCT03819296|Cortisone|cortisone|mesh-list
92746581|NCT03819296|Vedolizumab|vedolizumab|mesh-list
92746582|NCT03819296|Immunoglobulins|immunoglobulins|mesh-list
92746583|NCT03819296|Immunoglobulin G|immunoglobulin g|mesh-list
92746584|NCT03819296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746585|NCT03819296|Glucocorticoids|glucocorticoids|mesh-ancestor
92746586|NCT03819296|Hormones|hormones|mesh-ancestor
92746587|NCT03819296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746588|NCT03819296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746589|NCT03819296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92746590|NCT03819296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746591|NCT03819296|Immunologic Factors|immunologic factors|mesh-ancestor
92746592|NCT03819296|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92746593|NCT03819296|Dermatologic Agents|dermatologic agents|mesh-ancestor
92746594|NCT03819296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92746595|NCT03819296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746596|NCT03793478|Cytarabine|cytarabine|mesh-list
92746597|NCT03793478|Fludarabine|fludarabine|mesh-list
92746598|NCT03793478|Etoposide|etoposide|mesh-list
92746599|NCT03793478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746600|NCT03793478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746601|NCT03793478|Antimetabolites|antimetabolites|mesh-ancestor
92746602|NCT03793478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746603|NCT03793478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746604|NCT03793478|Immunologic Factors|immunologic factors|mesh-ancestor
92611648|NCT00468364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611650|NCT00149058|Hematinics|hematinics|mesh-ancestor
92611651|NCT00468520|Oxytocin|oxytocin|mesh-list
92611652|NCT00468520|Oxytocics|oxytocics|mesh-ancestor
92611653|NCT00468520|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018662|NCT04397107|Interleukin-2|interleukin-2|mesh-list
92746605|NCT03793478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746606|NCT03793478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746607|NCT03793478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92746608|NCT03793478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92746609|NCT03793478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746610|NCT03793478|Antiviral Agents|antiviral agents|mesh-ancestor
92746611|NCT03793478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746612|NCT03790488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92746613|NCT03790488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746614|NCT03790488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746615|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746616|NCT03775486|Paclitaxel|paclitaxel|mesh-list
92746617|NCT03775486|Cisplatin|cisplatin|mesh-list
92746618|NCT03775486|Carboplatin|carboplatin|mesh-list
92746619|NCT03775486|Gemcitabine|gemcitabine|mesh-list
92746620|NCT03775486|Pemetrexed|pemetrexed|mesh-list
92746621|NCT03775486|Durvalumab|durvalumab|mesh-list
92746622|NCT03775486|Olaparib|olaparib|mesh-list
92746623|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92746624|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746625|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746626|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746627|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746628|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746629|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746632|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746633|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92746634|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92746635|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746636|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
92746637|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746638|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746639|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92746640|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92746641|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92746642|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
92746643|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746644|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92746646|NCT03742895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746647|NCT03742895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746648|NCT03742895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746649|NCT03742895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746650|NCT03606499|Ustekinumab|ustekinumab|mesh-list
92746651|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92746652|NCT03576690|Atoltivimab, maftivimab, and odesivimab-ebgn drug combination|atoltivimab, maftivimab, and odesivimab-ebgn drug combination|mesh-list
92746653|NCT03576690|Atoltivimab|atoltivimab|mesh-list
92746654|NCT03576690|Odesivimab|odesivimab|mesh-list
92746655|NCT03576690|Maftivimab|maftivimab|mesh-list
92746656|NCT03576690|Antiviral Agents|antiviral agents|mesh-ancestor
92746657|NCT03576690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746658|NCT03573947|Paclitaxel|paclitaxel|mesh-list
92746659|NCT03573947|Nivolumab|nivolumab|mesh-list
92746660|NCT03573947|Ipilimumab|ipilimumab|mesh-list
92746661|NCT03573947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746662|NCT03573947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746663|NCT03573947|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746664|NCT03573947|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746665|NCT03573947|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746666|NCT03573947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746667|NCT03573947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746668|NCT03573947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746669|NCT03573310|JNJ-64619178|jnj-64619178|mesh-list
92746670|NCT03573310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611654|NCT00468520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746671|NCT03573310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746672|NCT03567642|Etoposide|etoposide|mesh-list
92746673|NCT03567642|Osimertinib|osimertinib|mesh-list
92746674|NCT03567642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746675|NCT03567642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746676|NCT03567642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92746677|NCT03567642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92746678|NCT03567642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746679|NCT03567642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746680|NCT03567642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746681|NCT03532880|Olaparib|olaparib|mesh-list
92746682|NCT03532880|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746683|NCT03532880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746684|NCT03532880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746685|NCT03532880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746686|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
92746687|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746688|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
92746689|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746690|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746691|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746692|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
92746693|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746694|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746695|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746696|NCT03473743|Carboplatin|carboplatin|mesh-list
92746697|NCT03473743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746698|NCT03462719|Venetoclax|venetoclax|mesh-list
92746699|NCT03462719|Obinutuzumab|obinutuzumab|mesh-list
92746700|NCT03462719|Chlorambucil|chlorambucil|mesh-list
92746701|NCT03462719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746704|NCT03462719|Alkylating Agents|alkylating agents|mesh-ancestor
92746705|NCT03462719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746706|NCT03431350|Prednisone|prednisone|mesh-list
92746707|NCT03431350|Abiraterone Acetate|abiraterone acetate|mesh-list
92746708|NCT03431350|Niraparib|niraparib|mesh-list
92746709|NCT03431350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746710|NCT03431350|Glucocorticoids|glucocorticoids|mesh-ancestor
92746711|NCT03431350|Hormones|hormones|mesh-ancestor
92746712|NCT03431350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746713|NCT03431350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746714|NCT03431350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92746715|NCT03431350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746716|NCT03431350|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92746717|NCT03431350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746718|NCT03431350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746719|NCT03431350|Hormone Antagonists|hormone antagonists|mesh-ancestor
92746720|NCT03431350|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92746721|NCT03431350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746722|NCT03425279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92746723|NCT03425279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399058|NCT01401075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746724|NCT03425279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746725|NCT03425279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746726|NCT03420508|Ensartinib|ensartinib|mesh-list
92746727|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746728|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746729|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746730|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746731|NCT03410875|Obinutuzumab|obinutuzumab|mesh-list
92746732|NCT03410875|Vemurafenib|vemurafenib|mesh-list
92746733|NCT03410875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746734|NCT03410875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746735|NCT03410875|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746736|NCT03410875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746737|NCT03410875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746738|NCT03384641|Bedaquiline|bedaquiline|mesh-list
92746739|NCT03384641|Antitubercular Agents|antitubercular agents|mesh-ancestor
92746740|NCT03384641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92746741|NCT03384641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611656|NCT03271450|Rivaroxaban|rivaroxaban|mesh-list
92611657|NCT03271450|Dabigatran|dabigatran|mesh-list
92611658|NCT03271450|Apixaban|apixaban|mesh-list
92611659|NCT03271450|Edoxaban|edoxaban|mesh-list
92611660|NCT03271450|Anticoagulants|anticoagulants|mesh-ancestor
92018669|NCT04397107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92746742|NCT03322865|Obinutuzumab|obinutuzumab|mesh-list
92746743|NCT03322865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746744|NCT03322865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746745|NCT03295240|Rituximab|rituximab|mesh-list
92746746|NCT03295240|Venetoclax|venetoclax|mesh-list
92746747|NCT03295240|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92746748|NCT03295240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746749|NCT03295240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746750|NCT03295240|Immunologic Factors|immunologic factors|mesh-ancestor
92746751|NCT03295240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746752|NCT03295240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746753|NCT03295240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746754|NCT03295240|Alkylating Agents|alkylating agents|mesh-ancestor
92746755|NCT03295240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746756|NCT03258567|Nivolumab|nivolumab|mesh-list
92746757|NCT03258567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746758|NCT03258567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746759|NCT03258567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746760|NCT03258567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746761|NCT03207945|Alirocumab|alirocumab|mesh-list
92746762|NCT03207945|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92746763|NCT03207945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92746764|NCT03207945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92746765|NCT03207945|Antimetabolites|antimetabolites|mesh-ancestor
92746766|NCT03207945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746767|NCT03207945|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92746768|NCT03207945|Protease Inhibitors|protease inhibitors|mesh-ancestor
92746769|NCT03207945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746770|NCT03207945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92746771|NCT03134703|Morphine|morphine|mesh-list
92746774|NCT03134703|Narcotics|narcotics|mesh-ancestor
92746775|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92746776|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746777|NCT03134703|Analgesics|analgesics|mesh-ancestor
92746778|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
92746779|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746780|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
92746781|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
92746782|NCT03118674|Sofosbuvir|sofosbuvir|mesh-list
92746783|NCT03118674|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92746784|NCT03118674|Ledipasvir|ledipasvir|mesh-list
92746785|NCT03118674|Antiviral Agents|antiviral agents|mesh-ancestor
92746786|NCT03118674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746787|NCT03085056|Paclitaxel|paclitaxel|mesh-list
92746788|NCT03085056|Trametinib|trametinib|mesh-list
92746789|NCT03085056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746790|NCT03085056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746791|NCT03085056|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746792|NCT03085056|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746793|NCT03085056|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746794|NCT03085056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746795|NCT03085056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746796|NCT03085056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746797|NCT03069352|Cytarabine|cytarabine|mesh-list
92746798|NCT03069352|Venetoclax|venetoclax|mesh-list
92746799|NCT03069352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746800|NCT03069352|Antimetabolites|antimetabolites|mesh-ancestor
92746801|NCT03069352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746802|NCT03069352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746803|NCT03069352|Antiviral Agents|antiviral agents|mesh-ancestor
92746804|NCT03069352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746805|NCT03069352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746806|NCT03069352|Immunologic Factors|immunologic factors|mesh-ancestor
92746807|NCT03069352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746808|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
92746809|NCT03037437|Sorafenib|sorafenib|mesh-list
92611661|NCT03271450|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92611662|NCT03271450|Antithrombins|antithrombins|mesh-ancestor
92611663|NCT03271450|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92611664|NCT03271450|Protease Inhibitors|protease inhibitors|mesh-ancestor
92611665|NCT03271450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611666|NCT03271450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611667|NCT00468754|Insulin|insulin|mesh-list
92611668|NCT00468754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92746810|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746811|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746812|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746813|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746814|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
92746815|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92746816|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92746817|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746818|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746819|NCT03036488|Paclitaxel|paclitaxel|mesh-list
92746820|NCT03036488|Cyclophosphamide|cyclophosphamide|mesh-list
92746821|NCT03036488|Carboplatin|carboplatin|mesh-list
92746822|NCT03036488|Doxorubicin|doxorubicin|mesh-list
92746823|NCT03036488|Pembrolizumab|pembrolizumab|mesh-list
92746824|NCT03036488|Epirubicin|epirubicin|mesh-list
92746825|NCT03036488|Lenograstim|lenograstim|mesh-list
92746826|NCT03036488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746827|NCT03036488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746828|NCT03036488|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746829|NCT03036488|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746830|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746831|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746832|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746833|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
92746834|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746835|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746836|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746837|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
92746838|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746839|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92746840|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92746841|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92746842|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746843|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746844|NCT03036488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746845|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92746846|NCT03023631|Vaccines|vaccines|mesh-list
92746847|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
92746851|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746852|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
92746853|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746854|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746855|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746856|NCT02989584|Gemcitabine|gemcitabine|mesh-list
92746857|NCT02989584|Atezolizumab|atezolizumab|mesh-list
92746858|NCT02989584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746859|NCT02989584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746860|NCT02989584|Antimetabolites|antimetabolites|mesh-ancestor
92746861|NCT02989584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399063|NCT01401179|Clarithromycin|clarithromycin|mesh-list
92746862|NCT02989584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746863|NCT02989584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746864|NCT02884219|Ibuprofen|ibuprofen|mesh-list
92746865|NCT02884219|Indomethacin|indomethacin|mesh-list
92746866|NCT02884219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
92746867|NCT02884219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92746868|NCT02884219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92746869|NCT02884219|Analgesics|analgesics|mesh-ancestor
92746870|NCT02884219|Sensory System Agents|sensory system agents|mesh-ancestor
92746871|NCT02884219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746872|NCT02884219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611669|NCT00468754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746873|NCT02884219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746874|NCT02884219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746875|NCT02884219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746876|NCT02884219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746877|NCT02884219|Gout Suppressants|gout suppressants|mesh-ancestor
92746878|NCT02884219|Tocolytic Agents|tocolytic agents|mesh-ancestor
92746879|NCT02884219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92746880|NCT02861573|Dexamethasone|dexamethasone|mesh-list
92746881|NCT02861573|Prednisone|prednisone|mesh-list
92746882|NCT02861573|Carboplatin|carboplatin|mesh-list
92746883|NCT02861573|Docetaxel|docetaxel|mesh-list
92746884|NCT02861573|Pembrolizumab|pembrolizumab|mesh-list
92746885|NCT02861573|Etoposide|etoposide|mesh-list
92746886|NCT02861573|Lenvatinib|lenvatinib|mesh-list
92746887|NCT02861573|Olaparib|olaparib|mesh-list
92746888|NCT02861573|Abiraterone Acetate|abiraterone acetate|mesh-list
92746889|NCT02861573|Belzutifan|belzutifan|mesh-list
92746890|NCT02861573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746891|NCT02861573|Antiemetics|antiemetics|mesh-ancestor
92746892|NCT02861573|Autonomic Agents|autonomic agents|mesh-ancestor
92746893|NCT02861573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92746894|NCT02861573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746895|NCT02861573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92746896|NCT02861573|Glucocorticoids|glucocorticoids|mesh-ancestor
92746897|NCT02861573|Hormones|hormones|mesh-ancestor
92746898|NCT02861573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92746899|NCT02861573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92746900|NCT02861573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746901|NCT02861573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746902|NCT02861573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746903|NCT02861573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746904|NCT02861573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746905|NCT02861573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746906|NCT02861573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746907|NCT02861573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746908|NCT02861573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92746909|NCT02861573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92746910|NCT02861573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746911|NCT02861573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746912|NCT02861573|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92746913|NCT02861573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92746914|NCT02861573|Hormone Antagonists|hormone antagonists|mesh-ancestor
92746915|NCT02861573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92746917|NCT02861417|Mycophenolic Acid|mycophenolic acid|mesh-list
92746918|NCT02861417|Cyclophosphamide|cyclophosphamide|mesh-list
92746919|NCT02861417|Busulfan|busulfan|mesh-list
92746920|NCT02861417|Thiotepa|thiotepa|mesh-list
92746921|NCT02861417|Fludarabine|fludarabine|mesh-list
92746922|NCT02861417|Fludarabine phosphate|fludarabine phosphate|mesh-list
92746923|NCT02861417|Tacrolimus|tacrolimus|mesh-list
92746927|NCT02861417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746928|NCT02861417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746929|NCT02861417|Alkylating Agents|alkylating agents|mesh-ancestor
92746930|NCT02861417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746931|NCT02861417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746932|NCT02861417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746933|NCT02861417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746934|NCT02861417|Antimetabolites|antimetabolites|mesh-ancestor
92746935|NCT02861417|Antiviral Agents|antiviral agents|mesh-ancestor
92746936|NCT02861417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746937|NCT02861417|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92746938|NCT02861417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746939|NCT02861417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92746940|NCT02861417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92746941|NCT02861417|Antitubercular Agents|antitubercular agents|mesh-ancestor
92746942|NCT02861417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92746943|NCT02858310|Aldesleukin|aldesleukin|mesh-list
92746944|NCT02858310|Cyclophosphamide|cyclophosphamide|mesh-list
92746945|NCT02858310|Fludarabine|fludarabine|mesh-list
92746946|NCT02858310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746947|NCT02858310|Immunologic Factors|immunologic factors|mesh-ancestor
92746948|NCT02858310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746949|NCT02858310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611671|NCT00468871|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92611672|NCT00468871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746950|NCT02858310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746951|NCT02858310|Alkylating Agents|alkylating agents|mesh-ancestor
92746952|NCT02858310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746953|NCT02858310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746954|NCT02858310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746955|NCT02858310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92746956|NCT02858310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92746957|NCT02858310|Antiviral Agents|antiviral agents|mesh-ancestor
92746958|NCT02858310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92746959|NCT02795429|Spartalizumab|spartalizumab|mesh-list
92746960|NCT02795429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746961|NCT02795429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746962|NCT02795429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746963|NCT02795429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746964|NCT02792114|Cyclophosphamide|cyclophosphamide|mesh-list
92746965|NCT02792114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746966|NCT02792114|Immunologic Factors|immunologic factors|mesh-ancestor
92746967|NCT02792114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746968|NCT02792114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92746969|NCT02792114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746970|NCT02792114|Alkylating Agents|alkylating agents|mesh-ancestor
92746971|NCT02792114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746972|NCT02792114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746973|NCT02792114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92746974|NCT02783625|Bortezomib|bortezomib|mesh-list
92746975|NCT02783625|Romidepsin|romidepsin|mesh-list
92746976|NCT02783625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746977|NCT02783625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92746978|NCT02783625|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92746979|NCT02783625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746980|NCT02783625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746981|NCT02752685|Paclitaxel|paclitaxel|mesh-list
92746982|NCT02752685|Pembrolizumab|pembrolizumab|mesh-list
92746983|NCT02752685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746984|NCT02752685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746985|NCT02752685|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746986|NCT02752685|Antimitotic Agents|antimitotic agents|mesh-ancestor
92746987|NCT02752685|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746988|NCT02752685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746989|NCT02752685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746990|NCT02752685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92746991|NCT02689427|Paclitaxel|paclitaxel|mesh-list
92746992|NCT02689427|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92746993|NCT02689427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92746997|NCT02689427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92746998|NCT02689427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746999|NCT02658279|Pembrolizumab|pembrolizumab|mesh-list
92747000|NCT02658279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747001|NCT02658279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747002|NCT02658279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92747003|NCT02658279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747004|NCT02632344|Pembrolizumab|pembrolizumab|mesh-list
92399076|NCT01401179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747005|NCT02632344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747006|NCT02632344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747007|NCT02632344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92747008|NCT02632344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747009|NCT02628067|Pembrolizumab|pembrolizumab|mesh-list
92747010|NCT02628067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747011|NCT02628067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747012|NCT02628067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92747013|NCT02628067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747014|NCT02605486|Palbociclib|palbociclib|mesh-list
92747015|NCT02605486|Bicalutamide|bicalutamide|mesh-list
92747016|NCT02605486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747017|NCT02605486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747018|NCT02605486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611674|NCT00468871|Hormones|hormones|mesh-ancestor
92747019|NCT02605486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747020|NCT02605486|Androgen Antagonists|androgen antagonists|mesh-ancestor
92747021|NCT02605486|Hormone Antagonists|hormone antagonists|mesh-ancestor
92747022|NCT02605486|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747023|NCT02605486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747024|NCT02576509|Nivolumab|nivolumab|mesh-list
92747025|NCT02576509|Sorafenib|sorafenib|mesh-list
92747026|NCT02576509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747027|NCT02576509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747028|NCT02576509|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92747029|NCT02576509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747030|NCT02576509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747031|NCT02576509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747032|NCT02538198|Lenalidomide|lenalidomide|mesh-list
92747033|NCT02538198|Immunologic Factors|immunologic factors|mesh-ancestor
92747034|NCT02538198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747035|NCT02538198|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747036|NCT02538198|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747037|NCT02538198|Growth Substances|growth substances|mesh-ancestor
92747038|NCT02538198|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747039|NCT02538198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747040|NCT02506959|Gemcitabine|gemcitabine|mesh-list
92747041|NCT02506959|Melphalan|melphalan|mesh-list
92747042|NCT02506959|Busulfan|busulfan|mesh-list
92747043|NCT02506959|Mechlorethamine|mechlorethamine|mesh-list
92747044|NCT02506959|Panobinostat|panobinostat|mesh-list
92747045|NCT02506959|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92747046|NCT02506959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747047|NCT02506959|Antimetabolites|antimetabolites|mesh-ancestor
92747048|NCT02506959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747049|NCT02506959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747050|NCT02506959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747051|NCT02506959|Alkylating Agents|alkylating agents|mesh-ancestor
92747052|NCT02506959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747053|NCT02506959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747054|NCT02506959|Immunologic Factors|immunologic factors|mesh-ancestor
92747055|NCT02506959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747056|NCT02506959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92747057|NCT02506959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747058|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92747059|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747060|NCT02477696|Acalabrutinib|acalabrutinib|mesh-list
92747061|NCT02477696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747062|NCT02471144|Etanercept|etanercept|mesh-list
92747063|NCT02471144|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92747064|NCT02471144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92747077|NCT02470585|Veliparib|veliparib|mesh-list
92747078|NCT02470585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747079|NCT02470585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747080|NCT02470585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747081|NCT02470585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747082|NCT02470585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747083|NCT02470585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399077|NCT01401192|Cisplatin|cisplatin|mesh-list
92747084|NCT02470585|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92747085|NCT02470585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747086|NCT02429570|Meclofenamic Acid|meclofenamic acid|mesh-list
92747087|NCT02429570|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92747088|NCT02429570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92747089|NCT02429570|Analgesics|analgesics|mesh-ancestor
92747090|NCT02429570|Sensory System Agents|sensory system agents|mesh-ancestor
92747091|NCT02429570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747092|NCT02429570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747093|NCT02429570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747094|NCT02429570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747095|NCT02429570|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92747096|NCT02429570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747097|NCT02429570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747098|NCT02341144|Ropivacaine|ropivacaine|mesh-list
92747099|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
92747100|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
92747101|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018685|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92611675|NCT00468871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92611676|NCT00468871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611677|NCT00468871|Immunologic Factors|immunologic factors|mesh-ancestor
92611679|NCT00468988|Latanoprost|latanoprost|mesh-list
92611680|NCT00468988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92611681|NCT00468988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92611682|NCT00468988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92611683|NCT00149136|Imatinib Mesylate|imatinib mesylate|mesh-list
92611684|NCT00149136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92611685|NCT00149136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92611686|NCT00149136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611687|NCT00149136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611688|NCT00469261|Doxycycline|doxycycline|mesh-list
92611689|NCT00469261|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92611690|NCT00469261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611691|NCT00469261|Antimalarials|antimalarials|mesh-ancestor
92747102|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747103|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
92747104|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747105|NCT02332668|Pembrolizumab|pembrolizumab|mesh-list
92747106|NCT02332668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747107|NCT02332668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747108|NCT02332668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92747109|NCT02332668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747110|NCT02213328|Tenofovir|tenofovir|mesh-list
92747111|NCT02213328|Emtricitabine|emtricitabine|mesh-list
92747112|NCT02213328|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92747113|NCT02213328|Antiviral Agents|antiviral agents|mesh-ancestor
92747114|NCT02213328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747115|NCT02213328|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92747116|NCT02213328|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92747117|NCT02213328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747118|NCT02213328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747119|NCT02213328|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92747120|NCT02213328|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92747121|NCT02204241|Dexamethasone|dexamethasone|mesh-list
92747122|NCT02204241|Cyclophosphamide|cyclophosphamide|mesh-list
92747123|NCT02204241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747124|NCT02204241|Immunologic Factors|immunologic factors|mesh-ancestor
92747125|NCT02204241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747126|NCT02204241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747127|NCT02204241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747129|NCT02204241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747130|NCT02204241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747131|NCT02204241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747132|NCT02204241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747133|NCT02204241|Antiemetics|antiemetics|mesh-ancestor
92747134|NCT02204241|Autonomic Agents|autonomic agents|mesh-ancestor
92399087|NCT01401387|Pancreatin|pancreatin|mesh-list
92747135|NCT02204241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747136|NCT02204241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747137|NCT02204241|Glucocorticoids|glucocorticoids|mesh-ancestor
92747138|NCT02204241|Hormones|hormones|mesh-ancestor
92611693|NCT00469261|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92611694|NCT00469300|Acyclovir|acyclovir|mesh-list
92747139|NCT02204241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747140|NCT02204241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747141|NCT02195479|Dexamethasone|dexamethasone|mesh-list
92747142|NCT02195479|Prednisone|prednisone|mesh-list
92747143|NCT02195479|Melphalan|melphalan|mesh-list
92747144|NCT02195479|Bortezomib|bortezomib|mesh-list
92747145|NCT02195479|Daratumumab|daratumumab|mesh-list
92747146|NCT02195479|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92747147|NCT02195479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747148|NCT02195479|Antiemetics|antiemetics|mesh-ancestor
92747149|NCT02195479|Autonomic Agents|autonomic agents|mesh-ancestor
92747150|NCT02195479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747151|NCT02195479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747152|NCT02195479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747153|NCT02195479|Glucocorticoids|glucocorticoids|mesh-ancestor
92747154|NCT02195479|Hormones|hormones|mesh-ancestor
92747155|NCT02195479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747156|NCT02195479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747157|NCT02195479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747158|NCT02195479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747159|NCT02195479|Alkylating Agents|alkylating agents|mesh-ancestor
92747160|NCT02195479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747161|NCT02195479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747162|NCT02195479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747163|NCT02195479|Immunologic Factors|immunologic factors|mesh-ancestor
92747164|NCT02185820|Dexamethasone|dexamethasone|mesh-list
92747165|NCT02185820|Pomalidomide|pomalidomide|mesh-list
92747166|NCT02185820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747167|NCT02185820|Antiemetics|antiemetics|mesh-ancestor
92747168|NCT02185820|Autonomic Agents|autonomic agents|mesh-ancestor
92747169|NCT02185820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747170|NCT02185820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747171|NCT02185820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747172|NCT02185820|Glucocorticoids|glucocorticoids|mesh-ancestor
92747173|NCT02185820|Hormones|hormones|mesh-ancestor
92747174|NCT02185820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747175|NCT02185820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747176|NCT02185820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747177|NCT02185820|Immunologic Factors|immunologic factors|mesh-ancestor
92747178|NCT02185820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747179|NCT02185820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747180|NCT02185820|Growth Substances|growth substances|mesh-ancestor
92747181|NCT02185820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747182|NCT02150967|Infigratinib|infigratinib|mesh-list
92747183|NCT02150967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747184|NCT02085408|Cytarabine|cytarabine|mesh-list
92747185|NCT02085408|Decitabine|decitabine|mesh-list
92747186|NCT02085408|Clofarabine|clofarabine|mesh-list
92747187|NCT02085408|Azacitidine|azacitidine|mesh-list
92747188|NCT02085408|Daunorubicin|daunorubicin|mesh-list
92747189|NCT02085408|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747190|NCT02085408|Antimetabolites|antimetabolites|mesh-ancestor
92747191|NCT02085408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747192|NCT02085408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747193|NCT02085408|Antiviral Agents|antiviral agents|mesh-ancestor
92747194|NCT02085408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747195|NCT02085408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747196|NCT02085408|Immunologic Factors|immunologic factors|mesh-ancestor
92747197|NCT02085408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747198|NCT02085408|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92747199|NCT02085408|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92747200|NCT02085408|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747201|NCT02085408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747202|NCT02004782|Prednisolone|prednisolone|mesh-list
92747204|NCT02004782|Glucocorticoids|glucocorticoids|mesh-ancestor
92747206|NCT02004782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747207|NCT02004782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747208|NCT02004782|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747209|NCT02004782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747210|NCT01908777|Cytarabine|cytarabine|mesh-list
92747211|NCT01908777|Etoposide|etoposide|mesh-list
92747212|NCT01908777|Melphalan|melphalan|mesh-list
92611695|NCT00469300|Antiviral Agents|antiviral agents|mesh-ancestor
92611696|NCT00469300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611697|NCT04697641|Amoxicillin|amoxicillin|mesh-list
92611698|NCT04697641|Clarithromycin|clarithromycin|mesh-list
92611699|NCT04697641|Pantoprazole|pantoprazole|mesh-list
92747213|NCT01908777|Carmustine|carmustine|mesh-list
92747214|NCT01908777|Romidepsin|romidepsin|mesh-list
92747215|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747216|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747217|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92747218|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747219|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747220|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747221|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747222|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
92747223|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
92747224|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747225|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747226|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
92747227|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747228|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747229|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
92747230|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747231|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92747232|NCT01908777|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92747233|NCT01873326|Paclitaxel|paclitaxel|mesh-list
92747234|NCT01873326|Etoposide|etoposide|mesh-list
92747235|NCT01873326|Ifosfamide|ifosfamide|mesh-list
92747236|NCT01873326|Bleomycin|bleomycin|mesh-list
92747237|NCT01873326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747238|NCT01873326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747239|NCT01873326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747240|NCT01873326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747241|NCT01873326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747242|NCT01873326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747243|NCT01873326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92747244|NCT01873326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747245|NCT01873326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747246|NCT01873326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747247|NCT01873326|Alkylating Agents|alkylating agents|mesh-ancestor
92747248|NCT01873326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92747249|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
92747250|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92747251|NCT01867606|Antibodies|antibodies|mesh-list
92747252|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
92747253|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747254|NCT01864109|Cyclophosphamide|cyclophosphamide|mesh-list
92747255|NCT01864109|Temozolomide|temozolomide|mesh-list
92747256|NCT01864109|Ifosfamide|ifosfamide|mesh-list
92747257|NCT01864109|Doxorubicin|doxorubicin|mesh-list
92747258|NCT01864109|Irinotecan|irinotecan|mesh-list
92747259|NCT01864109|Etoposide|etoposide|mesh-list
92747260|NCT01864109|Vincristine|vincristine|mesh-list
92747261|NCT01864109|Dexrazoxane|dexrazoxane|mesh-list
92747262|NCT01864109|Razoxane|razoxane|mesh-list
92747263|NCT01864109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747264|NCT01864109|Immunologic Factors|immunologic factors|mesh-ancestor
92747265|NCT01864109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747266|NCT01864109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747267|NCT01864109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747268|NCT01864109|Alkylating Agents|alkylating agents|mesh-ancestor
92747269|NCT01864109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747270|NCT01864109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747271|NCT01864109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747272|NCT01864109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92747273|NCT01864109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92747274|NCT01864109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747275|NCT01864109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747276|NCT01864109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92747277|NCT01864109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747278|NCT01864109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747282|NCT01864109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92747284|NCT01862315|Gemcitabine|gemcitabine|mesh-list
92747285|NCT01862315|Oxaliplatin|oxaliplatin|mesh-list
92611700|NCT04697641|Z 338|z 338|mesh-list
92611701|NCT04697641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92747286|NCT01862315|Floxuridine|floxuridine|mesh-list
92747287|NCT01862315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747288|NCT01862315|Antiemetics|antiemetics|mesh-ancestor
92747289|NCT01862315|Autonomic Agents|autonomic agents|mesh-ancestor
92747290|NCT01862315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747291|NCT01862315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747292|NCT01862315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747293|NCT01862315|Glucocorticoids|glucocorticoids|mesh-ancestor
92747294|NCT01862315|Hormones|hormones|mesh-ancestor
92747295|NCT01862315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747296|NCT01862315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747297|NCT01862315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747298|NCT01862315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747299|NCT01862315|Antimetabolites|antimetabolites|mesh-ancestor
92747300|NCT01862315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747301|NCT01745588|Clarithromycin|clarithromycin|mesh-list
92747302|NCT01745588|Dexamethasone|dexamethasone|mesh-list
92747303|NCT01745588|Pomalidomide|pomalidomide|mesh-list
92747304|NCT01745588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747305|NCT01745588|Antiemetics|antiemetics|mesh-ancestor
92747306|NCT01745588|Autonomic Agents|autonomic agents|mesh-ancestor
92747307|NCT01745588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747308|NCT01745588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747309|NCT01745588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747310|NCT01745588|Glucocorticoids|glucocorticoids|mesh-ancestor
92747311|NCT01745588|Hormones|hormones|mesh-ancestor
92747312|NCT01745588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747313|NCT01745588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747314|NCT01745588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747315|NCT01745588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92747316|NCT01745588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747317|NCT01745588|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92747318|NCT01745588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747319|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747320|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92747321|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92747322|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
92747323|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747324|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747325|NCT01745588|Growth Substances|growth substances|mesh-ancestor
92747326|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747327|NCT01730937|Sorafenib|sorafenib|mesh-list
92747328|NCT01730937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747329|NCT01730937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747330|NCT01730937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747331|NCT01730937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747332|NCT01496976|Methylprednisolone|methylprednisolone|mesh-list
92747333|NCT01496976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92747334|NCT01496976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92747335|NCT01496976|Prednisolone|prednisolone|mesh-list
92747336|NCT01496976|Prednisolone acetate|prednisolone acetate|mesh-list
92747337|NCT01496976|Lenalidomide|lenalidomide|mesh-list
92747338|NCT01496976|Ofatumumab|ofatumumab|mesh-list
92747339|NCT01496976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92747340|NCT01496976|Prednisolone phosphate|prednisolone phosphate|mesh-list
92747341|NCT01496976|Immunologic Factors|immunologic factors|mesh-ancestor
92747342|NCT01496976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747343|NCT01496976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747344|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747345|NCT01496976|Growth Substances|growth substances|mesh-ancestor
92747346|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747347|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747348|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747349|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
92747350|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
92747351|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747354|NCT01496976|Hormones|hormones|mesh-ancestor
92747355|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747356|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92747357|NCT01496976|Protective Agents|protective agents|mesh-ancestor
92747358|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747359|NCT01294020|Tacrolimus|tacrolimus|mesh-list
92611702|NCT04697641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92611703|NCT04697641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92611704|NCT04697641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611705|NCT04697641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018710|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747360|NCT01294020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747361|NCT01294020|Immunologic Factors|immunologic factors|mesh-ancestor
92747362|NCT01294020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747363|NCT01294020|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92747364|NCT01294020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747365|NCT01294020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747366|NCT01290692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92747367|NCT01290692|Immunologic Factors|immunologic factors|mesh-ancestor
92747368|NCT01290692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747369|NCT00996866|Vitamin D|vitamin d|mesh-list
92747370|NCT00996866|Cholecalciferol|cholecalciferol|mesh-list
92747371|NCT00996866|Vitamins|vitamins|mesh-ancestor
92747372|NCT00996866|Micronutrients|micronutrients|mesh-ancestor
92747373|NCT00996866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747374|NCT00996866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92747375|NCT00996866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92747376|NCT00876993|Bevacizumab|bevacizumab|mesh-list
92747377|NCT00876993|Irinotecan|irinotecan|mesh-list
92747378|NCT00876993|Temozolomide|temozolomide|mesh-list
92747379|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747380|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747381|NCT00876993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747382|NCT00876993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747383|NCT00876993|Growth Substances|growth substances|mesh-ancestor
92747384|NCT00876993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747385|NCT00876993|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747386|NCT00876993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92747387|NCT00876993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747388|NCT00876993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747389|NCT00876993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747390|NCT00876993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747391|NCT00876993|Alkylating Agents|alkylating agents|mesh-ancestor
92747392|NCT00700882|Dasatinib|dasatinib|mesh-list
92747393|NCT00700882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747394|NCT00700882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747395|NCT00700882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747396|NCT00700882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747397|NCT00673309|Insulin|insulin|mesh-list
92747398|NCT00673309|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92747399|NCT00673309|Itraconazole|itraconazole|mesh-list
92747400|NCT00673309|Propranolol|propranolol|mesh-list
92747401|NCT00673309|Hormones|hormones|mesh-list
92747402|NCT00673309|Oxandrolone|oxandrolone|mesh-list
92747403|NCT00673309|Nandrolone|nandrolone|mesh-list
92747404|NCT00673309|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92747405|NCT00673309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747406|NCT00673309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747407|NCT00673309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747408|NCT00673309|Antifungal Agents|antifungal agents|mesh-ancestor
92747409|NCT00673309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747410|NCT00673309|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92747411|NCT00673309|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92747412|NCT00673309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747413|NCT00673309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92747414|NCT00673309|Hormone Antagonists|hormone antagonists|mesh-ancestor
92747415|NCT00673309|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92747416|NCT00673309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92747417|NCT00673309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92747418|NCT00673309|Adrenergic Agents|adrenergic agents|mesh-ancestor
92747419|NCT00673309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747420|NCT00673309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92747421|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747422|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
92747423|NCT00673309|Androgens|androgens|mesh-ancestor
92611707|NCT04697641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92018716|NCT02453685|Insulin|insulin|mesh-list
92747424|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
92747425|NCT00666835|Epoetin Alfa|epoetin alfa|mesh-list
92747429|NCT00600496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92747430|NCT00600496|Temsirolimus|temsirolimus|mesh-list
92747431|NCT00600496|Dacarbazine|dacarbazine|mesh-list
92747432|NCT00600496|MTOR Inhibitors|mtor inhibitors|mesh-list
92747433|NCT00600496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747434|NCT00600496|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747435|NCT00600496|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747436|NCT00600496|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747437|NCT00600496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747438|NCT00600496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747439|NCT00600496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747440|NCT00600496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747441|NCT00600496|Immunologic Factors|immunologic factors|mesh-ancestor
92747442|NCT00600496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747443|NCT00600496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92747444|NCT00600496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747445|NCT00600496|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92747446|NCT00600496|Antifungal Agents|antifungal agents|mesh-ancestor
92747447|NCT00600496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747448|NCT00600496|Alkylating Agents|alkylating agents|mesh-ancestor
92747449|NCT00551759|Docetaxel|docetaxel|mesh-list
92747450|NCT00551759|Fluorouracil|fluorouracil|mesh-list
92747451|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
92747452|NCT00551759|Cetuximab|cetuximab|mesh-list
92747453|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747454|NCT00551759|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747455|NCT00551759|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747456|NCT00551759|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747457|NCT00551759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747458|NCT00551759|Antimetabolites|antimetabolites|mesh-ancestor
92747459|NCT00551759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747460|NCT00551759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747461|NCT00551759|Immunologic Factors|immunologic factors|mesh-ancestor
92747462|NCT00551759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747463|NCT00551759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747464|NCT00335140|Leucovorin|leucovorin|mesh-list
92747465|NCT00335140|Cytarabine|cytarabine|mesh-list
92747466|NCT00335140|Dexamethasone|dexamethasone|mesh-list
92747467|NCT00335140|Dexamethasone acetate|dexamethasone acetate|mesh-list
92747468|NCT00335140|Rituximab|rituximab|mesh-list
92747469|NCT00335140|Methotrexate|methotrexate|mesh-list
92747470|NCT00335140|Vincristine|vincristine|mesh-list
92747471|NCT00335140|Procarbazine|procarbazine|mesh-list
92747472|NCT00335140|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92747473|NCT00335140|BB 1101|bb 1101|mesh-list
92747474|NCT00335140|Levoleucovorin|levoleucovorin|mesh-list
92747475|NCT00335140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747476|NCT00335140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747477|NCT00335140|Immunologic Factors|immunologic factors|mesh-ancestor
92747478|NCT00335140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747479|NCT00335140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747480|NCT00335140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747481|NCT00335140|Antiemetics|antiemetics|mesh-ancestor
92747482|NCT00335140|Autonomic Agents|autonomic agents|mesh-ancestor
92747483|NCT00335140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747484|NCT00335140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747485|NCT00335140|Glucocorticoids|glucocorticoids|mesh-ancestor
92747486|NCT00335140|Hormones|hormones|mesh-ancestor
92747487|NCT00335140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747488|NCT00335140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747489|NCT00335140|Protease Inhibitors|protease inhibitors|mesh-ancestor
92747490|NCT00335140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747491|NCT00335140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747492|NCT00335140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92747493|NCT00335140|Abortifacient Agents|abortifacient agents|mesh-ancestor
92747494|NCT00335140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92747495|NCT00335140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747496|NCT00335140|Antimetabolites|antimetabolites|mesh-ancestor
92747497|NCT00335140|Dermatologic Agents|dermatologic agents|mesh-ancestor
92747498|NCT00335140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92747499|NCT00335140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747500|NCT00335140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92747505|NCT00335140|Vitamin B Complex|vitamin b complex|mesh-ancestor
92747506|NCT00335140|Vitamins|vitamins|mesh-ancestor
92747507|NCT00335140|Micronutrients|micronutrients|mesh-ancestor
92747508|NCT00335140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747509|NCT00335140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747510|NCT00335140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747511|NCT00335140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747512|NCT00304239|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92747513|NCT00304239|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92747514|NCT00304239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92747515|NCT00101283|Carboplatin|carboplatin|mesh-list
92747516|NCT00101283|Gemcitabine|gemcitabine|mesh-list
92747517|NCT00101283|Pemetrexed|pemetrexed|mesh-list
92747518|NCT00101283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747519|NCT00101283|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747520|NCT00101283|Antimetabolites|antimetabolites|mesh-ancestor
92747521|NCT00101283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747522|NCT00101283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747523|NCT00101283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92747524|NCT00101283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92747525|NCT01301729|Paclitaxel|paclitaxel|mesh-list
92747526|NCT01301729|Docetaxel|docetaxel|mesh-list
92747527|NCT01301729|Trastuzumab|trastuzumab|mesh-list
92747528|NCT01301729|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747529|NCT01301729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747530|NCT01301729|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747531|NCT01301729|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747532|NCT01301729|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747533|NCT01301729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747534|NCT01301729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747535|NCT05643677|Irinotecan|irinotecan|mesh-list
92747536|NCT05643677|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92747537|NCT05643677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747538|NCT05643677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747539|NCT05643677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747540|NCT05643677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747541|NCT02890589|Chromium|chromium|mesh-list
92747542|NCT02890589|Everolimus|everolimus|mesh-list
92747543|NCT02890589|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92747544|NCT02890589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747545|NCT02890589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747546|NCT02890589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747547|NCT02890589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747548|NCT02890589|Immunologic Factors|immunologic factors|mesh-ancestor
92747549|NCT02890589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747550|NCT02890589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747551|NCT02890589|Trace Elements|trace elements|mesh-ancestor
92747552|NCT02890589|Micronutrients|micronutrients|mesh-ancestor
92747553|NCT01301027|Pioglitazone|pioglitazone|mesh-list
92747554|NCT01301027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92747555|NCT01301027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747556|NCT04207385|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92747557|NCT04207385|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92747558|NCT04207385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92747559|NCT04207385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92747560|NCT04207385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747561|NCT04207385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747562|NCT04207385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747563|NCT04207385|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92747564|NCT04207385|Antidepressive Agents|antidepressive agents|mesh-ancestor
92747565|NCT04207385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92747566|NCT05641883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92747567|NCT02886897|Antibodies|antibodies|mesh-list
92747568|NCT02886897|Immunologic Factors|immunologic factors|mesh-ancestor
92747569|NCT02886897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747570|NCT05641649|Valproic Acid|valproic acid|mesh-list
92747571|NCT05641649|Anticonvulsants|anticonvulsants|mesh-ancestor
92747572|NCT05641649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747573|NCT05641649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747574|NCT05641649|GABA Agents|gaba agents|mesh-ancestor
92747578|NCT05641649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92611708|NCT04697641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92611709|NCT04697641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92611710|NCT04697641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92611711|NCT04697641|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92747579|NCT05641649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92747580|NCT05641649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92747581|NCT01184859|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92747582|NCT01184859|Hemostatics|hemostatics|mesh-ancestor
92747583|NCT01184859|Coagulants|coagulants|mesh-ancestor
92747584|NCT01184859|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92747585|NCT01184859|Natriuretic Agents|natriuretic agents|mesh-ancestor
92747586|NCT01184859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747587|NCT02890511|Paclitaxel|paclitaxel|mesh-list
92747588|NCT02890511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747589|NCT02890511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747590|NCT02890511|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747591|NCT02890511|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747592|NCT02890511|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747593|NCT02890511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747594|NCT01184079|Vaccines|vaccines|mesh-list
92747595|NCT01184079|Immunologic Factors|immunologic factors|mesh-ancestor
92747596|NCT01184079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747597|NCT05333289|Vaccines|vaccines|mesh-list
92747598|NCT05333289|Immunologic Factors|immunologic factors|mesh-ancestor
92747599|NCT05333289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747600|NCT01289990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92747601|NCT01289990|Empagliflozin|empagliflozin|mesh-list
92747602|NCT01289990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92747603|NCT01289990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747604|NCT01289990|Incretins|incretins|mesh-ancestor
92747605|NCT01289990|Hormones|hormones|mesh-ancestor
92747606|NCT01289990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747607|NCT01289990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92747608|NCT01289990|Protease Inhibitors|protease inhibitors|mesh-ancestor
92747609|NCT01289990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747610|NCT01289990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747611|NCT01289990|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92747612|NCT01190007|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92747613|NCT01190007|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92747614|NCT01190007|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92747615|NCT01190007|Antimetabolites|antimetabolites|mesh-ancestor
92747616|NCT01190007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747617|NCT01190007|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92747618|NCT01190007|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747619|NCT01190007|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92747620|NCT01190007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92747621|NCT01190007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92747622|NCT01190007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747623|NCT01190007|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92747624|NCT01190007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747625|NCT01300247|Cyclophosphamide|cyclophosphamide|mesh-list
92747626|NCT01300247|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92747627|NCT01300247|Fludarabine|fludarabine|mesh-list
92747628|NCT01300247|Obinutuzumab|obinutuzumab|mesh-list
92747629|NCT01300247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747630|NCT01300247|Immunologic Factors|immunologic factors|mesh-ancestor
92747631|NCT01300247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747632|NCT01300247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747633|NCT01300247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747634|NCT01300247|Alkylating Agents|alkylating agents|mesh-ancestor
92747635|NCT01300247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747636|NCT01300247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747637|NCT01300247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747638|NCT01300247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747639|NCT02890277|Anti-Infective Agents|anti-infective agents|mesh-list
92747640|NCT02890277|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92747641|NCT02890277|Chitosan|chitosan|mesh-list
92747642|NCT02890277|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92747643|NCT02890277|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92747644|NCT02890277|Antimetabolites|antimetabolites|mesh-ancestor
92611712|NCT04697641|Cholinergic Agents|cholinergic agents|mesh-ancestor
92747645|NCT02890277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747650|NCT02890277|Coagulants|coagulants|mesh-ancestor
92747652|NCT01289678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747653|NCT01289678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92747654|NCT01289678|Analgesics|analgesics|mesh-ancestor
92747655|NCT01289678|Sensory System Agents|sensory system agents|mesh-ancestor
92747656|NCT01289678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747657|NCT01289678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747658|NCT02890082|Tamoxifen|tamoxifen|mesh-list
92747659|NCT02890082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92747660|NCT02890082|Hormone Antagonists|hormone antagonists|mesh-ancestor
92747661|NCT02890082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747662|NCT02890082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747663|NCT02890082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747664|NCT02890082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747665|NCT02890082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92747666|NCT02890082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92747667|NCT02890082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92747668|NCT01183221|Oxytocin|oxytocin|mesh-list
92747669|NCT01183221|Oxytocics|oxytocics|mesh-ancestor
92747670|NCT01183221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92747671|NCT01183221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747672|NCT01183143|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92747673|NCT01183143|Hormones|hormones|mesh-ancestor
92747674|NCT01183143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747675|NCT01183143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747676|NCT01183065|Folic Acid|folic acid|mesh-list
92747677|NCT01183065|Vitamin B 12|vitamin b 12|mesh-list
92747678|NCT01183065|Hydroxocobalamin|hydroxocobalamin|mesh-list
92747679|NCT01183065|Vitamins|vitamins|mesh-ancestor
92747680|NCT01183065|Micronutrients|micronutrients|mesh-ancestor
92747681|NCT01183065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747682|NCT01183065|Hematinics|hematinics|mesh-ancestor
92747683|NCT01183065|Vitamin B Complex|vitamin b complex|mesh-ancestor
92747684|NCT01182441|Warfarin|warfarin|mesh-list
92747685|NCT01182441|Anticoagulants|anticoagulants|mesh-ancestor
92747686|NCT01182285|Valproic Acid|valproic acid|mesh-list
92747687|NCT01182285|Anticonvulsants|anticonvulsants|mesh-ancestor
92747688|NCT01182285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747689|NCT01182285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747690|NCT01182285|GABA Agents|gaba agents|mesh-ancestor
92747691|NCT01182285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747692|NCT01182285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747693|NCT01182285|Antimanic Agents|antimanic agents|mesh-ancestor
92747694|NCT01182285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92747695|NCT01182285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92747696|NCT01182285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92747697|NCT04315935|Fentanyl|fentanyl|mesh-list
92747698|NCT04315935|Butorphanol|butorphanol|mesh-list
92747699|NCT04315935|Propofol|propofol|mesh-list
92747700|NCT04315935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92747701|NCT04315935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92747702|NCT04315935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747703|NCT04315935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92747704|NCT04315935|Anesthetics, General|anesthetics, general|mesh-ancestor
92747705|NCT04315935|Anesthetics|anesthetics|mesh-ancestor
92747706|NCT04315935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92747707|NCT04315935|Narcotics|narcotics|mesh-ancestor
92747708|NCT04315935|Analgesics|analgesics|mesh-ancestor
92747709|NCT04315935|Sensory System Agents|sensory system agents|mesh-ancestor
92747710|NCT04315935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747711|NCT04315935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92747712|NCT04315935|Antitussive Agents|antitussive agents|mesh-ancestor
92747713|NCT04315935|Respiratory System Agents|respiratory system agents|mesh-ancestor
92747714|NCT04315935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92747715|NCT01182207|Drospirenone|drospirenone|mesh-list
92747716|NCT01182207|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92747717|NCT01182207|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92747718|NCT01182207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92747719|NCT01182207|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92747720|NCT01182207|Estradiol|estradiol|mesh-list
92747723|NCT01182207|Hormones|hormones|mesh-ancestor
92747724|NCT01182207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747725|NCT01182207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611713|NCT04697641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611714|NCT04697641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611715|NCT00469417|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92611716|NCT00469417|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92611717|NCT00469417|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92611718|NCT00469417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92611719|NCT00469495|Anthelmintics|anthelmintics|mesh-list
92611720|NCT00469495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92611721|NCT00469495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747726|NCT01182207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92747727|NCT01182207|Contraceptive Agents|contraceptive agents|mesh-ancestor
92747728|NCT01182207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92747729|NCT01182207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92747730|NCT01182207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92747731|NCT01182207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92747732|NCT01182207|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92747733|NCT01182207|Hormone Antagonists|hormone antagonists|mesh-ancestor
92747734|NCT01182207|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92747736|NCT01182207|Natriuretic Agents|natriuretic agents|mesh-ancestor
92747737|NCT01181895|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92747738|NCT01181895|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92747739|NCT01181895|Autonomic Agents|autonomic agents|mesh-ancestor
92747740|NCT01181895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747741|NCT01181895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747742|NCT01181895|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92747743|NCT01181895|Respiratory System Agents|respiratory system agents|mesh-ancestor
92747744|NCT01181895|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92747745|NCT01181895|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92747746|NCT01181895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92747747|NCT01181895|Adrenergic Agents|adrenergic agents|mesh-ancestor
92747748|NCT01181895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747749|NCT01181895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747750|NCT01181271|Sirolimus|sirolimus|mesh-list
92747751|NCT01181271|Cyclophosphamide|cyclophosphamide|mesh-list
92747752|NCT01181271|Busulfan|busulfan|mesh-list
92747753|NCT01181271|Methotrexate|methotrexate|mesh-list
92747754|NCT01181271|Fludarabine|fludarabine|mesh-list
92747755|NCT01181271|Etoposide|etoposide|mesh-list
92747756|NCT01181271|Tacrolimus|tacrolimus|mesh-list
92747757|NCT01181271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747758|NCT01181271|Immunologic Factors|immunologic factors|mesh-ancestor
92747759|NCT01181271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747760|NCT01181271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747761|NCT01181271|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92747762|NCT01181271|Alkylating Agents|alkylating agents|mesh-ancestor
92747763|NCT01181271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747764|NCT01181271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747765|NCT01181271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92747766|NCT01181271|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92747767|NCT01181271|Abortifacient Agents|abortifacient agents|mesh-ancestor
92747768|NCT01181271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92747769|NCT01181271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747770|NCT01181271|Antimetabolites|antimetabolites|mesh-ancestor
92747771|NCT01181271|Dermatologic Agents|dermatologic agents|mesh-ancestor
92747772|NCT01181271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747773|NCT01181271|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92747774|NCT01181271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92747775|NCT01181271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747776|NCT01181271|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92747777|NCT01181271|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747778|NCT01181271|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92747779|NCT01181271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92747780|NCT01181271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747781|NCT01181271|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92747782|NCT01181271|Antifungal Agents|antifungal agents|mesh-ancestor
92611722|NCT00469651|Vaccines|vaccines|mesh-list
92611723|NCT00469651|Immunologic Factors|immunologic factors|mesh-ancestor
92611724|NCT00469651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611725|NCT00149253|Etoricoxib|etoricoxib|mesh-list
92611726|NCT00149253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747783|NCT00624741|Pergolide|pergolide|mesh-list
92747784|NCT00624741|Dopamine Agonists|dopamine agonists|mesh-ancestor
92747785|NCT00624741|Dopamine Agents|dopamine agents|mesh-ancestor
92747786|NCT00624741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747787|NCT00624741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747788|NCT00624741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747789|NCT01180647|Naltrexone|naltrexone|mesh-list
92747790|NCT01180647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92747791|NCT01180647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92747792|NCT01180647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747793|NCT01180647|Sensory System Agents|sensory system agents|mesh-ancestor
92747795|NCT01178853|Warfarin|warfarin|mesh-list
92747796|NCT01178853|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92747797|NCT01178853|Pitavastatin|pitavastatin|mesh-list
92747798|NCT01178853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92747799|NCT01178853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92747800|NCT01178853|Antimetabolites|antimetabolites|mesh-ancestor
92747801|NCT01178853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747802|NCT01178853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92747803|NCT01178853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92747804|NCT01178853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747805|NCT01178853|Anticoagulants|anticoagulants|mesh-ancestor
92747806|NCT04286035|Bupivacaine|bupivacaine|mesh-list
92747807|NCT04286035|Anesthetics, Local|anesthetics, local|mesh-ancestor
92747808|NCT04286035|Anesthetics|anesthetics|mesh-ancestor
92747809|NCT04286035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92747810|NCT04286035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747811|NCT04286035|Sensory System Agents|sensory system agents|mesh-ancestor
92747812|NCT04286035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747813|NCT00629473|Dexamethasone|dexamethasone|mesh-list
92747814|NCT00629473|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92747815|NCT00629473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747816|NCT00629473|Antiemetics|antiemetics|mesh-ancestor
92747817|NCT00629473|Autonomic Agents|autonomic agents|mesh-ancestor
92747818|NCT00629473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747819|NCT00629473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747820|NCT00629473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747821|NCT00629473|Glucocorticoids|glucocorticoids|mesh-ancestor
92747822|NCT00629473|Hormones|hormones|mesh-ancestor
92747823|NCT00629473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92747824|NCT00629473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92747825|NCT00629473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747826|NCT00629473|Protease Inhibitors|protease inhibitors|mesh-ancestor
92747827|NCT00629473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747828|NCT00629473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747829|NCT04286503|Ritonavir|ritonavir|mesh-list
92747830|NCT04286503|Lopinavir|lopinavir|mesh-list
92747831|NCT04286503|Chloroquine|chloroquine|mesh-list
92747832|NCT04286503|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92747833|NCT04286503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92747834|NCT04286503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92747835|NCT04286503|Protease Inhibitors|protease inhibitors|mesh-ancestor
92747836|NCT04286503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747837|NCT04286503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747838|NCT04286503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92747839|NCT04286503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92747840|NCT04286503|Antiviral Agents|antiviral agents|mesh-ancestor
92747841|NCT04286503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747842|NCT04286503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92747843|NCT04286503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92747844|NCT04286503|Amebicides|amebicides|mesh-ancestor
92747845|NCT04286503|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92747846|NCT04286503|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92747847|NCT04286503|Antimalarials|antimalarials|mesh-ancestor
92747848|NCT04286503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747849|NCT04286503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92747850|NCT04286503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611727|NCT00149253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611728|NCT00149253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611729|NCT00149253|Analgesics|analgesics|mesh-ancestor
92611730|NCT00149253|Sensory System Agents|sensory system agents|mesh-ancestor
92747851|NCT04286503|Analgesics|analgesics|mesh-ancestor
92747852|NCT04286503|Sensory System Agents|sensory system agents|mesh-ancestor
92747853|NCT04286503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747854|NCT04286503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747855|NCT04286503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747856|NCT04286503|Filaricides|filaricides|mesh-ancestor
92747857|NCT04286503|Antinematodal Agents|antinematodal agents|mesh-ancestor
92747858|NCT04286503|Anthelmintics|anthelmintics|mesh-ancestor
92747859|NCT00968617|Darbepoetin alfa|darbepoetin alfa|mesh-list
92747860|NCT00968617|Hematinics|hematinics|mesh-ancestor
92747861|NCT00968539|Vaccines|vaccines|mesh-list
92747862|NCT00968539|Immunologic Factors|immunologic factors|mesh-ancestor
92747863|NCT00968539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747864|NCT00976573|Paclitaxel|paclitaxel|mesh-list
92747865|NCT00976573|Bevacizumab|bevacizumab|mesh-list
92747866|NCT00976573|Carboplatin|carboplatin|mesh-list
92747867|NCT00976573|Everolimus|everolimus|mesh-list
92747868|NCT00976573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92747869|NCT00976573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747872|NCT00976573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747873|NCT00976573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747874|NCT00976573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747875|NCT00976573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747876|NCT00976573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747877|NCT00976573|Growth Substances|growth substances|mesh-ancestor
92747878|NCT00976573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747879|NCT00976573|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747880|NCT00976573|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92747881|NCT00976573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747882|NCT00976573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747883|NCT00976573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747884|NCT00976573|Immunologic Factors|immunologic factors|mesh-ancestor
92747886|NCT03661723|Pembrolizumab|pembrolizumab|mesh-list
92747887|NCT03661723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92747888|NCT03661723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747889|NCT03661723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92747890|NCT03661723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92747891|NCT03661723|Growth Substances|growth substances|mesh-ancestor
92747892|NCT03661723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747893|NCT03661723|Growth Inhibitors|growth inhibitors|mesh-ancestor
92747894|NCT03661723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92747895|NCT03661723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747896|NCT00629863|Fluorouracil|fluorouracil|mesh-list
92747897|NCT00629863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747898|NCT00629863|Antimetabolites|antimetabolites|mesh-ancestor
92747899|NCT00629863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747900|NCT00629863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92747901|NCT00629863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747902|NCT00629863|Immunologic Factors|immunologic factors|mesh-ancestor
92747903|NCT00629863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747904|NCT02865733|Treprostinil|treprostinil|mesh-list
92747905|NCT02865733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747906|NCT00976495|Dapagliflozin|dapagliflozin|mesh-list
92747907|NCT00976495|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92747908|NCT00976495|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92747909|NCT00976495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747910|NCT00976495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92747911|NCT00976495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747912|NCT00976495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747913|NCT00976495|Diuretics|diuretics|mesh-ancestor
92747914|NCT00976495|Natriuretic Agents|natriuretic agents|mesh-ancestor
92747915|NCT00976495|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92747916|NCT00976495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92747917|NCT00630019|Moxifloxacin|moxifloxacin|mesh-list
92747918|NCT00630019|Levofloxacin|levofloxacin|mesh-list
92747919|NCT00630019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92611731|NCT00149253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611732|NCT00149253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611733|NCT00149253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611734|NCT00149253|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92611735|NCT00149253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92611736|NCT00149253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399117|NCT01401803|Cholinergic Agents|cholinergic agents|mesh-ancestor
92611737|NCT00149253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92611738|NCT00469690|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92611739|NCT00469690|Bromfenac|bromfenac|mesh-list
92611740|NCT00469690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92611741|NCT00469690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92611742|NCT00469690|Analgesics|analgesics|mesh-ancestor
92611743|NCT00469690|Sensory System Agents|sensory system agents|mesh-ancestor
92611744|NCT00469690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747920|NCT00630019|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92747921|NCT00630019|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92747922|NCT00630019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92747923|NCT00630019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747924|NCT00630019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92747925|NCT00630019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92747926|NCT00630019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747927|NCT00630019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747928|NCT00630019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747929|NCT00630019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92747930|NCT00630019|Contraceptive Agents|contraceptive agents|mesh-ancestor
92747931|NCT00630019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92747932|NCT00630019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747933|NCT00630019|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92747934|NCT00630019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92747935|NCT00630019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92747936|NCT00630019|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92747937|NCT00630019|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92747938|NCT00630019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92747939|NCT00998296|Nintedanib|nintedanib|mesh-list
92747940|NCT00998296|Afatinib|afatinib|mesh-list
92747944|NCT00998296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747946|NCT01178073|Tadalafil|tadalafil|mesh-list
92747947|NCT01178073|Vasodilator Agents|vasodilator agents|mesh-ancestor
92747948|NCT01178073|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92747949|NCT01178073|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92747950|NCT01178073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747951|NCT01178073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747952|NCT01178073|Urological Agents|urological agents|mesh-ancestor
92747953|NCT01178073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747954|NCT00997984|Guanfacine|guanfacine|mesh-list
92747955|NCT00997984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747956|NCT00997984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92747957|NCT00997984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92747958|NCT00997984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92747959|NCT00997984|Adrenergic Agents|adrenergic agents|mesh-ancestor
92747960|NCT00997984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747961|NCT00997984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747962|NCT00997984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747963|NCT01177293|Amlodipine|amlodipine|mesh-list
92747964|NCT01177293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92747965|NCT01177293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92747966|NCT01177293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92611745|NCT00469690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611746|NCT00469690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611820|NCT00470314|N-Methylaspartate|n-methylaspartate|mesh-list
92611821|NCT00470314|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92611823|NCT00470314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92611891|NCT00470743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611892|NCT00470743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611893|NCT00470743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611894|NCT00470743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611895|NCT00470743|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92611896|NCT00470743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92611960|NCT00157872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92611961|NCT00157872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92611962|NCT00157872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92611963|NCT00157872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92611964|NCT00157872|Gout Suppressants|gout suppressants|mesh-ancestor
92611965|NCT00157872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92612028|NCT00471484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92612029|NCT00471484|Immunologic Factors|immunologic factors|mesh-ancestor
92612030|NCT00471484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071110|NCT01893424|Hormones|hormones|mesh-ancestor
92612172|NCT00472927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92612173|NCT00472927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612174|NCT00337090|Mirabegron|mirabegron|mesh-list
92612175|NCT00337090|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92612176|NCT00337090|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92612177|NCT00337090|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92612178|NCT00337090|Adrenergic Agents|adrenergic agents|mesh-ancestor
92612237|NCT00149877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612238|NCT00149877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612310|NCT00405080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92612311|NCT00405080|Antitubercular Agents|antitubercular agents|mesh-ancestor
92612312|NCT00405080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92612313|NCT00405080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92612382|NCT00509353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92612384|NCT00405119|Ranitidine|ranitidine|mesh-list
92612386|NCT00405119|Loxtidine|loxtidine|mesh-list
92612458|NCT02953366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92612459|NCT02953366|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92612460|NCT00150111|Rituximab|rituximab|mesh-list
92612461|NCT00150111|Methimazole|methimazole|mesh-list
92612462|NCT00150111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92612463|NCT00150111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612464|NCT00150111|Immunologic Factors|immunologic factors|mesh-ancestor
92612529|NCT02953210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92612603|NCT00338221|Glycine|glycine|mesh-list
92612604|NCT00338221|Glycine Agents|glycine agents|mesh-ancestor
92612605|NCT00338221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92612608|NCT00338299|Epoetin Alfa|epoetin alfa|mesh-list
92612675|NCT00338767|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92612676|NCT00338767|Antidepressive Agents|antidepressive agents|mesh-ancestor
92612677|NCT00338767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92612745|NCT00339157|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92612746|NCT00339157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92612816|NCT04988282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92612817|NCT04988282|Protective Agents|protective agents|mesh-ancestor
92612819|NCT04988282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92612887|NCT00510406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92612888|NCT00510406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612889|NCT00510406|Urological Agents|urological agents|mesh-ancestor
92612890|NCT00510406|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92612891|NCT00510406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92612892|NCT00510406|Cholinergic Agents|cholinergic agents|mesh-ancestor
92612893|NCT00165555|Sodium thiosulfate|sodium thiosulfate|mesh-list
92612894|NCT00165555|Antidotes|antidotes|mesh-ancestor
92612895|NCT00165555|Protective Agents|protective agents|mesh-ancestor
92612896|NCT00165555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92612897|NCT00165555|Antioxidants|antioxidants|mesh-ancestor
92612950|NCT00165594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613025|NCT00165750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613026|NCT00165750|Nootropic Agents|nootropic agents|mesh-ancestor
92613027|NCT00511225|Cholecalciferol|cholecalciferol|mesh-list
92613028|NCT00511225|Vitamin D|vitamin d|mesh-list
92613029|NCT00511225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613030|NCT00511225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613031|NCT00511225|Vitamins|vitamins|mesh-ancestor
92613094|NCT00150852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92613095|NCT00150852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613096|NCT02952235|Sunscreening Agents|sunscreening agents|mesh-list
92613097|NCT02952235|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92613098|NCT02952235|Protective Agents|protective agents|mesh-ancestor
92613099|NCT02952235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613100|NCT02952235|Dermatologic Agents|dermatologic agents|mesh-ancestor
92613163|NCT00513058|Lapatinib|lapatinib|mesh-list
92613164|NCT00513058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92613165|NCT00513058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613166|NCT00513058|Tubulin Modulators|tubulin modulators|mesh-ancestor
92613167|NCT00513058|Antimitotic Agents|antimitotic agents|mesh-ancestor
92613168|NCT00513058|Mitosis Modulators|mitosis modulators|mesh-ancestor
92613169|NCT00513058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613170|NCT00513058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92613171|NCT00513058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613172|NCT02951962|Amlodipine|amlodipine|mesh-list
92613173|NCT02951962|Telmisartan|telmisartan|mesh-list
92613174|NCT02951962|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92613225|NCT00405236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613226|NCT00405236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613227|NCT00403949|Azelaic acid|azelaic acid|mesh-list
92613228|NCT00403949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613229|NCT00403949|Dermatologic Agents|dermatologic agents|mesh-ancestor
92613230|NCT00513643|Insulin|insulin|mesh-list
92613231|NCT00513643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92613232|NCT00513643|Insulin Aspart|insulin aspart|mesh-list
92613295|NCT00514072|Immunologic Factors|immunologic factors|mesh-ancestor
92613296|NCT00514072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613297|NCT00514072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92613367|NCT02950948|Hormones|hormones|mesh-ancestor
92613368|NCT02950948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92613370|NCT00515320|Fluoxetine|fluoxetine|mesh-list
92613435|NCT00515593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613436|NCT00515593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92613437|NCT00515788|Cytarabine|cytarabine|mesh-list
92613438|NCT00515788|Temozolomide|temozolomide|mesh-list
92613506|NCT00151242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92613507|NCT00151242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92613508|NCT00151242|Immunologic Factors|immunologic factors|mesh-ancestor
92613581|NCT02953405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613582|NCT02953405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613584|NCT00516802|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92613654|NCT05861154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613727|NCT05860153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92613728|NCT05860153|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92613729|NCT05860153|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92613800|NCT05859477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613801|NCT05859477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92613802|NCT05859477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92613803|NCT05859477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92613804|NCT05859412|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92613805|NCT05859412|Methylprednisolone|methylprednisolone|mesh-list
92613806|NCT05859412|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92338862|NCT00000311|Methadone|methadone|mesh-list
92613807|NCT05859412|Prednisolone|prednisolone|mesh-list
92613808|NCT05859412|Prednisolone acetate|prednisolone acetate|mesh-list
92613809|NCT05859412|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92613810|NCT05859412|Prednisolone phosphate|prednisolone phosphate|mesh-list
92613811|NCT05859412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92613812|NCT05859412|Antiemetics|antiemetics|mesh-ancestor
92613813|NCT05859412|Autonomic Agents|autonomic agents|mesh-ancestor
92613814|NCT05859412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92613815|NCT05859412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613816|NCT05859412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92613817|NCT05859412|Glucocorticoids|glucocorticoids|mesh-ancestor
92613857|NCT05822765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92613858|NCT05822765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92613859|NCT05822765|Adrenergic Agents|adrenergic agents|mesh-ancestor
92613860|NCT05822765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92613861|NCT05822765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92613862|NCT05822765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92613926|NCT05722782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92613927|NCT05722782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92613929|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
92613998|NCT05576792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92613999|NCT05576792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92614000|NCT05576792|Growth Substances|growth substances|mesh-ancestor
92614005|NCT05501665|Paclitaxel|paclitaxel|mesh-list
92614070|NCT05463783|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92614073|NCT05457582|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92614145|NCT05221320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614146|NCT05221320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614147|NCT05221320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614217|NCT05140512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614218|NCT05110170|Goserelin|goserelin|mesh-list
92614291|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614292|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92614293|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92614361|NCT04760275|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92614433|NCT04644016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92614507|NCT04463680|Leprostatic Agents|leprostatic agents|mesh-ancestor
92614508|NCT04463680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614509|NCT04463680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614510|NCT04463680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614578|NCT04300231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92614579|NCT04300231|Narcotics|narcotics|mesh-ancestor
92614580|NCT04300231|Analgesics|analgesics|mesh-ancestor
92614581|NCT04249362|Durvalumab|durvalumab|mesh-list
92614582|NCT04249362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614583|NCT04249362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614584|NCT04230148|Triclabendazole|triclabendazole|mesh-list
92747967|NCT01177293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747968|NCT01177293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92747969|NCT01177293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747970|NCT01177293|Vasodilator Agents|vasodilator agents|mesh-ancestor
92747971|NCT02886429|Dexmedetomidine|dexmedetomidine|mesh-list
92747972|NCT02886429|Bupivacaine|bupivacaine|mesh-list
92747973|NCT02886429|Anesthetics, Local|anesthetics, local|mesh-ancestor
92747974|NCT02886429|Anesthetics|anesthetics|mesh-ancestor
92747975|NCT02886429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92747976|NCT02886429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747977|NCT02886429|Sensory System Agents|sensory system agents|mesh-ancestor
92747978|NCT02886429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747979|NCT02886429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92747980|NCT02886429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92747981|NCT02886429|Analgesics|analgesics|mesh-ancestor
92747982|NCT02886429|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92747983|NCT02886429|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92747984|NCT02886429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92747985|NCT02886429|Adrenergic Agents|adrenergic agents|mesh-ancestor
92747986|NCT02886429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747987|NCT02886429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747988|NCT01299389|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92747989|NCT01299389|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92747990|NCT01299389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92747991|NCT01299389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92747992|NCT01299389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747993|NCT01299389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92747994|NCT01299389|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92747995|NCT01299389|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92747996|NCT01299389|Serotonin Agents|serotonin agents|mesh-ancestor
92747997|NCT01299389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747998|NCT01299389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92747999|NCT01299389|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92748000|NCT01299389|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92748001|NCT01299389|Dopamine Agents|dopamine agents|mesh-ancestor
92748002|NCT02886351|Nitrous Oxide|nitrous oxide|mesh-list
92748003|NCT02886351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92748004|NCT02886351|Anesthetics, General|anesthetics, general|mesh-ancestor
92748005|NCT02886351|Anesthetics|anesthetics|mesh-ancestor
92748006|NCT02886351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748007|NCT02886351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748008|NCT02886351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748009|NCT02886351|Analgesics|analgesics|mesh-ancestor
92748012|NCT00976027|Vaccines|vaccines|mesh-list
92748013|NCT00976027|Immunologic Factors|immunologic factors|mesh-ancestor
92748014|NCT00976027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748015|NCT01298765|Buprenorphine|buprenorphine|mesh-list
92748016|NCT01298765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92748017|NCT01298765|Narcotics|narcotics|mesh-ancestor
92748018|NCT01298765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748019|NCT01298765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748020|NCT01298765|Analgesics|analgesics|mesh-ancestor
92748021|NCT01298765|Sensory System Agents|sensory system agents|mesh-ancestor
92748022|NCT01298765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748023|NCT01298765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92748025|NCT04296214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92748026|NCT04296214|Antimetabolites|antimetabolites|mesh-ancestor
92748027|NCT04296214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614585|NCT04230148|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92614586|NCT04230148|Anthelmintics|anthelmintics|mesh-ancestor
92614587|NCT04230148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92614588|NCT04230148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614589|NCT04205630|Trastuzumab|trastuzumab|mesh-list
92748028|NCT04296214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748029|NCT04296214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748030|NCT04296370|Apatinib|apatinib|mesh-list
92748031|NCT04296370|Fluzoparib|fluzoparib|mesh-list
92748032|NCT04296370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748033|NCT04296370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748034|NCT04296370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748035|NCT04296370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748036|NCT04296370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92748037|NCT00997438|Thioctic Acid|thioctic acid|mesh-list
92748038|NCT00997438|Antioxidants|antioxidants|mesh-ancestor
92748039|NCT00997438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748040|NCT00997438|Protective Agents|protective agents|mesh-ancestor
92748041|NCT00997438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748042|NCT00997438|Vitamin B Complex|vitamin b complex|mesh-ancestor
92748043|NCT00997438|Vitamins|vitamins|mesh-ancestor
92748044|NCT00997438|Micronutrients|micronutrients|mesh-ancestor
92748045|NCT00997126|Alfentanil|alfentanil|mesh-list
92748046|NCT00997126|Propofol|propofol|mesh-list
92748047|NCT00997126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92748048|NCT00997126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748049|NCT00997126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748050|NCT00997126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92748051|NCT00997126|Anesthetics, General|anesthetics, general|mesh-ancestor
92748052|NCT00997126|Anesthetics|anesthetics|mesh-ancestor
92748053|NCT00997126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92748054|NCT00997126|Narcotics|narcotics|mesh-ancestor
92748055|NCT00997126|Analgesics|analgesics|mesh-ancestor
92748056|NCT00997126|Sensory System Agents|sensory system agents|mesh-ancestor
92748057|NCT00997126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748058|NCT01000636|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92748059|NCT01000636|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92748060|NCT01000636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92748061|NCT04433494|Tamoxifen|tamoxifen|mesh-list
92748062|NCT04433494|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92748063|NCT04433494|Hormone Antagonists|hormone antagonists|mesh-ancestor
92748064|NCT04433494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748065|NCT04433494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748066|NCT04433494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92748067|NCT04433494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748068|NCT04433494|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92748069|NCT04433494|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92748070|NCT04433494|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92748071|NCT01000480|Pemetrexed|pemetrexed|mesh-list
92748072|NCT01000480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748073|NCT01000480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748074|NCT01000480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748075|NCT01000480|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92748076|NCT01000480|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92748077|NCT02862691|Acetaminophen|acetaminophen|mesh-list
92748078|NCT02862691|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92748079|NCT02862691|Oxycodone|oxycodone|mesh-list
92748080|NCT02862691|Analgesics|analgesics|mesh-list
92748081|NCT02862691|Bupivacaine|bupivacaine|mesh-list
92748082|NCT02862691|Anesthetics, Local|anesthetics, local|mesh-list
92748083|NCT02862691|Anesthetics|anesthetics|mesh-list
92748085|NCT02862691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748086|NCT02862691|Sensory System Agents|sensory system agents|mesh-ancestor
92748087|NCT02862691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748088|NCT02862691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748090|NCT02862691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92748091|NCT02862691|Narcotics|narcotics|mesh-ancestor
92748092|NCT02862691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92748093|NCT02862691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748094|NCT02862691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748095|NCT00965341|Methyltestosterone|methyltestosterone|mesh-list
92748096|NCT00965341|Testosterone|testosterone|mesh-list
92614590|NCT04205630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614591|NCT04205630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614592|NCT04195633|Cyclosporine|cyclosporine|mesh-list
92614593|NCT04195633|Mycophenolic Acid|mycophenolic acid|mesh-list
92614594|NCT04195633|Cyclophosphamide|cyclophosphamide|mesh-list
92614595|NCT04195633|Treosulfan|treosulfan|mesh-list
92614596|NCT04195633|Busulfan|busulfan|mesh-list
92614597|NCT04195633|Fludarabine|fludarabine|mesh-list
92614598|NCT04195633|Cyclosporins|cyclosporins|mesh-list
92614599|NCT04195633|Lenograstim|lenograstim|mesh-list
92614600|NCT04195633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614601|NCT04195633|Immunologic Factors|immunologic factors|mesh-ancestor
92614602|NCT04195633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614603|NCT04195633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021589|NCT04810585|Aflibercept|aflibercept|mesh-list
92748097|NCT00965341|Testosterone undecanoate|testosterone undecanoate|mesh-list
92748098|NCT00965341|Testosterone enanthate|testosterone enanthate|mesh-list
92748099|NCT00965341|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92748100|NCT00965341|Androgens|androgens|mesh-ancestor
92748101|NCT00965341|Hormones|hormones|mesh-ancestor
92748102|NCT00965341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748103|NCT00965341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748104|NCT00965341|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92748105|NCT00965341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748106|NCT00965341|Anabolic Agents|anabolic agents|mesh-ancestor
92748107|NCT01175811|Insulin|insulin|mesh-list
92748108|NCT01175811|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92748109|NCT01175811|Insulin Glargine|insulin glargine|mesh-list
92748110|NCT01175811|Insulin Lispro|insulin lispro|mesh-list
92748111|NCT01175811|Insulin, Isophane|insulin, isophane|mesh-list
92748112|NCT01175811|Biphasic Insulins|biphasic insulins|mesh-list
92748113|NCT01175811|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
92748114|NCT01175811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92748115|NCT01175811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748116|NCT00965263|Cocaine|cocaine|mesh-list
92748117|NCT00965263|Anesthetics, Local|anesthetics, local|mesh-ancestor
92748118|NCT00965263|Anesthetics|anesthetics|mesh-ancestor
92748119|NCT00965263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748120|NCT00965263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748121|NCT00965263|Sensory System Agents|sensory system agents|mesh-ancestor
92748122|NCT00965263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748123|NCT00965263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92748124|NCT00965263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92748125|NCT00965263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92748126|NCT00965263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748127|NCT00965263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748128|NCT00965263|Dopamine Agents|dopamine agents|mesh-ancestor
92748129|NCT00965263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748130|NCT02886195|Pemetrexed|pemetrexed|mesh-list
92748131|NCT02886195|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92748132|NCT02886195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748133|NCT02886195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748134|NCT02886195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748135|NCT02886195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92748136|NCT02886195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92748137|NCT02886195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748138|NCT02862769|Lidocaine|lidocaine|mesh-list
92748139|NCT02862769|Anesthetics, Local|anesthetics, local|mesh-ancestor
92748140|NCT02862769|Anesthetics|anesthetics|mesh-ancestor
92748141|NCT02862769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748142|NCT02862769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748143|NCT02862769|Sensory System Agents|sensory system agents|mesh-ancestor
92614604|NCT04195633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92614605|NCT04195633|Alkylating Agents|alkylating agents|mesh-ancestor
92614606|NCT04195633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614607|NCT04195633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614608|NCT04195633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92614609|NCT04195633|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92614610|NCT04195633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748144|NCT02862769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748145|NCT02862769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92748146|NCT02862769|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92748147|NCT02862769|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92748148|NCT02862769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748149|NCT02862769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748150|NCT00965185|Atorvastatin|atorvastatin|mesh-list
92748151|NCT00965185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92748152|NCT00965185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92748153|NCT00965185|Antimetabolites|antimetabolites|mesh-ancestor
92748154|NCT00965185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748155|NCT00965185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92748159|NCT01174563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748160|NCT01174563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748161|NCT01174563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748162|NCT01174563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748163|NCT01298531|Etanercept|etanercept|mesh-list
92748164|NCT01298531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92748165|NCT01298531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748166|NCT01298531|Analgesics|analgesics|mesh-ancestor
92748167|NCT01298531|Sensory System Agents|sensory system agents|mesh-ancestor
92748168|NCT01298531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748169|NCT01298531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748170|NCT01298531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748171|NCT01298531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748172|NCT01298531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92748173|NCT01298531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748174|NCT01298531|Immunologic Factors|immunologic factors|mesh-ancestor
92748176|NCT02862145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748177|NCT02862145|Antiemetics|antiemetics|mesh-ancestor
92748178|NCT02862145|Autonomic Agents|autonomic agents|mesh-ancestor
92748179|NCT02862145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748180|NCT02862145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748181|NCT02862145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92748182|NCT02862145|Glucocorticoids|glucocorticoids|mesh-ancestor
92748183|NCT02862145|Hormones|hormones|mesh-ancestor
92748184|NCT02862145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748185|NCT02862145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92748186|NCT02862145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748187|NCT01174173|Ranolazine|ranolazine|mesh-list
92748188|NCT01174173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92748189|NCT01174173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748190|NCT01174173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748191|NCT00964795|Aflibercept|aflibercept|mesh-list
92748192|NCT00964795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92748193|NCT00964795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92748194|NCT00964795|Growth Substances|growth substances|mesh-ancestor
92748195|NCT00964795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748196|NCT00964795|Growth Inhibitors|growth inhibitors|mesh-ancestor
92748197|NCT00964795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748198|NCT01173471|Niacinamide|niacinamide|mesh-list
92748199|NCT01173471|Vitamin B Complex|vitamin b complex|mesh-ancestor
92748200|NCT01173471|Vitamins|vitamins|mesh-ancestor
92748201|NCT01173471|Micronutrients|micronutrients|mesh-ancestor
92748202|NCT01173471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748203|NCT01172847|Oseltamivir|oseltamivir|mesh-list
92748204|NCT01172847|Rimantadine|rimantadine|mesh-list
92748205|NCT01172847|Antiviral Agents|antiviral agents|mesh-ancestor
92748206|NCT01172847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614611|NCT04195633|Antifungal Agents|antifungal agents|mesh-ancestor
92614612|NCT04195633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614613|NCT04195633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92614614|NCT04195633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92614615|NCT04195633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92614616|NCT04195633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92614617|NCT04195633|Antitubercular Agents|antitubercular agents|mesh-ancestor
92748207|NCT01172847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750787|NCT05935059|Sensory System Agents|sensory system agents|mesh-ancestor
92748208|NCT01172847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748209|NCT01172847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92748210|NCT00966355|Octreotide|octreotide|mesh-list
92748211|NCT00966355|Terlipressin|terlipressin|mesh-list
92748212|NCT00966355|Somatostatin|somatostatin|mesh-list
92748213|NCT00966355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92748214|NCT00966355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92748215|NCT00966355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748216|NCT00966355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92748217|NCT00966355|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92748218|NCT00966355|Hormones|hormones|mesh-ancestor
92748219|NCT00966355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748220|NCT00966355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748221|NCT01172535|Ritonavir|ritonavir|mesh-list
92748222|NCT01172535|Lopinavir|lopinavir|mesh-list
92748223|NCT01172535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92748224|NCT01172535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92748225|NCT01172535|Protease Inhibitors|protease inhibitors|mesh-ancestor
92748226|NCT01172535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748227|NCT01172535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748228|NCT01172535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92748230|NCT01172535|Antiviral Agents|antiviral agents|mesh-ancestor
92748231|NCT01172535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748232|NCT01172535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92748233|NCT01172535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92748234|NCT05160493|Pregabalin|pregabalin|mesh-list
92748235|NCT05160493|Ketamine|ketamine|mesh-list
92748236|NCT05160493|Esketamine|esketamine|mesh-list
92748237|NCT05160493|Analgesics|analgesics|mesh-ancestor
92748238|NCT05160493|Sensory System Agents|sensory system agents|mesh-ancestor
92748239|NCT05160493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748240|NCT05160493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748241|NCT05160493|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92748242|NCT05160493|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92748243|NCT05160493|Anesthetics, General|anesthetics, general|mesh-ancestor
92748244|NCT05160493|Anesthetics|anesthetics|mesh-ancestor
92748245|NCT05160493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748246|NCT05160493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92748247|NCT05160493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92748248|NCT05160493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748249|NCT05160493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748250|NCT05160493|Anticonvulsants|anticonvulsants|mesh-ancestor
92748251|NCT05160493|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92748252|NCT05160493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748253|NCT05160493|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748254|NCT05160493|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92748255|NCT05160493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92748256|NCT05160493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92748257|NCT05160493|Antidepressive Agents|antidepressive agents|mesh-ancestor
92748258|NCT00966277|Dalteparin|dalteparin|mesh-list
92748259|NCT00966277|Tinzaparin|tinzaparin|mesh-list
92748260|NCT00966277|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92748261|NCT00966277|Anticoagulants|anticoagulants|mesh-ancestor
92748262|NCT00966277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92748263|NCT00966277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92748264|NCT00966277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748265|NCT04324307|Paclitaxel|paclitaxel|mesh-list
92748266|NCT04324307|Gemcitabine|gemcitabine|mesh-list
92748267|NCT04324307|Fluorouracil|fluorouracil|mesh-list
92748268|NCT04324307|Oxaliplatin|oxaliplatin|mesh-list
92748269|NCT04324307|Irinotecan|irinotecan|mesh-list
92748270|NCT04324307|Folfirinox|folfirinox|mesh-list
92614618|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614619|NCT04171050|Anesthetics|anesthetics|mesh-list
92614620|NCT04171050|Anesthetics, Local|anesthetics, local|mesh-list
92614621|NCT04171050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748271|NCT04324307|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92748272|NCT04324307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748273|NCT04324307|Tubulin Modulators|tubulin modulators|mesh-ancestor
92748274|NCT04324307|Antimitotic Agents|antimitotic agents|mesh-ancestor
92748275|NCT04324307|Mitosis Modulators|mitosis modulators|mesh-ancestor
92748276|NCT04324307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748277|NCT04324307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92748278|NCT04324307|Antimetabolites|antimetabolites|mesh-ancestor
92748279|NCT04324307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748280|NCT04324307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748281|NCT04324307|Immunologic Factors|immunologic factors|mesh-ancestor
92748282|NCT04324307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92748283|NCT04324307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92748284|NCT04324307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748285|NCT01297517|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92748286|NCT01297517|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92748287|NCT01297517|Brinzolamide|brinzolamide|mesh-list
92748288|NCT01297517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92748289|NCT01297517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92748290|NCT01297517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92748291|NCT01297517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92748292|NCT01297517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92748293|NCT01297517|Adrenergic Agents|adrenergic agents|mesh-ancestor
92748294|NCT01297517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748295|NCT01297517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748296|NCT01297517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748297|NCT01297517|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92748298|NCT01297517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748299|NCT01296347|Ketamine|ketamine|mesh-list
92748300|NCT01296347|Analgesics|analgesics|mesh-ancestor
92748301|NCT01296347|Sensory System Agents|sensory system agents|mesh-ancestor
92748302|NCT01296347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748303|NCT01296347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748306|NCT01296347|Anesthetics, General|anesthetics, general|mesh-ancestor
92748307|NCT01296347|Anesthetics|anesthetics|mesh-ancestor
92748308|NCT01296347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748309|NCT01296347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92748310|NCT01296347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92748311|NCT01296347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748312|NCT01296347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748313|NCT01296035|Panitumumab|panitumumab|mesh-list
92748314|NCT01296035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748315|NCT01296035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748316|NCT01294787|Glycopyrrolate|glycopyrrolate|mesh-list
92748317|NCT01294787|Bromides|bromides|mesh-list
92748318|NCT01294787|Tiotropium Bromide|tiotropium bromide|mesh-list
92748319|NCT01294787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92748320|NCT01294787|Autonomic Agents|autonomic agents|mesh-ancestor
92748321|NCT01294787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748322|NCT01294787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748324|NCT01294787|Respiratory System Agents|respiratory system agents|mesh-ancestor
92748325|NCT01294787|Parasympatholytics|parasympatholytics|mesh-ancestor
92748326|NCT01294787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92748327|NCT01294787|Cholinergic Agents|cholinergic agents|mesh-ancestor
92748328|NCT01294787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748329|NCT01294787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748330|NCT01294787|Anticonvulsants|anticonvulsants|mesh-ancestor
92748331|NCT01294787|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92748332|NCT01294787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92748333|NCT01294553|Metformin|metformin|mesh-list
92748334|NCT01294553|Rosiglitazone|rosiglitazone|mesh-list
92748335|NCT01294553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92748336|NCT01294553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748337|NCT04326023|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92748338|NCT04326023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614622|NCT04171050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614623|NCT04171050|Sensory System Agents|sensory system agents|mesh-ancestor
92614624|NCT04171050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614625|NCT04128696|Pembrolizumab|pembrolizumab|mesh-list
92748339|NCT04326023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748340|NCT04326023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748342|NCT01294397|Etanercept|etanercept|mesh-list
92748343|NCT01294397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92748344|NCT01294397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748345|NCT01294397|Analgesics|analgesics|mesh-ancestor
92748346|NCT01294397|Sensory System Agents|sensory system agents|mesh-ancestor
92748347|NCT01294397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748348|NCT01294397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748349|NCT01294397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748350|NCT01294397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748351|NCT01294397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92748352|NCT01294397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748353|NCT01294397|Immunologic Factors|immunologic factors|mesh-ancestor
92748354|NCT01294397|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92748355|NCT01293695|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92748356|NCT01293695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748357|NCT01293695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748358|NCT01293539|Melphalan|melphalan|mesh-list
92748359|NCT01293539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92748360|NCT01293539|Alkylating Agents|alkylating agents|mesh-ancestor
92748361|NCT01293539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748362|NCT01293539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748363|NCT01293539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92748364|NCT01293539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748365|NCT01293539|Immunologic Factors|immunologic factors|mesh-ancestor
92748366|NCT01293539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748367|NCT01292837|Levetiracetam|levetiracetam|mesh-list
92748368|NCT01292837|Anticonvulsants|anticonvulsants|mesh-ancestor
92748369|NCT01292837|Nootropic Agents|nootropic agents|mesh-ancestor
92748370|NCT00965731|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92748371|NCT00965731|Crizotinib|crizotinib|mesh-list
92748372|NCT00965731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748373|NCT00965731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748374|NCT00965731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748375|NCT00965731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748376|NCT00630175|Zolpidem|zolpidem|mesh-list
92748379|NCT00630175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748380|NCT00630175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748381|NCT00630175|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92748382|NCT00630175|GABA Agonists|gaba agonists|mesh-ancestor
92748383|NCT00630175|GABA Agents|gaba agents|mesh-ancestor
92748384|NCT00630175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748385|NCT00630175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748386|NCT00965575|Melatonin|melatonin|mesh-list
92748387|NCT00965575|Antioxidants|antioxidants|mesh-ancestor
92748388|NCT00965575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748389|NCT00965575|Protective Agents|protective agents|mesh-ancestor
92748390|NCT00965575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748391|NCT00965575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748392|NCT00965497|Escitalopram|escitalopram|mesh-list
92748393|NCT00965497|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92748394|NCT00965497|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92748395|NCT00965497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748396|NCT00965497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748397|NCT00965497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748398|NCT00965497|Serotonin Agents|serotonin agents|mesh-ancestor
92748399|NCT00965497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748400|NCT00963937|Sumatriptan|sumatriptan|mesh-list
92748401|NCT00963937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92748402|NCT00963937|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92748403|NCT00963937|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92748404|NCT00963937|Serotonin Agents|serotonin agents|mesh-ancestor
92748405|NCT00963937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614626|NCT04128696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614627|NCT04128696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614628|NCT04128696|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92748406|NCT00963937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748407|NCT00963937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748409|NCT01170663|Ramucirumab|ramucirumab|mesh-list
92748410|NCT01170663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92748411|NCT01170663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748412|NCT01170663|Tubulin Modulators|tubulin modulators|mesh-ancestor
92748413|NCT01170663|Antimitotic Agents|antimitotic agents|mesh-ancestor
92748414|NCT01170663|Mitosis Modulators|mitosis modulators|mesh-ancestor
92748415|NCT01170663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748416|NCT04315155|Nivolumab|nivolumab|mesh-list
92748417|NCT04315155|Ipilimumab|ipilimumab|mesh-list
92748418|NCT04315155|Belinostat|belinostat|mesh-list
92748419|NCT04315155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748420|NCT04315155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748421|NCT04315155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92748422|NCT04315155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748423|NCT04315155|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92748424|NCT04315155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748425|NCT01170273|Vitamin D|vitamin d|mesh-list
92748426|NCT01170273|Vitamins|vitamins|mesh-ancestor
92748427|NCT01170273|Micronutrients|micronutrients|mesh-ancestor
92748428|NCT01170273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748429|NCT01170273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92748430|NCT01170039|Lubiprostone|lubiprostone|mesh-list
92748431|NCT01170039|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92748432|NCT01170039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748433|NCT01170039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748434|NCT01286558|Amlodipine|amlodipine|mesh-list
92748435|NCT01286558|Telmisartan|telmisartan|mesh-list
92748436|NCT01286558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92748437|NCT01286558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92748438|NCT01286558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748439|NCT01286558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748440|NCT01286558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748441|NCT01286558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748442|NCT01286558|Vasodilator Agents|vasodilator agents|mesh-ancestor
92748443|NCT01286558|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92748444|NCT01286558|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92748445|NCT01169103|Hormones|hormones|mesh-list
92748446|NCT01169103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748450|NCT01286168|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92748451|NCT01286168|Eusol|eusol|mesh-list
92748452|NCT01286168|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92748453|NCT01286168|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92748454|NCT01286168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748455|NCT01286168|Disinfectants|disinfectants|mesh-ancestor
92748456|NCT01286168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92748457|NCT02889692|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92748458|NCT02889692|Gefitinib|gefitinib|mesh-list
92748459|NCT02889692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748460|NCT02889692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748461|NCT02889692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748462|NCT02889692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748463|NCT05569382|Verapamil|verapamil|mesh-list
92748464|NCT05569382|Bisoprolol|bisoprolol|mesh-list
92748465|NCT05569382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92748466|NCT05569382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92748467|NCT05569382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748468|NCT05569382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748469|NCT05569382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748470|NCT05569382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748471|NCT05569382|Vasodilator Agents|vasodilator agents|mesh-ancestor
92748472|NCT05569382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92748473|NCT05569382|Sympatholytics|sympatholytics|mesh-ancestor
92748474|NCT05569382|Autonomic Agents|autonomic agents|mesh-ancestor
92614629|NCT04128696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614630|NCT04098081|Gemcitabine|gemcitabine|mesh-list
92614631|NCT04098081|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|3-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene|mesh-list
92614632|NCT04098081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92748475|NCT05569382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399162|NCT01402089|Sunitinib|sunitinib|mesh-list
92748476|NCT05569382|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92748477|NCT05569382|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92748478|NCT05569382|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92748479|NCT05569382|Adrenergic Agents|adrenergic agents|mesh-ancestor
92748480|NCT05569382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748481|NCT00963547|Trastuzumab|trastuzumab|mesh-list
92748482|NCT00963547|Lapatinib|lapatinib|mesh-list
92748483|NCT00963547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748484|NCT00963547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748485|NCT00963547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748486|NCT00963547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748487|NCT00963547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748488|NCT01285310|Thalidomide|thalidomide|mesh-list
92748489|NCT01285310|Apremilast|apremilast|mesh-list
92748490|NCT01285310|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92748491|NCT01285310|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748492|NCT01285310|Analgesics|analgesics|mesh-ancestor
92748493|NCT01285310|Sensory System Agents|sensory system agents|mesh-ancestor
92748494|NCT01285310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748495|NCT01285310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748496|NCT01285310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748497|NCT01285310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748498|NCT01285310|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92748499|NCT01285310|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92748500|NCT01285310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748501|NCT01285310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748502|NCT01285310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748503|NCT01285310|Immunologic Factors|immunologic factors|mesh-ancestor
92748504|NCT01285310|Leprostatic Agents|leprostatic agents|mesh-ancestor
92748505|NCT01285310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92748506|NCT01285310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748507|NCT01285310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92748508|NCT01285310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92748509|NCT01285310|Growth Substances|growth substances|mesh-ancestor
92748510|NCT01285310|Growth Inhibitors|growth inhibitors|mesh-ancestor
92748511|NCT01285310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748512|NCT01254630|Vaccines|vaccines|mesh-list
92748513|NCT01254630|Immunologic Factors|immunologic factors|mesh-ancestor
92748514|NCT01254630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748515|NCT01253304|Dulaglutide|dulaglutide|mesh-list
92748516|NCT01253304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92748517|NCT01253304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748518|NCT04319484|Lenvatinib|lenvatinib|mesh-list
92748523|NCT01253226|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92748524|NCT01253226|Immunologic Factors|immunologic factors|mesh-ancestor
92748525|NCT01253226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748526|NCT01252134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92748528|NCT00624312|Hematinics|hematinics|mesh-ancestor
92748529|NCT01250418|Ketamine|ketamine|mesh-list
92748530|NCT01250418|Analgesics|analgesics|mesh-ancestor
92748531|NCT01250418|Sensory System Agents|sensory system agents|mesh-ancestor
92748532|NCT01250418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748533|NCT01250418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748534|NCT01250418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92748535|NCT01250418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92748536|NCT01250418|Anesthetics, General|anesthetics, general|mesh-ancestor
92748537|NCT01250418|Anesthetics|anesthetics|mesh-ancestor
92748538|NCT01250418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748539|NCT01250418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92748540|NCT01250418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92748541|NCT01250418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748542|NCT01250418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748543|NCT05491356|Plasminogen|plasminogen|mesh-list
92748544|NCT05491356|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92748545|NCT05491356|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92748546|NCT05491356|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92748547|NCT05491356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748548|NCT01292603|Cyclophosphamide|cyclophosphamide|mesh-list
92748550|NCT01292603|Fludarabine|fludarabine|mesh-list
92748551|NCT01292603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748552|NCT01292603|Immunologic Factors|immunologic factors|mesh-ancestor
92399172|NCT01402089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92748553|NCT01292603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748554|NCT01292603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748555|NCT01292603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92748556|NCT01292603|Alkylating Agents|alkylating agents|mesh-ancestor
92748557|NCT01292603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748558|NCT01292603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748559|NCT01292603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92748560|NCT01292603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748561|NCT01292057|Aripiprazole|aripiprazole|mesh-list
92748562|NCT01292057|Antidepressive Agents|antidepressive agents|mesh-ancestor
92748563|NCT01292057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92748564|NCT01292057|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92748565|NCT01292057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92748566|NCT01292057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748567|NCT01292057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748568|NCT01292057|Dopamine Agonists|dopamine agonists|mesh-ancestor
92748569|NCT01292057|Dopamine Agents|dopamine agents|mesh-ancestor
92748570|NCT01292057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748571|NCT01292057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748572|NCT01292057|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92748573|NCT01292057|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92748574|NCT01292057|Serotonin Agents|serotonin agents|mesh-ancestor
92748575|NCT01292057|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92748576|NCT01292057|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92748577|NCT01292057|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92748578|NCT01292057|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92748579|NCT01290887|Reslizumab|reslizumab|mesh-list
92748580|NCT01290887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92748581|NCT01290887|Respiratory System Agents|respiratory system agents|mesh-ancestor
92748582|NCT01290731|Interferons|interferons|mesh-list
92748583|NCT01290731|Ribavirin|ribavirin|mesh-list
92748584|NCT01290731|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92748585|NCT01290731|Simeprevir|simeprevir|mesh-list
92748586|NCT01290731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748587|NCT01290731|Antiviral Agents|antiviral agents|mesh-ancestor
92748588|NCT01290731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748589|NCT01290731|Antimetabolites|antimetabolites|mesh-ancestor
92748594|NCT01290341|Antifungal Agents|antifungal agents|mesh-ancestor
92748595|NCT01290341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748596|NCT01290263|Bevacizumab|bevacizumab|mesh-list
92748597|NCT01290263|Trebananib|trebananib|mesh-list
92748598|NCT01290263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748599|NCT01290263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748600|NCT01290263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92748601|NCT01290263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92748602|NCT01290263|Growth Substances|growth substances|mesh-ancestor
92748603|NCT01290263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748604|NCT01290263|Growth Inhibitors|growth inhibitors|mesh-ancestor
92748605|NCT01290029|Cinacalcet|cinacalcet|mesh-list
92748606|NCT01290029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748607|NCT01290029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748608|NCT01290029|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92748609|NCT01290029|Hormone Antagonists|hormone antagonists|mesh-ancestor
92748610|NCT01290029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748611|NCT02890199|Lidocaine|lidocaine|mesh-list
92748612|NCT02890199|Bupivacaine|bupivacaine|mesh-list
92748613|NCT02890199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92748614|NCT02890199|Anesthetics|anesthetics|mesh-ancestor
92748615|NCT02890199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748616|NCT02890199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748617|NCT02890199|Sensory System Agents|sensory system agents|mesh-ancestor
92748618|NCT02890199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748619|NCT02890199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92748620|NCT02890199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92748621|NCT02890199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92748622|NCT02890199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748623|NCT02890199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614633|NCT04098081|Antimetabolites|antimetabolites|mesh-ancestor
92614634|NCT04098081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614635|NCT04098081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614636|NCT04098081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614638|NCT04039607|Ipilimumab|ipilimumab|mesh-list
92614639|NCT04039607|Sorafenib|sorafenib|mesh-list
92614640|NCT04039607|Lenvatinib|lenvatinib|mesh-list
92614641|NCT04039607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748624|NCT01289639|Pioglitazone|pioglitazone|mesh-list
92748625|NCT01289639|Fenofibrate|fenofibrate|mesh-list
92748626|NCT01289639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92748627|NCT01289639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748628|NCT01289639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92748629|NCT01289639|Antimetabolites|antimetabolites|mesh-ancestor
92748630|NCT01289639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748631|NCT01289639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92748632|NCT01288937|Milnacipran|milnacipran|mesh-list
92748633|NCT01288937|Levomilnacipran|levomilnacipran|mesh-list
92748634|NCT01288937|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92748635|NCT01288937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92748636|NCT01288937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748637|NCT01288937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748638|NCT01288937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748639|NCT01288937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748640|NCT01288937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748641|NCT01288937|Analgesics|analgesics|mesh-ancestor
92748642|NCT01288937|Sensory System Agents|sensory system agents|mesh-ancestor
92748643|NCT01288937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748644|NCT01288937|Antidepressive Agents|antidepressive agents|mesh-ancestor
92748645|NCT01288937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92748646|NCT01288469|Atorvastatin|atorvastatin|mesh-list
92748647|NCT01288469|Alirocumab|alirocumab|mesh-list
92748648|NCT01288469|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92748649|NCT01288469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92748650|NCT01288469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92748651|NCT01288469|Antimetabolites|antimetabolites|mesh-ancestor
92748652|NCT01288469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748653|NCT01288469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92748654|NCT01288469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92748655|NCT01288469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748656|NCT01288469|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92748657|NCT01288469|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92748658|NCT01288469|Protease Inhibitors|protease inhibitors|mesh-ancestor
92748659|NCT01288469|Immunologic Factors|immunologic factors|mesh-ancestor
92748663|NCT01288079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92748664|NCT01288079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748665|NCT01288079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748666|NCT01288079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748667|NCT01288079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748668|NCT01288079|Analgesics|analgesics|mesh-ancestor
92748669|NCT01288079|Sensory System Agents|sensory system agents|mesh-ancestor
92748670|NCT01288079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748671|NCT01288079|Antidepressive Agents|antidepressive agents|mesh-ancestor
92748672|NCT01288079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92748673|NCT01288079|Dopamine Agents|dopamine agents|mesh-ancestor
92748674|NCT01287221|Riboflavin|riboflavin|mesh-list
92748675|NCT01287221|Rifampin|rifampin|mesh-list
92748676|NCT01287221|Vitamins|vitamins|mesh-ancestor
92748677|NCT01287221|Micronutrients|micronutrients|mesh-ancestor
92748678|NCT01287221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748679|NCT01287221|Vitamin B Complex|vitamin b complex|mesh-ancestor
92748680|NCT01287221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92748681|NCT01287221|Antitubercular Agents|antitubercular agents|mesh-ancestor
92748682|NCT01287221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92748683|NCT01287221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748684|NCT01287221|Leprostatic Agents|leprostatic agents|mesh-ancestor
92748685|NCT01287221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614642|NCT04039607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614643|NCT04039607|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614644|NCT04039607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614645|NCT04039607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614646|NCT04039607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021636|NCT01667419|Vemurafenib|vemurafenib|mesh-list
92748686|NCT01287221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748687|NCT01287221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748688|NCT01287221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92748689|NCT01287221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92748690|NCT01287221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92748691|NCT01287221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92748692|NCT01287221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92748693|NCT01287221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92748694|NCT01287221|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92748695|NCT01287221|Dermatologic Agents|dermatologic agents|mesh-ancestor
92748696|NCT05660213|Bevacizumab|bevacizumab|mesh-list
92748697|NCT05660213|Atezolizumab|atezolizumab|mesh-list
92748698|NCT05660213|Apatinib|apatinib|mesh-list
92748699|NCT05660213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748700|NCT05660213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748701|NCT05660213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92748702|NCT05660213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92748703|NCT05660213|Growth Substances|growth substances|mesh-ancestor
92748704|NCT05660213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748705|NCT05660213|Growth Inhibitors|growth inhibitors|mesh-ancestor
92748706|NCT05660213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92748707|NCT05660213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748708|NCT05660213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748709|NCT05660213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748710|NCT01167153|Amlodipine|amlodipine|mesh-list
92748711|NCT01167153|Valsartan|valsartan|mesh-list
92748712|NCT01167153|Nifedipine|nifedipine|mesh-list
92748713|NCT01167153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92748714|NCT01167153|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92748715|NCT01167153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748716|NCT01167153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748717|NCT01167153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748718|NCT01167153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748719|NCT01167153|Vasodilator Agents|vasodilator agents|mesh-ancestor
92748720|NCT01167153|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92748721|NCT01167153|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92748722|NCT01167153|Tocolytic Agents|tocolytic agents|mesh-ancestor
92748723|NCT01167153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92748724|NCT01166763|Vitamin D|vitamin d|mesh-list
92748725|NCT01166763|Cholecalciferol|cholecalciferol|mesh-list
92748726|NCT01166763|Vitamins|vitamins|mesh-ancestor
92748727|NCT01166763|Micronutrients|micronutrients|mesh-ancestor
92748728|NCT01166763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748730|NCT01166763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748732|NCT02885961|Antithrombins|antithrombins|mesh-ancestor
92748733|NCT02885961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92748734|NCT02885961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92748735|NCT02885961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748736|NCT02885961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748737|NCT02885961|Anticoagulants|anticoagulants|mesh-ancestor
92748738|NCT02885727|Durvalumab|durvalumab|mesh-list
92748739|NCT02885727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748740|NCT02885727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748741|NCT00963235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92748742|NCT00963235|Immunologic Factors|immunologic factors|mesh-ancestor
92748743|NCT00963235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748744|NCT00630097|Modafinil|modafinil|mesh-list
92748745|NCT00630097|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92748746|NCT00630097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748747|NCT00630097|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92614647|NCT04028986|Ulipristal acetate|ulipristal acetate|mesh-list
92614648|NCT04028986|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92614649|NCT04028986|Contraceptive Agents|contraceptive agents|mesh-ancestor
92614650|NCT04028986|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92614651|NCT04028986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021643|NCT04808791|Irinotecan|irinotecan|mesh-list
92748748|NCT00630097|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92748749|NCT00630097|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92748750|NCT00630097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748751|NCT01165281|Oxycodone|oxycodone|mesh-list
92748752|NCT01165281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92748753|NCT01165281|Narcotics|narcotics|mesh-ancestor
92748754|NCT01165281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748755|NCT01165281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748756|NCT01165281|Analgesics|analgesics|mesh-ancestor
92748757|NCT01165281|Sensory System Agents|sensory system agents|mesh-ancestor
92748758|NCT01165281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748759|NCT02860897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92748760|NCT02860897|Estrogens|estrogens|mesh-ancestor
92748761|NCT02860897|Hormones|hormones|mesh-ancestor
92748762|NCT02860897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748763|NCT02860897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748764|NCT02860819|Carboplatin|carboplatin|mesh-list
92748765|NCT02860819|Gemcitabine|gemcitabine|mesh-list
92748766|NCT02860819|Veliparib|veliparib|mesh-list
92748767|NCT02860819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748768|NCT02860819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92748769|NCT02860819|Antimetabolites|antimetabolites|mesh-ancestor
92748770|NCT02860819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748771|NCT02860819|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92748772|NCT02860819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748773|NCT04284007|Dexamethasone|dexamethasone|mesh-list
92748774|NCT04284007|Dexamethasone acetate|dexamethasone acetate|mesh-list
92748775|NCT04284007|Levobupivacaine|levobupivacaine|mesh-list
92748776|NCT04284007|BB 1101|bb 1101|mesh-list
92748777|NCT04284007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748778|NCT04284007|Antiemetics|antiemetics|mesh-ancestor
92748779|NCT04284007|Autonomic Agents|autonomic agents|mesh-ancestor
92748780|NCT04284007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748781|NCT04284007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748782|NCT04284007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92748783|NCT04284007|Glucocorticoids|glucocorticoids|mesh-ancestor
92748784|NCT04284007|Hormones|hormones|mesh-ancestor
92748785|NCT04284007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748786|NCT04284007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92748787|NCT04284007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748788|NCT04284007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92748789|NCT04284007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748790|NCT04284007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748791|NCT04284007|Anesthetics, Local|anesthetics, local|mesh-ancestor
92748792|NCT04284007|Anesthetics|anesthetics|mesh-ancestor
92748793|NCT04284007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748794|NCT04284007|Sensory System Agents|sensory system agents|mesh-ancestor
92748795|NCT02965963|Dopamine|dopamine|mesh-list
92748796|NCT02965963|Metoclopramide|metoclopramide|mesh-list
92748797|NCT02965963|Antiemetics|antiemetics|mesh-ancestor
92748798|NCT02965963|Autonomic Agents|autonomic agents|mesh-ancestor
92748799|NCT02965963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748800|NCT02965963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748805|NCT02965963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748806|NCT02965963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748807|NCT02965963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92748808|NCT02965963|Sympathomimetics|sympathomimetics|mesh-ancestor
92748809|NCT02965963|Protective Agents|protective agents|mesh-ancestor
92748810|NCT01165203|Vaccines|vaccines|mesh-list
92748811|NCT01165203|Immunologic Factors|immunologic factors|mesh-ancestor
92748812|NCT01165203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748813|NCT00960661|Insulin|insulin|mesh-list
92748814|NCT00960661|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92748815|NCT00960661|Metformin|metformin|mesh-list
92614652|NCT04028986|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92614654|NCT03914612|Carboplatin|carboplatin|mesh-list
92614655|NCT03914612|Pembrolizumab|pembrolizumab|mesh-list
92614656|NCT03914612|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92748816|NCT00960661|Exenatide|exenatide|mesh-list
92748817|NCT00960661|Insulin Lispro|insulin lispro|mesh-list
92748818|NCT00960661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92748819|NCT00960661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748820|NCT00960661|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92748821|NCT00960661|Incretins|incretins|mesh-ancestor
92748822|NCT00960661|Hormones|hormones|mesh-ancestor
92748823|NCT00960661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92748824|NCT00960193|Colchicine|colchicine|mesh-list
92748825|NCT00960193|Gout Suppressants|gout suppressants|mesh-ancestor
92748826|NCT00960193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748827|NCT00960193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92748828|NCT00960193|Antimitotic Agents|antimitotic agents|mesh-ancestor
92748829|NCT00960193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92748830|NCT00960193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748831|NCT00960193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748832|NCT00960115|Cyclophosphamide|cyclophosphamide|mesh-list
92748833|NCT00960115|Immunologic Factors|immunologic factors|mesh-ancestor
92748834|NCT00960115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748835|NCT00960115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748836|NCT00960115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748837|NCT00960115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92748838|NCT00960115|Alkylating Agents|alkylating agents|mesh-ancestor
92748839|NCT00960115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748840|NCT00960115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748841|NCT00960115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92748842|NCT00959647|Bevacizumab|bevacizumab|mesh-list
92748843|NCT00959647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748844|NCT00959647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748845|NCT00959647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92748846|NCT00959647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92748847|NCT00959647|Growth Substances|growth substances|mesh-ancestor
92748848|NCT00959647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748849|NCT00959647|Growth Inhibitors|growth inhibitors|mesh-ancestor
92748850|NCT00957853|Cetuximab|cetuximab|mesh-list
92748851|NCT00957853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92748852|NCT00957853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748853|NCT02725567|Ivacaftor|ivacaftor|mesh-list
92748854|NCT02725567|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92748855|NCT02725567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748856|NCT02725567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748857|NCT02859571|Oxytocin|oxytocin|mesh-list
92748858|NCT02859571|Oxytocics|oxytocics|mesh-ancestor
92748859|NCT02859571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92748860|NCT02859571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748861|NCT00956839|Vitamin D|vitamin d|mesh-list
92748862|NCT00956839|Ergocalciferols|ergocalciferols|mesh-list
92748863|NCT00956839|Cholecalciferol|cholecalciferol|mesh-list
92748864|NCT00956839|Vitamins|vitamins|mesh-list
92748865|NCT00956839|Micronutrients|micronutrients|mesh-ancestor
92748866|NCT00956839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748867|NCT00956839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92748868|NCT00956839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748869|NCT00956293|Cyclosporine|cyclosporine|mesh-list
92748870|NCT00956293|Mycophenolic Acid|mycophenolic acid|mesh-list
92748871|NCT00956293|Everolimus|everolimus|mesh-list
92748872|NCT00956293|Cyclosporins|cyclosporins|mesh-list
92748873|NCT00956293|Basiliximab|basiliximab|mesh-list
92748874|NCT00956293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748876|NCT00956293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748877|NCT00956293|Immunologic Factors|immunologic factors|mesh-ancestor
92748878|NCT00956293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748879|NCT00956293|Antifungal Agents|antifungal agents|mesh-ancestor
92748880|NCT00956293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748881|NCT00956293|Dermatologic Agents|dermatologic agents|mesh-ancestor
92748882|NCT00956293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748883|NCT00956293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92748884|NCT00956293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92614657|NCT03914612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92614658|NCT03914612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614659|NCT03914612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92748885|NCT00956293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748886|NCT00956293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748887|NCT00956293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92748888|NCT00956293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92748889|NCT00956293|Antitubercular Agents|antitubercular agents|mesh-ancestor
92748890|NCT00956293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92748891|NCT04282291|Morphine|morphine|mesh-list
92748892|NCT04282291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92748893|NCT04282291|Narcotics|narcotics|mesh-ancestor
92748894|NCT04282291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748895|NCT04282291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748896|NCT04282291|Analgesics|analgesics|mesh-ancestor
92748897|NCT04282291|Sensory System Agents|sensory system agents|mesh-ancestor
92748898|NCT04282291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748899|NCT00955825|Immunomodulating Agents|immunomodulating agents|mesh-list
92748900|NCT00955825|Immunologic Factors|immunologic factors|mesh-ancestor
92748901|NCT00955825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748902|NCT02859103|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92748903|NCT02859103|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92748904|NCT02859103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92748905|NCT02859103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92748906|NCT02859103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748907|NCT02859103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748908|NCT02859103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748909|NCT02859103|Antidepressive Agents|antidepressive agents|mesh-ancestor
92748910|NCT02859103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92748911|NCT02869009|Aspirin|aspirin|mesh-list
92748912|NCT02869009|Clopidogrel|clopidogrel|mesh-list
92748913|NCT02869009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92748914|NCT02869009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92748915|NCT02869009|Analgesics|analgesics|mesh-ancestor
92748916|NCT02869009|Sensory System Agents|sensory system agents|mesh-ancestor
92748917|NCT02869009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748918|NCT02869009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748919|NCT02869009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92748920|NCT02869009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748921|NCT02869009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92748922|NCT02869009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92748923|NCT02869009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748924|NCT02869009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92748925|NCT02869009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92748926|NCT02869009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748927|NCT02869009|Antipyretics|antipyretics|mesh-ancestor
92748928|NCT02869009|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92748929|NCT02869009|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92748930|NCT02869009|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92748931|NCT02869009|Purinergic Agents|purinergic agents|mesh-ancestor
92748932|NCT02869009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92748933|NCT01164579|Methotrexate|methotrexate|mesh-list
92748934|NCT01164579|Tofacitinib|tofacitinib|mesh-list
92748935|NCT01164579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92748936|NCT01164579|Abortifacient Agents|abortifacient agents|mesh-ancestor
92748937|NCT01164579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92748938|NCT01164579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748939|NCT01164579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92748940|NCT01164579|Antimetabolites|antimetabolites|mesh-ancestor
92748941|NCT01164579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748942|NCT01164579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748943|NCT01164579|Dermatologic Agents|dermatologic agents|mesh-ancestor
92748944|NCT01164579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748945|NCT01164579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92748946|NCT01164579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748948|NCT01164579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92748949|NCT01164579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92748950|NCT01164579|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92748951|NCT01164579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748952|NCT02859259|Fostemsavir|fostemsavir|mesh-list
92614660|NCT03914612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92614661|NCT03914612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614662|NCT03914612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748953|NCT02859259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92748954|NCT02859259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92748955|NCT02859259|Antiviral Agents|antiviral agents|mesh-ancestor
92748956|NCT02859259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92748957|NCT02859259|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92748958|NCT02859259|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92748959|NCT02859259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748961|NCT02857777|Antidepressive Agents|antidepressive agents|mesh-ancestor
92748962|NCT02857777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92748963|NCT00630643|Muromonab-CD3|muromonab-cd3|mesh-list
92748964|NCT00630643|Immunologic Factors|immunologic factors|mesh-ancestor
92748965|NCT00630643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748966|NCT00630643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92748967|NCT03202849|Vitamin D|vitamin d|mesh-list
92748968|NCT03202849|Ergocalciferols|ergocalciferols|mesh-list
92748969|NCT03202849|Cholecalciferol|cholecalciferol|mesh-list
92748970|NCT03202849|Vitamins|vitamins|mesh-list
92748971|NCT03202849|Micronutrients|micronutrients|mesh-ancestor
92748972|NCT03202849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748973|NCT03202849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92748974|NCT03202849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748975|NCT04277533|Calcium|calcium|mesh-list
92748976|NCT04277533|Bilirubin|bilirubin|mesh-list
92748977|NCT04277533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92748978|NCT04277533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748979|NCT04277533|Antioxidants|antioxidants|mesh-ancestor
92748980|NCT04277533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748981|NCT04277533|Protective Agents|protective agents|mesh-ancestor
92748982|NCT02445391|Cisplatin|cisplatin|mesh-list
92748983|NCT02445391|Carboplatin|carboplatin|mesh-list
92748984|NCT02445391|Capecitabine|capecitabine|mesh-list
92748985|NCT02445391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748986|NCT02445391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92748987|NCT02445391|Antimetabolites|antimetabolites|mesh-ancestor
92748988|NCT02445391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748989|NCT01246986|Sorafenib|sorafenib|mesh-list
92748990|NCT01246986|Ramucirumab|ramucirumab|mesh-list
92748991|NCT01246986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748992|NCT01246986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748993|NCT01246986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748994|NCT01246986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748995|NCT01164501|Empagliflozin|empagliflozin|mesh-list
92748996|NCT01164501|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92748997|NCT01164501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748998|NCT01164501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92748999|NCT01164501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749000|NCT01163721|Ranolazine|ranolazine|mesh-list
92749001|NCT01163721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92749002|NCT01163721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749003|NCT01163721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749004|NCT03150511|Tesamorelin|tesamorelin|mesh-list
92749005|NCT03150511|Growth Substances|growth substances|mesh-ancestor
92749006|NCT03150511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749007|NCT00958243|Vaccines|vaccines|mesh-list
92749008|NCT00958243|Immunologic Factors|immunologic factors|mesh-ancestor
92749009|NCT00958243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749010|NCT01241760|Interferons|interferons|mesh-list
92749011|NCT01241760|Ribavirin|ribavirin|mesh-list
92749012|NCT01241760|Interferon-alpha|interferon-alpha|mesh-list
92749013|NCT01241760|Interferon alpha-2|interferon alpha-2|mesh-list
92749014|NCT01241760|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92749015|NCT01241760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749016|NCT01241760|Antiviral Agents|antiviral agents|mesh-ancestor
92749017|NCT01241760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749018|NCT01241760|Antimetabolites|antimetabolites|mesh-ancestor
92749019|NCT01241760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749020|NCT01241760|Immunologic Factors|immunologic factors|mesh-ancestor
92749021|NCT01241760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749022|NCT04280263|Caffeine|caffeine|mesh-list
92614663|NCT03914612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614664|NCT03914612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614665|NCT03900793|Sunitinib|sunitinib|mesh-list
92614666|NCT03900793|Losartan|losartan|mesh-list
92614667|NCT03900793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021655|NCT04785547|Blinatumomab|blinatumomab|mesh-list
92749042|NCT02857153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749043|NCT02857153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749044|NCT02857153|Sympathomimetics|sympathomimetics|mesh-ancestor
92749045|NCT02857153|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92749046|NCT02857153|Nasal Decongestants|nasal decongestants|mesh-ancestor
92749047|NCT02857153|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749048|NCT02857153|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92749049|NCT02857153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92749050|NCT02857153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92749051|NCT02857153|Adrenergic Agents|adrenergic agents|mesh-ancestor
92749052|NCT02857153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749053|NCT02857153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749054|NCT02857153|Protective Agents|protective agents|mesh-ancestor
92749055|NCT02857153|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92749056|NCT02857153|Vasodilator Agents|vasodilator agents|mesh-ancestor
92749057|NCT02857153|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92749058|NCT02857153|Serotonin Agents|serotonin agents|mesh-ancestor
92749059|NCT02857153|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92749060|NCT02857153|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92749061|NCT02857153|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92749062|NCT00953017|Bisacodyl|bisacodyl|mesh-list
92749063|NCT00953017|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92749064|NCT00953017|Lubiprostone|lubiprostone|mesh-list
92749065|NCT00953017|Cathartics|cathartics|mesh-ancestor
92749066|NCT00953017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749067|NCT00953017|Laxatives|laxatives|mesh-ancestor
92749068|NCT00953017|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92749069|NCT00953017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749070|NCT00953017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749071|NCT00955357|Lacosamide|lacosamide|mesh-list
92749072|NCT00955357|Anticonvulsants|anticonvulsants|mesh-ancestor
92749073|NCT00955357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92749074|NCT00955357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92749075|NCT00955357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749076|NCT00955357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749077|NCT00955279|Golimumab|golimumab|mesh-list
92749078|NCT00955279|Ustekinumab|ustekinumab|mesh-list
92749079|NCT00955279|Dermatologic Agents|dermatologic agents|mesh-ancestor
92749082|NCT00955279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749083|NCT00955279|Immunologic Factors|immunologic factors|mesh-ancestor
92749084|NCT00955279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749085|NCT02857309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92749086|NCT02857309|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92749087|NCT02857309|Mineralocorticoids|mineralocorticoids|mesh-list
92749088|NCT02857309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749089|NCT02857309|Hormone Antagonists|hormone antagonists|mesh-ancestor
92749090|NCT02857309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749091|NCT02857309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749092|NCT02857309|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92749093|NCT02857309|Diuretics|diuretics|mesh-ancestor
92749094|NCT02857309|Natriuretic Agents|natriuretic agents|mesh-ancestor
92749095|NCT02857309|Hormones|hormones|mesh-ancestor
92749096|NCT04261231|Anesthetics|anesthetics|mesh-list
92749097|NCT04261231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749098|NCT04261231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749099|NCT02857465|Dexamethasone|dexamethasone|mesh-list
92749100|NCT02857465|Dexamethasone acetate|dexamethasone acetate|mesh-list
92749101|NCT02857465|Sufentanil|sufentanil|mesh-list
92749102|NCT02857465|Dsuvia|dsuvia|mesh-list
92749103|NCT02857465|Ropivacaine|ropivacaine|mesh-list
92749104|NCT02857465|BB 1101|bb 1101|mesh-list
92749105|NCT02857465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92749106|NCT02857465|Antiemetics|antiemetics|mesh-ancestor
92749107|NCT02857465|Autonomic Agents|autonomic agents|mesh-ancestor
92614668|NCT03900793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92614669|NCT03900793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92614670|NCT03900793|Growth Substances|growth substances|mesh-ancestor
92614671|NCT03900793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614672|NCT03900793|Growth Inhibitors|growth inhibitors|mesh-ancestor
92614673|NCT03900793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614674|NCT03900793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021663|NCT03843853|Bevacizumab|bevacizumab|mesh-list
92749108|NCT02857465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749109|NCT02857465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749110|NCT02857465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749111|NCT02857465|Glucocorticoids|glucocorticoids|mesh-ancestor
92749112|NCT02857465|Hormones|hormones|mesh-ancestor
92749113|NCT02857465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749114|NCT02857465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92749115|NCT02857465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749116|NCT02857465|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749117|NCT02857465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749118|NCT02857465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749119|NCT02857465|Anesthetics, Local|anesthetics, local|mesh-ancestor
92749120|NCT02857465|Anesthetics|anesthetics|mesh-ancestor
92749121|NCT02857465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749122|NCT02857465|Sensory System Agents|sensory system agents|mesh-ancestor
92749123|NCT02857465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92749124|NCT02857465|Narcotics|narcotics|mesh-ancestor
92749125|NCT02857465|Analgesics|analgesics|mesh-ancestor
92749126|NCT02857465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92749127|NCT02857465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92749128|NCT02857465|Anesthetics, General|anesthetics, general|mesh-ancestor
92749129|NCT04260139|Metronidazole|metronidazole|mesh-list
92749130|NCT04260139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749131|NCT04260139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92749132|NCT04260139|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92749133|NCT04260139|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92749134|NCT04206618|Denosumab|denosumab|mesh-list
92749135|NCT04206618|Teriparatide|teriparatide|mesh-list
92749136|NCT04206618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92749137|NCT04206618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749138|NCT04206618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92749139|NCT01239732|Paclitaxel|paclitaxel|mesh-list
92749140|NCT01239732|Bevacizumab|bevacizumab|mesh-list
92749141|NCT01239732|Carboplatin|carboplatin|mesh-list
92749142|NCT01239732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92749143|NCT01239732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749144|NCT01239732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92749145|NCT01239732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92749146|NCT01239732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92749147|NCT01239732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749148|NCT01239732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749149|NCT01239732|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92749150|NCT01239732|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92749151|NCT01239732|Growth Substances|growth substances|mesh-ancestor
92749152|NCT01239732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749153|NCT01239732|Growth Inhibitors|growth inhibitors|mesh-ancestor
92749156|NCT02856919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92749157|NCT02856919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92749159|NCT02856919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92749160|NCT02856919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749161|NCT02856919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749162|NCT02856919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749163|NCT00947011|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92749164|NCT00947011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749165|NCT00947011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749166|NCT00947011|Incretins|incretins|mesh-ancestor
92749167|NCT00947011|Hormones|hormones|mesh-ancestor
92749168|NCT00947011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614675|NCT03900793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614676|NCT03900793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92614677|NCT03900793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021666|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749169|NCT00947011|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92749170|NCT00947011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749171|NCT00947011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749172|NCT00947011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749173|NCT02856685|Mitoxantrone|mitoxantrone|mesh-list
92749174|NCT02856685|Analgesics|analgesics|mesh-ancestor
92749175|NCT02856685|Sensory System Agents|sensory system agents|mesh-ancestor
92749176|NCT02856685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151872|NCT01360866|Serotonin Agents|serotonin agents|mesh-ancestor
92749177|NCT02856685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749178|NCT02856685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749179|NCT02856685|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92749180|NCT02856685|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92749181|NCT02856685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749182|NCT02856685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749183|NCT01962415|Fludarabine|fludarabine|mesh-list
92749185|NCT01962415|Alemtuzumab|alemtuzumab|mesh-list
92749186|NCT01962415|Thiotepa|thiotepa|mesh-list
92749187|NCT01962415|Hydroxyurea|hydroxyurea|mesh-list
92749188|NCT01962415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749189|NCT01962415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749190|NCT01962415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749191|NCT01962415|Immunologic Factors|immunologic factors|mesh-ancestor
92749192|NCT01962415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749193|NCT01962415|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92749194|NCT01962415|Alkylating Agents|alkylating agents|mesh-ancestor
92749195|NCT01962415|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92749196|NCT01962415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749197|NCT01962415|Antisickling Agents|antisickling agents|mesh-ancestor
92749198|NCT01962415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749199|NCT01962415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92749200|NCT02860663|Vitamin D|vitamin d|mesh-list
92749201|NCT02860663|Ergocalciferols|ergocalciferols|mesh-list
92749202|NCT02860663|Cholecalciferol|cholecalciferol|mesh-list
92749203|NCT02860663|Vitamins|vitamins|mesh-list
92749204|NCT02860663|Micronutrients|micronutrients|mesh-ancestor
92749205|NCT02860663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749206|NCT02860663|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92749207|NCT02860663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92749208|NCT02854345|Parathyroid Hormone|parathyroid hormone|mesh-list
92749209|NCT02854345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92749210|NCT02854345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749211|NCT01239342|Everolimus|everolimus|mesh-list
92749212|NCT01239342|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92749213|NCT01239342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92749214|NCT01239342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749215|NCT01239342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749216|NCT01239342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749217|NCT01239342|Immunologic Factors|immunologic factors|mesh-ancestor
92749218|NCT01239342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749219|NCT01239342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749221|NCT00946309|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92749222|NCT00946309|Protective Agents|protective agents|mesh-ancestor
92749223|NCT00946309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749224|NCT00946309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749225|NCT02853799|Insulin|insulin|mesh-list
92749227|NCT02853799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749228|NCT01236534|Lubiprostone|lubiprostone|mesh-list
92749229|NCT01236534|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92749230|NCT01236534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749231|NCT01236534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749232|NCT01235598|Certolizumab Pegol|certolizumab pegol|mesh-list
92749233|NCT01235598|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92749234|NCT01235598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614678|NCT03900793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92614679|NCT03900793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92614680|NCT03897881|Pembrolizumab|pembrolizumab|mesh-list
92749235|NCT01235598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749236|NCT01235598|Immunologic Factors|immunologic factors|mesh-ancestor
92749237|NCT01235598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749238|NCT01235598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749239|NCT01235442|Etanercept|etanercept|mesh-list
92749240|NCT01235442|Clobetasol|clobetasol|mesh-list
92749241|NCT01235442|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92749242|NCT01235442|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92749243|NCT01235442|Analgesics|analgesics|mesh-ancestor
92749244|NCT01235442|Sensory System Agents|sensory system agents|mesh-ancestor
92749245|NCT01235442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749246|NCT01235442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749247|NCT01235442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92749248|NCT01235442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749249|NCT01235442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749250|NCT01235442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749251|NCT01235442|Immunologic Factors|immunologic factors|mesh-ancestor
92749252|NCT01235442|Glucocorticoids|glucocorticoids|mesh-ancestor
92749253|NCT01235442|Hormones|hormones|mesh-ancestor
92749254|NCT01235442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749255|NCT01163253|Tofacitinib|tofacitinib|mesh-list
92749256|NCT01163253|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92749257|NCT01163253|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92749258|NCT01163253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749259|NCT01163253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749260|NCT01162863|Lubiprostone|lubiprostone|mesh-list
92749261|NCT01162863|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92749262|NCT01162863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749263|NCT01162863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749264|NCT05304039|Nitric Oxide|nitric oxide|mesh-list
92749265|NCT05304039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92749266|NCT05304039|Autonomic Agents|autonomic agents|mesh-ancestor
92749267|NCT05304039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749268|NCT05304039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749269|NCT05304039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92749270|NCT05304039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749271|NCT05304039|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92749272|NCT05304039|Antioxidants|antioxidants|mesh-ancestor
92749273|NCT05304039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749274|NCT05304039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749275|NCT05304039|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92749276|NCT05304039|Vasodilator Agents|vasodilator agents|mesh-ancestor
92749277|NCT05304039|Gasotransmitters|gasotransmitters|mesh-ancestor
92749278|NCT05304039|Protective Agents|protective agents|mesh-ancestor
92749279|NCT01162473|Caseins|caseins|mesh-list
92749280|NCT01162473|Chelating Agents|chelating agents|mesh-ancestor
92749281|NCT01162473|Sequestering Agents|sequestering agents|mesh-ancestor
92749282|NCT01162473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749283|NCT01162239|Varenicline|varenicline|mesh-list
92749284|NCT01162239|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92749285|NCT01162239|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92749286|NCT01162239|Cholinergic Agents|cholinergic agents|mesh-ancestor
92749287|NCT01162239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749288|NCT01162239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749289|NCT01162239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749290|NCT01161537|Ivacaftor|ivacaftor|mesh-list
92749291|NCT01161537|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92749292|NCT01161537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749293|NCT01161537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749294|NCT04314297|Durvalumab|durvalumab|mesh-list
92749295|NCT04314297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749296|NCT04314297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749297|NCT04124133|Hyaluronic Acid|hyaluronic acid|mesh-list
92749298|NCT04124133|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92749304|NCT01233258|Coagulants|coagulants|mesh-ancestor
92749305|NCT01232790|Acetylcysteine|acetylcysteine|mesh-list
92749306|NCT01232790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92749307|NCT01232790|Antiviral Agents|antiviral agents|mesh-ancestor
92614681|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614682|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614683|NCT03897881|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614684|NCT03897881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614685|NCT03896880|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92614686|NCT03896880|Clotrimazole|clotrimazole|mesh-list
92614687|NCT03896880|Miconazole|miconazole|mesh-list
92749308|NCT01232790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749309|NCT01232790|Expectorants|expectorants|mesh-ancestor
92749310|NCT01232790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749311|NCT01232790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92749312|NCT01232790|Antioxidants|antioxidants|mesh-ancestor
92749313|NCT01232790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749314|NCT01232790|Protective Agents|protective agents|mesh-ancestor
92399223|NCT01402336|Cetrorelix|cetrorelix|mesh-list
92749315|NCT01232790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749316|NCT01232790|Antidotes|antidotes|mesh-ancestor
92749317|NCT01232556|Rituximab|rituximab|mesh-list
92749318|NCT01232556|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92749319|NCT01232556|Gemcitabine|gemcitabine|mesh-list
92749320|NCT01232556|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92749321|NCT01232556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749322|NCT01232556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749323|NCT01232556|Immunologic Factors|immunologic factors|mesh-ancestor
92749324|NCT01232556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749325|NCT01232556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749326|NCT01232556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92749327|NCT01232556|Antimetabolites|antimetabolites|mesh-ancestor
92749328|NCT01232556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749329|NCT01232556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92749330|NCT01232556|Alkylating Agents|alkylating agents|mesh-ancestor
92749331|NCT01232556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92749332|NCT01232556|Immunotoxins|immunotoxins|mesh-ancestor
92749333|NCT01232556|Immunoconjugates|immunoconjugates|mesh-ancestor
92749334|NCT00946153|Lenvatinib|lenvatinib|mesh-list
92749335|NCT00946153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749336|NCT00946153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92749337|NCT00946153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749338|NCT00946153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749339|NCT01914367|Vaccines|vaccines|mesh-list
92749340|NCT01914367|Immunologic Factors|immunologic factors|mesh-ancestor
92749341|NCT01914367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749342|NCT01160289|Tadalafil|tadalafil|mesh-list
92749343|NCT01160289|Vasodilator Agents|vasodilator agents|mesh-ancestor
92749344|NCT01160289|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92749345|NCT01160289|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92749346|NCT01160289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749347|NCT01160289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749348|NCT01160289|Urological Agents|urological agents|mesh-ancestor
92749349|NCT01159665|Plasminogen|plasminogen|mesh-list
92749350|NCT01159665|Fibrinolysin|fibrinolysin|mesh-list
92749351|NCT01159665|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92749352|NCT01159665|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92749353|NCT01159665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749354|NCT01158261|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92749355|NCT01158261|Hemostatics|hemostatics|mesh-ancestor
92749356|NCT01158261|Coagulants|coagulants|mesh-ancestor
92749357|NCT01157169|Buprenorphine|buprenorphine|mesh-list
92749358|NCT01157169|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92749359|NCT01157169|Narcotics|narcotics|mesh-ancestor
92749360|NCT01157169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749361|NCT01157169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749362|NCT01157169|Analgesics|analgesics|mesh-ancestor
92749363|NCT01157169|Sensory System Agents|sensory system agents|mesh-ancestor
92749364|NCT01157169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749365|NCT01157169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92749366|NCT04313907|Clonazepam|clonazepam|mesh-list
92749367|NCT04313907|Anticonvulsants|anticonvulsants|mesh-ancestor
92749368|NCT04313907|GABA Modulators|gaba modulators|mesh-ancestor
92749369|NCT04313907|GABA Agents|gaba agents|mesh-ancestor
92614688|NCT03896880|Antifungal Agents|antifungal agents|mesh-list
92614689|NCT03896880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614690|NCT03896880|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92614691|NCT03896880|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92749370|NCT04313907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749371|NCT04313907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749375|NCT01231620|Antiviral Agents|antiviral agents|mesh-ancestor
92749376|NCT01231620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749377|NCT01231620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749378|NCT01231620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749379|NCT01231464|Fluticasone|fluticasone|mesh-list
92749381|NCT01231464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92749382|NCT01231464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92749383|NCT01231464|Autonomic Agents|autonomic agents|mesh-ancestor
92749384|NCT01231464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749385|NCT01231464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749386|NCT01231464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92749387|NCT01231464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749388|NCT01231464|Dermatologic Agents|dermatologic agents|mesh-ancestor
92749389|NCT01231464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92749390|NCT01156311|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92749391|NCT01156311|Dermatologic Agents|dermatologic agents|mesh-ancestor
92749392|NCT01156311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749393|NCT01156311|Immunologic Factors|immunologic factors|mesh-ancestor
92749394|NCT01156311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749395|NCT04281745|Botulinum Toxins|botulinum toxins|mesh-list
92749396|NCT04281745|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92749397|NCT04281745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92749398|NCT04281745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92749399|NCT04281745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749400|NCT04281745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749401|NCT04281745|Cholinergic Agents|cholinergic agents|mesh-ancestor
92749402|NCT04281745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749403|NCT04281745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749404|NCT04281745|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92749405|NCT04281745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749406|NCT01155531|Sertraline|sertraline|mesh-list
92749407|NCT01155531|Telenzepine|telenzepine|mesh-list
92749408|NCT01155531|Antidepressive Agents|antidepressive agents|mesh-ancestor
92749409|NCT01155531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92749410|NCT01155531|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92749411|NCT01155531|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92749412|NCT01155531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749413|NCT01155531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749414|NCT01155531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749415|NCT01155531|Serotonin Agents|serotonin agents|mesh-ancestor
92749416|NCT01155531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749417|NCT01155531|Parasympatholytics|parasympatholytics|mesh-ancestor
92749418|NCT01155531|Autonomic Agents|autonomic agents|mesh-ancestor
92749419|NCT01155531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749420|NCT01155219|Latanoprost|latanoprost|mesh-list
92749421|NCT01155219|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92749422|NCT01155219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92749423|NCT01098955|Varenicline|varenicline|mesh-list
92749424|NCT01098955|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92749425|NCT01098955|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92749426|NCT01098955|Cholinergic Agents|cholinergic agents|mesh-ancestor
92749427|NCT01098955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749428|NCT01098955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749429|NCT01098955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749430|NCT00631033|Metformin|metformin|mesh-list
92749431|NCT00631033|Diazoxide|diazoxide|mesh-list
92749432|NCT00631033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749433|NCT00631033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749434|NCT00631033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92749435|NCT00631033|Vasodilator Agents|vasodilator agents|mesh-ancestor
92749436|NCT01155063|Exemestane|exemestane|mesh-list
92749437|NCT01155063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749438|NCT01155063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92749439|NCT01155063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92614692|NCT03896880|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92614693|NCT03896880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614694|NCT03896880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021683|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
92749440|NCT01155063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749441|NCT01155063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749442|NCT01155063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92749443|NCT01155063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92749444|NCT01155063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749448|NCT01154673|Tenofovir|tenofovir|mesh-list
92749449|NCT01154673|Emtricitabine|emtricitabine|mesh-list
92749450|NCT01154673|Raltegravir Potassium|raltegravir potassium|mesh-list
92749451|NCT01154673|Maraviroc|maraviroc|mesh-list
92749452|NCT01154673|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92749453|NCT01154673|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92749454|NCT01154673|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749455|NCT01154673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749456|NCT01154673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749457|NCT01154673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92749458|NCT01154673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92749459|NCT01154673|Antiviral Agents|antiviral agents|mesh-ancestor
92749460|NCT01154673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749461|NCT01154673|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92749462|NCT01154673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749463|NCT01154673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92749464|NCT01154673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92749465|NCT01154673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92749466|NCT01154673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92749467|NCT01154673|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92749468|NCT01154673|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92749469|NCT01154673|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92749470|NCT02884713|Doxycycline|doxycycline|mesh-list
92749471|NCT02884713|Levofloxacin|levofloxacin|mesh-list
92749472|NCT02884713|Esomeprazole|esomeprazole|mesh-list
92749473|NCT02884713|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92749474|NCT02884713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749475|NCT02884713|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92749476|NCT02884713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749477|NCT02884713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749478|NCT02884713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92749479|NCT02884713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749480|NCT02884713|Antimalarials|antimalarials|mesh-ancestor
92749481|NCT02884713|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92749482|NCT02884713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92749483|NCT02884713|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92749484|NCT02884713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92749485|NCT02884713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92749486|NCT02884713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749487|NCT02884713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92749488|NCT02884713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749489|NCT01154127|Glycopyrrolate|glycopyrrolate|mesh-list
92749490|NCT01154127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92749491|NCT01154127|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92749492|NCT01154127|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92749493|NCT01154127|Cholinergic Agents|cholinergic agents|mesh-ancestor
92749494|NCT01154127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749495|NCT01154127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749496|NCT01154127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749497|NCT01228734|Leucovorin|leucovorin|mesh-list
92749498|NCT01228734|Folic Acid|folic acid|mesh-list
92749499|NCT01228734|Fluorouracil|fluorouracil|mesh-list
92749500|NCT01228734|Oxaliplatin|oxaliplatin|mesh-list
92749501|NCT01228734|Cetuximab|cetuximab|mesh-list
92749502|NCT01228734|Levoleucovorin|levoleucovorin|mesh-list
92749503|NCT01228734|Antimetabolites|antimetabolites|mesh-ancestor
92749504|NCT01228734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749505|NCT01228734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92749506|NCT01228734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749507|NCT01228734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92614695|NCT03896880|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92021688|NCT03497689|Treprostinil|treprostinil|mesh-list
92749508|NCT01228734|Immunologic Factors|immunologic factors|mesh-ancestor
92749509|NCT01228734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749510|NCT01228734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749511|NCT01228734|Antidotes|antidotes|mesh-ancestor
92749512|NCT01228734|Protective Agents|protective agents|mesh-ancestor
92749513|NCT01228734|Vitamin B Complex|vitamin b complex|mesh-ancestor
92749514|NCT01228734|Vitamins|vitamins|mesh-ancestor
92749515|NCT01228734|Micronutrients|micronutrients|mesh-ancestor
92749516|NCT01228734|Hematinics|hematinics|mesh-ancestor
92749517|NCT01153971|Rituximab|rituximab|mesh-list
92749518|NCT01153971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749519|NCT01153971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749523|NCT01153893|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92749524|NCT01153893|Immunologic Factors|immunologic factors|mesh-ancestor
92749525|NCT01153893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749526|NCT00951379|Pioglitazone|pioglitazone|mesh-list
92749527|NCT00951379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749528|NCT00951379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749529|NCT01153815|Botulinum Toxins|botulinum toxins|mesh-list
92749530|NCT01153815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92749531|NCT01153815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92749532|NCT01153815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92749533|NCT01153815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749534|NCT01153815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749535|NCT01153815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92749536|NCT01153815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749537|NCT01153815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749538|NCT01153815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92749539|NCT01153815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749540|NCT01153425|Zoledronic Acid|zoledronic acid|mesh-list
92749541|NCT01153425|Teriparatide|teriparatide|mesh-list
92749542|NCT01153425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92749543|NCT01153425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749544|NCT01153425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92749545|NCT01153269|Ritonavir|ritonavir|mesh-list
92749546|NCT01153269|Lopinavir|lopinavir|mesh-list
92749547|NCT01153269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92749548|NCT01153269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92749549|NCT01153269|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749550|NCT01153269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749551|NCT01153269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749552|NCT01153269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92749553|NCT01153269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92749554|NCT01153269|Antiviral Agents|antiviral agents|mesh-ancestor
92749555|NCT01153269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749556|NCT01153269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92749557|NCT01153269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749558|NCT02884635|Methotrexate|methotrexate|mesh-list
92749559|NCT02884635|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92749560|NCT02884635|Abortifacient Agents|abortifacient agents|mesh-ancestor
92749561|NCT02884635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92749562|NCT02884635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749563|NCT02884635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92749564|NCT02884635|Antimetabolites|antimetabolites|mesh-ancestor
92749565|NCT02884635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749566|NCT02884635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749567|NCT02884635|Dermatologic Agents|dermatologic agents|mesh-ancestor
92749568|NCT02884635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749569|NCT02884635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92749570|NCT02884635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749571|NCT02884635|Immunologic Factors|immunologic factors|mesh-ancestor
92749572|NCT02884635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749573|NCT02884635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92749574|NCT02884479|Docetaxel|docetaxel|mesh-list
92749575|NCT02884479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749576|NCT02884479|Tubulin Modulators|tubulin modulators|mesh-ancestor
92749577|NCT02884479|Antimitotic Agents|antimitotic agents|mesh-ancestor
92749578|NCT02884479|Mitosis Modulators|mitosis modulators|mesh-ancestor
92749579|NCT02884479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749580|NCT01152021|Dexmedetomidine|dexmedetomidine|mesh-list
92614696|NCT03896880|Hormone Antagonists|hormone antagonists|mesh-ancestor
92614697|NCT03896880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749581|NCT01152021|Propofol|propofol|mesh-list
92749582|NCT01152021|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92749583|NCT01152021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749584|NCT01152021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749585|NCT01152021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92749586|NCT01152021|Analgesics|analgesics|mesh-ancestor
92749587|NCT01152021|Sensory System Agents|sensory system agents|mesh-ancestor
92749588|NCT01152021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749589|NCT01152021|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92749590|NCT01152021|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92749596|NCT01152021|Anesthetics, General|anesthetics, general|mesh-ancestor
92749597|NCT01152021|Anesthetics|anesthetics|mesh-ancestor
92749598|NCT01151085|Voriconazole|voriconazole|mesh-list
92749599|NCT01151085|Antifungal Agents|antifungal agents|mesh-ancestor
92749600|NCT01151085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749601|NCT01151085|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92749602|NCT01151085|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749603|NCT01151085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749604|NCT01151085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749605|NCT01151085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92749606|NCT01151085|Hormone Antagonists|hormone antagonists|mesh-ancestor
92749607|NCT01151085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399230|NCT01402336|Contraceptive Agents|contraceptive agents|mesh-ancestor
92749608|NCT01151085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749609|NCT01151085|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92749610|NCT01149369|Aprepitant|aprepitant|mesh-list
92749611|NCT01149369|Antiemetics|antiemetics|mesh-ancestor
92749612|NCT01149369|Autonomic Agents|autonomic agents|mesh-ancestor
92749613|NCT01149369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749614|NCT01149369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749615|NCT01149369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749616|NCT01149369|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92749617|NCT01149369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749618|NCT01149369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749619|NCT01740427|Letrozole|letrozole|mesh-list
92749620|NCT01740427|Palbociclib|palbociclib|mesh-list
92749621|NCT01740427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749622|NCT01740427|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92749623|NCT01740427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92749624|NCT01740427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749625|NCT01740427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749626|NCT01740427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92749627|NCT01740427|Hormone Antagonists|hormone antagonists|mesh-ancestor
92749628|NCT01740427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749629|NCT01740427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749630|NCT01740427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92749631|NCT00879931|Methylprednisolone|methylprednisolone|mesh-list
92749632|NCT00879931|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92749633|NCT00879931|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92749634|NCT00879931|Prednisolone|prednisolone|mesh-list
92749635|NCT00879931|Prednisolone acetate|prednisolone acetate|mesh-list
92749636|NCT00879931|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92749637|NCT00879931|Prednisolone phosphate|prednisolone phosphate|mesh-list
92749638|NCT00879931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92749639|NCT00879931|Antiemetics|antiemetics|mesh-ancestor
92749640|NCT00879931|Autonomic Agents|autonomic agents|mesh-ancestor
92749641|NCT00879931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749642|NCT00879931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749643|NCT00879931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749644|NCT00879931|Glucocorticoids|glucocorticoids|mesh-ancestor
92749645|NCT00879931|Hormones|hormones|mesh-ancestor
92749646|NCT00879931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749647|NCT00879931|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92749648|NCT00879931|Protective Agents|protective agents|mesh-ancestor
92749649|NCT00879931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92749650|NCT00879931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749651|NCT01737619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92749652|NCT01227564|Saponin QA-21V1|saponin qa-21v1|mesh-list
92614698|NCT03896880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614699|NCT03896880|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92614700|NCT03896880|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92614701|NCT03854019|Quinidine|quinidine|mesh-list
92749653|NCT01227564|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92749654|NCT01227564|Immunologic Factors|immunologic factors|mesh-ancestor
92749655|NCT01227564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749656|NCT00739141|Cyclophosphamide|cyclophosphamide|mesh-list
92749657|NCT00739141|Thiotepa|thiotepa|mesh-list
92749658|NCT00739141|Fludarabine|fludarabine|mesh-list
92749659|NCT00739141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749661|NCT00739141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749662|NCT00739141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749663|NCT00739141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92749664|NCT00739141|Alkylating Agents|alkylating agents|mesh-ancestor
92749665|NCT00739141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749666|NCT00739141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749667|NCT00739141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92749668|NCT01148979|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92749669|NCT01148979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92749670|NCT01148979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749671|NCT01148979|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92749672|NCT01148979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92749673|NCT01148979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749674|NCT01148979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749675|NCT01148979|Dopamine Agents|dopamine agents|mesh-ancestor
92749676|NCT01148979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749677|NCT01735825|Paclitaxel|paclitaxel|mesh-list
92749678|NCT01735825|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92749679|NCT01735825|Everolimus|everolimus|mesh-list
92749680|NCT01735825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92749681|NCT01735825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749682|NCT01735825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92749683|NCT01735825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92749684|NCT01735825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92749685|NCT01735825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749686|NCT01735825|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92749687|NCT01735825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92749688|NCT01735825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749689|NCT01735825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749690|NCT01735825|Immunologic Factors|immunologic factors|mesh-ancestor
92749691|NCT01735825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749692|NCT01148511|Ranibizumab|ranibizumab|mesh-list
92749693|NCT01148511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92749694|NCT01148511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92749695|NCT01148511|Growth Substances|growth substances|mesh-ancestor
92749696|NCT01148511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749697|NCT01148511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92749698|NCT01148511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749699|NCT02860117|Ketamine|ketamine|mesh-list
92749700|NCT02860117|Analgesics|analgesics|mesh-ancestor
92749701|NCT02860117|Sensory System Agents|sensory system agents|mesh-ancestor
92749702|NCT02860117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749703|NCT02860117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749704|NCT02860117|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92749705|NCT02860117|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92749706|NCT02860117|Anesthetics, General|anesthetics, general|mesh-ancestor
92749707|NCT02860117|Anesthetics|anesthetics|mesh-ancestor
92749708|NCT02860117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749709|NCT02860117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92749710|NCT02860117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92749711|NCT02860117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749712|NCT02860117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749713|NCT02853253|SMOFlipid|smoflipid|mesh-list
92749714|NCT02853253|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92749715|NCT02853253|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92749716|NCT02853253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92749717|NCT04269187|Theophylline|theophylline|mesh-list
92749718|NCT04269187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92614702|NCT03854019|Dextromethorphan|dextromethorphan|mesh-list
92614703|NCT03854019|Antitussive Agents|antitussive agents|mesh-ancestor
92614704|NCT03854019|Respiratory System Agents|respiratory system agents|mesh-ancestor
92614705|NCT03854019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92339759|NCT00002387|Efavirenz|efavirenz|mesh-list
92614707|NCT03854019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614708|NCT03854019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749719|NCT04269187|Autonomic Agents|autonomic agents|mesh-ancestor
92749720|NCT04269187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749721|NCT04269187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749722|NCT04269187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92749723|NCT04269187|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749724|NCT04269187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92749725|NCT04269187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749726|NCT04269187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749727|NCT04269187|Vasodilator Agents|vasodilator agents|mesh-ancestor
92749728|NCT04269187|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92749729|NCT04269187|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92749730|NCT04269187|Purinergic Agents|purinergic agents|mesh-ancestor
92749731|NCT04269187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749732|NCT04269109|Analgesics, Opioid|analgesics, opioid|mesh-list
92749733|NCT04269109|Narcotics|narcotics|mesh-ancestor
92749734|NCT04269109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749735|NCT04269109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749736|NCT04269109|Analgesics|analgesics|mesh-ancestor
92749737|NCT04269109|Sensory System Agents|sensory system agents|mesh-ancestor
92749738|NCT04269109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749739|NCT01226472|Mogamulizumab|mogamulizumab|mesh-list
92749740|NCT01226472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749742|NCT04268563|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92749743|NCT04268563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749744|NCT04268563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749745|NCT04268563|Incretins|incretins|mesh-ancestor
92749746|NCT04268563|Hormones|hormones|mesh-ancestor
92749747|NCT04268563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749748|NCT04268563|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92749749|NCT04268563|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749750|NCT04268563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749751|NCT04268563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749752|NCT01225146|Ranibizumab|ranibizumab|mesh-list
92749753|NCT01225146|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92749754|NCT01225146|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92749755|NCT01225146|Growth Substances|growth substances|mesh-ancestor
92749756|NCT01225146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749757|NCT01225146|Growth Inhibitors|growth inhibitors|mesh-ancestor
92749758|NCT01225146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749759|NCT01223196|Pioglitazone|pioglitazone|mesh-list
92749760|NCT01223196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749761|NCT01223196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749762|NCT01222416|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92749763|NCT01222416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749764|NCT00950911|Denosumab|denosumab|mesh-list
92749765|NCT00950911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92749766|NCT00950911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749767|NCT02855515|Anesthetics|anesthetics|mesh-list
92749768|NCT02855515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92749769|NCT02855515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749770|NCT04206228|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92749771|NCT04206228|Hematinics|hematinics|mesh-ancestor
92749772|NCT01218594|Endostatins|endostatins|mesh-list
92749773|NCT01218594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92749774|NCT01218594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92749775|NCT01218594|Growth Substances|growth substances|mesh-ancestor
92021701|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92614709|NCT03854019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614710|NCT03854019|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92614711|NCT03854019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92614712|NCT03854019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92614713|NCT03854019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92614714|NCT03854019|Antimalarials|antimalarials|mesh-ancestor
92614715|NCT03854019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92749776|NCT01218594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749777|NCT01218594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92749778|NCT01218594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749779|NCT01610557|Bevacizumab|bevacizumab|mesh-list
92749780|NCT01610557|Ranibizumab|ranibizumab|mesh-list
92749781|NCT01610557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749782|NCT01610557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749783|NCT01610557|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92749784|NCT01610557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92749785|NCT01610557|Growth Substances|growth substances|mesh-ancestor
92749786|NCT01610557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749787|NCT01610557|Growth Inhibitors|growth inhibitors|mesh-ancestor
92749788|NCT00943735|Fesoterodine|fesoterodine|mesh-list
92749789|NCT00943735|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92749790|NCT00943735|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92749791|NCT00943735|Cholinergic Agents|cholinergic agents|mesh-ancestor
92749792|NCT00943735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749793|NCT00943735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749794|NCT00943735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749795|NCT00943735|Urological Agents|urological agents|mesh-ancestor
92749796|NCT00943111|Eliglustat|eliglustat|mesh-list
92749797|NCT00943111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749802|NCT01147497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92749803|NCT01147497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749804|NCT01147497|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92749805|NCT01147497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749806|NCT01147497|Oxytocics|oxytocics|mesh-ancestor
92749807|NCT01147341|Certolizumab Pegol|certolizumab pegol|mesh-list
92749808|NCT01147341|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92749809|NCT01147341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92749810|NCT01147341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92749811|NCT01147341|Immunologic Factors|immunologic factors|mesh-ancestor
92749812|NCT01147341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749813|NCT01147341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749814|NCT00950755|Tositumomab I-131|tositumomab i-131|mesh-list
92749815|NCT00950755|Antibodies|antibodies|mesh-list
92749816|NCT00950755|Immunologic Factors|immunologic factors|mesh-ancestor
92749817|NCT00950755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749818|NCT00950755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749819|NCT01147107|Efavirenz|efavirenz|mesh-list
92749820|NCT01147107|Raltegravir Potassium|raltegravir potassium|mesh-list
92749821|NCT01147107|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92749822|NCT01147107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92749823|NCT01147107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749824|NCT01147107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749825|NCT01147107|Antiviral Agents|antiviral agents|mesh-ancestor
92749826|NCT01147107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749827|NCT01147107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92749828|NCT01147107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749829|NCT01147107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92749830|NCT01147107|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92749831|NCT01147107|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92749832|NCT01147107|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92749833|NCT01147107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92749834|NCT01147107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92749835|NCT01147107|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92749836|NCT01147107|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92749837|NCT01146951|Rufinamide|rufinamide|mesh-list
92749838|NCT01146951|Anticonvulsants|anticonvulsants|mesh-ancestor
92614716|NCT03854019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92614717|NCT03854019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614718|NCT03854019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614719|NCT03854019|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92614720|NCT03854019|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92614721|NCT03854019|Cholinergic Agents|cholinergic agents|mesh-ancestor
92614722|NCT03854019|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92614723|NCT03854019|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92749839|NCT01146951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92749840|NCT01146951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92749841|NCT01146951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92749842|NCT01146951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749843|NCT01146873|Ritonavir|ritonavir|mesh-list
92749844|NCT01146873|Lopinavir|lopinavir|mesh-list
92749845|NCT01146873|Abacavir|abacavir|mesh-list
92749846|NCT01146873|Stavudine|stavudine|mesh-list
92749847|NCT01146873|Efavirenz|efavirenz|mesh-list
92749848|NCT01146873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92749849|NCT01146873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92749850|NCT01146873|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749851|NCT01146873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749852|NCT01146873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749853|NCT01146873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92749854|NCT01146873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92749855|NCT01146873|Antiviral Agents|antiviral agents|mesh-ancestor
92749856|NCT01146873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749857|NCT01146873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92749858|NCT01146873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749859|NCT01146873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92749860|NCT01146873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92749861|NCT01146873|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92749862|NCT01146873|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92749863|NCT01146873|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92749864|NCT01146873|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92749865|NCT01146873|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92749866|NCT01146873|Antimetabolites|antimetabolites|mesh-ancestor
92749875|NCT01146795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749876|NCT01146795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749877|NCT01146795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92749878|NCT01146795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92749879|NCT01146795|Growth Substances|growth substances|mesh-ancestor
92749880|NCT01146795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749881|NCT01146795|Growth Inhibitors|growth inhibitors|mesh-ancestor
92749883|NCT01146561|Analgesics|analgesics|mesh-ancestor
92749884|NCT01146561|Sensory System Agents|sensory system agents|mesh-ancestor
92749885|NCT01146561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749886|NCT01146561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749887|NCT00942175|Esomeprazole|esomeprazole|mesh-list
92749888|NCT00942175|Omeprazole|omeprazole|mesh-list
92749889|NCT00942175|Lansoprazole|lansoprazole|mesh-list
92749890|NCT00942175|Dexlansoprazole|dexlansoprazole|mesh-list
92749891|NCT00942175|Clopidogrel|clopidogrel|mesh-list
92749892|NCT00942175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92749893|NCT00942175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92749894|NCT00942175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92749895|NCT00942175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92749896|NCT00942175|Purinergic Agents|purinergic agents|mesh-ancestor
92749897|NCT00942175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749898|NCT00942175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749899|NCT00942175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749900|NCT00942175|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92749901|NCT00942175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92749902|NCT00942175|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92749903|NCT00942175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749904|NCT01145625|Minoxidil|minoxidil|mesh-list
92614724|NCT03854019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92614725|NCT03854019|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92614726|NCT03854019|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92614728|NCT03815019|Megestrol Acetate|megestrol acetate|mesh-list
92749905|NCT01145625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92749906|NCT01145625|Vasodilator Agents|vasodilator agents|mesh-ancestor
92749907|NCT02855203|Pembrolizumab|pembrolizumab|mesh-list
92749908|NCT02855203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749909|NCT02855203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749910|NCT02855203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92749911|NCT02855203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749912|NCT02852083|Pioglitazone|pioglitazone|mesh-list
92749913|NCT02852083|Clarithromycin|clarithromycin|mesh-list
92749914|NCT02852083|Nivolumab|nivolumab|mesh-list
92749915|NCT02852083|Treosulfan|treosulfan|mesh-list
92749916|NCT02852083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92749917|NCT02852083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749918|NCT02852083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92749919|NCT02852083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749920|NCT02852083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749921|NCT02852083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749922|NCT02852083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92749923|NCT02852083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92749924|NCT02852083|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92749925|NCT02852083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749926|NCT02852083|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92749927|NCT02852083|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92749928|NCT02852083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92749929|NCT02852083|Alkylating Agents|alkylating agents|mesh-ancestor
92749930|NCT00602407|Cilostazol|cilostazol|mesh-list
92749931|NCT00602407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92749932|NCT00602407|Autonomic Agents|autonomic agents|mesh-ancestor
92749933|NCT00602407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749934|NCT00602407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749935|NCT00602407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92749938|NCT00602407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92749939|NCT00602407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749940|NCT00602407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92749941|NCT00602407|Vasodilator Agents|vasodilator agents|mesh-ancestor
92399247|NCT01402583|Antiviral Agents|antiviral agents|mesh-ancestor
92749942|NCT00602407|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92749943|NCT00602407|Protective Agents|protective agents|mesh-ancestor
92749944|NCT00602407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92749945|NCT00602407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92749946|NCT00602407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749947|NCT00950599|Saxagliptin|saxagliptin|mesh-list
92749948|NCT00950599|Incretins|incretins|mesh-ancestor
92749949|NCT00950599|Hormones|hormones|mesh-ancestor
92749950|NCT00950599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92749951|NCT00950599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749952|NCT00950599|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92749953|NCT00950599|Protease Inhibitors|protease inhibitors|mesh-ancestor
92749954|NCT00950599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749955|NCT00950599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749956|NCT00950599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92749957|NCT01143207|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92749958|NCT01143207|Medroxyprogesterone|medroxyprogesterone|mesh-list
92749959|NCT01143207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92749960|NCT01143207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92749961|NCT01143207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92749962|NCT01143207|Contraceptive Agents|contraceptive agents|mesh-ancestor
92749963|NCT01143207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92749964|NCT01143207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749965|NCT01143207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92749966|NCT01143207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92749967|NCT01143207|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92614729|NCT03815019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92614730|NCT03815019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92614731|NCT03815019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92614732|NCT03815019|Contraceptive Agents|contraceptive agents|mesh-ancestor
92614733|NCT03815019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92614734|NCT03815019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614735|NCT03815019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92614736|NCT03815019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92749968|NCT01143207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92749969|NCT01143207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749971|NCT01143051|Racepinephrine|racepinephrine|mesh-list
92749972|NCT01143051|Epinephryl borate|epinephryl borate|mesh-list
92749973|NCT01143051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92749974|NCT01143051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92749975|NCT01143051|Adrenergic Agents|adrenergic agents|mesh-ancestor
92749976|NCT01143051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749977|NCT01143051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749978|NCT01143051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749979|NCT01143051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92749980|NCT01143051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92749981|NCT01143051|Autonomic Agents|autonomic agents|mesh-ancestor
92749982|NCT01143051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749983|NCT01143051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92749984|NCT01143051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749985|NCT01143051|Mydriatics|mydriatics|mesh-ancestor
92749986|NCT01143051|Sympathomimetics|sympathomimetics|mesh-ancestor
92749987|NCT01143051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92749988|NCT05199597|Atropine|atropine|mesh-list
92749989|NCT05199597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92749990|NCT05199597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92749991|NCT05199597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92749992|NCT05199597|Autonomic Agents|autonomic agents|mesh-ancestor
92749993|NCT05199597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92749994|NCT05199597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749995|NCT05199597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92749996|NCT05199597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749997|NCT05199597|Mydriatics|mydriatics|mesh-ancestor
92749998|NCT05199597|Parasympatholytics|parasympatholytics|mesh-ancestor
92749999|NCT05199597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92750000|NCT05199597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92750001|NCT05199597|Cholinergic Agents|cholinergic agents|mesh-ancestor
92750002|NCT05199597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750003|NCT05199597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750004|NCT01142193|Topiramate|topiramate|mesh-list
92750005|NCT01142193|Anticonvulsants|anticonvulsants|mesh-ancestor
92750006|NCT01142193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750007|NCT01142193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750011|NCT01139775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750012|NCT01139775|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92750013|NCT01139775|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92750014|NCT01283516|Ceritinib|ceritinib|mesh-list
92750015|NCT01283516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750016|NCT01283516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750017|NCT01283516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750018|NCT01283516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750019|NCT01283282|Clopidogrel|clopidogrel|mesh-list
92750020|NCT01283282|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92750021|NCT01283282|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92750022|NCT01283282|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92750023|NCT01283282|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92750024|NCT01283282|Purinergic Agents|purinergic agents|mesh-ancestor
92750025|NCT01283282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750026|NCT01283282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750027|NCT01283282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614737|NCT03815019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614738|NCT03815019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614739|NCT03815019|Appetite Stimulants|appetite stimulants|mesh-ancestor
92614740|NCT03815019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92021725|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92750028|NCT01282814|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92750029|NCT01282814|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92750030|NCT01282814|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92750031|NCT01282814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750032|NCT01282814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750033|NCT01282814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750034|NCT01282814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750035|NCT01282814|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92750036|NCT01282814|Antidepressive Agents|antidepressive agents|mesh-ancestor
92750037|NCT01282814|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750039|NCT00941863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750040|NCT00941863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750041|NCT00941863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750042|NCT00941863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750043|NCT00602173|Cilostazol|cilostazol|mesh-list
92750044|NCT00602173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92750045|NCT00602173|Autonomic Agents|autonomic agents|mesh-ancestor
92750046|NCT00602173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750047|NCT00602173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750048|NCT00602173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92750049|NCT00602173|Respiratory System Agents|respiratory system agents|mesh-ancestor
92750050|NCT00602173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92750051|NCT00602173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92750052|NCT00602173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750053|NCT00602173|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92750054|NCT00602173|Vasodilator Agents|vasodilator agents|mesh-ancestor
92750055|NCT00602173|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92750056|NCT00602173|Protective Agents|protective agents|mesh-ancestor
92750057|NCT00602173|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92750058|NCT00602173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92750059|NCT00602173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750060|NCT02852239|Dabrafenib|dabrafenib|mesh-list
92750061|NCT02852239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750062|NCT02852239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750063|NCT02852239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750064|NCT02852239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750065|NCT01282424|Idelalisib|idelalisib|mesh-list
92750066|NCT01282424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750067|NCT01282424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750068|NCT01282424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750069|NCT00602251|Terbinafine|terbinafine|mesh-list
92750070|NCT00602251|Antifungal Agents|antifungal agents|mesh-ancestor
92750071|NCT00602251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750072|NCT00602251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750073|NCT00602251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750074|NCT01281956|Naluzotan|naluzotan|mesh-list
92750075|NCT01281956|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92750076|NCT01281956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92750078|NCT01281956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750079|NCT01281956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750080|NCT01281956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750082|NCT01279850|Analgesics|analgesics|mesh-ancestor
92750083|NCT01279850|Sensory System Agents|sensory system agents|mesh-ancestor
92750084|NCT01279850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750085|NCT01279850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750086|NCT01279850|Anticonvulsants|anticonvulsants|mesh-ancestor
92750087|NCT01279850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92750088|NCT01279850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750089|NCT01279850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614741|NCT03767218|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92750090|NCT01279850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750091|NCT01279850|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92750092|NCT01279850|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92750093|NCT01279850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750094|NCT01279850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750095|NCT00604357|Sirolimus|sirolimus|mesh-list
92750096|NCT00604357|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92750097|NCT00604357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750098|NCT00604357|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92750099|NCT00604357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750100|NCT00604357|Antifungal Agents|antifungal agents|mesh-ancestor
92750101|NCT00604357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750102|NCT00604357|Immunologic Factors|immunologic factors|mesh-ancestor
92750103|NCT00604357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750105|NCT00602719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92750106|NCT00602719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92750107|NCT00602719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750108|NCT00602719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750109|NCT00602719|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92750110|NCT00602719|GABA Agonists|gaba agonists|mesh-ancestor
92750111|NCT00602719|GABA Agents|gaba agents|mesh-ancestor
92750112|NCT00602719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750113|NCT00602719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750114|NCT00604435|Docetaxel|docetaxel|mesh-list
92750115|NCT00604435|Epirubicin|epirubicin|mesh-list
92750116|NCT00604435|Endostatins|endostatins|mesh-list
92750117|NCT00604435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750118|NCT00604435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92750119|NCT00604435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92750120|NCT00604435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92750121|NCT00604435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750122|NCT00604435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92750123|NCT00604435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92750124|NCT00604435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92750125|NCT00604435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750126|NCT00604435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92750127|NCT00604435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92750128|NCT00604435|Growth Substances|growth substances|mesh-ancestor
92750129|NCT00604435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750130|NCT00604435|Growth Inhibitors|growth inhibitors|mesh-ancestor
92750131|NCT01136967|Lenvatinib|lenvatinib|mesh-list
92750132|NCT01136967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750133|NCT01136967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750134|NCT01136967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750135|NCT01136967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750136|NCT01218516|Paclitaxel|paclitaxel|mesh-list
92750137|NCT01218516|Carboplatin|carboplatin|mesh-list
92750138|NCT01218516|Pemetrexed|pemetrexed|mesh-list
92750139|NCT01218516|Farletuzumab|farletuzumab|mesh-list
92750140|NCT01218516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92750141|NCT01218516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750142|NCT01218516|Tubulin Modulators|tubulin modulators|mesh-ancestor
92750143|NCT01218516|Antimitotic Agents|antimitotic agents|mesh-ancestor
92750144|NCT01218516|Mitosis Modulators|mitosis modulators|mesh-ancestor
92750145|NCT01218516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750146|NCT01218516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750147|NCT01218516|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92750148|NCT01218516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92750149|NCT00938431|Lacosamide|lacosamide|mesh-list
92750150|NCT00938431|Anticonvulsants|anticonvulsants|mesh-ancestor
92750153|NCT00938431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750154|NCT00938431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750155|NCT05381389|Bupivacaine|bupivacaine|mesh-list
92750156|NCT05381389|Anesthetics, Local|anesthetics, local|mesh-ancestor
92750157|NCT05381389|Anesthetics|anesthetics|mesh-ancestor
92750158|NCT05381389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750159|NCT05381389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750160|NCT05381389|Sensory System Agents|sensory system agents|mesh-ancestor
92750161|NCT05381389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750162|NCT00949117|Cyproheptadine|cyproheptadine|mesh-list
92750163|NCT00949117|Antipruritics|antipruritics|mesh-ancestor
92021732|NCT05611645|Growth Substances|growth substances|mesh-ancestor
92614743|NCT03767218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614744|NCT03767218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614745|NCT03739645|Metronidazole|metronidazole|mesh-list
92614746|NCT03739645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614747|NCT03739645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92614748|NCT03739645|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92614749|NCT03739645|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92614750|NCT03705585|Vaccines|vaccines|mesh-list
92614751|NCT03705585|Immunologic Factors|immunologic factors|mesh-ancestor
92750164|NCT00949117|Dermatologic Agents|dermatologic agents|mesh-ancestor
92750165|NCT00949117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750166|NCT00949117|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92750167|NCT00949117|Histamine Antagonists|histamine antagonists|mesh-ancestor
92750168|NCT00949117|Histamine Agents|histamine agents|mesh-ancestor
92750169|NCT00949117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750170|NCT00949117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750171|NCT00949117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750172|NCT00949117|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92750173|NCT00949117|Serotonin Agents|serotonin agents|mesh-ancestor
92750174|NCT00949117|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92750176|NCT04312347|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92750177|NCT04312347|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750178|NCT04312347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750179|NCT04312347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750180|NCT04312347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92750181|NCT04312347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750182|NCT04312347|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92750183|NCT04312347|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92750184|NCT04312347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92750185|NCT00938041|Tositumomab I-131|tositumomab i-131|mesh-list
92750186|NCT00938041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750187|NCT05379283|Lidocaine|lidocaine|mesh-list
92750188|NCT05379283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92750189|NCT05379283|Anesthetics|anesthetics|mesh-ancestor
92750190|NCT05379283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750191|NCT05379283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750192|NCT05379283|Sensory System Agents|sensory system agents|mesh-ancestor
92750193|NCT05379283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750194|NCT05379283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92750195|NCT05379283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92750196|NCT05379283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92750197|NCT05379283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750198|NCT05379283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750199|NCT01218438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92750200|NCT01218438|Immunoglobulins|immunoglobulins|mesh-list
92750201|NCT01218438|Antibodies|antibodies|mesh-list
92750202|NCT01218438|gamma-Globulins|gamma-globulins|mesh-list
92750203|NCT01218438|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92750204|NCT01218438|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92750205|NCT01218438|Immunoglobulin G|immunoglobulin g|mesh-list
92750206|NCT01218438|Immunologic Factors|immunologic factors|mesh-ancestor
92750207|NCT01218438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750208|NCT00604591|Tolcapone|tolcapone|mesh-list
92750209|NCT00604591|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92750210|NCT00604591|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92750211|NCT00604591|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92750212|NCT00604591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750213|NCT00604591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750214|NCT02691156|Carbon Monoxide|carbon monoxide|mesh-list
92750215|NCT02691156|Bilirubin|bilirubin|mesh-list
92750216|NCT02691156|Antimetabolites|antimetabolites|mesh-ancestor
92750217|NCT02691156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614752|NCT03705585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614754|NCT03695237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92614755|NCT03695237|Fertility Agents|fertility agents|mesh-ancestor
92614756|NCT03695237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92750218|NCT02691156|Gasotransmitters|gasotransmitters|mesh-ancestor
92750219|NCT02691156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750220|NCT02691156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750221|NCT02691156|Antioxidants|antioxidants|mesh-ancestor
92750222|NCT02691156|Protective Agents|protective agents|mesh-ancestor
92750226|NCT00603031|Hormones|hormones|mesh-ancestor
92750227|NCT00603031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750228|NCT00603031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750229|NCT00603031|Incretins|incretins|mesh-ancestor
92750230|NCT05379049|Adalimumab|adalimumab|mesh-list
92750231|NCT05379049|Infliximab|infliximab|mesh-list
92750232|NCT05379049|Etanercept|etanercept|mesh-list
92750233|NCT05379049|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92750234|NCT05379049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92750235|NCT05379049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92750236|NCT05379049|Dermatologic Agents|dermatologic agents|mesh-ancestor
92750237|NCT05379049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750238|NCT05379049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92750239|NCT05379049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92750240|NCT05379049|Analgesics|analgesics|mesh-ancestor
92750241|NCT05379049|Sensory System Agents|sensory system agents|mesh-ancestor
92750242|NCT05379049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750243|NCT05379049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750244|NCT05379049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750245|NCT05379049|Immunologic Factors|immunologic factors|mesh-ancestor
92750246|NCT02851459|Vaccines|vaccines|mesh-list
92750247|NCT02851459|Immunologic Factors|immunologic factors|mesh-ancestor
92750248|NCT02851459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750249|NCT00603343|Propiverine|propiverine|mesh-list
92750250|NCT00603343|Parasympatholytics|parasympatholytics|mesh-ancestor
92750251|NCT00603343|Autonomic Agents|autonomic agents|mesh-ancestor
92750252|NCT00603343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750253|NCT00603343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750254|NCT00603343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92750255|NCT00603343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92750256|NCT00603343|Cholinergic Agents|cholinergic agents|mesh-ancestor
92750257|NCT00603343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750258|NCT00603343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750259|NCT00603343|Urological Agents|urological agents|mesh-ancestor
92750260|NCT01277510|Cinacalcet|cinacalcet|mesh-list
92750261|NCT01277510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750262|NCT01277510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750263|NCT01277510|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92750264|NCT01277510|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750265|NCT01277510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750266|NCT00937495|Bortezomib|bortezomib|mesh-list
92750267|NCT00937495|Vorinostat|vorinostat|mesh-list
92750268|NCT00937495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750269|NCT00937495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92750270|NCT00937495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750271|NCT00937495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750272|NCT04265833|Calcium|calcium|mesh-list
92750273|NCT04265833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750274|NCT04265833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750275|NCT00606541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92750276|NCT00606541|Antidepressive Agents|antidepressive agents|mesh-ancestor
92750277|NCT00606541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750278|NCT00606541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92750279|NCT00606541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92750280|NCT00606541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750281|NCT00606541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750282|NCT00936715|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92750283|NCT00936715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92750284|NCT00936715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614757|NCT03695237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750285|NCT00936715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750286|NCT00936715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750287|NCT00936715|Antiviral Agents|antiviral agents|mesh-ancestor
92750288|NCT00936715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750289|NCT00936715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92750290|NCT00936715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92750292|NCT05378503|Phentermine|phentermine|mesh-list
92750293|NCT05378503|Anticonvulsants|anticonvulsants|mesh-ancestor
92750294|NCT05378503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750298|NCT05378503|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92750299|NCT05378503|Sympathomimetics|sympathomimetics|mesh-ancestor
92750300|NCT05378503|Autonomic Agents|autonomic agents|mesh-ancestor
92750301|NCT05378503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750302|NCT05378503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92750303|NCT05378503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750304|NCT05378503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750305|NCT05378191|Vaccines|vaccines|mesh-list
92750306|NCT05378191|Immunologic Factors|immunologic factors|mesh-ancestor
92750307|NCT05378191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750308|NCT00605137|Insulin|insulin|mesh-list
92750309|NCT00605137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92750310|NCT00605137|Insulin Detemir|insulin detemir|mesh-list
92750311|NCT00605137|Isophane Insulin, Human|isophane insulin, human|mesh-list
92750312|NCT00605137|Insulin, Isophane|insulin, isophane|mesh-list
92750313|NCT00605137|Isophane insulin, beef|isophane insulin, beef|mesh-list
92750314|NCT00605137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750315|NCT00605137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750316|NCT00606775|Carvedilol|carvedilol|mesh-list
92750317|NCT00606775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92750318|NCT00606775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92750319|NCT00606775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92750320|NCT00606775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750321|NCT00606775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750322|NCT00606775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750323|NCT00606775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92750324|NCT00606775|Antioxidants|antioxidants|mesh-ancestor
92750325|NCT00606775|Protective Agents|protective agents|mesh-ancestor
92750326|NCT00606775|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92750327|NCT00606775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750328|NCT00606775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750329|NCT00606775|Vasodilator Agents|vasodilator agents|mesh-ancestor
92750330|NCT00606775|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92750331|NCT00606775|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92750332|NCT00605371|Lamotrigine|lamotrigine|mesh-list
92750333|NCT00605371|Anticonvulsants|anticonvulsants|mesh-list
92750334|NCT00605371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92750335|NCT00605371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750336|NCT00605371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750337|NCT00605371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750338|NCT00605371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750339|NCT00605371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92750340|NCT00605371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92750341|NCT00605371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750342|NCT00605371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750343|NCT00605371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92750344|NCT01267994|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92750345|NCT01267994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92750346|NCT02850913|Doxycycline|doxycycline|mesh-list
92750347|NCT02850913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92750348|NCT02850913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750349|NCT02850913|Antimalarials|antimalarials|mesh-ancestor
92750350|NCT02850913|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92750351|NCT02850913|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92750352|NCT00934843|Methylprednisolone|methylprednisolone|mesh-list
92750353|NCT00934843|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92750354|NCT00934843|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92750355|NCT00934843|Prednisolone|prednisolone|mesh-list
92750356|NCT00934843|Prednisolone acetate|prednisolone acetate|mesh-list
92750357|NCT00934843|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92750358|NCT00934843|Prednisolone phosphate|prednisolone phosphate|mesh-list
92750359|NCT00934843|Glucocorticoids|glucocorticoids|mesh-list
92750360|NCT00934843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614758|NCT03695237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614759|NCT03695237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614760|NCT03603509|Vaccines|vaccines|mesh-list
92614761|NCT03603509|Immunologic Factors|immunologic factors|mesh-ancestor
92614762|NCT03603509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614763|NCT03526354|Antipsychotic Agents|antipsychotic agents|mesh-list
92614764|NCT03526354|Brexpiprazole|brexpiprazole|mesh-list
92614765|NCT03526354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92614766|NCT03526354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750361|NCT00934843|Antiemetics|antiemetics|mesh-ancestor
92750362|NCT00934843|Autonomic Agents|autonomic agents|mesh-ancestor
92750363|NCT00934843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750364|NCT00934843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750365|NCT00934843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750368|NCT00934843|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92750369|NCT00934843|Protective Agents|protective agents|mesh-ancestor
92750370|NCT00934843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92750371|NCT00934843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750372|NCT00605605|Dextromethorphan|dextromethorphan|mesh-list
92750373|NCT00605605|Antitussive Agents|antitussive agents|mesh-ancestor
92750374|NCT00605605|Respiratory System Agents|respiratory system agents|mesh-ancestor
92750375|NCT00605605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92750376|NCT00605605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92750377|NCT00605605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750378|NCT00605605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750379|NCT00605605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750380|NCT04267237|Atezolizumab|atezolizumab|mesh-list
92750381|NCT04267237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92750382|NCT04267237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750383|NCT04267237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750384|NCT04267237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750385|NCT00605995|Simvastatin|simvastatin|mesh-list
92750386|NCT00605995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92750387|NCT00605995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92750388|NCT00605995|Antimetabolites|antimetabolites|mesh-ancestor
92750389|NCT00605995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750390|NCT00605995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92750391|NCT00605995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92750392|NCT00605995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750393|NCT00605683|Cabergoline|cabergoline|mesh-list
92750394|NCT00605683|Pramipexole|pramipexole|mesh-list
92750395|NCT00605683|Ropinirole|ropinirole|mesh-list
92750396|NCT00605683|Bromocriptine|bromocriptine|mesh-list
92750397|NCT00605683|Lisuride|lisuride|mesh-list
92750398|NCT00605683|Apomorphine|apomorphine|mesh-list
92750399|NCT00605683|Pergolide|pergolide|mesh-list
92750400|NCT00605683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92750401|NCT00605683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92750402|NCT00605683|Dopamine Agonists|dopamine agonists|mesh-ancestor
92750403|NCT00605683|Dopamine Agents|dopamine agents|mesh-ancestor
92750404|NCT00605683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750405|NCT00605683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750406|NCT00605683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750407|NCT00605683|Antioxidants|antioxidants|mesh-ancestor
92750408|NCT00605683|Protective Agents|protective agents|mesh-ancestor
92750409|NCT00605683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750410|NCT00605683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750411|NCT00605683|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92750412|NCT00605683|Serotonin Agents|serotonin agents|mesh-ancestor
92750413|NCT00605683|Emetics|emetics|mesh-ancestor
92750414|NCT00605683|Autonomic Agents|autonomic agents|mesh-ancestor
92750415|NCT00605683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750416|NCT00605683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750417|NCT01266902|Rilpivirine|rilpivirine|mesh-list
92750418|NCT01266902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92750419|NCT01266902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92614767|NCT03526354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614768|NCT03526354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92614769|NCT03526354|Serotonin Agents|serotonin agents|mesh-ancestor
92614770|NCT03526354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92614771|NCT03526354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750420|NCT01266902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750421|NCT01266902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750422|NCT01266902|Antiviral Agents|antiviral agents|mesh-ancestor
92750423|NCT01266902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750424|NCT01266902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92750425|NCT01266902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92750426|NCT01266824|Proxymetacaine|proxymetacaine|mesh-list
92750427|NCT01266824|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92750428|NCT01266824|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92750429|NCT01266824|Anesthetics, Local|anesthetics, local|mesh-ancestor
92750430|NCT01266824|Anesthetics|anesthetics|mesh-ancestor
92750431|NCT01266824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750432|NCT01266824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750433|NCT01266824|Sensory System Agents|sensory system agents|mesh-ancestor
92750434|NCT01266824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750435|NCT04253119|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92750436|NCT04253119|Antiviral Agents|antiviral agents|mesh-ancestor
92750437|NCT04253119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750438|NCT01266590|Digoxin|digoxin|mesh-list
92750442|NCT01266590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750443|NCT01266590|Protective Agents|protective agents|mesh-ancestor
92750444|NCT01266590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750445|NCT01265498|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92750446|NCT01265498|Cathartics|cathartics|mesh-ancestor
92750447|NCT01265498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750448|NCT00607711|Isophosphamide mustard|isophosphamide mustard|mesh-list
92750449|NCT00607711|Ifosfamide|ifosfamide|mesh-list
92750450|NCT00607711|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92750451|NCT00607711|Alkylating Agents|alkylating agents|mesh-ancestor
92750452|NCT00607711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750453|NCT00607711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750454|NCT01263782|Bevacizumab|bevacizumab|mesh-list
92750455|NCT01263782|Carboplatin|carboplatin|mesh-list
92750456|NCT01263782|Pemetrexed|pemetrexed|mesh-list
92750457|NCT01263782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750458|NCT01263782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750459|NCT01263782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92750460|NCT01263782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92750461|NCT01263782|Growth Substances|growth substances|mesh-ancestor
92750462|NCT01263782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750463|NCT01263782|Growth Inhibitors|growth inhibitors|mesh-ancestor
92750464|NCT01263782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750465|NCT01263782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750466|NCT01263782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92750467|NCT01263782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92750468|NCT01263704|Cyclophosphamide|cyclophosphamide|mesh-list
92750469|NCT01263704|Rituximab|rituximab|mesh-list
92750470|NCT01263704|Fludarabine|fludarabine|mesh-list
92750471|NCT01263704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750472|NCT01263704|Immunologic Factors|immunologic factors|mesh-ancestor
92750473|NCT01263704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750474|NCT01263704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92750475|NCT01263704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92750476|NCT01263704|Alkylating Agents|alkylating agents|mesh-ancestor
92750477|NCT01263704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399283|NCT01402843|Valsartan|valsartan|mesh-list
92750478|NCT01263704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750479|NCT01263704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92750480|NCT01263704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750481|NCT01263470|Alogliptin|alogliptin|mesh-list
92750482|NCT01263470|Voglibose|voglibose|mesh-list
92750483|NCT01263470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750484|NCT01263470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750485|NCT01263470|Incretins|incretins|mesh-ancestor
92750486|NCT01263470|Hormones|hormones|mesh-ancestor
92750487|NCT01263470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614772|NCT03526354|Dopamine Agonists|dopamine agonists|mesh-ancestor
92614773|NCT03526354|Dopamine Agents|dopamine agents|mesh-ancestor
92614774|NCT03517969|Carboplatin|carboplatin|mesh-list
92614775|NCT03517969|Docetaxel|docetaxel|mesh-list
92614776|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614777|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
92614778|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
92750488|NCT01263470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92750489|NCT01263470|Protease Inhibitors|protease inhibitors|mesh-ancestor
92750490|NCT01263470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750491|NCT01263470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750492|NCT01263470|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92750493|NCT04322786|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92750494|NCT04322786|Protease Inhibitors|protease inhibitors|mesh-ancestor
92750495|NCT04322786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750496|NCT04322786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750497|NCT04322240|Thioctic Acid|thioctic acid|mesh-list
92750498|NCT04322240|Antioxidants|antioxidants|mesh-ancestor
92750499|NCT04322240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750500|NCT04322240|Protective Agents|protective agents|mesh-ancestor
92750501|NCT04322240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750502|NCT04322240|Vitamin B Complex|vitamin b complex|mesh-ancestor
92750503|NCT04322240|Vitamins|vitamins|mesh-ancestor
92750504|NCT04322240|Micronutrients|micronutrients|mesh-ancestor
92750505|NCT01262456|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92750506|NCT01262456|Hemostatics|hemostatics|mesh-ancestor
92750507|NCT01262456|Coagulants|coagulants|mesh-ancestor
92750508|NCT01262456|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92750509|NCT01262456|Natriuretic Agents|natriuretic agents|mesh-ancestor
92750510|NCT01262456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750516|NCT04321850|Micronutrients|micronutrients|mesh-ancestor
92750517|NCT04321850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750518|NCT04321850|Astringents|astringents|mesh-ancestor
92750519|NCT04321850|Dermatologic Agents|dermatologic agents|mesh-ancestor
92750520|NCT04321616|Hydroxychloroquine|hydroxychloroquine|mesh-list
92750521|NCT04321616|Remdesivir|remdesivir|mesh-list
92750522|NCT04321616|Antimalarials|antimalarials|mesh-ancestor
92750523|NCT04321616|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92750524|NCT04321616|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92750525|NCT04321616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750526|NCT04321616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750527|NCT04321616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750528|NCT04321616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92750529|NCT04321616|Antimetabolites|antimetabolites|mesh-ancestor
92750530|NCT04321616|Antiviral Agents|antiviral agents|mesh-ancestor
92750531|NCT00932893|Docetaxel|docetaxel|mesh-list
92750532|NCT00932893|Pemetrexed|pemetrexed|mesh-list
92750533|NCT00932893|Crizotinib|crizotinib|mesh-list
92750534|NCT00932893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750535|NCT00932893|Tubulin Modulators|tubulin modulators|mesh-ancestor
92750536|NCT00932893|Antimitotic Agents|antimitotic agents|mesh-ancestor
92750537|NCT00932893|Mitosis Modulators|mitosis modulators|mesh-ancestor
92750538|NCT00932893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750539|NCT00932893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750540|NCT00932893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92750541|NCT00932893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92750542|NCT00932893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750543|NCT04321070|Clindamycin|clindamycin|mesh-list
92750544|NCT04321070|Clindamycin palmitate|clindamycin palmitate|mesh-list
92750545|NCT04321070|Clindamycin phosphate|clindamycin phosphate|mesh-list
92750546|NCT04321070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92750547|NCT04321070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750548|NCT04321070|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92750549|NCT04321070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750550|NCT04321070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750551|NCT02889224|Hydrocortisone|hydrocortisone|mesh-list
92750552|NCT02889224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92750553|NCT01260896|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92750554|NCT01260896|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92750555|NCT01260896|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92614779|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
92614780|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614782|NCT03405792|Temozolomide|temozolomide|mesh-list
92021758|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92750556|NCT01260896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750557|NCT01260896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750558|NCT01260896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750559|NCT01260896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750560|NCT01260896|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92750561|NCT01260896|Antidepressive Agents|antidepressive agents|mesh-ancestor
92750562|NCT01260896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750563|NCT00939523|Lapatinib|lapatinib|mesh-list
92750564|NCT00939523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750565|NCT00939523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750566|NCT00939523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750567|NCT00939523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750568|NCT01260584|Clopidogrel|clopidogrel|mesh-list
92750569|NCT01260584|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92750570|NCT01260584|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92750571|NCT01260584|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92750572|NCT01260584|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92750573|NCT01260584|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92750574|NCT01260584|Purinergic Agents|purinergic agents|mesh-ancestor
92750575|NCT01260584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750576|NCT01260584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750577|NCT01260584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750578|NCT00607945|Rosiglitazone|rosiglitazone|mesh-list
92750579|NCT00607945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750580|NCT00607945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750581|NCT04262635|Capecitabine|capecitabine|mesh-list
92750582|NCT04262635|Cetuximab|cetuximab|mesh-list
92750585|NCT04262635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750587|NCT04262635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750588|NCT00608101|Dexamethasone|dexamethasone|mesh-list
92750589|NCT00608101|Fludrocortisone|fludrocortisone|mesh-list
92750590|NCT00608101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92750591|NCT00608101|Antiemetics|antiemetics|mesh-ancestor
92750592|NCT00608101|Autonomic Agents|autonomic agents|mesh-ancestor
92750593|NCT00608101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750594|NCT00608101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750595|NCT00608101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750596|NCT00608101|Glucocorticoids|glucocorticoids|mesh-ancestor
92750597|NCT00608101|Hormones|hormones|mesh-ancestor
92750598|NCT00608101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750599|NCT00608101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92750600|NCT00608101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750601|NCT04264039|Fludarabine|fludarabine|mesh-list
92750602|NCT04264039|Cyclophosphamide|cyclophosphamide|mesh-list
92750603|NCT04264039|Melphalan|melphalan|mesh-list
92750604|NCT04264039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750605|NCT04264039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750606|NCT04264039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750607|NCT04264039|Immunologic Factors|immunologic factors|mesh-ancestor
92750608|NCT04264039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750609|NCT04264039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92750610|NCT04264039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92750611|NCT04264039|Alkylating Agents|alkylating agents|mesh-ancestor
92750612|NCT04264039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92750613|NCT00608179|Glimepiride|glimepiride|mesh-list
92750614|NCT00608179|Glyburide|glyburide|mesh-list
92750615|NCT00608179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92750616|NCT00608179|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074018|NCT04779580|Anesthetics|anesthetics|mesh-list
92750617|NCT00608179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750618|NCT00608179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750619|NCT00608179|Immunologic Factors|immunologic factors|mesh-ancestor
92750620|NCT00608335|Micafungin|micafungin|mesh-list
92750621|NCT00608335|Antifungal Agents|antifungal agents|mesh-ancestor
92750622|NCT00608335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750623|NCT00927589|Carboplatin|carboplatin|mesh-list
92750625|NCT00927589|Trastuzumab|trastuzumab|mesh-list
92614783|NCT03405792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614784|NCT03405792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614785|NCT03405792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614786|NCT03405792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614787|NCT03405792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92750626|NCT00927589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750627|NCT00927589|Tubulin Modulators|tubulin modulators|mesh-ancestor
92750628|NCT00927589|Antimitotic Agents|antimitotic agents|mesh-ancestor
92750629|NCT00927589|Mitosis Modulators|mitosis modulators|mesh-ancestor
92750630|NCT00927589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750631|NCT00927589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750632|NCT05938725|Cyclophosphamide|cyclophosphamide|mesh-list
92750633|NCT05938725|Fludarabine|fludarabine|mesh-list
92750634|NCT05938725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750635|NCT05938725|Immunologic Factors|immunologic factors|mesh-ancestor
92750636|NCT05938725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750637|NCT05938725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92750638|NCT05938725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92750639|NCT05938725|Alkylating Agents|alkylating agents|mesh-ancestor
92750640|NCT05938725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750641|NCT05938725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750642|NCT05938725|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92750643|NCT05938712|Dapagliflozin|dapagliflozin|mesh-list
92750644|NCT05938712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92750645|NCT05938712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750646|NCT05938712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750647|NCT05938712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750648|NCT05938374|Fluzoparib|fluzoparib|mesh-list
92750649|NCT05938374|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92750650|NCT05938374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750651|NCT05938374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750652|NCT05938374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750653|NCT05938140|Ritonavir|ritonavir|mesh-list
92750654|NCT05938140|Nirmatrelvir|nirmatrelvir|mesh-list
92750660|NCT05938140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750662|NCT05938140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92750663|NCT05938140|Antiviral Agents|antiviral agents|mesh-ancestor
92750664|NCT05938140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750665|NCT05938140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92750666|NCT05938140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92750667|NCT05937880|Leflunomide|leflunomide|mesh-list
92750668|NCT05937880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750669|NCT05937880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750670|NCT05937880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750671|NCT05937880|Immunologic Factors|immunologic factors|mesh-ancestor
92750672|NCT05937880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750673|NCT05937841|Compound 21|compound 21|mesh-list
92750674|NCT05937841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92750675|NCT05937789|Vitamin D|vitamin d|mesh-list
92750676|NCT05937789|Vitamins|vitamins|mesh-ancestor
92750677|NCT05937789|Micronutrients|micronutrients|mesh-ancestor
92750678|NCT05937789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750679|NCT05937789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92750680|NCT05937776|Deoxyglucose|deoxyglucose|mesh-list
92750681|NCT05937776|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92750682|NCT05937776|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92750683|NCT05937776|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92750684|NCT05937776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750685|NCT05937776|Antimetabolites|antimetabolites|mesh-ancestor
92750686|NCT05937776|Antiviral Agents|antiviral agents|mesh-ancestor
92750687|NCT05937776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750688|NCT05937776|Chelating Agents|chelating agents|mesh-ancestor
92750689|NCT05937776|Sequestering Agents|sequestering agents|mesh-ancestor
92750690|NCT05937711|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92750691|NCT05937711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92750692|NCT05937711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92614788|NCT03405792|Alkylating Agents|alkylating agents|mesh-ancestor
92614789|NCT03361345|Tranexamic Acid|tranexamic acid|mesh-list
92614790|NCT03361345|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92614791|NCT03361345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92614792|NCT03361345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614794|NCT03361345|Coagulants|coagulants|mesh-ancestor
92614795|NCT03275285|Dexamethasone|dexamethasone|mesh-list
92614796|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92614797|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
92614798|NCT03275285|Autonomic Agents|autonomic agents|mesh-ancestor
92614799|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750693|NCT05937711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750694|NCT05937711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750695|NCT05937711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750696|NCT05937711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750698|NCT05937711|Sensory System Agents|sensory system agents|mesh-ancestor
92750699|NCT05937711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750700|NCT05937711|Antidepressive Agents|antidepressive agents|mesh-ancestor
92750701|NCT05937711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750702|NCT05937711|Dopamine Agents|dopamine agents|mesh-ancestor
92750703|NCT05937568|Imetelstat|imetelstat|mesh-list
92750704|NCT05937568|Motesanib diphosphate|motesanib diphosphate|mesh-list
92750705|NCT05937568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750706|NCT05937568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750707|NCT05937568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750708|NCT05937490|Leuprolide|leuprolide|mesh-list
92750709|NCT05937490|Dienogest|dienogest|mesh-list
92750710|NCT05937490|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92750711|NCT05937490|Fertility Agents|fertility agents|mesh-ancestor
92750712|NCT05937490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92750713|NCT05937490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750714|NCT05937490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92750715|NCT05937490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750716|NCT05937490|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92750717|NCT05937490|Contraceptive Agents|contraceptive agents|mesh-ancestor
92750718|NCT05937490|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92750719|NCT05937490|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92750720|NCT05937490|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92750721|NCT05937490|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92750722|NCT05937490|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750725|NCT05937438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750726|NCT05937438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750727|NCT05937438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750728|NCT05937191|Leflunomide|leflunomide|mesh-list
92750729|NCT05937191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750730|NCT05937191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750731|NCT05937191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92750732|NCT05937191|Immunologic Factors|immunologic factors|mesh-ancestor
92750733|NCT05937191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750734|NCT05937126|Anti-Infective Agents|anti-infective agents|mesh-list
92750735|NCT05937126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92750736|NCT05937100|Hyaluronic Acid|hyaluronic acid|mesh-list
92750737|NCT05937100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92750738|NCT05937100|Immunologic Factors|immunologic factors|mesh-ancestor
92750739|NCT05937100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750740|NCT05937100|Viscosupplements|viscosupplements|mesh-ancestor
92750741|NCT05937100|Protective Agents|protective agents|mesh-ancestor
92750742|NCT05936853|Anesthetics|anesthetics|mesh-list
92750743|NCT05936853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750744|NCT05936853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750745|NCT05936710|Dialysis Solutions|dialysis solutions|mesh-list
92750746|NCT05936710|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92614800|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614801|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92614802|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
92614803|NCT03275285|Hormones|hormones|mesh-ancestor
92614804|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614805|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92750792|NCT05935059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750793|NCT05935059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92750795|NCT05935059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92750796|NCT05935059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750797|NCT05935059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750798|NCT05935059|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92750800|NCT05928962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750801|NCT05924997|Apatinib|apatinib|mesh-list
92750802|NCT05924997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750803|NCT05924997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750804|NCT05924997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750805|NCT05924997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750806|NCT05910190|Buprenorphine|buprenorphine|mesh-list
92750807|NCT05910190|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92750808|NCT05910190|Narcotics|narcotics|mesh-ancestor
92614808|NCT03216187|Analgesics|analgesics|mesh-ancestor
92614809|NCT03216187|Sensory System Agents|sensory system agents|mesh-ancestor
92750809|NCT05910190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750810|NCT05910190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750811|NCT05910190|Analgesics|analgesics|mesh-ancestor
92750812|NCT05910190|Sensory System Agents|sensory system agents|mesh-ancestor
92750813|NCT05910190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750814|NCT05910190|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92750815|NCT05900388|Rivaroxaban|rivaroxaban|mesh-list
92750816|NCT05900388|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92750817|NCT05900388|Antithrombins|antithrombins|mesh-ancestor
92750818|NCT05900388|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92750819|NCT05900388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92750820|NCT05900388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750821|NCT05900388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750822|NCT05900388|Anticoagulants|anticoagulants|mesh-ancestor
92750823|NCT05898919|Neostigmine|neostigmine|mesh-list
92750824|NCT05898919|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92750825|NCT05898919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750826|NCT05898919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750827|NCT05898919|Cholinergic Agents|cholinergic agents|mesh-ancestor
92750828|NCT05898919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750829|NCT05898919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750830|NCT05898919|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92750831|NCT05898919|Autonomic Agents|autonomic agents|mesh-ancestor
92750832|NCT05898919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750833|NCT05881291|Alfentanil|alfentanil|mesh-list
92750834|NCT05881291|Propofol|propofol|mesh-list
92750835|NCT05881291|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92750836|NCT05881291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750837|NCT05881291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750838|NCT05881291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92750839|NCT05881291|Anesthetics, General|anesthetics, general|mesh-ancestor
92750840|NCT05881291|Anesthetics|anesthetics|mesh-ancestor
92750841|NCT05881291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92750842|NCT05881291|Narcotics|narcotics|mesh-ancestor
92750843|NCT05881291|Analgesics|analgesics|mesh-ancestor
92750845|NCT05881291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750846|NCT05867342|Lidocaine|lidocaine|mesh-list
92750847|NCT05867342|Epinephrine|epinephrine|mesh-list
92750848|NCT05867342|Racepinephrine|racepinephrine|mesh-list
92750849|NCT05867342|Epinephryl borate|epinephryl borate|mesh-list
92750850|NCT05867342|Anesthetics, Local|anesthetics, local|mesh-ancestor
92750851|NCT05867342|Anesthetics|anesthetics|mesh-ancestor
92750852|NCT05867342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750853|NCT05867342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750854|NCT05867342|Sensory System Agents|sensory system agents|mesh-ancestor
92750855|NCT05867342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92750856|NCT05867342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92750857|NCT05867342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92750858|NCT05867342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92750859|NCT05867342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92750860|NCT05867342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750861|NCT05867342|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92750862|NCT05867342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92750863|NCT05867342|Adrenergic Agents|adrenergic agents|mesh-ancestor
92399307|NCT01403103|Vitamin D|vitamin d|mesh-list
92750864|NCT05867342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750865|NCT05867342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92750866|NCT05867342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92750867|NCT05867342|Autonomic Agents|autonomic agents|mesh-ancestor
92750868|NCT05867342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92750871|NCT05867342|Sympathomimetics|sympathomimetics|mesh-ancestor
92750872|NCT05867342|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92750873|NCT05843448|Pembrolizumab|pembrolizumab|mesh-list
92750874|NCT05843448|Vaccines|vaccines|mesh-list
92750875|NCT05843448|Immunologic Factors|immunologic factors|mesh-ancestor
92750876|NCT05843448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750877|NCT05843448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750878|NCT05843448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750879|NCT05843448|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92750880|NCT05843448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750881|NCT05829655|Suvorexant|suvorexant|mesh-list
92614810|NCT03216187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614811|NCT03216187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614812|NCT03216187|Anticonvulsants|anticonvulsants|mesh-ancestor
92750882|NCT05829655|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92750883|NCT05829655|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92750884|NCT05829655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750885|NCT05829655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750886|NCT05829655|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92750887|NCT05829655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750888|NCT05829655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750889|NCT05827016|Lenalidomide|lenalidomide|mesh-list
92750890|NCT05827016|Immunologic Factors|immunologic factors|mesh-ancestor
92750891|NCT05827016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750892|NCT05827016|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92750893|NCT05827016|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92750894|NCT05827016|Growth Substances|growth substances|mesh-ancestor
92750895|NCT05827016|Growth Inhibitors|growth inhibitors|mesh-ancestor
92750896|NCT05827016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750897|NCT05810480|Immunoglobulins|immunoglobulins|mesh-list
92750898|NCT05810480|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92750899|NCT05810480|Antibodies|antibodies|mesh-list
92750900|NCT05810480|Immunoglobulin G|immunoglobulin g|mesh-list
92750901|NCT05810480|Autoantibodies|autoantibodies|mesh-list
92750902|NCT05810480|Immunologic Factors|immunologic factors|mesh-ancestor
92750903|NCT05810480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750904|NCT05809830|Doxorubicin|doxorubicin|mesh-list
92750905|NCT05809830|LB100|lb100|mesh-list
92750906|NCT05809830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92750907|NCT05809830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750908|NCT05809830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92750909|NCT05809830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92750910|NCT05809830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750911|NCT05809830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750912|NCT05806346|Tranexamic Acid|tranexamic acid|mesh-list
92750913|NCT05806346|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92750914|NCT05806346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92750915|NCT05806346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750916|NCT05806346|Hemostatics|hemostatics|mesh-ancestor
92750917|NCT05806346|Coagulants|coagulants|mesh-ancestor
92750918|NCT05798533|Tislelizumab|tislelizumab|mesh-list
92750919|NCT05798533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92750920|NCT05798533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750921|NCT05793632|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92750922|NCT05793632|Antidepressive Agents|antidepressive agents|mesh-ancestor
92750923|NCT05793632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92750924|NCT05793632|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92750925|NCT05793632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92750926|NCT05793632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750927|NCT05793632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750928|NCT05786547|Varenicline|varenicline|mesh-list
92750929|NCT05786547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92750930|NCT05786547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92750931|NCT05786547|Cholinergic Agents|cholinergic agents|mesh-ancestor
92750932|NCT05786547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92750933|NCT05786547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750934|NCT05786547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750935|NCT05780073|Dasatinib|dasatinib|mesh-list
92750936|NCT05780073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750937|NCT05780073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92750938|NCT05780073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750939|NCT05780073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750940|NCT05768191|Insulin|insulin|mesh-list
92750941|NCT05768191|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92750942|NCT05768191|Isophane Insulin, Human|isophane insulin, human|mesh-list
92750947|NCT05759481|Propofol|propofol|mesh-list
92750948|NCT05759481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92750949|NCT05759481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92750950|NCT05759481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750951|NCT05759481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92750952|NCT05759481|Anesthetics, General|anesthetics, general|mesh-ancestor
92614814|NCT03216187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92614815|NCT03216187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614816|NCT03216187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92614817|NCT03216187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92750953|NCT05759481|Anesthetics|anesthetics|mesh-ancestor
92750954|NCT05733351|Docetaxel|docetaxel|mesh-list
92750955|NCT05733351|Antibodies|antibodies|mesh-list
92750956|NCT05733351|Immunoglobulins|immunoglobulins|mesh-list
92750957|NCT05733351|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92750958|NCT05733351|Immunologic Factors|immunologic factors|mesh-ancestor
92750959|NCT05733351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750960|NCT05733351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750961|NCT05733351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92750962|NCT05733351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92750963|NCT05733351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92750964|NCT05733351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750965|NCT05677282|Azithromycin|azithromycin|mesh-list
92750966|NCT05677282|Rifaximin|rifaximin|mesh-list
92750967|NCT05677282|Loperamide|loperamide|mesh-list
92750968|NCT05677282|Antidiarrheals|antidiarrheals|mesh-list
92750969|NCT05677282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92750970|NCT05677282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750971|NCT05677282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750972|NCT05657613|Fluconazole|fluconazole|mesh-list
92750973|NCT05657613|Bosentan|bosentan|mesh-list
92750974|NCT05657613|Antifungal Agents|antifungal agents|mesh-ancestor
92750975|NCT05657613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750976|NCT05657613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92750977|NCT05657613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92750978|NCT05657613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750979|NCT05657613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750980|NCT05657613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92750981|NCT05657613|Hormone Antagonists|hormone antagonists|mesh-ancestor
92750982|NCT05657613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750983|NCT05657613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750984|NCT05657613|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92750985|NCT05657613|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92750986|NCT05657613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92750987|NCT05657613|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92750988|NCT05635110|Rifampin|rifampin|mesh-list
92750989|NCT05635110|Omeprazole|omeprazole|mesh-list
92750990|NCT05635110|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92750991|NCT05635110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750992|NCT05635110|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92750993|NCT05635110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750994|NCT05635110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92750995|NCT05635110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92750996|NCT05635110|Antitubercular Agents|antitubercular agents|mesh-ancestor
92750997|NCT05635110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92750998|NCT05635110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92750999|NCT05635110|Leprostatic Agents|leprostatic agents|mesh-ancestor
92751000|NCT05635110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92751001|NCT05635110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92399318|NCT01403181|Ribavirin|ribavirin|mesh-list
92751002|NCT05635110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92751003|NCT05635110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92751004|NCT05635110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92751005|NCT05635110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92751006|NCT05635110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92751008|NCT05624281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751009|NCT05624281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751010|NCT05624281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751011|NCT05624281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751012|NCT05615025|Propofol|propofol|mesh-list
92751013|NCT05615025|Sevoflurane|sevoflurane|mesh-list
92751014|NCT05615025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92751019|NCT05615025|Anesthetics|anesthetics|mesh-ancestor
92751020|NCT05615025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92614818|NCT03216187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92614819|NCT03216187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614820|NCT03216187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92614821|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92614822|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92614823|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614824|NCT03172754|Nivolumab|nivolumab|mesh-list
92614825|NCT03172754|Axitinib|axitinib|mesh-list
92751021|NCT05615025|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92751022|NCT05594043|Pembrolizumab|pembrolizumab|mesh-list
92751023|NCT05594043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751024|NCT05594043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751025|NCT05594043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751026|NCT05594043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751027|NCT05583721|Regadenoson|regadenoson|mesh-list
92751028|NCT05583721|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92751029|NCT05583721|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92751030|NCT05583721|Purinergic Agonists|purinergic agonists|mesh-ancestor
92751031|NCT05583721|Purinergic Agents|purinergic agents|mesh-ancestor
92751032|NCT05583721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751033|NCT05583721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751034|NCT05583721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751036|NCT05568095|Fluorouracil|fluorouracil|mesh-list
92751037|NCT05568095|Capecitabine|capecitabine|mesh-list
92751038|NCT05568095|Oxaliplatin|oxaliplatin|mesh-list
92751039|NCT05568095|Nivolumab|nivolumab|mesh-list
92751040|NCT05568095|Antimetabolites|antimetabolites|mesh-ancestor
92751041|NCT05568095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751042|NCT05568095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751043|NCT05568095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751044|NCT05568095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751045|NCT05568095|Immunologic Factors|immunologic factors|mesh-ancestor
92751046|NCT05568095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751047|NCT05568095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751048|NCT05568095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751049|NCT05568095|Antidotes|antidotes|mesh-ancestor
92751050|NCT05568095|Protective Agents|protective agents|mesh-ancestor
92751051|NCT05568095|Vitamin B Complex|vitamin b complex|mesh-ancestor
92751052|NCT05568095|Vitamins|vitamins|mesh-ancestor
92751053|NCT05568095|Micronutrients|micronutrients|mesh-ancestor
92751054|NCT05564052|Rituximab|rituximab|mesh-list
92751055|NCT05564052|Lenalidomide|lenalidomide|mesh-list
92751056|NCT05564052|Bortezomib|bortezomib|mesh-list
92751057|NCT05564052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751058|NCT05564052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751059|NCT05564052|Immunologic Factors|immunologic factors|mesh-ancestor
92751060|NCT05564052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751061|NCT05564052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751062|NCT05564052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92751063|NCT05564052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92751064|NCT05564052|Growth Substances|growth substances|mesh-ancestor
92751065|NCT05564052|Growth Inhibitors|growth inhibitors|mesh-ancestor
92751066|NCT05545280|Glycopyrrolate|glycopyrrolate|mesh-list
92751067|NCT05545280|Neostigmine|neostigmine|mesh-list
92751068|NCT05545280|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92751069|NCT05545280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348197|NCT01565694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92751070|NCT05545280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751071|NCT05545280|Cholinergic Agents|cholinergic agents|mesh-ancestor
92751072|NCT05545280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751073|NCT05545280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751074|NCT05545280|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92751075|NCT05545280|Autonomic Agents|autonomic agents|mesh-ancestor
92751076|NCT05545280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751077|NCT05545280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92751078|NCT05545280|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92751079|NCT05545280|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92751080|NCT05487235|Atezolizumab|atezolizumab|mesh-list
92614826|NCT03172754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614827|NCT03172754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614828|NCT03172754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751081|NCT05487235|Omeprazole|omeprazole|mesh-list
92751082|NCT05487235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751083|NCT05487235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751084|NCT05487235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751089|NCT05487235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751090|NCT05468697|Palbociclib|palbociclib|mesh-list
92751091|NCT05468697|Belzutifan|belzutifan|mesh-list
92751092|NCT05468697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751093|NCT05468697|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751094|NCT05468697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751095|NCT05468697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751096|NCT05467891|Letrozole|letrozole|mesh-list
92751097|NCT05467891|Fulvestrant|fulvestrant|mesh-list
92751098|NCT05467891|Anastrozole|anastrozole|mesh-list
92751099|NCT05467891|Exemestane|exemestane|mesh-list
92751100|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751101|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92751102|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92751103|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751104|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751105|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92751106|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
92751107|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751108|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751109|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751110|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92751111|NCT05457257|Prednisone|prednisone|mesh-list
92751112|NCT05457257|Olaparib|olaparib|mesh-list
92751113|NCT05457257|Abiraterone Acetate|abiraterone acetate|mesh-list
92751114|NCT05457257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751115|NCT05457257|Glucocorticoids|glucocorticoids|mesh-ancestor
92751116|NCT05457257|Hormones|hormones|mesh-ancestor
92751117|NCT05457257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751118|NCT05457257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751119|NCT05457257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751120|NCT05457257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751121|NCT05457257|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92751122|NCT05457257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751123|NCT05457257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751124|NCT05457257|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92751125|NCT05457257|Hormone Antagonists|hormone antagonists|mesh-ancestor
92751126|NCT05457257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92751127|NCT05408065|Triamcinolone|triamcinolone|mesh-list
92751128|NCT05408065|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92751129|NCT05408065|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92751130|NCT05408065|Cortisone|cortisone|mesh-list
92751131|NCT05408065|Hyaluronic Acid|hyaluronic acid|mesh-list
92751132|NCT05408065|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92751133|NCT05408065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751134|NCT05408065|Glucocorticoids|glucocorticoids|mesh-ancestor
92751135|NCT05408065|Hormones|hormones|mesh-ancestor
92751136|NCT05408065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751137|NCT05408065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751138|NCT05408065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751139|NCT05408065|Immunologic Factors|immunologic factors|mesh-ancestor
92751140|NCT05408065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751141|NCT05408065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751142|NCT05408065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92751143|NCT05408065|Viscosupplements|viscosupplements|mesh-ancestor
92751144|NCT05408065|Protective Agents|protective agents|mesh-ancestor
92751145|NCT05381753|Sunitinib|sunitinib|mesh-list
92751146|NCT05381753|Imatinib Mesylate|imatinib mesylate|mesh-list
92751147|NCT05381753|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92751148|NCT05381753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751149|NCT05381753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92751150|NCT05381753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92751151|NCT05381753|Growth Substances|growth substances|mesh-ancestor
92751152|NCT05381753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751153|NCT05381753|Growth Inhibitors|growth inhibitors|mesh-ancestor
92751154|NCT05381753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751155|NCT05381753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751158|NCT05276206|Anesthetics, Local|anesthetics, local|mesh-list
92751159|NCT05276206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751160|NCT05276206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751161|NCT05276206|Sensory System Agents|sensory system agents|mesh-ancestor
92751162|NCT05276206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751163|NCT05246111|Topotecan|topotecan|mesh-list
92751164|NCT05246111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92751165|NCT05246111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751166|NCT05246111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751167|NCT05246111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751168|NCT05246111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751169|NCT05207436|Oxytocin|oxytocin|mesh-list
92751170|NCT05207436|Oxytocics|oxytocics|mesh-ancestor
92751171|NCT05207436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92751172|NCT05207436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751173|NCT05183828|Letrozole|letrozole|mesh-list
92751174|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751175|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92751176|NCT05183828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92751177|NCT05183828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751178|NCT05183828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751179|NCT05183828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92751180|NCT05183828|Hormone Antagonists|hormone antagonists|mesh-ancestor
92751181|NCT05183828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751182|NCT05183828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751183|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
92751184|NCT05181527|Serotonin|serotonin|mesh-list
92751185|NCT05181527|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92751186|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
92751187|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
92751188|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92751189|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92751190|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751191|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751192|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751193|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92751194|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
92751195|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92751196|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92751197|NCT05168813|Vaccines|vaccines|mesh-list
92751198|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
92751199|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751200|NCT05149131|Leuprolide|leuprolide|mesh-list
92751201|NCT05149131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92751202|NCT05149131|Fertility Agents|fertility agents|mesh-ancestor
92751203|NCT05149131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92751204|NCT05149131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751205|NCT05149131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751206|NCT05149131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751207|NCT05141305|Clopidogrel|clopidogrel|mesh-list
92751208|NCT05141305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751209|NCT05141305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751210|NCT05141305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92751211|NCT05141305|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92751212|NCT05141305|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92751213|NCT05141305|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92751214|NCT05141305|Purinergic Agents|purinergic agents|mesh-ancestor
92751215|NCT05141305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751217|NCT05138822|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92751218|NCT05138822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751219|NCT05138822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92751220|NCT05107674|Paclitaxel|paclitaxel|mesh-list
92751221|NCT05107674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751222|NCT05107674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751223|NCT05107674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751224|NCT05107674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751225|NCT05107674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751226|NCT05107674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751230|NCT05090124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751231|NCT05054842|Metformin|metformin|mesh-list
92614829|NCT03172754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614830|NCT03172754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92614831|NCT03172754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614832|NCT03137888|Temozolomide|temozolomide|mesh-list
92614833|NCT03137888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92614834|NCT03137888|Alkylating Agents|alkylating agents|mesh-ancestor
92614835|NCT03137888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614836|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614837|NCT03123913|Methyltestosterone|methyltestosterone|mesh-list
92614838|NCT03123913|Testosterone|testosterone|mesh-list
92614839|NCT03123913|Testosterone undecanoate|testosterone undecanoate|mesh-list
92614840|NCT03123913|Testosterone enanthate|testosterone enanthate|mesh-list
92614841|NCT03123913|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92614842|NCT03123913|Androgens|androgens|mesh-ancestor
92751232|NCT05054842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92751233|NCT05054842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751234|NCT05022927|Bevacizumab|bevacizumab|mesh-list
92751235|NCT05022927|Atezolizumab|atezolizumab|mesh-list
92751236|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751237|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751238|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92751239|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92751240|NCT05022927|Growth Substances|growth substances|mesh-ancestor
92751241|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751242|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
92751243|NCT05022927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751244|NCT05022927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751245|NCT04984317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92751246|NCT04984317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92751247|NCT04984317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92751248|NCT04984317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751249|NCT04984317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751250|NCT04984317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92751251|NCT04984317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92751252|NCT04984317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751253|NCT04984317|Cholinergic Agents|cholinergic agents|mesh-ancestor
92751254|NCT04984317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751255|NCT04963296|Acetaminophen|acetaminophen|mesh-list
92751256|NCT04963296|Diphenhydramine|diphenhydramine|mesh-list
92751257|NCT04963296|Promethazine|promethazine|mesh-list
92751258|NCT04963296|Methylprednisolone|methylprednisolone|mesh-list
92751259|NCT04963296|Obinutuzumab|obinutuzumab|mesh-list
92751260|NCT04963296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92751261|NCT04963296|Analgesics|analgesics|mesh-ancestor
92751262|NCT04963296|Sensory System Agents|sensory system agents|mesh-ancestor
92751263|NCT04963296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751264|NCT04963296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751265|NCT04963296|Antipyretics|antipyretics|mesh-ancestor
92751266|NCT04963296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751267|NCT04963296|Antiemetics|antiemetics|mesh-ancestor
92751268|NCT04963296|Autonomic Agents|autonomic agents|mesh-ancestor
92751269|NCT04963296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751270|NCT04963296|Glucocorticoids|glucocorticoids|mesh-ancestor
92751271|NCT04963296|Hormones|hormones|mesh-ancestor
92751272|NCT04963296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751273|NCT04963296|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92751274|NCT04963296|Protective Agents|protective agents|mesh-ancestor
92751275|NCT04963296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751276|NCT04963296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751277|NCT04963296|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92614843|NCT03123913|Hormones|hormones|mesh-ancestor
92614844|NCT03123913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614845|NCT03123913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614846|NCT03123913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92614847|NCT03123913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751278|NCT04963296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92751279|NCT04963296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751280|NCT04963296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92751281|NCT04963296|Anesthetics|anesthetics|mesh-ancestor
92751282|NCT04963296|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92751283|NCT04963296|Histamine Antagonists|histamine antagonists|mesh-ancestor
92751284|NCT04963296|Histamine Agents|histamine agents|mesh-ancestor
92751285|NCT04963296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751286|NCT04963296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751287|NCT04963296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92751288|NCT04963296|Antipruritics|antipruritics|mesh-ancestor
92751289|NCT04963296|Dermatologic Agents|dermatologic agents|mesh-ancestor
92751290|NCT04915508|Hormones|hormones|mesh-list
92751291|NCT04915508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751292|NCT04915508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751293|NCT04886531|Trastuzumab|trastuzumab|mesh-list
92751294|NCT04886531|Letrozole|letrozole|mesh-list
92751295|NCT04886531|Anastrozole|anastrozole|mesh-list
92751296|NCT04886531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751297|NCT04886531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751298|NCT04886531|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92751299|NCT04886531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92751301|NCT04886531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751302|NCT04886531|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92751303|NCT04886531|Hormone Antagonists|hormone antagonists|mesh-ancestor
92751304|NCT04886531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751305|NCT04886531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751306|NCT04886531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751308|NCT04844866|Gemcitabine|gemcitabine|mesh-list
92751309|NCT04844866|Oxaliplatin|oxaliplatin|mesh-list
92751310|NCT04844866|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92751311|NCT04844866|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92751312|NCT04844866|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92751313|NCT04844866|Immunoconjugates|immunoconjugates|mesh-list
92751314|NCT04844866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751315|NCT04844866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751316|NCT04844866|Immunologic Factors|immunologic factors|mesh-ancestor
92751317|NCT04844866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751318|NCT04844866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751319|NCT04844866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751320|NCT04844866|Antimetabolites|antimetabolites|mesh-ancestor
92751321|NCT04844866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751322|NCT04844866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92751323|NCT04844866|Alkylating Agents|alkylating agents|mesh-ancestor
92751324|NCT04826003|Obinutuzumab|obinutuzumab|mesh-list
92751325|NCT04826003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751326|NCT04826003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751327|NCT04793867|Xenon|xenon|mesh-list
92751328|NCT04793867|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92751329|NCT04793867|Anesthetics, General|anesthetics, general|mesh-ancestor
92751330|NCT04793867|Anesthetics|anesthetics|mesh-ancestor
92751331|NCT04793867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751332|NCT04793867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751333|NCT04790903|Prednisone|prednisone|mesh-list
92751334|NCT04790903|Cyclophosphamide|cyclophosphamide|mesh-list
92751335|NCT04790903|Rituximab|rituximab|mesh-list
92751336|NCT04790903|Doxorubicin|doxorubicin|mesh-list
92751337|NCT04790903|Venetoclax|venetoclax|mesh-list
92751338|NCT04790903|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92751339|NCT04790903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751340|NCT04790903|Immunologic Factors|immunologic factors|mesh-ancestor
92751341|NCT04790903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751342|NCT04790903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751343|NCT04790903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92614848|NCT03123913|Anabolic Agents|anabolic agents|mesh-ancestor
92614849|NCT03075696|Obinutuzumab|obinutuzumab|mesh-list
92614850|NCT03075696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614851|NCT03075696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614852|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
92614853|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
92614854|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92751344|NCT04790903|Alkylating Agents|alkylating agents|mesh-ancestor
92751345|NCT04790903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751346|NCT04790903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751347|NCT04790903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92751348|NCT04790903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751349|NCT04790903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92751350|NCT04790903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92751351|NCT04790903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751352|NCT04790903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751353|NCT04790903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751354|NCT04790903|Glucocorticoids|glucocorticoids|mesh-ancestor
92751355|NCT04790903|Hormones|hormones|mesh-ancestor
92751356|NCT04790903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751357|NCT04790903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751358|NCT04790903|Immunoconjugates|immunoconjugates|mesh-ancestor
92751359|NCT04740918|Trastuzumab|trastuzumab|mesh-list
92751360|NCT04740918|Atezolizumab|atezolizumab|mesh-list
92751361|NCT04740918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92751362|NCT04740918|Maytansine|maytansine|mesh-list
92751363|NCT04740918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751364|NCT04740918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751365|NCT04740918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751366|NCT04740918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751367|NCT04740918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751368|NCT04740918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751369|NCT04740918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751370|NCT04740918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751371|NCT04740918|Immunotoxins|immunotoxins|mesh-ancestor
92751372|NCT04740918|Immunoconjugates|immunoconjugates|mesh-ancestor
92751373|NCT04740918|Immunologic Factors|immunologic factors|mesh-ancestor
92751382|NCT04736706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751383|NCT04736706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751384|NCT04736173|Paclitaxel|paclitaxel|mesh-list
92751385|NCT04736173|Carboplatin|carboplatin|mesh-list
92751386|NCT04736173|Pembrolizumab|pembrolizumab|mesh-list
92751387|NCT04736173|Pemetrexed|pemetrexed|mesh-list
92751388|NCT04736173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751389|NCT04736173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751390|NCT04736173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751391|NCT04736173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751392|NCT04736173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751393|NCT04736173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751394|NCT04736173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751395|NCT04736173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751396|NCT04736173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751397|NCT04736173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92751398|NCT04736173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92751399|NCT04729387|Paclitaxel|paclitaxel|mesh-list
92751400|NCT04729387|Doxorubicin|doxorubicin|mesh-list
92751401|NCT04729387|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92751402|NCT04729387|Olaparib|olaparib|mesh-list
92751403|NCT04729387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751404|NCT04729387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751405|NCT04729387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751406|NCT04729387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751407|NCT04729387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751408|NCT04729387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751409|NCT04729387|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92751410|NCT04729387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92751411|NCT04729387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751412|NCT04729387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614856|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614857|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
92614858|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92751413|NCT04729387|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92751414|NCT04686786|PF-06372865|pf-06372865|mesh-list
92751415|NCT04686786|GABA Modulators|gaba modulators|mesh-ancestor
92751416|NCT04686786|GABA Agents|gaba agents|mesh-ancestor
92751417|NCT04686786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751418|NCT04686786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751419|NCT04686786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751420|NCT04659603|Gemcitabine|gemcitabine|mesh-list
92751421|NCT04659603|Maytansine|maytansine|mesh-list
92751422|NCT04659603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751423|NCT04659603|Antimetabolites|antimetabolites|mesh-ancestor
92751424|NCT04659603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751425|NCT04659603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751426|NCT04659603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751427|NCT04659603|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751428|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751429|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751430|NCT04616534|Gemcitabine|gemcitabine|mesh-list
92751431|NCT04616534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751432|NCT04616534|Antimetabolites|antimetabolites|mesh-ancestor
92751433|NCT04616534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751434|NCT04616534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751435|NCT04603651|Bamlanivimab|bamlanivimab|mesh-list
92751436|NCT04603651|Antiviral Agents|antiviral agents|mesh-ancestor
92751437|NCT04603651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751438|NCT04600921|Ertugliflozin|ertugliflozin|mesh-list
92751439|NCT04600921|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92751440|NCT04600921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751443|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
92751444|NCT04535401|Leucovorin|leucovorin|mesh-list
92751445|NCT04535401|Folic Acid|folic acid|mesh-list
92751446|NCT04535401|Fluorouracil|fluorouracil|mesh-list
92751447|NCT04535401|Irinotecan|irinotecan|mesh-list
92751448|NCT04535401|Camptothecin|camptothecin|mesh-list
92751449|NCT04535401|Calcium|calcium|mesh-list
92751450|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
92751451|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92751452|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751453|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92751454|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
92751455|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751456|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751457|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751458|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751459|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
92751460|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92751461|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751462|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751463|NCT04535401|Antidotes|antidotes|mesh-ancestor
92751464|NCT04535401|Protective Agents|protective agents|mesh-ancestor
92751465|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
92751466|NCT04535401|Vitamins|vitamins|mesh-ancestor
92751467|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
92751468|NCT04535401|Hematinics|hematinics|mesh-ancestor
92751469|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751470|NCT04531982|Pimavanserin|pimavanserin|mesh-list
92751471|NCT04531982|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92751472|NCT04531982|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92751473|NCT04531982|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92751474|NCT04531982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92751475|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751476|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751477|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92751478|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92751479|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92751480|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
92751481|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751482|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614859|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92614860|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614861|NCT03007238|Aldesleukin|aldesleukin|mesh-list
92614862|NCT03007238|Interleukin-2|interleukin-2|mesh-list
92614863|NCT03007238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614864|NCT03007238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92614865|NCT03007238|Analgesics|analgesics|mesh-ancestor
92614866|NCT03007238|Sensory System Agents|sensory system agents|mesh-ancestor
92021836|NCT04330729|Aspirin|aspirin|mesh-list
92751483|NCT04526288|Cytarabine|cytarabine|mesh-list
92751484|NCT04526288|Daunorubicin|daunorubicin|mesh-list
92751485|NCT04526288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751486|NCT04526288|Antimetabolites|antimetabolites|mesh-ancestor
92751487|NCT04526288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751488|NCT04526288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751489|NCT04526288|Antiviral Agents|antiviral agents|mesh-ancestor
92751490|NCT04526288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751491|NCT04526288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751492|NCT04526288|Immunologic Factors|immunologic factors|mesh-ancestor
92751493|NCT04526288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751494|NCT04526288|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92751495|NCT04526288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92751496|NCT04526288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751497|NCT04526288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751498|NCT04520490|Exenatide|exenatide|mesh-list
92751499|NCT04520490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92751500|NCT04520490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751501|NCT04520490|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92751502|NCT04520490|Incretins|incretins|mesh-ancestor
92751503|NCT04520490|Hormones|hormones|mesh-ancestor
92751504|NCT04520490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751505|NCT04483778|Pembrolizumab|pembrolizumab|mesh-list
92751506|NCT04483778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751507|NCT04483778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751508|NCT04483778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751509|NCT04483778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751510|NCT04482309|Trastuzumab|trastuzumab|mesh-list
92751511|NCT04482309|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92751512|NCT04482309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751513|NCT04482309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751514|NCT04482309|Immunoconjugates|immunoconjugates|mesh-ancestor
92751515|NCT04482309|Immunologic Factors|immunologic factors|mesh-ancestor
92751516|NCT04482309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751518|NCT04480554|Buprenorphine|buprenorphine|mesh-list
92751519|NCT04480554|Methadone|methadone|mesh-list
92751520|NCT04480554|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92751521|NCT04480554|Naloxone|naloxone|mesh-list
92751522|NCT04480554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92751523|NCT04480554|Narcotics|narcotics|mesh-ancestor
92751524|NCT04480554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751525|NCT04480554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751526|NCT04480554|Analgesics|analgesics|mesh-ancestor
92751527|NCT04480554|Sensory System Agents|sensory system agents|mesh-ancestor
92751528|NCT04480554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751529|NCT04480554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92751530|NCT04480554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92751531|NCT04480554|Antitussive Agents|antitussive agents|mesh-ancestor
92751532|NCT04480554|Respiratory System Agents|respiratory system agents|mesh-ancestor
92751533|NCT04454476|Trametinib|trametinib|mesh-list
92751534|NCT04454476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751535|NCT04454476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751536|NCT04454476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751537|NCT04454476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751538|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92751539|NCT04428866|Glucagon|glucagon|mesh-list
92751540|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751541|NCT04428866|Hormones|hormones|mesh-ancestor
92751542|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92614867|NCT03007238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614868|NCT03007238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614870|NCT03007238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92751543|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751544|NCT04410042|Tranexamic Acid|tranexamic acid|mesh-list
92751545|NCT04410042|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92751546|NCT04410042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92751547|NCT04410042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751548|NCT04410042|Hemostatics|hemostatics|mesh-ancestor
92751549|NCT04410042|Coagulants|coagulants|mesh-ancestor
92751550|NCT04408638|Gemcitabine|gemcitabine|mesh-list
92751551|NCT04408638|Oxaliplatin|oxaliplatin|mesh-list
92751552|NCT04408638|Obinutuzumab|obinutuzumab|mesh-list
92751553|NCT04408638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751554|NCT04408638|Antimetabolites|antimetabolites|mesh-ancestor
92751555|NCT04408638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751556|NCT04408638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751557|NCT04408638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751558|NCT04396574|Lasmiditan|lasmiditan|mesh-list
92751559|NCT04396574|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92751560|NCT04396574|Serotonin Agents|serotonin agents|mesh-ancestor
92751561|NCT04396574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751562|NCT04396574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751563|NCT04396574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751564|NCT04396236|Lasmiditan|lasmiditan|mesh-list
92751565|NCT04396236|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92751566|NCT04396236|Serotonin Agents|serotonin agents|mesh-ancestor
92751567|NCT04396236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751568|NCT04396236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751569|NCT04396236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751570|NCT04375605|Leucovorin|leucovorin|mesh-list
92751571|NCT04375605|Docetaxel|docetaxel|mesh-list
92751572|NCT04375605|Fluorouracil|fluorouracil|mesh-list
92751573|NCT04375605|Oxaliplatin|oxaliplatin|mesh-list
92751574|NCT04375605|Calcium|calcium|mesh-list
92751575|NCT04375605|Levoleucovorin|levoleucovorin|mesh-list
92751576|NCT04375605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751577|NCT04375605|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751578|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751579|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751580|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751581|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92751582|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751583|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
92751584|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751585|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751586|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
92751587|NCT04375605|Antidotes|antidotes|mesh-ancestor
92751588|NCT04375605|Protective Agents|protective agents|mesh-ancestor
92751589|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
92751590|NCT04375605|Vitamins|vitamins|mesh-ancestor
92751591|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
92751592|NCT04268498|Acetaminophen|acetaminophen|mesh-list
92751595|NCT04268498|Dexamethasone|dexamethasone|mesh-list
92751598|NCT04268498|Daratumumab|daratumumab|mesh-list
92751599|NCT04268498|Montelukast|montelukast|mesh-list
92751600|NCT04268498|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751601|NCT04268498|Antiemetics|antiemetics|mesh-ancestor
92751602|NCT04268498|Autonomic Agents|autonomic agents|mesh-ancestor
92751603|NCT04268498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751604|NCT04268498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751605|NCT04268498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751606|NCT04268498|Glucocorticoids|glucocorticoids|mesh-ancestor
92751607|NCT04268498|Hormones|hormones|mesh-ancestor
92751608|NCT04268498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751609|NCT04268498|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751610|NCT04268498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751611|NCT04268498|Immunologic Factors|immunologic factors|mesh-ancestor
92751612|NCT04268498|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92751613|NCT04268498|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92751614|NCT04268498|Growth Substances|growth substances|mesh-ancestor
92751615|NCT04268498|Growth Inhibitors|growth inhibitors|mesh-ancestor
92614871|NCT03007238|Antiviral Agents|antiviral agents|mesh-ancestor
92614872|NCT03007238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614873|NCT02902198|Quinine|quinine|mesh-list
92751616|NCT04268498|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92751617|NCT04268498|Analgesics|analgesics|mesh-ancestor
92751618|NCT04268498|Sensory System Agents|sensory system agents|mesh-ancestor
92751619|NCT04268498|Antipyretics|antipyretics|mesh-ancestor
92751620|NCT04268498|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92751621|NCT04268498|Respiratory System Agents|respiratory system agents|mesh-ancestor
92399352|NCT01403363|Anesthetics|anesthetics|mesh-ancestor
92751622|NCT04268498|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92751623|NCT04268498|Hormone Antagonists|hormone antagonists|mesh-ancestor
92751624|NCT04268498|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92751625|NCT04268498|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92751626|NCT04268498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751627|NCT04268498|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92751628|NCT04268498|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92751629|NCT04268498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751630|NCT04268498|Anesthetics, Local|anesthetics, local|mesh-ancestor
92751631|NCT04268498|Anesthetics|anesthetics|mesh-ancestor
92751632|NCT04268498|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92751633|NCT04268498|Histamine Antagonists|histamine antagonists|mesh-ancestor
92751634|NCT04268498|Histamine Agents|histamine agents|mesh-ancestor
92751635|NCT04268498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751636|NCT04268498|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92751637|NCT04268498|Antipruritics|antipruritics|mesh-ancestor
92751638|NCT04268498|Dermatologic Agents|dermatologic agents|mesh-ancestor
92751639|NCT04220931|Botulinum Toxins|botulinum toxins|mesh-list
92751640|NCT04220931|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92751641|NCT04220931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92751642|NCT04220931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751643|NCT04220931|Cholinergic Agents|cholinergic agents|mesh-ancestor
92751644|NCT04220931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751645|NCT04220931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751646|NCT04194775|Lenvatinib|lenvatinib|mesh-list
92751647|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751648|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751649|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751650|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751651|NCT04191499|Fulvestrant|fulvestrant|mesh-list
92751652|NCT04191499|Palbociclib|palbociclib|mesh-list
92751653|NCT04191499|Inavolisib|inavolisib|mesh-list
92751654|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751655|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751656|NCT04191499|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92751657|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92751658|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
92751659|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751660|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751661|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751662|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751663|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751664|NCT04191499|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92751665|NCT04180488|Histamine Antagonists|histamine antagonists|mesh-list
92751666|NCT04180488|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92751669|NCT04180488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751670|NCT04180488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751671|NCT04180488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751672|NCT04144023|Molgramostim|molgramostim|mesh-list
92751673|NCT04144023|Vaccines|vaccines|mesh-list
92751674|NCT04144023|Sargramostim|sargramostim|mesh-list
92751675|NCT04144023|Immunologic Factors|immunologic factors|mesh-ancestor
92751676|NCT04144023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751677|NCT04144023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751678|NCT04098432|Nivolumab|nivolumab|mesh-list
92751679|NCT04098432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751680|NCT04098432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751681|NCT04098432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751682|NCT04098432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751683|NCT04024462|Cyclophosphamide|cyclophosphamide|mesh-list
92751684|NCT04024462|Docetaxel|docetaxel|mesh-list
92751685|NCT04024462|Doxorubicin|doxorubicin|mesh-list
92751686|NCT04024462|Trastuzumab|trastuzumab|mesh-list
92614874|NCT02902198|Antimalarials|antimalarials|mesh-ancestor
92614875|NCT02902198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92614876|NCT02902198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92614877|NCT02902198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614878|NCT02902198|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92614879|NCT02902198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614880|NCT02902198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92614881|NCT02902198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92614882|NCT02902198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92614883|NCT02902198|Analgesics|analgesics|mesh-ancestor
92614884|NCT02902198|Sensory System Agents|sensory system agents|mesh-ancestor
92751688|NCT04024462|Hormones|hormones|mesh-list
92751689|NCT04024462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751690|NCT04024462|Immunologic Factors|immunologic factors|mesh-ancestor
92751691|NCT04024462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751692|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751693|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92751694|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
92751695|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751696|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751697|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92751698|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751699|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751700|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751701|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92751702|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92751703|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751704|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751705|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751706|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751707|NCT04011410|Hydroxychloroquine|hydroxychloroquine|mesh-list
92751708|NCT04011410|Antimalarials|antimalarials|mesh-ancestor
92751709|NCT04011410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92751710|NCT04011410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92751711|NCT04011410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751712|NCT04011410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751713|NCT04011410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751714|NCT04011410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751715|NCT03996850|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92751716|NCT03996850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92751717|NCT03996850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751718|NCT03994627|Olaratumab|olaratumab|mesh-list
92751719|NCT03994627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751720|NCT03971409|Doxorubicin|doxorubicin|mesh-list
92751721|NCT03971409|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92751722|NCT03971409|Avelumab|avelumab|mesh-list
92751723|NCT03971409|Camptothecin|camptothecin|mesh-list
92751724|NCT03971409|Antibodies|antibodies|mesh-list
92751725|NCT03971409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92751726|NCT03971409|Immunoglobulin G|immunoglobulin g|mesh-list
92751727|NCT03971409|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92751728|NCT03971409|Immunoconjugates|immunoconjugates|mesh-list
92751729|NCT03971409|Immunologic Factors|immunologic factors|mesh-ancestor
92751730|NCT03971409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751731|NCT03971409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92751732|NCT03971409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751733|NCT03971409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92751734|NCT03971409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751735|NCT03971409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751736|NCT03971409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751737|NCT03971409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751738|NCT03971409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92614885|NCT02888743|Durvalumab|durvalumab|mesh-list
92614886|NCT02888743|Ipilimumab|ipilimumab|mesh-list
92614887|NCT02888743|Tremelimumab|tremelimumab|mesh-list
92614888|NCT02888743|Immunoglobulins|immunoglobulins|mesh-list
92614889|NCT02888743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92614890|NCT02888743|Immunoglobulin G|immunoglobulin g|mesh-list
92021856|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92751739|NCT03971409|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92751740|NCT03920007|Trimethoprim|trimethoprim|mesh-list
92751741|NCT03920007|Polymyxins|polymyxins|mesh-list
92751742|NCT03920007|Polymyxin B|polymyxin b|mesh-list
92751743|NCT03920007|Prednisone|prednisone|mesh-list
92751744|NCT03920007|Prednisolone|prednisolone|mesh-list
92751745|NCT03920007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751746|NCT03920007|Glucocorticoids|glucocorticoids|mesh-ancestor
92751747|NCT03920007|Hormones|hormones|mesh-ancestor
92751748|NCT03920007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751749|NCT03920007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751750|NCT03920007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751751|NCT03920007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751752|NCT03920007|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92751753|NCT03920007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751754|NCT03920007|Antimalarials|antimalarials|mesh-ancestor
92751755|NCT03920007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92751756|NCT03920007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92751757|NCT03920007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92751758|NCT03920007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751759|NCT03920007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751760|NCT03920007|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92751761|NCT03920007|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92751762|NCT03920007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92751763|NCT03920007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92751764|NCT03909165|Atropine|atropine|mesh-list
92751765|NCT03909165|Glycopyrrolate|glycopyrrolate|mesh-list
92751766|NCT03909165|Neostigmine|neostigmine|mesh-list
92751767|NCT03909165|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92751768|NCT03909165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92751769|NCT03909165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92751770|NCT03909165|Autonomic Agents|autonomic agents|mesh-ancestor
92751771|NCT03909165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751772|NCT03909165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751773|NCT03909165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92751774|NCT03909165|Respiratory System Agents|respiratory system agents|mesh-ancestor
92751775|NCT03909165|Mydriatics|mydriatics|mesh-ancestor
92751776|NCT03909165|Parasympatholytics|parasympatholytics|mesh-ancestor
92751777|NCT03909165|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92751778|NCT03909165|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92751779|NCT03909165|Cholinergic Agents|cholinergic agents|mesh-ancestor
92751780|NCT03909165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751781|NCT03909165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751782|NCT03909165|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92751783|NCT03909165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751784|NCT03909165|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92751785|NCT03906136|Adalimumab|adalimumab|mesh-list
92751786|NCT03906136|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92751787|NCT03906136|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751788|NCT03906136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751789|NCT03875573|Durvalumab|durvalumab|mesh-list
92751790|NCT03875573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751791|NCT03875573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751792|NCT03846310|Carboplatin|carboplatin|mesh-list
92751793|NCT03846310|Pembrolizumab|pembrolizumab|mesh-list
92751794|NCT03846310|Pemetrexed|pemetrexed|mesh-list
92751795|NCT03846310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751796|NCT03846310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751797|NCT03846310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751798|NCT03846310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751799|NCT03846310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614891|NCT02888743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614892|NCT02888743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614893|NCT02888743|Immunologic Factors|immunologic factors|mesh-ancestor
92614894|NCT02888743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614895|NCT02888743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614896|NCT02888743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614897|NCT02858869|Pembrolizumab|pembrolizumab|mesh-list
92614898|NCT02858869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614899|NCT02858869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614900|NCT02858869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614901|NCT02858869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614902|NCT02811523|Doxorubicin|doxorubicin|mesh-list
92614903|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92614904|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614905|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92614906|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92751800|NCT03846310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92751801|NCT03846310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92751802|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92751803|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
92751804|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751805|NCT03800524|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92751806|NCT03800524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751807|NCT03782207|Atezolizumab|atezolizumab|mesh-list
92751811|NCT03782207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399366|NCT01403415|Pegaspargase|pegaspargase|mesh-list
92751812|NCT03760523|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
92751813|NCT03760523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92751814|NCT03760523|Alkylating Agents|alkylating agents|mesh-ancestor
92751815|NCT03760523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751816|NCT03760523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751818|NCT03712943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751819|NCT03712943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751820|NCT03712943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751821|NCT03712943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751822|NCT03695744|Dexamethasone|dexamethasone|mesh-list
92751823|NCT03695744|Bortezomib|bortezomib|mesh-list
92751824|NCT03695744|Daratumumab|daratumumab|mesh-list
92751825|NCT03695744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751826|NCT03695744|Antiemetics|antiemetics|mesh-ancestor
92751827|NCT03695744|Autonomic Agents|autonomic agents|mesh-ancestor
92751828|NCT03695744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751829|NCT03695744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751830|NCT03695744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751831|NCT03695744|Glucocorticoids|glucocorticoids|mesh-ancestor
92751832|NCT03695744|Hormones|hormones|mesh-ancestor
92751833|NCT03695744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751834|NCT03695744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751835|NCT03695744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751836|NCT03690869|Cemiplimab|cemiplimab|mesh-list
92751837|NCT03690869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751838|NCT03690869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751839|NCT03637764|Atezolizumab|atezolizumab|mesh-list
92751840|NCT03637764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751841|NCT03637764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614907|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614908|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614909|NCT02750319|Acetylcysteine|acetylcysteine|mesh-list
92614910|NCT02750319|Amiodarone|amiodarone|mesh-list
92751842|NCT03637764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751843|NCT03637764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751844|NCT03611595|Tretinoin|tretinoin|mesh-list
92751845|NCT03611595|Isotretinoin|isotretinoin|mesh-list
92751846|NCT03611595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751847|NCT03611595|Keratolytic Agents|keratolytic agents|mesh-ancestor
92751848|NCT03611595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92751849|NCT03481569|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92751850|NCT03481569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751851|NCT03442556|Carboplatin|carboplatin|mesh-list
92751852|NCT03442556|Docetaxel|docetaxel|mesh-list
92751853|NCT03442556|Rucaparib|rucaparib|mesh-list
92751854|NCT03442556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751855|NCT03442556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751856|NCT03442556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751857|NCT03442556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751858|NCT03442556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751859|NCT03442556|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92751860|NCT03442556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751861|NCT03401853|Rituximab|rituximab|mesh-list
92751862|NCT03401853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92751863|NCT03401853|Pembrolizumab|pembrolizumab|mesh-list
92751864|NCT03401853|Obinutuzumab|obinutuzumab|mesh-list
92751865|NCT03401853|Antibodies|antibodies|mesh-list
92751866|NCT03401853|Immunoglobulins|immunoglobulins|mesh-list
92751867|NCT03401853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92751868|NCT03401853|Immunologic Factors|immunologic factors|mesh-ancestor
92751869|NCT03401853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751870|NCT03401853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751871|NCT03401853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751872|NCT03401853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751873|NCT03401853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751874|NCT03374085|Dexamethasone|dexamethasone|mesh-list
92751875|NCT03374085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751876|NCT03374085|Antiemetics|antiemetics|mesh-ancestor
92751877|NCT03374085|Autonomic Agents|autonomic agents|mesh-ancestor
92751878|NCT03374085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399368|NCT01403415|BB 1101|bb 1101|mesh-list
92751880|NCT03374085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751881|NCT03374085|Glucocorticoids|glucocorticoids|mesh-ancestor
92751882|NCT03374085|Hormones|hormones|mesh-ancestor
92751883|NCT03374085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751884|NCT03374085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92751885|NCT03374085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751886|NCT03367533|Ketamine|ketamine|mesh-list
92751887|NCT03367533|Analgesics|analgesics|mesh-ancestor
92751888|NCT03367533|Sensory System Agents|sensory system agents|mesh-ancestor
92751889|NCT03367533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92751890|NCT03367533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751891|NCT03367533|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92751892|NCT03367533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92751893|NCT03367533|Anesthetics, General|anesthetics, general|mesh-ancestor
92751894|NCT03367533|Anesthetics|anesthetics|mesh-ancestor
92751895|NCT03367533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751896|NCT03367533|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92751897|NCT03367533|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92751898|NCT03367533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92751899|NCT03367533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751900|NCT03338959|Pembrolizumab|pembrolizumab|mesh-list
92751901|NCT03338959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751902|NCT03338959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751903|NCT03338959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751904|NCT03338959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751905|NCT03281369|Leucovorin|leucovorin|mesh-list
92751906|NCT03281369|Linagliptin|linagliptin|mesh-list
92751907|NCT03281369|Paclitaxel|paclitaxel|mesh-list
92751908|NCT03281369|Fluorouracil|fluorouracil|mesh-list
92751909|NCT03281369|Oxaliplatin|oxaliplatin|mesh-list
92751910|NCT03281369|Atezolizumab|atezolizumab|mesh-list
92751911|NCT03281369|Ramucirumab|ramucirumab|mesh-list
92614911|NCT02750319|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92614912|NCT02750319|Antiviral Agents|antiviral agents|mesh-ancestor
92614913|NCT02750319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92614914|NCT02750319|Expectorants|expectorants|mesh-ancestor
92614915|NCT02750319|Respiratory System Agents|respiratory system agents|mesh-ancestor
92751912|NCT03281369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92751913|NCT03281369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751914|NCT03281369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751915|NCT03281369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751916|NCT03281369|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751917|NCT03281369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751918|NCT03281369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751919|NCT03281369|Antimetabolites|antimetabolites|mesh-ancestor
92751920|NCT03281369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92751921|NCT03281369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751922|NCT03281369|Immunologic Factors|immunologic factors|mesh-ancestor
92751923|NCT03281369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751924|NCT03281369|Antidotes|antidotes|mesh-ancestor
92751925|NCT03281369|Protective Agents|protective agents|mesh-ancestor
92751926|NCT03281369|Vitamin B Complex|vitamin b complex|mesh-ancestor
92751927|NCT03281369|Vitamins|vitamins|mesh-ancestor
92751928|NCT03281369|Micronutrients|micronutrients|mesh-ancestor
92751929|NCT03281369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751930|NCT03281369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751931|NCT03281369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92751932|NCT03281369|Incretins|incretins|mesh-ancestor
92751933|NCT03281369|Hormones|hormones|mesh-ancestor
92751934|NCT03281369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92751935|NCT03281369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92751936|NCT03281369|Protease Inhibitors|protease inhibitors|mesh-ancestor
92751937|NCT03281369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751938|NCT03222076|Nivolumab|nivolumab|mesh-list
92751939|NCT03222076|Ipilimumab|ipilimumab|mesh-list
92751940|NCT03222076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751941|NCT03222076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751942|NCT03222076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751943|NCT03222076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751944|NCT03215706|Paclitaxel|paclitaxel|mesh-list
92751945|NCT03215706|Carboplatin|carboplatin|mesh-list
92751946|NCT03215706|Nivolumab|nivolumab|mesh-list
92751947|NCT03215706|Pemetrexed|pemetrexed|mesh-list
92751948|NCT03215706|Ipilimumab|ipilimumab|mesh-list
92751949|NCT03215706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92751950|NCT03215706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751951|NCT03215706|Tubulin Modulators|tubulin modulators|mesh-ancestor
92751952|NCT03215706|Antimitotic Agents|antimitotic agents|mesh-ancestor
92751953|NCT03215706|Mitosis Modulators|mitosis modulators|mesh-ancestor
92751963|NCT03190265|Pancrelipase|pancrelipase|mesh-list
92751964|NCT03190265|Vaccines|vaccines|mesh-list
92751965|NCT03190265|Immunologic Factors|immunologic factors|mesh-ancestor
92751966|NCT03190265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751967|NCT03190265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92751968|NCT03190265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92751969|NCT03190265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92751970|NCT03190265|Alkylating Agents|alkylating agents|mesh-ancestor
92751971|NCT03190265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751972|NCT03190265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751973|NCT03190265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92751974|NCT03190265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751975|NCT03190265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751976|NCT03190265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751977|NCT03141177|Nivolumab|nivolumab|mesh-list
92751978|NCT03141177|Ipilimumab|ipilimumab|mesh-list
92751979|NCT03141177|Sunitinib|sunitinib|mesh-list
92751980|NCT03141177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751981|NCT03141177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751982|NCT03141177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751983|NCT03141177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751984|NCT03141177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92751985|NCT03141177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92751986|NCT03141177|Growth Substances|growth substances|mesh-ancestor
92751987|NCT03141177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614916|NCT02750319|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92614917|NCT02750319|Antioxidants|antioxidants|mesh-ancestor
92614918|NCT02750319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614919|NCT02750319|Protective Agents|protective agents|mesh-ancestor
92614920|NCT02750319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614921|NCT02750319|Antidotes|antidotes|mesh-ancestor
92614922|NCT02750319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92614923|NCT02750319|Vasodilator Agents|vasodilator agents|mesh-ancestor
92614924|NCT02750319|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92614925|NCT02750319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92614926|NCT02750319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92614927|NCT02750319|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92614928|NCT02750319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92614929|NCT02750319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614930|NCT02750319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92614931|NCT02750319|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92614932|NCT02750319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92614933|NCT02636582|Molgramostim|molgramostim|mesh-list
92614934|NCT02636582|Vaccines|vaccines|mesh-list
92614935|NCT02636582|Sargramostim|sargramostim|mesh-list
92614936|NCT02636582|Immunologic Factors|immunologic factors|mesh-ancestor
92614937|NCT02636582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92614938|NCT02636582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614939|NCT02611258|Tadalafil|tadalafil|mesh-list
92614940|NCT02611258|Vasodilator Agents|vasodilator agents|mesh-ancestor
92614941|NCT02611258|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92751988|NCT03141177|Growth Inhibitors|growth inhibitors|mesh-ancestor
92751989|NCT03141177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92751990|NCT03141177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751991|NCT02996487|Vancomycin|vancomycin|mesh-list
92751992|NCT02996487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92751993|NCT02996487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92751994|NCT02985957|Prednisone|prednisone|mesh-list
92751995|NCT02985957|Nivolumab|nivolumab|mesh-list
92751996|NCT02985957|Ipilimumab|ipilimumab|mesh-list
92751997|NCT02985957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751998|NCT02985957|Glucocorticoids|glucocorticoids|mesh-ancestor
92751999|NCT02985957|Hormones|hormones|mesh-ancestor
92752000|NCT02985957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752001|NCT02985957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752002|NCT02985957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752003|NCT02985957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752004|NCT02985957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752005|NCT02985957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92752006|NCT02985957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752007|NCT02936843|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92752008|NCT02936843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92614942|NCT02611258|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92614943|NCT02611258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92614944|NCT02611258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752009|NCT02936843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92752010|NCT02936843|Analgesics|analgesics|mesh-ancestor
92752011|NCT02936843|Sensory System Agents|sensory system agents|mesh-ancestor
92752012|NCT02936843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752013|NCT02936843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752014|NCT02936843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752015|NCT02936843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752016|NCT02908477|Docetaxel|docetaxel|mesh-list
92752017|NCT02908477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752018|NCT02908477|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752019|NCT02908477|Antimitotic Agents|antimitotic agents|mesh-ancestor
92752029|NCT02811861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752031|NCT02811861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92752032|NCT02811861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752033|NCT02811861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752034|NCT02811861|Immunologic Factors|immunologic factors|mesh-ancestor
92752035|NCT02811861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752036|NCT02811861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92752037|NCT02811861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92752038|NCT02811861|Growth Substances|growth substances|mesh-ancestor
92752039|NCT02811861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92752040|NCT02744612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92752041|NCT02744612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92752042|NCT02744612|Antibodies|antibodies|mesh-list
92752043|NCT02744612|Immunoglobulins|immunoglobulins|mesh-list
92752044|NCT02744612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92752045|NCT02744612|Immunoconjugates|immunoconjugates|mesh-list
92752046|NCT02744612|Immunologic Factors|immunologic factors|mesh-ancestor
92752047|NCT02744612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752048|NCT02744612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752049|NCT02744612|Immunotoxins|immunotoxins|mesh-ancestor
92752050|NCT02700451|Acetaminophen|acetaminophen|mesh-list
92752051|NCT02700451|Ketorolac|ketorolac|mesh-list
92752052|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92752053|NCT02700451|Analgesics|analgesics|mesh-ancestor
92752054|NCT02700451|Sensory System Agents|sensory system agents|mesh-ancestor
92752055|NCT02700451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752056|NCT02700451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752057|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
92752058|NCT02700451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92752059|NCT02700451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752060|NCT02700451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752061|NCT02700451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92752062|NCT02700451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752063|NCT02700451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752064|NCT02697344|Acetic Acid|acetic acid|mesh-list
92752065|NCT02697344|Dexamethasone|dexamethasone|mesh-list
92752066|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
92752067|NCT02697344|Lenalidomide|lenalidomide|mesh-list
92752068|NCT02697344|Retinol acetate|retinol acetate|mesh-list
92752069|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
92752070|NCT02697344|Gossypol|gossypol|mesh-list
92752071|NCT02697344|BB 1101|bb 1101|mesh-list
92752072|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752073|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
92752074|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
92752075|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752076|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752077|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752078|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
92752079|NCT02697344|Hormones|hormones|mesh-ancestor
92752080|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752081|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752082|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752083|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
92752084|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92752085|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92752086|NCT02697344|Growth Substances|growth substances|mesh-ancestor
92752093|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92614946|NCT02532231|Nivolumab|nivolumab|mesh-list
92614947|NCT02532231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752094|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92752095|NCT02697344|Protective Agents|protective agents|mesh-ancestor
92752096|NCT02697344|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92752097|NCT02697344|Contraceptive Agents|contraceptive agents|mesh-ancestor
92752098|NCT02697344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752099|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92752100|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92752101|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92752102|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92752103|NCT02667418|Vancomycin|vancomycin|mesh-list
92752104|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
92752105|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752106|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752107|NCT02623426|Dexamethasone|dexamethasone|mesh-list
92752108|NCT02623426|Methotrexate|methotrexate|mesh-list
92752109|NCT02623426|Ranibizumab|ranibizumab|mesh-list
92752110|NCT02623426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752111|NCT02623426|Antiemetics|antiemetics|mesh-ancestor
92752112|NCT02623426|Autonomic Agents|autonomic agents|mesh-ancestor
92752113|NCT02623426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752114|NCT02623426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752115|NCT02623426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752116|NCT02623426|Glucocorticoids|glucocorticoids|mesh-ancestor
92752117|NCT02623426|Hormones|hormones|mesh-ancestor
92752118|NCT02623426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752119|NCT02623426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752120|NCT02623426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752121|NCT02623426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92752122|NCT02623426|Abortifacient Agents|abortifacient agents|mesh-ancestor
92752123|NCT02623426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752124|NCT02623426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92752125|NCT02623426|Antimetabolites|antimetabolites|mesh-ancestor
92752126|NCT02623426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752127|NCT02623426|Dermatologic Agents|dermatologic agents|mesh-ancestor
92752128|NCT02623426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752129|NCT02623426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92752130|NCT02623426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752131|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
92752132|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752133|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92752134|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92752135|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92752136|NCT02623426|Growth Substances|growth substances|mesh-ancestor
92752137|NCT02623426|Growth Inhibitors|growth inhibitors|mesh-ancestor
92752138|NCT02580058|Doxorubicin|doxorubicin|mesh-list
92752139|NCT02580058|Avelumab|avelumab|mesh-list
92752140|NCT02580058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752141|NCT02580058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752142|NCT02580058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92752143|NCT02580058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92752144|NCT02580058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752145|NCT02580058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752146|NCT02580058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752147|NCT02539394|Methylprednisolone|methylprednisolone|mesh-list
92752148|NCT02539394|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92752149|NCT02539394|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92752150|NCT02539394|Prednisolone|prednisolone|mesh-list
92752151|NCT02539394|Prednisolone acetate|prednisolone acetate|mesh-list
92752152|NCT02539394|Hemostatics|hemostatics|mesh-list
92752153|NCT02539394|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92752154|NCT02539394|Prednisolone phosphate|prednisolone phosphate|mesh-list
92752155|NCT02539394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752157|NCT02539394|Autonomic Agents|autonomic agents|mesh-ancestor
92752158|NCT02539394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752159|NCT02539394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752160|NCT02539394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752161|NCT02539394|Glucocorticoids|glucocorticoids|mesh-ancestor
92752162|NCT02539394|Hormones|hormones|mesh-ancestor
92752163|NCT02539394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752164|NCT02539394|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92614948|NCT02532231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614949|NCT02532231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92614950|NCT02532231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614951|NCT02500407|Atezolizumab|atezolizumab|mesh-list
92614952|NCT02500407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92021920|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752165|NCT02539394|Protective Agents|protective agents|mesh-ancestor
92752166|NCT02539394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752167|NCT02539394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752168|NCT02539394|Coagulants|coagulants|mesh-ancestor
92752169|NCT02530437|Paclitaxel|paclitaxel|mesh-list
92752170|NCT02530437|Carboplatin|carboplatin|mesh-list
92752171|NCT02530437|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92752172|NCT02530437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92752173|NCT02530437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752174|NCT02530437|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752175|NCT02530437|Antimitotic Agents|antimitotic agents|mesh-ancestor
92752176|NCT02530437|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752177|NCT02530437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752178|NCT02412670|Cisplatin|cisplatin|mesh-list
92752179|NCT02412670|Carboplatin|carboplatin|mesh-list
92752180|NCT02412670|Gemcitabine|gemcitabine|mesh-list
92752181|NCT02412670|Doxorubicin|doxorubicin|mesh-list
92752182|NCT02412670|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92752183|NCT02412670|Methotrexate|methotrexate|mesh-list
92752184|NCT02412670|Vinblastine|vinblastine|mesh-list
92752185|NCT02412670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752186|NCT02412670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92752187|NCT02412670|Antimetabolites|antimetabolites|mesh-ancestor
92752188|NCT02412670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752189|NCT02412670|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752190|NCT02412670|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92752191|NCT02412670|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92752192|NCT02412670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752193|NCT02412670|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92752194|NCT02412670|Abortifacient Agents|abortifacient agents|mesh-ancestor
92752195|NCT02412670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752196|NCT02412670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752197|NCT02412670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92752198|NCT02412670|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92752199|NCT02412670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752200|NCT02412670|Immunologic Factors|immunologic factors|mesh-ancestor
92752201|NCT02412670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752202|NCT02412670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92752203|NCT02412670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92752204|NCT02412670|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752205|NCT02412670|Antimitotic Agents|antimitotic agents|mesh-ancestor
92752206|NCT02412670|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752207|NCT02141438|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92752208|NCT02141438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752209|NCT01961375|Levonorgestrel|levonorgestrel|mesh-list
92752210|NCT01961375|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92752211|NCT01961375|Contraceptive Agents|contraceptive agents|mesh-ancestor
92752212|NCT01961375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752213|NCT01961375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752214|NCT01961375|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92752215|NCT01961375|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92752216|NCT01961375|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92752217|NCT01889199|Flutamide|flutamide|mesh-list
92752218|NCT01889199|Androgen Antagonists|androgen antagonists|mesh-ancestor
92752219|NCT01889199|Hormone Antagonists|hormone antagonists|mesh-ancestor
92752220|NCT01889199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752221|NCT01889199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752222|NCT01889199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752223|NCT01889199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752224|NCT01737502|Sirolimus|sirolimus|mesh-list
92752225|NCT01737502|Auranofin|auranofin|mesh-list
92752226|NCT01737502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752227|NCT01737502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399384|NCT01403415|Antimetabolites|antimetabolites|mesh-ancestor
92614953|NCT02500407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92614954|NCT02500407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614955|NCT02500407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614956|NCT02367040|Rituximab|rituximab|mesh-list
92614957|NCT02367040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92614958|NCT02367040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92614959|NCT02367040|Immunologic Factors|immunologic factors|mesh-ancestor
92752228|NCT01737502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752229|NCT01737502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752230|NCT01737502|Antifungal Agents|antifungal agents|mesh-ancestor
92752232|NCT01737502|Immunologic Factors|immunologic factors|mesh-ancestor
92752233|NCT01737502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752234|NCT01737502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752236|NCT01666080|Busulfan|busulfan|mesh-list
92752237|NCT01666080|Levetiracetam|levetiracetam|mesh-list
92752238|NCT01666080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752239|NCT01666080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752240|NCT01666080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752241|NCT01666080|Immunologic Factors|immunologic factors|mesh-ancestor
92752242|NCT01666080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752243|NCT01666080|Alkylating Agents|alkylating agents|mesh-ancestor
92752244|NCT01666080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92752245|NCT01666080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92752246|NCT01666080|Anticonvulsants|anticonvulsants|mesh-ancestor
92752247|NCT01666080|Nootropic Agents|nootropic agents|mesh-ancestor
92752248|NCT01358877|Paclitaxel|paclitaxel|mesh-list
92752249|NCT01358877|Docetaxel|docetaxel|mesh-list
92752250|NCT01358877|Cyclophosphamide|cyclophosphamide|mesh-list
92752251|NCT01358877|Carboplatin|carboplatin|mesh-list
92752252|NCT01358877|Doxorubicin|doxorubicin|mesh-list
92752253|NCT01358877|Fluorouracil|fluorouracil|mesh-list
92752254|NCT01358877|Trastuzumab|trastuzumab|mesh-list
92752255|NCT01358877|Epirubicin|epirubicin|mesh-list
92752256|NCT01358877|Pertuzumab|pertuzumab|mesh-list
92752257|NCT01358877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92752258|NCT01358877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752259|NCT01358877|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752260|NCT01358877|Antimitotic Agents|antimitotic agents|mesh-ancestor
92752261|NCT01358877|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752262|NCT01358877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752263|NCT01358877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752264|NCT01358877|Immunologic Factors|immunologic factors|mesh-ancestor
92752265|NCT01358877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752266|NCT01358877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752267|NCT01358877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92752268|NCT01358877|Alkylating Agents|alkylating agents|mesh-ancestor
92752269|NCT01358877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92752270|NCT01358877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752271|NCT01358877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92752272|NCT01358877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92752273|NCT01358877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752274|NCT01358877|Antimetabolites|antimetabolites|mesh-ancestor
92752275|NCT01358877|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92752276|NCT01358877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752277|NCT01084252|Dexamethasone|dexamethasone|mesh-list
92752278|NCT01084252|Dexamethasone acetate|dexamethasone acetate|mesh-list
92752279|NCT01084252|BB 1101|bb 1101|mesh-list
92752280|NCT01084252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752281|NCT01084252|Antiemetics|antiemetics|mesh-ancestor
92752282|NCT01084252|Autonomic Agents|autonomic agents|mesh-ancestor
92752283|NCT01084252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752284|NCT01084252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752285|NCT01084252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752286|NCT01084252|Glucocorticoids|glucocorticoids|mesh-ancestor
92752287|NCT01084252|Hormones|hormones|mesh-ancestor
92752288|NCT01084252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752289|NCT01084252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752290|NCT01084252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752291|NCT01084252|Protease Inhibitors|protease inhibitors|mesh-ancestor
92614960|NCT02367040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615037|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
92615042|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
92615111|NCT00516958|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92615182|NCT00517621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615183|NCT00151515|Minoxidil|minoxidil|mesh-list
92399386|NCT01403415|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615255|NCT00151632|Antitubercular Agents|antitubercular agents|mesh-ancestor
92615256|NCT00151632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615257|NCT00151632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92615258|NCT02949232|Prednisolone|prednisolone|mesh-list
92615327|NCT02949349|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92615328|NCT02949349|Antitubercular Agents|antitubercular agents|mesh-ancestor
92615329|NCT02949349|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92615331|NCT02949349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615399|NCT00151749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92615400|NCT00151749|Antimetabolites|antimetabolites|mesh-ancestor
92615403|NCT00166881|Docetaxel|docetaxel|mesh-list
92615471|NCT04457180|Repaglinide|repaglinide|mesh-list
92615472|NCT04457180|Apatinib|apatinib|mesh-list
92615473|NCT04457180|Bupropion|bupropion|mesh-list
92615474|NCT04457180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615476|NCT04457180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615541|NCT00520585|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92615542|NCT00520585|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92615543|NCT00520585|Antimetabolites|antimetabolites|mesh-ancestor
92615544|NCT00520585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615545|NCT00520585|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92615546|NCT00520585|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92615547|NCT00520585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615548|NCT00152022|Amphetamine|amphetamine|mesh-list
92615549|NCT00152022|Dextroamphetamine|dextroamphetamine|mesh-list
92615550|NCT00152022|Adderall|adderall|mesh-list
92615551|NCT00152022|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92615553|NCT00152022|Sympathomimetics|sympathomimetics|mesh-ancestor
92615601|NCT04694092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615602|NCT04694092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92615674|NCT03458923|Endothelial Growth Factors|endothelial growth factors|mesh-list
92615675|NCT03458923|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92615676|NCT03458923|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92615677|NCT03458923|Growth Substances|growth substances|mesh-ancestor
92615678|NCT03458923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615679|NCT03458923|Growth Inhibitors|growth inhibitors|mesh-ancestor
92615680|NCT03458923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92615681|NCT03458923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92615682|NCT03458923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92615683|NCT03458923|Analgesics|analgesics|mesh-ancestor
92615684|NCT03458923|Sensory System Agents|sensory system agents|mesh-ancestor
92615685|NCT03458923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92615686|NCT03458923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615687|NCT03458923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92615688|NCT03458923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92615734|NCT00152178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92615735|NCT00152178|Alkylating Agents|alkylating agents|mesh-ancestor
92615804|NCT04726553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92615815|NCT02947945|Reslizumab|reslizumab|mesh-list
92615878|NCT00523354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92615879|NCT00523354|Dermatologic Agents|dermatologic agents|mesh-ancestor
92615880|NCT00523354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92615881|NCT00523354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92615882|NCT00523393|Insulin|insulin|mesh-list
92615883|NCT00523393|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92615884|NCT00523393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92615885|NCT00523393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92615886|NCT00523432|Sirolimus|sirolimus|mesh-list
92615887|NCT00523432|Topotecan|topotecan|mesh-list
92615888|NCT00523432|Temsirolimus|temsirolimus|mesh-list
92615889|NCT00523432|MTOR Inhibitors|mtor inhibitors|mesh-list
92615943|NCT00167583|Immunologic Factors|immunologic factors|mesh-ancestor
92616021|NCT00512668|Immunologic Factors|immunologic factors|mesh-ancestor
92616022|NCT00512668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92616023|NCT00512668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616094|NCT03879122|Hormones|hormones|mesh-ancestor
92616095|NCT03879122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616096|NCT03879122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616122|NCT02947711|Diltiazem|diltiazem|mesh-list
92616161|NCT00167856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92616162|NCT00167856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92399387|NCT01403415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616163|NCT00167856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616164|NCT00167856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616229|NCT03585452|Dexmedetomidine|dexmedetomidine|mesh-list
92616230|NCT03585452|Propofol|propofol|mesh-list
92616231|NCT03585452|Anesthetics|anesthetics|mesh-ancestor
92616236|NCT03585452|Analgesics|analgesics|mesh-ancestor
92616303|NCT00526318|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92616304|NCT00526318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92616305|NCT00526318|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92616306|NCT04693312|Methylprednisolone|methylprednisolone|mesh-list
92616307|NCT04693312|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92616308|NCT04693312|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92616309|NCT04693312|Prednisolone|prednisolone|mesh-list
92616371|NCT03186755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92616372|NCT03186755|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92616373|NCT03186755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92616374|NCT03186755|Histamine Antagonists|histamine antagonists|mesh-ancestor
92616375|NCT03186755|Histamine Agents|histamine agents|mesh-ancestor
92616376|NCT03186755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616377|NCT03186755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616378|NCT00525616|Rituximab|rituximab|mesh-list
92616379|NCT00525616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92616380|NCT00525616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92616381|NCT00525616|Immunologic Factors|immunologic factors|mesh-ancestor
92616382|NCT00525616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616383|NCT00525616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616384|NCT00525694|Cocaine|cocaine|mesh-list
92616385|NCT00525694|Anesthetics, Local|anesthetics, local|mesh-ancestor
92616386|NCT00525694|Anesthetics|anesthetics|mesh-ancestor
92616387|NCT00525694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92616388|NCT00525694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616389|NCT00525694|Sensory System Agents|sensory system agents|mesh-ancestor
92616390|NCT00525694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616391|NCT00525694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92616392|NCT00525694|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92616393|NCT00525694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92616394|NCT00525694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92616395|NCT00525694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616419|NCT00527020|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92616420|NCT00527020|Autonomic Agents|autonomic agents|mesh-ancestor
92616421|NCT00527020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616422|NCT00527020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616423|NCT00527020|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92616424|NCT00527020|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92616425|NCT00527020|Cholinergic Agents|cholinergic agents|mesh-ancestor
92616426|NCT00527020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616485|NCT03122639|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92616486|NCT03122639|Antimetabolites|antimetabolites|mesh-ancestor
92616487|NCT03122639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616488|NCT03122639|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92616489|NCT03122639|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92616490|NCT03122639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616491|NCT00527137|Darbepoetin alfa|darbepoetin alfa|mesh-list
92616492|NCT00527137|Hematinics|hematinics|mesh-ancestor
92616553|NCT00173667|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92616623|NCT02945527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92616624|NCT02945527|Antiemetics|antiemetics|mesh-ancestor
92616625|NCT02945527|Autonomic Agents|autonomic agents|mesh-ancestor
92616693|NCT00529750|Sympatholytics|sympatholytics|mesh-ancestor
92616694|NCT00529750|Autonomic Agents|autonomic agents|mesh-ancestor
92616695|NCT00529750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92616696|NCT00529750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92616697|NCT00529750|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92616698|NCT00529750|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92616699|NCT00529750|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92616700|NCT00529750|Adrenergic Agents|adrenergic agents|mesh-ancestor
92616701|NCT00529750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616757|NCT04692376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616758|NCT04692376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92616759|NCT04692376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92616760|NCT04692376|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92348198|NCT01565694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92616762|NCT04692376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92616763|NCT00527683|Vigabatrin|vigabatrin|mesh-list
92616764|NCT00527683|Anticonvulsants|anticonvulsants|mesh-ancestor
92616765|NCT00527683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616766|NCT00527683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616767|NCT00527683|GABA Agents|gaba agents|mesh-ancestor
92616768|NCT00527683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92616773|NCT00527761|Cisplatin|cisplatin|mesh-list
92616820|NCT00144677|Sirolimus|sirolimus|mesh-list
92616894|NCT00144833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92616895|NCT00144833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616896|NCT00144833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92616897|NCT00144833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92616898|NCT00144833|Antiviral Agents|antiviral agents|mesh-ancestor
92616899|NCT00144833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92616900|NCT00144833|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92616901|NCT00144833|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92616902|NCT02944942|Anesthetics|anesthetics|mesh-list
92616905|NCT00144872|Lamotrigine|lamotrigine|mesh-list
92616961|NCT00144911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92616962|NCT00168597|Vitamin A|vitamin a|mesh-list
92616963|NCT00168597|Vitamins|vitamins|mesh-ancestor
92617030|NCT00168714|Interferon-beta|interferon-beta|mesh-list
92617031|NCT00168714|Interferon beta-1a|interferon beta-1a|mesh-list
92617032|NCT00168714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617104|NCT00145106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92617106|NCT00145184|Vitamins|vitamins|mesh-list
92617176|NCT00168870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617177|NCT00168870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92617178|NCT00168870|Alkylating Agents|alkylating agents|mesh-ancestor
92617179|NCT02944201|Carvedilol|carvedilol|mesh-list
92617180|NCT02944201|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92617244|NCT00531856|Carbon Monoxide|carbon monoxide|mesh-list
92617245|NCT00531856|Antimetabolites|antimetabolites|mesh-ancestor
92617247|NCT00531856|Gasotransmitters|gasotransmitters|mesh-ancestor
92617316|NCT00169065|Antiemetics|antiemetics|mesh-ancestor
92617317|NCT00169065|Autonomic Agents|autonomic agents|mesh-ancestor
92617318|NCT00169065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92617319|NCT00169065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617320|NCT00169065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92617321|NCT00169065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92617322|NCT00169065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92617323|NCT00169065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617324|NCT00169065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92617325|NCT00169065|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92617326|NCT00169065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92617379|NCT02276911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92617380|NCT02276911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617453|NCT02942563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92617454|NCT02942563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617455|NCT00145925|Gliclazide|gliclazide|mesh-list
92617456|NCT00145925|Perindopril|perindopril|mesh-list
92617457|NCT00145925|Indapamide|indapamide|mesh-list
92617524|NCT00169299|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92617525|NCT00169299|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92617526|NCT00169299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92617527|NCT00169299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617595|NCT02276989|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92617596|NCT02276989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92617667|NCT00174876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92617668|NCT00174876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617669|NCT00174876|Dopamine Agonists|dopamine agonists|mesh-ancestor
92617670|NCT00174876|Dopamine Agents|dopamine agents|mesh-ancestor
92617671|NCT00174876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617672|NCT00174876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617673|NCT00174876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92617674|NCT00174876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92617675|NCT00174876|Serotonin Agents|serotonin agents|mesh-ancestor
92617676|NCT00174876|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92617677|NCT00174876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92617678|NCT00174876|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92617728|NCT02940535|Luteolytic Agents|luteolytic agents|mesh-ancestor
92617802|NCT00424229|Growth Inhibitors|growth inhibitors|mesh-ancestor
92617803|NCT00424229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92617804|NCT02944123|Clopidogrel|clopidogrel|mesh-list
92617805|NCT02944123|Ticagrelor|ticagrelor|mesh-list
92617806|NCT02944123|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92617807|NCT02944123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92617808|NCT02944123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92617809|NCT02944123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92617810|NCT02944123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92617811|NCT02944123|Purinergic Agents|purinergic agents|mesh-ancestor
92617812|NCT02944123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92617813|NCT02944123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92617814|NCT02944123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92617815|NCT02944045|Methylprednisolone|methylprednisolone|mesh-list
92617816|NCT02944045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92617817|NCT02944045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92617818|NCT02944045|Prednisolone|prednisolone|mesh-list
92617860|NCT00146783|Sulfadoxine|sulfadoxine|mesh-list
92617861|NCT00146783|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92617862|NCT00146783|Amodiaquine|amodiaquine|mesh-list
92617863|NCT00146783|Antimalarials|antimalarials|mesh-ancestor
92617930|NCT02940262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92617945|NCT02939482|Hormones|hormones|mesh-ancestor
92618003|NCT02938741|Immunologic Factors|immunologic factors|mesh-ancestor
92618004|NCT02938741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618005|NCT02938741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92618006|NCT00407589|Besifloxacin|besifloxacin|mesh-list
92618007|NCT00407589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92618008|NCT00407589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618009|NCT00407589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92618010|NCT00407589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92618065|NCT00147563|Diuretics|diuretics|mesh-ancestor
92618066|NCT00147563|Natriuretic Agents|natriuretic agents|mesh-ancestor
92618067|NCT00147563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92618068|NCT02938273|Cetuximab|cetuximab|mesh-list
92618138|NCT02941198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618211|NCT00147875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92618212|NCT00147875|Vinblastine|vinblastine|mesh-list
92618213|NCT00147875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92618282|NCT02930707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92343395|NCT00004787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92618284|NCT02930707|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92618285|NCT02930707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618286|NCT02930707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618287|NCT02930707|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92618289|NCT02930707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92618290|NCT00148031|Interferons|interferons|mesh-list
92618349|NCT00148265|Hormones|hormones|mesh-ancestor
92618350|NCT00148265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618351|NCT00148265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618352|NCT02929693|Gefitinib|gefitinib|mesh-list
92618353|NCT02929693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618354|NCT02929693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92618355|NCT02929693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618356|NCT02929693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618357|NCT00175734|Chrysarobin|chrysarobin|mesh-list
92618358|NCT00175734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92618359|NCT00175734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618360|NCT00175734|Analgesics|analgesics|mesh-ancestor
92618361|NCT00175734|Sensory System Agents|sensory system agents|mesh-ancestor
92618362|NCT00175734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92618363|NCT00175734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618364|NCT00175734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618365|NCT00175734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618367|NCT00148382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618368|NCT00148382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618369|NCT00148382|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92618370|NCT00148382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92618371|NCT00148421|Epoetin Alfa|epoetin alfa|mesh-list
92618372|NCT00148421|Darbepoetin alfa|darbepoetin alfa|mesh-list
92618373|NCT00148421|Hematinics|hematinics|mesh-ancestor
92618374|NCT02929888|Aspirin|aspirin|mesh-list
92618375|NCT02929888|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92618397|NCT00148460|Tenecteplase|tenecteplase|mesh-list
92618398|NCT00148460|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92618399|NCT00148460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92618400|NCT00148460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618401|NCT00170196|Prednisone|prednisone|mesh-list
92618402|NCT00170196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618403|NCT00170196|Glucocorticoids|glucocorticoids|mesh-ancestor
92618404|NCT00170196|Hormones|hormones|mesh-ancestor
92618405|NCT00170196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92618406|NCT00170196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618407|NCT00170196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92618408|NCT00170196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618409|NCT02929459|Vitamins|vitamins|mesh-list
92618410|NCT02929459|Riboflavin|riboflavin|mesh-list
92618411|NCT02929459|Vitamin B Complex|vitamin b complex|mesh-list
92618460|NCT03457597|Tolbutamide|tolbutamide|mesh-list
92618461|NCT03457597|Metoprolol|metoprolol|mesh-list
92618462|NCT03457597|Midazolam|midazolam|mesh-list
92618463|NCT03457597|Omeprazole|omeprazole|mesh-list
92618464|NCT03457597|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92618465|NCT03457597|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92618473|NCT03457597|Anesthetics|anesthetics|mesh-ancestor
92618533|NCT02928601|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92618534|NCT02928601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92618535|NCT02928601|Serotonin Agents|serotonin agents|mesh-ancestor
92618536|NCT02928601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618537|NCT02928601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618538|NCT02928328|Lidocaine|lidocaine|mesh-list
92618539|NCT02928328|Lorazepam|lorazepam|mesh-list
92618540|NCT02928328|Capsaicin|capsaicin|mesh-list
92618541|NCT02928328|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92618542|NCT02928328|Butyric Acid|butyric acid|mesh-list
92618543|NCT02928328|Anesthetics, Local|anesthetics, local|mesh-ancestor
92618544|NCT02928328|Anesthetics|anesthetics|mesh-ancestor
92618545|NCT02928328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618597|NCT02927509|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92618598|NCT02927509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92618599|NCT02927509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92618669|NCT00149162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92618670|NCT00149162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92618671|NCT00149162|Antiviral Agents|antiviral agents|mesh-ancestor
92618672|NCT00149162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92618673|NCT00149162|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618739|NCT00170781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618740|NCT00170781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92618741|NCT00170781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92618743|NCT00170820|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92618744|NCT00170820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92618745|NCT00170820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92618746|NCT00170820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618747|NCT00170820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92618748|NCT00170820|Immunologic Factors|immunologic factors|mesh-ancestor
92618749|NCT00170820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618750|NCT00170820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92618751|NCT02917018|Dexmedetomidine|dexmedetomidine|mesh-list
92618752|NCT02917018|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92618753|NCT02917018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92618754|NCT02917018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618755|NCT02917018|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92618756|NCT02917018|Analgesics|analgesics|mesh-ancestor
92618757|NCT02917018|Sensory System Agents|sensory system agents|mesh-ancestor
92618760|NCT02917018|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92618791|NCT00170898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92618792|NCT00170898|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92618860|NCT02916121|Micronutrients|micronutrients|mesh-ancestor
92618861|NCT02916121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92618928|NCT05786677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92618929|NCT05786612|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92618930|NCT05786612|Laxatives|laxatives|mesh-ancestor
92344067|NCT05590468|Niacin|niacin|mesh-list
92619001|NCT05785325|Growth Inhibitors|growth inhibitors|mesh-ancestor
92619150|NCT05764941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92619151|NCT05764941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619224|NCT05535764|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92619225|NCT05535764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619226|NCT05535764|Antiviral Agents|antiviral agents|mesh-ancestor
92619298|NCT05292339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619299|NCT05292339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92619300|NCT05292339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92619301|NCT05292339|Analgesics|analgesics|mesh-ancestor
92619302|NCT05292339|Sensory System Agents|sensory system agents|mesh-ancestor
92619303|NCT05292339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619366|NCT05091242|Analgesics|analgesics|mesh-ancestor
92619367|NCT05091242|Sensory System Agents|sensory system agents|mesh-ancestor
92619437|NCT04880863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619438|NCT04880863|Tubulin Modulators|tubulin modulators|mesh-ancestor
92619439|NCT04880863|Antimitotic Agents|antimitotic agents|mesh-ancestor
92619440|NCT04880863|Mitosis Modulators|mitosis modulators|mesh-ancestor
92619441|NCT04880863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619442|NCT04880863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92619443|NCT04880863|Immunoconjugates|immunoconjugates|mesh-ancestor
92619444|NCT04880863|Immunologic Factors|immunologic factors|mesh-ancestor
92619445|NCT04880863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619446|NCT04861987|Capecitabine|capecitabine|mesh-list
92619447|NCT04861987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619448|NCT04861987|Antimetabolites|antimetabolites|mesh-ancestor
92619449|NCT04861987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619450|NCT04861987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92619451|NCT04838808|Rivaroxaban|rivaroxaban|mesh-list
92619452|NCT04838808|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92619453|NCT04838808|Antithrombins|antithrombins|mesh-ancestor
92619454|NCT04838808|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92619493|NCT04748276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92619494|NCT04748276|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92619495|NCT04748276|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92619496|NCT04748276|Serotonin Agents|serotonin agents|mesh-ancestor
92619497|NCT04748276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92619498|NCT04748276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92619504|NCT04610658|Nivolumab|nivolumab|mesh-list
92619560|NCT04511247|Immunologic Factors|immunologic factors|mesh-ancestor
92619561|NCT04511247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619562|NCT04387084|Pembrolizumab|pembrolizumab|mesh-list
92619637|NCT04310176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92619638|NCT04310176|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92619711|NCT04049331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619712|NCT04049331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92619722|NCT04015596|Naproxen|naproxen|mesh-list
92619784|NCT03736720|Protective Agents|protective agents|mesh-ancestor
92619785|NCT03736720|Vitamin B Complex|vitamin b complex|mesh-ancestor
92619786|NCT03736720|Vitamins|vitamins|mesh-ancestor
92619787|NCT03736720|Micronutrients|micronutrients|mesh-ancestor
92619809|NCT03460366|Enalapril|enalapril|mesh-list
92619853|NCT03449472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92619926|NCT03056040|Ravulizumab|ravulizumab|mesh-list
92619927|NCT03056040|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92619999|NCT02295722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92620000|NCT02295722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92620001|NCT02295722|Immunologic Factors|immunologic factors|mesh-ancestor
92620002|NCT02295722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620004|NCT02282059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620005|NCT02282059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92620006|NCT02282059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92620007|NCT02282059|Growth Substances|growth substances|mesh-ancestor
92345126|NCT01473628|Rituximab|rituximab|mesh-list
92620008|NCT02282059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620009|NCT02282059|Growth Inhibitors|growth inhibitors|mesh-ancestor
92620010|NCT02282059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92620062|NCT01303341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92620063|NCT01303341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92620064|NCT01303341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620065|NCT01303341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92620067|NCT01064648|Cisplatin|cisplatin|mesh-list
92620068|NCT01064648|Pemetrexed|pemetrexed|mesh-list
92620069|NCT01064648|Cediranib|cediranib|mesh-list
92620070|NCT01064648|Maleic acid|maleic acid|mesh-list
92620071|NCT01064648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620072|NCT01064648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620073|NCT01064648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620125|NCT00392353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620126|NCT00392353|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92620127|NCT00382070|Letrozole|letrozole|mesh-list
92620198|NCT00405977|Analgesics|analgesics|mesh-ancestor
92620199|NCT00405977|Sensory System Agents|sensory system agents|mesh-ancestor
92620200|NCT00405977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620201|NCT00405977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620202|NCT00405977|Anesthetics|anesthetics|mesh-ancestor
92620268|NCT00150059|Immunologic Factors|immunologic factors|mesh-ancestor
92620269|NCT00150059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92620270|NCT00150059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620338|NCT02913430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620340|NCT02913469|Metoclopramide|metoclopramide|mesh-list
92620341|NCT02913469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92620342|NCT02913469|Narcotics|narcotics|mesh-ancestor
92620343|NCT02913469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92620344|NCT02913469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620345|NCT02913469|Analgesics|analgesics|mesh-ancestor
92620346|NCT02913469|Sensory System Agents|sensory system agents|mesh-ancestor
92620347|NCT02913469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620348|NCT02913469|Antiemetics|antiemetics|mesh-ancestor
92620349|NCT02913469|Autonomic Agents|autonomic agents|mesh-ancestor
92620350|NCT02913469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620352|NCT02913469|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92620400|NCT02913118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620402|NCT00150332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620403|NCT00150332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620404|NCT00150332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92620405|NCT00150332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620406|NCT00150332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620407|NCT00150371|Atorvastatin|atorvastatin|mesh-list
92620410|NCT00150371|Antimetabolites|antimetabolites|mesh-ancestor
92620466|NCT02911870|Moxifloxacin|moxifloxacin|mesh-list
92620467|NCT02911870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92620468|NCT02911870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92620469|NCT02911870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92620470|NCT02911870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92620471|NCT02911870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92620473|NCT02911870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92620604|NCT00150761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620605|NCT00171483|Tegaserod|tegaserod|mesh-list
92620676|NCT04723836|Micronutrients|micronutrients|mesh-ancestor
92620677|NCT04723836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620748|NCT00151073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92620821|NCT05466604|Dexamethasone|dexamethasone|mesh-list
92620822|NCT05466604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620823|NCT05466604|Antiemetics|antiemetics|mesh-ancestor
92620824|NCT05466604|Autonomic Agents|autonomic agents|mesh-ancestor
92620825|NCT05466604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620826|NCT05466604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620827|NCT05466604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92620828|NCT05466604|Glucocorticoids|glucocorticoids|mesh-ancestor
92620830|NCT05466604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399407|NCT01403506|Acetylcysteine|acetylcysteine|mesh-list
92620831|NCT05466604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92620888|NCT00171678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92620889|NCT00171678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92620891|NCT00171678|Sensory System Agents|sensory system agents|mesh-ancestor
92620892|NCT00171678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92620893|NCT00171678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92620894|NCT00171678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92620895|NCT00171678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92620896|NCT00171678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92620952|NCT00171756|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92621025|NCT05308030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621026|NCT05308030|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92621027|NCT05308030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92621028|NCT05308030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621029|NCT05308030|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92621030|NCT05308030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621031|NCT05308030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621032|NCT05308030|Antipyretics|antipyretics|mesh-ancestor
92621033|NCT05308030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92621089|NCT00151736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92621090|NCT00151736|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92621091|NCT00151736|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92621092|NCT00151736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621093|NCT00171990|Famciclovir|famciclovir|mesh-list
92621094|NCT00171990|Antiviral Agents|antiviral agents|mesh-ancestor
92621095|NCT00171990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621096|NCT00171990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92621097|NCT00171990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621154|NCT00532909|Growth Substances|growth substances|mesh-ancestor
92621225|NCT00533026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621226|NCT00533026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621227|NCT00533026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92621228|NCT00533026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621229|NCT00533026|Analgesics|analgesics|mesh-ancestor
92621230|NCT00533026|Sensory System Agents|sensory system agents|mesh-ancestor
92621231|NCT00533026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621232|NCT00533026|Antidepressive Agents|antidepressive agents|mesh-ancestor
92621290|NCT00152243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621291|NCT00172107|Parathyroid Hormone|parathyroid hormone|mesh-list
92621292|NCT00172107|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92621296|NCT00152282|Hormones|hormones|mesh-ancestor
92621360|NCT02937844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621361|NCT02937844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621362|NCT02937844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92621363|NCT02937415|Antioxidants|antioxidants|mesh-list
92621364|NCT02937415|Carbon Monoxide|carbon monoxide|mesh-list
92621366|NCT02937415|Protective Agents|protective agents|mesh-ancestor
92621429|NCT00152633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92621430|NCT00152633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92621503|NCT00165087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621576|NCT02935972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92621577|NCT02935972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621578|NCT02935972|Sensory System Agents|sensory system agents|mesh-ancestor
92621579|NCT02935972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621580|NCT02935972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92621581|NCT02935972|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92621582|NCT02935972|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92621583|NCT02935972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92621584|NCT02935972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621585|NCT02935972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92621586|NCT02935972|Anticonvulsants|anticonvulsants|mesh-ancestor
92621587|NCT02935972|Antiemetics|antiemetics|mesh-ancestor
92621639|NCT00152945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92621640|NCT00152945|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92621641|NCT00152945|Protective Agents|protective agents|mesh-ancestor
92621642|NCT00152945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621644|NCT02935114|Carbamide Peroxide|carbamide peroxide|mesh-list
92621645|NCT02935114|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92621646|NCT02935114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92621647|NCT02935231|Nicotine|nicotine|mesh-list
92621649|NCT02935231|Autonomic Agents|autonomic agents|mesh-ancestor
92621704|NCT00172419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92621777|NCT02934061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92621778|NCT02934061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621780|NCT02934061|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92621781|NCT02934061|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92621782|NCT02934061|Parasympatholytics|parasympatholytics|mesh-ancestor
92621783|NCT02934061|Autonomic Agents|autonomic agents|mesh-ancestor
92621784|NCT02934061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92621785|NCT02934061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92621786|NCT02934061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92621843|NCT00165399|Estramustine|estramustine|mesh-list
92621844|NCT00165399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621845|NCT00165399|Tubulin Modulators|tubulin modulators|mesh-ancestor
92621846|NCT00165399|Antimitotic Agents|antimitotic agents|mesh-ancestor
92621847|NCT00165399|Mitosis Modulators|mitosis modulators|mesh-ancestor
92621848|NCT00165399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92621849|NCT00165399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92621850|NCT00165399|Androgen Antagonists|androgen antagonists|mesh-ancestor
92621907|NCT00165477|Immunologic Factors|immunologic factors|mesh-ancestor
92621908|NCT00165477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92621909|NCT00165477|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92621910|NCT00165477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92621911|NCT00165477|Growth Substances|growth substances|mesh-ancestor
92621912|NCT00165477|Growth Inhibitors|growth inhibitors|mesh-ancestor
92621913|NCT00165477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92621914|NCT02932930|Ropivacaine|ropivacaine|mesh-list
92621915|NCT02932930|Anesthetics, Local|anesthetics, local|mesh-ancestor
92621972|NCT00153725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92621973|NCT00153725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622047|NCT00153998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622048|NCT00153998|Immunologic Factors|immunologic factors|mesh-ancestor
92622049|NCT00153998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622119|NCT00154115|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92622120|NCT00154115|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92622121|NCT00154115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622123|NCT00154115|Protective Agents|protective agents|mesh-ancestor
92622188|NCT00187941|Mycophenolic Acid|mycophenolic acid|mesh-list
92622189|NCT00187941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92622190|NCT00187941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622259|NCT02922673|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92622260|NCT02922673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622261|NCT02922673|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92622262|NCT02922673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92622264|NCT02922673|Antipyretics|antipyretics|mesh-ancestor
92622329|NCT00406250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92622330|NCT00406250|Growth Substances|growth substances|mesh-ancestor
92622405|NCT02920489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622480|NCT00154778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622481|NCT00154778|Vitamin B Complex|vitamin b complex|mesh-ancestor
92622554|NCT00188565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622555|NCT00155246|Pentoxifylline|pentoxifylline|mesh-list
92622556|NCT00155246|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92622557|NCT00155246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622558|NCT00155246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622559|NCT00155246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92622560|NCT00155246|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92622561|NCT00155246|Protective Agents|protective agents|mesh-ancestor
92622562|NCT00155246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622618|NCT00188643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92622619|NCT00188643|Antidepressive Agents|antidepressive agents|mesh-ancestor
92622691|NCT00533455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92622692|NCT00533455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92622693|NCT00533455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92622694|NCT00533455|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92622698|NCT00533455|Antimanic Agents|antimanic agents|mesh-ancestor
92622760|NCT00533923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622761|NCT00533923|Immunologic Factors|immunologic factors|mesh-ancestor
92622762|NCT00533923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622763|NCT00533923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92622764|NCT00533923|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92622765|NCT00533923|Alkylating Agents|alkylating agents|mesh-ancestor
92622766|NCT00533923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622767|NCT00533923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92622768|NCT00533923|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92622769|NCT00533923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92622770|NCT00533923|Antifungal Agents|antifungal agents|mesh-ancestor
92622771|NCT00533923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92622772|NCT00533923|Dermatologic Agents|dermatologic agents|mesh-ancestor
92622773|NCT00533923|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92622774|NCT00533923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92622775|NCT00409227|Alfuzosin|alfuzosin|mesh-list
92622776|NCT00409227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92622777|NCT00409227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92622814|NCT00409305|Vasodilator Agents|vasodilator agents|mesh-ancestor
92622815|NCT00409305|Histamine Agonists|histamine agonists|mesh-ancestor
92622816|NCT00409305|Histamine Agents|histamine agents|mesh-ancestor
92622817|NCT00409305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92622818|NCT00409305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92622819|NCT00409305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92622820|NCT00406679|Acetaminophen|acetaminophen|mesh-list
92622881|NCT00181935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92622882|NCT00409383|Paclitaxel|paclitaxel|mesh-list
92622883|NCT00409383|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92622884|NCT00409383|Temozolomide|temozolomide|mesh-list
92622885|NCT00409383|Oblimersen|oblimersen|mesh-list
92622898|NCT04883632|Lidocaine|lidocaine|mesh-list
92622953|NCT02081755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92622954|NCT02081755|Immunologic Factors|immunologic factors|mesh-ancestor
92622955|NCT02081755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623026|NCT00156299|Antiemetics|antiemetics|mesh-ancestor
92623027|NCT00156299|Autonomic Agents|autonomic agents|mesh-ancestor
92623028|NCT00156299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623029|NCT00156299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623030|NCT00156299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92623031|NCT00156299|Glucocorticoids|glucocorticoids|mesh-ancestor
92623032|NCT00156299|Hormones|hormones|mesh-ancestor
92623096|NCT00408525|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92623097|NCT00408525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623098|NCT00408525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623099|NCT00408525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92623100|NCT00408525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623101|NCT00408525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623102|NCT00408525|Nootropic Agents|nootropic agents|mesh-ancestor
92623103|NCT05469529|Dexmedetomidine|dexmedetomidine|mesh-list
92623104|NCT05469529|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92623105|NCT05469529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92623106|NCT05469529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623107|NCT05469529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92623108|NCT05469529|Analgesics|analgesics|mesh-ancestor
92623109|NCT05469529|Sensory System Agents|sensory system agents|mesh-ancestor
92623110|NCT05469529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92623155|NCT00156650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623156|NCT00156650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92623157|NCT00156650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92623158|NCT00156650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92623159|NCT00156650|Contraceptive Agents|contraceptive agents|mesh-ancestor
92623160|NCT00156650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92623222|NCT00182364|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92623223|NCT00182364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623224|NCT00536653|Calcium, Dietary|calcium, dietary|mesh-list
92623225|NCT00536653|Vitamin D|vitamin d|mesh-list
92623226|NCT00536653|Ergocalciferols|ergocalciferols|mesh-list
92623227|NCT00536653|Cholecalciferol|cholecalciferol|mesh-list
92623228|NCT00536653|Vitamins|vitamins|mesh-list
92623229|NCT00536653|Goserelin|goserelin|mesh-list
92623230|NCT00536653|Bicalutamide|bicalutamide|mesh-list
92623231|NCT00536653|Calcium|calcium|mesh-list
92623232|NCT00536653|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92623233|NCT00536653|Micronutrients|micronutrients|mesh-ancestor
92623234|NCT00536653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623235|NCT00536653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92623236|NCT00536653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92623284|NCT00182442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92623285|NCT00182442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623286|NCT00182442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92623287|NCT00182442|Serotonin Agents|serotonin agents|mesh-ancestor
92623288|NCT00182442|Antidepressive Agents|antidepressive agents|mesh-ancestor
92623290|NCT00536770|Gemcitabine|gemcitabine|mesh-list
92623291|NCT00536770|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92623292|NCT00536770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92623293|NCT00536770|Antimetabolites|antimetabolites|mesh-ancestor
92623303|NCT00536770|Vitamins|vitamins|mesh-ancestor
92623351|NCT00157079|Immunologic Factors|immunologic factors|mesh-ancestor
92623353|NCT00189501|Cinacalcet|cinacalcet|mesh-list
92623423|NCT00157508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92623424|NCT00157508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623573|NCT00189657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623574|NCT00189657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623575|NCT00189657|Antimetabolites|antimetabolites|mesh-ancestor
92623642|NCT04061161|Parasympatholytics|parasympatholytics|mesh-ancestor
92623643|NCT04061161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92623716|NCT00157859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623717|NCT00157859|Antimalarials|antimalarials|mesh-ancestor
92623718|NCT00157859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92623719|NCT00157859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92623720|NCT00157859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92623721|NCT00157859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623722|NCT00157859|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92623723|NCT00157898|Metronidazole|metronidazole|mesh-list
92623724|NCT00157898|Ceftriaxone|ceftriaxone|mesh-list
92623726|NCT00157898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623727|NCT00157898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623728|NCT00157898|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92623729|NCT00157898|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92623730|NCT03669523|Denosumab|denosumab|mesh-list
92623731|NCT03669523|Nivolumab|nivolumab|mesh-list
92623732|NCT03669523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92623733|NCT03669523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623734|NCT03669523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92623735|NCT03669523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92623738|NCT00157976|Tin etiopurpurin|tin etiopurpurin|mesh-list
92623771|NCT03429946|Spironolactone|spironolactone|mesh-list
92623772|NCT03429946|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92623773|NCT03429946|Hormone Antagonists|hormone antagonists|mesh-ancestor
92623774|NCT03429946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92623775|NCT03429946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92623776|NCT03429946|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92623777|NCT03429946|Diuretics|diuretics|mesh-ancestor
92623778|NCT03429946|Natriuretic Agents|natriuretic agents|mesh-ancestor
92623779|NCT00189930|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92623780|NCT00189930|Antiviral Agents|antiviral agents|mesh-ancestor
92623781|NCT00189930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623783|NCT00158132|Propranolol|propranolol|mesh-list
92623784|NCT00158132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92623786|NCT00158132|Adrenergic Agents|adrenergic agents|mesh-ancestor
92623830|NCT00158210|Protective Agents|protective agents|mesh-ancestor
92623909|NCT00538018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92623910|NCT00538018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92623911|NCT00538096|Blinatumomab|blinatumomab|mesh-list
92623912|NCT00538096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623913|NCT00158678|Cisplatin|cisplatin|mesh-list
92623914|NCT00158678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92623915|NCT00538174|Dapagliflozin|dapagliflozin|mesh-list
92623916|NCT00538174|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92623918|NCT00538174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92623978|NCT00538525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076655|NCT03915444|Paclitaxel|paclitaxel|mesh-list
92624051|NCT00158873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92624052|NCT00158873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92624053|NCT00158873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92624054|NCT00158873|GABA Modulators|gaba modulators|mesh-ancestor
92624124|NCT00537355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624125|NCT00537355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624127|NCT00183612|Antiemetics|antiemetics|mesh-ancestor
92624195|NCT00538876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624197|NCT00538876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92624269|NCT00540085|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92624270|NCT00540085|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92624271|NCT00540085|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92624272|NCT00540085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92624273|NCT00540085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624276|NCT00540202|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92624277|NCT00540202|Quinine|quinine|mesh-list
92624278|NCT00540202|Antimalarials|antimalarials|mesh-ancestor
92624279|NCT00540202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92624280|NCT00540202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92624281|NCT00540202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92624333|NCT00159302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624334|NCT00159302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624405|NCT00540826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624406|NCT00540943|Irinotecan|irinotecan|mesh-list
92624479|NCT00541372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624481|NCT00159536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92624550|NCT00159614|Diuretics|diuretics|mesh-ancestor
92624626|NCT00159731|Analgesics|analgesics|mesh-ancestor
92624627|NCT00159731|Sensory System Agents|sensory system agents|mesh-ancestor
92624698|NCT00542893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92624700|NCT00542893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624768|NCT00190632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92624769|NCT00190632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92624841|NCT00543634|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92624842|NCT00543634|Contraceptive Agents|contraceptive agents|mesh-ancestor
92624849|NCT00543634|Estrogens|estrogens|mesh-ancestor
92624909|NCT00544180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92624910|NCT00544180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92624911|NCT00544219|Prednisone|prednisone|mesh-list
92624912|NCT00544219|Cyclophosphamide|cyclophosphamide|mesh-list
92624913|NCT00544219|Rituximab|rituximab|mesh-list
92624914|NCT00544219|Doxorubicin|doxorubicin|mesh-list
92624977|NCT00190905|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92624978|NCT00190905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92624980|NCT00190905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92625048|NCT00544999|Immunologic Factors|immunologic factors|mesh-ancestor
92625049|NCT00544999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625050|NCT00544999|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92625120|NCT00545389|Mesalamine|mesalamine|mesh-list
92625121|NCT00545389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92625192|NCT00546130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92625193|NCT00546130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92625266|NCT00546520|Hormones|hormones|mesh-ancestor
92625267|NCT00546520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92625268|NCT00546520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625269|NCT00546520|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92625270|NCT00546559|Simvastatin|simvastatin|mesh-list
92625271|NCT00546559|Pravastatin|pravastatin|mesh-list
92625272|NCT00546559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92625273|NCT00546559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92625274|NCT00546559|Antimetabolites|antimetabolites|mesh-ancestor
92625275|NCT00546559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92625330|NCT00184626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625331|NCT00184626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625333|NCT00547417|Vasodilator Agents|vasodilator agents|mesh-ancestor
92625400|NCT00184665|Isophane insulin, beef|isophane insulin, beef|mesh-list
92625401|NCT00184665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92625403|NCT04983238|Sodium thiosulfate|sodium thiosulfate|mesh-list
92625473|NCT00191490|Tubulin Modulators|tubulin modulators|mesh-ancestor
92625474|NCT00191490|Antimitotic Agents|antimitotic agents|mesh-ancestor
92625475|NCT00191490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92625548|NCT00161291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92625620|NCT00549289|Cyclosporine|cyclosporine|mesh-list
92625621|NCT00549289|Cyclosporins|cyclosporins|mesh-list
92625622|NCT00549289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92625693|NCT00161486|Testosterone enanthate|testosterone enanthate|mesh-list
92625694|NCT00161486|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92625695|NCT00161486|Acyline|acyline|mesh-list
92625696|NCT00161486|Androgens|androgens|mesh-ancestor
92625764|NCT00550342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92625765|NCT00550342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92625767|NCT00161681|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92625768|NCT00161681|Estradiol|estradiol|mesh-list
92625769|NCT00161681|Estrogens|estrogens|mesh-ancestor
92625770|NCT00161681|Hormones|hormones|mesh-ancestor
92625834|NCT00185133|Amlodipine|amlodipine|mesh-list
92625835|NCT00185133|Olmesartan|olmesartan|mesh-list
92625836|NCT00185133|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92625908|NCT00191880|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92625912|NCT00191880|Adrenergic Agents|adrenergic agents|mesh-ancestor
92625981|NCT00191997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92625982|NCT00191997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92625983|NCT00191997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92625984|NCT00191997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92626052|NCT00162188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626053|NCT00162188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92626054|NCT00162188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92626120|NCT00162344|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92626121|NCT00162344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626123|NCT04382326|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92626124|NCT04382326|Immunologic Factors|immunologic factors|mesh-ancestor
92626125|NCT04382326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626126|NCT00162383|Dapsone|dapsone|mesh-list
92626127|NCT00162383|Debrisoquin|debrisoquin|mesh-list
92626128|NCT00162383|Mephenytoin|mephenytoin|mesh-list
92626129|NCT00162383|Caffeine|caffeine|mesh-list
92626130|NCT00162383|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92626131|NCT00162383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626132|NCT00162383|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92626135|NCT00162383|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92626182|NCT00185445|Immunologic Factors|immunologic factors|mesh-ancestor
92626183|NCT00185445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626184|NCT00552838|Anti-Infective Agents|anti-infective agents|mesh-list
92626185|NCT00552838|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92626186|NCT04233034|Verapamil|verapamil|mesh-list
92626187|NCT04233034|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92626250|NCT00162695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626251|NCT00162695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626252|NCT00162695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92626254|NCT00162734|Ribavirin|ribavirin|mesh-list
92626321|NCT03757585|Antioxidants|antioxidants|mesh-ancestor
92626393|NCT00185991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92626394|NCT00185991|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92626395|NCT00185991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626396|NCT00185991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626397|NCT03434158|Olaparib|olaparib|mesh-list
92626398|NCT03434158|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92626399|NCT03434158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626400|NCT03434158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626401|NCT03434158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626402|NCT00163202|Atorvastatin|atorvastatin|mesh-list
92626403|NCT00163202|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92626404|NCT00163202|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92626405|NCT00163202|Antimetabolites|antimetabolites|mesh-ancestor
92626407|NCT00163202|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92626455|NCT00192660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92626456|NCT00192660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92626457|NCT00192660|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92626458|NCT00192660|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92626459|NCT00192660|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92626460|NCT00192660|Antitubercular Agents|antitubercular agents|mesh-ancestor
92626461|NCT00192660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92626519|NCT02556931|Cyclophosphamide|cyclophosphamide|mesh-list
92626520|NCT02556931|Fludarabine|fludarabine|mesh-list
92626521|NCT02556931|Tacrolimus|tacrolimus|mesh-list
92626522|NCT02556931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626523|NCT02556931|Immunologic Factors|immunologic factors|mesh-ancestor
92626524|NCT02556931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626525|NCT02556931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92626526|NCT02556931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92626527|NCT02556931|Alkylating Agents|alkylating agents|mesh-ancestor
92626528|NCT02556931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626529|NCT02556931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626530|NCT02556931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92626531|NCT02556931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92626532|NCT02556931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92626533|NCT02556931|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92626538|NCT00163358|Ciclesonide|ciclesonide|mesh-list
92626579|NCT00066040|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
92626581|NCT00066040|Fluorides, Topical|fluorides, topical|mesh-list
92626582|NCT00066040|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92626583|NCT00066040|Cariostatic Agents|cariostatic agents|mesh-ancestor
92626584|NCT00066040|Protective Agents|protective agents|mesh-ancestor
92626585|NCT00066040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626586|NCT00066040|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92626647|NCT05808231|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92626720|NCT05807347|Azacitidine|azacitidine|mesh-list
92626722|NCT05807347|Aclacinomycins|aclacinomycins|mesh-list
92626723|NCT05807347|Lenograstim|lenograstim|mesh-list
92351878|NCT03584178|Hormones|hormones|mesh-ancestor
92626725|NCT05807347|Antimetabolites|antimetabolites|mesh-ancestor
92626792|NCT05693844|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92626793|NCT05693844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92626794|NCT05693844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92626795|NCT05693844|Tubulin Modulators|tubulin modulators|mesh-ancestor
92626796|NCT05693844|Antimitotic Agents|antimitotic agents|mesh-ancestor
92626797|NCT05693844|Mitosis Modulators|mitosis modulators|mesh-ancestor
92626798|NCT05693844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626859|NCT05627947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92626860|NCT05627947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92626861|NCT05627947|Immunologic Factors|immunologic factors|mesh-ancestor
92626862|NCT05627947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92626931|NCT05546658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627001|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92627002|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627072|NCT04833140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627073|NCT04826562|Lamivudine|lamivudine|mesh-list
92627143|NCT04577690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627153|NCT04531176|Topiramate|topiramate|mesh-list
92627219|NCT04303390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92627220|NCT04303390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92627221|NCT04093167|Pembrolizumab|pembrolizumab|mesh-list
92627222|NCT04093167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627223|NCT04093167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92627224|NCT04093167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627225|NCT04093167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627226|NCT04075110|Montelukast|montelukast|mesh-list
92627227|NCT04075110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92627228|NCT04075110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92627229|NCT04075110|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92627230|NCT04075110|Hormone Antagonists|hormone antagonists|mesh-ancestor
92627232|NCT04075110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627275|NCT03729245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92627276|NCT03729245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627277|NCT03712397|Irinotecan|irinotecan|mesh-list
92627347|NCT03412877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92627348|NCT03412877|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92627349|NCT03412877|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92627350|NCT03412877|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92627351|NCT03412877|Antiviral Agents|antiviral agents|mesh-ancestor
92627353|NCT03406299|Leucovorin|leucovorin|mesh-list
92627421|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92627422|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627494|NCT03217565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92627568|NCT02427620|Methotrexate|methotrexate|mesh-list
92627569|NCT02427620|Vincristine|vincristine|mesh-list
92627570|NCT02427620|Daunorubicin|daunorubicin|mesh-list
92627571|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92627572|NCT02427620|Antibodies|antibodies|mesh-list
92627573|NCT02427620|Immunoglobulins|immunoglobulins|mesh-list
92627574|NCT02427620|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92627575|NCT02427620|BB 1101|bb 1101|mesh-list
92627576|NCT02427620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92627577|NCT02427620|Immunologic Factors|immunologic factors|mesh-ancestor
92627578|NCT02427620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627579|NCT02427620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92627591|NCT02427620|Hormones|hormones|mesh-ancestor
92627631|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92627632|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627704|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92627714|NCT01359956|Interferons|interferons|mesh-list
92627776|NCT01075971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92627777|NCT00775749|Nicotine|nicotine|mesh-list
92627787|NCT00324922|Vancomycin|vancomycin|mesh-list
92627849|NCT00193011|Abortifacient Agents|abortifacient agents|mesh-ancestor
92627850|NCT00193011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92627925|NCT00163982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92627926|NCT00163982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92627927|NCT00163982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92627997|NCT05063734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92627998|NCT05063734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92627999|NCT05063734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628002|NCT00164216|Artesunate|artesunate|mesh-list
92628072|NCT04902703|Immunologic Factors|immunologic factors|mesh-ancestor
92628080|NCT04899778|Iron|iron|mesh-list
92628144|NCT00164801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628217|NCT00194064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628218|NCT00194064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628219|NCT00194064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92628224|NCT00194064|Serotonin Agents|serotonin agents|mesh-ancestor
92628287|NCT00165191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628360|NCT04082650|Vitamins|vitamins|mesh-ancestor
92628434|NCT03789916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628435|NCT03789916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628437|NCT03789916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92628505|NCT03413800|Dexamethasone|dexamethasone|mesh-list
92628506|NCT03413800|Lenalidomide|lenalidomide|mesh-list
92628577|NCT00194649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92628651|NCT05296213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92628652|NCT05296213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628653|NCT05296213|Cariostatic Agents|cariostatic agents|mesh-ancestor
92399454|NCT01403818|Calcium|calcium|mesh-list
92628654|NCT05296213|Protective Agents|protective agents|mesh-ancestor
92628655|NCT05296213|Chelating Agents|chelating agents|mesh-ancestor
92628656|NCT05296213|Sequestering Agents|sequestering agents|mesh-ancestor
92628657|NCT05296213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628658|NCT00166478|Sulindac sulfone|sulindac sulfone|mesh-list
92628659|NCT00166478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92628660|NCT00166478|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92628661|NCT00166478|Protective Agents|protective agents|mesh-ancestor
92628662|NCT00166478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628663|NCT00166478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92628664|NCT00166478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92628665|NCT00166478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92628666|NCT00166478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92628667|NCT00166478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92628668|NCT00166478|Analgesics|analgesics|mesh-ancestor
92628669|NCT00166478|Sensory System Agents|sensory system agents|mesh-ancestor
92628670|NCT00166478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92628671|NCT00166478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628672|NCT00166478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92628673|NCT05282875|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92628674|NCT05282875|Immunologic Factors|immunologic factors|mesh-ancestor
92628675|NCT05282875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628676|NCT00194766|Temozolomide|temozolomide|mesh-list
92628697|NCT00166595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92628698|NCT00166595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92628699|NCT00166595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628700|NCT00166595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92628701|NCT00166595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92628702|NCT00166595|Dopamine Agents|dopamine agents|mesh-ancestor
92628703|NCT05259631|Propofol|propofol|mesh-list
92628704|NCT05259631|Sevoflurane|sevoflurane|mesh-list
92628705|NCT05259631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92628706|NCT05259631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92628707|NCT05259631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628708|NCT05259631|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92628709|NCT05259631|Anesthetics, General|anesthetics, general|mesh-ancestor
92628710|NCT05259631|Anesthetics|anesthetics|mesh-ancestor
92628711|NCT05259631|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92628712|NCT05259631|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92628713|NCT00408135|Telithromycin|telithromycin|mesh-list
92628714|NCT00408135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92628715|NCT00408135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92628716|NCT00407225|Difluprednate|difluprednate|mesh-list
92628717|NCT00407225|Glucocorticoids|glucocorticoids|mesh-ancestor
92628718|NCT00407225|Hormones|hormones|mesh-ancestor
92628719|NCT00407225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628720|NCT00407225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628721|NCT05124067|Dexamethasone|dexamethasone|mesh-list
92628722|NCT05124067|Dexamethasone acetate|dexamethasone acetate|mesh-list
92628723|NCT05124067|Dexmedetomidine|dexmedetomidine|mesh-list
92628724|NCT05124067|Ondansetron|ondansetron|mesh-list
92628725|NCT05124067|BB 1101|bb 1101|mesh-list
92628726|NCT05124067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92628744|NCT05124067|Sensory System Agents|sensory system agents|mesh-ancestor
92628817|NCT00177411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92628818|NCT00177411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92628819|NCT00177411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92628829|NCT04660045|Acalabrutinib|acalabrutinib|mesh-list
92628885|NCT00177567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92628886|NCT00177567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92628887|NCT00177567|Antidepressive Agents|antidepressive agents|mesh-ancestor
92628958|NCT04299880|Tubulin Modulators|tubulin modulators|mesh-ancestor
92628959|NCT04299880|Antimitotic Agents|antimitotic agents|mesh-ancestor
92628960|NCT04299880|Mitosis Modulators|mitosis modulators|mesh-ancestor
92628961|NCT04299880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629029|NCT00167648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92629030|NCT00167648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629031|NCT00167648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92629032|NCT00167648|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92629033|NCT00167648|Fertility Agents|fertility agents|mesh-ancestor
92629034|NCT00167648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92629035|NCT00167648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92629036|NCT02906722|Colistin|colistin|mesh-list
92629037|NCT02906722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92629038|NCT02906722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92629039|NCT00167687|Prazosin|prazosin|mesh-list
92629040|NCT00167687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92629041|NCT00167687|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92629042|NCT00167687|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92629043|NCT00167687|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92629044|NCT00167687|Adrenergic Agents|adrenergic agents|mesh-ancestor
92629085|NCT00167843|Pyrimethamine|pyrimethamine|mesh-list
92629086|NCT00167843|Sulfadoxine|sulfadoxine|mesh-list
92629088|NCT00167843|Antimalarials|antimalarials|mesh-ancestor
92629157|NCT00167999|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92629158|NCT00167999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629159|NCT00167999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629161|NCT00177996|Antidepressive Agents|antidepressive agents|mesh-ancestor
92629162|NCT00177996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629163|NCT00177996|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92629164|NCT00177996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92629165|NCT00177996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92629166|NCT00177996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629167|NCT00177996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629170|NCT00168077|Thrombin|thrombin|mesh-list
92629220|NCT00195741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629221|NCT00195741|GABA Agents|gaba agents|mesh-ancestor
92629222|NCT00195741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92629223|NCT00195741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629224|NCT00195741|Antimanic Agents|antimanic agents|mesh-ancestor
92629225|NCT00195741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92629226|NCT00195741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92629227|NCT00195741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92629286|NCT00195780|Antimanic Agents|antimanic agents|mesh-ancestor
92629287|NCT00195780|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92629361|NCT02904031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92629362|NCT02904109|Mannitol|mannitol|mesh-list
92629363|NCT02904109|Triflusal|triflusal|mesh-list
92629434|NCT00195936|Hormone Antagonists|hormone antagonists|mesh-ancestor
92629441|NCT00168506|Serotonin Agents|serotonin agents|mesh-ancestor
92629505|NCT02902315|Micronutrients|micronutrients|mesh-ancestor
92348199|NCT01565694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92629506|NCT02902315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629507|NCT02902315|Antioxidants|antioxidants|mesh-ancestor
92629508|NCT02902315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629509|NCT02902315|Protective Agents|protective agents|mesh-ancestor
92629510|NCT02902432|Endostar protein|endostar protein|mesh-list
92629511|NCT02902432|Endostatins|endostatins|mesh-list
92629512|NCT02902432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92629513|NCT02902432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92629514|NCT02902432|Growth Substances|growth substances|mesh-ancestor
92629515|NCT02902432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629516|NCT02902432|Growth Inhibitors|growth inhibitors|mesh-ancestor
92629568|NCT00168896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629569|NCT00168896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92629639|NCT00169091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92629640|NCT00169091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92629641|NCT00169091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92629642|NCT00169091|Serotonin Agents|serotonin agents|mesh-ancestor
92629643|NCT00169091|GABA Antagonists|gaba antagonists|mesh-ancestor
92629644|NCT00169091|GABA Agents|gaba agents|mesh-ancestor
92354810|NCT03092856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92629645|NCT00169130|Cyclophosphamide|cyclophosphamide|mesh-list
92629646|NCT00169130|Doxorubicin|doxorubicin|mesh-list
92629647|NCT00169130|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92629648|NCT00169130|Immunologic Factors|immunologic factors|mesh-ancestor
92629649|NCT00169130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629650|NCT00169130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92629651|NCT00169130|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92629652|NCT00169130|Alkylating Agents|alkylating agents|mesh-ancestor
92629698|NCT02899702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629699|NCT02899507|Amoxicillin|amoxicillin|mesh-list
92629729|NCT02898961|Amikacin|amikacin|mesh-list
92629770|NCT00408174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92629771|NCT00408174|Analgesics|analgesics|mesh-ancestor
92629843|NCT02897830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92629918|NCT00196599|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92629923|NCT00178971|Buspirone|buspirone|mesh-list
92629990|NCT00196638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92629992|NCT02896270|Anticonvulsants|anticonvulsants|mesh-ancestor
92630061|NCT02895529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92630062|NCT02895529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630132|NCT05423821|Anesthetics|anesthetics|mesh-list
92630133|NCT05423821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92630134|NCT05423821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630135|NCT00170378|Enoxaparin|enoxaparin|mesh-list
92630136|NCT00170378|Anticoagulants|anticoagulants|mesh-ancestor
92630137|NCT00170378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92630138|NCT00170378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92630139|NCT00170378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630196|NCT05420350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630197|NCT05420350|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92630198|NCT05420350|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92630266|NCT00170729|Prednisolone acetate|prednisolone acetate|mesh-list
92630267|NCT00170729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92630268|NCT00170729|Prednisolone phosphate|prednisolone phosphate|mesh-list
92630336|NCT01356940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630337|NCT00170963|Amlodipine|amlodipine|mesh-list
92630405|NCT02102113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630406|NCT02102113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92630475|NCT00171392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630476|NCT00171392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630549|NCT05265052|Analgesics|analgesics|mesh-ancestor
92399529|NCT01404156|Antimetabolites|antimetabolites|mesh-ancestor
92630622|NCT00171782|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92630623|NCT00171782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92630624|NCT00197379|Roxithromycin|roxithromycin|mesh-list
92630625|NCT00197379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92630626|NCT00197379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630627|NCT00197418|Amoxicillin|amoxicillin|mesh-list
92630628|NCT00197418|Metronidazole|metronidazole|mesh-list
92630629|NCT00197418|Clarithromycin|clarithromycin|mesh-list
92630630|NCT00197418|Rabeprazole|rabeprazole|mesh-list
92630631|NCT00197418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92630632|NCT00197418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92630633|NCT00197418|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92630634|NCT00197418|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92630635|NCT00197418|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92630636|NCT00197418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630638|NCT00197418|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92630681|NCT00171899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630682|NCT00171938|Imatinib Mesylate|imatinib mesylate|mesh-list
92630683|NCT00171938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630684|NCT00171938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630685|NCT00171938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630686|NCT00171938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630687|NCT00171977|Imatinib Mesylate|imatinib mesylate|mesh-list
92630688|NCT00171977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92630689|NCT00171977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92630690|NCT00171977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92630691|NCT00171977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92630747|NCT00197613|Didanosine|didanosine|mesh-list
92630748|NCT00197613|Stavudine|stavudine|mesh-list
92630819|NCT00172172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630820|NCT02908711|Ropivacaine|ropivacaine|mesh-list
92630829|NCT02908438|Hormones|hormones|mesh-list
92630890|NCT00202605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92630891|NCT00202605|Sympathomimetics|sympathomimetics|mesh-ancestor
92630892|NCT00202605|Autonomic Agents|autonomic agents|mesh-ancestor
92630959|NCT00198198|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92630960|NCT00198198|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92630961|NCT00198198|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92630963|NCT02206087|Calcium heparin|calcium heparin|mesh-list
92631030|NCT04677868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92631105|NCT02072863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631180|NCT02018926|Mocetinostat|mocetinostat|mesh-list
92631181|NCT02018926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92631182|NCT02018926|Antimetabolites|antimetabolites|mesh-ancestor
92631183|NCT02018926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631184|NCT02018926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631185|NCT02018926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631186|NCT02018926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92631187|NCT01989325|Dexamethasone|dexamethasone|mesh-list
92631188|NCT01989325|Filanesib|filanesib|mesh-list
92631189|NCT01989325|Lenograstim|lenograstim|mesh-list
92631190|NCT01989325|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92631191|NCT01989325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92631192|NCT01989325|Antiemetics|antiemetics|mesh-ancestor
92631193|NCT01989325|Autonomic Agents|autonomic agents|mesh-ancestor
92631194|NCT01989325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92631195|NCT01989325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631196|NCT01989325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92631197|NCT01989325|Glucocorticoids|glucocorticoids|mesh-ancestor
92631198|NCT01989325|Hormones|hormones|mesh-ancestor
92631199|NCT01989325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92631200|NCT01989325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92631233|NCT02962986|Nasal Decongestants|nasal decongestants|mesh-ancestor
92631237|NCT02962986|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92631309|NCT01930357|Immunologic Factors|immunologic factors|mesh-ancestor
92631310|NCT01930357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631311|NCT01913158|Hydrocortisone|hydrocortisone|mesh-list
92631379|NCT01862224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631381|NCT01862224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631454|NCT00555139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92631527|NCT01768975|Dapansutrile|dapansutrile|mesh-list
92631602|NCT00174239|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92631604|NCT00174239|Dopamine Agonists|dopamine agonists|mesh-ancestor
92631674|NCT00174356|Antimitotic Agents|antimitotic agents|mesh-ancestor
92631675|NCT00174356|Mitosis Modulators|mitosis modulators|mesh-ancestor
92631676|NCT00174356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631744|NCT00203814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92631819|NCT01665391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92631820|NCT01665391|Immunologic Factors|immunologic factors|mesh-ancestor
92631821|NCT01665391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631822|NCT01660633|Melphalan|melphalan|mesh-list
92631823|NCT01660633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92631824|NCT01660633|Alkylating Agents|alkylating agents|mesh-ancestor
92631825|NCT01660633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631826|NCT01660633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631827|NCT01660633|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92631828|NCT01660633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92631829|NCT01660633|Immunologic Factors|immunologic factors|mesh-ancestor
92631830|NCT01660633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92631881|NCT00174629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92631882|NCT00174629|Tubulin Modulators|tubulin modulators|mesh-ancestor
92631954|NCT00174863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92631955|NCT00174863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92631956|NCT00174863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632028|NCT00555373|Antifungal Agents|antifungal agents|mesh-ancestor
92632029|NCT00555373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632030|NCT00555373|Immunologic Factors|immunologic factors|mesh-ancestor
92632031|NCT00555373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632032|NCT00555412|Loxapine|loxapine|mesh-list
92632033|NCT00555412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92632034|NCT00555412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92632035|NCT00555412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92632036|NCT00555412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632037|NCT00555412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92632038|NCT00555412|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92632039|NCT00555412|Dopamine Agents|dopamine agents|mesh-ancestor
92632040|NCT00555412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632041|NCT00555412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632042|NCT04676776|Levonorgestrel|levonorgestrel|mesh-list
92632086|NCT00199368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92632087|NCT00199368|Purinergic Agents|purinergic agents|mesh-ancestor
92632091|NCT04675528|Paclitaxel|paclitaxel|mesh-list
92632159|NCT00199407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92632160|NCT00199407|Purinergic Agents|purinergic agents|mesh-ancestor
92632161|NCT00199407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92632164|NCT00199446|Istradefylline|istradefylline|mesh-list
92632233|NCT00175643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92632234|NCT00175643|Immunologic Factors|immunologic factors|mesh-ancestor
92632235|NCT00175643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632236|NCT00175643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92632237|NCT00175643|Interferon Inducers|interferon inducers|mesh-ancestor
92632238|NCT00204438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92632239|NCT00204438|Desogestrel|desogestrel|mesh-list
92632240|NCT00204438|Estradiol|estradiol|mesh-list
92632298|NCT04111315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632299|NCT04111315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632300|NCT04111315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92632371|NCT00175838|Antisickling Agents|antisickling agents|mesh-ancestor
92632446|NCT00199953|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92632518|NCT00176618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632519|NCT00176618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632593|NCT00554203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92632594|NCT00554203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92632595|NCT00554203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92632597|NCT00554242|Ascorbic Acid|ascorbic acid|mesh-list
92632667|NCT00410982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92632739|NCT00176813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632740|NCT00176813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92632741|NCT00176813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92632810|NCT00177008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632811|NCT00177008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92632812|NCT00177008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92632960|NCT04657744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92632961|NCT04657744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92632962|NCT04657744|Immunologic Factors|immunologic factors|mesh-ancestor
92633031|NCT00200538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633032|NCT00200538|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92633033|NCT00200538|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92633099|NCT04654195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633100|NCT00200616|Anti-Infective Agents|anti-infective agents|mesh-list
92633101|NCT00200616|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92633168|NCT00178100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92633169|NCT00178100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633170|NCT04653415|Methylprednisolone|methylprednisolone|mesh-list
92633171|NCT04653415|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92633172|NCT04653415|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92633238|NCT04652128|Zoledronic Acid|zoledronic acid|mesh-list
92633239|NCT04652128|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92633310|NCT00206154|Glucocorticoids|glucocorticoids|mesh-ancestor
92633312|NCT00206154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633314|NCT00206154|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92633384|NCT00206193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633385|NCT00206193|Luteolytic Agents|luteolytic agents|mesh-ancestor
92633386|NCT00206193|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92633387|NCT00206193|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92633388|NCT04638439|Entecavir|entecavir|mesh-list
92633389|NCT04638439|Nivolumab|nivolumab|mesh-list
92633390|NCT04638439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92633391|NCT04638439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92633392|NCT04638439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92633393|NCT04638439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633394|NCT04638439|Antiviral Agents|antiviral agents|mesh-ancestor
92633444|NCT00560092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92633445|NCT00560170|Simvastatin|simvastatin|mesh-list
92633446|NCT00560170|Ezetimibe|ezetimibe|mesh-list
92633514|NCT00560443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633515|NCT00560443|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92633589|NCT00201396|Protective Agents|protective agents|mesh-ancestor
92633590|NCT00201396|Vitamin B Complex|vitamin b complex|mesh-ancestor
92633660|NCT00201630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633661|NCT00201630|Urological Agents|urological agents|mesh-ancestor
92633734|NCT00201747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92633735|NCT00179738|Lenalidomide|lenalidomide|mesh-list
92633736|NCT00179738|Immunologic Factors|immunologic factors|mesh-ancestor
92633806|NCT04630288|Ticagrelor|ticagrelor|mesh-list
92633807|NCT04630288|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92633808|NCT04630288|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92633809|NCT04630288|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92633810|NCT04630288|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92633811|NCT04630288|Purinergic Agents|purinergic agents|mesh-ancestor
92633812|NCT04630288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92633813|NCT04630288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633814|NCT04630288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633815|NCT00561028|Antibodies|antibodies|mesh-list
92633816|NCT00561028|Immunologic Factors|immunologic factors|mesh-ancestor
92633817|NCT00561028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633818|NCT00561067|Methylprednisolone|methylprednisolone|mesh-list
92633819|NCT00561067|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92633820|NCT00561067|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92633821|NCT00561067|Prednisolone|prednisolone|mesh-list
92633822|NCT00561067|Prednisolone acetate|prednisolone acetate|mesh-list
92633823|NCT00561067|Epoetin Alfa|epoetin alfa|mesh-list
92633824|NCT00561067|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92359018|NCT05266794|Vitamins|vitamins|mesh-ancestor
92633825|NCT00561067|Prednisolone phosphate|prednisolone phosphate|mesh-list
92633826|NCT00561067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633827|NCT00561067|Antiemetics|antiemetics|mesh-ancestor
92633859|NCT00186849|Topotecan|topotecan|mesh-list
92633860|NCT00186849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92633861|NCT00186849|Immunologic Factors|immunologic factors|mesh-ancestor
92633862|NCT00186849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633863|NCT00186849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92633864|NCT00186849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92633865|NCT00186849|Alkylating Agents|alkylating agents|mesh-ancestor
92633866|NCT00186849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633926|NCT00180050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633927|NCT00575302|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92633928|NCT00575302|Hormones|hormones|mesh-ancestor
92633929|NCT00575302|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92633930|NCT00575302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633931|NCT00575341|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92633932|NCT00575341|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92633933|NCT00575341|Immunologic Factors|immunologic factors|mesh-ancestor
92633934|NCT00575341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633935|NCT00180089|Budesonide|budesonide|mesh-list
92633936|NCT00180089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92633937|NCT00180089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92633938|NCT00180089|Autonomic Agents|autonomic agents|mesh-ancestor
92633939|NCT00180089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92633943|NCT00180089|Glucocorticoids|glucocorticoids|mesh-ancestor
92633985|NCT00575614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92633986|NCT00575614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92633987|NCT00575848|Glycine|glycine|mesh-list
92633999|NCT00576238|Hormones|hormones|mesh-ancestor
92634055|NCT00576706|Oxytocics|oxytocics|mesh-ancestor
92634056|NCT00576706|Antioxidants|antioxidants|mesh-ancestor
92634057|NCT00576706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634058|NCT00576706|Protective Agents|protective agents|mesh-ancestor
92634129|NCT00187005|Mercaptopurine|mercaptopurine|mesh-list
92634130|NCT00187005|Idarubicin|idarubicin|mesh-list
92634131|NCT00187005|Pegaspargase|pegaspargase|mesh-list
92634132|NCT00187005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92634133|NCT00187005|Immunologic Factors|immunologic factors|mesh-ancestor
92634134|NCT00187005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634135|NCT00187005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92634136|NCT00187005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634137|NCT00187005|Alkylating Agents|alkylating agents|mesh-ancestor
92634142|NCT00187005|Antiemetics|antiemetics|mesh-ancestor
92634198|NCT00187083|Teniposide|teniposide|mesh-list
92634199|NCT00187083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92634200|NCT00187083|Antiemetics|antiemetics|mesh-ancestor
92634201|NCT00187083|Autonomic Agents|autonomic agents|mesh-ancestor
92634202|NCT00187083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634203|NCT00187083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634204|NCT00187083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92634205|NCT00187083|Glucocorticoids|glucocorticoids|mesh-ancestor
92634206|NCT00187083|Hormones|hormones|mesh-ancestor
92634207|NCT00187083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92634208|NCT00187083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92634209|NCT00187083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634210|NCT00187083|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92634211|NCT00187083|Abortifacient Agents|abortifacient agents|mesh-ancestor
92634257|NCT00187122|Cyclophosphamide|cyclophosphamide|mesh-list
92634259|NCT00187122|Etoposide|etoposide|mesh-list
92634260|NCT00187122|Vincristine|vincristine|mesh-list
92634261|NCT00187122|Asparaginase|asparaginase|mesh-list
92634328|NCT00579085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92634329|NCT00579085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92634398|NCT00180791|Etoposide|etoposide|mesh-list
92634399|NCT00180791|Melphalan|melphalan|mesh-list
92634400|NCT00180791|Thiotepa|thiotepa|mesh-list
92634401|NCT00180791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634472|NCT00180908|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92634474|NCT00580450|Thymalfasin|thymalfasin|mesh-list
92634475|NCT00580450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92634476|NCT00580450|Immunologic Factors|immunologic factors|mesh-ancestor
92634477|NCT00580450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634478|NCT00180947|Vinorelbine|vinorelbine|mesh-list
92634479|NCT00180947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92634480|NCT00180947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634481|NCT00180947|Tubulin Modulators|tubulin modulators|mesh-ancestor
92634482|NCT00180947|Antimitotic Agents|antimitotic agents|mesh-ancestor
92634483|NCT00180947|Mitosis Modulators|mitosis modulators|mesh-ancestor
92634484|NCT00180947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634485|NCT00581035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92634486|NCT00581035|Immunologic Factors|immunologic factors|mesh-ancestor
92634487|NCT00581035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634488|NCT00581425|Interferons|interferons|mesh-list
92634489|NCT00581425|Interferon-alpha|interferon-alpha|mesh-list
92634490|NCT00581425|Imiquimod|imiquimod|mesh-list
92634491|NCT00581425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92634492|NCT00581425|Antiviral Agents|antiviral agents|mesh-ancestor
92634493|NCT00581425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92634494|NCT00581425|Immunologic Factors|immunologic factors|mesh-ancestor
92634495|NCT00581425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634496|NCT00581425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92634497|NCT00581425|Interferon Inducers|interferon inducers|mesh-ancestor
92634498|NCT00209079|Docetaxel|docetaxel|mesh-list
92634521|NCT04576975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634522|NCT04576975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92634525|NCT04576975|Anesthetics|anesthetics|mesh-ancestor
92634592|NCT00181220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92634593|NCT00181220|Antimanic Agents|antimanic agents|mesh-ancestor
92634594|NCT00181220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92634663|NCT04576390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92634664|NCT04576390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634672|NCT00181571|Dopamine Agents|dopamine agents|mesh-ancestor
92634732|NCT00584155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92634736|NCT00411372|Fluticasone|fluticasone|mesh-list
92634803|NCT00584662|Sympathomimetics|sympathomimetics|mesh-ancestor
92634804|NCT00584662|Autonomic Agents|autonomic agents|mesh-ancestor
92634805|NCT00584662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92634806|NCT00584662|Nasal Decongestants|nasal decongestants|mesh-ancestor
92634807|NCT00584662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92634808|NCT00584662|Respiratory System Agents|respiratory system agents|mesh-ancestor
92634809|NCT00584662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92634810|NCT00584662|Mydriatics|mydriatics|mesh-ancestor
92634811|NCT00584662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92634869|NCT00585442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92634943|NCT00408551|Vitamins|vitamins|mesh-ancestor
92634944|NCT00408551|Micronutrients|micronutrients|mesh-ancestor
92635015|NCT04575493|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92635017|NCT00587119|Budesonide|budesonide|mesh-list
92635089|NCT00182429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92635090|NCT00182429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92635091|NCT00182429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92635092|NCT00182429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92635158|NCT00182507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635159|NCT00182507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635231|NCT00182663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92635232|NCT00182663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92635239|NCT00216762|Rituximab|rituximab|mesh-list
92635304|NCT00588913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635306|NCT00588913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92635307|NCT00588913|Antiviral Agents|antiviral agents|mesh-ancestor
92635308|NCT00588913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92635309|NCT00588913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92635310|NCT00588913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635372|NCT00216840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635373|NCT00216840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92635374|NCT00216840|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635375|NCT00216840|Dermatologic Agents|dermatologic agents|mesh-ancestor
92635441|NCT04574791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635442|NCT04574791|Anticonvulsants|anticonvulsants|mesh-ancestor
92635443|NCT04574791|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92635444|NCT04574791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92635445|NCT04574791|Parasympatholytics|parasympatholytics|mesh-ancestor
92635446|NCT04574791|Autonomic Agents|autonomic agents|mesh-ancestor
92635447|NCT04574791|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92635448|NCT04574791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92635507|NCT00477295|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92635508|NCT00477295|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92635509|NCT00477295|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92635510|NCT00477295|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92635511|NCT00476593|Dexamethasone|dexamethasone|mesh-list
92635512|NCT00476593|Diclofenac|diclofenac|mesh-list
92635513|NCT00476593|Lactitol|lactitol|mesh-list
92635574|NCT00217152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635575|NCT00210210|Ketamine|ketamine|mesh-list
92635576|NCT00210210|Analgesics|analgesics|mesh-ancestor
92635577|NCT00210210|Sensory System Agents|sensory system agents|mesh-ancestor
92635578|NCT00210210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635579|NCT00210210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635580|NCT00210210|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92635581|NCT00210210|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92635582|NCT00210210|Anesthetics, General|anesthetics, general|mesh-ancestor
92635583|NCT00210210|Anesthetics|anesthetics|mesh-ancestor
92635584|NCT00210210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92635585|NCT00210210|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92635586|NCT00210210|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92635587|NCT00210210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92635588|NCT00210210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92635589|NCT00476086|Gemcitabine|gemcitabine|mesh-list
92635590|NCT00476086|Oxaliplatin|oxaliplatin|mesh-list
92635591|NCT00476086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92635592|NCT00476086|Antimetabolites|antimetabolites|mesh-ancestor
92635594|NCT00476086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635626|NCT00412035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635702|NCT00183950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92635703|NCT00210366|Idarubicin|idarubicin|mesh-list
92635704|NCT00210366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92635705|NCT00210366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92635773|NCT00475306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635844|NCT00210561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92635845|NCT00210561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635847|NCT00210561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92635848|NCT00210561|Narcotics|narcotics|mesh-ancestor
92635850|NCT00210600|Epoetin Alfa|epoetin alfa|mesh-list
92635917|NCT00210717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92635918|NCT00210717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92635994|NCT00210873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92635995|NCT00210912|Topiramate|topiramate|mesh-list
92635996|NCT00210912|Anticonvulsants|anticonvulsants|mesh-ancestor
92636067|NCT00185120|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92636068|NCT00185120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92636069|NCT00185120|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92636070|NCT00185120|Protease Inhibitors|protease inhibitors|mesh-ancestor
92636071|NCT00185120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636072|NCT00218049|Vanoxerine|vanoxerine|mesh-list
92636073|NCT00218049|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92636074|NCT00218049|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92636075|NCT00218049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92636076|NCT00218049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636078|NCT00218049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636079|NCT00218049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636129|NCT00409019|Tenofovir|tenofovir|mesh-list
92636203|NCT00218244|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92636204|NCT00218244|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92636273|NCT00185939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636274|NCT00218322|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92636343|NCT00186797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92636344|NCT00186797|Alkylating Agents|alkylating agents|mesh-ancestor
92636417|NCT00187070|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92636418|NCT00187070|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92636419|NCT00211848|Interferons|interferons|mesh-list
92636420|NCT00211848|Ribavirin|ribavirin|mesh-list
92636489|NCT00188045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636494|NCT00188045|Vasodilator Agents|vasodilator agents|mesh-ancestor
92636562|NCT00188552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636563|NCT00188552|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92636564|NCT00188552|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92636565|NCT00188552|Protective Agents|protective agents|mesh-ancestor
92636635|NCT00219765|Cytarabine|cytarabine|mesh-list
92636709|NCT00188942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636710|NCT00188942|Serotonin Agents|serotonin agents|mesh-ancestor
92636711|NCT00188942|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92636712|NCT00188942|Antidepressive Agents|antidepressive agents|mesh-ancestor
92636713|NCT00188942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92636714|NCT00188942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92636715|NCT00188942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92636716|NCT00219882|Turmeric extract|turmeric extract|mesh-list
92636717|NCT00219882|Antioxidants|antioxidants|mesh-ancestor
92636718|NCT00219882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92636719|NCT00219882|Protective Agents|protective agents|mesh-ancestor
92636720|NCT00219882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636721|NCT00189020|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92636722|NCT00189020|Immunologic Factors|immunologic factors|mesh-ancestor
92636723|NCT00189020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636766|NCT00189371|Epoetin Alfa|epoetin alfa|mesh-list
92636767|NCT00189371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92636768|NCT00189371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92636769|NCT00189371|Tubulin Modulators|tubulin modulators|mesh-ancestor
92636836|NCT00189722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92636908|NCT00189878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92636909|NCT00189878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92636978|NCT00189995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92636984|NCT00189995|GABA Agents|gaba agents|mesh-ancestor
92637051|NCT00220350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637052|NCT00220350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92637121|NCT00220506|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92637122|NCT00220506|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92637123|NCT00220506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637124|NCT00190619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92637125|NCT00190619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92637126|NCT00190619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637127|NCT00190619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637128|NCT00190619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637129|NCT00190619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637181|NCT00190814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637182|NCT00190814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637183|NCT00190814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637184|NCT00190814|Analgesics|analgesics|mesh-ancestor
92637185|NCT00190814|Sensory System Agents|sensory system agents|mesh-ancestor
92637250|NCT00190931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637251|NCT00190931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637253|NCT00190931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637255|NCT00220896|Donepezil|donepezil|mesh-list
92637316|NCT00191204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92637317|NCT00191204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92637318|NCT00191204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637386|NCT00191399|Serotonin Agents|serotonin agents|mesh-ancestor
92637387|NCT00191399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92637456|NCT00191516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637457|NCT00191516|Adrenergic Agents|adrenergic agents|mesh-ancestor
92637529|NCT00221481|Autonomic Agents|autonomic agents|mesh-ancestor
92637530|NCT00221481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637542|NCT00221481|Serotonin Agents|serotonin agents|mesh-ancestor
92637600|NCT00221637|Antimanic Agents|antimanic agents|mesh-ancestor
92637601|NCT00221637|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92637602|NCT00221637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92637603|NCT00221637|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92637604|NCT00123656|Fluticasone|fluticasone|mesh-list
92637605|NCT00123656|Esomeprazole|esomeprazole|mesh-list
92637606|NCT00123656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92637607|NCT00123656|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92637608|NCT00123656|Autonomic Agents|autonomic agents|mesh-ancestor
92637609|NCT00123656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637610|NCT00123656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637611|NCT00123656|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92637612|NCT00123656|Respiratory System Agents|respiratory system agents|mesh-ancestor
92637613|NCT00123656|Dermatologic Agents|dermatologic agents|mesh-ancestor
92637660|NCT00191867|Teriparatide|teriparatide|mesh-list
92637661|NCT00191867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92637662|NCT00191867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637730|NCT00215007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92637732|NCT00474994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637733|NCT00474994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92637734|NCT00474994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92637735|NCT00474994|Growth Substances|growth substances|mesh-ancestor
92637736|NCT00474994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637737|NCT00474994|Growth Inhibitors|growth inhibitors|mesh-ancestor
92637738|NCT00474994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92637739|NCT00474994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637741|NCT00474955|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92637793|NCT00221871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637795|NCT00474058|Dopamine Agonists|dopamine agonists|mesh-ancestor
92637796|NCT00474058|Dopamine Agents|dopamine agents|mesh-ancestor
92637797|NCT00474058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92637798|NCT00474058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637799|NCT00474058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637800|NCT02277730|Phenylephrine|phenylephrine|mesh-list
92637801|NCT02277730|Oxymetazoline|oxymetazoline|mesh-list
92637802|NCT02277730|Ephedrine|ephedrine|mesh-list
92637803|NCT02277730|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92637804|NCT02277730|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92637855|NCT00215163|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92637927|NCT00215358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637928|NCT00192569|Interferons|interferons|mesh-list
92637929|NCT00192569|Ribavirin|ribavirin|mesh-list
92637930|NCT00192569|Interferon-alpha|interferon-alpha|mesh-list
92637931|NCT00192569|Interferon alpha-2|interferon alpha-2|mesh-list
92637932|NCT00192569|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92637933|NCT00192569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92637934|NCT00192569|Antiviral Agents|antiviral agents|mesh-ancestor
92637935|NCT00192569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92637936|NCT00192569|Antimetabolites|antimetabolites|mesh-ancestor
92637937|NCT00192569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92637938|NCT00192569|Immunologic Factors|immunologic factors|mesh-ancestor
92637939|NCT00192569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637940|NCT00215397|Formoterol Fumarate|formoterol fumarate|mesh-list
92637941|NCT00215397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92637942|NCT00215397|Autonomic Agents|autonomic agents|mesh-ancestor
92637943|NCT00215397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92637944|NCT00215397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637983|NCT00215514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92637984|NCT00215514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92637985|NCT00215514|Immunologic Factors|immunologic factors|mesh-ancestor
92637986|NCT00215514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92637987|NCT00215514|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92637988|NCT00215514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92637989|NCT00215514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92637990|NCT00215514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92637992|NCT00192725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92363252|NCT02678052|Vedolizumab|vedolizumab|mesh-list
92637993|NCT00192725|Antidepressive Agents|antidepressive agents|mesh-ancestor
92637994|NCT00192725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92638043|NCT00411957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92638044|NCT00411957|Antiviral Agents|antiviral agents|mesh-ancestor
92638045|NCT00411957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638046|NCT00192803|Candesartan|candesartan|mesh-list
92638047|NCT00192803|Candesartan cilexetil|candesartan cilexetil|mesh-list
92638114|NCT00215631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638115|NCT00215631|Urological Agents|urological agents|mesh-ancestor
92638196|NCT00193271|Docetaxel|docetaxel|mesh-list
92638261|NCT00215748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638262|NCT00215826|Interferon-alpha|interferon-alpha|mesh-list
92638336|NCT00216138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638337|NCT00216138|Antimetabolites|antimetabolites|mesh-ancestor
92638407|NCT00193622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638409|NCT00473590|Bortezomib|bortezomib|mesh-list
92638410|NCT00473590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92638411|NCT00473590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638412|NCT00473590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92638413|NCT00473590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92638414|NCT00473590|Growth Substances|growth substances|mesh-ancestor
92638415|NCT00473590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638416|NCT00473590|Growth Inhibitors|growth inhibitors|mesh-ancestor
92638417|NCT00223275|Naltrexone|naltrexone|mesh-list
92638418|NCT00223275|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92638419|NCT00223275|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92638423|NCT00124787|Dimenhydrinate|dimenhydrinate|mesh-list
92638468|NCT00206310|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92638540|NCT00193973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92638614|NCT00223938|Ferric Compounds|ferric compounds|mesh-list
92638615|NCT00223938|Hematinics|hematinics|mesh-ancestor
92638616|NCT00125294|Methadone|methadone|mesh-list
92638617|NCT00125294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92638618|NCT00125294|Narcotics|narcotics|mesh-ancestor
92638619|NCT00125294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638620|NCT00125294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638621|NCT00125294|Analgesics|analgesics|mesh-ancestor
92638622|NCT00125294|Sensory System Agents|sensory system agents|mesh-ancestor
92638623|NCT00125294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638624|NCT00125294|Antitussive Agents|antitussive agents|mesh-ancestor
92638625|NCT00125294|Respiratory System Agents|respiratory system agents|mesh-ancestor
92638626|NCT00206466|Docetaxel|docetaxel|mesh-list
92638627|NCT00206466|Doxorubicin|doxorubicin|mesh-list
92638628|NCT00206466|Cyclophosphamide|cyclophosphamide|mesh-list
92638629|NCT00206466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92638630|NCT00206466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92638648|NCT00224094|Hormones|hormones|mesh-ancestor
92638674|NCT00206544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92638677|NCT00194324|Miconazole|miconazole|mesh-list
92638746|NCT00125489|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92638747|NCT00125489|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92638748|NCT00125489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92638749|NCT00125489|Antimalarials|antimalarials|mesh-ancestor
92638750|NCT00125489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92638751|NCT00125489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92638752|NCT00125489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92638753|NCT00125489|Analgesics|analgesics|mesh-ancestor
92638754|NCT00125489|Sensory System Agents|sensory system agents|mesh-ancestor
92638755|NCT00125489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92638756|NCT00125489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638757|NCT00125489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92638811|NCT00473083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638883|NCT00125801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92638884|NCT00125801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92638955|NCT00472303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92638956|NCT00472303|Adrenergic Agents|adrenergic agents|mesh-ancestor
92639026|NCT00471445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92639103|NCT00409760|Valsartan|valsartan|mesh-list
92639104|NCT00409760|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639105|NCT00409760|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92639110|NCT00409760|Vasodilator Agents|vasodilator agents|mesh-ancestor
92639171|NCT00195299|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92639173|NCT00471328|Sunitinib|sunitinib|mesh-list
92639247|NCT00225264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92639248|NCT00225264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639249|NCT00225264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92639250|NCT00225264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639251|NCT00225264|Immunologic Factors|immunologic factors|mesh-ancestor
92639252|NCT00126464|Tamoxifen|tamoxifen|mesh-list
92639253|NCT00126464|Fulvestrant|fulvestrant|mesh-list
92639254|NCT00126464|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92639255|NCT00126464|Hormone Antagonists|hormone antagonists|mesh-ancestor
92639256|NCT00126464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639257|NCT00126464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639258|NCT00126464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92639311|NCT00470470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639312|NCT00470470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639385|NCT00202358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639386|NCT00202358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639387|NCT00202358|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92639388|NCT00202358|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92639389|NCT00202358|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92639390|NCT00202358|Adrenergic Agents|adrenergic agents|mesh-ancestor
92639391|NCT00202358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639451|NCT00195806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639452|NCT00477529|Docetaxel|docetaxel|mesh-list
92639524|NCT00202592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639525|NCT00411333|Triamcinolone|triamcinolone|mesh-list
92639526|NCT00411333|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92639527|NCT00411333|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92639531|NCT00411333|Hormones|hormones|mesh-ancestor
92639596|NCT00226044|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92639597|NCT00226044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639598|NCT00226044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639599|NCT00202982|Glatiramer Acetate|glatiramer acetate|mesh-list
92639600|NCT00202982|(T,G)-A-L|(t,g)-a-l|mesh-list
92639601|NCT00202982|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92639602|NCT00202982|Immunologic Factors|immunologic factors|mesh-ancestor
92639603|NCT00202982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639604|NCT00202982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92639605|NCT00202982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92639606|NCT00207948|Ritonavir|ritonavir|mesh-list
92639607|NCT00207948|Lopinavir|lopinavir|mesh-list
92639660|NCT00208065|Nasal Decongestants|nasal decongestants|mesh-ancestor
92639661|NCT00208065|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92639662|NCT00208065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92639663|NCT00208065|Sympathomimetics|sympathomimetics|mesh-ancestor
92639664|NCT00208065|Adrenergic Agents|adrenergic agents|mesh-ancestor
92639665|NCT00208065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92639666|NCT00208065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639667|NCT00208065|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92639668|NCT00208065|Serotonin Agents|serotonin agents|mesh-ancestor
92639669|NCT00203099|Acetylcysteine|acetylcysteine|mesh-list
92639670|NCT00203099|Glatiramer Acetate|glatiramer acetate|mesh-list
92639671|NCT00203099|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92639672|NCT00203099|(T,G)-A-L|(t,g)-a-l|mesh-list
92639673|NCT00203099|Antiviral Agents|antiviral agents|mesh-ancestor
92639674|NCT00203099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92639675|NCT00203099|Expectorants|expectorants|mesh-ancestor
92639676|NCT00203099|Respiratory System Agents|respiratory system agents|mesh-ancestor
92639677|NCT00203099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92639678|NCT00203099|Antioxidants|antioxidants|mesh-ancestor
92639679|NCT00203099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639680|NCT00203099|Protective Agents|protective agents|mesh-ancestor
92639681|NCT00203099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639682|NCT00203099|Antidotes|antidotes|mesh-ancestor
92639683|NCT00203099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92639684|NCT00203099|Immunologic Factors|immunologic factors|mesh-ancestor
92639710|NCT00203177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639711|NCT00203177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639712|NCT00203177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92639780|NCT00208182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92639781|NCT00208182|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92639782|NCT00208182|Dopamine Agents|dopamine agents|mesh-ancestor
92639783|NCT00226395|Oxymorphone|oxymorphone|mesh-list
92639784|NCT00226395|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92639785|NCT00226395|Narcotics|narcotics|mesh-ancestor
92639786|NCT00226395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92639787|NCT00226395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639788|NCT00226395|Analgesics|analgesics|mesh-ancestor
92639789|NCT00226395|Sensory System Agents|sensory system agents|mesh-ancestor
92639790|NCT00226395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639791|NCT00226395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92365074|NCT03000036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92639792|NCT00208221|Telmisartan|telmisartan|mesh-list
92639793|NCT00208221|Ramipril|ramipril|mesh-list
92639794|NCT00208221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92639795|NCT00208221|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92639796|NCT00208221|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92639838|NCT00226473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639839|NCT00226473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92639908|NCT00410657|Alemtuzumab|alemtuzumab|mesh-list
92639909|NCT00410657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92639910|NCT00410657|Prednisolone phosphate|prednisolone phosphate|mesh-list
92639911|NCT00410657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92639912|NCT00410657|Glucocorticoids|glucocorticoids|mesh-ancestor
92639913|NCT00410657|Hormones|hormones|mesh-ancestor
92639914|NCT00410657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92639915|NCT00410657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92639916|NCT00410657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92639917|NCT00410657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639918|NCT00410657|Antiemetics|antiemetics|mesh-ancestor
92639919|NCT00410657|Autonomic Agents|autonomic agents|mesh-ancestor
92639920|NCT00410657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92639921|NCT00410657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92639922|NCT00410657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92639923|NCT00410657|Protective Agents|protective agents|mesh-ancestor
92639924|NCT00410657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639925|NCT00196820|Capecitabine|capecitabine|mesh-list
92639926|NCT00196820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92639927|NCT00196820|Antimetabolites|antimetabolites|mesh-ancestor
92639928|NCT00196820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92639929|NCT00196820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92639930|NCT00410696|Lenograstim|lenograstim|mesh-list
92639931|NCT00410696|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92639932|NCT00410696|Immunologic Factors|immunologic factors|mesh-ancestor
92639956|NCT00203372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92639957|NCT00203372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92639958|NCT00203372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92639969|NCT00226551|Isoproterenol|isoproterenol|mesh-list
92640024|NCT00208572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640098|NCT00203606|Ribavirin|ribavirin|mesh-list
92640099|NCT00203606|Interferon-alpha|interferon-alpha|mesh-list
92640172|NCT00226980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640247|NCT00204074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640260|NCT00197483|Pergolide|pergolide|mesh-list
92640322|NCT00227448|Autonomic Agents|autonomic agents|mesh-ancestor
92640323|NCT00227448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92640324|NCT00227448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640325|NCT00227448|Sympathomimetics|sympathomimetics|mesh-ancestor
92640326|NCT00227448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92640327|NCT00227448|Nasal Decongestants|nasal decongestants|mesh-ancestor
92640328|NCT00227448|Respiratory System Agents|respiratory system agents|mesh-ancestor
92640329|NCT00227448|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92640330|NCT00227448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92640331|NCT00227448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92640332|NCT00227448|Adrenergic Agents|adrenergic agents|mesh-ancestor
92640333|NCT00227448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640334|NCT00227448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640335|NCT00227448|Protective Agents|protective agents|mesh-ancestor
92640381|NCT00204308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640382|NCT00204308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92640383|NCT00204308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92640455|NCT00197834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92640528|NCT00227955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92640529|NCT00227955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92640530|NCT00227955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92640531|NCT00227955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640532|NCT00227955|Adrenergic Agents|adrenergic agents|mesh-ancestor
92640598|NCT00204698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92640671|NCT00228462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92640672|NCT00228462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92640673|NCT00228462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640674|NCT00198614|Metoprolol|metoprolol|mesh-list
92640675|NCT00198614|Carvedilol|carvedilol|mesh-list
92640742|NCT00198848|Micronutrients|micronutrients|mesh-ancestor
92640743|NCT00198848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640744|NCT00478426|Sunitinib|sunitinib|mesh-list
92640745|NCT00478426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92640746|NCT00478426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92640747|NCT00478426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92640748|NCT00478426|Growth Substances|growth substances|mesh-ancestor
92640749|NCT00478426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640750|NCT00478426|Growth Inhibitors|growth inhibitors|mesh-ancestor
92640751|NCT00478426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92640752|NCT00478426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640753|NCT00478426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640754|NCT00231855|Docetaxel|docetaxel|mesh-list
92640755|NCT00231855|Topotecan|topotecan|mesh-list
92640806|NCT00199004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92640807|NCT00199004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92640808|NCT00199004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92640809|NCT00199004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92640810|NCT00199004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92640811|NCT00199004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92640812|NCT00199004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92640813|NCT00199004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92640814|NCT00228852|Fludarabine|fludarabine|mesh-list
92640874|NCT00477412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92640875|NCT00477412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92640876|NCT00477412|Antimetabolites|antimetabolites|mesh-ancestor
92640945|NCT00232089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92640946|NCT00232089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640947|NCT00232089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640949|NCT00205166|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92640950|NCT00205166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92640951|NCT00205166|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92640952|NCT00205166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92640953|NCT00205166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92640954|NCT00205166|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92640955|NCT00205166|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92640956|NCT00205166|Purinergic Agents|purinergic agents|mesh-ancestor
92640957|NCT00205166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92641006|NCT00205322|Capecitabine|capecitabine|mesh-list
92641007|NCT00205322|Oxaliplatin|oxaliplatin|mesh-list
92641152|NCT00229593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641153|NCT00229593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92641154|NCT00229593|Contraceptive Agents|contraceptive agents|mesh-ancestor
92641223|NCT00411203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641224|NCT00411203|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92641225|NCT00411203|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92641226|NCT00411203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92641228|NCT00411281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92641229|NCT00411281|Antimetabolites|antimetabolites|mesh-ancestor
92641231|NCT00411281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641289|NCT01056159|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92366566|NCT00741468|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92641290|NCT01056159|Autonomic Agents|autonomic agents|mesh-ancestor
92641291|NCT01056159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641292|NCT01056159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641293|NCT01056159|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92641294|NCT01056159|Respiratory System Agents|respiratory system agents|mesh-ancestor
92641295|NCT01056159|Tocolytic Agents|tocolytic agents|mesh-ancestor
92641296|NCT01056159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92641298|NCT01056159|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92641351|NCT00206999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641423|NCT00233025|Sensory System Agents|sensory system agents|mesh-ancestor
92641425|NCT00233025|Antidepressive Agents|antidepressive agents|mesh-ancestor
92641496|NCT00411320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641497|NCT00411320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92641567|NCT00424580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92641570|NCT00424580|Cholinergic Agents|cholinergic agents|mesh-ancestor
92641636|NCT00208169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641637|NCT00208169|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92641707|NCT00208442|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92641708|NCT00208442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92641781|NCT01083316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92641782|NCT01083316|Antiemetics|antiemetics|mesh-ancestor
92641854|NCT00234000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92641855|NCT00234000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92641856|NCT00234000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92641857|NCT00234117|Rabeprazole|rabeprazole|mesh-list
92641926|NCT00209261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92641927|NCT00209300|Mesalamine|mesalamine|mesh-list
92641929|NCT00209300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92641998|NCT00209495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92641999|NCT00209495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642069|NCT02961855|Anesthetics, Local|anesthetics, local|mesh-ancestor
92642070|NCT02961855|Anesthetics|anesthetics|mesh-ancestor
92642071|NCT02961855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92642140|NCT00209729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642141|NCT00414180|Bupropion|bupropion|mesh-list
92642210|NCT01082068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642211|NCT01082068|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92642212|NCT01082068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92642213|NCT01082068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399578|NCT01404364|Glucocorticoids|glucocorticoids|mesh-ancestor
92642282|NCT00234546|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92642283|NCT00234546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92642284|NCT00234546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642353|NCT04991662|Sympathomimetics|sympathomimetics|mesh-ancestor
92642354|NCT04991662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92642424|NCT00210314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92642425|NCT00210314|Antiviral Agents|antiviral agents|mesh-ancestor
92642499|NCT04570345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92642500|NCT04570345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642501|NCT04570345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92642502|NCT04570345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92642503|NCT04570345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92642504|NCT04570345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92642568|NCT04569916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92642641|NCT00237939|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92642643|NCT04569214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92642644|NCT04569214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642645|NCT00210860|Topiramate|topiramate|mesh-list
92642646|NCT00210860|Anticonvulsants|anticonvulsants|mesh-ancestor
92642647|NCT00210860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92642648|NCT00210860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92642649|NCT00210899|Vancomycin|vancomycin|mesh-list
92642650|NCT00210899|Ceftazidime|ceftazidime|mesh-list
92642651|NCT00210899|Ceftobiprole|ceftobiprole|mesh-list
92642652|NCT00210899|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92642653|NCT00210899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92642654|NCT00210899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92642707|NCT04566796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92642787|NCT00238290|Trastuzumab|trastuzumab|mesh-list
92642860|NCT00238368|Hormones|hormones|mesh-ancestor
92642865|NCT00238368|Antimetabolites|antimetabolites|mesh-ancestor
92642933|NCT02894710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368285|NCT00973752|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643006|NCT05427175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643007|NCT05427175|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643008|NCT05427175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643025|NCT04680091|Efavirenz|efavirenz|mesh-list
92643071|NCT00211796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92643072|NCT00211796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92643073|NCT05426824|Pegaspargase|pegaspargase|mesh-list
92643146|NCT04668976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643223|NCT04668469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92643224|NCT04668469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643225|NCT04668469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643295|NCT00212069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643296|NCT00212069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643297|NCT00212069|Antimetabolites|antimetabolites|mesh-ancestor
92643298|NCT00212069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643299|NCT00212108|Celecoxib|celecoxib|mesh-list
92643300|NCT00212108|Gefitinib|gefitinib|mesh-list
92643301|NCT00212108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92643302|NCT00212108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643303|NCT00212108|Analgesics|analgesics|mesh-ancestor
92643304|NCT00212108|Sensory System Agents|sensory system agents|mesh-ancestor
92643360|NCT00239343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643361|NCT00411593|Bevacizumab|bevacizumab|mesh-list
92643434|NCT00239499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643435|NCT00239499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92643436|NCT00239499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92643437|NCT00239499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92643438|NCT00239499|Adrenergic Agents|adrenergic agents|mesh-ancestor
92643439|NCT00212615|Capecitabine|capecitabine|mesh-list
92643440|NCT00212615|Oxaliplatin|oxaliplatin|mesh-list
92643441|NCT00212615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643442|NCT00212615|Antimetabolites|antimetabolites|mesh-ancestor
92643445|NCT00222573|Metoprolol|metoprolol|mesh-list
92643496|NCT00213122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643500|NCT00213200|Morphine|morphine|mesh-list
92643567|NCT00213590|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92643568|NCT00240045|Octreotide|octreotide|mesh-list
92643569|NCT00240045|Midodrine|midodrine|mesh-list
92643570|NCT00240045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916354|NCT03962114|Niacinamide|niacinamide|mesh-list
92643571|NCT00240045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92643572|NCT00240045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643634|NCT00243750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92643635|NCT00243750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643636|NCT00243750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92643638|NCT00243750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643639|NCT00243750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92643640|NCT00243750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92643641|NCT00243750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92643642|NCT00243750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92643643|NCT00243750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92643698|NCT00214331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92643699|NCT00214331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92643700|NCT00214331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92643770|NCT00214604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92643771|NCT00214604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92643793|NCT00214682|Vitamins|vitamins|mesh-ancestor
92643845|NCT00214994|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92643849|NCT00214994|GABA Agents|gaba agents|mesh-ancestor
92643915|NCT00240708|Dopamine Agents|dopamine agents|mesh-ancestor
92643988|NCT00240786|Acetaminophen|acetaminophen|mesh-list
92643989|NCT00240786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92643990|NCT00240786|Analgesics|analgesics|mesh-ancestor
92643991|NCT00240786|Sensory System Agents|sensory system agents|mesh-ancestor
92643992|NCT00240786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92643993|NCT00240786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92643994|NCT00240786|Antipyretics|antipyretics|mesh-ancestor
92643995|NCT00215579|Risperidone|risperidone|mesh-list
92643996|NCT00215579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92643997|NCT00215579|Serotonin Agents|serotonin agents|mesh-ancestor
92644012|NCT00244452|Cetrorelix|cetrorelix|mesh-list
92644050|NCT04667299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644052|NCT04667299|Diuretics|diuretics|mesh-ancestor
92644053|NCT04667299|Natriuretic Agents|natriuretic agents|mesh-ancestor
92644055|NCT04667299|Expectorants|expectorants|mesh-ancestor
92644123|NCT04666324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644124|NCT04666324|Emollients|emollients|mesh-ancestor
92644196|NCT02961816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92644197|NCT02961816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369494|NCT04908371|Mydriatics|mydriatics|mesh-ancestor
92644266|NCT00241059|Antitubercular Agents|antitubercular agents|mesh-ancestor
92644267|NCT00241059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92644268|NCT00241059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644269|NCT00241059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92644336|NCT00216359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92644337|NCT00216359|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92644408|NCT00244998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92644410|NCT00216554|Risperidone|risperidone|mesh-list
92644482|NCT00245115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92644483|NCT00245115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92644558|NCT04660786|Micronutrients|micronutrients|mesh-ancestor
92644630|NCT04648813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92644631|NCT04648813|Anticonvulsants|anticonvulsants|mesh-ancestor
92644706|NCT00217373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644707|NCT00217373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644708|NCT00217373|Antiviral Agents|antiviral agents|mesh-ancestor
92644776|NCT04646317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92644777|NCT04646317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92644849|NCT00217607|Paclitaxel|paclitaxel|mesh-list
92644850|NCT00217607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92644851|NCT00217607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92644852|NCT00217607|Tubulin Modulators|tubulin modulators|mesh-ancestor
92644853|NCT00217607|Antimitotic Agents|antimitotic agents|mesh-ancestor
92644854|NCT00217607|Mitosis Modulators|mitosis modulators|mesh-ancestor
92644856|NCT04644484|Vaccines|vaccines|mesh-list
92644919|NCT04643821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92644995|NCT00218309|Sensory System Agents|sensory system agents|mesh-ancestor
92644996|NCT00218309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92644997|NCT00218348|Amphetamine|amphetamine|mesh-list
92644998|NCT00218348|Dextroamphetamine|dextroamphetamine|mesh-list
92644999|NCT00218348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92645000|NCT00218348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645001|NCT00218348|Sympathomimetics|sympathomimetics|mesh-ancestor
92645002|NCT00218348|Autonomic Agents|autonomic agents|mesh-ancestor
92645004|NCT00218348|Dopamine Agents|dopamine agents|mesh-ancestor
92645059|NCT00559429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92645060|NCT00559429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92645130|NCT04639804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645132|NCT00218855|Thalidomide|thalidomide|mesh-list
92645204|NCT00246285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645205|NCT00246285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645206|NCT00246285|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92645207|NCT00246285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92645208|NCT00246285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645209|NCT00246285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92645210|NCT00246285|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92645271|NCT00242346|Candesartan cilexetil|candesartan cilexetil|mesh-list
92645272|NCT00242346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92645273|NCT00242346|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92645274|NCT00242346|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92645275|NCT00242346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645276|NCT00219245|Rivastigmine|rivastigmine|mesh-list
92645285|NCT04627363|Bevacizumab|bevacizumab|mesh-list
92645336|NCT00246675|Natriuretic Agents|natriuretic agents|mesh-ancestor
92645337|NCT00246675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645338|NCT00246675|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92645405|NCT04626193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92645406|NCT04626193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92645407|NCT04626193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92645408|NCT04626193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645409|NCT04626193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92645410|NCT04626193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645411|NCT04626193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645412|NCT04626193|Antimalarials|antimalarials|mesh-ancestor
92645413|NCT04626193|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92645414|NCT04626193|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92645415|NCT04626193|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92645416|NCT04626193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92645467|NCT00246909|Pantoprazole|pantoprazole|mesh-list
92645468|NCT00246909|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92645469|NCT00246909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92645470|NCT00246909|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92645471|NCT00246909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645472|NCT00246909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645473|NCT00219869|Galantamine|galantamine|mesh-list
92645474|NCT00219869|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92645475|NCT00219869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645476|NCT00219869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645477|NCT00219869|Cholinergic Agents|cholinergic agents|mesh-ancestor
92645478|NCT00219869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92645479|NCT00219869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645480|NCT00219869|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92645481|NCT00219869|Autonomic Agents|autonomic agents|mesh-ancestor
92645482|NCT00219869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645526|NCT00242775|Hormones|hormones|mesh-ancestor
92645527|NCT00242775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645529|NCT00242775|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92645601|NCT01580683|Micronutrients|micronutrients|mesh-ancestor
92645602|NCT01580683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645603|NCT01580683|Antioxidants|antioxidants|mesh-ancestor
92645604|NCT01580683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645605|NCT01580683|Protective Agents|protective agents|mesh-ancestor
92645606|NCT00242814|Amlodipine|amlodipine|mesh-list
92645607|NCT00242814|Telmisartan|telmisartan|mesh-list
92645608|NCT00242814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92645609|NCT00242814|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92645610|NCT00242814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645611|NCT00242814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645612|NCT00242814|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92645613|NCT00242814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645614|NCT00242814|Vasodilator Agents|vasodilator agents|mesh-ancestor
92645615|NCT00242814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92645616|NCT00242814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92645617|NCT04623385|Tretinoin|tretinoin|mesh-list
92645618|NCT04623385|Isotretinoin|isotretinoin|mesh-list
92645619|NCT04623385|Testosterone|testosterone|mesh-list
92645620|NCT04623385|Androgens|androgens|mesh-ancestor
92645621|NCT04623385|Hormones|hormones|mesh-ancestor
92645622|NCT04623385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645623|NCT04623385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645624|NCT04623385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92645625|NCT04623385|Keratolytic Agents|keratolytic agents|mesh-ancestor
92645626|NCT04623385|Dermatologic Agents|dermatologic agents|mesh-ancestor
92645627|NCT00220220|Amlodipine|amlodipine|mesh-list
92645628|NCT00220220|Olmesartan|olmesartan|mesh-list
92645629|NCT00220220|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92645630|NCT00220220|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92645631|NCT00220220|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92645632|NCT00220220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645633|NCT00220220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645634|NCT00220220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92645635|NCT00220220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645637|NCT00220220|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92645638|NCT00220220|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92645707|NCT00220298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645711|NCT00220298|Anabolic Agents|anabolic agents|mesh-ancestor
92645779|NCT04621513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645854|NCT00220649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645855|NCT00220649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92645856|NCT00220649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92645857|NCT00220649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645925|NCT04619251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92645926|NCT04619251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92645927|NCT04619251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92645928|NCT04619251|Hormone Antagonists|hormone antagonists|mesh-ancestor
92645929|NCT04619251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645930|NCT04619251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645931|NCT04619251|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92645932|NCT00243399|Oxandrolone|oxandrolone|mesh-list
92645933|NCT00243399|Androgens|androgens|mesh-ancestor
92645934|NCT00243399|Hormones|hormones|mesh-ancestor
92645935|NCT00243399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92645937|NCT00243399|Anabolic Agents|anabolic agents|mesh-ancestor
92645986|NCT04617652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92645987|NCT04617652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92645988|NCT04617652|Anesthetics|anesthetics|mesh-ancestor
92645989|NCT04617652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92645990|NCT04617652|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92645991|NCT04617652|Anticonvulsants|anticonvulsants|mesh-ancestor
92645992|NCT04617652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92645993|NCT04617652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92645994|NCT04617652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371282|NCT01253460|Sapacitabine|sapacitabine|mesh-list
92645995|NCT04617652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92645996|NCT04617652|Tocolytic Agents|tocolytic agents|mesh-ancestor
92645997|NCT04617652|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92646043|NCT00247650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92646044|NCT00247650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646045|NCT00247650|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92646046|NCT00221429|Valproic Acid|valproic acid|mesh-list
92646047|NCT00221429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646048|NCT00221429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646049|NCT00221429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646050|NCT00221429|Antimanic Agents|antimanic agents|mesh-ancestor
92646051|NCT00221429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92646052|NCT00221429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646053|NCT00221429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646054|NCT00221429|Anticonvulsants|anticonvulsants|mesh-ancestor
92646055|NCT00221429|GABA Agents|gaba agents|mesh-ancestor
92646056|NCT00221429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646057|NCT00563017|Risperidone|risperidone|mesh-list
92646058|NCT00563017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92646059|NCT00563017|Serotonin Agents|serotonin agents|mesh-ancestor
92646060|NCT00563017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646061|NCT00563017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646062|NCT00563017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646063|NCT00563017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92646064|NCT00563017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92371377|NCT01275300|Aspirin|aspirin|mesh-list
92646093|NCT00221468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92646094|NCT00221468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92646097|NCT00563212|Interferons|interferons|mesh-list
92646169|NCT04615702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646170|NCT04615702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92646171|NCT04615702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92646242|NCT04613869|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92646243|NCT04613869|Narcotics|narcotics|mesh-ancestor
92646244|NCT04613869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92646245|NCT04613869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646246|NCT04613869|Analgesics|analgesics|mesh-ancestor
92646247|NCT04613869|Sensory System Agents|sensory system agents|mesh-ancestor
92646248|NCT04613869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646249|NCT04613869|Antidepressive Agents|antidepressive agents|mesh-ancestor
92646250|NCT04613869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646251|NCT04613557|Cyclophosphamide|cyclophosphamide|mesh-list
92646252|NCT04613557|Fludarabine|fludarabine|mesh-list
92646253|NCT04613557|Fludarabine phosphate|fludarabine phosphate|mesh-list
92646254|NCT04613557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92646255|NCT04613557|Immunologic Factors|immunologic factors|mesh-ancestor
92646256|NCT04613557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646257|NCT04613557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646258|NCT04613557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92646259|NCT04613557|Alkylating Agents|alkylating agents|mesh-ancestor
92646264|NCT04613557|Antimetabolites|antimetabolites|mesh-ancestor
92646299|NCT04613284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92646300|NCT00563641|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92646301|NCT00563641|Respiratory System Agents|respiratory system agents|mesh-ancestor
92646303|NCT00248118|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92371655|NCT01315002|Nicotine|nicotine|mesh-list
92646370|NCT00251472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92646371|NCT00251472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92646372|NCT00251472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92646442|NCT04611685|Analgesics|analgesics|mesh-ancestor
92371738|NCT01328184|Estrogens|estrogens|mesh-ancestor
92646443|NCT04611685|Sensory System Agents|sensory system agents|mesh-ancestor
92646444|NCT04611685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646445|NCT04611685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92646446|NCT04611685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92646447|NCT04611685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646448|NCT04611685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646449|NCT04611685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92646508|NCT00564031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399609|NCT01404442|Anesthetics, General|anesthetics, general|mesh-ancestor
92646582|NCT00222677|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92646583|NCT00222677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92646584|NCT00222677|Analgesics|analgesics|mesh-ancestor
92646585|NCT00222677|Sensory System Agents|sensory system agents|mesh-ancestor
92646586|NCT00222677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92646587|NCT00222677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92646588|NCT00222677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646589|NCT00222677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92646590|NCT00222677|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92646591|NCT00222677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92371916|NCT01347060|Xhance|xhance|mesh-list
92646644|NCT04608253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92646645|NCT04608253|Antimetabolites|antimetabolites|mesh-ancestor
92646646|NCT04608253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646647|NCT04608253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92646648|NCT04608253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92646649|NCT04608253|Nootropic Agents|nootropic agents|mesh-ancestor
92646650|NCT00222833|Aripiprazole|aripiprazole|mesh-list
92646651|NCT00222833|Antidepressive Agents|antidepressive agents|mesh-ancestor
92646652|NCT00222833|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92646653|NCT00222833|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92646654|NCT00222833|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92646668|NCT00564538|Tacrolimus|tacrolimus|mesh-list
92646707|NCT00199160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646708|NCT00199160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92646709|NCT00199160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646710|NCT00199160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646712|NCT04607629|Budesonide|budesonide|mesh-list
92646713|NCT04607629|Formoterol Fumarate|formoterol fumarate|mesh-list
92646724|NCT04607629|Hormones|hormones|mesh-ancestor
92646774|NCT00564655|Adrenergic Agents|adrenergic agents|mesh-ancestor
92646775|NCT00564655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92646776|NCT00564655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92646777|NCT00564655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92646778|NCT00564655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92646779|NCT00564655|Autonomic Agents|autonomic agents|mesh-ancestor
92646780|NCT00564655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92646839|NCT04605562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92646840|NCT04605562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92646911|NCT04604509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92646912|NCT04604509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92646913|NCT04604509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92646914|NCT04604509|Dopamine Agents|dopamine agents|mesh-ancestor
92646915|NCT04604509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92646916|NCT04604509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92646917|NCT04604509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92646918|NCT00565162|Insulin Glargine|insulin glargine|mesh-list
92646979|NCT05285813|Dexamethasone|dexamethasone|mesh-list
92646980|NCT05285813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92646981|NCT05285813|Antiemetics|antiemetics|mesh-ancestor
92647052|NCT00252330|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92647053|NCT00252330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92647054|NCT00252330|Adrenergic Agents|adrenergic agents|mesh-ancestor
92647055|NCT00252330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92647056|NCT00252330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647057|NCT00252330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647058|NCT00252330|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92647059|NCT04602013|Paclitaxel|paclitaxel|mesh-list
92647060|NCT04602013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92647061|NCT04602013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92647062|NCT04602013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647063|NCT04602013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92647064|NCT04602013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92647065|NCT04602013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92647066|NCT04602013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647067|NCT04601701|Dexamethasone|dexamethasone|mesh-list
92647068|NCT04601701|Bevacizumab|bevacizumab|mesh-list
92647069|NCT04601701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647070|NCT04601701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647071|NCT04601701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92647072|NCT04601701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92647073|NCT04601701|Growth Substances|growth substances|mesh-ancestor
92647074|NCT04601701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647077|NCT04601701|Antiemetics|antiemetics|mesh-ancestor
92647102|NCT05201144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92647103|NCT05201144|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92647104|NCT05201144|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92647173|NCT04599205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92647245|NCT00565708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92647246|NCT00565708|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92647247|NCT00565708|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92647248|NCT00565708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647249|NCT00565708|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92647250|NCT00565708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92647251|NCT00565708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647252|NCT00565708|Antipyretics|antipyretics|mesh-ancestor
92647253|NCT00252642|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92647254|NCT00252642|Antiviral Agents|antiviral agents|mesh-ancestor
92647255|NCT00252642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372551|NCT01508832|Anesthetics|anesthetics|mesh-ancestor
92647256|NCT04598542|Triamcinolone|triamcinolone|mesh-list
92647257|NCT04598542|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92647258|NCT04598542|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92647259|NCT04598542|Lorecivivint|lorecivivint|mesh-list
92647260|NCT04598542|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92647261|NCT04598542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92647262|NCT04598542|Glucocorticoids|glucocorticoids|mesh-ancestor
92647263|NCT04598542|Hormones|hormones|mesh-ancestor
92647264|NCT04598542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92647265|NCT04598542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647266|NCT04598542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647267|NCT04598542|Immunologic Factors|immunologic factors|mesh-ancestor
92647268|NCT04598542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92647269|NCT04598542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647270|NCT04995263|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92647271|NCT04995263|Caffeine|caffeine|mesh-list
92647272|NCT04995263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92647273|NCT04995263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647282|NCT04598191|Iloprost|iloprost|mesh-list
92647288|NCT04955366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92647289|NCT04955366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647290|NCT04955366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92647360|NCT04597762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92647436|NCT04595812|Oxytocics|oxytocics|mesh-ancestor
92647437|NCT04595812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92647510|NCT00566683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92647584|NCT04593706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647585|NCT04593706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92647658|NCT04592380|Clevidipine|clevidipine|mesh-list
92647659|NCT04592380|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92647660|NCT04592380|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92647661|NCT04592380|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92647662|NCT04592380|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92647663|NCT04592380|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92647664|NCT04592380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92647665|NCT04592380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92647666|NCT04592380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92647667|NCT04592380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647668|NCT00253188|Galantamine|galantamine|mesh-list
92647715|NCT04719585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92647789|NCT00253344|Lenalidomide|lenalidomide|mesh-list
92647790|NCT00253344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92647791|NCT00253344|Tubulin Modulators|tubulin modulators|mesh-ancestor
92647863|NCT04272242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92647864|NCT04272242|Antiviral Agents|antiviral agents|mesh-ancestor
92647891|NCT04589494|Morphine|morphine|mesh-list
92647936|NCT00567775|Insulin|insulin|mesh-list
92647937|NCT00567775|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92647938|NCT00567775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92647939|NCT00567775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92647940|NCT00567814|Oxazepam|oxazepam|mesh-list
92647941|NCT00567814|Metyrapone|metyrapone|mesh-list
92648008|NCT04587505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92648009|NCT04587505|Narcotics|narcotics|mesh-ancestor
92648010|NCT04587505|Analgesics|analgesics|mesh-ancestor
92648011|NCT04587505|Sensory System Agents|sensory system agents|mesh-ancestor
92648012|NCT04587505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648013|NCT04587505|Anesthetics, Local|anesthetics, local|mesh-ancestor
92648014|NCT04128683|Bromocriptine|bromocriptine|mesh-list
92648015|NCT04128683|Amisulpride|amisulpride|mesh-list
92648016|NCT04128683|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92648017|NCT04128683|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648018|NCT04128683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92648019|NCT04128683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648074|NCT00403286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648075|NCT00403286|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92648076|NCT00403286|Respiratory System Agents|respiratory system agents|mesh-ancestor
92648077|NCT00403286|Dermatologic Agents|dermatologic agents|mesh-ancestor
92648144|NCT04585321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92648145|NCT04585321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92648217|NCT00223418|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92648223|NCT04584736|Ezetimibe|ezetimibe|mesh-list
92648290|NCT04583137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648291|NCT04583137|Sensory System Agents|sensory system agents|mesh-ancestor
92648292|NCT04583137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92648365|NCT00223691|Histamine Agents|histamine agents|mesh-ancestor
92648366|NCT00223691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92648367|NCT00223691|Antipruritics|antipruritics|mesh-ancestor
92648368|NCT00223691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92648372|NCT00223691|Gout Suppressants|gout suppressants|mesh-ancestor
92648436|NCT04582084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92648437|NCT04582084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92648510|NCT00568711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92648583|NCT00224315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92648584|NCT00224315|Dopamine Agents|dopamine agents|mesh-ancestor
92648659|NCT00569920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92648660|NCT00569920|Glucocorticoids|glucocorticoids|mesh-ancestor
92648661|NCT00569920|Hormones|hormones|mesh-ancestor
92648665|NCT00569920|Protease Inhibitors|protease inhibitors|mesh-ancestor
92648729|NCT00224588|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92648803|NCT00571246|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92648879|NCT00254709|Antifungal Agents|antifungal agents|mesh-ancestor
92648880|NCT00254709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92648881|NCT00254709|Immunologic Factors|immunologic factors|mesh-ancestor
92648882|NCT00254709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92648948|NCT00572299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92649020|NCT00573001|Antiviral Agents|antiviral agents|mesh-ancestor
92649167|NCT00254865|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92649169|NCT00235053|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92649187|NCT00235053|Hormones|hormones|mesh-ancestor
92649238|NCT00574366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649239|NCT00574366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649240|NCT00225524|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92649241|NCT00225524|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92649242|NCT00225524|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92649243|NCT00225524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92649244|NCT00225524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649245|NCT00225524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92649246|NCT00225524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649247|NCT00225524|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92649248|NCT00225524|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649249|NCT00225524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649251|NCT00574483|Anticestodal Agents|anticestodal agents|mesh-ancestor
92649252|NCT00574483|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92649253|NCT00574483|Anthelmintics|anthelmintics|mesh-ancestor
92649254|NCT00574483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92649256|NCT00574483|Antimalarials|antimalarials|mesh-ancestor
92649293|NCT00255255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92649294|NCT00255255|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92649295|NCT00255255|Autonomic Agents|autonomic agents|mesh-ancestor
92649296|NCT00255255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649297|NCT00255255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649298|NCT00255255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92649299|NCT00255255|Respiratory System Agents|respiratory system agents|mesh-ancestor
92649300|NCT00255255|Glucocorticoids|glucocorticoids|mesh-ancestor
92649301|NCT00255255|Hormones|hormones|mesh-ancestor
92649304|NCT00255255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92649358|NCT03451981|Chlorhexidine|chlorhexidine|mesh-list
92649359|NCT03451981|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92649360|NCT03451981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92649361|NCT03451981|Disinfectants|disinfectants|mesh-ancestor
92649362|NCT00255372|Lactulose|lactulose|mesh-list
92649364|NCT00225914|Paroxetine|paroxetine|mesh-list
92649428|NCT03451318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92649429|NCT00255450|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92649430|NCT00255450|Hematinics|hematinics|mesh-ancestor
92649431|NCT00255450|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92374730|NCT01845636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92649499|NCT04572685|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92649500|NCT04572685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92649501|NCT04572685|Serotonin Agents|serotonin agents|mesh-ancestor
92649571|NCT00226382|Immunologic Factors|immunologic factors|mesh-ancestor
92649572|NCT00226382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649644|NCT00255762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649717|NCT00226538|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92649718|NCT00226538|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92649719|NCT00226538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92649730|NCT00226538|Anticonvulsants|anticonvulsants|mesh-ancestor
92649783|NCT00227123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649784|NCT00227123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92649785|NCT00227123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92649786|NCT00227123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649787|NCT00227123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92649788|NCT00227123|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92649789|NCT00227123|Dopamine Agents|dopamine agents|mesh-ancestor
92649790|NCT00227123|Antidepressive Agents|antidepressive agents|mesh-ancestor
92649791|NCT00235521|Iloprost|iloprost|mesh-list
92649792|NCT00235521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92649793|NCT00235521|Vasodilator Agents|vasodilator agents|mesh-ancestor
92649794|NCT00235560|Sirolimus|sirolimus|mesh-list
92649799|NCT00235560|Antifungal Agents|antifungal agents|mesh-ancestor
92649847|NCT00256230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649848|NCT00227669|Gemcitabine|gemcitabine|mesh-list
92649849|NCT00227669|Docetaxel|docetaxel|mesh-list
92649850|NCT00227669|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92649851|NCT00227669|Antimetabolites|antimetabolites|mesh-ancestor
92649852|NCT00227669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92649853|NCT00227669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92649854|NCT00227669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92649855|NCT00227669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92649856|NCT00227669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92649857|NCT00235794|Sirolimus|sirolimus|mesh-list
92649858|NCT00235794|Temsirolimus|temsirolimus|mesh-list
92649859|NCT00235794|MTOR Inhibitors|mtor inhibitors|mesh-list
92649860|NCT00235794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92649908|NCT00256347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92649909|NCT00256347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92649910|NCT00256347|Analgesics|analgesics|mesh-ancestor
92649911|NCT00256347|Sensory System Agents|sensory system agents|mesh-ancestor
92649912|NCT00256347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92649913|NCT00227747|Capecitabine|capecitabine|mesh-list
92649914|NCT00227747|Oxaliplatin|oxaliplatin|mesh-list
92649915|NCT00227747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92649976|NCT00256542|Sensory System Agents|sensory system agents|mesh-ancestor
92650049|NCT00228254|Micronutrients|micronutrients|mesh-ancestor
92650050|NCT00228254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650123|NCT00191854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650124|NCT00191854|Antimetabolites|antimetabolites|mesh-ancestor
92650197|NCT00414024|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92650198|NCT00414024|Serotonin Agents|serotonin agents|mesh-ancestor
92650199|NCT00414024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650269|NCT00191152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650270|NCT00191152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92650338|NCT00236379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92650414|NCT00193219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92650415|NCT00193219|Growth Substances|growth substances|mesh-ancestor
92650416|NCT00193219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650417|NCT00193219|Growth Inhibitors|growth inhibitors|mesh-ancestor
92650418|NCT00193219|Antimetabolites|antimetabolites|mesh-ancestor
92650419|NCT00193219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650420|NCT00193219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92650421|NCT00193219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92650422|NCT00193219|Immunologic Factors|immunologic factors|mesh-ancestor
92650423|NCT00193219|Antidotes|antidotes|mesh-ancestor
92650424|NCT00193219|Protective Agents|protective agents|mesh-ancestor
92650478|NCT00199394|Purinergic Agents|purinergic agents|mesh-ancestor
92650479|NCT00199394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650550|NCT00199745|Atorvastatin|atorvastatin|mesh-list
92650551|NCT00199745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92650552|NCT00199745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92375847|NCT01858740|Thiotepa|thiotepa|mesh-list
92650553|NCT00199745|Antimetabolites|antimetabolites|mesh-ancestor
92650554|NCT00199745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650555|NCT00199745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92650556|NCT00199745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92650557|NCT00199745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650558|NCT04709172|Cefditoren|cefditoren|mesh-list
92650559|NCT04709172|Cefditoren pivoxil|cefditoren pivoxil|mesh-list
92650560|NCT04709172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650561|NCT04709172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650562|NCT00199784|Phenylephrine|phenylephrine|mesh-list
92650563|NCT00199784|Oxymetazoline|oxymetazoline|mesh-list
92650564|NCT00199784|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92650565|NCT00199784|Mydriatics|mydriatics|mesh-ancestor
92650566|NCT00199784|Autonomic Agents|autonomic agents|mesh-ancestor
92650567|NCT00199784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92650568|NCT00199784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650569|NCT00199784|Sympathomimetics|sympathomimetics|mesh-ancestor
92650570|NCT00199784|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92650571|NCT00199784|Nasal Decongestants|nasal decongestants|mesh-ancestor
92650572|NCT00199784|Respiratory System Agents|respiratory system agents|mesh-ancestor
92650573|NCT00199784|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92650574|NCT00199784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92650575|NCT00199784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92650576|NCT00199784|Adrenergic Agents|adrenergic agents|mesh-ancestor
92650577|NCT00199784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650578|NCT00199784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752292|NCT01084252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752293|NCT01084252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752294|NCT00992238|Flavoxate|flavoxate|mesh-list
92752295|NCT00992238|Parasympatholytics|parasympatholytics|mesh-ancestor
92752296|NCT00992238|Autonomic Agents|autonomic agents|mesh-ancestor
92752297|NCT00992238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752298|NCT00992238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752299|NCT00992238|Urological Agents|urological agents|mesh-ancestor
92752300|NCT00858897|Insulin|insulin|mesh-list
92752301|NCT00858897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92752302|NCT00858897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92752303|NCT00858897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752304|NCT05940909|Amlodipine|amlodipine|mesh-list
92752305|NCT05940909|Perindopril|perindopril|mesh-list
92752306|NCT05940909|Indapamide|indapamide|mesh-list
92752307|NCT05940909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92650579|NCT00199784|Protective Agents|protective agents|mesh-ancestor
92650580|NCT00236769|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92650581|NCT00236769|Norelgestromin|norelgestromin|mesh-list
92650582|NCT00236769|Estradiol|estradiol|mesh-list
92650583|NCT00236769|Estrogens|estrogens|mesh-ancestor
92650584|NCT00236769|Hormones|hormones|mesh-ancestor
92650585|NCT00236769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92650586|NCT00236769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650587|NCT00236769|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92650588|NCT00236769|Contraceptive Agents|contraceptive agents|mesh-ancestor
92650589|NCT00236769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92650590|NCT00236769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92650591|NCT00236769|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92650592|NCT00236769|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92650593|NCT00415311|Lectins|lectins|mesh-list
92650594|NCT00415311|Agglutinins|agglutinins|mesh-ancestor
92650595|NCT00415311|Immunologic Factors|immunologic factors|mesh-ancestor
92650596|NCT00415311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650597|NCT00415311|Coagulants|coagulants|mesh-ancestor
92650598|NCT00199940|Ziprasidone|ziprasidone|mesh-list
92650599|NCT00199940|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92650600|NCT00199940|Serotonin Agents|serotonin agents|mesh-ancestor
92650601|NCT00199940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650602|NCT00199940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650603|NCT00199940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650604|NCT00199940|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92650605|NCT00199940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92650606|NCT00199940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92650607|NCT00199940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92650608|NCT00199940|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92650625|NCT00199979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650627|NCT00199979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92650628|NCT00199979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92650629|NCT00199979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92650630|NCT00199979|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92650631|NCT00199979|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92650632|NCT00257634|Dexamethasone|dexamethasone|mesh-list
92650633|NCT00257634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92650634|NCT00257634|Antiemetics|antiemetics|mesh-ancestor
92650635|NCT00257634|Autonomic Agents|autonomic agents|mesh-ancestor
92650690|NCT00257751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92650765|NCT00257868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92650766|NCT00257868|Cholinergic Agents|cholinergic agents|mesh-ancestor
92650767|NCT00257868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92650768|NCT00257868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650772|NCT00176605|Etoposide|etoposide|mesh-list
92650836|NCT00174967|Gout Suppressants|gout suppressants|mesh-ancestor
92650837|NCT00174967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92650838|NCT00200564|Ketamine|ketamine|mesh-list
92650839|NCT00200564|Analgesics|analgesics|mesh-ancestor
92650906|NCT00258258|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92650907|NCT00258258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92650982|NCT00201422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92650992|NCT00258609|Botulinum Toxins|botulinum toxins|mesh-list
92651053|NCT00410345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92651127|NCT00201812|Immunologic Factors|immunologic factors|mesh-ancestor
92651202|NCT00266058|Lumefantrine|lumefantrine|mesh-list
92651204|NCT00266058|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92651205|NCT00266058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92651206|NCT00266058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92651271|NCT00266136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92651272|NCT00266136|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92651273|NCT00266136|Antimetabolites|antimetabolites|mesh-ancestor
92651343|NCT00479401|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92651344|NCT00479401|Dopamine Agonists|dopamine agonists|mesh-ancestor
92651345|NCT00479401|Dopamine Agents|dopamine agents|mesh-ancestor
92651346|NCT00479401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651347|NCT00230789|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92651348|NCT00230789|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92651349|NCT00230789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92651350|NCT00230789|Cholinergic Agents|cholinergic agents|mesh-ancestor
92651351|NCT00230789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651352|NCT00230789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651353|NCT00230789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651354|NCT00230789|Urological Agents|urological agents|mesh-ancestor
92651355|NCT00478777|Dexamethasone|dexamethasone|mesh-list
92651356|NCT00478777|Lenalidomide|lenalidomide|mesh-list
92651357|NCT00478777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651358|NCT00478777|Antiemetics|antiemetics|mesh-ancestor
92651359|NCT00478777|Autonomic Agents|autonomic agents|mesh-ancestor
92651360|NCT00478777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651361|NCT00478777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651362|NCT00478777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651363|NCT00478777|Glucocorticoids|glucocorticoids|mesh-ancestor
92651398|NCT00266253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651400|NCT00230984|Testosterone|testosterone|mesh-list
92651401|NCT00230984|Testosterone undecanoate|testosterone undecanoate|mesh-list
92651402|NCT00230984|Testosterone enanthate|testosterone enanthate|mesh-list
92651403|NCT00230984|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92651404|NCT00230984|Androgens|androgens|mesh-ancestor
92651405|NCT00230984|Hormones|hormones|mesh-ancestor
92651406|NCT00230984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651407|NCT00230984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651408|NCT00230984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92651409|NCT00230984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92651410|NCT00230984|Anabolic Agents|anabolic agents|mesh-ancestor
92651411|NCT00415350|Azithromycin|azithromycin|mesh-list
92651412|NCT00415350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92651413|NCT00415350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651414|NCT00231023|Triamcinolone|triamcinolone|mesh-list
92651415|NCT00231023|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92651416|NCT00231023|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92651417|NCT00231023|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92651418|NCT00231023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651419|NCT00231023|Glucocorticoids|glucocorticoids|mesh-ancestor
92651420|NCT00231023|Hormones|hormones|mesh-ancestor
92651421|NCT00231023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651422|NCT00231023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651423|NCT00231023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651424|NCT00231023|Immunologic Factors|immunologic factors|mesh-ancestor
92651425|NCT00231023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651426|NCT00231023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651427|NCT00231101|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92651428|NCT00231101|Antidepressive Agents|antidepressive agents|mesh-ancestor
92651429|NCT00231101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92651430|NCT00231101|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92651431|NCT00231101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92651432|NCT00231101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92651433|NCT00231101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651434|NCT00231140|Thalidomide|thalidomide|mesh-list
92651435|NCT00231140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651436|NCT00231140|Immunologic Factors|immunologic factors|mesh-ancestor
92651437|NCT00231140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651438|NCT00231140|Leprostatic Agents|leprostatic agents|mesh-ancestor
92651439|NCT00231140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92651509|NCT00231569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92651510|NCT00231569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92651520|NCT00231608|Topiramate|topiramate|mesh-list
92651581|NCT04559425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651582|NCT04559425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651655|NCT00231959|Dopamine Agents|dopamine agents|mesh-ancestor
92651656|NCT00231959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651657|NCT00231998|Pimecrolimus|pimecrolimus|mesh-list
92651658|NCT00231998|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92651659|NCT00231998|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92651660|NCT00231998|Analgesics|analgesics|mesh-ancestor
92651661|NCT00231998|Sensory System Agents|sensory system agents|mesh-ancestor
92651662|NCT00231998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92651663|NCT00231998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651664|NCT00231998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92651665|NCT00231998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92651666|NCT00231998|Dermatologic Agents|dermatologic agents|mesh-ancestor
92651667|NCT00231998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92651668|NCT00231998|Immunologic Factors|immunologic factors|mesh-ancestor
92651669|NCT00231998|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92651715|NCT00232076|Immunologic Factors|immunologic factors|mesh-ancestor
92651716|NCT00232076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651717|NCT00232076|Antifungal Agents|antifungal agents|mesh-ancestor
92651718|NCT00232076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92651787|NCT04557397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92651788|NCT04557397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651789|NCT04557397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651790|NCT04557397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92651791|NCT04557397|Hormone Antagonists|hormone antagonists|mesh-ancestor
92651792|NCT04557397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92651793|NCT04557397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651794|NCT04557397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92651795|NCT04557397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92651796|NCT04557397|Antitubercular Agents|antitubercular agents|mesh-ancestor
92651806|NCT04557202|Tamsulosin|tamsulosin|mesh-list
92651847|NCT04566211|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92651848|NCT04566211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651849|NCT04566211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651850|NCT04566211|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92651915|NCT00232661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92651916|NCT00232661|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92651917|NCT00232661|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92651918|NCT00232661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92651919|NCT00232661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92651921|NCT00267267|Simvastatin|simvastatin|mesh-list
92651922|NCT00267267|Ezetimibe|ezetimibe|mesh-list
92651923|NCT00267267|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92651924|NCT00267267|Torcetrapib|torcetrapib|mesh-list
92651925|NCT00267267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92651926|NCT00267267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92651927|NCT00267267|Antimetabolites|antimetabolites|mesh-ancestor
92651976|NCT04564144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92651977|NCT04564144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92651978|NCT04564144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92651979|NCT04564144|Histamine Antagonists|histamine antagonists|mesh-ancestor
92651980|NCT04564144|Histamine Agents|histamine agents|mesh-ancestor
92651981|NCT04564144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92651986|NCT00267306|Visilizumab|visilizumab|mesh-list
92652046|NCT00232856|Immunologic Factors|immunologic factors|mesh-ancestor
92652047|NCT00232856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652048|NCT00259974|Rituximab|rituximab|mesh-list
92652049|NCT00259974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92652050|NCT00259974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652051|NCT00259974|Immunologic Factors|immunologic factors|mesh-ancestor
92652052|NCT00259974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652053|NCT00259974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652054|NCT00232895|Propofol|propofol|mesh-list
92652055|NCT00232895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377333|NCT02411916|Oxytocics|oxytocics|mesh-ancestor
92652056|NCT00232895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652058|NCT00232895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92652059|NCT00232895|Anesthetics, General|anesthetics, general|mesh-ancestor
92652060|NCT00232895|Anesthetics|anesthetics|mesh-ancestor
92652061|NCT00232934|Thalidomide|thalidomide|mesh-list
92652062|NCT00232934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652063|NCT00232934|Immunologic Factors|immunologic factors|mesh-ancestor
92652064|NCT00232934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652065|NCT00232934|Leprostatic Agents|leprostatic agents|mesh-ancestor
92652104|NCT04673500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92652105|NCT04673500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92652106|NCT04673500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92652107|NCT04673500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652108|NCT04673500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92652109|NCT04673500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92652172|NCT00260325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652244|NCT00233714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92652245|NCT00233714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652247|NCT04670497|Epinephrine|epinephrine|mesh-list
92652315|NCT00556192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652316|NCT00556192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652317|NCT00556270|Fentanyl|fentanyl|mesh-list
92652318|NCT00556270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92652319|NCT00556270|Narcotics|narcotics|mesh-ancestor
92652320|NCT00556270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652321|NCT00556270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652322|NCT00556270|Analgesics|analgesics|mesh-ancestor
92652323|NCT00556270|Sensory System Agents|sensory system agents|mesh-ancestor
92652324|NCT00556270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92652381|NCT00556348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92652382|NCT00556348|Growth Substances|growth substances|mesh-ancestor
92652383|NCT00556348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652384|NCT00556348|Growth Inhibitors|growth inhibitors|mesh-ancestor
92652449|NCT00234377|Antidepressive Agents|antidepressive agents|mesh-ancestor
92652450|NCT00234377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92652451|NCT00234377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92652521|NCT02211391|Sequestering Agents|sequestering agents|mesh-ancestor
92652522|NCT02211391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652594|NCT00234845|Dermatologic Agents|dermatologic agents|mesh-ancestor
92652595|NCT00234845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92652596|NCT00234845|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92652597|NCT00234845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92652598|NCT00234845|Immunologic Factors|immunologic factors|mesh-ancestor
92652599|NCT00234845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652600|NCT00234845|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92652601|NCT00234845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92652602|NCT00234845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92652603|NCT02211625|Oxycodone|oxycodone|mesh-list
92652604|NCT02211625|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92652605|NCT02211625|Narcotics|narcotics|mesh-ancestor
92652606|NCT02211625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92652607|NCT02211625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652654|NCT04551703|Adrenergic Agents|adrenergic agents|mesh-ancestor
92652655|NCT04551703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92652656|NCT04551703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92652657|NCT04551703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652658|NCT04551703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92652659|NCT04551703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92652721|NCT00235157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92652722|NCT00235157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92652723|NCT00235157|Antifungal Agents|antifungal agents|mesh-ancestor
92652794|NCT00268398|Leucovorin|leucovorin|mesh-list
92652795|NCT00268398|Folic Acid|folic acid|mesh-list
92652796|NCT00268398|Fluorouracil|fluorouracil|mesh-list
92652872|NCT04548700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92652873|NCT04548700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92652874|NCT04548700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92652875|NCT04548700|Alkylating Agents|alkylating agents|mesh-ancestor
92652943|NCT00268593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653020|NCT02212639|Digoxin|digoxin|mesh-list
92653089|NCT00235859|Methotrexate|methotrexate|mesh-list
92653163|NCT00235937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653164|NCT00235937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653165|NCT00235937|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92653166|NCT00235937|Hormone Antagonists|hormone antagonists|mesh-ancestor
92653167|NCT00235937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653168|NCT00235937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653169|NCT00261339|Pantoprazole|pantoprazole|mesh-list
92653170|NCT00261339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92653229|NCT00236093|Narcotics|narcotics|mesh-ancestor
92653230|NCT00236093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653231|NCT00236093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653303|NCT00261612|Glucocorticoids|glucocorticoids|mesh-ancestor
92653304|NCT00261612|Hormones|hormones|mesh-ancestor
92653307|NCT04547764|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92399663|NCT01404676|Vildagliptin|vildagliptin|mesh-list
92653373|NCT00236327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653375|NCT00236327|Sensory System Agents|sensory system agents|mesh-ancestor
92653376|NCT00236327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653377|NCT00236327|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92653378|NCT00236327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92653379|NCT00236327|Anesthetics, General|anesthetics, general|mesh-ancestor
92653380|NCT00236327|Anesthetics|anesthetics|mesh-ancestor
92653381|NCT00236366|Fentanyl|fentanyl|mesh-list
92653383|NCT00236366|Narcotics|narcotics|mesh-ancestor
92653440|NCT00236483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92653441|NCT00236483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653442|NCT00236483|Antipyretics|antipyretics|mesh-ancestor
92653443|NCT00236483|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92653444|NCT00236483|Narcotics|narcotics|mesh-ancestor
92653445|NCT00236483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653446|NCT04545970|Sunscreening Agents|sunscreening agents|mesh-list
92653447|NCT04545970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92653448|NCT04545970|Protective Agents|protective agents|mesh-ancestor
92653504|NCT02215330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92653505|NCT02215330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653578|NCT00236717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92653579|NCT00236717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653580|NCT00236717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92653581|NCT00236717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92653589|NCT00236756|Topiramate|topiramate|mesh-list
92653647|NCT00236912|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92653648|NCT00236912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92653650|NCT02215447|Carboplatin|carboplatin|mesh-list
92653716|NCT00237263|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92653717|NCT00237263|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92653718|NCT00237263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92653719|NCT00237263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653720|NCT00237302|Topiramate|topiramate|mesh-list
92653721|NCT00237302|Anticonvulsants|anticonvulsants|mesh-ancestor
92653722|NCT00237302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92653723|NCT00237302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92653724|NCT00262275|Aspirin|aspirin|mesh-list
92653782|NCT00237497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92653783|NCT00237497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92653853|NCT02215057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92653854|NCT02215057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92653855|NCT02215057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92653856|NCT00269685|Vasopressins|vasopressins|mesh-list
92653857|NCT00269685|Arginine Vasopressin|arginine vasopressin|mesh-list
92653858|NCT00269685|Hemostatics|hemostatics|mesh-ancestor
92653859|NCT00269685|Coagulants|coagulants|mesh-ancestor
92653860|NCT00269685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92653861|NCT00269685|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92653919|NCT04538521|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92654069|NCT04537780|Montelukast|montelukast|mesh-list
92654070|NCT04537780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92654141|NCT04536922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92654142|NCT04536922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92654143|NCT04536922|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92654214|NCT00238199|Docetaxel|docetaxel|mesh-list
92654215|NCT00238199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654216|NCT00238199|Tubulin Modulators|tubulin modulators|mesh-ancestor
92379536|NCT05510856|Lacosamide|lacosamide|mesh-list
92654288|NCT02216227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654289|NCT00238277|Temozolomide|temozolomide|mesh-list
92654290|NCT00238277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92654291|NCT00238277|Alkylating Agents|alkylating agents|mesh-ancestor
92654292|NCT00238277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654293|NCT00238277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92654294|NCT02216266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92654295|NCT02216266|Physostigmine|physostigmine|mesh-list
92654296|NCT02216266|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92379603|NCT03693846|Nivolumab|nivolumab|mesh-list
92654297|NCT02216266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92654298|NCT02216266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654299|NCT02216266|Cholinergic Agents|cholinergic agents|mesh-ancestor
92654300|NCT02216266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92654302|NCT02216266|Miotics|miotics|mesh-ancestor
92654346|NCT02216383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92654347|NCT00262782|Fludarabine|fludarabine|mesh-list
92654422|NCT04534465|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92654423|NCT04534465|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92654424|NCT04534465|Diuretics|diuretics|mesh-ancestor
92654427|NCT04534465|Laxatives|laxatives|mesh-ancestor
92654491|NCT00263133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654564|NCT02217007|Calcium, Dietary|calcium, dietary|mesh-list
92654636|NCT05896930|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92654637|NCT05896930|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92654710|NCT05896683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92654711|NCT05896631|Bupivacaine|bupivacaine|mesh-list
92654712|NCT05896631|Anesthetics, Local|anesthetics, local|mesh-ancestor
92654713|NCT05896631|Anesthetics|anesthetics|mesh-ancestor
92654714|NCT05896631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92654716|NCT05896631|Sensory System Agents|sensory system agents|mesh-ancestor
92654777|NCT05895942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92654851|NCT05815758|Histamine Antagonists|histamine antagonists|mesh-ancestor
92654852|NCT05815758|Histamine Agents|histamine agents|mesh-ancestor
92654923|NCT05586373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92654924|NCT05586373|Analgesics|analgesics|mesh-ancestor
92654925|NCT05586373|Sensory System Agents|sensory system agents|mesh-ancestor
92654997|NCT05360784|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92654998|NCT05360784|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92654999|NCT05360784|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92655000|NCT05360784|Adrenergic Agents|adrenergic agents|mesh-ancestor
92655001|NCT05360784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92655002|NCT05360784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655003|NCT05360784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655004|NCT05359939|Choline|choline|mesh-list
92655062|NCT05145764|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92655065|NCT05132075|Docetaxel|docetaxel|mesh-list
92655136|NCT05028062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92655137|NCT05028062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655138|NCT05028062|Sensory System Agents|sensory system agents|mesh-ancestor
92655211|NCT04898894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655213|NCT04898894|Antimetabolites|antimetabolites|mesh-ancestor
92655286|NCT04589845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92655287|NCT04589845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655288|NCT04589845|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92655358|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655359|NCT04381143|Antipyretics|antipyretics|mesh-ancestor
92655360|NCT04370093|Pioglitazone|pioglitazone|mesh-list
92655361|NCT04370093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92655362|NCT04370093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655363|NCT04340193|Nivolumab|nivolumab|mesh-list
92655364|NCT04340193|Ipilimumab|ipilimumab|mesh-list
92655365|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655366|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655367|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655368|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655369|NCT04313881|Azacitidine|azacitidine|mesh-list
92655370|NCT04313881|Magrolimab|magrolimab|mesh-list
92655371|NCT04313881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655372|NCT04313881|Antimetabolites|antimetabolites|mesh-ancestor
92655373|NCT04313881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655374|NCT04313881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655375|NCT04313881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655376|NCT04313881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92655414|NCT04166383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92655415|NCT04166383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92399673|NCT01404689|Dexmedetomidine|dexmedetomidine|mesh-list
92655416|NCT04166383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655487|NCT03887702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92655488|NCT03887702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92655489|NCT03878589|Oxytocin|oxytocin|mesh-list
92655490|NCT03878589|Oxytocics|oxytocics|mesh-ancestor
92655559|NCT03568890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92655560|NCT03568890|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92655634|NCT03424005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92655635|NCT03424005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92655636|NCT03424005|Growth Substances|growth substances|mesh-ancestor
92655637|NCT03424005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92655638|NCT03424005|Growth Inhibitors|growth inhibitors|mesh-ancestor
92655639|NCT03424005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92655640|NCT03424005|Antimetabolites|antimetabolites|mesh-ancestor
92655641|NCT03424005|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92655642|NCT03424005|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92655652|NCT03418961|Carvedilol|carvedilol|mesh-list
92655698|NCT03053440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92655699|NCT03053440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655771|NCT02740712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92655845|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92655915|NCT02217163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92655916|NCT02217163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92655917|NCT02217163|Alkylating Agents|alkylating agents|mesh-ancestor
92655985|NCT04531072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92655986|NCT04531072|Antimalarials|antimalarials|mesh-ancestor
92656059|NCT02217553|Cholecalciferol|cholecalciferol|mesh-list
92656133|NCT04529668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92656206|NCT00239447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92656207|NCT00239447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656208|NCT00239447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92656276|NCT01643629|Hormone Antagonists|hormone antagonists|mesh-ancestor
92656277|NCT01643629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656350|NCT04528888|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92656351|NCT04528888|Protective Agents|protective agents|mesh-ancestor
92656354|NCT04528888|Anticoagulants|anticoagulants|mesh-ancestor
92656420|NCT01646554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656421|NCT01646554|Growth Inhibitors|growth inhibitors|mesh-ancestor
92656422|NCT00250263|Immunomodulating Agents|immunomodulating agents|mesh-list
92656423|NCT00250263|Immunologic Factors|immunologic factors|mesh-ancestor
92656424|NCT00250263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656425|NCT00264069|Antipsychotic Agents|antipsychotic agents|mesh-list
92656426|NCT00264069|Antidepressive Agents|antidepressive agents|mesh-list
92656427|NCT00264069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92656428|NCT00264069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92656429|NCT00264069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92656430|NCT00264069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656485|NCT01647412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92656489|NCT01647412|Analgesics|analgesics|mesh-ancestor
92656557|NCT00240266|Antimetabolites|antimetabolites|mesh-ancestor
92656558|NCT00240266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656559|NCT00240266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92656560|NCT00240266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92656561|NCT00240266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656562|NCT01648036|Heparin|heparin|mesh-list
92656563|NCT01648036|Calcium heparin|calcium heparin|mesh-list
92656564|NCT01648036|Dalteparin|dalteparin|mesh-list
92656565|NCT01648036|Tinzaparin|tinzaparin|mesh-list
92656566|NCT01648036|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92656567|NCT01648036|Anticoagulants|anticoagulants|mesh-ancestor
92656568|NCT01648036|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92656569|NCT01648036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92656570|NCT01648036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656571|NCT00240305|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92656572|NCT00240305|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92656573|NCT00240305|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92656574|NCT00240305|Antimetabolites|antimetabolites|mesh-ancestor
92656575|NCT00240305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656576|NCT00240305|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92656577|NCT00240305|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92656578|NCT00240305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92656579|NCT01648231|Losartan|losartan|mesh-list
92656580|NCT01648231|Amlodipine|amlodipine|mesh-list
92656581|NCT01648231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656582|NCT01648231|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92656583|NCT01648231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656584|NCT01648231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656585|NCT01648231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656587|NCT01648231|Vasodilator Agents|vasodilator agents|mesh-ancestor
92656599|NCT00264186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656600|NCT00264186|Sympathomimetics|sympathomimetics|mesh-ancestor
92656673|NCT00415740|Dopamine Agonists|dopamine agonists|mesh-ancestor
92656674|NCT01649479|Antibodies|antibodies|mesh-list
92656745|NCT00240656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92656746|NCT00240656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92656747|NCT00240656|Antioxidants|antioxidants|mesh-ancestor
92656748|NCT00240656|Protective Agents|protective agents|mesh-ancestor
92656749|NCT00240656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92656750|NCT00240656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92656751|NCT00240656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92656752|NCT00240656|Vasodilator Agents|vasodilator agents|mesh-ancestor
92656753|NCT00240656|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92656754|NCT00240656|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92656809|NCT00240773|Gout Suppressants|gout suppressants|mesh-ancestor
92656883|NCT01688518|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92656884|NCT01688518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92656887|NCT00240851|Acetaminophen|acetaminophen|mesh-list
92656954|NCT00241046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92656955|NCT01689259|Cyclobenzaprine|cyclobenzaprine|mesh-list
92657027|NCT00264420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657028|NCT00241475|Gefitinib|gefitinib|mesh-list
92657029|NCT00241475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92657098|NCT00264615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92657099|NCT00264615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657100|NCT00264615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92657101|NCT02219191|Puerarin|puerarin|mesh-list
92657102|NCT02219191|Atorvastatin|atorvastatin|mesh-list
92657103|NCT02219191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92657104|NCT02219191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92657105|NCT02219191|Antimetabolites|antimetabolites|mesh-ancestor
92657106|NCT02219191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92657107|NCT02219191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92657109|NCT02219191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657165|NCT02219893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657236|NCT00241982|Glucocorticoids|glucocorticoids|mesh-ancestor
92657237|NCT00241982|Hormones|hormones|mesh-ancestor
92657309|NCT00242411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92657310|NCT00242411|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92657311|NCT00242411|Autonomic Agents|autonomic agents|mesh-ancestor
92657316|NCT00242411|Glucocorticoids|glucocorticoids|mesh-ancestor
92657377|NCT00242606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92657451|NCT00243113|Docetaxel|docetaxel|mesh-list
92657457|NCT00273429|Timolol|timolol|mesh-list
92657527|NCT00243737|Schistosomicides|schistosomicides|mesh-ancestor
92657528|NCT00243737|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92657529|NCT00243737|Anthelmintics|anthelmintics|mesh-ancestor
92657530|NCT00273702|Acetylcysteine|acetylcysteine|mesh-list
92657598|NCT00243893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92657599|NCT00243893|Antimalarials|antimalarials|mesh-ancestor
92657668|NCT00244322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92657670|NCT00244361|Rituximab|rituximab|mesh-list
92657740|NCT00244517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92657741|NCT00244517|Anesthetics, General|anesthetics, general|mesh-ancestor
92657742|NCT00244517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92657745|NCT00244517|Sensory System Agents|sensory system agents|mesh-ancestor
92657810|NCT00244907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92657811|NCT00244907|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92657818|NCT00244907|Estrogens|estrogens|mesh-ancestor
92657882|NCT00416637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92657956|NCT00245453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92657957|NCT00274560|Tiotropium Bromide|tiotropium bromide|mesh-list
92657958|NCT00274560|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92657959|NCT00274560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92383250|NCT00145704|Vitamin D|vitamin d|mesh-list
92657961|NCT00274560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92657962|NCT00274560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92657963|NCT00274560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92657964|NCT00274560|Respiratory System Agents|respiratory system agents|mesh-ancestor
92657965|NCT00274560|Parasympatholytics|parasympatholytics|mesh-ancestor
92657966|NCT00274560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92658019|NCT00274677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658020|NCT00274677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92658089|NCT00274833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92658164|NCT00274911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658165|NCT00274911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92658238|NCT00284583|Anesthetics, Local|anesthetics, local|mesh-ancestor
92658239|NCT00284583|Anesthetics|anesthetics|mesh-ancestor
92658240|NCT00284583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92658308|NCT00284778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658309|NCT00284778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92658382|NCT00247559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658386|NCT00285051|Ondansetron|ondansetron|mesh-list
92658456|NCT00278187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658457|NCT00278187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92658459|NCT00278187|Growth Substances|growth substances|mesh-ancestor
92658527|NCT00278382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658602|NCT00248729|Anesthetics|anesthetics|mesh-ancestor
92658603|NCT00248729|GABA Modulators|gaba modulators|mesh-ancestor
92658604|NCT00248729|GABA Agents|gaba agents|mesh-ancestor
92658605|NCT00248729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92658606|NCT00248729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658607|NCT00278694|Oxaliplatin|oxaliplatin|mesh-list
92658608|NCT00278694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92658609|NCT00248963|Levonorgestrel|levonorgestrel|mesh-list
92658610|NCT00248963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92658611|NCT00248963|Estradiol|estradiol|mesh-list
92658668|NCT00285597|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92658669|NCT00285597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92658739|NCT00249353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658740|NCT00249353|Dopamine Agents|dopamine agents|mesh-ancestor
92658812|NCT00249704|Micronutrients|micronutrients|mesh-ancestor
92658817|NCT00249782|Dapsone|dapsone|mesh-list
92658884|NCT00250172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92658885|NCT00250172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658887|NCT02961608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92658955|NCT00279747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92658956|NCT00279747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92659028|NCT00286611|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92659029|NCT00286611|Protective Agents|protective agents|mesh-ancestor
92659102|NCT00279903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659103|NCT00279903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659178|NCT01641406|Cyclophosphamide|cyclophosphamide|mesh-list
92659252|NCT05140096|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92659253|NCT05140096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92659254|NCT00251459|Ranibizumab|ranibizumab|mesh-list
92659325|NCT00280371|Formoterol Fumarate|formoterol fumarate|mesh-list
92659326|NCT00280371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92659327|NCT00280371|Autonomic Agents|autonomic agents|mesh-ancestor
92659328|NCT00280371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92659329|NCT00280371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659330|NCT00280371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92659331|NCT00280371|Respiratory System Agents|respiratory system agents|mesh-ancestor
92659332|NCT00280371|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92659390|NCT04822597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92659391|NCT04822597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92659392|NCT04822597|Sensory System Agents|sensory system agents|mesh-ancestor
92659460|NCT00287157|Autonomic Agents|autonomic agents|mesh-ancestor
92659461|NCT00287157|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92659462|NCT00287157|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92659463|NCT00287157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659529|NCT00252434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92659530|NCT00252434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92659531|NCT00252434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92659603|NCT02279875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92659604|NCT02279875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92659675|NCT00252668|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92659676|NCT02271997|Ferrous fumarate|ferrous fumarate|mesh-list
92659677|NCT02271997|Ferrous gluconate|ferrous gluconate|mesh-list
92659752|NCT00252785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92659753|NCT00252785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92659754|NCT00252785|Adrenergic Agents|adrenergic agents|mesh-ancestor
92659755|NCT00252785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659767|NCT01680952|Sirolimus|sirolimus|mesh-list
92659825|NCT00252863|Hormones|hormones|mesh-ancestor
92659826|NCT00252863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92659895|NCT02279914|Misoprostol|misoprostol|mesh-list
92659896|NCT02279914|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92659970|NCT00253058|Histamine Antagonists|histamine antagonists|mesh-ancestor
92659971|NCT00253058|Histamine Agents|histamine agents|mesh-ancestor
92659972|NCT00253058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92659973|NCT00253058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660041|NCT00287781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660042|NCT00287781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660043|NCT00287781|Sensory System Agents|sensory system agents|mesh-ancestor
92660045|NCT00287781|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92660112|NCT00287820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92660117|NCT00287820|Antiemetics|antiemetics|mesh-ancestor
92660185|NCT00417066|Luteolytic Agents|luteolytic agents|mesh-ancestor
92660259|NCT00253526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660260|NCT00253526|Mitosis Modulators|mitosis modulators|mesh-ancestor
92660261|NCT01686217|Niacinamide|niacinamide|mesh-list
92660262|NCT01686217|Peficitinib|peficitinib|mesh-list
92660263|NCT01686217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660264|NCT01686217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660265|NCT01686217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660269|NCT01686217|Vitamins|vitamins|mesh-ancestor
92660327|NCT01686802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92660328|NCT01686802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92660329|NCT01686802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660330|NCT00253721|Melphalan|melphalan|mesh-list
92660396|NCT01687582|Liraglutide|liraglutide|mesh-list
92660398|NCT01687582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92660471|NCT00288171|Protective Agents|protective agents|mesh-ancestor
92660472|NCT00288171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660473|NCT00253955|Levofloxacin|levofloxacin|mesh-list
92660544|NCT00415064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660547|NCT00415064|Hormones|hormones|mesh-ancestor
92660615|NCT01606969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92660616|NCT00288522|Lanreotide|lanreotide|mesh-list
92660617|NCT00288522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92660618|NCT00254267|Motesanib diphosphate|motesanib diphosphate|mesh-list
92660619|NCT00254267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92660682|NCT00254345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660683|NCT00254618|Mesalamine|mesalamine|mesh-list
92660684|NCT00254618|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92660685|NCT00254618|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92660686|NCT00254618|Analgesics|analgesics|mesh-ancestor
92660687|NCT00254618|Sensory System Agents|sensory system agents|mesh-ancestor
92660688|NCT00254618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660689|NCT00254618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660690|NCT00254618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92660691|NCT00254618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92660692|NCT00288717|Telmisartan|telmisartan|mesh-list
92660693|NCT00288717|Candesartan|candesartan|mesh-list
92660694|NCT00288717|Candesartan cilexetil|candesartan cilexetil|mesh-list
92660695|NCT00288717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92660696|NCT00288717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92660697|NCT00288717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92660698|NCT00288717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660699|NCT01601314|Magnesium Sulfate|magnesium sulfate|mesh-list
92660700|NCT01601314|Analgesics|analgesics|mesh-ancestor
92660735|NCT00254735|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92660736|NCT00254735|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92660809|NCT01608373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92660810|NCT01608373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92660811|NCT01608373|Sensory System Agents|sensory system agents|mesh-ancestor
92660812|NCT01608373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92660813|NCT01608373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92660814|NCT01608373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92660815|NCT01608373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92660816|NCT01608373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92660817|NCT01608373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92660818|NCT01608412|Everolimus|everolimus|mesh-list
92660819|NCT01608412|Tacrolimus|tacrolimus|mesh-list
92660820|NCT01608412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92660821|NCT01608412|Immunologic Factors|immunologic factors|mesh-ancestor
92660836|NCT01608646|Oxaliplatin|oxaliplatin|mesh-list
92660868|NCT02273440|Purinergic Agents|purinergic agents|mesh-ancestor
92660869|NCT02273440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92660870|NCT01588717|Glycopyrrolate|glycopyrrolate|mesh-list
92660871|NCT01588717|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92660941|NCT00107380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92660942|NCT00107380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92660945|NCT00107380|Glucocorticoids|glucocorticoids|mesh-ancestor
92661013|NCT00289419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661018|NCT00289419|Anesthetics|anesthetics|mesh-ancestor
92661090|NCT00255749|Epoetin Alfa|epoetin alfa|mesh-list
92661161|NCT00256100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92661162|NCT00256100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661163|NCT00256100|Anticoagulants|anticoagulants|mesh-ancestor
92661164|NCT00256100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92661165|NCT00256100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92661166|NCT00289926|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92661167|NCT00289926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92661168|NCT00289926|Immunologic Factors|immunologic factors|mesh-ancestor
92661169|NCT00289926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661170|NCT01609192|Hydroxyurea|hydroxyurea|mesh-list
92661226|NCT00270777|Dermatologic Agents|dermatologic agents|mesh-ancestor
92661227|NCT00270777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92661228|NCT00270777|Histamine Antagonists|histamine antagonists|mesh-ancestor
92661229|NCT00270777|Histamine Agents|histamine agents|mesh-ancestor
92661230|NCT00270777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92661231|NCT00270777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92661232|NCT00270777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92661233|NCT00270777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661234|NCT00270777|Anesthetics, Local|anesthetics, local|mesh-ancestor
92661235|NCT00270777|Anesthetics|anesthetics|mesh-ancestor
92661236|NCT00270777|Sensory System Agents|sensory system agents|mesh-ancestor
92661292|NCT00290082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92661293|NCT00290082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92661294|NCT00290082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92661295|NCT00290082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92661296|NCT00290082|Anesthetics, General|anesthetics, general|mesh-ancestor
92661297|NCT00290082|Anesthetics|anesthetics|mesh-ancestor
92661298|NCT00290082|GABA Modulators|gaba modulators|mesh-ancestor
92661299|NCT00290082|GABA Agents|gaba agents|mesh-ancestor
92661300|NCT00290082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661301|NCT00290082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92661361|NCT02270788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92661362|NCT02270788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92661366|NCT02270788|Antiviral Agents|antiviral agents|mesh-ancestor
92661434|NCT02271646|Bupivacaine|bupivacaine|mesh-list
92661435|NCT02271646|Anesthetics, Local|anesthetics, local|mesh-ancestor
92661436|NCT02271646|Anesthetics|anesthetics|mesh-ancestor
92661437|NCT02271646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92661438|NCT02271646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661439|NCT02271646|Sensory System Agents|sensory system agents|mesh-ancestor
92661441|NCT02271802|Butyric Acid|butyric acid|mesh-list
92661499|NCT02272387|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92661571|NCT00257270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92661647|NCT01601938|Trace Elements|trace elements|mesh-ancestor
92661723|NCT00290628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661724|NCT00290628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92661725|NCT00290628|Glucocorticoids|glucocorticoids|mesh-ancestor
92661726|NCT00290628|Hormones|hormones|mesh-ancestor
92661727|NCT00290628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92661728|NCT00290628|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92661729|NCT00290628|Protective Agents|protective agents|mesh-ancestor
92661730|NCT01602523|Budesonide|budesonide|mesh-list
92661731|NCT01602523|Formoterol Fumarate|formoterol fumarate|mesh-list
92661732|NCT01602523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661733|NCT01602523|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92661734|NCT01602523|Autonomic Agents|autonomic agents|mesh-ancestor
92661735|NCT01602523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92661785|NCT00290667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92661855|NCT00257699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92661856|NCT01603030|Moxifloxacin|moxifloxacin|mesh-list
92661857|NCT01603030|Prednisolone|prednisolone|mesh-list
92661858|NCT01603030|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92661859|NCT01603030|Methylprednisolone|methylprednisolone|mesh-list
92661860|NCT01603030|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92661861|NCT01603030|Prednisolone acetate|prednisolone acetate|mesh-list
92661862|NCT01603030|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92661863|NCT01603030|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92661864|NCT01603030|Prednisolone phosphate|prednisolone phosphate|mesh-list
92661865|NCT01603030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92661866|NCT01603030|Glucocorticoids|glucocorticoids|mesh-ancestor
92661867|NCT01603030|Hormones|hormones|mesh-ancestor
92661869|NCT01603030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92661916|NCT00290823|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92661990|NCT01603654|Magnesium citrate|magnesium citrate|mesh-list
92661991|NCT01603654|Picosulfate sodium|picosulfate sodium|mesh-list
92662064|NCT00290901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662065|NCT00290901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92662066|NCT00290901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92662067|NCT00290901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662137|NCT01604629|Sensory System Agents|sensory system agents|mesh-ancestor
92662138|NCT01604629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662139|NCT01604629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662140|NCT01604629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92662141|NCT01604629|Immunologic Factors|immunologic factors|mesh-ancestor
92662142|NCT00258284|Docetaxel|docetaxel|mesh-list
92662143|NCT00258284|Capecitabine|capecitabine|mesh-list
92662144|NCT00258284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662145|NCT00258284|Tubulin Modulators|tubulin modulators|mesh-ancestor
92662146|NCT00258284|Antimitotic Agents|antimitotic agents|mesh-ancestor
92662147|NCT00258284|Mitosis Modulators|mitosis modulators|mesh-ancestor
92662201|NCT01340014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92662202|NCT01340014|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92662203|NCT01340014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662205|NCT00258557|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92662274|NCT01334554|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92662275|NCT01334554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662276|NCT01334554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662277|NCT01334554|Urological Agents|urological agents|mesh-ancestor
92662278|NCT00291213|Levetiracetam|levetiracetam|mesh-list
92662279|NCT00291213|Anticonvulsants|anticonvulsants|mesh-ancestor
92662280|NCT00291213|Nootropic Agents|nootropic agents|mesh-ancestor
92662281|NCT01332799|Allopurinol|allopurinol|mesh-list
92662282|NCT01332799|Antimetabolites|antimetabolites|mesh-ancestor
92662341|NCT00271791|Prednisone|prednisone|mesh-list
92662342|NCT00271791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92662343|NCT00271791|Glucocorticoids|glucocorticoids|mesh-ancestor
92662344|NCT00271791|Hormones|hormones|mesh-ancestor
92662345|NCT00271791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92662346|NCT00271791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662347|NCT00271791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92662348|NCT00271791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662349|NCT01332331|Ambrisentan|ambrisentan|mesh-list
92662350|NCT01332331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92662351|NCT00259064|Gefitinib|gefitinib|mesh-list
92662352|NCT00259064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662356|NCT01332292|Fluticasone|fluticasone|mesh-list
92662410|NCT00291759|Tamoxifen|tamoxifen|mesh-list
92662481|NCT00415376|Anticonvulsants|anticonvulsants|mesh-ancestor
92662483|NCT00291915|Adalimumab|adalimumab|mesh-list
92662552|NCT00259883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662553|NCT00259883|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92662554|NCT00259883|Antidepressive Agents|antidepressive agents|mesh-ancestor
92662555|NCT00259883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92662556|NCT00259883|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92662557|NCT00259883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92662558|NCT00259883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662559|NCT04718376|Mitoxantrone|mitoxantrone|mesh-list
92662560|NCT04718376|Analgesics|analgesics|mesh-ancestor
92662561|NCT04718376|Sensory System Agents|sensory system agents|mesh-ancestor
92662562|NCT04718376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92662563|NCT04718376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662564|NCT04718376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662565|NCT04718376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92662566|NCT04718376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92662567|NCT04718376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92662569|NCT00272415|Temozolomide|temozolomide|mesh-list
92662608|NCT00292266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662609|NCT00292266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92662610|NCT00292266|Antiviral Agents|antiviral agents|mesh-ancestor
92662611|NCT00292266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662612|NCT00260039|Vaccines|vaccines|mesh-list
92662613|NCT00260039|Immunologic Factors|immunologic factors|mesh-ancestor
92662614|NCT00260039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92662615|NCT00292344|Rifaximin|rifaximin|mesh-list
92662616|NCT00292344|Loperamide|loperamide|mesh-list
92662617|NCT00292344|Antidiarrheals|antidiarrheals|mesh-list
92662618|NCT00292344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92662619|NCT00292344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92662620|NCT00292344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92662621|NCT00417768|Plasminogen|plasminogen|mesh-list
92662622|NCT00417768|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92662623|NCT00417768|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92662624|NCT00417768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92662625|NCT00417768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662626|NCT00272610|Vitamin A|vitamin a|mesh-list
92662665|NCT00292734|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92662666|NCT00292734|GABA Agonists|gaba agonists|mesh-ancestor
92662667|NCT00292734|GABA Agents|gaba agents|mesh-ancestor
92662668|NCT00292734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662736|NCT00424931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92662737|NCT00424931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92662738|NCT00424931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92662807|NCT01330459|GABA Modulators|gaba modulators|mesh-ancestor
92662808|NCT01330459|GABA Agents|gaba agents|mesh-ancestor
92662809|NCT01330459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92662953|NCT00261599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92663026|NCT00293475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92663027|NCT00293475|Carboplatin|carboplatin|mesh-list
92663028|NCT00293475|Methotrexate|methotrexate|mesh-list
92663029|NCT00293475|Mannitol|mannitol|mesh-list
92663030|NCT00293475|Antibodies|antibodies|mesh-list
92663031|NCT00293475|Immunoglobulins|immunoglobulins|mesh-list
92663032|NCT00293475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92663033|NCT00293475|Antidotes|antidotes|mesh-list
92663034|NCT00293475|Immunologic Factors|immunologic factors|mesh-ancestor
92663035|NCT00293475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663036|NCT00293475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663037|NCT00293475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92663094|NCT00299091|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92663095|NCT00299091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92663100|NCT00299208|Azithromycin|azithromycin|mesh-list
92663169|NCT00262418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92663170|NCT00262418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663171|NCT00262418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663243|NCT00262808|Micronutrients|micronutrients|mesh-ancestor
92663315|NCT00299676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92663316|NCT00299676|Nootropic Agents|nootropic agents|mesh-ancestor
92663318|NCT00263276|Dapagliflozin|dapagliflozin|mesh-list
92663319|NCT00263276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92663320|NCT00263276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663321|NCT00263276|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92663322|NCT00263276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663323|NCT00299754|Misoprostol|misoprostol|mesh-list
92663324|NCT00299754|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92663325|NCT00299754|Abortifacient Agents|abortifacient agents|mesh-ancestor
92663326|NCT00299754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92663327|NCT00299754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663328|NCT00299754|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92663329|NCT00299754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92663330|NCT00299754|Oxytocics|oxytocics|mesh-ancestor
92663331|NCT00263315|Amphotericin B|amphotericin b|mesh-list
92663371|NCT00299910|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92663372|NCT00299910|Respiratory System Agents|respiratory system agents|mesh-ancestor
92663373|NCT00299910|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92663374|NCT00299910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92663375|NCT00299910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663376|NCT00299910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663377|NCT00299910|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92663378|NCT00299910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92663379|NCT00299910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663380|NCT00263627|Immunomodulating Agents|immunomodulating agents|mesh-list
92663381|NCT00263627|Immunologic Factors|immunologic factors|mesh-ancestor
92663382|NCT00263627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663384|NCT00425594|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92663430|NCT00263978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92663431|NCT00264134|Carboplatin|carboplatin|mesh-list
92663432|NCT00264134|Docetaxel|docetaxel|mesh-list
92663501|NCT00294606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92663502|NCT00294606|Sympathomimetics|sympathomimetics|mesh-ancestor
92663571|NCT00264680|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92663572|NCT00264680|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92663643|NCT00300846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663645|NCT00300846|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92663715|NCT00295035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92663716|NCT00295035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92663717|NCT00295035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92663719|NCT00295035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92663786|NCT00265772|Hormones|hormones|mesh-ancestor
92663787|NCT00265772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92663856|NCT00295425|Mycophenolic Acid|mycophenolic acid|mesh-list
92663928|NCT00295542|Telmisartan|telmisartan|mesh-list
92663929|NCT00295542|Carvedilol|carvedilol|mesh-list
92663930|NCT00295542|Olmesartan|olmesartan|mesh-list
92663931|NCT00295542|Enalapril|enalapril|mesh-list
92663932|NCT00295542|Lisinopril|lisinopril|mesh-list
92663933|NCT00295542|Nebivolol|nebivolol|mesh-list
92663934|NCT00295542|Antihypertensive Agents|antihypertensive agents|mesh-list
92663935|NCT00295542|Doxazosin|doxazosin|mesh-list
92663936|NCT00295542|Indapamide|indapamide|mesh-list
92663937|NCT00295542|Quinapril|quinapril|mesh-list
92663938|NCT00295542|Torsemide|torsemide|mesh-list
92663939|NCT00295542|Spirapril|spirapril|mesh-list
92663940|NCT00295542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92663941|NCT00295542|Diuretics|diuretics|mesh-list
92663942|NCT00295542|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92663949|NCT00295542|Antioxidants|antioxidants|mesh-ancestor
92663992|NCT00301509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92663993|NCT00301509|Antiviral Agents|antiviral agents|mesh-ancestor
92664065|NCT00295776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92664066|NCT00295776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664137|NCT00296010|Alkylating Agents|alkylating agents|mesh-ancestor
92664138|NCT00296010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664139|NCT00296010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664210|NCT04718649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664282|NCT00267917|Fenoterol|fenoterol|mesh-list
92664356|NCT00268151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664357|NCT00268151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664358|NCT00418080|Bicalutamide|bicalutamide|mesh-list
92664359|NCT00418080|Androgen Antagonists|androgen antagonists|mesh-ancestor
92664426|NCT00296712|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92664431|NCT00268697|Ezetimibe|ezetimibe|mesh-list
92664499|NCT00296868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92664501|NCT00268970|Paclitaxel|paclitaxel|mesh-list
92664571|NCT00269204|Vitamin B Complex|vitamin b complex|mesh-ancestor
92664644|NCT00418431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92664648|NCT00269594|Lamotrigine|lamotrigine|mesh-list
92664715|NCT00269867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664716|NCT00269867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92664793|NCT00297765|Tacrolimus|tacrolimus|mesh-list
92664794|NCT00297765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92664867|NCT00418548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92664868|NCT00418548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92664869|NCT00418548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92664870|NCT00418548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92664938|NCT00306540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665012|NCT00306735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665013|NCT00306735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665014|NCT00271583|Levonorgestrel|levonorgestrel|mesh-list
92665083|NCT00272090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665157|NCT00272480|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92665158|NCT00272480|Antimetabolites|antimetabolites|mesh-ancestor
92665159|NCT00307671|Mycophenolic Acid|mycophenolic acid|mesh-list
92665160|NCT00307671|Prednisone|prednisone|mesh-list
92665161|NCT00307671|Methylprednisolone|methylprednisolone|mesh-list
92665162|NCT00307671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92665163|NCT00307671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92665164|NCT00307671|Prednisolone|prednisolone|mesh-list
92665165|NCT00307671|Prednisolone acetate|prednisolone acetate|mesh-list
92665166|NCT00307671|Cyclophosphamide|cyclophosphamide|mesh-list
92665167|NCT00307671|Methotrexate|methotrexate|mesh-list
92665168|NCT00307671|Azathioprine|azathioprine|mesh-list
92665169|NCT00307671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92665221|NCT00272597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92665222|NCT00272597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92665292|NCT00272831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92665293|NCT00272831|Vasodilator Agents|vasodilator agents|mesh-ancestor
92665294|NCT00272831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92665295|NCT00272831|Protective Agents|protective agents|mesh-ancestor
92665296|NCT00272831|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92665361|NCT00273026|Respiratory System Agents|respiratory system agents|mesh-ancestor
92665362|NCT00273026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92665434|NCT00273377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665435|NCT00273377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665436|NCT00273377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92665437|NCT00273377|Glucocorticoids|glucocorticoids|mesh-ancestor
92665503|NCT00308334|Autonomic Agents|autonomic agents|mesh-ancestor
92665504|NCT00308334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92665505|NCT00308334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665577|NCT00274040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92665578|NCT00274040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665648|NCT00274235|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92665649|NCT00274274|Insulin|insulin|mesh-list
92665650|NCT00274274|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92665651|NCT00274274|Insulin Aspart|insulin aspart|mesh-list
92665652|NCT00274274|Insulin Detemir|insulin detemir|mesh-list
92665653|NCT00274274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92665654|NCT00274274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92665655|NCT00308607|Interferons|interferons|mesh-list
92665716|NCT00274430|Glucocorticoids|glucocorticoids|mesh-ancestor
92665717|NCT00274430|Hormones|hormones|mesh-ancestor
92665718|NCT00274430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92665719|NCT00274430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92665720|NCT00274430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665721|NCT00274430|Vasodilator Agents|vasodilator agents|mesh-ancestor
92665722|NCT00274430|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92665723|NCT00274430|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92665724|NCT00274430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92665725|NCT00274430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92665726|NCT00274430|Urological Agents|urological agents|mesh-ancestor
92665778|NCT00274820|Dexamethasone|dexamethasone|mesh-list
92665779|NCT00274820|Arsenic Trioxide|arsenic trioxide|mesh-list
92665851|NCT00277199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92665925|NCT00277862|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92665926|NCT00277862|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92665999|NCT00278330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666000|NCT00278330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666001|NCT00278330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92666002|NCT00278330|Growth Substances|growth substances|mesh-ancestor
92666013|NCT00278369|Aldesleukin|aldesleukin|mesh-list
92666070|NCT00315744|Albuterol|albuterol|mesh-list
92399715|NCT01404767|Metoprolol|metoprolol|mesh-list
92666071|NCT00315744|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92666072|NCT00315744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92666073|NCT00315744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92666074|NCT00315744|Autonomic Agents|autonomic agents|mesh-ancestor
92666075|NCT00315744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92666076|NCT00315744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666077|NCT00315744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92666078|NCT00315744|Respiratory System Agents|respiratory system agents|mesh-ancestor
92666079|NCT00315744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92666080|NCT00315744|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92666081|NCT00315744|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92666082|NCT00315744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92666083|NCT00315744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92666084|NCT00315744|Adrenergic Agents|adrenergic agents|mesh-ancestor
92666085|NCT00315744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92666086|NCT00315744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666129|NCT00279110|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92666130|NCT00279110|Antiviral Agents|antiviral agents|mesh-ancestor
92666202|NCT00418860|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92666278|NCT00279539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666353|NCT00310128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92666354|NCT00310128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92666355|NCT00310128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92666356|NCT00310128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92666357|NCT00310128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666423|NCT00416819|Alkylating Agents|alkylating agents|mesh-ancestor
92666425|NCT00310206|Immunologic Factors|immunologic factors|mesh-ancestor
92666426|NCT00310206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666427|NCT00280007|Bevacizumab|bevacizumab|mesh-list
92666428|NCT00280007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92666429|NCT00280007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666430|NCT00280007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92666431|NCT00280007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92666432|NCT00280007|Growth Substances|growth substances|mesh-ancestor
92666433|NCT00280007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666434|NCT00280007|Growth Inhibitors|growth inhibitors|mesh-ancestor
92666435|NCT00316680|Vaccines|vaccines|mesh-list
92666436|NCT00316680|Immunologic Factors|immunologic factors|mesh-ancestor
92666437|NCT00316680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666438|NCT00280046|Insulin Aspart|insulin aspart|mesh-list
92666439|NCT00280046|Biphasic Insulins|biphasic insulins|mesh-list
92666440|NCT00280046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92666441|NCT00280046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666442|NCT00310323|Dextromethorphan|dextromethorphan|mesh-list
92666443|NCT00310323|Caffeine|caffeine|mesh-list
92666444|NCT00310323|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92666445|NCT00310323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92666446|NCT00310323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92666447|NCT00310323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92666448|NCT00310323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666449|NCT00310323|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92666450|NCT00310323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92666451|NCT00310323|Purinergic Agents|purinergic agents|mesh-ancestor
92666468|NCT00316758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92666541|NCT00419172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92666543|NCT00419172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666544|NCT00419172|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92666545|NCT00419172|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92666546|NCT00419172|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92666547|NCT00419172|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92666548|NCT00419172|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92666549|NCT00419172|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92666550|NCT00419172|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92666551|NCT00419172|Chelating Agents|chelating agents|mesh-ancestor
92666552|NCT00419172|Sequestering Agents|sequestering agents|mesh-ancestor
92666600|NCT00281255|Antimetabolites|antimetabolites|mesh-ancestor
92666606|NCT00281255|Antioxidants|antioxidants|mesh-ancestor
92666676|NCT00417014|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399716|NCT01404767|Esmolol|esmolol|mesh-list
92666677|NCT00417014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92666749|NCT00281606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92666821|NCT00311337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92666822|NCT00317811|Ascorbic Acid|ascorbic acid|mesh-list
92666823|NCT00317811|Bortezomib|bortezomib|mesh-list
92666895|NCT00317967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92666966|NCT00311883|Hydroxychloroquine|hydroxychloroquine|mesh-list
92666967|NCT00311883|Antimalarials|antimalarials|mesh-ancestor
92666968|NCT00311883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92666969|NCT00311883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92666971|NCT00311883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667035|NCT00283829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667036|NCT00311961|Prednisolone|prednisolone|mesh-list
92667108|NCT00419250|Growth Inhibitors|growth inhibitors|mesh-ancestor
92667109|NCT00419250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667110|NCT00284024|Domperidone|domperidone|mesh-list
92667111|NCT00284024|Antiemetics|antiemetics|mesh-ancestor
92667181|NCT00312273|Autonomic Agents|autonomic agents|mesh-ancestor
92667182|NCT00312273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667183|NCT00312273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667184|NCT00312273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92667185|NCT00312273|Respiratory System Agents|respiratory system agents|mesh-ancestor
92667186|NCT00312273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92667187|NCT00312273|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92667188|NCT00312273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667192|NCT00312273|Purinergic Agents|purinergic agents|mesh-ancestor
92667246|NCT00312546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667247|NCT00312546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667248|NCT00312546|Antimanic Agents|antimanic agents|mesh-ancestor
92667249|NCT00312546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92667250|NCT00312546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92667251|NCT00312546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667252|NCT00312546|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92667253|NCT00312546|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92667254|NCT00312546|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92667255|NCT00312546|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92667256|NCT00312546|Antiviral Agents|antiviral agents|mesh-ancestor
92667257|NCT00312546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667258|NCT00425009|Metformin|metformin|mesh-list
92667259|NCT00425009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667261|NCT04718402|Mitoxantrone|mitoxantrone|mesh-list
92667307|NCT00285389|Rituximab|rituximab|mesh-list
92667308|NCT00285389|Vincristine|vincristine|mesh-list
92667381|NCT00285662|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92667382|NCT00285662|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92667383|NCT00285662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92667384|NCT00285662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667385|NCT00285662|Antiviral Agents|antiviral agents|mesh-ancestor
92667386|NCT00285662|Schistosomicides|schistosomicides|mesh-ancestor
92667387|NCT00285662|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92667388|NCT00285662|Anthelmintics|anthelmintics|mesh-ancestor
92667389|NCT00285662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92667448|NCT00286130|Cetuximab|cetuximab|mesh-list
92667449|NCT00286130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667450|NCT00286130|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92667451|NCT00286130|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92667452|NCT00286130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667453|NCT00286130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667454|NCT00286130|Antidotes|antidotes|mesh-ancestor
92667455|NCT00286130|Protective Agents|protective agents|mesh-ancestor
92667456|NCT00286130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667457|NCT00286130|Vitamin B Complex|vitamin b complex|mesh-ancestor
92667512|NCT00313131|Alkylating Agents|alkylating agents|mesh-ancestor
92667513|NCT00313131|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92667514|NCT00319878|Cyclosporine|cyclosporine|mesh-list
92667516|NCT00319878|Cyclosporins|cyclosporins|mesh-list
92667517|NCT00319878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667583|NCT00320073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667584|NCT00320073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667585|NCT00320073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667655|NCT00286988|Anticonvulsants|anticonvulsants|mesh-ancestor
92667656|NCT00286988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667731|NCT00287300|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92667805|NCT00320697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667806|NCT00320697|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92667807|NCT00320697|Antidepressive Agents|antidepressive agents|mesh-ancestor
92667808|NCT00320697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92667809|NCT00320697|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92667810|NCT00320697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92667811|NCT00320697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92667812|NCT00320697|Dopamine Agents|dopamine agents|mesh-ancestor
92667813|NCT00320697|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92667814|NCT00320697|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92667815|NCT00320697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667816|NCT00287651|Insulin|insulin|mesh-list
92667817|NCT00287651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92667818|NCT00287651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92667819|NCT00287651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667820|NCT00322296|Bexarotene|bexarotene|mesh-list
92667821|NCT00322296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92667822|NCT00320736|Galantamine|galantamine|mesh-list
92667823|NCT00320736|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92667824|NCT00320736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667825|NCT00320736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92667826|NCT00320736|Cholinergic Agents|cholinergic agents|mesh-ancestor
92667827|NCT00320736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92667828|NCT00320736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92667829|NCT00320736|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92667830|NCT00320736|Autonomic Agents|autonomic agents|mesh-ancestor
92667831|NCT00320736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92667832|NCT00320736|Nootropic Agents|nootropic agents|mesh-ancestor
92667833|NCT00287768|Docetaxel|docetaxel|mesh-list
92667849|NCT00320814|Growth Substances|growth substances|mesh-ancestor
92667924|NCT00288002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92667998|NCT00288197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92667999|NCT00288197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668000|NCT00288197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92668001|NCT00288197|Hormone Antagonists|hormone antagonists|mesh-ancestor
92668002|NCT00288197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668003|NCT00288197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668004|NCT00288197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92668005|NCT00288236|Rimonabant|rimonabant|mesh-list
92668006|NCT00288236|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92668007|NCT00288236|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92668008|NCT00288236|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92668009|NCT00288236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668010|NCT00288236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668011|NCT00288236|Hormones|hormones|mesh-ancestor
92668012|NCT00288236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668013|NCT00288236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668014|NCT00321126|Zinc|zinc|mesh-list
92668015|NCT00321126|Trace Elements|trace elements|mesh-ancestor
92668016|NCT00321126|Micronutrients|micronutrients|mesh-ancestor
92668017|NCT00321126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668018|NCT00288353|Aripiprazole|aripiprazole|mesh-list
92668019|NCT00288353|Ziprasidone|ziprasidone|mesh-list
92668047|NCT00288431|Antifungal Agents|antifungal agents|mesh-ancestor
92668048|NCT00288431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92668049|NCT00288431|Immunologic Factors|immunologic factors|mesh-ancestor
92668121|NCT00288548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668122|NCT00288548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668129|NCT00321477|Casopitant|casopitant|mesh-list
92668193|NCT01059825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92668194|NCT01059825|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92668195|NCT01059825|Protease Inhibitors|protease inhibitors|mesh-ancestor
92668196|NCT01059825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668198|NCT01059825|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92668260|NCT00289406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92668263|NCT00323544|Tenofovir|tenofovir|mesh-list
92668337|NCT00289835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668338|NCT00289835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668339|NCT00289835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668410|NCT00323973|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92668411|NCT00323973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92668412|NCT00323973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668413|NCT00323973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668414|NCT00324012|Docetaxel|docetaxel|mesh-list
92668415|NCT00324012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668416|NCT00324012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668417|NCT00324012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668418|NCT00324012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668419|NCT00324012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668420|NCT00290264|Budesonide|budesonide|mesh-list
92668421|NCT00290264|Formoterol Fumarate|formoterol fumarate|mesh-list
92668422|NCT00290264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668423|NCT00290264|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92668424|NCT00290264|Autonomic Agents|autonomic agents|mesh-ancestor
92668425|NCT00290264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668426|NCT00290264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668427|NCT00290264|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92668428|NCT00290264|Respiratory System Agents|respiratory system agents|mesh-ancestor
92668429|NCT00290264|Glucocorticoids|glucocorticoids|mesh-ancestor
92668430|NCT00290264|Hormones|hormones|mesh-ancestor
92668432|NCT00290264|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92668462|NCT00303381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92668463|NCT00290420|Chloroquine|chloroquine|mesh-list
92668464|NCT00290420|Amebicides|amebicides|mesh-ancestor
92668534|NCT00291122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92668535|NCT00291122|Analgesics|analgesics|mesh-ancestor
92668536|NCT00291122|Sensory System Agents|sensory system agents|mesh-ancestor
92668537|NCT00291122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92668538|NCT00291122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668539|NCT00291122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668540|NCT00291122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92668603|NCT00303810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92668604|NCT00303810|Antimetabolites|antimetabolites|mesh-ancestor
92668605|NCT00303810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92668606|NCT00303810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668607|NCT00303810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92668608|NCT00303810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92668609|NCT00303810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92668610|NCT00303810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92668611|NCT00303810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92668612|NCT00303810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92668613|NCT00303810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92668614|NCT00303810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92668615|NCT00324480|Vorinostat|vorinostat|mesh-list
92668616|NCT00324480|Alvocidib|alvocidib|mesh-list
92668617|NCT00324480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668618|NCT00324480|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92668619|NCT00324480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92668620|NCT00324480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668621|NCT00324480|Growth Inhibitors|growth inhibitors|mesh-ancestor
92668658|NCT00419484|Pioglitazone|pioglitazone|mesh-list
92668659|NCT00419484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92668660|NCT00419484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92668732|NCT00304317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668733|NCT00324792|Insulin|insulin|mesh-list
92668807|NCT00292409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92668808|NCT00292409|Serotonin Agents|serotonin agents|mesh-ancestor
92668809|NCT00292409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92668810|NCT00292409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92668811|NCT00292409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92668812|NCT00292409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92668813|NCT00304473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92668814|NCT00304473|Antidepressive Agents|antidepressive agents|mesh-ancestor
92668873|NCT00418509|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92668874|NCT00418509|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92668875|NCT00418509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92668876|NCT00418509|Adrenergic Agents|adrenergic agents|mesh-ancestor
92668877|NCT00418509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92668878|NCT00418509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92668879|NCT00418509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92668880|NCT00418509|Dermatologic Agents|dermatologic agents|mesh-ancestor
92668881|NCT00418509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92668882|NCT00292721|Celecoxib|celecoxib|mesh-list
92668884|NCT00292721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92668937|NCT00292955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92668938|NCT00293072|Rituximab|rituximab|mesh-list
92669011|NCT00293696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92669012|NCT00293696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669017|NCT00293735|Labetalol|labetalol|mesh-list
92669083|NCT00294086|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92669084|NCT00294086|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92669151|NCT00325767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92669152|NCT00325767|Autonomic Agents|autonomic agents|mesh-ancestor
92669225|NCT00294593|Hematinics|hematinics|mesh-ancestor
92669227|NCT00325845|Viscosupplements|viscosupplements|mesh-ancestor
92669228|NCT00325845|Protective Agents|protective agents|mesh-ancestor
92669296|NCT00305838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92669297|NCT00305838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92669299|NCT00305838|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92669367|NCT00295685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92669443|NCT00295997|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92669444|NCT00295997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92669445|NCT00295997|Immunologic Factors|immunologic factors|mesh-ancestor
92669515|NCT00326820|Ibandronic Acid|ibandronic acid|mesh-list
92669588|NCT00296933|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92669589|NCT00296933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92669590|NCT00296933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669591|NCT00296933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669592|NCT00296933|Serotonin Agents|serotonin agents|mesh-ancestor
92669593|NCT00296933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92669655|NCT04485195|Procainamide|procainamide|mesh-list
92669656|NCT04485195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92669657|NCT04485195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92669726|NCT04231773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92669727|NCT04231773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92669728|NCT04231773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92669799|NCT05458089|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92669801|NCT03754140|Polidocanol|polidocanol|mesh-list
92669872|NCT00299039|Sensory System Agents|sensory system agents|mesh-ancestor
92669945|NCT00300014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92669946|NCT00300014|Glucocorticoids|glucocorticoids|mesh-ancestor
92670018|NCT01539447|Sensory System Agents|sensory system agents|mesh-ancestor
92670091|NCT00301106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670092|NCT00301106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92670163|NCT00301613|Antitubercular Agents|antitubercular agents|mesh-ancestor
92670164|NCT00301613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92670165|NCT00301613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92670166|NCT00301613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92670167|NCT00301613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395661|NCT01392534|Natriuretic Agents|natriuretic agents|mesh-ancestor
92670239|NCT05238831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92670306|NCT00302393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92670307|NCT00302393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670308|NCT00302393|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92670309|NCT00302393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92670310|NCT00302393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92670311|NCT00302393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670312|NCT00302393|Dopamine Agents|dopamine agents|mesh-ancestor
92670313|NCT00302393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92670314|NCT00328107|Hemagglutinins|hemagglutinins|mesh-list
92670315|NCT00328107|Agglutinins|agglutinins|mesh-ancestor
92670316|NCT00328107|Immunologic Factors|immunologic factors|mesh-ancestor
92670317|NCT00328107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670318|NCT00328107|Coagulants|coagulants|mesh-ancestor
92670319|NCT00302432|Menthol|menthol|mesh-list
92670320|NCT00302432|Antipruritics|antipruritics|mesh-ancestor
92399735|NCT01404806|Dolutegravir|dolutegravir|mesh-list
92670321|NCT00302432|Dermatologic Agents|dermatologic agents|mesh-ancestor
92670322|NCT00419913|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92670323|NCT00419913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92670324|NCT00419913|Immunologic Factors|immunologic factors|mesh-ancestor
92670325|NCT00419913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670326|NCT00302549|Tacrolimus|tacrolimus|mesh-list
92670327|NCT00302549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92670328|NCT00302549|Immunologic Factors|immunologic factors|mesh-ancestor
92670359|NCT00302666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670433|NCT00303017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92670434|NCT00303017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670507|NCT00419796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92670508|NCT00419796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92670509|NCT00419796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670579|NCT00303836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92670580|NCT00303836|Analgesics|analgesics|mesh-ancestor
92670581|NCT00303836|Sensory System Agents|sensory system agents|mesh-ancestor
92670649|NCT00304499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670650|NCT00304499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670651|NCT00304499|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92670657|NCT00304538|Glucagon|glucagon|mesh-list
92670717|NCT00332436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92670787|NCT00304772|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92670788|NCT00304811|Vancomycin|vancomycin|mesh-list
92670789|NCT00304811|Rifampin|rifampin|mesh-list
92670790|NCT00304811|Gentamicins|gentamicins|mesh-list
92670857|NCT00329355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92670930|NCT00329511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92670931|NCT00329511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671001|NCT00329628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92671002|NCT00329628|Protease Inhibitors|protease inhibitors|mesh-ancestor
92671003|NCT00329628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671072|NCT00305903|Rivastigmine|rivastigmine|mesh-list
92671073|NCT00305903|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92671074|NCT00305903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92671075|NCT00305903|Dopamine Agents|dopamine agents|mesh-ancestor
92671086|NCT00329823|Etanercept|etanercept|mesh-list
92671144|NCT00306254|Anticoagulants|anticoagulants|mesh-ancestor
92671145|NCT00306254|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92671215|NCT00451100|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92671216|NCT00451100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92671217|NCT00451100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92671218|NCT00420537|Cyclosporine|cyclosporine|mesh-list
92671219|NCT00420537|Mycophenolic Acid|mycophenolic acid|mesh-list
92671220|NCT00420537|Everolimus|everolimus|mesh-list
92671221|NCT00420537|Cyclosporins|cyclosporins|mesh-list
92671222|NCT00420537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92671223|NCT00420537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671224|NCT00420537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671225|NCT00420537|Immunologic Factors|immunologic factors|mesh-ancestor
92671226|NCT00420537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671282|NCT00451490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671283|NCT00330525|Sibutramine|sibutramine|mesh-list
92671288|NCT00333918|Bromfenac|bromfenac|mesh-list
92671355|NCT00451997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671356|NCT00451997|Antiviral Agents|antiviral agents|mesh-ancestor
92671357|NCT00451997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92671358|NCT00451997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92671359|NCT00451997|Immunologic Factors|immunologic factors|mesh-ancestor
92671424|NCT00334152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671426|NCT00334152|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92671497|NCT03275012|Sensory System Agents|sensory system agents|mesh-ancestor
92671571|NCT00334932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92671572|NCT00334932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397076|NCT05250141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92671719|NCT00453401|Adenylyl Cyclase Inhibitors|adenylyl cyclase inhibitors|mesh-ancestor
92671722|NCT00335673|Irbesartan|irbesartan|mesh-list
92671790|NCT00336414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92671791|NCT00336414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92671792|NCT00336414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399740|NCT01404806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92671861|NCT00230399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92671935|NCT00336960|Sensory System Agents|sensory system agents|mesh-ancestor
92671936|NCT00336960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92671942|NCT00306410|Cholecalciferol|cholecalciferol|mesh-list
92672009|NCT00337506|Dexamethasone|dexamethasone|mesh-list
92672010|NCT00337506|Bortezomib|bortezomib|mesh-list
92672011|NCT00337506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92672012|NCT00337506|Antiemetics|antiemetics|mesh-ancestor
92672013|NCT00337506|Autonomic Agents|autonomic agents|mesh-ancestor
92672014|NCT00337506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672080|NCT00307502|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92672081|NCT00307502|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92672082|NCT00307502|Antiviral Agents|antiviral agents|mesh-ancestor
92672083|NCT00307502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672084|NCT00307502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92672085|NCT00307502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92672100|NCT00307619|Topiramate|topiramate|mesh-list
92672149|NCT00338091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92672150|NCT00338091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92672153|NCT00338091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92672221|NCT00308360|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92672223|NCT00308360|Anticonvulsants|anticonvulsants|mesh-ancestor
92672224|NCT00308360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672225|NCT00308360|GABA Agents|gaba agents|mesh-ancestor
92672226|NCT00308360|Antimanic Agents|antimanic agents|mesh-ancestor
92672227|NCT00341250|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92672228|NCT00341250|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92672229|NCT00341250|Immunologic Factors|immunologic factors|mesh-ancestor
92672230|NCT00341250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672231|NCT00341250|Antacids|antacids|mesh-ancestor
92672232|NCT00341250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672286|NCT00309218|Prednisolone|prednisolone|mesh-list
92672287|NCT00309218|Prednisolone acetate|prednisolone acetate|mesh-list
92672288|NCT00309218|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92672291|NCT00309218|Antiemetics|antiemetics|mesh-ancestor
92672358|NCT00309569|Immunologic Factors|immunologic factors|mesh-ancestor
92672359|NCT00309569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672360|NCT00309569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672361|NCT00309569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92672362|NCT00309569|Alkylating Agents|alkylating agents|mesh-ancestor
92672363|NCT00309569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92672364|NCT00309569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672365|NCT00309569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92672366|NCT00309569|Antimetabolites|antimetabolites|mesh-ancestor
92672367|NCT00309569|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672368|NCT00309569|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92672369|NCT00309569|Abortifacient Agents|abortifacient agents|mesh-ancestor
92672370|NCT00309569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92672371|NCT00309569|Dermatologic Agents|dermatologic agents|mesh-ancestor
92672372|NCT00309569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92672373|NCT00309569|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92672374|NCT00309569|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92672375|NCT00309569|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92672376|NCT00309569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92672377|NCT00309569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92672378|NCT00309686|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92672392|NCT00309725|Galantamine|galantamine|mesh-list
92672410|NCT00338754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92672485|NCT00309998|Vinorelbine|vinorelbine|mesh-list
92672486|NCT00309998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92672487|NCT00309998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672488|NCT00309998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92672489|NCT00309998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92672490|NCT00309998|Growth Substances|growth substances|mesh-ancestor
92672491|NCT00309998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672492|NCT00309998|Growth Inhibitors|growth inhibitors|mesh-ancestor
92672494|NCT00309998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92672551|NCT00310505|Antifungal Agents|antifungal agents|mesh-ancestor
92672552|NCT00310505|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92672623|NCT00310895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92672625|NCT00310934|Methadone|methadone|mesh-list
92672626|NCT00310934|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92672693|NCT00311558|Interferon-alpha|interferon-alpha|mesh-list
92672694|NCT00311558|Interferon alpha-2|interferon alpha-2|mesh-list
92672695|NCT00311558|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92672696|NCT00311558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92672697|NCT00311558|Antiviral Agents|antiviral agents|mesh-ancestor
92672698|NCT00311558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92672699|NCT00311558|Immunologic Factors|immunologic factors|mesh-ancestor
92672700|NCT00311558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672701|NCT00311558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92672702|NCT00311558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92672760|NCT00311636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92672772|NCT00311753|Heparin|heparin|mesh-list
92672833|NCT00312182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92672834|NCT00312182|Antiviral Agents|antiviral agents|mesh-ancestor
92672905|NCT00312650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92672906|NCT00312650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92672907|NCT00312650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92672980|NCT00313157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92672981|NCT00313157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92672982|NCT00313157|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92672983|NCT00313157|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92673050|NCT00343707|Paroxetine|paroxetine|mesh-list
92673051|NCT00343707|Vestipitant|vestipitant|mesh-list
92673052|NCT00343707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92673053|NCT00343707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92673054|NCT00343707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92673055|NCT00343707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673056|NCT00343707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92673117|NCT00313625|Tacrolimus|tacrolimus|mesh-list
92673118|NCT00313625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92673119|NCT00313625|Abortifacient Agents|abortifacient agents|mesh-ancestor
92673123|NCT00313625|Antimetabolites|antimetabolites|mesh-ancestor
92673188|NCT00313937|Insulin Glargine|insulin glargine|mesh-list
92673189|NCT00313937|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92673191|NCT00313976|Interferons|interferons|mesh-list
92673263|NCT04715295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673264|NCT04715295|Anticoagulants|anticoagulants|mesh-ancestor
92673265|NCT04715295|Antimalarials|antimalarials|mesh-ancestor
92673266|NCT04715295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92673267|NCT04715295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92673268|NCT04715295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92673269|NCT00348504|Simendan|simendan|mesh-list
92673270|NCT00348504|Dobutamine|dobutamine|mesh-list
92673271|NCT00348504|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92673272|NCT00348504|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673273|NCT00348504|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92673274|NCT00348504|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92673275|NCT00348504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673276|NCT00348504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673277|NCT00348504|Protective Agents|protective agents|mesh-ancestor
92673278|NCT00348504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673321|NCT00314678|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92673322|NCT00314678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92673323|NCT00314678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92673325|NCT00344526|Melphalan|melphalan|mesh-list
92673326|NCT00344526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92673327|NCT00344526|Antiemetics|antiemetics|mesh-ancestor
92673328|NCT00344526|Autonomic Agents|autonomic agents|mesh-ancestor
92673329|NCT00344526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673330|NCT00344526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673331|NCT00344526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92673332|NCT00344526|Glucocorticoids|glucocorticoids|mesh-ancestor
92673333|NCT00344526|Hormones|hormones|mesh-ancestor
92673334|NCT00344526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92673335|NCT00344526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92673336|NCT00344526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673337|NCT00344526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92673338|NCT00344526|Alkylating Agents|alkylating agents|mesh-ancestor
92673339|NCT00344526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673377|NCT00314990|Micronutrients|micronutrients|mesh-ancestor
92673378|NCT00314990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673379|NCT02960126|Aspirin|aspirin|mesh-list
92673380|NCT02960126|Clopidogrel|clopidogrel|mesh-list
92673448|NCT00315536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673449|NCT00348972|Insulin Glargine|insulin glargine|mesh-list
92673522|NCT00421434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673523|NCT00421434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92673524|NCT00315965|Nitric Oxide|nitric oxide|mesh-list
92673593|NCT00316238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92673594|NCT00316238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92673595|NCT00316238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92673596|NCT00316238|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92673597|NCT00316238|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92673598|NCT00316238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92673599|NCT00316238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399043|NCT01401036|Umirolimus|umirolimus|mesh-list
92673660|NCT00349557|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92673661|NCT00349557|Growth Substances|growth substances|mesh-ancestor
92673733|NCT00316940|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92673734|NCT00316940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92673735|NCT00316940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92673737|NCT00316940|Sensory System Agents|sensory system agents|mesh-ancestor
92673738|NCT00316940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92673739|NCT00316940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673740|NCT00344994|Pramipexole|pramipexole|mesh-list
92673741|NCT00344994|Antioxidants|antioxidants|mesh-ancestor
92673742|NCT00344994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673743|NCT00344994|Protective Agents|protective agents|mesh-ancestor
92673744|NCT00344994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673796|NCT00317408|Cytarabine|cytarabine|mesh-list
92673797|NCT00317408|Cyclosporine|cyclosporine|mesh-list
92673798|NCT00317408|Dexamethasone|dexamethasone|mesh-list
92673874|NCT02959554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92673875|NCT02959554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673876|NCT02959554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92673877|NCT02959554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92673878|NCT02959554|Growth Substances|growth substances|mesh-ancestor
92673879|NCT02959554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92673880|NCT02959554|Growth Inhibitors|growth inhibitors|mesh-ancestor
92673881|NCT02959554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92673940|NCT00345501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92673941|NCT00345501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673942|NCT00345657|Niacin|niacin|mesh-list
92673943|NCT00345657|Lovastatin|lovastatin|mesh-list
92673944|NCT00345657|L 647318|l 647318|mesh-list
92673945|NCT00345657|Dihydromevinolin|dihydromevinolin|mesh-list
92673946|NCT00345657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92673947|NCT00345657|Antimetabolites|antimetabolites|mesh-ancestor
92673948|NCT00345657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92673949|NCT00345657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92673950|NCT00345657|Vasodilator Agents|vasodilator agents|mesh-ancestor
92673951|NCT00345657|Vitamin B Complex|vitamin b complex|mesh-ancestor
92673952|NCT00345657|Vitamins|vitamins|mesh-ancestor
92673958|NCT00317876|Cyclosporine|cyclosporine|mesh-list
92674001|NCT00317954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92674075|NCT02959749|Mitosis Modulators|mitosis modulators|mesh-ancestor
92674079|NCT00318383|Vaccines|vaccines|mesh-list
92674148|NCT00319007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674149|NCT00319007|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92674150|NCT00319007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674221|NCT00346359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92674226|NCT00346359|Antimetabolites|antimetabolites|mesh-ancestor
92674293|NCT00319865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674294|NCT00319865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92674295|NCT00319865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92674367|NCT00320567|Contraceptive Agents|contraceptive agents|mesh-ancestor
92674368|NCT00320567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92674369|NCT00320567|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92674373|NCT00346827|Apomorphine|apomorphine|mesh-list
92674438|NCT00347139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92674439|NCT00347139|Autonomic Agents|autonomic agents|mesh-ancestor
92674440|NCT00347139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92674441|NCT00347139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674442|NCT00347139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92674443|NCT00347139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92674444|NCT00347139|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92674445|NCT00347139|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92674446|NCT00347139|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92674447|NCT00347139|Adrenergic Agents|adrenergic agents|mesh-ancestor
92674448|NCT00347139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674449|NCT00347139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674450|NCT00321074|Tacrolimus|tacrolimus|mesh-list
92674451|NCT00321074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674452|NCT00321074|Immunologic Factors|immunologic factors|mesh-ancestor
92674453|NCT00321074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674454|NCT00321074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92674455|NCT00321074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674456|NCT00321074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674457|NCT00321113|Mycophenolic Acid|mycophenolic acid|mesh-list
92674458|NCT00321113|Tacrolimus|tacrolimus|mesh-list
92674459|NCT00321113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92674460|NCT00321113|Immunologic Factors|immunologic factors|mesh-ancestor
92674461|NCT00321113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674462|NCT00321113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92674463|NCT00321113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674464|NCT00321113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674465|NCT00321113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92674466|NCT00321113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674467|NCT00321113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92674468|NCT00321113|Antitubercular Agents|antitubercular agents|mesh-ancestor
92674469|NCT00321113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92674470|NCT00321113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752310|NCT05940909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752311|NCT05940909|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92752312|NCT05940909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752314|NCT05940909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92752315|NCT05940909|Protease Inhibitors|protease inhibitors|mesh-ancestor
92752316|NCT05940909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674471|NCT00347256|Cisplatin|cisplatin|mesh-list
92674472|NCT00347256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674546|NCT00352092|Mycophenolic Acid|mycophenolic acid|mesh-list
92674547|NCT00352092|Sirolimus|sirolimus|mesh-list
92674548|NCT00352092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92674620|NCT00352521|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92674621|NCT00352521|Growth Substances|growth substances|mesh-ancestor
92674622|NCT00352521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674623|NCT00352521|Growth Inhibitors|growth inhibitors|mesh-ancestor
92674624|NCT00352521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92674625|NCT00352521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92674626|NCT00352521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92674627|NCT00352521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92674628|NCT00352599|Lovastatin|lovastatin|mesh-list
92674629|NCT00352599|L 647318|l 647318|mesh-list
92674683|NCT00331305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92674685|NCT00331305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92674753|NCT00353067|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92674754|NCT00353067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92674755|NCT00353067|Analgesics|analgesics|mesh-ancestor
92674765|NCT00323219|Cefazolin|cefazolin|mesh-list
92674824|NCT00353340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92674825|NCT00353340|Expectorants|expectorants|mesh-ancestor
92674826|NCT00353340|Respiratory System Agents|respiratory system agents|mesh-ancestor
92674897|NCT00324077|Dasatinib|dasatinib|mesh-list
92674898|NCT00324077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92674899|NCT00324077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92674973|NCT00324467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92675047|NCT00426348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675052|NCT00426348|Antioxidants|antioxidants|mesh-ancestor
92399758|NCT01404871|Antidepressive Agents|antidepressive agents|mesh-ancestor
92675119|NCT00426543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675120|NCT00426543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92675190|NCT00354198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675191|NCT00354198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92675192|NCT00354198|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92675193|NCT00354198|Protective Agents|protective agents|mesh-ancestor
92675194|NCT00354198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675195|NCT00354198|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675196|NCT00354198|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92675197|NCT00354198|Antioxidants|antioxidants|mesh-ancestor
92675198|NCT00354198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92675199|NCT00354198|Glucocorticoids|glucocorticoids|mesh-ancestor
92675201|NCT00354198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675202|NCT00354198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92675205|NCT00325676|Pantoprazole|pantoprazole|mesh-list
92675248|NCT00354276|Antimetabolites|antimetabolites|mesh-ancestor
92675249|NCT00354276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675251|NCT00354276|Antiviral Agents|antiviral agents|mesh-ancestor
92675321|NCT00354354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675322|NCT00354354|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92675391|NCT00326768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92675393|NCT00326807|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92675394|NCT00326807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92675395|NCT00326807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675396|NCT00326807|Sensory System Agents|sensory system agents|mesh-ancestor
92675397|NCT00326807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92675398|NCT00354549|Bevacizumab|bevacizumab|mesh-list
92675399|NCT00354549|Carboplatin|carboplatin|mesh-list
92675400|NCT00354549|Gemcitabine|gemcitabine|mesh-list
92675401|NCT00354549|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92675402|NCT00354549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92675403|NCT00354549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675404|NCT00354549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92675405|NCT00354549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92675451|NCT00327080|Vasodilator Agents|vasodilator agents|mesh-ancestor
92675452|NCT00327080|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92675453|NCT00327080|Cholinergic Agents|cholinergic agents|mesh-ancestor
92675454|NCT00327080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675455|NCT00327080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675456|NCT00327080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675457|NCT00327119|Panitumumab|panitumumab|mesh-list
92675518|NCT00425841|Oxaliplatin|oxaliplatin|mesh-list
92675519|NCT00425841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92675520|NCT00425841|Antimetabolites|antimetabolites|mesh-ancestor
92675589|NCT05458076|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92675590|NCT05458076|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92675591|NCT05458076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92675661|NCT02957448|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92675662|NCT02957448|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92675663|NCT02957448|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92675664|NCT02957448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92675665|NCT00427596|Solabegron|solabegron|mesh-list
92675666|NCT00427596|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92675667|NCT00427596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92675668|NCT00427596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92675669|NCT00427596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92675670|NCT00427596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92675671|NCT00427596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92675672|NCT00427596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92675673|NCT00432510|Complement C1s|complement c1s|mesh-list
92675674|NCT00432510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92675720|NCT00427713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92675721|NCT00427713|Antimetabolites|antimetabolites|mesh-ancestor
92675723|NCT00427713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92675793|NCT00432588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92675794|NCT00432588|Oxytocics|oxytocics|mesh-ancestor
92675795|NCT00428025|Diclofenac|diclofenac|mesh-list
92675865|NCT00428142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92675866|NCT00428142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92675869|NCT00428181|Ethanol|ethanol|mesh-list
92675938|NCT01056276|Glucocorticoids|glucocorticoids|mesh-ancestor
92675939|NCT01056276|Hormones|hormones|mesh-ancestor
92675940|NCT01056276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92675941|NCT01056276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92676009|NCT00428727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92676082|NCT00433485|Antifungal Agents|antifungal agents|mesh-ancestor
92676086|NCT02676791|Povidone-Iodine|povidone-iodine|mesh-list
92676156|NCT04704297|Anesthetics, Local|anesthetics, local|mesh-ancestor
92676157|NCT04704297|Anesthetics|anesthetics|mesh-ancestor
92676163|NCT04704297|Analgesics|analgesics|mesh-ancestor
92676227|NCT00328718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92676228|NCT00328718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92676229|NCT00328718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92676230|NCT00328718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92676231|NCT00328718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92676232|NCT00328718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92676233|NCT00328718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92676234|NCT00328718|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92676235|NCT00328718|Hormone Antagonists|hormone antagonists|mesh-ancestor
92676236|NCT00328718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92676237|NCT00328718|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92676238|NCT00328718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92676239|NCT00328796|Lidocaine|lidocaine|mesh-list
92676240|NCT00328796|Anesthetics, Local|anesthetics, local|mesh-ancestor
92676285|NCT00433953|Antitubercular Agents|antitubercular agents|mesh-ancestor
92676286|NCT00433953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92676287|NCT00433953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92676355|NCT00434031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92676356|NCT00434031|Immunologic Factors|immunologic factors|mesh-ancestor
92676372|NCT00329225|Rosiglitazone|rosiglitazone|mesh-list
92676428|NCT00329498|Micronutrients|micronutrients|mesh-ancestor
92676429|NCT00329537|Sargramostim|sargramostim|mesh-list
92676498|NCT00329810|Antidepressive Agents|antidepressive agents|mesh-ancestor
92676499|NCT00329810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92676570|NCT00330317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92676571|NCT00330317|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92676645|NCT00330824|Moxifloxacin|moxifloxacin|mesh-list
92676646|NCT00330824|Dexamethasone|dexamethasone|mesh-list
92676720|NCT00331058|Prednisolone|prednisolone|mesh-list
92676793|NCT00431145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92676870|NCT00331994|Metronidazole|metronidazole|mesh-list
92676941|NCT00332306|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92677014|NCT00332774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677015|NCT00431769|Bortezomib|bortezomib|mesh-list
92677016|NCT00431769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677017|NCT00332852|Letrozole|letrozole|mesh-list
92677018|NCT00332852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677019|NCT00332852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92677020|NCT00332852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92677021|NCT00332852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677022|NCT00332852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677023|NCT00332852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92677077|NCT00435747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92677078|NCT00435747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677147|NCT00333281|Vasodilator Agents|vasodilator agents|mesh-ancestor
92677148|NCT00333281|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92677220|NCT00436059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677222|NCT00420524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677292|NCT00333944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92677293|NCT00334022|Enfuvirtide|enfuvirtide|mesh-list
92677294|NCT00334022|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92677295|NCT00334022|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92677364|NCT00438087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92677366|NCT00334412|Caspofungin|caspofungin|mesh-list
92677438|NCT00334685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92677439|NCT00334685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92677440|NCT00334685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92677509|NCT00436761|Glucocorticoids|glucocorticoids|mesh-ancestor
92677510|NCT00436761|Hormones|hormones|mesh-ancestor
92677511|NCT00436761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92677583|NCT00335192|Tenofovir|tenofovir|mesh-list
92677584|NCT00335192|Lamivudine|lamivudine|mesh-list
92677585|NCT00335192|Abacavir|abacavir|mesh-list
92677586|NCT00335192|Antiviral Agents|antiviral agents|mesh-ancestor
92677587|NCT00335192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677588|NCT00335192|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92677589|NCT00335192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92677590|NCT00335192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677591|NCT00335192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677592|NCT00335192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92677593|NCT00335192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92677594|NCT00437307|Topotecan|topotecan|mesh-list
92677595|NCT00437307|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92677596|NCT00437307|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92677597|NCT00437307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677598|NCT00437307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677599|NCT00437307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677600|NCT00335231|Gatifloxacin|gatifloxacin|mesh-list
92677601|NCT00335231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92677602|NCT00335231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92677603|NCT00335231|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92677604|NCT00335231|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92677605|NCT00335231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92677606|NCT00335231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92677607|NCT00335231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92677608|NCT00335231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92677610|NCT00335270|Ritonavir|ritonavir|mesh-list
92677631|NCT00335270|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92677632|NCT00335270|Antitubercular Agents|antitubercular agents|mesh-ancestor
92677705|NCT00335465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92677706|NCT00335465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92677707|NCT00335543|Gemcitabine|gemcitabine|mesh-list
92677849|NCT00347490|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92677850|NCT00347490|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92677921|NCT00421317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92677922|NCT00421317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92677930|NCT04699734|Lidocaine|lidocaine|mesh-list
92677992|NCT00444756|Anesthetics, Local|anesthetics, local|mesh-ancestor
92677993|NCT00444756|Anesthetics|anesthetics|mesh-ancestor
92678063|NCT00451230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92678064|NCT00451230|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92678065|NCT00451230|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92678066|NCT00451230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92678067|NCT00451230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92678068|NCT00451230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678069|NCT00451230|Dopamine Agents|dopamine agents|mesh-ancestor
92678070|NCT00451230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92678071|NCT00338000|Epoetin Alfa|epoetin alfa|mesh-list
92678128|NCT00338390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678129|NCT00338390|Antiviral Agents|antiviral agents|mesh-ancestor
92678134|NCT00338468|Epoetin Alfa|epoetin alfa|mesh-list
92678200|NCT00445497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92678201|NCT00445497|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92678202|NCT00451776|Propofol|propofol|mesh-list
92678266|NCT00420953|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92678267|NCT00420953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92678268|NCT00425204|Panitumumab|panitumumab|mesh-list
92678337|NCT00446433|Growth Inhibitors|growth inhibitors|mesh-ancestor
92678338|NCT00446433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678339|NCT00340574|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92678340|NCT00340574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92678341|NCT00340574|Immunologic Factors|immunologic factors|mesh-ancestor
92678343|NCT00340574|Antacids|antacids|mesh-ancestor
92678408|NCT00446667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678409|NCT03277755|Adafosbuvir|adafosbuvir|mesh-list
92678410|NCT03277755|Antiviral Agents|antiviral agents|mesh-ancestor
92678481|NCT00446784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92678482|NCT00446784|Antimetabolites|antimetabolites|mesh-ancestor
92678483|NCT00446784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678484|NCT00446784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678551|NCT00446901|Antioxidants|antioxidants|mesh-ancestor
92678553|NCT00446901|Protective Agents|protective agents|mesh-ancestor
92678623|NCT00453609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678624|NCT00453609|Sensory System Agents|sensory system agents|mesh-ancestor
92678626|NCT00447213|Insulin|insulin|mesh-list
92678694|NCT00343733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678770|NCT00344123|Antimetabolites|antimetabolites|mesh-ancestor
92678846|NCT00344669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92678848|NCT00344669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678919|NCT00344942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92678921|NCT00344942|Immunologic Factors|immunologic factors|mesh-ancestor
92678990|NCT00448305|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92678991|NCT00448305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92678992|NCT00448305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92678993|NCT00448305|Tubulin Modulators|tubulin modulators|mesh-ancestor
92678994|NCT00448305|Antimitotic Agents|antimitotic agents|mesh-ancestor
92678995|NCT00448305|Mitosis Modulators|mitosis modulators|mesh-ancestor
92678996|NCT00448305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92678997|NCT00345137|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92678998|NCT00345137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92678999|NCT00345137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679000|NCT00448383|Adalimumab|adalimumab|mesh-list
92679001|NCT00448383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92679002|NCT00448383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92679003|NCT00448383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92679004|NCT00448461|Heparin|heparin|mesh-list
92679005|NCT00448461|Bivalirudin|bivalirudin|mesh-list
92679006|NCT00448461|Anticoagulants|anticoagulants|mesh-ancestor
92679007|NCT00448461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92679008|NCT00448461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92679009|NCT00448461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679010|NCT00448461|Antithrombins|antithrombins|mesh-ancestor
92679011|NCT00448461|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92679012|NCT00448461|Protease Inhibitors|protease inhibitors|mesh-ancestor
92679013|NCT00448461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679014|NCT00454662|Amlodipine|amlodipine|mesh-list
92679015|NCT00454662|Olmesartan|olmesartan|mesh-list
92679016|NCT00454662|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92679017|NCT00454662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92679023|NCT00454662|Vasodilator Agents|vasodilator agents|mesh-ancestor
92679035|NCT00454701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92679036|NCT00454701|Immunologic Factors|immunologic factors|mesh-ancestor
92679108|NCT00346229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679109|NCT00346385|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
92679182|NCT04698213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92679183|NCT04698213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679185|NCT02273817|Ciclesonide|ciclesonide|mesh-list
92679255|NCT00455286|Abortifacient Agents|abortifacient agents|mesh-ancestor
92679256|NCT00455286|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92679259|NCT00455286|Antimetabolites|antimetabolites|mesh-ancestor
92679324|NCT00347555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679396|NCT00348023|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92679403|NCT00348062|Bimatoprost|bimatoprost|mesh-list
92679471|NCT00449319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679544|NCT00449397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679545|NCT00449397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679546|NCT00348491|Lumiracoxib|lumiracoxib|mesh-list
92679549|NCT00348491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92679615|NCT00348920|Bupivacaine|bupivacaine|mesh-list
92679687|NCT00456339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92679688|NCT00456339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679690|NCT00456339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92679758|NCT00349739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92679832|NCT00350441|Urological Agents|urological agents|mesh-ancestor
92679833|NCT00350480|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92679834|NCT00350480|Contraceptives, Oral|contraceptives, oral|mesh-list
92679835|NCT00350480|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92679836|NCT00350480|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92679837|NCT00350480|Contraceptive Agents|contraceptive agents|mesh-ancestor
92679838|NCT00350480|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92679898|NCT00421538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92679900|NCT00351026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92679901|NCT00351026|Narcotics|narcotics|mesh-ancestor
92679902|NCT00351026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92679969|NCT00457899|Antidepressive Agents|antidepressive agents|mesh-ancestor
92679970|NCT00457899|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92679971|NCT00457899|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92680042|NCT00450957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680115|NCT00105183|Antibodies|antibodies|mesh-list
92680116|NCT00105183|gamma-Globulins|gamma-globulins|mesh-list
92680117|NCT00105183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92680187|NCT00466518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680188|NCT00353561|Fluconazole|fluconazole|mesh-list
92680260|NCT00466713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92680261|NCT00466791|Methylphenidate|methylphenidate|mesh-list
92680268|NCT00466791|Dopamine Agents|dopamine agents|mesh-ancestor
92680332|NCT00354302|Calcium Carbonate|calcium carbonate|mesh-list
92680333|NCT00354302|Calcium|calcium|mesh-list
92680409|NCT00467181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92680410|NCT00467181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680556|NCT00426296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92680557|NCT00426296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92680629|NCT00467766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92680630|NCT00467766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680631|NCT00467766|Cholinergic Agents|cholinergic agents|mesh-ancestor
92680703|NCT00459615|Antiviral Agents|antiviral agents|mesh-ancestor
92680704|NCT00459615|Schistosomicides|schistosomicides|mesh-ancestor
92680705|NCT00459615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92680775|NCT01058642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92680776|NCT01058642|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92680777|NCT01058642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92680778|NCT01058642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92680845|NCT00427310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92680846|NCT00427310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92680855|NCT00427388|Prednisolone|prednisolone|mesh-list
92680916|NCT00469053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92680917|NCT00469053|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92680918|NCT00469131|Mycophenolic Acid|mycophenolic acid|mesh-list
92680987|NCT00428558|Antiviral Agents|antiviral agents|mesh-ancestor
92681028|NCT00460707|Casopitant|casopitant|mesh-list
92681060|NCT00460785|Sensory System Agents|sensory system agents|mesh-ancestor
92681073|NCT00469443|Leucovorin|leucovorin|mesh-list
92681136|NCT00469716|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92681213|NCT00430118|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92681214|NCT00430118|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92681215|NCT00430118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92681284|NCT00461643|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92681285|NCT00461643|Chelating Agents|chelating agents|mesh-ancestor
92681286|NCT00461643|Sequestering Agents|sequestering agents|mesh-ancestor
92681287|NCT00461643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100998|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
92681288|NCT00461643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92681289|NCT00461643|Hormone Antagonists|hormone antagonists|mesh-ancestor
92681290|NCT00461643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92681291|NCT00461643|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92681292|NCT00461643|Fertility Agents|fertility agents|mesh-ancestor
92681293|NCT00461643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92681294|NCT00461643|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92681295|NCT00461643|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92681296|NCT00430547|Carbimazole|carbimazole|mesh-list
92681297|NCT00430547|Antithyroid Agents|antithyroid agents|mesh-ancestor
92681298|NCT00430547|Hormone Antagonists|hormone antagonists|mesh-ancestor
92681300|NCT00430547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681335|NCT00470457|Immunologic Factors|immunologic factors|mesh-ancestor
92681336|NCT00470457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681337|NCT03271164|Vitamin E|vitamin e|mesh-list
92681338|NCT03271164|Vitamins|vitamins|mesh-ancestor
92681339|NCT03271164|Micronutrients|micronutrients|mesh-ancestor
92681340|NCT03271164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681341|NCT03271164|Antioxidants|antioxidants|mesh-ancestor
92681342|NCT03271164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681343|NCT03271164|Protective Agents|protective agents|mesh-ancestor
92681344|NCT00430898|Basiliximab|basiliximab|mesh-list
92681345|NCT00430898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681346|NCT00430898|Immunologic Factors|immunologic factors|mesh-ancestor
92399775|NCT01405118|Metformin|metformin|mesh-list
92681347|NCT00430898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681348|NCT00461916|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92681349|NCT00461916|Buserelin|buserelin|mesh-list
92681350|NCT00461916|Luteolytic Agents|luteolytic agents|mesh-ancestor
92681352|NCT00461916|Contraceptive Agents|contraceptive agents|mesh-ancestor
92681392|NCT00431210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681393|NCT00431249|Cilostazol|cilostazol|mesh-list
92681464|NCT00431678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681465|NCT00431678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92681475|NCT00471003|Telmisartan|telmisartan|mesh-list
92681610|NCT00471393|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92681611|NCT00471393|Protective Agents|protective agents|mesh-ancestor
92681612|NCT00471393|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92681613|NCT00471393|Antioxidants|antioxidants|mesh-ancestor
92681682|NCT00471510|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92681683|NCT00471510|Protease Inhibitors|protease inhibitors|mesh-ancestor
92681684|NCT00471510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681753|NCT00471588|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92681754|NCT00471588|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92681827|NCT01051661|Immunologic Factors|immunologic factors|mesh-ancestor
92681836|NCT01051466|Analgesics|analgesics|mesh-ancestor
92681900|NCT00591526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92681901|NCT00591526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92681974|NCT00464217|Idarubicin|idarubicin|mesh-list
92681975|NCT00464217|Molgramostim|molgramostim|mesh-list
92681976|NCT00464217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92681977|NCT00464217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92681978|NCT00464217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92681979|NCT00464217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92681980|NCT00464217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92681981|NCT00464217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681982|NCT00433784|Clopidogrel|clopidogrel|mesh-list
92681983|NCT00433784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92681984|NCT00433784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92681985|NCT00433784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92681986|NCT00433784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92681987|NCT00433784|Purinergic Agents|purinergic agents|mesh-ancestor
92681988|NCT00433784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92681989|NCT00433784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92681990|NCT00433784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92681991|NCT00464256|Rimonabant|rimonabant|mesh-list
92682027|NCT04702685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682100|NCT00434096|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92682101|NCT00434096|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92682102|NCT00434096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682103|NCT00434096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682105|NCT00434096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92682106|NCT00434096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682107|NCT01050569|Nicotine|nicotine|mesh-list
92682108|NCT01050569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92682109|NCT01050569|Autonomic Agents|autonomic agents|mesh-ancestor
92682110|NCT01050569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682111|NCT01050569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682112|NCT01050569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92682113|NCT01050569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92682114|NCT01050569|Cholinergic Agents|cholinergic agents|mesh-ancestor
92682155|NCT01050257|Oseltamivir|oseltamivir|mesh-list
92682156|NCT01050257|Antiviral Agents|antiviral agents|mesh-ancestor
92682157|NCT01050257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682226|NCT00464958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682227|NCT00464958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682228|NCT00472758|Sifalimumab|sifalimumab|mesh-list
92682229|NCT00472758|Immunologic Factors|immunologic factors|mesh-ancestor
92682230|NCT00472758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682231|NCT01055444|Lidocaine|lidocaine|mesh-list
92682232|NCT01055444|Tetracaine|tetracaine|mesh-list
92682233|NCT01055444|Anesthetics, Local|anesthetics, local|mesh-ancestor
92682234|NCT01055444|Anesthetics|anesthetics|mesh-ancestor
92682235|NCT01055444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682236|NCT01055444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682237|NCT01055444|Sensory System Agents|sensory system agents|mesh-ancestor
92682238|NCT01055444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682288|NCT00465036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682289|NCT04702061|Anesthetics|anesthetics|mesh-list
92682292|NCT00465075|Bazedoxifene|bazedoxifene|mesh-list
92682358|NCT00473460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682360|NCT00473460|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92682361|NCT00473460|Contraceptive Agents|contraceptive agents|mesh-ancestor
92682362|NCT00473460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92682363|NCT00473460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682364|NCT00473460|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92682365|NCT00473460|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92682366|NCT00473460|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92682367|NCT00435305|Vancomycin|vancomycin|mesh-list
92682368|NCT00435305|Meropenem|meropenem|mesh-list
92682421|NCT02957474|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92682422|NCT02957474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92682423|NCT02957474|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92682424|NCT02957474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682425|NCT02957474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682426|NCT00465231|Fentanyl|fentanyl|mesh-list
92682427|NCT00465231|Bupivacaine|bupivacaine|mesh-list
92682428|NCT00465231|Anesthetics, Local|anesthetics, local|mesh-ancestor
92682429|NCT00465231|Anesthetics|anesthetics|mesh-ancestor
92682430|NCT00465231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92682431|NCT00465231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92682432|NCT00465231|Sensory System Agents|sensory system agents|mesh-ancestor
92682433|NCT00465231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92682434|NCT00465231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92682435|NCT00465231|Narcotics|narcotics|mesh-ancestor
92682436|NCT00465231|Analgesics|analgesics|mesh-ancestor
92682437|NCT00465231|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92682438|NCT00465231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92682439|NCT00465231|Anesthetics, General|anesthetics, general|mesh-ancestor
92682440|NCT00436241|Capecitabine|capecitabine|mesh-list
92682441|NCT00436241|Oxaliplatin|oxaliplatin|mesh-list
92682477|NCT00481572|Natriuretic Agents|natriuretic agents|mesh-ancestor
92682495|NCT04697745|Hormones|hormones|mesh-ancestor
92682622|NCT00482079|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92682696|NCT00437957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682830|NCT00438269|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92682831|NCT00438269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92682832|NCT00438269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92682833|NCT00438269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92682834|NCT00438269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92682835|NCT00438269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92682836|NCT00438269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92682837|NCT00438269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682838|NCT00438269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682839|NCT00438269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92682840|NCT00438269|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92682841|NCT00438269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92682891|NCT00475059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92682892|NCT00475059|Histamine Antagonists|histamine antagonists|mesh-ancestor
92682893|NCT00475059|Histamine Agents|histamine agents|mesh-ancestor
92682894|NCT00475059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682895|NCT00475059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682899|NCT00475059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92682960|NCT00438776|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92682961|NCT00438776|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92682962|NCT00438776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92682963|NCT00438776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92682964|NCT00438776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92682965|NCT00438776|Serotonin Agents|serotonin agents|mesh-ancestor
92682966|NCT00475410|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92682967|NCT00475410|Hemostatics|hemostatics|mesh-ancestor
92682968|NCT00475410|Coagulants|coagulants|mesh-ancestor
92682969|NCT00475527|Amoxicillin|amoxicillin|mesh-list
92682970|NCT00475527|Metronidazole|metronidazole|mesh-list
92682971|NCT00475527|Clarithromycin|clarithromycin|mesh-list
92682972|NCT00475527|Omeprazole|omeprazole|mesh-list
92682975|NCT00475527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92683022|NCT00439166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92683023|NCT00439166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92683024|NCT00439166|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92683025|NCT00439166|Antitubercular Agents|antitubercular agents|mesh-ancestor
92683026|NCT00439166|Leprostatic Agents|leprostatic agents|mesh-ancestor
92683027|NCT00439166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683028|NCT00439166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683029|NCT00439166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683030|NCT00439166|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92683031|NCT00439166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92683032|NCT00439166|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92683033|NCT00439166|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92683034|NCT00439166|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92683035|NCT00439166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92683036|NCT00439283|Infliximab|infliximab|mesh-list
92683037|NCT00439283|Methotrexate|methotrexate|mesh-list
92683078|NCT00439361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683151|NCT00476268|Hormones|hormones|mesh-ancestor
92683152|NCT00476268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683153|NCT00105989|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92683160|NCT00105989|Analgesics|analgesics|mesh-ancestor
92683219|NCT00439829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683220|NCT00439829|Hormone Antagonists|hormone antagonists|mesh-ancestor
92683221|NCT00439829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92683222|NCT03277248|Teriflunomide|teriflunomide|mesh-list
92683223|NCT03277248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683224|NCT03277248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683288|NCT00438321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683290|NCT00438321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92683291|NCT00476619|Epoetin Alfa|epoetin alfa|mesh-list
92683292|NCT00476619|Hematinics|hematinics|mesh-ancestor
92683293|NCT03279536|Lactoferrin|lactoferrin|mesh-list
92683358|NCT00440687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92683359|NCT00440687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92683360|NCT00440687|Dermatologic Agents|dermatologic agents|mesh-ancestor
92683361|NCT00440687|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92683362|NCT03271047|Nivolumab|nivolumab|mesh-list
92683363|NCT03271047|Ipilimumab|ipilimumab|mesh-list
92683364|NCT03271047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92683365|NCT03271047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683366|NCT03271047|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92683367|NCT03271047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683368|NCT00440765|Bortezomib|bortezomib|mesh-list
92683369|NCT00440765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683370|NCT00440804|Ibuprofen|ibuprofen|mesh-list
92683371|NCT00440804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92683372|NCT00440804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683373|NCT00440804|Analgesics|analgesics|mesh-ancestor
92683374|NCT00440804|Sensory System Agents|sensory system agents|mesh-ancestor
92683375|NCT00440804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683376|NCT00440804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683377|NCT00440804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92683378|NCT00440804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92683379|NCT00440804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92683380|NCT00440804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683381|NCT00440804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683382|NCT00440843|Olanzapine|olanzapine|mesh-list
92683383|NCT00440843|Antiemetics|antiemetics|mesh-ancestor
92683384|NCT00440843|Autonomic Agents|autonomic agents|mesh-ancestor
92683385|NCT00440843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683386|NCT00440843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683387|NCT00440843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92683388|NCT00440843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92683389|NCT00440843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92683400|NCT00438789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683401|NCT00438789|Immunologic Factors|immunologic factors|mesh-ancestor
92683402|NCT00438789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683403|NCT00440921|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92683404|NCT00440921|Hemostatics|hemostatics|mesh-ancestor
92683405|NCT00440921|Coagulants|coagulants|mesh-ancestor
92683406|NCT00440960|Lidocaine|lidocaine|mesh-list
92683407|NCT00440960|Midazolam|midazolam|mesh-list
92683408|NCT00440960|Alfentanil|alfentanil|mesh-list
92683409|NCT00440960|Propofol|propofol|mesh-list
92683410|NCT00440960|Anesthetics, Local|anesthetics, local|mesh-ancestor
92683411|NCT00440960|Anesthetics|anesthetics|mesh-ancestor
92683412|NCT00440960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92683413|NCT00440960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683414|NCT00440960|Sensory System Agents|sensory system agents|mesh-ancestor
92683415|NCT00440960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683416|NCT00440960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92683417|NCT00440960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92683418|NCT00440960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92683419|NCT00440960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683420|NCT00440960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683421|NCT00440960|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92683422|NCT00440960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92683423|NCT00440960|Anesthetics, General|anesthetics, general|mesh-ancestor
92683424|NCT00440960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92683425|NCT00440960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92683426|NCT00440960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92683427|NCT00440960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92683449|NCT00441155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683450|NCT00441155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683451|NCT00106002|Pemetrexed|pemetrexed|mesh-list
92683452|NCT00106002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92683453|NCT00106002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683454|NCT00106002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683515|NCT00439062|Roxithromycin|roxithromycin|mesh-list
92683516|NCT00439062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92683517|NCT00439062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92683518|NCT02957162|Atorvastatin|atorvastatin|mesh-list
92683519|NCT02957162|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92683520|NCT02957162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92683585|NCT03279146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92683586|NCT03279146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92683658|NCT00477789|Antimetabolites|antimetabolites|mesh-ancestor
92683659|NCT00477789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683660|NCT00477789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92683731|NCT00443105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92683732|NCT00443105|Immunologic Factors|immunologic factors|mesh-ancestor
92683733|NCT00443105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683802|NCT04700228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92683803|NCT04700228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92683804|NCT04700228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92683805|NCT04700228|Analgesics|analgesics|mesh-ancestor
92683806|NCT04700228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92683807|NCT04700228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92683808|NCT04700228|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92683809|NCT04700228|Adrenergic Agents|adrenergic agents|mesh-ancestor
92683810|NCT04700228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92683811|NCT04700228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683813|NCT00440427|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92683814|NCT00440427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92683815|NCT00440427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92683863|NCT00443573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92683936|NCT00441207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92683937|NCT00441207|Protective Agents|protective agents|mesh-ancestor
92683938|NCT00441207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92683939|NCT00441207|Vitamins|vitamins|mesh-ancestor
92683940|NCT00441207|Micronutrients|micronutrients|mesh-ancestor
92683941|NCT00444041|Bevacizumab|bevacizumab|mesh-list
92683942|NCT00444041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92684002|NCT00479076|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684003|NCT00479076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684004|NCT00441519|Aspirin|aspirin|mesh-list
92684005|NCT00441519|Omeprazole|omeprazole|mesh-list
92684006|NCT00441519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92684007|NCT00441519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92684008|NCT00441519|Analgesics|analgesics|mesh-ancestor
92684009|NCT00441519|Sensory System Agents|sensory system agents|mesh-ancestor
92684010|NCT00441519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684011|NCT00441519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684012|NCT00441519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92684013|NCT00441519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684014|NCT00441519|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92684015|NCT00441519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92684016|NCT00441519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684017|NCT00441519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92684018|NCT00441519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92684019|NCT00441519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684020|NCT00441519|Antipyretics|antipyretics|mesh-ancestor
92684021|NCT00441519|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92684022|NCT00441519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92684023|NCT00441519|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92684024|NCT00441597|Atorvastatin|atorvastatin|mesh-list
92684025|NCT00441597|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92684052|NCT00444314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684053|NCT00444314|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684054|NCT00444314|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92684055|NCT00444314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684056|NCT00444314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684122|NCT04700592|Anesthetics|anesthetics|mesh-ancestor
92684123|NCT04700592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684125|NCT04700592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92684195|NCT00479778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684267|NCT00442221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92684268|NCT00442221|Gout Suppressants|gout suppressants|mesh-ancestor
92684269|NCT00442221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92684270|NCT00442221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684271|NCT00442221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684272|NCT00442221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92684273|NCT00442221|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92684337|NCT03278652|Analgesics|analgesics|mesh-list
92684412|NCT00455234|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92684413|NCT00455234|Antipruritics|antipruritics|mesh-ancestor
92684414|NCT00455234|Dermatologic Agents|dermatologic agents|mesh-ancestor
92684415|NCT00455234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92684416|NCT00455234|Histamine Antagonists|histamine antagonists|mesh-ancestor
92684417|NCT00455234|Histamine Agents|histamine agents|mesh-ancestor
92684418|NCT00455234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92684419|NCT00455234|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92684420|NCT00455234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92684421|NCT00455234|Anesthetics, Local|anesthetics, local|mesh-ancestor
92684477|NCT00455585|Antimetabolites|antimetabolites|mesh-ancestor
92684478|NCT00455624|Androgens|androgens|mesh-list
92684479|NCT00455624|Hormones|hormones|mesh-ancestor
92684480|NCT00455624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684481|NCT00455624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684482|NCT00455897|Rituximab|rituximab|mesh-list
92684547|NCT04700475|Sodium Citrate|sodium citrate|mesh-list
92684548|NCT04700475|Anticoagulants|anticoagulants|mesh-ancestor
92684549|NCT04700475|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92684550|NCT04700475|Chelating Agents|chelating agents|mesh-ancestor
92684551|NCT04700475|Sequestering Agents|sequestering agents|mesh-ancestor
92684552|NCT04700475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684553|NCT04700436|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92684554|NCT04700436|Ezetimibe|ezetimibe|mesh-list
92684555|NCT04700436|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92684556|NCT04700436|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92684557|NCT04700436|Antimetabolites|antimetabolites|mesh-ancestor
92684558|NCT04700436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684559|NCT04700436|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92684560|NCT04700436|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92684561|NCT04700436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92684562|NCT00480597|Gemcitabine|gemcitabine|mesh-list
92684563|NCT00480597|Capecitabine|capecitabine|mesh-list
92684564|NCT00480597|Vinorelbine|vinorelbine|mesh-list
92684565|NCT00480597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684566|NCT00480597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92684567|NCT00480597|Antimetabolites|antimetabolites|mesh-ancestor
92684568|NCT00480597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684569|NCT00480597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92684570|NCT00480597|Tubulin Modulators|tubulin modulators|mesh-ancestor
92684571|NCT00480597|Antimitotic Agents|antimitotic agents|mesh-ancestor
92684572|NCT00480597|Mitosis Modulators|mitosis modulators|mesh-ancestor
92684596|NCT00480675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92684597|NCT00480675|Glucocorticoids|glucocorticoids|mesh-ancestor
92684598|NCT00480675|Hormones|hormones|mesh-ancestor
92684599|NCT00480675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92684600|NCT00480675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92684601|NCT00480675|Protective Agents|protective agents|mesh-ancestor
92684602|NCT00480675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92684603|NCT00480675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684604|NCT00456560|Fluvoxamine|fluvoxamine|mesh-list
92684605|NCT00456560|Paroxetine|paroxetine|mesh-list
92684606|NCT00456560|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92684657|NCT00456872|Sensory System Agents|sensory system agents|mesh-ancestor
92684658|NCT00456872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684664|NCT00480753|Nitroglycerin|nitroglycerin|mesh-list
92684728|NCT00443508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684729|NCT00457340|Atorvastatin|atorvastatin|mesh-list
92684730|NCT00457340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92684731|NCT00457340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92684732|NCT00457340|Antimetabolites|antimetabolites|mesh-ancestor
92684733|NCT00457340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684734|NCT00457340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92684737|NCT03278379|Avelumab|avelumab|mesh-list
92684795|NCT00458081|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92684796|NCT00458081|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92684797|NCT00458081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684799|NCT00458081|Hormones|hormones|mesh-ancestor
92684866|NCT00458510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92684867|NCT00458510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684868|NCT00458510|Analgesics|analgesics|mesh-ancestor
92684869|NCT00458510|Sensory System Agents|sensory system agents|mesh-ancestor
92684870|NCT00458510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92684871|NCT00458510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92684872|NCT00458510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92684873|NCT00458510|Anesthetics, General|anesthetics, general|mesh-ancestor
92684928|NCT03278262|Aflibercept|aflibercept|mesh-list
92684929|NCT03278262|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92684930|NCT03278262|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92684931|NCT03278262|Growth Substances|growth substances|mesh-ancestor
92684932|NCT03278262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92684933|NCT03278262|Growth Inhibitors|growth inhibitors|mesh-ancestor
92684934|NCT03278262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92684935|NCT00459485|Zinc Sulfate|zinc sulfate|mesh-list
92684936|NCT00459485|Astringents|astringents|mesh-ancestor
92684995|NCT00488670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92684996|NCT00488670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92684997|NCT00488670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92684998|NCT00488670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92684999|NCT00488670|Serotonin Agents|serotonin agents|mesh-ancestor
92685000|NCT00488670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685001|NCT00459836|Gemcitabine|gemcitabine|mesh-list
92685002|NCT00459836|Docetaxel|docetaxel|mesh-list
92104751|NCT01595854|Dabigatran|dabigatran|mesh-list
92685004|NCT00459836|Antimetabolites|antimetabolites|mesh-ancestor
92685005|NCT00459836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685006|NCT00459836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685056|NCT00460226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92685057|NCT00460226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685058|NCT00460226|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92685059|NCT00460226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92685060|NCT00460226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685061|NCT00460226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92685125|NCT00460616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685126|NCT00460616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685127|NCT00460616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685128|NCT00495651|Isoniazid|isoniazid|mesh-list
92685129|NCT00495651|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92685130|NCT00495651|Antitubercular Agents|antitubercular agents|mesh-ancestor
92685131|NCT00495651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92685132|NCT00495651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92685133|NCT00495651|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92685134|NCT00495651|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92685135|NCT00495651|Antimetabolites|antimetabolites|mesh-ancestor
92685136|NCT00495651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685137|NCT00495651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92685138|NCT00495651|Antiviral Agents|antiviral agents|mesh-ancestor
92685139|NCT00460733|Vitamin D|vitamin d|mesh-list
92685140|NCT00460733|Cholecalciferol|cholecalciferol|mesh-list
92685141|NCT00460733|Risedronic Acid|risedronic acid|mesh-list
92685142|NCT00460733|Calcium|calcium|mesh-list
92685143|NCT00460733|Vitamins|vitamins|mesh-ancestor
92685144|NCT00460733|Micronutrients|micronutrients|mesh-ancestor
92685145|NCT00460733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685148|NCT00460733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92685177|NCT00495846|Octreotide|octreotide|mesh-list
92685178|NCT00495846|Lanreotide|lanreotide|mesh-list
92685179|NCT00495846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92685180|NCT00495846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92685181|NCT00495846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685182|NCT00105482|Naltrexone|naltrexone|mesh-list
92685183|NCT00105482|Nicotine|nicotine|mesh-list
92685184|NCT00105482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92685185|NCT00105482|Autonomic Agents|autonomic agents|mesh-ancestor
92685186|NCT00105482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685187|NCT00105482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685188|NCT00105482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92685189|NCT00105482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92685190|NCT00105482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92685191|NCT00105482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685196|NCT00496002|Adefovir|adefovir|mesh-list
92685239|NCT00496275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685240|NCT00496275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685241|NCT00496275|Antimetabolites|antimetabolites|mesh-ancestor
92685242|NCT00496275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685311|NCT00461825|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92685312|NCT00461825|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92685313|NCT00461825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685385|NCT00591916|Hemostatics|hemostatics|mesh-ancestor
92685386|NCT00591916|Coagulants|coagulants|mesh-ancestor
92685457|NCT00463073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685458|NCT00463073|Growth Inhibitors|growth inhibitors|mesh-ancestor
92685459|NCT00463073|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92685460|NCT00463073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92685528|NCT00463541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685531|NCT00463541|Urological Agents|urological agents|mesh-ancestor
92685602|NCT00463736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105342|NCT03357900|Propofol|propofol|mesh-list
92685673|NCT00497562|Serotonin Agents|serotonin agents|mesh-ancestor
92685748|NCT00464165|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92685749|NCT00464165|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92685750|NCT00464165|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92685751|NCT00464165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92685752|NCT00464165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685753|NCT00464165|Hormones|hormones|mesh-ancestor
92685754|NCT00464165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92685755|NCT00464165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685756|NCT00497913|Botulinum Toxins|botulinum toxins|mesh-list
92685757|NCT00497913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92685758|NCT00497913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92685808|NCT00498108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685809|NCT00498108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685810|NCT00464321|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92685811|NCT00464321|Immunologic Factors|immunologic factors|mesh-ancestor
92685812|NCT00464321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685813|NCT00498225|Gemcitabine|gemcitabine|mesh-list
92685814|NCT00498225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92685815|NCT00498225|Antimetabolites|antimetabolites|mesh-ancestor
92685816|NCT00498225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92685817|NCT00498225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92685873|NCT01243359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92685874|NCT01243359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92685875|NCT01243359|Growth Substances|growth substances|mesh-ancestor
92685944|NCT01327573|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92685945|NCT01327573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92685946|NCT01327573|Immunologic Factors|immunologic factors|mesh-ancestor
92685947|NCT01327573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685949|NCT02893384|Anesthetics, Local|anesthetics, local|mesh-list
92685950|NCT02893384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92685951|NCT02893384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92685952|NCT02893384|Sensory System Agents|sensory system agents|mesh-ancestor
92685953|NCT02893384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92685954|NCT02893228|Levobupivacaine|levobupivacaine|mesh-list
92685955|NCT02893228|Anesthetics, Local|anesthetics, local|mesh-ancestor
92686005|NCT00467012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686006|NCT00467012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92686008|NCT00467012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92686009|NCT00467012|Growth Substances|growth substances|mesh-ancestor
92686075|NCT00592111|Bleomycin|bleomycin|mesh-list
92686076|NCT00592111|Vinblastine|vinblastine|mesh-list
92686150|NCT00491790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686151|NCT00491790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686152|NCT00491790|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92686153|NCT00491790|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92686154|NCT00491790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686155|NCT03272009|Interferons|interferons|mesh-list
92686156|NCT03272009|Interferon-alpha|interferon-alpha|mesh-list
92686157|NCT03272009|Interferon alpha-2|interferon alpha-2|mesh-list
92686158|NCT03272009|Entecavir|entecavir|mesh-list
92686159|NCT03272009|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92686160|NCT03272009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686161|NCT03272009|Antiviral Agents|antiviral agents|mesh-ancestor
92686162|NCT03272009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686163|NCT03272009|Immunologic Factors|immunologic factors|mesh-ancestor
92686164|NCT03272009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686165|NCT00498888|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92686209|NCT02892916|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92686210|NCT02892916|Anesthetics, General|anesthetics, general|mesh-ancestor
92686212|NCT02892916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92686213|NCT02892916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92686214|NCT02892916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92686215|NCT02892916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686216|NCT02892916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686217|NCT00492102|Montelukast|montelukast|mesh-list
92686218|NCT00492102|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92686219|NCT00492102|Respiratory System Agents|respiratory system agents|mesh-ancestor
92686220|NCT00492102|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92686221|NCT00492102|Hormone Antagonists|hormone antagonists|mesh-ancestor
92686222|NCT00492102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686223|NCT00492102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686224|NCT00492102|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92686225|NCT00492102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92686226|NCT00492102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686261|NCT00492219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686262|NCT00492219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686263|NCT00492219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686264|NCT00492219|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92686265|NCT00492219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92686266|NCT00492219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686267|NCT00465257|Artesunate|artesunate|mesh-list
92686268|NCT00465257|Amodiaquine|amodiaquine|mesh-list
92686269|NCT00465257|Antimalarials|antimalarials|mesh-ancestor
92686270|NCT00465257|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92686271|NCT00465257|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92686272|NCT00465257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686273|NCT00465257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686322|NCT00492414|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92686323|NCT00492414|Antidepressive Agents|antidepressive agents|mesh-ancestor
92686324|NCT00492414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92686325|NCT00492414|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92686326|NCT00492414|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92686327|NCT00492414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686328|NCT01243632|Gemcitabine|gemcitabine|mesh-list
92686329|NCT01243632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92686330|NCT01243632|Antimetabolites|antimetabolites|mesh-ancestor
92686331|NCT01243632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686332|NCT01243632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686333|NCT00467909|Micronutrients|micronutrients|mesh-list
92686334|NCT00467909|Trace Elements|trace elements|mesh-list
92686335|NCT00467909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686336|NCT04327453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92686337|NCT04327453|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92686338|NCT04327453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686339|NCT04327453|Antitubercular Agents|antitubercular agents|mesh-ancestor
92686340|NCT00467948|Cefazolin|cefazolin|mesh-list
92686341|NCT00467948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92686342|NCT00467948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686343|NCT00592579|2-Methoxyestradiol|2-methoxyestradiol|mesh-list
92686344|NCT00592579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686345|NCT00592579|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686346|NCT00592579|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686347|NCT00592579|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686348|NCT00592579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686349|NCT00592618|Acetylcysteine|acetylcysteine|mesh-list
92686350|NCT00592618|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92686351|NCT00592618|Antiviral Agents|antiviral agents|mesh-ancestor
92686367|NCT01243710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686368|NCT01243710|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92686369|NCT01243710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686371|NCT00622843|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92686372|NCT00622843|Immunologic Factors|immunologic factors|mesh-ancestor
92686373|NCT00622843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686374|NCT01245543|Docetaxel|docetaxel|mesh-list
92686434|NCT00593125|Anticonvulsants|anticonvulsants|mesh-ancestor
92686435|NCT00593125|Nootropic Agents|nootropic agents|mesh-ancestor
92686436|NCT00593164|Magnesium Sulfate|magnesium sulfate|mesh-list
92686507|NCT01379521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686508|NCT00468260|Epothilone B|epothilone b|mesh-list
92686509|NCT00468260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686510|NCT00468260|Tubulin Modulators|tubulin modulators|mesh-ancestor
92686511|NCT00468260|Antimitotic Agents|antimitotic agents|mesh-ancestor
92686512|NCT00468260|Mitosis Modulators|mitosis modulators|mesh-ancestor
92686513|NCT00468260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686514|NCT01371994|Solifenacin Succinate|solifenacin succinate|mesh-list
92686515|NCT01371994|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92686516|NCT01371994|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92686517|NCT01371994|Cholinergic Agents|cholinergic agents|mesh-ancestor
92686518|NCT01371994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686519|NCT01371994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686520|NCT01371994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686521|NCT01371994|Urological Agents|urological agents|mesh-ancestor
92686522|NCT00465608|Propranolol|propranolol|mesh-list
92686523|NCT00465608|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92686524|NCT00465608|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92686525|NCT00465608|Adrenergic Agents|adrenergic agents|mesh-ancestor
92686526|NCT00465608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92686527|NCT00465608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686528|NCT00465608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686529|NCT00465608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92686530|NCT00465608|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92686531|NCT00465608|Vasodilator Agents|vasodilator agents|mesh-ancestor
92686532|NCT01371877|Vitamin D|vitamin d|mesh-list
92686533|NCT01371877|Ergocalciferols|ergocalciferols|mesh-list
92686534|NCT01371877|Cholecalciferol|cholecalciferol|mesh-list
92686550|NCT01245816|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92686551|NCT01245816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92686552|NCT01245816|Analgesics|analgesics|mesh-ancestor
92686553|NCT01245816|Sensory System Agents|sensory system agents|mesh-ancestor
92686554|NCT01245816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686555|NCT01245816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686556|NCT01245816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686557|NCT01245816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92686558|NCT01245816|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92686560|NCT00492687|Carboplatin|carboplatin|mesh-list
92686561|NCT00492687|Temozolomide|temozolomide|mesh-list
92686562|NCT00492687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686563|NCT00492687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686564|NCT00492687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92686565|NCT00492687|Alkylating Agents|alkylating agents|mesh-ancestor
92686566|NCT00492687|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92686567|NCT00492687|Hormone Antagonists|hormone antagonists|mesh-ancestor
92686568|NCT00492687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686569|NCT00492687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686570|NCT00492687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92686571|NCT00492687|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92686572|NCT00492687|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92686574|NCT01371838|Ceftriaxone|ceftriaxone|mesh-list
92686599|NCT00492765|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92686600|NCT00492765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686601|NCT00492765|Immunologic Factors|immunologic factors|mesh-ancestor
92686602|NCT00492765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686603|NCT00492765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92686604|NCT00468533|Aripiprazole|aripiprazole|mesh-list
92686612|NCT00468533|Dopamine Agents|dopamine agents|mesh-ancestor
92686666|NCT01605487|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92686667|NCT01605487|Serotonin Agents|serotonin agents|mesh-ancestor
92686668|NCT01605487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92686669|NCT01365910|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92686670|NCT01365910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92686671|NCT01365910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686672|NCT01365910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686673|NCT01605526|Doxorubicin|doxorubicin|mesh-list
92686674|NCT01605526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92686675|NCT01605526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686676|NCT01605526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92686677|NCT01605526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92686678|NCT01605526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686679|NCT01605526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686680|NCT00468689|Ketoconazole|ketoconazole|mesh-list
92686681|NCT00468689|Antifungal Agents|antifungal agents|mesh-ancestor
92686682|NCT00468689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686683|NCT00468689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92686684|NCT00468689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92686685|NCT00468689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92686686|NCT00468689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92686687|NCT00468689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92686688|NCT00468689|Hormone Antagonists|hormone antagonists|mesh-ancestor
92686689|NCT00468689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92686690|NCT00468689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686691|NCT00468689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92686692|NCT00473915|Fluticasone|fluticasone|mesh-list
92686693|NCT00473915|Xhance|xhance|mesh-list
92686694|NCT00473915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686695|NCT00473915|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92686696|NCT00473915|Autonomic Agents|autonomic agents|mesh-ancestor
92686703|NCT00493077|Interferons|interferons|mesh-list
92686706|NCT00493077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92686708|NCT00493077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92686778|NCT00493116|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92686854|NCT00493233|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92686855|NCT00493233|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92686856|NCT00493233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92686858|NCT00493233|GABA Antagonists|gaba antagonists|mesh-ancestor
92686859|NCT00493233|GABA Agents|gaba agents|mesh-ancestor
92686860|NCT00500253|Nitric Oxide|nitric oxide|mesh-list
92686861|NCT00500253|Methacholine Chloride|methacholine chloride|mesh-list
92686862|NCT00500253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92686883|NCT01243788|Xhance|xhance|mesh-list
92686919|NCT01243827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92686920|NCT01243827|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92686921|NCT00500409|Vitamin D|vitamin d|mesh-list
92686922|NCT00500409|Vitamins|vitamins|mesh-ancestor
92686923|NCT00500409|Micronutrients|micronutrients|mesh-ancestor
92686924|NCT00500409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686925|NCT00500409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92686926|NCT00469352|Ranibizumab|ranibizumab|mesh-list
92686927|NCT00469352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92686928|NCT00469352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92686929|NCT00469352|Growth Substances|growth substances|mesh-ancestor
92686930|NCT00469352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92686931|NCT00469352|Growth Inhibitors|growth inhibitors|mesh-ancestor
92686933|NCT00469430|Metronidazole|metronidazole|mesh-list
92686981|NCT00500721|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92686982|NCT00500721|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687054|NCT00469664|Adrenergic Agents|adrenergic agents|mesh-ancestor
92687070|NCT01244100|Aspirin|aspirin|mesh-list
92687128|NCT00474773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92687129|NCT00474773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687130|NCT00474773|Analgesics|analgesics|mesh-ancestor
92687131|NCT00474773|Sensory System Agents|sensory system agents|mesh-ancestor
92687132|NCT00474773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687133|NCT00474773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687134|NCT00474773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92687135|NCT00474773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687136|NCT00474773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92687137|NCT00474773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92687138|NCT00474773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687139|NCT00474773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687140|NCT00474890|Pseudoephedrine|pseudoephedrine|mesh-list
92687141|NCT00474890|Ephedrine|ephedrine|mesh-list
92687142|NCT00474890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92687143|NCT00474890|Autonomic Agents|autonomic agents|mesh-ancestor
92687144|NCT00474890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687145|NCT00474890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687146|NCT00474890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92687147|NCT00474890|Respiratory System Agents|respiratory system agents|mesh-ancestor
92687148|NCT00474890|Nasal Decongestants|nasal decongestants|mesh-ancestor
92687149|NCT00474890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92687150|NCT00474890|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92687151|NCT00474890|Sympathomimetics|sympathomimetics|mesh-ancestor
92687152|NCT00474890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92687153|NCT00474890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687154|NCT00474890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687155|NCT00501111|Donepezil|donepezil|mesh-list
92687156|NCT00501111|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92687157|NCT00501111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687158|NCT00501111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687169|NCT01340209|Tiotropium Bromide|tiotropium bromide|mesh-list
92687170|NCT01340209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92687241|NCT00599287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687242|NCT00599287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92687243|NCT00599287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92687244|NCT00599287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92687245|NCT00599287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92687246|NCT00599287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687247|NCT00599287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92687248|NCT00599287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92687249|NCT00599287|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92687250|NCT00599287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687251|NCT00599287|Cholinergic Agents|cholinergic agents|mesh-ancestor
92687252|NCT00599287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92687253|NCT00599287|Protective Agents|protective agents|mesh-ancestor
92687255|NCT04326166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92687256|NCT04326166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687257|NCT00501384|Satavaptan|satavaptan|mesh-list
92687258|NCT00501384|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92687259|NCT00501384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687260|NCT00501384|Natriuretic Agents|natriuretic agents|mesh-ancestor
92687262|NCT00599560|Vasopressins|vasopressins|mesh-list
92687295|NCT00469976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92687296|NCT00469976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687297|NCT00469976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687298|NCT00469976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687299|NCT00469976|Growth Substances|growth substances|mesh-ancestor
92687300|NCT00469976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687301|NCT00469976|Growth Inhibitors|growth inhibitors|mesh-ancestor
92687302|NCT00469976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687303|NCT00469976|Antimetabolites|antimetabolites|mesh-ancestor
92687304|NCT00469976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687305|NCT00599911|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92687306|NCT00599911|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92687307|NCT00599911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92687308|NCT00599911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92687309|NCT00599911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687310|NCT00599911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687311|NCT00599911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687312|NCT00599911|Analgesics|analgesics|mesh-ancestor
92687313|NCT00599911|Sensory System Agents|sensory system agents|mesh-ancestor
92687314|NCT00599911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687315|NCT00599911|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687316|NCT00599911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687317|NCT00599911|Dopamine Agents|dopamine agents|mesh-ancestor
92687318|NCT00599950|Mitomycins|mitomycins|mesh-list
92687319|NCT00599950|Mitomycin|mitomycin|mesh-list
92687320|NCT00599950|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92687321|NCT00599950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687322|NCT00599950|Alkylating Agents|alkylating agents|mesh-ancestor
92687323|NCT00599950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107077|NCT01786109|Analgesics|analgesics|mesh-ancestor
92687335|NCT00600145|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92687336|NCT00600145|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92687408|NCT00501618|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92687409|NCT00501618|Serotonin Agents|serotonin agents|mesh-ancestor
92687410|NCT00501618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687411|NCT00501618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687413|NCT00501618|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92687478|NCT00623155|Pyrimethamine|pyrimethamine|mesh-list
92687479|NCT00623155|Sulfadoxine|sulfadoxine|mesh-list
92687480|NCT00623155|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92687481|NCT00623155|Antimalarials|antimalarials|mesh-ancestor
92687482|NCT00623155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92687546|NCT00475397|Sensory System Agents|sensory system agents|mesh-ancestor
92687547|NCT00475397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687548|NCT00475397|Antidepressive Agents|antidepressive agents|mesh-ancestor
92687549|NCT00475397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92687550|NCT00475397|Dopamine Agents|dopamine agents|mesh-ancestor
92687552|NCT00601042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92687553|NCT00601042|Autonomic Agents|autonomic agents|mesh-ancestor
92687554|NCT00601042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92687555|NCT00601042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687556|NCT00601042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92687557|NCT00601042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92687558|NCT00601042|Cholinergic Agents|cholinergic agents|mesh-ancestor
92687611|NCT04325893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92687612|NCT04325893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92687613|NCT04325893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92687615|NCT04325893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92687680|NCT00470405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92687682|NCT00601978|Carbidopa|carbidopa|mesh-list
92687683|NCT00601978|Entacapone|entacapone|mesh-list
92687687|NCT00601978|Dopamine Agents|dopamine agents|mesh-ancestor
92687749|NCT00475553|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92687750|NCT00475553|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92687751|NCT00475553|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92687752|NCT00475553|Progestins|progestins|mesh-ancestor
92687753|NCT01326481|Capecitabine|capecitabine|mesh-list
92687754|NCT01326481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92687755|NCT01326481|Antimetabolites|antimetabolites|mesh-ancestor
92687756|NCT01326481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687757|NCT01326481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687816|NCT00502437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92687817|NCT00502437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92687818|NCT00502437|Serotonin Agents|serotonin agents|mesh-ancestor
92687819|NCT00502437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92687820|NCT00502437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92687821|NCT00470678|Ranibizumab|ranibizumab|mesh-list
92687822|NCT00470678|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92687823|NCT00470678|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92687824|NCT00470678|Growth Substances|growth substances|mesh-ancestor
92687825|NCT00470678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687880|NCT00476138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687881|NCT00476138|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92687882|NCT00476138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92687883|NCT00476138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92687884|NCT00476138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92687885|NCT02956083|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92687886|NCT02956083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92687887|NCT00470990|Acyline|acyline|mesh-list
92687888|NCT00470990|Hormone Antagonists|hormone antagonists|mesh-ancestor
92687889|NCT00470990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92687890|NCT00470990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92687891|NCT01246440|Catumaxomab|catumaxomab|mesh-list
92687893|NCT00471029|Esomeprazole|esomeprazole|mesh-list
92687941|NCT00471341|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92687942|NCT00471341|Analgesics|analgesics|mesh-ancestor
92687947|NCT00471341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92688015|NCT01324141|Immunologic Factors|immunologic factors|mesh-ancestor
92688089|NCT00471809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688090|NCT00471809|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92688091|NCT00471809|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92688092|NCT00471809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688093|NCT00471809|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688094|NCT00471809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688095|NCT00471809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688096|NCT00471809|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92688097|NCT00471809|Hormone Antagonists|hormone antagonists|mesh-ancestor
92688098|NCT00471809|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92688099|NCT00471809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92688100|NCT00503490|Levofloxacin|levofloxacin|mesh-list
92688101|NCT00503490|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92688102|NCT00503490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688103|NCT00503490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92688104|NCT00503490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92688105|NCT00503490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92688106|NCT00503490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688107|NCT00503490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688143|NCT00472004|Anabolic Agents|anabolic agents|mesh-ancestor
92688145|NCT00494715|Benazepril|benazepril|mesh-list
92688146|NCT00494715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92688147|NCT00494715|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92688148|NCT00494715|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92688149|NCT00494715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688150|NCT00494715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92688151|NCT00494715|Protease Inhibitors|protease inhibitors|mesh-ancestor
92688152|NCT00494715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688153|NCT00472043|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92688154|NCT00472043|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92688209|NCT00477035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688210|NCT00477035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688211|NCT00477035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92688212|NCT00477035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92688213|NCT00477035|Antimetabolites|antimetabolites|mesh-ancestor
92688214|NCT00477035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92688215|NCT00477035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92688216|NCT00477035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92688217|NCT00477035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688226|NCT00494832|Analgesics|analgesics|mesh-ancestor
92688272|NCT01323634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688273|NCT01323634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688274|NCT05645302|Lidocaine|lidocaine|mesh-list
92688342|NCT00472472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92688343|NCT00472472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688344|NCT00472472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688414|NCT00477581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688415|NCT00477581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92688416|NCT00477737|Propofol|propofol|mesh-list
92688417|NCT00477737|Sevoflurane|sevoflurane|mesh-list
92688418|NCT00477737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92688419|NCT00477737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92688420|NCT00477737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688421|NCT00477737|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92688422|NCT00477737|Anesthetics, General|anesthetics, general|mesh-ancestor
92688423|NCT00477737|Anesthetics|anesthetics|mesh-ancestor
92688424|NCT00477737|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92688425|NCT00477737|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92688426|NCT00477776|Metoclopramide|metoclopramide|mesh-list
92688427|NCT00477776|Antiemetics|antiemetics|mesh-ancestor
92688428|NCT00477776|Autonomic Agents|autonomic agents|mesh-ancestor
92688431|NCT00477776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92688475|NCT00478049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688476|NCT00478049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92688549|NCT01321723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688550|NCT01321723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92688551|NCT00478634|Irinotecan|irinotecan|mesh-list
92688623|NCT00478985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688624|NCT00478985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688628|NCT00472823|Vitamin D|vitamin d|mesh-list
92688696|NCT01248273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688697|NCT00473174|Ramipril|ramipril|mesh-list
92688698|NCT00473174|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92688699|NCT00473174|Protease Inhibitors|protease inhibitors|mesh-ancestor
92688700|NCT00473174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688701|NCT00473174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688702|NCT00473174|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92688703|NCT00473213|Interferons|interferons|mesh-list
92688704|NCT00473213|Interferon-beta|interferon-beta|mesh-list
92688705|NCT00473213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688706|NCT00473213|Antiviral Agents|antiviral agents|mesh-ancestor
92688707|NCT00473213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688708|NCT00473213|Immunologic Factors|immunologic factors|mesh-ancestor
92688709|NCT00473213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688710|NCT01320202|Dialysis Solutions|dialysis solutions|mesh-list
92688711|NCT01320202|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92688712|NCT01319383|Vorinostat|vorinostat|mesh-list
92688713|NCT01319383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688714|NCT01319383|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92688751|NCT04325113|Sensory System Agents|sensory system agents|mesh-ancestor
92688752|NCT04325113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92688753|NCT05644717|Ertugliflozin|ertugliflozin|mesh-list
92688754|NCT05644717|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92688755|NCT05644717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688756|NCT05644717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92688757|NCT05644717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92688758|NCT02891161|Durvalumab|durvalumab|mesh-list
92688759|NCT02891161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92688760|NCT02891161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688813|NCT01315249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92688814|NCT01315249|Adrenergic Agents|adrenergic agents|mesh-ancestor
92688815|NCT01315249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92688816|NCT01315249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688817|NCT01315249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92688818|NCT01315249|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92688819|NCT01315249|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92688820|NCT01315249|Cholinergic Agents|cholinergic agents|mesh-ancestor
92688821|NCT01315249|Glucocorticoids|glucocorticoids|mesh-ancestor
92688822|NCT01315249|Hormones|hormones|mesh-ancestor
92688825|NCT04207411|Lidocaine|lidocaine|mesh-list
92688876|NCT01248858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688877|NCT01313728|Dapsone|dapsone|mesh-list
92688878|NCT01313728|Tretinoin|tretinoin|mesh-list
92688879|NCT01313728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92688880|NCT01313728|Keratolytic Agents|keratolytic agents|mesh-ancestor
92688881|NCT01313728|Dermatologic Agents|dermatologic agents|mesh-ancestor
92688882|NCT01313728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92688883|NCT01313728|Antimalarials|antimalarials|mesh-ancestor
92688884|NCT01313728|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92688885|NCT01313728|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92688886|NCT01313728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92688887|NCT01313728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688889|NCT01313728|Leprostatic Agents|leprostatic agents|mesh-ancestor
92688938|NCT00481481|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92688939|NCT00481481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92688940|NCT00481481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92688941|NCT04516317|Artesunate|artesunate|mesh-list
92688942|NCT04516317|Quinine|quinine|mesh-list
92688943|NCT04516317|Antimalarials|antimalarials|mesh-ancestor
92688944|NCT04516317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92688945|NCT04516317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92688946|NCT04516317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689002|NCT00504855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92689003|NCT00504855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689004|NCT00504855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689005|NCT00504933|Cetirizine|cetirizine|mesh-list
92689006|NCT00504933|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92689007|NCT00504933|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92689008|NCT00504933|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92689009|NCT00504933|Histamine Antagonists|histamine antagonists|mesh-ancestor
92689010|NCT00504933|Histamine Agents|histamine agents|mesh-ancestor
92689011|NCT00504933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689012|NCT00504933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689013|NCT00504933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689065|NCT00480194|Nasal Decongestants|nasal decongestants|mesh-ancestor
92689066|NCT00480194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92689067|NCT00505089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92689070|NCT00505167|Memantine|memantine|mesh-list
92689139|NCT00482222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689140|NCT00482222|Antimetabolites|antimetabolites|mesh-ancestor
92689141|NCT00482222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689212|NCT04518618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689213|NCT04518618|Analgesics|analgesics|mesh-ancestor
92689214|NCT04518618|Sensory System Agents|sensory system agents|mesh-ancestor
92689215|NCT04518618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689216|NCT04518618|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92689217|NCT04518618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92689218|NCT04518618|Anesthetics, General|anesthetics, general|mesh-ancestor
92689279|NCT01240655|Tubulin Modulators|tubulin modulators|mesh-ancestor
92689280|NCT01240655|Antimitotic Agents|antimitotic agents|mesh-ancestor
92689351|NCT00482573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92689352|NCT00482573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689353|NCT00482573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92689354|NCT00482573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92689355|NCT00482573|Adrenergic Agents|adrenergic agents|mesh-ancestor
92689356|NCT00482573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92689357|NCT00482573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689358|NCT00482573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92689359|NCT00482573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92689361|NCT00482573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92689364|NCT00482573|Mydriatics|mydriatics|mesh-ancestor
92689411|NCT04517526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92689412|NCT04517526|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92689413|NCT01309204|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92689481|NCT04517214|Capecitabine|capecitabine|mesh-list
92689482|NCT04517214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92689550|NCT00482963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92689551|NCT00482963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92689552|NCT00482963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92689553|NCT00482963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92689554|NCT00482963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92689555|NCT00482963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92689556|NCT00482963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92689557|NCT00482963|Contraceptive Agents|contraceptive agents|mesh-ancestor
92689558|NCT00482963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92689559|NCT00482963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689560|NCT00482963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92689561|NCT00482963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92689562|NCT00482963|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92689564|NCT01241019|Anticonvulsants|anticonvulsants|mesh-ancestor
92689565|NCT01241019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92689566|NCT01241019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92689605|NCT00487994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689606|NCT00487994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92689607|NCT00487994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92689608|NCT00487994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689627|NCT01308580|Prednisone|prednisone|mesh-list
92689676|NCT00488189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689680|NCT02956421|Vaccines|vaccines|mesh-list
92689751|NCT00483834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92689752|NCT00483834|Antimetabolites|antimetabolites|mesh-ancestor
92689753|NCT00483834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689756|NCT00483834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689822|NCT04515732|Analgesics|analgesics|mesh-ancestor
92689823|NCT04515732|Sensory System Agents|sensory system agents|mesh-ancestor
92689827|NCT04515732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92689894|NCT01303861|Bupropion|bupropion|mesh-list
92689895|NCT01303861|Nicotine|nicotine|mesh-list
92689965|NCT00484055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92689966|NCT00484055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92689967|NCT00484055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92689968|NCT00484055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92689969|NCT00484055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92689970|NCT01302691|Losartan|losartan|mesh-list
92689971|NCT01302691|Amlodipine|amlodipine|mesh-list
92690033|NCT00484133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92690034|NCT00484133|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92690035|NCT00484133|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92690106|NCT00484692|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92690107|NCT00484692|Antidepressive Agents|antidepressive agents|mesh-ancestor
92690108|NCT00484692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690109|NCT00484692|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92690173|NCT00484809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690174|NCT00484809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92690175|NCT00484809|Immunologic Factors|immunologic factors|mesh-ancestor
92690176|NCT04514094|Fluorides|fluorides|mesh-list
92690177|NCT04514094|Cariostatic Agents|cariostatic agents|mesh-ancestor
92690178|NCT04514094|Protective Agents|protective agents|mesh-ancestor
92690179|NCT04514094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690180|NCT04514289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92690181|NCT00484926|Aspirin|aspirin|mesh-list
92690182|NCT00484926|Clopidogrel|clopidogrel|mesh-list
92690183|NCT00484926|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92690236|NCT00489398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690237|NCT00485004|Sirolimus|sirolimus|mesh-list
92690309|NCT00485108|Glucocorticoids|glucocorticoids|mesh-ancestor
92690310|NCT00485108|Hormones|hormones|mesh-ancestor
92690311|NCT00485108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92690312|NCT00485108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690313|NCT00485108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92690314|NCT00485108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690315|NCT00485108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690376|NCT00485342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690377|NCT00485342|Immunologic Factors|immunologic factors|mesh-ancestor
92690379|NCT00489593|Olanzapine|olanzapine|mesh-list
92110217|NCT01866592|Adalimumab|adalimumab|mesh-list
92690445|NCT04697511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92690516|NCT00485667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690517|NCT00485667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690518|NCT00485667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690519|NCT00489905|Zoledronic Acid|zoledronic acid|mesh-list
92690520|NCT00489905|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92690521|NCT00489905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690522|NCT00489944|Tamoxifen|tamoxifen|mesh-list
92690523|NCT00489944|Sunitinib|sunitinib|mesh-list
92690524|NCT00489944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690525|NCT00489944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690526|NCT00489944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92690578|NCT00485771|Lamotrigine|lamotrigine|mesh-list
92690579|NCT00485771|Olanzapine|olanzapine|mesh-list
92690580|NCT00485771|Fluoxetine|fluoxetine|mesh-list
92690581|NCT00485771|Antiemetics|antiemetics|mesh-ancestor
92690582|NCT00485771|Autonomic Agents|autonomic agents|mesh-ancestor
92690583|NCT00485771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92690584|NCT00485771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690585|NCT00485771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92690586|NCT00485771|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92690587|NCT00485771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92690588|NCT00485771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92690589|NCT00485771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690590|NCT00485771|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690591|NCT00485771|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92110371|NCT03832894|Estradiol|estradiol|mesh-list
92690636|NCT00485823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92690637|NCT00485823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92690638|NCT00485823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92690642|NCT00485823|Serotonin Agents|serotonin agents|mesh-ancestor
92690705|NCT00485940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690706|NCT00485940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690707|NCT00486005|Olanzapine|olanzapine|mesh-list
92690774|NCT00486317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92690775|NCT00486317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92690776|NCT00486317|Vasodilator Agents|vasodilator agents|mesh-ancestor
92690777|NCT00490880|Gemcitabine|gemcitabine|mesh-list
92690778|NCT00490880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92690779|NCT00490880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92690780|NCT00490880|Antimetabolites|antimetabolites|mesh-ancestor
92690781|NCT00490880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690782|NCT00486174|Methylene Blue|methylene blue|mesh-list
92690783|NCT00486174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690785|NCT00486356|Carboplatin|carboplatin|mesh-list
92690837|NCT04511637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690838|NCT04511637|Anticoagulants|anticoagulants|mesh-ancestor
92690839|NCT00486486|Timolol|timolol|mesh-list
92690909|NCT01301833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92690910|NCT01301833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92690911|NCT00486785|Alfuzosin|alfuzosin|mesh-list
92690979|NCT01242098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691051|NCT00487032|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92691052|NCT00487032|Respiratory System Agents|respiratory system agents|mesh-ancestor
92691053|NCT00487032|Dermatologic Agents|dermatologic agents|mesh-ancestor
92691054|NCT00487032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92691055|NCT00487032|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92691056|NCT00487032|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92691057|NCT00487032|Adrenergic Agents|adrenergic agents|mesh-ancestor
92691058|NCT00487032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691120|NCT00487110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92691121|NCT00487110|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92691122|NCT00487110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92691123|NCT00487110|Serotonin Agents|serotonin agents|mesh-ancestor
92691124|NCT00487110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691125|NCT00487110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691126|NCT00487136|Warfarin|warfarin|mesh-list
92691127|NCT00487136|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92691128|NCT00487136|Fenofibric acid|fenofibric acid|mesh-list
92691129|NCT00487136|Fenofibrate|fenofibrate|mesh-list
92691130|NCT00487136|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92691131|NCT00487136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92691132|NCT00487136|Antimetabolites|antimetabolites|mesh-ancestor
92691133|NCT00487136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691134|NCT00487136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92691135|NCT00487136|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92691136|NCT00487136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691137|NCT00487136|Anticoagulants|anticoagulants|mesh-ancestor
92691138|NCT02276001|Cyclosporine|cyclosporine|mesh-list
92691139|NCT02276001|Cyclosporins|cyclosporins|mesh-list
92691140|NCT02276001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691141|NCT02276001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691142|NCT02276001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691143|NCT02276001|Immunologic Factors|immunologic factors|mesh-ancestor
92691144|NCT02276001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691145|NCT02276001|Antifungal Agents|antifungal agents|mesh-ancestor
92691150|NCT00491582|Hormones|hormones|mesh-list
92691167|NCT00487227|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92691168|NCT00487227|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92691169|NCT00487227|Purinergic Agents|purinergic agents|mesh-ancestor
92691170|NCT00487227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691172|NCT01300351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92691173|NCT01300351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691174|NCT01300351|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92691175|NCT01300351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92691176|NCT01300351|Hormone Antagonists|hormone antagonists|mesh-ancestor
92691179|NCT00487253|Miltefosine|miltefosine|mesh-list
92691234|NCT04697355|Antioxidants|antioxidants|mesh-ancestor
92691235|NCT04697355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691236|NCT04697355|Protective Agents|protective agents|mesh-ancestor
92691237|NCT04697355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691238|NCT04697355|Provitamins|provitamins|mesh-ancestor
92691239|NCT04697355|Vitamins|vitamins|mesh-ancestor
92691240|NCT04697355|Micronutrients|micronutrients|mesh-ancestor
92691241|NCT04697355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92691242|NCT04697355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92691243|NCT04697355|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92691244|NCT04697355|Hormone Antagonists|hormone antagonists|mesh-ancestor
92111036|NCT02715804|Paclitaxel|paclitaxel|mesh-list
92111037|NCT02715804|Gemcitabine|gemcitabine|mesh-list
92111038|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92111039|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111040|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92691281|NCT00487448|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92691282|NCT00487448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92691283|NCT00487448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691284|NCT00506259|Melatonin|melatonin|mesh-list
92691285|NCT00506259|Antioxidants|antioxidants|mesh-ancestor
92691286|NCT00506259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691287|NCT00506259|Protective Agents|protective agents|mesh-ancestor
92691288|NCT00506259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691289|NCT00506259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92691290|NCT00506298|Diflunisal|diflunisal|mesh-list
92691291|NCT00506298|Bezafibrate|bezafibrate|mesh-list
92691292|NCT00506298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92691293|NCT00506298|Antimetabolites|antimetabolites|mesh-ancestor
92691295|NCT00506298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92691342|NCT00492128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92691343|NCT00492128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92691344|NCT00492128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92691412|NCT00487773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691413|NCT00487773|Tocolytic Agents|tocolytic agents|mesh-ancestor
92691414|NCT00487773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92691415|NCT00487773|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92691416|NCT00487773|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92691417|NCT00487773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92691418|NCT00487773|Adrenergic Agents|adrenergic agents|mesh-ancestor
92691419|NCT00487773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691420|NCT00487773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92691421|NCT00487773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92691422|NCT01299961|Abatacept|abatacept|mesh-list
92691423|NCT01299961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92691424|NCT01299961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691425|NCT01299961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92691426|NCT01299961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691427|NCT01299961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92691466|NCT01299805|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92691467|NCT01299805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92691468|NCT01299805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92691538|NCT00495326|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92691539|NCT00495326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92691540|NCT00495326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92691541|NCT00495326|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92691542|NCT00495326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92111338|NCT01775501|Leucovorin|leucovorin|mesh-list
92691543|NCT00495326|Antimetabolites|antimetabolites|mesh-ancestor
92691544|NCT00495326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92691546|NCT00492479|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92691606|NCT00492635|Vasodilator Agents|vasodilator agents|mesh-ancestor
92691607|NCT00492635|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92691608|NCT00492635|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92691609|NCT00492635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691610|NCT00492635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691611|NCT00492635|Urological Agents|urological agents|mesh-ancestor
92691613|NCT00507000|Cholecalciferol|cholecalciferol|mesh-list
92691614|NCT00507000|Vitamins|vitamins|mesh-ancestor
92691615|NCT00507000|Micronutrients|micronutrients|mesh-ancestor
92691616|NCT00507000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691617|NCT00507000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92111421|NCT03832816|Dronabinol|dronabinol|mesh-list
92691619|NCT00495872|Lenalidomide|lenalidomide|mesh-list
92691668|NCT01243736|Dopamine Agents|dopamine agents|mesh-ancestor
92691669|NCT01243736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92691670|NCT01243736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691671|NCT01243736|Antifoaming Agents|antifoaming agents|mesh-ancestor
92691672|NCT01243736|Emollients|emollients|mesh-ancestor
92691673|NCT01243736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92691674|NCT00492986|Sorafenib|sorafenib|mesh-list
92691675|NCT00492986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691676|NCT00492986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92691677|NCT00492986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691678|NCT00492986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691679|NCT01243970|Phenylephrine|phenylephrine|mesh-list
92691680|NCT01243970|Oxymetazoline|oxymetazoline|mesh-list
92691681|NCT01243970|Ephedrine|ephedrine|mesh-list
92691682|NCT01243970|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92691683|NCT01243970|Mydriatics|mydriatics|mesh-ancestor
92691727|NCT04511832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92691728|NCT04511832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92691799|NCT02274506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92691875|NCT01296412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92691877|NCT01296412|Hormones|hormones|mesh-ancestor
92691880|NCT01296412|Protease Inhibitors|protease inhibitors|mesh-ancestor
92691945|NCT00494156|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92691946|NCT00494156|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92692019|NCT00497120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692020|NCT00494468|Zolpidem|zolpidem|mesh-list
92692021|NCT00494468|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92692090|NCT00494663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92692091|NCT05146674|Tadalafil|tadalafil|mesh-list
92692092|NCT05146674|Vasodilator Agents|vasodilator agents|mesh-ancestor
92692163|NCT00507234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692164|NCT00507234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692166|NCT05148546|Ipilimumab|ipilimumab|mesh-list
92692167|NCT05148546|Relatlimab|relatlimab|mesh-list
92692168|NCT05148546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92692169|NCT05148546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692170|NCT05148546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92692171|NCT05148546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692172|NCT00506532|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92692173|NCT00506532|Calfactant|calfactant|mesh-list
92692174|NCT00506532|Respiratory System Agents|respiratory system agents|mesh-ancestor
92692175|NCT05149560|Ticagrelor|ticagrelor|mesh-list
92692176|NCT05149560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92692177|NCT05149560|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92692178|NCT05149560|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92692179|NCT05149560|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92692180|NCT05149560|Purinergic Agents|purinergic agents|mesh-ancestor
92692181|NCT05149560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692218|NCT00494897|Tubulin Modulators|tubulin modulators|mesh-ancestor
92692219|NCT00494897|Antimitotic Agents|antimitotic agents|mesh-ancestor
92692220|NCT00494897|Mitosis Modulators|mitosis modulators|mesh-ancestor
92692221|NCT00494897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92692222|NCT00494897|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92692223|NCT00494897|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92692225|NCT00497744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692226|NCT00497744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692227|NCT00495092|Biperiden|biperiden|mesh-list
92692285|NCT00498251|Albuterol|albuterol|mesh-list
92692286|NCT00498251|Ipratropium|ipratropium|mesh-list
92692287|NCT00498251|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92692288|NCT00498251|Autonomic Agents|autonomic agents|mesh-ancestor
92692289|NCT00498251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692290|NCT00498251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692291|NCT00498251|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92692292|NCT00498251|Respiratory System Agents|respiratory system agents|mesh-ancestor
92692293|NCT00498251|Tocolytic Agents|tocolytic agents|mesh-ancestor
92692294|NCT00498251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92692295|NCT00498251|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92692296|NCT00498251|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92692297|NCT00498251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92692298|NCT00498251|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692299|NCT00498251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692301|NCT00498251|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92692345|NCT00502970|Hematinics|hematinics|mesh-ancestor
92692346|NCT05149287|Ceftriaxone|ceftriaxone|mesh-list
92692347|NCT05149287|Lidocaine|lidocaine|mesh-list
92692348|NCT05149287|Anesthetics, Local|anesthetics, local|mesh-ancestor
92692349|NCT05149287|Anesthetics|anesthetics|mesh-ancestor
92692350|NCT05149287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692351|NCT05149287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692352|NCT05149287|Sensory System Agents|sensory system agents|mesh-ancestor
92692353|NCT05149287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92692354|NCT05149287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92692356|NCT05149287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92692410|NCT05145543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92692411|NCT05145543|Analgesics|analgesics|mesh-ancestor
92692412|NCT05145543|Sensory System Agents|sensory system agents|mesh-ancestor
92692413|NCT05145543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92692414|NCT05145543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92692415|NCT05145543|Anesthetics, General|anesthetics, general|mesh-ancestor
92692416|NCT05145543|Anesthetics|anesthetics|mesh-ancestor
92692478|NCT05145270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92692479|NCT05145270|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92692480|NCT05145270|Protective Agents|protective agents|mesh-ancestor
92692481|NCT05145270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692550|NCT05148195|Calcium|calcium|mesh-list
92692551|NCT05148195|Levoleucovorin|levoleucovorin|mesh-list
92692552|NCT05148195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692553|NCT05148195|Tubulin Modulators|tubulin modulators|mesh-ancestor
92692554|NCT05148195|Antimitotic Agents|antimitotic agents|mesh-ancestor
92692555|NCT05148195|Mitosis Modulators|mitosis modulators|mesh-ancestor
92692556|NCT05148195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692557|NCT05148195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92692618|NCT01246817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692619|NCT01246817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692677|NCT00503594|Antimitotic Agents|antimitotic agents|mesh-ancestor
92692678|NCT00503594|Mitosis Modulators|mitosis modulators|mesh-ancestor
92692679|NCT00503594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92692680|NCT00503594|Alkylating Agents|alkylating agents|mesh-ancestor
92692681|NCT00499811|Vorinostat|vorinostat|mesh-list
92692682|NCT00499811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692683|NCT00499811|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92692684|NCT00499811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692685|NCT00499811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692686|NCT00499850|Leucovorin|leucovorin|mesh-list
92692687|NCT00499850|Fluorouracil|fluorouracil|mesh-list
92692688|NCT00499850|Oxaliplatin|oxaliplatin|mesh-list
92692689|NCT00499850|Antimetabolites|antimetabolites|mesh-ancestor
92692690|NCT00499850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692691|NCT00499850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92692692|NCT00499850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92692693|NCT00499850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92692694|NCT00499850|Immunologic Factors|immunologic factors|mesh-ancestor
92692695|NCT00499850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692696|NCT00499850|Antidotes|antidotes|mesh-ancestor
92692697|NCT00499850|Protective Agents|protective agents|mesh-ancestor
92692698|NCT00499850|Vitamin B Complex|vitamin b complex|mesh-ancestor
92692699|NCT00499850|Vitamins|vitamins|mesh-ancestor
92692700|NCT00499850|Micronutrients|micronutrients|mesh-ancestor
92692701|NCT05146713|Propolis|propolis|mesh-list
92692702|NCT05146713|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92692704|NCT05146713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92692705|NCT05146713|Disinfectants|disinfectants|mesh-ancestor
92692706|NCT00503828|Naproxen|naproxen|mesh-list
92692707|NCT00503828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92692719|NCT00500006|Dasatinib|dasatinib|mesh-list
92692724|NCT00500123|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92692725|NCT00500123|Protein C Inhibitor|protein c inhibitor|mesh-list
92692726|NCT00500123|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92692727|NCT00500123|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92692728|NCT00500123|Protease Inhibitors|protease inhibitors|mesh-ancestor
92692729|NCT00500123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92692730|NCT00500123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692731|NCT00506727|Amphetamine|amphetamine|mesh-list
92692732|NCT00506727|Adderall|adderall|mesh-list
92692733|NCT00506727|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92692734|NCT00506727|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92692735|NCT00506727|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92692736|NCT00506727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92692737|NCT00506727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692738|NCT00506727|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692739|NCT00506727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692781|NCT03458247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92692782|NCT03458247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692783|NCT03458247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92692785|NCT01247558|Vitamin B Complex|vitamin b complex|mesh-ancestor
92692786|NCT01247558|Vitamins|vitamins|mesh-ancestor
92692787|NCT01247558|Micronutrients|micronutrients|mesh-ancestor
92692788|NCT01247558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692789|NCT00500552|Perhexiline|perhexiline|mesh-list
92692846|NCT00508287|Exenatide|exenatide|mesh-list
92692850|NCT00508287|Incretins|incretins|mesh-ancestor
92692920|NCT00507975|Cholinergic Agents|cholinergic agents|mesh-ancestor
92692921|NCT00507975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692922|NCT00507975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92692923|NCT01247909|Gentamicins|gentamicins|mesh-list
92692924|NCT01247909|Ceftriaxone|ceftriaxone|mesh-list
92692925|NCT01247909|Penicillins|penicillins|mesh-list
92692926|NCT01247909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92692990|NCT01246037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92692991|NCT01246037|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92692992|NCT01246037|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92692993|NCT01246037|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92692994|NCT01246037|Adrenergic Agents|adrenergic agents|mesh-ancestor
92692995|NCT01246037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92692997|NCT00501215|Parathyroid Hormone|parathyroid hormone|mesh-list
92693057|NCT00509379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92693058|NCT02274974|Lidocaine|lidocaine|mesh-list
92693059|NCT02274974|Epinephrine|epinephrine|mesh-list
92693060|NCT02274974|Anesthetics, Local|anesthetics, local|mesh-list
92693061|NCT02274974|Anesthetics|anesthetics|mesh-list
92693062|NCT02274974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693063|NCT02274974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693064|NCT02274974|Sensory System Agents|sensory system agents|mesh-ancestor
92693065|NCT02274974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693066|NCT02274974|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92693067|NCT02274974|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92693068|NCT02274974|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92693120|NCT00501410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92693121|NCT00501410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693122|NCT00501410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693190|NCT02953041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92693191|NCT02953041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693192|NCT02953041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693193|NCT00501566|Satavaptan|satavaptan|mesh-list
92693194|NCT00501566|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92693195|NCT00501566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693196|NCT00501566|Natriuretic Agents|natriuretic agents|mesh-ancestor
92693197|NCT00501566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693198|NCT00501605|Cediranib|cediranib|mesh-list
92693199|NCT00501605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693200|NCT00501605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92693201|NCT00501605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693202|NCT00501605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693249|NCT01248611|Anesthetics|anesthetics|mesh-ancestor
92693250|NCT00509964|Irinotecan|irinotecan|mesh-list
92693251|NCT00509964|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92693323|NCT00502034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693324|NCT00502034|Antiviral Agents|antiviral agents|mesh-ancestor
92693325|NCT00502034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693326|NCT00502034|Immunologic Factors|immunologic factors|mesh-ancestor
92693327|NCT00502034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693328|NCT00502034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92693330|NCT00502034|Sensory System Agents|sensory system agents|mesh-ancestor
92693331|NCT00502034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693333|NCT00510666|Butorphanol|butorphanol|mesh-list
92693334|NCT00510666|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92693335|NCT00510666|Narcotics|narcotics|mesh-ancestor
92693350|NCT00510705|Metformin|metformin|mesh-list
92693389|NCT01249001|Fosaprepitant|fosaprepitant|mesh-list
92693390|NCT01249001|Antiemetics|antiemetics|mesh-ancestor
92693391|NCT01249001|Autonomic Agents|autonomic agents|mesh-ancestor
92693392|NCT01249001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92693461|NCT02952807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693462|NCT02952807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92693463|NCT02952807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92693465|NCT02275130|Calcium, Dietary|calcium, dietary|mesh-list
92693466|NCT02275130|Calcium|calcium|mesh-list
92693467|NCT02275130|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92693468|NCT02275130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693469|NCT02275130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92693470|NCT03459417|Morphine|morphine|mesh-list
92693471|NCT03459417|Sulpiride|sulpiride|mesh-list
92693472|NCT03459417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92693473|NCT03459417|Narcotics|narcotics|mesh-ancestor
92693474|NCT03459417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693524|NCT00510939|Bortezomib|bortezomib|mesh-list
92693525|NCT00510939|Tipifarnib|tipifarnib|mesh-list
92693526|NCT00510939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92693599|NCT00510393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693600|NCT00510393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92693672|NCT00504296|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92693673|NCT00504296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693674|NCT00504296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693744|NCT00513162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693745|NCT00513162|Antimanic Agents|antimanic agents|mesh-ancestor
92693746|NCT00513162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92693747|NCT00513162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693748|NCT00513162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92693749|NCT00513201|Insulin|insulin|mesh-list
92693750|NCT00513201|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92693751|NCT00513201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92693752|NCT00513201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92693753|NCT00512265|Acetylcysteine|acetylcysteine|mesh-list
92693754|NCT00512265|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92693755|NCT00512265|Antiviral Agents|antiviral agents|mesh-ancestor
92693756|NCT00512265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693757|NCT00512265|Expectorants|expectorants|mesh-ancestor
92693758|NCT00512265|Respiratory System Agents|respiratory system agents|mesh-ancestor
92693760|NCT00512265|Antioxidants|antioxidants|mesh-ancestor
92693804|NCT00505037|Sequestering Agents|sequestering agents|mesh-ancestor
92693805|NCT00505037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693806|NCT00513552|Clarithromycin|clarithromycin|mesh-list
92693807|NCT00513552|Rifabutin|rifabutin|mesh-list
92693808|NCT00513552|Clofazimine|clofazimine|mesh-list
92693809|NCT00513552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92693810|NCT00513552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92693811|NCT00513552|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92693812|NCT00513552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92693813|NCT00513552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92693814|NCT00513552|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92693815|NCT00513552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92693816|NCT00513552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92693817|NCT00513552|Antitubercular Agents|antitubercular agents|mesh-ancestor
92113683|NCT04232306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92693854|NCT00504491|Immunologic Factors|immunologic factors|mesh-ancestor
92693926|NCT00513981|Leucovorin|leucovorin|mesh-list
92113750|NCT03936777|Fenfluramine|fenfluramine|mesh-list
92693927|NCT00513981|Methotrexate|methotrexate|mesh-list
92693996|NCT01244984|Fluticasone|fluticasone|mesh-list
92693998|NCT01244984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92693999|NCT01244984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92694000|NCT01244984|Autonomic Agents|autonomic agents|mesh-ancestor
92694001|NCT01244984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694002|NCT01244984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694003|NCT01244984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92694004|NCT01244984|Respiratory System Agents|respiratory system agents|mesh-ancestor
92694005|NCT01244984|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694064|NCT02955641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92694065|NCT01243268|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92694066|NCT01243268|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92694067|NCT01243268|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92694068|NCT01243268|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92694069|NCT01243268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694070|NCT00514995|Sodium Oxybate|sodium oxybate|mesh-list
92694071|NCT00514995|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92694072|NCT00514995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92694073|NCT00514995|Anesthetics, General|anesthetics, general|mesh-ancestor
92694083|NCT00515151|Octenidine|octenidine|mesh-list
92694127|NCT01241240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92694128|NCT01241240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92694129|NCT01241240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694130|NCT01241240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694131|NCT01241240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694132|NCT01241240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92694133|NCT01241240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92694134|NCT01241240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92694135|NCT01241240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92694136|NCT01241240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92694191|NCT01240382|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92694266|NCT04511975|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694267|NCT04511975|Antimetabolites|antimetabolites|mesh-ancestor
92694268|NCT04511975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694269|NCT04511975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694270|NCT04511975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694271|NCT04511897|Expectorants|expectorants|mesh-list
92694272|NCT04511897|Respiratory System Agents|respiratory system agents|mesh-ancestor
92694273|NCT04519463|Lidocaine|lidocaine|mesh-list
92399896|NCT01405482|Botulinum Toxins|botulinum toxins|mesh-list
92694274|NCT04519463|Anesthetics, Local|anesthetics, local|mesh-ancestor
92694275|NCT04519463|Anesthetics|anesthetics|mesh-ancestor
92694276|NCT04519463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92694277|NCT04519463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694278|NCT04519463|Sensory System Agents|sensory system agents|mesh-ancestor
92694326|NCT01249404|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92694327|NCT01249404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694328|NCT01249404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694329|NCT01249404|Cholinergic Agents|cholinergic agents|mesh-ancestor
92694330|NCT01249404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92694331|NCT01249404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694332|NCT01249404|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92694333|NCT01249404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92694390|NCT01249092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694391|NCT01249092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92694392|NCT01249092|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92694462|NCT02275299|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92694463|NCT02275299|Abortifacient Agents|abortifacient agents|mesh-ancestor
92694464|NCT02275299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694465|NCT02275299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694466|NCT02275299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92694467|NCT02275299|Antimetabolites|antimetabolites|mesh-ancestor
92694468|NCT02275299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694469|NCT02275299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694470|NCT02275299|Dermatologic Agents|dermatologic agents|mesh-ancestor
92694471|NCT02275299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694472|NCT02275299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92694473|NCT02275299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694474|NCT02275299|Immunologic Factors|immunologic factors|mesh-ancestor
92694482|NCT01246206|Tacrolimus|tacrolimus|mesh-list
92694520|NCT01243944|Hydroxyurea|hydroxyurea|mesh-list
92694521|NCT01243944|Pipobroman|pipobroman|mesh-list
92694522|NCT01243944|Anagrelide|anagrelide|mesh-list
92694594|NCT00516750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92694595|NCT00516750|Abortifacient Agents|abortifacient agents|mesh-ancestor
92694599|NCT00516750|Antimetabolites|antimetabolites|mesh-ancestor
92694666|NCT00516828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694667|NCT00516828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694668|NCT00516828|Antiviral Agents|antiviral agents|mesh-ancestor
92694669|NCT00516828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92694670|NCT00516828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92694671|NCT00516828|Immunologic Factors|immunologic factors|mesh-ancestor
92694672|NCT00516828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694673|NCT02949765|Iron|iron|mesh-list
92694674|NCT02949765|Trace Elements|trace elements|mesh-ancestor
92694675|NCT02949765|Micronutrients|micronutrients|mesh-ancestor
92694676|NCT02949765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694677|NCT04518176|Oxytocin|oxytocin|mesh-list
92694678|NCT04518176|Oxytocics|oxytocics|mesh-ancestor
92694679|NCT04518176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92694680|NCT04518176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694681|NCT00516945|Lamivudine|lamivudine|mesh-list
92694682|NCT00516945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92694683|NCT00516945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92694684|NCT00516945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694685|NCT00516945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694720|NCT00517257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694721|NCT00517257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92694794|NCT02949843|Nivolumab|nivolumab|mesh-list
92694795|NCT02949843|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92694796|NCT02949843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92694797|NCT02949843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694798|NCT02949843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92694799|NCT02949843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694800|NCT02949843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92694801|NCT02949843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694802|NCT00517764|Citalopram|citalopram|mesh-list
92694860|NCT01240629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694861|NCT01240629|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92694862|NCT01240629|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92694863|NCT01240629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694864|NCT01240629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694865|NCT00518232|Methylphenidate|methylphenidate|mesh-list
92694866|NCT00518232|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92694867|NCT00518232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92694868|NCT00518232|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92694869|NCT00518232|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92694870|NCT00518232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92694871|NCT00518232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694872|NCT00518232|Dopamine Agents|dopamine agents|mesh-ancestor
92694917|NCT00518583|Antimitotic Agents|antimitotic agents|mesh-ancestor
92694918|NCT00518583|Mitosis Modulators|mitosis modulators|mesh-ancestor
92694919|NCT00518583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694988|NCT02276300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694989|NCT02276300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92694990|NCT02276300|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92694991|NCT02276300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92694992|NCT02276300|Interferon Inducers|interferon inducers|mesh-ancestor
92694993|NCT00520026|Lithium Carbonate|lithium carbonate|mesh-list
92694994|NCT00520026|Antidepressive Agents|antidepressive agents|mesh-ancestor
92694995|NCT00520026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92694996|NCT00520026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92694997|NCT00520026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92694998|NCT00520026|Antimanic Agents|antimanic agents|mesh-ancestor
92694999|NCT00520026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92695000|NCT00520026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695001|NCT00520026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695002|NCT02955251|Nivolumab|nivolumab|mesh-list
92695003|NCT02955251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92695004|NCT02955251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695043|NCT00520260|Bromfenac|bromfenac|mesh-list
92695044|NCT00520260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695045|NCT00520260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695046|NCT00520260|Analgesics|analgesics|mesh-ancestor
92695047|NCT00520260|Sensory System Agents|sensory system agents|mesh-ancestor
92695048|NCT00520260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695049|NCT00520260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695050|NCT00520260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695051|NCT00520260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695052|NCT00520260|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92695053|NCT00520260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695103|NCT02590094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695104|NCT02590094|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92695105|NCT02590094|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92695106|NCT02590094|Growth Substances|growth substances|mesh-ancestor
92695107|NCT02590094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695108|NCT02590094|Growth Inhibitors|growth inhibitors|mesh-ancestor
92695109|NCT00520455|Levonorgestrel|levonorgestrel|mesh-list
92695110|NCT00520455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92695111|NCT00520455|Contraceptive Agents|contraceptive agents|mesh-ancestor
92695112|NCT00520455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695113|NCT00520455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114962|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695114|NCT00520455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92695115|NCT00520455|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92695118|NCT02949258|Etoposide|etoposide|mesh-list
92695161|NCT00519324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695162|NCT00519324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695163|NCT00519324|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695164|NCT00519324|Immunologic Factors|immunologic factors|mesh-ancestor
92695165|NCT00519324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695166|NCT00519324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695167|NCT00520650|Aripiprazole|aripiprazole|mesh-list
92695168|NCT00520650|Antidepressive Agents|antidepressive agents|mesh-ancestor
92695169|NCT00520650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92695170|NCT00520650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92695171|NCT00520650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92695172|NCT00520650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695173|NCT00520650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695174|NCT00520650|Dopamine Agonists|dopamine agonists|mesh-ancestor
92695175|NCT00520650|Dopamine Agents|dopamine agents|mesh-ancestor
92695176|NCT00520650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695177|NCT00520650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695178|NCT00520650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92695215|NCT02598557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695216|NCT02598557|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92695217|NCT02598557|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92695284|NCT00521157|Naltrexone|naltrexone|mesh-list
92695285|NCT00521157|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92695286|NCT00521157|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92695287|NCT00521157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695288|NCT00521157|Sensory System Agents|sensory system agents|mesh-ancestor
92695289|NCT00521157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695290|NCT00505817|Leuprolide|leuprolide|mesh-list
92695291|NCT00505817|Cetrorelix|cetrorelix|mesh-list
92695292|NCT00505817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92695293|NCT00505817|Fertility Agents|fertility agents|mesh-ancestor
92695294|NCT00505817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695351|NCT05146778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695352|NCT05146778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695353|NCT05146778|Sensory System Agents|sensory system agents|mesh-ancestor
92695354|NCT05146778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695355|NCT05146778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92695356|NCT05146778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92695357|NCT05146778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92695358|NCT05146778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695359|NCT05146778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695360|NCT05146778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92695361|NCT05146778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92695362|NCT05146778|Analgesics|analgesics|mesh-ancestor
92695363|NCT05146778|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92695412|NCT00523185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695413|NCT00523185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92695414|NCT00523185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92695415|NCT00523185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92695416|NCT00523185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92695417|NCT00523185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92695418|NCT00523185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92695419|NCT00523185|GABA Modulators|gaba modulators|mesh-ancestor
92695420|NCT00523185|GABA Agents|gaba agents|mesh-ancestor
92399930|NCT01405846|Gefitinib|gefitinib|mesh-list
92695421|NCT00523185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92695422|NCT00523185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695423|NCT00523185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92695424|NCT00523185|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92695425|NCT00523185|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92695426|NCT00523185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92695427|NCT00523185|Anesthetics, General|anesthetics, general|mesh-ancestor
92695428|NCT00523185|Anesthetics|anesthetics|mesh-ancestor
92695429|NCT04512404|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92695430|NCT04512404|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92695431|NCT04512404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92695432|NCT04512404|Antimetabolites|antimetabolites|mesh-ancestor
92695433|NCT04512404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695434|NCT04512404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695435|NCT04512404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92695436|NCT04693962|Mitogens|mitogens|mesh-list
92695437|NCT04693962|Mitosis Modulators|mitosis modulators|mesh-ancestor
92695438|NCT04693962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695439|NCT05144399|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92695440|NCT05144399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92695441|NCT00521703|Lidocaine|lidocaine|mesh-list
92695442|NCT00521703|Anesthetics, Local|anesthetics, local|mesh-ancestor
92695443|NCT00521703|Anesthetics|anesthetics|mesh-ancestor
92695444|NCT00521703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752335|NCT05940649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752336|NCT05940649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752337|NCT05940649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752338|NCT05940649|Sympathomimetics|sympathomimetics|mesh-ancestor
92695445|NCT00521703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695446|NCT00521703|Sensory System Agents|sensory system agents|mesh-ancestor
92695447|NCT00521703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695448|NCT00521703|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92695449|NCT00521703|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92695450|NCT00521703|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92695451|NCT00521703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92695452|NCT00521703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695453|NCT00521742|Pioglitazone|pioglitazone|mesh-list
92695454|NCT00521742|Glyburide|glyburide|mesh-list
92695455|NCT00521742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92695456|NCT00521742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695507|NCT00523380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695508|NCT00523380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92695579|NCT05148767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695580|NCT05148767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695581|NCT00523692|Etanercept|etanercept|mesh-list
92695582|NCT00523692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92695583|NCT00523692|Methylprednisolone|methylprednisolone|mesh-list
92695584|NCT00523692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92695585|NCT00523692|Prednisolone|prednisolone|mesh-list
92695586|NCT00523692|Prednisolone acetate|prednisolone acetate|mesh-list
92695587|NCT00523692|Methotrexate|methotrexate|mesh-list
92695588|NCT00523692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92695589|NCT00523692|Prednisolone phosphate|prednisolone phosphate|mesh-list
92695590|NCT00523692|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92695591|NCT00523692|Abortifacient Agents|abortifacient agents|mesh-ancestor
92695592|NCT00523692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92695593|NCT00523692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695594|NCT00523692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92695595|NCT00523692|Antimetabolites|antimetabolites|mesh-ancestor
92695596|NCT00523692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695597|NCT00523692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92695598|NCT00523692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92695599|NCT00523692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695600|NCT00523692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92695601|NCT00523692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92695602|NCT00523692|Immunologic Factors|immunologic factors|mesh-ancestor
92695603|NCT00523692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695604|NCT00523692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92695605|NCT00523692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92695626|NCT05148689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695699|NCT05142098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695773|NCT02276378|Diuretics|diuretics|mesh-ancestor
92695774|NCT02276378|Natriuretic Agents|natriuretic agents|mesh-ancestor
92695775|NCT02276378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695847|NCT00525993|Sensory System Agents|sensory system agents|mesh-ancestor
92695848|NCT00525993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92695849|NCT00525993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695850|NCT00525993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92695851|NCT00525993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92695852|NCT00525993|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92695853|NCT00525993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92695854|NCT00525993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92695855|NCT00525993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92695856|NCT02947854|Photosensitizing Agents|photosensitizing agents|mesh-list
92695857|NCT02947854|Poly ICLC|poly iclc|mesh-list
92695910|NCT02954588|Micronutrients|micronutrients|mesh-ancestor
92695911|NCT02954588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92695984|NCT02276859|Insulin Aspart|insulin aspart|mesh-list
92695985|NCT02276859|Insulin Lispro|insulin lispro|mesh-list
92696057|NCT00526305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92696058|NCT00526305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92696059|NCT00526305|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696128|NCT00525564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92696129|NCT00525564|Autonomic Agents|autonomic agents|mesh-ancestor
92696130|NCT00525564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696131|NCT00525564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696132|NCT00525564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92696133|NCT00525564|Respiratory System Agents|respiratory system agents|mesh-ancestor
92696134|NCT00525564|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92696135|NCT00525564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92696136|NCT00525564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92696137|NCT00525564|Adrenergic Agents|adrenergic agents|mesh-ancestor
92696138|NCT00525564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696139|NCT00525564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696140|NCT00525642|Cyclophosphamide|cyclophosphamide|mesh-list
92696141|NCT00525642|Docetaxel|docetaxel|mesh-list
92696142|NCT00525642|Doxorubicin|doxorubicin|mesh-list
92696143|NCT00525642|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92696144|NCT00525642|Epirubicin|epirubicin|mesh-list
92696145|NCT00525642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696185|NCT02945982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696186|NCT02945982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92696256|NCT00525759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92696259|NCT00507962|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92696260|NCT00507962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696261|NCT00507962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92696262|NCT00507962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696263|NCT00507962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696264|NCT00507962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696265|NCT00507962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696266|NCT00508040|Interferons|interferons|mesh-list
92696267|NCT00508040|Interferon-alpha|interferon-alpha|mesh-list
92696321|NCT02953847|Leprostatic Agents|leprostatic agents|mesh-ancestor
92696322|NCT02953847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92696323|NCT02953847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696324|NCT02953847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696325|NCT02953847|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92696326|NCT02953847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92696327|NCT02953847|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92696328|NCT02953847|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92696329|NCT02953847|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92696330|NCT02953847|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92696331|NCT02953847|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92696332|NCT02953847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92696333|NCT02953847|Antimetabolites|antimetabolites|mesh-ancestor
92052278|NCT02091986|Hormones|hormones|mesh-ancestor
92696334|NCT02953847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92696335|NCT00526695|Sevoflurane|sevoflurane|mesh-list
92696377|NCT04692558|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92696378|NCT04692558|Immunologic Factors|immunologic factors|mesh-ancestor
92696379|NCT04692558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696380|NCT04692558|Viscosupplements|viscosupplements|mesh-ancestor
92696381|NCT04692558|Protective Agents|protective agents|mesh-ancestor
92696447|NCT04692285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696448|NCT00509015|Artesunate|artesunate|mesh-list
92696449|NCT00509015|Pyrimethamine|pyrimethamine|mesh-list
92696450|NCT00509015|Primaquine|primaquine|mesh-list
92696451|NCT00509015|Sulfadoxine|sulfadoxine|mesh-list
92696452|NCT00509015|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92696453|NCT00509015|Antimalarials|antimalarials|mesh-ancestor
92696454|NCT00509015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92696455|NCT00509015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92696456|NCT00509015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696457|NCT00509015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696458|NCT00509015|Antiviral Agents|antiviral agents|mesh-ancestor
92696459|NCT00509015|Schistosomicides|schistosomicides|mesh-ancestor
92696460|NCT00509015|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92696461|NCT00509015|Anthelmintics|anthelmintics|mesh-ancestor
92696462|NCT00509015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92696463|NCT00509015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696466|NCT00528060|Ritonavir|ritonavir|mesh-list
92696507|NCT00509639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92696508|NCT00509639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92696509|NCT00509639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92696510|NCT00509639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92696511|NCT00528177|Morphine|morphine|mesh-list
92696512|NCT00528177|Oxycodone|oxycodone|mesh-list
92696513|NCT00528177|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92696514|NCT00528177|Narcotics|narcotics|mesh-ancestor
92696515|NCT00528177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92696516|NCT00528177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696571|NCT03459404|Sufentanil|sufentanil|mesh-list
92696572|NCT03459404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92696573|NCT03459404|Narcotics|narcotics|mesh-ancestor
92696643|NCT04692051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696644|NCT04692051|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696645|NCT04692051|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696646|NCT04692051|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696647|NCT04692051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696648|NCT04692051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696649|NCT04692051|Antimetabolites|antimetabolites|mesh-ancestor
92696650|NCT00528723|Albuterol|albuterol|mesh-list
92696651|NCT00528723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92696652|NCT00528723|Autonomic Agents|autonomic agents|mesh-ancestor
92696653|NCT00528723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92696654|NCT00528723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696708|NCT02953184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92696709|NCT02953184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92696710|NCT02953184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92696711|NCT02953184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696712|NCT02953184|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92696713|NCT02953184|Protective Agents|protective agents|mesh-ancestor
92696714|NCT00515229|Amitriptyline|amitriptyline|mesh-list
92696715|NCT00515229|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92696716|NCT00515229|Antidepressive Agents|antidepressive agents|mesh-ancestor
92696717|NCT00515229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92696718|NCT00515229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92696719|NCT00515229|Analgesics|analgesics|mesh-ancestor
92696720|NCT00515229|Sensory System Agents|sensory system agents|mesh-ancestor
92696729|NCT00511316|Montelukast|montelukast|mesh-list
92696765|NCT02944734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696766|NCT02944734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92696838|NCT00513032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696839|NCT00513110|Caffeine|caffeine|mesh-list
92696840|NCT00513110|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92696841|NCT00513110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696842|NCT00513110|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92696843|NCT00513110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696844|NCT00513110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696845|NCT00513110|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92696846|NCT00513110|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92696847|NCT00513110|Purinergic Agents|purinergic agents|mesh-ancestor
92696848|NCT00513110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92696849|NCT02951897|Pemetrexed|pemetrexed|mesh-list
92696850|NCT02951897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696851|NCT02951897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92696898|NCT02944227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696899|NCT02944227|Growth Inhibitors|growth inhibitors|mesh-ancestor
92696975|NCT00513266|Vitamins|vitamins|mesh-ancestor
92696976|NCT00513266|Micronutrients|micronutrients|mesh-ancestor
92696977|NCT00513383|Paclitaxel|paclitaxel|mesh-list
92696978|NCT00513383|Docetaxel|docetaxel|mesh-list
92696979|NCT00513383|Carboplatin|carboplatin|mesh-list
92696980|NCT00513383|Fluorouracil|fluorouracil|mesh-list
92696981|NCT00513383|Panitumumab|panitumumab|mesh-list
92696982|NCT00513383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92696983|NCT00513383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92696984|NCT00513383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92696985|NCT00513383|Antimitotic Agents|antimitotic agents|mesh-ancestor
92696986|NCT00513383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92696987|NCT00513383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92696988|NCT00513383|Antimetabolites|antimetabolites|mesh-ancestor
92696989|NCT00513383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92696990|NCT00513383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92696991|NCT00513383|Immunologic Factors|immunologic factors|mesh-ancestor
92696992|NCT00513383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92696994|NCT00515892|Immunotoxin HA22|immunotoxin ha22|mesh-list
92697037|NCT00512057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697038|NCT00512057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697039|NCT00512057|Gout Suppressants|gout suppressants|mesh-ancestor
92697040|NCT00512057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697041|NCT00512057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92697103|NCT00530361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697104|NCT00512408|Testosterone|testosterone|mesh-list
92697105|NCT00512408|Androgens|androgens|mesh-ancestor
92697107|NCT00512408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697108|NCT00512408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697109|NCT00530400|Cefuroxime|cefuroxime|mesh-list
92697110|NCT00530400|Cefuroxime axetil|cefuroxime axetil|mesh-list
92697111|NCT00530400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92697113|NCT00531336|Bevacizumab|bevacizumab|mesh-list
92697171|NCT02951975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697172|NCT02951975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92697173|NCT02951975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697174|NCT00514397|Temozolomide|temozolomide|mesh-list
92697175|NCT00514397|Motexafin gadolinium|motexafin gadolinium|mesh-list
92697176|NCT00514397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92697177|NCT00514397|Alkylating Agents|alkylating agents|mesh-ancestor
92697178|NCT00514397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697179|NCT00514397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697180|NCT00514397|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92697233|NCT00530907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697234|NCT00530907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697235|NCT00530907|GABA Agents|gaba agents|mesh-ancestor
92697236|NCT00530907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697237|NCT00530907|Antimanic Agents|antimanic agents|mesh-ancestor
92697238|NCT00530907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697239|NCT00530907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697240|NCT00530907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697241|NCT00531024|Bevacizumab|bevacizumab|mesh-list
92697242|NCT00531024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92697243|NCT00531024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697244|NCT00531024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92697296|NCT00515957|Immunologic Factors|immunologic factors|mesh-ancestor
92697297|NCT00515957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697368|NCT00514982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697369|NCT00514982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92697370|NCT00514982|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92697371|NCT00514982|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92697372|NCT00514982|Analgesics|analgesics|mesh-ancestor
92697373|NCT00514982|Sensory System Agents|sensory system agents|mesh-ancestor
92697374|NCT00514982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697375|NCT00531999|Ritonavir|ritonavir|mesh-list
92697376|NCT00531999|Lopinavir|lopinavir|mesh-list
92697377|NCT00531999|Raltegravir Potassium|raltegravir potassium|mesh-list
92697378|NCT00531999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92697379|NCT00531999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92697380|NCT00531999|Protease Inhibitors|protease inhibitors|mesh-ancestor
92697381|NCT00531999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697430|NCT00515138|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92697431|NCT00515138|Alkylating Agents|alkylating agents|mesh-ancestor
92697432|NCT05319834|Aspirin|aspirin|mesh-list
92697433|NCT05319834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92697434|NCT05319834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92697435|NCT05319834|Analgesics|analgesics|mesh-ancestor
92697436|NCT05319834|Sensory System Agents|sensory system agents|mesh-ancestor
92697437|NCT05319834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697438|NCT05319834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697439|NCT05319834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697440|NCT05319834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697441|NCT05319834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92697442|NCT05319834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92697443|NCT05319834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697444|NCT05319834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92697445|NCT05319834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92697487|NCT00516152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92697488|NCT00516152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697559|NCT02951039|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92697560|NCT02951039|Antithrombins|antithrombins|mesh-ancestor
92697561|NCT02951039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92697562|NCT02951039|Protease Inhibitors|protease inhibitors|mesh-ancestor
92697563|NCT02951039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697564|NCT02951039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697565|NCT02951039|Anticoagulants|anticoagulants|mesh-ancestor
92697566|NCT02951117|Dexamethasone|dexamethasone|mesh-list
92697567|NCT02951117|Venetoclax|venetoclax|mesh-list
92697568|NCT02951117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697569|NCT02951117|Antiemetics|antiemetics|mesh-ancestor
92697570|NCT02951117|Autonomic Agents|autonomic agents|mesh-ancestor
92697571|NCT02951117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697572|NCT02951117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697573|NCT02951117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697574|NCT02951117|Glucocorticoids|glucocorticoids|mesh-ancestor
92697575|NCT02951117|Hormones|hormones|mesh-ancestor
92697576|NCT02951117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697615|NCT05317611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697616|NCT05317572|Morphine|morphine|mesh-list
92697617|NCT05317572|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92697618|NCT05317572|Narcotics|narcotics|mesh-ancestor
92697619|NCT05317572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697620|NCT05317572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697621|NCT05317572|Analgesics|analgesics|mesh-ancestor
92697622|NCT05317572|Sensory System Agents|sensory system agents|mesh-ancestor
92697623|NCT05317572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697624|NCT00516425|Cyclophosphamide|cyclophosphamide|mesh-list
92697625|NCT00516425|Doxorubicin|doxorubicin|mesh-list
92697626|NCT00516425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92697627|NCT00516425|Epirubicin|epirubicin|mesh-list
92697628|NCT00516425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697629|NCT00516425|Immunologic Factors|immunologic factors|mesh-ancestor
92697630|NCT00516425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697631|NCT00516425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697632|NCT00516425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92697633|NCT00516425|Alkylating Agents|alkylating agents|mesh-ancestor
92697634|NCT00516425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697670|NCT02949752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697671|NCT02949752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697672|NCT02949752|Dopamine Agonists|dopamine agonists|mesh-ancestor
92697673|NCT02949752|Dopamine Agents|dopamine agents|mesh-ancestor
92697674|NCT02949752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92697675|NCT02949752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697676|NCT02949752|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92697677|NCT02949752|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92697737|NCT02940990|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92697738|NCT02940990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92697739|NCT02940990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697740|NCT02940990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92697741|NCT02940990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92697742|NCT00518297|Raltegravir Potassium|raltegravir potassium|mesh-list
92697744|NCT00518297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92697745|NCT00518297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92697746|NCT00518297|Antiviral Agents|antiviral agents|mesh-ancestor
92697747|NCT00518297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697748|NCT00518297|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92697749|NCT00518297|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92117604|NCT04780347|Paclitaxel|paclitaxel|mesh-list
92697750|NCT00518297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697751|NCT00518297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697752|NCT00518297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92697753|NCT00518297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92697754|NCT00518297|Protease Inhibitors|protease inhibitors|mesh-ancestor
92697755|NCT00518375|Cyclosporine|cyclosporine|mesh-list
92697756|NCT00518375|Sirolimus|sirolimus|mesh-list
92697757|NCT00518375|Cyclosporins|cyclosporins|mesh-list
92697758|NCT00518375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697759|NCT00518375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697760|NCT00518375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92697761|NCT00518375|Immunologic Factors|immunologic factors|mesh-ancestor
92697762|NCT00518375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697763|NCT00518375|Antifungal Agents|antifungal agents|mesh-ancestor
92697764|NCT00518375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697765|NCT00518375|Dermatologic Agents|dermatologic agents|mesh-ancestor
92697766|NCT00518375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697767|NCT00518375|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92697768|NCT00518375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92697778|NCT02942043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92697779|NCT00516971|Esomeprazole|esomeprazole|mesh-list
92697780|NCT00516971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92697781|NCT00516971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92697782|NCT00516971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92697783|NCT00516971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697784|NCT00516971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697785|NCT00518570|Levetiracetam|levetiracetam|mesh-list
92697786|NCT00518570|Anticonvulsants|anticonvulsants|mesh-ancestor
92697787|NCT00518570|Nootropic Agents|nootropic agents|mesh-ancestor
92697788|NCT03458208|Metformin|metformin|mesh-list
92697789|NCT03458208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92697790|NCT03458208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697791|NCT00517283|Exenatide|exenatide|mesh-list
92697792|NCT00517283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92697793|NCT00517283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697838|NCT02940717|Antidepressive Agents|antidepressive agents|mesh-ancestor
92697839|NCT02940717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697840|NCT02940717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92697841|NCT02940717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697842|NCT02940717|Antimanic Agents|antimanic agents|mesh-ancestor
92697843|NCT02940717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92697844|NCT02940717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697845|NCT02940717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697846|NCT00517517|Hemagglutinins|hemagglutinins|mesh-list
92697847|NCT00517517|Agglutinins|agglutinins|mesh-ancestor
92697848|NCT00517517|Immunologic Factors|immunologic factors|mesh-ancestor
92697849|NCT00517517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697850|NCT00517517|Coagulants|coagulants|mesh-ancestor
92697851|NCT02940756|Artesunate|artesunate|mesh-list
92697852|NCT02940756|Lumefantrine|lumefantrine|mesh-list
92697853|NCT02940756|Artemether|artemether|mesh-list
92697854|NCT02940756|Piperaquine|piperaquine|mesh-list
92697855|NCT02940756|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92697856|NCT02940756|Amodiaquine|amodiaquine|mesh-list
92697857|NCT02940756|Artenimol|artenimol|mesh-list
92697858|NCT02940756|Antimalarials|antimalarials|mesh-ancestor
92697859|NCT02940756|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92697860|NCT02940756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92697861|NCT02940756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697862|NCT02940756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697863|NCT02940756|Antiviral Agents|antiviral agents|mesh-ancestor
92697864|NCT02940756|Schistosomicides|schistosomicides|mesh-ancestor
92697865|NCT02940756|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92697866|NCT02940756|Anthelmintics|anthelmintics|mesh-ancestor
92697867|NCT02939547|Betadex|betadex|mesh-list
92697868|NCT02939547|Sequestering Agents|sequestering agents|mesh-ancestor
92697869|NCT02939547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697870|NCT02941068|Fluconazole|fluconazole|mesh-list
92697871|NCT02941068|Caspofungin|caspofungin|mesh-list
92697872|NCT02941068|Antifungal Agents|antifungal agents|mesh-ancestor
92697880|NCT02941068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92697881|NCT02941068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697882|NCT02941068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92697883|NCT02941068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92697884|NCT00517712|Arsenic Trioxide|arsenic trioxide|mesh-list
92697885|NCT00517712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92697945|NCT00517985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92697946|NCT00517985|Antidepressive Agents|antidepressive agents|mesh-ancestor
92697947|NCT00517985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92697948|NCT00517985|Dopamine Agents|dopamine agents|mesh-ancestor
92697949|NCT04690920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92697950|NCT04690920|Remdesivir|remdesivir|mesh-list
92697951|NCT04690920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92697952|NCT04690920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92697953|NCT04690920|Antimetabolites|antimetabolites|mesh-ancestor
92697954|NCT04690920|Antiviral Agents|antiviral agents|mesh-ancestor
92697955|NCT00518102|Becaplermin|becaplermin|mesh-list
92697956|NCT00518102|Anticoagulants|anticoagulants|mesh-ancestor
92697957|NCT00518102|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92697958|NCT00518102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92697959|NCT00518102|Growth Substances|growth substances|mesh-ancestor
92697960|NCT00518102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697961|NCT02939235|Morphine|morphine|mesh-list
92697962|NCT02939235|Metoclopramide|metoclopramide|mesh-list
92697963|NCT02939235|Ticagrelor|ticagrelor|mesh-list
92697964|NCT02939235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92697965|NCT02939235|Narcotics|narcotics|mesh-ancestor
92697966|NCT02939235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92697967|NCT02939235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697968|NCT02939235|Analgesics|analgesics|mesh-ancestor
92697969|NCT02939235|Sensory System Agents|sensory system agents|mesh-ancestor
92697984|NCT00518141|Aspirin|aspirin|mesh-list
92697996|NCT00518141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92697997|NCT00518141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92697998|NCT00518141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92697999|NCT00518141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92698000|NCT00518141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698001|NCT00518141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698002|NCT00518141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92698003|NCT00518141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92698004|NCT00518141|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92698005|NCT00518141|Antipyretics|antipyretics|mesh-ancestor
92698006|NCT02938962|Tranexamic Acid|tranexamic acid|mesh-list
92698007|NCT02938962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92698008|NCT02938962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92698010|NCT02938962|Hemostatics|hemostatics|mesh-ancestor
92698058|NCT02940561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698059|NCT02940561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698060|NCT02940561|Antimetabolites|antimetabolites|mesh-ancestor
92698061|NCT02940561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698062|NCT02940561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698063|NCT02940561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92698064|NCT02940561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698065|NCT02940561|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92698066|NCT02940561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698067|NCT02940561|Immunologic Factors|immunologic factors|mesh-ancestor
92698068|NCT02940561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698069|NCT02940561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92698070|NCT02940366|Atorvastatin|atorvastatin|mesh-list
92698071|NCT02940366|Pitavastatin|pitavastatin|mesh-list
92698072|NCT02940366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92698073|NCT02940366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92698074|NCT02940366|Antimetabolites|antimetabolites|mesh-ancestor
92698075|NCT02940366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698076|NCT02940366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92698077|NCT02940366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92698078|NCT02940366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698079|NCT02940405|Ketorolac|ketorolac|mesh-list
92698110|NCT04690647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698111|NCT04690647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92698112|NCT04690647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698114|NCT04690647|Sensory System Agents|sensory system agents|mesh-ancestor
92698115|NCT00519467|Artesunate|artesunate|mesh-list
92698116|NCT00519467|Dapsone|dapsone|mesh-list
92698117|NCT00519467|Chlorproguanil|chlorproguanil|mesh-list
92698118|NCT00519467|Antimalarials|antimalarials|mesh-ancestor
92698119|NCT00519467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92698120|NCT00519467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92698121|NCT00519467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92698122|NCT00519467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698123|NCT00519467|Antiviral Agents|antiviral agents|mesh-ancestor
92698124|NCT00519467|Schistosomicides|schistosomicides|mesh-ancestor
92698125|NCT00519467|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92698126|NCT00519467|Anthelmintics|anthelmintics|mesh-ancestor
92117982|NCT03254628|Oxytocin|oxytocin|mesh-list
92698168|NCT00520169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92698169|NCT00520169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92698170|NCT00520169|Anesthetics, General|anesthetics, general|mesh-ancestor
92698239|NCT02277132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92698240|NCT02277132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698310|NCT02931591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698311|NCT00521300|Octreotide|octreotide|mesh-list
92698312|NCT00521300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698313|NCT00521300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92698314|NCT00521300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698315|NCT00521690|Insulin Detemir|insulin detemir|mesh-list
92698316|NCT00521690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92698380|NCT02948348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698381|NCT02948348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92698382|NCT02948348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92698383|NCT04693910|Hormones|hormones|mesh-list
92698384|NCT04693910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698385|NCT04693910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698386|NCT00522158|Atorvastatin|atorvastatin|mesh-list
92698387|NCT00522158|Simvastatin|simvastatin|mesh-list
92698388|NCT00522158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92698389|NCT00522158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92698390|NCT00522158|Antimetabolites|antimetabolites|mesh-ancestor
92698391|NCT00522158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698392|NCT00522158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92698393|NCT00522158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92698394|NCT00522158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698440|NCT00522665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698441|NCT00522665|Immunologic Factors|immunologic factors|mesh-ancestor
92698442|NCT00522665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698443|NCT00522743|Hormones|hormones|mesh-list
92698444|NCT00522743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698445|NCT00522743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698446|NCT02937012|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92698447|NCT02937012|Bezafibrate|bezafibrate|mesh-list
92698448|NCT02937012|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92698449|NCT02937012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698450|NCT02937012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92698451|NCT02937012|Antimetabolites|antimetabolites|mesh-ancestor
92698502|NCT04694105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698503|NCT04694105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92698574|NCT00524615|Spironolactone|spironolactone|mesh-list
92698575|NCT00524615|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92698576|NCT00524615|Hormone Antagonists|hormone antagonists|mesh-ancestor
92698577|NCT00524615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698578|NCT00524615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698579|NCT00524615|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92698580|NCT00524615|Diuretics|diuretics|mesh-ancestor
92698581|NCT00524615|Natriuretic Agents|natriuretic agents|mesh-ancestor
92698582|NCT00523445|Varenicline|varenicline|mesh-list
92698583|NCT00523445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92698584|NCT00523445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92698585|NCT00523445|Cholinergic Agents|cholinergic agents|mesh-ancestor
92698586|NCT00523445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92698587|NCT00523445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698588|NCT00523445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698589|NCT02936661|Tranexamic Acid|tranexamic acid|mesh-list
92698593|NCT02936661|Hemostatics|hemostatics|mesh-ancestor
92698630|NCT00524693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698631|NCT00524693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698700|NCT00524810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698701|NCT00524810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92698702|NCT00524810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92698703|NCT00524810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698704|NCT00524810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698705|NCT00524849|Zoledronic Acid|zoledronic acid|mesh-list
92698706|NCT00524849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92698707|NCT00524849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698708|NCT00524927|Methoxyflurane|methoxyflurane|mesh-list
92698709|NCT00524927|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92698710|NCT00524927|Anesthetics, General|anesthetics, general|mesh-ancestor
92698711|NCT00524927|Anesthetics|anesthetics|mesh-ancestor
92698712|NCT00524927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698713|NCT00524927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698714|NCT00524966|Hemostatics|hemostatics|mesh-list
92698715|NCT00524966|Coagulants|coagulants|mesh-ancestor
92698716|NCT02276846|Paclitaxel|paclitaxel|mesh-list
92698717|NCT02276846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92698718|NCT02276846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698719|NCT02276846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92698720|NCT02276846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92698721|NCT02276846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92118582|NCT03237312|Hormones|hormones|mesh-list
92698722|NCT02276846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698723|NCT02935725|Ketamine|ketamine|mesh-list
92698724|NCT02935725|Analgesics|analgesics|mesh-ancestor
92698725|NCT02935725|Sensory System Agents|sensory system agents|mesh-ancestor
92698746|NCT02935764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698747|NCT02935764|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92698748|NCT02935764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92698749|NCT02935764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92698750|NCT02935764|Antidotes|antidotes|mesh-ancestor
92698751|NCT02935764|Protective Agents|protective agents|mesh-ancestor
92698752|NCT02935764|Vitamin B Complex|vitamin b complex|mesh-ancestor
92698753|NCT02935764|Vitamins|vitamins|mesh-ancestor
92698754|NCT02935764|Micronutrients|micronutrients|mesh-ancestor
92698755|NCT02935998|Ziprasidone|ziprasidone|mesh-list
92698815|NCT00525200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92698816|NCT00525200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92698817|NCT00525200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399986|NCT01406080|Analgesics|analgesics|mesh-ancestor
92698818|NCT00525200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698819|NCT00525200|Antimetabolites|antimetabolites|mesh-ancestor
92698820|NCT00525200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698821|NCT00525200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698822|NCT00525200|Immunologic Factors|immunologic factors|mesh-ancestor
92698823|NCT00525200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698824|NCT02930265|Liraglutide|liraglutide|mesh-list
92698825|NCT02930265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92698826|NCT02930265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698827|NCT02930265|Incretins|incretins|mesh-ancestor
92698828|NCT02930265|Hormones|hormones|mesh-ancestor
92698829|NCT02930265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92698830|NCT02947178|Bupivacaine|bupivacaine|mesh-list
92698831|NCT02947178|Anesthetics, Local|anesthetics, local|mesh-ancestor
92698832|NCT02947178|Anesthetics|anesthetics|mesh-ancestor
92698833|NCT02947178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92698834|NCT02947178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698835|NCT02947178|Sensory System Agents|sensory system agents|mesh-ancestor
92698836|NCT02947178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92698837|NCT02929797|Gemcitabine|gemcitabine|mesh-list
92698838|NCT02929797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92698839|NCT02929797|Antimetabolites|antimetabolites|mesh-ancestor
92698840|NCT02929797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698841|NCT02929797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92698842|NCT00525239|Ritonavir|ritonavir|mesh-list
92698843|NCT00525239|Lopinavir|lopinavir|mesh-list
92698844|NCT00525239|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92698845|NCT00525239|Efavirenz|efavirenz|mesh-list
92698859|NCT00525239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92698860|NCT00525239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92698861|NCT00525239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92698862|NCT00525239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92698863|NCT00525239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92698864|NCT02929914|Anti-Infective Agents|anti-infective agents|mesh-list
92698865|NCT02929914|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92698866|NCT02947334|Bococizumab|bococizumab|mesh-list
92698867|NCT02947334|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92698868|NCT02947334|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92698869|NCT02947334|Antimetabolites|antimetabolites|mesh-ancestor
92698870|NCT02947334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698871|NCT02947334|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92698920|NCT00526175|Daunorubicin|daunorubicin|mesh-list
92698921|NCT00526175|Asparaginase|asparaginase|mesh-list
92698922|NCT00526175|Mercaptopurine|mercaptopurine|mesh-list
92698923|NCT00526175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92698924|NCT00526175|Immunologic Factors|immunologic factors|mesh-ancestor
92698925|NCT00526175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698926|NCT00526175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92698927|NCT00526175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92698989|NCT04288323|Protective Agents|protective agents|mesh-ancestor
92698990|NCT04288323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92698991|NCT04288323|Chelating Agents|chelating agents|mesh-ancestor
92698992|NCT04288323|Sequestering Agents|sequestering agents|mesh-ancestor
92698993|NCT04288323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92698994|NCT04288323|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92698995|NCT04288323|Anticoagulants|anticoagulants|mesh-ancestor
92698996|NCT04288323|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92698997|NCT04288323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92698999|NCT02946359|Crizotinib|crizotinib|mesh-list
92699004|NCT02946359|Growth Substances|growth substances|mesh-ancestor
92699054|NCT02929212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699055|NCT02929212|Analgesics|analgesics|mesh-ancestor
92699056|NCT02929212|Sensory System Agents|sensory system agents|mesh-ancestor
92699127|NCT02946944|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92699128|NCT02946944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699129|NCT02946944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699130|NCT02946944|Urological Agents|urological agents|mesh-ancestor
92699131|NCT02946944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92699132|NCT02946944|Antithrombins|antithrombins|mesh-ancestor
92699133|NCT02946944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92699134|NCT02946944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92699135|NCT02946944|Anticoagulants|anticoagulants|mesh-ancestor
92699136|NCT02947061|Docetaxel|docetaxel|mesh-list
92699137|NCT02947061|Capecitabine|capecitabine|mesh-list
92699138|NCT02947061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699139|NCT02947061|Tubulin Modulators|tubulin modulators|mesh-ancestor
92699140|NCT02947061|Antimitotic Agents|antimitotic agents|mesh-ancestor
92699141|NCT02947061|Mitosis Modulators|mitosis modulators|mesh-ancestor
92699142|NCT02947061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699143|NCT02947061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699144|NCT02947061|Antimetabolites|antimetabolites|mesh-ancestor
92699145|NCT02928315|Magnesium Sulfate|magnesium sulfate|mesh-list
92699146|NCT02928315|Analgesics|analgesics|mesh-ancestor
92699184|NCT00526409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92699185|NCT00526409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92699186|NCT00526409|Tubulin Modulators|tubulin modulators|mesh-ancestor
92699187|NCT00526409|Antimitotic Agents|antimitotic agents|mesh-ancestor
92699188|NCT00526409|Mitosis Modulators|mitosis modulators|mesh-ancestor
92699189|NCT00526409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699190|NCT00526409|Glucocorticoids|glucocorticoids|mesh-ancestor
92699191|NCT00526409|Hormones|hormones|mesh-ancestor
92699192|NCT00526409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92699193|NCT00526409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92699247|NCT02945163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699249|NCT02945163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92699253|NCT02945163|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92699317|NCT00527033|Adrenergic Agents|adrenergic agents|mesh-ancestor
92699318|NCT00527033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92699319|NCT00527033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699320|NCT00527033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699321|NCT00527033|Urological Agents|urological agents|mesh-ancestor
92699322|NCT02945072|Sevoflurane|sevoflurane|mesh-list
92699323|NCT02945072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92699325|NCT02945072|Anesthetics, General|anesthetics, general|mesh-ancestor
92699326|NCT02945072|Anesthetics|anesthetics|mesh-ancestor
92699327|NCT02945072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92699328|NCT02945072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699330|NCT02924922|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92699380|NCT02924766|Niraparib|niraparib|mesh-list
92699382|NCT02924766|Glucocorticoids|glucocorticoids|mesh-ancestor
92699451|NCT00527228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699452|NCT00527228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92699453|NCT00527228|Immunologic Factors|immunologic factors|mesh-ancestor
92699454|NCT00527228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699455|NCT00527267|Cinacalcet|cinacalcet|mesh-list
92699456|NCT00527267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699457|NCT00527267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699458|NCT00527267|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92699459|NCT00527267|Hormone Antagonists|hormone antagonists|mesh-ancestor
92699516|NCT02926326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699518|NCT00528671|Anticoagulants|anticoagulants|mesh-ancestor
92699519|NCT00528827|Nicardipine|nicardipine|mesh-list
92699520|NCT00528827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92699521|NCT00528827|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92699522|NCT00528827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92699523|NCT00528827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699524|NCT00528827|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92699525|NCT00528827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699526|NCT00528827|Vasodilator Agents|vasodilator agents|mesh-ancestor
92699527|NCT02926170|Rivaroxaban|rivaroxaban|mesh-list
92699528|NCT02926170|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92699529|NCT02926170|Antithrombins|antithrombins|mesh-ancestor
92699530|NCT02926170|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92699531|NCT02926170|Protease Inhibitors|protease inhibitors|mesh-ancestor
92699532|NCT02926170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699533|NCT02926170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699534|NCT02926170|Anticoagulants|anticoagulants|mesh-ancestor
92699570|NCT00527540|Interferon-alpha|interferon-alpha|mesh-list
92699571|NCT00527540|Interferon alpha-2|interferon alpha-2|mesh-list
92699572|NCT00527540|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92699644|NCT02925975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699645|NCT02925975|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92699646|NCT02925975|Antioxidants|antioxidants|mesh-ancestor
92699717|NCT00529880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699718|NCT00529880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699790|NCT00531128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699791|NCT00531128|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92699793|NCT02925351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92699794|NCT02925351|Antimetabolites|antimetabolites|mesh-ancestor
92699795|NCT02925351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699796|NCT02925351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699797|NCT00531167|Lamivudine|lamivudine|mesh-list
92699798|NCT00531167|Adefovir|adefovir|mesh-list
92699799|NCT00531167|Entecavir|entecavir|mesh-list
92699800|NCT00531167|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92699801|NCT00531167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92699854|NCT00531323|Etravirine|etravirine|mesh-list
92699855|NCT00531323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92699856|NCT00531323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92699857|NCT00531323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699858|NCT00531323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699859|NCT00531323|Antiviral Agents|antiviral agents|mesh-ancestor
92699860|NCT00531323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699861|NCT00531362|Aspirin|aspirin|mesh-list
92699862|NCT00531362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92699863|NCT00531362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92699864|NCT00531362|Analgesics|analgesics|mesh-ancestor
92699865|NCT00531362|Sensory System Agents|sensory system agents|mesh-ancestor
92699866|NCT00531362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699867|NCT00531362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699868|NCT00531362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699881|NCT00531440|Everolimus|everolimus|mesh-list
92699914|NCT00530387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92699915|NCT00530387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92699916|NCT00530387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92699917|NCT00530387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92699918|NCT00530387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92699919|NCT00530387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699920|NCT00530387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699921|NCT00530387|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92699922|NCT00530387|Protective Agents|protective agents|mesh-ancestor
92699923|NCT00530387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92699924|NCT00530387|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92699977|NCT00531635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92699978|NCT00531635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92699979|NCT00531635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92699980|NCT00531635|Antitubercular Agents|antitubercular agents|mesh-ancestor
92699981|NCT00531635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92699982|NCT00531635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699983|NCT00531635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92699984|NCT00531635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699985|NCT02917551|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92699986|NCT02917551|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92699987|NCT02917551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92699988|NCT02917551|Antitubercular Agents|antitubercular agents|mesh-ancestor
92699989|NCT00531674|Tocopherols|tocopherols|mesh-list
92699990|NCT00531674|Antioxidants|antioxidants|mesh-ancestor
92699991|NCT00531674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92699992|NCT00531674|Protective Agents|protective agents|mesh-ancestor
92699993|NCT00531674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700034|NCT00531908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700035|NCT03403569|Triptolide|triptolide|mesh-list
92700036|NCT03403569|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92700037|NCT03403569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700038|NCT03403569|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92700039|NCT03403569|Contraceptive Agents|contraceptive agents|mesh-ancestor
92700040|NCT03403569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92700041|NCT03403569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92700042|NCT03403569|Immunologic Factors|immunologic factors|mesh-ancestor
92700043|NCT03403569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92700044|NCT03403569|Alkylating Agents|alkylating agents|mesh-ancestor
92700045|NCT03403569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700046|NCT03403569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700047|NCT00531791|Prednisone|prednisone|mesh-list
92700048|NCT00531791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700093|NCT02920827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92700094|NCT02920827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92700164|NCT02941913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700165|NCT02942693|Apatinib|apatinib|mesh-list
92700166|NCT02942693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700167|NCT02942693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92700168|NCT02942693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700169|NCT02942693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700170|NCT02920593|Vitamin D|vitamin d|mesh-list
92700171|NCT02920593|Ergocalciferols|ergocalciferols|mesh-list
92700172|NCT02920593|Cholecalciferol|cholecalciferol|mesh-list
92700173|NCT02920593|Vitamins|vitamins|mesh-list
92700174|NCT02920593|Micronutrients|micronutrients|mesh-ancestor
92700175|NCT02920593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700176|NCT02920593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92700177|NCT02920593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92700178|NCT02942732|Cholecalciferol|cholecalciferol|mesh-list
92700179|NCT02942732|Vitamin D|vitamin d|mesh-list
92700180|NCT02942732|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92700182|NCT02942732|Vitamins|vitamins|mesh-ancestor
92700222|NCT02941562|Micronutrients|micronutrients|mesh-ancestor
92700224|NCT02942888|Niacin|niacin|mesh-list
92700225|NCT02942888|Nicotinic Acids|nicotinic acids|mesh-list
92700226|NCT02942888|Vitamin B Complex|vitamin b complex|mesh-ancestor
92700227|NCT02942888|Vitamins|vitamins|mesh-ancestor
92700228|NCT02942888|Micronutrients|micronutrients|mesh-ancestor
92700229|NCT02942888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700230|NCT02942888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92700231|NCT02942888|Antimetabolites|antimetabolites|mesh-ancestor
92700235|NCT02916420|Dexamethasone|dexamethasone|mesh-list
92700289|NCT02941016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92700290|NCT02941016|Antimetabolites|antimetabolites|mesh-ancestor
92700291|NCT02941016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700292|NCT02941016|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92700293|NCT02941016|Protease Inhibitors|protease inhibitors|mesh-ancestor
92700294|NCT02941016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700295|NCT02941016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92700296|NCT03200379|Antiviral Agents|antiviral agents|mesh-list
92700297|NCT03200379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92700298|NCT02919735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92700299|NCT02941445|Metformin|metformin|mesh-list
92700354|NCT02919462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700432|NCT02919072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700433|NCT02919072|Sensory System Agents|sensory system agents|mesh-ancestor
92700506|NCT02915055|Analgesics|analgesics|mesh-ancestor
92700507|NCT02915055|Sensory System Agents|sensory system agents|mesh-ancestor
92700508|NCT02915055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700509|NCT02915055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700510|NCT02915055|Antipyretics|antipyretics|mesh-ancestor
92700511|NCT02915055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92700512|NCT02915055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92700513|NCT02915055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92700514|NCT02915055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92700515|NCT02915055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92700516|NCT02915055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700517|NCT02915055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92700518|NCT02915055|Narcotics|narcotics|mesh-ancestor
92700519|NCT02915055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700520|NCT01295827|Pembrolizumab|pembrolizumab|mesh-list
92700521|NCT01295827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700564|NCT03458078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92700565|NCT03458078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92700566|NCT03458078|Tocolytic Agents|tocolytic agents|mesh-ancestor
92700567|NCT03458078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92700568|NCT04690556|Ranibizumab|ranibizumab|mesh-list
92700569|NCT04690556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92700570|NCT04690556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92700571|NCT04690556|Growth Substances|growth substances|mesh-ancestor
92700572|NCT04690556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700573|NCT04690556|Growth Inhibitors|growth inhibitors|mesh-ancestor
92700574|NCT04690556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700575|NCT01294579|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92700576|NCT01294579|Ofatumumab|ofatumumab|mesh-list
92700577|NCT01294579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92700578|NCT01294579|Alkylating Agents|alkylating agents|mesh-ancestor
92700579|NCT01294579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700580|NCT01294579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700581|NCT02914626|Ranibizumab|ranibizumab|mesh-list
92700582|NCT02914626|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92700618|NCT01294462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92700692|NCT02938286|Autonomic Agents|autonomic agents|mesh-ancestor
92700693|NCT02938286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700766|NCT01290718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700767|NCT01290718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92700768|NCT04324294|Pancrelipase|pancrelipase|mesh-list
92700769|NCT04324294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92700770|NCT02937896|Ketorolac|ketorolac|mesh-list
92700771|NCT02937896|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92700772|NCT02937896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92700773|NCT02937896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92700774|NCT02937896|Analgesics|analgesics|mesh-ancestor
92700775|NCT02937896|Sensory System Agents|sensory system agents|mesh-ancestor
92700833|NCT02890186|Sensory System Agents|sensory system agents|mesh-ancestor
92700834|NCT02890186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700836|NCT02909751|Vitamin E|vitamin e|mesh-list
92700909|NCT02978391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700910|NCT02978391|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92700986|NCT02913573|Anesthetics, Local|anesthetics, local|mesh-ancestor
92700987|NCT02913573|Anesthetics|anesthetics|mesh-ancestor
92700988|NCT02913573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700989|NCT02913573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92700990|NCT02913573|Sensory System Agents|sensory system agents|mesh-ancestor
92700991|NCT02913573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92700992|NCT01289353|Carboplatin|carboplatin|mesh-list
92700993|NCT01289353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92700994|NCT02913300|Lidocaine|lidocaine|mesh-list
92700995|NCT02913300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92700996|NCT02913300|Anesthetics, Local|anesthetics, local|mesh-ancestor
92700997|NCT02913300|Anesthetics|anesthetics|mesh-ancestor
92700998|NCT02913300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92700999|NCT02913300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701000|NCT02913300|Sensory System Agents|sensory system agents|mesh-ancestor
92701045|NCT01287754|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92701046|NCT01287754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701047|NCT01287754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92701048|NCT01287754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701049|NCT01287754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701051|NCT02912793|Sequestering Agents|sequestering agents|mesh-ancestor
92701052|NCT02912793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701053|NCT02935751|Apixaban|apixaban|mesh-list
92701061|NCT02935790|Nivolumab|nivolumab|mesh-list
92701110|NCT02912676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701111|NCT02912676|Immunologic Factors|immunologic factors|mesh-ancestor
92701112|NCT02912676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701113|NCT02912676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701114|NCT02935985|Fibrin fragment D|fibrin fragment d|mesh-list
92701115|NCT02935985|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92701116|NCT02935985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92701117|NCT02935985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701118|NCT02935985|Hemostatics|hemostatics|mesh-ancestor
92701119|NCT02935985|Coagulants|coagulants|mesh-ancestor
92701120|NCT02912169|Anesthetics|anesthetics|mesh-list
92701121|NCT02912169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701125|NCT02935959|Midazolam|midazolam|mesh-list
92701175|NCT02935010|Metronidazole|metronidazole|mesh-list
92701176|NCT02935010|Clarithromycin|clarithromycin|mesh-list
92701177|NCT02935010|Levofloxacin|levofloxacin|mesh-list
92400010|NCT01406171|Midazolam|midazolam|mesh-list
92701250|NCT02934035|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92701251|NCT02934035|Analgesics|analgesics|mesh-ancestor
92701252|NCT02934035|Sensory System Agents|sensory system agents|mesh-ancestor
92701253|NCT02934035|Dopamine Agents|dopamine agents|mesh-ancestor
92701254|NCT02934035|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92701255|NCT02934035|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92701256|NCT02934035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701257|NCT02934152|Amoxicillin|amoxicillin|mesh-list
92701258|NCT02934152|Clarithromycin|clarithromycin|mesh-list
92701259|NCT02934152|Rabeprazole|rabeprazole|mesh-list
92701260|NCT02934152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92701261|NCT02934152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701262|NCT02934152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92701263|NCT02934152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701264|NCT02934152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701265|NCT02934152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92701266|NCT02934152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92701309|NCT02934945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701310|NCT02934945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701311|NCT02934945|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92701312|NCT02934945|Respiratory System Agents|respiratory system agents|mesh-ancestor
92701313|NCT02934945|Glucocorticoids|glucocorticoids|mesh-ancestor
92701314|NCT02934945|Hormones|hormones|mesh-ancestor
92701315|NCT02934945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92701316|NCT02934945|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92701317|NCT02934945|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92701318|NCT02934945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92701373|NCT02933099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701374|NCT02933099|Protease Inhibitors|protease inhibitors|mesh-ancestor
92701375|NCT02933099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701376|NCT02933099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701377|NCT02933099|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92701378|NCT02933099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701379|NCT02933099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92701380|NCT02933099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92701381|NCT02933099|Serotonin Agents|serotonin agents|mesh-ancestor
92701382|NCT02934906|Immunoglobulins|immunoglobulins|mesh-list
92701383|NCT02934906|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92701384|NCT02934906|Antibodies|antibodies|mesh-list
92701385|NCT02934906|gamma-Globulins|gamma-globulins|mesh-list
92701386|NCT02934906|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92701387|NCT02934906|Immunologic Factors|immunologic factors|mesh-ancestor
92701388|NCT02934906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701389|NCT02911350|Paclitaxel|paclitaxel|mesh-list
92701390|NCT02911350|Hormones|hormones|mesh-list
92701430|NCT02932007|Filaricides|filaricides|mesh-ancestor
92701431|NCT02932007|Antinematodal Agents|antinematodal agents|mesh-ancestor
92701432|NCT02932007|Anthelmintics|anthelmintics|mesh-ancestor
92701433|NCT02910882|Gemcitabine|gemcitabine|mesh-list
92701434|NCT02910882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92701435|NCT02910882|Antimetabolites|antimetabolites|mesh-ancestor
92701436|NCT02910882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701437|NCT02910882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701438|NCT02910765|Methylene Blue|methylene blue|mesh-list
92701439|NCT02910765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701440|NCT02910765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701441|NCT02925026|Lactoferrin|lactoferrin|mesh-list
92701442|NCT02925026|Muramidase|muramidase|mesh-list
92701443|NCT02925026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701444|NCT02924987|Aflibercept|aflibercept|mesh-list
92701445|NCT02924987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92701446|NCT02924987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92701447|NCT02924987|Growth Substances|growth substances|mesh-ancestor
92701448|NCT02924987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701487|NCT03847545|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92701488|NCT03847545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701489|NCT03847545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701491|NCT02924285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92701492|NCT02924285|Vasodilator Agents|vasodilator agents|mesh-ancestor
92701493|NCT02924285|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92701494|NCT02924285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701503|NCT01287520|Carboplatin|carboplatin|mesh-list
92701552|NCT02924090|Anesthetics|anesthetics|mesh-ancestor
92701553|NCT02924090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701554|NCT02924090|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92701555|NCT02924090|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92701556|NCT02924090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701557|NCT02924090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701558|NCT02924090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92701559|NCT04137770|Ketorolac|ketorolac|mesh-list
92701560|NCT04137770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92701614|NCT05590936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701615|NCT05590936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701616|NCT05590936|Antipruritics|antipruritics|mesh-ancestor
92701617|NCT05590936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701618|NCT05590936|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92701619|NCT05590936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92701620|NCT05590936|Serotonin Agents|serotonin agents|mesh-ancestor
92701621|NCT05590936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92701622|NCT05590936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701623|NCT05590936|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92701624|NCT05590936|Histamine Antagonists|histamine antagonists|mesh-ancestor
92701625|NCT05590936|Histamine Agents|histamine agents|mesh-ancestor
92701626|NCT02933814|Bupivacaine|bupivacaine|mesh-list
92701627|NCT02933814|Anesthetics, Local|anesthetics, local|mesh-ancestor
92701628|NCT02933814|Anesthetics|anesthetics|mesh-ancestor
92701629|NCT02933814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92701630|NCT02933814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701631|NCT02933814|Sensory System Agents|sensory system agents|mesh-ancestor
92701632|NCT02933814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701633|NCT02933775|Cyclophosphamide|cyclophosphamide|mesh-list
92701634|NCT02933775|Fludarabine|fludarabine|mesh-list
92701635|NCT02933775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701636|NCT02933775|Immunologic Factors|immunologic factors|mesh-ancestor
92701637|NCT02933775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701638|NCT02933775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701639|NCT02933775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92701663|NCT02933658|Amlodipine|amlodipine|mesh-list
92701664|NCT02933658|Telmisartan|telmisartan|mesh-list
92121498|NCT02449278|Prednisone|prednisone|mesh-list
92701665|NCT02933658|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92701666|NCT02933658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92701667|NCT02933658|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92701668|NCT02933658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92701669|NCT02933658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701670|NCT02933658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92701671|NCT02933658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701672|NCT02933658|Vasodilator Agents|vasodilator agents|mesh-ancestor
92701673|NCT02933658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92701674|NCT02933658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92701675|NCT02933658|Antimetabolites|antimetabolites|mesh-ancestor
92701676|NCT02933658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92701678|NCT02933658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701721|NCT02834559|Heparin|heparin|mesh-list
92701722|NCT02834559|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92701723|NCT02834559|Tinzaparin|tinzaparin|mesh-list
92701724|NCT02834559|Dalteparin|dalteparin|mesh-list
92701725|NCT02834559|Antimetabolites|antimetabolites|mesh-ancestor
92701726|NCT02834559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701727|NCT02834559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92701728|NCT02834559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701729|NCT02834559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92701730|NCT02834559|Immunologic Factors|immunologic factors|mesh-ancestor
92701731|NCT02834559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701786|NCT03924440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92701787|NCT03924440|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92701788|NCT01285492|Tiotropium Bromide|tiotropium bromide|mesh-list
92701789|NCT01285492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92701790|NCT01285492|Autonomic Agents|autonomic agents|mesh-ancestor
92701791|NCT01285492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701792|NCT01285492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701793|NCT01285492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92701794|NCT01285492|Respiratory System Agents|respiratory system agents|mesh-ancestor
92701795|NCT01285492|Parasympatholytics|parasympatholytics|mesh-ancestor
92701852|NCT02921360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701853|NCT02921360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701854|NCT02921360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701855|NCT02921360|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701856|NCT02921360|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92701857|NCT02921360|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92701858|NCT02921360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701859|NCT02921360|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92701860|NCT02921360|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92701862|NCT02921360|Antipyretics|antipyretics|mesh-ancestor
92701916|NCT01283386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701917|NCT01283386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701918|NCT01283386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92701919|NCT01283386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92701920|NCT02920931|Tenofovir|tenofovir|mesh-list
92701921|NCT02920931|Antiviral Agents|antiviral agents|mesh-ancestor
92701922|NCT02920931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92701923|NCT02920931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92701924|NCT02920931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92701925|NCT02920931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92701926|NCT02920931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92701927|NCT02920931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92701928|NCT02920931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92701929|NCT01283152|Lactulose|lactulose|mesh-list
92701930|NCT01283152|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92701931|NCT01283152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92701932|NCT01283152|Laxatives|laxatives|mesh-ancestor
92701933|NCT01283464|Vitamin A|vitamin a|mesh-list
92701934|NCT01283464|Tretinoin|tretinoin|mesh-list
92701935|NCT01283464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701936|NCT01283464|Keratolytic Agents|keratolytic agents|mesh-ancestor
92701937|NCT01283464|Dermatologic Agents|dermatologic agents|mesh-ancestor
92701938|NCT01283464|Vitamins|vitamins|mesh-ancestor
92701939|NCT01283464|Micronutrients|micronutrients|mesh-ancestor
92701940|NCT01283464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701965|NCT02932566|Sensory System Agents|sensory system agents|mesh-ancestor
92701966|NCT02932566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92701967|NCT02932566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92701968|NCT02932566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92701969|NCT02932566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92701970|NCT02932566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92701971|NCT02932566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92701972|NCT02932566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92701973|NCT00532389|Panobinostat|panobinostat|mesh-list
92701974|NCT00532389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702029|NCT01281865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702030|NCT01281865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702031|NCT02920658|Betamethasone|betamethasone|mesh-list
92702032|NCT02920658|Betamethasone Valerate|betamethasone valerate|mesh-list
92702033|NCT02920658|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92702034|NCT02920658|Betamethasone benzoate|betamethasone benzoate|mesh-list
92702035|NCT02920658|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92702036|NCT02920658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702037|NCT02920658|Glucocorticoids|glucocorticoids|mesh-ancestor
92702038|NCT02920658|Hormones|hormones|mesh-ancestor
92702039|NCT02920658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702040|NCT02920658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702041|NCT02920658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92702093|NCT02932020|Autonomic Agents|autonomic agents|mesh-ancestor
92702094|NCT02932020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702095|NCT02932020|Glucocorticoids|glucocorticoids|mesh-ancestor
92702096|NCT02932020|Hormones|hormones|mesh-ancestor
92702097|NCT02932020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702098|NCT02932020|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92702103|NCT01280656|Ribavirin|ribavirin|mesh-list
92702159|NCT02932254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92702161|NCT02920190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702162|NCT02920190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702163|NCT02920190|Incretins|incretins|mesh-ancestor
92702164|NCT02920190|Hormones|hormones|mesh-ancestor
92702166|NCT02919878|Gemcitabine|gemcitabine|mesh-list
92702167|NCT02919878|Capecitabine|capecitabine|mesh-list
92702227|NCT02919332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702229|NCT02919332|Antiviral Agents|antiviral agents|mesh-ancestor
92702230|NCT02919332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702231|NCT02919293|Vaccines|vaccines|mesh-list
92702232|NCT02919293|Immunologic Factors|immunologic factors|mesh-ancestor
92702233|NCT02919293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702234|NCT02919371|Bevacizumab|bevacizumab|mesh-list
92702235|NCT02919371|Sunitinib|sunitinib|mesh-list
92702236|NCT02919371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92702237|NCT02919371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702238|NCT02919371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92702292|NCT02918825|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92702293|NCT02918825|Antiemetics|antiemetics|mesh-ancestor
92702294|NCT02918825|Autonomic Agents|autonomic agents|mesh-ancestor
92702295|NCT02918825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702296|NCT02918825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702297|NCT02918825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702298|NCT02918825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92702299|NCT02918825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702300|NCT02918825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702301|NCT02918825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702302|NCT02918825|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92702303|NCT02918825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92702353|NCT02918591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92702354|NCT02918591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702355|NCT02918591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702356|NCT02918591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702357|NCT02918045|Cellulose, Oxidized|cellulose, oxidized|mesh-list
92702358|NCT02918045|Hemostatics|hemostatics|mesh-ancestor
92702359|NCT02918045|Coagulants|coagulants|mesh-ancestor
92702360|NCT00532545|Teriparatide|teriparatide|mesh-list
92702361|NCT00532545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92702362|NCT00532545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702363|NCT00532545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92702364|NCT00533520|Ranibizumab|ranibizumab|mesh-list
92702365|NCT00533520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92702366|NCT00533520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92702367|NCT00533520|Growth Substances|growth substances|mesh-ancestor
92702368|NCT00533520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702371|NCT03694262|Bevacizumab|bevacizumab|mesh-list
92702411|NCT04687332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92702412|NCT04687332|Antidepressive Agents|antidepressive agents|mesh-ancestor
92702413|NCT04687332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702414|NCT05467709|Midazolam|midazolam|mesh-list
92702415|NCT05467709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92702416|NCT05467709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92122246|NCT02097537|Miotics|miotics|mesh-ancestor
92702417|NCT05467709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702418|NCT05467709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702419|NCT05467709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92702420|NCT05467709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702421|NCT05467709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702422|NCT05467709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92702423|NCT05467709|Anesthetics, General|anesthetics, general|mesh-ancestor
92702424|NCT05467709|Anesthetics|anesthetics|mesh-ancestor
92702425|NCT05467709|GABA Modulators|gaba modulators|mesh-ancestor
92702426|NCT05467709|GABA Agents|gaba agents|mesh-ancestor
92702427|NCT05467709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702428|NCT05467709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702429|NCT00532623|Gemcitabine|gemcitabine|mesh-list
92702430|NCT00532623|Vinorelbine|vinorelbine|mesh-list
92702431|NCT00532623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92702432|NCT00532623|Antimetabolites|antimetabolites|mesh-ancestor
92702433|NCT00532623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702434|NCT00532623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702439|NCT05467670|Doxorubicin|doxorubicin|mesh-list
92702459|NCT00532662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702460|NCT00532662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92702461|NCT00532662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92702462|NCT00532662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702463|NCT00532662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702465|NCT05467436|Anesthetics|anesthetics|mesh-list
92702466|NCT05467436|Anesthetics, Local|anesthetics, local|mesh-list
92702467|NCT05467436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702468|NCT05467436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702469|NCT05467436|Sensory System Agents|sensory system agents|mesh-ancestor
92702471|NCT00533637|Cetirizine|cetirizine|mesh-list
92702522|NCT00532701|Immunologic Factors|immunologic factors|mesh-ancestor
92702523|NCT00532701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702524|NCT00532701|Antimetabolites|antimetabolites|mesh-ancestor
92702525|NCT00532701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702526|NCT01276639|Tofacitinib|tofacitinib|mesh-list
92702527|NCT01276639|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92702528|NCT01276639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92702529|NCT01276639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702530|NCT01276639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702531|NCT00532415|Triamcinolone|triamcinolone|mesh-list
92702532|NCT00532415|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92702533|NCT00532415|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92702534|NCT00532415|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92702535|NCT00532415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92702536|NCT00532415|Glucocorticoids|glucocorticoids|mesh-ancestor
92702537|NCT00532415|Hormones|hormones|mesh-ancestor
92702538|NCT00532415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92702539|NCT00532415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702540|NCT00532415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702541|NCT00532415|Immunologic Factors|immunologic factors|mesh-ancestor
92702544|NCT00532454|Tamoxifen|tamoxifen|mesh-list
92702571|NCT05459792|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92702572|NCT05459792|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92702573|NCT05459792|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92702574|NCT05459792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702575|NCT05459792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702576|NCT04686825|DA-8010|da-8010|mesh-list
92702577|NCT04686825|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92702578|NCT04686825|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92702579|NCT04686825|Cholinergic Agents|cholinergic agents|mesh-ancestor
92702580|NCT04686825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702585|NCT05281185|Factor VIII|factor viii|mesh-list
92122476|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
92122477|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702636|NCT00534183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92702637|NCT00534183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92702638|NCT00534183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92702639|NCT00534183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92702640|NCT00534183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92702641|NCT00534183|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92702642|NCT00532727|Carboplatin|carboplatin|mesh-list
92702644|NCT00532727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702645|NCT00532727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702646|NCT00532727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702647|NCT00532727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92702648|NCT00532727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702649|NCT04261218|Paclitaxel|paclitaxel|mesh-list
92702650|NCT04261218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92702651|NCT04261218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92702652|NCT04261218|Tubulin Modulators|tubulin modulators|mesh-ancestor
92702653|NCT04261218|Antimitotic Agents|antimitotic agents|mesh-ancestor
92702654|NCT04261218|Mitosis Modulators|mitosis modulators|mesh-ancestor
92702655|NCT04261218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702656|NCT04687449|Curcumin|curcumin|mesh-list
92702657|NCT04687449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92702658|NCT04687449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92702684|NCT00532818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702685|NCT00532818|GABA Agents|gaba agents|mesh-ancestor
92702686|NCT00532818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702687|NCT00532818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702688|NCT00532818|Antimanic Agents|antimanic agents|mesh-ancestor
92702689|NCT00532818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702690|NCT00532818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702691|NCT00532818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702692|NCT00532818|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92702693|NCT00532818|Vasodilator Agents|vasodilator agents|mesh-ancestor
92702694|NCT05209035|Trazodone|trazodone|mesh-list
92702695|NCT05209035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92702696|NCT05209035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702697|NCT05209035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702742|NCT05152004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92702743|NCT05152004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92702816|NCT00534573|Moclobemide|moclobemide|mesh-list
92702817|NCT00534573|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92702818|NCT00534573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92702819|NCT00534573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92702820|NCT00534573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702821|NCT00534573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702822|NCT00534573|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92702823|NCT00534573|Dopamine Agents|dopamine agents|mesh-ancestor
92702824|NCT00534573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92702830|NCT04686890|Acetaminophen|acetaminophen|mesh-list
92702882|NCT04942730|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92702883|NCT04942730|Antitubercular Agents|antitubercular agents|mesh-ancestor
92702884|NCT04942730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92702885|NCT04942730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702887|NCT01272193|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92702888|NCT01272193|Insulin Glargine|insulin glargine|mesh-list
92702889|NCT01272193|Insulin Aspart|insulin aspart|mesh-list
92702890|NCT01272193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702891|NCT01272193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702892|NCT04899206|Antidepressive Agents|antidepressive agents|mesh-list
92702893|NCT04899206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92702894|NCT04687163|Oxaliplatin|oxaliplatin|mesh-list
92702895|NCT04687163|Fluorouracil|fluorouracil|mesh-list
92702947|NCT02071862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702948|NCT02071862|Immunologic Factors|immunologic factors|mesh-ancestor
92702949|NCT02071862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702950|NCT00535691|Tacrolimus|tacrolimus|mesh-list
92702951|NCT00535691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92702952|NCT00535691|Immunologic Factors|immunologic factors|mesh-ancestor
92702953|NCT00535691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702954|NCT00535691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92702955|NCT00535691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92702956|NCT00535691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92702957|NCT01268683|Glyburide|glyburide|mesh-list
92702958|NCT01268683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92702959|NCT01268683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92702960|NCT02021474|Phenol|phenol|mesh-list
92702961|NCT02021474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92702962|NCT02021474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92702963|NCT02021474|Disinfectants|disinfectants|mesh-ancestor
92702964|NCT02021474|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92703005|NCT00535808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92703006|NCT00535808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92703007|NCT00535808|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92703008|NCT00535808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703009|NCT05471063|Fluconazole|fluconazole|mesh-list
92703010|NCT05471063|Amphotericin B|amphotericin b|mesh-list
92703011|NCT05471063|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92703012|NCT05471063|Flucytosine|flucytosine|mesh-list
92703013|NCT05471063|Cholesteryl sulfate|cholesteryl sulfate|mesh-list
92703014|NCT05471063|Antifungal Agents|antifungal agents|mesh-ancestor
92703015|NCT05471063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703016|NCT05471063|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92703017|NCT05471063|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92703019|NCT05471063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703020|NCT05471063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92703021|NCT05471063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92703022|NCT05471063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703023|NCT05471063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703024|NCT05471063|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92703025|NCT05471063|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92703026|NCT05471063|Amebicides|amebicides|mesh-ancestor
92703027|NCT05471063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92703028|NCT05471063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92703029|NCT05471063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92703030|NCT05471063|Antimetabolites|antimetabolites|mesh-ancestor
92703031|NCT05471063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92703032|NCT05471063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92703033|NCT05471063|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92703034|NCT05471063|Protective Agents|protective agents|mesh-ancestor
92703035|NCT05471063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703036|NCT04910100|Timolol|timolol|mesh-list
92703047|NCT04910100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92703048|NCT04910100|Vasodilator Agents|vasodilator agents|mesh-ancestor
92703049|NCT04910100|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92703050|NCT04910100|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92703051|NCT04910100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92703053|NCT01268059|Carboplatin|carboplatin|mesh-list
92703054|NCT01268059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92703055|NCT01268059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703056|NCT01268059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703057|NCT01268059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92703069|NCT00536003|Hormones|hormones|mesh-ancestor
92703113|NCT00593710|Atenolol|atenolol|mesh-list
92703114|NCT00593710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703115|NCT00593710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92703116|NCT00593710|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92703117|NCT00593710|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92703118|NCT00593710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703119|NCT00593710|Sympatholytics|sympatholytics|mesh-ancestor
92703120|NCT00593710|Autonomic Agents|autonomic agents|mesh-ancestor
92703121|NCT00593710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703122|NCT00593710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703123|NCT00593710|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92703124|NCT00593710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92703176|NCT00533247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703177|NCT01260181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92703178|NCT01260181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703179|NCT01260181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92703180|NCT01260181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703181|NCT01260181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703182|NCT00536276|Vitamin D|vitamin d|mesh-list
92703183|NCT00536276|Ergocalciferols|ergocalciferols|mesh-list
92703184|NCT00536276|Cholecalciferol|cholecalciferol|mesh-list
92703185|NCT00536276|Vitamins|vitamins|mesh-list
92703186|NCT00536276|Micronutrients|micronutrients|mesh-ancestor
92703187|NCT00536276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703188|NCT00536276|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92703189|NCT00536276|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92703190|NCT02690064|Vitamins|vitamins|mesh-list
92703191|NCT02690064|Ascorbic Acid|ascorbic acid|mesh-list
92703192|NCT02690064|Vitamin E|vitamin e|mesh-list
92703235|NCT01260142|Anesthetics|anesthetics|mesh-ancestor
92703236|NCT02116335|Bosentan|bosentan|mesh-list
92703237|NCT02116335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92703238|NCT02116335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92703239|NCT02116335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703240|NCT05469659|Metformin|metformin|mesh-list
92704675|NCT01199978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92704676|NCT01199978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92703297|NCT01259713|Antifungal Agents|antifungal agents|mesh-ancestor
92703298|NCT05469035|Heparin|heparin|mesh-list
92703299|NCT05469035|Calcium heparin|calcium heparin|mesh-list
92703300|NCT05469035|Anticoagulants|anticoagulants|mesh-ancestor
92703301|NCT05469035|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92703302|NCT05469035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92703303|NCT05469035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703304|NCT05582590|Cyclophosphamide|cyclophosphamide|mesh-list
92703305|NCT05582590|Fludarabine|fludarabine|mesh-list
92703306|NCT05582590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92703307|NCT05582590|Immunologic Factors|immunologic factors|mesh-ancestor
92703308|NCT05582590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703309|NCT05582590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703310|NCT05582590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92703311|NCT05582590|Alkylating Agents|alkylating agents|mesh-ancestor
92703312|NCT05582590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703313|NCT05582590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703314|NCT05582590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92703315|NCT05468879|Glimepiride|glimepiride|mesh-list
92703316|NCT05468879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92703317|NCT05468879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703318|NCT05468879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703319|NCT05468879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92703320|NCT05468879|Immunologic Factors|immunologic factors|mesh-ancestor
92703321|NCT05471427|Docetaxel|docetaxel|mesh-list
92703323|NCT05471427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703324|NCT05471427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92703347|NCT04326985|Viscosupplements|viscosupplements|mesh-ancestor
92703424|NCT00596050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92703425|NCT00596050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92703426|NCT00596050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92703427|NCT00596050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92703428|NCT00596050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92703429|NCT00596050|GABA Modulators|gaba modulators|mesh-ancestor
92703430|NCT00596050|GABA Agents|gaba agents|mesh-ancestor
92703431|NCT02888899|Loperamide|loperamide|mesh-list
92703432|NCT02888899|Antidiarrheals|antidiarrheals|mesh-list
92703433|NCT02888899|Calcium polycarbophil|calcium polycarbophil|mesh-list
92703434|NCT02888899|Psyllium|psyllium|mesh-list
92703435|NCT02888899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703436|NCT02888899|Cathartics|cathartics|mesh-ancestor
92703437|NCT05468645|Hemay005|hemay005|mesh-list
92703438|NCT05468645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92703439|NCT05468645|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92703440|NCT05468645|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92703441|NCT05468645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703442|NCT05468645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703443|NCT00596128|Insulin|insulin|mesh-list
92703444|NCT00596128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703445|NCT00596128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703446|NCT00596206|Leflunomide|leflunomide|mesh-list
92703447|NCT00596206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703448|NCT00596206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703449|NCT00596206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92703450|NCT00596206|Immunologic Factors|immunologic factors|mesh-ancestor
92703451|NCT00596206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703452|NCT00624130|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92703453|NCT00624130|Dacuronium|dacuronium|mesh-list
92703454|NCT00624130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92703468|NCT00596479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92703469|NCT00596479|Immunologic Factors|immunologic factors|mesh-ancestor
92703470|NCT00596479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703471|NCT05468372|Amphotericin B|amphotericin b|mesh-list
92703472|NCT05468372|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92703473|NCT05468372|Posaconazole|posaconazole|mesh-list
92703474|NCT05468372|Amebicides|amebicides|mesh-ancestor
92703475|NCT05468372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92703476|NCT05468372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92703477|NCT05468372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703478|NCT05468372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92703479|NCT05468372|Antifungal Agents|antifungal agents|mesh-ancestor
92703480|NCT05468372|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92703481|NCT05468372|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92703482|NCT05468372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92703483|NCT05468372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703484|NCT05468372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703485|NCT05468372|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92703486|NCT05468372|Hormone Antagonists|hormone antagonists|mesh-ancestor
92703487|NCT05468372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703488|NCT05468372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703521|NCT05312866|Antiemetics|antiemetics|mesh-ancestor
92703522|NCT05312866|Autonomic Agents|autonomic agents|mesh-ancestor
92703523|NCT05312866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703524|NCT05312866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703525|NCT05312866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703526|NCT05312866|Glucocorticoids|glucocorticoids|mesh-ancestor
92703527|NCT05312866|Hormones|hormones|mesh-ancestor
92703528|NCT05312866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703529|NCT05312866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92703530|NCT05312866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703531|NCT05312866|Anesthetics, Local|anesthetics, local|mesh-ancestor
92703532|NCT05312866|Anesthetics|anesthetics|mesh-ancestor
92703583|NCT00597181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703584|NCT00597181|Alkylating Agents|alkylating agents|mesh-ancestor
92703585|NCT00597181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703586|NCT00597181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92703653|NCT00598156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92703654|NCT00598156|Growth Substances|growth substances|mesh-ancestor
92703655|NCT00598156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703656|NCT00598156|Growth Inhibitors|growth inhibitors|mesh-ancestor
92703723|NCT02909400|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
92703724|NCT02909400|Antioxidants|antioxidants|mesh-ancestor
92703725|NCT02909400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703726|NCT02909400|Protective Agents|protective agents|mesh-ancestor
92703727|NCT02909400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703728|NCT02909478|Dexamethasone|dexamethasone|mesh-list
92703729|NCT02909478|Aprepitant|aprepitant|mesh-list
92703730|NCT02909478|Tropisetron|tropisetron|mesh-list
92703731|NCT02909478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703732|NCT02909478|Antiemetics|antiemetics|mesh-ancestor
92703733|NCT02909478|Autonomic Agents|autonomic agents|mesh-ancestor
92703734|NCT02909478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703735|NCT02909478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703736|NCT02909478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92703737|NCT02909478|Glucocorticoids|glucocorticoids|mesh-ancestor
92703738|NCT02909478|Hormones|hormones|mesh-ancestor
92703739|NCT02909478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92703740|NCT02909478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92703778|NCT00624208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703779|NCT00624208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92703851|NCT00537173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92703852|NCT00537173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92703853|NCT00537173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92703854|NCT00537173|Growth Substances|growth substances|mesh-ancestor
92703855|NCT00537173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703856|NCT00537173|Growth Inhibitors|growth inhibitors|mesh-ancestor
92703857|NCT02503839|Etoricoxib|etoricoxib|mesh-list
92703858|NCT02503839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92703859|NCT02503839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92703860|NCT02503839|Analgesics|analgesics|mesh-ancestor
92703861|NCT02503839|Sensory System Agents|sensory system agents|mesh-ancestor
92703862|NCT02503839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92703863|NCT02503839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703864|NCT02503839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92703865|NCT02503839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92703866|NCT02503839|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92703867|NCT02503839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92703868|NCT02503839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703869|NCT02503839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703870|NCT05469750|Capecitabine|capecitabine|mesh-list
92703871|NCT05469750|Letrozole|letrozole|mesh-list
92703872|NCT05469750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92703873|NCT05469750|Antimetabolites|antimetabolites|mesh-ancestor
92703874|NCT05469750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703875|NCT05469750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703899|NCT00537251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703900|NCT00537251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703901|NCT03457194|Vaccines|vaccines|mesh-list
92703902|NCT03457194|Immunologic Factors|immunologic factors|mesh-ancestor
92703903|NCT03457194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703904|NCT05478707|Dulaglutide|dulaglutide|mesh-list
92703905|NCT05478707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92703906|NCT05478707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703907|NCT05469204|Acetaminophen|acetaminophen|mesh-list
92703908|NCT05469204|Digoxin|digoxin|mesh-list
92703909|NCT05469204|Midazolam|midazolam|mesh-list
92703910|NCT05469204|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92703911|NCT05469204|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92703912|NCT05469204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92703913|NCT05469204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92703962|NCT01313923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92703963|NCT01313923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92703964|NCT01313923|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92703965|NCT01313923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92703966|NCT01313923|Antifungal Agents|antifungal agents|mesh-ancestor
92703967|NCT01313923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92703968|NCT01313923|Immunologic Factors|immunologic factors|mesh-ancestor
92703969|NCT01313923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92703970|NCT01313923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92703971|NCT01313923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92703972|NCT01313923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92703973|NCT01313884|Cyclophosphamide|cyclophosphamide|mesh-list
92703974|NCT01313884|Temozolomide|temozolomide|mesh-list
92703975|NCT01313884|Doxorubicin|doxorubicin|mesh-list
92703976|NCT01313884|Irinotecan|irinotecan|mesh-list
92703977|NCT01313884|Vincristine|vincristine|mesh-list
92703978|NCT01313884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704019|NCT01259284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704020|NCT03457025|Antiviral Agents|antiviral agents|mesh-list
92704021|NCT03457025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704022|NCT00537836|Estradiol|estradiol|mesh-list
92704023|NCT00537836|Estrogens|estrogens|mesh-ancestor
92704024|NCT00537836|Hormones|hormones|mesh-ancestor
92704025|NCT00537836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704026|NCT00537836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704027|NCT02277171|Nitric Oxide|nitric oxide|mesh-list
92704028|NCT02277171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92704029|NCT02277171|Autonomic Agents|autonomic agents|mesh-ancestor
92704030|NCT02277171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704032|NCT02277171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92704082|NCT00536640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92704083|NCT00536640|Growth Substances|growth substances|mesh-ancestor
92704084|NCT00536640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704085|NCT00536640|Growth Inhibitors|growth inhibitors|mesh-ancestor
92704086|NCT00536640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704087|NCT00536640|Antimetabolites|antimetabolites|mesh-ancestor
92704088|NCT00536640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704089|NCT00536640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92704090|NCT00536640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704091|NCT00552227|Ruboxistaurin|ruboxistaurin|mesh-list
92704092|NCT00552227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704094|NCT01259089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92704143|NCT01258738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92704144|NCT01258738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704145|NCT01258738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92704146|NCT01258738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704147|NCT01258738|Immunologic Factors|immunologic factors|mesh-ancestor
92704149|NCT00552656|Temsirolimus|temsirolimus|mesh-list
92704150|NCT00552656|MTOR Inhibitors|mtor inhibitors|mesh-list
92704151|NCT00552656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92704152|NCT00552656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704153|NCT00552656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92704154|NCT00552656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704155|NCT00552656|Antifungal Agents|antifungal agents|mesh-ancestor
92704156|NCT00552656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704157|NCT00552656|Immunologic Factors|immunologic factors|mesh-ancestor
92704158|NCT00552656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704159|NCT00552656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92704204|NCT04362527|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92704205|NCT04362527|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92704207|NCT04362527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704208|NCT04362527|Protective Agents|protective agents|mesh-ancestor
92704209|NCT04362527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704210|NCT04758975|Rituximab|rituximab|mesh-list
92704211|NCT04758975|Venetoclax|venetoclax|mesh-list
92704212|NCT04758975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92704213|NCT04758975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704214|NCT04758975|Immunologic Factors|immunologic factors|mesh-ancestor
92704215|NCT04758975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704216|NCT04758975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704217|NCT01614171|Hormones|hormones|mesh-list
92704218|NCT01614171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704219|NCT01614171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704220|NCT05567367|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92704227|NCT04656951|Daratumumab|daratumumab|mesh-list
92704258|NCT01258075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92704260|NCT04687878|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92704261|NCT04687878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92704262|NCT04687878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704263|NCT05116774|Eculizumab|eculizumab|mesh-list
92704264|NCT05116774|Ravulizumab|ravulizumab|mesh-list
92704265|NCT05116774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92704266|NCT05116774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704267|NCT05116774|Immunologic Factors|immunologic factors|mesh-ancestor
92704268|NCT05116774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704321|NCT04106999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92704322|NCT04106999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92704323|NCT04106999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92704324|NCT04106999|Adrenergic Agents|adrenergic agents|mesh-ancestor
92704325|NCT04106999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704326|NCT04106999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704327|NCT05478720|Diazooxonorleucine|diazooxonorleucine|mesh-list
92704328|NCT05478720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92704329|NCT05478720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704330|NCT05478720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92704382|NCT04005053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92704383|NCT04005053|Antiviral Agents|antiviral agents|mesh-ancestor
92704384|NCT04005053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704385|NCT04005053|Expectorants|expectorants|mesh-ancestor
92704386|NCT04005053|Respiratory System Agents|respiratory system agents|mesh-ancestor
92704387|NCT04005053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92704388|NCT04005053|Antioxidants|antioxidants|mesh-ancestor
92704389|NCT04005053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704390|NCT04005053|Protective Agents|protective agents|mesh-ancestor
92704391|NCT04005053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704392|NCT04005053|Antidotes|antidotes|mesh-ancestor
92704413|NCT01254604|Adrenergic Agents|adrenergic agents|mesh-ancestor
92704414|NCT01254604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704415|NCT01254604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704416|NCT01254604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92704417|NCT01254604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92704418|NCT01220583|Cisplatin|cisplatin|mesh-list
92704419|NCT01220583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704420|NCT04390698|Analgesics, Opioid|analgesics, opioid|mesh-list
92704421|NCT04390698|Anesthetics|anesthetics|mesh-list
92704422|NCT04390698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704423|NCT04390698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704424|NCT04390698|Narcotics|narcotics|mesh-ancestor
92704425|NCT04390698|Analgesics|analgesics|mesh-ancestor
92704426|NCT04390698|Sensory System Agents|sensory system agents|mesh-ancestor
92704427|NCT04390698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704475|NCT00537420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704476|NCT00537420|Appetite Depressants|appetite depressants|mesh-ancestor
92704477|NCT00537420|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92704478|NCT03534284|Trazodone|trazodone|mesh-list
92704479|NCT03534284|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92704480|NCT03534284|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92704481|NCT03534284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704482|NCT03534284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704483|NCT03534284|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704484|NCT03534284|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92704485|NCT03534284|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92704486|NCT03534284|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704535|NCT04515901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92704536|NCT04515901|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92704537|NCT04515901|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92704538|NCT04515901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704539|NCT04515901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704540|NCT02605421|Cyclophosphamide|cyclophosphamide|mesh-list
92704541|NCT02605421|Melphalan|melphalan|mesh-list
92704542|NCT02605421|Thiotepa|thiotepa|mesh-list
92704543|NCT02605421|Carboplatin|carboplatin|mesh-list
92704544|NCT02605421|Etoposide|etoposide|mesh-list
92704545|NCT02605421|Lenograstim|lenograstim|mesh-list
92704546|NCT02605421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92704547|NCT02605421|Immunologic Factors|immunologic factors|mesh-ancestor
92704548|NCT02605421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704549|NCT02605421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92704551|NCT02605421|Alkylating Agents|alkylating agents|mesh-ancestor
92704724|NCT02888548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704725|NCT02888548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92704726|NCT02888548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704727|NCT04246684|Leucovorin|leucovorin|mesh-list
92704728|NCT04246684|Folic Acid|folic acid|mesh-list
92704729|NCT04246684|Capecitabine|capecitabine|mesh-list
92704730|NCT04246684|Fluorouracil|fluorouracil|mesh-list
92704731|NCT04246684|Oxaliplatin|oxaliplatin|mesh-list
92704732|NCT04246684|Levoleucovorin|levoleucovorin|mesh-list
92704734|NCT04246684|Antimetabolites|antimetabolites|mesh-ancestor
92704790|NCT01250002|Sensory System Agents|sensory system agents|mesh-ancestor
92704791|NCT01250002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92704792|NCT01250002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92704793|NCT01250002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92704794|NCT01250002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92704795|NCT01250002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704796|NCT01250002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704797|NCT04157153|Sirolimus|sirolimus|mesh-list
92704798|NCT04157153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92704799|NCT04157153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704800|NCT04157153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92704801|NCT04157153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704802|NCT04157153|Antifungal Agents|antifungal agents|mesh-ancestor
92704806|NCT05329116|Lidocaine|lidocaine|mesh-list
92704848|NCT05264142|Antifungal Agents|antifungal agents|mesh-ancestor
92704849|NCT05264142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704850|NCT05264142|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92704851|NCT05264142|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92704852|NCT05264142|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92704853|NCT05264142|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704854|NCT05264142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704855|NCT05264142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704856|NCT05264142|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92704857|NCT05264142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92704858|NCT05264142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92704859|NCT05264142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92704860|NCT05264142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92704861|NCT05264142|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92704862|NCT05264142|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92704863|NCT05264142|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92704864|NCT05264142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92704866|NCT05264142|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92704870|NCT01246960|Leucovorin|leucovorin|mesh-list
92704900|NCT03851588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704901|NCT03851588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704902|NCT03851588|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92704903|NCT03851588|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92704904|NCT03851588|Antiviral Agents|antiviral agents|mesh-ancestor
92704905|NCT03851588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92704906|NCT01244620|Sildenafil Citrate|sildenafil citrate|mesh-list
92704907|NCT01244620|Tadalafil|tadalafil|mesh-list
92704908|NCT01244620|Sitaxsentan|sitaxsentan|mesh-list
92704909|NCT01244620|Vasodilator Agents|vasodilator agents|mesh-ancestor
92704964|NCT03778931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92704965|NCT03778931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92704966|NCT03778931|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92704967|NCT03778931|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92704968|NCT03778931|Hormone Antagonists|hormone antagonists|mesh-ancestor
92704969|NCT03778931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92704970|NCT03778931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92704971|NCT03778931|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92704972|NCT03778931|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92704973|NCT03778931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92704974|NCT03778931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92704975|NCT03736616|Cytarabine|cytarabine|mesh-list
92704976|NCT03736616|Rituximab|rituximab|mesh-list
92704977|NCT03736616|Carboplatin|carboplatin|mesh-list
92704978|NCT03736616|Etoposide|etoposide|mesh-list
92704979|NCT03736616|Melphalan|melphalan|mesh-list
92704980|NCT03736616|Ifosfamide|ifosfamide|mesh-list
92704981|NCT03736616|Carmustine|carmustine|mesh-list
92704982|NCT03736616|Acalabrutinib|acalabrutinib|mesh-list
92704985|NCT03736616|Immunologic Factors|immunologic factors|mesh-ancestor
92705021|NCT00537966|Raltegravir Potassium|raltegravir potassium|mesh-list
92705022|NCT00537966|Dolutegravir|dolutegravir|mesh-list
92705023|NCT00537966|Abacavir|abacavir|mesh-list
92705024|NCT00537966|Cobicistat|cobicistat|mesh-list
92705025|NCT00537966|Rilpivirine|rilpivirine|mesh-list
92705026|NCT00537966|Elvitegravir|elvitegravir|mesh-list
92705027|NCT00537966|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92705028|NCT00537966|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92705029|NCT00537966|Protease Inhibitors|protease inhibitors|mesh-ancestor
92705030|NCT00537966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705031|NCT00537966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705032|NCT00537966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92705033|NCT00537966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92705034|NCT00537966|Antiviral Agents|antiviral agents|mesh-ancestor
92705035|NCT00537966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705036|NCT00537966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92705037|NCT00537966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92705038|NCT00537966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92705042|NCT01266967|Dabrafenib|dabrafenib|mesh-list
92705078|NCT00538044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705079|NCT00538044|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92705080|NCT00538044|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92705081|NCT00538044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705082|NCT00545493|Tacrolimus|tacrolimus|mesh-list
92705083|NCT00545493|Immunoglobulins|immunoglobulins|mesh-list
92705084|NCT00545493|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92705085|NCT00545493|Antibodies|antibodies|mesh-list
92705086|NCT00545493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705087|NCT00545493|Immunologic Factors|immunologic factors|mesh-ancestor
92705088|NCT00545493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705089|NCT00545493|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92705090|NCT00545493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705091|NCT00545493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705092|NCT01266460|Vaccines|vaccines|mesh-list
92705139|NCT01266148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705140|NCT01266148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705141|NCT01266148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705142|NCT01266148|Immunologic Factors|immunologic factors|mesh-ancestor
92705143|NCT01266148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705144|NCT01266148|Antifungal Agents|antifungal agents|mesh-ancestor
92705145|NCT01266148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705146|NCT01266148|Dermatologic Agents|dermatologic agents|mesh-ancestor
92705205|NCT01265563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705206|NCT01265563|Protective Agents|protective agents|mesh-ancestor
92705207|NCT01265563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705208|NCT01265563|Antidotes|antidotes|mesh-ancestor
92705209|NCT01265563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92705210|NCT01265563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705211|NCT01265056|Gabapentin|gabapentin|mesh-list
92705212|NCT01265056|Analgesics|analgesics|mesh-ancestor
92705213|NCT01265056|Sensory System Agents|sensory system agents|mesh-ancestor
92705214|NCT01265056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705215|NCT01265056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705216|NCT01265056|Anticonvulsants|anticonvulsants|mesh-ancestor
92705267|NCT01264939|Hormone Antagonists|hormone antagonists|mesh-ancestor
92705268|NCT01264939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705269|NCT02889367|Odalasvir|odalasvir|mesh-list
92705270|NCT02889367|Antiviral Agents|antiviral agents|mesh-ancestor
92705271|NCT02889367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705272|NCT00546039|Genistein|genistein|mesh-list
92705273|NCT00546039|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92705274|NCT00546039|Protective Agents|protective agents|mesh-ancestor
92705275|NCT00546039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705276|NCT00546039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705330|NCT01263769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705331|NCT01263769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705332|NCT01263769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705333|NCT02623439|Cyclophosphamide|cyclophosphamide|mesh-list
92705334|NCT02623439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92705335|NCT02623439|Immunologic Factors|immunologic factors|mesh-ancestor
92705336|NCT02623439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705337|NCT02623439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705338|NCT02623439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92705339|NCT02623439|Alkylating Agents|alkylating agents|mesh-ancestor
92705340|NCT02623439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705343|NCT00539331|Paclitaxel|paclitaxel|mesh-list
92705394|NCT05541484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705395|NCT05541484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92705396|NCT05541484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705397|NCT01808456|Vaccines|vaccines|mesh-list
92705398|NCT01808456|Immunologic Factors|immunologic factors|mesh-ancestor
92705399|NCT01808456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705400|NCT01715714|Atorvastatin|atorvastatin|mesh-list
92705401|NCT01715714|Simvastatin|simvastatin|mesh-list
92705402|NCT01715714|Pravastatin|pravastatin|mesh-list
92705403|NCT01715714|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92705404|NCT01715714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92705405|NCT01715714|Antimetabolites|antimetabolites|mesh-ancestor
92705406|NCT01715714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705456|NCT00546507|Analgesics|analgesics|mesh-ancestor
92705457|NCT00546507|Sensory System Agents|sensory system agents|mesh-ancestor
92705458|NCT00546507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705459|NCT00546507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705460|NCT00546507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705461|NCT00546507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705462|NCT00546507|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92705463|NCT00546507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92705464|NCT00546507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705465|NCT00546507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705466|NCT00546546|Methotrexate|methotrexate|mesh-list
92705467|NCT00546546|Azathioprine|azathioprine|mesh-list
92705468|NCT00546546|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92705469|NCT00546546|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92705470|NCT00546546|Abortifacient Agents|abortifacient agents|mesh-ancestor
92705471|NCT00546546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92705472|NCT00546546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705474|NCT00546546|Antimetabolites|antimetabolites|mesh-ancestor
92705510|NCT00546741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705511|NCT02540330|Fulvestrant|fulvestrant|mesh-list
92705512|NCT02540330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92705513|NCT02540330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705514|NCT02540330|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92705515|NCT02540330|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92705516|NCT02540330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92705517|NCT02540330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92705518|NCT02540330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705519|NCT02467361|Pembrolizumab|pembrolizumab|mesh-list
92705520|NCT02467361|Nivolumab|nivolumab|mesh-list
92705521|NCT02467361|Ipilimumab|ipilimumab|mesh-list
92705522|NCT02467361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92705523|NCT02467361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705524|NCT02467361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92400068|NCT01406392|Oxytocics|oxytocics|mesh-ancestor
92705525|NCT02467361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705569|NCT01263496|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92705570|NCT01263496|Protease Inhibitors|protease inhibitors|mesh-ancestor
92705571|NCT01263496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705572|NCT01263496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705573|NCT01263496|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92705574|NCT04681937|Methylprednisolone|methylprednisolone|mesh-list
92705575|NCT04681937|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92705576|NCT04681937|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92705577|NCT04681937|Prednisolone|prednisolone|mesh-list
92705578|NCT04681937|Prednisolone acetate|prednisolone acetate|mesh-list
92705579|NCT04681937|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92705580|NCT04681937|Prednisolone phosphate|prednisolone phosphate|mesh-list
92705581|NCT04681937|Hyaluronic Acid|hyaluronic acid|mesh-list
92125337|NCT02402400|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92705583|NCT04681937|Antiemetics|antiemetics|mesh-ancestor
92705629|NCT00547170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92705630|NCT00547170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92705631|NCT00547209|Nitrous Oxide|nitrous oxide|mesh-list
92705632|NCT00547209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92705633|NCT00547209|Anesthetics, General|anesthetics, general|mesh-ancestor
92705634|NCT00547209|Anesthetics|anesthetics|mesh-ancestor
92705635|NCT00547209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705636|NCT00547209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705637|NCT00547209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92705638|NCT00547209|Analgesics|analgesics|mesh-ancestor
92705639|NCT00547209|Sensory System Agents|sensory system agents|mesh-ancestor
92705640|NCT00547209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705641|NCT00547287|Sildenafil Citrate|sildenafil citrate|mesh-list
92705642|NCT00547287|Tadalafil|tadalafil|mesh-list
92705643|NCT00547287|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705644|NCT00547287|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92705645|NCT00547287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705686|NCT00547599|Tadalafil|tadalafil|mesh-list
92705687|NCT00547599|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705688|NCT00547599|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92705689|NCT00547599|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92705690|NCT00547599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705691|NCT00547599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705692|NCT00547599|Urological Agents|urological agents|mesh-ancestor
92705693|NCT02908763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92705694|NCT02908763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92705695|NCT02908763|Antiviral Agents|antiviral agents|mesh-ancestor
92705696|NCT02908763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92705697|NCT02908412|Bupivacaine|bupivacaine|mesh-list
92705698|NCT02908412|Anesthetics, Local|anesthetics, local|mesh-ancestor
92705699|NCT02908412|Anesthetics|anesthetics|mesh-ancestor
92705700|NCT02908412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92705701|NCT02908412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705702|NCT02908412|Sensory System Agents|sensory system agents|mesh-ancestor
92705703|NCT02908412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705704|NCT02908295|Misoprostol|misoprostol|mesh-list
92705705|NCT02908295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92705706|NCT02908295|Abortifacient Agents|abortifacient agents|mesh-ancestor
92705709|NCT02908295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92705740|NCT03809442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92705741|NCT03809442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92705742|NCT03809442|Anesthetics, General|anesthetics, general|mesh-ancestor
92705743|NCT03809442|Anesthetics|anesthetics|mesh-ancestor
92705744|NCT03809442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92705745|NCT03809442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92705746|NCT03809442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92705747|NCT03809442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92705748|NCT03809442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92705749|NCT03809442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92705750|NCT03809442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92705751|NCT03809442|GABA Modulators|gaba modulators|mesh-ancestor
92705752|NCT03809442|GABA Agents|gaba agents|mesh-ancestor
92705753|NCT03809442|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92705754|NCT03809442|Narcotics|narcotics|mesh-ancestor
92705755|NCT00534729|Carboplatin|carboplatin|mesh-list
92705756|NCT00534729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705757|NCT00547989|Bupivacaine|bupivacaine|mesh-list
92705797|NCT00548067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705798|NCT00548067|Vasodilator Agents|vasodilator agents|mesh-ancestor
92705799|NCT00548067|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92705800|NCT00548067|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92705802|NCT00548067|Natriuretic Agents|natriuretic agents|mesh-ancestor
92705803|NCT00548067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92705804|NCT02907749|Carvedilol|carvedilol|mesh-list
92705805|NCT02907749|Spironolactone|spironolactone|mesh-list
92705806|NCT02907749|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92705827|NCT02907593|Budesonide|budesonide|mesh-list
92705861|NCT03781362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92705862|NCT03781362|Antimetabolites|antimetabolites|mesh-ancestor
92705863|NCT03781362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705864|NCT03781362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705865|NCT04682249|Apatinib|apatinib|mesh-list
92705866|NCT04682249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92705867|NCT04682249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92705868|NCT04682249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705869|NCT04682249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705870|NCT00548379|Vitamin D|vitamin d|mesh-list
92705871|NCT00548379|Vitamins|vitamins|mesh-ancestor
92705872|NCT00548379|Micronutrients|micronutrients|mesh-ancestor
92705873|NCT00548379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705874|NCT00548379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92705922|NCT01262872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705924|NCT00548574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92705925|NCT00548574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92705926|NCT00548574|Analgesics|analgesics|mesh-ancestor
92705927|NCT00548574|Sensory System Agents|sensory system agents|mesh-ancestor
92705928|NCT00548574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92705929|NCT00548574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705930|NCT00548574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92705931|NCT00548574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92705983|NCT00535119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92705984|NCT00535119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92705985|NCT00535119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705986|NCT00535119|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92705987|NCT00535119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92705988|NCT00535158|Vitamin D|vitamin d|mesh-list
92705989|NCT00535158|Ergocalciferols|ergocalciferols|mesh-list
92705990|NCT00535158|Vitamins|vitamins|mesh-ancestor
92705991|NCT00535158|Micronutrients|micronutrients|mesh-ancestor
92705992|NCT00535158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92705993|NCT00535158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92705994|NCT00535158|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92705995|NCT03436992|Resveratrol|resveratrol|mesh-list
92705996|NCT03436992|Antioxidants|antioxidants|mesh-list
92705997|NCT03436992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92705998|NCT03436992|Protective Agents|protective agents|mesh-ancestor
92705999|NCT03436992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706000|NCT03436992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706001|NCT03436992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92706002|NCT04083118|Listerine|listerine|mesh-list
92706003|NCT04083118|Fluorides|fluorides|mesh-list
92706004|NCT04083118|Sodium Fluoride|sodium fluoride|mesh-list
92706005|NCT04083118|Cariostatic Agents|cariostatic agents|mesh-ancestor
92706006|NCT04083118|Protective Agents|protective agents|mesh-ancestor
92706007|NCT04083118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706008|NCT04083118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92706009|NCT04083118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706034|NCT04043494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706035|NCT04043494|Immunologic Factors|immunologic factors|mesh-ancestor
92706036|NCT04043494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706037|NCT04043494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706038|NCT04043494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706039|NCT04043494|Alkylating Agents|alkylating agents|mesh-ancestor
92706040|NCT04043494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706041|NCT04043494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706042|NCT04043494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92706043|NCT04043494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92706044|NCT04043494|Antiemetics|antiemetics|mesh-ancestor
92706045|NCT04043494|Autonomic Agents|autonomic agents|mesh-ancestor
92706095|NCT00548964|Sensory System Agents|sensory system agents|mesh-ancestor
92706096|NCT00548964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706097|NCT00548964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706098|NCT00548964|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92706099|NCT00548964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92706100|NCT00548964|Anesthetics, General|anesthetics, general|mesh-ancestor
92706102|NCT00548964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706103|NCT00548964|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92706104|NCT00548964|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92706159|NCT04680884|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706160|NCT04680884|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706161|NCT04680884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706162|NCT04680884|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92706163|NCT04680884|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92706164|NCT00535470|Mechlorethamine|mechlorethamine|mesh-list
92706165|NCT00535470|Alkylating Agents|alkylating agents|mesh-ancestor
92706166|NCT00535470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706167|NCT00535470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706168|NCT00535470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706169|NCT00535509|Cisplatin|cisplatin|mesh-list
92706170|NCT00535509|Docetaxel|docetaxel|mesh-list
92706171|NCT00535509|Trastuzumab|trastuzumab|mesh-list
92706172|NCT00535509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706173|NCT00535509|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706174|NCT00535509|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706175|NCT00535509|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706215|NCT03898180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706216|NCT03898180|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92706217|NCT03898180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706218|NCT03898180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92706219|NCT03898180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706220|NCT04680962|Rituximab|rituximab|mesh-list
92706221|NCT04680962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92706222|NCT04680962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706223|NCT04680962|Immunologic Factors|immunologic factors|mesh-ancestor
92706224|NCT04680962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706225|NCT04680962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706226|NCT00549471|Botulinum Toxins|botulinum toxins|mesh-list
92706227|NCT00549471|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92706228|NCT00549471|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92706229|NCT00549471|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92706230|NCT00549471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92706231|NCT00549471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706232|NCT00549471|Cholinergic Agents|cholinergic agents|mesh-ancestor
92706233|NCT00549471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706234|NCT00549471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706235|NCT00549471|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92706236|NCT00549471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706237|NCT03088410|Zidovudine|zidovudine|mesh-list
92706238|NCT03088410|Nevirapine|nevirapine|mesh-list
92706239|NCT03088410|Antimetabolites|antimetabolites|mesh-ancestor
92706240|NCT03088410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706241|NCT03088410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92706250|NCT02897765|Nivolumab|nivolumab|mesh-list
92706259|NCT00549588|Sunscreening Agents|sunscreening agents|mesh-list
92706260|NCT00549588|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92706261|NCT00549588|Protective Agents|protective agents|mesh-ancestor
92706262|NCT00549588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706263|NCT00549588|Dermatologic Agents|dermatologic agents|mesh-ancestor
92706264|NCT04321642|Nitrous Oxide|nitrous oxide|mesh-list
92706265|NCT04321642|Entonox|entonox|mesh-list
92706266|NCT04321642|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92706267|NCT04321642|Anesthetics|anesthetics|mesh-ancestor
92706268|NCT04321642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706269|NCT04321642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706270|NCT04321642|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92706271|NCT04321642|Anesthetics, General|anesthetics, general|mesh-ancestor
92706272|NCT04321642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92706273|NCT04321642|Analgesics|analgesics|mesh-ancestor
92706274|NCT04321642|Sensory System Agents|sensory system agents|mesh-ancestor
92706317|NCT00549666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92706318|NCT00549666|Dopamine Agents|dopamine agents|mesh-ancestor
92706319|NCT00549666|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92706320|NCT00549666|Contraceptive Agents|contraceptive agents|mesh-ancestor
92706321|NCT00549666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706322|NCT00549666|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92706323|NCT00549666|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92706324|NCT00549666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92706381|NCT04321096|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92706382|NCT04321096|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92706383|NCT03556696|Remifentanil|remifentanil|mesh-list
92706384|NCT03556696|Propofol|propofol|mesh-list
92706385|NCT03556696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92706386|NCT03556696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706452|NCT00550095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92706453|NCT00550095|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92706454|NCT00550095|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92706455|NCT00550095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706457|NCT00551889|Cyclophosphamide|cyclophosphamide|mesh-list
92706458|NCT00551889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706459|NCT00551889|Immunologic Factors|immunologic factors|mesh-ancestor
92706460|NCT00551889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706461|NCT00551889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706462|NCT00551889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92706514|NCT02895659|Respiratory System Agents|respiratory system agents|mesh-ancestor
92706515|NCT02895659|Mydriatics|mydriatics|mesh-ancestor
92706516|NCT00552201|Tacrolimus|tacrolimus|mesh-list
92706517|NCT00552201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92706518|NCT00552201|Immunologic Factors|immunologic factors|mesh-ancestor
92706519|NCT00552201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706520|NCT00552201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92706521|NCT00552201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706522|NCT00552201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706523|NCT03391882|Apomorphine|apomorphine|mesh-list
92706524|NCT03391882|Emetics|emetics|mesh-ancestor
92706525|NCT03391882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706526|NCT03391882|Autonomic Agents|autonomic agents|mesh-ancestor
92706527|NCT03391882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706528|NCT03391882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92706529|NCT03391882|Dopamine Agonists|dopamine agonists|mesh-ancestor
92706530|NCT03391882|Dopamine Agents|dopamine agents|mesh-ancestor
92706531|NCT03391882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92706533|NCT00550329|Glipizide|glipizide|mesh-list
92706571|NCT02895113|Sensory System Agents|sensory system agents|mesh-ancestor
92706572|NCT02895113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92706573|NCT02895113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706574|NCT02895113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92706575|NCT02895113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92706576|NCT02895113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92706577|NCT02895113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92706578|NCT02895113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706638|NCT00550992|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706639|NCT00550992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92706640|NCT00550992|Antimetabolites|antimetabolites|mesh-ancestor
92706641|NCT00550992|Dermatologic Agents|dermatologic agents|mesh-ancestor
92706642|NCT00550992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706643|NCT00550992|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92706644|NCT00550992|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706645|NCT00550992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92706707|NCT00551343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92706708|NCT00551343|Incretins|incretins|mesh-ancestor
92706709|NCT00551343|Hormones|hormones|mesh-ancestor
92706710|NCT00551343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706711|NCT00551382|Montelukast|montelukast|mesh-list
92706712|NCT00551382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92706713|NCT00551382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92706714|NCT00551382|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92706715|NCT00551382|Hormone Antagonists|hormone antagonists|mesh-ancestor
92706716|NCT00551382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706717|NCT00551382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706718|NCT00551382|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92706719|NCT00551382|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92706720|NCT00551382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706721|NCT02894684|Aztreonam|aztreonam|mesh-list
92706722|NCT02894684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92706723|NCT02894684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706764|NCT02894645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92706765|NCT02894645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706767|NCT02894645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92706768|NCT02894645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92706769|NCT02894645|Tubulin Modulators|tubulin modulators|mesh-ancestor
92706770|NCT02894645|Antimitotic Agents|antimitotic agents|mesh-ancestor
92706771|NCT02894645|Mitosis Modulators|mitosis modulators|mesh-ancestor
92706772|NCT00552747|Fenofibrate|fenofibrate|mesh-list
92706773|NCT00552747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92706828|NCT01099449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92706829|NCT01099449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92706830|NCT01099449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706831|NCT01099449|Tocolytic Agents|tocolytic agents|mesh-ancestor
92706832|NCT01099449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92706833|NCT04680143|Epoetin Alfa|epoetin alfa|mesh-list
92706834|NCT04680143|Hematinics|hematinics|mesh-ancestor
92706835|NCT05426798|Azacitidine|azacitidine|mesh-list
92706836|NCT05426798|Decitabine|decitabine|mesh-list
92706837|NCT05426798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92706838|NCT05426798|Antimetabolites|antimetabolites|mesh-ancestor
92706839|NCT05426798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706840|NCT05426798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706841|NCT05426798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92706842|NCT01234402|Capecitabine|capecitabine|mesh-list
92706843|NCT01234402|Ramucirumab|ramucirumab|mesh-list
92706845|NCT01234402|Antimetabolites|antimetabolites|mesh-ancestor
92706888|NCT01211665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706889|NCT01211665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92706892|NCT01211665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92706893|NCT01211665|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92706894|NCT01211665|Protective Agents|protective agents|mesh-ancestor
92706895|NCT01211665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92706896|NCT01211665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92706897|NCT04401176|Lidocaine|lidocaine|mesh-list
92706898|NCT04401176|Heparin|heparin|mesh-list
92706899|NCT04401176|Anesthetics, Local|anesthetics, local|mesh-ancestor
92706900|NCT04401176|Anesthetics|anesthetics|mesh-ancestor
92706901|NCT04401176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92706902|NCT04401176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92706947|NCT01232452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92706948|NCT05345613|Epinephrine|epinephrine|mesh-list
92706949|NCT05345613|Tranexamic Acid|tranexamic acid|mesh-list
92706950|NCT05345613|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92706951|NCT05345613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92706952|NCT05345613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92706953|NCT05345613|Hemostatics|hemostatics|mesh-ancestor
92706954|NCT05345613|Coagulants|coagulants|mesh-ancestor
92707012|NCT00554138|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92707013|NCT00554138|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92707014|NCT00554138|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92707015|NCT00554138|Antimetabolites|antimetabolites|mesh-ancestor
92707016|NCT00554138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400097|NCT01406522|Cholinergic Agents|cholinergic agents|mesh-ancestor
92707017|NCT00554138|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92707018|NCT00554138|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92707019|NCT00554138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707020|NCT01231555|Efavirenz|efavirenz|mesh-list
92707021|NCT01231555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92707022|NCT01231555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92707023|NCT01231555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707024|NCT01231555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707025|NCT01231555|Antiviral Agents|antiviral agents|mesh-ancestor
92707026|NCT01231555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707027|NCT01231555|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92707028|NCT01231555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92707029|NCT01231555|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92707030|NCT01231555|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92707031|NCT01231555|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92707032|NCT01231555|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92707033|NCT04116528|Ketamine|ketamine|mesh-list
92707034|NCT04116528|Buprenorphine|buprenorphine|mesh-list
92707035|NCT04116528|Analgesics|analgesics|mesh-ancestor
92707036|NCT04116528|Sensory System Agents|sensory system agents|mesh-ancestor
92707037|NCT04116528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707038|NCT04116528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707039|NCT04116528|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92707054|NCT05288907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707055|NCT05288907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707057|NCT05288907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707058|NCT05288907|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92707059|NCT05288907|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92707060|NCT05288907|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92707061|NCT05288907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92707062|NCT05288907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707063|NCT03911336|Acetaminophen|acetaminophen|mesh-list
92707064|NCT03911336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92707065|NCT03911336|Ketoprofen|ketoprofen|mesh-list
92707066|NCT03911336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92707067|NCT03911336|Analgesics|analgesics|mesh-ancestor
92707068|NCT03911336|Sensory System Agents|sensory system agents|mesh-ancestor
92707071|NCT03911336|Antipyretics|antipyretics|mesh-ancestor
92707111|NCT03653000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707112|NCT03639389|Morphine|morphine|mesh-list
92707113|NCT03639389|Analgesics|analgesics|mesh-list
92707114|NCT03639389|Bupivacaine|bupivacaine|mesh-list
92707115|NCT03639389|Anesthetics, Local|anesthetics, local|mesh-ancestor
92707116|NCT03639389|Anesthetics|anesthetics|mesh-ancestor
92707117|NCT03639389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707118|NCT03639389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707119|NCT03639389|Sensory System Agents|sensory system agents|mesh-ancestor
92707120|NCT03639389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707121|NCT03639389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92707179|NCT03182231|Incretins|incretins|mesh-ancestor
92707180|NCT03182231|Hormones|hormones|mesh-ancestor
92707181|NCT03182231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707182|NCT03182192|Exenatide|exenatide|mesh-list
92707183|NCT03182192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707184|NCT03182192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707185|NCT03182192|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92707186|NCT03182192|Incretins|incretins|mesh-ancestor
92707187|NCT03182192|Hormones|hormones|mesh-ancestor
92707188|NCT03182192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707189|NCT02964884|Lovastatin|lovastatin|mesh-list
92707190|NCT02964884|L 647318|l 647318|mesh-list
92707191|NCT02964884|Dihydromevinolin|dihydromevinolin|mesh-list
92707192|NCT02964884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92707193|NCT02964884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92707194|NCT02964884|Antimetabolites|antimetabolites|mesh-ancestor
92707195|NCT02964884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707196|NCT02964884|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92707197|NCT02964884|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92707198|NCT02964884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707236|NCT05093205|Hormones|hormones|mesh-ancestor
92707237|NCT05093205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707238|NCT05093205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92707239|NCT05093205|Contraceptive Agents|contraceptive agents|mesh-ancestor
92707240|NCT05093205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92707241|NCT05093205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92707242|NCT05093205|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92707243|NCT05093205|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92707244|NCT05093205|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92707245|NCT02623751|Exemestane|exemestane|mesh-list
92707246|NCT02623751|Entinostat|entinostat|mesh-list
92707297|NCT00554177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92707298|NCT00554177|Contraceptive Agents|contraceptive agents|mesh-ancestor
92707299|NCT00554177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92707300|NCT00554177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92707301|NCT00554177|Hormone Antagonists|hormone antagonists|mesh-ancestor
92707302|NCT00554177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127067|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
92707303|NCT00554177|Luteolytic Agents|luteolytic agents|mesh-ancestor
92707304|NCT00554177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92707305|NCT00554177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92707306|NCT03425565|Pembrolizumab|pembrolizumab|mesh-list
92707307|NCT03425565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92707308|NCT03425565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707309|NCT03425565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92707310|NCT03425565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707311|NCT05073627|Dicloxacillin|dicloxacillin|mesh-list
92707354|NCT03147612|Immunoglobulins|immunoglobulins|mesh-list
92707355|NCT03147612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92707356|NCT03147612|Lenograstim|lenograstim|mesh-list
92707357|NCT03147612|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92707358|NCT03147612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707359|NCT03147612|Immunologic Factors|immunologic factors|mesh-ancestor
92707360|NCT03147612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707361|NCT03147612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707362|NCT03147612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92707363|NCT03147612|Alkylating Agents|alkylating agents|mesh-ancestor
92707364|NCT03147612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707365|NCT03147612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707366|NCT03147612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92707368|NCT03147612|Abortifacient Agents|abortifacient agents|mesh-ancestor
92707416|NCT04684017|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707417|NCT04684017|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92707418|NCT04684017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707419|NCT04684017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707420|NCT04684017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707421|NCT00554450|Dapagliflozin|dapagliflozin|mesh-list
92707422|NCT00554450|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92707423|NCT00554450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707424|NCT00554450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707425|NCT00554450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707426|NCT00553020|Insulin Glargine|insulin glargine|mesh-list
92707427|NCT00553020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707428|NCT00553020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707429|NCT00554528|Meloxicam|meloxicam|mesh-list
92707430|NCT00554528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92707431|NCT00554528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92707432|NCT00554528|Analgesics|analgesics|mesh-ancestor
92707433|NCT00554528|Sensory System Agents|sensory system agents|mesh-ancestor
92707434|NCT00554528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707435|NCT00554528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707436|NCT00554528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707437|NCT00554528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707438|NCT00554528|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92707464|NCT02339129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92707465|NCT02339129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92707466|NCT02339129|Analgesics|analgesics|mesh-ancestor
92707467|NCT02339129|Sensory System Agents|sensory system agents|mesh-ancestor
92707468|NCT02339129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707469|NCT02339129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707470|NCT02339129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707471|NCT02339129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707472|NCT02339129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92707473|NCT02339129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707474|NCT02339129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707475|NCT02884206|Valsartan|valsartan|mesh-list
92707477|NCT02884206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92707524|NCT02302079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92707525|NCT02302079|Growth Substances|growth substances|mesh-ancestor
92707526|NCT02302079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127291|NCT01539083|Leprostatic Agents|leprostatic agents|mesh-ancestor
92707527|NCT02302079|Growth Inhibitors|growth inhibitors|mesh-ancestor
92707528|NCT02302079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707529|NCT01210495|Axitinib|axitinib|mesh-list
92707530|NCT01210495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707531|NCT01210495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707532|NCT01210495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707533|NCT01210495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707534|NCT02289716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92707535|NCT02289716|Immunologic Factors|immunologic factors|mesh-ancestor
92707536|NCT02289716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707537|NCT04678076|Ketoprofen|ketoprofen|mesh-list
92707538|NCT04678076|Ketoprofen lysine|ketoprofen lysine|mesh-list
92707539|NCT04678076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92707540|NCT04678076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92707577|NCT02224235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92707578|NCT02224235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707579|NCT02224235|Antipyretics|antipyretics|mesh-ancestor
92707580|NCT02529852|Prednisone|prednisone|mesh-list
92707581|NCT02529852|Cyclophosphamide|cyclophosphamide|mesh-list
92707582|NCT02529852|Doxorubicin|doxorubicin|mesh-list
92707583|NCT02529852|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92707584|NCT02529852|Vincristine|vincristine|mesh-list
92707585|NCT02529852|Lenalidomide|lenalidomide|mesh-list
92707586|NCT02529852|Obinutuzumab|obinutuzumab|mesh-list
92707587|NCT02529852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707588|NCT02529852|Immunologic Factors|immunologic factors|mesh-ancestor
92707589|NCT02529852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707590|NCT02529852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707591|NCT02529852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92707592|NCT02529852|Alkylating Agents|alkylating agents|mesh-ancestor
92707593|NCT02529852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707594|NCT02529852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707595|NCT02529852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92707596|NCT02529852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92707597|NCT02529852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92707598|NCT02529852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92707599|NCT02529852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707600|NCT02529852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92707601|NCT02529852|Glucocorticoids|glucocorticoids|mesh-ancestor
92707603|NCT02529852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707604|NCT02529852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92707605|NCT02529852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92707606|NCT02529852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92707607|NCT02529852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92707608|NCT02529852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92707609|NCT02529852|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92707610|NCT02529852|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92707619|NCT02221232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707620|NCT02221232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707621|NCT02221232|Disinfectants|disinfectants|mesh-ancestor
92707622|NCT02221232|Dermatologic Agents|dermatologic agents|mesh-ancestor
92707623|NCT02206100|Enoxaparin|enoxaparin|mesh-list
92707624|NCT02206100|Anticoagulants|anticoagulants|mesh-ancestor
92707625|NCT02206100|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92707626|NCT02206100|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92707627|NCT02206100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707628|NCT01231516|Raltegravir Potassium|raltegravir potassium|mesh-list
92707629|NCT01231516|Dolutegravir|dolutegravir|mesh-list
92707630|NCT01231516|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92707631|NCT01231516|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92707632|NCT01231516|Antiviral Agents|antiviral agents|mesh-ancestor
92707633|NCT01231516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707634|NCT01231516|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92707635|NCT01231516|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92707636|NCT01231516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707637|NCT01231516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707638|NCT01962636|Cyclosporine|cyclosporine|mesh-list
92707639|NCT01962636|Cyclophosphamide|cyclophosphamide|mesh-list
92707640|NCT01962636|Fludarabine|fludarabine|mesh-list
92707641|NCT01962636|Cyclosporins|cyclosporins|mesh-list
92707642|NCT01962636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92707643|NCT01962636|Immunologic Factors|immunologic factors|mesh-ancestor
92707644|NCT01962636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707645|NCT01962636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92707646|NCT01962636|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92707647|NCT01962636|Alkylating Agents|alkylating agents|mesh-ancestor
92707648|NCT01962636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707649|NCT01962636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707650|NCT01962636|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92707651|NCT01962636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707661|NCT01722240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707662|NCT01722240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707663|NCT01722240|Incretins|incretins|mesh-ancestor
92707664|NCT01722240|Hormones|hormones|mesh-ancestor
92707665|NCT01722240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707666|NCT01210222|Trebananib|trebananib|mesh-list
92707667|NCT01210222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92707668|NCT01210222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92707669|NCT01210222|Growth Substances|growth substances|mesh-ancestor
92707670|NCT01210222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707671|NCT01210222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92707672|NCT01210222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707673|NCT01210144|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92707674|NCT01210144|Hormones|hormones|mesh-list
92707675|NCT01210144|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92707677|NCT01210144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707721|NCT04683159|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92707722|NCT04683159|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92707723|NCT04683159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92707724|NCT04683159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92707725|NCT04683159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92707726|NCT04683159|Adrenergic Agents|adrenergic agents|mesh-ancestor
92707727|NCT04683159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707728|NCT04683159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707729|NCT04683159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707730|NCT01230892|Atenolol|atenolol|mesh-list
92707731|NCT01230892|Nebivolol|nebivolol|mesh-list
92707732|NCT01230892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92707733|NCT01230892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92707734|NCT01230892|Sympatholytics|sympatholytics|mesh-ancestor
92707735|NCT01230892|Autonomic Agents|autonomic agents|mesh-ancestor
92707736|NCT01230892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707737|NCT01230892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707738|NCT01230892|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92707739|NCT01230892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92707740|NCT01230892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92707741|NCT01230892|Adrenergic Agents|adrenergic agents|mesh-ancestor
92707742|NCT01230892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707743|NCT01230892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707744|NCT01230892|Vasodilator Agents|vasodilator agents|mesh-ancestor
92707745|NCT01230892|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92707746|NCT01230892|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92707747|NCT01230892|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92707767|NCT01230814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92707768|NCT01230814|Antifungal Agents|antifungal agents|mesh-ancestor
92707769|NCT01230814|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92085358|NCT02994082|Nicotine|nicotine|mesh-list
92707770|NCT01230814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92707771|NCT01230814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707772|NCT01230814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707773|NCT01230814|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92707774|NCT01230814|Hormone Antagonists|hormone antagonists|mesh-ancestor
92707775|NCT01230814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92707776|NCT01230814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707777|NCT01230814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92707778|NCT01230814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92707779|NCT01230814|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92707780|NCT01230307|Vitamin D|vitamin d|mesh-list
92707781|NCT01230307|Cholecalciferol|cholecalciferol|mesh-list
92707782|NCT01230307|Vitamins|vitamins|mesh-ancestor
92707783|NCT01230307|Micronutrients|micronutrients|mesh-ancestor
92707784|NCT01230307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707785|NCT01230307|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92707787|NCT01209598|Palbociclib|palbociclib|mesh-list
92707817|NCT01209520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707818|NCT01209520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707819|NCT01209520|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92707820|NCT01209520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92707821|NCT01209520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92707822|NCT01209520|Antimetabolites|antimetabolites|mesh-ancestor
92707823|NCT04805541|Tropicamide|tropicamide|mesh-list
92707824|NCT04805541|Mydriatics|mydriatics|mesh-list
92707825|NCT04805541|Autonomic Agents|autonomic agents|mesh-ancestor
92707826|NCT04805541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92707827|NCT04805541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707828|NCT04805541|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92707829|NCT04805541|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92707830|NCT04805541|Cholinergic Agents|cholinergic agents|mesh-ancestor
92707831|NCT04805541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707832|NCT04805541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707833|NCT04784754|Melatonin|melatonin|mesh-list
92707874|NCT04721457|Povidone-Iodine|povidone-iodine|mesh-list
92707875|NCT04721457|Listerine|listerine|mesh-list
92707876|NCT04721457|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92707877|NCT04721457|Cetylpyridinium|cetylpyridinium|mesh-list
92707878|NCT04721457|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92707879|NCT04721457|Eusol|eusol|mesh-list
92707880|NCT04721457|Povidone|povidone|mesh-list
92707881|NCT04721457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92707882|NCT04721457|Sodium Fluoride|sodium fluoride|mesh-list
92707883|NCT04721457|Plasma Substitutes|plasma substitutes|mesh-ancestor
92707884|NCT04721457|Blood Substitutes|blood substitutes|mesh-ancestor
92707885|NCT04721457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92707886|NCT04721457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707887|NCT04721457|Cariostatic Agents|cariostatic agents|mesh-ancestor
92707888|NCT04721457|Protective Agents|protective agents|mesh-ancestor
92707889|NCT04721457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707890|NCT04721457|Disinfectants|disinfectants|mesh-ancestor
92707891|NCT04665986|Docetaxel|docetaxel|mesh-list
92707892|NCT04665986|Vinorelbine|vinorelbine|mesh-list
92707893|NCT04665986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707933|NCT04683237|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92707934|NCT04665362|Apatinib|apatinib|mesh-list
92707935|NCT04665362|Antibodies|antibodies|mesh-list
92707936|NCT04665362|Immunologic Factors|immunologic factors|mesh-ancestor
92707937|NCT04665362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707938|NCT04665362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92707939|NCT04665362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92707940|NCT04665362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707941|NCT04665362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707942|NCT04665284|Empagliflozin|empagliflozin|mesh-list
92707943|NCT04665284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92707944|NCT04665284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707945|NCT04665284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92707946|NCT04665284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707947|NCT04432974|Anesthetics|anesthetics|mesh-list
92707948|NCT04432974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92707949|NCT04432974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92707950|NCT04664894|Ribavirin|ribavirin|mesh-list
92707990|NCT04682691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92707991|NCT04682691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92707992|NCT04682691|Dopamine Agents|dopamine agents|mesh-ancestor
92707993|NCT04682691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92707994|NCT04682691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92707995|NCT04682691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92707996|NCT04682691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92707997|NCT04682691|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92707998|NCT04682691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92707999|NCT01209286|Blinatumomab|blinatumomab|mesh-list
92708000|NCT01209286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708001|NCT04663763|Capecitabine|capecitabine|mesh-list
92708002|NCT04663763|Oxaliplatin|oxaliplatin|mesh-list
92708003|NCT04663763|Antibodies|antibodies|mesh-list
92708004|NCT04663763|Immunologic Factors|immunologic factors|mesh-ancestor
92708007|NCT04663763|Antimetabolites|antimetabolites|mesh-ancestor
92708052|NCT04662866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708053|NCT04662866|Incretins|incretins|mesh-ancestor
92708054|NCT04662866|Hormones|hormones|mesh-ancestor
92717872|NCT04623021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708055|NCT04662866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708056|NCT04662866|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92708057|NCT04662866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708058|NCT04662476|Vitamin D|vitamin d|mesh-list
92708116|NCT00557180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92708117|NCT00557180|Autonomic Agents|autonomic agents|mesh-ancestor
92708118|NCT00557180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708119|NCT00557180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708120|NCT00557180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92708121|NCT00557180|Respiratory System Agents|respiratory system agents|mesh-ancestor
92708122|NCT00557180|Parasympatholytics|parasympatholytics|mesh-ancestor
92708123|NCT00557180|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92708124|NCT00557180|Cholinergic Agents|cholinergic agents|mesh-ancestor
92708125|NCT00557180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708126|NCT00557180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708127|NCT00557180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92708128|NCT00557180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92708129|NCT00557180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92708130|NCT00557180|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708131|NCT00557180|Anticonvulsants|anticonvulsants|mesh-ancestor
92708132|NCT00557180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708133|NCT00557180|Glucocorticoids|glucocorticoids|mesh-ancestor
92708172|NCT03776136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92708173|NCT03776136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708174|NCT03776136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92708175|NCT03776136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708176|NCT04661345|Coagulase|coagulase|mesh-list
92708177|NCT04661345|Coagulants|coagulants|mesh-ancestor
92708178|NCT00540072|Daptomycin|daptomycin|mesh-list
92708179|NCT00540072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92708180|NCT00540072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708181|NCT03689946|Listerine|listerine|mesh-list
92708182|NCT03689946|Evolocumab|evolocumab|mesh-list
92708183|NCT03689946|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92708184|NCT03689946|Fluorides|fluorides|mesh-list
92708185|NCT03689946|Sodium Fluoride|sodium fluoride|mesh-list
92708186|NCT03689946|Cariostatic Agents|cariostatic agents|mesh-ancestor
92708187|NCT03689946|Protective Agents|protective agents|mesh-ancestor
92708188|NCT03689946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708189|NCT03689946|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92708190|NCT03689946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708191|NCT03689946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92708192|NCT03689946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92708193|NCT03689946|Antimetabolites|antimetabolites|mesh-ancestor
92708199|NCT04660916|Isotretinoin|isotretinoin|mesh-list
92708225|NCT05420935|Immunologic Factors|immunologic factors|mesh-ancestor
92708226|NCT05420935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708227|NCT01208038|Methyltestosterone|methyltestosterone|mesh-list
92708228|NCT01208038|Testosterone|testosterone|mesh-list
92708229|NCT01208038|Testosterone undecanoate|testosterone undecanoate|mesh-list
92708230|NCT01208038|Testosterone enanthate|testosterone enanthate|mesh-list
92708231|NCT01208038|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92708232|NCT01208038|Androgens|androgens|mesh-ancestor
92708291|NCT00540384|Hematinics|hematinics|mesh-ancestor
92708292|NCT04659551|Cyclophosphamide|cyclophosphamide|mesh-list
92708293|NCT04659551|Nivolumab|nivolumab|mesh-list
92708294|NCT04659551|Epirubicin|epirubicin|mesh-list
92708295|NCT04659551|Exemestane|exemestane|mesh-list
92708296|NCT04659551|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92708297|NCT04659551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92708298|NCT04659551|Immunologic Factors|immunologic factors|mesh-ancestor
92708299|NCT04659551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708300|NCT04659551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708301|NCT04659551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92708302|NCT04659551|Alkylating Agents|alkylating agents|mesh-ancestor
92708311|NCT04659551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128120|NCT01560949|Immunologic Factors|immunologic factors|mesh-ancestor
92708355|NCT01207102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92708356|NCT01207102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708357|NCT01207102|Tubulin Modulators|tubulin modulators|mesh-ancestor
92708358|NCT01207102|Antimitotic Agents|antimitotic agents|mesh-ancestor
92708359|NCT01207102|Mitosis Modulators|mitosis modulators|mesh-ancestor
92708360|NCT01207102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708361|NCT04658732|Dexmedetomidine|dexmedetomidine|mesh-list
92708362|NCT04658732|Gabapentin|gabapentin|mesh-list
92708363|NCT04658732|Alprazolam|alprazolam|mesh-list
92708364|NCT04658732|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92708365|NCT04658732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708366|NCT04658732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708367|NCT04658732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708368|NCT04658732|Analgesics|analgesics|mesh-ancestor
92708369|NCT04658732|Sensory System Agents|sensory system agents|mesh-ancestor
92708412|NCT04658225|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92708413|NCT04658225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92708414|NCT04658225|Disinfectants|disinfectants|mesh-ancestor
92708415|NCT00540930|Ranibizumab|ranibizumab|mesh-list
92708416|NCT00540930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92708417|NCT00540930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92708418|NCT00540930|Growth Substances|growth substances|mesh-ancestor
92708419|NCT00540930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708420|NCT00540930|Growth Inhibitors|growth inhibitors|mesh-ancestor
92708421|NCT00540930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708423|NCT00541008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708424|NCT00541008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92708425|NCT00541008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92708426|NCT00541008|Growth Substances|growth substances|mesh-ancestor
92708427|NCT00541008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708428|NCT00541008|Growth Inhibitors|growth inhibitors|mesh-ancestor
92128199|NCT04489173|Trifluridine|trifluridine|mesh-list
92708430|NCT00541008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708468|NCT04657484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708469|NCT04657484|Glucocorticoids|glucocorticoids|mesh-ancestor
92708470|NCT04657484|Hormones|hormones|mesh-ancestor
92708471|NCT04657484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92708472|NCT04657484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708473|NCT04657484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92708474|NCT04657484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708475|NCT04657484|Antiemetics|antiemetics|mesh-ancestor
92708476|NCT04657484|Autonomic Agents|autonomic agents|mesh-ancestor
92708535|NCT00541320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708536|NCT00541320|Anticoagulants|anticoagulants|mesh-ancestor
92708537|NCT04657172|Pilocarpine|pilocarpine|mesh-list
92708538|NCT04657172|Miotics|miotics|mesh-ancestor
92708539|NCT04657172|Autonomic Agents|autonomic agents|mesh-ancestor
92708540|NCT04657172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708541|NCT04657172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708542|NCT04657172|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92708543|NCT04657172|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92708544|NCT04657172|Cholinergic Agents|cholinergic agents|mesh-ancestor
92708547|NCT03199794|Factor VIII|factor viii|mesh-list
92708600|NCT04655729|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92708601|NCT04655729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708602|NCT04655729|Dermatologic Agents|dermatologic agents|mesh-ancestor
92708603|NCT04655729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92708604|NCT04655729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708605|NCT00541554|Aripiprazole|aripiprazole|mesh-list
92708606|NCT00541554|Antidepressive Agents|antidepressive agents|mesh-ancestor
92708607|NCT00541554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92708608|NCT00541554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92708609|NCT00541554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92708610|NCT00541554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92708611|NCT00541554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708612|NCT00541554|Dopamine Agonists|dopamine agonists|mesh-ancestor
92708613|NCT00541554|Dopamine Agents|dopamine agents|mesh-ancestor
92708614|NCT00541554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708615|NCT00541554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708616|NCT00541554|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92708617|NCT00541554|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92708654|NCT00541905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708655|NCT00541905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92708656|NCT00541905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708657|NCT00542022|Oxymetazoline|oxymetazoline|mesh-list
92708658|NCT00542022|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92708659|NCT00542022|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92708660|NCT00542022|Adrenergic Agents|adrenergic agents|mesh-ancestor
92708661|NCT00542022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708662|NCT00542022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708663|NCT00542022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708664|NCT00542022|Sympathomimetics|sympathomimetics|mesh-ancestor
92708665|NCT00542022|Autonomic Agents|autonomic agents|mesh-ancestor
92708666|NCT00542022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708667|NCT00542022|Nasal Decongestants|nasal decongestants|mesh-ancestor
92708668|NCT00542022|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92708669|NCT00542022|Respiratory System Agents|respiratory system agents|mesh-ancestor
92708670|NCT02546583|Chlorothiazide|chlorothiazide|mesh-list
92708671|NCT02546583|Furosemide|furosemide|mesh-list
92708672|NCT02546583|Bumetanide|bumetanide|mesh-list
92708673|NCT02546583|Diuretics|diuretics|mesh-list
92708674|NCT02546583|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92708675|NCT02546583|Natriuretic Agents|natriuretic agents|mesh-ancestor
92708676|NCT02546583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708677|NCT02546583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92708678|NCT02546583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708679|NCT02546583|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92708680|NCT02546583|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92708701|NCT00542295|Alverine|alverine|mesh-list
92708702|NCT00542295|Parasympatholytics|parasympatholytics|mesh-ancestor
92708703|NCT00542295|Autonomic Agents|autonomic agents|mesh-ancestor
92708704|NCT00542295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708705|NCT00542295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708706|NCT00542295|Anticonvulsants|anticonvulsants|mesh-ancestor
92708707|NCT03454841|Ticagrelor|ticagrelor|mesh-list
92708708|NCT03454841|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92708709|NCT03454841|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92708710|NCT03454841|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92708711|NCT03454841|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92708712|NCT03454841|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92708713|NCT03454841|Purinergic Agents|purinergic agents|mesh-ancestor
92708714|NCT03454841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708715|NCT03454841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708716|NCT03454841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708717|NCT02293980|Nivolumab|nivolumab|mesh-list
92708718|NCT02293980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708719|NCT02293980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708757|NCT00542607|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92708758|NCT00542607|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92708759|NCT00542607|Histamine Antagonists|histamine antagonists|mesh-ancestor
92708760|NCT00542607|Histamine Agents|histamine agents|mesh-ancestor
92708761|NCT00542607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708762|NCT00542607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708763|NCT00542607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708764|NCT04685031|Clobetasol|clobetasol|mesh-list
92708765|NCT04685031|Nitroglycerin|nitroglycerin|mesh-list
92708766|NCT04685031|Vasodilator Agents|vasodilator agents|mesh-ancestor
92708821|NCT04652765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708822|NCT04652765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708823|NCT04652765|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92708824|NCT04652765|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92708825|NCT04652492|Tislelizumab|tislelizumab|mesh-list
92708826|NCT04652492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708827|NCT04652492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708828|NCT00543075|Oblimersen|oblimersen|mesh-list
92708829|NCT00543075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708830|NCT00543114|Rituximab|rituximab|mesh-list
92708831|NCT00543114|Fludarabine|fludarabine|mesh-list
92708832|NCT00543114|Lenalidomide|lenalidomide|mesh-list
92708833|NCT00543114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92708834|NCT00543114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92708883|NCT04651556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708884|NCT04651556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92708885|NCT04651556|Analgesics|analgesics|mesh-ancestor
92708886|NCT04651556|Antipyretics|antipyretics|mesh-ancestor
92708887|NCT04651556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92708888|NCT04651556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708889|NCT04651556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92708890|NCT04651556|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92708891|NCT04651556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92708892|NCT04651556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92708893|NCT04651556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92708894|NCT04651556|Anticonvulsants|anticonvulsants|mesh-ancestor
92708895|NCT04651556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92708945|NCT00557921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92708946|NCT00557921|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92708947|NCT00557921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92708948|NCT00557921|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92708949|NCT02352558|Dexamethasone|dexamethasone|mesh-list
92708950|NCT02352558|Bortezomib|bortezomib|mesh-list
92708951|NCT02352558|Imatinib Mesylate|imatinib mesylate|mesh-list
92708952|NCT02352558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92708953|NCT02352558|Antiemetics|antiemetics|mesh-ancestor
92708954|NCT02352558|Autonomic Agents|autonomic agents|mesh-ancestor
92708955|NCT02352558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92708956|NCT02352558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92708957|NCT02352558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92708958|NCT02352558|Glucocorticoids|glucocorticoids|mesh-ancestor
92708959|NCT02352558|Hormones|hormones|mesh-ancestor
92708964|NCT02352558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709004|NCT00558077|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92709005|NCT05077254|Mycophenolic Acid|mycophenolic acid|mesh-list
92709006|NCT05077254|Vaccines|vaccines|mesh-list
92709007|NCT05077254|Tacrolimus|tacrolimus|mesh-list
92709008|NCT05077254|Immunologic Factors|immunologic factors|mesh-ancestor
92709009|NCT05077254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709010|NCT05077254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709011|NCT05077254|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92709012|NCT05077254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709013|NCT05077254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709014|NCT05077254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92709015|NCT05077254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709017|NCT05077254|Antitubercular Agents|antitubercular agents|mesh-ancestor
92709068|NCT00544011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92709069|NCT00544011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92709070|NCT00544011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709071|NCT00544050|Levetiracetam|levetiracetam|mesh-list
92709072|NCT00544050|Anticonvulsants|anticonvulsants|mesh-ancestor
92709073|NCT00544050|Nootropic Agents|nootropic agents|mesh-ancestor
92709074|NCT04649723|Rifampin|rifampin|mesh-list
92709075|NCT04649723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92709076|NCT04649723|Antitubercular Agents|antitubercular agents|mesh-ancestor
92709077|NCT04649723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92709078|NCT04649723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709079|NCT04649723|Leprostatic Agents|leprostatic agents|mesh-ancestor
92709080|NCT04649723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92709081|NCT04649723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709082|NCT04649723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709129|NCT05476432|Fluorouracil|fluorouracil|mesh-list
92709130|NCT05476432|Oxaliplatin|oxaliplatin|mesh-list
92709131|NCT05476432|Antimetabolites|antimetabolites|mesh-ancestor
92709132|NCT05476432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709133|NCT05476432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709134|NCT05476432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709135|NCT05476432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709136|NCT05476432|Immunologic Factors|immunologic factors|mesh-ancestor
92709137|NCT05476432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709138|NCT05476432|Antidotes|antidotes|mesh-ancestor
92709139|NCT05476432|Protective Agents|protective agents|mesh-ancestor
92709140|NCT05476432|Vitamin B Complex|vitamin b complex|mesh-ancestor
92709141|NCT05476432|Vitamins|vitamins|mesh-ancestor
92709142|NCT05476432|Micronutrients|micronutrients|mesh-ancestor
92709143|NCT01239745|Exemestane|exemestane|mesh-list
92709144|NCT01239745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709145|NCT01239745|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92709146|NCT01239745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92709147|NCT01239745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709148|NCT01239745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709149|NCT01239745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92709150|NCT01239745|Hormone Antagonists|hormone antagonists|mesh-ancestor
92709151|NCT01239745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128942|NCT01500317|Analgesics|analgesics|mesh-ancestor
92709179|NCT02888275|Adrenergic Agents|adrenergic agents|mesh-ancestor
92709180|NCT02888275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717873|NCT04623021|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92709181|NCT02888275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709183|NCT03456531|Analgesics|analgesics|mesh-list
92709184|NCT03456531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92709185|NCT03456531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92709186|NCT03456531|Sensory System Agents|sensory system agents|mesh-ancestor
92709187|NCT03456531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709188|NCT03456531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709189|NCT03456531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709190|NCT03456531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92709191|NCT03456531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92709192|NCT03456531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92709193|NCT03456531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709194|NCT03456531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92709195|NCT03456531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92709196|NCT03456531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709197|NCT03456531|Antipyretics|antipyretics|mesh-ancestor
92709198|NCT02909049|Midazolam|midazolam|mesh-list
92709199|NCT02909049|Ketamine|ketamine|mesh-list
92709200|NCT02909049|Mepivacaine|mepivacaine|mesh-list
92709201|NCT02909049|Analgesics|analgesics|mesh-ancestor
92709202|NCT02909049|Sensory System Agents|sensory system agents|mesh-ancestor
92709203|NCT02909049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709204|NCT02909049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709205|NCT02909049|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92709206|NCT02909049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92709207|NCT02909049|Anesthetics, General|anesthetics, general|mesh-ancestor
92709208|NCT02909049|Anesthetics|anesthetics|mesh-ancestor
92709209|NCT02909049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709210|NCT02909049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92709211|NCT02909049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92709212|NCT02909049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709216|NCT02909049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92709217|NCT02909049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92709218|NCT02909049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709219|NCT02909049|GABA Modulators|gaba modulators|mesh-ancestor
92709220|NCT02909049|GABA Agents|gaba agents|mesh-ancestor
92709221|NCT02909049|Anesthetics, Local|anesthetics, local|mesh-ancestor
92709222|NCT01229449|Acetaminophen|acetaminophen|mesh-list
92709223|NCT01229449|Ibuprofen|ibuprofen|mesh-list
92709224|NCT01229449|Codeine|codeine|mesh-list
92709225|NCT01229449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92709226|NCT01229449|Analgesics|analgesics|mesh-ancestor
92709227|NCT01229449|Sensory System Agents|sensory system agents|mesh-ancestor
92709228|NCT01229449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709229|NCT01229449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709230|NCT01229449|Antipyretics|antipyretics|mesh-ancestor
92709231|NCT01229449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92709232|NCT01229449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709233|NCT01229449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92709234|NCT01229449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92709274|NCT02908581|Folic Acid|folic acid|mesh-list
92709275|NCT02908581|Vitamin B Complex|vitamin b complex|mesh-list
92709276|NCT02908581|Hematinics|hematinics|mesh-ancestor
92709277|NCT02908581|Vitamins|vitamins|mesh-ancestor
92709278|NCT02908581|Micronutrients|micronutrients|mesh-ancestor
92709279|NCT02908581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709280|NCT00544362|Fluorouracil|fluorouracil|mesh-list
92709281|NCT00544362|Cetuximab|cetuximab|mesh-list
92709282|NCT00544362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709283|NCT00544362|Antimetabolites|antimetabolites|mesh-ancestor
92709284|NCT00544362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709285|NCT00544362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92709286|NCT00544362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709340|NCT00544596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92709341|NCT00544596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709342|NCT00544596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709343|NCT00544596|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92709344|NCT00544596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709345|NCT00544596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92709346|NCT00544596|Immunologic Factors|immunologic factors|mesh-ancestor
92709347|NCT00544596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709348|NCT00544596|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92709356|NCT02908191|Tenofovir|tenofovir|mesh-list
92709404|NCT04647461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92709405|NCT04647461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92129163|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92709406|NCT04647461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92709407|NCT04647461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92709408|NCT04647461|Adrenergic Agents|adrenergic agents|mesh-ancestor
92709409|NCT04647461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709410|NCT04647461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709411|NCT04647461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709412|NCT01229371|Vaccines|vaccines|mesh-list
92709413|NCT01229371|Immunologic Factors|immunologic factors|mesh-ancestor
92709414|NCT01229371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709415|NCT02908152|Curcumin|curcumin|mesh-list
92709416|NCT02908152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92709417|NCT02908152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92709418|NCT02908152|Analgesics|analgesics|mesh-ancestor
92709419|NCT02908152|Sensory System Agents|sensory system agents|mesh-ancestor
92709420|NCT02908152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92709421|NCT02908152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709422|NCT02908152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92709423|NCT02908152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92709424|NCT02908152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709425|NCT02908152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709426|NCT02908152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709451|NCT02907021|Adrenergic Agents|adrenergic agents|mesh-ancestor
92709452|NCT02907021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709453|NCT02907021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709454|NCT02907021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709455|NCT01237054|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92709456|NCT01237054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92709457|NCT01237054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709458|NCT04647695|Interferons|interferons|mesh-list
92709459|NCT04647695|Interferon-beta|interferon-beta|mesh-list
92709460|NCT04647695|Remdesivir|remdesivir|mesh-list
92709461|NCT04647695|Interferon beta-1b|interferon beta-1b|mesh-list
92709462|NCT04647695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709463|NCT04647695|Antiviral Agents|antiviral agents|mesh-ancestor
92709464|NCT04647695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709465|NCT04647695|Immunologic Factors|immunologic factors|mesh-ancestor
92709466|NCT04647695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709467|NCT04647695|Antimetabolites|antimetabolites|mesh-ancestor
92709468|NCT04647695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709469|NCT04647695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92709506|NCT02908035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709507|NCT02908035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709508|NCT02908035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709509|NCT02908035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709510|NCT02908035|Immunologic Factors|immunologic factors|mesh-ancestor
92709511|NCT02908035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709512|NCT02908035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709513|NCT02908035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92709514|NCT02908035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709573|NCT04645940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709574|NCT04645940|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92709575|NCT04645940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709576|NCT04645940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709577|NCT00558506|Abatacept|abatacept|mesh-list
92709578|NCT00558506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92709579|NCT00558506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709580|NCT00558506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92709581|NCT00558506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709582|NCT00558506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92709583|NCT00558506|Immunologic Factors|immunologic factors|mesh-ancestor
92709584|NCT00558506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709585|NCT00558506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92709586|NCT00558623|Calcium Carbonate|calcium carbonate|mesh-list
92709587|NCT00558623|Calcium|calcium|mesh-list
92709588|NCT00558623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92709589|NCT00558623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709590|NCT00558623|Antacids|antacids|mesh-ancestor
92709591|NCT00558623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709592|NCT00558623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92709593|NCT00558662|Monensin|monensin|mesh-list
92709594|NCT00558662|Antifungal Agents|antifungal agents|mesh-ancestor
92709595|NCT00558662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92709622|NCT02906163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709623|NCT02906163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709624|NCT02906163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709625|NCT02906163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92709626|NCT02906163|Immunologic Factors|immunologic factors|mesh-ancestor
92709627|NCT02906163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709628|NCT04645745|Folic Acid|folic acid|mesh-list
92709629|NCT04645745|Inositol|inositol|mesh-list
92709630|NCT04645745|Hematinics|hematinics|mesh-ancestor
92709631|NCT04645745|Vitamin B Complex|vitamin b complex|mesh-ancestor
92709632|NCT04645745|Vitamins|vitamins|mesh-ancestor
92709633|NCT04645745|Micronutrients|micronutrients|mesh-ancestor
92709688|NCT02905305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92709689|NCT02905305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709690|NCT02899182|Nitrous Oxide|nitrous oxide|mesh-list
92709691|NCT02899182|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92709692|NCT02899182|Anesthetics, General|anesthetics, general|mesh-ancestor
92709693|NCT02899182|Anesthetics|anesthetics|mesh-ancestor
92709694|NCT02899182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709695|NCT02899182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709696|NCT02899182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92709697|NCT02899182|Analgesics|analgesics|mesh-ancestor
92709698|NCT02899182|Sensory System Agents|sensory system agents|mesh-ancestor
92709753|NCT00559169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709754|NCT00559169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92709755|NCT00559169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709756|NCT00559169|Vasodilator Agents|vasodilator agents|mesh-ancestor
92709757|NCT04642664|Apatinib|apatinib|mesh-list
92709758|NCT04642664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709759|NCT04642664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92709760|NCT04642664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92709761|NCT04642664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709762|NCT02904759|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92709763|NCT02904759|Hemostatics|hemostatics|mesh-ancestor
92709764|NCT02904759|Coagulants|coagulants|mesh-ancestor
92709765|NCT02904759|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92709766|NCT02904759|Natriuretic Agents|natriuretic agents|mesh-ancestor
92709767|NCT02904759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400160|NCT01407432|Vitamin B Complex|vitamin b complex|mesh-list
92709811|NCT04640831|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92709812|NCT04640831|Hallucinogens|hallucinogens|mesh-ancestor
92709813|NCT04640831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709814|NCT04640831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92709815|NCT04640831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92709816|NCT04640831|Serotonin Agents|serotonin agents|mesh-ancestor
92709817|NCT04640831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92709818|NCT04640831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92709819|NCT04640831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92709820|NCT02897934|Bupivacaine|bupivacaine|mesh-list
92709821|NCT02897934|Anesthetics, Local|anesthetics, local|mesh-ancestor
92709822|NCT02897934|Anesthetics|anesthetics|mesh-ancestor
92709823|NCT02897934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92709824|NCT02897934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92709862|NCT04640324|Protective Agents|protective agents|mesh-ancestor
92709863|NCT04640324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92709864|NCT04640324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92709935|NCT04639817|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92709936|NCT04639817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710008|NCT00559676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92710009|NCT00559676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710010|NCT00559676|Antidotes|antidotes|mesh-ancestor
92710080|NCT00559715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710081|NCT00559715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92710082|NCT00559715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92710083|NCT00559715|Growth Substances|growth substances|mesh-ancestor
92710150|NCT01235338|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92710151|NCT01235338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92710152|NCT01235338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710153|NCT01235338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710154|NCT01235338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710155|NCT01235338|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92710156|NCT01235338|Antidepressive Agents|antidepressive agents|mesh-ancestor
92710157|NCT01235338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92710158|NCT01235338|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92710159|NCT01235338|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92710212|NCT01227967|Antimetabolites|antimetabolites|mesh-ancestor
92710213|NCT01227967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710214|NCT01227967|Antiviral Agents|antiviral agents|mesh-ancestor
92710215|NCT01227967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710216|NCT01227967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710229|NCT04637204|Axitinib|axitinib|mesh-list
92710282|NCT02904369|Emtricitabine|emtricitabine|mesh-list
92710283|NCT02904369|Antiviral Agents|antiviral agents|mesh-ancestor
92710284|NCT02904369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710285|NCT02904369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92710356|NCT00624676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92710357|NCT00624676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92710358|NCT00624676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710359|NCT05655754|Methohexital|methohexital|mesh-list
92710360|NCT05655754|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92710361|NCT05655754|Anesthetics, General|anesthetics, general|mesh-ancestor
92710362|NCT05655754|Anesthetics|anesthetics|mesh-ancestor
92710363|NCT05655754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710364|NCT05655754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710422|NCT05655130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92710423|NCT05655130|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92710424|NCT05655130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710425|NCT05655130|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92710426|NCT05655130|Protective Agents|protective agents|mesh-ancestor
92710427|NCT04633967|Alemtuzumab|alemtuzumab|mesh-list
92710428|NCT04633967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92710429|NCT04633967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710430|NCT04633850|Dexamethasone|dexamethasone|mesh-list
92710431|NCT04633850|Bupivacaine|bupivacaine|mesh-list
92710488|NCT00445406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92710490|NCT00445406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710491|NCT00445406|Growth Inhibitors|growth inhibitors|mesh-ancestor
92400162|NCT01407432|Vitamins|vitamins|mesh-ancestor
92710492|NCT00445523|Interferons|interferons|mesh-list
92710493|NCT00445523|Interferon-alpha|interferon-alpha|mesh-list
92710494|NCT00445523|Vaccines|vaccines|mesh-list
92710495|NCT00445523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710496|NCT00445523|Antiviral Agents|antiviral agents|mesh-ancestor
92710497|NCT00445523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92710498|NCT00445523|Immunologic Factors|immunologic factors|mesh-ancestor
92710499|NCT00445523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710500|NCT02903004|Paclitaxel|paclitaxel|mesh-list
92710501|NCT02903004|Carboplatin|carboplatin|mesh-list
92710502|NCT02903004|Gemcitabine|gemcitabine|mesh-list
92710552|NCT00445874|Histamine Antagonists|histamine antagonists|mesh-ancestor
92710553|NCT00445874|Histamine Agents|histamine agents|mesh-ancestor
92710554|NCT00445874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710555|NCT00445874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710556|NCT00445874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710557|NCT00445874|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92710558|NCT02902731|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92710559|NCT02902731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92710560|NCT01225549|Budesonide|budesonide|mesh-list
92710561|NCT01225549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92710562|NCT01225549|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92710563|NCT01225549|Autonomic Agents|autonomic agents|mesh-ancestor
92710564|NCT01225549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92710565|NCT01225549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710566|NCT01225549|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92710568|NCT01225549|Glucocorticoids|glucocorticoids|mesh-ancestor
92710611|NCT01223404|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92710612|NCT01223404|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92710613|NCT01223404|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92710614|NCT00446420|Fentanyl|fentanyl|mesh-list
92710615|NCT00446420|Midazolam|midazolam|mesh-list
92710616|NCT00446420|Propofol|propofol|mesh-list
92710617|NCT00446420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92710618|NCT00446420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92710619|NCT00446420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710620|NCT00446420|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92710621|NCT00446420|Anesthetics, General|anesthetics, general|mesh-ancestor
92710622|NCT00446420|Anesthetics|anesthetics|mesh-ancestor
92710623|NCT00446420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92710624|NCT00446420|Narcotics|narcotics|mesh-ancestor
92710625|NCT00446420|Analgesics|analgesics|mesh-ancestor
92710626|NCT00446420|Sensory System Agents|sensory system agents|mesh-ancestor
92710628|NCT00446420|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92710671|NCT02956811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710672|NCT02956811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710742|NCT01221727|Midazolam|midazolam|mesh-list
92710743|NCT01221727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92710744|NCT01221727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92710813|NCT01220167|Antipruritics|antipruritics|mesh-ancestor
92710814|NCT01220167|Dermatologic Agents|dermatologic agents|mesh-ancestor
92710815|NCT01220167|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92710816|NCT01220167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92710817|NCT01220167|Serotonin Agents|serotonin agents|mesh-ancestor
92710818|NCT01220167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710819|NCT01220167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710820|NCT00447239|Insulin|insulin|mesh-list
92710821|NCT00447239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92710822|NCT00447239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710823|NCT05425914|Vitamin D|vitamin d|mesh-list
92710824|NCT05425914|Lubricant Eye Drops|lubricant eye drops|mesh-list
92710825|NCT05425914|Vitamins|vitamins|mesh-ancestor
92710826|NCT05425914|Micronutrients|micronutrients|mesh-ancestor
92710827|NCT05425914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92710828|NCT05425914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92710829|NCT05425914|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92710830|NCT05425914|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92710831|NCT00447356|Interferons|interferons|mesh-list
92710832|NCT00447356|Interferon-alpha|interferon-alpha|mesh-list
92710833|NCT00447356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92710834|NCT00447356|Antiviral Agents|antiviral agents|mesh-ancestor
92710868|NCT03455322|Midodrine|midodrine|mesh-list
92710869|NCT03455322|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92710870|NCT03455322|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92710871|NCT03455322|Adrenergic Agents|adrenergic agents|mesh-ancestor
92710872|NCT03455322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92710873|NCT03455322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92710937|NCT03276689|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92710938|NCT03276689|Analgesics|analgesics|mesh-ancestor
92711011|NCT02901288|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92711012|NCT02901288|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92711013|NCT02901288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711014|NCT02901288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711015|NCT02901288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711016|NCT02901288|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92711017|NCT02901288|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92711018|NCT02901288|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92711019|NCT02901288|Antitubercular Agents|antitubercular agents|mesh-ancestor
92711074|NCT05373901|Tretinoin|tretinoin|mesh-list
92711075|NCT05373901|Dinutuximab|dinutuximab|mesh-list
92711076|NCT05373901|Isotretinoin|isotretinoin|mesh-list
92711077|NCT05373901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711078|NCT05373901|Keratolytic Agents|keratolytic agents|mesh-ancestor
92711079|NCT05373901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92711080|NCT05368441|Midazolam|midazolam|mesh-list
92711081|NCT05368441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92711082|NCT05368441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92711083|NCT05368441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711140|NCT00449423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711213|NCT00449657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711214|NCT00449657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92711215|NCT00449657|Antimetabolites|antimetabolites|mesh-ancestor
92711216|NCT04318444|Hydroxychloroquine|hydroxychloroquine|mesh-list
92711284|NCT00450008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711285|NCT00450008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92711286|NCT00450008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92711287|NCT00450008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92711288|NCT00450008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711289|NCT00450008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711290|NCT00450008|Immunologic Factors|immunologic factors|mesh-ancestor
92711291|NCT00450008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711292|NCT00450008|Leprostatic Agents|leprostatic agents|mesh-ancestor
92711293|NCT00450008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711294|NCT00450008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711295|NCT00450008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711296|NCT00450008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711297|NCT00450008|Growth Substances|growth substances|mesh-ancestor
92711298|NCT00450008|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711299|NCT02900469|Denosumab|denosumab|mesh-list
92711300|NCT02900469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92711301|NCT02900469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711302|NCT00450086|Budesonide|budesonide|mesh-list
92711303|NCT00450086|Mesalamine|mesalamine|mesh-list
92711339|NCT00450164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711340|NCT00450164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92711341|NCT00450164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92711342|NCT00450164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92711343|NCT00450164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92711344|NCT00450164|Adrenergic Agents|adrenergic agents|mesh-ancestor
92711345|NCT00450164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711346|NCT00450164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92711347|NCT00450164|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92711348|NCT00450164|Sympatholytics|sympatholytics|mesh-ancestor
92711349|NCT00450164|Autonomic Agents|autonomic agents|mesh-ancestor
92711350|NCT00450164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92711351|NCT02900430|Antifungal Agents|antifungal agents|mesh-list
92711352|NCT02900430|Clotrimazole|clotrimazole|mesh-list
92711353|NCT02900430|Miconazole|miconazole|mesh-list
92711354|NCT02900430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711355|NCT02900430|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92711356|NCT02900430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92711357|NCT02900430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92711358|NCT02900430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711359|NCT02900430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711360|NCT02900430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92711361|NCT02900430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92711388|NCT04699097|Azithromycin|azithromycin|mesh-list
92711389|NCT04699097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711391|NCT04698746|Anesthetics|anesthetics|mesh-list
92711462|NCT01187953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711463|NCT01187953|Immunologic Factors|immunologic factors|mesh-ancestor
92711464|NCT01187953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711465|NCT01187953|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92711533|NCT04447040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92711534|NCT04447040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92711535|NCT04447040|Gout Suppressants|gout suppressants|mesh-ancestor
92711536|NCT04447040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92711537|NCT04447040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711538|NCT04447040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711539|NCT02930954|Bevacizumab|bevacizumab|mesh-list
92711540|NCT02930954|Carboplatin|carboplatin|mesh-list
92711541|NCT02930954|Gemcitabine|gemcitabine|mesh-list
92711542|NCT02930954|Pemetrexed|pemetrexed|mesh-list
92711543|NCT02930954|Gefitinib|gefitinib|mesh-list
92711544|NCT02930954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711545|NCT02930954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711546|NCT02930954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711547|NCT02930954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711548|NCT02930954|Growth Substances|growth substances|mesh-ancestor
92711565|NCT02930057|Hormones|hormones|mesh-ancestor
92711591|NCT03993132|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92711592|NCT03993132|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92711663|NCT02928692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711664|NCT04679142|Baclofen|baclofen|mesh-list
92711665|NCT04679142|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92711735|NCT02927405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711737|NCT02927405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92711738|NCT02927405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92711739|NCT02927405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92711740|NCT02927405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92711741|NCT02927405|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92711742|NCT02927405|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92711743|NCT02927405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711744|NCT02927405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711745|NCT02927405|Antimanic Agents|antimanic agents|mesh-ancestor
92711746|NCT05005299|Cyclophosphamide|cyclophosphamide|mesh-list
92711747|NCT05005299|Fludarabine|fludarabine|mesh-list
92711748|NCT05005299|Venetoclax|venetoclax|mesh-list
92711749|NCT05005299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711750|NCT05005299|Immunologic Factors|immunologic factors|mesh-ancestor
92711761|NCT02927522|Donepezil|donepezil|mesh-list
92711794|NCT02926976|GABA Antagonists|gaba antagonists|mesh-ancestor
92711795|NCT02927015|Iproplatin|iproplatin|mesh-list
92711796|NCT02927015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711797|NCT04680195|Thalidomide|thalidomide|mesh-list
92711798|NCT04680195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92711799|NCT04680195|Immunologic Factors|immunologic factors|mesh-ancestor
92711800|NCT04680195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711801|NCT04680195|Leprostatic Agents|leprostatic agents|mesh-ancestor
92711802|NCT04680195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92711803|NCT04680195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711804|NCT04680195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92711805|NCT04680195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92711806|NCT04680195|Growth Substances|growth substances|mesh-ancestor
92711807|NCT04680195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92711856|NCT02925416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92711857|NCT02925533|Pembrolizumab|pembrolizumab|mesh-list
92711858|NCT02925533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92711859|NCT02925533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92711860|NCT02925533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92711861|NCT02925533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711862|NCT02917889|Caffeine|caffeine|mesh-list
92400177|NCT01407484|Prednisone|prednisone|mesh-list
92711863|NCT02917889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92711864|NCT02917889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92711865|NCT02917889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92711866|NCT02917889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92711867|NCT02917889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92711868|NCT02917889|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92711869|NCT02917889|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92711870|NCT02917889|Purinergic Agents|purinergic agents|mesh-ancestor
92711871|NCT02917889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92711872|NCT02917967|Botulinum Toxins|botulinum toxins|mesh-list
92711873|NCT02917967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92711911|NCT03532022|Glucocorticoids|glucocorticoids|mesh-ancestor
92711912|NCT03532022|Hormones|hormones|mesh-ancestor
92711913|NCT03532022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92711984|NCT01228656|Sensory System Agents|sensory system agents|mesh-ancestor
92711985|NCT01228656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712055|NCT02916602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92712056|NCT02916602|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92712057|NCT02916602|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92712058|NCT02916602|Diuretics|diuretics|mesh-ancestor
92712059|NCT02916602|Natriuretic Agents|natriuretic agents|mesh-ancestor
92712060|NCT02916602|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92712061|NCT02916251|Glucagon|glucagon|mesh-list
92712062|NCT02916251|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92712063|NCT02916251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712064|NCT02916251|Hormones|hormones|mesh-ancestor
92712065|NCT02916251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712066|NCT02916251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712067|NCT02916251|Incretins|incretins|mesh-ancestor
92712068|NCT02106546|Paclitaxel|paclitaxel|mesh-list
92712069|NCT02106546|Carboplatin|carboplatin|mesh-list
92712070|NCT02106546|Veliparib|veliparib|mesh-list
92712071|NCT02106546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92712112|NCT04688723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712113|NCT04688723|Antithrombins|antithrombins|mesh-ancestor
92712114|NCT04688723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92712115|NCT04688723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92712116|NCT04688723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712117|NCT04688723|Anticoagulants|anticoagulants|mesh-ancestor
92712118|NCT01699464|Timolol|timolol|mesh-list
92712119|NCT01699464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92712120|NCT01699464|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92712121|NCT01699464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712122|NCT01699464|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92712179|NCT02915354|Sensory System Agents|sensory system agents|mesh-ancestor
92712187|NCT01661634|Ularitide|ularitide|mesh-list
92712253|NCT02914652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712254|NCT02081118|Exenatide|exenatide|mesh-list
92712328|NCT02063997|Colchicine|colchicine|mesh-list
92712329|NCT02063997|Allopurinol|allopurinol|mesh-list
92712330|NCT02063997|Gout Suppressants|gout suppressants|mesh-ancestor
92712331|NCT02063997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92712332|NCT02063997|Tubulin Modulators|tubulin modulators|mesh-ancestor
92712333|NCT02063997|Antimitotic Agents|antimitotic agents|mesh-ancestor
92712334|NCT02063997|Mitosis Modulators|mitosis modulators|mesh-ancestor
92712335|NCT02063997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712336|NCT02063997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712337|NCT02063997|Antimetabolites|antimetabolites|mesh-ancestor
92712338|NCT02063997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712339|NCT02063997|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92712340|NCT02063997|Antioxidants|antioxidants|mesh-ancestor
92712341|NCT02063997|Protective Agents|protective agents|mesh-ancestor
92712342|NCT02063997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712343|NCT00585507|Fulvestrant|fulvestrant|mesh-list
92712390|NCT02894307|Protease Inhibitors|protease inhibitors|mesh-ancestor
92712391|NCT02894307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400186|NCT01407679|Alitretinoin|alitretinoin|mesh-list
92712392|NCT02894307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712393|NCT02894307|Anticoagulants|anticoagulants|mesh-ancestor
92712394|NCT02052648|Bevacizumab|bevacizumab|mesh-list
92712396|NCT02052648|Tryptophan|tryptophan|mesh-list
92712457|NCT02894151|Contraceptive Agents|contraceptive agents|mesh-ancestor
92712458|NCT02894151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92712459|NCT02894151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712464|NCT02894151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712527|NCT02912234|Clarithromycin|clarithromycin|mesh-list
92712528|NCT02912234|Apixaban|apixaban|mesh-list
92712529|NCT02912234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92712598|NCT01993641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712599|NCT01993641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92712600|NCT01993641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712601|NCT01989429|Vitamin D|vitamin d|mesh-list
92712602|NCT01989429|Vitamins|vitamins|mesh-ancestor
92712603|NCT01989429|Micronutrients|micronutrients|mesh-ancestor
92712604|NCT01989429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712605|NCT01989429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92712621|NCT01973049|Ribavirin|ribavirin|mesh-list
92712668|NCT02910518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92712671|NCT01217437|Bevacizumab|bevacizumab|mesh-list
92712742|NCT04676997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92712743|NCT04676997|Alkylating Agents|alkylating agents|mesh-ancestor
92712817|NCT02910245|Prednisone|prednisone|mesh-list
92712818|NCT02910245|Mesalamine|mesalamine|mesh-list
92712819|NCT02910245|Mercaptopurine|mercaptopurine|mesh-list
92712820|NCT02910245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92712822|NCT02910245|Hormones|hormones|mesh-ancestor
92712887|NCT01940991|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92712888|NCT01940991|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92712889|NCT01940991|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92712890|NCT01940991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92712891|NCT01940991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712892|NCT01940991|Cholinergic Agents|cholinergic agents|mesh-ancestor
92712893|NCT01940991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92712894|NCT01940991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712895|NCT01940991|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92712896|NCT01940991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92712897|NCT02909465|Midazolam|midazolam|mesh-list
92712952|NCT00555867|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92712953|NCT00555867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92712954|NCT00555867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92712955|NCT00555867|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92712956|NCT00555867|Hormone Antagonists|hormone antagonists|mesh-ancestor
92712957|NCT00555867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92712958|NCT00555867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92712959|NCT00555984|Remifentanil|remifentanil|mesh-list
92712960|NCT00555984|Propofol|propofol|mesh-list
92713018|NCT04673487|Immunoglobulin M|immunoglobulin m|mesh-list
92713019|NCT04673487|Immunologic Factors|immunologic factors|mesh-ancestor
92713020|NCT04673487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713092|NCT05011214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713093|NCT05011214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92713094|NCT05011214|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92713095|NCT05011214|Antidepressive Agents|antidepressive agents|mesh-ancestor
92713096|NCT05011214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92713098|NCT00556062|Immunologic Factors|immunologic factors|mesh-ancestor
92713099|NCT00556062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713100|NCT04676763|Histamine|histamine|mesh-list
92713101|NCT04676763|Substance P|substance p|mesh-list
92713102|NCT04676763|Neurokinin A|neurokinin a|mesh-list
92713103|NCT04676763|Histamine Agonists|histamine agonists|mesh-ancestor
92713159|NCT01655225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713160|NCT01655225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713161|NCT01655225|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92713231|NCT01780428|Sensory System Agents|sensory system agents|mesh-ancestor
92713232|NCT01780428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713233|NCT01780428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713234|NCT01780428|Antipyretics|antipyretics|mesh-ancestor
92713235|NCT01780428|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92713236|NCT01780428|Narcotics|narcotics|mesh-ancestor
92713237|NCT01780428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713238|NCT01780428|Antitussive Agents|antitussive agents|mesh-ancestor
92713239|NCT01780428|Respiratory System Agents|respiratory system agents|mesh-ancestor
92713240|NCT01780428|Antipruritics|antipruritics|mesh-ancestor
92713241|NCT01780428|Dermatologic Agents|dermatologic agents|mesh-ancestor
92713242|NCT01780428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92713243|NCT01780428|Histamine Antagonists|histamine antagonists|mesh-ancestor
92713244|NCT01780428|Histamine Agents|histamine agents|mesh-ancestor
92713245|NCT01780428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713246|NCT01780428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713247|NCT01780428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92713248|NCT01780428|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92713249|NCT01780428|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713250|NCT01780428|Anesthetics, Local|anesthetics, local|mesh-ancestor
92713251|NCT01780428|Anesthetics|anesthetics|mesh-ancestor
92713252|NCT01780428|Antiemetics|antiemetics|mesh-ancestor
92713253|NCT01780428|Autonomic Agents|autonomic agents|mesh-ancestor
92713254|NCT01780428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713255|NCT04671420|Rituximab|rituximab|mesh-list
92713256|NCT04671420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92713257|NCT04671420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713258|NCT04671420|Immunologic Factors|immunologic factors|mesh-ancestor
92713259|NCT04671420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713260|NCT04671420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713261|NCT04573556|Lemborexant|lemborexant|mesh-list
92713275|NCT01779453|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92713277|NCT01779453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92713278|NCT01779453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92713279|NCT01779453|Antimetabolites|antimetabolites|mesh-ancestor
92713297|NCT04567160|Propofol|propofol|mesh-list
92713344|NCT04671069|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92713345|NCT04671069|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92713346|NCT04671069|Purinergic Agents|purinergic agents|mesh-ancestor
92713347|NCT04671069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713348|NCT04671069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713349|NCT04671069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713351|NCT04322123|Hydroxychloroquine|hydroxychloroquine|mesh-list
92713411|NCT01712451|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92713412|NCT01712451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92713413|NCT01712451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92713414|NCT01712451|Adrenergic Agents|adrenergic agents|mesh-ancestor
92713415|NCT01712451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713416|NCT01712451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713417|NCT01712217|Crizotinib|crizotinib|mesh-list
92713418|NCT01712217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713419|NCT01712217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92713420|NCT01712217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713421|NCT01712217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713422|NCT04669158|Idebenone|idebenone|mesh-list
92713423|NCT04669158|Antioxidants|antioxidants|mesh-ancestor
92713424|NCT04669158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713425|NCT04669158|Protective Agents|protective agents|mesh-ancestor
92713426|NCT04669158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713427|NCT04669821|Propofol|propofol|mesh-list
92713428|NCT04669821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92713429|NCT04669821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92713466|NCT00533390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713467|NCT00533390|Antiviral Agents|antiviral agents|mesh-ancestor
92713468|NCT00533390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92713469|NCT00533390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92713470|NCT00533390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92713471|NCT00533390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92713472|NCT00533390|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92713473|NCT00533390|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92713474|NCT00533390|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92713528|NCT00556413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92713529|NCT00556413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92713530|NCT00556413|Immunologic Factors|immunologic factors|mesh-ancestor
92713532|NCT00556413|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92713600|NCT04659057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92713675|NCT00557544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92713676|NCT00557544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713677|NCT00557544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92713678|NCT00557544|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92713679|NCT00557544|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92713680|NCT00557544|Dopamine Agents|dopamine agents|mesh-ancestor
92713681|NCT00557544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92713682|NCT00557544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92713683|NCT00557544|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92713684|NCT00557544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92713685|NCT00557544|Analgesics|analgesics|mesh-ancestor
92713686|NCT00557544|Sensory System Agents|sensory system agents|mesh-ancestor
92713687|NCT00557544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92713688|NCT00557544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92713689|NCT00557544|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92713690|NCT00557544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92713691|NCT04667910|Ranibizumab|ranibizumab|mesh-list
92713692|NCT04667910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92713693|NCT04667910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92713728|NCT04168502|Immunologic Factors|immunologic factors|mesh-ancestor
92713729|NCT04168502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92713880|NCT01215097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92713885|NCT03527576|Dexamethasone|dexamethasone|mesh-list
92713951|NCT04663269|Dexamethasone|dexamethasone|mesh-list
92713952|NCT04663269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714024|NCT00535418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92714025|NCT00535418|Hormone Antagonists|hormone antagonists|mesh-ancestor
92714026|NCT00535418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92714027|NCT00535418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714029|NCT04679064|Bevacizumab|bevacizumab|mesh-list
92714030|NCT04679064|Gemcitabine|gemcitabine|mesh-list
92714031|NCT04679064|Doxorubicin|doxorubicin|mesh-list
92714032|NCT04679064|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92714093|NCT01183468|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92714094|NCT01183468|Protein C Inhibitor|protein c inhibitor|mesh-list
92714095|NCT01183468|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92714096|NCT01183468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92714097|NCT01183468|Protease Inhibitors|protease inhibitors|mesh-ancestor
92714098|NCT01183468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714099|NCT01183468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714100|NCT03245021|Rituximab|rituximab|mesh-list
92714101|NCT03245021|Nivolumab|nivolumab|mesh-list
92714102|NCT03245021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714103|NCT03245021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714104|NCT03245021|Immunologic Factors|immunologic factors|mesh-ancestor
92714105|NCT03245021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714106|NCT03245021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92714107|NCT03245021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92714108|NCT03245021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714109|NCT04678791|Cisplatin|cisplatin|mesh-list
92714110|NCT04678791|Nimotuzumab|nimotuzumab|mesh-list
92714111|NCT04678791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714112|NCT04678791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714113|NCT01183390|Anastrozole|anastrozole|mesh-list
92714114|NCT01183390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92714115|NCT01183390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714116|NCT01183390|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92714117|NCT01183390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92714118|NCT01183390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714119|NCT01183390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714120|NCT01183390|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92714121|NCT01183390|Hormone Antagonists|hormone antagonists|mesh-ancestor
92714122|NCT01183390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92714124|NCT02887807|Cyclosporine|cyclosporine|mesh-list
92714135|NCT02887807|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92714136|NCT04663035|Tislelizumab|tislelizumab|mesh-list
92714137|NCT04663035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714209|NCT00538070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714210|NCT00538070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714211|NCT00538109|Imatinib Mesylate|imatinib mesylate|mesh-list
92714212|NCT00538109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92714213|NCT00538109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92714214|NCT00538109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714215|NCT00538109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714216|NCT00538148|Telithromycin|telithromycin|mesh-list
92714217|NCT00538148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92714218|NCT00538148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714219|NCT04661670|Salicylic Acid|salicylic acid|mesh-list
92714220|NCT04661670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92714221|NCT04661670|Antifungal Agents|antifungal agents|mesh-ancestor
92714222|NCT04661670|Keratolytic Agents|keratolytic agents|mesh-ancestor
92714223|NCT04661670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92714224|NCT05110391|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92714269|NCT04661709|Autonomic Agents|autonomic agents|mesh-ancestor
92714270|NCT04661709|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92714271|NCT04661709|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92714272|NCT04661709|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92714273|NCT04661709|Adrenergic Agents|adrenergic agents|mesh-ancestor
92714274|NCT04661709|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92714275|NCT04661709|Diuretics|diuretics|mesh-ancestor
92714339|NCT00538421|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92714412|NCT02436096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92714486|NCT02382510|Tiotropium Bromide|tiotropium bromide|mesh-list
92714488|NCT02382510|Autonomic Agents|autonomic agents|mesh-ancestor
92714559|NCT00540098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714561|NCT00540098|Antidepressive Agents|antidepressive agents|mesh-ancestor
92714634|NCT04659915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92714635|NCT04659915|Glucocorticoids|glucocorticoids|mesh-ancestor
92714708|NCT00541112|Vitamin B Complex|vitamin b complex|mesh-ancestor
92714710|NCT00541112|Micronutrients|micronutrients|mesh-ancestor
92714711|NCT00541112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92714773|NCT04659642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92714774|NCT04659642|Narcotics|narcotics|mesh-ancestor
92714775|NCT04659642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92714845|NCT00542165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714846|NCT00542165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92714847|NCT00542165|Urological Agents|urological agents|mesh-ancestor
92714849|NCT00542243|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92714850|NCT00542243|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92714851|NCT00542243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92714852|NCT00542243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714853|NCT00542243|Hormone Antagonists|hormone antagonists|mesh-ancestor
92714909|NCT04648917|Antioxidants|antioxidants|mesh-ancestor
92714913|NCT00543179|Lanreotide|lanreotide|mesh-list
92714983|NCT00543413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92714984|NCT00543413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92714985|NCT00554658|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92714986|NCT00554658|Antidepressive Agents|antidepressive agents|mesh-ancestor
92714987|NCT00554658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92714988|NCT00554658|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92714989|NCT00554658|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92714990|NCT00554658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92714991|NCT00554658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715049|NCT00543842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92715050|NCT00543842|Antimetabolites|antimetabolites|mesh-ancestor
92715052|NCT00543842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92715121|NCT00544232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715122|NCT00544232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715123|NCT00544232|Immunologic Factors|immunologic factors|mesh-ancestor
92715196|NCT00544505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92715197|NCT00544505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715198|NCT00544505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715199|NCT00544700|Bevacizumab|bevacizumab|mesh-list
92715200|NCT00544700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715201|NCT00544700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715202|NCT00544700|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92715203|NCT00544700|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715258|NCT05823701|Sensory System Agents|sensory system agents|mesh-ancestor
92715259|NCT05823701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715260|NCT05823701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715261|NCT05823701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92715264|NCT05823623|Vinorelbine|vinorelbine|mesh-list
92715326|NCT05817474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92715327|NCT05817474|Hemostatics|hemostatics|mesh-ancestor
92715328|NCT05817474|Coagulants|coagulants|mesh-ancestor
92715398|NCT05726916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92715399|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
92715400|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715401|NCT05704829|Trastuzumab|trastuzumab|mesh-list
92715402|NCT05704829|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92715403|NCT05704829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92715404|NCT05704829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715405|NCT05704829|Immunoconjugates|immunoconjugates|mesh-ancestor
92715406|NCT05704829|Immunologic Factors|immunologic factors|mesh-ancestor
92715408|NCT05685004|Temozolomide|temozolomide|mesh-list
92715464|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92715536|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92715537|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92715538|NCT05058287|Prednisolone|prednisolone|mesh-list
92715539|NCT05058287|Prednisolone acetate|prednisolone acetate|mesh-list
92715608|NCT04873102|Hormone Antagonists|hormone antagonists|mesh-ancestor
92715609|NCT04873102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92715610|NCT04873102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92715612|NCT04860141|Analgesics|analgesics|mesh-ancestor
92715679|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715680|NCT04778410|Cytarabine|cytarabine|mesh-list
92715681|NCT04778410|Etoposide|etoposide|mesh-list
92715682|NCT04778410|Mitoxantrone|mitoxantrone|mesh-list
92715751|NCT04609176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715752|NCT04609176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715753|NCT04593940|Remdesivir|remdesivir|mesh-list
92715823|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92715824|NCT04435197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92715825|NCT04435197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92715826|NCT04424901|Dipyridamole|dipyridamole|mesh-list
92715827|NCT04424901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92715828|NCT04424901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92715893|NCT04293562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92715894|NCT04293562|Antiviral Agents|antiviral agents|mesh-ancestor
92715895|NCT04293562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92715896|NCT04293562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92715897|NCT04293562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92715898|NCT04293562|Analgesics|analgesics|mesh-ancestor
92715899|NCT04293562|Sensory System Agents|sensory system agents|mesh-ancestor
92715900|NCT04293562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92715901|NCT04293562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92715961|NCT03933163|Protective Agents|protective agents|mesh-ancestor
92716036|NCT03416179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716037|NCT03416179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716108|NCT02793466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92716109|NCT02793466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716110|NCT02793466|Immunologic Factors|immunologic factors|mesh-ancestor
92716112|NCT02774005|Idebenone|idebenone|mesh-list
92716181|NCT01792934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716182|NCT01669915|Vitamin D|vitamin d|mesh-list
92716183|NCT01669915|Ergocalciferols|ergocalciferols|mesh-list
92716184|NCT01669915|Cholecalciferol|cholecalciferol|mesh-list
92716185|NCT01669915|Vitamins|vitamins|mesh-list
92716186|NCT01669915|Micronutrients|micronutrients|mesh-ancestor
92716187|NCT01669915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716188|NCT01669915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716189|NCT01669915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92716190|NCT01653223|Simvastatin|simvastatin|mesh-list
92716191|NCT01653223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92716198|NCT01549587|Listerine|listerine|mesh-list
92716244|NCT01356290|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92716245|NCT01356290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92716246|NCT01356290|Leprostatic Agents|leprostatic agents|mesh-ancestor
92716318|NCT00545480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92716393|NCT00545870|Bevacizumab|bevacizumab|mesh-list
92716465|NCT00546533|Immunologic Factors|immunologic factors|mesh-ancestor
92716466|NCT00558480|Vitamins|vitamins|mesh-list
92716467|NCT00558480|Vitamin A|vitamin a|mesh-list
92716468|NCT00558480|Retinol palmitate|retinol palmitate|mesh-list
92716469|NCT00558480|Micronutrients|micronutrients|mesh-ancestor
92716470|NCT00558480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716471|NCT00558480|Antioxidants|antioxidants|mesh-ancestor
92716472|NCT00558480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716473|NCT00558480|Protective Agents|protective agents|mesh-ancestor
92716474|NCT00558480|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92716475|NCT00558480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716476|NCT00546650|Sumatriptan|sumatriptan|mesh-list
92716477|NCT00546650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92716478|NCT00546650|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92716479|NCT00546650|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92716480|NCT00546650|Serotonin Agents|serotonin agents|mesh-ancestor
92716481|NCT00546650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716482|NCT00546650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716483|NCT00546650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716484|NCT00546923|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92716485|NCT00546923|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92716486|NCT00546923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92716489|NCT00546923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92716516|NCT00560274|Antimetabolites|antimetabolites|mesh-ancestor
92716517|NCT00560274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716518|NCT00560274|Antiviral Agents|antiviral agents|mesh-ancestor
92716519|NCT00560274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92716520|NCT00547547|Selenium|selenium|mesh-list
92716521|NCT00547547|Capecitabine|capecitabine|mesh-list
92716522|NCT00547547|Irinotecan|irinotecan|mesh-list
92716523|NCT00547547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92716524|NCT00547547|Antimetabolites|antimetabolites|mesh-ancestor
92716525|NCT00547547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716526|NCT00547547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716527|NCT00547547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92716528|NCT00547547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92716529|NCT00547547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92716530|NCT00547547|Antioxidants|antioxidants|mesh-ancestor
92716535|NCT00547625|Tadalafil|tadalafil|mesh-list
92716575|NCT04644354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716576|NCT04644354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92716647|NCT00548834|Immunologic Factors|immunologic factors|mesh-ancestor
92716648|NCT00548834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716649|NCT00548834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92716650|NCT04684199|Melatonin|melatonin|mesh-list
92716651|NCT04684199|Antioxidants|antioxidants|mesh-ancestor
92716652|NCT04684199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92716653|NCT04684199|Protective Agents|protective agents|mesh-ancestor
92716654|NCT04684199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716655|NCT04684199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92716656|NCT00560586|Budesonide|budesonide|mesh-list
92716657|NCT00560586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92716658|NCT00560586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92716659|NCT00560586|Autonomic Agents|autonomic agents|mesh-ancestor
92716660|NCT00560586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716661|NCT00560586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400228|NCT01408056|Mupirocin|mupirocin|mesh-list
92716662|NCT00560586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92716704|NCT00549146|Glucocorticoids|glucocorticoids|mesh-ancestor
92716705|NCT00549146|Hormones|hormones|mesh-ancestor
92716706|NCT00549146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92716707|NCT00549146|Sympathomimetics|sympathomimetics|mesh-ancestor
92716708|NCT00549341|Botulinum Toxins|botulinum toxins|mesh-list
92716709|NCT00549341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92716710|NCT00549341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92716769|NCT00549887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716770|NCT00549926|Atorvastatin|atorvastatin|mesh-list
92716843|NCT00560820|Deferasirox|deferasirox|mesh-list
92716918|NCT01125761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92716919|NCT01125761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92716920|NCT01125761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92716990|NCT04640883|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
92716991|NCT04640883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92716992|NCT04640883|Immunologic Factors|immunologic factors|mesh-ancestor
92716993|NCT04640883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717064|NCT05186675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717065|NCT05186675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92717066|NCT05186675|Adrenergic Agents|adrenergic agents|mesh-ancestor
92717067|NCT05186675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717068|NCT05186675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717070|NCT05186675|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92717130|NCT03454620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717131|NCT03454620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717132|NCT03454620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717133|NCT04628559|Dexmedetomidine|dexmedetomidine|mesh-list
92717134|NCT04628559|Ketamine|ketamine|mesh-list
92717135|NCT04628559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92717136|NCT04628559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717137|NCT04628559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717138|NCT04628559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717139|NCT04628559|Analgesics|analgesics|mesh-ancestor
92717140|NCT04628559|Sensory System Agents|sensory system agents|mesh-ancestor
92717143|NCT04628559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92717193|NCT04628325|Diuretics|diuretics|mesh-ancestor
92717194|NCT04628325|Natriuretic Agents|natriuretic agents|mesh-ancestor
92717266|NCT01213966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92717267|NCT01213966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717268|NCT01213264|Anesthetics|anesthetics|mesh-list
92717271|NCT04657107|Ketamine|ketamine|mesh-list
92717339|NCT04824911|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92717340|NCT04824911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717341|NCT04824911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92717412|NCT04627779|Sensory System Agents|sensory system agents|mesh-ancestor
92717413|NCT04627779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717414|NCT04627779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717415|NCT04627779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717416|NCT04627779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717417|NCT04627779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92717418|NCT04627779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717419|NCT04627779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92717420|NCT04627779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717421|NCT04627779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717422|NCT04537598|Morphine|morphine|mesh-list
92717423|NCT04537598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92717476|NCT04655040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717477|NCT04655040|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92717479|NCT04655040|Purinergic Agents|purinergic agents|mesh-ancestor
92717480|NCT04655040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92717481|NCT04626765|Cyclophosphamide|cyclophosphamide|mesh-list
92717482|NCT04626765|Fludarabine|fludarabine|mesh-list
92717483|NCT04626765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717484|NCT04626765|Immunologic Factors|immunologic factors|mesh-ancestor
92717485|NCT04626765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717486|NCT04626765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717487|NCT04626765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92717488|NCT04626765|Alkylating Agents|alkylating agents|mesh-ancestor
92717489|NCT04626765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717490|NCT04626765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717491|NCT04626765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92717492|NCT04626726|Cyclophosphamide|cyclophosphamide|mesh-list
92717493|NCT04626726|Fludarabine|fludarabine|mesh-list
92717494|NCT04626726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92717495|NCT04626726|Immunologic Factors|immunologic factors|mesh-ancestor
92717496|NCT04626726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717497|NCT04626726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92717498|NCT04626726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92717499|NCT04626726|Alkylating Agents|alkylating agents|mesh-ancestor
92717500|NCT04626726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717501|NCT04626726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717502|NCT04626726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92717503|NCT04654962|Anesthetics|anesthetics|mesh-list
92717504|NCT04654962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717505|NCT04654962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92717506|NCT04626414|Ferric maltol|ferric maltol|mesh-list
92717507|NCT04626414|Ferric Compounds|ferric compounds|mesh-list
92717517|NCT02906150|Cisplatin|cisplatin|mesh-list
92717518|NCT02906150|Carboplatin|carboplatin|mesh-list
92717519|NCT02906150|Pemetrexed|pemetrexed|mesh-list
92717520|NCT02906150|Thymalfasin|thymalfasin|mesh-list
92717521|NCT02906150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92717588|NCT02905760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92717589|NCT02905760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717590|NCT02905526|Contraceptive Agents|contraceptive agents|mesh-list
92717591|NCT02905526|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92717658|NCT04653792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717731|NCT04652427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717732|NCT04652427|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92717802|NCT02902640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92717803|NCT02902640|Antimalarials|antimalarials|mesh-ancestor
92717804|NCT02902640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92717805|NCT02902640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92412997|NCT01455350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92412998|NCT01455350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413070|NCT01459445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92413072|NCT01459445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92413075|NCT01459445|Hormones|hormones|mesh-ancestor
92413141|NCT01460498|Azacitidine|azacitidine|mesh-list
92413142|NCT01460498|Decitabine|decitabine|mesh-list
92137796|NCT02142153|Olorofim|olorofim|mesh-list
92413143|NCT01460498|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92413144|NCT01460498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92413145|NCT01460498|Antimetabolites|antimetabolites|mesh-ancestor
92413146|NCT01460498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413147|NCT01460498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413148|NCT01460498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413149|NCT01460498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92413150|NCT01460537|Gemcitabine|gemcitabine|mesh-list
92413151|NCT01460537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413205|NCT01460888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413206|NCT01460888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413207|NCT01460979|Sirolimus|sirolimus|mesh-list
92413208|NCT01460979|Temsirolimus|temsirolimus|mesh-list
92413279|NCT01461746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413280|NCT01461759|Cisplatin|cisplatin|mesh-list
92413352|NCT01463046|Daunorubicin|daunorubicin|mesh-list
92413353|NCT01463046|Panobinostat|panobinostat|mesh-list
92413354|NCT01463046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92413355|NCT01463046|Antimetabolites|antimetabolites|mesh-ancestor
92413356|NCT01463046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413419|NCT01463332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92413420|NCT01463332|Adrenergic Agents|adrenergic agents|mesh-ancestor
92413426|NCT01463592|Iodine|iodine|mesh-list
92413496|NCT01464008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413497|NCT01464008|Immunologic Factors|immunologic factors|mesh-ancestor
92400242|NCT01408095|Glimepiride|glimepiride|mesh-list
92413498|NCT01464008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413499|NCT01464060|Amoxicillin|amoxicillin|mesh-list
92413500|NCT01464060|Metronidazole|metronidazole|mesh-list
92413501|NCT01464060|Clarithromycin|clarithromycin|mesh-list
92413502|NCT01464060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92413503|NCT01464060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413504|NCT01464060|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92413505|NCT01464060|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92413506|NCT01464060|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92413507|NCT01464060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413561|NCT01464281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413562|NCT01464450|Rivaroxaban|rivaroxaban|mesh-list
92413632|NCT01466855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413633|NCT01466855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413634|NCT01466959|Acetic Acid|acetic acid|mesh-list
92413635|NCT01466959|Retinol acetate|retinol acetate|mesh-list
92413636|NCT01466959|Citric Acid|citric acid|mesh-list
92413637|NCT01466959|Dialysis Solutions|dialysis solutions|mesh-list
92413638|NCT01466959|Anticoagulants|anticoagulants|mesh-ancestor
92413639|NCT01466959|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92413640|NCT01466959|Chelating Agents|chelating agents|mesh-ancestor
92413641|NCT01466959|Sequestering Agents|sequestering agents|mesh-ancestor
92413642|NCT01466959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413699|NCT01467258|Antiviral Agents|antiviral agents|mesh-ancestor
92413700|NCT01467258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92413701|NCT01467258|Dopamine Agents|dopamine agents|mesh-ancestor
92413702|NCT01467258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92413703|NCT01467258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413704|NCT01467258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413770|NCT01467531|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92413772|NCT01467531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92413773|NCT01467531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413774|NCT01467531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92413775|NCT01467531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92413838|NCT01468025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92413839|NCT01468025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92413840|NCT01468025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92413841|NCT01468025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92413842|NCT01468025|Gout Suppressants|gout suppressants|mesh-ancestor
92413843|NCT01468025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92413906|NCT01468389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92413907|NCT01468389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92413908|NCT01468415|Phenol|phenol|mesh-list
92413975|NCT01468740|Cyclophosphamide|cyclophosphamide|mesh-list
92413976|NCT01468740|Dacarbazine|dacarbazine|mesh-list
92413978|NCT01468740|Etoposide|etoposide|mesh-list
92414049|NCT01469468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92414050|NCT01469468|Antimetabolites|antimetabolites|mesh-ancestor
92414051|NCT01469468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414064|NCT01469520|Lamivudine|lamivudine|mesh-list
92414120|NCT01469650|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414121|NCT01469702|Azithromycin|azithromycin|mesh-list
92414122|NCT01469702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92414123|NCT01469702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414124|NCT01469884|Cyclosporine|cyclosporine|mesh-list
92414125|NCT01469884|Everolimus|everolimus|mesh-list
92414126|NCT01469884|Tacrolimus|tacrolimus|mesh-list
92414127|NCT01469884|Cyclosporins|cyclosporins|mesh-list
92414128|NCT01469884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414129|NCT01469884|Immunologic Factors|immunologic factors|mesh-ancestor
92414130|NCT01469884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414131|NCT01469884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92414132|NCT01469884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414134|NCT01469884|Antifungal Agents|antifungal agents|mesh-ancestor
92414184|NCT01470053|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92414185|NCT01470053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414253|NCT01470352|Analgesics|analgesics|mesh-ancestor
92414254|NCT01470352|Sensory System Agents|sensory system agents|mesh-ancestor
92414255|NCT01470352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414256|NCT01470352|Antidepressive Agents|antidepressive agents|mesh-ancestor
92414257|NCT01470352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92414258|NCT01470352|Dopamine Agents|dopamine agents|mesh-ancestor
92414259|NCT01470443|Oxaliplatin|oxaliplatin|mesh-list
92414260|NCT01470443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414261|NCT01470456|Rituximab|rituximab|mesh-list
92414262|NCT01470456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414263|NCT01470456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414264|NCT01470456|Immunologic Factors|immunologic factors|mesh-ancestor
92414265|NCT01470456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414266|NCT01470456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92414267|NCT01470495|Sorafenib|sorafenib|mesh-list
92414268|NCT01470495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414269|NCT01470495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414314|NCT01471067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92414315|NCT01471067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414316|NCT01471067|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92414387|NCT01471535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414388|NCT01471613|Lithium Carbonate|lithium carbonate|mesh-list
92414389|NCT01471613|Antidepressive Agents|antidepressive agents|mesh-ancestor
92414390|NCT01471613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92414391|NCT01471613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414392|NCT01471613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414393|NCT01471613|Antimanic Agents|antimanic agents|mesh-ancestor
92414394|NCT01471613|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92414395|NCT01471613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92414396|NCT01471613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414398|NCT01471678|Dutasteride|dutasteride|mesh-list
92414399|NCT01471678|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92414400|NCT01471678|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92414401|NCT01471678|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92414402|NCT01471678|Adrenergic Agents|adrenergic agents|mesh-ancestor
92414403|NCT01471678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414404|NCT01471678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414405|NCT01471678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414406|NCT01471678|Urological Agents|urological agents|mesh-ancestor
92414407|NCT01471678|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92414408|NCT01471678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92414409|NCT01471678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414410|NCT01471678|Hormone Antagonists|hormone antagonists|mesh-ancestor
92414411|NCT01471678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92414412|NCT01471704|Verapamil|verapamil|mesh-list
92414413|NCT01471704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92414414|NCT01471704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92414415|NCT01471704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92414417|NCT01471704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92414431|NCT01471808|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92414432|NCT01471808|Protease Inhibitors|protease inhibitors|mesh-ancestor
92414433|NCT01471808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414434|NCT01471808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414435|NCT01471821|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92414436|NCT01471821|Antiviral Agents|antiviral agents|mesh-ancestor
92414437|NCT01471821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414438|NCT01471847|Capecitabine|capecitabine|mesh-list
92414439|NCT01471847|Trastuzumab|trastuzumab|mesh-list
92414440|NCT01471847|Lapatinib|lapatinib|mesh-list
92414441|NCT01471847|Dactolisib|dactolisib|mesh-list
92414442|NCT01471847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414443|NCT01471847|Antimetabolites|antimetabolites|mesh-ancestor
92414444|NCT01471847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414445|NCT01471847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414446|NCT01471847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92414447|NCT01471847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414448|NCT01471847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414449|NCT01471886|Ketorolac|ketorolac|mesh-list
92414450|NCT01471886|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92414451|NCT01471886|Naproxen|naproxen|mesh-list
92414452|NCT01471886|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92414453|NCT01471886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92414454|NCT01471886|Analgesics|analgesics|mesh-ancestor
92414455|NCT01471886|Sensory System Agents|sensory system agents|mesh-ancestor
92414456|NCT01471886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414457|NCT01471886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414480|NCT01471925|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92414481|NCT01471925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92414482|NCT01471925|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92414483|NCT01471925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414484|NCT01471925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414485|NCT01471964|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92414486|NCT01471964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414487|NCT01471964|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92414488|NCT01471964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414489|NCT01471964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414490|NCT01471990|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92414542|NCT01472263|Protective Agents|protective agents|mesh-ancestor
92414543|NCT01472263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414544|NCT01472263|Vasodilator Agents|vasodilator agents|mesh-ancestor
92414615|NCT01472926|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92414616|NCT01472926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414617|NCT01472978|Metronidazole|metronidazole|mesh-list
92414618|NCT01472978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92414619|NCT01472978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92414686|NCT01473303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414759|NCT01474187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92414760|NCT01474187|Antimetabolites|antimetabolites|mesh-ancestor
92414761|NCT01474187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414762|NCT01474187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92414763|NCT01474187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92414764|NCT01474187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92414765|NCT01474187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414766|NCT01474265|Varenicline|varenicline|mesh-list
92414767|NCT01474265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92414768|NCT01474265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92414769|NCT01474265|Cholinergic Agents|cholinergic agents|mesh-ancestor
92414770|NCT01474265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92414771|NCT01474265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414772|NCT01474265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414773|NCT01474304|Acetaminophen|acetaminophen|mesh-list
92414774|NCT01474304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92414775|NCT01474304|Analgesics|analgesics|mesh-ancestor
92414776|NCT01474304|Sensory System Agents|sensory system agents|mesh-ancestor
92414777|NCT01474304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414778|NCT01474304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414779|NCT01474304|Antipyretics|antipyretics|mesh-ancestor
92414780|NCT01474330|Pomalidomide|pomalidomide|mesh-list
92414781|NCT01474330|Immunologic Factors|immunologic factors|mesh-ancestor
92414782|NCT01474330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92414783|NCT01474330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92414784|NCT01474330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92414788|NCT01474382|Phentolamine|phentolamine|mesh-list
92414808|NCT01474473|Protease Inhibitors|protease inhibitors|mesh-ancestor
92414809|NCT01474473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92414810|NCT01474473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414811|NCT01474499|Sorbitol|sorbitol|mesh-list
92414812|NCT01474499|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92414882|NCT01475318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92414883|NCT01475318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92414884|NCT01475318|Hormone Antagonists|hormone antagonists|mesh-ancestor
92414892|NCT01475318|Oxytocics|oxytocics|mesh-ancestor
92414953|NCT01475760|Sequestering Agents|sequestering agents|mesh-ancestor
92414956|NCT01475877|Bromfenac|bromfenac|mesh-list
92414957|NCT01475877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91916356|NCT03962114|Nicotinic Acids|nicotinic acids|mesh-list
92414958|NCT01475877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92414959|NCT01475877|Analgesics|analgesics|mesh-ancestor
92414960|NCT01475877|Sensory System Agents|sensory system agents|mesh-ancestor
92414961|NCT01475877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92414962|NCT01475877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415024|NCT01476280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415025|NCT01476332|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92415026|NCT01476332|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92415027|NCT01476358|Vitamin A|vitamin a|mesh-list
92415028|NCT01476358|Retinol palmitate|retinol palmitate|mesh-list
92415029|NCT01476358|Vitamins|vitamins|mesh-ancestor
92415030|NCT01476358|Micronutrients|micronutrients|mesh-ancestor
92415031|NCT01476358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415032|NCT01476358|Antioxidants|antioxidants|mesh-ancestor
92415033|NCT01476358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415034|NCT01476358|Protective Agents|protective agents|mesh-ancestor
92415035|NCT01476358|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92415036|NCT01476358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415037|NCT01476410|Doxorubicin|doxorubicin|mesh-list
92415038|NCT01476410|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92415039|NCT01476410|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92415040|NCT01476410|Dacarbazine|dacarbazine|mesh-list
92415041|NCT01476410|Vinblastine|vinblastine|mesh-list
92415084|NCT01476683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415085|NCT01476683|Protease Inhibitors|protease inhibitors|mesh-ancestor
92415086|NCT01476683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415087|NCT01476683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415088|NCT01476774|Buprenorphine|buprenorphine|mesh-list
92415089|NCT01476774|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92415090|NCT01476774|Narcotics|narcotics|mesh-ancestor
92415091|NCT01476774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415092|NCT01476774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415093|NCT01476774|Analgesics|analgesics|mesh-ancestor
92415094|NCT01476774|Sensory System Agents|sensory system agents|mesh-ancestor
92415096|NCT01476774|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92415146|NCT01477060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415147|NCT01477060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92415151|NCT01477073|Hormones|hormones|mesh-ancestor
92415218|NCT01477411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415219|NCT01477411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415220|NCT01477411|Protective Agents|protective agents|mesh-ancestor
92415221|NCT01477411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415222|NCT01477424|Warfarin|warfarin|mesh-list
92415223|NCT01477424|Anticoagulants|anticoagulants|mesh-ancestor
92415224|NCT01477476|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92415225|NCT01477476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92415226|NCT01477489|Veliparib|veliparib|mesh-list
92415227|NCT01477489|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92415228|NCT01477489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415231|NCT01477580|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92415281|NCT01477736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415282|NCT01477736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92415283|NCT01477736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415284|NCT01477736|Parasympatholytics|parasympatholytics|mesh-ancestor
92415285|NCT01477736|Autonomic Agents|autonomic agents|mesh-ancestor
92415350|NCT01478074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92415351|NCT01478074|Immunologic Factors|immunologic factors|mesh-ancestor
92415352|NCT01478074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415423|NCT01478490|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92415424|NCT01478490|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92415425|NCT01478490|Urological Agents|urological agents|mesh-ancestor
92415426|NCT01478503|Mirabegron|mirabegron|mesh-list
92415427|NCT01478503|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92415428|NCT01478503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92415429|NCT01478503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92415430|NCT01478503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92415431|NCT01478503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415432|NCT01478503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415433|NCT01478503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415483|NCT01478685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92415484|NCT01478685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415485|NCT01478685|Tubulin Modulators|tubulin modulators|mesh-ancestor
92415486|NCT01478685|Antimitotic Agents|antimitotic agents|mesh-ancestor
92415487|NCT01478685|Mitosis Modulators|mitosis modulators|mesh-ancestor
92415488|NCT01478685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415489|NCT01478685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92415490|NCT01478685|Antimetabolites|antimetabolites|mesh-ancestor
92415491|NCT01478685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415492|NCT01478724|Caseins|caseins|mesh-list
92415493|NCT01478724|Chelating Agents|chelating agents|mesh-ancestor
92415546|NCT01479114|Lenograstim|lenograstim|mesh-list
92415547|NCT01479114|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92415548|NCT01479114|Immunologic Factors|immunologic factors|mesh-ancestor
92415549|NCT01479114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415550|NCT01479179|Trastuzumab|trastuzumab|mesh-list
92415551|NCT01479179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92415552|NCT01479179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415553|NCT01479192|Fenretinide|fenretinide|mesh-list
92415554|NCT01479192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415555|NCT01479192|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92415556|NCT01479192|Protective Agents|protective agents|mesh-ancestor
92415557|NCT01479192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415558|NCT01479231|Dexlansoprazole|dexlansoprazole|mesh-list
92415559|NCT01479231|Lansoprazole|lansoprazole|mesh-list
92415560|NCT01479231|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92415561|NCT01479231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415562|NCT01479231|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92415563|NCT01479231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415564|NCT01479231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415565|NCT01479244|Molgramostim|molgramostim|mesh-list
92415566|NCT01479244|Sargramostim|sargramostim|mesh-list
92415567|NCT01479244|Immunologic Factors|immunologic factors|mesh-ancestor
92415568|NCT01479244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415569|NCT01479244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415570|NCT01479283|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92415572|NCT01479283|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92415573|NCT01479283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415574|NCT01479283|Antitubercular Agents|antitubercular agents|mesh-ancestor
92415597|NCT01479556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415598|NCT01479556|Anticonvulsants|anticonvulsants|mesh-ancestor
92415599|NCT01479556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92415600|NCT01479556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92415601|NCT01479556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415602|NCT01479556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92415603|NCT01479556|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92415604|NCT01479556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92415605|NCT01479556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415606|NCT01479556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92415607|NCT01479634|Efavirenz|efavirenz|mesh-list
92415608|NCT01479634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92415609|NCT01479634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92415610|NCT01479634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92415611|NCT01479634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415612|NCT01479634|Antiviral Agents|antiviral agents|mesh-ancestor
92415613|NCT01479634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92415614|NCT01479634|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92415615|NCT01479634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92415616|NCT01479634|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92415617|NCT01479634|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92415618|NCT01479634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92415619|NCT01479634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92415620|NCT01479751|Magnesium Sulfate|magnesium sulfate|mesh-list
92415622|NCT01479751|Rocuronium|rocuronium|mesh-list
92415623|NCT01479751|Analgesics|analgesics|mesh-ancestor
92415624|NCT01479751|Sensory System Agents|sensory system agents|mesh-ancestor
92415625|NCT01479751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415626|NCT01479751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415627|NCT01479751|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92415628|NCT01479751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92415629|NCT01479751|Anesthetics, General|anesthetics, general|mesh-ancestor
92415630|NCT01479751|Anesthetics|anesthetics|mesh-ancestor
92415631|NCT01479751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92415632|NCT01479751|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92415634|NCT01479751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415635|NCT01479751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415636|NCT01479751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92415703|NCT01480141|Afatinib|afatinib|mesh-list
92415704|NCT01480141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415774|NCT01480752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415775|NCT01480752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415776|NCT01480752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92415777|NCT01480765|Pregabalin|pregabalin|mesh-list
92415778|NCT01480765|Ketamine|ketamine|mesh-list
92415844|NCT01481194|Cyclophosphamide|cyclophosphamide|mesh-list
92415845|NCT01481194|Doxorubicin|doxorubicin|mesh-list
92415846|NCT01481194|Lenalidomide|lenalidomide|mesh-list
92415847|NCT01481194|Bortezomib|bortezomib|mesh-list
92415848|NCT01481194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92415849|NCT01481194|Immunologic Factors|immunologic factors|mesh-ancestor
92415850|NCT01481194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92415851|NCT01481194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92415852|NCT01481194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92415853|NCT01481194|Alkylating Agents|alkylating agents|mesh-ancestor
92415854|NCT01481194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415855|NCT01481194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92415856|NCT01481194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92415857|NCT01481194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92415858|NCT01481194|Antiemetics|antiemetics|mesh-ancestor
92415859|NCT01481194|Autonomic Agents|autonomic agents|mesh-ancestor
92415860|NCT01481194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415861|NCT01481194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92415862|NCT01481194|Glucocorticoids|glucocorticoids|mesh-ancestor
92415863|NCT01481194|Hormones|hormones|mesh-ancestor
92415865|NCT01481194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92415900|NCT01481389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92415904|NCT01481389|Vasodilator Agents|vasodilator agents|mesh-ancestor
92415975|NCT01481831|Serotonin Agents|serotonin agents|mesh-ancestor
92415976|NCT01481831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92415977|NCT01481831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92415978|NCT01481844|Amoxicillin|amoxicillin|mesh-list
92415979|NCT01481844|Metronidazole|metronidazole|mesh-list
92415980|NCT01481844|Clarithromycin|clarithromycin|mesh-list
92415981|NCT01481844|Tetracycline|tetracycline|mesh-list
92415982|NCT01481844|Tinidazole|tinidazole|mesh-list
92415983|NCT01481844|Lansoprazole|lansoprazole|mesh-list
92415984|NCT01481844|Dexlansoprazole|dexlansoprazole|mesh-list
92415985|NCT01481844|Bismuth|bismuth|mesh-list
92415986|NCT01481844|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92416041|NCT01482117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400292|NCT01408199|Growth Inhibitors|growth inhibitors|mesh-ancestor
92416042|NCT01482117|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92416043|NCT01482117|Respiratory System Agents|respiratory system agents|mesh-ancestor
92416044|NCT01482117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92416045|NCT01482117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92416046|NCT01482117|Vasodilator Agents|vasodilator agents|mesh-ancestor
92416047|NCT01482117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92416107|NCT01482468|Antiemetics|antiemetics|mesh-ancestor
92416108|NCT01482468|Autonomic Agents|autonomic agents|mesh-ancestor
92416109|NCT01482468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416110|NCT01482468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416111|NCT01482468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92416112|NCT01482468|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92416113|NCT01482468|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92416176|NCT01483014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416177|NCT01483053|Agomelatine|agomelatine|mesh-list
92416178|NCT01483053|Escitalopram|escitalopram|mesh-list
92416179|NCT01483053|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92416180|NCT01483053|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92416181|NCT01483053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92416182|NCT01483053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416183|NCT01483053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92416184|NCT01483053|Serotonin Agents|serotonin agents|mesh-ancestor
92416241|NCT01483911|Antiviral Agents|antiviral agents|mesh-ancestor
92416242|NCT01483911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416243|NCT01484015|Cefepime|cefepime|mesh-list
92416244|NCT01484015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92416245|NCT01484015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416246|NCT01484080|Paclitaxel|paclitaxel|mesh-list
92416247|NCT01484080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92416309|NCT01484613|Contraceptive Agents|contraceptive agents|mesh-ancestor
92416310|NCT01484613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92416311|NCT01484613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416312|NCT01484613|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92416313|NCT01484613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92416314|NCT01484613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92416315|NCT01484717|Nicotine|nicotine|mesh-list
92416316|NCT01484717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92416325|NCT01484756|Micronutrients|micronutrients|mesh-list
92416375|NCT01485185|Analgesics|analgesics|mesh-ancestor
92416376|NCT01485185|Sensory System Agents|sensory system agents|mesh-ancestor
92416377|NCT01485185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416378|NCT01485185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416379|NCT01485185|Anticonvulsants|anticonvulsants|mesh-ancestor
92416380|NCT01485185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92416381|NCT01485185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92416382|NCT01485185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416383|NCT01485185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92416384|NCT01485185|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92416442|NCT01485445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92416443|NCT01485445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92416470|NCT01485692|Midazolam|midazolam|mesh-list
92416516|NCT01485731|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92416517|NCT01485731|Protease Inhibitors|protease inhibitors|mesh-ancestor
92416518|NCT01485731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416519|NCT01485731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416520|NCT01485731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92416521|NCT01485731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92416522|NCT01485731|Antiviral Agents|antiviral agents|mesh-ancestor
92416523|NCT01485731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92416525|NCT01485744|Fluorouracil|fluorouracil|mesh-list
92416526|NCT01485744|Oxaliplatin|oxaliplatin|mesh-list
92416527|NCT01485744|Irinotecan|irinotecan|mesh-list
92416528|NCT01485744|Folfirinox|folfirinox|mesh-list
92416529|NCT01485744|Antimetabolites|antimetabolites|mesh-ancestor
92416530|NCT01485744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92416534|NCT01485744|Immunologic Factors|immunologic factors|mesh-ancestor
92416582|NCT01485939|Anesthetics|anesthetics|mesh-ancestor
92416583|NCT01485939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92416592|NCT01485978|Ramipril|ramipril|mesh-list
92416651|NCT01486433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92416725|NCT01486706|Urological Agents|urological agents|mesh-ancestor
92416726|NCT01486823|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92416799|NCT01487135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92087244|NCT03804268|Miotics|miotics|mesh-ancestor
92416800|NCT01487135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92416801|NCT01487135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92416872|NCT01487629|Ranibizumab|ranibizumab|mesh-list
92416873|NCT01487629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92416874|NCT01487629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92416944|NCT01488266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417017|NCT01488552|Mitosis Modulators|mitosis modulators|mesh-ancestor
92417018|NCT01488552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417019|NCT01488552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417020|NCT01488552|Antimetabolites|antimetabolites|mesh-ancestor
92417021|NCT01488552|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417022|NCT01488552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417023|NCT01488565|Azacitidine|azacitidine|mesh-list
92417024|NCT01488565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92417025|NCT01488565|Antimetabolites|antimetabolites|mesh-ancestor
92417081|NCT01488955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417082|NCT01489033|Immunomodulating Agents|immunomodulating agents|mesh-list
92417083|NCT01489033|Immunologic Factors|immunologic factors|mesh-ancestor
92417084|NCT01489033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417086|NCT01489059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92417087|NCT01489059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417088|NCT01489059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92417089|NCT01489059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417090|NCT01489072|Remifentanil|remifentanil|mesh-list
92417091|NCT01489072|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92417092|NCT01489072|Narcotics|narcotics|mesh-ancestor
92417095|NCT01489072|Analgesics|analgesics|mesh-ancestor
92417145|NCT01489371|Interleukin-12|interleukin-12|mesh-list
92417146|NCT01489371|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92417219|NCT01489631|Anesthetics, General|anesthetics, general|mesh-ancestor
92417220|NCT01489644|Metformin|metformin|mesh-list
92417221|NCT01489644|Repaglinide|repaglinide|mesh-list
92417222|NCT01489644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92417223|NCT01489644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417224|NCT01489683|Lidocaine|lidocaine|mesh-list
92417225|NCT01489683|Anesthetics, Local|anesthetics, local|mesh-ancestor
92417226|NCT01489683|Anesthetics|anesthetics|mesh-ancestor
92417227|NCT01489683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92417228|NCT01489683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417229|NCT01489683|Sensory System Agents|sensory system agents|mesh-ancestor
92417230|NCT01489683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417281|NCT01489904|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92417282|NCT01489904|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92417353|NCT01490047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417354|NCT01490047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417355|NCT01490047|Analgesics|analgesics|mesh-ancestor
92417356|NCT01490047|Sensory System Agents|sensory system agents|mesh-ancestor
92417357|NCT01490047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417424|NCT01490333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417425|NCT01490333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92417426|NCT01490333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92417573|NCT01491048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417575|NCT01491061|Ranolazine|ranolazine|mesh-list
92417576|NCT01491061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92417577|NCT01491061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92417578|NCT01491061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417579|NCT01491100|Interferons|interferons|mesh-list
92417580|NCT01491100|Interferon-beta|interferon-beta|mesh-list
92417581|NCT01491100|Interferon beta-1b|interferon beta-1b|mesh-list
92417582|NCT01491100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92417638|NCT01491295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92417639|NCT01491295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142307|NCT03022123|Prednisone|prednisone|mesh-list
92417640|NCT01491295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417641|NCT01491295|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92417642|NCT01491295|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92417643|NCT01491321|Loxoprofen|loxoprofen|mesh-list
92417644|NCT01491321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92417645|NCT01491321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92417646|NCT01491321|Analgesics|analgesics|mesh-ancestor
92417647|NCT01491321|Sensory System Agents|sensory system agents|mesh-ancestor
92417648|NCT01491321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417649|NCT01491321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417650|NCT01491321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92417651|NCT01491321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92417652|NCT01491438|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92417653|NCT01491438|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92417654|NCT01491438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417655|NCT01491438|Antitubercular Agents|antitubercular agents|mesh-ancestor
92417656|NCT01491503|Cetirizine|cetirizine|mesh-list
92417657|NCT01491503|Montelukast|montelukast|mesh-list
92417658|NCT01491503|Levocetirizine|levocetirizine|mesh-list
92417659|NCT01491503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92417660|NCT01491503|Respiratory System Agents|respiratory system agents|mesh-ancestor
92417661|NCT01491503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92417662|NCT01491503|Hormone Antagonists|hormone antagonists|mesh-ancestor
92417669|NCT01491503|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92417686|NCT01492114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417689|NCT01492153|Insulin|insulin|mesh-list
92417757|NCT01492621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417758|NCT01492621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92417759|NCT01492621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417760|NCT01492621|Antidepressive Agents|antidepressive agents|mesh-ancestor
92417830|NCT01493102|Adrenergic Agents|adrenergic agents|mesh-ancestor
92417834|NCT01493102|Sympathomimetics|sympathomimetics|mesh-ancestor
92417903|NCT01493570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92417904|NCT01493570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92417905|NCT01493570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92417906|NCT01493622|Minocycline|minocycline|mesh-list
92417907|NCT01493622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92417908|NCT01493622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92417909|NCT01493635|Analgesics|analgesics|mesh-list
92417910|NCT01493635|Sensory System Agents|sensory system agents|mesh-ancestor
92417911|NCT01493635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92417912|NCT01493635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417913|NCT01493648|Vitamin D|vitamin d|mesh-list
92417914|NCT01493648|Cholecalciferol|cholecalciferol|mesh-list
92417915|NCT01493648|Vitamins|vitamins|mesh-ancestor
92417916|NCT01493648|Micronutrients|micronutrients|mesh-ancestor
92417917|NCT01493648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417918|NCT01493648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92417919|NCT01493648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92417920|NCT01493674|Folic Acid|folic acid|mesh-list
92417921|NCT01493674|Vitamin B Complex|vitamin b complex|mesh-list
92417922|NCT01493674|Hematinics|hematinics|mesh-ancestor
92417923|NCT01493674|Vitamins|vitamins|mesh-ancestor
92417924|NCT01493674|Micronutrients|micronutrients|mesh-ancestor
92417925|NCT01493674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417926|NCT01493791|Ulipristal acetate|ulipristal acetate|mesh-list
92417927|NCT01493791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92417928|NCT01493791|Contraceptive Agents|contraceptive agents|mesh-ancestor
92417929|NCT01493791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92417930|NCT01493791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92417931|NCT01493791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92417932|NCT01493843|Paclitaxel|paclitaxel|mesh-list
92417933|NCT01493843|Bevacizumab|bevacizumab|mesh-list
92417934|NCT01493843|Carboplatin|carboplatin|mesh-list
92417935|NCT01493843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92417937|NCT01493843|Tubulin Modulators|tubulin modulators|mesh-ancestor
92417946|NCT01493843|Growth Inhibitors|growth inhibitors|mesh-ancestor
92417947|NCT01493856|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92418019|NCT01494311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418020|NCT01494311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418021|NCT01494311|Sensory System Agents|sensory system agents|mesh-ancestor
92418022|NCT01494311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418023|NCT01494311|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92418024|NCT01494311|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92418025|NCT01494311|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92418026|NCT01494311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92418027|NCT01494311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418028|NCT01494363|Leucovorin|leucovorin|mesh-list
92418029|NCT01494363|Fluorouracil|fluorouracil|mesh-list
92418030|NCT01494363|Oxaliplatin|oxaliplatin|mesh-list
92418031|NCT01494363|Irinotecan|irinotecan|mesh-list
92418032|NCT01494363|Antimetabolites|antimetabolites|mesh-ancestor
92418079|NCT01494597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418080|NCT01494597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92418151|NCT01495026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418228|NCT01495260|Expectorants|expectorants|mesh-ancestor
92418229|NCT01495260|Respiratory System Agents|respiratory system agents|mesh-ancestor
92418230|NCT01495260|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92418231|NCT01495260|Antioxidants|antioxidants|mesh-ancestor
92418232|NCT01495260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418233|NCT01495260|Protective Agents|protective agents|mesh-ancestor
92418234|NCT01495260|Antidotes|antidotes|mesh-ancestor
92418235|NCT01495260|Vitamin B Complex|vitamin b complex|mesh-ancestor
92418236|NCT01495338|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92418237|NCT01495338|Cetirizine|cetirizine|mesh-list
92418238|NCT01495338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92418239|NCT01495338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92418240|NCT01495338|Analgesics|analgesics|mesh-ancestor
92418241|NCT01495338|Sensory System Agents|sensory system agents|mesh-ancestor
92418242|NCT01495338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418289|NCT01495624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418291|NCT01495624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418292|NCT01495624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418293|NCT01495624|Anesthetics, Local|anesthetics, local|mesh-ancestor
92418294|NCT01495624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92418355|NCT01496105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418356|NCT01496105|Sensory System Agents|sensory system agents|mesh-ancestor
92418357|NCT01496105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418424|NCT01496521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418425|NCT01496521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92418426|NCT01496521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92418427|NCT01496521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92418428|NCT01496521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92418429|NCT01496521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418430|NCT01496521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92418431|NCT01496521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92418432|NCT01496521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418433|NCT01496521|Antipyretics|antipyretics|mesh-ancestor
92418434|NCT01496534|Carboplatin|carboplatin|mesh-list
92418435|NCT01496534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418436|NCT01496677|Tedizolid phosphate|tedizolid phosphate|mesh-list
92418437|NCT01496677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418438|NCT01496677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418439|NCT01496690|Pregabalin|pregabalin|mesh-list
92418485|NCT01496989|Immunologic Factors|immunologic factors|mesh-ancestor
92418486|NCT01496989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418560|NCT01497431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418709|NCT01498081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92418712|NCT01498380|Dexmedetomidine|dexmedetomidine|mesh-list
92418782|NCT01498835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418783|NCT01498835|Growth Inhibitors|growth inhibitors|mesh-ancestor
92418784|NCT01498835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92418785|NCT01498835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418855|NCT01499121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418856|NCT01499121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418857|NCT01499225|Doxycycline|doxycycline|mesh-list
92418858|NCT01499225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92418859|NCT01499225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92418860|NCT01499225|Antimalarials|antimalarials|mesh-ancestor
92418861|NCT01499225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92418862|NCT01499225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92418863|NCT01499251|Temozolomide|temozolomide|mesh-list
92418920|NCT01499641|Antiemetics|antiemetics|mesh-ancestor
92418921|NCT01499641|Autonomic Agents|autonomic agents|mesh-ancestor
92418922|NCT01499641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92418923|NCT01499641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92418924|NCT01499641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92418925|NCT01499641|Glucocorticoids|glucocorticoids|mesh-ancestor
92418926|NCT01499641|Hormones|hormones|mesh-ancestor
92418927|NCT01499641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92418928|NCT01499641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92418929|NCT01499641|Protective Agents|protective agents|mesh-ancestor
92418930|NCT01499641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92418931|NCT01499641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92418932|NCT01499693|Pantoprazole|pantoprazole|mesh-list
92418933|NCT01499693|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92418934|NCT01499693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92418935|NCT01499693|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92418936|NCT01499693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418937|NCT01499693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418938|NCT01499758|Atorvastatin|atorvastatin|mesh-list
92418939|NCT01499758|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92418940|NCT01499758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92418941|NCT01499758|Antimetabolites|antimetabolites|mesh-ancestor
92418942|NCT01499758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418943|NCT01499758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92418944|NCT01499758|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92418945|NCT01499758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92418946|NCT01499771|Atorvastatin|atorvastatin|mesh-list
92418947|NCT01499771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92418948|NCT01499771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92418949|NCT01499771|Antimetabolites|antimetabolites|mesh-ancestor
92418950|NCT01499771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92418964|NCT01500018|Analgesics|analgesics|mesh-ancestor
92418965|NCT01500018|Sensory System Agents|sensory system agents|mesh-ancestor
92418971|NCT01500018|Anesthetics|anesthetics|mesh-ancestor
92419038|NCT01500538|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92419039|NCT01500538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419110|NCT01500837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92419111|NCT01500837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92419112|NCT01500837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92419113|NCT01500837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92419114|NCT01500837|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92419115|NCT01500850|Insulin|insulin|mesh-list
92419116|NCT01500850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92419117|NCT01500850|Insulin Glargine|insulin glargine|mesh-list
92419118|NCT01500850|Insulin glulisine|insulin glulisine|mesh-list
92419119|NCT01500850|Insulin, Isophane|insulin, isophane|mesh-list
92419120|NCT01500850|Isophane Insulin, Human|isophane insulin, human|mesh-list
92419121|NCT01500850|Isophane insulin, beef|isophane insulin, beef|mesh-list
92419127|NCT01500863|Estradiol|estradiol|mesh-list
92419174|NCT01501084|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92419175|NCT01501084|Incretins|incretins|mesh-ancestor
92419176|NCT01501084|Hormones|hormones|mesh-ancestor
92419177|NCT01501084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419250|NCT01501149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419251|NCT01501149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92419252|NCT01501149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92419253|NCT01501149|Antimetabolites|antimetabolites|mesh-ancestor
92419254|NCT01501149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419255|NCT01501149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92419256|NCT01501149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92419257|NCT01501149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419258|NCT01501149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419259|NCT01501214|Atosiban|atosiban|mesh-list
92419260|NCT01501214|Hormone Antagonists|hormone antagonists|mesh-ancestor
92419263|NCT01501214|Tocolytic Agents|tocolytic agents|mesh-ancestor
92419311|NCT01501396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419312|NCT01501396|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92419313|NCT01501396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419314|NCT01501396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419315|NCT01501396|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92419316|NCT01501396|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92419317|NCT01501396|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92419318|NCT01501396|Adrenergic Agents|adrenergic agents|mesh-ancestor
92419319|NCT01501396|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92419320|NCT01501396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92419321|NCT01501396|Serotonin Agents|serotonin agents|mesh-ancestor
92419322|NCT01501396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92419323|NCT01501396|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92419324|NCT01501396|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92419325|NCT01501396|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92419326|NCT01501396|Contraceptive Agents|contraceptive agents|mesh-ancestor
92419327|NCT01501396|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92419328|NCT01501396|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92419329|NCT01501396|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92419364|NCT01501487|Paclitaxel|paclitaxel|mesh-list
92144071|NCT02570503|Ketorolac|ketorolac|mesh-list
92419365|NCT01501487|Docetaxel|docetaxel|mesh-list
92419366|NCT01501487|Trastuzumab|trastuzumab|mesh-list
92419367|NCT01501487|Pertuzumab|pertuzumab|mesh-list
92419368|NCT01501487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92419369|NCT01501487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419370|NCT01501487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92419371|NCT01501487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92419372|NCT01501487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92419373|NCT01501487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419374|NCT01501487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92419375|NCT01501500|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92419376|NCT01501500|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92419377|NCT01501500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419378|NCT01501500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419379|NCT01501500|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92419421|NCT01501708|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92419422|NCT01501708|Hormone Antagonists|hormone antagonists|mesh-ancestor
92419493|NCT01501890|Hormone Antagonists|hormone antagonists|mesh-ancestor
92419494|NCT01501890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419566|NCT01502267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92419569|NCT01502267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92419639|NCT01502943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419640|NCT01502943|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92419641|NCT01502943|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92419642|NCT01502943|Antimetabolites|antimetabolites|mesh-ancestor
92419643|NCT01502943|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92419644|NCT01502943|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92419645|NCT01503008|Metformin|metformin|mesh-list
92419646|NCT01503008|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92419647|NCT01503008|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92419648|NCT01503008|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92419649|NCT01503008|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92419651|NCT01503008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419702|NCT01503359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419703|NCT01503372|Leucovorin|leucovorin|mesh-list
92419704|NCT01503372|Oxaliplatin|oxaliplatin|mesh-list
92419705|NCT01503372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419706|NCT01503372|Antidotes|antidotes|mesh-ancestor
92419707|NCT01503372|Protective Agents|protective agents|mesh-ancestor
92419708|NCT01503372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419709|NCT01503372|Vitamin B Complex|vitamin b complex|mesh-ancestor
92419710|NCT01503372|Vitamins|vitamins|mesh-ancestor
92419711|NCT01503372|Micronutrients|micronutrients|mesh-ancestor
92419767|NCT01503437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92419768|NCT01503437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92419769|NCT01503437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419770|NCT01503437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419771|NCT01503437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419772|NCT01503437|Serotonin Agents|serotonin agents|mesh-ancestor
92419774|NCT01503450|Antiemetics|antiemetics|mesh-ancestor
92419775|NCT01503450|Autonomic Agents|autonomic agents|mesh-ancestor
92419776|NCT01503450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92419777|NCT01503450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92419778|NCT01503450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92419779|NCT01503450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92419780|NCT01503450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92419781|NCT01503450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92419782|NCT01503450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92419783|NCT01503450|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92419784|NCT01503450|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92419785|NCT01503450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92419820|NCT01503658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92419821|NCT01503658|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92419822|NCT01503658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419824|NCT01503658|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92419825|NCT01503658|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92419826|NCT01503658|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92419827|NCT01503658|Purinergic Agents|purinergic agents|mesh-ancestor
92419828|NCT01503658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419829|NCT01503671|Atorvastatin|atorvastatin|mesh-list
92419832|NCT01503671|Antimetabolites|antimetabolites|mesh-ancestor
92419886|NCT01503905|Alkylating Agents|alkylating agents|mesh-ancestor
92419887|NCT01503905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92419888|NCT01503905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92419889|NCT01503905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92419890|NCT01503905|Tubulin Modulators|tubulin modulators|mesh-ancestor
92419891|NCT01503905|Antimitotic Agents|antimitotic agents|mesh-ancestor
92419892|NCT01503905|Mitosis Modulators|mitosis modulators|mesh-ancestor
92419893|NCT01503905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92419894|NCT01503905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92419895|NCT01503905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92419896|NCT01503905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92419897|NCT01503905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92419898|NCT01503905|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92419899|NCT01503905|Hormone Antagonists|hormone antagonists|mesh-ancestor
92419900|NCT01503905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92419901|NCT01503905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92419943|NCT01504126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92419944|NCT01504126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92419947|NCT01504126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92420019|NCT01504334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420020|NCT01504334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420021|NCT01504334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92420022|NCT01504334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92420023|NCT01504334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92420024|NCT01504334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92420025|NCT01504334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92420087|NCT01504724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92420088|NCT01504724|Growth Substances|growth substances|mesh-ancestor
92420161|NCT01505088|Protective Agents|protective agents|mesh-ancestor
92420162|NCT01505088|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92420163|NCT01505088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420164|NCT01505127|Amoxicillin|amoxicillin|mesh-list
92420165|NCT01505127|Clarithromycin|clarithromycin|mesh-list
92420166|NCT01505127|Lansoprazole|lansoprazole|mesh-list
92420167|NCT01505127|Dexlansoprazole|dexlansoprazole|mesh-list
92420168|NCT01505127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92420169|NCT01505127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92420170|NCT01505127|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92420171|NCT01505127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420172|NCT01505127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420173|NCT01505127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92420174|NCT01505127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92420175|NCT01505127|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92420176|NCT01505127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420177|NCT01505127|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92420178|NCT01505218|Propofol|propofol|mesh-list
92420179|NCT01505218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92420180|NCT01505218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420181|NCT01505218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420182|NCT01505218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92420183|NCT01505218|Anesthetics, General|anesthetics, general|mesh-ancestor
92420184|NCT01505218|Anesthetics|anesthetics|mesh-ancestor
92420185|NCT01505231|Vasopressins|vasopressins|mesh-list
92420186|NCT01505231|Arginine Vasopressin|arginine vasopressin|mesh-list
92420187|NCT01505231|Norepinephrine|norepinephrine|mesh-list
92420188|NCT01505231|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92420189|NCT01505231|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92420190|NCT01505231|Adrenergic Agents|adrenergic agents|mesh-ancestor
92420216|NCT01505283|Narcotics|narcotics|mesh-ancestor
92420281|NCT01505790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420282|NCT01505855|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92420283|NCT01505855|Immunologic Factors|immunologic factors|mesh-ancestor
92420284|NCT01505855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420286|NCT01505894|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92420287|NCT01505894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420288|NCT01505894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420289|NCT01505920|Lidocaine|lidocaine|mesh-list
92420290|NCT01505920|Anesthetics, Local|anesthetics, local|mesh-ancestor
92420291|NCT01505920|Anesthetics|anesthetics|mesh-ancestor
92420292|NCT01505920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420293|NCT01505920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420294|NCT01505920|Sensory System Agents|sensory system agents|mesh-ancestor
92420295|NCT01505920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420296|NCT01505920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92420297|NCT01505920|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92420298|NCT01505920|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92420299|NCT01505920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92420300|NCT01505920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420301|NCT01505946|Thrombin|thrombin|mesh-list
92420302|NCT01505946|Hemostatics|hemostatics|mesh-ancestor
92420303|NCT01505946|Coagulants|coagulants|mesh-ancestor
92420304|NCT01505998|Amlodipine|amlodipine|mesh-list
92420305|NCT01505998|Benazepril|benazepril|mesh-list
92420306|NCT01505998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92420307|NCT01505998|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92420308|NCT01505998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92420309|NCT01505998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420310|NCT01505998|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92420312|NCT01505998|Vasodilator Agents|vasodilator agents|mesh-ancestor
92420323|NCT01506011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420397|NCT01506167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420398|NCT01506167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92420399|NCT01506167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92420400|NCT01506167|Immunologic Factors|immunologic factors|mesh-ancestor
92420401|NCT01506167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92420402|NCT01506167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92420403|NCT01506167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92420541|NCT01506765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420543|NCT01506791|Pseudoephedrine|pseudoephedrine|mesh-list
92420544|NCT01506791|Ephedrine|ephedrine|mesh-list
92420545|NCT01506791|Desloratadine|desloratadine|mesh-list
92420546|NCT01506791|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92420547|NCT01506791|Cholinergic Agents|cholinergic agents|mesh-ancestor
92420548|NCT01506791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420549|NCT01506791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420550|NCT01506791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420551|NCT01506791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92420552|NCT01506791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92420553|NCT01506791|Histamine Antagonists|histamine antagonists|mesh-ancestor
92420554|NCT01506791|Histamine Agents|histamine agents|mesh-ancestor
92420555|NCT01506791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92420556|NCT01506791|Autonomic Agents|autonomic agents|mesh-ancestor
92420557|NCT01506791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420558|NCT01506791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92420559|NCT01506791|Respiratory System Agents|respiratory system agents|mesh-ancestor
92420560|NCT01506791|Nasal Decongestants|nasal decongestants|mesh-ancestor
92420597|NCT01506921|Anesthetics, General|anesthetics, general|mesh-ancestor
92420598|NCT01506921|Anesthetics|anesthetics|mesh-ancestor
92420599|NCT01506921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420600|NCT01506921|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92420601|NCT01506921|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92420602|NCT01506921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92420603|NCT01506921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92420604|NCT01506921|Antidepressive Agents|antidepressive agents|mesh-ancestor
92420606|NCT01507064|Sorafenib|sorafenib|mesh-list
92420664|NCT01507363|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92420665|NCT01507363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92420666|NCT01507363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92420667|NCT01507363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92420737|NCT01507558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420738|NCT01507558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420739|NCT01507558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92420740|NCT01507558|Glucocorticoids|glucocorticoids|mesh-ancestor
92420741|NCT01507558|Hormones|hormones|mesh-ancestor
92420742|NCT01507558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92420806|NCT01507857|Immunologic Factors|immunologic factors|mesh-ancestor
92420807|NCT01507857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420808|NCT01507922|Fenoverine|fenoverine|mesh-list
92420809|NCT01507922|Parasympatholytics|parasympatholytics|mesh-ancestor
92420810|NCT01507922|Autonomic Agents|autonomic agents|mesh-ancestor
92420811|NCT01507922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92420812|NCT01507922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420813|NCT01507974|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92420814|NCT01507974|Amoxicillin|amoxicillin|mesh-list
92420872|NCT01508182|Canagliflozin|canagliflozin|mesh-list
92420873|NCT01508182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92420874|NCT01508182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92420875|NCT01508182|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92420943|NCT01508468|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92420944|NCT01508468|Protease Inhibitors|protease inhibitors|mesh-ancestor
92420945|NCT01508468|Hormone Antagonists|hormone antagonists|mesh-ancestor
92420947|NCT01508468|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92421015|NCT01508858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145770|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92421089|NCT01509261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421090|NCT01509300|Mycophenolic Acid|mycophenolic acid|mesh-list
92421091|NCT01509300|Cyclophosphamide|cyclophosphamide|mesh-list
92421092|NCT01509300|Rituximab|rituximab|mesh-list
92421093|NCT01509300|Fludarabine|fludarabine|mesh-list
92421094|NCT01509300|Tacrolimus|tacrolimus|mesh-list
92421095|NCT01509300|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92421096|NCT01509300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421097|NCT01509300|Immunologic Factors|immunologic factors|mesh-ancestor
92421098|NCT01509300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421099|NCT01509300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92421100|NCT01509300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92421101|NCT01509300|Alkylating Agents|alkylating agents|mesh-ancestor
92421113|NCT01509365|Clopidogrel|clopidogrel|mesh-list
92421149|NCT01509521|Protective Agents|protective agents|mesh-ancestor
92421150|NCT01509521|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92421151|NCT01509521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92421152|NCT01509521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92421153|NCT01509560|Everolimus|everolimus|mesh-list
92421220|NCT01510171|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92421221|NCT01510171|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92421222|NCT01510171|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92421223|NCT01510171|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92421224|NCT01510171|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92421225|NCT01510171|Purinergic Agents|purinergic agents|mesh-ancestor
92421226|NCT01510171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421227|NCT01510171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421228|NCT01510171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421285|NCT01510613|Hormones|hormones|mesh-ancestor
92421286|NCT01510613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421287|NCT01510613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92421288|NCT01510613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421289|NCT01510613|Immunologic Factors|immunologic factors|mesh-ancestor
92421290|NCT01510613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92421291|NCT01510613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92421292|NCT01510613|Growth Substances|growth substances|mesh-ancestor
92421293|NCT01510613|Growth Inhibitors|growth inhibitors|mesh-ancestor
92421294|NCT01510626|Omalizumab|omalizumab|mesh-list
92421295|NCT01510626|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92421296|NCT01510626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92421348|NCT01511029|Dopamine Agents|dopamine agents|mesh-ancestor
92421349|NCT01511029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92421350|NCT01511146|Gemcitabine|gemcitabine|mesh-list
92421424|NCT01511237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92421425|NCT01511263|Amiodarone|amiodarone|mesh-list
92421426|NCT01511263|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92421495|NCT01511562|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92421496|NCT01511562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421497|NCT01511562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421498|NCT01511562|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92421499|NCT01511562|Antimetabolites|antimetabolites|mesh-ancestor
92421500|NCT01511562|Antiviral Agents|antiviral agents|mesh-ancestor
92421501|NCT01511562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421502|NCT01511562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92421503|NCT01511562|Immunologic Factors|immunologic factors|mesh-ancestor
92421504|NCT01511562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421505|NCT01511562|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92421506|NCT01511562|Alkylating Agents|alkylating agents|mesh-ancestor
92421507|NCT01511562|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92421508|NCT01511627|Anesthetics|anesthetics|mesh-list
92421509|NCT01511627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421510|NCT01511627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421511|NCT01511692|Liraglutide|liraglutide|mesh-list
92421512|NCT01511692|Glimepiride|glimepiride|mesh-list
92421513|NCT01511692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421514|NCT01511692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421515|NCT01511692|Incretins|incretins|mesh-ancestor
92421516|NCT01511692|Hormones|hormones|mesh-ancestor
92421517|NCT01511692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421547|NCT01511731|Famotidine|famotidine|mesh-list
92421548|NCT01511731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92421549|NCT01511731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92421552|NCT01511731|Histamine Agents|histamine agents|mesh-ancestor
92421618|NCT01511848|Chelating Agents|chelating agents|mesh-ancestor
92421619|NCT01511848|Sequestering Agents|sequestering agents|mesh-ancestor
92421622|NCT01511874|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92421691|NCT01512173|Vasodilator Agents|vasodilator agents|mesh-ancestor
92421693|NCT01512199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92421694|NCT01512199|Trastuzumab|trastuzumab|mesh-list
92421695|NCT01512199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92421696|NCT01512199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92421697|NCT01512199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421698|NCT01512199|Tubulin Modulators|tubulin modulators|mesh-ancestor
92421699|NCT01512199|Antimitotic Agents|antimitotic agents|mesh-ancestor
92421700|NCT01512199|Mitosis Modulators|mitosis modulators|mesh-ancestor
92421703|NCT01512199|Immunologic Factors|immunologic factors|mesh-ancestor
92421754|NCT01512537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92421755|NCT01512537|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92421756|NCT01512628|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92421757|NCT01512628|Plasma Substitutes|plasma substitutes|mesh-ancestor
92421758|NCT01512628|Blood Substitutes|blood substitutes|mesh-ancestor
92421759|NCT01512680|Insulin|insulin|mesh-list
92421760|NCT01512680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421761|NCT01512680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421762|NCT01512784|Vaccines|vaccines|mesh-list
92421763|NCT01512784|Immunologic Factors|immunologic factors|mesh-ancestor
92421764|NCT01512784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421765|NCT01512862|Calcitriol|calcitriol|mesh-list
92421766|NCT01512862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92421767|NCT01512862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421768|NCT01512862|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92421769|NCT01512862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92421772|NCT01512862|Vitamins|vitamins|mesh-ancestor
92421812|NCT01513044|Antitubercular Agents|antitubercular agents|mesh-ancestor
92421813|NCT01513044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92421814|NCT01513044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421815|NCT01513044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92421816|NCT01513044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421817|NCT01513057|Mycophenolic Acid|mycophenolic acid|mesh-list
92421818|NCT01513057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92421819|NCT01513057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92421820|NCT01513057|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92421821|NCT01513057|Antitubercular Agents|antitubercular agents|mesh-ancestor
92421822|NCT01513057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92421823|NCT01513057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92421826|NCT01513070|Aspirin|aspirin|mesh-list
92421875|NCT01513200|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92421876|NCT01513200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421878|NCT01513499|Oxytocics|oxytocics|mesh-ancestor
92421879|NCT01513499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92421880|NCT01513499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421881|NCT01513525|Liraglutide|liraglutide|mesh-list
92421882|NCT01513525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92421883|NCT01513525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421884|NCT01513525|Incretins|incretins|mesh-ancestor
92421885|NCT01513525|Hormones|hormones|mesh-ancestor
92421886|NCT01513525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92421887|NCT01513564|Morphine|morphine|mesh-list
92421888|NCT01513564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421889|NCT01513564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421935|NCT01513720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92421936|NCT01513720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92421937|NCT01513720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92421938|NCT01513720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92421939|NCT01513720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92421940|NCT01513720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92421941|NCT01513720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92421942|NCT01513720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92422001|NCT01514110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92422002|NCT01514110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422003|NCT01514110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422004|NCT01514110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422005|NCT01514110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422006|NCT01514110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422007|NCT01514110|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92422008|NCT01514110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92422009|NCT01514110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422010|NCT01514110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422011|NCT01514110|Immunologic Factors|immunologic factors|mesh-ancestor
92422012|NCT01514110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422013|NCT01514123|Bevacizumab|bevacizumab|mesh-list
92422014|NCT01514123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92422015|NCT01514123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422016|NCT01514123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92422017|NCT01514123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92422018|NCT01514123|Growth Substances|growth substances|mesh-ancestor
92422019|NCT01514123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422020|NCT01514123|Growth Inhibitors|growth inhibitors|mesh-ancestor
92422021|NCT01514175|Ibuprofen|ibuprofen|mesh-list
92422022|NCT01514175|Ketorolac|ketorolac|mesh-list
92422023|NCT01514175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92422024|NCT01514175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92422025|NCT01514175|Analgesics|analgesics|mesh-ancestor
92422026|NCT01514175|Sensory System Agents|sensory system agents|mesh-ancestor
92422027|NCT01514175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422028|NCT01514175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422029|NCT01514175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92422030|NCT01514175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422031|NCT01514175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92422044|NCT01514227|Analgesics|analgesics|mesh-ancestor
92422045|NCT01514227|Sensory System Agents|sensory system agents|mesh-ancestor
92422046|NCT01514227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92422047|NCT01514227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422116|NCT01514812|Protective Agents|protective agents|mesh-ancestor
92422192|NCT01515228|Paclitaxel|paclitaxel|mesh-list
92422193|NCT01515228|Everolimus|everolimus|mesh-list
92422194|NCT01515228|Cilostazol|cilostazol|mesh-list
92422195|NCT01515228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92422196|NCT01515228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422197|NCT01515228|Tubulin Modulators|tubulin modulators|mesh-ancestor
92422198|NCT01515228|Antimitotic Agents|antimitotic agents|mesh-ancestor
92422199|NCT01515228|Mitosis Modulators|mitosis modulators|mesh-ancestor
92422200|NCT01515228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422201|NCT01515228|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92422202|NCT01515228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92422203|NCT01515228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422204|NCT01515228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422205|NCT01515228|Immunologic Factors|immunologic factors|mesh-ancestor
92422255|NCT01515774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422256|NCT01515774|Protective Agents|protective agents|mesh-ancestor
92422257|NCT01515774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422258|NCT01515774|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92422259|NCT01515774|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92422260|NCT01515774|Dopamine Agonists|dopamine agonists|mesh-ancestor
92422321|NCT01515839|Acetylcarnitine|acetylcarnitine|mesh-list
92422322|NCT01515839|Acetylcysteine|acetylcysteine|mesh-list
92422392|NCT01516372|Moxifloxacin|moxifloxacin|mesh-list
92422393|NCT01516372|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92422394|NCT01516372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92422395|NCT01516372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92422396|NCT01516372|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92400409|NCT01408979|Analgesics|analgesics|mesh-ancestor
92422397|NCT01516372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422398|NCT01516372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422399|NCT01516372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422400|NCT01516372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422401|NCT01516372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92422402|NCT01516372|Contraceptive Agents|contraceptive agents|mesh-ancestor
92422403|NCT01516372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92422404|NCT01516372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422405|NCT01516372|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92422454|NCT01516580|Doxorubicin|doxorubicin|mesh-list
92422455|NCT01516580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92422456|NCT01516580|Methotrexate|methotrexate|mesh-list
92422457|NCT01516580|Vincristine|vincristine|mesh-list
92422458|NCT01516580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92422459|NCT01516580|Immunologic Factors|immunologic factors|mesh-ancestor
92422460|NCT01516580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422461|NCT01516580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92422462|NCT01516580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92422463|NCT01516580|Alkylating Agents|alkylating agents|mesh-ancestor
92422464|NCT01516580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422465|NCT01516580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422466|NCT01516580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92422467|NCT01516580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92422468|NCT01516580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92422469|NCT01516580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92422470|NCT01516580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92422471|NCT01516580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422472|NCT01516580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92422473|NCT01516580|Abortifacient Agents|abortifacient agents|mesh-ancestor
92422509|NCT01516814|Anticoagulants|anticoagulants|mesh-ancestor
92422510|NCT01516814|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92422511|NCT01516814|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422512|NCT01516814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422513|NCT01516814|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92422514|NCT01516814|Antithrombins|antithrombins|mesh-ancestor
92147194|NCT00801723|Budesonide|budesonide|mesh-list
92422515|NCT01516814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92422516|NCT01516814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422517|NCT01516814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422518|NCT01516840|Heparin|heparin|mesh-list
92422519|NCT01516840|Calcium heparin|calcium heparin|mesh-list
92422520|NCT01516840|Warfarin|warfarin|mesh-list
92422521|NCT01516840|Rivaroxaban|rivaroxaban|mesh-list
92422522|NCT01516840|Anticoagulants|anticoagulants|mesh-ancestor
92422523|NCT01516840|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92422524|NCT01516840|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422525|NCT01516840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422526|NCT01516840|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92422527|NCT01516840|Antithrombins|antithrombins|mesh-ancestor
92422528|NCT01516840|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92422529|NCT01516840|Protease Inhibitors|protease inhibitors|mesh-ancestor
92422530|NCT01516840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422531|NCT01516866|Listerine|listerine|mesh-list
92422532|NCT01516866|Fluorides|fluorides|mesh-list
92422533|NCT01516866|Sodium Fluoride|sodium fluoride|mesh-list
92422562|NCT01517022|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92422563|NCT01517022|Cholinergic Agents|cholinergic agents|mesh-ancestor
92422564|NCT01517022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92422565|NCT01517022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92422567|NCT01517165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92422568|NCT01517165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92422569|NCT01517308|Interferons|interferons|mesh-list
92422570|NCT01517308|Ribavirin|ribavirin|mesh-list
92422571|NCT01517308|Interferon-alpha|interferon-alpha|mesh-list
92422572|NCT01517308|Interferon alpha-2|interferon alpha-2|mesh-list
92422573|NCT01517308|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92422574|NCT01517308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92422627|NCT01517399|Anticoagulants|anticoagulants|mesh-ancestor
92422628|NCT01517399|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92422629|NCT01517399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92422630|NCT01517399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92422631|NCT01517399|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92422632|NCT01517399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92422633|NCT01517399|Purinergic Agents|purinergic agents|mesh-ancestor
92422634|NCT01517399|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92422635|NCT01517399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92422636|NCT01517399|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92422637|NCT01517399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92422638|NCT01517399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92422639|NCT01517399|Protective Agents|protective agents|mesh-ancestor
92422640|NCT01517399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92422641|NCT01517399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92422642|NCT01517399|Hemostatics|hemostatics|mesh-ancestor
92422643|NCT01517399|Coagulants|coagulants|mesh-ancestor
92422644|NCT01517490|Insulin|insulin|mesh-list
92422688|NCT01517828|Analgesics|analgesics|mesh-ancestor
92422689|NCT01517828|Sensory System Agents|sensory system agents|mesh-ancestor
92422695|NCT01517828|Anesthetics|anesthetics|mesh-ancestor
92422760|NCT01518166|Griseofulvin|griseofulvin|mesh-list
92422761|NCT01518166|Digoxin|digoxin|mesh-list
92422762|NCT01518166|Lisinopril|lisinopril|mesh-list
92422763|NCT01518166|Atorvastatin|atorvastatin|mesh-list
92422764|NCT01518166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92422834|NCT01518465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92422835|NCT01518465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92422905|NCT01518855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92422978|NCT01519154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92422981|NCT01519297|Irbesartan|irbesartan|mesh-list
92423052|NCT01519687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92423053|NCT01519726|Midazolam|midazolam|mesh-list
92423054|NCT01519726|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92423055|NCT01519726|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92423056|NCT01519726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423057|NCT01519726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423058|NCT01519726|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92423059|NCT01519726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92423060|NCT01519726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92423061|NCT01519726|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92423062|NCT01519726|Anesthetics, General|anesthetics, general|mesh-ancestor
92423063|NCT01519726|Anesthetics|anesthetics|mesh-ancestor
92423064|NCT01519726|GABA Modulators|gaba modulators|mesh-ancestor
92423065|NCT01519726|GABA Agents|gaba agents|mesh-ancestor
92423066|NCT01519726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423067|NCT01519726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423068|NCT01519752|Oxiconazole|oxiconazole|mesh-list
92423069|NCT01519752|Antifungal Agents|antifungal agents|mesh-ancestor
92423070|NCT01519752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92423071|NCT01519856|Piribedil|piribedil|mesh-list
92423072|NCT01519856|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92423073|NCT01519856|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92423074|NCT01519856|Dopamine Agonists|dopamine agonists|mesh-ancestor
92423075|NCT01519856|Dopamine Agents|dopamine agents|mesh-ancestor
92423076|NCT01519856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92423077|NCT01519856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423078|NCT01519856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423079|NCT01519986|Vitamin D|vitamin d|mesh-list
92423099|NCT01520077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423172|NCT01520415|Bupivacaine|bupivacaine|mesh-list
92423173|NCT01520415|Anesthetics, Local|anesthetics, local|mesh-ancestor
92423174|NCT01520415|Anesthetics|anesthetics|mesh-ancestor
92423175|NCT01520415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92423176|NCT01520415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423177|NCT01520415|Sensory System Agents|sensory system agents|mesh-ancestor
92423178|NCT01520415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423179|NCT01520415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92423180|NCT01520415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92423181|NCT01520415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92423223|NCT01520766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423224|NCT01520766|Adrenergic Agents|adrenergic agents|mesh-ancestor
92423225|NCT01520766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92423226|NCT01520766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92423227|NCT01520766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423228|NCT01520766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92423229|NCT01520792|Acetaminophen|acetaminophen|mesh-list
92423230|NCT01520792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92423231|NCT01520792|Analgesics|analgesics|mesh-ancestor
92423232|NCT01520792|Sensory System Agents|sensory system agents|mesh-ancestor
92423233|NCT01520792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92423234|NCT01520792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423235|NCT01520792|Antipyretics|antipyretics|mesh-ancestor
92423236|NCT01520818|Insulin|insulin|mesh-list
92423237|NCT01520818|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92423238|NCT01520818|Insulin Aspart|insulin aspart|mesh-list
92423239|NCT01520818|Insulin, Long-Acting|insulin, long-acting|mesh-list
92423280|NCT01521312|Hormones|hormones|mesh-ancestor
92423281|NCT01521312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92423282|NCT01521312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423283|NCT01521312|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92423284|NCT01521312|Protease Inhibitors|protease inhibitors|mesh-ancestor
92423285|NCT01521312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423286|NCT01521312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423287|NCT01521312|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92423344|NCT01521689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92423345|NCT01521689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423346|NCT01521689|Immunologic Factors|immunologic factors|mesh-ancestor
92423415|NCT01522092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92423416|NCT01522092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92423490|NCT01522625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423491|NCT01522625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92423492|NCT01522625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92423493|NCT01522677|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92423494|NCT01522677|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92423495|NCT01522677|Dermatologic Agents|dermatologic agents|mesh-ancestor
92423496|NCT01522729|Fentanyl|fentanyl|mesh-list
92423497|NCT01522729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92423498|NCT01522729|Narcotics|narcotics|mesh-ancestor
92423508|NCT01522820|Sirolimus|sirolimus|mesh-list
92423558|NCT01522989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423560|NCT01522989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92423633|NCT01523093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92423634|NCT01523093|Antipruritics|antipruritics|mesh-ancestor
92423635|NCT01523093|Dermatologic Agents|dermatologic agents|mesh-ancestor
92423636|NCT01523093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92423637|NCT01523093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92423703|NCT01523418|Anticoagulants|anticoagulants|mesh-ancestor
92423704|NCT01523431|Leucovorin|leucovorin|mesh-list
92423706|NCT01523431|Irinotecan|irinotecan|mesh-list
92423779|NCT01523860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92423780|NCT01523860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92423781|NCT01523860|Immunologic Factors|immunologic factors|mesh-ancestor
92423782|NCT01523860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423783|NCT01523860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92423784|NCT01523860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92423785|NCT01523860|Alkylating Agents|alkylating agents|mesh-ancestor
92423786|NCT01523860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423845|NCT01524237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92423846|NCT01524237|Anesthetics, General|anesthetics, general|mesh-ancestor
92423847|NCT01524237|Anesthetics|anesthetics|mesh-ancestor
92423915|NCT01524601|Antimetabolites|antimetabolites|mesh-ancestor
92423990|NCT01524861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92423991|NCT01524861|Protective Agents|protective agents|mesh-ancestor
92423992|NCT01524861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92423993|NCT01524861|Vitamin B Complex|vitamin b complex|mesh-ancestor
92423994|NCT01524861|Vitamins|vitamins|mesh-ancestor
92423995|NCT01524861|Micronutrients|micronutrients|mesh-ancestor
92423996|NCT01524861|Nootropic Agents|nootropic agents|mesh-ancestor
92423997|NCT01524874|Vitamin D|vitamin d|mesh-list
92423998|NCT01524874|Ergocalciferols|ergocalciferols|mesh-list
92423999|NCT01524874|Cholecalciferol|cholecalciferol|mesh-list
92424000|NCT01524874|Calcitriol|calcitriol|mesh-list
92424001|NCT01524874|Vitamins|vitamins|mesh-list
92424002|NCT01524874|Micronutrients|micronutrients|mesh-ancestor
92424003|NCT01524874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424004|NCT01524874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92424005|NCT01524874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92424006|NCT01524874|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92148684|NCT03243019|Sirolimus|sirolimus|mesh-list
92424007|NCT01524874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424008|NCT01524874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424009|NCT01524874|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92424010|NCT01524939|Immunoglobulins|immunoglobulins|mesh-list
92424011|NCT01524939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92424012|NCT01524939|Antibodies|antibodies|mesh-list
92424043|NCT01525537|Sensory System Agents|sensory system agents|mesh-ancestor
92424153|NCT01526161|Xhance|xhance|mesh-list
92424190|NCT01526278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424191|NCT01526278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92424193|NCT01526278|Micronutrients|micronutrients|mesh-ancestor
92424194|NCT01526317|Metformin|metformin|mesh-list
92424195|NCT01526317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92424196|NCT01526317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92424197|NCT01526317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424198|NCT01526317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92424205|NCT01526369|Paclitaxel|paclitaxel|mesh-list
92424258|NCT01526525|Anesthetics, General|anesthetics, general|mesh-ancestor
92424259|NCT01526525|Anesthetics|anesthetics|mesh-ancestor
92424266|NCT01526525|Narcotics|narcotics|mesh-ancestor
92424331|NCT01526850|Immunologic Factors|immunologic factors|mesh-ancestor
92424402|NCT01527097|Atorvastatin|atorvastatin|mesh-list
92424403|NCT01527097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92424475|NCT01527474|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92424476|NCT01527474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92424477|NCT01527474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92424478|NCT01527474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92424480|NCT01527474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424481|NCT01527539|Insulin Aspart|insulin aspart|mesh-list
92424482|NCT01527539|Biphasic Insulins|biphasic insulins|mesh-list
92424483|NCT01527539|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92424539|NCT01527864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92424540|NCT01527864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424541|NCT01527864|Tubulin Modulators|tubulin modulators|mesh-ancestor
92424612|NCT01528163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92424613|NCT01528163|Dermatologic Agents|dermatologic agents|mesh-ancestor
92424614|NCT01528163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424615|NCT01528163|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92424616|NCT01528163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424617|NCT01528163|Immunologic Factors|immunologic factors|mesh-ancestor
92424618|NCT01528163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92424619|NCT01528163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92424620|NCT01528176|Cholecalciferol|cholecalciferol|mesh-list
92424621|NCT01528176|Vitamin D|vitamin d|mesh-list
92424622|NCT01528176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92424623|NCT01528176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424624|NCT01528176|Vitamins|vitamins|mesh-ancestor
92424625|NCT01528176|Micronutrients|micronutrients|mesh-ancestor
92424626|NCT01528176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92424627|NCT01528371|Midazolam|midazolam|mesh-list
92424628|NCT01528371|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92424629|NCT01528371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92424637|NCT01528371|Anesthetics|anesthetics|mesh-ancestor
92424670|NCT01528618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92424748|NCT01529125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92424752|NCT01529138|Sirolimus|sirolimus|mesh-list
92424825|NCT01529229|Desloratadine|desloratadine|mesh-list
92424899|NCT01529437|Immunologic Factors|immunologic factors|mesh-list
92424900|NCT01529437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92424901|NCT01529476|Levofloxacin|levofloxacin|mesh-list
92424902|NCT01529476|Nemonoxacin|nemonoxacin|mesh-list
92424903|NCT01529476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92424904|NCT01529476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92424905|NCT01529476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92424906|NCT01529476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92424907|NCT01529476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92424908|NCT01529476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92424963|NCT01529892|Methamphetamine|methamphetamine|mesh-list
92424966|NCT01529892|Sympathomimetics|sympathomimetics|mesh-ancestor
92425035|NCT01530295|Docetaxel|docetaxel|mesh-list
92425036|NCT01530295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425037|NCT01530295|Tubulin Modulators|tubulin modulators|mesh-ancestor
92425038|NCT01530295|Antimitotic Agents|antimitotic agents|mesh-ancestor
92425039|NCT01530295|Mitosis Modulators|mitosis modulators|mesh-ancestor
92425040|NCT01530295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425041|NCT01530308|Dopamine|dopamine|mesh-list
92425105|NCT01530542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425106|NCT01530555|Thymoglobulin|thymoglobulin|mesh-list
92425107|NCT01530555|Immunologic Factors|immunologic factors|mesh-ancestor
92425108|NCT01530555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425109|NCT01530555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92425110|NCT01530594|Lenalidomide|lenalidomide|mesh-list
92425111|NCT01530594|Bortezomib|bortezomib|mesh-list
92425112|NCT01530594|Immunologic Factors|immunologic factors|mesh-ancestor
92425113|NCT01530594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425114|NCT01530594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92425115|NCT01530594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92425116|NCT01530594|Growth Substances|growth substances|mesh-ancestor
92425117|NCT01530594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92425118|NCT01530594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425119|NCT01530607|Cyclophosphamide|cyclophosphamide|mesh-list
92425120|NCT01530607|Goserelin|goserelin|mesh-list
92149811|NCT01457846|Paclitaxel|paclitaxel|mesh-list
92425165|NCT01530763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425166|NCT01530815|Bupivacaine|bupivacaine|mesh-list
92425167|NCT01530815|Anesthetics, Local|anesthetics, local|mesh-ancestor
92425238|NCT01531244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92425239|NCT01531244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425240|NCT01531244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92425241|NCT01531244|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92425242|NCT01531244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425243|NCT01531244|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92425244|NCT01531309|Agomelatine|agomelatine|mesh-list
92425245|NCT01531309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92425248|NCT01531322|Vaccines|vaccines|mesh-list
92425305|NCT01531712|Gemcitabine|gemcitabine|mesh-list
92425306|NCT01531712|Oxaliplatin|oxaliplatin|mesh-list
92425307|NCT01531712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92425308|NCT01531712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92425309|NCT01531712|Antimetabolites|antimetabolites|mesh-ancestor
92425310|NCT01531712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425311|NCT01531712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425312|NCT01531712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92088272|NCT01973231|Liraglutide|liraglutide|mesh-list
92425313|NCT01531712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425314|NCT01531764|Vinorelbine|vinorelbine|mesh-list
92425315|NCT01531764|Afatinib|afatinib|mesh-list
92425316|NCT01531764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92425317|NCT01531764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425318|NCT01531764|Tubulin Modulators|tubulin modulators|mesh-ancestor
92425319|NCT01531764|Antimitotic Agents|antimitotic agents|mesh-ancestor
92425320|NCT01531764|Mitosis Modulators|mitosis modulators|mesh-ancestor
92425321|NCT01531764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425322|NCT01531764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92425323|NCT01531764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92425324|NCT01531777|Apatinib|apatinib|mesh-list
92425325|NCT01531777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92425361|NCT01531920|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92425362|NCT01531920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92425371|NCT01532076|Hemostatics|hemostatics|mesh-ancestor
92425433|NCT01532804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425434|NCT01532804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92425443|NCT01532856|Thalidomide|thalidomide|mesh-list
92425503|NCT01533155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92425504|NCT01533155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425506|NCT01533155|Sensory System Agents|sensory system agents|mesh-ancestor
92425507|NCT01533155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425508|NCT01533155|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92425509|NCT01533155|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92425510|NCT01533155|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425514|NCT01533155|Antimalarials|antimalarials|mesh-ancestor
92425571|NCT01533324|Micronutrients|micronutrients|mesh-ancestor
92425573|NCT01533376|Lubricant Eye Drops|lubricant eye drops|mesh-list
92425574|NCT01533376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92425575|NCT01533376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92425576|NCT01533376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92425577|NCT01533376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92425578|NCT01533376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425579|NCT01533376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425580|NCT01533376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92425581|NCT01533376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92425582|NCT01533376|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92425583|NCT01533376|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92425584|NCT01533389|Silodosin|silodosin|mesh-list
92425586|NCT01533389|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92425633|NCT01533662|Oxymetazoline|oxymetazoline|mesh-list
92425634|NCT01533662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92425635|NCT01533662|Mydriatics|mydriatics|mesh-ancestor
92425636|NCT01533662|Autonomic Agents|autonomic agents|mesh-ancestor
92425637|NCT01533662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425638|NCT01533662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425639|NCT01533662|Sympathomimetics|sympathomimetics|mesh-ancestor
92425640|NCT01533662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92425641|NCT01533662|Nasal Decongestants|nasal decongestants|mesh-ancestor
92425642|NCT01533662|Respiratory System Agents|respiratory system agents|mesh-ancestor
92425643|NCT01533662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92425644|NCT01533662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92425698|NCT01533870|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92425703|NCT01534026|Aspirin|aspirin|mesh-list
92425772|NCT01534546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92425773|NCT01534546|Antimetabolites|antimetabolites|mesh-ancestor
92425774|NCT01534546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92425845|NCT01534949|Immunologic Factors|immunologic factors|mesh-ancestor
92425846|NCT01534949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425847|NCT01534949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92425848|NCT01535027|Alendronate|alendronate|mesh-list
92425849|NCT01535027|Teriparatide|teriparatide|mesh-list
92425850|NCT01535027|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92425851|NCT01535027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92425852|NCT01535027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92425853|NCT01535027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92425854|NCT01535027|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92425855|NCT01535027|Hormone Antagonists|hormone antagonists|mesh-ancestor
92425856|NCT01535027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92425858|NCT01535027|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92425904|NCT01535417|Analgesics|analgesics|mesh-ancestor
92425905|NCT01535417|Sensory System Agents|sensory system agents|mesh-ancestor
92425906|NCT01535417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92425975|NCT01535781|Hemostatics|hemostatics|mesh-ancestor
92426049|NCT01536158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92426050|NCT01536158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92426051|NCT01536158|Analgesics|analgesics|mesh-ancestor
92426052|NCT01536158|Sensory System Agents|sensory system agents|mesh-ancestor
92426053|NCT01536158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426054|NCT01536158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426055|NCT01536158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426056|NCT01536158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426057|NCT01536158|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92426058|NCT01536158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426113|NCT01536431|Insulin|insulin|mesh-list
92426114|NCT01536431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92426115|NCT01536431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92426117|NCT01536470|Norepinephrine|norepinephrine|mesh-list
92426185|NCT01536743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426186|NCT01536743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426187|NCT01536743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426188|NCT01536873|Dolutegravir|dolutegravir|mesh-list
92426189|NCT01536873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92426190|NCT01536873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92426191|NCT01536873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426192|NCT01536873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426193|NCT01536873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92426194|NCT01536873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92426195|NCT01536873|Antiviral Agents|antiviral agents|mesh-ancestor
92426196|NCT01536873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426197|NCT01537055|Amoxicillin|amoxicillin|mesh-list
92426198|NCT01537055|Levofloxacin|levofloxacin|mesh-list
92426245|NCT01537250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92426246|NCT01537250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92426247|NCT01537250|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92426248|NCT01537250|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92426249|NCT01537250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426250|NCT01537250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426251|NCT01537250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426252|NCT01537250|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92426254|NCT01537354|Poractant alfa|poractant alfa|mesh-list
92426312|NCT01537809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426315|NCT01537861|Thalidomide|thalidomide|mesh-list
92426388|NCT01538329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426389|NCT01538329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426390|NCT01538329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426391|NCT01538329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92426392|NCT01538329|Analgesics|analgesics|mesh-ancestor
92426393|NCT01538329|Sensory System Agents|sensory system agents|mesh-ancestor
92426394|NCT01538329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426395|NCT01538381|Afatinib|afatinib|mesh-list
92426396|NCT01538381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426453|NCT01538511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426455|NCT01538537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426456|NCT01538537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426524|NCT01538771|Darbepoetin alfa|darbepoetin alfa|mesh-list
92426525|NCT01538771|Hematinics|hematinics|mesh-ancestor
92426526|NCT01538797|Ranitidine|ranitidine|mesh-list
92426527|NCT01538797|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92426528|NCT01538797|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92426529|NCT01538797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92426530|NCT01538797|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92426531|NCT01538797|Histamine Antagonists|histamine antagonists|mesh-ancestor
92426532|NCT01538797|Histamine Agents|histamine agents|mesh-ancestor
92426533|NCT01538797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426534|NCT01538797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426535|NCT01538797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426536|NCT01538849|Esomeprazole|esomeprazole|mesh-list
92426537|NCT01538849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92426588|NCT01539044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426589|NCT01539044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92426590|NCT01539044|Respiratory System Agents|respiratory system agents|mesh-ancestor
92426591|NCT01539044|Mydriatics|mydriatics|mesh-ancestor
92426592|NCT01539044|Parasympatholytics|parasympatholytics|mesh-ancestor
92426593|NCT01539044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92426594|NCT01539044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92426595|NCT01539044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92426596|NCT01539044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426597|NCT01539044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426598|NCT01539044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92426599|NCT01539044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426600|NCT01539044|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92426601|NCT01539174|Prednisone|prednisone|mesh-list
92426602|NCT01539174|Cyclophosphamide|cyclophosphamide|mesh-list
92426603|NCT01539174|Rituximab|rituximab|mesh-list
92426604|NCT01539174|Doxorubicin|doxorubicin|mesh-list
92426605|NCT01539174|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92426606|NCT01539174|Vincristine|vincristine|mesh-list
92426607|NCT01539174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426643|NCT01539330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92426644|NCT01539330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426645|NCT01539330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426646|NCT01539330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92426647|NCT01539330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92426653|NCT01539408|Misoprostol|misoprostol|mesh-list
92426712|NCT01539655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426713|NCT01539655|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92426714|NCT01539655|Histamine Antagonists|histamine antagonists|mesh-ancestor
92426715|NCT01539655|Histamine Agents|histamine agents|mesh-ancestor
92426716|NCT01539655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426717|NCT01539655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426718|NCT01539681|Sorafenib|sorafenib|mesh-list
92426719|NCT01539681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426720|NCT01539681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92426721|NCT01539681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426722|NCT01539681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426723|NCT01539707|Solifenacin Succinate|solifenacin succinate|mesh-list
92426724|NCT01539707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92426725|NCT01539707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92426726|NCT01539707|Cholinergic Agents|cholinergic agents|mesh-ancestor
92426727|NCT01539707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92426728|NCT01539707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426729|NCT01539707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426730|NCT01539707|Urological Agents|urological agents|mesh-ancestor
92426731|NCT01539720|Levonorgestrel|levonorgestrel|mesh-list
92426732|NCT01539720|Ulipristal acetate|ulipristal acetate|mesh-list
92426733|NCT01539720|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92426734|NCT01539720|Contraceptive Agents|contraceptive agents|mesh-ancestor
92426735|NCT01539720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92426736|NCT01539720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426760|NCT01539733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92426761|NCT01539798|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92426762|NCT01539902|Cyclophosphamide|cyclophosphamide|mesh-list
92426763|NCT01539902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92426764|NCT01539902|Immunologic Factors|immunologic factors|mesh-ancestor
92426765|NCT01539902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426766|NCT01539902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426767|NCT01539902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92426768|NCT01539902|Alkylating Agents|alkylating agents|mesh-ancestor
92426770|NCT01539902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92426825|NCT01540500|Fluvoxamine|fluvoxamine|mesh-list
92426826|NCT01540500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92426827|NCT01540500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92426828|NCT01540500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92426829|NCT01540500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426830|NCT01540500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92426831|NCT01540500|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92426832|NCT01540500|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92426833|NCT01540500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92426834|NCT01540500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426889|NCT01540747|Hematinics|hematinics|mesh-ancestor
92426967|NCT01541124|Sensory System Agents|sensory system agents|mesh-ancestor
92426968|NCT01541124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426970|NCT01541137|Parecoxib|parecoxib|mesh-list
92426971|NCT01541137|Valdecoxib|valdecoxib|mesh-list
92426972|NCT01541137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92426973|NCT01541137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92426974|NCT01541137|Analgesics|analgesics|mesh-ancestor
92426975|NCT01541137|Sensory System Agents|sensory system agents|mesh-ancestor
92426976|NCT01541137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92426977|NCT01541137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92426978|NCT01541137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92426979|NCT01541137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92426980|NCT01541137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92426981|NCT01541137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92426982|NCT01541137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92426983|NCT01541137|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92426984|NCT01541189|Valsartan|valsartan|mesh-list
92426985|NCT01541189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92426986|NCT01541189|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92426987|NCT01541189|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92427019|NCT01541332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427020|NCT01541332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427021|NCT01541332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92427022|NCT01541332|Glucocorticoids|glucocorticoids|mesh-ancestor
92427023|NCT01541332|Hormones|hormones|mesh-ancestor
92427024|NCT01541332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427025|NCT01541332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92427026|NCT01541332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92427027|NCT01541332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92427028|NCT01541332|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92427029|NCT01541332|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92427030|NCT01541332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427031|NCT01541332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427032|NCT01541332|Immunologic Factors|immunologic factors|mesh-ancestor
92427033|NCT01541332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92427034|NCT01541332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92427035|NCT01541332|Growth Substances|growth substances|mesh-ancestor
92427036|NCT01541332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92427037|NCT01541436|Capsaicin|capsaicin|mesh-list
92427038|NCT01541436|Antipruritics|antipruritics|mesh-ancestor
92427039|NCT01541436|Dermatologic Agents|dermatologic agents|mesh-ancestor
92427040|NCT01541436|Sensory System Agents|sensory system agents|mesh-ancestor
92427071|NCT01541605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92427072|NCT01541605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427073|NCT01541605|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92427142|NCT01542060|Insulin Aspart|insulin aspart|mesh-list
92427143|NCT01542060|Biphasic Insulins|biphasic insulins|mesh-list
92427215|NCT01542450|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92427216|NCT01542450|Insulin Detemir|insulin detemir|mesh-list
92427289|NCT01542918|Immunologic Factors|immunologic factors|mesh-ancestor
92427290|NCT01542918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427291|NCT01542918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92427292|NCT01542918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92427293|NCT01542918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92427358|NCT01543399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92427359|NCT01543399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92427431|NCT01543945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427432|NCT01543945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427433|NCT01543945|Antipruritics|antipruritics|mesh-ancestor
92427434|NCT01543945|Dermatologic Agents|dermatologic agents|mesh-ancestor
92427435|NCT01543945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92427436|NCT01543945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92427437|NCT01543945|Serotonin Agents|serotonin agents|mesh-ancestor
92427438|NCT01543945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427439|NCT01543945|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92427440|NCT01543945|Histamine Antagonists|histamine antagonists|mesh-ancestor
92427441|NCT01543945|Histamine Agents|histamine agents|mesh-ancestor
92427442|NCT01543971|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92427443|NCT01543971|Lenograstim|lenograstim|mesh-list
92400474|NCT01409187|Ipilimumab|ipilimumab|mesh-list
92427444|NCT01543971|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92427494|NCT01544283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92427495|NCT01544283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92427568|NCT01544725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92427569|NCT01544725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92427570|NCT01544725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92427571|NCT01544725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92427572|NCT01544725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92427573|NCT01544725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427574|NCT01544751|Metformin|metformin|mesh-list
92427575|NCT01544751|Atorvastatin|atorvastatin|mesh-list
92427576|NCT01544751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92427577|NCT01544751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427578|NCT01544751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92427579|NCT01544751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92427580|NCT01544751|Antimetabolites|antimetabolites|mesh-ancestor
92427581|NCT01544751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427629|NCT01544959|Esmolol|esmolol|mesh-list
92427702|NCT01545479|Captopril|captopril|mesh-list
92427703|NCT01545479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92427704|NCT01545479|Protease Inhibitors|protease inhibitors|mesh-ancestor
92427705|NCT01545479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427706|NCT01545479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427707|NCT01545479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92427708|NCT01545635|Thrombin|thrombin|mesh-list
92427709|NCT01545635|Hemostatics|hemostatics|mesh-ancestor
92427710|NCT01545635|Coagulants|coagulants|mesh-ancestor
92427711|NCT01545778|Oxycodone|oxycodone|mesh-list
92427712|NCT01545778|Tapentadol|tapentadol|mesh-list
92427713|NCT01545778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92427714|NCT01545778|Narcotics|narcotics|mesh-ancestor
92427715|NCT01545778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92427716|NCT01545778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427717|NCT01545778|Analgesics|analgesics|mesh-ancestor
92427764|NCT01546051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92427840|NCT01546935|Oseltamivir|oseltamivir|mesh-list
92427841|NCT01546935|Antiviral Agents|antiviral agents|mesh-ancestor
92427842|NCT01546935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92427843|NCT01546935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427844|NCT01546935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427845|NCT01546961|Chloroquine|chloroquine|mesh-list
92427846|NCT01546961|Amebicides|amebicides|mesh-ancestor
92427847|NCT01546961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92427848|NCT01546961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92427907|NCT01547221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92427908|NCT01547221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427982|NCT01547546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92427984|NCT01547559|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92428055|NCT01548170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92152752|NCT04192331|Paclitaxel|paclitaxel|mesh-list
92428056|NCT01548170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92428057|NCT01548170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92428125|NCT01548521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428126|NCT01548560|Dapivirine|dapivirine|mesh-list
92428199|NCT01548924|Tubulin Modulators|tubulin modulators|mesh-ancestor
92428200|NCT01548924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92428201|NCT01548924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92428272|NCT01549431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428273|NCT01549431|Glucocorticoids|glucocorticoids|mesh-ancestor
92428274|NCT01549431|Hormones|hormones|mesh-ancestor
92428276|NCT01549431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92428343|NCT01549743|Protective Agents|protective agents|mesh-ancestor
92428344|NCT01549795|Capecitabine|capecitabine|mesh-list
92428345|NCT01549795|Liver Extracts|liver extracts|mesh-list
92428346|NCT01549795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92428347|NCT01549795|Antimetabolites|antimetabolites|mesh-ancestor
92428348|NCT01549795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428349|NCT01549795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428350|NCT01549795|Hematinics|hematinics|mesh-ancestor
92428351|NCT01549847|Piracetam|piracetam|mesh-list
92428355|NCT01549847|Nootropic Agents|nootropic agents|mesh-ancestor
92428410|NCT01550302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428412|NCT01550354|Propofol|propofol|mesh-list
92428413|NCT01550354|Rocuronium|rocuronium|mesh-list
92428414|NCT01550354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92428415|NCT01550354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92428416|NCT01550354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428417|NCT01550354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92428418|NCT01550354|Anesthetics, General|anesthetics, general|mesh-ancestor
92428419|NCT01550354|Anesthetics|anesthetics|mesh-ancestor
92428420|NCT01550354|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92428421|NCT01550354|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92428422|NCT01550354|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92428423|NCT01550354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428424|NCT01550354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92428425|NCT01550354|Narcotics|narcotics|mesh-ancestor
92428426|NCT01550354|Analgesics|analgesics|mesh-ancestor
92428427|NCT01550354|Sensory System Agents|sensory system agents|mesh-ancestor
92428428|NCT01550419|Atorvastatin|atorvastatin|mesh-list
92428429|NCT01550419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92428430|NCT01550419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92428467|NCT01550848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92428468|NCT01550848|Antimetabolites|antimetabolites|mesh-ancestor
92428469|NCT01550848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428471|NCT01550900|Metformin|metformin|mesh-list
92428535|NCT01551329|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92428536|NCT01551329|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92428537|NCT01551329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92428538|NCT01551329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428539|NCT01551368|Nimodipine|nimodipine|mesh-list
92428540|NCT01551368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92428541|NCT01551368|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92428542|NCT01551368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92428543|NCT01551368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92428544|NCT01551368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92428546|NCT01551368|Vasodilator Agents|vasodilator agents|mesh-ancestor
92428597|NCT01551589|Antimitotic Agents|antimitotic agents|mesh-ancestor
92428671|NCT01552018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428672|NCT01552018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92428673|NCT01552018|Protease Inhibitors|protease inhibitors|mesh-ancestor
92428674|NCT01552018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92428677|NCT01552044|Spironolactone|spironolactone|mesh-list
92428736|NCT01552629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92428737|NCT01552629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92428738|NCT01552629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92428809|NCT01553123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428810|NCT01553123|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92428812|NCT01553357|Lenalidomide|lenalidomide|mesh-list
92428813|NCT01553357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92428814|NCT01553357|Antiemetics|antiemetics|mesh-ancestor
92428815|NCT01553357|Autonomic Agents|autonomic agents|mesh-ancestor
92428816|NCT01553357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92428817|NCT01553357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92428818|NCT01553357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92428819|NCT01553357|Glucocorticoids|glucocorticoids|mesh-ancestor
92428820|NCT01553357|Hormones|hormones|mesh-ancestor
92428821|NCT01553357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92428822|NCT01553357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92428823|NCT01553357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92428824|NCT01553357|Immunologic Factors|immunologic factors|mesh-ancestor
92428825|NCT01553357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92428826|NCT01553357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92428867|NCT01553903|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92428868|NCT01553903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153574|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
92428870|NCT01553903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92428937|NCT01554657|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92428938|NCT01554657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92428941|NCT01554813|Vaccines|vaccines|mesh-list
92429013|NCT01554995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429017|NCT01555008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92429084|NCT01555632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92429085|NCT01555632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429087|NCT01555632|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92429155|NCT01555970|Protective Agents|protective agents|mesh-ancestor
92429156|NCT01555970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429157|NCT01555970|Antidotes|antidotes|mesh-ancestor
92429158|NCT01556035|Lenalidomide|lenalidomide|mesh-list
92429159|NCT01556035|Immunologic Factors|immunologic factors|mesh-ancestor
92429160|NCT01556035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429161|NCT01556035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92429162|NCT01556035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92429163|NCT01556035|Growth Substances|growth substances|mesh-ancestor
92429164|NCT01556035|Growth Inhibitors|growth inhibitors|mesh-ancestor
92429165|NCT01556035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429219|NCT01556529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92429220|NCT01556542|Paclitaxel|paclitaxel|mesh-list
92429293|NCT05847049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92429294|NCT05847049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92429295|NCT05847049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92429296|NCT05847049|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92429365|NCT05840653|Psychotropic Drugs|psychotropic drugs|mesh-list
92429366|NCT05840640|Lenograstim|lenograstim|mesh-list
92429367|NCT05840640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92429372|NCT05840536|Chlorothiazide|chlorothiazide|mesh-list
92717919|NCT04622202|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92717920|NCT04622202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92717921|NCT04622202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92717922|NCT04622202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92717923|NCT04622358|Rabeprazole|rabeprazole|mesh-list
92717924|NCT04622358|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92717925|NCT04622358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92717926|NCT04622358|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92717927|NCT04622358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92717928|NCT04622358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717929|NCT02901587|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92717984|NCT04621617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92717985|NCT01212757|Thalidomide|thalidomide|mesh-list
92717986|NCT01212757|Apremilast|apremilast|mesh-list
92717987|NCT01212757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92717988|NCT01212757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92717989|NCT01212757|Analgesics|analgesics|mesh-ancestor
92717990|NCT01212757|Sensory System Agents|sensory system agents|mesh-ancestor
92717991|NCT01212757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92717993|NCT01212757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92718047|NCT04621227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718048|NCT04621227|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92718049|NCT04621227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92718050|NCT04621227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92718051|NCT04621227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92718052|NCT04621227|Anesthetics, General|anesthetics, general|mesh-ancestor
92718053|NCT04621227|Anesthetics|anesthetics|mesh-ancestor
92718054|NCT04621227|GABA Modulators|gaba modulators|mesh-ancestor
92718055|NCT04621227|GABA Agents|gaba agents|mesh-ancestor
92718056|NCT04621227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718057|NCT04621227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718111|NCT04621110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92718112|NCT04621110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92718113|NCT04621110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92718114|NCT04621110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92718115|NCT04621110|GABA Modulators|gaba modulators|mesh-ancestor
92718116|NCT04621110|GABA Agents|gaba agents|mesh-ancestor
92718117|NCT04620720|Gabapentin|gabapentin|mesh-list
92718118|NCT04620720|Analgesics|analgesics|mesh-ancestor
92718119|NCT04620720|Sensory System Agents|sensory system agents|mesh-ancestor
92718120|NCT04620720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718121|NCT04620720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718122|NCT04620720|Anticonvulsants|anticonvulsants|mesh-ancestor
92718123|NCT04620720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92718174|NCT04619862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92718175|NCT04619862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92718176|NCT04619862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718177|NCT04619862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92718178|NCT04619862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92718179|NCT04619862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92718180|NCT04619862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92718181|NCT04619862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718183|NCT01190839|Infliximab|infliximab|mesh-list
92718240|NCT05312593|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92718241|NCT05312593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92718242|NCT05312593|Disinfectants|disinfectants|mesh-ancestor
92718243|NCT04314739|Resveratrol|resveratrol|mesh-list
92718244|NCT04314739|Antioxidants|antioxidants|mesh-ancestor
92718245|NCT04314739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718246|NCT04314739|Protective Agents|protective agents|mesh-ancestor
92718247|NCT04314739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718248|NCT04314739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92718249|NCT04314739|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92718250|NCT02885740|Adenosine|adenosine|mesh-list
92718304|NCT01165684|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92718377|NCT04652115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92718378|NCT04652115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92718379|NCT04652115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718380|NCT04652115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92718381|NCT04618107|Anesthetics|anesthetics|mesh-list
92718382|NCT04618107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718383|NCT04618107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718384|NCT05423015|Levan|levan|mesh-list
92718385|NCT05423015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92718386|NCT04618146|Morphine|morphine|mesh-list
92718387|NCT04618146|Bupivacaine|bupivacaine|mesh-list
92718388|NCT04618146|Anesthetics, Local|anesthetics, local|mesh-ancestor
92718389|NCT04618146|Anesthetics|anesthetics|mesh-ancestor
92718390|NCT04618146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92718391|NCT04618146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718392|NCT04618146|Sensory System Agents|sensory system agents|mesh-ancestor
92718393|NCT04618146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92718437|NCT05419583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92718438|NCT05419583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718511|NCT00557934|Sympathomimetics|sympathomimetics|mesh-ancestor
92718585|NCT05153525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718586|NCT04649892|Naltrexone|naltrexone|mesh-list
92718587|NCT04649892|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92718658|NCT04679558|Chlorhexidine|chlorhexidine|mesh-list
92718732|NCT04725812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718733|NCT04713371|Cyclophosphamide|cyclophosphamide|mesh-list
92718805|NCT00563433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92718806|NCT00563433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92718807|NCT00563472|Desogestrel|desogestrel|mesh-list
92718808|NCT00563472|Progesterone|progesterone|mesh-list
92718809|NCT00563472|Progestins|progestins|mesh-ancestor
92718810|NCT00563472|Hormones|hormones|mesh-ancestor
92718811|NCT00563472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92718812|NCT00563472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718813|NCT00563472|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92718814|NCT00563472|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92718815|NCT00563472|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92718816|NCT00563472|Contraceptive Agents|contraceptive agents|mesh-ancestor
92718867|NCT04612998|Dopamine Agents|dopamine agents|mesh-ancestor
92718868|NCT04612998|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92718869|NCT04612998|Sympathomimetics|sympathomimetics|mesh-ancestor
92718870|NCT04612998|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92718871|NCT04612998|Adrenergic Agents|adrenergic agents|mesh-ancestor
92718872|NCT00563589|Cyclosporine|cyclosporine|mesh-list
92718873|NCT00563589|Mycophenolic Acid|mycophenolic acid|mesh-list
92718874|NCT00563589|Methotrexate|methotrexate|mesh-list
92718875|NCT00563589|Cyclosporins|cyclosporins|mesh-list
92718876|NCT00563589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92718877|NCT00563589|Abortifacient Agents|abortifacient agents|mesh-ancestor
92718878|NCT00563589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92718879|NCT00563589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92718880|NCT00563589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92718881|NCT00563589|Antimetabolites|antimetabolites|mesh-ancestor
92718882|NCT00563589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718904|NCT02204345|Paclitaxel|paclitaxel|mesh-list
92718927|NCT02187302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92718928|NCT02187302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92718929|NCT02187302|Immunologic Factors|immunologic factors|mesh-ancestor
92719000|NCT02092922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92719001|NCT02092922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719002|NCT02092922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719003|NCT02092454|Benzocaine|benzocaine|mesh-list
92719004|NCT02092454|Anesthetics, Local|anesthetics, local|mesh-ancestor
92719005|NCT02092454|Anesthetics|anesthetics|mesh-ancestor
92719006|NCT02092454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719007|NCT02092454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719008|NCT02092454|Sensory System Agents|sensory system agents|mesh-ancestor
92719009|NCT02092454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719010|NCT02083289|Latanoprost|latanoprost|mesh-list
92719011|NCT02083289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92719019|NCT02081300|Hormones|hormones|mesh-ancestor
92719063|NCT02057315|Analgesics|analgesics|mesh-ancestor
92719064|NCT02057315|Sensory System Agents|sensory system agents|mesh-ancestor
92719065|NCT02057315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719138|NCT04611126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719211|NCT04677335|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92719212|NCT04677335|Antimetabolites|antimetabolites|mesh-ancestor
92719213|NCT04677335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719214|NCT04677335|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92719215|NCT04677335|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92719282|NCT01165021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719284|NCT01165021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719354|NCT01164007|Bevacizumab|bevacizumab|mesh-list
92719355|NCT01164007|Dacarbazine|dacarbazine|mesh-list
92719356|NCT01164007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92719357|NCT01164007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92719358|NCT01164007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92719359|NCT01164007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92719360|NCT01164007|Growth Substances|growth substances|mesh-ancestor
92719361|NCT01164007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719362|NCT01164007|Growth Inhibitors|growth inhibitors|mesh-ancestor
92719363|NCT01164007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92719364|NCT01164007|Alkylating Agents|alkylating agents|mesh-ancestor
92719365|NCT01164007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719417|NCT01909427|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92719418|NCT01909427|Abortifacient Agents|abortifacient agents|mesh-ancestor
92719419|NCT01909427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92719420|NCT01909427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719421|NCT01909427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92719422|NCT01909427|Antimetabolites|antimetabolites|mesh-ancestor
92719484|NCT01870505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719485|NCT01870505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719486|NCT01870505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92719487|NCT01870505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92719488|NCT01870505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92719489|NCT01870505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719490|NCT04629612|Anesthetics|anesthetics|mesh-list
92719491|NCT04629612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719492|NCT04629612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719493|NCT00564213|Mitomycins|mitomycins|mesh-list
92719494|NCT00564213|Mitomycin|mitomycin|mesh-list
92719514|NCT04629144|Belimumab|belimumab|mesh-list
92719545|NCT04609254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92719546|NCT04609254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719547|NCT04609254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719548|NCT04609254|Antipyretics|antipyretics|mesh-ancestor
92719549|NCT01846481|Cocaine|cocaine|mesh-list
92719550|NCT01846481|Anesthetics, Local|anesthetics, local|mesh-ancestor
92719551|NCT01846481|Anesthetics|anesthetics|mesh-ancestor
92719552|NCT01846481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92719553|NCT01846481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719554|NCT01846481|Sensory System Agents|sensory system agents|mesh-ancestor
92719555|NCT01846481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719556|NCT01846481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92719557|NCT01846481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92719558|NCT01846481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92719559|NCT01846481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92719563|NCT04609293|Apatinib|apatinib|mesh-list
92719603|NCT01802723|Autonomic Agents|autonomic agents|mesh-ancestor
92719604|NCT01802723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719605|NCT01802723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719606|NCT01802723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92719607|NCT01802723|Respiratory System Agents|respiratory system agents|mesh-ancestor
92719608|NCT01802723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92719609|NCT01802723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92719610|NCT01802723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92719611|NCT01802723|Adrenergic Agents|adrenergic agents|mesh-ancestor
92719612|NCT01802723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92719613|NCT01802723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719614|NCT01789736|Travoprost|travoprost|mesh-list
92719615|NCT01789736|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92719616|NCT01789736|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92719617|NCT01789736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92719618|NCT00564330|Esomeprazole|esomeprazole|mesh-list
92719619|NCT00564330|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92719620|NCT00564330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719621|NCT00564330|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92719622|NCT00564330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719623|NCT00564330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92719657|NCT00564408|Cholinergic Agents|cholinergic agents|mesh-ancestor
92719732|NCT04608669|Sensory System Agents|sensory system agents|mesh-ancestor
92719735|NCT04608669|Antipyretics|antipyretics|mesh-ancestor
92719803|NCT01697072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92719805|NCT00565500|Ibuprofen|ibuprofen|mesh-list
92719877|NCT04607733|Analgesics|analgesics|mesh-ancestor
92719878|NCT04607733|Sensory System Agents|sensory system agents|mesh-ancestor
92719879|NCT04607733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92719880|NCT04607733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92719881|NCT04607733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92719882|NCT04607733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92719883|NCT04607733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92719884|NCT04607733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719885|NCT01632137|Rebamipide|rebamipide|mesh-list
92719886|NCT01632137|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92719887|NCT01632137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92719888|NCT01632137|Antioxidants|antioxidants|mesh-ancestor
92719942|NCT01303796|Antimetabolites|antimetabolites|mesh-ancestor
92719944|NCT01303796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720013|NCT00564642|Antidotes|antidotes|mesh-ancestor
92720015|NCT00555386|Antioxidants|antioxidants|mesh-ancestor
92720016|NCT00555386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720017|NCT00555386|Protective Agents|protective agents|mesh-ancestor
92720018|NCT00555386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720019|NCT00555386|Trace Elements|trace elements|mesh-ancestor
92720020|NCT00555386|Micronutrients|micronutrients|mesh-ancestor
92720021|NCT00565929|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92720022|NCT00565929|Antiviral Agents|antiviral agents|mesh-ancestor
92720023|NCT00565929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92720024|NCT04676516|GSK-3326595|gsk-3326595|mesh-list
92720025|NCT04676516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720026|NCT04676516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720027|NCT04675697|Etoposide|etoposide|mesh-list
92720073|NCT00555542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92720075|NCT00555542|Immunologic Factors|immunologic factors|mesh-ancestor
92720147|NCT00555776|Anticonvulsants|anticonvulsants|mesh-ancestor
92720148|NCT00555776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92720149|NCT00555776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92720220|NCT00564720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720221|NCT00564720|Antimetabolites|antimetabolites|mesh-ancestor
92720225|NCT00564720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720294|NCT04631822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92720295|NCT04631822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720296|NCT04605705|Chrysarobin|chrysarobin|mesh-list
92720365|NCT01159171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92720366|NCT01159171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720367|NCT01159171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92720368|NCT01159171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92720438|NCT00561119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720439|NCT00561119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92720440|NCT00561119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92720441|NCT00561119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92720442|NCT00561119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720443|NCT00561119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720444|NCT00561119|Antimetabolites|antimetabolites|mesh-ancestor
92720445|NCT00561197|Gossypol acetic acid|gossypol acetic acid|mesh-list
92720446|NCT00561197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720455|NCT00564993|Dobutamine|dobutamine|mesh-list
92720503|NCT03454646|Donepezil|donepezil|mesh-list
92720504|NCT03454646|Galantamine|galantamine|mesh-list
92720505|NCT03454646|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92720506|NCT03454646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720507|NCT03454646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720508|NCT03454646|Cholinergic Agents|cholinergic agents|mesh-ancestor
92720509|NCT03454646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92720510|NCT03454646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720511|NCT03454646|Nootropic Agents|nootropic agents|mesh-ancestor
92720512|NCT03454646|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92720513|NCT03454646|Autonomic Agents|autonomic agents|mesh-ancestor
92720514|NCT03454646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720515|NCT03454646|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92720516|NCT03454646|Protective Agents|protective agents|mesh-ancestor
92720517|NCT00566553|Grape Seed Extract|grape seed extract|mesh-list
92720518|NCT00566553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92720519|NCT00566553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720520|NCT00566553|Antioxidants|antioxidants|mesh-ancestor
92720521|NCT00566553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400541|NCT01409616|Aspirin|aspirin|mesh-list
92720522|NCT00566553|Protective Agents|protective agents|mesh-ancestor
92720526|NCT01157182|Norethindrone|norethindrone|mesh-list
92720558|NCT01156792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92720559|NCT01156792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720560|NCT01156792|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92720561|NCT01156792|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92720562|NCT01156792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720563|NCT04604223|Pioglitazone|pioglitazone|mesh-list
92720564|NCT04604223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92720565|NCT04604223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720566|NCT04628624|Antioxidants|antioxidants|mesh-list
92720568|NCT04628624|Protective Agents|protective agents|mesh-ancestor
92720621|NCT04628000|Ergocalciferols|ergocalciferols|mesh-list
92720622|NCT04628000|Cholecalciferol|cholecalciferol|mesh-list
92720623|NCT04628000|Vitamins|vitamins|mesh-list
92720694|NCT01155583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92720695|NCT01155583|Antimetabolites|antimetabolites|mesh-ancestor
92720697|NCT01155583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720768|NCT04601688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92720769|NCT04601688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92720839|NCT04601259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92720840|NCT04601259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92720841|NCT04601259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720842|NCT00565383|Fentanyl|fentanyl|mesh-list
92720843|NCT00565383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92720844|NCT00565383|Narcotics|narcotics|mesh-ancestor
92720845|NCT00565383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720846|NCT00565383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720847|NCT00565383|Analgesics|analgesics|mesh-ancestor
92720848|NCT00565383|Sensory System Agents|sensory system agents|mesh-ancestor
92720849|NCT00565383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720850|NCT00565383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92720851|NCT00565383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92720852|NCT00565383|Anesthetics, General|anesthetics, general|mesh-ancestor
92720853|NCT00565383|Anesthetics|anesthetics|mesh-ancestor
92720854|NCT04625426|Protective Agents|protective agents|mesh-list
92720899|NCT00567216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92720900|NCT00567216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720901|NCT00567216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92720902|NCT00567216|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92720903|NCT00567216|Sympatholytics|sympatholytics|mesh-ancestor
92720904|NCT00567216|Autonomic Agents|autonomic agents|mesh-ancestor
92720905|NCT00567216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720906|NCT00562055|Reboxetine|reboxetine|mesh-list
92720907|NCT00562055|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92720908|NCT00562055|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92720964|NCT00567450|Mepivacaine|mepivacaine|mesh-list
92720965|NCT00567450|Anesthetics, Local|anesthetics, local|mesh-ancestor
92720966|NCT00567450|Anesthetics|anesthetics|mesh-ancestor
92720967|NCT00567450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92720968|NCT00567450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92720969|NCT00567450|Sensory System Agents|sensory system agents|mesh-ancestor
92720970|NCT00567450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92720971|NCT00567528|Ibuprofen|ibuprofen|mesh-list
92720972|NCT00567528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92720973|NCT00567528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92720974|NCT00567528|Analgesics|analgesics|mesh-ancestor
92720975|NCT00567528|Sensory System Agents|sensory system agents|mesh-ancestor
92721026|NCT00562289|Apixaban|apixaban|mesh-list
92721027|NCT00562289|Dabigatran|dabigatran|mesh-list
92721028|NCT00562289|Antivitamins K|antivitamins k|mesh-list
92721029|NCT00562289|Clopidogrel|clopidogrel|mesh-list
92721030|NCT00562289|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92721031|NCT00562289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92721032|NCT00562289|Analgesics|analgesics|mesh-ancestor
92721033|NCT00562289|Sensory System Agents|sensory system agents|mesh-ancestor
92721034|NCT00562289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721095|NCT04590183|Prednisolone phosphate|prednisolone phosphate|mesh-list
92408292|NCT01449578|Dopamine Agents|dopamine agents|mesh-ancestor
92721096|NCT04590183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721097|NCT04590183|Immunologic Factors|immunologic factors|mesh-ancestor
92721098|NCT04590183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721099|NCT04590183|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92721100|NCT04590183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721101|NCT04590183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721102|NCT04590183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721103|NCT04590183|Glucocorticoids|glucocorticoids|mesh-ancestor
92721104|NCT04590183|Hormones|hormones|mesh-ancestor
92721105|NCT04590183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721155|NCT01153009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92721156|NCT01153009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721158|NCT01153009|Sensory System Agents|sensory system agents|mesh-ancestor
92721159|NCT01153009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721160|NCT01153009|Antidepressive Agents|antidepressive agents|mesh-ancestor
92721161|NCT01153009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92721162|NCT01153009|Dopamine Agents|dopamine agents|mesh-ancestor
92721223|NCT04621487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721230|NCT01152190|Tadalafil|tadalafil|mesh-list
92721296|NCT04649697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721297|NCT04649697|Antioxidants|antioxidants|mesh-ancestor
92721298|NCT04649697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721365|NCT00637234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92721366|NCT00637234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92721436|NCT04619303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92721437|NCT04619303|Growth Inhibitors|growth inhibitors|mesh-ancestor
92721438|NCT04619303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92721440|NCT04619303|Autonomic Agents|autonomic agents|mesh-ancestor
92721441|NCT04619303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92721442|NCT04619303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92721443|NCT04619303|Glucocorticoids|glucocorticoids|mesh-ancestor
92721444|NCT04619303|Hormones|hormones|mesh-ancestor
92721445|NCT04619303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92721503|NCT04586790|Epinephryl borate|epinephryl borate|mesh-list
92721504|NCT04586790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92721505|NCT04586790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92721576|NCT04618367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92721647|NCT00569712|Sequestering Agents|sequestering agents|mesh-ancestor
92721648|NCT00569751|Paclitaxel|paclitaxel|mesh-list
92721649|NCT00569751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92721650|NCT00569751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92721651|NCT00569751|Tubulin Modulators|tubulin modulators|mesh-ancestor
92721652|NCT00569751|Antimitotic Agents|antimitotic agents|mesh-ancestor
92721653|NCT00569751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92721717|NCT04617626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92721718|NCT04617626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92721719|NCT04585230|Mineral Oil|mineral oil|mesh-list
92721720|NCT04585230|Emollients|emollients|mesh-ancestor
92721721|NCT04585230|Dermatologic Agents|dermatologic agents|mesh-ancestor
92721722|NCT00570180|Bortezomib|bortezomib|mesh-list
92721724|NCT02939846|Trametinib|trametinib|mesh-list
92721787|NCT00568152|Antipyretics|antipyretics|mesh-ancestor
92721788|NCT04610879|Carbamazepine|carbamazepine|mesh-list
92721789|NCT04610879|Levetiracetam|levetiracetam|mesh-list
92721862|NCT00563147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92721863|NCT00563147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92721864|NCT00563147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92721865|NCT00563147|Immunologic Factors|immunologic factors|mesh-ancestor
92721932|NCT04614584|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92721936|NCT00563303|Hydrocortisone|hydrocortisone|mesh-list
92722007|NCT04613726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722008|NCT04613804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92722009|NCT04613804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722077|NCT00568347|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722078|NCT00568347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92722150|NCT00563927|Immunologic Factors|immunologic factors|mesh-ancestor
92722151|NCT00563927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722152|NCT01150123|Vaccines|vaccines|mesh-list
92722223|NCT00575406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92722224|NCT00575406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722295|NCT04600271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92722296|NCT04600271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722368|NCT03454217|Analgesics|analgesics|mesh-ancestor
92722369|NCT03454217|Sensory System Agents|sensory system agents|mesh-ancestor
92722370|NCT03454217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722436|NCT04598594|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92722437|NCT04598594|Autonomic Agents|autonomic agents|mesh-ancestor
92722438|NCT04598594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722440|NCT04598594|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92722508|NCT04597775|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92722509|NCT04597775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92722510|NCT04597775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92722581|NCT00574470|Dermatologic Agents|dermatologic agents|mesh-ancestor
92722582|NCT00574470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92722583|NCT00574470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92722652|NCT04595318|Varenicline|varenicline|mesh-list
92722723|NCT04313335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92722724|NCT04313335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92722725|NCT04313335|Analgesics|analgesics|mesh-ancestor
92722726|NCT04313335|Sensory System Agents|sensory system agents|mesh-ancestor
92722727|NCT04313335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92722728|NCT04313335|Antidepressive Agents|antidepressive agents|mesh-ancestor
92722729|NCT04313335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92722730|NCT04313335|Dopamine Agents|dopamine agents|mesh-ancestor
92722731|NCT00577980|Testosterone|testosterone|mesh-list
92722866|NCT04592198|Palonosetron|palonosetron|mesh-list
92722867|NCT04592198|Antiemetics|antiemetics|mesh-ancestor
92722868|NCT04592198|Autonomic Agents|autonomic agents|mesh-ancestor
92722879|NCT04592081|BB 1101|bb 1101|mesh-list
92722939|NCT00580359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92722940|NCT00580437|Dobutamine|dobutamine|mesh-list
92722941|NCT00580437|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92723004|NCT00567554|Mitosis Modulators|mitosis modulators|mesh-ancestor
92723005|NCT00567554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723006|NCT00567554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92723007|NCT00567554|Immunologic Factors|immunologic factors|mesh-ancestor
92723008|NCT00567554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723009|NCT00567554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92723072|NCT04589429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723143|NCT00581685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92723144|NCT00581685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92723145|NCT00581685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723146|NCT00581685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92723147|NCT00581685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92723153|NCT04588220|Plasminogen|plasminogen|mesh-list
92723212|NCT04593108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92723220|NCT04585334|Diclofenac|diclofenac|mesh-list
92723284|NCT00566904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92723285|NCT00566904|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92723352|NCT04592211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92723353|NCT04583813|Empagliflozin|empagliflozin|mesh-list
92723354|NCT04583813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92723355|NCT04583813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92723356|NCT04583813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92723357|NCT04583813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723358|NCT04576143|Paclitaxel|paclitaxel|mesh-list
92723359|NCT04576143|Docetaxel|docetaxel|mesh-list
92723414|NCT01145755|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92723415|NCT01145755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92723416|NCT01145755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92723485|NCT00568295|Sensory System Agents|sensory system agents|mesh-ancestor
92723486|NCT00568295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92723487|NCT00568295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723546|NCT04575675|Adrenergic Agents|adrenergic agents|mesh-ancestor
92723547|NCT04575675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92723617|NCT00583869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92723618|NCT00568880|Hydroxychloroquine|hydroxychloroquine|mesh-list
92723619|NCT00568880|Bortezomib|bortezomib|mesh-list
92723620|NCT00568880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723691|NCT00570245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723692|NCT00570245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92723693|NCT00570245|Respiratory System Agents|respiratory system agents|mesh-ancestor
92723762|NCT04580342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92723763|NCT04580342|Vasodilator Agents|vasodilator agents|mesh-ancestor
92723764|NCT00571142|Bevacizumab|bevacizumab|mesh-list
92723766|NCT00571142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92723767|NCT00571142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92723778|NCT00571142|GABA Modulators|gaba modulators|mesh-ancestor
92723831|NCT00584610|Levonorgestrel|levonorgestrel|mesh-list
92723832|NCT00584610|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92723833|NCT00584610|Contraceptive Agents|contraceptive agents|mesh-ancestor
92723903|NCT01143337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92723904|NCT01143337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723905|NCT01143337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92723973|NCT00572390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92723974|NCT01142128|Esomeprazole|esomeprazole|mesh-list
92724046|NCT03451110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724047|NCT03451110|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92724048|NCT03451110|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92724049|NCT03451110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92724116|NCT01139008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724117|NCT01139008|Dermatologic Agents|dermatologic agents|mesh-ancestor
92724118|NCT00573599|Diphenhydramine|diphenhydramine|mesh-list
92724119|NCT00573599|Prochlorperazine|prochlorperazine|mesh-list
92724120|NCT00573599|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92724121|NCT00573599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92724122|NCT00573599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92724185|NCT01138150|Serotonin Agents|serotonin agents|mesh-ancestor
92724186|NCT01138150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92724260|NCT00574769|Growth Substances|growth substances|mesh-ancestor
92724261|NCT00574769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724262|NCT00574769|Growth Inhibitors|growth inhibitors|mesh-ancestor
92724263|NCT00574769|Tubulin Modulators|tubulin modulators|mesh-ancestor
92724264|NCT00574769|Antimitotic Agents|antimitotic agents|mesh-ancestor
92724265|NCT00574769|Mitosis Modulators|mitosis modulators|mesh-ancestor
92724266|NCT00574769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724328|NCT00586833|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92724329|NCT00586833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724330|NCT00586833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724331|NCT00575354|Sevoflurane|sevoflurane|mesh-list
92724400|NCT04674527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724475|NCT01137292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724476|NCT01137292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724550|NCT00587379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724551|NCT00587379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92400591|NCT01409733|Doxorubicin|doxorubicin|mesh-list
92724622|NCT01135498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92724623|NCT01135498|Growth Inhibitors|growth inhibitors|mesh-ancestor
92724625|NCT01135498|Antimetabolites|antimetabolites|mesh-ancestor
92724695|NCT00195351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92724697|NCT04609748|Nimesulide|nimesulide|mesh-list
92724770|NCT00193479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92724771|NCT00193479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92724772|NCT00193479|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92724776|NCT00193479|Analgesics|analgesics|mesh-ancestor
92724842|NCT00192075|Hematinics|hematinics|mesh-ancestor
92724843|NCT00192036|Gemcitabine|gemcitabine|mesh-list
92724844|NCT00192036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92724845|NCT00192036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92724846|NCT00192036|Antimetabolites|antimetabolites|mesh-ancestor
92724847|NCT00192036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92724848|NCT00191724|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92724849|NCT00191724|Enoxaparin|enoxaparin|mesh-list
92724850|NCT00191724|Protein C|protein c|mesh-list
92724851|NCT00191724|Anticoagulants|anticoagulants|mesh-ancestor
92724852|NCT00191724|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92724908|NCT00564512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92724909|NCT00564512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92724910|NCT00564551|Calcium, Dietary|calcium, dietary|mesh-list
92724911|NCT00564551|Calcium|calcium|mesh-list
92724978|NCT04607525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725051|NCT04605887|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92725052|NCT04605887|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92725124|NCT00565019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725196|NCT00476151|Sensory System Agents|sensory system agents|mesh-ancestor
92725197|NCT00476151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725198|NCT00476151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725199|NCT00476151|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92725264|NCT00474240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725340|NCT04601675|Autonomic Agents|autonomic agents|mesh-ancestor
92725341|NCT04601675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725342|NCT04601675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725343|NCT04601675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92725411|NCT04601324|Histamine Agents|histamine agents|mesh-ancestor
92725412|NCT04601324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725413|NCT00565331|Rituximab|rituximab|mesh-list
92725415|NCT00565331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725463|NCT00472641|Serotonin Agents|serotonin agents|mesh-ancestor
92725464|NCT00472641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725465|NCT00472641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725466|NCT00472641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725533|NCT01133665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92725534|NCT00583427|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92725535|NCT00583427|Anticoagulants|anticoagulants|mesh-ancestor
92725536|NCT00583427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92725537|NCT00583427|Antimetabolites|antimetabolites|mesh-ancestor
92725538|NCT00583427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725599|NCT00471237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92725601|NCT04570683|Nivolumab|nivolumab|mesh-list
92725670|NCT00470184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725671|NCT00470184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725735|NCT04575194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92725736|NCT04575194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92725737|NCT04575194|Incretins|incretins|mesh-ancestor
92725738|NCT04575194|Hormones|hormones|mesh-ancestor
92725739|NCT04575194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92725740|NCT04575194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92725741|NCT04575194|Antidepressive Agents|antidepressive agents|mesh-ancestor
92725742|NCT04575194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92725743|NCT04575194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92725744|NCT04575194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725745|NCT04575194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725746|NCT04575194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92725747|NCT04575194|Dopamine Agents|dopamine agents|mesh-ancestor
92725748|NCT04575194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92725749|NCT04575194|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92725750|NCT04575194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92725752|NCT00478179|Bupivacaine|bupivacaine|mesh-list
92725791|NCT00585455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92725792|NCT00585455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92725863|NCT01089504|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92725864|NCT03452696|Calcium|calcium|mesh-list
92725867|NCT01088997|Milrinone|milrinone|mesh-list
92725937|NCT04312204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92725938|NCT04312204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726082|NCT00587873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726083|NCT00587873|Immunologic Factors|immunologic factors|mesh-ancestor
92726142|NCT01083810|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92726144|NCT01083810|Protease Inhibitors|protease inhibitors|mesh-ancestor
92726216|NCT00589862|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92726217|NCT00589862|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92726218|NCT00589862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92726219|NCT00589862|Purinergic Agents|purinergic agents|mesh-ancestor
92726220|NCT00589862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726221|NCT00589862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726222|NCT00589862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726223|NCT00589901|Cyclophosphamide|cyclophosphamide|mesh-list
92726224|NCT00589901|Capecitabine|capecitabine|mesh-list
92726225|NCT00589901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726226|NCT00589901|Immunologic Factors|immunologic factors|mesh-ancestor
92726227|NCT00589901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726228|NCT00589901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726229|NCT00589901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92726230|NCT00589901|Alkylating Agents|alkylating agents|mesh-ancestor
92726231|NCT00589901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726232|NCT00589901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726233|NCT00589901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92726234|NCT00589901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726235|NCT00589901|Antimetabolites|antimetabolites|mesh-ancestor
92726236|NCT00590174|Aspirin|aspirin|mesh-list
92726237|NCT00590174|Clopidogrel|clopidogrel|mesh-list
92726238|NCT00590174|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92726239|NCT00590174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92726240|NCT00590174|Analgesics|analgesics|mesh-ancestor
92726241|NCT00590174|Sensory System Agents|sensory system agents|mesh-ancestor
92726242|NCT00590174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726243|NCT00590174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726259|NCT00590213|Androgen Antagonists|androgen antagonists|mesh-ancestor
92726260|NCT00590213|Hormone Antagonists|hormone antagonists|mesh-ancestor
92726261|NCT00590213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726330|NCT00590603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726332|NCT00590603|Micronutrients|micronutrients|mesh-ancestor
92726334|NCT01085097|Prednisone|prednisone|mesh-list
92726403|NCT00591188|Interferon-alpha|interferon-alpha|mesh-list
92726404|NCT00591188|Capecitabine|capecitabine|mesh-list
92726405|NCT00591188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726406|NCT00591188|Antimetabolites|antimetabolites|mesh-ancestor
92726408|NCT00591188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726472|NCT04573049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92726473|NCT04573049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726619|NCT03456947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726694|NCT00196976|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92726695|NCT04563936|Goserelin|goserelin|mesh-list
92726696|NCT04563936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92726697|NCT04563936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726698|NCT04563975|Paclitaxel|paclitaxel|mesh-list
92726699|NCT04563975|Docetaxel|docetaxel|mesh-list
92726700|NCT04563975|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92726701|NCT04563975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726702|NCT04563975|Tubulin Modulators|tubulin modulators|mesh-ancestor
92726703|NCT04563975|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726704|NCT04563975|Mitosis Modulators|mitosis modulators|mesh-ancestor
92726705|NCT04563975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726706|NCT00196313|Levonorgestrel|levonorgestrel|mesh-list
92726707|NCT00196313|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92726708|NCT00196313|Contraceptive Agents|contraceptive agents|mesh-ancestor
92726709|NCT00196313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726710|NCT00196313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726711|NCT00196313|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92726712|NCT00196313|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92726713|NCT00196313|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92726714|NCT00195650|Adalimumab|adalimumab|mesh-list
92726715|NCT00195650|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92726716|NCT00195650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726717|NCT00195650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726718|NCT04563780|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
92726719|NCT04563780|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92726721|NCT04560894|Sorafenib|sorafenib|mesh-list
92726742|NCT00195494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92726743|NCT00195494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726744|NCT00195494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92726745|NCT00195494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726746|NCT00195494|Immunologic Factors|immunologic factors|mesh-ancestor
92726747|NCT00195494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726748|NCT00195494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92726749|NCT00195494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92726750|NCT00195494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92726751|NCT00195494|Analgesics|analgesics|mesh-ancestor
92726752|NCT00195494|Sensory System Agents|sensory system agents|mesh-ancestor
92726753|NCT00195494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726754|NCT00195494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726755|NCT00195494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726756|NCT00194987|Prednisone|prednisone|mesh-list
92726757|NCT00194987|Immunoglobulins|immunoglobulins|mesh-list
92726758|NCT00194987|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92726759|NCT00194987|Antibodies|antibodies|mesh-list
92726760|NCT00194987|gamma-Globulins|gamma-globulins|mesh-list
92726761|NCT00194987|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92726762|NCT00194987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92726763|NCT00194987|Glucocorticoids|glucocorticoids|mesh-ancestor
92726764|NCT00194987|Hormones|hormones|mesh-ancestor
92726765|NCT00194987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726766|NCT00194987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726767|NCT00194987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92726768|NCT00194987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726769|NCT00194987|Immunologic Factors|immunologic factors|mesh-ancestor
92726770|NCT00194792|Paclitaxel|paclitaxel|mesh-list
92752339|NCT05940649|Autonomic Agents|autonomic agents|mesh-ancestor
92752340|NCT05940649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752341|NCT05940649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92752343|NCT05940545|Favipiravir|favipiravir|mesh-list
92752344|NCT05940545|Antimetabolites|antimetabolites|mesh-ancestor
92752345|NCT05940545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752346|NCT05940545|Antiviral Agents|antiviral agents|mesh-ancestor
92752347|NCT05940545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752348|NCT05940441|Capecitabine|capecitabine|mesh-list
92752349|NCT05940441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92752350|NCT05940441|Antimetabolites|antimetabolites|mesh-ancestor
92752351|NCT05940441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752352|NCT05940441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752353|NCT05940376|Insulin, Short-Acting|insulin, short-acting|mesh-list
92752354|NCT05940376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92726771|NCT00194792|Vinorelbine|vinorelbine|mesh-list
92726772|NCT00194792|Capecitabine|capecitabine|mesh-list
92726773|NCT00194792|Methotrexate|methotrexate|mesh-list
92726774|NCT00194792|Exemestane|exemestane|mesh-list
92726775|NCT00194792|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92726776|NCT00194792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92726777|NCT00194792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726778|NCT00194792|Tubulin Modulators|tubulin modulators|mesh-ancestor
92726779|NCT00194792|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726780|NCT00194792|Mitosis Modulators|mitosis modulators|mesh-ancestor
92726781|NCT00194792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726782|NCT00194792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726783|NCT00194792|Antimetabolites|antimetabolites|mesh-ancestor
92726784|NCT00194792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92726785|NCT00194792|Abortifacient Agents|abortifacient agents|mesh-ancestor
92726786|NCT00194792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92726787|NCT00194792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726788|NCT00194792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92752355|NCT05940376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752356|NCT05940324|Naltrexone|naltrexone|mesh-list
92752357|NCT05940324|Ketamine|ketamine|mesh-list
92752358|NCT05940324|Analgesics|analgesics|mesh-ancestor
92752359|NCT05940324|Sensory System Agents|sensory system agents|mesh-ancestor
92752360|NCT05940324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752361|NCT05940324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752362|NCT05940324|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92752363|NCT05940324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92752364|NCT05940324|Anesthetics, General|anesthetics, general|mesh-ancestor
92752365|NCT05940324|Anesthetics|anesthetics|mesh-ancestor
92752366|NCT05940324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752367|NCT05940324|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92752369|NCT05940324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752370|NCT05940324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752371|NCT05940324|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92752372|NCT05940324|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92752373|NCT05940285|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
92752374|NCT05940285|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92752375|NCT05940285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752376|NCT05940233|Letrozole|letrozole|mesh-list
92752377|NCT05940233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752378|NCT05940233|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92752379|NCT05940233|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92752380|NCT05940233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752381|NCT05940233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752382|NCT05940233|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92752383|NCT05940233|Hormone Antagonists|hormone antagonists|mesh-ancestor
92752384|NCT05940233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752385|NCT05940233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752386|NCT05940220|Acetazolamide|acetazolamide|mesh-list
92752387|NCT05940220|Anticonvulsants|anticonvulsants|mesh-ancestor
92752388|NCT05940220|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92752389|NCT05940220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752390|NCT05940220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752391|NCT05940220|Diuretics|diuretics|mesh-ancestor
92752392|NCT05940220|Natriuretic Agents|natriuretic agents|mesh-ancestor
92400629|NCT01410201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92752393|NCT05940220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752394|NCT05940064|Rituximab|rituximab|mesh-list
92726789|NCT00194792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726790|NCT00194792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92726791|NCT00194792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92726792|NCT00194792|Immunologic Factors|immunologic factors|mesh-ancestor
92726793|NCT00194792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92726794|NCT00194792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92726795|NCT00194792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92726796|NCT00194792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92726797|NCT00194792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92726798|NCT00194792|Hormone Antagonists|hormone antagonists|mesh-ancestor
92726799|NCT00194792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726800|NCT00194792|Luteolytic Agents|luteolytic agents|mesh-ancestor
92726801|NCT00194792|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92726802|NCT00194792|Contraceptive Agents|contraceptive agents|mesh-ancestor
92726803|NCT00194792|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92726804|NCT00194792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92726806|NCT02486367|Ticagrelor|ticagrelor|mesh-list
92726807|NCT02486367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92726808|NCT02486367|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92752395|NCT05940064|Zanubrutinib|zanubrutinib|mesh-list
92752396|NCT05940064|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92752397|NCT05940064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752398|NCT05940064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752399|NCT05940064|Immunologic Factors|immunologic factors|mesh-ancestor
92752400|NCT05940064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752401|NCT05940064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752402|NCT05940064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92752403|NCT05940064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752404|NCT05940064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752405|NCT05940064|Immunoconjugates|immunoconjugates|mesh-ancestor
92752406|NCT05940051|Rituximab|rituximab|mesh-list
92752407|NCT05940051|Zanubrutinib|zanubrutinib|mesh-list
92752408|NCT05940051|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92752409|NCT05940051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752410|NCT05940051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752411|NCT05940051|Immunologic Factors|immunologic factors|mesh-ancestor
92752412|NCT05940051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752413|NCT05940051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752414|NCT05940051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92752415|NCT05940051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752416|NCT05940051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752417|NCT05940051|Immunoconjugates|immunoconjugates|mesh-ancestor
92752418|NCT05939882|Atropine|atropine|mesh-list
92752419|NCT05939882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92752420|NCT05939882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92752421|NCT05939882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92752422|NCT05939882|Autonomic Agents|autonomic agents|mesh-ancestor
92752423|NCT05939882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752424|NCT05939882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752425|NCT05939882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92752426|NCT05939882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92752427|NCT05939882|Mydriatics|mydriatics|mesh-ancestor
92726809|NCT02486367|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92726811|NCT02486367|Purinergic Agents|purinergic agents|mesh-ancestor
92726812|NCT02486367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726813|NCT02486367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726814|NCT02486367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726815|NCT00194675|Testosterone|testosterone|mesh-list
92726816|NCT00194675|Dutasteride|dutasteride|mesh-list
92726817|NCT00194675|Androgens|androgens|mesh-ancestor
92726818|NCT00194675|Hormones|hormones|mesh-ancestor
92400641|NCT01410214|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726819|NCT00194675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92726820|NCT00194675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726821|NCT00194675|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92726822|NCT00194675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92726823|NCT00194675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726824|NCT00194675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726825|NCT00194675|Hormone Antagonists|hormone antagonists|mesh-ancestor
92726826|NCT00194012|Aripiprazole|aripiprazole|mesh-list
92726827|NCT00194012|Antidepressive Agents|antidepressive agents|mesh-ancestor
92726828|NCT00194012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92726829|NCT00194012|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92726830|NCT00194012|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92726831|NCT00194012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726832|NCT00194012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726833|NCT00194012|Dopamine Agonists|dopamine agonists|mesh-ancestor
92726834|NCT00194012|Dopamine Agents|dopamine agents|mesh-ancestor
92752428|NCT05939882|Parasympatholytics|parasympatholytics|mesh-ancestor
92752429|NCT05939882|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92752430|NCT05939882|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92752431|NCT05939882|Cholinergic Agents|cholinergic agents|mesh-ancestor
92752432|NCT05939882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752433|NCT05939882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752434|NCT05939817|Triamcinolone|triamcinolone|mesh-list
92752435|NCT05939817|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92752436|NCT05939817|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92752437|NCT05939817|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92752438|NCT05939817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752439|NCT05939817|Glucocorticoids|glucocorticoids|mesh-ancestor
92752444|NCT05939817|Immunologic Factors|immunologic factors|mesh-ancestor
92752445|NCT05939817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752446|NCT05939817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752447|NCT05939765|Antipsychotic Agents|antipsychotic agents|mesh-list
92752448|NCT05939765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92752449|NCT05939765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752450|NCT05939765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752451|NCT05939765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92752453|NCT05939726|Vitamin E|vitamin e|mesh-list
92752454|NCT05939726|Tocopherols|tocopherols|mesh-list
92726835|NCT00194012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726836|NCT00194012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726837|NCT00194012|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92726838|NCT00194012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92726839|NCT00194012|Serotonin Agents|serotonin agents|mesh-ancestor
92726840|NCT00194012|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92726841|NCT00194012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92726842|NCT00194012|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92726843|NCT00194012|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92726844|NCT04563351|Anesthetics|anesthetics|mesh-list
92726845|NCT04563351|Anesthetics, Local|anesthetics, local|mesh-list
92726846|NCT04563351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92726847|NCT04563351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726848|NCT04563351|Sensory System Agents|sensory system agents|mesh-ancestor
92726849|NCT04563351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92726850|NCT00192647|Ribavirin|ribavirin|mesh-list
92726851|NCT00192647|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92726852|NCT00192647|Interferon alpha-2|interferon alpha-2|mesh-list
92726853|NCT00192647|Antimetabolites|antimetabolites|mesh-ancestor
92726854|NCT00192647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726855|NCT00192647|Antiviral Agents|antiviral agents|mesh-ancestor
92726856|NCT00192647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726857|NCT00192647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726858|NCT04560816|Moxifloxacin|moxifloxacin|mesh-list
92726859|NCT04560816|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92726860|NCT04560816|Choline|choline|mesh-list
92726861|NCT04560816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92726862|NCT04560816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726863|NCT04560816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92752455|NCT05939726|Tocotrienols|tocotrienols|mesh-list
92752456|NCT05939726|alpha-Tocopherol|alpha-tocopherol|mesh-list
92752457|NCT05939726|Carbamide Peroxide|carbamide peroxide|mesh-list
92752458|NCT05939726|Micronutrients|micronutrients|mesh-ancestor
92752459|NCT05939726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752460|NCT05939726|Antioxidants|antioxidants|mesh-ancestor
92752461|NCT05939726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752462|NCT05939726|Protective Agents|protective agents|mesh-ancestor
92752463|NCT05939726|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92752464|NCT05939726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752465|NCT05939648|Vaccines|vaccines|mesh-list
92752466|NCT05939648|Immunologic Factors|immunologic factors|mesh-ancestor
92752467|NCT05939648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752468|NCT05939284|Cetrorelix|cetrorelix|mesh-list
92752469|NCT05939284|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92752470|NCT05939284|Fertility Agents|fertility agents|mesh-ancestor
92752471|NCT05939284|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752472|NCT05939284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726864|NCT04560816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92726865|NCT04560816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726866|NCT04560816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726867|NCT04560816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726868|NCT04560816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726869|NCT04560816|Lipotropic Agents|lipotropic agents|mesh-ancestor
92726870|NCT04560816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92726871|NCT04560816|Antimetabolites|antimetabolites|mesh-ancestor
92726872|NCT04560816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92726873|NCT04560816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92726874|NCT04560816|Nootropic Agents|nootropic agents|mesh-ancestor
92726875|NCT04560816|Chelating Agents|chelating agents|mesh-ancestor
92726876|NCT04560816|Sequestering Agents|sequestering agents|mesh-ancestor
92726877|NCT04560816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92726878|NCT04560816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92726879|NCT04560816|Growth Substances|growth substances|mesh-ancestor
92726880|NCT04560816|Growth Inhibitors|growth inhibitors|mesh-ancestor
92726881|NCT04563429|Vitamin A|vitamin a|mesh-list
92726882|NCT04563429|Vitamins|vitamins|mesh-ancestor
92726883|NCT04563429|Micronutrients|micronutrients|mesh-ancestor
92726884|NCT04563429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726885|NCT00192023|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92752473|NCT05939284|Hormone Antagonists|hormone antagonists|mesh-ancestor
92752474|NCT05939284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752475|NCT05939245|Furosemide|furosemide|mesh-list
92752476|NCT05939245|Diuretics|diuretics|mesh-ancestor
92752477|NCT05939245|Natriuretic Agents|natriuretic agents|mesh-ancestor
92752478|NCT05939245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752479|NCT05939245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92752480|NCT05939245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92752481|NCT05939245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752482|NCT05939180|Cytarabine|cytarabine|mesh-list
92752483|NCT05939180|Azacitidine|azacitidine|mesh-list
92752484|NCT05939180|Daunorubicin|daunorubicin|mesh-list
92752485|NCT05939180|Venetoclax|venetoclax|mesh-list
92752486|NCT05939180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92752487|NCT05939180|Antimetabolites|antimetabolites|mesh-ancestor
92752488|NCT05939180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752489|NCT05939180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752490|NCT05939180|Antiviral Agents|antiviral agents|mesh-ancestor
92752491|NCT05939180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752492|NCT05939180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752493|NCT05939180|Immunologic Factors|immunologic factors|mesh-ancestor
92752494|NCT05939180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752495|NCT05939180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752496|NCT05939180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752497|NCT05939180|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92752498|NCT05939180|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92752499|NCT05939076|Sotalol|sotalol|mesh-list
92752500|NCT05939076|Flecainide|flecainide|mesh-list
92752501|NCT05939076|Dronedarone|dronedarone|mesh-list
92752502|NCT05939076|Propafenone|propafenone|mesh-list
92752503|NCT05939076|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92752504|NCT05939076|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92752505|NCT05939076|Adrenergic Agents|adrenergic agents|mesh-ancestor
92726886|NCT00192023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92726887|NCT00192023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92726888|NCT00192023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726889|NCT00192023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726890|NCT00192023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92726891|NCT00192023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726892|NCT00192023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726893|NCT00191984|Irinotecan|irinotecan|mesh-list
92726894|NCT00191984|Pemetrexed|pemetrexed|mesh-list
92726895|NCT00191984|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92726896|NCT00191984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92726897|NCT00191984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726898|NCT00191984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726899|NCT00191984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726900|NCT00191984|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92726901|NCT00191984|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92726902|NCT04560426|Parathyroid Hormone|parathyroid hormone|mesh-list
92726903|NCT04560426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92726904|NCT04560426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726905|NCT00191906|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92726906|NCT00191906|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92726907|NCT00191906|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92726908|NCT00191906|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726909|NCT00191906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726910|NCT00191906|Adrenergic Agents|adrenergic agents|mesh-ancestor
92726911|NCT00191906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92726912|NCT00191906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726913|NCT00191789|Gemcitabine|gemcitabine|mesh-list
92726914|NCT00191789|Doxorubicin|doxorubicin|mesh-list
92726915|NCT00191789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752506|NCT05939076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752507|NCT05939076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752508|NCT05939076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752509|NCT05939076|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92752510|NCT05939076|Sympatholytics|sympatholytics|mesh-ancestor
92752519|NCT05939037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752520|NCT05939037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752521|NCT05938972|Omalizumab|omalizumab|mesh-list
92752522|NCT05938972|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92726916|NCT00191789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92726917|NCT00191789|Antimetabolites|antimetabolites|mesh-ancestor
92726918|NCT00191789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726919|NCT00191789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92726920|NCT00191789|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92726921|NCT00191789|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92726922|NCT00191789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726923|NCT00191282|Insulin|insulin|mesh-list
92726924|NCT00191282|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92726925|NCT00191282|Insulin Glargine|insulin glargine|mesh-list
92726926|NCT00191282|Insulin Lispro|insulin lispro|mesh-list
92726927|NCT00191282|Isophane Insulin, Human|isophane insulin, human|mesh-list
92726928|NCT00191282|Insulin, Isophane|insulin, isophane|mesh-list
92726929|NCT00191282|Isophane insulin, beef|isophane insulin, beef|mesh-list
92726930|NCT00191282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92726931|NCT00191282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726932|NCT04560231|Remdesivir|remdesivir|mesh-list
92726933|NCT04560231|Antimetabolites|antimetabolites|mesh-ancestor
92726934|NCT04560231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726935|NCT04560231|Antiviral Agents|antiviral agents|mesh-ancestor
92726936|NCT04560231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726937|NCT00190775|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92726938|NCT00190775|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92726939|NCT00190775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92726940|NCT00190775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92726941|NCT00190775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726945|NCT00198263|Bleomycin|bleomycin|mesh-list
92726964|NCT00198107|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92726965|NCT00198107|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92726966|NCT00198107|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92726967|NCT00198107|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92726968|NCT00198107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92726969|NCT00198107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92726970|NCT00198107|Antitubercular Agents|antitubercular agents|mesh-ancestor
92726971|NCT00198107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92726972|NCT00198107|Antimetabolites|antimetabolites|mesh-ancestor
92726973|NCT00179660|Lenalidomide|lenalidomide|mesh-list
92726974|NCT00179660|Immunologic Factors|immunologic factors|mesh-ancestor
92726975|NCT00179660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92726976|NCT00179660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92726977|NCT00179660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92726978|NCT00179660|Growth Substances|growth substances|mesh-ancestor
92726979|NCT00179660|Growth Inhibitors|growth inhibitors|mesh-ancestor
92726980|NCT00179660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726981|NCT00178256|Paclitaxel|paclitaxel|mesh-list
92726982|NCT00178256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92726983|NCT00178256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726984|NCT00178256|Tubulin Modulators|tubulin modulators|mesh-ancestor
92726985|NCT00178256|Antimitotic Agents|antimitotic agents|mesh-ancestor
92726986|NCT00178256|Mitosis Modulators|mitosis modulators|mesh-ancestor
92726987|NCT00178256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92726989|NCT02211222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92726990|NCT02211222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92726991|NCT02211222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92726992|NCT02211222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727012|NCT00177164|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727013|NCT00177164|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92727014|NCT00177164|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92727015|NCT00177164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92727016|NCT00177164|Antidepressive Agents|antidepressive agents|mesh-ancestor
92727017|NCT00177164|Dopamine Agonists|dopamine agonists|mesh-ancestor
92727018|NCT00177164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92727019|NCT00177164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92727020|NCT00177164|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92727021|NCT00177164|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92727022|NCT04559841|Simvastatin|simvastatin|mesh-list
92727023|NCT04559841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92727024|NCT04559841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92727025|NCT04559841|Antimetabolites|antimetabolites|mesh-ancestor
92727026|NCT04559841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727027|NCT04559841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92727028|NCT04559841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92727029|NCT04559841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727030|NCT02489942|Empagliflozin|empagliflozin|mesh-list
92727031|NCT02489942|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92727032|NCT02489942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727033|NCT02489942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92727034|NCT02489942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727035|NCT04559568|Midazolam|midazolam|mesh-list
92727036|NCT04559568|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92727037|NCT04559568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92727038|NCT04559568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727039|NCT04559568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727040|NCT04559568|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92727041|NCT04559568|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92727042|NCT04559568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92752523|NCT05938972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92752524|NCT05938972|Respiratory System Agents|respiratory system agents|mesh-ancestor
92752525|NCT05938959|Ropivacaine|ropivacaine|mesh-list
92752526|NCT05938959|Anesthetics, Local|anesthetics, local|mesh-ancestor
92752527|NCT05938959|Anesthetics|anesthetics|mesh-ancestor
92752528|NCT05938959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752529|NCT05938959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752530|NCT05938959|Sensory System Agents|sensory system agents|mesh-ancestor
92752531|NCT05938959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727043|NCT04559568|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92727044|NCT04559568|Anesthetics, General|anesthetics, general|mesh-ancestor
92727045|NCT04559568|Anesthetics|anesthetics|mesh-ancestor
92727046|NCT04559568|GABA Modulators|gaba modulators|mesh-ancestor
92727047|NCT04559568|GABA Agents|gaba agents|mesh-ancestor
92727048|NCT04559568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727049|NCT04559568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727050|NCT00176462|Leucovorin|leucovorin|mesh-list
92727051|NCT00176462|Cytarabine|cytarabine|mesh-list
92727052|NCT00176462|Dexamethasone|dexamethasone|mesh-list
92727053|NCT00176462|Hydrocortisone|hydrocortisone|mesh-list
92727054|NCT00176462|Cyclophosphamide|cyclophosphamide|mesh-list
92727055|NCT00176462|Methotrexate|methotrexate|mesh-list
92727056|NCT00176462|Vincristine|vincristine|mesh-list
92727057|NCT00176462|Asparaginase|asparaginase|mesh-list
92727058|NCT00176462|Mercaptopurine|mercaptopurine|mesh-list
92727059|NCT00176462|Thioguanine|thioguanine|mesh-list
92727060|NCT00176462|Daunorubicin|daunorubicin|mesh-list
92727061|NCT00176462|Aminopterin|aminopterin|mesh-list
92727062|NCT00176462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727063|NCT00176462|Immunologic Factors|immunologic factors|mesh-ancestor
92727064|NCT00176462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727065|NCT00176462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727066|NCT00176462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727067|NCT00176462|Alkylating Agents|alkylating agents|mesh-ancestor
92752532|NCT05938907|Mitogens|mitogens|mesh-list
92752533|NCT05938907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752534|NCT05938907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752535|NCT05938530|Sirolimus|sirolimus|mesh-list
92752536|NCT05938530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752537|NCT05938530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752538|NCT05938530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752539|NCT05938530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752540|NCT05938530|Antifungal Agents|antifungal agents|mesh-ancestor
92752541|NCT05938530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752542|NCT05938530|Immunologic Factors|immunologic factors|mesh-ancestor
92752543|NCT05938530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752544|NCT05937282|Lidocaine|lidocaine|mesh-list
92752545|NCT05937282|Dexmedetomidine|dexmedetomidine|mesh-list
92752546|NCT05937282|Propofol|propofol|mesh-list
92752547|NCT05937282|Anesthetics, Local|anesthetics, local|mesh-ancestor
92752548|NCT05937282|Anesthetics|anesthetics|mesh-ancestor
92752549|NCT05937282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752550|NCT05937282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752551|NCT05937282|Sensory System Agents|sensory system agents|mesh-ancestor
92752552|NCT05937282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752553|NCT05937282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92752554|NCT05937282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92752555|NCT05937282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92752556|NCT05937282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92752557|NCT05937282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752559|NCT05937282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92752560|NCT05937282|Analgesics|analgesics|mesh-ancestor
92752561|NCT05937282|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92752562|NCT05937282|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92752563|NCT05937282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92727068|NCT00176462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727069|NCT00176462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727070|NCT00176462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92727071|NCT00176462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727072|NCT00176462|Antiemetics|antiemetics|mesh-ancestor
92727073|NCT00176462|Autonomic Agents|autonomic agents|mesh-ancestor
92727074|NCT00176462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727075|NCT00176462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727076|NCT00176462|Glucocorticoids|glucocorticoids|mesh-ancestor
92727077|NCT00176462|Hormones|hormones|mesh-ancestor
92727078|NCT00176462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727079|NCT00176462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727080|NCT00176462|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92727081|NCT00176462|Abortifacient Agents|abortifacient agents|mesh-ancestor
92727082|NCT00176462|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92727083|NCT00176462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727084|NCT00176462|Antimetabolites|antimetabolites|mesh-ancestor
92727085|NCT00176462|Dermatologic Agents|dermatologic agents|mesh-ancestor
92727086|NCT00176462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727087|NCT00176462|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92727088|NCT00176462|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727089|NCT00176462|Antiviral Agents|antiviral agents|mesh-ancestor
92727090|NCT00176462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727091|NCT00176462|Antidotes|antidotes|mesh-ancestor
92727092|NCT00176462|Protective Agents|protective agents|mesh-ancestor
92727093|NCT00176462|Vitamin B Complex|vitamin b complex|mesh-ancestor
92727094|NCT00176462|Vitamins|vitamins|mesh-ancestor
92727095|NCT00176462|Micronutrients|micronutrients|mesh-ancestor
92727096|NCT00176462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92727097|NCT00176462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92727098|NCT00176462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727099|NCT00176462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727100|NCT00176462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92727101|NCT00176462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92727102|NCT00176462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92752564|NCT05937282|Adrenergic Agents|adrenergic agents|mesh-ancestor
92752565|NCT05937282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752566|NCT05937282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92752567|NCT05937282|Anesthetics, General|anesthetics, general|mesh-ancestor
92752568|NCT05936268|Colchicine|colchicine|mesh-list
92752569|NCT05936268|Gout Suppressants|gout suppressants|mesh-ancestor
92727103|NCT00175019|Allopurinol|allopurinol|mesh-list
92727104|NCT00175019|Febuxostat|febuxostat|mesh-list
92727105|NCT00175019|Antimetabolites|antimetabolites|mesh-ancestor
92727106|NCT00175019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727107|NCT00175019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727108|NCT00175019|Gout Suppressants|gout suppressants|mesh-ancestor
92727109|NCT00175019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727110|NCT00175019|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92727111|NCT00175019|Antioxidants|antioxidants|mesh-ancestor
92727112|NCT00175019|Protective Agents|protective agents|mesh-ancestor
92727113|NCT00175019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727114|NCT00174941|Febuxostat|febuxostat|mesh-list
92727115|NCT00174941|Gout Suppressants|gout suppressants|mesh-ancestor
92727116|NCT00174941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727117|NCT00171704|Tamoxifen|tamoxifen|mesh-list
92727118|NCT00171704|Letrozole|letrozole|mesh-list
92727119|NCT00171704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727120|NCT00171704|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92727121|NCT00171704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92727122|NCT00171704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727123|NCT00171704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727124|NCT00171704|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92727125|NCT00171704|Hormone Antagonists|hormone antagonists|mesh-ancestor
92727126|NCT00171704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752570|NCT05936268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752571|NCT05936268|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752572|NCT05936268|Antimitotic Agents|antimitotic agents|mesh-ancestor
92752573|NCT05936268|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752574|NCT05936268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752575|NCT05936268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752576|NCT05935787|Riboflavin|riboflavin|mesh-list
92752577|NCT05935787|Niacinamide|niacinamide|mesh-list
92752578|NCT05935787|Niacin|niacin|mesh-list
92752579|NCT05935787|Nicotinic Acids|nicotinic acids|mesh-list
92752593|NCT05933642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92752594|NCT05933642|Autonomic Agents|autonomic agents|mesh-ancestor
92752595|NCT05933642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752596|NCT05933642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752597|NCT05933642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92752598|NCT05933642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92752599|NCT05933642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92752600|NCT05933642|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92752601|NCT05933642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752602|NCT05933642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752603|NCT05933642|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92752604|NCT05933642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92752605|NCT05933642|Purinergic Agents|purinergic agents|mesh-ancestor
92752606|NCT05933642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752607|NCT05933642|Protective Agents|protective agents|mesh-ancestor
92752608|NCT05933642|Diuretics|diuretics|mesh-ancestor
92752609|NCT05933642|Natriuretic Agents|natriuretic agents|mesh-ancestor
92752610|NCT05933642|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92752611|NCT05933642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92727127|NCT00171704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727128|NCT00171704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727129|NCT00171704|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92727130|NCT00171704|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92727131|NCT00171704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92727132|NCT00171314|Zoledronic Acid|zoledronic acid|mesh-list
92727133|NCT00171314|Letrozole|letrozole|mesh-list
92727134|NCT00171314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727135|NCT00171314|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92727136|NCT00171314|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92727137|NCT00171314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727138|NCT00171314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727139|NCT00171314|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92727140|NCT00171314|Hormone Antagonists|hormone antagonists|mesh-ancestor
92727141|NCT00171314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727142|NCT00171314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727143|NCT00171314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92727144|NCT00171158|Imatinib Mesylate|imatinib mesylate|mesh-list
92727145|NCT00171158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727146|NCT00171158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727147|NCT00171158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727148|NCT00171158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727149|NCT00170846|Everolimus|everolimus|mesh-list
92727150|NCT00170846|Azathioprine|azathioprine|mesh-list
92727151|NCT00170846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92727152|NCT00170846|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92727153|NCT00170846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727154|NCT00170846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727155|NCT00170846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727156|NCT00170846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727157|NCT00170846|Immunologic Factors|immunologic factors|mesh-ancestor
92727158|NCT00170846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727159|NCT00170846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727160|NCT00170846|Antimetabolites|antimetabolites|mesh-ancestor
92752612|NCT05932251|Metformin|metformin|mesh-list
92752613|NCT05932251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92752614|NCT05932251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727161|NCT00170846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727162|NCT00170846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727163|NCT00476606|Ritonavir|ritonavir|mesh-list
92727164|NCT00476606|Nelfinavir|nelfinavir|mesh-list
92727165|NCT00476606|Indinavir|indinavir|mesh-list
92727166|NCT00476606|Saquinavir|saquinavir|mesh-list
92727167|NCT00476606|Lamivudine|lamivudine|mesh-list
92727168|NCT00476606|Zidovudine|zidovudine|mesh-list
92727169|NCT00476606|Nevirapine|nevirapine|mesh-list
92727170|NCT00476606|Didanosine|didanosine|mesh-list
92727171|NCT00476606|Stavudine|stavudine|mesh-list
92727172|NCT00476606|Efavirenz|efavirenz|mesh-list
92727173|NCT00476606|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92727174|NCT00476606|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92727175|NCT00476606|Protease Inhibitors|protease inhibitors|mesh-ancestor
92727176|NCT00476606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727177|NCT00476606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727178|NCT00476606|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92727179|NCT00476606|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92727180|NCT00476606|Antiviral Agents|antiviral agents|mesh-ancestor
92727181|NCT00476606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727182|NCT00476606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92727183|NCT00476606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92727184|NCT00476606|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92727185|NCT00476606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727186|NCT00476606|Antimetabolites|antimetabolites|mesh-ancestor
92752615|NCT05928520|Lidocaine|lidocaine|mesh-list
92752616|NCT05928520|Tramadol|tramadol|mesh-list
92752617|NCT05928520|Anesthetics, Local|anesthetics, local|mesh-ancestor
92752618|NCT05928520|Anesthetics|anesthetics|mesh-ancestor
92752619|NCT05928520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752620|NCT05928520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752621|NCT05928520|Sensory System Agents|sensory system agents|mesh-ancestor
92752622|NCT05928520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752623|NCT05928520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92752624|NCT05928520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92752625|NCT05928520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92752626|NCT05928520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92752627|NCT05928520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752628|NCT05928520|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92752629|NCT05928520|Narcotics|narcotics|mesh-ancestor
92752630|NCT05928520|Analgesics|analgesics|mesh-ancestor
92752631|NCT05928390|Pasireotide|pasireotide|mesh-list
92752632|NCT05928390|Hormones|hormones|mesh-ancestor
92752633|NCT05928390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752634|NCT05928390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752635|NCT05923411|Rabeprazole|rabeprazole|mesh-list
92752636|NCT05923411|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92752637|NCT05923411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752638|NCT05923411|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92752639|NCT05923411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752640|NCT05923411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752641|NCT05923190|Pembrolizumab|pembrolizumab|mesh-list
92727187|NCT00476606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92727188|NCT00476606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92727189|NCT00476606|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92727190|NCT00476606|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92727191|NCT00476606|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92727192|NCT04562103|Epinephrine|epinephrine|mesh-list
92727193|NCT04562103|Ropivacaine|ropivacaine|mesh-list
92727194|NCT04562103|Anesthetics, Local|anesthetics, local|mesh-ancestor
92727195|NCT04562103|Anesthetics|anesthetics|mesh-ancestor
92727196|NCT04562103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727197|NCT04562103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727198|NCT04562103|Sensory System Agents|sensory system agents|mesh-ancestor
92727199|NCT04562103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727200|NCT04562103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92727201|NCT04562103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92727202|NCT04562103|Adrenergic Agents|adrenergic agents|mesh-ancestor
92727203|NCT04562103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727204|NCT04562103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727205|NCT04562103|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92727206|NCT04562103|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92727207|NCT04562103|Autonomic Agents|autonomic agents|mesh-ancestor
92727208|NCT04562103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92727209|NCT04562103|Respiratory System Agents|respiratory system agents|mesh-ancestor
92727210|NCT04562103|Mydriatics|mydriatics|mesh-ancestor
92727211|NCT04562103|Sympathomimetics|sympathomimetics|mesh-ancestor
92727212|NCT04562103|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92727213|NCT04561635|Micronutrients|micronutrients|mesh-list
92727214|NCT04561635|Trace Elements|trace elements|mesh-list
92727215|NCT04561635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727216|NCT00479882|Simvastatin|simvastatin|mesh-list
92727217|NCT00479882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92752642|NCT05923190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752645|NCT05923190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752647|NCT05919173|Bupivacaine|bupivacaine|mesh-list
92752648|NCT05919173|Anesthetics, Local|anesthetics, local|mesh-ancestor
92752649|NCT05919173|Anesthetics|anesthetics|mesh-ancestor
92752650|NCT05919173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752651|NCT05919173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752652|NCT05919173|Sensory System Agents|sensory system agents|mesh-ancestor
92752653|NCT05919173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752654|NCT05919173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92752655|NCT05919173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92727219|NCT00479882|Antimetabolites|antimetabolites|mesh-ancestor
92727220|NCT00479882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727221|NCT00479882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92727222|NCT00479882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92727223|NCT00479882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727224|NCT00479765|Paclitaxel|paclitaxel|mesh-list
92727225|NCT00479765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92727226|NCT00479765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727227|NCT00479765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92727228|NCT00479765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727229|NCT00479765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727230|NCT00479765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727231|NCT00479687|Hyaluronic Acid|hyaluronic acid|mesh-list
92727232|NCT00479687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92727233|NCT00479687|Immunologic Factors|immunologic factors|mesh-ancestor
92727234|NCT00479687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727235|NCT00479687|Viscosupplements|viscosupplements|mesh-ancestor
92727236|NCT00479687|Protective Agents|protective agents|mesh-ancestor
92727237|NCT00479336|Tolvaptan|tolvaptan|mesh-list
92727238|NCT00479336|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92727239|NCT00479336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727240|NCT00479336|Natriuretic Agents|natriuretic agents|mesh-ancestor
92752656|NCT05919173|Analgesics|analgesics|mesh-ancestor
92752657|NCT05919173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92752658|NCT05919173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92752659|NCT05919173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92752660|NCT05919173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92752661|NCT05919173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752662|NCT05919173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752663|NCT05911776|Dexmedetomidine|dexmedetomidine|mesh-list
92752664|NCT05911776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92752665|NCT05911776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752666|NCT05911776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752667|NCT05911776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92752668|NCT05911776|Analgesics|analgesics|mesh-ancestor
92752669|NCT05911776|Sensory System Agents|sensory system agents|mesh-ancestor
92752670|NCT05911776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752671|NCT05911776|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92752672|NCT05911776|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92752673|NCT05911776|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92752674|NCT05911776|Adrenergic Agents|adrenergic agents|mesh-ancestor
92752675|NCT05911776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752676|NCT05911776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752677|NCT05908747|Paclitaxel|paclitaxel|mesh-list
92752678|NCT05908747|Gemcitabine|gemcitabine|mesh-list
92752679|NCT05908747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92752680|NCT05908747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752681|NCT05908747|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752682|NCT05908747|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727241|NCT00479336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727242|NCT00478244|Cyclophosphamide|cyclophosphamide|mesh-list
92727243|NCT00478244|Busulfan|busulfan|mesh-list
92727244|NCT00478244|Fludarabine|fludarabine|mesh-list
92727245|NCT00478244|Fludarabine phosphate|fludarabine phosphate|mesh-list
92727246|NCT00478244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727247|NCT00478244|Immunologic Factors|immunologic factors|mesh-ancestor
92727248|NCT00478244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727249|NCT00478244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727250|NCT00478244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727251|NCT00478244|Alkylating Agents|alkylating agents|mesh-ancestor
92727252|NCT00478244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727253|NCT00478244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727254|NCT00478244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92727255|NCT00478244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727256|NCT00478244|Antimetabolites|antimetabolites|mesh-ancestor
92727257|NCT00478205|Donepezil|donepezil|mesh-list
92727258|NCT00478205|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92727259|NCT00478205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727260|NCT00478205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727261|NCT00478205|Cholinergic Agents|cholinergic agents|mesh-ancestor
92727262|NCT00478205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727263|NCT00478205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727264|NCT00478205|Nootropic Agents|nootropic agents|mesh-ancestor
92727265|NCT00477971|Dexamethasone|dexamethasone|mesh-list
92727266|NCT00477971|Melphalan|melphalan|mesh-list
92727267|NCT00477971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727268|NCT00477971|Antiemetics|antiemetics|mesh-ancestor
92727269|NCT00477971|Autonomic Agents|autonomic agents|mesh-ancestor
92727270|NCT00477971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727271|NCT00477971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727272|NCT00477971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727273|NCT00477971|Glucocorticoids|glucocorticoids|mesh-ancestor
92727274|NCT00477971|Hormones|hormones|mesh-ancestor
92727275|NCT00477971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727276|NCT00477971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92752683|NCT05908747|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752684|NCT05908747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752685|NCT05908747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727277|NCT00477971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727278|NCT00477971|Immunologic Factors|immunologic factors|mesh-ancestor
92727279|NCT00477971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727280|NCT00477971|Alkylating Agents|alkylating agents|mesh-ancestor
92727281|NCT00477971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727282|NCT00477971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92727283|NCT00477971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727284|NCT00477464|Capecitabine|capecitabine|mesh-list
92727285|NCT00477464|Lapatinib|lapatinib|mesh-list
92727286|NCT00477464|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727287|NCT00477464|Antimetabolites|antimetabolites|mesh-ancestor
92727288|NCT00477464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727289|NCT00477464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727290|NCT00477464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727291|NCT00477464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727292|NCT00477386|Decitabine|decitabine|mesh-list
92727293|NCT00477386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727294|NCT00477386|Antimetabolites|antimetabolites|mesh-ancestor
92727295|NCT00477386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727296|NCT00477386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727297|NCT00477386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727298|NCT00477269|Imatinib Mesylate|imatinib mesylate|mesh-list
92752686|NCT05908747|Antimetabolites|antimetabolites|mesh-ancestor
92752687|NCT05906511|Dronabinol|dronabinol|mesh-list
92752688|NCT05906511|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92752689|NCT05906511|Hallucinogens|hallucinogens|mesh-ancestor
92752690|NCT05906511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752691|NCT05906511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92752692|NCT05906511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92752693|NCT05906511|Analgesics|analgesics|mesh-ancestor
92752694|NCT05906511|Sensory System Agents|sensory system agents|mesh-ancestor
92752695|NCT05906511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752696|NCT05906511|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92752697|NCT05906511|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92752698|NCT05906511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752699|NCT05906511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752700|NCT05906511|Hormones|hormones|mesh-ancestor
92752701|NCT05906511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752702|NCT05904808|Metolazone|metolazone|mesh-list
92752703|NCT05904808|Furosemide|furosemide|mesh-list
92752704|NCT05904808|Acetazolamide|acetazolamide|mesh-list
92752705|NCT05904808|Magnesium citrate|magnesium citrate|mesh-list
92752706|NCT05904808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752707|NCT05904808|Diuretics|diuretics|mesh-ancestor
92752708|NCT05904808|Natriuretic Agents|natriuretic agents|mesh-ancestor
92752709|NCT05904808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752710|NCT05904808|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92752711|NCT05904808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92752712|NCT05904808|Anticonvulsants|anticonvulsants|mesh-ancestor
92752732|NCT05888350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752733|NCT05888350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727299|NCT00477269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727300|NCT00477269|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727301|NCT00477269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727302|NCT00477269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727303|NCT00476996|Methotrexate|methotrexate|mesh-list
92727304|NCT00476996|Leflunomide|leflunomide|mesh-list
92727305|NCT00476996|Ocrelizumab|ocrelizumab|mesh-list
92727306|NCT00476996|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92727307|NCT00476996|Abortifacient Agents|abortifacient agents|mesh-ancestor
92727308|NCT00476996|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92727309|NCT00476996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727310|NCT00476996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92727311|NCT00476996|Antimetabolites|antimetabolites|mesh-ancestor
92727312|NCT00476996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727313|NCT00476996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727314|NCT00476996|Dermatologic Agents|dermatologic agents|mesh-ancestor
92727315|NCT00476996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727316|NCT00476996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92727317|NCT00476996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727318|NCT00476996|Immunologic Factors|immunologic factors|mesh-ancestor
92727319|NCT00476996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727320|NCT00476996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727321|NCT00476957|Sirolimus|sirolimus|mesh-list
92727322|NCT00476957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727323|NCT00476957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727324|NCT00476957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752734|NCT05888350|Glucocorticoids|glucocorticoids|mesh-ancestor
92752735|NCT05888350|Hormones|hormones|mesh-ancestor
92752736|NCT05888350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752737|NCT05886244|Eculizumab|eculizumab|mesh-list
92752738|NCT05886244|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92752739|NCT05886244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752740|NCT05886244|Immunologic Factors|immunologic factors|mesh-ancestor
92752741|NCT05886244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752742|NCT05883644|Durvalumab|durvalumab|mesh-list
92752743|NCT05883644|Tremelimumab|tremelimumab|mesh-list
92752744|NCT05883644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752745|NCT05883644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752746|NCT05881083|Nicotine|nicotine|mesh-list
92752747|NCT05881083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92752748|NCT05881083|Autonomic Agents|autonomic agents|mesh-ancestor
92752749|NCT05881083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752750|NCT05881083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752751|NCT05881083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92752752|NCT05881083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92752753|NCT05881083|Cholinergic Agents|cholinergic agents|mesh-ancestor
92752754|NCT05881083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752755|NCT05881083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752756|NCT05875961|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92727325|NCT00476957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727326|NCT00476957|Antifungal Agents|antifungal agents|mesh-ancestor
92727327|NCT00476957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727328|NCT00476957|Immunologic Factors|immunologic factors|mesh-ancestor
92727329|NCT00476957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727331|NCT00475865|Glatiramer Acetate|glatiramer acetate|mesh-list
92727332|NCT00475865|(T,G)-A-L|(t,g)-a-l|mesh-list
92727333|NCT00475865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92727334|NCT00475865|Immunologic Factors|immunologic factors|mesh-ancestor
92727335|NCT00475865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727336|NCT00475865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727337|NCT00475865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727338|NCT00475865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92727339|NCT00475865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92727340|NCT00475865|Analgesics|analgesics|mesh-ancestor
92727341|NCT00475865|Sensory System Agents|sensory system agents|mesh-ancestor
92727342|NCT00475865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727343|NCT00475865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727344|NCT00475670|Paclitaxel|paclitaxel|mesh-list
92727345|NCT00475670|Docetaxel|docetaxel|mesh-list
92727346|NCT00475670|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92727347|NCT00475670|Trastuzumab|trastuzumab|mesh-list
92727348|NCT00475670|Taxane|taxane|mesh-list
92727349|NCT00475670|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92727350|NCT00475670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727351|NCT00475670|Tubulin Modulators|tubulin modulators|mesh-ancestor
92727352|NCT00475670|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727353|NCT00475670|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727354|NCT00475670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752757|NCT05875961|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92752758|NCT05875961|Immunologic Factors|immunologic factors|mesh-ancestor
92752759|NCT05875961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752760|NCT05870683|Amoxicillin|amoxicillin|mesh-list
92752761|NCT05870683|Esomeprazole|esomeprazole|mesh-list
92752762|NCT05870683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752763|NCT05870683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752764|NCT05870683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92752765|NCT05870683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752766|NCT05870683|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92752767|NCT05870683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752768|NCT05870683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752769|NCT05866367|Insulin|insulin|mesh-list
92727355|NCT00475670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92727356|NCT04556760|Prednisolone|prednisolone|mesh-list
92727357|NCT04556760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727358|NCT04556760|Glucocorticoids|glucocorticoids|mesh-ancestor
92727359|NCT04556760|Hormones|hormones|mesh-ancestor
92727360|NCT04556760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727361|NCT04556760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727362|NCT04556760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727363|NCT04556760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727364|NCT00474929|Everolimus|everolimus|mesh-list
92727365|NCT00474929|Sorafenib|sorafenib|mesh-list
92727366|NCT00474929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92727367|NCT00474929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727368|NCT00474929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727369|NCT00474929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727370|NCT00474929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727371|NCT00474929|Immunologic Factors|immunologic factors|mesh-ancestor
92727372|NCT00474929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727373|NCT00474929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727374|NCT00474812|Dasatinib|dasatinib|mesh-list
92727375|NCT00474812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727376|NCT00474812|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727377|NCT00474812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752770|NCT05866367|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92752771|NCT05866367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92752772|NCT05866367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752773|NCT05860400|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92752774|NCT05860400|Immunologic Factors|immunologic factors|mesh-ancestor
92752775|NCT05860400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752776|NCT05854784|Afamelanotide|afamelanotide|mesh-list
92752777|NCT05854784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92752778|NCT05847686|Psilocybin|psilocybin|mesh-list
92752779|NCT05847686|Hallucinogens|hallucinogens|mesh-ancestor
92752780|NCT05847686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752781|NCT05847686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92752782|NCT05847452|Benralizumab|benralizumab|mesh-list
92752783|NCT05847452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92752784|NCT05847452|Respiratory System Agents|respiratory system agents|mesh-ancestor
92752785|NCT05833776|Fentanyl|fentanyl|mesh-list
92752786|NCT05833776|Bupivacaine|bupivacaine|mesh-list
92752787|NCT05833776|Anesthetics, Local|anesthetics, local|mesh-ancestor
92752788|NCT05833776|Anesthetics|anesthetics|mesh-ancestor
92752789|NCT05833776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752790|NCT05833776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752791|NCT05833776|Sensory System Agents|sensory system agents|mesh-ancestor
92752792|NCT05833776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752793|NCT05833776|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92752794|NCT05833776|Narcotics|narcotics|mesh-ancestor
92752795|NCT05833776|Analgesics|analgesics|mesh-ancestor
92752796|NCT05833776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92752797|NCT05833776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92752798|NCT05833776|Anesthetics, General|anesthetics, general|mesh-ancestor
92752799|NCT05823441|Oxytocin|oxytocin|mesh-list
92752800|NCT05823441|Oxytocics|oxytocics|mesh-ancestor
92727378|NCT00474812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727379|NCT00474383|Abiraterone Acetate|abiraterone acetate|mesh-list
92727380|NCT00474383|Glucocorticoids|glucocorticoids|mesh-list
92727381|NCT00474383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727382|NCT00474383|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92727383|NCT00474383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727384|NCT00474383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727385|NCT00474383|Hormone Antagonists|hormone antagonists|mesh-ancestor
92727386|NCT00474383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727387|NCT00474383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727388|NCT00474383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92727389|NCT00474383|Hormones|hormones|mesh-ancestor
92727390|NCT00472199|Pramipexole|pramipexole|mesh-list
92727391|NCT00472199|Antioxidants|antioxidants|mesh-ancestor
92727392|NCT00472199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727393|NCT00472199|Protective Agents|protective agents|mesh-ancestor
92727394|NCT00472199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727395|NCT00472199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92727396|NCT00472199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92727397|NCT00472199|Dopamine Agonists|dopamine agonists|mesh-ancestor
92727398|NCT00472199|Dopamine Agents|dopamine agents|mesh-ancestor
92727399|NCT00472199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727400|NCT04556136|Vitamin D|vitamin d|mesh-list
92727401|NCT04556136|Vitamins|vitamins|mesh-ancestor
92727402|NCT04556136|Micronutrients|micronutrients|mesh-ancestor
92727403|NCT04556136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727426|NCT00470366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92727427|NCT00470366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727428|NCT00470366|Tubulin Modulators|tubulin modulators|mesh-ancestor
92727429|NCT00470366|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727430|NCT00470366|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727431|NCT00470366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727432|NCT00470366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727433|NCT00470366|Alkylating Agents|alkylating agents|mesh-ancestor
92727434|NCT02212431|Cysteamine|cysteamine|mesh-list
92727435|NCT02212431|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92727436|NCT02212431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727437|NCT00470093|Interferons|interferons|mesh-list
92727438|NCT00470093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727439|NCT00470093|Antiviral Agents|antiviral agents|mesh-ancestor
92727440|NCT00470093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727441|NCT00470054|Dasatinib|dasatinib|mesh-list
92727442|NCT00470054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727443|NCT00470054|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727444|NCT00470054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727445|NCT00470054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727446|NCT00478595|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92727447|NCT00478595|Rimonabant|rimonabant|mesh-list
92727448|NCT00478595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92727449|NCT00478595|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92727450|NCT00478595|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92727451|NCT00478595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727452|NCT00478595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727453|NCT00478595|Hormones|hormones|mesh-ancestor
92752801|NCT05823441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752802|NCT05823441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752803|NCT05821309|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92752804|NCT05821309|Glycerol|glycerol|mesh-list
92752805|NCT05821309|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92752806|NCT05821309|Protective Agents|protective agents|mesh-ancestor
92752807|NCT05821309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752808|NCT05821309|Laxatives|laxatives|mesh-ancestor
92752809|NCT05821309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752810|NCT05816616|Xenon|xenon|mesh-list
92752811|NCT05816616|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92752812|NCT05816616|Anesthetics, General|anesthetics, general|mesh-ancestor
92752813|NCT05816616|Anesthetics|anesthetics|mesh-ancestor
92752814|NCT05816616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752815|NCT05816616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752816|NCT05792319|Copper|copper|mesh-list
92752817|NCT05792319|Trace Elements|trace elements|mesh-ancestor
92727454|NCT00478595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727455|NCT00478595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727457|NCT04555707|Betamethasone Valerate|betamethasone valerate|mesh-list
92727458|NCT04555707|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92727459|NCT04555707|Betamethasone benzoate|betamethasone benzoate|mesh-list
92727460|NCT04555707|Apremilast|apremilast|mesh-list
92727461|NCT04555707|Calcipotriene|calcipotriene|mesh-list
92727462|NCT04555707|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92727463|NCT04555707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727464|NCT04555707|Glucocorticoids|glucocorticoids|mesh-ancestor
92727465|NCT04555707|Hormones|hormones|mesh-ancestor
92727466|NCT04555707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727467|NCT04555707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727468|NCT04555707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92727469|NCT04555707|Respiratory System Agents|respiratory system agents|mesh-ancestor
92727470|NCT04555707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92727471|NCT04555707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92727472|NCT04555707|Analgesics|analgesics|mesh-ancestor
92727473|NCT04555707|Sensory System Agents|sensory system agents|mesh-ancestor
92752818|NCT05792319|Micronutrients|micronutrients|mesh-ancestor
92752819|NCT05792319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752820|NCT05775289|Paclitaxel|paclitaxel|mesh-list
92752821|NCT05775289|Carboplatin|carboplatin|mesh-list
92752824|NCT05775289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92752825|NCT05775289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752826|NCT05775289|Tubulin Modulators|tubulin modulators|mesh-ancestor
92752827|NCT05775289|Antimitotic Agents|antimitotic agents|mesh-ancestor
92752828|NCT05775289|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752829|NCT05775289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752830|NCT05775289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752831|NCT05775289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92752832|NCT05775289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752833|NCT05775289|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92752834|NCT05775289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92752835|NCT05760261|Midazolam|midazolam|mesh-list
92752836|NCT05760261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92752837|NCT05760261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92752838|NCT05760261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752839|NCT05760261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752840|NCT05760261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92752841|NCT05760261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92752842|NCT05760261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92752843|NCT05760261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92752845|NCT05760261|Anesthetics|anesthetics|mesh-ancestor
92752846|NCT05760261|GABA Modulators|gaba modulators|mesh-ancestor
92752847|NCT05760261|GABA Agents|gaba agents|mesh-ancestor
92752848|NCT05760261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752849|NCT05760261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752850|NCT05748171|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92752851|NCT05748171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752852|NCT05748171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752853|NCT05748171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92752854|NCT05748171|Immunotoxins|immunotoxins|mesh-ancestor
92727474|NCT04555707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727476|NCT04555707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92727477|NCT04555707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92727478|NCT04555707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727479|NCT04555707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727480|NCT04555707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92727481|NCT00474188|Dexamethasone|dexamethasone|mesh-list
92727482|NCT00474188|Lenalidomide|lenalidomide|mesh-list
92727483|NCT00474188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727484|NCT00474188|Antiemetics|antiemetics|mesh-ancestor
92727485|NCT00474188|Autonomic Agents|autonomic agents|mesh-ancestor
92727486|NCT00474188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727487|NCT00474188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727488|NCT00474188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727489|NCT00474188|Glucocorticoids|glucocorticoids|mesh-ancestor
92727490|NCT00474188|Hormones|hormones|mesh-ancestor
92727491|NCT00474188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727492|NCT00474188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727493|NCT00474188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727494|NCT00474188|Immunologic Factors|immunologic factors|mesh-ancestor
92727495|NCT00474188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92727496|NCT00474188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92752855|NCT05748171|Immunoconjugates|immunoconjugates|mesh-ancestor
92752856|NCT05748171|Immunologic Factors|immunologic factors|mesh-ancestor
92752857|NCT05748171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752858|NCT05746377|Metoclopramide|metoclopramide|mesh-list
92752859|NCT05746377|Antiemetics|antiemetics|mesh-ancestor
92752860|NCT05746377|Autonomic Agents|autonomic agents|mesh-ancestor
92752861|NCT05746377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752862|NCT05746377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752863|NCT05746377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752864|NCT05746377|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92752865|NCT05746377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92752866|NCT05746377|Dopamine Agents|dopamine agents|mesh-ancestor
92752867|NCT05746377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752868|NCT05746377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752869|NCT05729139|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92752870|NCT05729139|Interferon alpha-2|interferon alpha-2|mesh-list
92752871|NCT05729139|Cemiplimab|cemiplimab|mesh-list
92752872|NCT05729139|Antiviral Agents|antiviral agents|mesh-ancestor
92752873|NCT05729139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752874|NCT05729139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752875|NCT05729139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752876|NCT05725798|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92752877|NCT05725798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92752878|NCT05725798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752879|NCT05725798|Incretins|incretins|mesh-ancestor
92752880|NCT05725798|Hormones|hormones|mesh-ancestor
92752881|NCT05725798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400833|NCT01411969|Phenylephrine|phenylephrine|mesh-list
92752882|NCT05725798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92727497|NCT00474188|Growth Substances|growth substances|mesh-ancestor
92727498|NCT00474188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92727499|NCT01089647|Budesonide|budesonide|mesh-list
92727500|NCT01089647|Montelukast|montelukast|mesh-list
92727501|NCT01089647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727502|NCT01089647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92727503|NCT01089647|Autonomic Agents|autonomic agents|mesh-ancestor
92727504|NCT01089647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727505|NCT01089647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727506|NCT01089647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92727507|NCT01089647|Respiratory System Agents|respiratory system agents|mesh-ancestor
92727508|NCT01089647|Glucocorticoids|glucocorticoids|mesh-ancestor
92727510|NCT01089647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727511|NCT01089647|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92727512|NCT01089647|Hormone Antagonists|hormone antagonists|mesh-ancestor
92727513|NCT01089647|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92727514|NCT01089647|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92727515|NCT01089647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727516|NCT04673240|Botulinum Toxins|botulinum toxins|mesh-list
92727517|NCT04673240|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92727518|NCT04673240|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92727519|NCT04673240|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92727520|NCT04673240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92727521|NCT04673240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727522|NCT04673240|Cholinergic Agents|cholinergic agents|mesh-ancestor
92727523|NCT04673240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752883|NCT05725798|Protease Inhibitors|protease inhibitors|mesh-ancestor
92752884|NCT05725798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752885|NCT05725798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752886|NCT05708859|Tirzepatide|tirzepatide|mesh-list
92752887|NCT05708859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92752888|NCT05708859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752889|NCT05708859|Incretins|incretins|mesh-ancestor
92752890|NCT05708859|Hormones|hormones|mesh-ancestor
92752891|NCT05708859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752892|NCT05705258|Aflibercept|aflibercept|mesh-list
92752893|NCT05705258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92752894|NCT05705258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92752895|NCT05705258|Growth Substances|growth substances|mesh-ancestor
92752896|NCT05705258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752898|NCT05705258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752899|NCT05699252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92752900|NCT05699252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752901|NCT05699252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752902|NCT05683821|Nicotine|nicotine|mesh-list
92727524|NCT04673240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727525|NCT04673240|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92727526|NCT04673240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727527|NCT01089608|Azithromycin|azithromycin|mesh-list
92727528|NCT01089608|Povidone|povidone|mesh-list
92727529|NCT01089608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727530|NCT01089608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727531|NCT01089608|Plasma Substitutes|plasma substitutes|mesh-ancestor
92727532|NCT01089608|Blood Substitutes|blood substitutes|mesh-ancestor
92727533|NCT04554654|Progesterone|progesterone|mesh-list
92727534|NCT04554654|Progestins|progestins|mesh-ancestor
92727535|NCT04554654|Hormones|hormones|mesh-ancestor
92727536|NCT04554654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727537|NCT04554654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727538|NCT04554615|Insulin|insulin|mesh-list
92727539|NCT04554615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92727540|NCT04554615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727541|NCT01089413|Bevacizumab|bevacizumab|mesh-list
92727542|NCT01089413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92727543|NCT01089413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727544|NCT01089413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92727545|NCT01089413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92727546|NCT01089413|Growth Substances|growth substances|mesh-ancestor
92727547|NCT01089413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727548|NCT01089413|Growth Inhibitors|growth inhibitors|mesh-ancestor
92727549|NCT02212782|Linagliptin|linagliptin|mesh-list
92727550|NCT02212782|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92727551|NCT02212782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727552|NCT02212782|Incretins|incretins|mesh-ancestor
92727553|NCT02212782|Hormones|hormones|mesh-ancestor
92327598|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752903|NCT05683821|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92752904|NCT05683821|Autonomic Agents|autonomic agents|mesh-ancestor
92752905|NCT05683821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752906|NCT05683821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752907|NCT05683821|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92752908|NCT05683821|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92752909|NCT05683821|Cholinergic Agents|cholinergic agents|mesh-ancestor
92752910|NCT05683821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752911|NCT05683821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752912|NCT05683691|Acetaminophen, aspirin, caffeine drug combination|acetaminophen, aspirin, caffeine drug combination|mesh-list
92752913|NCT05683691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92752914|NCT05683691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92752915|NCT05683691|Analgesics|analgesics|mesh-ancestor
92727554|NCT02212782|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727555|NCT02212782|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92727556|NCT02212782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92727557|NCT02212782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727558|NCT02212782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727559|NCT01088984|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92727560|NCT01088984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727561|NCT01088984|Alkylating Agents|alkylating agents|mesh-ancestor
92727562|NCT01088984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727563|NCT01088984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727564|NCT02212821|Erythromycin|erythromycin|mesh-list
92727565|NCT02212821|Erythromycin Estolate|erythromycin estolate|mesh-list
92727566|NCT02212821|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92727567|NCT02212821|Erythromycin stearate|erythromycin stearate|mesh-list
92727568|NCT02212821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727569|NCT02212821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752917|NCT05683691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752918|NCT05683691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752919|NCT05683691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92752920|NCT05683691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752921|NCT05681195|Pemetrexed|pemetrexed|mesh-list
92752922|NCT05681195|Zanubrutinib|zanubrutinib|mesh-list
92752923|NCT05681195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752924|NCT05681195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752925|NCT05681195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752926|NCT05681195|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92752927|NCT05681195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92752928|NCT05681195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92752929|NCT05655949|Cisplatin|cisplatin|mesh-list
92752930|NCT05655949|Gemcitabine|gemcitabine|mesh-list
92752931|NCT05655949|Durvalumab|durvalumab|mesh-list
92752932|NCT05655949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752933|NCT05655949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92752934|NCT05655949|Antimetabolites|antimetabolites|mesh-ancestor
92752935|NCT05655949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752936|NCT05655949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752937|NCT05652205|Linaclotide|linaclotide|mesh-list
92400848|NCT01411969|Mydriatics|mydriatics|mesh-ancestor
92752938|NCT05652205|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92752939|NCT05652205|Enzyme Activators|enzyme activators|mesh-ancestor
92752940|NCT05652205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752941|NCT05652205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752942|NCT05646719|Phentolamine|phentolamine|mesh-list
92752943|NCT05646719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92752944|NCT05646719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92752945|NCT05646719|Pilocarpine|pilocarpine|mesh-list
92752946|NCT05646719|Miotics|miotics|mesh-ancestor
92752947|NCT05646719|Autonomic Agents|autonomic agents|mesh-ancestor
92752948|NCT05646719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752949|NCT05646719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752950|NCT05646719|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92752951|NCT05646719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92752952|NCT05646719|Cholinergic Agents|cholinergic agents|mesh-ancestor
92752953|NCT05646719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752954|NCT05646719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752955|NCT05646719|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92752956|NCT05646719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92727570|NCT02212821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727571|NCT02212821|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92727573|NCT02212821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727574|NCT01088243|Mesalamine|mesalamine|mesh-list
92727575|NCT01088243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92727576|NCT01088243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92727577|NCT01088243|Analgesics|analgesics|mesh-ancestor
92727578|NCT01088243|Sensory System Agents|sensory system agents|mesh-ancestor
92727579|NCT01088243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727580|NCT01088243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727581|NCT01088243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727582|NCT01088243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727584|NCT04672499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727585|NCT04554303|Amlodipine|amlodipine|mesh-list
92727586|NCT04554303|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92727587|NCT04554303|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92727588|NCT04554303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92727589|NCT04554303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727590|NCT04554303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92727591|NCT04554303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727592|NCT04554303|Vasodilator Agents|vasodilator agents|mesh-ancestor
92727593|NCT01088048|Rituximab|rituximab|mesh-list
92727594|NCT01088048|Fludarabine|fludarabine|mesh-list
92727595|NCT01088048|Lenalidomide|lenalidomide|mesh-list
92727596|NCT01088048|Everolimus|everolimus|mesh-list
92727597|NCT01088048|Bortezomib|bortezomib|mesh-list
92727598|NCT01088048|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92727599|NCT01088048|Ofatumumab|ofatumumab|mesh-list
92752957|NCT05646719|Adrenergic Agents|adrenergic agents|mesh-ancestor
92752958|NCT05646719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92752959|NCT05645432|Pregnanolone|pregnanolone|mesh-list
92752960|NCT05645432|Brexanolone|brexanolone|mesh-list
92752961|NCT05645432|Anesthetics|anesthetics|mesh-ancestor
92752962|NCT05645432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92752963|NCT05645432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752964|NCT05645432|Neurosteroids|neurosteroids|mesh-ancestor
92752965|NCT05645432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752966|NCT05645432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752967|NCT05645432|GABA Modulators|gaba modulators|mesh-ancestor
92752968|NCT05645432|GABA Agents|gaba agents|mesh-ancestor
92752969|NCT05645406|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92752970|NCT05645406|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92752974|NCT05645406|Hormones|hormones|mesh-ancestor
92752975|NCT05645406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752976|NCT05645406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752977|NCT05645406|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92727600|NCT01088048|Idelalisib|idelalisib|mesh-list
92727601|NCT01088048|Chlorambucil|chlorambucil|mesh-list
92727602|NCT01088048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92727603|NCT01088048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727604|NCT01088048|Immunologic Factors|immunologic factors|mesh-ancestor
92727605|NCT01088048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727606|NCT01088048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727607|NCT01088048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727608|NCT01088048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727609|NCT01088048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92727610|NCT01088048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92727611|NCT01088048|Growth Substances|growth substances|mesh-ancestor
92727612|NCT01088048|Growth Inhibitors|growth inhibitors|mesh-ancestor
92727613|NCT01088048|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92727614|NCT01088048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727615|NCT01088048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727616|NCT01088048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92727617|NCT01088048|Alkylating Agents|alkylating agents|mesh-ancestor
92727618|NCT01087970|Carboplatin|carboplatin|mesh-list
92727619|NCT01087970|Pemetrexed|pemetrexed|mesh-list
92727620|NCT01087970|Cetuximab|cetuximab|mesh-list
92727621|NCT01087970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727622|NCT01087970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727623|NCT01087970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727624|NCT01087970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92727625|NCT01087970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727626|NCT01087970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92727627|NCT01087814|Efavirenz|efavirenz|mesh-list
92752978|NCT05645406|Contraceptive Agents|contraceptive agents|mesh-ancestor
92752979|NCT05645406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92752980|NCT05645406|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92752981|NCT05645393|Estrogens|estrogens|mesh-list
92752982|NCT05645393|Hormones|hormones|mesh-ancestor
92752983|NCT05645393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752984|NCT05645393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752985|NCT05625594|Cyclophosphamide|cyclophosphamide|mesh-list
92752986|NCT05625594|Fludarabine|fludarabine|mesh-list
92752987|NCT05625594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752988|NCT05625594|Immunologic Factors|immunologic factors|mesh-ancestor
92752989|NCT05625594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752990|NCT05625594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92752992|NCT05625594|Alkylating Agents|alkylating agents|mesh-ancestor
92752993|NCT05625594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752994|NCT05625594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752995|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92752996|NCT05623020|Dexamethasone|dexamethasone|mesh-list
92752997|NCT05623020|Lenalidomide|lenalidomide|mesh-list
92752998|NCT05623020|Daratumumab|daratumumab|mesh-list
92727628|NCT01087814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92727629|NCT01087814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727630|NCT01087814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727631|NCT01087814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727632|NCT01087814|Antiviral Agents|antiviral agents|mesh-ancestor
92727633|NCT01087814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727634|NCT01087814|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92727635|NCT01087814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92727636|NCT01087814|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92727637|NCT01087814|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92727638|NCT01087814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92727639|NCT01087814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92727640|NCT04554030|Immunomodulating Agents|immunomodulating agents|mesh-list
92727641|NCT04554030|Immunologic Factors|immunologic factors|mesh-ancestor
92727642|NCT04554030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727643|NCT01087502|Glimepiride|glimepiride|mesh-list
92727644|NCT01087502|Linagliptin|linagliptin|mesh-list
92400867|NCT01412294|Capecitabine|capecitabine|mesh-list
92752999|NCT05623020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92753000|NCT05623020|Antiemetics|antiemetics|mesh-ancestor
92753001|NCT05623020|Autonomic Agents|autonomic agents|mesh-ancestor
92753002|NCT05623020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753003|NCT05623020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753004|NCT05623020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92753005|NCT05623020|Glucocorticoids|glucocorticoids|mesh-ancestor
92753006|NCT05623020|Hormones|hormones|mesh-ancestor
92753007|NCT05623020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753008|NCT05623020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92753009|NCT05623020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753010|NCT05623020|Immunologic Factors|immunologic factors|mesh-ancestor
92753011|NCT05623020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92753012|NCT05623020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92753013|NCT05623020|Growth Substances|growth substances|mesh-ancestor
92753014|NCT05623020|Growth Inhibitors|growth inhibitors|mesh-ancestor
92753015|NCT05618301|Natalizumab|natalizumab|mesh-list
92753016|NCT05618301|Immunologic Factors|immunologic factors|mesh-ancestor
92753017|NCT05618301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753018|NCT05617625|Fludarabine|fludarabine|mesh-list
92753019|NCT05617625|Melphalan|melphalan|mesh-list
92753020|NCT05617625|Busulfan|busulfan|mesh-list
92753021|NCT05617625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753022|NCT05617625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753023|NCT05617625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753024|NCT05617625|Immunologic Factors|immunologic factors|mesh-ancestor
92753025|NCT05617625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753026|NCT05617625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92753027|NCT05617625|Alkylating Agents|alkylating agents|mesh-ancestor
92753028|NCT05617625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92753029|NCT05612074|Nitric Oxide|nitric oxide|mesh-list
92753030|NCT05612074|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92753031|NCT05612074|Autonomic Agents|autonomic agents|mesh-ancestor
92753032|NCT05612074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753033|NCT05612074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753034|NCT05612074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92753035|NCT05612074|Respiratory System Agents|respiratory system agents|mesh-ancestor
92753036|NCT05612074|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92753037|NCT05612074|Antioxidants|antioxidants|mesh-ancestor
92727645|NCT01087502|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92727646|NCT01087502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92727647|NCT01087502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727648|NCT01087502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92727649|NCT01087502|Immunologic Factors|immunologic factors|mesh-ancestor
92727651|NCT01087502|Hormones|hormones|mesh-ancestor
92727652|NCT01087502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727653|NCT01087502|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92727654|NCT01087502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92727655|NCT01087502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727656|NCT01087502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753038|NCT05612074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753039|NCT05612074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753040|NCT05612074|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92753041|NCT05612074|Vasodilator Agents|vasodilator agents|mesh-ancestor
92753042|NCT05612074|Gasotransmitters|gasotransmitters|mesh-ancestor
92753043|NCT05612074|Protective Agents|protective agents|mesh-ancestor
92753044|NCT05610085|Levetiracetam|levetiracetam|mesh-list
92753053|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753054|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753055|NCT05610085|GABA Modulators|gaba modulators|mesh-ancestor
92753056|NCT05610085|GABA Agents|gaba agents|mesh-ancestor
92753057|NCT05610085|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92753058|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92753059|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92753060|NCT05597839|Nivolumab|nivolumab|mesh-list
92753061|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753062|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753063|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753064|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753065|NCT05581589|Camptothecin|camptothecin|mesh-list
92753066|NCT05581589|Irinotecan|irinotecan|mesh-list
92753067|NCT05581589|Immunoconjugates|immunoconjugates|mesh-list
92753068|NCT05581589|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92753069|NCT05581589|Immunologic Factors|immunologic factors|mesh-ancestor
92753070|NCT05581589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753071|NCT05581589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92753072|NCT05581589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753073|NCT05581589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92753074|NCT05581589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92753075|NCT05581589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753076|NCT05581589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753077|NCT05565105|Cyclophosphamide|cyclophosphamide|mesh-list
92753078|NCT05565105|Melphalan|melphalan|mesh-list
92753079|NCT05565105|Busulfan|busulfan|mesh-list
92753080|NCT05565105|Thiotepa|thiotepa|mesh-list
92753081|NCT05565105|Fludarabine|fludarabine|mesh-list
92753082|NCT05565105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753083|NCT05565105|Immunologic Factors|immunologic factors|mesh-ancestor
92753084|NCT05565105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753085|NCT05565105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753086|NCT05565105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92753087|NCT05565105|Alkylating Agents|alkylating agents|mesh-ancestor
92753088|NCT05565105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753089|NCT05565105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753090|NCT05565105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92753091|NCT05564403|Calcium, Dietary|calcium, dietary|mesh-list
92753092|NCT05564403|Leucovorin|leucovorin|mesh-list
92753093|NCT05564403|Folic Acid|folic acid|mesh-list
92727657|NCT02213211|Lumefantrine|lumefantrine|mesh-list
92727658|NCT02213211|Artemether|artemether|mesh-list
92727659|NCT02213211|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92727660|NCT02213211|Artemisinins|artemisinins|mesh-list
92727661|NCT02213211|Artemisinin|artemisinin|mesh-list
92727662|NCT02213211|Antimalarials|antimalarials|mesh-ancestor
92727663|NCT02213211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92727664|NCT02213211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92727665|NCT02213211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727666|NCT01086410|Fluticasone|fluticasone|mesh-list
92727667|NCT01086410|Xhance|xhance|mesh-list
92727668|NCT01086410|Prednisolone|prednisolone|mesh-list
92727669|NCT01086410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727670|NCT01086410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92727671|NCT01086410|Autonomic Agents|autonomic agents|mesh-ancestor
92727672|NCT01086410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727673|NCT01086410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727674|NCT01086410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92727675|NCT01086410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92727676|NCT01086410|Dermatologic Agents|dermatologic agents|mesh-ancestor
92727677|NCT01086410|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92727678|NCT01086410|Glucocorticoids|glucocorticoids|mesh-ancestor
92727679|NCT01086410|Hormones|hormones|mesh-ancestor
92727680|NCT01086410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727681|NCT01086410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727682|NCT01086410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727683|NCT04553601|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92727684|NCT04553601|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92727685|NCT04553601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727686|NCT04553328|Bupivacaine|bupivacaine|mesh-list
92727687|NCT04553328|Anesthetics, Local|anesthetics, local|mesh-ancestor
92727688|NCT04553328|Anesthetics|anesthetics|mesh-ancestor
92727689|NCT04553328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727691|NCT04553328|Sensory System Agents|sensory system agents|mesh-ancestor
92727702|NCT01085201|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92727703|NCT01085201|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92727704|NCT01085201|Purinergic Agonists|purinergic agonists|mesh-ancestor
92727705|NCT01085201|Purinergic Agents|purinergic agents|mesh-ancestor
92727706|NCT01085201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727707|NCT01085201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727708|NCT01085201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727709|NCT02213718|Sufentanil|sufentanil|mesh-list
92727710|NCT02213718|Propofol|propofol|mesh-list
92727711|NCT02213718|Desflurane|desflurane|mesh-list
92727712|NCT02213718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92727713|NCT02213718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727714|NCT02213718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727715|NCT02213718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92727716|NCT02213718|Anesthetics, General|anesthetics, general|mesh-ancestor
92727717|NCT02213718|Anesthetics|anesthetics|mesh-ancestor
92727718|NCT02213718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92727719|NCT02213718|Narcotics|narcotics|mesh-ancestor
92727720|NCT02213718|Analgesics|analgesics|mesh-ancestor
92727721|NCT02213718|Sensory System Agents|sensory system agents|mesh-ancestor
92727722|NCT02213718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727723|NCT02213718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92727724|NCT02213718|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92727725|NCT01085045|Bromides|bromides|mesh-list
92727726|NCT01085045|Formoterol Fumarate|formoterol fumarate|mesh-list
92727727|NCT01085045|Tiotropium Bromide|tiotropium bromide|mesh-list
92727728|NCT01085045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92727729|NCT01085045|Autonomic Agents|autonomic agents|mesh-ancestor
92727730|NCT01085045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727731|NCT01085045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727732|NCT01085045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92727733|NCT01085045|Respiratory System Agents|respiratory system agents|mesh-ancestor
92727734|NCT01085045|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92727735|NCT01085045|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92727736|NCT01085045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92727737|NCT01085045|Adrenergic Agents|adrenergic agents|mesh-ancestor
92753094|NCT05564403|Fluorouracil|fluorouracil|mesh-list
92753095|NCT05564403|Oxaliplatin|oxaliplatin|mesh-list
92753096|NCT05564403|Calcium|calcium|mesh-list
92753097|NCT05564403|Levoleucovorin|levoleucovorin|mesh-list
92727738|NCT01085045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727739|NCT01085045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727740|NCT01085045|Parasympatholytics|parasympatholytics|mesh-ancestor
92727741|NCT01085045|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92727742|NCT01085045|Cholinergic Agents|cholinergic agents|mesh-ancestor
92727744|NCT02213796|Meropenem|meropenem|mesh-list
92727745|NCT02213796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727746|NCT02213796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727747|NCT00179673|Lenalidomide|lenalidomide|mesh-list
92727748|NCT00179673|Immunologic Factors|immunologic factors|mesh-ancestor
92727749|NCT00179673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727750|NCT00179673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92727751|NCT00179673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92727752|NCT00179673|Growth Substances|growth substances|mesh-ancestor
92727753|NCT00179673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92727754|NCT00179673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727755|NCT01084655|Prednisone|prednisone|mesh-list
92727756|NCT01084655|Docetaxel|docetaxel|mesh-list
92727757|NCT01084655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727758|NCT01084655|Tubulin Modulators|tubulin modulators|mesh-ancestor
92727759|NCT01084655|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727760|NCT01084655|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727761|NCT01084655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727762|NCT01084655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727763|NCT01084655|Glucocorticoids|glucocorticoids|mesh-ancestor
92727764|NCT01084655|Hormones|hormones|mesh-ancestor
92727765|NCT01084655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727766|NCT01084655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727767|NCT01084655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727768|NCT04552431|Ciprofloxacin|ciprofloxacin|mesh-list
92727769|NCT04552431|Tamsulosin|tamsulosin|mesh-list
92727783|NCT04552431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727784|NCT04552431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727785|NCT04552431|Urological Agents|urological agents|mesh-ancestor
92727786|NCT01084538|Ergocalciferols|ergocalciferols|mesh-list
92727787|NCT01084538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92727788|NCT01084538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727790|NCT01084538|Micronutrients|micronutrients|mesh-ancestor
92727791|NCT01084538|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92727792|NCT00179517|Anastrozole|anastrozole|mesh-list
92727793|NCT00179517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727794|NCT00179517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727795|NCT00179517|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92727796|NCT00179517|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92727797|NCT00179517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727798|NCT00179517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727799|NCT00179517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92753098|NCT05564403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92753099|NCT05564403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753100|NCT05564403|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92753101|NCT05564403|Antimetabolites|antimetabolites|mesh-ancestor
92753102|NCT05564403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753103|NCT05564403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92753104|NCT05564403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753105|NCT05564403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753106|NCT05564403|Immunologic Factors|immunologic factors|mesh-ancestor
92753107|NCT05564403|Antidotes|antidotes|mesh-ancestor
92753108|NCT05564403|Protective Agents|protective agents|mesh-ancestor
92753109|NCT05564403|Vitamin B Complex|vitamin b complex|mesh-ancestor
92753110|NCT05564403|Vitamins|vitamins|mesh-ancestor
92753111|NCT05564403|Micronutrients|micronutrients|mesh-ancestor
92753112|NCT05564403|Hematinics|hematinics|mesh-ancestor
92753121|NCT05554367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753122|NCT05554367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753123|NCT05554367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753124|NCT05549778|Polaprezinc|polaprezinc|mesh-list
92753125|NCT05549778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92753126|NCT05549778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92753127|NCT05513924|Fluorouracil|fluorouracil|mesh-list
92753128|NCT05513924|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92753129|NCT05513924|Latanoprost|latanoprost|mesh-list
92753130|NCT05513924|Antimetabolites|antimetabolites|mesh-ancestor
92753131|NCT05513924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753132|NCT05513924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92753133|NCT05513924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753134|NCT05513924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753135|NCT05513924|Immunologic Factors|immunologic factors|mesh-ancestor
92753136|NCT05513924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753137|NCT05513924|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92753138|NCT05511025|Acetaminophen|acetaminophen|mesh-list
92753139|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753140|NCT05511025|Analgesics|analgesics|mesh-ancestor
92753141|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
92753142|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753143|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753145|NCT05505630|Midazolam|midazolam|mesh-list
92753146|NCT05505630|Dexmedetomidine|dexmedetomidine|mesh-list
92753147|NCT05505630|Ketamine|ketamine|mesh-list
92727800|NCT00179517|Hormone Antagonists|hormone antagonists|mesh-ancestor
92727801|NCT00179517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727802|NCT00179517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727803|NCT01083641|Estradiol|estradiol|mesh-list
92727804|NCT01083641|Estrogens|estrogens|mesh-ancestor
92727805|NCT01083641|Hormones|hormones|mesh-ancestor
92727806|NCT01083641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727807|NCT01083641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727808|NCT00179010|Adenosine|adenosine|mesh-list
92727809|NCT00179010|Analgesics|analgesics|mesh-ancestor
92727810|NCT00179010|Sensory System Agents|sensory system agents|mesh-ancestor
92727811|NCT00179010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727812|NCT00179010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727813|NCT00179010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92727814|NCT00179010|Vasodilator Agents|vasodilator agents|mesh-ancestor
92727815|NCT00179010|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92727816|NCT00179010|Purinergic Agonists|purinergic agonists|mesh-ancestor
92727817|NCT00179010|Purinergic Agents|purinergic agents|mesh-ancestor
92727818|NCT00179010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727819|NCT00179010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727820|NCT01083602|Dexamethasone|dexamethasone|mesh-list
92727821|NCT01083602|Bortezomib|bortezomib|mesh-list
92727822|NCT01083602|Panobinostat|panobinostat|mesh-list
92753148|NCT05505630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
92753149|NCT05505630|Anesthetics|anesthetics|mesh-list
92753150|NCT05505630|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92753151|NCT05505630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753152|NCT05505630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753153|NCT05505630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753154|NCT05505630|Analgesics|analgesics|mesh-ancestor
92753155|NCT05505630|Sensory System Agents|sensory system agents|mesh-ancestor
92753156|NCT05505630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753157|NCT05505630|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92753158|NCT05505630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92753159|NCT05505630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92753160|NCT05505630|Adrenergic Agents|adrenergic agents|mesh-ancestor
92753161|NCT05505630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753162|NCT05505630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753163|NCT05505630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92753164|NCT05505630|Anesthetics, General|anesthetics, general|mesh-ancestor
92753165|NCT05505630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92753166|NCT05505630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92753167|NCT05505630|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92753168|NCT05505630|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92753169|NCT05505630|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92753170|NCT05505630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92753171|NCT05505630|GABA Modulators|gaba modulators|mesh-ancestor
92753172|NCT05505630|GABA Agents|gaba agents|mesh-ancestor
92753173|NCT05494697|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92753174|NCT05494697|Antiviral Agents|antiviral agents|mesh-ancestor
92753175|NCT05494697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753176|NCT05477953|Nifurtimox|nifurtimox|mesh-list
92727823|NCT01083602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727824|NCT01083602|Antiemetics|antiemetics|mesh-ancestor
92727825|NCT01083602|Autonomic Agents|autonomic agents|mesh-ancestor
92727826|NCT01083602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727827|NCT01083602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727828|NCT01083602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727829|NCT01083602|Glucocorticoids|glucocorticoids|mesh-ancestor
92727830|NCT01083602|Hormones|hormones|mesh-ancestor
92727831|NCT01083602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92727832|NCT01083602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92727833|NCT01083602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727834|NCT01083602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92727835|NCT01083602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727836|NCT01083602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727837|NCT00178464|Aspirin|aspirin|mesh-list
92727838|NCT00178464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92727839|NCT00178464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92727840|NCT00178464|Analgesics|analgesics|mesh-ancestor
92727841|NCT00178464|Sensory System Agents|sensory system agents|mesh-ancestor
92727842|NCT00178464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727843|NCT00178464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727844|NCT00178464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92727845|NCT00178464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92727846|NCT00178464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92727847|NCT00178464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92727848|NCT00178464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727849|NCT00178464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92727850|NCT00178464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92727851|NCT00178464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727852|NCT00178464|Antipyretics|antipyretics|mesh-ancestor
92727853|NCT04671914|Hyaluronic Acid|hyaluronic acid|mesh-list
92727854|NCT04671914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92727855|NCT04671914|Immunologic Factors|immunologic factors|mesh-ancestor
92727856|NCT04671914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753177|NCT05477953|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92753178|NCT05477953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92753179|NCT05477953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92753180|NCT05477953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753181|NCT05473715|Aflibercept|aflibercept|mesh-list
92753182|NCT05473715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92727857|NCT04671914|Viscosupplements|viscosupplements|mesh-ancestor
92727858|NCT04671914|Protective Agents|protective agents|mesh-ancestor
92727859|NCT01083485|Oxycodone|oxycodone|mesh-list
92727860|NCT01083485|Naloxone|naloxone|mesh-list
92727861|NCT01083485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92727862|NCT01083485|Narcotics|narcotics|mesh-ancestor
92727863|NCT01083485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727864|NCT01083485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727865|NCT01083485|Analgesics|analgesics|mesh-ancestor
92727866|NCT01083485|Sensory System Agents|sensory system agents|mesh-ancestor
92727867|NCT01083485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727868|NCT01083485|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92727869|NCT04551924|Ropivacaine|ropivacaine|mesh-list
92727870|NCT04551924|Anesthetics, Local|anesthetics, local|mesh-ancestor
92727871|NCT04551924|Anesthetics|anesthetics|mesh-ancestor
92727872|NCT04551924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727873|NCT04551924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727874|NCT04551924|Sensory System Agents|sensory system agents|mesh-ancestor
92727875|NCT04551924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727876|NCT04671836|Lorazepam|lorazepam|mesh-list
92727877|NCT04671836|Anticonvulsants|anticonvulsants|mesh-ancestor
92727878|NCT04671836|Antiemetics|antiemetics|mesh-ancestor
92727879|NCT04671836|Autonomic Agents|autonomic agents|mesh-ancestor
92727880|NCT04671836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753185|NCT05473715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753186|NCT05473715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92753187|NCT05473715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753188|NCT05460533|Tisagenlecleucel|tisagenlecleucel|mesh-list
92753189|NCT05460533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753190|NCT05460533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753191|NCT05444777|Ketamine|ketamine|mesh-list
92753192|NCT05444777|Analgesics|analgesics|mesh-ancestor
92753193|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
92753194|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753195|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753196|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92753197|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92753198|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
92753199|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
92753200|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753201|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92753202|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92753203|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753204|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753205|NCT05433961|Xenon|xenon|mesh-list
92753206|NCT05433961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92753207|NCT05433961|Anesthetics, General|anesthetics, general|mesh-ancestor
92753208|NCT05433961|Anesthetics|anesthetics|mesh-ancestor
92753209|NCT05433961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753210|NCT05433961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753211|NCT05415215|Trastuzumab|trastuzumab|mesh-list
92753212|NCT05415215|Pertuzumab|pertuzumab|mesh-list
92753213|NCT05415215|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92753214|NCT05415215|Maytansine|maytansine|mesh-list
92727881|NCT04671836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727882|NCT04671836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92727883|NCT04671836|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92727884|NCT04671836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727885|NCT04671836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92727886|NCT04671836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92727887|NCT04671836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92727888|NCT04671836|GABA Modulators|gaba modulators|mesh-ancestor
92727889|NCT04671836|GABA Agents|gaba agents|mesh-ancestor
92727890|NCT04671836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727891|NCT04671836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727892|NCT00556088|Paclitaxel|paclitaxel|mesh-list
92727893|NCT00556088|Bevacizumab|bevacizumab|mesh-list
92727894|NCT00556088|Carboplatin|carboplatin|mesh-list
92727895|NCT00556088|Panobinostat|panobinostat|mesh-list
92727896|NCT00556088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92727897|NCT00556088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92727898|NCT00556088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753215|NCT05415215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753216|NCT05415215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753217|NCT05415215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92753218|NCT05415215|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753219|NCT05415215|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753220|NCT05415215|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753221|NCT05415215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753222|NCT05415215|Immunotoxins|immunotoxins|mesh-ancestor
92753223|NCT05415215|Immunoconjugates|immunoconjugates|mesh-ancestor
92753224|NCT05415215|Immunologic Factors|immunologic factors|mesh-ancestor
92753225|NCT05415215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753226|NCT05410821|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92753227|NCT05410821|Chelating Agents|chelating agents|mesh-ancestor
92753228|NCT05410821|Sequestering Agents|sequestering agents|mesh-ancestor
92753229|NCT05410821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753230|NCT05410418|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92753231|NCT05410418|Immunoconjugates|immunoconjugates|mesh-ancestor
92753232|NCT05410418|Immunologic Factors|immunologic factors|mesh-ancestor
92753233|NCT05410418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753234|NCT05402293|Lidocaine|lidocaine|mesh-list
92753235|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
92753236|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
92753237|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753238|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753239|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
92753240|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753241|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92753242|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92753243|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92753244|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92753245|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753246|NCT05355168|Nimotuzumab|nimotuzumab|mesh-list
92753247|NCT05355168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753248|NCT05355168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753249|NCT05352815|Insulin|insulin|mesh-list
92753250|NCT05352815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753251|NCT05352815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753252|NCT05348356|Nirogacestat|nirogacestat|mesh-list
92182558|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92727899|NCT00556088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92727900|NCT00556088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92727901|NCT00556088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727902|NCT00556088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92727903|NCT00556088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92727904|NCT00556088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92727905|NCT00556088|Growth Substances|growth substances|mesh-ancestor
92727906|NCT00556088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727907|NCT00556088|Growth Inhibitors|growth inhibitors|mesh-ancestor
92727908|NCT00556088|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92727909|NCT00556088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727910|NCT00177294|Escitalopram|escitalopram|mesh-list
92727911|NCT00177294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92727912|NCT00177294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92727913|NCT00177294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92727914|NCT00177294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727915|NCT00177294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727916|NCT00177294|Serotonin Agents|serotonin agents|mesh-ancestor
92727917|NCT00177294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727918|NCT01082081|Acetaminophen|acetaminophen|mesh-list
92727919|NCT01082081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92727920|NCT01082081|Analgesics|analgesics|mesh-ancestor
92727921|NCT01082081|Sensory System Agents|sensory system agents|mesh-ancestor
92727922|NCT01082081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92727923|NCT01082081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727924|NCT01082081|Antipyretics|antipyretics|mesh-ancestor
92727925|NCT00177216|Zolpidem|zolpidem|mesh-list
92727926|NCT00177216|Escitalopram|escitalopram|mesh-list
92727927|NCT00177216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92727928|NCT00177216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92727929|NCT00177216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92727931|NCT00177216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727939|NCT00177216|GABA Agents|gaba agents|mesh-ancestor
92727940|NCT01081769|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92727941|NCT01081769|Antipsychotic Agents|antipsychotic agents|mesh-list
92727942|NCT01081769|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92727943|NCT01081769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92727944|NCT01081769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92727945|NCT01081769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92727946|NCT01081769|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92727947|NCT01081769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92727948|NCT01081769|Serotonin Agents|serotonin agents|mesh-ancestor
92727949|NCT01081769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92727950|NCT01081769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727951|NCT01081769|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92727952|NCT01081769|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92727953|NCT01081769|Dopamine Agents|dopamine agents|mesh-ancestor
92727954|NCT04551768|Ribavirin|ribavirin|mesh-list
92727956|NCT04551768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727957|NCT04551768|Antiviral Agents|antiviral agents|mesh-ancestor
92727958|NCT04551768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727959|NCT04671563|Tenofovir|tenofovir|mesh-list
92727960|NCT04671563|Antiviral Agents|antiviral agents|mesh-ancestor
92727961|NCT04671563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727962|NCT04671563|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92727963|NCT04671563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727964|NCT04671563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727965|NCT04671563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727966|NCT04671563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92727967|NCT04671563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92727968|NCT04551573|Rifapentine|rifapentine|mesh-list
92727969|NCT04551573|Rifampin|rifampin|mesh-list
92727970|NCT04551573|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92727971|NCT04551573|Antitubercular Agents|antitubercular agents|mesh-ancestor
92753253|NCT05348356|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92753254|NCT05348356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753258|NCT05330130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753259|NCT05330130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753260|NCT05323981|Pertuzumab|pertuzumab|mesh-list
92753261|NCT05323981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753262|NCT05323981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753263|NCT05317364|Estradiol|estradiol|mesh-list
92753264|NCT05317364|Estrogens|estrogens|mesh-ancestor
92753265|NCT05317364|Hormones|hormones|mesh-ancestor
92182559|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727972|NCT04551573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92727973|NCT04551573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92727974|NCT04551573|Leprostatic Agents|leprostatic agents|mesh-ancestor
92727975|NCT04551573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92727976|NCT04551573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727977|NCT04551573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727978|NCT04551573|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92727979|NCT04551573|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92727980|NCT04551573|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92727981|NCT04551573|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92727982|NCT04551573|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92727983|NCT04551573|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92727984|NCT01081145|Guanfacine|guanfacine|mesh-list
92727985|NCT01081145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92727986|NCT01081145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92727987|NCT01081145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92727988|NCT01081145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92727989|NCT01081145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92727990|NCT01081145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753266|NCT05317364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753267|NCT05317364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753268|NCT05313243|Pembrolizumab|pembrolizumab|mesh-list
92753269|NCT05313243|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92753270|NCT05313243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753271|NCT05313243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753272|NCT05313243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753273|NCT05313243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753274|NCT05313243|Immunotoxins|immunotoxins|mesh-ancestor
92753275|NCT05313243|Immunoconjugates|immunoconjugates|mesh-ancestor
92753276|NCT05313243|Immunologic Factors|immunologic factors|mesh-ancestor
92753277|NCT05313243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753278|NCT05313009|Sotorasib|sotorasib|mesh-list
92753279|NCT05313009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753280|NCT05313009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753281|NCT05313009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753282|NCT05313009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753283|NCT05311475|Mometasone Furoate|mometasone furoate|mesh-list
92753284|NCT05311475|Azelastine|azelastine|mesh-list
92753285|NCT05311475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92753286|NCT05311475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92753287|NCT05311475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92753288|NCT05311475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92753289|NCT05311475|Autonomic Agents|autonomic agents|mesh-ancestor
92753290|NCT05311475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753291|NCT05311475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753292|NCT05311475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92753293|NCT05311475|Respiratory System Agents|respiratory system agents|mesh-ancestor
92753294|NCT05311475|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92753295|NCT05311475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753296|NCT05311475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753297|NCT05311475|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92753298|NCT05311475|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92727991|NCT01081145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727993|NCT00174915|Allopurinol|allopurinol|mesh-list
92727994|NCT00174915|Febuxostat|febuxostat|mesh-list
92727995|NCT00174915|Antimetabolites|antimetabolites|mesh-ancestor
92727996|NCT00174915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92727997|NCT00174915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92727998|NCT00174915|Gout Suppressants|gout suppressants|mesh-ancestor
92727999|NCT00174915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728000|NCT00174915|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92728001|NCT00174915|Antioxidants|antioxidants|mesh-ancestor
92728002|NCT00174915|Protective Agents|protective agents|mesh-ancestor
92728003|NCT00174915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728004|NCT01080716|Vaccines|vaccines|mesh-list
92728005|NCT01080716|Complement Factor H|complement factor h|mesh-list
92728006|NCT01080716|Immunologic Factors|immunologic factors|mesh-ancestor
92728007|NCT01080716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728008|NCT01080716|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92728009|NCT01080716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728010|NCT04671446|Autoantibodies|autoantibodies|mesh-list
92728011|NCT04671446|Immunologic Factors|immunologic factors|mesh-ancestor
92728012|NCT04671446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728013|NCT04571489|Gemcitabine|gemcitabine|mesh-list
92728014|NCT04571489|Tegafur|tegafur|mesh-list
92728015|NCT04571489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728016|NCT04571489|Antimetabolites|antimetabolites|mesh-ancestor
92728017|NCT04571489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728018|NCT04571489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728019|NCT00172185|Teduglutide|teduglutide|mesh-list
92728020|NCT00172185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728021|NCT00172185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92728022|NCT00172185|Protective Agents|protective agents|mesh-ancestor
92728023|NCT00172185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728034|NCT01080131|Glucocorticoids|glucocorticoids|mesh-ancestor
92728035|NCT01080131|Hormones|hormones|mesh-ancestor
92728036|NCT01080131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728037|NCT01080131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728038|NCT01080131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728039|NCT01080131|Immunologic Factors|immunologic factors|mesh-ancestor
92728040|NCT01080131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728041|NCT01080131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728042|NCT00171873|Octreotide|octreotide|mesh-list
92728043|NCT00171873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728044|NCT00171873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728045|NCT00171873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728046|NCT01087151|Rituximab|rituximab|mesh-list
92728047|NCT01087151|Navitoclax|navitoclax|mesh-list
92728048|NCT01087151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728049|NCT01087151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728050|NCT01087151|Immunologic Factors|immunologic factors|mesh-ancestor
92728051|NCT01087151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728052|NCT01087151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728053|NCT00171834|Epothilones|epothilones|mesh-list
92728054|NCT00171834|Epothilone B|epothilone b|mesh-list
92728055|NCT00171834|Tubulin Modulators|tubulin modulators|mesh-ancestor
92728056|NCT00171834|Antimitotic Agents|antimitotic agents|mesh-ancestor
92728057|NCT00171834|Mitosis Modulators|mitosis modulators|mesh-ancestor
92728058|NCT00171834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728059|NCT00171834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728060|NCT04571996|Acetaminophen|acetaminophen|mesh-list
92728061|NCT04571996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728062|NCT04571996|Analgesics|analgesics|mesh-ancestor
92728063|NCT04571996|Sensory System Agents|sensory system agents|mesh-ancestor
92753299|NCT05311475|Histamine Antagonists|histamine antagonists|mesh-ancestor
92753300|NCT05311475|Histamine Agents|histamine agents|mesh-ancestor
92753301|NCT05311475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753302|NCT05311176|Paclitaxel|paclitaxel|mesh-list
92753303|NCT05311176|Pembrolizumab|pembrolizumab|mesh-list
92753304|NCT05311176|Ramucirumab|ramucirumab|mesh-list
92753305|NCT05311176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92753306|NCT05311176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753307|NCT05311176|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753308|NCT05311176|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753309|NCT05311176|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753310|NCT05311176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753311|NCT05311176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753312|NCT05311176|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753313|NCT05304767|Xanomeline|xanomeline|mesh-list
92753314|NCT05304767|Trospium chloride|trospium chloride|mesh-list
92753315|NCT05304767|Parasympatholytics|parasympatholytics|mesh-ancestor
92728064|NCT04571996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728065|NCT04571996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728066|NCT04571996|Antipyretics|antipyretics|mesh-ancestor
92728067|NCT00171249|Imatinib Mesylate|imatinib mesylate|mesh-list
92728068|NCT00171249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728069|NCT00171249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728070|NCT00171249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728071|NCT00171249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728072|NCT04671056|Pioglitazone|pioglitazone|mesh-list
92728073|NCT04671056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728074|NCT04671056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728075|NCT01082549|Carboplatin|carboplatin|mesh-list
92728076|NCT01082549|Gemcitabine|gemcitabine|mesh-list
92728077|NCT01082549|Iniparib|iniparib|mesh-list
92728078|NCT01082549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728079|NCT01082549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728080|NCT01082549|Antimetabolites|antimetabolites|mesh-ancestor
92728081|NCT01082549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728082|NCT01082549|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92728083|NCT01082549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753316|NCT05304767|Autonomic Agents|autonomic agents|mesh-ancestor
92753317|NCT05304767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753318|NCT05304767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753319|NCT05304767|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92753320|NCT05304767|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92753321|NCT05304767|Cholinergic Agents|cholinergic agents|mesh-ancestor
92753322|NCT05304767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753323|NCT05304767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753324|NCT05304767|Urological Agents|urological agents|mesh-ancestor
92753325|NCT05304767|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92753331|NCT05302817|Anesthetics, General|anesthetics, general|mesh-ancestor
92753333|NCT05302817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753334|NCT05302817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753335|NCT05289492|Dexamethasone|dexamethasone|mesh-list
92753336|NCT05289492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92753337|NCT05289492|Antiemetics|antiemetics|mesh-ancestor
92753338|NCT05289492|Autonomic Agents|autonomic agents|mesh-ancestor
92753339|NCT05289492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753340|NCT05289492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753341|NCT05289492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92753342|NCT05289492|Glucocorticoids|glucocorticoids|mesh-ancestor
92753343|NCT05289492|Hormones|hormones|mesh-ancestor
92753344|NCT05289492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753345|NCT05289492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92753346|NCT05289492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753347|NCT05286801|Deoxyglucose|deoxyglucose|mesh-list
92753348|NCT05286801|Atezolizumab|atezolizumab|mesh-list
92753349|NCT05286801|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92753350|NCT05286801|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92753351|NCT05286801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753352|NCT05286801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753353|NCT05286801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753354|NCT05286801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753355|NCT05286801|Immunologic Factors|immunologic factors|mesh-ancestor
92728084|NCT04550949|Denosumab|denosumab|mesh-list
92728085|NCT04550949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92728086|NCT04550949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728087|NCT01085630|Pemetrexed|pemetrexed|mesh-list
92728088|NCT01085630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728089|NCT01085630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728090|NCT01085630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728091|NCT01085630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92728092|NCT01085630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92728093|NCT00171210|Deferasirox|deferasirox|mesh-list
92728094|NCT00171210|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92728095|NCT00171210|Chelating Agents|chelating agents|mesh-ancestor
92728096|NCT00171210|Sequestering Agents|sequestering agents|mesh-ancestor
92728097|NCT00171210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728098|NCT00171054|Amlodipine|amlodipine|mesh-list
92728099|NCT00171054|Valsartan|valsartan|mesh-list
92728100|NCT00171054|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92728101|NCT00171054|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92728102|NCT00171054|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92728103|NCT00171054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728104|NCT00171054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728105|NCT00171054|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92728106|NCT00171054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728107|NCT00171054|Vasodilator Agents|vasodilator agents|mesh-ancestor
92728108|NCT00171054|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92728109|NCT00171054|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92728110|NCT00171054|Diuretics|diuretics|mesh-ancestor
92728111|NCT00171054|Natriuretic Agents|natriuretic agents|mesh-ancestor
92728112|NCT00171054|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92728113|NCT00174837|Tirapazamine|tirapazamine|mesh-list
92728114|NCT00174837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728115|NCT00179400|Pioglitazone|pioglitazone|mesh-list
92728116|NCT00179400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728117|NCT00179400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728118|NCT04550793|Botulinum Toxins|botulinum toxins|mesh-list
92728123|NCT04550793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728124|NCT04550793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728126|NCT00479856|Docetaxel|docetaxel|mesh-list
92728127|NCT00479856|Capecitabine|capecitabine|mesh-list
92728128|NCT00479856|Lapatinib|lapatinib|mesh-list
92728129|NCT00479856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92728130|NCT00479856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728131|NCT00479856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92728132|NCT00479856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92728133|NCT00479856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92728134|NCT00479856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728135|NCT00479856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728136|NCT00479856|Antimetabolites|antimetabolites|mesh-ancestor
92728137|NCT00479856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728138|NCT00479856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728139|NCT04997759|Neostigmine|neostigmine|mesh-list
92728140|NCT04997759|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92728141|NCT04997759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728142|NCT04997759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728143|NCT04997759|Cholinergic Agents|cholinergic agents|mesh-ancestor
92728144|NCT04997759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728145|NCT04997759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728146|NCT04997759|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92728147|NCT04997759|Autonomic Agents|autonomic agents|mesh-ancestor
92728148|NCT04997759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728149|NCT00479466|Metformin|metformin|mesh-list
92728150|NCT00479466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753356|NCT05286801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753357|NCT05286801|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92753358|NCT05286801|Antimetabolites|antimetabolites|mesh-ancestor
92753359|NCT05286801|Antiviral Agents|antiviral agents|mesh-ancestor
92753360|NCT05286801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753361|NCT05274048|Trastuzumab|trastuzumab|mesh-list
92753362|NCT05274048|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92753363|NCT05274048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753364|NCT05274048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753365|NCT05274048|Immunoconjugates|immunoconjugates|mesh-ancestor
92753366|NCT05274048|Immunologic Factors|immunologic factors|mesh-ancestor
92753367|NCT05274048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753369|NCT05261399|Pemetrexed|pemetrexed|mesh-list
92753370|NCT05261399|Osimertinib|osimertinib|mesh-list
92753371|NCT05261399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753372|NCT05261399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753373|NCT05261399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753374|NCT05261399|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92753375|NCT05261399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92753376|NCT05261399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753377|NCT05260528|Cytarabine|cytarabine|mesh-list
92728151|NCT00479466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728152|NCT04991948|Pembrolizumab|pembrolizumab|mesh-list
92728153|NCT04991948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728154|NCT04991948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728155|NCT04991948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92728156|NCT04991948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728157|NCT04990778|Venetoclax|venetoclax|mesh-list
92728158|NCT04990778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728160|NCT00479388|Atorvastatin|atorvastatin|mesh-list
92728161|NCT00479388|Simvastatin|simvastatin|mesh-list
92728162|NCT00479388|Calcium|calcium|mesh-list
92728163|NCT00479388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92728164|NCT00479388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728165|NCT00479388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92728166|NCT00479388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92728167|NCT00479388|Antimetabolites|antimetabolites|mesh-ancestor
92728168|NCT00479388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728169|NCT00479388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92728170|NCT00479388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92728171|NCT00479388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728172|NCT00479388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92728173|NCT00479388|Vitamin B Complex|vitamin b complex|mesh-ancestor
92753378|NCT05260528|Idarubicin|idarubicin|mesh-list
92753379|NCT05260528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92753380|NCT05260528|Antimetabolites|antimetabolites|mesh-ancestor
92753381|NCT05260528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753382|NCT05260528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753383|NCT05260528|Antiviral Agents|antiviral agents|mesh-ancestor
92753384|NCT05260528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753385|NCT05260528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753386|NCT05260528|Immunologic Factors|immunologic factors|mesh-ancestor
92753387|NCT05260528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753388|NCT05260528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92753389|NCT05260528|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92753390|NCT05260528|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92753391|NCT05260528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753392|NCT05255666|Pembrolizumab|pembrolizumab|mesh-list
92753393|NCT05255666|Irinotecan|irinotecan|mesh-list
92753394|NCT05255666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753395|NCT05255666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753396|NCT05255666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753397|NCT05255666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753405|NCT05255146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753406|NCT05255146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753407|NCT05255146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753408|NCT05255146|Analgesics|analgesics|mesh-ancestor
92753409|NCT05255146|Sensory System Agents|sensory system agents|mesh-ancestor
92753410|NCT05255146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753411|NCT05254743|Pirtobrutinib|pirtobrutinib|mesh-list
92753412|NCT05254743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728174|NCT00479388|Vitamins|vitamins|mesh-ancestor
92728175|NCT00479388|Micronutrients|micronutrients|mesh-ancestor
92728176|NCT00479232|Decitabine|decitabine|mesh-list
92728177|NCT00479232|Vorinostat|vorinostat|mesh-list
92728178|NCT00479232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728179|NCT00479232|Antimetabolites|antimetabolites|mesh-ancestor
92728180|NCT00479232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728181|NCT00479232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728182|NCT00479232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728183|NCT00479232|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92728184|NCT00478881|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92728185|NCT00478881|Vasodilator Agents|vasodilator agents|mesh-ancestor
92728186|NCT00478881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92728187|NCT00478881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92728188|NCT00478881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728189|NCT00478881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728190|NCT00478881|Urological Agents|urological agents|mesh-ancestor
92728191|NCT00556127|Cytarabine|cytarabine|mesh-list
92728192|NCT00556127|Dexamethasone|dexamethasone|mesh-list
92728193|NCT00556127|Prednisone|prednisone|mesh-list
92728194|NCT00556127|Cyclophosphamide|cyclophosphamide|mesh-list
92728195|NCT00556127|Melphalan|melphalan|mesh-list
92728196|NCT00556127|Carmustine|carmustine|mesh-list
92728197|NCT00556127|Rituximab|rituximab|mesh-list
92753413|NCT05254743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753414|NCT05254743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753415|NCT05198609|Apatinib|apatinib|mesh-list
92753416|NCT05198609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753417|NCT05198609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753418|NCT05198609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753419|NCT05198609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753420|NCT05191004|Fulvestrant|fulvestrant|mesh-list
92753421|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92753422|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753423|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92753424|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92753425|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92753426|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753427|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753428|NCT05185089|Maleic acid|maleic acid|mesh-list
92753429|NCT05185089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753430|NCT05185089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753431|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92753432|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
92753433|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753434|NCT05157672|Letrozole|letrozole|mesh-list
92753435|NCT05157672|Nicotine|nicotine|mesh-list
92753436|NCT05157672|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92753437|NCT05157672|Autonomic Agents|autonomic agents|mesh-ancestor
92753438|NCT05157672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753439|NCT05157672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753440|NCT05157672|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92728199|NCT00556127|Vincristine|vincristine|mesh-list
92728200|NCT00556127|Epirubicin|epirubicin|mesh-list
92728201|NCT00556127|Mitoxantrone|mitoxantrone|mesh-list
92728202|NCT00556127|Lenograstim|lenograstim|mesh-list
92728203|NCT00556127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728204|NCT00556127|Immunologic Factors|immunologic factors|mesh-ancestor
92728205|NCT00556127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728206|NCT00556127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728207|NCT00556127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92728208|NCT00556127|Alkylating Agents|alkylating agents|mesh-ancestor
92401011|NCT01413230|Micronutrients|micronutrients|mesh-ancestor
92728209|NCT00556127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728210|NCT00556127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728211|NCT00556127|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92728212|NCT00556127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728213|NCT00556127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728214|NCT00556127|Antiemetics|antiemetics|mesh-ancestor
92728215|NCT00556127|Autonomic Agents|autonomic agents|mesh-ancestor
92728216|NCT00556127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728217|NCT00556127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728218|NCT00556127|Glucocorticoids|glucocorticoids|mesh-ancestor
92728219|NCT00556127|Hormones|hormones|mesh-ancestor
92753441|NCT05157672|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92753442|NCT05157672|Cholinergic Agents|cholinergic agents|mesh-ancestor
92753443|NCT05157672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753444|NCT05157672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753445|NCT05157672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753446|NCT05157672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92753447|NCT05157672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92753448|NCT05157672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753449|NCT05157672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92753450|NCT05157672|Hormone Antagonists|hormone antagonists|mesh-ancestor
92753451|NCT05157672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753452|NCT05145413|Xanomeline|xanomeline|mesh-list
92753453|NCT05145413|Trospium chloride|trospium chloride|mesh-list
92753454|NCT05145413|Parasympatholytics|parasympatholytics|mesh-ancestor
92753455|NCT05145413|Autonomic Agents|autonomic agents|mesh-ancestor
92753456|NCT05145413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753457|NCT05145413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753458|NCT05145413|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92753459|NCT05145413|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92753460|NCT05145413|Cholinergic Agents|cholinergic agents|mesh-ancestor
92753461|NCT05145413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753462|NCT05145413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753463|NCT05145413|Urological Agents|urological agents|mesh-ancestor
92753464|NCT05145413|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92753466|NCT05145413|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92753467|NCT05145413|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92753468|NCT05111145|Ivacaftor|ivacaftor|mesh-list
92753469|NCT05111145|Elexacaftor|elexacaftor|mesh-list
92753470|NCT05111145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92753471|NCT05111145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92753472|NCT05111145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753473|NCT05090033|Ofatumumab|ofatumumab|mesh-list
92753474|NCT05090033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728220|NCT00556127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728221|NCT00556127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728222|NCT00556127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92728223|NCT00556127|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92728224|NCT00556127|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92728225|NCT00556127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728226|NCT00556127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728227|NCT00556127|Antimetabolites|antimetabolites|mesh-ancestor
92728228|NCT00556127|Antiviral Agents|antiviral agents|mesh-ancestor
92728229|NCT00556127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728230|NCT00556127|Tubulin Modulators|tubulin modulators|mesh-ancestor
92728231|NCT00556127|Antimitotic Agents|antimitotic agents|mesh-ancestor
92728232|NCT00556127|Mitosis Modulators|mitosis modulators|mesh-ancestor
92728233|NCT00556127|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92728234|NCT00556127|Analgesics|analgesics|mesh-ancestor
92728235|NCT00556127|Sensory System Agents|sensory system agents|mesh-ancestor
92728236|NCT00556127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92728237|NCT00556205|Bevacizumab|bevacizumab|mesh-list
92728238|NCT00556205|Sunitinib|sunitinib|mesh-list
92728239|NCT00556205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728240|NCT00556205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728241|NCT00556205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92728242|NCT00556205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92753475|NCT05060432|Pembrolizumab|pembrolizumab|mesh-list
92753476|NCT05060432|Dostarlimab|dostarlimab|mesh-list
92753477|NCT05060432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753478|NCT05060432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753479|NCT05060432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753480|NCT05060432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753481|NCT05047172|Aspirin|aspirin|mesh-list
92753482|NCT05047172|Rivaroxaban|rivaroxaban|mesh-list
92753483|NCT05047172|Clopidogrel|clopidogrel|mesh-list
92753484|NCT05047172|Ticagrelor|ticagrelor|mesh-list
92753485|NCT05047172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92753486|NCT05047172|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753487|NCT05047172|Analgesics|analgesics|mesh-ancestor
92753488|NCT05047172|Sensory System Agents|sensory system agents|mesh-ancestor
92753489|NCT05047172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753490|NCT05047172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753491|NCT05047172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92753492|NCT05047172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753493|NCT05047172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92753494|NCT05047172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92753495|NCT05047172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753496|NCT05047172|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92753497|NCT05047172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92753498|NCT05047172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753499|NCT05047172|Antipyretics|antipyretics|mesh-ancestor
92753500|NCT05047172|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92753501|NCT05047172|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92753502|NCT05047172|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92728243|NCT00556205|Growth Substances|growth substances|mesh-ancestor
92728244|NCT00556205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728245|NCT00556205|Growth Inhibitors|growth inhibitors|mesh-ancestor
92728246|NCT00556205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728247|NCT00556205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728248|NCT00556205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728249|NCT00478608|Sirolimus|sirolimus|mesh-list
92728250|NCT00478608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92728251|NCT00478608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728252|NCT00478608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92728253|NCT00478608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728254|NCT00478608|Antifungal Agents|antifungal agents|mesh-ancestor
92728255|NCT00478608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728256|NCT00478608|Immunologic Factors|immunologic factors|mesh-ancestor
92728257|NCT00478608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728258|NCT00478140|Trastuzumab|trastuzumab|mesh-list
92728259|NCT00478140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728260|NCT00478140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728262|NCT00478023|Tapentadol|tapentadol|mesh-list
92728263|NCT00478023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92728264|NCT00478023|Narcotics|narcotics|mesh-ancestor
92728265|NCT00478023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728266|NCT00478023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728267|NCT00478023|Analgesics|analgesics|mesh-ancestor
92728268|NCT00478023|Sensory System Agents|sensory system agents|mesh-ancestor
92728269|NCT00478023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728270|NCT00478023|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92728271|NCT00478023|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92728272|NCT00478023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92327599|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753503|NCT05047172|Purinergic Agents|purinergic agents|mesh-ancestor
92753504|NCT05047172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753505|NCT05047172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92753506|NCT05047172|Antithrombins|antithrombins|mesh-ancestor
92753507|NCT05047172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92753508|NCT05047172|Protease Inhibitors|protease inhibitors|mesh-ancestor
92753509|NCT05047172|Anticoagulants|anticoagulants|mesh-ancestor
92753510|NCT05043090|Durvalumab|durvalumab|mesh-list
92753511|NCT05043090|Sunitinib|sunitinib|mesh-list
92753512|NCT05043090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753513|NCT05043090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753514|NCT05043090|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92753515|NCT05043090|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92753516|NCT05043090|Growth Substances|growth substances|mesh-ancestor
92728273|NCT00478023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728274|NCT00478023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92728275|NCT00478023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728276|NCT00477750|Prednisone|prednisone|mesh-list
92728277|NCT00477750|Lenalidomide|lenalidomide|mesh-list
92728278|NCT00477750|Melphalan|melphalan|mesh-list
92728279|NCT00477750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728280|NCT00477750|Glucocorticoids|glucocorticoids|mesh-ancestor
92728281|NCT00477750|Hormones|hormones|mesh-ancestor
92728282|NCT00477750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728283|NCT00477750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728284|NCT00477750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728285|NCT00477750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728286|NCT00477750|Immunologic Factors|immunologic factors|mesh-ancestor
92728287|NCT00477750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92728288|NCT00477750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92728289|NCT00477750|Growth Substances|growth substances|mesh-ancestor
92728290|NCT00477750|Growth Inhibitors|growth inhibitors|mesh-ancestor
92728291|NCT00477750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92728292|NCT00477750|Alkylating Agents|alkylating agents|mesh-ancestor
92728293|NCT00477750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728294|NCT00477750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92728295|NCT00477750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728296|NCT00477672|Pimavanserin|pimavanserin|mesh-list
92728297|NCT00477672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92728298|NCT00477672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92728299|NCT00477672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92728300|NCT00477672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92728301|NCT00477672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728302|NCT00477672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728303|NCT00477672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92728304|NCT00477672|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92728305|NCT00477672|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92753517|NCT05043090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753518|NCT05043090|Growth Inhibitors|growth inhibitors|mesh-ancestor
92753519|NCT05043090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753520|NCT05043090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753521|NCT05043090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753522|NCT05036278|Factor VIII|factor viii|mesh-list
92753523|NCT05036278|Coagulants|coagulants|mesh-ancestor
92753524|NCT05023980|Rituximab|rituximab|mesh-list
92728306|NCT00477672|Serotonin Agents|serotonin agents|mesh-ancestor
92728307|NCT00477672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728308|NCT00477672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728309|NCT04549935|Prednisolone|prednisolone|mesh-list
92728310|NCT04549935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728311|NCT04549935|Glucocorticoids|glucocorticoids|mesh-ancestor
92728312|NCT04549935|Hormones|hormones|mesh-ancestor
92728313|NCT04549935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728314|NCT04549935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728315|NCT04549935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728316|NCT04549935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728317|NCT00477633|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92728318|NCT00477633|Norethindrone|norethindrone|mesh-list
92728319|NCT00477633|Norethindrone Acetate|norethindrone acetate|mesh-list
92728320|NCT00477633|Estradiol|estradiol|mesh-list
92728321|NCT00477633|Estrogens|estrogens|mesh-ancestor
92728322|NCT00477633|Hormones|hormones|mesh-ancestor
92728323|NCT00477633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728324|NCT00477633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728325|NCT00477633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92728326|NCT00477633|Contraceptive Agents|contraceptive agents|mesh-ancestor
92728327|NCT00477633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92728328|NCT00477633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92753525|NCT05023980|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92753526|NCT05023980|Pirtobrutinib|pirtobrutinib|mesh-list
92753527|NCT05023980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753528|NCT05023980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753529|NCT05023980|Immunologic Factors|immunologic factors|mesh-ancestor
92753530|NCT05023980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753531|NCT05023980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753532|NCT05023980|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92753533|NCT05023980|Alkylating Agents|alkylating agents|mesh-ancestor
92753534|NCT05023980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753535|NCT05023980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753536|NCT05023980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753537|NCT05013229|Insulin|insulin|mesh-list
92753538|NCT05013229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92753543|NCT05007522|Ketotifen|ketotifen|mesh-list
92753544|NCT05007522|Indomethacin|indomethacin|mesh-list
92753545|NCT05007522|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92753546|NCT05007522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753547|NCT05007522|Analgesics|analgesics|mesh-ancestor
92753548|NCT05007522|Sensory System Agents|sensory system agents|mesh-ancestor
92753549|NCT05007522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753550|NCT05007522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753551|NCT05007522|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92753552|NCT05007522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753553|NCT05007522|Gout Suppressants|gout suppressants|mesh-ancestor
92753554|NCT05007522|Tocolytic Agents|tocolytic agents|mesh-ancestor
92753555|NCT05007522|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92753556|NCT05007522|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92753557|NCT05007522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728329|NCT00477633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92728330|NCT00477633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92728331|NCT00477633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92728332|NCT04541823|Propofol|propofol|mesh-list
92728333|NCT04541823|Desflurane|desflurane|mesh-list
92728334|NCT04541823|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92728335|NCT04541823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728336|NCT04541823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728337|NCT04541823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92728338|NCT04541823|Anesthetics, General|anesthetics, general|mesh-ancestor
92728339|NCT04541823|Anesthetics|anesthetics|mesh-ancestor
92728395|NCT04541277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728396|NCT04541277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728397|NCT04541277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92728398|NCT04541277|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92728399|NCT04541277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92728400|NCT04541277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92728401|NCT04995653|Vancomycin|vancomycin|mesh-list
92728402|NCT04995653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92728403|NCT04995653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728404|NCT04540926|Cyclosporine|cyclosporine|mesh-list
92728405|NCT04540926|Cyclosporins|cyclosporins|mesh-list
92728406|NCT04540926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728407|NCT04540926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728408|NCT04540926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728409|NCT04540926|Immunologic Factors|immunologic factors|mesh-ancestor
92728410|NCT04540926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728411|NCT04540926|Antifungal Agents|antifungal agents|mesh-ancestor
92728412|NCT04540926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728413|NCT04540926|Dermatologic Agents|dermatologic agents|mesh-ancestor
92728414|NCT04540926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728415|NCT04540926|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92753558|NCT05007522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753559|NCT05007522|Antipruritics|antipruritics|mesh-ancestor
92753560|NCT05007522|Dermatologic Agents|dermatologic agents|mesh-ancestor
92753561|NCT05007522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92753562|NCT05007522|Histamine Antagonists|histamine antagonists|mesh-ancestor
92753563|NCT05007522|Histamine Agents|histamine agents|mesh-ancestor
92753564|NCT05007522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753565|NCT05007522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92753566|NCT05003349|Salicylic Acid|salicylic acid|mesh-list
92753567|NCT05003349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753568|NCT05003349|Antifungal Agents|antifungal agents|mesh-ancestor
92753569|NCT05003349|Keratolytic Agents|keratolytic agents|mesh-ancestor
92753570|NCT05003349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92753571|NCT04999202|Pembrolizumab|pembrolizumab|mesh-list
92753572|NCT04999202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753573|NCT04999202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753574|NCT04999202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753575|NCT04999202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753576|NCT04952779|Insulin|insulin|mesh-list
92753577|NCT04952779|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92753578|NCT04952779|Liraglutide|liraglutide|mesh-list
92753579|NCT04952779|Insulin, Long-Acting|insulin, long-acting|mesh-list
92753580|NCT04952779|Xultophy|xultophy|mesh-list
92753581|NCT04952779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753582|NCT04952779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753583|NCT04952779|Incretins|incretins|mesh-ancestor
92753584|NCT04952779|Hormones|hormones|mesh-ancestor
92753585|NCT04952779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753586|NCT04941573|Xenon|xenon|mesh-list
92753587|NCT04941573|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92753588|NCT04941573|Anesthetics, General|anesthetics, general|mesh-ancestor
92753589|NCT04941573|Anesthetics|anesthetics|mesh-ancestor
92753590|NCT04941573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728416|NCT04540965|Famotidine|famotidine|mesh-list
92728417|NCT04540965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92728418|NCT04540965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728419|NCT04540965|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92728420|NCT04540965|Histamine Antagonists|histamine antagonists|mesh-ancestor
92728421|NCT04540965|Histamine Agents|histamine agents|mesh-ancestor
92728422|NCT04540965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728423|NCT04540965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728424|NCT04540965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728425|NCT04570865|Dapagliflozin|dapagliflozin|mesh-list
92728426|NCT04570865|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92728427|NCT04570865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728428|NCT04570865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728429|NCT04570865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728430|NCT04570592|Dexamethasone|dexamethasone|mesh-list
92728431|NCT04570592|Granisetron|granisetron|mesh-list
92728432|NCT04570592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92728433|NCT04570592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728434|NCT04570592|Antiemetics|antiemetics|mesh-ancestor
92728435|NCT04570592|Autonomic Agents|autonomic agents|mesh-ancestor
92728436|NCT04570592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728437|NCT04570592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728438|NCT04570592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728439|NCT04570592|Glucocorticoids|glucocorticoids|mesh-ancestor
92728440|NCT04570592|Hormones|hormones|mesh-ancestor
92728441|NCT04570592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728442|NCT04570592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728443|NCT04570592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728444|NCT04570592|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92753591|NCT04941573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753592|NCT04926948|Immunomodulating Agents|immunomodulating agents|mesh-list
92753593|NCT04926948|Immunologic Factors|immunologic factors|mesh-ancestor
92753594|NCT04926948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753596|NCT04900623|Cisplatin|cisplatin|mesh-list
92753597|NCT04900623|Carboplatin|carboplatin|mesh-list
92753598|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92753599|NCT04900623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753600|NCT04900623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753601|NCT04900623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753602|NCT04900623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753603|NCT04900623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753604|NCT04899050|Cannabidiol|cannabidiol|mesh-list
92753605|NCT04899050|Anticonvulsants|anticonvulsants|mesh-ancestor
92753606|NCT04876781|Tofacitinib|tofacitinib|mesh-list
92753607|NCT04876781|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92728445|NCT04570592|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92728446|NCT04570592|Serotonin Agents|serotonin agents|mesh-ancestor
92728447|NCT04570592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728448|NCT04570592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728449|NCT02215395|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92728450|NCT02215395|Contraceptive Agents|contraceptive agents|mesh-list
92728451|NCT02215395|Estradiol|estradiol|mesh-list
92728452|NCT02215395|Estrogens|estrogens|mesh-ancestor
92728453|NCT02215395|Hormones|hormones|mesh-ancestor
92728454|NCT02215395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728455|NCT02215395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728456|NCT02215395|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92728457|NCT02215395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92728458|NCT02215395|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92728459|NCT02215395|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92728460|NCT02215395|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92728461|NCT02215434|Methyltestosterone|methyltestosterone|mesh-list
92728462|NCT02215434|Testosterone|testosterone|mesh-list
92728463|NCT02215434|Testosterone undecanoate|testosterone undecanoate|mesh-list
92728464|NCT02215434|Testosterone enanthate|testosterone enanthate|mesh-list
92728465|NCT02215434|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92728466|NCT02215434|Androgens|androgens|mesh-ancestor
92728467|NCT02215434|Hormones|hormones|mesh-ancestor
92728468|NCT02215434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728469|NCT02215434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728470|NCT02215434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728471|NCT02215434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728472|NCT02215434|Anabolic Agents|anabolic agents|mesh-ancestor
92728473|NCT04561076|Myeloma Proteins|myeloma proteins|mesh-list
92728474|NCT04561076|Paraproteins|paraproteins|mesh-list
92728475|NCT04561076|Immunologic Factors|immunologic factors|mesh-ancestor
92753608|NCT04876781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753609|NCT04876781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753610|NCT04876781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753611|NCT04854499|Carboplatin|carboplatin|mesh-list
92753612|NCT04854499|Docetaxel|docetaxel|mesh-list
92753613|NCT04854499|Pembrolizumab|pembrolizumab|mesh-list
92753619|NCT04854499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753620|NCT04854499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753621|NCT04854499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753622|NCT04818216|Niacinamide|niacinamide|mesh-list
92753623|NCT04818216|Niacin|niacin|mesh-list
92753624|NCT04818216|Nicotinic Acids|nicotinic acids|mesh-list
92753625|NCT04818216|Vitamin B Complex|vitamin b complex|mesh-ancestor
92753626|NCT04818216|Vitamins|vitamins|mesh-ancestor
92728476|NCT04561076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728478|NCT02215473|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92728479|NCT02215473|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92728480|NCT02215473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728481|NCT02215473|Disinfectants|disinfectants|mesh-ancestor
92728482|NCT02215473|Dermatologic Agents|dermatologic agents|mesh-ancestor
92728483|NCT04548219|Mirikizumab|mirikizumab|mesh-list
92728484|NCT04548219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92728485|NCT04548219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728486|NCT04548219|Analgesics|analgesics|mesh-ancestor
92728487|NCT04548219|Sensory System Agents|sensory system agents|mesh-ancestor
92728488|NCT04548219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728489|NCT04548219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728490|NCT04548219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728491|NCT04548219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728492|NCT04548219|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92728493|NCT04548219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728494|NCT04547829|Lenograstim|lenograstim|mesh-list
92728495|NCT04547829|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92753627|NCT04818216|Micronutrients|micronutrients|mesh-ancestor
92753628|NCT04818216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753629|NCT04818216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92753630|NCT04818216|Antimetabolites|antimetabolites|mesh-ancestor
92753631|NCT04818216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753632|NCT04818216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92753633|NCT04818216|Vasodilator Agents|vasodilator agents|mesh-ancestor
92753634|NCT04808622|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92753635|NCT04808622|Antioxidants|antioxidants|mesh-ancestor
92753636|NCT04808622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753637|NCT04808622|Protective Agents|protective agents|mesh-ancestor
92753638|NCT04808622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753639|NCT04808622|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92753640|NCT04808622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753641|NCT04798339|Darbepoetin alfa|darbepoetin alfa|mesh-list
92753642|NCT04798339|Hematinics|hematinics|mesh-ancestor
92753643|NCT04783675|Rituximab|rituximab|mesh-list
92753644|NCT04783675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753645|NCT04783675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753646|NCT04783675|Immunologic Factors|immunologic factors|mesh-ancestor
92753647|NCT04783675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753648|NCT04783675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753649|NCT04708782|Treprostinil|treprostinil|mesh-list
92753650|NCT04708782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92753651|NCT04699838|Carboplatin|carboplatin|mesh-list
92753652|NCT04699838|Etoposide|etoposide|mesh-list
92753653|NCT04699838|Durvalumab|durvalumab|mesh-list
92753654|NCT04699838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753655|NCT04699838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92753656|NCT04699838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92753657|NCT04699838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92753658|NCT04699838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753659|NCT04699838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753660|NCT04699838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753661|NCT04695080|Cladribine|cladribine|mesh-list
92753662|NCT04695080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728496|NCT04547829|Immunologic Factors|immunologic factors|mesh-ancestor
92728497|NCT04547829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728498|NCT02211911|Bisacodyl|bisacodyl|mesh-list
92728499|NCT02211911|Picosulfate sodium|picosulfate sodium|mesh-list
92728500|NCT02211911|Cathartics|cathartics|mesh-ancestor
92728501|NCT02211911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728502|NCT02211911|Laxatives|laxatives|mesh-ancestor
92728503|NCT01131676|Empagliflozin|empagliflozin|mesh-list
92728504|NCT01131676|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92728505|NCT01131676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728506|NCT01131676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728507|NCT01131676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728508|NCT04560569|Antibodies|antibodies|mesh-list
92728509|NCT04560569|Immunologic Factors|immunologic factors|mesh-ancestor
92728510|NCT04560569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728511|NCT04560101|Botulinum Toxins|botulinum toxins|mesh-list
92728512|NCT04560101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92728513|NCT04560101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92728514|NCT04560101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92728515|NCT04560101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728516|NCT04560101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728517|NCT04560101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92728518|NCT04560101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728519|NCT04560101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728520|NCT04560101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92728521|NCT04560101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753663|NCT04695080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753664|NCT04695080|Immunologic Factors|immunologic factors|mesh-ancestor
92753665|NCT04695080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753666|NCT04662255|Acalabrutinib|acalabrutinib|mesh-list
92753667|NCT04662255|Zanubrutinib|zanubrutinib|mesh-list
92753668|NCT04662255|Pirtobrutinib|pirtobrutinib|mesh-list
92753669|NCT04662255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753670|NCT04662255|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753671|NCT04662255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753672|NCT04662255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753673|NCT04591353|Lidocaine|lidocaine|mesh-list
92753674|NCT04591353|Anesthetics, Local|anesthetics, local|mesh-ancestor
92753675|NCT04591353|Anesthetics|anesthetics|mesh-ancestor
92753676|NCT04591353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753677|NCT04591353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753678|NCT04591353|Sensory System Agents|sensory system agents|mesh-ancestor
92753679|NCT04591353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753680|NCT04591353|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92753681|NCT04591353|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92753682|NCT04591353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92753683|NCT04591353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92753684|NCT04591353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728522|NCT02214498|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92728523|NCT02214498|Enalapril|enalapril|mesh-list
92728524|NCT02214498|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92728525|NCT02214498|Diuretics|diuretics|mesh-ancestor
92728526|NCT02214498|Natriuretic Agents|natriuretic agents|mesh-ancestor
92728527|NCT02214498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728528|NCT02214498|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92728529|NCT02214498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728530|NCT02214498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728531|NCT02214498|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92728532|NCT02214498|Protease Inhibitors|protease inhibitors|mesh-ancestor
92728533|NCT02214498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728534|NCT04560218|Misoprostol|misoprostol|mesh-list
92728535|NCT04560218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92728536|NCT04560218|Abortifacient Agents|abortifacient agents|mesh-ancestor
92728537|NCT04560218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92728538|NCT04560218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728539|NCT04560218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92728540|NCT04560218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728541|NCT04560218|Oxytocics|oxytocics|mesh-ancestor
92728542|NCT05135104|Palbociclib|palbociclib|mesh-list
92728543|NCT05135104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728544|NCT05135104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728545|NCT05135104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753685|NCT04540211|Paclitaxel|paclitaxel|mesh-list
92753687|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92753688|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92753689|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753690|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753691|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753692|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753693|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753694|NCT04540211|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753695|NCT04540211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753696|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
92753697|NCT04540211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753698|NCT04505774|Dapagliflozin|dapagliflozin|mesh-list
92753699|NCT04505774|Empagliflozin|empagliflozin|mesh-list
92753700|NCT04505774|Canagliflozin|canagliflozin|mesh-list
92753701|NCT04505774|Ertugliflozin|ertugliflozin|mesh-list
92753702|NCT04505774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92753703|NCT04505774|Heparin|heparin|mesh-list
92753704|NCT04505774|Calcium heparin|calcium heparin|mesh-list
92753705|NCT04505774|Enoxaparin|enoxaparin|mesh-list
92753706|NCT04505774|Dalteparin|dalteparin|mesh-list
92753707|NCT04505774|Tinzaparin|tinzaparin|mesh-list
92753708|NCT04505774|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92753709|NCT04505774|Enoxaparin sodium|enoxaparin sodium|mesh-list
92753710|NCT04505774|Clopidogrel|clopidogrel|mesh-list
92753711|NCT04505774|Ticagrelor|ticagrelor|mesh-list
92753712|NCT04505774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92753713|NCT04505774|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92728546|NCT05135104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728547|NCT04540185|Neuroprotective Agents|neuroprotective agents|mesh-list
92728548|NCT04540185|Vaccines|vaccines|mesh-list
92728549|NCT04540185|Immunologic Factors|immunologic factors|mesh-ancestor
92728550|NCT04540185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728551|NCT04540185|Protective Agents|protective agents|mesh-ancestor
92728552|NCT01130272|Eluxadoline|eluxadoline|mesh-list
92728553|NCT01130272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728554|NCT04546815|Daptomycin|daptomycin|mesh-list
92728555|NCT04546815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92728556|NCT04546815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728557|NCT01129960|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92728558|NCT01129960|Anticonvulsants|anticonvulsants|mesh-ancestor
92728559|NCT01129960|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92728560|NCT01129960|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92728561|NCT01129960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728562|NCT01129960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728563|NCT04559165|Chitosan|chitosan|mesh-list
92728564|NCT04559165|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92728565|NCT04559165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92728566|NCT04559165|Antimetabolites|antimetabolites|mesh-ancestor
92728567|NCT04559165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728568|NCT04559165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92728569|NCT04559165|Chelating Agents|chelating agents|mesh-ancestor
92728570|NCT04559165|Sequestering Agents|sequestering agents|mesh-ancestor
92728571|NCT04559165|Hemostatics|hemostatics|mesh-ancestor
92728572|NCT04559165|Coagulants|coagulants|mesh-ancestor
92728573|NCT04312048|Isosorbide|isosorbide|mesh-list
92728574|NCT04312048|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92728575|NCT04312048|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92728576|NCT04312048|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92728577|NCT04312048|Diuretics|diuretics|mesh-ancestor
92753714|NCT04505774|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92753715|NCT04505774|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92753716|NCT04505774|Purinergic Agents|purinergic agents|mesh-ancestor
92753717|NCT04505774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753718|NCT04505774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753719|NCT04505774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753720|NCT04505774|Anticoagulants|anticoagulants|mesh-ancestor
92753721|NCT04505774|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92753722|NCT04505774|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92753723|NCT04505774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753724|NCT04499950|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
92753725|NCT04499950|Naltrexone|naltrexone|mesh-list
92753726|NCT04499950|Bupropion|bupropion|mesh-list
92728578|NCT04312048|Natriuretic Agents|natriuretic agents|mesh-ancestor
92728579|NCT04312048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728580|NCT04312048|Vasodilator Agents|vasodilator agents|mesh-ancestor
92728581|NCT04312048|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92728582|NCT04312048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753727|NCT04499950|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92753728|NCT04499950|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92753729|NCT04499950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753730|NCT04499950|Sensory System Agents|sensory system agents|mesh-ancestor
92753731|NCT04499950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753732|NCT04499950|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92753733|NCT04499950|Antidepressive Agents|antidepressive agents|mesh-ancestor
92753734|NCT04499950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92753735|NCT04499950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92401088|NCT01414231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92753736|NCT04499950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92753737|NCT04499950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92753738|NCT04499950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753740|NCT04499950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753741|NCT04499950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92753742|NCT04499950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92753743|NCT04499950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753744|NCT04499950|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92753745|NCT04444492|Ranibizumab|ranibizumab|mesh-list
92753746|NCT04444492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92753747|NCT04444492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92753748|NCT04444492|Growth Substances|growth substances|mesh-ancestor
92753749|NCT04444492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753750|NCT04444492|Growth Inhibitors|growth inhibitors|mesh-ancestor
92753751|NCT04444492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753752|NCT04402385|Aspirin|aspirin|mesh-list
92753753|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92753754|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753755|NCT04402385|Analgesics|analgesics|mesh-ancestor
92753756|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
92753757|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753758|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753764|NCT04402385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92753765|NCT04402385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92753767|NCT04402385|Antipyretics|antipyretics|mesh-ancestor
92753768|NCT04396730|Cannabidiol|cannabidiol|mesh-list
92753769|NCT04396730|Contraceptive Agents|contraceptive agents|mesh-list
92753770|NCT04396730|Contraceptives, Oral|contraceptives, oral|mesh-list
92753771|NCT04396730|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92753772|NCT04396730|Anticonvulsants|anticonvulsants|mesh-ancestor
92753773|NCT04396730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92753774|NCT04396730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753775|NCT04396730|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92753776|NCT04394858|Temozolomide|temozolomide|mesh-list
92753777|NCT04394858|Olaparib|olaparib|mesh-list
92753778|NCT04394858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92753779|NCT04394858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92753780|NCT04394858|Alkylating Agents|alkylating agents|mesh-ancestor
92753781|NCT04394858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753782|NCT04394858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753783|NCT04394858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753784|NCT04385368|Durvalumab|durvalumab|mesh-list
92753785|NCT04385368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753786|NCT04385368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753787|NCT04378868|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92753788|NCT04378868|Metronidazole|metronidazole|mesh-list
92753789|NCT04378868|Cefuroxime|cefuroxime|mesh-list
92753790|NCT04378868|Cefuroxime axetil|cefuroxime axetil|mesh-list
92753791|NCT04378868|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92753792|NCT04378868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753793|NCT04378868|Antitubercular Agents|antitubercular agents|mesh-ancestor
92753794|NCT04378868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92753795|NCT04378868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92728583|NCT04311697|Phentolamine|phentolamine|mesh-list
92728584|NCT04311697|Vasoactive Intestinal Peptide|vasoactive intestinal peptide|mesh-list
92728585|NCT04311697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92728586|NCT04311697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92728587|NCT04311697|Adrenergic Agents|adrenergic agents|mesh-ancestor
92728588|NCT04311697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728589|NCT04311697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728590|NCT04311697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728591|NCT04311697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92728592|NCT04311697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728593|NCT04311697|Vasodilator Agents|vasodilator agents|mesh-ancestor
92753796|NCT04345913|Halichondrin B|halichondrin b|mesh-list
92753797|NCT04345913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753798|NCT04345913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753799|NCT04345913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753800|NCT04345913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753801|NCT04345913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753802|NCT04300556|Farletuzumab|farletuzumab|mesh-list
92753803|NCT04300556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753804|NCT04251585|Insulin|insulin|mesh-list
92753805|NCT04251585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753806|NCT04251585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753807|NCT04218357|Probenecid|probenecid|mesh-list
92753808|NCT04218357|Uricosuric Agents|uricosuric agents|mesh-ancestor
92753809|NCT04218357|Gout Suppressants|gout suppressants|mesh-ancestor
92753810|NCT04218357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753811|NCT04166877|Magnesium Sulfate|magnesium sulfate|mesh-list
92753812|NCT04166877|Analgesics|analgesics|mesh-ancestor
92753813|NCT04166877|Sensory System Agents|sensory system agents|mesh-ancestor
92753814|NCT04166877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753815|NCT04166877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753816|NCT04166877|Anesthetics|anesthetics|mesh-ancestor
92753817|NCT04166877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753818|NCT04166877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92753819|NCT04166877|Anticonvulsants|anticonvulsants|mesh-ancestor
92753820|NCT04166877|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92753821|NCT04166877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92753822|NCT04166877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753823|NCT04166877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92753825|NCT04166877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92753826|NCT04164979|Pembrolizumab|pembrolizumab|mesh-list
92753827|NCT04164979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753828|NCT04164979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753829|NCT04164979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753843|NCT04135846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753844|NCT04135846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753845|NCT04135846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753846|NCT04117893|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92753847|NCT04117893|Hyaluronic Acid|hyaluronic acid|mesh-list
92753848|NCT04117893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92753849|NCT04117893|Immunologic Factors|immunologic factors|mesh-ancestor
92753850|NCT04117893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753851|NCT04117893|Viscosupplements|viscosupplements|mesh-ancestor
92753852|NCT04117893|Protective Agents|protective agents|mesh-ancestor
92753853|NCT04117893|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92753854|NCT04117893|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92753855|NCT04117893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92753856|NCT04117893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753857|NCT04117893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753858|NCT04117893|Analgesics|analgesics|mesh-ancestor
92753859|NCT04117893|Sensory System Agents|sensory system agents|mesh-ancestor
92753860|NCT04117893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728594|NCT04311697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92728595|NCT04311697|Protective Agents|protective agents|mesh-ancestor
92728597|NCT00575861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92728598|NCT00575861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728599|NCT00575861|Analgesics|analgesics|mesh-ancestor
92728600|NCT00575861|Sensory System Agents|sensory system agents|mesh-ancestor
92728601|NCT00575861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728602|NCT00575861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728603|NCT00575861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728604|NCT00575861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728605|NCT00575861|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92728606|NCT00575861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753861|NCT04117893|Antidepressive Agents|antidepressive agents|mesh-ancestor
92753862|NCT04117893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92753863|NCT04117893|Dopamine Agents|dopamine agents|mesh-ancestor
92753864|NCT04111458|Trametinib|trametinib|mesh-list
92753865|NCT04111458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753866|NCT04111458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753867|NCT04111458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753868|NCT04111458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753869|NCT04098003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92753870|NCT04098003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92753871|NCT04098003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92753872|NCT04098003|Antimetabolites|antimetabolites|mesh-ancestor
92753873|NCT04098003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753874|NCT04098003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92753875|NCT04098003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92753876|NCT04098003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753877|NCT04049851|Ivermectin|ivermectin|mesh-list
92753878|NCT04049851|Moxidectin|moxidectin|mesh-list
92753879|NCT04049851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92753880|NCT04049851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753881|NCT04049851|Anthelmintics|anthelmintics|mesh-ancestor
92753882|NCT04049851|Antinematodal Agents|antinematodal agents|mesh-ancestor
92753883|NCT04002115|Mycophenolic Acid|mycophenolic acid|mesh-list
92753884|NCT04002115|Cyclophosphamide|cyclophosphamide|mesh-list
92753885|NCT04002115|Busulfan|busulfan|mesh-list
92753886|NCT04002115|Fludarabine|fludarabine|mesh-list
92753887|NCT04002115|Clofarabine|clofarabine|mesh-list
92753888|NCT04002115|Tacrolimus|tacrolimus|mesh-list
92753889|NCT04002115|Lenograstim|lenograstim|mesh-list
92753890|NCT04002115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753891|NCT04002115|Immunologic Factors|immunologic factors|mesh-ancestor
92753902|NCT04002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753903|NCT04002115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92753904|NCT04002115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92753905|NCT04002115|Antitubercular Agents|antitubercular agents|mesh-ancestor
92753906|NCT04002115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92753907|NCT04002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753908|NCT04002115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92753909|NCT03970954|Interleukin-2|interleukin-2|mesh-list
92753910|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753911|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92753912|NCT03970954|Analgesics|analgesics|mesh-ancestor
92753913|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
92753914|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92753915|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753916|NCT03963375|Cladribine|cladribine|mesh-list
92753917|NCT03963375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753918|NCT03963375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753919|NCT03963375|Immunologic Factors|immunologic factors|mesh-ancestor
92753920|NCT03963375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753921|NCT03810105|Durvalumab|durvalumab|mesh-list
92753922|NCT03810105|Olaparib|olaparib|mesh-list
92728607|NCT00575861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728608|NCT00575861|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92728609|NCT00575861|Hormone Antagonists|hormone antagonists|mesh-ancestor
92728610|NCT00575861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728611|NCT04547088|Apatinib|apatinib|mesh-list
92728612|NCT04547088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753923|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753924|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753925|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92753926|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753927|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753928|NCT03798691|Vaccines|vaccines|mesh-list
92753929|NCT03798691|Immunologic Factors|immunologic factors|mesh-ancestor
92753930|NCT03798691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753931|NCT03785210|Vancomycin|vancomycin|mesh-list
92753932|NCT03785210|Nivolumab|nivolumab|mesh-list
92753933|NCT03785210|Tadalafil|tadalafil|mesh-list
92753934|NCT03785210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753935|NCT03785210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753936|NCT03785210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753937|NCT03785210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753938|NCT03785210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92753939|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92753940|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
92753941|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92753942|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92753943|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753944|NCT03785210|Urological Agents|urological agents|mesh-ancestor
92753945|NCT03757689|Pembrolizumab|pembrolizumab|mesh-list
92753946|NCT03757689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92753947|NCT03757689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753948|NCT03757689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92753949|NCT03757689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753950|NCT03750968|Carotenoids|carotenoids|mesh-list
92753951|NCT03750968|Antioxidants|antioxidants|mesh-ancestor
92753952|NCT03750968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753953|NCT03750968|Protective Agents|protective agents|mesh-ancestor
92753954|NCT03750968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753955|NCT03735979|Argatroban|argatroban|mesh-list
92753956|NCT03735979|Eptifibatide|eptifibatide|mesh-list
92753957|NCT03735979|Antithrombins|antithrombins|mesh-ancestor
92753958|NCT03735979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92753969|NCT03722498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753970|NCT03722498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92753971|NCT03722498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753972|NCT03722498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92753973|NCT03722498|Immunologic Factors|immunologic factors|mesh-ancestor
92753974|NCT03722498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753975|NCT03722498|Antidotes|antidotes|mesh-ancestor
92753976|NCT03722498|Protective Agents|protective agents|mesh-ancestor
92753977|NCT03722498|Vitamin B Complex|vitamin b complex|mesh-ancestor
92753978|NCT03722498|Vitamins|vitamins|mesh-ancestor
92753979|NCT03722498|Micronutrients|micronutrients|mesh-ancestor
92753980|NCT03722498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753981|NCT03722498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753982|NCT03710824|Nintedanib|nintedanib|mesh-list
92753983|NCT03710824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753984|NCT03710824|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92753985|NCT03710824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753986|NCT03710824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753987|NCT03648892|Raclopride|raclopride|mesh-list
92753988|NCT03648892|Fallypride|fallypride|mesh-list
92753989|NCT03648892|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92753990|NCT03648892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92753991|NCT03648892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753992|NCT03648892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753993|NCT03648892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92753994|NCT03648892|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92728613|NCT04547088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728614|NCT04547088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728615|NCT04547088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728616|NCT01129882|Aripiprazole|aripiprazole|mesh-list
92728617|NCT01129882|Antidepressive Agents|antidepressive agents|mesh-ancestor
92728618|NCT01129882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92728619|NCT01129882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92728620|NCT01129882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92753995|NCT03648892|Dopamine Agents|dopamine agents|mesh-ancestor
92753996|NCT03648892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92753997|NCT03648892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753998|NCT03648892|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92754000|NCT03637543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754001|NCT03637543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754002|NCT03637543|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754003|NCT03637543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754004|NCT03626831|Evolocumab|evolocumab|mesh-list
92754005|NCT03626831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92754006|NCT03626831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92754007|NCT03626831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92754008|NCT03626831|Antimetabolites|antimetabolites|mesh-ancestor
92754009|NCT03626831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754010|NCT03626831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92754011|NCT03626831|Protease Inhibitors|protease inhibitors|mesh-ancestor
92754012|NCT03626831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754013|NCT03626831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92754014|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
92754015|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92754016|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754017|NCT03619213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92754018|NCT03619213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754019|NCT03595059|Paclitaxel|paclitaxel|mesh-list
92754020|NCT03595059|Docetaxel|docetaxel|mesh-list
92754021|NCT03595059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754022|NCT03595059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754023|NCT03595059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92754024|NCT03595059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92754025|NCT03595059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92754029|NCT03570892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754030|NCT03530696|Palbociclib|palbociclib|mesh-list
92754031|NCT03530696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754032|NCT03530696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754033|NCT03530696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754034|NCT03530696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754035|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92754036|NCT03342690|Eplerenone|eplerenone|mesh-list
92754037|NCT03342690|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92754038|NCT03342690|Hormone Antagonists|hormone antagonists|mesh-ancestor
92754039|NCT03342690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754040|NCT03342690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754041|NCT03342690|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92754042|NCT03342690|Diuretics|diuretics|mesh-ancestor
92754043|NCT03342690|Natriuretic Agents|natriuretic agents|mesh-ancestor
92754044|NCT03342690|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92754045|NCT03333616|Nivolumab|nivolumab|mesh-list
92754046|NCT03333616|Ipilimumab|ipilimumab|mesh-list
92754047|NCT03333616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754048|NCT03333616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754049|NCT03333616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754050|NCT03333616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754051|NCT03262662|Varenicline|varenicline|mesh-list
92754052|NCT03262662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92754053|NCT03262662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92754054|NCT03262662|Cholinergic Agents|cholinergic agents|mesh-ancestor
92728621|NCT01129882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728622|NCT01129882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728623|NCT01129882|Dopamine Agonists|dopamine agonists|mesh-ancestor
92728624|NCT01129882|Dopamine Agents|dopamine agents|mesh-ancestor
92728625|NCT01129882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728626|NCT01129882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728627|NCT01129882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92754055|NCT03262662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754056|NCT03262662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754057|NCT03262662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754058|NCT03257267|Cemiplimab|cemiplimab|mesh-list
92754059|NCT03257267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754060|NCT03257267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754061|NCT03201458|Atezolizumab|atezolizumab|mesh-list
92754062|NCT03201458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92754063|NCT03201458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754064|NCT03201458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754065|NCT03201458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754066|NCT03201458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754067|NCT03201458|Immunologic Factors|immunologic factors|mesh-ancestor
92754068|NCT03201458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754069|NCT03191149|Osimertinib|osimertinib|mesh-list
92401124|NCT01414569|Glucocorticoids|glucocorticoids|mesh-ancestor
92754070|NCT03191149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754071|NCT03191149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754072|NCT03191149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754073|NCT03191149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754074|NCT03190668|Cefazolin|cefazolin|mesh-list
92754075|NCT03190668|Dialysis Solutions|dialysis solutions|mesh-list
92754076|NCT03190668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92754077|NCT03190668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754078|NCT03190668|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92754079|NCT03162653|Allopurinol|allopurinol|mesh-list
92754080|NCT03162653|Mannitol|mannitol|mesh-list
92754081|NCT03162653|Antimetabolites|antimetabolites|mesh-ancestor
92754082|NCT03162653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754083|NCT03162653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754084|NCT03162653|Gout Suppressants|gout suppressants|mesh-ancestor
92754085|NCT03162653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754086|NCT03162653|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92754087|NCT03162653|Antioxidants|antioxidants|mesh-ancestor
92754088|NCT03162653|Protective Agents|protective agents|mesh-ancestor
92754089|NCT03162653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754090|NCT03162653|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92754091|NCT03162653|Diuretics|diuretics|mesh-ancestor
92754092|NCT03162653|Natriuretic Agents|natriuretic agents|mesh-ancestor
92754093|NCT03064035|Thrombin|thrombin|mesh-list
92754094|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
92754095|NCT03064035|Coagulants|coagulants|mesh-ancestor
92754096|NCT03008278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92754106|NCT03008278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754107|NCT03008278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754108|NCT03008278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754109|NCT02991456|Ondansetron|ondansetron|mesh-list
92754110|NCT02991456|Rolapitant|rolapitant|mesh-list
92754111|NCT02991456|Antiemetics|antiemetics|mesh-ancestor
92754112|NCT02991456|Autonomic Agents|autonomic agents|mesh-ancestor
92754113|NCT02991456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754114|NCT02991456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754115|NCT02991456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754116|NCT02991456|Antipruritics|antipruritics|mesh-ancestor
92754117|NCT02991456|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754118|NCT02991456|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92754119|NCT02991456|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92754120|NCT02991456|Serotonin Agents|serotonin agents|mesh-ancestor
92754121|NCT02991456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754122|NCT02991456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754123|NCT02991456|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92728628|NCT01129882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92728629|NCT01129882|Serotonin Agents|serotonin agents|mesh-ancestor
92728630|NCT01129882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92728631|NCT01129882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92728632|NCT01129882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92754124|NCT02932618|Factor VIII|factor viii|mesh-list
92754125|NCT02932618|Coagulants|coagulants|mesh-ancestor
92754126|NCT02921256|Leucovorin|leucovorin|mesh-list
92754127|NCT02921256|Pembrolizumab|pembrolizumab|mesh-list
92754128|NCT02921256|Fluorouracil|fluorouracil|mesh-list
92754129|NCT02921256|Capecitabine|capecitabine|mesh-list
92754130|NCT02921256|Oxaliplatin|oxaliplatin|mesh-list
92754131|NCT02921256|Veliparib|veliparib|mesh-list
92754132|NCT02921256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754133|NCT02921256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754134|NCT02921256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754135|NCT02921256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754136|NCT02921256|Antimetabolites|antimetabolites|mesh-ancestor
92754137|NCT02921256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754138|NCT02921256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754139|NCT02921256|Immunologic Factors|immunologic factors|mesh-ancestor
92754140|NCT02921256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754141|NCT02921256|Antidotes|antidotes|mesh-ancestor
92754142|NCT02921256|Protective Agents|protective agents|mesh-ancestor
92754143|NCT02921256|Vitamin B Complex|vitamin b complex|mesh-ancestor
92754144|NCT02921256|Vitamins|vitamins|mesh-ancestor
92754145|NCT02921256|Micronutrients|micronutrients|mesh-ancestor
92754146|NCT02921256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92754147|NCT02921256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754148|NCT02867384|Obinutuzumab|obinutuzumab|mesh-list
92754149|NCT02867384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754150|NCT02867384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754151|NCT02842827|Tretinoin|tretinoin|mesh-list
92754152|NCT02842827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754153|NCT02842827|Keratolytic Agents|keratolytic agents|mesh-ancestor
92754154|NCT02842827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754155|NCT02825160|Iloprost|iloprost|mesh-list
92754156|NCT02825160|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92754157|NCT02825160|Vasodilator Agents|vasodilator agents|mesh-ancestor
92754158|NCT02823821|Dialysis Solutions|dialysis solutions|mesh-list
92754159|NCT02823821|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92754160|NCT02503774|Durvalumab|durvalumab|mesh-list
92754161|NCT02503774|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754162|NCT02503774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754163|NCT02477826|Paclitaxel|paclitaxel|mesh-list
92754164|NCT02477826|Carboplatin|carboplatin|mesh-list
92754165|NCT02477826|Gemcitabine|gemcitabine|mesh-list
92754166|NCT02477826|Nivolumab|nivolumab|mesh-list
92754167|NCT02477826|Pemetrexed|pemetrexed|mesh-list
92754168|NCT02477826|Ipilimumab|ipilimumab|mesh-list
92754171|NCT02477826|Tubulin Modulators|tubulin modulators|mesh-ancestor
92754172|NCT02477826|Antimitotic Agents|antimitotic agents|mesh-ancestor
92754173|NCT02477826|Mitosis Modulators|mitosis modulators|mesh-ancestor
92754174|NCT02477826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754175|NCT02477826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754176|NCT02477826|Antimetabolites|antimetabolites|mesh-ancestor
92754177|NCT02477826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754178|NCT02477826|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754179|NCT02477826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754180|NCT02477826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92754181|NCT02477826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92754182|NCT02432274|Etoposide|etoposide|mesh-list
92754183|NCT02432274|Etoposide phosphate|etoposide phosphate|mesh-list
92754184|NCT02432274|Ifosfamide|ifosfamide|mesh-list
92754185|NCT02432274|Isophosphamide mustard|isophosphamide mustard|mesh-list
92754186|NCT02432274|Lenvatinib|lenvatinib|mesh-list
92754187|NCT02432274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754188|NCT02432274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754189|NCT02432274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92754190|NCT02432274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92754191|NCT02432274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754192|NCT02432274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728633|NCT01129882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92728634|NCT02278419|Sofosbuvir|sofosbuvir|mesh-list
92728635|NCT02278419|Simeprevir|simeprevir|mesh-list
92728636|NCT02278419|Antiviral Agents|antiviral agents|mesh-ancestor
92728637|NCT02278419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728638|NCT02278419|Protease Inhibitors|protease inhibitors|mesh-ancestor
92728639|NCT02278419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728640|NCT02278419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728641|NCT02882737|Glucagon|glucagon|mesh-list
92728642|NCT02882737|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92728643|NCT02882737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728644|NCT02882737|Hormones|hormones|mesh-ancestor
92728645|NCT02882737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728646|NCT02882737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754193|NCT02432274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92754194|NCT02432274|Alkylating Agents|alkylating agents|mesh-ancestor
92754195|NCT02432274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754196|NCT02393859|Dexamethasone|dexamethasone|mesh-list
92754197|NCT02393859|Methotrexate|methotrexate|mesh-list
92754198|NCT02393859|Daunorubicin|daunorubicin|mesh-list
92754199|NCT02393859|Asparaginase|asparaginase|mesh-list
92754200|NCT02393859|Ifosfamide|ifosfamide|mesh-list
92754201|NCT02393859|Blinatumomab|blinatumomab|mesh-list
92754202|NCT02393859|Pegaspargase|pegaspargase|mesh-list
92754203|NCT02393859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754204|NCT02393859|Antiemetics|antiemetics|mesh-ancestor
92754205|NCT02393859|Autonomic Agents|autonomic agents|mesh-ancestor
92754206|NCT02393859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754207|NCT02393859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754208|NCT02393859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754209|NCT02393859|Glucocorticoids|glucocorticoids|mesh-ancestor
92754210|NCT02393859|Hormones|hormones|mesh-ancestor
92754211|NCT02393859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754212|NCT02393859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754213|NCT02393859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754214|NCT02393859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92754215|NCT02393859|Abortifacient Agents|abortifacient agents|mesh-ancestor
92754216|NCT02393859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92754217|NCT02393859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754218|NCT02393859|Antimetabolites|antimetabolites|mesh-ancestor
92754219|NCT02393859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754220|NCT02393859|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754221|NCT02393859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754222|NCT02393859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92754223|NCT02393859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754224|NCT02393859|Immunologic Factors|immunologic factors|mesh-ancestor
92754225|NCT02393859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754226|NCT02393859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92754227|NCT02393859|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92754228|NCT02393859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92754229|NCT02393859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92754230|NCT02393859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92754231|NCT02393859|Alkylating Agents|alkylating agents|mesh-ancestor
92754232|NCT02392429|Cytarabine|cytarabine|mesh-list
92754233|NCT02392429|Alovudine|alovudine|mesh-list
92754234|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754235|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
92754236|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754237|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754238|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
92754239|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754240|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754241|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
92728647|NCT02882737|Incretins|incretins|mesh-ancestor
92728648|NCT02211950|Acarbose|acarbose|mesh-list
92728649|NCT02211950|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92728650|NCT02211950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728651|NCT02211950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728652|NCT02211950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728653|NCT02211950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728654|NCT04559048|Tacrolimus|tacrolimus|mesh-list
92327600|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
92754243|NCT02379416|Paclitaxel|paclitaxel|mesh-list
92754244|NCT02379416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754245|NCT02379416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754246|NCT02379416|Tubulin Modulators|tubulin modulators|mesh-ancestor
92754247|NCT02379416|Antimitotic Agents|antimitotic agents|mesh-ancestor
92754248|NCT02379416|Mitosis Modulators|mitosis modulators|mesh-ancestor
92754249|NCT02379416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754250|NCT02231749|Nivolumab|nivolumab|mesh-list
92754251|NCT02231749|Ipilimumab|ipilimumab|mesh-list
92754252|NCT02231749|Sunitinib|sunitinib|mesh-list
92754253|NCT02231749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754254|NCT02231749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754255|NCT02231749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754256|NCT02231749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754257|NCT02231749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92754258|NCT02231749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92754259|NCT02231749|Growth Substances|growth substances|mesh-ancestor
92754260|NCT02231749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754261|NCT02231749|Growth Inhibitors|growth inhibitors|mesh-ancestor
92754262|NCT02231749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754263|NCT02231749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754264|NCT02197234|Osimertinib|osimertinib|mesh-list
92754265|NCT02197234|Simvastatin|simvastatin|mesh-list
92754266|NCT02197234|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92754267|NCT02197234|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92754268|NCT02197234|Antimetabolites|antimetabolites|mesh-ancestor
92754269|NCT02197234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754270|NCT02197234|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92754271|NCT02197234|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92754272|NCT02197234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754273|NCT02197234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754274|NCT02197234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754275|NCT02096588|Cyclophosphamide|cyclophosphamide|mesh-list
92754276|NCT02096588|Doxorubicin|doxorubicin|mesh-list
92754277|NCT02096588|Simvastatin|simvastatin|mesh-list
92754278|NCT02096588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754279|NCT02096588|Immunologic Factors|immunologic factors|mesh-ancestor
92754280|NCT02096588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754281|NCT02096588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754282|NCT02096588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92754283|NCT02096588|Alkylating Agents|alkylating agents|mesh-ancestor
92754284|NCT02096588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754285|NCT02096588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754286|NCT02096588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92754287|NCT02096588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92754288|NCT02096588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92754289|NCT02096588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92754290|NCT02096588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754291|NCT02096588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92754292|NCT02096588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92754293|NCT02096588|Antimetabolites|antimetabolites|mesh-ancestor
92754294|NCT02096588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92754295|NCT02096588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92754296|NCT02022982|Palbociclib|palbociclib|mesh-list
92754297|NCT02022982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754298|NCT02022982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728655|NCT04559048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92728656|NCT04559048|Immunologic Factors|immunologic factors|mesh-ancestor
92728657|NCT04559048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728658|NCT04559048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92728659|NCT04559048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728660|NCT04559048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728661|NCT04538820|Dexamethasone|dexamethasone|mesh-list
92728662|NCT04538820|Dexamethasone acetate|dexamethasone acetate|mesh-list
92728663|NCT04538820|BB 1101|bb 1101|mesh-list
92728664|NCT04538820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728665|NCT04538820|Antiemetics|antiemetics|mesh-ancestor
92728666|NCT04538820|Autonomic Agents|autonomic agents|mesh-ancestor
92728667|NCT04538820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728668|NCT04538820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754299|NCT02022982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754300|NCT02022982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754301|NCT01622335|Nitrous Oxide|nitrous oxide|mesh-list
92754302|NCT01622335|Anesthetics|anesthetics|mesh-ancestor
92754303|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754304|NCT01622335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754305|NCT01622335|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92754306|NCT01622335|Anesthetics, General|anesthetics, general|mesh-ancestor
92754307|NCT01622335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92754308|NCT01622335|Analgesics|analgesics|mesh-ancestor
92754309|NCT01622335|Sensory System Agents|sensory system agents|mesh-ancestor
92754310|NCT01622335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754311|NCT01359592|Prednisone|prednisone|mesh-list
92754312|NCT01359592|Cyclophosphamide|cyclophosphamide|mesh-list
92754313|NCT01359592|Rituximab|rituximab|mesh-list
92754314|NCT01359592|Doxorubicin|doxorubicin|mesh-list
92754316|NCT01359592|Vincristine|vincristine|mesh-list
92754317|NCT01359592|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92754318|NCT01359592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754319|NCT01359592|Immunologic Factors|immunologic factors|mesh-ancestor
92754320|NCT01359592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754321|NCT01359592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754322|NCT01359592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92754323|NCT01359592|Alkylating Agents|alkylating agents|mesh-ancestor
92754324|NCT01359592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754325|NCT01359592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754326|NCT01359592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92754327|NCT01359592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754328|NCT01359592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92754329|NCT01359592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92754330|NCT01359592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92754331|NCT01359592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754332|NCT01359592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754333|NCT01359592|Glucocorticoids|glucocorticoids|mesh-ancestor
92754334|NCT01359592|Hormones|hormones|mesh-ancestor
92754335|NCT01359592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754336|NCT01359592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754337|NCT01359592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754338|NCT01359592|Tubulin Modulators|tubulin modulators|mesh-ancestor
92754339|NCT01359592|Antimitotic Agents|antimitotic agents|mesh-ancestor
92754340|NCT01359592|Mitosis Modulators|mitosis modulators|mesh-ancestor
92754341|NCT01359592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92754342|NCT01331018|Plerixafor|plerixafor|mesh-list
92754343|NCT01331018|Prednisone|prednisone|mesh-list
92754344|NCT01331018|Methylprednisolone|methylprednisolone|mesh-list
92754345|NCT01331018|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92754346|NCT01331018|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92754347|NCT01331018|Prednisolone|prednisolone|mesh-list
92728669|NCT04538820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92728670|NCT04538820|Glucocorticoids|glucocorticoids|mesh-ancestor
92728671|NCT04538820|Hormones|hormones|mesh-ancestor
92728672|NCT04538820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728673|NCT04538820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92728674|NCT04538820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728675|NCT04538820|Protease Inhibitors|protease inhibitors|mesh-ancestor
92728676|NCT04538820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728677|NCT04538820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728678|NCT00575978|Hydralazine|hydralazine|mesh-list
92728679|NCT00575978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92728680|NCT00575978|Vasodilator Agents|vasodilator agents|mesh-ancestor
92728681|NCT04546347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92728682|NCT02882932|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92728683|NCT04539054|Caffeine|caffeine|mesh-list
92728684|NCT04539054|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92728685|NCT04539054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728686|NCT04539054|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92728687|NCT04539054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754348|NCT01331018|Prednisolone acetate|prednisolone acetate|mesh-list
92754349|NCT01331018|Cortisone|cortisone|mesh-list
92754350|NCT01331018|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92754351|NCT01331018|Prednisolone phosphate|prednisolone phosphate|mesh-list
92754352|NCT01331018|Lenograstim|lenograstim|mesh-list
92754353|NCT01331018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754354|NCT01331018|Glucocorticoids|glucocorticoids|mesh-ancestor
92754355|NCT01331018|Hormones|hormones|mesh-ancestor
92754356|NCT01331018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754357|NCT01331018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754358|NCT01331018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754359|NCT01331018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754360|NCT01331018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92754361|NCT01331018|Immunologic Factors|immunologic factors|mesh-ancestor
92754362|NCT01331018|Antiemetics|antiemetics|mesh-ancestor
92754363|NCT01331018|Autonomic Agents|autonomic agents|mesh-ancestor
92754364|NCT01331018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754365|NCT01331018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754366|NCT01331018|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92754367|NCT01331018|Protective Agents|protective agents|mesh-ancestor
92754368|NCT01331018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92754369|NCT01331018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92754370|NCT01331018|Antiviral Agents|antiviral agents|mesh-ancestor
92754371|NCT01331018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754372|NCT01064466|Etoposide|etoposide|mesh-list
92754373|NCT01064466|Etoposide phosphate|etoposide phosphate|mesh-list
92754374|NCT01064466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754375|NCT01064466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754376|NCT01064466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92754377|NCT01064466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92754378|NCT01064466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348200|NCT01565694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754379|NCT01064466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754380|NCT00840853|Acetaminophen|acetaminophen|mesh-list
92754381|NCT00840853|Diphenhydramine|diphenhydramine|mesh-list
92754382|NCT00840853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92754383|NCT00840853|Analgesics|analgesics|mesh-ancestor
92754384|NCT00840853|Sensory System Agents|sensory system agents|mesh-ancestor
92728688|NCT04539054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728689|NCT04539054|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92728690|NCT04539054|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92728691|NCT04539054|Purinergic Agents|purinergic agents|mesh-ancestor
92728692|NCT04539054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728693|NCT00576017|Fentanyl|fentanyl|mesh-list
92728694|NCT00576017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92728695|NCT00576017|Narcotics|narcotics|mesh-ancestor
92728696|NCT00576017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754385|NCT00840853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754386|NCT00840853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754387|NCT00840853|Antipyretics|antipyretics|mesh-ancestor
92754388|NCT00840853|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92754394|NCT00840853|Autonomic Agents|autonomic agents|mesh-ancestor
92754395|NCT00840853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754396|NCT00840853|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92754397|NCT00840853|Histamine Antagonists|histamine antagonists|mesh-ancestor
92754398|NCT00840853|Histamine Agents|histamine agents|mesh-ancestor
92754399|NCT00840853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754400|NCT00840853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754401|NCT00840853|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92754402|NCT00697073|Idebenone|idebenone|mesh-list
92754403|NCT00697073|Antioxidants|antioxidants|mesh-ancestor
92754404|NCT00697073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754405|NCT00697073|Protective Agents|protective agents|mesh-ancestor
92754406|NCT00697073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754407|NCT00656331|Amlodipine|amlodipine|mesh-list
92754408|NCT00656331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92754409|NCT00656331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92754410|NCT00656331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754411|NCT00656331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754412|NCT00656331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92754413|NCT00656331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754414|NCT00656331|Vasodilator Agents|vasodilator agents|mesh-ancestor
92754415|NCT00653432|Hyaluronic Acid|hyaluronic acid|mesh-list
92754416|NCT00653432|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92754417|NCT00653432|Immunologic Factors|immunologic factors|mesh-ancestor
92754418|NCT00653432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754419|NCT00653432|Viscosupplements|viscosupplements|mesh-ancestor
92754420|NCT00653432|Protective Agents|protective agents|mesh-ancestor
92754421|NCT00537680|Ubiquinone|ubiquinone|mesh-list
92754422|NCT00537680|Idebenone|idebenone|mesh-list
92754423|NCT00537680|Antioxidants|antioxidants|mesh-ancestor
92754424|NCT00537680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754425|NCT00537680|Protective Agents|protective agents|mesh-ancestor
92754426|NCT00537680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754427|NCT00537680|Micronutrients|micronutrients|mesh-ancestor
92754428|NCT00516724|Paclitaxel|paclitaxel|mesh-list
92754429|NCT00516724|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92754430|NCT00516724|Carboplatin|carboplatin|mesh-list
92754431|NCT00516724|Olaparib|olaparib|mesh-list
92754432|NCT00516724|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92754433|NCT00516724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754434|NCT00516724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754435|NCT00516724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92754436|NCT00516724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92754437|NCT00516724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92401156|NCT01414868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754438|NCT00516724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754439|NCT00516724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754440|NCT00446043|Adapalene|adapalene|mesh-list
92754441|NCT00446043|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92754442|NCT00446043|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92754443|NCT00446043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754444|NCT00446043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92754445|NCT00446043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92754446|NCT00446043|Analgesics|analgesics|mesh-ancestor
92728697|NCT00576017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728698|NCT00576017|Analgesics|analgesics|mesh-ancestor
92728699|NCT00576017|Sensory System Agents|sensory system agents|mesh-ancestor
92728700|NCT00576017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728701|NCT00576017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92728702|NCT00576017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92728703|NCT00576017|Anesthetics, General|anesthetics, general|mesh-ancestor
92728704|NCT00576017|Anesthetics|anesthetics|mesh-ancestor
92728705|NCT04558697|Tea Tree Oil|tea tree oil|mesh-list
92754447|NCT00446043|Sensory System Agents|sensory system agents|mesh-ancestor
92754448|NCT00446043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754449|NCT00446043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754450|NCT00446043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754451|NCT00446043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754452|NCT00400725|Clobetasol|clobetasol|mesh-list
92754453|NCT00400725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754454|NCT00400725|Glucocorticoids|glucocorticoids|mesh-ancestor
92754455|NCT00400725|Hormones|hormones|mesh-ancestor
92754456|NCT00400725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754457|NCT00400725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754458|NCT00099437|Fulvestrant|fulvestrant|mesh-list
92754459|NCT00099437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754461|NCT00099437|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92754462|NCT00099437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92754463|NCT00099437|Hormone Antagonists|hormone antagonists|mesh-ancestor
92754464|NCT00099437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754465|NCT00099437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754466|NCT00018044|Clofazimine|clofazimine|mesh-list
92754467|NCT00018044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754468|NCT00018044|Leprostatic Agents|leprostatic agents|mesh-ancestor
92754469|NCT00018044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92754470|NCT00018044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754471|NCT00932113|Folic Acid|folic acid|mesh-list
92754472|NCT00932113|Adalimumab|adalimumab|mesh-list
92754473|NCT00932113|Methotrexate|methotrexate|mesh-list
92754474|NCT00932113|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92754475|NCT00932113|Abortifacient Agents|abortifacient agents|mesh-ancestor
92754476|NCT00932113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92754477|NCT00932113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754478|NCT00932113|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754479|NCT00932113|Antimetabolites|antimetabolites|mesh-ancestor
92754480|NCT00932113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754481|NCT00932113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754482|NCT00932113|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754483|NCT00932113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754484|NCT00932113|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92754485|NCT00932113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754486|NCT00932113|Immunologic Factors|immunologic factors|mesh-ancestor
92754487|NCT00932113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754488|NCT00932113|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92401165|NCT01414881|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92754489|NCT00932113|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92754490|NCT00932113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754491|NCT00932113|Hematinics|hematinics|mesh-ancestor
92754492|NCT00932113|Vitamin B Complex|vitamin b complex|mesh-ancestor
92754493|NCT00932113|Vitamins|vitamins|mesh-ancestor
92754494|NCT00932113|Micronutrients|micronutrients|mesh-ancestor
92754495|NCT00931801|Tenofovir|tenofovir|mesh-list
92754496|NCT00931801|Emtricitabine|emtricitabine|mesh-list
92754497|NCT00931801|Raltegravir Potassium|raltegravir potassium|mesh-list
92754498|NCT00931801|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92754499|NCT00931801|Antiviral Agents|antiviral agents|mesh-ancestor
92754500|NCT00931801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754501|NCT00931801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92754502|NCT00931801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92754503|NCT00931801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728706|NCT04558697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92728707|NCT04558697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728709|NCT04558580|Anticonvulsants|anticonvulsants|mesh-ancestor
92728710|NCT04558580|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92728711|NCT04558580|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92728712|NCT04558580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754504|NCT00931801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754505|NCT00931801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92754506|NCT00931801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92754507|NCT00931801|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92754508|NCT00931801|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92754509|NCT00931801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92754510|NCT00931801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92754511|NCT00931801|Protease Inhibitors|protease inhibitors|mesh-ancestor
92754512|NCT00931723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92754513|NCT00931723|Antidepressive Agents|antidepressive agents|mesh-ancestor
92754514|NCT00931723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92754515|NCT00931723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92754516|NCT00931723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92754517|NCT00931723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754518|NCT00931723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754520|NCT05025397|Sevoflurane|sevoflurane|mesh-list
92754521|NCT05025397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92754522|NCT05025397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754523|NCT05025397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754524|NCT05025397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92754525|NCT05025397|Anesthetics, General|anesthetics, general|mesh-ancestor
92754526|NCT05025397|Anesthetics|anesthetics|mesh-ancestor
92754527|NCT05025397|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92754528|NCT05025397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92754529|NCT00608803|Doxorubicin|doxorubicin|mesh-list
92754530|NCT00608803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92754531|NCT00608803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754532|NCT00608803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92754533|NCT00608803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92754534|NCT00608803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754539|NCT00931255|Immunologic Factors|immunologic factors|mesh-ancestor
92754540|NCT00931255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754541|NCT00931255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92754542|NCT00931255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754543|NCT00931255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754544|NCT00931255|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92754545|NCT00931255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754546|NCT00931255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92754547|NCT00931255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401185|NCT01415128|Rosiglitazone|rosiglitazone|mesh-list
92754548|NCT00931255|Antifungal Agents|antifungal agents|mesh-ancestor
92754549|NCT00609193|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92754550|NCT00609193|Antidepressive Agents|antidepressive agents|mesh-ancestor
92754551|NCT00609193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92754552|NCT00609193|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92754553|NCT00609193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92754554|NCT00609193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754555|NCT00609193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754556|NCT00930553|Alemtuzumab|alemtuzumab|mesh-list
92754557|NCT00930553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754558|NCT00930553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754559|NCT04262089|Pembrolizumab|pembrolizumab|mesh-list
92754560|NCT04262089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754561|NCT04262089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754562|NCT04262089|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92754563|NCT04262089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754564|NCT00609817|Dexamethasone|dexamethasone|mesh-list
92754565|NCT00609817|Bortezomib|bortezomib|mesh-list
92754566|NCT00609817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754567|NCT00609817|Antiemetics|antiemetics|mesh-ancestor
92754568|NCT00609817|Autonomic Agents|autonomic agents|mesh-ancestor
92754569|NCT00609817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754570|NCT00609817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728713|NCT04558580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728715|NCT02278458|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92728716|NCT02278458|Antimetabolites|antimetabolites|mesh-ancestor
92728717|NCT02278458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728718|NCT02278458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754571|NCT00609817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754572|NCT00609817|Glucocorticoids|glucocorticoids|mesh-ancestor
92754573|NCT00609817|Hormones|hormones|mesh-ancestor
92754574|NCT00609817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754575|NCT00609817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754576|NCT00609817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754578|NCT00929695|Methylprednisolone|methylprednisolone|mesh-list
92754579|NCT00929695|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92754580|NCT00929695|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92754581|NCT00929695|Prednisolone|prednisolone|mesh-list
92754582|NCT00929695|Prednisolone acetate|prednisolone acetate|mesh-list
92754583|NCT00929695|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92754584|NCT00929695|Prednisolone phosphate|prednisolone phosphate|mesh-list
92754585|NCT00929695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754586|NCT00929695|Glucocorticoids|glucocorticoids|mesh-ancestor
92754587|NCT00929695|Hormones|hormones|mesh-ancestor
92754588|NCT00929695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754589|NCT00929695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754590|NCT00929695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754591|NCT00929695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754592|NCT00929695|Antiemetics|antiemetics|mesh-ancestor
92754593|NCT00929695|Autonomic Agents|autonomic agents|mesh-ancestor
92754594|NCT00929695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754595|NCT00929695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754596|NCT00929695|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92754597|NCT00929695|Protective Agents|protective agents|mesh-ancestor
92754598|NCT00609895|Insulin Glargine|insulin glargine|mesh-list
92754599|NCT00609895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92754600|NCT00609895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754601|NCT04261465|Paclitaxel|paclitaxel|mesh-list
92754602|NCT04261465|Carboplatin|carboplatin|mesh-list
92754603|NCT04261465|Olaparib|olaparib|mesh-list
92754604|NCT04261465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754605|NCT04261465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754606|NCT04261465|Tubulin Modulators|tubulin modulators|mesh-ancestor
92754607|NCT04261465|Antimitotic Agents|antimitotic agents|mesh-ancestor
92754610|NCT04261465|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92754611|NCT04261465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754613|NCT04260607|Analgesics|analgesics|mesh-ancestor
92754614|NCT04260607|Sensory System Agents|sensory system agents|mesh-ancestor
92754615|NCT04260607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754616|NCT04260607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754617|NCT04260607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92754618|NCT04260607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92754619|NCT04260607|Anesthetics, General|anesthetics, general|mesh-ancestor
92754620|NCT04260607|Anesthetics|anesthetics|mesh-ancestor
92754621|NCT04260607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754622|NCT04260607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92754623|NCT04260607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92754624|NCT04260607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754625|NCT04260607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754626|NCT00927355|Pioglitazone|pioglitazone|mesh-list
92754627|NCT00927355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92754628|NCT00927355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754629|NCT00923845|Sirolimus|sirolimus|mesh-list
92754630|NCT00923845|Cyclophosphamide|cyclophosphamide|mesh-list
92754631|NCT00923845|Pentostatin|pentostatin|mesh-list
92754632|NCT00923845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754633|NCT00923845|Immunologic Factors|immunologic factors|mesh-ancestor
92754634|NCT00923845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754635|NCT00923845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754636|NCT00923845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92728719|NCT01128595|Fluticasone|fluticasone|mesh-list
92728720|NCT01128595|Xhance|xhance|mesh-list
92728721|NCT01128595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728722|NCT01128595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92728723|NCT01128595|Autonomic Agents|autonomic agents|mesh-ancestor
92728724|NCT01128595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728725|NCT01128595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728726|NCT01128595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92728727|NCT01128595|Respiratory System Agents|respiratory system agents|mesh-ancestor
92728728|NCT01128595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92728729|NCT01128595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92728730|NCT01129336|Zoledronic Acid|zoledronic acid|mesh-list
92728731|NCT01129336|Diphosphonates|diphosphonates|mesh-list
92728732|NCT01129336|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92754637|NCT00923845|Alkylating Agents|alkylating agents|mesh-ancestor
92754638|NCT00923845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754639|NCT00923845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754640|NCT00923845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92754641|NCT00923845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92754642|NCT00923845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754643|NCT00923845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92754644|NCT00923845|Antifungal Agents|antifungal agents|mesh-ancestor
92754645|NCT00923845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754646|NCT00923845|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92754647|NCT05052541|Dronabinol|dronabinol|mesh-list
92754648|NCT05052541|Hallucinogens|hallucinogens|mesh-ancestor
92754649|NCT05052541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754650|NCT05052541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92754651|NCT05052541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92754652|NCT05052541|Analgesics|analgesics|mesh-ancestor
92754653|NCT05052541|Sensory System Agents|sensory system agents|mesh-ancestor
92754654|NCT05052541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754655|NCT05052541|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92754656|NCT05052541|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92754657|NCT05052541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754658|NCT05052541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754659|NCT05052541|Hormones|hormones|mesh-ancestor
92754660|NCT05052541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754661|NCT04260685|Lidocaine|lidocaine|mesh-list
92754662|NCT04260685|Esmolol|esmolol|mesh-list
92754663|NCT04260685|Anesthetics, Local|anesthetics, local|mesh-ancestor
92754664|NCT04260685|Anesthetics|anesthetics|mesh-ancestor
92754665|NCT04260685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754666|NCT04260685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754667|NCT04260685|Sensory System Agents|sensory system agents|mesh-ancestor
92754668|NCT04260685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754669|NCT04260685|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92754670|NCT04260685|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92754671|NCT04260685|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92754672|NCT04260685|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754673|NCT04260685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754674|NCT04260685|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92754675|NCT04260685|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92754676|NCT04260685|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92754677|NCT04260685|Adrenergic Agents|adrenergic agents|mesh-ancestor
92754685|NCT05013463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92754686|NCT05013463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754687|NCT05013463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754688|NCT05013463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754689|NCT05013463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728733|NCT01129336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728734|NCT01128244|Pyridoxine|pyridoxine|mesh-list
92728735|NCT01128244|Pyridoxal|pyridoxal|mesh-list
92728736|NCT01128244|Vitamin B 6|vitamin b 6|mesh-list
92728737|NCT01128244|Vitamins|vitamins|mesh-ancestor
92728738|NCT01128244|Micronutrients|micronutrients|mesh-ancestor
92728739|NCT01128244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728740|NCT01128244|Vitamin B Complex|vitamin b complex|mesh-ancestor
92728741|NCT01127893|Tanezumab|tanezumab|mesh-list
92728742|NCT01127893|Analgesics|analgesics|mesh-ancestor
92754690|NCT05013463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92754691|NCT05013463|Diuretics|diuretics|mesh-ancestor
92754692|NCT05013463|Natriuretic Agents|natriuretic agents|mesh-ancestor
92754693|NCT05013463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754694|NCT05013463|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92754695|NCT05013463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754696|NCT00922987|Pregabalin|pregabalin|mesh-list
92754697|NCT00922987|Analgesics|analgesics|mesh-ancestor
92754698|NCT00922987|Sensory System Agents|sensory system agents|mesh-ancestor
92754699|NCT00922987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754700|NCT00922987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754701|NCT00922987|Anticonvulsants|anticonvulsants|mesh-ancestor
92754702|NCT00922987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92754703|NCT00922987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754704|NCT00922987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754705|NCT00922987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92754706|NCT00922987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92754707|NCT00922987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92754708|NCT00922987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754709|NCT00922987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92754710|NCT00610909|Paroxetine|paroxetine|mesh-list
92754711|NCT00610909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92754712|NCT00610909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92754713|NCT00610909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754714|NCT00610909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754715|NCT00610909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754716|NCT00610909|Serotonin Agents|serotonin agents|mesh-ancestor
92754717|NCT00610909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754718|NCT00610909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92754719|NCT00610909|Antidepressive Agents|antidepressive agents|mesh-ancestor
92754720|NCT00610909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92754721|NCT00610909|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92754722|NCT00610909|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92754723|NCT00610909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754724|NCT00927901|Maleic acid|maleic acid|mesh-list
92754725|NCT00927901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754726|NCT00927901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754727|NCT04255771|Cisplatin|cisplatin|mesh-list
92754728|NCT04255771|Gemcitabine|gemcitabine|mesh-list
92754729|NCT04255771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754730|NCT04255771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754731|NCT04255771|Antimetabolites|antimetabolites|mesh-ancestor
92754732|NCT04255771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754733|NCT01218204|Atorvastatin|atorvastatin|mesh-list
92754734|NCT01218204|Ezetimibe|ezetimibe|mesh-list
92754735|NCT01218204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92754736|NCT01218204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92754737|NCT01218204|Antimetabolites|antimetabolites|mesh-ancestor
92754738|NCT01218204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754739|NCT01218204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92754740|NCT01218204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92754741|NCT01218204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754742|NCT00926575|Beclomethasone|beclomethasone|mesh-list
92754743|NCT00926575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754744|NCT00926575|Glucocorticoids|glucocorticoids|mesh-ancestor
92754745|NCT00926575|Hormones|hormones|mesh-ancestor
92754749|NCT00926575|Respiratory System Agents|respiratory system agents|mesh-ancestor
92728743|NCT01127893|Sensory System Agents|sensory system agents|mesh-ancestor
92728744|NCT01127893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728745|NCT01127893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728746|NCT00576173|Acetaminophen|acetaminophen|mesh-list
92728747|NCT00576173|Tramadol|tramadol|mesh-list
92728748|NCT00576173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728749|NCT00576173|Analgesics|analgesics|mesh-ancestor
92728750|NCT00576173|Sensory System Agents|sensory system agents|mesh-ancestor
92728751|NCT00576173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728752|NCT00576173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754750|NCT05456412|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92754751|NCT05456412|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754752|NCT05456412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754753|NCT05456412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754754|NCT01217892|Metformin|metformin|mesh-list
92754755|NCT01217892|Dapagliflozin|dapagliflozin|mesh-list
92754756|NCT01217892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92754757|NCT01217892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754758|NCT01217892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92754759|NCT01217892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754760|NCT01217814|Leucovorin|leucovorin|mesh-list
92754761|NCT01217814|Folic Acid|folic acid|mesh-list
92754762|NCT01217814|Golimumab|golimumab|mesh-list
92754763|NCT01217814|Methotrexate|methotrexate|mesh-list
92754764|NCT01217814|Levoleucovorin|levoleucovorin|mesh-list
92754765|NCT01217814|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92754766|NCT01217814|Abortifacient Agents|abortifacient agents|mesh-ancestor
92754767|NCT01217814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92754768|NCT01217814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754769|NCT01217814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754770|NCT01217814|Antimetabolites|antimetabolites|mesh-ancestor
92754771|NCT01217814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754772|NCT01217814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754773|NCT01217814|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754774|NCT01217814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754775|NCT01217814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92754776|NCT01217814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754777|NCT01217814|Immunologic Factors|immunologic factors|mesh-ancestor
92754778|NCT01217814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92754779|NCT01217814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92754780|NCT01217814|Antidotes|antidotes|mesh-ancestor
92754781|NCT01217814|Protective Agents|protective agents|mesh-ancestor
92754782|NCT01217814|Vitamin B Complex|vitamin b complex|mesh-ancestor
92754783|NCT01217814|Vitamins|vitamins|mesh-ancestor
92754784|NCT01217814|Micronutrients|micronutrients|mesh-ancestor
92754785|NCT01217814|Hematinics|hematinics|mesh-ancestor
92754786|NCT01217814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92754787|NCT01217814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754788|NCT01217190|Ondansetron|ondansetron|mesh-list
92754789|NCT01217190|Antiemetics|antiemetics|mesh-ancestor
92754790|NCT01217190|Autonomic Agents|autonomic agents|mesh-ancestor
92754791|NCT01217190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754792|NCT01217190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754793|NCT01217190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754794|NCT01217190|Antipruritics|antipruritics|mesh-ancestor
92754795|NCT01217190|Dermatologic Agents|dermatologic agents|mesh-ancestor
92754796|NCT01217190|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92754797|NCT01217190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92754798|NCT01217190|Serotonin Agents|serotonin agents|mesh-ancestor
92754799|NCT01217190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754800|NCT01217190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754801|NCT01136733|Everolimus|everolimus|mesh-list
92754802|NCT01136733|Lenvatinib|lenvatinib|mesh-list
92754803|NCT01136733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92754804|NCT01136733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92754805|NCT01136733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728754|NCT00576173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92728755|NCT00576173|Narcotics|narcotics|mesh-ancestor
92728756|NCT00576173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728757|NCT00625339|Lamivudine|lamivudine|mesh-list
92728758|NCT00625339|Entecavir|entecavir|mesh-list
92728759|NCT00625339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92728760|NCT00625339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92728761|NCT00625339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754806|NCT01136733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754807|NCT01136733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754808|NCT01136733|Immunologic Factors|immunologic factors|mesh-ancestor
92754809|NCT01136733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754810|NCT01136733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754811|NCT05178693|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92754812|NCT05178693|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92754813|NCT05178693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92754814|NCT05178693|Antimetabolites|antimetabolites|mesh-ancestor
92754815|NCT05178693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754816|NCT05178693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754825|NCT01136655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754826|NCT01136655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92754827|NCT01136655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92754829|NCT01136655|Hormones|hormones|mesh-ancestor
92754830|NCT01136655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754831|NCT01136655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92754832|NCT01136655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92754833|NCT01136655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92754834|NCT01136655|Adrenergic Agents|adrenergic agents|mesh-ancestor
92754835|NCT01136655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754836|NCT01136655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754837|NCT01135017|Dronedarone|dronedarone|mesh-list
92754838|NCT01135017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92754839|NCT01134705|Beclomethasone|beclomethasone|mesh-list
92754840|NCT01134705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754841|NCT01134705|Glucocorticoids|glucocorticoids|mesh-ancestor
92754842|NCT01134705|Hormones|hormones|mesh-ancestor
92754843|NCT01134705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754844|NCT01134705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754845|NCT01134705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92754846|NCT01134705|Respiratory System Agents|respiratory system agents|mesh-ancestor
92754847|NCT01134627|Minocycline|minocycline|mesh-list
92754848|NCT01134627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92754849|NCT01134627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754850|NCT01134393|Amlodipine|amlodipine|mesh-list
92754851|NCT01134393|Telmisartan|telmisartan|mesh-list
92754852|NCT01134393|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92754853|NCT01134393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92754854|NCT01134393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92754855|NCT01134393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754856|NCT01134393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754857|NCT01134393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92754858|NCT01134393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754859|NCT01134393|Vasodilator Agents|vasodilator agents|mesh-ancestor
92754860|NCT01134393|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92754861|NCT01134393|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92754862|NCT05331469|Insulin|insulin|mesh-list
92754863|NCT05331469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92754864|NCT05331469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754865|NCT00922441|Valsartan|valsartan|mesh-list
92754866|NCT00922441|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92754867|NCT00922441|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92754868|NCT00922441|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92728762|NCT00625339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728763|NCT00625339|Antiviral Agents|antiviral agents|mesh-ancestor
92728764|NCT00625339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728765|NCT00625339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92728766|NCT00625339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92754869|NCT00922441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754870|NCT01217112|Cannabidiol|cannabidiol|mesh-list
92754871|NCT01217112|Anticonvulsants|anticonvulsants|mesh-ancestor
92754872|NCT01216332|Vaccines|vaccines|mesh-list
92754873|NCT01216332|Immunologic Factors|immunologic factors|mesh-ancestor
92754874|NCT01216332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754875|NCT00922207|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92754876|NCT00922207|Entecavir|entecavir|mesh-list
92754877|NCT00922207|Adefovir|adefovir|mesh-list
92754878|NCT00922207|Antiviral Agents|antiviral agents|mesh-ancestor
92754879|NCT00922207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754880|NCT00922207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92754881|NCT00922207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92754890|NCT01134315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92754892|NCT01134315|Micronutrients|micronutrients|mesh-ancestor
92754893|NCT01134315|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92754894|NCT01216176|Anastrozole|anastrozole|mesh-list
92754895|NCT01216176|Saracatinib|saracatinib|mesh-list
92754896|NCT01216176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92754897|NCT01216176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754898|NCT01216176|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92754899|NCT01216176|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92754900|NCT01216176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754901|NCT01216176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754902|NCT01216176|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92754903|NCT01216176|Hormone Antagonists|hormone antagonists|mesh-ancestor
92754904|NCT01216176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754905|NCT01216176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754906|NCT01133847|Guanfacine|guanfacine|mesh-list
92754907|NCT01133847|Methylphenidate|methylphenidate|mesh-list
92754908|NCT01133847|Amphetamine|amphetamine|mesh-list
92754909|NCT01133847|Adderall|adderall|mesh-list
92754910|NCT01133847|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92754911|NCT01133847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92754912|NCT01133847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754913|NCT01133847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92754914|NCT01133847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92754915|NCT01133847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754916|NCT01133847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754917|NCT01133847|Dopamine Agents|dopamine agents|mesh-ancestor
92754918|NCT01133847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754919|NCT01133847|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92754920|NCT01133847|Adrenergic Agents|adrenergic agents|mesh-ancestor
92754921|NCT01133847|Sympathomimetics|sympathomimetics|mesh-ancestor
92754922|NCT01133847|Autonomic Agents|autonomic agents|mesh-ancestor
92754923|NCT01133847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754924|NCT01133847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92754925|NCT01133847|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92754926|NCT01133847|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92754927|NCT01133847|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92754928|NCT01133379|Fluorides|fluorides|mesh-list
92754929|NCT01133379|Cariostatic Agents|cariostatic agents|mesh-ancestor
92754930|NCT01133379|Protective Agents|protective agents|mesh-ancestor
92754931|NCT01133379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754932|NCT04253353|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92754933|NCT04253353|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92754934|NCT04253353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92754935|NCT04253353|Antimetabolites|antimetabolites|mesh-ancestor
92754936|NCT04253353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754937|NCT04253353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92754938|NCT04253353|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92754939|NCT04253353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754940|NCT05154669|Nicotine|nicotine|mesh-list
92754941|NCT05154669|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92754942|NCT05154669|Autonomic Agents|autonomic agents|mesh-ancestor
92728767|NCT02215863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92728768|NCT02215863|Immunologic Factors|immunologic factors|mesh-ancestor
92728769|NCT02215863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728770|NCT04558463|Oseltamivir|oseltamivir|mesh-list
92728771|NCT04558463|Favipiravir|favipiravir|mesh-list
92728772|NCT04558463|Antiviral Agents|antiviral agents|mesh-ancestor
92728773|NCT04558463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728774|NCT04558463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728775|NCT04558463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728776|NCT01126879|Genistein|genistein|mesh-list
92728777|NCT01126879|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92728778|NCT01126879|Protective Agents|protective agents|mesh-ancestor
92728779|NCT01126879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728780|NCT01126879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754943|NCT05154669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754944|NCT05154669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754945|NCT05154669|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92754952|NCT00637455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92754953|NCT00637455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92754954|NCT00637455|Histamine Antagonists|histamine antagonists|mesh-ancestor
92754955|NCT00637455|Histamine Agents|histamine agents|mesh-ancestor
92754956|NCT00637455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754957|NCT00637455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754958|NCT00637455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754959|NCT00919711|Denosumab|denosumab|mesh-list
92754960|NCT00919711|Risedronic Acid|risedronic acid|mesh-list
92754961|NCT00919711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92754962|NCT00919711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754963|NCT00919711|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92754964|NCT00919711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754965|NCT00919711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094130|NCT00948298|Vitamin D|vitamin d|mesh-list
92754966|NCT00919711|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92754967|NCT01131585|Ranibizumab|ranibizumab|mesh-list
92754968|NCT01131585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92754969|NCT01131585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92754970|NCT01131585|Growth Substances|growth substances|mesh-ancestor
92754971|NCT01131585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754972|NCT01131585|Growth Inhibitors|growth inhibitors|mesh-ancestor
92754973|NCT01131585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754974|NCT01131507|Pancrelipase|pancrelipase|mesh-list
92754975|NCT01131507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92754976|NCT00919633|Interferons|interferons|mesh-list
92754977|NCT00919633|Ribavirin|ribavirin|mesh-list
92754978|NCT00919633|Interferon-alpha|interferon-alpha|mesh-list
92754979|NCT00919633|Interferon alpha-2|interferon alpha-2|mesh-list
92754980|NCT00919633|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92754981|NCT00919633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754982|NCT00919633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754983|NCT00919633|Antiviral Agents|antiviral agents|mesh-ancestor
92754984|NCT00919633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92754985|NCT00919633|Antimetabolites|antimetabolites|mesh-ancestor
92754986|NCT00919633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754987|NCT00919633|Immunologic Factors|immunologic factors|mesh-ancestor
92754988|NCT00926029|Listerine|listerine|mesh-list
92754989|NCT00926029|Triclosan|triclosan|mesh-list
92754990|NCT00926029|Fluorides|fluorides|mesh-list
92754991|NCT00926029|Sodium Fluoride|sodium fluoride|mesh-list
92754992|NCT00926029|Cariostatic Agents|cariostatic agents|mesh-ancestor
92754993|NCT00926029|Protective Agents|protective agents|mesh-ancestor
92754994|NCT00926029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754995|NCT00926029|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92754996|NCT00926029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728781|NCT01126879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92728783|NCT01126879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728784|NCT01126879|Phytoestrogens|phytoestrogens|mesh-ancestor
92728785|NCT01126879|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92728786|NCT01126879|Estrogens|estrogens|mesh-ancestor
92728787|NCT01126879|Hormones|hormones|mesh-ancestor
92728788|NCT01126879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728789|NCT04311658|Isosorbide|isosorbide|mesh-list
92728790|NCT04311658|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92728791|NCT04311658|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92754997|NCT00926029|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92754998|NCT00926029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92754999|NCT00926029|Antimetabolites|antimetabolites|mesh-ancestor
92755000|NCT00926029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755001|NCT00926029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92755002|NCT04254835|Chlorhexidine, thymol drug combination|chlorhexidine, thymol drug combination|mesh-list
92755003|NCT04254835|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92755004|NCT04254835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755005|NCT04254913|Edaravone|edaravone|mesh-list
92755006|NCT04254913|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92755007|NCT04254913|Antioxidants|antioxidants|mesh-ancestor
92755008|NCT04254913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755009|NCT04254913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92755010|NCT04254913|Protective Agents|protective agents|mesh-ancestor
92755011|NCT04254913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755012|NCT01130493|Levodopa|levodopa|mesh-list
92755013|NCT01130493|Carbidopa|carbidopa|mesh-list
92755014|NCT01130493|Entacapone|entacapone|mesh-list
92755015|NCT01130493|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92755021|NCT01130493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755022|NCT01130493|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92755023|NCT01130493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755024|NCT01130493|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92755025|NCT01130493|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92755026|NCT01130493|Immunologic Factors|immunologic factors|mesh-ancestor
92755027|NCT01130493|Dopamine Agonists|dopamine agonists|mesh-ancestor
92755028|NCT01130337|Capecitabine|capecitabine|mesh-list
92755029|NCT01130337|Oxaliplatin|oxaliplatin|mesh-list
92755030|NCT01130337|Trastuzumab|trastuzumab|mesh-list
92755031|NCT01130337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92755032|NCT01130337|Antimetabolites|antimetabolites|mesh-ancestor
92755033|NCT01130337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401268|NCT01415596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92755034|NCT01130337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755035|NCT01130337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755037|NCT04901689|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92755038|NCT04901689|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92755039|NCT04901689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755040|NCT04901689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92755041|NCT04901689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92755042|NCT04901689|Antiviral Agents|antiviral agents|mesh-ancestor
92755043|NCT04901689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755044|NCT04252963|Streptokinase|streptokinase|mesh-list
92755045|NCT04252963|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92755046|NCT04252963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92755047|NCT04252963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755048|NCT04258657|Paclitaxel|paclitaxel|mesh-list
92755049|NCT04258657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755050|NCT04258657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755051|NCT04258657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755052|NCT04258657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755053|NCT04258657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755054|NCT04258657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728792|NCT04311658|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92728793|NCT04311658|Diuretics|diuretics|mesh-ancestor
92728794|NCT04311658|Natriuretic Agents|natriuretic agents|mesh-ancestor
92728795|NCT04311658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728796|NCT04311658|Vasodilator Agents|vasodilator agents|mesh-ancestor
92728797|NCT04311658|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92755055|NCT01130103|Paroxetine|paroxetine|mesh-list
92755056|NCT01130103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92755057|NCT01130103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92755058|NCT01130103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92755059|NCT01130103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755060|NCT01130103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755061|NCT01130103|Serotonin Agents|serotonin agents|mesh-ancestor
92755062|NCT01130103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755063|NCT01130103|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92755064|NCT01130103|Antidepressive Agents|antidepressive agents|mesh-ancestor
92755065|NCT01130103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92755066|NCT01130103|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92755067|NCT01130103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92755068|NCT01130103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755069|NCT04254523|Morphine|morphine|mesh-list
92755070|NCT04254523|Bupivacaine|bupivacaine|mesh-list
92755071|NCT04254523|Anesthetics, Local|anesthetics, local|mesh-ancestor
92755072|NCT04254523|Anesthetics|anesthetics|mesh-ancestor
92755073|NCT04254523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755074|NCT04254523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755075|NCT04254523|Sensory System Agents|sensory system agents|mesh-ancestor
92755076|NCT04254523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755077|NCT04254523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92755078|NCT04254523|Narcotics|narcotics|mesh-ancestor
92755079|NCT04254523|Analgesics|analgesics|mesh-ancestor
92755080|NCT00625209|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92755081|NCT00625209|Hydrocortisone|hydrocortisone|mesh-list
92401272|NCT01415687|Bisacodyl|bisacodyl|mesh-list
92755082|NCT00625209|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92755083|NCT00625209|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92755089|NCT00625209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92755090|NCT00625209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92755091|NCT00625209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755092|NCT00625209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755094|NCT04254601|Erythromycin Estolate|erythromycin estolate|mesh-list
92755095|NCT04254601|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92755096|NCT04254601|Erythromycin stearate|erythromycin stearate|mesh-list
92755097|NCT04254601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92755098|NCT04254601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755099|NCT04254601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92755100|NCT04254601|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92755101|NCT04254601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755102|NCT04254601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755103|NCT01129557|Valsartan|valsartan|mesh-list
92755104|NCT01129557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92755105|NCT01129557|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92755106|NCT01129557|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92755107|NCT01129557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755108|NCT04254679|Analgesics, Opioid|analgesics, opioid|mesh-list
92755109|NCT04254679|Analgesics|analgesics|mesh-list
92755110|NCT04254679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92755111|NCT04254679|Narcotics|narcotics|mesh-ancestor
92755112|NCT04254679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755113|NCT04254679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755114|NCT04254679|Sensory System Agents|sensory system agents|mesh-ancestor
92755115|NCT04254679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755116|NCT01129011|Naproxen|naproxen|mesh-list
92755117|NCT01129011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755118|NCT01129011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755119|NCT01129011|Analgesics|analgesics|mesh-ancestor
92755120|NCT01129011|Sensory System Agents|sensory system agents|mesh-ancestor
92755121|NCT01129011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755122|NCT01129011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728798|NCT04311658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728799|NCT02882308|Durvalumab|durvalumab|mesh-list
92728800|NCT02882308|Olaparib|olaparib|mesh-list
92728801|NCT02882308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728802|NCT02882308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92728803|NCT02882308|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92728804|NCT02882308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728805|NCT02882308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728806|NCT00625456|Molgramostim|molgramostim|mesh-list
92755123|NCT01129011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755124|NCT01129011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755125|NCT01129011|Gout Suppressants|gout suppressants|mesh-ancestor
92755126|NCT01129011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92755127|NCT01129011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755128|NCT01129011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755129|NCT04252885|Ritonavir|ritonavir|mesh-list
92755130|NCT04252885|Lopinavir|lopinavir|mesh-list
92755131|NCT04252885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92755132|NCT04252885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92755133|NCT04252885|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755134|NCT04252885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755135|NCT04252885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755136|NCT04252885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92755137|NCT04252885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92755138|NCT04252885|Antiviral Agents|antiviral agents|mesh-ancestor
92755139|NCT04252885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755140|NCT04252885|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92755141|NCT04252885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92755142|NCT04962841|Metformin|metformin|mesh-list
92755143|NCT04962841|Amlodipine|amlodipine|mesh-list
92755144|NCT04962841|Ramipril|ramipril|mesh-list
92755145|NCT04962841|Nebivolol|nebivolol|mesh-list
92755146|NCT04962841|Rivastigmine|rivastigmine|mesh-list
92755147|NCT04962841|Sertraline|sertraline|mesh-list
92755148|NCT04962841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92755149|NCT04962841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755150|NCT04962841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92755151|NCT04962841|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92755152|NCT04962841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92755153|NCT04962841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755154|NCT04962841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92755155|NCT04962841|Vasodilator Agents|vasodilator agents|mesh-ancestor
92755160|NCT04962841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755161|NCT04962841|Serotonin Agents|serotonin agents|mesh-ancestor
92755162|NCT04962841|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92755163|NCT04962841|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755164|NCT04962841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755165|NCT04962841|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92755166|NCT04962841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92755167|NCT04962841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92755168|NCT04962841|Adrenergic Agents|adrenergic agents|mesh-ancestor
92755169|NCT04962841|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92755170|NCT04962841|Cholinergic Agents|cholinergic agents|mesh-ancestor
92755171|NCT04962841|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92755172|NCT04962841|Protective Agents|protective agents|mesh-ancestor
92755173|NCT00919867|Guanfacine|guanfacine|mesh-list
92755174|NCT00919867|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92755175|NCT00919867|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92755176|NCT00919867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755177|NCT00919867|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92755178|NCT00919867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92755179|NCT00919867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92755180|NCT00919867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755181|NCT00919867|Dopamine Agents|dopamine agents|mesh-ancestor
92755182|NCT00919867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755183|NCT00919867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92755184|NCT00919867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92755185|NCT00919867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92755186|NCT00919867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92755187|NCT00919867|Adrenergic Agents|adrenergic agents|mesh-ancestor
92755188|NCT04252261|Sulforaphane|sulforaphane|mesh-list
92755189|NCT04252261|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92755190|NCT04252261|Protective Agents|protective agents|mesh-ancestor
92755191|NCT04252261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755192|NCT04252261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755193|NCT04251871|Interferons|interferons|mesh-list
92755194|NCT04251871|Ritonavir|ritonavir|mesh-list
92755195|NCT04251871|Lopinavir|lopinavir|mesh-list
92755196|NCT04251871|Interferon-alpha|interferon-alpha|mesh-list
92755197|NCT04251871|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92755198|NCT04251871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755199|NCT04251871|Antiviral Agents|antiviral agents|mesh-ancestor
92755200|NCT04251871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755201|NCT04251871|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92755202|NCT04251871|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92755203|NCT04251871|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755204|NCT04251871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755205|NCT04251871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755206|NCT04251871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92755207|NCT04251871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92755208|NCT04251871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92755209|NCT04251871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92755210|NCT04251871|Immunologic Factors|immunologic factors|mesh-ancestor
92755211|NCT04251871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755212|NCT01128621|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92755213|NCT01128621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92755214|NCT01128621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755215|NCT01128621|Incretins|incretins|mesh-ancestor
92755216|NCT01128621|Hormones|hormones|mesh-ancestor
92755217|NCT01128621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755218|NCT01128621|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92755219|NCT01128621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755220|NCT01128621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755221|NCT01128621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755222|NCT00918463|Dasatinib|dasatinib|mesh-list
92755223|NCT00918463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755224|NCT00918463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755225|NCT00918463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755228|NCT05330065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755230|NCT05330065|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92755231|NCT05330065|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92755232|NCT05330065|Growth Substances|growth substances|mesh-ancestor
92755233|NCT05330065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755234|NCT05330065|Growth Inhibitors|growth inhibitors|mesh-ancestor
92755235|NCT01128543|Vinorelbine|vinorelbine|mesh-list
92755236|NCT01128543|Lapatinib|lapatinib|mesh-list
92755237|NCT01128543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755238|NCT01128543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755239|NCT01128543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755240|NCT01128543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755241|NCT01128543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755242|NCT01128543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755243|NCT01128543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755244|NCT01128543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755246|NCT01128387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755247|NCT01128387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755248|NCT01214850|Vaccines|vaccines|mesh-list
92755249|NCT01214850|Immunologic Factors|immunologic factors|mesh-ancestor
92755250|NCT01214850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755251|NCT01128153|Saxagliptin|saxagliptin|mesh-list
92755252|NCT01128153|Incretins|incretins|mesh-ancestor
92755253|NCT01128153|Hormones|hormones|mesh-ancestor
92755254|NCT01128153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755255|NCT01128153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755256|NCT01128153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92755257|NCT01128153|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755258|NCT01128153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755259|NCT01128153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728808|NCT00625456|Immunologic Factors|immunologic factors|mesh-ancestor
92728809|NCT00625456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728810|NCT00625456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728811|NCT04539444|Tislelizumab|tislelizumab|mesh-list
92728812|NCT04539444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92728813|NCT04539444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755260|NCT01128153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92755261|NCT00925015|Irinotecan|irinotecan|mesh-list
92755262|NCT00925015|Cetuximab|cetuximab|mesh-list
92755263|NCT00925015|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92755264|NCT00925015|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92755265|NCT00925015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92755266|NCT00925015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755267|NCT00925015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755268|NCT00925015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755269|NCT00925015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755270|NCT00925015|Immunologic Factors|immunologic factors|mesh-ancestor
92755271|NCT00925015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755272|NCT01127763|Carboplatin|carboplatin|mesh-list
92755273|NCT01127763|Everolimus|everolimus|mesh-list
92755274|NCT01127763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755275|NCT01127763|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92755276|NCT01127763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755277|NCT01127763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755278|NCT01127763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755279|NCT01127763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755280|NCT01127763|Immunologic Factors|immunologic factors|mesh-ancestor
92755281|NCT01127763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755282|NCT01127607|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92755283|NCT01127607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92755284|NCT01127607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755285|NCT01127607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92755286|NCT01127607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92755287|NCT01127607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92755288|NCT01127607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755289|NCT01127607|Dopamine Agents|dopamine agents|mesh-ancestor
92755290|NCT01127607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755291|NCT00924781|Epoetin Alfa|epoetin alfa|mesh-list
92755292|NCT00924781|Hematinics|hematinics|mesh-ancestor
92755293|NCT01127451|Denileukin diftitox|denileukin diftitox|mesh-list
92755294|NCT01127451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755295|NCT01214616|Vinorelbine|vinorelbine|mesh-list
92755296|NCT01214616|Afatinib|afatinib|mesh-list
92755297|NCT01214616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755309|NCT01213836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92755310|NCT01213836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755311|NCT01213836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755312|NCT01213524|Nicotine|nicotine|mesh-list
92755313|NCT01213524|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92755314|NCT01213524|Autonomic Agents|autonomic agents|mesh-ancestor
92755315|NCT01213524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755316|NCT01213524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755317|NCT01213524|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92755318|NCT01213524|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92755319|NCT01213524|Cholinergic Agents|cholinergic agents|mesh-ancestor
92755320|NCT01213524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755321|NCT01213524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755322|NCT01212588|Mifepristone|mifepristone|mesh-list
92755323|NCT01212588|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92755324|NCT01212588|Abortifacient Agents|abortifacient agents|mesh-ancestor
92755325|NCT01212588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92755326|NCT01212588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755327|NCT01212588|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92755328|NCT01212588|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92755329|NCT01212588|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92755330|NCT01212588|Contraceptive Agents|contraceptive agents|mesh-ancestor
92755331|NCT01212588|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92755332|NCT01212588|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92728814|NCT04539444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728815|NCT04539444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728816|NCT00576329|Ketorolac|ketorolac|mesh-list
92728817|NCT00576329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92728818|NCT00576329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728819|NCT00576329|Analgesics|analgesics|mesh-ancestor
92728820|NCT00576329|Sensory System Agents|sensory system agents|mesh-ancestor
92755333|NCT01212588|Hormone Antagonists|hormone antagonists|mesh-ancestor
92755334|NCT01212588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755335|NCT01212588|Luteolytic Agents|luteolytic agents|mesh-ancestor
92755336|NCT01212588|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92755337|NCT01212588|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92755338|NCT00918385|Dasatinib|dasatinib|mesh-list
92755339|NCT00918385|Nilutamide|nilutamide|mesh-list
92755340|NCT00918385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755341|NCT00918385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755342|NCT00918385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755343|NCT00918385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755344|NCT00918385|Androgen Antagonists|androgen antagonists|mesh-ancestor
92755345|NCT00918385|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401320|NCT01415765|Hormones|hormones|mesh-ancestor
92755346|NCT00918385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755347|NCT00918385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755348|NCT00637819|Leflunomide|leflunomide|mesh-list
92755349|NCT00637819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755350|NCT00637819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755351|NCT00637819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755352|NCT00637819|Immunologic Factors|immunologic factors|mesh-ancestor
92755353|NCT00637819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755354|NCT00631501|Doxycycline|doxycycline|mesh-list
92755355|NCT00631501|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92755356|NCT00631501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755357|NCT00631501|Antimalarials|antimalarials|mesh-ancestor
92755358|NCT00631501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92755359|NCT00631501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92755360|NCT04746547|Dolutegravir|dolutegravir|mesh-list
92755364|NCT04746547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755365|NCT04746547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92755366|NCT04746547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92755367|NCT04746547|Antiviral Agents|antiviral agents|mesh-ancestor
92755368|NCT04746547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755369|NCT04782037|Calcium|calcium|mesh-list
92755370|NCT04782037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92755371|NCT04782037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755372|NCT00924469|Prednisone|prednisone|mesh-list
92755373|NCT00924469|Leuprolide|leuprolide|mesh-list
92755374|NCT00924469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755375|NCT00924469|Glucocorticoids|glucocorticoids|mesh-ancestor
92755376|NCT00924469|Hormones|hormones|mesh-ancestor
92755377|NCT00924469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755378|NCT00924469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755379|NCT00924469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92755380|NCT00924469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755381|NCT00924469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92755382|NCT00924469|Fertility Agents|fertility agents|mesh-ancestor
92755383|NCT00924469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92755384|NCT00631579|Rasburicase|rasburicase|mesh-list
92755385|NCT00631579|Gout Suppressants|gout suppressants|mesh-ancestor
92755386|NCT00631579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755387|NCT04256473|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92408744|NCT05962151|Nalbuphine|nalbuphine|mesh-list
92755388|NCT04256473|Saruplase|saruplase|mesh-list
92755389|NCT04256473|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92755390|NCT04256473|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92755391|NCT04256473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755392|NCT00916357|Insulin|insulin|mesh-list
92755393|NCT00916357|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92755394|NCT00916357|Insulin Lispro|insulin lispro|mesh-list
92755395|NCT00916357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728821|NCT00576329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728822|NCT00576329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728823|NCT00576329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728824|NCT00576329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728825|NCT00576329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92728826|NCT00576329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728827|NCT00576329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755396|NCT00916357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755397|NCT00916279|Paclitaxel|paclitaxel|mesh-list
92755398|NCT00916279|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755399|NCT00916279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755400|NCT00916279|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755401|NCT00916279|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755402|NCT00916279|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755403|NCT00916279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755404|NCT01209078|Linezolid|linezolid|mesh-list
92755405|NCT01209078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92755406|NCT01209078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755407|NCT01209078|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92755408|NCT01209078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755409|NCT01209078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755410|NCT04318158|Fentanyl|fentanyl|mesh-list
92755411|NCT04318158|Dexmedetomidine|dexmedetomidine|mesh-list
92755412|NCT04318158|Bupivacaine|bupivacaine|mesh-list
92755413|NCT04318158|Anesthetics, Local|anesthetics, local|mesh-ancestor
92755414|NCT04318158|Anesthetics|anesthetics|mesh-ancestor
92755415|NCT04318158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755416|NCT04318158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755417|NCT04318158|Sensory System Agents|sensory system agents|mesh-ancestor
92755418|NCT04318158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755419|NCT04318158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92755420|NCT04318158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755421|NCT04318158|Analgesics|analgesics|mesh-ancestor
92755422|NCT04318158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92755423|NCT04318158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92755424|NCT04318158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92755425|NCT04318158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92755426|NCT04318158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755427|NCT04318158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755428|NCT04318158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92755429|NCT04318158|Narcotics|narcotics|mesh-ancestor
92755430|NCT04318158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92755431|NCT04318158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92755432|NCT04318158|Anesthetics, General|anesthetics, general|mesh-ancestor
92755433|NCT01207596|Hydromorphone|hydromorphone|mesh-list
92755438|NCT01207596|Analgesics|analgesics|mesh-ancestor
92755439|NCT01207596|Sensory System Agents|sensory system agents|mesh-ancestor
92755440|NCT01207596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755441|NCT00915343|Hydrocortisone|hydrocortisone|mesh-list
92755442|NCT00915343|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92755443|NCT00915343|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92755444|NCT00915343|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92755445|NCT00915343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755446|NCT04203043|Pycnogenols|pycnogenols|mesh-list
92755447|NCT04203043|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92755448|NCT04203043|Immunologic Factors|immunologic factors|mesh-ancestor
92755449|NCT04203043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755450|NCT04203043|Antioxidants|antioxidants|mesh-ancestor
92755451|NCT04203043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755452|NCT04203043|Protective Agents|protective agents|mesh-ancestor
92755453|NCT04203043|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92755454|NCT04435015|Camostat|camostat|mesh-list
92755455|NCT04435015|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755456|NCT04435015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755457|NCT04435015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755458|NCT04435015|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92755459|NCT04435015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92728829|NCT02882581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728830|NCT02882581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728831|NCT02882347|Somatostatin|somatostatin|mesh-list
92728832|NCT02882347|Hormones|hormones|mesh-ancestor
92728833|NCT02882347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728834|NCT02882347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728835|NCT00576368|Insulin Glargine|insulin glargine|mesh-list
92755460|NCT00631813|Prucalopride|prucalopride|mesh-list
92755461|NCT00631813|Laxatives|laxatives|mesh-ancestor
92755462|NCT00631813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92755463|NCT00631813|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92755464|NCT00631813|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92755465|NCT00631813|Serotonin Agents|serotonin agents|mesh-ancestor
92755466|NCT00631813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755467|NCT00631813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755468|NCT00631813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755469|NCT04404049|UB-421|ub-421|mesh-list
92755470|NCT04404049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92755471|NCT04404049|Antiviral Agents|antiviral agents|mesh-ancestor
92755472|NCT04404049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755473|NCT04911517|Capecitabine|capecitabine|mesh-list
92755474|NCT04911517|Antibodies|antibodies|mesh-list
92755475|NCT04911517|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92755476|NCT04911517|Immunologic Factors|immunologic factors|mesh-ancestor
92755477|NCT04911517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755478|NCT04911517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92755479|NCT04911517|Antimetabolites|antimetabolites|mesh-ancestor
92755480|NCT04911517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755481|NCT04911517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755482|NCT00637897|Paclitaxel|paclitaxel|mesh-list
92755483|NCT00637897|Docetaxel|docetaxel|mesh-list
92755484|NCT00637897|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92755485|NCT00637897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755486|NCT00637897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755487|NCT00637897|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755488|NCT00637897|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755489|NCT00637897|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755490|NCT00637897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755491|NCT03992443|Reteplase|reteplase|mesh-list
92755492|NCT03992443|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92755493|NCT03992443|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92755494|NCT03992443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755495|NCT04329949|Paclitaxel|paclitaxel|mesh-list
92755496|NCT04329949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755497|NCT04329949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755498|NCT04329949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755499|NCT04329949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755500|NCT04329949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755501|NCT04329949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755502|NCT04597099|Flutamide|flutamide|mesh-list
92755503|NCT04597099|Estradiol|estradiol|mesh-list
92755504|NCT04597099|Progesterone|progesterone|mesh-list
92755505|NCT04597099|Estrogens|estrogens|mesh-ancestor
92755517|NCT04203511|Etoposide|etoposide|mesh-list
92755518|NCT04203511|Carboplatin|carboplatin|mesh-list
92755519|NCT04203511|Pemetrexed|pemetrexed|mesh-list
92755520|NCT04203511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92755521|NCT04203511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755522|NCT04203511|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755523|NCT04203511|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755524|NCT04203511|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755525|NCT04203511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755526|NCT04203511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92755527|NCT04203511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92755528|NCT04203511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755529|NCT04203511|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92755530|NCT04203511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92755531|NCT03690037|Tranexamic Acid|tranexamic acid|mesh-list
92728837|NCT00576368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728838|NCT00637468|Aspirin|aspirin|mesh-list
92728839|NCT00637468|Heparin|heparin|mesh-list
92728840|NCT00637468|Acetazolamide|acetazolamide|mesh-list
92728841|NCT00637468|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92728842|NCT00637468|Anticoagulants|anticoagulants|mesh-ancestor
92728843|NCT00637468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92755532|NCT03690037|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92755533|NCT03690037|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92755534|NCT03690037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755535|NCT03690037|Hemostatics|hemostatics|mesh-ancestor
92755536|NCT03690037|Coagulants|coagulants|mesh-ancestor
92755537|NCT00910273|Etanercept|etanercept|mesh-list
92755538|NCT00910273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755539|NCT00910273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755540|NCT00910273|Analgesics|analgesics|mesh-ancestor
92755541|NCT00910273|Sensory System Agents|sensory system agents|mesh-ancestor
92755542|NCT00910273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755543|NCT00910273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755544|NCT00910273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755545|NCT00910273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755546|NCT00910273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92755547|NCT00910273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755548|NCT00910273|Immunologic Factors|immunologic factors|mesh-ancestor
92755549|NCT04156087|Gemcitabine|gemcitabine|mesh-list
92755550|NCT04156087|Durvalumab|durvalumab|mesh-list
92755551|NCT04156087|Tremelimumab|tremelimumab|mesh-list
92401341|NCT01415895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92755552|NCT04156087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92755553|NCT04156087|Antimetabolites|antimetabolites|mesh-ancestor
92755554|NCT04156087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755555|NCT04156087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755556|NCT04156087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755557|NCT00910039|Sunitinib|sunitinib|mesh-list
92755558|NCT00910039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755559|NCT00910039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92755560|NCT00910039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92755561|NCT00910039|Growth Substances|growth substances|mesh-ancestor
92755562|NCT00910039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755563|NCT00910039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92755564|NCT00910039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755565|NCT00910039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755566|NCT00910039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755567|NCT00909181|Mandelic Acids|mandelic acids|mesh-list
92755568|NCT00909181|Oxybutynin|oxybutynin|mesh-list
92755569|NCT00909181|Parasympatholytics|parasympatholytics|mesh-ancestor
92755570|NCT00909181|Autonomic Agents|autonomic agents|mesh-ancestor
92755571|NCT00909181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755575|NCT00909181|Cholinergic Agents|cholinergic agents|mesh-ancestor
92755576|NCT00909181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755577|NCT00909181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755578|NCT00909181|Urological Agents|urological agents|mesh-ancestor
92755579|NCT00909181|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92755580|NCT00909181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755581|NCT05579665|Hyaluronic Acid|hyaluronic acid|mesh-list
92755582|NCT05579665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92755583|NCT05579665|Immunologic Factors|immunologic factors|mesh-ancestor
92755584|NCT05579665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755585|NCT05579665|Viscosupplements|viscosupplements|mesh-ancestor
92755586|NCT05579665|Protective Agents|protective agents|mesh-ancestor
92755587|NCT01286987|Talazoparib|talazoparib|mesh-list
92755588|NCT01286987|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92755589|NCT01286987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755590|NCT01286987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755591|NCT01286987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755592|NCT01286753|Vemurafenib|vemurafenib|mesh-list
92755593|NCT01286753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755594|NCT01286753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755595|NCT01286753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728844|NCT00637468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92728845|NCT00637468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728846|NCT00637468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92728847|NCT00637468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728848|NCT00637468|Analgesics|analgesics|mesh-ancestor
92728849|NCT00637468|Sensory System Agents|sensory system agents|mesh-ancestor
92728850|NCT00637468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755596|NCT01286753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755597|NCT01284959|Risperidone|risperidone|mesh-list
92755598|NCT01284959|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92755599|NCT01284959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92755600|NCT01284959|Serotonin Agents|serotonin agents|mesh-ancestor
92755601|NCT01284959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755602|NCT01284959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755603|NCT01284959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755604|NCT01284959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92755605|NCT01284959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92755606|NCT01284959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755607|NCT01284959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92755608|NCT01284959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92755609|NCT01284959|Dopamine Agents|dopamine agents|mesh-ancestor
92755610|NCT01284959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92755611|NCT01284959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92755612|NCT01283009|Methylprednisolone|methylprednisolone|mesh-list
92755613|NCT01283009|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92755614|NCT01283009|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92755615|NCT01283009|Prednisolone|prednisolone|mesh-list
92755616|NCT01283009|Prednisolone acetate|prednisolone acetate|mesh-list
92755617|NCT01283009|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92755618|NCT01283009|Prednisolone phosphate|prednisolone phosphate|mesh-list
92755619|NCT01283009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755620|NCT01283009|Antiemetics|antiemetics|mesh-ancestor
92755621|NCT01283009|Autonomic Agents|autonomic agents|mesh-ancestor
92755622|NCT01283009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755623|NCT01283009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755624|NCT01283009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92755625|NCT01283009|Glucocorticoids|glucocorticoids|mesh-ancestor
92755627|NCT01283009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755628|NCT01283009|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92755629|NCT01283009|Protective Agents|protective agents|mesh-ancestor
92755630|NCT01283009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92755631|NCT01283009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755632|NCT01282463|Docetaxel|docetaxel|mesh-list
92755633|NCT01282463|Ramucirumab|ramucirumab|mesh-list
92755634|NCT01282463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755635|NCT01282463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755636|NCT01282463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755637|NCT01282463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755638|NCT01282463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755639|NCT01281917|Sirolimus|sirolimus|mesh-list
92755640|NCT01281917|Bortezomib|bortezomib|mesh-list
92755641|NCT01281917|Temsirolimus|temsirolimus|mesh-list
92755642|NCT01281917|MTOR Inhibitors|mtor inhibitors|mesh-list
92755643|NCT01281917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755653|NCT01281917|Antifungal Agents|antifungal agents|mesh-ancestor
92755655|NCT01281839|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92755656|NCT01281839|Simeprevir|simeprevir|mesh-list
92755657|NCT01281839|Antimetabolites|antimetabolites|mesh-ancestor
92755658|NCT01281839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755659|NCT01281839|Antiviral Agents|antiviral agents|mesh-ancestor
92755660|NCT01281839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755661|NCT01281839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755662|NCT01281839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755663|NCT01280981|Tranexamic Acid|tranexamic acid|mesh-list
92755664|NCT01280981|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92755665|NCT01280981|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92755666|NCT01280981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755667|NCT01280981|Hemostatics|hemostatics|mesh-ancestor
92728851|NCT00637468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728852|NCT00637468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728853|NCT00637468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92728854|NCT00637468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92728855|NCT00637468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92728856|NCT00637468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728858|NCT00637468|Anticonvulsants|anticonvulsants|mesh-ancestor
92728859|NCT00637468|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92728860|NCT00637468|Diuretics|diuretics|mesh-ancestor
92728861|NCT00637468|Natriuretic Agents|natriuretic agents|mesh-ancestor
92728862|NCT00637468|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92728863|NCT00637468|Adrenergic Agents|adrenergic agents|mesh-ancestor
92728864|NCT00637468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755668|NCT01280981|Coagulants|coagulants|mesh-ancestor
92755669|NCT02889653|Anticoagulants|anticoagulants|mesh-list
92755670|NCT01280591|Naproxen|naproxen|mesh-list
92755671|NCT01280591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755672|NCT01280591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755673|NCT01280591|Analgesics|analgesics|mesh-ancestor
92755674|NCT01280591|Sensory System Agents|sensory system agents|mesh-ancestor
92755675|NCT01280591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755676|NCT01280591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755677|NCT01280591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755678|NCT01280591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755679|NCT01280591|Gout Suppressants|gout suppressants|mesh-ancestor
92755680|NCT01280591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92755681|NCT01280591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755682|NCT01280591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755683|NCT04323761|Remdesivir|remdesivir|mesh-list
92755684|NCT04323761|Antimetabolites|antimetabolites|mesh-ancestor
92755685|NCT04323761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755686|NCT04323761|Antiviral Agents|antiviral agents|mesh-ancestor
92755687|NCT04323761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755688|NCT05566223|Aldesleukin|aldesleukin|mesh-list
92755689|NCT05566223|Cyclophosphamide|cyclophosphamide|mesh-list
92755690|NCT05566223|Pembrolizumab|pembrolizumab|mesh-list
92755691|NCT05566223|Fludarabine|fludarabine|mesh-list
92755692|NCT05566223|Interleukin-2|interleukin-2|mesh-list
92755693|NCT05566223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755695|NCT05566223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755696|NCT05566223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755697|NCT05566223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92755698|NCT05566223|Alkylating Agents|alkylating agents|mesh-ancestor
92755699|NCT05566223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755700|NCT05566223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755701|NCT05566223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92755702|NCT05566223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755703|NCT05566223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92755704|NCT05566223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755705|NCT05566223|Analgesics|analgesics|mesh-ancestor
92755706|NCT05566223|Sensory System Agents|sensory system agents|mesh-ancestor
92755707|NCT05566223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755708|NCT05566223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92755709|NCT05566223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92755710|NCT05566223|Antiviral Agents|antiviral agents|mesh-ancestor
92755715|NCT01271933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755716|NCT01271933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755717|NCT01271933|Anticonvulsants|anticonvulsants|mesh-ancestor
92755718|NCT01271933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92755719|NCT01271933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728865|NCT02278575|Antithrombins|antithrombins|mesh-list
92728866|NCT02278575|Antithrombin III|antithrombin iii|mesh-list
92728867|NCT02278575|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92728868|NCT02278575|Protease Inhibitors|protease inhibitors|mesh-ancestor
92728869|NCT02278575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92728870|NCT02278575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728871|NCT02278575|Anticoagulants|anticoagulants|mesh-ancestor
92728872|NCT01126060|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92728873|NCT01126060|Hemostatics|hemostatics|mesh-ancestor
92728874|NCT01126060|Coagulants|coagulants|mesh-ancestor
92728875|NCT01125748|Omalizumab|omalizumab|mesh-list
92728876|NCT01125748|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92755720|NCT01271933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755721|NCT01271933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92755722|NCT01271933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92755723|NCT01271933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92755724|NCT01271933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755725|NCT01271933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92755726|NCT01269125|Leuprolide|leuprolide|mesh-list
92755727|NCT01269125|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92755728|NCT01269125|Fertility Agents|fertility agents|mesh-ancestor
92755729|NCT01269125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92755730|NCT01269125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755731|NCT01269125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92755732|NCT01269125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755733|NCT01268891|Rasagiline|rasagiline|mesh-list
92755734|NCT01268891|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92755735|NCT01268891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755736|NCT01268891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755737|NCT01268891|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92755738|NCT01268891|Protective Agents|protective agents|mesh-ancestor
92755739|NCT01268891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755740|NCT04323527|Chloroquine|chloroquine|mesh-list
92755741|NCT04323527|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92755742|NCT04323527|Amebicides|amebicides|mesh-ancestor
92755743|NCT04323527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92755744|NCT04323527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92755745|NCT04323527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755746|NCT04323527|Antimalarials|antimalarials|mesh-ancestor
92755747|NCT04323527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755748|NCT04323527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755749|NCT04323527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755750|NCT04323527|Analgesics|analgesics|mesh-ancestor
92755751|NCT04323527|Sensory System Agents|sensory system agents|mesh-ancestor
92755752|NCT04323527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755753|NCT04323527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755754|NCT04323527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755755|NCT04323527|Filaricides|filaricides|mesh-ancestor
92755756|NCT04323527|Antinematodal Agents|antinematodal agents|mesh-ancestor
92755757|NCT04323527|Anthelmintics|anthelmintics|mesh-ancestor
92755758|NCT02889497|Vaccines|vaccines|mesh-list
92755759|NCT02889497|Immunologic Factors|immunologic factors|mesh-ancestor
92755760|NCT02889497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755761|NCT01266317|Rituximab|rituximab|mesh-list
92755762|NCT01266317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755763|NCT01266317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755764|NCT01266317|Immunologic Factors|immunologic factors|mesh-ancestor
92755765|NCT01266317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755766|NCT01266317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755767|NCT01266161|Ibuprofen|ibuprofen|mesh-list
92755768|NCT01266161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755769|NCT01266161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755770|NCT01266161|Analgesics|analgesics|mesh-ancestor
92755771|NCT01266161|Sensory System Agents|sensory system agents|mesh-ancestor
92755772|NCT01266161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728878|NCT01125748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92728879|NCT04558268|Folic Acid|folic acid|mesh-list
92728880|NCT04558268|Prednisone|prednisone|mesh-list
92728881|NCT04558268|Progesterone|progesterone|mesh-list
92755773|NCT01266161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755774|NCT01266161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755775|NCT01266161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755776|NCT01266161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92755777|NCT01266161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755778|NCT01266161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755779|NCT01265849|Indomethacin|indomethacin|mesh-list
92755780|NCT01265849|Cyclophosphamide|cyclophosphamide|mesh-list
92755781|NCT01265849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755782|NCT01265849|Immunologic Factors|immunologic factors|mesh-ancestor
92755785|NCT01265849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92755786|NCT01265849|Alkylating Agents|alkylating agents|mesh-ancestor
92755787|NCT01265849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755788|NCT01265849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755789|NCT01265849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92755790|NCT01265849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755791|NCT01265849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755792|NCT01265849|Analgesics|analgesics|mesh-ancestor
92755793|NCT01265849|Sensory System Agents|sensory system agents|mesh-ancestor
92755794|NCT01265849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755795|NCT01265849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755796|NCT01265849|Gout Suppressants|gout suppressants|mesh-ancestor
92755797|NCT01265849|Tocolytic Agents|tocolytic agents|mesh-ancestor
92755798|NCT01265849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92755799|NCT01265849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92755800|NCT01265849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755801|NCT01265615|Cholecalciferol|cholecalciferol|mesh-list
92755802|NCT01265615|Vitamin D|vitamin d|mesh-list
92755803|NCT01265615|Calcitriol|calcitriol|mesh-list
92755804|NCT01265615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92755805|NCT01265615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755806|NCT01265615|Vitamins|vitamins|mesh-ancestor
92755807|NCT01265615|Micronutrients|micronutrients|mesh-ancestor
92755808|NCT01265615|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92755809|NCT01265615|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92755810|NCT01265615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92755811|NCT01265615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755812|NCT01265615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92755813|NCT01264679|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92755814|NCT01264679|Hematinics|hematinics|mesh-ancestor
92755815|NCT01264679|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92755816|NCT01264679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92755817|NCT05542667|Fluorides|fluorides|mesh-list
92755818|NCT05542667|Fluorides, Topical|fluorides, topical|mesh-list
92755819|NCT05542667|Cariostatic Agents|cariostatic agents|mesh-ancestor
92755820|NCT05542667|Protective Agents|protective agents|mesh-ancestor
92755821|NCT05542667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755822|NCT01263509|Inositol|inositol|mesh-list
92755823|NCT01263509|Alogliptin|alogliptin|mesh-list
92755824|NCT01263509|Voglibose|voglibose|mesh-list
92755825|NCT01263509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92755826|NCT01263509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755827|NCT01263509|Incretins|incretins|mesh-ancestor
92755828|NCT01263509|Hormones|hormones|mesh-ancestor
92755829|NCT01263509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755830|NCT01263509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92755831|NCT01263509|Protease Inhibitors|protease inhibitors|mesh-ancestor
92755832|NCT01263509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755833|NCT01263509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755834|NCT01263509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92755835|NCT01263509|Vitamin B Complex|vitamin b complex|mesh-ancestor
92755836|NCT01263509|Vitamins|vitamins|mesh-ancestor
92755837|NCT01263509|Micronutrients|micronutrients|mesh-ancestor
92755838|NCT01263197|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
92755839|NCT01263197|Propranolol|propranolol|mesh-list
92755840|NCT01263197|Albuterol|albuterol|mesh-list
92755841|NCT01263197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92755842|NCT01263197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92728882|NCT04558268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92728883|NCT04558268|Glucocorticoids|glucocorticoids|mesh-ancestor
92728884|NCT04558268|Hormones|hormones|mesh-ancestor
92728885|NCT04558268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92728886|NCT04558268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728887|NCT04558268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92755843|NCT01263197|Adrenergic Agents|adrenergic agents|mesh-ancestor
92755844|NCT01263197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755845|NCT01263197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755846|NCT01263197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755847|NCT01263197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92755848|NCT01263197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92755849|NCT01263197|Vasodilator Agents|vasodilator agents|mesh-ancestor
92755850|NCT01263197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92755851|NCT01263197|Autonomic Agents|autonomic agents|mesh-ancestor
92755852|NCT01263197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755853|NCT01263197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92755854|NCT01263197|Respiratory System Agents|respiratory system agents|mesh-ancestor
92755855|NCT01263197|Tocolytic Agents|tocolytic agents|mesh-ancestor
92755856|NCT01263197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92755860|NCT01263197|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92755861|NCT01263197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755862|NCT01263197|Disinfectants|disinfectants|mesh-ancestor
92755863|NCT01263119|Warfarin|warfarin|mesh-list
92755864|NCT01263119|Anticoagulants|anticoagulants|mesh-ancestor
92755865|NCT01262651|Nabiximols|nabiximols|mesh-list
92755866|NCT01262651|Analgesics|analgesics|mesh-ancestor
92755867|NCT01262651|Sensory System Agents|sensory system agents|mesh-ancestor
92755868|NCT01262651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755869|NCT01262651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755870|NCT01261793|Epratuzumab|epratuzumab|mesh-list
92755871|NCT01261793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92755872|NCT01261793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755873|NCT04321967|Nitroglycerin|nitroglycerin|mesh-list
92755874|NCT04321967|Vasodilator Agents|vasodilator agents|mesh-ancestor
92755875|NCT04321655|Ibuprofen|ibuprofen|mesh-list
92755876|NCT04321655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92755877|NCT04321655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92755878|NCT04321655|Analgesics|analgesics|mesh-ancestor
92755879|NCT04321655|Sensory System Agents|sensory system agents|mesh-ancestor
92755880|NCT04321655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92755881|NCT04321655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755882|NCT04321655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755883|NCT04321655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755884|NCT04321655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92755885|NCT04321655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755886|NCT04321655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755887|NCT05529251|Carboplatin|carboplatin|mesh-list
92755888|NCT05529251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755889|NCT01261325|Brivaracetam|brivaracetam|mesh-list
92755890|NCT01261325|Anticonvulsants|anticonvulsants|mesh-list
92409410|NCT05797246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92409483|NCT05739942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409860|NCT05601882|Upadacitinib|upadacitinib|mesh-list
92410007|NCT05537766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92410081|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410367|NCT05275738|Niacin|niacin|mesh-list
92410392|NCT05269849|Sirolimus|sirolimus|mesh-list
92410691|NCT05062304|Xhance|xhance|mesh-list
92411124|NCT04742777|Sirolimus|sirolimus|mesh-list
92411194|NCT04666740|Pembrolizumab|pembrolizumab|mesh-list
92412331|NCT03193190|Leucovorin|leucovorin|mesh-list
92412396|NCT02903368|Prednisone|prednisone|mesh-list
92412718|NCT01772420|Lenalidomide|lenalidomide|mesh-list
92412798|NCT01422148|Amiodarone|amiodarone|mesh-list
92322316|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92322317|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92322318|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322319|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92322320|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
92728888|NCT04558268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728889|NCT04558268|Progestins|progestins|mesh-ancestor
92728890|NCT04558268|Hematinics|hematinics|mesh-ancestor
92728891|NCT04558268|Vitamin B Complex|vitamin b complex|mesh-ancestor
92728892|NCT04558268|Vitamins|vitamins|mesh-ancestor
92728893|NCT04558268|Micronutrients|micronutrients|mesh-ancestor
92728894|NCT01125514|Furosemide|furosemide|mesh-list
92728895|NCT01125514|Diuretics|diuretics|mesh-ancestor
92728896|NCT01125514|Natriuretic Agents|natriuretic agents|mesh-ancestor
92728897|NCT01125514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728898|NCT01125514|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92728899|NCT01125514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728900|NCT01125514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728901|NCT04545879|Allicin|allicin|mesh-list
92728902|NCT04545879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92728903|NCT04545879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92728904|NCT04545879|Antimetabolites|antimetabolites|mesh-ancestor
92728905|NCT04545879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728906|NCT04545879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92728907|NCT04545879|Antioxidants|antioxidants|mesh-ancestor
92728908|NCT04545879|Protective Agents|protective agents|mesh-ancestor
92728909|NCT04545879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728910|NCT04545879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92728911|NCT04545879|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92728912|NCT04578782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92728913|NCT04578782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92728914|NCT04578782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92728915|NCT04578782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322321|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322322|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322323|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92322324|NCT00381134|Diuretics|diuretics|mesh-ancestor
92154171|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154172|NCT04149275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92154173|NCT04149275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154175|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92154176|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92154177|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154178|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154179|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154180|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92154181|NCT04148963|Dopamine Agents|dopamine agents|mesh-ancestor
92154182|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154183|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154184|NCT04022837|Pantoprazole|pantoprazole|mesh-list
92154185|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92154186|NCT04022837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154187|NCT04022837|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92728916|NCT04578782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728917|NCT04578782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92728918|NCT04578782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92728919|NCT04578782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728920|NCT04578782|Cholinergic Agents|cholinergic agents|mesh-ancestor
92728921|NCT04578782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728922|NCT04538391|Bupivacaine|bupivacaine|mesh-list
92728923|NCT04538391|Anesthetics, Local|anesthetics, local|mesh-ancestor
92728924|NCT04538391|Anesthetics|anesthetics|mesh-ancestor
92728925|NCT04538391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728926|NCT04538391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728927|NCT04538391|Sensory System Agents|sensory system agents|mesh-ancestor
92728928|NCT04538391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728929|NCT04545801|Ketamine|ketamine|mesh-list
92728930|NCT04545801|Analgesics|analgesics|mesh-ancestor
92728931|NCT04545801|Sensory System Agents|sensory system agents|mesh-ancestor
92728932|NCT04545801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728933|NCT04545801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154195|NCT04148885|Carboplatin|carboplatin|mesh-list
92154196|NCT04148885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92154197|NCT04148885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154198|NCT04148885|Tubulin Modulators|tubulin modulators|mesh-ancestor
92154199|NCT04148885|Antimitotic Agents|antimitotic agents|mesh-ancestor
92154200|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
92154201|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154202|NCT04022525|Leflunomide|leflunomide|mesh-list
92154203|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154204|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154205|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92154206|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
92154207|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154208|NCT04022291|Insulin|insulin|mesh-list
92154209|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92154210|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154211|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154212|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
92154213|NCT03074448|Cathartics|cathartics|mesh-ancestor
92154214|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154215|NCT04021433|Ketamine|ketamine|mesh-list
92154216|NCT04021433|Analgesics|analgesics|mesh-ancestor
92154217|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
92154218|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154219|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154220|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92154221|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92154222|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
92154223|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
92154224|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154225|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92154226|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92154227|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154228|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154229|NCT04147481|Anesthetics|anesthetics|mesh-list
92154230|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
92154231|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154232|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728934|NCT04545801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92728935|NCT04545801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92728936|NCT04545801|Anesthetics, General|anesthetics, general|mesh-ancestor
92728938|NCT04545801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401377|NCT01416116|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92728939|NCT04545801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92728940|NCT04545801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92728941|NCT04545801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728942|NCT04545801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728943|NCT04558424|Ascorbic Acid|ascorbic acid|mesh-list
92154233|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
92154234|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154235|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
92154236|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92154237|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92154238|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92154239|NCT04148261|Epinephrine|epinephrine|mesh-list
92154240|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92154241|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92154242|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154243|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154244|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154245|NCT04148261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154246|NCT04148261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92154247|NCT04148261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92154248|NCT04148261|Autonomic Agents|autonomic agents|mesh-ancestor
92154249|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154250|NCT04148261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92154251|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
92154252|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
92154253|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
92154254|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92154255|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92154269|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154270|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
92154271|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
92154272|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92154273|NCT04991064|Protective Agents|protective agents|mesh-ancestor
92154274|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154275|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92154276|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92154277|NCT00928083|Artefenomel|artefenomel|mesh-list
92154278|NCT00928083|Antimalarials|antimalarials|mesh-ancestor
92154279|NCT00928083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154280|NCT00928083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154281|NCT00928083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154282|NCT04996446|Tislelizumab|tislelizumab|mesh-list
92154283|NCT04996446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92154284|NCT04996446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154285|NCT04361721|Erenumab|erenumab|mesh-list
92154286|NCT04361721|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92154287|NCT04361721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154288|NCT04361721|Analgesics|analgesics|mesh-ancestor
92154289|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
92154290|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154291|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154292|NCT04361643|Lenalidomide|lenalidomide|mesh-list
92154293|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
92154294|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154295|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92154296|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92154297|NCT04361643|Growth Substances|growth substances|mesh-ancestor
92154298|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92154299|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728944|NCT04558424|Antioxidants|antioxidants|mesh-ancestor
92728945|NCT04558424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728946|NCT04558424|Protective Agents|protective agents|mesh-ancestor
92728947|NCT04558424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728949|NCT04558424|Micronutrients|micronutrients|mesh-ancestor
92728950|NCT00576602|Epoetin Alfa|epoetin alfa|mesh-list
92728951|NCT00576602|Hematinics|hematinics|mesh-ancestor
92728952|NCT02212223|Vitamin D|vitamin d|mesh-list
92728953|NCT02212223|Cholecalciferol|cholecalciferol|mesh-list
92728954|NCT02212223|Vitamins|vitamins|mesh-ancestor
92728955|NCT02212223|Micronutrients|micronutrients|mesh-ancestor
92728956|NCT02212223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728957|NCT02212223|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92154300|NCT04406051|Norepinephrine|norepinephrine|mesh-list
92154301|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92154302|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92154303|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154304|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154305|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154306|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154307|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
92154308|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
92154309|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154310|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92154311|NCT04991298|Fentanyl|fentanyl|mesh-list
92154312|NCT04991298|Midazolam|midazolam|mesh-list
92154313|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92154314|NCT04991298|Narcotics|narcotics|mesh-ancestor
92154315|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154319|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154320|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92154321|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92154322|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
92154323|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
92154324|NCT04991298|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92154325|NCT04991298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92154326|NCT04991298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92154327|NCT04991298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154328|NCT04991298|GABA Modulators|gaba modulators|mesh-ancestor
92154329|NCT04991298|GABA Agents|gaba agents|mesh-ancestor
92154330|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154331|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154332|NCT04361175|Letrozole|letrozole|mesh-list
92154333|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154334|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154335|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92154336|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92154337|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154338|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92154339|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
92154340|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154341|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154342|NCT04368819|Allopurinol|allopurinol|mesh-list
92154343|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
92154344|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154345|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154346|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
92154347|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154348|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92154349|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
92154350|NCT04368819|Protective Agents|protective agents|mesh-ancestor
92154351|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154352|NCT04368585|Simethicone|simethicone|mesh-list
92728958|NCT02212223|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92728960|NCT00637585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92728961|NCT00637585|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92728962|NCT00637585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92154353|NCT04368585|Omeprazole|omeprazole|mesh-list
92154354|NCT04368585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92154355|NCT04368585|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92154356|NCT04368585|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
92154357|NCT04368585|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
92154358|NCT04368585|TEMPO|tempo|mesh-list
92154359|NCT04368585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92154360|NCT04368585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154361|NCT04368585|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92154362|NCT04368585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154363|NCT04368585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154364|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
92154365|NCT04368585|Emollients|emollients|mesh-ancestor
92154366|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92401400|NCT01416220|Antimanic Agents|antimanic agents|mesh-ancestor
92154367|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92154368|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
92154369|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154370|NCT04368585|Antacids|antacids|mesh-ancestor
92154371|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
92154372|NCT04368585|Protective Agents|protective agents|mesh-ancestor
92154373|NCT04361331|Lenvatinib|lenvatinib|mesh-list
92154374|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154375|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92154376|NCT04361331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154377|NCT04361331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154378|NCT04990830|Heparin|heparin|mesh-list
92154379|NCT04990830|Enoxaparin|enoxaparin|mesh-list
92154380|NCT04990830|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92154381|NCT04990830|Tinzaparin|tinzaparin|mesh-list
92154382|NCT04990830|Dalteparin|dalteparin|mesh-list
92154383|NCT04990830|Enoxaparin sodium|enoxaparin sodium|mesh-list
92154384|NCT04990830|Anticoagulants|anticoagulants|mesh-ancestor
92154385|NCT04990830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92154386|NCT04990830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92154387|NCT04990830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154391|NCT04361409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154392|NCT04361409|Immunologic Factors|immunologic factors|mesh-ancestor
92154393|NCT04361409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154394|NCT04361409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154395|NCT04361409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154396|NCT04361409|Antimetabolites|antimetabolites|mesh-ancestor
92154397|NCT04361409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154398|NCT04368273|Antibodies|antibodies|mesh-list
92154399|NCT04368273|Immunologic Factors|immunologic factors|mesh-ancestor
92154400|NCT04368273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154401|NCT04995354|Mitogens|mitogens|mesh-list
92154402|NCT04995354|Mitosis Modulators|mitosis modulators|mesh-ancestor
92154403|NCT04995354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154404|NCT04368351|Azithromycin|azithromycin|mesh-list
92154405|NCT04368351|Hydroxychloroquine|hydroxychloroquine|mesh-list
92154406|NCT04368351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92154407|NCT04368351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154408|NCT04368351|Antimalarials|antimalarials|mesh-ancestor
92154409|NCT04368351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154410|NCT04368351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154411|NCT04368351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154412|NCT04368351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154413|NCT04368351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154414|NCT04360785|Methotrexate|methotrexate|mesh-list
92154415|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92154416|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
92154417|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92154418|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154419|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154420|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
92728963|NCT00637585|Histamine Antagonists|histamine antagonists|mesh-ancestor
92728964|NCT00637585|Histamine Agents|histamine agents|mesh-ancestor
92728965|NCT00637585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728966|NCT00637585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728967|NCT00637585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728968|NCT02214810|Bupivacaine|bupivacaine|mesh-list
92728969|NCT02214810|Anesthetics, Local|anesthetics, local|mesh-ancestor
92728970|NCT02214810|Anesthetics|anesthetics|mesh-ancestor
92728971|NCT02214810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92728972|NCT02214810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154421|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154422|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154423|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92154424|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154425|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92154426|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92154427|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
92154428|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154429|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92154430|NCT04360317|Docetaxel|docetaxel|mesh-list
92154431|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154432|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
92154433|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
92154434|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
92154435|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154436|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92154437|NCT03074136|Eusol|eusol|mesh-list
92154438|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
92154439|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154440|NCT04146155|Liraglutide|liraglutide|mesh-list
92154441|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154442|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154443|NCT04146155|Incretins|incretins|mesh-ancestor
92154444|NCT04146155|Hormones|hormones|mesh-ancestor
92154445|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154446|NCT04990752|Urinastatin|urinastatin|mesh-list
92154447|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92154448|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92154449|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
92154450|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154451|NCT04990752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154452|NCT02245191|Phenylephrine|phenylephrine|mesh-list
92154453|NCT02245191|Oxymetazoline|oxymetazoline|mesh-list
92154454|NCT02245191|Ephedrine|ephedrine|mesh-list
92154455|NCT02245191|Metaraminol|metaraminol|mesh-list
92154456|NCT02245191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92154457|NCT02245191|Mydriatics|mydriatics|mesh-ancestor
92154458|NCT02245191|Autonomic Agents|autonomic agents|mesh-ancestor
92154459|NCT02245191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154460|NCT02245191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154463|NCT02245191|Nasal Decongestants|nasal decongestants|mesh-ancestor
92154464|NCT02245191|Respiratory System Agents|respiratory system agents|mesh-ancestor
92154465|NCT02245191|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92154466|NCT02245191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92154467|NCT02245191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92154468|NCT02245191|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154469|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154470|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154471|NCT02245191|Protective Agents|protective agents|mesh-ancestor
92154472|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92154474|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92154475|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154476|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154477|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154478|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92728973|NCT02214810|Sensory System Agents|sensory system agents|mesh-ancestor
92728974|NCT02214810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92728975|NCT01125046|Bevacizumab|bevacizumab|mesh-list
92728976|NCT01125046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92728977|NCT01125046|Antibodies|antibodies|mesh-list
92728978|NCT01125046|Immunoglobulins|immunoglobulins|mesh-list
92728979|NCT01125046|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92728980|NCT01125046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728981|NCT01125046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92728982|NCT01125046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92154479|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154480|NCT04145921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92154481|NCT04145921|Autonomic Agents|autonomic agents|mesh-ancestor
92154482|NCT04145921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154483|NCT04145921|Nootropic Agents|nootropic agents|mesh-ancestor
92154484|NCT04145687|Metformin|metformin|mesh-list
92154485|NCT04145687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154486|NCT04145687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154487|NCT04359615|Hydroxychloroquine|hydroxychloroquine|mesh-list
92154488|NCT04359615|Favipiravir|favipiravir|mesh-list
92154489|NCT04359615|Antimalarials|antimalarials|mesh-ancestor
92154490|NCT04359615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154491|NCT04359615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154492|NCT04359615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154493|NCT04359615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154494|NCT04359615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154495|NCT04359615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154496|NCT04359615|Antiviral Agents|antiviral agents|mesh-ancestor
92154497|NCT02635386|Metformin|metformin|mesh-list
92154498|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
92154499|NCT02635386|Exenatide|exenatide|mesh-list
92154500|NCT02635386|Topiramate|topiramate|mesh-list
92154501|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92154502|NCT02635386|Phentermine|phentermine|mesh-list
92154503|NCT02635386|Glucagon|glucagon|mesh-list
92154504|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92154505|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154506|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154507|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154508|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92154509|NCT02635386|Incretins|incretins|mesh-ancestor
92154510|NCT02635386|Hormones|hormones|mesh-ancestor
92154511|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154512|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
92154513|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154514|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92154515|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
92154516|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
92154517|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
92154518|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154519|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154520|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154521|NCT03924947|Pancrelipase|pancrelipase|mesh-list
92154522|NCT03924947|Pancreatin|pancreatin|mesh-list
92154523|NCT03924947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154524|NCT00934635|Risperidone|risperidone|mesh-list
92154525|NCT00934635|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92154526|NCT00934635|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92154527|NCT00934635|Serotonin Agents|serotonin agents|mesh-ancestor
92154528|NCT00934635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154529|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154530|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154531|NCT00934635|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92154532|NCT00934635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92154533|NCT00934635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154534|NCT00934635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154535|NCT00934635|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92154536|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
92728984|NCT01125046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92728985|NCT01125046|Growth Inhibitors|growth inhibitors|mesh-ancestor
92728986|NCT01125046|Immunologic Factors|immunologic factors|mesh-ancestor
92728987|NCT04557878|Mitogens|mitogens|mesh-list
92728988|NCT04557878|Mitosis Modulators|mitosis modulators|mesh-ancestor
92728989|NCT04557878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728990|NCT01124734|Temozolomide|temozolomide|mesh-list
92728991|NCT01124734|Interleukin-2|interleukin-2|mesh-list
92728992|NCT01124734|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92728993|NCT01124734|Alkylating Agents|alkylating agents|mesh-ancestor
92728994|NCT01124734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92728995|NCT01124734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728996|NCT01124734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92728997|NCT01124734|Analgesics|analgesics|mesh-ancestor
92728998|NCT01124734|Sensory System Agents|sensory system agents|mesh-ancestor
92154552|NCT04356417|Antimalarials|antimalarials|mesh-list
92154553|NCT04356417|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92154554|NCT04356417|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92154555|NCT04356417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154556|NCT04356417|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154557|NCT04356417|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154558|NCT04356417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154559|NCT04355949|Vitamin D|vitamin d|mesh-list
92154560|NCT04355949|Ergocalciferols|ergocalciferols|mesh-list
92154561|NCT04355949|Cholecalciferol|cholecalciferol|mesh-list
92154562|NCT04355949|Vitamins|vitamins|mesh-list
92154563|NCT04355949|Folic Acid|folic acid|mesh-list
92154564|NCT04355949|Vitamin B 12|vitamin b 12|mesh-list
92154565|NCT04355949|Hydroxocobalamin|hydroxocobalamin|mesh-list
92154566|NCT04355949|Vitamin B Complex|vitamin b complex|mesh-list
92154567|NCT04355949|Micronutrients|micronutrients|mesh-ancestor
92154568|NCT04355949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401413|NCT01416246|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92154569|NCT04355949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92154570|NCT04355949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92154571|NCT04355949|Hematinics|hematinics|mesh-ancestor
92154572|NCT05580887|Paclitaxel|paclitaxel|mesh-list
92154573|NCT05580887|Cyclophosphamide|cyclophosphamide|mesh-list
92154574|NCT05580887|Carboplatin|carboplatin|mesh-list
92154575|NCT05580887|Doxorubicin|doxorubicin|mesh-list
92154576|NCT05580887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92154577|NCT05580887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154578|NCT05580887|Tubulin Modulators|tubulin modulators|mesh-ancestor
92154579|NCT05580887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92154580|NCT05580887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92154581|NCT05580887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154582|NCT05580887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92154583|NCT05580887|Immunologic Factors|immunologic factors|mesh-ancestor
92154584|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154585|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154586|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92154587|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
92154588|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92154589|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92154590|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92154591|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92154592|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154593|NCT04994262|Menthol|menthol|mesh-list
92154594|NCT04994262|Antipruritics|antipruritics|mesh-ancestor
92154595|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
92154596|NCT00939159|Panobinostat|panobinostat|mesh-list
92154597|NCT00939159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92728999|NCT01124734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729000|NCT01124734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729001|NCT04538976|Sildenafil Citrate|sildenafil citrate|mesh-list
92729002|NCT04538976|Vasodilator Agents|vasodilator agents|mesh-ancestor
92729003|NCT04538976|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92154599|NCT00939159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154600|NCT00939159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154601|NCT05620641|Gabapentin|gabapentin|mesh-list
92154602|NCT05620641|Ondansetron|ondansetron|mesh-list
92154603|NCT05620641|Analgesics|analgesics|mesh-ancestor
92154604|NCT05620641|Sensory System Agents|sensory system agents|mesh-ancestor
92154605|NCT05620641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154606|NCT05620641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154607|NCT05620641|Anticonvulsants|anticonvulsants|mesh-ancestor
92154608|NCT05620641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92154609|NCT05620641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92154610|NCT05620641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154611|NCT05620641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154612|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92154613|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92154614|NCT05620641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154615|NCT05620641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154616|NCT05620641|Antimanic Agents|antimanic agents|mesh-ancestor
92154617|NCT05620641|Antiemetics|antiemetics|mesh-ancestor
92154618|NCT05620641|Autonomic Agents|autonomic agents|mesh-ancestor
92154619|NCT05620641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154620|NCT05620641|Antipruritics|antipruritics|mesh-ancestor
92154621|NCT05620641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92154622|NCT05620641|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92154623|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92154624|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
92154625|NCT04144439|Butyric Acid|butyric acid|mesh-list
92154626|NCT04144439|Histamine Antagonists|histamine antagonists|mesh-ancestor
92154627|NCT04144439|Histamine Agents|histamine agents|mesh-ancestor
92154628|NCT04144439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154629|NCT04144439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154630|NCT04144439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154631|NCT04994574|Tiotropium Bromide|tiotropium bromide|mesh-list
92154632|NCT04994574|Olodaterol|olodaterol|mesh-list
92154633|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92154634|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
92154635|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154636|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154637|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92154638|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
92154639|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
92154640|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92154641|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154642|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154643|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154644|NCT04355637|Budesonide|budesonide|mesh-list
92154645|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92154646|NCT04355637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92154647|NCT04355637|Autonomic Agents|autonomic agents|mesh-ancestor
92154648|NCT04355637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154649|NCT04355637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154650|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92154651|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92154652|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
92154653|NCT04355637|Hormones|hormones|mesh-ancestor
92154654|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154655|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
92154656|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154657|NCT03076710|Bupivacaine|bupivacaine|mesh-list
92154658|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
92154659|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
92154660|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154661|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154662|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
92729004|NCT04538976|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92154663|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154665|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92154666|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154667|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154668|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154669|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92154670|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92154672|NCT03071172|Hormones|hormones|mesh-ancestor
92154673|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154674|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154675|NCT03071172|Progestins|progestins|mesh-ancestor
92154676|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
92154677|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92154678|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
92154679|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92154680|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92154681|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92154682|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154683|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
92154684|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92154685|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
92154686|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92154687|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92154688|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92154689|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92154690|NCT04143815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154691|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154692|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154693|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154694|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92154695|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154696|NCT04355247|Methylprednisolone|methylprednisolone|mesh-list
92154697|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92154698|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92154699|NCT04355247|Prednisolone|prednisolone|mesh-list
92154700|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
92154701|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92154702|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
92154703|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92154704|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
92154705|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
92154706|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154707|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154708|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154709|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
92154710|NCT04355247|Hormones|hormones|mesh-ancestor
92154711|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154712|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92154713|NCT04355247|Protective Agents|protective agents|mesh-ancestor
92154714|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92154715|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154716|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
92154717|NCT03903809|Hematinics|hematinics|mesh-ancestor
92154718|NCT04987554|Immunoferon|immunoferon|mesh-list
92154719|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92154720|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
92154721|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154722|NCT04358367|Dexmedetomidine|dexmedetomidine|mesh-list
92154723|NCT04358367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92154724|NCT04358367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154725|NCT04358367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154726|NCT04358367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92154727|NCT04358367|Analgesics|analgesics|mesh-ancestor
92154728|NCT04358367|Sensory System Agents|sensory system agents|mesh-ancestor
92154729|NCT04358367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154730|NCT04358367|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92154731|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92154732|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92154733|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154734|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154735|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729005|NCT04538976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729006|NCT04538976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729008|NCT04545450|Methyltestosterone|methyltestosterone|mesh-list
92729009|NCT04545450|Testosterone|testosterone|mesh-list
92729010|NCT04545450|Testosterone undecanoate|testosterone undecanoate|mesh-list
92729011|NCT04545450|Testosterone enanthate|testosterone enanthate|mesh-list
92729012|NCT04545450|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92729013|NCT04545450|Dutasteride|dutasteride|mesh-list
92729014|NCT04545450|Androgens|androgens|mesh-ancestor
92729015|NCT04545450|Hormones|hormones|mesh-ancestor
92154736|NCT04358523|Sofosbuvir|sofosbuvir|mesh-list
92154737|NCT04358523|Antiviral Agents|antiviral agents|mesh-ancestor
92154738|NCT04358523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154739|NCT00936663|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92154740|NCT00936663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154741|NCT00936663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154742|NCT00936663|Incretins|incretins|mesh-ancestor
92154743|NCT00936663|Hormones|hormones|mesh-ancestor
92154744|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154749|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
92154750|NCT03903185|Ledipasvir|ledipasvir|mesh-list
92154751|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92154752|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
92154753|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154754|NCT03917303|Adalimumab|adalimumab|mesh-list
92154755|NCT03917303|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92154756|NCT03917303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92154757|NCT03917303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154758|NCT03070860|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92154759|NCT03070860|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92154760|NCT03070860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154761|NCT05583149|Cyclophosphamide|cyclophosphamide|mesh-list
92154762|NCT05583149|Fludarabine|fludarabine|mesh-list
92154763|NCT05583149|Acalabrutinib|acalabrutinib|mesh-list
92154764|NCT05583149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401434|NCT01416558|Paclitaxel|paclitaxel|mesh-list
92154765|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
92154766|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154767|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154768|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92154769|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
92154770|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154771|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154772|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92154773|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
92154774|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154775|NCT04366869|Antifungal Agents|antifungal agents|mesh-ancestor
92154776|NCT04366869|Keratolytic Agents|keratolytic agents|mesh-ancestor
92154777|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
92154778|NCT04989270|Anesthetics|anesthetics|mesh-list
92154779|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154780|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154782|NCT04989348|Progestins|progestins|mesh-list
92154783|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
92154784|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154785|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154786|NCT04346823|Sevoflurane|sevoflurane|mesh-list
92154787|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92154788|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92154789|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
92154790|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
92154791|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154792|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154793|NCT05582837|Topiramate|topiramate|mesh-list
92154794|NCT05582837|Nortriptyline|nortriptyline|mesh-list
92154795|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
92154796|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92729016|NCT04545450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92729017|NCT04545450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729018|NCT04545450|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92729019|NCT04545450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729020|NCT04545450|Anabolic Agents|anabolic agents|mesh-ancestor
92154797|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154798|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92154799|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
92154800|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154801|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92154802|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92154803|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92154804|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154805|NCT05582837|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154806|NCT05582837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154808|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
92154809|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92154810|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
92154811|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154812|NCT04728633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154813|NCT05003700|Lenvatinib|lenvatinib|mesh-list
92154814|NCT05003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154815|NCT05003700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92154817|NCT05003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154819|NCT04143191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154820|NCT04143191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92154821|NCT04143191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154822|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154823|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92154824|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92154825|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154826|NCT04461288|Nicotine|nicotine|mesh-list
92154827|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92154828|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
92154829|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154830|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154831|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92154832|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92154833|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154834|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154835|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154836|NCT05582135|Morphine|morphine|mesh-list
92154837|NCT05582135|Esketamine|esketamine|mesh-list
92154838|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92154839|NCT05582135|Narcotics|narcotics|mesh-ancestor
92154840|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154841|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154842|NCT05582135|Analgesics|analgesics|mesh-ancestor
92154843|NCT05582135|Sensory System Agents|sensory system agents|mesh-ancestor
92154844|NCT05582135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154845|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
92154846|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154848|NCT03070704|Xultophy|xultophy|mesh-list
92154849|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154850|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154851|NCT03070704|Incretins|incretins|mesh-ancestor
92154852|NCT03070704|Hormones|hormones|mesh-ancestor
92154853|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154854|NCT03069768|Varenicline|varenicline|mesh-list
92154855|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92154856|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92154857|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154858|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154859|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154860|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729021|NCT04545450|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92729022|NCT04545450|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92729023|NCT04545450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729024|NCT04545450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729025|NCT04545450|Hormone Antagonists|hormone antagonists|mesh-ancestor
92729026|NCT04579133|Durvalumab|durvalumab|mesh-list
92154861|NCT04141553|Diltiazem|diltiazem|mesh-list
92154862|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92154863|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92154864|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92154865|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154866|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92154867|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154868|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
92154869|NCT04141163|Metformin|metformin|mesh-list
92154870|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154871|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154872|NCT00942825|Cisplatin|cisplatin|mesh-list
92154873|NCT00942825|Pemetrexed|pemetrexed|mesh-list
92154874|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154875|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154876|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154877|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92154878|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92154879|NCT04544943|Gentamicins|gentamicins|mesh-list
92154880|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92154881|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154882|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92154883|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154884|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154885|NCT04140461|Amphotericin B|amphotericin b|mesh-list
92154886|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92154887|NCT04140461|Flucytosine|flucytosine|mesh-list
92154888|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154892|NCT04140461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92154893|NCT04140461|Antifungal Agents|antifungal agents|mesh-ancestor
92154894|NCT04140461|Antimetabolites|antimetabolites|mesh-ancestor
92154895|NCT04140461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154896|NCT03021629|Vitamin D|vitamin d|mesh-list
92154897|NCT03021629|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92154898|NCT03021629|Vitamins|vitamins|mesh-ancestor
92154899|NCT03021629|Micronutrients|micronutrients|mesh-ancestor
92154900|NCT03021629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154901|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92154902|NCT03021395|Decitabine|decitabine|mesh-list
92154903|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154904|NCT03021395|Antimetabolites|antimetabolites|mesh-ancestor
92154905|NCT03021395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154906|NCT03021395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154907|NCT03021395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154908|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92154909|NCT03021317|Hormones|hormones|mesh-ancestor
92154910|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154911|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154912|NCT04987632|Letrozole|letrozole|mesh-list
92154913|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154914|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92154915|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92154916|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154917|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154918|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92154919|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
92154920|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154921|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154922|NCT03032367|Bedaquiline|bedaquiline|mesh-list
92154923|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
92154924|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92154925|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729028|NCT04579133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92729029|NCT04579133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729030|NCT04579133|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92729031|NCT04579133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729032|NCT04579133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729033|NCT00576914|Endostatins|endostatins|mesh-list
92154926|NCT02634606|Tocotrienols|tocotrienols|mesh-list
92154928|NCT02634606|Tocopherols|tocopherols|mesh-list
92154929|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
92154930|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154931|NCT02634606|Protective Agents|protective agents|mesh-ancestor
92154932|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154933|NCT02634606|Vitamins|vitamins|mesh-ancestor
92154934|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
92154935|NCT05002686|Paclitaxel|paclitaxel|mesh-list
92154936|NCT05002686|Capecitabine|capecitabine|mesh-list
92154937|NCT05002686|Oxaliplatin|oxaliplatin|mesh-list
92154938|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92154939|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154940|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92154941|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92154942|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92154943|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154944|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154945|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
92154946|NCT03588689|Ropivacaine|ropivacaine|mesh-list
92154947|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
92154948|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
92154949|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154950|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154951|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
92154952|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154953|NCT04985526|Octenidine|octenidine|mesh-list
92154954|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154955|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92154956|NCT03588611|Hirudins|hirudins|mesh-list
92154957|NCT03588611|Bivalirudin|bivalirudin|mesh-list
92154958|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
92154959|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92154960|NCT03588611|Protease Inhibitors|protease inhibitors|mesh-ancestor
92154961|NCT03588611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154962|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154963|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
92154971|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401449|NCT01416662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154972|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92154974|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92154975|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154976|NCT00939705|Topiramate|topiramate|mesh-list
92154977|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
92154978|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154979|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154980|NCT05001672|Tenofovir|tenofovir|mesh-list
92154981|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
92154982|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154983|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92154984|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92154985|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154986|NCT05001672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154987|NCT05001672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92154988|NCT05001672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92154989|NCT04354545|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92154990|NCT04354545|Lifitegrast|lifitegrast|mesh-list
92154991|NCT04354545|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92154992|NCT03587285|Goserelin|goserelin|mesh-list
92154993|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
92154994|NCT03587285|Bicalutamide|bicalutamide|mesh-list
92154995|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92154996|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729034|NCT00576914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92729035|NCT00576914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92729036|NCT00576914|Growth Substances|growth substances|mesh-ancestor
92729037|NCT00576914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729038|NCT00576914|Growth Inhibitors|growth inhibitors|mesh-ancestor
92729039|NCT00576914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729041|NCT02212340|Desflurane|desflurane|mesh-list
92729042|NCT02212340|Propofol|propofol|mesh-list
92729043|NCT02212340|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92154997|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92154998|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154999|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155000|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92155001|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155002|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155003|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92155004|NCT03587285|Androgen Antagonists|androgen antagonists|mesh-ancestor
92155006|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155007|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92155008|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155009|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155010|NCT02245503|Tamsulosin|tamsulosin|mesh-list
92155011|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92155012|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92155013|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92155014|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92155015|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155016|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155017|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155018|NCT02245503|Urological Agents|urological agents|mesh-ancestor
92155019|NCT03586817|Palonosetron|palonosetron|mesh-list
92155020|NCT03586817|Fosaprepitant|fosaprepitant|mesh-list
92155021|NCT03586817|Aprepitant|aprepitant|mesh-list
92155022|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
92155023|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
92155024|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155025|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155026|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155027|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92155028|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92155029|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
92155030|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155031|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155033|NCT03891173|Vinorelbine|vinorelbine|mesh-list
92155034|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155035|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155036|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155037|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155038|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155039|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155040|NCT03585725|Ribavirin|ribavirin|mesh-list
92155041|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
92155042|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155043|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
92155044|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155045|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92155046|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92155047|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92155048|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155049|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155050|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
92155051|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155052|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729045|NCT02212340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729046|NCT02212340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729047|NCT02212340|Analgesics|analgesics|mesh-ancestor
92729048|NCT02212340|Sensory System Agents|sensory system agents|mesh-ancestor
92729049|NCT02212340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729050|NCT02212340|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92729051|NCT02212340|Anesthetics, General|anesthetics, general|mesh-ancestor
92155053|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92155054|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155055|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
92155056|NCT03585179|Hydroquinone|hydroquinone|mesh-list
92155057|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92155058|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92155059|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155060|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
92155061|NCT03585179|Coagulants|coagulants|mesh-ancestor
92155062|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
92155063|NCT03585179|Protective Agents|protective agents|mesh-ancestor
92155064|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155065|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92155066|NCT03585101|Grazoprevir|grazoprevir|mesh-list
92155067|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92155068|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
92155069|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155071|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92155072|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92155073|NCT03834363|Fentanyl|fentanyl|mesh-list
92155074|NCT03834363|Morphine|morphine|mesh-list
92155075|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92155076|NCT03834363|Narcotics|narcotics|mesh-ancestor
92155077|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155078|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155079|NCT03834363|Analgesics|analgesics|mesh-ancestor
92155080|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
92155081|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155082|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92155083|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92155084|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
92155085|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
92155086|NCT03031353|Misoprostol|misoprostol|mesh-list
92155087|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92155088|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
92155089|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92155090|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155091|NCT03031353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92155092|NCT03031353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155093|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
92155094|NCT05702957|Letrozole|letrozole|mesh-list
92155095|NCT05702957|Clomiphene|clomiphene|mesh-list
92155096|NCT05702957|Enclomiphene|enclomiphene|mesh-list
92155097|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
92155098|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155099|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155100|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92155101|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92155102|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155103|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92155104|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
92155105|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155106|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155107|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92155109|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92155110|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92155111|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92155113|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155114|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155115|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
92729052|NCT02212340|Anesthetics|anesthetics|mesh-ancestor
92729053|NCT02212340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92729054|NCT02212340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92729055|NCT01124617|Tapentadol|tapentadol|mesh-list
92729056|NCT01124617|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92729057|NCT01124617|Narcotics|narcotics|mesh-ancestor
92729058|NCT01124617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729059|NCT01124617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729060|NCT01124617|Analgesics|analgesics|mesh-ancestor
92729061|NCT01124617|Sensory System Agents|sensory system agents|mesh-ancestor
92729062|NCT01124617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155116|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155117|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155118|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155119|NCT03580733|Caspofungin|caspofungin|mesh-list
92155120|NCT03580733|Antifungal Agents|antifungal agents|mesh-list
92155121|NCT03580733|Clotrimazole|clotrimazole|mesh-list
92155122|NCT03580733|Miconazole|miconazole|mesh-list
92155123|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155124|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155125|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155126|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92155127|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92155128|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92155129|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92155130|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
92155131|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155132|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155133|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92155134|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92155135|NCT03461445|Tacrolimus|tacrolimus|mesh-list
92155136|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155137|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
92155138|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155139|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92155140|NCT03461445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155141|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155142|NCT04939662|Bevacizumab|bevacizumab|mesh-list
92155143|NCT04939662|Olaparib|olaparib|mesh-list
92155144|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92155145|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155146|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92155147|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92155149|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155150|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
92155151|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92155152|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155153|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155154|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92155155|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92155156|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155157|NCT05331144|Losartan|losartan|mesh-list
92155158|NCT05331144|Amlodipine|amlodipine|mesh-list
92155159|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
92155160|NCT05331144|Angiotensin II|angiotensin ii|mesh-list
92155161|NCT05331144|Giapreza|giapreza|mesh-list
92155162|NCT05331144|Calcium|calcium|mesh-list
92155163|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92155164|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
92155165|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92155166|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155167|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92155168|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729063|NCT01124617|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92729064|NCT01124617|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92729065|NCT01124617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729066|NCT01124617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729067|NCT01124617|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729068|NCT01124617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729069|NCT04205890|Ketamine|ketamine|mesh-list
92729070|NCT04205890|Analgesics|analgesics|mesh-ancestor
92155169|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155170|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92155171|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92155172|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92155173|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92155174|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92155175|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
92155176|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155177|NCT03580499|Vitamins|vitamins|mesh-list
92155178|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
92155179|NCT03580499|Pyridoxal|pyridoxal|mesh-list
92155180|NCT03580499|Pyridoxine|pyridoxine|mesh-list
92155181|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
92155185|NCT00951561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92155186|NCT00951561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155187|NCT00951561|Analgesics|analgesics|mesh-ancestor
92155188|NCT00951561|Sensory System Agents|sensory system agents|mesh-ancestor
92155189|NCT00951561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155190|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155191|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155192|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155193|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92155194|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155195|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155196|NCT03031119|Atorvastatin|atorvastatin|mesh-list
92155197|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92155198|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92155199|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
92155200|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155201|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92155202|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92155203|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155204|NCT03076203|Niraparib|niraparib|mesh-list
92155205|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92155206|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92155207|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155208|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155209|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155210|NCT02943057|Ganciclovir|ganciclovir|mesh-list
92155211|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92155212|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
92155213|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155214|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92155215|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155216|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155217|NCT03581903|Vaccines|vaccines|mesh-list
92155218|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
92155219|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155220|NCT02783547|Azacitidine|azacitidine|mesh-list
92155221|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92155222|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
92155223|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155224|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155225|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155226|NCT02555007|Vinorelbine|vinorelbine|mesh-list
92155227|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155228|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155229|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92729071|NCT04205890|Sensory System Agents|sensory system agents|mesh-ancestor
92729072|NCT04205890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729073|NCT04205890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729074|NCT04205890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92729075|NCT04205890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92729076|NCT04205890|Anesthetics, General|anesthetics, general|mesh-ancestor
92729077|NCT04205890|Anesthetics|anesthetics|mesh-ancestor
92729078|NCT04205890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729079|NCT04205890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92155230|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155231|NCT02555007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155232|NCT02555007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155233|NCT03898037|Metformin|metformin|mesh-list
92155234|NCT03898037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92155235|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155236|NCT04982874|Furosemide|furosemide|mesh-list
92155237|NCT04982874|Diuretics|diuretics|mesh-ancestor
92155238|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
92155239|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155240|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92155241|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155242|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155243|NCT03584711|Panitumumab|panitumumab|mesh-list
92155244|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92155245|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155246|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92155247|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92155248|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
92155249|NCT03068208|Methylene Blue|methylene blue|mesh-list
92155250|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155251|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155252|NCT03067974|Ketamine|ketamine|mesh-list
92155255|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155256|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155257|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92155258|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92155260|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
92155261|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155262|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92155263|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92155264|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155265|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155266|NCT03582137|Cannabidiol|cannabidiol|mesh-list
92155267|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
92155268|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
92155269|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92155270|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
92155271|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155272|NCT04405193|Expectorants|expectorants|mesh-ancestor
92155273|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
92155274|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92155275|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
92155276|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155277|NCT04405193|Protective Agents|protective agents|mesh-ancestor
92155278|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155279|NCT04405193|Antidotes|antidotes|mesh-ancestor
92155280|NCT05227833|Pantoprazole|pantoprazole|mesh-list
92155281|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92155282|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155283|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92155284|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155285|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155286|NCT05083299|Sarpogrelate|sarpogrelate|mesh-list
92155287|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92155288|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92729080|NCT04205890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92729081|NCT04205890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729082|NCT04205890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729084|NCT00577109|Bevacizumab|bevacizumab|mesh-list
92729085|NCT00577109|Cetuximab|cetuximab|mesh-list
92155289|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155290|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92155292|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
92155293|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155294|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155295|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92155296|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92155297|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92155298|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
92155299|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155301|NCT04405271|Emtricitabine|emtricitabine|mesh-list
92155302|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92155303|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
92155304|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155305|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92155306|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92155307|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155308|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155309|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92155310|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92155311|NCT03034941|Metformin|metformin|mesh-list
92155312|NCT03034941|Liraglutide|liraglutide|mesh-list
92155313|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92155314|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155315|NCT03034941|Incretins|incretins|mesh-ancestor
92155316|NCT03034941|Hormones|hormones|mesh-ancestor
92155317|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155318|NCT03030105|Scopolamine|scopolamine|mesh-list
92155319|NCT03030105|Donepezil|donepezil|mesh-list
92155320|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92155321|NCT03030105|BPN14770|bpn14770|mesh-list
92155322|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92155323|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155324|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155325|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
92155326|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155327|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155332|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155333|NCT03030105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155334|NCT03030105|Mydriatics|mydriatics|mesh-ancestor
92155335|NCT03030105|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92155336|NCT03030105|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92155337|NCT03030105|Parasympatholytics|parasympatholytics|mesh-ancestor
92155338|NCT03030105|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92155339|NCT03030105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92155340|NCT03067896|Magnesium Sulfate|magnesium sulfate|mesh-list
92155341|NCT03067896|Dexmedetomidine|dexmedetomidine|mesh-list
92155342|NCT03067896|Bupivacaine|bupivacaine|mesh-list
92155343|NCT03067896|Anesthetics, Local|anesthetics, local|mesh-ancestor
92155344|NCT03067896|Anesthetics|anesthetics|mesh-ancestor
92155345|NCT03067896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155346|NCT03067896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155347|NCT03067896|Sensory System Agents|sensory system agents|mesh-ancestor
92155348|NCT03067896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155349|NCT03067896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92155350|NCT03067896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155351|NCT03067896|Analgesics|analgesics|mesh-ancestor
92155352|NCT03067896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92155353|NCT03067896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92155354|NCT03067896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92155355|NCT03067896|Adrenergic Agents|adrenergic agents|mesh-ancestor
92155356|NCT03067896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155357|NCT03067896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729087|NCT00577109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92729088|NCT00577109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729089|NCT00577109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92729090|NCT00577109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92729091|NCT00577109|Growth Substances|growth substances|mesh-ancestor
92729092|NCT00577109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729093|NCT00577109|Growth Inhibitors|growth inhibitors|mesh-ancestor
92729094|NCT00577109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92729095|NCT00577109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155358|NCT03067896|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92155359|NCT03067896|Anticonvulsants|anticonvulsants|mesh-ancestor
92155360|NCT03067896|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92155361|NCT03067896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155362|NCT03067896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92155363|NCT03067896|Tocolytic Agents|tocolytic agents|mesh-ancestor
92155364|NCT03067896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92155365|NCT03034707|Biotin|biotin|mesh-list
92155366|NCT03034707|Vitamin B Complex|vitamin b complex|mesh-ancestor
92155367|NCT03034707|Vitamins|vitamins|mesh-ancestor
92155368|NCT03034707|Micronutrients|micronutrients|mesh-ancestor
92155369|NCT03034707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155370|NCT03067740|Dexmedetomidine|dexmedetomidine|mesh-list
92155371|NCT03067740|Bupivacaine|bupivacaine|mesh-list
92155372|NCT03067740|Anesthetics, Local|anesthetics, local|mesh-ancestor
92155373|NCT03067740|Anesthetics|anesthetics|mesh-ancestor
92155374|NCT03067740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155375|NCT03067740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155376|NCT03067740|Sensory System Agents|sensory system agents|mesh-ancestor
92155377|NCT03067740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155378|NCT03067740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92155379|NCT03067740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155380|NCT03067740|Analgesics|analgesics|mesh-ancestor
92155381|NCT03067740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92155382|NCT03067740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92155383|NCT03067740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92155384|NCT03067740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92155385|NCT03067740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155386|NCT03067740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155387|NCT05730114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92155388|NCT03027843|Hormones|hormones|mesh-list
92155389|NCT03027843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155390|NCT03027843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155391|NCT03068832|Poly I-C|poly i-c|mesh-list
92155392|NCT03068832|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92155393|NCT03068832|Poly ICLC|poly iclc|mesh-list
92155394|NCT03068832|Interferon Inducers|interferon inducers|mesh-ancestor
92155395|NCT03068832|Immunologic Factors|immunologic factors|mesh-ancestor
92155396|NCT03068832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155397|NCT03068832|Laxatives|laxatives|mesh-ancestor
92155398|NCT03068832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155399|NCT03068832|Antiviral Agents|antiviral agents|mesh-ancestor
92155400|NCT03068832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155404|NCT04801797|Venetoclax|venetoclax|mesh-list
92155405|NCT04801797|Idarubicin|idarubicin|mesh-list
92155406|NCT04801797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92155407|NCT04801797|Antimetabolites|antimetabolites|mesh-ancestor
92155408|NCT04801797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155409|NCT04801797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155410|NCT04801797|Antiviral Agents|antiviral agents|mesh-ancestor
92155411|NCT04801797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155412|NCT04801797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155413|NCT04801797|Immunologic Factors|immunologic factors|mesh-ancestor
92155414|NCT04801797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155415|NCT04801797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155416|NCT04801797|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92729096|NCT00577109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729097|NCT00577109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729098|NCT00577109|Antidotes|antidotes|mesh-ancestor
92729099|NCT00577109|Protective Agents|protective agents|mesh-ancestor
92729100|NCT00577109|Vitamin B Complex|vitamin b complex|mesh-ancestor
92729101|NCT00577109|Vitamins|vitamins|mesh-ancestor
92729102|NCT00577109|Micronutrients|micronutrients|mesh-ancestor
92729103|NCT01124422|Fluticasone|fluticasone|mesh-list
92729105|NCT01124422|Bromides|bromides|mesh-list
92155417|NCT04801797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92155418|NCT04801797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155419|NCT03033537|Verapamil|verapamil|mesh-list
92155420|NCT03033537|Calcium Channel Blockers|calcium channel blockers|mesh-list
92155421|NCT03033537|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92155422|NCT03033537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155423|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92155424|NCT03033537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155425|NCT03033537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155426|NCT03033537|Vasodilator Agents|vasodilator agents|mesh-ancestor
92155427|NCT01670435|Ciprofloxacin|ciprofloxacin|mesh-list
92155428|NCT01670435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155429|NCT01670435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155430|NCT01670435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92155431|NCT01670435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155432|NCT01670435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155433|NCT01670435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155434|NCT01670435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155435|NCT01670435|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92155436|NCT01670435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92155437|NCT03069144|Calcitriol|calcitriol|mesh-list
92155438|NCT03069144|Calcipotriene|calcipotriene|mesh-list
92155439|NCT03069144|Dermatologic Agents|dermatologic agents|mesh-ancestor
92155440|NCT03069144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92322325|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
92155441|NCT03069144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155442|NCT03069144|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92155443|NCT03069144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155444|NCT03069144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155445|NCT03069144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92155446|NCT03069144|Vitamins|vitamins|mesh-ancestor
92155447|NCT03069144|Micronutrients|micronutrients|mesh-ancestor
92155448|NCT03069144|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92155449|NCT03017703|Eplerenone|eplerenone|mesh-list
92155450|NCT03017703|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92155451|NCT03017703|Hormone Antagonists|hormone antagonists|mesh-ancestor
92155452|NCT03017703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155453|NCT03017703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155454|NCT03017703|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92155455|NCT03017703|Diuretics|diuretics|mesh-ancestor
92155456|NCT03017703|Natriuretic Agents|natriuretic agents|mesh-ancestor
92155457|NCT03017703|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92155458|NCT01670669|Prucalopride|prucalopride|mesh-list
92155459|NCT01670669|Laxatives|laxatives|mesh-ancestor
92155460|NCT01670669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155461|NCT01670669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92155462|NCT01670669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92155463|NCT01670669|Serotonin Agents|serotonin agents|mesh-ancestor
92155464|NCT01670669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155465|NCT01670669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155466|NCT01670669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155467|NCT00946023|Mycophenolic Acid|mycophenolic acid|mesh-list
92155468|NCT00946023|Cyclophosphamide|cyclophosphamide|mesh-list
92155469|NCT00946023|Rituximab|rituximab|mesh-list
92155470|NCT00946023|Fludarabine|fludarabine|mesh-list
92155471|NCT00946023|Tacrolimus|tacrolimus|mesh-list
92155472|NCT00946023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155479|NCT00946023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729107|NCT01124422|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92729108|NCT01124422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729109|NCT01124422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92729110|NCT01124422|Autonomic Agents|autonomic agents|mesh-ancestor
92729111|NCT01124422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729112|NCT01124422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729113|NCT01124422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92155480|NCT00946023|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92155481|NCT00946023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92155482|NCT00946023|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92155483|NCT00946023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155484|NCT00946023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92155485|NCT00946023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92155486|NCT00946023|Antitubercular Agents|antitubercular agents|mesh-ancestor
92155487|NCT00946023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155488|NCT00946023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155489|NCT01672151|Sirolimus|sirolimus|mesh-list
92155490|NCT01672151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155491|NCT01672151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155492|NCT01672151|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92155493|NCT01672151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155494|NCT01672151|Antifungal Agents|antifungal agents|mesh-ancestor
92155495|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155496|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
92155497|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155498|NCT01672229|Bortezomib|bortezomib|mesh-list
92155499|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155500|NCT01672307|Minoxidil|minoxidil|mesh-list
92155501|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92155502|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
92155503|NCT03067194|Celecoxib|celecoxib|mesh-list
92155504|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92155505|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155506|NCT03067194|Analgesics|analgesics|mesh-ancestor
92155507|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
92155508|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155509|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155510|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155511|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155512|NCT03067194|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92155513|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92155514|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155515|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155517|NCT05629494|Naproxen|naproxen|mesh-list
92155518|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92155519|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155520|NCT05629494|Analgesics|analgesics|mesh-ancestor
92155521|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
92155522|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155523|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155524|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155525|NCT05629494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155526|NCT05629494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92155527|NCT05629494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155528|NCT05629494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155529|NCT05629494|Gout Suppressants|gout suppressants|mesh-ancestor
92155531|NCT00952653|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92155532|NCT00952653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92155533|NCT00952653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92155534|NCT00952653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155535|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155536|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92155537|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92155538|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92155539|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92729114|NCT01124422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92729115|NCT01124422|Dermatologic Agents|dermatologic agents|mesh-ancestor
92729116|NCT01124422|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92729117|NCT01124422|Parasympatholytics|parasympatholytics|mesh-ancestor
92729118|NCT01124422|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92155540|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
92155541|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
92155545|NCT00952653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155546|NCT00952653|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92155547|NCT00952653|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92155548|NCT00952653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155549|NCT00952653|Antidepressive Agents|antidepressive agents|mesh-ancestor
92155550|NCT01673087|Dexamethasone|dexamethasone|mesh-list
92155551|NCT01673087|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92155552|NCT01673087|Cosyntropin|cosyntropin|mesh-list
92155553|NCT01673087|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92155555|NCT01673087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155556|NCT01673087|Antiemetics|antiemetics|mesh-ancestor
92155557|NCT01673087|Autonomic Agents|autonomic agents|mesh-ancestor
92155558|NCT01673087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155559|NCT01673087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155560|NCT01673087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155561|NCT01673087|Glucocorticoids|glucocorticoids|mesh-ancestor
92155562|NCT01673087|Hormones|hormones|mesh-ancestor
92155563|NCT01673087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155564|NCT01673087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92155565|NCT01673087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155566|NCT01673087|Antimetabolites|antimetabolites|mesh-ancestor
92155567|NCT01673087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155568|NCT01673087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155569|NCT02299505|Ceritinib|ceritinib|mesh-list
92155570|NCT02299505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155571|NCT02299505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92155572|NCT02299505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155573|NCT02299505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155574|NCT01673399|Atosiban|atosiban|mesh-list
92155575|NCT01673399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92155576|NCT01673399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155577|NCT01673399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155578|NCT01673399|Tocolytic Agents|tocolytic agents|mesh-ancestor
92155579|NCT01673399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92155580|NCT02235701|Ifosfamide|ifosfamide|mesh-list
92155581|NCT02235701|Doxorubicin|doxorubicin|mesh-list
92155582|NCT02235701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92155583|NCT02235701|Alkylating Agents|alkylating agents|mesh-ancestor
92155584|NCT02235701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155585|NCT02235701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155586|NCT02235701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92155587|NCT02235701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92155588|NCT02235701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155590|NCT01674257|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92155591|NCT01674257|Fluorides|fluorides|mesh-list
92155592|NCT01674257|Cariostatic Agents|cariostatic agents|mesh-ancestor
92155593|NCT01674257|Protective Agents|protective agents|mesh-ancestor
92155594|NCT01674257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155596|NCT01674257|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92155597|NCT01674257|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92155598|NCT01674413|Adalimumab|adalimumab|mesh-list
92155599|NCT01674413|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92155600|NCT01674413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155601|NCT01674413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155602|NCT00953121|Bevacizumab|bevacizumab|mesh-list
92155603|NCT00953121|Carboplatin|carboplatin|mesh-list
92155604|NCT00953121|Irinotecan|irinotecan|mesh-list
92155605|NCT00953121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92155606|NCT00953121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155607|NCT00953121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92155608|NCT00953121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92729119|NCT01124422|Cholinergic Agents|cholinergic agents|mesh-ancestor
92729120|NCT01124422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729121|NCT01124422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729122|NCT01124422|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92729123|NCT01124422|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92729124|NCT01124422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92729125|NCT01124422|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729126|NCT01124422|Anticonvulsants|anticonvulsants|mesh-ancestor
92729128|NCT00625495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92729129|NCT00625495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92729130|NCT00625495|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92729131|NCT00625495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729132|NCT00625495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729133|NCT02882425|Selexipag|selexipag|mesh-list
92729134|NCT02882425|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92729135|NCT00577304|Nitroglycerin|nitroglycerin|mesh-list
92155609|NCT00953121|Growth Substances|growth substances|mesh-ancestor
92155610|NCT00953121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155611|NCT00953121|Growth Inhibitors|growth inhibitors|mesh-ancestor
92155612|NCT00953121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92155613|NCT00953121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155614|NCT00953121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155618|NCT03017391|Granisetron|granisetron|mesh-list
92155619|NCT03017391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155620|NCT03017391|Antiemetics|antiemetics|mesh-ancestor
92155621|NCT03017391|Autonomic Agents|autonomic agents|mesh-ancestor
92155622|NCT03017391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155623|NCT03017391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155624|NCT03017391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155625|NCT03017391|Glucocorticoids|glucocorticoids|mesh-ancestor
92155626|NCT03017391|Hormones|hormones|mesh-ancestor
92155627|NCT03017391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155628|NCT03017391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92155629|NCT03017391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155630|NCT03017391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92155631|NCT03017391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92155632|NCT03017391|Dopamine Agents|dopamine agents|mesh-ancestor
92155633|NCT03017391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155634|NCT03017391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155635|NCT03017391|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92155636|NCT03017391|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92155637|NCT03017391|Serotonin Agents|serotonin agents|mesh-ancestor
92155638|NCT00953199|Lidocaine|lidocaine|mesh-list
92155639|NCT00953199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92155640|NCT00953199|Anesthetics|anesthetics|mesh-ancestor
92155641|NCT00953199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155642|NCT00953199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155643|NCT00953199|Sensory System Agents|sensory system agents|mesh-ancestor
92155644|NCT00953199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155645|NCT00953199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92155646|NCT00953199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92155647|NCT00953199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92155648|NCT00953199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155649|NCT00953199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155650|NCT03033147|Amoxicillin|amoxicillin|mesh-list
92155651|NCT03033147|Clavulanic Acid|clavulanic acid|mesh-list
92155652|NCT03033147|Clavulanic Acids|clavulanic acids|mesh-list
92729136|NCT00577304|Vasodilator Agents|vasodilator agents|mesh-ancestor
92729137|NCT01124149|Mesalamine|mesalamine|mesh-list
92729138|NCT01124149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92729139|NCT01124149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92729140|NCT01124149|Analgesics|analgesics|mesh-ancestor
92729141|NCT01124149|Sensory System Agents|sensory system agents|mesh-ancestor
92729142|NCT01124149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155653|NCT03033147|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92155654|NCT03033147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155655|NCT03033147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155656|NCT03033147|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92155657|NCT03033147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155658|NCT03033147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155659|NCT01675895|Lidocaine|lidocaine|mesh-list
92155660|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
92155661|NCT01675895|Anesthetics|anesthetics|mesh-list
92155662|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
92322326|NCT00000506|Phentermine|phentermine|mesh-list
92155663|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155664|NCT01675895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155665|NCT01675895|Sensory System Agents|sensory system agents|mesh-ancestor
92155666|NCT01675895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155667|NCT01675895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92401500|NCT01416974|Cyclophosphamide|cyclophosphamide|mesh-list
92155668|NCT01675895|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92155669|NCT01675895|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92155670|NCT01675895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155671|NCT01675895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155673|NCT01675973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92155674|NCT01675973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92155675|NCT01675973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155676|NCT04764851|Ecopipam|ecopipam|mesh-list
92155677|NCT04764851|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92155678|NCT04764851|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92155679|NCT04764851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155680|NCT04764851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155681|NCT04764851|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92155682|NCT04764851|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92155683|NCT04764851|Dopamine Agents|dopamine agents|mesh-ancestor
92155684|NCT04764851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155687|NCT00956085|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92155688|NCT00956085|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92155689|NCT00956085|Dopamine Agents|dopamine agents|mesh-ancestor
92155690|NCT00956085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155691|NCT00956085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155692|NCT00956085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155693|NCT00956085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92155694|NCT00956085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92155695|NCT01005459|Bupivacaine|bupivacaine|mesh-list
92155696|NCT01005459|Tetracaine|tetracaine|mesh-list
92155697|NCT01005459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92155698|NCT01005459|Anesthetics|anesthetics|mesh-ancestor
92155699|NCT01005459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155700|NCT01005459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155701|NCT01005459|Sensory System Agents|sensory system agents|mesh-ancestor
92155702|NCT01005459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155703|NCT01676285|Metoprolol|metoprolol|mesh-list
92155704|NCT01676285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92155705|NCT01676285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92155706|NCT01676285|Sympatholytics|sympatholytics|mesh-ancestor
92155707|NCT01676285|Autonomic Agents|autonomic agents|mesh-ancestor
92155708|NCT01676285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155709|NCT01676285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155710|NCT01676285|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92155711|NCT01676285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92155712|NCT01676285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92155713|NCT01676285|Adrenergic Agents|adrenergic agents|mesh-ancestor
92155714|NCT01676285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729143|NCT01124149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729144|NCT01124149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92729145|NCT01124149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729146|NCT04545099|Neostigmine|neostigmine|mesh-list
92729147|NCT04545099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92729148|NCT04545099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92729149|NCT04545099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729150|NCT04545099|Cholinergic Agents|cholinergic agents|mesh-ancestor
92729151|NCT04545099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729152|NCT04545099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155715|NCT01676285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155716|NCT01676363|Diflunisal|diflunisal|mesh-list
92155717|NCT01676363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92155718|NCT01676363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155719|NCT01676363|Analgesics|analgesics|mesh-ancestor
92155720|NCT01676363|Sensory System Agents|sensory system agents|mesh-ancestor
92155721|NCT01676363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155722|NCT01676363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155723|NCT01676363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155724|NCT01676363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155725|NCT01676363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92155726|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155727|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155728|NCT00956709|Ropivacaine|ropivacaine|mesh-list
92155729|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
92155730|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
92155731|NCT00956709|Anesthetics|anesthetics|mesh-ancestor
92155732|NCT00956709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155733|NCT00956709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155734|NCT00956709|Sensory System Agents|sensory system agents|mesh-ancestor
92155735|NCT00956709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155736|NCT00957333|Ketamine|ketamine|mesh-list
92155738|NCT00957333|Sensory System Agents|sensory system agents|mesh-ancestor
92155739|NCT00957333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155740|NCT00957333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155741|NCT00957333|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92155742|NCT00957333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92155743|NCT00957333|Anesthetics, General|anesthetics, general|mesh-ancestor
92155744|NCT00957333|Anesthetics|anesthetics|mesh-ancestor
92155745|NCT00957333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155746|NCT00957333|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92155747|NCT00957333|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92155748|NCT00957333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155749|NCT00957333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155750|NCT02159547|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92155751|NCT02159547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92155752|NCT02159547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92155753|NCT02159547|Analgesics|analgesics|mesh-ancestor
92155754|NCT02159547|Sensory System Agents|sensory system agents|mesh-ancestor
92155755|NCT02159547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155756|NCT02159547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155767|NCT01011075|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155768|NCT01011075|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155769|NCT01011075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155770|NCT01011075|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92155771|NCT01011075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155773|NCT00958581|Aminocaproic Acid|aminocaproic acid|mesh-list
92155774|NCT00958581|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92155775|NCT00958581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92155776|NCT00958581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155777|NCT00958581|Hemostatics|hemostatics|mesh-ancestor
92155778|NCT00958581|Coagulants|coagulants|mesh-ancestor
92155779|NCT01012089|Daptomycin|daptomycin|mesh-list
92729154|NCT04545099|Autonomic Agents|autonomic agents|mesh-ancestor
92729155|NCT04545099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92729156|NCT02882269|Capecitabine|capecitabine|mesh-list
92729157|NCT02882269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92729158|NCT02882269|Antimetabolites|antimetabolites|mesh-ancestor
92155780|NCT01012089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155781|NCT01012089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155782|NCT04265651|Infigratinib|infigratinib|mesh-list
92155783|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155784|NCT04055753|Doxorubicin|doxorubicin|mesh-list
92155785|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92155786|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155787|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92155788|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155789|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155790|NCT04055753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155791|NCT03871361|Abatacept|abatacept|mesh-list
92155792|NCT03871361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92155793|NCT03871361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155794|NCT03871361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92155795|NCT03871361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155796|NCT03871361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155797|NCT03871361|Immunologic Factors|immunologic factors|mesh-ancestor
92155798|NCT03871361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155799|NCT03871361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155800|NCT04764227|Paclitaxel|paclitaxel|mesh-list
92155801|NCT04764227|Carboplatin|carboplatin|mesh-list
92155802|NCT04764227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155803|NCT04764227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155804|NCT04764227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155805|NCT04764227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155806|NCT04764227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155807|NCT04764227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155808|NCT03589547|Durvalumab|durvalumab|mesh-list
92155809|NCT03589547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92155810|NCT03589547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155812|NCT04764383|Histamine Agonists|histamine agonists|mesh-ancestor
92155813|NCT04764383|Histamine Agents|histamine agents|mesh-ancestor
92155814|NCT04764383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155815|NCT04764383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155816|NCT04764383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155818|NCT03016611|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92155819|NCT03016611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92155820|NCT03016611|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92155821|NCT03016611|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92155822|NCT03016611|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92155823|NCT03016611|Purinergic Agents|purinergic agents|mesh-ancestor
92155826|NCT03016611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155827|NCT00961233|Budesonide|budesonide|mesh-list
92155828|NCT00961233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155829|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92155830|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
92155831|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92155832|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155833|NCT00961233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92155834|NCT00961233|Respiratory System Agents|respiratory system agents|mesh-ancestor
92155835|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
92155836|NCT00961233|Hormones|hormones|mesh-ancestor
92155837|NCT00961233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155838|NCT00962871|Tenofovir|tenofovir|mesh-list
92155839|NCT00962871|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92155840|NCT00962871|Antiviral Agents|antiviral agents|mesh-ancestor
92155841|NCT00962871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155842|NCT00962871|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92155843|NCT00962871|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92155844|NCT00962871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155845|NCT00962871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729159|NCT02882269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729160|NCT02882269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729161|NCT01122862|Chlorhexidine|chlorhexidine|mesh-list
92729162|NCT01122862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92729163|NCT01122862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729164|NCT01122862|Disinfectants|disinfectants|mesh-ancestor
92729165|NCT04537767|Esmolol|esmolol|mesh-list
92155846|NCT00962871|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92155847|NCT00962871|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92155848|NCT01014351|Paclitaxel|paclitaxel|mesh-list
92155849|NCT01014351|Carboplatin|carboplatin|mesh-list
92155850|NCT01014351|Everolimus|everolimus|mesh-list
92155851|NCT01014351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155852|NCT01014351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155853|NCT01014351|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155854|NCT01014351|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155855|NCT01014351|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155856|NCT01014351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155857|NCT01014351|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92155858|NCT01014351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92155859|NCT01014351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155860|NCT01014351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155861|NCT01014351|Immunologic Factors|immunologic factors|mesh-ancestor
92155862|NCT01014351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155863|NCT01014741|Ibutilide|ibutilide|mesh-list
92155864|NCT01014741|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92155865|NCT01015443|Cyclophosphamide|cyclophosphamide|mesh-list
92155866|NCT01015443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92155867|NCT01015443|Immunologic Factors|immunologic factors|mesh-ancestor
92155868|NCT01015443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155869|NCT01015443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155870|NCT01015443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92155871|NCT01015443|Alkylating Agents|alkylating agents|mesh-ancestor
92155872|NCT01015443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155873|NCT01015443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401514|NCT01417065|Temsirolimus|temsirolimus|mesh-list
92155874|NCT01015443|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92155875|NCT00962949|Angiotensin II|angiotensin ii|mesh-list
92155876|NCT00962949|Giapreza|giapreza|mesh-list
92155877|NCT00962949|Angiotensinogen|angiotensinogen|mesh-list
92155878|NCT00962949|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92155879|NCT00962949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92155880|NCT00962949|Protease Inhibitors|protease inhibitors|mesh-ancestor
92155881|NCT00962949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155882|NCT00962949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155883|NCT01695941|Rituximab|rituximab|mesh-list
92155884|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92155885|NCT01695941|Bortezomib|bortezomib|mesh-list
92155886|NCT01695941|Antibodies|antibodies|mesh-list
92155887|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
92155888|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92155889|NCT01695941|Immunologic Factors|immunologic factors|mesh-ancestor
92155890|NCT01695941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155891|NCT01695941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155892|NCT01695941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155893|NCT01244789|Paclitaxel|paclitaxel|mesh-list
92155894|NCT01244789|Carboplatin|carboplatin|mesh-list
92155895|NCT01244789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155896|NCT01244789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155897|NCT01244789|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155915|NCT02631876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92155916|NCT02631876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155917|NCT02631876|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92155918|NCT02631876|Immunoconjugates|immunoconjugates|mesh-ancestor
92155919|NCT02631876|Immunologic Factors|immunologic factors|mesh-ancestor
92155920|NCT02631876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155921|NCT03156179|Calcium|calcium|mesh-list
92155922|NCT03156179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92155923|NCT03156179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155924|NCT04436796|Pancrelipase|pancrelipase|mesh-list
92155925|NCT04436796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155926|NCT02081963|Amikacin|amikacin|mesh-list
92729166|NCT04537767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92729167|NCT04537767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92729168|NCT04537767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92729169|NCT04537767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729170|NCT04537767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729171|NCT04537767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729172|NCT04537767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729173|NCT01121926|Trazodone|trazodone|mesh-list
92729174|NCT01121926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92729175|NCT01121926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92729176|NCT01121926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729177|NCT01121926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729178|NCT01121926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92729179|NCT01121926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92729180|NCT01121926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92729223|NCT00577850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729224|NCT00577850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92729225|NCT00577850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92729226|NCT00577850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92729227|NCT00577850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92729229|NCT00577967|Analgesics|analgesics|mesh-ancestor
92729289|NCT04544163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92729364|NCT00578825|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92729436|NCT04578236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92729437|NCT04578236|Keratolytic Agents|keratolytic agents|mesh-ancestor
92729509|NCT04532775|Bupivacaine|bupivacaine|mesh-list
92729510|NCT04532775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92729511|NCT04532775|Prednisolone phosphate|prednisolone phosphate|mesh-list
92729512|NCT04532775|Anesthetics, Local|anesthetics, local|mesh-ancestor
92729513|NCT04532775|Anesthetics|anesthetics|mesh-ancestor
92729514|NCT04532775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729578|NCT04532736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92729579|NCT04532736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92729652|NCT04531371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92729653|NCT04531371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92729654|NCT04531371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92729665|NCT00580112|Hormones|hormones|mesh-ancestor
92729723|NCT04530903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92729724|NCT04530474|Ivermectin|ivermectin|mesh-list
92729725|NCT04530474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92729726|NCT04530474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92729727|NCT04554680|Trametinib|trametinib|mesh-list
92729793|NCT04554524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92729867|NCT01120600|Vitamin D|vitamin d|mesh-list
92729868|NCT01120600|Cholecalciferol|cholecalciferol|mesh-list
92729941|NCT02882191|Levonorgestrel|levonorgestrel|mesh-list
92729942|NCT02882191|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92729943|NCT02882191|Contraceptive Agents|contraceptive agents|mesh-ancestor
92729944|NCT02882191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92729945|NCT02882191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92729946|NCT02882191|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92729947|NCT02882191|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92729948|NCT02882191|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92729949|NCT02218398|Albuterol|albuterol|mesh-list
92729950|NCT02218398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92730006|NCT02882230|Rilpivirine|rilpivirine|mesh-list
92730007|NCT02882230|Elvitegravir|elvitegravir|mesh-list
92730008|NCT02882230|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92730078|NCT01118455|Anticonvulsants|anticonvulsants|mesh-list
92730079|NCT02219100|Mifepristone|mifepristone|mesh-list
92730152|NCT04577378|Keratolytic Agents|keratolytic agents|mesh-ancestor
92730225|NCT03453281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730299|NCT01117051|Laxatives|laxatives|mesh-ancestor
92730374|NCT01643499|Levoleucovorin|levoleucovorin|mesh-list
92730375|NCT01643499|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730450|NCT01640574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92730451|NCT01640574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92730452|NCT01640574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92730522|NCT01116232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92730523|NCT01116232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730524|NCT01116232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730594|NCT04528797|Prednisolone phosphate|prednisolone phosphate|mesh-list
92730595|NCT04528797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92730596|NCT04528797|Antiemetics|antiemetics|mesh-ancestor
92730597|NCT04528797|Autonomic Agents|autonomic agents|mesh-ancestor
92730598|NCT04528797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92730665|NCT01182181|Hormone Antagonists|hormone antagonists|mesh-ancestor
92730666|NCT01182181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730669|NCT01181986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92730740|NCT01641510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92730741|NCT01641510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92730742|NCT01641510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92730808|NCT01641783|Antimitotic Agents|antimitotic agents|mesh-ancestor
92730809|NCT01641783|Mitosis Modulators|mitosis modulators|mesh-ancestor
92730861|NCT04546256|Xhance|xhance|mesh-list
92730880|NCT04546256|Hormones|hormones|mesh-ancestor
92730881|NCT04546256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92730882|NCT04546256|Sympathomimetics|sympathomimetics|mesh-ancestor
92730883|NCT01645449|Atorvastatin|atorvastatin|mesh-list
92730884|NCT01645449|Calcium|calcium|mesh-list
92730885|NCT01645449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92730886|NCT01645449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92730887|NCT01645449|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92730888|NCT01645449|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92730889|NCT01645449|Antimetabolites|antimetabolites|mesh-ancestor
92730890|NCT01645449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730891|NCT01645449|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92730892|NCT01645449|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92730893|NCT01645449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92730894|NCT04546022|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92730895|NCT01645800|Muramidase|muramidase|mesh-list
92730896|NCT01645800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92730897|NCT02214680|Timolol|timolol|mesh-list
92730898|NCT02214680|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92730899|NCT02214680|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92730900|NCT02214680|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92730933|NCT02756013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730934|NCT01680042|Phenytoin|phenytoin|mesh-list
92730935|NCT01680042|Anticonvulsants|anticonvulsants|mesh-ancestor
92730936|NCT01680042|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92730937|NCT01680042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92730938|NCT01680042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92730939|NCT01680042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92730940|NCT01680042|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92731000|NCT01680471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92731072|NCT01646775|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92731073|NCT01646775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92731074|NCT01646775|Anesthetics, General|anesthetics, general|mesh-ancestor
92731075|NCT01646775|Anesthetics|anesthetics|mesh-ancestor
92731076|NCT01646853|Fluorouracil|fluorouracil|mesh-list
92731143|NCT02214992|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92731144|NCT02214992|Protease Inhibitors|protease inhibitors|mesh-ancestor
92731218|NCT01681563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731293|NCT01648608|Exemestane|exemestane|mesh-list
92731294|NCT01648608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92731363|NCT01648881|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92731364|NCT01648881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731434|NCT04539119|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92731435|NCT04539119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92731436|NCT04539119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731437|NCT04539119|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92731438|NCT04539119|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92731503|NCT01202188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731504|NCT01202188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731575|NCT01200589|Immunologic Factors|immunologic factors|mesh-ancestor
92731576|NCT01200589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92731577|NCT01200589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92731578|NCT01683552|Fexofenadine|fexofenadine|mesh-list
92731579|NCT01683552|Prednisone|prednisone|mesh-list
92731647|NCT01178671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92731718|NCT01643070|Capecitabine|capecitabine|mesh-list
92731790|NCT04531475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92731791|NCT01684449|Sirolimus|sirolimus|mesh-list
92731792|NCT01684449|Gemcitabine|gemcitabine|mesh-list
92731863|NCT01200355|Antifungal Agents|antifungal agents|mesh-ancestor
92731864|NCT01200355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92731940|NCT02887534|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92731941|NCT02887534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92732013|NCT01199731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92732014|NCT01199731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732016|NCT01199731|Antiviral Agents|antiviral agents|mesh-ancestor
92732085|NCT04535960|Hormones|hormones|mesh-ancestor
92732086|NCT04535960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732087|NCT04535960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92732088|NCT04535960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732155|NCT05138484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92732156|NCT05138484|Disinfectants|disinfectants|mesh-ancestor
92732157|NCT05138484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92732158|NCT04535804|Aspirin|aspirin|mesh-list
92732159|NCT04535804|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92732160|NCT04535804|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92732161|NCT04535804|Analgesics|analgesics|mesh-ancestor
92732162|NCT04535804|Sensory System Agents|sensory system agents|mesh-ancestor
92732163|NCT04535804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92732164|NCT04535804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732165|NCT04535804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92732166|NCT04535804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732167|NCT04535804|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92732168|NCT04535804|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92732169|NCT04535804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732170|NCT04535804|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92732171|NCT04535804|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92732172|NCT04535804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732173|NCT04535804|Antipyretics|antipyretics|mesh-ancestor
92732174|NCT04529525|Ivermectin|ivermectin|mesh-list
92732175|NCT04529525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92732177|NCT02216409|Magrolimab|magrolimab|mesh-list
92732210|NCT02218658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732284|NCT01198132|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92732357|NCT04534322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92732358|NCT04534322|Alkylating Agents|alkylating agents|mesh-ancestor
92732428|NCT02219789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92732429|NCT02219789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732430|NCT02219828|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92732431|NCT02219828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92732432|NCT04533867|Ondansetron|ondansetron|mesh-list
92732433|NCT04533867|Palonosetron|palonosetron|mesh-list
92732434|NCT04533867|Antiemetics|antiemetics|mesh-ancestor
92732496|NCT01195675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732497|NCT01195675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732570|NCT02214563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92732572|NCT01194973|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92732640|NCT01177384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732641|NCT01177384|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92732642|NCT01177384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92732711|NCT01642745|Natriuretic Agents|natriuretic agents|mesh-ancestor
92732712|NCT01642745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92732713|NCT01642745|Miotics|miotics|mesh-ancestor
92732724|NCT01640990|GW 328267|gw 328267|mesh-list
92732780|NCT01643135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92732854|NCT02755844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92732855|NCT02755844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92732857|NCT02755844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92732927|NCT01680107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92732928|NCT01680146|Caseins|caseins|mesh-list
92732929|NCT01680146|Chelating Agents|chelating agents|mesh-ancestor
92732932|NCT01680185|Insulin|insulin|mesh-list
92732999|NCT01680536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733073|NCT01600365|Antiviral Agents|antiviral agents|mesh-ancestor
92733074|NCT01600365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733075|NCT01600365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92733145|NCT02484924|Ticagrelor|ticagrelor|mesh-list
92733220|NCT01681979|Xhance|xhance|mesh-list
92733221|NCT01681979|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92733222|NCT01681979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92733296|NCT01682408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733438|NCT01605357|Diuretics|diuretics|mesh-ancestor
92733439|NCT01605357|Natriuretic Agents|natriuretic agents|mesh-ancestor
92733516|NCT01648556|Glucocorticoids|glucocorticoids|mesh-ancestor
92733517|NCT01648556|Hormones|hormones|mesh-ancestor
92733521|NCT01648556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733590|NCT01688700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92733591|NCT01688700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92733592|NCT01688700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92733661|NCT01689090|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92733662|NCT01689090|Anticoagulants|anticoagulants|mesh-ancestor
92733663|NCT01689090|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92733731|NCT01684787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92733732|NCT01684787|Immunologic Factors|immunologic factors|mesh-ancestor
92733733|NCT01684787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92733803|NCT01606878|Protective Agents|protective agents|mesh-ancestor
92733877|NCT01606566|Bleomycin|bleomycin|mesh-list
92733878|NCT01606566|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92733879|NCT01606566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733945|NCT02270034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92733946|NCT02270034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92733947|NCT02270034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734015|NCT01688570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92734089|NCT02271282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92734090|NCT02271282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734091|NCT02271282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92734159|NCT01687127|Vitamin B Complex|vitamin b complex|mesh-list
92734161|NCT01687127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92734163|NCT01687127|Hematinics|hematinics|mesh-ancestor
92734230|NCT01588704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734231|NCT01588704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92734232|NCT01588704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92734302|NCT01689623|Antimetabolites|antimetabolites|mesh-ancestor
92734304|NCT01689623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92734374|NCT05654064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92734375|NCT05654064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734376|NCT05654064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92734377|NCT05654064|Analgesics|analgesics|mesh-ancestor
92734445|NCT03558854|Sensory System Agents|sensory system agents|mesh-ancestor
92734446|NCT03558854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92734447|NCT03558854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92734448|NCT03558854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92734590|NCT01332318|Diphenhydramine|diphenhydramine|mesh-list
92734592|NCT01332318|Gabapentin|gabapentin|mesh-list
92734593|NCT01332318|Analgesics|analgesics|mesh-ancestor
92734594|NCT01332318|Sensory System Agents|sensory system agents|mesh-ancestor
92734662|NCT01351350|Tubulin Modulators|tubulin modulators|mesh-ancestor
92734663|NCT01351350|Antimitotic Agents|antimitotic agents|mesh-ancestor
92734664|NCT01351350|Mitosis Modulators|mitosis modulators|mesh-ancestor
92734665|NCT01351350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92734666|NCT01351350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92734667|NCT02271503|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92734729|NCT01342887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92734730|NCT01342887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92734804|NCT04328493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92734805|NCT04328493|Antimalarials|antimalarials|mesh-ancestor
92734817|NCT04396587|Sufentanil|sufentanil|mesh-list
92734883|NCT02893371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92734884|NCT02893371|Serotonin Agents|serotonin agents|mesh-ancestor
92734952|NCT02893176|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92734953|NCT02893176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735022|NCT02894268|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92735023|NCT02894268|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92735024|NCT02894268|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92735169|NCT01600274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735170|NCT01600274|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92735241|NCT02273765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92735311|NCT01112059|Doxycycline|doxycycline|mesh-list
92735314|NCT01112059|Antimalarials|antimalarials|mesh-ancestor
92735386|NCT01607762|Dopamine Agonists|dopamine agonists|mesh-ancestor
92735461|NCT01111825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735462|NCT01111825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92735467|NCT01175590|Besifloxacin|besifloxacin|mesh-list
92735535|NCT01602302|Immunologic Factors|immunologic factors|mesh-ancestor
92735536|NCT01602302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92735611|NCT04310254|Antidotes|antidotes|mesh-ancestor
92735612|NCT04310254|Protective Agents|protective agents|mesh-ancestor
92735686|NCT00622830|Darapladib|darapladib|mesh-list
92735687|NCT00622830|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92735688|NCT00622830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92735760|NCT01173601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735761|NCT01173601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92735762|NCT01173601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92735831|NCT00593658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92735832|NCT00593658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92735902|NCT01605344|Protective Agents|protective agents|mesh-ancestor
92735903|NCT01605344|Vitamin B Complex|vitamin b complex|mesh-ancestor
92735904|NCT01605344|Vitamins|vitamins|mesh-ancestor
92735905|NCT01605344|Micronutrients|micronutrients|mesh-ancestor
92735969|NCT01605734|Hormones|hormones|mesh-ancestor
92735971|NCT01605734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736026|NCT00594633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736028|NCT00594633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736029|NCT00594633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736030|NCT00594633|Nootropic Agents|nootropic agents|mesh-ancestor
92736031|NCT01605968|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92736032|NCT01605968|Laxatives|laxatives|mesh-ancestor
92736033|NCT01605968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92736034|NCT01606046|Anesthetics|anesthetics|mesh-list
92736035|NCT01606046|Ethyl Chloride|ethyl chloride|mesh-list
92736036|NCT01606046|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92736037|NCT01606046|Anesthetics, Local|anesthetics, local|mesh-list
92736038|NCT01606046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92736039|NCT01606046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736040|NCT01606046|Sensory System Agents|sensory system agents|mesh-ancestor
92736069|NCT01606241|Immunologic Factors|immunologic factors|mesh-ancestor
92736070|NCT01606241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736144|NCT02271347|Antiviral Agents|antiviral agents|mesh-ancestor
92736145|NCT02271347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92736146|NCT01172938|Thalidomide|thalidomide|mesh-list
92736147|NCT01172938|Apremilast|apremilast|mesh-list
92736148|NCT01172938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92736149|NCT01172938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92736150|NCT01172938|Analgesics|analgesics|mesh-ancestor
92736151|NCT01172938|Sensory System Agents|sensory system agents|mesh-ancestor
92736152|NCT01172938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736153|NCT01172938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736154|NCT01172938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92736155|NCT01172938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736156|NCT01172938|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92736157|NCT01172938|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92736158|NCT01172938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736159|NCT01172938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736160|NCT01172938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736161|NCT01172938|Immunologic Factors|immunologic factors|mesh-ancestor
92736200|NCT04326894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92736201|NCT04326894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736202|NCT04326894|Immunologic Factors|immunologic factors|mesh-ancestor
92736203|NCT04326894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736204|NCT04326894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92736205|NCT02271542|Propofol|propofol|mesh-list
92736206|NCT02271542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92736208|NCT02271542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736334|NCT02272829|Analgesics, Opioid|analgesics, opioid|mesh-list
92736335|NCT02272829|Narcotics|narcotics|mesh-ancestor
92736338|NCT02272829|Analgesics|analgesics|mesh-ancestor
92736408|NCT04327401|Autonomic Agents|autonomic agents|mesh-ancestor
92736409|NCT04327401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92736474|NCT00107900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736475|NCT00107900|Anticoagulants|anticoagulants|mesh-ancestor
92736506|NCT01335698|Ritonavir|ritonavir|mesh-list
92736546|NCT00107198|Mitosis Modulators|mitosis modulators|mesh-ancestor
92736547|NCT00107120|Escitalopram|escitalopram|mesh-list
92736548|NCT00107120|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92736617|NCT01332968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92736618|NCT01332968|Immunologic Factors|immunologic factors|mesh-ancestor
92736619|NCT01332968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92736620|NCT01332968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92736621|NCT01332968|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92736687|NCT01332149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92736688|NCT01332149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92736695|NCT01326702|Rituximab|rituximab|mesh-list
92736758|NCT01380080|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92736830|NCT01357616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92736831|NCT01357616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92736832|NCT01357616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92736901|NCT01342484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92736902|NCT01342484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92736973|NCT00598338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92736974|NCT00598338|Serotonin Agents|serotonin agents|mesh-ancestor
92736975|NCT00598338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92736976|NCT00598338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737043|NCT00623220|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92737111|NCT01171183|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92737112|NCT01171183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92737113|NCT01171183|Adrenergic Agents|adrenergic agents|mesh-ancestor
92737183|NCT01106677|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92737184|NCT01106677|Canagliflozin|canagliflozin|mesh-list
92737185|NCT01106677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92737254|NCT01103245|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92737255|NCT01103245|Spironolactone|spironolactone|mesh-list
92737328|NCT04328636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737330|NCT04328636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92737398|NCT00592670|Antidepressive Agents|antidepressive agents|mesh-ancestor
92737399|NCT00592670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92737400|NCT00592670|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92737401|NCT00592670|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92737402|NCT00592670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737403|NCT04327232|Spironolactone|spironolactone|mesh-list
92737404|NCT04327232|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92737463|NCT00595322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737464|NCT00595322|Growth Inhibitors|growth inhibitors|mesh-ancestor
92737465|NCT00596336|Imiquimod|imiquimod|mesh-list
92737528|NCT00598676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737529|NCT00598676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92737537|NCT00599222|Ranibizumab|ranibizumab|mesh-list
92737600|NCT00600626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737602|NCT00623168|Antimetabolites|antimetabolites|mesh-ancestor
92737603|NCT00623168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737604|NCT00623168|Antiviral Agents|antiviral agents|mesh-ancestor
92737605|NCT00623168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737606|NCT00601016|Imiquimod|imiquimod|mesh-list
92737607|NCT00601016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92737608|NCT00601016|Immunologic Factors|immunologic factors|mesh-ancestor
92737609|NCT00601016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92737610|NCT00601016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737611|NCT00601016|Interferon Inducers|interferon inducers|mesh-ancestor
92737612|NCT00601328|Calcitriol|calcitriol|mesh-list
92737664|NCT01096849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92737665|NCT01096849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92737666|NCT01096849|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92737667|NCT01096849|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92737668|NCT01096849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737669|NCT01096849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92737670|NCT01096849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737671|NCT01096849|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92737672|NCT01096849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92737674|NCT01324388|Metoprolol|metoprolol|mesh-list
92737675|NCT01324388|Lisinopril|lisinopril|mesh-list
92737676|NCT01324388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92737725|NCT01095835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92737726|NCT01095835|Antiviral Agents|antiviral agents|mesh-ancestor
92737799|NCT02891967|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92737874|NCT00600405|Urological Agents|urological agents|mesh-ancestor
92737875|NCT00600639|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92737876|NCT00600639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92737877|NCT00600639|Prednisolone|prednisolone|mesh-list
92737878|NCT00600639|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92737879|NCT00600639|Methylprednisolone|methylprednisolone|mesh-list
92737880|NCT00600639|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92737881|NCT00600639|Prednisolone acetate|prednisolone acetate|mesh-list
92737882|NCT00600639|Albuterol|albuterol|mesh-list
92737883|NCT00600639|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92737884|NCT00600639|Prednisolone phosphate|prednisolone phosphate|mesh-list
92737941|NCT00601575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92737943|NCT00601575|Antimanic Agents|antimanic agents|mesh-ancestor
92738014|NCT01324323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738015|NCT01324323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738086|NCT01317615|Everolimus|everolimus|mesh-list
92738087|NCT01317615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92738101|NCT01078675|Calcium|calcium|mesh-list
92738162|NCT01321008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92738237|NCT01310127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92738239|NCT01310127|Analgesics|analgesics|mesh-ancestor
92738310|NCT01169350|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92738458|NCT01078441|Glucocorticoids|glucocorticoids|mesh-ancestor
92738459|NCT01078441|Hormones|hormones|mesh-ancestor
92738460|NCT01078441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738461|NCT01078441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738530|NCT02877901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738531|NCT02877901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738532|NCT02877901|Urological Agents|urological agents|mesh-ancestor
92738533|NCT04306159|Anesthetics|anesthetics|mesh-list
92738601|NCT01074307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92738602|NCT01074307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92738603|NCT01076335|Docetaxel|docetaxel|mesh-list
92738674|NCT01104766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92738675|NCT01104766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92738676|NCT01104766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92738677|NCT01104766|Dopamine Agonists|dopamine agonists|mesh-ancestor
92738741|NCT01072357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92738743|NCT01072357|Growth Substances|growth substances|mesh-ancestor
92738813|NCT01102972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92738886|NCT01102426|Glucocorticoids|glucocorticoids|mesh-ancestor
92738887|NCT01102426|Hormones|hormones|mesh-ancestor
92738888|NCT01102426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92738889|NCT01102426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92738891|NCT04308850|Vitamin D|vitamin d|mesh-list
92738956|NCT01307319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739028|NCT02875717|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92739029|NCT02875717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92739101|NCT00594269|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92739102|NCT00594269|Antidepressive Agents|antidepressive agents|mesh-ancestor
92739103|NCT00594269|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92739104|NCT00594269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92739105|NCT00594269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92739106|NCT00594347|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92739107|NCT00594347|Immunologic Factors|immunologic factors|mesh-ancestor
92739108|NCT00594347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739109|NCT04326959|Triamcinolone|triamcinolone|mesh-list
92739110|NCT04326959|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92739111|NCT04326959|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92739112|NCT04326959|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92739113|NCT04326959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739114|NCT04326959|Glucocorticoids|glucocorticoids|mesh-ancestor
92739115|NCT04326959|Hormones|hormones|mesh-ancestor
92739118|NCT04326959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739158|NCT00596297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92739233|NCT00597623|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92739234|NCT00597623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92739308|NCT00598247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739309|NCT00598403|Ciprofloxacin|ciprofloxacin|mesh-list
92739382|NCT00599573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92739383|NCT00599573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739387|NCT01048099|Pertuzumab|pertuzumab|mesh-list
92739456|NCT01045447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92739458|NCT00623207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92739459|NCT00623207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92739460|NCT00623207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92739601|NCT04303819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92739603|NCT04303819|Hormones|hormones|mesh-ancestor
92739676|NCT01035463|Antiviral Agents|antiviral agents|mesh-ancestor
92739677|NCT01035463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92739678|NCT01035463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92739747|NCT01100944|Belinostat|belinostat|mesh-list
92739801|NCT04309240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92739802|NCT04309240|Anticoagulants|anticoagulants|mesh-ancestor
92739873|NCT00623285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92739874|NCT00623285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92739875|NCT00623285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92739950|NCT01093534|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92739951|NCT01093534|Cholinergic Agents|cholinergic agents|mesh-ancestor
92739952|NCT01093534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92740021|NCT01313273|Anabolic Agents|anabolic agents|mesh-ancestor
92740022|NCT01313273|Hormone Antagonists|hormone antagonists|mesh-ancestor
92740023|NCT01091974|Modafinil|modafinil|mesh-list
92740093|NCT01309997|Imatinib Mesylate|imatinib mesylate|mesh-list
92740094|NCT01309997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92740095|NCT01309997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740096|NCT01309997|Immunologic Factors|immunologic factors|mesh-ancestor
92740097|NCT01309997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740098|NCT01309997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92740161|NCT01057693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92740162|NCT01057693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92740163|NCT01057693|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92740164|NCT01057693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92740228|NCT01033825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92740229|NCT01033825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92740231|NCT01033825|Protease Inhibitors|protease inhibitors|mesh-ancestor
92740298|NCT01029535|Hyaluronic Acid|hyaluronic acid|mesh-list
92740299|NCT01029535|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92740300|NCT01029535|Immunologic Factors|immunologic factors|mesh-ancestor
92740359|NCT01294683|Niacin|niacin|mesh-list
92740429|NCT01292187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92740501|NCT02872597|Prednisolone|prednisolone|mesh-list
92740502|NCT02872597|Albuterol|albuterol|mesh-list
92740503|NCT02872597|Ipratropium|ipratropium|mesh-list
92740504|NCT02872597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92740505|NCT02872597|Antiemetics|antiemetics|mesh-ancestor
92740506|NCT02872597|Autonomic Agents|autonomic agents|mesh-ancestor
92740572|NCT01014013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740573|NCT01013701|Fluticasone|fluticasone|mesh-list
92740646|NCT01288443|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92740647|NCT01288443|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92740648|NCT01288443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92740721|NCT01281813|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92740722|NCT01281813|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92740723|NCT01281813|Antiviral Agents|antiviral agents|mesh-ancestor
92740793|NCT01078168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92740794|NCT01086358|Naproxen|naproxen|mesh-list
92740867|NCT01079806|Antiviral Agents|antiviral agents|mesh-ancestor
92740868|NCT01079806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92740878|NCT01313676|Xhance|xhance|mesh-list
92740941|NCT01024231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92740942|NCT01024231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92740944|NCT01012999|Sufentanil|sufentanil|mesh-list
92741004|NCT01012765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92741005|NCT01012765|Parasympatholytics|parasympatholytics|mesh-ancestor
92741006|NCT01012765|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92741077|NCT01012219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92741078|NCT01012219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741090|NCT01012219|Vitamins|vitamins|mesh-ancestor
92741153|NCT01310868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92741154|NCT01310868|Alkylating Agents|alkylating agents|mesh-ancestor
92401594|NCT01417494|Antimetabolites|antimetabolites|mesh-ancestor
92741155|NCT01310868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741156|NCT01310868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741222|NCT01266603|Sensory System Agents|sensory system agents|mesh-ancestor
92741296|NCT01264887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92741297|NCT01264887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741298|NCT01264887|Adrenergic Agents|adrenergic agents|mesh-ancestor
92741370|NCT01003639|Gout Suppressants|gout suppressants|mesh-ancestor
92741373|NCT01003639|Diuretics|diuretics|mesh-ancestor
92741444|NCT04322175|Sensory System Agents|sensory system agents|mesh-ancestor
92741445|NCT04322175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741513|NCT02889003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741590|NCT04479267|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92741591|NCT04479267|Protective Agents|protective agents|mesh-ancestor
92741592|NCT04439799|Methyltestosterone|methyltestosterone|mesh-list
92741666|NCT03219177|Sensory System Agents|sensory system agents|mesh-ancestor
92741667|NCT03219177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92741736|NCT01302054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92741737|NCT01302054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92741810|NCT01256385|Antibodies|antibodies|mesh-list
92741811|NCT01256385|Immunoglobulins|immunoglobulins|mesh-list
92741812|NCT01256385|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92741813|NCT01256385|Immunologic Factors|immunologic factors|mesh-ancestor
92741814|NCT01256385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92741815|NCT01256385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92741816|NCT01256385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92741817|NCT01256385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741818|NCT01256385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92741819|NCT01256385|Antifungal Agents|antifungal agents|mesh-ancestor
92741820|NCT01256385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92741821|NCT01256385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92741822|NCT01256385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92741823|NCT01256385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92741872|NCT01297062|Moxifloxacin|moxifloxacin|mesh-list
92741873|NCT01297062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92741874|NCT01297062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92741876|NCT01297062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92741944|NCT01295034|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92742016|NCT01292226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742017|NCT01292226|Antifungal Agents|antifungal agents|mesh-ancestor
92742018|NCT01292226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92742019|NCT01292226|Dermatologic Agents|dermatologic agents|mesh-ancestor
92742020|NCT01292226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92742021|NCT01292226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92742085|NCT01285908|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92742086|NCT01285908|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92742159|NCT02874820|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92742160|NCT02874820|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92742161|NCT02874820|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92742162|NCT02874820|Adrenergic Agents|adrenergic agents|mesh-ancestor
92742163|NCT02874820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742164|NCT02874820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742165|NCT02874820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742166|NCT04305028|Aspirin|aspirin|mesh-list
92742224|NCT01282476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92742225|NCT02889822|Alprostadil|alprostadil|mesh-list
92742226|NCT02889822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92742294|NCT04319601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742365|NCT01036594|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92742438|NCT01033942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92742513|NCT01029652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742514|NCT01029652|Immunologic Factors|immunologic factors|mesh-ancestor
92742515|NCT01029652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92742585|NCT01028014|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92742586|NCT01028014|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92742587|NCT01028014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92742655|NCT01237587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92742656|NCT01237587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92742657|NCT01237587|Analgesics|analgesics|mesh-ancestor
92742658|NCT01237587|Sensory System Agents|sensory system agents|mesh-ancestor
92742729|NCT01026220|Etoposide phosphate|etoposide phosphate|mesh-list
92742730|NCT01026220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92742731|NCT01026220|Immunologic Factors|immunologic factors|mesh-ancestor
92742801|NCT01301066|Pitavastatin|pitavastatin|mesh-list
92742802|NCT01301066|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92742803|NCT01301066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92742804|NCT01301066|Antimetabolites|antimetabolites|mesh-ancestor
92742874|NCT01299896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92742947|NCT01057810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743018|NCT02873026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743093|NCT01259388|Lithium Carbonate|lithium carbonate|mesh-list
92743094|NCT01259388|Antidepressive Agents|antidepressive agents|mesh-ancestor
92743095|NCT01259388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92743096|NCT01259388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743166|NCT03434418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92743167|NCT03434418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743239|NCT00691158|Pramlintide|pramlintide|mesh-list
92743252|NCT05601648|Psilocybin|psilocybin|mesh-list
92743312|NCT01232283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743313|NCT01232283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92743314|NCT01232283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92743315|NCT01232283|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92743316|NCT01232283|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92743317|NCT01232283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92743318|NCT01232283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743319|NCT01232127|Ritonavir|ritonavir|mesh-list
92743320|NCT01232127|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92743321|NCT01232127|Tenofovir|tenofovir|mesh-list
92743322|NCT01232127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92743323|NCT01232127|Famotidine|famotidine|mesh-list
92743375|NCT01054222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743376|NCT01054222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743448|NCT01020526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743449|NCT01020526|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92743594|NCT04325659|Sensory System Agents|sensory system agents|mesh-ancestor
92743595|NCT04325659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743596|NCT04325659|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92743597|NCT04325659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92743598|NCT04325659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92743599|NCT04325659|Adrenergic Agents|adrenergic agents|mesh-ancestor
92743600|NCT04325659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743601|NCT04325659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743603|NCT01007149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92743604|NCT01007149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92743605|NCT01007149|Respiratory System Agents|respiratory system agents|mesh-ancestor
92743606|NCT04433767|Nicotine|nicotine|mesh-list
92743607|NCT04433767|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92743608|NCT04433767|Autonomic Agents|autonomic agents|mesh-ancestor
92743609|NCT04433767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743610|NCT04433767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743611|NCT04433767|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92743612|NCT04433767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92743613|NCT04433767|Cholinergic Agents|cholinergic agents|mesh-ancestor
92743614|NCT04433767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92743615|NCT04433767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743616|NCT00998335|Insulin|insulin|mesh-list
92743617|NCT00998335|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92743647|NCT01006603|Hormones|hormones|mesh-ancestor
92743648|NCT01006603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743649|NCT01006603|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92743717|NCT01224639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743718|NCT01293968|Diphenhydramine|diphenhydramine|mesh-list
92743720|NCT01293968|Ibuprofen|ibuprofen|mesh-list
92743747|NCT01293032|Tamoxifen|tamoxifen|mesh-list
92743789|NCT01222533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92743863|NCT02869165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92743864|NCT02869165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92743865|NCT01219959|Icodextrin|icodextrin|mesh-list
92743866|NCT01219959|Dialysis Solutions|dialysis solutions|mesh-ancestor
92743936|NCT00993031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92743937|NCT00993031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92743939|NCT00993031|Antiviral Agents|antiviral agents|mesh-ancestor
92744008|NCT01218867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744009|NCT01218867|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92744010|NCT01218867|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92744081|NCT01218477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92744082|NCT01218477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744083|NCT01218477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744155|NCT01215357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744156|NCT01215357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744157|NCT01215357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92744158|NCT01215357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92744159|NCT01215357|Dopamine Agents|dopamine agents|mesh-ancestor
92744160|NCT01215357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92744162|NCT01017874|Pemetrexed|pemetrexed|mesh-list
92744222|NCT00982657|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92744225|NCT02867839|Oxaliplatin|oxaliplatin|mesh-list
92744295|NCT04297462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744374|NCT00978757|Anesthetics|anesthetics|mesh-ancestor
92744445|NCT00628810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744446|NCT00628810|Growth Inhibitors|growth inhibitors|mesh-ancestor
92744447|NCT00628810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92744517|NCT00973765|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92744518|NCT00973765|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92744519|NCT00973765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92744520|NCT00973765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92744521|NCT00973765|Antimalarials|antimalarials|mesh-ancestor
92744522|NCT00973765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92744523|NCT00973765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92744524|NCT01211769|Naltrexone|naltrexone|mesh-list
92744525|NCT01211769|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92744526|NCT01211769|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92744527|NCT01211769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744528|NCT01211769|Sensory System Agents|sensory system agents|mesh-ancestor
92744529|NCT01211769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744530|NCT04288765|Dexamethasone|dexamethasone|mesh-list
92744531|NCT04288765|Lenalidomide|lenalidomide|mesh-list
92744532|NCT04288765|Daratumumab|daratumumab|mesh-list
92744533|NCT04288765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92744534|NCT04288765|Antiemetics|antiemetics|mesh-ancestor
92744535|NCT04288765|Autonomic Agents|autonomic agents|mesh-ancestor
92744536|NCT04288765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744537|NCT04288765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744538|NCT04288765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92744539|NCT04288765|Glucocorticoids|glucocorticoids|mesh-ancestor
92744540|NCT04288765|Hormones|hormones|mesh-ancestor
92744541|NCT04288765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744542|NCT04288765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92744565|NCT02863861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744566|NCT02863861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92744567|NCT02863861|Anesthetics, General|anesthetics, general|mesh-ancestor
92744569|NCT02863861|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92744570|NCT02863861|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92744571|NCT02863861|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92744572|NCT05406765|Bupivacaine|bupivacaine|mesh-list
92744573|NCT05406765|Anesthetics, Local|anesthetics, local|mesh-ancestor
92744574|NCT05406765|Anesthetics|anesthetics|mesh-ancestor
92744575|NCT05406765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92744576|NCT05406765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744577|NCT05406765|Sensory System Agents|sensory system agents|mesh-ancestor
92744578|NCT05406765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744579|NCT03846505|Oxytocin|oxytocin|mesh-list
92744580|NCT03846505|Oxytocics|oxytocics|mesh-ancestor
92744581|NCT03846505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92744582|NCT03846505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744583|NCT01011556|Teriparatide|teriparatide|mesh-list
92744584|NCT01011556|Hormones|hormones|mesh-list
92744585|NCT01011556|Parathyroid Hormone|parathyroid hormone|mesh-list
92744586|NCT01011556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92744587|NCT01011556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744589|NCT01011556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92744615|NCT00628342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744616|NCT00628342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744617|NCT01210443|Sitaxsentan|sitaxsentan|mesh-list
92744686|NCT01208181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92744758|NCT01205451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92744761|NCT04294732|Anesthetics|anesthetics|mesh-ancestor
92744829|NCT01201785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92744830|NCT01201785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92744902|NCT04290169|Botulinum Toxins|botulinum toxins|mesh-list
92744976|NCT00972595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92744977|NCT00972595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92744999|NCT00972283|Insulin|insulin|mesh-list
92745049|NCT02863705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92745050|NCT02863705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92745051|NCT01193283|Cyclosporine|cyclosporine|mesh-list
92745052|NCT01193283|Cyclophosphamide|cyclophosphamide|mesh-list
92745122|NCT01306643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745196|NCT05658549|Respiratory System Agents|respiratory system agents|mesh-ancestor
92745197|NCT05658549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92745198|NCT05658549|Antioxidants|antioxidants|mesh-ancestor
92745267|NCT01304147|Anesthetics|anesthetics|mesh-ancestor
92745271|NCT01304147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745336|NCT05927922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92745337|NCT05927922|Analgesics|analgesics|mesh-ancestor
92745410|NCT05927155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92745411|NCT05927155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745484|NCT05926570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92745485|NCT05926570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745489|NCT05926466|Moxifloxacin|moxifloxacin|mesh-list
92745555|NCT05926180|Antimetabolites|antimetabolites|mesh-ancestor
92745556|NCT05926180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92745558|NCT05926180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745628|NCT05835011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745629|NCT05835011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92745630|NCT05835011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92745631|NCT05835011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745632|NCT05817851|Vitamins|vitamins|mesh-list
92745633|NCT05817851|Thiamine|thiamine|mesh-list
92745634|NCT05817851|Micronutrients|micronutrients|mesh-ancestor
92745635|NCT05817851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745636|NCT05817851|Vitamin B Complex|vitamin b complex|mesh-ancestor
92745637|NCT05798481|Acetylcysteine|acetylcysteine|mesh-list
92745638|NCT05798481|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92745639|NCT05798481|Antiviral Agents|antiviral agents|mesh-ancestor
92745640|NCT05798481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92745692|NCT05691010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92745693|NCT05691010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92745764|NCT05605509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92745766|NCT05601492|Apremilast|apremilast|mesh-list
92745836|NCT05528588|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92745837|NCT05528588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92745839|NCT05518877|Ketamine|ketamine|mesh-list
92745904|NCT05421858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92745905|NCT05421858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92745906|NCT05421858|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92745907|NCT05421858|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92745908|NCT05416320|Calcipotriene|calcipotriene|mesh-list
92745909|NCT05416320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92745910|NCT05394350|Pembrolizumab|pembrolizumab|mesh-list
92745911|NCT05394350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746046|NCT05267600|Prednisone|prednisone|mesh-list
92746047|NCT05267600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92746048|NCT05267600|Glucocorticoids|glucocorticoids|mesh-ancestor
92746049|NCT05267600|Hormones|hormones|mesh-ancestor
92746120|NCT05038982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92746121|NCT05038982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92746122|NCT05038982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746123|NCT05000216|Mycophenolic Acid|mycophenolic acid|mesh-list
92746125|NCT05000216|Vaccines|vaccines|mesh-list
92746189|NCT04949256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92746190|NCT04949256|Antidotes|antidotes|mesh-ancestor
92746191|NCT04949256|Protective Agents|protective agents|mesh-ancestor
92746193|NCT04949256|Vitamins|vitamins|mesh-ancestor
92746265|NCT04767061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92746266|NCT04767061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746270|NCT04767061|Vasodilator Agents|vasodilator agents|mesh-ancestor
92746335|NCT04630158|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92746336|NCT04630158|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92746337|NCT04617535|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92746407|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92746483|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746555|NCT03945591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92746556|NCT03945591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746630|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92746631|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
92746645|NCT03742895|Olaparib|olaparib|mesh-list
92746702|NCT03462719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92746703|NCT03462719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92746772|NCT03134703|Methadone|methadone|mesh-list
92746773|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92746848|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746849|NCT02993523|Azacitidine|azacitidine|mesh-list
92746850|NCT02993523|Venetoclax|venetoclax|mesh-list
92746924|NCT02861417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92746925|NCT02861417|Immunologic Factors|immunologic factors|mesh-ancestor
92746926|NCT02861417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92746994|NCT02689427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92746995|NCT02689427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92746996|NCT02689427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747065|NCT02471144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92747066|NCT02471144|Analgesics|analgesics|mesh-ancestor
92747067|NCT02471144|Sensory System Agents|sensory system agents|mesh-ancestor
92747068|NCT02471144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747069|NCT02471144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747070|NCT02471144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92747071|NCT02471144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92747072|NCT02471144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747073|NCT02471144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92747074|NCT02471144|Immunologic Factors|immunologic factors|mesh-ancestor
92747075|NCT02470585|Paclitaxel|paclitaxel|mesh-list
92747076|NCT02470585|Carboplatin|carboplatin|mesh-list
92747128|NCT02204241|Alkylating Agents|alkylating agents|mesh-ancestor
92747205|NCT02004782|Hormones|hormones|mesh-ancestor
92747279|NCT01864109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747280|NCT01864109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92747281|NCT01864109|Protective Agents|protective agents|mesh-ancestor
92747283|NCT01862315|Dexamethasone|dexamethasone|mesh-list
92747352|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92747353|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
92747426|NCT00666835|Hematinics|hematinics|mesh-ancestor
92747427|NCT00600496|Sirolimus|sirolimus|mesh-list
92747428|NCT00600496|Docetaxel|docetaxel|mesh-list
92747502|NCT00335140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92747503|NCT00335140|Antidotes|antidotes|mesh-ancestor
92747504|NCT00335140|Protective Agents|protective agents|mesh-ancestor
92747575|NCT05641649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92747576|NCT05641649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92747577|NCT05641649|Antimanic Agents|antimanic agents|mesh-ancestor
92747646|NCT02890277|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92747647|NCT02890277|Chelating Agents|chelating agents|mesh-ancestor
92747648|NCT02890277|Sequestering Agents|sequestering agents|mesh-ancestor
92747649|NCT02890277|Hemostatics|hemostatics|mesh-ancestor
92747721|NCT01182207|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92747722|NCT01182207|Estrogens|estrogens|mesh-ancestor
92747794|NCT01180647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92747870|NCT00976573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92747871|NCT00976573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92747941|NCT00998296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92747942|NCT00998296|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92747943|NCT00998296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92747945|NCT01178073|Ambrisentan|ambrisentan|mesh-list
92748010|NCT02886351|Sensory System Agents|sensory system agents|mesh-ancestor
92748011|NCT02886351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92748084|NCT02862691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92748089|NCT02862691|Antipyretics|antipyretics|mesh-ancestor
92748156|NCT00965185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92748157|NCT00965185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748158|NCT01174563|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92748229|NCT01172535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92748304|NCT01296347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92748305|NCT01296347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92748377|NCT00630175|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92748378|NCT00630175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92748447|NCT01169103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748448|NCT01286168|Chlorhexidine|chlorhexidine|mesh-list
92748449|NCT01286168|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92748519|NCT04319484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92748520|NCT04319484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92748521|NCT04319484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748522|NCT04319484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748527|NCT00624312|Epoetin Alfa|epoetin alfa|mesh-list
92748590|NCT01290731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92748591|NCT01290731|Protease Inhibitors|protease inhibitors|mesh-ancestor
92748592|NCT01290731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92748593|NCT01290341|Naftifine|naftifine|mesh-list
92748660|NCT01288469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92748661|NCT01288079|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92748662|NCT01288079|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92748729|NCT01166763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92748731|NCT02885961|Dabigatran|dabigatran|mesh-list
92748801|NCT02965963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92748802|NCT02965963|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92748803|NCT02965963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92748804|NCT02965963|Dopamine Agents|dopamine agents|mesh-ancestor
92748875|NCT00956293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749023|NCT04280263|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92749024|NCT04280263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749025|NCT04280263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92749026|NCT04280263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92749027|NCT04280263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749028|NCT04280263|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92749029|NCT04280263|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92749030|NCT04280263|Purinergic Agents|purinergic agents|mesh-ancestor
92749031|NCT04280263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749033|NCT00953329|Dermatologic Agents|dermatologic agents|mesh-ancestor
92749034|NCT00953329|Immunologic Factors|immunologic factors|mesh-ancestor
92749035|NCT00953329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749036|NCT02857153|Urapidil|urapidil|mesh-list
92749037|NCT02857153|Phenylephrine|phenylephrine|mesh-list
92749038|NCT02857153|Oxymetazoline|oxymetazoline|mesh-list
92749039|NCT02857153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92749040|NCT02857153|Mydriatics|mydriatics|mesh-ancestor
92749041|NCT02857153|Autonomic Agents|autonomic agents|mesh-ancestor
92749080|NCT00955279|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92749081|NCT00955279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92749154|NCT02856919|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92749155|NCT02856919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92749158|NCT02856919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92749299|NCT04124133|Immunologic Factors|immunologic factors|mesh-ancestor
92749300|NCT04124133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749301|NCT04124133|Viscosupplements|viscosupplements|mesh-ancestor
92749302|NCT04124133|Protective Agents|protective agents|mesh-ancestor
92749303|NCT01233258|Factor VIII|factor viii|mesh-list
92749372|NCT04313907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749380|NCT01231464|Xhance|xhance|mesh-list
92749445|NCT01155063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749447|NCT01154673|Lopinavir|lopinavir|mesh-list
92749521|NCT01153971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92749522|NCT01153971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92749591|NCT01152021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92749592|NCT01152021|Adrenergic Agents|adrenergic agents|mesh-ancestor
92749593|NCT01152021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92749594|NCT01152021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749595|NCT01152021|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92749660|NCT00739141|Immunologic Factors|immunologic factors|mesh-ancestor
92749741|NCT04268563|Metformin|metformin|mesh-list
92749798|NCT00943111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92749800|NCT01147497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92749801|NCT01147497|Abortifacient Agents|abortifacient agents|mesh-ancestor
92749867|NCT01146795|Paclitaxel|paclitaxel|mesh-list
92749868|NCT01146795|Bevacizumab|bevacizumab|mesh-list
92749869|NCT01146795|Carboplatin|carboplatin|mesh-list
92749870|NCT01146795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92749871|NCT01146795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92749872|NCT01146795|Tubulin Modulators|tubulin modulators|mesh-ancestor
92749873|NCT01146795|Antimitotic Agents|antimitotic agents|mesh-ancestor
92749874|NCT01146795|Mitosis Modulators|mitosis modulators|mesh-ancestor
92749936|NCT00602407|Respiratory System Agents|respiratory system agents|mesh-ancestor
92749937|NCT00602407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92750008|NCT01139775|Pemetrexed|pemetrexed|mesh-list
92750009|NCT01139775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750010|NCT01139775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750077|NCT01281956|Serotonin Agents|serotonin agents|mesh-ancestor
92750081|NCT01279850|Pregabalin|pregabalin|mesh-list
92750152|NCT00938431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92750223|NCT00603031|Glucagon|glucagon|mesh-list
92750224|NCT00603031|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92750225|NCT00603031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92750295|NCT05378503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92750296|NCT05378503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92750297|NCT05378503|Appetite Depressants|appetite depressants|mesh-ancestor
92750366|NCT00934843|Hormones|hormones|mesh-ancestor
92750367|NCT00934843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750440|NCT01266590|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92750441|NCT01266590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750511|NCT04321694|Mogamulizumab|mogamulizumab|mesh-list
92750512|NCT04321694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750513|NCT04321850|Zinc|zinc|mesh-list
92750514|NCT04321850|Zinc Sulfate|zinc sulfate|mesh-list
92750515|NCT04321850|Trace Elements|trace elements|mesh-ancestor
92750583|NCT04262635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92750584|NCT04262635|Antimetabolites|antimetabolites|mesh-ancestor
92750586|NCT04262635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92750655|NCT05938140|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92750656|NCT05938140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92750657|NCT05938140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92750659|NCT05938140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92750661|NCT05938140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92750723|NCT05937490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92750724|NCT05937438|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92750794|NCT05935059|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92750799|NCT05928962|Tremelimumab|tremelimumab|mesh-list
92750869|NCT05867342|Respiratory System Agents|respiratory system agents|mesh-ancestor
92750870|NCT05867342|Mydriatics|mydriatics|mesh-ancestor
92750943|NCT05768191|Insulin, Isophane|insulin, isophane|mesh-list
92750944|NCT05768191|Isophane insulin, beef|isophane insulin, beef|mesh-list
92750945|NCT05768191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92750946|NCT05768191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751015|NCT05615025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92751016|NCT05615025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751017|NCT05615025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92751018|NCT05615025|Anesthetics, General|anesthetics, general|mesh-ancestor
92751035|NCT05568095|Leucovorin|leucovorin|mesh-list
92751085|NCT05487235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751086|NCT05487235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92751087|NCT05487235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92751088|NCT05487235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92751156|NCT05381753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751157|NCT05276206|Anesthetics|anesthetics|mesh-list
92751227|NCT05090124|Adalimumab|adalimumab|mesh-list
92751228|NCT05090124|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92751229|NCT05090124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92751300|NCT04886531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751374|NCT04740918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751376|NCT04736706|Lenvatinib|lenvatinib|mesh-list
92751377|NCT04736706|Belzutifan|belzutifan|mesh-list
92751378|NCT04736706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751379|NCT04736706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92751380|NCT04736706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751381|NCT04736706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751441|NCT04600921|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92751442|NCT04600921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751517|NCT04480554|Naltrexone|naltrexone|mesh-list
92751593|NCT04268498|Diphenhydramine|diphenhydramine|mesh-list
92751594|NCT04268498|Promethazine|promethazine|mesh-list
92751597|NCT04268498|Bortezomib|bortezomib|mesh-list
92751667|NCT04180488|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
92751668|NCT04180488|Histamine Agents|histamine agents|mesh-ancestor
92751808|NCT03782207|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751809|NCT03782207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751810|NCT03782207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751879|NCT03374085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92751954|NCT03215706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92751955|NCT03215706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92751956|NCT03215706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92751957|NCT03215706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92751958|NCT03215706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92751959|NCT03215706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92751960|NCT03190265|Cyclophosphamide|cyclophosphamide|mesh-list
92751961|NCT03190265|Nivolumab|nivolumab|mesh-list
92751962|NCT03190265|Ipilimumab|ipilimumab|mesh-list
92752020|NCT02908477|Mitosis Modulators|mitosis modulators|mesh-ancestor
92752021|NCT02908477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752022|NCT02811861|Pembrolizumab|pembrolizumab|mesh-list
92752023|NCT02811861|Everolimus|everolimus|mesh-list
92752024|NCT02811861|Sunitinib|sunitinib|mesh-list
92752025|NCT02811861|Lenvatinib|lenvatinib|mesh-list
92752026|NCT02811861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92752027|NCT02811861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752028|NCT02811861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92752030|NCT02811861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92752088|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
92752089|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752090|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752091|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92752092|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92752156|NCT02539394|Antiemetics|antiemetics|mesh-ancestor
92752231|NCT01737502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752235|NCT01666080|Fludarabine|fludarabine|mesh-list
92752308|NCT05940909|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92752309|NCT05940909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92752313|NCT05940909|Vasodilator Agents|vasodilator agents|mesh-ancestor
92752368|NCT05940324|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92752440|NCT05939817|Hormones|hormones|mesh-ancestor
92752441|NCT05939817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92752442|NCT05939817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752443|NCT05939817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92752452|NCT05939726|Vitamins|vitamins|mesh-list
92752511|NCT05939076|Autonomic Agents|autonomic agents|mesh-ancestor
92752512|NCT05939076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752513|NCT05939076|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92752514|NCT05939076|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92752515|NCT05939076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92752516|NCT05939037|Zanubrutinib|zanubrutinib|mesh-list
92752517|NCT05939037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752518|NCT05939037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92752581|NCT05935787|Vitamins|vitamins|mesh-ancestor
92752582|NCT05935787|Micronutrients|micronutrients|mesh-ancestor
92752583|NCT05935787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752584|NCT05935787|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92752585|NCT05935787|Dermatologic Agents|dermatologic agents|mesh-ancestor
92752586|NCT05935787|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92752587|NCT05935787|Antimetabolites|antimetabolites|mesh-ancestor
92752588|NCT05935787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92752589|NCT05935787|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92752590|NCT05935787|Vasodilator Agents|vasodilator agents|mesh-ancestor
92752591|NCT05933642|Aminophylline|aminophylline|mesh-list
92752592|NCT05933642|Furosemide|furosemide|mesh-list
92752643|NCT05923190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92752644|NCT05923190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92752646|NCT05919173|Dexmedetomidine|dexmedetomidine|mesh-list
92752713|NCT05904808|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92752714|NCT05904808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92752715|NCT05904808|Cathartics|cathartics|mesh-ancestor
92752716|NCT05904808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92752717|NCT05904808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92752718|NCT05904808|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92752719|NCT05888350|Beclomethasone|beclomethasone|mesh-list
92752720|NCT05888350|Formoterol Fumarate|formoterol fumarate|mesh-list
92752721|NCT05888350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92752722|NCT05888350|Autonomic Agents|autonomic agents|mesh-ancestor
92752723|NCT05888350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92752724|NCT05888350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92752725|NCT05888350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92752726|NCT05888350|Respiratory System Agents|respiratory system agents|mesh-ancestor
92752727|NCT05888350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92752728|NCT05888350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92752729|NCT05888350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92752730|NCT05888350|Adrenergic Agents|adrenergic agents|mesh-ancestor
92752731|NCT05888350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92752822|NCT05775289|Pembrolizumab|pembrolizumab|mesh-list
92752823|NCT05775289|Pemetrexed|pemetrexed|mesh-list
92752971|NCT05645406|Estradiol|estradiol|mesh-list
92752972|NCT05645406|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92752973|NCT05645406|Estrogens|estrogens|mesh-ancestor
92753045|NCT05610085|Phenobarbital|phenobarbital|mesh-list
92753046|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
92753047|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
92753048|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92753049|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92753050|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753051|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92753052|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92753113|NCT05556512|Tirzepatide|tirzepatide|mesh-list
92753114|NCT05556512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753115|NCT05556512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753116|NCT05556512|Incretins|incretins|mesh-ancestor
92753117|NCT05556512|Hormones|hormones|mesh-ancestor
92753118|NCT05556512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92753119|NCT05554367|Palbociclib|palbociclib|mesh-list
92753120|NCT05554367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753184|NCT05473715|Growth Substances|growth substances|mesh-ancestor
92753255|NCT05348356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753256|NCT05330130|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92753326|NCT05304767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92753327|NCT05304767|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92753328|NCT05304767|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92753329|NCT05302817|Xenon|xenon|mesh-list
92753330|NCT05302817|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92753332|NCT05302817|Anesthetics|anesthetics|mesh-ancestor
92753398|NCT05255666|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92753399|NCT05255666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92753400|NCT05255666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753401|NCT05255146|Nitrous Oxide|nitrous oxide|mesh-list
92753402|NCT05255146|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92753403|NCT05255146|Anesthetics, General|anesthetics, general|mesh-ancestor
92753404|NCT05255146|Anesthetics|anesthetics|mesh-ancestor
92753465|NCT05145413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92753539|NCT05013229|Insulin Glargine|insulin glargine|mesh-list
92753540|NCT05013229|Insulin Aspart|insulin aspart|mesh-list
92753541|NCT05013229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92753542|NCT05013229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753615|NCT04854499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753616|NCT04854499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753617|NCT04854499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753618|NCT04854499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753686|NCT04540211|Atezolizumab|atezolizumab|mesh-list
92753759|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92753760|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92753761|NCT04402385|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92753762|NCT04402385|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92753763|NCT04402385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753766|NCT04402385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753830|NCT04164979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753831|NCT04154956|Docetaxel|docetaxel|mesh-list
92753832|NCT04154956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753833|NCT04154956|Tubulin Modulators|tubulin modulators|mesh-ancestor
92753834|NCT04154956|Antimitotic Agents|antimitotic agents|mesh-ancestor
92753835|NCT04154956|Mitosis Modulators|mitosis modulators|mesh-ancestor
92753836|NCT04154956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753837|NCT04135846|Doxazosin|doxazosin|mesh-list
92753838|NCT04135846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92753839|NCT04135846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92753840|NCT04135846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92753841|NCT04135846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92753842|NCT04135846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92753892|NCT04002115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92753895|NCT04002115|Alkylating Agents|alkylating agents|mesh-ancestor
92753896|NCT04002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753897|NCT04002115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92753898|NCT04002115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92753899|NCT04002115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92753900|NCT04002115|Antimetabolites|antimetabolites|mesh-ancestor
92753901|NCT04002115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92753959|NCT03735979|Protease Inhibitors|protease inhibitors|mesh-ancestor
92753960|NCT03735979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92753961|NCT03735979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92753962|NCT03735979|Anticoagulants|anticoagulants|mesh-ancestor
92753963|NCT03735979|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92753964|NCT03722498|Leucovorin|leucovorin|mesh-list
92753965|NCT03722498|Fluorouracil|fluorouracil|mesh-list
92753966|NCT03722498|Oxaliplatin|oxaliplatin|mesh-list
92753967|NCT03722498|Sorafenib|sorafenib|mesh-list
92753968|NCT03722498|Antimetabolites|antimetabolites|mesh-ancestor
92754026|NCT03595059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754027|NCT03570892|Tisagenlecleucel|tisagenlecleucel|mesh-list
92754028|NCT03570892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92754097|NCT03008278|Olaparib|olaparib|mesh-list
92754098|NCT03008278|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92754099|NCT03008278|Ramucirumab|ramucirumab|mesh-list
92754100|NCT03008278|Antibodies|antibodies|mesh-list
92754101|NCT03008278|Immunoglobulins|immunoglobulins|mesh-list
92754102|NCT03008278|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92754103|NCT03008278|Lexatumumab|lexatumumab|mesh-list
92754104|NCT03008278|Immunologic Factors|immunologic factors|mesh-ancestor
92754105|NCT03008278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754169|NCT02477826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92754170|NCT02477826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754242|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754315|NCT01359592|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92754389|NCT00840853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92754390|NCT00840853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92754391|NCT00840853|Anesthetics, Local|anesthetics, local|mesh-ancestor
92754393|NCT00840853|Antiemetics|antiemetics|mesh-ancestor
92754460|NCT00099437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92754535|NCT00608803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754537|NCT00931255|Tacrolimus|tacrolimus|mesh-list
92754538|NCT00931255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92754608|NCT04261465|Mitosis Modulators|mitosis modulators|mesh-ancestor
92754609|NCT04261465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754612|NCT04260607|Ketamine|ketamine|mesh-list
92754678|NCT04260685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754679|NCT05052151|Dialysis Solutions|dialysis solutions|mesh-list
92754680|NCT05052151|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92754681|NCT05013463|Hydroxychloroquine|hydroxychloroquine|mesh-list
92754682|NCT05013463|Indapamide|indapamide|mesh-list
92754683|NCT05013463|Antimalarials|antimalarials|mesh-ancestor
92754684|NCT05013463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92754746|NCT00926575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92754747|NCT00926575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754748|NCT00926575|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92754817|NCT05178693|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92754818|NCT01136655|Budesonide|budesonide|mesh-list
92754819|NCT01136655|Formoterol Fumarate|formoterol fumarate|mesh-list
92754820|NCT01136655|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92754821|NCT01136655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92754822|NCT01136655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92754823|NCT01136655|Autonomic Agents|autonomic agents|mesh-ancestor
92754824|NCT01136655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92754828|NCT01136655|Glucocorticoids|glucocorticoids|mesh-ancestor
92754882|NCT00922207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92754883|NCT00922207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754884|NCT01134315|Calcitriol|calcitriol|mesh-list
92754885|NCT01134315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92754886|NCT01134315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92754887|NCT01134315|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92754888|NCT01134315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92754889|NCT01134315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754891|NCT01134315|Vitamins|vitamins|mesh-ancestor
92754946|NCT05154669|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92754947|NCT05154669|Cholinergic Agents|cholinergic agents|mesh-ancestor
92754948|NCT05154669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92754949|NCT05154669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92754950|NCT00637455|Fexofenadine|fexofenadine|mesh-list
92754951|NCT00637455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92755016|NCT01130493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92755017|NCT01130493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92755018|NCT01130493|Dopamine Agents|dopamine agents|mesh-ancestor
92755019|NCT01130493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92755020|NCT01130493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755084|NCT00625209|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92755086|NCT00625209|Protein C|protein c|mesh-list
92755087|NCT00625209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92755088|NCT00625209|Anticoagulants|anticoagulants|mesh-ancestor
92755157|NCT04962841|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92755158|NCT04962841|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92755159|NCT04962841|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92755226|NCT00918463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755227|NCT05330065|Bevacizumab|bevacizumab|mesh-list
92755229|NCT05330065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755298|NCT01214616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755299|NCT01214616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92755300|NCT01214616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92755301|NCT01214616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92755302|NCT01214616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755303|NCT01214616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755304|NCT01214616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755305|NCT01213836|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92755306|NCT01213836|Antidepressive Agents|antidepressive agents|mesh-ancestor
92755307|NCT01213836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92755308|NCT01213836|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92755361|NCT04746547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92755362|NCT04746547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92755363|NCT04746547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755435|NCT01207596|Narcotics|narcotics|mesh-ancestor
92755436|NCT01207596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92755437|NCT01207596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755506|NCT04597099|Hormones|hormones|mesh-ancestor
92755507|NCT04597099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92755508|NCT04597099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755509|NCT04597099|Progestins|progestins|mesh-ancestor
92755510|NCT04597099|Androgen Antagonists|androgen antagonists|mesh-ancestor
92755511|NCT04597099|Hormone Antagonists|hormone antagonists|mesh-ancestor
92755512|NCT04597099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92755513|NCT04597099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92755514|NCT04816513|Ustekinumab|ustekinumab|mesh-list
92755515|NCT04816513|Dermatologic Agents|dermatologic agents|mesh-ancestor
92755516|NCT04203511|Paclitaxel|paclitaxel|mesh-list
92755572|NCT00909181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755573|NCT00909181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92755574|NCT00909181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92755644|NCT01281917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92755645|NCT01281917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92755646|NCT01281917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92755647|NCT01281917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92755648|NCT01281917|Immunologic Factors|immunologic factors|mesh-ancestor
92755649|NCT01281917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755650|NCT01281917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92755651|NCT01281917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755652|NCT01281917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92755654|NCT01281839|Ribavirin|ribavirin|mesh-list
92755711|NCT05566223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92755712|NCT01271933|Pregabalin|pregabalin|mesh-list
92755713|NCT01271933|Analgesics|analgesics|mesh-ancestor
92755714|NCT01271933|Sensory System Agents|sensory system agents|mesh-ancestor
92755783|NCT01265849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92755784|NCT01265849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92755857|NCT01263197|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92755858|NCT01263197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92755859|NCT01263197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92154188|NCT04022837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154189|NCT04022837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154190|NCT04022993|Insulin Glargine|insulin glargine|mesh-list
92154191|NCT04022993|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92154192|NCT04022993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92154193|NCT04022993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154194|NCT04148885|Paclitaxel|paclitaxel|mesh-list
92154256|NCT03072264|Fluoxetine|fluoxetine|mesh-list
92154257|NCT03072264|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92154258|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92154259|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92154260|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154261|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154262|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
92154263|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154264|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92154265|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
92154266|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92154267|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92154268|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92154316|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154317|NCT04991298|Analgesics|analgesics|mesh-ancestor
92154318|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
92391703|NCT01725048|Mirtazapine|mirtazapine|mesh-list
92154389|NCT04361409|Gemcitabine|gemcitabine|mesh-list
92154390|NCT04361409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391704|NCT01725048|Citalopram|citalopram|mesh-list
92154461|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
92154462|NCT02245191|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92154537|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92154538|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92154540|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
92154541|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154542|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154543|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154544|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154545|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154546|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154547|NCT03922997|Atezolizumab|atezolizumab|mesh-list
92154548|NCT03922997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92154549|NCT03922997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154550|NCT03922997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92154551|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154598|NCT00939159|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92154671|NCT03071172|Progesterone|progesterone|mesh-list
92154746|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92154747|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154748|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154816|NCT05003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154818|NCT04143191|Sorafenib|sorafenib|mesh-list
92154890|NCT04140461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154891|NCT04140461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154964|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92154965|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92154966|NCT03588533|Capecitabine|capecitabine|mesh-list
92154967|NCT03588533|Trastuzumab|trastuzumab|mesh-list
92154968|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154969|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154970|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
92154973|NCT03068442|Flutemetamol|flutemetamol|mesh-list
92155032|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92155108|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
92155112|NCT04405505|Paclitaxel|paclitaxel|mesh-list
92155182|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
92155183|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155184|NCT00951561|Ibuprofen|ibuprofen|mesh-list
92155254|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
92155259|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
92155329|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92155330|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
92155331|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
92155401|NCT04801797|Cytarabine|cytarabine|mesh-list
92155402|NCT04801797|Azacitidine|azacitidine|mesh-list
92155403|NCT04801797|Daunorubicin|daunorubicin|mesh-list
92155473|NCT00946023|Immunologic Factors|immunologic factors|mesh-ancestor
92155474|NCT00946023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155475|NCT00946023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155476|NCT00946023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92155477|NCT00946023|Alkylating Agents|alkylating agents|mesh-ancestor
92155478|NCT00946023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155542|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
92155543|NCT00952653|GABA Agents|gaba agents|mesh-ancestor
92155544|NCT00952653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155615|NCT00953121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155616|NCT03017391|Dexamethasone|dexamethasone|mesh-list
92155617|NCT03017391|Metoclopramide|metoclopramide|mesh-list
92155685|NCT04764851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155686|NCT00956085|Memantine|memantine|mesh-list
92155757|NCT02159547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92155758|NCT02159547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92155759|NCT00958035|Bimatoprost|bimatoprost|mesh-list
92155760|NCT00958035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92155761|NCT00958035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92155762|NCT01011075|Paclitaxel|paclitaxel|mesh-list
92155763|NCT01011075|Imatinib Mesylate|imatinib mesylate|mesh-list
92155764|NCT01011075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155765|NCT01011075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155766|NCT01011075|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155772|NCT00958581|Tranexamic Acid|tranexamic acid|mesh-list
92155824|NCT03016611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155825|NCT03016611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155898|NCT01244789|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155899|NCT01244789|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155900|NCT01244789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155901|NCT02631876|Paclitaxel|paclitaxel|mesh-list
92155902|NCT02631876|Maytansine|maytansine|mesh-list
92155903|NCT02631876|Doxorubicin|doxorubicin|mesh-list
92155904|NCT02631876|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92155905|NCT02631876|Topotecan|topotecan|mesh-list
92155906|NCT02631876|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92155907|NCT02631876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155908|NCT02631876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155909|NCT02631876|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155910|NCT02631876|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155911|NCT02631876|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155912|NCT02631876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155913|NCT02631876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92155914|NCT02631876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92155927|NCT02081963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155928|NCT02081963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155930|NCT04765085|Antidepressive Agents|antidepressive agents|mesh-ancestor
92155931|NCT04765085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92155932|NCT04765085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92155933|NCT04765085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92155934|NCT04765085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92155935|NCT04765085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155936|NCT04765085|Dopamine Agonists|dopamine agonists|mesh-ancestor
92155937|NCT04765085|Dopamine Agents|dopamine agents|mesh-ancestor
92155938|NCT04765085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92155939|NCT04765085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155940|NCT04765085|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92155941|NCT04765085|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92155942|NCT04765085|Serotonin Agents|serotonin agents|mesh-ancestor
92155943|NCT04765085|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92155944|NCT04765085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92155945|NCT04765085|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92155946|NCT04765085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92155947|NCT02633046|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92155949|NCT02633046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92155950|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155951|NCT03881345|Anticoagulants|anticoagulants|mesh-list
92155952|NCT01676597|Rifaximin|rifaximin|mesh-list
92155953|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
92155954|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155955|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155956|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92155957|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92155958|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92155959|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156171|NCT01016769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92155960|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92155961|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92155963|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155964|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
92155965|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92155966|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
92155967|NCT04374630|Paclitaxel|paclitaxel|mesh-list
92155968|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92155969|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92155970|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
92155971|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
92155972|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
92155973|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92155974|NCT05540964|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92155975|NCT05540964|Antiviral Agents|antiviral agents|mesh-ancestor
92155976|NCT05540964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156233|NCT01017237|Anesthetics|anesthetics|mesh-ancestor
92155978|NCT04364802|Cadexomer iodine|cadexomer iodine|mesh-list
92155979|NCT04364802|Povidone-Iodine|povidone-iodine|mesh-list
92155980|NCT04364802|Povidone|povidone|mesh-list
92155981|NCT04364802|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92155982|NCT04364802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92155983|NCT04364802|Trace Elements|trace elements|mesh-ancestor
92155984|NCT04364802|Micronutrients|micronutrients|mesh-ancestor
92156375|NCT02083679|Cisplatin|cisplatin|mesh-list
92155985|NCT04364802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155986|NCT04364802|Plasma Substitutes|plasma substitutes|mesh-ancestor
92155987|NCT04364802|Blood Substitutes|blood substitutes|mesh-ancestor
92155988|NCT03155087|Metformin|metformin|mesh-list
92155989|NCT03155087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92155990|NCT03155087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155991|NCT03867617|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92155992|NCT03867617|Immunologic Factors|immunologic factors|mesh-ancestor
92155993|NCT03867617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155994|NCT00963105|Lenalidomide|lenalidomide|mesh-list
92155995|NCT00963105|Immunologic Factors|immunologic factors|mesh-ancestor
92155996|NCT00963105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92155997|NCT00963105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92155998|NCT00963105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92155999|NCT00963105|Growth Substances|growth substances|mesh-ancestor
92156000|NCT00963105|Growth Inhibitors|growth inhibitors|mesh-ancestor
92156001|NCT00963105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156002|NCT04879992|Amoxicillin|amoxicillin|mesh-list
92156003|NCT04879992|Metronidazole|metronidazole|mesh-list
92156004|NCT04879992|Tetracycline|tetracycline|mesh-list
92156005|NCT04879992|Rifabutin|rifabutin|mesh-list
92156006|NCT04879992|Potassium Citrate|potassium citrate|mesh-list
92156007|NCT04879992|Esomeprazole|esomeprazole|mesh-list
92156008|NCT04879992|Bismuth|bismuth|mesh-list
92156009|NCT04879992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156010|NCT04879992|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92156011|NCT04879992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156012|NCT04879992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92156013|NCT04879992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92156014|NCT04879992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92156015|NCT04879992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92156016|NCT04879992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92156017|NCT04879992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156018|NCT04879992|Antacids|antacids|mesh-ancestor
92156019|NCT04879992|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92156020|NCT04879992|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92156021|NCT04879992|Antitubercular Agents|antitubercular agents|mesh-ancestor
92156022|NCT04879992|Diuretics|diuretics|mesh-ancestor
92156023|NCT04879992|Natriuretic Agents|natriuretic agents|mesh-ancestor
92156024|NCT04879992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156025|NCT04879992|Expectorants|expectorants|mesh-ancestor
92156026|NCT04879992|Respiratory System Agents|respiratory system agents|mesh-ancestor
92156027|NCT01016691|Bimatoprost|bimatoprost|mesh-list
92156028|NCT01016691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92156029|NCT04181736|Guanfacine|guanfacine|mesh-list
92156030|NCT04181736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92156031|NCT04181736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92156032|NCT04181736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92156034|NCT04181736|Adrenergic Agents|adrenergic agents|mesh-ancestor
92156035|NCT04181736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156036|NCT04181736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156037|NCT04181736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156038|NCT04404491|Capecitabine|capecitabine|mesh-list
92156039|NCT04404491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156040|NCT04404491|Antimetabolites|antimetabolites|mesh-ancestor
92156041|NCT04404491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156042|NCT04404491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156043|NCT03861299|Anesthetics|anesthetics|mesh-list
92156044|NCT03861299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156045|NCT03861299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156046|NCT05573568|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92156047|NCT05573568|Hallucinogens|hallucinogens|mesh-ancestor
92156048|NCT05573568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156049|NCT05573568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92156050|NCT05573568|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92156051|NCT05573568|Serotonin Agents|serotonin agents|mesh-ancestor
92156052|NCT05573568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156053|NCT05573568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156054|NCT05573568|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92156056|NCT03858491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92156057|NCT03858491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92156058|NCT03858491|Antiviral Agents|antiviral agents|mesh-ancestor
92156059|NCT03858491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156060|NCT03858491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92156061|NCT03858491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92156062|NCT03858491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156063|NCT03858491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156064|NCT01672788|Metformin|metformin|mesh-list
92156065|NCT01672788|Empagliflozin|empagliflozin|mesh-list
92156066|NCT01672788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92156067|NCT01672788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156068|NCT01672788|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92156069|NCT01672788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156070|NCT02705963|Trametinib|trametinib|mesh-list
92156071|NCT02705963|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92156072|NCT02705963|Norethindrone|norethindrone|mesh-list
92156073|NCT02705963|Norethindrone Acetate|norethindrone acetate|mesh-list
92156074|NCT02705963|Contraceptive Agents|contraceptive agents|mesh-list
92156075|NCT02705963|Contraceptives, Oral|contraceptives, oral|mesh-list
92156076|NCT02705963|Estradiol|estradiol|mesh-list
92156077|NCT02705963|Estrogens|estrogens|mesh-ancestor
92156078|NCT02705963|Hormones|hormones|mesh-ancestor
92156079|NCT02705963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156080|NCT02705963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156081|NCT02705963|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92156082|NCT02705963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92156083|NCT02705963|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92156084|NCT02705963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156085|NCT02705963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156892|NCT03062904|Methacholine Chloride|methacholine chloride|mesh-list
92156087|NCT02705963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156088|NCT02705963|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92156972|NCT03638375|Interferons|interferons|mesh-list
92156089|NCT02705963|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92156090|NCT03065868|Clarithromycin|clarithromycin|mesh-list
92156091|NCT03065868|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92156092|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156093|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92156094|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156095|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156096|NCT03065868|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92401714|NCT01418183|Anesthetics, Local|anesthetics, local|mesh-ancestor
92156097|NCT03065868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92156098|NCT03844061|Mycophenolic Acid|mycophenolic acid|mesh-list
92156100|NCT03844061|Belimumab|belimumab|mesh-list
92156101|NCT03844061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156102|NCT03844061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156103|NCT03844061|Immunologic Factors|immunologic factors|mesh-ancestor
92156104|NCT03844061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156105|NCT03844061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156106|NCT03844061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92156107|NCT03844061|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92156108|NCT03844061|Antitubercular Agents|antitubercular agents|mesh-ancestor
92156109|NCT03844061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92156110|NCT03844061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157100|NCT00991809|Diphenhydramine|diphenhydramine|mesh-list
92322327|NCT00000506|Fenfluramine|fenfluramine|mesh-list
92156112|NCT03844061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156113|NCT03844061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156114|NCT03840239|Capecitabine|capecitabine|mesh-list
92156115|NCT03840239|Oxaliplatin|oxaliplatin|mesh-list
92156116|NCT03840239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156117|NCT03840239|Antimetabolites|antimetabolites|mesh-ancestor
92156118|NCT03840239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156119|NCT03840239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156120|NCT02632110|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92156121|NCT02632110|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92156122|NCT02632110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92156123|NCT03830723|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92156125|NCT03830723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156126|NCT03830723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157605|NCT01053819|Etanercept|etanercept|mesh-list
92156130|NCT03829319|Lenvatinib|lenvatinib|mesh-list
92156131|NCT03829319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156132|NCT03829319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156133|NCT03829319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92156134|NCT03829319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156135|NCT03829319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156136|NCT03829319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92156137|NCT03829319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92157826|NCT03805581|Defibrotide|defibrotide|mesh-list
92156138|NCT03829319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156141|NCT03814109|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92157973|NCT02089685|Ipilimumab|ipilimumab|mesh-list
92156142|NCT03814109|Diuretics|diuretics|mesh-ancestor
92156143|NCT03814109|Natriuretic Agents|natriuretic agents|mesh-ancestor
92156144|NCT03814109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156145|NCT03814109|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92156146|NCT03814109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156147|NCT03814109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156148|NCT03814109|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92156149|NCT03814109|Antimetabolites|antimetabolites|mesh-ancestor
92156150|NCT03814109|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92156151|NCT03814109|Vasodilator Agents|vasodilator agents|mesh-ancestor
92156152|NCT03814109|Vitamin B Complex|vitamin b complex|mesh-ancestor
92156153|NCT03814109|Vitamins|vitamins|mesh-ancestor
92156154|NCT03814109|Micronutrients|micronutrients|mesh-ancestor
92156155|NCT01016769|Sirolimus|sirolimus|mesh-list
92156156|NCT01016769|Paclitaxel|paclitaxel|mesh-list
92156157|NCT01016769|Carboplatin|carboplatin|mesh-list
92156158|NCT01016769|Temsirolimus|temsirolimus|mesh-list
92156160|NCT01016769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92156161|NCT01016769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156162|NCT01016769|Tubulin Modulators|tubulin modulators|mesh-ancestor
92156163|NCT01016769|Antimitotic Agents|antimitotic agents|mesh-ancestor
92156164|NCT01016769|Mitosis Modulators|mitosis modulators|mesh-ancestor
92401721|NCT01418235|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92156165|NCT01016769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156166|NCT01016769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156167|NCT01016769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156168|NCT01016769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156169|NCT01016769|Immunologic Factors|immunologic factors|mesh-ancestor
92156170|NCT01016769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156172|NCT01016769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156173|NCT01016769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92156174|NCT01016769|Antifungal Agents|antifungal agents|mesh-ancestor
92156175|NCT03807479|Ponatinib|ponatinib|mesh-list
92156177|NCT03807479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156178|NCT03807479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156179|NCT03807479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156181|NCT03019809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92156182|NCT03019809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92156183|NCT03019809|Antiviral Agents|antiviral agents|mesh-ancestor
92156184|NCT03019809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156185|NCT00964353|Warfarin|warfarin|mesh-list
92156186|NCT00964353|Anticoagulants|anticoagulants|mesh-ancestor
92156187|NCT00964431|Celecoxib|celecoxib|mesh-list
92158536|NCT05363514|Naltrexone|naltrexone|mesh-list
92156188|NCT00964431|Indomethacin|indomethacin|mesh-list
92156189|NCT00964431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92156190|NCT00964431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156191|NCT00964431|Analgesics|analgesics|mesh-ancestor
92156192|NCT00964431|Sensory System Agents|sensory system agents|mesh-ancestor
92156193|NCT00964431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156194|NCT00964431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156195|NCT00964431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156196|NCT00964431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156197|NCT00964431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92156198|NCT00964431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92158602|NCT05219409|Hormones|hormones|mesh-ancestor
92156200|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156201|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
92156202|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
92156203|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92156204|NCT05475054|Liver Extracts|liver extracts|mesh-list
92156205|NCT05475054|Hematinics|hematinics|mesh-ancestor
92156207|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
92156208|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156209|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
92156211|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
92156212|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156213|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156214|NCT01017237|Midazolam|midazolam|mesh-list
92156215|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
92156216|NCT01017237|Ketamine|ketamine|mesh-list
92156217|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92156218|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156219|NCT01017237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156220|NCT01017237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156221|NCT01017237|Analgesics|analgesics|mesh-ancestor
92156222|NCT01017237|Sensory System Agents|sensory system agents|mesh-ancestor
92156223|NCT01017237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156224|NCT01017237|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92159043|NCT04550234|Verinurad|verinurad|mesh-list
92156225|NCT01017237|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92156226|NCT01017237|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92156227|NCT01017237|Adrenergic Agents|adrenergic agents|mesh-ancestor
92156228|NCT01017237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156229|NCT01017237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156230|NCT01017237|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92156231|NCT01017237|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92156232|NCT01017237|Anesthetics, General|anesthetics, general|mesh-ancestor
92156234|NCT01017237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92156235|NCT01017237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92156236|NCT01017237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92156237|NCT01017237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92156238|NCT01017237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92156239|NCT01017237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92156240|NCT01017237|GABA Modulators|gaba modulators|mesh-ancestor
92156241|NCT01017237|GABA Agents|gaba agents|mesh-ancestor
92156242|NCT04442412|Vitamin D|vitamin d|mesh-list
92156243|NCT04442412|Cholecalciferol|cholecalciferol|mesh-list
92156244|NCT04442412|Vitamins|vitamins|mesh-ancestor
92156245|NCT04442412|Micronutrients|micronutrients|mesh-ancestor
92156246|NCT04442412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156247|NCT04442412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92156248|NCT04442412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92156249|NCT01018095|Metronidazole|metronidazole|mesh-list
92156250|NCT01018095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156251|NCT01018095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92156252|NCT01018095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92156253|NCT01018095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92156254|NCT03788759|Thioctic Acid|thioctic acid|mesh-list
92156255|NCT03788759|Antioxidants|antioxidants|mesh-ancestor
92156256|NCT03788759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156257|NCT03788759|Protective Agents|protective agents|mesh-ancestor
92156258|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156259|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
92156260|NCT03788759|Vitamins|vitamins|mesh-ancestor
92159341|NCT03697512|Rituximab|rituximab|mesh-list
92156261|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
92156262|NCT00967551|Zinc|zinc|mesh-list
92156263|NCT00967551|Trace Elements|trace elements|mesh-list
92156264|NCT00967551|Micronutrients|micronutrients|mesh-list
92156265|NCT00967551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156267|NCT03778073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92159536|NCT03040778|Vitamin E|vitamin e|mesh-list
92156268|NCT03778073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156269|NCT03778073|Alkylating Agents|alkylating agents|mesh-ancestor
92156270|NCT03778073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156271|NCT03778073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156272|NCT03778073|Immunologic Factors|immunologic factors|mesh-ancestor
92156273|NCT03778073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156275|NCT00970203|Androgens|androgens|mesh-list
92156276|NCT00970203|Immunologic Factors|immunologic factors|mesh-ancestor
92156277|NCT00970203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156278|NCT00970203|Hormones|hormones|mesh-ancestor
92156279|NCT00970203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156280|NCT00971295|Metformin|metformin|mesh-list
92156281|NCT00971295|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92156282|NCT00971295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92156283|NCT00971295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156284|NCT00971295|Anticonvulsants|anticonvulsants|mesh-ancestor
92159603|NCT02863809|Dermatologic Agents|dermatologic agents|mesh-ancestor
92156285|NCT00971295|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92156287|NCT00971295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156288|NCT00971295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156289|NCT00954681|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92156290|NCT00954681|Antidepressive Agents|antidepressive agents|mesh-ancestor
92156291|NCT00954681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92156292|NCT00954681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92156293|NCT00954681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92156294|NCT00954681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156295|NCT00954681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156296|NCT00971841|Paclitaxel|paclitaxel|mesh-list
92156297|NCT00971841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92156298|NCT00971841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156299|NCT00971841|Tubulin Modulators|tubulin modulators|mesh-ancestor
92156300|NCT00971841|Antimitotic Agents|antimitotic agents|mesh-ancestor
92156301|NCT00971841|Mitosis Modulators|mitosis modulators|mesh-ancestor
92156302|NCT00971841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156303|NCT04913220|Cemiplimab|cemiplimab|mesh-list
92156304|NCT04913220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156305|NCT04913220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156306|NCT05395299|Ethylene|ethylene|mesh-list
92156307|NCT05395299|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92156308|NCT05395299|Growth Substances|growth substances|mesh-ancestor
92156309|NCT05395299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156310|NCT02246049|Leucovorin|leucovorin|mesh-list
92156311|NCT02246049|Bevacizumab|bevacizumab|mesh-list
92156312|NCT02246049|Fluorouracil|fluorouracil|mesh-list
92156313|NCT02246049|Oxaliplatin|oxaliplatin|mesh-list
92156314|NCT02246049|Irinotecan|irinotecan|mesh-list
92156315|NCT02246049|Calcium|calcium|mesh-list
92156316|NCT02246049|Levoleucovorin|levoleucovorin|mesh-list
92160250|NCT04728971|Antifungal Agents|antifungal agents|mesh-ancestor
92156317|NCT02246049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156318|NCT02246049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156319|NCT02246049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92156320|NCT02246049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92156321|NCT02246049|Growth Substances|growth substances|mesh-ancestor
92160479|NCT01114971|Sympathomimetics|sympathomimetics|mesh-ancestor
92156322|NCT02246049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156323|NCT02246049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92156324|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92156325|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
92156326|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156327|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156328|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156329|NCT02246049|Immunologic Factors|immunologic factors|mesh-ancestor
92156330|NCT02246049|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92156331|NCT02246049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92156332|NCT02246049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156333|NCT02246049|Antidotes|antidotes|mesh-ancestor
92156334|NCT02246049|Protective Agents|protective agents|mesh-ancestor
92156335|NCT02246049|Vitamin B Complex|vitamin b complex|mesh-ancestor
92156336|NCT02246049|Vitamins|vitamins|mesh-ancestor
92156337|NCT02246049|Micronutrients|micronutrients|mesh-ancestor
92156338|NCT05395143|Zinc Sulfate|zinc sulfate|mesh-list
92156339|NCT05395143|Astringents|astringents|mesh-ancestor
92156340|NCT05395143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160832|NCT03012009|Mydriatics|mydriatics|mesh-ancestor
92156341|NCT05395143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92156342|NCT05394909|Methylprednisolone|methylprednisolone|mesh-list
92156343|NCT05394909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156344|NCT05394909|Antiemetics|antiemetics|mesh-ancestor
92156345|NCT05394909|Autonomic Agents|autonomic agents|mesh-ancestor
92156346|NCT05394909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156347|NCT05394909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156348|NCT05394909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92156349|NCT05394909|Glucocorticoids|glucocorticoids|mesh-ancestor
92156359|NCT05694858|Sensory System Agents|sensory system agents|mesh-ancestor
92156360|NCT05694858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156361|NCT05694858|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92156362|NCT05694858|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92156363|NCT05694858|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92156364|NCT05694858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156365|NCT05694858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156366|NCT02159859|Ertapenem|ertapenem|mesh-list
92161357|NCT00084617|Irinotecan|irinotecan|mesh-list
92156367|NCT02159859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92156368|NCT02159859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156369|NCT00974493|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92156370|NCT00974493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92156371|NCT00974493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156372|NCT00974493|Antitubercular Agents|antitubercular agents|mesh-ancestor
92161570|NCT03084419|Abatacept|abatacept|mesh-list
92156374|NCT02083679|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92156376|NCT02083679|Carboplatin|carboplatin|mesh-list
92156377|NCT02083679|Gemcitabine|gemcitabine|mesh-list
92156378|NCT02083679|Pemetrexed|pemetrexed|mesh-list
92156379|NCT02083679|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92161718|NCT01214109|Pramipexole|pramipexole|mesh-list
92156380|NCT02083679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92156381|NCT02083679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156382|NCT02083679|Tubulin Modulators|tubulin modulators|mesh-ancestor
92156383|NCT02083679|Antimitotic Agents|antimitotic agents|mesh-ancestor
92161876|NCT01150461|Losartan|losartan|mesh-list
92156384|NCT02083679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161933|NCT01221207|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92156385|NCT02083679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156386|NCT02083679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156388|NCT02083679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156389|NCT02083679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92156390|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92156391|NCT02083679|Immunologic Factors|immunologic factors|mesh-ancestor
92156392|NCT02083679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162205|NCT04399187|Eusol|eusol|mesh-list
92156403|NCT01672710|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92156404|NCT01672710|Antimetabolites|antimetabolites|mesh-ancestor
92156405|NCT01672710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156406|NCT01672710|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92156407|NCT01672710|Vasodilator Agents|vasodilator agents|mesh-ancestor
92156408|NCT01672710|Vitamin B Complex|vitamin b complex|mesh-ancestor
92156409|NCT01672710|Vitamins|vitamins|mesh-ancestor
92156410|NCT01672710|Micronutrients|micronutrients|mesh-ancestor
92156411|NCT01672710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156412|NCT03766763|Venetoclax|venetoclax|mesh-list
92156413|NCT03766763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156414|NCT04790448|Irinotecan|irinotecan|mesh-list
92156415|NCT04790448|Camptothecin|camptothecin|mesh-list
92156416|NCT04790448|Cetuximab|cetuximab|mesh-list
92156417|NCT04790448|Vemurafenib|vemurafenib|mesh-list
92156418|NCT04790448|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92156419|NCT04790448|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92156420|NCT04790448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156421|NCT04790448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162446|NCT03353831|Atezolizumab|atezolizumab|mesh-list
92156423|NCT04790448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156424|NCT04790448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156425|NCT04790448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92156426|NCT04784052|Cyclophosphamide|cyclophosphamide|mesh-list
92156427|NCT04784052|Rituximab|rituximab|mesh-list
92156428|NCT04784052|Fludarabine|fludarabine|mesh-list
92156429|NCT04784052|Thymoglobulin|thymoglobulin|mesh-list
92156430|NCT04784052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92156431|NCT04784052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156432|NCT04784052|Immunologic Factors|immunologic factors|mesh-ancestor
92156433|NCT04784052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156434|NCT04784052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156435|NCT04784052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156436|NCT04784052|Alkylating Agents|alkylating agents|mesh-ancestor
92156437|NCT04784052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156438|NCT04784052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156439|NCT04784052|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92156440|NCT04784052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156443|NCT05319756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92156444|NCT05319756|Narcotics|narcotics|mesh-ancestor
92156445|NCT05319756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156446|NCT05319756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156447|NCT05319756|Analgesics|analgesics|mesh-ancestor
92156448|NCT05319756|Sensory System Agents|sensory system agents|mesh-ancestor
92162943|NCT04275115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92156450|NCT05319756|Anticonvulsants|anticonvulsants|mesh-ancestor
92156451|NCT05319756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92156453|NCT05319756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92156454|NCT05319756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92156455|NCT05319756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92156456|NCT05319756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156457|NCT05319756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156458|NCT05319756|Antimanic Agents|antimanic agents|mesh-ancestor
92156459|NCT00976521|Abciximab|abciximab|mesh-list
92156460|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
92156461|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92156463|NCT04410588|Levobupivacaine|levobupivacaine|mesh-list
92156464|NCT04410588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92156465|NCT04410588|Narcotics|narcotics|mesh-ancestor
92156466|NCT04410588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156467|NCT04410588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156468|NCT04410588|Analgesics|analgesics|mesh-ancestor
92401753|NCT01418443|Pantoprazole|pantoprazole|mesh-list
92156469|NCT04410588|Sensory System Agents|sensory system agents|mesh-ancestor
92156470|NCT04410588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156471|NCT04410588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92156472|NCT04410588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92163223|NCT02392637|Paclitaxel|paclitaxel|mesh-list
92156473|NCT04410588|Anesthetics, General|anesthetics, general|mesh-ancestor
92156474|NCT04410588|Anesthetics|anesthetics|mesh-ancestor
92156475|NCT04410588|Anesthetics, Local|anesthetics, local|mesh-ancestor
92156476|NCT05303220|Branebrutinib|branebrutinib|mesh-list
92156477|NCT05303220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156478|NCT05303220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156479|NCT05303220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156480|NCT04444830|Ketorolac|ketorolac|mesh-list
92156481|NCT04444830|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92163443|NCT00634751|Sorafenib|sorafenib|mesh-list
92156482|NCT04444830|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156483|NCT04444830|Analgesics|analgesics|mesh-ancestor
92156484|NCT04444830|Sensory System Agents|sensory system agents|mesh-ancestor
92156485|NCT04444830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156486|NCT04444830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156487|NCT04444830|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156488|NCT04444830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156489|NCT04444830|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92156490|NCT04444830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156491|NCT04444830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156492|NCT01273259|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92163658|NCT04121767|Edoxaban|edoxaban|mesh-list
92156493|NCT01273259|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92156494|NCT01273259|Immunologic Factors|immunologic factors|mesh-ancestor
92156495|NCT01273259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156496|NCT03738917|Bromides|bromides|mesh-list
92156497|NCT03738917|Dextromethorphan|dextromethorphan|mesh-list
92156498|NCT03738917|Ipratropium|ipratropium|mesh-list
92156499|NCT03738917|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92156500|NCT03738917|Anticonvulsants|anticonvulsants|mesh-ancestor
92156501|NCT03738917|Antitussive Agents|antitussive agents|mesh-ancestor
92156502|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
92156503|NCT03738917|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92156504|NCT03738917|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92164028|NCT02943733|Temozolomide|temozolomide|mesh-list
92156505|NCT03738917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156506|NCT03738917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156507|NCT03738917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156508|NCT03738917|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92156509|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
92156510|NCT03738917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156511|NCT03738917|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92156512|NCT03738917|Cholinergic Agents|cholinergic agents|mesh-ancestor
92156513|NCT00976599|Methotrexate|methotrexate|mesh-list
92156514|NCT00976599|Tofacitinib|tofacitinib|mesh-list
92156515|NCT00976599|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92156516|NCT00976599|Abortifacient Agents|abortifacient agents|mesh-ancestor
92156517|NCT00976599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92156518|NCT00976599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156519|NCT00976599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156520|NCT00976599|Antimetabolites|antimetabolites|mesh-ancestor
92156521|NCT00976599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156522|NCT00976599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156523|NCT00976599|Dermatologic Agents|dermatologic agents|mesh-ancestor
92156524|NCT00976599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156525|NCT00976599|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92156526|NCT00976599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156527|NCT00976599|Immunologic Factors|immunologic factors|mesh-ancestor
92156528|NCT00976599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156529|NCT00976599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92156530|NCT00976599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92156531|NCT00976599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156533|NCT02630472|Antimalarials|antimalarials|mesh-ancestor
92164382|NCT01305213|Bevacizumab|bevacizumab|mesh-list
92156534|NCT02630472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92156535|NCT02630472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92156536|NCT02630472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156537|NCT02630472|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92156538|NCT02630472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164535|NCT01925729|Sympathomimetics|sympathomimetics|mesh-ancestor
92156539|NCT02630472|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92156540|NCT02630472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156541|NCT02630472|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156542|NCT02630472|Analgesics|analgesics|mesh-ancestor
92156543|NCT02630472|Sensory System Agents|sensory system agents|mesh-ancestor
92156545|NCT03729011|Sevoflurane|sevoflurane|mesh-list
92156546|NCT03729011|Desflurane|desflurane|mesh-list
92156547|NCT03729011|Isoflurane|isoflurane|mesh-list
92156548|NCT03729011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92156549|NCT03729011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164823|NCT04122755|Buprenorphine|buprenorphine|mesh-list
92156550|NCT03729011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156551|NCT03729011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92156552|NCT03729011|Anesthetics, General|anesthetics, general|mesh-ancestor
92156553|NCT03729011|Anesthetics|anesthetics|mesh-ancestor
92156554|NCT03729011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92156555|NCT03729011|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92156556|NCT05264922|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92156557|NCT05264922|Hemostatics|hemostatics|mesh-ancestor
92156558|NCT05264922|Coagulants|coagulants|mesh-ancestor
92156560|NCT00977769|Carbetocin|carbetocin|mesh-list
92156561|NCT00977769|Oxytocics|oxytocics|mesh-ancestor
92156562|NCT00977769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92156563|NCT00977769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156565|NCT03725501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92156566|NCT03725501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92156567|NCT03725501|Growth Substances|growth substances|mesh-ancestor
92156568|NCT03725501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156569|NCT03725501|Growth Inhibitors|growth inhibitors|mesh-ancestor
92165337|NCT04670081|Niacinamide|niacinamide|mesh-list
92156570|NCT03725501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156571|NCT00979017|Bevacizumab|bevacizumab|mesh-list
92156573|NCT00979017|Temozolomide|temozolomide|mesh-list
92156574|NCT00979017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156575|NCT00979017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156576|NCT00979017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92156577|NCT00979017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92156578|NCT00979017|Growth Substances|growth substances|mesh-ancestor
92156579|NCT00979017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165557|NCT03038802|Vaccines|vaccines|mesh-list
92156580|NCT00979017|Growth Inhibitors|growth inhibitors|mesh-ancestor
92156581|NCT00979017|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92156582|NCT00979017|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92156583|NCT00979017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156584|NCT00979017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156585|NCT00979017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156586|NCT00979017|Alkylating Agents|alkylating agents|mesh-ancestor
92156587|NCT01670526|Rivastigmine|rivastigmine|mesh-list
92156588|NCT01670526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92165776|NCT01647828|Paclitaxel|paclitaxel|mesh-list
92156589|NCT01670526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156590|NCT01670526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156591|NCT01670526|Cholinergic Agents|cholinergic agents|mesh-ancestor
92156592|NCT01670526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156593|NCT01670526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156594|NCT01670526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92156595|NCT01670526|Protective Agents|protective agents|mesh-ancestor
92156596|NCT00945035|Etoricoxib|etoricoxib|mesh-list
92165912|NCT03061032|Ribavirin|ribavirin|mesh-list
92156597|NCT00945035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92156598|NCT00945035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156599|NCT00945035|Analgesics|analgesics|mesh-ancestor
92156600|NCT00945035|Sensory System Agents|sensory system agents|mesh-ancestor
92156601|NCT00945035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156602|NCT00945035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156603|NCT00945035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156604|NCT00945035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156605|NCT00945035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92156606|NCT00945035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92156607|NCT00945035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156608|NCT00945035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156609|NCT03720431|Pembrolizumab|pembrolizumab|mesh-list
92156610|NCT03720431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156611|NCT03720431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156612|NCT03720431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92156613|NCT03720431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166280|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
92156615|NCT05176548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92166349|NCT03058536|Progesterone|progesterone|mesh-list
92156617|NCT05176548|Paraproteins|paraproteins|mesh-list
92156618|NCT05176548|Immunologic Factors|immunologic factors|mesh-ancestor
92156619|NCT05176548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156620|NCT03719105|Dexamethasone|dexamethasone|mesh-list
92156621|NCT03719105|Prednisone|prednisone|mesh-list
92156622|NCT03719105|Cyclophosphamide|cyclophosphamide|mesh-list
92156623|NCT03719105|Ifosfamide|ifosfamide|mesh-list
92156624|NCT03719105|Doxorubicin|doxorubicin|mesh-list
92156625|NCT03719105|Methotrexate|methotrexate|mesh-list
92156627|NCT03719105|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92156628|NCT03719105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156629|NCT03719105|Immunologic Factors|immunologic factors|mesh-ancestor
92156630|NCT03719105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156631|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156632|NCT03719105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156633|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
92166714|NCT05160987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92156634|NCT03719105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156635|NCT03719105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156636|NCT03719105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92156637|NCT03719105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156638|NCT03719105|Antiemetics|antiemetics|mesh-ancestor
92156639|NCT03719105|Autonomic Agents|autonomic agents|mesh-ancestor
92156640|NCT03719105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156641|NCT03719105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167016|NCT02655601|Manganese|manganese|mesh-list
92156642|NCT03719105|Glucocorticoids|glucocorticoids|mesh-ancestor
92156643|NCT03719105|Hormones|hormones|mesh-ancestor
92156644|NCT03719105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156645|NCT03719105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92156646|NCT03719105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92156647|NCT03719105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92156648|NCT03719105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92156649|NCT03719105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156650|NCT03719105|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92156651|NCT03719105|Abortifacient Agents|abortifacient agents|mesh-ancestor
92156652|NCT03719105|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92156653|NCT03719105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156654|NCT03719105|Antimetabolites|antimetabolites|mesh-ancestor
92156655|NCT03719105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92156656|NCT03719105|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92167309|NCT04918914|Leprostatic Agents|leprostatic agents|mesh-ancestor
92156657|NCT03719105|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92156658|NCT03719105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92156659|NCT03719105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167389|NCT02620020|Fasinumab|fasinumab|mesh-list
92156660|NCT03719105|Immunotoxins|immunotoxins|mesh-ancestor
92156661|NCT03719105|Immunoconjugates|immunoconjugates|mesh-ancestor
92156662|NCT00979875|Insulin|insulin|mesh-list
92156664|NCT00979875|Insulin Aspart|insulin aspart|mesh-list
92156665|NCT00979875|Insulin Lispro|insulin lispro|mesh-list
92156666|NCT00979875|Insulin glulisine|insulin glulisine|mesh-list
92156667|NCT00979875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92156668|NCT00979875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156669|NCT03710603|Dexamethasone|dexamethasone|mesh-list
92156670|NCT03710603|Dexamethasone acetate|dexamethasone acetate|mesh-list
92156671|NCT03710603|Lenalidomide|lenalidomide|mesh-list
92156672|NCT03710603|Bortezomib|bortezomib|mesh-list
92156673|NCT03710603|Daratumumab|daratumumab|mesh-list
92156674|NCT03710603|BB 1101|bb 1101|mesh-list
92156675|NCT03710603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156676|NCT03710603|Antiemetics|antiemetics|mesh-ancestor
92156677|NCT03710603|Autonomic Agents|autonomic agents|mesh-ancestor
92156678|NCT03710603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156679|NCT03710603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156680|NCT03710603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92156681|NCT03710603|Glucocorticoids|glucocorticoids|mesh-ancestor
92156682|NCT03710603|Hormones|hormones|mesh-ancestor
92156683|NCT03710603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156684|NCT03710603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92156685|NCT03710603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156686|NCT03710603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92156687|NCT03710603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156688|NCT03710603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156689|NCT03710603|Immunologic Factors|immunologic factors|mesh-ancestor
92156690|NCT03710603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92156691|NCT03710603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92156692|NCT03710603|Growth Substances|growth substances|mesh-ancestor
92156693|NCT03710603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92156694|NCT02630706|Metformin|metformin|mesh-list
92156695|NCT02630706|Glimepiride|glimepiride|mesh-list
92156696|NCT02630706|Ertugliflozin|ertugliflozin|mesh-list
92156697|NCT02630706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92156698|NCT02630706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156699|NCT02630706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92156700|NCT02630706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156701|NCT02630706|Immunologic Factors|immunologic factors|mesh-ancestor
92156702|NCT02630706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92156703|NCT02630706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156704|NCT03709043|Ethanol|ethanol|mesh-list
92156705|NCT03709043|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92168732|NCT04109885|Autonomic Agents|autonomic agents|mesh-ancestor
92156706|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156707|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156708|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156709|NCT03707951|Acetylcysteine|acetylcysteine|mesh-list
92156710|NCT03707951|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92156712|NCT03707951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156713|NCT03707951|Expectorants|expectorants|mesh-ancestor
92156714|NCT03707951|Respiratory System Agents|respiratory system agents|mesh-ancestor
92168969|NCT05909462|Glucocorticoids|glucocorticoids|mesh-ancestor
92156715|NCT03707951|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92156716|NCT03707951|Antioxidants|antioxidants|mesh-ancestor
92156717|NCT03707951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156718|NCT03707951|Protective Agents|protective agents|mesh-ancestor
92156719|NCT03707951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156720|NCT03707951|Antidotes|antidotes|mesh-ancestor
92156721|NCT04763057|Calcium|calcium|mesh-list
92156722|NCT04763057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92156723|NCT04763057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156724|NCT03702179|Durvalumab|durvalumab|mesh-list
92156725|NCT03702179|Tremelimumab|tremelimumab|mesh-list
92169042|NCT05908864|Analgesics|analgesics|mesh-ancestor
92156726|NCT03702179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156727|NCT03702179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156728|NCT01677143|Bupivacaine|bupivacaine|mesh-list
92156729|NCT01677143|Anesthetics, Local|anesthetics, local|mesh-ancestor
92156730|NCT01677143|Anesthetics|anesthetics|mesh-ancestor
92156731|NCT01677143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156732|NCT01677143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156734|NCT01677143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156735|NCT03692663|Cyclophosphamide|cyclophosphamide|mesh-list
92156736|NCT03692663|Fludarabine|fludarabine|mesh-list
92156737|NCT03692663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156738|NCT03692663|Immunologic Factors|immunologic factors|mesh-ancestor
92156739|NCT03692663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156741|NCT03692663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156742|NCT03692663|Alkylating Agents|alkylating agents|mesh-ancestor
92156743|NCT03692663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156744|NCT03692663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156745|NCT03692663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92156747|NCT02084069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92156748|NCT02084069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92156749|NCT02084069|Antimetabolites|antimetabolites|mesh-ancestor
92401769|NCT01418534|Vasodilator Agents|vasodilator agents|mesh-ancestor
92156750|NCT02084069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156751|NCT02084069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92156752|NCT02084069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92169604|NCT05797376|Rivaroxaban|rivaroxaban|mesh-list
92156753|NCT02084069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156754|NCT03685331|Fulvestrant|fulvestrant|mesh-list
92156756|NCT03685331|Palbociclib|palbociclib|mesh-list
92156757|NCT03685331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92156758|NCT03685331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169852|NCT05467293|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92156759|NCT03685331|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92156760|NCT03685331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92156761|NCT03685331|Hormone Antagonists|hormone antagonists|mesh-ancestor
92156762|NCT03685331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156763|NCT03685331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156764|NCT03685331|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92156765|NCT03685331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156766|NCT03685331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156767|NCT03685331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156768|NCT04626024|Imatinib Mesylate|imatinib mesylate|mesh-list
92156769|NCT04626024|Dasatinib|dasatinib|mesh-list
92156771|NCT04626024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156772|NCT04626024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156773|NCT04626024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156774|NCT00981045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92156775|NCT00981045|Hematinics|hematinics|mesh-ancestor
92156776|NCT00981435|Prednisolone|prednisolone|mesh-list
92156777|NCT00981435|Prednisolone acetate|prednisolone acetate|mesh-list
92156778|NCT00981435|Ketorolac|ketorolac|mesh-list
92156779|NCT00981435|Lubricant Eye Drops|lubricant eye drops|mesh-list
92156781|NCT00981435|Glucocorticoids|glucocorticoids|mesh-ancestor
92156782|NCT00981435|Hormones|hormones|mesh-ancestor
92156783|NCT00981435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156784|NCT00981435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156785|NCT00981435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92156786|NCT00981435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156787|NCT00981435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156788|NCT00981435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92156789|NCT00981435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156790|NCT00981435|Analgesics|analgesics|mesh-ancestor
92156791|NCT00981435|Sensory System Agents|sensory system agents|mesh-ancestor
92156792|NCT00981435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156793|NCT00981435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92156794|NCT00981435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156795|NCT00981435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156796|NCT00981435|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92156797|NCT00981435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92156798|NCT04571580|Reteplase|reteplase|mesh-list
92156799|NCT04571580|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92156800|NCT04571580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92156801|NCT04571580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92156802|NCT04571580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156803|NCT00981669|Vaccines|vaccines|mesh-list
92156804|NCT00981669|Immunologic Factors|immunologic factors|mesh-ancestor
92156805|NCT00981669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156806|NCT00981825|Listerine|listerine|mesh-list
92156807|NCT00981825|Triclosan|triclosan|mesh-list
92156808|NCT00981825|Fluorides|fluorides|mesh-list
92156809|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
92156810|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
92156811|NCT00981825|Protective Agents|protective agents|mesh-ancestor
92156812|NCT00981825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156813|NCT00981825|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92156815|NCT00981825|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92156816|NCT00981825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92156817|NCT00981825|Antimetabolites|antimetabolites|mesh-ancestor
92156818|NCT00981825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156819|NCT00981825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92156820|NCT00983307|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92156821|NCT00983307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156822|NCT00983307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92156823|NCT00983307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156824|NCT00983307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156825|NCT04762745|Thalidomide|thalidomide|mesh-list
92156826|NCT04762745|Dexamethasone|dexamethasone|mesh-list
92156827|NCT04762745|Dexamethasone acetate|dexamethasone acetate|mesh-list
92156828|NCT04762745|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92156829|NCT04762745|Pomalidomide|pomalidomide|mesh-list
92156830|NCT04762745|BB 1101|bb 1101|mesh-list
92156831|NCT04762745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156832|NCT04762745|Antiemetics|antiemetics|mesh-ancestor
92156833|NCT04762745|Autonomic Agents|autonomic agents|mesh-ancestor
92156834|NCT04762745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156835|NCT04762745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156836|NCT04762745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92156837|NCT04762745|Glucocorticoids|glucocorticoids|mesh-ancestor
92156838|NCT04762745|Hormones|hormones|mesh-ancestor
92156839|NCT04762745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92156840|NCT04762745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92156841|NCT04762745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156842|NCT04762745|Protease Inhibitors|protease inhibitors|mesh-ancestor
92156843|NCT04762745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156844|NCT04762745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156845|NCT04762745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156846|NCT04762745|Alkylating Agents|alkylating agents|mesh-ancestor
92156847|NCT04762745|Immunologic Factors|immunologic factors|mesh-ancestor
92156848|NCT04762745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92156849|NCT04762745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92156850|NCT04762745|Growth Substances|growth substances|mesh-ancestor
92156851|NCT04762745|Growth Inhibitors|growth inhibitors|mesh-ancestor
92156852|NCT04762745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156853|NCT04762745|Leprostatic Agents|leprostatic agents|mesh-ancestor
92156854|NCT04762745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92156855|NCT04762745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156856|NCT00983541|Gemcitabine|gemcitabine|mesh-list
92156857|NCT00983541|Fluorouracil|fluorouracil|mesh-list
92156858|NCT00983541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92156859|NCT00983541|Antimetabolites|antimetabolites|mesh-ancestor
92156860|NCT00983541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156861|NCT00983541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156862|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156863|NCT00983541|Immunologic Factors|immunologic factors|mesh-ancestor
92156864|NCT00983541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156865|NCT03667703|Famotidine|famotidine|mesh-list
92156866|NCT03667703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92156867|NCT03667703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92156868|NCT03667703|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92156869|NCT03667703|Histamine Antagonists|histamine antagonists|mesh-ancestor
92156870|NCT03667703|Histamine Agents|histamine agents|mesh-ancestor
92156871|NCT03667703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156872|NCT03667703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156873|NCT03667703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156874|NCT05074056|Ketorolac|ketorolac|mesh-list
92156875|NCT05074056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92156876|NCT05074056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92156877|NCT05074056|Analgesics|analgesics|mesh-ancestor
92156878|NCT05074056|Sensory System Agents|sensory system agents|mesh-ancestor
92156879|NCT05074056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156880|NCT05074056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156881|NCT05074056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92156883|NCT05074056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92401782|NCT01418586|Alfuzosin|alfuzosin|mesh-list
92156884|NCT05074056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156885|NCT05074056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156886|NCT03656549|Pemetrexed|pemetrexed|mesh-list
92156887|NCT03656549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156888|NCT03656549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156889|NCT03656549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156890|NCT03656549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92156891|NCT03656549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92156893|NCT03062904|Bronchodilator Agents|bronchodilator agents|mesh-list
92156894|NCT03062904|Miotics|miotics|mesh-ancestor
92156895|NCT03062904|Autonomic Agents|autonomic agents|mesh-ancestor
92156896|NCT03062904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156897|NCT03062904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156898|NCT03062904|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92156899|NCT03062904|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92156900|NCT03062904|Respiratory System Agents|respiratory system agents|mesh-ancestor
92156901|NCT03062904|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92156902|NCT03062904|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92156903|NCT03062904|Cholinergic Agents|cholinergic agents|mesh-ancestor
92156904|NCT03062904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156905|NCT03062904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156906|NCT03062904|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92156907|NCT00986583|Succinylcholine|succinylcholine|mesh-list
92156908|NCT00986583|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92156909|NCT00986583|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92156910|NCT00986583|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92156911|NCT00986583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156912|NCT00986583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156913|NCT05056974|UB-421|ub-421|mesh-list
92156914|NCT05056974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92156915|NCT05056974|Antiviral Agents|antiviral agents|mesh-ancestor
92156916|NCT05056974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156917|NCT03643913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92156918|NCT03643913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92156919|NCT03643913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156920|NCT03643913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156921|NCT04762511|Vaccines|vaccines|mesh-list
92156922|NCT04762511|Immunologic Factors|immunologic factors|mesh-ancestor
92156923|NCT04762511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156924|NCT04762901|Paclitaxel|paclitaxel|mesh-list
92156925|NCT04762901|Cyclophosphamide|cyclophosphamide|mesh-list
92156926|NCT04762901|Carboplatin|carboplatin|mesh-list
92156927|NCT04762901|Doxorubicin|doxorubicin|mesh-list
92156928|NCT04762901|Niraparib|niraparib|mesh-list
92156929|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92156930|NCT04762901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156931|NCT04762901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92156932|NCT04762901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92156933|NCT04762901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92156934|NCT04762901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156935|NCT04762901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92156936|NCT04762901|Immunologic Factors|immunologic factors|mesh-ancestor
92156937|NCT04762901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156938|NCT04762901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92156939|NCT04762901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92156940|NCT04762901|Alkylating Agents|alkylating agents|mesh-ancestor
92156941|NCT04762901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92156942|NCT04762901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170204|NCT05100628|Doxorubicin|doxorubicin|mesh-list
92156943|NCT04762901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92156944|NCT04762901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92156945|NCT04762901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92156946|NCT04762901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92156947|NCT00988143|Vaccines|vaccines|mesh-list
92156948|NCT00988143|Immunologic Factors|immunologic factors|mesh-ancestor
92156949|NCT00988143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156950|NCT03018171|Clonidine|clonidine|mesh-list
92156951|NCT03018171|Sufentanil|sufentanil|mesh-list
92156952|NCT03018171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92156953|NCT03018171|Narcotics|narcotics|mesh-ancestor
92156954|NCT03018171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92156955|NCT03018171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156956|NCT03018171|Analgesics|analgesics|mesh-ancestor
92156957|NCT03018171|Sensory System Agents|sensory system agents|mesh-ancestor
92156958|NCT03018171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156959|NCT03018171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92156960|NCT03018171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92156961|NCT03018171|Anesthetics, General|anesthetics, general|mesh-ancestor
92156962|NCT03018171|Anesthetics|anesthetics|mesh-ancestor
92156963|NCT03018171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92156964|NCT03018171|Sympatholytics|sympatholytics|mesh-ancestor
92156965|NCT03018171|Autonomic Agents|autonomic agents|mesh-ancestor
92156966|NCT03018171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92156967|NCT03018171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92156968|NCT03018171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92156969|NCT03018171|Adrenergic Agents|adrenergic agents|mesh-ancestor
92156970|NCT03018171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156971|NCT03018171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156973|NCT03638375|Interferon-alpha|interferon-alpha|mesh-list
92156975|NCT03638375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92156976|NCT03638375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92156977|NCT03638375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92156978|NCT03638375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156979|NCT03638375|Antiviral Agents|antiviral agents|mesh-ancestor
92156980|NCT03638375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92156981|NCT03638375|Immunologic Factors|immunologic factors|mesh-ancestor
92156982|NCT03638375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156983|NCT00989157|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92156984|NCT00989157|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92156985|NCT00989157|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92156986|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92156987|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92156988|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92156989|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92156990|NCT00989157|Analgesics|analgesics|mesh-ancestor
92156991|NCT00989157|Sensory System Agents|sensory system agents|mesh-ancestor
92156992|NCT00989157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92156993|NCT00989157|Antidepressive Agents|antidepressive agents|mesh-ancestor
92156994|NCT00989157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92156995|NCT00989157|Dopamine Agents|dopamine agents|mesh-ancestor
92156996|NCT00990561|Clobetasol|clobetasol|mesh-list
92156997|NCT00990561|Halobetasol|halobetasol|mesh-list
92156998|NCT00990561|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92156999|NCT00990561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157000|NCT00990561|Glucocorticoids|glucocorticoids|mesh-ancestor
92157001|NCT00990561|Hormones|hormones|mesh-ancestor
92157002|NCT00990561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157003|NCT00990561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157004|NCT03018015|Ibuprofen|ibuprofen|mesh-list
92157005|NCT03018015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157006|NCT03018015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157007|NCT03018015|Analgesics|analgesics|mesh-ancestor
92157008|NCT03018015|Sensory System Agents|sensory system agents|mesh-ancestor
92157009|NCT03018015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157010|NCT03018015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157011|NCT03018015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157012|NCT03018015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157013|NCT03018015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92157014|NCT03018015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157015|NCT03018015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157017|NCT03614741|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92157018|NCT03614741|Dalteparin|dalteparin|mesh-list
92157019|NCT03614741|Anticoagulants|anticoagulants|mesh-ancestor
92157020|NCT03614741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92157021|NCT03614741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92157022|NCT03614741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157023|NCT03609593|Rituximab|rituximab|mesh-list
92157024|NCT03609593|Venetoclax|venetoclax|mesh-list
92157025|NCT03609593|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92157026|NCT03609593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157027|NCT03609593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157028|NCT03609593|Immunologic Factors|immunologic factors|mesh-ancestor
92157029|NCT03609593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157030|NCT03609593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157031|NCT03609593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92157032|NCT03609593|Alkylating Agents|alkylating agents|mesh-ancestor
92157033|NCT03609593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157034|NCT00004547|Paclitaxel|paclitaxel|mesh-list
92157035|NCT00004547|Cisplatin|cisplatin|mesh-list
92157036|NCT00004547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92157037|NCT00004547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157038|NCT00004547|Tubulin Modulators|tubulin modulators|mesh-ancestor
92157039|NCT00004547|Antimitotic Agents|antimitotic agents|mesh-ancestor
92157040|NCT00004547|Mitosis Modulators|mitosis modulators|mesh-ancestor
92157041|NCT00004547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157042|NCT00005669|Metformin|metformin|mesh-list
92157043|NCT00005669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92157044|NCT00005669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157045|NCT02089997|Risedronic Acid|risedronic acid|mesh-list
92157046|NCT02089997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92157047|NCT02089997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92157048|NCT02089997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157049|NCT02089997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92157050|NCT02089997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157051|NCT02089997|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92157053|NCT01363661|Vasodilator Agents|vasodilator agents|mesh-ancestor
92157054|NCT01363661|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92157055|NCT01363661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157056|NCT02628600|Amikacin|amikacin|mesh-list
92157057|NCT02628600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92157058|NCT02628600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157059|NCT00006101|Eflornithine|eflornithine|mesh-list
92157060|NCT00006101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157061|NCT00006101|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92157062|NCT00006101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92157063|NCT00006101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92157064|NCT00006101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157065|NCT00006101|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92157066|NCT00006101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157067|NCT00006101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157068|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
92157069|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92157070|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
92157071|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157072|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157073|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157074|NCT04437888|Ketamine|ketamine|mesh-list
92157075|NCT04437888|Analgesics|analgesics|mesh-ancestor
92157076|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
92157077|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157078|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157079|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92157080|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92157081|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
92157082|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
92157083|NCT04437888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157084|NCT04437888|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92157085|NCT04437888|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92157086|NCT04437888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157087|NCT04437888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157088|NCT00591318|Ceftriaxone|ceftriaxone|mesh-list
92157089|NCT00591318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92157090|NCT00591318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157091|NCT00991029|Clopidogrel|clopidogrel|mesh-list
92157092|NCT00991029|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92157093|NCT00991029|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92157094|NCT00991029|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92157095|NCT00991029|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92157096|NCT00991029|Purinergic Agents|purinergic agents|mesh-ancestor
92157097|NCT00991029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157098|NCT00991029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157099|NCT00991029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157101|NCT00991809|Promethazine|promethazine|mesh-list
92157102|NCT00991809|Alfentanil|alfentanil|mesh-list
92157103|NCT00991809|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92157104|NCT00991809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92157105|NCT00991809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157106|NCT00991809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157107|NCT00991809|Anesthetics, Local|anesthetics, local|mesh-ancestor
92157108|NCT00991809|Anesthetics|anesthetics|mesh-ancestor
92157109|NCT00991809|Sensory System Agents|sensory system agents|mesh-ancestor
92157111|NCT00991809|Antiemetics|antiemetics|mesh-ancestor
92157112|NCT00991809|Autonomic Agents|autonomic agents|mesh-ancestor
92157113|NCT00991809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92157114|NCT00991809|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92157115|NCT00991809|Histamine Antagonists|histamine antagonists|mesh-ancestor
92157116|NCT00991809|Histamine Agents|histamine agents|mesh-ancestor
92157117|NCT00991809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157118|NCT00991809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157119|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92157120|NCT00991809|Antipruritics|antipruritics|mesh-ancestor
92157121|NCT00991809|Dermatologic Agents|dermatologic agents|mesh-ancestor
92157122|NCT00991809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157123|NCT00991809|Narcotics|narcotics|mesh-ancestor
92157124|NCT00991809|Analgesics|analgesics|mesh-ancestor
92157125|NCT00991809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92157126|NCT00991809|Anesthetics, General|anesthetics, general|mesh-ancestor
92157127|NCT02627274|Trastuzumab|trastuzumab|mesh-list
92157128|NCT02627274|Cetuximab|cetuximab|mesh-list
92157129|NCT02627274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157130|NCT02627274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157131|NCT04982016|Methamphetamine|methamphetamine|mesh-list
92157132|NCT04982016|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92157133|NCT04982016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157134|NCT04982016|Sympathomimetics|sympathomimetics|mesh-ancestor
92157135|NCT04982016|Autonomic Agents|autonomic agents|mesh-ancestor
92157136|NCT04982016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157137|NCT04982016|Dopamine Agents|dopamine agents|mesh-ancestor
92157138|NCT04982016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157139|NCT04982016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157140|NCT04982016|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157141|NCT04982016|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92157142|NCT04982016|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92157143|NCT04982016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92157144|NCT04982016|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92157146|NCT04436250|Esketamine|esketamine|mesh-list
92157147|NCT04436250|Analgesics|analgesics|mesh-ancestor
92157148|NCT04436250|Sensory System Agents|sensory system agents|mesh-ancestor
92157149|NCT04436250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157150|NCT04436250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157151|NCT04436250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92157152|NCT04436250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92157153|NCT04436250|Anesthetics, General|anesthetics, general|mesh-ancestor
92157154|NCT04436250|Anesthetics|anesthetics|mesh-ancestor
92157155|NCT04436250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157156|NCT04436250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92157157|NCT04436250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92157158|NCT04436250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157159|NCT04436250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157160|NCT04436250|Antidepressive Agents|antidepressive agents|mesh-ancestor
92157161|NCT04436250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92157162|NCT00994929|Oprelvekin|oprelvekin|mesh-list
92157163|NCT00994929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157164|NCT00929253|Buprenorphine|buprenorphine|mesh-list
92157165|NCT00929253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92157166|NCT00929253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157167|NCT00929253|Narcotics|narcotics|mesh-ancestor
92157168|NCT00929253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157169|NCT00929253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157170|NCT00929253|Analgesics|analgesics|mesh-ancestor
92157171|NCT00929253|Sensory System Agents|sensory system agents|mesh-ancestor
92157172|NCT00929253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157173|NCT00929253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92157174|NCT00771693|Insulin Aspart|insulin aspart|mesh-list
92157175|NCT00771693|Insulin, Long-Acting|insulin, long-acting|mesh-list
92157176|NCT00771693|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92157177|NCT00771693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92157178|NCT00771693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157180|NCT04374903|Azithromycin|azithromycin|mesh-list
92157181|NCT04374903|Hydroxychloroquine|hydroxychloroquine|mesh-list
92157182|NCT04374903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92157183|NCT04374903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157184|NCT04374903|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92157185|NCT04374903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157186|NCT04374903|Antifungal Agents|antifungal agents|mesh-ancestor
92157187|NCT04374903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157188|NCT04374903|Immunologic Factors|immunologic factors|mesh-ancestor
92157189|NCT04374903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157190|NCT04374903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157191|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157192|NCT04374903|Antimalarials|antimalarials|mesh-ancestor
92157193|NCT04374903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92157194|NCT04374903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92157195|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157196|NCT03062982|Fluzoparib|fluzoparib|mesh-list
92157197|NCT03062982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92157198|NCT03062982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157199|NCT03062982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157200|NCT03062982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157201|NCT03062436|Tin Fluorides|tin fluorides|mesh-list
92157202|NCT03062436|Cariostatic Agents|cariostatic agents|mesh-ancestor
92157203|NCT03062436|Protective Agents|protective agents|mesh-ancestor
92157204|NCT03062436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157205|NCT03500874|Leucovorin|leucovorin|mesh-list
92157206|NCT03500874|Fluorouracil|fluorouracil|mesh-list
92157207|NCT03500874|Floxuridine|floxuridine|mesh-list
92157208|NCT03500874|Oxaliplatin|oxaliplatin|mesh-list
92157209|NCT03500874|Antimetabolites|antimetabolites|mesh-ancestor
92157210|NCT03500874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157211|NCT03500874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92157212|NCT03500874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157213|NCT03500874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157214|NCT03500874|Immunologic Factors|immunologic factors|mesh-ancestor
92157215|NCT03500874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157216|NCT03500874|Antidotes|antidotes|mesh-ancestor
92157217|NCT03500874|Protective Agents|protective agents|mesh-ancestor
92157218|NCT03500874|Vitamin B Complex|vitamin b complex|mesh-ancestor
92157219|NCT03500874|Vitamins|vitamins|mesh-ancestor
92157220|NCT03500874|Micronutrients|micronutrients|mesh-ancestor
92157221|NCT00997113|Alfentanil|alfentanil|mesh-list
92157222|NCT00997113|Propofol|propofol|mesh-list
92157223|NCT00997113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92157224|NCT00997113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157225|NCT00997113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170362|NCT04983888|Obinutuzumab|obinutuzumab|mesh-list
92157226|NCT00997113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92157228|NCT00997113|Anesthetics|anesthetics|mesh-ancestor
92157229|NCT00997113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157230|NCT00997113|Narcotics|narcotics|mesh-ancestor
92157231|NCT00997113|Analgesics|analgesics|mesh-ancestor
92157232|NCT00997113|Sensory System Agents|sensory system agents|mesh-ancestor
92157233|NCT00997113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157234|NCT04981704|Itraconazole|itraconazole|mesh-list
92157235|NCT04981704|Phenytoin|phenytoin|mesh-list
92157236|NCT04981704|Paroxetine|paroxetine|mesh-list
92157237|NCT04981704|Antifungal Agents|antifungal agents|mesh-ancestor
92157238|NCT04981704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157239|NCT04981704|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92157240|NCT04981704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92157241|NCT04981704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327614|NCT00003086|Sensory System Agents|sensory system agents|mesh-ancestor
92157242|NCT04981704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157243|NCT04981704|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92157244|NCT04981704|Hormone Antagonists|hormone antagonists|mesh-ancestor
92157245|NCT04981704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157246|NCT04981704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157247|NCT04981704|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92157248|NCT04981704|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92157249|NCT04981704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92157250|NCT04981704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92157251|NCT04981704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157252|NCT04981704|Serotonin Agents|serotonin agents|mesh-ancestor
92157253|NCT04981704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92157254|NCT04981704|Antidepressive Agents|antidepressive agents|mesh-ancestor
92157255|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92157256|NCT04981704|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92157257|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
92157258|NCT04981704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92157259|NCT04981704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92157260|NCT04981704|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92157262|NCT02163837|Rifaximin|rifaximin|mesh-list
92157263|NCT02163837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92157264|NCT02163837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157265|NCT02163837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92157266|NCT04974060|Remifentanil|remifentanil|mesh-list
92157267|NCT04974060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157268|NCT04974060|Narcotics|narcotics|mesh-ancestor
92157269|NCT04974060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157270|NCT04974060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157271|NCT04974060|Analgesics|analgesics|mesh-ancestor
92157272|NCT04974060|Sensory System Agents|sensory system agents|mesh-ancestor
92157273|NCT04974060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157274|NCT01021761|Ketorolac|ketorolac|mesh-list
92157275|NCT01021761|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92157276|NCT01021761|Nepafenac|nepafenac|mesh-list
92157277|NCT01021761|Bromfenac|bromfenac|mesh-list
92157278|NCT01021761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157279|NCT01021761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157280|NCT01021761|Analgesics|analgesics|mesh-ancestor
92157281|NCT01021761|Sensory System Agents|sensory system agents|mesh-ancestor
92157282|NCT01021761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157283|NCT01021761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157284|NCT01021761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157285|NCT01021761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157286|NCT01021761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92157287|NCT01021761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157288|NCT01021761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157289|NCT04973904|Paclitaxel|paclitaxel|mesh-list
92157290|NCT04973904|Bevacizumab|bevacizumab|mesh-list
92157291|NCT04973904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92157292|NCT04973904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157293|NCT04973904|Tubulin Modulators|tubulin modulators|mesh-ancestor
92157294|NCT04973904|Antimitotic Agents|antimitotic agents|mesh-ancestor
92157295|NCT04973904|Mitosis Modulators|mitosis modulators|mesh-ancestor
92157296|NCT04973904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157297|NCT04973904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157298|NCT04973904|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92157299|NCT04973904|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92157300|NCT04973904|Growth Substances|growth substances|mesh-ancestor
92157301|NCT04973904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157302|NCT04973904|Growth Inhibitors|growth inhibitors|mesh-ancestor
92157303|NCT00998049|Plerixafor|plerixafor|mesh-list
92157304|NCT00998049|Lenograstim|lenograstim|mesh-list
92157305|NCT00998049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92157306|NCT00998049|Immunologic Factors|immunologic factors|mesh-ancestor
92157307|NCT00998049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157308|NCT00998049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92157309|NCT00998049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92157310|NCT00998049|Antiviral Agents|antiviral agents|mesh-ancestor
92157311|NCT00998049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157312|NCT00998205|Atropine|atropine|mesh-list
92157313|NCT00998205|Dobutamine|dobutamine|mesh-list
92157314|NCT00998205|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92157315|NCT00998205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92157316|NCT00998205|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92157317|NCT00998205|Autonomic Agents|autonomic agents|mesh-ancestor
92157318|NCT00998205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157319|NCT00998205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157320|NCT00998205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92157321|NCT00998205|Respiratory System Agents|respiratory system agents|mesh-ancestor
92157322|NCT00998205|Mydriatics|mydriatics|mesh-ancestor
92157323|NCT00998205|Parasympatholytics|parasympatholytics|mesh-ancestor
92157324|NCT00998205|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92157325|NCT00998205|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92157326|NCT00998205|Cholinergic Agents|cholinergic agents|mesh-ancestor
92157327|NCT00998205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157328|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157329|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92157330|NCT00998205|Sympathomimetics|sympathomimetics|mesh-ancestor
92157331|NCT00998205|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92157332|NCT00998205|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92157333|NCT00998205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92157334|NCT00998205|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157335|NCT00998205|Protective Agents|protective agents|mesh-ancestor
92157336|NCT02626182|Sildenafil Citrate|sildenafil citrate|mesh-list
92157338|NCT02626182|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92157339|NCT02626182|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92157340|NCT02626182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157341|NCT02626182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157342|NCT02626182|Urological Agents|urological agents|mesh-ancestor
92157343|NCT01023477|Chloroquine|chloroquine|mesh-list
92157344|NCT01023477|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92157345|NCT01023477|Amebicides|amebicides|mesh-ancestor
92157346|NCT01023477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92157347|NCT01023477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92157348|NCT01023477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157349|NCT01023477|Antimalarials|antimalarials|mesh-ancestor
92157350|NCT01023477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157351|NCT01023477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157352|NCT01023477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157353|NCT01023477|Analgesics|analgesics|mesh-ancestor
92157354|NCT01023477|Sensory System Agents|sensory system agents|mesh-ancestor
92157355|NCT01023477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157356|NCT01023477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157357|NCT01023477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157358|NCT01023477|Filaricides|filaricides|mesh-ancestor
92157359|NCT01023477|Antinematodal Agents|antinematodal agents|mesh-ancestor
92157360|NCT01023477|Anthelmintics|anthelmintics|mesh-ancestor
92157361|NCT01023711|Vaccines|vaccines|mesh-list
92157362|NCT01023711|Immunologic Factors|immunologic factors|mesh-ancestor
92157363|NCT01023711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157364|NCT01001403|Nafamostat|nafamostat|mesh-list
92157365|NCT01001403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157366|NCT01001403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157367|NCT01001403|Analgesics|analgesics|mesh-ancestor
92157368|NCT01001403|Sensory System Agents|sensory system agents|mesh-ancestor
92157369|NCT01001403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157370|NCT01001403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157371|NCT01001403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157372|NCT01001403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157373|NCT01001403|Anticoagulants|anticoagulants|mesh-ancestor
92157374|NCT01001403|Protease Inhibitors|protease inhibitors|mesh-ancestor
92157375|NCT01001403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157376|NCT01001403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157377|NCT01001403|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92157378|NCT01001403|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92157379|NCT01001403|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92157380|NCT01001403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157381|NCT01001403|Immunologic Factors|immunologic factors|mesh-ancestor
92157382|NCT01024335|Naltrexone|naltrexone|mesh-list
92157383|NCT01024335|Dronabinol|dronabinol|mesh-list
92157384|NCT01024335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92157385|NCT01024335|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92157386|NCT01024335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157387|NCT01024335|Sensory System Agents|sensory system agents|mesh-ancestor
92157388|NCT01024335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157389|NCT01024335|Hallucinogens|hallucinogens|mesh-ancestor
92157390|NCT01024335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92157391|NCT01024335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157392|NCT01024335|Analgesics|analgesics|mesh-ancestor
92157393|NCT01024335|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92157394|NCT01024335|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92157395|NCT01024335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157396|NCT01024335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157397|NCT01024335|Hormones|hormones|mesh-ancestor
92157398|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157399|NCT01001559|Norepinephrine|norepinephrine|mesh-list
92157400|NCT01001559|Serotonin|serotonin|mesh-list
92170507|NCT04724252|Anticonvulsants|anticonvulsants|mesh-ancestor
92157401|NCT01001559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92157402|NCT01001559|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
92157403|NCT01001559|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92157404|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92157405|NCT01001559|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157406|NCT01001559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157407|NCT01001559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157408|NCT01001559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157410|NCT01001559|Autonomic Agents|autonomic agents|mesh-ancestor
92157411|NCT01001559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157412|NCT01001559|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92157413|NCT01001559|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92157414|NCT01001559|Serotonin Agents|serotonin agents|mesh-ancestor
92157415|NCT01001559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92157416|NCT01001559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92157417|NCT01025427|Tenofovir|tenofovir|mesh-list
92157418|NCT01025427|Emtricitabine|emtricitabine|mesh-list
92157419|NCT01025427|Raltegravir Potassium|raltegravir potassium|mesh-list
92157420|NCT01025427|Antiviral Agents|antiviral agents|mesh-ancestor
92157421|NCT01025427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157422|NCT01025427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92157423|NCT01025427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92157424|NCT01025427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157425|NCT01025427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157426|NCT01025427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92157427|NCT01025427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92157428|NCT01025427|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92157429|NCT01025427|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92157430|NCT02162433|Dexmedetomidine|dexmedetomidine|mesh-list
92157431|NCT02162433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92157432|NCT02162433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157433|NCT02162433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157434|NCT02162433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157435|NCT02162433|Analgesics|analgesics|mesh-ancestor
92157436|NCT02162433|Sensory System Agents|sensory system agents|mesh-ancestor
92157437|NCT02162433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157438|NCT02162433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92157439|NCT02162433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92157440|NCT02162433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92157441|NCT02162433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157442|NCT02162433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157443|NCT02162433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157444|NCT01004991|Prednisone|prednisone|mesh-list
92157445|NCT01004991|Cyclophosphamide|cyclophosphamide|mesh-list
92157447|NCT01004991|Doxorubicin|doxorubicin|mesh-list
92157448|NCT01004991|Vincristine|vincristine|mesh-list
92157449|NCT01004991|Azacitidine|azacitidine|mesh-list
92157450|NCT01004991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157451|NCT01004991|Immunologic Factors|immunologic factors|mesh-ancestor
92157452|NCT01004991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157453|NCT01004991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157454|NCT01004991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92401897|NCT01419340|Nootropic Agents|nootropic agents|mesh-ancestor
92157455|NCT01004991|Alkylating Agents|alkylating agents|mesh-ancestor
92157456|NCT01004991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157457|NCT01004991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157458|NCT01004991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92157459|NCT01004991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157460|NCT01004991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92157461|NCT01004991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92157462|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92157463|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157464|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157465|NCT01004991|Glucocorticoids|glucocorticoids|mesh-ancestor
92157466|NCT01004991|Hormones|hormones|mesh-ancestor
92157467|NCT01004991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157468|NCT01004991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92157469|NCT01004991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92157470|NCT01004991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92157471|NCT01004991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92157472|NCT01004991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92157473|NCT01004991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92157474|NCT01004991|Antimetabolites|antimetabolites|mesh-ancestor
92157475|NCT03063060|Vitamin D|vitamin d|mesh-list
92157476|NCT03063060|Calcium|calcium|mesh-list
92157477|NCT03063060|Vitamins|vitamins|mesh-ancestor
92157478|NCT03063060|Micronutrients|micronutrients|mesh-ancestor
92157479|NCT03063060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157480|NCT03063060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92157481|NCT03063060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92157482|NCT03115047|Meperidine|meperidine|mesh-list
92157483|NCT03115047|Dexmedetomidine|dexmedetomidine|mesh-list
92157484|NCT03115047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92157485|NCT03115047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157486|NCT03115047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157487|NCT03115047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157489|NCT03115047|Sensory System Agents|sensory system agents|mesh-ancestor
92157490|NCT03115047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157491|NCT03115047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92157492|NCT03115047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92157493|NCT03115047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92157494|NCT03115047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157495|NCT03115047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157496|NCT03115047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157497|NCT03115047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157499|NCT03115047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92157500|NCT01026909|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92157501|NCT01026909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157502|NCT03015519|rGLP-1 protein|rglp-1 protein|mesh-list
92157503|NCT03015519|Incretins|incretins|mesh-ancestor
92157504|NCT03015519|Hormones|hormones|mesh-ancestor
92157505|NCT03015519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157506|NCT03015519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157507|NCT01030653|Voriconazole|voriconazole|mesh-list
92157508|NCT01030653|Antifungal Agents|antifungal agents|mesh-ancestor
92157509|NCT01030653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157510|NCT01030653|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92157511|NCT01030653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92157512|NCT01030653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157513|NCT01030653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157514|NCT01030653|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92157515|NCT01030653|Hormone Antagonists|hormone antagonists|mesh-ancestor
92157516|NCT01030653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157517|NCT01030653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157518|NCT01030653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92157519|NCT01031043|Bethanechol|bethanechol|mesh-list
92157520|NCT01031043|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92157521|NCT01031043|Autonomic Agents|autonomic agents|mesh-ancestor
92157522|NCT01031043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157523|NCT01031043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157524|NCT01031043|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92157525|NCT01031043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92157526|NCT01031043|Cholinergic Agents|cholinergic agents|mesh-ancestor
92157527|NCT01031043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157528|NCT01031043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157529|NCT01050153|Aspirin|aspirin|mesh-list
92157530|NCT01050153|Dalteparin|dalteparin|mesh-list
92157531|NCT01050153|Tinzaparin|tinzaparin|mesh-list
92157532|NCT01050153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92157533|NCT01050153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157534|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157535|NCT01050153|Analgesics|analgesics|mesh-ancestor
92157536|NCT01050153|Sensory System Agents|sensory system agents|mesh-ancestor
92157537|NCT01050153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157538|NCT01050153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157539|NCT01050153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157540|NCT01050153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157541|NCT01050153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92157542|NCT01050153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92157543|NCT01050153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170596|NCT04510207|Vaccines|vaccines|mesh-list
92157544|NCT01050153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92157545|NCT01050153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92157546|NCT01050153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157547|NCT01050153|Antipyretics|antipyretics|mesh-ancestor
92157548|NCT01050153|Anticoagulants|anticoagulants|mesh-ancestor
92157549|NCT04358133|Morphine|morphine|mesh-list
92157550|NCT04358133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157551|NCT04358133|Narcotics|narcotics|mesh-ancestor
92157552|NCT04358133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157553|NCT04358133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157554|NCT04358133|Analgesics|analgesics|mesh-ancestor
92157555|NCT04358133|Sensory System Agents|sensory system agents|mesh-ancestor
92157556|NCT04358133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157557|NCT04291209|Acetylcysteine|acetylcysteine|mesh-list
92157558|NCT04291209|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92157559|NCT04291209|Antiviral Agents|antiviral agents|mesh-ancestor
92157560|NCT04291209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157562|NCT04291209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92157563|NCT04291209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92157564|NCT04291209|Antioxidants|antioxidants|mesh-ancestor
92157565|NCT04291209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157566|NCT04291209|Protective Agents|protective agents|mesh-ancestor
92157567|NCT04291209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157568|NCT04291209|Antidotes|antidotes|mesh-ancestor
92157569|NCT01032759|Memantine|memantine|mesh-list
92157570|NCT01032759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92157571|NCT01032759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92157572|NCT01032759|Dopamine Agents|dopamine agents|mesh-ancestor
92157573|NCT01032759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157574|NCT01032759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157575|NCT01032759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157576|NCT01032759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92157577|NCT01032759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92157578|NCT01032993|Ubiquinone|ubiquinone|mesh-list
92157579|NCT01032993|Coenzyme Q10|coenzyme q10|mesh-list
92157580|NCT01032993|Micronutrients|micronutrients|mesh-ancestor
92157581|NCT01032993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157582|NCT01032993|Vitamins|vitamins|mesh-ancestor
92157583|NCT01033773|Metformin|metformin|mesh-list
92157584|NCT01033773|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92157585|NCT01033773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157586|NCT01053507|Naproxen|naproxen|mesh-list
92157588|NCT01053507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157589|NCT01053507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157590|NCT01053507|Analgesics|analgesics|mesh-ancestor
92157591|NCT01053507|Sensory System Agents|sensory system agents|mesh-ancestor
92157592|NCT01053507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157593|NCT01053507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157594|NCT01053507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157595|NCT01053507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157596|NCT01053507|Gout Suppressants|gout suppressants|mesh-ancestor
92157597|NCT01053507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92157598|NCT01053507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157599|NCT01053507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157600|NCT01053507|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92157601|NCT01053507|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92157602|NCT01053507|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92157603|NCT01053507|Serotonin Agents|serotonin agents|mesh-ancestor
92157604|NCT01053507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157606|NCT01053819|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157607|NCT01053819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157608|NCT01053819|Analgesics|analgesics|mesh-ancestor
92157609|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
92157610|NCT01053819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157611|NCT01053819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157612|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157613|NCT01053819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157614|NCT01053819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92157615|NCT01053819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157616|NCT01053819|Immunologic Factors|immunologic factors|mesh-ancestor
92157617|NCT01054911|Sunitinib|sunitinib|mesh-list
92157618|NCT01054911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157619|NCT01054911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92157620|NCT01054911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92157621|NCT01054911|Growth Substances|growth substances|mesh-ancestor
92157622|NCT01054911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157623|NCT01054911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92157624|NCT01054911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92157625|NCT01054911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157626|NCT01054911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157627|NCT01055223|Troglitazone|troglitazone|mesh-list
92157629|NCT01055223|Spironolactone|spironolactone|mesh-list
92157630|NCT01055223|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92157631|NCT01055223|Hormone Antagonists|hormone antagonists|mesh-ancestor
92157632|NCT01055223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157633|NCT01055223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157634|NCT01055223|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92157635|NCT01055223|Diuretics|diuretics|mesh-ancestor
92157636|NCT01055223|Natriuretic Agents|natriuretic agents|mesh-ancestor
92157637|NCT01055223|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92157638|NCT01055223|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92157639|NCT01055223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401917|NCT01419366|Nootropic Agents|nootropic agents|mesh-ancestor
92157640|NCT01055223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157641|NCT01055223|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92157642|NCT01055223|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92157643|NCT02168361|Interferons|interferons|mesh-list
92157644|NCT02168361|Ribavirin|ribavirin|mesh-list
92157645|NCT02168361|Interferon-alpha|interferon-alpha|mesh-list
92157646|NCT02168361|Interferon alpha-2|interferon alpha-2|mesh-list
92157647|NCT02168361|Sofosbuvir|sofosbuvir|mesh-list
92157648|NCT02168361|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92157649|NCT02168361|Simeprevir|simeprevir|mesh-list
92157650|NCT02168361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157651|NCT02168361|Antiviral Agents|antiviral agents|mesh-ancestor
92157652|NCT02168361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157653|NCT02168361|Antimetabolites|antimetabolites|mesh-ancestor
92157654|NCT02168361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157655|NCT02168361|Immunologic Factors|immunologic factors|mesh-ancestor
92157656|NCT02168361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157657|NCT02168361|Protease Inhibitors|protease inhibitors|mesh-ancestor
92157658|NCT02168361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157659|NCT01360554|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92157660|NCT01360554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157661|NCT01360554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92157662|NCT01360554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170693|NCT04263831|Aldesleukin|aldesleukin|mesh-list
92157663|NCT01360554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157664|NCT01055769|Linezolid|linezolid|mesh-list
92157665|NCT01055769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92157666|NCT01055769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157667|NCT01055769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92157668|NCT01055769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157669|NCT01055769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157670|NCT01057017|Panitumumab|panitumumab|mesh-list
92157671|NCT01057017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157672|NCT01057017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157673|NCT04972032|Estrogens|estrogens|mesh-list
92157674|NCT04972032|Hyaluronic Acid|hyaluronic acid|mesh-list
92157675|NCT04972032|Hormones|hormones|mesh-ancestor
92157676|NCT04972032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157677|NCT04972032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157678|NCT04972032|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92157679|NCT04972032|Immunologic Factors|immunologic factors|mesh-ancestor
92157680|NCT04972032|Viscosupplements|viscosupplements|mesh-ancestor
92157681|NCT04972032|Protective Agents|protective agents|mesh-ancestor
92157682|NCT04432662|Darbepoetin alfa|darbepoetin alfa|mesh-list
92157683|NCT04432662|Hematinics|hematinics|mesh-ancestor
92157684|NCT02918370|Aripiprazole|aripiprazole|mesh-list
92157685|NCT02918370|Antidepressive Agents|antidepressive agents|mesh-ancestor
92157686|NCT02918370|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92157687|NCT02918370|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92157688|NCT02918370|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92157689|NCT02918370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157690|NCT02918370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157691|NCT02918370|Dopamine Agonists|dopamine agonists|mesh-ancestor
92157692|NCT02918370|Dopamine Agents|dopamine agents|mesh-ancestor
92157693|NCT02918370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157694|NCT02918370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157695|NCT02918370|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92170740|NCT04225260|Botulinum Toxins|botulinum toxins|mesh-list
92157696|NCT02918370|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92157697|NCT02918370|Serotonin Agents|serotonin agents|mesh-ancestor
92157698|NCT02918370|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92157699|NCT02918370|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92157700|NCT02918370|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92157701|NCT02918370|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92157702|NCT04152564|Bupivacaine|bupivacaine|mesh-list
92157703|NCT04152564|Levobupivacaine|levobupivacaine|mesh-list
92157704|NCT04152564|Anesthetics, Local|anesthetics, local|mesh-ancestor
92157706|NCT04152564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157707|NCT04152564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157708|NCT04152564|Sensory System Agents|sensory system agents|mesh-ancestor
92157709|NCT04152564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157710|NCT04977960|Canrenone|canrenone|mesh-list
92157711|NCT04977960|Canrenoic Acid|canrenoic acid|mesh-list
92157712|NCT04977960|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92157713|NCT04977960|Hormone Antagonists|hormone antagonists|mesh-ancestor
92157714|NCT04977960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157715|NCT04977960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157716|NCT04977960|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92157717|NCT04977960|Diuretics|diuretics|mesh-ancestor
92157718|NCT04977960|Natriuretic Agents|natriuretic agents|mesh-ancestor
92157719|NCT05593809|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
92157720|NCT05593809|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92157721|NCT05593809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157722|NCT05593731|Melatonin|melatonin|mesh-list
92157723|NCT05593731|Antioxidants|antioxidants|mesh-ancestor
92157724|NCT05593731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157725|NCT05593731|Protective Agents|protective agents|mesh-ancestor
92157726|NCT05593731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157727|NCT05593731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157728|NCT01062009|Zinc Sulfate|zinc sulfate|mesh-list
92157729|NCT01062009|Astringents|astringents|mesh-ancestor
92157730|NCT01062009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157731|NCT01062009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92157732|NCT01062165|Caspofungin|caspofungin|mesh-list
92157733|NCT01062165|Antifungal Agents|antifungal agents|mesh-ancestor
92157734|NCT01062165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157735|NCT01062165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157736|NCT01062165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157737|NCT05592951|Methamphetamine|methamphetamine|mesh-list
92157738|NCT05592951|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92157739|NCT05592951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157740|NCT05592951|Sympathomimetics|sympathomimetics|mesh-ancestor
92157741|NCT05592951|Autonomic Agents|autonomic agents|mesh-ancestor
92157742|NCT05592951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157743|NCT05592951|Dopamine Agents|dopamine agents|mesh-ancestor
92157744|NCT05592951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157745|NCT05592951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157746|NCT05592951|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157747|NCT05592951|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92157748|NCT05592951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92157749|NCT05592951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92157750|NCT05592951|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92157752|NCT04041843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92157753|NCT04041843|Antithrombins|antithrombins|mesh-ancestor
92157754|NCT04041843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92157755|NCT04041843|Protease Inhibitors|protease inhibitors|mesh-ancestor
92157756|NCT04041843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157757|NCT04041843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157758|NCT04041843|Anticoagulants|anticoagulants|mesh-ancestor
92157759|NCT01068873|Ritonavir|ritonavir|mesh-list
92157760|NCT01068873|Lopinavir|lopinavir|mesh-list
92157761|NCT01068873|Maraviroc|maraviroc|mesh-list
92157762|NCT01068873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92157763|NCT01068873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92157764|NCT01068873|Protease Inhibitors|protease inhibitors|mesh-ancestor
92157765|NCT01068873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157766|NCT01068873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157767|NCT01068873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92157768|NCT01068873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92157769|NCT01068873|Antiviral Agents|antiviral agents|mesh-ancestor
92157770|NCT01068873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157771|NCT01068873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92157772|NCT01068873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92157773|NCT01068873|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92157774|NCT01068873|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92157775|NCT01068873|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92157776|NCT01072773|Dexamethasone|dexamethasone|mesh-list
92157777|NCT01072773|Cyclophosphamide|cyclophosphamide|mesh-list
92157778|NCT01072773|Bortezomib|bortezomib|mesh-list
92157779|NCT01072773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157780|NCT01072773|Immunologic Factors|immunologic factors|mesh-ancestor
92157781|NCT01072773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157782|NCT01072773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157783|NCT01072773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92157784|NCT01072773|Alkylating Agents|alkylating agents|mesh-ancestor
92157785|NCT01072773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157786|NCT01072773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157787|NCT01072773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92157788|NCT01072773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157789|NCT01072773|Antiemetics|antiemetics|mesh-ancestor
92157790|NCT01072773|Autonomic Agents|autonomic agents|mesh-ancestor
92157791|NCT01072773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157792|NCT01072773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92157793|NCT01072773|Glucocorticoids|glucocorticoids|mesh-ancestor
92157795|NCT01072773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92157796|NCT01072773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92157797|NCT03013647|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92157798|NCT03013647|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92157799|NCT03013647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92157800|NCT03013647|Dermatologic Agents|dermatologic agents|mesh-ancestor
92157801|NCT01074177|Afatinib|afatinib|mesh-list
92157802|NCT01074177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157803|NCT01074177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92157804|NCT01074177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157805|NCT01074177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157806|NCT01076283|Cyproheptadine|cyproheptadine|mesh-list
92157807|NCT01076283|Baclofen|baclofen|mesh-list
92157808|NCT01076283|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92157809|NCT01076283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157810|NCT01076283|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92157811|NCT01076283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157812|NCT01076283|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92157813|NCT01076283|GABA Agonists|gaba agonists|mesh-ancestor
92157814|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
92157815|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157816|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157817|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
92157818|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92157819|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92157820|NCT01076283|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92157821|NCT01076283|Histamine Antagonists|histamine antagonists|mesh-ancestor
92157822|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
92157823|NCT01076283|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92157824|NCT01076283|Serotonin Agents|serotonin agents|mesh-ancestor
92157825|NCT01076283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92157827|NCT03805581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92157828|NCT03805581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92157829|NCT03805581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157830|NCT03805581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92157831|NCT01076985|Ritonavir|ritonavir|mesh-list
92157832|NCT01076985|Lopinavir|lopinavir|mesh-list
92157833|NCT01076985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92157834|NCT01076985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92157835|NCT01076985|Protease Inhibitors|protease inhibitors|mesh-ancestor
92157836|NCT01076985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157837|NCT01076985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157838|NCT01076985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92157839|NCT01076985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92157840|NCT01076985|Antiviral Agents|antiviral agents|mesh-ancestor
92157841|NCT01076985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157842|NCT01076985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92157843|NCT01076985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92157844|NCT02176005|Moxifloxacin|moxifloxacin|mesh-list
92157845|NCT02176005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92157846|NCT02176005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92157847|NCT02176005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92157848|NCT02176005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92157849|NCT02176005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157850|NCT02176005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157851|NCT02176005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157853|NCT05539911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157854|NCT05539911|Narcotics|narcotics|mesh-ancestor
92157855|NCT05539911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157856|NCT05539911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157857|NCT05539911|Analgesics|analgesics|mesh-ancestor
92157858|NCT05539911|Sensory System Agents|sensory system agents|mesh-ancestor
92157859|NCT05539911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157860|NCT05539911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92157861|NCT05539911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92157862|NCT05539911|Anesthetics, General|anesthetics, general|mesh-ancestor
92157863|NCT05539911|Anesthetics|anesthetics|mesh-ancestor
92157864|NCT03589833|Methotrexate|methotrexate|mesh-list
92157865|NCT03589833|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92157866|NCT03589833|Abortifacient Agents|abortifacient agents|mesh-ancestor
92157867|NCT03589833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92157868|NCT03589833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157869|NCT03589833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92157870|NCT03589833|Antimetabolites|antimetabolites|mesh-ancestor
92157871|NCT03589833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157872|NCT03589833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157873|NCT03589833|Dermatologic Agents|dermatologic agents|mesh-ancestor
92157874|NCT03589833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157875|NCT03589833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92157876|NCT03589833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157877|NCT03589833|Immunologic Factors|immunologic factors|mesh-ancestor
92157878|NCT03589833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157879|NCT03589833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92157880|NCT01077921|Propranolol|propranolol|mesh-list
92157881|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92157882|NCT01077921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92157883|NCT01077921|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157884|NCT01077921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157885|NCT01077921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157886|NCT01077921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157887|NCT01077921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92170850|NCT04074746|Antimetabolites|antimetabolites|mesh-ancestor
92157888|NCT01077921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92157889|NCT01077921|Vasodilator Agents|vasodilator agents|mesh-ancestor
92157890|NCT05498181|Valsartan|valsartan|mesh-list
92157891|NCT05498181|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92157892|NCT05498181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92157893|NCT05498181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92157894|NCT05498181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92157895|NCT05498181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157896|NCT04970238|Simendan|simendan|mesh-list
92157897|NCT04970238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92157898|NCT04970238|Vasodilator Agents|vasodilator agents|mesh-ancestor
92157899|NCT04970238|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92157900|NCT04970238|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92157901|NCT04970238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157902|NCT04970238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157903|NCT04970238|Protective Agents|protective agents|mesh-ancestor
92157904|NCT04970238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157905|NCT02169453|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92157906|NCT02169453|Opicapone|opicapone|mesh-list
92157907|NCT02169453|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92157908|NCT02169453|Immunologic Factors|immunologic factors|mesh-ancestor
92157909|NCT02169453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157910|NCT02169453|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92157911|NCT02169453|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92157912|NCT02169453|Dopamine Agonists|dopamine agonists|mesh-ancestor
92157913|NCT02169453|Dopamine Agents|dopamine agents|mesh-ancestor
92157914|NCT02169453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157915|NCT02169453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157916|NCT02169453|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92157917|NCT02169453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157918|NCT01822314|Paclitaxel|paclitaxel|mesh-list
92157919|NCT01822314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92157920|NCT01822314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92157921|NCT01822314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157922|NCT01822314|Tubulin Modulators|tubulin modulators|mesh-ancestor
92157923|NCT01822314|Antimitotic Agents|antimitotic agents|mesh-ancestor
92157924|NCT01822314|Mitosis Modulators|mitosis modulators|mesh-ancestor
92157925|NCT01822314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157926|NCT01765296|Celecoxib|celecoxib|mesh-list
92157927|NCT01765296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157928|NCT01765296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157929|NCT01765296|Analgesics|analgesics|mesh-ancestor
92157930|NCT01765296|Sensory System Agents|sensory system agents|mesh-ancestor
92157931|NCT01765296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157932|NCT01765296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157933|NCT01765296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157934|NCT01765296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157935|NCT01765296|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92157936|NCT01765296|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92157937|NCT01765296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157938|NCT01765296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157939|NCT01081041|Carboplatin|carboplatin|mesh-list
92157940|NCT01081041|Fluorouracil|fluorouracil|mesh-list
92157941|NCT01081041|Cetuximab|cetuximab|mesh-list
92157942|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157943|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
92157944|NCT01081041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157945|NCT01081041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92157946|NCT01081041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92157947|NCT01081041|Immunologic Factors|immunologic factors|mesh-ancestor
92157948|NCT01081041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157949|NCT01081041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157950|NCT03022617|Apremilast|apremilast|mesh-list
92157951|NCT03022617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92157952|NCT03022617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157953|NCT03022617|Analgesics|analgesics|mesh-ancestor
92157954|NCT03022617|Sensory System Agents|sensory system agents|mesh-ancestor
92157955|NCT03022617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157956|NCT03022617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157957|NCT03022617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92157958|NCT03022617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92157959|NCT03022617|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92157960|NCT03022617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92157961|NCT03022617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92157962|NCT03022617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157963|NCT05427981|Buprenorphine|buprenorphine|mesh-list
92157964|NCT05427981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92157965|NCT05427981|Narcotics|narcotics|mesh-ancestor
92157966|NCT05427981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157967|NCT05427981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157968|NCT05427981|Analgesics|analgesics|mesh-ancestor
92157969|NCT05427981|Sensory System Agents|sensory system agents|mesh-ancestor
92157970|NCT05427981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157971|NCT05427981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92157972|NCT02089685|Pembrolizumab|pembrolizumab|mesh-list
92157974|NCT02089685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157975|NCT02089685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92157976|NCT02089685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92157977|NCT02089685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157978|NCT01088295|Telmisartan|telmisartan|mesh-list
92157979|NCT01088295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92157980|NCT01088295|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92157981|NCT01088295|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92157982|NCT01088295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157983|NCT04730609|Dexmedetomidine|dexmedetomidine|mesh-list
92157984|NCT04730609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92157985|NCT04730609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92157986|NCT04730609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92157987|NCT04730609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92157988|NCT04730609|Analgesics|analgesics|mesh-ancestor
92157989|NCT04730609|Sensory System Agents|sensory system agents|mesh-ancestor
92157990|NCT04730609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92157991|NCT04730609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92157992|NCT04730609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92157993|NCT04730609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92157994|NCT04730609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92157995|NCT04730609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92157996|NCT04730609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92157997|NCT03013335|Nivolumab|nivolumab|mesh-list
92157998|NCT03013335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92157999|NCT03013335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158000|NCT03013335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158001|NCT03013335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158003|NCT04730531|Bupivacaine|bupivacaine|mesh-list
92158004|NCT04730531|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158005|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
92158006|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158007|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158008|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
92158009|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158010|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92158011|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92158012|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158013|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158014|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158015|NCT04730531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92158016|NCT04730531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92158017|NCT04730531|Autonomic Agents|autonomic agents|mesh-ancestor
92158018|NCT04730531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92158019|NCT04730531|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158020|NCT04730531|Mydriatics|mydriatics|mesh-ancestor
92158021|NCT04730531|Sympathomimetics|sympathomimetics|mesh-ancestor
92158022|NCT04730531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92158023|NCT05569733|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92158024|NCT05569733|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92158025|NCT05569733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158026|NCT05853341|Rivastigmine|rivastigmine|mesh-list
92158027|NCT05853341|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92158028|NCT05853341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158029|NCT05853341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158030|NCT05853341|Cholinergic Agents|cholinergic agents|mesh-ancestor
92158031|NCT05853341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158032|NCT05853341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158033|NCT05853341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92158034|NCT05853341|Protective Agents|protective agents|mesh-ancestor
92158035|NCT05853289|Analgesics, Opioid|analgesics, opioid|mesh-list
92158036|NCT05853289|Narcotics|narcotics|mesh-ancestor
92158037|NCT05853289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158038|NCT05853289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158039|NCT05853289|Analgesics|analgesics|mesh-ancestor
92158040|NCT05853289|Sensory System Agents|sensory system agents|mesh-ancestor
92158041|NCT05853289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158042|NCT05853224|Lidocaine|lidocaine|mesh-list
92158043|NCT05853224|Hyaluronic Acid|hyaluronic acid|mesh-list
92158044|NCT05853224|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158045|NCT05853224|Anesthetics|anesthetics|mesh-ancestor
92158046|NCT05853224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158047|NCT05853224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158048|NCT05853224|Sensory System Agents|sensory system agents|mesh-ancestor
92170982|NCT03907488|Doxorubicin|doxorubicin|mesh-list
92158049|NCT05853224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158050|NCT05853224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92158051|NCT05853224|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92158052|NCT05853224|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92158053|NCT05853224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158054|NCT05853224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158055|NCT05853224|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92158056|NCT05853224|Immunologic Factors|immunologic factors|mesh-ancestor
92158057|NCT05853224|Viscosupplements|viscosupplements|mesh-ancestor
92158058|NCT05853224|Protective Agents|protective agents|mesh-ancestor
92158059|NCT05853172|Paclitaxel|paclitaxel|mesh-list
92158060|NCT05853172|Apatinib|apatinib|mesh-list
92401967|NCT01419821|Vitamin D|vitamin d|mesh-list
92158061|NCT05853172|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92158062|NCT05853172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158063|NCT05853172|Tubulin Modulators|tubulin modulators|mesh-ancestor
92158064|NCT05853172|Antimitotic Agents|antimitotic agents|mesh-ancestor
92158065|NCT05853172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92158066|NCT05853172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158067|NCT05853172|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92158068|NCT05853172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158069|NCT05853263|Acetaminophen|acetaminophen|mesh-list
92158070|NCT05853263|Morphine|morphine|mesh-list
92158071|NCT05853263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92158072|NCT05853263|Narcotics|narcotics|mesh-ancestor
92158073|NCT05853263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158074|NCT05853263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158076|NCT05853263|Sensory System Agents|sensory system agents|mesh-ancestor
92158077|NCT05853263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158078|NCT05853263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158079|NCT05853263|Antipyretics|antipyretics|mesh-ancestor
92158080|NCT03001869|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92158081|NCT03001869|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92158082|NCT03001869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158083|NCT05852873|Ritonavir|ritonavir|mesh-list
92158084|NCT05852873|Nirmatrelvir|nirmatrelvir|mesh-list
92158085|NCT05852873|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92158086|NCT05852873|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92158087|NCT05852873|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92158088|NCT05852873|Protease Inhibitors|protease inhibitors|mesh-ancestor
92158089|NCT05852873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158090|NCT05852873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158091|NCT05852873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92158092|NCT05852873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92158093|NCT05852873|Antiviral Agents|antiviral agents|mesh-ancestor
92158094|NCT05852873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158095|NCT05852873|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92158096|NCT05852873|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92158098|NCT05852847|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92158099|NCT05852847|Hormone Antagonists|hormone antagonists|mesh-ancestor
92158100|NCT05852847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158101|NCT05852847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158102|NCT05852704|Dapagliflozin|dapagliflozin|mesh-list
92158103|NCT05852704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92158104|NCT05852704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158105|NCT05852704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92158106|NCT05852704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158107|NCT05852496|Vitamin D|vitamin d|mesh-list
92158108|NCT05852496|Vitamins|vitamins|mesh-ancestor
92158109|NCT05852496|Micronutrients|micronutrients|mesh-ancestor
92158110|NCT05852496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158111|NCT05852496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92158112|NCT05852223|Pembrolizumab|pembrolizumab|mesh-list
92158113|NCT05852223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158114|NCT05852223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158115|NCT05852223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158116|NCT05852223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158117|NCT05852197|Anticoagulants|anticoagulants|mesh-list
92158118|NCT05852197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92158119|NCT05852119|Anticoagulants|anticoagulants|mesh-list
92158120|NCT05852093|Celecoxib|celecoxib|mesh-list
92158121|NCT05852093|Buprenorphine|buprenorphine|mesh-list
92158122|NCT05852093|Tizanidine|tizanidine|mesh-list
92158123|NCT05852093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92158124|NCT05852093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158125|NCT05852093|Analgesics|analgesics|mesh-ancestor
92158126|NCT05852093|Sensory System Agents|sensory system agents|mesh-ancestor
92158127|NCT05852093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158128|NCT05852093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158129|NCT05852093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92401975|NCT01419847|Ciclopirox|ciclopirox|mesh-list
92158130|NCT05852093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92158131|NCT05852093|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92158132|NCT05852093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92158133|NCT05852093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158134|NCT05852093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158135|NCT05852093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92158136|NCT05852093|Narcotics|narcotics|mesh-ancestor
92158137|NCT05852093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158138|NCT05852093|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92158139|NCT05852093|Anticonvulsants|anticonvulsants|mesh-ancestor
92158140|NCT05852093|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92158141|NCT05852093|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92158142|NCT05852093|Parasympatholytics|parasympatholytics|mesh-ancestor
92158143|NCT05852093|Autonomic Agents|autonomic agents|mesh-ancestor
92158144|NCT05852093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92158145|NCT05852093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92158146|NCT05852093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92158147|NCT05852093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158148|NCT05852093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158149|NCT05852002|Hyaluronic Acid|hyaluronic acid|mesh-list
92158150|NCT05852002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92158151|NCT05852002|Immunologic Factors|immunologic factors|mesh-ancestor
92158152|NCT05852002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158154|NCT05852002|Protective Agents|protective agents|mesh-ancestor
92158156|NCT05851976|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92158157|NCT05851976|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92158158|NCT05851976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92158159|NCT05851976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158160|NCT05851976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158161|NCT05851976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158162|NCT05851976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158163|NCT05851976|Analgesics|analgesics|mesh-ancestor
92158164|NCT05851976|Sensory System Agents|sensory system agents|mesh-ancestor
92158165|NCT05851976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158166|NCT05851976|Antidepressive Agents|antidepressive agents|mesh-ancestor
92158167|NCT05851976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158168|NCT05851976|Dopamine Agents|dopamine agents|mesh-ancestor
92158169|NCT05851976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92158170|NCT05851976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158171|NCT05851976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158172|NCT05851976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92158173|NCT05851976|Gout Suppressants|gout suppressants|mesh-ancestor
92158174|NCT05851976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92158175|NCT05851976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158176|NCT05851898|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92158177|NCT05851898|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92158178|NCT05851898|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92158179|NCT05851898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158180|NCT05851898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158181|NCT05851898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158182|NCT05851898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158183|NCT05851898|Analgesics|analgesics|mesh-ancestor
92158184|NCT05851898|Sensory System Agents|sensory system agents|mesh-ancestor
92158185|NCT05851898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158186|NCT05851898|Antidepressive Agents|antidepressive agents|mesh-ancestor
92158187|NCT05851898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158188|NCT05851898|Dopamine Agents|dopamine agents|mesh-ancestor
92158189|NCT05851781|Lacosamide|lacosamide|mesh-list
92158190|NCT05851781|Anticonvulsants|anticonvulsants|mesh-ancestor
92158191|NCT05851781|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92158192|NCT05851781|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92158193|NCT05851781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158194|NCT05851781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158195|NCT05849129|Ascorbic Acid|ascorbic acid|mesh-list
92158196|NCT05849129|Vitamins|vitamins|mesh-ancestor
92158197|NCT05849129|Micronutrients|micronutrients|mesh-ancestor
92158198|NCT05849129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158199|NCT05849129|Antioxidants|antioxidants|mesh-ancestor
92158200|NCT05849129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158201|NCT05849129|Protective Agents|protective agents|mesh-ancestor
92158202|NCT05848843|Durvalumab|durvalumab|mesh-list
92158203|NCT05848843|Adagrasib|adagrasib|mesh-list
92158204|NCT05848843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158205|NCT05848843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158206|NCT05845762|Obinutuzumab|obinutuzumab|mesh-list
92158207|NCT05845762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158208|NCT05845762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158209|NCT05830396|Ambroxol|ambroxol|mesh-list
92158210|NCT05830396|Expectorants|expectorants|mesh-ancestor
92158211|NCT05830396|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158212|NCT05817656|Sucralfate|sucralfate|mesh-list
92158213|NCT05817656|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92158214|NCT05817656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158215|NCT05810311|Darbepoetin alfa|darbepoetin alfa|mesh-list
92158216|NCT05810311|Hematinics|hematinics|mesh-ancestor
92158217|NCT05809297|Ciclopirox|ciclopirox|mesh-list
92158218|NCT05809297|Chitosan|chitosan|mesh-list
92158219|NCT05809297|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92158220|NCT05809297|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92158221|NCT05809297|Antimetabolites|antimetabolites|mesh-ancestor
92158222|NCT05809297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158223|NCT05809297|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92158224|NCT05809297|Chelating Agents|chelating agents|mesh-ancestor
92158225|NCT05809297|Sequestering Agents|sequestering agents|mesh-ancestor
92158226|NCT05809297|Hemostatics|hemostatics|mesh-ancestor
92158227|NCT05809297|Coagulants|coagulants|mesh-ancestor
92158229|NCT05809297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158230|NCT05807412|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92158231|NCT05807412|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92158232|NCT05807412|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92158233|NCT05807412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158234|NCT05807412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158235|NCT05807412|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92158236|NCT05807412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158237|NCT05807412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158238|NCT05807412|Cholinergic Agents|cholinergic agents|mesh-ancestor
92158239|NCT05807412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158240|NCT05778591|Buprenorphine|buprenorphine|mesh-list
92158241|NCT05778591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92158242|NCT05778591|Narcotics|narcotics|mesh-ancestor
92158243|NCT05778591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158244|NCT05778591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158245|NCT05778591|Analgesics|analgesics|mesh-ancestor
92158246|NCT05778591|Sensory System Agents|sensory system agents|mesh-ancestor
92158247|NCT05778591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158248|NCT05778591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92158249|NCT05770375|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92158250|NCT05770375|Hallucinogens|hallucinogens|mesh-ancestor
92158251|NCT05770375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158252|NCT05770375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158253|NCT05770375|Serotonin Agents|serotonin agents|mesh-ancestor
92158254|NCT05770375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158255|NCT05770375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158256|NCT05770375|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92158257|NCT05770375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92158258|NCT05770375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158259|NCT05770375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158260|NCT05745987|Vaccines|vaccines|mesh-list
92158261|NCT05745987|Immunologic Factors|immunologic factors|mesh-ancestor
92158262|NCT05745987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158263|NCT05736198|Dexmedetomidine|dexmedetomidine|mesh-list
92158264|NCT05736198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92158265|NCT05736198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158266|NCT05736198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158267|NCT05736198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158268|NCT05736198|Analgesics|analgesics|mesh-ancestor
92158269|NCT05736198|Sensory System Agents|sensory system agents|mesh-ancestor
92158270|NCT05736198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158271|NCT05736198|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92158272|NCT05736198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92158273|NCT05736198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92158274|NCT05736198|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158275|NCT05736198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158276|NCT05736198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158277|NCT05734495|Venetoclax|venetoclax|mesh-list
92158278|NCT05734495|Pirtobrutinib|pirtobrutinib|mesh-list
92158279|NCT05734495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158280|NCT05734495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92158281|NCT05734495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158282|NCT05734495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158283|NCT05729503|Lidocaine|lidocaine|mesh-list
92158284|NCT05729503|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158285|NCT05729503|Anesthetics|anesthetics|mesh-ancestor
92158286|NCT05729503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158287|NCT05729503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158288|NCT05729503|Sensory System Agents|sensory system agents|mesh-ancestor
92158289|NCT05729503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158290|NCT05729503|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92158291|NCT05729503|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92158292|NCT05729503|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92158293|NCT05729503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158294|NCT05729503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158295|NCT05725876|Ustekinumab|ustekinumab|mesh-list
92158296|NCT05725876|Dermatologic Agents|dermatologic agents|mesh-ancestor
92158297|NCT05720390|Quinine|quinine|mesh-list
92158298|NCT05720390|Antimalarials|antimalarials|mesh-ancestor
92158299|NCT05720390|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92158300|NCT05720390|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92158301|NCT05720390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158302|NCT05720390|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92171193|NCT03721068|Fludarabine|fludarabine|mesh-list
92158303|NCT05720390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158304|NCT05720390|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92158305|NCT05720390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158306|NCT05720390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158307|NCT05720390|Analgesics|analgesics|mesh-ancestor
92158308|NCT05720390|Sensory System Agents|sensory system agents|mesh-ancestor
92158310|NCT05711641|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158311|NCT05711641|Anesthetics|anesthetics|mesh-ancestor
92158312|NCT05711641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158313|NCT05711641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158314|NCT05711641|Sensory System Agents|sensory system agents|mesh-ancestor
92158315|NCT05711641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158316|NCT05711641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92158317|NCT05711641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92158318|NCT05711641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92158319|NCT05711641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158320|NCT05711641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158321|NCT05702970|Vitamin D|vitamin d|mesh-list
92158322|NCT05702970|Vitamins|vitamins|mesh-ancestor
92158323|NCT05702970|Micronutrients|micronutrients|mesh-ancestor
92158324|NCT05702970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158325|NCT05702970|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92158326|NCT05693467|Dexamethasone|dexamethasone|mesh-list
92158327|NCT05693467|Ropivacaine|ropivacaine|mesh-list
92158328|NCT05693467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158329|NCT05693467|Antiemetics|antiemetics|mesh-ancestor
92158330|NCT05693467|Autonomic Agents|autonomic agents|mesh-ancestor
92158331|NCT05693467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158332|NCT05693467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158333|NCT05693467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158334|NCT05693467|Glucocorticoids|glucocorticoids|mesh-ancestor
92158335|NCT05693467|Hormones|hormones|mesh-ancestor
92158336|NCT05693467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158337|NCT05693467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92158338|NCT05693467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158339|NCT05693467|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158340|NCT05693467|Anesthetics|anesthetics|mesh-ancestor
92158341|NCT05693467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158342|NCT05693467|Sensory System Agents|sensory system agents|mesh-ancestor
92158343|NCT05682339|Quinine|quinine|mesh-list
92158344|NCT05682339|Antimalarials|antimalarials|mesh-ancestor
92158345|NCT05682339|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92158346|NCT05682339|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92158347|NCT05682339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158348|NCT05682339|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92158349|NCT05682339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158350|NCT05682339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92158351|NCT05682339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158352|NCT05682339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158353|NCT05682339|Analgesics|analgesics|mesh-ancestor
92158354|NCT05682339|Sensory System Agents|sensory system agents|mesh-ancestor
92158355|NCT05676931|Docetaxel|docetaxel|mesh-list
92158356|NCT05676931|Quemliclustat|quemliclustat|mesh-list
92158357|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158358|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92158359|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92158360|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92158361|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158362|NCT05676931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158363|NCT05676931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158364|NCT05658887|Gabapentin|gabapentin|mesh-list
92158365|NCT05658887|Analgesics|analgesics|mesh-ancestor
92158366|NCT05658887|Sensory System Agents|sensory system agents|mesh-ancestor
92158367|NCT05658887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158368|NCT05658887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158369|NCT05658887|Anticonvulsants|anticonvulsants|mesh-ancestor
92158370|NCT05658887|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92158371|NCT05658887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92158372|NCT05658887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158373|NCT05658887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158374|NCT05658887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92158375|NCT05658887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92158377|NCT05658887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158378|NCT05658887|Antimanic Agents|antimanic agents|mesh-ancestor
92158379|NCT05652283|Pamiparib|pamiparib|mesh-list
92158380|NCT05652283|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92158381|NCT05652283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158382|NCT05652283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158383|NCT05652283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158384|NCT05651282|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92158385|NCT05651282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92158386|NCT05651282|Contraceptive Agents|contraceptive agents|mesh-ancestor
92158387|NCT05651282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92158388|NCT05651282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158389|NCT05651282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92158390|NCT05651282|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92158391|NCT05651282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92158392|NCT05651282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158393|NCT05627115|Tislelizumab|tislelizumab|mesh-list
92158394|NCT05627115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158395|NCT05627115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158396|NCT05626920|Disulfiram|disulfiram|mesh-list
92158397|NCT05626920|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92158398|NCT05626920|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92158399|NCT05626920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158400|NCT05626920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158401|NCT05605366|Minocycline|minocycline|mesh-list
92158402|NCT05605366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92158403|NCT05605366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158405|NCT05572255|Anticonvulsants|anticonvulsants|mesh-ancestor
92158406|NCT05531123|Gemcitabine|gemcitabine|mesh-list
92158407|NCT05531123|Tislelizumab|tislelizumab|mesh-list
92158408|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158409|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92158410|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
92401996|NCT01420094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158411|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158412|NCT05531123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158413|NCT05523609|Vitamin D|vitamin d|mesh-list
92158414|NCT05523609|Letrozole|letrozole|mesh-list
92158415|NCT05523609|Vitamins|vitamins|mesh-ancestor
92158416|NCT05523609|Micronutrients|micronutrients|mesh-ancestor
92158417|NCT05523609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158418|NCT05523609|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92158419|NCT05523609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158420|NCT05523609|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92158421|NCT05523609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92158422|NCT05523609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158423|NCT05523609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158424|NCT05523609|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92158425|NCT05523609|Hormone Antagonists|hormone antagonists|mesh-ancestor
92158426|NCT05523609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158427|NCT05488366|Pembrolizumab|pembrolizumab|mesh-list
92158428|NCT05488366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158429|NCT05488366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158430|NCT05488366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158431|NCT05488366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158432|NCT05483465|Niacinamide|niacinamide|mesh-list
92158433|NCT05483465|Niacin|niacin|mesh-list
92158434|NCT05483465|Nicotinic Acids|nicotinic acids|mesh-list
92158435|NCT05483465|Vitamin B Complex|vitamin b complex|mesh-ancestor
92158436|NCT05483465|Vitamins|vitamins|mesh-ancestor
92158437|NCT05483465|Micronutrients|micronutrients|mesh-ancestor
92158438|NCT05483465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158439|NCT05483465|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92158440|NCT05483465|Antimetabolites|antimetabolites|mesh-ancestor
92158441|NCT05483465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158442|NCT05483465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92158443|NCT05483465|Vasodilator Agents|vasodilator agents|mesh-ancestor
92158444|NCT05477108|Budesonide|budesonide|mesh-list
92158445|NCT05477108|Formoterol Fumarate|formoterol fumarate|mesh-list
92158446|NCT05477108|Charcoal|charcoal|mesh-list
92158448|NCT05477108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92158449|NCT05477108|Autonomic Agents|autonomic agents|mesh-ancestor
92158451|NCT05477108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158452|NCT05477108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92158453|NCT05477108|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158454|NCT05477108|Glucocorticoids|glucocorticoids|mesh-ancestor
92158455|NCT05477108|Hormones|hormones|mesh-ancestor
92158456|NCT05477108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158457|NCT05477108|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92158458|NCT05477108|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92158459|NCT05477108|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92158460|NCT05477108|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158461|NCT05477108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158462|NCT05477108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158463|NCT05477108|Antidotes|antidotes|mesh-ancestor
92158464|NCT05477108|Protective Agents|protective agents|mesh-ancestor
92158465|NCT05464979|Fentanyl|fentanyl|mesh-list
92158466|NCT05464979|Midazolam|midazolam|mesh-list
92158467|NCT05464979|Ketamine|ketamine|mesh-list
92158468|NCT05464979|Esketamine|esketamine|mesh-list
92158469|NCT05464979|Analgesics|analgesics|mesh-ancestor
92158470|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
92158471|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158472|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158473|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92158474|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92158475|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
92158476|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
92158477|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158478|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92158479|NCT05464979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92158480|NCT05464979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158481|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158482|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92158483|NCT05464979|Narcotics|narcotics|mesh-ancestor
92158484|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92158485|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92158486|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92158487|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92158488|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158489|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
92158490|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
92158491|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
92158492|NCT05444582|Levonorgestrel|levonorgestrel|mesh-list
92158493|NCT05444582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92158494|NCT05444582|Contraceptive Agents|contraceptive agents|mesh-ancestor
92158495|NCT05444582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92158496|NCT05444582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158497|NCT05444582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92158498|NCT05444582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92158499|NCT05444582|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92158501|NCT05442463|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92158502|NCT05442463|Protease Inhibitors|protease inhibitors|mesh-ancestor
92158503|NCT05442463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158504|NCT05442463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158505|NCT05442463|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92158506|NCT05435222|Psychotropic Drugs|psychotropic drugs|mesh-list
92158507|NCT05402319|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92158508|NCT05402319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92158509|NCT05402319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158510|NCT05402319|Antitubercular Agents|antitubercular agents|mesh-ancestor
92158511|NCT05398289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92158512|NCT05398289|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92158513|NCT05398289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158514|NCT05398289|Antitubercular Agents|antitubercular agents|mesh-ancestor
92158515|NCT05384938|Benralizumab|benralizumab|mesh-list
92158516|NCT05384938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92158517|NCT05384938|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158518|NCT05373108|Macitentan|macitentan|mesh-list
92158519|NCT05373108|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92158520|NCT05373108|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92158521|NCT05373108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158522|NCT05373108|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92158524|NCT05368753|Ropivacaine|ropivacaine|mesh-list
92158525|NCT05368753|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158526|NCT05368753|Anesthetics|anesthetics|mesh-ancestor
92158527|NCT05368753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158528|NCT05368753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158529|NCT05368753|Sensory System Agents|sensory system agents|mesh-ancestor
92158530|NCT05368753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158531|NCT05368753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92158532|NCT05368753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92158533|NCT05368753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92171355|NCT03579446|Levorphanol|levorphanol|mesh-list
92158534|NCT05368753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158535|NCT05368753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158537|NCT05363514|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92158538|NCT05363514|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92158539|NCT05363514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158540|NCT05363514|Sensory System Agents|sensory system agents|mesh-ancestor
92158541|NCT05363514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158542|NCT05359653|Clemastine|clemastine|mesh-list
92158543|NCT05359653|Antipruritics|antipruritics|mesh-ancestor
92158544|NCT05359653|Dermatologic Agents|dermatologic agents|mesh-ancestor
92158545|NCT05359653|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92158546|NCT05359653|Histamine Antagonists|histamine antagonists|mesh-ancestor
92158547|NCT05359653|Histamine Agents|histamine agents|mesh-ancestor
92158548|NCT05359653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158549|NCT05359653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158550|NCT05359653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158551|NCT05359653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92158552|NCT05345691|Denosumab|denosumab|mesh-list
92158553|NCT05345691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92158554|NCT05345691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158555|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
92158556|NCT05325073|Hematinics|hematinics|mesh-ancestor
92158557|NCT05314998|Leucovorin|leucovorin|mesh-list
92158558|NCT05314998|Folic Acid|folic acid|mesh-list
92158559|NCT05314998|Gemcitabine|gemcitabine|mesh-list
92158560|NCT05314998|Fluorouracil|fluorouracil|mesh-list
92158561|NCT05314998|Capecitabine|capecitabine|mesh-list
92158562|NCT05314998|Oxaliplatin|oxaliplatin|mesh-list
92158563|NCT05314998|Irinotecan|irinotecan|mesh-list
92158564|NCT05314998|Levoleucovorin|levoleucovorin|mesh-list
92158565|NCT05314998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92158566|NCT05314998|Antimetabolites|antimetabolites|mesh-ancestor
92158567|NCT05314998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158568|NCT05314998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158569|NCT05314998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92158570|NCT05314998|Immunologic Factors|immunologic factors|mesh-ancestor
92158571|NCT05314998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158572|NCT05314998|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92158573|NCT05314998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92158574|NCT05314998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158575|NCT05314998|Antidotes|antidotes|mesh-ancestor
92158576|NCT05314998|Protective Agents|protective agents|mesh-ancestor
92158577|NCT05314998|Vitamin B Complex|vitamin b complex|mesh-ancestor
92158578|NCT05314998|Vitamins|vitamins|mesh-ancestor
92158579|NCT05314998|Micronutrients|micronutrients|mesh-ancestor
92158580|NCT05314998|Hematinics|hematinics|mesh-ancestor
92158581|NCT05284344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92158582|NCT05284344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158583|NCT05269615|Valsartan|valsartan|mesh-list
92158584|NCT05269615|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92158585|NCT05269615|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92158586|NCT05269615|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92158587|NCT05269615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158588|NCT05250895|Misonidazole|misonidazole|mesh-list
92158589|NCT05250895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158590|NCT05250895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92158591|NCT05250895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92158592|NCT05250895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158593|NCT05250011|Dapagliflozin|dapagliflozin|mesh-list
92158594|NCT05250011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92158595|NCT05250011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158596|NCT05250011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92158597|NCT05250011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158598|NCT05219409|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92158599|NCT05219409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92158600|NCT05219409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158603|NCT05219409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158604|NCT05219409|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92158605|NCT05219409|Protease Inhibitors|protease inhibitors|mesh-ancestor
92158606|NCT05219409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158607|NCT05219409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158608|NCT05196932|Antibodies|antibodies|mesh-list
92158609|NCT05196932|Immunologic Factors|immunologic factors|mesh-ancestor
92158610|NCT05196932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158611|NCT05194111|Valsartan|valsartan|mesh-list
92158612|NCT05194111|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92158613|NCT05194111|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92158614|NCT05194111|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92158615|NCT05194111|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92158616|NCT05194111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158617|NCT05189756|Aprepitant|aprepitant|mesh-list
92158618|NCT05189756|Fosaprepitant|fosaprepitant|mesh-list
92158619|NCT05189756|Antiemetics|antiemetics|mesh-ancestor
92158620|NCT05189756|Autonomic Agents|autonomic agents|mesh-ancestor
92158621|NCT05189756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158622|NCT05189756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158623|NCT05189756|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158624|NCT05189756|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92158625|NCT05189756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158626|NCT05189756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158627|NCT05181150|Glucagon|glucagon|mesh-list
92158628|NCT05181150|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92158629|NCT05181150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158630|NCT05181150|Hormones|hormones|mesh-ancestor
92158631|NCT05181150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158632|NCT05181150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158633|NCT05181150|Incretins|incretins|mesh-ancestor
92158634|NCT05174637|Immunoconjugates|immunoconjugates|mesh-list
92171423|NCT03366142|Ustekinumab|ustekinumab|mesh-list
92158635|NCT05174637|Immunologic Factors|immunologic factors|mesh-ancestor
92158636|NCT05174637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158637|NCT05168657|Pancrelipase|pancrelipase|mesh-list
92158638|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158639|NCT05151159|Antibodies|antibodies|mesh-list
92158640|NCT05151159|Immunologic Factors|immunologic factors|mesh-ancestor
92158641|NCT05151159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158642|NCT05144529|Nivolumab|nivolumab|mesh-list
92158643|NCT05144529|Ipilimumab|ipilimumab|mesh-list
92158644|NCT05144529|Evolocumab|evolocumab|mesh-list
92158645|NCT05144529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158646|NCT05144529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158647|NCT05144529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158648|NCT05144529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158649|NCT05144529|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92158650|NCT05144529|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92158651|NCT05144529|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92158652|NCT05144529|Antimetabolites|antimetabolites|mesh-ancestor
92158653|NCT05144529|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92158654|NCT05144529|Protease Inhibitors|protease inhibitors|mesh-ancestor
92158655|NCT05144529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158656|NCT05144529|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92158657|NCT05132920|Dexamethasone|dexamethasone|mesh-list
92158658|NCT05132920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158659|NCT05132920|Antiemetics|antiemetics|mesh-ancestor
92158660|NCT05132920|Autonomic Agents|autonomic agents|mesh-ancestor
92158661|NCT05132920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158662|NCT05132920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158663|NCT05132920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158664|NCT05132920|Glucocorticoids|glucocorticoids|mesh-ancestor
92158665|NCT05132920|Hormones|hormones|mesh-ancestor
92158666|NCT05132920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158667|NCT05132920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92158668|NCT05132920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158669|NCT05129085|Dexamethasone|dexamethasone|mesh-list
92158670|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158671|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
92158672|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
92158673|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158675|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158676|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
92158677|NCT05129085|Hormones|hormones|mesh-ancestor
92158678|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158679|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92158680|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158681|NCT05105542|Cholinergic Agents|cholinergic agents|mesh-list
92158682|NCT05105542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158683|NCT05105542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158684|NCT05105542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158685|NCT05099471|Dexamethasone|dexamethasone|mesh-list
92158686|NCT05099471|Cyclophosphamide|cyclophosphamide|mesh-list
92158687|NCT05099471|Rituximab|rituximab|mesh-list
92158688|NCT05099471|Venetoclax|venetoclax|mesh-list
92158689|NCT05099471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92158690|NCT05099471|Immunologic Factors|immunologic factors|mesh-ancestor
92158691|NCT05099471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158692|NCT05099471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92158693|NCT05099471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92158694|NCT05099471|Alkylating Agents|alkylating agents|mesh-ancestor
92158695|NCT05099471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158696|NCT05099471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158697|NCT05099471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92158698|NCT05099471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158699|NCT05099471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158700|NCT05099471|Antiemetics|antiemetics|mesh-ancestor
92158701|NCT05099471|Autonomic Agents|autonomic agents|mesh-ancestor
92158702|NCT05099471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158703|NCT05099471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158704|NCT05099471|Glucocorticoids|glucocorticoids|mesh-ancestor
92158705|NCT05099471|Hormones|hormones|mesh-ancestor
92402011|NCT01420302|Insulin|insulin|mesh-list
92158706|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158707|NCT05099471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92158708|NCT05087693|Albuterol|albuterol|mesh-list
92158709|NCT05087693|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92158710|NCT05087693|Autonomic Agents|autonomic agents|mesh-ancestor
92158711|NCT05087693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158712|NCT05087693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158713|NCT05087693|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92158714|NCT05087693|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158715|NCT05087693|Tocolytic Agents|tocolytic agents|mesh-ancestor
92158716|NCT05087693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92158717|NCT05087693|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92158718|NCT05087693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92158719|NCT05087693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92158720|NCT05087693|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158721|NCT05087693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158722|NCT05087693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158723|NCT05081583|Midazolam|midazolam|mesh-list
92158724|NCT05081583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92158725|NCT05081583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92158726|NCT05081583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158727|NCT05081583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158728|NCT05081583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92158729|NCT05081583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92158730|NCT05081583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158731|NCT05081583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92158732|NCT05081583|Anesthetics, General|anesthetics, general|mesh-ancestor
92158733|NCT05081583|Anesthetics|anesthetics|mesh-ancestor
92158734|NCT05081583|GABA Modulators|gaba modulators|mesh-ancestor
92158735|NCT05081583|GABA Agents|gaba agents|mesh-ancestor
92158736|NCT05081583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158737|NCT05081583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158738|NCT05070754|Cantharidin|cantharidin|mesh-list
92158739|NCT05070754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158740|NCT05070754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158741|NCT05067387|Dronabinol|dronabinol|mesh-list
92158742|NCT05067387|Hallucinogens|hallucinogens|mesh-ancestor
92158743|NCT05067387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158744|NCT05067387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158745|NCT05067387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158746|NCT05067387|Analgesics|analgesics|mesh-ancestor
92158747|NCT05067387|Sensory System Agents|sensory system agents|mesh-ancestor
92158748|NCT05067387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158749|NCT05067387|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92158750|NCT05067387|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92158752|NCT05067387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158753|NCT05067387|Hormones|hormones|mesh-ancestor
92158754|NCT05067387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158755|NCT05060731|Iron|iron|mesh-list
92158756|NCT05060731|Trace Elements|trace elements|mesh-ancestor
92158757|NCT05060731|Micronutrients|micronutrients|mesh-ancestor
92158758|NCT05060731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158759|NCT05057806|Empagliflozin|empagliflozin|mesh-list
92158760|NCT05057806|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92158761|NCT05057806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158762|NCT05057806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92158763|NCT05057806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158764|NCT05052099|Bevacizumab|bevacizumab|mesh-list
92158765|NCT05052099|Atezolizumab|atezolizumab|mesh-list
92158766|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158767|NCT05052099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158768|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92158769|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92158770|NCT05052099|Growth Substances|growth substances|mesh-ancestor
92158771|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158772|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
92158773|NCT05052099|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158774|NCT05052099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158775|NCT05050253|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92158776|NCT05037487|Dronabinol|dronabinol|mesh-list
92158777|NCT05037487|Hallucinogens|hallucinogens|mesh-ancestor
92158778|NCT05037487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158779|NCT05037487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158780|NCT05037487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92158781|NCT05037487|Analgesics|analgesics|mesh-ancestor
92158782|NCT05037487|Sensory System Agents|sensory system agents|mesh-ancestor
92158783|NCT05037487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158784|NCT05037487|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92158785|NCT05037487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92158786|NCT05037487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158787|NCT05037487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158788|NCT05037487|Hormones|hormones|mesh-ancestor
92158789|NCT05037487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158790|NCT05030441|Ivosidenib|ivosidenib|mesh-list
92158791|NCT05030441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158792|NCT05030441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158793|NCT05030441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158794|NCT05011266|Buprenorphine|buprenorphine|mesh-list
92158795|NCT05011266|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92158796|NCT05011266|Naloxone|naloxone|mesh-list
92158797|NCT05011266|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92158798|NCT05011266|Narcotics|narcotics|mesh-ancestor
92158799|NCT05011266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158800|NCT05011266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158801|NCT05011266|Analgesics|analgesics|mesh-ancestor
92158802|NCT05011266|Sensory System Agents|sensory system agents|mesh-ancestor
92158803|NCT05011266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158804|NCT05011266|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92158805|NCT05001074|Tacrolimus|tacrolimus|mesh-list
92158806|NCT05001074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92158807|NCT05001074|Immunologic Factors|immunologic factors|mesh-ancestor
92158808|NCT05001074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158809|NCT05001074|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92158810|NCT05001074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158811|NCT05001074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158812|NCT04985890|UB-421|ub-421|mesh-list
92158813|NCT04985890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92158814|NCT04985890|Antiviral Agents|antiviral agents|mesh-ancestor
92158815|NCT04985890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158816|NCT04977453|Pembrolizumab|pembrolizumab|mesh-list
92158817|NCT04977453|Lenvatinib|lenvatinib|mesh-list
92158818|NCT04977453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158819|NCT04977453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158828|NCT04946461|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92158829|NCT04946461|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92158830|NCT04946461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92158831|NCT04946461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158832|NCT04946461|Dopamine Agents|dopamine agents|mesh-ancestor
92158833|NCT04946461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158834|NCT04928664|Bupivacaine|bupivacaine|mesh-list
92158835|NCT04928664|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158836|NCT04928664|Anesthetics|anesthetics|mesh-ancestor
92158837|NCT04928664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158838|NCT04928664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158839|NCT04928664|Sensory System Agents|sensory system agents|mesh-ancestor
92158840|NCT04928664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158850|NCT04916392|Bupivacaine|bupivacaine|mesh-list
92171580|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
92158851|NCT04916392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158852|NCT04916392|Anesthetics|anesthetics|mesh-ancestor
92158853|NCT04916392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158854|NCT04916392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158855|NCT04916392|Sensory System Agents|sensory system agents|mesh-ancestor
92158856|NCT04916392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158858|NCT04903119|Dabrafenib|dabrafenib|mesh-list
92158859|NCT04903119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158860|NCT04903119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92158861|NCT04903119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158862|NCT04903119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158863|NCT04899115|Vancomycin|vancomycin|mesh-list
92158864|NCT04899115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92158865|NCT04899115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158866|NCT04892875|Cisplatin|cisplatin|mesh-list
92171597|NCT03164616|Gemcitabine|gemcitabine|mesh-list
92158867|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158868|NCT04871594|Nivolumab|nivolumab|mesh-list
92402015|NCT01420328|Simvastatin|simvastatin|mesh-list
92158869|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158870|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158871|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158872|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158873|NCT04868903|Vitamin D|vitamin d|mesh-list
92158874|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
92158875|NCT04868903|Vitamins|vitamins|mesh-ancestor
92158876|NCT04868903|Micronutrients|micronutrients|mesh-ancestor
92158877|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158878|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92158879|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92158880|NCT04859530|Lugol's solution|lugol's solution|mesh-list
92158881|NCT04859530|Hemostatics|hemostatics|mesh-ancestor
92158882|NCT04859530|Coagulants|coagulants|mesh-ancestor
92158883|NCT04851301|Naloxone|naloxone|mesh-list
92158884|NCT04851301|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92158885|NCT04851301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158886|NCT04851301|Sensory System Agents|sensory system agents|mesh-ancestor
92158887|NCT04851301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158888|NCT04843982|Esketamine|esketamine|mesh-list
92158889|NCT04843982|Antidepressive Agents|antidepressive agents|mesh-ancestor
92158890|NCT04843982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158891|NCT04811027|Pembrolizumab|pembrolizumab|mesh-list
92158892|NCT04811027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158893|NCT04811027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158894|NCT04811027|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158895|NCT04811027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158897|NCT04801966|Nivolumab|nivolumab|mesh-list
92158898|NCT04801966|Atezolizumab|atezolizumab|mesh-list
92158899|NCT04801966|Olaparib|olaparib|mesh-list
92158900|NCT04801966|Palbociclib|palbociclib|mesh-list
92158901|NCT04801966|Trametinib|trametinib|mesh-list
92158902|NCT04801966|Vemurafenib|vemurafenib|mesh-list
92158903|NCT04801966|Dabrafenib|dabrafenib|mesh-list
92158904|NCT04801966|Talazoparib|talazoparib|mesh-list
92158905|NCT04801966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92158906|NCT04801966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158907|NCT04801966|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92158908|NCT04801966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158909|NCT04801966|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92158910|NCT04801966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92158911|NCT04801966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92158912|NCT04789915|Memantine|memantine|mesh-list
92158913|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92158914|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92158916|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158917|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158918|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158919|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92158920|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92158921|NCT04771299|Cariprazine|cariprazine|mesh-list
92158922|NCT04771299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92158923|NCT04771299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92158924|NCT04771299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158925|NCT04771299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158926|NCT04771299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92158927|NCT04725656|Nicotine|nicotine|mesh-list
92158928|NCT04725656|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92158929|NCT04725656|Autonomic Agents|autonomic agents|mesh-ancestor
92158930|NCT04725656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171707|NCT03025087|Hydroxychloroquine|hydroxychloroquine|mesh-list
92158931|NCT04725656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158932|NCT04725656|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92158933|NCT04725656|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92158934|NCT04725656|Cholinergic Agents|cholinergic agents|mesh-ancestor
92158935|NCT04725656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158936|NCT04725656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158938|NCT04704063|Tocopherols|tocopherols|mesh-list
92158939|NCT04704063|Tocotrienols|tocotrienols|mesh-list
92158940|NCT04704063|Tocovid|tocovid|mesh-list
92158941|NCT04704063|Vitamins|vitamins|mesh-ancestor
92158942|NCT04704063|Micronutrients|micronutrients|mesh-ancestor
92158943|NCT04704063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158944|NCT04704063|Antioxidants|antioxidants|mesh-ancestor
92402019|NCT01420328|Antimetabolites|antimetabolites|mesh-ancestor
92158945|NCT04704063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158946|NCT04704063|Protective Agents|protective agents|mesh-ancestor
92158947|NCT04703036|Acetylcysteine|acetylcysteine|mesh-list
92158948|NCT04703036|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92158949|NCT04703036|Glycine|glycine|mesh-list
92158950|NCT04703036|Antiviral Agents|antiviral agents|mesh-ancestor
92158951|NCT04703036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92158952|NCT04703036|Expectorants|expectorants|mesh-ancestor
92158953|NCT04703036|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158954|NCT04703036|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92158955|NCT04703036|Antioxidants|antioxidants|mesh-ancestor
92158956|NCT04703036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158957|NCT04703036|Protective Agents|protective agents|mesh-ancestor
92158958|NCT04703036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158959|NCT04703036|Antidotes|antidotes|mesh-ancestor
92158960|NCT04703036|Glycine Agents|glycine agents|mesh-ancestor
92158961|NCT04703036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92158963|NCT04636255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92158964|NCT04636255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158965|NCT04635176|Dexamethasone|dexamethasone|mesh-list
92158966|NCT04635176|Epinephrine|epinephrine|mesh-list
92158967|NCT04635176|Bupivacaine|bupivacaine|mesh-list
92158968|NCT04635176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92158969|NCT04635176|Antiemetics|antiemetics|mesh-ancestor
92158970|NCT04635176|Autonomic Agents|autonomic agents|mesh-ancestor
92158971|NCT04635176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92158972|NCT04635176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92158973|NCT04635176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92158974|NCT04635176|Glucocorticoids|glucocorticoids|mesh-ancestor
92158976|NCT04635176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92158977|NCT04635176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92158978|NCT04635176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92158979|NCT04635176|Anesthetics, Local|anesthetics, local|mesh-ancestor
92158980|NCT04635176|Anesthetics|anesthetics|mesh-ancestor
92158981|NCT04635176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92158982|NCT04635176|Sensory System Agents|sensory system agents|mesh-ancestor
92158983|NCT04635176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92158984|NCT04635176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92158985|NCT04635176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92158986|NCT04635176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92171798|NCT02877303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92158987|NCT04635176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92158988|NCT04635176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92158989|NCT04635176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92158990|NCT04635176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92158991|NCT04635176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92158992|NCT04635176|Mydriatics|mydriatics|mesh-ancestor
92158993|NCT04635176|Sympathomimetics|sympathomimetics|mesh-ancestor
92158994|NCT04635176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92158995|NCT04625907|Dactinomycin|dactinomycin|mesh-list
92158996|NCT04625907|Cyclophosphamide|cyclophosphamide|mesh-list
92158997|NCT04625907|Temozolomide|temozolomide|mesh-list
92158998|NCT04625907|Ifosfamide|ifosfamide|mesh-list
92158999|NCT04625907|Doxorubicin|doxorubicin|mesh-list
92159000|NCT04625907|Irinotecan|irinotecan|mesh-list
92159001|NCT04625907|Vincristine|vincristine|mesh-list
92159002|NCT04625907|Vinorelbine|vinorelbine|mesh-list
92159003|NCT04625907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159004|NCT04625907|Immunologic Factors|immunologic factors|mesh-ancestor
92159005|NCT04625907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159006|NCT04625907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159007|NCT04625907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159008|NCT04625907|Alkylating Agents|alkylating agents|mesh-ancestor
92159009|NCT04625907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159010|NCT04625907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159011|NCT04625907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159012|NCT04625907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92159013|NCT04625907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92159014|NCT04625907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92159015|NCT04625907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159016|NCT04625907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92402021|NCT01420328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92159017|NCT04625907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159018|NCT04625907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159019|NCT04625907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159020|NCT04625907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159021|NCT04625907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92159022|NCT04625907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159023|NCT04625907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92159024|NCT04625907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92159025|NCT04623086|Insulin|insulin|mesh-list
92159026|NCT04623086|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92159027|NCT04623086|Insulin Glargine|insulin glargine|mesh-list
92159028|NCT04623086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159029|NCT04623086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159030|NCT04574713|Candesartan|candesartan|mesh-list
92159031|NCT04574713|Candesartan cilexetil|candesartan cilexetil|mesh-list
92159032|NCT04574713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92159033|NCT04574713|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92159034|NCT04574713|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92159035|NCT04574713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159036|NCT04569877|Molgramostim|molgramostim|mesh-list
92159037|NCT04569877|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92159038|NCT04569877|Sargramostim|sargramostim|mesh-list
92159039|NCT04569877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159040|NCT04569877|Immunologic Factors|immunologic factors|mesh-ancestor
92159041|NCT04569877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159042|NCT04550234|Allopurinol|allopurinol|mesh-list
92159044|NCT04550234|Antimetabolites|antimetabolites|mesh-ancestor
92159045|NCT04550234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159046|NCT04550234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159047|NCT04550234|Gout Suppressants|gout suppressants|mesh-ancestor
92159048|NCT04550234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159049|NCT04550234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92159050|NCT04550234|Antioxidants|antioxidants|mesh-ancestor
92159051|NCT04550234|Protective Agents|protective agents|mesh-ancestor
92159052|NCT04550234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159053|NCT04542070|Rilpivirine|rilpivirine|mesh-list
92159054|NCT04542070|Cabotegravir|cabotegravir|mesh-list
92159055|NCT04542070|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92159056|NCT04542070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92159057|NCT04542070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171965|NCT02299518|Analgesics|analgesics|mesh-ancestor
92159058|NCT04542070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159059|NCT04542070|Antiviral Agents|antiviral agents|mesh-ancestor
92159060|NCT04542070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159061|NCT04542070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92159062|NCT04542070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92159063|NCT04542070|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92159064|NCT04542070|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92159065|NCT04541797|Empagliflozin|empagliflozin|mesh-list
92159066|NCT04541797|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92159067|NCT04541797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159068|NCT04541797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159069|NCT04541797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159071|NCT04540666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92159072|NCT04540666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159073|NCT04540666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159074|NCT04540666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159075|NCT04540666|Anesthetics, General|anesthetics, general|mesh-ancestor
92159076|NCT04540666|Anesthetics|anesthetics|mesh-ancestor
92159077|NCT04530383|Metformin|metformin|mesh-list
92159078|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159079|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159080|NCT04507555|Antidepressive Agents|antidepressive agents|mesh-list
92159081|NCT04507555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92159082|NCT04495621|Cetuximab|cetuximab|mesh-list
92159083|NCT04495621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159084|NCT04495621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159085|NCT04485130|Disulfiram|disulfiram|mesh-list
92159086|NCT04485130|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92159087|NCT04485130|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92159088|NCT04485130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159089|NCT04485130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159090|NCT04469491|Interferons|interferons|mesh-list
92159091|NCT04469491|Interferon Type I|interferon type i|mesh-list
92159092|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159093|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
92159094|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159095|NCT04431245|Entecavir|entecavir|mesh-list
92159096|NCT04431245|Antiviral Agents|antiviral agents|mesh-ancestor
92159097|NCT04431245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159098|NCT04421248|Methylphenidate|methylphenidate|mesh-list
92159099|NCT04421248|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92159100|NCT04421248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159101|NCT04421248|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92159102|NCT04421248|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92159103|NCT04421248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159104|NCT04421248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159105|NCT04421248|Dopamine Agents|dopamine agents|mesh-ancestor
92159106|NCT04421248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159107|NCT04355572|Vitamin D|vitamin d|mesh-list
92159108|NCT04355572|Vitamins|vitamins|mesh-ancestor
92159109|NCT04355572|Micronutrients|micronutrients|mesh-ancestor
92159110|NCT04355572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159111|NCT04355572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92159112|NCT04310059|Folic Acid|folic acid|mesh-list
92159113|NCT04310059|Hematinics|hematinics|mesh-ancestor
92159114|NCT04310059|Vitamin B Complex|vitamin b complex|mesh-ancestor
92159115|NCT04310059|Vitamins|vitamins|mesh-ancestor
92159116|NCT04310059|Micronutrients|micronutrients|mesh-ancestor
92159117|NCT04310059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159118|NCT04303780|Docetaxel|docetaxel|mesh-list
92159119|NCT04303780|Sotorasib|sotorasib|mesh-list
92159120|NCT04303780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159121|NCT04303780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159122|NCT04303780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159124|NCT04303780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159125|NCT04303780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159126|NCT04303780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159127|NCT04303689|Colchicine|colchicine|mesh-list
92159128|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
92159129|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159130|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159131|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159132|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159133|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159134|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159135|NCT04217278|Cytarabine|cytarabine|mesh-list
92159136|NCT04217278|Fludarabine|fludarabine|mesh-list
92159137|NCT04217278|Busulfan|busulfan|mesh-list
92159138|NCT04217278|Thiotepa|thiotepa|mesh-list
92159139|NCT04217278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159140|NCT04217278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92159141|NCT04217278|Antimetabolites|antimetabolites|mesh-ancestor
92159142|NCT04217278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159143|NCT04217278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159144|NCT04217278|Immunologic Factors|immunologic factors|mesh-ancestor
92159145|NCT04217278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159146|NCT04217278|Antiviral Agents|antiviral agents|mesh-ancestor
92159147|NCT04217278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159148|NCT04217278|Alkylating Agents|alkylating agents|mesh-ancestor
92159149|NCT04217278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159150|NCT04217278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159151|NCT04202809|Durvalumab|durvalumab|mesh-list
92159152|NCT04202809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159153|NCT04202809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159154|NCT04177953|Carboplatin|carboplatin|mesh-list
92159155|NCT04177953|Nivolumab|nivolumab|mesh-list
92159156|NCT04177953|Pemetrexed|pemetrexed|mesh-list
92159157|NCT04177953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159158|NCT04177953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159159|NCT04177953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159160|NCT04177953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172092|NCT01991873|Levoleucovorin|levoleucovorin|mesh-list
92159161|NCT04177953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159162|NCT04177953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92159163|NCT04177953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92159164|NCT04143061|Vaccines|vaccines|mesh-list
92159165|NCT04143061|Immunologic Factors|immunologic factors|mesh-ancestor
92159166|NCT04143061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159167|NCT04064840|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92159168|NCT04064840|Luteolytic Agents|luteolytic agents|mesh-ancestor
92159169|NCT04064840|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92159170|NCT04064840|Contraceptive Agents|contraceptive agents|mesh-ancestor
92159171|NCT04064840|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92159172|NCT04064840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159173|NCT04064840|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92159174|NCT04064840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159175|NCT04064840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159176|NCT04063579|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92159177|NCT04063579|Natriuretic Agents|natriuretic agents|mesh-ancestor
92159178|NCT04063579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159179|NCT04061512|Dexamethasone|dexamethasone|mesh-list
92159180|NCT04061512|Cyclophosphamide|cyclophosphamide|mesh-list
92159181|NCT04061512|Rituximab|rituximab|mesh-list
92159182|NCT04061512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159183|NCT04061512|Immunologic Factors|immunologic factors|mesh-ancestor
92159184|NCT04061512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159185|NCT04061512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159186|NCT04061512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159187|NCT04061512|Alkylating Agents|alkylating agents|mesh-ancestor
92159188|NCT04061512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159189|NCT04061512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159190|NCT04061512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159191|NCT04061512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159192|NCT04061512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92159193|NCT04061512|Antiemetics|antiemetics|mesh-ancestor
92159194|NCT04061512|Autonomic Agents|autonomic agents|mesh-ancestor
92159195|NCT04061512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159196|NCT04061512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92159197|NCT04061512|Glucocorticoids|glucocorticoids|mesh-ancestor
92159199|NCT04061512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92159200|NCT04061512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159201|NCT04036461|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92159202|NCT04036461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402061|NCT01420523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159203|NCT04036461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159204|NCT04019548|Cisplatin|cisplatin|mesh-list
92159205|NCT04019548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159206|NCT04006925|Sodium Oxybate|sodium oxybate|mesh-list
92159207|NCT04006925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92159208|NCT04006925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159209|NCT04006925|Anesthetics, General|anesthetics, general|mesh-ancestor
92159210|NCT04006925|Anesthetics|anesthetics|mesh-ancestor
92159211|NCT04006925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159212|NCT04006925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159213|NCT04002271|Propofol|propofol|mesh-list
92159214|NCT04002271|Sevoflurane|sevoflurane|mesh-list
92159215|NCT04002271|Anesthetics|anesthetics|mesh-ancestor
92159216|NCT04002271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159217|NCT04002271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159218|NCT04002271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92159219|NCT04002271|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159220|NCT04002271|Anesthetics, General|anesthetics, general|mesh-ancestor
92172175|NCT01843556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92159221|NCT04002271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92159222|NCT04002271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92159224|NCT03972592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92159225|NCT03972592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159226|NCT03972592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92159227|NCT03972592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159228|NCT03972592|Antifungal Agents|antifungal agents|mesh-ancestor
92159229|NCT03972592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159230|NCT03972592|Immunologic Factors|immunologic factors|mesh-ancestor
92159231|NCT03972592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159232|NCT03889743|Dexamethasone|dexamethasone|mesh-list
92159233|NCT03889743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92159234|NCT03889743|Antiemetics|antiemetics|mesh-ancestor
92159235|NCT03889743|Autonomic Agents|autonomic agents|mesh-ancestor
92159236|NCT03889743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159237|NCT03889743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159238|NCT03889743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92159239|NCT03889743|Glucocorticoids|glucocorticoids|mesh-ancestor
92159240|NCT03889743|Hormones|hormones|mesh-ancestor
92159241|NCT03889743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92159242|NCT03889743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159243|NCT03889743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159244|NCT03875872|Propofol|propofol|mesh-list
92159245|NCT03875872|Anesthetics|anesthetics|mesh-list
92159246|NCT03875872|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
92159247|NCT03875872|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92159248|NCT03875872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159249|NCT03875872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159250|NCT03875872|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159251|NCT03875872|Anesthetics, General|anesthetics, general|mesh-ancestor
92159252|NCT03871036|Paclitaxel|paclitaxel|mesh-list
92159253|NCT03871036|Durvalumab|durvalumab|mesh-list
92159254|NCT03871036|Tremelimumab|tremelimumab|mesh-list
92159255|NCT03871036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159256|NCT03871036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159257|NCT03871036|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159258|NCT03871036|Antimitotic Agents|antimitotic agents|mesh-ancestor
92391728|NCT01725204|Dasatinib|dasatinib|mesh-list
92159259|NCT03871036|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159260|NCT03871036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159261|NCT03871036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159262|NCT03859908|Ethanol|ethanol|mesh-list
92159263|NCT03859908|Chlorhexidine|chlorhexidine|mesh-list
92159264|NCT03859908|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92159265|NCT03859908|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92159266|NCT03859908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159267|NCT03859908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159268|NCT03859908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159269|NCT03859908|Disinfectants|disinfectants|mesh-ancestor
92159270|NCT03859908|Dermatologic Agents|dermatologic agents|mesh-ancestor
92159271|NCT03825536|Methamphetamine|methamphetamine|mesh-list
92159272|NCT03825536|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92159273|NCT03825536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159274|NCT03825536|Sympathomimetics|sympathomimetics|mesh-ancestor
92159275|NCT03825536|Autonomic Agents|autonomic agents|mesh-ancestor
92159276|NCT03825536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159277|NCT03825536|Dopamine Agents|dopamine agents|mesh-ancestor
92159278|NCT03825536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159279|NCT03825536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159280|NCT03825536|Adrenergic Agents|adrenergic agents|mesh-ancestor
92159281|NCT03825536|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92159282|NCT03825536|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92159283|NCT03825536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159284|NCT03825536|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92159285|NCT03797196|Mycophenolic Acid|mycophenolic acid|mesh-list
92159286|NCT03797196|Everolimus|everolimus|mesh-list
92159287|NCT03797196|Tacrolimus|tacrolimus|mesh-list
92159288|NCT03797196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172242|NCT01328171|Folic Acid|folic acid|mesh-list
92159289|NCT03797196|Immunologic Factors|immunologic factors|mesh-ancestor
92159290|NCT03797196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159291|NCT03797196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92159292|NCT03797196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159293|NCT03797196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159295|NCT03797196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92159296|NCT03797196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159297|NCT03797196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92159298|NCT03797196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92159299|NCT03797196|Antitubercular Agents|antitubercular agents|mesh-ancestor
92159300|NCT03797196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92159301|NCT03797196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159302|NCT03775382|Ascorbic Acid|ascorbic acid|mesh-list
92159303|NCT03775382|Vitamins|vitamins|mesh-ancestor
92159304|NCT03775382|Micronutrients|micronutrients|mesh-ancestor
92159305|NCT03775382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159306|NCT03775382|Antioxidants|antioxidants|mesh-ancestor
92159307|NCT03775382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159308|NCT03775382|Protective Agents|protective agents|mesh-ancestor
92159309|NCT03747432|Dexmedetomidine|dexmedetomidine|mesh-list
92159310|NCT03747432|Propofol|propofol|mesh-list
92159311|NCT03747432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92159312|NCT03747432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159313|NCT03747432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159314|NCT03747432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92159315|NCT03747432|Analgesics|analgesics|mesh-ancestor
92159316|NCT03747432|Sensory System Agents|sensory system agents|mesh-ancestor
92159317|NCT03747432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159318|NCT03747432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92159319|NCT03747432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92159320|NCT03747432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92159321|NCT03747432|Adrenergic Agents|adrenergic agents|mesh-ancestor
92159322|NCT03747432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159323|NCT03747432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159324|NCT03747432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159325|NCT03747432|Anesthetics, General|anesthetics, general|mesh-ancestor
92159326|NCT03747432|Anesthetics|anesthetics|mesh-ancestor
92159327|NCT03724019|Ketamine|ketamine|mesh-list
92159328|NCT03724019|Analgesics|analgesics|mesh-ancestor
92159329|NCT03724019|Sensory System Agents|sensory system agents|mesh-ancestor
92159330|NCT03724019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159331|NCT03724019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159332|NCT03724019|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92159333|NCT03724019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159334|NCT03724019|Anesthetics, General|anesthetics, general|mesh-ancestor
92159335|NCT03724019|Anesthetics|anesthetics|mesh-ancestor
92159336|NCT03724019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159337|NCT03724019|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92159338|NCT03724019|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92159339|NCT03724019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159340|NCT03724019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159342|NCT03697512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159343|NCT03697512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159344|NCT03697512|Immunologic Factors|immunologic factors|mesh-ancestor
92159345|NCT03697512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159346|NCT03697512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159347|NCT03691610|Vaccines|vaccines|mesh-list
92159348|NCT03691610|Immunologic Factors|immunologic factors|mesh-ancestor
92159349|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159350|NCT03686332|Atezolizumab|atezolizumab|mesh-list
92159351|NCT03686332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92159352|NCT03686332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159353|NCT03686332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159354|NCT03686332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159355|NCT03686332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159356|NCT03686332|Immunologic Factors|immunologic factors|mesh-ancestor
92159357|NCT03686332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159358|NCT03683069|Amlodipine|amlodipine|mesh-list
92159359|NCT03683069|Eplerenone|eplerenone|mesh-list
92159360|NCT03683069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92159361|NCT03683069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92159362|NCT03683069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159363|NCT03683069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159364|NCT03683069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92159365|NCT03683069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159366|NCT03683069|Vasodilator Agents|vasodilator agents|mesh-ancestor
92159367|NCT03683069|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92159369|NCT03683069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92159370|NCT03683069|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92159371|NCT03683069|Diuretics|diuretics|mesh-ancestor
92159372|NCT03683069|Natriuretic Agents|natriuretic agents|mesh-ancestor
92159373|NCT03667651|Decanoic acid|decanoic acid|mesh-list
92159374|NCT03667651|Antifungal Agents|antifungal agents|mesh-ancestor
92159375|NCT03667651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159377|NCT03649633|Hydrocortisone|hydrocortisone|mesh-list
92159378|NCT03649633|Micronutrients|micronutrients|mesh-ancestor
92159379|NCT03649633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159380|NCT03649633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92159381|NCT03620903|Rituximab|rituximab|mesh-list
92159382|NCT03620903|Bortezomib|bortezomib|mesh-list
92159383|NCT03620903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159384|NCT03620903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159385|NCT03620903|Immunologic Factors|immunologic factors|mesh-ancestor
92159386|NCT03620903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159387|NCT03620903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159388|NCT03497156|Lercanidipine|lercanidipine|mesh-list
92159389|NCT03497156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92159390|NCT03497156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92159391|NCT03497156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159392|NCT03497156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159393|NCT03497156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92159394|NCT03497156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159395|NCT03471117|Pioglitazone|pioglitazone|mesh-list
92159396|NCT03471117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159397|NCT03471117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159398|NCT03464292|Capsaicin|capsaicin|mesh-list
92159399|NCT03464292|Antipruritics|antipruritics|mesh-ancestor
92159400|NCT03464292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92159401|NCT03464292|Sensory System Agents|sensory system agents|mesh-ancestor
92159402|NCT03464292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159403|NCT03464292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159404|NCT03448718|Olaparib|olaparib|mesh-list
92159405|NCT03448718|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92159406|NCT03448718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159407|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159408|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159409|NCT03435939|Losartan|losartan|mesh-list
92159410|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92159411|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92159412|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92159413|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92159414|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159415|NCT03422393|Venetoclax|venetoclax|mesh-list
92159416|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159417|NCT03385226|Pembrolizumab|pembrolizumab|mesh-list
92159418|NCT03385226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159419|NCT03385226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159420|NCT03385226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159421|NCT03385226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159422|NCT03377543|Aspirin|aspirin|mesh-list
92159424|NCT03377543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92159425|NCT03377543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92159426|NCT03377543|Analgesics|analgesics|mesh-ancestor
92159427|NCT03377543|Sensory System Agents|sensory system agents|mesh-ancestor
92159428|NCT03377543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159429|NCT03377543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159430|NCT03377543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159431|NCT03377543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92159432|NCT03377543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92159433|NCT03377543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159434|NCT03377543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92159435|NCT03377543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92159436|NCT03377543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159437|NCT03377543|Antipyretics|antipyretics|mesh-ancestor
92159438|NCT03365908|Ropivacaine|ropivacaine|mesh-list
92159439|NCT03365908|Anesthetics, Local|anesthetics, local|mesh-ancestor
92159440|NCT03365908|Anesthetics|anesthetics|mesh-ancestor
92159441|NCT03365908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159442|NCT03365908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159443|NCT03365908|Sensory System Agents|sensory system agents|mesh-ancestor
92159444|NCT03365908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172541|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
92159446|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92159447|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92159448|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159449|NCT03362047|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92159450|NCT03337919|Nivolumab|nivolumab|mesh-list
92159451|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159452|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159453|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159454|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159455|NCT03334305|Vaccines|vaccines|mesh-list
92159456|NCT03334305|Immunologic Factors|immunologic factors|mesh-ancestor
92159457|NCT03334305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159458|NCT03236324|Epinephrine|epinephrine|mesh-list
92159459|NCT03236324|Bupivacaine|bupivacaine|mesh-list
92159460|NCT03236324|Anesthetics, Local|anesthetics, local|mesh-ancestor
92159461|NCT03236324|Anesthetics|anesthetics|mesh-ancestor
92159462|NCT03236324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159463|NCT03236324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159464|NCT03236324|Sensory System Agents|sensory system agents|mesh-ancestor
92159465|NCT03236324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159466|NCT03236324|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92159467|NCT03236324|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92159468|NCT03236324|Adrenergic Agents|adrenergic agents|mesh-ancestor
92159469|NCT03236324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159470|NCT03236324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159471|NCT03236324|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92159472|NCT03236324|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92159473|NCT03236324|Autonomic Agents|autonomic agents|mesh-ancestor
92159474|NCT03236324|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92159475|NCT03236324|Respiratory System Agents|respiratory system agents|mesh-ancestor
92159476|NCT03236324|Mydriatics|mydriatics|mesh-ancestor
92159477|NCT03236324|Sympathomimetics|sympathomimetics|mesh-ancestor
92159478|NCT03236324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92159479|NCT03229850|Insulin Lispro|insulin lispro|mesh-list
92159480|NCT03229850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159481|NCT03229850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159482|NCT03229538|Methylprednisolone|methylprednisolone|mesh-list
92159483|NCT03229538|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92159484|NCT03229538|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92159485|NCT03229538|Prednisolone|prednisolone|mesh-list
92159486|NCT03229538|Prednisolone acetate|prednisolone acetate|mesh-list
92159487|NCT03229538|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92159488|NCT03229538|Prednisolone phosphate|prednisolone phosphate|mesh-list
92159489|NCT03229538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92159490|NCT03229538|Antiemetics|antiemetics|mesh-ancestor
92159491|NCT03229538|Autonomic Agents|autonomic agents|mesh-ancestor
92159492|NCT03229538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159493|NCT03229538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159494|NCT03229538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92159495|NCT03229538|Glucocorticoids|glucocorticoids|mesh-ancestor
92159497|NCT03229538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92159498|NCT03229538|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92159499|NCT03229538|Protective Agents|protective agents|mesh-ancestor
92159500|NCT03229538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159501|NCT03229538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159502|NCT03154359|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92159503|NCT03154359|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92159504|NCT03154359|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92159505|NCT03154359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92159506|NCT03154359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159507|NCT03154359|Adrenergic Agents|adrenergic agents|mesh-ancestor
92159508|NCT03154359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159509|NCT03154359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159510|NCT03148795|Talazoparib|talazoparib|mesh-list
92159511|NCT03148795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92159512|NCT03148795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159513|NCT03148795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159514|NCT03148795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159516|NCT03070054|Bupivacaine|bupivacaine|mesh-list
92159517|NCT03070054|Anesthetics, Local|anesthetics, local|mesh-ancestor
92159518|NCT03070054|Anesthetics|anesthetics|mesh-ancestor
92159519|NCT03070054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159520|NCT03070054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159521|NCT03070054|Sensory System Agents|sensory system agents|mesh-ancestor
92159522|NCT03070054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159523|NCT03070054|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92159524|NCT03070054|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92159525|NCT03070054|Adrenergic Agents|adrenergic agents|mesh-ancestor
92159526|NCT03070054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159527|NCT03070054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159528|NCT03070054|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92159529|NCT03070054|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92159530|NCT03070054|Autonomic Agents|autonomic agents|mesh-ancestor
92159531|NCT03070054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92159532|NCT03070054|Respiratory System Agents|respiratory system agents|mesh-ancestor
92159533|NCT03070054|Mydriatics|mydriatics|mesh-ancestor
92159534|NCT03070054|Sympathomimetics|sympathomimetics|mesh-ancestor
92159535|NCT03070054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92159537|NCT03040778|Tocopherols|tocopherols|mesh-list
92159538|NCT03040778|Tocotrienols|tocotrienols|mesh-list
92159539|NCT03040778|alpha-Tocopherol|alpha-tocopherol|mesh-list
92159540|NCT03040778|Pentoxifylline|pentoxifylline|mesh-list
92159541|NCT03040778|Vitamins|vitamins|mesh-ancestor
92159542|NCT03040778|Micronutrients|micronutrients|mesh-ancestor
92159543|NCT03040778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159544|NCT03040778|Antioxidants|antioxidants|mesh-ancestor
92159545|NCT03040778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159546|NCT03040778|Protective Agents|protective agents|mesh-ancestor
92159547|NCT03040778|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92159548|NCT03040778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159549|NCT03040778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92159550|NCT03040778|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92159551|NCT03040778|Vasodilator Agents|vasodilator agents|mesh-ancestor
92159552|NCT03040778|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92159553|NCT03025256|Nivolumab|nivolumab|mesh-list
92159554|NCT03025256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159555|NCT03025256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159556|NCT03025256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92172790|NCT02851303|Morphine|morphine|mesh-list
92159557|NCT03025256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159559|NCT02962414|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92159560|NCT02962414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92159561|NCT02962414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159562|NCT02962414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159563|NCT02962414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159564|NCT02962414|Immunologic Factors|immunologic factors|mesh-ancestor
92159565|NCT02962414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159566|NCT02962414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159567|NCT02959047|Alirocumab|alirocumab|mesh-list
92159568|NCT02959047|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92159569|NCT02959047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92159570|NCT02959047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92159571|NCT02959047|Antimetabolites|antimetabolites|mesh-ancestor
92159572|NCT02959047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159573|NCT02959047|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92159574|NCT02959047|Protease Inhibitors|protease inhibitors|mesh-ancestor
92159575|NCT02959047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173212|NCT01334229|Protease Inhibitors|protease inhibitors|mesh-ancestor
92159576|NCT02959047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92159577|NCT02913313|Nivolumab|nivolumab|mesh-list
92159578|NCT02913313|Ipilimumab|ipilimumab|mesh-list
92173279|NCT01390233|Dinoprostone|dinoprostone|mesh-list
92159579|NCT02913313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159580|NCT02913313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159581|NCT02913313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159582|NCT02913313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159584|NCT02895750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159585|NCT02895750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159586|NCT02895360|Lisavanbulin|lisavanbulin|mesh-list
92173424|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
92159587|NCT02895360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159588|NCT02895360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173499|NCT01335867|Vigabatrin|vigabatrin|mesh-list
92159589|NCT02895360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159590|NCT02895360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159591|NCT02890784|Dasatinib|dasatinib|mesh-list
92159592|NCT02890784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159593|NCT02890784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92159594|NCT02890784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173801|NCT04897854|Folfirinox|folfirinox|mesh-list
92159595|NCT02890784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159597|NCT02863809|Dextrans|dextrans|mesh-list
92159598|NCT02863809|Vitamins|vitamins|mesh-ancestor
92159599|NCT02863809|Micronutrients|micronutrients|mesh-ancestor
92159600|NCT02863809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159601|NCT02863809|Vitamin B Complex|vitamin b complex|mesh-ancestor
92159602|NCT02863809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92159604|NCT02863809|Anticoagulants|anticoagulants|mesh-ancestor
92159605|NCT02863809|Plasma Substitutes|plasma substitutes|mesh-ancestor
92159606|NCT02863809|Blood Substitutes|blood substitutes|mesh-ancestor
92159607|NCT02829957|Rivaroxaban|rivaroxaban|mesh-list
92159608|NCT02829957|Apixaban|apixaban|mesh-list
92159609|NCT02829957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92159610|NCT02829957|Antithrombins|antithrombins|mesh-ancestor
92159611|NCT02829957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92159612|NCT02829957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92159613|NCT02829957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159614|NCT02829957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159615|NCT02829957|Anticoagulants|anticoagulants|mesh-ancestor
92159616|NCT02823028|Nicotine|nicotine|mesh-list
92159617|NCT02823028|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92159618|NCT02823028|Autonomic Agents|autonomic agents|mesh-ancestor
92159619|NCT02823028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159620|NCT02823028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159621|NCT02823028|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92174074|NCT02143219|Irinotecan|irinotecan|mesh-list
92159623|NCT02823028|Cholinergic Agents|cholinergic agents|mesh-ancestor
92159624|NCT02823028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159625|NCT02823028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159626|NCT02785224|Vasopressins|vasopressins|mesh-list
92159627|NCT02785224|Arginine Vasopressin|arginine vasopressin|mesh-list
92159628|NCT02785224|Epinephrine|epinephrine|mesh-list
92159629|NCT02785224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92159631|NCT02785224|Adrenergic Agents|adrenergic agents|mesh-ancestor
92159632|NCT02785224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159633|NCT02785224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159634|NCT02785224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159635|NCT02785224|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92174286|NCT02980835|Glucocorticoids|glucocorticoids|mesh-ancestor
92159636|NCT02785224|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92159637|NCT02785224|Autonomic Agents|autonomic agents|mesh-ancestor
92159638|NCT02785224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159639|NCT02785224|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92174352|NCT04871646|Immunologic Factors|immunologic factors|mesh-ancestor
92159640|NCT02785224|Respiratory System Agents|respiratory system agents|mesh-ancestor
92159641|NCT02785224|Mydriatics|mydriatics|mesh-ancestor
92159642|NCT02785224|Sympathomimetics|sympathomimetics|mesh-ancestor
92159643|NCT02785224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92159644|NCT02785224|Hemostatics|hemostatics|mesh-ancestor
92159645|NCT02785224|Coagulants|coagulants|mesh-ancestor
92159646|NCT02785224|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92159647|NCT02785224|Natriuretic Agents|natriuretic agents|mesh-ancestor
92159649|NCT02768363|Antiviral Agents|antiviral agents|mesh-ancestor
92159650|NCT02768363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159651|NCT02729805|Ketamine|ketamine|mesh-list
92159652|NCT02729805|Analgesics|analgesics|mesh-ancestor
92159653|NCT02729805|Sensory System Agents|sensory system agents|mesh-ancestor
92159654|NCT02729805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159655|NCT02729805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159656|NCT02729805|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92159657|NCT02729805|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159658|NCT02729805|Anesthetics, General|anesthetics, general|mesh-ancestor
92159659|NCT02729805|Anesthetics|anesthetics|mesh-ancestor
92174514|NCT01895257|Leucovorin|leucovorin|mesh-list
92159660|NCT02729805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159661|NCT02729805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92159662|NCT02729805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92159663|NCT02729805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92159664|NCT02729805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159665|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
92159666|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159667|NCT02616666|Dapagliflozin|dapagliflozin|mesh-list
92159668|NCT02616666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92159669|NCT02616666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159670|NCT02616666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92159671|NCT02616666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159672|NCT02582905|Choline|choline|mesh-list
92159673|NCT02582905|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92159674|NCT02582905|Lipotropic Agents|lipotropic agents|mesh-ancestor
92159675|NCT02582905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92159676|NCT02582905|Antimetabolites|antimetabolites|mesh-ancestor
92159677|NCT02582905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159678|NCT02582905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92159679|NCT02582905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92159680|NCT02582905|Nootropic Agents|nootropic agents|mesh-ancestor
92159682|NCT02521311|Antipruritics|antipruritics|mesh-ancestor
92159683|NCT02521311|Dermatologic Agents|dermatologic agents|mesh-ancestor
92159684|NCT02521311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92174848|NCT03047538|Amlodipine|amlodipine|mesh-list
92159685|NCT02521311|Histamine Antagonists|histamine antagonists|mesh-ancestor
92159686|NCT02521311|Histamine Agents|histamine agents|mesh-ancestor
92159687|NCT02521311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174982|NCT04873440|Micronutrients|micronutrients|mesh-ancestor
92159688|NCT02521311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159689|NCT02521311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159690|NCT02521311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92159691|NCT02508038|Zoledronic Acid|zoledronic acid|mesh-list
92175130|NCT03045510|Decitabine|decitabine|mesh-list
92159692|NCT02508038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92159693|NCT02508038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159694|NCT02494258|Azacitidine|azacitidine|mesh-list
92175201|NCT01452659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92159696|NCT02494258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92159697|NCT02494258|Antimetabolites|antimetabolites|mesh-ancestor
92159698|NCT02494258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175274|NCT00580489|Analgesics|analgesics|mesh-ancestor
92159699|NCT02494258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159700|NCT02494258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159701|NCT02437045|Meropenem|meropenem|mesh-list
92159702|NCT02437045|Tazobactam|tazobactam|mesh-list
92159703|NCT02437045|Piperacillin|piperacillin|mesh-list
92159704|NCT02437045|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92159705|NCT02437045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92159706|NCT02437045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92159707|NCT02437045|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92159708|NCT02437045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159709|NCT02437045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159710|NCT02362035|Pembrolizumab|pembrolizumab|mesh-list
92159711|NCT02362035|Acalabrutinib|acalabrutinib|mesh-list
92159712|NCT02362035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159713|NCT02362035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159714|NCT02362035|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92159715|NCT02362035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159716|NCT02328014|Acalabrutinib|acalabrutinib|mesh-list
92159717|NCT02328014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159718|NCT02308527|Cyclophosphamide|cyclophosphamide|mesh-list
92159719|NCT02308527|Temozolomide|temozolomide|mesh-list
92159720|NCT02308527|Bevacizumab|bevacizumab|mesh-list
92159721|NCT02308527|Irinotecan|irinotecan|mesh-list
92159723|NCT02308527|Dinutuximab|dinutuximab|mesh-list
92175709|NCT04776655|Leucovorin|leucovorin|mesh-list
92159724|NCT02308527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159725|NCT02308527|Immunologic Factors|immunologic factors|mesh-ancestor
92159726|NCT02308527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159727|NCT02308527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159728|NCT02308527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159729|NCT02308527|Alkylating Agents|alkylating agents|mesh-ancestor
92175850|NCT01419795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92159730|NCT02308527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159731|NCT02308527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159732|NCT02308527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159733|NCT02308527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159734|NCT02308527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92159735|NCT02308527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92159736|NCT02308527|Growth Substances|growth substances|mesh-ancestor
92159737|NCT02308527|Growth Inhibitors|growth inhibitors|mesh-ancestor
92159738|NCT02308527|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92159739|NCT02308527|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92159740|NCT02308527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159742|NCT02308072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159743|NCT02308072|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92159744|NCT02308072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159745|NCT02308072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159747|NCT02289079|Anesthetics, Local|anesthetics, local|mesh-ancestor
92159748|NCT02289079|Anesthetics|anesthetics|mesh-ancestor
92159749|NCT02289079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159750|NCT02289079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159751|NCT02289079|Sensory System Agents|sensory system agents|mesh-ancestor
92159752|NCT02289079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159753|NCT02213926|Acalabrutinib|acalabrutinib|mesh-list
92159754|NCT02213926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159756|NCT02131753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159757|NCT02131753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159758|NCT02131753|Immunologic Factors|immunologic factors|mesh-ancestor
92159759|NCT02131753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159760|NCT02101788|Tamoxifen|tamoxifen|mesh-list
92159761|NCT02101788|Paclitaxel|paclitaxel|mesh-list
92159762|NCT02101788|Doxorubicin|doxorubicin|mesh-list
92159763|NCT02101788|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92159764|NCT02101788|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92159765|NCT02101788|Letrozole|letrozole|mesh-list
92159766|NCT02101788|Topotecan|topotecan|mesh-list
92159767|NCT02101788|Trametinib|trametinib|mesh-list
92159768|NCT02101788|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92159769|NCT02101788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159770|NCT02101788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159771|NCT02101788|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159772|NCT02101788|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159773|NCT02101788|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159774|NCT02101788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159775|NCT02101788|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92159776|NCT02101788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92159777|NCT02101788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92175990|NCT01421355|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92159778|NCT02101788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159779|NCT02101788|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92159780|NCT02101788|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92159781|NCT02101788|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92159782|NCT02101788|Hormone Antagonists|hormone antagonists|mesh-ancestor
92159783|NCT02101788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176249|NCT01485393|Zolpidem|zolpidem|mesh-list
92159784|NCT02101788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159785|NCT02101788|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92159786|NCT02101788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159787|NCT02101788|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92159788|NCT02101788|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92159789|NCT02101788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92159790|NCT02101788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92159791|NCT02101788|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92159792|NCT02101788|Protective Agents|protective agents|mesh-ancestor
92159793|NCT02101788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92159795|NCT02095132|Irinotecan|irinotecan|mesh-list
92159796|NCT02095132|Camptothecin|camptothecin|mesh-list
92176367|NCT01890863|Xhance|xhance|mesh-list
92159797|NCT02095132|Adavosertib|adavosertib|mesh-list
92159798|NCT02095132|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92159799|NCT02095132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92176394|NCT01891019|Thalidomide|thalidomide|mesh-list
92159800|NCT02095132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159801|NCT02095132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159802|NCT02095132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159803|NCT02095132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159804|NCT02079740|Trametinib|trametinib|mesh-list
92159805|NCT02079740|Navitoclax|navitoclax|mesh-list
92176611|NCT05606107|Hormones|hormones|mesh-ancestor
92159806|NCT02079740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159807|NCT02079740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92176687|NCT02214615|Analgesics|analgesics|mesh-ancestor
92159808|NCT02079740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159809|NCT02079740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159810|NCT02058706|Leuprolide|leuprolide|mesh-list
92159811|NCT02058706|Goserelin|goserelin|mesh-list
92159812|NCT02058706|Bicalutamide|bicalutamide|mesh-list
92159813|NCT02058706|Androgens|androgens|mesh-list
92159814|NCT02058706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92159815|NCT02058706|Fertility Agents|fertility agents|mesh-ancestor
92159816|NCT02058706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92159817|NCT02058706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159818|NCT02058706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159819|NCT02058706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159820|NCT02058706|Hormones|hormones|mesh-ancestor
92159821|NCT02058706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92159822|NCT02058706|Androgen Antagonists|androgen antagonists|mesh-ancestor
92159823|NCT02058706|Hormone Antagonists|hormone antagonists|mesh-ancestor
92159824|NCT02015117|Trametinib|trametinib|mesh-list
92159825|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159826|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92159827|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159828|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159829|NCT01644110|Pomalidomide|pomalidomide|mesh-list
92159830|NCT01644110|Immunologic Factors|immunologic factors|mesh-ancestor
92159831|NCT01644110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159832|NCT01644110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92159833|NCT01644110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92159834|NCT01644110|Growth Substances|growth substances|mesh-ancestor
92159835|NCT01644110|Growth Inhibitors|growth inhibitors|mesh-ancestor
92159836|NCT01644110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159837|NCT01478542|Rituximab|rituximab|mesh-list
92159838|NCT01478542|Vincristine|vincristine|mesh-list
92159839|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159840|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159841|NCT01478542|Immunologic Factors|immunologic factors|mesh-ancestor
92159842|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159843|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92159844|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159845|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159846|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159847|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159848|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159849|NCT01407263|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92159850|NCT01407263|Hemostatics|hemostatics|mesh-list
92159851|NCT01407263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177266|NCT02205515|Everolimus|everolimus|mesh-list
92159853|NCT01406678|Sufentanil|sufentanil|mesh-list
92159854|NCT01406678|Dsuvia|dsuvia|mesh-list
92159855|NCT01406678|Isoflurane|isoflurane|mesh-list
92159856|NCT01406678|Anesthetics|anesthetics|mesh-ancestor
92159857|NCT01406678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159858|NCT01406678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159859|NCT01406678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92159860|NCT01406678|Narcotics|narcotics|mesh-ancestor
92159861|NCT01406678|Analgesics|analgesics|mesh-ancestor
92159862|NCT01406678|Sensory System Agents|sensory system agents|mesh-ancestor
92159863|NCT01406678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92159864|NCT01406678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92159865|NCT01406678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159866|NCT01406678|Anesthetics, General|anesthetics, general|mesh-ancestor
92159867|NCT01406678|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92159868|NCT01397929|Lisavanbulin|lisavanbulin|mesh-list
92159869|NCT01397929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92177462|NCT02062463|Hormones|hormones|mesh-ancestor
92159870|NCT01397929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159871|NCT01397929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92159873|NCT01370330|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92159874|NCT01370330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159876|NCT01370330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159877|NCT01370330|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92159878|NCT00843323|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92159879|NCT00843323|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92159880|NCT00843323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92159881|NCT00715611|Carboplatin|carboplatin|mesh-list
92159882|NCT00715611|Pemetrexed|pemetrexed|mesh-list
92159883|NCT00715611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159884|NCT00715611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159885|NCT00715611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159886|NCT00715611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92402134|NCT01420913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92159887|NCT00715611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92159888|NCT00695214|Propofol|propofol|mesh-list
92159889|NCT00695214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92159890|NCT00695214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92159891|NCT00695214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159892|NCT00695214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92159893|NCT00695214|Anesthetics, General|anesthetics, general|mesh-ancestor
92159894|NCT00695214|Anesthetics|anesthetics|mesh-ancestor
92159895|NCT00678327|Prednisolone|prednisolone|mesh-list
92159896|NCT00678327|Cyclophosphamide|cyclophosphamide|mesh-list
92159897|NCT00678327|Dacarbazine|dacarbazine|mesh-list
92159898|NCT00678327|Doxorubicin|doxorubicin|mesh-list
92177663|NCT00153985|Busulfan|busulfan|mesh-list
92159899|NCT00678327|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92159900|NCT00678327|Etoposide|etoposide|mesh-list
92159901|NCT00678327|Vincristine|vincristine|mesh-list
92159902|NCT00678327|Bleomycin|bleomycin|mesh-list
92159903|NCT00678327|Vinblastine|vinblastine|mesh-list
92159904|NCT00678327|Procarbazine|procarbazine|mesh-list
92159905|NCT00678327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159906|NCT00678327|Immunologic Factors|immunologic factors|mesh-ancestor
92159907|NCT00678327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177881|NCT01189643|Bevacizumab|bevacizumab|mesh-list
92159908|NCT00678327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177947|NCT01064375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159909|NCT00678327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159911|NCT00678327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159912|NCT00678327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159913|NCT00678327|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159914|NCT00678327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92159915|NCT00678327|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92178168|NCT05617950|Salicylates|salicylates|mesh-list
92159916|NCT00678327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92159917|NCT00678327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159918|NCT00678327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92159919|NCT00678327|Tubulin Modulators|tubulin modulators|mesh-ancestor
92159920|NCT00678327|Antimitotic Agents|antimitotic agents|mesh-ancestor
92159921|NCT00678327|Mitosis Modulators|mitosis modulators|mesh-ancestor
92159922|NCT00678327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92159923|NCT00678327|Glucocorticoids|glucocorticoids|mesh-ancestor
92159924|NCT00678327|Hormones|hormones|mesh-ancestor
92159925|NCT00678327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92159926|NCT00678327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159927|NCT00602667|Cyclophosphamide|cyclophosphamide|mesh-list
92159928|NCT00602667|Cisplatin|cisplatin|mesh-list
92159929|NCT00602667|Carboplatin|carboplatin|mesh-list
92159930|NCT00602667|Methotrexate|methotrexate|mesh-list
92159931|NCT00602667|Etoposide|etoposide|mesh-list
92159932|NCT00602667|Etoposide phosphate|etoposide phosphate|mesh-list
92159933|NCT00602667|Vincristine|vincristine|mesh-list
92159934|NCT00602667|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92159936|NCT00602667|Vinblastine|vinblastine|mesh-list
92159937|NCT00602667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92159938|NCT00602667|Immunologic Factors|immunologic factors|mesh-ancestor
92159939|NCT00602667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159941|NCT00602667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159942|NCT00602667|Alkylating Agents|alkylating agents|mesh-ancestor
92159943|NCT00602667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178835|NCT04816968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159944|NCT00602667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92159945|NCT00602667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92159946|NCT00602667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92159947|NCT00602667|Abortifacient Agents|abortifacient agents|mesh-ancestor
92159948|NCT00602667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92159949|NCT00602667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92159950|NCT00602667|Antimetabolites|antimetabolites|mesh-ancestor
92159951|NCT00602667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92159952|NCT00602667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92159984|NCT00569127|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92159985|NCT00544466|Fludarabine|fludarabine|mesh-list
92159986|NCT00544466|Fludarabine phosphate|fludarabine phosphate|mesh-list
92159987|NCT00544466|Melphalan|melphalan|mesh-list
92159988|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178975|NCT00585559|Analgesics|analgesics|mesh-ancestor
92159989|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92159990|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
92159991|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92159993|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
92159994|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92159995|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92159997|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92160047|NCT00492999|Calcium|calcium|mesh-list
92160048|NCT00492999|Levoleucovorin|levoleucovorin|mesh-list
92160049|NCT00492999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160050|NCT00492999|Antiemetics|antiemetics|mesh-ancestor
92160051|NCT00492999|Autonomic Agents|autonomic agents|mesh-ancestor
92160052|NCT00492999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179257|NCT03001635|Oxytocin|oxytocin|mesh-list
92160053|NCT00492999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160054|NCT00492999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92160055|NCT00492999|Glucocorticoids|glucocorticoids|mesh-ancestor
92160056|NCT00492999|Hormones|hormones|mesh-ancestor
92160057|NCT00492999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160058|NCT00492999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92160059|NCT00492999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179413|NCT01531959|Midodrine|midodrine|mesh-list
92160060|NCT00492999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92160061|NCT00492999|Antimetabolites|antimetabolites|mesh-ancestor
92160062|NCT00492999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179479|NCT03006627|Morphine|morphine|mesh-list
92160063|NCT00492999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92160064|NCT00492999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160065|NCT00492999|Immunologic Factors|immunologic factors|mesh-ancestor
92160066|NCT00492999|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92160067|NCT00492999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92160068|NCT00492999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160069|NCT00492999|Antidotes|antidotes|mesh-ancestor
92160070|NCT00492999|Protective Agents|protective agents|mesh-ancestor
92160071|NCT00492999|Vitamin B Complex|vitamin b complex|mesh-ancestor
92160072|NCT00492999|Vitamins|vitamins|mesh-ancestor
92160073|NCT00492999|Micronutrients|micronutrients|mesh-ancestor
92160074|NCT00413439|Isavuconazole|isavuconazole|mesh-list
92160075|NCT00413439|Antifungal Agents|antifungal agents|mesh-ancestor
92160076|NCT00413439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160077|NCT00374075|Valproic Acid|valproic acid|mesh-list
92160078|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
92160079|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179833|NCT04800978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92179908|NCT04790838|Sympathomimetics|sympathomimetics|mesh-ancestor
92160080|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160081|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
92179989|NCT04790136|Cannabidiol|cannabidiol|mesh-list
92160082|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160083|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180095|NCT02219997|Hormones|hormones|mesh-ancestor
92160084|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
92180130|NCT04785768|Morphine|morphine|mesh-list
92160085|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92160086|NCT00374075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160087|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92160088|NCT00309621|Alitretinoin|alitretinoin|mesh-list
92160089|NCT00309621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160090|NCT00309621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160091|NCT00124475|Alitretinoin|alitretinoin|mesh-list
92160092|NCT00124475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160093|NCT00124475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160094|NCT00124436|Alitretinoin|alitretinoin|mesh-list
92160095|NCT00124436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160096|NCT00124436|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160097|NCT00112931|Rituximab|rituximab|mesh-list
92180425|NCT03281811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92160098|NCT00112931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160099|NCT00112931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160100|NCT00112931|Immunologic Factors|immunologic factors|mesh-ancestor
92160101|NCT00112931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160103|NCT00110110|Cyclosporine|cyclosporine|mesh-list
92160104|NCT00110110|Carboplatin|carboplatin|mesh-list
92160105|NCT00110110|Etoposide|etoposide|mesh-list
92160106|NCT00110110|Vincristine|vincristine|mesh-list
92160107|NCT00110110|Cyclosporins|cyclosporins|mesh-list
92160108|NCT00110110|Lenograstim|lenograstim|mesh-list
92160109|NCT00110110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160110|NCT00110110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92160111|NCT00110110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92160112|NCT00110110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92160113|NCT00110110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160114|NCT00110110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160115|NCT00110110|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92160116|NCT00110110|Immunologic Factors|immunologic factors|mesh-ancestor
92160117|NCT00110110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160118|NCT00110110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92180950|NCT00194779|Antimetabolites|antimetabolites|mesh-ancestor
92160119|NCT00110110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92160120|NCT00110110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92160121|NCT00110110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160122|NCT00110110|Antifungal Agents|antifungal agents|mesh-ancestor
92181081|NCT04089072|Oxymetazoline|oxymetazoline|mesh-list
92160123|NCT00110110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160124|NCT00110110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160125|NCT00110110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160126|NCT00110110|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92160127|NCT05307003|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92160129|NCT05307003|Antidepressive Agents|antidepressive agents|mesh-ancestor
92160130|NCT05307003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92160131|NCT05307003|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92160132|NCT05307003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92160133|NCT05307003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160134|NCT05307003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160135|NCT05307003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92160136|NCT05307003|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92160137|NCT05307003|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92160138|NCT05307003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92181522|NCT01946373|Analgesics|analgesics|mesh-ancestor
92160139|NCT05307003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181670|NCT00048737|Antimetabolites|antimetabolites|mesh-ancestor
92160142|NCT05307003|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92160144|NCT03153917|Melatonin|melatonin|mesh-list
92160145|NCT03153917|Antioxidants|antioxidants|mesh-ancestor
92160146|NCT03153917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160147|NCT03153917|Protective Agents|protective agents|mesh-ancestor
92160148|NCT03153917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160149|NCT03153917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160150|NCT03153917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160152|NCT01096875|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92181959|NCT01702233|Dexamethasone|dexamethasone|mesh-list
92160153|NCT01096875|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92160154|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
92160155|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160156|NCT01096875|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92160157|NCT01096875|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92160158|NCT01096875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182215|NCT01666782|Vaccines|vaccines|mesh-list
92160159|NCT01097343|Clopidogrel|clopidogrel|mesh-list
92160160|NCT01097343|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92182254|NCT00061373|Sensory System Agents|sensory system agents|mesh-ancestor
92160161|NCT01097343|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92160162|NCT01097343|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92182323|NCT05547828|Tislelizumab|tislelizumab|mesh-list
92160163|NCT01097343|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92160164|NCT01097343|Purinergic Agents|purinergic agents|mesh-ancestor
92160165|NCT01097343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160166|NCT01097343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160167|NCT01097343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160169|NCT03580187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92160170|NCT03580187|Narcotics|narcotics|mesh-ancestor
92182472|NCT05547516|Gemcitabine|gemcitabine|mesh-list
92160171|NCT03580187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182545|NCT00073073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160172|NCT03580187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160173|NCT03580187|Analgesics|analgesics|mesh-ancestor
92160174|NCT03580187|Sensory System Agents|sensory system agents|mesh-ancestor
92160175|NCT03580187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160176|NCT01098747|Ibuprofen|ibuprofen|mesh-list
92160177|NCT01098747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92160178|NCT01098747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160179|NCT01098747|Analgesics|analgesics|mesh-ancestor
92160180|NCT01098747|Sensory System Agents|sensory system agents|mesh-ancestor
92160181|NCT01098747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160182|NCT01098747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160183|NCT01098747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160184|NCT01098747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160185|NCT01098747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92160186|NCT01098747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182686|NCT01686165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160187|NCT01098747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160188|NCT02085161|Tiotropium Bromide|tiotropium bromide|mesh-list
92160189|NCT02085161|Olodaterol|olodaterol|mesh-list
92160190|NCT02085161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92160191|NCT02085161|Autonomic Agents|autonomic agents|mesh-ancestor
92160192|NCT02085161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160193|NCT02085161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182841|NCT00079001|Calcium|calcium|mesh-list
92160194|NCT02085161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92160195|NCT02085161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160196|NCT02085161|Parasympatholytics|parasympatholytics|mesh-ancestor
92160197|NCT02085161|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92160198|NCT02085161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92160199|NCT02085161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160200|NCT02085161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160201|NCT01034553|Bortezomib|bortezomib|mesh-list
92183111|NCT00145249|Amebicides|amebicides|mesh-ancestor
92160202|NCT01034553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160203|NCT01035333|Orlistat|orlistat|mesh-list
92160204|NCT01035333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160205|NCT01035333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183257|NCT00099047|Celecoxib|celecoxib|mesh-list
92160206|NCT01035333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92160207|NCT01035333|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92160208|NCT05073549|Anti-Infective Agents|anti-infective agents|mesh-list
92160209|NCT05073549|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92160210|NCT03152981|Remifentanil|remifentanil|mesh-list
92160211|NCT03152981|Propofol|propofol|mesh-list
92160212|NCT03152981|Desflurane|desflurane|mesh-list
92160213|NCT03152981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92160214|NCT03152981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160215|NCT03152981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160216|NCT03152981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92160217|NCT03152981|Anesthetics, General|anesthetics, general|mesh-ancestor
92160218|NCT03152981|Anesthetics|anesthetics|mesh-ancestor
92160219|NCT03152981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92160220|NCT03152981|Narcotics|narcotics|mesh-ancestor
92160221|NCT03152981|Analgesics|analgesics|mesh-ancestor
92160222|NCT03152981|Sensory System Agents|sensory system agents|mesh-ancestor
92160223|NCT03152981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160224|NCT03152981|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92160225|NCT05384015|Carboplatin|carboplatin|mesh-list
92160226|NCT05384015|Pembrolizumab|pembrolizumab|mesh-list
92160227|NCT05384015|Etoposide|etoposide|mesh-list
92160228|NCT05384015|Etoposide phosphate|etoposide phosphate|mesh-list
92160229|NCT05384015|Lenvatinib|lenvatinib|mesh-list
92160230|NCT05384015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183838|NCT01729845|Antimetabolites|antimetabolites|mesh-ancestor
92160231|NCT05384015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160232|NCT05384015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92160233|NCT05384015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183983|NCT05536128|Fulvestrant|fulvestrant|mesh-list
92160234|NCT05384015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92160235|NCT05384015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92160236|NCT05384015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92184135|NCT01748643|Glycopyrrolate|glycopyrrolate|mesh-list
92160237|NCT05384015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160238|NCT05384015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92160239|NCT03572387|Azacitidine|azacitidine|mesh-list
92160240|NCT03572387|Tretinoin|tretinoin|mesh-list
92160241|NCT03572387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92160242|NCT03572387|Antimetabolites|antimetabolites|mesh-ancestor
92160243|NCT03572387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160244|NCT03572387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160245|NCT03572387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160246|NCT03572387|Keratolytic Agents|keratolytic agents|mesh-ancestor
92160247|NCT03572387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160249|NCT04728971|Micafungin|micafungin|mesh-list
92160251|NCT04728971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160252|NCT04728971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160253|NCT04728971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160254|NCT03568643|Amoxicillin|amoxicillin|mesh-list
92160255|NCT03568643|Azithromycin|azithromycin|mesh-list
92160256|NCT03568643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92160257|NCT03568643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160258|NCT01100931|Paclitaxel|paclitaxel|mesh-list
92160259|NCT01100931|Carboplatin|carboplatin|mesh-list
92184437|NCT02094443|Ribavirin|ribavirin|mesh-list
92160260|NCT01100931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92160261|NCT01100931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160262|NCT01100931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92160263|NCT01100931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92160264|NCT01100931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92160265|NCT01100931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160266|NCT01101867|Insulin Aspart|insulin aspart|mesh-list
92160267|NCT01101867|Insulin, Long-Acting|insulin, long-acting|mesh-list
92160268|NCT01101867|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92160269|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92160270|NCT01101867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160271|NCT04999449|Scopolamine|scopolamine|mesh-list
92160272|NCT04999449|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92160273|NCT04999449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92160274|NCT04999449|Antiemetics|antiemetics|mesh-ancestor
92160275|NCT04999449|Autonomic Agents|autonomic agents|mesh-ancestor
92160276|NCT04999449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160277|NCT04999449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160278|NCT04999449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92160280|NCT04999449|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92160281|NCT04999449|Cholinergic Agents|cholinergic agents|mesh-ancestor
92160282|NCT04999449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184998|NCT00189137|Ifosfamide|ifosfamide|mesh-list
92185019|NCT02256189|Hormones|hormones|mesh-ancestor
92160283|NCT04999449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160284|NCT04999449|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92160285|NCT04999449|Parasympatholytics|parasympatholytics|mesh-ancestor
92160286|NCT03013959|Pyranoprofen|pyranoprofen|mesh-list
92160287|NCT03013959|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92160288|NCT03013959|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160289|NCT03013959|Analgesics|analgesics|mesh-ancestor
92160290|NCT03013959|Sensory System Agents|sensory system agents|mesh-ancestor
92160291|NCT03013959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160292|NCT03013959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160293|NCT03013959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160294|NCT03013959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160295|NCT03013959|Gout Suppressants|gout suppressants|mesh-ancestor
92160296|NCT02246595|Vilobelimab|vilobelimab|mesh-list
92160297|NCT02246595|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92160298|NCT02246595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160299|NCT02246595|Immunologic Factors|immunologic factors|mesh-ancestor
92160300|NCT02246595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160301|NCT01106859|Zolpidem|zolpidem|mesh-list
92160302|NCT01106859|Zopiclone|zopiclone|mesh-list
92160303|NCT01106859|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92160304|NCT01106859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92160305|NCT01106859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160306|NCT01106859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160307|NCT01106859|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92160308|NCT01106859|GABA Agonists|gaba agonists|mesh-ancestor
92160309|NCT01106859|GABA Agents|gaba agents|mesh-ancestor
92160310|NCT01106859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160311|NCT01106859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160312|NCT01042509|Rituximab|rituximab|mesh-list
92160313|NCT01042509|Alemtuzumab|alemtuzumab|mesh-list
92160314|NCT01042509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160315|NCT01042509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185412|NCT00257309|Tenecteplase|tenecteplase|mesh-list
92160316|NCT01042509|Immunologic Factors|immunologic factors|mesh-ancestor
92160317|NCT01042509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160318|NCT01042509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160320|NCT04814355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92160321|NCT04814355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160323|NCT04814355|Sensory System Agents|sensory system agents|mesh-ancestor
92160324|NCT04814355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402218|NCT01421693|Ceftriaxone|ceftriaxone|mesh-list
92160325|NCT04814355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160326|NCT04814355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185719|NCT05532618|Anesthetics|anesthetics|mesh-ancestor
92160327|NCT04814355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160328|NCT04814355|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92185773|NCT00216125|Docetaxel|docetaxel|mesh-list
92160329|NCT04814355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92160330|NCT04814355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160331|NCT04814355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160332|NCT02179671|Docetaxel|docetaxel|mesh-list
92160333|NCT02179671|Gefitinib|gefitinib|mesh-list
92160334|NCT02179671|Tremelimumab|tremelimumab|mesh-list
92160335|NCT02179671|Osimertinib|osimertinib|mesh-list
92160336|NCT02179671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185917|NCT01830699|Glucocorticoids|glucocorticoids|mesh-ancestor
92160337|NCT02179671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92160338|NCT02179671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92160339|NCT02179671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92160340|NCT02179671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160341|NCT02179671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92160342|NCT02179671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160343|NCT01110135|Dexamethasone|dexamethasone|mesh-list
92186246|NCT04871061|Fentanyl|fentanyl|mesh-list
92160345|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
92160346|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92160347|NCT01110135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160348|NCT01110135|Antiemetics|antiemetics|mesh-ancestor
92160349|NCT01110135|Autonomic Agents|autonomic agents|mesh-ancestor
92186285|NCT00285779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160350|NCT01110135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186355|NCT04058678|Danazol|danazol|mesh-list
92160351|NCT01110135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186432|NCT01847001|Immunologic Factors|immunologic factors|mesh-ancestor
92160352|NCT01110135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92160353|NCT01110135|Glucocorticoids|glucocorticoids|mesh-ancestor
92160354|NCT01110135|Hormones|hormones|mesh-ancestor
92186504|NCT01727193|Immunologic Factors|immunologic factors|mesh-ancestor
92160355|NCT01110135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160356|NCT01110135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92160358|NCT01110135|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92160359|NCT01110135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92186577|NCT01853553|Spironolactone|spironolactone|mesh-list
92160360|NCT01110135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92160361|NCT01110135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160362|NCT01110135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160363|NCT01110135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92160364|NCT01110135|Alkylating Agents|alkylating agents|mesh-ancestor
92160365|NCT01112241|Albuterol|albuterol|mesh-list
92160366|NCT01112241|Tiotropium Bromide|tiotropium bromide|mesh-list
92160367|NCT01112241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92160368|NCT01112241|Autonomic Agents|autonomic agents|mesh-ancestor
92160369|NCT01112241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160370|NCT01112241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160371|NCT01112241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92160372|NCT01112241|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160373|NCT01112241|Parasympatholytics|parasympatholytics|mesh-ancestor
92160374|NCT01112241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92160375|NCT01112241|Cholinergic Agents|cholinergic agents|mesh-ancestor
92160376|NCT01112241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160377|NCT01112241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160378|NCT01112241|Tocolytic Agents|tocolytic agents|mesh-ancestor
92160379|NCT01112241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92160380|NCT01112241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92160381|NCT01112241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92187004|NCT05950061|Dexetimide|dexetimide|mesh-list
92160382|NCT01112241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160383|NCT01112241|Adrenergic Agents|adrenergic agents|mesh-ancestor
92160384|NCT03013881|Trastuzumab|trastuzumab|mesh-list
92187078|NCT05949424|Sunitinib|sunitinib|mesh-list
92160385|NCT03013881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160386|NCT03013881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160387|NCT02174913|Fentanyl|fentanyl|mesh-list
92160388|NCT02174913|Propofol|propofol|mesh-list
92160389|NCT02174913|Atracurium|atracurium|mesh-list
92160390|NCT02174913|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92187306|NCT05656235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160391|NCT02174913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160392|NCT02174913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187540|NCT05310253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187617|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
92187690|NCT05125224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92187801|NCT04750616|Niacinamide|niacinamide|mesh-list
92160393|NCT02174913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92160394|NCT02174913|Anesthetics, General|anesthetics, general|mesh-ancestor
92160395|NCT02174913|Anesthetics|anesthetics|mesh-ancestor
92160396|NCT02174913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92160397|NCT02174913|Narcotics|narcotics|mesh-ancestor
92160398|NCT02174913|Analgesics|analgesics|mesh-ancestor
92160399|NCT02174913|Sensory System Agents|sensory system agents|mesh-ancestor
92160400|NCT02174913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160401|NCT02174913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92187952|NCT04529772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160402|NCT02174913|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92160403|NCT02174913|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92160404|NCT02174913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92160405|NCT02174913|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92160406|NCT02174913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92160407|NCT02174913|Cholinergic Agents|cholinergic agents|mesh-ancestor
92160408|NCT02174913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160409|NCT02174913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160410|NCT01114503|Methylprednisolone|methylprednisolone|mesh-list
92160411|NCT01114503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92188091|NCT04204941|Doxorubicin|doxorubicin|mesh-list
92160412|NCT01114503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92160413|NCT01114503|Prednisolone|prednisolone|mesh-list
92160414|NCT01114503|Prednisolone acetate|prednisolone acetate|mesh-list
92160415|NCT01114503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92160416|NCT01114503|Prednisolone phosphate|prednisolone phosphate|mesh-list
92160417|NCT01114503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160418|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
92160420|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160421|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160422|NCT01114503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92160423|NCT01114503|Glucocorticoids|glucocorticoids|mesh-ancestor
92160424|NCT01114503|Hormones|hormones|mesh-ancestor
92160425|NCT01114503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160426|NCT01114503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92160427|NCT01114503|Protective Agents|protective agents|mesh-ancestor
92160428|NCT01114503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92160430|NCT03015831|Colchicine|colchicine|mesh-list
92188601|NCT02320435|Trastuzumab|trastuzumab|mesh-list
92160431|NCT03015831|Gout Suppressants|gout suppressants|mesh-ancestor
92160432|NCT03015831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160433|NCT03015831|Tubulin Modulators|tubulin modulators|mesh-ancestor
92160434|NCT03015831|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188755|NCT00334633|Tinidazole|tinidazole|mesh-list
92160435|NCT03015831|Mitosis Modulators|mitosis modulators|mesh-ancestor
92160436|NCT03015831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160437|NCT03015831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160438|NCT01114581|Phenylpropanolamine|phenylpropanolamine|mesh-list
92188891|NCT00553059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92160440|NCT01114581|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92160441|NCT01114581|Expectorants|expectorants|mesh-ancestor
92160442|NCT01114581|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160443|NCT01114581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92189040|NCT00552279|Vaccines|vaccines|mesh-list
92160444|NCT01114581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160445|NCT01114581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92160446|NCT01114581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160447|NCT01114581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189186|NCT05265793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160448|NCT01114581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160449|NCT01114581|Appetite Depressants|appetite depressants|mesh-ancestor
92160450|NCT01114581|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92160452|NCT01114581|Autonomic Agents|autonomic agents|mesh-ancestor
92189331|NCT00353431|Insulin Aspart|insulin aspart|mesh-list
92160453|NCT01114581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160454|NCT01114581|Nasal Decongestants|nasal decongestants|mesh-ancestor
92160455|NCT01114581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92160456|NCT01114893|Travoprost|travoprost|mesh-list
92160457|NCT01114893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92160458|NCT01114971|Labetalol|labetalol|mesh-list
92160459|NCT01114971|Fentanyl|fentanyl|mesh-list
92160460|NCT01114971|Esmolol|esmolol|mesh-list
92160461|NCT01114971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92160462|NCT01114971|Narcotics|narcotics|mesh-ancestor
92160463|NCT01114971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160464|NCT01114971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160465|NCT01114971|Analgesics|analgesics|mesh-ancestor
92160466|NCT01114971|Sensory System Agents|sensory system agents|mesh-ancestor
92160467|NCT01114971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160468|NCT01114971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92160469|NCT01114971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92160470|NCT01114971|Anesthetics, General|anesthetics, general|mesh-ancestor
92160471|NCT01114971|Anesthetics|anesthetics|mesh-ancestor
92160472|NCT01114971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92160473|NCT01114971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92160474|NCT01114971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92160475|NCT01114971|Adrenergic Agents|adrenergic agents|mesh-ancestor
92160476|NCT01114971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160477|NCT01114971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160478|NCT01114971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92160480|NCT01114971|Autonomic Agents|autonomic agents|mesh-ancestor
92160481|NCT01114971|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92160482|NCT01114971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92160483|NCT01044693|Metoprolol|metoprolol|mesh-list
92160484|NCT01044693|Nebivolol|nebivolol|mesh-list
92160485|NCT01044693|Sildenafil Citrate|sildenafil citrate|mesh-list
92160486|NCT01044693|Vasodilator Agents|vasodilator agents|mesh-ancestor
92160487|NCT01044693|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92160488|NCT01044693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92160489|NCT01044693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189473|NCT00550953|Vasodilator Agents|vasodilator agents|mesh-ancestor
92160490|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160491|NCT01044693|Urological Agents|urological agents|mesh-ancestor
92160492|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92160493|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92160494|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
92160495|NCT01044693|Autonomic Agents|autonomic agents|mesh-ancestor
92160496|NCT01044693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160497|NCT01044693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160498|NCT01044693|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92160499|NCT01044693|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92160500|NCT01044693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92160501|NCT01044693|Adrenergic Agents|adrenergic agents|mesh-ancestor
92160502|NCT01044693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160504|NCT01044693|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92160505|NCT01044693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160506|NCT01115517|Bevacizumab|bevacizumab|mesh-list
92160507|NCT01115517|Mitomycins|mitomycins|mesh-list
92160508|NCT01115517|Mitomycin|mitomycin|mesh-list
92160509|NCT01115517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160510|NCT01115517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160511|NCT01115517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92160512|NCT01115517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92160513|NCT01115517|Growth Substances|growth substances|mesh-ancestor
92160514|NCT01115517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160515|NCT01115517|Growth Inhibitors|growth inhibitors|mesh-ancestor
92160516|NCT01115517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92160517|NCT01115517|Alkylating Agents|alkylating agents|mesh-ancestor
92160518|NCT01115517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160519|NCT01115517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92160520|NCT01115517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160521|NCT03015675|Ascorbic Acid|ascorbic acid|mesh-list
92160522|NCT03015675|Vitamins|vitamins|mesh-ancestor
92160523|NCT03015675|Micronutrients|micronutrients|mesh-ancestor
92160524|NCT03015675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160525|NCT03015675|Antioxidants|antioxidants|mesh-ancestor
92160526|NCT03015675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160527|NCT03015675|Protective Agents|protective agents|mesh-ancestor
92160529|NCT01044771|Raltegravir Potassium|raltegravir potassium|mesh-list
92160530|NCT01044771|Antiviral Agents|antiviral agents|mesh-ancestor
92160531|NCT01044771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160532|NCT01044771|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92160533|NCT01044771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92160534|NCT01044771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160535|NCT01044771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160536|NCT01044771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92160537|NCT01044771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92160538|NCT01044771|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92160539|NCT01044771|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92160540|NCT01115673|Acetaminophen|acetaminophen|mesh-list
92160541|NCT01115673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160542|NCT01115673|Analgesics|analgesics|mesh-ancestor
92160543|NCT01115673|Sensory System Agents|sensory system agents|mesh-ancestor
92160544|NCT01115673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160545|NCT01115673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160546|NCT01115673|Antipyretics|antipyretics|mesh-ancestor
92160547|NCT01116921|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92160548|NCT01116921|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160549|NCT04582383|Doxycycline|doxycycline|mesh-list
92160550|NCT04582383|Spironolactone|spironolactone|mesh-list
92160551|NCT04582383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92160552|NCT04582383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160553|NCT04582383|Antimalarials|antimalarials|mesh-ancestor
92160554|NCT04582383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92160555|NCT04582383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92160556|NCT04582383|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92160557|NCT04582383|Hormone Antagonists|hormone antagonists|mesh-ancestor
92160558|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160559|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160560|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92160561|NCT04582383|Diuretics|diuretics|mesh-ancestor
92160562|NCT04582383|Natriuretic Agents|natriuretic agents|mesh-ancestor
92160564|NCT01118091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160565|NCT01118091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92160566|NCT01118091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92160567|NCT01118091|Antiviral Agents|antiviral agents|mesh-ancestor
92160568|NCT01118091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160569|NCT01045551|Apremilast|apremilast|mesh-list
92160570|NCT01045551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92160571|NCT01045551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160572|NCT01045551|Analgesics|analgesics|mesh-ancestor
92160573|NCT01045551|Sensory System Agents|sensory system agents|mesh-ancestor
92160574|NCT01045551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160575|NCT01045551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160576|NCT01045551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160577|NCT01045551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160578|NCT01045551|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92160580|NCT01045551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160581|NCT01045551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160582|NCT01047189|Clindamycin|clindamycin|mesh-list
92160583|NCT01047189|Clindamycin palmitate|clindamycin palmitate|mesh-list
92160584|NCT01047189|Clindamycin phosphate|clindamycin phosphate|mesh-list
92160585|NCT01047189|Tretinoin|tretinoin|mesh-list
92160586|NCT01047189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92160587|NCT01047189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160588|NCT01047189|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92160589|NCT01047189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160590|NCT01047189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160591|NCT01047189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160592|NCT01047189|Keratolytic Agents|keratolytic agents|mesh-ancestor
92160593|NCT01047189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160594|NCT03380559|Botulinum Toxins|botulinum toxins|mesh-list
92160595|NCT03380559|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92160596|NCT03380559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92160597|NCT03380559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160598|NCT03380559|Cholinergic Agents|cholinergic agents|mesh-ancestor
92160599|NCT03380559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160600|NCT03380559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160601|NCT03012945|Anesthetics|anesthetics|mesh-list
92160602|NCT03012945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160603|NCT03012945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160604|NCT01121211|Testosterone|testosterone|mesh-list
92160605|NCT01121211|Androgens|androgens|mesh-ancestor
92160606|NCT01121211|Hormones|hormones|mesh-ancestor
92160607|NCT01121211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160608|NCT01121211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160609|NCT01162551|Sirolimus|sirolimus|mesh-list
92160610|NCT01162551|Methotrexate|methotrexate|mesh-list
92160611|NCT01162551|Temsirolimus|temsirolimus|mesh-list
92160612|NCT01162551|MTOR Inhibitors|mtor inhibitors|mesh-list
92160613|NCT01162551|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92160614|NCT01162551|Abortifacient Agents|abortifacient agents|mesh-ancestor
92160615|NCT01162551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92160616|NCT01162551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160617|NCT01162551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92160618|NCT01162551|Antimetabolites|antimetabolites|mesh-ancestor
92160619|NCT01162551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160620|NCT01162551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160621|NCT01162551|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160622|NCT01162551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160624|NCT01162551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160625|NCT01162551|Immunologic Factors|immunologic factors|mesh-ancestor
92160626|NCT01162551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160627|NCT01162551|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92160628|NCT01162551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92160629|NCT01162551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160630|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92160631|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
92160632|NCT01162551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92160633|NCT01163097|Heparin|heparin|mesh-list
92160634|NCT01163097|Anticoagulants|anticoagulants|mesh-ancestor
92160635|NCT01163097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92160636|NCT01163097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92160637|NCT01163097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160639|NCT03013101|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92160640|NCT03013101|Immunologic Factors|immunologic factors|mesh-ancestor
92160641|NCT03013101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160642|NCT03088137|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92160643|NCT03088137|Hormones|hormones|mesh-ancestor
92160644|NCT03088137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160645|NCT03088137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160646|NCT01165047|Nitric Oxide|nitric oxide|mesh-list
92160647|NCT01165047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92160648|NCT01165047|Autonomic Agents|autonomic agents|mesh-ancestor
92160649|NCT01165047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160650|NCT01165047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160651|NCT01165047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92160652|NCT01165047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160653|NCT01165047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92160654|NCT01165047|Antioxidants|antioxidants|mesh-ancestor
92160655|NCT01165047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190122|NCT00354887|Capecitabine|capecitabine|mesh-list
92160656|NCT01165047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160657|NCT01165047|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92160658|NCT01165047|Vasodilator Agents|vasodilator agents|mesh-ancestor
92160659|NCT01165047|Gasotransmitters|gasotransmitters|mesh-ancestor
92160660|NCT01165047|Protective Agents|protective agents|mesh-ancestor
92160661|NCT01166997|Heparin|heparin|mesh-list
92160662|NCT01166997|Calcium heparin|calcium heparin|mesh-list
92160663|NCT01166997|Anticoagulants|anticoagulants|mesh-ancestor
92160664|NCT01166997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92160665|NCT01166997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92160666|NCT01166997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160667|NCT02802969|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92160668|NCT02802969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92160669|NCT02802969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160670|NCT01170117|Olanzapine|olanzapine|mesh-list
92160671|NCT01170117|Antiemetics|antiemetics|mesh-ancestor
92160672|NCT01170117|Autonomic Agents|autonomic agents|mesh-ancestor
92160673|NCT01170117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190340|NCT00356993|Nicotine|nicotine|mesh-list
92160674|NCT01170117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160675|NCT01170117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92160676|NCT01170117|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92160677|NCT01170117|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92160678|NCT01170117|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160679|NCT01170117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92160680|NCT01170117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92160681|NCT01170117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92190466|NCT01794533|Racepinephrine|racepinephrine|mesh-list
92160682|NCT01170117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92160683|NCT01170117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160684|NCT01170117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160685|NCT01170117|Serotonin Agents|serotonin agents|mesh-ancestor
92160686|NCT01172145|Modafinil|modafinil|mesh-list
92160687|NCT01172145|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92160688|NCT01172145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160689|NCT01172145|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92160690|NCT01172145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92160691|NCT01172145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92160692|NCT01172145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160693|NCT01175343|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92160694|NCT01175343|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92160695|NCT01175343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160696|NCT01175343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160697|NCT01176435|Levodopa|levodopa|mesh-list
92160698|NCT01176435|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92402254|NCT01421914|Bupivacaine|bupivacaine|mesh-list
92160699|NCT01176435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92160700|NCT01176435|Dopamine Agents|dopamine agents|mesh-ancestor
92160701|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160702|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160703|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160704|NCT01176591|Aprepitant|aprepitant|mesh-list
92160705|NCT01176591|Fosaprepitant|fosaprepitant|mesh-list
92160706|NCT01176591|Antiemetics|antiemetics|mesh-ancestor
92160707|NCT01176591|Autonomic Agents|autonomic agents|mesh-ancestor
92160708|NCT01176591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160709|NCT01176591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160710|NCT01176591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92160711|NCT01176591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92160712|NCT01176591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160713|NCT01176591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160714|NCT01176981|Methotrexate|methotrexate|mesh-list
92160715|NCT01176981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92160716|NCT01176981|Abortifacient Agents|abortifacient agents|mesh-ancestor
92160717|NCT01176981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92160718|NCT01176981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160719|NCT01176981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92160720|NCT01176981|Antimetabolites|antimetabolites|mesh-ancestor
92160721|NCT01176981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160722|NCT01176981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160723|NCT01176981|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160724|NCT01176981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160725|NCT01176981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92160726|NCT01176981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160727|NCT01176981|Immunologic Factors|immunologic factors|mesh-ancestor
92160728|NCT01176981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160729|NCT01176981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92160730|NCT01126593|Bupivacaine|bupivacaine|mesh-list
92160731|NCT01126593|Anesthetics, Local|anesthetics, local|mesh-ancestor
92160732|NCT01126593|Anesthetics|anesthetics|mesh-ancestor
92160733|NCT01126593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160734|NCT01126593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160735|NCT01126593|Sensory System Agents|sensory system agents|mesh-ancestor
92160736|NCT01126593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160737|NCT01181349|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92160738|NCT01181349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92160739|NCT01181349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160740|NCT01181349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160741|NCT01126671|Vitamin D|vitamin d|mesh-list
92160742|NCT01126671|Vitamins|vitamins|mesh-ancestor
92160743|NCT01126671|Micronutrients|micronutrients|mesh-ancestor
92160744|NCT01126671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160745|NCT01126671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92160746|NCT01182675|Plerixafor|plerixafor|mesh-list
92160747|NCT01182675|Alemtuzumab|alemtuzumab|mesh-list
92160748|NCT01182675|Lenograstim|lenograstim|mesh-list
92160749|NCT01182675|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92160750|NCT01182675|Immunologic Factors|immunologic factors|mesh-ancestor
92160751|NCT01182675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160752|NCT01182675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160753|NCT01182675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160754|NCT01182675|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92160755|NCT01182675|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92191074|NCT03562975|Ocrelizumab|ocrelizumab|mesh-list
92160757|NCT01182675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160758|NCT01129245|Celecoxib|celecoxib|mesh-list
92160759|NCT01129245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92160760|NCT01129245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160761|NCT01129245|Analgesics|analgesics|mesh-ancestor
92160762|NCT01129245|Sensory System Agents|sensory system agents|mesh-ancestor
92160763|NCT01129245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160764|NCT01129245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160765|NCT01129245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160766|NCT01129245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160767|NCT01129245|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92402284|NCT01421992|Methylphenidate|methylphenidate|mesh-list
92160768|NCT01129245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92160769|NCT01129245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160770|NCT01129245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160771|NCT01183533|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92160772|NCT01183533|Plasminogen|plasminogen|mesh-list
92160773|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92160774|NCT01183533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92160775|NCT01183533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191268|NCT00374231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92160777|NCT01188369|Simendan|simendan|mesh-list
92160778|NCT01188369|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92160779|NCT01188369|Vasodilator Agents|vasodilator agents|mesh-ancestor
92160780|NCT01188369|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92160781|NCT01188369|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92160782|NCT01188369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160783|NCT01188369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160784|NCT01188369|Protective Agents|protective agents|mesh-ancestor
92160785|NCT01188369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160786|NCT01135329|Mycophenolic Acid|mycophenolic acid|mesh-list
92160787|NCT01135329|Cyclophosphamide|cyclophosphamide|mesh-list
92160788|NCT01135329|Busulfan|busulfan|mesh-list
92160789|NCT01135329|Fludarabine|fludarabine|mesh-list
92160790|NCT01135329|Tacrolimus|tacrolimus|mesh-list
92160791|NCT01135329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160792|NCT01135329|Immunologic Factors|immunologic factors|mesh-ancestor
92160793|NCT01135329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160794|NCT01135329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160795|NCT01135329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92160796|NCT01135329|Alkylating Agents|alkylating agents|mesh-ancestor
92160797|NCT01135329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160798|NCT01135329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160799|NCT01135329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92160800|NCT01135329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92160801|NCT01135329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160802|NCT01135329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92160803|NCT01135329|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92160804|NCT01135329|Antitubercular Agents|antitubercular agents|mesh-ancestor
92160805|NCT01135329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92160806|NCT01135329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160807|NCT03012009|Lidocaine|lidocaine|mesh-list
92160808|NCT03012009|Epinephrine|epinephrine|mesh-list
92160809|NCT03012009|Racepinephrine|racepinephrine|mesh-list
92160810|NCT03012009|Anesthetics, Local|anesthetics, local|mesh-list
92160811|NCT03012009|Anesthetics|anesthetics|mesh-list
92160812|NCT03012009|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92160813|NCT03012009|Epinephryl borate|epinephryl borate|mesh-list
92160814|NCT03012009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92160815|NCT03012009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160816|NCT03012009|Sensory System Agents|sensory system agents|mesh-ancestor
92160817|NCT03012009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160818|NCT03012009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92160819|NCT03012009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92160820|NCT03012009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92160821|NCT03012009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92160822|NCT03012009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160823|NCT03012009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92160824|NCT03012009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160825|NCT03012009|Adrenergic Agents|adrenergic agents|mesh-ancestor
92160826|NCT03012009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160827|NCT03012009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92160828|NCT03012009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92160829|NCT03012009|Autonomic Agents|autonomic agents|mesh-ancestor
92160830|NCT03012009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92160831|NCT03012009|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160833|NCT03012009|Sympathomimetics|sympathomimetics|mesh-ancestor
92160834|NCT03012009|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92160835|NCT03012009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92160836|NCT03012009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92160837|NCT04403555|Ivermectin|ivermectin|mesh-list
92160838|NCT04403555|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92160839|NCT04403555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160840|NCT03565835|Prednisone|prednisone|mesh-list
92160841|NCT03565835|Abiraterone Acetate|abiraterone acetate|mesh-list
92160842|NCT03565835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160843|NCT03565835|Glucocorticoids|glucocorticoids|mesh-ancestor
92160844|NCT03565835|Hormones|hormones|mesh-ancestor
92191522|NCT00407381|Growth Inhibitors|growth inhibitors|mesh-ancestor
92160845|NCT03565835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160846|NCT03565835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160847|NCT03565835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92160849|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92160850|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160851|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160852|NCT03565835|Hormone Antagonists|hormone antagonists|mesh-ancestor
92160853|NCT03565835|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92160855|NCT01624259|Liraglutide|liraglutide|mesh-list
92160856|NCT01624259|Dulaglutide|dulaglutide|mesh-list
92160857|NCT01624259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92160858|NCT01624259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160859|NCT01624259|Incretins|incretins|mesh-ancestor
92160860|NCT01624259|Hormones|hormones|mesh-ancestor
92182560|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160861|NCT01624259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160862|NCT02081183|Mycophenolic Acid|mycophenolic acid|mesh-list
92160863|NCT02081183|Prednisone|prednisone|mesh-list
92160864|NCT02081183|Cyclophosphamide|cyclophosphamide|mesh-list
92160865|NCT02081183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160866|NCT02081183|Immunologic Factors|immunologic factors|mesh-ancestor
92160867|NCT02081183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160868|NCT02081183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160869|NCT02081183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92160870|NCT02081183|Alkylating Agents|alkylating agents|mesh-ancestor
92182561|NCT00075335|Plerixafor|plerixafor|mesh-list
92160871|NCT02081183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160873|NCT02081183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92160874|NCT02081183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160875|NCT02081183|Glucocorticoids|glucocorticoids|mesh-ancestor
92160876|NCT02081183|Hormones|hormones|mesh-ancestor
92160877|NCT02081183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160878|NCT02081183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92160879|NCT02081183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92160880|NCT02081183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92160881|NCT02081183|Antitubercular Agents|antitubercular agents|mesh-ancestor
92160882|NCT02081183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191925|NCT00414167|Dopamine Agents|dopamine agents|mesh-ancestor
92160883|NCT02081183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160884|NCT02081183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160885|NCT02080403|Chlorhexidine|chlorhexidine|mesh-list
92160886|NCT02080403|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92182562|NCT00075335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92160887|NCT02080403|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92160888|NCT02080403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160889|NCT02080403|Disinfectants|disinfectants|mesh-ancestor
92160891|NCT02079077|Aspirin|aspirin|mesh-list
92160892|NCT02079077|Hydroxychloroquine|hydroxychloroquine|mesh-list
92160893|NCT02079077|Antimalarials|antimalarials|mesh-ancestor
92160894|NCT02079077|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92160895|NCT02079077|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92160896|NCT02079077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92160897|NCT02079077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160898|NCT02079077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160899|NCT02079077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160900|NCT02079077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92160901|NCT02079077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92160902|NCT02079077|Analgesics|analgesics|mesh-ancestor
92160903|NCT02079077|Sensory System Agents|sensory system agents|mesh-ancestor
92192207|NCT02108171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160904|NCT02079077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192266|NCT00536341|Growth Substances|growth substances|mesh-ancestor
92160905|NCT02079077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160907|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92160908|NCT02079077|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92160909|NCT02079077|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92160910|NCT02079077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92182563|NCT00075335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92182564|NCT00075335|Antiviral Agents|antiviral agents|mesh-ancestor
92160913|NCT03547271|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92160914|NCT03547271|Immunologic Factors|immunologic factors|mesh-ancestor
92160915|NCT03547271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160916|NCT03547115|Venetoclax|venetoclax|mesh-list
92160917|NCT03547115|Voruciclib|voruciclib|mesh-list
92192713|NCT00490009|Antipyretics|antipyretics|mesh-ancestor
92160918|NCT03547115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160919|NCT03547115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92160920|NCT03547115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160921|NCT03547115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160922|NCT01191255|Sevelamer|sevelamer|mesh-list
92160923|NCT01191255|Chelating Agents|chelating agents|mesh-ancestor
92160924|NCT01191255|Sequestering Agents|sequestering agents|mesh-ancestor
92160925|NCT01191255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160926|NCT02078219|Allopurinol|allopurinol|mesh-list
92160927|NCT02078219|Verinurad|verinurad|mesh-list
92160928|NCT02078219|Antimetabolites|antimetabolites|mesh-ancestor
92160929|NCT02078219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160930|NCT02078219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160931|NCT02078219|Gout Suppressants|gout suppressants|mesh-ancestor
92160932|NCT02078219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92160933|NCT02078219|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92160934|NCT02078219|Antioxidants|antioxidants|mesh-ancestor
92160935|NCT02078219|Protective Agents|protective agents|mesh-ancestor
92160936|NCT02078219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160937|NCT03536039|Prednisone|prednisone|mesh-list
92160938|NCT03536039|Cyclophosphamide|cyclophosphamide|mesh-list
92160939|NCT03536039|Rituximab|rituximab|mesh-list
92160940|NCT03536039|Doxorubicin|doxorubicin|mesh-list
92160941|NCT03536039|Vincristine|vincristine|mesh-list
92160942|NCT03536039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92160943|NCT03536039|Immunologic Factors|immunologic factors|mesh-ancestor
92160944|NCT03536039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160945|NCT03536039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193072|NCT03590912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160946|NCT03536039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92160947|NCT03536039|Alkylating Agents|alkylating agents|mesh-ancestor
92160948|NCT03536039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160949|NCT03536039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193149|NCT00506155|Bevacizumab|bevacizumab|mesh-list
92160950|NCT03536039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92160951|NCT03536039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160952|NCT03536039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92160953|NCT03536039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92160954|NCT03536039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92160955|NCT03536039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92160956|NCT03536039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92160957|NCT03536039|Glucocorticoids|glucocorticoids|mesh-ancestor
92160958|NCT03536039|Hormones|hormones|mesh-ancestor
92160959|NCT03536039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92160960|NCT03536039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193434|NCT00216476|Risperidone|risperidone|mesh-list
92160961|NCT03536039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92160962|NCT03536039|Tubulin Modulators|tubulin modulators|mesh-ancestor
92160963|NCT03536039|Antimitotic Agents|antimitotic agents|mesh-ancestor
92160964|NCT03536039|Mitosis Modulators|mitosis modulators|mesh-ancestor
92160965|NCT02075255|Benralizumab|benralizumab|mesh-list
92160966|NCT02075255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92160967|NCT02075255|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160968|NCT03532217|Nivolumab|nivolumab|mesh-list
92160969|NCT03532217|Ipilimumab|ipilimumab|mesh-list
92160970|NCT03532217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92160971|NCT03532217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92160972|NCT03532217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92160973|NCT03532217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160974|NCT03529487|Phenylephrine|phenylephrine|mesh-list
92160975|NCT03529487|Oxymetazoline|oxymetazoline|mesh-list
92193959|NCT04027166|Methadone|methadone|mesh-list
92160976|NCT03529487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92160977|NCT03529487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92160978|NCT03529487|Adrenergic Agents|adrenergic agents|mesh-ancestor
92160979|NCT03529487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160980|NCT03529487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160981|NCT03529487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160982|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
92160983|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
92160984|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92160985|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
92160986|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92160987|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92160988|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92194169|NCT00477191|Etanercept|etanercept|mesh-list
92160990|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92160991|NCT03529487|Protective Agents|protective agents|mesh-ancestor
92160992|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92160993|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
92160994|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92160995|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92160996|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92160997|NCT03527927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92160998|NCT03527147|Rituximab|rituximab|mesh-list
92161000|NCT03527147|Acalabrutinib|acalabrutinib|mesh-list
92161001|NCT03527147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161002|NCT03527147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161003|NCT03527147|Immunologic Factors|immunologic factors|mesh-ancestor
92161004|NCT03527147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161005|NCT03527147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161006|NCT03527069|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92161007|NCT03527069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92161008|NCT03527069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92161009|NCT03527069|Antimetabolites|antimetabolites|mesh-ancestor
92161010|NCT03527069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161011|NCT03527069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92161012|NCT03527069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92161013|NCT03527069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161014|NCT01677611|Resveratrol|resveratrol|mesh-list
92161015|NCT01677611|Antioxidants|antioxidants|mesh-ancestor
92161016|NCT01677611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161017|NCT01677611|Protective Agents|protective agents|mesh-ancestor
92161018|NCT01677611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161020|NCT01677611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92161021|NCT03518801|Cannabidiol|cannabidiol|mesh-list
92161022|NCT03518801|Anticonvulsants|anticonvulsants|mesh-ancestor
92161023|NCT01191723|Moxifloxacin|moxifloxacin|mesh-list
92195073|NCT00555321|Abatacept|abatacept|mesh-list
92161024|NCT01191723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92161025|NCT01191723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161026|NCT01191723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92161027|NCT01191723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161029|NCT01191723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161030|NCT01191723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161031|NCT01193049|Prednisone|prednisone|mesh-list
92161032|NCT01193049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161033|NCT01193049|Glucocorticoids|glucocorticoids|mesh-ancestor
92161034|NCT01193049|Hormones|hormones|mesh-ancestor
92161035|NCT01193049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161036|NCT01193049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161037|NCT01193049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161038|NCT01193049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161040|NCT01679951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92161041|NCT01679951|Abortifacient Agents|abortifacient agents|mesh-ancestor
92161042|NCT01679951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195402|NCT00615433|Olanzapine|olanzapine|mesh-list
92161043|NCT01679951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161044|NCT01679951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161045|NCT01679951|Antimetabolites|antimetabolites|mesh-ancestor
92161046|NCT01679951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195552|NCT03589898|Gabapentin|gabapentin|mesh-list
92161047|NCT01679951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161048|NCT01679951|Dermatologic Agents|dermatologic agents|mesh-ancestor
92161049|NCT01679951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161050|NCT01679951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92195612|NCT00578071|Oxaliplatin|oxaliplatin|mesh-list
92161051|NCT01679951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161052|NCT01679951|Immunologic Factors|immunologic factors|mesh-ancestor
92161053|NCT01679951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161054|NCT01679951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92161055|NCT03514589|Cosyntropin|cosyntropin|mesh-list
92161056|NCT03514589|Hormones|hormones|mesh-ancestor
92161057|NCT03514589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161058|NCT03514589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161059|NCT01194297|Vaccines|vaccines|mesh-list
92161060|NCT01194297|Immunologic Factors|immunologic factors|mesh-ancestor
92161061|NCT01194297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161062|NCT01194453|Folic Acid|folic acid|mesh-list
92161063|NCT01194453|Vitamin B 12|vitamin b 12|mesh-list
92161064|NCT01194453|Dexamethasone|dexamethasone|mesh-list
92161065|NCT01194453|Cisplatin|cisplatin|mesh-list
92161066|NCT01194453|Gemcitabine|gemcitabine|mesh-list
92161067|NCT01194453|Vitamins|vitamins|mesh-ancestor
92161068|NCT01194453|Micronutrients|micronutrients|mesh-ancestor
92161069|NCT01194453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161070|NCT01194453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161071|NCT01194453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161072|NCT01194453|Antiemetics|antiemetics|mesh-ancestor
92161073|NCT01194453|Autonomic Agents|autonomic agents|mesh-ancestor
92161074|NCT01194453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161075|NCT01194453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92161076|NCT01194453|Glucocorticoids|glucocorticoids|mesh-ancestor
92161077|NCT01194453|Hormones|hormones|mesh-ancestor
92161078|NCT01194453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161079|NCT01194453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161080|NCT01194453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161081|NCT01194453|Antimetabolites|antimetabolites|mesh-ancestor
92182565|NCT00075335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161082|NCT01194453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161084|NCT01194453|Vitamin B Complex|vitamin b complex|mesh-ancestor
92161085|NCT03507413|Metformin|metformin|mesh-list
92196102|NCT01855451|Cetuximab|cetuximab|mesh-list
92161086|NCT03507413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92161087|NCT03507413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161088|NCT01195467|Tenofovir|tenofovir|mesh-list
92161089|NCT01195467|Emtricitabine|emtricitabine|mesh-list
92161090|NCT01195467|Efavirenz|efavirenz|mesh-list
92161091|NCT01195467|Raltegravir Potassium|raltegravir potassium|mesh-list
92161092|NCT01195467|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92161093|NCT01195467|Antiviral Agents|antiviral agents|mesh-ancestor
92161094|NCT01195467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161095|NCT01195467|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92161096|NCT01195467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92196390|NCT00630955|Memantine|memantine|mesh-list
92161097|NCT01195467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402323|NCT01422109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161098|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161099|NCT01195467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92196481|NCT03158246|Vitamin D|vitamin d|mesh-list
92161100|NCT01195467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92161101|NCT01195467|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92161102|NCT01195467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92161103|NCT01195467|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92161104|NCT01195467|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92161105|NCT01195467|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92161106|NCT01195467|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92161107|NCT01195467|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92161108|NCT01195467|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92161109|NCT01677221|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92161110|NCT01677221|Dermatologic Agents|dermatologic agents|mesh-ancestor
92161113|NCT03492437|Antithrombins|antithrombins|mesh-ancestor
92161114|NCT03492437|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92161115|NCT03492437|Protease Inhibitors|protease inhibitors|mesh-ancestor
92161116|NCT03492437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196982|NCT00654511|Fentanyl|fentanyl|mesh-list
92161117|NCT03492437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161118|NCT03492437|Anticoagulants|anticoagulants|mesh-ancestor
92161119|NCT03492437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161120|NCT01195779|Vaccines|vaccines|mesh-list
92161121|NCT01195779|Immunologic Factors|immunologic factors|mesh-ancestor
92161122|NCT01195779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161124|NCT02405585|Gemcitabine|gemcitabine|mesh-list
92161125|NCT02405585|Fluorouracil|fluorouracil|mesh-list
92161126|NCT02405585|Oxaliplatin|oxaliplatin|mesh-list
92161127|NCT02405585|Irinotecan|irinotecan|mesh-list
92197213|NCT01675076|Rivaroxaban|rivaroxaban|mesh-list
92161128|NCT02405585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161129|NCT02405585|Antimetabolites|antimetabolites|mesh-ancestor
92161130|NCT02405585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161131|NCT02405585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161132|NCT02405585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161133|NCT02405585|Immunologic Factors|immunologic factors|mesh-ancestor
92161134|NCT02405585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197367|NCT00557193|Hormones|hormones|mesh-ancestor
92161135|NCT02405585|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92161136|NCT02405585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161137|NCT02405585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161139|NCT02405585|Protective Agents|protective agents|mesh-ancestor
92161140|NCT02405585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92161141|NCT02405585|Vitamins|vitamins|mesh-ancestor
92161142|NCT02405585|Micronutrients|micronutrients|mesh-ancestor
92161143|NCT03491345|Avelumab|avelumab|mesh-list
92161144|NCT03491345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161145|NCT03491345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161147|NCT00089999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161148|NCT00089999|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92161149|NCT00089999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161150|NCT00089999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161151|NCT03454451|Pembrolizumab|pembrolizumab|mesh-list
92182567|NCT01680549|Analgesics|analgesics|mesh-ancestor
92161152|NCT03454451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161153|NCT03454451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161154|NCT03454451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197793|NCT00661453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92161155|NCT03454451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197870|NCT03546608|Tepotinib|tepotinib|mesh-list
92161156|NCT00089843|Risedronic Acid|risedronic acid|mesh-list
92161157|NCT00089843|Etidronic Acid|etidronic acid|mesh-list
92161158|NCT00089843|Methyltestosterone|methyltestosterone|mesh-list
92161159|NCT00089843|Testosterone|testosterone|mesh-list
92161160|NCT00089843|Testosterone undecanoate|testosterone undecanoate|mesh-list
92197939|NCT03605654|Tacrolimus|tacrolimus|mesh-list
92161161|NCT00089843|Testosterone enanthate|testosterone enanthate|mesh-list
92161162|NCT00089843|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92161163|NCT00089843|Androgens|androgens|mesh-ancestor
92161164|NCT00089843|Hormones|hormones|mesh-ancestor
92161165|NCT00089843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161166|NCT00089843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161167|NCT00089843|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161168|NCT00089843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161169|NCT00089843|Anabolic Agents|anabolic agents|mesh-ancestor
92161170|NCT00089843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92161172|NCT00089843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161173|NCT00089843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92161174|NCT00089843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92161175|NCT01677923|Metformin|metformin|mesh-list
92161176|NCT01677923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92161177|NCT01677923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161178|NCT00089297|Paclitaxel|paclitaxel|mesh-list
92161179|NCT00089297|Carboplatin|carboplatin|mesh-list
92161180|NCT00089297|Cetuximab|cetuximab|mesh-list
92161181|NCT00089297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92161182|NCT00089297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161183|NCT00089297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92161184|NCT00089297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92161185|NCT00089297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92198283|NCT00590863|Dopamine Agents|dopamine agents|mesh-ancestor
92161186|NCT00089297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161187|NCT00089297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161188|NCT01678001|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92161189|NCT01678001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92161190|NCT01678001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161191|NCT01678001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161192|NCT01678001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92161193|NCT01678001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92161194|NCT01678001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198354|NCT00698035|Testosterone|testosterone|mesh-list
92161195|NCT01678001|Cholinergic Agents|cholinergic agents|mesh-ancestor
92161196|NCT01678001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161197|NCT03482297|Midodrine|midodrine|mesh-list
92161198|NCT03482297|Sympathomimetics|sympathomimetics|mesh-ancestor
92161199|NCT03482297|Autonomic Agents|autonomic agents|mesh-ancestor
92198491|NCT03790839|Incretins|incretins|mesh-ancestor
92161200|NCT03482297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161201|NCT03482297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161202|NCT03482297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92161203|NCT03482297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92161204|NCT03482297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92161205|NCT03482297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92161207|NCT03482297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161208|NCT03482297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161209|NCT00088907|Docetaxel|docetaxel|mesh-list
92161210|NCT00088907|Gefitinib|gefitinib|mesh-list
92161211|NCT00088907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161212|NCT00088907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92161213|NCT00088907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92161214|NCT00088907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161215|NCT00088907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161216|NCT00088907|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92161217|NCT00088907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161219|NCT00088829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92161220|NCT00088829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92161221|NCT00088829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161222|NCT00088829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92161223|NCT00088829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92161224|NCT00088829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161225|NCT00088829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161226|NCT00088595|Pasireotide|pasireotide|mesh-list
92161227|NCT00088595|Hormones|hormones|mesh-ancestor
92161228|NCT00088595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161229|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161230|NCT03450707|Thiamine|thiamine|mesh-list
92161231|NCT03450707|Vitamins|vitamins|mesh-ancestor
92161232|NCT03450707|Micronutrients|micronutrients|mesh-ancestor
92199212|NCT01944423|Autonomic Agents|autonomic agents|mesh-ancestor
92161233|NCT03450707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161235|NCT01678079|Calcium, Dietary|calcium, dietary|mesh-list
92161237|NCT01678079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92161238|NCT01678079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161239|NCT01678079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92161240|NCT01678235|Insulin|insulin|mesh-list
92161241|NCT01678235|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92161242|NCT01678235|Insulin Aspart|insulin aspart|mesh-list
92161243|NCT01678235|Insulin glulisine|insulin glulisine|mesh-list
92161245|NCT01678235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161247|NCT01197495|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92161248|NCT01197495|Immunologic Factors|immunologic factors|mesh-ancestor
92161249|NCT01197495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161250|NCT01197495|Viscosupplements|viscosupplements|mesh-ancestor
92161251|NCT01197495|Protective Agents|protective agents|mesh-ancestor
92161252|NCT01197573|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92161253|NCT01197573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92161254|NCT01197573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92182568|NCT01680549|Sensory System Agents|sensory system agents|mesh-ancestor
92161255|NCT01197573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161256|NCT03011931|Simvastatin|simvastatin|mesh-list
92161257|NCT03011931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92161258|NCT03011931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92161259|NCT03011931|Antimetabolites|antimetabolites|mesh-ancestor
92199798|NCT01902459|Hemostatics|hemostatics|mesh-ancestor
92161260|NCT03011931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161261|NCT03011931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92161262|NCT03011931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92161263|NCT03011931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161264|NCT02185131|Mirtazapine|mirtazapine|mesh-list
92161265|NCT02185131|Antidepressive Agents|antidepressive agents|mesh-ancestor
92161266|NCT02185131|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92161267|NCT02185131|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92161268|NCT02185131|Histamine Antagonists|histamine antagonists|mesh-ancestor
92161269|NCT02185131|Histamine Agents|histamine agents|mesh-ancestor
92161270|NCT02185131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161271|NCT02185131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161272|NCT02185131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161273|NCT02185131|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92161274|NCT02185131|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92161275|NCT02185131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161276|NCT02185131|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92161277|NCT02185131|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92161278|NCT02185131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92161279|NCT02185131|Adrenergic Agents|adrenergic agents|mesh-ancestor
92161280|NCT02185131|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92200006|NCT00578903|Tacrolimus|tacrolimus|mesh-list
92161281|NCT02185131|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92161282|NCT02185131|Serotonin Agents|serotonin agents|mesh-ancestor
92161283|NCT02185131|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92161284|NCT00085709|Cytarabine|cytarabine|mesh-list
92161286|NCT00085709|Gemtuzumab|gemtuzumab|mesh-list
92161287|NCT00085709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161288|NCT00085709|Antimetabolites|antimetabolites|mesh-ancestor
92161289|NCT00085709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161290|NCT00085709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161291|NCT00085709|Antiviral Agents|antiviral agents|mesh-ancestor
92161292|NCT00085709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161293|NCT00085709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161294|NCT00085709|Immunologic Factors|immunologic factors|mesh-ancestor
92161295|NCT00085709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161296|NCT00085709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92161297|NCT00085709|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92161298|NCT00085709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161299|NCT00085709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161300|NCT00085709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161301|NCT00085709|Immunotoxins|immunotoxins|mesh-ancestor
92161302|NCT00085709|Immunoconjugates|immunoconjugates|mesh-ancestor
92161303|NCT01201863|Testosterone|testosterone|mesh-list
92161304|NCT01201863|Androgens|androgens|mesh-ancestor
92161305|NCT01201863|Hormones|hormones|mesh-ancestor
92161306|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161307|NCT01201863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161308|NCT01202253|Anidulafungin|anidulafungin|mesh-list
92161309|NCT01202253|Antifungal Agents|antifungal agents|mesh-ancestor
92161310|NCT01202253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161311|NCT01678703|Misoprostol|misoprostol|mesh-list
92161313|NCT01678703|Abortifacient Agents|abortifacient agents|mesh-ancestor
92200175|NCT01925781|Nicotine|nicotine|mesh-list
92161314|NCT01678703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92161315|NCT01678703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161316|NCT01678703|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92161317|NCT01678703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92161318|NCT01678703|Oxytocics|oxytocics|mesh-ancestor
92161319|NCT00085631|Cisplatin|cisplatin|mesh-list
92161320|NCT00085631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161321|NCT01141491|Vaccines|vaccines|mesh-list
92161322|NCT01141491|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92161323|NCT01141491|Immunologic Factors|immunologic factors|mesh-ancestor
92161324|NCT01141491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161325|NCT01141569|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92161326|NCT01141569|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-list
92161328|NCT01141569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161329|NCT01141725|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92161330|NCT01141725|Idarubicin|idarubicin|mesh-list
92161331|NCT01141725|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92161332|NCT01141725|Alkylating Agents|alkylating agents|mesh-ancestor
92182569|NCT01680549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161333|NCT01141725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161334|NCT01141725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161335|NCT01141725|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92161336|NCT01141725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92200282|NCT03084380|Cyclophosphamide|cyclophosphamide|mesh-list
92161337|NCT01141725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161339|NCT01202721|Atenolol|atenolol|mesh-list
92161340|NCT01202721|Telmisartan|telmisartan|mesh-list
92161341|NCT01202721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92161342|NCT01202721|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92161343|NCT01202721|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92161344|NCT01202721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161345|NCT01202721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92161346|NCT01202721|Sympatholytics|sympatholytics|mesh-ancestor
92161347|NCT01202721|Autonomic Agents|autonomic agents|mesh-ancestor
92161348|NCT01202721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161349|NCT01202721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161350|NCT01202721|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92161351|NCT01202721|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92161352|NCT01202721|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92161353|NCT01202721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92161354|NCT01202721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161355|NCT00084617|Capecitabine|capecitabine|mesh-list
92161356|NCT00084617|Oxaliplatin|oxaliplatin|mesh-list
92200520|NCT03400826|Simvastatin|simvastatin|mesh-list
92161358|NCT00084617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161359|NCT00084617|Antimetabolites|antimetabolites|mesh-ancestor
92182570|NCT01680549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161360|NCT00084617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931111|NCT05786716|Pertuzumab|pertuzumab|mesh-list
92161361|NCT00084617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161362|NCT00084617|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92161363|NCT00084617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161364|NCT00084617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161365|NCT01203189|Ketoconazole|ketoconazole|mesh-list
92161366|NCT01203189|Antifungal Agents|antifungal agents|mesh-ancestor
92161367|NCT01203189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161368|NCT01203189|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92161369|NCT01203189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92161370|NCT01203189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182571|NCT01680549|Anticonvulsants|anticonvulsants|mesh-ancestor
92161371|NCT01203189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161372|NCT01203189|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92201051|NCT00672737|Remifentanil|remifentanil|mesh-list
92161373|NCT01203189|Hormone Antagonists|hormone antagonists|mesh-ancestor
92161374|NCT01203189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161375|NCT01203189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161376|NCT01203189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92161377|NCT01204203|Zoledronic Acid|zoledronic acid|mesh-list
92161378|NCT01204203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92201193|NCT04771871|Paclitaxel|paclitaxel|mesh-list
92161379|NCT01204203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161380|NCT01679327|Calcium, Dietary|calcium, dietary|mesh-list
92161382|NCT01679327|Bevacizumab|bevacizumab|mesh-list
92161383|NCT01679327|Oxaliplatin|oxaliplatin|mesh-list
92161384|NCT01679327|Calcium|calcium|mesh-list
92161385|NCT01679327|Levoleucovorin|levoleucovorin|mesh-list
92161386|NCT01679327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161387|NCT01679327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161388|NCT01679327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92161389|NCT01679327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92201557|NCT04746495|Eplerenone|eplerenone|mesh-list
92161390|NCT01679327|Growth Substances|growth substances|mesh-ancestor
92161391|NCT01679327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161392|NCT01679327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92161393|NCT01679327|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92161394|NCT01679327|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92161396|NCT01679327|Protective Agents|protective agents|mesh-ancestor
92161397|NCT01679327|Vitamin B Complex|vitamin b complex|mesh-ancestor
92161398|NCT01679327|Vitamins|vitamins|mesh-ancestor
92161399|NCT01679327|Micronutrients|micronutrients|mesh-ancestor
92161400|NCT01206387|Desoximetasone|desoximetasone|mesh-list
92161401|NCT01206387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161403|NCT01206387|Hormones|hormones|mesh-ancestor
92161404|NCT01206387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182572|NCT01680549|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92161405|NCT01206387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161406|NCT01679561|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92161407|NCT01679561|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92161408|NCT01679561|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92161409|NCT01679561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92161410|NCT01679639|Rifampin|rifampin|mesh-list
92161411|NCT01679639|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92161412|NCT01679639|Antitubercular Agents|antitubercular agents|mesh-ancestor
92161413|NCT01679639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92161414|NCT01679639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161415|NCT01679639|Leprostatic Agents|leprostatic agents|mesh-ancestor
92161416|NCT01679639|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92161417|NCT01679639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182573|NCT01680549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92161418|NCT01679639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161419|NCT01679639|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92161420|NCT01679639|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92202352|NCT00656201|Hormones|hormones|mesh-ancestor
92161421|NCT01679639|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92161422|NCT01679639|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92161423|NCT01679639|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92161424|NCT01679639|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92161426|NCT01679795|Androgen Antagonists|androgen antagonists|mesh-ancestor
92161427|NCT01679795|Hormone Antagonists|hormone antagonists|mesh-ancestor
92161428|NCT01679795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161430|NCT01679795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92161431|NCT01679795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161432|NCT01679795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161433|NCT01679795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92161434|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
92161435|NCT01679795|Hormones|hormones|mesh-ancestor
92161436|NCT01206465|Fluorouracil|fluorouracil|mesh-list
92161437|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
92161438|NCT01206465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202709|NCT00659633|Anesthetics|anesthetics|mesh-ancestor
92161439|NCT01206465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161440|NCT01206465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161441|NCT01206465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161442|NCT01206465|Immunologic Factors|immunologic factors|mesh-ancestor
92161443|NCT01206465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161444|NCT01207401|Lidocaine|lidocaine|mesh-list
92161445|NCT01207401|Anesthetics, Local|anesthetics, local|mesh-ancestor
92161446|NCT01207401|Anesthetics|anesthetics|mesh-ancestor
92402345|NCT01422291|Analgesics|analgesics|mesh-ancestor
92161447|NCT01207401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161448|NCT01207401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202853|NCT00661895|Metoprolol|metoprolol|mesh-list
92161449|NCT01207401|Sensory System Agents|sensory system agents|mesh-ancestor
92161450|NCT01207401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161451|NCT01207401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92202922|NCT03816176|Isavuconazole|isavuconazole|mesh-list
92161452|NCT01207401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92161453|NCT01207401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92161454|NCT01207401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92161459|NCT04761731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161460|NCT04761731|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92161461|NCT04761731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161462|NCT04761731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161466|NCT03087539|Abciximab|abciximab|mesh-list
92161467|NCT03087539|Anticoagulants|anticoagulants|mesh-ancestor
92161468|NCT03087539|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92161470|NCT03087149|Vitamins|vitamins|mesh-ancestor
92161471|NCT03087149|Micronutrients|micronutrients|mesh-ancestor
92161472|NCT03087149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161473|NCT03087149|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92203433|NCT00721513|Docetaxel|docetaxel|mesh-list
92161475|NCT03086681|Endostar protein|endostar protein|mesh-list
92161476|NCT03086681|Endostatins|endostatins|mesh-list
92161477|NCT03086681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161478|NCT03086681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92161479|NCT03086681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92161481|NCT03086681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161482|NCT03086681|Growth Inhibitors|growth inhibitors|mesh-ancestor
92161484|NCT03086759|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92161485|NCT03086759|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92161486|NCT03086759|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92161487|NCT03086759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161488|NCT03086759|Glucocorticoids|glucocorticoids|mesh-ancestor
92161489|NCT03086759|Hormones|hormones|mesh-ancestor
92161490|NCT03086759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161491|NCT03086759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161492|NCT03086759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161493|NCT03086759|Immunologic Factors|immunologic factors|mesh-ancestor
92161494|NCT03086759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161495|NCT03086759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161496|NCT03086291|Simvastatin|simvastatin|mesh-list
92161497|NCT03086291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92161498|NCT03086291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92161499|NCT03086291|Antimetabolites|antimetabolites|mesh-ancestor
92161500|NCT03086291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161502|NCT03086291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92161503|NCT03086291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161504|NCT03086915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92161505|NCT03086915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92161506|NCT03086915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161507|NCT03086915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161508|NCT01209195|Paclitaxel|paclitaxel|mesh-list
92161509|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92161510|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161511|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
92161512|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
92161513|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161514|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161515|NCT03084809|Leucovorin|leucovorin|mesh-list
92161516|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
92161517|NCT03084809|Fluorouracil|fluorouracil|mesh-list
92161518|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
92161519|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161520|NCT03084809|Antidotes|antidotes|mesh-ancestor
92161521|NCT03084809|Protective Agents|protective agents|mesh-ancestor
92161522|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161523|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
92161524|NCT03084809|Vitamins|vitamins|mesh-ancestor
92161525|NCT03084809|Micronutrients|micronutrients|mesh-ancestor
92161526|NCT03084809|Antimetabolites|antimetabolites|mesh-ancestor
92161527|NCT03084809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161528|NCT03084809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161529|NCT03084809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161530|NCT03084809|Immunologic Factors|immunologic factors|mesh-ancestor
92161532|NCT01144143|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92161533|NCT01144143|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92161534|NCT01144143|Prednisolone|prednisolone|mesh-list
92161535|NCT01144143|Prednisolone acetate|prednisolone acetate|mesh-list
92161536|NCT01144143|Infliximab|infliximab|mesh-list
92161537|NCT01144143|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92161538|NCT01144143|Prednisolone phosphate|prednisolone phosphate|mesh-list
92161539|NCT01144143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161540|NCT01144143|Antiemetics|antiemetics|mesh-ancestor
92161541|NCT01144143|Autonomic Agents|autonomic agents|mesh-ancestor
92161542|NCT01144143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161543|NCT01144143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161544|NCT01144143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92161547|NCT01144143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161548|NCT01144143|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92161549|NCT01144143|Protective Agents|protective agents|mesh-ancestor
92161550|NCT01144143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161551|NCT01144143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161552|NCT01144143|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92161553|NCT01144143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92161554|NCT01144143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161555|NCT03084575|Glycerol|glycerol|mesh-list
92161556|NCT03084575|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92161557|NCT03084575|Protective Agents|protective agents|mesh-ancestor
92204810|NCT01272947|Diclofenac|diclofenac|mesh-list
92161558|NCT03084575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204867|NCT04387097|Narcotics|narcotics|mesh-ancestor
92161560|NCT01212471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92161561|NCT01212471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92161562|NCT01212471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92161563|NCT01212471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92161564|NCT01212471|Analgesics|analgesics|mesh-ancestor
92161565|NCT01212471|Sensory System Agents|sensory system agents|mesh-ancestor
92161566|NCT01212471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204940|NCT01277861|Narcotics|narcotics|mesh-ancestor
92161567|NCT01212471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161568|NCT01212471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161569|NCT01212471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161571|NCT03084419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92161572|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161573|NCT03084419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161574|NCT03084419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161575|NCT03084419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161576|NCT03084419|Immunologic Factors|immunologic factors|mesh-ancestor
92161577|NCT03084419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161578|NCT03084419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161579|NCT03084029|Oxytocin|oxytocin|mesh-list
92161580|NCT03084029|Oxytocics|oxytocics|mesh-ancestor
92161581|NCT03084029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92161582|NCT03084029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161583|NCT04278053|Inositol|inositol|mesh-list
92161584|NCT04278053|Vitamin B Complex|vitamin b complex|mesh-ancestor
92161585|NCT04278053|Vitamins|vitamins|mesh-ancestor
92161586|NCT04278053|Micronutrients|micronutrients|mesh-ancestor
92161587|NCT04278053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161588|NCT05346107|Paclitaxel|paclitaxel|mesh-list
92161589|NCT05346107|Cyclophosphamide|cyclophosphamide|mesh-list
92161590|NCT05346107|Doxorubicin|doxorubicin|mesh-list
92161591|NCT05346107|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92161592|NCT05346107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92161593|NCT05346107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161594|NCT05346107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92161595|NCT05346107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92161596|NCT05346107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92161597|NCT05346107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161598|NCT05346107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161599|NCT05346107|Immunologic Factors|immunologic factors|mesh-ancestor
92402351|NCT01422291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161600|NCT05346107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161601|NCT05346107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161602|NCT05346107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92161603|NCT05346107|Alkylating Agents|alkylating agents|mesh-ancestor
92161604|NCT05346107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92205016|NCT01276457|Everolimus|everolimus|mesh-list
92161605|NCT05346107|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92161606|NCT05346107|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92161607|NCT05346107|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161608|NCT05346107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161609|NCT03082001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92161610|NCT00083915|Thalidomide|thalidomide|mesh-list
92161611|NCT00083915|Dexamethasone|dexamethasone|mesh-list
92161612|NCT00083915|Cyclophosphamide|cyclophosphamide|mesh-list
92161613|NCT00083915|Melphalan|melphalan|mesh-list
92161614|NCT00083915|Cisplatin|cisplatin|mesh-list
92161615|NCT00083915|Doxorubicin|doxorubicin|mesh-list
92161616|NCT00083915|Etoposide|etoposide|mesh-list
92161618|NCT00083915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161619|NCT00083915|Immunologic Factors|immunologic factors|mesh-ancestor
92161620|NCT00083915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161621|NCT00083915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161622|NCT00083915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92161623|NCT00083915|Alkylating Agents|alkylating agents|mesh-ancestor
92161624|NCT00083915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161625|NCT00083915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161626|NCT00083915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92161627|NCT00083915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161629|NCT00083915|Autonomic Agents|autonomic agents|mesh-ancestor
92161630|NCT00083915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161631|NCT00083915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92161632|NCT00083915|Glucocorticoids|glucocorticoids|mesh-ancestor
92161633|NCT00083915|Hormones|hormones|mesh-ancestor
92161634|NCT00083915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161635|NCT00083915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161636|NCT00083915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92161637|NCT00083915|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92161638|NCT00083915|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161639|NCT00083915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161640|NCT00083915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92161641|NCT00083915|Leprostatic Agents|leprostatic agents|mesh-ancestor
92161642|NCT00083915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92161643|NCT00083915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161644|NCT00083915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92161645|NCT00083915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92161646|NCT00083915|Growth Substances|growth substances|mesh-ancestor
92161647|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
92161648|NCT04401839|Oxytocin|oxytocin|mesh-list
92161649|NCT04401839|Oxytocics|oxytocics|mesh-ancestor
92161650|NCT04401839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92161651|NCT04401839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161652|NCT04761185|Raltitrexed|raltitrexed|mesh-list
92161653|NCT04761185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161654|NCT04761185|Antimetabolites|antimetabolites|mesh-ancestor
92161655|NCT04761185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161656|NCT04761185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161657|NCT04761185|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92161658|NCT04761185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161659|NCT01144455|Gemcitabine|gemcitabine|mesh-list
92161660|NCT01144455|Phosphoramide Mustards|phosphoramide mustards|mesh-list
92161661|NCT01144455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161662|NCT01144455|Antimetabolites|antimetabolites|mesh-ancestor
92161663|NCT01144455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161664|NCT01144455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161665|NCT01144455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92161666|NCT01144455|Alkylating Agents|alkylating agents|mesh-ancestor
92161667|NCT03080675|Vitamins|vitamins|mesh-list
92161668|NCT03080675|Micronutrients|micronutrients|mesh-ancestor
92161669|NCT03080675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161670|NCT03080363|Lidocaine|lidocaine|mesh-list
92161671|NCT03080363|Bupivacaine|bupivacaine|mesh-list
92161672|NCT03080363|Anesthetics, Local|anesthetics, local|mesh-ancestor
92161673|NCT03080363|Anesthetics|anesthetics|mesh-ancestor
92161674|NCT03080363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205158|NCT01276379|Leucovorin|leucovorin|mesh-list
92161675|NCT03080363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161676|NCT03080363|Sensory System Agents|sensory system agents|mesh-ancestor
92161677|NCT03080363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161678|NCT03080363|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92161679|NCT03080363|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92161680|NCT03080363|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92161681|NCT03080363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92161682|NCT03080363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161684|NCT01145001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92161685|NCT01145001|Autonomic Agents|autonomic agents|mesh-ancestor
92161686|NCT01145001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205211|NCT00789685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161687|NCT01145001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161688|NCT01145001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92161689|NCT01145001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92161690|NCT01145001|Cholinergic Agents|cholinergic agents|mesh-ancestor
92161691|NCT01145001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161692|NCT01145001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161693|NCT03011463|Clarithromycin|clarithromycin|mesh-list
92161695|NCT03011463|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92161696|NCT03011463|Trospium chloride|trospium chloride|mesh-list
92161697|NCT03011463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92161698|NCT03011463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161699|NCT03011463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92161700|NCT03011463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161701|NCT03011463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161702|NCT03011463|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92161703|NCT03011463|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92161704|NCT03011463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92161705|NCT03011463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92161706|NCT03011463|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92161707|NCT03011463|Histamine Antagonists|histamine antagonists|mesh-ancestor
92161708|NCT03011463|Histamine Agents|histamine agents|mesh-ancestor
92161709|NCT03011463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161710|NCT03011463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161711|NCT03011463|Parasympatholytics|parasympatholytics|mesh-ancestor
92161712|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
92205353|NCT03801733|Sulfasalazine|sulfasalazine|mesh-list
92161713|NCT03011463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161714|NCT03011463|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92161715|NCT03011463|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92161716|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
92161717|NCT03011463|Urological Agents|urological agents|mesh-ancestor
92161719|NCT01214109|Antioxidants|antioxidants|mesh-ancestor
92161720|NCT01214109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161721|NCT01214109|Protective Agents|protective agents|mesh-ancestor
92161722|NCT01214109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161723|NCT01214109|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92161724|NCT01214109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92161725|NCT01214109|Dopamine Agonists|dopamine agonists|mesh-ancestor
92161726|NCT01214109|Dopamine Agents|dopamine agents|mesh-ancestor
92161727|NCT01214109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161728|NCT05688761|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92161729|NCT05688761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161730|NCT05688761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161731|NCT01215123|Bevacizumab|bevacizumab|mesh-list
92161732|NCT01215123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92161733|NCT01215123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161734|NCT01215123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92161735|NCT01215123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92161736|NCT01215123|Growth Substances|growth substances|mesh-ancestor
92161737|NCT01215123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161738|NCT01215123|Growth Inhibitors|growth inhibitors|mesh-ancestor
92161740|NCT05688449|Bupivacaine|bupivacaine|mesh-list
92161741|NCT05688449|Anesthetics, Local|anesthetics, local|mesh-ancestor
92161742|NCT05688449|Anesthetics|anesthetics|mesh-ancestor
92161743|NCT05688449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402361|NCT01422317|Vitamins|vitamins|mesh-ancestor
92161744|NCT05688449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161745|NCT05688449|Sensory System Agents|sensory system agents|mesh-ancestor
92161746|NCT05688449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161747|NCT05688449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92161748|NCT05688449|Narcotics|narcotics|mesh-ancestor
92161749|NCT05688449|Analgesics|analgesics|mesh-ancestor
92161750|NCT05688449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92161751|NCT05688449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92161752|NCT05688449|Anesthetics, General|anesthetics, general|mesh-ancestor
92161753|NCT04401137|Topiramate|topiramate|mesh-list
92161754|NCT04401137|Anticonvulsants|anticonvulsants|mesh-ancestor
92161755|NCT04401137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92161756|NCT04401137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161757|NCT02189889|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92161758|NCT02189889|Hematinics|hematinics|mesh-ancestor
92161759|NCT02189889|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92161760|NCT02189889|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92161761|NCT01148745|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92161762|NCT01148745|Hematinics|hematinics|mesh-ancestor
92161763|NCT01148745|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92161764|NCT01148745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92161765|NCT04761029|Tramadol|tramadol|mesh-list
92161766|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92161767|NCT04761029|Narcotics|narcotics|mesh-ancestor
92161768|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161769|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161770|NCT04761029|Analgesics|analgesics|mesh-ancestor
92161771|NCT04761029|Sensory System Agents|sensory system agents|mesh-ancestor
92161772|NCT04761029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161773|NCT05687981|Dexamethasone|dexamethasone|mesh-list
92161774|NCT05687981|Bupivacaine|bupivacaine|mesh-list
92161775|NCT05687981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161776|NCT05687981|Antiemetics|antiemetics|mesh-ancestor
92161777|NCT05687981|Autonomic Agents|autonomic agents|mesh-ancestor
92205645|NCT00763061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92161778|NCT05687981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161779|NCT05687981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161780|NCT05687981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92161781|NCT05687981|Glucocorticoids|glucocorticoids|mesh-ancestor
92161783|NCT05687981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161784|NCT05687981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92161785|NCT05687981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161786|NCT05687981|Anesthetics, Local|anesthetics, local|mesh-ancestor
92161787|NCT05687981|Anesthetics|anesthetics|mesh-ancestor
92161788|NCT05687981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161789|NCT05687981|Sensory System Agents|sensory system agents|mesh-ancestor
92161790|NCT05687747|FAPI-46|fapi-46|mesh-list
92161791|NCT05687747|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92205715|NCT01981863|Aminocaproic Acid|aminocaproic acid|mesh-list
92161792|NCT05687747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161793|NCT05687669|Phentolamine|phentolamine|mesh-list
92161794|NCT05687669|Nitroglycerin|nitroglycerin|mesh-list
92161795|NCT05687669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92161796|NCT05687669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92161797|NCT05687669|Adrenergic Agents|adrenergic agents|mesh-ancestor
92161798|NCT05687669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161799|NCT05687669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161800|NCT05687669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161801|NCT05687669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92161802|NCT05687669|Vasodilator Agents|vasodilator agents|mesh-ancestor
92161803|NCT04400747|Vitamin D|vitamin d|mesh-list
92161804|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
92161805|NCT04400747|Vitamins|vitamins|mesh-ancestor
92161806|NCT04400747|Micronutrients|micronutrients|mesh-ancestor
92161807|NCT04400747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161808|NCT04400747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92161809|NCT04400747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92161810|NCT02190903|Anesthetics|anesthetics|mesh-list
92161811|NCT02190903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161812|NCT02190903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161813|NCT03369041|Irinotecan|irinotecan|mesh-list
92161814|NCT03369041|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92161815|NCT03369041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92161816|NCT03369041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161817|NCT03369041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161818|NCT03369041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161819|NCT01149759|Cyclosporine|cyclosporine|mesh-list
92161820|NCT01149759|Cyclosporins|cyclosporins|mesh-list
92161821|NCT01149759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161822|NCT01149759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161823|NCT01149759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92161824|NCT01149759|Immunologic Factors|immunologic factors|mesh-ancestor
92161825|NCT01149759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161826|NCT01149759|Antifungal Agents|antifungal agents|mesh-ancestor
92161827|NCT01149759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161828|NCT01149759|Dermatologic Agents|dermatologic agents|mesh-ancestor
92161829|NCT01149759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161830|NCT01149759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92161831|NCT01216761|Iodine|iodine|mesh-list
92161832|NCT01216761|Chlorhexidine|chlorhexidine|mesh-list
92161833|NCT01216761|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92161834|NCT01216761|Cadexomer iodine|cadexomer iodine|mesh-list
92161835|NCT01216761|Povidone-Iodine|povidone-iodine|mesh-list
92161837|NCT01216761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92161838|NCT01216761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161839|NCT01216761|Disinfectants|disinfectants|mesh-ancestor
92161840|NCT01216761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92161841|NCT01216761|Trace Elements|trace elements|mesh-ancestor
92161842|NCT01216761|Micronutrients|micronutrients|mesh-ancestor
92161843|NCT01216761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161844|NCT01216761|Plasma Substitutes|plasma substitutes|mesh-ancestor
92161845|NCT01216761|Blood Substitutes|blood substitutes|mesh-ancestor
92161846|NCT04279379|Decitabine|decitabine|mesh-list
92161847|NCT04279379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92161848|NCT04279379|Antimetabolites|antimetabolites|mesh-ancestor
92161849|NCT04279379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161850|NCT04279379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161851|NCT04279379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161852|NCT05685719|Itraconazole|itraconazole|mesh-list
92161853|NCT05685719|Rifampin|rifampin|mesh-list
92161854|NCT05685719|Antifungal Agents|antifungal agents|mesh-ancestor
92161855|NCT05685719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92161856|NCT05685719|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92161857|NCT05685719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92161858|NCT05685719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161859|NCT05685719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161860|NCT05685719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92161861|NCT05685719|Hormone Antagonists|hormone antagonists|mesh-ancestor
92161862|NCT05685719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161863|NCT05685719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161864|NCT05685719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92161865|NCT05685719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92161866|NCT05685719|Antitubercular Agents|antitubercular agents|mesh-ancestor
92161867|NCT05685719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92161868|NCT05685719|Leprostatic Agents|leprostatic agents|mesh-ancestor
92161869|NCT05685719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92161870|NCT05685719|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92161871|NCT05685719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92161872|NCT05685719|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92161873|NCT05685719|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92161874|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92161875|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92161878|NCT01150461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92161879|NCT01150461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92161880|NCT01150461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92161881|NCT01150461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92161882|NCT01150461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161883|NCT01150461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92161884|NCT01218399|Budesonide|budesonide|mesh-list
92161885|NCT01218399|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92161886|NCT01218399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161887|NCT01218399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92161888|NCT01218399|Autonomic Agents|autonomic agents|mesh-ancestor
92161889|NCT01218399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161890|NCT01218399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161891|NCT01218399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92161892|NCT01218399|Respiratory System Agents|respiratory system agents|mesh-ancestor
92161893|NCT01218399|Glucocorticoids|glucocorticoids|mesh-ancestor
92161894|NCT01218399|Hormones|hormones|mesh-ancestor
92161895|NCT01218399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161896|NCT01219881|Sevoflurane|sevoflurane|mesh-list
92161897|NCT01219881|Desflurane|desflurane|mesh-list
92161898|NCT01219881|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92206050|NCT01985763|Genistein|genistein|mesh-list
92161899|NCT01219881|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92161900|NCT01219881|Anesthetics, General|anesthetics, general|mesh-ancestor
92161901|NCT01219881|Anesthetics|anesthetics|mesh-ancestor
92161902|NCT01219881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161903|NCT01219881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161904|NCT01220973|Celecoxib|celecoxib|mesh-list
92161905|NCT01220973|Atorvastatin|atorvastatin|mesh-list
92161906|NCT01220973|Calcium|calcium|mesh-list
92161907|NCT01220973|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92161908|NCT01220973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161909|NCT01220973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92161910|NCT01220973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92161911|NCT01220973|Antimetabolites|antimetabolites|mesh-ancestor
92161912|NCT01220973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161913|NCT01220973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206131|NCT02397291|Inositol|inositol|mesh-list
92206180|NCT02008617|Sensory System Agents|sensory system agents|mesh-ancestor
92161914|NCT01220973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92161915|NCT01220973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161916|NCT01220973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92161917|NCT01220973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92161919|NCT01220973|Sensory System Agents|sensory system agents|mesh-ancestor
92161920|NCT01220973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92161921|NCT01220973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92161922|NCT01220973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92161923|NCT01220973|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92161924|NCT01220973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92161925|NCT05375747|Propofol|propofol|mesh-list
92161926|NCT05375747|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92161927|NCT05375747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92161928|NCT05375747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161929|NCT05375747|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92161930|NCT05375747|Anesthetics, General|anesthetics, general|mesh-ancestor
92161931|NCT05375747|Anesthetics|anesthetics|mesh-ancestor
92161932|NCT01221207|Calpastatin|calpastatin|mesh-list
92161934|NCT01221207|Protease Inhibitors|protease inhibitors|mesh-ancestor
92161935|NCT01221207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206252|NCT05217355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92161936|NCT01221207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161937|NCT03296813|Torsemide|torsemide|mesh-list
92161938|NCT03296813|Furosemide|furosemide|mesh-list
92161939|NCT03296813|Diuretics|diuretics|mesh-ancestor
92161940|NCT03296813|Natriuretic Agents|natriuretic agents|mesh-ancestor
92161941|NCT03296813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161942|NCT03296813|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92161943|NCT03296813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92161944|NCT03296813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161945|NCT03296813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92161946|NCT05338619|Lazertinib|lazertinib|mesh-list
92161947|NCT05338619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92161948|NCT05338619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161949|NCT05338619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161950|NCT03289949|Ketanserin|ketanserin|mesh-list
92161952|NCT03289949|Hallucinogens|hallucinogens|mesh-ancestor
92161953|NCT03289949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161954|NCT03289949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92161955|NCT03289949|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92161956|NCT03289949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92161957|NCT03289949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92161958|NCT03289949|Serotonin Agents|serotonin agents|mesh-ancestor
92161959|NCT03289949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92161960|NCT03289949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161961|NCT01222299|Bepotastine besilate|bepotastine besilate|mesh-list
92161962|NCT01222299|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92161963|NCT04400045|Treosulfan|treosulfan|mesh-list
92161964|NCT04400045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92161965|NCT04400045|Alkylating Agents|alkylating agents|mesh-ancestor
92161966|NCT04400045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161967|NCT04400045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161968|NCT01222689|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92161969|NCT01222689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92161970|NCT01222689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92161971|NCT01222689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92161972|NCT01222689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92161973|NCT01153581|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92161974|NCT01153581|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92161975|NCT01153581|Estradiol|estradiol|mesh-list
92161976|NCT01153581|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92161977|NCT01153581|Progesterone|progesterone|mesh-list
92161978|NCT01153581|Ganirelix|ganirelix|mesh-list
92161979|NCT01153581|Estrogens|estrogens|mesh-ancestor
92161980|NCT01153581|Hormones|hormones|mesh-ancestor
92206363|NCT02071095|Poly ICLC|poly iclc|mesh-list
92161981|NCT01153581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92161982|NCT01153581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161983|NCT01153581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92161984|NCT01153581|Contraceptive Agents|contraceptive agents|mesh-ancestor
92161985|NCT01153581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92161986|NCT01153581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92161987|NCT01153581|Progestins|progestins|mesh-ancestor
92161988|NCT01153581|Hormone Antagonists|hormone antagonists|mesh-ancestor
92161989|NCT04278599|Zinc|zinc|mesh-list
92161990|NCT04278599|Trace Elements|trace elements|mesh-ancestor
92161991|NCT04278599|Micronutrients|micronutrients|mesh-ancestor
92161992|NCT04278599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161993|NCT05277623|Mannitol|mannitol|mesh-list
92161994|NCT05277623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92161996|NCT05277623|Natriuretic Agents|natriuretic agents|mesh-ancestor
92161997|NCT05277623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92161998|NCT01224015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92161999|NCT01224015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92162000|NCT01224015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92162001|NCT01224015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162002|NCT01224015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162003|NCT01224015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92162004|NCT01224015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92162005|NCT01224015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162006|NCT01224015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92162007|NCT01224015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162008|NCT04760327|Cisplatin|cisplatin|mesh-list
92162009|NCT04760327|Bleomycin|bleomycin|mesh-list
92162010|NCT04760327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162011|NCT04760327|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92162012|NCT01225263|Vitamin D|vitamin d|mesh-list
92162013|NCT01225263|Simvastatin|simvastatin|mesh-list
92162014|NCT01225263|Vitamins|vitamins|mesh-ancestor
92162015|NCT01225263|Micronutrients|micronutrients|mesh-ancestor
92162016|NCT01225263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206479|NCT02410707|Propofol|propofol|mesh-list
92162017|NCT01225263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92162018|NCT01225263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92162019|NCT01225263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92162020|NCT01225263|Antimetabolites|antimetabolites|mesh-ancestor
92162021|NCT01225263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162022|NCT01225263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162023|NCT01225263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92162024|NCT01225263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162025|NCT04278287|Paclitaxel|paclitaxel|mesh-list
92162026|NCT04278287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92162027|NCT04278287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92162028|NCT04278287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162029|NCT04278287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92162030|NCT04278287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92162031|NCT04278287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92162032|NCT04278287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162033|NCT05162027|Erenumab|erenumab|mesh-list
92162034|NCT05162027|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92162035|NCT05162027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162036|NCT05162027|Analgesics|analgesics|mesh-ancestor
92162037|NCT05162027|Sensory System Agents|sensory system agents|mesh-ancestor
92162038|NCT05162027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162039|NCT05162027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162040|NCT03278717|Olaparib|olaparib|mesh-list
92162041|NCT03278717|Cediranib|cediranib|mesh-list
92206602|NCT00849121|Vaccines|vaccines|mesh-list
92162042|NCT03278717|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92162043|NCT03278717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162044|NCT03278717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162045|NCT03278717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162046|NCT03278717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92162047|NCT01227993|Finasteride|finasteride|mesh-list
92162048|NCT01227993|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92162049|NCT01227993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92162050|NCT01227993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162051|NCT01227993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162052|NCT01227993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92162053|NCT01227993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162054|NCT01227993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162055|NCT01227993|Urological Agents|urological agents|mesh-ancestor
92162056|NCT01155999|Tobramycin|tobramycin|mesh-list
92162057|NCT01155999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92162058|NCT01155999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162060|NCT03275597|Tremelimumab|tremelimumab|mesh-list
92162061|NCT03275597|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162062|NCT03275597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162063|NCT01228149|Acetazolamide|acetazolamide|mesh-list
92162064|NCT01228149|Anticonvulsants|anticonvulsants|mesh-ancestor
92162065|NCT01228149|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92162066|NCT01228149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162067|NCT01228149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162068|NCT01228149|Diuretics|diuretics|mesh-ancestor
92162069|NCT01228149|Natriuretic Agents|natriuretic agents|mesh-ancestor
92162070|NCT01228149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162071|NCT04989413|Dronabinol|dronabinol|mesh-list
92162072|NCT04989413|Cannabidiol|cannabidiol|mesh-list
92162073|NCT04989413|Anticonvulsants|anticonvulsants|mesh-ancestor
92162074|NCT04989413|Hallucinogens|hallucinogens|mesh-ancestor
92162075|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162076|NCT04989413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162077|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162078|NCT04989413|Analgesics|analgesics|mesh-ancestor
92162079|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
92162080|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162081|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92162082|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92162083|NCT04989413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162084|NCT04989413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162085|NCT04989413|Hormones|hormones|mesh-ancestor
92162086|NCT04989413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162087|NCT04986839|Acetaminophen|acetaminophen|mesh-list
92162088|NCT04986839|Ibuprofen|ibuprofen|mesh-list
92162089|NCT04986839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162090|NCT04986839|Analgesics|analgesics|mesh-ancestor
92162091|NCT04986839|Sensory System Agents|sensory system agents|mesh-ancestor
92162092|NCT04986839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162093|NCT04986839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162094|NCT04986839|Antipyretics|antipyretics|mesh-ancestor
92162095|NCT04986839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162096|NCT04986839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207023|NCT02369835|Eusol|eusol|mesh-list
92162097|NCT04986839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162098|NCT04986839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92162099|NCT04986839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207054|NCT02370693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162100|NCT04986839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162101|NCT04968587|Dialysis Solutions|dialysis solutions|mesh-list
92162102|NCT04968587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92162104|NCT02192541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92162105|NCT02192541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92162106|NCT02192541|Growth Substances|growth substances|mesh-ancestor
92162107|NCT02192541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162108|NCT02192541|Growth Inhibitors|growth inhibitors|mesh-ancestor
92162109|NCT02192541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162110|NCT01156701|Zanamivir|zanamivir|mesh-list
92162111|NCT01156701|Antiviral Agents|antiviral agents|mesh-ancestor
92162112|NCT01156701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162113|NCT01156701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162114|NCT01156701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162115|NCT03266081|Bupivacaine|bupivacaine|mesh-list
92162116|NCT03266081|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162117|NCT03266081|Anesthetics|anesthetics|mesh-ancestor
92162118|NCT03266081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162119|NCT03266081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162120|NCT03266081|Sensory System Agents|sensory system agents|mesh-ancestor
92162121|NCT03266081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162122|NCT03010995|Prazosin|prazosin|mesh-list
92162123|NCT03010995|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92162124|NCT03010995|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92162125|NCT03010995|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92162126|NCT03010995|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92162127|NCT03010995|Adrenergic Agents|adrenergic agents|mesh-ancestor
92162128|NCT03010995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182574|NCT01680549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162129|NCT03010995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162130|NCT03010995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162131|NCT01230177|Etanercept|etanercept|mesh-list
92162132|NCT01230177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162133|NCT01230177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162134|NCT01230177|Analgesics|analgesics|mesh-ancestor
92162135|NCT01230177|Sensory System Agents|sensory system agents|mesh-ancestor
92162136|NCT01230177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162137|NCT01230177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162138|NCT01230177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162139|NCT01230177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207467|NCT05644587|Buprenorphine|buprenorphine|mesh-list
92162140|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207539|NCT00797459|Viscosupplements|viscosupplements|mesh-ancestor
92162141|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162143|NCT02984657|Anesthetics|anesthetics|mesh-list
92162144|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162145|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162146|NCT01158651|Everolimus|everolimus|mesh-list
92162148|NCT01158651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92162149|NCT01158651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182575|NCT01680549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207834|NCT04112823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207907|NCT04923113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327615|NCT00003086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162150|NCT01158651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208056|NCT00845039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162151|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162152|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
92162153|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162154|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162155|NCT04852679|Lanreotide|lanreotide|mesh-list
92162156|NCT04852679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162157|NCT04826393|Cemiplimab|cemiplimab|mesh-list
92162158|NCT04826393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162159|NCT04826393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162161|NCT03262103|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92162162|NCT03262103|Poly ICLC|poly iclc|mesh-list
92162163|NCT03262103|Interferon Inducers|interferon inducers|mesh-ancestor
92162164|NCT03262103|Immunologic Factors|immunologic factors|mesh-ancestor
92162165|NCT03262103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162166|NCT03262103|Laxatives|laxatives|mesh-ancestor
92162167|NCT03262103|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92162168|NCT03262103|Antiviral Agents|antiviral agents|mesh-ancestor
92162169|NCT03262103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162170|NCT04777643|Cannabidiol|cannabidiol|mesh-list
92162171|NCT04777643|Anticonvulsants|anticonvulsants|mesh-ancestor
92162172|NCT04775225|Lidocaine|lidocaine|mesh-list
92162173|NCT04775225|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162174|NCT04775225|Anesthetics|anesthetics|mesh-ancestor
92162175|NCT04775225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208641|NCT00827099|Antitubercular Agents|antitubercular agents|mesh-ancestor
92162177|NCT04775225|Sensory System Agents|sensory system agents|mesh-ancestor
92162178|NCT04775225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162179|NCT04775225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92162180|NCT04775225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92162181|NCT04775225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92162182|NCT04775225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92162183|NCT04775225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162184|NCT04731467|Paclitaxel|paclitaxel|mesh-list
92162185|NCT04731467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92162186|NCT04731467|Gemcitabine|gemcitabine|mesh-list
92162187|NCT04731467|Nivolumab|nivolumab|mesh-list
92162188|NCT04731467|Fluorouracil|fluorouracil|mesh-list
92162189|NCT04731467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92162190|NCT04731467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162191|NCT04731467|Tubulin Modulators|tubulin modulators|mesh-ancestor
92162192|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
92162193|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
92162194|NCT04731467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162195|NCT04731467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92162196|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
92162197|NCT04731467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162198|NCT04731467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162199|NCT04731467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162200|NCT04731467|Immunologic Factors|immunologic factors|mesh-ancestor
92162201|NCT04731467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162202|NCT04685915|Acalabrutinib|acalabrutinib|mesh-list
92208788|NCT00859495|Doxorubicin|doxorubicin|mesh-list
92162203|NCT04685915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162204|NCT04399187|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92162206|NCT04399187|Disinfectants|disinfectants|mesh-ancestor
92162207|NCT04399187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162208|NCT03240809|Brodalumab|brodalumab|mesh-list
92162209|NCT03240809|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92162210|NCT03240809|Dermatologic Agents|dermatologic agents|mesh-ancestor
92162211|NCT03240809|Immunologic Factors|immunologic factors|mesh-ancestor
92162212|NCT03240809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162213|NCT03239561|JNJ-64326067|jnj-64326067|mesh-list
92162214|NCT03239561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92208907|NCT04344483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92162215|NCT03239561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162216|NCT04746365|Hydroxychloroquine|hydroxychloroquine|mesh-list
92162217|NCT04746365|Ivermectin|ivermectin|mesh-list
92162218|NCT04746365|Antimalarials|antimalarials|mesh-ancestor
92162220|NCT04746365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92162221|NCT04746365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162222|NCT04746365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162223|NCT04746365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162224|NCT04746365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162226|NCT04399343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92162227|NCT04399343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162228|NCT04399343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162229|NCT04399343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162230|NCT04399343|Analgesics|analgesics|mesh-ancestor
92162231|NCT04399343|Sensory System Agents|sensory system agents|mesh-ancestor
92162232|NCT04399343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162233|NCT04399343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92162234|NCT04399343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92162235|NCT04399343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92162236|NCT04399343|Adrenergic Agents|adrenergic agents|mesh-ancestor
92162237|NCT04399343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162238|NCT04399343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162239|NCT03676049|Cannabidiol|cannabidiol|mesh-list
92162240|NCT03676049|Anticonvulsants|anticonvulsants|mesh-ancestor
92162241|NCT03233633|Cannabidiol|cannabidiol|mesh-list
92162242|NCT03233633|Anticonvulsants|anticonvulsants|mesh-ancestor
92162243|NCT02984345|Caseins|caseins|mesh-list
92162244|NCT02984345|Chelating Agents|chelating agents|mesh-ancestor
92162245|NCT02984345|Sequestering Agents|sequestering agents|mesh-ancestor
92162246|NCT02984345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162247|NCT01232205|Micronutrients|micronutrients|mesh-list
92162248|NCT01232205|Trace Elements|trace elements|mesh-list
92162249|NCT01232205|Antioxidants|antioxidants|mesh-list
92162250|NCT01232205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162251|NCT01232205|Protective Agents|protective agents|mesh-ancestor
92162252|NCT01232205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162253|NCT04584125|Riboflavin|riboflavin|mesh-list
92162254|NCT04584125|Flavin Mononucleotide|flavin mononucleotide|mesh-list
92162255|NCT04584125|Dextrans|dextrans|mesh-list
92162256|NCT04584125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92162257|NCT04584125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92162258|NCT04584125|Vitamin B Complex|vitamin b complex|mesh-ancestor
92162259|NCT04584125|Vitamins|vitamins|mesh-ancestor
92162260|NCT04584125|Micronutrients|micronutrients|mesh-ancestor
92162261|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162262|NCT04584125|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92162263|NCT04584125|Dermatologic Agents|dermatologic agents|mesh-ancestor
92162264|NCT04584125|Anticoagulants|anticoagulants|mesh-ancestor
92162265|NCT04584125|Plasma Substitutes|plasma substitutes|mesh-ancestor
92162266|NCT04584125|Blood Substitutes|blood substitutes|mesh-ancestor
92162267|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
92162269|NCT04348409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162270|NCT01158885|Cytarabine|cytarabine|mesh-list
92162271|NCT01158885|Methotrexate|methotrexate|mesh-list
92162272|NCT01158885|Clofarabine|clofarabine|mesh-list
92162273|NCT01158885|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92162274|NCT01158885|Abortifacient Agents|abortifacient agents|mesh-ancestor
92162275|NCT01158885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92209375|NCT03215407|Betamethasone|betamethasone|mesh-list
92162276|NCT01158885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162277|NCT01158885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92162278|NCT01158885|Antimetabolites|antimetabolites|mesh-ancestor
92182576|NCT01680549|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92162279|NCT01158885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162280|NCT01158885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162281|NCT01158885|Dermatologic Agents|dermatologic agents|mesh-ancestor
92162282|NCT01158885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162283|NCT01158885|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92209527|NCT00887653|Raltegravir Potassium|raltegravir potassium|mesh-list
92162284|NCT01158885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162285|NCT01158885|Immunologic Factors|immunologic factors|mesh-ancestor
92162286|NCT01158885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162287|NCT01158885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92162288|NCT01158885|Antiviral Agents|antiviral agents|mesh-ancestor
92162289|NCT01158885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162290|NCT01232829|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92162291|NCT01232829|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92162292|NCT01232829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182577|NCT01680549|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92182578|NCT01680549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210121|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
92162293|NCT01232829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162296|NCT01233921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162298|NCT03367013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162299|NCT03226301|Venetoclax|venetoclax|mesh-list
92162300|NCT03226301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162301|NCT01236105|Charcoal|charcoal|mesh-list
92162302|NCT01236105|Antidotes|antidotes|mesh-ancestor
92162303|NCT01236105|Protective Agents|protective agents|mesh-ancestor
92210256|NCT04380025|Antioxidants|antioxidants|mesh-ancestor
92162304|NCT01236105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162305|NCT04533347|Tafenoquine|tafenoquine|mesh-list
92210328|NCT02494102|Modafinil|modafinil|mesh-list
92162306|NCT04533347|Antimalarials|antimalarials|mesh-ancestor
92162307|NCT04533347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92162308|NCT04533347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92162309|NCT04533347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162310|NCT01160445|Aldesleukin|aldesleukin|mesh-list
92162311|NCT01160445|Zanolimumab|zanolimumab|mesh-list
92162312|NCT01160445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162314|NCT01160445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92162315|NCT01160445|Antiviral Agents|antiviral agents|mesh-ancestor
92162316|NCT01160445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162317|NCT01160445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162318|NCT01237041|Niacin|niacin|mesh-list
92162319|NCT01237041|Niacinamide|niacinamide|mesh-list
92162320|NCT01237041|Nicotinic Acids|nicotinic acids|mesh-list
92162321|NCT01237041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92162322|NCT01237041|Antimetabolites|antimetabolites|mesh-ancestor
92162323|NCT01237041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162324|NCT01237041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162325|NCT01237041|Vasodilator Agents|vasodilator agents|mesh-ancestor
92162326|NCT01237041|Vitamin B Complex|vitamin b complex|mesh-ancestor
92162327|NCT01237041|Vitamins|vitamins|mesh-ancestor
92162328|NCT01237041|Micronutrients|micronutrients|mesh-ancestor
92162329|NCT01237041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162330|NCT01237197|Exenatide|exenatide|mesh-list
92162331|NCT01237197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92162332|NCT01237197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162333|NCT01237197|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92162335|NCT01237197|Hormones|hormones|mesh-ancestor
92162336|NCT01237197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162337|NCT01237353|Rabeprazole|rabeprazole|mesh-list
92162338|NCT01237353|Betaine|betaine|mesh-list
92162339|NCT01237353|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92162340|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92162341|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92162342|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210909|NCT02939872|Antipyretics|antipyretics|mesh-ancestor
92162343|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162344|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
92162345|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92162346|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
92162347|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162348|NCT03634241|Pembrolizumab|pembrolizumab|mesh-list
92162349|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162350|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162351|NCT03634241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162352|NCT03634241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162353|NCT04410341|Vildagliptin|vildagliptin|mesh-list
92162354|NCT04410341|Escitalopram|escitalopram|mesh-list
92211125|NCT01728961|Artemether|artemether|mesh-list
92162355|NCT04410341|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92162356|NCT04410341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92162357|NCT04410341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92162358|NCT04410341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162359|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162360|NCT04410341|Serotonin Agents|serotonin agents|mesh-ancestor
92162361|NCT04410341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162362|NCT04410341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92211190|NCT00872729|Cysteamine|cysteamine|mesh-list
92162363|NCT04410341|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92162365|NCT04410341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162367|NCT03010761|Escitalopram|escitalopram|mesh-list
92162368|NCT03010761|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92162369|NCT03010761|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92162370|NCT03010761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92162371|NCT03010761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402405|NCT01422616|Esmolol|esmolol|mesh-list
92162372|NCT03010761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162374|NCT03010761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162375|NCT03010761|Antidepressive Agents|antidepressive agents|mesh-ancestor
92162376|NCT03010761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162377|NCT03010761|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92162378|NCT03010761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162379|NCT01243593|Anesthetics|anesthetics|mesh-list
92162380|NCT01243593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162381|NCT01243593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162382|NCT04362761|Ivacaftor|ivacaftor|mesh-list
92162383|NCT04362761|Elexacaftor|elexacaftor|mesh-list
92162384|NCT04362761|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92162385|NCT04362761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92162386|NCT04362761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162387|NCT01162005|Tacrolimus|tacrolimus|mesh-list
92162388|NCT01162005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162389|NCT01162005|Immunologic Factors|immunologic factors|mesh-ancestor
92162390|NCT01162005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162391|NCT01162005|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92162392|NCT01162005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162393|NCT01162005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162394|NCT04596995|Rozanolixizumab|rozanolixizumab|mesh-list
92162395|NCT04596995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162396|NCT04596995|Immunologic Factors|immunologic factors|mesh-ancestor
92211682|NCT04295850|Antipyretics|antipyretics|mesh-ancestor
92162397|NCT04596995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162399|NCT04354649|Antimalarials|antimalarials|mesh-ancestor
92162400|NCT04354649|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92162401|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92162402|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162403|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162404|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162405|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162406|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92162407|NCT01244451|Ofatumumab|ofatumumab|mesh-list
92162408|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92162409|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
92212043|NCT02761252|Respiratory System Agents|respiratory system agents|mesh-ancestor
92162410|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162411|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162412|NCT05632211|Golimumab|golimumab|mesh-list
92162413|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92162414|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162415|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162417|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162418|NCT01246401|Naltrexone|naltrexone|mesh-list
92162419|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92162420|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92162421|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162422|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
92162423|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162424|NCT05627375|Anticoagulants|anticoagulants|mesh-list
92162425|NCT01281501|Scopolamine|scopolamine|mesh-list
92162426|NCT01281501|Pantoprazole|pantoprazole|mesh-list
92162427|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
92162428|NCT01281501|Antacids|antacids|mesh-list
92162429|NCT01281501|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92162430|NCT01281501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212258|NCT01041859|Tapentadol|tapentadol|mesh-list
92162431|NCT01281501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92162432|NCT01281501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162433|NCT01281501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162434|NCT01281501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92162436|NCT01281501|Autonomic Agents|autonomic agents|mesh-ancestor
92162438|NCT01281501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162439|NCT01281501|Mydriatics|mydriatics|mesh-ancestor
92162440|NCT01281501|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92162441|NCT01281501|Cholinergic Agents|cholinergic agents|mesh-ancestor
92162442|NCT01281501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162443|NCT01281501|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92162444|NCT01281501|Parasympatholytics|parasympatholytics|mesh-ancestor
92162445|NCT03353831|Bevacizumab|bevacizumab|mesh-list
92162447|NCT03353831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162448|NCT03353831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162449|NCT03353831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92162450|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92162452|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162453|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92162454|NCT03353831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92212683|NCT02781454|Mexiletine|mexiletine|mesh-list
92162455|NCT03353831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212761|NCT03400267|Fentanyl|fentanyl|mesh-list
92162457|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162458|NCT01246713|Analgesics|analgesics|mesh-ancestor
92162459|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
92162460|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162461|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162462|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
92162463|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92162464|NCT01246791|Norethindrone|norethindrone|mesh-list
92162465|NCT01246791|Norinyl|norinyl|mesh-list
92162466|NCT01246791|Estradiol|estradiol|mesh-list
92162467|NCT01246791|Estrogens|estrogens|mesh-ancestor
92162468|NCT01246791|Hormones|hormones|mesh-ancestor
92162469|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162470|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162471|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92162472|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
92162473|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92162474|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92162475|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92162476|NCT01246791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92162477|NCT01246791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92162478|NCT01246791|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92162479|NCT04319081|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92162480|NCT04319081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92162481|NCT04319081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92162482|NCT04319081|Antimetabolites|antimetabolites|mesh-ancestor
92162483|NCT04319081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213259|NCT03216941|Ketamine|ketamine|mesh-list
92162484|NCT04319081|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92162485|NCT04319081|Protease Inhibitors|protease inhibitors|mesh-ancestor
92162486|NCT04319081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162487|NCT04319081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162489|NCT05345639|Anesthetics|anesthetics|mesh-ancestor
92162490|NCT05345639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162491|NCT05345639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162492|NCT05345639|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162493|NCT05345639|Sensory System Agents|sensory system agents|mesh-ancestor
92162494|NCT05345639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162495|NCT04303325|Esketamine|esketamine|mesh-list
92162496|NCT04303325|Antidepressive Agents|antidepressive agents|mesh-ancestor
92162497|NCT04303325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162498|NCT04248335|Midazolam|midazolam|mesh-list
92162499|NCT04248335|Pantoprazole|pantoprazole|mesh-list
92162500|NCT04248335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92162501|NCT04248335|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92162502|NCT04248335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213617|NCT04371523|Hydroxychloroquine|hydroxychloroquine|mesh-list
92162503|NCT04248335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162504|NCT04248335|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92213693|NCT02242825|Telmisartan|telmisartan|mesh-list
92162505|NCT04248335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92162506|NCT04248335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162507|NCT04248335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92162508|NCT04248335|Anesthetics, General|anesthetics, general|mesh-ancestor
92213851|NCT03401593|Fentanyl|fentanyl|mesh-list
92162510|NCT04248335|GABA Modulators|gaba modulators|mesh-ancestor
92162511|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
92213932|NCT00929071|Lidocaine|lidocaine|mesh-list
92162513|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162514|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92162515|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92162516|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92162517|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162518|NCT04746209|Blinatumomab|blinatumomab|mesh-list
92162519|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162520|NCT04176419|Acetaminophen|acetaminophen|mesh-list
92162521|NCT04176419|Celecoxib|celecoxib|mesh-list
92162522|NCT04176419|Lidocaine|lidocaine|mesh-list
92162523|NCT04176419|Ketamine|ketamine|mesh-list
92162524|NCT04176419|Gabapentin|gabapentin|mesh-list
92162525|NCT04176419|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162526|NCT04176419|Anesthetics|anesthetics|mesh-ancestor
92162527|NCT04176419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162528|NCT04176419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162529|NCT04176419|Sensory System Agents|sensory system agents|mesh-ancestor
92162530|NCT04176419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162531|NCT04176419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92162532|NCT04176419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92162533|NCT04176419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92162534|NCT04176419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92162535|NCT04176419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162536|NCT04176419|Analgesics|analgesics|mesh-ancestor
92162537|NCT04176419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92162538|NCT04176419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92162539|NCT04176419|Anesthetics, General|anesthetics, general|mesh-ancestor
92162540|NCT04176419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92162541|NCT04176419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92162542|NCT04176419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162543|NCT04176419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162544|NCT04176419|Antipyretics|antipyretics|mesh-ancestor
92162545|NCT04176419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162546|NCT04176419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162547|NCT04176419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162548|NCT04176419|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92214552|NCT01047683|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162549|NCT04176419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92162552|NCT04176419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92162553|NCT04176419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92162554|NCT04176419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162556|NCT04168931|Trastuzumab|trastuzumab|mesh-list
92162557|NCT04168931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162558|NCT04168931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162559|NCT04165967|Nivolumab|nivolumab|mesh-list
92162560|NCT04165967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162561|NCT04165967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162562|NCT04165967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162563|NCT04165967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162564|NCT03211949|Mepivacaine|mepivacaine|mesh-list
92162565|NCT03211949|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162566|NCT03211949|Anesthetics|anesthetics|mesh-ancestor
92162567|NCT03211949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402442|NCT01422733|Dexamethasone|dexamethasone|mesh-list
92162568|NCT03211949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214990|NCT03033589|Bupivacaine|bupivacaine|mesh-list
92162570|NCT03211949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162571|NCT01285635|Docetaxel|docetaxel|mesh-list
92162572|NCT01285635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162573|NCT01285635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92162574|NCT01285635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92162575|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92215292|NCT01041287|Metoprolol|metoprolol|mesh-list
92162576|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162577|NCT01286259|Disulfiram|disulfiram|mesh-list
92162578|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92215354|NCT02049957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92162579|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92162580|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327616|NCT00003092|Paclitaxel|paclitaxel|mesh-list
92162581|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162583|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162584|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
92162585|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162586|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162587|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
92162589|NCT01288521|Ketoconazole|ketoconazole|mesh-list
92162590|NCT01288521|Tacrolimus|tacrolimus|mesh-list
92162591|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162592|NCT01288521|Immunologic Factors|immunologic factors|mesh-ancestor
92162593|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162594|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92162595|NCT01288521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215711|NCT02240927|Enoxaparin|enoxaparin|mesh-list
92162596|NCT01288521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162597|NCT01288521|Antifungal Agents|antifungal agents|mesh-ancestor
92162599|NCT01288521|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92162600|NCT01288521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92162601|NCT01288521|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92162602|NCT01288521|Hormone Antagonists|hormone antagonists|mesh-ancestor
92162603|NCT01288521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162604|NCT01288521|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92162606|NCT00632749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92162607|NCT00632749|Antimetabolites|antimetabolites|mesh-ancestor
92162608|NCT00632749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162609|NCT00632749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162610|NCT00632749|Antiviral Agents|antiviral agents|mesh-ancestor
92216072|NCT05475639|Diclofenac|diclofenac|mesh-list
92162611|NCT00632749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162612|NCT00632749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162613|NCT00632749|Immunologic Factors|immunologic factors|mesh-ancestor
92216142|NCT00358683|Immunologic Factors|immunologic factors|mesh-ancestor
92162614|NCT00632749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162616|NCT01289067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162617|NCT01248585|Dexamethasone|dexamethasone|mesh-list
92162618|NCT01248585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216241|NCT05595993|Cilostazol|cilostazol|mesh-list
92162619|NCT01248585|Antiemetics|antiemetics|mesh-ancestor
92162620|NCT01248585|Autonomic Agents|autonomic agents|mesh-ancestor
92162621|NCT01248585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162622|NCT01248585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162623|NCT01248585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216294|NCT00932321|Estradiol|estradiol|mesh-list
92162624|NCT01248585|Glucocorticoids|glucocorticoids|mesh-ancestor
92162625|NCT01248585|Hormones|hormones|mesh-ancestor
92162626|NCT01248585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162627|NCT01248585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92162628|NCT01248585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162629|NCT00632359|Lenalidomide|lenalidomide|mesh-list
92162630|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
92216432|NCT03051646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162631|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162632|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92162633|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92162634|NCT00632359|Growth Substances|growth substances|mesh-ancestor
92162635|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92162636|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162638|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
92162639|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162640|NCT03954899|Protective Agents|protective agents|mesh-ancestor
92162641|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162642|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162643|NCT03934307|Irbesartan|irbesartan|mesh-list
92162644|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92162645|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92162646|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92162647|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162648|NCT03924635|Budesonide|budesonide|mesh-list
92162649|NCT03924635|Albuterol|albuterol|mesh-list
92162650|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
92162651|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92162652|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162653|NCT03924635|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92162654|NCT03924635|Autonomic Agents|autonomic agents|mesh-ancestor
92162655|NCT03924635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162656|NCT03924635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162657|NCT03924635|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92217003|NCT02976597|Morphine|morphine|mesh-list
92162658|NCT03924635|Respiratory System Agents|respiratory system agents|mesh-ancestor
92162659|NCT03924635|Glucocorticoids|glucocorticoids|mesh-ancestor
92162661|NCT03924635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162662|NCT03924635|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92162663|NCT03924635|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92162664|NCT03924635|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92162665|NCT03924635|Adrenergic Agents|adrenergic agents|mesh-ancestor
92162666|NCT03924635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217221|NCT03019081|Isoproterenol|isoproterenol|mesh-list
92162667|NCT03924635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162668|NCT03924635|Tocolytic Agents|tocolytic agents|mesh-ancestor
92162669|NCT03924635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92162671|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
92162672|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162673|NCT00632203|Temozolomide|temozolomide|mesh-list
92162674|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92162675|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
92162676|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162677|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162678|NCT01289457|Cytarabine|cytarabine|mesh-list
92162679|NCT01289457|Fludarabine|fludarabine|mesh-list
92162680|NCT01289457|Idarubicin|idarubicin|mesh-list
92162681|NCT01289457|Clofarabine|clofarabine|mesh-list
92162682|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162683|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92162684|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
92162685|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162686|NCT01289457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217724|NCT00993187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162688|NCT01289457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162689|NCT01289457|Antiviral Agents|antiviral agents|mesh-ancestor
92217806|NCT04342065|Celecoxib|celecoxib|mesh-list
92162690|NCT01289457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162691|NCT01289457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92217869|NCT00421863|Analgesics|analgesics|mesh-ancestor
92162692|NCT01289457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92162693|NCT01289457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92162694|NCT01289457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162696|NCT03830333|Meropenem|meropenem|mesh-list
92162697|NCT03830333|Tazobactam|tazobactam|mesh-list
92218086|NCT04444843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92162699|NCT03830333|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92218163|NCT00362271|Dopamine Agents|dopamine agents|mesh-ancestor
92162700|NCT03830333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162701|NCT03830333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92162702|NCT03830333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92162703|NCT03830333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92162704|NCT03830333|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92162705|NCT03830333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218308|NCT00634244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162706|NCT03830333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162707|NCT03830333|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92162708|NCT01251315|Acetylcysteine|acetylcysteine|mesh-list
92162709|NCT01251315|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92218456|NCT01000987|Varenicline|varenicline|mesh-list
92162711|NCT01251315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162712|NCT01251315|Expectorants|expectorants|mesh-ancestor
92162713|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
92162714|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92162715|NCT01251315|Antioxidants|antioxidants|mesh-ancestor
92218675|NCT00635882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92162716|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162717|NCT01251315|Protective Agents|protective agents|mesh-ancestor
92162718|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162720|NCT03810287|Domperidone|domperidone|mesh-list
92162721|NCT03810287|Antiemetics|antiemetics|mesh-ancestor
92162722|NCT03810287|Autonomic Agents|autonomic agents|mesh-ancestor
92162723|NCT03810287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162724|NCT03810287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162725|NCT03810287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92162727|NCT03810287|Dopamine Agents|dopamine agents|mesh-ancestor
92162728|NCT03810287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162729|NCT03810287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162730|NCT03749057|Rivaroxaban|rivaroxaban|mesh-list
92162731|NCT03749057|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92162732|NCT03749057|Antithrombins|antithrombins|mesh-ancestor
92162733|NCT03749057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92162734|NCT03749057|Protease Inhibitors|protease inhibitors|mesh-ancestor
92162735|NCT03749057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162736|NCT03749057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162737|NCT03749057|Anticoagulants|anticoagulants|mesh-ancestor
92162738|NCT01290237|Vancomycin|vancomycin|mesh-list
92219105|NCT01925456|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92162739|NCT01290237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92162740|NCT01290237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162741|NCT03613727|Ascorbic Acid|ascorbic acid|mesh-list
92162742|NCT03613727|Vitamins|vitamins|mesh-ancestor
92162743|NCT03613727|Micronutrients|micronutrients|mesh-ancestor
92162744|NCT03613727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162745|NCT03613727|Antioxidants|antioxidants|mesh-ancestor
92219323|NCT03489850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162746|NCT03613727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162747|NCT03613727|Protective Agents|protective agents|mesh-ancestor
92162748|NCT01251393|Biperiden|biperiden|mesh-list
92162749|NCT01251393|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92162750|NCT01251393|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92162751|NCT01251393|Parasympatholytics|parasympatholytics|mesh-ancestor
92162752|NCT01251393|Autonomic Agents|autonomic agents|mesh-ancestor
92162753|NCT01251393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162754|NCT01251393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162755|NCT01251393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92162756|NCT01251393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92162757|NCT01251393|Cholinergic Agents|cholinergic agents|mesh-ancestor
92219616|NCT02973646|Entecavir|entecavir|mesh-list
92162758|NCT01251393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162759|NCT01251393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162760|NCT00631969|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92162761|NCT00631969|Vasodilator Agents|vasodilator agents|mesh-ancestor
92162762|NCT00631969|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92162763|NCT00631969|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92162764|NCT00631969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219694|NCT03378076|Triamcinolone|triamcinolone|mesh-list
92162765|NCT00631969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162766|NCT00631969|Urological Agents|urological agents|mesh-ancestor
92162767|NCT01255137|Axitinib|axitinib|mesh-list
92162768|NCT01255137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162769|NCT01255137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92162770|NCT01255137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219829|NCT01084759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92402459|NCT01422785|Tretinoin|tretinoin|mesh-list
92162771|NCT01255137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162773|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92162774|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
92162775|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162776|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162777|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92162778|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
92162779|NCT01255449|Tocolytic Agents|tocolytic agents|mesh-ancestor
92162780|NCT01255449|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92162781|NCT01255449|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92162782|NCT01255449|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92162783|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92162784|NCT01255449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92162785|NCT01255449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162786|NCT01255449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162787|NCT00631657|Mirtazapine|mirtazapine|mesh-list
92162788|NCT00631657|Antidepressive Agents|antidepressive agents|mesh-ancestor
92162789|NCT00631657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162790|NCT00631657|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92219962|NCT02673931|Exenatide|exenatide|mesh-list
92162791|NCT00631657|Histamine Antagonists|histamine antagonists|mesh-ancestor
92162792|NCT00631657|Histamine Agents|histamine agents|mesh-ancestor
92162793|NCT00631657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220121|NCT03393208|Metformin|metformin|mesh-list
92162794|NCT00631657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162795|NCT00631657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162797|NCT00631657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92162798|NCT00631657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162799|NCT00631657|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92162800|NCT00631657|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92220336|NCT00939731|Crizotinib|crizotinib|mesh-list
92162801|NCT00631657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92162802|NCT00631657|Adrenergic Agents|adrenergic agents|mesh-ancestor
92220405|NCT03030911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92162803|NCT00631657|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92162804|NCT00631657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92162805|NCT00631657|Serotonin Agents|serotonin agents|mesh-ancestor
92162806|NCT00631657|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92162807|NCT01257087|Insulin|insulin|mesh-list
92162808|NCT01257087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92162809|NCT01257087|Insulin Glargine|insulin glargine|mesh-list
92162810|NCT01257087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92162811|NCT01257087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162812|NCT03106415|Pembrolizumab|pembrolizumab|mesh-list
92162813|NCT03106415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162814|NCT03106415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220883|NCT03017495|Midazolam|midazolam|mesh-list
92162815|NCT03106415|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162816|NCT03106415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162818|NCT00631189|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92162819|NCT00631189|Pravastatin|pravastatin|mesh-list
92162821|NCT00631189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92162822|NCT00631189|Antimetabolites|antimetabolites|mesh-ancestor
92162823|NCT00631189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162824|NCT00631189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162825|NCT00631189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92162826|NCT00631189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162827|NCT00630877|Aspirin|aspirin|mesh-list
92162828|NCT00630877|Niacin|niacin|mesh-list
92162829|NCT00630877|Niacinamide|niacinamide|mesh-list
92162830|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
92162831|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162832|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220993|NCT05313958|Cytarabine|cytarabine|mesh-list
92162833|NCT00630877|Analgesics|analgesics|mesh-ancestor
92162834|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
92162835|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162836|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162837|NCT00630877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162838|NCT00630877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162839|NCT00630877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92162840|NCT00630877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92162841|NCT00630877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162842|NCT00630877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92162843|NCT00630877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92162844|NCT00630877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162845|NCT00630877|Antipyretics|antipyretics|mesh-ancestor
92162846|NCT00630877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92162847|NCT00630877|Antimetabolites|antimetabolites|mesh-ancestor
92162848|NCT00630877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92162849|NCT00630877|Vasodilator Agents|vasodilator agents|mesh-ancestor
92162850|NCT00630877|Vitamin B Complex|vitamin b complex|mesh-ancestor
92162851|NCT00630877|Vitamins|vitamins|mesh-ancestor
92162852|NCT00630877|Micronutrients|micronutrients|mesh-ancestor
92162853|NCT04557163|Itraconazole|itraconazole|mesh-list
92162854|NCT04557163|Antifungal Agents|antifungal agents|mesh-ancestor
92162855|NCT04557163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162856|NCT04557163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92162857|NCT04557163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92162858|NCT04557163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162859|NCT04557163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162860|NCT04557163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92162861|NCT04557163|Hormone Antagonists|hormone antagonists|mesh-ancestor
92221339|NCT00957359|Niacin|niacin|mesh-list
92162862|NCT04557163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92162863|NCT04557163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162864|NCT04557163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92162865|NCT02915783|Everolimus|everolimus|mesh-list
92162866|NCT02915783|Lenvatinib|lenvatinib|mesh-list
92162867|NCT02915783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92162868|NCT02915783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92162869|NCT02915783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162870|NCT02915783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162871|NCT02915783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92162872|NCT02915783|Immunologic Factors|immunologic factors|mesh-ancestor
92162873|NCT02915783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162874|NCT02915783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162875|NCT02736149|Ubenimex|ubenimex|mesh-list
92162876|NCT02736149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92162877|NCT02736149|Immunologic Factors|immunologic factors|mesh-ancestor
92162878|NCT02736149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162879|NCT02736149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92162880|NCT02736149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162881|NCT02736149|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92162882|NCT02736149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162883|NCT02736149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92221613|NCT05314270|Copper|copper|mesh-list
92162884|NCT02736149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162885|NCT02736149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162886|NCT02736149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92162887|NCT02736149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92162888|NCT02736149|Antiviral Agents|antiviral agents|mesh-ancestor
92221685|NCT01126255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162890|NCT02307149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162891|NCT02307149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162892|NCT02307149|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162893|NCT02307149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162895|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92162896|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92162897|NCT04397393|Midazolam|midazolam|mesh-list
92162898|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92162899|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92162900|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162901|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162902|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92162903|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92162904|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162905|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92162906|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
92162907|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
92162908|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
92162909|NCT04397393|GABA Agents|gaba agents|mesh-ancestor
92162910|NCT04397393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162911|NCT04397393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162912|NCT03168737|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92162913|NCT03168737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92162914|NCT03168737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162915|NCT01176461|Nivolumab|nivolumab|mesh-list
92162916|NCT01176461|Vaccines|vaccines|mesh-list
92162917|NCT01176461|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92162918|NCT01176461|Immunologic Factors|immunologic factors|mesh-ancestor
92162919|NCT01176461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162920|NCT01176461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92162921|NCT01176461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162922|NCT01176461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92162923|NCT01176461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162924|NCT01176461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92162926|NCT00630331|Immunologic Factors|immunologic factors|mesh-ancestor
92162927|NCT00630331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162928|NCT04555291|Ropivacaine|ropivacaine|mesh-list
92162929|NCT04555291|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162930|NCT04555291|Anesthetics|anesthetics|mesh-ancestor
92162931|NCT04555291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162932|NCT04555291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162933|NCT04555291|Sensory System Agents|sensory system agents|mesh-ancestor
92162934|NCT04555291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162935|NCT04275115|Midazolam|midazolam|mesh-list
92162936|NCT04275115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92162937|NCT04275115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92162938|NCT04275115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92162939|NCT04275115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162940|NCT04275115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92162941|NCT04275115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92162942|NCT04275115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92162944|NCT04275115|Anesthetics, General|anesthetics, general|mesh-ancestor
92162945|NCT04275115|Anesthetics|anesthetics|mesh-ancestor
92162946|NCT04275115|GABA Modulators|gaba modulators|mesh-ancestor
92162947|NCT04275115|GABA Agents|gaba agents|mesh-ancestor
92162948|NCT04275115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92162949|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162950|NCT00633997|Vildagliptin|vildagliptin|mesh-list
92162951|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92162952|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162953|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92162954|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
92162955|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222375|NCT02185339|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92162956|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162959|NCT04559347|Anesthetics, Local|anesthetics, local|mesh-ancestor
92162960|NCT04559347|Anesthetics|anesthetics|mesh-ancestor
92162962|NCT04559347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162963|NCT04559347|Sensory System Agents|sensory system agents|mesh-ancestor
92162964|NCT04559347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162965|NCT00631111|Aspirin|aspirin|mesh-list
92162966|NCT00631111|Ibuprofen|ibuprofen|mesh-list
92162967|NCT00631111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162968|NCT00631111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162969|NCT00631111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162971|NCT00631111|Sensory System Agents|sensory system agents|mesh-ancestor
92222735|NCT05600660|Antimetabolites|antimetabolites|mesh-ancestor
92162972|NCT00631111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162973|NCT00631111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162974|NCT00631111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222813|NCT00955487|Antioxidants|antioxidants|mesh-ancestor
92162975|NCT00631111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92162976|NCT00631111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92162977|NCT00631111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92162978|NCT00631111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92162979|NCT00631111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92162980|NCT00631111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92162981|NCT00631111|Antipyretics|antipyretics|mesh-ancestor
92162982|NCT00630799|Leuprolide|leuprolide|mesh-list
92162983|NCT00630799|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92162984|NCT00630799|Fertility Agents|fertility agents|mesh-ancestor
92162985|NCT00630799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92162986|NCT00630799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162987|NCT00630799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92162988|NCT00630799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162989|NCT01925287|Curcumin|curcumin|mesh-list
92162990|NCT01925287|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92162991|NCT01925287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92162992|NCT01925287|Analgesics|analgesics|mesh-ancestor
92162993|NCT01925287|Sensory System Agents|sensory system agents|mesh-ancestor
92162994|NCT01925287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92162995|NCT01925287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92162996|NCT01925287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92162997|NCT01925287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92162998|NCT01925287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92162999|NCT01925287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223476|NCT03821714|Vitamins|vitamins|mesh-list
92163000|NCT01925287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223544|NCT05564286|Dexamethasone|dexamethasone|mesh-list
92163002|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163003|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92163004|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163005|NCT00667121|Tamoxifen|tamoxifen|mesh-list
92163006|NCT00667121|Gabapentin|gabapentin|mesh-list
92163007|NCT00667121|Dexetimide|dexetimide|mesh-list
92163008|NCT00667121|Citalopram|citalopram|mesh-list
92163009|NCT00667121|Sertraline|sertraline|mesh-list
92223691|NCT01453946|Hormones|hormones|mesh-ancestor
92223759|NCT01456208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163010|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92163012|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163013|NCT00667121|Analgesics|analgesics|mesh-ancestor
92163014|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
92163015|NCT00667121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163016|NCT00667121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163017|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
92163018|NCT00667121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92163019|NCT00667121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92223982|NCT04066426|Antipyretics|antipyretics|mesh-ancestor
92163020|NCT00667121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163021|NCT00667121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163022|NCT00667121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92163023|NCT00667121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92163024|NCT00667121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163026|NCT00667121|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92163027|NCT00667121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92163028|NCT00667121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92163029|NCT00667121|Serotonin Agents|serotonin agents|mesh-ancestor
92163030|NCT00667121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92163031|NCT00667121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92163032|NCT00667121|Parasympatholytics|parasympatholytics|mesh-ancestor
92163033|NCT00667121|Autonomic Agents|autonomic agents|mesh-ancestor
92163034|NCT00667121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92163035|NCT00667121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92163036|NCT00667121|Cholinergic Agents|cholinergic agents|mesh-ancestor
92163037|NCT00667121|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92163038|NCT00667121|Antidepressive Agents|antidepressive agents|mesh-ancestor
92163039|NCT00667121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92163040|NCT00667121|Hormone Antagonists|hormone antagonists|mesh-ancestor
92224488|NCT03150160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92163041|NCT00667121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163042|NCT00667121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163043|NCT00667121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163044|NCT00667121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92224631|NCT05493618|Dexamethasone|dexamethasone|mesh-list
92163045|NCT00667121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92163046|NCT00667121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92163047|NCT00667121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92163048|NCT04828343|Rozanolixizumab|rozanolixizumab|mesh-list
92163049|NCT04828343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92224857|NCT05499234|Antipyretics|antipyretics|mesh-ancestor
92163050|NCT04828343|Immunologic Factors|immunologic factors|mesh-ancestor
92224933|NCT01662648|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92163051|NCT04828343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163052|NCT04276649|Calcium Carbonate|calcium carbonate|mesh-list
92163053|NCT04276649|Antacids|antacids|mesh-ancestor
92163054|NCT04276649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163055|NCT04276649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163056|NCT04553419|Cephalexin|cephalexin|mesh-list
92163057|NCT04553419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163058|NCT04553419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163059|NCT03097783|Lidocaine|lidocaine|mesh-list
92163060|NCT03097783|Anesthetics, Local|anesthetics, local|mesh-ancestor
92163061|NCT03097783|Anesthetics|anesthetics|mesh-ancestor
92163062|NCT03097783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163063|NCT03097783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163064|NCT03097783|Sensory System Agents|sensory system agents|mesh-ancestor
92163065|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163066|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92163067|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92163068|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92163069|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225064|NCT02518750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163070|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163071|NCT04346407|Dronabinol|dronabinol|mesh-list
92163072|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
92163073|NCT04346407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163075|NCT04346407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92163076|NCT04346407|Analgesics|analgesics|mesh-ancestor
92163077|NCT04346407|Sensory System Agents|sensory system agents|mesh-ancestor
92225210|NCT01662492|Cholinergic Agents|cholinergic agents|mesh-ancestor
92163078|NCT04346407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163079|NCT04346407|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92163080|NCT04346407|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92163081|NCT04346407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163082|NCT04346407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163083|NCT04346407|Hormones|hormones|mesh-ancestor
92225352|NCT02130622|Anesthetics|anesthetics|mesh-ancestor
92163084|NCT04346407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163085|NCT04397549|Morphine|morphine|mesh-list
92163086|NCT04397549|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92163087|NCT04397549|Narcotics|narcotics|mesh-ancestor
92163088|NCT04397549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225425|NCT00996502|Growth Substances|growth substances|mesh-ancestor
92163089|NCT04397549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163090|NCT04397549|Analgesics|analgesics|mesh-ancestor
92163091|NCT04397549|Sensory System Agents|sensory system agents|mesh-ancestor
92163092|NCT04397549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163093|NCT03080441|Midodrine|midodrine|mesh-list
92163094|NCT03080441|Sympathomimetics|sympathomimetics|mesh-ancestor
92163095|NCT03080441|Autonomic Agents|autonomic agents|mesh-ancestor
92163096|NCT03080441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163097|NCT03080441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163098|NCT03080441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92225636|NCT03428958|Growth Inhibitors|growth inhibitors|mesh-ancestor
92163099|NCT03080441|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92163100|NCT03080441|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92163101|NCT03080441|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92163102|NCT03080441|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225856|NCT01566370|Zonisamide|zonisamide|mesh-list
92163103|NCT03080441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163104|NCT03080441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163105|NCT01925755|Rivaroxaban|rivaroxaban|mesh-list
92163106|NCT01925755|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92163107|NCT01925755|Antithrombins|antithrombins|mesh-ancestor
92163108|NCT01925755|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92163109|NCT01925755|Protease Inhibitors|protease inhibitors|mesh-ancestor
92163110|NCT01925755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163111|NCT01925755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163112|NCT01925755|Anticoagulants|anticoagulants|mesh-ancestor
92226149|NCT01662336|Lopinavir|lopinavir|mesh-list
92163115|NCT01920919|Antiemetics|antiemetics|mesh-ancestor
92163116|NCT01920919|Autonomic Agents|autonomic agents|mesh-ancestor
92163118|NCT01920919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163119|NCT01920919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163120|NCT01920919|Glucocorticoids|glucocorticoids|mesh-ancestor
92163121|NCT01920919|Hormones|hormones|mesh-ancestor
92163122|NCT01920919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226299|NCT00000808|Nevirapine|nevirapine|mesh-list
92163123|NCT01920919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163124|NCT01920919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163126|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92163127|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92163128|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163129|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163130|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92163131|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92163132|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163133|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92163134|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
92163135|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
92163136|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
92163137|NCT01925911|GABA Agents|gaba agents|mesh-ancestor
92163138|NCT01925911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163139|NCT01925911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163140|NCT05241431|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92163141|NCT05241431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163142|NCT05241431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92163143|NCT05241431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163145|NCT01921231|Prilocaine|prilocaine|mesh-list
92163146|NCT01921231|Anesthetics, Local|anesthetics, local|mesh-ancestor
92163147|NCT01921231|Anesthetics|anesthetics|mesh-ancestor
92226720|NCT03252600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163148|NCT01921231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163149|NCT01921231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163150|NCT01921231|Sensory System Agents|sensory system agents|mesh-ancestor
92163151|NCT01921231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163152|NCT03056833|Paclitaxel|paclitaxel|mesh-list
92163153|NCT03056833|Carboplatin|carboplatin|mesh-list
92163154|NCT03056833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92163155|NCT03056833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163156|NCT03056833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92163157|NCT03056833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92163158|NCT03056833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92163159|NCT03056833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163160|NCT05240261|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92163161|NCT05240261|Antidepressive Agents|antidepressive agents|mesh-ancestor
92163162|NCT05240261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163163|NCT05240261|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92163164|NCT05240261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92163165|NCT05240261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163166|NCT05240261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163167|NCT03148457|Rivaroxaban|rivaroxaban|mesh-list
92163168|NCT03148457|Apixaban|apixaban|mesh-list
92163169|NCT03148457|Edoxaban|edoxaban|mesh-list
92163170|NCT03148457|Dabigatran|dabigatran|mesh-list
92163171|NCT03148457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92163172|NCT03148457|Antithrombins|antithrombins|mesh-ancestor
92163173|NCT03148457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92163174|NCT03148457|Protease Inhibitors|protease inhibitors|mesh-ancestor
92163175|NCT03148457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163176|NCT03148457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163177|NCT03148457|Anticoagulants|anticoagulants|mesh-ancestor
92163178|NCT01926379|Isoniazid|isoniazid|mesh-list
92163179|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
92163180|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163181|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163182|NCT01926379|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92163183|NCT01926379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92163184|NCT01926379|Antimetabolites|antimetabolites|mesh-ancestor
92163185|NCT01926379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163186|NCT01926379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92163187|NCT05249309|Ketamine|ketamine|mesh-list
92163188|NCT05249309|Analgesics|analgesics|mesh-ancestor
92163189|NCT05249309|Sensory System Agents|sensory system agents|mesh-ancestor
92163190|NCT05249309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163191|NCT05249309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163192|NCT05249309|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92163193|NCT05249309|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92163194|NCT05249309|Anesthetics, General|anesthetics, general|mesh-ancestor
92163196|NCT05249309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163197|NCT05249309|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92163198|NCT05249309|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92163199|NCT05249309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163200|NCT05249309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163202|NCT02393183|Antioxidants|antioxidants|mesh-list
92163203|NCT02393183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163204|NCT02393183|Protective Agents|protective agents|mesh-ancestor
92163205|NCT02393183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163206|NCT02393183|Trace Elements|trace elements|mesh-ancestor
92163207|NCT02393183|Micronutrients|micronutrients|mesh-ancestor
92163208|NCT05599295|Oritavancin|oritavancin|mesh-list
92163209|NCT05599295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163210|NCT05599295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163211|NCT03351647|Ustekinumab|ustekinumab|mesh-list
92163212|NCT03351647|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163213|NCT05601271|Allopurinol|allopurinol|mesh-list
92163214|NCT05601271|Antimetabolites|antimetabolites|mesh-ancestor
92163215|NCT05601271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163216|NCT05601271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163217|NCT05601271|Gout Suppressants|gout suppressants|mesh-ancestor
92163218|NCT05601271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163219|NCT05601271|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92163220|NCT05601271|Antioxidants|antioxidants|mesh-ancestor
92163221|NCT05601271|Protective Agents|protective agents|mesh-ancestor
92163222|NCT05601271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163224|NCT02392637|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92163225|NCT02392637|Cisplatin|cisplatin|mesh-list
92163226|NCT02392637|Gemcitabine|gemcitabine|mesh-list
92163227|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92163228|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163229|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
92163230|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
92163231|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
92163232|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163233|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92163234|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
92163235|NCT05600881|Methylphenidate|methylphenidate|mesh-list
92163236|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92163237|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163238|NCT05600881|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92163239|NCT05600881|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92163240|NCT05600881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92163241|NCT05600881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163242|NCT05600881|Dopamine Agents|dopamine agents|mesh-ancestor
92163243|NCT05600881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163244|NCT01926769|Metformin|metformin|mesh-list
92163245|NCT01926769|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92163246|NCT01926769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163247|NCT04394143|Mannitol|mannitol|mesh-list
92163248|NCT04394143|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92163249|NCT04394143|Diuretics|diuretics|mesh-ancestor
92163250|NCT04394143|Natriuretic Agents|natriuretic agents|mesh-ancestor
92163251|NCT04394143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163252|NCT00639509|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92163253|NCT00639509|Immunologic Factors|immunologic factors|mesh-ancestor
92163254|NCT00639509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163255|NCT01926847|Riociguat|riociguat|mesh-list
92163256|NCT01926847|Enzyme Activators|enzyme activators|mesh-ancestor
92163257|NCT01926847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163258|NCT05586815|Minocycline|minocycline|mesh-list
92163259|NCT05586815|Colistin|colistin|mesh-list
92163260|NCT05586815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163261|NCT05586815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163262|NCT05607901|Hydrocortisone|hydrocortisone|mesh-list
92163264|NCT05607901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163265|NCT05607901|Immunologic Factors|immunologic factors|mesh-ancestor
92163266|NCT05607901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163267|NCT05607901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92163268|NCT05607901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163269|NCT05607901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163270|NCT05607901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92163271|NCT03133325|Lidocaine|lidocaine|mesh-list
92163272|NCT03133325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92163273|NCT03133325|Anesthetics|anesthetics|mesh-ancestor
92163274|NCT03133325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163275|NCT03133325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163276|NCT03133325|Sensory System Agents|sensory system agents|mesh-ancestor
92163277|NCT03133325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163278|NCT03133325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92163279|NCT03133325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92163280|NCT03133325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92163281|NCT03133325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92163282|NCT03133325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163283|NCT00638963|Temozolomide|temozolomide|mesh-list
92163284|NCT00638963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92163285|NCT00638963|Alkylating Agents|alkylating agents|mesh-ancestor
92163286|NCT00638963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163287|NCT00638963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163288|NCT04278677|Melatonin|melatonin|mesh-list
92163289|NCT04278677|Antioxidants|antioxidants|mesh-ancestor
92163290|NCT04278677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163291|NCT04278677|Protective Agents|protective agents|mesh-ancestor
92163292|NCT04278677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163293|NCT04278677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163294|NCT00638027|Memantine|memantine|mesh-list
92163295|NCT00638027|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92163296|NCT00638027|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92163297|NCT00638027|Dopamine Agents|dopamine agents|mesh-ancestor
92163298|NCT00638027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163299|NCT00638027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163300|NCT00638027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163301|NCT00638027|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92163302|NCT00638027|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92163303|NCT03342911|Paclitaxel|paclitaxel|mesh-list
92163304|NCT03342911|Carboplatin|carboplatin|mesh-list
92163305|NCT03342911|Nivolumab|nivolumab|mesh-list
92163306|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92163307|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163308|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92163309|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92163311|NCT03342911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163312|NCT03342911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92163313|NCT03342911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92163314|NCT05607199|Calcium|calcium|mesh-list
92163315|NCT05607199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92163316|NCT05607199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163317|NCT01927315|Fenofibrate|fenofibrate|mesh-list
92163318|NCT01927315|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92163319|NCT01927315|Antimetabolites|antimetabolites|mesh-ancestor
92163320|NCT01927315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163321|NCT01927315|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92163322|NCT00636155|Cyclophosphamide|cyclophosphamide|mesh-list
92163324|NCT00636155|Fludarabine|fludarabine|mesh-list
92163325|NCT00636155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163326|NCT00636155|Immunologic Factors|immunologic factors|mesh-ancestor
92163327|NCT00636155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163328|NCT00636155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163329|NCT00636155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92163330|NCT00636155|Alkylating Agents|alkylating agents|mesh-ancestor
92163331|NCT00636155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163332|NCT00636155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163333|NCT00636155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92163334|NCT00636155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92163335|NCT00634907|Warfarin|warfarin|mesh-list
92163337|NCT04124497|Dexamethasone|dexamethasone|mesh-list
92163338|NCT04124497|Daratumumab|daratumumab|mesh-list
92163339|NCT04124497|Pomalidomide|pomalidomide|mesh-list
92163340|NCT04124497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92163341|NCT04124497|Antiemetics|antiemetics|mesh-ancestor
92163342|NCT04124497|Autonomic Agents|autonomic agents|mesh-ancestor
92163343|NCT04124497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163344|NCT04124497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163345|NCT04124497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163346|NCT04124497|Glucocorticoids|glucocorticoids|mesh-ancestor
92163347|NCT04124497|Hormones|hormones|mesh-ancestor
92163348|NCT04124497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163349|NCT04124497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163350|NCT04124497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163351|NCT04124497|Immunologic Factors|immunologic factors|mesh-ancestor
92163352|NCT04124497|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92163353|NCT04124497|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92163354|NCT04124497|Growth Substances|growth substances|mesh-ancestor
92163355|NCT04124497|Growth Inhibitors|growth inhibitors|mesh-ancestor
92163356|NCT04127851|Cyclosporine|cyclosporine|mesh-list
92163357|NCT04127851|Cyclosporins|cyclosporins|mesh-list
92163359|NCT04127851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163360|NCT04127851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163361|NCT04127851|Immunologic Factors|immunologic factors|mesh-ancestor
92163362|NCT04127851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163363|NCT04127851|Antifungal Agents|antifungal agents|mesh-ancestor
92163364|NCT04127851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163365|NCT04127851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163366|NCT04127851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163367|NCT04127851|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92163368|NCT04394533|Bupivacaine|bupivacaine|mesh-list
92163369|NCT04394533|Prilocaine|prilocaine|mesh-list
92163370|NCT04394533|Anesthetics, Local|anesthetics, local|mesh-ancestor
92163371|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
92163372|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163373|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227716|NCT02483936|Olmesartan|olmesartan|mesh-list
92163374|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
92163375|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163377|NCT05602129|Calcium heparin|calcium heparin|mesh-list
92163378|NCT05602129|Anticoagulants|anticoagulants|mesh-ancestor
92163379|NCT05602129|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92163380|NCT05602129|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92163381|NCT05602129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163382|NCT05609929|Omeprazole|omeprazole|mesh-list
92163383|NCT05609929|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92227785|NCT01150981|Rosiglitazone|rosiglitazone|mesh-list
92163384|NCT05609929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163385|NCT05609929|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92163386|NCT05609929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163387|NCT05609929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163388|NCT01928563|Udenafil|udenafil|mesh-list
92163389|NCT01928563|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92163390|NCT01928563|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92163391|NCT01928563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163392|NCT01928563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163393|NCT04129255|Octreotide|octreotide|mesh-list
92163394|NCT04129255|Somatostatin|somatostatin|mesh-list
92163395|NCT04129255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163396|NCT04129255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163397|NCT04129255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163398|NCT04129255|Hormones|hormones|mesh-ancestor
92163399|NCT04129255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163400|NCT04129255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163401|NCT03044977|Octreotide|octreotide|mesh-list
92163402|NCT03044977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163403|NCT03044977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163404|NCT03044977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163405|NCT03422731|Alovudine|alovudine|mesh-list
92163406|NCT03422731|Antiviral Agents|antiviral agents|mesh-ancestor
92163407|NCT03422731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163408|NCT04129489|Cannabidiol|cannabidiol|mesh-list
92163409|NCT04129489|Anticonvulsants|anticonvulsants|mesh-ancestor
92163410|NCT04128787|Omeprazole|omeprazole|mesh-list
92163411|NCT04128787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92163412|NCT04128787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227983|NCT00002074|Amebicides|amebicides|mesh-ancestor
92163413|NCT04128787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92163414|NCT04128787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163415|NCT04128787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163417|NCT04394377|Enoxaparin|enoxaparin|mesh-list
92163418|NCT04394377|Calcium heparin|calcium heparin|mesh-list
92163419|NCT04394377|Rivaroxaban|rivaroxaban|mesh-list
92163420|NCT04394377|Enoxaparin sodium|enoxaparin sodium|mesh-list
92163421|NCT04394377|Anticoagulants|anticoagulants|mesh-ancestor
92163422|NCT04394377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92163423|NCT04394377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92163424|NCT04394377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228118|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
92163425|NCT04394377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92163426|NCT04394377|Antithrombins|antithrombins|mesh-ancestor
92163427|NCT04394377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92163428|NCT04394377|Protease Inhibitors|protease inhibitors|mesh-ancestor
92163429|NCT04394377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163431|NCT02984293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92163432|NCT02984293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92163433|NCT02984293|Antimetabolites|antimetabolites|mesh-ancestor
92163434|NCT02984293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163435|NCT02984293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92163436|NCT02984293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92163437|NCT02984293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163438|NCT01929187|Amorolfine|amorolfine|mesh-list
92163439|NCT01929187|Antifungal Agents|antifungal agents|mesh-ancestor
92163440|NCT01929187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163441|NCT00634751|Capecitabine|capecitabine|mesh-list
92163442|NCT00634751|Oxaliplatin|oxaliplatin|mesh-list
92163444|NCT00634751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92163445|NCT00634751|Antimetabolites|antimetabolites|mesh-ancestor
92163446|NCT00634751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163447|NCT00634751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163448|NCT00634751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92163449|NCT00634751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163450|NCT04396223|Methotrexate|methotrexate|mesh-list
92163451|NCT04396223|Avelumab|avelumab|mesh-list
92163452|NCT04396223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92163453|NCT04396223|Abortifacient Agents|abortifacient agents|mesh-ancestor
92163454|NCT04396223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92163455|NCT04396223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163456|NCT04396223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92163457|NCT04396223|Antimetabolites|antimetabolites|mesh-ancestor
92228253|NCT00001498|Doxorubicin|doxorubicin|mesh-list
92163458|NCT04396223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163459|NCT04396223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163460|NCT04396223|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163461|NCT04396223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163462|NCT04396223|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92163463|NCT04396223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163464|NCT04396223|Immunologic Factors|immunologic factors|mesh-ancestor
92163465|NCT04396223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163466|NCT04396223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92163467|NCT04396223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92163468|NCT04396067|Tretinoin|tretinoin|mesh-list
92163469|NCT04396067|Isotretinoin|isotretinoin|mesh-list
92163470|NCT04396067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163471|NCT04396067|Keratolytic Agents|keratolytic agents|mesh-ancestor
92163472|NCT04396067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163473|NCT05608213|Lenvatinib|lenvatinib|mesh-list
92163474|NCT05608213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163475|NCT05608213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92163476|NCT05608213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163477|NCT05608213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163478|NCT04124107|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92163479|NCT04124107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92163480|NCT04124107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163481|NCT03015259|Budesonide|budesonide|mesh-list
92163482|NCT03015259|Formoterol Fumarate|formoterol fumarate|mesh-list
92163483|NCT03015259|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92163484|NCT03015259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92163485|NCT03015259|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92163486|NCT03015259|Autonomic Agents|autonomic agents|mesh-ancestor
92163487|NCT03015259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163488|NCT03015259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163489|NCT03015259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92163490|NCT03015259|Respiratory System Agents|respiratory system agents|mesh-ancestor
92163491|NCT03015259|Glucocorticoids|glucocorticoids|mesh-ancestor
92163492|NCT03015259|Hormones|hormones|mesh-ancestor
92163493|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163495|NCT03015259|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92163496|NCT03015259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92163497|NCT03015259|Adrenergic Agents|adrenergic agents|mesh-ancestor
92163498|NCT03015259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163499|NCT03015259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163500|NCT03236545|Estradiol|estradiol|mesh-list
92163501|NCT03236545|Estrogens|estrogens|mesh-list
92163502|NCT03236545|Hormones|hormones|mesh-ancestor
92163503|NCT03236545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163504|NCT03236545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163505|NCT04126993|Apatinib|apatinib|mesh-list
92163506|NCT04126993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163507|NCT04126993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92163508|NCT04126993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163509|NCT04126993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163510|NCT04127227|Gemcitabine|gemcitabine|mesh-list
92163511|NCT04127227|Oxaliplatin|oxaliplatin|mesh-list
92163512|NCT04127227|Pegaspargase|pegaspargase|mesh-list
92163513|NCT04127227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92163514|NCT04127227|Antimetabolites|antimetabolites|mesh-ancestor
92163515|NCT04127227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163516|NCT04127227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163517|NCT04274803|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92163518|NCT04274803|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92163519|NCT04274803|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92228375|NCT00000628|Zidovudine|zidovudine|mesh-list
92163520|NCT04274803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92163521|NCT03292861|Mycophenolic Acid|mycophenolic acid|mesh-list
92163522|NCT03292861|Sirolimus|sirolimus|mesh-list
92163523|NCT03292861|Tacrolimus|tacrolimus|mesh-list
92163524|NCT03292861|Thymoglobulin|thymoglobulin|mesh-list
92163525|NCT03292861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163526|NCT03292861|Immunologic Factors|immunologic factors|mesh-ancestor
92163527|NCT03292861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163528|NCT03292861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92163529|NCT03292861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228405|NCT00002134|Ganciclovir|ganciclovir|mesh-list
92163530|NCT03292861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163531|NCT03292861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92163532|NCT03292861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163533|NCT03292861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92163534|NCT03292861|Antitubercular Agents|antitubercular agents|mesh-ancestor
92163535|NCT03292861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163536|NCT03292861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163537|NCT03292861|Antifungal Agents|antifungal agents|mesh-ancestor
92163538|NCT03828175|Anesthetics|anesthetics|mesh-list
92163539|NCT03828175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163540|NCT03828175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163541|NCT04392973|Hydroxychloroquine|hydroxychloroquine|mesh-list
92163542|NCT04392973|Favipiravir|favipiravir|mesh-list
92163543|NCT04392973|Antimalarials|antimalarials|mesh-ancestor
92163544|NCT04392973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92163545|NCT04392973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92163546|NCT04392973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163547|NCT04392973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163548|NCT04392973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163549|NCT04392973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163550|NCT04392973|Antiviral Agents|antiviral agents|mesh-ancestor
92163551|NCT03267277|Sodium thiosulfate|sodium thiosulfate|mesh-list
92163552|NCT03267277|Antidotes|antidotes|mesh-ancestor
92163553|NCT03267277|Protective Agents|protective agents|mesh-ancestor
92163554|NCT03267277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163555|NCT03267277|Antioxidants|antioxidants|mesh-ancestor
92163556|NCT03267277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163557|NCT03267277|Antitubercular Agents|antitubercular agents|mesh-ancestor
92163558|NCT03267277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163559|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163560|NCT03267277|Chelating Agents|chelating agents|mesh-ancestor
92163561|NCT03267277|Sequestering Agents|sequestering agents|mesh-ancestor
92163562|NCT00634049|Isavuconazole|isavuconazole|mesh-list
92163563|NCT00634049|Antifungal Agents|antifungal agents|mesh-ancestor
92163564|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163566|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92163567|NCT04123249|Anesthetics|anesthetics|mesh-list
92163568|NCT04123249|Sevoflurane|sevoflurane|mesh-list
92163570|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163571|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163572|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
92163573|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92228812|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
92163574|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92163575|NCT04758871|Progesterone|progesterone|mesh-list
92163576|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
92163577|NCT04758871|Progestins|progestins|mesh-ancestor
92163578|NCT04758871|Hormones|hormones|mesh-ancestor
92163579|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163580|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163581|NCT03336203|Allopurinol|allopurinol|mesh-list
92163582|NCT03336203|Febuxostat|febuxostat|mesh-list
92163583|NCT03336203|Antimetabolites|antimetabolites|mesh-ancestor
92163584|NCT03336203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163585|NCT03336203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163586|NCT03336203|Gout Suppressants|gout suppressants|mesh-ancestor
92163587|NCT03336203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402549|NCT01423305|Glucocorticoids|glucocorticoids|mesh-ancestor
92163588|NCT03336203|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92163589|NCT03336203|Antioxidants|antioxidants|mesh-ancestor
92163590|NCT03336203|Protective Agents|protective agents|mesh-ancestor
92163591|NCT03336203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163592|NCT04274413|Adrenergic Agents|adrenergic agents|mesh-list
92163593|NCT04274413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163594|NCT04274413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163595|NCT04274413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163596|NCT04274257|Rituximab|rituximab|mesh-list
92163597|NCT04274257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92163598|NCT04274257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163599|NCT04274257|Immunologic Factors|immunologic factors|mesh-ancestor
92163600|NCT04274257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163601|NCT04274257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163602|NCT03128879|Venetoclax|venetoclax|mesh-list
92163603|NCT03128879|Acalabrutinib|acalabrutinib|mesh-list
92163604|NCT03128879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163605|NCT03831815|Rocuronium|rocuronium|mesh-list
92163606|NCT03831815|Cisatracurium|cisatracurium|mesh-list
92163607|NCT03831815|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92163608|NCT03831815|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92163609|NCT03831815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92163610|NCT03831815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228957|NCT00002362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163611|NCT03831815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163612|NCT00632099|Progesterone|progesterone|mesh-list
92163613|NCT00632099|Progestins|progestins|mesh-ancestor
92163614|NCT00632099|Hormones|hormones|mesh-ancestor
92163615|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163616|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163617|NCT03827629|Naloxone|naloxone|mesh-list
92163618|NCT03827629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92163619|NCT03827629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163620|NCT03827629|Sensory System Agents|sensory system agents|mesh-ancestor
92163621|NCT03827629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163622|NCT00631475|Bosentan|bosentan|mesh-list
92163623|NCT00631475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92163624|NCT00631475|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92163625|NCT00631475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163626|NCT03826615|Gabapentin|gabapentin|mesh-list
92163627|NCT03826615|Analgesics|analgesics|mesh-ancestor
92163628|NCT03826615|Sensory System Agents|sensory system agents|mesh-ancestor
92163629|NCT03826615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163630|NCT03826615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163631|NCT03826615|Anticonvulsants|anticonvulsants|mesh-ancestor
92163632|NCT03826615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92163633|NCT03826615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92163634|NCT03826615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163635|NCT03826615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163636|NCT03826615|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92163637|NCT03826615|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92163638|NCT03826615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163639|NCT03826615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163640|NCT03826615|Antimanic Agents|antimanic agents|mesh-ancestor
92163641|NCT04124887|Calcium, Dietary|calcium, dietary|mesh-list
92163642|NCT04124887|Listerine|listerine|mesh-list
92163643|NCT04124887|Calcium|calcium|mesh-list
92163644|NCT04124887|Fluorides|fluorides|mesh-list
92163645|NCT04124887|Sodium Fluoride|sodium fluoride|mesh-list
92163646|NCT04124887|Caseins|caseins|mesh-list
92163647|NCT04124887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92163648|NCT04124887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163649|NCT04124887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92163650|NCT04124887|Cariostatic Agents|cariostatic agents|mesh-ancestor
92163651|NCT04124887|Protective Agents|protective agents|mesh-ancestor
92163652|NCT04124887|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92163653|NCT04124887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163654|NCT04124887|Chelating Agents|chelating agents|mesh-ancestor
92163655|NCT04124887|Sequestering Agents|sequestering agents|mesh-ancestor
92163656|NCT04124887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163657|NCT04121767|Warfarin|warfarin|mesh-list
92163659|NCT04121767|Anticoagulants|anticoagulants|mesh-ancestor
92163660|NCT04121767|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92163661|NCT04121767|Antithrombins|antithrombins|mesh-ancestor
92163662|NCT04121767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92163663|NCT04121767|Protease Inhibitors|protease inhibitors|mesh-ancestor
92163664|NCT04121767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163665|NCT04121767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163666|NCT04121689|Caseins|caseins|mesh-list
92163667|NCT04121689|Chelating Agents|chelating agents|mesh-ancestor
92163668|NCT04121689|Sequestering Agents|sequestering agents|mesh-ancestor
92163669|NCT04121689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163671|NCT03830827|Antidepressive Agents|antidepressive agents|mesh-ancestor
92229252|NCT01241539|Dabigatran|dabigatran|mesh-list
92163672|NCT03830827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163673|NCT03830827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92163674|NCT03830827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92163675|NCT03830827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92229400|NCT01897454|Antidotes|antidotes|mesh-ancestor
92163676|NCT03830827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229474|NCT01459484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163677|NCT03830827|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92163678|NCT03830827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92163679|NCT03830827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92229547|NCT01002755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92163680|NCT03830827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163681|NCT03830827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163682|NCT03830827|Serotonin Agents|serotonin agents|mesh-ancestor
92229621|NCT01421810|Hormones|hormones|mesh-ancestor
92163683|NCT03830827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92163684|NCT03830827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92163685|NCT03830827|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92163686|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92163687|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92163688|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163689|NCT03098485|Azithromycin|azithromycin|mesh-list
92163690|NCT03098485|Levofloxacin|levofloxacin|mesh-list
92163691|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
92163692|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
92163693|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163694|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163695|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92229928|NCT00002494|Antidotes|antidotes|mesh-ancestor
92163696|NCT03098485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92163697|NCT03098485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92163698|NCT03098485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229982|NCT03845621|Antifungal Agents|antifungal agents|mesh-ancestor
92163699|NCT03098485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163700|NCT03098485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230059|NCT00002524|Vitamins|vitamins|mesh-ancestor
92163701|NCT03098485|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92163702|NCT03098485|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92163703|NCT04121533|Vitamin D|vitamin d|mesh-list
92163704|NCT04121533|Cholecalciferol|cholecalciferol|mesh-list
92163705|NCT04121533|Vitamins|vitamins|mesh-ancestor
92163706|NCT04121533|Micronutrients|micronutrients|mesh-ancestor
92163707|NCT04121533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163708|NCT04121533|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92163709|NCT04121533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92163710|NCT03822169|Choline|choline|mesh-list
92163711|NCT03822169|Lipotropic Agents|lipotropic agents|mesh-ancestor
92163712|NCT03822169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92163713|NCT03822169|Antimetabolites|antimetabolites|mesh-ancestor
92163714|NCT03822169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163715|NCT03822169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163720|NCT03825601|Protective Agents|protective agents|mesh-ancestor
92163721|NCT03825601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163722|NCT03825601|GABA Modulators|gaba modulators|mesh-ancestor
92163723|NCT03825601|GABA Agents|gaba agents|mesh-ancestor
92230498|NCT00002548|Prednisone|prednisone|mesh-list
92163724|NCT03825601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163725|NCT03825601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182579|NCT01680549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182580|NCT01680549|Antimanic Agents|antimanic agents|mesh-ancestor
92163726|NCT03821701|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92163727|NCT03821701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92163728|NCT03821701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163729|NCT03825445|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92163730|NCT03825445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230828|NCT00002656|NSC 366140|nsc 366140|mesh-list
92163731|NCT03825445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163732|NCT03064867|Rituximab|rituximab|mesh-list
92163733|NCT03064867|Carboplatin|carboplatin|mesh-list
92163734|NCT03064867|Etoposide|etoposide|mesh-list
92163735|NCT03064867|Venetoclax|venetoclax|mesh-list
92163736|NCT03064867|Ifosfamide|ifosfamide|mesh-list
92163737|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92163738|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163739|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
92163740|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231101|NCT00002704|Vitamins|vitamins|mesh-ancestor
92163741|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163742|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92163743|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92163744|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92163745|NCT03064867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163746|NCT03064867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182582|NCT01466348|Caffeine|caffeine|mesh-list
92163747|NCT03064867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92163748|NCT03064867|Alkylating Agents|alkylating agents|mesh-ancestor
92163752|NCT03824743|Plasma-lyte 148|plasma-lyte 148|mesh-list
92163753|NCT03824743|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92163754|NCT03824743|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92163756|NCT03824665|Nalbuphine|nalbuphine|mesh-list
92163757|NCT03824665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92163759|NCT03824665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231462|NCT04748848|Venetoclax|venetoclax|mesh-list
92163761|NCT03824665|Analgesics|analgesics|mesh-ancestor
92163762|NCT03824665|Sensory System Agents|sensory system agents|mesh-ancestor
92163763|NCT03824665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163764|NCT03824665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92163765|NCT03824665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92163766|NCT03824665|Anesthetics, General|anesthetics, general|mesh-ancestor
92163767|NCT03824665|Anesthetics|anesthetics|mesh-ancestor
92163769|NCT04120831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92163770|NCT04120831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163771|NCT04120831|Immunologic Factors|immunologic factors|mesh-ancestor
92163772|NCT04120831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163773|NCT04120831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163774|NCT04120831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92163775|NCT04120831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163776|NCT04120831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163777|NCT00631163|Deferasirox|deferasirox|mesh-list
92163778|NCT00631163|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92163779|NCT00631163|Chelating Agents|chelating agents|mesh-ancestor
92163780|NCT00631163|Sequestering Agents|sequestering agents|mesh-ancestor
92163781|NCT00631163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163782|NCT02677051|Sulforaphane|sulforaphane|mesh-list
92163783|NCT02677051|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92163784|NCT02677051|Protective Agents|protective agents|mesh-ancestor
92163785|NCT02677051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163786|NCT02677051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163787|NCT04120519|Thalidomide|thalidomide|mesh-list
92163788|NCT04120519|Dexamethasone|dexamethasone|mesh-list
92163789|NCT04120519|Cyclophosphamide|cyclophosphamide|mesh-list
92163790|NCT04120519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92163791|NCT04120519|Immunologic Factors|immunologic factors|mesh-ancestor
92163792|NCT04120519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163793|NCT04120519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92163794|NCT04120519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92163795|NCT04120519|Alkylating Agents|alkylating agents|mesh-ancestor
92163796|NCT04120519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163797|NCT04120519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163798|NCT04120519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92163799|NCT04120519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92163800|NCT04120519|Antiemetics|antiemetics|mesh-ancestor
92163801|NCT04120519|Autonomic Agents|autonomic agents|mesh-ancestor
92163802|NCT04120519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163803|NCT04120519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163804|NCT04120519|Glucocorticoids|glucocorticoids|mesh-ancestor
92163805|NCT04120519|Hormones|hormones|mesh-ancestor
92163806|NCT04120519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163807|NCT04120519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163808|NCT04120519|Leprostatic Agents|leprostatic agents|mesh-ancestor
92163809|NCT04120519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92163810|NCT04120519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163811|NCT04120519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92163812|NCT04120519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92163813|NCT04120519|Growth Substances|growth substances|mesh-ancestor
92163814|NCT04120519|Growth Inhibitors|growth inhibitors|mesh-ancestor
92163815|NCT00631007|Pioglitazone|pioglitazone|mesh-list
92163816|NCT00631007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92231927|NCT03836014|Glucocorticoids|glucocorticoids|mesh-ancestor
92163817|NCT00631007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163818|NCT03014167|Albendazole|albendazole|mesh-list
92163819|NCT03014167|Anthelmintics|anthelmintics|mesh-ancestor
92163820|NCT03014167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92163821|NCT03014167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92163822|NCT03014167|Anticestodal Agents|anticestodal agents|mesh-ancestor
92163823|NCT03014167|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92163824|NCT03014167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92163825|NCT03014167|Tubulin Modulators|tubulin modulators|mesh-ancestor
92163826|NCT03014167|Antimitotic Agents|antimitotic agents|mesh-ancestor
92163827|NCT03014167|Mitosis Modulators|mitosis modulators|mesh-ancestor
92163828|NCT03014167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163829|NCT03014167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163830|NCT00630539|Tamoxifen|tamoxifen|mesh-list
92232063|NCT03089866|GABA Modulators|gaba modulators|mesh-ancestor
92163832|NCT00630539|Hormone Antagonists|hormone antagonists|mesh-ancestor
92163833|NCT00630539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163834|NCT00630539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163835|NCT00630539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163836|NCT00630539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163837|NCT00630539|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92163838|NCT00630539|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92163839|NCT00630539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92163841|NCT00634829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92163842|NCT00634829|Autonomic Agents|autonomic agents|mesh-ancestor
92163843|NCT00634829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163844|NCT00634829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402588|NCT01423539|Rituximab|rituximab|mesh-list
92163845|NCT00634829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92163846|NCT00634829|Respiratory System Agents|respiratory system agents|mesh-ancestor
92163847|NCT00634829|Tocolytic Agents|tocolytic agents|mesh-ancestor
92163848|NCT00634829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92163849|NCT00634829|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92163850|NCT00634829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92163851|NCT00634829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92163852|NCT00634829|Adrenergic Agents|adrenergic agents|mesh-ancestor
92163853|NCT00634829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163854|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163855|NCT00634517|Albuterol|albuterol|mesh-list
92163856|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92163857|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
92163858|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163859|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163860|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92163861|NCT00634517|Respiratory System Agents|respiratory system agents|mesh-ancestor
92163862|NCT00634517|Tocolytic Agents|tocolytic agents|mesh-ancestor
92163863|NCT00634517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92163864|NCT00634517|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92163865|NCT00634517|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92163866|NCT00634517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92163867|NCT00634517|Adrenergic Agents|adrenergic agents|mesh-ancestor
92163868|NCT00634517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163869|NCT00634517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163870|NCT04008355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92232293|NCT01281007|Acyclovir|acyclovir|mesh-list
92163871|NCT01920113|Dexmedetomidine|dexmedetomidine|mesh-list
92163872|NCT01920113|Remifentanil|remifentanil|mesh-list
92163874|NCT01920113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92163875|NCT01920113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163876|NCT01920113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163877|NCT01920113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92163878|NCT01920113|Analgesics|analgesics|mesh-ancestor
92163879|NCT01920113|Sensory System Agents|sensory system agents|mesh-ancestor
92163880|NCT01920113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163881|NCT01920113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92163882|NCT01920113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92163883|NCT01920113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92163884|NCT01920113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92163885|NCT01920113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163886|NCT01920113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163887|NCT01920113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92163888|NCT01920113|Anesthetics, General|anesthetics, general|mesh-ancestor
92163889|NCT01920113|Anesthetics|anesthetics|mesh-ancestor
92163890|NCT01920113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92163891|NCT01920113|Narcotics|narcotics|mesh-ancestor
92163892|NCT01920191|Poly ICLC|poly iclc|mesh-list
92163893|NCT01920191|Interferon Inducers|interferon inducers|mesh-ancestor
92163894|NCT01920191|Immunologic Factors|immunologic factors|mesh-ancestor
92163895|NCT01920191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163896|NCT01920269|Mitomycins|mitomycins|mesh-list
92163897|NCT01920269|Mitomycin|mitomycin|mesh-list
92163898|NCT01920269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92163899|NCT01920269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163900|NCT01920269|Alkylating Agents|alkylating agents|mesh-ancestor
92232371|NCT01555268|Antimetabolites|antimetabolites|mesh-ancestor
92163901|NCT01920269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163902|NCT01920269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92163903|NCT01920269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163904|NCT02921893|Dexamethasone|dexamethasone|mesh-list
92402599|NCT01423591|Infliximab|infliximab|mesh-list
92163905|NCT02921893|Dexamethasone acetate|dexamethasone acetate|mesh-list
92163906|NCT02921893|Lenalidomide|lenalidomide|mesh-list
92163907|NCT02921893|Ixazomib|ixazomib|mesh-list
92163908|NCT02921893|Ichthammol|ichthammol|mesh-list
92163909|NCT02921893|BB 1101|bb 1101|mesh-list
92163910|NCT02921893|Glycine|glycine|mesh-list
92163911|NCT02921893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92163912|NCT02921893|Antiemetics|antiemetics|mesh-ancestor
92163913|NCT02921893|Autonomic Agents|autonomic agents|mesh-ancestor
92163914|NCT02921893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232583|NCT04777838|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92163915|NCT02921893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163916|NCT02921893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163917|NCT02921893|Glucocorticoids|glucocorticoids|mesh-ancestor
92163919|NCT02921893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163920|NCT02921893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92163921|NCT02921893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163922|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
92163923|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92163924|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163925|NCT02921893|Immunologic Factors|immunologic factors|mesh-ancestor
92163926|NCT02921893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92163927|NCT02921893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92163928|NCT02921893|Growth Substances|growth substances|mesh-ancestor
92163929|NCT02921893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92163930|NCT02921893|Dermatologic Agents|dermatologic agents|mesh-ancestor
92163931|NCT02921893|Glycine Agents|glycine agents|mesh-ancestor
92163932|NCT02921893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163933|NCT01920503|Doxorubicin|doxorubicin|mesh-list
92232942|NCT05423210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163934|NCT01920503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92163935|NCT01920503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92163936|NCT01920503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92163937|NCT01920503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92163938|NCT01920503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233013|NCT00058370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163939|NCT01920503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163940|NCT01293825|Ziprasidone|ziprasidone|mesh-list
92163941|NCT01293825|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92163942|NCT01293825|Serotonin Agents|serotonin agents|mesh-ancestor
92163943|NCT01293825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163944|NCT01293825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163945|NCT01293825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163946|NCT01293825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92163947|NCT01293825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92163948|NCT01293825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92163949|NCT01293825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92163950|NCT01293825|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92163951|NCT01293825|Dopamine Agents|dopamine agents|mesh-ancestor
92163952|NCT03009513|Glimepiride|glimepiride|mesh-list
92163953|NCT03009513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92163954|NCT03009513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92233082|NCT00064844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92163955|NCT03009513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163957|NCT03009513|Immunologic Factors|immunologic factors|mesh-ancestor
92163958|NCT02983591|Misoprostol|misoprostol|mesh-list
92163959|NCT02983591|Oxytocin|oxytocin|mesh-list
92163960|NCT02983591|Oxytocics|oxytocics|mesh-ancestor
92402614|NCT01423708|Everolimus|everolimus|mesh-list
92163961|NCT02983591|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92163962|NCT02983591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163963|NCT02983591|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92163964|NCT02983591|Abortifacient Agents|abortifacient agents|mesh-ancestor
92163965|NCT02983591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92163966|NCT02983591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92163967|NCT03829891|Insulin Glargine|insulin glargine|mesh-list
92233215|NCT00003622|Paclitaxel|paclitaxel|mesh-list
92163968|NCT03829891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92163969|NCT03829891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163970|NCT03115151|Fentanyl|fentanyl|mesh-list
92163971|NCT03115151|Hydromorphone|hydromorphone|mesh-list
92163972|NCT03115151|Bupivacaine|bupivacaine|mesh-list
92233282|NCT00002812|Asparaginase|asparaginase|mesh-list
92163973|NCT03115151|Anesthetics, Local|anesthetics, local|mesh-ancestor
92163974|NCT03115151|Anesthetics|anesthetics|mesh-ancestor
92163975|NCT03115151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92233355|NCT00003172|Doxorubicin|doxorubicin|mesh-list
92163976|NCT03115151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163977|NCT03115151|Sensory System Agents|sensory system agents|mesh-ancestor
92163978|NCT03115151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92163979|NCT03115151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92163980|NCT03115151|Narcotics|narcotics|mesh-ancestor
92163981|NCT03115151|Analgesics|analgesics|mesh-ancestor
92163982|NCT03115151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92163983|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92163985|NCT01263717|Hormones|hormones|mesh-list
92163986|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92163987|NCT01263717|Tesamorelin|tesamorelin|mesh-list
92182583|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92163988|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92163989|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92163990|NCT01263717|Growth Substances|growth substances|mesh-ancestor
92163991|NCT04120753|Amlodipine|amlodipine|mesh-list
92163992|NCT04120753|Olmesartan|olmesartan|mesh-list
92163993|NCT04120753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92163994|NCT04120753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92163995|NCT04120753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92163996|NCT04120753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92163997|NCT04120753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92163998|NCT04120753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233858|NCT00003700|Hormones|hormones|mesh-ancestor
92163999|NCT04120753|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164000|NCT04120753|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92164001|NCT04120753|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92164002|NCT01921361|Dexmedetomidine|dexmedetomidine|mesh-list
92164003|NCT01921361|Levobupivacaine|levobupivacaine|mesh-list
92164004|NCT01921361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92164005|NCT01921361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164006|NCT01921361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164007|NCT01921361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92164008|NCT01921361|Analgesics|analgesics|mesh-ancestor
92164009|NCT01921361|Sensory System Agents|sensory system agents|mesh-ancestor
92164010|NCT01921361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164011|NCT01921361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92164012|NCT01921361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92164013|NCT01921361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92234159|NCT00089024|Vitamins|vitamins|mesh-ancestor
92164014|NCT01921361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164015|NCT01921361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164016|NCT01921361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164017|NCT01921361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92164019|NCT01921673|Docetaxel|docetaxel|mesh-list
92164020|NCT01921673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164021|NCT01921673|Tubulin Modulators|tubulin modulators|mesh-ancestor
92164022|NCT01921673|Antimitotic Agents|antimitotic agents|mesh-ancestor
92402624|NCT01423747|Etoposide|etoposide|mesh-list
92164023|NCT01921673|Mitosis Modulators|mitosis modulators|mesh-ancestor
92164024|NCT01921673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164025|NCT01921985|Terlipressin|terlipressin|mesh-list
92164026|NCT01921985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164027|NCT01921985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92164029|NCT02943733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92164030|NCT02943733|Alkylating Agents|alkylating agents|mesh-ancestor
92164031|NCT02943733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164032|NCT02943733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164033|NCT01922141|Amlodipine|amlodipine|mesh-list
92164034|NCT01922141|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92164035|NCT01922141|Ramipril|ramipril|mesh-list
92164036|NCT01922141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164037|NCT01922141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92164038|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182584|NCT01466348|Analgesics|analgesics|mesh-ancestor
92164039|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234727|NCT00004102|Antimetabolites|antimetabolites|mesh-ancestor
92164040|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92164041|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164042|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164043|NCT01922141|Diuretics|diuretics|mesh-ancestor
92164044|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
92164045|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92164046|NCT01922141|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92164047|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
92164048|NCT01922141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164049|NCT03828019|Cyclosporine|cyclosporine|mesh-list
92164050|NCT03828019|Adalimumab|adalimumab|mesh-list
92164051|NCT03828019|Methotrexate|methotrexate|mesh-list
92164052|NCT03828019|Azathioprine|azathioprine|mesh-list
92164053|NCT03828019|Tacrolimus|tacrolimus|mesh-list
92164054|NCT03828019|Cyclosporins|cyclosporins|mesh-list
92164055|NCT03828019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92235018|NCT05775536|Aspirin|aspirin|mesh-list
92164056|NCT03828019|Abortifacient Agents|abortifacient agents|mesh-ancestor
92235086|NCT05773222|Apixaban|apixaban|mesh-list
92164058|NCT03828019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164059|NCT03828019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92164060|NCT03828019|Antimetabolites|antimetabolites|mesh-ancestor
92164061|NCT03828019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164062|NCT03828019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164063|NCT03828019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92164064|NCT03828019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164065|NCT03828019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92164066|NCT03828019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164067|NCT03828019|Immunologic Factors|immunologic factors|mesh-ancestor
92164068|NCT03828019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164069|NCT03828019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92164070|NCT03828019|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92164071|NCT03828019|Antifungal Agents|antifungal agents|mesh-ancestor
92164072|NCT03828019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164073|NCT03828019|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92164074|NCT03828019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164075|NCT03111485|Levodopa|levodopa|mesh-list
92164076|NCT03111485|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92164077|NCT03111485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92164078|NCT03111485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92164079|NCT03111485|Dopamine Agents|dopamine agents|mesh-ancestor
92164080|NCT03111485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235668|NCT02840539|Immunologic Factors|immunologic factors|mesh-ancestor
92164081|NCT03111485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164082|NCT03111485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164083|NCT03111485|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92164085|NCT03111485|Dopamine Agonists|dopamine agonists|mesh-ancestor
92164086|NCT02856295|Enoxaparin|enoxaparin|mesh-list
92235822|NCT00199056|Idarubicin|idarubicin|mesh-list
92402641|NCT01423838|Oxybutynin|oxybutynin|mesh-list
92164089|NCT02856295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92164090|NCT02856295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164091|NCT01266447|Topotecan|topotecan|mesh-list
92164092|NCT01266447|Veliparib|veliparib|mesh-list
92164094|NCT01266447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92164095|NCT01266447|Immunologic Factors|immunologic factors|mesh-ancestor
92164096|NCT01266447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164097|NCT01266447|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92164098|NCT01266447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92164099|NCT01266447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164100|NCT01266447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164101|NCT01266447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164102|NCT01266447|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92164103|NCT01922375|Naftopidil|naftopidil|mesh-list
92164104|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92164105|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92164106|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164107|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164108|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164109|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164110|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164111|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92164112|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164113|NCT01922375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92164114|NCT01922375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92164115|NCT03823339|Liraglutide|liraglutide|mesh-list
92164116|NCT03823339|Xultophy|xultophy|mesh-list
92164117|NCT03823339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92164118|NCT03823339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164119|NCT03823339|Incretins|incretins|mesh-ancestor
92164120|NCT03823339|Hormones|hormones|mesh-ancestor
92164121|NCT03823339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164122|NCT01922687|Amlodipine|amlodipine|mesh-list
92164123|NCT01922687|Atorvastatin|atorvastatin|mesh-list
92236114|NCT00004192|Immunologic Factors|immunologic factors|mesh-ancestor
92164124|NCT01922687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92236159|NCT00004204|Temozolomide|temozolomide|mesh-list
92164125|NCT01922687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92164126|NCT01922687|Antimetabolites|antimetabolites|mesh-ancestor
92164127|NCT01922687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164128|NCT01922687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92236233|NCT00004216|Antimalarials|antimalarials|mesh-ancestor
92164129|NCT01922687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92164130|NCT01922687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164131|NCT01922687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164132|NCT01922687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92164133|NCT01922687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164134|NCT01922687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92164135|NCT01922687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164136|NCT01922687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164137|NCT01268553|Treprostinil|treprostinil|mesh-list
92164138|NCT01268553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164139|NCT01922999|Melatonin|melatonin|mesh-list
92164140|NCT01922999|Antioxidants|antioxidants|mesh-ancestor
92164141|NCT01922999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164142|NCT01922999|Protective Agents|protective agents|mesh-ancestor
92164143|NCT01922999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164144|NCT01922999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164145|NCT01268943|Capecitabine|capecitabine|mesh-list
92164146|NCT01268943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92164147|NCT01268943|Antimetabolites|antimetabolites|mesh-ancestor
92164148|NCT01268943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164149|NCT01268943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164150|NCT01923077|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92164151|NCT01923077|Simvastatin|simvastatin|mesh-list
92164152|NCT01923077|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92164153|NCT01923077|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92164154|NCT01923077|Antimetabolites|antimetabolites|mesh-ancestor
92164155|NCT01923077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164156|NCT01923077|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92164157|NCT01923077|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92164158|NCT01923077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164159|NCT01269801|Botulinum Toxins|botulinum toxins|mesh-list
92164160|NCT01269801|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92164161|NCT01269801|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92236658|NCT00030992|Histamine Agents|histamine agents|mesh-ancestor
92164162|NCT01269801|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92164163|NCT01269801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236728|NCT00004420|Analgesics|analgesics|mesh-ancestor
92164164|NCT01269801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164165|NCT01269801|Cholinergic Agents|cholinergic agents|mesh-ancestor
92164166|NCT01269801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164167|NCT01269801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164168|NCT01269801|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92164169|NCT01269801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164171|NCT01297335|Analgesics|analgesics|mesh-ancestor
92164172|NCT01297335|Sensory System Agents|sensory system agents|mesh-ancestor
92164173|NCT01297335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164174|NCT01297335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164175|NCT01297335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164176|NCT01297335|Sympatholytics|sympatholytics|mesh-ancestor
92164177|NCT01297335|Autonomic Agents|autonomic agents|mesh-ancestor
92164178|NCT01297335|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92164179|NCT01297335|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92164180|NCT01297335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92164181|NCT01297335|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164182|NCT01297335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164183|NCT01297335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164185|NCT05498129|Trace Elements|trace elements|mesh-list
92237006|NCT01270555|Dopamine Agents|dopamine agents|mesh-ancestor
92164186|NCT05498129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164187|NCT01270659|Acetaminophen|acetaminophen|mesh-list
92237147|NCT01342549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92164188|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92164189|NCT01270659|Fentanyl|fentanyl|mesh-list
92164190|NCT01270659|Oxycodone|oxycodone|mesh-list
92164191|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92164192|NCT01270659|Narcotics|narcotics|mesh-ancestor
92164193|NCT01270659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164194|NCT01270659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164196|NCT01270659|Sensory System Agents|sensory system agents|mesh-ancestor
92164197|NCT01270659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164198|NCT01270659|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92164199|NCT01270659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92164200|NCT01270659|Anesthetics, General|anesthetics, general|mesh-ancestor
92164201|NCT01270659|Anesthetics|anesthetics|mesh-ancestor
92164202|NCT01270659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92164204|NCT01270659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92164205|NCT01270659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164206|NCT01270659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164207|NCT01271907|Aldesleukin|aldesleukin|mesh-list
92164208|NCT01271907|Cyclophosphamide|cyclophosphamide|mesh-list
92164209|NCT01271907|Fludarabine|fludarabine|mesh-list
92237523|NCT00257894|Baclofen|baclofen|mesh-list
92164210|NCT01271907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164211|NCT01271907|Immunologic Factors|immunologic factors|mesh-ancestor
92237590|NCT03015857|Sympathomimetics|sympathomimetics|mesh-ancestor
92164212|NCT01271907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164213|NCT01271907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164214|NCT01271907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92164215|NCT01271907|Alkylating Agents|alkylating agents|mesh-ancestor
92164216|NCT01271907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164217|NCT01271907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164218|NCT01271907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92164219|NCT01271907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92164220|NCT01271907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92164221|NCT01271907|Antiviral Agents|antiviral agents|mesh-ancestor
92164222|NCT01271907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164223|NCT01929941|Paclitaxel|paclitaxel|mesh-list
92164224|NCT01929941|Gemcitabine|gemcitabine|mesh-list
92164225|NCT01929941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92164226|NCT01929941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164227|NCT01929941|Tubulin Modulators|tubulin modulators|mesh-ancestor
92164228|NCT01929941|Antimitotic Agents|antimitotic agents|mesh-ancestor
92164229|NCT01929941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92164230|NCT01929941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164231|NCT01929941|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92164232|NCT01929941|Antimetabolites|antimetabolites|mesh-ancestor
92164233|NCT01920737|Leucovorin|leucovorin|mesh-list
92164234|NCT01920737|Cytarabine|cytarabine|mesh-list
92164235|NCT01920737|Dexamethasone|dexamethasone|mesh-list
92164236|NCT01920737|Prednisone|prednisone|mesh-list
92164237|NCT01920737|Cyclophosphamide|cyclophosphamide|mesh-list
92164238|NCT01920737|Methotrexate|methotrexate|mesh-list
92164239|NCT01920737|Vincristine|vincristine|mesh-list
92164240|NCT01920737|Daunorubicin|daunorubicin|mesh-list
92164241|NCT01920737|Asparaginase|asparaginase|mesh-list
92164242|NCT01920737|Mercaptopurine|mercaptopurine|mesh-list
92164243|NCT01920737|Pegaspargase|pegaspargase|mesh-list
92164244|NCT01920737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164245|NCT01920737|Immunologic Factors|immunologic factors|mesh-ancestor
92164246|NCT01920737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164247|NCT01920737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164248|NCT01920737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92164249|NCT01920737|Alkylating Agents|alkylating agents|mesh-ancestor
92164250|NCT01920737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164251|NCT01920737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164252|NCT01920737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92164253|NCT01920737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164254|NCT01920737|Antiemetics|antiemetics|mesh-ancestor
92164255|NCT01920737|Autonomic Agents|autonomic agents|mesh-ancestor
92164256|NCT01920737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164257|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164258|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
92164259|NCT01920737|Hormones|hormones|mesh-ancestor
92164260|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164261|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164262|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92164263|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
92164264|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92164265|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92164266|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
92164267|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92164268|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164269|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92164270|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92164271|NCT01920737|Antiviral Agents|antiviral agents|mesh-ancestor
92164272|NCT01920737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164273|NCT01920737|Antidotes|antidotes|mesh-ancestor
92164274|NCT01920737|Protective Agents|protective agents|mesh-ancestor
92164275|NCT01920737|Vitamin B Complex|vitamin b complex|mesh-ancestor
92164276|NCT01920737|Vitamins|vitamins|mesh-ancestor
92164277|NCT01920737|Micronutrients|micronutrients|mesh-ancestor
92164278|NCT01920737|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92164279|NCT01920737|Tubulin Modulators|tubulin modulators|mesh-ancestor
92164280|NCT01920737|Antimitotic Agents|antimitotic agents|mesh-ancestor
92164281|NCT01920737|Mitosis Modulators|mitosis modulators|mesh-ancestor
92164282|NCT01920737|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92164283|NCT01920737|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92164284|NCT01920737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92164285|NCT01922843|Calcitriol|calcitriol|mesh-list
92164286|NCT01922843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92164287|NCT01922843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164288|NCT01922843|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92164289|NCT01922843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164290|NCT01922843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164291|NCT01922843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92164292|NCT01922843|Vitamins|vitamins|mesh-ancestor
92164293|NCT01922843|Micronutrients|micronutrients|mesh-ancestor
92164294|NCT01922843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92164295|NCT01302483|Lidocaine|lidocaine|mesh-list
92164296|NCT01302483|Phenylephrine|phenylephrine|mesh-list
92164297|NCT01302483|Oxymetazoline|oxymetazoline|mesh-list
92164298|NCT01302483|Tetracaine|tetracaine|mesh-list
92164299|NCT01302483|Anesthetics, Local|anesthetics, local|mesh-ancestor
92164300|NCT01302483|Anesthetics|anesthetics|mesh-ancestor
92164301|NCT01302483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164302|NCT01302483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164303|NCT01302483|Sensory System Agents|sensory system agents|mesh-ancestor
92164304|NCT01302483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164305|NCT01302483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92164306|NCT01302483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92164307|NCT01302483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92164308|NCT01302483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164309|NCT01302483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164310|NCT01302483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92164311|NCT01302483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92164312|NCT01302483|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164313|NCT01302483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164314|NCT01302483|Sympathomimetics|sympathomimetics|mesh-ancestor
92164315|NCT01302483|Autonomic Agents|autonomic agents|mesh-ancestor
92164316|NCT01302483|Nasal Decongestants|nasal decongestants|mesh-ancestor
92164317|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92164318|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
92164319|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92164321|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92164322|NCT01302483|Protective Agents|protective agents|mesh-ancestor
92164323|NCT04769583|Metronidazole|metronidazole|mesh-list
92164324|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164325|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92164326|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92164327|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92164328|NCT01279317|Acetic Acid|acetic acid|mesh-list
92164329|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92164330|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164331|NCT01304589|Milnacipran|milnacipran|mesh-list
92164332|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
92164333|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92164334|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92164335|NCT01304589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164336|NCT01304589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164337|NCT01304589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164338|NCT01304589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164339|NCT01304589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92164340|NCT01304589|Analgesics|analgesics|mesh-ancestor
92164341|NCT01304589|Sensory System Agents|sensory system agents|mesh-ancestor
92164342|NCT01304589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164343|NCT01304589|Antidepressive Agents|antidepressive agents|mesh-ancestor
92164344|NCT01304589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92164345|NCT01280409|Metformin|metformin|mesh-list
92164346|NCT01280409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92164347|NCT01280409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164348|NCT01926197|Leucovorin|leucovorin|mesh-list
92164349|NCT01926197|Fluorouracil|fluorouracil|mesh-list
92164350|NCT01926197|Oxaliplatin|oxaliplatin|mesh-list
92164351|NCT01926197|Irinotecan|irinotecan|mesh-list
92164352|NCT01926197|Camptothecin|camptothecin|mesh-list
92164353|NCT01926197|Antimetabolites|antimetabolites|mesh-ancestor
92164354|NCT01926197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164355|NCT01926197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92164356|NCT01926197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164357|NCT01926197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164358|NCT01926197|Immunologic Factors|immunologic factors|mesh-ancestor
92164359|NCT01926197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164360|NCT01926197|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92164361|NCT01926197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92164362|NCT01926197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164363|NCT01926197|Antidotes|antidotes|mesh-ancestor
92164364|NCT01926197|Protective Agents|protective agents|mesh-ancestor
92164365|NCT01926197|Vitamin B Complex|vitamin b complex|mesh-ancestor
92164366|NCT01926197|Vitamins|vitamins|mesh-ancestor
92164367|NCT01926197|Micronutrients|micronutrients|mesh-ancestor
92164368|NCT01926197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92164369|NCT01923545|Lenograstim|lenograstim|mesh-list
92164370|NCT01923545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92164371|NCT01923545|Immunologic Factors|immunologic factors|mesh-ancestor
92164372|NCT01923545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164374|NCT01925027|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92164375|NCT01925027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164376|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92164377|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164378|NCT01925027|Antifungal Agents|antifungal agents|mesh-ancestor
92164379|NCT01925027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164380|NCT01925027|Immunologic Factors|immunologic factors|mesh-ancestor
92164381|NCT01925027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164383|NCT01305213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92164384|NCT01305213|Fosbretabulin|fosbretabulin|mesh-list
92164385|NCT01305213|Endothelial Growth Factors|endothelial growth factors|mesh-list
92164386|NCT01305213|Antibodies|antibodies|mesh-list
92164387|NCT01305213|Immunoglobulins|immunoglobulins|mesh-list
92164388|NCT01305213|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92164389|NCT01305213|Immunoglobulin G|immunoglobulin g|mesh-list
92164390|NCT01305213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164391|NCT01305213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92164392|NCT01305213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92164393|NCT01305213|Growth Substances|growth substances|mesh-ancestor
92239152|NCT00277394|Heparin|heparin|mesh-list
92164394|NCT01305213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164395|NCT01305213|Growth Inhibitors|growth inhibitors|mesh-ancestor
92164396|NCT01305213|Immunologic Factors|immunologic factors|mesh-ancestor
92164397|NCT01305213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92164398|NCT00989963|Beraprost|beraprost|mesh-list
92164399|NCT00989963|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92164400|NCT00989963|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164401|NCT01339299|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92164402|NCT01339299|Hormones|hormones|mesh-list
92164403|NCT01339299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164404|NCT01339299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164405|NCT01339299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92164407|NCT01307007|Iron-Dextran Complex|iron-dextran complex|mesh-list
92164408|NCT01307007|Anticoagulants|anticoagulants|mesh-ancestor
92164409|NCT01307007|Plasma Substitutes|plasma substitutes|mesh-ancestor
92164410|NCT01307007|Blood Substitutes|blood substitutes|mesh-ancestor
92164411|NCT01307007|Hematinics|hematinics|mesh-ancestor
92164412|NCT02197455|Tofacitinib|tofacitinib|mesh-list
92164413|NCT02197455|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92164414|NCT02197455|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92164415|NCT02197455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164416|NCT02197455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164418|NCT03101501|Mitomycin|mitomycin|mesh-list
92164419|NCT03101501|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92164420|NCT03101501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164421|NCT03101501|Alkylating Agents|alkylating agents|mesh-ancestor
92164422|NCT03101501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239347|NCT01108445|Sunitinib|sunitinib|mesh-list
92164423|NCT03101501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92164424|NCT03101501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164425|NCT01923623|Ropivacaine|ropivacaine|mesh-list
92164426|NCT01923623|Anesthetics, Local|anesthetics, local|mesh-ancestor
92164427|NCT01923623|Anesthetics|anesthetics|mesh-ancestor
92239491|NCT00290654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92164428|NCT01923623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164429|NCT01923623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164430|NCT01923623|Sensory System Agents|sensory system agents|mesh-ancestor
92239636|NCT00298610|Antiviral Agents|antiviral agents|mesh-ancestor
92164431|NCT01923623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164432|NCT01923857|Enclomiphene|enclomiphene|mesh-list
92164433|NCT01923857|Clomiphene|clomiphene|mesh-list
92164434|NCT01923857|Zuclomiphene|zuclomiphene|mesh-list
92164435|NCT01923857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92164436|NCT01923857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92164437|NCT01923857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164438|NCT01923857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164439|NCT01923857|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92164440|NCT01923857|Fertility Agents|fertility agents|mesh-ancestor
92164441|NCT01923857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92164442|NCT01923857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92164443|NCT01923857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92164444|NCT03100253|Adalimumab|adalimumab|mesh-list
92164445|NCT03100253|Infliximab|infliximab|mesh-list
92164446|NCT03100253|Golimumab|golimumab|mesh-list
92164447|NCT03100253|Certolizumab Pegol|certolizumab pegol|mesh-list
92164448|NCT03100253|Etanercept|etanercept|mesh-list
92164449|NCT03100253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92164450|NCT03100253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164451|NCT03100253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164452|NCT03100253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92164453|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164454|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92164455|NCT03100253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92164456|NCT03100253|Analgesics|analgesics|mesh-ancestor
92164457|NCT03100253|Sensory System Agents|sensory system agents|mesh-ancestor
92164458|NCT03100253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164459|NCT03100253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164460|NCT03100253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164461|NCT03100253|Immunologic Factors|immunologic factors|mesh-ancestor
92164462|NCT01924091|Dapivirine|dapivirine|mesh-list
92164463|NCT01924091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92164464|NCT01924091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92164465|NCT01924091|Antiviral Agents|antiviral agents|mesh-ancestor
92164466|NCT01924091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164467|NCT03485729|TIC10 compound|tic10 compound|mesh-list
92164468|NCT03485729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164469|NCT01924325|Aspirin|aspirin|mesh-list
92164470|NCT01924325|Apixaban|apixaban|mesh-list
92164471|NCT01924325|Clopidogrel|clopidogrel|mesh-list
92164472|NCT01924325|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92164473|NCT01924325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92164474|NCT01924325|Analgesics|analgesics|mesh-ancestor
92164475|NCT01924325|Sensory System Agents|sensory system agents|mesh-ancestor
92164476|NCT01924325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164477|NCT01924325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164478|NCT01924325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164479|NCT01924325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164480|NCT01924325|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92239902|NCT00234884|Adalimumab|adalimumab|mesh-list
92164481|NCT01924325|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92164482|NCT01924325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239956|NCT00301028|Paclitaxel|paclitaxel|mesh-list
92164483|NCT01924325|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92164484|NCT01924325|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92164485|NCT01924325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164486|NCT01924325|Antipyretics|antipyretics|mesh-ancestor
92164487|NCT01924325|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92164488|NCT01924325|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92164489|NCT01924325|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92164490|NCT01924325|Purinergic Agents|purinergic agents|mesh-ancestor
92164491|NCT01924325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164492|NCT01924325|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92164493|NCT01924325|Antithrombins|antithrombins|mesh-ancestor
92164494|NCT01924325|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92164495|NCT01924325|Protease Inhibitors|protease inhibitors|mesh-ancestor
92164496|NCT01924325|Anticoagulants|anticoagulants|mesh-ancestor
92164497|NCT01924481|Theobromine|theobromine|mesh-list
92164499|NCT01924481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92240239|NCT05266274|Antimetabolites|antimetabolites|mesh-ancestor
92164500|NCT01924481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164501|NCT01924481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92240311|NCT01392859|Histamine Agents|histamine agents|mesh-ancestor
92164503|NCT01924481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164504|NCT01924481|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92164505|NCT01924481|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92164506|NCT01924481|Purinergic Agents|purinergic agents|mesh-ancestor
92164507|NCT01924481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164508|NCT01924481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92164509|NCT01924481|Autonomic Agents|autonomic agents|mesh-ancestor
92164510|NCT01924481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164511|NCT01924481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92164512|NCT01924481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92164513|NCT01924481|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164514|NCT01924637|Insulin|insulin|mesh-list
92164515|NCT01924637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92164516|NCT01924637|Insulin Aspart|insulin aspart|mesh-list
92164517|NCT01924637|Insulin, Long-Acting|insulin, long-acting|mesh-list
92164518|NCT01924637|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92164519|NCT01924637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92164520|NCT01924637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164521|NCT01925729|Phenylephrine|phenylephrine|mesh-list
92164522|NCT01925729|Pseudoephedrine|pseudoephedrine|mesh-list
92164523|NCT01925729|Oxymetazoline|oxymetazoline|mesh-list
92164524|NCT01925729|Ephedrine|ephedrine|mesh-list
92164525|NCT01925729|Histamine|histamine|mesh-list
92164526|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92164527|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
92164528|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164529|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164530|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92164531|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
92164532|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
92164533|NCT01925729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92164534|NCT01925729|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92164536|NCT01925729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164537|NCT01925729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164538|NCT01925729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164539|NCT01925729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92164540|NCT01925729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92164541|NCT01925729|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92164542|NCT01925729|Mydriatics|mydriatics|mesh-ancestor
92240816|NCT00306488|Antioxidants|antioxidants|mesh-list
92164543|NCT01925729|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92164544|NCT01925729|Protective Agents|protective agents|mesh-ancestor
92164545|NCT01925729|Histamine Agonists|histamine agonists|mesh-ancestor
92164546|NCT01925729|Histamine Agents|histamine agents|mesh-ancestor
92164547|NCT01926587|Azacitidine|azacitidine|mesh-list
92164548|NCT01926587|ON 01910|on 01910|mesh-list
92164549|NCT01926587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92164550|NCT01926587|Antimetabolites|antimetabolites|mesh-ancestor
92164551|NCT01926587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164552|NCT01926587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164553|NCT01926587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164554|NCT01926587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92164555|NCT01922765|Amoxicillin|amoxicillin|mesh-list
92164556|NCT01922765|Metronidazole|metronidazole|mesh-list
92164557|NCT01922765|Clarithromycin|clarithromycin|mesh-list
92164558|NCT01922765|Rabeprazole|rabeprazole|mesh-list
92164559|NCT01922765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92164560|NCT01922765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164561|NCT01922765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92164562|NCT01922765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92164563|NCT01922765|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92164564|NCT01922765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164565|NCT01922765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164566|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92164567|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92164568|NCT01922765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92164569|NCT01922765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164570|NCT01922765|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92164571|NCT01926665|Dexamethasone|dexamethasone|mesh-list
92164572|NCT01926665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164574|NCT01926665|Autonomic Agents|autonomic agents|mesh-ancestor
92164575|NCT01926665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164576|NCT01926665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164577|NCT01926665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164579|NCT01926665|Hormones|hormones|mesh-ancestor
92241158|NCT05329428|Vitamins|vitamins|mesh-list
92164580|NCT01926665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164581|NCT01926665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164582|NCT01926665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164583|NCT01926821|Sizofiran|sizofiran|mesh-list
92164584|NCT01926821|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92164585|NCT01926821|Immunologic Factors|immunologic factors|mesh-ancestor
92164586|NCT01926821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164587|NCT01926821|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92164588|NCT01926821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164589|NCT01926899|Bortezomib|bortezomib|mesh-list
92164590|NCT01926899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164591|NCT03430661|Clopidogrel|clopidogrel|mesh-list
92164592|NCT03430661|Ticagrelor|ticagrelor|mesh-list
92164593|NCT03430661|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92164594|NCT03430661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92164595|NCT03430661|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92164596|NCT03430661|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92164597|NCT03430661|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92164598|NCT03430661|Purinergic Agents|purinergic agents|mesh-ancestor
92164599|NCT03430661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241645|NCT05567315|Anesthetics, Local|anesthetics, local|mesh-list
92164600|NCT03430661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164601|NCT03430661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164602|NCT01927835|Vaccines|vaccines|mesh-list
92164603|NCT01927835|Immunologic Factors|immunologic factors|mesh-ancestor
92164604|NCT01927835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164605|NCT01927913|Deferasirox|deferasirox|mesh-list
92164606|NCT01927913|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92164607|NCT01927913|Chelating Agents|chelating agents|mesh-ancestor
92164608|NCT01927913|Sequestering Agents|sequestering agents|mesh-ancestor
92164609|NCT01927913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164610|NCT01928069|Montelukast|montelukast|mesh-list
92164611|NCT01928069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92164612|NCT01928069|Respiratory System Agents|respiratory system agents|mesh-ancestor
92164613|NCT01928069|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92164614|NCT01928069|Hormone Antagonists|hormone antagonists|mesh-ancestor
92241938|NCT04772209|Heparin|heparin|mesh-list
92164615|NCT01928069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164616|NCT01928069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164617|NCT01928069|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92164618|NCT01928069|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92164619|NCT01928069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164620|NCT01928459|Infigratinib|infigratinib|mesh-list
92164621|NCT01928459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164622|NCT01928537|ON 01910|on 01910|mesh-list
92164623|NCT01928537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164624|NCT01928537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242079|NCT04623541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164626|NCT01928537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164627|NCT01307397|Vemurafenib|vemurafenib|mesh-list
92164628|NCT01307397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164629|NCT01307397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92164631|NCT01307397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164632|NCT01929161|Oxytocin|oxytocin|mesh-list
92164633|NCT01929161|Oxytocics|oxytocics|mesh-ancestor
92164634|NCT01929161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92164635|NCT01929161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164636|NCT03373877|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
92164637|NCT03373877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164638|NCT04552535|Afatinib|afatinib|mesh-list
92164639|NCT04552535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164640|NCT04552535|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92164641|NCT04552535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164642|NCT04552535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164643|NCT02197767|Rituximab|rituximab|mesh-list
92164644|NCT02197767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164645|NCT02197767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164646|NCT02197767|Immunologic Factors|immunologic factors|mesh-ancestor
92164647|NCT02197767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164648|NCT02197767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164649|NCT01342029|Ranolazine|ranolazine|mesh-list
92164650|NCT01342029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92164651|NCT01342029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164652|NCT01342029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164653|NCT01342107|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92164654|NCT05601479|Acetylcarnitine|acetylcarnitine|mesh-list
92164655|NCT05601479|Vitamin B Complex|vitamin b complex|mesh-ancestor
92164656|NCT05601479|Vitamins|vitamins|mesh-ancestor
92164657|NCT05601479|Micronutrients|micronutrients|mesh-ancestor
92164658|NCT05601479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164659|NCT05601479|Nootropic Agents|nootropic agents|mesh-ancestor
92164660|NCT04275245|Meplazumab|meplazumab|mesh-list
92164661|NCT04275245|Antiviral Agents|antiviral agents|mesh-ancestor
92164662|NCT04275245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164663|NCT01346085|Thymoglobulin|thymoglobulin|mesh-list
92164664|NCT01346085|Immunologic Factors|immunologic factors|mesh-ancestor
92164665|NCT01346085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164666|NCT01346085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92164667|NCT04394897|Remifentanil|remifentanil|mesh-list
92164668|NCT04394897|Propofol|propofol|mesh-list
92164669|NCT04394897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92164670|NCT04394897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242479|NCT03522246|Nivolumab|nivolumab|mesh-list
92164671|NCT04394897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164672|NCT04394897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92164673|NCT04394897|Anesthetics, General|anesthetics, general|mesh-ancestor
92164674|NCT04394897|Anesthetics|anesthetics|mesh-ancestor
92242556|NCT03309878|Pembrolizumab|pembrolizumab|mesh-list
92164675|NCT04394897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92164676|NCT04394897|Narcotics|narcotics|mesh-ancestor
92164677|NCT04394897|Analgesics|analgesics|mesh-ancestor
92164678|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
92164679|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164680|NCT05607641|Ketorolac|ketorolac|mesh-list
92164681|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92164682|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92164683|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92164684|NCT05607641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92164685|NCT05607641|Analgesics|analgesics|mesh-ancestor
92164686|NCT05607641|Sensory System Agents|sensory system agents|mesh-ancestor
92242771|NCT01366612|Antiviral Agents|antiviral agents|mesh-ancestor
92164687|NCT05607641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164688|NCT05607641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164689|NCT05607641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164690|NCT05607641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92164691|NCT05607641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92164692|NCT05607641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164693|NCT05607641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164694|NCT05607017|Losartan|losartan|mesh-list
92243063|NCT00401882|Mydriatics|mydriatics|mesh-ancestor
92164695|NCT05607017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92164696|NCT05607017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164697|NCT05607017|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92243136|NCT05268120|Antimalarials|antimalarials|mesh-ancestor
92164698|NCT05607017|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92164699|NCT05607017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164700|NCT05603039|Bevacizumab|bevacizumab|mesh-list
92164701|NCT05603039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164702|NCT05603039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164703|NCT05603039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92164704|NCT05603039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92164705|NCT05603039|Growth Substances|growth substances|mesh-ancestor
92164706|NCT05603039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164707|NCT05603039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92164709|NCT05609903|Atezolizumab|atezolizumab|mesh-list
92164710|NCT05609903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92164711|NCT05609903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164712|NCT05609903|Tubulin Modulators|tubulin modulators|mesh-ancestor
92164713|NCT05609903|Antimitotic Agents|antimitotic agents|mesh-ancestor
92164714|NCT05609903|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182585|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
92164715|NCT05609903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164716|NCT05609903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92243339|NCT05256264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402686|NCT01424124|Montelukast|montelukast|mesh-list
92164717|NCT05609903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164718|NCT03045029|Treprostinil|treprostinil|mesh-list
92164719|NCT03045029|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92164720|NCT04161599|Metronidazole|metronidazole|mesh-list
92164721|NCT04161599|Cefuroxime|cefuroxime|mesh-list
92164722|NCT04161599|Cefuroxime axetil|cefuroxime axetil|mesh-list
92164724|NCT04161599|Magnesium Oxide|magnesium oxide|mesh-list
92164725|NCT04161599|Citric Acid|citric acid|mesh-list
92164726|NCT04161599|Sodium Citrate|sodium citrate|mesh-list
92164727|NCT04161599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164728|NCT04161599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92164729|NCT04161599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92164730|NCT04161599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92164731|NCT04161599|Anticoagulants|anticoagulants|mesh-ancestor
92243627|NCT05246046|Bromides|bromides|mesh-list
92164732|NCT04161599|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92164733|NCT04161599|Chelating Agents|chelating agents|mesh-ancestor
92164734|NCT04161599|Sequestering Agents|sequestering agents|mesh-ancestor
92243771|NCT05236530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92164735|NCT04161599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164736|NCT04161599|Cathartics|cathartics|mesh-ancestor
92164737|NCT04161599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164738|NCT04161599|Antacids|antacids|mesh-ancestor
92164739|NCT04759235|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92164740|NCT04759235|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92164741|NCT04759235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164742|NCT05608499|Clobetasol|clobetasol|mesh-list
92164743|NCT05608499|Halobetasol|halobetasol|mesh-list
92164744|NCT05608499|Tazarotene|tazarotene|mesh-list
92164745|NCT05608499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92164746|NCT05608499|Keratolytic Agents|keratolytic agents|mesh-ancestor
92164747|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92164748|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164749|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
92164750|NCT05608499|Hormones|hormones|mesh-ancestor
92164751|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164752|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164753|NCT05601167|Ritonavir|ritonavir|mesh-list
92164754|NCT05601167|Nirmatrelvir|nirmatrelvir|mesh-list
92164755|NCT05601167|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92164756|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92164757|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92164758|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92164759|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164760|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164761|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92164762|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92164763|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
92164764|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243918|NCT05480046|Dopamine Agents|dopamine agents|mesh-ancestor
92164765|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92164766|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92164767|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92164769|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
92164770|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164771|NCT05605613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164772|NCT05605613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164773|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164775|NCT05602259|Chelating Agents|chelating agents|mesh-ancestor
92164776|NCT05602259|Sequestering Agents|sequestering agents|mesh-ancestor
92244183|NCT00466310|Dopamine Agents|dopamine agents|mesh-ancestor
92164777|NCT05602259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164778|NCT04393883|Pembrolizumab|pembrolizumab|mesh-list
92244257|NCT05096832|Immunologic Factors|immunologic factors|mesh-ancestor
92164779|NCT04393883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164780|NCT04393883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164781|NCT04393883|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92164782|NCT04393883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244403|NCT00420992|Narcotics|narcotics|mesh-ancestor
92164784|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
92164785|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92164786|NCT03029429|Theophylline|theophylline|mesh-list
92164787|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92164788|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
92164789|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244554|NCT00546104|Dasatinib|dasatinib|mesh-list
92164790|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164792|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
92244625|NCT00493064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164793|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92182586|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164795|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164796|NCT03029429|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164797|NCT03029429|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92164798|NCT03029429|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92164799|NCT03029429|Purinergic Agents|purinergic agents|mesh-ancestor
92164800|NCT03029429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164801|NCT04120363|Methyltestosterone|methyltestosterone|mesh-list
92164802|NCT04120363|Testosterone|testosterone|mesh-list
92164803|NCT04120363|Testosterone undecanoate|testosterone undecanoate|mesh-list
92164804|NCT04120363|Testosterone enanthate|testosterone enanthate|mesh-list
92244903|NCT05029596|Heparin|heparin|mesh-list
92164805|NCT04120363|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92164806|NCT04120363|Androgens|androgens|mesh-ancestor
92164807|NCT04120363|Hormones|hormones|mesh-ancestor
92164808|NCT04120363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164809|NCT04120363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164810|NCT04120363|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164811|NCT04120363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164812|NCT04120363|Anabolic Agents|anabolic agents|mesh-ancestor
92164814|NCT04125745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164816|NCT04393805|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92164817|NCT04393805|Tinzaparin|tinzaparin|mesh-list
92164818|NCT04393805|Dalteparin|dalteparin|mesh-list
92164819|NCT04393805|Anticoagulants|anticoagulants|mesh-ancestor
92164820|NCT04393805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92164821|NCT04393805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92164822|NCT04393805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164824|NCT04122755|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92164825|NCT04122755|Narcotics|narcotics|mesh-ancestor
92164826|NCT04122755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164827|NCT04122755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164828|NCT04122755|Analgesics|analgesics|mesh-ancestor
92164829|NCT04122755|Sensory System Agents|sensory system agents|mesh-ancestor
92164830|NCT04122755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164832|NCT04129697|Dexamethasone|dexamethasone|mesh-list
92164833|NCT04129697|Methylprednisolone|methylprednisolone|mesh-list
92164834|NCT04129697|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92164835|NCT04129697|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92164836|NCT04129697|Prednisolone|prednisolone|mesh-list
92164837|NCT04129697|Prednisolone acetate|prednisolone acetate|mesh-list
92164838|NCT04129697|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92164839|NCT04129697|Prednisolone phosphate|prednisolone phosphate|mesh-list
92164840|NCT04129697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164842|NCT04129697|Autonomic Agents|autonomic agents|mesh-ancestor
92164843|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164844|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164845|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164846|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
92164847|NCT04129697|Hormones|hormones|mesh-ancestor
92245797|NCT01510327|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92164848|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164849|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164850|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164851|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92164852|NCT04129697|Protective Agents|protective agents|mesh-ancestor
92164853|NCT04128137|Fludrocortisone|fludrocortisone|mesh-list
92164854|NCT04128137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164855|NCT05793892|Lidocaine|lidocaine|mesh-list
92164856|NCT05793892|Tetracaine|tetracaine|mesh-list
92164857|NCT05793892|Anesthetics, Local|anesthetics, local|mesh-ancestor
92164858|NCT05793892|Anesthetics|anesthetics|mesh-ancestor
92164859|NCT05793892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164860|NCT05793892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164861|NCT05793892|Sensory System Agents|sensory system agents|mesh-ancestor
92246086|NCT03303950|Busulfan|busulfan|mesh-list
92164862|NCT05793892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164863|NCT05793892|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92164864|NCT05793892|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92164865|NCT05793892|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92164866|NCT05793892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164867|NCT05793892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164868|NCT05793359|Methylprednisolone|methylprednisolone|mesh-list
92164869|NCT05793359|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92164870|NCT05793359|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92164871|NCT05793359|Prednisolone|prednisolone|mesh-list
92164872|NCT05793359|Prednisolone acetate|prednisolone acetate|mesh-list
92164873|NCT05793359|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92164874|NCT05793359|Prednisolone phosphate|prednisolone phosphate|mesh-list
92164875|NCT05793359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164876|NCT05793359|Antiemetics|antiemetics|mesh-ancestor
92164877|NCT05793359|Autonomic Agents|autonomic agents|mesh-ancestor
92164878|NCT05793359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164879|NCT05793359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164880|NCT05793359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92164881|NCT05793359|Glucocorticoids|glucocorticoids|mesh-ancestor
92164882|NCT05793359|Hormones|hormones|mesh-ancestor
92164883|NCT05793359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164884|NCT05793359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92164885|NCT05793359|Protective Agents|protective agents|mesh-ancestor
92164886|NCT05793359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164887|NCT05793359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164888|NCT05793268|Tenofovir|tenofovir|mesh-list
92164889|NCT05793268|Entecavir|entecavir|mesh-list
92164890|NCT05793268|Antiviral Agents|antiviral agents|mesh-ancestor
92164891|NCT05793268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164892|NCT05793268|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92164893|NCT05793268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92164894|NCT05793268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164895|NCT05793268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164896|NCT05793268|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92164897|NCT05793268|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92164898|NCT05793099|Propolis|propolis|mesh-list
92164899|NCT05793099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164901|NCT05792995|Nivolumab|nivolumab|mesh-list
92164902|NCT05792995|Durvalumab|durvalumab|mesh-list
92246866|NCT00605384|Adefovir|adefovir|mesh-list
92164903|NCT05792995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164904|NCT05792995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164905|NCT05792995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92164906|NCT05792995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164907|NCT05792878|Interferons|interferons|mesh-list
92164908|NCT05792878|Interferon-alpha|interferon-alpha|mesh-list
92164909|NCT05792878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164910|NCT05792878|Antiviral Agents|antiviral agents|mesh-ancestor
92164911|NCT05792878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164912|NCT05792878|Immunologic Factors|immunologic factors|mesh-ancestor
92164913|NCT05792878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164914|NCT05792865|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92164915|NCT05792865|Antiviral Agents|antiviral agents|mesh-ancestor
92164916|NCT05792865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164917|NCT05792761|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92164918|NCT05792761|Antiviral Agents|antiviral agents|mesh-ancestor
92164919|NCT05792761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164920|NCT05792748|Hemostatics|hemostatics|mesh-list
92164921|NCT05792748|Coagulants|coagulants|mesh-ancestor
92164922|NCT05792644|Crizotinib|crizotinib|mesh-list
92164923|NCT05792644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402704|NCT01424137|Hormones|hormones|mesh-ancestor
92164924|NCT05792644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92164925|NCT05792644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247224|NCT01585441|Finasteride|finasteride|mesh-list
92164926|NCT05792644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164927|NCT05792410|Bevacizumab|bevacizumab|mesh-list
92164928|NCT05792410|Fulvestrant|fulvestrant|mesh-list
92164929|NCT05792410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92164930|NCT05792410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92164931|NCT05792410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92164932|NCT05792410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92164933|NCT05792410|Growth Substances|growth substances|mesh-ancestor
92164934|NCT05792410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164935|NCT05792410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92164936|NCT05792410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92164937|NCT05792410|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92164938|NCT05792410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92247500|NCT00653276|Cyclosporine|cyclosporine|mesh-list
92164939|NCT05792410|Hormone Antagonists|hormone antagonists|mesh-ancestor
92247571|NCT05134363|Sensory System Agents|sensory system agents|mesh-ancestor
92164940|NCT05792410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164941|NCT05792111|Triamcinolone|triamcinolone|mesh-list
92164942|NCT05792111|Lidocaine|lidocaine|mesh-list
92164943|NCT05792111|Bupivacaine|bupivacaine|mesh-list
92164944|NCT05792111|Anesthetics, Local|anesthetics, local|mesh-ancestor
92247696|NCT00551876|Ezetimibe|ezetimibe|mesh-list
92164945|NCT05792111|Anesthetics|anesthetics|mesh-ancestor
92247718|NCT00628394|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164946|NCT05792111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92164947|NCT05792111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164948|NCT05792111|Sensory System Agents|sensory system agents|mesh-ancestor
92164949|NCT05792111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164950|NCT05792111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92164951|NCT05792111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92164952|NCT05792111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92247870|NCT00687908|Adapalene|adapalene|mesh-list
92164953|NCT05792111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164954|NCT05792111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164955|NCT05792111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92164956|NCT05792111|Glucocorticoids|glucocorticoids|mesh-ancestor
92164957|NCT05792111|Hormones|hormones|mesh-ancestor
92164958|NCT05792111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92164959|NCT05789732|Tadalafil|tadalafil|mesh-list
92164960|NCT05789732|Silodosin|silodosin|mesh-list
92164961|NCT05789732|Vasodilator Agents|vasodilator agents|mesh-ancestor
92164962|NCT05789732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92164963|NCT05789732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92164964|NCT05789732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164965|NCT05789732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164966|NCT05789732|Urological Agents|urological agents|mesh-ancestor
92164967|NCT05789732|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92164968|NCT05789732|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92164969|NCT05789732|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92164970|NCT05789732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164971|NCT05789732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164972|NCT05789732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92164973|NCT05789615|Letermovir|letermovir|mesh-list
92164974|NCT05789615|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92164975|NCT05789615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92164976|NCT05789615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164977|NCT05789615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402707|NCT01424176|Pramipexole|pramipexole|mesh-list
92164978|NCT05789615|Antiviral Agents|antiviral agents|mesh-ancestor
92164979|NCT05789615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92164980|NCT05783817|Methamphetamine|methamphetamine|mesh-list
92164981|NCT05783817|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92164982|NCT05783817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934751|NCT02306785|Analgesics|analgesics|mesh-ancestor
92164983|NCT05783817|Sympathomimetics|sympathomimetics|mesh-ancestor
92164984|NCT05783817|Autonomic Agents|autonomic agents|mesh-ancestor
92164985|NCT05783817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92164986|NCT05783817|Dopamine Agents|dopamine agents|mesh-ancestor
92164987|NCT05783817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92164988|NCT05783817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92164989|NCT05783817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92164990|NCT05783817|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92164991|NCT05783817|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92164992|NCT05783817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92164993|NCT05783817|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92164994|NCT05761080|Amoxicillin|amoxicillin|mesh-list
92164995|NCT05761080|Clavulanic Acids|clavulanic acids|mesh-list
92164996|NCT05761080|Clavulanic Acid|clavulanic acid|mesh-list
92164997|NCT05761080|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92164998|NCT05761080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92164999|NCT05761080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165000|NCT05761080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165001|NCT05761080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165002|NCT05761080|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92165003|NCT05743764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92165004|NCT05743764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92165005|NCT05737186|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92248783|NCT00667004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165006|NCT05737186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165007|NCT05737186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92165008|NCT05737186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165010|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92165011|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165012|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248993|NCT01210079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92165013|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165014|NCT05652660|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92165015|NCT05652660|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92165016|NCT05652660|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92165017|NCT05652660|Antimetabolites|antimetabolites|mesh-ancestor
92182587|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165018|NCT05652660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165019|NCT05652660|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92165020|NCT05652660|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92165021|NCT05652660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165022|NCT05642026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92165023|NCT05642026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92165024|NCT05642026|Ropivacaine|ropivacaine|mesh-list
92165025|NCT05642026|Anesthetics, Local|anesthetics, local|mesh-ancestor
92165026|NCT05642026|Anesthetics|anesthetics|mesh-ancestor
92165027|NCT05642026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165028|NCT05642026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165029|NCT05642026|Sensory System Agents|sensory system agents|mesh-ancestor
92182588|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
92165030|NCT05642026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165031|NCT05642026|Analgesics|analgesics|mesh-ancestor
92165032|NCT05642026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92249496|NCT01273454|Analgesics|analgesics|mesh-ancestor
92165033|NCT05642026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165034|NCT05617742|FAPI-46|fapi-46|mesh-list
92165036|NCT05617742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165037|NCT05593575|Valsartan|valsartan|mesh-list
92165038|NCT05593575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92165039|NCT05593575|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92165040|NCT05593575|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92165041|NCT05593575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165042|NCT05558137|Mivacurium|mivacurium|mesh-list
92249642|NCT04385264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165043|NCT05558137|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92249710|NCT01275638|Methylprednisolone|methylprednisolone|mesh-list
92165044|NCT05558137|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92165045|NCT05558137|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92165046|NCT05558137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249782|NCT00249002|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165047|NCT05558137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165048|NCT05521828|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92165049|NCT05521828|Dydrogesterone|dydrogesterone|mesh-list
92165050|NCT05521828|Hormones|hormones|mesh-ancestor
92165051|NCT05521828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165052|NCT05521828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165053|NCT05521828|Progestins|progestins|mesh-ancestor
92165054|NCT05505214|Mometasone Furoate|mometasone furoate|mesh-list
92165055|NCT05505214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165056|NCT05505214|Dermatologic Agents|dermatologic agents|mesh-ancestor
92165057|NCT05505214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92165058|NCT05501769|Everolimus|everolimus|mesh-list
92165059|NCT05501769|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92165060|NCT05501769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165061|NCT05501769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165062|NCT05501769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165063|NCT05501769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165064|NCT05501769|Immunologic Factors|immunologic factors|mesh-ancestor
92165065|NCT05501769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165066|NCT05501769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165067|NCT05463224|Lazertinib|lazertinib|mesh-list
92165068|NCT05463224|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165069|NCT05463224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165070|NCT05463224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165071|NCT05456932|Iron|iron|mesh-list
92165072|NCT05456932|Ferrous fumarate|ferrous fumarate|mesh-list
92165073|NCT05456932|Ferric maltol|ferric maltol|mesh-list
92165074|NCT05456932|Trace Elements|trace elements|mesh-ancestor
92165075|NCT05456932|Micronutrients|micronutrients|mesh-ancestor
92165076|NCT05456932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165077|NCT05456932|Hematinics|hematinics|mesh-ancestor
92165078|NCT05447780|Anesthetics|anesthetics|mesh-list
92165079|NCT05447780|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165080|NCT05447780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165081|NCT05437289|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92165082|NCT05437289|Antiviral Agents|antiviral agents|mesh-ancestor
92165083|NCT05437289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165084|NCT05419011|Vaccines|vaccines|mesh-list
92165085|NCT05419011|Immunologic Factors|immunologic factors|mesh-ancestor
92165086|NCT05419011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165087|NCT05413343|Ceftazidime|ceftazidime|mesh-list
92165088|NCT05413343|Avibactam|avibactam|mesh-list
92165089|NCT05413343|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92165090|NCT05413343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92165091|NCT05413343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165092|NCT05413343|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92165093|NCT05413343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165094|NCT05413343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165096|NCT05403502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92165097|NCT05403502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165098|NCT05389930|Ethanol|ethanol|mesh-list
92250181|NCT00781508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165099|NCT05389930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92165100|NCT05389930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165101|NCT05389930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165102|NCT05389930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165103|NCT05382546|Ketorolac|ketorolac|mesh-list
92165104|NCT05382546|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92250258|NCT01303835|Naltrexone|naltrexone|mesh-list
92165105|NCT05382546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92165106|NCT05382546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92165107|NCT05382546|Analgesics|analgesics|mesh-ancestor
92250393|NCT01216943|Timolol|timolol|mesh-list
92165108|NCT05382546|Sensory System Agents|sensory system agents|mesh-ancestor
92165109|NCT05382546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165110|NCT05382546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165111|NCT05382546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165112|NCT05382546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165113|NCT05382546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92165114|NCT05382546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182589|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92165115|NCT05382546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165116|NCT05372133|Morphine|morphine|mesh-list
92165117|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92165118|NCT05372133|Narcotics|narcotics|mesh-ancestor
92165119|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165120|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165121|NCT05372133|Analgesics|analgesics|mesh-ancestor
92165122|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
92165123|NCT05372133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165124|NCT05351554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92165125|NCT05351554|Immunologic Factors|immunologic factors|mesh-ancestor
92165126|NCT05351554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165127|NCT05341115|Leuprolide|leuprolide|mesh-list
92165128|NCT05341115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92165129|NCT05341115|Fertility Agents|fertility agents|mesh-ancestor
92165130|NCT05341115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92165131|NCT05341115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165132|NCT05341115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165133|NCT05341115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165134|NCT05292664|Leucovorin|leucovorin|mesh-list
92165135|NCT05292664|Cytarabine|cytarabine|mesh-list
92165136|NCT05292664|Dexamethasone|dexamethasone|mesh-list
92165137|NCT05292664|Dexamethasone acetate|dexamethasone acetate|mesh-list
92165138|NCT05292664|Hydrocortisone|hydrocortisone|mesh-list
92165139|NCT05292664|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92165140|NCT05292664|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92165141|NCT05292664|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92165143|NCT05292664|Doxorubicin|doxorubicin|mesh-list
92165144|NCT05292664|Methotrexate|methotrexate|mesh-list
92165145|NCT05292664|Vincristine|vincristine|mesh-list
92165146|NCT05292664|Azacitidine|azacitidine|mesh-list
92165147|NCT05292664|Venetoclax|venetoclax|mesh-list
92165149|NCT05292664|Razoxane|razoxane|mesh-list
92165150|NCT05292664|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92165151|NCT05292664|BB 1101|bb 1101|mesh-list
92165152|NCT05292664|Levoleucovorin|levoleucovorin|mesh-list
92165153|NCT05292664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165154|NCT05292664|Antiemetics|antiemetics|mesh-ancestor
92165155|NCT05292664|Autonomic Agents|autonomic agents|mesh-ancestor
92165156|NCT05292664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165157|NCT05292664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165158|NCT05292664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165160|NCT05292664|Hormones|hormones|mesh-ancestor
92165161|NCT05292664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165162|NCT05292664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165163|NCT05292664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165164|NCT05292664|Protease Inhibitors|protease inhibitors|mesh-ancestor
92165165|NCT05292664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165166|NCT05292664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165167|NCT05292664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92165168|NCT05292664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92165169|NCT05292664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92165170|NCT05292664|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92165171|NCT05292664|Abortifacient Agents|abortifacient agents|mesh-ancestor
92165172|NCT05292664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92251258|NCT00809276|Fludarabine|fludarabine|mesh-list
92165173|NCT05292664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92165174|NCT05292664|Antimetabolites|antimetabolites|mesh-ancestor
92165175|NCT05292664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92165176|NCT05292664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92165177|NCT05292664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165178|NCT05292664|Immunologic Factors|immunologic factors|mesh-ancestor
92165179|NCT05292664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165180|NCT05292664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92251460|NCT00806234|Antiemetics|antiemetics|mesh-ancestor
92165181|NCT05292664|Antiviral Agents|antiviral agents|mesh-ancestor
92165182|NCT05292664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165183|NCT05292664|Antidotes|antidotes|mesh-ancestor
92165184|NCT05292664|Protective Agents|protective agents|mesh-ancestor
92165185|NCT05292664|Vitamin B Complex|vitamin b complex|mesh-ancestor
92165186|NCT05292664|Vitamins|vitamins|mesh-ancestor
92165187|NCT05292664|Micronutrients|micronutrients|mesh-ancestor
92251606|NCT02193815|Vitamins|vitamins|mesh-ancestor
92165188|NCT05292664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92165189|NCT05292664|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165190|NCT05292664|Antimitotic Agents|antimitotic agents|mesh-ancestor
92165191|NCT05292664|Mitosis Modulators|mitosis modulators|mesh-ancestor
92165192|NCT05292664|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92165193|NCT05283109|Vaccines|vaccines|mesh-list
92165194|NCT05283109|Poly ICLC|poly iclc|mesh-list
92165195|NCT05283109|Immunologic Factors|immunologic factors|mesh-ancestor
92165196|NCT05283109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165197|NCT05283109|Interferon Inducers|interferon inducers|mesh-ancestor
92165198|NCT05278975|Thiostrepton|thiostrepton|mesh-list
92165199|NCT05278975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92165200|NCT05278975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165201|NCT05278351|Irinotecan|irinotecan|mesh-list
92165202|NCT05278351|Cetuximab|cetuximab|mesh-list
92165203|NCT05278351|Tislelizumab|tislelizumab|mesh-list
92165204|NCT05278351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92165205|NCT05278351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92251815|NCT00815360|Triamcinolone|triamcinolone|mesh-list
92165206|NCT05278351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251884|NCT01369745|Antiemetics|antiemetics|mesh-ancestor
92182590|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92165207|NCT05278351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165208|NCT05278351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165209|NCT05278351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165210|NCT05275907|Amlodipine|amlodipine|mesh-list
92165211|NCT05275907|Chlorthalidone|chlorthalidone|mesh-list
92165212|NCT05275907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92165213|NCT05275907|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92165214|NCT05275907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92165215|NCT05275907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165216|NCT05275907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92165217|NCT05275907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165218|NCT05275907|Vasodilator Agents|vasodilator agents|mesh-ancestor
92165220|NCT05275907|Natriuretic Agents|natriuretic agents|mesh-ancestor
92165221|NCT05275907|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92165222|NCT05269628|Dronabinol|dronabinol|mesh-list
92165223|NCT05269628|Cannabidiol|cannabidiol|mesh-list
92165224|NCT05269628|Anticonvulsants|anticonvulsants|mesh-ancestor
92165225|NCT05269628|Hallucinogens|hallucinogens|mesh-ancestor
92182591|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165226|NCT05269628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165227|NCT05269628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92165228|NCT05269628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92165230|NCT05269628|Sensory System Agents|sensory system agents|mesh-ancestor
92165231|NCT05269628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165232|NCT05269628|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92165233|NCT05269628|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92165234|NCT05269628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165235|NCT05269628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165236|NCT05269628|Hormones|hormones|mesh-ancestor
92165237|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165238|NCT05263700|FAPI-46|fapi-46|mesh-list
92165239|NCT05263700|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92165240|NCT05263700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165241|NCT05257447|Baclofen|baclofen|mesh-list
92165242|NCT05257447|Chlorzoxazone|chlorzoxazone|mesh-list
92165243|NCT05257447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92165244|NCT05257447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165245|NCT05257447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92165246|NCT05257447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165247|NCT05257447|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92165248|NCT05257447|GABA Agonists|gaba agonists|mesh-ancestor
92165249|NCT05257447|GABA Agents|gaba agents|mesh-ancestor
92165250|NCT05257447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165251|NCT05257447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165252|NCT05211154|Diclofenac|diclofenac|mesh-list
92165253|NCT05211154|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92165254|NCT05211154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92165255|NCT05211154|Analgesics|analgesics|mesh-ancestor
92165256|NCT05211154|Sensory System Agents|sensory system agents|mesh-ancestor
92165257|NCT05211154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165258|NCT05211154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165259|NCT05211154|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165260|NCT05211154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165261|NCT05211154|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92165262|NCT05211154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165263|NCT05211154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165264|NCT05128344|Vigabatrin|vigabatrin|mesh-list
92165265|NCT05128344|Anticonvulsants|anticonvulsants|mesh-ancestor
92165266|NCT05128344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165267|NCT05128344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165268|NCT05128344|GABA Agents|gaba agents|mesh-ancestor
92165269|NCT05128344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165270|NCT05128344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165271|NCT05093296|Naltrexone|naltrexone|mesh-list
92165272|NCT05093296|Oxytocin|oxytocin|mesh-list
92165273|NCT05093296|Oxytocics|oxytocics|mesh-ancestor
92165274|NCT05093296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92165275|NCT05093296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165276|NCT05093296|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92165277|NCT05093296|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92165278|NCT05093296|Sensory System Agents|sensory system agents|mesh-ancestor
92165279|NCT05093296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165280|NCT05071833|Peppermint oil|peppermint oil|mesh-list
92165281|NCT05071833|Antiemetics|antiemetics|mesh-ancestor
92165282|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
92165283|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165284|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165285|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165286|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
92165287|NCT05023369|Dexamethasone|dexamethasone|mesh-list
92252714|NCT03439280|Dexamethasone|dexamethasone|mesh-list
92165288|NCT05023369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165289|NCT05023369|Antiemetics|antiemetics|mesh-ancestor
92165290|NCT05023369|Autonomic Agents|autonomic agents|mesh-ancestor
92165291|NCT05023369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165292|NCT05023369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165293|NCT05023369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165294|NCT05023369|Glucocorticoids|glucocorticoids|mesh-ancestor
92165295|NCT05023369|Hormones|hormones|mesh-ancestor
92165296|NCT05023369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252925|NCT02203019|Narcotics|narcotics|mesh-ancestor
92165297|NCT05023369|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165298|NCT05023369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165300|NCT04818632|Palbociclib|palbociclib|mesh-list
92165301|NCT04818632|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92165303|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165304|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165306|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
92165307|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165308|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165309|NCT04749628|Cannabidiol|cannabidiol|mesh-list
92165310|NCT04749628|Anticonvulsants|anticonvulsants|mesh-ancestor
92165311|NCT04729101|Lansoprazole|lansoprazole|mesh-list
92165312|NCT04729101|Dexlansoprazole|dexlansoprazole|mesh-list
92165313|NCT04729101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92165314|NCT04729101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165315|NCT04729101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92165316|NCT04729101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165317|NCT04729101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165318|NCT04713969|Pantoprazole|pantoprazole|mesh-list
92165319|NCT04713969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92253217|NCT05945979|Biotin|biotin|mesh-list
92165320|NCT04713969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165321|NCT04713969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92165322|NCT04713969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165323|NCT04713969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165325|NCT04707872|Immunologic Factors|immunologic factors|mesh-ancestor
92165326|NCT04707872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165327|NCT04673448|Niraparib|niraparib|mesh-list
92165328|NCT04673448|Dostarlimab|dostarlimab|mesh-list
92165329|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
92165330|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
92165331|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
92165332|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165333|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92165334|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165335|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165336|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165339|NCT04670081|Nicotinic Acids|nicotinic acids|mesh-list
92165340|NCT04670081|Psilocybin|psilocybin|mesh-list
92165341|NCT04670081|Vitamin B Complex|vitamin b complex|mesh-ancestor
92165342|NCT04670081|Vitamins|vitamins|mesh-ancestor
92165343|NCT04670081|Micronutrients|micronutrients|mesh-ancestor
92165344|NCT04670081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165345|NCT04670081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92165346|NCT04670081|Antimetabolites|antimetabolites|mesh-ancestor
92165347|NCT04670081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165348|NCT04670081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92165349|NCT04670081|Vasodilator Agents|vasodilator agents|mesh-ancestor
92165350|NCT04670081|Hallucinogens|hallucinogens|mesh-ancestor
92165351|NCT04670081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92165353|NCT04648280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92165354|NCT04648280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92165355|NCT04648280|Antiviral Agents|antiviral agents|mesh-ancestor
92165356|NCT04648280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165357|NCT04648280|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92165358|NCT04648280|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92165359|NCT04648280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165360|NCT04602377|Pembrolizumab|pembrolizumab|mesh-list
92165361|NCT04602377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165362|NCT04602377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165363|NCT04602377|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92165364|NCT04602377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165366|NCT04601961|Sevoflurane|sevoflurane|mesh-list
92165367|NCT04601961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92165368|NCT04601961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165369|NCT04601961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165370|NCT04601961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92165371|NCT04601961|Anesthetics, General|anesthetics, general|mesh-ancestor
92165373|NCT04601961|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92165374|NCT04601961|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92165375|NCT04551430|Nivolumab|nivolumab|mesh-list
92165377|NCT04551430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165378|NCT04551430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165379|NCT04551430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254503|NCT03718065|Lofexidine|lofexidine|mesh-list
92165380|NCT04551430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165381|NCT04513314|Valproic Acid|valproic acid|mesh-list
92165382|NCT04513314|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92165383|NCT04513314|Antidepressive Agents|antidepressive agents|mesh-ancestor
92165384|NCT04513314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92165385|NCT04513314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92165386|NCT04513314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92165387|NCT04513314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165388|NCT04513314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165389|NCT04513314|Anticonvulsants|anticonvulsants|mesh-ancestor
92165390|NCT04513314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165391|NCT04513314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165393|NCT04513314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165394|NCT04513314|Antimanic Agents|antimanic agents|mesh-ancestor
92165395|NCT04485559|Everolimus|everolimus|mesh-list
92165396|NCT04485559|Trametinib|trametinib|mesh-list
92165397|NCT04485559|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92165398|NCT04485559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165399|NCT04485559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165400|NCT04485559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165401|NCT04485559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165402|NCT04485559|Immunologic Factors|immunologic factors|mesh-ancestor
92165403|NCT04485559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165404|NCT04485559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165405|NCT04469868|Analgesics, Opioid|analgesics, opioid|mesh-list
92165406|NCT04469868|Narcotics|narcotics|mesh-ancestor
92165407|NCT04469868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165408|NCT04469868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165409|NCT04469868|Analgesics|analgesics|mesh-ancestor
92165410|NCT04469868|Sensory System Agents|sensory system agents|mesh-ancestor
92165411|NCT04469868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165412|NCT04451187|Zopiclone|zopiclone|mesh-list
92165413|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92165414|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165415|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255242|NCT01549223|Oxytocin|oxytocin|mesh-list
92165416|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
92255299|NCT03215264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92165417|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92165418|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165419|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92165420|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165421|NCT04301778|Durvalumab|durvalumab|mesh-list
92165422|NCT04301778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165423|NCT04301778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165424|NCT04287049|Azithromycin|azithromycin|mesh-list
92165425|NCT04287049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92165426|NCT04287049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165427|NCT04282629|Milrinone|milrinone|mesh-list
92165428|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92165429|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92165430|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92165431|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92165432|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92165433|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165434|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165435|NCT04282629|Protective Agents|protective agents|mesh-ancestor
92165436|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165437|NCT04275492|Pramipexole|pramipexole|mesh-list
92165438|NCT04275492|Antioxidants|antioxidants|mesh-ancestor
92165439|NCT04275492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165440|NCT04275492|Protective Agents|protective agents|mesh-ancestor
92165441|NCT04275492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255428|NCT00904826|Eculizumab|eculizumab|mesh-list
92165442|NCT04275492|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92165443|NCT04275492|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92165444|NCT04275492|Dopamine Agonists|dopamine agonists|mesh-ancestor
92165445|NCT04275492|Dopamine Agents|dopamine agents|mesh-ancestor
92165446|NCT04275492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165447|NCT04265105|Fluticasone|fluticasone|mesh-list
92165449|NCT04265105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92165450|NCT04265105|Autonomic Agents|autonomic agents|mesh-ancestor
92255565|NCT01833728|Acetaminophen|acetaminophen|mesh-list
92165451|NCT04265105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165452|NCT04265105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165453|NCT04265105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92165454|NCT04265105|Respiratory System Agents|respiratory system agents|mesh-ancestor
92165455|NCT04265105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92165456|NCT04265105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92165458|NCT04246229|Antioxidants|antioxidants|mesh-ancestor
92165459|NCT04246229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165460|NCT04246229|Protective Agents|protective agents|mesh-ancestor
92165461|NCT04246229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165462|NCT04239703|Antibodies|antibodies|mesh-list
92165463|NCT04239703|Immunologic Factors|immunologic factors|mesh-ancestor
92165464|NCT04239703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165465|NCT04031833|Amphotericin B|amphotericin b|mesh-list
92165466|NCT04031833|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92165467|NCT04031833|Amebicides|amebicides|mesh-ancestor
92165468|NCT04031833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92165469|NCT04031833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92165470|NCT04031833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165471|NCT04031833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92165472|NCT04031833|Antifungal Agents|antifungal agents|mesh-ancestor
92165474|NCT03943875|Immunologic Factors|immunologic factors|mesh-ancestor
92165475|NCT03943875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165476|NCT03933202|Cladribine|cladribine|mesh-list
92165477|NCT03933202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165478|NCT03933202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165479|NCT03933202|Immunologic Factors|immunologic factors|mesh-ancestor
92165480|NCT03933202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165482|NCT03908307|Dexamethasone acetate|dexamethasone acetate|mesh-list
92165483|NCT03908307|BB 1101|bb 1101|mesh-list
92165484|NCT03908307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165485|NCT03908307|Antiemetics|antiemetics|mesh-ancestor
92165486|NCT03908307|Autonomic Agents|autonomic agents|mesh-ancestor
92255985|NCT01837628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92165487|NCT03908307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165488|NCT03908307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165489|NCT03908307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165490|NCT03908307|Glucocorticoids|glucocorticoids|mesh-ancestor
92165491|NCT03908307|Hormones|hormones|mesh-ancestor
92256060|NCT01464359|Busulfan|busulfan|mesh-list
92165492|NCT03908307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165493|NCT03908307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165494|NCT03908307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165495|NCT03908307|Protease Inhibitors|protease inhibitors|mesh-ancestor
92165496|NCT03908307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165497|NCT03908307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165498|NCT03841058|Abaloparatide|abaloparatide|mesh-list
92165499|NCT03841058|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92165500|NCT03841058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165501|NCT03731923|Liver Extracts|liver extracts|mesh-list
92165502|NCT03731923|Hematinics|hematinics|mesh-ancestor
92165503|NCT03723564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92165504|NCT03688789|Hydrocortisone|hydrocortisone|mesh-list
92165505|NCT03688789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165506|NCT03684590|Analgesics, Opioid|analgesics, opioid|mesh-list
92165507|NCT03684590|Narcotics|narcotics|mesh-ancestor
92165508|NCT03684590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165509|NCT03684590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165510|NCT03684590|Analgesics|analgesics|mesh-ancestor
92165511|NCT03684590|Sensory System Agents|sensory system agents|mesh-ancestor
92165512|NCT03684590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165513|NCT03492775|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92165514|NCT03492775|Obinutuzumab|obinutuzumab|mesh-list
92165515|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92165516|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
92165517|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165518|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165519|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165520|NCT03385304|Iodine|iodine|mesh-list
92165521|NCT03385304|Chlorhexidine|chlorhexidine|mesh-list
92165522|NCT03385304|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92165523|NCT03385304|Povidone-Iodine|povidone-iodine|mesh-list
92165524|NCT03385304|Povidone|povidone|mesh-list
92165525|NCT03385304|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92165526|NCT03385304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165527|NCT03385304|Disinfectants|disinfectants|mesh-ancestor
92165528|NCT03385304|Dermatologic Agents|dermatologic agents|mesh-ancestor
92165529|NCT03385304|Trace Elements|trace elements|mesh-ancestor
92165530|NCT03385304|Micronutrients|micronutrients|mesh-ancestor
92165531|NCT03385304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165532|NCT03385304|Plasma Substitutes|plasma substitutes|mesh-ancestor
92165533|NCT03385304|Blood Substitutes|blood substitutes|mesh-ancestor
92165534|NCT03351998|Atorvastatin|atorvastatin|mesh-list
92165535|NCT03351998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92165536|NCT03351998|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92165537|NCT03351998|Antimetabolites|antimetabolites|mesh-ancestor
92165538|NCT03351998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916357|NCT03962114|Vitamins|vitamins|mesh-ancestor
92165539|NCT03351998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92165540|NCT03351998|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92165541|NCT03351998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165543|NCT03331198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165544|NCT03285568|Palbociclib|palbociclib|mesh-list
92165545|NCT03285568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165546|NCT03285568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165547|NCT03285568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165548|NCT03285568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165549|NCT03117816|Interferons|interferons|mesh-list
92165550|NCT03117816|Interferon-alpha|interferon-alpha|mesh-list
92165551|NCT03117816|Interferon alpha-2|interferon alpha-2|mesh-list
92165552|NCT03117816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165553|NCT03117816|Antiviral Agents|antiviral agents|mesh-ancestor
92165554|NCT03117816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165555|NCT03117816|Immunologic Factors|immunologic factors|mesh-ancestor
92165556|NCT03117816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165558|NCT03038802|Immunologic Factors|immunologic factors|mesh-ancestor
92165559|NCT03038802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165560|NCT02938793|Durvalumab|durvalumab|mesh-list
92165561|NCT02938793|Tremelimumab|tremelimumab|mesh-list
92165562|NCT02938793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92256616|NCT02517528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92165563|NCT02938793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165564|NCT02837094|Insulin|insulin|mesh-list
92165565|NCT02837094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92256667|NCT03007121|Sufentanil|sufentanil|mesh-list
92165566|NCT02837094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165567|NCT02836925|Sofosbuvir|sofosbuvir|mesh-list
92165568|NCT02836925|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92165569|NCT02836925|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92165570|NCT02836925|Ledipasvir|ledipasvir|mesh-list
92165571|NCT02836925|Velpatasvir|velpatasvir|mesh-list
92165572|NCT02836925|Antiviral Agents|antiviral agents|mesh-ancestor
92165573|NCT02836925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165574|NCT02756962|Cytarabine|cytarabine|mesh-list
92165575|NCT02756962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92165576|NCT02756962|Antimetabolites|antimetabolites|mesh-ancestor
92165577|NCT02756962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165578|NCT02756962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165579|NCT02756962|Antiviral Agents|antiviral agents|mesh-ancestor
92165580|NCT02756962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165581|NCT02756962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165582|NCT02756962|Immunologic Factors|immunologic factors|mesh-ancestor
92165583|NCT02756962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165584|NCT02728037|Lidocaine|lidocaine|mesh-list
92165585|NCT02728037|Magnesium Sulfate|magnesium sulfate|mesh-list
92165586|NCT02728037|Anesthetics, Local|anesthetics, local|mesh-ancestor
92165587|NCT02728037|Anesthetics|anesthetics|mesh-ancestor
92165588|NCT02728037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256737|NCT03001271|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92165589|NCT02728037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165590|NCT02728037|Sensory System Agents|sensory system agents|mesh-ancestor
92165591|NCT02728037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165592|NCT02728037|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92165593|NCT02728037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92165594|NCT02728037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92165595|NCT02728037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92165596|NCT02728037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165597|NCT02728037|Analgesics|analgesics|mesh-ancestor
92165598|NCT02728037|Anticonvulsants|anticonvulsants|mesh-ancestor
92165599|NCT02728037|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92402836|NCT01424839|Cisplatin|cisplatin|mesh-list
92165600|NCT02728037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92165601|NCT02728037|Tocolytic Agents|tocolytic agents|mesh-ancestor
92165602|NCT02728037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92165603|NCT02546440|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92256923|NCT03000413|Fentanyl|fentanyl|mesh-list
92165606|NCT02546440|Immunologic Factors|immunologic factors|mesh-ancestor
92165607|NCT02546440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165608|NCT02392572|TIC10 compound|tic10 compound|mesh-list
92165609|NCT02392572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165611|NCT02275780|Darunavir|darunavir|mesh-list
92165612|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92165613|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92165614|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92165615|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
92165616|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165617|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165619|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92165620|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
92165621|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165622|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92165623|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92165624|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92165625|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92165626|NCT02158091|Cyclophosphamide|cyclophosphamide|mesh-list
92165627|NCT02158091|Rituximab|rituximab|mesh-list
92165628|NCT02158091|Fludarabine|fludarabine|mesh-list
92165629|NCT02158091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165630|NCT02158091|Immunologic Factors|immunologic factors|mesh-ancestor
92165631|NCT02158091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165632|NCT02158091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165633|NCT02158091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92165634|NCT02158091|Alkylating Agents|alkylating agents|mesh-ancestor
92165635|NCT02158091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165636|NCT02158091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165637|NCT02158091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92165638|NCT02158091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165639|NCT01746836|Ponatinib|ponatinib|mesh-list
92165640|NCT01746836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165641|NCT01746836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165642|NCT01746836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165643|NCT01746836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165644|NCT00545077|Bevacizumab|bevacizumab|mesh-list
92165645|NCT00545077|Letrozole|letrozole|mesh-list
92165646|NCT00545077|Fulvestrant|fulvestrant|mesh-list
92165647|NCT00545077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165648|NCT00545077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165649|NCT00545077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92165650|NCT00545077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92165651|NCT00545077|Growth Substances|growth substances|mesh-ancestor
92165652|NCT00545077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165653|NCT00545077|Growth Inhibitors|growth inhibitors|mesh-ancestor
92165654|NCT00545077|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92165655|NCT00545077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92165656|NCT00545077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165657|NCT00545077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165658|NCT00545077|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92165659|NCT00545077|Hormone Antagonists|hormone antagonists|mesh-ancestor
92165660|NCT00545077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257330|NCT04526951|Aspirin|aspirin|mesh-list
92165661|NCT00545077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165662|NCT00545077|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92165664|NCT00251433|Trastuzumab|trastuzumab|mesh-list
92165665|NCT00251433|Lapatinib|lapatinib|mesh-list
92165666|NCT00251433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165667|NCT00251433|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165668|NCT00251433|Antimitotic Agents|antimitotic agents|mesh-ancestor
92165669|NCT00251433|Mitosis Modulators|mitosis modulators|mesh-ancestor
92402849|NCT01424839|Alkylating Agents|alkylating agents|mesh-ancestor
92165670|NCT00251433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165671|NCT00251433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165672|NCT00251433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165673|NCT00251433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165674|NCT00130533|Capecitabine|capecitabine|mesh-list
92165675|NCT00130533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92165676|NCT00130533|Antimetabolites|antimetabolites|mesh-ancestor
92165677|NCT00130533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165678|NCT00130533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165679|NCT00129935|Cyclophosphamide|cyclophosphamide|mesh-list
92165680|NCT00129935|Docetaxel|docetaxel|mesh-list
92165681|NCT00129935|Capecitabine|capecitabine|mesh-list
92165682|NCT00129935|Epirubicin|epirubicin|mesh-list
92165683|NCT00129935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165684|NCT00129935|Immunologic Factors|immunologic factors|mesh-ancestor
92165685|NCT00129935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165686|NCT00129935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165687|NCT00129935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92165688|NCT00129935|Alkylating Agents|alkylating agents|mesh-ancestor
92165689|NCT00129935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165690|NCT00129935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165691|NCT00129935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92165692|NCT00129935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165693|NCT00129935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92165694|NCT00129935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92165695|NCT00129935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92165696|NCT00129935|Antimetabolites|antimetabolites|mesh-ancestor
92165697|NCT00129935|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92165698|NCT00129935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92165699|NCT00129935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92165700|NCT00129935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165702|NCT02760667|Carboplatin|carboplatin|mesh-list
92165703|NCT02760667|Docetaxel|docetaxel|mesh-list
92165704|NCT02760667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165705|NCT02760667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165706|NCT02760667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92402865|NCT01425073|Antimalarials|antimalarials|mesh-ancestor
92165707|NCT02760667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92165708|NCT02760667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165709|NCT04127357|Fluorides|fluorides|mesh-list
92165710|NCT04127357|Cariostatic Agents|cariostatic agents|mesh-ancestor
92165711|NCT04127357|Protective Agents|protective agents|mesh-ancestor
92165712|NCT04127357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165713|NCT01450111|Lacosamide|lacosamide|mesh-list
92165714|NCT01450111|Anticonvulsants|anticonvulsants|mesh-ancestor
92165715|NCT01450111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92165716|NCT01450111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92165717|NCT01450111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92165718|NCT01450111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165719|NCT02697253|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92165720|NCT02697253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92165721|NCT02697253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165722|NCT02697253|Incretins|incretins|mesh-ancestor
92165723|NCT02697253|Hormones|hormones|mesh-ancestor
92165724|NCT02697253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165725|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92165726|NCT02697253|Protease Inhibitors|protease inhibitors|mesh-ancestor
92165727|NCT02697253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165728|NCT02697253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165730|NCT02660905|Emtricitabine|emtricitabine|mesh-list
92165731|NCT02660905|Sofosbuvir|sofosbuvir|mesh-list
92165732|NCT02660905|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92165733|NCT02660905|Rilpivirine|rilpivirine|mesh-list
92165734|NCT02660905|Ledipasvir|ledipasvir|mesh-list
92165735|NCT02660905|Antiviral Agents|antiviral agents|mesh-ancestor
92165736|NCT02660905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165737|NCT02660905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92257766|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92165738|NCT02660905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92165739|NCT02660905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165740|NCT02660905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165741|NCT02660905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92165742|NCT02660905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92165743|NCT03822715|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92165744|NCT03822715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92165745|NCT03822715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165746|NCT03822715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165747|NCT03822715|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92165749|NCT03822715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165750|NCT03822715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165751|NCT01450345|Pregabalin|pregabalin|mesh-list
92165752|NCT01450345|Analgesics|analgesics|mesh-ancestor
92165753|NCT01450345|Sensory System Agents|sensory system agents|mesh-ancestor
92165754|NCT01450345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165755|NCT01450345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165756|NCT01450345|Anticonvulsants|anticonvulsants|mesh-ancestor
92165757|NCT01450345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92165758|NCT01450345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92165759|NCT01450345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165760|NCT01450345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92165761|NCT01450345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92165762|NCT01450345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92165763|NCT01450345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165764|NCT01450345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92165765|NCT03822559|Timolol|timolol|mesh-list
92165766|NCT03822559|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92165767|NCT03822559|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92165768|NCT03822559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92165769|NCT03822559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92165770|NCT03822559|Adrenergic Agents|adrenergic agents|mesh-ancestor
92165771|NCT03822559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165772|NCT03822559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165773|NCT03822559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165774|NCT03822559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92165775|NCT03822559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92165777|NCT01647828|Gemcitabine|gemcitabine|mesh-list
92165778|NCT01647828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92165779|NCT01647828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165780|NCT01647828|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165781|NCT01647828|Antimitotic Agents|antimitotic agents|mesh-ancestor
92165782|NCT01647828|Mitosis Modulators|mitosis modulators|mesh-ancestor
92165783|NCT01647828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165784|NCT01647828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258127|NCT04376216|Prednisone|prednisone|mesh-list
92165785|NCT01647828|Antimetabolites|antimetabolites|mesh-ancestor
92165786|NCT03825367|Nivolumab|nivolumab|mesh-list
92165787|NCT03825367|Azacitidine|azacitidine|mesh-list
92165788|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258169|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
92165789|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165790|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92165791|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165792|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92165794|NCT03825367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165795|NCT04273321|Methylprednisolone|methylprednisolone|mesh-list
92165796|NCT04273321|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92165797|NCT04273321|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92165798|NCT04273321|Prednisolone|prednisolone|mesh-list
92165799|NCT04273321|Prednisolone acetate|prednisolone acetate|mesh-list
92165800|NCT04273321|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92165801|NCT04273321|Prednisolone phosphate|prednisolone phosphate|mesh-list
92165802|NCT04273321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165803|NCT04273321|Antiemetics|antiemetics|mesh-ancestor
92165804|NCT04273321|Autonomic Agents|autonomic agents|mesh-ancestor
92165805|NCT04273321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165806|NCT04273321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165807|NCT04273321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92165808|NCT04273321|Glucocorticoids|glucocorticoids|mesh-ancestor
92165809|NCT04273321|Hormones|hormones|mesh-ancestor
92165810|NCT04273321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165811|NCT04273321|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92165812|NCT04273321|Protective Agents|protective agents|mesh-ancestor
92165813|NCT04273321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165814|NCT04273321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165816|NCT02654119|Cyclophosphamide|cyclophosphamide|mesh-list
92165817|NCT02654119|Trastuzumab|trastuzumab|mesh-list
92165818|NCT02654119|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92165819|NCT02654119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92165820|NCT02654119|Antibodies|antibodies|mesh-list
92165821|NCT02654119|Immunoglobulins|immunoglobulins|mesh-list
92165822|NCT02654119|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92165823|NCT02654119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92165824|NCT02654119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165825|NCT02654119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165826|NCT02654119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92165827|NCT02654119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92258731|NCT01651793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92165828|NCT02654119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165829|NCT02654119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165830|NCT02654119|Immunologic Factors|immunologic factors|mesh-ancestor
92165831|NCT02654119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165833|NCT02654119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92165834|NCT02654119|Alkylating Agents|alkylating agents|mesh-ancestor
92165835|NCT02654119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92165836|NCT01243476|Lenalidomide|lenalidomide|mesh-list
92165837|NCT01243476|Immunologic Factors|immunologic factors|mesh-ancestor
92165838|NCT01243476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165839|NCT01243476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92165840|NCT01243476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92165841|NCT01243476|Growth Substances|growth substances|mesh-ancestor
92165842|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
92165843|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165844|NCT01453933|Raltegravir Potassium|raltegravir potassium|mesh-list
92165845|NCT01453933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92165846|NCT01453933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92165847|NCT01453933|Antiviral Agents|antiviral agents|mesh-ancestor
92165848|NCT01453933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165849|NCT01453933|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92165850|NCT01453933|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92165851|NCT01453933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165852|NCT01453933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165853|NCT04976478|Nimotuzumab|nimotuzumab|mesh-list
92258814|NCT01614509|Hormones|hormones|mesh-ancestor
92165854|NCT04976478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165855|NCT04976478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165856|NCT01454011|Methyltestosterone|methyltestosterone|mesh-list
92165857|NCT01454011|Testosterone|testosterone|mesh-list
92165858|NCT01454011|Testosterone undecanoate|testosterone undecanoate|mesh-list
92165859|NCT01454011|Testosterone enanthate|testosterone enanthate|mesh-list
92258937|NCT04359212|PENTA|penta|mesh-list
92165860|NCT01454011|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92165861|NCT01454011|Androgens|androgens|mesh-ancestor
92165862|NCT01454011|Hormones|hormones|mesh-ancestor
92259002|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92165863|NCT01454011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165864|NCT01454011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259074|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92165865|NCT01454011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165866|NCT01454011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165867|NCT01454011|Anabolic Agents|anabolic agents|mesh-ancestor
92165868|NCT03060018|Oxitropium|oxitropium|mesh-list
92165869|NCT03060018|Parasympatholytics|parasympatholytics|mesh-ancestor
92165870|NCT03060018|Autonomic Agents|autonomic agents|mesh-ancestor
92165871|NCT03060018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165872|NCT03060018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165873|NCT04976088|Diclofenac|diclofenac|mesh-list
92165874|NCT04976088|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92165875|NCT04976088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92165876|NCT04976088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92165877|NCT04976088|Analgesics|analgesics|mesh-ancestor
92165878|NCT04976088|Sensory System Agents|sensory system agents|mesh-ancestor
92259209|NCT03034382|Nalbuphine|nalbuphine|mesh-list
92165879|NCT04976088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165880|NCT04976088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165881|NCT04976088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165882|NCT04976088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259350|NCT03033368|Antiviral Agents|antiviral agents|mesh-ancestor
92165883|NCT04976088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92165884|NCT04976088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165885|NCT04976088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165886|NCT04975932|Chlorotrianisene|chlorotrianisene|mesh-list
92165887|NCT04975932|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92165888|NCT04975932|Estrogens|estrogens|mesh-ancestor
92165889|NCT04975932|Hormones|hormones|mesh-ancestor
92165890|NCT04975932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92165891|NCT04975932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165892|NCT04975932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92165893|NCT04975932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165894|NCT04968132|Analgesics, Opioid|analgesics, opioid|mesh-list
92165895|NCT04968132|Narcotics|narcotics|mesh-ancestor
92165896|NCT04968132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165897|NCT04968132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165899|NCT04968132|Sensory System Agents|sensory system agents|mesh-ancestor
92165900|NCT04968132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165901|NCT03829111|Nivolumab|nivolumab|mesh-list
92165902|NCT03829111|Ipilimumab|ipilimumab|mesh-list
92165903|NCT03829111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92165904|NCT03829111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165905|NCT03829111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92165907|NCT01454479|Lapatinib|lapatinib|mesh-list
92165908|NCT01454479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165909|NCT01454479|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92165910|NCT01454479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165911|NCT01454479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165913|NCT03061032|Sofosbuvir|sofosbuvir|mesh-list
92165914|NCT03061032|Ledipasvir|ledipasvir|mesh-list
92165915|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
92165916|NCT03061032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165917|NCT03061032|Antiviral Agents|antiviral agents|mesh-ancestor
92165918|NCT03061032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165919|NCT02911831|Tranexamic Acid|tranexamic acid|mesh-list
92260156|NCT00994760|Fentanyl|fentanyl|mesh-list
92165920|NCT02911831|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92165921|NCT02911831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92260221|NCT01031498|Ondansetron|ondansetron|mesh-list
92165922|NCT02911831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165923|NCT02911831|Hemostatics|hemostatics|mesh-ancestor
92165924|NCT02911831|Coagulants|coagulants|mesh-ancestor
92165925|NCT03061734|Acetaminophen|acetaminophen|mesh-list
92165927|NCT03061734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92165928|NCT03061734|Analgesics|analgesics|mesh-ancestor
92165929|NCT03061734|Sensory System Agents|sensory system agents|mesh-ancestor
92165930|NCT03061734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92165931|NCT03061734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165932|NCT03061734|Antipyretics|antipyretics|mesh-ancestor
92165933|NCT03061734|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92165934|NCT03061734|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92165935|NCT03061656|Cyclophosphamide|cyclophosphamide|mesh-list
92165936|NCT03061656|Melphalan|melphalan|mesh-list
92165937|NCT03061656|Thiotepa|thiotepa|mesh-list
92165938|NCT03061656|Carboplatin|carboplatin|mesh-list
92165939|NCT03061656|Etoposide|etoposide|mesh-list
92165940|NCT03061656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92165941|NCT03061656|Immunologic Factors|immunologic factors|mesh-ancestor
92165942|NCT03061656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165943|NCT03061656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165944|NCT03061656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92165945|NCT03061656|Alkylating Agents|alkylating agents|mesh-ancestor
92165946|NCT03061656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260728|NCT01080248|Gemcitabine|gemcitabine|mesh-list
92165947|NCT03061656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165948|NCT03061656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92165949|NCT03061656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92165951|NCT03061656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92260906|NCT02179892|Hormones|hormones|mesh-ancestor
92165952|NCT03061656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165954|NCT02906761|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92165955|NCT02906761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92165956|NCT02906761|Analgesics|analgesics|mesh-ancestor
92261019|NCT01113398|Bevacizumab|bevacizumab|mesh-list
92261086|NCT04341675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92165957|NCT02906761|Sensory System Agents|sensory system agents|mesh-ancestor
92165958|NCT02906761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261161|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
92402927|NCT01425320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165959|NCT02906761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165960|NCT02906761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92165961|NCT02906761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92165962|NCT02906761|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92165963|NCT02906761|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92261382|NCT02542761|Carbon Fiber|carbon fiber|mesh-list
92165964|NCT02906761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165965|NCT02906761|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92165966|NCT02906761|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92165967|NCT02906761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92165968|NCT02906761|Antipyretics|antipyretics|mesh-ancestor
92165969|NCT02905591|Ascorbic Acid|ascorbic acid|mesh-list
92165970|NCT02905591|Paclitaxel|paclitaxel|mesh-list
92165971|NCT02905591|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92165972|NCT02905591|Carboplatin|carboplatin|mesh-list
92165973|NCT02905591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92165974|NCT02905591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92165975|NCT02905591|Tubulin Modulators|tubulin modulators|mesh-ancestor
92165976|NCT02905591|Antimitotic Agents|antimitotic agents|mesh-ancestor
92165977|NCT02905591|Mitosis Modulators|mitosis modulators|mesh-ancestor
92165978|NCT02905591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92165979|NCT02905591|Vitamins|vitamins|mesh-ancestor
92165980|NCT02905591|Micronutrients|micronutrients|mesh-ancestor
92165981|NCT02905591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165983|NCT02905591|Protective Agents|protective agents|mesh-ancestor
92165984|NCT01455025|Plerixafor|plerixafor|mesh-list
92165985|NCT01455025|Lenograstim|lenograstim|mesh-list
92165986|NCT01455025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92165987|NCT01455025|Immunologic Factors|immunologic factors|mesh-ancestor
92165988|NCT01455025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165989|NCT01455025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92165990|NCT01455025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92165992|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92165993|NCT03060798|Desflurane|desflurane|mesh-list
92165994|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92165995|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
92165996|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
92165997|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92165998|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92165999|NCT01451593|Phenytoin|phenytoin|mesh-list
92166000|NCT01451593|Anticonvulsants|anticonvulsants|mesh-ancestor
92166001|NCT01451593|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92166002|NCT01451593|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92166003|NCT01451593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166004|NCT01451593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166005|NCT01451593|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92166006|NCT01451593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92166007|NCT01455103|BMS-936559|bms-936559|mesh-list
92166008|NCT01455103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92166009|NCT01455103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166010|NCT01455103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166011|NCT01455103|Immunologic Factors|immunologic factors|mesh-ancestor
92166012|NCT01455103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166013|NCT04975074|Iron|iron|mesh-list
92166014|NCT04975074|Ferrous succinate|ferrous succinate|mesh-list
92166015|NCT04975074|Trace Elements|trace elements|mesh-ancestor
92166016|NCT04975074|Micronutrients|micronutrients|mesh-ancestor
92166017|NCT04975074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166018|NCT04975074|Hematinics|hematinics|mesh-ancestor
92166020|NCT04963998|Trace Elements|trace elements|mesh-ancestor
92166021|NCT04963998|Micronutrients|micronutrients|mesh-ancestor
92166022|NCT04963998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166023|NCT01451905|Liraglutide|liraglutide|mesh-list
92166024|NCT01451905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92166025|NCT01451905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166026|NCT01451905|Incretins|incretins|mesh-ancestor
92166027|NCT01451905|Hormones|hormones|mesh-ancestor
92262009|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166028|NCT01451905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166029|NCT01455649|Cyclosporine|cyclosporine|mesh-list
92166030|NCT01455649|Everolimus|everolimus|mesh-list
92166031|NCT01455649|Tacrolimus|tacrolimus|mesh-list
92166032|NCT01455649|Cyclosporins|cyclosporins|mesh-list
92166033|NCT01455649|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92166034|NCT01455649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166035|NCT01455649|Immunologic Factors|immunologic factors|mesh-ancestor
92166036|NCT01455649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166037|NCT01455649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166038|NCT01455649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166039|NCT01455649|Antifungal Agents|antifungal agents|mesh-ancestor
92166040|NCT01455649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166041|NCT01455649|Dermatologic Agents|dermatologic agents|mesh-ancestor
92166042|NCT01455649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166043|NCT01455649|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92166044|NCT01455649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92166045|NCT01455649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166046|NCT04974294|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92166047|NCT04974294|Immunologic Factors|immunologic factors|mesh-ancestor
92166048|NCT04974294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166049|NCT01452139|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92166050|NCT01452139|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92166051|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
92166052|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92166053|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166054|NCT01455883|Glimepiride|glimepiride|mesh-list
92166055|NCT01455883|Exenatide|exenatide|mesh-list
92166056|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92166057|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92166058|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166059|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166060|NCT01455883|Immunologic Factors|immunologic factors|mesh-ancestor
92166061|NCT01455883|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92166063|NCT01455883|Hormones|hormones|mesh-ancestor
92166064|NCT01455883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166065|NCT01452217|Secretin|secretin|mesh-list
92166066|NCT01452217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166067|NCT01452217|Hormones|hormones|mesh-ancestor
92262192|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
92166068|NCT01452217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166069|NCT01452217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166070|NCT04966884|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92166071|NCT04966884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92166072|NCT04966884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262261|NCT01189292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166073|NCT04966884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166074|NCT02637583|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92166075|NCT02637583|Immunologic Factors|immunologic factors|mesh-ancestor
92166076|NCT02637583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166077|NCT04954560|Losartan|losartan|mesh-list
92166078|NCT04954560|Eprosartan|eprosartan|mesh-list
92166079|NCT04954560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92166080|NCT04954560|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92166081|NCT04954560|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92166082|NCT04954560|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92166083|NCT04954560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166084|NCT04954560|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92166085|NCT01456117|Pioglitazone|pioglitazone|mesh-list
92166086|NCT01456117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92166087|NCT01456117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166088|NCT04962672|Anesthetics|anesthetics|mesh-list
92166089|NCT04962672|Propofol|propofol|mesh-list
92166090|NCT04962672|Sevoflurane|sevoflurane|mesh-list
92166091|NCT04962672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166092|NCT04962672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166093|NCT04962672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92166094|NCT04962672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92166095|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
92166096|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92166098|NCT03829345|Olaparib|olaparib|mesh-list
92166099|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92166100|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166101|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166102|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166103|NCT01456351|Rituximab|rituximab|mesh-list
92166104|NCT01456351|Fludarabine|fludarabine|mesh-list
92166105|NCT01456351|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92166106|NCT01456351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166107|NCT01456351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262667|NCT05859269|Glucocorticoids|glucocorticoids|mesh-ancestor
92166109|NCT01456351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166110|NCT01456351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166111|NCT01456351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166112|NCT01456351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92166113|NCT01456351|Alkylating Agents|alkylating agents|mesh-ancestor
92166114|NCT02541955|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92166115|NCT02541955|Hormones|hormones|mesh-ancestor
92262887|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166116|NCT02541955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166117|NCT02541955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166118|NCT01452685|Leuprolide|leuprolide|mesh-list
92166119|NCT01452685|Relugolix|relugolix|mesh-list
92263042|NCT05232123|Cannabidiol|cannabidiol|mesh-list
92166120|NCT01452685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92166121|NCT01452685|Fertility Agents|fertility agents|mesh-ancestor
92166122|NCT01452685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92166123|NCT01452685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166124|NCT01452685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92263107|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
92166125|NCT01452685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166126|NCT01452685|Androgen Antagonists|androgen antagonists|mesh-ancestor
92166127|NCT01452685|Hormone Antagonists|hormone antagonists|mesh-ancestor
92263181|NCT04731779|Cannabidiol|cannabidiol|mesh-list
92166128|NCT01452685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166129|NCT01452763|Lansoprazole|lansoprazole|mesh-list
92166130|NCT01452763|Dexlansoprazole|dexlansoprazole|mesh-list
92166131|NCT01452763|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92166132|NCT01452763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166133|NCT01452763|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92166134|NCT01452763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166135|NCT01452763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166137|NCT04954014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166138|NCT04954014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263398|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
92166139|NCT04954014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92166140|NCT04954014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92166141|NCT04954014|Growth Substances|growth substances|mesh-ancestor
92166142|NCT04954014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166143|NCT04954014|Growth Inhibitors|growth inhibitors|mesh-ancestor
92166144|NCT00988559|Imiquimod|imiquimod|mesh-list
92166145|NCT00988559|Vaccines|vaccines|mesh-list
92166146|NCT00988559|Immunologic Factors|immunologic factors|mesh-ancestor
92166147|NCT00988559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166148|NCT00988559|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92166149|NCT00988559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166150|NCT00988559|Interferon Inducers|interferon inducers|mesh-ancestor
92166151|NCT02967289|Irinotecan|irinotecan|mesh-list
92166152|NCT02967289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92166153|NCT02967289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92166154|NCT02967289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166155|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166156|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166157|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92166158|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166159|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92263703|NCT02550652|Antiemetics|antiemetics|mesh-ancestor
92166160|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166161|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166162|NCT02967133|Paclitaxel|paclitaxel|mesh-list
92166163|NCT02967133|Nivolumab|nivolumab|mesh-list
92166164|NCT02967133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92166165|NCT02967133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166166|NCT02967133|Tubulin Modulators|tubulin modulators|mesh-ancestor
92166167|NCT02967133|Antimitotic Agents|antimitotic agents|mesh-ancestor
92166168|NCT02967133|Mitosis Modulators|mitosis modulators|mesh-ancestor
92166169|NCT02967133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166170|NCT02967133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166171|NCT02967133|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92166172|NCT04961970|Leucovorin|leucovorin|mesh-list
92166173|NCT04961970|Gemcitabine|gemcitabine|mesh-list
92166174|NCT04961970|Fluorouracil|fluorouracil|mesh-list
92166175|NCT04961970|Oxaliplatin|oxaliplatin|mesh-list
92166176|NCT04961970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166177|NCT04961970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92166178|NCT04961970|Antimetabolites|antimetabolites|mesh-ancestor
92166179|NCT04961970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166180|NCT04961970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166181|NCT04961970|Immunologic Factors|immunologic factors|mesh-ancestor
92166182|NCT04961970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166183|NCT04961970|Antidotes|antidotes|mesh-ancestor
92166184|NCT04961970|Protective Agents|protective agents|mesh-ancestor
92166185|NCT04961970|Vitamin B Complex|vitamin b complex|mesh-ancestor
92166187|NCT04961970|Micronutrients|micronutrients|mesh-ancestor
92166188|NCT01311687|Dexamethasone|dexamethasone|mesh-list
92166190|NCT01311687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166191|NCT01311687|Antiemetics|antiemetics|mesh-ancestor
92166192|NCT01311687|Autonomic Agents|autonomic agents|mesh-ancestor
92166193|NCT01311687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166194|NCT01311687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166195|NCT01311687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166196|NCT01311687|Glucocorticoids|glucocorticoids|mesh-ancestor
92166197|NCT01311687|Hormones|hormones|mesh-ancestor
92166198|NCT01311687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166199|NCT01311687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92166200|NCT01311687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166201|NCT01311687|Immunologic Factors|immunologic factors|mesh-ancestor
92166202|NCT01311687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92166203|NCT01311687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92166204|NCT01311687|Growth Substances|growth substances|mesh-ancestor
92264188|NCT00003407|Cytarabine|cytarabine|mesh-list
92166206|NCT00988091|Hyaluronic Acid|hyaluronic acid|mesh-list
92166207|NCT00988091|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92166208|NCT00988091|Immunologic Factors|immunologic factors|mesh-ancestor
92166209|NCT00988091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166210|NCT00988091|Viscosupplements|viscosupplements|mesh-ancestor
92166211|NCT00988091|Protective Agents|protective agents|mesh-ancestor
92166212|NCT04965324|Anesthetics|anesthetics|mesh-list
92166213|NCT04965324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166214|NCT04965324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166215|NCT04961268|Acetaminophen|acetaminophen|mesh-list
92166217|NCT04961268|Tramadol|tramadol|mesh-list
92166218|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166219|NCT04961268|Analgesics|analgesics|mesh-ancestor
92166220|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
92166221|NCT04961268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166222|NCT04961268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166223|NCT04961268|Antipyretics|antipyretics|mesh-ancestor
92166224|NCT04961268|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92166225|NCT04961268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166226|NCT04961268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166227|NCT04961268|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92166228|NCT04961268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166229|NCT04961268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166230|NCT04961268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92166232|NCT04961268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166233|NCT03828643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92166234|NCT03828643|Immunologic Factors|immunologic factors|mesh-ancestor
92166235|NCT03828643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166236|NCT01346397|Cyclosporine|cyclosporine|mesh-list
92166237|NCT01346397|Tacrolimus|tacrolimus|mesh-list
92166238|NCT01346397|Cyclosporins|cyclosporins|mesh-list
92166239|NCT01346397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166240|NCT01346397|Immunologic Factors|immunologic factors|mesh-ancestor
92166241|NCT01346397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166242|NCT01346397|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92166243|NCT01346397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166244|NCT01346397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166245|NCT01346397|Antifungal Agents|antifungal agents|mesh-ancestor
92166246|NCT01346397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166247|NCT01346397|Dermatologic Agents|dermatologic agents|mesh-ancestor
92166248|NCT01346397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166249|NCT01347255|Betamethasone|betamethasone|mesh-list
92166250|NCT01347255|Betamethasone Valerate|betamethasone valerate|mesh-list
92166251|NCT01347255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92166252|NCT01347255|Betamethasone benzoate|betamethasone benzoate|mesh-list
92166253|NCT01347255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92166254|NCT01347255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166255|NCT01347255|Glucocorticoids|glucocorticoids|mesh-ancestor
92166256|NCT01347255|Hormones|hormones|mesh-ancestor
92166257|NCT01347255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166258|NCT01347255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166259|NCT01347255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92166260|NCT01347255|Respiratory System Agents|respiratory system agents|mesh-ancestor
92166261|NCT04392427|Ribavirin|ribavirin|mesh-list
92166262|NCT04392427|Ivermectin|ivermectin|mesh-list
92166263|NCT04392427|Nitazoxanide|nitazoxanide|mesh-list
92166264|NCT04392427|Antimetabolites|antimetabolites|mesh-ancestor
92166265|NCT04392427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166266|NCT04392427|Antiviral Agents|antiviral agents|mesh-ancestor
92264718|NCT02613117|Fluorides|fluorides|mesh-list
92166267|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166268|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92166269|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
92166271|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166272|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
92264856|NCT01307462|Azithromycin|azithromycin|mesh-list
92166273|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166275|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92166276|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
92166277|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166278|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166279|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92166281|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
92166282|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92166283|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92166284|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166285|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92166286|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166287|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166288|NCT01455337|Prednisolone|prednisolone|mesh-list
92166289|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
92166290|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166291|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
92166292|NCT01455337|Hormones|hormones|mesh-ancestor
92166293|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166294|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166295|NCT01455337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92166296|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166297|NCT01455337|Protective Agents|protective agents|mesh-ancestor
92166298|NCT01455337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92166299|NCT01455337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265133|NCT01749215|Topiramate|topiramate|mesh-list
92166300|NCT01455337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166301|NCT01455337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92265205|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
92402961|NCT01425476|Cholecalciferol|cholecalciferol|mesh-list
92166302|NCT01455337|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92166303|NCT01455337|Vasodilator Agents|vasodilator agents|mesh-ancestor
92166304|NCT01455337|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92166305|NCT01455337|Antioxidants|antioxidants|mesh-ancestor
92166306|NCT03059316|Labetalol|labetalol|mesh-list
92166307|NCT03059316|Nitroglycerin|nitroglycerin|mesh-list
92166308|NCT03059316|Vasodilator Agents|vasodilator agents|mesh-ancestor
92166309|NCT03059316|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92166310|NCT03059316|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92166311|NCT03059316|Adrenergic Agents|adrenergic agents|mesh-ancestor
92166312|NCT03059316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166313|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166314|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166315|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92166316|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
92166317|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
92166318|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166319|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92166320|NCT03059316|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92166321|NCT01312389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92166322|NCT01312389|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92265340|NCT01316042|Metformin|metformin|mesh-list
92166323|NCT01312389|Immunologic Factors|immunologic factors|mesh-ancestor
92166324|NCT01312389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166325|NCT01312389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92166326|NCT01312389|Antiviral Agents|antiviral agents|mesh-ancestor
92166328|NCT04943952|Asparaginase|asparaginase|mesh-list
92166329|NCT04943952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166330|NCT04410978|Teriflunomide|teriflunomide|mesh-list
92166331|NCT04410978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92166332|NCT04410978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166333|NCT04410978|Analgesics|analgesics|mesh-ancestor
92166334|NCT04410978|Sensory System Agents|sensory system agents|mesh-ancestor
92166335|NCT04410978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166336|NCT04410978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166337|NCT04410978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166338|NCT04410978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166339|NCT04410978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166340|NCT04410978|Immunologic Factors|immunologic factors|mesh-ancestor
92166341|NCT01352637|Cycloserine|cycloserine|mesh-list
92166342|NCT01352637|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92166343|NCT01352637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166344|NCT01352637|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92166345|NCT01352637|Antitubercular Agents|antitubercular agents|mesh-ancestor
92166346|NCT01352637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92166347|NCT01352637|Antimetabolites|antimetabolites|mesh-ancestor
92166348|NCT01352637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166350|NCT03058536|Progestins|progestins|mesh-ancestor
92166351|NCT03058536|Hormones|hormones|mesh-ancestor
92166352|NCT03058536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166353|NCT03058536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166354|NCT01314417|Methotrexate|methotrexate|mesh-list
92166355|NCT01314417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92166356|NCT01314417|Abortifacient Agents|abortifacient agents|mesh-ancestor
92265780|NCT04351412|Fluorides|fluorides|mesh-list
92166357|NCT01314417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92265823|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166358|NCT01314417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166359|NCT01314417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92166361|NCT01314417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265899|NCT01365650|Analgesics|analgesics|mesh-ancestor
92166362|NCT01314417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166363|NCT01314417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92166365|NCT01314417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92166366|NCT01314417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166367|NCT01314417|Immunologic Factors|immunologic factors|mesh-ancestor
92166368|NCT01314417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166369|NCT01314417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92166371|NCT01457911|Glimepiride|glimepiride|mesh-list
92166372|NCT01457911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92166373|NCT01457911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166374|NCT01457911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92166375|NCT01457911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166376|NCT01457911|Immunologic Factors|immunologic factors|mesh-ancestor
92166378|NCT02893423|Anesthetics, Local|anesthetics, local|mesh-ancestor
92166379|NCT02893423|Anesthetics|anesthetics|mesh-ancestor
92166380|NCT02893423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266187|NCT02382575|Rituximab|rituximab|mesh-list
92166381|NCT02893423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166382|NCT02893423|Sensory System Agents|sensory system agents|mesh-ancestor
92166383|NCT02893423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166385|NCT05586919|Polidocanol|polidocanol|mesh-list
92166386|NCT05586919|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92166387|NCT05586919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166388|NCT05586919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166389|NCT05586919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166390|NCT05586919|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92166391|NCT05586919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92166392|NCT01890889|Ezetimibe|ezetimibe|mesh-list
92266469|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
92166393|NCT01890889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92166394|NCT01890889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92166395|NCT01890889|Antimetabolites|antimetabolites|mesh-ancestor
92166396|NCT01890889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166397|NCT01890889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92166399|NCT04951752|Anesthetics, Local|anesthetics, local|mesh-ancestor
92166400|NCT04951752|Anesthetics|anesthetics|mesh-ancestor
92166401|NCT04951752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166402|NCT04951752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166403|NCT04951752|Sensory System Agents|sensory system agents|mesh-ancestor
92166404|NCT04951752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166405|NCT01315665|Sulforaphane|sulforaphane|mesh-list
92166406|NCT01315665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92166407|NCT01315665|Protective Agents|protective agents|mesh-ancestor
92166408|NCT01315665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166409|NCT01315665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166410|NCT01454089|Carboplatin|carboplatin|mesh-list
92166411|NCT01454089|Gemcitabine|gemcitabine|mesh-list
92266687|NCT01799213|Analgesics|analgesics|mesh-ancestor
92166412|NCT01454089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166413|NCT01454089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92166414|NCT01454089|Antimetabolites|antimetabolites|mesh-ancestor
92166415|NCT01454089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166416|NCT01457989|Ezogabine|ezogabine|mesh-list
92166417|NCT01457989|Anticonvulsants|anticonvulsants|mesh-ancestor
92166418|NCT01457989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166419|NCT01457989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166420|NCT01458067|GSK2636771|gsk2636771|mesh-list
92166421|NCT01458067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266746|NCT02194088|Mydriatics|mydriatics|mesh-ancestor
92166422|NCT01458067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92166423|NCT01458067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166424|NCT01458067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166425|NCT04942860|Methotrexate|methotrexate|mesh-list
92266810|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166426|NCT04942860|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92166427|NCT04942860|Abortifacient Agents|abortifacient agents|mesh-ancestor
92166428|NCT04942860|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92166429|NCT04942860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166430|NCT04942860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92166431|NCT04942860|Antimetabolites|antimetabolites|mesh-ancestor
92322328|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92166432|NCT04942860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166433|NCT04942860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166434|NCT04942860|Dermatologic Agents|dermatologic agents|mesh-ancestor
92166435|NCT04942860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166436|NCT04942860|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92166437|NCT04942860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92166438|NCT04942860|Immunologic Factors|immunologic factors|mesh-ancestor
92166439|NCT04942860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166440|NCT04942860|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92166441|NCT01458223|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92166442|NCT01458223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92166443|NCT01458223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166444|NCT01458223|Antitubercular Agents|antitubercular agents|mesh-ancestor
92166445|NCT04959786|Ribavirin|ribavirin|mesh-list
92166446|NCT04959786|Ivermectin|ivermectin|mesh-list
92166447|NCT04959786|Nitazoxanide|nitazoxanide|mesh-list
92166448|NCT04959786|Antimetabolites|antimetabolites|mesh-ancestor
92166449|NCT04959786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166450|NCT04959786|Antiviral Agents|antiviral agents|mesh-ancestor
92166451|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166452|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92166453|NCT01452451|Exenatide|exenatide|mesh-list
92166454|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92166455|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166456|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92166457|NCT01452451|Incretins|incretins|mesh-ancestor
92166459|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166460|NCT04951128|Anesthetics|anesthetics|mesh-list
92166461|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
92267008|NCT05587257|Minoxidil|minoxidil|mesh-list
92166462|NCT04951128|Tranexamic Acid|tranexamic acid|mesh-list
92166463|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166464|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166465|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92166466|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92166467|NCT04951128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166468|NCT04951128|Hemostatics|hemostatics|mesh-ancestor
92166469|NCT04951128|Coagulants|coagulants|mesh-ancestor
92166470|NCT04951128|Sensory System Agents|sensory system agents|mesh-ancestor
92166471|NCT04951128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166472|NCT01458301|Leuprolide|leuprolide|mesh-list
92166473|NCT01458301|Relugolix|relugolix|mesh-list
92166474|NCT01458301|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92166475|NCT01458301|Fertility Agents|fertility agents|mesh-ancestor
92166476|NCT01458301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92166477|NCT01458301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166478|NCT01458301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92166479|NCT01458301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166480|NCT01458301|Androgen Antagonists|androgen antagonists|mesh-ancestor
92166481|NCT01458301|Hormone Antagonists|hormone antagonists|mesh-ancestor
92166482|NCT01458301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166483|NCT03059238|Celecoxib|celecoxib|mesh-list
92166484|NCT03059238|Parecoxib|parecoxib|mesh-list
92166485|NCT03059238|Oxycodone|oxycodone|mesh-list
92166486|NCT03059238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92166487|NCT03059238|Narcotics|narcotics|mesh-ancestor
92166488|NCT03059238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166489|NCT03059238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166490|NCT03059238|Analgesics|analgesics|mesh-ancestor
92166491|NCT03059238|Sensory System Agents|sensory system agents|mesh-ancestor
92166492|NCT03059238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166493|NCT03059238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92166494|NCT03059238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166495|NCT03059238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166496|NCT03059238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166497|NCT03059238|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92166498|NCT03059238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92166499|NCT03059238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166500|NCT03059238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166501|NCT01891201|Oxytocin|oxytocin|mesh-list
92166502|NCT01891201|Oxytocics|oxytocics|mesh-ancestor
92267644|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
92166503|NCT01891201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92166504|NCT01891201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166505|NCT04942002|Methylprednisolone|methylprednisolone|mesh-list
92166506|NCT04942002|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92402987|NCT01425580|Incretins|incretins|mesh-ancestor
92166507|NCT04942002|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92166510|NCT04942002|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92166511|NCT04942002|Prednisolone phosphate|prednisolone phosphate|mesh-list
92166512|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166513|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
92166514|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
92166515|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166516|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166517|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166518|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
92267785|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92267850|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166520|NCT04942002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166521|NCT04942002|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92166522|NCT04942002|Protective Agents|protective agents|mesh-ancestor
92267926|NCT05444751|Anesthetics|anesthetics|mesh-list
92166523|NCT04942002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92166524|NCT04942002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166525|NCT01891435|Acetaminophen|acetaminophen|mesh-list
92166526|NCT01891435|Diclofenac|diclofenac|mesh-list
92166527|NCT01891435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166528|NCT01891435|Analgesics|analgesics|mesh-ancestor
92166529|NCT01891435|Sensory System Agents|sensory system agents|mesh-ancestor
92166530|NCT01891435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267999|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166531|NCT01891435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166532|NCT01891435|Antipyretics|antipyretics|mesh-ancestor
92166533|NCT01891435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92268066|NCT01868633|Dexamethasone|dexamethasone|mesh-list
92166534|NCT01891435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166535|NCT01891435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166536|NCT01891435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92166537|NCT01891435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166538|NCT01891435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166540|NCT01458769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92166541|NCT01458769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92166543|NCT01458769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166544|NCT01458769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166545|NCT01458769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92166546|NCT01458769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92166547|NCT01458769|Antiviral Agents|antiviral agents|mesh-ancestor
92166548|NCT01458769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268428|NCT01546454|Hormones|hormones|mesh-ancestor
92166549|NCT01458847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92166551|NCT04941846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92166552|NCT04941846|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92166553|NCT04941846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166554|NCT04941846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166555|NCT04941846|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92166556|NCT04941846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166557|NCT04941846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92166558|NCT01891513|Losartan|losartan|mesh-list
92166559|NCT01891513|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92166560|NCT01891513|Perindopril|perindopril|mesh-list
92166561|NCT01891513|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92166562|NCT01891513|Diuretics|diuretics|mesh-list
92166563|NCT01891513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92166564|NCT01891513|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92166565|NCT01891513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92166566|NCT01891513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92166567|NCT01891513|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92166568|NCT01891513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166569|NCT01891513|Natriuretic Agents|natriuretic agents|mesh-ancestor
92166570|NCT01891513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268584|NCT02371746|Travoprost|travoprost|mesh-list
92166571|NCT01891513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166572|NCT01891513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92166573|NCT01891513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166575|NCT04843423|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92166576|NCT04843423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92268625|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
92166577|NCT04843423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166578|NCT04843423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166579|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92166580|NCT01459081|Zanamivir|zanamivir|mesh-list
92166581|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
92166583|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166584|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166585|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
92166587|NCT04421196|Narcotics|narcotics|mesh-ancestor
92166588|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166589|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166590|NCT04421196|Sensory System Agents|sensory system agents|mesh-ancestor
92166591|NCT04421196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166593|NCT01459315|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92166594|NCT01459315|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92166595|NCT01459315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268980|NCT05511779|Brincidofovir|brincidofovir|mesh-list
92166596|NCT01459315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166597|NCT01459315|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92166598|NCT01459315|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92166599|NCT01459315|Antiviral Agents|antiviral agents|mesh-ancestor
92166600|NCT01459315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166601|NCT04948788|Gemcitabine|gemcitabine|mesh-list
92166602|NCT04948788|Oxaliplatin|oxaliplatin|mesh-list
92166603|NCT04948788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92166604|NCT04948788|Antimetabolites|antimetabolites|mesh-ancestor
92166605|NCT04948788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166606|NCT04948788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166607|NCT02865811|Doxorubicin|doxorubicin|mesh-list
92166608|NCT02865811|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92166610|NCT02865811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92166611|NCT02865811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166612|NCT02865811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92403006|NCT01425658|Clonidine|clonidine|mesh-list
92166613|NCT02865811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92166614|NCT02865811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166615|NCT02865811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166616|NCT02865811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166617|NCT02865811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92166618|NCT03058224|Acetaminophen|acetaminophen|mesh-list
92166619|NCT03058224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166620|NCT03058224|Analgesics|analgesics|mesh-ancestor
92166621|NCT03058224|Sensory System Agents|sensory system agents|mesh-ancestor
92166622|NCT03058224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269406|NCT01562678|Liraglutide|liraglutide|mesh-list
92166623|NCT03058224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166624|NCT03058224|Antipyretics|antipyretics|mesh-ancestor
92269476|NCT02392104|Warfarin|warfarin|mesh-list
92166625|NCT04957212|Carboplatin|carboplatin|mesh-list
92166626|NCT04957212|Docetaxel|docetaxel|mesh-list
92166627|NCT04957212|Trastuzumab|trastuzumab|mesh-list
92166628|NCT04957212|Pertuzumab|pertuzumab|mesh-list
92166629|NCT04957212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166630|NCT04957212|Tubulin Modulators|tubulin modulators|mesh-ancestor
92166631|NCT04957212|Antimitotic Agents|antimitotic agents|mesh-ancestor
92166632|NCT04957212|Mitosis Modulators|mitosis modulators|mesh-ancestor
92166633|NCT04957212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166634|NCT04957212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166636|NCT02879617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92166637|NCT02879617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166638|NCT04390789|Calcium|calcium|mesh-list
92166639|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92166640|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166641|NCT04947774|Immunomodulating Agents|immunomodulating agents|mesh-list
92166642|NCT04947774|Immunologic Factors|immunologic factors|mesh-ancestor
92166643|NCT04947774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166644|NCT04948164|Naproxen|naproxen|mesh-list
92166645|NCT04948164|Sumatriptan|sumatriptan|mesh-list
92166646|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92166647|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166648|NCT04948164|Analgesics|analgesics|mesh-ancestor
92166649|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
92166650|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166651|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269749|NCT01515566|Narcotics|narcotics|mesh-ancestor
92166652|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166653|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92166654|NCT04948164|Gout Suppressants|gout suppressants|mesh-ancestor
92166655|NCT04948164|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92166656|NCT04948164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166657|NCT04948164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166659|NCT04948164|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92166660|NCT04948164|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92166661|NCT04948164|Serotonin Agents|serotonin agents|mesh-ancestor
92166663|NCT02808871|Pirfenidone|pirfenidone|mesh-list
92166664|NCT02808871|Analgesics|analgesics|mesh-ancestor
92166665|NCT02808871|Sensory System Agents|sensory system agents|mesh-ancestor
92166666|NCT02808871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166667|NCT02808871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166668|NCT02808871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270115|NCT01578278|Xhance|xhance|mesh-list
92166669|NCT02808871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166670|NCT02808871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166671|NCT02808871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270190|NCT00373659|Growth Substances|growth substances|mesh-ancestor
92166672|NCT02808871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166673|NCT01892683|Propofol|propofol|mesh-list
92166674|NCT01892683|Anesthetics|anesthetics|mesh-ancestor
92270261|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166675|NCT01892683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270336|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
92166676|NCT01892683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166677|NCT01892683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92166678|NCT01892683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92166679|NCT01892683|Anesthetics, General|anesthetics, general|mesh-ancestor
92166680|NCT01459627|Ticagrelor|ticagrelor|mesh-list
92166681|NCT01459627|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92166682|NCT01459627|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92166683|NCT01459627|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92166684|NCT01459627|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92166685|NCT01459627|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92166686|NCT01459627|Purinergic Agents|purinergic agents|mesh-ancestor
92166687|NCT01459627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166688|NCT01459627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166689|NCT01459627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166690|NCT02467621|Pantoprazole|pantoprazole|mesh-list
92166691|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92166692|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270685|NCT01595516|Bradykinin|bradykinin|mesh-list
92166693|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92166694|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166695|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166696|NCT04937946|Fentanyl|fentanyl|mesh-list
92166697|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92166698|NCT04937946|Narcotics|narcotics|mesh-ancestor
92270838|NCT03000218|Metformin|metformin|mesh-list
92166699|NCT04937946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166700|NCT04937946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166702|NCT04937946|Sensory System Agents|sensory system agents|mesh-ancestor
92166703|NCT04937946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166704|NCT04937946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92166705|NCT04937946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92166706|NCT04937946|Anesthetics, General|anesthetics, general|mesh-ancestor
92166707|NCT04937946|Anesthetics|anesthetics|mesh-ancestor
92166709|NCT05160987|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92271059|NCT01880099|Galantamine|galantamine|mesh-list
92166710|NCT05160987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92271127|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
92166711|NCT05160987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166712|NCT05160987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166713|NCT05160987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92166715|NCT05160987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92166716|NCT05160987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92166717|NCT05160987|Anesthetics, General|anesthetics, general|mesh-ancestor
92166718|NCT05160987|Anesthetics|anesthetics|mesh-ancestor
92166719|NCT05160987|GABA Modulators|gaba modulators|mesh-ancestor
92166720|NCT05160987|GABA Agents|gaba agents|mesh-ancestor
92166721|NCT05160987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924286|NCT05485766|Paclitaxel|paclitaxel|mesh-list
92271466|NCT03002090|Iron|iron|mesh-list
92271566|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92166722|NCT05160987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166724|NCT01892995|Analgesics|analgesics|mesh-ancestor
92166725|NCT01892995|Sensory System Agents|sensory system agents|mesh-ancestor
92166726|NCT01892995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166727|NCT01892995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166728|NCT01892995|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92166729|NCT01892995|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92166730|NCT01892995|Anesthetics, General|anesthetics, general|mesh-ancestor
92166731|NCT01892995|Anesthetics|anesthetics|mesh-ancestor
92166732|NCT01892995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166733|NCT01892995|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92166734|NCT01892995|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92166735|NCT01892995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166736|NCT01892995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166737|NCT04938102|Botulinum Toxins|botulinum toxins|mesh-list
92166738|NCT04938102|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92166739|NCT04938102|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92166740|NCT04938102|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92166741|NCT04938102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166742|NCT04938102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166743|NCT04938102|Cholinergic Agents|cholinergic agents|mesh-ancestor
92166744|NCT04938102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166745|NCT04938102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166746|NCT04938102|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92166747|NCT04938102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166748|NCT02181075|Doxorubicin|doxorubicin|mesh-list
92271792|NCT02987465|Norepinephrine|norepinephrine|mesh-list
92166749|NCT02181075|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92166751|NCT02181075|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92166752|NCT02181075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166753|NCT02181075|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92166754|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92166755|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166756|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166757|NCT02181075|Hematinics|hematinics|mesh-ancestor
92166758|NCT01359735|Bacitracin|bacitracin|mesh-list
92166759|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92166760|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166761|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92166762|NCT01361217|Midazolam|midazolam|mesh-list
92166763|NCT01361217|Dextromethorphan|dextromethorphan|mesh-list
92166764|NCT01361217|Caffeine|caffeine|mesh-list
92166765|NCT01361217|Fluoxetine|fluoxetine|mesh-list
92166766|NCT01361217|Omeprazole|omeprazole|mesh-list
92166768|NCT01361217|L 647318|l 647318|mesh-list
92166769|NCT01361217|Dihydromevinolin|dihydromevinolin|mesh-list
92272220|NCT01694966|Methylene Blue|methylene blue|mesh-list
92166770|NCT01361217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92166771|NCT01361217|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92166772|NCT01361217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166773|NCT01361217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166774|NCT01361217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92166775|NCT01361217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92166776|NCT01361217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92166777|NCT01361217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92166778|NCT01361217|Anesthetics, General|anesthetics, general|mesh-ancestor
92166779|NCT01361217|Anesthetics|anesthetics|mesh-ancestor
92166780|NCT01361217|GABA Modulators|gaba modulators|mesh-ancestor
92166781|NCT01361217|GABA Agents|gaba agents|mesh-ancestor
92166782|NCT01361217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272424|NCT01928849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166783|NCT01361217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166784|NCT01361217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92166785|NCT01361217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92166786|NCT01361217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166787|NCT01361217|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92166788|NCT01361217|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92166789|NCT01361217|Purinergic Agents|purinergic agents|mesh-ancestor
92166790|NCT01361217|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92166791|NCT01361217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166792|NCT01361217|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92166793|NCT01361217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92166794|NCT01361217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92166795|NCT01361217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166796|NCT01361217|Serotonin Agents|serotonin agents|mesh-ancestor
92166797|NCT01361217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92166798|NCT01361217|Antidepressive Agents|antidepressive agents|mesh-ancestor
92166799|NCT01361217|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92166800|NCT01361217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92166801|NCT01361217|Antitussive Agents|antitussive agents|mesh-ancestor
92166802|NCT01361217|Respiratory System Agents|respiratory system agents|mesh-ancestor
92166803|NCT01361217|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92166804|NCT01361217|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92166805|NCT01361217|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92166806|NCT01361217|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92166807|NCT01361217|Antimetabolites|antimetabolites|mesh-ancestor
92166808|NCT01361217|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92272997|NCT02992886|Raltitrexed|raltitrexed|mesh-list
92273069|NCT05738681|Protective Agents|protective agents|mesh-ancestor
92166809|NCT01361217|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92166810|NCT04271839|Fluticasone|fluticasone|mesh-list
92166811|NCT04271839|Formoterol Fumarate|formoterol fumarate|mesh-list
92166812|NCT04271839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166813|NCT04271839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92166814|NCT04271839|Autonomic Agents|autonomic agents|mesh-ancestor
92166815|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166816|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166817|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92166818|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
92166819|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
92166820|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92166821|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92166822|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92166823|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92166824|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
92166825|NCT04271839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166826|NCT04271839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166827|NCT04945434|Methamphetamine|methamphetamine|mesh-list
92273215|NCT01646762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166828|NCT04945434|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92166829|NCT04945434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166830|NCT04945434|Sympathomimetics|sympathomimetics|mesh-ancestor
92166831|NCT04945434|Autonomic Agents|autonomic agents|mesh-ancestor
92273344|NCT01659866|Ciprofloxacin|ciprofloxacin|mesh-list
92166832|NCT04945434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166833|NCT04945434|Dopamine Agents|dopamine agents|mesh-ancestor
92273420|NCT02683265|Dopamine Agents|dopamine agents|mesh-ancestor
92166834|NCT04945434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166835|NCT04945434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166836|NCT04945434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92166837|NCT04945434|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92273563|NCT03325647|Androgens|androgens|mesh-ancestor
92166838|NCT04945434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92166839|NCT04945434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166840|NCT04945434|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92166841|NCT04411758|Propolis|propolis|mesh-list
92166842|NCT04411758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166843|NCT04408560|Acetaminophen|acetaminophen|mesh-list
92166845|NCT04408560|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166847|NCT04408560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166848|NCT04408560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166849|NCT04408560|Antipyretics|antipyretics|mesh-ancestor
92166850|NCT04844905|Ivermectin|ivermectin|mesh-list
92166851|NCT04844905|Piperaquine|piperaquine|mesh-list
92166852|NCT04844905|Artenimol|artenimol|mesh-list
92166853|NCT04844905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92166854|NCT04844905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166855|NCT04844905|Antimalarials|antimalarials|mesh-ancestor
92166856|NCT04844905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92166857|NCT04418856|Methamphetamine|methamphetamine|mesh-list
92273995|NCT04436133|Vaccines|vaccines|mesh-list
92166858|NCT04418856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92166859|NCT04418856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166860|NCT04418856|Sympathomimetics|sympathomimetics|mesh-ancestor
92166861|NCT04418856|Autonomic Agents|autonomic agents|mesh-ancestor
92166862|NCT04418856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166863|NCT04418856|Dopamine Agents|dopamine agents|mesh-ancestor
92166864|NCT04418856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166865|NCT04418856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166866|NCT04418856|Adrenergic Agents|adrenergic agents|mesh-ancestor
92166867|NCT04418856|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92274211|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166868|NCT04418856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92166869|NCT04418856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166870|NCT04418856|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92166871|NCT01454635|Sertraline|sertraline|mesh-list
92166872|NCT01454635|Antidepressive Agents|antidepressive agents|mesh-ancestor
92166873|NCT01454635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92166874|NCT01454635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92166875|NCT01454635|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92166876|NCT01454635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92166877|NCT01454635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166878|NCT01454635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166879|NCT01454635|Serotonin Agents|serotonin agents|mesh-ancestor
92166880|NCT01454635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166882|NCT02196831|Growth Substances|growth substances|mesh-ancestor
92166883|NCT02196831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166884|NCT04944966|Lumefantrine|lumefantrine|mesh-list
92166885|NCT04944966|Artemether|artemether|mesh-list
92166886|NCT04944966|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92166887|NCT04944966|Antimalarials|antimalarials|mesh-ancestor
92166888|NCT04944966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92166889|NCT04944966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92166890|NCT04944966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166891|NCT04955262|Nivolumab|nivolumab|mesh-list
92166892|NCT04955262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274646|NCT03258645|Dabigatran|dabigatran|mesh-list
92166893|NCT04955262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166894|NCT04955262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92166895|NCT04955262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166896|NCT01363479|Dexamethasone|dexamethasone|mesh-list
92166897|NCT01363479|Palonosetron|palonosetron|mesh-list
92166898|NCT01363479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92166899|NCT01363479|Antiemetics|antiemetics|mesh-ancestor
92166900|NCT01363479|Autonomic Agents|autonomic agents|mesh-ancestor
92166901|NCT01363479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166902|NCT01363479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166903|NCT01363479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92166904|NCT01363479|Glucocorticoids|glucocorticoids|mesh-ancestor
92166905|NCT01363479|Hormones|hormones|mesh-ancestor
92182592|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403103|NCT05386121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166906|NCT01363479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92166907|NCT01363479|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92166908|NCT01363479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166909|NCT01363479|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92274928|NCT02399345|Ritonavir|ritonavir|mesh-list
92166910|NCT01363479|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92166911|NCT01363479|Serotonin Agents|serotonin agents|mesh-ancestor
92166912|NCT01363479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166913|NCT01363479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166914|NCT01893385|Vitamin D|vitamin d|mesh-list
92166915|NCT01893385|Vitamins|vitamins|mesh-ancestor
92166916|NCT01893385|Micronutrients|micronutrients|mesh-ancestor
92166917|NCT01893385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166918|NCT01893385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92166920|NCT04935450|Chelating Agents|chelating agents|mesh-ancestor
92166921|NCT04935450|Sequestering Agents|sequestering agents|mesh-ancestor
92275095|NCT02037893|Benzocaine|benzocaine|mesh-list
92166922|NCT04935450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166923|NCT02181231|Buprenorphine|buprenorphine|mesh-list
92166924|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92275139|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92166925|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92275214|NCT02355821|Bisoprolol|bisoprolol|mesh-list
92166927|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92166928|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166930|NCT02181231|Sensory System Agents|sensory system agents|mesh-ancestor
92166931|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166932|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92166933|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92275503|NCT02373137|Protective Agents|protective agents|mesh-ancestor
92275505|NCT02373137|Mydriatics|mydriatics|mesh-ancestor
92166934|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92166935|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275578|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
92166936|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166937|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92166938|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92166939|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
92166940|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92166941|NCT04922034|Amoxicillin|amoxicillin|mesh-list
92166942|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92166943|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92166944|NCT01364259|Amifostine|amifostine|mesh-list
92166945|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92166946|NCT01364259|Protective Agents|protective agents|mesh-ancestor
92166947|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166948|NCT01321437|Axitinib|axitinib|mesh-list
92166949|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275794|NCT01777412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92166950|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92275882|NCT01783574|Hormones|hormones|mesh-ancestor
92166952|NCT01321437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166953|NCT01365585|Sildenafil Citrate|sildenafil citrate|mesh-list
92166954|NCT01365585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166955|NCT01365585|Vasodilator Agents|vasodilator agents|mesh-ancestor
92166956|NCT01365585|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92166957|NCT01365585|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92166958|NCT01365585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166966|NCT02664181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166967|NCT02664181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92166968|NCT02664181|Antimetabolites|antimetabolites|mesh-ancestor
92166969|NCT02664181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92166970|NCT04407390|Niacinamide|niacinamide|mesh-list
92166971|NCT04407390|Niacin|niacin|mesh-list
92276012|NCT01787240|Escitalopram|escitalopram|mesh-list
92166972|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
92166973|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
92166975|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
92166976|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166977|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92166978|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
92166979|NCT04407390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92166980|NCT04407390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92166981|NCT04407390|Vasodilator Agents|vasodilator agents|mesh-ancestor
92166982|NCT02181387|Acetaminophen|acetaminophen|mesh-list
92166983|NCT02181387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92166984|NCT02181387|Analgesics|analgesics|mesh-ancestor
92166985|NCT02181387|Sensory System Agents|sensory system agents|mesh-ancestor
92166986|NCT02181387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166987|NCT02181387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166989|NCT04921878|Mitoxantrone|mitoxantrone|mesh-list
92166990|NCT04921878|Analgesics|analgesics|mesh-ancestor
92166991|NCT04921878|Sensory System Agents|sensory system agents|mesh-ancestor
92166992|NCT04921878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92166993|NCT04921878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92166994|NCT04921878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92166995|NCT04921878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92166996|NCT04921878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92276430|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92166998|NCT04921878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167000|NCT04351347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92167001|NCT04351347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167003|NCT04932564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167004|NCT04932564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167005|NCT04932564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167006|NCT04932564|Immunologic Factors|immunologic factors|mesh-ancestor
92167007|NCT04932564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167008|NCT04921566|Torsemide|torsemide|mesh-list
92167009|NCT04921566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92167010|NCT04921566|Diuretics|diuretics|mesh-ancestor
92167011|NCT04921566|Natriuretic Agents|natriuretic agents|mesh-ancestor
92167012|NCT04921566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167013|NCT04921566|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92167014|NCT04921566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92276647|NCT01803074|BMS-955176|bms-955176|mesh-list
92276661|NCT05327894|Blinatumomab|blinatumomab|mesh-list
92167015|NCT04921566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167018|NCT02655601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92167019|NCT02655601|Alkylating Agents|alkylating agents|mesh-ancestor
92167020|NCT02655601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167021|NCT02655601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167023|NCT02655601|Micronutrients|micronutrients|mesh-ancestor
92167024|NCT02655601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167025|NCT02652247|Dimercaprol|dimercaprol|mesh-list
92167026|NCT02652247|Chelating Agents|chelating agents|mesh-ancestor
92167027|NCT02652247|Sequestering Agents|sequestering agents|mesh-ancestor
92182593|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92167028|NCT02652247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167034|NCT01365819|Varenicline|varenicline|mesh-list
92167035|NCT01365819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92167036|NCT01365819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92167037|NCT01365819|Cholinergic Agents|cholinergic agents|mesh-ancestor
92167038|NCT01365819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167039|NCT01365819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167040|NCT01365819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167042|NCT02635555|Oxymetazoline|oxymetazoline|mesh-list
92167044|NCT02635555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92167045|NCT02635555|Mydriatics|mydriatics|mesh-ancestor
92167046|NCT02635555|Autonomic Agents|autonomic agents|mesh-ancestor
92167047|NCT02635555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167048|NCT02635555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167049|NCT02635555|Sympathomimetics|sympathomimetics|mesh-ancestor
92167050|NCT02635555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92167051|NCT02635555|Nasal Decongestants|nasal decongestants|mesh-ancestor
92167052|NCT02635555|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277292|NCT03705273|Hormones|hormones|mesh-ancestor
92167053|NCT02635555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92167054|NCT02635555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92167055|NCT02635555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92167056|NCT02635555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92167057|NCT02635555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182594|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92167058|NCT02635555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167059|NCT02635555|Protective Agents|protective agents|mesh-ancestor
92167060|NCT02635555|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92167061|NCT01893541|Propranolol|propranolol|mesh-list
92277506|NCT02353572|Dexamethasone|dexamethasone|mesh-list
92167062|NCT01893541|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92167063|NCT01893541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92167064|NCT01893541|Adrenergic Agents|adrenergic agents|mesh-ancestor
92167065|NCT01893541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182595|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
92167066|NCT01893541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167067|NCT01893541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167068|NCT01893541|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92167069|NCT01893541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92167070|NCT01893541|Vasodilator Agents|vasodilator agents|mesh-ancestor
92167072|NCT02849899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92167073|NCT02849899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167074|NCT02849899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92167075|NCT02849899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92167076|NCT02849899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182596|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167077|NCT02849899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167078|NCT02771197|Pembrolizumab|pembrolizumab|mesh-list
92167079|NCT02771197|Fludarabine|fludarabine|mesh-list
92167080|NCT02771197|Melphalan|melphalan|mesh-list
92167081|NCT02771197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167082|NCT02771197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167083|NCT02771197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92167084|NCT02771197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167085|NCT02771197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167086|NCT02771197|Immunologic Factors|immunologic factors|mesh-ancestor
92167087|NCT02771197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167088|NCT02771197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92167089|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
92167090|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92167092|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
92167093|NCT01369875|Fludarabine|fludarabine|mesh-list
92167094|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167095|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
92167096|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167097|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167098|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92167099|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
92167100|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167101|NCT01369875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167102|NCT01369875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92167104|NCT01369875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92167105|NCT01369875|Antiviral Agents|antiviral agents|mesh-ancestor
92167106|NCT01369875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167107|NCT02620189|Adalimumab|adalimumab|mesh-list
92167109|NCT02620189|Etanercept|etanercept|mesh-list
92167110|NCT02620189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92167111|NCT02620189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167112|NCT02620189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278739|NCT00924807|Sorafenib|sorafenib|mesh-list
92167113|NCT02620189|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92167114|NCT02620189|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92167115|NCT02620189|Analgesics|analgesics|mesh-ancestor
92167116|NCT02620189|Sensory System Agents|sensory system agents|mesh-ancestor
92167117|NCT02620189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167118|NCT02620189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167119|NCT02620189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167120|NCT02620189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167121|NCT02620189|Immunologic Factors|immunologic factors|mesh-ancestor
92167123|NCT02763319|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92167124|NCT02763319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167125|NCT02763319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167126|NCT02763319|Immunologic Factors|immunologic factors|mesh-ancestor
92167127|NCT02763319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167128|NCT02763319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167129|NCT02763319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92167130|NCT02763319|Alkylating Agents|alkylating agents|mesh-ancestor
92167131|NCT02763319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167132|NCT02755597|Dexamethasone|dexamethasone|mesh-list
92167133|NCT02755597|Bortezomib|bortezomib|mesh-list
92167134|NCT02755597|Venetoclax|venetoclax|mesh-list
92167135|NCT02755597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167136|NCT02755597|Antiemetics|antiemetics|mesh-ancestor
92167137|NCT02755597|Autonomic Agents|autonomic agents|mesh-ancestor
92167138|NCT02755597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167139|NCT02755597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167140|NCT02755597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167141|NCT02755597|Glucocorticoids|glucocorticoids|mesh-ancestor
92167142|NCT02755597|Hormones|hormones|mesh-ancestor
92167143|NCT02755597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167144|NCT02755597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92167145|NCT02755597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167146|NCT01323153|Dalcetrapib|dalcetrapib|mesh-list
92167147|NCT01323153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92167148|NCT01323153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92167149|NCT01323153|Antimetabolites|antimetabolites|mesh-ancestor
92167150|NCT01323153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322587|NCT00002162|Lamivudine|lamivudine|mesh-list
92167151|NCT01323153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92167152|NCT02594371|Paclitaxel|paclitaxel|mesh-list
92167153|NCT02594371|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92279375|NCT00487461|Simvastatin|simvastatin|mesh-list
92167154|NCT02594371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92167155|NCT02594371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167156|NCT02594371|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167157|NCT02594371|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167158|NCT02594371|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167159|NCT02594371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167160|NCT02197065|Atorvastatin|atorvastatin|mesh-list
92167161|NCT02197065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92167162|NCT02197065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92167163|NCT02197065|Antimetabolites|antimetabolites|mesh-ancestor
92279523|NCT00379977|Vaccines|vaccines|mesh-list
92167164|NCT02197065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167165|NCT02197065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92167166|NCT02197065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92167167|NCT02197065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167168|NCT04405596|Ambroxol|ambroxol|mesh-list
92167169|NCT04405596|Expectorants|expectorants|mesh-ancestor
92167170|NCT04405596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92167172|NCT01375491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167173|NCT01375491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167174|NCT01375491|Antimalarials|antimalarials|mesh-ancestor
92167175|NCT01375491|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91932780|NCT02361567|Oxycodone|oxycodone|mesh-list
92167176|NCT01375491|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92167177|NCT02591251|Povidone-Iodine|povidone-iodine|mesh-list
92167178|NCT02591251|Povidone|povidone|mesh-list
92167179|NCT02591251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92167180|NCT02591251|Plasma Substitutes|plasma substitutes|mesh-ancestor
92167181|NCT02591251|Blood Substitutes|blood substitutes|mesh-ancestor
92167182|NCT02591251|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92167183|NCT02591251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167184|NCT01325181|Ranibizumab|ranibizumab|mesh-list
92167185|NCT01325181|Verteporfin|verteporfin|mesh-list
92167186|NCT01325181|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92167187|NCT01325181|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92167188|NCT01325181|Growth Substances|growth substances|mesh-ancestor
92167189|NCT01325181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167190|NCT01325181|Growth Inhibitors|growth inhibitors|mesh-ancestor
92167191|NCT01325181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167192|NCT01325181|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92167193|NCT01325181|Dermatologic Agents|dermatologic agents|mesh-ancestor
92167194|NCT02754037|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92167195|NCT02754037|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92167196|NCT02754037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167198|NCT04238637|Tremelimumab|tremelimumab|mesh-list
92167199|NCT04238637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167200|NCT04238637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167202|NCT02588443|Gemcitabine|gemcitabine|mesh-list
92167203|NCT02588443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92167204|NCT02588443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167205|NCT02588443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167206|NCT02588443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167207|NCT02588443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167208|NCT02588443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167209|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92167210|NCT02588443|Antimetabolites|antimetabolites|mesh-ancestor
92167211|NCT02741323|Maraviroc|maraviroc|mesh-list
92167212|NCT02741323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92167213|NCT02741323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92167214|NCT02741323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167215|NCT02741323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92167216|NCT02741323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92167217|NCT02741323|Antiviral Agents|antiviral agents|mesh-ancestor
92167218|NCT02741323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167219|NCT02741323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92167220|NCT02582359|Cytarabine|cytarabine|mesh-list
92167221|NCT02582359|Daunorubicin|daunorubicin|mesh-list
92167222|NCT02582359|Ixazomib|ixazomib|mesh-list
92167223|NCT02582359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92167224|NCT02582359|Antimetabolites|antimetabolites|mesh-ancestor
92167225|NCT02582359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167226|NCT02582359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167227|NCT02582359|Antiviral Agents|antiviral agents|mesh-ancestor
92167228|NCT02582359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167229|NCT02582359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167230|NCT02582359|Immunologic Factors|immunologic factors|mesh-ancestor
92280537|NCT02279862|Ipilimumab|ipilimumab|mesh-list
92167231|NCT02582359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167232|NCT02582359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92167233|NCT02582359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92167234|NCT02582359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92167235|NCT02582359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167236|NCT02582359|Protease Inhibitors|protease inhibitors|mesh-ancestor
92167238|NCT00227253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167239|NCT00227253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167240|NCT05021809|Calcium|calcium|mesh-list
92167241|NCT05021809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92167242|NCT05021809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167244|NCT02730715|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92167245|NCT02730715|Basiliximab|basiliximab|mesh-list
92167246|NCT02730715|Immunologic Factors|immunologic factors|mesh-ancestor
92167247|NCT02730715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167248|NCT02730715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167249|NCT04919460|Tolonium Chloride|tolonium chloride|mesh-list
92167250|NCT04919460|Hemostatics|hemostatics|mesh-ancestor
92167251|NCT04919460|Coagulants|coagulants|mesh-ancestor
92167252|NCT04919460|Heparin Antagonists|heparin antagonists|mesh-ancestor
92182597|NCT01466270|Donepezil|donepezil|mesh-list
92403131|NCT05385861|Carboplatin|carboplatin|mesh-list
92167253|NCT04919460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167254|NCT04037241|Leucovorin|leucovorin|mesh-list
92167255|NCT04037241|Paclitaxel|paclitaxel|mesh-list
92167256|NCT04037241|Gemcitabine|gemcitabine|mesh-list
92167257|NCT04037241|Capecitabine|capecitabine|mesh-list
92281323|NCT00002325|Fluconazole|fluconazole|mesh-list
92167258|NCT04037241|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92167259|NCT04037241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167260|NCT04037241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167261|NCT04037241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167262|NCT04037241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167263|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167264|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92167266|NCT04037241|Antidotes|antidotes|mesh-ancestor
92167267|NCT04037241|Protective Agents|protective agents|mesh-ancestor
92167268|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167269|NCT04037241|Vitamin B Complex|vitamin b complex|mesh-ancestor
92167271|NCT04037241|Micronutrients|micronutrients|mesh-ancestor
92281629|NCT00002415|Tenofovir|tenofovir|mesh-list
92167272|NCT04912128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92167273|NCT04912128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92167274|NCT04912128|Growth Substances|growth substances|mesh-ancestor
92167275|NCT04912128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167276|NCT04912128|Growth Inhibitors|growth inhibitors|mesh-ancestor
92167277|NCT04912128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167279|NCT01327677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92167281|NCT01327677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92281851|NCT00002481|Hormones|hormones|mesh-ancestor
92167282|NCT01327677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167283|NCT01327677|Analgesics|analgesics|mesh-ancestor
92167284|NCT01327677|Sensory System Agents|sensory system agents|mesh-ancestor
92167285|NCT01327677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167286|NCT01327677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92167287|NCT01327677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92167288|NCT01327677|Anesthetics, General|anesthetics, general|mesh-ancestor
92167289|NCT01327677|Anesthetics|anesthetics|mesh-ancestor
92167290|NCT03054480|Botulinum Toxins|botulinum toxins|mesh-list
92167291|NCT03054480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92167292|NCT03054480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92282136|NCT00002217|Lamivudine|lamivudine|mesh-list
92167293|NCT03054480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92167294|NCT03054480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92167295|NCT03054480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167296|NCT03054480|Cholinergic Agents|cholinergic agents|mesh-ancestor
92167297|NCT03054480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167298|NCT03054480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167299|NCT03054480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92167300|NCT03054480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167301|NCT04918914|Dapsone|dapsone|mesh-list
92167302|NCT04918914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167303|NCT04918914|Antimalarials|antimalarials|mesh-ancestor
92167304|NCT04918914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92167305|NCT04918914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92167306|NCT04918914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92167307|NCT04918914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167308|NCT04918914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167310|NCT04918914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167311|NCT04918524|Aspirin|aspirin|mesh-list
92167312|NCT04918524|Hydroxychloroquine|hydroxychloroquine|mesh-list
92167313|NCT04918524|Prednisone|prednisone|mesh-list
92167314|NCT04918524|Heparin|heparin|mesh-list
92167315|NCT04918524|Enoxaparin|enoxaparin|mesh-list
92167316|NCT04918524|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92167317|NCT04918524|Tinzaparin|tinzaparin|mesh-list
92167318|NCT04918524|Dalteparin|dalteparin|mesh-list
92167319|NCT04918524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167320|NCT04918524|Glucocorticoids|glucocorticoids|mesh-ancestor
92167321|NCT04918524|Hormones|hormones|mesh-ancestor
92167322|NCT04918524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167323|NCT04918524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167324|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92167325|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167326|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92167327|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92167328|NCT04918524|Analgesics|analgesics|mesh-ancestor
92167329|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
92167330|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167331|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167332|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92282788|NCT05627635|Antibodies|antibodies|mesh-list
92167333|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92182598|NCT01466270|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92167334|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167335|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92167336|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92167337|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167338|NCT04918524|Antipyretics|antipyretics|mesh-ancestor
92167339|NCT04918524|Anticoagulants|anticoagulants|mesh-ancestor
92167340|NCT04918524|Antimalarials|antimalarials|mesh-ancestor
92167341|NCT04918524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92167342|NCT04918524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92167343|NCT04918524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167344|NCT01328379|4-Aminopyridine|4-aminopyridine|mesh-list
92167345|NCT01328379|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92167346|NCT01328379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92167347|NCT01328379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283146|NCT04186299|Mydriatics|mydriatics|mesh-ancestor
92167350|NCT05586763|Metoclopramide|metoclopramide|mesh-list
92167351|NCT05586763|Antiemetics|antiemetics|mesh-ancestor
92167352|NCT05586763|Autonomic Agents|autonomic agents|mesh-ancestor
92167353|NCT05586763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167354|NCT05586763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167356|NCT05586763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92167357|NCT05586763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92167358|NCT05586763|Dopamine Agents|dopamine agents|mesh-ancestor
92167359|NCT05586763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167360|NCT05586763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167361|NCT05586763|Antipruritics|antipruritics|mesh-ancestor
92167362|NCT05586763|Dermatologic Agents|dermatologic agents|mesh-ancestor
92167363|NCT05586763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92167364|NCT05586763|Histamine Antagonists|histamine antagonists|mesh-ancestor
92167365|NCT05586763|Histamine Agents|histamine agents|mesh-ancestor
92167366|NCT05586763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92167367|NCT05586763|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92167368|NCT05586763|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92283595|NCT01322139|Analgesics|analgesics|mesh-ancestor
92167369|NCT05586763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167370|NCT05586763|Anesthetics, Local|anesthetics, local|mesh-ancestor
92167371|NCT05586763|Anesthetics|anesthetics|mesh-ancestor
92167372|NCT05586763|Sensory System Agents|sensory system agents|mesh-ancestor
92167373|NCT01328769|Febuxostat|febuxostat|mesh-list
92283808|NCT00002691|Glucocorticoids|glucocorticoids|mesh-ancestor
92167374|NCT01328769|Gout Suppressants|gout suppressants|mesh-ancestor
92167375|NCT01328769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167376|NCT02552641|Amoxicillin|amoxicillin|mesh-list
92167377|NCT02552641|Clarithromycin|clarithromycin|mesh-list
92167378|NCT02552641|Esomeprazole|esomeprazole|mesh-list
92167379|NCT02552641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167380|NCT02552641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167381|NCT02552641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92167382|NCT02552641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167383|NCT02552641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92284113|NCT00002793|Leucovorin|leucovorin|mesh-list
92167384|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167385|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284179|NCT04276493|Docetaxel|docetaxel|mesh-list
92167386|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92167387|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92284308|NCT05749575|Paclitaxel|paclitaxel|mesh-list
92167388|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92167390|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92167391|NCT02620020|Analgesics|analgesics|mesh-ancestor
92167392|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
92167393|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182599|NCT01466270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167394|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167395|NCT02551237|Capecitabine|capecitabine|mesh-list
92167396|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284466|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
92167397|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
92167398|NCT02551237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167399|NCT02551237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167400|NCT01378299|Methyltestosterone|methyltestosterone|mesh-list
92167401|NCT01378299|Testosterone|testosterone|mesh-list
92167402|NCT01378299|Testosterone undecanoate|testosterone undecanoate|mesh-list
92167403|NCT01378299|Testosterone enanthate|testosterone enanthate|mesh-list
92167404|NCT01378299|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92167405|NCT01378299|Androgens|androgens|mesh-ancestor
92167406|NCT01378299|Hormones|hormones|mesh-ancestor
92167407|NCT01378299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284679|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167408|NCT01378299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167409|NCT01378299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92167410|NCT01378299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167411|NCT01378299|Anabolic Agents|anabolic agents|mesh-ancestor
92167413|NCT04929522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167414|NCT04929522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167415|NCT02549833|Poly I-C|poly i-c|mesh-list
92167416|NCT02549833|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92167417|NCT02549833|Poly ICLC|poly iclc|mesh-list
92167418|NCT02549833|Interferon Inducers|interferon inducers|mesh-ancestor
92167419|NCT02549833|Immunologic Factors|immunologic factors|mesh-ancestor
92167420|NCT02549833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167421|NCT02549833|Laxatives|laxatives|mesh-ancestor
92167422|NCT02549833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167423|NCT02549833|Antiviral Agents|antiviral agents|mesh-ancestor
92167424|NCT02549833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167426|NCT02542969|Simvastatin|simvastatin|mesh-list
92167427|NCT02542969|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92167428|NCT02542969|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92167429|NCT02542969|Antimetabolites|antimetabolites|mesh-ancestor
92167430|NCT02542969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167431|NCT02542969|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92167432|NCT02542969|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92167433|NCT02542969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167434|NCT04928586|Pirfenidone|pirfenidone|mesh-list
92167435|NCT04928586|Analgesics|analgesics|mesh-ancestor
92167436|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
92167437|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167438|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167439|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92167441|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167442|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167443|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167444|NCT03054168|Goserelin|goserelin|mesh-list
92167445|NCT03054168|Testosterone|testosterone|mesh-list
92167446|NCT03054168|Hormones|hormones|mesh-ancestor
92167447|NCT03054168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167448|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167449|NCT03054168|Androgens|androgens|mesh-ancestor
92167450|NCT03054168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285537|NCT04752033|Morphine|morphine|mesh-list
92167451|NCT03054168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167453|NCT02518945|Liraglutide|liraglutide|mesh-list
92167454|NCT02518945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92167455|NCT02518945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167456|NCT02518945|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92167457|NCT02518945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167459|NCT02518945|Hormones|hormones|mesh-ancestor
92285753|NCT05681702|Analgesics|analgesics|mesh-ancestor
92167460|NCT02518945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167461|NCT02390869|Rituximab|rituximab|mesh-list
92167462|NCT02390869|Lenalidomide|lenalidomide|mesh-list
92167463|NCT02390869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167464|NCT02390869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167465|NCT02390869|Immunologic Factors|immunologic factors|mesh-ancestor
92167466|NCT02390869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167467|NCT02390869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167468|NCT02390869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92167469|NCT02390869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92167470|NCT02390869|Growth Substances|growth substances|mesh-ancestor
92167471|NCT02390869|Growth Inhibitors|growth inhibitors|mesh-ancestor
92167473|NCT04757779|Irinotecan|irinotecan|mesh-list
92167474|NCT04757779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167475|NCT04757779|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167476|NCT04757779|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167477|NCT04757779|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167478|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167479|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92167480|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92167481|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167482|NCT03053856|Paclitaxel|paclitaxel|mesh-list
92167483|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
92167484|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92167485|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286042|NCT03634917|Calcium, Dietary|calcium, dietary|mesh-list
92167486|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167487|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167488|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167489|NCT03053856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167490|NCT03053856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167491|NCT03053856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92167495|NCT02389309|Dasatinib|dasatinib|mesh-list
92167496|NCT02389309|MTOR Inhibitors|mtor inhibitors|mesh-list
92167497|NCT02389309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167498|NCT02389309|Immunologic Factors|immunologic factors|mesh-ancestor
92167499|NCT02389309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167500|NCT02389309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167501|NCT02389309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92167502|NCT02389309|Alkylating Agents|alkylating agents|mesh-ancestor
92286170|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167503|NCT02389309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167504|NCT02389309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167505|NCT02389309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92167506|NCT02389309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167507|NCT02389309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167508|NCT02389309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92167509|NCT02389309|Antifungal Agents|antifungal agents|mesh-ancestor
92167510|NCT02389309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92167511|NCT02389309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167513|NCT02489695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167514|NCT02489695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92167515|NCT02489695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167516|NCT02489695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167517|NCT03053388|Nitric Oxide|nitric oxide|mesh-list
92167518|NCT03053388|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92167519|NCT03053388|Autonomic Agents|autonomic agents|mesh-ancestor
92167520|NCT03053388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167521|NCT03053388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167522|NCT03053388|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92167523|NCT03053388|Respiratory System Agents|respiratory system agents|mesh-ancestor
92167524|NCT03053388|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92167525|NCT03053388|Antioxidants|antioxidants|mesh-ancestor
92167526|NCT03053388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167527|NCT03053388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167528|NCT03053388|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92167529|NCT03053388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92167530|NCT03053388|Gasotransmitters|gasotransmitters|mesh-ancestor
92167531|NCT03053388|Protective Agents|protective agents|mesh-ancestor
92167532|NCT03053544|Metformin|metformin|mesh-list
92167533|NCT03053544|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92167534|NCT03053544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167535|NCT02384083|Dexamethasone|dexamethasone|mesh-list
92167536|NCT02384083|Pomalidomide|pomalidomide|mesh-list
92167537|NCT02384083|Filanesib|filanesib|mesh-list
92167538|NCT02384083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167539|NCT02384083|Antiemetics|antiemetics|mesh-ancestor
92167540|NCT02384083|Autonomic Agents|autonomic agents|mesh-ancestor
92167541|NCT02384083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286585|NCT02296346|Prednisolone|prednisolone|mesh-list
92167542|NCT02384083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167543|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167544|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
92167545|NCT02384083|Hormones|hormones|mesh-ancestor
92167546|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167547|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92167548|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167549|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
92167550|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92167551|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92286791|NCT04341857|Antibodies|antibodies|mesh-list
92167553|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
92167554|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167555|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286858|NCT04635241|Heparin|heparin|mesh-list
92167556|NCT02384083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167557|NCT04926480|Anesthetics|anesthetics|mesh-list
92167558|NCT04926480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167559|NCT04926480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167560|NCT03053622|Mirikizumab|mirikizumab|mesh-list
92167561|NCT03053622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92167562|NCT03053622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92167563|NCT03053622|Analgesics|analgesics|mesh-ancestor
92167564|NCT03053622|Sensory System Agents|sensory system agents|mesh-ancestor
92167565|NCT03053622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167566|NCT03053622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167567|NCT03053622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167568|NCT03053622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167569|NCT03053622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92167570|NCT03053622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167572|NCT02380573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167573|NCT02380573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167575|NCT02461537|Analgesics|analgesics|mesh-ancestor
92167576|NCT02461537|Sensory System Agents|sensory system agents|mesh-ancestor
92167577|NCT02461537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287226|NCT00003099|Tamoxifen|tamoxifen|mesh-list
92167578|NCT02461537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167580|NCT02461537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92167581|NCT02461537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92167582|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167583|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167584|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92167585|NCT05028673|Antacids|antacids|mesh-list
92167586|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92167587|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92167588|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
92167589|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167590|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167591|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167592|NCT04916574|Antibodies|antibodies|mesh-list
92167593|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
92167594|NCT04916574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167595|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
92167596|NCT02460445|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92167597|NCT02460445|Cyproterone|cyproterone|mesh-list
92167598|NCT02460445|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92167599|NCT02460445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92167600|NCT02460445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92167601|NCT02460445|Contraceptive Agents|contraceptive agents|mesh-ancestor
92167602|NCT02460445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92167603|NCT02460445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167604|NCT02460445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92167606|NCT02460445|Hormones|hormones|mesh-ancestor
92287733|NCT03499483|Tenofovir|tenofovir|mesh-list
92167607|NCT02460445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167608|NCT02460445|Androgen Antagonists|androgen antagonists|mesh-ancestor
92167609|NCT02460445|Hormone Antagonists|hormone antagonists|mesh-ancestor
92167610|NCT02460445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167611|NCT02460445|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92167612|NCT02455687|Budesonide|budesonide|mesh-list
92167613|NCT02455687|Magnesium Sulfate|magnesium sulfate|mesh-list
92167614|NCT02455687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167615|NCT02455687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92167616|NCT02455687|Autonomic Agents|autonomic agents|mesh-ancestor
92287942|NCT01789255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92167617|NCT02455687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167618|NCT02455687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167619|NCT02455687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92167620|NCT02455687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92167622|NCT02455687|Hormones|hormones|mesh-ancestor
92288237|NCT02530541|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92167623|NCT02455687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167624|NCT02455687|Analgesics|analgesics|mesh-ancestor
92167625|NCT02455687|Sensory System Agents|sensory system agents|mesh-ancestor
92167626|NCT02455687|Anesthetics|anesthetics|mesh-ancestor
92167627|NCT02455687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167628|NCT02455687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92167629|NCT02455687|Anticonvulsants|anticonvulsants|mesh-ancestor
92167630|NCT02455687|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92167631|NCT02455687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92167632|NCT02455687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167633|NCT02455687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92167634|NCT02455687|Tocolytic Agents|tocolytic agents|mesh-ancestor
92167635|NCT02455687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92167636|NCT05023837|Pembrolizumab|pembrolizumab|mesh-list
92167637|NCT05023837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167638|NCT05023837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288444|NCT02420951|Sensory System Agents|sensory system agents|mesh-ancestor
92167640|NCT05023837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167641|NCT02358967|Vitamin E|vitamin e|mesh-list
92167642|NCT02358967|Tocopherols|tocopherols|mesh-list
91941346|NCT02258074|Niacin|niacin|mesh-list
92167643|NCT02358967|Tocotrienols|tocotrienols|mesh-list
92167644|NCT02358967|Vitamins|vitamins|mesh-ancestor
92167645|NCT02358967|Micronutrients|micronutrients|mesh-ancestor
92167646|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167647|NCT02358967|Antioxidants|antioxidants|mesh-ancestor
92167648|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167650|NCT03052998|Ivermectin|ivermectin|mesh-list
92167651|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
92167652|NCT03052998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92167653|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167654|NCT05586061|Tislelizumab|tislelizumab|mesh-list
92167655|NCT05586061|Disitamab vedotin|disitamab vedotin|mesh-list
92167656|NCT05586061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167658|NCT05586061|Immunoconjugates|immunoconjugates|mesh-ancestor
92167659|NCT05586061|Immunologic Factors|immunologic factors|mesh-ancestor
92167660|NCT05586061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167661|NCT02354131|Bevacizumab|bevacizumab|mesh-list
92167662|NCT02354131|Niraparib|niraparib|mesh-list
92167663|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288958|NCT00363857|Ropinirole|ropinirole|mesh-list
92167664|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167665|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92167666|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92167667|NCT02354131|Growth Substances|growth substances|mesh-ancestor
92167668|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167669|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
92167670|NCT02354131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92167671|NCT02354131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167672|NCT02354131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167673|NCT02352337|Gemcitabine|gemcitabine|mesh-list
92167674|NCT02352337|Folfirinox|folfirinox|mesh-list
92167675|NCT02352337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92167676|NCT02352337|Antimetabolites|antimetabolites|mesh-ancestor
92167677|NCT02352337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167678|NCT02352337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167679|NCT02349217|Hydrocortisone|hydrocortisone|mesh-list
92167680|NCT02349217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167681|NCT02827201|Paclitaxel|paclitaxel|mesh-list
92289464|NCT00365339|Histamine Agents|histamine agents|mesh-ancestor
92167683|NCT02827201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92167684|NCT02827201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289534|NCT02647099|Analgesics|analgesics|mesh-ancestor
92167685|NCT02827201|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167686|NCT02827201|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167687|NCT02827201|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167688|NCT02827201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289607|NCT01644474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92167689|NCT02827201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92167692|NCT02346253|Goserelin|goserelin|mesh-list
92167693|NCT02346253|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92167694|NCT02346253|Bicalutamide|bicalutamide|mesh-list
92167695|NCT02346253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92167696|NCT02346253|Fertility Agents|fertility agents|mesh-ancestor
92167697|NCT02346253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92403214|NCT05113615|Bromides|bromides|mesh-list
92167698|NCT02346253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167699|NCT02346253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92167700|NCT02346253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167701|NCT02346253|Androgen Antagonists|androgen antagonists|mesh-ancestor
92167702|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
92167703|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167704|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
92167705|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92167706|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
92167707|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92167708|NCT01378377|Niacinamide|niacinamide|mesh-list
92167709|NCT01378377|Sirolimus|sirolimus|mesh-list
92167710|NCT01378377|Temsirolimus|temsirolimus|mesh-list
92167711|NCT01378377|MTOR Inhibitors|mtor inhibitors|mesh-list
92167712|NCT01378377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92167713|NCT01378377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289874|NCT00550147|Dopamine Agents|dopamine agents|mesh-ancestor
92167714|NCT01378377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167715|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167716|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
92167717|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167718|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167719|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167720|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167721|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92167722|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
92167723|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
92167724|NCT01378377|Vitamins|vitamins|mesh-ancestor
92167725|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
92167726|NCT03012321|Prednisone|prednisone|mesh-list
92167727|NCT03012321|Olaparib|olaparib|mesh-list
92167728|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
92167729|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92167730|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
92167731|NCT03012321|Hormones|hormones|mesh-ancestor
92167732|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167733|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167734|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92167735|NCT03012321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167736|NCT03012321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92167737|NCT03012321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167738|NCT03012321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167739|NCT03012321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92167740|NCT03012321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92167741|NCT03012321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92167742|NCT03009045|Tedizolid|tedizolid|mesh-list
92167743|NCT03009045|Tedizolid phosphate|tedizolid phosphate|mesh-list
92167744|NCT03009045|Oxazolidinones|oxazolidinones|mesh-list
92167745|NCT03009045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167746|NCT03009045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167747|NCT03009045|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92167748|NCT03009045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167749|NCT03009045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167750|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92167751|NCT04907838|BQ 788|bq 788|mesh-list
92167752|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92167753|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92167754|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167755|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92167756|NCT03056274|Metformin|metformin|mesh-list
92167757|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92167758|NCT03056274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92167759|NCT03056274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167760|NCT03056274|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92167761|NCT03056274|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92167763|NCT03056118|Clopidogrel|clopidogrel|mesh-list
92167764|NCT03056118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92167765|NCT03056118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92167766|NCT03056118|Analgesics|analgesics|mesh-ancestor
92167767|NCT03056118|Sensory System Agents|sensory system agents|mesh-ancestor
92167768|NCT03056118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403229|NCT04850378|Tinzaparin|tinzaparin|mesh-list
92167769|NCT03056118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290348|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
92167771|NCT03056118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167772|NCT03056118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92167773|NCT03056118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92167774|NCT03056118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167775|NCT03056118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92290417|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
92167776|NCT03056118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92167777|NCT03056118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167778|NCT03056118|Antipyretics|antipyretics|mesh-ancestor
92167779|NCT03056118|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92167780|NCT03056118|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92167781|NCT03056118|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92167782|NCT03056118|Purinergic Agents|purinergic agents|mesh-ancestor
92167783|NCT03056118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167784|NCT04923516|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92167785|NCT04923516|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92167786|NCT04923516|Dermatologic Agents|dermatologic agents|mesh-ancestor
92167787|NCT00987935|Sorafenib|sorafenib|mesh-list
92167788|NCT00987935|Nintedanib|nintedanib|mesh-list
92167789|NCT00987935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167790|NCT00987935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92167792|NCT00987935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167794|NCT00987467|Cyclosporins|cyclosporins|mesh-list
92167795|NCT00987467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167796|NCT00987467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167797|NCT00987467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167798|NCT00987467|Immunologic Factors|immunologic factors|mesh-ancestor
92167799|NCT00987467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167800|NCT00987467|Antifungal Agents|antifungal agents|mesh-ancestor
92167801|NCT00987467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167802|NCT00987467|Dermatologic Agents|dermatologic agents|mesh-ancestor
92167803|NCT00987467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167804|NCT00987467|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92167805|NCT05874440|Tenofovir|tenofovir|mesh-list
92167806|NCT05874440|Antiviral Agents|antiviral agents|mesh-ancestor
92167807|NCT05874440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167808|NCT05874440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92290833|NCT00369239|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92167809|NCT05874440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92167810|NCT05874440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167811|NCT05874440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167812|NCT05874440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92167813|NCT05874440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92167814|NCT05874219|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92167815|NCT05874219|Mupirocin|mupirocin|mesh-list
92167816|NCT05874219|Neomycin|neomycin|mesh-list
92167817|NCT05874219|Bacitracin|bacitracin|mesh-list
92167818|NCT05874219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167819|NCT05874219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92167820|NCT05874219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167821|NCT05874219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167822|NCT05874219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92167824|NCT05874180|Linagliptin|linagliptin|mesh-list
92167825|NCT05874180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92167826|NCT05874180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167827|NCT05874180|Incretins|incretins|mesh-ancestor
92167828|NCT05874180|Hormones|hormones|mesh-ancestor
92167829|NCT05874180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167830|NCT05874180|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92167831|NCT05874180|Protease Inhibitors|protease inhibitors|mesh-ancestor
92167832|NCT05874180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167833|NCT05874180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167834|NCT05874167|Metformin|metformin|mesh-list
92167835|NCT05874167|Linagliptin|linagliptin|mesh-list
92167836|NCT05874167|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92167837|NCT05874167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167838|NCT05874167|Incretins|incretins|mesh-ancestor
92167839|NCT05874167|Hormones|hormones|mesh-ancestor
92291096|NCT00619931|APD791|apd791|mesh-list
92167840|NCT05874167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167841|NCT05874167|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92291099|NCT00619931|Serotonin Agents|serotonin agents|mesh-ancestor
92167842|NCT05874167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92167843|NCT05874167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167844|NCT05874167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167845|NCT05874154|Botulinum Toxins|botulinum toxins|mesh-list
92167846|NCT05874154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92167847|NCT05874154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92167848|NCT05874154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167849|NCT05874154|Cholinergic Agents|cholinergic agents|mesh-ancestor
92167850|NCT05874154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167851|NCT05874154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167853|NCT05874141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92167854|NCT05874141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167856|NCT05873972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167857|NCT05873972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167858|NCT05873881|Thiamine|thiamine|mesh-list
92167859|NCT05873881|Colchicine|colchicine|mesh-list
92167860|NCT05873881|Gout Suppressants|gout suppressants|mesh-ancestor
92167861|NCT05873881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167862|NCT05873881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92167863|NCT05873881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92167864|NCT05873881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92167865|NCT05873881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167866|NCT05873881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167867|NCT05873881|Vitamin B Complex|vitamin b complex|mesh-ancestor
92167868|NCT05873881|Vitamins|vitamins|mesh-ancestor
92167869|NCT05873881|Micronutrients|micronutrients|mesh-ancestor
92167870|NCT05873881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167871|NCT05873751|Vaccines|vaccines|mesh-list
92167872|NCT05873751|Immunologic Factors|immunologic factors|mesh-ancestor
92167873|NCT05873751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167874|NCT05873738|Nicotine|nicotine|mesh-list
92167875|NCT05873738|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92167876|NCT05873738|Autonomic Agents|autonomic agents|mesh-ancestor
92167877|NCT05873738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167878|NCT05873738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167879|NCT05873738|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92167880|NCT05873738|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92167881|NCT05873738|Cholinergic Agents|cholinergic agents|mesh-ancestor
92167882|NCT05873738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291452|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167883|NCT05873738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291524|NCT00371111|Hormones|hormones|mesh-ancestor
92167884|NCT05873712|Cyclophosphamide|cyclophosphamide|mesh-list
92291611|NCT04021121|Linezolid|linezolid|mesh-list
92167886|NCT05873712|Zanubrutinib|zanubrutinib|mesh-list
92291664|NCT00370019|Estradiol|estradiol|mesh-list
92167887|NCT05873712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92167889|NCT05873712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167890|NCT05873712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92167891|NCT05873712|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92167892|NCT05873712|Alkylating Agents|alkylating agents|mesh-ancestor
92167893|NCT05873712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167894|NCT05873712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167895|NCT05873712|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92292023|NCT02287909|Ticagrelor|ticagrelor|mesh-list
92167896|NCT05873712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92167897|NCT05873712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167898|NCT05873673|Ubiquinone|ubiquinone|mesh-list
92167899|NCT05873673|Coenzyme Q10|coenzyme q10|mesh-list
92167900|NCT05873673|Micronutrients|micronutrients|mesh-ancestor
92167901|NCT05873673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167903|NCT05873465|Fentanyl|fentanyl|mesh-list
92292183|NCT04337099|Tempol|tempol|mesh-list
92167905|NCT05873465|Propofol|propofol|mesh-list
92167906|NCT05873465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92167907|NCT05873465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167908|NCT05873465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292239|NCT05602207|Abrocitinib|abrocitinib|mesh-list
92167909|NCT05873465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92167910|NCT05873465|Anesthetics, General|anesthetics, general|mesh-ancestor
92167911|NCT05873465|Anesthetics|anesthetics|mesh-ancestor
92167912|NCT05873465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92167913|NCT05873465|Narcotics|narcotics|mesh-ancestor
92167914|NCT05873465|Analgesics|analgesics|mesh-ancestor
92167915|NCT05873465|Sensory System Agents|sensory system agents|mesh-ancestor
92403233|NCT04850378|Antithrombins|antithrombins|mesh-ancestor
92167916|NCT05873465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167917|NCT05873465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92167919|NCT05873465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92167920|NCT05873465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92167921|NCT05873465|GABA Modulators|gaba modulators|mesh-ancestor
92167922|NCT05873465|GABA Agents|gaba agents|mesh-ancestor
92292456|NCT03763175|Lovastatin|lovastatin|mesh-list
92167923|NCT05873465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167924|NCT05873465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167925|NCT05873244|Sorafenib|sorafenib|mesh-list
92167926|NCT05873244|Lenvatinib|lenvatinib|mesh-list
92167927|NCT05873244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292524|NCT02990845|Leuprolide|leuprolide|mesh-list
92167928|NCT05873244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92167929|NCT05873244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292592|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92167930|NCT05873244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167931|NCT05873192|Talazoparib|talazoparib|mesh-list
92167932|NCT05873192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92167933|NCT05873192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292667|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92167934|NCT05873192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167935|NCT05873192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167936|NCT05872932|Botulinum Toxins|botulinum toxins|mesh-list
92167937|NCT05872932|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92167938|NCT05872932|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92167939|NCT05872932|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92167940|NCT05872932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92167941|NCT05872932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292807|NCT02789033|Chitosan|chitosan|mesh-list
92167942|NCT05872932|Cholinergic Agents|cholinergic agents|mesh-ancestor
92167943|NCT05872932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167944|NCT05872932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167945|NCT05872932|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92167946|NCT05872932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167947|NCT05872867|Pembrolizumab|pembrolizumab|mesh-list
92167948|NCT05872867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92167949|NCT05872867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167950|NCT05872867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92167951|NCT05872867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167952|NCT05872698|Carvedilol|carvedilol|mesh-list
92167953|NCT05872698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92167954|NCT05872698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92167955|NCT05872698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92167956|NCT05872698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92167957|NCT05872698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167958|NCT05872698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167959|NCT05872698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92167960|NCT05872698|Antioxidants|antioxidants|mesh-ancestor
92167961|NCT05872698|Protective Agents|protective agents|mesh-ancestor
92167962|NCT05872698|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92167963|NCT05872698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92167964|NCT05872698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92167965|NCT05872698|Vasodilator Agents|vasodilator agents|mesh-ancestor
92167966|NCT05872698|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92167967|NCT05872698|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92167968|NCT05872685|Oxaliplatin|oxaliplatin|mesh-list
92167969|NCT05872685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167970|NCT05872568|Mycophenolic Acid|mycophenolic acid|mesh-list
92167971|NCT05872568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92167972|NCT05872568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92167973|NCT05872568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92167974|NCT05872568|Antitubercular Agents|antitubercular agents|mesh-ancestor
92167975|NCT05872568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92167976|NCT05872568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92167977|NCT05872568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92167978|NCT05872568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92167979|NCT05872555|Antipsychotic Agents|antipsychotic agents|mesh-list
92167980|NCT05872555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92167981|NCT05872555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167982|NCT05872555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167983|NCT05872555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92167984|NCT05872451|Bromides|bromides|mesh-list
92167985|NCT05872451|Rocuronium|rocuronium|mesh-list
92167986|NCT05872451|Anticonvulsants|anticonvulsants|mesh-ancestor
92167987|NCT05872451|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92167988|NCT05872451|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92293819|NCT02869451|Nicotine|nicotine|mesh-list
92167989|NCT05872451|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92167990|NCT05872451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92167991|NCT05872451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167992|NCT05872386|Buprenorphine|buprenorphine|mesh-list
92167993|NCT05872386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92167994|NCT05872386|Narcotics|narcotics|mesh-ancestor
92167995|NCT05872386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92167996|NCT05872386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92167997|NCT05872386|Analgesics|analgesics|mesh-ancestor
92167998|NCT05872386|Sensory System Agents|sensory system agents|mesh-ancestor
92167999|NCT05872386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168000|NCT05872386|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92168001|NCT05872256|Halobetasol|halobetasol|mesh-list
92168002|NCT05872256|Tazarotene|tazarotene|mesh-list
92168003|NCT05872256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92168004|NCT05872256|Keratolytic Agents|keratolytic agents|mesh-ancestor
92168005|NCT05872256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92168006|NCT05872087|Midazolam|midazolam|mesh-list
92168007|NCT05872087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92168008|NCT05872087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92168009|NCT05872087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168010|NCT05872087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168011|NCT05872087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92168012|NCT05872087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92168013|NCT05872087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92168014|NCT05872087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92168015|NCT05872087|Anesthetics, General|anesthetics, general|mesh-ancestor
92168016|NCT05872087|Anesthetics|anesthetics|mesh-ancestor
92168017|NCT05872087|GABA Modulators|gaba modulators|mesh-ancestor
92168018|NCT05872087|GABA Agents|gaba agents|mesh-ancestor
92168019|NCT05872087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168020|NCT05872087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168021|NCT05871619|Fluorides|fluorides|mesh-list
92168022|NCT05871619|Fluorides, Topical|fluorides, topical|mesh-list
92168023|NCT05871619|Cariostatic Agents|cariostatic agents|mesh-ancestor
92168024|NCT05871619|Protective Agents|protective agents|mesh-ancestor
92168025|NCT05871619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168026|NCT05871177|Hyaluronic Acid|hyaluronic acid|mesh-list
92168027|NCT05871177|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92168028|NCT05871177|Immunologic Factors|immunologic factors|mesh-ancestor
92168029|NCT05871177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168030|NCT05871177|Viscosupplements|viscosupplements|mesh-ancestor
92168031|NCT05871177|Protective Agents|protective agents|mesh-ancestor
92168032|NCT05870800|Leucovorin|leucovorin|mesh-list
92168033|NCT05870800|Fluorouracil|fluorouracil|mesh-list
92168034|NCT05870800|Capecitabine|capecitabine|mesh-list
92168035|NCT05870800|Oxaliplatin|oxaliplatin|mesh-list
92168036|NCT05870800|Atezolizumab|atezolizumab|mesh-list
92168037|NCT05870800|Antimetabolites|antimetabolites|mesh-ancestor
92168038|NCT05870800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168039|NCT05870800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92168040|NCT05870800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168041|NCT05870800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92168042|NCT05870800|Immunologic Factors|immunologic factors|mesh-ancestor
92168043|NCT05870800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168044|NCT05870800|Antidotes|antidotes|mesh-ancestor
92168045|NCT05870800|Protective Agents|protective agents|mesh-ancestor
92168046|NCT05870800|Vitamin B Complex|vitamin b complex|mesh-ancestor
92168047|NCT05870800|Vitamins|vitamins|mesh-ancestor
92168048|NCT05870800|Micronutrients|micronutrients|mesh-ancestor
92168049|NCT05870800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168050|NCT05870800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168051|NCT05870319|Carboplatin|carboplatin|mesh-list
92168052|NCT05870319|Pemetrexed|pemetrexed|mesh-list
92168053|NCT05870319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168054|NCT05870319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294045|NCT01985581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92168055|NCT05870319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168057|NCT05870319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92168058|NCT05869357|Turmeric extract|turmeric extract|mesh-list
92168059|NCT05869357|Antioxidants|antioxidants|mesh-ancestor
92294194|NCT02059213|Palbociclib|palbociclib|mesh-list
92168060|NCT05869357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168061|NCT05869357|Protective Agents|protective agents|mesh-ancestor
92168062|NCT05869357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168063|NCT05869188|Isotretinoin|isotretinoin|mesh-list
92168064|NCT05869188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92168065|NCT05868889|Trabectedin|trabectedin|mesh-list
92294410|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
92168066|NCT05868889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92168068|NCT05868889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168069|NCT05868889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168070|NCT05868174|Peposertib|peposertib|mesh-list
92294554|NCT02044796|Antiviral Agents|antiviral agents|mesh-ancestor
92168071|NCT05868174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92168072|NCT05868174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168073|NCT05868174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168074|NCT05865457|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92168075|NCT05865457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92168076|NCT05865379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92168077|NCT05865379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92168078|NCT05849740|Daratumumab|daratumumab|mesh-list
92168079|NCT05849740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168080|NCT05813587|Meplazumab|meplazumab|mesh-list
92168081|NCT05813587|Antiviral Agents|antiviral agents|mesh-ancestor
92168082|NCT05813587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168083|NCT05811676|Tranexamic Acid|tranexamic acid|mesh-list
92168084|NCT05811676|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92168085|NCT05811676|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92168086|NCT05811676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168087|NCT05811676|Hemostatics|hemostatics|mesh-ancestor
92168088|NCT05811676|Coagulants|coagulants|mesh-ancestor
92168089|NCT05799326|Levofloxacin|levofloxacin|mesh-list
92168090|NCT05799326|Ofloxacin|ofloxacin|mesh-list
92168091|NCT05799326|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92168092|NCT05799326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168093|NCT05799326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92168094|NCT05799326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92168098|NCT05799326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168099|NCT05799326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92168100|NCT05799326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92294899|NCT03068897|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92168103|NCT05797467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168104|NCT05797467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168106|NCT05797467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92168107|NCT05797467|Growth Substances|growth substances|mesh-ancestor
92295045|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
92168108|NCT05797467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168109|NCT05797467|Growth Inhibitors|growth inhibitors|mesh-ancestor
92168110|NCT05796973|Atorvastatin|atorvastatin|mesh-list
92295189|NCT04603937|Aflibercept|aflibercept|mesh-list
92168111|NCT05796973|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92168112|NCT05796973|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92168113|NCT05796973|Antimetabolites|antimetabolites|mesh-ancestor
92295264|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
92168114|NCT05796973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168115|NCT05796973|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168116|NCT05796973|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92168117|NCT05796973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168122|NCT05766553|Nicotine|nicotine|mesh-list
92168123|NCT05766553|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92168124|NCT05766553|Autonomic Agents|autonomic agents|mesh-ancestor
92168125|NCT05766553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168126|NCT05766553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168127|NCT05766553|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92168128|NCT05766553|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92168129|NCT05766553|Cholinergic Agents|cholinergic agents|mesh-ancestor
92168130|NCT05766553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295612|NCT04630964|Niacin|niacin|mesh-list
92168131|NCT05766553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168132|NCT05741905|Levofloxacin|levofloxacin|mesh-list
92168133|NCT05741905|Ofloxacin|ofloxacin|mesh-list
92168134|NCT05741905|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92168135|NCT05741905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295700|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168136|NCT05741905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92168137|NCT05741905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92168138|NCT05741905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168139|NCT05741905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168140|NCT05741905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168141|NCT05741905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168142|NCT05741905|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92295846|NCT03198221|Cathartics|cathartics|mesh-ancestor
92168143|NCT05741905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92168144|NCT05741658|Dapagliflozin|dapagliflozin|mesh-list
92295919|NCT02354833|Adrenergic Agents|adrenergic agents|mesh-ancestor
92168145|NCT05741658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92168146|NCT05741658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168147|NCT05741658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168148|NCT05741658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168149|NCT05739123|Relugolix|relugolix|mesh-list
92168150|NCT05739123|Androgen Antagonists|androgen antagonists|mesh-ancestor
92168151|NCT05739123|Hormone Antagonists|hormone antagonists|mesh-ancestor
92168152|NCT05739123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168153|NCT05739123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168154|NCT05733923|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92168155|NCT05733923|Eusol|eusol|mesh-list
92168156|NCT05733923|Disinfectants|disinfectants|mesh-ancestor
92168157|NCT05733923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168158|NCT05733741|Benoxinate|benoxinate|mesh-list
92296210|NCT03417193|Narcotics|narcotics|mesh-ancestor
92168160|NCT05733741|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92168161|NCT05733741|Immunologic Factors|immunologic factors|mesh-ancestor
92168162|NCT05733741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168163|NCT05733741|Viscosupplements|viscosupplements|mesh-ancestor
92296353|NCT05658055|Amoxicillin|amoxicillin|mesh-list
92168164|NCT05733741|Protective Agents|protective agents|mesh-ancestor
92168165|NCT05733741|Anesthetics, Local|anesthetics, local|mesh-ancestor
92168166|NCT05733741|Anesthetics|anesthetics|mesh-ancestor
92168167|NCT05733741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168168|NCT05733741|Sensory System Agents|sensory system agents|mesh-ancestor
92168169|NCT05733741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168170|NCT05711082|Dopamine|dopamine|mesh-list
92168171|NCT05711082|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92168172|NCT05711082|Sympathomimetics|sympathomimetics|mesh-ancestor
92168173|NCT05711082|Autonomic Agents|autonomic agents|mesh-ancestor
92168174|NCT05711082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168175|NCT05711082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168177|NCT05711082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168178|NCT05711082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168179|NCT05711082|Protective Agents|protective agents|mesh-ancestor
92168180|NCT05694637|Varenicline|varenicline|mesh-list
92168181|NCT05694637|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92168182|NCT05694637|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92168183|NCT05694637|Cholinergic Agents|cholinergic agents|mesh-ancestor
92168184|NCT05694637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168185|NCT05694637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168186|NCT05694637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168187|NCT05689463|Immunoglobulins|immunoglobulins|mesh-list
92168188|NCT05689463|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92168189|NCT05689463|Antibodies|antibodies|mesh-list
92168190|NCT05689463|Immunologic Factors|immunologic factors|mesh-ancestor
92168191|NCT05689463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168192|NCT05686993|Nifedipine|nifedipine|mesh-list
92168193|NCT05686993|Cinnarizine|cinnarizine|mesh-list
92168194|NCT05686993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92168195|NCT05686993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296779|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92168196|NCT05686993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168197|NCT05686993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92168198|NCT05686993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168200|NCT05686993|Tocolytic Agents|tocolytic agents|mesh-ancestor
92168201|NCT05686993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92168202|NCT05686993|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92168203|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
92168204|NCT05686993|Histamine Agents|histamine agents|mesh-ancestor
92168205|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168206|NCT05673577|Cetuximab|cetuximab|mesh-list
92168207|NCT05673577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168208|NCT05673577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168209|NCT05658146|Sulconazole|sulconazole|mesh-list
92168210|NCT05658146|Antifungal Agents|antifungal agents|mesh-ancestor
92168211|NCT05658146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168212|NCT05591755|Ketotifen|ketotifen|mesh-list
92297178|NCT03834571|Paclitaxel|paclitaxel|mesh-list
92168213|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92168214|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92168215|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92168216|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92297217|NCT04290871|Antioxidants|antioxidants|mesh-ancestor
92168217|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92168218|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92168219|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92168220|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
92168221|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168222|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168223|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297358|NCT00356941|Docetaxel|docetaxel|mesh-list
92168224|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
92168225|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92168226|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92297432|NCT05483010|Atorvastatin|atorvastatin|mesh-list
92168227|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
92168228|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
92168229|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92168230|NCT05579730|Ketotifen|ketotifen|mesh-list
92168231|NCT05579730|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92297575|NCT05925283|Midazolam|midazolam|mesh-list
92168233|NCT05579730|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92168234|NCT05579730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92168235|NCT05579730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92168236|NCT05579730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92297668|NCT05924321|Carbetocin|carbetocin|mesh-list
92168237|NCT05579730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92168238|NCT05579730|Adrenergic Agents|adrenergic agents|mesh-ancestor
92168239|NCT05579730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168240|NCT05579730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297717|NCT05923970|Vaccines|vaccines|mesh-list
92168241|NCT05579730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168242|NCT05579730|Antipruritics|antipruritics|mesh-ancestor
92168243|NCT05579730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92168244|NCT05579730|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92168247|NCT05579730|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92168248|NCT05533164|Rituximab|rituximab|mesh-list
92168249|NCT05533164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168250|NCT05533164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168251|NCT05533164|Immunologic Factors|immunologic factors|mesh-ancestor
92168252|NCT05533164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168253|NCT05533164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168254|NCT05533125|Rituximab|rituximab|mesh-list
92168255|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168256|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168257|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
92168258|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168259|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168260|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92168261|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168262|NCT05525455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168263|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168264|NCT05407584|Paclitaxel|paclitaxel|mesh-list
92168265|NCT05407584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92168266|NCT05407584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298227|NCT05871606|Nitrous Oxide|nitrous oxide|mesh-list
92168267|NCT05407584|Tubulin Modulators|tubulin modulators|mesh-ancestor
92168268|NCT05407584|Antimitotic Agents|antimitotic agents|mesh-ancestor
92168269|NCT05407584|Mitosis Modulators|mitosis modulators|mesh-ancestor
92168270|NCT05407584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168271|NCT05335122|Bimatoprost|bimatoprost|mesh-list
92168272|NCT05335122|Travoprost|travoprost|mesh-list
92168273|NCT05335122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92168275|NCT05321251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168276|NCT05321251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168279|NCT05294588|Ciprofloxacin|ciprofloxacin|mesh-list
92168280|NCT05294588|Ceftriaxone|ceftriaxone|mesh-list
92168281|NCT05294588|Cefixime|cefixime|mesh-list
92168282|NCT05294588|Vaccines|vaccines|mesh-list
92168283|NCT05294588|Immunologic Factors|immunologic factors|mesh-ancestor
92298300|NCT05832892|Paclitaxel|paclitaxel|mesh-list
92168284|NCT05294588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168285|NCT05294588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92168286|NCT05294588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168287|NCT05294588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92168288|NCT05294588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168289|NCT05294588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168290|NCT05294588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168292|NCT05294588|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92298428|NCT05768139|Fulvestrant|fulvestrant|mesh-list
92168294|NCT05260021|Tirzepatide|tirzepatide|mesh-list
92168295|NCT05260021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92298505|NCT05725837|Fluoxetine|fluoxetine|mesh-list
92168296|NCT05260021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168297|NCT05260021|Incretins|incretins|mesh-ancestor
92168298|NCT05260021|Hormones|hormones|mesh-ancestor
92168299|NCT05260021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168300|NCT05188508|Pembrolizumab|pembrolizumab|mesh-list
92168301|NCT05188508|Temozolomide|temozolomide|mesh-list
92168302|NCT05188508|Olaparib|olaparib|mesh-list
92168303|NCT05188508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298727|NCT05578872|Pembrolizumab|pembrolizumab|mesh-list
92168304|NCT05188508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168305|NCT05188508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168306|NCT05188508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168307|NCT05188508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92168308|NCT05188508|Alkylating Agents|alkylating agents|mesh-ancestor
92168309|NCT05188508|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92168310|NCT05188508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299001|NCT05216952|Abortifacient Agents|abortifacient agents|mesh-ancestor
92168312|NCT05170139|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92168313|NCT05170139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168314|NCT05170139|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92168315|NCT05170139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168316|NCT05170139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168317|NCT05170139|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92168318|NCT05170139|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92168319|NCT05170139|Purinergic Agents|purinergic agents|mesh-ancestor
92168320|NCT05170139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168322|NCT05140811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92168323|NCT05140811|Antimetabolites|antimetabolites|mesh-ancestor
92168324|NCT05140811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168325|NCT05140811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168326|NCT05140811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299363|NCT04828486|Pembrolizumab|pembrolizumab|mesh-list
92168327|NCT05117398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92168328|NCT05117398|Dalbavancin|dalbavancin|mesh-list
92168329|NCT05117398|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92168330|NCT05117398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168331|NCT05117398|Antitubercular Agents|antitubercular agents|mesh-ancestor
92168332|NCT05096169|Citric Acid|citric acid|mesh-list
92168333|NCT05096169|Sodium Citrate|sodium citrate|mesh-list
92168334|NCT05096169|Clomiphene|clomiphene|mesh-list
92168335|NCT05096169|Enclomiphene|enclomiphene|mesh-list
92168337|NCT05096169|Anticoagulants|anticoagulants|mesh-ancestor
92168338|NCT05096169|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92168339|NCT05096169|Chelating Agents|chelating agents|mesh-ancestor
92168340|NCT05096169|Sequestering Agents|sequestering agents|mesh-ancestor
92403255|NCT04765371|BB 1101|bb 1101|mesh-list
92168341|NCT05096169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168342|NCT05096169|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92168343|NCT05096169|Hormone Antagonists|hormone antagonists|mesh-ancestor
92168344|NCT05096169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168345|NCT05096169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168346|NCT05096169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92168347|NCT05096169|Fertility Agents|fertility agents|mesh-ancestor
92168348|NCT05096169|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92168349|NCT05096169|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92168350|NCT05096169|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92168351|NCT05079841|Oxytocin|oxytocin|mesh-list
92168352|NCT05079841|Oxytocics|oxytocics|mesh-ancestor
92168353|NCT05079841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92168354|NCT05079841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168355|NCT05046184|Midazolam|midazolam|mesh-list
92168356|NCT05046184|Ketamine|ketamine|mesh-list
92168357|NCT05046184|Analgesics|analgesics|mesh-ancestor
92168358|NCT05046184|Sensory System Agents|sensory system agents|mesh-ancestor
92168359|NCT05046184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168360|NCT05046184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168361|NCT05046184|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92168362|NCT05046184|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92168363|NCT05046184|Anesthetics, General|anesthetics, general|mesh-ancestor
92168364|NCT05046184|Anesthetics|anesthetics|mesh-ancestor
92168365|NCT05046184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168366|NCT05046184|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92168367|NCT05046184|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92168368|NCT05046184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168369|NCT05046184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168370|NCT05046184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92168371|NCT05046184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92168372|NCT05046184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92168373|NCT05046184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92168374|NCT05046184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92168375|NCT05046184|GABA Modulators|gaba modulators|mesh-ancestor
92168376|NCT05046184|GABA Agents|gaba agents|mesh-ancestor
92168378|NCT05033522|Lenvatinib|lenvatinib|mesh-list
92168379|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168380|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92168381|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168382|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168383|NCT05020028|Cannabidiol|cannabidiol|mesh-list
92168384|NCT05020028|Anticonvulsants|anticonvulsants|mesh-ancestor
92168385|NCT04976868|Pimecrolimus|pimecrolimus|mesh-list
92168386|NCT04976868|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92168387|NCT04976868|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92168388|NCT04976868|Analgesics|analgesics|mesh-ancestor
92168389|NCT04976868|Sensory System Agents|sensory system agents|mesh-ancestor
92168390|NCT04976868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168391|NCT04976868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168392|NCT04976868|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92168393|NCT04976868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168395|NCT04976868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92168396|NCT04976868|Immunologic Factors|immunologic factors|mesh-ancestor
92168397|NCT04976868|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92168398|NCT04976868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168399|NCT04976868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168400|NCT04944654|Emtricitabine|emtricitabine|mesh-list
92168401|NCT04944654|Antiviral Agents|antiviral agents|mesh-ancestor
92168402|NCT04944654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168403|NCT04944654|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92168404|NCT04944654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92168405|NCT04944654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168406|NCT04944654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168408|NCT04944654|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92168409|NCT04939623|Benzoic Acid|benzoic acid|mesh-list
92168410|NCT04939623|Probenecid|probenecid|mesh-list
92168411|NCT04939623|Uricosuric Agents|uricosuric agents|mesh-ancestor
92168412|NCT04939623|Gout Suppressants|gout suppressants|mesh-ancestor
92300572|NCT03631784|Pemetrexed|pemetrexed|mesh-list
92168413|NCT04939623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168414|NCT04939623|Antifungal Agents|antifungal agents|mesh-ancestor
92168415|NCT04939623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168416|NCT04939597|Memantine|memantine|mesh-list
92168417|NCT04939597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92168418|NCT04939597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92168419|NCT04939597|Dopamine Agents|dopamine agents|mesh-ancestor
92168420|NCT04939597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168421|NCT04939597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300794|NCT03248167|Cannabidiol|cannabidiol|mesh-list
92168422|NCT04939597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168423|NCT04939597|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92168424|NCT04939597|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92168425|NCT04933227|Capecitabine|capecitabine|mesh-list
92168426|NCT04933227|Oxaliplatin|oxaliplatin|mesh-list
92168427|NCT04933227|Atezolizumab|atezolizumab|mesh-list
92168428|NCT04933227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91953661|NCT03432923|Benzocaine|benzocaine|mesh-list
92168429|NCT04933227|Antimetabolites|antimetabolites|mesh-ancestor
92168430|NCT04933227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168431|NCT04933227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168432|NCT04933227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92301077|NCT02625480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168433|NCT04933227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168434|NCT04886232|Lidocaine|lidocaine|mesh-list
92168435|NCT04886232|Anesthetics, Local|anesthetics, local|mesh-ancestor
92168436|NCT04886232|Anesthetics|anesthetics|mesh-ancestor
92168437|NCT04886232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168438|NCT04886232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168439|NCT04886232|Sensory System Agents|sensory system agents|mesh-ancestor
92168440|NCT04886232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168441|NCT04886232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92168442|NCT04886232|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92168443|NCT04886232|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92168444|NCT04886232|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92168445|NCT04886232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168446|NCT04885712|Metformin|metformin|mesh-list
92168447|NCT04885712|Pioglitazone|pioglitazone|mesh-list
92168448|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
92168449|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168450|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168451|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92168452|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168453|NCT04843046|Pioglitazone|pioglitazone|mesh-list
92168454|NCT04843046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168455|NCT04843046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168456|NCT04789499|Theophylline|theophylline|mesh-list
92168457|NCT04789499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92168459|NCT04789499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168460|NCT04789499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168461|NCT04789499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92168462|NCT04789499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92168463|NCT04789499|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92168464|NCT04789499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301423|NCT01145495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168465|NCT04789499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168466|NCT04789499|Vasodilator Agents|vasodilator agents|mesh-ancestor
92168467|NCT04789499|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92168468|NCT04789499|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92168469|NCT04789499|Purinergic Agents|purinergic agents|mesh-ancestor
92168470|NCT04789499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168477|NCT04774380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168478|NCT04774380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168479|NCT04774380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168480|NCT04774380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168482|NCT04706130|Primaquine|primaquine|mesh-list
92168483|NCT04706130|Antimalarials|antimalarials|mesh-ancestor
92168484|NCT04706130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92168485|NCT04706130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92168486|NCT04706130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168487|NCT04706130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168488|NCT04706130|Antiviral Agents|antiviral agents|mesh-ancestor
92168489|NCT04706130|Schistosomicides|schistosomicides|mesh-ancestor
92168490|NCT04706130|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92168491|NCT04706130|Anthelmintics|anthelmintics|mesh-ancestor
92168492|NCT04697823|Hyaluronic Acid|hyaluronic acid|mesh-list
92168493|NCT04697823|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92168494|NCT04697823|Immunologic Factors|immunologic factors|mesh-ancestor
92168495|NCT04697823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168496|NCT04697823|Viscosupplements|viscosupplements|mesh-ancestor
92168497|NCT04697823|Protective Agents|protective agents|mesh-ancestor
92168498|NCT04675827|Trastuzumab|trastuzumab|mesh-list
92168499|NCT04675827|Pertuzumab|pertuzumab|mesh-list
92168500|NCT04675827|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92168501|NCT04675827|Maytansine|maytansine|mesh-list
92168502|NCT04675827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168503|NCT04675827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301693|NCT00078949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92168504|NCT04675827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92168505|NCT04675827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92168506|NCT04675827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92168507|NCT04675827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92168508|NCT04675827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168510|NCT04675827|Immunoconjugates|immunoconjugates|mesh-ancestor
92168511|NCT04675827|Immunologic Factors|immunologic factors|mesh-ancestor
92168512|NCT04675827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168518|NCT04674462|Vaccines|vaccines|mesh-list
92168519|NCT04674462|Immunologic Factors|immunologic factors|mesh-ancestor
92168520|NCT04674462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168521|NCT04665843|Atezolizumab|atezolizumab|mesh-list
92168522|NCT04665843|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168523|NCT04665843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168524|NCT04665843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168525|NCT04665843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168526|NCT04657016|Tirzepatide|tirzepatide|mesh-list
92168527|NCT04657016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168528|NCT04657016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168529|NCT04657016|Incretins|incretins|mesh-ancestor
92168530|NCT04657016|Hormones|hormones|mesh-ancestor
92168531|NCT04657016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168532|NCT04641871|Irinotecan|irinotecan|mesh-list
92168533|NCT04641871|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92168534|NCT04641871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168535|NCT04641871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168536|NCT04641871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168537|NCT04641871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168538|NCT04638036|Cetuximab|cetuximab|mesh-list
92168539|NCT04638036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168540|NCT04638036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168541|NCT04598074|Analgesics, Opioid|analgesics, opioid|mesh-list
92168542|NCT04598074|Narcotics|narcotics|mesh-ancestor
92168543|NCT04598074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168544|NCT04598074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168545|NCT04598074|Analgesics|analgesics|mesh-ancestor
92168546|NCT04598074|Sensory System Agents|sensory system agents|mesh-ancestor
92168547|NCT04598074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168548|NCT04593758|Hydroxychloroquine|hydroxychloroquine|mesh-list
92168549|NCT04593758|Antimalarials|antimalarials|mesh-ancestor
92168550|NCT04593758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92168551|NCT04593758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92168552|NCT04593758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168553|NCT04593758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302338|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92168554|NCT04593758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168555|NCT04593758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168556|NCT04560010|Tranexamic Acid|tranexamic acid|mesh-list
92168557|NCT04560010|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92168558|NCT04560010|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92168559|NCT04560010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168561|NCT04560010|Coagulants|coagulants|mesh-ancestor
92168563|NCT04558866|Testosterone|testosterone|mesh-list
92168564|NCT04558866|Testosterone undecanoate|testosterone undecanoate|mesh-list
92168565|NCT04558866|Testosterone enanthate|testosterone enanthate|mesh-list
92168566|NCT04558866|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92168568|NCT04558866|Hormones|hormones|mesh-ancestor
92168569|NCT04558866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168570|NCT04558866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168571|NCT04558866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92168572|NCT04558866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168574|NCT04430452|Durvalumab|durvalumab|mesh-list
92168575|NCT04430452|Ipilimumab|ipilimumab|mesh-list
92168576|NCT04430452|Tremelimumab|tremelimumab|mesh-list
92168577|NCT04430452|Immunoglobulins|immunoglobulins|mesh-list
92302993|NCT05346666|Anticonvulsants|anticonvulsants|mesh-ancestor
92168578|NCT04430452|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92168579|NCT04430452|Immunoglobulin G|immunoglobulin g|mesh-list
92303145|NCT03557333|Analgesics|analgesics|mesh-ancestor
92168580|NCT04430452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303215|NCT05448872|Valsartan|valsartan|mesh-list
92168581|NCT04430452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168582|NCT04430452|Immunologic Factors|immunologic factors|mesh-ancestor
92168583|NCT04430452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168584|NCT04430452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168585|NCT04430452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168587|NCT04402073|Lomustine|lomustine|mesh-list
92168588|NCT04402073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168589|NCT04402073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92168590|NCT04402073|Tubulin Modulators|tubulin modulators|mesh-ancestor
92168591|NCT04402073|Antimitotic Agents|antimitotic agents|mesh-ancestor
92168592|NCT04402073|Mitosis Modulators|mitosis modulators|mesh-ancestor
92168593|NCT04402073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168594|NCT04402073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92168595|NCT04402073|Alkylating Agents|alkylating agents|mesh-ancestor
92168596|NCT04397679|Chloroquine|chloroquine|mesh-list
92168597|NCT04397679|Temozolomide|temozolomide|mesh-list
92168598|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92168599|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
92168600|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168601|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168602|NCT04397679|Amebicides|amebicides|mesh-ancestor
92168603|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92168604|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92168605|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168606|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
92168607|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168608|NCT04363164|Methyltestosterone|methyltestosterone|mesh-list
92168609|NCT04363164|Testosterone|testosterone|mesh-list
92168610|NCT04363164|Testosterone undecanoate|testosterone undecanoate|mesh-list
92168611|NCT04363164|Testosterone enanthate|testosterone enanthate|mesh-list
92168612|NCT04363164|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92168613|NCT04363164|Androgens|androgens|mesh-ancestor
92168614|NCT04363164|Hormones|hormones|mesh-ancestor
92168615|NCT04363164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168616|NCT04363164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168617|NCT04363164|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92168618|NCT04363164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168619|NCT04363164|Anabolic Agents|anabolic agents|mesh-ancestor
92168620|NCT04258423|Everolimus|everolimus|mesh-list
92168621|NCT04258423|Tacrolimus|tacrolimus|mesh-list
92168622|NCT04258423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92168623|NCT04258423|Immunologic Factors|immunologic factors|mesh-ancestor
92168624|NCT04258423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168625|NCT04258423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92168626|NCT04258423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168627|NCT04258423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168628|NCT04258423|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92168629|NCT04258423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92168630|NCT04258423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168631|NCT04211987|Cytarabine|cytarabine|mesh-list
92168632|NCT04211987|Methotrexate|methotrexate|mesh-list
92168633|NCT04211987|Etoposide|etoposide|mesh-list
92168634|NCT04211987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92168635|NCT04211987|Antimetabolites|antimetabolites|mesh-ancestor
92168636|NCT04211987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168637|NCT04211987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168638|NCT04211987|Antiviral Agents|antiviral agents|mesh-ancestor
92168639|NCT04211987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168640|NCT04211987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92168641|NCT04211987|Immunologic Factors|immunologic factors|mesh-ancestor
92168642|NCT04211987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168643|NCT04211987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92168644|NCT04211987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92168645|NCT04211987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168646|NCT04211987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168648|NCT04211987|Abortifacient Agents|abortifacient agents|mesh-ancestor
92168649|NCT04211987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92168650|NCT04211987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92168651|NCT04211987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92168652|NCT04211987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303899|NCT02453360|Bupivacaine|bupivacaine|mesh-list
92168653|NCT04211987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92168656|NCT04190433|Spironolactone|spironolactone|mesh-list
92168657|NCT04190433|Pravastatin|pravastatin|mesh-list
92303968|NCT00358969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92168658|NCT04190433|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92168659|NCT04190433|Hormone Antagonists|hormone antagonists|mesh-ancestor
92168660|NCT04190433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168661|NCT04190433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168662|NCT04190433|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92168663|NCT04190433|Diuretics|diuretics|mesh-ancestor
92168664|NCT04190433|Natriuretic Agents|natriuretic agents|mesh-ancestor
92168665|NCT04190433|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92168666|NCT04190433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92168667|NCT04190433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92168668|NCT04190433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168669|NCT04190433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168670|NCT04190433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92168671|NCT04190433|Antioxidants|antioxidants|mesh-ancestor
92168672|NCT04190433|Protective Agents|protective agents|mesh-ancestor
92168673|NCT04190433|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92168674|NCT04190433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92168675|NCT04190433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92168676|NCT04190433|Vasodilator Agents|vasodilator agents|mesh-ancestor
92168677|NCT04190433|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92168678|NCT04190433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92168679|NCT04190433|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92168680|NCT04190433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92168681|NCT04190433|Antimetabolites|antimetabolites|mesh-ancestor
92168682|NCT04190433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168683|NCT04190433|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92168684|NCT04190433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168685|NCT04190433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92168686|NCT04190433|Protease Inhibitors|protease inhibitors|mesh-ancestor
92168687|NCT04190433|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92168688|NCT04177810|Plerixafor|plerixafor|mesh-list
92168690|NCT04177810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92168692|NCT04177810|Antiviral Agents|antiviral agents|mesh-ancestor
92168693|NCT04177810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168694|NCT04177810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168695|NCT04177810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168696|NCT04163900|Gemcitabine|gemcitabine|mesh-list
92168697|NCT04163900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168706|NCT04146038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92168707|NCT04146038|Antimetabolites|antimetabolites|mesh-ancestor
92304299|NCT02976805|Bisacodyl|bisacodyl|mesh-list
92304320|NCT04500613|BB 1101|bb 1101|mesh-list
92168708|NCT04146038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168709|NCT04146038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168710|NCT04146038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168711|NCT04146038|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92168712|NCT04146038|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92168713|NCT04146038|Analgesics|analgesics|mesh-ancestor
92168714|NCT04146038|Sensory System Agents|sensory system agents|mesh-ancestor
92168715|NCT04146038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168716|NCT04146038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304521|NCT00361075|Estradiol|estradiol|mesh-list
92168717|NCT04146038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92168718|NCT04146038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168719|NCT04146038|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92168720|NCT04109885|Diphenhydramine|diphenhydramine|mesh-list
92168721|NCT04109885|Promethazine|promethazine|mesh-list
92168722|NCT04109885|Prochlorperazine|prochlorperazine|mesh-list
92168723|NCT04109885|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92168724|NCT04109885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92168725|NCT04109885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168726|NCT04109885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168727|NCT04109885|Anesthetics, Local|anesthetics, local|mesh-ancestor
92168728|NCT04109885|Anesthetics|anesthetics|mesh-ancestor
92168729|NCT04109885|Sensory System Agents|sensory system agents|mesh-ancestor
92168730|NCT04109885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168731|NCT04109885|Antiemetics|antiemetics|mesh-ancestor
92168733|NCT04109885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92168734|NCT04109885|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92168735|NCT04109885|Histamine Antagonists|histamine antagonists|mesh-ancestor
92168736|NCT04109885|Histamine Agents|histamine agents|mesh-ancestor
92168737|NCT04109885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304871|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
92168738|NCT04109885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168739|NCT04109885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92168740|NCT04109885|Antipruritics|antipruritics|mesh-ancestor
92168741|NCT04109885|Dermatologic Agents|dermatologic agents|mesh-ancestor
92168742|NCT04109885|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92168743|NCT04109885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92168744|NCT04109885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92168745|NCT04109885|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92168746|NCT04109885|Dopamine Agents|dopamine agents|mesh-ancestor
92168747|NCT04098068|Pembrolizumab|pembrolizumab|mesh-list
92168748|NCT04098068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168749|NCT04098068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168750|NCT04098068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168751|NCT04098068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168752|NCT04087668|Anesthetics|anesthetics|mesh-list
92168753|NCT04087668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168754|NCT04087668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168755|NCT04025372|Bicalutamide|bicalutamide|mesh-list
92168756|NCT04025372|Androgen Antagonists|androgen antagonists|mesh-ancestor
92168757|NCT04025372|Hormone Antagonists|hormone antagonists|mesh-ancestor
92168758|NCT04025372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92168759|NCT04025372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168760|NCT04025372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168761|NCT04006873|Ivacaftor|ivacaftor|mesh-list
92168762|NCT04006873|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92168763|NCT04006873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92168764|NCT04006873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168773|NCT03942419|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92168774|NCT03942419|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92305381|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
92168775|NCT03942419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92168776|NCT03942419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92168777|NCT03942419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92168778|NCT03942419|Autonomic Agents|autonomic agents|mesh-ancestor
92168779|NCT03942419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168780|NCT03942419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168781|NCT03942419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92168782|NCT03942419|Respiratory System Agents|respiratory system agents|mesh-ancestor
92168783|NCT03942419|Mydriatics|mydriatics|mesh-ancestor
92168784|NCT03942419|Parasympatholytics|parasympatholytics|mesh-ancestor
92168785|NCT03942419|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92168786|NCT03942419|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92168787|NCT03942419|Cholinergic Agents|cholinergic agents|mesh-ancestor
92168788|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92305602|NCT00003957|Cytarabine|cytarabine|mesh-list
92168789|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168791|NCT03878095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92168792|NCT03878095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168793|NCT03878095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305758|NCT03468985|Nivolumab|nivolumab|mesh-list
92168794|NCT03878095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168795|NCT03820310|Immunomodulating Agents|immunomodulating agents|mesh-list
92168796|NCT03820310|Immunologic Factors|immunologic factors|mesh-ancestor
92168797|NCT03820310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168798|NCT03780673|Rifaximin|rifaximin|mesh-list
92168799|NCT03780673|Simvastatin|simvastatin|mesh-list
92168800|NCT03780673|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92168801|NCT03780673|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92168802|NCT03780673|Antimetabolites|antimetabolites|mesh-ancestor
92168803|NCT03780673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168804|NCT03780673|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168805|NCT03780673|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92168806|NCT03780673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168807|NCT03780673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92168808|NCT03780673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168809|NCT03780673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92168810|NCT03779334|Risdiplam|risdiplam|mesh-list
92168811|NCT03779334|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92168812|NCT03779334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168813|NCT03779334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168814|NCT03769311|Cetuximab|cetuximab|mesh-list
92168815|NCT03769311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168816|NCT03769311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168817|NCT03767335|Trastuzumab|trastuzumab|mesh-list
92168818|NCT03767335|Fulvestrant|fulvestrant|mesh-list
92168819|NCT03767335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168820|NCT03767335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168821|NCT03767335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92168822|NCT03767335|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92168823|NCT03767335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92168824|NCT03767335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92168825|NCT03767335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306329|NCT00004197|Vaccines|vaccines|mesh-list
92168826|NCT03767335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168827|NCT03746106|Thiamine|thiamine|mesh-list
92168828|NCT03746106|Metformin|metformin|mesh-list
92168830|NCT03746106|Vitamins|vitamins|mesh-ancestor
92168831|NCT03746106|Micronutrients|micronutrients|mesh-ancestor
92306469|NCT00004233|Fluorouracil|fluorouracil|mesh-list
92168832|NCT03746106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168833|NCT03746106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168834|NCT03746106|Vitamin B Complex|vitamin b complex|mesh-ancestor
92168835|NCT03746106|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92168836|NCT03746106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168838|NCT03746106|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92168839|NCT03746106|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92168840|NCT03746106|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92168841|NCT03746106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306692|NCT00003759|Valrubicin|valrubicin|mesh-list
92168842|NCT03746106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168843|NCT03746106|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92168844|NCT03746106|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92306833|NCT00385437|Mirtazapine|mirtazapine|mesh-list
92168845|NCT03746106|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92168846|NCT03745430|Ramucirumab|ramucirumab|mesh-list
92168847|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168851|NCT03651882|Oxytocin|oxytocin|mesh-list
92168852|NCT03651882|Carbetocin|carbetocin|mesh-list
92168854|NCT03651882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92168855|NCT03651882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168856|NCT03636932|Acetylcysteine|acetylcysteine|mesh-list
92168857|NCT03636932|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92168858|NCT03636932|Antiviral Agents|antiviral agents|mesh-ancestor
92168859|NCT03636932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168860|NCT03636932|Expectorants|expectorants|mesh-ancestor
92168861|NCT03636932|Respiratory System Agents|respiratory system agents|mesh-ancestor
92307121|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
92168863|NCT03636932|Antioxidants|antioxidants|mesh-ancestor
92168864|NCT03636932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168865|NCT03636932|Protective Agents|protective agents|mesh-ancestor
91959868|NCT05555797|Hormones|hormones|mesh-ancestor
92168866|NCT03636932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168868|NCT05910554|Metformin|metformin|mesh-list
92168869|NCT05910554|Glyburide|glyburide|mesh-list
92307267|NCT00005625|Trabectedin|trabectedin|mesh-list
92168870|NCT05910554|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92168871|NCT05910554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168872|NCT05910476|Ezetimibe|ezetimibe|mesh-list
92168873|NCT05910476|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92168875|NCT05910476|Antimetabolites|antimetabolites|mesh-ancestor
92307409|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
92168876|NCT05910476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168877|NCT05910476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168878|NCT05910450|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92168879|NCT05910177|Etoposide|etoposide|mesh-list
92168880|NCT05910177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168881|NCT05910177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92168882|NCT05910177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92168883|NCT05910177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168884|NCT05910177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307626|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92168885|NCT05910177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168887|NCT05910125|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92168889|NCT05910125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92168890|NCT05910125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92168891|NCT05910125|Analgesics|analgesics|mesh-ancestor
92168892|NCT05910125|Sensory System Agents|sensory system agents|mesh-ancestor
92168893|NCT05910125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168894|NCT05910125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168895|NCT05910125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92168896|NCT05910125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168897|NCT05910125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92168898|NCT05910125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92168899|NCT05910125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168900|NCT05910125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92168901|NCT05910125|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92168902|NCT05910125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168903|NCT05910125|Antipyretics|antipyretics|mesh-ancestor
92307848|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
92168904|NCT05910125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92168905|NCT05910125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92168906|NCT05910125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92168907|NCT05910125|Purinergic Agents|purinergic agents|mesh-ancestor
92168908|NCT05910125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168909|NCT05910034|Docetaxel|docetaxel|mesh-list
92168910|NCT05910034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168911|NCT05910034|Tubulin Modulators|tubulin modulators|mesh-ancestor
92168912|NCT05910034|Antimitotic Agents|antimitotic agents|mesh-ancestor
92168913|NCT05910034|Mitosis Modulators|mitosis modulators|mesh-ancestor
92168914|NCT05910034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168915|NCT05909995|Ipilimumab|ipilimumab|mesh-list
92168916|NCT05909995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168917|NCT05909995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308123|NCT02535806|Pegaspargase|pegaspargase|mesh-list
92168918|NCT05909995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168919|NCT05909995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168924|NCT05909852|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92168925|NCT05909852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92168927|NCT05909826|Dexamethasone|dexamethasone|mesh-list
92168928|NCT05909826|Cyclophosphamide|cyclophosphamide|mesh-list
92168929|NCT05909826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92168930|NCT05909826|Immunologic Factors|immunologic factors|mesh-ancestor
92168931|NCT05909826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168932|NCT05909826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92168933|NCT05909826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92168934|NCT05909826|Alkylating Agents|alkylating agents|mesh-ancestor
92168935|NCT05909826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308495|NCT04341038|Protective Agents|protective agents|mesh-ancestor
92168936|NCT05909826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168937|NCT05909826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92168938|NCT05909826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92168939|NCT05909826|Antiemetics|antiemetics|mesh-ancestor
92168940|NCT05909826|Autonomic Agents|autonomic agents|mesh-ancestor
92168941|NCT05909826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168942|NCT05909826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92168943|NCT05909826|Glucocorticoids|glucocorticoids|mesh-ancestor
92168944|NCT05909826|Hormones|hormones|mesh-ancestor
92308714|NCT00364442|Xhance|xhance|mesh-list
92168945|NCT05909826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308780|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
92168946|NCT05909826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92168948|NCT05909800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92308869|NCT05731778|Listerine|listerine|mesh-list
92168949|NCT05909800|Antimetabolites|antimetabolites|mesh-ancestor
92308923|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
92168950|NCT05909800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168951|NCT05909800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92168952|NCT05909462|Triamcinolone|triamcinolone|mesh-list
92168953|NCT05909462|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92168954|NCT05909462|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92168955|NCT05909462|Lidocaine|lidocaine|mesh-list
92168956|NCT05909462|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92168957|NCT05909462|Anesthetics, Local|anesthetics, local|mesh-ancestor
92168958|NCT05909462|Anesthetics|anesthetics|mesh-ancestor
92168959|NCT05909462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92168960|NCT05909462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168961|NCT05909462|Sensory System Agents|sensory system agents|mesh-ancestor
92168962|NCT05909462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168963|NCT05909462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92168964|NCT05909462|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92168965|NCT05909462|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92168966|NCT05909462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92168967|NCT05909462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168968|NCT05909462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92168971|NCT05909462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309054|NCT04740554|Glucocorticoids|glucocorticoids|mesh-ancestor
92168972|NCT05909462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92168973|NCT05909462|Immunologic Factors|immunologic factors|mesh-ancestor
92168974|NCT05909462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92168975|NCT05909423|Pembrolizumab|pembrolizumab|mesh-list
92168976|NCT05909423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92168978|NCT05909423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92168979|NCT05909423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168980|NCT05909293|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92168981|NCT05909293|Venetoclax|venetoclax|mesh-list
92168982|NCT05909293|Antiemetics|antiemetics|mesh-list
92168983|NCT05909293|Lenograstim|lenograstim|mesh-list
92168984|NCT05909293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92168985|NCT05909293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92168986|NCT05909293|Immunologic Factors|immunologic factors|mesh-ancestor
92168987|NCT05909293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168988|NCT05909293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92168990|NCT05909293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92168991|NCT05909293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92168992|NCT05909267|Carbidopa|carbidopa|mesh-list
92168993|NCT05909267|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92168994|NCT05909267|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92168995|NCT05909267|Dopamine Agents|dopamine agents|mesh-ancestor
92168996|NCT05909267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92168997|NCT05909267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92168998|NCT05909267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92168999|NCT05909267|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92169000|NCT05909267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169001|NCT05909215|Dexmedetomidine|dexmedetomidine|mesh-list
92169002|NCT05909215|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92169003|NCT05909215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169004|NCT05909215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169005|NCT05909215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169006|NCT05909215|Analgesics|analgesics|mesh-ancestor
92169007|NCT05909215|Sensory System Agents|sensory system agents|mesh-ancestor
92309632|NCT00367094|Benazepril|benazepril|mesh-list
92169008|NCT05909215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169009|NCT05909215|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92169010|NCT05909215|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92169011|NCT05909215|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92169012|NCT05909215|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309787|NCT02495779|Tenofovir|tenofovir|mesh-list
92169013|NCT05909215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169014|NCT05909215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169015|NCT05909137|Immunomodulating Agents|immunomodulating agents|mesh-list
92169016|NCT05909137|Immunologic Factors|immunologic factors|mesh-ancestor
92169017|NCT05909137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169018|NCT05909072|Tranexamic Acid|tranexamic acid|mesh-list
92169019|NCT05909072|Hyaluronic Acid|hyaluronic acid|mesh-list
92169020|NCT05909072|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92169021|NCT05909072|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92169022|NCT05909072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169023|NCT05909072|Hemostatics|hemostatics|mesh-ancestor
92169024|NCT05909072|Coagulants|coagulants|mesh-ancestor
92169025|NCT05909072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92169026|NCT05909072|Immunologic Factors|immunologic factors|mesh-ancestor
92169027|NCT05909072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169028|NCT05909072|Viscosupplements|viscosupplements|mesh-ancestor
92169029|NCT05909072|Protective Agents|protective agents|mesh-ancestor
92169030|NCT05909059|Cyclophosphamide|cyclophosphamide|mesh-list
92169031|NCT05909059|Fludarabine|fludarabine|mesh-list
92169032|NCT05909059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169033|NCT05909059|Immunologic Factors|immunologic factors|mesh-ancestor
92169034|NCT05909059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169035|NCT05909059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169036|NCT05909059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92169037|NCT05909059|Alkylating Agents|alkylating agents|mesh-ancestor
92169038|NCT05909059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169039|NCT05909059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169040|NCT05909059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92169041|NCT05908864|Magnesium Sulfate|magnesium sulfate|mesh-list
92169043|NCT05908864|Sensory System Agents|sensory system agents|mesh-ancestor
92169044|NCT05908864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169045|NCT05908864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169046|NCT05908864|Anesthetics|anesthetics|mesh-ancestor
92169047|NCT05908864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169048|NCT05908864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92169049|NCT05908864|Anticonvulsants|anticonvulsants|mesh-ancestor
92169050|NCT05908864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92169051|NCT05908864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169052|NCT05908864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169053|NCT05908864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92169054|NCT05908864|Tocolytic Agents|tocolytic agents|mesh-ancestor
92169055|NCT05908864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92169056|NCT05908851|Ketorolac|ketorolac|mesh-list
92169057|NCT05908851|Epinephrine|epinephrine|mesh-list
92169059|NCT05908851|Ropivacaine|ropivacaine|mesh-list
92169060|NCT05908851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92169061|NCT05908851|Narcotics|narcotics|mesh-ancestor
92169062|NCT05908851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169063|NCT05908851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169064|NCT05908851|Analgesics|analgesics|mesh-ancestor
92169065|NCT05908851|Sensory System Agents|sensory system agents|mesh-ancestor
92169066|NCT05908851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169067|NCT05908851|Anesthetics, Local|anesthetics, local|mesh-ancestor
92169068|NCT05908851|Anesthetics|anesthetics|mesh-ancestor
92169069|NCT05908851|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92169070|NCT05908851|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92169071|NCT05908851|Adrenergic Agents|adrenergic agents|mesh-ancestor
92169072|NCT05908851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169073|NCT05908851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169074|NCT05908851|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92169075|NCT05908851|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92169076|NCT05908851|Autonomic Agents|autonomic agents|mesh-ancestor
92169077|NCT05908851|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92169078|NCT05908851|Respiratory System Agents|respiratory system agents|mesh-ancestor
92169079|NCT05908851|Mydriatics|mydriatics|mesh-ancestor
92169080|NCT05908851|Sympathomimetics|sympathomimetics|mesh-ancestor
92169081|NCT05908851|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92169082|NCT05908851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92169083|NCT05908851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169084|NCT05908851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169085|NCT05908851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169086|NCT05908851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92169087|NCT05908851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169088|NCT05908799|Pembrolizumab|pembrolizumab|mesh-list
92169089|NCT05908799|Pemetrexed|pemetrexed|mesh-list
92169090|NCT05908799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169091|NCT05908799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310100|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92169092|NCT05908799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92169093|NCT05908799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169094|NCT05908799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169095|NCT05908799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92169096|NCT05908799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92169097|NCT05906732|Dofetilide|dofetilide|mesh-list
92169098|NCT05906732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92169099|NCT05906732|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92169100|NCT05906732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169101|NCT05906732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169102|NCT05906121|Lidocaine|lidocaine|mesh-list
92169103|NCT05906121|Ketamine|ketamine|mesh-list
92169104|NCT05906121|Anesthetics, Local|anesthetics, local|mesh-ancestor
92169105|NCT05906121|Anesthetics|anesthetics|mesh-ancestor
92169106|NCT05906121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169107|NCT05906121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169108|NCT05906121|Sensory System Agents|sensory system agents|mesh-ancestor
92169109|NCT05906121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169110|NCT05906121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92169111|NCT05906121|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92169112|NCT05906121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92169113|NCT05906121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169114|NCT05906121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169115|NCT05906121|Analgesics|analgesics|mesh-ancestor
92169116|NCT05906121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92169117|NCT05906121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92169118|NCT05906121|Anesthetics, General|anesthetics, general|mesh-ancestor
92169119|NCT05906121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92169120|NCT05906121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92169121|NCT05906121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169122|NCT05904587|Imidacloprid|imidacloprid|mesh-list
92169123|NCT05904587|Cholinergic Agents|cholinergic agents|mesh-ancestor
92169124|NCT05904587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169125|NCT05904587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169126|NCT05904587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169128|NCT05904470|Antiviral Agents|antiviral agents|mesh-ancestor
92169129|NCT05904470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169130|NCT05904457|Bevacizumab|bevacizumab|mesh-list
92169131|NCT05904457|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92169132|NCT05904457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169133|NCT05904457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169134|NCT05904457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92169135|NCT05904457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92169136|NCT05904457|Growth Substances|growth substances|mesh-ancestor
92169137|NCT05904457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169138|NCT05904457|Growth Inhibitors|growth inhibitors|mesh-ancestor
92169139|NCT05904457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92169140|NCT05904457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169141|NCT05904457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169142|NCT05904275|Dexamethasone|dexamethasone|mesh-list
92169143|NCT05904275|Ropivacaine|ropivacaine|mesh-list
92169144|NCT05904275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169145|NCT05904275|Antiemetics|antiemetics|mesh-ancestor
92169146|NCT05904275|Autonomic Agents|autonomic agents|mesh-ancestor
92169147|NCT05904275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169148|NCT05904275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169149|NCT05904275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169150|NCT05904275|Glucocorticoids|glucocorticoids|mesh-ancestor
92169151|NCT05904275|Hormones|hormones|mesh-ancestor
92169152|NCT05904275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169153|NCT05904275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92169154|NCT05904275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169155|NCT05904275|Anesthetics, Local|anesthetics, local|mesh-ancestor
92169156|NCT05904275|Anesthetics|anesthetics|mesh-ancestor
92169157|NCT05904275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310200|NCT05572645|Pertuzumab|pertuzumab|mesh-list
92169158|NCT05904275|Sensory System Agents|sensory system agents|mesh-ancestor
92169159|NCT05904184|Calcium, Dietary|calcium, dietary|mesh-list
92169160|NCT05904184|Calcium|calcium|mesh-list
92169161|NCT05904184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92169162|NCT05904184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169163|NCT05904184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92169164|NCT05904119|Lomustine|lomustine|mesh-list
92169165|NCT05904119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92169166|NCT05904119|Alkylating Agents|alkylating agents|mesh-ancestor
92169167|NCT05904119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169168|NCT05904119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169169|NCT05904106|Azacitidine|azacitidine|mesh-list
92169170|NCT05904106|Venetoclax|venetoclax|mesh-list
92169171|NCT05904106|Gemtuzumab|gemtuzumab|mesh-list
92169172|NCT05904106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169173|NCT05904106|Antimetabolites|antimetabolites|mesh-ancestor
92169174|NCT05904106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169175|NCT05904106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169176|NCT05904106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169177|NCT05904106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169178|NCT05904106|Immunotoxins|immunotoxins|mesh-ancestor
92169179|NCT05904106|Immunoconjugates|immunoconjugates|mesh-ancestor
92169181|NCT05904106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169182|NCT05904080|Nivolumab|nivolumab|mesh-list
92169183|NCT05904080|Ipilimumab|ipilimumab|mesh-list
92169184|NCT05904080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169185|NCT05904080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169186|NCT05904080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92169187|NCT05904080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169188|NCT05904028|Faricimab|faricimab|mesh-list
92169189|NCT05904028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92169190|NCT05904028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92169191|NCT05904028|Growth Substances|growth substances|mesh-ancestor
92169192|NCT05904028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169193|NCT05904028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92169194|NCT05904028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169195|NCT05904002|Budesonide|budesonide|mesh-list
92169196|NCT05904002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169197|NCT05904002|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92169198|NCT05904002|Autonomic Agents|autonomic agents|mesh-ancestor
92169199|NCT05904002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169200|NCT05904002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169201|NCT05904002|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92169202|NCT05904002|Respiratory System Agents|respiratory system agents|mesh-ancestor
92169203|NCT05904002|Glucocorticoids|glucocorticoids|mesh-ancestor
92169205|NCT05904002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169206|NCT05903963|Midazolam|midazolam|mesh-list
92169207|NCT05903963|Dexmedetomidine|dexmedetomidine|mesh-list
92169208|NCT05903963|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92169209|NCT05903963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169210|NCT05903963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169211|NCT05903963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169212|NCT05903963|Analgesics|analgesics|mesh-ancestor
92169213|NCT05903963|Sensory System Agents|sensory system agents|mesh-ancestor
92169214|NCT05903963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169215|NCT05903963|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92169216|NCT05903963|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92169217|NCT05903963|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92169218|NCT05903963|Adrenergic Agents|adrenergic agents|mesh-ancestor
92169219|NCT05903963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169220|NCT05903963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169221|NCT05903963|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92169222|NCT05903963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92169223|NCT05903963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92169224|NCT05903963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92169225|NCT05903963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92169226|NCT05903963|Anesthetics, General|anesthetics, general|mesh-ancestor
92169227|NCT05903963|Anesthetics|anesthetics|mesh-ancestor
92169228|NCT05903963|GABA Modulators|gaba modulators|mesh-ancestor
92169229|NCT05903963|GABA Agents|gaba agents|mesh-ancestor
92169230|NCT05903937|Melphalan|melphalan|mesh-list
92169231|NCT05903937|Interleukin-2|interleukin-2|mesh-list
92169232|NCT05903937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92169233|NCT05903937|Alkylating Agents|alkylating agents|mesh-ancestor
92169234|NCT05903937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169235|NCT05903937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169236|NCT05903937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92169237|NCT05903937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169238|NCT05903937|Immunologic Factors|immunologic factors|mesh-ancestor
92169239|NCT05903937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169240|NCT05903937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169242|NCT05903937|Sensory System Agents|sensory system agents|mesh-ancestor
92169243|NCT05903937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169244|NCT05903833|Pembrolizumab|pembrolizumab|mesh-list
92169245|NCT05903833|Lenvatinib|lenvatinib|mesh-list
92169246|NCT05903833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169247|NCT05903833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169248|NCT05903833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92169249|NCT05903833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169250|NCT05903833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92169251|NCT05903833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169252|NCT05903820|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92169253|NCT05903820|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92169254|NCT05903820|Estradiol|estradiol|mesh-list
92169255|NCT05903820|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92169256|NCT05903820|Progesterone|progesterone|mesh-list
92169257|NCT05903820|Estrogens|estrogens|mesh-ancestor
92169258|NCT05903820|Hormones|hormones|mesh-ancestor
92169259|NCT05903820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169260|NCT05903820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169261|NCT05903820|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92169262|NCT05903820|Contraceptive Agents|contraceptive agents|mesh-ancestor
92169263|NCT05903820|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92169264|NCT05903820|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92169265|NCT05903820|Progestins|progestins|mesh-ancestor
92169266|NCT05903807|FAPI-46|fapi-46|mesh-list
92169267|NCT05903807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92169268|NCT05903807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169269|NCT05903755|Methamphetamine|methamphetamine|mesh-list
92169270|NCT05903755|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92169271|NCT05903755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169272|NCT05903755|Sympathomimetics|sympathomimetics|mesh-ancestor
92169273|NCT05903755|Autonomic Agents|autonomic agents|mesh-ancestor
92169274|NCT05903755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169275|NCT05903755|Dopamine Agents|dopamine agents|mesh-ancestor
92169276|NCT05903755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169277|NCT05903755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169278|NCT05903755|Adrenergic Agents|adrenergic agents|mesh-ancestor
92169279|NCT05903755|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92169280|NCT05903755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92169281|NCT05903755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169282|NCT05903755|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92169283|NCT05903716|Isotretinoin|isotretinoin|mesh-list
92169284|NCT05903716|Hormones|hormones|mesh-list
92169285|NCT05903716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169286|NCT05903716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169287|NCT05903716|Dermatologic Agents|dermatologic agents|mesh-ancestor
92169288|NCT05903703|Canagliflozin|canagliflozin|mesh-list
92169289|NCT05903703|Gemcitabine|gemcitabine|mesh-list
92169290|NCT05903703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169291|NCT05903703|Antimetabolites|antimetabolites|mesh-ancestor
92169292|NCT05903703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169293|NCT05903703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169294|NCT05903703|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92169295|NCT05903703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92169296|NCT05903703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169298|NCT05903456|Immunologic Factors|immunologic factors|mesh-list
92169299|NCT05903456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169300|NCT05903456|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92169301|NCT05903456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169302|NCT05903456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169303|NCT05903456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169304|NCT05903339|MEDI9197|medi9197|mesh-list
92169305|NCT05903339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92169306|NCT05903339|Immunologic Factors|immunologic factors|mesh-ancestor
92169307|NCT05903339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169308|NCT05903326|Dexmedetomidine|dexmedetomidine|mesh-list
92169309|NCT05903326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92169310|NCT05903326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169311|NCT05903326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169312|NCT05903326|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169313|NCT05903326|Analgesics|analgesics|mesh-ancestor
92169314|NCT05903326|Sensory System Agents|sensory system agents|mesh-ancestor
92169315|NCT05903326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169316|NCT05903326|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92169317|NCT05903326|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92169318|NCT05903326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92169319|NCT05903326|Adrenergic Agents|adrenergic agents|mesh-ancestor
92169320|NCT05903326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169321|NCT05903326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169322|NCT05903131|Levonorgestrel|levonorgestrel|mesh-list
92169323|NCT05903131|Progestins|progestins|mesh-list
92169324|NCT05903131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92169325|NCT05903131|Contraceptive Agents|contraceptive agents|mesh-ancestor
92169326|NCT05903131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92169327|NCT05903131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169328|NCT05903131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92169329|NCT05903131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92169330|NCT05903131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92169331|NCT05903131|Hormones|hormones|mesh-ancestor
92169332|NCT05903131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169333|NCT05903040|Lasmiditan|lasmiditan|mesh-list
92169334|NCT05903040|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92169335|NCT05903040|Serotonin Agents|serotonin agents|mesh-ancestor
92169336|NCT05903040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169337|NCT05903040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169338|NCT05903040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169339|NCT05902819|Minocycline|minocycline|mesh-list
92169340|NCT05902819|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92169341|NCT05902819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169342|NCT05902754|Sulforaphane|sulforaphane|mesh-list
92169343|NCT05902754|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92169344|NCT05902754|Protective Agents|protective agents|mesh-ancestor
92169345|NCT05902754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169346|NCT05902754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169347|NCT05902728|Itraconazole|itraconazole|mesh-list
92169348|NCT05902728|Rifampin|rifampin|mesh-list
92169349|NCT05902728|Antifungal Agents|antifungal agents|mesh-ancestor
92169350|NCT05902728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169351|NCT05902728|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92169352|NCT05902728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92169353|NCT05902728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169354|NCT05902728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169355|NCT05902728|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92169356|NCT05902728|Hormone Antagonists|hormone antagonists|mesh-ancestor
92169357|NCT05902728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169358|NCT05902728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169359|NCT05902728|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92169360|NCT05902728|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92169361|NCT05902728|Antitubercular Agents|antitubercular agents|mesh-ancestor
92169362|NCT05902728|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92169363|NCT05902728|Leprostatic Agents|leprostatic agents|mesh-ancestor
92169364|NCT05902728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92169365|NCT05902728|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92169366|NCT05902728|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92169367|NCT05902728|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92169368|NCT05902728|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92169369|NCT05902728|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92169370|NCT05902728|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92169371|NCT05902533|Capecitabine|capecitabine|mesh-list
92169372|NCT05902533|Mitomycins|mitomycins|mesh-list
92169373|NCT05902533|Mitomycin|mitomycin|mesh-list
92169374|NCT05902533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169375|NCT05902533|Antimetabolites|antimetabolites|mesh-ancestor
92169376|NCT05902533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169377|NCT05902533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169378|NCT05902533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92169379|NCT05902533|Alkylating Agents|alkylating agents|mesh-ancestor
92169380|NCT05902533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92169381|NCT05902533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169382|NCT05902468|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92169383|NCT05902468|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92169384|NCT05902468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169385|NCT05902429|Cladribine|cladribine|mesh-list
92169386|NCT05902429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169387|NCT05902429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169388|NCT05902429|Immunologic Factors|immunologic factors|mesh-ancestor
92169389|NCT05902429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169390|NCT05901428|Cyclophosphamide|cyclophosphamide|mesh-list
92169391|NCT05901428|Carboplatin|carboplatin|mesh-list
92169392|NCT05901428|Docetaxel|docetaxel|mesh-list
92169393|NCT05901428|Epirubicin|epirubicin|mesh-list
92169394|NCT05901428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169395|NCT05901428|Immunologic Factors|immunologic factors|mesh-ancestor
92169396|NCT05901428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310474|NCT02625181|Analgesics|analgesics|mesh-ancestor
92169397|NCT05901428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169398|NCT05901428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92169399|NCT05901428|Alkylating Agents|alkylating agents|mesh-ancestor
92169400|NCT05901428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169401|NCT05901428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169402|NCT05901428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92169403|NCT05901428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92169404|NCT05901428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92169405|NCT05901428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92169406|NCT05901428|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92169407|NCT05901428|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92169408|NCT05901428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92169409|NCT05901428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169410|NCT05899140|Clindamycin|clindamycin|mesh-list
92169411|NCT05899140|Clindamycin palmitate|clindamycin palmitate|mesh-list
92169412|NCT05899140|Clindamycin phosphate|clindamycin phosphate|mesh-list
92169413|NCT05899140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92169414|NCT05899140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169415|NCT05899140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92169416|NCT05899140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169417|NCT05899140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169418|NCT05895838|Dexamethasone|dexamethasone|mesh-list
92169419|NCT05895838|Olanzapine|olanzapine|mesh-list
92169420|NCT05895838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169421|NCT05895838|Antiemetics|antiemetics|mesh-ancestor
92169422|NCT05895838|Autonomic Agents|autonomic agents|mesh-ancestor
92169423|NCT05895838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169424|NCT05895838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169425|NCT05895838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169426|NCT05895838|Glucocorticoids|glucocorticoids|mesh-ancestor
92169427|NCT05895838|Hormones|hormones|mesh-ancestor
92169428|NCT05895838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169429|NCT05895838|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92169430|NCT05895838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169431|NCT05895838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92169432|NCT05895838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92169433|NCT05895838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169434|NCT05895838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92169435|NCT05895838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92169436|NCT05895838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92169437|NCT05895838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169438|NCT05895838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169439|NCT05895838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169440|NCT05895838|Serotonin Agents|serotonin agents|mesh-ancestor
92169441|NCT05895383|Nitrous Oxide|nitrous oxide|mesh-list
92169442|NCT05895383|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92169443|NCT05895383|Anesthetics, General|anesthetics, general|mesh-ancestor
92169444|NCT05895383|Anesthetics|anesthetics|mesh-ancestor
92169445|NCT05895383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169446|NCT05895383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169447|NCT05895383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169448|NCT05895383|Analgesics|analgesics|mesh-ancestor
92169449|NCT05895383|Sensory System Agents|sensory system agents|mesh-ancestor
92169450|NCT05895383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169451|NCT05893030|Anesthetics|anesthetics|mesh-list
92169452|NCT05893030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169453|NCT05893030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169454|NCT05885685|Nabilone|nabilone|mesh-list
92169455|NCT05885685|Antiemetics|antiemetics|mesh-ancestor
92169456|NCT05885685|Autonomic Agents|autonomic agents|mesh-ancestor
92169457|NCT05885685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169458|NCT05885685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169459|NCT05885685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169460|NCT05885685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92169461|NCT05885685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92169462|NCT05885685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169463|NCT05885685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92169464|NCT05880394|Copper|copper|mesh-list
92169465|NCT05880394|Trace Elements|trace elements|mesh-ancestor
92169466|NCT05880394|Micronutrients|micronutrients|mesh-ancestor
92169467|NCT05880394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169468|NCT05878093|Budesonide|budesonide|mesh-list
92169469|NCT05878093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169470|NCT05878093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92169471|NCT05878093|Autonomic Agents|autonomic agents|mesh-ancestor
92169472|NCT05878093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169473|NCT05878093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169474|NCT05878093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92310623|NCT00367471|Paclitaxel|paclitaxel|mesh-list
92169475|NCT05878093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92169476|NCT05878093|Glucocorticoids|glucocorticoids|mesh-ancestor
92169478|NCT05878093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169479|NCT05866471|Psilocybin|psilocybin|mesh-list
92169480|NCT05866471|Hallucinogens|hallucinogens|mesh-ancestor
92169481|NCT05866471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169482|NCT05866471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92169483|NCT05861570|Triamcinolone|triamcinolone|mesh-list
92169484|NCT05861570|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92169485|NCT05861570|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92169486|NCT05861570|Lidocaine|lidocaine|mesh-list
92169487|NCT05861570|Hyaluronic Acid|hyaluronic acid|mesh-list
92169488|NCT05861570|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92169489|NCT05861570|Anesthetics, Local|anesthetics, local|mesh-ancestor
92169490|NCT05861570|Anesthetics|anesthetics|mesh-ancestor
92169491|NCT05861570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169492|NCT05861570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169493|NCT05861570|Sensory System Agents|sensory system agents|mesh-ancestor
92169494|NCT05861570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169495|NCT05861570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92169496|NCT05861570|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92169497|NCT05861570|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92169498|NCT05861570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92169499|NCT05861570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169500|NCT05861570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169501|NCT05861570|Glucocorticoids|glucocorticoids|mesh-ancestor
92169502|NCT05861570|Hormones|hormones|mesh-ancestor
92169503|NCT05861570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310665|NCT02206620|Donepezil|donepezil|mesh-list
92169504|NCT05861570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169505|NCT05861570|Immunologic Factors|immunologic factors|mesh-ancestor
92169506|NCT05861570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169507|NCT05861570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92169509|NCT05861570|Protective Agents|protective agents|mesh-ancestor
92169510|NCT05857163|Amoxicillin|amoxicillin|mesh-list
92169511|NCT05857163|Clarithromycin|clarithromycin|mesh-list
92169512|NCT05857163|Potassium Citrate|potassium citrate|mesh-list
92169513|NCT05857163|Rabeprazole|rabeprazole|mesh-list
92169514|NCT05857163|Bismuth|bismuth|mesh-list
92169515|NCT05857163|Citric Acid|citric acid|mesh-list
92169516|NCT05857163|Sodium Citrate|sodium citrate|mesh-list
92169517|NCT05857163|Anticoagulants|anticoagulants|mesh-ancestor
92169518|NCT05857163|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92169519|NCT05857163|Chelating Agents|chelating agents|mesh-ancestor
92169520|NCT05857163|Sequestering Agents|sequestering agents|mesh-ancestor
92169521|NCT05857163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169522|NCT05857163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92169523|NCT05857163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169524|NCT05857163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92169525|NCT05857163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169526|NCT05857163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92169527|NCT05857163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92169528|NCT05857163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92169529|NCT05857163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169530|NCT05857163|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92169531|NCT05857163|Antacids|antacids|mesh-ancestor
92169532|NCT05857163|Diuretics|diuretics|mesh-ancestor
92169533|NCT05857163|Natriuretic Agents|natriuretic agents|mesh-ancestor
92169534|NCT05857163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169535|NCT05857163|Expectorants|expectorants|mesh-ancestor
92169536|NCT05857163|Respiratory System Agents|respiratory system agents|mesh-ancestor
92169537|NCT05856851|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92169538|NCT05856851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92169539|NCT05856851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92169540|NCT05856851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169541|NCT05840510|Sirolimus|sirolimus|mesh-list
92169542|NCT05840510|Adagrasib|adagrasib|mesh-list
92169543|NCT05840510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92169544|NCT05840510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169545|NCT05840510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92169546|NCT05840510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169547|NCT05840510|Antifungal Agents|antifungal agents|mesh-ancestor
92169548|NCT05840510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169549|NCT05840510|Immunologic Factors|immunologic factors|mesh-ancestor
92169550|NCT05840510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169551|NCT05839301|Vaccines|vaccines|mesh-list
92169552|NCT05839301|Immunologic Factors|immunologic factors|mesh-ancestor
92169553|NCT05839301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169555|NCT05826574|Esomeprazole|esomeprazole|mesh-list
92169556|NCT05826574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92169557|NCT05826574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169558|NCT05826574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92169559|NCT05826574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169560|NCT05826574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169561|NCT05826574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92169562|NCT05826574|Antitubercular Agents|antitubercular agents|mesh-ancestor
92169563|NCT05826574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92169564|NCT05826574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169565|NCT05826574|Leprostatic Agents|leprostatic agents|mesh-ancestor
92169566|NCT05826574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92169567|NCT05826574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92169568|NCT05826574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92169569|NCT05826574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92169570|NCT05826574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92169571|NCT05826574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92169572|NCT05826574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92169573|NCT05821556|Paclitaxel|paclitaxel|mesh-list
92169574|NCT05821556|Gemcitabine|gemcitabine|mesh-list
92169575|NCT05821556|Capecitabine|capecitabine|mesh-list
92169576|NCT05821556|Valproic Acid|valproic acid|mesh-list
92169577|NCT05821556|Simvastatin|simvastatin|mesh-list
92169578|NCT05821556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92169579|NCT05821556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169580|NCT05821556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92169581|NCT05821556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92169582|NCT05821556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92169583|NCT05821556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169584|NCT05821556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169585|NCT05821556|Antimetabolites|antimetabolites|mesh-ancestor
92169586|NCT05821556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92169587|NCT05821556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92169588|NCT05821556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92169589|NCT05821556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92169590|NCT05821556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169591|NCT05821556|Anticonvulsants|anticonvulsants|mesh-ancestor
92169592|NCT05821556|GABA Agents|gaba agents|mesh-ancestor
92169593|NCT05821556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169594|NCT05821556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169595|NCT05821556|Antimanic Agents|antimanic agents|mesh-ancestor
92169596|NCT05821556|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92169597|NCT05821556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169598|NCT05821556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92169599|NCT05815173|Sotorasib|sotorasib|mesh-list
92169600|NCT05815173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92327617|NCT00003092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92169601|NCT05815173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169602|NCT05815173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169603|NCT05815173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169605|NCT05797376|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92169606|NCT05797376|Antithrombins|antithrombins|mesh-ancestor
92169607|NCT05797376|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92169608|NCT05797376|Protease Inhibitors|protease inhibitors|mesh-ancestor
92169609|NCT05797376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169610|NCT05797376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169611|NCT05797376|Anticoagulants|anticoagulants|mesh-ancestor
92169612|NCT05776979|Lenalidomide|lenalidomide|mesh-list
92169613|NCT05776979|Immunologic Factors|immunologic factors|mesh-ancestor
92169614|NCT05776979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169615|NCT05776979|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92169616|NCT05776979|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92169617|NCT05776979|Growth Substances|growth substances|mesh-ancestor
92169618|NCT05776979|Growth Inhibitors|growth inhibitors|mesh-ancestor
92169619|NCT05776979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169620|NCT05774717|Tranexamic Acid|tranexamic acid|mesh-list
92169621|NCT05774717|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92169622|NCT05774717|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92169623|NCT05774717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169624|NCT05774717|Hemostatics|hemostatics|mesh-ancestor
92169625|NCT05774717|Coagulants|coagulants|mesh-ancestor
92169626|NCT05767359|Cyclophosphamide|cyclophosphamide|mesh-list
92169627|NCT05767359|Fludarabine|fludarabine|mesh-list
92169629|NCT05767359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169630|NCT05767359|Immunologic Factors|immunologic factors|mesh-ancestor
92169631|NCT05767359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169632|NCT05767359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169633|NCT05767359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92169634|NCT05767359|Alkylating Agents|alkylating agents|mesh-ancestor
92169635|NCT05767359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169636|NCT05767359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169637|NCT05767359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92169638|NCT05767359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169639|NCT05767359|Antimetabolites|antimetabolites|mesh-ancestor
92169640|NCT05733286|Suvorexant|suvorexant|mesh-list
92169641|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92169642|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92169643|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169644|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169645|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92169646|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169647|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169648|NCT05722327|Irinotecan|irinotecan|mesh-list
92169649|NCT05722327|Cetuximab|cetuximab|mesh-list
92169650|NCT05722327|Adagrasib|adagrasib|mesh-list
92169651|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92169652|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92169653|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169654|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169655|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169656|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169657|NCT05708755|Valganciclovir|valganciclovir|mesh-list
92169658|NCT05708755|Antiviral Agents|antiviral agents|mesh-ancestor
92169659|NCT05708755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169660|NCT05704647|Nivolumab|nivolumab|mesh-list
92169661|NCT05704647|Relatlimab|relatlimab|mesh-list
92403315|NCT04638660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92169662|NCT05704647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169663|NCT05704647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169664|NCT05704647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92169665|NCT05704647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169666|NCT05689424|Insulin Lispro|insulin lispro|mesh-list
92169667|NCT05689424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92169668|NCT05689424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169669|NCT05683171|Rituximab|rituximab|mesh-list
92169670|NCT05683171|Lenalidomide|lenalidomide|mesh-list
92169686|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169687|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92169688|NCT05678257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92169689|NCT05678257|Growth Substances|growth substances|mesh-ancestor
92169690|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169691|NCT05678257|Growth Inhibitors|growth inhibitors|mesh-ancestor
92169692|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
92169693|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169694|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169695|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169696|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
92169697|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92169698|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92169699|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169700|NCT05678257|Antidotes|antidotes|mesh-ancestor
92169701|NCT05678257|Protective Agents|protective agents|mesh-ancestor
92169702|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
92169704|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
92169705|NCT05677633|Sargramostim|sargramostim|mesh-list
92169706|NCT05677633|Immunologic Factors|immunologic factors|mesh-ancestor
92169707|NCT05677633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169708|NCT05669625|Vaccines|vaccines|mesh-list
92169709|NCT05669625|Immunologic Factors|immunologic factors|mesh-ancestor
92169710|NCT05669625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169711|NCT05669339|Irinotecan|irinotecan|mesh-list
92169712|NCT05669339|Sorafenib|sorafenib|mesh-list
92169713|NCT05669339|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92169714|NCT05669339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92169715|NCT05669339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169716|NCT05669339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169717|NCT05669339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169718|NCT05669339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92169733|NCT05663411|Cinacalcet|cinacalcet|mesh-list
92169734|NCT05663411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92169735|NCT05663411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169736|NCT05663411|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92169737|NCT05663411|Hormone Antagonists|hormone antagonists|mesh-ancestor
92169738|NCT05663411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169739|NCT05654506|Daratumumab|daratumumab|mesh-list
92169740|NCT05654506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169741|NCT05640674|Acetaminophen|acetaminophen|mesh-list
92169742|NCT05640674|Ibuprofen|ibuprofen|mesh-list
92169743|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92169744|NCT05640674|Hydrocodone|hydrocodone|mesh-list
92169745|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169746|NCT05640674|Analgesics|analgesics|mesh-ancestor
92169747|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
92169748|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169749|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169751|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92169752|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169753|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169754|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92169755|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169756|NCT05640674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169757|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92169758|NCT05640674|Narcotics|narcotics|mesh-ancestor
92169759|NCT05640674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403320|NCT04622020|Anesthetics|anesthetics|mesh-list
92169760|NCT05640674|Antitussive Agents|antitussive agents|mesh-ancestor
92169761|NCT05640674|Respiratory System Agents|respiratory system agents|mesh-ancestor
92169762|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
92169763|NCT05634785|Fludarabine|fludarabine|mesh-list
92169764|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169765|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
92169766|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169767|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169768|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92169769|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
92169770|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169771|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169772|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92169773|NCT05612594|Ertugliflozin|ertugliflozin|mesh-list
92169774|NCT05612594|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92169775|NCT05612594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169776|NCT05612594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92169777|NCT05612594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169778|NCT05600231|Listerine|listerine|mesh-list
92169779|NCT05600231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92169780|NCT05600231|Sodium Fluoride|sodium fluoride|mesh-list
92169781|NCT05600231|Cariostatic Agents|cariostatic agents|mesh-ancestor
92169782|NCT05600231|Protective Agents|protective agents|mesh-ancestor
92169783|NCT05600231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169784|NCT05600231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92169785|NCT05564650|Azacitidine|azacitidine|mesh-list
92169786|NCT05564650|Decitabine|decitabine|mesh-list
92169787|NCT05564650|Venetoclax|venetoclax|mesh-list
92169788|NCT05564650|Navitoclax|navitoclax|mesh-list
92169789|NCT05564650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169790|NCT05564650|Antimetabolites|antimetabolites|mesh-ancestor
92169791|NCT05564650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169792|NCT05564650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169793|NCT05564650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169794|NCT05554627|Aripiprazole|aripiprazole|mesh-list
92169795|NCT05554627|Esketamine|esketamine|mesh-list
92169796|NCT05554627|Antidepressive Agents|antidepressive agents|mesh-ancestor
92169797|NCT05554627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92169798|NCT05554627|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92169799|NCT05554627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92169800|NCT05554627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169801|NCT05554627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169802|NCT05554627|Dopamine Agonists|dopamine agonists|mesh-ancestor
92169803|NCT05554627|Dopamine Agents|dopamine agents|mesh-ancestor
92169804|NCT05554627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169805|NCT05554627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169806|NCT05554627|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92169807|NCT05554627|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92169809|NCT05554627|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92169810|NCT05554627|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92169811|NCT05554627|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92169812|NCT05554627|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92169813|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92169814|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92169815|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
92169816|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92169817|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92169818|NCT05510895|Cetuximab|cetuximab|mesh-list
92169819|NCT05510895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92169820|NCT05510895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169821|NCT05489731|Osimertinib|osimertinib|mesh-list
92169822|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169823|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92169824|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169825|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169826|NCT05478291|Vitamin D|vitamin d|mesh-list
92169827|NCT05478291|Vitamins|vitamins|mesh-ancestor
92169828|NCT05478291|Micronutrients|micronutrients|mesh-ancestor
92169829|NCT05478291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169830|NCT05478291|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92169831|NCT05472792|Tamoxifen|tamoxifen|mesh-list
92169832|NCT05472792|Toremifene|toremifene|mesh-list
92169833|NCT05472792|Letrozole|letrozole|mesh-list
92169834|NCT05472792|Fulvestrant|fulvestrant|mesh-list
92169835|NCT05472792|Anastrozole|anastrozole|mesh-list
92169836|NCT05472792|Exemestane|exemestane|mesh-list
92169837|NCT05472792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169838|NCT05472792|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92169839|NCT05472792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92169840|NCT05472792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169841|NCT05472792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169842|NCT05472792|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92169843|NCT05472792|Hormone Antagonists|hormone antagonists|mesh-ancestor
92169844|NCT05472792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169845|NCT05472792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169846|NCT05472792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92169847|NCT05472792|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92169848|NCT05472792|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92169849|NCT05472792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92169850|NCT05472792|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92169851|NCT05467293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92169853|NCT05464836|Venetoclax|venetoclax|mesh-list
92169854|NCT05464836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169855|NCT05463367|Acetaminophen|acetaminophen|mesh-list
92169856|NCT05463367|Naproxen|naproxen|mesh-list
92169857|NCT05463367|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92169858|NCT05463367|Oxymorphone|oxymorphone|mesh-list
92169859|NCT05463367|Morphine|morphine|mesh-list
92169860|NCT05463367|Oxycodone|oxycodone|mesh-list
92169861|NCT05463367|Tramadol|tramadol|mesh-list
92169862|NCT05463367|Hydrocodone|hydrocodone|mesh-list
92169863|NCT05463367|Codeine|codeine|mesh-list
92169864|NCT05463367|Levodopa|levodopa|mesh-list
92169865|NCT05463367|Carbidopa|carbidopa|mesh-list
92169866|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92169867|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92169869|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92169870|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169871|NCT05463367|Analgesics|analgesics|mesh-ancestor
92169872|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
92169873|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169874|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169875|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
92169876|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92169877|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169878|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169879|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
92169880|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92169881|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169882|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169883|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92169884|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92169886|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169887|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92169888|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
92169889|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
92169890|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92169891|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
92169892|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
92169893|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92169895|NCT05436535|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92169896|NCT05436535|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92169897|NCT05436535|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92169898|NCT05436535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169899|NCT05436535|Glucocorticoids|glucocorticoids|mesh-ancestor
92169901|NCT05436535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169902|NCT05436535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169903|NCT05436535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92169904|NCT05436535|Immunologic Factors|immunologic factors|mesh-ancestor
92169905|NCT05436535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169906|NCT05436535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169907|NCT05401097|Azacitidine|azacitidine|mesh-list
92169908|NCT05401097|Venetoclax|venetoclax|mesh-list
92169909|NCT05401097|Ivosidenib|ivosidenib|mesh-list
92169910|NCT05401097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169911|NCT05401097|Antimetabolites|antimetabolites|mesh-ancestor
92169912|NCT05401097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169913|NCT05401097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169914|NCT05401097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169915|NCT05395091|Denosumab|denosumab|mesh-list
92169916|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92169917|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169918|NCT05391828|Cimetidine|cimetidine|mesh-list
92169919|NCT05391828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92169920|NCT05391828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92169921|NCT05391828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92169922|NCT05391828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92169923|NCT05391828|Histamine Agents|histamine agents|mesh-ancestor
92169924|NCT05391828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92169925|NCT05391828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169926|NCT05391828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169927|NCT05391828|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92169928|NCT05391828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92169929|NCT05391828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169930|NCT05384119|Palbociclib|palbociclib|mesh-list
92169931|NCT05384119|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92169932|NCT05384119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169933|NCT05384119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92169934|NCT05384119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311250|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
92169935|NCT05384119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169936|NCT05384119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92169937|NCT05384119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92169938|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
92169939|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92169940|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169942|NCT05382871|Immunologic Factors|immunologic factors|mesh-ancestor
92169943|NCT05382871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169944|NCT05377905|Doxorubicin|doxorubicin|mesh-list
92169945|NCT05377905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92169946|NCT05377905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92169947|NCT05377905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169948|NCT05377905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92169949|NCT05377905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92169950|NCT05377905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169951|NCT05377905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169952|NCT05377242|Curcumin|curcumin|mesh-list
92169953|NCT05377242|Resveratrol|resveratrol|mesh-list
92169954|NCT05377242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92169955|NCT05377242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92169956|NCT05377242|Analgesics|analgesics|mesh-ancestor
92169957|NCT05377242|Sensory System Agents|sensory system agents|mesh-ancestor
92169958|NCT05377242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169960|NCT05377242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92169961|NCT05377242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92169962|NCT05377242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169963|NCT05377242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169964|NCT05377242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169965|NCT05377242|Antioxidants|antioxidants|mesh-ancestor
92169966|NCT05377242|Protective Agents|protective agents|mesh-ancestor
92169967|NCT05377242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92169968|NCT05374954|Vaccines|vaccines|mesh-list
92169969|NCT05374954|Immunologic Factors|immunologic factors|mesh-ancestor
92169970|NCT05374954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169971|NCT05363007|Leucovorin|leucovorin|mesh-list
92169972|NCT05363007|Irinotecan|irinotecan|mesh-list
92169973|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92169974|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92169975|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92169976|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169977|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169978|NCT05363007|Antidotes|antidotes|mesh-ancestor
92169979|NCT05363007|Protective Agents|protective agents|mesh-ancestor
92169980|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169981|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
92169982|NCT05363007|Vitamins|vitamins|mesh-ancestor
92169983|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
92169984|NCT05360160|Venetoclax|venetoclax|mesh-list
92169985|NCT05360160|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92169986|NCT05360160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92169987|NCT05360160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92169988|NCT05360160|Antimetabolites|antimetabolites|mesh-ancestor
92169989|NCT05360160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92169990|NCT05351606|Bupropion|bupropion|mesh-list
92169991|NCT05351606|Nicotine|nicotine|mesh-list
92169992|NCT05351606|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92169993|NCT05351606|Autonomic Agents|autonomic agents|mesh-ancestor
92169994|NCT05351606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92169995|NCT05351606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92169996|NCT05351606|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92169997|NCT05351606|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92169998|NCT05351606|Cholinergic Agents|cholinergic agents|mesh-ancestor
92169999|NCT05351606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170000|NCT05351606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170001|NCT05351606|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92170002|NCT05351606|Antidepressive Agents|antidepressive agents|mesh-ancestor
92170003|NCT05351606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92170004|NCT05351606|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92170005|NCT05351606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92170006|NCT05351606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170007|NCT05351606|Dopamine Agents|dopamine agents|mesh-ancestor
92170008|NCT05351606|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92170009|NCT05351606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92170010|NCT05351606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170011|NCT05347212|Nivolumab|nivolumab|mesh-list
92170012|NCT05347212|Relatlimab|relatlimab|mesh-list
92170013|NCT05347212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170014|NCT05347212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170015|NCT05347212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311393|NCT05470465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92170016|NCT05347212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170018|NCT05346159|Hormones|hormones|mesh-ancestor
92170019|NCT05346159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170020|NCT05346159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170021|NCT05338723|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92170022|NCT05338723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92170023|NCT05338723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92170024|NCT05338723|Antimetabolites|antimetabolites|mesh-ancestor
92170025|NCT05338723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170026|NCT05338723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92170027|NCT05338723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92170028|NCT05338723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170029|NCT05329545|Immunoconjugates|immunoconjugates|mesh-list
92170030|NCT05329545|Immunologic Factors|immunologic factors|mesh-ancestor
92170031|NCT05329545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170033|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170034|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170035|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
92170036|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170037|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170038|NCT05328154|Diphosphonates|diphosphonates|mesh-list
92170039|NCT05328154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92170040|NCT05328154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170041|NCT05324059|Pregabalin|pregabalin|mesh-list
92170042|NCT05324059|Tramadol|tramadol|mesh-list
92170043|NCT05324059|Analgesics|analgesics|mesh-ancestor
92170044|NCT05324059|Sensory System Agents|sensory system agents|mesh-ancestor
92170045|NCT05324059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170046|NCT05324059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170061|NCT05303636|Drospirenone|drospirenone|mesh-list
92170062|NCT05303636|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92170063|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
92170064|NCT05303636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170065|NCT05303636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170066|NCT05303636|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92170067|NCT05303636|Diuretics|diuretics|mesh-ancestor
92170068|NCT05303636|Natriuretic Agents|natriuretic agents|mesh-ancestor
92170083|NCT05268003|Venetoclax|venetoclax|mesh-list
92170084|NCT05268003|Ponatinib|ponatinib|mesh-list
92170085|NCT05268003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170086|NCT05268003|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170087|NCT05268003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170088|NCT05268003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170089|NCT05238142|Insulin|insulin|mesh-list
92170090|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92170091|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170092|NCT05232071|Empagliflozin|empagliflozin|mesh-list
92170093|NCT05232071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92170094|NCT05232071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170095|NCT05232071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92170096|NCT05232071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170097|NCT05226429|Vaccines|vaccines|mesh-list
92170098|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
92170099|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170100|NCT05217446|Pembrolizumab|pembrolizumab|mesh-list
92170101|NCT05217446|Cetuximab|cetuximab|mesh-list
92170102|NCT05217446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170103|NCT05217446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170104|NCT05217446|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311488|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
92170105|NCT05217446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170106|NCT05212012|Methadone|methadone|mesh-list
92170107|NCT05212012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92170108|NCT05212012|Narcotics|narcotics|mesh-ancestor
92170109|NCT05212012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170110|NCT05212012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170111|NCT05212012|Analgesics|analgesics|mesh-ancestor
92170112|NCT05212012|Sensory System Agents|sensory system agents|mesh-ancestor
92170113|NCT05212012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170114|NCT05212012|Antitussive Agents|antitussive agents|mesh-ancestor
92170115|NCT05212012|Respiratory System Agents|respiratory system agents|mesh-ancestor
92170116|NCT05198804|Niraparib|niraparib|mesh-list
92170117|NCT05198804|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92170118|NCT05198804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170119|NCT05198804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170120|NCT05198804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170122|NCT05197439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92170123|NCT05197439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170124|NCT05197439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170125|NCT05197439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170126|NCT05197439|Analgesics|analgesics|mesh-ancestor
92170127|NCT05197439|Sensory System Agents|sensory system agents|mesh-ancestor
92170128|NCT05197439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170129|NCT05197439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92170130|NCT05197439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92170131|NCT05197439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92170132|NCT05197439|Adrenergic Agents|adrenergic agents|mesh-ancestor
92170133|NCT05197439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170134|NCT05197439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170136|NCT05195918|Nintedanib|nintedanib|mesh-list
92170137|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92170138|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170139|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170140|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170141|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170142|NCT05195918|Analgesics|analgesics|mesh-ancestor
92170143|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
92170144|NCT05195918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170145|NCT05195918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170146|NCT05195918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92170147|NCT05195918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170148|NCT05195918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92170149|NCT05195918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170150|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
92170151|NCT05195918|Protective Agents|protective agents|mesh-ancestor
92170152|NCT05195918|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92170153|NCT05195918|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92170154|NCT05195918|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92170155|NCT05169372|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92170156|NCT05169372|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92170157|NCT05169372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170158|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92170159|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92170160|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170161|NCT05169060|Analgesics|analgesics|mesh-ancestor
92170162|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
92170163|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170164|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170165|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92170166|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170167|NCT05153408|Carboplatin|carboplatin|mesh-list
92170168|NCT05153408|Pemetrexed|pemetrexed|mesh-list
92170169|NCT05153408|Osimertinib|osimertinib|mesh-list
92170170|NCT05153408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170171|NCT05153408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170172|NCT05153408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170173|NCT05153408|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92170174|NCT05153408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92170175|NCT05153408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170176|NCT05114980|Parathyroid Hormone|parathyroid hormone|mesh-list
92170177|NCT05114980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92170178|NCT05114980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170179|NCT05113251|Paclitaxel|paclitaxel|mesh-list
92170180|NCT05113251|Cyclophosphamide|cyclophosphamide|mesh-list
92170181|NCT05113251|Doxorubicin|doxorubicin|mesh-list
92170182|NCT05113251|Trastuzumab|trastuzumab|mesh-list
92170183|NCT05113251|Pertuzumab|pertuzumab|mesh-list
92170184|NCT05113251|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92170185|NCT05113251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92170186|NCT05113251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170187|NCT05113251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92170188|NCT05113251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92170189|NCT05113251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92170190|NCT05113251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170191|NCT05113251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170192|NCT05113251|Immunologic Factors|immunologic factors|mesh-ancestor
92170193|NCT05113251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170194|NCT05113251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170195|NCT05113251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170196|NCT05113251|Alkylating Agents|alkylating agents|mesh-ancestor
92170197|NCT05113251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170198|NCT05113251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170199|NCT05113251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92170200|NCT05113251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92170201|NCT05113251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170202|NCT05113251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170203|NCT05113251|Immunoconjugates|immunoconjugates|mesh-ancestor
92170205|NCT05100628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170206|NCT05100628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170207|NCT05100628|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92170208|NCT05100628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92170210|NCT05100628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170211|NCT05093959|Metformin|metformin|mesh-list
92170212|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92170213|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170214|NCT05091619|Vaccines|vaccines|mesh-list
92170215|NCT05091619|Immunologic Factors|immunologic factors|mesh-ancestor
92170216|NCT05091619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170217|NCT05089916|Osimertinib|osimertinib|mesh-list
92170218|NCT05089916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170219|NCT05089916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170220|NCT05089916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170221|NCT05089916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170222|NCT05089370|Nivolumab|nivolumab|mesh-list
92170223|NCT05089370|Decitabine|decitabine|mesh-list
92170224|NCT05089370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170225|NCT05089370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170226|NCT05089370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170227|NCT05089370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170228|NCT05089370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170230|NCT05089370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170231|NCT05086250|Ketamine|ketamine|mesh-list
92170232|NCT05086250|Analgesics|analgesics|mesh-ancestor
92170233|NCT05086250|Sensory System Agents|sensory system agents|mesh-ancestor
92170234|NCT05086250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170235|NCT05086250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170236|NCT05086250|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92170237|NCT05086250|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92170238|NCT05086250|Anesthetics, General|anesthetics, general|mesh-ancestor
92170239|NCT05086250|Anesthetics|anesthetics|mesh-ancestor
92170240|NCT05086250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170241|NCT05086250|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92170242|NCT05086250|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92170243|NCT05086250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170244|NCT05086250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170245|NCT05084911|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92170246|NCT05084911|Antiviral Agents|antiviral agents|mesh-ancestor
92170247|NCT05084911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170248|NCT05081388|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92170249|NCT05081388|Antiviral Agents|antiviral agents|mesh-ancestor
92170250|NCT05081388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170251|NCT05076149|Ivacaftor|ivacaftor|mesh-list
92170252|NCT05076149|Elexacaftor|elexacaftor|mesh-list
92170253|NCT05076149|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92170254|NCT05076149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170255|NCT05076149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170256|NCT05075993|Paclitaxel|paclitaxel|mesh-list
92170257|NCT05075993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92170258|NCT05075993|Cyclophosphamide|cyclophosphamide|mesh-list
92170259|NCT05075993|Bevacizumab|bevacizumab|mesh-list
92170260|NCT05075993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92170261|NCT05075993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170262|NCT05075993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92170263|NCT05075993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92170264|NCT05075993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92327618|NCT00003092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170265|NCT05075993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170266|NCT05075993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170267|NCT05075993|Immunologic Factors|immunologic factors|mesh-ancestor
92170268|NCT05075993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170269|NCT05075993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170270|NCT05075993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170272|NCT05075993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170273|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170274|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92170275|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92170276|NCT05075993|Growth Substances|growth substances|mesh-ancestor
92170277|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
92170278|NCT05054374|Fulvestrant|fulvestrant|mesh-list
92170279|NCT05054374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92170280|NCT05054374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170281|NCT05054374|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92170282|NCT05054374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92170283|NCT05054374|Hormone Antagonists|hormone antagonists|mesh-ancestor
92170284|NCT05054374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170285|NCT05054374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170286|NCT05039177|Cetuximab|cetuximab|mesh-list
92170287|NCT05039177|Palbociclib|palbociclib|mesh-list
92170288|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170289|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170290|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170291|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170292|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170293|NCT05027308|Teduglutide|teduglutide|mesh-list
92170295|NCT05027308|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92170296|NCT05027308|Protective Agents|protective agents|mesh-ancestor
92170297|NCT05027308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170298|NCT05025800|Rituximab|rituximab|mesh-list
92170299|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92170300|NCT05025800|Lenalidomide|lenalidomide|mesh-list
92170301|NCT05025800|Antibodies|antibodies|mesh-list
92170302|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
92170303|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92170304|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
92170305|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170306|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170307|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170308|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92170309|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92170310|NCT05025800|Growth Substances|growth substances|mesh-ancestor
92170311|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92170312|NCT05020899|Nicotine|nicotine|mesh-list
92170313|NCT05020899|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92170314|NCT05020899|Autonomic Agents|autonomic agents|mesh-ancestor
92170315|NCT05020899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170316|NCT05020899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170317|NCT05020899|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92170318|NCT05020899|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92170319|NCT05020899|Cholinergic Agents|cholinergic agents|mesh-ancestor
92170320|NCT05020899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170321|NCT05020899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170322|NCT05017246|Lidocaine|lidocaine|mesh-list
92170323|NCT05017246|Morphine|morphine|mesh-list
92170324|NCT05017246|Bupivacaine|bupivacaine|mesh-list
92170325|NCT05017246|Anesthetics, Local|anesthetics, local|mesh-ancestor
92170326|NCT05017246|Anesthetics|anesthetics|mesh-ancestor
92170327|NCT05017246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170328|NCT05017246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170329|NCT05017246|Sensory System Agents|sensory system agents|mesh-ancestor
92170330|NCT05017246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311867|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92170331|NCT05017246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92170332|NCT05017246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92170333|NCT05017246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92170334|NCT05017246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92327620|NCT00003092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92170335|NCT05017246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170336|NCT05017246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92170337|NCT05017246|Narcotics|narcotics|mesh-ancestor
92170338|NCT05017246|Analgesics|analgesics|mesh-ancestor
92170339|NCT05017025|Osimertinib|osimertinib|mesh-list
92170340|NCT05017025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170341|NCT05017025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170342|NCT05017025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170343|NCT05017025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170344|NCT05007041|Vaccines|vaccines|mesh-list
92170345|NCT05007041|Immunologic Factors|immunologic factors|mesh-ancestor
92170346|NCT05007041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170347|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92170348|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170349|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92170350|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170351|NCT05001555|Analgesics|analgesics|mesh-ancestor
92170352|NCT05001555|Sensory System Agents|sensory system agents|mesh-ancestor
92170353|NCT05001555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170354|NCT05001555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92170355|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170356|NCT04995003|Pembrolizumab|pembrolizumab|mesh-list
92170357|NCT04995003|Nivolumab|nivolumab|mesh-list
92170358|NCT04995003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92170359|NCT04995003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170360|NCT04995003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170361|NCT04995003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403352|NCT04425902|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92170363|NCT04983888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170364|NCT04983888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170366|NCT04978675|Cariostatic Agents|cariostatic agents|mesh-ancestor
92170367|NCT04978675|Protective Agents|protective agents|mesh-ancestor
92170368|NCT04978675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170369|NCT04977024|Vaccines|vaccines|mesh-list
92170370|NCT04977024|Immunologic Factors|immunologic factors|mesh-ancestor
92170371|NCT04977024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170372|NCT04960709|Durvalumab|durvalumab|mesh-list
92170373|NCT04960709|Tremelimumab|tremelimumab|mesh-list
92170374|NCT04960709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170375|NCT04960709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170376|NCT04935177|Antibodies|antibodies|mesh-list
92170377|NCT04935177|Immunoglobulins|immunoglobulins|mesh-list
92170378|NCT04935177|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92170379|NCT04935177|gamma-Globulins|gamma-globulins|mesh-list
92170380|NCT04935177|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92170381|NCT04935177|Eculizumab|eculizumab|mesh-list
92170382|NCT04935177|Immunologic Factors|immunologic factors|mesh-ancestor
92170383|NCT04935177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170384|NCT04935177|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92170385|NCT04935177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170386|NCT04884360|Olaparib|olaparib|mesh-list
92170387|NCT04884360|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92170388|NCT04884360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170389|NCT04884360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170390|NCT04884360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170391|NCT04883255|Dronabinol|dronabinol|mesh-list
92170392|NCT04883255|Cannabidiol|cannabidiol|mesh-list
92311971|NCT05444738|Oxytocin|oxytocin|mesh-list
92170393|NCT04883255|Anticonvulsants|anticonvulsants|mesh-ancestor
92170394|NCT04883255|Hallucinogens|hallucinogens|mesh-ancestor
92170395|NCT04883255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170396|NCT04883255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92170397|NCT04883255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170398|NCT04883255|Analgesics|analgesics|mesh-ancestor
92170399|NCT04883255|Sensory System Agents|sensory system agents|mesh-ancestor
92170400|NCT04883255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170401|NCT04883255|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92170402|NCT04883255|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92170403|NCT04883255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170404|NCT04883255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170405|NCT04883255|Hormones|hormones|mesh-ancestor
92170406|NCT04883255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170407|NCT04880850|Insulin|insulin|mesh-list
92170408|NCT04880850|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92170409|NCT04880850|Insulin Glargine|insulin glargine|mesh-list
92170410|NCT04880850|Insulin Aspart|insulin aspart|mesh-list
92170411|NCT04880850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92170412|NCT04880850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170413|NCT04874194|Venetoclax|venetoclax|mesh-list
92170414|NCT04874194|Homoharringtonine|homoharringtonine|mesh-list
92170415|NCT04874194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170416|NCT04874194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92170417|NCT04874194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92170418|NCT04874194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170419|NCT04874194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170430|NCT04790786|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92170431|NCT04790786|Antiviral Agents|antiviral agents|mesh-ancestor
92170432|NCT04790786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170434|NCT04786210|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92170435|NCT04786210|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92170436|NCT04786210|Fluorouracil|fluorouracil|mesh-list
92170437|NCT04786210|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92170438|NCT04786210|Antimetabolites|antimetabolites|mesh-ancestor
92170439|NCT04786210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170440|NCT04786210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170442|NCT04786210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170443|NCT04786210|Immunologic Factors|immunologic factors|mesh-ancestor
92170444|NCT04786210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170445|NCT04786210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92170446|NCT04786210|Glucocorticoids|glucocorticoids|mesh-ancestor
92170447|NCT04786210|Hormones|hormones|mesh-ancestor
92170448|NCT04786210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170449|NCT04786210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170450|NCT04785950|Levonorgestrel|levonorgestrel|mesh-list
92170451|NCT04785950|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92170452|NCT04785950|Contraceptive Agents|contraceptive agents|mesh-ancestor
92170453|NCT04785950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92170454|NCT04785950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170455|NCT04785950|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92170456|NCT04785950|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92170457|NCT04785950|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92170458|NCT04781855|Nivolumab|nivolumab|mesh-list
92170459|NCT04781855|Ipilimumab|ipilimumab|mesh-list
92312052|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170460|NCT04781855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170461|NCT04781855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170462|NCT04781855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170463|NCT04781855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170464|NCT04774393|Decitabine|decitabine|mesh-list
92170465|NCT04774393|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92170466|NCT04774393|Venetoclax|venetoclax|mesh-list
92170467|NCT04774393|Ivosidenib|ivosidenib|mesh-list
92170468|NCT04774393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170469|NCT04774393|Antimetabolites|antimetabolites|mesh-ancestor
92170470|NCT04774393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170471|NCT04774393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170472|NCT04774393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170473|NCT04743505|Osimertinib|osimertinib|mesh-list
92170474|NCT04743505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170475|NCT04743505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170476|NCT04743505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170477|NCT04743505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170487|NCT04729322|Metronidazole|metronidazole|mesh-list
92170488|NCT04729322|Vancomycin|vancomycin|mesh-list
92170489|NCT04729322|Neomycin|neomycin|mesh-list
92170490|NCT04729322|Pembrolizumab|pembrolizumab|mesh-list
92170491|NCT04729322|Nivolumab|nivolumab|mesh-list
92170492|NCT04729322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170493|NCT04729322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170494|NCT04729322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170495|NCT04729322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170496|NCT04729322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170497|NCT04729322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92170498|NCT04729322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92170499|NCT04729322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92170500|NCT04729322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92170501|NCT04729322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170502|NCT04724252|Gabapentin|gabapentin|mesh-list
92170503|NCT04724252|Analgesics|analgesics|mesh-ancestor
92170504|NCT04724252|Sensory System Agents|sensory system agents|mesh-ancestor
92170505|NCT04724252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170506|NCT04724252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170508|NCT04724252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92170509|NCT04724252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92170510|NCT04724252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170511|NCT04724252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92170512|NCT04724252|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92170513|NCT04724252|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92170514|NCT04724252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170515|NCT04724252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170516|NCT04724252|Antimanic Agents|antimanic agents|mesh-ancestor
92170517|NCT04683939|Paclitaxel|paclitaxel|mesh-list
92170518|NCT04683939|Gemcitabine|gemcitabine|mesh-list
92170519|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92170520|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170521|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
92170522|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
92170523|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
92170524|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170525|NCT04683939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170526|NCT04683939|Antimetabolites|antimetabolites|mesh-ancestor
92170527|NCT04677569|Azithromycin|azithromycin|mesh-list
92170528|NCT04677569|Amikacin|amikacin|mesh-list
92170529|NCT04677569|Ethambutol|ethambutol|mesh-list
92170530|NCT04677569|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92170531|NCT04677569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170532|NCT04677569|Antitubercular Agents|antitubercular agents|mesh-ancestor
92170533|NCT04670068|Cyclophosphamide|cyclophosphamide|mesh-list
92170534|NCT04670068|Fludarabine|fludarabine|mesh-list
92170535|NCT04670068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170536|NCT04670068|Immunologic Factors|immunologic factors|mesh-ancestor
92170537|NCT04670068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170538|NCT04670068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170539|NCT04670068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170540|NCT04670068|Alkylating Agents|alkylating agents|mesh-ancestor
92170541|NCT04670068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170542|NCT04670068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170543|NCT04670068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170544|NCT04645160|Tivozanib|tivozanib|mesh-list
92170545|NCT04645160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170546|NCT04645160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170547|NCT04645160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170548|NCT04622267|Anti-Infective Agents|anti-infective agents|mesh-list
92170549|NCT04622267|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92170550|NCT04618289|Vitamin D|vitamin d|mesh-list
92170551|NCT04618289|Cholecalciferol|cholecalciferol|mesh-list
92170552|NCT04618289|Vitamins|vitamins|mesh-ancestor
92170553|NCT04618289|Micronutrients|micronutrients|mesh-ancestor
92170554|NCT04618289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170555|NCT04618289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92170556|NCT04618289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92170557|NCT04617795|Insulin|insulin|mesh-list
92170558|NCT04617795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92170559|NCT04617795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170560|NCT04592237|Carboplatin|carboplatin|mesh-list
92170561|NCT04592237|Niraparib|niraparib|mesh-list
92312186|NCT00369044|Prednisone|prednisone|mesh-list
92170562|NCT04592237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170563|NCT04592237|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92170564|NCT04592237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170565|NCT04592237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170566|NCT04588441|Adenosine|adenosine|mesh-list
92170567|NCT04588441|Analgesics|analgesics|mesh-ancestor
92170568|NCT04588441|Sensory System Agents|sensory system agents|mesh-ancestor
92170569|NCT04588441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170570|NCT04588441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170571|NCT04588441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92170572|NCT04588441|Vasodilator Agents|vasodilator agents|mesh-ancestor
92170573|NCT04588441|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92170574|NCT04588441|Purinergic Agonists|purinergic agonists|mesh-ancestor
92170575|NCT04588441|Purinergic Agents|purinergic agents|mesh-ancestor
92170576|NCT04588441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170577|NCT04588441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170578|NCT04578015|Metronidazole|metronidazole|mesh-list
92170579|NCT04578015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170580|NCT04578015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92170581|NCT04578015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92170582|NCT04578015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92170583|NCT04555044|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92170584|NCT04555044|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92170585|NCT04555044|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92170586|NCT04555044|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92170587|NCT04534205|Pembrolizumab|pembrolizumab|mesh-list
92170588|NCT04534205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170589|NCT04534205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170590|NCT04534205|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170591|NCT04534205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170592|NCT04520451|Glucocorticoids|glucocorticoids|mesh-list
92170593|NCT04520451|Hormones|hormones|mesh-ancestor
92170594|NCT04520451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170595|NCT04520451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170597|NCT04510207|Immunologic Factors|immunologic factors|mesh-ancestor
92312229|NCT05438810|Fulvestrant|fulvestrant|mesh-list
92170598|NCT04510207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170600|NCT04494425|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92170601|NCT04494425|Capecitabine|capecitabine|mesh-list
92170602|NCT04494425|Trastuzumab|trastuzumab|mesh-list
92170603|NCT04494425|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92170604|NCT04494425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92170605|NCT04494425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170606|NCT04494425|Tubulin Modulators|tubulin modulators|mesh-ancestor
92170607|NCT04494425|Antimitotic Agents|antimitotic agents|mesh-ancestor
92170608|NCT04494425|Mitosis Modulators|mitosis modulators|mesh-ancestor
92170609|NCT04494425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170610|NCT04494425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170611|NCT04494425|Antimetabolites|antimetabolites|mesh-ancestor
92170612|NCT04494425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170613|NCT04494425|Immunoconjugates|immunoconjugates|mesh-ancestor
92170614|NCT04494425|Immunologic Factors|immunologic factors|mesh-ancestor
92170615|NCT04494425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170616|NCT04454658|Navitoclax|navitoclax|mesh-list
92170617|NCT04454658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170618|NCT04445519|Latanoprost|latanoprost|mesh-list
92170619|NCT04445519|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92170620|NCT04445519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92170621|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92170622|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
92170623|NCT04420585|Coagulants|coagulants|mesh-ancestor
92170624|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92170625|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
92170626|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170627|NCT04396860|Nivolumab|nivolumab|mesh-list
92170628|NCT04396860|Ipilimumab|ipilimumab|mesh-list
92170629|NCT04396860|Temozolomide|temozolomide|mesh-list
92170630|NCT04396860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170631|NCT04396860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170632|NCT04396860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170633|NCT04396860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170634|NCT04396860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170635|NCT04396860|Alkylating Agents|alkylating agents|mesh-ancestor
92170636|NCT04396496|Daratumumab|daratumumab|mesh-list
92170637|NCT04396496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170638|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92170639|NCT04354103|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92170640|NCT04354103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92170641|NCT04354103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170642|NCT04354103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170643|NCT04354103|Adrenergic Agents|adrenergic agents|mesh-ancestor
92170644|NCT04354103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170645|NCT04354103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170646|NCT04338204|Tofacitinib|tofacitinib|mesh-list
92170647|NCT04338204|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92170648|NCT04338204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170649|NCT04338204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170650|NCT04338204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170652|NCT04294225|Anastrozole|anastrozole|mesh-list
92170653|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170654|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92170655|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92170657|NCT04294225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170658|NCT04294225|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92170659|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
92170660|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170661|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170662|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92170663|NCT04279392|Zoledronic Acid|zoledronic acid|mesh-list
92170664|NCT04279392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92170665|NCT04279392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170666|NCT04268303|Dexmedetomidine|dexmedetomidine|mesh-list
92170667|NCT04268303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92170668|NCT04268303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170669|NCT04268303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170670|NCT04268303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170671|NCT04268303|Analgesics|analgesics|mesh-ancestor
92170672|NCT04268303|Sensory System Agents|sensory system agents|mesh-ancestor
92170673|NCT04268303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170674|NCT04268303|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92170675|NCT04268303|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92170676|NCT04268303|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92170677|NCT04268303|Adrenergic Agents|adrenergic agents|mesh-ancestor
92170678|NCT04268303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170679|NCT04268303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170680|NCT04267497|Amphotericin B|amphotericin b|mesh-list
92170681|NCT04267497|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92170682|NCT04267497|Amebicides|amebicides|mesh-ancestor
92170683|NCT04267497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92170684|NCT04267497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92312356|NCT04793659|Fasudil|fasudil|mesh-list
92170685|NCT04267497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170686|NCT04267497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92170687|NCT04267497|Antifungal Agents|antifungal agents|mesh-ancestor
92170688|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
92170689|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170690|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170691|NCT04266730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170692|NCT04266730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170694|NCT04263831|Interleukin-2|interleukin-2|mesh-list
92170695|NCT04263831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170696|NCT04263831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92170697|NCT04263831|Analgesics|analgesics|mesh-ancestor
92170698|NCT04263831|Sensory System Agents|sensory system agents|mesh-ancestor
92170699|NCT04263831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170700|NCT04263831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170701|NCT04263831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92170702|NCT04263831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92170703|NCT04263831|Antiviral Agents|antiviral agents|mesh-ancestor
92170704|NCT04263831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170705|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
92170706|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170707|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170708|NCT04260529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170709|NCT04260529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170710|NCT04249687|Botulinum Toxins|botulinum toxins|mesh-list
92170711|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92170712|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170713|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170714|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
92170715|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170716|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170717|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
92170718|NCT04249583|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92170719|NCT04249583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170720|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170721|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
92170722|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170723|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170725|NCT04239092|Temozolomide|temozolomide|mesh-list
92170726|NCT04239092|Irinotecan|irinotecan|mesh-list
92170727|NCT04239092|Topotecan|topotecan|mesh-list
92170728|NCT04239092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170729|NCT04239092|Immunologic Factors|immunologic factors|mesh-ancestor
92170730|NCT04239092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170731|NCT04239092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170732|NCT04239092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170733|NCT04239092|Alkylating Agents|alkylating agents|mesh-ancestor
92170734|NCT04239092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170735|NCT04239092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170736|NCT04239092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170737|NCT04239092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92170738|NCT04239092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92170739|NCT04239092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170741|NCT04225260|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92403376|NCT04425902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92170742|NCT04225260|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92170743|NCT04225260|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92170744|NCT04225260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170745|NCT04225260|Cholinergic Agents|cholinergic agents|mesh-ancestor
92170746|NCT04225260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170747|NCT04224740|Cisplatin|cisplatin|mesh-list
92170748|NCT04224740|Carboplatin|carboplatin|mesh-list
92170749|NCT04224740|Pembrolizumab|pembrolizumab|mesh-list
92170750|NCT04224740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170751|NCT04224740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170752|NCT04224740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170753|NCT04224740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170754|NCT04223765|Cyclophosphamide|cyclophosphamide|mesh-list
92170755|NCT04223765|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92170756|NCT04223765|Fludarabine|fludarabine|mesh-list
92170757|NCT04223765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170758|NCT04223765|Immunologic Factors|immunologic factors|mesh-ancestor
92170759|NCT04223765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170760|NCT04223765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170761|NCT04223765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170762|NCT04223765|Alkylating Agents|alkylating agents|mesh-ancestor
92170763|NCT04223765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170764|NCT04223765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170765|NCT04223765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170766|NCT04205227|Pembrolizumab|pembrolizumab|mesh-list
92170767|NCT04205227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170768|NCT04205227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170769|NCT04205227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170770|NCT04205227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170771|NCT04159155|Paclitaxel|paclitaxel|mesh-list
92170772|NCT04159155|Carboplatin|carboplatin|mesh-list
92170773|NCT04159155|Niraparib|niraparib|mesh-list
92170774|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92170775|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170776|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
92170777|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
92170778|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
92170779|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170780|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92170781|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170782|NCT04141696|Midazolam|midazolam|mesh-list
92170783|NCT04141696|Ketamine|ketamine|mesh-list
92170784|NCT04141696|Analgesics|analgesics|mesh-ancestor
92170785|NCT04141696|Sensory System Agents|sensory system agents|mesh-ancestor
92170786|NCT04141696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170787|NCT04141696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170788|NCT04141696|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92170789|NCT04141696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92170790|NCT04141696|Anesthetics, General|anesthetics, general|mesh-ancestor
92170791|NCT04141696|Anesthetics|anesthetics|mesh-ancestor
92170792|NCT04141696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170793|NCT04141696|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92170794|NCT04141696|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92170795|NCT04141696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92170796|NCT04141696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170797|NCT04141696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92170798|NCT04141696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92170799|NCT04141696|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92170800|NCT04141696|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92170801|NCT04141696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92170802|NCT04141696|GABA Modulators|gaba modulators|mesh-ancestor
92170803|NCT04141696|GABA Agents|gaba agents|mesh-ancestor
92170804|NCT04117074|Bupivacaine|bupivacaine|mesh-list
92170805|NCT04117074|Anesthetics, Local|anesthetics, local|mesh-ancestor
92170806|NCT04117074|Anesthetics|anesthetics|mesh-ancestor
92170807|NCT04117074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92170808|NCT04117074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170809|NCT04117074|Sensory System Agents|sensory system agents|mesh-ancestor
92170810|NCT04117074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170811|NCT04108858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92170812|NCT04108858|Trastuzumab|trastuzumab|mesh-list
92170813|NCT04108858|Pertuzumab|pertuzumab|mesh-list
92170814|NCT04108858|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92170815|NCT04108858|Antibodies|antibodies|mesh-list
92170816|NCT04108858|Immunoglobulins|immunoglobulins|mesh-list
92170817|NCT04108858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92170818|NCT04108858|Immunologic Factors|immunologic factors|mesh-ancestor
92170819|NCT04108858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170820|NCT04108858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170822|NCT04094675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92170823|NCT04094675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170824|NCT04094675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170825|NCT04094675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170826|NCT04094675|Antifungal Agents|antifungal agents|mesh-ancestor
92170827|NCT04094675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170828|NCT04094675|Immunologic Factors|immunologic factors|mesh-ancestor
92170829|NCT04094675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170830|NCT04092452|PF-06700841|pf-06700841|mesh-list
92404044|NCT01428492|Glucocorticoids|glucocorticoids|mesh-ancestor
92170831|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170832|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170833|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170834|NCT04074746|Vidarabine|vidarabine|mesh-list
92170835|NCT04074746|Cyclophosphamide|cyclophosphamide|mesh-list
92170836|NCT04074746|Fludarabine|fludarabine|mesh-list
92170837|NCT04074746|Fludarabine phosphate|fludarabine phosphate|mesh-list
92170838|NCT04074746|Antibodies|antibodies|mesh-list
92170839|NCT04074746|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92170840|NCT04074746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170841|NCT04074746|Immunologic Factors|immunologic factors|mesh-ancestor
92170842|NCT04074746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170843|NCT04074746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170844|NCT04074746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170845|NCT04074746|Alkylating Agents|alkylating agents|mesh-ancestor
92170846|NCT04074746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170847|NCT04074746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170848|NCT04074746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170849|NCT04074746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170851|NCT04074746|Antiviral Agents|antiviral agents|mesh-ancestor
92170852|NCT04074746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170853|NCT04047641|Cytarabine|cytarabine|mesh-list
92170854|NCT04047641|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92170855|NCT04047641|Idarubicin|idarubicin|mesh-list
92170856|NCT04047641|Cladribine|cladribine|mesh-list
92170857|NCT04047641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92170858|NCT04047641|Antimetabolites|antimetabolites|mesh-ancestor
92170859|NCT04047641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170860|NCT04047641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170861|NCT04047641|Antiviral Agents|antiviral agents|mesh-ancestor
92170862|NCT04047641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404117|NCT01429025|Growth Substances|growth substances|mesh-ancestor
92170863|NCT04047641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170864|NCT04047641|Immunologic Factors|immunologic factors|mesh-ancestor
92170865|NCT04047641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170866|NCT04047641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170867|NCT04047641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92170868|NCT04047641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92170869|NCT04047641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170870|NCT04046614|Nivolumab|nivolumab|mesh-list
92170871|NCT04046614|Nintedanib|nintedanib|mesh-list
92170872|NCT04046614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170873|NCT04046614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404252|NCT01429818|Metformin|metformin|mesh-list
92170874|NCT04046614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92170875|NCT04046614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170876|NCT04046614|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170877|NCT04046614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170878|NCT04029116|Fluconazole|fluconazole|mesh-list
92170879|NCT04029116|Ibrexafungerp|ibrexafungerp|mesh-list
92170880|NCT04029116|Antifungal Agents|antifungal agents|mesh-ancestor
92170881|NCT04029116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170882|NCT04029116|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92170883|NCT04029116|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92170884|NCT04029116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170885|NCT04029116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170886|NCT04029116|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92170887|NCT04029116|Hormone Antagonists|hormone antagonists|mesh-ancestor
92170888|NCT04029116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404440|NCT01431118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170889|NCT04029116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170890|NCT04029116|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92170891|NCT04029116|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92170892|NCT04025489|Vitamin D|vitamin d|mesh-list
92170893|NCT04025489|Vitamins|vitamins|mesh-ancestor
92170894|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
92170895|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170896|NCT04025489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92170898|NCT04002947|Acalabrutinib|acalabrutinib|mesh-list
92170899|NCT04002947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92170900|NCT04002947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170901|NCT04002947|Immunologic Factors|immunologic factors|mesh-ancestor
92404811|NCT01432665|Hormones|hormones|mesh-ancestor
92170902|NCT04002947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170903|NCT04002947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170904|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
92170905|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
92404889|NCT01433614|Paclitaxel|paclitaxel|mesh-list
92170906|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92170907|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
92170908|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92404966|NCT01434017|Antipruritics|antipruritics|mesh-ancestor
92170909|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92170910|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170911|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92170912|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170913|NCT03998839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170914|NCT03998839|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92405113|NCT01434381|Antacids|antacids|mesh-ancestor
92170915|NCT03983850|Mycophenolic Acid|mycophenolic acid|mesh-list
92170916|NCT03983850|Sirolimus|sirolimus|mesh-list
92170917|NCT03983850|Cyclophosphamide|cyclophosphamide|mesh-list
92170918|NCT03983850|Busulfan|busulfan|mesh-list
92170919|NCT03983850|Fludarabine|fludarabine|mesh-list
92170920|NCT03983850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92170921|NCT03983850|Immunologic Factors|immunologic factors|mesh-ancestor
92170922|NCT03983850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170923|NCT03983850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92170924|NCT03983850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92170925|NCT03983850|Alkylating Agents|alkylating agents|mesh-ancestor
92170926|NCT03983850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170927|NCT03983850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170928|NCT03983850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92170929|NCT03983850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170930|NCT03983850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92170932|NCT03983850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92170933|NCT03983850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099685|NCT03902418|Tenofovir|tenofovir|mesh-list
92170934|NCT03983850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170935|NCT03983850|Antifungal Agents|antifungal agents|mesh-ancestor
92170936|NCT03962894|Prednisolone|prednisolone|mesh-list
92170937|NCT03962894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92170938|NCT03962894|Glucocorticoids|glucocorticoids|mesh-ancestor
92170939|NCT03962894|Hormones|hormones|mesh-ancestor
92170940|NCT03962894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170941|NCT03962894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170942|NCT03962894|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099771|NCT03831321|Diclofenac|diclofenac|mesh-list
92170943|NCT03962894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170944|NCT03959488|Palivizumab|palivizumab|mesh-list
92170945|NCT03959488|Antiviral Agents|antiviral agents|mesh-ancestor
92170946|NCT03959488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92170947|NCT03946878|Venetoclax|venetoclax|mesh-list
92170948|NCT03946878|Acalabrutinib|acalabrutinib|mesh-list
92170949|NCT03946878|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92170950|NCT03946878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170951|NCT03946878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92170952|NCT03946878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099968|NCT01339858|Acetylcysteine|acetylcysteine|mesh-list
92170953|NCT03946878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100042|NCT01247272|Fluoxetine|fluoxetine|mesh-list
92170954|NCT03926026|Fluticasone|fluticasone|mesh-list
92170955|NCT03926026|Xhance|xhance|mesh-list
92170956|NCT03926026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312761|NCT03737461|Lidocaine|lidocaine|mesh-list
92100107|NCT01928511|Entecavir|entecavir|mesh-list
92170957|NCT03926026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92170958|NCT03926026|Autonomic Agents|autonomic agents|mesh-ancestor
92170959|NCT03926026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92170960|NCT03926026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170961|NCT03926026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92100181|NCT01929603|Rifampin|rifampin|mesh-list
92170962|NCT03926026|Respiratory System Agents|respiratory system agents|mesh-ancestor
92170963|NCT03926026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92170964|NCT03926026|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92170966|NCT03917082|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92170967|NCT03917082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92170968|NCT03917082|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92100251|NCT01925937|Vitamins|vitamins|mesh-ancestor
92170969|NCT03917082|Hormone Antagonists|hormone antagonists|mesh-ancestor
92170970|NCT03917082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92170971|NCT03917082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170972|NCT03917082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92170973|NCT03917082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170974|NCT03917082|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92170975|NCT03917082|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92170976|NCT03917082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92100400|NCT03423030|Macozinone|macozinone|mesh-list
92170977|NCT03917082|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92170979|NCT03907488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92170980|NCT03907488|Nivolumab|nivolumab|mesh-list
92170981|NCT03907488|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92170983|NCT03907488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92170984|NCT03907488|Dacarbazine|dacarbazine|mesh-list
92170985|NCT03907488|Vinblastine|vinblastine|mesh-list
92170986|NCT03907488|Antibodies|antibodies|mesh-list
92170987|NCT03907488|Immunoglobulins|immunoglobulins|mesh-list
92170988|NCT03907488|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92170989|NCT03907488|Lenograstim|lenograstim|mesh-list
92170990|NCT03907488|Imidazole|imidazole|mesh-list
92170991|NCT03907488|Immunoconjugates|immunoconjugates|mesh-list
92170992|NCT03907488|Immunologic Factors|immunologic factors|mesh-ancestor
92170993|NCT03907488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92170994|NCT03907488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92170995|NCT03907488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92170996|NCT03907488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92100688|NCT03425994|Cobicistat|cobicistat|mesh-list
92100754|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
92170997|NCT03907488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92100829|NCT05604261|Rabeprazole|rabeprazole|mesh-list
92170998|NCT03907488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92170999|NCT03907488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171000|NCT03907488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171001|NCT03907488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92171002|NCT03907488|Immunotoxins|immunotoxins|mesh-ancestor
92100971|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92171003|NCT03907488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171004|NCT03907488|Alkylating Agents|alkylating agents|mesh-ancestor
92312858|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171005|NCT03907488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171006|NCT03907488|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171007|NCT03907488|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171008|NCT03907488|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171009|NCT03875690|Methylprednisolone|methylprednisolone|mesh-list
92171010|NCT03875690|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92171011|NCT03875690|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92171012|NCT03875690|Prednisolone|prednisolone|mesh-list
92171013|NCT03875690|Prednisolone acetate|prednisolone acetate|mesh-list
92171014|NCT03875690|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92171015|NCT03875690|Prednisolone phosphate|prednisolone phosphate|mesh-list
92171016|NCT03875690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171017|NCT03875690|Antiemetics|antiemetics|mesh-ancestor
92171018|NCT03875690|Autonomic Agents|autonomic agents|mesh-ancestor
92171019|NCT03875690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171020|NCT03875690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171021|NCT03875690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92171022|NCT03875690|Glucocorticoids|glucocorticoids|mesh-ancestor
92171023|NCT03875690|Hormones|hormones|mesh-ancestor
92101171|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92171024|NCT03875690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171025|NCT03875690|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92171026|NCT03875690|Protective Agents|protective agents|mesh-ancestor
92171027|NCT03875690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92101316|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101393|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92171028|NCT03875690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171029|NCT03856216|Rituximab|rituximab|mesh-list
92171030|NCT03856216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92171031|NCT03856216|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92171032|NCT03856216|Methotrexate|methotrexate|mesh-list
92171033|NCT03856216|Fludarabine|fludarabine|mesh-list
92171034|NCT03856216|Melphalan|melphalan|mesh-list
92171035|NCT03856216|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92171036|NCT03856216|Mechlorethamine|mechlorethamine|mesh-list
92171037|NCT03856216|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92171038|NCT03856216|Antibodies|antibodies|mesh-list
92171039|NCT03856216|Immunoglobulins|immunoglobulins|mesh-list
92171040|NCT03856216|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92171041|NCT03856216|Lenograstim|lenograstim|mesh-list
92171042|NCT03856216|Tacrolimus|tacrolimus|mesh-list
92171043|NCT03856216|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92171044|NCT03856216|Immunologic Factors|immunologic factors|mesh-ancestor
92171045|NCT03856216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171046|NCT03856216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171047|NCT03856216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101681|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92171048|NCT03856216|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92171049|NCT03856216|Abortifacient Agents|abortifacient agents|mesh-ancestor
92171050|NCT03856216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92171051|NCT03856216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171052|NCT03856216|Antimetabolites|antimetabolites|mesh-ancestor
92171053|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171054|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171055|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171056|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92171057|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171058|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171059|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92171060|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92171061|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171062|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
92171063|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171064|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92171065|NCT03856216|Immunotoxins|immunotoxins|mesh-ancestor
92171066|NCT03856216|Immunoconjugates|immunoconjugates|mesh-ancestor
92171067|NCT03834493|Pembrolizumab|pembrolizumab|mesh-list
92171068|NCT03834493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171069|NCT03834493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171070|NCT03834493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171071|NCT03834493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171072|NCT03829254|Pembrolizumab|pembrolizumab|mesh-list
92171073|NCT03829254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171074|NCT03829254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171075|NCT03829254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171076|NCT03829254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171077|NCT03808610|Cytarabine|cytarabine|mesh-list
92171078|NCT03808610|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
92171079|NCT03808610|Dexamethasone|dexamethasone|mesh-list
92171080|NCT03808610|Dexamethasone acetate|dexamethasone acetate|mesh-list
92171081|NCT03808610|Prednisone|prednisone|mesh-list
92171082|NCT03808610|Cortisone|cortisone|mesh-list
92171083|NCT03808610|Cyclophosphamide|cyclophosphamide|mesh-list
92171084|NCT03808610|Rituximab|rituximab|mesh-list
92171085|NCT03808610|Methotrexate|methotrexate|mesh-list
92171086|NCT03808610|Vincristine|vincristine|mesh-list
92171087|NCT03808610|Venetoclax|venetoclax|mesh-list
92171088|NCT03808610|Asparaginase|asparaginase|mesh-list
92171089|NCT03808610|Pegaspargase|pegaspargase|mesh-list
92171090|NCT03808610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92171091|NCT03808610|Antibodies|antibodies|mesh-list
92171092|NCT03808610|Immunoglobulins|immunoglobulins|mesh-list
92171093|NCT03808610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92171094|NCT03808610|BB 1101|bb 1101|mesh-list
92171095|NCT03808610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171096|NCT03808610|Immunologic Factors|immunologic factors|mesh-ancestor
92171102|NCT03808610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171103|NCT03808610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171104|NCT03808610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171105|NCT03808610|Antiemetics|antiemetics|mesh-ancestor
92171106|NCT03808610|Autonomic Agents|autonomic agents|mesh-ancestor
92171107|NCT03808610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171108|NCT03808610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92171109|NCT03808610|Glucocorticoids|glucocorticoids|mesh-ancestor
92171110|NCT03808610|Hormones|hormones|mesh-ancestor
92171111|NCT03808610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171112|NCT03808610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92171113|NCT03808610|Protease Inhibitors|protease inhibitors|mesh-ancestor
92171114|NCT03808610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171115|NCT03808610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92171116|NCT03808610|Abortifacient Agents|abortifacient agents|mesh-ancestor
92171117|NCT03808610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92171118|NCT03808610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171119|NCT03808610|Antimetabolites|antimetabolites|mesh-ancestor
92171120|NCT03808610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171121|NCT03808610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92171122|NCT03808610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171123|NCT03808610|Antiviral Agents|antiviral agents|mesh-ancestor
92171124|NCT03808610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171125|NCT03808610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171126|NCT03808610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171127|NCT03808610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171128|NCT03808610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171130|NCT03774446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171131|NCT03774446|Antiviral Agents|antiviral agents|mesh-ancestor
92171132|NCT03774446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171133|NCT03774446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92171134|NCT03774446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171135|NCT03774446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171141|NCT03739996|Cabotegravir|cabotegravir|mesh-list
92171142|NCT03739996|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92171143|NCT03739996|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92171144|NCT03739996|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92171145|NCT03739996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171146|NCT03739996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171147|NCT03739996|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92171148|NCT03739996|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92171149|NCT03739996|Antiviral Agents|antiviral agents|mesh-ancestor
92171150|NCT03739996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171151|NCT03739996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171152|NCT03734029|Paclitaxel|paclitaxel|mesh-list
92171153|NCT03734029|Camptothecin|camptothecin|mesh-list
92171154|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92171155|NCT03734029|Gemcitabine|gemcitabine|mesh-list
92171156|NCT03734029|Capecitabine|capecitabine|mesh-list
92171157|NCT03734029|Trastuzumab|trastuzumab|mesh-list
92171158|NCT03734029|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92171159|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
92171160|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171161|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171162|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171163|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171164|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171165|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171166|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171167|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
92171168|NCT03734029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171169|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
92171170|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171171|NCT03734029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92171172|NCT03734029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171173|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171174|NCT03732820|Olaparib|olaparib|mesh-list
92171175|NCT03732820|Abiraterone Acetate|abiraterone acetate|mesh-list
92171176|NCT03732820|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92171177|NCT03732820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171178|NCT03732820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171179|NCT03732820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171180|NCT03732820|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92171181|NCT03732820|Hormone Antagonists|hormone antagonists|mesh-ancestor
92171182|NCT03732820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171183|NCT03732820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171184|NCT03732820|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92171185|NCT03732677|Gemcitabine|gemcitabine|mesh-list
92171186|NCT03732677|Durvalumab|durvalumab|mesh-list
92171187|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171188|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171189|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
92171190|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171191|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171192|NCT03721068|Cyclophosphamide|cyclophosphamide|mesh-list
92171194|NCT03721068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171195|NCT03721068|Immunologic Factors|immunologic factors|mesh-ancestor
92171196|NCT03721068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171197|NCT03721068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171198|NCT03721068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171199|NCT03721068|Alkylating Agents|alkylating agents|mesh-ancestor
92171200|NCT03721068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171201|NCT03721068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171202|NCT03721068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171203|NCT03711058|Nivolumab|nivolumab|mesh-list
92171204|NCT03711058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171205|NCT03711058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171206|NCT03711058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171207|NCT03711058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171209|NCT03710772|Dexamethasone|dexamethasone|mesh-list
92171210|NCT03710772|Dexamethasone acetate|dexamethasone acetate|mesh-list
92171211|NCT03710772|Cyclophosphamide|cyclophosphamide|mesh-list
92171212|NCT03710772|Rituximab|rituximab|mesh-list
92171213|NCT03710772|Doxorubicin|doxorubicin|mesh-list
92171214|NCT03710772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92171215|NCT03710772|Methotrexate|methotrexate|mesh-list
92171216|NCT03710772|Vincristine|vincristine|mesh-list
92171217|NCT03710772|Venetoclax|venetoclax|mesh-list
92171218|NCT03710772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92171219|NCT03710772|Antibodies|antibodies|mesh-list
92171220|NCT03710772|Immunoglobulins|immunoglobulins|mesh-list
92171221|NCT03710772|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92171222|NCT03710772|BB 1101|bb 1101|mesh-list
92313205|NCT04337606|Decitabine|decitabine|mesh-list
92171223|NCT03710772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171224|NCT03710772|Immunologic Factors|immunologic factors|mesh-ancestor
92171225|NCT03710772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171226|NCT03710772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171227|NCT03710772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171228|NCT03710772|Alkylating Agents|alkylating agents|mesh-ancestor
92171229|NCT03710772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171230|NCT03710772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171231|NCT03710772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171232|NCT03710772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171234|NCT03710772|Autonomic Agents|autonomic agents|mesh-ancestor
92171235|NCT03710772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171236|NCT03710772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92171237|NCT03710772|Glucocorticoids|glucocorticoids|mesh-ancestor
92171238|NCT03710772|Hormones|hormones|mesh-ancestor
92171239|NCT03710772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171240|NCT03710772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92171241|NCT03710772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92171242|NCT03710772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171243|NCT03710772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92171244|NCT03710772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92171245|NCT03710772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171246|NCT03710772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92101940|NCT01390246|Bupropion|bupropion|mesh-list
92171247|NCT03710772|Abortifacient Agents|abortifacient agents|mesh-ancestor
92171248|NCT03710772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92171249|NCT03710772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171250|NCT03710772|Antimetabolites|antimetabolites|mesh-ancestor
92171251|NCT03710772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171252|NCT03710772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92171253|NCT03710772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171254|NCT03710772|Antiviral Agents|antiviral agents|mesh-ancestor
92171255|NCT03710772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171256|NCT03710772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171257|NCT03710772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171258|NCT03710772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171259|NCT03710772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171260|NCT03705962|Tobramycin|tobramycin|mesh-list
92171261|NCT03705962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92171262|NCT03705962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171263|NCT03693183|Ketorolac|ketorolac|mesh-list
92171264|NCT03693183|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92171265|NCT03693183|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92171266|NCT03693183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92171267|NCT03693183|Analgesics|analgesics|mesh-ancestor
92171268|NCT03693183|Sensory System Agents|sensory system agents|mesh-ancestor
92171269|NCT03693183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171270|NCT03693183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171271|NCT03693183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171272|NCT03693183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171273|NCT03693183|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92171274|NCT03693183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171275|NCT03693183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171276|NCT03679650|Decitabine|decitabine|mesh-list
92171277|NCT03679650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171278|NCT03679650|Antimetabolites|antimetabolites|mesh-ancestor
92171279|NCT03679650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171280|NCT03679650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171281|NCT03679650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171283|NCT03672539|Daunorubicin|daunorubicin|mesh-list
92171284|NCT03672539|Gemtuzumab|gemtuzumab|mesh-list
92171285|NCT03672539|Calicheamicins|calicheamicins|mesh-list
92171286|NCT03672539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171287|NCT03672539|Antimetabolites|antimetabolites|mesh-ancestor
92171288|NCT03672539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171289|NCT03672539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171290|NCT03672539|Antiviral Agents|antiviral agents|mesh-ancestor
92171291|NCT03672539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171292|NCT03672539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171293|NCT03672539|Immunologic Factors|immunologic factors|mesh-ancestor
92171294|NCT03672539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171295|NCT03672539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92171296|NCT03672539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92171297|NCT03672539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171298|NCT03672539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171299|NCT03672539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171300|NCT03672539|Immunotoxins|immunotoxins|mesh-ancestor
92171301|NCT03672539|Immunoconjugates|immunoconjugates|mesh-ancestor
92171302|NCT03661307|Decitabine|decitabine|mesh-list
92171303|NCT03661307|Venetoclax|venetoclax|mesh-list
92102349|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92171304|NCT03661307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171305|NCT03661307|Antimetabolites|antimetabolites|mesh-ancestor
92102454|NCT03399708|Apremilast|apremilast|mesh-list
92171306|NCT03661307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171307|NCT03661307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171308|NCT03661307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171309|NCT03657797|Latanoprost|latanoprost|mesh-list
92171310|NCT03657797|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92171311|NCT03657797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92171312|NCT03631043|Lenalidomide|lenalidomide|mesh-list
92171313|NCT03631043|Vaccines|vaccines|mesh-list
92171314|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
92171315|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171316|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92102646|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92171317|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92171318|NCT03631043|Growth Substances|growth substances|mesh-ancestor
92171319|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92171320|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171321|NCT03616886|Paclitaxel|paclitaxel|mesh-list
92171328|NCT03616886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171329|NCT03616886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171330|NCT03616886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171332|NCT03610711|Relatlimab|relatlimab|mesh-list
92171333|NCT03610711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171334|NCT03610711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171335|NCT03610711|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171336|NCT03610711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171337|NCT03595124|Nivolumab|nivolumab|mesh-list
92171338|NCT03595124|Axitinib|axitinib|mesh-list
92171339|NCT03595124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171340|NCT03595124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171341|NCT03595124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171342|NCT03595124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171343|NCT03595124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92171344|NCT03595124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103009|NCT03125772|Paclitaxel|paclitaxel|mesh-list
92171350|NCT03579446|Oxymorphone|oxymorphone|mesh-list
92171351|NCT03579446|Morphine|morphine|mesh-list
92171352|NCT03579446|Oxycodone|oxycodone|mesh-list
92171353|NCT03579446|Hydromorphone|hydromorphone|mesh-list
92171354|NCT03579446|Hydrocodone|hydrocodone|mesh-list
92171356|NCT03579446|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92171357|NCT03579446|Narcotics|narcotics|mesh-ancestor
92171358|NCT03579446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92171359|NCT03579446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171361|NCT03579446|Sensory System Agents|sensory system agents|mesh-ancestor
92171362|NCT03579446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171363|NCT03579446|Antitussive Agents|antitussive agents|mesh-ancestor
92171364|NCT03579446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92171365|NCT03579446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92171366|NCT03546361|Pembrolizumab|pembrolizumab|mesh-list
92171367|NCT03546361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171368|NCT03546361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171369|NCT03546361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171370|NCT03546361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171371|NCT03534804|Pembrolizumab|pembrolizumab|mesh-list
92171372|NCT03534804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171373|NCT03534804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171374|NCT03534804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171375|NCT03534804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171376|NCT03473574|Gemcitabine|gemcitabine|mesh-list
92171377|NCT03473574|Durvalumab|durvalumab|mesh-list
92171378|NCT03473574|Tremelimumab|tremelimumab|mesh-list
92171379|NCT03473574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171380|NCT03473574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171381|NCT03473574|Antimetabolites|antimetabolites|mesh-ancestor
92103413|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
92171382|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171383|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171384|NCT03472040|Berotralstat|berotralstat|mesh-list
92171385|NCT03472040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92103507|NCT03389958|Copper|copper|mesh-list
92171386|NCT03472040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92171387|NCT03472040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171388|NCT03472040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103711|NCT05173584|Albuterol|albuterol|mesh-list
92171389|NCT03452137|Atezolizumab|atezolizumab|mesh-list
92171390|NCT03452137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171391|NCT03452137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171392|NCT03452137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171393|NCT03452137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171394|NCT03428126|Durvalumab|durvalumab|mesh-list
92171395|NCT03428126|Trametinib|trametinib|mesh-list
92171396|NCT03428126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171397|NCT03428126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171398|NCT03428126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92171399|NCT03428126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171400|NCT03428126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171401|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
92171402|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
92171403|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171404|NCT03416530|TIC10 compound|tic10 compound|mesh-list
92171405|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171406|NCT03367871|Paclitaxel|paclitaxel|mesh-list
92171407|NCT03367871|Bevacizumab|bevacizumab|mesh-list
92171408|NCT03367871|Carboplatin|carboplatin|mesh-list
92171409|NCT03367871|Pembrolizumab|pembrolizumab|mesh-list
92171410|NCT03367871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171411|NCT03367871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171412|NCT03367871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171413|NCT03367871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92103986|NCT02968446|Vitamin D|vitamin d|mesh-list
92171414|NCT03367871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171415|NCT03367871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171416|NCT03367871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171417|NCT03367871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92171418|NCT03367871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92171419|NCT03367871|Growth Substances|growth substances|mesh-ancestor
92171420|NCT03367871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171421|NCT03367871|Growth Inhibitors|growth inhibitors|mesh-ancestor
92171422|NCT03367871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171424|NCT03366142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171425|NCT03345810|Paclitaxel|paclitaxel|mesh-list
92171426|NCT03345810|Vinorelbine|vinorelbine|mesh-list
92171427|NCT03345810|Carboplatin|carboplatin|mesh-list
92171428|NCT03345810|Gemcitabine|gemcitabine|mesh-list
92171429|NCT03345810|Durvalumab|durvalumab|mesh-list
92171430|NCT03345810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171431|NCT03345810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171432|NCT03345810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171433|NCT03345810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171434|NCT03345810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92104271|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92171435|NCT03345810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171436|NCT03345810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171437|NCT03345810|Antimetabolites|antimetabolites|mesh-ancestor
92171438|NCT03345810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171439|NCT03344965|Olaparib|olaparib|mesh-list
92171440|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92171441|NCT03344965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171442|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171445|NCT03323385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92104484|NCT01585324|Ribavirin|ribavirin|mesh-list
92171446|NCT03323385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92171447|NCT03323385|Analgesics|analgesics|mesh-ancestor
92171448|NCT03323385|Sensory System Agents|sensory system agents|mesh-ancestor
92171449|NCT03323385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171450|NCT03323385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171451|NCT03323385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171452|NCT03323385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171453|NCT03323385|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92171454|NCT03323385|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92171455|NCT03323385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104620|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171456|NCT03323385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171457|NCT03298451|Sorafenib|sorafenib|mesh-list
92171458|NCT03298451|Durvalumab|durvalumab|mesh-list
92171459|NCT03298451|Tremelimumab|tremelimumab|mesh-list
92171460|NCT03298451|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92171461|NCT03298451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171462|NCT03298451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92171464|NCT03298451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171465|NCT03298451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171466|NCT03298451|Immunologic Factors|immunologic factors|mesh-ancestor
92171467|NCT03298451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171468|NCT03295396|TIC10 compound|tic10 compound|mesh-list
92171469|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171470|NCT03278782|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92171525|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
92171526|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171527|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
92171528|NCT03223610|Hormones|hormones|mesh-ancestor
92171529|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171530|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171531|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92171532|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171533|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
92171534|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92171535|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92105054|NCT03361800|Entinostat|entinostat|mesh-list
92171536|NCT03223610|Growth Substances|growth substances|mesh-ancestor
92171537|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92171538|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171539|NCT03217747|Avelumab|avelumab|mesh-list
92171540|NCT03217747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92171541|NCT03217747|Immunoglobulin G|immunoglobulin g|mesh-list
92171542|NCT03217747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171543|NCT03217747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171544|NCT03217747|Immunologic Factors|immunologic factors|mesh-ancestor
92171545|NCT03217747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171546|NCT03215719|Cisplatin|cisplatin|mesh-list
92171547|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171548|NCT03206060|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92063284|NCT04196608|Tazobactam|tazobactam|mesh-list
92171549|NCT03206060|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92171550|NCT03206060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171551|NCT03202628|Dexamethasone|dexamethasone|mesh-list
92171552|NCT03202628|Dexamethasone acetate|dexamethasone acetate|mesh-list
92171553|NCT03202628|Pomalidomide|pomalidomide|mesh-list
92171554|NCT03202628|Ixazomib|ixazomib|mesh-list
92171555|NCT03202628|Ichthammol|ichthammol|mesh-list
92171556|NCT03202628|BB 1101|bb 1101|mesh-list
92171557|NCT03202628|Glycine|glycine|mesh-list
92171558|NCT03202628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171559|NCT03202628|Antiemetics|antiemetics|mesh-ancestor
92171560|NCT03202628|Autonomic Agents|autonomic agents|mesh-ancestor
92171561|NCT03202628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171562|NCT03202628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171563|NCT03202628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92171564|NCT03202628|Glucocorticoids|glucocorticoids|mesh-ancestor
92171565|NCT03202628|Hormones|hormones|mesh-ancestor
92171566|NCT03202628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171567|NCT03202628|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92105409|NCT04521192|Fluzoparib|fluzoparib|mesh-list
92171568|NCT03202628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171569|NCT03202628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171570|NCT03202628|Protease Inhibitors|protease inhibitors|mesh-ancestor
92171571|NCT03202628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171572|NCT03202628|Immunologic Factors|immunologic factors|mesh-ancestor
92171573|NCT03202628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92171574|NCT03202628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92171575|NCT03202628|Growth Substances|growth substances|mesh-ancestor
92171576|NCT03202628|Growth Inhibitors|growth inhibitors|mesh-ancestor
92171577|NCT03202628|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171578|NCT03202628|Glycine Agents|glycine agents|mesh-ancestor
92171579|NCT03202628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92171581|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171582|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171583|NCT03197467|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171584|NCT03197467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171585|NCT03181867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92171586|NCT03181867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92171587|NCT03181867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171588|NCT03172299|Aflibercept|aflibercept|mesh-list
92171589|NCT03172299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92171590|NCT03172299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92171591|NCT03172299|Growth Substances|growth substances|mesh-ancestor
92171592|NCT03172299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105825|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
92171593|NCT03172299|Growth Inhibitors|growth inhibitors|mesh-ancestor
92171594|NCT03172299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171595|NCT03164616|Cisplatin|cisplatin|mesh-list
92171596|NCT03164616|Carboplatin|carboplatin|mesh-list
92171598|NCT03164616|Pemetrexed|pemetrexed|mesh-list
92171599|NCT03164616|Durvalumab|durvalumab|mesh-list
92171600|NCT03164616|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92171601|NCT03164616|Tremelimumab|tremelimumab|mesh-list
92171602|NCT03164616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171603|NCT03164616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171604|NCT03164616|Antimetabolites|antimetabolites|mesh-ancestor
92105903|NCT01631110|Vaccines|vaccines|mesh-list
92171605|NCT03164616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171606|NCT03164616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171607|NCT03164616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92171608|NCT03164616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171609|NCT03164616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171610|NCT03132636|Cemiplimab|cemiplimab|mesh-list
92171611|NCT03132636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171612|NCT03132636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171613|NCT03131908|Pembrolizumab|pembrolizumab|mesh-list
92171614|NCT03131908|GSK2636771|gsk2636771|mesh-list
92171615|NCT03131908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171616|NCT03131908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171617|NCT03131908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171618|NCT03131908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171619|NCT03131908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92171620|NCT03131908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171622|NCT03089983|Rifapentine|rifapentine|mesh-list
92171623|NCT03089983|Buprenorphine|buprenorphine|mesh-list
92171625|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92171626|NCT03089983|Naloxone|naloxone|mesh-list
92171627|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92171628|NCT03089983|Narcotics|narcotics|mesh-ancestor
92106043|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
92171629|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92171630|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171631|NCT03089983|Analgesics|analgesics|mesh-ancestor
92171632|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
92171633|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171634|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92171635|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
92171636|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
92171637|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
92171638|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92171639|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171640|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92171641|NCT03089983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92171642|NCT03089983|Antimetabolites|antimetabolites|mesh-ancestor
92171643|NCT03089983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171644|NCT03089983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92171645|NCT03089983|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92171646|NCT03089983|Leprostatic Agents|leprostatic agents|mesh-ancestor
92171647|NCT03079999|Aspirin|aspirin|mesh-list
92171648|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92171649|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92171651|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
92171652|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171653|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171654|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171655|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171656|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92171657|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92171658|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171659|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92171660|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92171661|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171662|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
92171663|NCT03070184|Metoprolol|metoprolol|mesh-list
92171664|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92171665|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92171666|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
92171667|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
92171668|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171669|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171670|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92106288|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92171671|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92313802|NCT00372853|Ipilimumab|ipilimumab|mesh-list
92171672|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92106360|NCT02516826|Olmesartan|olmesartan|mesh-list
92171673|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92171674|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92171675|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171676|NCT03047993|Azacitidine|azacitidine|mesh-list
92171677|NCT03047993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171678|NCT03047993|Antimetabolites|antimetabolites|mesh-ancestor
92171679|NCT03047993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171680|NCT03047993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171681|NCT03047993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171682|NCT03044587|Leucovorin|leucovorin|mesh-list
92171683|NCT03044587|Gemcitabine|gemcitabine|mesh-list
92171684|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171685|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171686|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
92171687|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171688|NCT03044587|Antidotes|antidotes|mesh-ancestor
92171689|NCT03044587|Protective Agents|protective agents|mesh-ancestor
92171690|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171691|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
92171692|NCT03044587|Vitamins|vitamins|mesh-ancestor
92171693|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
92171694|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
92171695|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
92171696|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171697|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
92171698|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171699|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171700|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171701|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
92171702|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171703|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171704|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171705|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171706|NCT03029403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171708|NCT03025087|Antimalarials|antimalarials|mesh-ancestor
92171709|NCT03025087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92171710|NCT03025087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92171711|NCT03025087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171712|NCT03025087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171713|NCT03025087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171714|NCT03025087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171715|NCT03016377|Cyclophosphamide|cyclophosphamide|mesh-list
92171717|NCT03016377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171718|NCT03016377|Immunologic Factors|immunologic factors|mesh-ancestor
92171719|NCT03016377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171720|NCT03016377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171721|NCT03016377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171722|NCT03016377|Alkylating Agents|alkylating agents|mesh-ancestor
92171723|NCT03016377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171724|NCT03016377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171725|NCT03016377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171726|NCT03003962|Paclitaxel|paclitaxel|mesh-list
92171727|NCT03003962|Cisplatin|cisplatin|mesh-list
92171728|NCT03003962|Carboplatin|carboplatin|mesh-list
92171729|NCT03003962|Gemcitabine|gemcitabine|mesh-list
92171730|NCT03003962|Pemetrexed|pemetrexed|mesh-list
92171731|NCT03003962|Durvalumab|durvalumab|mesh-list
92171732|NCT03003962|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171733|NCT03003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171734|NCT03003962|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171735|NCT03003962|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171736|NCT03003962|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171737|NCT03003962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171738|NCT03003962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171739|NCT03003962|Antimetabolites|antimetabolites|mesh-ancestor
92171740|NCT03003962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171741|NCT03003962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92171742|NCT03003962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171743|NCT03003962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171744|NCT02947620|Metformin|metformin|mesh-list
92171745|NCT02947620|Atorvastatin|atorvastatin|mesh-list
92171746|NCT02947620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92171747|NCT02947620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171748|NCT02947620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92171749|NCT02947620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92171750|NCT02947620|Antimetabolites|antimetabolites|mesh-ancestor
92171751|NCT02947620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171752|NCT02947620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92171753|NCT02947620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92171754|NCT02947620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171755|NCT02877303|Cytarabine|cytarabine|mesh-list
92171756|NCT02877303|Dexamethasone|dexamethasone|mesh-list
92171757|NCT02877303|Dexamethasone acetate|dexamethasone acetate|mesh-list
92171758|NCT02877303|Prednisone|prednisone|mesh-list
92171759|NCT02877303|Cortisone|cortisone|mesh-list
92171760|NCT02877303|Cyclophosphamide|cyclophosphamide|mesh-list
92171761|NCT02877303|Rituximab|rituximab|mesh-list
92171762|NCT02877303|Doxorubicin|doxorubicin|mesh-list
92171763|NCT02877303|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92171764|NCT02877303|Methotrexate|methotrexate|mesh-list
92171765|NCT02877303|Vincristine|vincristine|mesh-list
92171766|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
92171767|NCT02877303|Ofatumumab|ofatumumab|mesh-list
92171768|NCT02877303|Blinatumomab|blinatumomab|mesh-list
92171769|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92171770|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92171771|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
92171772|NCT02877303|Antibodies|antibodies|mesh-list
92171773|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
92171774|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92171775|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92171776|NCT02877303|BB 1101|bb 1101|mesh-list
92171777|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171778|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
92171779|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171780|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171781|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171782|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
92171783|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171784|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171785|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171786|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92171788|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
92171789|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171790|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92171791|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
92171792|NCT02877303|Hormones|hormones|mesh-ancestor
92171793|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171794|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92171795|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
92171796|NCT02877303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171797|NCT02877303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92171799|NCT02877303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171800|NCT02877303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92171801|NCT02877303|Abortifacient Agents|abortifacient agents|mesh-ancestor
92171802|NCT02877303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92171803|NCT02877303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171804|NCT02877303|Antimetabolites|antimetabolites|mesh-ancestor
92171805|NCT02877303|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171806|NCT02877303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92171807|NCT02877303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92171808|NCT02877303|Antiviral Agents|antiviral agents|mesh-ancestor
92171809|NCT02877303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171810|NCT02877303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171811|NCT02877303|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171812|NCT02877303|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171813|NCT02877303|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171814|NCT02877303|Immunotoxins|immunotoxins|mesh-ancestor
92171815|NCT02877303|Immunoconjugates|immunoconjugates|mesh-ancestor
92171816|NCT02869789|Nivolumab|nivolumab|mesh-list
92171817|NCT02869789|Ipilimumab|ipilimumab|mesh-list
92171818|NCT02869789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171819|NCT02869789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171820|NCT02869789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171821|NCT02869789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171822|NCT02863445|Levonorgestrel|levonorgestrel|mesh-list
92171823|NCT02863445|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92171824|NCT02863445|Contraceptive Agents|contraceptive agents|mesh-ancestor
92171825|NCT02863445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92171826|NCT02863445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171827|NCT02863445|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92171828|NCT02863445|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92171829|NCT02863445|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92171830|NCT02696993|Nivolumab|nivolumab|mesh-list
92171831|NCT02696993|Ipilimumab|ipilimumab|mesh-list
92171832|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171833|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171834|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171835|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171836|NCT02671890|Gemcitabine|gemcitabine|mesh-list
92171837|NCT02671890|Disulfiram|disulfiram|mesh-list
92171838|NCT02671890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171839|NCT02671890|Antimetabolites|antimetabolites|mesh-ancestor
92171840|NCT02671890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171841|NCT02671890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171842|NCT02671890|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92171843|NCT02671890|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92171844|NCT02671890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171845|NCT02661282|Temozolomide|temozolomide|mesh-list
92171846|NCT02661282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171847|NCT02661282|Alkylating Agents|alkylating agents|mesh-ancestor
92171848|NCT02661282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171849|NCT02661282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314076|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
92171850|NCT02659527|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92171851|NCT02659527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92171852|NCT02659527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171853|NCT02634333|Aflibercept|aflibercept|mesh-list
92171854|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
92171855|NCT02634333|Mitogens|mitogens|mesh-list
92171856|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92171857|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92171858|NCT02634333|Growth Substances|growth substances|mesh-ancestor
92171859|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171860|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
92171861|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171862|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171863|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171864|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
92023369|NCT04428385|Artemisinins|artemisinins|mesh-list
92171865|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171866|NCT02530463|Nivolumab|nivolumab|mesh-list
92171867|NCT02530463|Ipilimumab|ipilimumab|mesh-list
92171868|NCT02530463|Azacitidine|azacitidine|mesh-list
92171869|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171870|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171871|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171872|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171873|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171874|NCT02530463|Antimetabolites|antimetabolites|mesh-ancestor
92171875|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171876|NCT02515630|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92171877|NCT02515630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92171878|NCT02515630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171879|NCT02515630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171880|NCT02450331|Atezolizumab|atezolizumab|mesh-list
92171881|NCT02450331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92314114|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171882|NCT02450331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171883|NCT02450331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171884|NCT02450331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171885|NCT02443077|Cytarabine|cytarabine|mesh-list
92171886|NCT02443077|Cyclophosphamide|cyclophosphamide|mesh-list
92171887|NCT02443077|Melphalan|melphalan|mesh-list
92171888|NCT02443077|Mechlorethamine|mechlorethamine|mesh-list
92171889|NCT02443077|Carmustine|carmustine|mesh-list
92171890|NCT02443077|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92171891|NCT02443077|Etoposide|etoposide|mesh-list
92171892|NCT02443077|Etoposide phosphate|etoposide phosphate|mesh-list
92171893|NCT02443077|Podophyllotoxin|podophyllotoxin|mesh-list
92171894|NCT02443077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171895|NCT02443077|Immunologic Factors|immunologic factors|mesh-ancestor
92171896|NCT02443077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171897|NCT02443077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92171898|NCT02443077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92171899|NCT02443077|Alkylating Agents|alkylating agents|mesh-ancestor
92171900|NCT02443077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171901|NCT02443077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171902|NCT02443077|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92171903|NCT02443077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171904|NCT02443077|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92171905|NCT02443077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171906|NCT02443077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171907|NCT02443077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92314159|NCT02806544|Tamoxifen|tamoxifen|mesh-list
92171908|NCT02443077|Antimetabolites|antimetabolites|mesh-ancestor
92171909|NCT02443077|Antiviral Agents|antiviral agents|mesh-ancestor
92171910|NCT02443077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171911|NCT02443077|Keratolytic Agents|keratolytic agents|mesh-ancestor
92171912|NCT02443077|Dermatologic Agents|dermatologic agents|mesh-ancestor
92171913|NCT02443077|Tubulin Modulators|tubulin modulators|mesh-ancestor
92171914|NCT02443077|Antimitotic Agents|antimitotic agents|mesh-ancestor
92171915|NCT02443077|Mitosis Modulators|mitosis modulators|mesh-ancestor
92171916|NCT02411656|Pembrolizumab|pembrolizumab|mesh-list
92171917|NCT02411656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171918|NCT02411656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171919|NCT02411656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171920|NCT02411656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171922|NCT02397720|Ipilimumab|ipilimumab|mesh-list
92171923|NCT02397720|Azacitidine|azacitidine|mesh-list
92171924|NCT02397720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171925|NCT02397720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171926|NCT02397720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92171927|NCT02397720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171928|NCT02397720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171929|NCT02397720|Antimetabolites|antimetabolites|mesh-ancestor
92171930|NCT02397720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171931|NCT02391025|Citric Acid|citric acid|mesh-list
92171932|NCT02391025|Sodium Citrate|sodium citrate|mesh-list
92171933|NCT02391025|Anticoagulants|anticoagulants|mesh-ancestor
92171934|NCT02391025|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92171935|NCT02391025|Chelating Agents|chelating agents|mesh-ancestor
92171936|NCT02391025|Sequestering Agents|sequestering agents|mesh-ancestor
92314205|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
92171937|NCT02391025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171938|NCT02386800|Panobinostat|panobinostat|mesh-list
92171939|NCT02386800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171940|NCT02386800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92171941|NCT02386800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171942|NCT02386800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171943|NCT02335944|Nazartinib|nazartinib|mesh-list
92171944|NCT02335944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171945|NCT02326974|Pertuzumab|pertuzumab|mesh-list
92171946|NCT02326974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92171947|NCT02326974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171948|NCT02299518|Cytarabine|cytarabine|mesh-list
92171949|NCT02299518|Etoposide|etoposide|mesh-list
92171950|NCT02299518|Mitoxantrone|mitoxantrone|mesh-list
92171951|NCT02299518|Etoposide phosphate|etoposide phosphate|mesh-list
92171952|NCT02299518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92171953|NCT02299518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171954|NCT02299518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92171955|NCT02299518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92171956|NCT02299518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171957|NCT02299518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171958|NCT02299518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171959|NCT02299518|Antimetabolites|antimetabolites|mesh-ancestor
92171960|NCT02299518|Antiviral Agents|antiviral agents|mesh-ancestor
92171961|NCT02299518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92171962|NCT02299518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92171963|NCT02299518|Immunologic Factors|immunologic factors|mesh-ancestor
92171964|NCT02299518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171966|NCT02299518|Sensory System Agents|sensory system agents|mesh-ancestor
92171967|NCT02299518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92171968|NCT02257138|Decitabine|decitabine|mesh-list
92171969|NCT02257138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92171970|NCT02257138|Antimetabolites|antimetabolites|mesh-ancestor
92171971|NCT02257138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171972|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171973|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171974|NCT02246621|Letrozole|letrozole|mesh-list
92171975|NCT02246621|Anastrozole|anastrozole|mesh-list
92171976|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92171977|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92171978|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92171979|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92171980|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92171981|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92171982|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
92171983|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92171984|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171985|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92171986|NCT02214550|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92171987|NCT02214550|Norinyl|norinyl|mesh-list
92171988|NCT02214550|Mestranol|mestranol|mesh-list
92171989|NCT02214550|Norethindrone|norethindrone|mesh-list
92171990|NCT02214550|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92171991|NCT02214550|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92171992|NCT02214550|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92171993|NCT02214550|Contraceptive Agents|contraceptive agents|mesh-ancestor
92171994|NCT02214550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92171995|NCT02214550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92171996|NCT02214550|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92171997|NCT02214550|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92171998|NCT02214550|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92171999|NCT02214550|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92172000|NCT02214550|Estrogens|estrogens|mesh-ancestor
92172001|NCT02214550|Hormones|hormones|mesh-ancestor
92172002|NCT02214550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172003|NCT02200445|Aldesleukin|aldesleukin|mesh-list
92172004|NCT02200445|Interleukin-2|interleukin-2|mesh-list
92172005|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172006|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92172007|NCT02200445|Analgesics|analgesics|mesh-ancestor
92172008|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
92172009|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172010|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172011|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92172012|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92172013|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
92172014|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172015|NCT02180711|Rituximab|rituximab|mesh-list
92172016|NCT02180711|Lenalidomide|lenalidomide|mesh-list
92172017|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
92172018|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172019|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172020|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
92172021|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172022|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172023|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172024|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172025|NCT02180711|Growth Substances|growth substances|mesh-ancestor
92172026|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172027|NCT02152982|Temozolomide|temozolomide|mesh-list
92172028|NCT02152982|Veliparib|veliparib|mesh-list
92172029|NCT02152982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172030|NCT02152982|Alkylating Agents|alkylating agents|mesh-ancestor
92172031|NCT02152982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172032|NCT02152982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172033|NCT02152982|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92172034|NCT02152982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172035|NCT02151084|Gemcitabine|gemcitabine|mesh-list
92172036|NCT02151084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172037|NCT02151084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172038|NCT02151084|Antimetabolites|antimetabolites|mesh-ancestor
92172039|NCT02151084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172040|NCT02120352|Rilpivirine|rilpivirine|mesh-list
92172041|NCT02120352|Cabotegravir|cabotegravir|mesh-list
92172042|NCT02120352|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92172043|NCT02120352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92172044|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172045|NCT02120352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172046|NCT02120352|Antiviral Agents|antiviral agents|mesh-ancestor
92172047|NCT02120352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172048|NCT02120352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92172049|NCT02120352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92172050|NCT02120352|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92172051|NCT02120352|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92172052|NCT02058693|Amphetamine|amphetamine|mesh-list
92172053|NCT02058693|Adderall|adderall|mesh-list
92172054|NCT02058693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92172055|NCT02058693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172056|NCT02058693|Sympathomimetics|sympathomimetics|mesh-ancestor
92172057|NCT02058693|Autonomic Agents|autonomic agents|mesh-ancestor
92314398|NCT02823080|Cetrorelix|cetrorelix|mesh-list
92172058|NCT02058693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172059|NCT02058693|Dopamine Agents|dopamine agents|mesh-ancestor
92172060|NCT02058693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172061|NCT02058693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172062|NCT02058693|Adrenergic Agents|adrenergic agents|mesh-ancestor
92172063|NCT02058693|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92172064|NCT02058693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92172065|NCT02058693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92172066|NCT02058693|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92172067|NCT02047513|Paclitaxel|paclitaxel|mesh-list
92172068|NCT02047513|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92172069|NCT02047513|Gemcitabine|gemcitabine|mesh-list
92172070|NCT02047513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172071|NCT02047513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172072|NCT02047513|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172073|NCT02047513|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172074|NCT02047513|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172075|NCT02047513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172076|NCT02047513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172077|NCT02047513|Antimetabolites|antimetabolites|mesh-ancestor
92172079|NCT02007044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172080|NCT02007044|Antibodies|antibodies|mesh-list
92172081|NCT02007044|Immunoglobulins|immunoglobulins|mesh-list
92172082|NCT02007044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172083|NCT02007044|Immunologic Factors|immunologic factors|mesh-ancestor
92172084|NCT02007044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172085|NCT02007044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172086|NCT02007044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172087|NCT01991873|Leucovorin|leucovorin|mesh-list
92172088|NCT01991873|Folic Acid|folic acid|mesh-list
92172089|NCT01991873|Fluorouracil|fluorouracil|mesh-list
92172090|NCT01991873|Oxaliplatin|oxaliplatin|mesh-list
92172091|NCT01991873|Panitumumab|panitumumab|mesh-list
92172093|NCT01991873|Antimetabolites|antimetabolites|mesh-ancestor
92172094|NCT01991873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172095|NCT01991873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172096|NCT01991873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172097|NCT01991873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172098|NCT01991873|Immunologic Factors|immunologic factors|mesh-ancestor
92172099|NCT01991873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172101|NCT01991873|Protective Agents|protective agents|mesh-ancestor
92172102|NCT01991873|Vitamin B Complex|vitamin b complex|mesh-ancestor
92172104|NCT01991873|Micronutrients|micronutrients|mesh-ancestor
92172105|NCT01991873|Hematinics|hematinics|mesh-ancestor
92172106|NCT01991873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172107|NCT01955460|Aldesleukin|aldesleukin|mesh-list
92172108|NCT01955460|Cyclophosphamide|cyclophosphamide|mesh-list
92172109|NCT01955460|Fludarabine|fludarabine|mesh-list
92172110|NCT01955460|Fludarabine phosphate|fludarabine phosphate|mesh-list
92172111|NCT01955460|Interleukin-2|interleukin-2|mesh-list
92172112|NCT01955460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172113|NCT01955460|Immunologic Factors|immunologic factors|mesh-ancestor
92172114|NCT01955460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172115|NCT01955460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172116|NCT01955460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172117|NCT01955460|Alkylating Agents|alkylating agents|mesh-ancestor
92172118|NCT01955460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172119|NCT01955460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172120|NCT01955460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172121|NCT01955460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172122|NCT01955460|Antimetabolites|antimetabolites|mesh-ancestor
92172123|NCT01955460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92172124|NCT01955460|Analgesics|analgesics|mesh-ancestor
92172125|NCT01955460|Sensory System Agents|sensory system agents|mesh-ancestor
92172126|NCT01955460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172127|NCT01955460|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92172128|NCT01955460|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92172129|NCT01955460|Antiviral Agents|antiviral agents|mesh-ancestor
92172130|NCT01955460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172131|NCT01954979|Abatacept|abatacept|mesh-list
92172132|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92172133|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172134|NCT01954979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172135|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967185|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
92172136|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172137|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
92172138|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172139|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172141|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92172142|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172143|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172144|NCT01927744|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172145|NCT01927744|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172146|NCT01927744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172147|NCT01927744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172148|NCT01927744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172149|NCT01878617|Cyclophosphamide|cyclophosphamide|mesh-list
92172150|NCT01878617|Gemcitabine|gemcitabine|mesh-list
92172151|NCT01878617|Vincristine|vincristine|mesh-list
92172152|NCT01878617|Pemetrexed|pemetrexed|mesh-list
92172154|NCT01878617|Immunologic Factors|immunologic factors|mesh-ancestor
92172155|NCT01878617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172156|NCT01878617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172157|NCT01878617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172158|NCT01878617|Alkylating Agents|alkylating agents|mesh-ancestor
92172159|NCT01878617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172160|NCT01878617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172161|NCT01878617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172162|NCT01878617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172163|NCT01878617|Antimetabolites|antimetabolites|mesh-ancestor
92172164|NCT01878617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172165|NCT01878617|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172166|NCT01878617|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172167|NCT01878617|Mitosis Modulators|mitosis modulators|mesh-ancestor
92314522|NCT03035929|BB 1101|bb 1101|mesh-list
92172168|NCT01878617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172169|NCT01878617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92172170|NCT01878617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92172171|NCT01843556|Donepezil|donepezil|mesh-list
92172172|NCT01843556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92172173|NCT01843556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172174|NCT01843556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172176|NCT01843556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172177|NCT01843556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172178|NCT01843556|Nootropic Agents|nootropic agents|mesh-ancestor
92172180|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172181|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
92172182|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172183|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172184|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172185|NCT01751425|Imatinib Mesylate|imatinib mesylate|mesh-list
92172186|NCT01751425|Dasatinib|dasatinib|mesh-list
92172187|NCT01751425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92172188|NCT01751425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172189|NCT01751425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172190|NCT01751425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172191|NCT01751425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172192|NCT01618136|Paclitaxel|paclitaxel|mesh-list
92172193|NCT01618136|Carboplatin|carboplatin|mesh-list
92172194|NCT01618136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172195|NCT01618136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172196|NCT01618136|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172197|NCT01618136|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172198|NCT01618136|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172199|NCT01618136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391705|NCT01725048|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92391706|NCT01725048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92391707|NCT01725048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391708|NCT01725048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391709|NCT01725048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391710|NCT01725048|Serotonin Agents|serotonin agents|mesh-ancestor
92391711|NCT01725048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391712|NCT01725048|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92391713|NCT01725048|Antidepressive Agents|antidepressive agents|mesh-ancestor
92391714|NCT01725048|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92391715|NCT01725048|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92391716|NCT01725048|Histamine Antagonists|histamine antagonists|mesh-ancestor
92391717|NCT01725048|Histamine Agents|histamine agents|mesh-ancestor
92391718|NCT01725048|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92391719|NCT01725048|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92391720|NCT01725048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391721|NCT01725048|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92391722|NCT01725048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92391723|NCT01725048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92391724|NCT01725048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92391725|NCT01725048|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92391726|NCT01725048|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92391727|NCT01725048|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92391729|NCT01725204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172200|NCT01539031|Donepezil|donepezil|mesh-list
92172201|NCT01539031|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92172202|NCT01539031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172203|NCT01539031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314661|NCT05829551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92172204|NCT01539031|Cholinergic Agents|cholinergic agents|mesh-ancestor
92172205|NCT01539031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172206|NCT01539031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172207|NCT01539031|Nootropic Agents|nootropic agents|mesh-ancestor
92172208|NCT01508312|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92172209|NCT01508312|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172210|NCT01508312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172211|NCT01508312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172212|NCT01508312|Immunotoxins|immunotoxins|mesh-ancestor
92172213|NCT01508312|Immunoconjugates|immunoconjugates|mesh-ancestor
92172214|NCT01508312|Immunologic Factors|immunologic factors|mesh-ancestor
92172215|NCT01508312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172216|NCT01386385|Paclitaxel|paclitaxel|mesh-list
92172217|NCT01386385|Carboplatin|carboplatin|mesh-list
92172218|NCT01386385|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92172219|NCT01386385|Veliparib|veliparib|mesh-list
92172220|NCT01386385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172221|NCT01386385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172222|NCT01386385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172223|NCT01386385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172224|NCT01386385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172225|NCT01386385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172226|NCT01386385|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92172227|NCT01386385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172228|NCT01375140|Prednisone|prednisone|mesh-list
92172229|NCT01375140|Lenalidomide|lenalidomide|mesh-list
92172230|NCT01375140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92172231|NCT01375140|Glucocorticoids|glucocorticoids|mesh-ancestor
92172232|NCT01375140|Hormones|hormones|mesh-ancestor
92172233|NCT01375140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172234|NCT01375140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172235|NCT01375140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92172236|NCT01375140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172237|NCT01375140|Immunologic Factors|immunologic factors|mesh-ancestor
92172238|NCT01375140|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172239|NCT01375140|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172240|NCT01375140|Growth Substances|growth substances|mesh-ancestor
92172241|NCT01375140|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172243|NCT01328171|Vitamin B Complex|vitamin b complex|mesh-list
92172244|NCT01328171|Oxaliplatin|oxaliplatin|mesh-list
92172245|NCT01328171|Irinotecan|irinotecan|mesh-list
92172246|NCT01328171|Panitumumab|panitumumab|mesh-list
92172247|NCT01328171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172248|NCT01328171|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92172249|NCT01328171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172250|NCT01328171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314777|NCT05828199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172251|NCT01328171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172252|NCT01328171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172253|NCT01328171|Hematinics|hematinics|mesh-ancestor
92172255|NCT01328171|Micronutrients|micronutrients|mesh-ancestor
92172256|NCT01328171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172257|NCT01288963|Aldesleukin|aldesleukin|mesh-list
92172258|NCT01288963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172259|NCT01288963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92172260|NCT01288963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92172261|NCT01288963|Antiviral Agents|antiviral agents|mesh-ancestor
92172262|NCT01288963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172263|NCT01269190|Proflavine|proflavine|mesh-list
92172264|NCT01269190|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92172265|NCT01269190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172266|NCT01248715|Oseltamivir|oseltamivir|mesh-list
92172267|NCT01248715|Antiviral Agents|antiviral agents|mesh-ancestor
92172268|NCT01248715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172269|NCT01248715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172270|NCT01248715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172271|NCT01167712|Paclitaxel|paclitaxel|mesh-list
92172272|NCT01167712|Bevacizumab|bevacizumab|mesh-list
92172273|NCT01167712|Carboplatin|carboplatin|mesh-list
92172274|NCT01167712|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92172275|NCT01167712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172276|NCT01167712|Endothelial Growth Factors|endothelial growth factors|mesh-list
92172277|NCT01167712|Antibodies|antibodies|mesh-list
92172278|NCT01167712|Immunoglobulins|immunoglobulins|mesh-list
92172279|NCT01167712|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172280|NCT01167712|Immunoglobulin G|immunoglobulin g|mesh-list
92172281|NCT01167712|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172282|NCT01167712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172283|NCT01167712|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172284|NCT01167712|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172285|NCT01167712|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172286|NCT01167712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172287|NCT01167712|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172288|NCT01167712|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172289|NCT01167712|Growth Substances|growth substances|mesh-ancestor
92172290|NCT01167712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172291|NCT01167712|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172292|NCT01167712|Immunologic Factors|immunologic factors|mesh-ancestor
92172293|NCT00963040|Oxytocin|oxytocin|mesh-list
92172294|NCT00963040|Oxytocics|oxytocics|mesh-ancestor
92172295|NCT00963040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92172296|NCT00963040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172297|NCT00941109|Decitabine|decitabine|mesh-list
92172298|NCT00941109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172299|NCT00941109|Antimetabolites|antimetabolites|mesh-ancestor
92172300|NCT00941109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172301|NCT00941109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172302|NCT00941109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172304|NCT00908050|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92172305|NCT00908050|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92172306|NCT00908050|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92172307|NCT00908050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92172308|NCT00908050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172309|NCT00908050|Cholinergic Agents|cholinergic agents|mesh-ancestor
92172310|NCT00908050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172311|NCT00908050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172312|NCT00908050|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92172313|NCT00908050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172314|NCT00812214|Eszopiclone|eszopiclone|mesh-list
92172315|NCT00812214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92172316|NCT00812214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172317|NCT00812214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172318|NCT00792948|Calcium, Dietary|calcium, dietary|mesh-list
92172319|NCT00792948|Leucovorin|leucovorin|mesh-list
92172320|NCT00792948|Folic Acid|folic acid|mesh-list
92172321|NCT00792948|Cytarabine|cytarabine|mesh-list
92172322|NCT00792948|Sirolimus|sirolimus|mesh-list
92172323|NCT00792948|Dexamethasone|dexamethasone|mesh-list
92172324|NCT00792948|Dexamethasone acetate|dexamethasone acetate|mesh-list
92172325|NCT00792948|Prednisone|prednisone|mesh-list
92172326|NCT00792948|Methylprednisolone|methylprednisolone|mesh-list
92172327|NCT00792948|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92172328|NCT00792948|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92172329|NCT00792948|Prednisolone|prednisolone|mesh-list
92172330|NCT00792948|Prednisolone acetate|prednisolone acetate|mesh-list
92172331|NCT00792948|Cortisone|cortisone|mesh-list
92172332|NCT00792948|Cyclophosphamide|cyclophosphamide|mesh-list
92172333|NCT00792948|Doxorubicin|doxorubicin|mesh-list
92172334|NCT00792948|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92172335|NCT00792948|Methotrexate|methotrexate|mesh-list
92172336|NCT00792948|Etoposide|etoposide|mesh-list
92172337|NCT00792948|Vincristine|vincristine|mesh-list
92172338|NCT00792948|Etoposide phosphate|etoposide phosphate|mesh-list
92172339|NCT00792948|Dasatinib|dasatinib|mesh-list
92172340|NCT00792948|Podophyllotoxin|podophyllotoxin|mesh-list
92172341|NCT00792948|Tacrolimus|tacrolimus|mesh-list
92172342|NCT00792948|Lenograstim|lenograstim|mesh-list
92172343|NCT00792948|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92172344|NCT00792948|Prednisolone phosphate|prednisolone phosphate|mesh-list
92172345|NCT00792948|BB 1101|bb 1101|mesh-list
92172346|NCT00792948|Calcium|calcium|mesh-list
92172347|NCT00792948|Levoleucovorin|levoleucovorin|mesh-list
92172348|NCT00792948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172349|NCT00792948|Immunologic Factors|immunologic factors|mesh-ancestor
92172350|NCT00792948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172351|NCT00792948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172352|NCT00792948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172353|NCT00792948|Alkylating Agents|alkylating agents|mesh-ancestor
92172354|NCT00792948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172355|NCT00792948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172356|NCT00792948|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172357|NCT00792948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92172358|NCT00792948|Antiemetics|antiemetics|mesh-ancestor
92172359|NCT00792948|Autonomic Agents|autonomic agents|mesh-ancestor
92172360|NCT00792948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172361|NCT00792948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92172362|NCT00792948|Glucocorticoids|glucocorticoids|mesh-ancestor
92172363|NCT00792948|Hormones|hormones|mesh-ancestor
92172364|NCT00792948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314893|NCT05790213|Androgens|androgens|mesh-list
92172365|NCT00792948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92172366|NCT00792948|Protease Inhibitors|protease inhibitors|mesh-ancestor
92172367|NCT00792948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172368|NCT00792948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172369|NCT00792948|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92172370|NCT00792948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172371|NCT00792948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92172372|NCT00792948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92172373|NCT00792948|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92172374|NCT00792948|Abortifacient Agents|abortifacient agents|mesh-ancestor
92172375|NCT00792948|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92172376|NCT00792948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172377|NCT00792948|Antimetabolites|antimetabolites|mesh-ancestor
92172378|NCT00792948|Dermatologic Agents|dermatologic agents|mesh-ancestor
92172379|NCT00792948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92172380|NCT00792948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92172381|NCT00792948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172382|NCT00792948|Antiviral Agents|antiviral agents|mesh-ancestor
92172383|NCT00792948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172384|NCT00792948|Antidotes|antidotes|mesh-ancestor
92172385|NCT00792948|Protective Agents|protective agents|mesh-ancestor
92172386|NCT00792948|Vitamin B Complex|vitamin b complex|mesh-ancestor
92172388|NCT00792948|Micronutrients|micronutrients|mesh-ancestor
92172389|NCT00792948|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92172390|NCT00792948|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92172391|NCT00792948|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172392|NCT00792948|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172393|NCT00792948|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172394|NCT00792948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92172395|NCT00792948|Antifungal Agents|antifungal agents|mesh-ancestor
92172396|NCT00792948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172397|NCT00792948|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92172398|NCT00792948|Hematinics|hematinics|mesh-ancestor
92172399|NCT00792948|Keratolytic Agents|keratolytic agents|mesh-ancestor
92172400|NCT00658814|Azacitidine|azacitidine|mesh-list
92172401|NCT00658814|Gemtuzumab|gemtuzumab|mesh-list
92172402|NCT00658814|Calicheamicins|calicheamicins|mesh-list
92172403|NCT00658814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172404|NCT00658814|Antimetabolites|antimetabolites|mesh-ancestor
92172405|NCT00658814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172406|NCT00658814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172407|NCT00658814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172408|NCT00658814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172409|NCT00658814|Immunotoxins|immunotoxins|mesh-ancestor
92172410|NCT00658814|Immunoconjugates|immunoconjugates|mesh-ancestor
92172411|NCT00658814|Immunologic Factors|immunologic factors|mesh-ancestor
92172412|NCT00658814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172413|NCT00658814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172414|NCT00601900|Tamoxifen|tamoxifen|mesh-list
92172415|NCT00601900|Bevacizumab|bevacizumab|mesh-list
92172416|NCT00601900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172417|NCT00601900|Letrozole|letrozole|mesh-list
92172418|NCT00601900|Endothelial Growth Factors|endothelial growth factors|mesh-list
92172419|NCT00601900|Antibodies|antibodies|mesh-list
92172420|NCT00601900|Immunoglobulins|immunoglobulins|mesh-list
92172421|NCT00601900|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172422|NCT00601900|Immunoglobulin G|immunoglobulin g|mesh-list
92172423|NCT00601900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172424|NCT00601900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172425|NCT00601900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172426|NCT00601900|Growth Substances|growth substances|mesh-ancestor
92172427|NCT00601900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172428|NCT00601900|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172429|NCT00601900|Immunologic Factors|immunologic factors|mesh-ancestor
92172430|NCT00601900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172431|NCT00601900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92172432|NCT00601900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92172433|NCT00601900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172434|NCT00601900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92172435|NCT00601900|Hormone Antagonists|hormone antagonists|mesh-ancestor
92172436|NCT00601900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172437|NCT00601900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92172438|NCT00601900|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92172439|NCT00601900|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92172440|NCT00601900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92172441|NCT00444613|Vitamin B 12|vitamin b 12|mesh-list
92172442|NCT00444613|Vitamin B Complex|vitamin b complex|mesh-ancestor
92172443|NCT00444613|Vitamins|vitamins|mesh-ancestor
92172444|NCT00444613|Micronutrients|micronutrients|mesh-ancestor
92172445|NCT00444613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172446|NCT00433511|Paclitaxel|paclitaxel|mesh-list
92172447|NCT00433511|Cyclophosphamide|cyclophosphamide|mesh-list
92172448|NCT00433511|Bevacizumab|bevacizumab|mesh-list
92172449|NCT00433511|Doxorubicin|doxorubicin|mesh-list
92172450|NCT00433511|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92172451|NCT00433511|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92172452|NCT00433511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172453|NCT00433511|Antibodies|antibodies|mesh-list
92172454|NCT00433511|Immunoglobulins|immunoglobulins|mesh-list
92172455|NCT00433511|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172456|NCT00433511|Immunoglobulin G|immunoglobulin g|mesh-list
92172457|NCT00433511|Endothelial Growth Factors|endothelial growth factors|mesh-list
92172458|NCT00433511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172459|NCT00433511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172460|NCT00433511|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172461|NCT00433511|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172462|NCT00433511|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172463|NCT00433511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172464|NCT00433511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172465|NCT00433511|Immunologic Factors|immunologic factors|mesh-ancestor
92172466|NCT00433511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172467|NCT00433511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172468|NCT00433511|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172469|NCT00433511|Alkylating Agents|alkylating agents|mesh-ancestor
92172470|NCT00433511|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172471|NCT00433511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172472|NCT00433511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172473|NCT00433511|Growth Substances|growth substances|mesh-ancestor
92172474|NCT00433511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172475|NCT00433511|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172476|NCT00433511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92172477|NCT00433511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172478|NCT00433511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315091|NCT05491187|Fentanyl|fentanyl|mesh-list
92172480|NCT00359684|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92172481|NCT00359684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172482|NCT00324805|Bevacizumab|bevacizumab|mesh-list
92172483|NCT00324805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172484|NCT00324805|Cisplatin|cisplatin|mesh-list
92172485|NCT00324805|Gemcitabine|gemcitabine|mesh-list
92172486|NCT00324805|Docetaxel|docetaxel|mesh-list
92172487|NCT00324805|Pemetrexed|pemetrexed|mesh-list
92172488|NCT00324805|Vinorelbine|vinorelbine|mesh-list
92172489|NCT00324805|Endothelial Growth Factors|endothelial growth factors|mesh-list
92172490|NCT00324805|Antibodies|antibodies|mesh-list
92172491|NCT00324805|Immunoglobulins|immunoglobulins|mesh-list
92172492|NCT00324805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172493|NCT00324805|Immunoglobulin G|immunoglobulin g|mesh-list
92172494|NCT00324805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172495|NCT00324805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172496|NCT00324805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172497|NCT00324805|Growth Substances|growth substances|mesh-ancestor
92172498|NCT00324805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172499|NCT00324805|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172500|NCT00324805|Immunologic Factors|immunologic factors|mesh-ancestor
92172501|NCT00324805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315170|NCT05376319|Rituximab|rituximab|mesh-list
92172502|NCT00324805|Antimetabolites|antimetabolites|mesh-ancestor
92172503|NCT00324805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172504|NCT00324805|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172505|NCT00324805|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172506|NCT00324805|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172507|NCT00324805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172508|NCT00324805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92172509|NCT00324805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92172510|NCT00324805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172511|NCT00310180|Tamoxifen|tamoxifen|mesh-list
92172512|NCT00310180|Letrozole|letrozole|mesh-list
92172513|NCT00310180|Anastrozole|anastrozole|mesh-list
92172514|NCT00310180|Exemestane|exemestane|mesh-list
92172515|NCT00310180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172516|NCT00310180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172517|NCT00310180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92172518|NCT00310180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92172519|NCT00310180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172520|NCT00310180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92172521|NCT00310180|Hormone Antagonists|hormone antagonists|mesh-ancestor
92172522|NCT00310180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172523|NCT00310180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172524|NCT00310180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92172525|NCT00310180|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92172526|NCT00310180|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92172527|NCT00310180|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92172528|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
92172529|NCT00217737|Leucovorin|leucovorin|mesh-list
92172530|NCT00217737|Folic Acid|folic acid|mesh-list
92172532|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172533|NCT00217737|Fluorouracil|fluorouracil|mesh-list
92315209|NCT05326087|Cetrorelix|cetrorelix|mesh-list
92172534|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
92172535|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
92172536|NCT00217737|Antibodies|antibodies|mesh-list
92172537|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
92172538|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172539|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
92172540|NCT00217737|Calcium|calcium|mesh-list
92172542|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172543|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172544|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172545|NCT00217737|Growth Substances|growth substances|mesh-ancestor
92172546|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172547|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172548|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
92172549|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92172550|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92172551|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
92172552|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172553|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172554|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172555|NCT00217737|Antidotes|antidotes|mesh-ancestor
92172556|NCT00217737|Protective Agents|protective agents|mesh-ancestor
92172557|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
92172558|NCT00217737|Vitamins|vitamins|mesh-ancestor
92172559|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
92172560|NCT00217737|Hematinics|hematinics|mesh-ancestor
92172561|NCT00217425|Prednisone|prednisone|mesh-list
92172562|NCT00217425|Cyclophosphamide|cyclophosphamide|mesh-list
92172563|NCT00217425|Bevacizumab|bevacizumab|mesh-list
92172564|NCT00217425|Doxorubicin|doxorubicin|mesh-list
92172565|NCT00217425|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92172566|NCT00217425|Vincristine|vincristine|mesh-list
92172567|NCT00217425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172568|NCT00217425|Immunologic Factors|immunologic factors|mesh-ancestor
92172569|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172570|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172571|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172572|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
92172573|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172574|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172575|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172576|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172577|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92172578|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92172579|NCT00217425|Growth Substances|growth substances|mesh-ancestor
92172580|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
92172581|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172582|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92172583|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172584|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172585|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92172586|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
92172587|NCT00217425|Hormones|hormones|mesh-ancestor
92172588|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172589|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92172590|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172591|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172592|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172593|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
92172594|NCT00209599|Fospropofol|fospropofol|mesh-list
92172595|NCT00209599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92172596|NCT00209599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172597|NCT00209599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172598|NCT00070499|Imatinib Mesylate|imatinib mesylate|mesh-list
92172599|NCT00070499|Dasatinib|dasatinib|mesh-list
92172600|NCT00070499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172601|NCT00070499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172602|NCT00070499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172603|NCT00070499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172604|NCT00060567|Irinotecan|irinotecan|mesh-list
92172605|NCT00060567|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92172606|NCT00060567|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92172607|NCT00060567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172608|NCT00060567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172609|NCT00060567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172610|NCT00060567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172611|NCT00060567|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92172612|NCT00049348|Gemcitabine|gemcitabine|mesh-list
92172613|NCT00049348|Fluorouracil|fluorouracil|mesh-list
92172614|NCT00049348|Epoetin Alfa|epoetin alfa|mesh-list
92172615|NCT00049348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172616|NCT00049348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172617|NCT00049348|Antimetabolites|antimetabolites|mesh-ancestor
92172618|NCT00049348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172619|NCT00049348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172620|NCT00049348|Immunologic Factors|immunologic factors|mesh-ancestor
92172621|NCT00049348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172622|NCT00049348|Hematinics|hematinics|mesh-ancestor
92172623|NCT00004125|Tamoxifen|tamoxifen|mesh-list
92172624|NCT00004125|Paclitaxel|paclitaxel|mesh-list
92172625|NCT00004125|Docetaxel|docetaxel|mesh-list
92172626|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
92172627|NCT00004125|Doxorubicin|doxorubicin|mesh-list
92172628|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92172629|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92172630|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172631|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92172632|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92172633|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315337|NCT04994444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172634|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172635|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172636|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
92172637|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172638|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172639|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172640|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
92172641|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172642|NCT00004125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172643|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92172644|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172645|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172646|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92172647|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
92172648|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172649|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92172650|NCT00004125|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92172651|NCT00004125|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92172652|NCT00004125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92172653|NCT00002981|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92172654|NCT00002981|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92172655|NCT00002981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172657|NCT03452865|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92172658|NCT03452865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92172659|NCT03452865|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92172660|NCT03452865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172661|NCT03452865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172662|NCT03449108|Aldesleukin|aldesleukin|mesh-list
92172663|NCT03449108|Cyclophosphamide|cyclophosphamide|mesh-list
92172664|NCT03449108|Nivolumab|nivolumab|mesh-list
92172665|NCT03449108|Fludarabine|fludarabine|mesh-list
92172666|NCT03449108|Ipilimumab|ipilimumab|mesh-list
92172667|NCT03449108|Interleukin-2|interleukin-2|mesh-list
92172668|NCT03449108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172669|NCT03449108|Immunologic Factors|immunologic factors|mesh-ancestor
92172670|NCT03449108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172671|NCT03449108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172672|NCT03449108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172673|NCT03449108|Alkylating Agents|alkylating agents|mesh-ancestor
92172674|NCT03449108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315431|NCT04724148|Analgesics|analgesics|mesh-ancestor
92172675|NCT03449108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172676|NCT03449108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172677|NCT03449108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172678|NCT03449108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92172679|NCT03449108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92172681|NCT03449108|Sensory System Agents|sensory system agents|mesh-ancestor
92172683|NCT03449108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92172684|NCT03449108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92172685|NCT03449108|Antiviral Agents|antiviral agents|mesh-ancestor
92172686|NCT03449108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172687|NCT03446001|Methylene Blue|methylene blue|mesh-list
92172688|NCT03446001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172689|NCT03446001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172690|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92172691|NCT03390296|Avelumab|avelumab|mesh-list
92172692|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
92172693|NCT03390296|Azacitidine|azacitidine|mesh-list
92172694|NCT03390296|Venetoclax|venetoclax|mesh-list
92172695|NCT03390296|Calicheamicins|calicheamicins|mesh-list
92172696|NCT03390296|Antibodies|antibodies|mesh-list
92172698|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92172699|NCT03390296|Maleic acid|maleic acid|mesh-list
92172700|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
92172701|NCT03390296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172702|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172703|NCT03390296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92172704|NCT03390296|Antimetabolites|antimetabolites|mesh-ancestor
92172705|NCT03390296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172706|NCT03390296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172707|NCT03390296|Immunotoxins|immunotoxins|mesh-ancestor
92172708|NCT03390296|Immunoconjugates|immunoconjugates|mesh-ancestor
92172709|NCT03390296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172710|NCT03345095|Temozolomide|temozolomide|mesh-list
92172711|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172712|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
92172713|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172714|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172715|NCT03315910|Nicotine|nicotine|mesh-list
92172716|NCT03315910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92172717|NCT03315910|Autonomic Agents|autonomic agents|mesh-ancestor
92172718|NCT03315910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172719|NCT03315910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172720|NCT03315910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92172721|NCT03315910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92172722|NCT03315910|Cholinergic Agents|cholinergic agents|mesh-ancestor
92315536|NCT04460326|Insulin Aspart|insulin aspart|mesh-list
92172723|NCT03315910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172724|NCT03315910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172726|NCT03248570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172727|NCT03248570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172728|NCT03248570|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92172729|NCT03248570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172730|NCT03208231|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92172731|NCT03208231|Antiviral Agents|antiviral agents|mesh-ancestor
92172732|NCT03208231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172733|NCT03198000|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92172734|NCT03198000|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92172735|NCT03152058|Certolizumab Pegol|certolizumab pegol|mesh-list
92172736|NCT03152058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92172737|NCT03152058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92172738|NCT03152058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92315599|NCT04150042|Vitamins|vitamins|mesh-list
92172739|NCT03152058|Immunologic Factors|immunologic factors|mesh-ancestor
92172740|NCT03152058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172741|NCT03152058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172742|NCT03113617|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
92172743|NCT03113617|Bombesin|bombesin|mesh-list
92172744|NCT03113617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172745|NCT03113617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172746|NCT03113617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172747|NCT03113617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92172748|NCT03102242|Atezolizumab|atezolizumab|mesh-list
92172749|NCT03102242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92172750|NCT03102242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172751|NCT03102242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172752|NCT03102242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172753|NCT03090776|Ketamine|ketamine|mesh-list
92172754|NCT03090776|Analgesics|analgesics|mesh-ancestor
92172755|NCT03090776|Sensory System Agents|sensory system agents|mesh-ancestor
92172756|NCT03090776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172757|NCT03090776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172758|NCT03090776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92172759|NCT03090776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92172760|NCT03090776|Anesthetics, General|anesthetics, general|mesh-ancestor
92172761|NCT03090776|Anesthetics|anesthetics|mesh-ancestor
92315645|NCT04044534|Insulin|insulin|mesh-list
92172762|NCT03090776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172763|NCT03090776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92106601|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92172764|NCT03090776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92172765|NCT03090776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172766|NCT03090776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172768|NCT02994784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92172769|NCT02994784|Alkylating Agents|alkylating agents|mesh-ancestor
92172770|NCT02994784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172771|NCT02994784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172772|NCT02994784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92172773|NCT02994784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172774|NCT02994784|Immunologic Factors|immunologic factors|mesh-ancestor
92172775|NCT02994784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172776|NCT02966847|Anesthetics|anesthetics|mesh-list
92172777|NCT02966847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172778|NCT02966847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172779|NCT02908685|Risdiplam|risdiplam|mesh-list
92172780|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92172781|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315710|NCT03680053|Cetrorelix|cetrorelix|mesh-list
92172782|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172783|NCT02884440|Ropivacaine|ropivacaine|mesh-list
92172784|NCT02884440|Anesthetics|anesthetics|mesh-ancestor
92172785|NCT02884440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172786|NCT02884440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172787|NCT02884440|Anesthetics, Local|anesthetics, local|mesh-ancestor
92172788|NCT02884440|Sensory System Agents|sensory system agents|mesh-ancestor
92172789|NCT02884440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172791|NCT02851303|Methadone|methadone|mesh-list
92172792|NCT02851303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92172793|NCT02851303|Narcotics|narcotics|mesh-ancestor
92172794|NCT02851303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92172795|NCT02851303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172796|NCT02851303|Analgesics|analgesics|mesh-ancestor
92172797|NCT02851303|Sensory System Agents|sensory system agents|mesh-ancestor
92172798|NCT02851303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172799|NCT02851303|Antitussive Agents|antitussive agents|mesh-ancestor
92172800|NCT02851303|Respiratory System Agents|respiratory system agents|mesh-ancestor
92172801|NCT02775500|Apremilast|apremilast|mesh-list
92172802|NCT02775500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92172803|NCT02775500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92172804|NCT02775500|Analgesics|analgesics|mesh-ancestor
92172805|NCT02775500|Sensory System Agents|sensory system agents|mesh-ancestor
92172806|NCT02775500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172807|NCT02775500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172808|NCT02775500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92172809|NCT02775500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92172810|NCT02775500|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92172811|NCT02775500|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92315753|NCT03646175|Choline|choline|mesh-list
92172812|NCT02775500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391730|NCT01725204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172813|NCT02775500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172814|NCT02689440|Venetoclax|venetoclax|mesh-list
92172815|NCT02689440|Dasatinib|dasatinib|mesh-list
92172816|NCT02689440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172817|NCT02689440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172818|NCT02689440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172819|NCT02689440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172820|NCT02549170|Immunoglobulins|immunoglobulins|mesh-list
92172821|NCT02549170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92172822|NCT02549170|Antibodies|antibodies|mesh-list
92172823|NCT02549170|Immunoglobulin G|immunoglobulin g|mesh-list
92172824|NCT02549170|gamma-Globulins|gamma-globulins|mesh-list
92172825|NCT02549170|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92172826|NCT02549170|Immunologic Factors|immunologic factors|mesh-ancestor
92172827|NCT02549170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172828|NCT02476916|Mitapivat|mitapivat|mesh-list
92172829|NCT02476916|Enzyme Activators|enzyme activators|mesh-ancestor
92322329|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172830|NCT02476916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172831|NCT02384122|Octreotide|octreotide|mesh-list
92172832|NCT02384122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92172833|NCT02384122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106608|NCT02515734|Leucovorin|leucovorin|mesh-list
92172834|NCT02384122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172835|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92172836|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92172837|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172838|NCT02363335|Incretins|incretins|mesh-ancestor
92172839|NCT02363335|Hormones|hormones|mesh-ancestor
92172840|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172841|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92172842|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
92172843|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172844|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172845|NCT02271919|Nicotine|nicotine|mesh-list
92172846|NCT02271919|Varenicline|varenicline|mesh-list
92172847|NCT02271919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92172848|NCT02271919|Autonomic Agents|autonomic agents|mesh-ancestor
92172849|NCT02271919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172850|NCT02271919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172851|NCT02271919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92172852|NCT02271919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92172853|NCT02271919|Cholinergic Agents|cholinergic agents|mesh-ancestor
92172854|NCT02271919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172855|NCT02271919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172857|NCT02103361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92172858|NCT01918397|Levofloxacin|levofloxacin|mesh-list
92172859|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92172860|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172861|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92172862|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92172863|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92172864|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172865|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172866|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172867|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92172868|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92172869|NCT01883024|Insulin|insulin|mesh-list
92172870|NCT01883024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92172871|NCT01883024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172872|NCT01611116|Sirolimus|sirolimus|mesh-list
92172873|NCT01611116|Temsirolimus|temsirolimus|mesh-list
92172874|NCT01611116|MTOR Inhibitors|mtor inhibitors|mesh-list
92172875|NCT01611116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172876|NCT01611116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172877|NCT01611116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172878|NCT01611116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92315903|NCT02652195|Oxytocin|oxytocin|mesh-list
92172879|NCT01611116|Immunologic Factors|immunologic factors|mesh-ancestor
92172880|NCT01611116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172881|NCT01611116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172882|NCT01611116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92172883|NCT01611116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172884|NCT01611116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172885|NCT01611116|Antifungal Agents|antifungal agents|mesh-ancestor
92172886|NCT01576315|Itraconazole|itraconazole|mesh-list
92172887|NCT01576315|Voriconazole|voriconazole|mesh-list
92172888|NCT01576315|Antifungal Agents|antifungal agents|mesh-ancestor
92172889|NCT01576315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172890|NCT01576315|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92172891|NCT01576315|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92172892|NCT01576315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172893|NCT01576315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172894|NCT01576315|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92172895|NCT01576315|Hormone Antagonists|hormone antagonists|mesh-ancestor
92172896|NCT01576315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172897|NCT01576315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172898|NCT01576315|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92172899|NCT01388387|Tacrolimus|tacrolimus|mesh-list
92172900|NCT01388387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172901|NCT01388387|Immunologic Factors|immunologic factors|mesh-ancestor
92172902|NCT01388387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172903|NCT01388387|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92172904|NCT01388387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172905|NCT01388387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172906|NCT01039090|Dopamine|dopamine|mesh-list
92172907|NCT01039090|Apomorphine|apomorphine|mesh-list
92172908|NCT01039090|Dopamine Agonists|dopamine agonists|mesh-list
92172909|NCT01039090|Emetics|emetics|mesh-ancestor
92315958|NCT01740557|Aldesleukin|aldesleukin|mesh-list
92172910|NCT01039090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172911|NCT01039090|Autonomic Agents|autonomic agents|mesh-ancestor
92172912|NCT01039090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172913|NCT01039090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92172914|NCT01039090|Dopamine Agents|dopamine agents|mesh-ancestor
92172915|NCT01039090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172916|NCT01039090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172917|NCT01039090|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92172918|NCT01039090|Sympathomimetics|sympathomimetics|mesh-ancestor
92172919|NCT01039090|Protective Agents|protective agents|mesh-ancestor
92172920|NCT00819637|Albuterol|albuterol|mesh-list
92172921|NCT00819637|Formoterol Fumarate|formoterol fumarate|mesh-list
92172922|NCT00819637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92172923|NCT00819637|Autonomic Agents|autonomic agents|mesh-ancestor
92172924|NCT00819637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172925|NCT00819637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172926|NCT00819637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92172927|NCT00819637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92172928|NCT00819637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92316001|NCT02834624|Poractant alfa|poractant alfa|mesh-list
92172929|NCT00819637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92172930|NCT00819637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92172931|NCT00819637|Adrenergic Agents|adrenergic agents|mesh-ancestor
92172932|NCT00819637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172933|NCT00819637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172934|NCT00819637|Tocolytic Agents|tocolytic agents|mesh-ancestor
92172935|NCT00819637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92172936|NCT00593060|Sirolimus|sirolimus|mesh-list
92172937|NCT00593060|Cetuximab|cetuximab|mesh-list
92172938|NCT00593060|Temsirolimus|temsirolimus|mesh-list
92172939|NCT00593060|MTOR Inhibitors|mtor inhibitors|mesh-list
92172940|NCT00593060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92172941|NCT00593060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172942|NCT00593060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172943|NCT00593060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172944|NCT00593060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172945|NCT00593060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92172946|NCT00593060|Immunologic Factors|immunologic factors|mesh-ancestor
92172947|NCT00593060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172948|NCT00593060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92172949|NCT00593060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172950|NCT00593060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92172951|NCT00593060|Antifungal Agents|antifungal agents|mesh-ancestor
92172952|NCT00287105|Imatinib Mesylate|imatinib mesylate|mesh-list
92172953|NCT00287105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92172954|NCT00287105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92172955|NCT00287105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92172956|NCT00287105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172957|NCT01332357|Fluticasone|fluticasone|mesh-list
92172959|NCT01332357|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92172960|NCT01332357|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92172961|NCT01332357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92172962|NCT01332357|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92172963|NCT01332357|Autonomic Agents|autonomic agents|mesh-ancestor
92172964|NCT01332357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92172965|NCT01332357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172966|NCT01332357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92172967|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
92172968|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316109|NCT02846792|Nivolumab|nivolumab|mesh-list
92172969|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92172970|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92172971|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92172972|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92172973|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
92172974|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92172975|NCT01332357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172976|NCT01332357|Glucocorticoids|glucocorticoids|mesh-ancestor
92172978|NCT01332357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92172979|NCT01332357|Sympathomimetics|sympathomimetics|mesh-ancestor
92172981|NCT04914936|Acalabrutinib|acalabrutinib|mesh-list
92172982|NCT04914936|Omeprazole|omeprazole|mesh-list
92172983|NCT04914936|Calcium Carbonate|calcium carbonate|mesh-list
92172984|NCT04914936|Calcium|calcium|mesh-list
92172985|NCT04914936|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92172986|NCT04914936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92172987|NCT04914936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92172988|NCT04914936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92172989|NCT04914936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92172990|NCT04914936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316179|NCT03050294|Hormones|hormones|mesh-ancestor
92172991|NCT04914936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92172992|NCT04914936|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92172993|NCT04914936|Antitubercular Agents|antitubercular agents|mesh-ancestor
92172994|NCT04914936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92172995|NCT04914936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92172996|NCT04914936|Leprostatic Agents|leprostatic agents|mesh-ancestor
92172997|NCT04914936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92172998|NCT04914936|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92172999|NCT04914936|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92173000|NCT04914936|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92173001|NCT04914936|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92173002|NCT04914936|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92173003|NCT04914936|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92173004|NCT04914936|Antacids|antacids|mesh-ancestor
92173005|NCT04914936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173006|NCT04914390|Paclitaxel|paclitaxel|mesh-list
92173007|NCT04914390|Tislelizumab|tislelizumab|mesh-list
92173008|NCT04914390|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173009|NCT04914390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173010|NCT04914390|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173011|NCT04914390|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173012|NCT04914390|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173013|NCT04914390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173014|NCT04914390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173015|NCT03054948|SMOFlipid|smoflipid|mesh-list
92173016|NCT03054948|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92173017|NCT03054948|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92173018|NCT03054948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92173019|NCT00986921|Mifepristone|mifepristone|mesh-list
92173020|NCT00986921|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92173021|NCT00986921|Abortifacient Agents|abortifacient agents|mesh-ancestor
92173022|NCT00986921|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92173023|NCT00986921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173024|NCT00986921|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92173025|NCT00986921|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92173026|NCT00986921|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92173027|NCT00986921|Contraceptive Agents|contraceptive agents|mesh-ancestor
92173028|NCT00986921|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92173029|NCT00986921|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92173030|NCT00986921|Hormone Antagonists|hormone antagonists|mesh-ancestor
92173031|NCT00986921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173032|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
92173033|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92173034|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92173035|NCT01383759|Dexamethasone|dexamethasone|mesh-list
92173036|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
92173037|NCT01383759|Bortezomib|bortezomib|mesh-list
92173038|NCT01383759|BB 1101|bb 1101|mesh-list
92173039|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173040|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
92173041|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
92173042|NCT01383759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173043|NCT01383759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173044|NCT01383759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173045|NCT01383759|Glucocorticoids|glucocorticoids|mesh-ancestor
92173046|NCT01383759|Hormones|hormones|mesh-ancestor
92173047|NCT01383759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173048|NCT01383759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173049|NCT01383759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173050|NCT01383759|Protease Inhibitors|protease inhibitors|mesh-ancestor
92173052|NCT01383759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173053|NCT01384539|Cholecalciferol|cholecalciferol|mesh-list
92173054|NCT01384539|Vitamin D|vitamin d|mesh-list
92173055|NCT01384539|Calcitriol|calcitriol|mesh-list
92173056|NCT01384539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92173057|NCT01384539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173058|NCT01384539|Vitamins|vitamins|mesh-ancestor
92173059|NCT01384539|Micronutrients|micronutrients|mesh-ancestor
92173060|NCT01384539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92173061|NCT01384539|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92173062|NCT01384539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173063|NCT01384539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173064|NCT01384539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92173065|NCT04902222|Morphine|morphine|mesh-list
92173066|NCT04902222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92173067|NCT04902222|Narcotics|narcotics|mesh-ancestor
92173068|NCT04902222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92173069|NCT04902222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173070|NCT04902222|Analgesics|analgesics|mesh-ancestor
92173071|NCT04902222|Sensory System Agents|sensory system agents|mesh-ancestor
92173072|NCT04902222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173073|NCT04904406|Lamivudine|lamivudine|mesh-list
92173074|NCT04904406|Abacavir|abacavir|mesh-list
92173075|NCT04904406|Dolutegravir|dolutegravir|mesh-list
92173076|NCT04904406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92173077|NCT04904406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92173078|NCT04904406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173079|NCT04904406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173080|NCT04904406|Antiviral Agents|antiviral agents|mesh-ancestor
92173081|NCT04904406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173082|NCT04904406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92173083|NCT04904406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92173084|NCT04904406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92173085|NCT04904406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92173086|NCT00985751|Vaccines|vaccines|mesh-list
92173087|NCT00985751|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92173088|NCT00985751|Immunologic Factors|immunologic factors|mesh-ancestor
92173089|NCT00985751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173090|NCT02337985|Prednisone|prednisone|mesh-list
92173091|NCT02337985|Cyclophosphamide|cyclophosphamide|mesh-list
92173092|NCT02337985|Rituximab|rituximab|mesh-list
92173093|NCT02337985|Doxorubicin|doxorubicin|mesh-list
92173094|NCT02337985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92173095|NCT02337985|Etoposide|etoposide|mesh-list
92173096|NCT02337985|Vincristine|vincristine|mesh-list
92173097|NCT02337985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173098|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
92173099|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173100|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173101|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92173102|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
92173103|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173104|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173105|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92173106|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173107|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92173108|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173109|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173110|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316352|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
92173111|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173112|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
92173113|NCT02337985|Hormones|hormones|mesh-ancestor
92173114|NCT02337985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173115|NCT02337985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173116|NCT02337985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173117|NCT02337985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173118|NCT02337985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173119|NCT02337985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173120|NCT02429557|Midodrine|midodrine|mesh-list
92173121|NCT02429557|Sympathomimetics|sympathomimetics|mesh-ancestor
92173122|NCT02429557|Autonomic Agents|autonomic agents|mesh-ancestor
92173123|NCT02429557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173124|NCT02429557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173125|NCT02429557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92173126|NCT02429557|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92173127|NCT02429557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92173128|NCT02429557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92173129|NCT02429557|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173130|NCT02429557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173131|NCT02429557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173132|NCT03052140|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92173133|NCT03052140|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92173134|NCT04884516|Vitamin A|vitamin a|mesh-list
92173135|NCT04884516|Vitamins|vitamins|mesh-ancestor
92173136|NCT04884516|Micronutrients|micronutrients|mesh-ancestor
92173137|NCT04884516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173138|NCT04884282|Docetaxel|docetaxel|mesh-list
92173139|NCT04884282|Nivolumab|nivolumab|mesh-list
92173140|NCT04884282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173141|NCT04884282|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173142|NCT04884282|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173143|NCT04884282|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173144|NCT04884282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173145|NCT04884282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173146|NCT04884282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92173147|NCT04346329|Hydroxychloroquine|hydroxychloroquine|mesh-list
92173148|NCT04346329|Antimalarials|antimalarials|mesh-ancestor
92173149|NCT04346329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92173150|NCT04346329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92173151|NCT04346329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173152|NCT04346329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173153|NCT04346329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173154|NCT04346329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173155|NCT02422381|Gemcitabine|gemcitabine|mesh-list
92173156|NCT02422381|Pembrolizumab|pembrolizumab|mesh-list
92173157|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92173158|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
92173159|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173160|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173161|NCT02422381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173162|NCT02422381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92173163|NCT04883736|Tretinoin|tretinoin|mesh-list
92173164|NCT04883736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173165|NCT04883736|Keratolytic Agents|keratolytic agents|mesh-ancestor
92173166|NCT04883736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92173167|NCT02312557|Pembrolizumab|pembrolizumab|mesh-list
92173168|NCT02312557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173169|NCT02312557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173170|NCT02312557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92173171|NCT02312557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173172|NCT01387815|Adalimumab|adalimumab|mesh-list
92173173|NCT01387815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92173174|NCT01387815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173175|NCT01387815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173176|NCT04883034|Analgesics|analgesics|mesh-list
92173177|NCT04883034|Sensory System Agents|sensory system agents|mesh-ancestor
92173178|NCT04883034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173179|NCT04883034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173180|NCT01596504|Metformin|metformin|mesh-list
92173181|NCT01596504|Insulin Glargine|insulin glargine|mesh-list
92173182|NCT01596504|Liraglutide|liraglutide|mesh-list
92173183|NCT01596504|Lixisenatide|lixisenatide|mesh-list
92173184|NCT01596504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391731|NCT01725204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173185|NCT01596504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173187|NCT01596504|Hormones|hormones|mesh-ancestor
92173188|NCT01596504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173189|NCT02394769|Aspirin|aspirin|mesh-list
92173190|NCT02394769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92173191|NCT02394769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92173192|NCT02394769|Analgesics|analgesics|mesh-ancestor
92173193|NCT02394769|Sensory System Agents|sensory system agents|mesh-ancestor
92173194|NCT02394769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173195|NCT02394769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173197|NCT02394769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173198|NCT02394769|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92173199|NCT02394769|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92173200|NCT02394769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173201|NCT02394769|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92173202|NCT02394769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92173203|NCT02394769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173204|NCT02394769|Antipyretics|antipyretics|mesh-ancestor
92173205|NCT01334229|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92173206|NCT01334229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92173207|NCT01334229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173208|NCT01334229|Incretins|incretins|mesh-ancestor
92173209|NCT01334229|Hormones|hormones|mesh-ancestor
92327622|NCT00003092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173210|NCT01334229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173211|NCT01334229|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92173213|NCT01334229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173214|NCT01334229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173215|NCT01390077|Nitisinone|nitisinone|mesh-list
92173216|NCT01390077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173217|NCT01390077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173218|NCT02292979|Doxorubicin|doxorubicin|mesh-list
92173219|NCT02292979|Bleomycin|bleomycin|mesh-list
92173220|NCT02292979|Dacarbazine|dacarbazine|mesh-list
92173221|NCT02292979|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92173222|NCT02292979|Vinblastine|vinblastine|mesh-list
92173223|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92173224|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316466|NCT03117140|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92173225|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173226|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173227|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173228|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173229|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92173230|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
92173231|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173232|NCT02292979|Immunotoxins|immunotoxins|mesh-ancestor
92173233|NCT02292979|Immunoconjugates|immunoconjugates|mesh-ancestor
92173234|NCT02292979|Immunologic Factors|immunologic factors|mesh-ancestor
92173235|NCT02292979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173236|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173237|NCT02292979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173238|NCT02292979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173239|NCT02292979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173240|NCT02394535|Paclitaxel|paclitaxel|mesh-list
92173241|NCT02394535|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92173242|NCT02394535|Capecitabine|capecitabine|mesh-list
92173243|NCT02394535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173244|NCT02394535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173245|NCT02394535|Tubulin Modulators|tubulin modulators|mesh-ancestor
92316512|NCT03070730|Droxidopa|droxidopa|mesh-list
92173246|NCT02394535|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173247|NCT02394535|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173248|NCT02394535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173249|NCT02394535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92173250|NCT02394535|Antimetabolites|antimetabolites|mesh-ancestor
92173251|NCT02285959|Bevacizumab|bevacizumab|mesh-list
92173252|NCT02285959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173253|NCT02285959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173254|NCT02285959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92173255|NCT02285959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92173256|NCT02285959|Growth Substances|growth substances|mesh-ancestor
92043038|NCT02269943|Cc-486|cc-486|mesh-list
92173257|NCT02285959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173258|NCT02285959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92173260|NCT01404429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92173261|NCT01404429|Abortifacient Agents|abortifacient agents|mesh-ancestor
92173262|NCT01404429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92173263|NCT01404429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173264|NCT01404429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92173265|NCT01404429|Antimetabolites|antimetabolites|mesh-ancestor
92173266|NCT01404429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173267|NCT01404429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173268|NCT01404429|Dermatologic Agents|dermatologic agents|mesh-ancestor
92173269|NCT01404429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173270|NCT01404429|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92173271|NCT01404429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173272|NCT01404429|Immunologic Factors|immunologic factors|mesh-ancestor
92173273|NCT01404429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173274|NCT01404429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92173276|NCT03051906|Durvalumab|durvalumab|mesh-list
92173277|NCT03051906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173278|NCT03051906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173281|NCT01390233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92173282|NCT01390233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173283|NCT03051360|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92173284|NCT03051360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92173285|NCT03051360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92173286|NCT03051360|Antimetabolites|antimetabolites|mesh-ancestor
92173287|NCT03051360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173288|NCT03051360|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92173289|NCT03051360|Protease Inhibitors|protease inhibitors|mesh-ancestor
92173290|NCT03051360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173291|NCT03051360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92173292|NCT05026567|Midazolam|midazolam|mesh-list
92173293|NCT05026567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92173294|NCT05026567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92173295|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92173296|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173297|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92173298|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92173299|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92173300|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92173301|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
92173302|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
92173303|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
92173304|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
92173305|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173306|NCT05026567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173307|NCT01391013|Ritonavir|ritonavir|mesh-list
92173308|NCT01391013|Darunavir|darunavir|mesh-list
92173309|NCT01391013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92173310|NCT01391013|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92173311|NCT01391013|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92173312|NCT01391013|Protease Inhibitors|protease inhibitors|mesh-ancestor
92173313|NCT01391013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173314|NCT01391013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173315|NCT01391013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92173316|NCT01391013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92173317|NCT01391013|Antiviral Agents|antiviral agents|mesh-ancestor
92173318|NCT01391013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173319|NCT01391013|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92173320|NCT01391013|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92173321|NCT01391013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92173322|NCT01891747|Bevacizumab|bevacizumab|mesh-list
92173323|NCT01891747|Temozolomide|temozolomide|mesh-list
92173324|NCT01891747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173325|NCT01891747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173326|NCT01891747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92173327|NCT01891747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92173328|NCT01891747|Growth Substances|growth substances|mesh-ancestor
92173329|NCT01891747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173330|NCT01891747|Growth Inhibitors|growth inhibitors|mesh-ancestor
92173331|NCT01891747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92106636|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92173332|NCT01891747|Alkylating Agents|alkylating agents|mesh-ancestor
92173333|NCT01891747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173334|NCT04899570|Prednisone|prednisone|mesh-list
92173335|NCT04899570|Cyclophosphamide|cyclophosphamide|mesh-list
92173336|NCT04899570|Rituximab|rituximab|mesh-list
92173337|NCT04899570|Epirubicin|epirubicin|mesh-list
92173338|NCT04899570|Zanubrutinib|zanubrutinib|mesh-list
92173339|NCT04899570|Vindesine|vindesine|mesh-list
92173340|NCT04899570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173341|NCT04899570|Immunologic Factors|immunologic factors|mesh-ancestor
92173342|NCT04899570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173343|NCT04899570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173344|NCT04899570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92173345|NCT04899570|Alkylating Agents|alkylating agents|mesh-ancestor
92173346|NCT04899570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173347|NCT04899570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173349|NCT04899570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173350|NCT04899570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173351|NCT04899570|Glucocorticoids|glucocorticoids|mesh-ancestor
92173352|NCT04899570|Hormones|hormones|mesh-ancestor
92316646|NCT02858713|Betamethasone|betamethasone|mesh-list
92173353|NCT04899570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173354|NCT04899570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173355|NCT04899570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92173356|NCT04899570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173357|NCT04899570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173358|NCT04899570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173359|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92173360|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173361|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173362|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173363|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173364|NCT02274415|Vaccines|vaccines|mesh-list
92173365|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92173366|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
92173367|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173368|NCT03049878|Acetaminophen|acetaminophen|mesh-list
92173369|NCT03049878|Codeine|codeine|mesh-list
92173370|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92173371|NCT03049878|Analgesics|analgesics|mesh-ancestor
92173372|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
92173373|NCT03049878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173374|NCT03049878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173375|NCT03049878|Antipyretics|antipyretics|mesh-ancestor
92173376|NCT03049878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92173377|NCT03049878|Narcotics|narcotics|mesh-ancestor
92173378|NCT03049878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92173379|NCT03049878|Antitussive Agents|antitussive agents|mesh-ancestor
92173380|NCT03049878|Respiratory System Agents|respiratory system agents|mesh-ancestor
92173381|NCT01391325|Allopurinol|allopurinol|mesh-list
92173382|NCT01391325|Antimetabolites|antimetabolites|mesh-ancestor
92316686|NCT03082196|Cariostatic Agents|cariostatic agents|mesh-ancestor
92173383|NCT01391325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173384|NCT01391325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173385|NCT01391325|Gout Suppressants|gout suppressants|mesh-ancestor
92173386|NCT01391325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173387|NCT01391325|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92173388|NCT01391325|Antioxidants|antioxidants|mesh-ancestor
92173389|NCT01391325|Protective Agents|protective agents|mesh-ancestor
92173390|NCT01391325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173391|NCT01980823|Metformin|metformin|mesh-list
92173392|NCT01980823|Atorvastatin|atorvastatin|mesh-list
92173393|NCT01980823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92173394|NCT01980823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173395|NCT01980823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92173396|NCT01980823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92173397|NCT01980823|Antimetabolites|antimetabolites|mesh-ancestor
92173398|NCT01980823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173399|NCT01980823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92316731|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92173400|NCT01980823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92173401|NCT01980823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173402|NCT01976065|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92173403|NCT01976065|Metronidazole|metronidazole|mesh-list
92173404|NCT01976065|Ciprofloxacin|ciprofloxacin|mesh-list
92173405|NCT01976065|Minocycline|minocycline|mesh-list
92173406|NCT01976065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173407|NCT01976065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92173408|NCT01976065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92173409|NCT01976065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173410|NCT01976065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173411|NCT01976065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173412|NCT01976065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173413|NCT01976065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173414|NCT01976065|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92173415|NCT01976065|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92173416|NCT04891458|Dexmedetomidine|dexmedetomidine|mesh-list
92173417|NCT04891458|Anesthetics|anesthetics|mesh-list
92173419|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92173420|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173421|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92322330|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
92173422|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92173425|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173426|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92173427|NCT04891458|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92173428|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92173429|NCT04891458|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173430|NCT04891458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173431|NCT04891458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173432|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92173433|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
92173434|NCT04899414|Dexamethasone|dexamethasone|mesh-list
92173435|NCT04899414|Azacitidine|azacitidine|mesh-list
92173436|NCT04899414|Tislelizumab|tislelizumab|mesh-list
92173437|NCT04899414|Pegaspargase|pegaspargase|mesh-list
92173438|NCT04899414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173439|NCT04899414|Antiemetics|antiemetics|mesh-ancestor
92173440|NCT04899414|Autonomic Agents|autonomic agents|mesh-ancestor
92173441|NCT04899414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173442|NCT04899414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173443|NCT04899414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173444|NCT04899414|Glucocorticoids|glucocorticoids|mesh-ancestor
92173445|NCT04899414|Hormones|hormones|mesh-ancestor
92173446|NCT04899414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173447|NCT04899414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173448|NCT04899414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173449|NCT04899414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92173450|NCT04899414|Antimetabolites|antimetabolites|mesh-ancestor
92173451|NCT04899414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173452|NCT04899414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173453|NCT04899414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173454|NCT03008655|Tranexamic Acid|tranexamic acid|mesh-list
92173455|NCT03008655|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92173456|NCT03008655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92173457|NCT03008655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173458|NCT03008655|Hemostatics|hemostatics|mesh-ancestor
92173460|NCT01894633|Chloroquine|chloroquine|mesh-list
92173461|NCT01894633|Amebicides|amebicides|mesh-ancestor
92173462|NCT01894633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92173463|NCT01894633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92173464|NCT01894633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173465|NCT01894633|Antimalarials|antimalarials|mesh-ancestor
92173466|NCT01894633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173467|NCT05585671|Belimumab|belimumab|mesh-list
92173468|NCT05585671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173469|NCT05585671|Immunologic Factors|immunologic factors|mesh-ancestor
92173470|NCT05585671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173471|NCT01391559|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92173472|NCT01391559|Formoterol Fumarate|formoterol fumarate|mesh-list
92173473|NCT01391559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92173474|NCT01391559|Autonomic Agents|autonomic agents|mesh-ancestor
92173475|NCT01391559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173476|NCT01391559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173477|NCT01391559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92173478|NCT01391559|Respiratory System Agents|respiratory system agents|mesh-ancestor
92173479|NCT01391559|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92173480|NCT01391559|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92173481|NCT01391559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92173482|NCT01391559|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173483|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173484|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173485|NCT01335789|Oxytocin|oxytocin|mesh-list
92173486|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
92173487|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92173488|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173489|NCT02202135|Vancomycin|vancomycin|mesh-list
92173490|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92173491|NCT02202135|Aztreonam|aztreonam|mesh-list
92173492|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92173493|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173494|NCT05585281|Fluzoparib|fluzoparib|mesh-list
92173495|NCT05585281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92173496|NCT05585281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173497|NCT05585281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173500|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
92173501|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173502|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173503|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
92173504|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173505|NCT01335867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173506|NCT01894711|Trastuzumab|trastuzumab|mesh-list
92173507|NCT01894711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173508|NCT01894711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173509|NCT00985439|Celecoxib|celecoxib|mesh-list
92173510|NCT00985439|Diclofenac|diclofenac|mesh-list
92173511|NCT00985439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92173512|NCT00985439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92173513|NCT00985439|Analgesics|analgesics|mesh-ancestor
92173514|NCT00985439|Sensory System Agents|sensory system agents|mesh-ancestor
92173515|NCT00985439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173516|NCT00985439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173517|NCT00985439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173518|NCT00985439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173519|NCT00985439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92173520|NCT00985439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92173521|NCT00985439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173522|NCT00985439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173523|NCT02984111|Epoetin Alfa|epoetin alfa|mesh-list
92173524|NCT02984111|Hematinics|hematinics|mesh-ancestor
92173525|NCT04412148|Triamcinolone|triamcinolone|mesh-list
92173526|NCT04412148|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92173527|NCT04412148|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92173528|NCT04412148|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92173529|NCT04412148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173530|NCT04412148|Glucocorticoids|glucocorticoids|mesh-ancestor
92173531|NCT04412148|Hormones|hormones|mesh-ancestor
92173532|NCT04412148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173533|NCT04412148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173534|NCT04412148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173535|NCT04412148|Immunologic Factors|immunologic factors|mesh-ancestor
92173536|NCT04412148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173537|NCT04412148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173538|NCT04890522|Gemcitabine|gemcitabine|mesh-list
92173539|NCT04890522|Fluorouracil|fluorouracil|mesh-list
92173540|NCT04890522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173541|NCT04890522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92173542|NCT04890522|Antimetabolites|antimetabolites|mesh-ancestor
92173543|NCT04890522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173544|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173545|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
92173546|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173547|NCT01525069|Dexamethasone|dexamethasone|mesh-list
92173548|NCT01525069|Gemcitabine|gemcitabine|mesh-list
92173549|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
92173550|NCT01525069|Floxuridine|floxuridine|mesh-list
92173551|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173552|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
92173553|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
92173554|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173555|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173556|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173557|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
92173558|NCT01525069|Hormones|hormones|mesh-ancestor
92173559|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173560|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173561|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173562|NCT01525069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92317034|NCT02222922|Avelumab|avelumab|mesh-list
92173563|NCT01525069|Antimetabolites|antimetabolites|mesh-ancestor
92173564|NCT01525069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173566|NCT04898946|Immunologic Factors|immunologic factors|mesh-ancestor
92173567|NCT04898946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173568|NCT02249065|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92173569|NCT02249065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92173570|NCT02249065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92173571|NCT02249065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92173573|NCT02249065|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173574|NCT02249065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173575|NCT02249065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173576|NCT02249065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173577|NCT00983957|Moxifloxacin|moxifloxacin|mesh-list
92173578|NCT00983957|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92173579|NCT00983957|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92173580|NCT00983957|Contraceptive Agents|contraceptive agents|mesh-ancestor
92173581|NCT00983957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92173582|NCT00983957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173583|NCT00983957|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92173584|NCT00983957|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92173585|NCT00983957|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92173586|NCT00983957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92173587|NCT00983957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173588|NCT00983957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173589|NCT00983957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173590|NCT00983957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173591|NCT00983957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173592|NCT00983957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173593|NCT01894867|Magnesium Oxide|magnesium oxide|mesh-list
92173594|NCT01894867|Antacids|antacids|mesh-ancestor
92173595|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173596|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173597|NCT01521403|Metronidazole|metronidazole|mesh-list
92173598|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173599|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92173600|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92173601|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92173602|NCT04881942|Menthol|menthol|mesh-list
92173603|NCT04881942|Nicotine|nicotine|mesh-list
92173604|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92173605|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
92173606|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173607|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173608|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92173609|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92173610|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
92173611|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173612|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173613|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
92173614|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
92173615|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
92173616|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173617|NCT04126811|Apatinib|apatinib|mesh-list
92173618|NCT04126811|Ifosfamide|ifosfamide|mesh-list
92173619|NCT04126811|Isophosphamide mustard|isophosphamide mustard|mesh-list
92173620|NCT04126811|Pirarubicin|pirarubicin|mesh-list
92173621|NCT04126811|Doxorubicin|doxorubicin|mesh-list
92173622|NCT04126811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173623|NCT04126811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92173624|NCT04126811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173625|NCT04126811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173626|NCT04126811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92173627|NCT04126811|Alkylating Agents|alkylating agents|mesh-ancestor
92173628|NCT04126811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92173629|NCT04126811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173630|NCT04126811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173631|NCT01406223|Bupropion|bupropion|mesh-list
92173632|NCT01406223|Nicotine|nicotine|mesh-list
92173633|NCT01406223|Varenicline|varenicline|mesh-list
92173634|NCT01406223|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92173636|NCT01406223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173637|NCT01406223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173638|NCT01406223|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92173639|NCT01406223|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92317121|NCT03087578|Mirabegron|mirabegron|mesh-list
92173640|NCT01406223|Cholinergic Agents|cholinergic agents|mesh-ancestor
92173641|NCT01406223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173642|NCT01406223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173643|NCT01406223|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92173644|NCT01406223|Antidepressive Agents|antidepressive agents|mesh-ancestor
92173645|NCT01406223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92173646|NCT01406223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92173648|NCT01406223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173649|NCT01406223|Dopamine Agents|dopamine agents|mesh-ancestor
92173650|NCT01406223|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92173651|NCT01406223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92173652|NCT01406223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173653|NCT02230969|Interferons|interferons|mesh-list
92173654|NCT02230969|Interferon-beta|interferon-beta|mesh-list
92173655|NCT02230969|Interferon beta-1a|interferon beta-1a|mesh-list
92173656|NCT02230969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173657|NCT02230969|Antiviral Agents|antiviral agents|mesh-ancestor
92173658|NCT02230969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173659|NCT02230969|Immunologic Factors|immunologic factors|mesh-ancestor
92173660|NCT02230969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173661|NCT02230969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92173663|NCT04881474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92173664|NCT04881474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92173665|NCT04881474|Analgesics|analgesics|mesh-ancestor
92173666|NCT04881474|Sensory System Agents|sensory system agents|mesh-ancestor
92173667|NCT04881474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173668|NCT04881474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173669|NCT04881474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173670|NCT04881474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173671|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92173672|NCT04881474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173673|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173674|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92173675|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92173676|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92173677|NCT00981149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173678|NCT00981149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173679|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173680|NCT00981149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173681|NCT00981149|Analgesics|analgesics|mesh-ancestor
92173682|NCT00981149|Sensory System Agents|sensory system agents|mesh-ancestor
92173683|NCT00981149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173684|NCT00981149|Antidepressive Agents|antidepressive agents|mesh-ancestor
92173685|NCT00981149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92173686|NCT00981149|Dopamine Agents|dopamine agents|mesh-ancestor
92173688|NCT04881006|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92173689|NCT04881006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173690|NCT04881006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92173691|NCT04881006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173692|NCT01595646|Insulin|insulin|mesh-list
92173693|NCT01595646|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92173694|NCT01595646|Insulin Detemir|insulin detemir|mesh-list
92173695|NCT01595646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92173696|NCT01595646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173697|NCT01907191|Bupivacaine|bupivacaine|mesh-list
92173698|NCT01907191|Anesthetics, Local|anesthetics, local|mesh-ancestor
92173699|NCT01907191|Anesthetics|anesthetics|mesh-ancestor
92173700|NCT01907191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92173701|NCT01907191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173702|NCT01907191|Sensory System Agents|sensory system agents|mesh-ancestor
92173703|NCT01907191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173704|NCT01395537|Paclitaxel|paclitaxel|mesh-list
92173705|NCT01395537|Carboplatin|carboplatin|mesh-list
92173706|NCT01395537|Lapatinib|lapatinib|mesh-list
92173707|NCT01395537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173708|NCT01395537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173709|NCT01395537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173711|NCT01395537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173712|NCT01395537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173713|NCT01395537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92173714|NCT01395537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173715|NCT04898712|Tranexamic Acid|tranexamic acid|mesh-list
92173716|NCT04898712|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92173717|NCT04898712|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92173718|NCT04898712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173719|NCT04898712|Hemostatics|hemostatics|mesh-ancestor
92173721|NCT04898556|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92173722|NCT04898556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92173723|NCT04898556|Immunologic Factors|immunologic factors|mesh-ancestor
92173724|NCT04898556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173725|NCT02317549|Tranexamic Acid|tranexamic acid|mesh-list
92173726|NCT02317549|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92173727|NCT02317549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92173728|NCT02317549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173729|NCT02317549|Hemostatics|hemostatics|mesh-ancestor
92173730|NCT02317549|Coagulants|coagulants|mesh-ancestor
92173731|NCT05583643|Calcium, Dietary|calcium, dietary|mesh-list
92173732|NCT05583643|Atorvastatin|atorvastatin|mesh-list
92173733|NCT05583643|Calcium|calcium|mesh-list
92173734|NCT05583643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92173735|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173736|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92173737|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92173738|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92173739|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
92173740|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173741|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92173742|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92173743|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173744|NCT02225275|Lenalidomide|lenalidomide|mesh-list
92173745|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
92173746|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
92173747|NCT02225275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173748|NCT02225275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92173749|NCT02225275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92173750|NCT02225275|Growth Substances|growth substances|mesh-ancestor
92173751|NCT02225275|Growth Inhibitors|growth inhibitors|mesh-ancestor
92173752|NCT02225275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173753|NCT02225275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173754|NCT01897441|Paclitaxel|paclitaxel|mesh-list
92173755|NCT01897441|Cyclophosphamide|cyclophosphamide|mesh-list
92173756|NCT01897441|Doxorubicin|doxorubicin|mesh-list
92173757|NCT01897441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92173758|NCT01897441|Trastuzumab|trastuzumab|mesh-list
92173759|NCT01897441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92173760|NCT01897441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92173761|NCT01897441|Antibodies|antibodies|mesh-list
92173762|NCT01897441|Immunoglobulins|immunoglobulins|mesh-list
92173763|NCT01897441|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92106662|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
92173764|NCT01897441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92173765|NCT01897441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173766|NCT01897441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92173767|NCT01897441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92173768|NCT01897441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173769|NCT01897441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173770|NCT01897441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173771|NCT01897441|Immunologic Factors|immunologic factors|mesh-ancestor
92173772|NCT01897441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173773|NCT01897441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173774|NCT01897441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92173775|NCT01897441|Alkylating Agents|alkylating agents|mesh-ancestor
92173776|NCT01897441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92173777|NCT01897441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92173778|NCT01897441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92173779|NCT01897441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92173780|NCT01897441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173781|NCT01411137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92173782|NCT01411137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92173783|NCT01411137|Immunologic Factors|immunologic factors|mesh-ancestor
92173784|NCT01411137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173785|NCT01411137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92173786|NCT01411137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92173787|NCT01411137|Dopamine Agonists|dopamine agonists|mesh-ancestor
92173788|NCT01411137|Dopamine Agents|dopamine agents|mesh-ancestor
92173789|NCT01411137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173790|NCT01411137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173792|NCT04430556|Antidepressive Agents|antidepressive agents|mesh-ancestor
92173793|NCT04430556|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92173794|NCT04430556|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92173795|NCT04430556|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92173796|NCT04430556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173797|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173798|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173799|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
92173800|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173802|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173803|NCT01892527|Cetuximab|cetuximab|mesh-list
92173804|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173805|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173806|NCT01399827|Methylphenidate|methylphenidate|mesh-list
92173807|NCT01399827|Amphetamine|amphetamine|mesh-list
92173808|NCT01399827|Adderall|adderall|mesh-list
92173809|NCT01399827|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92173810|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
92173811|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92173812|NCT01399827|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92173813|NCT01399827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173814|NCT01399827|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92173815|NCT01399827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92173816|NCT01399827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173817|NCT01399827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173818|NCT01399827|Dopamine Agents|dopamine agents|mesh-ancestor
92173819|NCT01399827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173820|NCT01399827|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92173821|NCT01399827|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173822|NCT01399827|Sympathomimetics|sympathomimetics|mesh-ancestor
92173823|NCT01399827|Autonomic Agents|autonomic agents|mesh-ancestor
92173824|NCT01399827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173825|NCT04897386|Pemetrexed|pemetrexed|mesh-list
92173826|NCT04897386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173827|NCT04897386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173828|NCT04897386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173829|NCT04897386|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92173830|NCT04897386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92173831|NCT04879446|Mitogens|mitogens|mesh-list
92173832|NCT04879446|Mitosis Modulators|mitosis modulators|mesh-ancestor
92173833|NCT04879446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173834|NCT02618382|Tranexamic Acid|tranexamic acid|mesh-list
92173835|NCT02618382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92173836|NCT02618382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92173837|NCT02618382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173838|NCT02618382|Hemostatics|hemostatics|mesh-ancestor
92173839|NCT02618382|Coagulants|coagulants|mesh-ancestor
92173840|NCT02196961|Nivolumab|nivolumab|mesh-list
92173841|NCT02196961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173842|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173843|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92173844|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173845|NCT02177071|Infliximab|infliximab|mesh-list
92173846|NCT02177071|Methotrexate|methotrexate|mesh-list
92173847|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
92173848|NCT02177071|Azathioprine|azathioprine|mesh-list
92173849|NCT02177071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92173850|NCT02177071|Abortifacient Agents|abortifacient agents|mesh-ancestor
92173851|NCT02177071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92173852|NCT02177071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173853|NCT02177071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92173854|NCT02177071|Antimetabolites|antimetabolites|mesh-ancestor
92173855|NCT02177071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173856|NCT02177071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173857|NCT02177071|Dermatologic Agents|dermatologic agents|mesh-ancestor
92173858|NCT02177071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173859|NCT02177071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92173860|NCT02177071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173861|NCT02177071|Immunologic Factors|immunologic factors|mesh-ancestor
92173862|NCT02177071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92173863|NCT02177071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92173864|NCT02177071|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92173865|NCT02177071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173866|NCT02177071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173867|NCT04889196|Fluorides|fluorides|mesh-list
92173869|NCT04889196|Protective Agents|protective agents|mesh-ancestor
92173870|NCT04889196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173871|NCT03049176|Tenofovir|tenofovir|mesh-list
92173872|NCT03049176|Emtricitabine|emtricitabine|mesh-list
92173873|NCT03049176|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92173874|NCT03049176|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92173875|NCT03049176|Antiviral Agents|antiviral agents|mesh-ancestor
92173876|NCT03049176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173877|NCT03049176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92173878|NCT03049176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92173879|NCT03049176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173880|NCT03049176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173881|NCT03049176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92173882|NCT01895023|Midazolam|midazolam|mesh-list
92173883|NCT01895023|Dexmedetomidine|dexmedetomidine|mesh-list
92173884|NCT01895023|GABA Modulators|gaba modulators|mesh-list
92173885|NCT01895023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92173886|NCT01895023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92173887|NCT01895023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173888|NCT01895023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92173889|NCT01895023|Analgesics|analgesics|mesh-ancestor
92173890|NCT01895023|Sensory System Agents|sensory system agents|mesh-ancestor
92173891|NCT01895023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173892|NCT01895023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92173893|NCT01895023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92173894|NCT01895023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92173895|NCT01895023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173896|NCT01895023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173897|NCT01895023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173898|NCT01895023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92173899|NCT01895023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92173900|NCT01895023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92173901|NCT01895023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92173902|NCT01895023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92173903|NCT01895023|Anesthetics, General|anesthetics, general|mesh-ancestor
92173905|NCT01895023|GABA Agents|gaba agents|mesh-ancestor
92173906|NCT04888728|Nebivolol|nebivolol|mesh-list
92173907|NCT04888728|Paroxetine|paroxetine|mesh-list
92173908|NCT04888728|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92173909|NCT04888728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92173910|NCT04888728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92173911|NCT04888728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173912|NCT04888728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92173913|NCT04888728|Serotonin Agents|serotonin agents|mesh-ancestor
92173914|NCT04888728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173915|NCT04888728|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92173916|NCT04888728|Antidepressive Agents|antidepressive agents|mesh-ancestor
92173917|NCT04888728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92173918|NCT04888728|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92173919|NCT04888728|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92173920|NCT04888728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173921|NCT04888728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92173922|NCT04888728|Vasodilator Agents|vasodilator agents|mesh-ancestor
92173923|NCT04888728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92173924|NCT04888728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92173925|NCT04888728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92173926|NCT04888728|Adrenergic Agents|adrenergic agents|mesh-ancestor
92173927|NCT04125719|Nivolumab|nivolumab|mesh-list
92173928|NCT04125719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92173929|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173930|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92327623|NCT00381199|Amitriptyline|amitriptyline|mesh-list
92173931|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173933|NCT01428973|Sirolimus|sirolimus|mesh-list
92173934|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92173935|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173936|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92173937|NCT01428973|Antitubercular Agents|antitubercular agents|mesh-ancestor
92173938|NCT01428973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92173939|NCT01428973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173940|NCT01428973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173941|NCT01428973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173942|NCT01428973|Antifungal Agents|antifungal agents|mesh-ancestor
92173943|NCT01428973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92173944|NCT01428973|Immunologic Factors|immunologic factors|mesh-ancestor
92173945|NCT01428973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173946|NCT01421797|Dexamethasone|dexamethasone|mesh-list
92173947|NCT01421797|Cosyntropin|cosyntropin|mesh-list
92173948|NCT01421797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173949|NCT01421797|Antiemetics|antiemetics|mesh-ancestor
92173950|NCT01421797|Autonomic Agents|autonomic agents|mesh-ancestor
92173951|NCT01421797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173952|NCT01421797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173953|NCT01421797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173954|NCT01421797|Glucocorticoids|glucocorticoids|mesh-ancestor
92173956|NCT01421797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173957|NCT01421797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173958|NCT01421797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173959|NCT01475643|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92173960|NCT01475643|Prednisolone|prednisolone|mesh-list
92173961|NCT01475643|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92173962|NCT01475643|Methylprednisolone|methylprednisolone|mesh-list
92173963|NCT01475643|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92173964|NCT01475643|Prednisolone acetate|prednisolone acetate|mesh-list
92173965|NCT01475643|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92173967|NCT01475643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92173968|NCT01475643|Glucocorticoids|glucocorticoids|mesh-ancestor
92173969|NCT01475643|Hormones|hormones|mesh-ancestor
92173970|NCT01475643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92173971|NCT01475643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92173972|NCT01475643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92173973|NCT01475643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92173974|NCT01475643|Antiemetics|antiemetics|mesh-ancestor
92173975|NCT01475643|Autonomic Agents|autonomic agents|mesh-ancestor
92173976|NCT01475643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92173977|NCT01475643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173978|NCT01475643|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92106675|NCT02512380|Docetaxel|docetaxel|mesh-list
92173979|NCT01475643|Protective Agents|protective agents|mesh-ancestor
92173980|NCT01475643|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92173981|NCT01846663|Rifaximin|rifaximin|mesh-list
92173982|NCT01846663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92173983|NCT01846663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92173984|NCT01846663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92173985|NCT03004001|Atorvastatin|atorvastatin|mesh-list
92173986|NCT03004001|Alirocumab|alirocumab|mesh-list
92173987|NCT03004001|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92173988|NCT03004001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92173989|NCT03004001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92173990|NCT03004001|Antimetabolites|antimetabolites|mesh-ancestor
92173991|NCT03004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92173992|NCT03004001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92173993|NCT03004001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92173994|NCT03004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92173995|NCT03004001|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92173996|NCT03004001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92173997|NCT03004001|Protease Inhibitors|protease inhibitors|mesh-ancestor
92173998|NCT03004001|Immunologic Factors|immunologic factors|mesh-ancestor
92173999|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174000|NCT04395222|Fludarabine|fludarabine|mesh-list
92174002|NCT04395222|Thymoglobulin|thymoglobulin|mesh-list
92174003|NCT04395222|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92174004|NCT04395222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174005|NCT04395222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174006|NCT04395222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92174007|NCT04395222|Immunologic Factors|immunologic factors|mesh-ancestor
92174008|NCT04395222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174009|NCT04395222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92174010|NCT04395222|Alkylating Agents|alkylating agents|mesh-ancestor
92174011|NCT04395222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92174012|NCT04124003|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92174013|NCT04124003|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92174014|NCT04124003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92174015|NCT04124003|Antimetabolites|antimetabolites|mesh-ancestor
92174016|NCT04124003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174017|NCT04124003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92174018|NCT04124003|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92174019|NCT04124003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174020|NCT03237377|Durvalumab|durvalumab|mesh-list
92174021|NCT03237377|Tremelimumab|tremelimumab|mesh-list
92174022|NCT03237377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174023|NCT03237377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174024|NCT04124081|Entecavir|entecavir|mesh-list
92174025|NCT04124081|Antiviral Agents|antiviral agents|mesh-ancestor
92174026|NCT04124081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174027|NCT04123925|Nivolumab|nivolumab|mesh-list
92174028|NCT04123925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174029|NCT04123925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174030|NCT04123925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174031|NCT04123925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174032|NCT04759079|Antiemetics|antiemetics|mesh-list
92174033|NCT04759079|Autonomic Agents|autonomic agents|mesh-ancestor
92174034|NCT04759079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174035|NCT04759079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174036|NCT04759079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92174037|NCT03048942|Paclitaxel|paclitaxel|mesh-list
92174038|NCT03048942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92174039|NCT03048942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174040|NCT03048942|Tubulin Modulators|tubulin modulators|mesh-ancestor
92174041|NCT03048942|Antimitotic Agents|antimitotic agents|mesh-ancestor
92174042|NCT03048942|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174043|NCT03048942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174044|NCT04393025|Clopidogrel|clopidogrel|mesh-list
92174045|NCT04393025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174046|NCT04393025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174047|NCT04393025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92174048|NCT04393025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92174049|NCT04393025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92174050|NCT04393025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92174051|NCT04393025|Purinergic Agents|purinergic agents|mesh-ancestor
92174052|NCT04393025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174053|NCT01419067|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92174054|NCT01419067|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92174055|NCT01419067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174056|NCT05580445|Gemcitabine|gemcitabine|mesh-list
92174057|NCT05580445|Conteltinib|conteltinib|mesh-list
92174058|NCT05580445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92174059|NCT05580445|Antimetabolites|antimetabolites|mesh-ancestor
92174060|NCT05580445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174061|NCT05580445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174062|NCT05580445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92174063|NCT05580445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174064|NCT05257902|Choline|choline|mesh-list
92174065|NCT05257902|Lipotropic Agents|lipotropic agents|mesh-ancestor
92174066|NCT05257902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92174067|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
92174068|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174069|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92174070|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92174071|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
92174072|NCT02143219|Leucovorin|leucovorin|mesh-list
92174073|NCT02143219|Folic Acid|folic acid|mesh-list
92174075|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
92174076|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
92174077|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92174078|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92174079|NCT02143219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174080|NCT02143219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174081|NCT02143219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174082|NCT02143219|Antidotes|antidotes|mesh-ancestor
92174083|NCT02143219|Protective Agents|protective agents|mesh-ancestor
92174084|NCT02143219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174085|NCT02143219|Vitamin B Complex|vitamin b complex|mesh-ancestor
92174086|NCT02143219|Vitamins|vitamins|mesh-ancestor
92174087|NCT02143219|Micronutrients|micronutrients|mesh-ancestor
92174088|NCT02143219|Hematinics|hematinics|mesh-ancestor
92174089|NCT04122911|Temozolomide|temozolomide|mesh-list
92174090|NCT04122911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92174091|NCT04122911|Alkylating Agents|alkylating agents|mesh-ancestor
92174092|NCT04122911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174093|NCT04122911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174094|NCT04122599|Melatonin|melatonin|mesh-list
92174095|NCT04122599|Antioxidants|antioxidants|mesh-ancestor
92174096|NCT04122599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174097|NCT04122599|Protective Agents|protective agents|mesh-ancestor
92174098|NCT04122599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174099|NCT04122599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174100|NCT01475955|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92174101|NCT01475955|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92174102|NCT01475955|Dermatologic Agents|dermatologic agents|mesh-ancestor
92174103|NCT03048474|Nivolumab|nivolumab|mesh-list
92174104|NCT03048474|Ipilimumab|ipilimumab|mesh-list
92174105|NCT03048474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174106|NCT03048474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174107|NCT03048474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174108|NCT03048474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174109|NCT04121975|Endostar protein|endostar protein|mesh-list
92174110|NCT04121975|Endostatins|endostatins|mesh-list
92174111|NCT04121975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174112|NCT04121975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92174113|NCT04121975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92174114|NCT04121975|Growth Substances|growth substances|mesh-ancestor
92174115|NCT04121975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174116|NCT04121975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92174117|NCT02139319|Botulinum Toxins|botulinum toxins|mesh-list
92174118|NCT02139319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92174119|NCT02139319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174120|NCT02139319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174121|NCT02139319|Cholinergic Agents|cholinergic agents|mesh-ancestor
92174122|NCT02139319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174123|NCT02139319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174124|NCT03830957|Metoprolol|metoprolol|mesh-list
92174125|NCT03830957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92174126|NCT03830957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92174127|NCT03830957|Sympatholytics|sympatholytics|mesh-ancestor
92174128|NCT03830957|Autonomic Agents|autonomic agents|mesh-ancestor
92174129|NCT03830957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174130|NCT03830957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174131|NCT03830957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92174132|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92174133|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92174134|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
92174135|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174136|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174137|NCT04121819|Cytarabine|cytarabine|mesh-list
92174138|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92174139|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
92174140|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174141|NCT04121819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174142|NCT04121819|Antiviral Agents|antiviral agents|mesh-ancestor
92174143|NCT04121819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174144|NCT04121819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92174145|NCT04121819|Immunologic Factors|immunologic factors|mesh-ancestor
92174146|NCT04121819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174147|NCT01476267|Dalcetrapib|dalcetrapib|mesh-list
92174148|NCT01476267|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92174149|NCT01476267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92174150|NCT01476267|Antimetabolites|antimetabolites|mesh-ancestor
92174151|NCT01476267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174152|NCT01476267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92174153|NCT05189730|Paclitaxel|paclitaxel|mesh-list
92174154|NCT05189730|Carboplatin|carboplatin|mesh-list
92174155|NCT05189730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92174156|NCT05189730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174157|NCT05189730|Tubulin Modulators|tubulin modulators|mesh-ancestor
92174158|NCT05189730|Antimitotic Agents|antimitotic agents|mesh-ancestor
92174159|NCT05189730|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174160|NCT05189730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174161|NCT04121273|Immunomodulating Agents|immunomodulating agents|mesh-list
92174162|NCT04121273|Immunologic Factors|immunologic factors|mesh-ancestor
92174163|NCT04121273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174164|NCT01476345|Insulin Glargine|insulin glargine|mesh-list
92174165|NCT01476345|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92174166|NCT01476345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174167|NCT04121039|Apatinib|apatinib|mesh-list
92174168|NCT04121039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174169|NCT04121039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92174170|NCT04121039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174171|NCT04121039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174172|NCT01401543|Tadalafil|tadalafil|mesh-list
92174173|NCT01401543|Vasodilator Agents|vasodilator agents|mesh-ancestor
92174174|NCT01401543|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92174175|NCT01401543|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92174176|NCT01401543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174177|NCT01401543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174178|NCT01401543|Urological Agents|urological agents|mesh-ancestor
92174179|NCT02985749|Oxytocin|oxytocin|mesh-list
92174180|NCT02985749|Oxytocics|oxytocics|mesh-ancestor
92174181|NCT02985749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92174182|NCT02985749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174183|NCT04120259|Metformin|metformin|mesh-list
92174184|NCT04120259|Acetic Acid|acetic acid|mesh-list
92174185|NCT04120259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92174186|NCT04120259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174187|NCT04120259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92174188|NCT04120259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174190|NCT04392102|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92174191|NCT04392102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174192|NCT04392102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174193|NCT04392102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174194|NCT02127073|Oxytocin|oxytocin|mesh-list
92174195|NCT02127073|Oxytocics|oxytocics|mesh-ancestor
92174196|NCT02127073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92174197|NCT02127073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174198|NCT02124421|Paclitaxel|paclitaxel|mesh-list
92174199|NCT02124421|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92174200|NCT02124421|Carboplatin|carboplatin|mesh-list
92174201|NCT02124421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92174202|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174203|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
92174204|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
92174205|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174206|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174207|NCT05256342|Etoricoxib|etoricoxib|mesh-list
92174208|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92174209|NCT05256342|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92174210|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92174211|NCT05256342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174212|NCT05256342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174213|NCT05256342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174214|NCT05256342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174215|NCT05256342|Analgesics|analgesics|mesh-ancestor
92174216|NCT05256342|Sensory System Agents|sensory system agents|mesh-ancestor
92174217|NCT05256342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174218|NCT05256342|Antidepressive Agents|antidepressive agents|mesh-ancestor
92174219|NCT05256342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92174220|NCT05256342|Dopamine Agents|dopamine agents|mesh-ancestor
92174221|NCT05256342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174222|NCT05256342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174223|NCT05256342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174224|NCT05256342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174225|NCT05256342|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92174226|NCT05256342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92174227|NCT05256342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174229|NCT02117167|Durvalumab|durvalumab|mesh-list
92174230|NCT02117167|Olaparib|olaparib|mesh-list
92174231|NCT02117167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174232|NCT02117167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174233|NCT02117167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174234|NCT02117167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92174235|NCT02117167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92174236|NCT02117167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174237|NCT02117167|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92174239|NCT04123379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174241|NCT04123379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174242|NCT04123379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174243|NCT01895881|Estradiol|estradiol|mesh-list
92174244|NCT01895881|Estrogens|estrogens|mesh-ancestor
92174245|NCT01895881|Hormones|hormones|mesh-ancestor
92174246|NCT01895881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174247|NCT01895881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174248|NCT04537962|Listerine|listerine|mesh-list
92174249|NCT04537962|Cetylpyridinium|cetylpyridinium|mesh-list
92174250|NCT04537962|Fluorides|fluorides|mesh-list
92174251|NCT04537962|Sodium Fluoride|sodium fluoride|mesh-list
92174252|NCT04537962|Fluorophosphate|fluorophosphate|mesh-list
92174253|NCT04537962|Tin Fluorides|tin fluorides|mesh-list
92174254|NCT04537962|Cariostatic Agents|cariostatic agents|mesh-ancestor
92174255|NCT04537962|Protective Agents|protective agents|mesh-ancestor
92174256|NCT04537962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174257|NCT04537962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92174258|NCT04537962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174259|NCT04126733|Nivolumab|nivolumab|mesh-list
92174260|NCT04126733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174261|NCT04126733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174262|NCT04126733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174263|NCT04126733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174264|NCT04387734|Ocrelizumab|ocrelizumab|mesh-list
92174265|NCT04387734|Immunologic Factors|immunologic factors|mesh-ancestor
92174266|NCT04387734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174268|NCT04885764|Immunologic Factors|immunologic factors|mesh-ancestor
92174269|NCT04885764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174270|NCT04311606|Aflibercept|aflibercept|mesh-list
92174271|NCT04311606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92174272|NCT04311606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92174273|NCT04311606|Growth Substances|growth substances|mesh-ancestor
92174274|NCT04311606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174275|NCT04311606|Growth Inhibitors|growth inhibitors|mesh-ancestor
92174276|NCT04311606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174277|NCT02980835|Dexamethasone|dexamethasone|mesh-list
92174278|NCT02980835|Epinephrine|epinephrine|mesh-list
92174279|NCT02980835|Ropivacaine|ropivacaine|mesh-list
92174280|NCT02980835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174281|NCT02980835|Antiemetics|antiemetics|mesh-ancestor
92174282|NCT02980835|Autonomic Agents|autonomic agents|mesh-ancestor
92174283|NCT02980835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174284|NCT02980835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174285|NCT02980835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92174287|NCT02980835|Hormones|hormones|mesh-ancestor
92174288|NCT02980835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174289|NCT02980835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92174290|NCT02980835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174291|NCT02980835|Anesthetics, Local|anesthetics, local|mesh-ancestor
92174292|NCT02980835|Anesthetics|anesthetics|mesh-ancestor
92174293|NCT02980835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174294|NCT02980835|Sensory System Agents|sensory system agents|mesh-ancestor
92174295|NCT02980835|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92174296|NCT02980835|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92174297|NCT02980835|Adrenergic Agents|adrenergic agents|mesh-ancestor
92174298|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174299|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174300|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92174301|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92174302|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92174303|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174305|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
92174306|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92174307|NCT03824327|Papaverine|papaverine|mesh-list
92174308|NCT03824327|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92174309|NCT03824327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174310|NCT03824327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174311|NCT03824327|Vasodilator Agents|vasodilator agents|mesh-ancestor
92174312|NCT03824327|Urological Agents|urological agents|mesh-ancestor
92174313|NCT04871724|Fluconazole|fluconazole|mesh-list
92174314|NCT04871724|Antifungal Agents|antifungal agents|mesh-ancestor
92174315|NCT04871724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174316|NCT04871724|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92174317|NCT04871724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92174318|NCT04871724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174319|NCT04871724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174320|NCT04871724|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92174321|NCT04871724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92174322|NCT04871724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174323|NCT04871724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174324|NCT04871724|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92174325|NCT04871724|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92174326|NCT04871802|Taxifolin|taxifolin|mesh-list
92174327|NCT04871802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174328|NCT04871802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174329|NCT04871802|Analgesics|analgesics|mesh-ancestor
92174330|NCT04871802|Sensory System Agents|sensory system agents|mesh-ancestor
92174331|NCT04871802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174332|NCT04871802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174333|NCT04871802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174334|NCT04871802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174335|NCT04871646|Nafamostat|nafamostat|mesh-list
92174336|NCT04871646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174337|NCT04871646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174338|NCT04871646|Analgesics|analgesics|mesh-ancestor
92174339|NCT04871646|Sensory System Agents|sensory system agents|mesh-ancestor
92174340|NCT04871646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174341|NCT04871646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174342|NCT04871646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174343|NCT04871646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174344|NCT04871646|Anticoagulants|anticoagulants|mesh-ancestor
92174345|NCT04871646|Protease Inhibitors|protease inhibitors|mesh-ancestor
92174346|NCT04871646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174347|NCT04871646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174348|NCT04871646|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92174349|NCT04871646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92174350|NCT04871646|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92174351|NCT04871646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92174353|NCT03748680|Oxaliplatin|oxaliplatin|mesh-list
92174354|NCT03748680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174355|NCT03589014|Propranolol|propranolol|mesh-list
92174356|NCT03589014|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92174357|NCT03589014|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92174358|NCT03589014|Adrenergic Agents|adrenergic agents|mesh-ancestor
92174359|NCT03589014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174360|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174361|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174362|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92174363|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92174364|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
92174365|NCT04884906|Paclitaxel|paclitaxel|mesh-list
92174366|NCT04884906|Cisplatin|cisplatin|mesh-list
92174367|NCT04884906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92174368|NCT04884906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174369|NCT04884906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92174370|NCT04884906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92174371|NCT04884906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174372|NCT04884906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174373|NCT03826589|Avelumab|avelumab|mesh-list
92174374|NCT03826589|Axitinib|axitinib|mesh-list
92174375|NCT03826589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174376|NCT03826589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174377|NCT03826589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92174378|NCT03826589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174379|NCT03826589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174380|NCT03046758|Metronidazole|metronidazole|mesh-list
92174382|NCT03046758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174383|NCT03046758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92174384|NCT03046758|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92174385|NCT03046758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92174386|NCT04382664|Nivolumab|nivolumab|mesh-list
92174387|NCT04382664|Ipilimumab|ipilimumab|mesh-list
92174388|NCT04382664|Sargramostim|sargramostim|mesh-list
92174389|NCT04382664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174390|NCT04382664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174391|NCT04382664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174392|NCT04382664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174393|NCT04382664|Immunologic Factors|immunologic factors|mesh-ancestor
92174394|NCT04382664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174395|NCT04392479|Aflibercept|aflibercept|mesh-list
92174396|NCT04392479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92174397|NCT04392479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92174398|NCT04392479|Growth Substances|growth substances|mesh-ancestor
92174399|NCT04392479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174400|NCT04392479|Growth Inhibitors|growth inhibitors|mesh-ancestor
92174401|NCT04392479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174402|NCT03825887|Morphine|morphine|mesh-list
92174403|NCT03825887|Nalbuphine|nalbuphine|mesh-list
92174404|NCT03825887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92174405|NCT03825887|Narcotics|narcotics|mesh-ancestor
92174406|NCT03825887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174407|NCT03825887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174408|NCT03825887|Analgesics|analgesics|mesh-ancestor
92174409|NCT03825887|Sensory System Agents|sensory system agents|mesh-ancestor
92174410|NCT03825887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174411|NCT03825809|Acetaminophen|acetaminophen|mesh-list
92174412|NCT03825809|Celecoxib|celecoxib|mesh-list
92174413|NCT03825809|Ketorolac|ketorolac|mesh-list
92174414|NCT03825809|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92174415|NCT03825809|Diazepam|diazepam|mesh-list
92174416|NCT03825809|Gabapentin|gabapentin|mesh-list
92174417|NCT03825809|Hydrocodone|hydrocodone|mesh-list
92174418|NCT03825809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174419|NCT03825809|Analgesics|analgesics|mesh-ancestor
92174420|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
92174421|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174422|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174423|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
92174424|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174425|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174426|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174427|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92174428|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92174429|NCT03825809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318049|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92174430|NCT03825809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174431|NCT03825809|Anticonvulsants|anticonvulsants|mesh-ancestor
92174432|NCT03825809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92174433|NCT03825809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92174434|NCT03825809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174435|NCT03825809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92174436|NCT03825809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92174437|NCT03825809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92174438|NCT03825809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174439|NCT03825809|Antimanic Agents|antimanic agents|mesh-ancestor
92174440|NCT03825809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92174441|NCT03825809|Narcotics|narcotics|mesh-ancestor
92174442|NCT03825809|Antitussive Agents|antitussive agents|mesh-ancestor
92174443|NCT03825809|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174444|NCT03825809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92174445|NCT03825809|Antiemetics|antiemetics|mesh-ancestor
92174446|NCT03825809|Autonomic Agents|autonomic agents|mesh-ancestor
92174447|NCT03825809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92174448|NCT03825809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92174449|NCT03825809|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92174450|NCT03825809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92174451|NCT03825809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92174452|NCT03825809|Anesthetics, General|anesthetics, general|mesh-ancestor
92174453|NCT03825809|Anesthetics|anesthetics|mesh-ancestor
92174454|NCT03825809|GABA Modulators|gaba modulators|mesh-ancestor
92174455|NCT03825809|GABA Agents|gaba agents|mesh-ancestor
92174456|NCT03824717|Ropivacaine|ropivacaine|mesh-list
92174457|NCT03824717|Anesthetics, Local|anesthetics, local|mesh-ancestor
92174458|NCT03824717|Anesthetics|anesthetics|mesh-ancestor
92174459|NCT03824717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174460|NCT03824717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174461|NCT03824717|Sensory System Agents|sensory system agents|mesh-ancestor
92174462|NCT03824717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174463|NCT04392557|Metformin|metformin|mesh-list
92174464|NCT04392557|Pioglitazone|pioglitazone|mesh-list
92174465|NCT04392557|Alogliptin|alogliptin|mesh-list
92174466|NCT04392557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92174467|NCT04392557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174468|NCT04392557|Incretins|incretins|mesh-ancestor
92174469|NCT04392557|Hormones|hormones|mesh-ancestor
92106698|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174470|NCT04392557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174471|NCT04392557|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92174472|NCT04392557|Protease Inhibitors|protease inhibitors|mesh-ancestor
92174473|NCT04392557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174474|NCT04392557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174475|NCT02115373|Tepotinib|tepotinib|mesh-list
92174476|NCT02115373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174477|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
92174478|NCT03824171|Vitamin D|vitamin d|mesh-list
92174479|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92174480|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92174481|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174482|NCT03824171|Vitamins|vitamins|mesh-ancestor
92174483|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
92174484|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92174485|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92174486|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
92174487|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174488|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92174489|NCT03824171|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92174490|NCT02079181|Fluorides|fluorides|mesh-list
92174491|NCT02079181|Cariostatic Agents|cariostatic agents|mesh-ancestor
92174492|NCT02079181|Protective Agents|protective agents|mesh-ancestor
92174493|NCT02079181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174494|NCT02946125|Phenylephrine|phenylephrine|mesh-list
92174495|NCT02946125|Oxymetazoline|oxymetazoline|mesh-list
92174496|NCT02946125|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92174497|NCT02946125|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92174498|NCT02946125|Mydriatics|mydriatics|mesh-ancestor
92174499|NCT02946125|Autonomic Agents|autonomic agents|mesh-ancestor
92174500|NCT02946125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174501|NCT02946125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174502|NCT02946125|Sympathomimetics|sympathomimetics|mesh-ancestor
92174503|NCT02946125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92174504|NCT02946125|Nasal Decongestants|nasal decongestants|mesh-ancestor
92174505|NCT02946125|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174506|NCT02946125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92174507|NCT02946125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92174508|NCT02946125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92174509|NCT02946125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92174510|NCT02946125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174511|NCT02946125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174512|NCT02946125|Protective Agents|protective agents|mesh-ancestor
92174513|NCT02946125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92174515|NCT01895257|Fluorouracil|fluorouracil|mesh-list
92174516|NCT01895257|Levoleucovorin|levoleucovorin|mesh-list
92174517|NCT01895257|Antidotes|antidotes|mesh-ancestor
92174518|NCT01895257|Protective Agents|protective agents|mesh-ancestor
92174519|NCT01895257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174520|NCT01895257|Vitamin B Complex|vitamin b complex|mesh-ancestor
92174521|NCT01895257|Vitamins|vitamins|mesh-ancestor
92174522|NCT01895257|Micronutrients|micronutrients|mesh-ancestor
92174523|NCT01895257|Antimetabolites|antimetabolites|mesh-ancestor
92174524|NCT01895257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174525|NCT01895257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92174526|NCT01895257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174527|NCT01895257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92174528|NCT01895257|Immunologic Factors|immunologic factors|mesh-ancestor
92174529|NCT02064673|Curcumin|curcumin|mesh-list
92174530|NCT02064673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174531|NCT02064673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174532|NCT02064673|Analgesics|analgesics|mesh-ancestor
92174533|NCT02064673|Sensory System Agents|sensory system agents|mesh-ancestor
92174534|NCT02064673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174535|NCT02064673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174536|NCT02064673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174537|NCT02064673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174538|NCT02064673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174539|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174540|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174541|NCT04392713|Ivermectin|ivermectin|mesh-list
92174542|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92174543|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174544|NCT03823625|Nivolumab|nivolumab|mesh-list
92174545|NCT03823625|Ipilimumab|ipilimumab|mesh-list
92174546|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174547|NCT03823625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174548|NCT03823625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174549|NCT03823625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174550|NCT02053909|Aspirin|aspirin|mesh-list
92174551|NCT02053909|Ticagrelor|ticagrelor|mesh-list
92174552|NCT02053909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174553|NCT02053909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174554|NCT02053909|Analgesics|analgesics|mesh-ancestor
92174555|NCT02053909|Sensory System Agents|sensory system agents|mesh-ancestor
92174556|NCT02053909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174557|NCT02053909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174558|NCT02053909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174559|NCT02053909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174560|NCT02053909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92174561|NCT02053909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92174562|NCT02053909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174563|NCT02053909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92174564|NCT02053909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92174565|NCT02053909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174566|NCT02053909|Antipyretics|antipyretics|mesh-ancestor
92174567|NCT02053909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92174568|NCT02053909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92174569|NCT02053909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92174570|NCT02053909|Purinergic Agents|purinergic agents|mesh-ancestor
92174571|NCT02053909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174572|NCT02863991|TIC10 compound|tic10 compound|mesh-list
92174573|NCT02863991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174574|NCT02860091|Ropivacaine|ropivacaine|mesh-list
92174575|NCT02860091|Anesthetics, Local|anesthetics, local|mesh-ancestor
92174576|NCT02860091|Anesthetics|anesthetics|mesh-ancestor
92174577|NCT02860091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174578|NCT02860091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174579|NCT02860091|Sensory System Agents|sensory system agents|mesh-ancestor
92174580|NCT02860091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174581|NCT02858219|Botulinum Toxins|botulinum toxins|mesh-list
92174582|NCT02858219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92174583|NCT02858219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92174584|NCT02858219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92174585|NCT02858219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174586|NCT02858219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174587|NCT02858219|Cholinergic Agents|cholinergic agents|mesh-ancestor
92174588|NCT02858219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174589|NCT02858219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174590|NCT02858219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92174591|NCT02858219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174592|NCT03823781|Milrinone|milrinone|mesh-list
92174593|NCT03823781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92174594|NCT03823781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92174595|NCT03823781|Vasodilator Agents|vasodilator agents|mesh-ancestor
92174596|NCT03823781|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92174597|NCT03823781|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92318261|NCT02213094|Niacin|niacin|mesh-list
92174598|NCT03823781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174599|NCT03823781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174600|NCT03823781|Protective Agents|protective agents|mesh-ancestor
92174601|NCT03823781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174602|NCT02935361|Atezolizumab|atezolizumab|mesh-list
92174603|NCT02935361|Guadecitabine|guadecitabine|mesh-list
92174604|NCT02935361|Azacitidine|azacitidine|mesh-list
92174605|NCT02935361|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92174606|NCT02935361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174607|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174608|NCT02935361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174609|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174610|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
92174611|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174612|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92174613|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
92174614|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174615|NCT02614794|Capecitabine|capecitabine|mesh-list
92174616|NCT02614794|Trastuzumab|trastuzumab|mesh-list
92174617|NCT02614794|Tucatinib|tucatinib|mesh-list
92174618|NCT02614794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92174619|NCT02614794|Antimetabolites|antimetabolites|mesh-ancestor
92174620|NCT02614794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174621|NCT02614794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174622|NCT02614794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174623|NCT02614794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92174624|NCT02614794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174625|NCT03823079|Irinotecan|irinotecan|mesh-list
92174626|NCT03823079|Raltitrexed|raltitrexed|mesh-list
92174627|NCT03823079|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92174628|NCT03823079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92174629|NCT03823079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174630|NCT03823079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318298|NCT00376064|Octreotide|octreotide|mesh-list
92174631|NCT03823079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174632|NCT03823079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92174633|NCT03823079|Antimetabolites|antimetabolites|mesh-ancestor
92174634|NCT03823079|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92174635|NCT02839265|Flt3 ligand protein|flt3 ligand protein|mesh-list
92174636|NCT02839265|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92174637|NCT02839265|Immunologic Factors|immunologic factors|mesh-ancestor
92174638|NCT02839265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174639|NCT02839265|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92174640|NCT02839265|Protective Agents|protective agents|mesh-ancestor
92174641|NCT00988247|Beclomethasone|beclomethasone|mesh-list
92174642|NCT00988247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174643|NCT00988247|Glucocorticoids|glucocorticoids|mesh-ancestor
92174644|NCT00988247|Hormones|hormones|mesh-ancestor
92174645|NCT00988247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174646|NCT00988247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174647|NCT00988247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92174648|NCT00988247|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174649|NCT02832401|Caffeine|caffeine|mesh-list
92174650|NCT02832401|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92174651|NCT02832401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174652|NCT02832401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92174653|NCT02832401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174654|NCT02832401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174655|NCT02832401|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92174656|NCT02832401|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92174657|NCT02832401|Purinergic Agents|purinergic agents|mesh-ancestor
92174658|NCT02832401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174659|NCT03044808|Lidocaine|lidocaine|mesh-list
92174660|NCT03044808|Anesthetics, Local|anesthetics, local|mesh-ancestor
92174661|NCT03044808|Anesthetics|anesthetics|mesh-ancestor
92174662|NCT03044808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174663|NCT03044808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174664|NCT03044808|Sensory System Agents|sensory system agents|mesh-ancestor
92174665|NCT03044808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174666|NCT03044808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92174667|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92318345|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
92174668|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92174669|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174670|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174671|NCT04430166|Antibodies|antibodies|mesh-list
92174672|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92174673|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
92174674|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174675|NCT04877106|Metformin|metformin|mesh-list
92174676|NCT04877106|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92174677|NCT04877106|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92174678|NCT04877106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174679|NCT04877106|Incretins|incretins|mesh-ancestor
92174680|NCT04877106|Hormones|hormones|mesh-ancestor
92174681|NCT04877106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174682|NCT04877106|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92174684|NCT04877106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174685|NCT04877106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174686|NCT00981617|ALKS-33|alks-33|mesh-list
92174687|NCT00981617|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92174688|NCT00981617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174689|NCT00981617|Sensory System Agents|sensory system agents|mesh-ancestor
92174690|NCT00981617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174691|NCT04876716|Voriconazole|voriconazole|mesh-list
92174693|NCT04876716|Isavuconazole|isavuconazole|mesh-list
92174694|NCT04876716|Anidulafungin|anidulafungin|mesh-list
92174695|NCT04876716|Antifungal Agents|antifungal agents|mesh-ancestor
92174696|NCT04876716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174697|NCT04876716|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92174698|NCT04876716|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92174699|NCT04876716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174700|NCT04876716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174701|NCT04876716|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92174702|NCT04876716|Hormone Antagonists|hormone antagonists|mesh-ancestor
92174703|NCT04876716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174704|NCT04876716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174705|NCT04876716|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92174706|NCT04876716|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92174707|NCT04876716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92174708|NCT04876716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92174709|NCT04865250|Paclitaxel|paclitaxel|mesh-list
92174710|NCT04865250|Carboplatin|carboplatin|mesh-list
92174711|NCT04865250|Atezolizumab|atezolizumab|mesh-list
92174712|NCT04865250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92174713|NCT04865250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174714|NCT04865250|Tubulin Modulators|tubulin modulators|mesh-ancestor
92174715|NCT04865250|Antimitotic Agents|antimitotic agents|mesh-ancestor
92174716|NCT04865250|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174717|NCT04865250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174718|NCT04865250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92174719|NCT04865250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174720|NCT04865562|Methyltestosterone|methyltestosterone|mesh-list
92174721|NCT04865562|Testosterone|testosterone|mesh-list
92174722|NCT04865562|Testosterone undecanoate|testosterone undecanoate|mesh-list
92174723|NCT04865562|Testosterone enanthate|testosterone enanthate|mesh-list
92174724|NCT04865562|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92174725|NCT04865562|Androgens|androgens|mesh-ancestor
92174726|NCT04865562|Hormones|hormones|mesh-ancestor
92174727|NCT04865562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174728|NCT04865562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174729|NCT04865562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92174730|NCT04865562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174731|NCT04865562|Anabolic Agents|anabolic agents|mesh-ancestor
92174732|NCT04864782|Paclitaxel|paclitaxel|mesh-list
92174733|NCT04864782|Carboplatin|carboplatin|mesh-list
92174734|NCT04864782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92174735|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174736|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
92174737|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
92174738|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
92174739|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174740|NCT04875858|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92174741|NCT04875858|Immunologic Factors|immunologic factors|mesh-ancestor
92174742|NCT04875858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174743|NCT04385940|Vitamin D|vitamin d|mesh-list
92174744|NCT04385940|Cholecalciferol|cholecalciferol|mesh-list
92174745|NCT04385940|Vitamins|vitamins|mesh-ancestor
92174746|NCT04385940|Micronutrients|micronutrients|mesh-ancestor
92174747|NCT04385940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174748|NCT04385940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92174749|NCT04385940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92174750|NCT00984659|Fluticasone|fluticasone|mesh-list
92174751|NCT00984659|Xhance|xhance|mesh-list
92174752|NCT00984659|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92318412|NCT02175966|Ribavirin|ribavirin|mesh-list
92174753|NCT00984659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174754|NCT00984659|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92174755|NCT00984659|Autonomic Agents|autonomic agents|mesh-ancestor
92174756|NCT00984659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174757|NCT00984659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174758|NCT00984659|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92174759|NCT00984659|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174760|NCT00984659|Dermatologic Agents|dermatologic agents|mesh-ancestor
92174761|NCT00984659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92174762|NCT00984659|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92174763|NCT00984659|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92174764|NCT00984659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92174765|NCT00984659|Adrenergic Agents|adrenergic agents|mesh-ancestor
92174766|NCT00984659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174767|NCT00984659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174768|NCT04864314|Superoxide Dismutase|superoxide dismutase|mesh-list
92174769|NCT04864314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92174770|NCT04864314|Antioxidants|antioxidants|mesh-ancestor
92174771|NCT04864314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174772|NCT04864314|Protective Agents|protective agents|mesh-ancestor
92174773|NCT04864314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174774|NCT04874844|Antibodies|antibodies|mesh-list
92174775|NCT04874844|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92174776|NCT04874844|Immunologic Factors|immunologic factors|mesh-ancestor
92174777|NCT04874844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174778|NCT03046290|Lidocaine|lidocaine|mesh-list
92174779|NCT03046290|Ropivacaine|ropivacaine|mesh-list
92174780|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92174781|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
92174782|NCT03046290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174783|NCT03046290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174784|NCT03046290|Sensory System Agents|sensory system agents|mesh-ancestor
92174785|NCT03046290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174786|NCT03046290|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92174787|NCT03046290|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92174788|NCT03046290|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92174789|NCT03046290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174790|NCT03046290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174791|NCT04874688|Provitamins|provitamins|mesh-list
92174792|NCT04874688|Beta Carotene|beta carotene|mesh-list
92174793|NCT04874688|Vitamins|vitamins|mesh-ancestor
92174794|NCT04874688|Micronutrients|micronutrients|mesh-ancestor
92174795|NCT04874688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174796|NCT02612064|Fluorides|fluorides|mesh-list
92174797|NCT02612064|Tin Fluorides|tin fluorides|mesh-list
92174798|NCT02612064|Fluorophosphate|fluorophosphate|mesh-list
92174799|NCT02612064|Cariostatic Agents|cariostatic agents|mesh-ancestor
92174800|NCT02612064|Protective Agents|protective agents|mesh-ancestor
92174801|NCT02612064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174802|NCT04553003|Prednisone|prednisone|mesh-list
92174803|NCT04553003|Methylprednisolone|methylprednisolone|mesh-list
92174804|NCT04553003|Choline|choline|mesh-list
92174805|NCT04553003|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92174806|NCT04553003|Glucocorticoids|glucocorticoids|mesh-list
92174807|NCT04553003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174808|NCT04553003|Hormones|hormones|mesh-ancestor
92174809|NCT04553003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174810|NCT04553003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174811|NCT04553003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92174812|NCT04553003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174813|NCT04553003|Antiemetics|antiemetics|mesh-ancestor
92174814|NCT04553003|Autonomic Agents|autonomic agents|mesh-ancestor
92174815|NCT04553003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174816|NCT04553003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92174817|NCT04553003|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92318477|NCT03523988|Acetaminophen|acetaminophen|mesh-list
92174818|NCT04553003|Protective Agents|protective agents|mesh-ancestor
92174819|NCT04553003|Lipotropic Agents|lipotropic agents|mesh-ancestor
92174820|NCT04553003|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92174821|NCT04553003|Antimetabolites|antimetabolites|mesh-ancestor
92174822|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174823|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92174824|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
92174825|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
92174826|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
92174827|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92174828|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92174829|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174830|NCT03044184|Hemostatics|hemostatics|mesh-ancestor
92174831|NCT03044184|Coagulants|coagulants|mesh-ancestor
92174832|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
92174833|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92174834|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92174835|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174836|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92174837|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92174838|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174839|NCT03044184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174840|NCT03047772|Atorvastatin|atorvastatin|mesh-list
92322331|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92174841|NCT03047772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92174842|NCT03047772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92174843|NCT03047772|Antimetabolites|antimetabolites|mesh-ancestor
92174844|NCT03047772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174845|NCT03047772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92174846|NCT03047772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92318531|NCT02133924|Antiemetics|antiemetics|mesh-ancestor
92174849|NCT03047538|Perindopril|perindopril|mesh-list
92174850|NCT03047538|Atorvastatin|atorvastatin|mesh-list
92174851|NCT03047538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92174852|NCT03047538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92174853|NCT03047538|Antimetabolites|antimetabolites|mesh-ancestor
92174854|NCT03047538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174855|NCT03047538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92174856|NCT03047538|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92174857|NCT03047538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174858|NCT03047538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92174859|NCT03047538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92174860|NCT03047538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174861|NCT03047538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92174862|NCT03047538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174863|NCT03047538|Vasodilator Agents|vasodilator agents|mesh-ancestor
92174864|NCT03047538|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92174865|NCT03047538|Protease Inhibitors|protease inhibitors|mesh-ancestor
92174866|NCT01728805|Vorinostat|vorinostat|mesh-list
92174867|NCT01728805|Mogamulizumab|mogamulizumab|mesh-list
92174868|NCT01728805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174869|NCT01728805|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92174870|NCT01728805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174871|NCT01728805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174872|NCT02043457|Hormones|hormones|mesh-list
92174873|NCT02043457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92174874|NCT02043457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174875|NCT03822065|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92174876|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92174877|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92174878|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92174879|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174880|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174881|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318582|NCT04501640|Mirabegron|mirabegron|mesh-list
92174882|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
92174883|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92174884|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
92174885|NCT03821987|Busulfan|busulfan|mesh-list
92174886|NCT03821987|Fludarabine|fludarabine|mesh-list
92174887|NCT03821987|Thymoglobulin|thymoglobulin|mesh-list
92174888|NCT03821987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92174889|NCT03821987|Immunologic Factors|immunologic factors|mesh-ancestor
92174890|NCT03821987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174891|NCT03821987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174892|NCT03821987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92174893|NCT03821987|Alkylating Agents|alkylating agents|mesh-ancestor
92174894|NCT03821987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174895|NCT03821987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174896|NCT03821987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92174897|NCT04273763|Interferons|interferons|mesh-list
92174898|NCT04273763|Bromhexine|bromhexine|mesh-list
92174899|NCT04273763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174900|NCT04273763|Antiviral Agents|antiviral agents|mesh-ancestor
92174901|NCT04273763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174902|NCT04273763|Expectorants|expectorants|mesh-ancestor
92174903|NCT04273763|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174904|NCT01712815|Clevudine|clevudine|mesh-list
92174905|NCT01712815|Antiviral Agents|antiviral agents|mesh-ancestor
92174906|NCT01712815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174907|NCT03820193|Acetaminophen|acetaminophen|mesh-list
92174908|NCT03820193|Celecoxib|celecoxib|mesh-list
92174910|NCT03820193|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92174911|NCT03820193|Diazepam|diazepam|mesh-list
92174912|NCT03820193|Gabapentin|gabapentin|mesh-list
92174913|NCT03820193|Hydrocodone|hydrocodone|mesh-list
92174914|NCT03820193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92174915|NCT03820193|Analgesics|analgesics|mesh-ancestor
92174916|NCT03820193|Sensory System Agents|sensory system agents|mesh-ancestor
92174917|NCT03820193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92174918|NCT03820193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174919|NCT03820193|Antipyretics|antipyretics|mesh-ancestor
92174920|NCT03820193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92174921|NCT03820193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174922|NCT03820193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92174923|NCT03820193|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92174924|NCT03820193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92174925|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174926|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174927|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
92174928|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92174929|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92174930|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92174931|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92174932|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92174933|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92174934|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92174935|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
92174936|NCT03820193|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92174937|NCT03820193|Narcotics|narcotics|mesh-ancestor
92174938|NCT03820193|Antitussive Agents|antitussive agents|mesh-ancestor
92174939|NCT03820193|Respiratory System Agents|respiratory system agents|mesh-ancestor
92174940|NCT03820193|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92174941|NCT03820193|Antiemetics|antiemetics|mesh-ancestor
92174942|NCT03820193|Autonomic Agents|autonomic agents|mesh-ancestor
92174943|NCT03820193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92174944|NCT03820193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92174945|NCT03820193|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92174946|NCT03820193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92174947|NCT03820193|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92174948|NCT03820193|Anesthetics, General|anesthetics, general|mesh-ancestor
92174949|NCT03820193|Anesthetics|anesthetics|mesh-ancestor
92174950|NCT03820193|GABA Modulators|gaba modulators|mesh-ancestor
92174951|NCT03820193|GABA Agents|gaba agents|mesh-ancestor
92174952|NCT03820037|Opicapone|opicapone|mesh-list
92174953|NCT03820037|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92174954|NCT03820037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174955|NCT03820037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174956|NCT03820037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92174957|NCT03820037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92174958|NCT03829007|Durvalumab|durvalumab|mesh-list
92174959|NCT03829007|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92174960|NCT03829007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92174961|NCT03829007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174962|NCT03829007|Immunologic Factors|immunologic factors|mesh-ancestor
92174963|NCT03829007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174964|NCT02614560|Fludarabine|fludarabine|mesh-list
92174965|NCT02614560|Melphalan|melphalan|mesh-list
92174966|NCT02614560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174967|NCT02614560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174968|NCT02614560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92174969|NCT02614560|Immunologic Factors|immunologic factors|mesh-ancestor
92174970|NCT02614560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174971|NCT02614560|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92174972|NCT02614560|Alkylating Agents|alkylating agents|mesh-ancestor
92174973|NCT02614560|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92174974|NCT03828929|Thiamine|thiamine|mesh-list
92174975|NCT03828929|Vitamins|vitamins|mesh-ancestor
92174976|NCT03828929|Micronutrients|micronutrients|mesh-ancestor
92174977|NCT03828929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174978|NCT03828929|Vitamin B Complex|vitamin b complex|mesh-ancestor
92174979|NCT04873440|Manganese|manganese|mesh-list
92174980|NCT04873440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92174981|NCT04873440|Trace Elements|trace elements|mesh-ancestor
92174983|NCT04867980|Moxifloxacin|moxifloxacin|mesh-list
92174984|NCT04867980|Acalabrutinib|acalabrutinib|mesh-list
92174985|NCT04867980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92174986|NCT04867980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174987|NCT04867980|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92174988|NCT04867980|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92174989|NCT04867980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92174990|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92174991|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92174992|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92174993|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92174994|NCT04391621|Triamcinolone|triamcinolone|mesh-list
92174995|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92174996|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92174997|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92174998|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92174999|NCT04391621|Glucocorticoids|glucocorticoids|mesh-ancestor
92175000|NCT04391621|Hormones|hormones|mesh-ancestor
92175001|NCT04391621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318831|NCT03949244|Latanoprost|latanoprost|mesh-list
92175002|NCT04391621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175003|NCT04391621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175004|NCT04391621|Immunologic Factors|immunologic factors|mesh-ancestor
92175005|NCT04391621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175006|NCT04391621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175008|NCT01669122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92175009|NCT01669122|Autonomic Agents|autonomic agents|mesh-ancestor
92175010|NCT01669122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175011|NCT01669122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175012|NCT01669122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92175013|NCT01669122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92175014|NCT01669122|Cholinergic Agents|cholinergic agents|mesh-ancestor
92175015|NCT01669122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175016|NCT01669122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175017|NCT03629483|Dexmedetomidine|dexmedetomidine|mesh-list
92175018|NCT03629483|Ropivacaine|ropivacaine|mesh-list
92175019|NCT03629483|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92175020|NCT03629483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175021|NCT03629483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175022|NCT03629483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92175023|NCT03629483|Analgesics|analgesics|mesh-ancestor
92175024|NCT03629483|Sensory System Agents|sensory system agents|mesh-ancestor
92175025|NCT03629483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175026|NCT03629483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92175027|NCT03629483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92175028|NCT03629483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92175029|NCT03629483|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175030|NCT03629483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175031|NCT03629483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175032|NCT03629483|Anesthetics, Local|anesthetics, local|mesh-ancestor
92175033|NCT03629483|Anesthetics|anesthetics|mesh-ancestor
92175034|NCT04873284|Dexamethasone|dexamethasone|mesh-list
92175035|NCT04873284|Aprepitant|aprepitant|mesh-list
92175036|NCT04873284|Fosaprepitant|fosaprepitant|mesh-list
92175037|NCT04873284|Granisetron|granisetron|mesh-list
92175038|NCT04873284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175040|NCT04873284|Autonomic Agents|autonomic agents|mesh-ancestor
92175041|NCT04873284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175042|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175043|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175044|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
92175045|NCT04873284|Hormones|hormones|mesh-ancestor
92175046|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175047|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92175048|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175049|NCT04873284|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92175050|NCT04873284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175051|NCT04873284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175052|NCT04873284|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92175053|NCT04873284|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92175054|NCT04873284|Serotonin Agents|serotonin agents|mesh-ancestor
92175055|NCT01450865|Flupirtine|flupirtine|mesh-list
92175056|NCT01450865|Analgesics|analgesics|mesh-ancestor
92175057|NCT01450865|Sensory System Agents|sensory system agents|mesh-ancestor
92175058|NCT01450865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175059|NCT01450865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175061|NCT01308619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92175062|NCT01308619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175063|NCT01308619|Antimalarials|antimalarials|mesh-ancestor
92175064|NCT01308619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92175065|NCT01308619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92175066|NCT02611752|Buprenorphine|buprenorphine|mesh-list
92175067|NCT02611752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92175068|NCT02611752|Narcotics|narcotics|mesh-ancestor
92175069|NCT02611752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175070|NCT02611752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175071|NCT02611752|Analgesics|analgesics|mesh-ancestor
92175072|NCT02611752|Sensory System Agents|sensory system agents|mesh-ancestor
92175073|NCT02611752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175074|NCT02611752|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92175076|NCT01307605|Lenalidomide|lenalidomide|mesh-list
92175077|NCT01307605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175078|NCT01307605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175079|NCT01307605|Immunologic Factors|immunologic factors|mesh-ancestor
92175080|NCT01307605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175081|NCT01307605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175082|NCT01307605|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92175083|NCT01307605|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92175084|NCT01307605|Growth Substances|growth substances|mesh-ancestor
92175085|NCT01307605|Growth Inhibitors|growth inhibitors|mesh-ancestor
92175086|NCT04758689|Methotrexate|methotrexate|mesh-list
92175087|NCT04758689|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92175088|NCT04758689|Abortifacient Agents|abortifacient agents|mesh-ancestor
92175089|NCT04758689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175090|NCT04758689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175091|NCT04758689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175092|NCT04758689|Antimetabolites|antimetabolites|mesh-ancestor
92175093|NCT04758689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175094|NCT04758689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175095|NCT04758689|Dermatologic Agents|dermatologic agents|mesh-ancestor
92175096|NCT04758689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175097|NCT04758689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92175098|NCT04758689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175099|NCT04758689|Immunologic Factors|immunologic factors|mesh-ancestor
92175100|NCT04758689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175101|NCT04758689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92175102|NCT01451333|Efavirenz|efavirenz|mesh-list
92175103|NCT01451333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92175104|NCT01451333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92175105|NCT01451333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175106|NCT01451333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175107|NCT01451333|Antiviral Agents|antiviral agents|mesh-ancestor
92175108|NCT01451333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175109|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92175110|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92175111|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92175112|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92175113|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92175114|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92175115|NCT01702831|Lenalidomide|lenalidomide|mesh-list
92175116|NCT01702831|Melphalan|melphalan|mesh-list
92175117|NCT01702831|Busulfan|busulfan|mesh-list
92175118|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
92175119|NCT01702831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175120|NCT01702831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92175121|NCT01702831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92175122|NCT01702831|Growth Substances|growth substances|mesh-ancestor
92175123|NCT01702831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92175124|NCT01702831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175125|NCT01702831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92175126|NCT01702831|Alkylating Agents|alkylating agents|mesh-ancestor
92175127|NCT01702831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175128|NCT01702831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92175129|NCT01702831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175131|NCT03045510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175132|NCT03045510|Antimetabolites|antimetabolites|mesh-ancestor
92175133|NCT03045510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175134|NCT03045510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175135|NCT03045510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175136|NCT01451879|Miglustat|miglustat|mesh-list
92175137|NCT01451879|Rituximab|rituximab|mesh-list
92175138|NCT01451879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175139|NCT01451879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175140|NCT01451879|Immunologic Factors|immunologic factors|mesh-ancestor
92175141|NCT01451879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175142|NCT01451879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175143|NCT01451879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175144|NCT01451879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175145|NCT01451879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92175146|NCT01451879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92175147|NCT01451879|Antiviral Agents|antiviral agents|mesh-ancestor
92175148|NCT01451879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175149|NCT01451879|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92175150|NCT01451879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175151|NCT03045198|Azithromycin|azithromycin|mesh-list
92175152|NCT03045198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92175153|NCT03045198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175154|NCT01452113|Vildagliptin|vildagliptin|mesh-list
92175155|NCT01452113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175156|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175157|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92175158|NCT01452113|Protease Inhibitors|protease inhibitors|mesh-ancestor
92175159|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175160|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175161|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
92175162|NCT02022709|Sertraline|sertraline|mesh-list
92175163|NCT02022709|Fluoxetine|fluoxetine|mesh-list
92175164|NCT02022709|Paroxetine|paroxetine|mesh-list
92175165|NCT02022709|Citalopram|citalopram|mesh-list
92175166|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
92175167|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92175168|NCT02022709|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92175169|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92175170|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92175171|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175172|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175174|NCT02022709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175175|NCT02022709|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92175176|NCT02022709|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92175177|NCT02022709|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92175178|NCT02022709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175179|NCT02022709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92175180|NCT02022709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92175181|NCT02022709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175182|NCT02022709|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92175183|NCT02022709|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92175184|NCT02635841|Deferiprone|deferiprone|mesh-list
92175185|NCT02635841|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92175186|NCT02635841|Chelating Agents|chelating agents|mesh-ancestor
92175187|NCT02635841|Sequestering Agents|sequestering agents|mesh-ancestor
92175188|NCT02635841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175189|NCT00608725|Propranolol|propranolol|mesh-list
92175190|NCT00608725|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92175191|NCT00608725|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92175192|NCT00608725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175193|NCT00608725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175194|NCT00608725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175195|NCT00608725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175196|NCT00608725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92175197|NCT00608725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92175198|NCT00608725|Vasodilator Agents|vasodilator agents|mesh-ancestor
92175199|NCT01452659|Relugolix|relugolix|mesh-list
92175200|NCT01452659|Androgen Antagonists|androgen antagonists|mesh-ancestor
92175202|NCT01452659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175203|NCT01452659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175204|NCT01896349|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92175205|NCT01896349|Amitriptyline|amitriptyline|mesh-list
92175206|NCT01896349|Risperidone|risperidone|mesh-list
92175207|NCT01896349|Sulpiride|sulpiride|mesh-list
92175208|NCT01896349|Mirtazapine|mirtazapine|mesh-list
92175209|NCT01896349|Fluvoxamine|fluvoxamine|mesh-list
92175210|NCT01896349|Trazodone|trazodone|mesh-list
92175211|NCT01896349|Tranylcypromine|tranylcypromine|mesh-list
92175212|NCT01896349|Citalopram|citalopram|mesh-list
92175213|NCT01896349|Bupropion|bupropion|mesh-list
92175215|NCT01896349|Fluoxetine|fluoxetine|mesh-list
92175216|NCT01896349|Paroxetine|paroxetine|mesh-list
92175217|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92175218|NCT01896349|Nortriptyline|nortriptyline|mesh-list
92175219|NCT01896349|Imipramine|imipramine|mesh-list
92175220|NCT01896349|Clomipramine|clomipramine|mesh-list
92175221|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
92175222|NCT01896349|Escitalopram|escitalopram|mesh-list
92175223|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92175224|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
92175225|NCT01896349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175226|NCT01896349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175227|NCT01896349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175228|NCT01896349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92175229|NCT01896349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92175230|NCT01896349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175231|NCT01896349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92175232|NCT01896349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92175233|NCT01896349|Dopamine Agents|dopamine agents|mesh-ancestor
92319143|NCT04081610|Hyaluronic Acid|hyaluronic acid|mesh-list
92175234|NCT01896349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92175235|NCT01896349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92175236|NCT01896349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92175237|NCT01896349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175238|NCT01896349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92175239|NCT01896349|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92175240|NCT01896349|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92175241|NCT01896349|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92175242|NCT01896349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175243|NCT01896349|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92175244|NCT01896349|Analgesics|analgesics|mesh-ancestor
92175245|NCT01896349|Sensory System Agents|sensory system agents|mesh-ancestor
92175246|NCT01896349|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92175247|NCT01896349|Histamine Antagonists|histamine antagonists|mesh-ancestor
92175248|NCT01896349|Histamine Agents|histamine agents|mesh-ancestor
92175249|NCT01896349|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92175250|NCT01896349|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92175251|NCT01896349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92175252|NCT01896349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92175253|NCT01896349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175254|NCT01896349|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92175255|NCT01896349|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92175256|NCT01896349|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92175257|NCT01896349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92175258|NCT01896349|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92175259|NCT01896349|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92175260|NCT01896349|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92175261|NCT01896349|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92175262|NCT01452737|Bisacodyl|bisacodyl|mesh-list
92175263|NCT01452737|Cathartics|cathartics|mesh-ancestor
92175264|NCT01452737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175265|NCT01452737|Laxatives|laxatives|mesh-ancestor
92175267|NCT00595933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175268|NCT00580489|Fentanyl|fentanyl|mesh-list
92175269|NCT00580489|Morphine|morphine|mesh-list
92175270|NCT00580489|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92175271|NCT00580489|Narcotics|narcotics|mesh-ancestor
92175272|NCT00580489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92327624|NCT00381199|Nabilone|nabilone|mesh-list
92175273|NCT00580489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175275|NCT00580489|Sensory System Agents|sensory system agents|mesh-ancestor
92175276|NCT00580489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175277|NCT00580489|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92175278|NCT00580489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92175279|NCT00580489|Anesthetics, General|anesthetics, general|mesh-ancestor
92175280|NCT00580489|Anesthetics|anesthetics|mesh-ancestor
92175281|NCT01659307|Aspirin|aspirin|mesh-list
92175282|NCT01659307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92175283|NCT01659307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92175285|NCT01659307|Sensory System Agents|sensory system agents|mesh-ancestor
92175286|NCT01659307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175287|NCT01659307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175288|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175289|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175290|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92175291|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92175292|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175293|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92175294|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92175295|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175296|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
92175297|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
92175298|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92175299|NCT01594476|Contraceptive Agents|contraceptive agents|mesh-ancestor
92175300|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175301|NCT01594476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175302|NCT01594476|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92175303|NCT01594476|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92175304|NCT01594476|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92175305|NCT04391231|Pentoxifylline|pentoxifylline|mesh-list
92175306|NCT04391231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92175307|NCT04391231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175308|NCT04391231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175309|NCT04391231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92175310|NCT04391231|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92106787|NCT04443036|Paclitaxel|paclitaxel|mesh-list
92175311|NCT04391231|Protective Agents|protective agents|mesh-ancestor
92175312|NCT04391231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175313|NCT04391231|Vasodilator Agents|vasodilator agents|mesh-ancestor
92175314|NCT04391231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92175315|NCT04391231|Antioxidants|antioxidants|mesh-ancestor
92175316|NCT04872270|Caffeine|caffeine|mesh-list
92175317|NCT04872270|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92175318|NCT04872270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175319|NCT04872270|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92175320|NCT04872270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175321|NCT04872270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175322|NCT04872270|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92175323|NCT04872270|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92175324|NCT04872270|Purinergic Agents|purinergic agents|mesh-ancestor
92175325|NCT04872270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175326|NCT04872192|Anesthetics|anesthetics|mesh-list
92175327|NCT04872192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175328|NCT04872192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175329|NCT01624285|Sorafenib|sorafenib|mesh-list
92175330|NCT01624285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175331|NCT01624285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92175332|NCT01624285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175333|NCT01624285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175334|NCT01454609|Clonidine|clonidine|mesh-list
92175335|NCT01454609|Bupivacaine|bupivacaine|mesh-list
92175336|NCT01454609|Anesthetics, Local|anesthetics, local|mesh-ancestor
92175337|NCT01454609|Anesthetics|anesthetics|mesh-ancestor
92175338|NCT01454609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175339|NCT01454609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175340|NCT01454609|Sensory System Agents|sensory system agents|mesh-ancestor
92175341|NCT01454609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175342|NCT01454609|Analgesics|analgesics|mesh-ancestor
92175343|NCT01454609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92175344|NCT01454609|Sympatholytics|sympatholytics|mesh-ancestor
92175345|NCT01454609|Autonomic Agents|autonomic agents|mesh-ancestor
92175346|NCT01454609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92175347|NCT01454609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92175348|NCT01454609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92175349|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175350|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175351|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175352|NCT03042234|Insulin|insulin|mesh-list
92175353|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92175354|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175355|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175356|NCT02905799|Resveratrol|resveratrol|mesh-list
92175357|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
92175358|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175359|NCT02905799|Protective Agents|protective agents|mesh-ancestor
92175360|NCT02905799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175361|NCT02905799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175362|NCT02905799|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92175363|NCT00469183|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92175364|NCT00469183|Tretinoin|tretinoin|mesh-list
92175365|NCT00469183|Hydroquinone|hydroquinone|mesh-list
92175366|NCT00469183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175367|NCT00469183|Keratolytic Agents|keratolytic agents|mesh-ancestor
92175368|NCT00469183|Dermatologic Agents|dermatologic agents|mesh-ancestor
92175369|NCT00469183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175370|NCT00469183|Glucocorticoids|glucocorticoids|mesh-ancestor
92175371|NCT00469183|Hormones|hormones|mesh-ancestor
92175372|NCT00469183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175373|NCT00469183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175374|NCT00469183|Antioxidants|antioxidants|mesh-ancestor
92175375|NCT00469183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175376|NCT00469183|Protective Agents|protective agents|mesh-ancestor
92175377|NCT00469183|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92175378|NCT01455935|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92175379|NCT01455935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92175380|NCT01455935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92175381|NCT01455935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175382|NCT00468715|Bicalutamide|bicalutamide|mesh-list
92175383|NCT00468715|Androgen Antagonists|androgen antagonists|mesh-ancestor
92175384|NCT00468715|Hormone Antagonists|hormone antagonists|mesh-ancestor
92175385|NCT00468715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175386|NCT00468715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175387|NCT00468715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175388|NCT01456247|Lansoprazole|lansoprazole|mesh-list
92175389|NCT01456247|Dexlansoprazole|dexlansoprazole|mesh-list
92175390|NCT01456247|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92175391|NCT01456247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175392|NCT01456247|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92175393|NCT01456247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175394|NCT01456247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175395|NCT01456325|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92175396|NCT01456325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175397|NCT01456325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92175398|NCT01456325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175399|NCT01456325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175400|NCT04866498|Analgesics|analgesics|mesh-list
92175401|NCT04866498|Sensory System Agents|sensory system agents|mesh-ancestor
92175402|NCT04866498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175403|NCT04866498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175404|NCT04866654|Nivolumab|nivolumab|mesh-list
92175405|NCT04866654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175406|NCT04866654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175407|NCT04866654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92175408|NCT04866654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175409|NCT01456715|Vaccines|vaccines|mesh-list
92175410|NCT01456715|Immunologic Factors|immunologic factors|mesh-ancestor
92175411|NCT01456715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175412|NCT01895569|Metformin|metformin|mesh-list
92175413|NCT01895569|Pioglitazone|pioglitazone|mesh-list
92175414|NCT01895569|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92175415|NCT01895569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175416|NCT01895569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175417|NCT01895569|Incretins|incretins|mesh-ancestor
92175418|NCT01895569|Hormones|hormones|mesh-ancestor
92175419|NCT01895569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175420|NCT01895569|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92175421|NCT01895569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92175422|NCT01895569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175423|NCT01895569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175424|NCT01457261|Albuterol|albuterol|mesh-list
92175425|NCT01457261|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92175426|NCT01457261|Autonomic Agents|autonomic agents|mesh-ancestor
92175427|NCT01457261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175428|NCT01457261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175429|NCT01457261|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92175430|NCT01457261|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175431|NCT01457261|Tocolytic Agents|tocolytic agents|mesh-ancestor
92175432|NCT01457261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175433|NCT01457261|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92175434|NCT01457261|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92175435|NCT01457261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92175436|NCT01457261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175437|NCT01457261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175438|NCT01457261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175439|NCT01457495|Edetic Acid|edetic acid|mesh-list
92175440|NCT01457495|Pentetic Acid|pentetic acid|mesh-list
92175441|NCT01457495|Antidotes|antidotes|mesh-ancestor
92175442|NCT01457495|Protective Agents|protective agents|mesh-ancestor
92175443|NCT01457495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175444|NCT01457495|Chelating Agents|chelating agents|mesh-ancestor
92175445|NCT01457495|Sequestering Agents|sequestering agents|mesh-ancestor
92175446|NCT01457495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175447|NCT01457495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92175448|NCT01457495|Anticoagulants|anticoagulants|mesh-ancestor
92175449|NCT01457495|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92175450|NCT04778137|Omalizumab|omalizumab|mesh-list
92175451|NCT04778137|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92175452|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92175453|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175454|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92175455|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92175456|NCT03815929|Estradiol|estradiol|mesh-list
92175457|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92175458|NCT03815929|Estrogens|estrogens|mesh-ancestor
92175459|NCT03815929|Hormones|hormones|mesh-ancestor
92175460|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175461|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175462|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92175463|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
92175464|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175465|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92175466|NCT00394147|Gemcitabine|gemcitabine|mesh-list
92175467|NCT00394147|Pemetrexed|pemetrexed|mesh-list
92175468|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175469|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
92175470|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175471|NCT00394147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175472|NCT00394147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175473|NCT00394147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92175474|NCT00394147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92175475|NCT01458041|Iloprost|iloprost|mesh-list
92175476|NCT01458041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92175477|NCT01458041|Vasodilator Agents|vasodilator agents|mesh-ancestor
92175478|NCT02610816|Fluticasone|fluticasone|mesh-list
92175480|NCT02610816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175481|NCT02610816|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92175482|NCT02610816|Autonomic Agents|autonomic agents|mesh-ancestor
92175483|NCT02610816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175484|NCT02610816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175485|NCT02610816|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92175486|NCT02610816|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175487|NCT02610816|Dermatologic Agents|dermatologic agents|mesh-ancestor
92175488|NCT02610816|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92175489|NCT00332605|Acetylcysteine|acetylcysteine|mesh-list
92175490|NCT00332605|Naltrexone|naltrexone|mesh-list
92175491|NCT00332605|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92175492|NCT00332605|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92175493|NCT00332605|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92175494|NCT00332605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175495|NCT00332605|Sensory System Agents|sensory system agents|mesh-ancestor
92175496|NCT00332605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319496|NCT03756038|Lorazepam|lorazepam|mesh-list
92175498|NCT00332605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175499|NCT00332605|Expectorants|expectorants|mesh-ancestor
92175500|NCT00332605|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175501|NCT00332605|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92175502|NCT00332605|Antioxidants|antioxidants|mesh-ancestor
92175503|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175504|NCT00332605|Protective Agents|protective agents|mesh-ancestor
92175505|NCT00332605|Antidotes|antidotes|mesh-ancestor
92175506|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92175507|NCT01458743|Cephalosporins|cephalosporins|mesh-list
92175508|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92175509|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175510|NCT01415583|Dexamethasone|dexamethasone|mesh-list
92175511|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175512|NCT01415583|Antiemetics|antiemetics|mesh-ancestor
92175513|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
92175514|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175515|NCT01415583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175516|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175517|NCT01415583|Glucocorticoids|glucocorticoids|mesh-ancestor
92175518|NCT01415583|Hormones|hormones|mesh-ancestor
92175519|NCT01415583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175520|NCT01415583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92175521|NCT01415583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175522|NCT01458977|Tenofovir|tenofovir|mesh-list
92175523|NCT01458977|Emtricitabine|emtricitabine|mesh-list
92175524|NCT01458977|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92175525|NCT01458977|Antiviral Agents|antiviral agents|mesh-ancestor
92175526|NCT01458977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175527|NCT01458977|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92175528|NCT01458977|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92175529|NCT01458977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175530|NCT01458977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175531|NCT01458977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92175532|NCT01458977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92175533|NCT02508311|Albuterol|albuterol|mesh-list
92175534|NCT02508311|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92175535|NCT02508311|Autonomic Agents|autonomic agents|mesh-ancestor
92175536|NCT02508311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175537|NCT02508311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175538|NCT02508311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92175539|NCT02508311|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175540|NCT02508311|Tocolytic Agents|tocolytic agents|mesh-ancestor
92175541|NCT02508311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175542|NCT02508311|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92175543|NCT02508311|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92175544|NCT02508311|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92175545|NCT02508311|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175546|NCT02508311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175547|NCT02508311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175548|NCT00256399|Alfuzosin|alfuzosin|mesh-list
92175549|NCT00256399|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92175550|NCT00256399|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92175551|NCT00256399|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92175552|NCT00256399|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175553|NCT00256399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175554|NCT00256399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175555|NCT00256399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175556|NCT00256399|Urological Agents|urological agents|mesh-ancestor
92175557|NCT01459133|Insulin|insulin|mesh-list
92175558|NCT01459133|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175559|NCT01459133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175560|NCT01459211|Dexamethasone|dexamethasone|mesh-list
92175561|NCT01459211|Lenalidomide|lenalidomide|mesh-list
92175562|NCT01459211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175563|NCT01459211|Antiemetics|antiemetics|mesh-ancestor
92175564|NCT01459211|Autonomic Agents|autonomic agents|mesh-ancestor
92175565|NCT01459211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175566|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175567|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175568|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
92175569|NCT01459211|Hormones|hormones|mesh-ancestor
92319563|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175570|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175571|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92175572|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175573|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
92175574|NCT01459211|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92175575|NCT01459211|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92175576|NCT01459211|Growth Substances|growth substances|mesh-ancestor
92175577|NCT01459211|Growth Inhibitors|growth inhibitors|mesh-ancestor
92175579|NCT00198991|Dexamethasone|dexamethasone|mesh-list
92175580|NCT00198991|Prednisolone|prednisolone|mesh-list
92175581|NCT00198991|Cyclophosphamide|cyclophosphamide|mesh-list
92175582|NCT00198991|Methotrexate|methotrexate|mesh-list
92175583|NCT00198991|Fludarabine|fludarabine|mesh-list
92175585|NCT00198991|Etoposide phosphate|etoposide phosphate|mesh-list
92175586|NCT00198991|Vincristine|vincristine|mesh-list
92175587|NCT00198991|Doxorubicin|doxorubicin|mesh-list
92175588|NCT00198991|Daunorubicin|daunorubicin|mesh-list
92175589|NCT00198991|Asparaginase|asparaginase|mesh-list
92175590|NCT00198991|Mercaptopurine|mercaptopurine|mesh-list
92175591|NCT00198991|Idarubicin|idarubicin|mesh-list
92175592|NCT00198991|Thioguanine|thioguanine|mesh-list
92175593|NCT00198991|Cladribine|cladribine|mesh-list
92175594|NCT00198991|Vindesine|vindesine|mesh-list
92175595|NCT00198991|Pegaspargase|pegaspargase|mesh-list
92175596|NCT00198991|Teniposide|teniposide|mesh-list
92175597|NCT00198991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175598|NCT00198991|Immunologic Factors|immunologic factors|mesh-ancestor
92175599|NCT00198991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175600|NCT00198991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175601|NCT00198991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92175602|NCT00198991|Alkylating Agents|alkylating agents|mesh-ancestor
92175603|NCT00198991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175604|NCT00198991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175605|NCT00198991|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92175606|NCT00198991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175607|NCT00198991|Antiemetics|antiemetics|mesh-ancestor
92175608|NCT00198991|Autonomic Agents|autonomic agents|mesh-ancestor
92175609|NCT00198991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175610|NCT00198991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175611|NCT00198991|Glucocorticoids|glucocorticoids|mesh-ancestor
92175612|NCT00198991|Hormones|hormones|mesh-ancestor
92175613|NCT00198991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175614|NCT00198991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92175615|NCT00198991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92175616|NCT00198991|Abortifacient Agents|abortifacient agents|mesh-ancestor
92175617|NCT00198991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175618|NCT00198991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175619|NCT00198991|Antimetabolites|antimetabolites|mesh-ancestor
92175620|NCT00198991|Dermatologic Agents|dermatologic agents|mesh-ancestor
92175621|NCT00198991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175622|NCT00198991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92175623|NCT00198991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92175624|NCT00198991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92175625|NCT00198991|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92175626|NCT00198991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92175627|NCT00198991|Antiviral Agents|antiviral agents|mesh-ancestor
92175628|NCT00198991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175629|NCT00198991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92175630|NCT00198991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92175631|NCT00198991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92175632|NCT00198991|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92175633|NCT01459367|Lansoprazole|lansoprazole|mesh-list
92175634|NCT01459367|Dexlansoprazole|dexlansoprazole|mesh-list
92175635|NCT01459367|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92175636|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319651|NCT01347632|Metronidazole|metronidazole|mesh-list
92175637|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92175638|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175639|NCT01459367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175640|NCT04777591|Bupivacaine|bupivacaine|mesh-list
92175641|NCT04777591|Anesthetics, Local|anesthetics, local|mesh-ancestor
92175642|NCT04777591|Anesthetics|anesthetics|mesh-ancestor
92175643|NCT04777591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175644|NCT04777591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175645|NCT04777591|Sensory System Agents|sensory system agents|mesh-ancestor
92175646|NCT04777591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175647|NCT01459601|Cabergoline|cabergoline|mesh-list
92175648|NCT01459601|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92175649|NCT01459601|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92175650|NCT01459601|Dopamine Agonists|dopamine agonists|mesh-ancestor
92175651|NCT01459601|Dopamine Agents|dopamine agents|mesh-ancestor
92175652|NCT01459601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175653|NCT01459601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175654|NCT01459601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175655|NCT01418001|Gemcitabine|gemcitabine|mesh-list
92175656|NCT01418001|Docetaxel|docetaxel|mesh-list
92175657|NCT01418001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175658|NCT01418001|Antimetabolites|antimetabolites|mesh-ancestor
92175659|NCT01418001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175660|NCT01418001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175661|NCT01418001|Tubulin Modulators|tubulin modulators|mesh-ancestor
92175662|NCT01418001|Antimitotic Agents|antimitotic agents|mesh-ancestor
92175663|NCT01418001|Mitosis Modulators|mitosis modulators|mesh-ancestor
92175664|NCT04776889|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92175665|NCT04776889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92175666|NCT04776889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92175667|NCT04776889|Antimetabolites|antimetabolites|mesh-ancestor
92175668|NCT04776889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175669|NCT04776889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92106804|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175670|NCT04776889|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92175671|NCT04776889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175672|NCT01542255|Cyclophosphamide|cyclophosphamide|mesh-list
92175673|NCT01542255|Dacarbazine|dacarbazine|mesh-list
92175674|NCT01542255|Vinblastine|vinblastine|mesh-list
92175675|NCT01542255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175676|NCT01542255|Immunologic Factors|immunologic factors|mesh-ancestor
92175677|NCT01542255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175678|NCT01542255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175679|NCT01542255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92175680|NCT01542255|Alkylating Agents|alkylating agents|mesh-ancestor
92319707|NCT03565328|Niacin|niacin|mesh-list
92175681|NCT01542255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175682|NCT01542255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175683|NCT01542255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92175684|NCT01542255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92175685|NCT01542255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92175686|NCT01542255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92175687|NCT01542255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92175689|NCT01456481|Sympathomimetics|sympathomimetics|mesh-ancestor
92175690|NCT01456481|Autonomic Agents|autonomic agents|mesh-ancestor
92175691|NCT01456481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175692|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175693|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92175694|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92175695|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92175696|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92175697|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175698|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175699|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175700|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
92175701|NCT02872259|Trametinib|trametinib|mesh-list
92175702|NCT02872259|Dabrafenib|dabrafenib|mesh-list
92175703|NCT02872259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175704|NCT02872259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175705|NCT02872259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92175706|NCT02872259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175707|NCT02872259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92175708|NCT02872259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175710|NCT04776655|Bevacizumab|bevacizumab|mesh-list
92175711|NCT04776655|Cetuximab|cetuximab|mesh-list
92175712|NCT04776655|Fluorouracil|fluorouracil|mesh-list
92175713|NCT04776655|Irinotecan|irinotecan|mesh-list
92175714|NCT04776655|Calcium|calcium|mesh-list
92175715|NCT04776655|Levoleucovorin|levoleucovorin|mesh-list
92175716|NCT04776655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175717|NCT04776655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175718|NCT04776655|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92175719|NCT04776655|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92175720|NCT04776655|Growth Substances|growth substances|mesh-ancestor
92175721|NCT04776655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175722|NCT04776655|Growth Inhibitors|growth inhibitors|mesh-ancestor
92175723|NCT04776655|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92175724|NCT04776655|Antimetabolites|antimetabolites|mesh-ancestor
92175725|NCT04776655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175726|NCT04776655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175727|NCT04776655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175728|NCT04776655|Immunologic Factors|immunologic factors|mesh-ancestor
92175729|NCT04776655|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92175730|NCT04776655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92175731|NCT04776655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175733|NCT04776655|Protective Agents|protective agents|mesh-ancestor
92175734|NCT04776655|Vitamin B Complex|vitamin b complex|mesh-ancestor
92175735|NCT04776655|Vitamins|vitamins|mesh-ancestor
92175736|NCT04776655|Micronutrients|micronutrients|mesh-ancestor
92175738|NCT01455233|Besifloxacin|besifloxacin|mesh-list
92175739|NCT01455233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92175740|NCT01455233|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92175741|NCT01455233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92175742|NCT01455233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92175743|NCT01455233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175744|NCT01455233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92175745|NCT01455233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92175746|NCT01455233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175747|NCT01455233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175748|NCT01455233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175749|NCT01455233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92175750|NCT01455233|Contraceptive Agents|contraceptive agents|mesh-ancestor
92175751|NCT01455233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92175752|NCT01455233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175753|NCT01455233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92175754|NCT01455233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92175755|NCT01455233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92175756|NCT01459679|Riboflavin|riboflavin|mesh-list
92175757|NCT01459679|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92175758|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92175759|NCT01459679|Vitamin B Complex|vitamin b complex|mesh-ancestor
92175760|NCT01459679|Vitamins|vitamins|mesh-ancestor
92175761|NCT01459679|Micronutrients|micronutrients|mesh-ancestor
92175762|NCT01459679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175763|NCT01459679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92175764|NCT01459679|Dermatologic Agents|dermatologic agents|mesh-ancestor
92175765|NCT00048295|Alicaforsen|alicaforsen|mesh-list
92175766|NCT00048295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92175767|NCT00048295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175768|NCT00048295|Immunologic Factors|immunologic factors|mesh-ancestor
92175769|NCT00048295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175771|NCT01455857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175772|NCT01455857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175773|NCT01455857|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92175774|NCT01455857|Incretins|incretins|mesh-ancestor
92175775|NCT01455857|Hormones|hormones|mesh-ancestor
92175776|NCT01455857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175777|NCT03043248|Digoxin|digoxin|mesh-list
92175778|NCT03043248|Midazolam|midazolam|mesh-list
92175779|NCT03043248|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92175780|NCT03043248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92175781|NCT03043248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175782|NCT03043248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175783|NCT03043248|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92175784|NCT03043248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92175785|NCT03043248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92175786|NCT03043248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92175787|NCT03043248|Anesthetics, General|anesthetics, general|mesh-ancestor
92175788|NCT03043248|Anesthetics|anesthetics|mesh-ancestor
92175789|NCT03043248|GABA Modulators|gaba modulators|mesh-ancestor
92175790|NCT03043248|GABA Agents|gaba agents|mesh-ancestor
92175791|NCT03043248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175792|NCT03043248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175793|NCT03043248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92175794|NCT03043248|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92175795|NCT03043248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175796|NCT03043248|Protective Agents|protective agents|mesh-ancestor
92175797|NCT04843631|Ustekinumab|ustekinumab|mesh-list
92175798|NCT04843631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92175799|NCT03043326|Tenofovir|tenofovir|mesh-list
92175800|NCT03043326|Emtricitabine|emtricitabine|mesh-list
92175801|NCT03043326|Antiviral Agents|antiviral agents|mesh-ancestor
92175802|NCT03043326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175803|NCT03043326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92175804|NCT03043326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92175805|NCT03043326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175806|NCT03043326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175807|NCT03043326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92175808|NCT03043326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92175809|NCT04845737|Vitamin D|vitamin d|mesh-list
92175810|NCT04845737|Vitamins|vitamins|mesh-ancestor
92175811|NCT04845737|Micronutrients|micronutrients|mesh-ancestor
92175812|NCT04845737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175813|NCT04845737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92175815|NCT04849715|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92175816|NCT04849715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175817|NCT04849715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175818|NCT04849715|Immunologic Factors|immunologic factors|mesh-ancestor
92322332|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
92175819|NCT04849715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175820|NCT04849715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106812|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175821|NCT04849715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92175822|NCT04849715|Alkylating Agents|alkylating agents|mesh-ancestor
92175823|NCT04849715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175824|NCT03044964|Ranolazine|ranolazine|mesh-list
92175825|NCT03044964|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92175826|NCT03044964|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92175827|NCT03044964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175828|NCT01419639|Everolimus|everolimus|mesh-list
92175829|NCT01419639|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92175830|NCT01419639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92175831|NCT01419639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175832|NCT01419639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175833|NCT01419639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92175834|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
92175835|NCT01419639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175836|NCT01419639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175837|NCT02856893|Gefitinib|gefitinib|mesh-list
92175838|NCT02856893|Osimertinib|osimertinib|mesh-list
92175839|NCT02856893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175840|NCT02856893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92175841|NCT02856893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175842|NCT02856893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175843|NCT01419795|Rituximab|rituximab|mesh-list
92175844|NCT01419795|Lenalidomide|lenalidomide|mesh-list
92175845|NCT01419795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175846|NCT01419795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175847|NCT01419795|Immunologic Factors|immunologic factors|mesh-ancestor
92175848|NCT01419795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175849|NCT01419795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175851|NCT01419795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92175852|NCT01419795|Growth Substances|growth substances|mesh-ancestor
92175853|NCT01419795|Growth Inhibitors|growth inhibitors|mesh-ancestor
92175854|NCT04783753|Itraconazole|itraconazole|mesh-list
92175855|NCT04783753|Quinidine|quinidine|mesh-list
92175856|NCT04783753|Carbamazepine|carbamazepine|mesh-list
92175857|NCT04783753|Antifungal Agents|antifungal agents|mesh-ancestor
92175858|NCT04783753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92175859|NCT04783753|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92175860|NCT04783753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92175861|NCT04783753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175862|NCT04783753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175863|NCT04783753|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92175864|NCT04783753|Hormone Antagonists|hormone antagonists|mesh-ancestor
92175865|NCT04783753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92175866|NCT04783753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175867|NCT04783753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92175868|NCT04783753|Anticonvulsants|anticonvulsants|mesh-ancestor
92175869|NCT04783753|Antimanic Agents|antimanic agents|mesh-ancestor
92175870|NCT04783753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92175871|NCT04783753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175872|NCT04783753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92175873|NCT04783753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92175874|NCT04783753|Analgesics|analgesics|mesh-ancestor
92175875|NCT04783753|Sensory System Agents|sensory system agents|mesh-ancestor
92175876|NCT04783753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175877|NCT04783753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92175878|NCT04783753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92175879|NCT04783753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92175880|NCT04783753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92175881|NCT04783753|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92175882|NCT04783753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92175883|NCT04783753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92175884|NCT04783753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175885|NCT04783753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92106816|NCT02514642|Clopidogrel|clopidogrel|mesh-list
92175886|NCT04783753|Antimalarials|antimalarials|mesh-ancestor
92175887|NCT04783753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92175888|NCT04783753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92175889|NCT04783753|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92175890|NCT04783753|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92175891|NCT04783753|Cholinergic Agents|cholinergic agents|mesh-ancestor
92175892|NCT04783753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92175893|NCT04783753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92175894|NCT02856581|Varenicline|varenicline|mesh-list
92175895|NCT02856581|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92175896|NCT02856581|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92175897|NCT02856581|Cholinergic Agents|cholinergic agents|mesh-ancestor
92175898|NCT02856581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175899|NCT02856581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175900|NCT02856581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175901|NCT03042000|Capecitabine|capecitabine|mesh-list
92175902|NCT03042000|Oxaliplatin|oxaliplatin|mesh-list
92175903|NCT03042000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92175904|NCT03042000|Antimetabolites|antimetabolites|mesh-ancestor
92175905|NCT03042000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175906|NCT03042000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175907|NCT01039285|Poractant alfa|poractant alfa|mesh-list
92175908|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92175909|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175910|NCT03043482|Calcitriol|calcitriol|mesh-list
92175911|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92175912|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175913|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92175914|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92175915|NCT03043482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175916|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92175917|NCT03043482|Vitamins|vitamins|mesh-ancestor
92175918|NCT03043482|Micronutrients|micronutrients|mesh-ancestor
92175919|NCT03043482|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92175920|NCT04775563|Vaccines|vaccines|mesh-list
92175921|NCT04775563|Immunologic Factors|immunologic factors|mesh-ancestor
92175922|NCT04775563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175923|NCT01480089|Ropivacaine|ropivacaine|mesh-list
92175924|NCT01480089|Anesthetics, Local|anesthetics, local|mesh-ancestor
92175925|NCT01480089|Anesthetics|anesthetics|mesh-ancestor
92175926|NCT01480089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175927|NCT01480089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175928|NCT01480089|Sensory System Agents|sensory system agents|mesh-ancestor
92175929|NCT01480089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175930|NCT03523975|Rituximab|rituximab|mesh-list
92175931|NCT03523975|Lenalidomide|lenalidomide|mesh-list
92175932|NCT03523975|Venetoclax|venetoclax|mesh-list
92175933|NCT03523975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92175934|NCT03523975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92175935|NCT03523975|Immunologic Factors|immunologic factors|mesh-ancestor
92175936|NCT03523975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175937|NCT03523975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175938|NCT03523975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92175939|NCT03523975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92175940|NCT03523975|Growth Substances|growth substances|mesh-ancestor
92175941|NCT03523975|Growth Inhibitors|growth inhibitors|mesh-ancestor
92175942|NCT01542645|Fentanyl|fentanyl|mesh-list
92175943|NCT01542645|Analgesics, Opioid|analgesics, opioid|mesh-list
92175944|NCT01542645|Methadone|methadone|mesh-list
92175945|NCT01542645|Narcotics|narcotics|mesh-ancestor
92175946|NCT01542645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175947|NCT01542645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175948|NCT01542645|Analgesics|analgesics|mesh-ancestor
92175949|NCT01542645|Sensory System Agents|sensory system agents|mesh-ancestor
92175950|NCT01542645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175951|NCT01542645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92175952|NCT01542645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92175953|NCT01542645|Anesthetics, General|anesthetics, general|mesh-ancestor
92175954|NCT01542645|Anesthetics|anesthetics|mesh-ancestor
92175955|NCT01542645|Antitussive Agents|antitussive agents|mesh-ancestor
92175956|NCT01542645|Respiratory System Agents|respiratory system agents|mesh-ancestor
92175957|NCT04857450|Ketamine|ketamine|mesh-list
92175958|NCT04857450|Etomidate|etomidate|mesh-list
92175959|NCT04857450|Analgesics|analgesics|mesh-ancestor
92175960|NCT04857450|Sensory System Agents|sensory system agents|mesh-ancestor
92319935|NCT01035944|Hemostatics|hemostatics|mesh-ancestor
92175961|NCT04857450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175962|NCT04857450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175963|NCT04857450|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92175964|NCT04857450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92175965|NCT04857450|Anesthetics, General|anesthetics, general|mesh-ancestor
92175966|NCT04857450|Anesthetics|anesthetics|mesh-ancestor
92175967|NCT04857450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92175968|NCT04857450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92175969|NCT04857450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92175970|NCT04857450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92175971|NCT04857450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175972|NCT04857450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92175974|NCT01420653|Ibuprofen|ibuprofen|mesh-list
92175975|NCT01420653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92175976|NCT01420653|Analgesics|analgesics|mesh-ancestor
92175977|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
92175978|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92175979|NCT01420653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175980|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
92175981|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92175982|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92175983|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92175984|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92175985|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175986|NCT01420653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175987|NCT03042936|Insulin|insulin|mesh-list
92175988|NCT03042936|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92175989|NCT03042936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92175991|NCT01421355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92175992|NCT01421355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92175993|NCT01421355|Protease Inhibitors|protease inhibitors|mesh-ancestor
92175994|NCT01421355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92175995|NCT01421355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92175996|NCT01421355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92175997|NCT01421355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92175998|NCT01421355|Antiviral Agents|antiviral agents|mesh-ancestor
92175999|NCT01421355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176000|NCT04844957|Vitamin D|vitamin d|mesh-list
92176001|NCT04844957|Ergocalciferols|ergocalciferols|mesh-list
92176002|NCT04844957|Cholecalciferol|cholecalciferol|mesh-list
92176003|NCT04844957|Vitamins|vitamins|mesh-list
92176004|NCT04844957|Micronutrients|micronutrients|mesh-ancestor
92176005|NCT04844957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176006|NCT04844957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92176007|NCT04844957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92176008|NCT04782115|RC28-E protein|rc28-e protein|mesh-list
92176009|NCT04782115|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92176010|NCT04782115|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92176011|NCT04782115|Growth Substances|growth substances|mesh-ancestor
92176012|NCT04782115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176013|NCT04782115|Growth Inhibitors|growth inhibitors|mesh-ancestor
92176014|NCT04782115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176015|NCT01421589|Hormones|hormones|mesh-list
92176016|NCT01421589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176017|NCT01421589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176018|NCT01422135|Contraceptive Agents|contraceptive agents|mesh-list
92176019|NCT01422135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92176020|NCT01422135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176021|NCT00962845|Hydroxychloroquine|hydroxychloroquine|mesh-list
92176022|NCT00962845|Antimalarials|antimalarials|mesh-ancestor
92176023|NCT00962845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92176024|NCT00962845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92176025|NCT00962845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176026|NCT00962845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176027|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176028|NCT00962845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176029|NCT04390685|Tacrolimus|tacrolimus|mesh-list
92176030|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176031|NCT04390685|Immunologic Factors|immunologic factors|mesh-ancestor
92320017|NCT00379730|Prednisolone|prednisolone|mesh-list
92176032|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176033|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92176035|NCT04390685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176036|NCT04848246|Bupropion|bupropion|mesh-list
92176037|NCT04848246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92176038|NCT04848246|Antidepressive Agents|antidepressive agents|mesh-ancestor
92176039|NCT04848246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92176040|NCT04848246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92176041|NCT04848246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92176042|NCT04848246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176043|NCT04848246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176045|NCT04848246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176046|NCT04848246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176047|NCT04848246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92176048|NCT04848246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92176049|NCT04848246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176050|NCT04842071|Listerine|listerine|mesh-list
92176051|NCT04842071|Fluorides|fluorides|mesh-list
92176052|NCT04842071|Sodium Fluoride|sodium fluoride|mesh-list
92176053|NCT04842071|Cariostatic Agents|cariostatic agents|mesh-ancestor
92176054|NCT04842071|Protective Agents|protective agents|mesh-ancestor
92176055|NCT04842071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176056|NCT04842071|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92176057|NCT04842071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176058|NCT04038619|Loperamide|loperamide|mesh-list
92176059|NCT04038619|Antidiarrheals|antidiarrheals|mesh-list
92176060|NCT04038619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176061|NCT04774627|Olaparib|olaparib|mesh-list
92176062|NCT04774627|Niraparib|niraparib|mesh-list
92176063|NCT04774627|Talazoparib|talazoparib|mesh-list
92176064|NCT04774627|Veliparib|veliparib|mesh-list
92176065|NCT04774627|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92176066|NCT04774627|Rucaparib|rucaparib|mesh-list
92176067|NCT04774627|Pamiparib|pamiparib|mesh-list
92176068|NCT04774627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176069|NCT04774627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176070|NCT04774627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176071|NCT01545141|Interferons|interferons|mesh-list
92176072|NCT01545141|Interferon-alpha|interferon-alpha|mesh-list
92176073|NCT01545141|Interferon alpha-2|interferon alpha-2|mesh-list
92176074|NCT01545141|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92176075|NCT01545141|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92176076|NCT01545141|Poly I-C|poly i-c|mesh-list
92176077|NCT01545141|Celecoxib|celecoxib|mesh-list
92176078|NCT01545141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176079|NCT01545141|Antiviral Agents|antiviral agents|mesh-ancestor
92176080|NCT01545141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176081|NCT01545141|Immunologic Factors|immunologic factors|mesh-ancestor
92176082|NCT01545141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176083|NCT01545141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92176084|NCT01545141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92176085|NCT01545141|Analgesics|analgesics|mesh-ancestor
92176086|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
92176087|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176088|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176089|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176090|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92176091|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92176092|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176093|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176094|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
92176095|NCT04855968|Analgesics|analgesics|mesh-list
92176096|NCT04855968|Sensory System Agents|sensory system agents|mesh-ancestor
92176097|NCT04855968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176098|NCT04855968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176099|NCT01545765|Lidocaine|lidocaine|mesh-list
92176100|NCT01545765|Tetracaine|tetracaine|mesh-list
92176101|NCT01545765|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176102|NCT01545765|Anesthetics|anesthetics|mesh-ancestor
92176103|NCT01545765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320153|NCT00379028|Respiratory System Agents|respiratory system agents|mesh-ancestor
92176104|NCT01545765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176105|NCT01545765|Sensory System Agents|sensory system agents|mesh-ancestor
92176106|NCT01545765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176107|NCT01545765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92176108|NCT01545765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92176109|NCT01545765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92176110|NCT01545765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176111|NCT01545765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176112|NCT04856124|Ketamine|ketamine|mesh-list
92176113|NCT04856124|Esketamine|esketamine|mesh-list
92176114|NCT04856124|Analgesics|analgesics|mesh-ancestor
92176115|NCT04856124|Sensory System Agents|sensory system agents|mesh-ancestor
92176116|NCT04856124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176117|NCT04856124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176118|NCT04856124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92176119|NCT04856124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92176121|NCT04856124|Anesthetics|anesthetics|mesh-ancestor
92176122|NCT04856124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176123|NCT04856124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92176124|NCT04856124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92176125|NCT04856124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176126|NCT04856124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176127|NCT04856124|Antidepressive Agents|antidepressive agents|mesh-ancestor
92176128|NCT04856124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92176129|NCT04028479|Immunomodulating Agents|immunomodulating agents|mesh-list
92176130|NCT04028479|Immunologic Factors|immunologic factors|mesh-ancestor
92176131|NCT04028479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176132|NCT02208297|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92176133|NCT02208297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92176134|NCT04847622|Remdesivir|remdesivir|mesh-list
92176135|NCT04847622|Antimetabolites|antimetabolites|mesh-ancestor
92176136|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176137|NCT04847622|Antiviral Agents|antiviral agents|mesh-ancestor
92176138|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176139|NCT04781803|Cyclosporine|cyclosporine|mesh-list
92176140|NCT04781803|Cyclosporins|cyclosporins|mesh-list
92176141|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176142|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176143|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176144|NCT04781803|Immunologic Factors|immunologic factors|mesh-ancestor
92176145|NCT04781803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176146|NCT04781803|Antifungal Agents|antifungal agents|mesh-ancestor
92176147|NCT04781803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176148|NCT04781803|Dermatologic Agents|dermatologic agents|mesh-ancestor
92176149|NCT04781803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176150|NCT04781803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92176151|NCT01422369|Ritonavir|ritonavir|mesh-list
92176152|NCT01422369|Darunavir|darunavir|mesh-list
92176153|NCT01422369|Pitavastatin|pitavastatin|mesh-list
92176154|NCT01422369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92176155|NCT01422369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92176156|NCT01422369|Protease Inhibitors|protease inhibitors|mesh-ancestor
92176157|NCT01422369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176158|NCT01422369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176159|NCT01422369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92176160|NCT01422369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92176161|NCT01422369|Antiviral Agents|antiviral agents|mesh-ancestor
92176162|NCT01422369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176163|NCT01422369|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92176164|NCT01422369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92176165|NCT01422369|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92176166|NCT01422369|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92176167|NCT01422369|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92176168|NCT01422369|Antimetabolites|antimetabolites|mesh-ancestor
92176169|NCT01422369|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92176170|NCT05023343|Ropivacaine|ropivacaine|mesh-list
92176171|NCT05023343|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176172|NCT05023343|Anesthetics|anesthetics|mesh-ancestor
92176173|NCT05023343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176174|NCT05023343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176175|NCT05023343|Sensory System Agents|sensory system agents|mesh-ancestor
92176176|NCT05023343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176178|NCT04859556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92176179|NCT04859556|Adrenergic Agents|adrenergic agents|mesh-ancestor
92176180|NCT04859556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176181|NCT04859556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176182|NCT04859556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176183|NCT04781335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92176184|NCT04781335|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92176185|NCT04781335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176186|NCT04781335|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92176187|NCT04773301|Ropivacaine|ropivacaine|mesh-list
92176188|NCT04773301|Levobupivacaine|levobupivacaine|mesh-list
92176189|NCT04773301|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176190|NCT04773301|Anesthetics|anesthetics|mesh-ancestor
92176191|NCT04773301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176192|NCT04773301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322333|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
92176193|NCT04773301|Sensory System Agents|sensory system agents|mesh-ancestor
92176194|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176195|NCT04780945|Olaparib|olaparib|mesh-list
92176196|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92176197|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176198|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176199|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176200|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
92176201|NCT05021315|Povidone|povidone|mesh-list
92176202|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
92176203|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
92176204|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92176205|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176206|NCT01427517|Acetylcysteine|acetylcysteine|mesh-list
92176207|NCT01427517|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92176208|NCT01427517|Antiviral Agents|antiviral agents|mesh-ancestor
92176209|NCT01427517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176210|NCT01427517|Expectorants|expectorants|mesh-ancestor
92176211|NCT01427517|Respiratory System Agents|respiratory system agents|mesh-ancestor
92176212|NCT01427517|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92176213|NCT01427517|Antioxidants|antioxidants|mesh-ancestor
92176214|NCT01427517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176215|NCT01427517|Protective Agents|protective agents|mesh-ancestor
92176216|NCT01427517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176217|NCT01427517|Antidotes|antidotes|mesh-ancestor
92176218|NCT02835131|Pasireotide|pasireotide|mesh-list
92176219|NCT02835131|Hormones|hormones|mesh-ancestor
92176220|NCT02835131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176221|NCT02835131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176222|NCT04846452|Paclitaxel|paclitaxel|mesh-list
92176223|NCT04846452|Carboplatin|carboplatin|mesh-list
92176224|NCT04846452|Pemetrexed|pemetrexed|mesh-list
92176225|NCT04846452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92176226|NCT04846452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176227|NCT04846452|Tubulin Modulators|tubulin modulators|mesh-ancestor
92176228|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
92176229|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
92176230|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176231|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176232|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92176233|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92176234|NCT04859244|Remdesivir|remdesivir|mesh-list
92176235|NCT04859244|GS-441524|gs-441524|mesh-list
92176236|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
92176237|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176238|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
92176239|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176240|NCT05028725|Lugol's solution|lugol's solution|mesh-list
92176241|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
92176242|NCT05028725|Coagulants|coagulants|mesh-ancestor
92176244|NCT04779853|Immunologic Factors|immunologic factors|mesh-ancestor
92176245|NCT04779853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176246|NCT04855110|Warfarin|warfarin|mesh-list
92176247|NCT04855110|Anticoagulants|anticoagulants|mesh-ancestor
92176248|NCT01485393|Dexmedetomidine|dexmedetomidine|mesh-list
92176250|NCT01485393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92176251|NCT01485393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176252|NCT01485393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176253|NCT01485393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92176254|NCT01485393|Analgesics|analgesics|mesh-ancestor
92176255|NCT01485393|Sensory System Agents|sensory system agents|mesh-ancestor
92176256|NCT01485393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176257|NCT01485393|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92176258|NCT01485393|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92176259|NCT01485393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92176260|NCT01485393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92176261|NCT01485393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176262|NCT01485393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176263|NCT01485393|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92176264|NCT01485393|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92176265|NCT01485393|GABA Agonists|gaba agonists|mesh-ancestor
92176266|NCT01485393|GABA Agents|gaba agents|mesh-ancestor
92176268|NCT04772521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92176269|NCT04772521|Autonomic Agents|autonomic agents|mesh-ancestor
92320371|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176270|NCT04772521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176271|NCT04772521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176272|NCT04772521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92176273|NCT04772521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92176274|NCT04772521|Cholinergic Agents|cholinergic agents|mesh-ancestor
92176275|NCT04772521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176276|NCT04772521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176277|NCT04772287|Paclitaxel|paclitaxel|mesh-list
92176278|NCT04772287|Vinorelbine|vinorelbine|mesh-list
92176279|NCT04772287|Docetaxel|docetaxel|mesh-list
92176280|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92176281|NCT04772287|Cisplatin|cisplatin|mesh-list
92176282|NCT04772287|Carboplatin|carboplatin|mesh-list
92176283|NCT04772287|Gemcitabine|gemcitabine|mesh-list
92176284|NCT04772287|Pemetrexed|pemetrexed|mesh-list
92176285|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92176286|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176287|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92176288|NCT04772287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92176289|NCT04772287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92176290|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176291|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92176292|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
92176293|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176294|NCT04772287|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92176295|NCT04772287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92176296|NCT01890005|Aspirin|aspirin|mesh-list
92320422|NCT00634322|Antidotes|antidotes|mesh-ancestor
92176297|NCT01890005|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92176299|NCT01890005|Analgesics|analgesics|mesh-ancestor
92176300|NCT01890005|Sensory System Agents|sensory system agents|mesh-ancestor
92176301|NCT01890005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176302|NCT01890005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176303|NCT01890005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176304|NCT01890005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176305|NCT01890005|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92176306|NCT01890005|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92176307|NCT01890005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176308|NCT01890005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92176309|NCT01890005|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92176310|NCT01890005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176311|NCT01890005|Antipyretics|antipyretics|mesh-ancestor
92176312|NCT02822573|Donepezil|donepezil|mesh-list
92176313|NCT02822573|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92176314|NCT02822573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176315|NCT02822573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176316|NCT02822573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92176317|NCT02822573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176318|NCT02822573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176319|NCT02822573|Nootropic Agents|nootropic agents|mesh-ancestor
92176320|NCT04854252|Fentanyl|fentanyl|mesh-list
92176321|NCT04854252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92176322|NCT04854252|Narcotics|narcotics|mesh-ancestor
92176323|NCT04854252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176324|NCT04854252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176325|NCT04854252|Analgesics|analgesics|mesh-ancestor
92176326|NCT04854252|Sensory System Agents|sensory system agents|mesh-ancestor
92176327|NCT04854252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176328|NCT04854252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92176329|NCT04854252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92176330|NCT04854252|Anesthetics, General|anesthetics, general|mesh-ancestor
92176331|NCT04854252|Anesthetics|anesthetics|mesh-ancestor
92176332|NCT03040830|Progesterone|progesterone|mesh-list
92176333|NCT03040830|Progestins|progestins|mesh-ancestor
92176334|NCT03040830|Hormones|hormones|mesh-ancestor
92176335|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176336|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176337|NCT04390295|Metformin|metformin|mesh-list
92176338|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92176339|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176340|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
92176341|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92176342|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176343|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92176344|NCT03030235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176345|NCT04845672|Chlorhexidine|chlorhexidine|mesh-list
92176346|NCT04845672|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92176347|NCT04845672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92176348|NCT04845672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176349|NCT04845672|Disinfectants|disinfectants|mesh-ancestor
92176350|NCT04845672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92176352|NCT01890629|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92176353|NCT01890629|Glimepiride|glimepiride|mesh-list
92176354|NCT01890629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92176355|NCT01890629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176356|NCT01890629|Incretins|incretins|mesh-ancestor
92176357|NCT01890629|Hormones|hormones|mesh-ancestor
92176358|NCT01890629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176359|NCT01890629|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92176360|NCT01890629|Protease Inhibitors|protease inhibitors|mesh-ancestor
92176361|NCT01890629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176362|NCT01890629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176363|NCT01890629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92176364|NCT01890629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176365|NCT01890629|Immunologic Factors|immunologic factors|mesh-ancestor
92176366|NCT01890863|Fluticasone|fluticasone|mesh-list
92176368|NCT01890863|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92176369|NCT01890863|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92176370|NCT01890863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176371|NCT01890863|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92176372|NCT01890863|Autonomic Agents|autonomic agents|mesh-ancestor
92176373|NCT01890863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176374|NCT01890863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176375|NCT01890863|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92176376|NCT01890863|Respiratory System Agents|respiratory system agents|mesh-ancestor
92176377|NCT01890863|Dermatologic Agents|dermatologic agents|mesh-ancestor
92176378|NCT01890863|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92176379|NCT01890863|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92176380|NCT01890863|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92176381|NCT01890863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92176382|NCT01890863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92176383|NCT01890863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176384|NCT01890863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176385|NCT01890863|Glucocorticoids|glucocorticoids|mesh-ancestor
92176386|NCT01890863|Hormones|hormones|mesh-ancestor
92327625|NCT00381199|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92176387|NCT01890863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176388|NCT01890863|Sympathomimetics|sympathomimetics|mesh-ancestor
92176389|NCT02955511|Pyrithione zinc|pyrithione zinc|mesh-list
92176390|NCT02955511|Keratolytic Agents|keratolytic agents|mesh-ancestor
92176391|NCT02955511|Dermatologic Agents|dermatologic agents|mesh-ancestor
92176392|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92176393|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92176395|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176396|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
92176397|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176398|NCT01891019|Leprostatic Agents|leprostatic agents|mesh-ancestor
92176399|NCT01891019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92176400|NCT01891019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176401|NCT01891019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92176402|NCT01891019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92176403|NCT01891019|Growth Substances|growth substances|mesh-ancestor
92176404|NCT01891019|Growth Inhibitors|growth inhibitors|mesh-ancestor
92176405|NCT01891019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176406|NCT04374474|Budesonide|budesonide|mesh-list
92176407|NCT04374474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176408|NCT04374474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92176409|NCT04374474|Autonomic Agents|autonomic agents|mesh-ancestor
92176410|NCT04374474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176411|NCT04374474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176412|NCT04374474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92176413|NCT04374474|Respiratory System Agents|respiratory system agents|mesh-ancestor
92176414|NCT04374474|Glucocorticoids|glucocorticoids|mesh-ancestor
92176415|NCT04374474|Hormones|hormones|mesh-ancestor
92176416|NCT04374474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176417|NCT02983097|Cytarabine|cytarabine|mesh-list
92176418|NCT02983097|Dexamethasone|dexamethasone|mesh-list
92176419|NCT02983097|Rituximab|rituximab|mesh-list
92176420|NCT02983097|Carboplatin|carboplatin|mesh-list
92176421|NCT02983097|Lenalidomide|lenalidomide|mesh-list
92176422|NCT02983097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92176423|NCT02983097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176425|NCT02983097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176426|NCT02983097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176427|NCT02983097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176428|NCT02983097|Antiemetics|antiemetics|mesh-ancestor
92176429|NCT02983097|Autonomic Agents|autonomic agents|mesh-ancestor
92176430|NCT02983097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176431|NCT02983097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176432|NCT02983097|Glucocorticoids|glucocorticoids|mesh-ancestor
92176433|NCT02983097|Hormones|hormones|mesh-ancestor
92176434|NCT02983097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176435|NCT02983097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92176436|NCT02983097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92176437|NCT02983097|Antimetabolites|antimetabolites|mesh-ancestor
92176438|NCT02983097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176439|NCT02983097|Antiviral Agents|antiviral agents|mesh-ancestor
92176440|NCT02983097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176441|NCT02983097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176442|NCT02983097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92176443|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92176444|NCT02983097|Growth Substances|growth substances|mesh-ancestor
92176445|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
92176446|NCT01891175|Anesthetics|anesthetics|mesh-list
92176447|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176448|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176449|NCT02347865|Denosumab|denosumab|mesh-list
92176450|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92176451|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176452|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
92176453|NCT01550367|Aldesleukin|aldesleukin|mesh-list
92176454|NCT01550367|Antimalarials|antimalarials|mesh-ancestor
92176455|NCT01550367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92176456|NCT01550367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92176457|NCT01550367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176458|NCT01550367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176459|NCT01550367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176460|NCT01550367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176461|NCT01550367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176462|NCT01550367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92176463|NCT01550367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92176464|NCT01550367|Antiviral Agents|antiviral agents|mesh-ancestor
92176465|NCT01427595|Metformin|metformin|mesh-list
92176466|NCT01427595|Progesterone|progesterone|mesh-list
92176467|NCT01427595|Estradiol|estradiol|mesh-list
92176468|NCT01427595|Estrogens|estrogens|mesh-list
92176469|NCT01427595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92176470|NCT01427595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176471|NCT01427595|Progestins|progestins|mesh-ancestor
92176472|NCT01427595|Hormones|hormones|mesh-ancestor
92176473|NCT01427595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176474|NCT04390061|Hydroxychloroquine|hydroxychloroquine|mesh-list
92176475|NCT04390061|Tofacitinib|tofacitinib|mesh-list
92176476|NCT04390061|Antimalarials|antimalarials|mesh-ancestor
92176477|NCT04390061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92176478|NCT04390061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92176479|NCT04390061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176480|NCT04390061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176481|NCT04390061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176482|NCT04390061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176483|NCT04390061|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92176484|NCT04390061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92176485|NCT01892813|Bupropion|bupropion|mesh-list
92176486|NCT01892813|Nicotine|nicotine|mesh-list
92176487|NCT01892813|Varenicline|varenicline|mesh-list
92176488|NCT01892813|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92176489|NCT01892813|Autonomic Agents|autonomic agents|mesh-ancestor
92176490|NCT01892813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176491|NCT01892813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176492|NCT01892813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92176493|NCT01892813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92176494|NCT01892813|Cholinergic Agents|cholinergic agents|mesh-ancestor
92176495|NCT01892813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176496|NCT01892813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176497|NCT01892813|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92176498|NCT01892813|Antidepressive Agents|antidepressive agents|mesh-ancestor
92176499|NCT01892813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92176500|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92176501|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92176502|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176504|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92176505|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92176506|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176507|NCT00716443|Lidocaine|lidocaine|mesh-list
92176508|NCT00716443|Tetracaine|tetracaine|mesh-list
92176509|NCT00716443|Benzocaine|benzocaine|mesh-list
92176510|NCT00716443|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176511|NCT00716443|Anesthetics|anesthetics|mesh-ancestor
92176512|NCT00716443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176513|NCT00716443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176514|NCT00716443|Sensory System Agents|sensory system agents|mesh-ancestor
92176515|NCT00716443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176516|NCT00716443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92176517|NCT00716443|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92176518|NCT00716443|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92176519|NCT00716443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92106868|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
92176520|NCT00716443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176521|NCT00650143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92176522|NCT00650143|Lenograstim|lenograstim|mesh-list
92176523|NCT00650143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92176524|NCT00650143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176525|NCT00650143|Incretins|incretins|mesh-ancestor
92176526|NCT00650143|Hormones|hormones|mesh-ancestor
92176527|NCT00650143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176528|NCT00650143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92176529|NCT00650143|Protease Inhibitors|protease inhibitors|mesh-ancestor
92176530|NCT00650143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176531|NCT00650143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176532|NCT00650143|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92176533|NCT00650143|Immunologic Factors|immunologic factors|mesh-ancestor
92176534|NCT04770961|Ropivacaine|ropivacaine|mesh-list
92176535|NCT04770961|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176536|NCT04770961|Anesthetics|anesthetics|mesh-ancestor
92176537|NCT04770961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176538|NCT04770961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176539|NCT04770961|Sensory System Agents|sensory system agents|mesh-ancestor
92176540|NCT04770961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176541|NCT04753489|Rivaroxaban|rivaroxaban|mesh-list
92176542|NCT04753489|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92176543|NCT04753489|Antithrombins|antithrombins|mesh-ancestor
92176544|NCT04753489|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92176546|NCT04753489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176547|NCT04753489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176548|NCT04753489|Anticoagulants|anticoagulants|mesh-ancestor
92176549|NCT04769557|Acetaminophen|acetaminophen|mesh-list
92176550|NCT04769557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92176551|NCT04769557|Analgesics|analgesics|mesh-ancestor
92176552|NCT04769557|Sensory System Agents|sensory system agents|mesh-ancestor
92176553|NCT04769557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176554|NCT04769557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176555|NCT04769557|Antipyretics|antipyretics|mesh-ancestor
92176556|NCT05606497|Dexamethasone|dexamethasone|mesh-list
92176557|NCT05606497|Betamethasone|betamethasone|mesh-list
92176558|NCT05606497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176559|NCT05606497|Antiemetics|antiemetics|mesh-ancestor
92176560|NCT05606497|Autonomic Agents|autonomic agents|mesh-ancestor
92176561|NCT05606497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176562|NCT05606497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176563|NCT05606497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176564|NCT05606497|Glucocorticoids|glucocorticoids|mesh-ancestor
92176565|NCT05606497|Hormones|hormones|mesh-ancestor
92176566|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176567|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92176568|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176569|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92176570|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
92176571|NCT04778917|Heparin|heparin|mesh-list
92176572|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92176575|NCT04778917|Calcium heparin|calcium heparin|mesh-list
92176576|NCT04778917|Calcium|calcium|mesh-list
92176577|NCT04778917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92176578|NCT04778917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176579|NCT04778917|Anticoagulants|anticoagulants|mesh-ancestor
92176580|NCT04778917|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92176581|NCT04778917|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92176582|NCT04778917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176584|NCT02213289|Trastuzumab|trastuzumab|mesh-list
92176585|NCT02213289|Bemarituzumab|bemarituzumab|mesh-list
92176586|NCT02213289|Ramucirumab|ramucirumab|mesh-list
92176587|NCT02213289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92176588|NCT02213289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176589|NCT02213289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92176590|NCT02213289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176591|NCT02779751|Pembrolizumab|pembrolizumab|mesh-list
92176592|NCT02779751|Anastrozole|anastrozole|mesh-list
92176593|NCT02779751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92176594|NCT02779751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176595|NCT02779751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92176596|NCT02779751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176597|NCT02779751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92176598|NCT02779751|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92176599|NCT02779751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92176600|NCT02779751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176601|NCT02779751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92176602|NCT02779751|Hormone Antagonists|hormone antagonists|mesh-ancestor
92176603|NCT02779751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176604|NCT02779751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176605|NCT05606107|Tofacitinib|tofacitinib|mesh-list
92176606|NCT05606107|Glucocorticoids|glucocorticoids|mesh-list
92176607|NCT05606107|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92176608|NCT05606107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92176609|NCT05606107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327626|NCT00381199|Antidepressive Agents|antidepressive agents|mesh-ancestor
92176610|NCT05606107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176612|NCT05606107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176613|NCT05606107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176614|NCT00053989|Mycophenolic Acid|mycophenolic acid|mesh-list
92176615|NCT00053989|Methylprednisolone|methylprednisolone|mesh-list
92176616|NCT00053989|Cyclophosphamide|cyclophosphamide|mesh-list
92176617|NCT00053989|Fludarabine|fludarabine|mesh-list
92176618|NCT00053989|Fludarabine phosphate|fludarabine phosphate|mesh-list
92176619|NCT00053989|Tacrolimus|tacrolimus|mesh-list
92176620|NCT00053989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92176621|NCT00053989|Sargramostim|sargramostim|mesh-list
92176622|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176623|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
92176624|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176625|NCT00053989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176626|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92176627|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
92176628|NCT00053989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176629|NCT00053989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176630|NCT00053989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92176631|NCT00053989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92176632|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
92176633|NCT00053989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92176634|NCT00053989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176635|NCT00053989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92176636|NCT00053989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92176637|NCT00053989|Antitubercular Agents|antitubercular agents|mesh-ancestor
92176638|NCT00053989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92176639|NCT00053989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176640|NCT00053989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176641|NCT00053989|Antiemetics|antiemetics|mesh-ancestor
92176642|NCT00053989|Autonomic Agents|autonomic agents|mesh-ancestor
92176643|NCT00053989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176644|NCT00053989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176645|NCT00053989|Glucocorticoids|glucocorticoids|mesh-ancestor
92176646|NCT00053989|Hormones|hormones|mesh-ancestor
92176647|NCT00053989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176648|NCT00053989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92176649|NCT00053989|Protective Agents|protective agents|mesh-ancestor
92176651|NCT02740595|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92176652|NCT02740595|Autonomic Agents|autonomic agents|mesh-ancestor
92176653|NCT02740595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176654|NCT02740595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176655|NCT02740595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92176656|NCT02740595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92176657|NCT02740595|Cholinergic Agents|cholinergic agents|mesh-ancestor
92176658|NCT02740595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106886|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
92176659|NCT02740595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176660|NCT02713997|Etanercept|etanercept|mesh-list
92176661|NCT02713997|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92176662|NCT02713997|Protein C Inhibitor|protein c inhibitor|mesh-list
92176663|NCT02713997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92176664|NCT02713997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92176665|NCT02713997|Analgesics|analgesics|mesh-ancestor
92176666|NCT02713997|Sensory System Agents|sensory system agents|mesh-ancestor
92176667|NCT02713997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176668|NCT02713997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176669|NCT02713997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176670|NCT02713997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176671|NCT02713997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176672|NCT02713997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176673|NCT02713997|Immunologic Factors|immunologic factors|mesh-ancestor
92176674|NCT02713997|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92176675|NCT02713997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92176676|NCT02713997|Protease Inhibitors|protease inhibitors|mesh-ancestor
92176677|NCT02713997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176678|NCT02713997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176679|NCT02214615|Carbamazepine|carbamazepine|mesh-list
92176680|NCT02214615|Anticonvulsants|anticonvulsants|mesh-ancestor
92176681|NCT02214615|Antimanic Agents|antimanic agents|mesh-ancestor
92176682|NCT02214615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92176683|NCT02214615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176684|NCT02214615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176685|NCT02214615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92176686|NCT02214615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92176688|NCT02214615|Sensory System Agents|sensory system agents|mesh-ancestor
92176689|NCT02214615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176690|NCT02214615|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92176691|NCT02214615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176692|NCT02214615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176693|NCT02214615|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92176694|NCT02214615|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92176695|NCT02661503|Dexamethasone|dexamethasone|mesh-list
92176696|NCT02661503|Prednisone|prednisone|mesh-list
92176697|NCT02661503|Cyclophosphamide|cyclophosphamide|mesh-list
92176698|NCT02661503|Dacarbazine|dacarbazine|mesh-list
92176699|NCT02661503|Doxorubicin|doxorubicin|mesh-list
92176700|NCT02661503|Etoposide|etoposide|mesh-list
92176701|NCT02661503|Vincristine|vincristine|mesh-list
92176702|NCT02661503|Bleomycin|bleomycin|mesh-list
92176703|NCT02661503|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92176704|NCT02661503|Procarbazine|procarbazine|mesh-list
92176705|NCT02661503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176706|NCT02661503|Immunologic Factors|immunologic factors|mesh-ancestor
92176707|NCT02661503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176708|NCT02661503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176709|NCT02661503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92176710|NCT02661503|Alkylating Agents|alkylating agents|mesh-ancestor
92176711|NCT02661503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176712|NCT02661503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176713|NCT02661503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92176714|NCT02661503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176715|NCT02661503|Antiemetics|antiemetics|mesh-ancestor
92176716|NCT02661503|Autonomic Agents|autonomic agents|mesh-ancestor
92176717|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176718|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176719|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
92176720|NCT02661503|Hormones|hormones|mesh-ancestor
92176721|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176722|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92176723|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92176724|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92176725|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92176726|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176727|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92176728|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
92176729|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
92176730|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
92176731|NCT02661503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92176732|NCT02661503|Immunotoxins|immunotoxins|mesh-ancestor
92176733|NCT02661503|Immunoconjugates|immunoconjugates|mesh-ancestor
92176734|NCT01430091|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92176735|NCT01430091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92176736|NCT02647385|Lidocaine|lidocaine|mesh-list
92176737|NCT02647385|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176738|NCT02647385|Anesthetics|anesthetics|mesh-ancestor
92176739|NCT02647385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176740|NCT02647385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176741|NCT02647385|Sensory System Agents|sensory system agents|mesh-ancestor
92176742|NCT02647385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176743|NCT02647385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92176744|NCT02647385|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92176745|NCT02647385|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92176746|NCT02647385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176747|NCT02647385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176748|NCT03040752|Nifedipine|nifedipine|mesh-list
92176749|NCT03040752|Ritodrine|ritodrine|mesh-list
92320980|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
92176750|NCT03040752|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92176751|NCT03040752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176752|NCT03040752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176753|NCT03040752|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92176754|NCT03040752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176755|NCT03040752|Vasodilator Agents|vasodilator agents|mesh-ancestor
92176756|NCT03040752|Tocolytic Agents|tocolytic agents|mesh-ancestor
92176757|NCT03040752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92176758|NCT03040752|Sympathomimetics|sympathomimetics|mesh-ancestor
92176759|NCT03040752|Autonomic Agents|autonomic agents|mesh-ancestor
92176760|NCT03040752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176761|NCT03040752|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92176762|NCT03040752|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92176763|NCT03040752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92176764|NCT03040752|Adrenergic Agents|adrenergic agents|mesh-ancestor
92176765|NCT03040752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176766|NCT01668654|Ezogabine|ezogabine|mesh-list
92176767|NCT01668654|Anticonvulsants|anticonvulsants|mesh-ancestor
92176768|NCT01668654|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176769|NCT01668654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176770|NCT01431105|Atorvastatin|atorvastatin|mesh-list
92176771|NCT01431105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92176772|NCT01431105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92176773|NCT01431105|Antimetabolites|antimetabolites|mesh-ancestor
92176774|NCT01431105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176775|NCT01431105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92176776|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92176777|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176778|NCT03038958|Prilocaine|prilocaine|mesh-list
92176779|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
92176780|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
92176781|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
92176782|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176783|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176784|NCT03038958|Sensory System Agents|sensory system agents|mesh-ancestor
92176785|NCT03038958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176786|NCT04840290|Paclitaxel|paclitaxel|mesh-list
92176787|NCT04840290|Carboplatin|carboplatin|mesh-list
92176788|NCT04840290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92176789|NCT04840290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176790|NCT04840290|Tubulin Modulators|tubulin modulators|mesh-ancestor
92176791|NCT04840290|Antimitotic Agents|antimitotic agents|mesh-ancestor
92176792|NCT04840290|Mitosis Modulators|mitosis modulators|mesh-ancestor
92176793|NCT04840290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176794|NCT02630069|Choline|choline|mesh-list
92176795|NCT02630069|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92176796|NCT02630069|Lipotropic Agents|lipotropic agents|mesh-ancestor
92176797|NCT02630069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92176798|NCT02630069|Antimetabolites|antimetabolites|mesh-ancestor
92176799|NCT02630069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176800|NCT02630069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106897|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
92176801|NCT02630069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92176802|NCT02630069|Nootropic Agents|nootropic agents|mesh-ancestor
92176803|NCT01431339|Vancomycin|vancomycin|mesh-list
92176804|NCT01431339|Linezolid|linezolid|mesh-list
92176805|NCT01431339|Dalbavancin|dalbavancin|mesh-list
92176806|NCT01431339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92176807|NCT01431339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176808|NCT01431339|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92176809|NCT01431339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176810|NCT01431339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176811|NCT02596685|Nicotine|nicotine|mesh-list
92176812|NCT02596685|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92176813|NCT02596685|Autonomic Agents|autonomic agents|mesh-ancestor
92176814|NCT02596685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176815|NCT02596685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176816|NCT02596685|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92176817|NCT02596685|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92176818|NCT02596685|Cholinergic Agents|cholinergic agents|mesh-ancestor
92176819|NCT02596685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176820|NCT02596685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176821|NCT01431573|Lithium Carbonate|lithium carbonate|mesh-list
92176822|NCT01431573|Antidepressive Agents|antidepressive agents|mesh-ancestor
92176823|NCT01431573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92176824|NCT01431573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176825|NCT01431573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176826|NCT01431573|Antimanic Agents|antimanic agents|mesh-ancestor
92176827|NCT01431573|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92176828|NCT01431573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176829|NCT01431573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176830|NCT04843644|Propolis|propolis|mesh-list
92176831|NCT04843644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92176832|NCT02588105|Leucovorin|leucovorin|mesh-list
92176833|NCT02588105|Folic Acid|folic acid|mesh-list
92176834|NCT02588105|Fluorouracil|fluorouracil|mesh-list
92176835|NCT02588105|Irinotecan|irinotecan|mesh-list
92176836|NCT02588105|Olaparib|olaparib|mesh-list
92176837|NCT02588105|AZD0156|azd0156|mesh-list
92176838|NCT02588105|Levoleucovorin|levoleucovorin|mesh-list
92176839|NCT02588105|Antimetabolites|antimetabolites|mesh-ancestor
92176840|NCT02588105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176841|NCT02588105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92176842|NCT02588105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176843|NCT02588105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176844|NCT02588105|Immunologic Factors|immunologic factors|mesh-ancestor
92176845|NCT02588105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176846|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92176847|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92176848|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176849|NCT02588105|Antidotes|antidotes|mesh-ancestor
92176850|NCT02588105|Protective Agents|protective agents|mesh-ancestor
92176851|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
92176852|NCT02588105|Vitamins|vitamins|mesh-ancestor
92176853|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
92176854|NCT02588105|Hematinics|hematinics|mesh-ancestor
92176855|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92176856|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92176857|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92176858|NCT01488279|Dexamethasone|dexamethasone|mesh-list
92176859|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
92176860|NCT01488279|BB 1101|bb 1101|mesh-list
92176861|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176862|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
92176863|NCT01488279|Autonomic Agents|autonomic agents|mesh-ancestor
92176864|NCT01488279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176865|NCT01488279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176866|NCT01488279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92176867|NCT01488279|Glucocorticoids|glucocorticoids|mesh-ancestor
92176868|NCT01488279|Hormones|hormones|mesh-ancestor
92176869|NCT01488279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92176870|NCT01488279|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92176871|NCT01488279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176872|NCT01488279|Protease Inhibitors|protease inhibitors|mesh-ancestor
92176873|NCT01488279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176874|NCT01488279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176877|NCT01488279|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92176878|NCT02586623|Droxidopa|droxidopa|mesh-list
92176879|NCT02586623|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92176880|NCT02586623|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92176881|NCT01490073|Nitroglycerin|nitroglycerin|mesh-list
92176882|NCT01490073|Vasodilator Agents|vasodilator agents|mesh-ancestor
92176883|NCT03008109|Endostatins|endostatins|mesh-list
92176884|NCT03008109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176885|NCT03008109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92176886|NCT03008109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92176887|NCT03008109|Growth Substances|growth substances|mesh-ancestor
91973792|NCT04950933|Riluzole|riluzole|mesh-list
92176888|NCT03008109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176889|NCT03008109|Growth Inhibitors|growth inhibitors|mesh-ancestor
92176890|NCT02562443|ON 01910|on 01910|mesh-list
92176891|NCT02562443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176892|NCT02562443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92176893|NCT02562443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176894|NCT02562443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176895|NCT04843098|Paclitaxel|paclitaxel|mesh-list
92176896|NCT04843098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92176897|NCT04843098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176898|NCT04843098|Tubulin Modulators|tubulin modulators|mesh-ancestor
92176899|NCT04843098|Antimitotic Agents|antimitotic agents|mesh-ancestor
92176900|NCT04843098|Mitosis Modulators|mitosis modulators|mesh-ancestor
92176901|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176902|NCT01490931|Ketorolac|ketorolac|mesh-list
92176903|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92176904|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92176905|NCT01490931|Analgesics|analgesics|mesh-ancestor
92176906|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
92176907|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176908|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176909|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92176910|NCT01490931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176911|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92176912|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176913|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176914|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
92176915|NCT02562365|Carboplatin|carboplatin|mesh-list
92176916|NCT02562365|Etoposide|etoposide|mesh-list
92176917|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92176918|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
92176919|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176920|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92176921|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92176922|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
92176923|NCT02562365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176924|NCT02562365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176925|NCT02562365|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92176926|NCT02562365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92176927|NCT02562365|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92176928|NCT02562365|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92176929|NCT02562365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176930|NCT01491633|Dasatinib|dasatinib|mesh-list
92176931|NCT01491633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176932|NCT01491633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92176933|NCT01491633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92176934|NCT01491633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176935|NCT01433913|Metformin|metformin|mesh-list
92176936|NCT01433913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92176937|NCT01433913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176938|NCT04839198|Nicotine|nicotine|mesh-list
92176939|NCT04839198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92176940|NCT04839198|Autonomic Agents|autonomic agents|mesh-ancestor
92176941|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176942|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106910|NCT02505282|Vitamins|vitamins|mesh-ancestor
92176943|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92176944|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92176945|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
92176946|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176947|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176948|NCT02509793|Tetrabenazine|tetrabenazine|mesh-list
92176949|NCT02509793|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92176950|NCT02509793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92176951|NCT02509793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176952|NCT02509793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176953|NCT02509793|Adrenergic Agents|adrenergic agents|mesh-ancestor
92176954|NCT02509793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92176955|NCT02509793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176956|NCT02508467|Fisogatinib|fisogatinib|mesh-list
92176957|NCT02508467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176958|NCT05586347|Nicardipine|nicardipine|mesh-list
92176959|NCT05586347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92176960|NCT05586347|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92176961|NCT05586347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92176962|NCT05586347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176963|NCT05586347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92176964|NCT05586347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176965|NCT05586347|Vasodilator Agents|vasodilator agents|mesh-ancestor
92176966|NCT01436799|Alfentanil|alfentanil|mesh-list
92176967|NCT01436799|Propofol|propofol|mesh-list
92176968|NCT01436799|Desflurane|desflurane|mesh-list
92176969|NCT01436799|Rocuronium|rocuronium|mesh-list
92176970|NCT01436799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92176971|NCT01436799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92176972|NCT01436799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176973|NCT01436799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92176974|NCT01436799|Anesthetics, General|anesthetics, general|mesh-ancestor
92176975|NCT01436799|Anesthetics|anesthetics|mesh-ancestor
92176976|NCT01436799|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92176977|NCT01436799|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92176978|NCT01436799|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92176979|NCT01436799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176980|NCT01436799|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92176981|NCT01436799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92176982|NCT01436799|Narcotics|narcotics|mesh-ancestor
92176983|NCT01436799|Analgesics|analgesics|mesh-ancestor
92176984|NCT01436799|Sensory System Agents|sensory system agents|mesh-ancestor
92176985|NCT04851132|Durvalumab|durvalumab|mesh-list
92176986|NCT04851132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92176987|NCT04851132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176988|NCT02504489|Docetaxel|docetaxel|mesh-list
92176989|NCT02504489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92176990|NCT02504489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92176991|NCT02504489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92176992|NCT02504489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92176993|NCT02504489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92176994|NCT02479451|Theophylline|theophylline|mesh-list
92176995|NCT02479451|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92176996|NCT02479451|Autonomic Agents|autonomic agents|mesh-ancestor
92176997|NCT02479451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92176998|NCT02479451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92176999|NCT02479451|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92177000|NCT02479451|Respiratory System Agents|respiratory system agents|mesh-ancestor
92177001|NCT02479451|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92177002|NCT02479451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177003|NCT02479451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177004|NCT02479451|Vasodilator Agents|vasodilator agents|mesh-ancestor
92177005|NCT02479451|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92177006|NCT02479451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92177007|NCT02479451|Purinergic Agents|purinergic agents|mesh-ancestor
92177008|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177009|NCT02424617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92106916|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
92177010|NCT02424617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177011|NCT02424617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177012|NCT02424617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177013|NCT02424617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177014|NCT02415413|Dexamethasone|dexamethasone|mesh-list
92177015|NCT02415413|Lenalidomide|lenalidomide|mesh-list
92177016|NCT02415413|Melphalan|melphalan|mesh-list
92177017|NCT02415413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177018|NCT02415413|Antiemetics|antiemetics|mesh-ancestor
92177019|NCT02415413|Autonomic Agents|autonomic agents|mesh-ancestor
92177020|NCT02415413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177021|NCT02415413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177022|NCT02415413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177023|NCT02415413|Glucocorticoids|glucocorticoids|mesh-ancestor
92177025|NCT02415413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177026|NCT02415413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92177027|NCT02415413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177028|NCT02415413|Immunologic Factors|immunologic factors|mesh-ancestor
92177029|NCT02415413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177030|NCT02415413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177031|NCT02415413|Growth Substances|growth substances|mesh-ancestor
92177032|NCT02415413|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177033|NCT02415413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177034|NCT02415413|Alkylating Agents|alkylating agents|mesh-ancestor
92177035|NCT02415413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177036|NCT02415413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92177037|NCT02415413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177038|NCT02379377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92177039|NCT02379377|Fluorides|fluorides|mesh-list
92177040|NCT02379377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92177041|NCT02379377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177042|NCT02379377|Cariostatic Agents|cariostatic agents|mesh-ancestor
92177043|NCT02379377|Protective Agents|protective agents|mesh-ancestor
92177044|NCT02379377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177045|NCT01894061|Bevacizumab|bevacizumab|mesh-list
92177046|NCT01894061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92177047|NCT01894061|Antibodies|antibodies|mesh-list
92177048|NCT01894061|Immunoglobulins|immunoglobulins|mesh-list
92177049|NCT01894061|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92177050|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177051|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177052|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177053|NCT01894061|Growth Substances|growth substances|mesh-ancestor
92177054|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177055|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177056|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
92177057|NCT01561053|Immunoglobulins|immunoglobulins|mesh-list
92177058|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92177059|NCT01561053|Antibodies|antibodies|mesh-list
92177060|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
92177061|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177062|NCT01561833|Sorafenib|sorafenib|mesh-list
92177063|NCT01561833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177064|NCT01561833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177065|NCT01561833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177066|NCT01561833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177067|NCT02607306|Insulin|insulin|mesh-list
92177068|NCT02607306|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92177069|NCT02607306|Liraglutide|liraglutide|mesh-list
92177070|NCT02607306|Insulin, Long-Acting|insulin, long-acting|mesh-list
92177071|NCT02607306|Xultophy|xultophy|mesh-list
92177072|NCT02607306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92177073|NCT02607306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177074|NCT02607306|Incretins|incretins|mesh-ancestor
92177075|NCT02607306|Hormones|hormones|mesh-ancestor
92177076|NCT02607306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177077|NCT03040128|Minocycline|minocycline|mesh-list
92177078|NCT03040128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92177079|NCT03040128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177080|NCT04850040|Oxaliplatin|oxaliplatin|mesh-list
92177081|NCT04850040|Apatinib|apatinib|mesh-list
92177082|NCT04850040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177083|NCT04850040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177084|NCT04850040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177085|NCT04850040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177086|NCT03038334|Magnesium Sulfate|magnesium sulfate|mesh-list
92177087|NCT03038334|Analgesics|analgesics|mesh-ancestor
92177088|NCT03038334|Sensory System Agents|sensory system agents|mesh-ancestor
92177089|NCT03038334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177090|NCT03038334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177091|NCT03038334|Anesthetics|anesthetics|mesh-ancestor
92177092|NCT03038334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177093|NCT03038334|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92177094|NCT03038334|Anticonvulsants|anticonvulsants|mesh-ancestor
92177095|NCT03038334|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92177096|NCT03038334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92177097|NCT03038334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177098|NCT03038334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92177099|NCT03038334|Tocolytic Agents|tocolytic agents|mesh-ancestor
92177100|NCT03038334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92177101|NCT01441245|Furosemide|furosemide|mesh-list
92177102|NCT01441245|Diuretics|diuretics|mesh-ancestor
92177103|NCT01441245|Natriuretic Agents|natriuretic agents|mesh-ancestor
92177104|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177105|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92177106|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92177107|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177108|NCT02298257|Doxorubicin|doxorubicin|mesh-list
92177109|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92177110|NCT02298257|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92177111|NCT02298257|Dacarbazine|dacarbazine|mesh-list
92177112|NCT02298257|Vinblastine|vinblastine|mesh-list
92177113|NCT02298257|Antibodies|antibodies|mesh-list
92177114|NCT02298257|Immunoglobulins|immunoglobulins|mesh-list
92177115|NCT02298257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92177116|NCT02298257|Immunoconjugates|immunoconjugates|mesh-list
92177117|NCT02298257|Immunologic Factors|immunologic factors|mesh-ancestor
92177118|NCT02298257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177119|NCT02298257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92177120|NCT02298257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177121|NCT02298257|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92177122|NCT02298257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177123|NCT02298257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177124|NCT02298257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177125|NCT02298257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177126|NCT02298257|Immunotoxins|immunotoxins|mesh-ancestor
92177127|NCT02298257|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177128|NCT02298257|Alkylating Agents|alkylating agents|mesh-ancestor
92177129|NCT02298257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92177130|NCT02298257|Tubulin Modulators|tubulin modulators|mesh-ancestor
92177131|NCT02298257|Antimitotic Agents|antimitotic agents|mesh-ancestor
92177132|NCT02298257|Mitosis Modulators|mitosis modulators|mesh-ancestor
92177133|NCT01563081|Cetirizine|cetirizine|mesh-list
92177134|NCT01563081|Levocetirizine|levocetirizine|mesh-list
92177135|NCT01563081|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92177136|NCT01563081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92177137|NCT01563081|Histamine Antagonists|histamine antagonists|mesh-ancestor
92177138|NCT01563081|Histamine Agents|histamine agents|mesh-ancestor
92177139|NCT01563081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177140|NCT01563081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177141|NCT01563081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177142|NCT01563081|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92177143|NCT02278601|Fentanyl|fentanyl|mesh-list
92177144|NCT02278601|Ropivacaine|ropivacaine|mesh-list
92177145|NCT02278601|Anesthetics, Local|anesthetics, local|mesh-list
92177146|NCT02278601|Anesthetics|anesthetics|mesh-list
92321342|NCT00001790|Micafungin|micafungin|mesh-list
92177147|NCT02278601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177148|NCT02278601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177149|NCT02278601|Sensory System Agents|sensory system agents|mesh-ancestor
92177150|NCT02278601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177151|NCT02278601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92177152|NCT02278601|Narcotics|narcotics|mesh-ancestor
92177153|NCT02278601|Analgesics|analgesics|mesh-ancestor
92177154|NCT02278601|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92177155|NCT02278601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92177156|NCT02278601|Anesthetics, General|anesthetics, general|mesh-ancestor
92177157|NCT04833738|Triamcinolone|triamcinolone|mesh-list
92177158|NCT04833738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92177159|NCT04833738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92177160|NCT04833738|Hyaluronic Acid|hyaluronic acid|mesh-list
92177161|NCT04833738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92177162|NCT04833738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177163|NCT04833738|Glucocorticoids|glucocorticoids|mesh-ancestor
92177164|NCT04833738|Hormones|hormones|mesh-ancestor
92177165|NCT04833738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177166|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177167|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177168|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
92177169|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177170|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177171|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92177172|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
92177173|NCT04833738|Protective Agents|protective agents|mesh-ancestor
92177174|NCT01441401|Gabapentin|gabapentin|mesh-list
92177175|NCT01441401|Analgesics|analgesics|mesh-ancestor
92177176|NCT01441401|Sensory System Agents|sensory system agents|mesh-ancestor
92177177|NCT01441401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177178|NCT01441401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177179|NCT01441401|Anticonvulsants|anticonvulsants|mesh-ancestor
92177180|NCT01441401|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92177181|NCT01441401|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92321369|NCT04331600|Chloroquine|chloroquine|mesh-list
92177182|NCT01441401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177183|NCT01441401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92177184|NCT01441401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92177185|NCT01441401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92177186|NCT01441401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177187|NCT01441401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177188|NCT01441401|Antimanic Agents|antimanic agents|mesh-ancestor
92177190|NCT02268695|Cetuximab|cetuximab|mesh-list
92177191|NCT02268695|Lenograstim|lenograstim|mesh-list
92177192|NCT02268695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177193|NCT02268695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92177194|NCT02268695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92177195|NCT02268695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92177196|NCT02268695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177197|NCT02268695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177198|NCT02268695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92177199|NCT02268695|Immunologic Factors|immunologic factors|mesh-ancestor
92177200|NCT02268695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177201|NCT01495923|Gabapentin|gabapentin|mesh-list
92177202|NCT01495923|Analgesics|analgesics|mesh-ancestor
92177203|NCT01495923|Sensory System Agents|sensory system agents|mesh-ancestor
92177204|NCT01495923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177205|NCT01495923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177206|NCT01495923|Anticonvulsants|anticonvulsants|mesh-ancestor
92177207|NCT01495923|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92177208|NCT01495923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92177209|NCT01495923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177210|NCT01495923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92177211|NCT01495923|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92177212|NCT01495923|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92177213|NCT01495923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177214|NCT01495923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177215|NCT01495923|Antimanic Agents|antimanic agents|mesh-ancestor
92177216|NCT03037944|Drospirenone|drospirenone|mesh-list
92177217|NCT03037944|Levonorgestrel|levonorgestrel|mesh-list
92177218|NCT03037944|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92177219|NCT03037944|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92177220|NCT03037944|Estradiol|estradiol|mesh-list
92177221|NCT03037944|Estrogens|estrogens|mesh-ancestor
92177222|NCT03037944|Hormones|hormones|mesh-ancestor
92177223|NCT03037944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177224|NCT03037944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177225|NCT03037944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92177226|NCT03037944|Contraceptive Agents|contraceptive agents|mesh-ancestor
92177227|NCT03037944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92177228|NCT03037944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92177229|NCT03037944|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91936702|NCT01590719|Leucovorin|leucovorin|mesh-list
92177230|NCT03037944|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92177231|NCT03037944|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92177232|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92177233|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
92177234|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92177235|NCT03037944|Diuretics|diuretics|mesh-ancestor
92177236|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
92177237|NCT03060473|Amoxicillin|amoxicillin|mesh-list
92177238|NCT03060473|Azithromycin|azithromycin|mesh-list
92177239|NCT03060473|Erythromycin|erythromycin|mesh-list
92177240|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
92177241|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92177242|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
92177243|NCT03060473|Ampicillin|ampicillin|mesh-list
92177244|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92177245|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177246|NCT03060473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177247|NCT03060473|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92177248|NCT03060473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177249|NCT03060473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177250|NCT03039426|Diclofenac|diclofenac|mesh-list
92177251|NCT03039426|Bupivacaine|bupivacaine|mesh-list
92177252|NCT03039426|Anesthetics, Local|anesthetics, local|mesh-ancestor
92177253|NCT03039426|Anesthetics|anesthetics|mesh-ancestor
92177254|NCT03039426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177255|NCT03039426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177256|NCT03039426|Sensory System Agents|sensory system agents|mesh-ancestor
92177257|NCT03039426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177258|NCT03039426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92177259|NCT03039426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92177260|NCT03039426|Analgesics|analgesics|mesh-ancestor
92177261|NCT03039426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177262|NCT03039426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177263|NCT03039426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92177264|NCT03039426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177265|NCT03039426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177267|NCT02205515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92177268|NCT02205515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177269|NCT02205515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177270|NCT02205515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177271|NCT02205515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177272|NCT02205515|Immunologic Factors|immunologic factors|mesh-ancestor
92177273|NCT02205515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177274|NCT02205515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177275|NCT04833036|Irinotecan|irinotecan|mesh-list
92177276|NCT04833036|Cetuximab|cetuximab|mesh-list
92177277|NCT04833036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92177278|NCT04833036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177279|NCT04833036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177280|NCT04833036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177281|NCT04833036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177282|NCT04833036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177283|NCT04832880|Remdesivir|remdesivir|mesh-list
92177284|NCT04832880|Dexamethasone|dexamethasone|mesh-list
92177285|NCT04832880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177286|NCT04832880|Antiemetics|antiemetics|mesh-ancestor
92177287|NCT04832880|Autonomic Agents|autonomic agents|mesh-ancestor
92177288|NCT04832880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177289|NCT04832880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177290|NCT04832880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177291|NCT04832880|Glucocorticoids|glucocorticoids|mesh-ancestor
92177292|NCT04832880|Hormones|hormones|mesh-ancestor
92177293|NCT04832880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177294|NCT04832880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92177295|NCT04832880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177296|NCT04832880|Antimetabolites|antimetabolites|mesh-ancestor
92177297|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177298|NCT04832880|Antiviral Agents|antiviral agents|mesh-ancestor
92177299|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177300|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
92177301|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92177302|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177303|NCT01894295|Vitamin D|vitamin d|mesh-list
92177304|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92177305|NCT01894295|Vitamins|vitamins|mesh-ancestor
92177306|NCT01894295|Micronutrients|micronutrients|mesh-ancestor
92177307|NCT01894295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177308|NCT01894295|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92177309|NCT02169089|Spironolactone|spironolactone|mesh-list
92177310|NCT02169089|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92177311|NCT02169089|Hormone Antagonists|hormone antagonists|mesh-ancestor
92177312|NCT02169089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177313|NCT02169089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177314|NCT02169089|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92177315|NCT02169089|Diuretics|diuretics|mesh-ancestor
92177316|NCT02169089|Natriuretic Agents|natriuretic agents|mesh-ancestor
92177317|NCT04788186|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92177318|NCT04788186|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92177319|NCT04788186|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177320|NCT04788186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177321|NCT04788186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177322|NCT04788186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177323|NCT01498419|Moxifloxacin|moxifloxacin|mesh-list
92177325|NCT01498419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92177326|NCT01498419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177327|NCT01498419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92177328|NCT01498419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177329|NCT01498419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177330|NCT01498419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177331|NCT01498419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177332|NCT01498419|Antitubercular Agents|antitubercular agents|mesh-ancestor
92177333|NCT04824924|Venetoclax|venetoclax|mesh-list
92177334|NCT04824924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177335|NCT04553705|Quinine|quinine|mesh-list
92177336|NCT04553705|Antimalarials|antimalarials|mesh-ancestor
92177337|NCT04553705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92177338|NCT04553705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92177339|NCT04553705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177340|NCT04553705|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92177341|NCT04553705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177342|NCT04553705|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92177343|NCT04553705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177344|NCT04553705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92177345|NCT04553705|Analgesics|analgesics|mesh-ancestor
92177346|NCT04553705|Sensory System Agents|sensory system agents|mesh-ancestor
92177347|NCT02140151|Ranibizumab|ranibizumab|mesh-list
92177348|NCT02140151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177349|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177350|NCT02140151|Growth Substances|growth substances|mesh-ancestor
92177351|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177352|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177353|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177354|NCT02135315|Isosorbide|isosorbide|mesh-list
92177355|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92177356|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92177357|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92177358|NCT02135315|Diuretics|diuretics|mesh-ancestor
92177359|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
92177360|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177361|NCT02135315|Vasodilator Agents|vasodilator agents|mesh-ancestor
92177362|NCT02135315|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92177363|NCT02135315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177364|NCT01894373|Immunomodulating Agents|immunomodulating agents|mesh-list
92177365|NCT01894373|Immunologic Factors|immunologic factors|mesh-ancestor
92177366|NCT01894373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177367|NCT02117297|Gemtuzumab|gemtuzumab|mesh-list
92321504|NCT00000950|Ethambutol|ethambutol|mesh-list
92177368|NCT02117297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177370|NCT02117297|Immunotoxins|immunotoxins|mesh-ancestor
92177371|NCT02117297|Immunoconjugates|immunoconjugates|mesh-ancestor
92177372|NCT02117297|Immunologic Factors|immunologic factors|mesh-ancestor
92177373|NCT02117297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177374|NCT04837170|Ketamine|ketamine|mesh-list
92177375|NCT04837170|Esketamine|esketamine|mesh-list
92177376|NCT04837170|Analgesics|analgesics|mesh-ancestor
92177377|NCT04837170|Sensory System Agents|sensory system agents|mesh-ancestor
92177378|NCT04837170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177379|NCT04837170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177380|NCT04837170|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92177381|NCT04837170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92177382|NCT04837170|Anesthetics, General|anesthetics, general|mesh-ancestor
92177383|NCT04837170|Anesthetics|anesthetics|mesh-ancestor
92177384|NCT04837170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177385|NCT04837170|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92177386|NCT04837170|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92177387|NCT04837170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177388|NCT04837170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177389|NCT04837170|Antidepressive Agents|antidepressive agents|mesh-ancestor
92177390|NCT04837170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92177391|NCT04824612|Triamcinolone|triamcinolone|mesh-list
92177392|NCT04824612|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92177393|NCT04824612|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92177394|NCT04824612|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92177395|NCT04824612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177396|NCT04824612|Glucocorticoids|glucocorticoids|mesh-ancestor
92177397|NCT04824612|Hormones|hormones|mesh-ancestor
92177398|NCT04824612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177399|NCT04824612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177401|NCT04824612|Immunologic Factors|immunologic factors|mesh-ancestor
92177402|NCT04824612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177403|NCT04824612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177404|NCT02113553|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92177405|NCT02113553|Luteolytic Agents|luteolytic agents|mesh-ancestor
92177406|NCT02113553|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92177407|NCT02113553|Contraceptive Agents|contraceptive agents|mesh-ancestor
92177408|NCT02113553|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92177409|NCT02113553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177410|NCT02113553|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92177411|NCT02113553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92177412|NCT02113553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177413|NCT02101775|Gemcitabine|gemcitabine|mesh-list
92177414|NCT02101775|Adavosertib|adavosertib|mesh-list
92177415|NCT02101775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92177416|NCT02101775|Antimetabolites|antimetabolites|mesh-ancestor
92177417|NCT02101775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177418|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177419|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177421|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92177422|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177423|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
92177424|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177425|NCT01568073|Levodopa|levodopa|mesh-list
92177426|NCT01568073|Carbidopa|carbidopa|mesh-list
92177427|NCT01568073|Opicapone|opicapone|mesh-list
92177428|NCT01568073|Entacapone|entacapone|mesh-list
92177429|NCT01568073|Benserazide|benserazide|mesh-list
92177430|NCT01568073|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92177431|NCT01568073|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92177432|NCT01568073|Dopamine Agents|dopamine agents|mesh-ancestor
92177433|NCT01568073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177434|NCT01568073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177435|NCT01568073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177436|NCT01568073|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92177437|NCT01568073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177438|NCT01568073|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92177439|NCT04274933|Capecitabine|capecitabine|mesh-list
92177440|NCT04274933|Venetoclax|venetoclax|mesh-list
92177441|NCT04274933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92177442|NCT04274933|Antimetabolites|antimetabolites|mesh-ancestor
92177443|NCT04274933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177444|NCT04274933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177445|NCT02603952|Oseltamivir|oseltamivir|mesh-list
92177446|NCT02603952|MEDI8852|medi8852|mesh-list
92177447|NCT02603952|Antiviral Agents|antiviral agents|mesh-ancestor
92177448|NCT02603952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177449|NCT02603952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177450|NCT02603952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177451|NCT02062463|Budesonide|budesonide|mesh-list
92177452|NCT02062463|Formoterol Fumarate|formoterol fumarate|mesh-list
92177453|NCT02062463|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92177454|NCT02062463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177455|NCT02062463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92177456|NCT02062463|Autonomic Agents|autonomic agents|mesh-ancestor
92177457|NCT02062463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177458|NCT02062463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177459|NCT02062463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92177460|NCT02062463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92177461|NCT02062463|Glucocorticoids|glucocorticoids|mesh-ancestor
92177463|NCT02062463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177464|NCT02062463|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92177465|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92177466|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92177467|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177468|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177469|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177470|NCT01501929|Metoprolol|metoprolol|mesh-list
92177471|NCT01501929|Nebivolol|nebivolol|mesh-list
92177472|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92177473|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92177475|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
92177476|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177477|NCT01501929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177478|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92177479|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92177480|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92177481|NCT01501929|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177482|NCT01501929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177483|NCT01501929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177484|NCT01501929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92177485|NCT01501929|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92177486|NCT01501929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92177487|NCT01501929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92177488|NCT05618496|Hyaluronic Acid|hyaluronic acid|mesh-list
92177489|NCT05618496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92177490|NCT05618496|Immunologic Factors|immunologic factors|mesh-ancestor
92177491|NCT05618496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177492|NCT05618496|Viscosupplements|viscosupplements|mesh-ancestor
92177493|NCT05618496|Protective Agents|protective agents|mesh-ancestor
92177494|NCT02049593|Irinotecan|irinotecan|mesh-list
92177495|NCT02049593|Temozolomide|temozolomide|mesh-list
92177496|NCT02049593|Talazoparib|talazoparib|mesh-list
92177497|NCT02049593|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92177498|NCT02049593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92177499|NCT02049593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177500|NCT02049593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177501|NCT02049593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177502|NCT02049593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177503|NCT02049593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177504|NCT02049593|Alkylating Agents|alkylating agents|mesh-ancestor
92177505|NCT02049047|Everolimus|everolimus|mesh-list
92177506|NCT02049047|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92177507|NCT02049047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177508|NCT02049047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177509|NCT02049047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177510|NCT02049047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177511|NCT02049047|Immunologic Factors|immunologic factors|mesh-ancestor
92106942|NCT02510586|Sevoflurane|sevoflurane|mesh-list
92177512|NCT02049047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177513|NCT02049047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177514|NCT04778358|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92177515|NCT04778358|Hormones|hormones|mesh-ancestor
92177516|NCT04778358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177517|NCT04778358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177518|NCT01449747|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92177519|NCT01449747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92177520|NCT01449747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177521|NCT01449747|Incretins|incretins|mesh-ancestor
92177522|NCT01449747|Hormones|hormones|mesh-ancestor
92177523|NCT01449747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177524|NCT01449747|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92177525|NCT01449747|Protease Inhibitors|protease inhibitors|mesh-ancestor
92177526|NCT01449747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177527|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177528|NCT03035838|Fosaprepitant|fosaprepitant|mesh-list
92177529|NCT03035838|Aprepitant|aprepitant|mesh-list
92177530|NCT03035838|Antiemetics|antiemetics|mesh-ancestor
92177531|NCT03035838|Autonomic Agents|autonomic agents|mesh-ancestor
92177532|NCT03035838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177533|NCT03035838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177534|NCT03035838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177535|NCT03035838|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92321652|NCT00001016|Leucovorin|leucovorin|mesh-list
92177536|NCT03035838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177537|NCT03035838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177538|NCT01569087|Lenograstim|lenograstim|mesh-list
92177539|NCT01569087|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92177540|NCT01569087|Immunologic Factors|immunologic factors|mesh-ancestor
92177541|NCT01569087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177542|NCT02024087|Sorafenib|sorafenib|mesh-list
92177543|NCT02024087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177544|NCT02024087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177545|NCT02024087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322334|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177546|NCT02024087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177548|NCT01895621|Antioxidants|antioxidants|mesh-ancestor
92177549|NCT01895621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177550|NCT01895621|Protective Agents|protective agents|mesh-ancestor
92177551|NCT01895621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177552|NCT01895621|Vitamin B Complex|vitamin b complex|mesh-ancestor
92177553|NCT01895621|Vitamins|vitamins|mesh-ancestor
92177554|NCT01895621|Micronutrients|micronutrients|mesh-ancestor
92177555|NCT01517711|Tramadol|tramadol|mesh-list
92177556|NCT01517711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92177557|NCT01517711|Narcotics|narcotics|mesh-ancestor
92177558|NCT01517711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177559|NCT01517711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177560|NCT01517711|Analgesics|analgesics|mesh-ancestor
92177561|NCT01517711|Sensory System Agents|sensory system agents|mesh-ancestor
92177562|NCT01517711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177563|NCT04836078|Chitosan|chitosan|mesh-list
92177564|NCT04836078|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92177565|NCT04836078|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92177566|NCT04836078|Antimetabolites|antimetabolites|mesh-ancestor
92177567|NCT04836078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177568|NCT04836078|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92177569|NCT04836078|Chelating Agents|chelating agents|mesh-ancestor
92177570|NCT04836078|Sequestering Agents|sequestering agents|mesh-ancestor
92177571|NCT04836078|Hemostatics|hemostatics|mesh-ancestor
92177572|NCT04836078|Coagulants|coagulants|mesh-ancestor
92177573|NCT01517243|Sirolimus|sirolimus|mesh-list
92177574|NCT01517243|Sunitinib|sunitinib|mesh-list
92177575|NCT01517243|Temsirolimus|temsirolimus|mesh-list
92177576|NCT01517243|MTOR Inhibitors|mtor inhibitors|mesh-list
92177577|NCT01517243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177578|NCT01517243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177579|NCT01517243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177580|NCT01517243|Growth Substances|growth substances|mesh-ancestor
92177581|NCT01517243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177582|NCT01517243|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177583|NCT01517243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177584|NCT01517243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177585|NCT01517243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177586|NCT01517243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177587|NCT01517243|Immunologic Factors|immunologic factors|mesh-ancestor
92177588|NCT01517243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92177589|NCT01517243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177590|NCT01517243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92321666|NCT00001016|Antimetabolites|antimetabolites|mesh-ancestor
92177591|NCT01517243|Antifungal Agents|antifungal agents|mesh-ancestor
92177592|NCT00055237|Bevacizumab|bevacizumab|mesh-list
92177593|NCT00055237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177594|NCT00055237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177595|NCT00055237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177596|NCT00055237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177597|NCT00055237|Growth Substances|growth substances|mesh-ancestor
92177598|NCT00055237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177599|NCT00055237|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177600|NCT04836156|Cyclophosphamide|cyclophosphamide|mesh-list
92177601|NCT04836156|Carboplatin|carboplatin|mesh-list
92177602|NCT04836156|Docetaxel|docetaxel|mesh-list
92177603|NCT04836156|Epirubicin|epirubicin|mesh-list
92177604|NCT04836156|Phenobarbital|phenobarbital|mesh-list
92177605|NCT04836156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177606|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
92177607|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177608|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177609|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177610|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
92177611|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177612|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177613|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92177614|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
92177615|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
92177616|NCT04836156|Mitosis Modulators|mitosis modulators|mesh-ancestor
92177617|NCT04836156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92177618|NCT04836156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92177619|NCT04836156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177620|NCT04836156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177621|NCT04836156|Anticonvulsants|anticonvulsants|mesh-ancestor
92177622|NCT04836156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92177623|NCT04836156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177624|NCT04836156|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92177626|NCT04836156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177627|NCT04836156|GABA Modulators|gaba modulators|mesh-ancestor
92177628|NCT04836156|GABA Agents|gaba agents|mesh-ancestor
92177629|NCT04836156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92177630|NCT04836156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92177631|NCT04836156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92177632|NCT01502787|Metoprolol|metoprolol|mesh-list
92177633|NCT01502787|Nebivolol|nebivolol|mesh-list
92177634|NCT01502787|Angiotensin II|angiotensin ii|mesh-list
92177635|NCT01502787|Giapreza|giapreza|mesh-list
92177636|NCT01502787|Angiotensinogen|angiotensinogen|mesh-list
92177637|NCT01502787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92177638|NCT01502787|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92177639|NCT01502787|Sympatholytics|sympatholytics|mesh-ancestor
92177640|NCT01502787|Autonomic Agents|autonomic agents|mesh-ancestor
92177641|NCT01502787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177642|NCT01502787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177643|NCT01502787|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92177644|NCT01502787|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92177645|NCT01502787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92177646|NCT01502787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177647|NCT01502787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177648|NCT01502787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177649|NCT01502787|Vasodilator Agents|vasodilator agents|mesh-ancestor
92177650|NCT01502787|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92177651|NCT01502787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92177652|NCT01502787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92177653|NCT01502787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92106952|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
92177654|NCT01502787|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92177655|NCT01502787|Protease Inhibitors|protease inhibitors|mesh-ancestor
92177656|NCT01502787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177657|NCT04829916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92177658|NCT04835922|Anesthetics|anesthetics|mesh-list
92177659|NCT04835922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177660|NCT04835922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177661|NCT00153985|Fludarabine|fludarabine|mesh-list
92177662|NCT00153985|Alemtuzumab|alemtuzumab|mesh-list
92177664|NCT00153985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177665|NCT00153985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177666|NCT00153985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177667|NCT00153985|Immunologic Factors|immunologic factors|mesh-ancestor
92177668|NCT00153985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177669|NCT00153985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177670|NCT00153985|Alkylating Agents|alkylating agents|mesh-ancestor
92177671|NCT00153985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177672|NCT00153985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92177673|NCT02318303|Mometasone Furoate|mometasone furoate|mesh-list
92177674|NCT02318303|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92177675|NCT02318303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177676|NCT02318303|Dermatologic Agents|dermatologic agents|mesh-ancestor
92177677|NCT02318303|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92177678|NCT02318303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92177679|NCT02318303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92177681|NCT02318303|Sensory System Agents|sensory system agents|mesh-ancestor
92177682|NCT02318303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177683|NCT02318303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177684|NCT02318303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177685|NCT02318303|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92177686|NCT02318303|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92177687|NCT02318303|Histamine Antagonists|histamine antagonists|mesh-ancestor
92177688|NCT02318303|Histamine Agents|histamine agents|mesh-ancestor
92177689|NCT02318303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177690|NCT02318303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177691|NCT01451775|Empagliflozin|empagliflozin|mesh-list
92177692|NCT01451775|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92177693|NCT01451775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177694|NCT01451775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92177695|NCT01451775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177697|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92177698|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
92177699|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177700|NCT00156013|Clofarabine|clofarabine|mesh-list
92177701|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92177702|NCT00156013|Antimetabolites|antimetabolites|mesh-ancestor
92321759|NCT00001964|Cyclosporins|cyclosporins|mesh-list
92177703|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177704|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177705|NCT01358669|Denosumab|denosumab|mesh-list
92177706|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92177707|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177708|NCT00156247|Acitretin|acitretin|mesh-list
92177709|NCT00156247|Keratolytic Agents|keratolytic agents|mesh-ancestor
92177710|NCT00156247|Dermatologic Agents|dermatologic agents|mesh-ancestor
92177711|NCT00156715|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92177712|NCT00156715|Antidepressive Agents|antidepressive agents|mesh-ancestor
92177713|NCT00156715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92177714|NCT00156715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92177715|NCT00156715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92177716|NCT00156715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177717|NCT00156715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177718|NCT01573533|Rituximab|rituximab|mesh-list
92177719|NCT01573533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177720|NCT01573533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177721|NCT01573533|Immunologic Factors|immunologic factors|mesh-ancestor
92177722|NCT01573533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177723|NCT01573533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177724|NCT01455519|Hydromorphone|hydromorphone|mesh-list
92177725|NCT01455519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92177726|NCT01455519|Narcotics|narcotics|mesh-ancestor
92327627|NCT00381199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92177727|NCT01455519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177728|NCT01455519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177729|NCT01455519|Analgesics|analgesics|mesh-ancestor
92177730|NCT01455519|Sensory System Agents|sensory system agents|mesh-ancestor
92177731|NCT01455519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177732|NCT00157573|Sargramostim|sargramostim|mesh-list
92177733|NCT00157573|Immunologic Factors|immunologic factors|mesh-ancestor
92177734|NCT00157573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177735|NCT04822038|Vitamin D|vitamin d|mesh-list
92177736|NCT04822038|Cholecalciferol|cholecalciferol|mesh-list
92177737|NCT04822038|Vitamins|vitamins|mesh-ancestor
92177738|NCT04822038|Micronutrients|micronutrients|mesh-ancestor
92177739|NCT04822038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177740|NCT04822038|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92177741|NCT04822038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92177742|NCT01576809|Acetaminophen|acetaminophen|mesh-list
92177743|NCT01576809|Phenylpropanolamine|phenylpropanolamine|mesh-list
92177744|NCT01576809|Phenylephrine|phenylephrine|mesh-list
92177745|NCT01576809|Oxymetazoline|oxymetazoline|mesh-list
92177746|NCT01576809|Guaifenesin|guaifenesin|mesh-list
92177747|NCT01576809|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92177748|NCT01576809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92177749|NCT01576809|Analgesics|analgesics|mesh-ancestor
92177750|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
92177751|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177752|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177753|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
92177754|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92177755|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
92177756|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
92177757|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
92177758|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92177759|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
92177760|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
92177761|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92177762|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92177763|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92177764|NCT01576809|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177765|NCT01576809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177766|NCT01576809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177767|NCT01576809|Protective Agents|protective agents|mesh-ancestor
92177768|NCT01576809|Expectorants|expectorants|mesh-ancestor
92177769|NCT01576809|Appetite Depressants|appetite depressants|mesh-ancestor
92177770|NCT01576809|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92177772|NCT01456143|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92177773|NCT01456143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177774|NCT01456299|Remifentanil|remifentanil|mesh-list
92177775|NCT01456299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92177776|NCT01456299|Narcotics|narcotics|mesh-ancestor
92177777|NCT01456299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177778|NCT01456299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177780|NCT01456299|Sensory System Agents|sensory system agents|mesh-ancestor
92321839|NCT00000308|Amphetamine|amphetamine|mesh-list
92177781|NCT01456299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177783|NCT00158743|Antibodies|antibodies|mesh-list
92177784|NCT00158743|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
92177785|NCT00158743|Immunologic Factors|immunologic factors|mesh-ancestor
92177786|NCT00158743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177787|NCT00158743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92177788|NCT00158743|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92177789|NCT00158743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177790|NCT00158743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177791|NCT00158743|Protective Agents|protective agents|mesh-ancestor
92177792|NCT00161473|Prazosin|prazosin|mesh-list
92177793|NCT00161473|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92177794|NCT00161473|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92177795|NCT00161473|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92177796|NCT00161473|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92177797|NCT00161473|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177798|NCT00161473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177799|NCT00161473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177800|NCT00161473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177801|NCT01319981|Cytarabine|cytarabine|mesh-list
92177802|NCT01319981|Dexamethasone|dexamethasone|mesh-list
92177803|NCT01319981|Methylprednisolone|methylprednisolone|mesh-list
92177804|NCT01319981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92177805|NCT01319981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92177806|NCT01319981|Prednisolone|prednisolone|mesh-list
92177807|NCT01319981|Prednisolone acetate|prednisolone acetate|mesh-list
92177808|NCT01319981|Cyclophosphamide|cyclophosphamide|mesh-list
92177809|NCT01319981|Rituximab|rituximab|mesh-list
92177810|NCT01319981|Doxorubicin|doxorubicin|mesh-list
92177811|NCT01319981|Methotrexate|methotrexate|mesh-list
92177812|NCT01319981|Vincristine|vincristine|mesh-list
92177813|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
92177814|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92177815|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
92177816|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177817|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
92177818|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177819|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177820|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177821|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
92177822|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177823|NCT01319981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321886|NCT00002000|Acyclovir|acyclovir|mesh-list
92177824|NCT01319981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92177825|NCT01319981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177826|NCT01319981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177827|NCT01319981|Antiemetics|antiemetics|mesh-ancestor
92177828|NCT01319981|Autonomic Agents|autonomic agents|mesh-ancestor
92177829|NCT01319981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177830|NCT01319981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177831|NCT01319981|Glucocorticoids|glucocorticoids|mesh-ancestor
92177832|NCT01319981|Hormones|hormones|mesh-ancestor
92177833|NCT01319981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177834|NCT01319981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92177835|NCT01319981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92177836|NCT01319981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92177837|NCT01319981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177838|NCT01319981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177839|NCT01319981|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92177840|NCT01319981|Abortifacient Agents|abortifacient agents|mesh-ancestor
92177841|NCT01319981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92177842|NCT01319981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92177843|NCT01319981|Antimetabolites|antimetabolites|mesh-ancestor
92177844|NCT01319981|Dermatologic Agents|dermatologic agents|mesh-ancestor
92177845|NCT01319981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92177846|NCT01319981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92177847|NCT01319981|Antiviral Agents|antiviral agents|mesh-ancestor
92177848|NCT01319981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177849|NCT01319981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92177850|NCT01319981|Tubulin Modulators|tubulin modulators|mesh-ancestor
92177851|NCT01319981|Antimitotic Agents|antimitotic agents|mesh-ancestor
92177852|NCT01319981|Mitosis Modulators|mitosis modulators|mesh-ancestor
92177853|NCT01319981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92177854|NCT01319981|Protective Agents|protective agents|mesh-ancestor
92177855|NCT01319981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177856|NCT01458561|Thrombin|thrombin|mesh-list
92177857|NCT01458561|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92177858|NCT01458561|Hemostatics|hemostatics|mesh-ancestor
92177859|NCT01458561|Coagulants|coagulants|mesh-ancestor
92177860|NCT00065611|Dexamethasone|dexamethasone|mesh-list
92177861|NCT00065611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92177862|NCT00065611|Antiemetics|antiemetics|mesh-ancestor
92177863|NCT00065611|Autonomic Agents|autonomic agents|mesh-ancestor
92177864|NCT00065611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177865|NCT00065611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177866|NCT00065611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92177867|NCT00065611|Glucocorticoids|glucocorticoids|mesh-ancestor
92177868|NCT00065611|Hormones|hormones|mesh-ancestor
92177869|NCT00065611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92321910|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177870|NCT00065611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92177871|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177872|NCT00066781|Gemcitabine|gemcitabine|mesh-list
92177873|NCT00066781|Irinotecan|irinotecan|mesh-list
92177874|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92177875|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
92177876|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177877|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177878|NCT00066781|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92177879|NCT00066781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177880|NCT00066781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177882|NCT01189643|Irinotecan|irinotecan|mesh-list
92177883|NCT01189643|Temozolomide|temozolomide|mesh-list
92177884|NCT01189643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177885|NCT01189643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177886|NCT01189643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177887|NCT01189643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177888|NCT01189643|Growth Substances|growth substances|mesh-ancestor
92177889|NCT01189643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177890|NCT01189643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177891|NCT01189643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92177892|NCT01189643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92177893|NCT01189643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177894|NCT01189643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177895|NCT01189643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177896|NCT01189643|Alkylating Agents|alkylating agents|mesh-ancestor
92177897|NCT01431755|Lidocaine|lidocaine|mesh-list
92177898|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
92177899|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
92177900|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
92177901|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92177902|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177903|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
92177904|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177905|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92177906|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92177907|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92177908|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92177909|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177910|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92177911|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
92177912|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
92177913|NCT01431755|Protective Agents|protective agents|mesh-ancestor
92177914|NCT00066937|Benztropine|benztropine|mesh-list
92177915|NCT00066937|Nortriptyline|nortriptyline|mesh-list
92177916|NCT00066937|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92177917|NCT00066937|Antidepressive Agents|antidepressive agents|mesh-ancestor
92177918|NCT00066937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92177919|NCT00066937|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92177920|NCT00066937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92177921|NCT00066937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322335|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
92177922|NCT00066937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177924|NCT00066937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92177925|NCT00066937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177926|NCT00066937|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92177927|NCT00066937|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92177928|NCT00066937|Parasympatholytics|parasympatholytics|mesh-ancestor
92177929|NCT00066937|Autonomic Agents|autonomic agents|mesh-ancestor
92177930|NCT00066937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92177931|NCT00066937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92177932|NCT00066937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92177933|NCT00066937|Cholinergic Agents|cholinergic agents|mesh-ancestor
92177934|NCT00066937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92177935|NCT00066937|Dopamine Agents|dopamine agents|mesh-ancestor
92177936|NCT01064375|Cyclophosphamide|cyclophosphamide|mesh-list
92177937|NCT01064375|Molgramostim|molgramostim|mesh-list
92177938|NCT01064375|Sargramostim|sargramostim|mesh-list
92177939|NCT01064375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92177940|NCT01064375|Immunologic Factors|immunologic factors|mesh-ancestor
92177941|NCT01064375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177942|NCT01064375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92177943|NCT01064375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92177944|NCT01064375|Alkylating Agents|alkylating agents|mesh-ancestor
92177945|NCT01064375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177946|NCT01064375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177948|NCT01061411|Sunitinib|sunitinib|mesh-list
92177949|NCT01061411|Dalteparin|dalteparin|mesh-list
92177950|NCT01061411|Tinzaparin|tinzaparin|mesh-list
92177951|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92177952|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177953|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92177954|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92177955|NCT01061411|Growth Substances|growth substances|mesh-ancestor
92177956|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177957|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
92177958|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177959|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177960|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177961|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
92177962|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92177963|NCT01061411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92177964|NCT01505673|Liraglutide|liraglutide|mesh-list
92177965|NCT01505673|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92177966|NCT01505673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177967|NCT01505673|Incretins|incretins|mesh-ancestor
92177968|NCT01505673|Hormones|hormones|mesh-ancestor
92177969|NCT01505673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92177970|NCT04834986|Lenvatinib|lenvatinib|mesh-list
92177971|NCT04834986|Tislelizumab|tislelizumab|mesh-list
92177972|NCT04834986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92177973|NCT04834986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92177974|NCT04834986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92177975|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177976|NCT04834986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92177977|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
92177978|NCT04827966|Listerine|listerine|mesh-list
92177979|NCT04827966|Calcium|calcium|mesh-list
92177980|NCT04827966|Fluorides|fluorides|mesh-list
92177981|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
92177982|NCT04827966|Caseins|caseins|mesh-list
92177983|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92177984|NCT04827966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92177985|NCT04827966|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92177986|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
92177987|NCT04827966|Protective Agents|protective agents|mesh-ancestor
92177988|NCT04827966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92177989|NCT04827966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92177990|NCT04827966|Chelating Agents|chelating agents|mesh-ancestor
92177991|NCT04827966|Sequestering Agents|sequestering agents|mesh-ancestor
92177992|NCT04827966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92177993|NCT02247141|Immunoglobulins|immunoglobulins|mesh-list
92177994|NCT02247141|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92177995|NCT02247141|Antibodies|antibodies|mesh-list
92177996|NCT02247141|Immunologic Factors|immunologic factors|mesh-ancestor
92177998|NCT01896245|Sevoflurane|sevoflurane|mesh-list
92177999|NCT01896245|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92178000|NCT01896245|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92178001|NCT01896245|Anesthetics, General|anesthetics, general|mesh-ancestor
92178002|NCT01896245|Anesthetics|anesthetics|mesh-ancestor
92178003|NCT01896245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178004|NCT01896245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178005|NCT04821804|Hyaluronic Acid|hyaluronic acid|mesh-list
92178006|NCT04821804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92178007|NCT04821804|Immunologic Factors|immunologic factors|mesh-ancestor
92178008|NCT04821804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178009|NCT04821804|Viscosupplements|viscosupplements|mesh-ancestor
92178010|NCT04821804|Protective Agents|protective agents|mesh-ancestor
92178011|NCT04835064|Paclitaxel|paclitaxel|mesh-list
92178012|NCT04835064|Gemcitabine|gemcitabine|mesh-list
92178013|NCT04835064|Folfirinox|folfirinox|mesh-list
92178014|NCT04835064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178015|NCT04835064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178016|NCT04835064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178017|NCT04835064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178018|NCT04835064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178019|NCT04835064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178020|NCT04835064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92178021|NCT04835064|Antimetabolites|antimetabolites|mesh-ancestor
92178022|NCT00819221|Doxorubicin|doxorubicin|mesh-list
92178023|NCT00819221|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92178024|NCT00819221|Olaparib|olaparib|mesh-list
92178025|NCT00819221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92178026|NCT00819221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178027|NCT00819221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92178028|NCT00819221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92178029|NCT00819221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178030|NCT00819221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178031|NCT00819221|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92178032|NCT01507779|Vaccines|vaccines|mesh-list
92178033|NCT01507779|Immunologic Factors|immunologic factors|mesh-ancestor
92178034|NCT01507779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178035|NCT01896323|Ketoconazole|ketoconazole|mesh-list
92178036|NCT01896323|Antifungal Agents|antifungal agents|mesh-ancestor
92178037|NCT01896323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178038|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92322034|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
92178039|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92178040|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178041|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178042|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92178043|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
92178044|NCT01896323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178045|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178046|NCT01896323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92178047|NCT00068341|Carboplatin|carboplatin|mesh-list
92178049|NCT00068341|Trastuzumab|trastuzumab|mesh-list
92178050|NCT00068341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178051|NCT00068341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178052|NCT00068341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178053|NCT00068341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178054|NCT00068341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178055|NCT00068341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92178056|NCT02605824|Acetylcysteine|acetylcysteine|mesh-list
92178057|NCT02605824|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92178058|NCT02605824|Antiviral Agents|antiviral agents|mesh-ancestor
92178059|NCT02605824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178060|NCT02605824|Expectorants|expectorants|mesh-ancestor
92178061|NCT02605824|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178062|NCT02605824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92178063|NCT02605824|Antioxidants|antioxidants|mesh-ancestor
92178064|NCT02605824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178065|NCT02605824|Protective Agents|protective agents|mesh-ancestor
92178066|NCT02605824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178067|NCT02605824|Antidotes|antidotes|mesh-ancestor
92178068|NCT01896661|Amlodipine|amlodipine|mesh-list
92178069|NCT01896661|Chlorthalidone|chlorthalidone|mesh-list
92178070|NCT01896661|Calcium Channel Blockers|calcium channel blockers|mesh-list
92178071|NCT01896661|Amiloride|amiloride|mesh-list
92178072|NCT01896661|Calcium|calcium|mesh-list
92178073|NCT01896661|Diuretics|diuretics|mesh-list
92178074|NCT01896661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92322078|NCT00001112|Interferons|interferons|mesh-list
92178075|NCT01896661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178076|NCT01896661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92178077|NCT01896661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178078|NCT01896661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178079|NCT01896661|Vasodilator Agents|vasodilator agents|mesh-ancestor
92178080|NCT01896661|Natriuretic Agents|natriuretic agents|mesh-ancestor
92106980|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92178081|NCT01896661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92178082|NCT01896661|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92178083|NCT01896661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92178084|NCT01896661|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92178085|NCT01896661|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92178086|NCT01462773|Interferons|interferons|mesh-list
92178087|NCT01462773|Interferon-alpha|interferon-alpha|mesh-list
92178088|NCT01462773|Interferon alpha-2|interferon alpha-2|mesh-list
92178089|NCT01462773|Bortezomib|bortezomib|mesh-list
92178090|NCT01462773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178091|NCT01462773|Antiviral Agents|antiviral agents|mesh-ancestor
92178092|NCT01462773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178093|NCT01462773|Immunologic Factors|immunologic factors|mesh-ancestor
92178094|NCT01462773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178095|NCT02096029|Nicotine|nicotine|mesh-list
92178096|NCT02096029|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92178097|NCT02096029|Autonomic Agents|autonomic agents|mesh-ancestor
92178098|NCT02096029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178099|NCT02096029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178100|NCT02096029|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92178101|NCT02096029|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92178102|NCT02096029|Cholinergic Agents|cholinergic agents|mesh-ancestor
92178103|NCT02096029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178104|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178105|NCT02205801|Bupivacaine|bupivacaine|mesh-list
92178106|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178107|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
92178108|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178109|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178110|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
92178111|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178112|NCT02096107|Everolimus|everolimus|mesh-list
92178113|NCT02096107|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92178114|NCT02096107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92178115|NCT02096107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178116|NCT02096107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178117|NCT02096107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178118|NCT02096107|Immunologic Factors|immunologic factors|mesh-ancestor
92178119|NCT02096107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178120|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178121|NCT04834440|Ropivacaine|ropivacaine|mesh-list
92178122|NCT04834440|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178123|NCT04834440|Anesthetics|anesthetics|mesh-ancestor
92178124|NCT04834440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178125|NCT04834440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178126|NCT04834440|Sensory System Agents|sensory system agents|mesh-ancestor
92178127|NCT04834440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178128|NCT00068575|Interferons|interferons|mesh-list
92178129|NCT00068575|Interferon-alpha|interferon-alpha|mesh-list
92178130|NCT00068575|Interferon alpha-2|interferon alpha-2|mesh-list
92178131|NCT00068575|Cisplatin|cisplatin|mesh-list
92178132|NCT00068575|Fluorouracil|fluorouracil|mesh-list
92178133|NCT00068575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178134|NCT00068575|Antimetabolites|antimetabolites|mesh-ancestor
92178135|NCT00068575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178136|NCT00068575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92178137|NCT00068575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178138|NCT00068575|Immunologic Factors|immunologic factors|mesh-ancestor
92178139|NCT00068575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178140|NCT00068575|Antiviral Agents|antiviral agents|mesh-ancestor
92178141|NCT00068575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178142|NCT00784823|Bortezomib|bortezomib|mesh-list
92178143|NCT00784823|Melphalan|melphalan|mesh-list
92178144|NCT00784823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178145|NCT00784823|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92322161|NCT00002066|Thymopentin|thymopentin|mesh-list
92178146|NCT00784823|Alkylating Agents|alkylating agents|mesh-ancestor
92178147|NCT00784823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178148|NCT00784823|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92178149|NCT00784823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178150|NCT00784823|Immunologic Factors|immunologic factors|mesh-ancestor
92106986|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
92178151|NCT00784823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178153|NCT04428684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178154|NCT04428684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178155|NCT01509105|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92178156|NCT01509105|Immunologic Factors|immunologic factors|mesh-ancestor
92178157|NCT01509105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178159|NCT00773357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92178160|NCT00773357|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92178161|NCT00773357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92178162|NCT00773357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92178163|NCT00773357|Adrenergic Agents|adrenergic agents|mesh-ancestor
92178164|NCT00773357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178165|NCT00773357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178166|NCT00773357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178167|NCT05617950|Salicylic Acid|salicylic acid|mesh-list
92178169|NCT05617950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178170|NCT05617950|Antifungal Agents|antifungal agents|mesh-ancestor
92178171|NCT05617950|Keratolytic Agents|keratolytic agents|mesh-ancestor
92178172|NCT05617950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92178173|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92178174|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92178175|NCT05617950|Analgesics|analgesics|mesh-ancestor
92178176|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
92178177|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178178|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178179|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178180|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178181|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92178182|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178183|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178184|NCT04834752|Esomeprazole|esomeprazole|mesh-list
92178185|NCT04834752|Omeprazole|omeprazole|mesh-list
92178186|NCT04834752|Rabeprazole|rabeprazole|mesh-list
92178187|NCT04834752|Pantoprazole|pantoprazole|mesh-list
92178188|NCT04834752|Lansoprazole|lansoprazole|mesh-list
92178189|NCT04834752|Dexlansoprazole|dexlansoprazole|mesh-list
92178190|NCT04834752|Famotidine|famotidine|mesh-list
92178191|NCT04834752|Ranitidine|ranitidine|mesh-list
92178192|NCT04834752|Cimetidine|cimetidine|mesh-list
92178193|NCT04834752|Nizatidine|nizatidine|mesh-list
92178194|NCT04834752|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92178195|NCT04834752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178196|NCT04834752|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92178197|NCT04834752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178198|NCT04834752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178200|NCT04834752|Histamine Antagonists|histamine antagonists|mesh-ancestor
92178201|NCT04834752|Histamine Agents|histamine agents|mesh-ancestor
92178202|NCT04834752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178203|NCT04834752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178204|NCT04834752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92178205|NCT04834752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92178206|NCT04834674|Apatinib|apatinib|mesh-list
92178207|NCT04834674|Antibodies|antibodies|mesh-list
92178208|NCT04834674|Immunologic Factors|immunologic factors|mesh-ancestor
92178209|NCT04834674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178210|NCT04834674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178211|NCT04834674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92178212|NCT04834674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178213|NCT04834674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178214|NCT04318938|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92178215|NCT04318938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92178216|NCT04318938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178217|NCT04318938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178218|NCT04826406|Apatinib|apatinib|mesh-list
92178219|NCT04826406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178220|NCT04826406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92178221|NCT04826406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178222|NCT04826406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178223|NCT05617872|Acetic Acid|acetic acid|mesh-list
92178224|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92178225|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178226|NCT04198727|Capecitabine|capecitabine|mesh-list
92178227|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92178228|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
92178229|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178230|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178231|NCT00437255|Betamethasone|betamethasone|mesh-list
92178232|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
92178233|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92178234|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
92178235|NCT00437255|Clobetasol|clobetasol|mesh-list
92178236|NCT00437255|Calcipotriene|calcipotriene|mesh-list
92178237|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92178238|NCT00437255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178239|NCT00437255|Glucocorticoids|glucocorticoids|mesh-ancestor
92178240|NCT00437255|Hormones|hormones|mesh-ancestor
92178241|NCT00437255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178242|NCT00437255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178243|NCT00437255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92178244|NCT00437255|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178245|NCT00437255|Dermatologic Agents|dermatologic agents|mesh-ancestor
92178246|NCT02324673|Cannabidiol|cannabidiol|mesh-list
92178247|NCT02324673|Anticonvulsants|anticonvulsants|mesh-ancestor
92178248|NCT00373217|Paclitaxel|paclitaxel|mesh-list
92178249|NCT00373217|Carboplatin|carboplatin|mesh-list
92178250|NCT00373217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178251|NCT00373217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178252|NCT00373217|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178253|NCT00373217|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178254|NCT00373217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178255|NCT00373217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178256|NCT02605122|Amoxicillin|amoxicillin|mesh-list
92178257|NCT02605122|Azithromycin|azithromycin|mesh-list
92178258|NCT02605122|Ceftriaxone|ceftriaxone|mesh-list
92178259|NCT02605122|Erythromycin|erythromycin|mesh-list
92178260|NCT02605122|Erythromycin Estolate|erythromycin estolate|mesh-list
92178261|NCT02605122|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92178262|NCT02605122|Erythromycin stearate|erythromycin stearate|mesh-list
92178263|NCT02605122|Clavulanic Acids|clavulanic acids|mesh-list
92178264|NCT02605122|Clavulanic Acid|clavulanic acid|mesh-list
92178265|NCT02605122|Ampicillin|ampicillin|mesh-list
92178266|NCT02605122|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92178267|NCT02605122|Solithromycin|solithromycin|mesh-list
92178268|NCT02605122|Erythromycin lactobionate|erythromycin lactobionate|mesh-list
92178269|NCT02605122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92178270|NCT02605122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178271|NCT02605122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178272|NCT02605122|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92178273|NCT02605122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178274|NCT02605122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178275|NCT02605122|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92178276|NCT01579305|Lidocaine|lidocaine|mesh-list
92178277|NCT01579305|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178278|NCT01579305|Anesthetics|anesthetics|mesh-ancestor
92178279|NCT01579305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178280|NCT01579305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178281|NCT01579305|Sensory System Agents|sensory system agents|mesh-ancestor
92178282|NCT01579305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178283|NCT01579305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92178284|NCT01579305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92178285|NCT01579305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92178286|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178287|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178288|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
92178289|NCT00212147|Anesthetics|anesthetics|mesh-list
92178290|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178291|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178292|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92178293|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
92178294|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92178295|NCT00212147|Analgesics|analgesics|mesh-ancestor
92178296|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
92178297|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178298|NCT04820010|Insulin|insulin|mesh-list
92178299|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92178300|NCT04820010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178301|NCT04819776|Iloperidone|iloperidone|mesh-list
92178302|NCT04819776|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92178303|NCT04819776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92178304|NCT04819776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178305|NCT04819776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178306|NCT04819776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92178308|NCT01454102|Bevacizumab|bevacizumab|mesh-list
92178309|NCT01454102|Carboplatin|carboplatin|mesh-list
92178310|NCT01454102|Gemcitabine|gemcitabine|mesh-list
92178311|NCT01454102|Nivolumab|nivolumab|mesh-list
92178312|NCT01454102|Pemetrexed|pemetrexed|mesh-list
92178313|NCT01454102|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92178314|NCT01454102|Ipilimumab|ipilimumab|mesh-list
92178315|NCT01454102|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178316|NCT01454102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178317|NCT01454102|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178318|NCT01454102|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178319|NCT01454102|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178320|NCT01454102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178321|NCT01454102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92178322|NCT01454102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92322638|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
92178323|NCT01454102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92178324|NCT01454102|Growth Substances|growth substances|mesh-ancestor
92178325|NCT01454102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178326|NCT01454102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92178327|NCT01454102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92178328|NCT01454102|Antimetabolites|antimetabolites|mesh-ancestor
92178329|NCT01454102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92178330|NCT01454102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178331|NCT01454102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92178332|NCT01454102|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92178333|NCT01454102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92178334|NCT04192253|Paclitaxel|paclitaxel|mesh-list
92178335|NCT04192253|Carboplatin|carboplatin|mesh-list
92178336|NCT04192253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178337|NCT04192253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178338|NCT04192253|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178339|NCT04192253|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178340|NCT04192253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178341|NCT04192253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178342|NCT04825938|Paclitaxel|paclitaxel|mesh-list
92178343|NCT04825938|Carboplatin|carboplatin|mesh-list
92178344|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178345|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178346|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178347|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178348|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178349|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178350|NCT04826016|Paclitaxel|paclitaxel|mesh-list
92178351|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178352|NCT04826016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178353|NCT04826016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178354|NCT04826016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178355|NCT04826016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178356|NCT04826016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178357|NCT01509807|Morphine|morphine|mesh-list
92178358|NCT01509807|Bupivacaine|bupivacaine|mesh-list
92178359|NCT01509807|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178360|NCT01509807|Anesthetics|anesthetics|mesh-ancestor
92322686|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178361|NCT01509807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178362|NCT01509807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178363|NCT01509807|Sensory System Agents|sensory system agents|mesh-ancestor
92178364|NCT01509807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178365|NCT01509807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92178366|NCT01509807|Narcotics|narcotics|mesh-ancestor
92178367|NCT01509807|Analgesics|analgesics|mesh-ancestor
92178368|NCT00070135|Methotrexate|methotrexate|mesh-list
92178369|NCT00070135|Fludarabine phosphate|fludarabine phosphate|mesh-list
92178370|NCT00070135|Fludarabine|fludarabine|mesh-list
92178371|NCT00070135|Busulfan|busulfan|mesh-list
92178372|NCT00070135|Tacrolimus|tacrolimus|mesh-list
92178373|NCT00070135|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92178374|NCT00070135|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92178375|NCT00070135|Abortifacient Agents|abortifacient agents|mesh-ancestor
92178376|NCT00070135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92178377|NCT00070135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178378|NCT00070135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92178379|NCT00070135|Antimetabolites|antimetabolites|mesh-ancestor
92178380|NCT00070135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178381|NCT00070135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178382|NCT00070135|Dermatologic Agents|dermatologic agents|mesh-ancestor
92178383|NCT00070135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178384|NCT00070135|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92178385|NCT00070135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178386|NCT00070135|Immunologic Factors|immunologic factors|mesh-ancestor
92178387|NCT00070135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178388|NCT00070135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92178389|NCT00070135|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92178390|NCT00070135|Alkylating Agents|alkylating agents|mesh-ancestor
92178391|NCT00070135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92178392|NCT00070135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92178393|NCT01583985|Analgesics, Opioid|analgesics, opioid|mesh-list
92178394|NCT01583985|Narcotics|narcotics|mesh-ancestor
92178395|NCT01583985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178396|NCT01583985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178397|NCT01583985|Analgesics|analgesics|mesh-ancestor
92178398|NCT01583985|Sensory System Agents|sensory system agents|mesh-ancestor
92178399|NCT01583985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178400|NCT04816344|Anesthetics|anesthetics|mesh-list
92178401|NCT04816344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178402|NCT04816344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178403|NCT01467999|Guanfacine|guanfacine|mesh-list
92178404|NCT01467999|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92178405|NCT01467999|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92178406|NCT01467999|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92178407|NCT01467999|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92178408|NCT01467999|Adrenergic Agents|adrenergic agents|mesh-ancestor
92178409|NCT01467999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178410|NCT01467999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178411|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178412|NCT05617482|Anesthetics|anesthetics|mesh-list
92178413|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178414|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178415|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
92178416|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92178417|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
92178418|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178419|NCT01470027|Expectorants|expectorants|mesh-ancestor
92178420|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178421|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92178422|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
92178423|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178424|NCT01470027|Protective Agents|protective agents|mesh-ancestor
92178425|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178426|NCT01470027|Antidotes|antidotes|mesh-ancestor
92178427|NCT01470651|Modafinil|modafinil|mesh-list
92178428|NCT01470651|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92178429|NCT01470651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178430|NCT01470651|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92178431|NCT01470651|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92178432|NCT01470651|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92178433|NCT01470651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178434|NCT01512225|Domperidone|domperidone|mesh-list
92178435|NCT01512225|Maleic acid|maleic acid|mesh-list
92178436|NCT01512225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178437|NCT01512225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178438|NCT01512225|Antiemetics|antiemetics|mesh-ancestor
92178439|NCT01512225|Autonomic Agents|autonomic agents|mesh-ancestor
92178440|NCT01512225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178441|NCT01512225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178442|NCT01512225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178443|NCT01512225|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92178444|NCT01512225|Dopamine Agents|dopamine agents|mesh-ancestor
92178445|NCT01512225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178447|NCT01472445|Cholecalciferol|cholecalciferol|mesh-list
92178448|NCT01472445|Vitamins|vitamins|mesh-ancestor
92178449|NCT01472445|Micronutrients|micronutrients|mesh-ancestor
92178450|NCT01472445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178451|NCT01472445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92178452|NCT01472445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92178453|NCT04782089|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92178454|NCT04782089|Fluzoparib|fluzoparib|mesh-list
92178455|NCT04782089|Antibodies|antibodies|mesh-list
92178456|NCT04782089|Immunologic Factors|immunologic factors|mesh-ancestor
92178457|NCT04782089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178459|NCT04782089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178460|NCT04782089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178461|NCT02604342|Docetaxel|docetaxel|mesh-list
92178462|NCT02604342|Pemetrexed|pemetrexed|mesh-list
92178463|NCT02604342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178464|NCT02604342|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178465|NCT02604342|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178466|NCT02604342|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178467|NCT02604342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178468|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178469|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92178470|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92178471|NCT04781777|Insulin|insulin|mesh-list
92178472|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92178473|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178474|NCT04781075|Bupivacaine|bupivacaine|mesh-list
92178475|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178476|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
92178477|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178478|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178479|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
92178480|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178482|NCT01586091|Levocetirizine|levocetirizine|mesh-list
92178483|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92178484|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92178485|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
92178486|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
92178487|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178488|NCT01586091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178489|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178490|NCT01586091|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92178491|NCT05565573|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92178492|NCT05565573|Levonorgestrel|levonorgestrel|mesh-list
92178493|NCT05565573|Medroxyprogesterone|medroxyprogesterone|mesh-list
92178494|NCT05565573|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92178495|NCT05565573|Contraceptive Agents|contraceptive agents|mesh-ancestor
92178496|NCT05565573|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92178497|NCT05565573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178498|NCT05565573|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92178499|NCT05565573|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92178500|NCT05565573|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92178501|NCT05565573|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92178502|NCT05565573|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92178503|NCT05565573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178504|NCT05565573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178505|NCT04389359|Hydroxychloroquine|hydroxychloroquine|mesh-list
92178506|NCT04389359|Antimalarials|antimalarials|mesh-ancestor
92178507|NCT04389359|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92178508|NCT04389359|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92178509|NCT04389359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178510|NCT04389359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178511|NCT04389359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178512|NCT04389359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178513|NCT01587027|Aminophylline|aminophylline|mesh-list
92178514|NCT01587027|Methazolamide|methazolamide|mesh-list
92178515|NCT01587027|Theophylline|theophylline|mesh-list
92178516|NCT01587027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92178517|NCT01587027|Autonomic Agents|autonomic agents|mesh-ancestor
92178518|NCT01587027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178519|NCT01587027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178520|NCT01587027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92178521|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178522|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92178523|NCT01587027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178524|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178525|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
92178526|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92178527|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92178528|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
92178529|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178530|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92322830|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
92178531|NCT01587027|Protective Agents|protective agents|mesh-ancestor
92178532|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92178533|NCT01587027|Diuretics|diuretics|mesh-ancestor
92178534|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
92178535|NCT01471340|Mometasone Furoate|mometasone furoate|mesh-list
92178536|NCT01471340|Prednisone|prednisone|mesh-list
92178537|NCT01471340|Prednisolone|prednisolone|mesh-list
92178538|NCT01471340|Albuterol|albuterol|mesh-list
92178539|NCT01471340|Formoterol Fumarate|formoterol fumarate|mesh-list
92178540|NCT01471340|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
92178541|NCT01471340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178542|NCT01471340|Glucocorticoids|glucocorticoids|mesh-ancestor
92178543|NCT01471340|Hormones|hormones|mesh-ancestor
92178544|NCT01471340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178545|NCT01471340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178546|NCT01471340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178547|NCT01471340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178548|NCT01471340|Autonomic Agents|autonomic agents|mesh-ancestor
92178549|NCT01471340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178550|NCT01471340|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92178551|NCT01471340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92178552|NCT01471340|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178553|NCT01471340|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92178554|NCT01471340|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92178555|NCT01471340|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92178556|NCT01471340|Adrenergic Agents|adrenergic agents|mesh-ancestor
92178557|NCT01471340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178558|NCT01471340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178559|NCT01471340|Tocolytic Agents|tocolytic agents|mesh-ancestor
92178560|NCT01471340|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92178561|NCT01471340|Dermatologic Agents|dermatologic agents|mesh-ancestor
92178562|NCT01471340|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92178563|NCT04754789|Aspirin|aspirin|mesh-list
92178564|NCT04754789|Ticagrelor|ticagrelor|mesh-list
92178565|NCT04754789|Atorvastatin|atorvastatin|mesh-list
92178566|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92178567|NCT04754789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92178568|NCT04754789|Analgesics|analgesics|mesh-ancestor
92178569|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
92178570|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178571|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178572|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178573|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178574|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92178575|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92178576|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178577|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92178578|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92178579|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178580|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
92178581|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92178582|NCT04754789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92178583|NCT04754789|Antimetabolites|antimetabolites|mesh-ancestor
92178584|NCT04754789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92178585|NCT04754789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92178586|NCT04754789|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92178587|NCT04754789|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92178588|NCT04754789|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92178589|NCT04754789|Purinergic Agents|purinergic agents|mesh-ancestor
92178590|NCT04754789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178591|NCT04817904|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92178592|NCT04817904|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92178593|NCT04817904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92178594|NCT04817904|Antimetabolites|antimetabolites|mesh-ancestor
92178595|NCT04817904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178596|NCT04817904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92178597|NCT04817904|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92178598|NCT04817904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178599|NCT04815408|Paclitaxel|paclitaxel|mesh-list
92178600|NCT04815408|Carboplatin|carboplatin|mesh-list
92178601|NCT04815408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92178602|NCT04815408|Tislelizumab|tislelizumab|mesh-list
92178603|NCT04815408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178604|NCT04815408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178605|NCT04815408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92178606|NCT04815408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92178607|NCT04815408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92178608|NCT04815408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178609|NCT04815408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92178610|NCT04778813|Artesunate|artesunate|mesh-list
92178611|NCT04778813|Lumefantrine|lumefantrine|mesh-list
92178612|NCT04778813|Artemether|artemether|mesh-list
92178613|NCT04778813|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92178614|NCT04778813|Artenimol|artenimol|mesh-list
92178615|NCT04778813|Pyronaridine|pyronaridine|mesh-list
92178616|NCT04778813|Antimalarials|antimalarials|mesh-ancestor
92178617|NCT04778813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92178618|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92178619|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178620|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178621|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
92178622|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
92178623|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92178624|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
92178625|NCT04817982|Dexamethasone|dexamethasone|mesh-list
92178626|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
92178627|NCT04817982|Lidocaine|lidocaine|mesh-list
92178628|NCT04817982|BB 1101|bb 1101|mesh-list
92178629|NCT04817982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178630|NCT04817982|Antiemetics|antiemetics|mesh-ancestor
92178631|NCT04817982|Autonomic Agents|autonomic agents|mesh-ancestor
92178632|NCT04817982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178633|NCT04817982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178634|NCT04817982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178635|NCT04817982|Glucocorticoids|glucocorticoids|mesh-ancestor
92178636|NCT04817982|Hormones|hormones|mesh-ancestor
92178637|NCT04817982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178638|NCT04817982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178639|NCT04817982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178640|NCT04817982|Protease Inhibitors|protease inhibitors|mesh-ancestor
92178641|NCT04817982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178642|NCT04817982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178643|NCT04817982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178644|NCT04817982|Anesthetics|anesthetics|mesh-ancestor
92178645|NCT04817982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178646|NCT04817982|Sensory System Agents|sensory system agents|mesh-ancestor
92178647|NCT04817982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92178648|NCT04817982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92178649|NCT04817982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92178650|NCT04817982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178651|NCT04779047|Ritonavir|ritonavir|mesh-list
92178652|NCT04779047|Lopinavir|lopinavir|mesh-list
92178653|NCT04779047|Hydroxychloroquine|hydroxychloroquine|mesh-list
92178654|NCT04779047|Ivermectin|ivermectin|mesh-list
92178655|NCT04779047|Remdesivir|remdesivir|mesh-list
92178656|NCT04779047|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92178657|NCT04779047|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92178658|NCT04779047|Protease Inhibitors|protease inhibitors|mesh-ancestor
92178659|NCT04779047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178660|NCT04779047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178661|NCT04779047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92178662|NCT04779047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92178663|NCT04779047|Antiviral Agents|antiviral agents|mesh-ancestor
92178664|NCT04779047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178665|NCT04779047|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92178666|NCT04779047|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92178667|NCT04779047|Antimalarials|antimalarials|mesh-ancestor
92178668|NCT04779047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92178669|NCT04779047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92178670|NCT04779047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178671|NCT04779047|Antimetabolites|antimetabolites|mesh-ancestor
92178672|NCT04427826|Morphine|morphine|mesh-list
92178673|NCT04427826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92178674|NCT04427826|Narcotics|narcotics|mesh-ancestor
92178675|NCT04427826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178676|NCT04427826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178677|NCT04427826|Analgesics|analgesics|mesh-ancestor
92178679|NCT04427826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178680|NCT03699995|Lidocaine|lidocaine|mesh-list
92178681|NCT03699995|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178682|NCT03699995|Anesthetics|anesthetics|mesh-ancestor
92178683|NCT03699995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178684|NCT03699995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178685|NCT03699995|Sensory System Agents|sensory system agents|mesh-ancestor
92178686|NCT03699995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178687|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92178688|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92178689|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92178690|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178691|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178692|NCT01515345|Clopidogrel|clopidogrel|mesh-list
92178693|NCT01515345|Ticagrelor|ticagrelor|mesh-list
92178694|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92178695|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92178696|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92178697|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92178698|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92178699|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
92178700|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178701|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178702|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178703|NCT01492400|Dexamethasone|dexamethasone|mesh-list
92178704|NCT01492400|Ranibizumab|ranibizumab|mesh-list
92178705|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178706|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
92178707|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
92178708|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178709|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178710|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178711|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
92178712|NCT01492400|Hormones|hormones|mesh-ancestor
92178713|NCT01492400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178714|NCT01492400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178715|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178716|NCT01492400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92178717|NCT01492400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92178718|NCT01492400|Growth Substances|growth substances|mesh-ancestor
92178719|NCT01492400|Growth Inhibitors|growth inhibitors|mesh-ancestor
92178720|NCT00168337|Dexamethasone|dexamethasone|mesh-list
92178721|NCT00168337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178722|NCT00168337|Antiemetics|antiemetics|mesh-ancestor
92178723|NCT00168337|Autonomic Agents|autonomic agents|mesh-ancestor
92178724|NCT00168337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178725|NCT00168337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178726|NCT00168337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178727|NCT00168337|Glucocorticoids|glucocorticoids|mesh-ancestor
92178728|NCT00168337|Hormones|hormones|mesh-ancestor
92178729|NCT00168337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178730|NCT00168337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178731|NCT00168337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178732|NCT01515657|Aspirin|aspirin|mesh-list
92178733|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92178734|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92178735|NCT01515657|Analgesics|analgesics|mesh-ancestor
92178736|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
92178737|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178738|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178739|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178740|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178741|NCT01515657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92178742|NCT01515657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92178743|NCT01515657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178744|NCT01515657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92178745|NCT01515657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92178746|NCT01515657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178747|NCT01515657|Antipyretics|antipyretics|mesh-ancestor
92178748|NCT01515891|Opicapone|opicapone|mesh-list
92178749|NCT01515891|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92178750|NCT01515891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178751|NCT01515891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178752|NCT01515891|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92178753|NCT01515891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92178754|NCT00073957|Cytarabine|cytarabine|mesh-list
92178755|NCT00073957|Rituximab|rituximab|mesh-list
92178756|NCT00073957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92178757|NCT00073957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178758|NCT00073957|Immunologic Factors|immunologic factors|mesh-ancestor
92178759|NCT00073957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178760|NCT00073957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178761|NCT00073957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92322963|NCT00002234|Efavirenz|efavirenz|mesh-list
92178762|NCT00073957|Antimetabolites|antimetabolites|mesh-ancestor
92178763|NCT00073957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178764|NCT00073957|Antiviral Agents|antiviral agents|mesh-ancestor
92178765|NCT00073957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178766|NCT00073957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178767|NCT04354428|Folic Acid|folic acid|mesh-list
92178768|NCT04354428|Ascorbic Acid|ascorbic acid|mesh-list
92178769|NCT04354428|Ritonavir|ritonavir|mesh-list
92178770|NCT04354428|Lopinavir|lopinavir|mesh-list
92178771|NCT04354428|Azithromycin|azithromycin|mesh-list
92178772|NCT04354428|Hydroxychloroquine|hydroxychloroquine|mesh-list
92178773|NCT04354428|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92178774|NCT04354428|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92178775|NCT04354428|Protease Inhibitors|protease inhibitors|mesh-ancestor
92178776|NCT04354428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178777|NCT04354428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178778|NCT04354428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92178779|NCT04354428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92178780|NCT04354428|Antiviral Agents|antiviral agents|mesh-ancestor
92178781|NCT04354428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178782|NCT04354428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92178783|NCT04354428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92178784|NCT04354428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92178785|NCT04354428|Antimalarials|antimalarials|mesh-ancestor
92178786|NCT04354428|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92178787|NCT04354428|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92178788|NCT04354428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178789|NCT04354428|Hematinics|hematinics|mesh-ancestor
92178790|NCT04354428|Vitamin B Complex|vitamin b complex|mesh-ancestor
92178791|NCT04354428|Vitamins|vitamins|mesh-ancestor
92178792|NCT04354428|Micronutrients|micronutrients|mesh-ancestor
92178793|NCT04354428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178794|NCT04354428|Antioxidants|antioxidants|mesh-ancestor
92178795|NCT04354428|Protective Agents|protective agents|mesh-ancestor
92178796|NCT02090075|Warfarin|warfarin|mesh-list
92178797|NCT02090075|Apixaban|apixaban|mesh-list
92178798|NCT02090075|Anticoagulants|anticoagulants|mesh-ancestor
92178799|NCT02090075|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92178800|NCT02090075|Antithrombins|antithrombins|mesh-ancestor
92178801|NCT02090075|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92178802|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
92178803|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178804|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178805|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92178806|NCT04817202|Antibodies|antibodies|mesh-list
92178807|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
92178808|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92178809|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
92178810|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178811|NCT04817202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178812|NCT04775303|Cyclosporine|cyclosporine|mesh-list
92178813|NCT04775303|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92178814|NCT04775303|Cyclosporins|cyclosporins|mesh-list
92178815|NCT04775303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178816|NCT04775303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178817|NCT04775303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178818|NCT04775303|Immunologic Factors|immunologic factors|mesh-ancestor
92178819|NCT04775303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178820|NCT04775303|Antifungal Agents|antifungal agents|mesh-ancestor
92178821|NCT04775303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178822|NCT04775303|Dermatologic Agents|dermatologic agents|mesh-ancestor
92178823|NCT04775303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178824|NCT04775303|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92178825|NCT04775303|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92178826|NCT04816968|Vancomycin|vancomycin|mesh-list
92178827|NCT04816968|Meropenem|meropenem|mesh-list
92178828|NCT04816968|Tazobactam|tazobactam|mesh-list
92178829|NCT04816968|Piperacillin|piperacillin|mesh-list
92178830|NCT04816968|Cefepime|cefepime|mesh-list
92178831|NCT04816968|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92178833|NCT04816968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178834|NCT04816968|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92178836|NCT04816968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178837|NCT02210247|Bupivacaine|bupivacaine|mesh-list
92178838|NCT02210247|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178839|NCT02210247|Anesthetics|anesthetics|mesh-ancestor
92178840|NCT02210247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178841|NCT02210247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178842|NCT02210247|Sensory System Agents|sensory system agents|mesh-ancestor
92178843|NCT02210247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178844|NCT04775459|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92178845|NCT04775459|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178846|NCT04806438|Lidocaine|lidocaine|mesh-list
92178847|NCT04806438|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178848|NCT04806438|Anesthetics|anesthetics|mesh-ancestor
92178849|NCT04806438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178850|NCT04806438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178851|NCT04806438|Sensory System Agents|sensory system agents|mesh-ancestor
92178852|NCT04806438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178853|NCT04806438|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92178854|NCT04806438|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92178855|NCT04806438|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92178856|NCT04806438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178857|NCT04806438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178858|NCT00074035|Pentostatin|pentostatin|mesh-list
92178859|NCT00074035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178860|NCT00074035|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92178861|NCT00074035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178862|NCT00074035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178863|NCT01591317|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92178864|NCT01591317|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92178865|NCT00074815|Fluvoxamine|fluvoxamine|mesh-list
92178866|NCT00074815|Citalopram|citalopram|mesh-list
92178867|NCT00074815|Fluoxetine|fluoxetine|mesh-list
92178868|NCT00074815|Paroxetine|paroxetine|mesh-list
92178869|NCT00074815|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92178870|NCT00074815|Sertraline|sertraline|mesh-list
92178871|NCT00074815|Clomipramine|clomipramine|mesh-list
92178872|NCT00074815|Escitalopram|escitalopram|mesh-list
92178873|NCT00074815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92178874|NCT00074815|Serotonin|serotonin|mesh-list
92178875|NCT00074815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92178876|NCT00074815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178877|NCT00074815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178878|NCT00074815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178879|NCT00074815|Serotonin Agents|serotonin agents|mesh-ancestor
92178880|NCT00074815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178881|NCT00074815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92178882|NCT00074815|Antidepressive Agents|antidepressive agents|mesh-ancestor
92178883|NCT00074815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92178884|NCT00074815|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92178885|NCT00074815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92178886|NCT00074815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323069|NCT02721277|SMOFlipid|smoflipid|mesh-list
92178887|NCT00074815|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92178888|NCT00074815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92178889|NCT00074815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92178890|NCT00074815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178891|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92178892|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92178893|NCT00074815|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92178894|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92178895|NCT04772729|Insulin|insulin|mesh-list
92178896|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92178897|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
92178898|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92178899|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178900|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
92178901|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
92178902|NCT05562375|Coagulants|coagulants|mesh-ancestor
92178903|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
92178904|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178905|NCT00075829|Thalidomide|thalidomide|mesh-list
92178906|NCT00075829|Dexamethasone|dexamethasone|mesh-list
92178907|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92178908|NCT00075829|Antiemetics|antiemetics|mesh-ancestor
92178909|NCT00075829|Autonomic Agents|autonomic agents|mesh-ancestor
92178910|NCT00075829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178911|NCT00075829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178912|NCT00075829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92178913|NCT00075829|Glucocorticoids|glucocorticoids|mesh-ancestor
92178914|NCT00075829|Hormones|hormones|mesh-ancestor
92178915|NCT00075829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92178916|NCT00075829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92178917|NCT00075829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323105|NCT00002360|Didanosine|didanosine|mesh-list
92178918|NCT00075829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92178919|NCT00075829|Immunologic Factors|immunologic factors|mesh-ancestor
92178920|NCT00075829|Leprostatic Agents|leprostatic agents|mesh-ancestor
92178921|NCT00075829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92178922|NCT00075829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178923|NCT00075829|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92178924|NCT00075829|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92178925|NCT00075829|Growth Substances|growth substances|mesh-ancestor
92178926|NCT00075829|Growth Inhibitors|growth inhibitors|mesh-ancestor
92178927|NCT02218203|Lidocaine|lidocaine|mesh-list
92178928|NCT02218203|Dextromethorphan|dextromethorphan|mesh-list
92178929|NCT02218203|Anesthetics, Local|anesthetics, local|mesh-ancestor
92178930|NCT02218203|Anesthetics|anesthetics|mesh-ancestor
92178931|NCT02218203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92178932|NCT02218203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178933|NCT02218203|Sensory System Agents|sensory system agents|mesh-ancestor
92178934|NCT02218203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178935|NCT02218203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92178936|NCT02218203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92178937|NCT02218203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92178938|NCT02218203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92178939|NCT02218203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178940|NCT02218203|Antitussive Agents|antitussive agents|mesh-ancestor
92178941|NCT02218203|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178942|NCT02218203|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92178943|NCT02218203|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92178944|NCT02218203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92178945|NCT04771715|Pembrolizumab|pembrolizumab|mesh-list
92178946|NCT04771715|Nivolumab|nivolumab|mesh-list
92178947|NCT04771715|Tislelizumab|tislelizumab|mesh-list
92323150|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178948|NCT04771715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92178949|NCT04771715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178950|NCT04771715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92178951|NCT04771715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178952|NCT04771559|Antibodies|antibodies|mesh-list
92178953|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
92178954|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178955|NCT02592876|Rituximab|rituximab|mesh-list
92178956|NCT02592876|Carboplatin|carboplatin|mesh-list
92178957|NCT02592876|Etoposide|etoposide|mesh-list
92178958|NCT02592876|Ifosfamide|ifosfamide|mesh-list
92178959|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92178960|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92178961|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
92178962|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178963|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92178964|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92178965|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92178966|NCT02592876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92178967|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92178968|NCT02592876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178969|NCT02592876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92178970|NCT02592876|Alkylating Agents|alkylating agents|mesh-ancestor
92178971|NCT00585559|Acetaminophen|acetaminophen|mesh-list
92178972|NCT00585559|Acetylcysteine|acetylcysteine|mesh-list
92178973|NCT00585559|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92178974|NCT00585559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92178976|NCT00585559|Sensory System Agents|sensory system agents|mesh-ancestor
92178977|NCT00585559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92178978|NCT00585559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178980|NCT00585559|Antiviral Agents|antiviral agents|mesh-ancestor
92178981|NCT00585559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92178982|NCT00585559|Expectorants|expectorants|mesh-ancestor
92178983|NCT00585559|Respiratory System Agents|respiratory system agents|mesh-ancestor
92178984|NCT00585559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92178985|NCT00585559|Antioxidants|antioxidants|mesh-ancestor
92178986|NCT00585559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92178987|NCT00585559|Protective Agents|protective agents|mesh-ancestor
92178988|NCT00585559|Antidotes|antidotes|mesh-ancestor
92178989|NCT02763137|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92178990|NCT02763137|Carbidopa|carbidopa|mesh-list
92178991|NCT02763137|Levodopa|levodopa|mesh-list
92178992|NCT02763137|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92178993|NCT02763137|Immunologic Factors|immunologic factors|mesh-ancestor
92178994|NCT02763137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92178995|NCT02763137|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92178996|NCT02763137|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92178997|NCT02763137|Dopamine Agonists|dopamine agonists|mesh-ancestor
92178998|NCT02763137|Dopamine Agents|dopamine agents|mesh-ancestor
92178999|NCT02763137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179000|NCT02763137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179001|NCT02763137|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92179002|NCT02763137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179004|NCT01896739|Immunologic Factors|immunologic factors|mesh-ancestor
92179005|NCT01896739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179006|NCT00176839|Cyclophosphamide|cyclophosphamide|mesh-list
92179008|NCT00176839|Busulfan|busulfan|mesh-list
92179009|NCT00176839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92179010|NCT00176839|Lenograstim|lenograstim|mesh-list
92179011|NCT00176839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179012|NCT00176839|Immunologic Factors|immunologic factors|mesh-ancestor
92179013|NCT00176839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179014|NCT00176839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179015|NCT00176839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92179016|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
92179017|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179018|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179019|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179020|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92179021|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
92179022|NCT00176917|Busulfan|busulfan|mesh-list
92179023|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
92179024|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179025|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
92179026|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179027|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179028|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92179029|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
92179030|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179031|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179032|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179033|NCT02664155|Vitamin K|vitamin k|mesh-list
92179034|NCT02664155|Heparin|heparin|mesh-list
92179035|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
92179036|NCT02664155|Apixaban|apixaban|mesh-list
92179037|NCT02664155|Vitamins|vitamins|mesh-ancestor
92179038|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
92179039|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179040|NCT02664155|Anticoagulants|anticoagulants|mesh-ancestor
92179041|NCT02664155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92179042|NCT02664155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92179043|NCT02664155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179044|NCT02664155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92179045|NCT02664155|Antithrombins|antithrombins|mesh-ancestor
92179046|NCT02664155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92179047|NCT02664155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92179048|NCT02664155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179049|NCT02664155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92179050|NCT02664155|Hemostatics|hemostatics|mesh-ancestor
92179051|NCT02664155|Coagulants|coagulants|mesh-ancestor
92179052|NCT04770389|Ezetimibe|ezetimibe|mesh-list
92179053|NCT04770389|Hypolipidemic Agents|hypolipidemic agents|mesh-list
92179054|NCT04770389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92179055|NCT04770389|Antimetabolites|antimetabolites|mesh-ancestor
92179056|NCT04770389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179057|NCT04770389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92179059|NCT04753619|Anticestodal Agents|anticestodal agents|mesh-ancestor
92179060|NCT04753619|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92179061|NCT04753619|Anthelmintics|anthelmintics|mesh-ancestor
92179062|NCT04753619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92179063|NCT04753619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179064|NCT04753619|Antinematodal Agents|antinematodal agents|mesh-ancestor
92179065|NCT01492088|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92179066|NCT01492088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92179067|NCT01492088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179068|NCT01492088|Immunotoxins|immunotoxins|mesh-ancestor
92179069|NCT01492088|Immunoconjugates|immunoconjugates|mesh-ancestor
92179070|NCT01492088|Immunologic Factors|immunologic factors|mesh-ancestor
92179071|NCT01492088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179072|NCT04753151|Tranexamic Acid|tranexamic acid|mesh-list
92179073|NCT04753151|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92107052|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
92179074|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92179075|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179076|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
92179077|NCT04753151|Coagulants|coagulants|mesh-ancestor
92179078|NCT05606315|Midazolam|midazolam|mesh-list
92179079|NCT05606315|Propofol|propofol|mesh-list
92179080|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92179081|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179082|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179083|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92179084|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
92179085|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
92179086|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92179087|NCT05606315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92179088|NCT05606315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92179089|NCT05606315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92179090|NCT05606315|GABA Modulators|gaba modulators|mesh-ancestor
92179091|NCT05606315|GABA Agents|gaba agents|mesh-ancestor
92179092|NCT05606315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179093|NCT05606315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179094|NCT05605925|Ivermectin|ivermectin|mesh-list
92179095|NCT05605925|Lumefantrine|lumefantrine|mesh-list
92179096|NCT05605925|Artemether|artemether|mesh-list
92179097|NCT05605925|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92179098|NCT05605925|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92179099|NCT05605925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179100|NCT05605925|Antimalarials|antimalarials|mesh-ancestor
92179101|NCT05605925|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92179102|NCT01520727|Opicapone|opicapone|mesh-list
92179103|NCT01520727|Entacapone|entacapone|mesh-list
92179104|NCT01520727|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92179105|NCT01520727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179106|NCT01520727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179107|NCT01520727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92179108|NCT01520727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92179109|NCT02503709|Cyclin-Dependent Kinase Inhibitor Proteins|cyclin-dependent kinase inhibitor proteins|mesh-list
92179110|NCT02503709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92179111|NCT02503709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179112|NCT02503709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179114|NCT01855607|Antipruritics|antipruritics|mesh-ancestor
92179115|NCT01855607|Dermatologic Agents|dermatologic agents|mesh-ancestor
92179116|NCT01596699|Fludarabine|fludarabine|mesh-list
92179117|NCT01596699|Busulfan|busulfan|mesh-list
92179118|NCT01596699|Alemtuzumab|alemtuzumab|mesh-list
92179119|NCT01596699|Clofarabine|clofarabine|mesh-list
92179120|NCT01596699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179121|NCT01596699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92179122|NCT01596699|Antimetabolites|antimetabolites|mesh-ancestor
92179123|NCT01596699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179124|NCT01596699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179125|NCT01596699|Immunologic Factors|immunologic factors|mesh-ancestor
92179126|NCT01596699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179127|NCT01596699|Alkylating Agents|alkylating agents|mesh-ancestor
92179128|NCT01596699|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92179129|NCT01596699|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179130|NCT01596699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92179131|NCT01148849|Margetuximab|margetuximab|mesh-list
92179132|NCT01148849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179133|NCT05605301|Deoxyglucose|deoxyglucose|mesh-list
92179134|NCT05605301|Antimetabolites|antimetabolites|mesh-ancestor
92179135|NCT05605301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179136|NCT05605301|Antiviral Agents|antiviral agents|mesh-ancestor
92179137|NCT05605301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179138|NCT05566743|Capecitabine|capecitabine|mesh-list
92179139|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92179140|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
92179141|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179142|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179143|NCT05596721|Azithromycin|azithromycin|mesh-list
92179144|NCT05596721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92179145|NCT05596721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179146|NCT00076687|Botulinum Toxins|botulinum toxins|mesh-list
92179147|NCT00076687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92179148|NCT00076687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92179149|NCT00076687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92179150|NCT00076687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179151|NCT00076687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179152|NCT00076687|Cholinergic Agents|cholinergic agents|mesh-ancestor
92179153|NCT00076687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179154|NCT00076687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179155|NCT00076687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92179156|NCT00076687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179157|NCT01525173|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92179158|NCT01525173|Bimatoprost|bimatoprost|mesh-list
92179159|NCT01525173|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92179160|NCT01525173|Latanoprost|latanoprost|mesh-list
92179161|NCT01525173|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92179162|NCT01525173|Lubricant Eye Drops|lubricant eye drops|mesh-list
92179163|NCT01525173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92179164|NCT01525173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92179165|NCT01525173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92179166|NCT01525173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92179167|NCT01525173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179168|NCT01525173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179169|NCT01525173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179170|NCT01525173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179172|NCT03007563|Antioxidants|antioxidants|mesh-ancestor
92179173|NCT03007563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179174|NCT03007563|Protective Agents|protective agents|mesh-ancestor
92179175|NCT03007563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179176|NCT05331131|Ketamine|ketamine|mesh-list
92179177|NCT05331131|Analgesics|analgesics|mesh-ancestor
92179178|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
92179179|NCT05331131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179180|NCT05331131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179181|NCT05331131|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92179182|NCT05331131|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92179183|NCT05331131|Anesthetics, General|anesthetics, general|mesh-ancestor
92179184|NCT05331131|Anesthetics|anesthetics|mesh-ancestor
92179185|NCT05331131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179186|NCT05331131|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92179187|NCT05331131|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92179188|NCT05331131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179189|NCT05331131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179190|NCT01526577|Ticagrelor|ticagrelor|mesh-list
92179191|NCT01526577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92179192|NCT01526577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92179193|NCT01526577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92179194|NCT01526577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92179195|NCT01526577|Purinergic Agents|purinergic agents|mesh-ancestor
92179196|NCT01526577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179197|NCT01526577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179198|NCT01526577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179199|NCT01894451|Bevacizumab|bevacizumab|mesh-list
92179200|NCT01894451|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
92179201|NCT01894451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92179202|NCT01894451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179203|NCT01894451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92179204|NCT01894451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92179205|NCT01894451|Growth Substances|growth substances|mesh-ancestor
92179206|NCT01894451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179207|NCT01894451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92179208|NCT01894451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92179209|NCT01894451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179210|NCT01527045|Calcium, Dietary|calcium, dietary|mesh-list
92179211|NCT01527045|Cyclosporine|cyclosporine|mesh-list
92179212|NCT01527045|Mycophenolic Acid|mycophenolic acid|mesh-list
92179213|NCT01527045|Fludarabine|fludarabine|mesh-list
92179214|NCT01527045|Fludarabine phosphate|fludarabine phosphate|mesh-list
92179215|NCT01527045|Atorvastatin|atorvastatin|mesh-list
92179217|NCT01527045|Cyclosporins|cyclosporins|mesh-list
92179218|NCT01527045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92179219|NCT01527045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179220|NCT01527045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92179221|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179222|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92179223|NCT01527045|Antimetabolites|antimetabolites|mesh-ancestor
92179224|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179225|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179226|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
92179227|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179228|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
92179229|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179230|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
92179231|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179232|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92179233|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92179234|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92179235|NCT01527045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92179236|NCT01527045|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92179237|NCT01527045|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92179238|NCT01527045|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92179239|NCT01527045|Antitubercular Agents|antitubercular agents|mesh-ancestor
92179240|NCT01527045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92179241|NCT00078403|Ribavirin|ribavirin|mesh-list
92179242|NCT00078403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92179243|NCT00078403|Antimetabolites|antimetabolites|mesh-ancestor
92179244|NCT00078403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179245|NCT00078403|Antiviral Agents|antiviral agents|mesh-ancestor
92179246|NCT00078403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179247|NCT01976585|Poly ICLC|poly iclc|mesh-list
92179248|NCT01976585|Interferon Inducers|interferon inducers|mesh-ancestor
92179249|NCT01976585|Immunologic Factors|immunologic factors|mesh-ancestor
92179250|NCT01976585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179251|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92179252|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
92179253|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92179254|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92179255|NCT01527513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179256|NCT01527513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179258|NCT03001635|Oxytocics|oxytocics|mesh-ancestor
92179259|NCT03001635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92179260|NCT03001635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179261|NCT02592798|Abatacept|abatacept|mesh-list
92179262|NCT02592798|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92179263|NCT02592798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179264|NCT02592798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92179265|NCT02592798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179266|NCT02592798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179267|NCT02592798|Immunologic Factors|immunologic factors|mesh-ancestor
92179268|NCT02592798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179269|NCT02592798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179270|NCT01530243|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92179271|NCT01530243|Terazosin|terazosin|mesh-list
92179272|NCT01530243|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92179273|NCT01530243|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92179274|NCT01530243|Cholinergic Agents|cholinergic agents|mesh-ancestor
92179275|NCT01530243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179276|NCT01530243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179277|NCT01530243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107084|NCT01786109|Hormones|hormones|mesh-ancestor
92179278|NCT01530243|Urological Agents|urological agents|mesh-ancestor
92179279|NCT01530243|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92179280|NCT01530243|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92179281|NCT01530243|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92179282|NCT01530243|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179283|NCT04797546|Morphine|morphine|mesh-list
92179284|NCT04797546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92179285|NCT04797546|Narcotics|narcotics|mesh-ancestor
92179286|NCT04797546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179287|NCT04797546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179288|NCT04797546|Analgesics|analgesics|mesh-ancestor
92179289|NCT04797546|Sensory System Agents|sensory system agents|mesh-ancestor
92179290|NCT04797546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179291|NCT02980809|Apatinib|apatinib|mesh-list
92179292|NCT02980809|Topotecan|topotecan|mesh-list
92179293|NCT02980809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179294|NCT02980809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92179295|NCT02980809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179296|NCT02980809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179297|NCT02980809|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92179298|NCT02980809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179299|NCT00078559|Acetaminophen|acetaminophen|mesh-list
92179300|NCT00078559|Diphenhydramine|diphenhydramine|mesh-list
92179301|NCT00078559|Promethazine|promethazine|mesh-list
92179302|NCT00078559|Sirolimus|sirolimus|mesh-list
92179303|NCT00078559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92179304|NCT00078559|Nystatin|nystatin|mesh-list
92179305|NCT00078559|Clotrimazole|clotrimazole|mesh-list
92179306|NCT00078559|Miconazole|miconazole|mesh-list
92179307|NCT00078559|Pentamidine|pentamidine|mesh-list
92179308|NCT00078559|Trimethoprim|trimethoprim|mesh-list
92179309|NCT00078559|Acyclovir|acyclovir|mesh-list
92179310|NCT00078559|Valganciclovir|valganciclovir|mesh-list
92179311|NCT00078559|Methylprednisolone|methylprednisolone|mesh-list
92179312|NCT00078559|Alemtuzumab|alemtuzumab|mesh-list
92179313|NCT00078559|Tacrolimus|tacrolimus|mesh-list
92179314|NCT00078559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179315|NCT00078559|Immunologic Factors|immunologic factors|mesh-ancestor
92179316|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179317|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92179318|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179319|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179320|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92179321|NCT00078559|Analgesics|analgesics|mesh-ancestor
92179322|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
92179323|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179324|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
92179325|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92179326|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179327|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92179328|NCT00078559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179329|NCT00078559|Antifungal Agents|antifungal agents|mesh-ancestor
92179330|NCT00078559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92179331|NCT00078559|Antiemetics|antiemetics|mesh-ancestor
92179332|NCT00078559|Autonomic Agents|autonomic agents|mesh-ancestor
92179333|NCT00078559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179334|NCT00078559|Glucocorticoids|glucocorticoids|mesh-ancestor
92179335|NCT00078559|Hormones|hormones|mesh-ancestor
92179336|NCT00078559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92179337|NCT00078559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92179338|NCT00078559|Protective Agents|protective agents|mesh-ancestor
92179339|NCT00078559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92179340|NCT00078559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92179341|NCT00078559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92179342|NCT00078559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179343|NCT00078559|Anesthetics, Local|anesthetics, local|mesh-ancestor
92179344|NCT00078559|Anesthetics|anesthetics|mesh-ancestor
92179345|NCT00078559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92179346|NCT00078559|Histamine Antagonists|histamine antagonists|mesh-ancestor
92179347|NCT00078559|Histamine Agents|histamine agents|mesh-ancestor
92179348|NCT00078559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179349|NCT00078559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92179350|NCT00078559|Antipruritics|antipruritics|mesh-ancestor
92179351|NCT00078559|Dermatologic Agents|dermatologic agents|mesh-ancestor
92107090|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92179352|NCT00078559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92179353|NCT00078559|Antimalarials|antimalarials|mesh-ancestor
92179354|NCT00078559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92179355|NCT00078559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92179356|NCT00078559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92179357|NCT00078559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92179358|NCT00078559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92179359|NCT00078559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323436|NCT05701436|Doxorubicin|doxorubicin|mesh-list
92179361|NCT00078559|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92179362|NCT00078559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92179363|NCT00078559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92179364|NCT00078559|Hormone Antagonists|hormone antagonists|mesh-ancestor
92179365|NCT00078559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92179366|NCT00078559|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92179367|NCT00078559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92179368|NCT00078559|Ionophores|ionophores|mesh-ancestor
92179369|NCT00078559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179370|NCT00081653|Ibandronic Acid|ibandronic acid|mesh-list
92179371|NCT00081653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92179372|NCT00081653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179373|NCT00078715|Yohimbine|yohimbine|mesh-list
92179374|NCT00078715|Mydriatics|mydriatics|mesh-ancestor
92179375|NCT00078715|Autonomic Agents|autonomic agents|mesh-ancestor
92179376|NCT00078715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179377|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179378|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92179379|NCT00078715|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92179380|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92179381|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179382|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179383|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179384|NCT00078715|Urological Agents|urological agents|mesh-ancestor
92179385|NCT04805034|Antiviral Agents|antiviral agents|mesh-list
92179386|NCT04805034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179387|NCT01530399|Tranexamic Acid|tranexamic acid|mesh-list
92179388|NCT01530399|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92179389|NCT01530399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92179390|NCT01530399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179391|NCT01530399|Hemostatics|hemostatics|mesh-ancestor
92179392|NCT01530399|Coagulants|coagulants|mesh-ancestor
92179393|NCT01531803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92179394|NCT02596620|Amoxicillin|amoxicillin|mesh-list
92179395|NCT02596620|Metronidazole|metronidazole|mesh-list
92179396|NCT02596620|Levofloxacin|levofloxacin|mesh-list
92179397|NCT02596620|Esomeprazole|esomeprazole|mesh-list
92179398|NCT02596620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92179399|NCT02596620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179400|NCT02596620|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92179401|NCT02596620|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92179402|NCT02596620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92179403|NCT02596620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179404|NCT02596620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92179405|NCT02596620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179406|NCT02596620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179407|NCT02596620|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92179408|NCT02596620|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92179409|NCT02596620|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179410|NCT02596620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179411|NCT02596620|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92179412|NCT02596620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92179414|NCT01531959|Sympathomimetics|sympathomimetics|mesh-ancestor
92179415|NCT01531959|Autonomic Agents|autonomic agents|mesh-ancestor
92179416|NCT01531959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179417|NCT01531959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179418|NCT01531959|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92179419|NCT01531959|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92179420|NCT01531959|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92179421|NCT01531959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92179422|NCT01531959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179423|NCT01531959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179424|NCT01531959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179425|NCT01532349|Cholecalciferol|cholecalciferol|mesh-list
92179426|NCT01532349|Vitamin D|vitamin d|mesh-list
92179427|NCT01532349|Vitamins|vitamins|mesh-ancestor
92179428|NCT01532349|Micronutrients|micronutrients|mesh-ancestor
92179429|NCT01532349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179430|NCT01532349|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92179431|NCT01532349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92179432|NCT03001089|Fludrocortisone|fludrocortisone|mesh-list
92179433|NCT03001089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92179434|NCT01533207|Gemcitabine|gemcitabine|mesh-list
92179435|NCT01533207|Docetaxel|docetaxel|mesh-list
92179436|NCT01533207|Doxorubicin|doxorubicin|mesh-list
92179437|NCT01533207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92179438|NCT01533207|Lenograstim|lenograstim|mesh-list
92179439|NCT01533207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92179440|NCT01533207|Antimetabolites|antimetabolites|mesh-ancestor
92179441|NCT01533207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179442|NCT01533207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179443|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
92179444|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
92179445|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
92179446|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92179447|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92179448|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179449|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179450|NCT01533207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92179451|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
92179452|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179453|NCT00182767|Doxorubicin|doxorubicin|mesh-list
92179454|NCT00182767|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92179455|NCT00182767|Epothilone B|epothilone b|mesh-list
92179456|NCT00182767|Epothilones|epothilones|mesh-list
92179457|NCT00182767|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92179458|NCT00182767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179459|NCT00182767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92179460|NCT00182767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179461|NCT00182767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179462|NCT00182767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179463|NCT00182767|Tubulin Modulators|tubulin modulators|mesh-ancestor
92179464|NCT00182767|Antimitotic Agents|antimitotic agents|mesh-ancestor
92179465|NCT00182767|Mitosis Modulators|mitosis modulators|mesh-ancestor
92179466|NCT01533597|Tamsulosin|tamsulosin|mesh-list
92179467|NCT01533597|Solifenacin Succinate|solifenacin succinate|mesh-list
92179468|NCT01533597|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92179469|NCT01533597|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92179470|NCT01533597|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92179471|NCT01533597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179472|NCT01533597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179473|NCT01533597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179474|NCT01533597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179475|NCT01533597|Urological Agents|urological agents|mesh-ancestor
92179476|NCT01533597|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92179477|NCT01533597|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92179478|NCT01533597|Cholinergic Agents|cholinergic agents|mesh-ancestor
92179480|NCT03006627|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92179481|NCT03006627|Narcotics|narcotics|mesh-ancestor
92179482|NCT03006627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179483|NCT03006627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179484|NCT03006627|Analgesics|analgesics|mesh-ancestor
92179485|NCT03006627|Sensory System Agents|sensory system agents|mesh-ancestor
92179486|NCT03006627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179487|NCT04796688|Cyclophosphamide|cyclophosphamide|mesh-list
92179488|NCT04796688|Fludarabine|fludarabine|mesh-list
92179489|NCT04796688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179490|NCT04796688|Immunologic Factors|immunologic factors|mesh-ancestor
92179491|NCT04796688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179492|NCT04796688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179493|NCT04796688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92179494|NCT04796688|Alkylating Agents|alkylating agents|mesh-ancestor
92179495|NCT04796688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179496|NCT04796688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179497|NCT04796688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179498|NCT01535001|Acetaminophen|acetaminophen|mesh-list
92179499|NCT01535001|Pantoprazole|pantoprazole|mesh-list
92179500|NCT01535001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92179501|NCT01535001|Analgesics|analgesics|mesh-ancestor
92179502|NCT01535001|Sensory System Agents|sensory system agents|mesh-ancestor
92179503|NCT01535001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179504|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179505|NCT01535001|Antipyretics|antipyretics|mesh-ancestor
92179506|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92179507|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179508|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92179509|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179510|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179512|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
92179513|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179514|NCT03000777|Protective Agents|protective agents|mesh-ancestor
92179515|NCT03000777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179516|NCT03000777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179517|NCT03006003|Alendronate|alendronate|mesh-list
92179518|NCT03006003|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92179519|NCT03006003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92179520|NCT03006003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179521|NCT03006003|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92179522|NCT03006003|Hormone Antagonists|hormone antagonists|mesh-ancestor
92179523|NCT03006003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92179524|NCT03006003|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92179525|NCT03006003|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92179526|NCT04426734|Dexamethasone|dexamethasone|mesh-list
92179527|NCT04426734|Prednisolone|prednisolone|mesh-list
92179528|NCT04426734|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92179529|NCT04426734|Methylprednisolone|methylprednisolone|mesh-list
92323572|NCT00002474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179530|NCT04426734|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92179531|NCT04426734|Prednisolone acetate|prednisolone acetate|mesh-list
92179532|NCT04426734|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92179533|NCT04426734|Prednisolone phosphate|prednisolone phosphate|mesh-list
92179534|NCT04426734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92179535|NCT04426734|Antiemetics|antiemetics|mesh-ancestor
92179536|NCT04426734|Autonomic Agents|autonomic agents|mesh-ancestor
92179537|NCT04426734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179538|NCT04426734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179539|NCT04426734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179540|NCT04426734|Glucocorticoids|glucocorticoids|mesh-ancestor
92179541|NCT04426734|Hormones|hormones|mesh-ancestor
92179542|NCT04426734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92179543|NCT04426734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92179544|NCT04426734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179545|NCT04426734|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92179546|NCT04426734|Protective Agents|protective agents|mesh-ancestor
92179547|NCT03006081|Aflibercept|aflibercept|mesh-list
92179548|NCT03006081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92179549|NCT03006081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92179550|NCT03006081|Growth Substances|growth substances|mesh-ancestor
92179551|NCT03006081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179552|NCT03006081|Growth Inhibitors|growth inhibitors|mesh-ancestor
92179553|NCT03006081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179554|NCT01535937|Midazolam|midazolam|mesh-list
92179555|NCT01535937|Ketamine|ketamine|mesh-list
92179556|NCT01535937|Analgesics|analgesics|mesh-ancestor
92179557|NCT01535937|Sensory System Agents|sensory system agents|mesh-ancestor
92179558|NCT01535937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179559|NCT01535937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179560|NCT01535937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92179561|NCT01535937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92179562|NCT01535937|Anesthetics, General|anesthetics, general|mesh-ancestor
92179563|NCT01535937|Anesthetics|anesthetics|mesh-ancestor
92179564|NCT01535937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179565|NCT01535937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92179566|NCT01535937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92179567|NCT01535937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179568|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179569|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92179570|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92179571|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92179572|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92179573|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92179574|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
92179575|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
92179576|NCT04813848|Fluorides|fluorides|mesh-list
92179577|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
92179578|NCT04813848|Protective Agents|protective agents|mesh-ancestor
92323607|NCT02373865|Protease Inhibitors|protease inhibitors|mesh-ancestor
92179579|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179580|NCT02999841|Vildagliptin|vildagliptin|mesh-list
92179581|NCT02999841|Acarbose|acarbose|mesh-list
92179582|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92179583|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179584|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92179585|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
92179586|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179587|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179588|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92179589|NCT01537029|Cyclophosphamide|cyclophosphamide|mesh-list
92179590|NCT01537029|Doxorubicin|doxorubicin|mesh-list
92179591|NCT01537029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179592|NCT01537029|Immunologic Factors|immunologic factors|mesh-ancestor
92179593|NCT01537029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179594|NCT01537029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179595|NCT01537029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92179596|NCT01537029|Alkylating Agents|alkylating agents|mesh-ancestor
92179597|NCT01537029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179598|NCT01537029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179599|NCT01537029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179600|NCT01537029|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92179601|NCT01537029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92179602|NCT01537029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179603|NCT01537029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179604|NCT01667562|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92179605|NCT01667562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179606|NCT01667562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92179607|NCT01667562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179608|NCT01667562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179609|NCT04803318|Everolimus|everolimus|mesh-list
92179610|NCT04803318|Lenvatinib|lenvatinib|mesh-list
92179611|NCT04803318|Trametinib|trametinib|mesh-list
92179612|NCT04803318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92179613|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92179614|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323779|NCT00002546|Alkylating Agents|alkylating agents|mesh-ancestor
92179615|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179616|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179617|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
92179618|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179619|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179620|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
92179621|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92179622|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
92179623|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179625|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92179626|NCT04803162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179627|NCT04803162|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92179628|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179629|NCT04803162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179630|NCT02999217|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92179631|NCT02999217|Hematinics|hematinics|mesh-ancestor
92179632|NCT02595528|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92179633|NCT02595528|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92179634|NCT02980965|Cyclophosphamide|cyclophosphamide|mesh-list
92179635|NCT02980965|Docetaxel|docetaxel|mesh-list
92179636|NCT02980965|Fluorouracil|fluorouracil|mesh-list
92179637|NCT02980965|Letrozole|letrozole|mesh-list
92179638|NCT02980965|Epirubicin|epirubicin|mesh-list
92179639|NCT02980965|Leuprolide|leuprolide|mesh-list
92179640|NCT02980965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92179641|NCT02980965|Immunologic Factors|immunologic factors|mesh-ancestor
92179642|NCT02980965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179643|NCT02980965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179644|NCT02980965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92179645|NCT02980965|Alkylating Agents|alkylating agents|mesh-ancestor
92179646|NCT02980965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179647|NCT02980965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179648|NCT02980965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92179649|NCT02980965|Tubulin Modulators|tubulin modulators|mesh-ancestor
92179650|NCT02980965|Antimitotic Agents|antimitotic agents|mesh-ancestor
92179651|NCT02980965|Mitosis Modulators|mitosis modulators|mesh-ancestor
92179652|NCT02980965|Antimetabolites|antimetabolites|mesh-ancestor
92179653|NCT02980965|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92179654|NCT02980965|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92179655|NCT02980965|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92179656|NCT02980965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179657|NCT02980965|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92179658|NCT02980965|Hormone Antagonists|hormone antagonists|mesh-ancestor
92179659|NCT02980965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92179660|NCT02980965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92179661|NCT02980965|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92179662|NCT02980965|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179663|NCT02980965|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92179664|NCT02980965|Fertility Agents|fertility agents|mesh-ancestor
92179665|NCT02980965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92179666|NCT02980965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92179667|NCT01538745|Ketamine|ketamine|mesh-list
92179668|NCT01538745|Morphine|morphine|mesh-list
92179669|NCT01538745|Analgesics|analgesics|mesh-ancestor
92179671|NCT01538745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179672|NCT01538745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179673|NCT01538745|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92179674|NCT01538745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92179675|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
92179676|NCT01538745|Anesthetics|anesthetics|mesh-ancestor
92179677|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179678|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92179679|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92179680|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179681|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179682|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92179683|NCT01538745|Narcotics|narcotics|mesh-ancestor
92179684|NCT04803240|Hyaluronic Acid|hyaluronic acid|mesh-list
92179685|NCT04803240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92179686|NCT04803240|Immunologic Factors|immunologic factors|mesh-ancestor
92179687|NCT04803240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179688|NCT04803240|Viscosupplements|viscosupplements|mesh-ancestor
92179689|NCT04803240|Protective Agents|protective agents|mesh-ancestor
92179691|NCT04803474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92179692|NCT04803474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179693|NCT01539135|Methylene Blue|methylene blue|mesh-list
92179694|NCT01539135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179695|NCT01539135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179696|NCT04426578|Perhexiline|perhexiline|mesh-list
92179697|NCT04426578|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92179698|NCT04426578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179699|NCT04426578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179700|NCT04426578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92179701|NCT04426578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179702|NCT04426578|Vasodilator Agents|vasodilator agents|mesh-ancestor
92179703|NCT04802928|Isoniazid|isoniazid|mesh-list
92323889|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179704|NCT04802928|Antitubercular Agents|antitubercular agents|mesh-ancestor
92179705|NCT04802928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92179706|NCT04802928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179707|NCT04802928|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92179708|NCT04802928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92179709|NCT04802928|Antimetabolites|antimetabolites|mesh-ancestor
92179710|NCT04802928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179711|NCT04802928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92179712|NCT05365425|Choline|choline|mesh-list
92179713|NCT05365425|Policosanol|policosanol|mesh-list
92179714|NCT05365425|Fenofibrate|fenofibrate|mesh-list
92179715|NCT05365425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92179716|NCT05365425|Antimetabolites|antimetabolites|mesh-ancestor
92179717|NCT05365425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179718|NCT05365425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92179719|NCT05365425|Lipotropic Agents|lipotropic agents|mesh-ancestor
92179720|NCT05365425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92179721|NCT05365425|Nootropic Agents|nootropic agents|mesh-ancestor
92179722|NCT05365425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92179723|NCT05365425|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92179724|NCT02595450|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92179725|NCT02595450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179726|NCT02595450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92179727|NCT02595450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179728|NCT02595450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179729|NCT04794738|Morphine|morphine|mesh-list
92179730|NCT04794738|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92179731|NCT04794738|Narcotics|narcotics|mesh-ancestor
92179732|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179733|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179734|NCT04794738|Analgesics|analgesics|mesh-ancestor
92179735|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
92179736|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179737|NCT04794426|Fluorides|fluorides|mesh-list
92179738|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
92179739|NCT04794426|Protective Agents|protective agents|mesh-ancestor
92179740|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179741|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92179742|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92179743|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179744|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179745|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92179746|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179747|NCT04794504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179748|NCT04794504|Cholinergic Agents|cholinergic agents|mesh-ancestor
92179749|NCT04794504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179750|NCT05073315|Adalimumab|adalimumab|mesh-list
92179751|NCT05073315|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92179752|NCT05073315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92179753|NCT05073315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92179754|NCT02591238|Melatonin|melatonin|mesh-list
92179755|NCT02591238|Antioxidants|antioxidants|mesh-ancestor
92179756|NCT02591238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179757|NCT02591238|Protective Agents|protective agents|mesh-ancestor
92179758|NCT02591238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179759|NCT02591238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179760|NCT02221947|Bryostatin 1|bryostatin 1|mesh-list
92179761|NCT02221947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92179762|NCT02221947|Immunologic Factors|immunologic factors|mesh-ancestor
92179763|NCT02221947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179764|NCT02221947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179765|NCT04793256|Listerine|listerine|mesh-list
92179766|NCT04793256|Fluorides|fluorides|mesh-list
92179767|NCT04793256|Sodium Fluoride|sodium fluoride|mesh-list
92179768|NCT04793256|Fluorides, Topical|fluorides, topical|mesh-list
92179769|NCT04793256|Cariostatic Agents|cariostatic agents|mesh-ancestor
92179770|NCT04793256|Protective Agents|protective agents|mesh-ancestor
92179771|NCT04793256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179772|NCT04793256|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92179773|NCT04793256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179774|NCT03004521|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92179775|NCT03004521|Antidepressive Agents|antidepressive agents|mesh-ancestor
92179776|NCT03004521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92179777|NCT03004521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92179778|NCT03004521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92179779|NCT03004521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179780|NCT03004521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179781|NCT04792710|Metronidazole|metronidazole|mesh-list
92179782|NCT04792710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179783|NCT04792710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92179784|NCT04792710|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92179785|NCT04792710|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92179786|NCT04792398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92179787|NCT04792398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92179788|NCT04792398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179789|NCT04792398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179790|NCT04792398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92179792|NCT04792398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179793|NCT04792398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92179794|NCT04792398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179795|NCT04814433|Lidocaine|lidocaine|mesh-list
92179796|NCT04814433|Epinephrine|epinephrine|mesh-list
92179797|NCT04814433|Racepinephrine|racepinephrine|mesh-list
92179798|NCT04814433|Bupivacaine|bupivacaine|mesh-list
92179799|NCT04814433|Tranexamic Acid|tranexamic acid|mesh-list
92179800|NCT04814433|Aminocaproic Acid|aminocaproic acid|mesh-list
92179801|NCT04814433|Thrombin|thrombin|mesh-list
92179802|NCT04814433|Epinephryl borate|epinephryl borate|mesh-list
92179803|NCT04814433|Anesthetics, Local|anesthetics, local|mesh-ancestor
92179804|NCT04814433|Anesthetics|anesthetics|mesh-ancestor
92179805|NCT04814433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179806|NCT04814433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179807|NCT04814433|Sensory System Agents|sensory system agents|mesh-ancestor
92179808|NCT04814433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179809|NCT04814433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92179810|NCT04814433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92179811|NCT04814433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92179812|NCT04814433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179813|NCT04814433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179814|NCT04814433|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92179815|NCT04814433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92179816|NCT04814433|Hemostatics|hemostatics|mesh-ancestor
92179817|NCT04814433|Coagulants|coagulants|mesh-ancestor
92179818|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92179819|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92179820|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179821|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179822|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92179823|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92179824|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
92179825|NCT04814433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92179826|NCT04814433|Respiratory System Agents|respiratory system agents|mesh-ancestor
92179828|NCT04814433|Sympathomimetics|sympathomimetics|mesh-ancestor
92179829|NCT04814433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92179830|NCT03004209|Epoetin Alfa|epoetin alfa|mesh-list
92179831|NCT03004209|Hematinics|hematinics|mesh-ancestor
92179832|NCT04800978|Durvalumab|durvalumab|mesh-list
92179834|NCT04800978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179836|NCT04791774|Chelating Agents|chelating agents|mesh-ancestor
92179837|NCT04791774|Sequestering Agents|sequestering agents|mesh-ancestor
92179838|NCT04791774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179839|NCT00183469|Lamotrigine|lamotrigine|mesh-list
92179840|NCT00183469|Valproic Acid|valproic acid|mesh-list
92179841|NCT00183469|Anticonvulsants|anticonvulsants|mesh-ancestor
92179842|NCT00183469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92179843|NCT00183469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179844|NCT00183469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179845|NCT00183469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92179846|NCT00183469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179847|NCT00183469|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92179848|NCT00183469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92179849|NCT00183469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179850|NCT00183469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92179851|NCT00183469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92179852|NCT00183469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179853|NCT00183469|GABA Agents|gaba agents|mesh-ancestor
92179854|NCT00183469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179855|NCT00183469|Antimanic Agents|antimanic agents|mesh-ancestor
92179856|NCT02248155|Pramipexole|pramipexole|mesh-list
92179857|NCT02248155|Antioxidants|antioxidants|mesh-ancestor
92179858|NCT02248155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179859|NCT02248155|Protective Agents|protective agents|mesh-ancestor
92179860|NCT02248155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179861|NCT02248155|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92179862|NCT02248155|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92179863|NCT02248155|Dopamine Agonists|dopamine agonists|mesh-ancestor
92179864|NCT02248155|Dopamine Agents|dopamine agents|mesh-ancestor
92179865|NCT02248155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179866|NCT02597946|Paclitaxel|paclitaxel|mesh-list
92179867|NCT02597946|Afatinib|afatinib|mesh-list
92179868|NCT02597946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92179869|NCT02597946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179870|NCT02597946|Tubulin Modulators|tubulin modulators|mesh-ancestor
92179871|NCT02597946|Antimitotic Agents|antimitotic agents|mesh-ancestor
92179872|NCT02597946|Mitosis Modulators|mitosis modulators|mesh-ancestor
92179873|NCT02597946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179874|NCT02597946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92179875|NCT02597946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179876|NCT02248233|Nimodipine|nimodipine|mesh-list
92179877|NCT02248233|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92179878|NCT02248233|Nootropic Agents|nootropic agents|mesh-ancestor
92179879|NCT02248233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92179880|NCT02248233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92179881|NCT02248233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92179882|NCT02248233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179883|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92179884|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179885|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
92179886|NCT04790838|Fluticasone|fluticasone|mesh-list
92179887|NCT04790838|Xhance|xhance|mesh-list
92179888|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92179889|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92179890|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92179891|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92179892|NCT04790838|Autonomic Agents|autonomic agents|mesh-ancestor
92179893|NCT04790838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179894|NCT04790838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179895|NCT04790838|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92179896|NCT04790838|Respiratory System Agents|respiratory system agents|mesh-ancestor
92179897|NCT04790838|Dermatologic Agents|dermatologic agents|mesh-ancestor
92179898|NCT04790838|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92179899|NCT04790838|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92179900|NCT04790838|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92179901|NCT04790838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92179902|NCT04790838|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179903|NCT04790838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179904|NCT04790838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179906|NCT04790838|Hormones|hormones|mesh-ancestor
92179907|NCT04790838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92179909|NCT03003273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92179910|NCT03003273|Amoxicillin|amoxicillin|mesh-list
92179911|NCT03003273|Levofloxacin|levofloxacin|mesh-list
92179912|NCT03003273|Clavulanic Acids|clavulanic acids|mesh-list
92179913|NCT03003273|Clavulanic Acid|clavulanic acid|mesh-list
92179914|NCT03003273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92179915|NCT03003273|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92179916|NCT03003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92179917|NCT03003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92179918|NCT03003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92179919|NCT03003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179920|NCT03003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179921|NCT03003273|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92179922|NCT03003273|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92179923|NCT03003273|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92324248|NCT00002696|Methotrexate|methotrexate|mesh-list
92179926|NCT05571345|Narcotics|narcotics|mesh-ancestor
92179927|NCT05571345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179928|NCT05571345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179929|NCT05571345|Analgesics|analgesics|mesh-ancestor
92179930|NCT05571345|Sensory System Agents|sensory system agents|mesh-ancestor
92179931|NCT05571345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179932|NCT02981121|Metformin|metformin|mesh-list
92179933|NCT02981121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92179934|NCT02981121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179935|NCT02597478|Fentanyl|fentanyl|mesh-list
92179936|NCT02597478|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92179937|NCT02597478|Narcotics|narcotics|mesh-ancestor
92179938|NCT02597478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179939|NCT02597478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179940|NCT02597478|Analgesics|analgesics|mesh-ancestor
92179941|NCT02597478|Sensory System Agents|sensory system agents|mesh-ancestor
92179942|NCT02597478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179943|NCT02597478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92179944|NCT02597478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92179945|NCT02597478|Anesthetics, General|anesthetics, general|mesh-ancestor
92179946|NCT02597478|Anesthetics|anesthetics|mesh-ancestor
92179947|NCT04811274|Dimercaprol|dimercaprol|mesh-list
92179948|NCT04811274|Chelating Agents|chelating agents|mesh-ancestor
92179949|NCT04811274|Sequestering Agents|sequestering agents|mesh-ancestor
92179950|NCT04811274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179951|NCT04799184|Epinephrine|epinephrine|mesh-list
92179952|NCT04799184|Racepinephrine|racepinephrine|mesh-list
92179953|NCT04799184|Bupivacaine|bupivacaine|mesh-list
92179954|NCT04799184|Levobupivacaine|levobupivacaine|mesh-list
92179955|NCT04799184|Epinephryl borate|epinephryl borate|mesh-list
92179956|NCT04799184|Anesthetics, Local|anesthetics, local|mesh-ancestor
92179957|NCT04799184|Anesthetics|anesthetics|mesh-ancestor
92179958|NCT04799184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92179959|NCT04799184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179960|NCT04799184|Sensory System Agents|sensory system agents|mesh-ancestor
92179961|NCT04799184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92179962|NCT04799184|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92179963|NCT04799184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92179964|NCT04799184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92179965|NCT04799184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92179966|NCT04799184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179967|NCT04799184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92179968|NCT04799184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92179969|NCT04799184|Autonomic Agents|autonomic agents|mesh-ancestor
92179970|NCT04799184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92179971|NCT04799184|Respiratory System Agents|respiratory system agents|mesh-ancestor
92179972|NCT04799184|Mydriatics|mydriatics|mesh-ancestor
92179973|NCT04799184|Sympathomimetics|sympathomimetics|mesh-ancestor
92179974|NCT04799184|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92179975|NCT05562297|Paclitaxel|paclitaxel|mesh-list
92179976|NCT05562297|Gemcitabine|gemcitabine|mesh-list
92179977|NCT05562297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92179978|NCT05562297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179979|NCT05562297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92179980|NCT05562297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92179981|NCT05562297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92179982|NCT05562297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179983|NCT05562297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92179985|NCT03003195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92179986|NCT03003195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92179987|NCT03003195|Immunologic Factors|immunologic factors|mesh-ancestor
92179988|NCT03003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92179990|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
92179991|NCT04339101|Sirolimus|sirolimus|mesh-list
92179992|NCT04339101|Fludarabine|fludarabine|mesh-list
92179993|NCT04339101|Melphalan|melphalan|mesh-list
92179994|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
92179995|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92179996|NCT04339101|Tacrolimus|tacrolimus|mesh-list
92179997|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92179998|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92179999|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180000|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
92180001|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180002|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92180003|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180004|NCT04339101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180005|NCT04339101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180006|NCT04339101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180007|NCT04339101|Antifungal Agents|antifungal agents|mesh-ancestor
92180008|NCT04339101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180009|NCT04339101|Alkylating Agents|alkylating agents|mesh-ancestor
92180010|NCT04339101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180011|NCT03003039|Rituximab|rituximab|mesh-list
92180012|NCT03003039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92180013|NCT03003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180014|NCT03003039|Immunologic Factors|immunologic factors|mesh-ancestor
92180015|NCT03003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180016|NCT03003039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180017|NCT03002961|Buprenorphine|buprenorphine|mesh-list
92180018|NCT03002961|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92180019|NCT03002961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92180020|NCT03002961|Narcotics|narcotics|mesh-ancestor
92180021|NCT03002961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180022|NCT03002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180023|NCT03002961|Analgesics|analgesics|mesh-ancestor
92180024|NCT03002961|Sensory System Agents|sensory system agents|mesh-ancestor
92180025|NCT03002961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180026|NCT03002961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92180027|NCT03002805|Doxorubicin|doxorubicin|mesh-list
92180028|NCT03002805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180029|NCT03002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180030|NCT03002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92180031|NCT03002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180032|NCT03002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180033|NCT03002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180034|NCT04214691|Acetaminophen|acetaminophen|mesh-list
92180035|NCT04214691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180036|NCT04214691|Analgesics|analgesics|mesh-ancestor
92180037|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
92180038|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180039|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180040|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
92180041|NCT04786158|Apomorphine|apomorphine|mesh-list
92180042|NCT04786158|Emetics|emetics|mesh-ancestor
92180043|NCT04786158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180044|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
92180045|NCT04786158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180046|NCT04786158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180047|NCT04786158|Dopamine Agonists|dopamine agonists|mesh-ancestor
92180048|NCT04786158|Dopamine Agents|dopamine agents|mesh-ancestor
92180049|NCT04786158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180050|NCT04786158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180051|NCT05367687|Apatinib|apatinib|mesh-list
92180052|NCT05367687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180053|NCT05367687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92180054|NCT05367687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180055|NCT05367687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180056|NCT03002493|Rifampin|rifampin|mesh-list
92180057|NCT03002493|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92180058|NCT03002493|Antitubercular Agents|antitubercular agents|mesh-ancestor
92180059|NCT03002493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180061|NCT03002493|Leprostatic Agents|leprostatic agents|mesh-ancestor
92180062|NCT03002493|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92180063|NCT03002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180064|NCT03002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180065|NCT03002493|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92180066|NCT03002493|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92180067|NCT03002493|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92180068|NCT03002493|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92180069|NCT03002493|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92180070|NCT03002493|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92180071|NCT04786470|Ropivacaine|ropivacaine|mesh-list
92180072|NCT04786470|Anesthetics, Local|anesthetics, local|mesh-ancestor
92180073|NCT04786470|Anesthetics|anesthetics|mesh-ancestor
92107128|NCT02500212|Tacrolimus|tacrolimus|mesh-list
92180074|NCT04786470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180075|NCT04786470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180076|NCT04786470|Sensory System Agents|sensory system agents|mesh-ancestor
92180077|NCT04786470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180078|NCT02219997|Methamphetamine|methamphetamine|mesh-list
92180079|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
92180080|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92180081|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92180082|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92180083|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180084|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
92180085|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
92180086|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180087|NCT02219997|Dopamine Agents|dopamine agents|mesh-ancestor
92180088|NCT02219997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180089|NCT02219997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180090|NCT02219997|Adrenergic Agents|adrenergic agents|mesh-ancestor
92180091|NCT02219997|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92180092|NCT02219997|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92180093|NCT02219997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92180094|NCT02219997|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92180096|NCT02219997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180097|NCT04786002|Busulfan|busulfan|mesh-list
92180098|NCT04786002|Alkylating Agents|alkylating agents|mesh-ancestor
92180099|NCT04786002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180100|NCT04786002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180101|NCT04786002|Immunologic Factors|immunologic factors|mesh-ancestor
92180102|NCT04786002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180103|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180104|NCT04786002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180105|NCT04786002|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180106|NCT04788654|Acetaminophen|acetaminophen|mesh-list
92180107|NCT04788654|Dexamethasone|dexamethasone|mesh-list
92180108|NCT04788654|Celecoxib|celecoxib|mesh-list
92180109|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180110|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
92180111|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
92180112|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180113|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180114|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180115|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
92180116|NCT04788654|Hormones|hormones|mesh-ancestor
92180117|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180118|NCT04788654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180119|NCT04788654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180120|NCT04788654|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180121|NCT04788654|Analgesics|analgesics|mesh-ancestor
92180122|NCT04788654|Sensory System Agents|sensory system agents|mesh-ancestor
92180123|NCT04788654|Antipyretics|antipyretics|mesh-ancestor
92180124|NCT04788654|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92180125|NCT04788654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180126|NCT04788654|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92180127|NCT04788654|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92180128|NCT04788654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180129|NCT04788654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180133|NCT04785768|Narcotics|narcotics|mesh-ancestor
92180134|NCT04785768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180135|NCT04785768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180136|NCT04785768|Analgesics|analgesics|mesh-ancestor
92180137|NCT04785768|Sensory System Agents|sensory system agents|mesh-ancestor
92180138|NCT04785768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180139|NCT02223351|Ritonavir|ritonavir|mesh-list
92180140|NCT02223351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92180141|NCT02223351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92180142|NCT02223351|Protease Inhibitors|protease inhibitors|mesh-ancestor
92180143|NCT02223351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180144|NCT02223351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180145|NCT02223351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92180146|NCT02223351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92180147|NCT02223351|Antiviral Agents|antiviral agents|mesh-ancestor
92180148|NCT02223351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180149|NCT02223351|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92180150|NCT02223351|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92180151|NCT02223429|Vasopressins|vasopressins|mesh-list
92180152|NCT02223429|Arginine Vasopressin|arginine vasopressin|mesh-list
92180153|NCT02223429|Oxytocin|oxytocin|mesh-list
92180154|NCT02223429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180155|NCT02223429|Oxytocics|oxytocics|mesh-ancestor
92180156|NCT02223429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92180157|NCT02223429|Hemostatics|hemostatics|mesh-ancestor
92180158|NCT02223429|Coagulants|coagulants|mesh-ancestor
92180159|NCT02223429|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92180160|NCT02223429|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92180161|NCT02223429|Natriuretic Agents|natriuretic agents|mesh-ancestor
92180162|NCT03002649|Tofacitinib|tofacitinib|mesh-list
92180163|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180164|NCT03002649|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92180165|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92180166|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180167|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
92180168|NCT04785222|Bupivacaine|bupivacaine|mesh-list
92180169|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
92180170|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
92180171|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180172|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180173|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
92180174|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180175|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92180176|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180177|NCT04785222|Analgesics|analgesics|mesh-ancestor
92180178|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92180179|NCT04785222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92180180|NCT04785222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92180181|NCT04785222|Adrenergic Agents|adrenergic agents|mesh-ancestor
92180182|NCT04785222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180183|NCT04785222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180184|NCT04808856|Methylprednisolone|methylprednisolone|mesh-list
92180185|NCT04808856|Hormones|hormones|mesh-list
92180186|NCT04808856|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92180187|NCT04808856|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92180188|NCT04808856|beta-Endorphin|beta-endorphin|mesh-list
92180189|NCT04808856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180190|NCT04808856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180191|NCT04808856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180192|NCT04808856|Antiemetics|antiemetics|mesh-ancestor
92180193|NCT04808856|Autonomic Agents|autonomic agents|mesh-ancestor
92180194|NCT04808856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180195|NCT04808856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180196|NCT04808856|Glucocorticoids|glucocorticoids|mesh-ancestor
92180197|NCT04808856|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92180198|NCT04808856|Protective Agents|protective agents|mesh-ancestor
92180199|NCT04808856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180200|NCT04808856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180201|NCT02247687|Raltegravir Potassium|raltegravir potassium|mesh-list
92180202|NCT02247687|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92180203|NCT02247687|Protease Inhibitors|protease inhibitors|mesh-list
92180204|NCT02247687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92180205|NCT02247687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92180206|NCT02247687|Antiviral Agents|antiviral agents|mesh-ancestor
92180207|NCT02247687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180208|NCT02247687|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92180209|NCT02247687|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92180210|NCT02247687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180211|NCT02247687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180212|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92180213|NCT04784988|BAX 855|bax 855|mesh-list
92180214|NCT04784988|Coagulants|coagulants|mesh-ancestor
92180215|NCT04784910|Lansoprazole|lansoprazole|mesh-list
92180216|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
92180217|NCT04784910|Fexuprazan|fexuprazan|mesh-list
92180218|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92324500|NCT00002750|Melphalan|melphalan|mesh-list
92180219|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180220|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92180221|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180222|NCT04784910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180224|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
92180225|NCT01625013|Protective Agents|protective agents|mesh-ancestor
92180226|NCT01625013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180227|NCT00083551|Interferons|interferons|mesh-list
92180228|NCT00083551|Cytarabine|cytarabine|mesh-list
92180229|NCT00083551|Interferon-alpha|interferon-alpha|mesh-list
92180230|NCT00083551|Interferon alpha-2|interferon alpha-2|mesh-list
92180231|NCT00083551|Thalidomide|thalidomide|mesh-list
92180232|NCT00083551|Dexamethasone|dexamethasone|mesh-list
92180233|NCT00083551|Cyclophosphamide|cyclophosphamide|mesh-list
92180234|NCT00083551|Melphalan|melphalan|mesh-list
92180235|NCT00083551|Carmustine|carmustine|mesh-list
92180236|NCT00083551|Cisplatin|cisplatin|mesh-list
92180237|NCT00083551|Doxorubicin|doxorubicin|mesh-list
92180238|NCT00083551|Etoposide|etoposide|mesh-list
92180239|NCT00083551|Vincristine|vincristine|mesh-list
92180240|NCT00083551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180241|NCT00083551|Immunologic Factors|immunologic factors|mesh-ancestor
92180242|NCT00083551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180243|NCT00083551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180244|NCT00083551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180245|NCT00083551|Alkylating Agents|alkylating agents|mesh-ancestor
92180246|NCT00083551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180247|NCT00083551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180248|NCT00083551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180249|NCT00083551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180250|NCT00083551|Antiemetics|antiemetics|mesh-ancestor
92180251|NCT00083551|Autonomic Agents|autonomic agents|mesh-ancestor
92180252|NCT00083551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180253|NCT00083551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180254|NCT00083551|Glucocorticoids|glucocorticoids|mesh-ancestor
92180255|NCT00083551|Hormones|hormones|mesh-ancestor
92180256|NCT00083551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180257|NCT00083551|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180258|NCT00083551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180259|NCT00083551|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92180260|NCT00083551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180261|NCT00083551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180262|NCT00083551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92180263|NCT00083551|Antiviral Agents|antiviral agents|mesh-ancestor
92180264|NCT00083551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180265|NCT00083551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180266|NCT00083551|Antimetabolites|antimetabolites|mesh-ancestor
92180267|NCT00083551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92180268|NCT00083551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92180269|NCT00083551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92180270|NCT00083551|Leprostatic Agents|leprostatic agents|mesh-ancestor
92180271|NCT00083551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180272|NCT00083551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92180273|NCT00083551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92180275|NCT00083551|Growth Inhibitors|growth inhibitors|mesh-ancestor
92180276|NCT01625169|Etravirine|etravirine|mesh-list
92180277|NCT01625169|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92180278|NCT01625169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92180279|NCT01625169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327628|NCT00381199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180280|NCT01625169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180281|NCT01625169|Antiviral Agents|antiviral agents|mesh-ancestor
92180282|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180283|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92180284|NCT03933813|Hematinics|hematinics|mesh-ancestor
92180285|NCT01628601|Timolol|timolol|mesh-list
92180286|NCT01628601|Bimatoprost|bimatoprost|mesh-list
92180287|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92180288|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92180289|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
92180290|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180291|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180292|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180293|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92180294|NCT01628601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92180295|NCT01470248|Arsenic Trioxide|arsenic trioxide|mesh-list
92180296|NCT01470248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180297|NCT04091022|Eflornithine|eflornithine|mesh-list
92180298|NCT04091022|Diclofenac|diclofenac|mesh-list
92180299|NCT04091022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92180300|NCT04091022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180301|NCT04091022|Analgesics|analgesics|mesh-ancestor
92180302|NCT04091022|Sensory System Agents|sensory system agents|mesh-ancestor
92180303|NCT04091022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180304|NCT04091022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180305|NCT04091022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180306|NCT04091022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180307|NCT04091022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92180308|NCT04091022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180309|NCT04091022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180310|NCT04091022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180311|NCT04091022|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92180312|NCT04091022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92180313|NCT04091022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92180314|NCT04091022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180315|NCT04091022|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92180316|NCT01490918|Metformin|metformin|mesh-list
92180317|NCT01490918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92180318|NCT01490918|Acarbose|acarbose|mesh-list
92180319|NCT01490918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92180320|NCT01490918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180321|NCT01490918|Incretins|incretins|mesh-ancestor
92180322|NCT01490918|Hormones|hormones|mesh-ancestor
92180323|NCT01490918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180324|NCT01490918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92180325|NCT01490918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92180326|NCT01490918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180327|NCT01490918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180328|NCT01490918|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92180329|NCT02230995|Metformin|metformin|mesh-list
92180330|NCT02230995|Empagliflozin|empagliflozin|mesh-list
92180331|NCT02230995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92180332|NCT02230995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180333|NCT02230995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92180334|NCT02230995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180335|NCT02995083|Methylprednisolone|methylprednisolone|mesh-list
92180336|NCT02995083|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92180337|NCT02995083|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92180338|NCT02995083|Prednisolone|prednisolone|mesh-list
92180339|NCT02995083|Prednisolone acetate|prednisolone acetate|mesh-list
92180340|NCT02995083|Lidocaine|lidocaine|mesh-list
92180341|NCT02995083|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92180342|NCT02995083|Prednisolone phosphate|prednisolone phosphate|mesh-list
92180343|NCT02995083|Anesthetics, Local|anesthetics, local|mesh-ancestor
92180344|NCT02995083|Anesthetics|anesthetics|mesh-ancestor
92180345|NCT02995083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180346|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180347|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
92180348|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180349|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92180350|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92180351|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92180352|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92180353|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180354|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180355|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
92180356|NCT02995083|Autonomic Agents|autonomic agents|mesh-ancestor
92180357|NCT02995083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180358|NCT02995083|Glucocorticoids|glucocorticoids|mesh-ancestor
92180359|NCT02995083|Hormones|hormones|mesh-ancestor
92180360|NCT02995083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180361|NCT02995083|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92180362|NCT02995083|Protective Agents|protective agents|mesh-ancestor
92180363|NCT02995083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180364|NCT02995083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180365|NCT03794388|Pregabalin|pregabalin|mesh-list
92180366|NCT03794388|Capsaicin|capsaicin|mesh-list
92180367|NCT03794388|Analgesics|analgesics|mesh-ancestor
92180368|NCT03794388|Sensory System Agents|sensory system agents|mesh-ancestor
92180369|NCT03794388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324642|NCT00002780|Immunologic Factors|immunologic factors|mesh-ancestor
92180370|NCT03794388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180372|NCT03794388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92180373|NCT03794388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92180374|NCT03794388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180375|NCT03794388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92180376|NCT03794388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92180377|NCT03794388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92180378|NCT03794388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180379|NCT03794388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92180380|NCT03794388|Antipruritics|antipruritics|mesh-ancestor
92180381|NCT03794388|Dermatologic Agents|dermatologic agents|mesh-ancestor
92180382|NCT04426422|Metformin|metformin|mesh-list
92180383|NCT04426422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92180384|NCT04426422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180385|NCT05471700|Azacitidine|azacitidine|mesh-list
92180386|NCT05471700|Venetoclax|venetoclax|mesh-list
92180387|NCT05471700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180388|NCT05471700|Antimetabolites|antimetabolites|mesh-ancestor
92180389|NCT05471700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180390|NCT05471700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180391|NCT05471700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180392|NCT01632423|Bimatoprost|bimatoprost|mesh-list
92180393|NCT01632423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92180394|NCT05466318|Cytarabine|cytarabine|mesh-list
92180395|NCT05466318|Gemcitabine|gemcitabine|mesh-list
92180396|NCT05466318|Etoposide|etoposide|mesh-list
92180397|NCT05466318|Melphalan|melphalan|mesh-list
92180398|NCT05466318|Busulfan|busulfan|mesh-list
92180399|NCT05466318|Carmustine|carmustine|mesh-list
92180400|NCT05466318|Cladribine|cladribine|mesh-list
92180401|NCT05466318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180402|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
92180403|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180404|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180405|NCT05466318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92180406|NCT05466318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92180407|NCT05466318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180408|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180409|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
92180410|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180411|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180412|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
92180413|NCT05466318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180414|NCT05466318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180415|NCT05466318|Alkylating Agents|alkylating agents|mesh-ancestor
92180416|NCT05466318|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180417|NCT01633827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92180418|NCT01633827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180419|NCT01633827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180421|NCT01469546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180422|NCT01469546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92180423|NCT01469546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180424|NCT01469546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180426|NCT03281811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92180427|NCT03281811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92180428|NCT05613894|177Lu-PSMA-617|177lu-psma-617|mesh-list
92180429|NCT05613894|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92180430|NCT05613894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180431|NCT00081263|Celecoxib|celecoxib|mesh-list
92180432|NCT00081263|Benzenesulfonamide|benzenesulfonamide|mesh-list
92180433|NCT00081263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92180434|NCT00081263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180435|NCT00081263|Analgesics|analgesics|mesh-ancestor
92180437|NCT00081263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180438|NCT00081263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180439|NCT00081263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180440|NCT00081263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180441|NCT00081263|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92180442|NCT00081263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92180443|NCT00081263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180444|NCT00081263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180445|NCT00081263|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92180446|NCT03138603|Metoprolol|metoprolol|mesh-list
92180447|NCT03138603|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92180448|NCT03138603|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92180449|NCT03138603|Sympatholytics|sympatholytics|mesh-ancestor
92180450|NCT03138603|Autonomic Agents|autonomic agents|mesh-ancestor
92324786|NCT05594407|Sensory System Agents|sensory system agents|mesh-ancestor
92180451|NCT03138603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180452|NCT03138603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180453|NCT03138603|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92180454|NCT03138603|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92180455|NCT03138603|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92180456|NCT03138603|Adrenergic Agents|adrenergic agents|mesh-ancestor
92180457|NCT03138603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180458|NCT03138603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180459|NCT05087381|Cyproheptadine|cyproheptadine|mesh-list
92180460|NCT05087381|Niclosamide|niclosamide|mesh-list
92180461|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
92180462|NCT05087381|Bromhexine|bromhexine|mesh-list
92180463|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180464|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180465|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92180466|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92180467|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180468|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180469|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92180470|NCT05087381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92180471|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92180472|NCT05087381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92180473|NCT05087381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180474|NCT05087381|Serotonin Agents|serotonin agents|mesh-ancestor
92180475|NCT05087381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92180476|NCT05087381|Antidepressive Agents|antidepressive agents|mesh-ancestor
92180477|NCT05087381|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92180478|NCT05087381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92180479|NCT05087381|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92180480|NCT05087381|Anticestodal Agents|anticestodal agents|mesh-ancestor
92180481|NCT05087381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92180482|NCT05087381|Anthelmintics|anthelmintics|mesh-ancestor
92180483|NCT05087381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92180484|NCT05087381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180485|NCT05087381|Antinematodal Agents|antinematodal agents|mesh-ancestor
92180486|NCT05087381|Antipruritics|antipruritics|mesh-ancestor
92180487|NCT05087381|Dermatologic Agents|dermatologic agents|mesh-ancestor
92180488|NCT05087381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180489|NCT05087381|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92180490|NCT05087381|Histamine Antagonists|histamine antagonists|mesh-ancestor
92180491|NCT05087381|Histamine Agents|histamine agents|mesh-ancestor
92180492|NCT05087381|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92180493|NCT05087381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92180494|NCT05087381|Expectorants|expectorants|mesh-ancestor
92180495|NCT05087381|Respiratory System Agents|respiratory system agents|mesh-ancestor
92180496|NCT00080483|Methyltestosterone|methyltestosterone|mesh-list
92180497|NCT00080483|Testosterone|testosterone|mesh-list
92180498|NCT00080483|Testosterone undecanoate|testosterone undecanoate|mesh-list
92180499|NCT00080483|Testosterone enanthate|testosterone enanthate|mesh-list
92180500|NCT00080483|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92180501|NCT00080483|Androgens|androgens|mesh-ancestor
92180502|NCT00080483|Hormones|hormones|mesh-ancestor
92180503|NCT00080483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180504|NCT00080483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180505|NCT00080483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180506|NCT00080483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180507|NCT00080483|Anabolic Agents|anabolic agents|mesh-ancestor
92180508|NCT05248620|Amoxicillin|amoxicillin|mesh-list
92180510|NCT05248620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180512|NCT01639599|Dexamethasone acetate|dexamethasone acetate|mesh-list
92180513|NCT01639599|Haloperidol|haloperidol|mesh-list
92180514|NCT01639599|Haloperidol decanoate|haloperidol decanoate|mesh-list
92180515|NCT01639599|BB 1101|bb 1101|mesh-list
92180516|NCT01639599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180517|NCT01639599|Antiemetics|antiemetics|mesh-ancestor
92180518|NCT01639599|Autonomic Agents|autonomic agents|mesh-ancestor
92180519|NCT01639599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180520|NCT01639599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180521|NCT01639599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180522|NCT01639599|Glucocorticoids|glucocorticoids|mesh-ancestor
92180523|NCT01639599|Hormones|hormones|mesh-ancestor
92180524|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180525|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180526|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180527|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
92180528|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180529|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180530|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92180531|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92180532|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180533|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92180534|NCT01639599|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92180535|NCT01639599|Dopamine Agents|dopamine agents|mesh-ancestor
92180536|NCT01639599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180537|NCT01639599|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92180538|NCT00089141|Mycophenolic Acid|mycophenolic acid|mesh-list
92180539|NCT00089141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180540|NCT00089141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180541|NCT00089141|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92180542|NCT00089141|Antitubercular Agents|antitubercular agents|mesh-ancestor
92180543|NCT00089141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180544|NCT00089141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180545|NCT00089141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180546|NCT00089141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180547|NCT02227329|Ethanol|ethanol|mesh-list
92180548|NCT02227329|Heparin|heparin|mesh-list
92180549|NCT02227329|Calcium heparin|calcium heparin|mesh-list
92180550|NCT02227329|Anticoagulants|anticoagulants|mesh-ancestor
92180551|NCT02227329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92180552|NCT02227329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92180553|NCT02227329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180554|NCT02227329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92180555|NCT02227329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180556|NCT02227329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180557|NCT02227329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180559|NCT05611242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92180560|NCT05611242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92180561|NCT05611242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92180562|NCT05611242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92180563|NCT05611242|Purinergic Agents|purinergic agents|mesh-ancestor
92180564|NCT05611242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180565|NCT05611242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180566|NCT05611242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180567|NCT05615142|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92180568|NCT05615142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180569|NCT05615142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92180570|NCT05615142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180571|NCT02227485|Chlorhexidine|chlorhexidine|mesh-list
92180572|NCT02227485|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92180573|NCT02227485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180574|NCT02227485|Disinfectants|disinfectants|mesh-ancestor
92180575|NCT03172897|Dexmedetomidine|dexmedetomidine|mesh-list
92180576|NCT03172897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92180577|NCT03172897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180578|NCT03172897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180579|NCT03172897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180580|NCT03172897|Analgesics|analgesics|mesh-ancestor
92180581|NCT03172897|Sensory System Agents|sensory system agents|mesh-ancestor
92180582|NCT03172897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180583|NCT03172897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92180584|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92180585|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92180586|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
92180587|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180588|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180589|NCT00086723|Captopril|captopril|mesh-list
92180590|NCT00086723|Plasminogen|plasminogen|mesh-list
92180591|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92180592|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92180593|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92180594|NCT00086723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180595|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92180596|NCT00086723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92180597|NCT00086723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180598|NCT00086723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92180600|NCT03849534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180601|NCT03849534|Antifungal Agents|antifungal agents|mesh-ancestor
92180602|NCT03849534|Keratolytic Agents|keratolytic agents|mesh-ancestor
92180603|NCT03849534|Dermatologic Agents|dermatologic agents|mesh-ancestor
92180604|NCT05346419|Vitamin D|vitamin d|mesh-list
92180605|NCT05346419|Risedronic Acid|risedronic acid|mesh-list
92180606|NCT05346419|Vitamins|vitamins|mesh-ancestor
92180607|NCT05346419|Micronutrients|micronutrients|mesh-ancestor
92180608|NCT05346419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180609|NCT05346419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92180610|NCT05346419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92180611|NCT05346419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92180612|NCT05346419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180613|NCT05346419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92180614|NCT00084409|Iloprost|iloprost|mesh-list
92180615|NCT00084409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92180616|NCT00084409|Vasodilator Agents|vasodilator agents|mesh-ancestor
92180617|NCT03831165|Acyclovir|acyclovir|mesh-list
92180618|NCT03831165|Melatonin|melatonin|mesh-list
92180619|NCT03831165|Antioxidants|antioxidants|mesh-ancestor
92180620|NCT03831165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180621|NCT03831165|Protective Agents|protective agents|mesh-ancestor
92180622|NCT03831165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180623|NCT03831165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180624|NCT03831165|Antiviral Agents|antiviral agents|mesh-ancestor
92180625|NCT03831165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180626|NCT00088621|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92180627|NCT00088621|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92180628|NCT00088621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92180629|NCT00088621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180630|NCT00088621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180631|NCT00088621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92180632|NCT00088621|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92180633|NCT00088621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92180634|NCT00088621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92180635|NCT00088621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92180636|NCT00088621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107180|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92180637|NCT00088621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327629|NCT00381199|Analgesics|analgesics|mesh-ancestor
92180638|NCT00088621|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92180639|NCT00088621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92180641|NCT00088621|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92180642|NCT00088621|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92180643|NCT00088621|Dopamine Agents|dopamine agents|mesh-ancestor
92180644|NCT03849651|Cyclophosphamide|cyclophosphamide|mesh-list
92180645|NCT03849651|Melphalan|melphalan|mesh-list
92180647|NCT03849651|Fludarabine|fludarabine|mesh-list
92180648|NCT03849651|Blinatumomab|blinatumomab|mesh-list
92180649|NCT03849651|Thymoglobulin|thymoglobulin|mesh-list
92180650|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180651|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
92180652|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180653|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180654|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180655|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
92180656|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180657|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180658|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180659|NCT05574985|Vaccines|vaccines|mesh-list
92180660|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
92180661|NCT05574985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180662|NCT01642485|Moxifloxacin|moxifloxacin|mesh-list
92180663|NCT01642485|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92180664|NCT01642485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180665|NCT01642485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180666|NCT01642485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180667|NCT01642485|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92180668|NCT01642485|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180669|NCT01642485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180670|NCT01642485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180671|NCT01642485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180672|NCT01642485|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92180673|NCT01642485|Contraceptive Agents|contraceptive agents|mesh-ancestor
92180674|NCT01642485|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92180675|NCT01642485|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92180676|NCT01642485|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92180677|NCT01642485|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92180678|NCT04773366|Cytarabine|cytarabine|mesh-list
92180679|NCT04773366|Prednisone|prednisone|mesh-list
92180680|NCT04773366|Vincristine|vincristine|mesh-list
92180681|NCT04773366|Mercaptopurine|mercaptopurine|mesh-list
92180682|NCT04773366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180683|NCT04773366|Glucocorticoids|glucocorticoids|mesh-ancestor
92180684|NCT04773366|Hormones|hormones|mesh-ancestor
92180685|NCT04773366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180686|NCT04773366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180687|NCT04773366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180688|NCT04773366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180689|NCT04773366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180690|NCT04773366|Antimetabolites|antimetabolites|mesh-ancestor
92180691|NCT04773366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180692|NCT04773366|Antiviral Agents|antiviral agents|mesh-ancestor
92180693|NCT04773366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180694|NCT04773366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180695|NCT04773366|Immunologic Factors|immunologic factors|mesh-ancestor
92180696|NCT04773366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92180697|NCT04773366|Tubulin Modulators|tubulin modulators|mesh-ancestor
92180698|NCT04773366|Antimitotic Agents|antimitotic agents|mesh-ancestor
92180699|NCT04773366|Mitosis Modulators|mitosis modulators|mesh-ancestor
92180700|NCT04773366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92180701|NCT04773366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180702|NCT04714541|Ketamine|ketamine|mesh-list
92180703|NCT04714541|Analgesics|analgesics|mesh-ancestor
92180704|NCT04714541|Sensory System Agents|sensory system agents|mesh-ancestor
92180705|NCT04714541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180706|NCT04714541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180707|NCT04714541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92180708|NCT04714541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92180709|NCT04714541|Anesthetics, General|anesthetics, general|mesh-ancestor
92180710|NCT04714541|Anesthetics|anesthetics|mesh-ancestor
92180711|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180712|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92180713|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92180714|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325060|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92180715|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180716|NCT02414724|Gemcitabine|gemcitabine|mesh-list
92180717|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180718|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
92180719|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180720|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180722|NCT00187681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92180723|NCT00187681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180724|NCT00083759|Natalizumab|natalizumab|mesh-list
92180725|NCT00083759|Immunologic Factors|immunologic factors|mesh-ancestor
92180726|NCT00083759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180727|NCT02412228|Dexamethasone|dexamethasone|mesh-list
92180728|NCT02412228|Cyclophosphamide|cyclophosphamide|mesh-list
92180729|NCT02412228|Ixazomib|ixazomib|mesh-list
92180730|NCT02412228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180731|NCT02412228|Immunologic Factors|immunologic factors|mesh-ancestor
92180733|NCT02412228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180734|NCT02412228|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180735|NCT02412228|Alkylating Agents|alkylating agents|mesh-ancestor
92180736|NCT02412228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180737|NCT02412228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180738|NCT02412228|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180739|NCT02412228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92180740|NCT02412228|Antiemetics|antiemetics|mesh-ancestor
92180741|NCT02412228|Autonomic Agents|autonomic agents|mesh-ancestor
92180742|NCT02412228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180743|NCT02412228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92180744|NCT02412228|Glucocorticoids|glucocorticoids|mesh-ancestor
92180745|NCT02412228|Hormones|hormones|mesh-ancestor
92180746|NCT02412228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180747|NCT02412228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180748|NCT02412228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92180749|NCT02412228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180751|NCT03693807|Fluorouracil|fluorouracil|mesh-list
92180752|NCT03693807|Floxuridine|floxuridine|mesh-list
92180753|NCT03693807|Oxaliplatin|oxaliplatin|mesh-list
92180754|NCT03693807|Irinotecan|irinotecan|mesh-list
92180755|NCT03693807|Cetuximab|cetuximab|mesh-list
92180756|NCT03693807|Panitumumab|panitumumab|mesh-list
92180757|NCT03693807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180758|NCT03693807|Antimetabolites|antimetabolites|mesh-ancestor
92180759|NCT03693807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180760|NCT03693807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180761|NCT03693807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92180762|NCT03693807|Immunologic Factors|immunologic factors|mesh-ancestor
92180763|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180764|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92180765|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180766|NCT03693807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180767|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92180768|NCT01646151|Bimatoprost|bimatoprost|mesh-list
92180769|NCT01646151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92180770|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92180771|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92180772|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180773|NCT03692403|Quinagolide|quinagolide|mesh-list
92180774|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
92180775|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
92325133|NCT04713332|Protective Agents|protective agents|mesh-ancestor
92180776|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180777|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180778|NCT03692403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180779|NCT01828710|Folic Acid|folic acid|mesh-list
92180780|NCT01828710|Inositol|inositol|mesh-list
92180781|NCT01828710|Hematinics|hematinics|mesh-ancestor
92180782|NCT01828710|Vitamin B Complex|vitamin b complex|mesh-ancestor
92180783|NCT01828710|Vitamins|vitamins|mesh-ancestor
92180784|NCT01828710|Micronutrients|micronutrients|mesh-ancestor
92180785|NCT01828710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180786|NCT00088699|Ketamine|ketamine|mesh-list
92180787|NCT00088699|Analgesics|analgesics|mesh-ancestor
92180788|NCT00088699|Sensory System Agents|sensory system agents|mesh-ancestor
92180789|NCT00088699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180790|NCT00088699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180791|NCT00088699|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92180792|NCT00088699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92180793|NCT00088699|Anesthetics, General|anesthetics, general|mesh-ancestor
92180794|NCT00088699|Anesthetics|anesthetics|mesh-ancestor
92180795|NCT00088699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180796|NCT00088699|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92180797|NCT00088699|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92180798|NCT00088699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180799|NCT00088699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180800|NCT00089011|Mycophenolic Acid|mycophenolic acid|mesh-list
92180801|NCT00089011|Fludarabine|fludarabine|mesh-list
92180802|NCT00089011|Fludarabine phosphate|fludarabine phosphate|mesh-list
92180803|NCT00089011|Tacrolimus|tacrolimus|mesh-list
92180804|NCT00089011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180805|NCT00089011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180806|NCT00089011|Antimetabolites|antimetabolites|mesh-ancestor
92322336|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180807|NCT00089011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180809|NCT00089011|Immunologic Factors|immunologic factors|mesh-ancestor
92180810|NCT00089011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180811|NCT00089011|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92180812|NCT00089011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180813|NCT00089011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180814|NCT00089011|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92180815|NCT00089011|Antitubercular Agents|antitubercular agents|mesh-ancestor
92180816|NCT00089011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180818|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
92180819|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
92180820|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180821|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180822|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92180823|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
92180824|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92180825|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180826|NCT01898377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180827|NCT01898377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180828|NCT01898377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92180829|NCT00347412|Paclitaxel|paclitaxel|mesh-list
92180830|NCT00347412|Carboplatin|carboplatin|mesh-list
92180831|NCT00347412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92180832|NCT00347412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180833|NCT00347412|Tubulin Modulators|tubulin modulators|mesh-ancestor
92180834|NCT00347412|Antimitotic Agents|antimitotic agents|mesh-ancestor
92180835|NCT00347412|Mitosis Modulators|mitosis modulators|mesh-ancestor
92180836|NCT00347412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180837|NCT00189475|Montelukast|montelukast|mesh-list
92180838|NCT00189475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92180839|NCT00189475|Respiratory System Agents|respiratory system agents|mesh-ancestor
92180840|NCT00189475|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92180841|NCT00189475|Hormone Antagonists|hormone antagonists|mesh-ancestor
92180842|NCT00189475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180843|NCT00189475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180844|NCT00189475|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92180845|NCT00189475|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92180846|NCT00189475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180847|NCT00091273|Sargramostim|sargramostim|mesh-list
92180848|NCT00091273|Freund's Adjuvant|freund's adjuvant|mesh-list
92180849|NCT00091273|Immunologic Factors|immunologic factors|mesh-ancestor
92180850|NCT00091273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180851|NCT00091273|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92180852|NCT00193375|Bevacizumab|bevacizumab|mesh-list
92180853|NCT00193375|Carboplatin|carboplatin|mesh-list
92180854|NCT00193375|Irinotecan|irinotecan|mesh-list
92180855|NCT00193375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92180856|NCT00193375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180857|NCT00193375|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92180858|NCT00193375|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92180859|NCT00193375|Growth Substances|growth substances|mesh-ancestor
92180860|NCT00193375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180861|NCT00193375|Growth Inhibitors|growth inhibitors|mesh-ancestor
92180862|NCT00193375|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92180863|NCT00193375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180864|NCT00193375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180865|NCT00193375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180866|NCT05475210|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92180867|NCT05475210|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
92180868|NCT05475210|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92180869|NCT05475210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180870|NCT00193453|Gemcitabine|gemcitabine|mesh-list
92180871|NCT00193453|Docetaxel|docetaxel|mesh-list
92180872|NCT00193453|Cetuximab|cetuximab|mesh-list
92180873|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180874|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
92180875|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180876|NCT00193453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180877|NCT00193453|Tubulin Modulators|tubulin modulators|mesh-ancestor
92180878|NCT00193453|Antimitotic Agents|antimitotic agents|mesh-ancestor
92180879|NCT00193453|Mitosis Modulators|mitosis modulators|mesh-ancestor
92180880|NCT00193453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92180881|NCT05614518|Methylene diphosphonate|methylene diphosphonate|mesh-list
92180883|NCT05614518|Fluorides|fluorides|mesh-list
92180884|NCT05614518|Sodium Fluoride|sodium fluoride|mesh-list
92180885|NCT05614518|Cariostatic Agents|cariostatic agents|mesh-ancestor
92180886|NCT05614518|Protective Agents|protective agents|mesh-ancestor
92180887|NCT05614518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180888|NCT05614518|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92180889|NCT05614518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180890|NCT05614518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92180891|NCT00091507|Insulin|insulin|mesh-list
92180892|NCT00091507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92180893|NCT00091507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180894|NCT05611086|Acetylcysteine|acetylcysteine|mesh-list
92180895|NCT05611086|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92180896|NCT05611086|Antiviral Agents|antiviral agents|mesh-ancestor
92180897|NCT05611086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92180898|NCT05611086|Expectorants|expectorants|mesh-ancestor
92180899|NCT05611086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92180900|NCT05611086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92180901|NCT05611086|Antioxidants|antioxidants|mesh-ancestor
92180902|NCT05611086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180903|NCT05611086|Protective Agents|protective agents|mesh-ancestor
92180904|NCT05611086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180905|NCT05611086|Antidotes|antidotes|mesh-ancestor
92180906|NCT05614440|Tramadol|tramadol|mesh-list
92180907|NCT05614440|Anesthetics|anesthetics|mesh-list
92180908|NCT05614440|Anesthetics, Local|anesthetics, local|mesh-list
92180909|NCT05614440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180910|NCT05614440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180911|NCT05614440|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92180912|NCT05614440|Narcotics|narcotics|mesh-ancestor
92180913|NCT05614440|Analgesics|analgesics|mesh-ancestor
92180914|NCT05614440|Sensory System Agents|sensory system agents|mesh-ancestor
92180915|NCT05614440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180916|NCT05613192|Vitamin D|vitamin d|mesh-list
92180917|NCT05613192|Cholecalciferol|cholecalciferol|mesh-list
92180918|NCT05613192|Vitamins|vitamins|mesh-ancestor
92180919|NCT05613192|Micronutrients|micronutrients|mesh-ancestor
92180920|NCT05613192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180921|NCT05613192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92180922|NCT05613192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92180923|NCT00194779|Tamoxifen|tamoxifen|mesh-list
92180924|NCT00194779|Vinorelbine|vinorelbine|mesh-list
92180925|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
92180926|NCT00194779|Doxorubicin|doxorubicin|mesh-list
92180927|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92180928|NCT00194779|Capecitabine|capecitabine|mesh-list
92180929|NCT00194779|Methotrexate|methotrexate|mesh-list
92180930|NCT00194779|Trastuzumab|trastuzumab|mesh-list
92180931|NCT00194779|Letrozole|letrozole|mesh-list
92180932|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92180933|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180934|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
92180935|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
92180936|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
92180937|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180939|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
92180940|NCT00194779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180941|NCT00194779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92180942|NCT00194779|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92180943|NCT00194779|Alkylating Agents|alkylating agents|mesh-ancestor
92180944|NCT00194779|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92180945|NCT00194779|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92180946|NCT00194779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92180947|NCT00194779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92180948|NCT00194779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92180949|NCT00194779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92180951|NCT00194779|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92180952|NCT00194779|Abortifacient Agents|abortifacient agents|mesh-ancestor
92180953|NCT00194779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92180954|NCT00194779|Dermatologic Agents|dermatologic agents|mesh-ancestor
92180955|NCT00194779|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92180957|NCT00194779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92180958|NCT00194779|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92180959|NCT00194779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92180960|NCT00194779|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92180961|NCT00194779|Hormone Antagonists|hormone antagonists|mesh-ancestor
92180962|NCT00194779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92180963|NCT00194779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92180964|NCT00194779|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92180965|NCT00194779|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92180966|NCT00194779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92180968|NCT05474664|Protease Inhibitors|protease inhibitors|mesh-ancestor
92180969|NCT05474664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325326|NCT00746239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92180970|NCT05474664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92180972|NCT05474664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92180973|NCT02096575|Nitrous Oxide|nitrous oxide|mesh-list
92180974|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92180975|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
92180976|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
92180977|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180978|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180979|NCT02096575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92180980|NCT02096575|Analgesics|analgesics|mesh-ancestor
92180981|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
92180982|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180983|NCT04338984|Fentanyl|fentanyl|mesh-list
92180984|NCT04338984|Ropivacaine|ropivacaine|mesh-list
92180985|NCT04338984|Anesthetics|anesthetics|mesh-list
92180986|NCT04338984|Anesthetics, General|anesthetics, general|mesh-list
92180987|NCT04338984|Anesthetics, Local|anesthetics, local|mesh-ancestor
92180988|NCT04338984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92180989|NCT04338984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92180990|NCT04338984|Sensory System Agents|sensory system agents|mesh-ancestor
92180991|NCT04338984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92180992|NCT04338984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92180993|NCT04338984|Narcotics|narcotics|mesh-ancestor
92180994|NCT04338984|Analgesics|analgesics|mesh-ancestor
92180995|NCT04338984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92180996|NCT04338984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92180997|NCT00095563|Lapatinib|lapatinib|mesh-list
92180998|NCT00095563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92180999|NCT00095563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181000|NCT00095563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181001|NCT00095563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181002|NCT05473806|Pioglitazone|pioglitazone|mesh-list
92181003|NCT05473806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92181004|NCT05473806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181005|NCT00089609|Thalidomide|thalidomide|mesh-list
92181006|NCT00089609|Prednisone|prednisone|mesh-list
92181007|NCT00089609|Bevacizumab|bevacizumab|mesh-list
92181008|NCT00089609|Docetaxel|docetaxel|mesh-list
92181009|NCT00089609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181010|NCT00089609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181011|NCT00089609|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92181012|NCT00089609|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92181013|NCT00089609|Growth Substances|growth substances|mesh-ancestor
92181014|NCT00089609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181015|NCT00089609|Growth Inhibitors|growth inhibitors|mesh-ancestor
92181016|NCT00089609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181017|NCT00089609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181018|NCT00089609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92181019|NCT00089609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181020|NCT00089609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181021|NCT00089609|Glucocorticoids|glucocorticoids|mesh-ancestor
92181022|NCT00089609|Hormones|hormones|mesh-ancestor
92181023|NCT00089609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181024|NCT00089609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92181025|NCT00089609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181026|NCT00089609|Immunologic Factors|immunologic factors|mesh-ancestor
92181027|NCT00089609|Leprostatic Agents|leprostatic agents|mesh-ancestor
92181028|NCT00089609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181029|NCT00089609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181030|NCT04661514|Psilocybin|psilocybin|mesh-list
92181031|NCT04661514|Hallucinogens|hallucinogens|mesh-ancestor
92181032|NCT04661514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181033|NCT04661514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92181034|NCT00195403|Etanercept|etanercept|mesh-list
92325416|NCT00728845|Growth Substances|growth substances|mesh-ancestor
92181035|NCT00195403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181037|NCT00195403|Analgesics|analgesics|mesh-ancestor
92181038|NCT00195403|Sensory System Agents|sensory system agents|mesh-ancestor
92181039|NCT00195403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181040|NCT00195403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181041|NCT00195403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181042|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181043|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181044|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181045|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
92181046|NCT04643327|Levetiracetam|levetiracetam|mesh-list
92181047|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
92181048|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
92181049|NCT00095875|Carboplatin|carboplatin|mesh-list
92181050|NCT00095875|Docetaxel|docetaxel|mesh-list
92181051|NCT00095875|Fluorouracil|fluorouracil|mesh-list
92181052|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181053|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181054|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181055|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92181056|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181057|NCT00095875|Antimetabolites|antimetabolites|mesh-ancestor
92181058|NCT00095875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181059|NCT00095875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181060|NCT00095875|Immunologic Factors|immunologic factors|mesh-ancestor
92181061|NCT00095875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181062|NCT03086993|Gemcitabine|gemcitabine|mesh-list
92181063|NCT03086993|Melphalan|melphalan|mesh-list
92181064|NCT03086993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181065|NCT03086993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181066|NCT03086993|Antimetabolites|antimetabolites|mesh-ancestor
92181067|NCT03086993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181068|NCT03086993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181069|NCT03086993|Alkylating Agents|alkylating agents|mesh-ancestor
92181070|NCT03086993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92181071|NCT03086993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181072|NCT03086993|Immunologic Factors|immunologic factors|mesh-ancestor
92181073|NCT03086993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181074|NCT03704363|Infliximab|infliximab|mesh-list
92181075|NCT03704363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92181076|NCT03704363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181077|NCT03704363|Dermatologic Agents|dermatologic agents|mesh-ancestor
92181078|NCT03704363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181079|NCT03704363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181080|NCT04089072|Phenylephrine|phenylephrine|mesh-list
92181082|NCT04089072|Methylene Blue|methylene blue|mesh-list
92181083|NCT04089072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92181084|NCT04089072|Mydriatics|mydriatics|mesh-ancestor
92181085|NCT04089072|Autonomic Agents|autonomic agents|mesh-ancestor
92181086|NCT04089072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181087|NCT04089072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181088|NCT04089072|Sympathomimetics|sympathomimetics|mesh-ancestor
92181089|NCT04089072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92181090|NCT04089072|Nasal Decongestants|nasal decongestants|mesh-ancestor
92181091|NCT04089072|Respiratory System Agents|respiratory system agents|mesh-ancestor
92181092|NCT04089072|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92181093|NCT04089072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92181094|NCT04089072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92181095|NCT04089072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92181096|NCT04089072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181097|NCT04089072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181098|NCT04089072|Protective Agents|protective agents|mesh-ancestor
92181099|NCT04089072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181101|NCT00006227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92181102|NCT00006227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181103|NCT00006227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181104|NCT00006227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181105|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92181106|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181108|NCT00097669|Hematinics|hematinics|mesh-ancestor
92181109|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
92181110|NCT00097669|Vitamins|vitamins|mesh-ancestor
92181111|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
92181112|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181113|NCT05612880|Androgens|androgens|mesh-list
92181114|NCT05612880|Hormones|hormones|mesh-ancestor
92181115|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181116|NCT05612880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181117|NCT00010439|Alendronate|alendronate|mesh-list
92181118|NCT00010439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92181119|NCT00010439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181120|NCT05468892|Trifluridine|trifluridine|mesh-list
92181121|NCT05468892|Panitumumab|panitumumab|mesh-list
92181122|NCT05468892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181123|NCT05468892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181124|NCT05468892|Antimetabolites|antimetabolites|mesh-ancestor
92181125|NCT05468892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181126|NCT05468892|Antiviral Agents|antiviral agents|mesh-ancestor
92181127|NCT05468892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181128|NCT00200161|Temozolomide|temozolomide|mesh-list
92181129|NCT00200161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181130|NCT00200161|Alkylating Agents|alkylating agents|mesh-ancestor
92181131|NCT00200161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181132|NCT00200161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181133|NCT00016913|Paclitaxel|paclitaxel|mesh-list
92181134|NCT00016913|Carboplatin|carboplatin|mesh-list
92181135|NCT00016913|Leuprolide|leuprolide|mesh-list
92181136|NCT00016913|Goserelin|goserelin|mesh-list
92181137|NCT00016913|Estramustine|estramustine|mesh-list
92181138|NCT00016913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92181139|NCT00016913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181140|NCT00016913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181141|NCT00016913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181142|NCT00016913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92181143|NCT00016913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181144|NCT00016913|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92181145|NCT00016913|Fertility Agents|fertility agents|mesh-ancestor
92181146|NCT00016913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92181147|NCT00016913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181148|NCT00016913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92181149|NCT00016913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181150|NCT00016913|Alkylating Agents|alkylating agents|mesh-ancestor
92181151|NCT00023309|Lamivudine|lamivudine|mesh-list
92181152|NCT00023309|Adefovir|adefovir|mesh-list
92181153|NCT00023309|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92181154|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92181155|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92181156|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181157|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181158|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
92181159|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181160|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92181161|NCT00023309|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92181162|NCT02233101|Tranexamic Acid|tranexamic acid|mesh-list
92181163|NCT02233101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92181164|NCT02233101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92181165|NCT02233101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181166|NCT02233101|Hemostatics|hemostatics|mesh-ancestor
92181167|NCT02233101|Coagulants|coagulants|mesh-ancestor
92181168|NCT00098059|Famciclovir|famciclovir|mesh-list
92181169|NCT00098059|Antiviral Agents|antiviral agents|mesh-ancestor
92181170|NCT00098059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181171|NCT00098059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92181172|NCT00098059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181173|NCT00098059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181174|NCT02440581|Alendronate|alendronate|mesh-list
92181175|NCT02440581|Teriparatide|teriparatide|mesh-list
92181176|NCT02440581|Cinacalcet|cinacalcet|mesh-list
92181177|NCT02440581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92181178|NCT02440581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181179|NCT02440581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92181180|NCT02440581|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92181181|NCT02440581|Hormone Antagonists|hormone antagonists|mesh-ancestor
92181182|NCT02440581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181183|NCT01359150|Tofacitinib|tofacitinib|mesh-list
92181184|NCT01359150|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92107224|NCT03343548|Analgesics|analgesics|mesh-ancestor
92107250|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
92181185|NCT01359150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181186|NCT01359150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107476|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92181187|NCT01359150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107645|NCT04869592|Vaccines|vaccines|mesh-list
92107780|NCT02238808|Estradiol|estradiol|mesh-list
92181188|NCT00098371|Alvocidib|alvocidib|mesh-list
92181189|NCT00098371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181190|NCT00098371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92181191|NCT00098371|Growth Substances|growth substances|mesh-ancestor
92108164|NCT01723384|Naltrexone|naltrexone|mesh-list
92108297|NCT03109158|Cetuximab|cetuximab|mesh-list
92108374|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
92181192|NCT00098371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181193|NCT00098371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108450|NCT03331302|Xenon|xenon|mesh-list
92181194|NCT00098371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108597|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
92108675|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
92108895|NCT01752712|Oxytocin|oxytocin|mesh-list
92108974|NCT04955236|Analgesics|analgesics|mesh-ancestor
92181195|NCT00098371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181196|NCT04745988|Leucovorin|leucovorin|mesh-list
92181197|NCT04745988|Docetaxel|docetaxel|mesh-list
92181198|NCT04745988|Pembrolizumab|pembrolizumab|mesh-list
92181199|NCT04745988|Fluorouracil|fluorouracil|mesh-list
92181200|NCT04745988|Oxaliplatin|oxaliplatin|mesh-list
92181201|NCT04745988|Lenvatinib|lenvatinib|mesh-list
92181202|NCT04745988|Levoleucovorin|levoleucovorin|mesh-list
92181203|NCT04745988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181204|NCT04745988|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181205|NCT04745988|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181206|NCT04745988|Mitosis Modulators|mitosis modulators|mesh-ancestor
92181207|NCT04745988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181208|NCT04745988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181209|NCT04745988|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92325632|NCT00000277|Mazindol|mazindol|mesh-list
92110025|NCT01804673|Fentanyl|fentanyl|mesh-list
92181210|NCT04745988|Antimetabolites|antimetabolites|mesh-ancestor
92181211|NCT04745988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92110242|NCT00704418|Analgesics|analgesics|mesh-ancestor
92110318|NCT02473302|Tocotrienols|tocotrienols|mesh-list
92181212|NCT04745988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181213|NCT04745988|Immunologic Factors|immunologic factors|mesh-ancestor
92110624|NCT02466984|Metoclopramide|metoclopramide|mesh-list
92110695|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92181214|NCT04745988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110771|NCT04630834|Antipyretics|antipyretics|mesh-ancestor
92110845|NCT04601584|Antibodies|antibodies|mesh-list
92110929|NCT04058470|Prednisone|prednisone|mesh-list
92181215|NCT04745988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181216|NCT04745988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181217|NCT04745988|Antidotes|antidotes|mesh-ancestor
92181218|NCT04745988|Protective Agents|protective agents|mesh-ancestor
92181219|NCT04745988|Vitamin B Complex|vitamin b complex|mesh-ancestor
92181220|NCT04745988|Vitamins|vitamins|mesh-ancestor
92181221|NCT04745988|Micronutrients|micronutrients|mesh-ancestor
92181222|NCT01647945|Tacrolimus|tacrolimus|mesh-list
92181223|NCT01647945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111240|NCT01777139|Ezogabine|ezogabine|mesh-list
92181224|NCT01647945|Immunologic Factors|immunologic factors|mesh-ancestor
92181225|NCT01647945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181226|NCT01647945|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92181227|NCT01647945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111466|NCT04127721|Methotrexate|methotrexate|mesh-list
92181228|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111767|NCT03004833|Nivolumab|nivolumab|mesh-list
92111848|NCT02974257|Vitamins|vitamins|mesh-ancestor
92181229|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
92181230|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92181231|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92181232|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
92112297|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
92112364|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92181233|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112439|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92181234|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181235|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181236|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
92112690|NCT02555787|Tacrolimus|tacrolimus|mesh-list
92181237|NCT04351191|Chloroquine|chloroquine|mesh-list
92181238|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
92112778|NCT05827081|Letrozole|letrozole|mesh-list
92181239|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92112915|NCT05824897|Vitamin D|vitamin d|mesh-list
92181240|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92112990|NCT05823363|Bupivacaine|bupivacaine|mesh-list
92113067|NCT05733546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113141|NCT05487859|Acarbose|acarbose|mesh-list
92113217|NCT05331664|Antimalarials|antimalarials|mesh-ancestor
92181241|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113373|NCT04911166|Atezolizumab|atezolizumab|mesh-list
92181242|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113534|NCT04620304|UB-421|ub-421|mesh-list
92113590|NCT04447027|Lenalidomide|lenalidomide|mesh-list
92113592|NCT04447027|Romidepsin|romidepsin|mesh-list
92113670|NCT04235608|Propofol|propofol|mesh-list
92113774|NCT03889756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113849|NCT03613181|Paclitaxel|paclitaxel|mesh-list
92181243|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181244|NCT04351191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181245|NCT04351191|Amebicides|amebicides|mesh-ancestor
92181246|NCT01469000|Pemetrexed|pemetrexed|mesh-list
92181247|NCT01469000|Gefitinib|gefitinib|mesh-list
92181248|NCT01469000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181249|NCT01469000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114379|NCT01729559|Heparin|heparin|mesh-list
92114613|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181250|NCT01469000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114845|NCT02162667|Trastuzumab|trastuzumab|mesh-list
92181251|NCT01469000|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92115215|NCT04776850|Rituximab|rituximab|mesh-list
92181252|NCT01469000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92181253|NCT01469000|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181254|NCT05557578|Gemcitabine|gemcitabine|mesh-list
92181255|NCT05557578|Oxaliplatin|oxaliplatin|mesh-list
92181256|NCT05557578|Tislelizumab|tislelizumab|mesh-list
92181257|NCT05557578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181258|NCT05557578|Antimetabolites|antimetabolites|mesh-ancestor
92116207|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
92116285|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116368|NCT02069704|Antidotes|antidotes|mesh-ancestor
92116439|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116531|NCT03288402|Caffeine|caffeine|mesh-list
92181259|NCT05557578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181260|NCT05557578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116675|NCT03286296|Antibodies|antibodies|mesh-list
92116821|NCT03475134|Analgesics|analgesics|mesh-ancestor
92181261|NCT05557578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181262|NCT00201877|Rituximab|rituximab|mesh-list
92117198|NCT03267654|Apatinib|apatinib|mesh-list
92117293|NCT02456454|Valproic Acid|valproic acid|mesh-list
92181263|NCT00201877|Bortezomib|bortezomib|mesh-list
92181264|NCT00201877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181265|NCT00201877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117876|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
92118031|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
92181267|NCT00201877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118220|NCT04773093|Lidocaine|lidocaine|mesh-list
92181268|NCT00201877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181269|NCT05399628|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92118405|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
92181270|NCT05399628|Respiratory System Agents|respiratory system agents|mesh-ancestor
92181271|NCT01490060|Dexamethasone|dexamethasone|mesh-list
92181272|NCT01490060|Dexamethasone acetate|dexamethasone acetate|mesh-list
92118853|NCT02028754|Laxatives|laxatives|mesh-ancestor
92119044|NCT03232554|Iron|iron|mesh-list
92181273|NCT01490060|Doxorubicin|doxorubicin|mesh-list
92181274|NCT01490060|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92181275|NCT01490060|Vincristine|vincristine|mesh-list
92119385|NCT00081939|Thalidomide|thalidomide|mesh-list
92181276|NCT01490060|Ifosfamide|ifosfamide|mesh-list
92181277|NCT01490060|Isophosphamide mustard|isophosphamide mustard|mesh-list
92181278|NCT01490060|Fosaprepitant|fosaprepitant|mesh-list
92181279|NCT01490060|Aprepitant|aprepitant|mesh-list
92181280|NCT01490060|BB 1101|bb 1101|mesh-list
92119905|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
92181281|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181282|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
92181283|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
92181284|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120359|NCT02450682|Warfarin|warfarin|mesh-list
92181285|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078540|NCT05267392|Durvalumab|durvalumab|mesh-list
92181286|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181287|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
92120723|NCT04637620|Sertraline|sertraline|mesh-list
92181288|NCT01490060|Hormones|hormones|mesh-ancestor
92117035|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
92348201|NCT01565694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120954|NCT02447094|Plasminogen|plasminogen|mesh-list
92121101|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121252|NCT02450058|Epirubicin|epirubicin|mesh-list
92121554|NCT01336530|Antacids|antacids|mesh-list
92129558|NCT05800587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92121636|NCT00105027|Hormones|hormones|mesh-ancestor
92348202|NCT01565694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181289|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121857|NCT05718544|Sufentanil|sufentanil|mesh-list
92348203|NCT01565694|Urological Agents|urological agents|mesh-ancestor
92122080|NCT05136976|Rituximab|rituximab|mesh-list
92181290|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122238|NCT00703326|Docetaxel|docetaxel|mesh-list
92181291|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122548|NCT04941898|BAX 855|bax 855|mesh-list
92181292|NCT01490060|Protease Inhibitors|protease inhibitors|mesh-ancestor
92181293|NCT01490060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348204|NCT01543152|Cyclophosphamide|cyclophosphamide|mesh-list
92122920|NCT00702546|Progestins|progestins|mesh-ancestor
92123008|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
92181294|NCT01490060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123221|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123296|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92181295|NCT01490060|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92123445|NCT01702961|Rituximab|rituximab|mesh-list
92123524|NCT02421042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123597|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92181296|NCT01490060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92181297|NCT01490060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92082105|NCT04012827|Apatinib|apatinib|mesh-list
92124072|NCT02458690|Dopamine|dopamine|mesh-list
92181298|NCT01490060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92124212|NCT02467504|Folic Acid|folic acid|mesh-list
92181299|NCT01490060|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124347|NCT02412150|Remifentanil|remifentanil|mesh-list
92124508|NCT02409186|Cisplatin|cisplatin|mesh-list
92181300|NCT01490060|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124767|NCT02407782|Ivermectin|ivermectin|mesh-list
92124967|NCT01582451|Insulin|insulin|mesh-list
92125264|NCT02603926|Pregnanolone|pregnanolone|mesh-list
92181301|NCT01490060|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125342|NCT02610868|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92181302|NCT01490060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181303|NCT01490060|Alkylating Agents|alkylating agents|mesh-ancestor
92125564|NCT02393586|Rifampin|rifampin|mesh-list
92125635|NCT02397330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181304|NCT01490060|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92125793|NCT02643862|Omalizumab|omalizumab|mesh-list
92126095|NCT03165240|Diuretics|diuretics|mesh-ancestor
92181305|NCT01490060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181306|NCT04090736|Azacitidine|azacitidine|mesh-list
92181307|NCT04090736|Pevonedistat|pevonedistat|mesh-list
92126634|NCT03293368|Hormones|hormones|mesh-ancestor
92126704|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126851|NCT02767804|Ensartinib|ensartinib|mesh-list
92126923|NCT01556165|Rasagiline|rasagiline|mesh-list
92181308|NCT04090736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181309|NCT04090736|Antimetabolites|antimetabolites|mesh-ancestor
92126996|NCT01537081|Appetite Depressants|appetite depressants|mesh-ancestor
92127066|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
92348205|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181310|NCT04090736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181311|NCT04090736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181312|NCT04090736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181313|NCT05557344|Acetaminophen|acetaminophen|mesh-list
92127335|NCT01534637|Aprepitant|aprepitant|mesh-list
92181314|NCT05557344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181315|NCT05557344|Analgesics|analgesics|mesh-ancestor
92181316|NCT05557344|Sensory System Agents|sensory system agents|mesh-ancestor
92181317|NCT05557344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348206|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
92181318|NCT05557344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181319|NCT05557344|Antipyretics|antipyretics|mesh-ancestor
92181320|NCT00101413|Sorafenib|sorafenib|mesh-list
92181321|NCT00101413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181322|NCT00101413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92127674|NCT01531673|Ivacaftor|ivacaftor|mesh-list
92181323|NCT00101413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181324|NCT00101413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181325|NCT01246869|Deoxyglucose|deoxyglucose|mesh-list
92181326|NCT01246869|Imidazole|imidazole|mesh-list
92181327|NCT01246869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127809|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
92127886|NCT00267111|Sensory System Agents|sensory system agents|mesh-ancestor
92181328|NCT01246869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181329|NCT01246869|Antimetabolites|antimetabolites|mesh-ancestor
92181330|NCT01246869|Antiviral Agents|antiviral agents|mesh-ancestor
92181331|NCT01246869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181332|NCT01452152|Clopidogrel|clopidogrel|mesh-list
92181333|NCT01452152|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92181334|NCT01452152|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92181335|NCT01452152|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92181336|NCT01452152|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92181337|NCT01452152|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92181339|NCT01452152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181340|NCT01452152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181341|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181342|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
92181343|NCT01451762|Promethazine|promethazine|mesh-list
92128171|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
92181344|NCT01451762|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92181345|NCT01451762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92181346|NCT01451762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181347|NCT01451762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181348|NCT01451762|Anesthetics, Local|anesthetics, local|mesh-ancestor
92181349|NCT01451762|Anesthetics|anesthetics|mesh-ancestor
92181350|NCT01451762|Sensory System Agents|sensory system agents|mesh-ancestor
92181351|NCT01451762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181352|NCT01451762|Antiemetics|antiemetics|mesh-ancestor
92181353|NCT01451762|Autonomic Agents|autonomic agents|mesh-ancestor
92181354|NCT01451762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181355|NCT01451762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92181356|NCT01451762|Histamine Antagonists|histamine antagonists|mesh-ancestor
92181357|NCT01451762|Histamine Agents|histamine agents|mesh-ancestor
92181358|NCT01451762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181359|NCT01451762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181360|NCT01451762|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92181361|NCT01451762|Antipruritics|antipruritics|mesh-ancestor
92128387|NCT03027973|Hemostatics|hemostatics|mesh-ancestor
92181362|NCT01451762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92181364|NCT01654107|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92181365|NCT01654107|Autonomic Agents|autonomic agents|mesh-ancestor
92128453|NCT02661594|Moxifloxacin|moxifloxacin|mesh-list
92181366|NCT01654107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181367|NCT01654107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181368|NCT01654107|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92181369|NCT01654107|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92181370|NCT01654107|Cholinergic Agents|cholinergic agents|mesh-ancestor
92181371|NCT01654107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181372|NCT01654107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181373|NCT03085680|Curcumin|curcumin|mesh-list
92181374|NCT03085680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181375|NCT03085680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181376|NCT03085680|Analgesics|analgesics|mesh-ancestor
92181377|NCT03085680|Sensory System Agents|sensory system agents|mesh-ancestor
92181378|NCT03085680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181379|NCT03085680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181380|NCT03085680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181381|NCT03085680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128740|NCT02385474|Fluorides|fluorides|mesh-list
92181382|NCT03085680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181383|NCT03085680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348207|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181384|NCT03085680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181385|NCT01468844|Minocycline|minocycline|mesh-list
92181386|NCT01468844|Bevacizumab|bevacizumab|mesh-list
92181387|NCT01468844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181388|NCT01468844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128889|NCT00330915|Pemetrexed|pemetrexed|mesh-list
92181389|NCT01468844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92128957|NCT00332163|Irinotecan|irinotecan|mesh-list
92181390|NCT01468844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129108|NCT01498679|Xhance|xhance|mesh-list
92181391|NCT01468844|Growth Substances|growth substances|mesh-ancestor
92181392|NCT01468844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181393|NCT01468844|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129249|NCT00345033|Dopamine Agents|dopamine agents|mesh-ancestor
92181394|NCT01468844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181395|NCT01468844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181396|NCT03029598|Carboplatin|carboplatin|mesh-list
92181397|NCT03029598|Pembrolizumab|pembrolizumab|mesh-list
92129473|NCT01498289|Antidotes|antidotes|mesh-ancestor
92181398|NCT03029598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181399|NCT03029598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181400|NCT03029598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92348208|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181401|NCT03029598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181402|NCT01451606|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92129796|NCT05796167|Serotonin Agents|serotonin agents|mesh-ancestor
92181403|NCT01451606|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92181404|NCT01451606|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92181405|NCT01451606|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92181406|NCT01451606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181407|NCT01451606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181408|NCT01451606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181410|NCT01451606|Sensory System Agents|sensory system agents|mesh-ancestor
92181411|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181412|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
92181413|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92181414|NCT01451606|Dopamine Agents|dopamine agents|mesh-ancestor
92181415|NCT00204373|Lansoprazole|lansoprazole|mesh-list
92181416|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
92181417|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92181418|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181419|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92181420|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181421|NCT00204373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181422|NCT01655043|Regadenoson|regadenoson|mesh-list
92181423|NCT01655043|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92181424|NCT01655043|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92181425|NCT01655043|Purinergic Agonists|purinergic agonists|mesh-ancestor
92181426|NCT01655043|Purinergic Agents|purinergic agents|mesh-ancestor
92181427|NCT01655043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181428|NCT01655043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181429|NCT01655043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181430|NCT00473343|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92181431|NCT00473343|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92181432|NCT00473343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92181433|NCT00473343|Dermatologic Agents|dermatologic agents|mesh-ancestor
92181434|NCT00032591|Thrombin|thrombin|mesh-list
92181435|NCT00032591|Hemostatics|hemostatics|mesh-ancestor
92181436|NCT00032591|Coagulants|coagulants|mesh-ancestor
92181437|NCT01660191|Atorvastatin|atorvastatin|mesh-list
92181438|NCT01660191|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92181439|NCT01660191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92088384|NCT01149850|Bevacizumab|bevacizumab|mesh-list
92181440|NCT01660191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92181441|NCT01660191|Antimetabolites|antimetabolites|mesh-ancestor
92181442|NCT01660191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181443|NCT01660191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92181444|NCT01660191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92181445|NCT01660191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130274|NCT04411654|Hormones|hormones|mesh-ancestor
92181446|NCT00033917|Indomethacin|indomethacin|mesh-list
92181447|NCT00033917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181448|NCT00033917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181449|NCT00033917|Analgesics|analgesics|mesh-ancestor
92181450|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
92130429|NCT03859427|Dexamethasone|dexamethasone|mesh-list
92181451|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130501|NCT03326947|Docetaxel|docetaxel|mesh-list
92181452|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181453|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181455|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
92181456|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
92130577|NCT02927249|Antipyretics|antipyretics|mesh-ancestor
92181457|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92181458|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92181459|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181460|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181461|NCT00036569|Interferons|interferons|mesh-list
92181462|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
92181463|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181464|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
92181465|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181466|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
92181467|NCT00036569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181468|NCT01660893|Phenylephrine|phenylephrine|mesh-list
92181469|NCT01660893|Oxymetazoline|oxymetazoline|mesh-list
92181470|NCT01660893|Tetracaine|tetracaine|mesh-list
92181471|NCT01660893|Anesthetics, Local|anesthetics, local|mesh-ancestor
92181472|NCT01660893|Anesthetics|anesthetics|mesh-ancestor
92181473|NCT01660893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181474|NCT01660893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181475|NCT01660893|Sensory System Agents|sensory system agents|mesh-ancestor
92181476|NCT01660893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131172|NCT02985697|Midazolam|midazolam|mesh-list
92181477|NCT01660893|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92181478|NCT01660893|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92181479|NCT01660893|Adrenergic Agents|adrenergic agents|mesh-ancestor
92181480|NCT01660893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181481|NCT01660893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181482|NCT01660893|Sympathomimetics|sympathomimetics|mesh-ancestor
92181483|NCT01660893|Autonomic Agents|autonomic agents|mesh-ancestor
92181484|NCT01660893|Nasal Decongestants|nasal decongestants|mesh-ancestor
92181485|NCT01660893|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92326028|NCT00000847|polysaccharide-K|polysaccharide-k|mesh-list
92181486|NCT01660893|Respiratory System Agents|respiratory system agents|mesh-ancestor
92181489|NCT01660893|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92181490|NCT01660893|Protective Agents|protective agents|mesh-ancestor
92181491|NCT01661283|Bevacizumab|bevacizumab|mesh-list
92181492|NCT01661283|Everolimus|everolimus|mesh-list
92181493|NCT01661283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181494|NCT01661283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181495|NCT01661283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92181496|NCT01661283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92181497|NCT01661283|Growth Substances|growth substances|mesh-ancestor
92181498|NCT01661283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181499|NCT01661283|Growth Inhibitors|growth inhibitors|mesh-ancestor
92181500|NCT01661283|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92181501|NCT01661283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181502|NCT01661283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181503|NCT01661283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181504|NCT01661283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181505|NCT01661283|Immunologic Factors|immunologic factors|mesh-ancestor
92181506|NCT01946373|Cyclophosphamide|cyclophosphamide|mesh-list
92181507|NCT01946373|Fludarabine|fludarabine|mesh-list
92181508|NCT01946373|Fludarabine phosphate|fludarabine phosphate|mesh-list
92181509|NCT01946373|Interleukin-2|interleukin-2|mesh-list
92181510|NCT01946373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181511|NCT01946373|Immunologic Factors|immunologic factors|mesh-ancestor
92181512|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181513|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181514|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181515|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
92131739|NCT02347878|Aprepitant|aprepitant|mesh-list
92181516|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181517|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181518|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92181519|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181520|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
92181521|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181523|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
92181524|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181525|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92181526|NCT01662297|Trazodone|trazodone|mesh-list
92181527|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
92181528|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92181529|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92181530|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92181531|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181532|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181533|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92181534|NCT01662297|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92181535|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92181536|NCT01662297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92181537|NCT01662297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181538|NCT01662297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181539|NCT01662297|Serotonin Agents|serotonin agents|mesh-ancestor
92181540|NCT01662297|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92181541|NCT01600287|Propofol|propofol|mesh-list
92181542|NCT01600287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92181543|NCT01600287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131886|NCT00323739|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92181544|NCT01600287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181545|NCT01600287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92181546|NCT01600287|Anesthetics, General|anesthetics, general|mesh-ancestor
92181547|NCT01600287|Anesthetics|anesthetics|mesh-ancestor
92181548|NCT00040937|Thalidomide|thalidomide|mesh-list
92181550|NCT00040937|Prednisone|prednisone|mesh-list
92181551|NCT00040937|Cyclophosphamide|cyclophosphamide|mesh-list
92181552|NCT00040937|Melphalan|melphalan|mesh-list
92181553|NCT00040937|Sargramostim|sargramostim|mesh-list
92132010|NCT03148704|Palonosetron|palonosetron|mesh-list
92181554|NCT00040937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181555|NCT00040937|Immunologic Factors|immunologic factors|mesh-ancestor
92181556|NCT00040937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132154|NCT00396201|Plerixafor|plerixafor|mesh-list
92181557|NCT00040937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181558|NCT00040937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181559|NCT00040937|Alkylating Agents|alkylating agents|mesh-ancestor
92181560|NCT00040937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181561|NCT00040937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181562|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92181563|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181564|NCT00040937|Antiemetics|antiemetics|mesh-ancestor
92181565|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
92181566|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181567|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181568|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
92181569|NCT00040937|Hormones|hormones|mesh-ancestor
92181570|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181571|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92181572|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
92181573|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181574|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132598|NCT02330406|Anagliptin|anagliptin|mesh-list
92181575|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92181576|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92181577|NCT00040937|Growth Substances|growth substances|mesh-ancestor
92181578|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
92181579|NCT04756895|Vancomycin|vancomycin|mesh-list
92181580|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181581|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181582|NCT02234115|Leuprolide|leuprolide|mesh-list
92181583|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92181584|NCT02234115|Fertility Agents|fertility agents|mesh-ancestor
92181585|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92181586|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181587|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92181588|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181589|NCT02234427|Aspirin|aspirin|mesh-list
92181590|NCT02234427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181591|NCT02234427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181592|NCT02234427|Analgesics|analgesics|mesh-ancestor
92181593|NCT02234427|Sensory System Agents|sensory system agents|mesh-ancestor
92181594|NCT02234427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181595|NCT02234427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181596|NCT02234427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181597|NCT02234427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181598|NCT02234427|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92181599|NCT02234427|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92181600|NCT02234427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181601|NCT02234427|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92181602|NCT02234427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92181603|NCT02234427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181604|NCT02234427|Antipyretics|antipyretics|mesh-ancestor
92181605|NCT00041717|4-Aminopyridine|4-aminopyridine|mesh-list
92181606|NCT00041717|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92181607|NCT00041717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92181608|NCT00041717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181609|NCT01663935|Levodopa|levodopa|mesh-list
92181610|NCT01663935|Carbidopa|carbidopa|mesh-list
92181611|NCT01663935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92181612|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92181613|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
92181614|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326222|NCT03015896|Nivolumab|nivolumab|mesh-list
92181615|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181616|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181617|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92181618|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181620|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181621|NCT01664559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181622|NCT01664559|Analgesics|analgesics|mesh-ancestor
92181623|NCT01664559|Sensory System Agents|sensory system agents|mesh-ancestor
92181624|NCT01664559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181625|NCT01664559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181626|NCT01664559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181627|NCT01664559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181628|NCT01664559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92133252|NCT00420771|Gabapentin|gabapentin|mesh-list
92181629|NCT01664559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181630|NCT01664559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181631|NCT00046475|Midodrine|midodrine|mesh-list
92181632|NCT00046475|Sympathomimetics|sympathomimetics|mesh-ancestor
92181633|NCT00046475|Autonomic Agents|autonomic agents|mesh-ancestor
92181634|NCT00046475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181635|NCT00046475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181636|NCT00046475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92181637|NCT00046475|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92181638|NCT00046475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92181639|NCT00046475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92181640|NCT00046475|Adrenergic Agents|adrenergic agents|mesh-ancestor
92181641|NCT00046475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181642|NCT00046475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181643|NCT01894685|Mesalamine|mesalamine|mesh-list
92181644|NCT01894685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181645|NCT01894685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181647|NCT01894685|Sensory System Agents|sensory system agents|mesh-ancestor
92133353|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92181648|NCT01894685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181649|NCT01894685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181650|NCT01894685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181651|NCT01894685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181652|NCT01695291|Minocycline|minocycline|mesh-list
92181653|NCT01695291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181654|NCT01695291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181655|NCT00048737|Cyclophosphamide|cyclophosphamide|mesh-list
92181656|NCT00048737|Rituximab|rituximab|mesh-list
92181657|NCT00048737|Fludarabine|fludarabine|mesh-list
92181658|NCT00048737|Fludarabine phosphate|fludarabine phosphate|mesh-list
92181659|NCT00048737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181660|NCT00048737|Immunologic Factors|immunologic factors|mesh-ancestor
92181661|NCT00048737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181662|NCT00048737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181663|NCT00048737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181664|NCT00048737|Alkylating Agents|alkylating agents|mesh-ancestor
92327630|NCT00381199|Sensory System Agents|sensory system agents|mesh-ancestor
92181665|NCT00048737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181666|NCT00048737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181667|NCT00048737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92133629|NCT01477853|Metformin|metformin|mesh-list
92181668|NCT00048737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181669|NCT00048737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92133697|NCT00442611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181671|NCT01604109|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
92181672|NCT01604109|Caseins|caseins|mesh-list
92181673|NCT01604109|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92181674|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
92181675|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181676|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181677|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181678|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
92181679|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
92181680|NCT01666197|Diclofenac|diclofenac|mesh-list
92181681|NCT01666197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181682|NCT01666197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181683|NCT01666197|Analgesics|analgesics|mesh-ancestor
92133839|NCT01484275|Siltuximab|siltuximab|mesh-list
92181684|NCT01666197|Sensory System Agents|sensory system agents|mesh-ancestor
92181685|NCT01666197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181686|NCT01666197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133910|NCT04650217|Levodopa|levodopa|mesh-list
92181687|NCT01666197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181688|NCT01666197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181689|NCT01666197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92181690|NCT01666197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181691|NCT01666197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133978|NCT01470989|Glucocorticoids|glucocorticoids|mesh-ancestor
92181692|NCT01697709|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92181693|NCT01697709|Antidepressive Agents|antidepressive agents|mesh-ancestor
92181694|NCT01697709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92181695|NCT01697709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92181696|NCT01697709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92181697|NCT01697709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181698|NCT01697709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181699|NCT00048815|Citalopram|citalopram|mesh-list
92181700|NCT00048815|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92134212|NCT00531843|PENTA|penta|mesh-list
92181701|NCT00048815|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92181702|NCT00048815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92181703|NCT00048815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181704|NCT00048815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92181705|NCT00048815|Serotonin Agents|serotonin agents|mesh-ancestor
92181706|NCT00048815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181707|NCT00048815|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92181708|NCT00048815|Antidepressive Agents|antidepressive agents|mesh-ancestor
92181710|NCT01605903|Acetaminophen|acetaminophen|mesh-list
92181711|NCT01605903|Ibuprofen|ibuprofen|mesh-list
92181712|NCT01605903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92181714|NCT01605903|Sensory System Agents|sensory system agents|mesh-ancestor
92181715|NCT01605903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181716|NCT01605903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181717|NCT01605903|Antipyretics|antipyretics|mesh-ancestor
92181718|NCT01605903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92181719|NCT01605903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181720|NCT01605903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181721|NCT01605903|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92181722|NCT01605903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181723|NCT01605903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181724|NCT00048893|Metronidazole|metronidazole|mesh-list
92181725|NCT00048893|Paclitaxel|paclitaxel|mesh-list
92181726|NCT00048893|Cyclophosphamide|cyclophosphamide|mesh-list
92181727|NCT00048893|Doxorubicin|doxorubicin|mesh-list
92181728|NCT00048893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92181729|NCT00048893|Fludarabine|fludarabine|mesh-list
92181730|NCT00048893|Fludarabine phosphate|fludarabine phosphate|mesh-list
92181731|NCT00048893|Vaccines|vaccines|mesh-list
92181732|NCT00048893|Sargramostim|sargramostim|mesh-list
92181733|NCT00048893|Immunologic Factors|immunologic factors|mesh-ancestor
92134788|NCT01463111|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92181734|NCT00048893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181735|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92181736|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181737|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181738|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181739|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
92181740|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326379|NCT00000991|Zidovudine|zidovudine|mesh-list
92181741|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181742|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135002|NCT01472965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92181743|NCT00048893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181744|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
92181745|NCT00048893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92135080|NCT00553839|Anesthetics, General|anesthetics, general|mesh-ancestor
92181746|NCT00048893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92181747|NCT00048893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92181748|NCT00048893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92181749|NCT00048893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181750|NCT00048893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181751|NCT00048893|Antimetabolites|antimetabolites|mesh-ancestor
92181752|NCT00048893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181753|NCT00048893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181754|NCT00048893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92181755|NCT00048893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92181756|NCT01607853|Calcitriol|calcitriol|mesh-list
92181757|NCT01607853|Betamethasone|betamethasone|mesh-list
92181758|NCT01607853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181759|NCT01607853|Glucocorticoids|glucocorticoids|mesh-ancestor
92181760|NCT01607853|Hormones|hormones|mesh-ancestor
92181761|NCT01607853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181762|NCT01607853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181763|NCT01607853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92181764|NCT01607853|Respiratory System Agents|respiratory system agents|mesh-ancestor
92181765|NCT01607853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92181766|NCT01607853|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92135426|NCT01687478|Olanzapine|olanzapine|mesh-list
92181767|NCT01607853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135498|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
92181768|NCT01607853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181769|NCT01607853|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92181770|NCT01607853|Vitamins|vitamins|mesh-ancestor
92135575|NCT01559012|Clonidine|clonidine|mesh-list
92181771|NCT01607853|Micronutrients|micronutrients|mesh-ancestor
92181772|NCT01607853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92181773|NCT03089723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92181774|NCT01700517|Anesthetics|anesthetics|mesh-list
92181775|NCT01700517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92326423|NCT00002972|Paclitaxel|paclitaxel|mesh-list
92135721|NCT01451515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92135818|NCT01556438|Bortezomib|bortezomib|mesh-list
92181776|NCT01700517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181777|NCT00101647|Dasatinib|dasatinib|mesh-list
92181778|NCT00101647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181779|NCT00101647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181780|NCT00101647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181781|NCT00101647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181782|NCT01669785|Listerine|listerine|mesh-list
92181783|NCT01669785|Fluorides|fluorides|mesh-list
92181784|NCT01669785|Sodium Fluoride|sodium fluoride|mesh-list
92181785|NCT01669785|Cariostatic Agents|cariostatic agents|mesh-ancestor
92181786|NCT01669785|Protective Agents|protective agents|mesh-ancestor
92181787|NCT01669785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181788|NCT01669785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92181789|NCT01669785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181791|NCT05327491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92348209|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181792|NCT05327491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181793|NCT05327491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181794|NCT05327491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181795|NCT03089645|Docetaxel|docetaxel|mesh-list
92181796|NCT03089645|Durvalumab|durvalumab|mesh-list
92181797|NCT03089645|Tremelimumab|tremelimumab|mesh-list
92181798|NCT03089645|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92181799|NCT03089645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181800|NCT03089645|Tubulin Modulators|tubulin modulators|mesh-ancestor
92181801|NCT03089645|Antimitotic Agents|antimitotic agents|mesh-ancestor
92181802|NCT03089645|Mitosis Modulators|mitosis modulators|mesh-ancestor
92348210|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
92136446|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92181803|NCT03089645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136519|NCT00564681|Cholinergic Agents|cholinergic agents|mesh-ancestor
92136595|NCT01448057|Antipyretics|antipyretics|mesh-ancestor
92181804|NCT03089645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92181805|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
92181806|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181807|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
92181808|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136750|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
92181809|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181810|NCT02587962|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92181811|NCT02587962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181812|NCT01931033|Oxytocin|oxytocin|mesh-list
92181813|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
92181814|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92181815|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181816|NCT01671423|Prednisone|prednisone|mesh-list
92181817|NCT01671423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181818|NCT01671423|Glucocorticoids|glucocorticoids|mesh-ancestor
92181819|NCT01671423|Hormones|hormones|mesh-ancestor
92181820|NCT01671423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181821|NCT01671423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181822|NCT01671423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92181823|NCT01671423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181824|NCT02092181|Mirabegron|mirabegron|mesh-list
92181825|NCT02092181|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92181826|NCT02092181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92181827|NCT02092181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92181828|NCT02092181|Adrenergic Agents|adrenergic agents|mesh-ancestor
92137253|NCT00614445|Vitamins|vitamins|mesh-ancestor
92181829|NCT02092181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137337|NCT01441973|Elotuzumab|elotuzumab|mesh-list
92137408|NCT00623181|Vaccines|vaccines|mesh-list
92181830|NCT02092181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181831|NCT02092181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181832|NCT02092181|Urological Agents|urological agents|mesh-ancestor
92181833|NCT01672827|Flutemetamol|flutemetamol|mesh-list
92181834|NCT01672827|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92181835|NCT01672827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181836|NCT01700907|Sevoflurane|sevoflurane|mesh-list
92181837|NCT01700907|Desflurane|desflurane|mesh-list
92137842|NCT00674739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181838|NCT01700907|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92137917|NCT04120961|Hirudins|hirudins|mesh-list
92137995|NCT00678015|Masoprocol|masoprocol|mesh-list
92181839|NCT01700907|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92181840|NCT01700907|Anesthetics, General|anesthetics, general|mesh-ancestor
92181841|NCT01700907|Anesthetics|anesthetics|mesh-ancestor
92181842|NCT01700907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939340|NCT02276560|Pemetrexed|pemetrexed|mesh-list
92181843|NCT01700907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181844|NCT03089567|Listerine|listerine|mesh-list
92138441|NCT01414855|Prednisone|prednisone|mesh-list
92181845|NCT03089567|Fluorides|fluorides|mesh-list
92181846|NCT03089567|Sodium Fluoride|sodium fluoride|mesh-list
92181847|NCT03089567|Cariostatic Agents|cariostatic agents|mesh-ancestor
92181848|NCT03089567|Protective Agents|protective agents|mesh-ancestor
92138588|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
92181849|NCT03089567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181850|NCT03089567|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92138660|NCT04497155|Norepinephrine|norepinephrine|mesh-list
92138733|NCT01413503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92181851|NCT03089567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181853|NCT03431987|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92181854|NCT03431987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181855|NCT03431987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181856|NCT03431987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181857|NCT01612221|Acetylcysteine|acetylcysteine|mesh-list
92139032|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
92181858|NCT01612221|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92181859|NCT01612221|Antiviral Agents|antiviral agents|mesh-ancestor
92181860|NCT01612221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181861|NCT01612221|Expectorants|expectorants|mesh-ancestor
92139342|NCT01525628|Anesthetics|anesthetics|mesh-ancestor
92139415|NCT01426009|Parasympatholytics|parasympatholytics|mesh-ancestor
92139486|NCT01404325|Everolimus|everolimus|mesh-list
92181862|NCT01612221|Respiratory System Agents|respiratory system agents|mesh-ancestor
92181863|NCT01612221|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92181864|NCT01612221|Antioxidants|antioxidants|mesh-ancestor
92139797|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
92139868|NCT05086848|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92117036|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117037|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92181865|NCT01612221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140263|NCT01270035|Adalimumab|adalimumab|mesh-list
92181866|NCT01612221|Protective Agents|protective agents|mesh-ancestor
92140335|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
92181867|NCT01612221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181868|NCT01612221|Antidotes|antidotes|mesh-ancestor
92181869|NCT00105001|Mycophenolic Acid|mycophenolic acid|mesh-list
92181871|NCT00105001|Fludarabine|fludarabine|mesh-list
92140641|NCT02998905|Antipyretics|antipyretics|mesh-ancestor
92181872|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
92181873|NCT00105001|Tacrolimus|tacrolimus|mesh-list
92181874|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140792|NCT05364385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92181875|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181876|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
92181877|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141178|NCT01272609|Timolol|timolol|mesh-list
92141248|NCT01278459|Atorvastatin|atorvastatin|mesh-list
92141325|NCT04044131|Sorbitol|sorbitol|mesh-list
92141463|NCT01677858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181878|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181879|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
92181880|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181881|NCT00105001|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92181882|NCT00105001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181883|NCT00105001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92181884|NCT00105001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92181885|NCT00105001|Antitubercular Agents|antitubercular agents|mesh-ancestor
92181886|NCT00105001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181887|NCT00105001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181888|NCT00105001|Antifungal Agents|antifungal agents|mesh-ancestor
92181889|NCT02642640|Melatonin|melatonin|mesh-list
92181890|NCT02642640|Antioxidants|antioxidants|mesh-ancestor
92181891|NCT02642640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181892|NCT02642640|Protective Agents|protective agents|mesh-ancestor
92181893|NCT02642640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181894|NCT02642640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181895|NCT01701375|Palbociclib|palbociclib|mesh-list
92181896|NCT01701375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181897|NCT01701375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92181898|NCT01701375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181899|NCT01701375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181900|NCT05556408|Propofol|propofol|mesh-list
92143133|NCT04765267|Astringents|astringents|mesh-ancestor
92143285|NCT04518306|Diuretics|diuretics|mesh-ancestor
92143353|NCT05701813|Inositol|inositol|mesh-list
92181901|NCT05556408|Succinylcholine|succinylcholine|mesh-list
92181902|NCT05556408|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92181903|NCT05556408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92181904|NCT05556408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181906|NCT05556408|Anesthetics, General|anesthetics, general|mesh-ancestor
92181907|NCT05556408|Anesthetics|anesthetics|mesh-ancestor
92181908|NCT05556408|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92181909|NCT05556408|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92181910|NCT05556408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92144263|NCT01674283|Hormones|hormones|mesh-ancestor
92181911|NCT05556408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181912|NCT00054353|Cyclosporine|cyclosporine|mesh-list
92181913|NCT00054353|Mycophenolic Acid|mycophenolic acid|mesh-list
92181914|NCT00054353|Fludarabine|fludarabine|mesh-list
92181915|NCT00054353|Fludarabine phosphate|fludarabine phosphate|mesh-list
92181916|NCT00054353|Melphalan|melphalan|mesh-list
92144722|NCT02651220|Analgesics|analgesics|mesh-ancestor
92144806|NCT03628339|Tepotinib|tepotinib|mesh-list
92144874|NCT01274247|Benzocaine|benzocaine|mesh-list
92181917|NCT00054353|Cyclosporins|cyclosporins|mesh-list
92181918|NCT00054353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181919|NCT00054353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145095|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
92145576|NCT03802071|Durvalumab|durvalumab|mesh-list
92145628|NCT04412850|Analgesics|analgesics|mesh-ancestor
92145702|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
92181920|NCT00054353|Antimetabolites|antimetabolites|mesh-ancestor
92145929|NCT00089479|Capecitabine|capecitabine|mesh-list
92117116|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117117|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92181921|NCT00054353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181922|NCT00054353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181923|NCT00054353|Immunologic Factors|immunologic factors|mesh-ancestor
92181924|NCT00054353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181925|NCT00054353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146684|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
92181926|NCT00054353|Antifungal Agents|antifungal agents|mesh-ancestor
92181927|NCT00054353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146833|NCT03445728|Vitamins|vitamins|mesh-ancestor
92181928|NCT00054353|Dermatologic Agents|dermatologic agents|mesh-ancestor
92181929|NCT00054353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181930|NCT00054353|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92181931|NCT00054353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92117118|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92117119|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147437|NCT01421303|Etanercept|etanercept|mesh-list
92181932|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92147659|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92147732|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92147812|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
92147932|NCT04278859|Antibodies|antibodies|mesh-list
92148133|NCT03379051|Lenalidomide|lenalidomide|mesh-list
92181933|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
91939582|NCT02273752|Everolimus|everolimus|mesh-list
92148596|NCT02154477|Insulin|insulin|mesh-list
92148664|NCT02155257|Gabapentin|gabapentin|mesh-list
92148744|NCT05246371|Propofol|propofol|mesh-list
92148895|NCT03858465|Sympathomimetics|sympathomimetics|mesh-ancestor
92181934|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181935|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92149572|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149648|NCT03212781|Trace Elements|trace elements|mesh-ancestor
92149873|NCT05310591|Nivolumab|nivolumab|mesh-list
92181937|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92150031|NCT01494506|Leucovorin|leucovorin|mesh-list
92181938|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
92181939|NCT00208975|Rituximab|rituximab|mesh-list
92181940|NCT00208975|Fludarabine|fludarabine|mesh-list
92181941|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
92181942|NCT00208975|Sargramostim|sargramostim|mesh-list
92150795|NCT00795522|Histamine Agents|histamine agents|mesh-ancestor
92150865|NCT01720875|Dexamethasone|dexamethasone|mesh-list
92150945|NCT00653796|Atorvastatin|atorvastatin|mesh-list
92181943|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92181944|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
92151240|NCT00915603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151319|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92181945|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181946|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92181947|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92181948|NCT00208975|Alkylating Agents|alkylating agents|mesh-ancestor
92181949|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152237|NCT05040906|Rituximab|rituximab|mesh-list
92152303|NCT03598673|Nebivolol|nebivolol|mesh-list
92152542|NCT03406689|Nepafenac|nepafenac|mesh-list
92181950|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181951|NCT00208975|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92152760|NCT00919035|Temsirolimus|temsirolimus|mesh-list
92152831|NCT04196621|Lubricant Eye Drops|lubricant eye drops|mesh-list
92152910|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153294|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
92181952|NCT00208975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153558|NCT05000892|Paclitaxel|paclitaxel|mesh-list
92181953|NCT00208975|Analgesics|analgesics|mesh-ancestor
92181954|NCT00208975|Sensory System Agents|sensory system agents|mesh-ancestor
92153689|NCT02243241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92181955|NCT00208975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92181956|NCT00208975|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92181957|NCT00208975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92154072|NCT04912596|Miotics|miotics|mesh-ancestor
92181958|NCT00208975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181960|NCT01702233|Dexamethasone acetate|dexamethasone acetate|mesh-list
92181961|NCT01702233|BB 1101|bb 1101|mesh-list
92181962|NCT01702233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92181963|NCT01702233|Antiemetics|antiemetics|mesh-ancestor
92181964|NCT01702233|Autonomic Agents|autonomic agents|mesh-ancestor
92405717|NCT05465174|Nivolumab|nivolumab|mesh-list
92405863|NCT04922567|Prednisone|prednisone|mesh-list
92406024|NCT04332393|Metformin|metformin|mesh-list
92406391|NCT01438567|Oxycodone|oxycodone|mesh-list
92406619|NCT01440335|Fenoterol|fenoterol|mesh-list
92406773|NCT01441193|Vaccines|vaccines|mesh-list
92407000|NCT01442519|Alkylating Agents|alkylating agents|mesh-ancestor
92407155|NCT01443065|Vitamin B Complex|vitamin b complex|mesh-ancestor
92407233|NCT01443377|Panitumumab|panitumumab|mesh-list
92181965|NCT01702233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407464|NCT01444976|GABA Agents|gaba agents|mesh-ancestor
92407615|NCT01445860|Simvastatin|simvastatin|mesh-list
92181966|NCT01702233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407833|NCT01447069|Tocolytic Agents|tocolytic agents|mesh-ancestor
92407993|NCT01448291|NuvaRing|nuvaring|mesh-list
92408139|NCT01448837|Latanoprost|latanoprost|mesh-list
92181967|NCT01702233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92181968|NCT01702233|Glucocorticoids|glucocorticoids|mesh-ancestor
92181969|NCT01702233|Hormones|hormones|mesh-ancestor
92181970|NCT01702233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92181971|NCT01702233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92181972|NCT01702233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181973|NCT01702233|Protease Inhibitors|protease inhibitors|mesh-ancestor
92181974|NCT01702233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92181975|NCT01702233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181976|NCT01852890|Ascorbic Acid|ascorbic acid|mesh-list
92181977|NCT01852890|Gemcitabine|gemcitabine|mesh-list
92181978|NCT01852890|Vitamins|vitamins|mesh-ancestor
92181979|NCT01852890|Micronutrients|micronutrients|mesh-ancestor
92181980|NCT01852890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181981|NCT01852890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92181982|NCT01852890|Antimetabolites|antimetabolites|mesh-ancestor
92181983|NCT01852890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92181984|NCT01852890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92181985|NCT01852890|Antioxidants|antioxidants|mesh-ancestor
92181986|NCT01852890|Protective Agents|protective agents|mesh-ancestor
92181987|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
92181988|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92181989|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
92181990|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
92181991|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
92181992|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
92181993|NCT01757418|Antibodies|antibodies|mesh-list
92181994|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
92181995|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92181996|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92181997|NCT01757418|Immunologic Factors|immunologic factors|mesh-ancestor
92181998|NCT01757418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92181999|NCT00217399|Sorafenib|sorafenib|mesh-list
92182000|NCT00217399|Anastrozole|anastrozole|mesh-list
92182001|NCT00217399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182002|NCT00217399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92182003|NCT00217399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182004|NCT00217399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182005|NCT00217399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182006|NCT00217399|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92182007|NCT00217399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92182008|NCT00217399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92182009|NCT00217399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92326655|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92322337|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182010|NCT00217399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182011|NCT00217399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182013|NCT04739670|Atezolizumab|atezolizumab|mesh-list
92182014|NCT04739670|Carboplatin|carboplatin|mesh-list
92182015|NCT04739670|Gemcitabine|gemcitabine|mesh-list
92182016|NCT04739670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182017|NCT04739670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182018|NCT04739670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92182019|NCT04739670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92182020|NCT04739670|Growth Substances|growth substances|mesh-ancestor
92182021|NCT04739670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182022|NCT04739670|Growth Inhibitors|growth inhibitors|mesh-ancestor
92182023|NCT04739670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182024|NCT04739670|Antimetabolites|antimetabolites|mesh-ancestor
92182025|NCT04739670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182026|NCT04739670|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92182027|NCT05286619|Carboplatin|carboplatin|mesh-list
92182028|NCT05286619|Gemcitabine|gemcitabine|mesh-list
92182029|NCT05286619|Pembrolizumab|pembrolizumab|mesh-list
92182030|NCT05286619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182031|NCT05286619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182032|NCT05286619|Antimetabolites|antimetabolites|mesh-ancestor
92182033|NCT05286619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182034|NCT05286619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182035|NCT05286619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92182036|NCT04329624|Simendan|simendan|mesh-list
92182037|NCT04329624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92182038|NCT04329624|Vasodilator Agents|vasodilator agents|mesh-ancestor
92182039|NCT04329624|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92182040|NCT04329624|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92182041|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182042|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182043|NCT04329624|Protective Agents|protective agents|mesh-ancestor
92182044|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182045|NCT00559182|Omeprazole|omeprazole|mesh-list
92182046|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92182047|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182048|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92182049|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182050|NCT00559182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182051|NCT00218023|Naltrexone|naltrexone|mesh-list
92182052|NCT00218023|Levodopa|levodopa|mesh-list
92182053|NCT00218023|Carbidopa|carbidopa|mesh-list
92182054|NCT00218023|Modafinil|modafinil|mesh-list
92182055|NCT00218023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92182056|NCT00218023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92182057|NCT00218023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182058|NCT00218023|Sensory System Agents|sensory system agents|mesh-ancestor
92182059|NCT00218023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182060|NCT00218023|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92182061|NCT00218023|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92182062|NCT00218023|Dopamine Agents|dopamine agents|mesh-ancestor
92182063|NCT00218023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182064|NCT00218023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182065|NCT00218023|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92182066|NCT00218023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182067|NCT00218023|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92182068|NCT00218023|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92182069|NCT00218023|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92182070|NCT00218023|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92182071|NCT00054665|Prednisone|prednisone|mesh-list
92182072|NCT00054665|Cyclophosphamide|cyclophosphamide|mesh-list
92182073|NCT00054665|Doxorubicin|doxorubicin|mesh-list
92182074|NCT00054665|Etoposide|etoposide|mesh-list
92182075|NCT00054665|Vincristine|vincristine|mesh-list
92182076|NCT00054665|Bortezomib|bortezomib|mesh-list
92182077|NCT00054665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182078|NCT00054665|Immunologic Factors|immunologic factors|mesh-ancestor
92182079|NCT00054665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182080|NCT00054665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182081|NCT00054665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92182082|NCT00054665|Alkylating Agents|alkylating agents|mesh-ancestor
92182083|NCT00054665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182084|NCT00054665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182085|NCT00054665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92182086|NCT00054665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92182087|NCT00054665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92182088|NCT00054665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92182089|NCT00054665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182090|NCT00054665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182092|NCT00054665|Hormones|hormones|mesh-ancestor
92182093|NCT00054665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182094|NCT00054665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182095|NCT00054665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92182096|NCT00054665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92182097|NCT00054665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182098|NCT00054665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182099|NCT00476190|Cytarabine|cytarabine|mesh-list
92182100|NCT00476190|Dexamethasone|dexamethasone|mesh-list
92182101|NCT00476190|Hydrocortisone|hydrocortisone|mesh-list
92182102|NCT00476190|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92182103|NCT00476190|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92182104|NCT00476190|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92182105|NCT00476190|Cyclophosphamide|cyclophosphamide|mesh-list
92182106|NCT00476190|Doxorubicin|doxorubicin|mesh-list
92182107|NCT00476190|Methotrexate|methotrexate|mesh-list
92182108|NCT00476190|Etoposide|etoposide|mesh-list
92182109|NCT00476190|Vincristine|vincristine|mesh-list
92182110|NCT00476190|Asparaginase|asparaginase|mesh-list
92182111|NCT00476190|Pegaspargase|pegaspargase|mesh-list
92182112|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92326773|NCT00002347|Zidovudine|zidovudine|mesh-list
92182113|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
92182114|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182115|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182116|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92182117|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
92182118|NCT00476190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182119|NCT00476190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182120|NCT00476190|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92182121|NCT00476190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182122|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
92182123|NCT00476190|Autonomic Agents|autonomic agents|mesh-ancestor
92182124|NCT00476190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182125|NCT00476190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182126|NCT00476190|Glucocorticoids|glucocorticoids|mesh-ancestor
92182127|NCT00476190|Hormones|hormones|mesh-ancestor
92182128|NCT00476190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182129|NCT00476190|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182130|NCT00476190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92182131|NCT00476190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92182132|NCT00476190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92182133|NCT00476190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182134|NCT00476190|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92182135|NCT00476190|Abortifacient Agents|abortifacient agents|mesh-ancestor
92182136|NCT00476190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92182137|NCT00476190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182138|NCT00476190|Antimetabolites|antimetabolites|mesh-ancestor
92182139|NCT00476190|Dermatologic Agents|dermatologic agents|mesh-ancestor
92182140|NCT00476190|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92182141|NCT00476190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92182142|NCT00476190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92182143|NCT00476190|Antiviral Agents|antiviral agents|mesh-ancestor
92182144|NCT00476190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182145|NCT00476190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92182146|NCT00476190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182147|NCT00476190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182148|NCT00057551|Antidepressive Agents|antidepressive agents|mesh-list
92182149|NCT00057551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92182150|NCT05555316|Lenvatinib|lenvatinib|mesh-list
92182151|NCT05555316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182152|NCT05555316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92182153|NCT05555316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182154|NCT05555316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182155|NCT00218491|Acetylcysteine|acetylcysteine|mesh-list
92182156|NCT00218491|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92182157|NCT00218491|Antiviral Agents|antiviral agents|mesh-ancestor
92182158|NCT00218491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182159|NCT00218491|Expectorants|expectorants|mesh-ancestor
92182160|NCT00218491|Respiratory System Agents|respiratory system agents|mesh-ancestor
92182162|NCT00218491|Antioxidants|antioxidants|mesh-ancestor
92182163|NCT00218491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182164|NCT00218491|Protective Agents|protective agents|mesh-ancestor
92182165|NCT00218491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182166|NCT00218491|Antidotes|antidotes|mesh-ancestor
92182167|NCT05700864|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92182168|NCT05700864|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92182169|NCT00221299|Risedronic Acid|risedronic acid|mesh-list
92182170|NCT00221299|Hormones|hormones|mesh-list
92182171|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
92182172|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182173|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182174|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92182175|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182176|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182177|NCT00221299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92182178|NCT00221299|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92182180|NCT05554848|Dexmedetomidine|dexmedetomidine|mesh-list
92182181|NCT05554848|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92182182|NCT05554848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182183|NCT05554848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182184|NCT05554848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92182185|NCT05554848|Analgesics|analgesics|mesh-ancestor
92182186|NCT05554848|Sensory System Agents|sensory system agents|mesh-ancestor
92182187|NCT05554848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182188|NCT05554848|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92182189|NCT05554848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92182190|NCT05554848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92182191|NCT05554848|Adrenergic Agents|adrenergic agents|mesh-ancestor
92182192|NCT05554848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182193|NCT05554848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182194|NCT05554848|Anesthetics|anesthetics|mesh-ancestor
92182195|NCT05554848|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92182196|NCT05554848|Anticonvulsants|anticonvulsants|mesh-ancestor
92182197|NCT05554848|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92182198|NCT05554848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182199|NCT05554848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92182200|NCT05554848|Tocolytic Agents|tocolytic agents|mesh-ancestor
92326913|NCT00001381|Suramin|suramin|mesh-list
92182201|NCT05554848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92182202|NCT00057785|Fluorouracil|fluorouracil|mesh-list
92182203|NCT00057785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182204|NCT00057785|Antimetabolites|antimetabolites|mesh-ancestor
92182205|NCT00057785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182206|NCT00057785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182207|NCT00057785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182208|NCT00057785|Immunologic Factors|immunologic factors|mesh-ancestor
92182209|NCT00057785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182210|NCT05554224|Liver Extracts|liver extracts|mesh-list
92182211|NCT05554224|Hematinics|hematinics|mesh-ancestor
92182212|NCT05548998|Anesthetics|anesthetics|mesh-list
92182213|NCT05548998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182214|NCT05548998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182216|NCT01666782|Immunologic Factors|immunologic factors|mesh-ancestor
92182217|NCT01666782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182218|NCT00058019|Epothilones|epothilones|mesh-list
92182219|NCT00058019|Epothilone B|epothilone b|mesh-list
92182220|NCT00058019|Tubulin Modulators|tubulin modulators|mesh-ancestor
92182221|NCT00058019|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182222|NCT00058019|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182223|NCT00058019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182224|NCT00058019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182225|NCT01439360|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92182226|NCT01439360|Immunologic Factors|immunologic factors|mesh-ancestor
92182227|NCT01439360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182228|NCT00110461|Aripiprazole|aripiprazole|mesh-list
92182229|NCT00110461|Antidepressive Agents|antidepressive agents|mesh-ancestor
92182230|NCT00110461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92182231|NCT00110461|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92182232|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92182233|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182235|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
92182236|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
92182237|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326956|NCT00002041|Amphotericin B|amphotericin b|mesh-list
92182238|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182239|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92182240|NCT00110461|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92182242|NCT00110461|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92182243|NCT00110461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92182244|NCT00110461|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92182245|NCT00110461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92182246|NCT00061373|Aspirin|aspirin|mesh-list
92182247|NCT00061373|Tinzaparin|tinzaparin|mesh-list
92182248|NCT00061373|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92182249|NCT00061373|Dalteparin|dalteparin|mesh-list
92182250|NCT00061373|Eptifibatide|eptifibatide|mesh-list
92182251|NCT00061373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92182252|NCT00061373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92182253|NCT00061373|Analgesics|analgesics|mesh-ancestor
92182255|NCT00061373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182256|NCT00061373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182257|NCT00061373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182258|NCT00061373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182259|NCT00061373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92182260|NCT00061373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92182261|NCT00061373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182262|NCT00061373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92182263|NCT00061373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92182264|NCT00061373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182265|NCT00061373|Antipyretics|antipyretics|mesh-ancestor
92182266|NCT00061373|Anticoagulants|anticoagulants|mesh-ancestor
92182267|NCT01897337|Aprepitant|aprepitant|mesh-list
92182268|NCT01897337|Antiemetics|antiemetics|mesh-ancestor
92182269|NCT01897337|Autonomic Agents|autonomic agents|mesh-ancestor
92182270|NCT01897337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182271|NCT01897337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182272|NCT01897337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182273|NCT01897337|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92182274|NCT01897337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182275|NCT01897337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182276|NCT03089333|Dapagliflozin|dapagliflozin|mesh-list
92182277|NCT03089333|Glyburide|glyburide|mesh-list
92182278|NCT03089333|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92182279|NCT03089333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182280|NCT03089333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182281|NCT03089333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182282|NCT00112723|Alvocidib|alvocidib|mesh-list
92182283|NCT00112723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182284|NCT00112723|Growth Inhibitors|growth inhibitors|mesh-ancestor
92182285|NCT00112723|Growth Substances|growth substances|mesh-ancestor
92182286|NCT00112723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182287|NCT00112723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92182288|NCT00112723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182289|NCT00112723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182290|NCT04327206|Vaccines|vaccines|mesh-list
92182291|NCT04327206|BCG Vaccine|bcg vaccine|mesh-list
92182292|NCT04327206|Immunologic Factors|immunologic factors|mesh-ancestor
92182293|NCT04327206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182294|NCT04327206|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92182295|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92182296|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92182297|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182298|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182299|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92182300|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
92182301|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182302|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182303|NCT00115297|Montelukast|montelukast|mesh-list
92182304|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92182305|NCT00115297|Respiratory System Agents|respiratory system agents|mesh-ancestor
92182306|NCT00115297|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92182307|NCT00115297|Hormone Antagonists|hormone antagonists|mesh-ancestor
92182308|NCT00115297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182309|NCT00115297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182310|NCT00115297|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92182311|NCT00115297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92182312|NCT00115297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182314|NCT00116857|Antidepressive Agents|antidepressive agents|mesh-ancestor
92182315|NCT00116857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92182316|NCT00116857|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92182317|NCT00116857|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92182318|NCT00116857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182319|NCT00116857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182320|NCT00116857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182321|NCT00116857|Serotonin Agents|serotonin agents|mesh-ancestor
92182322|NCT00116857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327158|NCT00002437|Antiviral Agents|antiviral agents|mesh-ancestor
92182324|NCT05547828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182325|NCT05547828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182327|NCT01672983|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92182328|NCT01672983|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92182329|NCT01672983|Protease Inhibitors|protease inhibitors|mesh-ancestor
92182330|NCT01672983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182331|NCT01672983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182332|NCT01672983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92182333|NCT01672983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92182334|NCT01672983|Antiviral Agents|antiviral agents|mesh-ancestor
92182335|NCT01672983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182336|NCT01672983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92182337|NCT01672983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92182338|NCT00117715|Dextromethorphan|dextromethorphan|mesh-list
92182339|NCT00117715|Caffeine|caffeine|mesh-list
92182340|NCT00117715|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92182341|NCT00117715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182342|NCT00117715|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92408601|NCT05963139|Morphine|morphine|mesh-list
92182343|NCT00117715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182344|NCT00117715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182345|NCT00117715|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92182346|NCT00117715|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92182347|NCT00117715|Purinergic Agents|purinergic agents|mesh-ancestor
92182348|NCT00117715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182349|NCT00117715|Antitussive Agents|antitussive agents|mesh-ancestor
92182350|NCT00117715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92182351|NCT00117715|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92182352|NCT00117715|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92182353|NCT00228943|Tryptophan|tryptophan|mesh-list
92182354|NCT00228943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92182355|NCT00228943|Antidepressive Agents|antidepressive agents|mesh-ancestor
92182356|NCT00228943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92182357|NCT01879085|Gemcitabine|gemcitabine|mesh-list
92182358|NCT01879085|Docetaxel|docetaxel|mesh-list
92182359|NCT01879085|Vorinostat|vorinostat|mesh-list
92182360|NCT01879085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182361|NCT01879085|Antimetabolites|antimetabolites|mesh-ancestor
92182362|NCT01879085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182363|NCT01879085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182365|NCT01879085|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182366|NCT01879085|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182367|NCT01879085|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92182368|NCT01879085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182369|NCT01439204|Abatacept|abatacept|mesh-list
92182370|NCT01439204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92182371|NCT01439204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182372|NCT01439204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182373|NCT01439204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182374|NCT01439204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182375|NCT01439204|Immunologic Factors|immunologic factors|mesh-ancestor
92182376|NCT01439204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182379|NCT00063635|Metformin|metformin|mesh-list
92182380|NCT00063635|Vitamins|vitamins|mesh-ancestor
92182381|NCT00063635|Micronutrients|micronutrients|mesh-ancestor
92182382|NCT00063635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182383|NCT00063635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182384|NCT00063635|Antioxidants|antioxidants|mesh-ancestor
92182385|NCT00063635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182386|NCT00063635|Protective Agents|protective agents|mesh-ancestor
92182388|NCT01439126|Analgesics|analgesics|mesh-ancestor
92182389|NCT01439126|Sensory System Agents|sensory system agents|mesh-ancestor
92182390|NCT01439126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182391|NCT01439126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182392|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92182393|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
92182394|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
92182395|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92182396|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92182397|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92182398|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92182399|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182400|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182401|NCT00066677|Docetaxel|docetaxel|mesh-list
92182402|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182403|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92182404|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182405|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182406|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182407|NCT01615731|Digoxin|digoxin|mesh-list
92182408|NCT01615731|Misoprostol|misoprostol|mesh-list
92182409|NCT01615731|Mifepristone|mifepristone|mesh-list
92182410|NCT01615731|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92182411|NCT01615731|Abortifacient Agents|abortifacient agents|mesh-ancestor
92182412|NCT01615731|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92182413|NCT01615731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182414|NCT01615731|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92182415|NCT01615731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182416|NCT01615731|Oxytocics|oxytocics|mesh-ancestor
92182417|NCT01615731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92182418|NCT01615731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92182419|NCT01615731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182420|NCT01615731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182421|NCT01615731|Protective Agents|protective agents|mesh-ancestor
92182422|NCT01615731|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92182423|NCT01615731|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92182424|NCT01615731|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92182425|NCT01615731|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92182426|NCT01615731|Contraceptive Agents|contraceptive agents|mesh-ancestor
92182427|NCT01615731|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92182428|NCT01615731|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92182429|NCT01615731|Hormone Antagonists|hormone antagonists|mesh-ancestor
92182430|NCT01615731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182431|NCT01615731|Luteolytic Agents|luteolytic agents|mesh-ancestor
92182432|NCT01615731|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92182433|NCT01615731|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92182434|NCT02334800|Palbociclib|palbociclib|mesh-list
92182435|NCT02334800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182436|NCT02334800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92182437|NCT02334800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182438|NCT02334800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182439|NCT01665144|Siponimod|siponimod|mesh-list
92182440|NCT01665144|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92182441|NCT01665144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182442|NCT01665144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182443|NCT01665144|Immunologic Factors|immunologic factors|mesh-ancestor
92182444|NCT01665144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182445|NCT01675635|Morphine|morphine|mesh-list
92182446|NCT01675635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92182447|NCT01675635|Narcotics|narcotics|mesh-ancestor
92182448|NCT01675635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182449|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182450|NCT01675635|Analgesics|analgesics|mesh-ancestor
92182451|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
92182452|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182453|NCT01615809|Amphotericin B|amphotericin b|mesh-list
92182454|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92182455|NCT01615809|Amebicides|amebicides|mesh-ancestor
92182456|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92182457|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92182458|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182459|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92182460|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
92182461|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
92182463|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
92182464|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182465|NCT01676415|Hormones|hormones|mesh-ancestor
92182466|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182467|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182468|NCT01676415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182469|NCT01676415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182470|NCT01676415|Dermatologic Agents|dermatologic agents|mesh-ancestor
92182471|NCT01676415|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92182473|NCT05547516|Epirubicin|epirubicin|mesh-list
92182474|NCT05547516|Mitomycins|mitomycins|mesh-list
92182475|NCT05547516|Mitomycin|mitomycin|mesh-list
92182476|NCT05547516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182477|NCT05547516|Antimetabolites|antimetabolites|mesh-ancestor
92182478|NCT05547516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182479|NCT05547516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182480|NCT05547516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92182482|NCT05547516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92182483|NCT05547516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182484|NCT05547516|Alkylating Agents|alkylating agents|mesh-ancestor
92182485|NCT05547516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92182486|NCT01678443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92182487|NCT01678443|Antibodies|antibodies|mesh-list
92182488|NCT01678443|Immunoglobulins|immunoglobulins|mesh-list
92182489|NCT01678443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92182490|NCT01678443|Immunologic Factors|immunologic factors|mesh-ancestor
92182491|NCT01678443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182492|NCT01678443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182493|NCT01707225|Octreotide|octreotide|mesh-list
92182494|NCT01707225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182495|NCT01707225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182496|NCT01707225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182497|NCT01707381|Timolol|timolol|mesh-list
92117120|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92182498|NCT01707381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182499|NCT01707381|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92182500|NCT01707381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92182501|NCT01707381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92182502|NCT01707381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182503|NCT01707381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182504|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92182505|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92182506|NCT05552586|Melatonin|melatonin|mesh-list
92182507|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
92182508|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182509|NCT05552586|Protective Agents|protective agents|mesh-ancestor
92182510|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182511|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182512|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92182513|NCT00069329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182514|NCT00072449|Rituximab|rituximab|mesh-list
92182515|NCT00072449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182516|NCT00072449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182517|NCT00072449|Immunologic Factors|immunologic factors|mesh-ancestor
92182518|NCT00072449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182519|NCT00072449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327512|NCT00002197|Abacavir|abacavir|mesh-list
92182520|NCT04756661|Misoprostol|misoprostol|mesh-list
92182521|NCT04756661|Oxytocin|oxytocin|mesh-list
92182522|NCT04756661|Carbetocin|carbetocin|mesh-list
92182523|NCT04756661|Oxytocics|oxytocics|mesh-ancestor
92182524|NCT04756661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92182525|NCT04756661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182526|NCT04756661|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92182527|NCT04756661|Abortifacient Agents|abortifacient agents|mesh-ancestor
92182528|NCT04756661|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92182529|NCT04756661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182531|NCT01708629|Brodalumab|brodalumab|mesh-list
92182532|NCT01708629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92182533|NCT01708629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92182534|NCT01708629|Immunologic Factors|immunologic factors|mesh-ancestor
92182535|NCT01708629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182536|NCT00073073|Vitamin D|vitamin d|mesh-list
92182537|NCT00073073|Exemestane|exemestane|mesh-list
92182538|NCT00073073|Calcium Carbonate|calcium carbonate|mesh-list
92182539|NCT00073073|Calcium|calcium|mesh-list
92182540|NCT00073073|Vitamins|vitamins|mesh-ancestor
92182541|NCT00073073|Micronutrients|micronutrients|mesh-ancestor
92182542|NCT00073073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182543|NCT00073073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92182544|NCT00073073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92182546|NCT00073073|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92182547|NCT00073073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92182548|NCT00073073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182549|NCT00073073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182550|NCT00073073|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92182551|NCT00073073|Hormone Antagonists|hormone antagonists|mesh-ancestor
92182552|NCT00073073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182553|NCT00073073|Antacids|antacids|mesh-ancestor
92182554|NCT00073073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182555|NCT01466660|Gefitinib|gefitinib|mesh-list
92182556|NCT01466660|Afatinib|afatinib|mesh-list
92182557|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182600|NCT01466270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182601|NCT01466270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92182602|NCT01466270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182603|NCT01466270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182604|NCT01466270|Nootropic Agents|nootropic agents|mesh-ancestor
92182605|NCT02235987|Octreotide|octreotide|mesh-list
92182606|NCT02235987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182607|NCT02235987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182608|NCT02235987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182609|NCT01466192|Ribavirin|ribavirin|mesh-list
92182610|NCT01466192|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92182612|NCT01466192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182613|NCT01466192|Antiviral Agents|antiviral agents|mesh-ancestor
92182614|NCT01466192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182615|NCT00120523|Pimecrolimus|pimecrolimus|mesh-list
92182616|NCT00120523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92182617|NCT00120523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92182618|NCT00120523|Analgesics|analgesics|mesh-ancestor
92182619|NCT00120523|Sensory System Agents|sensory system agents|mesh-ancestor
92182620|NCT00120523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182621|NCT00120523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182622|NCT00120523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182623|NCT00120523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182624|NCT00120523|Dermatologic Agents|dermatologic agents|mesh-ancestor
92182625|NCT00120523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327931|NCT00002798|Antiemetics|antiemetics|mesh-ancestor
92182626|NCT00120523|Immunologic Factors|immunologic factors|mesh-ancestor
92182627|NCT00120523|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92182628|NCT00120523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182629|NCT00120523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182630|NCT01438814|Metformin|metformin|mesh-list
92182631|NCT01438814|Linagliptin|linagliptin|mesh-list
92182632|NCT01438814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182633|NCT01438814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182634|NCT01438814|Incretins|incretins|mesh-ancestor
92182635|NCT01438814|Hormones|hormones|mesh-ancestor
92327990|NCT00002804|Mesna|mesna|mesh-list
92182636|NCT01438814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182637|NCT01438814|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92182638|NCT01438814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92182639|NCT01438814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328055|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182640|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182641|NCT04425876|Fluzoparib|fluzoparib|mesh-list
92182642|NCT04425876|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92182643|NCT04425876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182644|NCT04425876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182645|NCT04425876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182646|NCT01681095|Tryptophan|tryptophan|mesh-list
92182647|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92182648|NCT01681095|Antidepressive Agents|antidepressive agents|mesh-ancestor
92182649|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92182650|NCT00121225|Vorinostat|vorinostat|mesh-list
92182651|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182652|NCT00121225|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92182653|NCT00121225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328131|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182654|NCT00121225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182656|NCT05134987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182657|NCT05134987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182658|NCT05545800|Insulin|insulin|mesh-list
92328194|NCT00003152|Hormones|hormones|mesh-ancestor
92182660|NCT05545800|Metformin|metformin|mesh-list
92182661|NCT05545800|Insulin Glargine|insulin glargine|mesh-list
92182662|NCT05545800|Empagliflozin|empagliflozin|mesh-list
92182663|NCT05545800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182664|NCT05545800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182665|NCT05545800|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92328335|NCT00003158|Carboplatin|carboplatin|mesh-list
92182666|NCT05545800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182667|NCT00230737|Melatonin|melatonin|mesh-list
92182668|NCT00230737|Antioxidants|antioxidants|mesh-ancestor
92182669|NCT00230737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182670|NCT00230737|Protective Agents|protective agents|mesh-ancestor
92182671|NCT00230737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182672|NCT00230737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92182673|NCT04425564|Capecitabine|capecitabine|mesh-list
92182675|NCT04425564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92182676|NCT04425564|Antimetabolites|antimetabolites|mesh-ancestor
92182677|NCT04425564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182678|NCT04425564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182679|NCT01686165|Rituximab|rituximab|mesh-list
92182680|NCT01686165|Belinostat|belinostat|mesh-list
92182681|NCT01686165|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92182682|NCT01686165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182683|NCT01686165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182684|NCT01686165|Immunologic Factors|immunologic factors|mesh-ancestor
92182685|NCT01686165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182687|NCT01686165|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92182688|NCT01686165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182689|NCT01686165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182690|NCT00123643|Rosiglitazone|rosiglitazone|mesh-list
92182691|NCT00123643|Glyburide|glyburide|mesh-list
92182692|NCT00123643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182693|NCT00123643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182694|NCT00235573|Vitamin B 12|vitamin b 12|mesh-list
92182695|NCT00235573|Hydroxocobalamin|hydroxocobalamin|mesh-list
92182697|NCT00235573|Micronutrients|micronutrients|mesh-ancestor
92182698|NCT00235573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182699|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
92182700|NCT00235573|Hematinics|hematinics|mesh-ancestor
92182701|NCT01687179|Sirolimus|sirolimus|mesh-list
92182702|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
92182703|NCT01687179|Temsirolimus|temsirolimus|mesh-list
92182704|NCT01687179|MTOR Inhibitors|mtor inhibitors|mesh-list
92182705|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92182706|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182707|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92182708|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182709|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
92182710|NCT01687179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182711|NCT01687179|Immunologic Factors|immunologic factors|mesh-ancestor
92182712|NCT01687179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182713|NCT01687179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92182714|NCT01687179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182715|NCT01687179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182716|NCT01687179|Antimalarials|antimalarials|mesh-ancestor
92182717|NCT01687179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92182718|NCT01687179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92182719|NCT01687179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182720|NCT00124579|Thalidomide|thalidomide|mesh-list
92182721|NCT00124579|Dexamethasone|dexamethasone|mesh-list
92182722|NCT00124579|Bortezomib|bortezomib|mesh-list
92182723|NCT00124579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182724|NCT00124579|Antiemetics|antiemetics|mesh-ancestor
92328586|NCT00003194|Thiotepa|thiotepa|mesh-list
92182725|NCT00124579|Autonomic Agents|autonomic agents|mesh-ancestor
92182726|NCT00124579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182727|NCT00124579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182728|NCT00124579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182729|NCT00124579|Glucocorticoids|glucocorticoids|mesh-ancestor
92182731|NCT00124579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182732|NCT00124579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182733|NCT00124579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182734|NCT00124579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182735|NCT00124579|Immunologic Factors|immunologic factors|mesh-ancestor
92182737|NCT00124579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92328734|NCT00003212|Ifosfamide|ifosfamide|mesh-list
92182738|NCT00124579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182739|NCT00124579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92182740|NCT00124579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92182741|NCT00124579|Growth Substances|growth substances|mesh-ancestor
92182742|NCT00124579|Growth Inhibitors|growth inhibitors|mesh-ancestor
92182743|NCT05550090|Immunomodulating Agents|immunomodulating agents|mesh-list
92182744|NCT05550090|Immunologic Factors|immunologic factors|mesh-ancestor
92182745|NCT05550090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182746|NCT00124735|Rocuronium|rocuronium|mesh-list
92182747|NCT00124735|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92328795|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182748|NCT00124735|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92182749|NCT00124735|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92182750|NCT00124735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182751|NCT00124735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182752|NCT05340309|Atezolizumab|atezolizumab|mesh-list
92182753|NCT05340309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92182754|NCT05340309|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92182755|NCT05340309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328861|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92182756|NCT05340309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182757|NCT05340309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182758|NCT05340309|Immunologic Factors|immunologic factors|mesh-ancestor
92182759|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182761|NCT00125515|Memantine|memantine|mesh-list
92182762|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92182763|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92182764|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182765|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
92182766|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182767|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92182768|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92182769|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
92182770|NCT00125515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182771|NCT00125515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182772|NCT00125515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92328927|NCT00003992|Doxorubicin|doxorubicin|mesh-list
92182773|NCT00125515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92182774|NCT00125593|Simvastatin|simvastatin|mesh-list
92182775|NCT00125593|Ezetimibe|ezetimibe|mesh-list
92182776|NCT00125593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92182777|NCT00125593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92182778|NCT00125593|Antimetabolites|antimetabolites|mesh-ancestor
92182779|NCT00125593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182780|NCT00125593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92182781|NCT00125593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92182782|NCT00125593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182783|NCT01689441|Calcitriol|calcitriol|mesh-list
92182784|NCT01689441|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92182785|NCT01689441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182786|NCT01689441|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92182787|NCT01689441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182788|NCT01689441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182789|NCT01689441|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92182791|NCT01689441|Micronutrients|micronutrients|mesh-ancestor
92182792|NCT01689441|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92182793|NCT00236977|Iron|iron|mesh-list
92182794|NCT00236977|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92182795|NCT00236977|Trace Elements|trace elements|mesh-ancestor
92182796|NCT00236977|Micronutrients|micronutrients|mesh-ancestor
92182797|NCT00236977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182798|NCT00236977|Hematinics|hematinics|mesh-ancestor
92182799|NCT04753177|Paclitaxel|paclitaxel|mesh-list
92182800|NCT04753177|Cyclophosphamide|cyclophosphamide|mesh-list
92182801|NCT04753177|Doxorubicin|doxorubicin|mesh-list
92182802|NCT04753177|Fulvestrant|fulvestrant|mesh-list
92182803|NCT04753177|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92182804|NCT04753177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92182805|NCT04753177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182806|NCT04753177|Tubulin Modulators|tubulin modulators|mesh-ancestor
92182807|NCT04753177|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182808|NCT04753177|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182809|NCT04753177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182810|NCT04753177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182811|NCT04753177|Immunologic Factors|immunologic factors|mesh-ancestor
92182812|NCT04753177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182813|NCT04753177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182814|NCT04753177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92182815|NCT04753177|Alkylating Agents|alkylating agents|mesh-ancestor
92182816|NCT04753177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329114|NCT00004010|Vinblastine|vinblastine|mesh-list
92182817|NCT04753177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92182818|NCT04753177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92182819|NCT04753177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92182820|NCT04753177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182821|NCT04753177|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92182822|NCT04753177|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92182823|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92182824|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
92182825|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182826|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
92182827|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92329173|NCT00003554|Prednisone|prednisone|mesh-list
92182828|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
92182829|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92182830|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92182832|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92182833|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92182834|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92182835|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182836|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
92182837|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182838|NCT01691313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182840|NCT00079001|Zoledronic Acid|zoledronic acid|mesh-list
92182842|NCT00079001|Androgens|androgens|mesh-list
92182843|NCT00079001|Vitamins|vitamins|mesh-ancestor
92182844|NCT00079001|Micronutrients|micronutrients|mesh-ancestor
92182845|NCT00079001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182846|NCT00079001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92182847|NCT00079001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92182848|NCT00079001|Hormones|hormones|mesh-ancestor
92329378|NCT00002701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92182849|NCT00079001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182851|NCT05234307|Adenosine|adenosine|mesh-list
92182852|NCT05234307|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-list
92182853|NCT05234307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182854|NCT05234307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182855|NCT05234307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92182856|NCT05234307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182857|NCT05234307|Analgesics|analgesics|mesh-ancestor
92182858|NCT05234307|Sensory System Agents|sensory system agents|mesh-ancestor
92182859|NCT05234307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182860|NCT05234307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182861|NCT05234307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92182862|NCT05234307|Vasodilator Agents|vasodilator agents|mesh-ancestor
92182863|NCT05234307|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92182864|NCT05234307|Purinergic Agonists|purinergic agonists|mesh-ancestor
92182865|NCT05234307|Purinergic Agents|purinergic agents|mesh-ancestor
92182866|NCT05234307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182867|NCT05234307|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92182868|NCT05234307|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92182869|NCT00238615|Carboplatin|carboplatin|mesh-list
92182870|NCT00238615|Docetaxel|docetaxel|mesh-list
92329455|NCT00002719|Cytarabine|cytarabine|mesh-list
92182871|NCT00238615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182872|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92182873|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92182874|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92182875|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182876|NCT02243943|Neostigmine|neostigmine|mesh-list
92182877|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92182878|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182879|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182880|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
92182881|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182882|NCT02243943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182883|NCT02243943|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92182884|NCT02243943|Autonomic Agents|autonomic agents|mesh-ancestor
92182885|NCT02243943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182886|NCT03088631|Metformin|metformin|mesh-list
92182887|NCT03088631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92182888|NCT03088631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182889|NCT00131677|Tenofovir|tenofovir|mesh-list
92182891|NCT00131677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182892|NCT00131677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92182893|NCT00131677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92182894|NCT00131677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329713|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92182895|NCT00131677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182896|NCT00131677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92182897|NCT00131677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92182899|NCT00240487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92182900|NCT00240487|Autonomic Agents|autonomic agents|mesh-ancestor
92182901|NCT00240487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329858|NCT00002767|Interferons|interferons|mesh-list
92182902|NCT00240487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182904|NCT00240487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92182905|NCT00240487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92182906|NCT00240487|Antioxidants|antioxidants|mesh-ancestor
92182907|NCT00240487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182908|NCT00240487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92182909|NCT00240487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92182910|NCT00240487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92182911|NCT00240487|Gasotransmitters|gasotransmitters|mesh-ancestor
92182912|NCT00240487|Protective Agents|protective agents|mesh-ancestor
92182913|NCT02126917|Ethanol|ethanol|mesh-list
92182915|NCT02126917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92182916|NCT02126917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182917|NCT02126917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117121|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
92182918|NCT02126917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182919|NCT02126917|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92182920|NCT02126917|Narcotics|narcotics|mesh-ancestor
92182921|NCT02126917|Analgesics|analgesics|mesh-ancestor
92182922|NCT02126917|Sensory System Agents|sensory system agents|mesh-ancestor
92182923|NCT02126917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182924|NCT02126917|Antitussive Agents|antitussive agents|mesh-ancestor
92182925|NCT02126917|Respiratory System Agents|respiratory system agents|mesh-ancestor
92182926|NCT01895075|Budesonide|budesonide|mesh-list
92182927|NCT01895075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182928|NCT01895075|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92182929|NCT01895075|Autonomic Agents|autonomic agents|mesh-ancestor
92182930|NCT01895075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92182931|NCT01895075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182932|NCT01895075|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92182933|NCT01895075|Respiratory System Agents|respiratory system agents|mesh-ancestor
92182934|NCT01895075|Glucocorticoids|glucocorticoids|mesh-ancestor
92182935|NCT01895075|Hormones|hormones|mesh-ancestor
92182936|NCT01895075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182937|NCT05168475|Infliximab|infliximab|mesh-list
92182938|NCT05168475|Rituximab|rituximab|mesh-list
92330134|NCT05495035|Dexamethasone|dexamethasone|mesh-list
92182939|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92182940|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182941|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
92330277|NCT00003728|Vincristine|vincristine|mesh-list
92182942|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182943|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182944|NCT05168475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92182945|NCT05168475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92182946|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92182947|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182948|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
92182949|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
92182950|NCT03088709|Tacrolimus|tacrolimus|mesh-list
92182951|NCT03088709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182952|NCT03088709|Immunologic Factors|immunologic factors|mesh-ancestor
92182953|NCT03088709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182954|NCT03088709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92182955|NCT03088709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92182956|NCT03088709|Alkylating Agents|alkylating agents|mesh-ancestor
92182957|NCT03088709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182958|NCT03088709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92182959|NCT03088709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92182960|NCT03088709|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92182961|NCT03088709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182962|NCT03088709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92182963|NCT03088709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92182964|NCT03088709|Antitubercular Agents|antitubercular agents|mesh-ancestor
92182965|NCT03088709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92182966|NCT03088709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182967|NCT03139305|Glucagon|glucagon|mesh-list
92182968|NCT03139305|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92182969|NCT03139305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92182970|NCT03139305|Hormones|hormones|mesh-ancestor
92182971|NCT03139305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92182972|NCT03139305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92182973|NCT03139305|Incretins|incretins|mesh-ancestor
92182974|NCT00084149|Ritonavir|ritonavir|mesh-list
92182975|NCT00084149|Lopinavir|lopinavir|mesh-list
92182976|NCT00084149|Lamivudine|lamivudine|mesh-list
92182977|NCT00084149|Zidovudine|zidovudine|mesh-list
92182978|NCT00084149|Abacavir|abacavir|mesh-list
92182979|NCT00084149|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92182980|NCT00084149|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92182981|NCT00084149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92182982|NCT00084149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92182983|NCT00084149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92182984|NCT00084149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92182985|NCT00084149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92182987|NCT00084149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92182988|NCT00084149|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92182989|NCT00084149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92182990|NCT00084149|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92182991|NCT00084149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92182992|NCT00084149|Antimetabolites|antimetabolites|mesh-ancestor
92182993|NCT02959905|Cyclophosphamide|cyclophosphamide|mesh-list
92182994|NCT02959905|Fludarabine|fludarabine|mesh-list
92182995|NCT02959905|Fludarabine phosphate|fludarabine phosphate|mesh-list
92182996|NCT02959905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92182997|NCT02959905|Immunologic Factors|immunologic factors|mesh-ancestor
92182998|NCT02959905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183000|NCT02959905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183001|NCT02959905|Alkylating Agents|alkylating agents|mesh-ancestor
92183002|NCT02959905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330979|NCT00003908|Carboplatin|carboplatin|mesh-list
92183003|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183004|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183005|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183006|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
92183007|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
92183008|NCT00134017|Busulfan|busulfan|mesh-list
92183009|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183010|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
92183011|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183012|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183013|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183014|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
92183015|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183016|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183017|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183018|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
92183019|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
92183020|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
91983860|NCT05488899|Iodine|iodine|mesh-list
92183021|NCT04783051|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92183022|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
92183023|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92183024|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92183025|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183026|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92183027|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183028|NCT04783051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183029|NCT04783051|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92331354|NCT00004814|(T,G)-A-L|(t,g)-a-l|mesh-list
92183030|NCT04783051|Antiviral Agents|antiviral agents|mesh-ancestor
92183031|NCT00243061|Cediranib|cediranib|mesh-list
92183032|NCT00243061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183033|NCT00243061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183034|NCT00243061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183035|NCT00243061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183037|NCT00245557|Antidepressive Agents|antidepressive agents|mesh-ancestor
92183038|NCT00245557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92331406|NCT00004778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183039|NCT00245557|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92183040|NCT00245557|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92183041|NCT00245557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183042|NCT00245557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183043|NCT00245557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183044|NCT00245557|Serotonin Agents|serotonin agents|mesh-ancestor
92183045|NCT00245557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183046|NCT00245635|Fluoxetine|fluoxetine|mesh-list
92183047|NCT00245635|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92183049|NCT00245635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183050|NCT00245635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183052|NCT00245635|Serotonin Agents|serotonin agents|mesh-ancestor
92183053|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183054|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92183055|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
92183056|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92183057|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92183058|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92183059|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183061|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
92183062|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
92183063|NCT00249379|Acamprosate|acamprosate|mesh-list
92183064|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92183065|NCT00141739|Etanercept|etanercept|mesh-list
92183066|NCT00141739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92183067|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92183068|NCT00141739|Analgesics|analgesics|mesh-ancestor
92183069|NCT00141739|Sensory System Agents|sensory system agents|mesh-ancestor
92183070|NCT00141739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183071|NCT00141739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183072|NCT00141739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183073|NCT00141739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183074|NCT00141739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92183075|NCT00141739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183076|NCT00141739|Immunologic Factors|immunologic factors|mesh-ancestor
92183077|NCT00143845|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92183078|NCT00143845|Immunologic Factors|immunologic factors|mesh-ancestor
92183079|NCT00143845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183080|NCT00086957|Docetaxel|docetaxel|mesh-list
92183081|NCT00086957|Trastuzumab|trastuzumab|mesh-list
92183082|NCT00086957|Gefitinib|gefitinib|mesh-list
92183083|NCT00086957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183084|NCT00086957|Tubulin Modulators|tubulin modulators|mesh-ancestor
92183085|NCT00086957|Antimitotic Agents|antimitotic agents|mesh-ancestor
92183086|NCT00086957|Mitosis Modulators|mitosis modulators|mesh-ancestor
92183087|NCT00086957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183088|NCT00086957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183089|NCT00086957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183090|NCT00086957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183091|NCT00144391|Testosterone|testosterone|mesh-list
92183092|NCT00144391|Androgens|androgens|mesh-ancestor
92183093|NCT00144391|Hormones|hormones|mesh-ancestor
92183094|NCT00144391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183095|NCT00144391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183096|NCT00145249|Fluconazole|fluconazole|mesh-list
92183097|NCT00145249|Amphotericin B|amphotericin b|mesh-list
92183098|NCT00145249|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92183099|NCT00145249|Antifungal Agents|antifungal agents|mesh-ancestor
92183100|NCT00145249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183101|NCT00145249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92183102|NCT00145249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92183103|NCT00145249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183104|NCT00145249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183105|NCT00145249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92183106|NCT00145249|Hormone Antagonists|hormone antagonists|mesh-ancestor
92183107|NCT00145249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183108|NCT00145249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183109|NCT00145249|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92183110|NCT00145249|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92183112|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92183113|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92332075|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
92183114|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92183115|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92183116|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332157|NCT02283853|Interferons|interferons|mesh-list
92183117|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183118|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183119|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183120|NCT00252967|Atorvastatin|atorvastatin|mesh-list
92183121|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92183122|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92183123|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
92183124|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183125|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92183126|NCT00252967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92183127|NCT00252967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183129|NCT00088985|Vinorelbine|vinorelbine|mesh-list
92183130|NCT00088985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183131|NCT00088985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183132|NCT00088985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92183133|NCT00088985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92183134|NCT00088985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92183135|NCT00088985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92183136|NCT00088985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183137|NCT00156923|Naltrexone|naltrexone|mesh-list
92183138|NCT00156923|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92183139|NCT00156923|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92183140|NCT00156923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183141|NCT00156923|Sensory System Agents|sensory system agents|mesh-ancestor
92332446|NCT00003445|Docetaxel|docetaxel|mesh-list
92183142|NCT00156923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183143|NCT00093041|Zalutumumab|zalutumumab|mesh-list
92183144|NCT00093041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183145|NCT00093041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332505|NCT00003493|Glucocorticoids|glucocorticoids|mesh-ancestor
92183146|NCT00158249|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92183148|NCT01769885|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92183149|NCT01769885|Tivozanib|tivozanib|mesh-list
92183150|NCT01769885|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183151|NCT01769885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183152|NCT01769885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183153|NCT01895231|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92183154|NCT01895231|Hematinics|hematinics|mesh-ancestor
92183155|NCT04745663|Iodine|iodine|mesh-list
92183156|NCT04745663|Cadexomer iodine|cadexomer iodine|mesh-list
92183157|NCT04745663|Povidone-Iodine|povidone-iodine|mesh-list
92183158|NCT04745663|Povidone|povidone|mesh-list
92183159|NCT04745663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92183160|NCT04745663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183161|NCT04745663|Trace Elements|trace elements|mesh-ancestor
92183162|NCT04745663|Micronutrients|micronutrients|mesh-ancestor
92183163|NCT04745663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183164|NCT04745663|Plasma Substitutes|plasma substitutes|mesh-ancestor
92183165|NCT04745663|Blood Substitutes|blood substitutes|mesh-ancestor
92183166|NCT01747577|Solifenacin Succinate|solifenacin succinate|mesh-list
92183167|NCT01747577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92183168|NCT01747577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92183169|NCT01747577|Cholinergic Agents|cholinergic agents|mesh-ancestor
92183170|NCT01747577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183171|NCT01747577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183172|NCT01747577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183173|NCT01747577|Urological Agents|urological agents|mesh-ancestor
92183174|NCT00159263|Budesonide|budesonide|mesh-list
92183175|NCT00159263|Formoterol Fumarate|formoterol fumarate|mesh-list
92183176|NCT00159263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183177|NCT00159263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92183178|NCT00159263|Autonomic Agents|autonomic agents|mesh-ancestor
92183179|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183180|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183181|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92183182|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
92183184|NCT00159263|Hormones|hormones|mesh-ancestor
92183185|NCT00159263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183186|NCT00159263|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92183187|NCT00159263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92183188|NCT00159263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92183189|NCT00159263|Adrenergic Agents|adrenergic agents|mesh-ancestor
92183190|NCT00159263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183191|NCT00159263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183192|NCT00159419|Alendronate|alendronate|mesh-list
92183193|NCT00159419|Pamidronate|pamidronate|mesh-list
92183194|NCT00159419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92183195|NCT00159419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183196|NCT00159965|Sertraline|sertraline|mesh-list
92183197|NCT00159965|Antidepressive Agents|antidepressive agents|mesh-ancestor
92183198|NCT00159965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92183199|NCT00159965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92183200|NCT00159965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92183201|NCT00159965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183202|NCT00159965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183203|NCT00159965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183204|NCT00159965|Serotonin Agents|serotonin agents|mesh-ancestor
92183205|NCT00159965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183206|NCT02926833|Cyclophosphamide|cyclophosphamide|mesh-list
92183207|NCT02926833|Fludarabine|fludarabine|mesh-list
92183208|NCT02926833|Atezolizumab|atezolizumab|mesh-list
92183209|NCT02926833|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92183210|NCT02926833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183211|NCT02926833|Immunologic Factors|immunologic factors|mesh-ancestor
92183212|NCT02926833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183213|NCT02926833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183214|NCT02926833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183215|NCT02926833|Alkylating Agents|alkylating agents|mesh-ancestor
92183216|NCT02926833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183217|NCT02926833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183218|NCT02926833|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183219|NCT02926833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92183220|NCT02926833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183221|NCT00096161|Cyclosporine|cyclosporine|mesh-list
92183222|NCT00096161|Mycophenolic Acid|mycophenolic acid|mesh-list
92183223|NCT00096161|Vidarabine|vidarabine|mesh-list
92183224|NCT00096161|Pentostatin|pentostatin|mesh-list
92183225|NCT00096161|Cyclosporins|cyclosporins|mesh-list
92183226|NCT00096161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183227|NCT00096161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183228|NCT00096161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183229|NCT00096161|Immunologic Factors|immunologic factors|mesh-ancestor
92183230|NCT00096161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183231|NCT00096161|Antifungal Agents|antifungal agents|mesh-ancestor
92183232|NCT00096161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183233|NCT00096161|Dermatologic Agents|dermatologic agents|mesh-ancestor
92183234|NCT00096161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183235|NCT00096161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92183236|NCT00096161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92183237|NCT00096161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183238|NCT00096161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92183239|NCT00096161|Antitubercular Agents|antitubercular agents|mesh-ancestor
92183240|NCT00096161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92183241|NCT00096161|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92183242|NCT00096161|Antimetabolites|antimetabolites|mesh-ancestor
92183243|NCT00096161|Antiviral Agents|antiviral agents|mesh-ancestor
92183244|NCT00097253|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92183245|NCT00097253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183246|NCT01898039|Cyclophosphamide|cyclophosphamide|mesh-list
92183247|NCT01898039|Vaccines|vaccines|mesh-list
92183248|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
92183249|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183250|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183251|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183252|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183253|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
92183254|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183255|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183256|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183258|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92183259|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92183260|NCT00099047|Analgesics|analgesics|mesh-ancestor
92183261|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
92183262|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183263|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183264|NCT00099047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183265|NCT00099047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183266|NCT00099047|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92183267|NCT00099047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92183268|NCT00099047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183269|NCT00099047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183270|NCT02851797|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92183271|NCT02851797|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92183272|NCT02851797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183273|NCT02851797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183274|NCT00253435|Carboplatin|carboplatin|mesh-list
92183275|NCT00253435|Etoposide|etoposide|mesh-list
92183276|NCT00253435|Melphalan|melphalan|mesh-list
92183277|NCT00253435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183278|NCT00253435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92183279|NCT00253435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92183280|NCT00253435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92183281|NCT00253435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183282|NCT00253435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183283|NCT00253435|Immunologic Factors|immunologic factors|mesh-ancestor
92183284|NCT00253435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183285|NCT00253435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183286|NCT00253435|Alkylating Agents|alkylating agents|mesh-ancestor
92183287|NCT00253435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183288|NCT00253435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183289|NCT00253513|Fludarabine|fludarabine|mesh-list
92183290|NCT00253513|Treosulfan|treosulfan|mesh-list
92183291|NCT00253513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183292|NCT00253513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183293|NCT00253513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183295|NCT05033847|Vaccines|vaccines|mesh-list
92183296|NCT05033847|Immunologic Factors|immunologic factors|mesh-ancestor
92183297|NCT05033847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183298|NCT04963725|Ustekinumab|ustekinumab|mesh-list
92183299|NCT04963725|Dermatologic Agents|dermatologic agents|mesh-ancestor
92183300|NCT02098993|Heparin|heparin|mesh-list
92183301|NCT02098993|Calcium heparin|calcium heparin|mesh-list
92183302|NCT02098993|Anticoagulants|anticoagulants|mesh-ancestor
92183303|NCT02098993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92183304|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92183305|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183306|NCT04930107|Fluconazole|fluconazole|mesh-list
92183307|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
92183308|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183309|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92183310|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92183311|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183312|NCT04930107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183313|NCT04930107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92183314|NCT04930107|Hormone Antagonists|hormone antagonists|mesh-ancestor
92183315|NCT04930107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183316|NCT04930107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183317|NCT04930107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92183318|NCT04930107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92183319|NCT00100841|Leucovorin|leucovorin|mesh-list
92183320|NCT00100841|Bevacizumab|bevacizumab|mesh-list
92183321|NCT00100841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92183322|NCT00100841|Cetuximab|cetuximab|mesh-list
92183323|NCT00100841|Fluorouracil|fluorouracil|mesh-list
92183324|NCT00100841|Oxaliplatin|oxaliplatin|mesh-list
92183325|NCT00100841|Antibodies|antibodies|mesh-list
92183326|NCT00100841|Immunoglobulins|immunoglobulins|mesh-list
92183327|NCT00100841|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92183328|NCT00100841|Levoleucovorin|levoleucovorin|mesh-list
92183329|NCT00100841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183330|NCT00100841|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92183331|NCT00100841|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92183332|NCT00100841|Growth Substances|growth substances|mesh-ancestor
92183333|NCT00100841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183334|NCT00100841|Growth Inhibitors|growth inhibitors|mesh-ancestor
92183335|NCT00100841|Immunologic Factors|immunologic factors|mesh-ancestor
92183336|NCT00100841|Antimetabolites|antimetabolites|mesh-ancestor
92183337|NCT00100841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183338|NCT00100841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183339|NCT00100841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183340|NCT00100841|Antidotes|antidotes|mesh-ancestor
92183341|NCT00100841|Protective Agents|protective agents|mesh-ancestor
92183342|NCT00100841|Vitamin B Complex|vitamin b complex|mesh-ancestor
92183343|NCT00100841|Vitamins|vitamins|mesh-ancestor
92183344|NCT00100841|Micronutrients|micronutrients|mesh-ancestor
92183345|NCT00147199|Treprostinil|treprostinil|mesh-list
92183346|NCT00147199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92183347|NCT05709171|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92183348|NCT05709171|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92183349|NCT05709171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183350|NCT00149227|Valsartan|valsartan|mesh-list
92183351|NCT00149227|Antihypertensive Agents|antihypertensive agents|mesh-list
92183352|NCT00149227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92183353|NCT00149227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92183354|NCT00149227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183355|NCT00445965|Antibodies|antibodies|mesh-list
92183356|NCT00445965|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92183357|NCT00445965|Immunologic Factors|immunologic factors|mesh-ancestor
92183358|NCT00445965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183359|NCT02096081|Botulinum Toxins|botulinum toxins|mesh-list
92183360|NCT02096081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92183361|NCT02096081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92183362|NCT02096081|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92333272|NCT00384553|Rituximab|rituximab|mesh-list
92183363|NCT02096081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92183364|NCT02096081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183365|NCT02096081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183366|NCT02096081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92183367|NCT02096081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183368|NCT02096081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183369|NCT02096081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92183370|NCT02096081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183371|NCT05708235|Inavolisib|inavolisib|mesh-list
92183372|NCT05708235|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92183373|NCT05708235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183374|NCT05708235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183375|NCT02240589|Memantine|memantine|mesh-list
92183376|NCT02240589|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92183377|NCT02240589|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92183378|NCT02240589|Dopamine Agents|dopamine agents|mesh-ancestor
92183379|NCT02240589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183380|NCT02240589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183381|NCT02240589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183382|NCT02240589|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92183383|NCT02240589|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92183384|NCT00258349|Trastuzumab|trastuzumab|mesh-list
92183385|NCT00258349|Vorinostat|vorinostat|mesh-list
92183386|NCT00258349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183387|NCT00258349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183388|NCT00258349|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92183389|NCT00258349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183390|NCT00258349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183391|NCT01713621|Artefenomel|artefenomel|mesh-list
92183392|NCT01713621|Antimalarials|antimalarials|mesh-ancestor
92183393|NCT01713621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92183394|NCT01713621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92183395|NCT01713621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183396|NCT05165485|Tiotropium Bromide|tiotropium bromide|mesh-list
92183397|NCT05165485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92183398|NCT05165485|Autonomic Agents|autonomic agents|mesh-ancestor
92183399|NCT05165485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183400|NCT05165485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183401|NCT05165485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92183402|NCT05165485|Respiratory System Agents|respiratory system agents|mesh-ancestor
92183403|NCT05165485|Parasympatholytics|parasympatholytics|mesh-ancestor
92183404|NCT05165485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92183405|NCT05165485|Cholinergic Agents|cholinergic agents|mesh-ancestor
92183406|NCT05165485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183407|NCT05165485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183408|NCT00258817|Vaccines|vaccines|mesh-list
92183409|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
92183410|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183411|NCT00259285|Pemetrexed|pemetrexed|mesh-list
92183412|NCT00259285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183413|NCT00259285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183414|NCT00259285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183415|NCT00259285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92183416|NCT00259285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92183417|NCT01716039|Adalimumab|adalimumab|mesh-list
92183418|NCT01716039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92183419|NCT01716039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183420|NCT01716039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183421|NCT01716195|Paclitaxel|paclitaxel|mesh-list
92183422|NCT01716195|Carboplatin|carboplatin|mesh-list
92183423|NCT01716195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92183424|NCT01716195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183425|NCT01716195|Tubulin Modulators|tubulin modulators|mesh-ancestor
92183426|NCT01716195|Antimitotic Agents|antimitotic agents|mesh-ancestor
92183427|NCT01716195|Mitosis Modulators|mitosis modulators|mesh-ancestor
92183428|NCT01716195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183429|NCT02249481|Bupivacaine|bupivacaine|mesh-list
92183430|NCT02249481|Anesthetics, Local|anesthetics, local|mesh-ancestor
92183431|NCT02249481|Anesthetics|anesthetics|mesh-ancestor
92183432|NCT02249481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92333278|NCT00003991|Aldesleukin|aldesleukin|mesh-list
92183433|NCT02249481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183434|NCT02249481|Sensory System Agents|sensory system agents|mesh-ancestor
92183435|NCT02249481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183436|NCT01717053|Prednisone|prednisone|mesh-list
92183437|NCT01717053|Abiraterone Acetate|abiraterone acetate|mesh-list
92183438|NCT01717053|Androgens|androgens|mesh-list
92183439|NCT01717053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183440|NCT01717053|Glucocorticoids|glucocorticoids|mesh-ancestor
92183441|NCT01717053|Hormones|hormones|mesh-ancestor
92183442|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183443|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183444|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92183445|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183446|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92183447|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183448|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183449|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
92183450|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92183451|NCT01666314|Prednisone|prednisone|mesh-list
92183452|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183453|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
92183454|NCT01666314|Hormones|hormones|mesh-ancestor
92183455|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183456|NCT01666314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183457|NCT01666314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92183458|NCT01666314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183459|NCT01717209|Epoprostenol|epoprostenol|mesh-list
92183460|NCT01717209|Nitric Oxide|nitric oxide|mesh-list
92183461|NCT01717209|Tezosentan|tezosentan|mesh-list
92183462|NCT01717209|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92183463|NCT01717209|Autonomic Agents|autonomic agents|mesh-ancestor
92183464|NCT01717209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183465|NCT01717209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183466|NCT01717209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92183467|NCT01717209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92183468|NCT01717209|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92183469|NCT01717209|Antioxidants|antioxidants|mesh-ancestor
92183470|NCT01717209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183471|NCT01717209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183472|NCT01717209|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92183473|NCT01717209|Vasodilator Agents|vasodilator agents|mesh-ancestor
92183474|NCT01717209|Gasotransmitters|gasotransmitters|mesh-ancestor
92183475|NCT01717209|Protective Agents|protective agents|mesh-ancestor
92183476|NCT01717209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92183477|NCT01717209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92183478|NCT00260689|Cyclosporine|cyclosporine|mesh-list
92183479|NCT00260689|Alemtuzumab|alemtuzumab|mesh-list
92183480|NCT00260689|Cyclosporins|cyclosporins|mesh-list
92183481|NCT00260689|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92183482|NCT00260689|Thymoglobulin|thymoglobulin|mesh-list
92183483|NCT00260689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183484|NCT00260689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183485|NCT00260689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183486|NCT00260689|Immunologic Factors|immunologic factors|mesh-ancestor
92183487|NCT00260689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183488|NCT00260689|Antifungal Agents|antifungal agents|mesh-ancestor
92183489|NCT00260689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183490|NCT00260689|Dermatologic Agents|dermatologic agents|mesh-ancestor
92183491|NCT00260689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183492|NCT00260689|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92183493|NCT00260689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183494|NCT00260689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183495|NCT00262639|Gabapentin|gabapentin|mesh-list
92183496|NCT00262639|Flumazenil|flumazenil|mesh-list
92183497|NCT00262639|Analgesics|analgesics|mesh-ancestor
92183498|NCT00262639|Sensory System Agents|sensory system agents|mesh-ancestor
92183499|NCT00262639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183500|NCT00262639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183501|NCT00262639|Anticonvulsants|anticonvulsants|mesh-ancestor
92183502|NCT00262639|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92183503|NCT00262639|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92183504|NCT00262639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92183505|NCT00262639|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92183506|NCT00262639|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92183507|NCT00262639|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92183508|NCT00262639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183509|NCT00262639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183510|NCT00262639|Antimanic Agents|antimanic agents|mesh-ancestor
92183511|NCT00262639|Antidotes|antidotes|mesh-ancestor
92183512|NCT00262639|Protective Agents|protective agents|mesh-ancestor
92183513|NCT00262639|GABA Modulators|gaba modulators|mesh-ancestor
92183514|NCT00262639|GABA Agents|gaba agents|mesh-ancestor
92183515|NCT01062451|Candesartan|candesartan|mesh-list
92183516|NCT01062451|Candesartan cilexetil|candesartan cilexetil|mesh-list
92183517|NCT01062451|Perindopril|perindopril|mesh-list
92183518|NCT01062451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92183519|NCT01062451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92183520|NCT01062451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92183521|NCT01062451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183522|NCT01062451|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92183523|NCT01062451|Protease Inhibitors|protease inhibitors|mesh-ancestor
92183524|NCT01062451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183525|NCT04639843|Doxorubicin|doxorubicin|mesh-list
92183526|NCT04639843|Romidepsin|romidepsin|mesh-list
92183527|NCT04639843|Azacitidine|azacitidine|mesh-list
92183528|NCT04639843|Cc-486|cc-486|mesh-list
92183529|NCT04639843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92183530|NCT04639843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183531|NCT04639843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92183532|NCT04639843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92183533|NCT04639843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183534|NCT04639843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183535|NCT04639843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183536|NCT04639843|Antimetabolites|antimetabolites|mesh-ancestor
92183537|NCT04639843|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92183538|NCT01718691|Rituximab|rituximab|mesh-list
92183539|NCT01718691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183540|NCT01718691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183541|NCT01718691|Immunologic Factors|immunologic factors|mesh-ancestor
92183542|NCT01718691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183543|NCT01718691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183544|NCT05699148|Ivacaftor|ivacaftor|mesh-list
92183545|NCT05699148|Elexacaftor|elexacaftor|mesh-list
92183546|NCT05699148|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92183547|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183548|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183549|NCT04638517|Danazol|danazol|mesh-list
92183550|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92183551|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
92183552|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183553|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183554|NCT04467723|Pirfenidone|pirfenidone|mesh-list
92183555|NCT04467723|Atezolizumab|atezolizumab|mesh-list
92183556|NCT04467723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92183557|NCT04467723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183558|NCT04467723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183559|NCT04467723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183560|NCT04467723|Analgesics|analgesics|mesh-ancestor
92183561|NCT04467723|Sensory System Agents|sensory system agents|mesh-ancestor
92183562|NCT04467723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183563|NCT04467723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183564|NCT04467723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92183565|NCT04467723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92183567|NCT04467723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183568|NCT04425642|Methamphetamine|methamphetamine|mesh-list
92183569|NCT04425642|SMOFlipid|smoflipid|mesh-list
92183570|NCT04425642|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92183571|NCT04425642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183572|NCT04425642|Sympathomimetics|sympathomimetics|mesh-ancestor
92183573|NCT04425642|Autonomic Agents|autonomic agents|mesh-ancestor
92183574|NCT04425642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183575|NCT04425642|Dopamine Agents|dopamine agents|mesh-ancestor
92183576|NCT04425642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183577|NCT04425642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183578|NCT04425642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92183579|NCT04425642|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92183580|NCT04425642|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92183581|NCT04425642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183582|NCT04425642|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92183583|NCT04425642|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92183584|NCT04425642|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92183585|NCT04425642|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92183586|NCT00266851|Azithromycin|azithromycin|mesh-list
92183587|NCT00266851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92183588|NCT00266851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183589|NCT00015847|Interferons|interferons|mesh-list
92183590|NCT00015847|Interferon-alpha|interferon-alpha|mesh-list
92183591|NCT00015847|Imatinib Mesylate|imatinib mesylate|mesh-list
92183592|NCT00015847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183593|NCT00015847|Antiviral Agents|antiviral agents|mesh-ancestor
92183594|NCT00015847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183595|NCT00015847|Immunologic Factors|immunologic factors|mesh-ancestor
92183596|NCT00015847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183597|NCT00015847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183598|NCT00015847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183599|NCT00015847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183600|NCT01665768|Rituximab|rituximab|mesh-list
92183601|NCT01665768|Everolimus|everolimus|mesh-list
92183602|NCT01665768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183603|NCT01665768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183604|NCT01665768|Immunologic Factors|immunologic factors|mesh-ancestor
92183605|NCT01665768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183606|NCT01665768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183607|NCT01665768|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92183608|NCT01665768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183609|NCT01665768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183610|NCT01665768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183611|NCT01665768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183612|NCT01720173|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92183613|NCT01720173|Immunologic Factors|immunologic factors|mesh-ancestor
92183614|NCT01720173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183615|NCT04617457|Leucovorin|leucovorin|mesh-list
92183616|NCT04617457|Folic Acid|folic acid|mesh-list
92183617|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
92183618|NCT04617457|Irinotecan|irinotecan|mesh-list
92183619|NCT04617457|Fluorouracil|fluorouracil|mesh-list
92183620|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
92183621|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183622|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92183623|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92183624|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183625|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183626|NCT04617457|Antidotes|antidotes|mesh-ancestor
92183627|NCT04617457|Protective Agents|protective agents|mesh-ancestor
92183628|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183629|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
92183630|NCT04617457|Vitamins|vitamins|mesh-ancestor
92183631|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
92183632|NCT04617457|Hematinics|hematinics|mesh-ancestor
92183633|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
92183634|NCT04617457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183635|NCT04617457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183636|NCT04617457|Immunologic Factors|immunologic factors|mesh-ancestor
92183637|NCT00017563|Docetaxel|docetaxel|mesh-list
92183638|NCT00017563|Mitoxantrone|mitoxantrone|mesh-list
92183639|NCT00017563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183640|NCT00017563|Tubulin Modulators|tubulin modulators|mesh-ancestor
92183641|NCT00017563|Antimitotic Agents|antimitotic agents|mesh-ancestor
92183642|NCT00017563|Mitosis Modulators|mitosis modulators|mesh-ancestor
92183643|NCT00017563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183644|NCT00017563|Analgesics|analgesics|mesh-ancestor
92183645|NCT00017563|Sensory System Agents|sensory system agents|mesh-ancestor
92183646|NCT00017563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183647|NCT00017563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183648|NCT00017563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92183649|NCT00017563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92183650|NCT00017563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183652|NCT00018031|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92183653|NCT00018031|Interferon-alpha|interferon-alpha|mesh-list
92183654|NCT00018031|Antimetabolites|antimetabolites|mesh-ancestor
92183655|NCT00018031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183656|NCT00018031|Antiviral Agents|antiviral agents|mesh-ancestor
92183657|NCT00018031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183658|NCT00018031|Immunologic Factors|immunologic factors|mesh-ancestor
92183659|NCT00018031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183660|NCT04734210|Betamethasone|betamethasone|mesh-list
92183661|NCT04734210|Betamethasone Valerate|betamethasone valerate|mesh-list
92183662|NCT04734210|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92183663|NCT04734210|Betamethasone benzoate|betamethasone benzoate|mesh-list
92183664|NCT04734210|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92183665|NCT04734210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183666|NCT04734210|Glucocorticoids|glucocorticoids|mesh-ancestor
92183667|NCT04734210|Hormones|hormones|mesh-ancestor
92117122|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
92183668|NCT04734210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183669|NCT04734210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183670|NCT04734210|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92183671|NCT04734210|Respiratory System Agents|respiratory system agents|mesh-ancestor
92183672|NCT00267085|Imatinib Mesylate|imatinib mesylate|mesh-list
92183673|NCT00267085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183674|NCT00267085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183675|NCT00267085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183676|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183677|NCT04221451|Venglustat|venglustat|mesh-list
92183678|NCT04221451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183679|NCT04221451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183680|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
92183681|NCT04476511|Vitamin D|vitamin d|mesh-list
92183682|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92183683|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183684|NCT04476511|Vitamins|vitamins|mesh-ancestor
92183685|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
92183686|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92183687|NCT00026221|Interferons|interferons|mesh-list
92183688|NCT00026221|Interferon-alpha|interferon-alpha|mesh-list
92183689|NCT00026221|Bevacizumab|bevacizumab|mesh-list
92183690|NCT00026221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183691|NCT00026221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183692|NCT00026221|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92183693|NCT00026221|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92183694|NCT00026221|Growth Substances|growth substances|mesh-ancestor
92183695|NCT00026221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183696|NCT00026221|Growth Inhibitors|growth inhibitors|mesh-ancestor
92183697|NCT00026221|Antiviral Agents|antiviral agents|mesh-ancestor
92183698|NCT00026221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183699|NCT00026221|Immunologic Factors|immunologic factors|mesh-ancestor
92183700|NCT00028093|Ribavirin|ribavirin|mesh-list
92183701|NCT00028093|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92183702|NCT00028093|Interferon-alpha|interferon-alpha|mesh-list
92183703|NCT00028093|Antimetabolites|antimetabolites|mesh-ancestor
92183704|NCT00028093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183705|NCT00028093|Antiviral Agents|antiviral agents|mesh-ancestor
92183706|NCT00028093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183707|NCT00028093|Immunologic Factors|immunologic factors|mesh-ancestor
92183708|NCT00028093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183709|NCT01721967|Ranolazine|ranolazine|mesh-list
92183710|NCT01721967|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92183711|NCT01721967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183712|NCT01721967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183713|NCT04026451|Propofol|propofol|mesh-list
92183714|NCT04026451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92183715|NCT04026451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92183716|NCT04026451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183717|NCT04026451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92183718|NCT04026451|Anesthetics, General|anesthetics, general|mesh-ancestor
92183719|NCT04026451|Anesthetics|anesthetics|mesh-ancestor
92183720|NCT01722435|Opiate Alkaloids|opiate alkaloids|mesh-list
92183721|NCT01722435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92183722|NCT01722435|Narcotics|narcotics|mesh-ancestor
92183723|NCT01722435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92183724|NCT01722435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183725|NCT01722435|Analgesics|analgesics|mesh-ancestor
92183726|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
92183727|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183728|NCT00029107|Rituximab|rituximab|mesh-list
92183729|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183730|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183731|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
92183732|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183733|NCT00029107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183734|NCT04389229|Aldesleukin|aldesleukin|mesh-list
92183735|NCT04389229|Cyclophosphamide|cyclophosphamide|mesh-list
92183736|NCT04389229|Fludarabine|fludarabine|mesh-list
92183737|NCT04389229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183738|NCT04389229|Immunologic Factors|immunologic factors|mesh-ancestor
92183739|NCT04389229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183740|NCT04389229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183741|NCT04389229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183742|NCT04389229|Alkylating Agents|alkylating agents|mesh-ancestor
92117123|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
92183743|NCT04389229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183744|NCT04389229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183745|NCT04389229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183746|NCT04389229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92183747|NCT04389229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92183748|NCT04389229|Antiviral Agents|antiviral agents|mesh-ancestor
92183749|NCT04389229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183750|NCT03723252|Dapagliflozin|dapagliflozin|mesh-list
92183751|NCT03723252|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92183752|NCT03723252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183753|NCT03723252|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92183754|NCT03723252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183755|NCT05538702|Menthol|menthol|mesh-list
92183756|NCT05538702|Antipruritics|antipruritics|mesh-ancestor
92183757|NCT05538702|Dermatologic Agents|dermatologic agents|mesh-ancestor
92183758|NCT00271219|Buprenorphine|buprenorphine|mesh-list
92183759|NCT00271219|Methadone|methadone|mesh-list
92183760|NCT00271219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92183761|NCT00271219|Narcotics|narcotics|mesh-ancestor
92183762|NCT00271219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92183763|NCT00271219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183764|NCT00271219|Analgesics|analgesics|mesh-ancestor
92183765|NCT00271219|Sensory System Agents|sensory system agents|mesh-ancestor
92183766|NCT00271219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183767|NCT00271219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92183768|NCT00271219|Antitussive Agents|antitussive agents|mesh-ancestor
92183769|NCT00271219|Respiratory System Agents|respiratory system agents|mesh-ancestor
92183770|NCT02240667|Vitamin K|vitamin k|mesh-list
92183771|NCT02240667|Dabigatran|dabigatran|mesh-list
92183772|NCT02240667|Phenprocoumon|phenprocoumon|mesh-list
92183773|NCT02240667|Vitamins|vitamins|mesh-ancestor
92183774|NCT02240667|Micronutrients|micronutrients|mesh-ancestor
92183775|NCT02240667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183776|NCT02240667|Antithrombins|antithrombins|mesh-ancestor
92183777|NCT02240667|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92183778|NCT02240667|Protease Inhibitors|protease inhibitors|mesh-ancestor
92183779|NCT02240667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183780|NCT02240667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183781|NCT02240667|Anticoagulants|anticoagulants|mesh-ancestor
92183782|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92183783|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92183784|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
92183785|NCT02240667|Coagulants|coagulants|mesh-ancestor
92183786|NCT00272311|Aspirin|aspirin|mesh-list
92183787|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92183788|NCT00272311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92183789|NCT00272311|Analgesics|analgesics|mesh-ancestor
92183790|NCT00272311|Sensory System Agents|sensory system agents|mesh-ancestor
92183791|NCT00272311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183792|NCT00272311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183793|NCT00272311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183794|NCT00272311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183795|NCT00272311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92183796|NCT00272311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92183797|NCT00272311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183798|NCT00272311|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92183799|NCT00272311|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92183800|NCT00272311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183801|NCT00272311|Antipyretics|antipyretics|mesh-ancestor
92183802|NCT00038857|Fludarabine|fludarabine|mesh-list
92183803|NCT00038857|Fludarabine phosphate|fludarabine phosphate|mesh-list
92183804|NCT00038857|Melphalan|melphalan|mesh-list
92183805|NCT00038857|Thiotepa|thiotepa|mesh-list
92183806|NCT00038857|Thymoglobulin|thymoglobulin|mesh-list
92183807|NCT00038857|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92183808|NCT00038857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183809|NCT00038857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183810|NCT00038857|Antimetabolites|antimetabolites|mesh-ancestor
92183811|NCT00038857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183812|NCT00038857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183813|NCT00038857|Immunologic Factors|immunologic factors|mesh-ancestor
92183814|NCT00038857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183815|NCT00038857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92183816|NCT00038857|Alkylating Agents|alkylating agents|mesh-ancestor
92183817|NCT00038857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92183818|NCT03097068|Ranibizumab|ranibizumab|mesh-list
92183819|NCT03097068|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92117124|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
92183820|NCT03097068|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92183821|NCT03097068|Growth Substances|growth substances|mesh-ancestor
92183822|NCT03097068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183823|NCT03097068|Growth Inhibitors|growth inhibitors|mesh-ancestor
92183824|NCT03097068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183825|NCT01729845|Cytarabine|cytarabine|mesh-list
92183826|NCT01729845|Etoposide|etoposide|mesh-list
92183827|NCT01729845|Podophyllotoxin|podophyllotoxin|mesh-list
92183828|NCT01729845|Mitoxantrone|mitoxantrone|mesh-list
92183829|NCT01729845|Etoposide phosphate|etoposide phosphate|mesh-list
92183830|NCT01729845|Decitabine|decitabine|mesh-list
92183831|NCT01729845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92183832|NCT01729845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183833|NCT01729845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92183834|NCT01729845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92183835|NCT01729845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183836|NCT01729845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183837|NCT01729845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183839|NCT01729845|Antiviral Agents|antiviral agents|mesh-ancestor
92183840|NCT01729845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92183841|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92183842|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
92183843|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183844|NCT01729845|Analgesics|analgesics|mesh-ancestor
92183845|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
92183846|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183847|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
92183848|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
92183849|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92183850|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92183851|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92183852|NCT01729923|Celecoxib|celecoxib|mesh-list
92183853|NCT01729923|Capecitabine|capecitabine|mesh-list
92183854|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
92183855|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183856|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
92183857|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183858|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183859|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92183860|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92183861|NCT01729923|Analgesics|analgesics|mesh-ancestor
92183862|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
92183863|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183864|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183865|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183866|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183867|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92183868|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92183869|NCT01729923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183870|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92183871|NCT02584452|Dexamethasone|dexamethasone|mesh-list
92183873|NCT02584452|Bupivacaine|bupivacaine|mesh-list
92183874|NCT02584452|Ropivacaine|ropivacaine|mesh-list
92183875|NCT02584452|Mepivacaine|mepivacaine|mesh-list
92183876|NCT02584452|Propofol|propofol|mesh-list
92183877|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183878|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
92183879|NCT02584452|Autonomic Agents|autonomic agents|mesh-ancestor
92183880|NCT02584452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183881|NCT02584452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183882|NCT02584452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92183883|NCT02584452|Glucocorticoids|glucocorticoids|mesh-ancestor
92183884|NCT02584452|Hormones|hormones|mesh-ancestor
92183885|NCT02584452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183886|NCT02584452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92183887|NCT02584452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183888|NCT02584452|Anesthetics, Local|anesthetics, local|mesh-ancestor
92183889|NCT02584452|Anesthetics|anesthetics|mesh-ancestor
92183890|NCT02584452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92183891|NCT02584452|Sensory System Agents|sensory system agents|mesh-ancestor
92183892|NCT02584452|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92183893|NCT02584452|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92183894|NCT02584452|Anesthetics, General|anesthetics, general|mesh-ancestor
92183895|NCT02584452|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92183896|NCT02584452|Narcotics|narcotics|mesh-ancestor
92183897|NCT02584452|Analgesics|analgesics|mesh-ancestor
92183898|NCT02584452|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92183899|NCT02502006|Celecoxib|celecoxib|mesh-list
92183900|NCT02502006|Naproxen|naproxen|mesh-list
92183901|NCT02502006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92183902|NCT02502006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92183903|NCT02502006|Analgesics|analgesics|mesh-ancestor
92183904|NCT02502006|Sensory System Agents|sensory system agents|mesh-ancestor
92183905|NCT02502006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92183906|NCT02502006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183907|NCT02502006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92183908|NCT02502006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92183909|NCT02502006|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92183910|NCT02502006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92183911|NCT02502006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183912|NCT02502006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183913|NCT02502006|Gout Suppressants|gout suppressants|mesh-ancestor
92183914|NCT05679102|Amlodipine|amlodipine|mesh-list
92183915|NCT05679102|Atorvastatin|atorvastatin|mesh-list
92183916|NCT05679102|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92183917|NCT05679102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92183918|NCT05679102|Antimetabolites|antimetabolites|mesh-ancestor
92183919|NCT05679102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183920|NCT05679102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92183921|NCT05679102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92183922|NCT05679102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183923|NCT05679102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92183924|NCT05679102|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92183925|NCT05679102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92183926|NCT05679102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92183927|NCT05679102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183928|NCT05679102|Vasodilator Agents|vasodilator agents|mesh-ancestor
92183929|NCT03520491|Nivolumab|nivolumab|mesh-list
92183931|NCT03520491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183932|NCT03520491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183933|NCT03520491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92183934|NCT03520491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183935|NCT05588934|Caffeine|caffeine|mesh-list
92183936|NCT05588934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92183937|NCT05588934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183938|NCT05588934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92183939|NCT05588934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183940|NCT05588934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183941|NCT05588934|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92183942|NCT05588934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92183943|NCT05588934|Purinergic Agents|purinergic agents|mesh-ancestor
92183944|NCT05588934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92183945|NCT02243007|Paclitaxel|paclitaxel|mesh-list
92183946|NCT02243007|Gemcitabine|gemcitabine|mesh-list
92183947|NCT02243007|Capecitabine|capecitabine|mesh-list
92183949|NCT02243007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92183950|NCT02243007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183951|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92183952|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92183953|NCT02243007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92183954|NCT02243007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183955|NCT02243007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92183956|NCT02243007|Antimetabolites|antimetabolites|mesh-ancestor
92183957|NCT05536596|Hydroxocobalamin|hydroxocobalamin|mesh-list
92183958|NCT05536596|Vitamin B 12|vitamin b 12|mesh-list
92183959|NCT05536596|Melatonin|melatonin|mesh-list
92183960|NCT05536596|Antioxidants|antioxidants|mesh-ancestor
92183961|NCT05536596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183962|NCT05536596|Protective Agents|protective agents|mesh-ancestor
92183963|NCT05536596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183964|NCT05536596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92183965|NCT05536596|Hematinics|hematinics|mesh-ancestor
92183966|NCT05536596|Vitamin B Complex|vitamin b complex|mesh-ancestor
92183967|NCT05536596|Vitamins|vitamins|mesh-ancestor
92183968|NCT05536596|Micronutrients|micronutrients|mesh-ancestor
92183969|NCT03469011|Imatinib Mesylate|imatinib mesylate|mesh-list
92183970|NCT03469011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183971|NCT03469011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92183972|NCT03469011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183973|NCT03469011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183974|NCT05488626|Immunomodulating Agents|immunomodulating agents|mesh-list
92183975|NCT05488626|Immunologic Factors|immunologic factors|mesh-ancestor
92183976|NCT05488626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183977|NCT03430791|Nivolumab|nivolumab|mesh-list
92183978|NCT03430791|Ipilimumab|ipilimumab|mesh-list
92183979|NCT03430791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92183980|NCT03430791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183981|NCT03430791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92183982|NCT03430791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183984|NCT05536128|Olaparib|olaparib|mesh-list
92183985|NCT05536128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92183986|NCT05536128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92183987|NCT05536128|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92183988|NCT05536128|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92183989|NCT05536128|Hormone Antagonists|hormone antagonists|mesh-ancestor
92183990|NCT05536128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92183991|NCT05536128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92183992|NCT05536128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92183993|NCT05536128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92183994|NCT05536128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183995|NCT04790175|Tolvaptan|tolvaptan|mesh-list
92183996|NCT04790175|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92183997|NCT04790175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92183998|NCT04790175|Natriuretic Agents|natriuretic agents|mesh-ancestor
92183999|NCT04790175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184000|NCT05316675|Isotretinoin|isotretinoin|mesh-list
92184001|NCT05316675|Dermatologic Agents|dermatologic agents|mesh-ancestor
92184002|NCT02582814|Dapagliflozin|dapagliflozin|mesh-list
92184003|NCT02582814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92184004|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184005|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92184006|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184007|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
92184009|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92184010|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184011|NCT01736865|Vitamins|vitamins|mesh-ancestor
92184012|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
92184013|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92184014|NCT01736943|Doxorubicin|doxorubicin|mesh-list
92184015|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92184016|NCT01736943|Bortezomib|bortezomib|mesh-list
92184017|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92184018|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184019|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92184020|NCT01736943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92184021|NCT01736943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184022|NCT01736943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184023|NCT01739361|Acetaminophen|acetaminophen|mesh-list
92184024|NCT01739361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92184025|NCT01739361|Analgesics|analgesics|mesh-ancestor
92184026|NCT01739361|Sensory System Agents|sensory system agents|mesh-ancestor
92184027|NCT01739361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184028|NCT01739361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184029|NCT01739361|Antipyretics|antipyretics|mesh-ancestor
92184030|NCT01743729|Lifitegrast|lifitegrast|mesh-list
92184031|NCT01743729|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92184032|NCT01743729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92184033|NCT01744353|Oxaliplatin|oxaliplatin|mesh-list
92184034|NCT01744353|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92184035|NCT01744353|Paclitaxel|paclitaxel|mesh-list
92184036|NCT01744353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184037|NCT01744353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184038|NCT01744353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92184039|NCT01744353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92184040|NCT01744353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92184041|NCT01744353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92184042|NCT01744821|Vitamin D|vitamin d|mesh-list
92184043|NCT01744821|Cholecalciferol|cholecalciferol|mesh-list
92184044|NCT01744821|Vitamins|vitamins|mesh-ancestor
92184045|NCT01744821|Micronutrients|micronutrients|mesh-ancestor
92184046|NCT01744821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184047|NCT01744821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92184048|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92184049|NCT04369365|Azithromycin|azithromycin|mesh-list
92184050|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92184051|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184052|NCT01745055|Methotrexate|methotrexate|mesh-list
92184054|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92184055|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
92184056|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184057|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184058|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92184059|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
92184060|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184061|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184062|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
92184063|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184064|NCT01745055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92184065|NCT01745055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184066|NCT01745055|Immunologic Factors|immunologic factors|mesh-ancestor
92184067|NCT01745055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184068|NCT01745055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92184069|NCT01745055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92184070|NCT01745055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92184071|NCT01745133|Calcitriol|calcitriol|mesh-list
92184072|NCT01745133|Clobetasol|clobetasol|mesh-list
92184073|NCT01745133|Calcipotriene|calcipotriene|mesh-list
92184074|NCT01745133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184075|NCT01745133|Glucocorticoids|glucocorticoids|mesh-ancestor
92184076|NCT01745133|Hormones|hormones|mesh-ancestor
92184077|NCT01745133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184078|NCT01745133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184079|NCT01745133|Dermatologic Agents|dermatologic agents|mesh-ancestor
92184080|NCT01745133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92184081|NCT01745133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92184082|NCT01745133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92184083|NCT01745133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184084|NCT01745133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92184085|NCT01745133|Vitamins|vitamins|mesh-ancestor
92184086|NCT01745133|Micronutrients|micronutrients|mesh-ancestor
92184087|NCT01745133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92184088|NCT05302011|Carboplatin|carboplatin|mesh-list
92184089|NCT05302011|Docetaxel|docetaxel|mesh-list
92184090|NCT05302011|Pembrolizumab|pembrolizumab|mesh-list
92184091|NCT05302011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184092|NCT05302011|Tubulin Modulators|tubulin modulators|mesh-ancestor
92184093|NCT05302011|Antimitotic Agents|antimitotic agents|mesh-ancestor
92184094|NCT05302011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92184095|NCT05302011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184096|NCT05302011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184097|NCT05302011|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92184098|NCT04769271|Tea Tree Oil|tea tree oil|mesh-list
92184099|NCT04769271|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92184101|NCT04246359|Interferons|interferons|mesh-list
92184102|NCT04246359|Rituximab|rituximab|mesh-list
92184103|NCT04246359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184104|NCT04246359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184105|NCT04246359|Immunologic Factors|immunologic factors|mesh-ancestor
92184106|NCT04246359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184107|NCT04246359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184108|NCT04246359|Antiviral Agents|antiviral agents|mesh-ancestor
92184109|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184110|NCT05213169|Apomorphine|apomorphine|mesh-list
92184111|NCT05213169|Emetics|emetics|mesh-ancestor
92184112|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184113|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
92184114|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184115|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184116|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
92184117|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
92184118|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184119|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184120|NCT05192265|Artesunate|artesunate|mesh-list
92184121|NCT05192265|Lumefantrine|lumefantrine|mesh-list
92184122|NCT05192265|Artemether|artemether|mesh-list
92184123|NCT05192265|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92184124|NCT05192265|Pyronaridine|pyronaridine|mesh-list
92184125|NCT05192265|Antimalarials|antimalarials|mesh-list
92184126|NCT05192265|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92184127|NCT05192265|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92184128|NCT05192265|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92184129|NCT05192265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184130|NCT05192265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184131|NCT05192265|Antiviral Agents|antiviral agents|mesh-ancestor
92184132|NCT05192265|Schistosomicides|schistosomicides|mesh-ancestor
92184133|NCT05192265|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92184134|NCT05192265|Anthelmintics|anthelmintics|mesh-ancestor
92184136|NCT01748643|Rocuronium|rocuronium|mesh-list
92184137|NCT01748643|Neostigmine|neostigmine|mesh-list
92184138|NCT01748643|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92184139|NCT01748643|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92184140|NCT01748643|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92184141|NCT01748643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184142|NCT01748643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184143|NCT01748643|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92184144|NCT01748643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184145|NCT01748643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184146|NCT01748643|Cholinergic Agents|cholinergic agents|mesh-ancestor
92184147|NCT01748643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184148|NCT01748643|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92184149|NCT01748643|Autonomic Agents|autonomic agents|mesh-ancestor
92184150|NCT01748643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92184151|NCT01748643|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92184152|NCT01748643|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92184153|NCT00106535|Methotrexate|methotrexate|mesh-list
92184154|NCT00106535|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92184155|NCT00106535|Abortifacient Agents|abortifacient agents|mesh-ancestor
92184156|NCT00106535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184157|NCT00106535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184158|NCT00106535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92184159|NCT00106535|Antimetabolites|antimetabolites|mesh-ancestor
92184160|NCT00106535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184161|NCT00106535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184162|NCT00106535|Dermatologic Agents|dermatologic agents|mesh-ancestor
92184163|NCT00106535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184164|NCT00106535|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92184165|NCT00106535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184166|NCT00106535|Immunologic Factors|immunologic factors|mesh-ancestor
92184167|NCT00106535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184168|NCT00106535|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92184169|NCT01748799|Ethanol|ethanol|mesh-list
92184170|NCT01748799|Nabiximols|nabiximols|mesh-list
92184171|NCT01748799|Dronabinol|dronabinol|mesh-list
92184172|NCT01748799|Cannabidiol|cannabidiol|mesh-list
92184173|NCT01748799|Peppermint oil|peppermint oil|mesh-list
92184174|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
92184175|NCT01748799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92184176|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184177|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184178|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184179|NCT01748799|Analgesics|analgesics|mesh-ancestor
92184180|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
92184181|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184182|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
92184183|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184184|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92184185|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92184186|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92184187|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184188|NCT01748799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184189|NCT01748799|Hormones|hormones|mesh-ancestor
92184190|NCT01748799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184191|NCT01748799|Antiemetics|antiemetics|mesh-ancestor
92184192|NCT01748799|Autonomic Agents|autonomic agents|mesh-ancestor
92184193|NCT01748799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184194|NCT01748799|Parasympatholytics|parasympatholytics|mesh-ancestor
92184195|NCT04107051|Nalmefene|nalmefene|mesh-list
92184196|NCT04107051|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92184197|NCT04107051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184198|NCT04107051|Sensory System Agents|sensory system agents|mesh-ancestor
92184199|NCT04107051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184200|NCT05696886|Meperidine|meperidine|mesh-list
92184201|NCT05696886|Tramadol|tramadol|mesh-list
92184202|NCT05696886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92184203|NCT05696886|Narcotics|narcotics|mesh-ancestor
92184204|NCT05696886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184205|NCT05696886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184206|NCT05696886|Analgesics|analgesics|mesh-ancestor
92184207|NCT05696886|Sensory System Agents|sensory system agents|mesh-ancestor
92184208|NCT05696886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184209|NCT05696886|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92184210|NCT01748955|Bupropion|bupropion|mesh-list
92184211|NCT01748955|Paroxetine|paroxetine|mesh-list
92184212|NCT01748955|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92184213|NCT01748955|Antidepressive Agents|antidepressive agents|mesh-ancestor
92184214|NCT01748955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184215|NCT01748955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92184216|NCT01748955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92184217|NCT01748955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92184218|NCT01748955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184219|NCT01748955|Dopamine Agents|dopamine agents|mesh-ancestor
92184220|NCT01748955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184221|NCT01748955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184222|NCT01748955|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92184223|NCT01748955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92184224|NCT01748955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184225|NCT01748955|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92184226|NCT01748955|Serotonin Agents|serotonin agents|mesh-ancestor
92184227|NCT05687448|Warfarin|warfarin|mesh-list
92184228|NCT05687448|Apixaban|apixaban|mesh-list
92184229|NCT05687448|Anticoagulants|anticoagulants|mesh-ancestor
92184230|NCT05687448|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92184231|NCT05687448|Antithrombins|antithrombins|mesh-ancestor
92184232|NCT05687448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92184233|NCT05687448|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184234|NCT05687448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184235|NCT05687448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184236|NCT05156268|Pembrolizumab|pembrolizumab|mesh-list
92184237|NCT05156268|Olaparib|olaparib|mesh-list
92184238|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184239|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184240|NCT05156268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92184241|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184242|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92184243|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184244|NCT01749501|Rocuronium|rocuronium|mesh-list
92184245|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92184246|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92184247|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92184248|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184249|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184250|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92184251|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92184252|NCT02255175|Estradiol|estradiol|mesh-list
92184253|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92184254|NCT02255175|Progesterone|progesterone|mesh-list
92184255|NCT02255175|Estrogens|estrogens|mesh-ancestor
92184256|NCT02255175|Hormones|hormones|mesh-ancestor
92184257|NCT02255175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184258|NCT02255175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184259|NCT02255175|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92184260|NCT02255175|Contraceptive Agents|contraceptive agents|mesh-ancestor
92184261|NCT02255175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184262|NCT02255175|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92184263|NCT02255175|Progestins|progestins|mesh-ancestor
92184264|NCT02585778|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92184265|NCT02585778|Alirocumab|alirocumab|mesh-list
92184266|NCT02585778|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92184267|NCT02585778|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92184268|NCT02585778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92184269|NCT02585778|Antimetabolites|antimetabolites|mesh-ancestor
92184270|NCT02585778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184271|NCT02585778|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92184272|NCT02585778|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184273|NCT02585778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184274|NCT02585778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92184275|NCT02585778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184276|NCT03899103|Mycophenolic Acid|mycophenolic acid|mesh-list
92184277|NCT03899103|Rituximab|rituximab|mesh-list
92184278|NCT03899103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184279|NCT03899103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184280|NCT03899103|Immunologic Factors|immunologic factors|mesh-ancestor
92184281|NCT03899103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184282|NCT03899103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184283|NCT03899103|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92184284|NCT03899103|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92184285|NCT03899103|Antitubercular Agents|antitubercular agents|mesh-ancestor
92184286|NCT03899103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92184287|NCT03899103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184288|NCT03899103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184289|NCT03899103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184290|NCT01751451|Abiraterone Acetate|abiraterone acetate|mesh-list
92184291|NCT01751451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184292|NCT01751451|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92184293|NCT01751451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184294|NCT01751451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184295|NCT01751451|Hormone Antagonists|hormone antagonists|mesh-ancestor
92184296|NCT01751451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184297|NCT01751451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184298|NCT01751451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92184299|NCT01438424|Lamivudine|lamivudine|mesh-list
92184300|NCT01438424|Entecavir|entecavir|mesh-list
92184301|NCT01438424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92184302|NCT01438424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92184303|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184304|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184305|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
92184306|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184307|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92184308|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92184309|NCT02580240|Hydrocortisone|hydrocortisone|mesh-list
92184310|NCT02580240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184311|NCT01465958|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92184312|NCT01465958|gamma-Globulins|gamma-globulins|mesh-list
92184313|NCT01465958|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92184314|NCT01465958|Immunoglobulin G|immunoglobulin g|mesh-list
92184315|NCT01465958|Immunologic Factors|immunologic factors|mesh-ancestor
92184316|NCT01465958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184317|NCT05299866|Ketamine|ketamine|mesh-list
92184318|NCT05299866|Esketamine|esketamine|mesh-list
92184319|NCT05299866|Analgesics|analgesics|mesh-ancestor
92184320|NCT05299866|Sensory System Agents|sensory system agents|mesh-ancestor
92184321|NCT05299866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184322|NCT05299866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184323|NCT05299866|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92184324|NCT05299866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92184325|NCT05299866|Anesthetics, General|anesthetics, general|mesh-ancestor
92184326|NCT05299866|Anesthetics|anesthetics|mesh-ancestor
92184327|NCT05299866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184328|NCT05299866|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92184329|NCT05299866|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92184330|NCT05299866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184331|NCT05299866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184332|NCT05299866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92184333|NCT05299866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184334|NCT04133376|Nicotine|nicotine|mesh-list
92184335|NCT04133376|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92184336|NCT04133376|Autonomic Agents|autonomic agents|mesh-ancestor
92184337|NCT04133376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184338|NCT04133376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184339|NCT04133376|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92184340|NCT04133376|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92184341|NCT04133376|Cholinergic Agents|cholinergic agents|mesh-ancestor
92184342|NCT04133376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184343|NCT04133376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184344|NCT01753557|Interferon alpha-2|interferon alpha-2|mesh-list
92184345|NCT01753557|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92184346|NCT01753557|Antiviral Agents|antiviral agents|mesh-ancestor
92184347|NCT01753557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184348|NCT01753557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184349|NCT05267886|Dobutamine|dobutamine|mesh-list
92184350|NCT05267886|Milrinone|milrinone|mesh-list
92184351|NCT05267886|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92184352|NCT05267886|Sympathomimetics|sympathomimetics|mesh-ancestor
92184353|NCT05267886|Autonomic Agents|autonomic agents|mesh-ancestor
92184354|NCT05267886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184355|NCT05267886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184356|NCT05267886|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92184357|NCT05267886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92184358|NCT05267886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92184359|NCT05267886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92184360|NCT05267886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184361|NCT05267886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184362|NCT05267886|Protective Agents|protective agents|mesh-ancestor
92184363|NCT05267886|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92184364|NCT05267886|Vasodilator Agents|vasodilator agents|mesh-ancestor
92184365|NCT05267886|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92184366|NCT05267886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92184367|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184368|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
92184369|NCT02250807|Simeprevir|simeprevir|mesh-list
92184370|NCT02250807|Antiviral Agents|antiviral agents|mesh-ancestor
92184371|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184372|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184373|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184374|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184375|NCT05694936|Cetuximab|cetuximab|mesh-list
92184376|NCT05694936|Panitumumab|panitumumab|mesh-list
92184377|NCT05694936|Valproic Acid|valproic acid|mesh-list
92184378|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184379|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184380|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
92184381|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184382|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184383|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
92184384|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184385|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184386|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
92184387|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184388|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184389|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184390|NCT00168389|Dexamethasone|dexamethasone|mesh-list
92184391|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184392|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
92184393|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
92184394|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184395|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184396|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184397|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
92184398|NCT00168389|Hormones|hormones|mesh-ancestor
92184399|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184400|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92184402|NCT02252445|Propofol|propofol|mesh-list
92184403|NCT02252445|Sevoflurane|sevoflurane|mesh-list
92184404|NCT02252445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92184405|NCT02252445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184406|NCT02252445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184407|NCT02252445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92184408|NCT02252445|Anesthetics, General|anesthetics, general|mesh-ancestor
92184409|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
92184410|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92184411|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92184412|NCT04592952|Calcitonin|calcitonin|mesh-list
92184413|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
92184414|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92184415|NCT04592952|Erenumab|erenumab|mesh-list
92184416|NCT04592952|Katacalcin|katacalcin|mesh-list
92184417|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92184418|NCT04592952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184419|NCT04592952|Analgesics|analgesics|mesh-ancestor
92184420|NCT04592952|Sensory System Agents|sensory system agents|mesh-ancestor
92184421|NCT04592952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184422|NCT04592952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184423|NCT04592952|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92184424|NCT04592952|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92184425|NCT04592952|Vasodilator Agents|vasodilator agents|mesh-ancestor
92184426|NCT00176423|Galantamine|galantamine|mesh-list
91916358|NCT03962114|Micronutrients|micronutrients|mesh-ancestor
92184427|NCT00176423|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92184428|NCT00176423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184429|NCT00176423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184430|NCT00176423|Cholinergic Agents|cholinergic agents|mesh-ancestor
92184431|NCT00176423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184432|NCT00176423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184433|NCT00176423|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92184434|NCT00176423|Autonomic Agents|autonomic agents|mesh-ancestor
92184435|NCT00176423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184436|NCT00176423|Nootropic Agents|nootropic agents|mesh-ancestor
92184438|NCT02094443|Antimetabolites|antimetabolites|mesh-ancestor
92184439|NCT02094443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184440|NCT02094443|Antiviral Agents|antiviral agents|mesh-ancestor
92184441|NCT02094443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184442|NCT00110513|Antithrombins|antithrombins|mesh-list
92184443|NCT00110513|Antithrombin III|antithrombin iii|mesh-list
92184444|NCT00110513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92184445|NCT00110513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184446|NCT00110513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184447|NCT00110513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184448|NCT00110513|Anticoagulants|anticoagulants|mesh-ancestor
92184449|NCT05691426|Nitric Oxide|nitric oxide|mesh-list
92184450|NCT05691426|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92184451|NCT05691426|Autonomic Agents|autonomic agents|mesh-ancestor
92184452|NCT05691426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184453|NCT05691426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184454|NCT05691426|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92184455|NCT05691426|Respiratory System Agents|respiratory system agents|mesh-ancestor
92184456|NCT05691426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92184457|NCT05691426|Antioxidants|antioxidants|mesh-ancestor
92184458|NCT05691426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184459|NCT05691426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184460|NCT05691426|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92184461|NCT05691426|Vasodilator Agents|vasodilator agents|mesh-ancestor
92184462|NCT05691426|Gasotransmitters|gasotransmitters|mesh-ancestor
92184463|NCT05691426|Protective Agents|protective agents|mesh-ancestor
92184464|NCT05696574|Misoprostol|misoprostol|mesh-list
92184465|NCT05696574|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92184466|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
92184467|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184468|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184469|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92184470|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184471|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
92184472|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
92184473|NCT00112151|Testosterone|testosterone|mesh-list
92184474|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
92184475|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
92184476|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92184477|NCT00112151|Androgens|androgens|mesh-ancestor
92184478|NCT00112151|Hormones|hormones|mesh-ancestor
92184479|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184480|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184481|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92184482|NCT00112151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184483|NCT00112151|Anabolic Agents|anabolic agents|mesh-ancestor
92184484|NCT05162742|Colchicine|colchicine|mesh-list
92184485|NCT05162742|Gout Suppressants|gout suppressants|mesh-ancestor
92184486|NCT05162742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184487|NCT05162742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92184488|NCT05162742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92184489|NCT05162742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92184490|NCT05162742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184491|NCT05162742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184492|NCT04303026|Zoledronic Acid|zoledronic acid|mesh-list
92184493|NCT04303026|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92184494|NCT04303026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184495|NCT00113321|Decitabine|decitabine|mesh-list
92184496|NCT00113321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92184497|NCT00113321|Antimetabolites|antimetabolites|mesh-ancestor
92184498|NCT00113321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184499|NCT00113321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184500|NCT00113321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184501|NCT05669742|Empagliflozin|empagliflozin|mesh-list
92184502|NCT05669742|Olanzapine|olanzapine|mesh-list
91916971|NCT01564979|Botulinum Toxins|botulinum toxins|mesh-list
92184503|NCT05669742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92184504|NCT05669742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184505|NCT05669742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92184506|NCT05669742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184507|NCT05669742|Antiemetics|antiemetics|mesh-ancestor
92184508|NCT05669742|Autonomic Agents|autonomic agents|mesh-ancestor
92184509|NCT05669742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184510|NCT05669742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184511|NCT05669742|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92184512|NCT05669742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184513|NCT05669742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184514|NCT05669742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184515|NCT05669742|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92184516|NCT05669742|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92184517|NCT05669742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92184518|NCT05669742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184519|NCT05669742|Serotonin Agents|serotonin agents|mesh-ancestor
92184520|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
92184521|NCT00177047|Melphalan|melphalan|mesh-list
92184522|NCT00177047|Lenograstim|lenograstim|mesh-list
92184523|NCT00177047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184524|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
92184525|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184526|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184527|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92184528|NCT00177047|Alkylating Agents|alkylating agents|mesh-ancestor
92184529|NCT00177047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184530|NCT00177047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184531|NCT00177047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92184532|NCT00177047|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92184533|NCT03573921|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92184534|NCT00178841|Rosiglitazone|rosiglitazone|mesh-list
92184535|NCT00178841|Bexarotene|bexarotene|mesh-list
92184536|NCT00178841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92184537|NCT00178841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184538|NCT00178841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184539|NCT01756209|Acetaminophen|acetaminophen|mesh-list
92184540|NCT01756209|Ibuprofen|ibuprofen|mesh-list
92184541|NCT01756209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92184542|NCT01756209|Analgesics|analgesics|mesh-ancestor
92184543|NCT01756209|Sensory System Agents|sensory system agents|mesh-ancestor
92184544|NCT01756209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184545|NCT01756209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184546|NCT01756209|Antipyretics|antipyretics|mesh-ancestor
92184547|NCT01756209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92184548|NCT01756209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184549|NCT01756209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184550|NCT01756209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92184551|NCT01756209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184552|NCT01756209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184553|NCT00116207|Niacinamide|niacinamide|mesh-list
92184554|NCT00116207|Allopurinol|allopurinol|mesh-list
92184555|NCT00116207|Antioxidants|antioxidants|mesh-list
92184556|NCT00116207|Antimetabolites|antimetabolites|mesh-ancestor
92184557|NCT00116207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184558|NCT00116207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184559|NCT00116207|Gout Suppressants|gout suppressants|mesh-ancestor
92184560|NCT00116207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184561|NCT00116207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92184562|NCT00116207|Protective Agents|protective agents|mesh-ancestor
92184563|NCT00116207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184564|NCT00116207|Vitamin B Complex|vitamin b complex|mesh-ancestor
92184565|NCT00116207|Vitamins|vitamins|mesh-ancestor
92184566|NCT00116207|Micronutrients|micronutrients|mesh-ancestor
92184567|NCT04129398|Letermovir|letermovir|mesh-list
92184568|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92184569|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184570|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184571|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184572|NCT04129398|Antiviral Agents|antiviral agents|mesh-ancestor
92184573|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184574|NCT00178919|Trimethaphan|trimethaphan|mesh-list
92184575|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
92184576|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184577|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92184578|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92184579|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92184580|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
92184581|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184582|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184583|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92184584|NCT00178919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92184585|NCT00178919|Cholinergic Agents|cholinergic agents|mesh-ancestor
92184586|NCT00178919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184587|NCT00178919|Vasodilator Agents|vasodilator agents|mesh-ancestor
92184588|NCT05609682|Gabapentin|gabapentin|mesh-list
92184589|NCT05609682|Analgesics|analgesics|mesh-ancestor
92184590|NCT05609682|Sensory System Agents|sensory system agents|mesh-ancestor
92184591|NCT05609682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184592|NCT05609682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184593|NCT05609682|Anticonvulsants|anticonvulsants|mesh-ancestor
92184594|NCT05609682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92184595|NCT05609682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184596|NCT05609682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184597|NCT05609682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184598|NCT05609682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92184599|NCT05609682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92184600|NCT05609682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184601|NCT05609682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184602|NCT05609682|Antimanic Agents|antimanic agents|mesh-ancestor
92184603|NCT04284839|Warfarin|warfarin|mesh-list
92184604|NCT04284839|Rivaroxaban|rivaroxaban|mesh-list
92184605|NCT04284839|Dabigatran|dabigatran|mesh-list
92184606|NCT04284839|Apixaban|apixaban|mesh-list
92184607|NCT04284839|Edoxaban|edoxaban|mesh-list
92184608|NCT04284839|Anticoagulants|anticoagulants|mesh-ancestor
92184609|NCT04284839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92184610|NCT04284839|Antithrombins|antithrombins|mesh-ancestor
92184611|NCT04284839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92184612|NCT04284839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184613|NCT04284839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184614|NCT04284839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184615|NCT05577000|Cyclophosphamide|cyclophosphamide|mesh-list
92184616|NCT05577000|Fludarabine|fludarabine|mesh-list
92184617|NCT05577000|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
92184618|NCT05577000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184619|NCT05577000|Immunologic Factors|immunologic factors|mesh-ancestor
92184620|NCT05577000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184621|NCT05577000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184622|NCT05577000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92184623|NCT05577000|Alkylating Agents|alkylating agents|mesh-ancestor
92184624|NCT05577000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184625|NCT05577000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184627|NCT05577000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184628|NCT00122369|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92184629|NCT00122369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184630|NCT00122369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184631|NCT00122447|Aspirin|aspirin|mesh-list
92184632|NCT00122447|Thioctic Acid|thioctic acid|mesh-list
92184633|NCT00122447|Olmesartan|olmesartan|mesh-list
92184634|NCT00122447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92184635|NCT00122447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92184636|NCT00122447|Analgesics|analgesics|mesh-ancestor
92184637|NCT00122447|Sensory System Agents|sensory system agents|mesh-ancestor
92184638|NCT00122447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184639|NCT00122447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184640|NCT00122447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184641|NCT00122447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184642|NCT00122447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92184643|NCT00122447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92184644|NCT00122447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184645|NCT00122447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92184646|NCT00122447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92184647|NCT00122447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184648|NCT00122447|Antipyretics|antipyretics|mesh-ancestor
92184649|NCT00122447|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92184650|NCT00122447|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92184651|NCT00122447|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92184652|NCT00122447|Antioxidants|antioxidants|mesh-ancestor
92184653|NCT00122447|Protective Agents|protective agents|mesh-ancestor
92184654|NCT00122447|Vitamin B Complex|vitamin b complex|mesh-ancestor
92184655|NCT00122447|Vitamins|vitamins|mesh-ancestor
92184656|NCT00122447|Micronutrients|micronutrients|mesh-ancestor
92184657|NCT00125957|Bupropion|bupropion|mesh-list
92184658|NCT00125957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92184659|NCT00125957|Antidepressive Agents|antidepressive agents|mesh-ancestor
92184660|NCT00125957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184661|NCT00125957|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92184662|NCT00125957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92184663|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92184664|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184665|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
92184666|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184667|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184668|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92184669|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92184670|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184671|NCT00183443|Valproic Acid|valproic acid|mesh-list
92184672|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92184673|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
92184674|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184675|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92184676|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184677|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184678|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184679|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184680|NCT00183443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184681|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
92184682|NCT00183443|Anticonvulsants|anticonvulsants|mesh-ancestor
92184683|NCT00183443|GABA Agents|gaba agents|mesh-ancestor
92184684|NCT00183443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184685|NCT02579928|Midazolam|midazolam|mesh-list
92184686|NCT02579928|Ketamine|ketamine|mesh-list
92184687|NCT02579928|Analgesics|analgesics|mesh-ancestor
92184688|NCT02579928|Sensory System Agents|sensory system agents|mesh-ancestor
92184689|NCT02579928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184690|NCT02579928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184691|NCT02579928|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92184692|NCT02579928|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92184693|NCT02579928|Anesthetics, General|anesthetics, general|mesh-ancestor
92184694|NCT02579928|Anesthetics|anesthetics|mesh-ancestor
92184695|NCT02579928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184696|NCT02579928|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92184697|NCT02579928|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92184698|NCT02579928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184699|NCT02579928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184700|NCT02579928|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92184701|NCT02579928|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92184702|NCT02579928|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92184703|NCT02579928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184704|NCT02579928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184705|NCT02579928|GABA Modulators|gaba modulators|mesh-ancestor
92184706|NCT02579928|GABA Agents|gaba agents|mesh-ancestor
92184707|NCT00183677|Escitalopram|escitalopram|mesh-list
92184708|NCT00183677|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92184709|NCT00183677|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92184710|NCT00183677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92184711|NCT00183677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184712|NCT00183677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184713|NCT00183677|Serotonin Agents|serotonin agents|mesh-ancestor
92184714|NCT00183677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184716|NCT00186017|Antiemetics|antiemetics|mesh-ancestor
92184717|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
92184718|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184719|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184720|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184721|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92184722|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184723|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184724|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184725|NCT00186017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92184726|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92184727|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92184728|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184729|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184730|NCT00186017|Serotonin Agents|serotonin agents|mesh-ancestor
92184731|NCT00041119|Paclitaxel|paclitaxel|mesh-list
92184732|NCT00041119|Cyclophosphamide|cyclophosphamide|mesh-list
92184733|NCT00041119|Doxorubicin|doxorubicin|mesh-list
92184734|NCT00041119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92184735|NCT00041119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92184736|NCT00041119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184737|NCT00041119|Tubulin Modulators|tubulin modulators|mesh-ancestor
92184738|NCT00041119|Antimitotic Agents|antimitotic agents|mesh-ancestor
92184739|NCT00041119|Mitosis Modulators|mitosis modulators|mesh-ancestor
92184740|NCT00041119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184741|NCT00041119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184742|NCT00041119|Immunologic Factors|immunologic factors|mesh-ancestor
92184743|NCT00041119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184744|NCT00041119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184745|NCT00041119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92184746|NCT00041119|Alkylating Agents|alkylating agents|mesh-ancestor
92184747|NCT00041119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92184748|NCT00041119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92184749|NCT00041119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92184750|NCT00041119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92184751|NCT00041119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184752|NCT00186875|Cytarabine|cytarabine|mesh-list
92184753|NCT00186875|Dexamethasone|dexamethasone|mesh-list
92184754|NCT00186875|Dexamethasone acetate|dexamethasone acetate|mesh-list
92184755|NCT00186875|Cyclophosphamide|cyclophosphamide|mesh-list
92184756|NCT00186875|Methotrexate|methotrexate|mesh-list
92184757|NCT00186875|Etoposide|etoposide|mesh-list
92184758|NCT00186875|Etoposide phosphate|etoposide phosphate|mesh-list
92184759|NCT00186875|Vincristine|vincristine|mesh-list
92184760|NCT00186875|Asparaginase|asparaginase|mesh-list
92184761|NCT00186875|Mitoxantrone|mitoxantrone|mesh-list
92184762|NCT00186875|Mercaptopurine|mercaptopurine|mesh-list
92184763|NCT00186875|Vinblastine|vinblastine|mesh-list
92184764|NCT00186875|Pegaspargase|pegaspargase|mesh-list
92184765|NCT00186875|Teniposide|teniposide|mesh-list
92184766|NCT00186875|BB 1101|bb 1101|mesh-list
92184767|NCT00186875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184768|NCT00186875|Immunologic Factors|immunologic factors|mesh-ancestor
92184769|NCT00186875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184770|NCT00186875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184771|NCT00186875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92184772|NCT00186875|Alkylating Agents|alkylating agents|mesh-ancestor
92184773|NCT00186875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184774|NCT00186875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184775|NCT00186875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92184776|NCT00186875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184778|NCT00186875|Autonomic Agents|autonomic agents|mesh-ancestor
92184779|NCT00186875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184780|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184781|NCT00186875|Glucocorticoids|glucocorticoids|mesh-ancestor
92184782|NCT00186875|Hormones|hormones|mesh-ancestor
92184783|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184784|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92184785|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184786|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184787|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92184788|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
92184789|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184790|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92184791|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
92184792|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92184793|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92184794|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92184795|NCT00186875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92184796|NCT00186875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92184797|NCT00186875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92184798|NCT00186875|Antiviral Agents|antiviral agents|mesh-ancestor
92184799|NCT00186875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184800|NCT00186875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92184801|NCT00186875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92184802|NCT00186875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92184803|NCT00186875|Analgesics|analgesics|mesh-ancestor
92184804|NCT00186875|Sensory System Agents|sensory system agents|mesh-ancestor
92184805|NCT00551460|Methotrexate|methotrexate|mesh-list
92184806|NCT00551460|Mercaptopurine|mercaptopurine|mesh-list
92184807|NCT00551460|Arsenic Trioxide|arsenic trioxide|mesh-list
92184808|NCT00551460|Tretinoin|tretinoin|mesh-list
92184809|NCT00551460|Gemtuzumab|gemtuzumab|mesh-list
92184810|NCT00551460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92184811|NCT00551460|Abortifacient Agents|abortifacient agents|mesh-ancestor
92184812|NCT00551460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184813|NCT00551460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184814|NCT00551460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92184815|NCT00551460|Antimetabolites|antimetabolites|mesh-ancestor
92184816|NCT00551460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184817|NCT00551460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184818|NCT00551460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92184819|NCT00551460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184820|NCT00551460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92184821|NCT00551460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184822|NCT00551460|Immunologic Factors|immunologic factors|mesh-ancestor
92184823|NCT00551460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184824|NCT00551460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92184825|NCT00551460|Keratolytic Agents|keratolytic agents|mesh-ancestor
92184826|NCT00551460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92184827|NCT00551460|Immunotoxins|immunotoxins|mesh-ancestor
92184828|NCT00551460|Immunoconjugates|immunoconjugates|mesh-ancestor
92184829|NCT04751227|Modafinil|modafinil|mesh-list
92184830|NCT04751227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92184831|NCT04751227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184832|NCT04751227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92184833|NCT04751227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92184834|NCT04751227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92184835|NCT04751227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184836|NCT02579772|Acetylcysteine|acetylcysteine|mesh-list
92184837|NCT02579772|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92184838|NCT02579772|Antiviral Agents|antiviral agents|mesh-ancestor
92184839|NCT02579772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184840|NCT02579772|Expectorants|expectorants|mesh-ancestor
92184841|NCT02579772|Respiratory System Agents|respiratory system agents|mesh-ancestor
92184842|NCT02579772|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92184843|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
92184844|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184845|NCT02579772|Protective Agents|protective agents|mesh-ancestor
92184846|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184847|NCT02579772|Antidotes|antidotes|mesh-ancestor
92184848|NCT05535036|Dexamethasone|dexamethasone|mesh-list
92184849|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184850|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
92184851|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
92184852|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184853|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184855|NCT05535036|Glucocorticoids|glucocorticoids|mesh-ancestor
92184856|NCT05535036|Hormones|hormones|mesh-ancestor
92184857|NCT05535036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184858|NCT05535036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92184859|NCT05535036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184860|NCT00044005|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92184861|NCT00044005|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92184862|NCT00044005|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92184863|NCT00044005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184864|NCT00044005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184865|NCT00044005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92184866|NCT00044005|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92184867|NCT00044005|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92184868|NCT00044005|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92184869|NCT00044005|Adrenergic Agents|adrenergic agents|mesh-ancestor
92184870|NCT00044005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184871|NCT00044005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184872|NCT00044005|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92184873|NCT00044005|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92184874|NCT00044005|Serotonin Agents|serotonin agents|mesh-ancestor
92184875|NCT00044005|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92184876|NCT00044005|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92184877|NCT00044005|Dopamine Agents|dopamine agents|mesh-ancestor
92184878|NCT02989701|Plerixafor|plerixafor|mesh-list
92184879|NCT02989701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92184880|NCT02989701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92184881|NCT02989701|Antiviral Agents|antiviral agents|mesh-ancestor
92184882|NCT02989701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184883|NCT01790737|Cyclophosphamide|cyclophosphamide|mesh-list
92184884|NCT01790737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92184885|NCT01790737|Immunologic Factors|immunologic factors|mesh-ancestor
92184886|NCT01790737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184887|NCT01790737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184888|NCT01790737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92184889|NCT01790737|Alkylating Agents|alkylating agents|mesh-ancestor
92184890|NCT01790737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184891|NCT01790737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184892|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92184893|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
92184894|NCT04953156|Dexmedetomidine|dexmedetomidine|mesh-list
92184895|NCT04953156|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92184896|NCT04953156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184897|NCT04953156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184898|NCT04953156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92184899|NCT04953156|Analgesics|analgesics|mesh-ancestor
92184900|NCT04953156|Sensory System Agents|sensory system agents|mesh-ancestor
92184901|NCT04953156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184902|NCT04953156|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92184903|NCT04953156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92184904|NCT04953156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92184905|NCT04953156|Adrenergic Agents|adrenergic agents|mesh-ancestor
92184906|NCT04953156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92184907|NCT04953156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184908|NCT04953156|Vasodilator Agents|vasodilator agents|mesh-ancestor
92184909|NCT01761747|Ponatinib|ponatinib|mesh-list
92184910|NCT01761747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184911|NCT01761747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92184912|NCT01761747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184913|NCT01761747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184914|NCT00045487|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92184915|NCT00045487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184916|NCT00045487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92184917|NCT00045487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184918|NCT00045487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184919|NCT00278863|Capecitabine|capecitabine|mesh-list
92184920|NCT00278863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92184921|NCT00278863|Antimetabolites|antimetabolites|mesh-ancestor
92184922|NCT00278863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184923|NCT00278863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184924|NCT01762059|Pancrelipase|pancrelipase|mesh-list
92184925|NCT01762059|Pancreatin|pancreatin|mesh-list
92184926|NCT01762059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184927|NCT04938024|Ascorbic Acid|ascorbic acid|mesh-list
92184928|NCT04938024|Vitamins|vitamins|mesh-ancestor
92184929|NCT04938024|Micronutrients|micronutrients|mesh-ancestor
92184930|NCT04938024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184931|NCT04938024|Antioxidants|antioxidants|mesh-ancestor
92184932|NCT04938024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184933|NCT04938024|Protective Agents|protective agents|mesh-ancestor
92184934|NCT01808547|Bromfenac|bromfenac|mesh-list
92184935|NCT01808547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92184936|NCT01808547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92184937|NCT01808547|Analgesics|analgesics|mesh-ancestor
92184938|NCT01808547|Sensory System Agents|sensory system agents|mesh-ancestor
92184939|NCT01808547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184940|NCT01808547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184941|NCT01808547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92184942|NCT01808547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92184943|NCT00187655|Cefotaxime|cefotaxime|mesh-list
92184944|NCT00187655|Cefoxitin|cefoxitin|mesh-list
92184945|NCT00187655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92184946|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184947|NCT02991651|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92184948|NCT02991651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184949|NCT02991651|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92184950|NCT02991651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184951|NCT02991651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184952|NCT02579616|Lenvatinib|lenvatinib|mesh-list
92184953|NCT02579616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184954|NCT02579616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92184955|NCT02579616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184956|NCT02579616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184957|NCT00131885|Levonorgestrel|levonorgestrel|mesh-list
92184958|NCT00131885|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92184959|NCT00131885|Contraceptive Agents|contraceptive agents|mesh-ancestor
92184960|NCT00131885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92184961|NCT00131885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184962|NCT00131885|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92184963|NCT00131885|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92184964|NCT00131885|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92184965|NCT05534802|Urinastatin|urinastatin|mesh-list
92184966|NCT05534802|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92184967|NCT05534802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92184968|NCT05534802|Protease Inhibitors|protease inhibitors|mesh-ancestor
92184969|NCT05534802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92184970|NCT05534802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92184971|NCT01899703|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92184972|NCT01899703|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92184973|NCT01899703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92184974|NCT01899781|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92184975|NCT01899781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92184976|NCT01790893|Aflibercept|aflibercept|mesh-list
92184977|NCT01790893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92184978|NCT01790893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92184979|NCT01790893|Growth Substances|growth substances|mesh-ancestor
92184980|NCT01790893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184981|NCT01790893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92184982|NCT01790893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92184983|NCT02256111|Androgens|androgens|mesh-list
92184984|NCT02256111|Hormones|hormones|mesh-ancestor
92184985|NCT02256111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92184986|NCT02256111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184987|NCT01790971|Morphine|morphine|mesh-list
92184988|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92184989|NCT01790971|Narcotics|narcotics|mesh-ancestor
92184990|NCT01790971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92184991|NCT01790971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92184992|NCT01790971|Analgesics|analgesics|mesh-ancestor
92184993|NCT01790971|Sensory System Agents|sensory system agents|mesh-ancestor
92184994|NCT01790971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92184995|NCT00189137|Gemcitabine|gemcitabine|mesh-list
92184996|NCT00189137|Docetaxel|docetaxel|mesh-list
92184997|NCT00189137|Doxorubicin|doxorubicin|mesh-list
92185000|NCT00189137|Antimetabolites|antimetabolites|mesh-ancestor
92185001|NCT00189137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185002|NCT00189137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185003|NCT00189137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92185004|NCT00189137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92185005|NCT00189137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92185006|NCT00189137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92185007|NCT00189137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92185008|NCT00189137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92185009|NCT00189137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185010|NCT00189137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185011|NCT00189137|Alkylating Agents|alkylating agents|mesh-ancestor
92185013|NCT02099461|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92185014|NCT02099461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185015|NCT02256189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92185016|NCT02256189|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92185017|NCT02256189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185018|NCT02256189|Incretins|incretins|mesh-ancestor
92185020|NCT02256189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185021|NCT02256189|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92185022|NCT02256189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92185023|NCT02256189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185024|NCT02256189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185025|NCT00193037|Docetaxel|docetaxel|mesh-list
92185026|NCT00193037|Doxorubicin|doxorubicin|mesh-list
92185027|NCT00193037|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92185028|NCT00193037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185029|NCT00193037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92185030|NCT00193037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92185031|NCT00193037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333431|NCT00003151|Amoxicillin|amoxicillin|mesh-list
92185032|NCT00193037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185033|NCT00193037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92185034|NCT00193037|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92185035|NCT00193037|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92185036|NCT00193037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185037|NCT02100007|Topotecan|topotecan|mesh-list
92185038|NCT02100007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92185039|NCT02100007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92185040|NCT02100007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185041|NCT02100007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185042|NCT02100007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185043|NCT05392764|Empagliflozin|empagliflozin|mesh-list
92185044|NCT05392764|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92185045|NCT05392764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185046|NCT05392764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92185047|NCT05392764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185048|NCT02866383|Nivolumab|nivolumab|mesh-list
92185049|NCT02866383|Ipilimumab|ipilimumab|mesh-list
92185050|NCT02866383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185051|NCT02866383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185052|NCT02866383|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92185053|NCT02866383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185054|NCT01809639|Progesterone|progesterone|mesh-list
92185055|NCT01809639|Progestins|progestins|mesh-ancestor
92185056|NCT01809639|Hormones|hormones|mesh-ancestor
92185057|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185058|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185059|NCT05391750|Venetoclax|venetoclax|mesh-list
92185060|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
92185061|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
92185062|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
92185063|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185064|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185065|NCT01763931|Digoxin|digoxin|mesh-list
92185066|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92185067|NCT01763931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92185068|NCT01763931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185069|NCT01763931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185070|NCT01763931|Protective Agents|protective agents|mesh-ancestor
92185071|NCT01763931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185072|NCT02822625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92185073|NCT02822625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185074|NCT02822625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185075|NCT04677114|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92185076|NCT04677114|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92185077|NCT04677114|Buprenorphine|buprenorphine|mesh-list
92185078|NCT04677114|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92185079|NCT04677114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185080|NCT04677114|Antitubercular Agents|antitubercular agents|mesh-ancestor
92185081|NCT04677114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92185082|NCT04677114|Narcotics|narcotics|mesh-ancestor
92185083|NCT04677114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185084|NCT04677114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185085|NCT04677114|Analgesics|analgesics|mesh-ancestor
92185086|NCT04677114|Sensory System Agents|sensory system agents|mesh-ancestor
92185087|NCT04677114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185088|NCT04677114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92185089|NCT02783859|Amoxicillin|amoxicillin|mesh-list
92185090|NCT02783859|Clavulanic Acids|clavulanic acids|mesh-list
92185091|NCT02783859|Clavulanic Acid|clavulanic acid|mesh-list
92185092|NCT02783859|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92185093|NCT02783859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92185094|NCT02783859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185095|NCT02783859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185096|NCT02783859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185097|NCT02783859|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92185098|NCT01765803|Thioridazine|thioridazine|mesh-list
92185099|NCT01765803|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92185100|NCT01765803|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92185101|NCT01765803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92333434|NCT00003151|Tetracycline|tetracycline|mesh-list
92185102|NCT01765803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408612|NCT05963087|Cetuximab|cetuximab|mesh-list
92185103|NCT01765803|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185104|NCT01765803|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92185105|NCT01765803|Dopamine Agents|dopamine agents|mesh-ancestor
92185106|NCT01765803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185107|NCT01765803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185108|NCT02566395|Cyclophosphamide|cyclophosphamide|mesh-list
92185109|NCT02566395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92185110|NCT02566395|Immunologic Factors|immunologic factors|mesh-ancestor
92185111|NCT02566395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185112|NCT02566395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185113|NCT02566395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185114|NCT02566395|Alkylating Agents|alkylating agents|mesh-ancestor
92185115|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185116|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185117|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92185118|NCT01811355|Mexiletine|mexiletine|mesh-list
92185119|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92185120|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92185121|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92185122|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185123|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185124|NCT05534334|Hydrocortisone|hydrocortisone|mesh-list
92185125|NCT05534334|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92185126|NCT05534334|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92185127|NCT05534334|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92185128|NCT05534334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185129|NCT01767285|Etonogestrel|etonogestrel|mesh-list
92185130|NCT01767285|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92185131|NCT01767285|Contraceptive Agents|contraceptive agents|mesh-ancestor
92185132|NCT01767285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92185133|NCT01767285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185134|NCT01767285|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92185135|NCT02100891|Immunomodulating Agents|immunomodulating agents|mesh-list
92185136|NCT02100891|Immunologic Factors|immunologic factors|mesh-ancestor
92185137|NCT02100891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185138|NCT01465802|Doxycycline|doxycycline|mesh-list
92185139|NCT01465802|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
92185140|NCT01465802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92185141|NCT01465802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185142|NCT01465802|Antimalarials|antimalarials|mesh-ancestor
92185143|NCT01465802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92185144|NCT01465802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92185146|NCT01465802|Glucocorticoids|glucocorticoids|mesh-ancestor
92185148|NCT01465802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185149|NCT01465802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185150|NCT01813149|Clonidine|clonidine|mesh-list
92185151|NCT01813149|Phenylephrine|phenylephrine|mesh-list
92185152|NCT01813149|Oxymetazoline|oxymetazoline|mesh-list
92185153|NCT01813149|Anesthetics|anesthetics|mesh-list
92185154|NCT01813149|Anesthetics, Local|anesthetics, local|mesh-list
92185155|NCT01813149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185156|NCT01813149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185157|NCT01813149|Sensory System Agents|sensory system agents|mesh-ancestor
92185158|NCT01813149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185159|NCT01813149|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92185160|NCT01813149|Mydriatics|mydriatics|mesh-ancestor
92185161|NCT01813149|Autonomic Agents|autonomic agents|mesh-ancestor
92185162|NCT01813149|Sympathomimetics|sympathomimetics|mesh-ancestor
92185163|NCT01813149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92185164|NCT01813149|Nasal Decongestants|nasal decongestants|mesh-ancestor
92185165|NCT01813149|Respiratory System Agents|respiratory system agents|mesh-ancestor
92185166|NCT01813149|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92185167|NCT01813149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92185168|NCT01813149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92185169|NCT01813149|Adrenergic Agents|adrenergic agents|mesh-ancestor
92185170|NCT01813149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185171|NCT01813149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185172|NCT01813149|Protective Agents|protective agents|mesh-ancestor
92185173|NCT01813149|Analgesics|analgesics|mesh-ancestor
92185174|NCT01813149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92185175|NCT01813149|Sympatholytics|sympatholytics|mesh-ancestor
92185176|NCT01813149|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92185177|NCT00137969|Acetaminophen|acetaminophen|mesh-list
92185178|NCT00137969|Diphenhydramine|diphenhydramine|mesh-list
92185179|NCT00137969|Promethazine|promethazine|mesh-list
92185180|NCT00137969|Prednisone|prednisone|mesh-list
92185181|NCT00137969|Rituximab|rituximab|mesh-list
92185182|NCT00137969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185183|NCT00137969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185184|NCT00137969|Immunologic Factors|immunologic factors|mesh-ancestor
92185185|NCT00137969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185186|NCT00137969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185187|NCT00137969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185188|NCT00137969|Glucocorticoids|glucocorticoids|mesh-ancestor
92185189|NCT00137969|Hormones|hormones|mesh-ancestor
92185190|NCT00137969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185191|NCT00137969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92185192|NCT00137969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92185193|NCT00137969|Analgesics|analgesics|mesh-ancestor
92185194|NCT00137969|Sensory System Agents|sensory system agents|mesh-ancestor
92185195|NCT00137969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185196|NCT00137969|Antipyretics|antipyretics|mesh-ancestor
92185197|NCT00137969|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92185198|NCT00137969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92185199|NCT00137969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185200|NCT00137969|Anesthetics, Local|anesthetics, local|mesh-ancestor
92185201|NCT00137969|Anesthetics|anesthetics|mesh-ancestor
92185202|NCT00137969|Antiemetics|antiemetics|mesh-ancestor
92185203|NCT00137969|Autonomic Agents|autonomic agents|mesh-ancestor
92185204|NCT00137969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92185205|NCT00137969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92185206|NCT00137969|Histamine Antagonists|histamine antagonists|mesh-ancestor
92185207|NCT00137969|Histamine Agents|histamine agents|mesh-ancestor
92185208|NCT00137969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185209|NCT00137969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185210|NCT00137969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92185211|NCT00137969|Antipruritics|antipruritics|mesh-ancestor
92185212|NCT00137969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92185213|NCT01437878|Iloprost|iloprost|mesh-list
92185214|NCT01437878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92185215|NCT01437878|Vasodilator Agents|vasodilator agents|mesh-ancestor
92185216|NCT04767308|Cyclophosphamide|cyclophosphamide|mesh-list
92185217|NCT04767308|Fludarabine|fludarabine|mesh-list
92185218|NCT04767308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92185219|NCT04767308|Immunologic Factors|immunologic factors|mesh-ancestor
92185220|NCT04767308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185221|NCT04767308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185222|NCT04767308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185223|NCT04767308|Alkylating Agents|alkylating agents|mesh-ancestor
92185224|NCT04767308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185225|NCT04767308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185226|NCT04767308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92185227|NCT00138125|Trastuzumab|trastuzumab|mesh-list
92185228|NCT00138125|Fulvestrant|fulvestrant|mesh-list
92185229|NCT00138125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185230|NCT00138125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185231|NCT00138125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92185232|NCT00138125|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92185233|NCT00138125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92185234|NCT00138125|Hormone Antagonists|hormone antagonists|mesh-ancestor
92185235|NCT00138125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185236|NCT00138125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185237|NCT01815333|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92185238|NCT01815333|Hematinics|hematinics|mesh-ancestor
92185239|NCT01815333|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92185240|NCT01815333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92185241|NCT01465178|Cholecalciferol|cholecalciferol|mesh-list
92185242|NCT01465178|Vitamin D|vitamin d|mesh-list
92185243|NCT01465178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92185244|NCT01465178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185245|NCT01465178|Vitamins|vitamins|mesh-ancestor
92185246|NCT01465178|Micronutrients|micronutrients|mesh-ancestor
92185247|NCT01465178|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92185248|NCT00138203|Vorinostat|vorinostat|mesh-list
92185249|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185250|NCT00138203|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92185251|NCT00138203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185252|NCT00138203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185253|NCT01732809|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92185254|NCT01732809|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92185255|NCT01732809|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92185256|NCT01732809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185257|NCT01732809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185258|NCT01732809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92185259|NCT01732809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185260|NCT01732809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185261|NCT01732809|Cholinergic Agents|cholinergic agents|mesh-ancestor
92185262|NCT01732809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185263|NCT00194129|Valproic Acid|valproic acid|mesh-list
92185264|NCT00194129|Lithium Carbonate|lithium carbonate|mesh-list
92185265|NCT00194129|Antidepressive Agents|antidepressive agents|mesh-ancestor
92185266|NCT00194129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185267|NCT00194129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185268|NCT00194129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185269|NCT00194129|Antimanic Agents|antimanic agents|mesh-ancestor
92185270|NCT00194129|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92185271|NCT00194129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185272|NCT00194129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185273|NCT00194129|Anticonvulsants|anticonvulsants|mesh-ancestor
92185274|NCT00194129|GABA Agents|gaba agents|mesh-ancestor
92185275|NCT00194129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185276|NCT01817907|Trazodone|trazodone|mesh-list
92185277|NCT01817907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92185278|NCT01817907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92185279|NCT01817907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185280|NCT01817907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185281|NCT01817907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185282|NCT01817907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92185283|NCT01817907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92185284|NCT01817907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185285|NCT01817907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185286|NCT01817907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185287|NCT01817907|Serotonin Agents|serotonin agents|mesh-ancestor
92185288|NCT01817907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92185289|NCT01817907|Antidepressive Agents|antidepressive agents|mesh-ancestor
92185290|NCT01445678|Metronidazole|metronidazole|mesh-list
92185291|NCT01445678|Meropenem|meropenem|mesh-list
92185292|NCT01445678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185293|NCT01445678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92185294|NCT01445678|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92185295|NCT01445678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92185296|NCT01818063|Paclitaxel|paclitaxel|mesh-list
92185298|NCT01818063|Carboplatin|carboplatin|mesh-list
92185299|NCT01818063|Doxorubicin|doxorubicin|mesh-list
92185300|NCT01818063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92185301|NCT01818063|Veliparib|veliparib|mesh-list
92185302|NCT01818063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92185303|NCT01818063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185304|NCT01818063|Tubulin Modulators|tubulin modulators|mesh-ancestor
92185305|NCT01818063|Antimitotic Agents|antimitotic agents|mesh-ancestor
92185306|NCT01818063|Mitosis Modulators|mitosis modulators|mesh-ancestor
92185307|NCT01818063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185308|NCT01818063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92185309|NCT01818063|Immunologic Factors|immunologic factors|mesh-ancestor
92185310|NCT01818063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185311|NCT01818063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185312|NCT01818063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185313|NCT01818063|Alkylating Agents|alkylating agents|mesh-ancestor
92185314|NCT01818063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92185315|NCT01818063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92185316|NCT01818063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92185317|NCT01818063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92185318|NCT01818063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185319|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92185320|NCT01465022|Estrogens|estrogens|mesh-list
92185321|NCT01465022|Progestins|progestins|mesh-list
92185322|NCT01465022|Hormones|hormones|mesh-ancestor
92185323|NCT01465022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185324|NCT01465022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185325|NCT02258217|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92185326|NCT02258217|Hormones|hormones|mesh-ancestor
92185327|NCT02258217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185328|NCT02258217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185329|NCT01464788|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92185330|NCT01464788|Argatroban|argatroban|mesh-list
92185331|NCT01464788|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92185332|NCT01464788|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92185333|NCT01464788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185334|NCT01464788|Antithrombins|antithrombins|mesh-ancestor
92185335|NCT01464788|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92185336|NCT01464788|Protease Inhibitors|protease inhibitors|mesh-ancestor
92185337|NCT01464788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185338|NCT01464788|Anticoagulants|anticoagulants|mesh-ancestor
92185339|NCT01464788|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92185340|NCT01444898|Exenatide|exenatide|mesh-list
92185341|NCT01444898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92185342|NCT01444898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185343|NCT01444898|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92185344|NCT01444898|Incretins|incretins|mesh-ancestor
92185345|NCT01444898|Hormones|hormones|mesh-ancestor
92185346|NCT01444898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185347|NCT00201773|Celecoxib|celecoxib|mesh-list
92185348|NCT00201773|Exemestane|exemestane|mesh-list
92185349|NCT00201773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92185350|NCT00201773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92185351|NCT00201773|Analgesics|analgesics|mesh-ancestor
92185352|NCT00201773|Sensory System Agents|sensory system agents|mesh-ancestor
92185353|NCT00201773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185354|NCT00201773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185355|NCT00201773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185356|NCT00201773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185357|NCT00201773|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92185358|NCT00201773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92185359|NCT00201773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185360|NCT00201773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185361|NCT00201773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185362|NCT00201773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92185363|NCT00201773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92185364|NCT00201773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92185365|NCT00201773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92185366|NCT00201773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185367|NCT00256217|Anastrozole|anastrozole|mesh-list
92185368|NCT00256217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92185369|NCT00256217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185370|NCT00256217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92185371|NCT00256217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92185372|NCT00256217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185373|NCT00256217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185374|NCT00256217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92185375|NCT00256217|Hormone Antagonists|hormone antagonists|mesh-ancestor
92185376|NCT00256217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185377|NCT00256217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185378|NCT05643066|Ketamine|ketamine|mesh-list
92185379|NCT05643066|Propofol|propofol|mesh-list
92185380|NCT05643066|Esketamine|esketamine|mesh-list
92185381|NCT05643066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92185382|NCT05643066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185383|NCT05643066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185384|NCT05643066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92185385|NCT05643066|Anesthetics, General|anesthetics, general|mesh-ancestor
92185386|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
92185387|NCT05643066|Analgesics|analgesics|mesh-ancestor
92185388|NCT05643066|Sensory System Agents|sensory system agents|mesh-ancestor
92185389|NCT05643066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185390|NCT05643066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92185391|NCT05643066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92185392|NCT05643066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92185393|NCT05643066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185394|NCT05643066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185395|NCT05643066|Antidepressive Agents|antidepressive agents|mesh-ancestor
92185396|NCT05643066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185398|NCT00256451|Naltrexone|naltrexone|mesh-list
92185399|NCT00256451|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92185400|NCT00256451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185401|NCT00256451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185402|NCT00256451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185403|NCT00256451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92185404|NCT00256451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92185405|NCT00256451|Sensory System Agents|sensory system agents|mesh-ancestor
92185406|NCT00256451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185407|NCT03582618|Sorafenib|sorafenib|mesh-list
92185408|NCT03582618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185409|NCT03582618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92185410|NCT03582618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185411|NCT03582618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185413|NCT00257309|Clopidogrel|clopidogrel|mesh-list
92185414|NCT00257309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92185415|NCT00257309|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92185416|NCT00257309|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92185417|NCT00257309|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92185418|NCT00257309|Purinergic Agents|purinergic agents|mesh-ancestor
92185419|NCT00257309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185420|NCT00257309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185421|NCT00257309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185422|NCT00257309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92185423|NCT00257309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92185424|NCT01444742|Cytarabine|cytarabine|mesh-list
92185425|NCT01444742|Clofarabine|clofarabine|mesh-list
92185426|NCT01444742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185427|NCT01444742|Antimetabolites|antimetabolites|mesh-ancestor
92185428|NCT01444742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185429|NCT01444742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185430|NCT01444742|Antiviral Agents|antiviral agents|mesh-ancestor
92185431|NCT01444742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185432|NCT01444742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92185433|NCT01444742|Immunologic Factors|immunologic factors|mesh-ancestor
92185434|NCT01444742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185435|NCT01770483|Interferons|interferons|mesh-list
92185436|NCT01770483|Ribavirin|ribavirin|mesh-list
92185437|NCT01770483|Interferon-alpha|interferon-alpha|mesh-list
92185438|NCT01770483|Nitazoxanide|nitazoxanide|mesh-list
92185439|NCT01770483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185440|NCT01770483|Antiviral Agents|antiviral agents|mesh-ancestor
92185441|NCT01770483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185442|NCT01770483|Antimetabolites|antimetabolites|mesh-ancestor
92185443|NCT01770483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185444|NCT01770483|Immunologic Factors|immunologic factors|mesh-ancestor
92185445|NCT01770483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185446|NCT01770483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92185447|NCT00257933|Prednisolone|prednisolone|mesh-list
92185448|NCT00257933|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92185449|NCT00257933|Methylprednisolone|methylprednisolone|mesh-list
92333460|NCT00003715|Vaccines|vaccines|mesh-list
92185450|NCT00257933|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92185451|NCT00257933|Prednisolone acetate|prednisolone acetate|mesh-list
92185452|NCT00257933|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92185453|NCT00257933|Prednisolone phosphate|prednisolone phosphate|mesh-list
92185454|NCT00257933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185455|NCT00257933|Glucocorticoids|glucocorticoids|mesh-ancestor
92185456|NCT00257933|Hormones|hormones|mesh-ancestor
92185457|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185458|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185459|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92185460|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185461|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
92185462|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
92185463|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185464|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92185465|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92185466|NCT00257933|Protective Agents|protective agents|mesh-ancestor
92185467|NCT01734525|Anidulafungin|anidulafungin|mesh-list
92185468|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
92185469|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185470|NCT01819935|Vancomycin|vancomycin|mesh-list
92185471|NCT01819935|Linezolid|linezolid|mesh-list
92185472|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92185473|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185474|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92185475|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185476|NCT01819935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185477|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92185478|NCT01821105|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92185479|NCT01821105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185480|NCT00264641|Insulin|insulin|mesh-list
92185481|NCT00264641|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92185482|NCT00264641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92185483|NCT00264641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185484|NCT01735617|Hydrocortisone|hydrocortisone|mesh-list
92185485|NCT01735617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185486|NCT00208091|Botulinum Toxins|botulinum toxins|mesh-list
92185487|NCT00208091|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92185488|NCT00208091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185489|NCT00208091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185490|NCT00208091|Cholinergic Agents|cholinergic agents|mesh-ancestor
92185491|NCT00208091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185492|NCT00208091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185493|NCT00266279|Capecitabine|capecitabine|mesh-list
92185494|NCT00266279|Oxaliplatin|oxaliplatin|mesh-list
92185495|NCT00266279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185496|NCT00266279|Antimetabolites|antimetabolites|mesh-ancestor
92185497|NCT00266279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185498|NCT00266279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185499|NCT01736085|Nicotine|nicotine|mesh-list
92185500|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92185501|NCT01736085|Autonomic Agents|autonomic agents|mesh-ancestor
92185502|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185503|NCT01736085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185504|NCT01736085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92185505|NCT01736085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92185506|NCT01736085|Cholinergic Agents|cholinergic agents|mesh-ancestor
92185507|NCT01736085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185508|NCT01736085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185509|NCT00210353|Rituximab|rituximab|mesh-list
92185510|NCT00210353|Chlorambucil|chlorambucil|mesh-list
92185511|NCT00210353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185512|NCT00210353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185513|NCT00210353|Immunologic Factors|immunologic factors|mesh-ancestor
92185514|NCT00210353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185515|NCT00210353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185516|NCT00210353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185517|NCT00210353|Alkylating Agents|alkylating agents|mesh-ancestor
92185518|NCT00210353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185519|NCT00267059|Lenalidomide|lenalidomide|mesh-list
92185520|NCT00267059|Immunologic Factors|immunologic factors|mesh-ancestor
92185521|NCT00267059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185522|NCT00267059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92185523|NCT00267059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92185524|NCT00267059|Growth Substances|growth substances|mesh-ancestor
92185525|NCT00267059|Growth Inhibitors|growth inhibitors|mesh-ancestor
92185526|NCT00267059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185527|NCT00213239|Remifentanil|remifentanil|mesh-list
92185528|NCT00213239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92185529|NCT00213239|Narcotics|narcotics|mesh-ancestor
92185530|NCT00213239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185531|NCT00213239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185532|NCT00213239|Analgesics|analgesics|mesh-ancestor
92185533|NCT00213239|Sensory System Agents|sensory system agents|mesh-ancestor
92185534|NCT00213239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185535|NCT01444430|Budesonide|budesonide|mesh-list
92185536|NCT01444430|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92185537|NCT01444430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185538|NCT01444430|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92185539|NCT01444430|Autonomic Agents|autonomic agents|mesh-ancestor
92185540|NCT01444430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185541|NCT01444430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185542|NCT01444430|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92185543|NCT01444430|Respiratory System Agents|respiratory system agents|mesh-ancestor
92185544|NCT01444430|Glucocorticoids|glucocorticoids|mesh-ancestor
92185545|NCT01444430|Hormones|hormones|mesh-ancestor
92185546|NCT01444430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185547|NCT01774149|Diazepam|diazepam|mesh-list
92185548|NCT01774149|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92185549|NCT01774149|Anticonvulsants|anticonvulsants|mesh-ancestor
92185550|NCT01774149|Antiemetics|antiemetics|mesh-ancestor
92185551|NCT01774149|Autonomic Agents|autonomic agents|mesh-ancestor
92185552|NCT01774149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185553|NCT01774149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185554|NCT01774149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92185555|NCT01774149|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92185556|NCT01774149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185557|NCT01774149|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92185558|NCT01774149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92185559|NCT01774149|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92185560|NCT01774149|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92185561|NCT01774149|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185562|NCT01774149|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92185563|NCT01774149|Anesthetics, General|anesthetics, general|mesh-ancestor
92185564|NCT01774149|Anesthetics|anesthetics|mesh-ancestor
92185565|NCT01774149|GABA Modulators|gaba modulators|mesh-ancestor
92185566|NCT01774149|GABA Agents|gaba agents|mesh-ancestor
92185567|NCT01774149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185568|NCT01774149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185569|NCT01898507|Nicotine|nicotine|mesh-list
92185570|NCT01898507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92185571|NCT01898507|Autonomic Agents|autonomic agents|mesh-ancestor
92185572|NCT01898507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185573|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185574|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92185575|NCT01898507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92185576|NCT01898507|Cholinergic Agents|cholinergic agents|mesh-ancestor
92185577|NCT01898507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185578|NCT01898507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185579|NCT00267293|Acetaminophen|acetaminophen|mesh-list
92185580|NCT00267293|Ibuprofen|ibuprofen|mesh-list
92185581|NCT00267293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92185582|NCT00267293|Analgesics|analgesics|mesh-ancestor
92185583|NCT00267293|Sensory System Agents|sensory system agents|mesh-ancestor
92185584|NCT00267293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185585|NCT00267293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185586|NCT00267293|Antipyretics|antipyretics|mesh-ancestor
92185587|NCT00267293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92185588|NCT00267293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185589|NCT00267293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333471|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
92185590|NCT00267293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92185591|NCT00267293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185592|NCT00267293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185593|NCT01436162|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92185594|NCT01436162|Antidepressive Agents|antidepressive agents|mesh-list
92185595|NCT01436162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185596|NCT01436162|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92185597|NCT01436162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185598|NCT01436162|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92185599|NCT01436162|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92185600|NCT01436162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185601|NCT01436162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185602|NCT01436162|Dopamine Agents|dopamine agents|mesh-ancestor
92185603|NCT01436162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185604|NCT02579382|Vesatolimod|vesatolimod|mesh-list
92185605|NCT02579382|Antiviral Agents|antiviral agents|mesh-ancestor
92185606|NCT02579382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185607|NCT01774851|Paclitaxel|paclitaxel|mesh-list
92185608|NCT01774851|Trastuzumab|trastuzumab|mesh-list
92185609|NCT01774851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92185610|NCT01774851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185611|NCT01774851|Tubulin Modulators|tubulin modulators|mesh-ancestor
92185612|NCT01774851|Antimitotic Agents|antimitotic agents|mesh-ancestor
92185613|NCT01774851|Mitosis Modulators|mitosis modulators|mesh-ancestor
92185614|NCT01774851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185615|NCT01774851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185616|NCT02990013|Chlorhexidine|chlorhexidine|mesh-list
92185617|NCT02990013|Povidone-Iodine|povidone-iodine|mesh-list
92185618|NCT02990013|Povidone|povidone|mesh-list
92185619|NCT02990013|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92185620|NCT02990013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185621|NCT02990013|Disinfectants|disinfectants|mesh-ancestor
92185622|NCT02990013|Plasma Substitutes|plasma substitutes|mesh-ancestor
92185623|NCT02990013|Blood Substitutes|blood substitutes|mesh-ancestor
92185624|NCT03440112|Clarithromycin|clarithromycin|mesh-list
92185625|NCT03440112|Flumazenil|flumazenil|mesh-list
92185626|NCT03440112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92185627|NCT03440112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185628|NCT03440112|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92185629|NCT03440112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185630|NCT03440112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185631|NCT03440112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92185632|NCT03440112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92185633|NCT03440112|Antidotes|antidotes|mesh-ancestor
92185634|NCT03440112|Protective Agents|protective agents|mesh-ancestor
92185635|NCT03440112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185636|NCT03440112|GABA Modulators|gaba modulators|mesh-ancestor
92185637|NCT03440112|GABA Agents|gaba agents|mesh-ancestor
92185638|NCT03440112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185639|NCT01775865|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92185640|NCT01775865|Sodium Salicylate|sodium salicylate|mesh-list
92185641|NCT01775865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92185642|NCT01775865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92185643|NCT01775865|Analgesics|analgesics|mesh-ancestor
92185644|NCT01775865|Sensory System Agents|sensory system agents|mesh-ancestor
92185645|NCT01775865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185646|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185647|NCT01775865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185648|NCT01775865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185649|NCT01775865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92185650|NCT01775865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185651|NCT01775865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185652|NCT01419236|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92185653|NCT01419236|Testosterone|testosterone|mesh-list
92185654|NCT01419236|Androgens|androgens|mesh-ancestor
92185655|NCT01419236|Hormones|hormones|mesh-ancestor
92185656|NCT01419236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185657|NCT01419236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185658|NCT03323658|Bexarotene|bexarotene|mesh-list
92185659|NCT03323658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185660|NCT01443026|Lycopene|lycopene|mesh-list
92185661|NCT01443026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185662|NCT01443026|Antioxidants|antioxidants|mesh-ancestor
92185663|NCT01443026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185664|NCT01443026|Protective Agents|protective agents|mesh-ancestor
92185665|NCT01443026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185666|NCT01443026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92185667|NCT01443026|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92185668|NCT01443026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185669|NCT01879371|Ibuprofen|ibuprofen|mesh-list
92185670|NCT01879371|Caffeine|caffeine|mesh-list
92185671|NCT01879371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92185672|NCT01879371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92185673|NCT01879371|Analgesics|analgesics|mesh-ancestor
92185674|NCT01879371|Sensory System Agents|sensory system agents|mesh-ancestor
92185675|NCT01879371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185676|NCT01879371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185677|NCT01879371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185678|NCT01879371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185679|NCT01879371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92185680|NCT01879371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185681|NCT01879371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185682|NCT01879371|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92185683|NCT01879371|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92185684|NCT01879371|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92185685|NCT01879371|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92185686|NCT01879371|Purinergic Agents|purinergic agents|mesh-ancestor
92185687|NCT01879371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185688|NCT01733745|Vitamins|vitamins|mesh-list
92185689|NCT01733745|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92185690|NCT01733745|Micronutrients|micronutrients|mesh-ancestor
92185691|NCT01733745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185692|NCT01733745|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92185693|NCT03276468|Atezolizumab|atezolizumab|mesh-list
92185694|NCT03276468|Venetoclax|venetoclax|mesh-list
92185695|NCT03276468|Obinutuzumab|obinutuzumab|mesh-list
92185696|NCT03276468|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92185697|NCT03276468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185698|NCT03276468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185699|NCT03276468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185700|NCT01442714|Lenalidomide|lenalidomide|mesh-list
92185701|NCT01442714|Azacitidine|azacitidine|mesh-list
92185702|NCT01442714|Immunologic Factors|immunologic factors|mesh-ancestor
92185703|NCT01442714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185704|NCT01442714|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92185705|NCT01442714|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92185706|NCT01442714|Growth Substances|growth substances|mesh-ancestor
92185707|NCT01442714|Growth Inhibitors|growth inhibitors|mesh-ancestor
92185708|NCT01442714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185709|NCT01442714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185710|NCT01442714|Antimetabolites|antimetabolites|mesh-ancestor
92185711|NCT01442714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185712|NCT01442714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185713|NCT05328921|Antihypertensive Agents|antihypertensive agents|mesh-list
92185714|NCT05532852|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92185715|NCT05532852|Antiviral Agents|antiviral agents|mesh-ancestor
92185716|NCT05532852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185717|NCT05532618|Levobupivacaine|levobupivacaine|mesh-list
92185718|NCT05532618|Anesthetics, Local|anesthetics, local|mesh-ancestor
92185720|NCT05532618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185721|NCT05532618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185722|NCT05532618|Sensory System Agents|sensory system agents|mesh-ancestor
92185723|NCT05532618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185724|NCT05501574|Tacrolimus|tacrolimus|mesh-list
92185725|NCT05501574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92185726|NCT05501574|Immunologic Factors|immunologic factors|mesh-ancestor
92185727|NCT05501574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185728|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92185729|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185730|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333483|NCT00003727|Melphalan|melphalan|mesh-list
92185731|NCT01435928|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92185732|NCT01435928|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92185733|NCT01435928|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92185734|NCT01435928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185735|NCT01435928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185736|NCT01435928|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185737|NCT01435928|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92185738|NCT01435928|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92185739|NCT01435928|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92185740|NCT01435928|Adrenergic Agents|adrenergic agents|mesh-ancestor
92185741|NCT01435928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185742|NCT01435928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185743|NCT01435928|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92185744|NCT01435928|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92185745|NCT01435928|Serotonin Agents|serotonin agents|mesh-ancestor
92185746|NCT01435928|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92185747|NCT01435928|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92185748|NCT01435928|Dopamine Agents|dopamine agents|mesh-ancestor
92185749|NCT01828515|Hydrocortisone|hydrocortisone|mesh-list
92185750|NCT01828515|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92185751|NCT01828515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185752|NCT01828515|Antidepressive Agents|antidepressive agents|mesh-ancestor
92185753|NCT01828515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185754|NCT01828515|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92185755|NCT01828515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92185756|NCT01828515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185757|NCT01828515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185758|NCT01828515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185759|NCT01828515|Serotonin Agents|serotonin agents|mesh-ancestor
92185760|NCT01828515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185761|NCT01828515|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92185762|NCT01828515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92185763|NCT01828593|Immunoglobulins|immunoglobulins|mesh-list
92185764|NCT01828593|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92185765|NCT01828593|Antibodies|antibodies|mesh-list
92185766|NCT01828593|Immunologic Factors|immunologic factors|mesh-ancestor
92185767|NCT01828593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185768|NCT01781169|Vitamin D|vitamin d|mesh-list
92185769|NCT01781169|Vitamins|vitamins|mesh-ancestor
92185770|NCT01781169|Micronutrients|micronutrients|mesh-ancestor
92185771|NCT01781169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185772|NCT01781169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92185774|NCT00216125|Etoposide|etoposide|mesh-list
92185775|NCT00216125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185776|NCT00216125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92185777|NCT00216125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92185778|NCT00216125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92185779|NCT00216125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185780|NCT00216125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92185781|NCT00216125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92185782|NCT00216125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92185783|NCT00216125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185784|NCT01781403|Capecitabine|capecitabine|mesh-list
92185785|NCT01781403|Temozolomide|temozolomide|mesh-list
92185786|NCT01781403|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185787|NCT01781403|Antimetabolites|antimetabolites|mesh-ancestor
92185788|NCT01781403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185789|NCT01781403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185790|NCT01781403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185791|NCT01781403|Alkylating Agents|alkylating agents|mesh-ancestor
92185792|NCT00218387|Modafinil|modafinil|mesh-list
92185793|NCT00218387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92185794|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185795|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92185796|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92185797|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92185798|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185799|NCT00218465|Glycine|glycine|mesh-list
92185800|NCT00218465|Glycine Agents|glycine agents|mesh-ancestor
92185801|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185802|NCT00218465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185803|NCT00218465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185804|NCT01898585|Vemurafenib|vemurafenib|mesh-list
92185805|NCT01898585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185806|NCT01898585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92185807|NCT01898585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185808|NCT01898585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185809|NCT00220961|Pioglitazone|pioglitazone|mesh-list
92185810|NCT00220961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92185811|NCT00220961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185812|NCT00222131|Esomeprazole|esomeprazole|mesh-list
92185813|NCT00222131|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92185814|NCT00222131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92185815|NCT00222131|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92185816|NCT00222131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185817|NCT00222131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185818|NCT00225017|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92185819|NCT00225017|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92185820|NCT00225017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92185821|NCT00225017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92185822|NCT00225017|Protease Inhibitors|protease inhibitors|mesh-ancestor
92185823|NCT00225017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185824|NCT00225017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185825|NCT00225017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92185826|NCT00225017|Antiviral Agents|antiviral agents|mesh-ancestor
92185827|NCT00225017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185828|NCT01782963|Dexamethasone|dexamethasone|mesh-list
92185829|NCT01782963|Lenalidomide|lenalidomide|mesh-list
92185830|NCT01782963|Bortezomib|bortezomib|mesh-list
92185831|NCT01782963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185832|NCT01782963|Antiemetics|antiemetics|mesh-ancestor
92185833|NCT01782963|Autonomic Agents|autonomic agents|mesh-ancestor
92185834|NCT01782963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185835|NCT01782963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185836|NCT01782963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92185837|NCT01782963|Glucocorticoids|glucocorticoids|mesh-ancestor
92185838|NCT01782963|Hormones|hormones|mesh-ancestor
92185839|NCT01782963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185840|NCT01782963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92185841|NCT01782963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185842|NCT01782963|Immunologic Factors|immunologic factors|mesh-ancestor
92185843|NCT01782963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92185844|NCT01782963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92185845|NCT01782963|Growth Substances|growth substances|mesh-ancestor
92185846|NCT01782963|Growth Inhibitors|growth inhibitors|mesh-ancestor
92185847|NCT01829217|Sunitinib|sunitinib|mesh-list
92185848|NCT01829217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185849|NCT01829217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92185850|NCT01829217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92185851|NCT01829217|Growth Substances|growth substances|mesh-ancestor
92185852|NCT01829217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185853|NCT01829217|Growth Inhibitors|growth inhibitors|mesh-ancestor
92185854|NCT01829217|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92185855|NCT01829217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185856|NCT01829217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185857|NCT05327751|Celecoxib|celecoxib|mesh-list
92185858|NCT05327751|Capecitabine|capecitabine|mesh-list
92185859|NCT05327751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185860|NCT05327751|Antimetabolites|antimetabolites|mesh-ancestor
92185861|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185862|NCT05327751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185863|NCT05327751|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92185864|NCT05327751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92185865|NCT05327751|Analgesics|analgesics|mesh-ancestor
92185866|NCT05327751|Sensory System Agents|sensory system agents|mesh-ancestor
92185867|NCT05327751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185868|NCT05327751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185869|NCT05327751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185870|NCT05327751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185871|NCT05327751|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92185872|NCT05327751|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92185873|NCT05327751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185874|NCT02096861|Infliximab|infliximab|mesh-list
92185875|NCT02096861|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92185876|NCT02096861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185877|NCT02096861|Dermatologic Agents|dermatologic agents|mesh-ancestor
92185878|NCT02096861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92185879|NCT02096861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185880|NCT01829919|Paroxetine|paroxetine|mesh-list
92185881|NCT01829919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92185882|NCT01829919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92185883|NCT01829919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92185884|NCT01829919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185885|NCT01829919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185886|NCT01829919|Serotonin Agents|serotonin agents|mesh-ancestor
92185887|NCT01829919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185888|NCT01829919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92185889|NCT01829919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92185890|NCT01829919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185891|NCT01829919|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92185892|NCT01829919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92185895|NCT02097641|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92185896|NCT02097641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92185897|NCT00274781|Arsenic Trioxide|arsenic trioxide|mesh-list
92185898|NCT00274781|Gemtuzumab|gemtuzumab|mesh-list
92185899|NCT00274781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185900|NCT00274781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185901|NCT00274781|Immunotoxins|immunotoxins|mesh-ancestor
92185902|NCT00274781|Immunoconjugates|immunoconjugates|mesh-ancestor
92185903|NCT00274781|Immunologic Factors|immunologic factors|mesh-ancestor
92185904|NCT00274781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185905|NCT00226577|Gemcitabine|gemcitabine|mesh-list
92185906|NCT00226577|Pemetrexed|pemetrexed|mesh-list
92185907|NCT00226577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92185908|NCT00226577|Antimetabolites|antimetabolites|mesh-ancestor
92185909|NCT00226577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185910|NCT00226577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185911|NCT00226577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185912|NCT00226577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92185913|NCT00226577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92185914|NCT01830699|Triamcinolone|triamcinolone|mesh-list
92185915|NCT01830699|Rilonacept|rilonacept|mesh-list
92185916|NCT01830699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185918|NCT01830699|Hormones|hormones|mesh-ancestor
92185919|NCT01830699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185920|NCT01830699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185921|NCT00280241|Cyclophosphamide|cyclophosphamide|mesh-list
92185922|NCT00280241|Rituximab|rituximab|mesh-list
92185923|NCT00280241|Fludarabine|fludarabine|mesh-list
92185924|NCT00280241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92185925|NCT00280241|Immunologic Factors|immunologic factors|mesh-ancestor
92185926|NCT00280241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185927|NCT00280241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185928|NCT00280241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92185929|NCT00280241|Alkylating Agents|alkylating agents|mesh-ancestor
92185930|NCT00280241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185931|NCT00280241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185932|NCT00280241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92185933|NCT00280241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185934|NCT01899755|Adalimumab|adalimumab|mesh-list
92185935|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92185936|NCT01899755|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92185937|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185938|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185939|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92185940|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92185941|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185942|NCT00229619|Rituximab|rituximab|mesh-list
92185943|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92185944|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185945|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
92185946|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185947|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92185948|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92185950|NCT00281021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185951|NCT00281021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92185952|NCT00281021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185953|NCT00281021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185954|NCT00281021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92185955|NCT00281021|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92185956|NCT00281021|Protective Agents|protective agents|mesh-ancestor
92185957|NCT00281021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185958|NCT01786161|Vancomycin|vancomycin|mesh-list
92185959|NCT01786161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92185960|NCT01786161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92185961|NCT01786239|Risperidone|risperidone|mesh-list
92185962|NCT01786239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92185963|NCT01786239|Serotonin Agents|serotonin agents|mesh-ancestor
92185964|NCT01786239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92185965|NCT01786239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185966|NCT01786239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185968|NCT01786239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92185969|NCT01786239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92185970|NCT01786239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92185971|NCT01786239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92185972|NCT01786239|Dopamine Agents|dopamine agents|mesh-ancestor
92185973|NCT01832961|Bronchodilator Agents|bronchodilator agents|mesh-list
92185974|NCT01832961|Autonomic Agents|autonomic agents|mesh-ancestor
92185975|NCT01832961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185976|NCT01832961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185977|NCT01832961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92185978|NCT01832961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92185979|NCT01833741|Bimatoprost|bimatoprost|mesh-list
92185980|NCT01833741|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92185981|NCT02261727|Prednisone|prednisone|mesh-list
92185982|NCT02261727|Cortisone|cortisone|mesh-list
92185983|NCT02261727|Theophylline|theophylline|mesh-list
92185984|NCT02261727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92185985|NCT02261727|Glucocorticoids|glucocorticoids|mesh-ancestor
92185986|NCT02261727|Hormones|hormones|mesh-ancestor
92185987|NCT02261727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92185988|NCT02261727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92185989|NCT02261727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92185990|NCT02261727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92185991|NCT02261727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92185992|NCT02261727|Autonomic Agents|autonomic agents|mesh-ancestor
92185993|NCT02261727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92185994|NCT02261727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92185995|NCT02261727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92185996|NCT02261727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92185997|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92185998|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92185999|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
92186000|NCT02261727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92186001|NCT02261727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92186002|NCT02261727|Purinergic Agents|purinergic agents|mesh-ancestor
92186003|NCT02261727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186004|NCT02261805|Doxorubicin|doxorubicin|mesh-list
92186005|NCT02261805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92186006|NCT02261805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186007|NCT02261805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92186008|NCT02261805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92186009|NCT02261805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186010|NCT02261805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186011|NCT05300841|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92186012|NCT05300841|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92186013|NCT05300841|Estradiol|estradiol|mesh-list
92186014|NCT05300841|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92186015|NCT05300841|Dydrogesterone|dydrogesterone|mesh-list
92186016|NCT05300841|Estrogens|estrogens|mesh-ancestor
92186017|NCT05300841|Hormones|hormones|mesh-ancestor
92186018|NCT05300841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186019|NCT05300841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186020|NCT05300841|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92186021|NCT05300841|Contraceptive Agents|contraceptive agents|mesh-ancestor
92186022|NCT05300841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92186023|NCT05300841|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92186024|NCT05300841|Progestins|progestins|mesh-ancestor
92186025|NCT00232505|Carboplatin|carboplatin|mesh-list
92186026|NCT00232505|Cetuximab|cetuximab|mesh-list
92186027|NCT00232505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186028|NCT00232505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186029|NCT00232583|Metformin|metformin|mesh-list
92186030|NCT00232583|Pioglitazone|pioglitazone|mesh-list
92186031|NCT00232583|Glyburide|glyburide|mesh-list
92186032|NCT00232583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92186033|NCT00232583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186034|NCT00232739|Sirolimus|sirolimus|mesh-list
92186035|NCT00232739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92186036|NCT00232739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186037|NCT00232739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92186038|NCT00232739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186039|NCT00232739|Antifungal Agents|antifungal agents|mesh-ancestor
92186040|NCT00232739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186041|NCT00232739|Immunologic Factors|immunologic factors|mesh-ancestor
92186042|NCT00232739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186043|NCT01789905|Tigecycline|tigecycline|mesh-list
92186044|NCT01789905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92186045|NCT01789905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186046|NCT01789905|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92186047|NCT01789905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186048|NCT01789905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186049|NCT01790685|Dexamethasone|dexamethasone|mesh-list
92186050|NCT01790685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186051|NCT01790685|Antiemetics|antiemetics|mesh-ancestor
92186052|NCT01790685|Autonomic Agents|autonomic agents|mesh-ancestor
92186053|NCT01790685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186054|NCT01790685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186055|NCT01790685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186056|NCT01790685|Glucocorticoids|glucocorticoids|mesh-ancestor
92186057|NCT01790685|Hormones|hormones|mesh-ancestor
92186058|NCT01790685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186059|NCT01790685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92186060|NCT01790685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186061|NCT01838655|Nitisinone|nitisinone|mesh-list
92186062|NCT01838655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186063|NCT01838655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186064|NCT00050089|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92186065|NCT00050089|Antiviral Agents|antiviral agents|mesh-ancestor
92186066|NCT00050089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186067|NCT00282971|Insulin|insulin|mesh-list
92186068|NCT00282971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92186069|NCT00282971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186070|NCT01791465|Exenatide|exenatide|mesh-list
92186071|NCT01791465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92186072|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186073|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92186074|NCT01791465|Incretins|incretins|mesh-ancestor
92186075|NCT01791465|Hormones|hormones|mesh-ancestor
92186076|NCT01791465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186077|NCT04484701|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92186078|NCT04484701|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92186079|NCT04484701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186080|NCT00285467|Vitamin D|vitamin d|mesh-list
92186081|NCT00285467|Cholecalciferol|cholecalciferol|mesh-list
92186082|NCT00285467|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92186083|NCT00285467|Vitamins|vitamins|mesh-ancestor
92186084|NCT00285467|Micronutrients|micronutrients|mesh-ancestor
92186085|NCT00285467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186086|NCT00285467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92186087|NCT00285467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92186088|NCT00281671|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92186089|NCT00281671|Natriuretic Agents|natriuretic agents|mesh-ancestor
92186090|NCT00281671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186091|NCT05261321|Dronabinol|dronabinol|mesh-list
92186092|NCT05261321|Hallucinogens|hallucinogens|mesh-ancestor
92186093|NCT05261321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186094|NCT05261321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92186095|NCT05261321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186096|NCT05261321|Analgesics|analgesics|mesh-ancestor
92186097|NCT05261321|Sensory System Agents|sensory system agents|mesh-ancestor
92186098|NCT05261321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186099|NCT05261321|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92186100|NCT05261321|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92186101|NCT05261321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186102|NCT05261321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186103|NCT05261321|Hormones|hormones|mesh-ancestor
92186104|NCT05261321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186105|NCT01676753|Pembrolizumab|pembrolizumab|mesh-list
92186106|NCT01676753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186107|NCT01676753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186108|NCT01676753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92186109|NCT01676753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186110|NCT01794039|Dexamethasone|dexamethasone|mesh-list
92186111|NCT01794039|Dexamethasone acetate|dexamethasone acetate|mesh-list
92186112|NCT01794039|Lenalidomide|lenalidomide|mesh-list
92186113|NCT01794039|Pomalidomide|pomalidomide|mesh-list
92186114|NCT01794039|Ichthammol|ichthammol|mesh-list
92186115|NCT01794039|BB 1101|bb 1101|mesh-list
92186116|NCT01794039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186117|NCT01794039|Antiemetics|antiemetics|mesh-ancestor
92186118|NCT01794039|Autonomic Agents|autonomic agents|mesh-ancestor
92186119|NCT01794039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186120|NCT01794039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186121|NCT01794039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186122|NCT01794039|Glucocorticoids|glucocorticoids|mesh-ancestor
92186123|NCT01794039|Hormones|hormones|mesh-ancestor
92186124|NCT01794039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186125|NCT01794039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92186126|NCT01794039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186127|NCT01794039|Immunologic Factors|immunologic factors|mesh-ancestor
92186128|NCT01794039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92186129|NCT01794039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92186130|NCT01794039|Growth Substances|growth substances|mesh-ancestor
92186131|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92186132|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
92186133|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186134|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186135|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
92186136|NCT00281827|Thalidomide|thalidomide|mesh-list
92186137|NCT00281827|Carboplatin|carboplatin|mesh-list
92186138|NCT00281827|Gemcitabine|gemcitabine|mesh-list
92186139|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186140|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186141|NCT00281827|Antimetabolites|antimetabolites|mesh-ancestor
92186142|NCT00281827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186143|NCT00281827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186144|NCT00281827|Immunologic Factors|immunologic factors|mesh-ancestor
92186145|NCT00281827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186146|NCT00281827|Leprostatic Agents|leprostatic agents|mesh-ancestor
92186147|NCT00281827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92186148|NCT00281827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186149|NCT00281827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92186150|NCT00281827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92186151|NCT00281827|Growth Substances|growth substances|mesh-ancestor
92186152|NCT00281827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92186153|NCT01898819|Dexmedetomidine|dexmedetomidine|mesh-list
92186154|NCT01898819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92186155|NCT01898819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186156|NCT01898819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186157|NCT01898819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186158|NCT01898819|Analgesics|analgesics|mesh-ancestor
92186159|NCT01898819|Sensory System Agents|sensory system agents|mesh-ancestor
92186160|NCT01898819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186161|NCT01898819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92186162|NCT01898819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92186163|NCT01898819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92186164|NCT01898819|Adrenergic Agents|adrenergic agents|mesh-ancestor
92186165|NCT01898819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186166|NCT01898819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186167|NCT01794741|Fluticasone|fluticasone|mesh-list
92186168|NCT01794741|Xhance|xhance|mesh-list
92186169|NCT01794741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186170|NCT01794741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92186171|NCT01794741|Autonomic Agents|autonomic agents|mesh-ancestor
92186172|NCT01794741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186173|NCT01794741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186174|NCT01794741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92186175|NCT01794741|Respiratory System Agents|respiratory system agents|mesh-ancestor
92186176|NCT01794741|Dermatologic Agents|dermatologic agents|mesh-ancestor
92186177|NCT01794741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92186178|NCT04446871|Methylene Blue|methylene blue|mesh-list
92186179|NCT04446871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186180|NCT04446871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186181|NCT04085419|Zoledronic Acid|zoledronic acid|mesh-list
92186183|NCT04085419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92186184|NCT04085419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186185|NCT02989623|Copper|copper|mesh-list
92186186|NCT02989623|Trace Elements|trace elements|mesh-ancestor
92186187|NCT02989623|Micronutrients|micronutrients|mesh-ancestor
92186188|NCT02989623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186189|NCT00052429|Fluorouracil|fluorouracil|mesh-list
92186190|NCT00052429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186191|NCT00052429|Antimetabolites|antimetabolites|mesh-ancestor
92186192|NCT00052429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186193|NCT00052429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186194|NCT00052429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186195|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
92186196|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186197|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
92186198|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92186199|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186200|NCT03972397|Bupivacaine|bupivacaine|mesh-list
92186201|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
92186202|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
92186203|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186204|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186205|NCT03972397|Sensory System Agents|sensory system agents|mesh-ancestor
92186206|NCT03972397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186207|NCT00287053|Valproic Acid|valproic acid|mesh-list
92186208|NCT00287053|Anticonvulsants|anticonvulsants|mesh-ancestor
92186209|NCT00287053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186210|NCT00287053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186211|NCT00287053|GABA Agents|gaba agents|mesh-ancestor
92186212|NCT00287053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186213|NCT00287053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186214|NCT00287053|Antimanic Agents|antimanic agents|mesh-ancestor
92186215|NCT00287053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92186216|NCT00287053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186217|NCT00287053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92186218|NCT01435460|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92186219|NCT01435460|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92186220|NCT01435460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92186221|NCT01435460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92186222|NCT01435460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186223|NCT01435460|Analgesics|analgesics|mesh-ancestor
92186224|NCT01435460|Sensory System Agents|sensory system agents|mesh-ancestor
92186225|NCT01435460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186226|NCT01435460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186227|NCT01435460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186228|NCT01435460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186229|NCT01435460|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92186230|NCT01435460|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92186231|NCT01435460|Histamine Antagonists|histamine antagonists|mesh-ancestor
92186232|NCT01435460|Histamine Agents|histamine agents|mesh-ancestor
92186233|NCT01435460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186234|NCT01435460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186235|NCT00236951|Epoetin Alfa|epoetin alfa|mesh-list
92186236|NCT00236951|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92186237|NCT00236951|Hematinics|hematinics|mesh-ancestor
92186238|NCT00287287|Lenalidomide|lenalidomide|mesh-list
92186239|NCT00287287|Immunologic Factors|immunologic factors|mesh-ancestor
92186240|NCT00287287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186241|NCT00287287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92186242|NCT00287287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92186243|NCT00287287|Growth Substances|growth substances|mesh-ancestor
92186244|NCT00287287|Growth Inhibitors|growth inhibitors|mesh-ancestor
92186245|NCT00287287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186247|NCT04871061|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92186248|NCT04871061|Narcotics|narcotics|mesh-ancestor
92186249|NCT04871061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186250|NCT04871061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186251|NCT04871061|Analgesics|analgesics|mesh-ancestor
92186252|NCT04871061|Sensory System Agents|sensory system agents|mesh-ancestor
92186253|NCT04871061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186254|NCT04871061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92186255|NCT04871061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92186256|NCT04871061|Anesthetics, General|anesthetics, general|mesh-ancestor
92186257|NCT04871061|Anesthetics|anesthetics|mesh-ancestor
92186258|NCT00287989|Paclitaxel|paclitaxel|mesh-list
92186259|NCT00287989|Carboplatin|carboplatin|mesh-list
92186260|NCT00287989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92186261|NCT00287989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92186262|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186264|NCT00287989|Antimitotic Agents|antimitotic agents|mesh-ancestor
92186265|NCT00287989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92186266|NCT00287989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186267|NCT00287989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92186268|NCT00287989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186269|NCT00288067|Rituximab|rituximab|mesh-list
92186270|NCT00288067|Fenretinide|fenretinide|mesh-list
92186271|NCT00288067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186272|NCT00288067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186273|NCT00288067|Immunologic Factors|immunologic factors|mesh-ancestor
92186274|NCT00288067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186275|NCT00288067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186276|NCT00288067|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92186277|NCT00288067|Protective Agents|protective agents|mesh-ancestor
92186279|NCT00285779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92186280|NCT00285779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186281|NCT00285779|Analgesics|analgesics|mesh-ancestor
92186282|NCT00285779|Sensory System Agents|sensory system agents|mesh-ancestor
92186283|NCT00285779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186284|NCT00285779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186286|NCT00285779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186287|NCT00285779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186288|NCT00285779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186289|NCT00285779|Immunologic Factors|immunologic factors|mesh-ancestor
92186290|NCT04827537|Metronidazole|metronidazole|mesh-list
92186291|NCT04827537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186292|NCT04827537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92186293|NCT04827537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92186294|NCT04827537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92186295|NCT04728087|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92186296|NCT04728087|Hemostatics|hemostatics|mesh-ancestor
92186297|NCT04728087|Coagulants|coagulants|mesh-ancestor
92186298|NCT01435382|Bococizumab|bococizumab|mesh-list
92186299|NCT01435382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92186300|NCT01435382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92186301|NCT01435382|Antimetabolites|antimetabolites|mesh-ancestor
92186302|NCT01435382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186303|NCT01435382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92186304|NCT01801449|Rilonacept|rilonacept|mesh-list
92186305|NCT01801449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186306|NCT00286325|Rituximab|rituximab|mesh-list
92186307|NCT00286325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186308|NCT00286325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186309|NCT00286325|Immunologic Factors|immunologic factors|mesh-ancestor
92186310|NCT00286325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186311|NCT00286325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186312|NCT00238355|Voriconazole|voriconazole|mesh-list
92186313|NCT00238355|Caspofungin|caspofungin|mesh-list
92186314|NCT00238355|Antifungal Agents|antifungal agents|mesh-ancestor
92186315|NCT00238355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186316|NCT00238355|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92186317|NCT00238355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92186318|NCT00238355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186319|NCT00238355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186320|NCT00238355|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92186321|NCT00238355|Hormone Antagonists|hormone antagonists|mesh-ancestor
92186322|NCT00238355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186323|NCT00238355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186324|NCT00238355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92186325|NCT01791439|Lidocaine|lidocaine|mesh-list
92186326|NCT01791439|Anesthetics, Local|anesthetics, local|mesh-ancestor
92186327|NCT01791439|Anesthetics|anesthetics|mesh-ancestor
92186328|NCT01791439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186329|NCT01791439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186330|NCT01791439|Sensory System Agents|sensory system agents|mesh-ancestor
92186331|NCT01791439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186332|NCT01791439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92186333|NCT01791439|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92186334|NCT01791439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92186335|NCT01791439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92186336|NCT01791439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186338|NCT01650701|Lenalidomide|lenalidomide|mesh-list
92186339|NCT01650701|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92186340|NCT01650701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186341|NCT01650701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186342|NCT01650701|Immunologic Factors|immunologic factors|mesh-ancestor
92186343|NCT01650701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186344|NCT01650701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186345|NCT01650701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92186346|NCT01650701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92186347|NCT01650701|Growth Substances|growth substances|mesh-ancestor
92186348|NCT01650701|Growth Inhibitors|growth inhibitors|mesh-ancestor
92186349|NCT01650701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92186350|NCT01650701|Alkylating Agents|alkylating agents|mesh-ancestor
92186351|NCT01650701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186352|NCT00290329|Vaccines|vaccines|mesh-list
92186353|NCT00290329|Immunologic Factors|immunologic factors|mesh-ancestor
92186354|NCT00290329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333788|NCT00003805|Vancomycin|vancomycin|mesh-list
92186356|NCT04058678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92186357|NCT04058678|Hormone Antagonists|hormone antagonists|mesh-ancestor
92186358|NCT04058678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186359|NCT04058678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186360|NCT00286949|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92186361|NCT00286949|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92186362|NCT00286949|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92186363|NCT00286949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92186364|NCT00286949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186365|NCT00286949|Adrenergic Agents|adrenergic agents|mesh-ancestor
92186366|NCT00286949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186367|NCT00286949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186368|NCT00287339|Esomeprazole|esomeprazole|mesh-list
92186369|NCT00287339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92186370|NCT00287339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186371|NCT00287339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92186372|NCT00287339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186373|NCT00287339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186374|NCT00291655|Levetiracetam|levetiracetam|mesh-list
92186375|NCT00291655|Anticonvulsants|anticonvulsants|mesh-ancestor
92186376|NCT00291655|Nootropic Agents|nootropic agents|mesh-ancestor
92186377|NCT01846455|Promethazine|promethazine|mesh-list
92186378|NCT01846455|Diphenhydramine|diphenhydramine|mesh-list
92186379|NCT01846455|Buprenorphine|buprenorphine|mesh-list
92186380|NCT01846455|Naloxone|naloxone|mesh-list
92186381|NCT01846455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92186382|NCT01846455|Narcotics|narcotics|mesh-ancestor
92186383|NCT01846455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186384|NCT01846455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186385|NCT01846455|Analgesics|analgesics|mesh-ancestor
92186386|NCT01846455|Sensory System Agents|sensory system agents|mesh-ancestor
92186387|NCT01846455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186388|NCT01846455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92186389|NCT01846455|Antipruritics|antipruritics|mesh-ancestor
92186390|NCT01846455|Dermatologic Agents|dermatologic agents|mesh-ancestor
92186391|NCT01846455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92186392|NCT01846455|Histamine Antagonists|histamine antagonists|mesh-ancestor
92186393|NCT01846455|Histamine Agents|histamine agents|mesh-ancestor
92186394|NCT01846455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186395|NCT01846455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186397|NCT01846455|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92186398|NCT01846455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92186399|NCT01846455|Anesthetics, Local|anesthetics, local|mesh-ancestor
92186400|NCT01846455|Anesthetics|anesthetics|mesh-ancestor
92186401|NCT01846455|Antiemetics|antiemetics|mesh-ancestor
92186402|NCT01846455|Autonomic Agents|autonomic agents|mesh-ancestor
92186403|NCT01846455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186404|NCT03366415|Cisplatin|cisplatin|mesh-list
92186405|NCT03366415|Gemcitabine|gemcitabine|mesh-list
92186406|NCT03366415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186407|NCT03366415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186408|NCT03366415|Antimetabolites|antimetabolites|mesh-ancestor
92186409|NCT03366415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186410|NCT00292591|Vitamin D|vitamin d|mesh-list
92186411|NCT00292591|Ergocalciferols|ergocalciferols|mesh-list
92186412|NCT00292591|Cholecalciferol|cholecalciferol|mesh-list
92186413|NCT00292591|Vitamins|vitamins|mesh-list
92186414|NCT00292591|Micronutrients|micronutrients|mesh-ancestor
92186415|NCT00292591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186416|NCT00292591|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92186417|NCT00292591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92186418|NCT01847001|Paclitaxel|paclitaxel|mesh-list
92186419|NCT01847001|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92186420|NCT01847001|Cyclophosphamide|cyclophosphamide|mesh-list
92186421|NCT01847001|Doxorubicin|doxorubicin|mesh-list
92186422|NCT01847001|Trastuzumab|trastuzumab|mesh-list
92186423|NCT01847001|Pertuzumab|pertuzumab|mesh-list
92186424|NCT01847001|Propranolol|propranolol|mesh-list
92186425|NCT01847001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92186426|NCT01847001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186427|NCT01847001|Tubulin Modulators|tubulin modulators|mesh-ancestor
92186428|NCT01847001|Antimitotic Agents|antimitotic agents|mesh-ancestor
92186429|NCT01847001|Mitosis Modulators|mitosis modulators|mesh-ancestor
92186430|NCT01847001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186431|NCT01847001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186433|NCT01847001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186434|NCT01847001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186435|NCT01847001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92186436|NCT01847001|Alkylating Agents|alkylating agents|mesh-ancestor
92186437|NCT01847001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92186438|NCT01847001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92186439|NCT01847001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92186440|NCT01847001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92186441|NCT01847001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186442|NCT01847001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186443|NCT01847001|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92186444|NCT01847001|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92186445|NCT01847001|Adrenergic Agents|adrenergic agents|mesh-ancestor
92186446|NCT01847001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186447|NCT01847001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92186448|NCT01847001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92186449|NCT01847001|Vasodilator Agents|vasodilator agents|mesh-ancestor
92186450|NCT01847469|Zonisamide|zonisamide|mesh-list
92186451|NCT01847469|Anticonvulsants|anticonvulsants|mesh-ancestor
92186452|NCT01847469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92186453|NCT01847469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92186454|NCT01847469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186455|NCT01847469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92186456|NCT01847469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186457|NCT01804101|Cytarabine|cytarabine|mesh-list
92186458|NCT01804101|Daunorubicin|daunorubicin|mesh-list
92186459|NCT01804101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186460|NCT01804101|Antimetabolites|antimetabolites|mesh-ancestor
92186461|NCT01804101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186462|NCT01804101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186463|NCT01804101|Antiviral Agents|antiviral agents|mesh-ancestor
92186464|NCT01804101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186465|NCT01804101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186466|NCT01804101|Immunologic Factors|immunologic factors|mesh-ancestor
92186467|NCT01804101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186468|NCT01804101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92186469|NCT01804101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92186470|NCT01804101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92186471|NCT01804101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186472|NCT00287729|Pirfenidone|pirfenidone|mesh-list
92186473|NCT00287729|Analgesics|analgesics|mesh-ancestor
92186474|NCT00287729|Sensory System Agents|sensory system agents|mesh-ancestor
92186475|NCT00287729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186476|NCT00287729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186477|NCT00287729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92186478|NCT00287729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186479|NCT00287729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186480|NCT00287729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186481|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186482|NCT01433978|Maleic acid|maleic acid|mesh-list
92186483|NCT01433978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186484|NCT01433978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186485|NCT00289211|Complement C1s|complement c1s|mesh-list
92186486|NCT00289211|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92186487|NCT00289211|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92186488|NCT00289211|Immunologic Factors|immunologic factors|mesh-ancestor
92186489|NCT00289211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186490|NCT00289211|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92186491|NCT00289211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186493|NCT01619111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186494|NCT01619111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92186495|NCT01619111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186496|NCT01619111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186498|NCT01727193|Leflunomide|leflunomide|mesh-list
92186499|NCT01727193|Antimetabolites|antimetabolites|mesh-ancestor
92186500|NCT01727193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186501|NCT01727193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186502|NCT01727193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186503|NCT01727193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186505|NCT01727193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186506|NCT01727193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186507|NCT01727193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186508|NCT00181701|Paclitaxel|paclitaxel|mesh-list
92186509|NCT00181701|Carboplatin|carboplatin|mesh-list
92186510|NCT00181701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92186511|NCT00181701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186512|NCT00181701|Tubulin Modulators|tubulin modulators|mesh-ancestor
92186513|NCT00181701|Antimitotic Agents|antimitotic agents|mesh-ancestor
92186514|NCT00181701|Mitosis Modulators|mitosis modulators|mesh-ancestor
92186515|NCT00181701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186516|NCT01849419|Oxytocin|oxytocin|mesh-list
92186517|NCT01849419|Oxytocics|oxytocics|mesh-ancestor
92186518|NCT01849419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92186519|NCT01849419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186520|NCT00295867|Zoledronic Acid|zoledronic acid|mesh-list
92186521|NCT00295867|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92186522|NCT00295867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186523|NCT05098067|Ondansetron|ondansetron|mesh-list
92186524|NCT05098067|Metoclopramide|metoclopramide|mesh-list
92186525|NCT05098067|Capsaicin|capsaicin|mesh-list
92186526|NCT05098067|Antiemetics|antiemetics|mesh-ancestor
92186527|NCT05098067|Autonomic Agents|autonomic agents|mesh-ancestor
92186528|NCT05098067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186529|NCT05098067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186530|NCT05098067|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186531|NCT05098067|Antipruritics|antipruritics|mesh-ancestor
92186532|NCT05098067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92186533|NCT05098067|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92186534|NCT05098067|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92186535|NCT05098067|Serotonin Agents|serotonin agents|mesh-ancestor
92186536|NCT05098067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186537|NCT05098067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186538|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
92186539|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92186540|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92186541|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
92186542|NCT01852383|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92186543|NCT01852383|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92186544|NCT01852383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92186545|NCT01852383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92186546|NCT01852383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186547|NCT01852383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186548|NCT01852383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186549|NCT01852383|Analgesics|analgesics|mesh-ancestor
92186550|NCT01852383|Sensory System Agents|sensory system agents|mesh-ancestor
92186551|NCT01852383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186552|NCT01852383|Antidepressive Agents|antidepressive agents|mesh-ancestor
92186553|NCT01852383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92186554|NCT01852383|Dopamine Agents|dopamine agents|mesh-ancestor
92186555|NCT04272333|Nivolumab|nivolumab|mesh-list
92186556|NCT04272333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186557|NCT04272333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186558|NCT04272333|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92186559|NCT04272333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186560|NCT02273115|Oxytocin|oxytocin|mesh-list
92186561|NCT02273115|Oxytocics|oxytocics|mesh-ancestor
92186562|NCT02273115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92186563|NCT02273115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186565|NCT01853085|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92186566|NCT01853085|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92186567|NCT01853085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92186568|NCT02989467|Aprepitant|aprepitant|mesh-list
92186569|NCT02989467|Antiemetics|antiemetics|mesh-ancestor
92186570|NCT02989467|Autonomic Agents|autonomic agents|mesh-ancestor
92186571|NCT02989467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186572|NCT02989467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186573|NCT02989467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186574|NCT02989467|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92186575|NCT02989467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186576|NCT02989467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186578|NCT01853553|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92186579|NCT01853553|Hormone Antagonists|hormone antagonists|mesh-ancestor
92186580|NCT01853553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186581|NCT01853553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186582|NCT01853553|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92186583|NCT01853553|Diuretics|diuretics|mesh-ancestor
92186584|NCT01853553|Natriuretic Agents|natriuretic agents|mesh-ancestor
92186585|NCT05748561|Methylprednisolone|methylprednisolone|mesh-list
92186586|NCT05748561|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92186587|NCT05748561|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92186588|NCT05748561|Prednisolone|prednisolone|mesh-list
92186589|NCT05748561|Prednisolone acetate|prednisolone acetate|mesh-list
92186590|NCT05748561|Epoetin Alfa|epoetin alfa|mesh-list
92186591|NCT05748561|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92186592|NCT05748561|Prednisolone phosphate|prednisolone phosphate|mesh-list
92186593|NCT05748561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186594|NCT05748561|Antiemetics|antiemetics|mesh-ancestor
92186595|NCT05748561|Autonomic Agents|autonomic agents|mesh-ancestor
92186596|NCT05748561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186597|NCT05748561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186598|NCT05748561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186599|NCT05748561|Glucocorticoids|glucocorticoids|mesh-ancestor
92186600|NCT05748561|Hormones|hormones|mesh-ancestor
92186601|NCT05748561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92186602|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92186603|NCT05748561|Protective Agents|protective agents|mesh-ancestor
92186604|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92186605|NCT05748561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186606|NCT05748561|Hematinics|hematinics|mesh-ancestor
92186607|NCT00290537|Paclitaxel|paclitaxel|mesh-list
92186608|NCT00290537|Carboplatin|carboplatin|mesh-list
92186609|NCT00290537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92186610|NCT00290537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186611|NCT00290537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92186612|NCT00290537|Antimitotic Agents|antimitotic agents|mesh-ancestor
92186613|NCT00290537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92186614|NCT00290537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186615|NCT05748483|Topiramate|topiramate|mesh-list
92186616|NCT05748483|Anticonvulsants|anticonvulsants|mesh-ancestor
92186617|NCT05748483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92186618|NCT05748483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186619|NCT00290615|Bevacizumab|bevacizumab|mesh-list
92186620|NCT00290615|Cetuximab|cetuximab|mesh-list
92186621|NCT00290615|Capecitabine|capecitabine|mesh-list
92186622|NCT00290615|Oxaliplatin|oxaliplatin|mesh-list
92186623|NCT00290615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186624|NCT00290615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186625|NCT00290615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92186626|NCT00290615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92186627|NCT00290615|Growth Substances|growth substances|mesh-ancestor
92186628|NCT00290615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186629|NCT00290615|Growth Inhibitors|growth inhibitors|mesh-ancestor
92186630|NCT00290615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186631|NCT00290615|Antimetabolites|antimetabolites|mesh-ancestor
92186632|NCT00290615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186633|NCT01854177|Aprepitant|aprepitant|mesh-list
92186634|NCT01854177|Fosaprepitant|fosaprepitant|mesh-list
92186635|NCT01854177|Antiemetics|antiemetics|mesh-ancestor
92186636|NCT01854177|Autonomic Agents|autonomic agents|mesh-ancestor
92186637|NCT01854177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186638|NCT01854177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186639|NCT01854177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186640|NCT01854177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92186641|NCT01854177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186642|NCT01854177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186643|NCT00243191|Imatinib Mesylate|imatinib mesylate|mesh-list
92186644|NCT00243191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186645|NCT00243191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92186646|NCT00243191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186647|NCT00243191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186648|NCT00299221|Mycophenolic Acid|mycophenolic acid|mesh-list
92186650|NCT00299221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186651|NCT00299221|Immunologic Factors|immunologic factors|mesh-ancestor
92186652|NCT00299221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186653|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92186654|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186655|NCT00299221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186656|NCT00299221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92186657|NCT00299221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186658|NCT00299221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92186659|NCT00299221|Antitubercular Agents|antitubercular agents|mesh-ancestor
92186660|NCT00299221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92186661|NCT00299221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186662|NCT03799731|Trifluridine|trifluridine|mesh-list
92186663|NCT03799731|Antimetabolites|antimetabolites|mesh-ancestor
92186664|NCT03799731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186665|NCT03799731|Antiviral Agents|antiviral agents|mesh-ancestor
92186666|NCT03799731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186667|NCT00299689|Denileukin diftitox|denileukin diftitox|mesh-list
92186668|NCT00299689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186669|NCT00244985|Rituximab|rituximab|mesh-list
92186670|NCT00244985|Doxorubicin|doxorubicin|mesh-list
92186671|NCT00244985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92186672|NCT00244985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186673|NCT00244985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186674|NCT00244985|Immunologic Factors|immunologic factors|mesh-ancestor
92186675|NCT00244985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186676|NCT00244985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186677|NCT00244985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92186678|NCT00244985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92186679|NCT00244985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92186680|NCT00244985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186681|NCT00244985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186682|NCT01857297|Vaccines|vaccines|mesh-list
92186683|NCT01857297|Immunologic Factors|immunologic factors|mesh-ancestor
92186684|NCT01857297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186685|NCT00300391|Haloperidol|haloperidol|mesh-list
92186686|NCT00300391|Haloperidol decanoate|haloperidol decanoate|mesh-list
92186687|NCT00300391|Antiemetics|antiemetics|mesh-ancestor
92408620|NCT05963074|Venetoclax|venetoclax|mesh-list
92186688|NCT00300391|Autonomic Agents|autonomic agents|mesh-ancestor
92186689|NCT00300391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186690|NCT00300391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186691|NCT00300391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186692|NCT00300391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92186693|NCT00300391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92186694|NCT00300391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186695|NCT00300391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92186696|NCT00300391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92186697|NCT00300391|Dopamine Agents|dopamine agents|mesh-ancestor
92186698|NCT00300391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186699|NCT00300391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186700|NCT00300391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92186701|NCT01859013|Topiramate|topiramate|mesh-list
92186702|NCT01859013|Anticonvulsants|anticonvulsants|mesh-ancestor
92186703|NCT01859013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92186704|NCT01859013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186705|NCT00294515|Valganciclovir|valganciclovir|mesh-list
92186706|NCT00294515|Antiviral Agents|antiviral agents|mesh-ancestor
92186707|NCT00294515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186708|NCT00300469|Atorvastatin|atorvastatin|mesh-list
92186709|NCT00300469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92186710|NCT00300469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92186711|NCT00300469|Antimetabolites|antimetabolites|mesh-ancestor
92186712|NCT00300469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186713|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92186714|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92186716|NCT01543763|Abexinostat|abexinostat|mesh-list
92186717|NCT01543763|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92186718|NCT01543763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186719|NCT01543763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186720|NCT01859637|Lenograstim|lenograstim|mesh-list
92186721|NCT01859637|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92186722|NCT01859637|Immunologic Factors|immunologic factors|mesh-ancestor
92186723|NCT01859637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186724|NCT00295061|Protease Inhibitors|protease inhibitors|mesh-list
92186725|NCT00295061|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92186726|NCT00295061|Protein C Inhibitor|protein c inhibitor|mesh-list
92186727|NCT00295061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186728|NCT00295061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186729|NCT00295061|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92186730|NCT00295061|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92186731|NCT02117141|Hydrocodone|hydrocodone|mesh-list
92186732|NCT02117141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92186733|NCT02117141|Narcotics|narcotics|mesh-ancestor
92186734|NCT02117141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186735|NCT02117141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186736|NCT02117141|Analgesics|analgesics|mesh-ancestor
92186737|NCT02117141|Sensory System Agents|sensory system agents|mesh-ancestor
92186738|NCT02117141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186739|NCT02117141|Antitussive Agents|antitussive agents|mesh-ancestor
92186740|NCT02117141|Respiratory System Agents|respiratory system agents|mesh-ancestor
92186741|NCT00299741|Sunitinib|sunitinib|mesh-list
92186742|NCT00299741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186743|NCT00299741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92186744|NCT00299741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92186745|NCT00299741|Growth Substances|growth substances|mesh-ancestor
92186746|NCT00299741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186747|NCT00299741|Growth Inhibitors|growth inhibitors|mesh-ancestor
92186748|NCT00299741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92186749|NCT00299741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186750|NCT00299741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186751|NCT00328861|Aldesleukin|aldesleukin|mesh-list
92186752|NCT00328861|Cyclophosphamide|cyclophosphamide|mesh-list
92186753|NCT00328861|Fludarabine|fludarabine|mesh-list
92186754|NCT00328861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186755|NCT00328861|Immunologic Factors|immunologic factors|mesh-ancestor
92186756|NCT00328861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186757|NCT00328861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186758|NCT00328861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92186759|NCT00328861|Alkylating Agents|alkylating agents|mesh-ancestor
92186760|NCT00328861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186761|NCT00328861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186762|NCT00328861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92186763|NCT00328861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92186764|NCT00328861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92186765|NCT00328861|Antiviral Agents|antiviral agents|mesh-ancestor
92186766|NCT00328861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186767|NCT00248807|Enalaprilat|enalaprilat|mesh-list
92186768|NCT00248807|Enalapril|enalapril|mesh-list
92186769|NCT00248807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92186770|NCT00248807|Protease Inhibitors|protease inhibitors|mesh-ancestor
92186771|NCT00248807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186772|NCT00248807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186773|NCT00248807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92186774|NCT01860807|Ibudilast|ibudilast|mesh-list
92186775|NCT01860807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92186776|NCT01860807|Autonomic Agents|autonomic agents|mesh-ancestor
92186777|NCT01860807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186778|NCT01860807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186779|NCT01860807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92186780|NCT01860807|Respiratory System Agents|respiratory system agents|mesh-ancestor
92186781|NCT01860807|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92186782|NCT01860807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186783|NCT01860807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186784|NCT01860807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92186785|NCT01860807|Vasodilator Agents|vasodilator agents|mesh-ancestor
92186786|NCT00330421|Sorafenib|sorafenib|mesh-list
92186787|NCT00330421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186788|NCT00330421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92186790|NCT00330421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186791|NCT04350645|Tranexamic Acid|tranexamic acid|mesh-list
92186792|NCT04350645|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92186793|NCT04350645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92186794|NCT04350645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186796|NCT04350645|Coagulants|coagulants|mesh-ancestor
92186797|NCT00330733|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92186798|NCT00330733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92186799|NCT00330733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186800|NCT00330733|Analgesics|analgesics|mesh-ancestor
92186801|NCT00330733|Sensory System Agents|sensory system agents|mesh-ancestor
92186802|NCT00330733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186803|NCT00330733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186804|NCT00330733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186805|NCT00330733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186806|NCT05192369|Moxifloxacin|moxifloxacin|mesh-list
92186807|NCT05192369|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92186808|NCT05192369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92186809|NCT05192369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92186810|NCT05192369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92186811|NCT05192369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186812|NCT05192369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186813|NCT05192369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186814|NCT05185973|Micronutrients|micronutrients|mesh-list
92186815|NCT05185973|Trace Elements|trace elements|mesh-list
92186816|NCT05185973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186817|NCT00301873|Zoledronic Acid|zoledronic acid|mesh-list
92186818|NCT00301873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92186819|NCT00301873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186820|NCT01892839|Dialysis Solutions|dialysis solutions|mesh-list
92186821|NCT01892839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92186822|NCT00251225|Docetaxel|docetaxel|mesh-list
92186823|NCT00251225|Imatinib Mesylate|imatinib mesylate|mesh-list
92186824|NCT00251225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186825|NCT00251225|Tubulin Modulators|tubulin modulators|mesh-ancestor
92186826|NCT00251225|Antimitotic Agents|antimitotic agents|mesh-ancestor
92186827|NCT00251225|Mitosis Modulators|mitosis modulators|mesh-ancestor
92186828|NCT00251225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186829|NCT00251225|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92186830|NCT00251225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186831|NCT02979327|Adderall|adderall|mesh-list
92186832|NCT02979327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92186833|NCT02979327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186834|NCT05951075|Vitamins|vitamins|mesh-list
92186835|NCT05951075|Micronutrients|micronutrients|mesh-ancestor
92186836|NCT05951075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186837|NCT05951062|Antihypertensive Agents|antihypertensive agents|mesh-list
92186838|NCT05951023|Eszopiclone|eszopiclone|mesh-list
92186839|NCT05951023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92186840|NCT05951023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186841|NCT05951023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186842|NCT05950997|Obinutuzumab|obinutuzumab|mesh-list
92186843|NCT05950997|Acalabrutinib|acalabrutinib|mesh-list
92186844|NCT05950997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186845|NCT05950997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186846|NCT05950971|Amiodarone|amiodarone|mesh-list
92186847|NCT05950971|Diltiazem|diltiazem|mesh-list
92186848|NCT05950971|Esmolol|esmolol|mesh-list
92186849|NCT05950971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92186850|NCT05950971|Vasodilator Agents|vasodilator agents|mesh-ancestor
92186851|NCT05950971|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92186852|NCT05950971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92186853|NCT05950971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186854|NCT05950971|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92186855|NCT05950971|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92186856|NCT05950971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92186857|NCT05950971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186858|NCT05950971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92186859|NCT05950971|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92186860|NCT05950971|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92186862|NCT05950971|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92186863|NCT05950971|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92186864|NCT05950971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186865|NCT05950971|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92186866|NCT05950971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92186867|NCT05950971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92186868|NCT05950971|Adrenergic Agents|adrenergic agents|mesh-ancestor
92186869|NCT05950971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186870|NCT05950945|Trastuzumab|trastuzumab|mesh-list
92186871|NCT05950945|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92186872|NCT05950945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186873|NCT05950945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186874|NCT05950945|Immunoconjugates|immunoconjugates|mesh-ancestor
92186875|NCT05950945|Immunologic Factors|immunologic factors|mesh-ancestor
92186876|NCT05950945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186877|NCT05950841|Locust bean gum|locust bean gum|mesh-list
92186878|NCT05950841|Antidiarrheals|antidiarrheals|mesh-ancestor
92186879|NCT05950841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186880|NCT05950724|Etanercept|etanercept|mesh-list
92186881|NCT05950724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92186882|NCT05950724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186883|NCT05950724|Analgesics|analgesics|mesh-ancestor
92186884|NCT05950724|Sensory System Agents|sensory system agents|mesh-ancestor
92186885|NCT05950724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186886|NCT05950724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186887|NCT05950724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186888|NCT05950724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186889|NCT05950724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186890|NCT05950724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186891|NCT05950724|Immunologic Factors|immunologic factors|mesh-ancestor
92186892|NCT05950711|Ketamine|ketamine|mesh-list
92186893|NCT05950711|Analgesics|analgesics|mesh-ancestor
92186894|NCT05950711|Sensory System Agents|sensory system agents|mesh-ancestor
92186895|NCT05950711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186896|NCT05950711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186897|NCT05950711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92186898|NCT05950711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92186899|NCT05950711|Anesthetics, General|anesthetics, general|mesh-ancestor
92186900|NCT05950711|Anesthetics|anesthetics|mesh-ancestor
92186901|NCT05950711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186902|NCT05950711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92186903|NCT05950711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92186904|NCT05950711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186905|NCT05950711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186906|NCT05950555|Dexmedetomidine|dexmedetomidine|mesh-list
92186907|NCT05950555|Ketamine|ketamine|mesh-list
92186908|NCT05950555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92186909|NCT05950555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92186910|NCT05950555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186911|NCT05950555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186912|NCT05950555|Analgesics|analgesics|mesh-ancestor
92186913|NCT05950555|Sensory System Agents|sensory system agents|mesh-ancestor
92186914|NCT05950555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186915|NCT05950555|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92186916|NCT05950555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92186917|NCT05950555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92186918|NCT05950555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92186919|NCT05950555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92186920|NCT05950555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186921|NCT05950555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92186922|NCT05950555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92186923|NCT05950555|Anesthetics, General|anesthetics, general|mesh-ancestor
92186924|NCT05950555|Anesthetics|anesthetics|mesh-ancestor
92186925|NCT05950555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92186926|NCT05950555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92186927|NCT05950529|Sorbitol|sorbitol|mesh-list
92186928|NCT05950529|Cathartics|cathartics|mesh-ancestor
92186929|NCT05950529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186930|NCT05950490|Methotrexate|methotrexate|mesh-list
92186931|NCT05950490|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92186932|NCT05950490|Abortifacient Agents|abortifacient agents|mesh-ancestor
92186933|NCT05950490|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92186934|NCT05950490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186935|NCT05950490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92186936|NCT05950490|Antimetabolites|antimetabolites|mesh-ancestor
92186937|NCT05950490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186938|NCT05950490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186939|NCT05950490|Dermatologic Agents|dermatologic agents|mesh-ancestor
92186940|NCT05950490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186941|NCT05950490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92186942|NCT05950490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186943|NCT05950490|Immunologic Factors|immunologic factors|mesh-ancestor
92186944|NCT05950490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186945|NCT05950490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92186946|NCT05950334|Cyclophosphamide|cyclophosphamide|mesh-list
92186947|NCT05950334|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92186948|NCT05950334|Rituximab|rituximab|mesh-list
92186949|NCT05950334|Fludarabine|fludarabine|mesh-list
92186950|NCT05950334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186951|NCT05950334|Immunologic Factors|immunologic factors|mesh-ancestor
92186952|NCT05950334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186953|NCT05950334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186954|NCT05950334|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92186955|NCT05950334|Alkylating Agents|alkylating agents|mesh-ancestor
92186956|NCT05950334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186957|NCT05950334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186958|NCT05950334|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92349497|NCT01491672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186959|NCT05950334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92186960|NCT05950204|Calcium, Dietary|calcium, dietary|mesh-list
92186961|NCT05950204|Vitamin D|vitamin d|mesh-list
92186962|NCT05950204|Ergocalciferols|ergocalciferols|mesh-list
92186963|NCT05950204|Cholecalciferol|cholecalciferol|mesh-list
92186964|NCT05950204|Vitamins|vitamins|mesh-list
92186965|NCT05950204|Calcium Carbonate|calcium carbonate|mesh-list
92186966|NCT05950204|Calcium|calcium|mesh-list
92186967|NCT05950204|Micronutrients|micronutrients|mesh-ancestor
92186968|NCT05950204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186969|NCT05950204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92186970|NCT05950204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92186971|NCT05950204|Antacids|antacids|mesh-ancestor
92186972|NCT05950204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186973|NCT05950204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92186974|NCT05950152|Meloxicam|meloxicam|mesh-list
92186975|NCT05950152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92186976|NCT05950152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92186977|NCT05950152|Analgesics|analgesics|mesh-ancestor
92186978|NCT05950152|Sensory System Agents|sensory system agents|mesh-ancestor
92186979|NCT05950152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92186980|NCT05950152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186981|NCT05950152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92186982|NCT05950152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186983|NCT05950152|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92186984|NCT05950152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92186985|NCT05950152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92186986|NCT05950152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186987|NCT05950113|Deoxyglucose|deoxyglucose|mesh-list
92186988|NCT05950113|Cyclophosphamide|cyclophosphamide|mesh-list
92186989|NCT05950113|Fludarabine|fludarabine|mesh-list
92186990|NCT05950113|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92186991|NCT05950113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92186992|NCT05950113|Immunologic Factors|immunologic factors|mesh-ancestor
92186993|NCT05950113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92186994|NCT05950113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92186995|NCT05950113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92186996|NCT05950113|Alkylating Agents|alkylating agents|mesh-ancestor
92186997|NCT05950113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92186998|NCT05950113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92186999|NCT05950113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92187000|NCT05950113|Antimetabolites|antimetabolites|mesh-ancestor
92187001|NCT05950113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92187002|NCT05950113|Antiviral Agents|antiviral agents|mesh-ancestor
92187003|NCT05950113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187005|NCT05950061|Citalopram|citalopram|mesh-list
92187006|NCT05950061|Sertraline|sertraline|mesh-list
92187007|NCT05950061|Escitalopram|escitalopram|mesh-list
92187008|NCT05950061|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92187009|NCT05950061|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92187010|NCT05950061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187011|NCT05950061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187012|NCT05950061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187013|NCT05950061|Serotonin Agents|serotonin agents|mesh-ancestor
92187014|NCT05950061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187015|NCT05950061|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92187016|NCT05950061|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92187017|NCT05950061|Parasympatholytics|parasympatholytics|mesh-ancestor
92187018|NCT05950061|Autonomic Agents|autonomic agents|mesh-ancestor
92187019|NCT05950061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187020|NCT05950061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92187021|NCT05950061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92187022|NCT05950061|Cholinergic Agents|cholinergic agents|mesh-ancestor
92187023|NCT05950061|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92187024|NCT05950061|Antidepressive Agents|antidepressive agents|mesh-ancestor
92187025|NCT05950061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92187026|NCT05949762|Azacitidine|azacitidine|mesh-list
92187027|NCT05949762|Venetoclax|venetoclax|mesh-list
92187028|NCT05949762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92187029|NCT05949762|Antimetabolites|antimetabolites|mesh-ancestor
92334082|NCT04225819|Vitamin D|vitamin d|mesh-list
92187030|NCT05949762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187032|NCT05949762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187033|NCT05949658|Sirolimus|sirolimus|mesh-list
92187034|NCT05949658|Everolimus|everolimus|mesh-list
92187035|NCT05949658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92187036|NCT05949658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187037|NCT05949658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187038|NCT05949658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187039|NCT05949658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92187040|NCT05949658|Immunologic Factors|immunologic factors|mesh-ancestor
92187041|NCT05949658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187042|NCT05949658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187043|NCT05949658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92187044|NCT05949658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187045|NCT05949658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92187046|NCT05949658|Antifungal Agents|antifungal agents|mesh-ancestor
92187047|NCT05949554|Ketamine|ketamine|mesh-list
92187048|NCT05949554|Analgesics|analgesics|mesh-ancestor
92187049|NCT05949554|Sensory System Agents|sensory system agents|mesh-ancestor
92187050|NCT05949554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187051|NCT05949554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187052|NCT05949554|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92187053|NCT05949554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92187054|NCT05949554|Anesthetics, General|anesthetics, general|mesh-ancestor
92187055|NCT05949554|Anesthetics|anesthetics|mesh-ancestor
92187056|NCT05949554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187057|NCT05949554|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92187058|NCT05949554|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92187059|NCT05949554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187060|NCT05949554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187061|NCT05949541|Everolimus|everolimus|mesh-list
92187062|NCT05949541|Fulvestrant|fulvestrant|mesh-list
92187063|NCT05949541|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92187064|NCT05949541|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92187065|NCT05949541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187066|NCT05949541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187067|NCT05949541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187068|NCT05949541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92187069|NCT05949541|Immunologic Factors|immunologic factors|mesh-ancestor
92187070|NCT05949541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187071|NCT05949541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187072|NCT05949541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187073|NCT05949541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92187074|NCT05949541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92187075|NCT05949541|Hormone Antagonists|hormone antagonists|mesh-ancestor
92187076|NCT05949541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187077|NCT05949541|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92187079|NCT05949424|Lenvatinib|lenvatinib|mesh-list
92187080|NCT05949424|Olaparib|olaparib|mesh-list
92187081|NCT05949424|Palbociclib|palbociclib|mesh-list
92187082|NCT05949424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187083|NCT05949424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92187084|NCT05949424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92187085|NCT05949424|Growth Substances|growth substances|mesh-ancestor
92187086|NCT05949424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187087|NCT05949424|Growth Inhibitors|growth inhibitors|mesh-ancestor
92187088|NCT05949424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187089|NCT05949424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187090|NCT05949424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187091|NCT05949424|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92187092|NCT05949411|Lactulose|lactulose|mesh-list
92187093|NCT05949411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187094|NCT05949385|Itraconazole|itraconazole|mesh-list
92187095|NCT05949385|Antifungal Agents|antifungal agents|mesh-ancestor
92187096|NCT05949385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187097|NCT05949385|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92187098|NCT05949385|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92187099|NCT05949385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334086|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187100|NCT05949385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187101|NCT05949385|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92187102|NCT05949385|Hormone Antagonists|hormone antagonists|mesh-ancestor
92187103|NCT05949385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187104|NCT05949385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187105|NCT05949385|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92187106|NCT05949281|Colchicine|colchicine|mesh-list
92187107|NCT05949281|Gout Suppressants|gout suppressants|mesh-ancestor
92187108|NCT05949281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187109|NCT05949281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92187110|NCT05949281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92187111|NCT05949281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92187112|NCT05949281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187113|NCT05949281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187114|NCT05944965|Oxybutynin|oxybutynin|mesh-list
92187115|NCT05944965|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92187116|NCT05944965|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92187117|NCT05944965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92187118|NCT05944965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187119|NCT05944965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187120|NCT05944965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92187121|NCT05944965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187122|NCT05944965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187123|NCT05944965|Parasympatholytics|parasympatholytics|mesh-ancestor
92187124|NCT05944965|Autonomic Agents|autonomic agents|mesh-ancestor
92187125|NCT05944965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187126|NCT05944965|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92187127|NCT05944965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92187128|NCT05944965|Cholinergic Agents|cholinergic agents|mesh-ancestor
92187129|NCT05944965|Urological Agents|urological agents|mesh-ancestor
92187130|NCT05944510|Dextromethorphan|dextromethorphan|mesh-list
92187131|NCT05944510|Antitussive Agents|antitussive agents|mesh-ancestor
92187132|NCT05944510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92187133|NCT05944510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92187134|NCT05944510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92187135|NCT05944510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187136|NCT05944510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187137|NCT05944510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187138|NCT05936086|Cyclosporine|cyclosporine|mesh-list
92187139|NCT05936086|Dexamethasone|dexamethasone|mesh-list
92187140|NCT05936086|Etoposide|etoposide|mesh-list
92187141|NCT05936086|Cyclophosphamide|cyclophosphamide|mesh-list
92187142|NCT05936086|Cyclosporins|cyclosporins|mesh-list
92187143|NCT05936086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187144|NCT05936086|Antiemetics|antiemetics|mesh-ancestor
92187145|NCT05936086|Autonomic Agents|autonomic agents|mesh-ancestor
92187146|NCT05936086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187147|NCT05936086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187148|NCT05936086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187149|NCT05936086|Glucocorticoids|glucocorticoids|mesh-ancestor
92187150|NCT05936086|Hormones|hormones|mesh-ancestor
92187151|NCT05936086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187152|NCT05936086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187153|NCT05936086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187154|NCT05936086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92187155|NCT05936086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92187156|NCT05936086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92187157|NCT05936086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187158|NCT05936086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187159|NCT05936086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92187160|NCT05936086|Immunologic Factors|immunologic factors|mesh-ancestor
92187161|NCT05936086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187162|NCT05936086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92187163|NCT05936086|Alkylating Agents|alkylating agents|mesh-ancestor
92187164|NCT05936086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92187165|NCT05936086|Antifungal Agents|antifungal agents|mesh-ancestor
92187166|NCT05936086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187167|NCT05936086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92187174|NCT05930028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187175|NCT05930028|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92187176|NCT05930028|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92187177|NCT05930028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187178|NCT05926960|Pembrolizumab|pembrolizumab|mesh-list
92187179|NCT05926960|Nivolumab|nivolumab|mesh-list
92187180|NCT05926960|Ipilimumab|ipilimumab|mesh-list
92187181|NCT05926960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187182|NCT05926960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187183|NCT05926960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187184|NCT05926960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187185|NCT05915442|Quemliclustat|quemliclustat|mesh-list
92187186|NCT05915442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187187|NCT05915442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187188|NCT05915442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187189|NCT05915442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187190|NCT05882357|Ivacaftor|ivacaftor|mesh-list
92187191|NCT05882357|Elexacaftor|elexacaftor|mesh-list
92187192|NCT05882357|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92187193|NCT05882357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187194|NCT05882357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187195|NCT05882214|Niacinamide|niacinamide|mesh-list
92187196|NCT05882214|Niacin|niacin|mesh-list
92187197|NCT05882214|Nicotinic Acids|nicotinic acids|mesh-list
92187198|NCT05882214|Vitamin B Complex|vitamin b complex|mesh-ancestor
92187199|NCT05882214|Vitamins|vitamins|mesh-ancestor
92187200|NCT05882214|Micronutrients|micronutrients|mesh-ancestor
92187201|NCT05882214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187202|NCT05882214|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92187203|NCT05882214|Antimetabolites|antimetabolites|mesh-ancestor
92187204|NCT05882214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187205|NCT05882214|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92187206|NCT05882214|Vasodilator Agents|vasodilator agents|mesh-ancestor
92187207|NCT05866315|Remifentanil|remifentanil|mesh-list
92187208|NCT05866315|Desflurane|desflurane|mesh-list
92187209|NCT05866315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92187210|NCT05866315|Narcotics|narcotics|mesh-ancestor
92187211|NCT05866315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187212|NCT05866315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187213|NCT05866315|Analgesics|analgesics|mesh-ancestor
92187214|NCT05866315|Sensory System Agents|sensory system agents|mesh-ancestor
92187215|NCT05866315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187216|NCT05866315|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92187217|NCT05866315|Anesthetics, General|anesthetics, general|mesh-ancestor
92187218|NCT05866315|Anesthetics|anesthetics|mesh-ancestor
92187219|NCT05805501|Pembrolizumab|pembrolizumab|mesh-list
92187220|NCT05805501|Axitinib|axitinib|mesh-list
92187221|NCT05805501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187222|NCT05805501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187223|NCT05805501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187224|NCT05805501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187225|NCT05805501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187226|NCT05805501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187232|NCT05788081|Rituximab|rituximab|mesh-list
92187233|NCT05788081|Nivolumab|nivolumab|mesh-list
92187234|NCT05788081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187235|NCT05788081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187236|NCT05788081|Immunologic Factors|immunologic factors|mesh-ancestor
92187237|NCT05788081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187238|NCT05788081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187239|NCT05788081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187240|NCT05788081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187241|NCT05765487|Sildenafil Citrate|sildenafil citrate|mesh-list
92187242|NCT05765487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92187243|NCT05765487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92187244|NCT05765487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92187245|NCT05765487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187246|NCT05765487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187247|NCT05765487|Urological Agents|urological agents|mesh-ancestor
92334096|NCT00004237|Cyclophosphamide|cyclophosphamide|mesh-list
92187249|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187250|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187251|NCT05701956|Tenecteplase|tenecteplase|mesh-list
92187252|NCT05701956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92187253|NCT05701956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92187254|NCT05701956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187255|NCT05673187|Adagrasib|adagrasib|mesh-list
92187256|NCT05673187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187257|NCT05669989|Dexamethasone|dexamethasone|mesh-list
92187258|NCT05669989|Lenalidomide|lenalidomide|mesh-list
92187259|NCT05669989|Pomalidomide|pomalidomide|mesh-list
92187260|NCT05669989|Cemiplimab|cemiplimab|mesh-list
92187261|NCT05669989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187262|NCT05669989|Antiemetics|antiemetics|mesh-ancestor
92187263|NCT05669989|Autonomic Agents|autonomic agents|mesh-ancestor
92187264|NCT05669989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187265|NCT05669989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187266|NCT05669989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187267|NCT05669989|Glucocorticoids|glucocorticoids|mesh-ancestor
92187268|NCT05669989|Hormones|hormones|mesh-ancestor
92187269|NCT05669989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187270|NCT05669989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187271|NCT05669989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187272|NCT05669989|Immunologic Factors|immunologic factors|mesh-ancestor
92187273|NCT05669989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92187274|NCT05669989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92187275|NCT05669989|Growth Substances|growth substances|mesh-ancestor
92187276|NCT05669989|Growth Inhibitors|growth inhibitors|mesh-ancestor
92187277|NCT05669989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187278|NCT05662228|Lorazepam|lorazepam|mesh-list
92187279|NCT05662228|Immunoglobulins|immunoglobulins|mesh-list
92187280|NCT05662228|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92187281|NCT05662228|Antibodies|antibodies|mesh-list
92187282|NCT05662228|gamma-Globulins|gamma-globulins|mesh-list
92187283|NCT05662228|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92187284|NCT05662228|Tofacitinib|tofacitinib|mesh-list
92187285|NCT05662228|Immunologic Factors|immunologic factors|mesh-ancestor
92187286|NCT05662228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187287|NCT05662228|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92187288|NCT05662228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187289|NCT05662228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187290|NCT05662228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187291|NCT05662228|Anticonvulsants|anticonvulsants|mesh-ancestor
92187292|NCT05662228|Antiemetics|antiemetics|mesh-ancestor
92187293|NCT05662228|Autonomic Agents|autonomic agents|mesh-ancestor
92187294|NCT05662228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187295|NCT05662228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187296|NCT05662228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92187297|NCT05662228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187298|NCT05662228|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92187299|NCT05662228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92187300|NCT05662228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92187301|NCT05662228|GABA Modulators|gaba modulators|mesh-ancestor
92187302|NCT05662228|GABA Agents|gaba agents|mesh-ancestor
92187303|NCT05662228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187304|NCT05656235|Pembrolizumab|pembrolizumab|mesh-list
92187305|NCT05656235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187307|NCT05656235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187308|NCT05656235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187309|NCT05641246|Diclofenac|diclofenac|mesh-list
92187310|NCT05641246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92187311|NCT05641246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92187312|NCT05641246|Analgesics|analgesics|mesh-ancestor
92187313|NCT05641246|Sensory System Agents|sensory system agents|mesh-ancestor
92187314|NCT05641246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187315|NCT05641246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187316|NCT05641246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187317|NCT05641246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187318|NCT05641246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92187319|NCT05641246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187320|NCT05641246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187321|NCT05605093|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92187322|NCT05605093|Protease Inhibitors|protease inhibitors|mesh-list
92187323|NCT05605093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187324|NCT05605093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187325|NCT05605093|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92187327|NCT05605093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92187328|NCT05605093|Antiviral Agents|antiviral agents|mesh-ancestor
92187329|NCT05605093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187330|NCT05593627|Lithium Carbonate|lithium carbonate|mesh-list
92187331|NCT05593627|Calcium Carbonate|calcium carbonate|mesh-list
92187332|NCT05593627|Calcium|calcium|mesh-list
92187333|NCT05593627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92187334|NCT05593627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187335|NCT05593627|Antidepressive Agents|antidepressive agents|mesh-ancestor
92187336|NCT05593627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92187337|NCT05593627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187338|NCT05593627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187339|NCT05593627|Antimanic Agents|antimanic agents|mesh-ancestor
92187340|NCT05593627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92187341|NCT05593627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187342|NCT05593627|Antacids|antacids|mesh-ancestor
92187343|NCT05593627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187344|NCT05582096|Tirzepatide|tirzepatide|mesh-list
92187345|NCT05582096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92187346|NCT05582096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187347|NCT05582096|Incretins|incretins|mesh-ancestor
92187348|NCT05582096|Hormones|hormones|mesh-ancestor
92187349|NCT05582096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187350|NCT05577715|Farletuzumab|farletuzumab|mesh-list
92187351|NCT05577715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187352|NCT05571059|Ifetroban|ifetroban|mesh-list
92187353|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92187354|NCT05563961|Acetaminophen|acetaminophen|mesh-list
92187355|NCT05563961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92187356|NCT05563961|Analgesics|analgesics|mesh-ancestor
92187357|NCT05563961|Sensory System Agents|sensory system agents|mesh-ancestor
92187358|NCT05563961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187359|NCT05563961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187360|NCT05563961|Antipyretics|antipyretics|mesh-ancestor
92187361|NCT05552222|Dexamethasone|dexamethasone|mesh-list
92187362|NCT05552222|Lenalidomide|lenalidomide|mesh-list
92187363|NCT05552222|Daratumumab|daratumumab|mesh-list
92187364|NCT05552222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187365|NCT05552222|Antiemetics|antiemetics|mesh-ancestor
92187366|NCT05552222|Autonomic Agents|autonomic agents|mesh-ancestor
92187367|NCT05552222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187368|NCT05552222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187369|NCT05552222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187370|NCT05552222|Glucocorticoids|glucocorticoids|mesh-ancestor
92187371|NCT05552222|Hormones|hormones|mesh-ancestor
92187372|NCT05552222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187373|NCT05552222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187374|NCT05552222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187375|NCT05552222|Immunologic Factors|immunologic factors|mesh-ancestor
92187376|NCT05552222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92187377|NCT05552222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92187378|NCT05552222|Growth Substances|growth substances|mesh-ancestor
92187379|NCT05552222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92187380|NCT05542407|Atezolizumab|atezolizumab|mesh-list
92187381|NCT05542407|TIC10 compound|tic10 compound|mesh-list
92187382|NCT05542407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187383|NCT05542407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187384|NCT05542407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187385|NCT05542407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187386|NCT05527834|Ceftibuten|ceftibuten|mesh-list
92187387|NCT05527834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92187388|NCT05527834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187389|NCT05522660|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92187390|NCT05522660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187391|NCT05522660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187392|NCT05522660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187393|NCT05507658|Capecitabine|capecitabine|mesh-list
92187394|NCT05507658|Oxaliplatin|oxaliplatin|mesh-list
92187401|NCT05502250|Gemcitabine|gemcitabine|mesh-list
92187402|NCT05502250|Tislelizumab|tislelizumab|mesh-list
92187403|NCT05502250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187404|NCT05502250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92187405|NCT05502250|Antimetabolites|antimetabolites|mesh-ancestor
92187406|NCT05502250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187407|NCT05502250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187409|NCT05488678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92187410|NCT05488678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187411|NCT05480384|Nivolumab|nivolumab|mesh-list
92187412|NCT05480384|Trastuzumab|trastuzumab|mesh-list
92187413|NCT05480384|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92187414|NCT05480384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187415|NCT05480384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187416|NCT05480384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187417|NCT05480384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187418|NCT05480384|Immunoconjugates|immunoconjugates|mesh-ancestor
92187419|NCT05480384|Immunologic Factors|immunologic factors|mesh-ancestor
92187420|NCT05480384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187421|NCT05480306|Bevacizumab|bevacizumab|mesh-list
92187422|NCT05480306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187423|NCT05480306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187424|NCT05480306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92187425|NCT05480306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92187426|NCT05480306|Growth Substances|growth substances|mesh-ancestor
92187427|NCT05480306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187428|NCT05480306|Growth Inhibitors|growth inhibitors|mesh-ancestor
92187429|NCT05473520|Doxycycline|doxycycline|mesh-list
92187430|NCT05473520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92187431|NCT05473520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187432|NCT05473520|Antimalarials|antimalarials|mesh-ancestor
92187433|NCT05473520|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92187434|NCT05473520|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92187441|NCT05457868|Albuterol|albuterol|mesh-list
92187442|NCT05457868|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92187443|NCT05457868|Autonomic Agents|autonomic agents|mesh-ancestor
92187444|NCT05457868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187445|NCT05457868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187446|NCT05457868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92187447|NCT05457868|Respiratory System Agents|respiratory system agents|mesh-ancestor
92187448|NCT05457868|Tocolytic Agents|tocolytic agents|mesh-ancestor
92187449|NCT05457868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92187450|NCT05457868|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92187451|NCT05457868|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92187452|NCT05457868|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92187453|NCT05457868|Adrenergic Agents|adrenergic agents|mesh-ancestor
92187454|NCT05457868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187455|NCT05457868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187456|NCT05448547|Hormones|hormones|mesh-list
92187457|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187458|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187459|NCT05434065|Celecoxib|celecoxib|mesh-list
92187460|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92187461|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92187462|NCT05434065|Analgesics|analgesics|mesh-ancestor
92187463|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
92187464|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187465|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187466|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187467|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187468|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92187469|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92187470|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187471|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187472|NCT05425979|Bupivacaine|bupivacaine|mesh-list
92187473|NCT05425979|Mepivacaine|mepivacaine|mesh-list
92187474|NCT05425979|Anesthetics, Local|anesthetics, local|mesh-ancestor
92187475|NCT05425979|Anesthetics|anesthetics|mesh-ancestor
92187476|NCT05425979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187477|NCT05425979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187478|NCT05425979|Sensory System Agents|sensory system agents|mesh-ancestor
92187479|NCT05425979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187482|NCT05398757|Propofol|propofol|mesh-list
92187483|NCT05398757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92187484|NCT05398757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187485|NCT05398757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187486|NCT05398757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92187487|NCT05398757|Anesthetics, General|anesthetics, general|mesh-ancestor
92187488|NCT05398757|Anesthetics|anesthetics|mesh-ancestor
92187489|NCT05398757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92187490|NCT05398757|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92187491|NCT05398757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92187492|NCT05398757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92187493|NCT05398757|GABA Modulators|gaba modulators|mesh-ancestor
92187494|NCT05398757|GABA Agents|gaba agents|mesh-ancestor
92187495|NCT05398757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187496|NCT05398757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187497|NCT05398757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92187498|NCT05398757|Analgesics|analgesics|mesh-ancestor
92187499|NCT05398757|Sensory System Agents|sensory system agents|mesh-ancestor
92187500|NCT05398757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187501|NCT05398757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92187502|NCT05398757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92187503|NCT05398757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92187504|NCT05398757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92187505|NCT05384496|Nivolumab|nivolumab|mesh-list
92187506|NCT05384496|Ipilimumab|ipilimumab|mesh-list
92187507|NCT05384496|Axitinib|axitinib|mesh-list
92187508|NCT05384496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187509|NCT05384496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187510|NCT05384496|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187511|NCT05384496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187512|NCT05384496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187513|NCT05384496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187514|NCT05378269|Tamoxifen|tamoxifen|mesh-list
92187515|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92187516|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
92187517|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187518|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187519|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187520|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187521|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92187522|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92187523|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92187524|NCT05323552|Curare|curare|mesh-list
92187525|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92187526|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92187527|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92187528|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187529|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187530|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92187531|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92187532|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
92187533|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187534|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187535|NCT05322954|Psilocybin|psilocybin|mesh-list
92187536|NCT05322954|Hallucinogens|hallucinogens|mesh-ancestor
92187537|NCT05322954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187538|NCT05322954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92187539|NCT05310253|Fludrocortisone|fludrocortisone|mesh-list
92187541|NCT05291039|Adalimumab|adalimumab|mesh-list
92187542|NCT05291039|Infliximab|infliximab|mesh-list
92187543|NCT05291039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92187544|NCT05291039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187545|NCT05291039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187546|NCT05291039|Dermatologic Agents|dermatologic agents|mesh-ancestor
92187547|NCT05291039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187548|NCT05274633|Ravulizumab|ravulizumab|mesh-list
92187549|NCT05274633|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92187550|NCT05274633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92187551|NCT05274633|Immunologic Factors|immunologic factors|mesh-ancestor
92187552|NCT05274633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187553|NCT05263388|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92187555|NCT05263388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187556|NCT05263388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187557|NCT05256901|Glycopyrrolate|glycopyrrolate|mesh-list
92187558|NCT05256901|Neostigmine|neostigmine|mesh-list
92187559|NCT05256901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92187560|NCT05256901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187561|NCT05256901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187562|NCT05256901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92187563|NCT05256901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187564|NCT05256901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187565|NCT05256901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92187566|NCT05256901|Autonomic Agents|autonomic agents|mesh-ancestor
92187567|NCT05256901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187568|NCT05256901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92187569|NCT05256901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92187570|NCT05256901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92187571|NCT05249101|Capecitabine|capecitabine|mesh-list
92187572|NCT05249101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92187573|NCT05249101|Antimetabolites|antimetabolites|mesh-ancestor
92187574|NCT05249101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187575|NCT05249101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187576|NCT05224089|Dexamethasone|dexamethasone|mesh-list
92187577|NCT05224089|Epinephrine|epinephrine|mesh-list
92187578|NCT05224089|Bupivacaine|bupivacaine|mesh-list
92187579|NCT05224089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187580|NCT05224089|Antiemetics|antiemetics|mesh-ancestor
92187581|NCT05224089|Autonomic Agents|autonomic agents|mesh-ancestor
92187582|NCT05224089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187583|NCT05224089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187584|NCT05224089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187585|NCT05224089|Glucocorticoids|glucocorticoids|mesh-ancestor
92187587|NCT05224089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187588|NCT05224089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187589|NCT05224089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187590|NCT05224089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187591|NCT05224089|Anesthetics, Local|anesthetics, local|mesh-ancestor
92187592|NCT05224089|Anesthetics|anesthetics|mesh-ancestor
92187593|NCT05224089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187594|NCT05224089|Sensory System Agents|sensory system agents|mesh-ancestor
92187595|NCT05224089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92187596|NCT05224089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92187597|NCT05224089|Adrenergic Agents|adrenergic agents|mesh-ancestor
92187598|NCT05224089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187599|NCT05224089|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92187600|NCT05224089|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92187601|NCT05224089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92187602|NCT05224089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92187603|NCT05224089|Mydriatics|mydriatics|mesh-ancestor
92187604|NCT05224089|Sympathomimetics|sympathomimetics|mesh-ancestor
92187605|NCT05224089|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92187606|NCT05215340|Pembrolizumab|pembrolizumab|mesh-list
92187607|NCT05215340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92334122|NCT00003259|Vinorelbine|vinorelbine|mesh-list
92187608|NCT05215340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187609|NCT05215340|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187610|NCT05215340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187611|NCT05208047|Sunitinib|sunitinib|mesh-list
92187612|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187613|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92187614|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92187615|NCT05208047|Growth Substances|growth substances|mesh-ancestor
92187616|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187618|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187619|NCT05208047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187620|NCT05208047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187621|NCT05206773|Venglustat|venglustat|mesh-list
92187622|NCT05206773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187623|NCT05206773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187624|NCT05205252|Dexamethasone|dexamethasone|mesh-list
92187625|NCT05205252|Lenalidomide|lenalidomide|mesh-list
92187626|NCT05205252|Daratumumab|daratumumab|mesh-list
92187627|NCT05205252|Pomalidomide|pomalidomide|mesh-list
92187628|NCT05205252|Acalabrutinib|acalabrutinib|mesh-list
92187629|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92187630|NCT05205252|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92187631|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187632|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
92187633|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
92187634|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187635|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187636|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187637|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
92187638|NCT05205252|Hormones|hormones|mesh-ancestor
92187639|NCT05205252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187640|NCT05205252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187641|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187642|NCT05205252|Immunologic Factors|immunologic factors|mesh-ancestor
92187643|NCT05205252|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92187644|NCT05205252|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92187645|NCT05205252|Growth Substances|growth substances|mesh-ancestor
92187646|NCT05205252|Growth Inhibitors|growth inhibitors|mesh-ancestor
92187647|NCT05205252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187648|NCT05205252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187649|NCT05205252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187650|NCT05188677|Vaccines|vaccines|mesh-list
92187651|NCT05188677|Immunologic Factors|immunologic factors|mesh-ancestor
92187652|NCT05188677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187653|NCT05180240|Cannabidiol|cannabidiol|mesh-list
92187654|NCT05180240|Anticonvulsants|anticonvulsants|mesh-ancestor
92187655|NCT05171777|Atezolizumab|atezolizumab|mesh-list
92187656|NCT05171777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187657|NCT05171777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187658|NCT05171777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187659|NCT05171777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187660|NCT05152472|Atezolizumab|atezolizumab|mesh-list
92187661|NCT05152472|Imatinib Mesylate|imatinib mesylate|mesh-list
92187662|NCT05152472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187663|NCT05152472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187664|NCT05152472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187665|NCT05152472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187666|NCT05152472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187667|NCT05152472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187668|NCT05127044|Bilirubin|bilirubin|mesh-list
92187669|NCT05127044|Antioxidants|antioxidants|mesh-ancestor
92187670|NCT05127044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187671|NCT05127044|Protective Agents|protective agents|mesh-ancestor
92187672|NCT05127044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187673|NCT05125237|Amiloride|amiloride|mesh-list
92187674|NCT05125237|Triamterene|triamterene|mesh-list
92187675|NCT05125237|Diuretics|diuretics|mesh-ancestor
92187676|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
92187677|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334136|NCT00003913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187678|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92187679|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92187680|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187681|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939836|NCT04970108|Empagliflozin|empagliflozin|mesh-list
92187682|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92187683|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92187684|NCT05125224|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92187685|NCT05125224|Calcium Channel Blockers|calcium channel blockers|mesh-list
92187686|NCT05125224|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
92187687|NCT05125224|Calcium|calcium|mesh-list
92187688|NCT05125224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92187689|NCT05125224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187691|NCT05125224|Diuretics|diuretics|mesh-ancestor
92187692|NCT05125224|Natriuretic Agents|natriuretic agents|mesh-ancestor
92187711|NCT05057247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92187712|NCT05057247|Antimitotic Agents|antimitotic agents|mesh-ancestor
92187713|NCT05057247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92187714|NCT05057247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187715|NCT05016947|Dexamethasone|dexamethasone|mesh-list
92187716|NCT05016947|Venetoclax|venetoclax|mesh-list
92187717|NCT05016947|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92187718|NCT05016947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187719|NCT05016947|Antiemetics|antiemetics|mesh-ancestor
92187720|NCT05016947|Autonomic Agents|autonomic agents|mesh-ancestor
92187721|NCT05016947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92187722|NCT05016947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187723|NCT05016947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92187724|NCT05016947|Glucocorticoids|glucocorticoids|mesh-ancestor
92187725|NCT05016947|Hormones|hormones|mesh-ancestor
92187726|NCT05016947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187727|NCT05016947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187728|NCT05016947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187729|NCT05016947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187730|NCT05016947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92187731|NCT05016947|Immunotoxins|immunotoxins|mesh-ancestor
92187732|NCT05016947|Immunoconjugates|immunoconjugates|mesh-ancestor
92187733|NCT05016947|Immunologic Factors|immunologic factors|mesh-ancestor
92187734|NCT04989816|Trastuzumab|trastuzumab|mesh-list
92187735|NCT04989816|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92187736|NCT04989816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187737|NCT04989816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187738|NCT04989816|Immunoconjugates|immunoconjugates|mesh-ancestor
92187739|NCT04989816|Immunologic Factors|immunologic factors|mesh-ancestor
92187740|NCT04989816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187741|NCT04963712|Thymalfasin|thymalfasin|mesh-list
92187742|NCT04963712|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92187743|NCT04963712|Immunologic Factors|immunologic factors|mesh-ancestor
92187744|NCT04963712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187745|NCT04936542|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92187746|NCT04936542|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92187747|NCT04936542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92187748|NCT04936542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187749|NCT04936542|Cholinergic Agents|cholinergic agents|mesh-ancestor
92187750|NCT04936542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187751|NCT04936542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187772|NCT04895709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92187773|NCT04895709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92187774|NCT04895709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92187775|NCT04895709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187776|NCT04895709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187777|NCT04895709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187778|NCT04895436|Venetoclax|venetoclax|mesh-list
92187779|NCT04895436|Obinutuzumab|obinutuzumab|mesh-list
92187780|NCT04895436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187781|NCT04895436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187782|NCT04870112|Carboplatin|carboplatin|mesh-list
92187783|NCT04870112|Etoposide|etoposide|mesh-list
92187784|NCT04870112|Durvalumab|durvalumab|mesh-list
92187785|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187786|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92187787|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92187788|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92187789|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187790|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187791|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187792|NCT04821089|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92187793|NCT04821089|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92187794|NCT04821089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917048|NCT04976036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187795|NCT04821089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187796|NCT04821089|Cholinergic Agents|cholinergic agents|mesh-ancestor
92187797|NCT04821089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187798|NCT04821089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187799|NCT04754399|Cannabidiol|cannabidiol|mesh-list
92187800|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
92187803|NCT04750616|Nicotinic Acids|nicotinic acids|mesh-list
92187804|NCT04750616|Vitamin B Complex|vitamin b complex|mesh-ancestor
92187805|NCT04750616|Vitamins|vitamins|mesh-ancestor
92187806|NCT04750616|Micronutrients|micronutrients|mesh-ancestor
92187807|NCT04750616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187808|NCT04750616|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92187809|NCT04750616|Antimetabolites|antimetabolites|mesh-ancestor
92187810|NCT04750616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187811|NCT04750616|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92187812|NCT04750616|Vasodilator Agents|vasodilator agents|mesh-ancestor
92187813|NCT04734652|Tenofovir|tenofovir|mesh-list
92187814|NCT04734652|Lamivudine|lamivudine|mesh-list
92187815|NCT04734652|Dolutegravir|dolutegravir|mesh-list
92187816|NCT04734652|Antiviral Agents|antiviral agents|mesh-ancestor
92187817|NCT04734652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187818|NCT04734652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92187819|NCT04734652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92187820|NCT04734652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187821|NCT04734652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187822|NCT04734652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92187823|NCT04734652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92187824|NCT04734652|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92187825|NCT04734652|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92187826|NCT04717375|Pembrolizumab|pembrolizumab|mesh-list
92187827|NCT04717375|Cetuximab|cetuximab|mesh-list
92187828|NCT04717375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187829|NCT04717375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187830|NCT04717375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187831|NCT04717375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187832|NCT04697628|Gemcitabine|gemcitabine|mesh-list
92187833|NCT04697628|Irinotecan|irinotecan|mesh-list
92187834|NCT04697628|Pemetrexed|pemetrexed|mesh-list
92187835|NCT04697628|Topotecan|topotecan|mesh-list
92187836|NCT04697628|Vinorelbine|vinorelbine|mesh-list
92187837|NCT04697628|Tisotumab vedotin|tisotumab vedotin|mesh-list
92187838|NCT04697628|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92187839|NCT04697628|Antimetabolites|antimetabolites|mesh-ancestor
92187840|NCT04697628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187841|NCT04697628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187842|NCT04697628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92187843|NCT04697628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92187844|NCT04697628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187845|NCT04697628|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92187846|NCT04697628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92187847|NCT04697628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92187848|NCT04697628|Tubulin Modulators|tubulin modulators|mesh-ancestor
92187849|NCT04697628|Antimitotic Agents|antimitotic agents|mesh-ancestor
92187850|NCT04697628|Mitosis Modulators|mitosis modulators|mesh-ancestor
92187851|NCT04697628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187852|NCT04697576|Pembrolizumab|pembrolizumab|mesh-list
92187853|NCT04697576|Nivolumab|nivolumab|mesh-list
92187854|NCT04697576|Ipilimumab|ipilimumab|mesh-list
92187855|NCT04697576|Relatlimab|relatlimab|mesh-list
92187856|NCT04697576|Vaccines|vaccines|mesh-list
92187857|NCT04697576|Immunologic Factors|immunologic factors|mesh-ancestor
92187858|NCT04697576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334143|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
92187859|NCT04697576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187860|NCT04697576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187861|NCT04697576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187862|NCT04697576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187863|NCT04676646|Spironolactone|spironolactone|mesh-list
92187864|NCT04676646|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92187865|NCT04676646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92187866|NCT04676646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187867|NCT04676646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187868|NCT04676646|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92187869|NCT04676646|Diuretics|diuretics|mesh-ancestor
92187870|NCT04676646|Natriuretic Agents|natriuretic agents|mesh-ancestor
92187871|NCT04673422|Montelukast|montelukast|mesh-list
92187872|NCT04673422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92187873|NCT04673422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92187874|NCT04673422|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92187875|NCT04673422|Hormone Antagonists|hormone antagonists|mesh-ancestor
92187876|NCT04673422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187877|NCT04673422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187878|NCT04673422|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92187879|NCT04673422|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92187880|NCT04673422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187881|NCT04646356|Tacrolimus|tacrolimus|mesh-list
92187882|NCT04646356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92187883|NCT04646356|Immunologic Factors|immunologic factors|mesh-ancestor
92187884|NCT04646356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187885|NCT04646356|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92187886|NCT04646356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187887|NCT04646356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187888|NCT04644068|Paclitaxel|paclitaxel|mesh-list
92187889|NCT04644068|Carboplatin|carboplatin|mesh-list
92187891|NCT04644068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187892|NCT04644068|Tubulin Modulators|tubulin modulators|mesh-ancestor
92187893|NCT04644068|Antimitotic Agents|antimitotic agents|mesh-ancestor
92187894|NCT04644068|Mitosis Modulators|mitosis modulators|mesh-ancestor
92187895|NCT04644068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187896|NCT04624243|Risperidone|risperidone|mesh-list
92187897|NCT04624243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92187898|NCT04624243|Serotonin Agents|serotonin agents|mesh-ancestor
92187899|NCT04624243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92187900|NCT04624243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187901|NCT04624243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187902|NCT04624243|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92187903|NCT04624243|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92187904|NCT04624243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92187905|NCT04624243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92187906|NCT04624243|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92187907|NCT04624243|Dopamine Agents|dopamine agents|mesh-ancestor
92187908|NCT04618016|Vitamins|vitamins|mesh-list
92187909|NCT04618016|Vitamin E|vitamin e|mesh-list
92187910|NCT04618016|Tocopherols|tocopherols|mesh-list
92187911|NCT04618016|Tocotrienols|tocotrienols|mesh-list
92187912|NCT04618016|alpha-Tocopherol|alpha-tocopherol|mesh-list
92187913|NCT04618016|Micronutrients|micronutrients|mesh-ancestor
92187914|NCT04618016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187915|NCT04618016|Antioxidants|antioxidants|mesh-ancestor
92187916|NCT04618016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187917|NCT04618016|Protective Agents|protective agents|mesh-ancestor
92187919|NCT04609566|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92187920|NCT04609566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187921|NCT04609566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187922|NCT04609566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187923|NCT04609566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187924|NCT04609566|Immunotoxins|immunotoxins|mesh-ancestor
92187925|NCT04609566|Immunoconjugates|immunoconjugates|mesh-ancestor
92187926|NCT04609566|Immunologic Factors|immunologic factors|mesh-ancestor
92334151|NCT00003913|Protective Agents|protective agents|mesh-ancestor
92187927|NCT04609566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187928|NCT04576156|Imetelstat|imetelstat|mesh-list
92187929|NCT04576156|Motesanib diphosphate|motesanib diphosphate|mesh-list
92187930|NCT04576156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187931|NCT04576156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187932|NCT04576156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92187933|NCT04529772|Prednisone|prednisone|mesh-list
92187934|NCT04529772|Cyclophosphamide|cyclophosphamide|mesh-list
92187935|NCT04529772|Rituximab|rituximab|mesh-list
92187936|NCT04529772|Doxorubicin|doxorubicin|mesh-list
92187937|NCT04529772|Vincristine|vincristine|mesh-list
92187938|NCT04529772|Acalabrutinib|acalabrutinib|mesh-list
92187939|NCT04529772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92187940|NCT04529772|Immunologic Factors|immunologic factors|mesh-ancestor
92187941|NCT04529772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187942|NCT04529772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92187943|NCT04529772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92187944|NCT04529772|Alkylating Agents|alkylating agents|mesh-ancestor
92187945|NCT04529772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187946|NCT04529772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187947|NCT04529772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92187948|NCT04529772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187949|NCT04529772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92187950|NCT04529772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92187951|NCT04529772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92187953|NCT04529772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92187954|NCT04529772|Glucocorticoids|glucocorticoids|mesh-ancestor
92187955|NCT04529772|Hormones|hormones|mesh-ancestor
92187956|NCT04529772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187957|NCT04529772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92187958|NCT04529772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92187959|NCT04529772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92187960|NCT04529772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92187961|NCT04529772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92187962|NCT04515472|Hormones|hormones|mesh-list
92187963|NCT04515472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187964|NCT04515472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92187966|NCT04508023|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92187967|NCT04508023|Antithrombins|antithrombins|mesh-ancestor
92187968|NCT04508023|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92187969|NCT04508023|Protease Inhibitors|protease inhibitors|mesh-ancestor
92187970|NCT04508023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92187971|NCT04508023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187972|NCT04508023|Anticoagulants|anticoagulants|mesh-ancestor
92187973|NCT04505098|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92187974|NCT04505098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92187975|NCT04505098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92187976|NCT04489732|Interferons|interferons|mesh-list
92187977|NCT04489732|Interferon-gamma|interferon-gamma|mesh-list
92187978|NCT04489732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187979|NCT04489732|Antiviral Agents|antiviral agents|mesh-ancestor
92187980|NCT04489732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92187981|NCT04451746|Contraceptive Agents|contraceptive agents|mesh-list
92187982|NCT04451746|Contraceptives, Oral|contraceptives, oral|mesh-list
92187983|NCT04451746|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92187984|NCT04451746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92187985|NCT04451746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92187986|NCT04451746|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92187987|NCT04430738|Leucovorin|leucovorin|mesh-list
92187988|NCT04430738|Pembrolizumab|pembrolizumab|mesh-list
92187989|NCT04430738|Trastuzumab|trastuzumab|mesh-list
92187990|NCT04430738|Fluorouracil|fluorouracil|mesh-list
92187991|NCT04430738|Capecitabine|capecitabine|mesh-list
92187992|NCT04430738|Oxaliplatin|oxaliplatin|mesh-list
92187993|NCT04430738|Tucatinib|tucatinib|mesh-list
92187994|NCT04430738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92187995|NCT04430738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92187996|NCT04430738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92187997|NCT04430738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92187998|NCT04430738|Antimetabolites|antimetabolites|mesh-ancestor
92187999|NCT04430738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188000|NCT04430738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92188001|NCT04430738|Immunologic Factors|immunologic factors|mesh-ancestor
92188002|NCT04430738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188003|NCT04430738|Antidotes|antidotes|mesh-ancestor
92188004|NCT04430738|Protective Agents|protective agents|mesh-ancestor
92188005|NCT04430738|Vitamin B Complex|vitamin b complex|mesh-ancestor
92188006|NCT04430738|Vitamins|vitamins|mesh-ancestor
92188007|NCT04430738|Micronutrients|micronutrients|mesh-ancestor
92188008|NCT04430738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188009|NCT04430738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188010|NCT04429542|Pembrolizumab|pembrolizumab|mesh-list
92188011|NCT04429542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188012|NCT04429542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188013|NCT04429542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188014|NCT04429542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188015|NCT04425018|Paclitaxel|paclitaxel|mesh-list
92188016|NCT04425018|Trastuzumab|trastuzumab|mesh-list
92188017|NCT04425018|Pertuzumab|pertuzumab|mesh-list
92188018|NCT04425018|Margetuximab|margetuximab|mesh-list
92188019|NCT04425018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92188020|NCT04425018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188021|NCT04425018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188022|NCT04425018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188023|NCT04425018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188024|NCT04425018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188025|NCT04425018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188026|NCT04389632|Pembrolizumab|pembrolizumab|mesh-list
92188027|NCT04389632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188028|NCT04389632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188029|NCT04389632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188030|NCT04389632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188031|NCT04363801|Leucovorin|leucovorin|mesh-list
92188032|NCT04363801|Fluorouracil|fluorouracil|mesh-list
92188033|NCT04363801|Capecitabine|capecitabine|mesh-list
92188034|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
92188035|NCT04363801|Tislelizumab|tislelizumab|mesh-list
92188036|NCT04363801|Calcium|calcium|mesh-list
92188037|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
92188038|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92188039|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188040|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
92188041|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188042|NCT04363801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188044|NCT04363801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92188045|NCT04363801|Immunologic Factors|immunologic factors|mesh-ancestor
92188046|NCT04363801|Antidotes|antidotes|mesh-ancestor
92188047|NCT04363801|Protective Agents|protective agents|mesh-ancestor
92188048|NCT04363801|Vitamin B Complex|vitamin b complex|mesh-ancestor
92188049|NCT04363801|Vitamins|vitamins|mesh-ancestor
92188050|NCT04363801|Micronutrients|micronutrients|mesh-ancestor
92188051|NCT04363801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188052|NCT04333576|Contraceptive Agents|contraceptive agents|mesh-list
92188053|NCT04333576|Contraceptives, Oral|contraceptives, oral|mesh-list
92188054|NCT04333576|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92188055|NCT04333576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92188056|NCT04333576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188057|NCT04333576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92188058|NCT04300595|Anesthetics|anesthetics|mesh-list
92188059|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92188060|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188061|NCT04290546|Cetuximab|cetuximab|mesh-list
92188062|NCT04290546|Ipilimumab|ipilimumab|mesh-list
92188063|NCT04290546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92188064|NCT04290546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188065|NCT04290546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188066|NCT04290546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188067|NCT04246086|Lenalidomide|lenalidomide|mesh-list
92188068|NCT04246086|Immunologic Factors|immunologic factors|mesh-ancestor
92188069|NCT04246086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188070|NCT04246086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92188071|NCT04246086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92334163|NCT00003925|Leucovorin|leucovorin|mesh-list
92188072|NCT04246086|Growth Substances|growth substances|mesh-ancestor
92188073|NCT04246086|Growth Inhibitors|growth inhibitors|mesh-ancestor
92188074|NCT04246086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188075|NCT04237649|Spartalizumab|spartalizumab|mesh-list
92188076|NCT04237649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188077|NCT04237649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188078|NCT04237649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188079|NCT04237649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188080|NCT04227847|Azacitidine|azacitidine|mesh-list
92188081|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188082|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
92188083|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188084|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188085|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188086|NCT04212026|Nivolumab|nivolumab|mesh-list
92188087|NCT04212026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188088|NCT04212026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188089|NCT04212026|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188090|NCT04212026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188092|NCT04204941|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92188093|NCT04204941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92188094|NCT04204941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188095|NCT04204941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92188096|NCT04204941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188097|NCT04204941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188098|NCT04204941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188099|NCT04187144|Nitrofurantoin|nitrofurantoin|mesh-list
92188100|NCT04187144|Gepotidacin|gepotidacin|mesh-list
92188101|NCT04187144|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92188102|NCT04187144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188103|NCT04187144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188104|NCT04187144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188105|NCT04187144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188106|NCT04187144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188107|NCT04187144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188108|NCT04161066|Psilocybin|psilocybin|mesh-list
92188109|NCT04161066|Hallucinogens|hallucinogens|mesh-ancestor
92188110|NCT04161066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188111|NCT04161066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92188112|NCT04098250|Erenumab|erenumab|mesh-list
92188113|NCT04098250|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92188114|NCT04098250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188116|NCT04098250|Sensory System Agents|sensory system agents|mesh-ancestor
92188117|NCT04098250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188118|NCT04098250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188119|NCT04096638|Atezolizumab|atezolizumab|mesh-list
92188120|NCT04096638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188121|NCT04096638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188122|NCT04096638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188123|NCT04096638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188124|NCT04093323|Interferons|interferons|mesh-list
92188125|NCT04093323|Interferon-alpha|interferon-alpha|mesh-list
92188126|NCT04093323|Interferon alpha-2|interferon alpha-2|mesh-list
92188127|NCT04093323|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92188128|NCT04093323|Celecoxib|celecoxib|mesh-list
92188129|NCT04093323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92188130|NCT04093323|Benzenesulfonamide|benzenesulfonamide|mesh-list
92188131|NCT04093323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188132|NCT04093323|Antiviral Agents|antiviral agents|mesh-ancestor
92188133|NCT04093323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188134|NCT04093323|Immunologic Factors|immunologic factors|mesh-ancestor
92188135|NCT04093323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188136|NCT04093323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92188137|NCT04093323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188138|NCT04093323|Analgesics|analgesics|mesh-ancestor
92188139|NCT04093323|Sensory System Agents|sensory system agents|mesh-ancestor
92188140|NCT04093323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188141|NCT04093323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188142|NCT04093323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188143|NCT04093323|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92188144|NCT04093323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92188146|NCT04093323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188147|NCT04093323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188148|NCT04093323|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92188150|NCT04065399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92188151|NCT04065399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92188152|NCT04065399|Antiviral Agents|antiviral agents|mesh-ancestor
92188153|NCT04065399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188154|NCT04065399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92188155|NCT04065399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92188156|NCT04065399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188157|NCT04065399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188158|NCT04027946|Pembrolizumab|pembrolizumab|mesh-list
92188159|NCT04027946|LMB-100|lmb-100|mesh-list
92188160|NCT04027946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188161|NCT04027946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188162|NCT04027946|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188163|NCT04027946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188164|NCT04027946|Immunoconjugates|immunoconjugates|mesh-ancestor
92188165|NCT04027946|Immunologic Factors|immunologic factors|mesh-ancestor
92188166|NCT04027946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188167|NCT04017468|Vancomycin|vancomycin|mesh-list
92188168|NCT04017468|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188169|NCT04017468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188170|NCT03976310|Benralizumab|benralizumab|mesh-list
92188171|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92188172|NCT03976310|Respiratory System Agents|respiratory system agents|mesh-ancestor
92188173|NCT03975647|Tucatinib|tucatinib|mesh-list
92188174|NCT03975647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188175|NCT03975647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188176|NCT03975647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188177|NCT03975647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188178|NCT03950570|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92188179|NCT03950570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188180|NCT03949764|Sofosbuvir|sofosbuvir|mesh-list
92188181|NCT03949764|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92188182|NCT03949764|Velpatasvir|velpatasvir|mesh-list
92188183|NCT03949764|Antiviral Agents|antiviral agents|mesh-ancestor
92188184|NCT03949764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188185|NCT03944954|Dronabinol|dronabinol|mesh-list
92188186|NCT03944954|Hallucinogens|hallucinogens|mesh-ancestor
92188187|NCT03944954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188188|NCT03944954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92188189|NCT03944954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188190|NCT03944954|Analgesics|analgesics|mesh-ancestor
92188191|NCT03944954|Sensory System Agents|sensory system agents|mesh-ancestor
92188192|NCT03944954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188193|NCT03944954|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92188194|NCT03944954|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92188195|NCT03944954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188196|NCT03944954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188198|NCT03944954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188199|NCT03930212|Progesterone|progesterone|mesh-list
92188200|NCT03930212|Progestins|progestins|mesh-ancestor
92188201|NCT03930212|Hormones|hormones|mesh-ancestor
92188202|NCT03930212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188203|NCT03930212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188204|NCT03901339|Gemcitabine|gemcitabine|mesh-list
92188205|NCT03901339|Capecitabine|capecitabine|mesh-list
92188206|NCT03901339|Vinorelbine|vinorelbine|mesh-list
92188207|NCT03901339|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92188208|NCT03901339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188209|NCT03901339|Antimetabolites|antimetabolites|mesh-ancestor
92334177|NCT00003925|Vitamins|vitamins|mesh-ancestor
92188210|NCT03901339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188211|NCT03901339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188212|NCT03901339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92188213|NCT03901339|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188214|NCT03901339|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188215|NCT03901339|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188217|NCT03901339|Immunologic Factors|immunologic factors|mesh-ancestor
92188218|NCT03901339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188219|NCT03893617|Propranolol|propranolol|mesh-list
92188220|NCT03893617|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92188221|NCT03893617|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92188222|NCT03893617|Adrenergic Agents|adrenergic agents|mesh-ancestor
92188223|NCT03893617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188224|NCT03893617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188225|NCT03893617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188226|NCT03893617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92188227|NCT03893617|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92188228|NCT03893617|Vasodilator Agents|vasodilator agents|mesh-ancestor
92188229|NCT03856047|Liraglutide|liraglutide|mesh-list
92188230|NCT03856047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92188231|NCT03856047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188232|NCT03856047|Incretins|incretins|mesh-ancestor
92188233|NCT03856047|Hormones|hormones|mesh-ancestor
92188234|NCT03856047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188235|NCT03850782|Bimatoprost|bimatoprost|mesh-list
92188236|NCT03850782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92188237|NCT03810742|Irinotecan|irinotecan|mesh-list
92188238|NCT03810742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92188239|NCT03810742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188240|NCT03810742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188241|NCT03810742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188242|NCT03810742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188243|NCT03809624|Pembrolizumab|pembrolizumab|mesh-list
92188244|NCT03809624|Antibodies|antibodies|mesh-list
92188245|NCT03809624|Immunologic Factors|immunologic factors|mesh-ancestor
92188246|NCT03809624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188247|NCT03809624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188248|NCT03809624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188249|NCT03809624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188250|NCT03809624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188251|NCT03797014|Tenofovir|tenofovir|mesh-list
92188252|NCT03797014|Emtricitabine|emtricitabine|mesh-list
92188253|NCT03797014|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92188254|NCT03797014|Antiviral Agents|antiviral agents|mesh-ancestor
92188255|NCT03797014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188256|NCT03797014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92188257|NCT03797014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92188258|NCT03797014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188259|NCT03797014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188260|NCT03797014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92188261|NCT03797014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92188262|NCT03787628|Cannabidiol|cannabidiol|mesh-list
92188263|NCT03787628|Anticonvulsants|anticonvulsants|mesh-ancestor
92188264|NCT03761173|Anticoagulants|anticoagulants|mesh-list
92188265|NCT03752684|Calcium|calcium|mesh-list
92188266|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92188267|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188268|NCT03751709|Blinatumomab|blinatumomab|mesh-list
92188269|NCT03751709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188270|NCT03737136|Bortezomib|bortezomib|mesh-list
92188271|NCT03737136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188272|NCT03725202|Upadacitinib|upadacitinib|mesh-list
92188273|NCT03725202|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92188274|NCT03725202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188275|NCT03725202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188276|NCT03725202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188277|NCT03725202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188278|NCT03691376|Aldesleukin|aldesleukin|mesh-list
92188279|NCT03691376|Melphalan|melphalan|mesh-list
92188280|NCT03691376|Mechlorethamine|mechlorethamine|mesh-list
92188281|NCT03691376|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92188282|NCT03691376|Interleukin-2|interleukin-2|mesh-list
92188283|NCT03691376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92188284|NCT03691376|Alkylating Agents|alkylating agents|mesh-ancestor
92188285|NCT03691376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188286|NCT03691376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188287|NCT03691376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92188288|NCT03691376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92188289|NCT03691376|Immunologic Factors|immunologic factors|mesh-ancestor
92188290|NCT03691376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188291|NCT03691376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188292|NCT03691376|Analgesics|analgesics|mesh-ancestor
92188293|NCT03691376|Sensory System Agents|sensory system agents|mesh-ancestor
92188294|NCT03691376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188295|NCT03691376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92188296|NCT03691376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92188297|NCT03691376|Antiviral Agents|antiviral agents|mesh-ancestor
92188298|NCT03691376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188299|NCT03678753|Cenobamate|cenobamate|mesh-list
92188300|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
92188301|NCT03647163|Pembrolizumab|pembrolizumab|mesh-list
92188302|NCT03647163|Nivolumab|nivolumab|mesh-list
92188303|NCT03647163|Ipilimumab|ipilimumab|mesh-list
92188304|NCT03647163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188305|NCT03647163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188306|NCT03647163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188307|NCT03647163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188308|NCT03635749|Atorvastatin|atorvastatin|mesh-list
92188309|NCT03635749|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92188310|NCT03635749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188311|NCT03635749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188312|NCT03635749|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92188313|NCT03635749|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92188314|NCT03635749|Antimetabolites|antimetabolites|mesh-ancestor
92188315|NCT03635749|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92188316|NCT03599453|Interferons|interferons|mesh-list
92188317|NCT03599453|Interferon-alpha|interferon-alpha|mesh-list
92188318|NCT03599453|Interferon alpha-2|interferon alpha-2|mesh-list
92188319|NCT03599453|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92188320|NCT03599453|Poly I-C|poly i-c|mesh-list
92188321|NCT03599453|Celecoxib|celecoxib|mesh-list
92188322|NCT03599453|Pembrolizumab|pembrolizumab|mesh-list
92188323|NCT03599453|Immunoglobulins|immunoglobulins|mesh-list
92188324|NCT03599453|Immunoglobulin G|immunoglobulin g|mesh-list
92188325|NCT03599453|Benzenesulfonamide|benzenesulfonamide|mesh-list
92188326|NCT03599453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188327|NCT03599453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188328|NCT03599453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188329|NCT03599453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188330|NCT03599453|Antiviral Agents|antiviral agents|mesh-ancestor
92188331|NCT03599453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188332|NCT03599453|Immunologic Factors|immunologic factors|mesh-ancestor
92188333|NCT03599453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188334|NCT03599453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92188335|NCT03599453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188336|NCT03599453|Analgesics|analgesics|mesh-ancestor
92188337|NCT03599453|Sensory System Agents|sensory system agents|mesh-ancestor
92188338|NCT03599453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188339|NCT03599453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188340|NCT03599453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188341|NCT03599453|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92188342|NCT03599453|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92188343|NCT03599453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188344|NCT03599453|Interferon Inducers|interferon inducers|mesh-ancestor
92188345|NCT03599453|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92188347|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188348|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188349|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188350|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188351|NCT03559647|Atezolizumab|atezolizumab|mesh-list
92188352|NCT03559647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188353|NCT03559647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188354|NCT03559647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188355|NCT03559647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188356|NCT03554473|Temozolomide|temozolomide|mesh-list
92188357|NCT03554473|Topotecan|topotecan|mesh-list
92188358|NCT03554473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92188359|NCT03554473|Alkylating Agents|alkylating agents|mesh-ancestor
92188360|NCT03554473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188361|NCT03554473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188362|NCT03554473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92188363|NCT03554473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188364|NCT03554473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188365|NCT03554291|Famotidine|famotidine|mesh-list
92188366|NCT03554291|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92188367|NCT03554291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188368|NCT03554291|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92188369|NCT03554291|Histamine Antagonists|histamine antagonists|mesh-ancestor
92188370|NCT03554291|Histamine Agents|histamine agents|mesh-ancestor
92188371|NCT03554291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188372|NCT03554291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188373|NCT03554291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188374|NCT03524235|Rituximab|rituximab|mesh-list
92188375|NCT03524235|Fludarabine|fludarabine|mesh-list
92188376|NCT03524235|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92188377|NCT03524235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188378|NCT03524235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188379|NCT03524235|Immunologic Factors|immunologic factors|mesh-ancestor
92188380|NCT03524235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188381|NCT03524235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188382|NCT03524235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188383|NCT03524235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92188384|NCT03524235|Alkylating Agents|alkylating agents|mesh-ancestor
92188385|NCT03485209|Carboplatin|carboplatin|mesh-list
92188386|NCT03485209|Pembrolizumab|pembrolizumab|mesh-list
92188387|NCT03485209|Tisotumab vedotin|tisotumab vedotin|mesh-list
92188388|NCT03485209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188389|NCT03485209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188390|NCT03485209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188391|NCT03485209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188392|NCT03464461|Ketorolac|ketorolac|mesh-list
92188393|NCT03464461|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92188394|NCT03464461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92188395|NCT03464461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188396|NCT03464461|Analgesics|analgesics|mesh-ancestor
92188397|NCT03464461|Sensory System Agents|sensory system agents|mesh-ancestor
92188398|NCT03464461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188399|NCT03464461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188400|NCT03464461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188401|NCT03464461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188402|NCT03464461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92188403|NCT03464461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188404|NCT03464461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188405|NCT03440437|Paclitaxel|paclitaxel|mesh-list
92188406|NCT03440437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92188407|NCT03440437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188408|NCT03440437|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188409|NCT03440437|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188410|NCT03440437|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188411|NCT03440437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188412|NCT03414658|Trastuzumab|trastuzumab|mesh-list
92188413|NCT03414658|Avelumab|avelumab|mesh-list
92188414|NCT03414658|Vinorelbine|vinorelbine|mesh-list
92188415|NCT03414658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188417|NCT03414658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92188418|NCT03414658|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188419|NCT03414658|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188420|NCT03414658|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188421|NCT03414658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188422|NCT03392246|Osimertinib|osimertinib|mesh-list
92188423|NCT03392246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188424|NCT03392246|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188425|NCT03392246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188426|NCT03392246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188427|NCT03387423|Tofacitinib|tofacitinib|mesh-list
92188428|NCT03387423|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92188429|NCT03387423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188430|NCT03387423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188431|NCT03387423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188432|NCT03374956|Liraglutide|liraglutide|mesh-list
92188433|NCT03374956|Topiramate|topiramate|mesh-list
92188434|NCT03374956|Phentermine|phentermine|mesh-list
92188435|NCT03374956|Naltrexone|naltrexone|mesh-list
92188436|NCT03374956|Bupropion|bupropion|mesh-list
92188437|NCT03374956|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92188438|NCT03374956|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92188439|NCT03374956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188440|NCT03374956|Sensory System Agents|sensory system agents|mesh-ancestor
92188441|NCT03374956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188442|NCT03374956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92188443|NCT03374956|Incretins|incretins|mesh-ancestor
92188444|NCT03374956|Hormones|hormones|mesh-ancestor
92188445|NCT03374956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188446|NCT03374956|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92188447|NCT03374956|Antidepressive Agents|antidepressive agents|mesh-ancestor
92188448|NCT03374956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92188449|NCT03374956|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92188450|NCT03374956|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92188451|NCT03374956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92188452|NCT03374956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188453|NCT03374956|Dopamine Agents|dopamine agents|mesh-ancestor
92188454|NCT03374956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188455|NCT03374956|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92188456|NCT03374956|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92188457|NCT03374956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188458|NCT03374956|Anticonvulsants|anticonvulsants|mesh-ancestor
92188459|NCT03374956|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92188460|NCT03374956|Appetite Depressants|appetite depressants|mesh-ancestor
92188461|NCT03374956|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92188462|NCT03374956|Sympathomimetics|sympathomimetics|mesh-ancestor
92188463|NCT03374956|Autonomic Agents|autonomic agents|mesh-ancestor
92188464|NCT03374956|Adrenergic Agents|adrenergic agents|mesh-ancestor
92188465|NCT03334682|Doxycycline|doxycycline|mesh-list
92188466|NCT03334682|Spironolactone|spironolactone|mesh-list
92188467|NCT03334682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188468|NCT03334682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188469|NCT03334682|Antimalarials|antimalarials|mesh-ancestor
92188470|NCT03334682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92188471|NCT03334682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92188472|NCT03334682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92188473|NCT03334682|Hormone Antagonists|hormone antagonists|mesh-ancestor
92188474|NCT03334682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188475|NCT03334682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188476|NCT03334682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92188477|NCT03334682|Diuretics|diuretics|mesh-ancestor
92188478|NCT03334682|Natriuretic Agents|natriuretic agents|mesh-ancestor
92188479|NCT03264131|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92188480|NCT03264131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188481|NCT03264131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188482|NCT03264131|Immunotoxins|immunotoxins|mesh-ancestor
92188483|NCT03264131|Immunoconjugates|immunoconjugates|mesh-ancestor
92188484|NCT03264131|Immunologic Factors|immunologic factors|mesh-ancestor
92188485|NCT03264131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188486|NCT03211416|Pembrolizumab|pembrolizumab|mesh-list
92188487|NCT03211416|Sorafenib|sorafenib|mesh-list
92188488|NCT03211416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188489|NCT03211416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188490|NCT03211416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188491|NCT03211416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188492|NCT03211416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188494|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
92188495|NCT03112603|Sirolimus|sirolimus|mesh-list
92188496|NCT03112603|Infliximab|infliximab|mesh-list
92188497|NCT03112603|Rituximab|rituximab|mesh-list
92188499|NCT03112603|Everolimus|everolimus|mesh-list
92188500|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
92188501|NCT03112603|Pentostatin|pentostatin|mesh-list
92188502|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188503|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188504|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
92188505|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188506|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188507|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92188508|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
92188509|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92188510|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188511|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
92188512|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188513|NCT03112603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92188514|NCT03112603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188515|NCT03112603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92188516|NCT03112603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92188517|NCT03112603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92188518|NCT03112603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92188519|NCT03112603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188520|NCT03112603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92188521|NCT03112603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92188522|NCT03112603|Antitubercular Agents|antitubercular agents|mesh-ancestor
92188523|NCT03112603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188524|NCT03112603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188525|NCT03112603|Antifungal Agents|antifungal agents|mesh-ancestor
92188526|NCT03112603|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92188527|NCT03112603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188528|NCT03112603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188529|NCT03112603|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92188530|NCT03110107|Nivolumab|nivolumab|mesh-list
92188531|NCT03110107|Ipilimumab|ipilimumab|mesh-list
92188532|NCT03110107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188533|NCT03110107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188534|NCT03110107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188535|NCT03110107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188536|NCT03073317|Mitogens|mitogens|mesh-list
92188537|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188538|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188539|NCT03056001|Doxorubicin|doxorubicin|mesh-list
92188540|NCT03056001|Pembrolizumab|pembrolizumab|mesh-list
92188541|NCT03056001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92188542|NCT03056001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188543|NCT03056001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92188544|NCT03056001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188545|NCT03056001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188546|NCT03056001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188547|NCT03056001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188548|NCT03056001|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188549|NCT03000439|Tofacitinib|tofacitinib|mesh-list
92188550|NCT03000439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92188551|NCT03000439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188552|NCT03000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188553|NCT03000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188554|NCT02973789|Docetaxel|docetaxel|mesh-list
92188555|NCT02973789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92188556|NCT02973789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188557|NCT02973789|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188558|NCT02973789|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188559|NCT02973789|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188560|NCT02973789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188561|NCT02973789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188562|NCT02752035|Azacitidine|azacitidine|mesh-list
92188563|NCT02752035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188564|NCT02752035|Antimetabolites|antimetabolites|mesh-ancestor
92188565|NCT02752035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188566|NCT02752035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188568|NCT02736266|Pembrolizumab|pembrolizumab|mesh-list
92188569|NCT02736266|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188570|NCT02736266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188571|NCT02736266|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188572|NCT02736266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188573|NCT02627963|Sorafenib|sorafenib|mesh-list
92188574|NCT02627963|Tivozanib|tivozanib|mesh-list
92188575|NCT02627963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188576|NCT02627963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188577|NCT02627963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188578|NCT02627963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188579|NCT02589691|Rocuronium|rocuronium|mesh-list
92188580|NCT02589691|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92188581|NCT02589691|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92188582|NCT02589691|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92188583|NCT02589691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188584|NCT02589691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188585|NCT02585258|Prednisolone|prednisolone|mesh-list
92188586|NCT02585258|Glucocorticoids|glucocorticoids|mesh-list
92188587|NCT02585258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188588|NCT02585258|Hormones|hormones|mesh-ancestor
92188589|NCT02585258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188590|NCT02585258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188591|NCT02585258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92188592|NCT02585258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188593|NCT02491099|Afatinib|afatinib|mesh-list
92188594|NCT02491099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188595|NCT02491099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188596|NCT02491099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92188597|NCT02491099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188598|NCT02346747|Immunomodulating Agents|immunomodulating agents|mesh-list
92188599|NCT02346747|Immunologic Factors|immunologic factors|mesh-ancestor
92188600|NCT02346747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188602|NCT02320435|Pertuzumab|pertuzumab|mesh-list
92188603|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188604|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188605|NCT02320292|Rituximab|rituximab|mesh-list
92188606|NCT02320292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92188607|NCT02320292|Antibodies|antibodies|mesh-list
92188608|NCT02320292|Immunoglobulins|immunoglobulins|mesh-list
92188609|NCT02320292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92188610|NCT02320292|Immunologic Factors|immunologic factors|mesh-ancestor
92188611|NCT02320292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188612|NCT02320292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188613|NCT02320292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188614|NCT02213107|Finasteride|finasteride|mesh-list
92188615|NCT02213107|Dutasteride|dutasteride|mesh-list
92188616|NCT02213107|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92188617|NCT02213107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92188618|NCT02213107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188619|NCT02213107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188620|NCT02213107|Hormone Antagonists|hormone antagonists|mesh-ancestor
92188621|NCT02213107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188622|NCT02213107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188623|NCT02213107|Urological Agents|urological agents|mesh-ancestor
92188624|NCT02203604|Aldesleukin|aldesleukin|mesh-list
92188625|NCT02203604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92188626|NCT02203604|Ipilimumab|ipilimumab|mesh-list
92188627|NCT02203604|Interleukin-2|interleukin-2|mesh-list
92188628|NCT02203604|Antibodies|antibodies|mesh-list
92188629|NCT02203604|Immunoglobulins|immunoglobulins|mesh-list
92188630|NCT02203604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92188631|NCT02203604|Immunologic Factors|immunologic factors|mesh-ancestor
92188632|NCT02203604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188633|NCT02203604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188634|NCT02203604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92188635|NCT02203604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188636|NCT02203604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188637|NCT02203604|Analgesics|analgesics|mesh-ancestor
92188638|NCT02203604|Sensory System Agents|sensory system agents|mesh-ancestor
92188639|NCT02203604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188640|NCT02203604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92188641|NCT02203604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92188642|NCT02203604|Antiviral Agents|antiviral agents|mesh-ancestor
92188643|NCT02203604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188644|NCT02188745|Letrozole|letrozole|mesh-list
92188645|NCT02188745|Anastrozole|anastrozole|mesh-list
92188646|NCT02188745|Exemestane|exemestane|mesh-list
92188647|NCT02188745|Estradiol|estradiol|mesh-list
92188648|NCT02188745|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92188649|NCT02188745|Estrogens|estrogens|mesh-ancestor
92188650|NCT02188745|Hormones|hormones|mesh-ancestor
92188651|NCT02188745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188652|NCT02188745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188653|NCT02188745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188654|NCT02188745|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92188655|NCT02188745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188656|NCT02188745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188657|NCT02188745|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92188658|NCT02188745|Hormone Antagonists|hormone antagonists|mesh-ancestor
92188659|NCT02188745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92188660|NCT01874353|Olaparib|olaparib|mesh-list
92188661|NCT01874353|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92188662|NCT01874353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188663|NCT01874353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188664|NCT01874353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188665|NCT01228240|Metformin|metformin|mesh-list
92188666|NCT01228240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92188667|NCT01228240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188668|NCT00903110|Mecasermin|mecasermin|mesh-list
92188669|NCT00903110|Growth Substances|growth substances|mesh-ancestor
92188670|NCT00903110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188671|NCT00701220|Atorvastatin|atorvastatin|mesh-list
92188672|NCT00701220|Calcium|calcium|mesh-list
92188673|NCT00701220|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92188674|NCT00701220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188675|NCT00701220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92188676|NCT00701220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92188677|NCT00701220|Antimetabolites|antimetabolites|mesh-ancestor
92188678|NCT00701220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188679|NCT00701220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92188680|NCT00701220|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92188681|NCT00701220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188682|NCT00677924|Zalutumumab|zalutumumab|mesh-list
92188683|NCT00677924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188684|NCT00677924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188685|NCT00251303|Riluzole|riluzole|mesh-list
92188686|NCT00251303|Anticonvulsants|anticonvulsants|mesh-ancestor
92188687|NCT00251303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92188688|NCT00251303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92188689|NCT00251303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188690|NCT00251303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188691|NCT00251303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188692|NCT00251303|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92188693|NCT00251303|Protective Agents|protective agents|mesh-ancestor
92188694|NCT00303823|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92188695|NCT00303823|Antioxidants|antioxidants|mesh-ancestor
92188696|NCT00303823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188697|NCT00303823|Protective Agents|protective agents|mesh-ancestor
92188698|NCT00303823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188699|NCT00303823|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92188700|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92188701|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188702|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92188703|NCT00300677|Voriconazole|voriconazole|mesh-list
92188704|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
92188705|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188706|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92188707|NCT00300677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92188708|NCT00300677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188709|NCT00300677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188710|NCT00300677|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92188711|NCT00300677|Hormone Antagonists|hormone antagonists|mesh-ancestor
92188712|NCT00300677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188713|NCT00300677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188714|NCT00300677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92188715|NCT00559845|Paclitaxel|paclitaxel|mesh-list
92188716|NCT00559845|Cyclophosphamide|cyclophosphamide|mesh-list
92188717|NCT00559845|Bevacizumab|bevacizumab|mesh-list
92188718|NCT00559845|Fluorouracil|fluorouracil|mesh-list
92188719|NCT00559845|Epirubicin|epirubicin|mesh-list
92188720|NCT00559845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92188721|NCT00559845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188722|NCT00559845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188723|NCT00559845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188724|NCT00559845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188725|NCT00559845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188726|NCT00559845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92188727|NCT00559845|Immunologic Factors|immunologic factors|mesh-ancestor
92188728|NCT00559845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188729|NCT00559845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188730|NCT00559845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92188731|NCT00559845|Alkylating Agents|alkylating agents|mesh-ancestor
92188732|NCT00559845|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92188733|NCT00559845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92188734|NCT00559845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92188735|NCT00559845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92188736|NCT00559845|Growth Substances|growth substances|mesh-ancestor
92188737|NCT00559845|Growth Inhibitors|growth inhibitors|mesh-ancestor
92188738|NCT00559845|Antimetabolites|antimetabolites|mesh-ancestor
92188739|NCT00559845|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92188740|NCT00559845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92188741|NCT00559845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92188742|NCT00559845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188743|NCT00559845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188744|NCT00304187|Erythromycin|erythromycin|mesh-list
92188745|NCT00304187|Erythromycin Estolate|erythromycin estolate|mesh-list
92188746|NCT00304187|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92188747|NCT00304187|Erythromycin stearate|erythromycin stearate|mesh-list
92188748|NCT00304187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188749|NCT00304187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188750|NCT00304187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188751|NCT00304187|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92188752|NCT00304187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188753|NCT00304187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188754|NCT00334633|Metronidazole|metronidazole|mesh-list
92188756|NCT00334633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188757|NCT00334633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188758|NCT00334633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92188759|NCT00334633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92188760|NCT00334633|Alkylating Agents|alkylating agents|mesh-ancestor
92188761|NCT00334633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188762|NCT00334633|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92188763|NCT01393964|Dexamethasone|dexamethasone|mesh-list
92188764|NCT01393964|Dexamethasone acetate|dexamethasone acetate|mesh-list
92188765|NCT01393964|Lenalidomide|lenalidomide|mesh-list
92188766|NCT01393964|Elotuzumab|elotuzumab|mesh-list
92188767|NCT01393964|BB 1101|bb 1101|mesh-list
92188768|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188769|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
92188770|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
92188771|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188772|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188773|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188774|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
92188775|NCT01393964|Hormones|hormones|mesh-ancestor
92188776|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188777|NCT01393964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92188778|NCT01393964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188779|NCT01393964|Protease Inhibitors|protease inhibitors|mesh-ancestor
92188780|NCT01393964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334207|NCT00004255|Protective Agents|protective agents|mesh-ancestor
92188781|NCT01393964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188783|NCT01393964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92188784|NCT01393964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92188785|NCT01393964|Growth Substances|growth substances|mesh-ancestor
92188786|NCT01393964|Growth Inhibitors|growth inhibitors|mesh-ancestor
92188787|NCT01790555|Diazepam|diazepam|mesh-list
92188788|NCT01790555|Dronabinol|dronabinol|mesh-list
92188789|NCT01790555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92188790|NCT01790555|Anticonvulsants|anticonvulsants|mesh-ancestor
92188791|NCT01790555|Antiemetics|antiemetics|mesh-ancestor
92188792|NCT01790555|Autonomic Agents|autonomic agents|mesh-ancestor
92188793|NCT01790555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188794|NCT01790555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188795|NCT01790555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188796|NCT01790555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92188797|NCT01790555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92188798|NCT01790555|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92188799|NCT01790555|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92188800|NCT01790555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92188801|NCT01790555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92188802|NCT01790555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92188803|NCT01790555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92188804|NCT01790555|Anesthetics, General|anesthetics, general|mesh-ancestor
92188805|NCT01790555|Anesthetics|anesthetics|mesh-ancestor
92188806|NCT01790555|GABA Modulators|gaba modulators|mesh-ancestor
92188807|NCT01790555|GABA Agents|gaba agents|mesh-ancestor
92188808|NCT01790555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188809|NCT01790555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188810|NCT01790555|Hallucinogens|hallucinogens|mesh-ancestor
92188811|NCT01790555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188812|NCT01790555|Analgesics|analgesics|mesh-ancestor
92188813|NCT01790555|Sensory System Agents|sensory system agents|mesh-ancestor
92188814|NCT01790555|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92188815|NCT01790555|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92188816|NCT01790555|Hormones|hormones|mesh-ancestor
92188817|NCT01790555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188818|NCT00335725|Hormones|hormones|mesh-list
92188819|NCT00335725|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92188820|NCT00335725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188821|NCT00335725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188822|NCT01393730|Prednisone|prednisone|mesh-list
92188823|NCT01393730|Abiraterone Acetate|abiraterone acetate|mesh-list
92188824|NCT01393730|Dutasteride|dutasteride|mesh-list
92188825|NCT01393730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188826|NCT01393730|Glucocorticoids|glucocorticoids|mesh-ancestor
92188827|NCT01393730|Hormones|hormones|mesh-ancestor
92188828|NCT01393730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188829|NCT01393730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188830|NCT01393730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92188831|NCT01393730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188832|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92188833|NCT01393730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188834|NCT01393730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188835|NCT01393730|Hormone Antagonists|hormone antagonists|mesh-ancestor
92188836|NCT01393730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92188837|NCT01393730|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92188838|NCT00336817|Mycophenolic Acid|mycophenolic acid|mesh-list
92188839|NCT00336817|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92188840|NCT00336817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188841|NCT00336817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92188842|NCT00336817|Antitubercular Agents|antitubercular agents|mesh-ancestor
92188843|NCT00336817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92188844|NCT00336817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92188845|NCT00336817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188846|NCT00336817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188847|NCT00337987|Prednisone|prednisone|mesh-list
92188848|NCT00337987|Cyclophosphamide|cyclophosphamide|mesh-list
92188849|NCT00337987|Vincristine|vincristine|mesh-list
92188850|NCT00337987|Doxorubicin|doxorubicin|mesh-list
92188851|NCT00337987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92188852|NCT00337987|Denileukin diftitox|denileukin diftitox|mesh-list
92188853|NCT00337987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92188854|NCT00337987|Immunologic Factors|immunologic factors|mesh-ancestor
92188855|NCT00337987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188856|NCT00337987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92188857|NCT00337987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92188858|NCT00337987|Alkylating Agents|alkylating agents|mesh-ancestor
92188859|NCT00337987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188860|NCT00337987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188861|NCT00337987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92188862|NCT00337987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188863|NCT00337987|Glucocorticoids|glucocorticoids|mesh-ancestor
92188864|NCT00337987|Hormones|hormones|mesh-ancestor
92188865|NCT00337987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188866|NCT00337987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92188867|NCT00337987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92188868|NCT00337987|Tubulin Modulators|tubulin modulators|mesh-ancestor
92188869|NCT00337987|Antimitotic Agents|antimitotic agents|mesh-ancestor
92188870|NCT00337987|Mitosis Modulators|mitosis modulators|mesh-ancestor
92188871|NCT00337987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92188872|NCT00337987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92188873|NCT00337987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92188874|NCT00337987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188875|NCT01393106|Idelalisib|idelalisib|mesh-list
92188876|NCT01393106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188877|NCT01393106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188878|NCT01393106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188879|NCT00553059|Dexamethasone|dexamethasone|mesh-list
92188880|NCT00553059|Dronabinol|dronabinol|mesh-list
92188881|NCT00553059|Palonosetron|palonosetron|mesh-list
92188882|NCT00553059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92188883|NCT00553059|Antiemetics|antiemetics|mesh-ancestor
92188884|NCT00553059|Autonomic Agents|autonomic agents|mesh-ancestor
92188885|NCT00553059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188886|NCT00553059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188887|NCT00553059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188888|NCT00553059|Glucocorticoids|glucocorticoids|mesh-ancestor
92188889|NCT00553059|Hormones|hormones|mesh-ancestor
92188890|NCT00553059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188892|NCT00553059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92188893|NCT00553059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92188894|NCT00553059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92188895|NCT00553059|Serotonin Agents|serotonin agents|mesh-ancestor
92188896|NCT00553059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188897|NCT00553059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188898|NCT00553059|Hallucinogens|hallucinogens|mesh-ancestor
92188899|NCT00553059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92188900|NCT00553059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92188901|NCT00553059|Analgesics|analgesics|mesh-ancestor
92188902|NCT00553059|Sensory System Agents|sensory system agents|mesh-ancestor
92188903|NCT00553059|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92188904|NCT00553059|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92188905|NCT04047836|Nicotine|nicotine|mesh-list
92188906|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92188907|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
92188908|NCT04047836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92188909|NCT04047836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188910|NCT04047836|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92188911|NCT04047836|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92188912|NCT04047836|Cholinergic Agents|cholinergic agents|mesh-ancestor
92188913|NCT04047836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188914|NCT04047836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188916|NCT02989311|Trace Elements|trace elements|mesh-ancestor
92188917|NCT02989311|Micronutrients|micronutrients|mesh-ancestor
92188918|NCT02989311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188919|NCT00325403|Treprostinil|treprostinil|mesh-list
92188920|NCT00325403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92188921|NCT02015611|Vitamin D|vitamin d|mesh-list
92188922|NCT02015611|Vitamins|vitamins|mesh-ancestor
92188923|NCT02015611|Micronutrients|micronutrients|mesh-ancestor
92188924|NCT02015611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188925|NCT02015611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92188926|NCT01872819|Antineoplastic Agents|antineoplastic agents|mesh-list
92188927|NCT01413542|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92188928|NCT01413542|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92188929|NCT01413542|Enalaprilat|enalaprilat|mesh-list
92188930|NCT01413542|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92188931|NCT01413542|Bradykinin|bradykinin|mesh-list
92188932|NCT01413542|Glucagon|glucagon|mesh-list
92188933|NCT01413542|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92188934|NCT01413542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92188935|NCT01413542|Substance P|substance p|mesh-list
92188936|NCT01413542|Neurokinin A|neurokinin a|mesh-list
92188937|NCT01413542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92188938|NCT01413542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188939|NCT01413542|Incretins|incretins|mesh-ancestor
92188940|NCT01413542|Hormones|hormones|mesh-ancestor
92188941|NCT01413542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188942|NCT01413542|Protease Inhibitors|protease inhibitors|mesh-ancestor
92188943|NCT01413542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188944|NCT01413542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188945|NCT01413542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92188946|NCT01413542|Natriuretic Agents|natriuretic agents|mesh-ancestor
92188947|NCT01413542|Vasodilator Agents|vasodilator agents|mesh-ancestor
92188948|NCT01413542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92188949|NCT01413542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188950|NCT01873989|Testosterone|testosterone|mesh-list
92188951|NCT01873989|Androgens|androgens|mesh-ancestor
92188952|NCT01873989|Hormones|hormones|mesh-ancestor
92188953|NCT01873989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92188954|NCT01873989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188955|NCT01875159|Caffeine|caffeine|mesh-list
92188956|NCT01875159|Caffeine citrate|caffeine citrate|mesh-list
92188957|NCT01875159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188958|NCT01875159|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92188959|NCT01875159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188960|NCT01875159|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92188961|NCT01875159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188962|NCT01875159|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92188963|NCT01875159|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92188964|NCT01875159|Purinergic Agents|purinergic agents|mesh-ancestor
92188965|NCT01875159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188966|NCT01432574|Vaccines|vaccines|mesh-list
92188967|NCT01432574|Immunologic Factors|immunologic factors|mesh-ancestor
92188968|NCT01432574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188969|NCT00339079|Fluoxetine|fluoxetine|mesh-list
92188970|NCT00339079|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92188971|NCT00339079|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92188972|NCT00339079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92188973|NCT00339079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188974|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92188975|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
92188976|NCT00339079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188977|NCT00339079|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92188978|NCT00339079|Antidepressive Agents|antidepressive agents|mesh-ancestor
92188979|NCT00339079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92188980|NCT00339079|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92188981|NCT00339079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92188982|NCT00339079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188983|NCT01392560|Empagliflozin|empagliflozin|mesh-list
92188984|NCT01392560|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92188985|NCT01392560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92188986|NCT01392560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92188987|NCT01392560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92188988|NCT00342355|Ritonavir|ritonavir|mesh-list
92188989|NCT00342355|Lopinavir|lopinavir|mesh-list
92188990|NCT00342355|Lamivudine|lamivudine|mesh-list
92188991|NCT00342355|Zidovudine|zidovudine|mesh-list
92188992|NCT00342355|Didanosine|didanosine|mesh-list
92188993|NCT00342355|Stavudine|stavudine|mesh-list
92188994|NCT00342355|Efavirenz|efavirenz|mesh-list
92188995|NCT00342355|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92188996|NCT00342355|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92188997|NCT00342355|Protease Inhibitors|protease inhibitors|mesh-ancestor
92188998|NCT00342355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92188999|NCT00342355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189000|NCT00342355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92189001|NCT00342355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92189002|NCT00342355|Antiviral Agents|antiviral agents|mesh-ancestor
92189003|NCT00342355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917125|NCT01666730|Oxaliplatin|oxaliplatin|mesh-list
92189004|NCT00342355|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92189005|NCT00342355|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92189006|NCT00342355|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92189007|NCT00342355|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92189009|NCT00342355|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92189010|NCT00342355|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92189011|NCT00342355|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92189012|NCT00342355|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92189013|NCT00342355|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92189014|NCT00306163|Fluticasone|fluticasone|mesh-list
92189015|NCT00306163|Ciclesonide|ciclesonide|mesh-list
92189016|NCT00306163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189017|NCT00306163|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92189018|NCT00306163|Autonomic Agents|autonomic agents|mesh-ancestor
92189019|NCT00306163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189020|NCT00306163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189021|NCT00306163|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92189022|NCT00306163|Respiratory System Agents|respiratory system agents|mesh-ancestor
92189023|NCT00306163|Dermatologic Agents|dermatologic agents|mesh-ancestor
92189024|NCT00306163|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92189025|NCT00306163|Glucocorticoids|glucocorticoids|mesh-ancestor
92189026|NCT00306163|Hormones|hormones|mesh-ancestor
92189027|NCT00306163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189028|NCT01861665|Bupivacaine|bupivacaine|mesh-list
92189029|NCT01861665|Anesthetics, Local|anesthetics, local|mesh-ancestor
92189030|NCT01861665|Anesthetics|anesthetics|mesh-ancestor
92189031|NCT01861665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189032|NCT01861665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189033|NCT01861665|Sensory System Agents|sensory system agents|mesh-ancestor
92189034|NCT01861665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189035|NCT00330161|Vorinostat|vorinostat|mesh-list
92189036|NCT00330161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189037|NCT00330161|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92189038|NCT00330161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189039|NCT00330161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189041|NCT00552279|Immunologic Factors|immunologic factors|mesh-ancestor
92189042|NCT00552279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189043|NCT00309751|Atorvastatin|atorvastatin|mesh-list
92189044|NCT00309751|Pitavastatin|pitavastatin|mesh-list
92189045|NCT00309751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92189046|NCT00309751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92189047|NCT00309751|Antimetabolites|antimetabolites|mesh-ancestor
92189048|NCT00309751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189049|NCT00309751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92189050|NCT00309751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92189051|NCT00309751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189052|NCT04346095|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92189053|NCT04346095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189054|NCT04346095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189055|NCT02988999|Erythritol|erythritol|mesh-list
92189056|NCT02988999|Vasodilator Agents|vasodilator agents|mesh-ancestor
92189057|NCT00313729|Temozolomide|temozolomide|mesh-list
92189058|NCT00313729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92189059|NCT00313729|Alkylating Agents|alkylating agents|mesh-ancestor
92189060|NCT00313729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189061|NCT00313729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189062|NCT00559377|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92189063|NCT00559377|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92189064|NCT00559377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189065|NCT05266651|Tadalafil|tadalafil|mesh-list
92189066|NCT05266651|Vasodilator Agents|vasodilator agents|mesh-ancestor
92189067|NCT05266651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92189068|NCT05266651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92189069|NCT05266651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189070|NCT05266651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189071|NCT05266651|Urological Agents|urological agents|mesh-ancestor
92189072|NCT05746689|Sirolimus|sirolimus|mesh-list
92189073|NCT05746689|Prednisone|prednisone|mesh-list
92189074|NCT05746689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189075|NCT05746689|Glucocorticoids|glucocorticoids|mesh-ancestor
92189076|NCT05746689|Hormones|hormones|mesh-ancestor
92189077|NCT05746689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189078|NCT05746689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189079|NCT05746689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92189080|NCT05746689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189081|NCT05746689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189082|NCT05746689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189083|NCT05746689|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92189084|NCT05746689|Antifungal Agents|antifungal agents|mesh-ancestor
92189085|NCT05746689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189086|NCT05746689|Immunologic Factors|immunologic factors|mesh-ancestor
92189087|NCT01412060|Cariprazine|cariprazine|mesh-list
92189088|NCT01412060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92189089|NCT01412060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189090|NCT01412060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189091|NCT01412060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189092|NCT01412060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189093|NCT00345865|Cytarabine|cytarabine|mesh-list
92189094|NCT00345865|Cyclophosphamide|cyclophosphamide|mesh-list
92189095|NCT00345865|Carmustine|carmustine|mesh-list
92189096|NCT00345865|Etoposide|etoposide|mesh-list
92189097|NCT00345865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189098|NCT00345865|Immunologic Factors|immunologic factors|mesh-ancestor
92189099|NCT00345865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189100|NCT00345865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189101|NCT00345865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92189102|NCT00345865|Alkylating Agents|alkylating agents|mesh-ancestor
92189103|NCT00345865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189104|NCT00345865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189105|NCT00345865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92189106|NCT00345865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92189107|NCT00345865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92189108|NCT00345865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92189109|NCT00345865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189110|NCT00345865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189111|NCT00345865|Antimetabolites|antimetabolites|mesh-ancestor
92189112|NCT00345865|Antiviral Agents|antiviral agents|mesh-ancestor
92189113|NCT00345865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189114|NCT00551421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92189115|NCT00551421|Cetuximab|cetuximab|mesh-list
92189116|NCT00551421|Pertuzumab|pertuzumab|mesh-list
92189117|NCT00551421|Irinotecan|irinotecan|mesh-list
92189118|NCT00551421|Antibodies|antibodies|mesh-list
92189119|NCT00551421|Immunoglobulins|immunoglobulins|mesh-list
92189120|NCT00551421|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92189121|NCT00551421|Immunologic Factors|immunologic factors|mesh-ancestor
92189122|NCT00551421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189123|NCT00551421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189124|NCT00551421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92189125|NCT00551421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92189126|NCT00551421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189127|NCT00551421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189129|NCT01791751|Enclomiphene|enclomiphene|mesh-list
92189130|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
92189131|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92189132|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
92189133|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189134|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189135|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92189136|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
92189137|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92189138|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92189139|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92189140|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
92189141|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
92189142|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
92189143|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92189144|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189145|NCT05266261|Vitamins|vitamins|mesh-ancestor
92189146|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
92189147|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92189148|NCT05266261|Antacids|antacids|mesh-ancestor
92189149|NCT05266261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189150|NCT05266261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189151|NCT04830813|Chiauranib|chiauranib|mesh-list
92189152|NCT04830813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189153|NCT04830813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92189154|NCT04830813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189155|NCT04830813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189156|NCT05266105|Palbociclib|palbociclib|mesh-list
92189157|NCT05266105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189158|NCT05266105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92189159|NCT05266105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189160|NCT05266105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189162|NCT01891643|Dexamethasone acetate|dexamethasone acetate|mesh-list
92189163|NCT01891643|Lenalidomide|lenalidomide|mesh-list
92189164|NCT01891643|Elotuzumab|elotuzumab|mesh-list
92189165|NCT01891643|BB 1101|bb 1101|mesh-list
92189166|NCT01891643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189167|NCT01891643|Antiemetics|antiemetics|mesh-ancestor
92189168|NCT01891643|Autonomic Agents|autonomic agents|mesh-ancestor
92189169|NCT01891643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189170|NCT01891643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189171|NCT01891643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189172|NCT01891643|Glucocorticoids|glucocorticoids|mesh-ancestor
92189173|NCT01891643|Hormones|hormones|mesh-ancestor
92189174|NCT01891643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189175|NCT01891643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92189176|NCT01891643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189177|NCT01891643|Protease Inhibitors|protease inhibitors|mesh-ancestor
92189178|NCT01891643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189179|NCT01891643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189180|NCT01891643|Immunologic Factors|immunologic factors|mesh-ancestor
92189181|NCT01891643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92189182|NCT01891643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92189183|NCT01891643|Growth Substances|growth substances|mesh-ancestor
92189184|NCT01891643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92189185|NCT05265793|Apatinib|apatinib|mesh-list
92189187|NCT05265793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92189188|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189189|NCT05265793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189190|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
92189191|NCT04005599|Remifentanil|remifentanil|mesh-list
92189192|NCT04005599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92189193|NCT04005599|Narcotics|narcotics|mesh-ancestor
92189194|NCT04005599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189195|NCT04005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189197|NCT04005599|Sensory System Agents|sensory system agents|mesh-ancestor
92189198|NCT04005599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189199|NCT04005599|Anesthetics|anesthetics|mesh-ancestor
92189200|NCT04005599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92189201|NCT04005599|Anticonvulsants|anticonvulsants|mesh-ancestor
92189202|NCT04005599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92189203|NCT04005599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189204|NCT04005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189205|NCT04005599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92189206|NCT04005599|Tocolytic Agents|tocolytic agents|mesh-ancestor
92189207|NCT04005599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92189208|NCT00330863|Olanzapine|olanzapine|mesh-list
92189209|NCT00330863|Risperidone|risperidone|mesh-list
92189210|NCT00330863|Aripiprazole|aripiprazole|mesh-list
92189211|NCT00330863|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92189212|NCT00330863|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92189213|NCT00330863|Ziprasidone|ziprasidone|mesh-list
92189214|NCT00330863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92189215|NCT00330863|Serotonin Agents|serotonin agents|mesh-ancestor
92189216|NCT00330863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189217|NCT00330863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189218|NCT00330863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189219|NCT00330863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92189220|NCT00330863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189221|NCT00330863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189222|NCT00330863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189223|NCT00330863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92189224|NCT00330863|Dopamine Agents|dopamine agents|mesh-ancestor
92189225|NCT00330863|Antiemetics|antiemetics|mesh-ancestor
92189226|NCT00330863|Autonomic Agents|autonomic agents|mesh-ancestor
92189227|NCT00330863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189228|NCT00330863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189229|NCT00330863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92189230|NCT00330863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92189231|NCT00330863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189232|NCT00330863|Antidepressive Agents|antidepressive agents|mesh-ancestor
92189233|NCT00330863|Dopamine Agonists|dopamine agonists|mesh-ancestor
92189234|NCT00330863|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92189235|NCT00330863|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92189236|NCT00330863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92189237|NCT00330863|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92189238|NCT01899521|Zinc Sulfate|zinc sulfate|mesh-list
92189239|NCT01899521|Astringents|astringents|mesh-ancestor
92189240|NCT01899521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189241|NCT01899521|Dermatologic Agents|dermatologic agents|mesh-ancestor
92189242|NCT01790009|Acetaminophen|acetaminophen|mesh-list
92189243|NCT01790009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92189244|NCT01790009|Analgesics|analgesics|mesh-ancestor
92189245|NCT01790009|Sensory System Agents|sensory system agents|mesh-ancestor
92189246|NCT01790009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189247|NCT01790009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189248|NCT01790009|Antipyretics|antipyretics|mesh-ancestor
92189249|NCT05737329|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92189250|NCT05737329|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92189251|NCT05737329|Estradiol|estradiol|mesh-list
92189252|NCT05737329|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92189253|NCT05737329|Estrogens|estrogens|mesh-ancestor
92189254|NCT05737329|Hormones|hormones|mesh-ancestor
92189255|NCT05737329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189256|NCT05737329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189257|NCT05737329|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92189258|NCT05737329|Contraceptive Agents|contraceptive agents|mesh-ancestor
92189259|NCT05737329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92189260|NCT05737329|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92189261|NCT00317941|Interferon beta-1b|interferon beta-1b|mesh-list
92189262|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92189263|NCT00317941|Immunologic Factors|immunologic factors|mesh-ancestor
92189264|NCT00317941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189265|NCT01790087|Moxifloxacin|moxifloxacin|mesh-list
92189266|NCT01790087|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189267|NCT01790087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189268|NCT01790087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92189269|NCT01790087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92189271|NCT01790087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189272|NCT01790087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189273|NCT05266937|Paclitaxel|paclitaxel|mesh-list
92189274|NCT05266937|Carboplatin|carboplatin|mesh-list
92189275|NCT05266937|Atezolizumab|atezolizumab|mesh-list
92189276|NCT05266937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92189277|NCT05266937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189278|NCT05266937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92189279|NCT05266937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92189280|NCT05266937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92189281|NCT05266937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189282|NCT05266937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92189283|NCT05266937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189284|NCT00332579|Naltrexone|naltrexone|mesh-list
92189285|NCT00332579|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92189286|NCT00332579|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92189287|NCT00332579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189288|NCT00332579|Sensory System Agents|sensory system agents|mesh-ancestor
92189289|NCT00332579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189290|NCT00318409|Bupropion|bupropion|mesh-list
92189291|NCT00318409|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92189292|NCT00318409|Antidepressive Agents|antidepressive agents|mesh-ancestor
92189293|NCT00318409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189294|NCT00318409|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92189295|NCT00318409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92189296|NCT00318409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189297|NCT00318409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189298|NCT00318409|Dopamine Agents|dopamine agents|mesh-ancestor
92189299|NCT00318409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189300|NCT00318409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189301|NCT00318409|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92189302|NCT00318409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92189303|NCT00318409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189304|NCT00333437|Mycophenolic Acid|mycophenolic acid|mesh-list
92189305|NCT00333437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92189306|NCT00333437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189307|NCT00333437|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92189308|NCT00333437|Antitubercular Agents|antitubercular agents|mesh-ancestor
92189309|NCT00333437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189310|NCT00333437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189311|NCT00333437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189312|NCT00333437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189313|NCT04129619|Ether|ether|mesh-list
92189314|NCT04129619|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92189315|NCT04129619|Anesthetics, General|anesthetics, general|mesh-ancestor
92189316|NCT04129619|Anesthetics|anesthetics|mesh-ancestor
92189317|NCT04129619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189318|NCT04129619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189319|NCT00353119|Etanercept|etanercept|mesh-list
92189320|NCT00353119|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92189321|NCT00353119|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92189322|NCT00353119|Analgesics|analgesics|mesh-ancestor
92189323|NCT00353119|Sensory System Agents|sensory system agents|mesh-ancestor
92189324|NCT00353119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189325|NCT00353119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189326|NCT00353119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189327|NCT00353119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189328|NCT00353119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189329|NCT00353119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189330|NCT00353119|Immunologic Factors|immunologic factors|mesh-ancestor
92189332|NCT00353431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92189333|NCT00353431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189335|NCT04971187|Carboplatin|carboplatin|mesh-list
92189336|NCT04971187|Pemetrexed|pemetrexed|mesh-list
92189337|NCT04971187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189338|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189339|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189340|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92189341|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92189342|NCT00353977|Vaccines|vaccines|mesh-list
92189343|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
92189344|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189345|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
92189346|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92189347|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92189348|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92189349|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189350|NCT00320281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189351|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
92189352|NCT00320281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189353|NCT00320281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189354|NCT00320281|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92189355|NCT00320281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189356|NCT01792375|Dinoprostone|dinoprostone|mesh-list
92189357|NCT01792375|Oxytocics|oxytocics|mesh-ancestor
92189358|NCT01792375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92189359|NCT01792375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189360|NCT01392326|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92189361|NCT01392326|Immunologic Factors|immunologic factors|mesh-ancestor
92189362|NCT01392326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189363|NCT00320671|Risperidone|risperidone|mesh-list
92189364|NCT00320671|Aripiprazole|aripiprazole|mesh-list
92189365|NCT00320671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92189366|NCT00320671|Serotonin Agents|serotonin agents|mesh-ancestor
92189367|NCT00320671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189368|NCT00320671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189369|NCT00320671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189370|NCT00320671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92189371|NCT00320671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189372|NCT00320671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189373|NCT00320671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189374|NCT00320671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92189375|NCT00320671|Dopamine Agents|dopamine agents|mesh-ancestor
92189376|NCT00320671|Antidepressive Agents|antidepressive agents|mesh-ancestor
92189377|NCT00320671|Dopamine Agonists|dopamine agonists|mesh-ancestor
92189378|NCT00320671|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92189379|NCT00320671|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92189380|NCT00320671|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92189381|NCT00320671|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92189383|NCT00320749|Capecitabine|capecitabine|mesh-list
92189384|NCT00320749|Docetaxel|docetaxel|mesh-list
92189385|NCT00320749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189386|NCT00320749|Antimetabolites|antimetabolites|mesh-ancestor
92189387|NCT00320749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189388|NCT00320749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189389|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
92189390|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
92189391|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
92189392|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
92189393|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
92189394|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189395|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92189396|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189397|NCT00354913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189398|NCT00354913|Antisickling Agents|antisickling agents|mesh-ancestor
92189399|NCT00354913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92189400|NCT01432262|Vaccines|vaccines|mesh-list
92189401|NCT01432262|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92189402|NCT01432262|Immunologic Factors|immunologic factors|mesh-ancestor
92189403|NCT01432262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189404|NCT00322309|Mirtazapine|mirtazapine|mesh-list
92189405|NCT00322309|Antidepressive Agents|antidepressive agents|mesh-ancestor
92334272|NCT04074343|Irinotecan|irinotecan|mesh-list
92189406|NCT00322309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189407|NCT00322309|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92189408|NCT00322309|Histamine Antagonists|histamine antagonists|mesh-ancestor
92189409|NCT00322309|Histamine Agents|histamine agents|mesh-ancestor
92189410|NCT00322309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189411|NCT00322309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189412|NCT00322309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189413|NCT00322309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92189414|NCT00322309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189415|NCT00322309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189416|NCT00322309|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92189417|NCT00322309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92189418|NCT00322309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92189419|NCT00322309|Adrenergic Agents|adrenergic agents|mesh-ancestor
92189420|NCT00322309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92189421|NCT00322309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92189422|NCT00322309|Serotonin Agents|serotonin agents|mesh-ancestor
92189423|NCT00322309|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92189425|NCT04046744|Analgesics|analgesics|mesh-list
92189426|NCT04046744|Ropivacaine|ropivacaine|mesh-list
92189427|NCT04046744|Anesthetics, Local|anesthetics, local|mesh-list
92189428|NCT04046744|Anesthetics|anesthetics|mesh-list
92189429|NCT04046744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189430|NCT04046744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189431|NCT04046744|Sensory System Agents|sensory system agents|mesh-ancestor
92189432|NCT04046744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189433|NCT04046744|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92189434|NCT04046744|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92189435|NCT04046744|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92189436|NCT04046744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189437|NCT04046744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189438|NCT01431950|Fluticasone|fluticasone|mesh-list
92189439|NCT01431950|Xhance|xhance|mesh-list
92189440|NCT01431950|Albuterol|albuterol|mesh-list
92189441|NCT01431950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189442|NCT01431950|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92189443|NCT01431950|Autonomic Agents|autonomic agents|mesh-ancestor
92189444|NCT01431950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189445|NCT01431950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189446|NCT01431950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92189447|NCT01431950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92189448|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92189449|NCT01431950|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92189450|NCT01431950|Tocolytic Agents|tocolytic agents|mesh-ancestor
92189451|NCT01431950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92189452|NCT01431950|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92189453|NCT01431950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92189454|NCT01431950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92189455|NCT01431950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92189456|NCT01431950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189457|NCT01431950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189459|NCT00551031|Immunologic Factors|immunologic factors|mesh-ancestor
92189460|NCT00551031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189461|NCT01431716|Epoprostenol|epoprostenol|mesh-list
92189462|NCT01431716|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92189463|NCT01431716|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92189464|NCT00550953|Amlodipine|amlodipine|mesh-list
92189465|NCT00550953|Telmisartan|telmisartan|mesh-list
92189466|NCT00550953|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92189467|NCT00550953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92334278|NCT00003301|Irinotecan|irinotecan|mesh-list
92189468|NCT00550953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92189469|NCT00550953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189470|NCT00550953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189471|NCT00550953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92189472|NCT00550953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189474|NCT00550953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92189475|NCT00550953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92189476|NCT00322465|Azithromycin|azithromycin|mesh-list
92189477|NCT00322465|Doxycycline|doxycycline|mesh-list
92189478|NCT00322465|Tinidazole|tinidazole|mesh-list
92189479|NCT00322465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189480|NCT00322465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189481|NCT00322465|Antimalarials|antimalarials|mesh-ancestor
92189482|NCT00322465|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92189483|NCT00322465|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92189484|NCT00322465|Alkylating Agents|alkylating agents|mesh-ancestor
92189485|NCT00322465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189486|NCT00322465|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92189487|NCT00558831|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92189488|NCT00558831|Dermatologic Agents|dermatologic agents|mesh-ancestor
92189489|NCT03021993|Nivolumab|nivolumab|mesh-list
92189490|NCT03021993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189491|NCT03021993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189492|NCT03021993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92189493|NCT03021993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189494|NCT01392170|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92189495|NCT01392170|Antiviral Agents|antiviral agents|mesh-ancestor
92189496|NCT01392170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189497|NCT00558753|Pregabalin|pregabalin|mesh-list
92189498|NCT00558753|Analgesics|analgesics|mesh-ancestor
92189499|NCT00558753|Sensory System Agents|sensory system agents|mesh-ancestor
92189500|NCT00558753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189501|NCT00558753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189502|NCT00558753|Anticonvulsants|anticonvulsants|mesh-ancestor
92189503|NCT00558753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92189504|NCT00558753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189505|NCT00558753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189506|NCT00558753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92189507|NCT00558753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92189508|NCT00558753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189509|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189510|NCT00558753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189511|NCT00324259|Estradiol|estradiol|mesh-list
92189512|NCT00324259|Estrogens|estrogens|mesh-ancestor
92189513|NCT00324259|Hormones|hormones|mesh-ancestor
92189514|NCT00324259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189515|NCT00324259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189516|NCT04598451|Prednisone|prednisone|mesh-list
92189517|NCT04598451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189518|NCT04598451|Glucocorticoids|glucocorticoids|mesh-ancestor
92189519|NCT04598451|Hormones|hormones|mesh-ancestor
92189520|NCT04598451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189521|NCT04598451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189522|NCT04598451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92189523|NCT04598451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189524|NCT04600141|Heparin|heparin|mesh-list
92189525|NCT04600141|Calcium heparin|calcium heparin|mesh-list
92189526|NCT04600141|Anticoagulants|anticoagulants|mesh-ancestor
92189527|NCT04600141|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92189528|NCT04600141|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92189529|NCT04600141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189530|NCT00324415|Fluorouracil|fluorouracil|mesh-list
92189531|NCT00324415|Cetuximab|cetuximab|mesh-list
92189532|NCT00324415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189533|NCT00324415|Antimetabolites|antimetabolites|mesh-ancestor
92189534|NCT00324415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189535|NCT00324415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189536|NCT00324415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189537|NCT00324415|Immunologic Factors|immunologic factors|mesh-ancestor
92189538|NCT00324415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189539|NCT00324415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189540|NCT00390559|Nicotine|nicotine|mesh-list
92189541|NCT00390559|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92189542|NCT00390559|Autonomic Agents|autonomic agents|mesh-ancestor
92189543|NCT00390559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189544|NCT00390559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189545|NCT00390559|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92189546|NCT00390559|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92189547|NCT00390559|Cholinergic Agents|cholinergic agents|mesh-ancestor
92189548|NCT00390559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189549|NCT00390559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189550|NCT02107339|Methadone|methadone|mesh-list
92189551|NCT02107339|Hydromorphone|hydromorphone|mesh-list
92189552|NCT02107339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92189553|NCT02107339|Narcotics|narcotics|mesh-ancestor
92189554|NCT02107339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189555|NCT02107339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189556|NCT02107339|Analgesics|analgesics|mesh-ancestor
92189557|NCT02107339|Sensory System Agents|sensory system agents|mesh-ancestor
92189558|NCT02107339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189559|NCT02107339|Antitussive Agents|antitussive agents|mesh-ancestor
92189560|NCT02107339|Respiratory System Agents|respiratory system agents|mesh-ancestor
92189561|NCT00392041|Eszopiclone|eszopiclone|mesh-list
92189562|NCT00392041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92189563|NCT00392041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189564|NCT00392041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189565|NCT01390844|Ribavirin|ribavirin|mesh-list
92189566|NCT01390844|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92189567|NCT01390844|Antimetabolites|antimetabolites|mesh-ancestor
92189568|NCT01390844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189569|NCT01390844|Antiviral Agents|antiviral agents|mesh-ancestor
92189570|NCT01390844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189571|NCT04035278|Vaccines|vaccines|mesh-list
92189572|NCT04035278|Immunologic Factors|immunologic factors|mesh-ancestor
92189573|NCT04035278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189574|NCT00395161|Selenium|selenium|mesh-list
92189575|NCT00395161|Metoclopramide|metoclopramide|mesh-list
92189576|NCT00395161|Antioxidants|antioxidants|mesh-ancestor
92189577|NCT00395161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189578|NCT00395161|Protective Agents|protective agents|mesh-ancestor
92189579|NCT00395161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189580|NCT00395161|Trace Elements|trace elements|mesh-ancestor
92189581|NCT00395161|Micronutrients|micronutrients|mesh-ancestor
92189582|NCT00395161|Antiemetics|antiemetics|mesh-ancestor
92189583|NCT00395161|Autonomic Agents|autonomic agents|mesh-ancestor
92189584|NCT00395161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189585|NCT00395161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189586|NCT00395161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92189587|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92189588|NCT00395161|Dopamine Agents|dopamine agents|mesh-ancestor
92189589|NCT00395161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189590|NCT01409564|Cilostazol|cilostazol|mesh-list
92189591|NCT01409564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92189592|NCT01409564|Autonomic Agents|autonomic agents|mesh-ancestor
92189593|NCT01409564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189594|NCT01409564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189595|NCT01409564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92189596|NCT01409564|Respiratory System Agents|respiratory system agents|mesh-ancestor
92189597|NCT01409564|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92189598|NCT01409564|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92189599|NCT01409564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189600|NCT01409564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92189601|NCT01409564|Vasodilator Agents|vasodilator agents|mesh-ancestor
92189602|NCT01409564|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92189603|NCT01409564|Protective Agents|protective agents|mesh-ancestor
92334292|NCT00003313|Paclitaxel|paclitaxel|mesh-list
92189604|NCT01409564|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92189605|NCT01409564|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92189606|NCT01409564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189607|NCT02009449|Leucovorin|leucovorin|mesh-list
92189608|NCT02009449|Paclitaxel|paclitaxel|mesh-list
92189609|NCT02009449|Docetaxel|docetaxel|mesh-list
92189610|NCT02009449|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92189611|NCT02009449|Carboplatin|carboplatin|mesh-list
92189612|NCT02009449|Gemcitabine|gemcitabine|mesh-list
92189613|NCT02009449|Pembrolizumab|pembrolizumab|mesh-list
92189614|NCT02009449|Fluorouracil|fluorouracil|mesh-list
92189615|NCT02009449|Capecitabine|capecitabine|mesh-list
92189616|NCT02009449|Oxaliplatin|oxaliplatin|mesh-list
92189617|NCT02009449|Nivolumab|nivolumab|mesh-list
92189618|NCT02009449|Levoleucovorin|levoleucovorin|mesh-list
92189619|NCT02009449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92189620|NCT02009449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189621|NCT02009449|Tubulin Modulators|tubulin modulators|mesh-ancestor
92189622|NCT02009449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92189623|NCT02009449|Mitosis Modulators|mitosis modulators|mesh-ancestor
92189624|NCT02009449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189625|NCT02009449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189626|NCT02009449|Antimetabolites|antimetabolites|mesh-ancestor
92189627|NCT02009449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189628|NCT02009449|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92189629|NCT02009449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189630|NCT02009449|Immunologic Factors|immunologic factors|mesh-ancestor
92189631|NCT02009449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189632|NCT02009449|Antidotes|antidotes|mesh-ancestor
92189633|NCT02009449|Protective Agents|protective agents|mesh-ancestor
92189634|NCT02009449|Vitamin B Complex|vitamin b complex|mesh-ancestor
92189635|NCT02009449|Vitamins|vitamins|mesh-ancestor
92189636|NCT02009449|Micronutrients|micronutrients|mesh-ancestor
92189637|NCT01794091|Eplerenone|eplerenone|mesh-list
92189638|NCT01794091|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92189639|NCT01794091|Hormone Antagonists|hormone antagonists|mesh-ancestor
92189640|NCT01794091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189641|NCT01794091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189642|NCT01794091|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92189643|NCT01794091|Diuretics|diuretics|mesh-ancestor
92189644|NCT01794091|Natriuretic Agents|natriuretic agents|mesh-ancestor
92189645|NCT01794091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92189646|NCT01794169|Cytarabine|cytarabine|mesh-list
92189647|NCT01794169|Azacitidine|azacitidine|mesh-list
92189648|NCT01794169|Daunorubicin|daunorubicin|mesh-list
92189649|NCT01794169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189650|NCT01794169|Antimetabolites|antimetabolites|mesh-ancestor
92189651|NCT01794169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189652|NCT01794169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189653|NCT01794169|Antiviral Agents|antiviral agents|mesh-ancestor
92189654|NCT01794169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189655|NCT01794169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189656|NCT01794169|Immunologic Factors|immunologic factors|mesh-ancestor
92189657|NCT01794169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189658|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189659|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92189660|NCT01794169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92189661|NCT01794169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92189662|NCT00396019|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92189663|NCT00396019|Antiviral Agents|antiviral agents|mesh-ancestor
92189664|NCT00396019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189666|NCT01390220|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92189667|NCT01390220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92189668|NCT01390220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189669|NCT01390220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189670|NCT01390220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92189671|NCT01390220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189672|NCT01390220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189673|NCT01390220|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92189674|NCT01390220|Anesthetics, General|anesthetics, general|mesh-ancestor
92189675|NCT01390220|Anesthetics|anesthetics|mesh-ancestor
92189676|NCT01390220|GABA Modulators|gaba modulators|mesh-ancestor
92189677|NCT01390220|GABA Agents|gaba agents|mesh-ancestor
92189678|NCT01390220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189679|NCT01390220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189680|NCT00357331|Potassium Citrate|potassium citrate|mesh-list
92189681|NCT00357331|Diuretics|diuretics|mesh-ancestor
92189682|NCT00357331|Natriuretic Agents|natriuretic agents|mesh-ancestor
92189683|NCT00357331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189684|NCT00357331|Expectorants|expectorants|mesh-ancestor
92189685|NCT00357331|Respiratory System Agents|respiratory system agents|mesh-ancestor
92189686|NCT00550173|Pemetrexed|pemetrexed|mesh-list
92189687|NCT00550173|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92189688|NCT00550173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189689|NCT00550173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189690|NCT00550173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189691|NCT00550173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92189692|NCT00550173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92189693|NCT00550173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92189694|NCT04163107|Hydroxychloroquine|hydroxychloroquine|mesh-list
92189695|NCT04163107|Dexamethasone|dexamethasone|mesh-list
92189696|NCT04163107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189697|NCT04163107|Antiemetics|antiemetics|mesh-ancestor
92189698|NCT04163107|Autonomic Agents|autonomic agents|mesh-ancestor
92189699|NCT04163107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189700|NCT04163107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189701|NCT04163107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189702|NCT04163107|Glucocorticoids|glucocorticoids|mesh-ancestor
92189703|NCT04163107|Hormones|hormones|mesh-ancestor
92189704|NCT04163107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189705|NCT04163107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92189706|NCT04163107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189707|NCT04163107|Antimalarials|antimalarials|mesh-ancestor
92189708|NCT04163107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92189709|NCT04163107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92189710|NCT04163107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189711|NCT04163107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189712|NCT04163107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189713|NCT04163107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189714|NCT01429298|Hydromorphone|hydromorphone|mesh-list
92334324|NCT00004879|Panitumumab|panitumumab|mesh-list
92189715|NCT01429298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92189716|NCT01429298|Narcotics|narcotics|mesh-ancestor
92189717|NCT01429298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189718|NCT01429298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189719|NCT01429298|Analgesics|analgesics|mesh-ancestor
92189720|NCT01429298|Sensory System Agents|sensory system agents|mesh-ancestor
92189721|NCT01429298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189722|NCT01408628|Insulin|insulin|mesh-list
92189723|NCT01408628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92189724|NCT01408628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189725|NCT01389752|Charcoal|charcoal|mesh-list
92189726|NCT01389752|Antidotes|antidotes|mesh-ancestor
92189727|NCT01389752|Protective Agents|protective agents|mesh-ancestor
92189728|NCT01389752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189729|NCT01428128|Arsenic Trioxide|arsenic trioxide|mesh-list
92189730|NCT01428128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189731|NCT00358501|Defibrotide|defibrotide|mesh-list
92189732|NCT00358501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92189733|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92189734|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189735|NCT00358501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92189736|NCT01427972|Eplerenone|eplerenone|mesh-list
92189737|NCT01427972|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92189738|NCT01427972|Hormone Antagonists|hormone antagonists|mesh-ancestor
92189739|NCT01427972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92189740|NCT01427972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189741|NCT01427972|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92189742|NCT01427972|Diuretics|diuretics|mesh-ancestor
92189743|NCT01427972|Natriuretic Agents|natriuretic agents|mesh-ancestor
92189744|NCT01427972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92189745|NCT00336323|Bevacizumab|bevacizumab|mesh-list
92189746|NCT00336323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189747|NCT00336323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189748|NCT00336323|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92189749|NCT00336323|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92189750|NCT00336323|Growth Substances|growth substances|mesh-ancestor
92189751|NCT00336323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189752|NCT00336323|Growth Inhibitors|growth inhibitors|mesh-ancestor
92189753|NCT01427738|Nystatin|nystatin|mesh-list
92189754|NCT01427738|Gentian Violet|gentian violet|mesh-list
92189755|NCT01427738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189756|NCT01427738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189757|NCT01427738|Antifungal Agents|antifungal agents|mesh-ancestor
92189758|NCT01427738|Ionophores|ionophores|mesh-ancestor
92189759|NCT01427738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189760|NCT01427738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189761|NCT01427738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92189762|NCT01426958|Ritonavir|ritonavir|mesh-list
92189763|NCT01426958|Afatinib|afatinib|mesh-list
92189764|NCT01426958|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92189765|NCT01426958|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92189766|NCT01426958|Protease Inhibitors|protease inhibitors|mesh-ancestor
92189767|NCT01426958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189768|NCT01426958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189769|NCT01426958|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92189770|NCT01426958|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92189771|NCT01426958|Antiviral Agents|antiviral agents|mesh-ancestor
92189772|NCT01426958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189773|NCT01426958|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92189774|NCT01426958|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92189775|NCT01426958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189776|NCT01426958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92189777|NCT00397813|Cyclosporine|cyclosporine|mesh-list
92189778|NCT00397813|Mycophenolic Acid|mycophenolic acid|mesh-list
92189779|NCT00397813|Fludarabine|fludarabine|mesh-list
92189780|NCT00397813|Fludarabine phosphate|fludarabine phosphate|mesh-list
92189781|NCT00397813|Cyclosporins|cyclosporins|mesh-list
92189782|NCT00397813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189783|NCT00397813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189784|NCT00397813|Antimetabolites|antimetabolites|mesh-ancestor
92189785|NCT00397813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189786|NCT00397813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189787|NCT00397813|Immunologic Factors|immunologic factors|mesh-ancestor
92189788|NCT00397813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189789|NCT00397813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189790|NCT00397813|Antifungal Agents|antifungal agents|mesh-ancestor
92189791|NCT00397813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189792|NCT00397813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92189793|NCT00397813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189794|NCT00397813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92189795|NCT00397813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92189797|NCT00397813|Antitubercular Agents|antitubercular agents|mesh-ancestor
92189798|NCT00397813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189800|NCT00398983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189801|NCT00398983|Antimetabolites|antimetabolites|mesh-ancestor
92189802|NCT00398983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189803|NCT00398983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189804|NCT00398983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189805|NCT00358579|Vasopressins|vasopressins|mesh-list
92189806|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
92189807|NCT00358579|Epinephrine|epinephrine|mesh-list
92189808|NCT00358579|Racepinephrine|racepinephrine|mesh-list
92189809|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
92189810|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189811|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92189812|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92189813|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
92189814|NCT00358579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189815|NCT00358579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189816|NCT00358579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92189817|NCT00358579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92189818|NCT00358579|Autonomic Agents|autonomic agents|mesh-ancestor
92189819|NCT00358579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189820|NCT00358579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92189821|NCT00358579|Respiratory System Agents|respiratory system agents|mesh-ancestor
92189822|NCT00358579|Mydriatics|mydriatics|mesh-ancestor
92189823|NCT00358579|Sympathomimetics|sympathomimetics|mesh-ancestor
92189824|NCT00358579|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92189825|NCT00358579|Hemostatics|hemostatics|mesh-ancestor
92189826|NCT00358579|Coagulants|coagulants|mesh-ancestor
92189827|NCT00358579|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92189828|NCT00358579|Natriuretic Agents|natriuretic agents|mesh-ancestor
92189829|NCT00338039|Gemcitabine|gemcitabine|mesh-list
92189830|NCT00338039|Capecitabine|capecitabine|mesh-list
92189831|NCT00338039|Oxaliplatin|oxaliplatin|mesh-list
92189832|NCT00338039|Cetuximab|cetuximab|mesh-list
92189833|NCT00338039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189834|NCT00338039|Antimetabolites|antimetabolites|mesh-ancestor
92189835|NCT00338039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189836|NCT00338039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189837|NCT00338039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189838|NCT00358657|Mycophenolic Acid|mycophenolic acid|mesh-list
92189840|NCT00358657|Cyclophosphamide|cyclophosphamide|mesh-list
92189841|NCT00358657|Fludarabine|fludarabine|mesh-list
92189842|NCT00358657|Fludarabine phosphate|fludarabine phosphate|mesh-list
92189843|NCT00358657|Tacrolimus|tacrolimus|mesh-list
92189844|NCT00358657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189845|NCT00358657|Immunologic Factors|immunologic factors|mesh-ancestor
92189846|NCT00358657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189847|NCT00358657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189848|NCT00358657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92189849|NCT00358657|Alkylating Agents|alkylating agents|mesh-ancestor
92189850|NCT00358657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189851|NCT00358657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189852|NCT00358657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92189853|NCT00358657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189854|NCT00358657|Antimetabolites|antimetabolites|mesh-ancestor
92189855|NCT00358657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92189856|NCT00358657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189857|NCT00358657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92189858|NCT00358657|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92189859|NCT00358657|Antitubercular Agents|antitubercular agents|mesh-ancestor
92189860|NCT00358657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189861|NCT00358657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189862|NCT00358657|Antifungal Agents|antifungal agents|mesh-ancestor
92189863|NCT00340379|Haloperidol|haloperidol|mesh-list
92189864|NCT00340379|Haloperidol decanoate|haloperidol decanoate|mesh-list
92189865|NCT00340379|Ziprasidone|ziprasidone|mesh-list
92189866|NCT00340379|Sertraline|sertraline|mesh-list
92189867|NCT00340379|Antidepressive Agents|antidepressive agents|mesh-ancestor
92189868|NCT00340379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92189869|NCT00340379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92189870|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92189871|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92189872|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189873|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189875|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189876|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
92189877|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
92189878|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189879|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189880|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92189881|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92189882|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189883|NCT00340379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92189884|NCT00340379|Dopamine Agents|dopamine agents|mesh-ancestor
92189885|NCT00340379|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92189886|NCT00340379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92189887|NCT00342563|Mecamylamine|mecamylamine|mesh-list
92189888|NCT00342563|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92189889|NCT00342563|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92189890|NCT00342563|Autonomic Agents|autonomic agents|mesh-ancestor
92189891|NCT00342563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189892|NCT00342563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189893|NCT00342563|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92189894|NCT00342563|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92189895|NCT00342563|Cholinergic Agents|cholinergic agents|mesh-ancestor
92189896|NCT00342563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189897|NCT00342563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189898|NCT00358735|Enoxaparin|enoxaparin|mesh-list
92189899|NCT00358735|Anticoagulants|anticoagulants|mesh-ancestor
92189900|NCT00358735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92189901|NCT00358735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92189902|NCT00358735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189903|NCT01793519|Adalimumab|adalimumab|mesh-list
92189904|NCT01793519|Infliximab|infliximab|mesh-list
92189905|NCT01793519|Etanercept|etanercept|mesh-list
92189906|NCT01793519|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92189907|NCT01793519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189908|NCT01793519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189909|NCT01793519|Dermatologic Agents|dermatologic agents|mesh-ancestor
92189910|NCT01793519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92189911|NCT01793519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92189912|NCT01793519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92189913|NCT01793519|Analgesics|analgesics|mesh-ancestor
92189914|NCT01793519|Sensory System Agents|sensory system agents|mesh-ancestor
92189915|NCT01793519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189916|NCT01793519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189917|NCT01793519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92189918|NCT01793519|Immunologic Factors|immunologic factors|mesh-ancestor
92189919|NCT00345371|Topiramate|topiramate|mesh-list
92189920|NCT00345371|Anticonvulsants|anticonvulsants|mesh-ancestor
92189921|NCT00345371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92189922|NCT00345371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189923|NCT03006276|Celecoxib|celecoxib|mesh-list
92189924|NCT03006276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92189925|NCT03006276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92189926|NCT03006276|Analgesics|analgesics|mesh-ancestor
92189927|NCT03006276|Sensory System Agents|sensory system agents|mesh-ancestor
92189928|NCT03006276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189929|NCT03006276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189930|NCT03006276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92189931|NCT03006276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92189932|NCT03006276|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92189933|NCT03006276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92189934|NCT03006276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189935|NCT03006276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189937|NCT00350363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92189938|NCT00350363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92189939|NCT00350363|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92189940|NCT00350363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92189941|NCT00350363|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92189942|NCT00350363|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92189943|NCT00350363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189944|NCT00350363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189945|NCT00350363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189946|NCT00351299|Dexmedetomidine|dexmedetomidine|mesh-list
92189947|NCT00351299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92189948|NCT00351299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189949|NCT00351299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189950|NCT00351299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92189951|NCT00351299|Analgesics|analgesics|mesh-ancestor
92189952|NCT00351299|Sensory System Agents|sensory system agents|mesh-ancestor
92189953|NCT00351299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189954|NCT00351299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92189955|NCT00351299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92189956|NCT00351299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92189957|NCT00351299|Adrenergic Agents|adrenergic agents|mesh-ancestor
92189958|NCT00351299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189959|NCT00351299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189960|NCT00352001|Lenalidomide|lenalidomide|mesh-list
92189961|NCT00352001|Azacitidine|azacitidine|mesh-list
92189962|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
92189963|NCT00352001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189964|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92189965|NCT00352001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92189966|NCT00352001|Growth Substances|growth substances|mesh-ancestor
92189967|NCT00352001|Growth Inhibitors|growth inhibitors|mesh-ancestor
92189968|NCT00352001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189969|NCT00352001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92189970|NCT00352001|Antimetabolites|antimetabolites|mesh-ancestor
92189971|NCT00352001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189972|NCT00352001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92189973|NCT00401401|Zalutumumab|zalutumumab|mesh-list
92189974|NCT00401401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189975|NCT00401401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189976|NCT00352781|Nicotine|nicotine|mesh-list
92189977|NCT00352781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92189978|NCT00352781|Autonomic Agents|autonomic agents|mesh-ancestor
92189979|NCT00352781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92189980|NCT00352781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189981|NCT00352781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92189982|NCT00352781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92189983|NCT00352781|Cholinergic Agents|cholinergic agents|mesh-ancestor
92189984|NCT00352781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92189985|NCT00352781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189986|NCT02812524|Ipilimumab|ipilimumab|mesh-list
92189987|NCT02812524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92189988|NCT02812524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92189989|NCT02812524|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92189990|NCT02812524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92189991|NCT01793753|Propofol|propofol|mesh-list
92189992|NCT01793753|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92189993|NCT01793753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92189994|NCT01793753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92189995|NCT01793753|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92189996|NCT01793753|Anesthetics, General|anesthetics, general|mesh-ancestor
92189997|NCT01793753|Anesthetics|anesthetics|mesh-ancestor
92189998|NCT00360685|Mycophenolic Acid|mycophenolic acid|mesh-list
92189999|NCT00360685|Methotrexate|methotrexate|mesh-list
92190000|NCT00360685|Tacrolimus|tacrolimus|mesh-list
92190001|NCT00360685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92190002|NCT00360685|Abortifacient Agents|abortifacient agents|mesh-ancestor
92334362|NCT00004885|Irinotecan|irinotecan|mesh-list
92190003|NCT00360685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92190004|NCT00360685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190005|NCT00360685|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190006|NCT00360685|Antimetabolites|antimetabolites|mesh-ancestor
92190007|NCT00360685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190008|NCT00360685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190009|NCT00360685|Dermatologic Agents|dermatologic agents|mesh-ancestor
92190010|NCT00360685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190011|NCT00360685|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92190012|NCT00360685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190013|NCT00360685|Immunologic Factors|immunologic factors|mesh-ancestor
92190014|NCT00360685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190015|NCT00360685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92190016|NCT00360685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92190017|NCT00360685|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92190018|NCT00360685|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92190019|NCT00360685|Antitubercular Agents|antitubercular agents|mesh-ancestor
92190020|NCT00360685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92190021|NCT00360685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190022|NCT05487456|Menthol|menthol|mesh-list
92190023|NCT05487456|Nicotine|nicotine|mesh-list
92190024|NCT05487456|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92190025|NCT05487456|Autonomic Agents|autonomic agents|mesh-ancestor
92190026|NCT05487456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190027|NCT05487456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190028|NCT05487456|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92190029|NCT05487456|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92190030|NCT05487456|Cholinergic Agents|cholinergic agents|mesh-ancestor
92190031|NCT05487456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190032|NCT05487456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190033|NCT05487456|Antipruritics|antipruritics|mesh-ancestor
92190034|NCT05487456|Dermatologic Agents|dermatologic agents|mesh-ancestor
92190035|NCT00558519|Cytarabine|cytarabine|mesh-list
92190036|NCT00558519|Dexamethasone|dexamethasone|mesh-list
92190037|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
92190038|NCT00558519|Doxorubicin|doxorubicin|mesh-list
92190039|NCT00558519|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92190040|NCT00558519|Methotrexate|methotrexate|mesh-list
92190041|NCT00558519|Vincristine|vincristine|mesh-list
92190042|NCT00558519|Daunorubicin|daunorubicin|mesh-list
92190043|NCT00558519|Mercaptopurine|mercaptopurine|mesh-list
92190044|NCT00558519|Pegaspargase|pegaspargase|mesh-list
92190045|NCT00558519|Thioguanine|thioguanine|mesh-list
92190046|NCT00558519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190047|NCT00558519|Immunologic Factors|immunologic factors|mesh-ancestor
92190048|NCT00558519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190049|NCT00558519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190050|NCT00558519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92190051|NCT00558519|Alkylating Agents|alkylating agents|mesh-ancestor
92190052|NCT00558519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190053|NCT00558519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190054|NCT00558519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92190055|NCT00558519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190056|NCT00558519|Antiemetics|antiemetics|mesh-ancestor
92190057|NCT00558519|Autonomic Agents|autonomic agents|mesh-ancestor
92190058|NCT00558519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190059|NCT00558519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92190060|NCT00558519|Glucocorticoids|glucocorticoids|mesh-ancestor
92190061|NCT00558519|Hormones|hormones|mesh-ancestor
92190062|NCT00558519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190063|NCT00558519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92190064|NCT00558519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92190065|NCT00558519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92190066|NCT00558519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92190067|NCT00558519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190068|NCT00558519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92190069|NCT00558519|Abortifacient Agents|abortifacient agents|mesh-ancestor
92190070|NCT00558519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92190071|NCT00558519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190072|NCT00558519|Antimetabolites|antimetabolites|mesh-ancestor
92190073|NCT00558519|Dermatologic Agents|dermatologic agents|mesh-ancestor
92190074|NCT00558519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92190075|NCT00558519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92190076|NCT00558519|Antiviral Agents|antiviral agents|mesh-ancestor
92190077|NCT00558519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190078|NCT00558519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92190079|NCT00558519|Tubulin Modulators|tubulin modulators|mesh-ancestor
92190080|NCT00558519|Antimitotic Agents|antimitotic agents|mesh-ancestor
92190081|NCT00558519|Mitosis Modulators|mitosis modulators|mesh-ancestor
92190083|NCT00403117|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92190084|NCT00403117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92190085|NCT00403117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190086|NCT00403117|Sensory System Agents|sensory system agents|mesh-ancestor
92190087|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190088|NCT00558285|Glycopyrrolate|glycopyrrolate|mesh-list
92190089|NCT00558285|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92190090|NCT00558285|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92190091|NCT00558285|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92190092|NCT00558285|Cholinergic Agents|cholinergic agents|mesh-ancestor
92190093|NCT00558285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190094|NCT00558285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190095|NCT00558285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190096|NCT01389596|Pregabalin|pregabalin|mesh-list
92190097|NCT01389596|Analgesics|analgesics|mesh-ancestor
92190098|NCT01389596|Sensory System Agents|sensory system agents|mesh-ancestor
92190099|NCT01389596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190100|NCT01389596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190101|NCT01389596|Anticonvulsants|anticonvulsants|mesh-ancestor
92190102|NCT01389596|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92190103|NCT01389596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190104|NCT01389596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190105|NCT01389596|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92190106|NCT01389596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92190107|NCT01389596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92190108|NCT01389596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190109|NCT01389596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190110|NCT00558207|Gemcitabine|gemcitabine|mesh-list
92190111|NCT00558207|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190112|NCT00558207|Antimetabolites|antimetabolites|mesh-ancestor
92190113|NCT00558207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190114|NCT00558207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190115|NCT00407485|Aflibercept|aflibercept|mesh-list
92190116|NCT00407485|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92190117|NCT00407485|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190118|NCT00407485|Growth Substances|growth substances|mesh-ancestor
92190119|NCT00407485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190120|NCT00407485|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190121|NCT00407485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190123|NCT00354887|Oxaliplatin|oxaliplatin|mesh-list
92190124|NCT00354887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190125|NCT00354887|Antimetabolites|antimetabolites|mesh-ancestor
92190126|NCT00354887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190127|NCT00354887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190128|NCT02111863|Aldesleukin|aldesleukin|mesh-list
92190129|NCT02111863|Cyclophosphamide|cyclophosphamide|mesh-list
92190130|NCT02111863|Fludarabine|fludarabine|mesh-list
92190131|NCT02111863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190132|NCT02111863|Immunologic Factors|immunologic factors|mesh-ancestor
92190133|NCT02111863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190134|NCT02111863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190135|NCT02111863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92190136|NCT02111863|Alkylating Agents|alkylating agents|mesh-ancestor
92190137|NCT02111863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190138|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190139|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92190140|NCT02111863|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92190141|NCT02111863|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92190142|NCT02111863|Antiviral Agents|antiviral agents|mesh-ancestor
92190143|NCT02111863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190144|NCT02660411|Propofol|propofol|mesh-list
92190145|NCT02660411|Sevoflurane|sevoflurane|mesh-list
92190146|NCT02660411|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92190147|NCT02660411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190148|NCT02660411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190149|NCT02660411|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92190150|NCT02660411|Anesthetics, General|anesthetics, general|mesh-ancestor
92190151|NCT02660411|Anesthetics|anesthetics|mesh-ancestor
92190152|NCT02660411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92190153|NCT02660411|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92190154|NCT02078492|Ketorolac|ketorolac|mesh-list
92190155|NCT02078492|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92190156|NCT02078492|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92190157|NCT02078492|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190158|NCT02078492|Analgesics|analgesics|mesh-ancestor
92190159|NCT02078492|Sensory System Agents|sensory system agents|mesh-ancestor
92190160|NCT02078492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190161|NCT02078492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190162|NCT02078492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190163|NCT02078492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190164|NCT02078492|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92190165|NCT02078492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190166|NCT02078492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190167|NCT02988921|Paclitaxel|paclitaxel|mesh-list
92190168|NCT02988921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92190169|NCT02988921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190170|NCT02988921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92190171|NCT02988921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92190172|NCT02988921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92190173|NCT02988921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190174|NCT04528563|Ketorolac|ketorolac|mesh-list
92190175|NCT04528563|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92190176|NCT04528563|Morphine|morphine|mesh-list
92190177|NCT04528563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92190178|NCT04528563|Narcotics|narcotics|mesh-ancestor
92190179|NCT04528563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190180|NCT04528563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190181|NCT04528563|Analgesics|analgesics|mesh-ancestor
92190182|NCT04528563|Sensory System Agents|sensory system agents|mesh-ancestor
92190183|NCT04528563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190184|NCT04528563|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92190185|NCT04528563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190186|NCT04528563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190187|NCT04528563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190188|NCT04528563|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92190189|NCT04528563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190190|NCT04528563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190191|NCT00355199|Rituximab|rituximab|mesh-list
92190192|NCT00355199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190193|NCT00355199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190194|NCT00355199|Immunologic Factors|immunologic factors|mesh-ancestor
92190195|NCT00355199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190196|NCT00355199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190197|NCT01791647|Inositol|inositol|mesh-list
92190198|NCT01791647|Metformin|metformin|mesh-list
92190199|NCT01791647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92190200|NCT01791647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190201|NCT01791647|Vitamin B Complex|vitamin b complex|mesh-ancestor
92190202|NCT01791647|Vitamins|vitamins|mesh-ancestor
92190203|NCT01791647|Micronutrients|micronutrients|mesh-ancestor
92190204|NCT00363883|Vorinostat|vorinostat|mesh-list
92190205|NCT00363883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190206|NCT00363883|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92190207|NCT00363883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190208|NCT00363883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190210|NCT00364819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190211|NCT00364819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190212|NCT00364819|Immunologic Factors|immunologic factors|mesh-ancestor
92190213|NCT00364819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190214|NCT00364819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190216|NCT04524351|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92190217|NCT04524351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190218|NCT04524351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190219|NCT04524351|Cholinergic Agents|cholinergic agents|mesh-ancestor
92190220|NCT04524351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190221|NCT04524351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190222|NCT04523961|Lidocaine|lidocaine|mesh-list
92190223|NCT04523961|Tetracaine|tetracaine|mesh-list
92190224|NCT04523961|Prilocaine|prilocaine|mesh-list
92190225|NCT04523961|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92190226|NCT04523961|Anesthetics, Local|anesthetics, local|mesh-ancestor
92190227|NCT04523961|Anesthetics|anesthetics|mesh-ancestor
92190228|NCT04523961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190229|NCT04523961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190230|NCT04523961|Sensory System Agents|sensory system agents|mesh-ancestor
92190231|NCT04523961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190232|NCT04523961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92190233|NCT04523961|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92190234|NCT04523961|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92190235|NCT04523961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190236|NCT04523961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190237|NCT04523961|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92190238|NCT01792505|Imiquimod|imiquimod|mesh-list
92190239|NCT01792505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92190240|NCT01792505|Immunologic Factors|immunologic factors|mesh-ancestor
92190241|NCT01792505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190242|NCT01792505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190243|NCT01792505|Interferon Inducers|interferon inducers|mesh-ancestor
92190244|NCT00365053|Belinostat|belinostat|mesh-list
92190245|NCT00365053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190246|NCT00365053|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92190247|NCT00365053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190248|NCT00365053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190249|NCT00555789|Tacrolimus|tacrolimus|mesh-list
92190250|NCT00555789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190251|NCT00555789|Immunologic Factors|immunologic factors|mesh-ancestor
92190252|NCT00555789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190253|NCT00555789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92190254|NCT00555789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190255|NCT00555789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190256|NCT04288895|Vortioxetine|vortioxetine|mesh-list
92190257|NCT04288895|Antidepressive Agents|antidepressive agents|mesh-ancestor
92190258|NCT04288895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190259|NCT04288895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92190260|NCT04288895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92190261|NCT04288895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190262|NCT04288895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190263|NCT04288895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92190264|NCT04288895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92190265|NCT04288895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190266|NCT04288895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190267|NCT04288895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190268|NCT04288895|Serotonin Agents|serotonin agents|mesh-ancestor
92190269|NCT04288895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92190270|NCT04288895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92190271|NCT04288895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92190272|NCT04288895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92190273|NCT00365209|Curcumin|curcumin|mesh-list
92190274|NCT00365209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92190275|NCT00365209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190276|NCT00365209|Analgesics|analgesics|mesh-ancestor
92190277|NCT00365209|Sensory System Agents|sensory system agents|mesh-ancestor
92190278|NCT00365209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190279|NCT00365209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190280|NCT00365209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190281|NCT00365209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190282|NCT00365209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190283|NCT00365209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190284|NCT00365209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190285|NCT04417257|Fenretinide|fenretinide|mesh-list
92190286|NCT04417257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190287|NCT04417257|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92190288|NCT04417257|Protective Agents|protective agents|mesh-ancestor
92190289|NCT04417257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190290|NCT00409825|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92190291|NCT00409825|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92190292|NCT00409825|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92190293|NCT00409825|Hormone Antagonists|hormone antagonists|mesh-ancestor
92190294|NCT00409825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190295|NCT00409825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190296|NCT00409825|Progestins|progestins|mesh-ancestor
92190298|NCT00410059|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92190299|NCT00410059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190300|NCT00410059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190301|NCT00410059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190302|NCT00410059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190303|NCT04749069|Remifentanil|remifentanil|mesh-list
92190304|NCT04749069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92190305|NCT04749069|Narcotics|narcotics|mesh-ancestor
92190306|NCT04749069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190307|NCT04749069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190308|NCT04749069|Analgesics|analgesics|mesh-ancestor
92190309|NCT04749069|Sensory System Agents|sensory system agents|mesh-ancestor
92190310|NCT04749069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190311|NCT00411463|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92190312|NCT00411463|Antidepressive Agents|antidepressive agents|mesh-ancestor
92190313|NCT00411463|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190314|NCT00411463|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92190315|NCT00411463|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92190316|NCT00411463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190317|NCT00411463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190318|NCT03239015|Trastuzumab|trastuzumab|mesh-list
92190319|NCT03239015|Everolimus|everolimus|mesh-list
92190320|NCT03239015|Olaparib|olaparib|mesh-list
92190321|NCT03239015|Palbociclib|palbociclib|mesh-list
92190322|NCT03239015|Gefitinib|gefitinib|mesh-list
92190323|NCT03239015|Afatinib|afatinib|mesh-list
92190324|NCT03239015|Vemurafenib|vemurafenib|mesh-list
92190325|NCT03239015|Dabrafenib|dabrafenib|mesh-list
92190326|NCT03239015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92190327|NCT03239015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190328|NCT03239015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190329|NCT03239015|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92190330|NCT03239015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190331|NCT03239015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190332|NCT03239015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190333|NCT03239015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190334|NCT03239015|Immunologic Factors|immunologic factors|mesh-ancestor
92190335|NCT03239015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190336|NCT03239015|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92190337|NCT03239015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190338|NCT03239015|Growth Substances|growth substances|mesh-ancestor
92190339|NCT03239015|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190341|NCT00356993|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92190342|NCT00356993|Autonomic Agents|autonomic agents|mesh-ancestor
92190343|NCT00356993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190344|NCT00356993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190345|NCT00356993|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92190346|NCT00356993|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92190347|NCT00356993|Cholinergic Agents|cholinergic agents|mesh-ancestor
92190348|NCT00356993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190349|NCT00356993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190350|NCT01793077|Leuprolide|leuprolide|mesh-list
92190351|NCT01793077|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92190352|NCT01793077|Fertility Agents|fertility agents|mesh-ancestor
92190353|NCT01793077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92190354|NCT01793077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190355|NCT01793077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92190356|NCT01793077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190357|NCT00555477|Anastrozole|anastrozole|mesh-list
92190358|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92190359|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190360|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92190361|NCT00555477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92190362|NCT00555477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190363|NCT00555477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190364|NCT00555477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92190365|NCT00555477|Hormone Antagonists|hormone antagonists|mesh-ancestor
92190366|NCT00555477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190367|NCT00555477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190368|NCT00365599|Tamoxifen|tamoxifen|mesh-list
92190369|NCT00365599|Vorinostat|vorinostat|mesh-list
92190370|NCT00365599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190371|NCT00365599|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92190372|NCT00365599|Hormone Antagonists|hormone antagonists|mesh-ancestor
92190373|NCT00365599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190374|NCT00365599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190375|NCT00365599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92190376|NCT00365599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190377|NCT00365599|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92190378|NCT00365599|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92190379|NCT00365599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92190380|NCT00365599|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92190381|NCT00365599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190382|NCT00554619|Ambrisentan|ambrisentan|mesh-list
92190383|NCT00554619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92190384|NCT02104739|Exenatide|exenatide|mesh-list
92190385|NCT02104739|Saxagliptin|saxagliptin|mesh-list
92190386|NCT02104739|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92190387|NCT02104739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190388|NCT02104739|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92190389|NCT02104739|Incretins|incretins|mesh-ancestor
92190390|NCT02104739|Hormones|hormones|mesh-ancestor
92190391|NCT02104739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190392|NCT02104739|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92190393|NCT02104739|Protease Inhibitors|protease inhibitors|mesh-ancestor
92190394|NCT02104739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190395|NCT02104739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190397|NCT00411619|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92190398|NCT00411619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190399|NCT00411619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190400|NCT00411619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190401|NCT00411619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190402|NCT00411619|Immunologic Factors|immunologic factors|mesh-ancestor
92190403|NCT00411619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190404|NCT00411619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190405|NCT00412087|Vitamin D|vitamin d|mesh-list
92190406|NCT00412087|Ergocalciferols|ergocalciferols|mesh-list
92190407|NCT00412087|Cholecalciferol|cholecalciferol|mesh-list
92190408|NCT00412087|Vitamins|vitamins|mesh-list
92190409|NCT00412087|Micronutrients|micronutrients|mesh-ancestor
92190410|NCT00412087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190411|NCT00412087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92190412|NCT00412087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92190413|NCT00312923|Policosanol|policosanol|mesh-list
92190414|NCT00312923|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92190415|NCT00312923|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92190416|NCT00312923|Antimetabolites|antimetabolites|mesh-ancestor
92190417|NCT00312923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190418|NCT00312923|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92190419|NCT00312923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92190420|NCT00412243|Cyclophosphamide|cyclophosphamide|mesh-list
92190421|NCT00412243|Clofarabine|clofarabine|mesh-list
92190422|NCT00412243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190423|NCT00412243|Immunologic Factors|immunologic factors|mesh-ancestor
92190424|NCT00412243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190425|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190426|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92190427|NCT00412243|Alkylating Agents|alkylating agents|mesh-ancestor
92190428|NCT00412243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190429|NCT00412243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190430|NCT00412243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92190431|NCT00412243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190432|NCT00412243|Antimetabolites|antimetabolites|mesh-ancestor
92190433|NCT01426412|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92190434|NCT01426412|Immunologic Factors|immunologic factors|mesh-ancestor
92190435|NCT01426412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190436|NCT00315341|Buprenorphine|buprenorphine|mesh-list
92190437|NCT00315341|Methadone|methadone|mesh-list
92334453|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92190438|NCT00315341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92190440|NCT00315341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92190441|NCT00315341|Narcotics|narcotics|mesh-ancestor
92190442|NCT00315341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190443|NCT00315341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190444|NCT00315341|Analgesics|analgesics|mesh-ancestor
92190445|NCT00315341|Sensory System Agents|sensory system agents|mesh-ancestor
92190446|NCT00315341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190447|NCT00315341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92190448|NCT00315341|Antitussive Agents|antitussive agents|mesh-ancestor
92190449|NCT00315341|Respiratory System Agents|respiratory system agents|mesh-ancestor
92190450|NCT02277249|Digoxin|digoxin|mesh-list
92190451|NCT02277249|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92190452|NCT02277249|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92190453|NCT02277249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190454|NCT02277249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190455|NCT02277249|Protective Agents|protective agents|mesh-ancestor
92190456|NCT02277249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190457|NCT04767542|Acetaminophen|acetaminophen|mesh-list
92190458|NCT04767542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190459|NCT04767542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190460|NCT04767542|Analgesics|analgesics|mesh-ancestor
92190461|NCT04767542|Sensory System Agents|sensory system agents|mesh-ancestor
92190462|NCT04767542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190463|NCT04767542|Antipyretics|antipyretics|mesh-ancestor
92190464|NCT01794533|Lidocaine|lidocaine|mesh-list
92190465|NCT01794533|Epinephrine|epinephrine|mesh-list
92190467|NCT01794533|Fentanyl|fentanyl|mesh-list
92190468|NCT01794533|Epinephryl borate|epinephryl borate|mesh-list
92190469|NCT01794533|Anesthetics, Local|anesthetics, local|mesh-ancestor
92190470|NCT01794533|Anesthetics|anesthetics|mesh-ancestor
92190471|NCT01794533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190472|NCT01794533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190473|NCT01794533|Sensory System Agents|sensory system agents|mesh-ancestor
92190474|NCT01794533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190475|NCT01794533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92190476|NCT01794533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92190477|NCT01794533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92190478|NCT01794533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190479|NCT01794533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190480|NCT01794533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92190481|NCT01794533|Narcotics|narcotics|mesh-ancestor
92190482|NCT01794533|Analgesics|analgesics|mesh-ancestor
92190483|NCT01794533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92190484|NCT01794533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92190485|NCT01794533|Anesthetics, General|anesthetics, general|mesh-ancestor
92190486|NCT01794533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92190487|NCT01794533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92190488|NCT01794533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92190489|NCT01794533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190490|NCT01794533|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92190491|NCT01794533|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92190492|NCT01794533|Autonomic Agents|autonomic agents|mesh-ancestor
92190493|NCT01794533|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92190494|NCT01794533|Respiratory System Agents|respiratory system agents|mesh-ancestor
92190495|NCT01794533|Mydriatics|mydriatics|mesh-ancestor
92190496|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
92190497|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92190498|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92190499|NCT00412867|Plasminogen|plasminogen|mesh-list
92190500|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92190501|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92190502|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190503|NCT01730833|Paclitaxel|paclitaxel|mesh-list
92190504|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92190505|NCT01730833|Trastuzumab|trastuzumab|mesh-list
92190506|NCT01730833|Pertuzumab|pertuzumab|mesh-list
92190507|NCT01730833|Antibodies|antibodies|mesh-list
92190508|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
92190509|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92190510|NCT01730833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190511|NCT01730833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92190513|NCT01730833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92190514|NCT01730833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190515|NCT01730833|Immunologic Factors|immunologic factors|mesh-ancestor
92190516|NCT01730833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190517|NCT01730833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190518|NCT00413335|Rosiglitazone|rosiglitazone|mesh-list
92190519|NCT00413335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92190520|NCT00413335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190521|NCT00414271|Docetaxel|docetaxel|mesh-list
92190522|NCT00414271|Capecitabine|capecitabine|mesh-list
92190523|NCT00414271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190524|NCT00414271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92190525|NCT00414271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92190526|NCT00414271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92190527|NCT00414271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190528|NCT00414271|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190529|NCT00414271|Antimetabolites|antimetabolites|mesh-ancestor
92190530|NCT00360971|Cisplatin|cisplatin|mesh-list
92190531|NCT00360971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190532|NCT01791881|Botulinum Toxins|botulinum toxins|mesh-list
92190533|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92190534|NCT01791881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92190535|NCT01791881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92190536|NCT01791881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190537|NCT01791881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190538|NCT01791881|Cholinergic Agents|cholinergic agents|mesh-ancestor
92190539|NCT01791881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190540|NCT01791881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190541|NCT01791881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92190542|NCT01791881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190543|NCT03636503|Rituximab|rituximab|mesh-list
92190544|NCT03636503|Avelumab|avelumab|mesh-list
92190545|NCT03636503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190546|NCT03636503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190547|NCT03636503|Immunologic Factors|immunologic factors|mesh-ancestor
92190548|NCT03636503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190549|NCT03636503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190550|NCT03448159|Fluoxetine|fluoxetine|mesh-list
92190551|NCT03448159|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92190552|NCT03448159|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92190553|NCT03448159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190554|NCT03448159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190555|NCT03448159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190556|NCT03448159|Serotonin Agents|serotonin agents|mesh-ancestor
92190557|NCT03448159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190558|NCT03448159|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92190559|NCT03448159|Antidepressive Agents|antidepressive agents|mesh-ancestor
92190560|NCT03448159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190561|NCT03448159|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92190562|NCT03448159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92190563|NCT03448159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190564|NCT00361439|Mometasone Furoate|mometasone furoate|mesh-list
92190565|NCT00361439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190566|NCT00361439|Dermatologic Agents|dermatologic agents|mesh-ancestor
92190567|NCT00361439|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92190568|NCT00361595|Zoledronic Acid|zoledronic acid|mesh-list
92190569|NCT00361595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92190570|NCT00361595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190571|NCT03438487|Vaccines|vaccines|mesh-list
92190572|NCT03438487|Immunologic Factors|immunologic factors|mesh-ancestor
92190573|NCT03438487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190574|NCT03458117|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92190575|NCT03458117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190576|NCT03458117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190577|NCT01792037|Methylprednisolone|methylprednisolone|mesh-list
92190578|NCT01792037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92190579|NCT01792037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92190580|NCT01792037|Prednisolone|prednisolone|mesh-list
92190581|NCT01792037|Prednisolone acetate|prednisolone acetate|mesh-list
92190582|NCT01792037|Midazolam|midazolam|mesh-list
92190583|NCT01792037|Etomidate|etomidate|mesh-list
92190584|NCT01792037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92190585|NCT01792037|Prednisolone phosphate|prednisolone phosphate|mesh-list
92190586|NCT01792037|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92190587|NCT01792037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92190588|NCT01792037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190589|NCT01792037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190590|NCT01792037|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92190591|NCT01792037|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92190592|NCT01792037|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190593|NCT01792037|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92190594|NCT01792037|Anesthetics, General|anesthetics, general|mesh-ancestor
92190595|NCT01792037|Anesthetics|anesthetics|mesh-ancestor
92190596|NCT01792037|GABA Modulators|gaba modulators|mesh-ancestor
92190597|NCT01792037|GABA Agents|gaba agents|mesh-ancestor
92190598|NCT01792037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190599|NCT01792037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190600|NCT01792037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190601|NCT01792037|Antiemetics|antiemetics|mesh-ancestor
92190602|NCT01792037|Autonomic Agents|autonomic agents|mesh-ancestor
92190603|NCT01792037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190604|NCT01792037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92190605|NCT01792037|Glucocorticoids|glucocorticoids|mesh-ancestor
92190606|NCT01792037|Hormones|hormones|mesh-ancestor
92190607|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190608|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92190609|NCT01792037|Protective Agents|protective agents|mesh-ancestor
92190610|NCT01792037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92190611|NCT01792037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190612|NCT00373399|Dronabinol|dronabinol|mesh-list
92190613|NCT00373399|Hallucinogens|hallucinogens|mesh-ancestor
92190614|NCT00373399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190615|NCT00373399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190616|NCT00373399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190617|NCT00373399|Analgesics|analgesics|mesh-ancestor
92190618|NCT00373399|Sensory System Agents|sensory system agents|mesh-ancestor
92190619|NCT00373399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190620|NCT00373399|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92190621|NCT00373399|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92190622|NCT00373399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190623|NCT00373399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190624|NCT00373399|Hormones|hormones|mesh-ancestor
92190625|NCT00373399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190626|NCT00318929|Valproic Acid|valproic acid|mesh-list
92190627|NCT00318929|Anticonvulsants|anticonvulsants|mesh-ancestor
92190628|NCT00318929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190629|NCT00318929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190630|NCT00318929|GABA Agents|gaba agents|mesh-ancestor
92190631|NCT00318929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190632|NCT00318929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190633|NCT00318929|Antimanic Agents|antimanic agents|mesh-ancestor
92190634|NCT00318929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92190635|NCT00318929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190636|NCT00318929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190637|NCT00418093|Bevacizumab|bevacizumab|mesh-list
92190638|NCT00418093|Gemcitabine|gemcitabine|mesh-list
92190639|NCT00418093|Oxaliplatin|oxaliplatin|mesh-list
92190640|NCT00418093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190641|NCT00418093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190642|NCT00418093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92190643|NCT00418093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190644|NCT00418093|Growth Substances|growth substances|mesh-ancestor
92190645|NCT00418093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190646|NCT00418093|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190647|NCT00418093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190648|NCT00418093|Antimetabolites|antimetabolites|mesh-ancestor
92190649|NCT00418093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190651|NCT03855371|Arsenic Trioxide|arsenic trioxide|mesh-list
92190652|NCT03855371|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190653|NCT03855371|Antimetabolites|antimetabolites|mesh-ancestor
92190654|NCT03855371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190656|NCT03855371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190657|NCT03284723|Letrozole|letrozole|mesh-list
92190658|NCT03284723|Palbociclib|palbociclib|mesh-list
92190659|NCT03284723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190660|NCT03284723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92190661|NCT03284723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92190662|NCT03284723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190663|NCT03284723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190664|NCT03284723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92190665|NCT03284723|Hormone Antagonists|hormone antagonists|mesh-ancestor
92190666|NCT03284723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190667|NCT03284723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190668|NCT03284723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190669|NCT00374803|Mycophenolic Acid|mycophenolic acid|mesh-list
92190670|NCT00374803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92190671|NCT00374803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190672|NCT00374803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92190673|NCT00374803|Antitubercular Agents|antitubercular agents|mesh-ancestor
92190674|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92190675|NCT00374803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190676|NCT00374803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917126|NCT01666730|Calcium|calcium|mesh-list
92190677|NCT00374803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190678|NCT00418951|Voriconazole|voriconazole|mesh-list
92190679|NCT00418951|Amphotericin B|amphotericin b|mesh-list
92190680|NCT00418951|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92190681|NCT00418951|Antifungal Agents|antifungal agents|mesh-ancestor
92190682|NCT00418951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190683|NCT00418951|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92190684|NCT00418951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92190685|NCT00418951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190686|NCT00418951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190687|NCT00418951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92190688|NCT00418951|Hormone Antagonists|hormone antagonists|mesh-ancestor
92190689|NCT00418951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190690|NCT00418951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190691|NCT00418951|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92190692|NCT00418951|Amebicides|amebicides|mesh-ancestor
92190693|NCT00418951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92190694|NCT00418951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92190695|NCT00418951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92190696|NCT00363077|Vaccines|vaccines|mesh-list
92190697|NCT00363077|Immunologic Factors|immunologic factors|mesh-ancestor
92190698|NCT00363077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190699|NCT00375973|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92334480|NCT00004921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190700|NCT00375973|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92190701|NCT00375973|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92190702|NCT00375973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92190703|NCT00375973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190704|NCT00375973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190705|NCT00375973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190706|NCT00375973|Analgesics|analgesics|mesh-ancestor
92190707|NCT00375973|Sensory System Agents|sensory system agents|mesh-ancestor
92190708|NCT00375973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190709|NCT00375973|Antidepressive Agents|antidepressive agents|mesh-ancestor
92190710|NCT00375973|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190711|NCT00375973|Dopamine Agents|dopamine agents|mesh-ancestor
92190712|NCT00421603|Topiramate|topiramate|mesh-list
92190713|NCT00421603|Adderall|adderall|mesh-list
92190714|NCT00421603|Anticonvulsants|anticonvulsants|mesh-ancestor
92190715|NCT00421603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92190716|NCT00421603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190717|NCT00421603|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92190718|NCT00363779|Cyclosporine|cyclosporine|mesh-list
92190719|NCT00363779|Cyclosporins|cyclosporins|mesh-list
92190720|NCT00363779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190721|NCT00363779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190722|NCT00363779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190723|NCT00363779|Immunologic Factors|immunologic factors|mesh-ancestor
92190724|NCT00363779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190725|NCT00363779|Antifungal Agents|antifungal agents|mesh-ancestor
92190726|NCT00363779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190727|NCT00363779|Dermatologic Agents|dermatologic agents|mesh-ancestor
92190728|NCT00363779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190729|NCT00363779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92190730|NCT01405820|Natalizumab|natalizumab|mesh-list
92190731|NCT01405820|Immunologic Factors|immunologic factors|mesh-ancestor
92190732|NCT01405820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190733|NCT01405742|Factor VIII|factor viii|mesh-list
92190734|NCT01405742|Coagulants|coagulants|mesh-ancestor
92190735|NCT01794767|Heparin|heparin|mesh-list
92190736|NCT01794767|Calcium heparin|calcium heparin|mesh-list
92190737|NCT01794767|Anticoagulants|anticoagulants|mesh-ancestor
92190738|NCT01794767|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92190739|NCT01794767|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92190740|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190741|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
92190742|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92190743|NCT02076152|Bevacizumab|bevacizumab|mesh-list
92190744|NCT02076152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190745|NCT02076152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190746|NCT02076152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92190747|NCT02076152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190748|NCT02076152|Growth Substances|growth substances|mesh-ancestor
92190749|NCT02076152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190750|NCT02076152|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190752|NCT03025958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190753|NCT03025958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190754|NCT00380029|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92190755|NCT00380029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190756|NCT00380029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190757|NCT00380029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190758|NCT00380029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190759|NCT01405508|Brivaracetam|brivaracetam|mesh-list
92190760|NCT01405508|Anticonvulsants|anticonvulsants|mesh-ancestor
92190761|NCT00426283|Fluticasone|fluticasone|mesh-list
92190763|NCT00426283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190764|NCT00426283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92190765|NCT00426283|Autonomic Agents|autonomic agents|mesh-ancestor
92190766|NCT00426283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190767|NCT00426283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190768|NCT00426283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92190769|NCT00426283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92190770|NCT00426283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92190771|NCT00426283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92190772|NCT00322439|Etanercept|etanercept|mesh-list
92190773|NCT00322439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92190774|NCT00322439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190776|NCT00322439|Sensory System Agents|sensory system agents|mesh-ancestor
92190777|NCT00322439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190778|NCT00322439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190779|NCT00322439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190780|NCT00322439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190781|NCT00322439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92190782|NCT00322439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190783|NCT00322439|Immunologic Factors|immunologic factors|mesh-ancestor
92190784|NCT01795027|Oxaliplatin|oxaliplatin|mesh-list
92190785|NCT01795027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190786|NCT00365261|Eszopiclone|eszopiclone|mesh-list
92190787|NCT00365261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92190788|NCT00365261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190789|NCT00365261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190790|NCT00426517|Sirolimus|sirolimus|mesh-list
92190791|NCT00426517|Busulfan|busulfan|mesh-list
92190792|NCT00426517|Alemtuzumab|alemtuzumab|mesh-list
92190793|NCT00426517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92190794|NCT00426517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190795|NCT00426517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92190796|NCT00426517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190797|NCT00426517|Antifungal Agents|antifungal agents|mesh-ancestor
92190798|NCT00426517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190799|NCT00426517|Immunologic Factors|immunologic factors|mesh-ancestor
92190800|NCT00426517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190801|NCT00426517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190802|NCT00426517|Alkylating Agents|alkylating agents|mesh-ancestor
92190803|NCT00426517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92190804|NCT00426517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92190805|NCT00426517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190806|NCT00365417|Cyclophosphamide|cyclophosphamide|mesh-list
92190807|NCT00365417|Bevacizumab|bevacizumab|mesh-list
92190808|NCT00365417|Docetaxel|docetaxel|mesh-list
92190809|NCT00365417|Doxorubicin|doxorubicin|mesh-list
92190810|NCT00365417|Capecitabine|capecitabine|mesh-list
92190811|NCT00365417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190812|NCT00365417|Immunologic Factors|immunologic factors|mesh-ancestor
92190813|NCT00365417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190814|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190815|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92190816|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
92190817|NCT00365417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190818|NCT00365417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190819|NCT00365417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92190820|NCT00365417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190821|NCT00365417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92190822|NCT00365417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190823|NCT00365417|Growth Substances|growth substances|mesh-ancestor
92190824|NCT00365417|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190825|NCT00365417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92190826|NCT00365417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92190827|NCT00365417|Mitosis Modulators|mitosis modulators|mesh-ancestor
91917127|NCT01666730|Levoleucovorin|levoleucovorin|mesh-list
92190828|NCT00365417|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92190829|NCT00365417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92190830|NCT00365417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92190831|NCT00365417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190832|NCT00365417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92190833|NCT00365417|Antimetabolites|antimetabolites|mesh-ancestor
92190834|NCT00427297|Ritonavir|ritonavir|mesh-list
92190835|NCT00427297|Lopinavir|lopinavir|mesh-list
92190836|NCT00427297|Tenofovir|tenofovir|mesh-list
92190837|NCT00427297|Lamivudine|lamivudine|mesh-list
92190838|NCT00427297|Zidovudine|zidovudine|mesh-list
92190839|NCT00427297|Nevirapine|nevirapine|mesh-list
92190840|NCT00427297|Abacavir|abacavir|mesh-list
92190841|NCT00427297|Didanosine|didanosine|mesh-list
92190842|NCT00427297|Stavudine|stavudine|mesh-list
92190843|NCT00427297|Efavirenz|efavirenz|mesh-list
92190844|NCT00427297|Dideoxynucleosides|dideoxynucleosides|mesh-list
92190845|NCT00427297|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92190846|NCT00427297|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92190847|NCT00427297|Protease Inhibitors|protease inhibitors|mesh-ancestor
92190848|NCT00427297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190849|NCT00427297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190850|NCT00427297|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92190851|NCT00427297|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92190852|NCT00427297|Antiviral Agents|antiviral agents|mesh-ancestor
92190853|NCT00427297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190854|NCT00427297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92190855|NCT00427297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92190856|NCT00427297|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92190857|NCT00427297|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92190858|NCT00427297|Antimetabolites|antimetabolites|mesh-ancestor
92190859|NCT00427297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92190860|NCT00427297|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92190861|NCT00427297|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92190862|NCT00427297|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92190863|NCT00427297|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92190864|NCT00427765|Melphalan|melphalan|mesh-list
92190865|NCT00427765|Busulfan|busulfan|mesh-list
92190866|NCT00427765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92190867|NCT00427765|Alkylating Agents|alkylating agents|mesh-ancestor
92190868|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190869|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190870|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92190871|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92190872|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
92190873|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190874|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
92190875|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
92190876|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190877|NCT00384865|Aspirin|aspirin|mesh-list
92190878|NCT00384865|Simvastatin|simvastatin|mesh-list
92190879|NCT00384865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92190880|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92190882|NCT00384865|Sensory System Agents|sensory system agents|mesh-ancestor
92190883|NCT00384865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190884|NCT00384865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190885|NCT00384865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92190886|NCT00384865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92190887|NCT00384865|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92190888|NCT00384865|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92190889|NCT00384865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190890|NCT00384865|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92190891|NCT00384865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92190892|NCT00384865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190893|NCT00384865|Antipyretics|antipyretics|mesh-ancestor
92190894|NCT00384865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92190895|NCT00384865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92190896|NCT00384865|Antimetabolites|antimetabolites|mesh-ancestor
92190897|NCT00384865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92190898|NCT00384865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92190899|NCT00367601|Bevacizumab|bevacizumab|mesh-list
92190900|NCT00367601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92334508|NCT00004993|Parathyroid Hormone|parathyroid hormone|mesh-list
92190901|NCT00367601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92190902|NCT00367601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190903|NCT00367601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92190904|NCT00367601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190905|NCT00367601|Growth Substances|growth substances|mesh-ancestor
92190906|NCT00367601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190907|NCT00367601|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190908|NCT00367601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190909|NCT00367601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190910|NCT00367601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190911|NCT00385801|Risperidone|risperidone|mesh-list
92190912|NCT00385801|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92190913|NCT00385801|Serotonin Agents|serotonin agents|mesh-ancestor
92190914|NCT00385801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190915|NCT00385801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190916|NCT00385801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190917|NCT00385801|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92190918|NCT00385801|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92190919|NCT00385801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92190920|NCT00385801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92190921|NCT00385801|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92190922|NCT00385801|Dopamine Agents|dopamine agents|mesh-ancestor
92190923|NCT00429403|Goserelin|goserelin|mesh-list
92190924|NCT00429403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92190925|NCT00429403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190926|NCT05286931|Ciprofloxacin|ciprofloxacin|mesh-list
92190927|NCT05286931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92190928|NCT05286931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92190929|NCT05286931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92190930|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92190931|NCT05286931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190932|NCT05286931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190933|NCT05286931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190934|NCT05286931|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92190935|NCT05286931|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92190936|NCT00368459|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92190937|NCT00368459|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92190938|NCT00368459|Hormone Antagonists|hormone antagonists|mesh-ancestor
92190939|NCT00368459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190940|NCT00368459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190941|NCT00368459|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92334529|NCT00003361|Decitabine|decitabine|mesh-list
92190942|NCT00368459|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92190943|NCT00368459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92190944|NCT00429949|Dasatinib|dasatinib|mesh-list
92190945|NCT00429949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190946|NCT00429949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190947|NCT00429949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190948|NCT00429949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190949|NCT02078726|Glucagon|glucagon|mesh-list
92190950|NCT02078726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92190952|NCT02078726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92190953|NCT02078726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190954|NCT00431041|Solifenacin Succinate|solifenacin succinate|mesh-list
92190955|NCT00431041|Oxybutynin|oxybutynin|mesh-list
92190956|NCT00431041|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92190957|NCT00431041|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92190958|NCT00431041|Cholinergic Agents|cholinergic agents|mesh-ancestor
92190959|NCT00431041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92190960|NCT00431041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190961|NCT00431041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190962|NCT00431041|Urological Agents|urological agents|mesh-ancestor
92190963|NCT00431041|Parasympatholytics|parasympatholytics|mesh-ancestor
92190964|NCT00431041|Autonomic Agents|autonomic agents|mesh-ancestor
92190965|NCT00431041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190966|NCT00390611|Paclitaxel|paclitaxel|mesh-list
92190967|NCT00390611|Carboplatin|carboplatin|mesh-list
92190968|NCT00390611|Sorafenib|sorafenib|mesh-list
92190969|NCT00390611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92190970|NCT00390611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190971|NCT00390611|Tubulin Modulators|tubulin modulators|mesh-ancestor
92190972|NCT00390611|Antimitotic Agents|antimitotic agents|mesh-ancestor
92190973|NCT00390611|Mitosis Modulators|mitosis modulators|mesh-ancestor
92190974|NCT00390611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92190975|NCT00390611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190976|NCT00390611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190977|NCT00391079|Nabiximols|nabiximols|mesh-list
92190978|NCT00391079|Analgesics|analgesics|mesh-ancestor
92190979|NCT00391079|Sensory System Agents|sensory system agents|mesh-ancestor
92190980|NCT00391079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92190981|NCT00391079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190982|NCT00387751|Bevacizumab|bevacizumab|mesh-list
92190983|NCT00387751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92190984|NCT00387751|Sorafenib|sorafenib|mesh-list
92190985|NCT00387751|Endothelial Growth Factors|endothelial growth factors|mesh-list
92190986|NCT00387751|Antibodies|antibodies|mesh-list
92190987|NCT00387751|Immunoglobulins|immunoglobulins|mesh-list
92190988|NCT00387751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92190989|NCT00387751|Immunoglobulin G|immunoglobulin g|mesh-list
92190990|NCT00387751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92190991|NCT00387751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92190992|NCT00387751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92190993|NCT00387751|Growth Substances|growth substances|mesh-ancestor
92190994|NCT00387751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92190995|NCT00387751|Growth Inhibitors|growth inhibitors|mesh-ancestor
92190996|NCT00387751|Immunologic Factors|immunologic factors|mesh-ancestor
92190997|NCT00387751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92190998|NCT00387751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92190999|NCT00387751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191000|NCT01795235|Atenolol|atenolol|mesh-list
92191001|NCT01795235|Glucagon|glucagon|mesh-list
92191002|NCT01795235|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92191003|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92191004|NCT01795235|Hormones|hormones|mesh-ancestor
92191005|NCT01795235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191006|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191007|NCT01795235|Incretins|incretins|mesh-ancestor
92191008|NCT01795235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92191009|NCT01795235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92191010|NCT01795235|Sympatholytics|sympatholytics|mesh-ancestor
92191011|NCT01795235|Autonomic Agents|autonomic agents|mesh-ancestor
92191012|NCT01795235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191013|NCT01795235|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92191014|NCT01795235|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92191015|NCT01795235|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92191016|NCT01795235|Adrenergic Agents|adrenergic agents|mesh-ancestor
92191017|NCT01795235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191018|NCT01795235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191019|NCT00387829|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92191020|NCT00387829|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92191021|NCT00387829|Estradiol|estradiol|mesh-list
92191022|NCT00387829|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92191023|NCT00387829|Estrogens|estrogens|mesh-ancestor
92191024|NCT00387829|Hormones|hormones|mesh-ancestor
92191025|NCT00387829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191026|NCT00387829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191027|NCT00387829|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92191028|NCT00387829|Contraceptive Agents|contraceptive agents|mesh-ancestor
92191029|NCT00387829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92191030|NCT00387829|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92191031|NCT01512407|Ethiodized Oil|ethiodized oil|mesh-list
92191032|NCT01512407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191033|NCT00392951|Sirolimus|sirolimus|mesh-list
92191034|NCT00392951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191035|NCT00392951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191036|NCT00392951|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92191037|NCT00392951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191038|NCT00392951|Antifungal Agents|antifungal agents|mesh-ancestor
92191039|NCT00392951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191040|NCT00392951|Immunologic Factors|immunologic factors|mesh-ancestor
92191041|NCT00392951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191042|NCT01424930|Prednisone|prednisone|mesh-list
92191043|NCT01424930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191044|NCT01424930|Glucocorticoids|glucocorticoids|mesh-ancestor
92191045|NCT01424930|Hormones|hormones|mesh-ancestor
92191046|NCT01424930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191047|NCT01424930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191048|NCT01424930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191049|NCT01424930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191050|NCT00389857|Vaccines|vaccines|mesh-list
92191051|NCT00389857|Immunologic Factors|immunologic factors|mesh-ancestor
92191052|NCT00389857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191053|NCT01795183|Amisulpride|amisulpride|mesh-list
92191054|NCT01795183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92191055|NCT01795183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92191056|NCT01795183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191057|NCT01795183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191058|NCT01795183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191059|NCT01795183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92191060|NCT01795183|Dopamine Agents|dopamine agents|mesh-ancestor
92191061|NCT01795183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191062|NCT01795183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191063|NCT01795183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92191064|NCT01795183|Antidepressive Agents|antidepressive agents|mesh-ancestor
92191065|NCT01424228|Prucalopride|prucalopride|mesh-list
92191066|NCT01424228|Laxatives|laxatives|mesh-ancestor
92191067|NCT01424228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92191068|NCT01424228|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92191069|NCT01424228|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92191072|NCT01424228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191073|NCT01424228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191075|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
92191076|NCT03562975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191077|NCT04750603|Fluticasone|fluticasone|mesh-list
92191078|NCT04750603|Xhance|xhance|mesh-list
92191079|NCT04750603|Albuterol|albuterol|mesh-list
92191080|NCT04750603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191081|NCT04750603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92191082|NCT04750603|Autonomic Agents|autonomic agents|mesh-ancestor
92191083|NCT04750603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191084|NCT04750603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191085|NCT04750603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92191086|NCT04750603|Respiratory System Agents|respiratory system agents|mesh-ancestor
92191087|NCT04750603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92191088|NCT04750603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92191089|NCT04750603|Tocolytic Agents|tocolytic agents|mesh-ancestor
92191090|NCT04750603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92191091|NCT04750603|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92191092|NCT04750603|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92191093|NCT04750603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92191094|NCT04750603|Adrenergic Agents|adrenergic agents|mesh-ancestor
92191095|NCT04750603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191096|NCT04750603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191097|NCT01423916|Moxifloxacin|moxifloxacin|mesh-list
92191098|NCT01423916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191099|NCT01423916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191101|NCT01423916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92191102|NCT01423916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191103|NCT01423916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191104|NCT01423916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191105|NCT00436969|Hyaluronic Acid|hyaluronic acid|mesh-list
92191106|NCT00436969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92191107|NCT00436969|Immunologic Factors|immunologic factors|mesh-ancestor
92191108|NCT00436969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191109|NCT00436969|Viscosupplements|viscosupplements|mesh-ancestor
92191110|NCT00436969|Protective Agents|protective agents|mesh-ancestor
92191111|NCT00455689|Leuprolide|leuprolide|mesh-list
92191112|NCT00455689|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92191113|NCT00455689|Fertility Agents|fertility agents|mesh-ancestor
92191114|NCT00455689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92191115|NCT00455689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191116|NCT00455689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191117|NCT00455689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191118|NCT00394277|Ribavirin|ribavirin|mesh-list
92191119|NCT00394277|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92191120|NCT00394277|Interferon-alpha|interferon-alpha|mesh-list
92191121|NCT00394277|Antimetabolites|antimetabolites|mesh-ancestor
92191122|NCT00394277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191123|NCT00394277|Antiviral Agents|antiviral agents|mesh-ancestor
92191124|NCT00394277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191125|NCT00394277|Immunologic Factors|immunologic factors|mesh-ancestor
92191126|NCT00394277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191127|NCT00395057|Ranibizumab|ranibizumab|mesh-list
92191128|NCT00395057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191129|NCT00395057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92334583|NCT00004399|Nimodipine|nimodipine|mesh-list
92191130|NCT00395057|Growth Substances|growth substances|mesh-ancestor
92191131|NCT00395057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191132|NCT00395057|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191133|NCT00395057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191134|NCT00438451|Lamotrigine|lamotrigine|mesh-list
92191135|NCT00438451|Carbamazepine|carbamazepine|mesh-list
92191136|NCT00438451|Levetiracetam|levetiracetam|mesh-list
92191137|NCT00438451|Anticonvulsants|anticonvulsants|mesh-ancestor
92191138|NCT00438451|Nootropic Agents|nootropic agents|mesh-ancestor
92191139|NCT00438451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92191140|NCT00438451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92327631|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191141|NCT00438451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191142|NCT00438451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92191143|NCT00438451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191144|NCT00438451|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92191145|NCT00438451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92191146|NCT00438451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191147|NCT00438451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191148|NCT00438451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92191149|NCT00438451|Antimanic Agents|antimanic agents|mesh-ancestor
92191150|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92191151|NCT00438451|Analgesics|analgesics|mesh-ancestor
92191152|NCT00438451|Sensory System Agents|sensory system agents|mesh-ancestor
92191153|NCT00438451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191154|NCT00438451|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92191155|NCT00438451|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92191156|NCT00456625|Vaccines|vaccines|mesh-list
92191157|NCT00456625|Immunologic Factors|immunologic factors|mesh-ancestor
92191158|NCT00456625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191159|NCT00457795|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92191160|NCT00457795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92191161|NCT00457795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92191162|NCT00457795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92191163|NCT00457795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92191164|NCT00457795|Adrenergic Agents|adrenergic agents|mesh-ancestor
92191165|NCT00457795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191166|NCT00457795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191167|NCT00457795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191168|NCT04749979|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92191169|NCT04749979|Luteolytic Agents|luteolytic agents|mesh-ancestor
92191170|NCT04749979|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92191171|NCT04749979|Contraceptive Agents|contraceptive agents|mesh-ancestor
92191172|NCT04749979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92191173|NCT04749979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191174|NCT04749979|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92191175|NCT04749979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191176|NCT04749979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191178|NCT01423604|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191179|NCT01423604|Antimetabolites|antimetabolites|mesh-ancestor
92191180|NCT01423604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191181|NCT01423604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191182|NCT01402544|Ranibizumab|ranibizumab|mesh-list
92191183|NCT01402544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191184|NCT01402544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191185|NCT01402544|Growth Substances|growth substances|mesh-ancestor
92191186|NCT01402544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191187|NCT01402544|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191188|NCT01402544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191189|NCT00460993|Eszopiclone|eszopiclone|mesh-list
92191190|NCT00460993|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92191191|NCT00460993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191192|NCT00460993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191193|NCT00441883|Latanoprost|latanoprost|mesh-list
92191194|NCT00441883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92191195|NCT00441883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92191196|NCT00461773|Bevacizumab|bevacizumab|mesh-list
92191197|NCT00461773|Letrozole|letrozole|mesh-list
92191198|NCT00461773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191199|NCT00461773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191200|NCT00461773|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191201|NCT00461773|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191202|NCT00461773|Growth Substances|growth substances|mesh-ancestor
92191203|NCT00461773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191204|NCT00461773|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191205|NCT00461773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92191206|NCT00461773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92191207|NCT00461773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191208|NCT00461773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191209|NCT00461773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92191210|NCT00461773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92191211|NCT00461773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191212|NCT00461851|Carboplatin|carboplatin|mesh-list
92191213|NCT00461851|Gemcitabine|gemcitabine|mesh-list
92191214|NCT00461851|Sorafenib|sorafenib|mesh-list
92191215|NCT00461851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191216|NCT00461851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191217|NCT00461851|Antimetabolites|antimetabolites|mesh-ancestor
92191218|NCT00461851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191219|NCT00461851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191220|NCT00461851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191221|NCT00442507|Bevacizumab|bevacizumab|mesh-list
92191222|NCT00442507|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92191223|NCT00442507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191224|NCT00442507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191225|NCT00442507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191226|NCT00442507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191227|NCT00442507|Growth Substances|growth substances|mesh-ancestor
92191228|NCT00442507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191229|NCT00442507|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191230|NCT00442507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191231|NCT00442507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191232|NCT00442507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191233|NCT01401530|Denileukin diftitox|denileukin diftitox|mesh-list
92191234|NCT01401530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191235|NCT01387022|Tenofovir|tenofovir|mesh-list
92191236|NCT01387022|Lamivudine|lamivudine|mesh-list
92191237|NCT01387022|Efavirenz|efavirenz|mesh-list
92191238|NCT01387022|Antiviral Agents|antiviral agents|mesh-ancestor
92191239|NCT01387022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191240|NCT01387022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92191241|NCT01387022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92191242|NCT01387022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191243|NCT01387022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191244|NCT01387022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92191245|NCT01387022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92191246|NCT01387022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92191247|NCT01387022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92191248|NCT01387022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92191249|NCT01387022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92191250|NCT01387022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92191251|NCT01387022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92191253|NCT00374231|Prednisone|prednisone|mesh-list
92191254|NCT00374231|Tacrolimus|tacrolimus|mesh-list
92191255|NCT00374231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191256|NCT00374231|Glucocorticoids|glucocorticoids|mesh-ancestor
92191257|NCT00374231|Hormones|hormones|mesh-ancestor
92191258|NCT00374231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191259|NCT00374231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191260|NCT00374231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191261|NCT00374231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191262|NCT00374231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191263|NCT00374231|Immunologic Factors|immunologic factors|mesh-ancestor
92191264|NCT00374231|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92191265|NCT00374231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191266|NCT00374231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191267|NCT00374231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92191269|NCT00374231|Antitubercular Agents|antitubercular agents|mesh-ancestor
92191270|NCT00374231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191271|NCT00374231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191272|NCT00400205|Docetaxel|docetaxel|mesh-list
92191273|NCT00400205|Fluorouracil|fluorouracil|mesh-list
92191274|NCT00400205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191275|NCT00400205|Tubulin Modulators|tubulin modulators|mesh-ancestor
92191276|NCT00400205|Antimitotic Agents|antimitotic agents|mesh-ancestor
92191277|NCT00400205|Mitosis Modulators|mitosis modulators|mesh-ancestor
92191278|NCT00400205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191279|NCT00400205|Antimetabolites|antimetabolites|mesh-ancestor
92191280|NCT00400205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191281|NCT00400205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191282|NCT00400205|Immunologic Factors|immunologic factors|mesh-ancestor
92191283|NCT00400205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191284|NCT01386554|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92191285|NCT01386554|Hormones|hormones|mesh-ancestor
92191286|NCT01386554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191287|NCT01386554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191288|NCT00400439|Dalcetrapib|dalcetrapib|mesh-list
92191289|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92191290|NCT00400439|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92191291|NCT00400439|Antimetabolites|antimetabolites|mesh-ancestor
92191292|NCT00400439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191293|NCT00400439|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92191295|NCT00448201|Fludarabine phosphate|fludarabine phosphate|mesh-list
92191296|NCT00448201|Fludarabine|fludarabine|mesh-list
92191297|NCT00448201|Busulfan|busulfan|mesh-list
92191298|NCT00448201|Tacrolimus|tacrolimus|mesh-list
92191299|NCT00448201|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92191300|NCT00448201|Sargramostim|sargramostim|mesh-list
92191301|NCT00448201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92191302|NCT00448201|Abortifacient Agents|abortifacient agents|mesh-ancestor
92191303|NCT00448201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92191304|NCT00448201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191305|NCT00448201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191306|NCT00448201|Antimetabolites|antimetabolites|mesh-ancestor
92191307|NCT00448201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191308|NCT00448201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191309|NCT00448201|Dermatologic Agents|dermatologic agents|mesh-ancestor
92191310|NCT00448201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191311|NCT00448201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92191312|NCT00448201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191313|NCT00448201|Immunologic Factors|immunologic factors|mesh-ancestor
92191314|NCT00448201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92191315|NCT00448201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92191316|NCT00448201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92191317|NCT00448201|Alkylating Agents|alkylating agents|mesh-ancestor
92191318|NCT00448201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92191319|NCT00448201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92191320|NCT05287607|Bilirubin|bilirubin|mesh-list
92191321|NCT05287607|Antioxidants|antioxidants|mesh-ancestor
92191322|NCT05287607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191323|NCT05287607|Protective Agents|protective agents|mesh-ancestor
92191324|NCT05287607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191325|NCT00375713|Cetirizine|cetirizine|mesh-list
92191326|NCT00375713|Hydrocortisone|hydrocortisone|mesh-list
92191327|NCT00375713|Levocetirizine|levocetirizine|mesh-list
92191328|NCT00375713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191329|NCT00375713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92191330|NCT00375713|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92191331|NCT00375713|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92191332|NCT00375713|Histamine Antagonists|histamine antagonists|mesh-ancestor
92191333|NCT00375713|Histamine Agents|histamine agents|mesh-ancestor
92191334|NCT00375713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191335|NCT00375713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191336|NCT00375713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191337|NCT00465595|Psilocybin|psilocybin|mesh-list
92191338|NCT00465595|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92191339|NCT00465595|Hallucinogens|hallucinogens|mesh-ancestor
92191340|NCT00465595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191341|NCT00465595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191342|NCT00465595|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92191343|NCT00465595|Serotonin Agents|serotonin agents|mesh-ancestor
92191344|NCT00465595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191345|NCT00465595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191346|NCT00465595|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92191347|NCT00376805|Cyclophosphamide|cyclophosphamide|mesh-list
92191348|NCT00376805|Fludarabine|fludarabine|mesh-list
92191349|NCT00376805|Interleukin-2|interleukin-2|mesh-list
92191350|NCT00376805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191351|NCT00376805|Immunologic Factors|immunologic factors|mesh-ancestor
92191352|NCT00376805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191353|NCT00376805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92191354|NCT00376805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92191355|NCT00376805|Alkylating Agents|alkylating agents|mesh-ancestor
92191356|NCT00376805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191357|NCT00376805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191358|NCT00376805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334664|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92191359|NCT00376805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92191360|NCT00376805|Analgesics|analgesics|mesh-ancestor
92191361|NCT00376805|Sensory System Agents|sensory system agents|mesh-ancestor
92191362|NCT00376805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191363|NCT00448357|Methotrexate|methotrexate|mesh-list
92191364|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
92191365|NCT00448357|Fludarabine|fludarabine|mesh-list
92191366|NCT00448357|Busulfan|busulfan|mesh-list
92191367|NCT00448357|Tacrolimus|tacrolimus|mesh-list
92191368|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92191369|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
92191370|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92191371|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
92191372|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92191373|NCT00448357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191374|NCT00448357|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191375|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
92191376|NCT00448357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191377|NCT00448357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191378|NCT00448357|Dermatologic Agents|dermatologic agents|mesh-ancestor
92191379|NCT00448357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191380|NCT00448357|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92191381|NCT00448357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191382|NCT00448357|Immunologic Factors|immunologic factors|mesh-ancestor
92191383|NCT00448357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92191384|NCT00448357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92191385|NCT00448357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92191386|NCT00448357|Alkylating Agents|alkylating agents|mesh-ancestor
92191387|NCT00448357|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92191388|NCT00448357|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92191389|NCT00450073|Vitamin D|vitamin d|mesh-list
92191390|NCT00450073|Ergocalciferols|ergocalciferols|mesh-list
92191391|NCT00450073|Cholecalciferol|cholecalciferol|mesh-list
92191392|NCT00450073|Vitamins|vitamins|mesh-list
92191393|NCT00450073|Micronutrients|micronutrients|mesh-ancestor
92191394|NCT00450073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191395|NCT00450073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92191396|NCT00450073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92191397|NCT00467077|Interferons|interferons|mesh-list
92191399|NCT00467077|Interferon alpha-2|interferon alpha-2|mesh-list
92191400|NCT00467077|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92191401|NCT00467077|Gefitinib|gefitinib|mesh-list
92191402|NCT00467077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191403|NCT00467077|Antiviral Agents|antiviral agents|mesh-ancestor
92191404|NCT00467077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191405|NCT00467077|Immunologic Factors|immunologic factors|mesh-ancestor
92191406|NCT00467077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191407|NCT00467077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191408|NCT00467077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191409|NCT00467077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191410|NCT00467389|Donepezil|donepezil|mesh-list
92191411|NCT00467389|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92191412|NCT00467389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191413|NCT00467389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191414|NCT00467389|Cholinergic Agents|cholinergic agents|mesh-ancestor
92191415|NCT00467389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191416|NCT00467389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191417|NCT00467389|Nootropic Agents|nootropic agents|mesh-ancestor
92191418|NCT00377741|Valganciclovir|valganciclovir|mesh-list
92191419|NCT00377741|Antiviral Agents|antiviral agents|mesh-ancestor
92191420|NCT00377741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191421|NCT00379145|Trabectedin|trabectedin|mesh-list
92191422|NCT00379145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92191423|NCT00379145|Alkylating Agents|alkylating agents|mesh-ancestor
92191424|NCT00379145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191425|NCT00379145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191426|NCT00382031|Zalutumumab|zalutumumab|mesh-list
92191427|NCT00382031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92191428|NCT00382031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191429|NCT00382031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191430|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
92191431|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191432|NCT00382265|Tamsulosin|tamsulosin|mesh-list
92191433|NCT00382265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92191434|NCT00382265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92191435|NCT00382265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92191436|NCT00382265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92191437|NCT00382265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191438|NCT00382265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191439|NCT00382265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191440|NCT00382265|Urological Agents|urological agents|mesh-ancestor
92191441|NCT00383747|Nicotine|nicotine|mesh-list
92191442|NCT00383747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92191443|NCT00383747|Autonomic Agents|autonomic agents|mesh-ancestor
92191444|NCT00383747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191445|NCT00383747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191446|NCT00383747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92191447|NCT00383747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92191448|NCT00383747|Cholinergic Agents|cholinergic agents|mesh-ancestor
92191449|NCT00383747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191450|NCT00383747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191451|NCT01421342|Aripiprazole|aripiprazole|mesh-list
92191452|NCT01421342|Bupropion|bupropion|mesh-list
92191453|NCT01421342|Antidepressive Agents|antidepressive agents|mesh-list
92191454|NCT01421342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92191455|NCT01421342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191456|NCT01421342|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92191457|NCT01421342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92191458|NCT01421342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92191459|NCT01421342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191460|NCT01421342|Dopamine Agents|dopamine agents|mesh-ancestor
92191461|NCT01421342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191462|NCT01421342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191463|NCT01421342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92191464|NCT01421342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92191465|NCT01421342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191466|NCT01421342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92191467|NCT01421342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92191468|NCT01421342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191469|NCT01421342|Dopamine Agonists|dopamine agonists|mesh-ancestor
92191470|NCT01421342|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92191471|NCT01421342|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92191472|NCT01421342|Serotonin Agents|serotonin agents|mesh-ancestor
92191473|NCT01421342|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92191474|NCT01421342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92191475|NCT01421342|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92191476|NCT01421342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92191477|NCT00403403|Bevacizumab|bevacizumab|mesh-list
92191478|NCT00403403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191479|NCT00403403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191480|NCT00403403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191481|NCT00403403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191482|NCT00403403|Growth Substances|growth substances|mesh-ancestor
92191483|NCT00403403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191484|NCT00403403|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191485|NCT00405353|Methyltestosterone|methyltestosterone|mesh-list
92191486|NCT00405353|Testosterone|testosterone|mesh-list
92191487|NCT00405353|Testosterone undecanoate|testosterone undecanoate|mesh-list
92191488|NCT00405353|Testosterone enanthate|testosterone enanthate|mesh-list
92191489|NCT00405353|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92191490|NCT00405353|Androgens|androgens|mesh-ancestor
92191492|NCT00405353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191493|NCT00405353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191494|NCT00405353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191495|NCT00405353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191496|NCT00405353|Anabolic Agents|anabolic agents|mesh-ancestor
92191497|NCT01384292|Naloxegol|naloxegol|mesh-list
92191498|NCT01384292|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92191499|NCT01384292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191500|NCT01384292|Sensory System Agents|sensory system agents|mesh-ancestor
92191501|NCT01384292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191502|NCT00450463|Metronidazole|metronidazole|mesh-list
92191503|NCT00450463|Molgramostim|molgramostim|mesh-list
92191504|NCT00450463|Flutamide|flutamide|mesh-list
92191505|NCT00450463|Sargramostim|sargramostim|mesh-list
92191506|NCT00450463|Immunologic Factors|immunologic factors|mesh-ancestor
92191507|NCT00450463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191508|NCT00450463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191509|NCT00450463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191510|NCT00450463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191511|NCT00450463|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92191512|NCT00450463|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92191513|NCT00450463|Androgen Antagonists|androgen antagonists|mesh-ancestor
92191514|NCT00450463|Hormone Antagonists|hormone antagonists|mesh-ancestor
92191515|NCT00450463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191516|NCT00450463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191517|NCT00407381|Ranibizumab|ranibizumab|mesh-list
92191518|NCT00407381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191519|NCT00407381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191520|NCT00407381|Growth Substances|growth substances|mesh-ancestor
92191521|NCT00407381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191523|NCT00407381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191524|NCT00384449|Ranibizumab|ranibizumab|mesh-list
92191525|NCT00384449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191526|NCT00384449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191527|NCT00384449|Growth Substances|growth substances|mesh-ancestor
92191528|NCT00384449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191529|NCT00384449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191530|NCT00384449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191531|NCT00452335|Lubiprostone|lubiprostone|mesh-list
92191532|NCT00452335|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92191533|NCT00452335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92191534|NCT00452335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191535|NCT00386243|Analgesics, Opioid|analgesics, opioid|mesh-list
92191537|NCT00386243|Narcotics|narcotics|mesh-ancestor
92191538|NCT00386243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191539|NCT00386243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191540|NCT00386243|Sensory System Agents|sensory system agents|mesh-ancestor
92191541|NCT00386243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191542|NCT01400516|Vitamin D|vitamin d|mesh-list
92191543|NCT01400516|Teriparatide|teriparatide|mesh-list
92191544|NCT01400516|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92191545|NCT01400516|Calcium|calcium|mesh-list
92191546|NCT01400516|Vitamins|vitamins|mesh-ancestor
92191547|NCT01400516|Micronutrients|micronutrients|mesh-ancestor
92191548|NCT01400516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191549|NCT01400516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92191550|NCT01400516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92191551|NCT01400516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191552|NCT01383356|Metformin|metformin|mesh-list
92191553|NCT01383356|Linagliptin|linagliptin|mesh-list
92191554|NCT01383356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92191555|NCT01383356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191556|NCT01383356|Incretins|incretins|mesh-ancestor
92191557|NCT01383356|Hormones|hormones|mesh-ancestor
92191558|NCT01383356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191559|NCT01383356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92191560|NCT01383356|Protease Inhibitors|protease inhibitors|mesh-ancestor
92191561|NCT01383356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191562|NCT01383356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191563|NCT02111447|Propofol|propofol|mesh-list
92191564|NCT02111447|Sevoflurane|sevoflurane|mesh-list
92191565|NCT02111447|Isoflurane|isoflurane|mesh-list
92191566|NCT02111447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92191567|NCT02111447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191568|NCT02111447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191569|NCT02111447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92191570|NCT02111447|Anesthetics, General|anesthetics, general|mesh-ancestor
92191571|NCT02111447|Anesthetics|anesthetics|mesh-ancestor
92191572|NCT02111447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92191573|NCT02111447|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92191574|NCT00386477|Povidone-Iodine|povidone-iodine|mesh-list
92191575|NCT00386477|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92191576|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191577|NCT00453193|Alemtuzumab|alemtuzumab|mesh-list
92191578|NCT00453193|Pentostatin|pentostatin|mesh-list
92191579|NCT00453193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191580|NCT00453193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191581|NCT00453193|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92191582|NCT00453193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191583|NCT00453193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191584|NCT00387023|Rituximab|rituximab|mesh-list
92191585|NCT00387023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191586|NCT00387023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191587|NCT00387023|Immunologic Factors|immunologic factors|mesh-ancestor
92191588|NCT00387023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191589|NCT00387023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92191590|NCT00472849|Cytarabine|cytarabine|mesh-list
92191591|NCT00472849|Rituximab|rituximab|mesh-list
92191592|NCT00472849|Oxaliplatin|oxaliplatin|mesh-list
92191593|NCT00472849|Fludarabine|fludarabine|mesh-list
92191594|NCT00472849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191595|NCT00472849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191596|NCT00472849|Immunologic Factors|immunologic factors|mesh-ancestor
92191597|NCT00472849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191598|NCT00472849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92191599|NCT00472849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191601|NCT00472849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191602|NCT00472849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191603|NCT00472849|Antiviral Agents|antiviral agents|mesh-ancestor
92191604|NCT00472849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191605|NCT00453895|Sunitinib|sunitinib|mesh-list
92191606|NCT00453895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191607|NCT00453895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191608|NCT00453895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191609|NCT00453895|Growth Substances|growth substances|mesh-ancestor
92191610|NCT00453895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191611|NCT00453895|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191612|NCT00453895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191613|NCT00453895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191614|NCT00453895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191615|NCT00528541|Botulinum Toxins|botulinum toxins|mesh-list
92191616|NCT00528541|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92191617|NCT00528541|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92191618|NCT00528541|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92191619|NCT00528541|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92191620|NCT00528541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191621|NCT00528541|Cholinergic Agents|cholinergic agents|mesh-ancestor
92191622|NCT00528541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191623|NCT00528541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191624|NCT00528541|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92191625|NCT00528541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191626|NCT00409565|Bevacizumab|bevacizumab|mesh-list
92191627|NCT00409565|Cetuximab|cetuximab|mesh-list
92191628|NCT00409565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191629|NCT00409565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191630|NCT00409565|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191631|NCT00409565|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191632|NCT00409565|Growth Substances|growth substances|mesh-ancestor
92191633|NCT00409565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191634|NCT00409565|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191635|NCT00475501|Methyltestosterone|methyltestosterone|mesh-list
92191636|NCT00475501|Finasteride|finasteride|mesh-list
92191637|NCT00475501|Testosterone|testosterone|mesh-list
92191638|NCT00475501|Testosterone undecanoate|testosterone undecanoate|mesh-list
92191639|NCT00475501|Testosterone enanthate|testosterone enanthate|mesh-list
92191640|NCT00475501|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92191641|NCT00475501|Androgens|androgens|mesh-ancestor
92191642|NCT00475501|Hormones|hormones|mesh-ancestor
92191643|NCT00475501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191644|NCT00475501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191645|NCT00475501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191646|NCT00475501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191647|NCT00475501|Anabolic Agents|anabolic agents|mesh-ancestor
92191648|NCT00475501|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92191649|NCT00475501|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92191650|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191651|NCT00475501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191652|NCT00475501|Hormone Antagonists|hormone antagonists|mesh-ancestor
92191653|NCT00475501|Urological Agents|urological agents|mesh-ancestor
92191654|NCT00529555|Minocycline|minocycline|mesh-list
92191655|NCT00529555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191656|NCT00529555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191657|NCT00387335|Sunitinib|sunitinib|mesh-list
92191658|NCT00387335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191659|NCT00387335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191660|NCT00387335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191661|NCT00387335|Growth Substances|growth substances|mesh-ancestor
92191662|NCT00387335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191663|NCT00387335|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191664|NCT00387335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191665|NCT00387335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191666|NCT00387335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191667|NCT01797757|Orlistat|orlistat|mesh-list
92191669|NCT01797757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191670|NCT01797757|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92191671|NCT01797757|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92191672|NCT01796899|Brivaracetam|brivaracetam|mesh-list
92191673|NCT01796899|Anticonvulsants|anticonvulsants|mesh-ancestor
92191674|NCT00477451|Alprazolam|alprazolam|mesh-list
92191675|NCT00477451|Doxapram|doxapram|mesh-list
92191676|NCT00477451|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92191677|NCT00477451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191678|NCT00477451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191679|NCT00477451|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92191680|NCT00477451|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92191681|NCT00477451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191682|NCT00477451|GABA Modulators|gaba modulators|mesh-ancestor
92191683|NCT00477451|GABA Agents|gaba agents|mesh-ancestor
92191684|NCT00477451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191685|NCT00477451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191686|NCT00477451|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92191687|NCT00477451|Respiratory System Agents|respiratory system agents|mesh-ancestor
92191688|NCT00530803|Lidocaine|lidocaine|mesh-list
92191689|NCT00530803|Tetracaine|tetracaine|mesh-list
92191690|NCT00530803|Prilocaine|prilocaine|mesh-list
92191691|NCT00530803|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92191692|NCT00530803|Anesthetics, Local|anesthetics, local|mesh-ancestor
92191693|NCT00530803|Anesthetics|anesthetics|mesh-ancestor
92191694|NCT00530803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92191695|NCT00530803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191696|NCT00530803|Sensory System Agents|sensory system agents|mesh-ancestor
92191697|NCT00530803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191698|NCT00530803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92191699|NCT00530803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92191700|NCT00530803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92191701|NCT00530803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92191702|NCT00530803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191703|NCT00530803|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92191704|NCT04372927|Cisplatin|cisplatin|mesh-list
92191705|NCT04372927|Etoposide|etoposide|mesh-list
92191706|NCT04372927|Pemetrexed|pemetrexed|mesh-list
92191707|NCT04372927|Etoposide phosphate|etoposide phosphate|mesh-list
92191708|NCT04372927|Durvalumab|durvalumab|mesh-list
92191709|NCT04372927|Podophyllotoxin|podophyllotoxin|mesh-list
92191710|NCT04372927|Immunoglobulins|immunoglobulins|mesh-list
92191711|NCT04372927|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92191712|NCT04372927|Immunoglobulin G|immunoglobulin g|mesh-list
92191713|NCT04372927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191714|NCT04372927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92191715|NCT04372927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92191716|NCT04372927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92191717|NCT04372927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191718|NCT04372927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191719|NCT04372927|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92191720|NCT04372927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92191721|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191722|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
92191723|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334756|NCT00005593|Carboplatin|carboplatin|mesh-list
92191724|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
92191725|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
92191726|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
92191727|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
92191728|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
92191729|NCT01381874|Prednisone|prednisone|mesh-list
92191730|NCT01381874|Prednisolone|prednisolone|mesh-list
92191731|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92191732|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
92191733|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92191734|NCT01381874|Prednisolone acetate|prednisolone acetate|mesh-list
92191735|NCT01381874|Exemestane|exemestane|mesh-list
92191736|NCT01381874|Abiraterone Acetate|abiraterone acetate|mesh-list
92191737|NCT01381874|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92191738|NCT01381874|Prednisolone phosphate|prednisolone phosphate|mesh-list
92191739|NCT01381874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191740|NCT01381874|Glucocorticoids|glucocorticoids|mesh-ancestor
92191741|NCT01381874|Hormones|hormones|mesh-ancestor
92191742|NCT01381874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191743|NCT01381874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191744|NCT01381874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191745|NCT01381874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191746|NCT01381874|Antiemetics|antiemetics|mesh-ancestor
92191747|NCT01381874|Autonomic Agents|autonomic agents|mesh-ancestor
92191748|NCT01381874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191749|NCT01381874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92191750|NCT01381874|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92191751|NCT01381874|Protective Agents|protective agents|mesh-ancestor
92191752|NCT01381874|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92191753|NCT01381874|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92191754|NCT01381874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191755|NCT01381874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191756|NCT01381874|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92191757|NCT01381874|Hormone Antagonists|hormone antagonists|mesh-ancestor
92191758|NCT01381874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92191759|NCT01399190|Bevacizumab|bevacizumab|mesh-list
92191760|NCT01399190|Capecitabine|capecitabine|mesh-list
92191761|NCT01399190|Oxaliplatin|oxaliplatin|mesh-list
92191762|NCT01399190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191763|NCT01399190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191764|NCT01399190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191765|NCT01399190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191766|NCT01399190|Growth Substances|growth substances|mesh-ancestor
92191767|NCT01399190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191768|NCT01399190|Growth Inhibitors|growth inhibitors|mesh-ancestor
92191769|NCT01399190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191770|NCT01399190|Antimetabolites|antimetabolites|mesh-ancestor
92191771|NCT01399190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191772|NCT01381718|Modafinil|modafinil|mesh-list
92191773|NCT01381718|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92191774|NCT01381718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191775|NCT01381718|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92191776|NCT01381718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92191777|NCT01381718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92191778|NCT01381718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191779|NCT05365178|Fulvestrant|fulvestrant|mesh-list
92191780|NCT05365178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191781|NCT05365178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191782|NCT05365178|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92191783|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92191784|NCT05365178|Hormone Antagonists|hormone antagonists|mesh-ancestor
92191785|NCT05365178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191786|NCT05365178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191787|NCT00479089|Dexamethasone|dexamethasone|mesh-list
92191788|NCT00479089|Docetaxel|docetaxel|mesh-list
92191789|NCT00479089|Gefitinib|gefitinib|mesh-list
92191790|NCT00479089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92191791|NCT00479089|Antiemetics|antiemetics|mesh-ancestor
92191792|NCT00479089|Autonomic Agents|autonomic agents|mesh-ancestor
92191793|NCT00479089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191794|NCT00479089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191795|NCT00479089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92191796|NCT00479089|Glucocorticoids|glucocorticoids|mesh-ancestor
92191797|NCT00479089|Hormones|hormones|mesh-ancestor
92191798|NCT00479089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191799|NCT00479089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92191800|NCT00479089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191801|NCT00479089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92191802|NCT00479089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92191803|NCT00479089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92191804|NCT00479089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191805|NCT00479089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191806|NCT00479089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191807|NCT01398956|Levetiracetam|levetiracetam|mesh-list
92191808|NCT01398956|Anticonvulsants|anticonvulsants|mesh-ancestor
92191809|NCT01398956|Nootropic Agents|nootropic agents|mesh-ancestor
92191810|NCT00410423|Cytarabine|cytarabine|mesh-list
92191811|NCT00410423|Etoposide|etoposide|mesh-list
92191812|NCT00410423|Mitoxantrone|mitoxantrone|mesh-list
92191813|NCT00410423|Bortezomib|bortezomib|mesh-list
92191814|NCT00410423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92191815|NCT00410423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191816|NCT00410423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92191817|NCT00410423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92191818|NCT00410423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191819|NCT00410423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191820|NCT00410423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191822|NCT00410423|Antiviral Agents|antiviral agents|mesh-ancestor
92191823|NCT00410423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191824|NCT00410423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191825|NCT00410423|Immunologic Factors|immunologic factors|mesh-ancestor
92191826|NCT00410423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191827|NCT00410423|Analgesics|analgesics|mesh-ancestor
92191828|NCT00410423|Sensory System Agents|sensory system agents|mesh-ancestor
92191829|NCT00410423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191830|NCT00387959|Cyclosporine|cyclosporine|mesh-list
92191831|NCT00387959|Mycophenolic Acid|mycophenolic acid|mesh-list
92191832|NCT00387959|Cyclophosphamide|cyclophosphamide|mesh-list
92191833|NCT00387959|Rituximab|rituximab|mesh-list
92191834|NCT00387959|Fludarabine|fludarabine|mesh-list
92191835|NCT00387959|Fludarabine phosphate|fludarabine phosphate|mesh-list
92191836|NCT00387959|Cyclosporins|cyclosporins|mesh-list
92191837|NCT00387959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191838|NCT00387959|Immunologic Factors|immunologic factors|mesh-ancestor
92191839|NCT00387959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191840|NCT00387959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92191841|NCT00387959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92191842|NCT00387959|Alkylating Agents|alkylating agents|mesh-ancestor
92191843|NCT00387959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191844|NCT00387959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191845|NCT00387959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92191846|NCT00387959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191847|NCT00387959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92191848|NCT00387959|Antimetabolites|antimetabolites|mesh-ancestor
92191849|NCT00387959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191850|NCT00387959|Antifungal Agents|antifungal agents|mesh-ancestor
92191851|NCT00387959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191852|NCT00387959|Dermatologic Agents|dermatologic agents|mesh-ancestor
92191853|NCT00387959|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92191854|NCT00387959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92191855|NCT00387959|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92191856|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
92191857|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191858|NCT00410891|Gatifloxacin|gatifloxacin|mesh-list
92191859|NCT00410891|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191860|NCT00410891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191861|NCT00410891|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92191862|NCT00410891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92191863|NCT00410891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92191864|NCT00410891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334770|NCT00004495|Folic Acid|folic acid|mesh-list
92191865|NCT00410891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191866|NCT00410891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191867|NCT00410891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191869|NCT01381562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92191870|NCT01381562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191871|NCT01381016|Hormones|hormones|mesh-list
92191872|NCT01381016|Estradiol|estradiol|mesh-list
92191873|NCT01381016|Progesterone|progesterone|mesh-list
92191874|NCT01381016|Estrogens|estrogens|mesh-list
92191875|NCT01381016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92191876|NCT01381016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191877|NCT01381016|Progestins|progestins|mesh-ancestor
92191878|NCT00412451|Plasminogen|plasminogen|mesh-list
92191879|NCT00412451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92191880|NCT00412451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92191881|NCT00412451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191882|NCT01398410|Rabeprazole|rabeprazole|mesh-list
92191883|NCT01398410|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92191884|NCT01398410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92191885|NCT01398410|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92191886|NCT01398410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191887|NCT01398410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191888|NCT00412529|Entecavir|entecavir|mesh-list
92191889|NCT00412529|Telbivudine|telbivudine|mesh-list
92191890|NCT00412529|Antiviral Agents|antiviral agents|mesh-ancestor
92191891|NCT00412529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191892|NCT00412529|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92191893|NCT00412529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191894|NCT00412529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191896|NCT00412841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92191897|NCT00412841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92191898|NCT00412841|Antimetabolites|antimetabolites|mesh-ancestor
92191899|NCT00412841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191900|NCT00412841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92191901|NCT00412841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92191902|NCT00412841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191903|NCT01796483|Clonidine|clonidine|mesh-list
92191904|NCT01796483|Analgesics|analgesics|mesh-ancestor
92191905|NCT01796483|Sensory System Agents|sensory system agents|mesh-ancestor
92191906|NCT01796483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92191907|NCT01796483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191908|NCT01796483|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92191909|NCT01796483|Sympatholytics|sympatholytics|mesh-ancestor
92191910|NCT01796483|Autonomic Agents|autonomic agents|mesh-ancestor
92191911|NCT01796483|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92191912|NCT01796483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92191913|NCT01796483|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92191914|NCT01796483|Adrenergic Agents|adrenergic agents|mesh-ancestor
92191915|NCT01796483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191916|NCT01796483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191917|NCT00414167|Bupropion|bupropion|mesh-list
92191918|NCT00414167|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92191919|NCT00414167|Antidepressive Agents|antidepressive agents|mesh-ancestor
92191920|NCT00414167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191921|NCT00414167|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92191922|NCT00414167|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92191923|NCT00414167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92191924|NCT00414167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191926|NCT00414167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191927|NCT00414167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191928|NCT00414167|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92191929|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92191930|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191931|NCT01380782|Nintedanib|nintedanib|mesh-list
92191932|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191933|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92191934|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191935|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191936|NCT00534001|Bupropion|bupropion|mesh-list
92191937|NCT00534001|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92191938|NCT00534001|Antidepressive Agents|antidepressive agents|mesh-ancestor
92191939|NCT00534001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92191940|NCT00534001|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92191941|NCT00534001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92191942|NCT00534001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92191943|NCT00534001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191944|NCT00534001|Dopamine Agents|dopamine agents|mesh-ancestor
92191945|NCT00534001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92191946|NCT00534001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191947|NCT00534001|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92191948|NCT00534001|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92191949|NCT00534001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191950|NCT00481351|Simvastatin|simvastatin|mesh-list
92191951|NCT00481351|Ezetimibe|ezetimibe|mesh-list
92191952|NCT00481351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92191953|NCT00481351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92191954|NCT00481351|Antimetabolites|antimetabolites|mesh-ancestor
92191955|NCT00481351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191956|NCT00481351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92191957|NCT00481351|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92191958|NCT00481351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191959|NCT00455975|Bevacizumab|bevacizumab|mesh-list
92191960|NCT00455975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191961|NCT00455975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191962|NCT00455975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92191963|NCT00455975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92191964|NCT00455975|Growth Substances|growth substances|mesh-ancestor
92191965|NCT00455975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191967|NCT05366192|Ritonavir|ritonavir|mesh-list
92191968|NCT05366192|Nirmatrelvir|nirmatrelvir|mesh-list
92191969|NCT05366192|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92191970|NCT05366192|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92191971|NCT05366192|Protease Inhibitors|protease inhibitors|mesh-ancestor
92191972|NCT05366192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92191973|NCT05366192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191974|NCT05366192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92191975|NCT05366192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92191976|NCT05366192|Antiviral Agents|antiviral agents|mesh-ancestor
92191977|NCT05366192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92191978|NCT05366192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92191979|NCT05366192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92191980|NCT04013672|Pembrolizumab|pembrolizumab|mesh-list
92191981|NCT04013672|Sargramostim|sargramostim|mesh-list
92191982|NCT04013672|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92191983|NCT04013672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191984|NCT04013672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191985|NCT04013672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92191986|NCT04013672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191987|NCT04013672|Immunologic Factors|immunologic factors|mesh-ancestor
92191988|NCT04013672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191989|NCT04013672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92191990|NCT02078882|Abatacept|abatacept|mesh-list
92191991|NCT02078882|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92191992|NCT02078882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92191993|NCT02078882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92191994|NCT02078882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92191995|NCT02078882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92191996|NCT02078882|Immunologic Factors|immunologic factors|mesh-ancestor
92334783|NCT00005089|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92191997|NCT02078882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92191998|NCT02078882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192000|NCT00458237|Everolimus|everolimus|mesh-list
92192001|NCT00458237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92192002|NCT00458237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192003|NCT00458237|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92192004|NCT00458237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92192005|NCT00458237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192006|NCT00458237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192007|NCT00458237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92192008|NCT00458237|Immunologic Factors|immunologic factors|mesh-ancestor
92192009|NCT00458237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192010|NCT00418457|Anesthetics|anesthetics|mesh-list
92192011|NCT00418457|Propofol|propofol|mesh-list
92192012|NCT00418457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192013|NCT00418457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192014|NCT00418457|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92192015|NCT00418457|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92192016|NCT00418457|Anesthetics, General|anesthetics, general|mesh-ancestor
92192017|NCT00482677|Temozolomide|temozolomide|mesh-list
92192018|NCT00482677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92192019|NCT00482677|Alkylating Agents|alkylating agents|mesh-ancestor
92192020|NCT00482677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192021|NCT00482677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192022|NCT01397552|Dexamethasone|dexamethasone|mesh-list
92192023|NCT01397552|Methylprednisolone|methylprednisolone|mesh-list
92192024|NCT01397552|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92192025|NCT01397552|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92192026|NCT01397552|Prednisolone|prednisolone|mesh-list
92192027|NCT01397552|Prednisolone acetate|prednisolone acetate|mesh-list
92192028|NCT01397552|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92192029|NCT01397552|Prednisolone phosphate|prednisolone phosphate|mesh-list
92192030|NCT01397552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192031|NCT01397552|Antiemetics|antiemetics|mesh-ancestor
92192032|NCT01397552|Autonomic Agents|autonomic agents|mesh-ancestor
92192033|NCT01397552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192034|NCT01397552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192035|NCT01397552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192036|NCT01397552|Glucocorticoids|glucocorticoids|mesh-ancestor
92192037|NCT01397552|Hormones|hormones|mesh-ancestor
92192038|NCT01397552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192039|NCT01397552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92192040|NCT01397552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192041|NCT01397552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92192042|NCT01397552|Protective Agents|protective agents|mesh-ancestor
92192043|NCT05368376|Metoprolol|metoprolol|mesh-list
92192044|NCT05368376|Labetalol|labetalol|mesh-list
92192045|NCT05368376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92192046|NCT05368376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92192047|NCT05368376|Sympatholytics|sympatholytics|mesh-ancestor
92192048|NCT05368376|Autonomic Agents|autonomic agents|mesh-ancestor
92192049|NCT05368376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192050|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192051|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92192052|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92192053|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92192054|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192055|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192056|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192057|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
92192058|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92192059|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92192060|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
92192061|NCT00482911|Lenalidomide|lenalidomide|mesh-list
92192062|NCT00482911|Sunitinib|sunitinib|mesh-list
92192063|NCT00482911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92192064|NCT00482911|Immunologic Factors|immunologic factors|mesh-ancestor
92192065|NCT00482911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192066|NCT00482911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192067|NCT00482911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92192068|NCT00482911|Alkylating Agents|alkylating agents|mesh-ancestor
92192069|NCT00482911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192070|NCT00482911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192071|NCT00482911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92192072|NCT00482911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192073|NCT00482911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192074|NCT00482911|Growth Substances|growth substances|mesh-ancestor
92192075|NCT00482911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192076|NCT00482911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92192077|NCT00482911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192078|NCT01397162|Fluticasone|fluticasone|mesh-list
92192079|NCT01397162|Xhance|xhance|mesh-list
92192080|NCT01397162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192081|NCT01397162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92192082|NCT01397162|Autonomic Agents|autonomic agents|mesh-ancestor
92192083|NCT01397162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192084|NCT01397162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192085|NCT01397162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92192086|NCT01397162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92192087|NCT01397162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92192088|NCT01397162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92192089|NCT05362916|Letermovir|letermovir|mesh-list
92192090|NCT05362916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92192091|NCT05362916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192092|NCT05362916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192093|NCT05362916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192094|NCT05362916|Antiviral Agents|antiviral agents|mesh-ancestor
92192095|NCT05362916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192096|NCT00483223|Carboplatin|carboplatin|mesh-list
92192097|NCT00483223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192098|NCT01397084|Esomeprazole|esomeprazole|mesh-list
92192099|NCT01397084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92192100|NCT01397084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192101|NCT01397084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92192102|NCT01397084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192103|NCT01397084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192104|NCT00420017|Amiodarone|amiodarone|mesh-list
92192105|NCT00420017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92192106|NCT00420017|Vasodilator Agents|vasodilator agents|mesh-ancestor
92192107|NCT00420017|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92192108|NCT00420017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939902|NCT04959266|Rifampin|rifampin|mesh-list
92192109|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192110|NCT00420017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92192111|NCT00420017|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92192112|NCT00420017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92192113|NCT00420017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192114|NCT00420017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92192115|NCT00420017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92192116|NCT00420017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92192118|NCT00484393|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192119|NCT00484393|Anesthetics|anesthetics|mesh-ancestor
92192120|NCT00484393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192121|NCT00484393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192122|NCT00484393|Sensory System Agents|sensory system agents|mesh-ancestor
92192123|NCT00484393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192124|NCT00485485|Docetaxel|docetaxel|mesh-list
92192125|NCT00485485|Imatinib Mesylate|imatinib mesylate|mesh-list
92192126|NCT00485485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192127|NCT00485485|Tubulin Modulators|tubulin modulators|mesh-ancestor
92192128|NCT00485485|Antimitotic Agents|antimitotic agents|mesh-ancestor
92192129|NCT00485485|Mitosis Modulators|mitosis modulators|mesh-ancestor
92192130|NCT00485485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192131|NCT00485485|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92192132|NCT00485485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192133|NCT00422201|Mifepristone|mifepristone|mesh-list
92192134|NCT00422201|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92192135|NCT00422201|Abortifacient Agents|abortifacient agents|mesh-ancestor
92192136|NCT00422201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92192137|NCT00422201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192138|NCT00422201|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92192139|NCT00422201|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92192140|NCT00422201|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92192141|NCT00422201|Contraceptive Agents|contraceptive agents|mesh-ancestor
92192142|NCT00422201|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92192143|NCT00422201|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92192144|NCT00422201|Hormone Antagonists|hormone antagonists|mesh-ancestor
92192145|NCT00422201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192146|NCT00422201|Luteolytic Agents|luteolytic agents|mesh-ancestor
92192147|NCT00422201|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92192148|NCT00422201|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92192150|NCT01396148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192151|NCT01396148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192152|NCT01396148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192153|NCT01396148|Growth Substances|growth substances|mesh-ancestor
92192154|NCT01396148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192155|NCT01396148|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192156|NCT01396148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92192157|NCT01396148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192158|NCT01396148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192159|NCT00485953|Risedronic Acid|risedronic acid|mesh-list
92192160|NCT00485953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92192161|NCT00485953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192162|NCT00485953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192163|NCT00485953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92192164|NCT00485953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192165|NCT00485953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92192166|NCT00486031|Balsalazide|balsalazide|mesh-list
92192167|NCT00486031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92334828|NCT00005113|Cyclosporine|cyclosporine|mesh-list
92192168|NCT00486031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92192169|NCT00486031|Analgesics|analgesics|mesh-ancestor
92192170|NCT00486031|Sensory System Agents|sensory system agents|mesh-ancestor
92192171|NCT00486031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192172|NCT00486031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192173|NCT00486031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192174|NCT00486031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192175|NCT00486031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192176|NCT04019834|Bupivacaine|bupivacaine|mesh-list
92192177|NCT04019834|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192178|NCT04019834|Anesthetics|anesthetics|mesh-ancestor
92192179|NCT04019834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192180|NCT04019834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192181|NCT04019834|Sensory System Agents|sensory system agents|mesh-ancestor
92192182|NCT04019834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192183|NCT04017962|Letermovir|letermovir|mesh-list
92192184|NCT04017962|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92192185|NCT04017962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192186|NCT04017962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192187|NCT04017962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192188|NCT04017962|Antiviral Agents|antiviral agents|mesh-ancestor
92192189|NCT04017962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192190|NCT01396070|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92192191|NCT01396070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92192192|NCT01396070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192193|NCT01396070|Immunotoxins|immunotoxins|mesh-ancestor
92192194|NCT01396070|Immunoconjugates|immunoconjugates|mesh-ancestor
92192195|NCT01396070|Immunologic Factors|immunologic factors|mesh-ancestor
92192196|NCT01396070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192197|NCT02108171|Dexmedetomidine|dexmedetomidine|mesh-list
92192198|NCT02108171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92192199|NCT02108171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192200|NCT02108171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192201|NCT02108171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92192202|NCT02108171|Analgesics|analgesics|mesh-ancestor
92192203|NCT02108171|Sensory System Agents|sensory system agents|mesh-ancestor
92192204|NCT02108171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192205|NCT02108171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92192206|NCT02108171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92192208|NCT02108171|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192209|NCT02108171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192210|NCT02108171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192211|NCT03940807|Estradiol|estradiol|mesh-list
92192212|NCT03940807|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92192213|NCT03940807|Estrogens|estrogens|mesh-ancestor
92192214|NCT03940807|Hormones|hormones|mesh-ancestor
92192215|NCT03940807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192216|NCT03940807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192217|NCT00535873|Lenalidomide|lenalidomide|mesh-list
92192218|NCT00535873|Immunologic Factors|immunologic factors|mesh-ancestor
92192219|NCT00535873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192220|NCT00535873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192221|NCT00535873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192222|NCT00535873|Growth Substances|growth substances|mesh-ancestor
92192223|NCT00535873|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192224|NCT00535873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192225|NCT00487669|Paclitaxel|paclitaxel|mesh-list
92192226|NCT00487669|Pemetrexed|pemetrexed|mesh-list
92192227|NCT00487669|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92192228|NCT00487669|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92192229|NCT00487669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192230|NCT00487669|Tubulin Modulators|tubulin modulators|mesh-ancestor
92192231|NCT00487669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92192232|NCT00487669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92192233|NCT00487669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192234|NCT00487669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192235|NCT00487669|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92192236|NCT00487669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92192237|NCT00488059|Enfuvirtide|enfuvirtide|mesh-list
92192238|NCT00488059|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-list
92192239|NCT00488059|Integrase Inhibitors|integrase inhibitors|mesh-list
92192240|NCT00488059|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92192241|NCT00488059|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92192242|NCT00488059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192243|NCT00488059|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92192244|NCT00488059|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92192245|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
92192246|NCT00488059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192247|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192248|NCT02120287|Bevacizumab|bevacizumab|mesh-list
92192249|NCT02120287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92192250|NCT02120287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192251|NCT02120287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192252|NCT02120287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192253|NCT02120287|Growth Substances|growth substances|mesh-ancestor
92192254|NCT02120287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192255|NCT02120287|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192256|NCT00536341|Rituximab|rituximab|mesh-list
92192257|NCT00536341|Fludarabine|fludarabine|mesh-list
92192258|NCT00536341|Lenalidomide|lenalidomide|mesh-list
92192259|NCT00536341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92192260|NCT00536341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192261|NCT00536341|Immunologic Factors|immunologic factors|mesh-ancestor
92192262|NCT00536341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192263|NCT00536341|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192264|NCT00536341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192265|NCT00536341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192267|NCT00536341|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192268|NCT02122471|Plecanatide|plecanatide|mesh-list
92192269|NCT02122471|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92192270|NCT02122471|Enzyme Activators|enzyme activators|mesh-ancestor
92192271|NCT02122471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192272|NCT02122471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192273|NCT00461591|Apaziquone|apaziquone|mesh-list
92192274|NCT00461591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192275|NCT00533117|Fluoxetine|fluoxetine|mesh-list
92192276|NCT00533117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92192277|NCT00533117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92192278|NCT00533117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192279|NCT00533117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192280|NCT00533117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192281|NCT00533117|Serotonin Agents|serotonin agents|mesh-ancestor
92192282|NCT00533117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192283|NCT00533117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92192284|NCT00533117|Antidepressive Agents|antidepressive agents|mesh-ancestor
92192285|NCT00533117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92192286|NCT00533117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92192287|NCT00533117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92192288|NCT00533117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192289|NCT00423683|PENTA|penta|mesh-list
92192290|NCT00423683|Fondaparinux|fondaparinux|mesh-list
92192291|NCT00423683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92192292|NCT00423683|Antithrombins|antithrombins|mesh-ancestor
92192293|NCT00423683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92192294|NCT00423683|Protease Inhibitors|protease inhibitors|mesh-ancestor
92192295|NCT00423683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192296|NCT00423683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192297|NCT00423683|Anticoagulants|anticoagulants|mesh-ancestor
92192298|NCT00423683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92192299|NCT00423683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92192300|NCT00424619|Vitamin D|vitamin d|mesh-list
92192301|NCT00424619|Ergocalciferols|ergocalciferols|mesh-list
92192302|NCT00424619|Cholecalciferol|cholecalciferol|mesh-list
92192303|NCT00424619|Vitamins|vitamins|mesh-list
92192304|NCT00424619|Micronutrients|micronutrients|mesh-ancestor
92192305|NCT00424619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192306|NCT00424619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92192307|NCT00424619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92192308|NCT00425477|Bexarotene|bexarotene|mesh-list
92192309|NCT00425477|Sargramostim|sargramostim|mesh-list
92192310|NCT00425477|Immunologic Factors|immunologic factors|mesh-ancestor
92192311|NCT00425477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192312|NCT00425477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192313|NCT00427037|Vitamin D|vitamin d|mesh-list
92192314|NCT00427037|Cholecalciferol|cholecalciferol|mesh-list
92192315|NCT00427037|Vitamins|vitamins|mesh-ancestor
92192316|NCT00427037|Micronutrients|micronutrients|mesh-ancestor
92192317|NCT00427037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192318|NCT00427037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92192319|NCT00427037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92192320|NCT02113241|Dapagliflozin|dapagliflozin|mesh-list
92192321|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92192322|NCT02113241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192323|NCT02113241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92192324|NCT02113241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192325|NCT00427661|Cyclosporine|cyclosporine|mesh-list
92192326|NCT00427661|Fludarabine|fludarabine|mesh-list
92192327|NCT00427661|Busulfan|busulfan|mesh-list
92192328|NCT00427661|Cyclosporins|cyclosporins|mesh-list
92192329|NCT00427661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192330|NCT00427661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192331|NCT00427661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92192332|NCT00427661|Immunologic Factors|immunologic factors|mesh-ancestor
92192333|NCT00427661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192334|NCT00427661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192335|NCT00427661|Antifungal Agents|antifungal agents|mesh-ancestor
92192336|NCT00427661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192337|NCT00427661|Dermatologic Agents|dermatologic agents|mesh-ancestor
92192338|NCT00427661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192339|NCT00427661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92192340|NCT00427661|Alkylating Agents|alkylating agents|mesh-ancestor
92192341|NCT00427661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92192342|NCT00427661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92192344|NCT00427973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192345|NCT00427973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192346|NCT00427973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192347|NCT00427973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92192348|NCT01795703|Prednisolone|prednisolone|mesh-list
92192349|NCT01795703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192350|NCT01795703|Glucocorticoids|glucocorticoids|mesh-ancestor
92192351|NCT01795703|Hormones|hormones|mesh-ancestor
92192352|NCT01795703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192353|NCT01795703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192354|NCT01795703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92192355|NCT01795703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192356|NCT00429143|Mycophenolic Acid|mycophenolic acid|mesh-list
92192357|NCT00429143|Cyclophosphamide|cyclophosphamide|mesh-list
92192358|NCT00429143|Tacrolimus|tacrolimus|mesh-list
92192359|NCT00429143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92192360|NCT00429143|Immunologic Factors|immunologic factors|mesh-ancestor
92192361|NCT00429143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192362|NCT00429143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192363|NCT00429143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92192364|NCT00429143|Alkylating Agents|alkylating agents|mesh-ancestor
92192365|NCT00429143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192367|NCT00429143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92192368|NCT00429143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92192369|NCT00429143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192370|NCT00429143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92192371|NCT00429143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92192372|NCT00429143|Antitubercular Agents|antitubercular agents|mesh-ancestor
92192373|NCT00429143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192374|NCT00429143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192375|NCT00432341|Botulinum Toxins|botulinum toxins|mesh-list
92192376|NCT00432341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92192377|NCT00432341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92192378|NCT00432341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92192379|NCT00432341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192380|NCT00432341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192381|NCT00432341|Cholinergic Agents|cholinergic agents|mesh-ancestor
92192382|NCT00432341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192383|NCT00432341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192384|NCT00432341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92192385|NCT00432341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192386|NCT00433745|Vaccines|vaccines|mesh-list
92192387|NCT00433745|Immunologic Factors|immunologic factors|mesh-ancestor
92192388|NCT00433745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192389|NCT01395758|Gemcitabine|gemcitabine|mesh-list
92192390|NCT01395758|Docetaxel|docetaxel|mesh-list
92192391|NCT01395758|Pemetrexed|pemetrexed|mesh-list
92192392|NCT01395758|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92192393|NCT01395758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92192394|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
92192395|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192396|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192397|NCT01395758|Tubulin Modulators|tubulin modulators|mesh-ancestor
92192398|NCT01395758|Antimitotic Agents|antimitotic agents|mesh-ancestor
92192399|NCT01395758|Mitosis Modulators|mitosis modulators|mesh-ancestor
92192400|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192401|NCT01395758|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92192402|NCT01395758|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92192403|NCT01395758|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92192404|NCT00462605|Entinostat|entinostat|mesh-list
92192405|NCT00462605|Sargramostim|sargramostim|mesh-list
92192406|NCT00462605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92192407|NCT00462605|Immunologic Factors|immunologic factors|mesh-ancestor
92192408|NCT00462605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192409|NCT00462605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192410|NCT00462605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192411|NCT00462605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192412|NCT00534833|Vaccines|vaccines|mesh-list
92192413|NCT00534833|Immunologic Factors|immunologic factors|mesh-ancestor
92192414|NCT00534833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192415|NCT00434993|Albuterol|albuterol|mesh-list
92192416|NCT00434993|Dimercaprol|dimercaprol|mesh-list
92192417|NCT00434993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92192418|NCT00434993|Autonomic Agents|autonomic agents|mesh-ancestor
92192419|NCT00434993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192420|NCT00434993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192421|NCT00434993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92192422|NCT00434993|Respiratory System Agents|respiratory system agents|mesh-ancestor
92192423|NCT00434993|Tocolytic Agents|tocolytic agents|mesh-ancestor
92192424|NCT00434993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92192425|NCT00434993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92192426|NCT00434993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92192427|NCT00434993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92192428|NCT00434993|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192429|NCT00434993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192430|NCT00434993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192431|NCT00434993|Chelating Agents|chelating agents|mesh-ancestor
92192432|NCT00434993|Sequestering Agents|sequestering agents|mesh-ancestor
92192433|NCT01395524|Naloxegol|naloxegol|mesh-list
92192434|NCT01395524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92192435|NCT01395524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192436|NCT01395524|Sensory System Agents|sensory system agents|mesh-ancestor
92192437|NCT01395524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192438|NCT04338698|Azithromycin|azithromycin|mesh-list
92192439|NCT04338698|Hydroxychloroquine|hydroxychloroquine|mesh-list
92192440|NCT04338698|Oseltamivir|oseltamivir|mesh-list
92192441|NCT04338698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192442|NCT04338698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192443|NCT04338698|Antimalarials|antimalarials|mesh-ancestor
92192444|NCT04338698|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92192445|NCT04338698|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92192446|NCT04338698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192447|NCT04338698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192448|NCT04338698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192449|NCT04338698|Antiviral Agents|antiviral agents|mesh-ancestor
92192450|NCT00435539|Plasminogen|plasminogen|mesh-list
92192451|NCT00435539|Fibrinolysin|fibrinolysin|mesh-list
92192452|NCT00435539|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92192453|NCT00435539|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92192454|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192455|NCT00464711|Escitalopram|escitalopram|mesh-list
92192456|NCT00464711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92192457|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92192458|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192459|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192460|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192461|NCT00464711|Serotonin Agents|serotonin agents|mesh-ancestor
92192462|NCT00464711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192463|NCT02078180|Bupropion|bupropion|mesh-list
92192464|NCT02078180|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92192465|NCT02078180|Antidepressive Agents|antidepressive agents|mesh-ancestor
92192466|NCT02078180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92192467|NCT02078180|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92192468|NCT02078180|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92192469|NCT02078180|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192470|NCT02078180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192471|NCT02078180|Dopamine Agents|dopamine agents|mesh-ancestor
92192472|NCT02078180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192473|NCT02078180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192474|NCT02078180|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92192475|NCT02078180|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92192476|NCT02078180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192477|NCT00535613|Propofol|propofol|mesh-list
92192478|NCT00535613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92192479|NCT00535613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192480|NCT00535613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192481|NCT00535613|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92192482|NCT00535613|Anesthetics, General|anesthetics, general|mesh-ancestor
92192484|NCT00466661|Acamprosate|acamprosate|mesh-list
92192485|NCT00466661|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92192486|NCT05360576|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92192487|NCT05360576|Etonogestrel|etonogestrel|mesh-list
92192488|NCT05360576|NuvaRing|nuvaring|mesh-list
92192489|NCT05360576|Estradiol|estradiol|mesh-list
92192490|NCT05360576|Estrogens|estrogens|mesh-ancestor
92192491|NCT05360576|Hormones|hormones|mesh-ancestor
92334886|NCT00005635|Paclitaxel|paclitaxel|mesh-list
92192492|NCT05360576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192493|NCT05360576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192494|NCT05360576|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92192495|NCT05360576|Contraceptive Agents|contraceptive agents|mesh-ancestor
92192496|NCT05360576|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92192497|NCT05360576|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92192498|NCT05360576|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92192499|NCT05360576|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92192500|NCT00535925|Aspirin|aspirin|mesh-list
92192501|NCT00535925|Atenolol|atenolol|mesh-list
92192502|NCT00535925|Amlodipine|amlodipine|mesh-list
92192503|NCT00535925|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92192504|NCT00535925|Clonidine|clonidine|mesh-list
92192505|NCT00535925|Ramipril|ramipril|mesh-list
92192506|NCT00535925|Irbesartan|irbesartan|mesh-list
92192507|NCT00535925|Doxazosin|doxazosin|mesh-list
92192508|NCT00535925|Furosemide|furosemide|mesh-list
92192509|NCT00535925|Epoetin Alfa|epoetin alfa|mesh-list
92192510|NCT00535925|Simvastatin|simvastatin|mesh-list
92192511|NCT00535925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192512|NCT00535925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92192513|NCT00535925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92192514|NCT00535925|Analgesics|analgesics|mesh-ancestor
92192515|NCT00535925|Sensory System Agents|sensory system agents|mesh-ancestor
92192516|NCT00535925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192518|NCT00535925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192519|NCT00535925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92192520|NCT00535925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92192521|NCT00535925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192522|NCT00535925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92192523|NCT00535925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92192524|NCT00535925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192525|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
92192526|NCT00535925|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92192527|NCT00535925|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92192528|NCT00535925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192529|NCT00535925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92192530|NCT00535925|Vasodilator Agents|vasodilator agents|mesh-ancestor
92192531|NCT00535925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92192532|NCT00535925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92192533|NCT00535925|Antimetabolites|antimetabolites|mesh-ancestor
92192534|NCT00535925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92192535|NCT00535925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92192536|NCT00535925|Diuretics|diuretics|mesh-ancestor
92192537|NCT00535925|Natriuretic Agents|natriuretic agents|mesh-ancestor
92192538|NCT00535925|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92192539|NCT00535925|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92192540|NCT00535925|Sympatholytics|sympatholytics|mesh-ancestor
92192541|NCT00535925|Autonomic Agents|autonomic agents|mesh-ancestor
92192542|NCT00535925|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92192543|NCT00535925|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92192544|NCT00535925|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92192545|NCT00535925|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192546|NCT00535925|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192547|NCT00535925|Hematinics|hematinics|mesh-ancestor
92192548|NCT00535925|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92192549|NCT00535925|Protease Inhibitors|protease inhibitors|mesh-ancestor
92192550|NCT00535925|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92192551|NCT00535925|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92192552|NCT00535925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92192553|NCT00535925|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92192554|NCT00535925|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92192555|NCT00535925|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92192556|NCT00535925|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92192557|NCT00535925|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92192558|NCT00211172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92192560|NCT00211172|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192561|NCT00211172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192562|NCT00211172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192563|NCT00211172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192565|NCT01796093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92192566|NCT01796093|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92192567|NCT01796093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192568|NCT01796093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192569|NCT01796093|Protective Agents|protective agents|mesh-ancestor
92192570|NCT01796093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192571|NCT00537511|Etoposide|etoposide|mesh-list
92192572|NCT00537511|Etoposide phosphate|etoposide phosphate|mesh-list
92192573|NCT00537511|Pomalidomide|pomalidomide|mesh-list
92192574|NCT00537511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192575|NCT00537511|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92192576|NCT00537511|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92192577|NCT00537511|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92192578|NCT00537511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192579|NCT00537511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192580|NCT00537511|Immunologic Factors|immunologic factors|mesh-ancestor
92192581|NCT00537511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192582|NCT00537511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192583|NCT00537511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192584|NCT00537511|Growth Substances|growth substances|mesh-ancestor
92192585|NCT00537511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192586|NCT00435929|Ritonavir|ritonavir|mesh-list
92192587|NCT00435929|Saquinavir|saquinavir|mesh-list
92192588|NCT00435929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92192589|NCT00435929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92192590|NCT00435929|Protease Inhibitors|protease inhibitors|mesh-ancestor
92192591|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192592|NCT00435929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192593|NCT00435929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92192594|NCT00435929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92192595|NCT00435929|Antiviral Agents|antiviral agents|mesh-ancestor
92192596|NCT00435929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192597|NCT00435929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92192598|NCT00435929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92192599|NCT00436475|Calcium, Dietary|calcium, dietary|mesh-list
92192600|NCT00436475|Vitamin D|vitamin d|mesh-list
92192601|NCT00436475|Ergocalciferols|ergocalciferols|mesh-list
92192602|NCT00436475|Cholecalciferol|cholecalciferol|mesh-list
92192603|NCT00436475|Vitamins|vitamins|mesh-list
92192604|NCT00436475|Calcium Carbonate|calcium carbonate|mesh-list
92192605|NCT00436475|Calcium|calcium|mesh-list
92192606|NCT00436475|Micronutrients|micronutrients|mesh-ancestor
92192607|NCT00436475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192608|NCT00436475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92192609|NCT00436475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92192610|NCT00436475|Antacids|antacids|mesh-ancestor
92192611|NCT00436475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192612|NCT00436475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192613|NCT00210626|Epoetin Alfa|epoetin alfa|mesh-list
92192614|NCT00210626|Hematinics|hematinics|mesh-ancestor
92192615|NCT03595514|Dexamethasone|dexamethasone|mesh-list
92192616|NCT03595514|Lidocaine|lidocaine|mesh-list
92192617|NCT03595514|Epinephrine|epinephrine|mesh-list
92192618|NCT03595514|Bupivacaine|bupivacaine|mesh-list
92192619|NCT03595514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192620|NCT03595514|Antiemetics|antiemetics|mesh-ancestor
92192621|NCT03595514|Autonomic Agents|autonomic agents|mesh-ancestor
92192622|NCT03595514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192623|NCT03595514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192624|NCT03595514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192625|NCT03595514|Glucocorticoids|glucocorticoids|mesh-ancestor
92192626|NCT03595514|Hormones|hormones|mesh-ancestor
92192627|NCT03595514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192628|NCT03595514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92192629|NCT03595514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192630|NCT03595514|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192631|NCT03595514|Anesthetics|anesthetics|mesh-ancestor
92192632|NCT03595514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192633|NCT03595514|Sensory System Agents|sensory system agents|mesh-ancestor
92192634|NCT03595514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92192635|NCT03595514|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92192636|NCT03595514|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92192637|NCT03595514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117125|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192638|NCT03595514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192639|NCT03595514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92192640|NCT03595514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92192641|NCT03595514|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192642|NCT03595514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192643|NCT03595514|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92192644|NCT03595514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92192645|NCT03595514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92192646|NCT03595514|Respiratory System Agents|respiratory system agents|mesh-ancestor
92192648|NCT03595514|Sympathomimetics|sympathomimetics|mesh-ancestor
92192649|NCT03595514|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92192650|NCT00215852|Interferon-alpha|interferon-alpha|mesh-list
92192651|NCT00215852|Antiviral Agents|antiviral agents|mesh-ancestor
92192652|NCT00215852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192653|NCT00215852|Immunologic Factors|immunologic factors|mesh-ancestor
92192654|NCT00215852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192655|NCT03595046|Dexamethasone|dexamethasone|mesh-list
92192656|NCT03595046|Dexamethasone acetate|dexamethasone acetate|mesh-list
92192657|NCT03595046|Ropivacaine|ropivacaine|mesh-list
92192658|NCT03595046|BB 1101|bb 1101|mesh-list
92192659|NCT03595046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192660|NCT03595046|Antiemetics|antiemetics|mesh-ancestor
92192661|NCT03595046|Autonomic Agents|autonomic agents|mesh-ancestor
92192662|NCT03595046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192663|NCT03595046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192664|NCT03595046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192665|NCT03595046|Glucocorticoids|glucocorticoids|mesh-ancestor
92192666|NCT03595046|Hormones|hormones|mesh-ancestor
92192667|NCT03595046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192668|NCT03595046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92192670|NCT03595046|Protease Inhibitors|protease inhibitors|mesh-ancestor
92192671|NCT03595046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192672|NCT03595046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192673|NCT03595046|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192674|NCT03595046|Anesthetics|anesthetics|mesh-ancestor
92192675|NCT03595046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192676|NCT03595046|Sensory System Agents|sensory system agents|mesh-ancestor
92192677|NCT00217022|Budesonide|budesonide|mesh-list
92192678|NCT00217022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192679|NCT00217022|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92192680|NCT00217022|Autonomic Agents|autonomic agents|mesh-ancestor
92192681|NCT00217022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192682|NCT00217022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192683|NCT00217022|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92192684|NCT00217022|Respiratory System Agents|respiratory system agents|mesh-ancestor
92192685|NCT00217022|Glucocorticoids|glucocorticoids|mesh-ancestor
92192686|NCT00217022|Hormones|hormones|mesh-ancestor
92192687|NCT00217022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192688|NCT03594968|Progesterone|progesterone|mesh-list
92192689|NCT03594968|Progestins|progestins|mesh-ancestor
92192690|NCT03594968|Hormones|hormones|mesh-ancestor
92192691|NCT03594968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192692|NCT03594968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192693|NCT00538915|Immunoglobulins|immunoglobulins|mesh-list
92192694|NCT00538915|Antibodies|antibodies|mesh-list
92192695|NCT00538915|gamma-Globulins|gamma-globulins|mesh-list
92192696|NCT00538915|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92192697|NCT00538915|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92192698|NCT00538915|Immunologic Factors|immunologic factors|mesh-ancestor
92192699|NCT00538915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192700|NCT00490009|Acetaminophen|acetaminophen|mesh-list
92192702|NCT00490009|Diphenhydramine|diphenhydramine|mesh-list
92192703|NCT00490009|Promethazine|promethazine|mesh-list
92192704|NCT00490009|Cadexomer iodine|cadexomer iodine|mesh-list
92192705|NCT00490009|Tositumomab I-131|tositumomab i-131|mesh-list
92192706|NCT00490009|Lugol's solution|lugol's solution|mesh-list
92192707|NCT00490009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92192708|NCT00490009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92192709|NCT00490009|Analgesics|analgesics|mesh-ancestor
92192710|NCT00490009|Sensory System Agents|sensory system agents|mesh-ancestor
92192711|NCT00490009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192712|NCT00490009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192714|NCT00490009|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92192715|NCT00490009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192716|NCT00490009|Trace Elements|trace elements|mesh-ancestor
92192717|NCT00490009|Micronutrients|micronutrients|mesh-ancestor
92192718|NCT00490009|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92192719|NCT00490009|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92192720|NCT00490009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192721|NCT00490009|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192722|NCT00490009|Anesthetics|anesthetics|mesh-ancestor
92192723|NCT00490009|Antiemetics|antiemetics|mesh-ancestor
92192724|NCT00490009|Autonomic Agents|autonomic agents|mesh-ancestor
92192725|NCT00490009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192726|NCT00490009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92192727|NCT00490009|Histamine Antagonists|histamine antagonists|mesh-ancestor
92192728|NCT00490009|Histamine Agents|histamine agents|mesh-ancestor
92192729|NCT00490009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192730|NCT00490009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192731|NCT00490009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92192732|NCT00490009|Antipruritics|antipruritics|mesh-ancestor
92192733|NCT00490009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92192734|NCT00490009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192735|NCT00490009|Hemostatics|hemostatics|mesh-ancestor
92192736|NCT00490009|Coagulants|coagulants|mesh-ancestor
92192737|NCT03769532|Pembrolizumab|pembrolizumab|mesh-list
92192738|NCT03769532|Azacitidine|azacitidine|mesh-list
92192739|NCT03769532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92192740|NCT03769532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192741|NCT03769532|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92192742|NCT03769532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192743|NCT03769532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92192744|NCT03769532|Antimetabolites|antimetabolites|mesh-ancestor
92192745|NCT03769532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192747|NCT00490477|Polymyxin B|polymyxin b|mesh-list
92192748|NCT00490477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192749|NCT00490477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192750|NCT03997370|Carboplatin|carboplatin|mesh-list
92192751|NCT03997370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192752|NCT00492973|Cefuroxime|cefuroxime|mesh-list
92192753|NCT00492973|Methylprednisolone|methylprednisolone|mesh-list
92192754|NCT00492973|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92192755|NCT00492973|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92192756|NCT00492973|Prednisolone|prednisolone|mesh-list
92192757|NCT00492973|Prednisolone acetate|prednisolone acetate|mesh-list
92192758|NCT00492973|Clonidine|clonidine|mesh-list
92192759|NCT00492973|Epinephrine|epinephrine|mesh-list
92192760|NCT00492973|Morphine|morphine|mesh-list
92192761|NCT00492973|Bupivacaine|bupivacaine|mesh-list
92192762|NCT00492973|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92192763|NCT00492973|Prednisolone phosphate|prednisolone phosphate|mesh-list
92192764|NCT00492973|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192765|NCT00492973|Anesthetics|anesthetics|mesh-ancestor
92192766|NCT00492973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192767|NCT00492973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192768|NCT00492973|Sensory System Agents|sensory system agents|mesh-ancestor
92192769|NCT00492973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192770|NCT00492973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92192771|NCT00492973|Narcotics|narcotics|mesh-ancestor
92192772|NCT00492973|Analgesics|analgesics|mesh-ancestor
92192773|NCT00492973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192774|NCT00492973|Antiemetics|antiemetics|mesh-ancestor
92192775|NCT00492973|Autonomic Agents|autonomic agents|mesh-ancestor
92192776|NCT00492973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192777|NCT00492973|Glucocorticoids|glucocorticoids|mesh-ancestor
92192778|NCT00492973|Hormones|hormones|mesh-ancestor
92334914|NCT00005641|Abortifacient Agents|abortifacient agents|mesh-ancestor
92192779|NCT00492973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92192780|NCT00492973|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92192781|NCT00492973|Protective Agents|protective agents|mesh-ancestor
92192782|NCT00492973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92192783|NCT00492973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192784|NCT00492973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92192785|NCT00492973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92192786|NCT00492973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92192787|NCT00492973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192788|NCT00492973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192789|NCT00492973|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92192790|NCT00492973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92192791|NCT00492973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92192792|NCT00492973|Respiratory System Agents|respiratory system agents|mesh-ancestor
92192793|NCT00492973|Mydriatics|mydriatics|mesh-ancestor
92192794|NCT00492973|Sympathomimetics|sympathomimetics|mesh-ancestor
92192795|NCT00492973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92192796|NCT00492973|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92192797|NCT00492973|Sympatholytics|sympatholytics|mesh-ancestor
92192798|NCT00492973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92192799|NCT00492973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192800|NCT00492973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192801|NCT05630534|Minocycline|minocycline|mesh-list
92192802|NCT05630534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192803|NCT05630534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192804|NCT00495079|Vincristine|vincristine|mesh-list
92192805|NCT00495079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92192806|NCT00495079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192807|NCT00495079|Tubulin Modulators|tubulin modulators|mesh-ancestor
92192808|NCT00495079|Antimitotic Agents|antimitotic agents|mesh-ancestor
92192809|NCT00495079|Mitosis Modulators|mitosis modulators|mesh-ancestor
92192810|NCT00495079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192811|NCT05630222|Acetaminophen|acetaminophen|mesh-list
92192814|NCT05630222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92192815|NCT05630222|Narcotics|narcotics|mesh-ancestor
92192816|NCT05630222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192817|NCT05630222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192818|NCT05630222|Analgesics|analgesics|mesh-ancestor
92192819|NCT05630222|Sensory System Agents|sensory system agents|mesh-ancestor
92192820|NCT05630222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192821|NCT05630222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92192822|NCT05630222|Antipyretics|antipyretics|mesh-ancestor
92192823|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92192824|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92192825|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92192826|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92192827|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192828|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192829|NCT03594188|Anesthetics|anesthetics|mesh-list
92192830|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192831|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192832|NCT00539695|Aldesleukin|aldesleukin|mesh-list
92192833|NCT00539695|Interleukin-2|interleukin-2|mesh-list
92192834|NCT00539695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192835|NCT00539695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92192836|NCT00539695|Analgesics|analgesics|mesh-ancestor
92192837|NCT00539695|Sensory System Agents|sensory system agents|mesh-ancestor
92192838|NCT00539695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192839|NCT00539695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192840|NCT00539695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92192841|NCT00539695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92192842|NCT00539695|Antiviral Agents|antiviral agents|mesh-ancestor
92192843|NCT00539695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192844|NCT03593954|Ritonavir|ritonavir|mesh-list
92192845|NCT03593954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92192846|NCT03593954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92192847|NCT03593954|Protease Inhibitors|protease inhibitors|mesh-ancestor
92192848|NCT03593954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192849|NCT03593954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192850|NCT03593954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92192851|NCT03593954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92192852|NCT03593954|Antiviral Agents|antiviral agents|mesh-ancestor
92192853|NCT03593954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192854|NCT03593954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92192855|NCT03593954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92192857|NCT03590210|Trabectedin|trabectedin|mesh-list
92192858|NCT03590210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92192859|NCT03590210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192860|NCT03590210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92192861|NCT03590210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192862|NCT03590210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92192863|NCT03590210|Alkylating Agents|alkylating agents|mesh-ancestor
92192864|NCT05632328|Paclitaxel|paclitaxel|mesh-list
92192865|NCT05632328|Gemcitabine|gemcitabine|mesh-list
92192866|NCT05632328|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92192867|NCT05632328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92192868|NCT05632328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192869|NCT05632328|Tubulin Modulators|tubulin modulators|mesh-ancestor
92192870|NCT05632328|Antimitotic Agents|antimitotic agents|mesh-ancestor
92192871|NCT05632328|Mitosis Modulators|mitosis modulators|mesh-ancestor
92192872|NCT05632328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192873|NCT05632328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92192874|NCT05632328|Antimetabolites|antimetabolites|mesh-ancestor
92192875|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
92192876|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192877|NCT03599726|Donepezil|donepezil|mesh-list
92192878|NCT03599726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92192879|NCT03599726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192880|NCT03599726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192881|NCT03599726|Cholinergic Agents|cholinergic agents|mesh-ancestor
92192882|NCT03599726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192883|NCT03599726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192884|NCT03599726|Nootropic Agents|nootropic agents|mesh-ancestor
92192885|NCT00466817|Valganciclovir|valganciclovir|mesh-list
92192886|NCT00466817|Antiviral Agents|antiviral agents|mesh-ancestor
92192887|NCT00466817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192888|NCT04406870|Sirolimus|sirolimus|mesh-list
92192889|NCT04406870|Propranolol|propranolol|mesh-list
92192890|NCT04406870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192891|NCT04406870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192892|NCT04406870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92192893|NCT04406870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192894|NCT04406870|Antifungal Agents|antifungal agents|mesh-ancestor
92192895|NCT04406870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92192896|NCT04406870|Immunologic Factors|immunologic factors|mesh-ancestor
92192897|NCT04406870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192898|NCT04406870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192899|NCT04406870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92192900|NCT04406870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92192902|NCT04406870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192903|NCT04406870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92192904|NCT04406870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92192905|NCT04406870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92192906|NCT03985514|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92192907|NCT03985514|Ciprofloxacin|ciprofloxacin|mesh-list
92192908|NCT03985514|Tazobactam|tazobactam|mesh-list
92192909|NCT03985514|Piperacillin|piperacillin|mesh-list
92192910|NCT03985514|Metronidazole|metronidazole|mesh-list
92192911|NCT03985514|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92192912|NCT03985514|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92192913|NCT03985514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192914|NCT03985514|Antitubercular Agents|antitubercular agents|mesh-ancestor
92192915|NCT03985514|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92192916|NCT03985514|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92192917|NCT03985514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192918|NCT03985514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192919|NCT03985514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192920|NCT03985514|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92192921|NCT03985514|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92192922|NCT03985514|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92192923|NCT03985514|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92192924|NCT03985514|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92192925|NCT00540007|Lenalidomide|lenalidomide|mesh-list
92192926|NCT00540007|Immunologic Factors|immunologic factors|mesh-ancestor
92192927|NCT00540007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192928|NCT00540007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92192929|NCT00540007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92192930|NCT00540007|Growth Substances|growth substances|mesh-ancestor
92192931|NCT00540007|Growth Inhibitors|growth inhibitors|mesh-ancestor
92192932|NCT00540007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92192933|NCT02982889|Bupivacaine|bupivacaine|mesh-list
92192934|NCT02982889|Hyaluronic Acid|hyaluronic acid|mesh-list
92192935|NCT02982889|Anesthetics, Local|anesthetics, local|mesh-ancestor
92192936|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
92192937|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192938|NCT02982889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192939|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
92192940|NCT02982889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192941|NCT02982889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92192942|NCT02982889|Immunologic Factors|immunologic factors|mesh-ancestor
92192943|NCT02982889|Viscosupplements|viscosupplements|mesh-ancestor
92192944|NCT02982889|Protective Agents|protective agents|mesh-ancestor
92192945|NCT01867333|Metronidazole|metronidazole|mesh-list
92192946|NCT01867333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192947|NCT01867333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92192948|NCT01867333|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92192949|NCT01867333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92192950|NCT03592082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92192952|NCT03592082|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92192953|NCT03592082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92192954|NCT03592082|Antacids|antacids|mesh-ancestor
92192955|NCT03592082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192956|NCT03592082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92192957|NCT03592082|Antidiarrheals|antidiarrheals|mesh-ancestor
92192958|NCT03598868|Vortioxetine|vortioxetine|mesh-list
92192959|NCT03598868|Antidepressive Agents|antidepressive agents|mesh-ancestor
92192960|NCT03598868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92192961|NCT03598868|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92192962|NCT03598868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92192963|NCT03598868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192964|NCT03598868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192965|NCT03598868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92192966|NCT03598868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92192967|NCT03598868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92192968|NCT03598868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192969|NCT03598868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192970|NCT03598868|Serotonin Agents|serotonin agents|mesh-ancestor
92192971|NCT03598868|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92192972|NCT03598868|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92192973|NCT03598868|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92192974|NCT03598868|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92192975|NCT00501631|Naltrexone|naltrexone|mesh-list
92192976|NCT00501631|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92192977|NCT00501631|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92192978|NCT00501631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192979|NCT00501631|Sensory System Agents|sensory system agents|mesh-ancestor
92192980|NCT00501631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92192981|NCT05631704|Midazolam|midazolam|mesh-list
92192982|NCT05631704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92192983|NCT05631704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92192984|NCT05631704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92192985|NCT05631704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92192986|NCT05631704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92192987|NCT05631704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92192988|NCT05631704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92192989|NCT05631704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92192990|NCT05631704|Anesthetics, General|anesthetics, general|mesh-ancestor
92192992|NCT05631704|GABA Modulators|gaba modulators|mesh-ancestor
92192993|NCT05631704|GABA Agents|gaba agents|mesh-ancestor
92192994|NCT05631704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92192995|NCT05631704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92192996|NCT03591536|Pentoxifylline|pentoxifylline|mesh-list
92192997|NCT03591536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92192998|NCT03591536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92192999|NCT03591536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193000|NCT03591536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92193001|NCT03591536|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92193002|NCT03591536|Protective Agents|protective agents|mesh-ancestor
92193003|NCT03591536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193004|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
92193005|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92193006|NCT03591536|Antioxidants|antioxidants|mesh-ancestor
92193007|NCT00501943|Interferons|interferons|mesh-list
92193008|NCT00501943|Interferon-beta|interferon-beta|mesh-list
92193009|NCT00501943|Interferon beta-1a|interferon beta-1a|mesh-list
92193010|NCT00501943|Riluzole|riluzole|mesh-list
92193011|NCT00501943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193012|NCT00501943|Antiviral Agents|antiviral agents|mesh-ancestor
92193013|NCT00501943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193014|NCT00501943|Immunologic Factors|immunologic factors|mesh-ancestor
92193015|NCT00501943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193016|NCT00501943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92193017|NCT00501943|Anticonvulsants|anticonvulsants|mesh-ancestor
92193018|NCT00501943|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92193019|NCT00501943|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92193020|NCT00501943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193021|NCT00501943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193022|NCT00501943|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92193023|NCT00501943|Protective Agents|protective agents|mesh-ancestor
92193024|NCT03598634|Riboflavin|riboflavin|mesh-list
92193025|NCT03598634|Vitamin B Complex|vitamin b complex|mesh-ancestor
92193026|NCT03598634|Vitamins|vitamins|mesh-ancestor
92193027|NCT03598634|Micronutrients|micronutrients|mesh-ancestor
92193028|NCT03598634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193029|NCT03598634|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92193030|NCT03598634|Dermatologic Agents|dermatologic agents|mesh-ancestor
92193031|NCT03598556|Vitamin D|vitamin d|mesh-list
92193032|NCT03598556|Cholecalciferol|cholecalciferol|mesh-list
92193033|NCT03598556|Vitamins|vitamins|mesh-ancestor
92193034|NCT03598556|Micronutrients|micronutrients|mesh-ancestor
92193035|NCT03598556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193036|NCT03598556|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92193037|NCT03598556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193038|NCT03024476|Olmesartan|olmesartan|mesh-list
92193039|NCT03024476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92193040|NCT03024476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92193041|NCT03024476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92193042|NCT03024476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193043|NCT03590912|Mometasone Furoate|mometasone furoate|mesh-list
92193044|NCT03590912|Cetirizine|cetirizine|mesh-list
92193045|NCT03590912|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92193046|NCT03590912|Cefpodoxime|cefpodoxime|mesh-list
92193048|NCT03590912|Phenylephrine|phenylephrine|mesh-list
92193049|NCT03590912|Oxymetazoline|oxymetazoline|mesh-list
92193050|NCT03590912|Nasal Decongestants|nasal decongestants|mesh-list
92193051|NCT03590912|Levocetirizine|levocetirizine|mesh-list
92193052|NCT03590912|Histamine Antagonists|histamine antagonists|mesh-list
92193053|NCT03590912|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92193054|NCT03590912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193055|NCT03590912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193057|NCT03590912|Hormones|hormones|mesh-ancestor
92193058|NCT03590912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193059|NCT03590912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193060|NCT03590912|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193061|NCT03590912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193062|NCT03590912|Autonomic Agents|autonomic agents|mesh-ancestor
92193063|NCT03590912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193064|NCT03590912|Protective Agents|protective agents|mesh-ancestor
92193065|NCT03590912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92193066|NCT03590912|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92193067|NCT03590912|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92193068|NCT03590912|Histamine Agents|histamine agents|mesh-ancestor
92193069|NCT03590912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327632|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193070|NCT03590912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193071|NCT03590912|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92193073|NCT03590912|Adrenergic Agents|adrenergic agents|mesh-ancestor
92193074|NCT03590912|Sympathomimetics|sympathomimetics|mesh-ancestor
92193075|NCT03590912|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92193076|NCT03590912|Respiratory System Agents|respiratory system agents|mesh-ancestor
92193077|NCT03590912|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92193078|NCT03590912|Mydriatics|mydriatics|mesh-ancestor
92193079|NCT03590912|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92193080|NCT00503113|Alendronate|alendronate|mesh-list
92193081|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
92193082|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92193083|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193084|NCT00542971|Cytarabine|cytarabine|mesh-list
92193085|NCT00542971|Sorafenib|sorafenib|mesh-list
92193086|NCT00542971|Idarubicin|idarubicin|mesh-list
92193087|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193088|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
92193089|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193090|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193091|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
92193092|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193093|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193094|NCT00542971|Immunologic Factors|immunologic factors|mesh-ancestor
92193095|NCT00542971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193096|NCT00542971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193097|NCT00542971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193098|NCT00542971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92193099|NCT00542971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92193100|NCT00542971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193102|NCT00504751|Rituximab|rituximab|mesh-list
92193103|NCT00504751|Etoposide|etoposide|mesh-list
92193104|NCT00504751|Bortezomib|bortezomib|mesh-list
92193105|NCT00504751|Ifosfamide|ifosfamide|mesh-list
92193106|NCT00504751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193107|NCT00504751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193108|NCT00504751|Immunologic Factors|immunologic factors|mesh-ancestor
92193109|NCT00504751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193110|NCT00504751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193111|NCT00504751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193112|NCT00504751|Antiemetics|antiemetics|mesh-ancestor
92193113|NCT00504751|Autonomic Agents|autonomic agents|mesh-ancestor
92193114|NCT00504751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193115|NCT00504751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92193116|NCT00504751|Glucocorticoids|glucocorticoids|mesh-ancestor
92193117|NCT00504751|Hormones|hormones|mesh-ancestor
92193118|NCT00504751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193119|NCT00504751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193120|NCT00504751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92193121|NCT00504751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92193122|NCT00504751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193123|NCT00504751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193124|NCT00504751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193125|NCT00504751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92193126|NCT00504751|Alkylating Agents|alkylating agents|mesh-ancestor
92193128|NCT01013779|Etoposide|etoposide|mesh-list
92193129|NCT01013779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193130|NCT01013779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92193131|NCT01013779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92193132|NCT01013779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193133|NCT01013779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193134|NCT01013779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193135|NCT05630846|Vaccines|vaccines|mesh-list
92193136|NCT05630846|Immunologic Factors|immunologic factors|mesh-ancestor
92193137|NCT05630846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193138|NCT05630768|Vitamin D|vitamin d|mesh-list
92193139|NCT05630768|Risedronic Acid|risedronic acid|mesh-list
92193140|NCT05630768|Calcium|calcium|mesh-list
92193141|NCT05630768|Vitamins|vitamins|mesh-ancestor
92193142|NCT05630768|Micronutrients|micronutrients|mesh-ancestor
92193143|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193144|NCT05630768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193145|NCT05630768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92193146|NCT05630768|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92193147|NCT05630768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92193148|NCT05630768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193150|NCT00506155|Cisplatin|cisplatin|mesh-list
92193151|NCT00506155|Doxorubicin|doxorubicin|mesh-list
92193152|NCT00506155|Methotrexate|methotrexate|mesh-list
92193153|NCT00506155|Vinblastine|vinblastine|mesh-list
92193154|NCT00506155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193155|NCT00506155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193156|NCT00506155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92193157|NCT00506155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92193158|NCT00506155|Growth Substances|growth substances|mesh-ancestor
92193159|NCT00506155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193160|NCT00506155|Growth Inhibitors|growth inhibitors|mesh-ancestor
92193161|NCT00506155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92193162|NCT00506155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92193163|NCT00506155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193164|NCT00506155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193165|NCT00506155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193166|NCT00506155|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92193167|NCT00506155|Abortifacient Agents|abortifacient agents|mesh-ancestor
92193168|NCT00506155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92193170|NCT00506155|Antimetabolites|antimetabolites|mesh-ancestor
92193171|NCT00506155|Dermatologic Agents|dermatologic agents|mesh-ancestor
92193172|NCT00506155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92193173|NCT00506155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193174|NCT00506155|Immunologic Factors|immunologic factors|mesh-ancestor
92193175|NCT00506155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193176|NCT00506155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92193177|NCT00506155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92193178|NCT00506155|Tubulin Modulators|tubulin modulators|mesh-ancestor
92193179|NCT00506155|Antimitotic Agents|antimitotic agents|mesh-ancestor
92193180|NCT00506155|Mitosis Modulators|mitosis modulators|mesh-ancestor
92193181|NCT03590444|Ranibizumab|ranibizumab|mesh-list
92193182|NCT03590444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92193183|NCT03590444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92193184|NCT03590444|Growth Substances|growth substances|mesh-ancestor
92193185|NCT03590444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193186|NCT03590444|Growth Inhibitors|growth inhibitors|mesh-ancestor
92193187|NCT03590444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193188|NCT00506857|Fludarabine|fludarabine|mesh-list
92193189|NCT00506857|Fludarabine phosphate|fludarabine phosphate|mesh-list
92193190|NCT00506857|Busulfan|busulfan|mesh-list
92193191|NCT00506857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193192|NCT00506857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193193|NCT00506857|Antimetabolites|antimetabolites|mesh-ancestor
92193194|NCT00506857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193195|NCT00506857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193196|NCT00506857|Immunologic Factors|immunologic factors|mesh-ancestor
92193197|NCT00506857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193198|NCT00506857|Alkylating Agents|alkylating agents|mesh-ancestor
92193199|NCT00506857|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92193200|NCT00506857|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92193202|NCT04005170|Cisplatin|cisplatin|mesh-list
92193203|NCT04005170|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92193204|NCT04005170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193205|NCT04005170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92193206|NCT04005170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92193207|NCT04005170|Mitosis Modulators|mitosis modulators|mesh-ancestor
92193208|NCT04005170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193209|NCT03597308|Acetaminophen|acetaminophen|mesh-list
92193210|NCT03597308|Ibuprofen|ibuprofen|mesh-list
92193211|NCT03597308|Oxycodone|oxycodone|mesh-list
92193212|NCT03597308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92193213|NCT03597308|Analgesics|analgesics|mesh-ancestor
92193214|NCT03597308|Sensory System Agents|sensory system agents|mesh-ancestor
92193215|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193216|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193217|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
92193218|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92193219|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193220|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193221|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92193222|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193223|NCT03597308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193224|NCT03597308|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92193225|NCT03597308|Narcotics|narcotics|mesh-ancestor
92193226|NCT03597308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193227|NCT04750135|Metformin|metformin|mesh-list
92193228|NCT04750135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92193229|NCT04750135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193230|NCT04003922|Adalimumab|adalimumab|mesh-list
92193231|NCT04003922|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92193232|NCT04003922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193233|NCT04003922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193234|NCT03781934|Pembrolizumab|pembrolizumab|mesh-list
92193235|NCT03781934|Lenvatinib|lenvatinib|mesh-list
92193236|NCT03781934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193237|NCT03781934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193238|NCT03781934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92193239|NCT03781934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193240|NCT03781934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193241|NCT03781934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193242|NCT00558571|Empagliflozin|empagliflozin|mesh-list
92193243|NCT00558571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92193244|NCT00558571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193245|NCT00558571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92193246|NCT00558571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193247|NCT03970382|Aldesleukin|aldesleukin|mesh-list
92193248|NCT03970382|Nivolumab|nivolumab|mesh-list
92193249|NCT03970382|Interleukin-2|interleukin-2|mesh-list
92193250|NCT03970382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193251|NCT03970382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193252|NCT03970382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92193253|NCT03970382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193254|NCT03970382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92193255|NCT03970382|Analgesics|analgesics|mesh-ancestor
92193256|NCT03970382|Sensory System Agents|sensory system agents|mesh-ancestor
92193257|NCT03970382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193258|NCT03970382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193259|NCT03970382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92193260|NCT03970382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92193261|NCT03970382|Antiviral Agents|antiviral agents|mesh-ancestor
92193262|NCT03970382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193263|NCT01797133|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92193264|NCT01797133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92193265|NCT01797133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193266|NCT01797133|Antitubercular Agents|antitubercular agents|mesh-ancestor
92193267|NCT01797913|Gemcitabine|gemcitabine|mesh-list
92193268|NCT01797913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193269|NCT01797913|Antimetabolites|antimetabolites|mesh-ancestor
92193270|NCT01797913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193271|NCT01797913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193272|NCT03596294|Rifampin|rifampin|mesh-list
92193273|NCT03596294|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92193274|NCT03596294|Antitubercular Agents|antitubercular agents|mesh-ancestor
92193275|NCT03596294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92193276|NCT03596294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193277|NCT03596294|Leprostatic Agents|leprostatic agents|mesh-ancestor
92193278|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92193279|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193280|NCT03596294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193281|NCT03596294|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92193282|NCT03596294|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92193283|NCT03596294|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92193284|NCT03596294|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92193285|NCT03596294|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92193286|NCT03596294|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92193287|NCT00537407|Ribavirin|ribavirin|mesh-list
92193288|NCT00537407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92193289|NCT00537407|Antimetabolites|antimetabolites|mesh-ancestor
92193290|NCT00537407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193291|NCT00537407|Antiviral Agents|antiviral agents|mesh-ancestor
92193292|NCT00537407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193293|NCT00214916|Insulin|insulin|mesh-list
92193294|NCT00214916|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92193295|NCT00214916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92193296|NCT00214916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193297|NCT00438971|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92193298|NCT00438971|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92193299|NCT00438971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92193300|NCT00438971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92193301|NCT00438971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193302|NCT00438971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193303|NCT00438971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193304|NCT00438971|Analgesics|analgesics|mesh-ancestor
92193305|NCT00438971|Sensory System Agents|sensory system agents|mesh-ancestor
92193306|NCT00438971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193307|NCT00438971|Antidepressive Agents|antidepressive agents|mesh-ancestor
92193308|NCT00438971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92193309|NCT00438971|Dopamine Agents|dopamine agents|mesh-ancestor
92193310|NCT00219284|Levodopa|levodopa|mesh-list
92193311|NCT00219284|Carbidopa|carbidopa|mesh-list
92193312|NCT00219284|Entacapone|entacapone|mesh-list
92193313|NCT00219284|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92193314|NCT00219284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92193315|NCT00219284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92193316|NCT00219284|Dopamine Agents|dopamine agents|mesh-ancestor
92193317|NCT00219284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193318|NCT00219284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193319|NCT00219284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193320|NCT00219284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92193321|NCT00219284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193322|NCT00219284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92193323|NCT00219284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92193324|NCT00219284|Immunologic Factors|immunologic factors|mesh-ancestor
92193325|NCT00219284|Dopamine Agonists|dopamine agonists|mesh-ancestor
92193326|NCT00509041|Dasatinib|dasatinib|mesh-list
92193327|NCT00509041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193328|NCT00509041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193329|NCT00509041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193330|NCT00509041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193331|NCT03781700|Prednisolone|prednisolone|mesh-list
92193332|NCT03781700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193333|NCT03781700|Glucocorticoids|glucocorticoids|mesh-ancestor
92193334|NCT03781700|Hormones|hormones|mesh-ancestor
92193335|NCT03781700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193336|NCT03781700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193337|NCT03781700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193338|NCT03781700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193339|NCT00439673|Azacitidine|azacitidine|mesh-list
92193340|NCT00439673|Valproic Acid|valproic acid|mesh-list
92193341|NCT00439673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193342|NCT00439673|Antimetabolites|antimetabolites|mesh-ancestor
92193343|NCT00439673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193344|NCT00439673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193345|NCT00439673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193346|NCT00439673|Anticonvulsants|anticonvulsants|mesh-ancestor
92193347|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
92193348|NCT00439673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193349|NCT00439673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193350|NCT00439673|Antimanic Agents|antimanic agents|mesh-ancestor
92193351|NCT00439673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92193352|NCT00439673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193353|NCT00439673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92193354|NCT03596060|Fentanyl|fentanyl|mesh-list
92193355|NCT03596060|Morphine|morphine|mesh-list
92193356|NCT03596060|Propofol|propofol|mesh-list
92193357|NCT03596060|Rocuronium|rocuronium|mesh-list
92193358|NCT03596060|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92193359|NCT03596060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193360|NCT03596060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193361|NCT03596060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92193362|NCT03596060|Anesthetics, General|anesthetics, general|mesh-ancestor
92193363|NCT03596060|Anesthetics|anesthetics|mesh-ancestor
92193364|NCT03596060|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92193365|NCT03596060|Narcotics|narcotics|mesh-ancestor
92193366|NCT03596060|Analgesics|analgesics|mesh-ancestor
92193367|NCT03596060|Sensory System Agents|sensory system agents|mesh-ancestor
92193368|NCT03596060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193369|NCT03596060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92193370|NCT03596060|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92193371|NCT03596060|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92193372|NCT03596060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92193373|NCT00473837|Chloroquine|chloroquine|mesh-list
92193374|NCT00473837|Amebicides|amebicides|mesh-ancestor
92193375|NCT00473837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92193376|NCT00473837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92193377|NCT00473837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193378|NCT00473837|Antimalarials|antimalarials|mesh-ancestor
92193379|NCT00473837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193380|NCT04198922|Acalabrutinib|acalabrutinib|mesh-list
92193381|NCT04198922|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92193382|NCT04198922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193383|NCT04198922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193384|NCT04198922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193385|NCT04198922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193386|NCT00509197|Fluticasone|fluticasone|mesh-list
92193387|NCT00509197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193388|NCT00509197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92193389|NCT00509197|Autonomic Agents|autonomic agents|mesh-ancestor
92193390|NCT00509197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193391|NCT00509197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193392|NCT00509197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92193393|NCT00509197|Respiratory System Agents|respiratory system agents|mesh-ancestor
92193394|NCT00509197|Dermatologic Agents|dermatologic agents|mesh-ancestor
92193395|NCT00509197|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92193396|NCT00442013|Lansoprazole|lansoprazole|mesh-list
92193397|NCT00442013|Dexlansoprazole|dexlansoprazole|mesh-list
92193398|NCT00442013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92193399|NCT00442013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92193400|NCT00442013|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92193401|NCT00442013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193402|NCT00442013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193403|NCT02121067|Levonorgestrel|levonorgestrel|mesh-list
92193404|NCT02121067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92193405|NCT02121067|Contraceptive Agents|contraceptive agents|mesh-ancestor
92193406|NCT02121067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92193407|NCT02121067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193408|NCT02121067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92193409|NCT02121067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92193410|NCT02121067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92193412|NCT00509665|Doxorubicin|doxorubicin|mesh-list
92193413|NCT00509665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92193414|NCT00509665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193415|NCT00509665|Antimetabolites|antimetabolites|mesh-ancestor
92193416|NCT00509665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193417|NCT00509665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193418|NCT00509665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92193419|NCT00509665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92193420|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193421|NCT00509665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193422|NCT00513799|Chlorhexidine|chlorhexidine|mesh-list
92193423|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92193424|NCT00513799|Mupirocin|mupirocin|mesh-list
92193425|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92193426|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193427|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
92193428|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92193429|NCT00513799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92193430|NCT00513799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92193431|NCT00513799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193432|NCT00513799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193433|NCT00442169|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92193435|NCT00216476|Aripiprazole|aripiprazole|mesh-list
92193436|NCT00216476|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92193437|NCT00216476|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92193438|NCT00216476|Serotonin Agents|serotonin agents|mesh-ancestor
92193439|NCT00216476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193440|NCT00216476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193441|NCT00216476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193442|NCT00216476|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92193443|NCT00216476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92193444|NCT00216476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193445|NCT00216476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92193446|NCT00216476|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92193447|NCT00216476|Dopamine Agents|dopamine agents|mesh-ancestor
92193448|NCT00216476|Antidepressive Agents|antidepressive agents|mesh-ancestor
92193449|NCT00216476|Dopamine Agonists|dopamine agonists|mesh-ancestor
92193450|NCT00216476|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92193451|NCT00216476|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92193452|NCT00216476|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92193453|NCT00216476|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92193454|NCT00515437|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92193455|NCT00515437|Botulinum Toxins|botulinum toxins|mesh-list
92193456|NCT00515437|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92193457|NCT00515437|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92193458|NCT00515437|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92193459|NCT00515437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92193460|NCT00515437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193461|NCT00515437|Cholinergic Agents|cholinergic agents|mesh-ancestor
92193462|NCT00515437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193463|NCT00515437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193464|NCT00515437|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92193465|NCT00515437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193466|NCT00515437|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92193467|NCT00216086|Capecitabine|capecitabine|mesh-list
92193468|NCT00216086|Irinotecan|irinotecan|mesh-list
92193469|NCT00216086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193470|NCT00216086|Antimetabolites|antimetabolites|mesh-ancestor
92193471|NCT00216086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193472|NCT00216086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193473|NCT00216086|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92193474|NCT00216086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193475|NCT00216086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193476|NCT00474851|Norethindrone|norethindrone|mesh-list
92193477|NCT00474851|Norethindrone Acetate|norethindrone acetate|mesh-list
92193478|NCT00474851|Estrogens|estrogens|mesh-list
92193479|NCT00474851|Hormones|hormones|mesh-ancestor
92193480|NCT00474851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193481|NCT00474851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193482|NCT00474851|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92193483|NCT00474851|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92193484|NCT00474851|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92193485|NCT00474851|Contraceptive Agents|contraceptive agents|mesh-ancestor
92193486|NCT00474851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92193487|NCT00474851|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92193488|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92193489|NCT00215150|Ziprasidone|ziprasidone|mesh-list
92193490|NCT00215150|Sertraline|sertraline|mesh-list
92193491|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
92193492|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92193493|NCT00215150|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92193494|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92193495|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92193496|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193497|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193498|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
92193499|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193500|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92193501|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92193502|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92193503|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193504|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92193505|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
92193506|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92193507|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193508|NCT04198844|Warfarin|warfarin|mesh-list
92193509|NCT04198844|Apixaban|apixaban|mesh-list
92193510|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
92193511|NCT04198844|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92193512|NCT04198844|Antithrombins|antithrombins|mesh-ancestor
92193513|NCT04198844|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92193514|NCT04198844|Protease Inhibitors|protease inhibitors|mesh-ancestor
92193515|NCT04198844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193516|NCT04198844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193517|NCT03023852|Oseltamivir|oseltamivir|mesh-list
92193518|NCT03023852|Antiviral Agents|antiviral agents|mesh-ancestor
92193519|NCT03023852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193520|NCT03023852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193521|NCT03023852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193522|NCT00213980|Zoledronic Acid|zoledronic acid|mesh-list
92193523|NCT00213980|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92193524|NCT00213980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193525|NCT00516217|Galiximab|galiximab|mesh-list
92193526|NCT00516217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193527|NCT00516217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193528|NCT04001504|Vaccines|vaccines|mesh-list
92193529|NCT04001504|Immunologic Factors|immunologic factors|mesh-ancestor
92193530|NCT04001504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193531|NCT00516919|Orlistat|orlistat|mesh-list
92193532|NCT00516919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193533|NCT00516919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193534|NCT00516919|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92193535|NCT00516919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92193536|NCT00547105|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92193537|NCT00547105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193538|NCT00547105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193539|NCT00547105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193540|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193541|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92193542|NCT04195100|Pilocarpine|pilocarpine|mesh-list
92193543|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92193544|NCT04195100|Miotics|miotics|mesh-ancestor
92193545|NCT04195100|Autonomic Agents|autonomic agents|mesh-ancestor
92193546|NCT04195100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193547|NCT04195100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193548|NCT04195100|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92193549|NCT04195100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92193550|NCT04195100|Cholinergic Agents|cholinergic agents|mesh-ancestor
92193551|NCT04195100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193552|NCT04195100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193553|NCT04193774|Anesthetics|anesthetics|mesh-list
92193554|NCT04193774|Benoxinate|benoxinate|mesh-list
92193555|NCT04193774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92193556|NCT04193774|Lubricant Eye Drops|lubricant eye drops|mesh-list
92193557|NCT04193774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193558|NCT04193774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193559|NCT04193774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92193560|NCT04193774|Anesthetics, Local|anesthetics, local|mesh-ancestor
92193561|NCT04193774|Sensory System Agents|sensory system agents|mesh-ancestor
92193562|NCT04193774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193563|NCT00518089|Gatifloxacin|gatifloxacin|mesh-list
92193564|NCT00518089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92193565|NCT00518089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92193566|NCT00518089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92193567|NCT00518089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193568|NCT00518089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92193569|NCT00518089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92193570|NCT00518089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193571|NCT00518089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193572|NCT00518089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193573|NCT02985242|Empagliflozin|empagliflozin|mesh-list
92193574|NCT02985242|Glimepiride|glimepiride|mesh-list
92193575|NCT02985242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92193576|NCT02985242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193577|NCT02985242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92193578|NCT02985242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193579|NCT02985242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92193580|NCT02985242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193581|NCT02985242|Immunologic Factors|immunologic factors|mesh-ancestor
92193582|NCT03023774|Lenograstim|lenograstim|mesh-list
92193583|NCT03023774|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92193584|NCT03023774|Immunologic Factors|immunologic factors|mesh-ancestor
92193585|NCT03023774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193586|NCT04196426|Calcium|calcium|mesh-list
92193587|NCT04196426|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193588|NCT04196426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193589|NCT00518713|Clobazam|clobazam|mesh-list
92193590|NCT00518713|Anticonvulsants|anticonvulsants|mesh-ancestor
92193591|NCT00518713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92193592|NCT00518713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92193593|NCT00518713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193594|NCT00518713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193595|NCT00518713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92193596|NCT00518713|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92193597|NCT00518713|GABA Agonists|gaba agonists|mesh-ancestor
92193598|NCT00518713|GABA Agents|gaba agents|mesh-ancestor
92193599|NCT00518713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193600|NCT00518713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193601|NCT03948464|Morphine|morphine|mesh-list
92193602|NCT03948464|Methadone|methadone|mesh-list
92193603|NCT03948464|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92193604|NCT03948464|Narcotics|narcotics|mesh-ancestor
92193605|NCT03948464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193606|NCT03948464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193607|NCT03948464|Analgesics|analgesics|mesh-ancestor
92193608|NCT03948464|Sensory System Agents|sensory system agents|mesh-ancestor
92193609|NCT03948464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193610|NCT03948464|Antitussive Agents|antitussive agents|mesh-ancestor
92193611|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92193612|NCT04196270|Ropivacaine|ropivacaine|mesh-list
92193613|NCT04196270|Anesthetics, Local|anesthetics, local|mesh-ancestor
92193614|NCT04196270|Anesthetics|anesthetics|mesh-ancestor
92193615|NCT04196270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193616|NCT04196270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193617|NCT04196270|Sensory System Agents|sensory system agents|mesh-ancestor
92193618|NCT04196270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193619|NCT04020380|Azithromycin|azithromycin|mesh-list
92193620|NCT04020380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92193621|NCT04020380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193622|NCT00521989|Prednisolone|prednisolone|mesh-list
92193623|NCT00521989|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92193624|NCT00521989|Methylprednisolone|methylprednisolone|mesh-list
92193625|NCT00521989|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92193626|NCT00521989|Prednisolone acetate|prednisolone acetate|mesh-list
92193627|NCT00521989|Dipyridamole|dipyridamole|mesh-list
92193628|NCT00521989|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92193629|NCT00521989|Prednisolone phosphate|prednisolone phosphate|mesh-list
92193630|NCT00521989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193631|NCT00521989|Glucocorticoids|glucocorticoids|mesh-ancestor
92193632|NCT00521989|Hormones|hormones|mesh-ancestor
92193633|NCT00521989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193634|NCT00521989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193635|NCT00521989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193636|NCT00521989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193637|NCT00521989|Antiemetics|antiemetics|mesh-ancestor
92193638|NCT00521989|Autonomic Agents|autonomic agents|mesh-ancestor
92193639|NCT00521989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193640|NCT00521989|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92193641|NCT00521989|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92193642|NCT00521989|Protective Agents|protective agents|mesh-ancestor
92193643|NCT00521989|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92193644|NCT00521989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193645|NCT00521989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193646|NCT00521989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92193647|NCT00521989|Vasodilator Agents|vasodilator agents|mesh-ancestor
92193649|NCT04029350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193650|NCT04029350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193651|NCT04029350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193652|NCT04029350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193653|NCT00548197|Bevacizumab|bevacizumab|mesh-list
92193654|NCT00548197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193655|NCT00548197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193656|NCT00548197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92193657|NCT00548197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92193658|NCT00548197|Growth Substances|growth substances|mesh-ancestor
92193659|NCT00548197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193660|NCT00548197|Growth Inhibitors|growth inhibitors|mesh-ancestor
92193661|NCT04029272|Metformin|metformin|mesh-list
92193662|NCT04029272|Exenatide|exenatide|mesh-list
92193663|NCT04029272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92193664|NCT04029272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193665|NCT04029272|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92193666|NCT04029272|Incretins|incretins|mesh-ancestor
92193667|NCT04029272|Hormones|hormones|mesh-ancestor
92193668|NCT04029272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193669|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
92193670|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
92193671|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193672|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92193673|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193674|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193675|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
92193676|NCT00548431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193677|NCT00548431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92193678|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193679|NCT04028804|Deoxyglucose|deoxyglucose|mesh-list
92193680|NCT04028804|Fluorides|fluorides|mesh-list
92193681|NCT04028804|Cariostatic Agents|cariostatic agents|mesh-ancestor
92193682|NCT04028804|Protective Agents|protective agents|mesh-ancestor
92193683|NCT04028804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193684|NCT04028804|Antimetabolites|antimetabolites|mesh-ancestor
92193685|NCT04028804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193686|NCT04028804|Antiviral Agents|antiviral agents|mesh-ancestor
92193687|NCT04028804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193688|NCT00524017|Cetuximab|cetuximab|mesh-list
92193689|NCT00524017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193690|NCT00524017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193691|NCT02985554|Nivolumab|nivolumab|mesh-list
92193692|NCT02985554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193693|NCT02985554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193694|NCT02985554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92193695|NCT02985554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193697|NCT05560165|Anesthetics|anesthetics|mesh-list
92193698|NCT05560165|Anesthetics, Local|anesthetics, local|mesh-list
92193699|NCT05560165|Fluorides|fluorides|mesh-list
92193700|NCT05560165|Sodium Fluoride|sodium fluoride|mesh-list
92193701|NCT05560165|Cariostatic Agents|cariostatic agents|mesh-ancestor
92193702|NCT05560165|Protective Agents|protective agents|mesh-ancestor
92193703|NCT05560165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193704|NCT05560165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193705|NCT05560165|Sensory System Agents|sensory system agents|mesh-ancestor
92193706|NCT05560165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193707|NCT05560165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92193708|NCT05560165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193709|NCT00525421|Curcumin|curcumin|mesh-list
92193710|NCT00525421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92193711|NCT00525421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92193712|NCT00525421|Analgesics|analgesics|mesh-ancestor
92193713|NCT00525421|Sensory System Agents|sensory system agents|mesh-ancestor
92193714|NCT00525421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193715|NCT00525421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193716|NCT00525421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193717|NCT00525421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193718|NCT00525421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193719|NCT00525421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193720|NCT00525421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193721|NCT04023110|Carvedilol|carvedilol|mesh-list
92193722|NCT04023110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92193724|NCT04023110|Adrenergic Agents|adrenergic agents|mesh-ancestor
92193725|NCT04023110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193726|NCT04023110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193727|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193728|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92193729|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
92193730|NCT04023110|Protective Agents|protective agents|mesh-ancestor
92193731|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92193732|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92193733|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193734|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
92193735|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92193736|NCT04023110|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92193737|NCT00525733|Ritonavir|ritonavir|mesh-list
92193738|NCT00525733|Darunavir|darunavir|mesh-list
92193739|NCT00525733|Raltegravir Potassium|raltegravir potassium|mesh-list
92193740|NCT00525733|Maraviroc|maraviroc|mesh-list
92193741|NCT00525733|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92193742|NCT00525733|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92193743|NCT00525733|Protease Inhibitors|protease inhibitors|mesh-ancestor
92193744|NCT00525733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193745|NCT00525733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193746|NCT00525733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92193747|NCT00525733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92193748|NCT00525733|Antiviral Agents|antiviral agents|mesh-ancestor
92193749|NCT00525733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193750|NCT00525733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92193751|NCT00525733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92335009|NCT00004759|Hormones|hormones|mesh-ancestor
92193752|NCT00525733|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92193753|NCT00525733|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92193754|NCT00525733|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92193755|NCT00525733|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92193756|NCT00525733|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92193758|NCT04028024|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92193759|NCT04028024|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92193760|NCT04028024|Protease Inhibitors|protease inhibitors|mesh-ancestor
92193761|NCT04028024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193762|NCT04028024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193763|NCT00526591|Everolimus|everolimus|mesh-list
92193764|NCT00526591|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92193765|NCT00526591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92193766|NCT00526591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193767|NCT00526591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193768|NCT00526591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193769|NCT00526591|Immunologic Factors|immunologic factors|mesh-ancestor
92193770|NCT00526591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193771|NCT00526591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193772|NCT05559619|Calcium, Dietary|calcium, dietary|mesh-list
92193774|NCT05559619|Cholecalciferol|cholecalciferol|mesh-list
92193775|NCT05559619|Calcium Carbonate|calcium carbonate|mesh-list
92193776|NCT05559619|Calcium|calcium|mesh-list
92193777|NCT05559619|Vitamins|vitamins|mesh-ancestor
92193778|NCT05559619|Micronutrients|micronutrients|mesh-ancestor
92193779|NCT05559619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193780|NCT05559619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193781|NCT05559619|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92193782|NCT05559619|Antacids|antacids|mesh-ancestor
92193783|NCT05559619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193784|NCT05559619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92193785|NCT04194086|Posaconazole|posaconazole|mesh-list
92193786|NCT04194086|Antifungal Agents|antifungal agents|mesh-ancestor
92193787|NCT04194086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193788|NCT04194086|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92193789|NCT04194086|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92193790|NCT04194086|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92193791|NCT04194086|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92193792|NCT04194086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92193793|NCT04194086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193794|NCT04194086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193795|NCT04194086|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92193796|NCT04194086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92193797|NCT04194086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193798|NCT04194086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193800|NCT04021862|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92193801|NCT04021862|Immunologic Factors|immunologic factors|mesh-ancestor
92193802|NCT04021862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193803|NCT04023266|Acetylcysteine|acetylcysteine|mesh-list
92193804|NCT04023266|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92193805|NCT04023266|Antiviral Agents|antiviral agents|mesh-ancestor
92193806|NCT04023266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193807|NCT04023266|Expectorants|expectorants|mesh-ancestor
92193808|NCT04023266|Respiratory System Agents|respiratory system agents|mesh-ancestor
92193809|NCT04023266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92193810|NCT04023266|Antioxidants|antioxidants|mesh-ancestor
92193811|NCT04023266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193812|NCT04023266|Protective Agents|protective agents|mesh-ancestor
92193813|NCT04023266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193814|NCT04023266|Antidotes|antidotes|mesh-ancestor
92193815|NCT00475085|Dexamethasone|dexamethasone|mesh-list
92193816|NCT00475085|Aprepitant|aprepitant|mesh-list
92193817|NCT00475085|Palonosetron|palonosetron|mesh-list
92193818|NCT00475085|Granisetron|granisetron|mesh-list
92193819|NCT00475085|Prochlorperazine|prochlorperazine|mesh-list
92193820|NCT00475085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193821|NCT00475085|Antiemetics|antiemetics|mesh-ancestor
92193822|NCT00475085|Autonomic Agents|autonomic agents|mesh-ancestor
92193823|NCT00475085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193824|NCT00475085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193825|NCT00475085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92193826|NCT00475085|Glucocorticoids|glucocorticoids|mesh-ancestor
92193827|NCT00475085|Hormones|hormones|mesh-ancestor
92193828|NCT00475085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193829|NCT00475085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193830|NCT00475085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193831|NCT00475085|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92193832|NCT00475085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193833|NCT00475085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193834|NCT00475085|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92193835|NCT00475085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92193836|NCT00475085|Serotonin Agents|serotonin agents|mesh-ancestor
92193837|NCT00475085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92193838|NCT00475085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92193839|NCT00475085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193840|NCT00475085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92193841|NCT00475085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92193842|NCT00475085|Dopamine Agents|dopamine agents|mesh-ancestor
92193843|NCT00551707|Prednisolone|prednisolone|mesh-list
92193844|NCT00551707|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92193845|NCT00551707|Methylprednisolone|methylprednisolone|mesh-list
92193846|NCT00551707|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92193847|NCT00551707|Prednisolone acetate|prednisolone acetate|mesh-list
92193848|NCT00551707|Dipyridamole|dipyridamole|mesh-list
92193849|NCT00551707|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92193850|NCT00551707|Prednisolone phosphate|prednisolone phosphate|mesh-list
92193851|NCT00551707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92193852|NCT00551707|Glucocorticoids|glucocorticoids|mesh-ancestor
92193853|NCT00551707|Hormones|hormones|mesh-ancestor
92193854|NCT00551707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193855|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193856|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193857|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193858|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
92193859|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
92193860|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193861|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92193862|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92193863|NCT00551707|Protective Agents|protective agents|mesh-ancestor
92193864|NCT00551707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92193865|NCT00551707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193866|NCT00551707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193867|NCT00551707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92193868|NCT00551707|Vasodilator Agents|vasodilator agents|mesh-ancestor
92193869|NCT04193930|Letrozole|letrozole|mesh-list
92193870|NCT04193930|Menotropins|menotropins|mesh-list
92193871|NCT04193930|Hormones|hormones|mesh-list
92193872|NCT04193930|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92193873|NCT04193930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193874|NCT04193930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193875|NCT04193930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193876|NCT04193930|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92193877|NCT04193930|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92193878|NCT04193930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193879|NCT04193930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193880|NCT04193930|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92193881|NCT04193930|Hormone Antagonists|hormone antagonists|mesh-ancestor
92193882|NCT04193930|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92193884|NCT04193930|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92193885|NCT00445211|Heparin|heparin|mesh-list
92193886|NCT00445211|Calcium heparin|calcium heparin|mesh-list
92193887|NCT00445211|Anticoagulants|anticoagulants|mesh-ancestor
92193888|NCT00445211|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92193889|NCT00445211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92193890|NCT00445211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193891|NCT04193852|Dienogest|dienogest|mesh-list
92193892|NCT04193852|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92193893|NCT04193852|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92193894|NCT04193852|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92193895|NCT04193852|Estradiol|estradiol|mesh-list
92193896|NCT04193852|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92193897|NCT04193852|Nandrolone|nandrolone|mesh-list
92193898|NCT04193852|Estrogens|estrogens|mesh-ancestor
92193899|NCT04193852|Hormones|hormones|mesh-ancestor
92193900|NCT04193852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92193901|NCT04193852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193902|NCT04193852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92193903|NCT04193852|Contraceptive Agents|contraceptive agents|mesh-ancestor
92193904|NCT04193852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92193905|NCT04193852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92193906|NCT04193852|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92193907|NCT04193852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92193908|NCT04193852|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92193909|NCT04193852|Hormone Antagonists|hormone antagonists|mesh-ancestor
92193910|NCT04193852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92193911|NCT04193852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193912|NCT04193852|Androgens|androgens|mesh-ancestor
92193913|NCT04193852|Anabolic Agents|anabolic agents|mesh-ancestor
92193914|NCT00552409|Cholecalciferol|cholecalciferol|mesh-list
92193915|NCT00552409|Vitamin D|vitamin d|mesh-list
92193916|NCT00552409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193917|NCT00552409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193918|NCT00552409|Vitamins|vitamins|mesh-ancestor
92193919|NCT00552409|Micronutrients|micronutrients|mesh-ancestor
92193920|NCT00552409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92193921|NCT03830918|Temozolomide|temozolomide|mesh-list
92193922|NCT03830918|Atezolizumab|atezolizumab|mesh-list
92193923|NCT03830918|Niraparib|niraparib|mesh-list
92193924|NCT03830918|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92193925|NCT03830918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92193926|NCT03830918|Alkylating Agents|alkylating agents|mesh-ancestor
92193927|NCT03830918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193928|NCT03830918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92193929|NCT03830918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92193930|NCT03830918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92193931|NCT03830918|Immunologic Factors|immunologic factors|mesh-ancestor
92193932|NCT03830918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193933|NCT03830918|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92193934|NCT03830918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193935|NCT00553735|Cyclosporine|cyclosporine|mesh-list
92193936|NCT00553735|Lubricant Eye Drops|lubricant eye drops|mesh-list
92193937|NCT00553735|Cyclosporins|cyclosporins|mesh-list
92193938|NCT00553735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193939|NCT00553735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193940|NCT00553735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92193941|NCT00553735|Immunologic Factors|immunologic factors|mesh-ancestor
92193942|NCT00553735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193943|NCT00553735|Antifungal Agents|antifungal agents|mesh-ancestor
92193944|NCT00553735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193945|NCT00553735|Dermatologic Agents|dermatologic agents|mesh-ancestor
92193946|NCT00553735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92193947|NCT00553735|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92193948|NCT00553735|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92193949|NCT00553735|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92193950|NCT00523237|Raltegravir Potassium|raltegravir potassium|mesh-list
92193951|NCT00523237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92193952|NCT00523237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92193953|NCT00523237|Antiviral Agents|antiviral agents|mesh-ancestor
92193954|NCT00523237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193955|NCT00523237|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92193956|NCT00523237|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92193957|NCT00523237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193958|NCT00523237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193960|NCT04027166|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92193961|NCT04027166|Narcotics|narcotics|mesh-ancestor
92193962|NCT04027166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92193963|NCT04027166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193964|NCT04027166|Analgesics|analgesics|mesh-ancestor
92193965|NCT04027166|Sensory System Agents|sensory system agents|mesh-ancestor
92193966|NCT04027166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92193967|NCT04027166|Antitussive Agents|antitussive agents|mesh-ancestor
92193968|NCT04027166|Respiratory System Agents|respiratory system agents|mesh-ancestor
92193969|NCT00543101|Darunavir|darunavir|mesh-list
92193970|NCT00543101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92193971|NCT00543101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92193972|NCT00543101|Protease Inhibitors|protease inhibitors|mesh-ancestor
92193973|NCT00543101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193974|NCT00543101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193975|NCT00543101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92193976|NCT00543101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92193977|NCT00543101|Antiviral Agents|antiviral agents|mesh-ancestor
92193978|NCT00543101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92193979|NCT00553969|Carvedilol|carvedilol|mesh-list
92193980|NCT00553969|Lisinopril|lisinopril|mesh-list
92193981|NCT00553969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92193982|NCT00553969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92193983|NCT00553969|Adrenergic Agents|adrenergic agents|mesh-ancestor
92193984|NCT00553969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92193985|NCT00553969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92193986|NCT00553969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92193987|NCT00553969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92193988|NCT00553969|Antioxidants|antioxidants|mesh-ancestor
92193989|NCT00553969|Protective Agents|protective agents|mesh-ancestor
92193990|NCT00553969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92193991|NCT00553969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92193992|NCT00553969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92193993|NCT00553969|Vasodilator Agents|vasodilator agents|mesh-ancestor
92193994|NCT00553969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92193995|NCT00553969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92193996|NCT00553969|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92193997|NCT00553969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92193998|NCT00553969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92193999|NCT00553969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92194001|NCT03946202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92194002|NCT03946202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194003|NCT05533567|Sufentanil|sufentanil|mesh-list
92194004|NCT05533567|Dsuvia|dsuvia|mesh-list
92194005|NCT05533567|Propofol|propofol|mesh-list
92194006|NCT05533567|Cisatracurium|cisatracurium|mesh-list
92194007|NCT05533567|Atracurium|atracurium|mesh-list
92194008|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92194009|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194010|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194011|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92194012|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
92194013|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
92194014|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92194015|NCT05533567|Narcotics|narcotics|mesh-ancestor
92194016|NCT05533567|Analgesics|analgesics|mesh-ancestor
92194017|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
92194018|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194019|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92194020|NCT05533567|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92194021|NCT05533567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92194022|NCT05533567|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92194023|NCT05533567|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
91917128|NCT01666730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194024|NCT05533567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92194025|NCT05533567|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194026|NCT05533567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194027|NCT05533567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194029|NCT04026464|Ibuprofen|ibuprofen|mesh-list
92194030|NCT04026464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194031|NCT04026464|Analgesics|analgesics|mesh-ancestor
92194032|NCT04026464|Sensory System Agents|sensory system agents|mesh-ancestor
92194033|NCT04026464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194034|NCT04026464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194035|NCT04026464|Antipyretics|antipyretics|mesh-ancestor
92194036|NCT04026464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92194037|NCT04026464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194038|NCT04026464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194039|NCT04026464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92194040|NCT04026464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194041|NCT04026464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194042|NCT04192916|Rivaroxaban|rivaroxaban|mesh-list
92194043|NCT04192916|Apixaban|apixaban|mesh-list
92194044|NCT04192916|Edoxaban|edoxaban|mesh-list
92194045|NCT04192916|Dabigatran|dabigatran|mesh-list
92194046|NCT04192916|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92194047|NCT04192916|Antithrombins|antithrombins|mesh-ancestor
92194048|NCT04192916|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92194049|NCT04192916|Protease Inhibitors|protease inhibitors|mesh-ancestor
92194050|NCT04192916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194051|NCT04192916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194052|NCT04192916|Anticoagulants|anticoagulants|mesh-ancestor
92194053|NCT01797991|Dexamethasone|dexamethasone|mesh-list
92194054|NCT01797991|Dexamethasone acetate|dexamethasone acetate|mesh-list
92194055|NCT01797991|BB 1101|bb 1101|mesh-list
92194056|NCT01797991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194057|NCT01797991|Antiemetics|antiemetics|mesh-ancestor
92194058|NCT01797991|Autonomic Agents|autonomic agents|mesh-ancestor
92194059|NCT01797991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194060|NCT01797991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194061|NCT01797991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194062|NCT01797991|Glucocorticoids|glucocorticoids|mesh-ancestor
92194063|NCT01797991|Hormones|hormones|mesh-ancestor
92194064|NCT01797991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194065|NCT01797991|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92194066|NCT01797991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194067|NCT01797991|Protease Inhibitors|protease inhibitors|mesh-ancestor
92194068|NCT01797991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194069|NCT01797991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194070|NCT00475319|Rebamipide|rebamipide|mesh-list
92194071|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92194072|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194073|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
92194074|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194075|NCT00475319|Protective Agents|protective agents|mesh-ancestor
92194076|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194077|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194078|NCT04026074|Clonidine|clonidine|mesh-list
92194079|NCT04026074|Fentanyl|fentanyl|mesh-list
92194080|NCT04026074|Remifentanil|remifentanil|mesh-list
92194081|NCT04026074|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92194082|NCT04026074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92194083|NCT04026074|Narcotics|narcotics|mesh-ancestor
92194084|NCT04026074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194085|NCT04026074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194086|NCT04026074|Analgesics|analgesics|mesh-ancestor
92194087|NCT04026074|Sensory System Agents|sensory system agents|mesh-ancestor
92194088|NCT04026074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194089|NCT04026074|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92194090|NCT04026074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92194091|NCT04026074|Anesthetics, General|anesthetics, general|mesh-ancestor
92194092|NCT04026074|Anesthetics|anesthetics|mesh-ancestor
92194093|NCT04026074|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92194094|NCT04026074|Sympatholytics|sympatholytics|mesh-ancestor
92194095|NCT04026074|Autonomic Agents|autonomic agents|mesh-ancestor
92194096|NCT04026074|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92194097|NCT04026074|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92194098|NCT04026074|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92194099|NCT04026074|Adrenergic Agents|adrenergic agents|mesh-ancestor
92194100|NCT04026074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939946|NCT04947254|Niraparib|niraparib|mesh-list
92194101|NCT04026074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194102|NCT04026074|Anesthetics, Local|anesthetics, local|mesh-ancestor
92194103|NCT04026074|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92194104|NCT00555997|Ziprasidone|ziprasidone|mesh-list
92194105|NCT00555997|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92194106|NCT00555997|Serotonin Agents|serotonin agents|mesh-ancestor
92194107|NCT00555997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194108|NCT00555997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194109|NCT00555997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194110|NCT00555997|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92194111|NCT00555997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92194112|NCT00555997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194113|NCT00555997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92194114|NCT00555997|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92194115|NCT00555997|Dopamine Agents|dopamine agents|mesh-ancestor
92194116|NCT00446147|Pyridoxine|pyridoxine|mesh-list
92194117|NCT00446147|Vitamin B Complex|vitamin b complex|mesh-ancestor
92194118|NCT00446147|Vitamins|vitamins|mesh-ancestor
92194119|NCT00446147|Micronutrients|micronutrients|mesh-ancestor
92194120|NCT00446147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194121|NCT04345471|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92194122|NCT04345471|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92194123|NCT04345471|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92194124|NCT04345471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194125|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194126|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194127|NCT04345471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194128|NCT04345471|Antidepressive Agents|antidepressive agents|mesh-ancestor
92194129|NCT04345471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92194130|NCT00476021|Levonorgestrel|levonorgestrel|mesh-list
92194131|NCT00476021|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92194132|NCT00476021|Contraceptive Agents|contraceptive agents|mesh-ancestor
92194133|NCT00476021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92194134|NCT00476021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194135|NCT00476021|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92194136|NCT00476021|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92194137|NCT00476021|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92194138|NCT04192292|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92194139|NCT04192292|Gliclazide|gliclazide|mesh-list
92194140|NCT04192292|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92194141|NCT04192292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194142|NCT04192292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194143|NCT04192292|Incretins|incretins|mesh-ancestor
92194144|NCT04192292|Hormones|hormones|mesh-ancestor
92194145|NCT04192292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194147|NCT04192292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194148|NCT04192292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194149|NCT00448175|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92194150|NCT00448175|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92194151|NCT00448175|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92194152|NCT00448175|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194153|NCT00448175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194154|NCT00448175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194155|NCT00448175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194156|NCT00448175|Urological Agents|urological agents|mesh-ancestor
92194157|NCT04176835|Oxytocin|oxytocin|mesh-list
92194158|NCT04176835|Oxytocics|oxytocics|mesh-ancestor
92194159|NCT04176835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92194160|NCT04176835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194161|NCT00476645|Fulvestrant|fulvestrant|mesh-list
92194162|NCT00476645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92194163|NCT00476645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194164|NCT00476645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92194165|NCT00476645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92194166|NCT00476645|Hormone Antagonists|hormone antagonists|mesh-ancestor
92194167|NCT00476645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194168|NCT00476645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194170|NCT00477191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92194171|NCT00477191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194172|NCT00477191|Analgesics|analgesics|mesh-ancestor
92194173|NCT00477191|Sensory System Agents|sensory system agents|mesh-ancestor
92194174|NCT00477191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194175|NCT00477191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194176|NCT00477191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194177|NCT00477191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194178|NCT00477191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194179|NCT00477191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194180|NCT00477191|Immunologic Factors|immunologic factors|mesh-ancestor
92194181|NCT04025918|Phenylephrine|phenylephrine|mesh-list
92194182|NCT04025918|Oxymetazoline|oxymetazoline|mesh-list
92194184|NCT04025918|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92194185|NCT04025918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92194186|NCT04025918|Mydriatics|mydriatics|mesh-ancestor
92194187|NCT04025918|Autonomic Agents|autonomic agents|mesh-ancestor
92194188|NCT04025918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194189|NCT04025918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194190|NCT04025918|Sympathomimetics|sympathomimetics|mesh-ancestor
92194191|NCT04025918|Nasal Decongestants|nasal decongestants|mesh-ancestor
92194192|NCT04025918|Respiratory System Agents|respiratory system agents|mesh-ancestor
92194193|NCT04025918|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92194194|NCT04025918|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92194195|NCT04025918|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92194196|NCT04025918|Adrenergic Agents|adrenergic agents|mesh-ancestor
92194197|NCT04025918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194198|NCT04025918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194199|NCT04025918|Protective Agents|protective agents|mesh-ancestor
92194200|NCT04025918|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92194201|NCT05415397|Celecoxib|celecoxib|mesh-list
92194202|NCT05415397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92194203|NCT05415397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194204|NCT05415397|Analgesics|analgesics|mesh-ancestor
92194205|NCT05415397|Sensory System Agents|sensory system agents|mesh-ancestor
92194206|NCT05415397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194207|NCT05415397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194208|NCT05415397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194209|NCT05415397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194210|NCT05415397|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92194211|NCT05415397|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92194212|NCT05415397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194213|NCT05415397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194214|NCT04406246|Nitazoxanide|nitazoxanide|mesh-list
92194215|NCT04406246|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92194216|NCT04406246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194217|NCT02115347|Ertugliflozin|ertugliflozin|mesh-list
92194218|NCT02115347|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92194219|NCT02115347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194220|NCT02115347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194221|NCT02115347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194222|NCT02115581|Ubiquinone|ubiquinone|mesh-list
92194223|NCT02115581|Coenzyme Q10|coenzyme q10|mesh-list
92194224|NCT02115581|Micronutrients|micronutrients|mesh-ancestor
92194225|NCT02115581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194226|NCT02115581|Vitamins|vitamins|mesh-ancestor
92194227|NCT00477659|Donepezil|donepezil|mesh-list
92194228|NCT00477659|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92194229|NCT00477659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194230|NCT00477659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194231|NCT00477659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194232|NCT00477659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194233|NCT00477659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194234|NCT00477659|Nootropic Agents|nootropic agents|mesh-ancestor
92194235|NCT04191278|Varenicline|varenicline|mesh-list
92194236|NCT04191278|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92194237|NCT04191278|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92194238|NCT04191278|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194239|NCT04191278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194240|NCT04191278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194241|NCT04191278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194242|NCT04148534|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-list
92194243|NCT04148534|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92194244|NCT04148534|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92335047|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
92194245|NCT04148534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194246|NCT04148534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194248|NCT03988387|Emtricitabine|emtricitabine|mesh-list
92194249|NCT03988387|Antiviral Agents|antiviral agents|mesh-ancestor
92194250|NCT03988387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194251|NCT03988387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92194252|NCT03988387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92194253|NCT03988387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194254|NCT03988387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194255|NCT03988387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92194256|NCT03988387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92194257|NCT03748082|Nitric Oxide|nitric oxide|mesh-list
92194258|NCT03748082|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92194259|NCT03748082|Autonomic Agents|autonomic agents|mesh-ancestor
92194260|NCT03748082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194261|NCT03748082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194262|NCT03748082|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92194263|NCT03748082|Respiratory System Agents|respiratory system agents|mesh-ancestor
92194264|NCT03748082|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92194265|NCT03748082|Antioxidants|antioxidants|mesh-ancestor
92194266|NCT03748082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194267|NCT03748082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194268|NCT03748082|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92194269|NCT03748082|Vasodilator Agents|vasodilator agents|mesh-ancestor
92194270|NCT03748082|Gasotransmitters|gasotransmitters|mesh-ancestor
92194271|NCT03748082|Protective Agents|protective agents|mesh-ancestor
92194272|NCT00478361|Paclitaxel|paclitaxel|mesh-list
92194273|NCT00478361|Gemcitabine|gemcitabine|mesh-list
92194274|NCT00478361|Doxorubicin|doxorubicin|mesh-list
92194275|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92194276|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92194277|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194278|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
92194279|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
92194280|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
92194281|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194282|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92194283|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
92194284|NCT00478361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92194285|NCT00478361|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92194286|NCT00478361|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92194287|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194288|NCT02129725|Sildenafil Citrate|sildenafil citrate|mesh-list
92194289|NCT02129725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194290|NCT02129725|Vasodilator Agents|vasodilator agents|mesh-ancestor
92194291|NCT02129725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92194292|NCT02129725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92194293|NCT02129725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194294|NCT02129725|Urological Agents|urological agents|mesh-ancestor
92194295|NCT00483509|Doxorubicin|doxorubicin|mesh-list
92194296|NCT00483509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92194297|NCT00483509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194298|NCT00483509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92194299|NCT00483509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92194300|NCT00483509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194301|NCT00483509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194302|NCT03864211|Immunomodulating Agents|immunomodulating agents|mesh-list
92194303|NCT03864211|Immunologic Factors|immunologic factors|mesh-ancestor
92194304|NCT03864211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194305|NCT03840200|Rucaparib|rucaparib|mesh-list
92194306|NCT03840200|Ipatasertib|ipatasertib|mesh-list
92194307|NCT03840200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92194308|NCT03840200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194309|NCT03840200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194310|NCT03840200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194311|NCT03840200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92194312|NCT03842839|Albuterol|albuterol|mesh-list
92194313|NCT03842839|Tiotropium Bromide|tiotropium bromide|mesh-list
92194314|NCT03842839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92194315|NCT03842839|Autonomic Agents|autonomic agents|mesh-ancestor
92194316|NCT03842839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194317|NCT03842839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194318|NCT03842839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92194319|NCT03842839|Respiratory System Agents|respiratory system agents|mesh-ancestor
92194320|NCT03842839|Parasympatholytics|parasympatholytics|mesh-ancestor
92194321|NCT03842839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92194322|NCT03842839|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194323|NCT03842839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194324|NCT03842839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194325|NCT03842839|Tocolytic Agents|tocolytic agents|mesh-ancestor
92194326|NCT03842839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92194327|NCT03842839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92194328|NCT03842839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92194329|NCT03842839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92194330|NCT03842839|Adrenergic Agents|adrenergic agents|mesh-ancestor
92194331|NCT00450983|Methotrexate|methotrexate|mesh-list
92194332|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
92194333|NCT00450983|Fludarabine|fludarabine|mesh-list
92194334|NCT00450983|Thiotepa|thiotepa|mesh-list
92194335|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
92194336|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92194337|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
92194338|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92194339|NCT00450983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194340|NCT00450983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92194341|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
92194342|NCT00450983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194343|NCT00450983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194344|NCT00450983|Dermatologic Agents|dermatologic agents|mesh-ancestor
92194345|NCT00450983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194346|NCT00450983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92194347|NCT00450983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194348|NCT00450983|Immunologic Factors|immunologic factors|mesh-ancestor
92194349|NCT00450983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194350|NCT00450983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92194351|NCT00450983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92194352|NCT00450983|Alkylating Agents|alkylating agents|mesh-ancestor
92194353|NCT00450983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92194354|NCT01796405|Clofarabine|clofarabine|mesh-list
92194355|NCT01796405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92194356|NCT01796405|Antimetabolites|antimetabolites|mesh-ancestor
92194357|NCT01796405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194358|NCT01796405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194359|NCT03298295|Insulin|insulin|mesh-list
92194360|NCT03298295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194361|NCT03298295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194362|NCT03649321|Paclitaxel|paclitaxel|mesh-list
92194363|NCT03649321|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92194364|NCT03649321|Gemcitabine|gemcitabine|mesh-list
92194365|NCT03649321|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92194366|NCT03649321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194367|NCT03649321|Tubulin Modulators|tubulin modulators|mesh-ancestor
92194368|NCT03649321|Antimitotic Agents|antimitotic agents|mesh-ancestor
92194369|NCT03649321|Mitosis Modulators|mitosis modulators|mesh-ancestor
92194370|NCT03649321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194371|NCT03649321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92194372|NCT03649321|Antimetabolites|antimetabolites|mesh-ancestor
92194374|NCT04149938|Anesthetics, Local|anesthetics, local|mesh-ancestor
92194375|NCT04149938|Anesthetics|anesthetics|mesh-ancestor
92194376|NCT04149938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194377|NCT04149938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194378|NCT04149938|Sensory System Agents|sensory system agents|mesh-ancestor
92194379|NCT04149938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194380|NCT04149938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92194381|NCT04149938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92194382|NCT04149938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92194383|NCT04149938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194384|NCT04149938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194385|NCT01797601|Insulin|insulin|mesh-list
92194386|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92194387|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194388|NCT01797601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194389|NCT02984930|Esomeprazole|esomeprazole|mesh-list
92194390|NCT02984930|Mosapride|mosapride|mesh-list
92194391|NCT02984930|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92194392|NCT02984930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194393|NCT02984930|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92194394|NCT02984930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194395|NCT02984930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194397|NCT02984930|Serotonin Agents|serotonin agents|mesh-ancestor
92194398|NCT02984930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194399|NCT02984930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194400|NCT02123017|Lactulose|lactulose|mesh-list
92194401|NCT02123017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194402|NCT04149626|Midazolam|midazolam|mesh-list
92194403|NCT04149626|Dexmedetomidine|dexmedetomidine|mesh-list
92194404|NCT04149626|Remifentanil|remifentanil|mesh-list
92194405|NCT04149626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92194406|NCT04149626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194407|NCT04149626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194408|NCT04149626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194409|NCT04149626|Analgesics|analgesics|mesh-ancestor
92194410|NCT04149626|Sensory System Agents|sensory system agents|mesh-ancestor
92194411|NCT04149626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194412|NCT04149626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92194413|NCT04149626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92194414|NCT04149626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92194415|NCT04149626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92194416|NCT04149626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194417|NCT04149626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194418|NCT04149626|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92194419|NCT04149626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92194420|NCT04149626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92194421|NCT04149626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92194422|NCT04149626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92194423|NCT04149626|Anesthetics, General|anesthetics, general|mesh-ancestor
92194424|NCT04149626|Anesthetics|anesthetics|mesh-ancestor
92194425|NCT04149626|GABA Modulators|gaba modulators|mesh-ancestor
92194426|NCT04149626|GABA Agents|gaba agents|mesh-ancestor
92194427|NCT04149626|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92194428|NCT04149626|Narcotics|narcotics|mesh-ancestor
92194429|NCT00486863|Praziquantel|praziquantel|mesh-list
92194430|NCT00486863|Anthelmintics|anthelmintics|mesh-ancestor
92194431|NCT00486863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92194432|NCT00486863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194433|NCT03934814|Rituximab|rituximab|mesh-list
92194434|NCT03934814|Pembrolizumab|pembrolizumab|mesh-list
92194435|NCT03934814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92194436|NCT03934814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194437|NCT03934814|Immunologic Factors|immunologic factors|mesh-ancestor
92194438|NCT03934814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194439|NCT03934814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194440|NCT03934814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92194441|NCT03934814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194442|NCT04023344|Insulin Lispro|insulin lispro|mesh-list
92194443|NCT04023344|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194444|NCT04023344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194445|NCT00452387|Prednisone|prednisone|mesh-list
92194446|NCT00452387|Sorafenib|sorafenib|mesh-list
92194447|NCT00452387|Mitoxantrone|mitoxantrone|mesh-list
92194448|NCT00452387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194449|NCT00452387|Glucocorticoids|glucocorticoids|mesh-ancestor
92194450|NCT00452387|Hormones|hormones|mesh-ancestor
92194451|NCT00452387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194452|NCT00452387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194453|NCT00452387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92194454|NCT00452387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194455|NCT00452387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92194456|NCT00452387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194457|NCT00452387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194458|NCT00452387|Analgesics|analgesics|mesh-ancestor
92194459|NCT00452387|Sensory System Agents|sensory system agents|mesh-ancestor
92194460|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335062|NCT00385645|Zidovudine|zidovudine|mesh-list
92194461|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92194463|NCT03945656|Insulin|insulin|mesh-list
92194464|NCT03945656|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92194465|NCT03945656|Insulin Glargine|insulin glargine|mesh-list
92194466|NCT03945656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194467|NCT03945656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194468|NCT00452543|Acamprosate|acamprosate|mesh-list
92194469|NCT00452543|Dexetimide|dexetimide|mesh-list
92194470|NCT00452543|Citalopram|citalopram|mesh-list
92194471|NCT00452543|Escitalopram|escitalopram|mesh-list
92194472|NCT00452543|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92194473|NCT00452543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92194474|NCT00452543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194475|NCT00452543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194476|NCT00452543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194477|NCT00452543|Serotonin Agents|serotonin agents|mesh-ancestor
92074226|NCT01475253|Lidocaine|lidocaine|mesh-list
92194478|NCT00452543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194479|NCT00452543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92194480|NCT00452543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92194481|NCT00452543|Parasympatholytics|parasympatholytics|mesh-ancestor
92194482|NCT00452543|Autonomic Agents|autonomic agents|mesh-ancestor
92194483|NCT00452543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194484|NCT00452543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92194485|NCT00452543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92194486|NCT00452543|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194487|NCT00452543|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92194488|NCT00452543|Antidepressive Agents|antidepressive agents|mesh-ancestor
92194489|NCT00452543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92194490|NCT00452543|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92194491|NCT04961359|Vaccines|vaccines|mesh-list
92194492|NCT04961359|Immunologic Factors|immunologic factors|mesh-ancestor
92194493|NCT04961359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194494|NCT05621707|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92194495|NCT05621707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194496|NCT05621707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92194497|NCT05621707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194498|NCT04765904|Fluorides|fluorides|mesh-list
92194499|NCT04765904|Cariostatic Agents|cariostatic agents|mesh-ancestor
92194500|NCT04765904|Protective Agents|protective agents|mesh-ancestor
92194501|NCT04765904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194502|NCT05621551|Dapagliflozin|dapagliflozin|mesh-list
92194503|NCT05621551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92194504|NCT05621551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194505|NCT05621551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194506|NCT05621551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194507|NCT00565669|Cyclosporine|cyclosporine|mesh-list
92194508|NCT00565669|Cyclosporins|cyclosporins|mesh-list
92194509|NCT00565669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194510|NCT00565669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194511|NCT00565669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194512|NCT00565669|Immunologic Factors|immunologic factors|mesh-ancestor
92194513|NCT00565669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194514|NCT00565669|Antifungal Agents|antifungal agents|mesh-ancestor
92194515|NCT00565669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194516|NCT00565669|Dermatologic Agents|dermatologic agents|mesh-ancestor
92194517|NCT00565669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194519|NCT04165135|Factor VIII|factor viii|mesh-list
92194520|NCT04165135|Coagulants|coagulants|mesh-ancestor
92194521|NCT02132533|Nifedipine|nifedipine|mesh-list
92194522|NCT02132533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92194523|NCT02132533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194524|NCT02132533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194525|NCT02132533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92194526|NCT02132533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194527|NCT02132533|Vasodilator Agents|vasodilator agents|mesh-ancestor
92194528|NCT02132533|Tocolytic Agents|tocolytic agents|mesh-ancestor
92194529|NCT02132533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92194530|NCT03926702|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92194531|NCT03926702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194532|NCT00567229|Rituximab|rituximab|mesh-list
92194533|NCT00567229|Lenalidomide|lenalidomide|mesh-list
92194534|NCT00567229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92194535|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194536|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
92194537|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194538|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194539|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92194540|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92194541|NCT00567229|Growth Substances|growth substances|mesh-ancestor
92194542|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
92194543|NCT04148846|Dexamethasone|dexamethasone|mesh-list
92194544|NCT04148846|Ketoprofen|ketoprofen|mesh-list
92194545|NCT04148846|Theophylline|theophylline|mesh-list
92194546|NCT04148846|Gabapentin|gabapentin|mesh-list
92194548|NCT04148846|Antiemetics|antiemetics|mesh-ancestor
92194549|NCT04148846|Autonomic Agents|autonomic agents|mesh-ancestor
92194550|NCT04148846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194551|NCT04148846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194552|NCT04148846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194553|NCT04148846|Glucocorticoids|glucocorticoids|mesh-ancestor
92194554|NCT04148846|Hormones|hormones|mesh-ancestor
92194555|NCT04148846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194556|NCT04148846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92194557|NCT04148846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194558|NCT04148846|Analgesics|analgesics|mesh-ancestor
92194559|NCT04148846|Sensory System Agents|sensory system agents|mesh-ancestor
92194560|NCT04148846|Anticonvulsants|anticonvulsants|mesh-ancestor
92194561|NCT04148846|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92194562|NCT04148846|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92194563|NCT04148846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194564|NCT04148846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92194565|NCT04148846|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92194566|NCT04148846|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92194567|NCT04148846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194568|NCT04148846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194569|NCT04148846|Antimanic Agents|antimanic agents|mesh-ancestor
92194570|NCT04148846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92194571|NCT04148846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194572|NCT04148846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194573|NCT04148846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92194574|NCT04148846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194575|NCT04148846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92194576|NCT04148846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92194577|NCT04148846|Respiratory System Agents|respiratory system agents|mesh-ancestor
92194578|NCT04148846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92194579|NCT04148846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92194580|NCT04148846|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92194581|NCT04148846|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92194582|NCT04148846|Purinergic Agents|purinergic agents|mesh-ancestor
92194583|NCT00568087|Acetylcysteine|acetylcysteine|mesh-list
92194584|NCT00568087|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92194585|NCT00568087|Antiviral Agents|antiviral agents|mesh-ancestor
92194586|NCT00568087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194587|NCT00568087|Expectorants|expectorants|mesh-ancestor
92194588|NCT00568087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92194589|NCT00568087|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92194590|NCT00568087|Antioxidants|antioxidants|mesh-ancestor
92194591|NCT00568087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194592|NCT00568087|Protective Agents|protective agents|mesh-ancestor
92194593|NCT00568087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194595|NCT00487721|Silymarin|silymarin|mesh-list
92194596|NCT00487721|Antioxidants|antioxidants|mesh-ancestor
92194597|NCT00487721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194598|NCT00487721|Protective Agents|protective agents|mesh-ancestor
92194599|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194600|NCT00568633|Cyclosporine|cyclosporine|mesh-list
92194601|NCT00568633|Mycophenolic Acid|mycophenolic acid|mesh-list
92194602|NCT00568633|Methylprednisolone|methylprednisolone|mesh-list
92194603|NCT00568633|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92194604|NCT00568633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92194605|NCT00568633|Prednisolone|prednisolone|mesh-list
92194606|NCT00568633|Prednisolone acetate|prednisolone acetate|mesh-list
92194607|NCT00568633|Cyclosporins|cyclosporins|mesh-list
92194608|NCT00568633|Thymoglobulin|thymoglobulin|mesh-list
92194609|NCT00568633|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92194610|NCT00568633|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92194611|NCT00568633|Prednisolone phosphate|prednisolone phosphate|mesh-list
92194612|NCT00568633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194613|NCT00568633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194614|NCT00568633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194615|NCT00568633|Immunologic Factors|immunologic factors|mesh-ancestor
92194616|NCT00568633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194617|NCT00568633|Antifungal Agents|antifungal agents|mesh-ancestor
92194618|NCT00568633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194619|NCT00568633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92194620|NCT00568633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194621|NCT00568633|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92194622|NCT00568633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92194623|NCT00568633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194624|NCT00568633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92194625|NCT00568633|Antitubercular Agents|antitubercular agents|mesh-ancestor
92194626|NCT00568633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92194627|NCT00568633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194628|NCT00568633|Antiemetics|antiemetics|mesh-ancestor
92194629|NCT00568633|Autonomic Agents|autonomic agents|mesh-ancestor
92194630|NCT00568633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194631|NCT00568633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92194632|NCT00568633|Glucocorticoids|glucocorticoids|mesh-ancestor
92194633|NCT00568633|Hormones|hormones|mesh-ancestor
92194634|NCT00568633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194635|NCT00568633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92194636|NCT00568633|Protective Agents|protective agents|mesh-ancestor
92194637|NCT00568633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92194638|NCT03022838|Caffeine|caffeine|mesh-list
92194639|NCT03022838|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92194640|NCT03022838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194641|NCT03022838|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92194642|NCT03022838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194643|NCT03022838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194644|NCT03022838|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92194645|NCT03022838|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92194646|NCT03022838|Purinergic Agents|purinergic agents|mesh-ancestor
92194647|NCT03022838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194648|NCT05363449|Naftifine|naftifine|mesh-list
92194649|NCT05363449|Antifungal Agents|antifungal agents|mesh-ancestor
92194650|NCT05363449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194651|NCT00489281|Mycophenolic Acid|mycophenolic acid|mesh-list
92194652|NCT00489281|Sirolimus|sirolimus|mesh-list
92194653|NCT00489281|Cyclophosphamide|cyclophosphamide|mesh-list
92194654|NCT00489281|Fludarabine|fludarabine|mesh-list
92194655|NCT00489281|Levetiracetam|levetiracetam|mesh-list
92194656|NCT00489281|Thymoglobulin|thymoglobulin|mesh-list
92194657|NCT00489281|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92194658|NCT00489281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194659|NCT00489281|Immunologic Factors|immunologic factors|mesh-ancestor
92194660|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194661|NCT00489281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194662|NCT00489281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92194663|NCT00489281|Alkylating Agents|alkylating agents|mesh-ancestor
92194664|NCT00489281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194665|NCT00489281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194666|NCT00489281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92194667|NCT00489281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92194668|NCT00489281|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92194670|NCT00489281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92194671|NCT00489281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194672|NCT00489281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194673|NCT00489281|Antifungal Agents|antifungal agents|mesh-ancestor
92194674|NCT00489281|Anticonvulsants|anticonvulsants|mesh-ancestor
92194675|NCT00489281|Nootropic Agents|nootropic agents|mesh-ancestor
92194676|NCT05362513|Ivermectin|ivermectin|mesh-list
92194677|NCT05362513|Permethrin|permethrin|mesh-list
92194678|NCT05362513|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92194679|NCT05362513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194680|NCT05362513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335071|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
92194681|NCT05362513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194682|NCT04457297|Trifluridine|trifluridine|mesh-list
92194683|NCT04457297|Antimetabolites|antimetabolites|mesh-ancestor
92194684|NCT04457297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194685|NCT04457297|Antiviral Agents|antiviral agents|mesh-ancestor
92194686|NCT04457297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194687|NCT04146116|Povidone-Iodine|povidone-iodine|mesh-list
92194688|NCT04146116|Povidone|povidone|mesh-list
92194689|NCT04146116|Plasma Substitutes|plasma substitutes|mesh-ancestor
92194690|NCT04146116|Blood Substitutes|blood substitutes|mesh-ancestor
92194691|NCT04146116|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92194692|NCT04146116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194693|NCT04145804|Insulin|insulin|mesh-list
92194694|NCT04145804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194695|NCT04145804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194696|NCT02120261|Triamcinolone|triamcinolone|mesh-list
92194697|NCT02120261|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92194698|NCT02120261|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92194699|NCT02120261|Lidocaine|lidocaine|mesh-list
92194700|NCT02120261|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92194701|NCT02120261|Anesthetics, Local|anesthetics, local|mesh-ancestor
92194702|NCT02120261|Anesthetics|anesthetics|mesh-ancestor
92194703|NCT02120261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194704|NCT02120261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194705|NCT02120261|Sensory System Agents|sensory system agents|mesh-ancestor
92194706|NCT02120261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194707|NCT02120261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92194708|NCT02120261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92194709|NCT02120261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92194710|NCT02120261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194711|NCT02120261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194712|NCT02120261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194713|NCT02120261|Glucocorticoids|glucocorticoids|mesh-ancestor
92194714|NCT02120261|Hormones|hormones|mesh-ancestor
92194715|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92194716|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194717|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
92194718|NCT02120261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194719|NCT03907046|Aspirin|aspirin|mesh-list
92194720|NCT03907046|Apixaban|apixaban|mesh-list
92194721|NCT03907046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92194722|NCT03907046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194723|NCT03907046|Analgesics|analgesics|mesh-ancestor
92194724|NCT03907046|Sensory System Agents|sensory system agents|mesh-ancestor
92194725|NCT03907046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194726|NCT03907046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194727|NCT03907046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194728|NCT03907046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194729|NCT03907046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92194730|NCT03907046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92194731|NCT03907046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194732|NCT03907046|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92194733|NCT03907046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92194734|NCT03907046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194735|NCT03907046|Antipyretics|antipyretics|mesh-ancestor
92194736|NCT03907046|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92194737|NCT03907046|Antithrombins|antithrombins|mesh-ancestor
92194738|NCT03907046|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92194739|NCT03907046|Protease Inhibitors|protease inhibitors|mesh-ancestor
92194740|NCT03907046|Anticoagulants|anticoagulants|mesh-ancestor
92194741|NCT03840421|Cisplatin|cisplatin|mesh-list
92194742|NCT03840421|Gemcitabine|gemcitabine|mesh-list
92194743|NCT03840421|Fluorouracil|fluorouracil|mesh-list
92194744|NCT03840421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194745|NCT03840421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92194746|NCT03840421|Antimetabolites|antimetabolites|mesh-ancestor
92194747|NCT03840421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194748|NCT03840421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194749|NCT03840421|Immunologic Factors|immunologic factors|mesh-ancestor
92194750|NCT03840421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194751|NCT00492089|Bevacizumab|bevacizumab|mesh-list
92194752|NCT00492089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92194753|NCT00492089|Antibodies|antibodies|mesh-list
92194754|NCT00492089|Immunoglobulins|immunoglobulins|mesh-list
92194755|NCT00492089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92194756|NCT00492089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194757|NCT00492089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92194758|NCT00492089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92194759|NCT00492089|Growth Substances|growth substances|mesh-ancestor
92194760|NCT00492089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194761|NCT00492089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92194762|NCT00492089|Immunologic Factors|immunologic factors|mesh-ancestor
92194763|NCT01798537|Vancomycin|vancomycin|mesh-list
92194764|NCT01798537|Colistin|colistin|mesh-list
92194765|NCT01798537|Neomycin|neomycin|mesh-list
92194766|NCT01798537|Nystatin|nystatin|mesh-list
92194767|NCT01798537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92194768|NCT01798537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194769|NCT01798537|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92194770|NCT01798537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194771|NCT01798537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194772|NCT01798537|Antifungal Agents|antifungal agents|mesh-ancestor
92194773|NCT01798537|Ionophores|ionophores|mesh-ancestor
92194774|NCT01798537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194775|NCT04315181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92194776|NCT04315181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194777|NCT04315181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194778|NCT03805477|Nintedanib|nintedanib|mesh-list
92194779|NCT03805477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194780|NCT03805477|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92194781|NCT03805477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194782|NCT03805477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194783|NCT04140422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92194784|NCT04140422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92194785|NCT01797341|Tacrolimus|tacrolimus|mesh-list
92194786|NCT01797341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92194787|NCT01797341|Immunologic Factors|immunologic factors|mesh-ancestor
92194788|NCT01797341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194789|NCT01797341|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92194790|NCT01797341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194791|NCT01797341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194792|NCT04145570|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92194793|NCT04145570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194794|NCT04145570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92194795|NCT04145570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194796|NCT04145570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194797|NCT04145492|Vitamin D|vitamin d|mesh-list
92194798|NCT04145492|Cholecalciferol|cholecalciferol|mesh-list
92194799|NCT04145492|Calcifediol|calcifediol|mesh-list
92194800|NCT04145492|Vitamins|vitamins|mesh-list
92194801|NCT04145492|Vitamin K|vitamin k|mesh-list
92194802|NCT04145492|Vitamin K 2|vitamin k 2|mesh-list
92194803|NCT04145492|Micronutrients|micronutrients|mesh-ancestor
92194804|NCT04145492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194805|NCT04145492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92194806|NCT04145492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92194807|NCT04145492|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92194808|NCT04145492|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92194809|NCT04145492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194810|NCT04145492|Hemostatics|hemostatics|mesh-ancestor
92194811|NCT04145492|Coagulants|coagulants|mesh-ancestor
92194812|NCT04147754|Morphine|morphine|mesh-list
92194813|NCT04147754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194814|NCT04147754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194815|NCT04147754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92194816|NCT04147754|Narcotics|narcotics|mesh-ancestor
92194817|NCT04147754|Analgesics|analgesics|mesh-ancestor
92194818|NCT04147754|Sensory System Agents|sensory system agents|mesh-ancestor
92194819|NCT04147754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194820|NCT00492401|Decitabine|decitabine|mesh-list
92194821|NCT00492401|Azacitidine|azacitidine|mesh-list
92194822|NCT00492401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92194823|NCT00492401|Antimetabolites|antimetabolites|mesh-ancestor
92194824|NCT00492401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194825|NCT00492401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194826|NCT00492401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194827|NCT03674827|Immunomodulating Agents|immunomodulating agents|mesh-list
92194828|NCT03674827|Immunologic Factors|immunologic factors|mesh-ancestor
92194829|NCT03674827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194831|NCT04147286|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92194832|NCT04147286|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92194833|NCT04147286|Antimetabolites|antimetabolites|mesh-ancestor
92194834|NCT04147286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194835|NCT04147286|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92194836|NCT04147286|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92194837|NCT04147286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194838|NCT00493181|Oprelvekin|oprelvekin|mesh-list
92194839|NCT00493181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194840|NCT04143659|Levonorgestrel|levonorgestrel|mesh-list
92194841|NCT04143659|Levonorgestrel butanoate|levonorgestrel butanoate|mesh-list
92194842|NCT04143659|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92194843|NCT04143659|Contraceptive Agents|contraceptive agents|mesh-ancestor
92194844|NCT04143659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92194845|NCT04143659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194846|NCT04143659|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92194847|NCT04143659|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92194848|NCT04143659|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92194849|NCT04143659|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92194850|NCT00493805|Interferons|interferons|mesh-list
92194851|NCT00493805|Ribavirin|ribavirin|mesh-list
92194852|NCT00493805|Interferon-alpha|interferon-alpha|mesh-list
92194853|NCT00493805|Interferon alpha-2|interferon alpha-2|mesh-list
92194854|NCT00493805|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92194855|NCT00493805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194856|NCT00493805|Antiviral Agents|antiviral agents|mesh-ancestor
92194857|NCT00493805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194858|NCT00493805|Antimetabolites|antimetabolites|mesh-ancestor
92194859|NCT00493805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194860|NCT00493805|Immunologic Factors|immunologic factors|mesh-ancestor
92194861|NCT00493805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194862|NCT04145102|Propolis|propolis|mesh-list
92194863|NCT04145102|Fluorides|fluorides|mesh-list
92194864|NCT04145102|Cariostatic Agents|cariostatic agents|mesh-ancestor
92194865|NCT04145102|Protective Agents|protective agents|mesh-ancestor
92194866|NCT04145102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194867|NCT04145102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194868|NCT05581706|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92194869|NCT05581706|Calcium|calcium|mesh-list
92194870|NCT05581706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92194871|NCT05581706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194872|NCT05581706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194873|NCT03558373|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92194874|NCT03558373|Immunologic Factors|immunologic factors|mesh-ancestor
92194875|NCT03558373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194876|NCT05183191|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92194877|NCT05183191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194878|NCT03588494|Endostar protein|endostar protein|mesh-list
92194879|NCT03588494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92194880|NCT03588494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92194881|NCT03588494|Growth Substances|growth substances|mesh-ancestor
92194882|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194883|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
92194884|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194885|NCT00550277|Panobinostat|panobinostat|mesh-list
92194886|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194887|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92194888|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194889|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194890|NCT03921242|Metformin|metformin|mesh-list
92194891|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92194892|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92194893|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92194894|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194895|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194896|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
92194897|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194899|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
92194900|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92194901|NCT00550589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194902|NCT00550589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194903|NCT04144712|Caffeine|caffeine|mesh-list
92194904|NCT04144712|Caffeine citrate|caffeine citrate|mesh-list
92194905|NCT04144712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194906|NCT04144712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92194907|NCT04144712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194908|NCT04144712|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92194909|NCT04144712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194910|NCT04144712|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92194911|NCT04144712|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92194912|NCT04144712|Purinergic Agents|purinergic agents|mesh-ancestor
92194913|NCT04144712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194914|NCT03588338|Acetaminophen|acetaminophen|mesh-list
92194915|NCT03588338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194916|NCT03588338|Analgesics|analgesics|mesh-ancestor
92194917|NCT03588338|Sensory System Agents|sensory system agents|mesh-ancestor
92194918|NCT03588338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194919|NCT03588338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194920|NCT03588338|Antipyretics|antipyretics|mesh-ancestor
92194921|NCT05099185|Trace Elements|trace elements|mesh-list
92194922|NCT05099185|Micronutrients|micronutrients|mesh-list
92194923|NCT05099185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194924|NCT05068609|Nivolumab|nivolumab|mesh-list
92194925|NCT05068609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92194926|NCT05068609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194927|NCT05068609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92194928|NCT05068609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194929|NCT00496379|Epothilones|epothilones|mesh-list
92194930|NCT00496379|Sagopilone|sagopilone|mesh-list
92194931|NCT00496379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92194932|NCT00496379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92194933|NCT00496379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92194934|NCT00496379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194935|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194936|NCT00497081|Mirtazapine|mirtazapine|mesh-list
92194937|NCT00497081|Antidepressive Agents|antidepressive agents|mesh-ancestor
92194938|NCT00497081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92194939|NCT00497081|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92194940|NCT00497081|Histamine Antagonists|histamine antagonists|mesh-ancestor
92194941|NCT00497081|Histamine Agents|histamine agents|mesh-ancestor
92194942|NCT00497081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194943|NCT00497081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194944|NCT00497081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194945|NCT00497081|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92194946|NCT00497081|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92194947|NCT00497081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92194948|NCT00497081|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92194949|NCT00497081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92194950|NCT00497081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92194951|NCT00497081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92194952|NCT00497081|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92194953|NCT00497081|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92194954|NCT00497081|Serotonin Agents|serotonin agents|mesh-ancestor
92194955|NCT00497081|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92194956|NCT01796951|Aspirin|aspirin|mesh-list
92194957|NCT01796951|Celecoxib|celecoxib|mesh-list
92194958|NCT01796951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92194959|NCT01796951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92194961|NCT01796951|Sensory System Agents|sensory system agents|mesh-ancestor
92194962|NCT01796951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194963|NCT01796951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194964|NCT01796951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92194965|NCT01796951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92194966|NCT01796951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92194967|NCT01796951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92194968|NCT01796951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194969|NCT01796951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92194970|NCT01796951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92194971|NCT01796951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194972|NCT01796951|Antipyretics|antipyretics|mesh-ancestor
92194973|NCT01796951|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92194974|NCT04838041|Imatinib Mesylate|imatinib mesylate|mesh-list
92194975|NCT04838041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92194976|NCT04838041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92194977|NCT04838041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194978|NCT04838041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194979|NCT03895502|Edoxaban|edoxaban|mesh-list
92194980|NCT03895502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92194981|NCT03895502|Antithrombins|antithrombins|mesh-ancestor
92194982|NCT03895502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92194983|NCT03895502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92194984|NCT03895502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92194985|NCT03895502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194986|NCT03895502|Anticoagulants|anticoagulants|mesh-ancestor
92194987|NCT04143854|Botulinum Toxins|botulinum toxins|mesh-list
92194988|NCT04143854|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92194989|NCT04143854|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92194990|NCT04143854|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92194991|NCT04143854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92194992|NCT04143854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92194993|NCT04143854|Cholinergic Agents|cholinergic agents|mesh-ancestor
92194994|NCT04143854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92194995|NCT04143854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92194996|NCT04143854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92194997|NCT04143854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92194998|NCT03587558|Flecainide|flecainide|mesh-list
92194999|NCT03587558|Carvedilol|carvedilol|mesh-list
92195000|NCT03587558|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92195001|NCT03587558|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92195002|NCT03587558|Adrenergic Agents|adrenergic agents|mesh-ancestor
92195003|NCT03587558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195004|NCT03587558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195005|NCT03587558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195006|NCT03587558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92195007|NCT03587558|Antioxidants|antioxidants|mesh-ancestor
92195008|NCT03587558|Protective Agents|protective agents|mesh-ancestor
92195009|NCT03587558|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92195010|NCT03587558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195011|NCT03587558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92195012|NCT03587558|Vasodilator Agents|vasodilator agents|mesh-ancestor
92195013|NCT03587558|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92195014|NCT03587558|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92195015|NCT03587558|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92195016|NCT03587558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92195017|NCT03587558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92195018|NCT04415905|Propofol|propofol|mesh-list
92195019|NCT04415905|Sevoflurane|sevoflurane|mesh-list
92195020|NCT04415905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92195021|NCT04415905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195022|NCT04415905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195023|NCT04415905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92195024|NCT04415905|Anesthetics, General|anesthetics, general|mesh-ancestor
92195025|NCT04415905|Anesthetics|anesthetics|mesh-ancestor
92195026|NCT04415905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92195027|NCT04415905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92195028|NCT02979704|Atorvastatin|atorvastatin|mesh-list
92195029|NCT02979704|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92195030|NCT02979704|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92195031|NCT02979704|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92195032|NCT02979704|Antimetabolites|antimetabolites|mesh-ancestor
92195033|NCT02979704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195034|NCT02979704|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92327633|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92195035|NCT02979704|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92195036|NCT02979704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195037|NCT03587324|Clopidogrel|clopidogrel|mesh-list
92195038|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92195039|NCT03587324|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92195040|NCT03587324|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92195041|NCT03587324|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92195042|NCT03587324|Purinergic Agents|purinergic agents|mesh-ancestor
92195043|NCT03587324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195044|NCT03587324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195045|NCT03587324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195047|NCT03919292|Anticonvulsants|anticonvulsants|mesh-ancestor
92195048|NCT03919292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195049|NCT03919292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195050|NCT03919292|GABA Agents|gaba agents|mesh-ancestor
92195051|NCT03919292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195052|NCT03919292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195053|NCT03919292|Antimanic Agents|antimanic agents|mesh-ancestor
92195054|NCT03919292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92195055|NCT03919292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195056|NCT03919292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195057|NCT01798459|Methylphenidate|methylphenidate|mesh-list
92195058|NCT01798459|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92195059|NCT01798459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195060|NCT01798459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92195061|NCT01798459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92195062|NCT01798459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195063|NCT01798459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195064|NCT01798459|Dopamine Agents|dopamine agents|mesh-ancestor
92195065|NCT01798459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195066|NCT01980355|Tranexamic Acid|tranexamic acid|mesh-list
92195067|NCT01980355|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92195068|NCT01980355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92195069|NCT01980355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195070|NCT01980355|Hemostatics|hemostatics|mesh-ancestor
92195071|NCT01980355|Coagulants|coagulants|mesh-ancestor
92195072|NCT00555321|Mycophenolic Acid|mycophenolic acid|mesh-list
92195074|NCT00555321|Tacrolimus|tacrolimus|mesh-list
92195075|NCT00555321|Basiliximab|basiliximab|mesh-list
92195076|NCT00555321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195077|NCT00555321|Immunologic Factors|immunologic factors|mesh-ancestor
92195078|NCT00555321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195079|NCT00555321|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92195080|NCT00555321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195081|NCT00555321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195082|NCT00555321|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92195083|NCT00555321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195084|NCT00555321|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92195085|NCT00555321|Antitubercular Agents|antitubercular agents|mesh-ancestor
92195086|NCT00555321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195087|NCT00555321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195088|NCT00555321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92195089|NCT00555321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195090|NCT00555321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195091|NCT05583266|Pentoxifylline|pentoxifylline|mesh-list
92195092|NCT05583266|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92195093|NCT05583266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195094|NCT05583266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195095|NCT05583266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92195096|NCT05583266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92195097|NCT05583266|Protective Agents|protective agents|mesh-ancestor
92195098|NCT05583266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195099|NCT05583266|Vasodilator Agents|vasodilator agents|mesh-ancestor
92195100|NCT05583266|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92195101|NCT05583266|Antioxidants|antioxidants|mesh-ancestor
92195102|NCT04142840|Dexmedetomidine|dexmedetomidine|mesh-list
92195103|NCT04142840|Propofol|propofol|mesh-list
92195104|NCT04142840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92195105|NCT04142840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195106|NCT04142840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195107|NCT04142840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195108|NCT04142840|Analgesics|analgesics|mesh-ancestor
92195109|NCT04142840|Sensory System Agents|sensory system agents|mesh-ancestor
92195110|NCT04142840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195111|NCT04142840|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92195112|NCT04142840|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92195113|NCT04142840|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92195114|NCT04142840|Adrenergic Agents|adrenergic agents|mesh-ancestor
92195115|NCT04142840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195116|NCT04142840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195118|NCT04142840|Anesthetics, General|anesthetics, general|mesh-ancestor
92195119|NCT04142840|Anesthetics|anesthetics|mesh-ancestor
92195120|NCT04142762|Itraconazole|itraconazole|mesh-list
92195121|NCT04142762|Rifampin|rifampin|mesh-list
92195122|NCT04142762|Midazolam|midazolam|mesh-list
92195123|NCT04142762|Esomeprazole|esomeprazole|mesh-list
92195124|NCT04142762|Levonorgestrel|levonorgestrel|mesh-list
92195125|NCT04142762|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92195126|NCT04142762|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92195127|NCT04142762|Contraceptive Agents|contraceptive agents|mesh-list
92195128|NCT04142762|Contraceptives, Oral|contraceptives, oral|mesh-list
92195129|NCT04142762|Estradiol|estradiol|mesh-list
92195130|NCT04142762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92195131|NCT04142762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92195132|NCT04142762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195133|NCT04142762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195134|NCT04142762|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92195135|NCT04142762|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92195136|NCT04142762|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195137|NCT04142762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92195138|NCT04142762|Anesthetics, General|anesthetics, general|mesh-ancestor
92195139|NCT04142762|Anesthetics|anesthetics|mesh-ancestor
92195140|NCT04142762|GABA Modulators|gaba modulators|mesh-ancestor
92195141|NCT04142762|GABA Agents|gaba agents|mesh-ancestor
92195142|NCT04142762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195143|NCT04142762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195144|NCT04142762|Estrogens|estrogens|mesh-ancestor
92195145|NCT04142762|Hormones|hormones|mesh-ancestor
92195146|NCT04142762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92195147|NCT04142762|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92195148|NCT04142762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195149|NCT04142762|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92195150|NCT04142762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92195151|NCT04142762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195152|NCT04142762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92195153|NCT04142762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195154|NCT04142762|Antifungal Agents|antifungal agents|mesh-ancestor
92195155|NCT04142762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195156|NCT04142762|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92195157|NCT04142762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92195158|NCT04142762|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92195159|NCT04142762|Hormone Antagonists|hormone antagonists|mesh-ancestor
92195160|NCT04142762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92195161|NCT04142762|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92195162|NCT04142762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92195163|NCT04142762|Antitubercular Agents|antitubercular agents|mesh-ancestor
92195164|NCT04142762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195165|NCT04142762|Leprostatic Agents|leprostatic agents|mesh-ancestor
92195166|NCT04142762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92195167|NCT04142762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92195168|NCT04142762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92195169|NCT04142762|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92195170|NCT04142762|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92195171|NCT04142762|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92195172|NCT04142762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92195173|NCT04142762|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92195174|NCT04142762|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92195175|NCT05582876|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92195176|NCT05582876|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92195177|NCT05582876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195178|NCT02139007|Alendronate|alendronate|mesh-list
92195179|NCT02139007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92195180|NCT02139007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195181|NCT01590277|Ethanol|ethanol|mesh-list
92195182|NCT01590277|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92195183|NCT01590277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195184|NCT01590277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195185|NCT01590277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195186|NCT03586466|Buprenorphine|buprenorphine|mesh-list
92195187|NCT03586466|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92195188|NCT03586466|Naloxone|naloxone|mesh-list
92195189|NCT03586466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92195190|NCT03586466|Narcotics|narcotics|mesh-ancestor
92195191|NCT03586466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195192|NCT03586466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195193|NCT03586466|Analgesics|analgesics|mesh-ancestor
92195194|NCT03586466|Sensory System Agents|sensory system agents|mesh-ancestor
92195195|NCT03586466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195196|NCT03586466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92195197|NCT00570349|Nitric Oxide|nitric oxide|mesh-list
92195198|NCT00570349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92195199|NCT00570349|Autonomic Agents|autonomic agents|mesh-ancestor
92195200|NCT00570349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195201|NCT00570349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195202|NCT00570349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92195203|NCT00570349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92195204|NCT00570349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92195205|NCT00570349|Antioxidants|antioxidants|mesh-ancestor
92195206|NCT00570349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195207|NCT00570349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195208|NCT00570349|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92195209|NCT00570349|Vasodilator Agents|vasodilator agents|mesh-ancestor
92195210|NCT00570349|Gasotransmitters|gasotransmitters|mesh-ancestor
92195211|NCT00570349|Protective Agents|protective agents|mesh-ancestor
92195212|NCT03586388|Immunomodulating Agents|immunomodulating agents|mesh-list
92195213|NCT03586388|Immunologic Factors|immunologic factors|mesh-ancestor
92195214|NCT03586388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195215|NCT02985086|Cefoxitin|cefoxitin|mesh-list
92195216|NCT02985086|Misoprostol|misoprostol|mesh-list
92195217|NCT02985086|Oxytocin|oxytocin|mesh-list
92195218|NCT02985086|Oxytocics|oxytocics|mesh-ancestor
92195219|NCT02985086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195220|NCT02985086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195221|NCT02985086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92195222|NCT02985086|Abortifacient Agents|abortifacient agents|mesh-ancestor
92195223|NCT02985086|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92195224|NCT02985086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195225|NCT02985086|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195226|NCT02985086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195228|NCT04157985|Nivolumab|nivolumab|mesh-list
92195229|NCT04157985|Ipilimumab|ipilimumab|mesh-list
92195230|NCT04157985|Atezolizumab|atezolizumab|mesh-list
92195231|NCT04157985|Cemiplimab|cemiplimab|mesh-list
92335112|NCT00005791|Fluorouracil|fluorouracil|mesh-list
92195232|NCT04157985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91939965|NCT04947254|Vitamins|vitamins|mesh-ancestor
92195233|NCT04157985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195234|NCT04157985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195235|NCT04157985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195237|NCT00609739|Cyclosporine|cyclosporine|mesh-list
92195238|NCT00609739|Methylprednisolone|methylprednisolone|mesh-list
92195239|NCT00609739|Methotrexate|methotrexate|mesh-list
92195240|NCT00609739|Mitoxantrone|mitoxantrone|mesh-list
92195241|NCT00609739|Tretinoin|tretinoin|mesh-list
92195242|NCT00609739|Isotretinoin|isotretinoin|mesh-list
92195243|NCT00609739|Cyclosporins|cyclosporins|mesh-list
92195244|NCT00609739|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92195245|NCT00609739|Abortifacient Agents|abortifacient agents|mesh-ancestor
92195246|NCT00609739|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195247|NCT00609739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195248|NCT00609739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195249|NCT00609739|Antimetabolites|antimetabolites|mesh-ancestor
92195250|NCT00609739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195251|NCT00609739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195252|NCT00609739|Dermatologic Agents|dermatologic agents|mesh-ancestor
92195253|NCT00609739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195254|NCT00609739|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92195255|NCT00609739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195256|NCT00609739|Immunologic Factors|immunologic factors|mesh-ancestor
92195257|NCT00609739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195258|NCT00609739|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92195259|NCT00609739|Antiviral Agents|antiviral agents|mesh-ancestor
92195260|NCT00609739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195261|NCT00609739|Antifungal Agents|antifungal agents|mesh-ancestor
92195262|NCT00609739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92195263|NCT00609739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195264|NCT00609739|Antiemetics|antiemetics|mesh-ancestor
92195265|NCT00609739|Autonomic Agents|autonomic agents|mesh-ancestor
92195266|NCT00609739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195267|NCT00609739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195268|NCT00609739|Glucocorticoids|glucocorticoids|mesh-ancestor
92195270|NCT00609739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92195271|NCT00609739|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92195272|NCT00609739|Protective Agents|protective agents|mesh-ancestor
92195273|NCT00609739|Analgesics|analgesics|mesh-ancestor
92195274|NCT00609739|Sensory System Agents|sensory system agents|mesh-ancestor
92195275|NCT00609739|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92195276|NCT00609739|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92195277|NCT00609739|Keratolytic Agents|keratolytic agents|mesh-ancestor
92195278|NCT00610987|Cefazolin|cefazolin|mesh-list
92195279|NCT00610987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195280|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195281|NCT04140578|Ertapenem|ertapenem|mesh-list
92195282|NCT04140578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195283|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195284|NCT00574171|Capecitabine|capecitabine|mesh-list
92195285|NCT00574171|Lapatinib|lapatinib|mesh-list
92195286|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195287|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
92195288|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195289|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195290|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92195291|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195292|NCT03585998|Cisplatin|cisplatin|mesh-list
92195293|NCT03585998|Etoposide|etoposide|mesh-list
92195294|NCT03585998|Durvalumab|durvalumab|mesh-list
92195295|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195296|NCT03585998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92195297|NCT03585998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92195298|NCT03585998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92195299|NCT03585998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195300|NCT03585998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195301|NCT03585998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195302|NCT00612235|Lamotrigine|lamotrigine|mesh-list
92195303|NCT00612235|Carbamazepine|carbamazepine|mesh-list
92195304|NCT00612235|Levetiracetam|levetiracetam|mesh-list
92195305|NCT00612235|Anticonvulsants|anticonvulsants|mesh-ancestor
92195306|NCT00612235|Nootropic Agents|nootropic agents|mesh-ancestor
92195307|NCT00612235|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92195308|NCT00612235|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195309|NCT00612235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195310|NCT00612235|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92195311|NCT00612235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195312|NCT00612235|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92195313|NCT00612235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92195314|NCT00612235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195315|NCT00612235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195316|NCT00612235|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92195317|NCT00612235|Antimanic Agents|antimanic agents|mesh-ancestor
92195318|NCT00612235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195319|NCT00612235|Analgesics|analgesics|mesh-ancestor
92195320|NCT00612235|Sensory System Agents|sensory system agents|mesh-ancestor
92195321|NCT00612235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195322|NCT00612235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92195323|NCT00612235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92195324|NCT00575029|Megestrol|megestrol|mesh-list
92195325|NCT00575029|Megestrol Acetate|megestrol acetate|mesh-list
92195326|NCT00575029|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92195327|NCT00575029|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92195328|NCT00575029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92195329|NCT00575029|Contraceptive Agents|contraceptive agents|mesh-ancestor
92195330|NCT00575029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195331|NCT00575029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195332|NCT00575029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92195333|NCT00575029|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92195334|NCT00575029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92195335|NCT00575029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195336|NCT00575029|Appetite Stimulants|appetite stimulants|mesh-ancestor
92195337|NCT00575029|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92195338|NCT00499109|Carboplatin|carboplatin|mesh-list
92195339|NCT00499109|Gemcitabine|gemcitabine|mesh-list
92195340|NCT00499109|Docetaxel|docetaxel|mesh-list
92195341|NCT00499109|Vinorelbine|vinorelbine|mesh-list
92195342|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
92195343|NCT00499109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195344|NCT00499109|Antimetabolites|antimetabolites|mesh-ancestor
92195345|NCT00499109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195346|NCT00499109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92195347|NCT00499109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92195348|NCT00499109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92195349|NCT00499109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92195350|NCT03585530|Raltitrexed|raltitrexed|mesh-list
92195351|NCT03585530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195352|NCT03585530|Antimetabolites|antimetabolites|mesh-ancestor
92195353|NCT03585530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195354|NCT03585530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195355|NCT03585530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92195356|NCT03585530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195357|NCT03021590|Amoxicillin|amoxicillin|mesh-list
92195358|NCT03021590|Clarithromycin|clarithromycin|mesh-list
92195359|NCT03021590|Levofloxacin|levofloxacin|mesh-list
92195360|NCT03021590|Tinidazole|tinidazole|mesh-list
92195361|NCT03021590|Esomeprazole|esomeprazole|mesh-list
92195362|NCT03021590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195363|NCT03021590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195364|NCT03021590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92195365|NCT03021590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195366|NCT03021590|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92195367|NCT03021590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195368|NCT03021590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195369|NCT03021590|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92195370|NCT03021590|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92195371|NCT03021590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92195372|NCT03021590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92195373|NCT03021590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92195374|NCT03021590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92195375|NCT03021590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195376|NCT03021590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92195377|NCT03021590|Alkylating Agents|alkylating agents|mesh-ancestor
92195378|NCT03021590|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92195379|NCT03021590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92195380|NCT03021590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92195381|NCT02125721|Penicillamine|penicillamine|mesh-list
92195382|NCT02125721|Antidotes|antidotes|mesh-ancestor
92195383|NCT02125721|Protective Agents|protective agents|mesh-ancestor
92195384|NCT02125721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195385|NCT02125721|Chelating Agents|chelating agents|mesh-ancestor
92195386|NCT02125721|Sequestering Agents|sequestering agents|mesh-ancestor
92195387|NCT02125721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195388|NCT02125721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195389|NCT00552695|Lidocaine|lidocaine|mesh-list
92195390|NCT00552695|Tetracaine|tetracaine|mesh-list
92195391|NCT00552695|Anesthetics, Local|anesthetics, local|mesh-ancestor
92195392|NCT00552695|Anesthetics|anesthetics|mesh-ancestor
92195393|NCT00552695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195394|NCT00552695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195395|NCT00552695|Sensory System Agents|sensory system agents|mesh-ancestor
92195396|NCT00552695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195397|NCT00552695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92195398|NCT00552695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92195399|NCT00552695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92195400|NCT00552695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195401|NCT00552695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195403|NCT00615433|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92195404|NCT00615433|Antiemetics|antiemetics|mesh-ancestor
92195405|NCT00615433|Autonomic Agents|autonomic agents|mesh-ancestor
92195406|NCT00615433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195407|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195408|NCT00615433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195409|NCT00615433|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92195410|NCT00615433|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92195411|NCT00615433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195412|NCT00615433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195413|NCT00615433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92195414|NCT00615433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92195415|NCT00615433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195416|NCT00615433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195417|NCT00615433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195418|NCT00615433|Serotonin Agents|serotonin agents|mesh-ancestor
92195419|NCT00615433|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92195420|NCT00615433|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92195421|NCT00615433|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92195422|NCT00615433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92195423|NCT00615433|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92195424|NCT00615433|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92195425|NCT00615433|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92195426|NCT00615433|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92195427|NCT00615433|Dopamine Agents|dopamine agents|mesh-ancestor
92195428|NCT03899402|Dapagliflozin|dapagliflozin|mesh-list
92195429|NCT03899402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92195430|NCT03899402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195431|NCT03899402|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92195432|NCT03899402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195433|NCT03585374|Acetaminophen|acetaminophen|mesh-list
92195434|NCT03585374|Ketoprofen|ketoprofen|mesh-list
92195435|NCT03585374|Morphine|morphine|mesh-list
92195436|NCT03585374|Methoxyflurane|methoxyflurane|mesh-list
92195437|NCT03585374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92195438|NCT03585374|Narcotics|narcotics|mesh-ancestor
92195439|NCT03585374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195440|NCT03585374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195441|NCT03585374|Analgesics|analgesics|mesh-ancestor
92195442|NCT03585374|Sensory System Agents|sensory system agents|mesh-ancestor
92195443|NCT03585374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195444|NCT03585374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195445|NCT03585374|Antipyretics|antipyretics|mesh-ancestor
92195446|NCT03585374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92195447|NCT03585374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195448|NCT03585374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195449|NCT03585374|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92195450|NCT03585374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195451|NCT03585374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195452|NCT03585374|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92195453|NCT03585374|Anesthetics, General|anesthetics, general|mesh-ancestor
92195454|NCT03585374|Anesthetics|anesthetics|mesh-ancestor
92195455|NCT00499343|Rituximab|rituximab|mesh-list
92195456|NCT00499343|Etoposide|etoposide|mesh-list
92195457|NCT00499343|Ifosfamide|ifosfamide|mesh-list
92195458|NCT00499343|Isophosphamide mustard|isophosphamide mustard|mesh-list
92195459|NCT00499343|Sargramostim|sargramostim|mesh-list
92195460|NCT00499343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195461|NCT00499343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195462|NCT00499343|Immunologic Factors|immunologic factors|mesh-ancestor
92195463|NCT00499343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195464|NCT00499343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195465|NCT00499343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92195466|NCT00499343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92195467|NCT00499343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92195468|NCT00499343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195469|NCT00499343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195470|NCT00499343|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195471|NCT00499343|Alkylating Agents|alkylating agents|mesh-ancestor
92195472|NCT00615589|Fludarabine|fludarabine|mesh-list
92195473|NCT00615589|Busulfan|busulfan|mesh-list
92195474|NCT00615589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195475|NCT00615589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195476|NCT00615589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195477|NCT00615589|Immunologic Factors|immunologic factors|mesh-ancestor
92195478|NCT00615589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195479|NCT00615589|Alkylating Agents|alkylating agents|mesh-ancestor
92195480|NCT00615589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195481|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92195482|NCT00499655|Celecoxib|celecoxib|mesh-list
92195483|NCT00499655|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92195484|NCT00499655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195485|NCT00499655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92195486|NCT00499655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195487|NCT00499655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195488|NCT00499655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92195489|NCT00499655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195490|NCT00499655|Analgesics|analgesics|mesh-ancestor
92195491|NCT00499655|Sensory System Agents|sensory system agents|mesh-ancestor
92195492|NCT00499655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195493|NCT00499655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195494|NCT00499655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195495|NCT00499655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195496|NCT00499655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92195497|NCT00499655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92195498|NCT03585140|Doxycycline|doxycycline|mesh-list
92195499|NCT03585140|Adapalene|adapalene|mesh-list
92195500|NCT03585140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195501|NCT03585140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195502|NCT03585140|Antimalarials|antimalarials|mesh-ancestor
92195503|NCT03585140|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92195504|NCT03585140|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92195505|NCT03585140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92195506|NCT03585140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195507|NCT03585140|Analgesics|analgesics|mesh-ancestor
92195508|NCT03585140|Sensory System Agents|sensory system agents|mesh-ancestor
92195509|NCT03585140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335141|NCT00005815|Temozolomide|temozolomide|mesh-list
92195510|NCT03585140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195511|NCT03585140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195512|NCT03585140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195513|NCT03585140|Dermatologic Agents|dermatologic agents|mesh-ancestor
92195514|NCT03584984|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92195515|NCT03584984|Hemostatics|hemostatics|mesh-ancestor
92195516|NCT03584984|Coagulants|coagulants|mesh-ancestor
92195517|NCT00575887|Temozolomide|temozolomide|mesh-list
92195518|NCT00575887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195519|NCT00575887|Alkylating Agents|alkylating agents|mesh-ancestor
92195520|NCT00575887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195521|NCT00575887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195522|NCT00575965|Simvastatin|simvastatin|mesh-list
92195523|NCT00575965|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92195524|NCT00575965|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92195525|NCT00575965|Antimetabolites|antimetabolites|mesh-ancestor
92195526|NCT00575965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195527|NCT00575965|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92195528|NCT00575965|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92195529|NCT00575965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195530|NCT03217097|Oxaliplatin|oxaliplatin|mesh-list
92195531|NCT03217097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195532|NCT03623828|Apomorphine|apomorphine|mesh-list
92195533|NCT03623828|Emetics|emetics|mesh-ancestor
92195534|NCT03623828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195535|NCT03623828|Autonomic Agents|autonomic agents|mesh-ancestor
92195536|NCT03623828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195537|NCT03623828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195538|NCT03623828|Dopamine Agonists|dopamine agonists|mesh-ancestor
92195539|NCT03623828|Dopamine Agents|dopamine agents|mesh-ancestor
92195540|NCT03623828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195541|NCT03623828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195542|NCT00501995|Cyclophosphamide|cyclophosphamide|mesh-list
92195543|NCT00501995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195544|NCT00501995|Immunologic Factors|immunologic factors|mesh-ancestor
92195545|NCT00501995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195546|NCT00501995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195547|NCT00501995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195548|NCT00501995|Alkylating Agents|alkylating agents|mesh-ancestor
92195549|NCT00501995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195550|NCT00501995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195551|NCT00501995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92195553|NCT03589898|Analgesics|analgesics|mesh-ancestor
92195554|NCT03589898|Sensory System Agents|sensory system agents|mesh-ancestor
92195555|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195556|NCT03589898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195557|NCT03589898|Anticonvulsants|anticonvulsants|mesh-ancestor
92195558|NCT03589898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92195559|NCT03589898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92195560|NCT03589898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195561|NCT03589898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195562|NCT03589898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92195563|NCT03589898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92195564|NCT03589898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195565|NCT03589898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195566|NCT03589898|Antimanic Agents|antimanic agents|mesh-ancestor
92195567|NCT00577135|Furosemide|furosemide|mesh-list
92195568|NCT00577135|Diuretics|diuretics|mesh-list
92195569|NCT00577135|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92195570|NCT00577135|Natriuretic Agents|natriuretic agents|mesh-ancestor
92195571|NCT00577135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195572|NCT00577135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195573|NCT00577135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195574|NCT00502853|Rituximab|rituximab|mesh-list
92195575|NCT00502853|Methotrexate|methotrexate|mesh-list
92195576|NCT00502853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195577|NCT00502853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195578|NCT00502853|Immunologic Factors|immunologic factors|mesh-ancestor
92195579|NCT00502853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195580|NCT00502853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195581|NCT00502853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92195582|NCT00502853|Abortifacient Agents|abortifacient agents|mesh-ancestor
92195583|NCT00502853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195584|NCT00502853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195585|NCT00502853|Antimetabolites|antimetabolites|mesh-ancestor
92195586|NCT00502853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195587|NCT00502853|Dermatologic Agents|dermatologic agents|mesh-ancestor
92195588|NCT00502853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195589|NCT00502853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92195590|NCT00502853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195591|NCT00502853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92195592|NCT00617539|Irinotecan|irinotecan|mesh-list
92195593|NCT00617539|Temozolomide|temozolomide|mesh-list
92195594|NCT00617539|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92195595|NCT00617539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92195596|NCT00617539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195597|NCT00617539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195598|NCT00617539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195599|NCT00617539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195600|NCT00617539|Alkylating Agents|alkylating agents|mesh-ancestor
92195601|NCT03620123|Docetaxel|docetaxel|mesh-list
92195602|NCT03620123|Nivolumab|nivolumab|mesh-list
92195603|NCT03620123|Ipilimumab|ipilimumab|mesh-list
92195604|NCT03620123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195605|NCT03620123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92195606|NCT03620123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92195607|NCT03620123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92195608|NCT03620123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917371|NCT05125055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92195609|NCT03620123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195610|NCT03620123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92195611|NCT00578071|Capecitabine|capecitabine|mesh-list
92195613|NCT00578071|Panitumumab|panitumumab|mesh-list
92195614|NCT00578071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195615|NCT00578071|Antimetabolites|antimetabolites|mesh-ancestor
92195616|NCT00578071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195617|NCT00578071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195618|NCT00578071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195619|NCT00555581|Imatinib Mesylate|imatinib mesylate|mesh-list
92195620|NCT00555581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195621|NCT00555581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92195622|NCT00555581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195623|NCT00555581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195624|NCT00504023|Imiquimod|imiquimod|mesh-list
92195625|NCT00504023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92195626|NCT00504023|Immunologic Factors|immunologic factors|mesh-ancestor
92195627|NCT00504023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195628|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195629|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
92195630|NCT03589430|Protein C|protein c|mesh-list
92195631|NCT03589430|Antithrombins|antithrombins|mesh-list
92195632|NCT03589430|Antithrombin III|antithrombin iii|mesh-list
92195633|NCT03589430|Protein S|protein s|mesh-list
92195634|NCT03589430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92195635|NCT03589430|Protease Inhibitors|protease inhibitors|mesh-ancestor
92195636|NCT03589430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195637|NCT03589430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195638|NCT03589430|Anticoagulants|anticoagulants|mesh-ancestor
92195639|NCT03589430|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92195640|NCT03589430|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92195641|NCT05702762|Gentamicins|gentamicins|mesh-list
92195642|NCT05702762|Cephalexin|cephalexin|mesh-list
92195643|NCT05702762|Nitrofurantoin|nitrofurantoin|mesh-list
92195644|NCT05702762|Cefdinir|cefdinir|mesh-list
92195645|NCT05702762|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92195646|NCT05702762|Trimethoprim|trimethoprim|mesh-list
92195647|NCT05702762|Sulfamethoxazole|sulfamethoxazole|mesh-list
92195648|NCT05702762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195649|NCT05702762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195650|NCT05702762|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92195651|NCT05702762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195652|NCT05702762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195653|NCT05702762|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92195654|NCT05702762|Antimalarials|antimalarials|mesh-ancestor
92195655|NCT05702762|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92195656|NCT05702762|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92195657|NCT05702762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92195658|NCT05702762|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92195659|NCT05702762|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92195660|NCT05702762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92195661|NCT03580694|Cemiplimab|cemiplimab|mesh-list
92195662|NCT03580694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195663|NCT03580694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195664|NCT03583892|Gabapentin|gabapentin|mesh-list
92195665|NCT03583892|Analgesics|analgesics|mesh-ancestor
92195666|NCT03583892|Sensory System Agents|sensory system agents|mesh-ancestor
92195667|NCT03583892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195668|NCT03583892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195669|NCT03583892|Anticonvulsants|anticonvulsants|mesh-ancestor
92195670|NCT03583892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92195671|NCT03583892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92195672|NCT03583892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195673|NCT03583892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195674|NCT03583892|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92195675|NCT03583892|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92195676|NCT03583892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195677|NCT03583892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195678|NCT03583892|Antimanic Agents|antimanic agents|mesh-ancestor
92195680|NCT03589040|Rilpivirine|rilpivirine|mesh-list
92195681|NCT03589040|Etonogestrel|etonogestrel|mesh-list
92195682|NCT03589040|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92195683|NCT03589040|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92195684|NCT03589040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92195685|NCT03589040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195686|NCT03589040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195687|NCT03589040|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92195688|NCT03589040|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92195689|NCT03589040|Antiviral Agents|antiviral agents|mesh-ancestor
92195690|NCT03589040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195691|NCT03589040|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92195692|NCT03589040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92195693|NCT03589040|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92195694|NCT03589040|Contraceptive Agents|contraceptive agents|mesh-ancestor
92195695|NCT03589040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195696|NCT03589040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195697|NCT03589040|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92195698|NCT03583424|Cytarabine|cytarabine|mesh-list
92195699|NCT03583424|Etoposide|etoposide|mesh-list
92195700|NCT03583424|Podophyllotoxin|podophyllotoxin|mesh-list
92195701|NCT03583424|Etoposide phosphate|etoposide phosphate|mesh-list
92195702|NCT03583424|Melphalan|melphalan|mesh-list
92195703|NCT03583424|Venetoclax|venetoclax|mesh-list
92195704|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
92195705|NCT03583424|Carmustine|carmustine|mesh-list
92195706|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92195707|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92195708|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195709|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92195710|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92195711|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195712|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195713|NCT03583424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195714|NCT03583424|Antimetabolites|antimetabolites|mesh-ancestor
92195715|NCT03583424|Antiviral Agents|antiviral agents|mesh-ancestor
92195716|NCT03583424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195717|NCT03583424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195718|NCT03583424|Immunologic Factors|immunologic factors|mesh-ancestor
92195719|NCT03583424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195720|NCT03583424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195721|NCT03583424|Alkylating Agents|alkylating agents|mesh-ancestor
92195722|NCT03583424|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92195723|NCT03583424|Keratolytic Agents|keratolytic agents|mesh-ancestor
92195724|NCT03583424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92195725|NCT03583424|Tubulin Modulators|tubulin modulators|mesh-ancestor
92195726|NCT03583424|Antimitotic Agents|antimitotic agents|mesh-ancestor
92195728|NCT00578305|Folic Acid|folic acid|mesh-list
92195729|NCT00578305|Methylprednisolone|methylprednisolone|mesh-list
92195730|NCT00578305|Rituximab|rituximab|mesh-list
92195731|NCT00578305|Methotrexate|methotrexate|mesh-list
92195732|NCT00578305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195733|NCT00578305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195734|NCT00578305|Immunologic Factors|immunologic factors|mesh-ancestor
92195735|NCT00578305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195736|NCT00578305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195737|NCT00578305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92195738|NCT00578305|Abortifacient Agents|abortifacient agents|mesh-ancestor
92195739|NCT00578305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195740|NCT00578305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195741|NCT00578305|Antimetabolites|antimetabolites|mesh-ancestor
92195742|NCT00578305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195743|NCT00578305|Dermatologic Agents|dermatologic agents|mesh-ancestor
92195744|NCT00578305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195745|NCT00578305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92195746|NCT00578305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195747|NCT00578305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92195748|NCT00578305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195749|NCT00578305|Antiemetics|antiemetics|mesh-ancestor
92195750|NCT00578305|Autonomic Agents|autonomic agents|mesh-ancestor
92195751|NCT00578305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195752|NCT00578305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195753|NCT00578305|Glucocorticoids|glucocorticoids|mesh-ancestor
92195754|NCT00578305|Hormones|hormones|mesh-ancestor
92195755|NCT00578305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92195756|NCT00578305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92195757|NCT00578305|Protective Agents|protective agents|mesh-ancestor
92195758|NCT00578305|Hematinics|hematinics|mesh-ancestor
92195759|NCT00578305|Vitamin B Complex|vitamin b complex|mesh-ancestor
92195760|NCT00578305|Vitamins|vitamins|mesh-ancestor
92195761|NCT00578305|Micronutrients|micronutrients|mesh-ancestor
92195762|NCT00578461|Cytarabine|cytarabine|mesh-list
92195763|NCT00578461|Cyclophosphamide|cyclophosphamide|mesh-list
92195764|NCT00578461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195765|NCT00578461|Immunologic Factors|immunologic factors|mesh-ancestor
92195766|NCT00578461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195767|NCT00578461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195768|NCT00578461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195769|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
92195770|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195771|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195772|NCT00578461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92195773|NCT00578461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195774|NCT00578461|Antimetabolites|antimetabolites|mesh-ancestor
92195775|NCT00578461|Antiviral Agents|antiviral agents|mesh-ancestor
92195776|NCT00578461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195777|NCT03580070|Immunomodulating Agents|immunomodulating agents|mesh-list
92195778|NCT03580070|Immunologic Factors|immunologic factors|mesh-ancestor
92195779|NCT03580070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195780|NCT03156296|Dexmedetomidine|dexmedetomidine|mesh-list
92195781|NCT03156296|Bupivacaine|bupivacaine|mesh-list
92195782|NCT03156296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92195783|NCT03156296|Anesthetics|anesthetics|mesh-ancestor
92195784|NCT03156296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92195785|NCT03156296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195786|NCT03156296|Sensory System Agents|sensory system agents|mesh-ancestor
92195787|NCT03156296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195788|NCT03156296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92195789|NCT03156296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195790|NCT03156296|Analgesics|analgesics|mesh-ancestor
92195791|NCT03156296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92195792|NCT03156296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92195793|NCT03156296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92195794|NCT03156296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92195795|NCT03156296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195796|NCT03156296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195797|NCT00578539|Cytarabine|cytarabine|mesh-list
92195798|NCT00578539|Cyclophosphamide|cyclophosphamide|mesh-list
92195799|NCT00578539|Alemtuzumab|alemtuzumab|mesh-list
92195800|NCT00578539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195801|NCT00578539|Immunologic Factors|immunologic factors|mesh-ancestor
92195802|NCT00578539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195803|NCT00578539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195804|NCT00578539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195805|NCT00578539|Alkylating Agents|alkylating agents|mesh-ancestor
92195806|NCT00578539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195807|NCT00578539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195808|NCT00578539|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92195809|NCT00578539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195810|NCT00578539|Antimetabolites|antimetabolites|mesh-ancestor
92195811|NCT00578539|Antiviral Agents|antiviral agents|mesh-ancestor
92195812|NCT00578539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195813|NCT00578539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195814|NCT00578617|Amiodarone|amiodarone|mesh-list
92195815|NCT00578617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195816|NCT00578617|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92195817|NCT00578617|Vasodilator Agents|vasodilator agents|mesh-ancestor
92195818|NCT00578617|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92195819|NCT00578617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195821|NCT00578617|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92195822|NCT00578617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92195823|NCT00578617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195824|NCT00578617|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92195825|NCT00578617|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92195826|NCT00578617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92195827|NCT00505895|Rituximab|rituximab|mesh-list
92195828|NCT00505895|Fludarabine|fludarabine|mesh-list
92195829|NCT00505895|Fludarabine phosphate|fludarabine phosphate|mesh-list
92195830|NCT00505895|Melphalan|melphalan|mesh-list
92195831|NCT00505895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195832|NCT00505895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195833|NCT00505895|Immunologic Factors|immunologic factors|mesh-ancestor
92195834|NCT00505895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195835|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195836|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195837|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
92195838|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195839|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195840|NCT00505895|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92195841|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
92195842|NCT00505895|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92195843|NCT03582332|Indomethacin|indomethacin|mesh-list
92195844|NCT03582332|Etoricoxib|etoricoxib|mesh-list
92195845|NCT03582332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92195846|NCT03582332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195847|NCT03582332|Analgesics|analgesics|mesh-ancestor
92195848|NCT03582332|Sensory System Agents|sensory system agents|mesh-ancestor
92335181|NCT02131272|Insulin|insulin|mesh-list
92195849|NCT03582332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195850|NCT03582332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195851|NCT03582332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195852|NCT03582332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195853|NCT03582332|Gout Suppressants|gout suppressants|mesh-ancestor
92195854|NCT03582332|Tocolytic Agents|tocolytic agents|mesh-ancestor
92195855|NCT03582332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92195856|NCT03582332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92195857|NCT03582332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195858|NCT03582332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195859|NCT03582332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92195860|NCT00619723|Choline|choline|mesh-list
92195861|NCT00619723|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92195862|NCT00619723|Lipotropic Agents|lipotropic agents|mesh-ancestor
92195863|NCT00619723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92195864|NCT00619723|Antimetabolites|antimetabolites|mesh-ancestor
92195865|NCT00619723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195866|NCT00619723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92195867|NCT00619723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92195868|NCT00619723|Nootropic Agents|nootropic agents|mesh-ancestor
92195869|NCT03410615|Durvalumab|durvalumab|mesh-list
92195870|NCT03410615|Tremelimumab|tremelimumab|mesh-list
92195871|NCT03410615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195872|NCT03410615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195873|NCT03582098|Rituximab|rituximab|mesh-list
92195874|NCT03582098|Idelalisib|idelalisib|mesh-list
92195875|NCT03582098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195876|NCT03582098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195877|NCT03582098|Immunologic Factors|immunologic factors|mesh-ancestor
92195878|NCT03582098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195879|NCT03582098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195880|NCT03582098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195881|NCT03582098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195882|NCT00555893|Oseltamivir|oseltamivir|mesh-list
92195883|NCT00555893|Antiviral Agents|antiviral agents|mesh-ancestor
92195884|NCT00555893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195885|NCT00555893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195886|NCT00555893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195887|NCT00578929|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92195888|NCT00578929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92195889|NCT00578929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92195890|NCT00578929|Analgesics|analgesics|mesh-ancestor
92195891|NCT00578929|Sensory System Agents|sensory system agents|mesh-ancestor
92195892|NCT00578929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195893|NCT00578929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195894|NCT00578929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92195895|NCT00578929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92195896|NCT00578929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92195897|NCT00578929|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92195898|NCT00578929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92195899|NCT00578929|Histamine Antagonists|histamine antagonists|mesh-ancestor
92195900|NCT00578929|Histamine Agents|histamine agents|mesh-ancestor
92195901|NCT00578929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195902|NCT00578929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195903|NCT00556049|Gemcitabine|gemcitabine|mesh-list
92195904|NCT00556049|Sunitinib|sunitinib|mesh-list
92195905|NCT00556049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92195906|NCT00556049|Antimetabolites|antimetabolites|mesh-ancestor
92195907|NCT00556049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195908|NCT00556049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195909|NCT00556049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92195910|NCT00556049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92195911|NCT00556049|Growth Substances|growth substances|mesh-ancestor
92195912|NCT00556049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195913|NCT00556049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92195914|NCT00556049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92195915|NCT00556049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195916|NCT01797107|Azithromycin|azithromycin|mesh-list
92195917|NCT01797107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195918|NCT01797107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195919|NCT03155984|Antibodies|antibodies|mesh-list
92195920|NCT03155984|Immunologic Factors|immunologic factors|mesh-ancestor
92195921|NCT03155984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195922|NCT00620191|Metformin|metformin|mesh-list
92195923|NCT00620191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92195924|NCT00620191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195925|NCT00506597|Asparaginase|asparaginase|mesh-list
92195926|NCT00506597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195927|NCT03589976|Sirolimus|sirolimus|mesh-list
92195928|NCT03589976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92195929|NCT03589976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92195930|NCT03589976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92195931|NCT03589976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195932|NCT03589976|Antifungal Agents|antifungal agents|mesh-ancestor
92195933|NCT03589976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92195934|NCT03589976|Immunologic Factors|immunologic factors|mesh-ancestor
92195935|NCT03589976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195936|NCT03581630|Naltrexone|naltrexone|mesh-list
92195937|NCT03581630|Bupropion|bupropion|mesh-list
92195938|NCT03581630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92195939|NCT03581630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92195940|NCT03581630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195941|NCT03581630|Sensory System Agents|sensory system agents|mesh-ancestor
92195942|NCT03581630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195943|NCT03581630|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92195944|NCT03581630|Antidepressive Agents|antidepressive agents|mesh-ancestor
92195945|NCT03581630|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92195946|NCT03581630|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92195947|NCT03581630|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92195948|NCT03581630|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92195949|NCT03581630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195950|NCT03581630|Dopamine Agents|dopamine agents|mesh-ancestor
92195951|NCT03581630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195952|NCT03581630|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92195953|NCT03581630|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92195954|NCT03581630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195955|NCT00506675|Atropine|atropine|mesh-list
92195956|NCT00506675|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92195957|NCT00506675|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92195958|NCT00506675|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92195959|NCT00506675|Autonomic Agents|autonomic agents|mesh-ancestor
92195960|NCT00506675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92195961|NCT00506675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195962|NCT00506675|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92195963|NCT00506675|Respiratory System Agents|respiratory system agents|mesh-ancestor
92195964|NCT00506675|Mydriatics|mydriatics|mesh-ancestor
92195965|NCT00506675|Parasympatholytics|parasympatholytics|mesh-ancestor
92195966|NCT00506675|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92195967|NCT00506675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92195968|NCT00506675|Cholinergic Agents|cholinergic agents|mesh-ancestor
92195969|NCT00506675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92195970|NCT00506675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195971|NCT00507767|Dasatinib|dasatinib|mesh-list
92195972|NCT00507767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195973|NCT00507767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92195974|NCT00507767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195975|NCT00507767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195976|NCT00621049|Bevacizumab|bevacizumab|mesh-list
92195977|NCT00621049|Carboplatin|carboplatin|mesh-list
92195978|NCT00621049|Docetaxel|docetaxel|mesh-list
92195979|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92195980|NCT00621049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92195981|NCT00621049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92195982|NCT00621049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92195983|NCT00621049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92195984|NCT00621049|Growth Substances|growth substances|mesh-ancestor
92195985|NCT00621049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92195986|NCT00621049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92195987|NCT00621049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92195988|NCT00621049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92195989|NCT00621049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92195990|NCT00621049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92195991|NCT00621049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92195992|NCT00621049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92195993|NCT00508469|Timolol|timolol|mesh-list
92195994|NCT00508469|Travoprost|travoprost|mesh-list
92195995|NCT00508469|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92195996|NCT00508469|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92195997|NCT00508469|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92195998|NCT00508469|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92195999|NCT00508469|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196000|NCT00508469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196001|NCT00508469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196002|NCT00508469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196003|NCT00508469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92196004|NCT00508469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196005|NCT05702996|Eculizumab|eculizumab|mesh-list
92196006|NCT05702996|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92196007|NCT05702996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196008|NCT05702996|Immunologic Factors|immunologic factors|mesh-ancestor
92196009|NCT05702996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196010|NCT00580333|Paclitaxel|paclitaxel|mesh-list
92196011|NCT00580333|Cyclophosphamide|cyclophosphamide|mesh-list
92196012|NCT00580333|Bevacizumab|bevacizumab|mesh-list
92196013|NCT00580333|Doxorubicin|doxorubicin|mesh-list
92196014|NCT00580333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92196015|NCT00580333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196016|NCT00580333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92196017|NCT00580333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92196018|NCT00580333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92196019|NCT00580333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196020|NCT00580333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196022|NCT00580333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196023|NCT00580333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196024|NCT00580333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92196025|NCT00580333|Alkylating Agents|alkylating agents|mesh-ancestor
92196026|NCT00580333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92196027|NCT00580333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196028|NCT00580333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92196029|NCT00580333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92196030|NCT00580333|Growth Substances|growth substances|mesh-ancestor
92196031|NCT00580333|Growth Inhibitors|growth inhibitors|mesh-ancestor
92196032|NCT00580333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92196033|NCT00580333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92196034|NCT00580333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92196035|NCT00580333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196036|NCT00580645|Varenicline|varenicline|mesh-list
92196037|NCT00580645|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92196038|NCT00580645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92196039|NCT00580645|Cholinergic Agents|cholinergic agents|mesh-ancestor
92196040|NCT00580645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196041|NCT00580645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196042|NCT00580645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196043|NCT00580957|Trimethaphan|trimethaphan|mesh-list
92196044|NCT00580957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92196045|NCT00580957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196046|NCT00580957|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92196047|NCT00580957|Autonomic Agents|autonomic agents|mesh-ancestor
92196048|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196049|NCT00580957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196050|NCT00580957|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92196051|NCT00580957|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92196052|NCT00580957|Cholinergic Agents|cholinergic agents|mesh-ancestor
92196053|NCT00580957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196054|NCT00580957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196055|NCT00509249|Aflibercept|aflibercept|mesh-list
92196056|NCT00509249|Endothelial Growth Factors|endothelial growth factors|mesh-list
92196057|NCT00509249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92196058|NCT00509249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92196059|NCT00509249|Growth Substances|growth substances|mesh-ancestor
92196060|NCT00509249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196061|NCT00509249|Growth Inhibitors|growth inhibitors|mesh-ancestor
92196062|NCT00509249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196063|NCT00624013|Sertraline|sertraline|mesh-list
92196064|NCT00624013|Antidepressive Agents|antidepressive agents|mesh-ancestor
92196065|NCT00624013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92196066|NCT00624013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92196067|NCT00624013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92196068|NCT00624013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196069|NCT00624013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196070|NCT00624013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196071|NCT00624013|Serotonin Agents|serotonin agents|mesh-ancestor
92196072|NCT00624013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196073|NCT02121041|Losartan|losartan|mesh-list
92196074|NCT02121041|Amlodipine|amlodipine|mesh-list
92196075|NCT02121041|Chlorthalidone|chlorthalidone|mesh-list
92196076|NCT02121041|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196077|NCT02121041|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92196078|NCT02121041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196079|NCT02121041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196080|NCT02121041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92196081|NCT02121041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196082|NCT02121041|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196083|NCT02121041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92196084|NCT02121041|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92196085|NCT02121041|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92196086|NCT02121041|Diuretics|diuretics|mesh-ancestor
92196087|NCT02121041|Natriuretic Agents|natriuretic agents|mesh-ancestor
92196088|NCT02121041|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92196089|NCT00509873|Gatifloxacin|gatifloxacin|mesh-list
92196090|NCT00509873|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92196091|NCT00509873|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92196092|NCT00509873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92196093|NCT00509873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196094|NCT00509873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92196095|NCT00509873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92196096|NCT00509873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196097|NCT00509873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196098|NCT00509873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196099|NCT02133781|Vaccines|vaccines|mesh-list
92196100|NCT02133781|Immunologic Factors|immunologic factors|mesh-ancestor
92196101|NCT02133781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196103|NCT01855451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196104|NCT01855451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196105|NCT02134951|Ketamine|ketamine|mesh-list
92196106|NCT02134951|Analgesics|analgesics|mesh-ancestor
92196107|NCT02134951|Sensory System Agents|sensory system agents|mesh-ancestor
92196108|NCT02134951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196109|NCT02134951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196110|NCT02134951|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92196111|NCT02134951|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92196112|NCT02134951|Anesthetics, General|anesthetics, general|mesh-ancestor
92196113|NCT02134951|Anesthetics|anesthetics|mesh-ancestor
92196114|NCT02134951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196115|NCT02134951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92196116|NCT02134951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92196117|NCT02134951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196118|NCT02134951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196119|NCT03029780|Nivolumab|nivolumab|mesh-list
92196120|NCT03029780|Ipilimumab|ipilimumab|mesh-list
92196121|NCT03029780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196122|NCT03029780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196123|NCT03029780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92196124|NCT03029780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196125|NCT00624559|Celecoxib|celecoxib|mesh-list
92196126|NCT00624559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92196127|NCT00624559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92196128|NCT00624559|Analgesics|analgesics|mesh-ancestor
92196129|NCT00624559|Sensory System Agents|sensory system agents|mesh-ancestor
92196130|NCT00624559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196131|NCT00624559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196132|NCT00624559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196133|NCT00624559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196134|NCT00624559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92074228|NCT01475253|Anesthetics|anesthetics|mesh-ancestor
92196135|NCT00624559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92196136|NCT00624559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196137|NCT00624559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196138|NCT00510809|Ethanol|ethanol|mesh-list
92196139|NCT00510809|Policosanol|policosanol|mesh-list
92196140|NCT00510809|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92196141|NCT00510809|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92196142|NCT00510809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196143|NCT00510809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196144|NCT00510809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196145|NCT00510809|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92196146|NCT00510809|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92196147|NCT00510809|Antimetabolites|antimetabolites|mesh-ancestor
92196148|NCT00510809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196149|NCT00510809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196150|NCT00510809|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92196151|NCT00510809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92196152|NCT00625729|Aldesleukin|aldesleukin|mesh-list
92196153|NCT00625729|Cyclophosphamide|cyclophosphamide|mesh-list
92196154|NCT00625729|Rituximab|rituximab|mesh-list
92196155|NCT00625729|Fludarabine|fludarabine|mesh-list
92196156|NCT00625729|Fludarabine phosphate|fludarabine phosphate|mesh-list
92196157|NCT00625729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196158|NCT00625729|Immunologic Factors|immunologic factors|mesh-ancestor
92196159|NCT00625729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196160|NCT00625729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196161|NCT00625729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92196162|NCT00625729|Alkylating Agents|alkylating agents|mesh-ancestor
92196163|NCT00625729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196164|NCT00625729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196165|NCT00625729|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92196166|NCT00625729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196167|NCT00625729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92196168|NCT00625729|Antimetabolites|antimetabolites|mesh-ancestor
92196169|NCT00625729|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92196170|NCT00625729|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92196171|NCT00625729|Antiviral Agents|antiviral agents|mesh-ancestor
92196172|NCT00625729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196173|NCT00581971|Celecoxib|celecoxib|mesh-list
92196174|NCT00581971|Paclitaxel|paclitaxel|mesh-list
92196175|NCT00581971|Carboplatin|carboplatin|mesh-list
92196176|NCT00581971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92196177|NCT00581971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196178|NCT00581971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92196179|NCT00581971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92196180|NCT00581971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92196181|NCT00581971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196182|NCT00581971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92196183|NCT00581971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92196184|NCT00581971|Analgesics|analgesics|mesh-ancestor
92196185|NCT00581971|Sensory System Agents|sensory system agents|mesh-ancestor
92196186|NCT00581971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196187|NCT00581971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196188|NCT00581971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196189|NCT00581971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196190|NCT00581971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92196191|NCT00581971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92196192|NCT00581971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196193|NCT03029234|Dexamethasone|dexamethasone|mesh-list
92196194|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196195|NCT03029234|Antiemetics|antiemetics|mesh-ancestor
92196196|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
92196197|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196198|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196199|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196200|NCT03029234|Glucocorticoids|glucocorticoids|mesh-ancestor
92196201|NCT03029234|Hormones|hormones|mesh-ancestor
92196202|NCT03029234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196203|NCT03029234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92196204|NCT03029234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196205|NCT01670318|Chromium|chromium|mesh-list
92196206|NCT01670318|Everolimus|everolimus|mesh-list
92196207|NCT01670318|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92196208|NCT01670318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92196209|NCT01670318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196210|NCT01670318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196211|NCT01670318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196212|NCT01670318|Immunologic Factors|immunologic factors|mesh-ancestor
92196213|NCT01670318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196214|NCT01670318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196215|NCT01670318|Trace Elements|trace elements|mesh-ancestor
92196216|NCT01670318|Micronutrients|micronutrients|mesh-ancestor
92196217|NCT03155204|Tiotropium Bromide|tiotropium bromide|mesh-list
92196218|NCT03155204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92196219|NCT03155204|Autonomic Agents|autonomic agents|mesh-ancestor
92196220|NCT03155204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196221|NCT03155204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196222|NCT03155204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196223|NCT03155204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196224|NCT03155204|Parasympatholytics|parasympatholytics|mesh-ancestor
92196225|NCT03155204|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92196226|NCT03155204|Cholinergic Agents|cholinergic agents|mesh-ancestor
92196227|NCT03155204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196228|NCT03155204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196229|NCT03111992|Spartalizumab|spartalizumab|mesh-list
92196230|NCT03111992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92196231|NCT03111992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196232|NCT03111992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196233|NCT03111992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196234|NCT00626431|Leuprolide|leuprolide|mesh-list
92196235|NCT00626431|Hormones|hormones|mesh-list
92196236|NCT00626431|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92196237|NCT00626431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196238|NCT00626431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196239|NCT00626431|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92196240|NCT00626431|Fertility Agents|fertility agents|mesh-ancestor
92196241|NCT00626431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92196242|NCT00626431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92196243|NCT00626431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196244|NCT01670474|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92196245|NCT01670474|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92196246|NCT01670474|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92196247|NCT01670474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196248|NCT00582205|Paclitaxel|paclitaxel|mesh-list
92196249|NCT00582205|Cisplatin|cisplatin|mesh-list
92196250|NCT00582205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92196251|NCT00582205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196252|NCT00582205|Tubulin Modulators|tubulin modulators|mesh-ancestor
92196253|NCT00582205|Antimitotic Agents|antimitotic agents|mesh-ancestor
92196254|NCT00582205|Mitosis Modulators|mitosis modulators|mesh-ancestor
92196255|NCT00582205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196256|NCT00626743|Amlodipine|amlodipine|mesh-list
92196257|NCT00626743|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196258|NCT00626743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92196259|NCT00626743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196260|NCT00626743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196261|NCT00626743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92196262|NCT00626743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196263|NCT00626743|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196265|NCT03155048|Estrogens|estrogens|mesh-list
92196266|NCT03155048|Hormones|hormones|mesh-ancestor
92196267|NCT03155048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196268|NCT03155048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196269|NCT01661647|Anesthetics|anesthetics|mesh-list
92196270|NCT01661647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196271|NCT01661647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196272|NCT00627367|Hydromorphone|hydromorphone|mesh-list
92196273|NCT00627367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92196274|NCT00627367|Narcotics|narcotics|mesh-ancestor
92196275|NCT00627367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196276|NCT00627367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196277|NCT00627367|Analgesics|analgesics|mesh-ancestor
92196278|NCT00627367|Sensory System Agents|sensory system agents|mesh-ancestor
92196279|NCT00627367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196280|NCT00627679|Budesonide|budesonide|mesh-list
92196281|NCT00627679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196282|NCT00627679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92196283|NCT00627679|Autonomic Agents|autonomic agents|mesh-ancestor
92196284|NCT00627679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196285|NCT00627679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196286|NCT00627679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196287|NCT00627679|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196288|NCT00627679|Glucocorticoids|glucocorticoids|mesh-ancestor
92196289|NCT00627679|Hormones|hormones|mesh-ancestor
92196290|NCT00627679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196291|NCT00514709|Vaccines|vaccines|mesh-list
92196292|NCT00514709|Immunologic Factors|immunologic factors|mesh-ancestor
92196293|NCT00514709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196294|NCT03154814|Urinastatin|urinastatin|mesh-list
92196295|NCT03154814|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92196296|NCT03154814|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92196297|NCT03154814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92196298|NCT03154814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196299|NCT03154814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196300|NCT00515021|Eplerenone|eplerenone|mesh-list
92196301|NCT00515021|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92196302|NCT00515021|Hormone Antagonists|hormone antagonists|mesh-ancestor
92196303|NCT00515021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196304|NCT00515021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196305|NCT00515021|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92196306|NCT00515021|Diuretics|diuretics|mesh-ancestor
92196307|NCT00515021|Natriuretic Agents|natriuretic agents|mesh-ancestor
92196308|NCT00515021|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196309|NCT00515177|Eszopiclone|eszopiclone|mesh-list
92196310|NCT00515177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92196311|NCT00515177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196312|NCT00515177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196313|NCT01671410|Morphine|morphine|mesh-list
92196314|NCT01671410|Buprenorphine|buprenorphine|mesh-list
92196315|NCT01671410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92196316|NCT01671410|Narcotics|narcotics|mesh-ancestor
92196317|NCT01671410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196318|NCT01671410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196319|NCT01671410|Analgesics|analgesics|mesh-ancestor
92196320|NCT01671410|Sensory System Agents|sensory system agents|mesh-ancestor
92196321|NCT01671410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196322|NCT01671410|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92196323|NCT00630253|Cyclosporine|cyclosporine|mesh-list
92196324|NCT00630253|Mycophenolic Acid|mycophenolic acid|mesh-list
92196325|NCT00630253|Methylprednisolone|methylprednisolone|mesh-list
92196326|NCT00630253|Cyclophosphamide|cyclophosphamide|mesh-list
92196327|NCT00630253|Fludarabine|fludarabine|mesh-list
92196328|NCT00630253|Cyclosporins|cyclosporins|mesh-list
92196329|NCT00630253|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92196330|NCT00630253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196331|NCT00630253|Immunologic Factors|immunologic factors|mesh-ancestor
92196332|NCT00630253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196333|NCT00630253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196334|NCT00630253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92196335|NCT00630253|Alkylating Agents|alkylating agents|mesh-ancestor
92196336|NCT00630253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196337|NCT00630253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196338|NCT00630253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92196339|NCT00630253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196340|NCT00630253|Antifungal Agents|antifungal agents|mesh-ancestor
92196341|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196342|NCT00630253|Dermatologic Agents|dermatologic agents|mesh-ancestor
92196343|NCT00630253|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92196344|NCT00630253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92196345|NCT00630253|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92196346|NCT00630253|Antitubercular Agents|antitubercular agents|mesh-ancestor
92196347|NCT00630253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92196348|NCT00630253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196349|NCT00630253|Antiemetics|antiemetics|mesh-ancestor
92196350|NCT00630253|Autonomic Agents|autonomic agents|mesh-ancestor
92196351|NCT00630253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196352|NCT00630253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196353|NCT00630253|Glucocorticoids|glucocorticoids|mesh-ancestor
92196354|NCT00630253|Hormones|hormones|mesh-ancestor
92196355|NCT00630253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196356|NCT00630253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92196357|NCT00630253|Protective Agents|protective agents|mesh-ancestor
92196358|NCT01671722|Montelukast|montelukast|mesh-list
92196359|NCT01671722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196360|NCT01671722|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196361|NCT01671722|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92196362|NCT01671722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92196363|NCT01671722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196364|NCT01671722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196365|NCT01671722|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92196366|NCT01671722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92196367|NCT01671722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196368|NCT00584701|Risperidone|risperidone|mesh-list
92196369|NCT00584701|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92196370|NCT00584701|Serotonin Agents|serotonin agents|mesh-ancestor
92196371|NCT00584701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196372|NCT00584701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196373|NCT00584701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196374|NCT00584701|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92196375|NCT00584701|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92196376|NCT00584701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196377|NCT00584701|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92196378|NCT00584701|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92196379|NCT00584701|Dopamine Agents|dopamine agents|mesh-ancestor
92196380|NCT00630409|Gemcitabine|gemcitabine|mesh-list
92196381|NCT00630409|Doxorubicin|doxorubicin|mesh-list
92196382|NCT00630409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92196383|NCT00630409|Antimetabolites|antimetabolites|mesh-ancestor
92196384|NCT00630409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196385|NCT00630409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196386|NCT00630409|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92196387|NCT00630409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92196388|NCT00630409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92196389|NCT00630409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196391|NCT00630955|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92196392|NCT00630955|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92196393|NCT00630955|Dopamine Agents|dopamine agents|mesh-ancestor
92196394|NCT00630955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196395|NCT00630955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196396|NCT00630955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196397|NCT00630955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92196398|NCT00630955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92196399|NCT00584857|Paclitaxel|paclitaxel|mesh-list
92196400|NCT00584857|Carboplatin|carboplatin|mesh-list
92196401|NCT00584857|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92196402|NCT00584857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196403|NCT00584857|Tubulin Modulators|tubulin modulators|mesh-ancestor
92196404|NCT00584857|Antimitotic Agents|antimitotic agents|mesh-ancestor
92196405|NCT00584857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92196406|NCT00584857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196407|NCT00585013|Nitric Oxide|nitric oxide|mesh-list
92196408|NCT00585013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92196409|NCT00585013|Autonomic Agents|autonomic agents|mesh-ancestor
92196410|NCT00585013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196411|NCT00585013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196412|NCT00585013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196413|NCT00585013|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196414|NCT00585013|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92196415|NCT00585013|Antioxidants|antioxidants|mesh-ancestor
92196416|NCT00585013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196417|NCT00585013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196418|NCT00585013|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92196419|NCT00585013|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196420|NCT00585013|Gasotransmitters|gasotransmitters|mesh-ancestor
92196421|NCT00585013|Protective Agents|protective agents|mesh-ancestor
92196422|NCT01672112|Oxycodone|oxycodone|mesh-list
92196423|NCT01672112|Codeine|codeine|mesh-list
92196424|NCT01672112|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92196425|NCT01672112|Narcotics|narcotics|mesh-ancestor
92196426|NCT01672112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196427|NCT01672112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196428|NCT01672112|Analgesics|analgesics|mesh-ancestor
92196429|NCT01672112|Sensory System Agents|sensory system agents|mesh-ancestor
92196430|NCT01672112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196431|NCT01672112|Antitussive Agents|antitussive agents|mesh-ancestor
91917372|NCT05125055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92196432|NCT01672112|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196433|NCT00585637|Vitamin D|vitamin d|mesh-list
92196434|NCT00585637|Vitamins|vitamins|mesh-ancestor
92196435|NCT00585637|Micronutrients|micronutrients|mesh-ancestor
92196436|NCT00585637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196437|NCT00585637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92196438|NCT03158792|Enoxaparin|enoxaparin|mesh-list
92196439|NCT03158792|Enoxaparin sodium|enoxaparin sodium|mesh-list
92196440|NCT03158792|Anticoagulants|anticoagulants|mesh-ancestor
92196441|NCT03158792|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92196442|NCT03158792|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92196443|NCT03158792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196444|NCT01798771|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92196445|NCT01798771|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92196446|NCT01798771|Dermatologic Agents|dermatologic agents|mesh-ancestor
92196447|NCT03158480|Immunomodulating Agents|immunomodulating agents|mesh-list
92196448|NCT03158480|Immunologic Factors|immunologic factors|mesh-ancestor
92196449|NCT03158480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196450|NCT00633919|Prednisone|prednisone|mesh-list
92196451|NCT00633919|Budesonide|budesonide|mesh-list
92196452|NCT00633919|Albuterol|albuterol|mesh-list
92196453|NCT00633919|Formoterol Fumarate|formoterol fumarate|mesh-list
92196454|NCT00633919|Desloratadine|desloratadine|mesh-list
92196455|NCT00633919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196456|NCT00633919|Glucocorticoids|glucocorticoids|mesh-ancestor
92196457|NCT00633919|Hormones|hormones|mesh-ancestor
92196458|NCT00633919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196459|NCT00633919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196460|NCT00633919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92196461|NCT00633919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196462|NCT00633919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92196463|NCT00633919|Autonomic Agents|autonomic agents|mesh-ancestor
92196464|NCT00633919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196465|NCT00633919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196466|NCT00633919|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196467|NCT00633919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92196468|NCT00633919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92196469|NCT00633919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92196470|NCT00633919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196471|NCT00633919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196472|NCT00633919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196473|NCT00633919|Tocolytic Agents|tocolytic agents|mesh-ancestor
92196474|NCT00633919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92196475|NCT00633919|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92196476|NCT00633919|Cholinergic Agents|cholinergic agents|mesh-ancestor
92196477|NCT00633919|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92196478|NCT00633919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92196479|NCT00633919|Histamine Antagonists|histamine antagonists|mesh-ancestor
92196480|NCT00633919|Histamine Agents|histamine agents|mesh-ancestor
92196482|NCT03158246|Zoledronic Acid|zoledronic acid|mesh-list
92196484|NCT03158246|Vitamins|vitamins|mesh-ancestor
92196485|NCT03158246|Micronutrients|micronutrients|mesh-ancestor
92196486|NCT03158246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196487|NCT03158246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92196488|NCT03158246|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92196489|NCT00515411|Leucovorin|leucovorin|mesh-list
92196490|NCT00515411|Cisplatin|cisplatin|mesh-list
92196491|NCT00515411|Docetaxel|docetaxel|mesh-list
92196492|NCT00515411|Fluorouracil|fluorouracil|mesh-list
92196493|NCT00515411|Trastuzumab|trastuzumab|mesh-list
92196494|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196495|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
92196496|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
92196497|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
92196498|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196499|NCT00515411|Antimetabolites|antimetabolites|mesh-ancestor
92196500|NCT00515411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92196501|NCT00515411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196502|NCT00515411|Immunologic Factors|immunologic factors|mesh-ancestor
92196503|NCT00515411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196504|NCT00515411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196505|NCT00515411|Antidotes|antidotes|mesh-ancestor
92196506|NCT00515411|Protective Agents|protective agents|mesh-ancestor
92196507|NCT00515411|Vitamin B Complex|vitamin b complex|mesh-ancestor
92196508|NCT00515411|Vitamins|vitamins|mesh-ancestor
92196509|NCT00515411|Micronutrients|micronutrients|mesh-ancestor
92196510|NCT00586261|Pioglitazone|pioglitazone|mesh-list
92196511|NCT00586261|Nitroglycerin|nitroglycerin|mesh-list
92196512|NCT00586261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92196513|NCT00586261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196514|NCT00586261|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196515|NCT00515723|Olanzapine|olanzapine|mesh-list
92196516|NCT00515723|Risperidone|risperidone|mesh-list
92196517|NCT00515723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92196518|NCT00515723|Ziprasidone|ziprasidone|mesh-list
92196519|NCT00515723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92196520|NCT00515723|Serotonin Agents|serotonin agents|mesh-ancestor
92196521|NCT00515723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196522|NCT00515723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196523|NCT00515723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196524|NCT00515723|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92196525|NCT00515723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92196526|NCT00515723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196527|NCT00515723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92196528|NCT00515723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92196529|NCT00515723|Dopamine Agents|dopamine agents|mesh-ancestor
92196530|NCT00515723|Antiemetics|antiemetics|mesh-ancestor
92196531|NCT00515723|Autonomic Agents|autonomic agents|mesh-ancestor
92196532|NCT00515723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196533|NCT00515723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196534|NCT00515723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92196535|NCT00515723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92196536|NCT00515723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196537|NCT00515723|Antidepressive Agents|antidepressive agents|mesh-ancestor
92196538|NCT04405154|Cisplatin|cisplatin|mesh-list
92196539|NCT04405154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196540|NCT00586573|Memantine|memantine|mesh-list
92196541|NCT00586573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92196542|NCT00586573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92196543|NCT00586573|Dopamine Agents|dopamine agents|mesh-ancestor
92196544|NCT00586573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196545|NCT00586573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196546|NCT00586573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196547|NCT00586573|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92196548|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92196550|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196551|NCT00515879|Cycloserine|cycloserine|mesh-list
92196552|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92196553|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196554|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92196555|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
92196556|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92196557|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
92196558|NCT00515879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196559|NCT03152942|Aminophylline|aminophylline|mesh-list
92196560|NCT03152942|Progesterone|progesterone|mesh-list
92196561|NCT03152942|Progestins|progestins|mesh-ancestor
92196562|NCT03152942|Hormones|hormones|mesh-ancestor
92196563|NCT03152942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196564|NCT03152942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196565|NCT03152942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92196566|NCT03152942|Autonomic Agents|autonomic agents|mesh-ancestor
92196567|NCT03152942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196568|NCT03152942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196569|NCT03152942|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196570|NCT03152942|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92196571|NCT03152942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92196572|NCT03152942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196573|NCT03152942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196574|NCT03152942|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92196575|NCT03152942|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92196576|NCT03152942|Purinergic Agents|purinergic agents|mesh-ancestor
92196577|NCT03152942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196578|NCT03152942|Protective Agents|protective agents|mesh-ancestor
92196579|NCT00586729|Mafenide|mafenide|mesh-list
92196580|NCT00586729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92196581|NCT00586729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196582|NCT00586729|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92196583|NCT00586729|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92196584|NCT00586729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196585|NCT00586729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196586|NCT01672346|Adenosine|adenosine|mesh-list
92196587|NCT01672346|Analgesics|analgesics|mesh-ancestor
92196588|NCT01672346|Sensory System Agents|sensory system agents|mesh-ancestor
92196589|NCT01672346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196590|NCT01672346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196591|NCT01672346|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92196592|NCT01672346|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196593|NCT01672346|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92196594|NCT01672346|Purinergic Agonists|purinergic agonists|mesh-ancestor
92196595|NCT01672346|Purinergic Agents|purinergic agents|mesh-ancestor
92196596|NCT01672346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196597|NCT01672346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196598|NCT00516503|Ketamine|ketamine|mesh-list
92196599|NCT00516503|Amitriptyline|amitriptyline|mesh-list
92196600|NCT00516503|Baclofen|baclofen|mesh-list
92196601|NCT00516503|Analgesics|analgesics|mesh-ancestor
92196602|NCT00516503|Sensory System Agents|sensory system agents|mesh-ancestor
92196603|NCT00516503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196604|NCT00516503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196605|NCT00516503|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92196606|NCT00516503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92196607|NCT00516503|Anesthetics, General|anesthetics, general|mesh-ancestor
92196608|NCT00516503|Anesthetics|anesthetics|mesh-ancestor
92196609|NCT00516503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196610|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92196611|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92196612|NCT00516503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196613|NCT00516503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196614|NCT00516503|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92196615|NCT00516503|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92196616|NCT00516503|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92196618|NCT00516503|GABA Agents|gaba agents|mesh-ancestor
92196619|NCT00516503|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92196620|NCT00516503|Antidepressive Agents|antidepressive agents|mesh-ancestor
92196621|NCT00516503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92196622|NCT00516503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92196623|NCT00516503|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92196624|NCT00516503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92196625|NCT00516503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196626|NCT00516503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196627|NCT03157310|Gefitinib|gefitinib|mesh-list
92196628|NCT03157310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196629|NCT03157310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92196630|NCT03157310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196631|NCT03157310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196632|NCT03157388|Vancomycin|vancomycin|mesh-list
92196633|NCT03157388|Gentamicins|gentamicins|mesh-list
92196634|NCT03157388|Meropenem|meropenem|mesh-list
92196635|NCT03157388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92196636|NCT03157388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196637|NCT03157388|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92196638|NCT03157388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196639|NCT03157388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196641|NCT03156920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92196642|NCT03156920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92196643|NCT03156920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92196644|NCT03156920|Serotonin Agents|serotonin agents|mesh-ancestor
92196645|NCT03156920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196646|NCT03156920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196647|NCT03156920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196648|NCT05247385|Ticagrelor|ticagrelor|mesh-list
92196649|NCT05247385|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92196650|NCT05247385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92196651|NCT05247385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92196652|NCT05247385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92196653|NCT05247385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92196654|NCT05247385|Purinergic Agents|purinergic agents|mesh-ancestor
92196655|NCT05247385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196656|NCT05247385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196657|NCT05247385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196658|NCT03156842|Amlodipine|amlodipine|mesh-list
92196659|NCT03156842|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92196660|NCT03156842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196661|NCT03156842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92196662|NCT03156842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196663|NCT03156842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196664|NCT03156842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92196665|NCT03156842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196666|NCT03156842|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196667|NCT03156842|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92196668|NCT03156842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92196669|NCT03156842|Antimetabolites|antimetabolites|mesh-ancestor
92196670|NCT03156842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92196671|NCT03156842|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92196672|NCT03156842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196673|NCT01672580|Vitamins|vitamins|mesh-list
92196674|NCT01672580|Micronutrients|micronutrients|mesh-ancestor
92196675|NCT01672580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196676|NCT00636649|Escitalopram|escitalopram|mesh-list
92196677|NCT00636649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92196678|NCT00636649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92196679|NCT00636649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196680|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196681|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196682|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
92196683|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196684|NCT05061524|Omalizumab|omalizumab|mesh-list
92196685|NCT05061524|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92196686|NCT05061524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92196687|NCT05061524|Respiratory System Agents|respiratory system agents|mesh-ancestor
92196688|NCT00636805|Dexamethasone|dexamethasone|mesh-list
92196689|NCT00636805|Palonosetron|palonosetron|mesh-list
92196690|NCT00636805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196692|NCT00636805|Autonomic Agents|autonomic agents|mesh-ancestor
92196693|NCT00636805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196694|NCT00636805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196695|NCT00636805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196696|NCT00636805|Glucocorticoids|glucocorticoids|mesh-ancestor
92196697|NCT00636805|Hormones|hormones|mesh-ancestor
92196698|NCT00636805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196699|NCT00636805|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92196700|NCT00636805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196701|NCT00636805|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92196702|NCT00636805|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92196703|NCT00636805|Serotonin Agents|serotonin agents|mesh-ancestor
92196704|NCT00636805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196705|NCT00636805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196706|NCT05247151|Oxytocin|oxytocin|mesh-list
92196707|NCT05247151|Oxytocics|oxytocics|mesh-ancestor
92196708|NCT05247151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92196709|NCT05247151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196710|NCT01676246|Flupirtine|flupirtine|mesh-list
92196711|NCT01676246|Analgesics|analgesics|mesh-ancestor
92196713|NCT01676246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196714|NCT01676246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196715|NCT00517595|Bevacizumab|bevacizumab|mesh-list
92196716|NCT00517595|Gemcitabine|gemcitabine|mesh-list
92196717|NCT00517595|Pemetrexed|pemetrexed|mesh-list
92196718|NCT00517595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196719|NCT00517595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196720|NCT00517595|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92196721|NCT00517595|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92196722|NCT00517595|Growth Substances|growth substances|mesh-ancestor
92196723|NCT00517595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196724|NCT00517595|Growth Inhibitors|growth inhibitors|mesh-ancestor
92196725|NCT00517595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92196726|NCT00517595|Antimetabolites|antimetabolites|mesh-ancestor
92196727|NCT00517595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196728|NCT00517595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196729|NCT00517595|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92196730|NCT00517595|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92196731|NCT01672814|Riboflavin|riboflavin|mesh-list
92196732|NCT01672814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92196733|NCT01672814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92196734|NCT01672814|Vitamin B Complex|vitamin b complex|mesh-ancestor
92196735|NCT01672814|Vitamins|vitamins|mesh-ancestor
92196736|NCT01672814|Micronutrients|micronutrients|mesh-ancestor
92196737|NCT01672814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196738|NCT01672814|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92196739|NCT01672814|Dermatologic Agents|dermatologic agents|mesh-ancestor
92196740|NCT00524225|Oprelvekin|oprelvekin|mesh-list
92196741|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196742|NCT00669019|Saracatinib|saracatinib|mesh-list
92196743|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196744|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196745|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196746|NCT05560373|Huperzine A|huperzine a|mesh-list
92196747|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92196748|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196749|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196750|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
92196751|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196752|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196753|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92196754|NCT05560373|Protective Agents|protective agents|mesh-ancestor
92196755|NCT00670267|Nadolol|nadolol|mesh-list
92196756|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92196757|NCT00670267|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92196758|NCT00670267|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196759|NCT00670267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196760|NCT00670267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196761|NCT00670267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196762|NCT00670267|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92196763|NCT00670267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196764|NCT00670267|Sympatholytics|sympatholytics|mesh-ancestor
92196765|NCT00670267|Autonomic Agents|autonomic agents|mesh-ancestor
92196766|NCT00670267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196767|NCT05621915|Nadroparin|nadroparin|mesh-list
92196768|NCT05621915|Anticoagulants|anticoagulants|mesh-ancestor
92196769|NCT05621915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92196770|NCT05621915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92196771|NCT05621915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196772|NCT01673204|Calcitriol|calcitriol|mesh-list
92196773|NCT01673204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92196774|NCT01673204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196775|NCT01673204|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92196776|NCT01673204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196777|NCT01673204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196778|NCT01673204|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92196779|NCT01673204|Vitamins|vitamins|mesh-ancestor
92196780|NCT01673204|Micronutrients|micronutrients|mesh-ancestor
92196781|NCT01673204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92196782|NCT04393298|Leucovorin|leucovorin|mesh-list
92196783|NCT04393298|Trifluridine|trifluridine|mesh-list
92196784|NCT04393298|Fluorouracil|fluorouracil|mesh-list
92196785|NCT04393298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196786|NCT04393298|Antimetabolites|antimetabolites|mesh-ancestor
92196787|NCT04393298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196788|NCT04393298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92196789|NCT04393298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196790|NCT04393298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196791|NCT04393298|Immunologic Factors|immunologic factors|mesh-ancestor
92196792|NCT04393298|Antiviral Agents|antiviral agents|mesh-ancestor
92196793|NCT04393298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196794|NCT04393298|Antidotes|antidotes|mesh-ancestor
92196795|NCT04393298|Protective Agents|protective agents|mesh-ancestor
92196796|NCT04393298|Vitamin B Complex|vitamin b complex|mesh-ancestor
92196797|NCT04393298|Vitamins|vitamins|mesh-ancestor
92196798|NCT04393298|Micronutrients|micronutrients|mesh-ancestor
92196799|NCT00641563|Midazolam|midazolam|mesh-list
92196800|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
92196801|NCT00641563|Remifentanil|remifentanil|mesh-list
92196802|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92196803|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196804|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196805|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92196806|NCT00641563|Analgesics|analgesics|mesh-ancestor
92196807|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
92196808|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196809|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92196810|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92196811|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92196812|NCT00641563|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196813|NCT00641563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196814|NCT00641563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196815|NCT00641563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92196816|NCT00641563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92196817|NCT00641563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92196818|NCT00641563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92196819|NCT00641563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92196820|NCT00641563|Anesthetics, General|anesthetics, general|mesh-ancestor
92196821|NCT00641563|Anesthetics|anesthetics|mesh-ancestor
92196822|NCT00641563|GABA Modulators|gaba modulators|mesh-ancestor
92196823|NCT00641563|GABA Agents|gaba agents|mesh-ancestor
92196824|NCT00641563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92196825|NCT00641563|Narcotics|narcotics|mesh-ancestor
92196826|NCT05621759|Cyclophosphamide|cyclophosphamide|mesh-list
92196827|NCT05621759|Abatacept|abatacept|mesh-list
92196828|NCT05621759|Tacrolimus|tacrolimus|mesh-list
92196829|NCT05621759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92196830|NCT05621759|Immunologic Factors|immunologic factors|mesh-ancestor
92196831|NCT05621759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196832|NCT05621759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92196833|NCT05621759|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92196834|NCT05621759|Alkylating Agents|alkylating agents|mesh-ancestor
92196835|NCT05621759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196836|NCT05621759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196837|NCT05621759|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92196838|NCT05621759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92196839|NCT05621759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196840|NCT05621759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92196841|NCT05621759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196842|NCT02251262|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92196843|NCT02251262|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92196844|NCT02251262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196846|NCT00641641|Emtricitabine|emtricitabine|mesh-list
92196847|NCT00641641|Raltegravir Potassium|raltegravir potassium|mesh-list
92196848|NCT00641641|Antiviral Agents|antiviral agents|mesh-ancestor
92196849|NCT00641641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92196850|NCT00641641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92196851|NCT00641641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92196852|NCT00641641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196853|NCT00641641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196854|NCT00641641|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92196855|NCT00641641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92196856|NCT00641641|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92196857|NCT00641641|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92196858|NCT03152474|Vitamin A|vitamin a|mesh-list
92196859|NCT03152474|Methylprednisolone|methylprednisolone|mesh-list
92196860|NCT03152474|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92196861|NCT03152474|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92196862|NCT03152474|Prednisolone|prednisolone|mesh-list
92196863|NCT03152474|Prednisolone acetate|prednisolone acetate|mesh-list
92196864|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92196865|NCT03152474|Prednisolone phosphate|prednisolone phosphate|mesh-list
92196867|NCT03152474|Micronutrients|micronutrients|mesh-ancestor
92196868|NCT03152474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196869|NCT03152474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92196870|NCT03152474|Antiemetics|antiemetics|mesh-ancestor
92196871|NCT03152474|Autonomic Agents|autonomic agents|mesh-ancestor
92196872|NCT03152474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196873|NCT03152474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196874|NCT03152474|Glucocorticoids|glucocorticoids|mesh-ancestor
92196875|NCT03152474|Hormones|hormones|mesh-ancestor
92196876|NCT03152474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92196877|NCT03152474|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92196878|NCT03152474|Protective Agents|protective agents|mesh-ancestor
92196879|NCT03152474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92196880|NCT03152474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196881|NCT00641797|Diphenhydramine|diphenhydramine|mesh-list
92196882|NCT00641797|Promethazine|promethazine|mesh-list
92196883|NCT00641797|Meclizine|meclizine|mesh-list
92196884|NCT00641797|Lorazepam|lorazepam|mesh-list
92196885|NCT00641797|Ondansetron|ondansetron|mesh-list
92196886|NCT00641797|Antiemetics|antiemetics|mesh-ancestor
92196887|NCT00641797|Autonomic Agents|autonomic agents|mesh-ancestor
92196888|NCT00641797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196889|NCT00641797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196890|NCT00641797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196891|NCT00641797|Antipruritics|antipruritics|mesh-ancestor
92196892|NCT00641797|Dermatologic Agents|dermatologic agents|mesh-ancestor
91917521|NCT04053140|Penicillin G|penicillin g|mesh-list
92196893|NCT00641797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92196894|NCT00641797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92196895|NCT00641797|Serotonin Agents|serotonin agents|mesh-ancestor
92196896|NCT00641797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196897|NCT00641797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196898|NCT00641797|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92196899|NCT00641797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92196900|NCT00641797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196901|NCT00641797|Anesthetics, Local|anesthetics, local|mesh-ancestor
92196902|NCT00641797|Anesthetics|anesthetics|mesh-ancestor
92196903|NCT00641797|Sensory System Agents|sensory system agents|mesh-ancestor
92196904|NCT00641797|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92196905|NCT00641797|Histamine Antagonists|histamine antagonists|mesh-ancestor
92196906|NCT00641797|Histamine Agents|histamine agents|mesh-ancestor
92196907|NCT00641797|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92196908|NCT00641797|Anticonvulsants|anticonvulsants|mesh-ancestor
92196909|NCT00641797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92196910|NCT00641797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92196911|NCT00641797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92196912|NCT00641797|GABA Modulators|gaba modulators|mesh-ancestor
92196913|NCT00641797|GABA Agents|gaba agents|mesh-ancestor
92196914|NCT00641797|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92196915|NCT00641797|Cholinergic Agents|cholinergic agents|mesh-ancestor
92196916|NCT04333459|Vaccines|vaccines|mesh-list
92196917|NCT04333459|Immunologic Factors|immunologic factors|mesh-ancestor
92196918|NCT04333459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196919|NCT00671515|Pioglitazone|pioglitazone|mesh-list
92196920|NCT00671515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92196921|NCT00671515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196922|NCT01893320|Decitabine|decitabine|mesh-list
92196923|NCT01893320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92196924|NCT01893320|Antimetabolites|antimetabolites|mesh-ancestor
92196925|NCT01893320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196926|NCT01893320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196927|NCT01893320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196928|NCT04120766|Nicorandil|nicorandil|mesh-list
92196929|NCT04120766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92196930|NCT04120766|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196931|NCT04120766|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196932|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
92196934|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
92196935|NCT04120766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196936|NCT00673075|Carvedilol|carvedilol|mesh-list
92196937|NCT00673075|Nebivolol|nebivolol|mesh-list
92196938|NCT00673075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92196939|NCT00673075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92196940|NCT00673075|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196941|NCT00673075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92196942|NCT00673075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196943|NCT00673075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196944|NCT00673075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92196945|NCT00673075|Antioxidants|antioxidants|mesh-ancestor
92196946|NCT00673075|Protective Agents|protective agents|mesh-ancestor
92196947|NCT00673075|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92196948|NCT00673075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92196949|NCT00673075|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92196950|NCT00673075|Vasodilator Agents|vasodilator agents|mesh-ancestor
92196951|NCT00673075|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92196952|NCT00673075|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92196953|NCT00673075|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92196954|NCT00673075|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92196955|NCT00673075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92196956|NCT02250014|Sargramostim|sargramostim|mesh-list
92196957|NCT02250014|Immunologic Factors|immunologic factors|mesh-ancestor
92196958|NCT02250014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196959|NCT04022096|Lansoprazole|lansoprazole|mesh-list
92196960|NCT04022096|Dexlansoprazole|dexlansoprazole|mesh-list
92196961|NCT04022096|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92196962|NCT04022096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92196963|NCT04022096|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92196964|NCT04022096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196965|NCT04022096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196966|NCT00673153|Vorinostat|vorinostat|mesh-list
92196967|NCT00673153|Gemtuzumab|gemtuzumab|mesh-list
92196968|NCT00673153|Calicheamicins|calicheamicins|mesh-list
92196969|NCT00673153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92196970|NCT00673153|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92196971|NCT00673153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92196972|NCT00673153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196973|NCT00673153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92196974|NCT00673153|Immunotoxins|immunotoxins|mesh-ancestor
92196975|NCT00673153|Immunoconjugates|immunoconjugates|mesh-ancestor
92196976|NCT00673153|Immunologic Factors|immunologic factors|mesh-ancestor
92196977|NCT00673153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196978|NCT00673153|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92196979|NCT00673855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92196980|NCT00673855|Lubricant Eye Drops|lubricant eye drops|mesh-list
92196981|NCT00673855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92196983|NCT00654511|Dexmedetomidine|dexmedetomidine|mesh-list
92196984|NCT00654511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92196985|NCT00654511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92196986|NCT00654511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92196987|NCT00654511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92196988|NCT00654511|Analgesics|analgesics|mesh-ancestor
92196989|NCT00654511|Sensory System Agents|sensory system agents|mesh-ancestor
92196990|NCT00654511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92196991|NCT00654511|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92196992|NCT00654511|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92196993|NCT00654511|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92196994|NCT00654511|Adrenergic Agents|adrenergic agents|mesh-ancestor
92196995|NCT00654511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335317|NCT02100228|Antithrombins|antithrombins|mesh-ancestor
92196996|NCT00654511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92196997|NCT00654511|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92196998|NCT00654511|Narcotics|narcotics|mesh-ancestor
92196999|NCT00654511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92197000|NCT00654511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92197001|NCT00654511|Anesthetics, General|anesthetics, general|mesh-ancestor
92197002|NCT00654511|Anesthetics|anesthetics|mesh-ancestor
92197003|NCT01670084|Leucovorin|leucovorin|mesh-list
92197004|NCT01670084|Cytarabine|cytarabine|mesh-list
92197005|NCT01670084|Dexamethasone|dexamethasone|mesh-list
92197006|NCT01670084|Prednisone|prednisone|mesh-list
92197007|NCT01670084|Cyclophosphamide|cyclophosphamide|mesh-list
92197008|NCT01670084|Rituximab|rituximab|mesh-list
92197009|NCT01670084|Doxorubicin|doxorubicin|mesh-list
92197010|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92197011|NCT01670084|Methotrexate|methotrexate|mesh-list
92197012|NCT01670084|Vincristine|vincristine|mesh-list
92197013|NCT01670084|Levoleucovorin|levoleucovorin|mesh-list
92197014|NCT01670084|Mesna|mesna|mesh-list
92197015|NCT01670084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197016|NCT01670084|Immunologic Factors|immunologic factors|mesh-ancestor
92197017|NCT01670084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197018|NCT01670084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197019|NCT01670084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92197020|NCT01670084|Alkylating Agents|alkylating agents|mesh-ancestor
92197021|NCT01670084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197022|NCT01670084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197023|NCT01670084|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92197024|NCT01670084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197025|NCT01670084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197026|NCT01670084|Antiemetics|antiemetics|mesh-ancestor
92197027|NCT01670084|Autonomic Agents|autonomic agents|mesh-ancestor
92197028|NCT01670084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197029|NCT01670084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197030|NCT01670084|Glucocorticoids|glucocorticoids|mesh-ancestor
92197031|NCT01670084|Hormones|hormones|mesh-ancestor
92197032|NCT01670084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197033|NCT01670084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197034|NCT01670084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197035|NCT01670084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197036|NCT01670084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197037|NCT01670084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197038|NCT01670084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92197039|NCT01670084|Abortifacient Agents|abortifacient agents|mesh-ancestor
92197040|NCT01670084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92197041|NCT01670084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92197042|NCT01670084|Antimetabolites|antimetabolites|mesh-ancestor
92197043|NCT01670084|Dermatologic Agents|dermatologic agents|mesh-ancestor
92197044|NCT01670084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92197045|NCT01670084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92197046|NCT01670084|Antiviral Agents|antiviral agents|mesh-ancestor
92197047|NCT01670084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197048|NCT01670084|Antidotes|antidotes|mesh-ancestor
92197049|NCT01670084|Protective Agents|protective agents|mesh-ancestor
92197050|NCT01670084|Vitamin B Complex|vitamin b complex|mesh-ancestor
92197051|NCT01670084|Vitamins|vitamins|mesh-ancestor
92197052|NCT01670084|Micronutrients|micronutrients|mesh-ancestor
92197053|NCT01670084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197054|NCT01670084|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197055|NCT01670084|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197056|NCT01670084|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197057|NCT01670162|Aflibercept|aflibercept|mesh-list
92197058|NCT01670162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92197059|NCT01670162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92197060|NCT01670162|Growth Substances|growth substances|mesh-ancestor
92197061|NCT01670162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197062|NCT01670162|Growth Inhibitors|growth inhibitors|mesh-ancestor
92197063|NCT01670162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197065|NCT04345783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197066|NCT04345783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92197067|NCT04345783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197068|NCT04345783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197069|NCT00675259|Paclitaxel|paclitaxel|mesh-list
92197070|NCT00675259|Bevacizumab|bevacizumab|mesh-list
92197071|NCT00675259|Carboplatin|carboplatin|mesh-list
92197072|NCT00675259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197073|NCT00675259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197074|NCT00675259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197075|NCT00675259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197076|NCT00675259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197077|NCT00675259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197078|NCT00675259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197079|NCT00675259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92197080|NCT00675259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92197081|NCT00675259|Growth Substances|growth substances|mesh-ancestor
92197082|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197083|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
92197084|NCT01674218|Moxifloxacin|moxifloxacin|mesh-list
92197085|NCT01674218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197086|NCT01674218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197087|NCT01674218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197088|NCT01674218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197089|NCT01674218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197090|NCT01674218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197091|NCT01674218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197092|NCT01670240|Adalimumab|adalimumab|mesh-list
92197093|NCT01670240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92197094|NCT01670240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197095|NCT01670240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197096|NCT04404686|Indomethacin|indomethacin|mesh-list
92197097|NCT04404686|Nifedipine|nifedipine|mesh-list
92197098|NCT04404686|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92197099|NCT04404686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197100|NCT04404686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197101|NCT04404686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92197102|NCT04404686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197103|NCT04404686|Vasodilator Agents|vasodilator agents|mesh-ancestor
92197104|NCT04404686|Tocolytic Agents|tocolytic agents|mesh-ancestor
92197105|NCT04404686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92197106|NCT04404686|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92197107|NCT04404686|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92197108|NCT04404686|Analgesics|analgesics|mesh-ancestor
92197109|NCT04404686|Sensory System Agents|sensory system agents|mesh-ancestor
92197110|NCT04404686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197111|NCT04404686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197112|NCT04404686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197113|NCT04404686|Gout Suppressants|gout suppressants|mesh-ancestor
92197114|NCT04404686|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92197115|NCT04404686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197116|NCT00676585|Hydrocortisone|hydrocortisone|mesh-list
92197117|NCT00676585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197118|NCT00658411|Deferoxamine|deferoxamine|mesh-list
92197119|NCT00658411|Siderophores|siderophores|mesh-ancestor
92197120|NCT00658411|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92197121|NCT00658411|Chelating Agents|chelating agents|mesh-ancestor
92197122|NCT00658411|Sequestering Agents|sequestering agents|mesh-ancestor
92197123|NCT00658411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197124|NCT01674530|Lubiprostone|lubiprostone|mesh-list
92197125|NCT01674530|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92197126|NCT01674530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197127|NCT01674530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197128|NCT00676897|Simvastatin|simvastatin|mesh-list
92197129|NCT00676897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92197130|NCT00676897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92197131|NCT00676897|Antimetabolites|antimetabolites|mesh-ancestor
92197132|NCT00676897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197133|NCT00676897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92197134|NCT00676897|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92197135|NCT00676897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197137|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92197138|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92197139|NCT02115074|Analgesics|analgesics|mesh-ancestor
92197140|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
92197141|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197142|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197143|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197144|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197151|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92197152|NCT01674686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92197153|NCT01674686|Antimetabolites|antimetabolites|mesh-ancestor
92197154|NCT01674686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197155|NCT01674686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92197156|NCT01674686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92197157|NCT01674686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197158|NCT01674686|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92197159|NCT01674686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92197160|NCT01674686|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92197161|NCT01674686|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92197162|NCT01674686|Serotonin Agents|serotonin agents|mesh-ancestor
92197163|NCT01674686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197164|NCT01674686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197165|NCT02082392|Escitalopram|escitalopram|mesh-list
92197166|NCT02082392|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92197167|NCT02082392|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92197168|NCT02082392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197169|NCT02082392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197170|NCT02082392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197171|NCT02082392|Serotonin Agents|serotonin agents|mesh-ancestor
92197172|NCT02082392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197179|NCT01674842|Cisplatin|cisplatin|mesh-list
92197180|NCT01674842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197181|NCT03845894|Bupivacaine|bupivacaine|mesh-list
92197182|NCT03845894|Anesthetics, Local|anesthetics, local|mesh-ancestor
92197183|NCT03845894|Anesthetics|anesthetics|mesh-ancestor
92197184|NCT03845894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197185|NCT03845894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197186|NCT03845894|Sensory System Agents|sensory system agents|mesh-ancestor
92197187|NCT03845894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197188|NCT03161132|Doxorubicin|doxorubicin|mesh-list
92197189|NCT03161132|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92197190|NCT03161132|Olaparib|olaparib|mesh-list
92197191|NCT03161132|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197192|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197193|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197194|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197195|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197196|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197197|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92197198|NCT03844256|Capecitabine|capecitabine|mesh-list
92197199|NCT03844256|Nivolumab|nivolumab|mesh-list
92197200|NCT03844256|Ipilimumab|ipilimumab|mesh-list
92197201|NCT03844256|Mitomycins|mitomycins|mesh-list
92197202|NCT03844256|Mitomycin|mitomycin|mesh-list
92197203|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92197204|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
92197205|NCT03844256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197206|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197207|NCT03844256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197208|NCT03844256|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197209|NCT03844256|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197210|NCT03844256|Alkylating Agents|alkylating agents|mesh-ancestor
92197211|NCT03844256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92197212|NCT03844256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197214|NCT01675076|Apixaban|apixaban|mesh-list
92197215|NCT01675076|Dabigatran|dabigatran|mesh-list
92197216|NCT01675076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92197217|NCT01675076|Antithrombins|antithrombins|mesh-ancestor
92197218|NCT01675076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92197219|NCT01675076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92197220|NCT01675076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197221|NCT01675076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197222|NCT01675076|Anticoagulants|anticoagulants|mesh-ancestor
92197223|NCT03018080|Paclitaxel|paclitaxel|mesh-list
92197224|NCT03018080|Pembrolizumab|pembrolizumab|mesh-list
92197225|NCT03018080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197226|NCT03018080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197227|NCT03018080|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197228|NCT03018080|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197229|NCT03018080|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197230|NCT03018080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197231|NCT03018080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197232|NCT03018080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197233|NCT03838796|Lenvatinib|lenvatinib|mesh-list
92197234|NCT03838796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197235|NCT03838796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92197236|NCT03838796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197237|NCT03838796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197238|NCT03719690|Tipifarnib|tipifarnib|mesh-list
92197239|NCT03719690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197240|NCT01675466|Anesthetics|anesthetics|mesh-list
92197241|NCT01675466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197242|NCT01675466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197243|NCT01675700|Nitroglycerin|nitroglycerin|mesh-list
92197244|NCT01675700|Vasodilator Agents|vasodilator agents|mesh-ancestor
92197245|NCT01676558|Rituximab|rituximab|mesh-list
92197246|NCT01676558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197247|NCT01676558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197248|NCT01676558|Immunologic Factors|immunologic factors|mesh-ancestor
92197249|NCT01676558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197250|NCT01676558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197252|NCT02510300|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92197253|NCT02510300|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92197254|NCT02510300|Ledipasvir|ledipasvir|mesh-list
92197255|NCT02510300|Velpatasvir|velpatasvir|mesh-list
92197256|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
92197257|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197258|NCT00678535|Capecitabine|capecitabine|mesh-list
92197259|NCT00678535|Cetuximab|cetuximab|mesh-list
92197260|NCT00678535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197261|NCT00678535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92197262|NCT00678535|Antimetabolites|antimetabolites|mesh-ancestor
92197263|NCT00678535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197264|NCT00678535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197265|NCT00659737|Scopolamine|scopolamine|mesh-list
92197266|NCT00659737|Aprepitant|aprepitant|mesh-list
92197267|NCT00659737|Fosaprepitant|fosaprepitant|mesh-list
92197268|NCT00659737|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92197269|NCT00659737|Antiemetics|antiemetics|mesh-ancestor
92197270|NCT00659737|Autonomic Agents|autonomic agents|mesh-ancestor
92197271|NCT00659737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197272|NCT00659737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197273|NCT00659737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197274|NCT00659737|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92197275|NCT00659737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197276|NCT00659737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197277|NCT00659737|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92197278|NCT00659737|Mydriatics|mydriatics|mesh-ancestor
92197279|NCT00659737|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92197280|NCT00659737|Cholinergic Agents|cholinergic agents|mesh-ancestor
92197281|NCT00659737|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92197282|NCT00659737|Parasympatholytics|parasympatholytics|mesh-ancestor
92197283|NCT04763876|Ketorolac|ketorolac|mesh-list
92197284|NCT04763876|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92197285|NCT04763876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408636|NCT05962970|Anesthetics|anesthetics|mesh-ancestor
92197286|NCT04763876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92197287|NCT04763876|Analgesics|analgesics|mesh-ancestor
92197288|NCT04763876|Sensory System Agents|sensory system agents|mesh-ancestor
92197289|NCT04763876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197290|NCT04763876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197291|NCT04763876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197292|NCT04763876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197293|NCT04763876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92197294|NCT04763876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197295|NCT04763876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197297|NCT00680797|Estrogens|estrogens|mesh-list
92197298|NCT00680797|Androgens|androgens|mesh-ancestor
92197299|NCT00680797|Hormones|hormones|mesh-ancestor
92197300|NCT00680797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197301|NCT00680797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197302|NCT02984852|Tenofovir|tenofovir|mesh-list
92197303|NCT02984852|Emtricitabine|emtricitabine|mesh-list
92197304|NCT02984852|Darunavir|darunavir|mesh-list
92197305|NCT02984852|Cobicistat|cobicistat|mesh-list
92197306|NCT02984852|Antiviral Agents|antiviral agents|mesh-ancestor
92197307|NCT02984852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197308|NCT02984852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92197309|NCT02984852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92197310|NCT02984852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197311|NCT02984852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197312|NCT02984852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92197313|NCT02984852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92197314|NCT02984852|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92197315|NCT02984852|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92197316|NCT02984852|Protease Inhibitors|protease inhibitors|mesh-ancestor
92197317|NCT02984852|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92197318|NCT02984852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92197319|NCT00557193|Calcium, Dietary|calcium, dietary|mesh-list
92197320|NCT00557193|Leucovorin|leucovorin|mesh-list
92197321|NCT00557193|Folic Acid|folic acid|mesh-list
92197322|NCT00557193|Cytarabine|cytarabine|mesh-list
92197323|NCT00557193|Dexamethasone|dexamethasone|mesh-list
92197324|NCT00557193|Dexamethasone acetate|dexamethasone acetate|mesh-list
92197325|NCT00557193|Prednisone|prednisone|mesh-list
92197326|NCT00557193|Methylprednisolone|methylprednisolone|mesh-list
92197327|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92197328|NCT00557193|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92197330|NCT00557193|Prednisolone acetate|prednisolone acetate|mesh-list
92197331|NCT00557193|Hydrocortisone|hydrocortisone|mesh-list
92197332|NCT00557193|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92197333|NCT00557193|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92197334|NCT00557193|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92197335|NCT00557193|Cortisone|cortisone|mesh-list
92197336|NCT00557193|Cyclophosphamide|cyclophosphamide|mesh-list
92197337|NCT00557193|Methotrexate|methotrexate|mesh-list
92197338|NCT00557193|Etoposide|etoposide|mesh-list
92197339|NCT00557193|Vincristine|vincristine|mesh-list
92197340|NCT00557193|Etoposide phosphate|etoposide phosphate|mesh-list
92197341|NCT00557193|Daunorubicin|daunorubicin|mesh-list
92197342|NCT00557193|Asparaginase|asparaginase|mesh-list
92197343|NCT00557193|Mercaptopurine|mercaptopurine|mesh-list
92197344|NCT00557193|Podophyllotoxin|podophyllotoxin|mesh-list
92197345|NCT00557193|Pegaspargase|pegaspargase|mesh-list
92197346|NCT00557193|Lenograstim|lenograstim|mesh-list
92197347|NCT00557193|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92197348|NCT00557193|Prednisolone phosphate|prednisolone phosphate|mesh-list
92197349|NCT00557193|BB 1101|bb 1101|mesh-list
92197350|NCT00557193|Calcium|calcium|mesh-list
92197351|NCT00557193|Levoleucovorin|levoleucovorin|mesh-list
92197352|NCT00557193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197353|NCT00557193|Immunologic Factors|immunologic factors|mesh-ancestor
92197354|NCT00557193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197355|NCT00557193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197356|NCT00557193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92197357|NCT00557193|Alkylating Agents|alkylating agents|mesh-ancestor
92327634|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92197358|NCT00557193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197359|NCT00557193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197360|NCT00557193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92197361|NCT00557193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197363|NCT00557193|Autonomic Agents|autonomic agents|mesh-ancestor
92197364|NCT00557193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197365|NCT00557193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197366|NCT00557193|Glucocorticoids|glucocorticoids|mesh-ancestor
92197368|NCT00557193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197369|NCT00557193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197370|NCT00557193|Protease Inhibitors|protease inhibitors|mesh-ancestor
92197371|NCT00557193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197372|NCT00557193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92197373|NCT00557193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92197374|NCT00557193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92197375|NCT00557193|Abortifacient Agents|abortifacient agents|mesh-ancestor
92197376|NCT00557193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92197377|NCT00557193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92197378|NCT00557193|Antimetabolites|antimetabolites|mesh-ancestor
92197379|NCT00557193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92197380|NCT00557193|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92197381|NCT00557193|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92197382|NCT00557193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197383|NCT00557193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197384|NCT00557193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197385|NCT00557193|Antiviral Agents|antiviral agents|mesh-ancestor
92197386|NCT00557193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197387|NCT00557193|Antidotes|antidotes|mesh-ancestor
92197388|NCT00557193|Protective Agents|protective agents|mesh-ancestor
92197389|NCT00557193|Vitamin B Complex|vitamin b complex|mesh-ancestor
92197390|NCT00557193|Vitamins|vitamins|mesh-ancestor
92197391|NCT00557193|Micronutrients|micronutrients|mesh-ancestor
92197392|NCT00557193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92197393|NCT00557193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197394|NCT00557193|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197395|NCT00557193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197396|NCT00557193|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92197397|NCT00557193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197398|NCT00557193|Hematinics|hematinics|mesh-ancestor
92197399|NCT00557193|Keratolytic Agents|keratolytic agents|mesh-ancestor
92197400|NCT00660517|Fluticasone|fluticasone|mesh-list
92197401|NCT00660517|Xhance|xhance|mesh-list
92197402|NCT00660517|Azelastine|azelastine|mesh-list
92197403|NCT00660517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197404|NCT00660517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92197405|NCT00660517|Autonomic Agents|autonomic agents|mesh-ancestor
92197406|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197407|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197408|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92197409|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
92197410|NCT00660517|Dermatologic Agents|dermatologic agents|mesh-ancestor
92197411|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92197412|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92197413|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197414|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197415|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92197416|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92197417|NCT00660517|Histamine Antagonists|histamine antagonists|mesh-ancestor
92197418|NCT00660517|Histamine Agents|histamine agents|mesh-ancestor
92197419|NCT00660517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197420|NCT02141581|Vaccines|vaccines|mesh-list
92197421|NCT02141581|Immunologic Factors|immunologic factors|mesh-ancestor
92197422|NCT02141581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197423|NCT03826628|Sirolimus|sirolimus|mesh-list
92197424|NCT03826628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197425|NCT03826628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197426|NCT03826628|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197427|NCT03826628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197428|NCT03826628|Antifungal Agents|antifungal agents|mesh-ancestor
92197429|NCT03826628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197430|NCT03826628|Immunologic Factors|immunologic factors|mesh-ancestor
92197431|NCT03826628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197432|NCT03991299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92197433|NCT03991299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92197434|NCT03991299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197435|NCT03991299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197436|NCT03991299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92197437|NCT03991299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197438|NCT03991299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197439|NCT03991299|Cholinergic Agents|cholinergic agents|mesh-ancestor
92197440|NCT03991299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197441|NCT03751436|Venetoclax|venetoclax|mesh-list
92197442|NCT03751436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197443|NCT03819530|Micronutrients|micronutrients|mesh-list
92197444|NCT03819530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197445|NCT02279667|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92197446|NCT02279667|Anticonvulsants|anticonvulsants|mesh-ancestor
92197447|NCT02279667|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92197448|NCT02279667|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92197449|NCT02279667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197450|NCT02279667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197452|NCT03818672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197453|NCT03818672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197454|NCT03818672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197455|NCT03749018|Prednisone|prednisone|mesh-list
92197456|NCT03749018|Cortisone|cortisone|mesh-list
92197457|NCT03749018|Cyclophosphamide|cyclophosphamide|mesh-list
92197458|NCT03749018|Rituximab|rituximab|mesh-list
92197459|NCT03749018|Doxorubicin|doxorubicin|mesh-list
92197460|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92197461|NCT03749018|Nivolumab|nivolumab|mesh-list
92197462|NCT03749018|Etoposide|etoposide|mesh-list
92197463|NCT03749018|Vincristine|vincristine|mesh-list
92197464|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
92197465|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
92197466|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92197467|NCT03749018|Antibodies|antibodies|mesh-list
92197468|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
92197469|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92197470|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197471|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
92197472|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197473|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197474|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92197475|NCT03749018|Alkylating Agents|alkylating agents|mesh-ancestor
92197476|NCT03749018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197477|NCT03749018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197478|NCT03749018|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92197479|NCT03749018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197480|NCT03749018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197481|NCT03749018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197482|NCT03749018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197483|NCT03749018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197485|NCT03749018|Hormones|hormones|mesh-ancestor
92197486|NCT03749018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197487|NCT03749018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197488|NCT03749018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197489|NCT03749018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197490|NCT03749018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197491|NCT03749018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197492|NCT03749018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197493|NCT03749018|Keratolytic Agents|keratolytic agents|mesh-ancestor
92197494|NCT03749018|Dermatologic Agents|dermatologic agents|mesh-ancestor
92197495|NCT01931163|Everolimus|everolimus|mesh-list
92197496|NCT01931163|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92197497|NCT01931163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92197498|NCT01931163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197499|NCT01931163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197500|NCT01931163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197501|NCT01931163|Immunologic Factors|immunologic factors|mesh-ancestor
92197502|NCT01931163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197503|NCT01931163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197504|NCT04763486|Cefazolin|cefazolin|mesh-list
92197505|NCT04763486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197506|NCT04763486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197507|NCT02988063|Polidocanol|polidocanol|mesh-list
92197508|NCT02988063|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92197509|NCT02988063|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92197510|NCT03877406|Empagliflozin|empagliflozin|mesh-list
92197511|NCT03877406|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92197512|NCT03877406|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92197513|NCT03877406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197514|NCT03877406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197515|NCT03025269|Ocrelizumab|ocrelizumab|mesh-list
92197516|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
92197517|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197518|NCT03744026|Carboplatin|carboplatin|mesh-list
92197519|NCT03744026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197520|NCT03869450|Lidocaine|lidocaine|mesh-list
92197521|NCT03869450|Hyaluronic Acid|hyaluronic acid|mesh-list
92197522|NCT03869450|Anesthetics, Local|anesthetics, local|mesh-ancestor
92197523|NCT03869450|Anesthetics|anesthetics|mesh-ancestor
92197524|NCT03869450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197525|NCT03869450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197526|NCT03869450|Sensory System Agents|sensory system agents|mesh-ancestor
92197527|NCT03869450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197528|NCT03869450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92197529|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92197530|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92197531|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197532|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197533|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92197534|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
92197535|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
92197536|NCT03869450|Protective Agents|protective agents|mesh-ancestor
92197537|NCT03799874|Carbon Monoxide|carbon monoxide|mesh-list
92197538|NCT03799874|Antimetabolites|antimetabolites|mesh-ancestor
92197539|NCT03799874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197540|NCT03799874|Gasotransmitters|gasotransmitters|mesh-ancestor
92197541|NCT03799874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197542|NCT03799874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197543|NCT03736928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92197544|NCT03736928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92197545|NCT03736928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92197546|NCT03736928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197547|NCT03736928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197548|NCT03736928|Cholinergic Agents|cholinergic agents|mesh-ancestor
92197549|NCT03736928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197550|NCT03736928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197551|NCT03736928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92197552|NCT03736928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197554|NCT01101464|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92197555|NCT01101464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92197556|NCT01101464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197557|NCT01101464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197558|NCT01101464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92197559|NCT03736538|Nitrous Oxide|nitrous oxide|mesh-list
92197560|NCT03736538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92197561|NCT03736538|Anesthetics, General|anesthetics, general|mesh-ancestor
92197562|NCT03736538|Anesthetics|anesthetics|mesh-ancestor
92197563|NCT03736538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197564|NCT03736538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197565|NCT03736538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92197566|NCT03736538|Analgesics|analgesics|mesh-ancestor
92197567|NCT03736538|Sensory System Agents|sensory system agents|mesh-ancestor
92197568|NCT03736538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197569|NCT01676948|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92197570|NCT01676948|Immunologic Factors|immunologic factors|mesh-ancestor
92197571|NCT01676948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197572|NCT03725930|Clonidine|clonidine|mesh-list
92197573|NCT03725930|Analgesics|analgesics|mesh-ancestor
92197574|NCT03725930|Sensory System Agents|sensory system agents|mesh-ancestor
92197575|NCT03725930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197576|NCT03725930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197577|NCT03725930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92197578|NCT03725930|Sympatholytics|sympatholytics|mesh-ancestor
92197579|NCT03725930|Autonomic Agents|autonomic agents|mesh-ancestor
92197580|NCT03725930|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92197581|NCT03725930|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92197582|NCT03725930|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92197583|NCT03725930|Adrenergic Agents|adrenergic agents|mesh-ancestor
92197584|NCT03725930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197585|NCT03725930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197586|NCT03781388|Bupivacaine|bupivacaine|mesh-list
92197587|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
92197588|NCT03781388|Anesthetics|anesthetics|mesh-ancestor
92197589|NCT03781388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197590|NCT03781388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197591|NCT03781388|Sensory System Agents|sensory system agents|mesh-ancestor
92197592|NCT03781388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197593|NCT03779048|Phentermine|phentermine|mesh-list
92197594|NCT03779048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92197595|NCT03779048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197596|NCT03779048|Appetite Depressants|appetite depressants|mesh-ancestor
92197597|NCT03779048|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92197598|NCT03779048|Sympathomimetics|sympathomimetics|mesh-ancestor
92197599|NCT03779048|Autonomic Agents|autonomic agents|mesh-ancestor
92197600|NCT03779048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197601|NCT03779048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92197602|NCT03779048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197603|NCT03779048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197605|NCT03778580|Vitamin B Complex|vitamin b complex|mesh-ancestor
92197606|NCT03778580|Vitamins|vitamins|mesh-ancestor
92197607|NCT03778580|Micronutrients|micronutrients|mesh-ancestor
92197608|NCT03778580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197609|NCT03722342|Pembrolizumab|pembrolizumab|mesh-list
92197610|NCT03722342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197611|NCT03722342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197612|NCT03722342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197613|NCT03722342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197614|NCT03722108|Irinotecan|irinotecan|mesh-list
92197615|NCT03722108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92197616|NCT03722108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197617|NCT03722108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197618|NCT03722108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197619|NCT03722108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197620|NCT03775070|Simvastatin|simvastatin|mesh-list
92197621|NCT03775070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92197622|NCT03775070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92197623|NCT03775070|Antimetabolites|antimetabolites|mesh-ancestor
92197624|NCT03775070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197625|NCT03775070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92197626|NCT03775070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92197627|NCT03775070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197628|NCT02083406|Artefenomel|artefenomel|mesh-list
92197629|NCT02083406|Antimalarials|antimalarials|mesh-ancestor
92197630|NCT02083406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92197631|NCT02083406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92197632|NCT02083406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197633|NCT03773666|Durvalumab|durvalumab|mesh-list
92197634|NCT03773666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197635|NCT03773666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197636|NCT04762784|Glucocorticoids|glucocorticoids|mesh-list
92197637|NCT04762784|Hormones|hormones|mesh-ancestor
92197638|NCT04762784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197639|NCT04762784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197640|NCT00003644|Paclitaxel|paclitaxel|mesh-list
92197641|NCT00003644|Carboplatin|carboplatin|mesh-list
92197642|NCT00003644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197643|NCT00003644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197644|NCT00003644|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197645|NCT00003644|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197646|NCT00003644|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197647|NCT00003644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197648|NCT02142049|Lenalidomide|lenalidomide|mesh-list
92197649|NCT02142049|Immunologic Factors|immunologic factors|mesh-ancestor
92197650|NCT02142049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197651|NCT02142049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92197652|NCT02142049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92197653|NCT02142049|Growth Substances|growth substances|mesh-ancestor
92197654|NCT02142049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92197655|NCT02142049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197656|NCT03717194|Ertugliflozin|ertugliflozin|mesh-list
92197657|NCT03717194|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92197658|NCT03717194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197659|NCT03717194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92197660|NCT03717194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197661|NCT03716180|Paclitaxel|paclitaxel|mesh-list
92197662|NCT03716180|Trastuzumab|trastuzumab|mesh-list
92197663|NCT03716180|Pertuzumab|pertuzumab|mesh-list
92197664|NCT03716180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197665|NCT03716180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197666|NCT03716180|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197667|NCT03716180|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197668|NCT03716180|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197669|NCT03716180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197670|NCT03716180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197671|NCT03715244|Anesthetics|anesthetics|mesh-list
92197672|NCT03715244|Anesthetics, Local|anesthetics, local|mesh-list
92197673|NCT03715244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197674|NCT03715244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197675|NCT03715244|Sensory System Agents|sensory system agents|mesh-ancestor
92197676|NCT03715244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197678|NCT03714620|Analgesics|analgesics|mesh-ancestor
92197679|NCT03714620|Sensory System Agents|sensory system agents|mesh-ancestor
92197680|NCT03714620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197681|NCT03714620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197682|NCT03714620|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92197683|NCT03714620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92197684|NCT03714620|Anesthetics, General|anesthetics, general|mesh-ancestor
92197685|NCT03714620|Anesthetics|anesthetics|mesh-ancestor
92197686|NCT03714620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197687|NCT03714620|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92197688|NCT03714620|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92197689|NCT03714620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197690|NCT03714620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197691|NCT03629288|Azithromycin|azithromycin|mesh-list
92197692|NCT03629288|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197693|NCT03629288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197694|NCT04763096|Tacrolimus|tacrolimus|mesh-list
92197695|NCT04763096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197696|NCT04763096|Immunologic Factors|immunologic factors|mesh-ancestor
92197697|NCT04763096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197698|NCT04763096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92197699|NCT04763096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197700|NCT04763096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197701|NCT00680953|Denosumab|denosumab|mesh-list
92197702|NCT00680953|Alendronate|alendronate|mesh-list
92197703|NCT00680953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92197704|NCT00680953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197705|NCT00660985|Adapalene|adapalene|mesh-list
92197706|NCT00660985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92197707|NCT00660985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92197708|NCT00660985|Analgesics|analgesics|mesh-ancestor
92197709|NCT00660985|Sensory System Agents|sensory system agents|mesh-ancestor
92197710|NCT00660985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197711|NCT00660985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197712|NCT00660985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197713|NCT00660985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197714|NCT00660985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92197715|NCT03551522|Seladelpar|seladelpar|mesh-list
92197716|NCT03551522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92197717|NCT03551522|Antimetabolites|antimetabolites|mesh-ancestor
92197718|NCT03551522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197719|NCT03551522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92197720|NCT03704714|Prednisone|prednisone|mesh-list
92197721|NCT03704714|Cortisone|cortisone|mesh-list
92197722|NCT03704714|Cyclophosphamide|cyclophosphamide|mesh-list
92197723|NCT03704714|Rituximab|rituximab|mesh-list
92197724|NCT03704714|Doxorubicin|doxorubicin|mesh-list
92197725|NCT03704714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92197726|NCT03704714|Nivolumab|nivolumab|mesh-list
92197727|NCT03704714|Vincristine|vincristine|mesh-list
92197728|NCT03704714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92197729|NCT03704714|Antibodies|antibodies|mesh-list
92197730|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
92197731|NCT03704714|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92197732|NCT03704714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197733|NCT03704714|Immunologic Factors|immunologic factors|mesh-ancestor
92197734|NCT03704714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197735|NCT03704714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197736|NCT03704714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92197737|NCT03704714|Alkylating Agents|alkylating agents|mesh-ancestor
92197738|NCT03704714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197739|NCT03704714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197740|NCT03704714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92197741|NCT03704714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197742|NCT03704714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197743|NCT03704714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197744|NCT03704714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917981|NCT00664040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92197745|NCT03704714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197746|NCT03704714|Glucocorticoids|glucocorticoids|mesh-ancestor
92197747|NCT03704714|Hormones|hormones|mesh-ancestor
92197748|NCT03704714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197749|NCT03704714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197750|NCT03704714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197751|NCT03704714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197752|NCT03704714|Tubulin Modulators|tubulin modulators|mesh-ancestor
92197753|NCT03704714|Antimitotic Agents|antimitotic agents|mesh-ancestor
92197754|NCT03704714|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197755|NCT00661141|Ethanol|ethanol|mesh-list
92197756|NCT00661141|Fomepizole|fomepizole|mesh-list
92197757|NCT00661141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92197758|NCT00661141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197759|NCT00661141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197760|NCT00661141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197761|NCT00661141|Antidotes|antidotes|mesh-ancestor
92197762|NCT00661141|Protective Agents|protective agents|mesh-ancestor
92197763|NCT00661141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197764|NCT00661141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197765|NCT03616574|Trifluridine|trifluridine|mesh-list
92197766|NCT03616574|Antimetabolites|antimetabolites|mesh-ancestor
92197767|NCT03616574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197768|NCT03616574|Antiviral Agents|antiviral agents|mesh-ancestor
92197769|NCT03616574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197770|NCT00681265|Glycerol|glycerol|mesh-list
92197771|NCT00681265|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92197772|NCT00681265|Protective Agents|protective agents|mesh-ancestor
92197773|NCT00681265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197774|NCT01677104|Liraglutide|liraglutide|mesh-list
92197775|NCT01677104|Exenatide|exenatide|mesh-list
92197776|NCT01677104|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92197777|NCT01677104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92197778|NCT01677104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197779|NCT01677104|Incretins|incretins|mesh-ancestor
92197780|NCT01677104|Hormones|hormones|mesh-ancestor
92197781|NCT01677104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197782|NCT01677104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92197783|NCT00661453|Valproic Acid|valproic acid|mesh-list
92197784|NCT00661453|Anticonvulsants|anticonvulsants|mesh-ancestor
92197785|NCT00661453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197786|NCT00661453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197787|NCT00661453|GABA Agents|gaba agents|mesh-ancestor
92197788|NCT00661453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197789|NCT00661453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197790|NCT00661453|Antimanic Agents|antimanic agents|mesh-ancestor
92197791|NCT00661453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92197792|NCT00661453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197794|NCT03547622|Galantamine|galantamine|mesh-list
92197795|NCT03547622|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92197796|NCT03547622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197797|NCT03547622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197798|NCT03547622|Cholinergic Agents|cholinergic agents|mesh-ancestor
92197799|NCT03547622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197800|NCT03547622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197801|NCT03547622|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92197802|NCT03547622|Autonomic Agents|autonomic agents|mesh-ancestor
92197803|NCT03547622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197804|NCT03547622|Nootropic Agents|nootropic agents|mesh-ancestor
92197805|NCT00681889|Ranibizumab|ranibizumab|mesh-list
92197806|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92197807|NCT00681889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92197808|NCT00681889|Growth Substances|growth substances|mesh-ancestor
92197809|NCT00681889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197810|NCT00681889|Growth Inhibitors|growth inhibitors|mesh-ancestor
92197811|NCT00681889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197812|NCT03610490|Cyclophosphamide|cyclophosphamide|mesh-list
92197813|NCT03610490|Fludarabine|fludarabine|mesh-list
92197814|NCT03610490|Interleukin-2|interleukin-2|mesh-list
92197815|NCT03610490|Mitogens|mitogens|mesh-list
92197816|NCT03610490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197817|NCT03610490|Immunologic Factors|immunologic factors|mesh-ancestor
92197818|NCT03610490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197819|NCT03610490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197820|NCT03610490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92197821|NCT03610490|Alkylating Agents|alkylating agents|mesh-ancestor
92197822|NCT03610490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197823|NCT03610490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197824|NCT03610490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92197825|NCT03610490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92197827|NCT03610490|Sensory System Agents|sensory system agents|mesh-ancestor
92197828|NCT03610490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197829|NCT03610490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92197830|NCT00682357|Methylprednisolone|methylprednisolone|mesh-list
92197831|NCT00682357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92197832|NCT00682357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92197833|NCT00682357|Prednisolone|prednisolone|mesh-list
92197834|NCT00682357|Prednisolone acetate|prednisolone acetate|mesh-list
92197835|NCT00682357|Lidocaine|lidocaine|mesh-list
92197836|NCT00682357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92197837|NCT00682357|Prednisolone phosphate|prednisolone phosphate|mesh-list
92197838|NCT00682357|Anesthetics, Local|anesthetics, local|mesh-ancestor
92197839|NCT00682357|Anesthetics|anesthetics|mesh-ancestor
92197840|NCT00682357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197841|NCT00682357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197842|NCT00682357|Sensory System Agents|sensory system agents|mesh-ancestor
92197843|NCT00682357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197844|NCT00682357|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92197845|NCT00682357|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92197846|NCT00682357|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92197847|NCT00682357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92197848|NCT00682357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197849|NCT00682357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197850|NCT00682357|Antiemetics|antiemetics|mesh-ancestor
92197851|NCT00682357|Autonomic Agents|autonomic agents|mesh-ancestor
92197852|NCT00682357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197853|NCT00682357|Glucocorticoids|glucocorticoids|mesh-ancestor
92197854|NCT00682357|Hormones|hormones|mesh-ancestor
92197855|NCT00682357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197856|NCT00682357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92197857|NCT00682357|Protective Agents|protective agents|mesh-ancestor
92197858|NCT00682357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197859|NCT00682357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197861|NCT00662155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92197862|NCT00662155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92197863|NCT00662155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92197864|NCT00662155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197865|NCT00662155|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92197866|NCT00662155|GABA Agonists|gaba agonists|mesh-ancestor
92197867|NCT00662155|GABA Agents|gaba agents|mesh-ancestor
92197868|NCT00662155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92197869|NCT00662155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197871|NCT03546608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197872|NCT00662545|Tenofovir|tenofovir|mesh-list
92197873|NCT00662545|Lamivudine|lamivudine|mesh-list
92197874|NCT00662545|Emtricitabine|emtricitabine|mesh-list
92197875|NCT00662545|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92197876|NCT00662545|Entecavir|entecavir|mesh-list
92197877|NCT00662545|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92197878|NCT00662545|Antiviral Agents|antiviral agents|mesh-ancestor
92197879|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197880|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92197881|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92197882|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197883|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197884|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92197885|NCT03539198|Nivolumab|nivolumab|mesh-list
92197886|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197887|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197888|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197889|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197890|NCT00663169|Dexamethasone|dexamethasone|mesh-list
92197891|NCT00663169|Dexamethasone acetate|dexamethasone acetate|mesh-list
92197892|NCT00663169|BB 1101|bb 1101|mesh-list
92197893|NCT00663169|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92197894|NCT00663169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197895|NCT00663169|Antiemetics|antiemetics|mesh-ancestor
92197896|NCT00663169|Autonomic Agents|autonomic agents|mesh-ancestor
92197897|NCT00663169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92197898|NCT00663169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197899|NCT00663169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197900|NCT00663169|Glucocorticoids|glucocorticoids|mesh-ancestor
92197901|NCT00663169|Hormones|hormones|mesh-ancestor
92197902|NCT00663169|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197903|NCT00663169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197904|NCT00663169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197905|NCT00663169|Protease Inhibitors|protease inhibitors|mesh-ancestor
92197906|NCT00663169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197907|NCT00663169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197908|NCT00663169|Immunologic Factors|immunologic factors|mesh-ancestor
92197909|NCT00663403|Daptomycin|daptomycin|mesh-list
92197910|NCT00663403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197911|NCT00663403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197912|NCT00663793|Methyltestosterone|methyltestosterone|mesh-list
92197913|NCT00663793|Finasteride|finasteride|mesh-list
92197914|NCT00663793|Testosterone|testosterone|mesh-list
92197915|NCT00663793|Testosterone undecanoate|testosterone undecanoate|mesh-list
92197916|NCT00663793|Testosterone enanthate|testosterone enanthate|mesh-list
92197917|NCT00663793|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92197918|NCT00663793|Acyline|acyline|mesh-list
92197919|NCT00663793|Androgens|androgens|mesh-ancestor
92197920|NCT00663793|Hormones|hormones|mesh-ancestor
92197921|NCT00663793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92197922|NCT00663793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197923|NCT00663793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197924|NCT00663793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197925|NCT00663793|Anabolic Agents|anabolic agents|mesh-ancestor
92197926|NCT00663793|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92197927|NCT00663793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92197928|NCT00663793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197929|NCT00663793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197930|NCT00663793|Hormone Antagonists|hormone antagonists|mesh-ancestor
92197931|NCT00663793|Urological Agents|urological agents|mesh-ancestor
92197932|NCT03690986|Nivolumab|nivolumab|mesh-list
92197933|NCT03690986|Ipilimumab|ipilimumab|mesh-list
92197934|NCT03690986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197935|NCT03690986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197936|NCT03690986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92197937|NCT03690986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197938|NCT03605654|Mycophenolic Acid|mycophenolic acid|mesh-list
92197940|NCT03605654|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92197941|NCT03605654|Immunologic Factors|immunologic factors|mesh-ancestor
92197942|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197943|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92197944|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197945|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197946|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92197947|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197948|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92197949|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
92197950|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92197951|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197952|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
92197953|NCT02336438|Cathartics|cathartics|mesh-ancestor
92197954|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92197955|NCT00667615|Prednisone|prednisone|mesh-list
92197956|NCT00667615|Cyclophosphamide|cyclophosphamide|mesh-list
92197957|NCT00667615|Rituximab|rituximab|mesh-list
92197958|NCT00667615|Etoposide|etoposide|mesh-list
92197959|NCT00667615|Vorinostat|vorinostat|mesh-list
92197960|NCT00667615|Lenograstim|lenograstim|mesh-list
92197961|NCT00667615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92197962|NCT00667615|Immunologic Factors|immunologic factors|mesh-ancestor
92197963|NCT00667615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92197964|NCT00667615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92197965|NCT00667615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92197966|NCT00667615|Alkylating Agents|alkylating agents|mesh-ancestor
92197967|NCT00667615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197968|NCT00667615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197969|NCT00667615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92197970|NCT00667615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197971|NCT00667615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92197972|NCT00667615|Glucocorticoids|glucocorticoids|mesh-ancestor
92197973|NCT00667615|Hormones|hormones|mesh-ancestor
92197974|NCT00667615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918294|NCT02408289|Antioxidants|antioxidants|mesh-ancestor
92197975|NCT00667615|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92197976|NCT00667615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92197977|NCT00667615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92197978|NCT00667615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92197979|NCT00667615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197980|NCT00667615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92197981|NCT00667615|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92197982|NCT03683810|Lactoferrin|lactoferrin|mesh-list
92197983|NCT03683810|Epoetin Alfa|epoetin alfa|mesh-list
92197984|NCT03683810|Hematinics|hematinics|mesh-ancestor
92197985|NCT03683810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92197986|NCT01587235|Simvastatin|simvastatin|mesh-list
92197987|NCT01587235|Ezetimibe|ezetimibe|mesh-list
92197988|NCT01587235|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92197989|NCT01587235|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92197990|NCT01587235|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92197991|NCT01587235|Antimetabolites|antimetabolites|mesh-ancestor
92197992|NCT01587235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92197993|NCT01587235|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92197994|NCT01587235|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92197995|NCT01587235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92197996|NCT03601442|Tisagenlecleucel|tisagenlecleucel|mesh-list
92197997|NCT03601442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92197998|NCT03601442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92197999|NCT00705133|Treprostinil|treprostinil|mesh-list
92198000|NCT00705133|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92198001|NCT00652717|Simvastatin|simvastatin|mesh-list
92198002|NCT00652717|Ezetimibe|ezetimibe|mesh-list
92198003|NCT00652717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92198004|NCT00652717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198005|NCT00652717|Antimetabolites|antimetabolites|mesh-ancestor
92198006|NCT00652717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198007|NCT00652717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198008|NCT00652717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92198009|NCT00652717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198010|NCT00553891|Mometasone Furoate|mometasone furoate|mesh-list
92198011|NCT00553891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198012|NCT00553891|Dermatologic Agents|dermatologic agents|mesh-ancestor
92198013|NCT00553891|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92198015|NCT00684775|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92198016|NCT00684775|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92198017|NCT00684775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198018|NCT00684775|Sensory System Agents|sensory system agents|mesh-ancestor
92198019|NCT00684775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198020|NCT00395473|Ezetimibe|ezetimibe|mesh-list
92198021|NCT00395473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92198022|NCT00395473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198023|NCT00395473|Antimetabolites|antimetabolites|mesh-ancestor
92198024|NCT00395473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198025|NCT00395473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198026|NCT00393211|Etoricoxib|etoricoxib|mesh-list
92198027|NCT00393211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198028|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198029|NCT00393211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198030|NCT00393211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92198031|NCT00393211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92198032|NCT00393211|Analgesics|analgesics|mesh-ancestor
92198033|NCT00393211|Sensory System Agents|sensory system agents|mesh-ancestor
92198034|NCT00393211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198035|NCT00393211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198036|NCT00393211|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92198037|NCT00393211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92198038|NCT00393211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198039|NCT03676556|Lidocaine|lidocaine|mesh-list
92198040|NCT03676556|Anesthetics, Local|anesthetics, local|mesh-ancestor
92198041|NCT03676556|Anesthetics|anesthetics|mesh-ancestor
92198042|NCT03676556|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198043|NCT03676556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198044|NCT03676556|Sensory System Agents|sensory system agents|mesh-ancestor
92198045|NCT03676556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198046|NCT03676556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92198047|NCT03676556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92198048|NCT03676556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92198049|NCT03676556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198050|NCT03676556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198051|NCT03519230|Pamiparib|pamiparib|mesh-list
92198052|NCT03519230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92198053|NCT03519230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198054|NCT03519230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198055|NCT03519230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198056|NCT02144233|Salicylic Acid|salicylic acid|mesh-list
92198057|NCT02144233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198058|NCT02144233|Antifungal Agents|antifungal agents|mesh-ancestor
92198059|NCT02144233|Keratolytic Agents|keratolytic agents|mesh-ancestor
92198060|NCT02144233|Dermatologic Agents|dermatologic agents|mesh-ancestor
92198061|NCT03592472|Abexinostat|abexinostat|mesh-list
92198062|NCT03592472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92198063|NCT03592472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198064|NCT03592472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198065|NCT00269191|Ibuprofen|ibuprofen|mesh-list
92198066|NCT00269191|Etoricoxib|etoricoxib|mesh-list
92198067|NCT00269191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92198068|NCT00269191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92198069|NCT00269191|Analgesics|analgesics|mesh-ancestor
92198070|NCT00269191|Sensory System Agents|sensory system agents|mesh-ancestor
92198071|NCT00269191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198072|NCT00269191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198073|NCT00269191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198074|NCT00269191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198075|NCT00269191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92198076|NCT00269191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198077|NCT00269191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198078|NCT00269191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92198079|NCT00690235|Pramlintide|pramlintide|mesh-list
92198080|NCT00690235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92198081|NCT00690235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198083|NCT00092833|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92198084|NCT00092833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198085|NCT00092833|Antimetabolites|antimetabolites|mesh-ancestor
92198086|NCT00092833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198087|NCT00092833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198088|NCT01799083|Decitabine|decitabine|mesh-list
92198089|NCT01799083|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92198090|NCT01799083|Antimetabolites|antimetabolites|mesh-ancestor
92198091|NCT01799083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198092|NCT01799083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198093|NCT01799083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198094|NCT01799161|Theophylline|theophylline|mesh-list
92198095|NCT01799161|Vaccines|vaccines|mesh-list
92198096|NCT01799161|Immunologic Factors|immunologic factors|mesh-ancestor
92198097|NCT01799161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198098|NCT01799161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92198099|NCT01799161|Autonomic Agents|autonomic agents|mesh-ancestor
92198100|NCT01799161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198101|NCT01799161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92198102|NCT01799161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92198103|NCT01799161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92198104|NCT01799161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198105|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198106|NCT01799161|Vasodilator Agents|vasodilator agents|mesh-ancestor
92198107|NCT01799161|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92198108|NCT01799161|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92198109|NCT01799161|Purinergic Agents|purinergic agents|mesh-ancestor
92198110|NCT01799161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198111|NCT00006110|Paclitaxel|paclitaxel|mesh-list
92198112|NCT00006110|Cyclophosphamide|cyclophosphamide|mesh-list
92198113|NCT00006110|Doxorubicin|doxorubicin|mesh-list
92198114|NCT00006110|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92198115|NCT00006110|Trastuzumab|trastuzumab|mesh-list
92198116|NCT00006110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92198117|NCT00006110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198118|NCT00006110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92198119|NCT00006110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92198120|NCT00006110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92198121|NCT00006110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198122|NCT00006110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198123|NCT00006110|Immunologic Factors|immunologic factors|mesh-ancestor
92198125|NCT00006110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198126|NCT00006110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92198127|NCT00006110|Alkylating Agents|alkylating agents|mesh-ancestor
92198128|NCT00006110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92198129|NCT00006110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92198130|NCT00006110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92198131|NCT00006110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92198132|NCT00006110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198133|NCT00006110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198134|NCT03591770|Vaccines|vaccines|mesh-list
92198135|NCT03591770|Immunologic Factors|immunologic factors|mesh-ancestor
92198136|NCT03591770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198137|NCT00692185|Olanzapine|olanzapine|mesh-list
92198138|NCT00692185|Antiemetics|antiemetics|mesh-ancestor
92198139|NCT00692185|Autonomic Agents|autonomic agents|mesh-ancestor
92198140|NCT00692185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198141|NCT00692185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198142|NCT00692185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92198143|NCT00692185|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92198144|NCT00692185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92198145|NCT00692185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198146|NCT00692185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92198147|NCT00692185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92198148|NCT00692185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92198149|NCT00692185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198150|NCT00692185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198151|NCT00692185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198152|NCT00692185|Serotonin Agents|serotonin agents|mesh-ancestor
92198153|NCT04270279|Nitroglycerin|nitroglycerin|mesh-list
92198154|NCT04270279|Vasodilator Agents|vasodilator agents|mesh-ancestor
92198155|NCT00692341|Axitinib|axitinib|mesh-list
92198156|NCT00692341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198157|NCT00692341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92198158|NCT00692341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198159|NCT00692341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198160|NCT03511976|Methylphenidate|methylphenidate|mesh-list
92198161|NCT03511976|Amphetamine|amphetamine|mesh-list
92198162|NCT03511976|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92198163|NCT03511976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198164|NCT03511976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92198165|NCT03511976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92198166|NCT03511976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198167|NCT03511976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198168|NCT03511976|Dopamine Agents|dopamine agents|mesh-ancestor
92198169|NCT03511976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198170|NCT03511976|Sympathomimetics|sympathomimetics|mesh-ancestor
92198171|NCT03511976|Autonomic Agents|autonomic agents|mesh-ancestor
92198172|NCT03511976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198173|NCT03511976|Adrenergic Agents|adrenergic agents|mesh-ancestor
92198174|NCT03511976|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92198175|NCT00694603|Cetuximab|cetuximab|mesh-list
92198176|NCT00694603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198177|NCT00694603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198178|NCT03582722|Orlistat|orlistat|mesh-list
92198179|NCT03582722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198180|NCT03582722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198181|NCT03582722|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92198182|NCT03582722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198183|NCT00590161|Pentoxifylline|pentoxifylline|mesh-list
92198184|NCT00590161|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92198185|NCT00590161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198186|NCT00590161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198187|NCT00590161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92198188|NCT00590161|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92198189|NCT00590161|Protective Agents|protective agents|mesh-ancestor
92198190|NCT00590161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198191|NCT00590161|Vasodilator Agents|vasodilator agents|mesh-ancestor
92198192|NCT00590161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92198193|NCT00590161|Antioxidants|antioxidants|mesh-ancestor
92198194|NCT00590395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92198195|NCT00590395|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92198196|NCT00590395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198197|NCT00006170|Bupropion|bupropion|mesh-list
92198198|NCT00006170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92198199|NCT00006170|Antidepressive Agents|antidepressive agents|mesh-ancestor
92198200|NCT00006170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92198201|NCT00006170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92198202|NCT00006170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92198203|NCT00006170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198204|NCT00006170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198205|NCT00006170|Dopamine Agents|dopamine agents|mesh-ancestor
92198206|NCT00006170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198207|NCT00006170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198208|NCT00006170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92198209|NCT00006170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92198210|NCT00006170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198211|NCT02123849|Aspirin|aspirin|mesh-list
92198212|NCT02123849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92198213|NCT02123849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92198214|NCT02123849|Analgesics|analgesics|mesh-ancestor
92198215|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
92198216|NCT02123849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198217|NCT02123849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198218|NCT02123849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198219|NCT02123849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198220|NCT02123849|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92198221|NCT02123849|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92198222|NCT02123849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198223|NCT02123849|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92198224|NCT02123849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92198225|NCT02123849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198226|NCT02123849|Antipyretics|antipyretics|mesh-ancestor
92198227|NCT05347160|Calcium|calcium|mesh-list
92198228|NCT05347160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92198229|NCT05347160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198230|NCT00671528|Gentamicins|gentamicins|mesh-list
92198231|NCT00671528|Clotrimazole|clotrimazole|mesh-list
92198232|NCT00671528|Miconazole|miconazole|mesh-list
92198233|NCT00671528|Betamethasone|betamethasone|mesh-list
92198234|NCT00671528|Betamethasone Valerate|betamethasone valerate|mesh-list
92198235|NCT00671528|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92198236|NCT00671528|Betamethasone benzoate|betamethasone benzoate|mesh-list
92198237|NCT00671528|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92198238|NCT00671528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198239|NCT00671528|Glucocorticoids|glucocorticoids|mesh-ancestor
92198240|NCT00671528|Hormones|hormones|mesh-ancestor
92198241|NCT00671528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198242|NCT00671528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198243|NCT00671528|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92198244|NCT00671528|Respiratory System Agents|respiratory system agents|mesh-ancestor
92198245|NCT00671528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92198246|NCT00671528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198247|NCT00671528|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92198248|NCT00671528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198249|NCT00671528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198250|NCT00671528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92198251|NCT00671528|Antifungal Agents|antifungal agents|mesh-ancestor
92198252|NCT00671528|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92198253|NCT00671528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92198254|NCT00671528|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92198255|NCT00671528|Hormone Antagonists|hormone antagonists|mesh-ancestor
92198256|NCT00671528|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92198257|NCT00671528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92198258|NCT00590863|Dexetimide|dexetimide|mesh-list
92198259|NCT00590863|Mirtazapine|mirtazapine|mesh-list
92198260|NCT00590863|Citalopram|citalopram|mesh-list
92198261|NCT00590863|Bupropion|bupropion|mesh-list
92198262|NCT00590863|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92198263|NCT00590863|Escitalopram|escitalopram|mesh-list
92198264|NCT00590863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92198265|NCT00590863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92198266|NCT00590863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198267|NCT00590863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198268|NCT00590863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198269|NCT00590863|Serotonin Agents|serotonin agents|mesh-ancestor
92198270|NCT00590863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198271|NCT00590863|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92198272|NCT00590863|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92198273|NCT00590863|Parasympatholytics|parasympatholytics|mesh-ancestor
92198274|NCT00590863|Autonomic Agents|autonomic agents|mesh-ancestor
92335419|NCT01627782|Ketamine|ketamine|mesh-list
92198275|NCT00590863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198276|NCT00590863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92198277|NCT00590863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92198278|NCT00590863|Cholinergic Agents|cholinergic agents|mesh-ancestor
92198279|NCT00590863|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92198280|NCT00590863|Antidepressive Agents|antidepressive agents|mesh-ancestor
92198281|NCT00590863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92198282|NCT00590863|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92198284|NCT00590863|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92198285|NCT00590863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92198286|NCT00590863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198287|NCT00590863|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92198288|NCT00590863|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92198289|NCT00590863|Histamine Antagonists|histamine antagonists|mesh-ancestor
92198291|NCT00590863|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92198292|NCT00590863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92198293|NCT00590863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198294|NCT00590863|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92198295|NCT00590863|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92198296|NCT00590863|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92198297|NCT00590863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92198298|NCT00590863|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92198299|NCT00590863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92198300|NCT00590863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92198301|NCT00591019|Modafinil|modafinil|mesh-list
92198302|NCT00591019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92198303|NCT00591019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198304|NCT00591019|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92198305|NCT00591019|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92198306|NCT00591019|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92198307|NCT00591019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198308|NCT02996695|Artesunate|artesunate|mesh-list
92198309|NCT02996695|Chloroquine|chloroquine|mesh-list
92198310|NCT02996695|Antimalarials|antimalarials|mesh-ancestor
92198311|NCT02996695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92198312|NCT02996695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92198313|NCT02996695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198314|NCT02996695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198315|NCT02996695|Antiviral Agents|antiviral agents|mesh-ancestor
92198316|NCT02996695|Schistosomicides|schistosomicides|mesh-ancestor
92198317|NCT02996695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92198318|NCT02996695|Anthelmintics|anthelmintics|mesh-ancestor
92198319|NCT02996695|Amebicides|amebicides|mesh-ancestor
92198320|NCT02996695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198321|NCT00359138|Cetirizine|cetirizine|mesh-list
92198322|NCT00359138|Loratadine|loratadine|mesh-list
92198323|NCT00359138|Levocetirizine|levocetirizine|mesh-list
92198324|NCT00359138|Desloratadine|desloratadine|mesh-list
92198325|NCT00359138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92198326|NCT00359138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92198327|NCT00359138|Histamine Antagonists|histamine antagonists|mesh-ancestor
92198328|NCT00359138|Histamine Agents|histamine agents|mesh-ancestor
92198329|NCT00359138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198330|NCT00359138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198331|NCT00359138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198332|NCT00359138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92198333|NCT00359138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92198334|NCT00359138|Cholinergic Agents|cholinergic agents|mesh-ancestor
92198335|NCT00359138|Antipruritics|antipruritics|mesh-ancestor
92198336|NCT00359138|Dermatologic Agents|dermatologic agents|mesh-ancestor
92198337|NCT05503979|Sofosbuvir|sofosbuvir|mesh-list
92198338|NCT05503979|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92198339|NCT05503979|Velpatasvir|velpatasvir|mesh-list
92198340|NCT05503979|Antiviral Agents|antiviral agents|mesh-ancestor
92198341|NCT05503979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198343|NCT04703621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198344|NCT02996227|Bupivacaine|bupivacaine|mesh-list
92198345|NCT02996227|Anesthetics, Local|anesthetics, local|mesh-ancestor
92198346|NCT02996227|Anesthetics|anesthetics|mesh-ancestor
92198347|NCT02996227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198348|NCT02996227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198349|NCT02996227|Sensory System Agents|sensory system agents|mesh-ancestor
92198350|NCT02996227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198351|NCT00698035|Methyltestosterone|methyltestosterone|mesh-list
92198352|NCT00698035|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92198353|NCT00698035|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92198355|NCT00698035|Testosterone undecanoate|testosterone undecanoate|mesh-list
92198356|NCT00698035|Testosterone enanthate|testosterone enanthate|mesh-list
92198357|NCT00698035|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92198358|NCT00698035|Estradiol|estradiol|mesh-list
92198359|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92198360|NCT00698035|Androgens|androgens|mesh-ancestor
92198361|NCT00698035|Hormones|hormones|mesh-ancestor
92198362|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198363|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198364|NCT00698035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92198365|NCT00698035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198366|NCT00698035|Anabolic Agents|anabolic agents|mesh-ancestor
92198367|NCT00698035|Estrogens|estrogens|mesh-ancestor
92198368|NCT00698035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92198369|NCT00698035|Contraceptive Agents|contraceptive agents|mesh-ancestor
92198370|NCT00698035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92198371|NCT00698035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92198372|NCT02129075|Poly I-C|poly i-c|mesh-list
92198373|NCT02129075|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92198374|NCT02129075|Poly ICLC|poly iclc|mesh-list
92198375|NCT02129075|Flt3 ligand protein|flt3 ligand protein|mesh-list
92198376|NCT02129075|Interferon Inducers|interferon inducers|mesh-ancestor
92198377|NCT02129075|Immunologic Factors|immunologic factors|mesh-ancestor
92198378|NCT02129075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198379|NCT02129075|Laxatives|laxatives|mesh-ancestor
92198380|NCT02129075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92198381|NCT02129075|Antiviral Agents|antiviral agents|mesh-ancestor
92198382|NCT02129075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198383|NCT02129075|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92198384|NCT02129075|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92198385|NCT02129075|Protective Agents|protective agents|mesh-ancestor
92198386|NCT02775903|Azacitidine|azacitidine|mesh-list
92198387|NCT02775903|Durvalumab|durvalumab|mesh-list
92198388|NCT02775903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92198389|NCT02775903|Antimetabolites|antimetabolites|mesh-ancestor
92198390|NCT02775903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198391|NCT02775903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198392|NCT02775903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198393|NCT02775903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198394|NCT01782443|Aflibercept|aflibercept|mesh-list
92198395|NCT01782443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92198396|NCT01782443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92198397|NCT01782443|Growth Substances|growth substances|mesh-ancestor
92198398|NCT01782443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198399|NCT01782443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92198400|NCT01782443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198401|NCT01933425|Rocuronium|rocuronium|mesh-list
92198402|NCT01933425|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92198403|NCT01933425|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92198404|NCT01933425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92198405|NCT01933425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198406|NCT01933425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198407|NCT04239599|Leuprolide|leuprolide|mesh-list
92198408|NCT04239599|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92198409|NCT04239599|Fertility Agents|fertility agents|mesh-ancestor
92198410|NCT04239599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92198411|NCT04239599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198412|NCT04239599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92198413|NCT04239599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198414|NCT03487016|Paclitaxel|paclitaxel|mesh-list
92198415|NCT03487016|Gemcitabine|gemcitabine|mesh-list
92198416|NCT03487016|Oxaliplatin|oxaliplatin|mesh-list
92198417|NCT03487016|Irinotecan|irinotecan|mesh-list
92198418|NCT03487016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92198419|NCT03487016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198420|NCT03487016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92335427|NCT01627782|Anesthetics|anesthetics|mesh-ancestor
92198421|NCT03487016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92198422|NCT03487016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92198423|NCT03487016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198424|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92198425|NCT03487016|Antimetabolites|antimetabolites|mesh-ancestor
92198426|NCT03487016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92198427|NCT03487016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92198428|NCT03487016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198429|NCT05346926|Calpastatin|calpastatin|mesh-list
92198430|NCT05346926|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92198431|NCT05346926|Protease Inhibitors|protease inhibitors|mesh-ancestor
92198432|NCT05346926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198433|NCT05346926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198434|NCT05292209|Riluzole|riluzole|mesh-list
92198435|NCT05292209|Anticonvulsants|anticonvulsants|mesh-ancestor
92198436|NCT05292209|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92198437|NCT05292209|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92198438|NCT05292209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198439|NCT05292209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198440|NCT05292209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198441|NCT05292209|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92198442|NCT05292209|Protective Agents|protective agents|mesh-ancestor
92198443|NCT03023319|Pemetrexed|pemetrexed|mesh-list
92198444|NCT03023319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198445|NCT03023319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198446|NCT03023319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198447|NCT03023319|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92198448|NCT03023319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92198449|NCT02980653|Megestrol|megestrol|mesh-list
92198450|NCT02980653|Megestrol Acetate|megestrol acetate|mesh-list
92198451|NCT02980653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92198452|NCT02980653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92198453|NCT02980653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92198454|NCT02980653|Contraceptive Agents|contraceptive agents|mesh-ancestor
92198455|NCT02980653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92198456|NCT02980653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198457|NCT02980653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92198458|NCT02980653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92198459|NCT02980653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92198460|NCT02980653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198461|NCT02980653|Appetite Stimulants|appetite stimulants|mesh-ancestor
92198462|NCT02980653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92198463|NCT05265065|Vaccines|vaccines|mesh-list
92198464|NCT05265065|Immunologic Factors|immunologic factors|mesh-ancestor
92198465|NCT05265065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198466|NCT01677338|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92198467|NCT01677338|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92198468|NCT01677338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198469|NCT03088280|Thymoglobulin|thymoglobulin|mesh-list
92198470|NCT03088280|Immunologic Factors|immunologic factors|mesh-ancestor
92198471|NCT03088280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198472|NCT03088280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198473|NCT03087968|Prednisolone|prednisolone|mesh-list
92198474|NCT03087968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198475|NCT03087968|Glucocorticoids|glucocorticoids|mesh-ancestor
92198476|NCT03087968|Hormones|hormones|mesh-ancestor
92198477|NCT03087968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198478|NCT03087968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198479|NCT03087968|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92198480|NCT03087968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198481|NCT03845049|Aflibercept|aflibercept|mesh-list
92198482|NCT03845049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92198483|NCT03845049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92198484|NCT03845049|Growth Substances|growth substances|mesh-ancestor
92198485|NCT03845049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198486|NCT03845049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92198487|NCT03845049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198488|NCT03790839|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92335433|NCT02119650|Pemetrexed|pemetrexed|mesh-list
92198489|NCT03790839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92198490|NCT03790839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198492|NCT03790839|Hormones|hormones|mesh-ancestor
92198493|NCT03790839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198494|NCT03790839|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92198495|NCT03790839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92198496|NCT03790839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198497|NCT03790839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198498|NCT03088046|Progesterone|progesterone|mesh-list
92198499|NCT03088046|Progestins|progestins|mesh-ancestor
92198500|NCT03088046|Hormones|hormones|mesh-ancestor
92198501|NCT03088046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198502|NCT03088046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198503|NCT01677884|Bevacizumab|bevacizumab|mesh-list
92198504|NCT01677884|Capecitabine|capecitabine|mesh-list
92198505|NCT01677884|Irinotecan|irinotecan|mesh-list
92198506|NCT01677884|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198507|NCT01677884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198508|NCT01677884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92198509|NCT01677884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92198510|NCT01677884|Growth Substances|growth substances|mesh-ancestor
92198511|NCT01677884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198512|NCT01677884|Growth Inhibitors|growth inhibitors|mesh-ancestor
92198513|NCT01677884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92198514|NCT01677884|Antimetabolites|antimetabolites|mesh-ancestor
92198515|NCT01677884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198516|NCT01677884|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92198517|NCT01677884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92198518|NCT01677884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198519|NCT02124083|Vorinostat|vorinostat|mesh-list
92198520|NCT02124083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198521|NCT02124083|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92198522|NCT02124083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198523|NCT02124083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198524|NCT02405078|Deoxyglucose|deoxyglucose|mesh-list
92198525|NCT02405078|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92198526|NCT02405078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92198527|NCT02405078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198528|NCT02405078|Antimetabolites|antimetabolites|mesh-ancestor
92198529|NCT02405078|Antiviral Agents|antiviral agents|mesh-ancestor
92198530|NCT02405078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198531|NCT00701389|Sumatriptan|sumatriptan|mesh-list
92198532|NCT00701389|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92198533|NCT00701389|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92198534|NCT00701389|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92198535|NCT00701389|Serotonin Agents|serotonin agents|mesh-ancestor
92198536|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198537|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198538|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198539|NCT02336594|Verinurad|verinurad|mesh-list
92198540|NCT02336594|Gout Suppressants|gout suppressants|mesh-ancestor
92198541|NCT02336594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198542|NCT01799317|Vitamin D|vitamin d|mesh-list
92198543|NCT01799317|Ergocalciferols|ergocalciferols|mesh-list
92198544|NCT01799317|Vitamins|vitamins|mesh-ancestor
92198545|NCT01799317|Micronutrients|micronutrients|mesh-ancestor
92198546|NCT01799317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198547|NCT01799317|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92198548|NCT01799317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92198549|NCT03925025|Magnesium Sulfate|magnesium sulfate|mesh-list
92198550|NCT03925025|Nimodipine|nimodipine|mesh-list
92198551|NCT03925025|Analgesics|analgesics|mesh-ancestor
92198552|NCT03925025|Sensory System Agents|sensory system agents|mesh-ancestor
92198553|NCT03925025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198554|NCT03925025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198555|NCT03925025|Anesthetics|anesthetics|mesh-ancestor
92198556|NCT03925025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198557|NCT03925025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92198558|NCT03925025|Anticonvulsants|anticonvulsants|mesh-ancestor
92198559|NCT03925025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92335437|NCT02119650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92198560|NCT03925025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198561|NCT03925025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198562|NCT03925025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92198563|NCT03925025|Tocolytic Agents|tocolytic agents|mesh-ancestor
92198564|NCT03925025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92198565|NCT03925025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92198566|NCT03925025|Vasodilator Agents|vasodilator agents|mesh-ancestor
92198567|NCT01677962|Poly ICLC|poly iclc|mesh-list
92198568|NCT01677962|Interferon Inducers|interferon inducers|mesh-ancestor
92198569|NCT01677962|Immunologic Factors|immunologic factors|mesh-ancestor
92198570|NCT01677962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198571|NCT00595153|Budesonide|budesonide|mesh-list
92198572|NCT00595153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198573|NCT00595153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92198574|NCT00595153|Autonomic Agents|autonomic agents|mesh-ancestor
92198575|NCT00595153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198576|NCT00595153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198577|NCT00595153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92198578|NCT00595153|Respiratory System Agents|respiratory system agents|mesh-ancestor
92198579|NCT00595153|Glucocorticoids|glucocorticoids|mesh-ancestor
92198580|NCT00595153|Hormones|hormones|mesh-ancestor
92198581|NCT00595153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198582|NCT02995291|Phentolamine|phentolamine|mesh-list
92198583|NCT02995291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92198584|NCT02995291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92198585|NCT02995291|Adrenergic Agents|adrenergic agents|mesh-ancestor
92198586|NCT02995291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198587|NCT02995291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198588|NCT02995291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198589|NCT02995291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92198590|NCT00595231|Rufinamide|rufinamide|mesh-list
92198591|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
92198592|NCT00595231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92198593|NCT00595231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92198594|NCT00595231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198595|NCT00595231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198596|NCT02995057|Nickel|nickel|mesh-list
92198597|NCT02995057|Trace Elements|trace elements|mesh-ancestor
92198598|NCT02995057|Micronutrients|micronutrients|mesh-ancestor
92198599|NCT02995057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198600|NCT02474173|Paclitaxel|paclitaxel|mesh-list
92198601|NCT02474173|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92198602|NCT02474173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92198603|NCT02474173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198604|NCT02474173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92198605|NCT02474173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92198606|NCT02474173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92198607|NCT02474173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198608|NCT03482102|Durvalumab|durvalumab|mesh-list
92198609|NCT03482102|Tremelimumab|tremelimumab|mesh-list
92198610|NCT03482102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198611|NCT03482102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198612|NCT02402270|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92198613|NCT02402270|Laxatives|laxatives|mesh-ancestor
92198614|NCT02402270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92198615|NCT00701935|Exenatide|exenatide|mesh-list
92198616|NCT00701935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92198617|NCT00701935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198618|NCT00701935|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92198619|NCT00701935|Incretins|incretins|mesh-ancestor
92198620|NCT00701935|Hormones|hormones|mesh-ancestor
92198621|NCT00701935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198622|NCT02984696|Estradiol|estradiol|mesh-list
92198623|NCT02984696|Estrogens|estrogens|mesh-ancestor
92198624|NCT02984696|Hormones|hormones|mesh-ancestor
92198625|NCT02984696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198626|NCT02984696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198627|NCT03277313|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92198628|NCT03277313|Immunologic Factors|immunologic factors|mesh-ancestor
92198629|NCT03277313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198630|NCT00596167|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92198631|NCT00596167|Vancomycin|vancomycin|mesh-list
92198632|NCT00596167|Levofloxacin|levofloxacin|mesh-list
92198633|NCT00596167|Gentamicins|gentamicins|mesh-list
92198634|NCT00596167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198635|NCT00596167|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92198636|NCT00596167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92198637|NCT00596167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92198638|NCT00596167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198639|NCT00596167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198640|NCT00596167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198641|NCT00596167|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92198642|NCT00596167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92198644|NCT03087032|Insulin Glargine|insulin glargine|mesh-list
92198645|NCT03087032|Liraglutide|liraglutide|mesh-list
92198646|NCT03087032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92198647|NCT03087032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198648|NCT03087032|Incretins|incretins|mesh-ancestor
92198649|NCT03087032|Hormones|hormones|mesh-ancestor
92198650|NCT03087032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198651|NCT02994745|Atorvastatin|atorvastatin|mesh-list
92198652|NCT02994745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92198653|NCT02994745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198654|NCT02994745|Antimetabolites|antimetabolites|mesh-ancestor
92198655|NCT02994745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198656|NCT02994745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198657|NCT02994745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92198658|NCT02994745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198659|NCT00703261|Atorvastatin|atorvastatin|mesh-list
92198660|NCT00703261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92198661|NCT00703261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198662|NCT00703261|Antimetabolites|antimetabolites|mesh-ancestor
92198663|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198664|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198665|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92198666|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198667|NCT04912115|Midazolam|midazolam|mesh-list
92198668|NCT04912115|Ketamine|ketamine|mesh-list
92198669|NCT04912115|Analgesics|analgesics|mesh-ancestor
92198670|NCT04912115|Sensory System Agents|sensory system agents|mesh-ancestor
92198671|NCT04912115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198672|NCT04912115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198673|NCT04912115|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92198674|NCT04912115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92198675|NCT04912115|Anesthetics, General|anesthetics, general|mesh-ancestor
92198676|NCT04912115|Anesthetics|anesthetics|mesh-ancestor
92198677|NCT04912115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198678|NCT04912115|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92198679|NCT04912115|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92198680|NCT04912115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198681|NCT04912115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198682|NCT04912115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92198683|NCT04912115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92198684|NCT04912115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92198685|NCT04912115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92198686|NCT04912115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92198687|NCT04912115|GABA Modulators|gaba modulators|mesh-ancestor
92198688|NCT04912115|GABA Agents|gaba agents|mesh-ancestor
92198689|NCT04346147|Imatinib Mesylate|imatinib mesylate|mesh-list
92198690|NCT04346147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198691|NCT04346147|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92198692|NCT04346147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198693|NCT04346147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198694|NCT03478358|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92198695|NCT03478358|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92198696|NCT03478358|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
92198697|NCT03478358|Chelating Agents|chelating agents|mesh-ancestor
92198698|NCT03478358|Sequestering Agents|sequestering agents|mesh-ancestor
92198699|NCT03478358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198700|NCT03478358|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92198701|NCT04200833|Golimumab|golimumab|mesh-list
92198702|NCT04200833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92198703|NCT04200833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198704|NCT04200833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198705|NCT04200833|Immunologic Factors|immunologic factors|mesh-ancestor
92198706|NCT04200833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198707|NCT01678352|Imiquimod|imiquimod|mesh-list
92198708|NCT01678352|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92198709|NCT01678352|Immunologic Factors|immunologic factors|mesh-ancestor
92198710|NCT01678352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198711|NCT01678352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198712|NCT01678352|Interferon Inducers|interferon inducers|mesh-ancestor
92198713|NCT01678430|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92198714|NCT01678430|Chlorambucil|chlorambucil|mesh-list
92198715|NCT01678430|Ofatumumab|ofatumumab|mesh-list
92198716|NCT01678430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92198717|NCT01678430|Alkylating Agents|alkylating agents|mesh-ancestor
92198718|NCT01678430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198719|NCT01678430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198720|NCT01678664|Doxorubicin|doxorubicin|mesh-list
92198721|NCT01678664|Everolimus|everolimus|mesh-list
91918681|NCT03171831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198722|NCT01678664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92198723|NCT01678664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198724|NCT01678664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92198725|NCT01678664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92198726|NCT01678664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198727|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198728|NCT01678664|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92198729|NCT01678664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92198730|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198731|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
92198732|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198733|NCT00597493|Temozolomide|temozolomide|mesh-list
92198734|NCT00597493|Sorafenib|sorafenib|mesh-list
92198735|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92198736|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
92198737|NCT00597493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198738|NCT00597493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198739|NCT00597493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92198740|NCT00597493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198741|NCT03086954|Immunomodulating Agents|immunomodulating agents|mesh-list
92198742|NCT03086954|Immunologic Factors|immunologic factors|mesh-ancestor
92198743|NCT03086954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198744|NCT03086720|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92198745|NCT03086720|Eusol|eusol|mesh-list
92198746|NCT03086720|Disinfectants|disinfectants|mesh-ancestor
92198747|NCT03086720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198748|NCT04402112|Pitavastatin|pitavastatin|mesh-list
92198749|NCT04402112|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92198750|NCT04402112|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92198751|NCT04402112|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92198752|NCT04402112|Antimetabolites|antimetabolites|mesh-ancestor
92198753|NCT04402112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198754|NCT04402112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198755|NCT04402112|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92198756|NCT00597727|Glycerol|glycerol|mesh-list
92198757|NCT00597727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92198758|NCT00597727|Protective Agents|protective agents|mesh-ancestor
92198759|NCT00597727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198760|NCT03952403|Bevacizumab|bevacizumab|mesh-list
92198761|NCT03952403|Carboplatin|carboplatin|mesh-list
92198762|NCT03952403|Pemetrexed|pemetrexed|mesh-list
92198763|NCT03952403|Antibodies|antibodies|mesh-list
92198764|NCT03952403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198765|NCT03952403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198766|NCT03952403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92198767|NCT03952403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92198768|NCT03952403|Growth Substances|growth substances|mesh-ancestor
92198769|NCT03952403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198770|NCT03952403|Growth Inhibitors|growth inhibitors|mesh-ancestor
92198771|NCT03952403|Immunologic Factors|immunologic factors|mesh-ancestor
92198772|NCT03952403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198773|NCT03952403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198774|NCT03952403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92198775|NCT03952403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92198776|NCT03474770|Huperzine A|huperzine a|mesh-list
92198777|NCT03474770|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92198778|NCT03474770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198779|NCT03474770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198780|NCT03474770|Cholinergic Agents|cholinergic agents|mesh-ancestor
92198781|NCT03474770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198782|NCT03474770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198783|NCT03474770|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92198784|NCT03474770|Protective Agents|protective agents|mesh-ancestor
92198785|NCT02998645|Cyclosporine|cyclosporine|mesh-list
92198786|NCT02998645|Cyclosporins|cyclosporins|mesh-list
92198787|NCT02998645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198788|NCT02998645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198789|NCT02998645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198790|NCT02998645|Immunologic Factors|immunologic factors|mesh-ancestor
92198791|NCT02998645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198792|NCT02998645|Antifungal Agents|antifungal agents|mesh-ancestor
92198793|NCT02998645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198794|NCT02998645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92198795|NCT02998645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198796|NCT02998645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92198797|NCT03450122|Aldesleukin|aldesleukin|mesh-list
92198798|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
92198799|NCT03450122|Interleukin-2|interleukin-2|mesh-list
92198800|NCT03450122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198801|NCT03450122|Immunologic Factors|immunologic factors|mesh-ancestor
92198802|NCT03450122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198803|NCT03450122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198804|NCT03450122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92198805|NCT03450122|Alkylating Agents|alkylating agents|mesh-ancestor
92198806|NCT03450122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198807|NCT03450122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198808|NCT03450122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92198809|NCT03450122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92198810|NCT03450122|Analgesics|analgesics|mesh-ancestor
92198811|NCT03450122|Sensory System Agents|sensory system agents|mesh-ancestor
92198812|NCT03450122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198813|NCT03450122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92198814|NCT03450122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92198815|NCT03450122|Antiviral Agents|antiviral agents|mesh-ancestor
92198816|NCT03450122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92198817|NCT00707863|Escitalopram|escitalopram|mesh-list
92198818|NCT00707863|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92198819|NCT00707863|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92198820|NCT00707863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198821|NCT00707863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198822|NCT00707863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198823|NCT00707863|Serotonin Agents|serotonin agents|mesh-ancestor
92198824|NCT00707863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198825|NCT00565643|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92198826|NCT00565643|Hyaluronic Acid|hyaluronic acid|mesh-list
92198827|NCT00565643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92198828|NCT00565643|Immunologic Factors|immunologic factors|mesh-ancestor
92198829|NCT00565643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198830|NCT00565643|Viscosupplements|viscosupplements|mesh-ancestor
92198831|NCT00565643|Protective Agents|protective agents|mesh-ancestor
92198832|NCT00565643|Laxatives|laxatives|mesh-ancestor
92198833|NCT00565643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92198834|NCT01798277|Amiodarone|amiodarone|mesh-list
92198835|NCT01798277|Sotalol|sotalol|mesh-list
92198836|NCT01798277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92198837|NCT01798277|Vasodilator Agents|vasodilator agents|mesh-ancestor
92198838|NCT01798277|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92198839|NCT01798277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198840|NCT01798277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198841|NCT01798277|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92198842|NCT01798277|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92198843|NCT01798277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92198844|NCT01798277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198845|NCT01798277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92198846|NCT01798277|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92198847|NCT01798277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92198848|NCT01798277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92198849|NCT01798277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92198850|NCT01798277|Adrenergic Agents|adrenergic agents|mesh-ancestor
92198851|NCT01798277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198852|NCT01798277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198853|NCT01798277|Sympatholytics|sympatholytics|mesh-ancestor
92198854|NCT01798277|Autonomic Agents|autonomic agents|mesh-ancestor
92198855|NCT01798277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198856|NCT00598507|Sagopilone|sagopilone|mesh-list
92198857|NCT00598507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198858|NCT00566813|Exenatide|exenatide|mesh-list
92198859|NCT00566813|Etanercept|etanercept|mesh-list
92198860|NCT00566813|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92198861|NCT00566813|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92198862|NCT00566813|Analgesics|analgesics|mesh-ancestor
92198863|NCT00566813|Sensory System Agents|sensory system agents|mesh-ancestor
92198864|NCT00566813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198865|NCT00566813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198866|NCT00566813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198867|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92198868|NCT00566813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92198869|NCT00566813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92198870|NCT00566813|Immunologic Factors|immunologic factors|mesh-ancestor
92198871|NCT00566813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92198872|NCT00566813|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92198873|NCT00566813|Incretins|incretins|mesh-ancestor
92198874|NCT00566813|Hormones|hormones|mesh-ancestor
92198875|NCT00566813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198876|NCT00088166|Corticotropin-Releasing Hormone|corticotropin-releasing hormone|mesh-list
92198877|NCT00088166|Hormones|hormones|mesh-ancestor
92198878|NCT00088166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198879|NCT00088166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198880|NCT00566969|Carvedilol|carvedilol|mesh-list
92198881|NCT00566969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92198882|NCT00566969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92198883|NCT00566969|Adrenergic Agents|adrenergic agents|mesh-ancestor
92198884|NCT00566969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198885|NCT00566969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198886|NCT00566969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198887|NCT00566969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92198888|NCT00566969|Antioxidants|antioxidants|mesh-ancestor
92198889|NCT00566969|Protective Agents|protective agents|mesh-ancestor
92198890|NCT00566969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92198891|NCT00566969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198892|NCT00566969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92198893|NCT00566969|Vasodilator Agents|vasodilator agents|mesh-ancestor
92198894|NCT00566969|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92198895|NCT00566969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92198896|NCT03086564|Chlorotrianisene|chlorotrianisene|mesh-list
92198897|NCT03086564|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92198898|NCT03086564|Estrogens|estrogens|mesh-ancestor
92198899|NCT03086564|Hormones|hormones|mesh-ancestor
92198900|NCT03086564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198901|NCT03086564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198902|NCT03086564|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92198903|NCT03086564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198904|NCT00598663|Insulin|insulin|mesh-list
92198905|NCT00598663|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92198906|NCT00598663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92198907|NCT00598663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198908|NCT00704353|Ferric gluconate|ferric gluconate|mesh-list
92198909|NCT00704353|Iron-Dextran Complex|iron-dextran complex|mesh-list
92198910|NCT00704353|Hematinics|hematinics|mesh-ancestor
92198911|NCT00087698|Pemetrexed|pemetrexed|mesh-list
92198912|NCT00087698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198913|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198914|NCT00087698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198915|NCT00087698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92198916|NCT00087698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92198917|NCT03755739|Pembrolizumab|pembrolizumab|mesh-list
92198918|NCT03755739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92198919|NCT03755739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198920|NCT03755739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92198921|NCT03755739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198922|NCT05245721|Nalbuphine|nalbuphine|mesh-list
92198923|NCT05245721|Bupivacaine|bupivacaine|mesh-list
92198924|NCT05245721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92198925|NCT05245721|Anesthetics|anesthetics|mesh-ancestor
92198926|NCT05245721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198927|NCT05245721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198928|NCT05245721|Sensory System Agents|sensory system agents|mesh-ancestor
92198929|NCT05245721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198930|NCT05245721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92198931|NCT05245721|Narcotics|narcotics|mesh-ancestor
92198932|NCT05245721|Analgesics|analgesics|mesh-ancestor
92198933|NCT04402892|Lithium Carbonate|lithium carbonate|mesh-list
92198934|NCT04402892|Antidepressive Agents|antidepressive agents|mesh-ancestor
92198935|NCT04402892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92198936|NCT04402892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92198937|NCT04402892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198938|NCT04402892|Antimanic Agents|antimanic agents|mesh-ancestor
92198939|NCT04402892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92198940|NCT04402892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198941|NCT04402892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198942|NCT03472586|Nivolumab|nivolumab|mesh-list
92198943|NCT03472586|Ipilimumab|ipilimumab|mesh-list
92198944|NCT03472586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91919451|NCT02581202|Protease Inhibitors|protease inhibitors|mesh-ancestor
92198945|NCT03472586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198946|NCT03472586|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92198947|NCT03472586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198948|NCT02987985|Acetaminophen|acetaminophen|mesh-list
92198949|NCT02987985|Dexamethasone|dexamethasone|mesh-list
92198950|NCT02987985|Lidocaine|lidocaine|mesh-list
92198951|NCT02987985|Fentanyl|fentanyl|mesh-list
92198952|NCT02987985|Dexmedetomidine|dexmedetomidine|mesh-list
92198953|NCT02987985|Ketamine|ketamine|mesh-list
92198954|NCT02987985|Gabapentin|gabapentin|mesh-list
92198955|NCT02987985|Analgesics, Opioid|analgesics, opioid|mesh-list
92198956|NCT02987985|Ondansetron|ondansetron|mesh-list
92198957|NCT02987985|Sevoflurane|sevoflurane|mesh-list
92198958|NCT02987985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92198959|NCT02987985|Antiemetics|antiemetics|mesh-ancestor
92198960|NCT02987985|Autonomic Agents|autonomic agents|mesh-ancestor
92198961|NCT02987985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92198962|NCT02987985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92198963|NCT02987985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92198964|NCT02987985|Glucocorticoids|glucocorticoids|mesh-ancestor
92198965|NCT02987985|Hormones|hormones|mesh-ancestor
92198966|NCT02987985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92198967|NCT02987985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92198968|NCT02987985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92198969|NCT02987985|Anesthetics, Local|anesthetics, local|mesh-ancestor
92198970|NCT02987985|Anesthetics|anesthetics|mesh-ancestor
92198971|NCT02987985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92198972|NCT02987985|Sensory System Agents|sensory system agents|mesh-ancestor
92198973|NCT02987985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92198974|NCT02987985|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92198975|NCT02987985|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92198976|NCT02987985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92198977|NCT02987985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92198978|NCT02987985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92198979|NCT02987985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92198980|NCT02987985|Analgesics|analgesics|mesh-ancestor
92198981|NCT02987985|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92198982|NCT02987985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92198983|NCT02987985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92198984|NCT02987985|Adrenergic Agents|adrenergic agents|mesh-ancestor
92198985|NCT02987985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92198986|NCT02987985|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92198987|NCT02987985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92198988|NCT02987985|Anesthetics, General|anesthetics, general|mesh-ancestor
92198989|NCT02987985|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92198990|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92198991|NCT02987985|Narcotics|narcotics|mesh-ancestor
92198992|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92198993|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
92198994|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92198995|NCT02987985|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92198996|NCT02987985|Anticonvulsants|anticonvulsants|mesh-ancestor
92198997|NCT02987985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92198998|NCT02987985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92198999|NCT02987985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92199000|NCT02987985|Antimanic Agents|antimanic agents|mesh-ancestor
92199001|NCT02987985|Antipruritics|antipruritics|mesh-ancestor
92199002|NCT02987985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92199003|NCT02987985|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92199004|NCT02987985|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92199005|NCT02987985|Serotonin Agents|serotonin agents|mesh-ancestor
92199006|NCT00708721|Clofarabine|clofarabine|mesh-list
92199007|NCT00708721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92199008|NCT00708721|Antimetabolites|antimetabolites|mesh-ancestor
92199009|NCT00708721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199010|NCT00708721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199011|NCT00087152|Capecitabine|capecitabine|mesh-list
92199012|NCT00087152|Imatinib Mesylate|imatinib mesylate|mesh-list
92199013|NCT00087152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92199014|NCT00087152|Antimetabolites|antimetabolites|mesh-ancestor
92199015|NCT00087152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199016|NCT00087152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199017|NCT00087152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199018|NCT00087152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199019|NCT05362799|Metformin|metformin|mesh-list
92199020|NCT05362799|Letrozole|letrozole|mesh-list
92199021|NCT05362799|Lactitol|lactitol|mesh-list
92199022|NCT05362799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199023|NCT05362799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199024|NCT05362799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199025|NCT05362799|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92199026|NCT05362799|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92199027|NCT05362799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199028|NCT05362799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199029|NCT05362799|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92199030|NCT05362799|Hormone Antagonists|hormone antagonists|mesh-ancestor
92199031|NCT05362799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199032|NCT05362799|Cathartics|cathartics|mesh-ancestor
92199033|NCT05362799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199034|NCT01940523|Tranexamic Acid|tranexamic acid|mesh-list
92199035|NCT01940523|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92199036|NCT01940523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92199037|NCT01940523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199038|NCT01940523|Hemostatics|hemostatics|mesh-ancestor
92199039|NCT01940523|Coagulants|coagulants|mesh-ancestor
92199040|NCT04403282|Eflornithine|eflornithine|mesh-list
92199041|NCT04403282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199042|NCT04403282|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92199043|NCT04403282|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92199044|NCT04403282|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92199045|NCT04403282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199046|NCT04403282|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92199047|NCT04403282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199048|NCT04403282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199049|NCT02994433|Nitrous Oxide|nitrous oxide|mesh-list
92199050|NCT02994433|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92199051|NCT02994433|Anesthetics, General|anesthetics, general|mesh-ancestor
92199052|NCT02994433|Anesthetics|anesthetics|mesh-ancestor
92199053|NCT02994433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199054|NCT02994433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199055|NCT02994433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199056|NCT02994433|Analgesics|analgesics|mesh-ancestor
92199058|NCT02994433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199059|NCT04388189|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92199060|NCT04388189|Bupropion|bupropion|mesh-list
92199061|NCT04388189|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92199062|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
92199063|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92199064|NCT04388189|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92199065|NCT04388189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92199066|NCT04388189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199067|NCT04388189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199068|NCT04388189|Dopamine Agents|dopamine agents|mesh-ancestor
92199069|NCT04388189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199070|NCT04388189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199071|NCT04388189|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92199072|NCT04388189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92199073|NCT04388189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199074|NCT04388189|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92199075|NCT04388189|Analgesics|analgesics|mesh-ancestor
92199076|NCT04388189|Sensory System Agents|sensory system agents|mesh-ancestor
92199077|NCT04388189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199078|NCT00599053|Azithromycin|azithromycin|mesh-list
92199079|NCT00599053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199080|NCT00599053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199081|NCT01941927|Trametinib|trametinib|mesh-list
92199082|NCT01941927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199083|NCT01941927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199084|NCT01941927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199085|NCT01941927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199086|NCT05220917|Insulin|insulin|mesh-list
92199087|NCT05220917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92199088|NCT05220917|Metformin|metformin|mesh-list
92199089|NCT05220917|Insulin Glargine|insulin glargine|mesh-list
92199090|NCT05220917|Pioglitazone|pioglitazone|mesh-list
92199091|NCT05220917|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92199092|NCT05220917|Dapagliflozin|dapagliflozin|mesh-list
92199093|NCT05220917|Liraglutide|liraglutide|mesh-list
92199094|NCT05220917|Empagliflozin|empagliflozin|mesh-list
92199095|NCT05220917|Exenatide|exenatide|mesh-list
92199096|NCT05220917|Glimepiride|glimepiride|mesh-list
92199097|NCT05220917|Linagliptin|linagliptin|mesh-list
92199098|NCT05220917|Rosiglitazone|rosiglitazone|mesh-list
92199099|NCT05220917|Canagliflozin|canagliflozin|mesh-list
92199100|NCT05220917|Saxagliptin|saxagliptin|mesh-list
92199101|NCT05220917|Alogliptin|alogliptin|mesh-list
92199102|NCT05220917|Dulaglutide|dulaglutide|mesh-list
92199103|NCT05220917|Glyburide|glyburide|mesh-list
92199104|NCT05220917|Ertugliflozin|ertugliflozin|mesh-list
92199105|NCT05220917|Lixisenatide|lixisenatide|mesh-list
92199106|NCT05220917|Glipizide|glipizide|mesh-list
92199107|NCT05220917|Xultophy|xultophy|mesh-list
92199108|NCT05220917|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92199109|NCT05220917|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92199110|NCT05220917|Simvastatin|simvastatin|mesh-list
92199111|NCT05220917|rGLP-1 protein|rglp-1 protein|mesh-list
92199112|NCT05220917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199113|NCT05220917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199114|NCT05220917|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92199115|NCT05220917|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92199116|NCT05220917|Antimetabolites|antimetabolites|mesh-ancestor
92199117|NCT05220917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199118|NCT05220917|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92199119|NCT05220917|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92199120|NCT05220917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199122|NCT05220917|Hormones|hormones|mesh-ancestor
92199123|NCT05220917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199124|NCT05220917|Protease Inhibitors|protease inhibitors|mesh-ancestor
92199125|NCT05220917|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92199126|NCT05220917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92199127|NCT05220917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199128|NCT05220917|Immunologic Factors|immunologic factors|mesh-ancestor
92199130|NCT00086996|Oxaliplatin|oxaliplatin|mesh-list
92199131|NCT00086996|Antimetabolites|antimetabolites|mesh-ancestor
92199132|NCT00086996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199133|NCT00086996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92199134|NCT00086996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199135|NCT00086996|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199136|NCT00086996|Immunologic Factors|immunologic factors|mesh-ancestor
92199137|NCT00086996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199138|NCT01943565|Hydromorphone|hydromorphone|mesh-list
92199139|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199140|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199141|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92199142|NCT01943565|Narcotics|narcotics|mesh-ancestor
92199143|NCT01943565|Analgesics|analgesics|mesh-ancestor
92199144|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
92199145|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199146|NCT03316859|Naloxegol|naloxegol|mesh-list
92199147|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92199148|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199149|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
92199150|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199151|NCT04401878|Lidocaine|lidocaine|mesh-list
92199152|NCT04401878|Anesthetics, Local|anesthetics, local|mesh-ancestor
92199153|NCT04401878|Anesthetics|anesthetics|mesh-ancestor
92199154|NCT04401878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199155|NCT04401878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199156|NCT04401878|Sensory System Agents|sensory system agents|mesh-ancestor
92199157|NCT04401878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199158|NCT04401878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92199159|NCT04401878|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92199160|NCT04401878|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92199161|NCT04401878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199162|NCT04401878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199163|NCT05362019|Norethindrone|norethindrone|mesh-list
92199164|NCT05362019|Norethindrone enanthate|norethindrone enanthate|mesh-list
92199165|NCT05362019|Norethindrone Acetate|norethindrone acetate|mesh-list
92199166|NCT05362019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92199167|NCT05362019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92199168|NCT05362019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92199169|NCT05362019|Contraceptive Agents|contraceptive agents|mesh-ancestor
92199170|NCT05362019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92199171|NCT05362019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199172|NCT05362019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92199173|NCT05362019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92199174|NCT03654105|Aspirin|aspirin|mesh-list
92199175|NCT03654105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92199176|NCT03654105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199177|NCT03654105|Analgesics|analgesics|mesh-ancestor
92199178|NCT03654105|Sensory System Agents|sensory system agents|mesh-ancestor
92199179|NCT03654105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199180|NCT03654105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199181|NCT03654105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199182|NCT03654105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92199183|NCT03654105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92199184|NCT03654105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92199185|NCT03654105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199186|NCT03654105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92199187|NCT03654105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92199188|NCT03654105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199189|NCT03654105|Antipyretics|antipyretics|mesh-ancestor
92199190|NCT04388111|Morphine|morphine|mesh-list
92199191|NCT04388111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92199192|NCT04388111|Narcotics|narcotics|mesh-ancestor
92199193|NCT04388111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199194|NCT04388111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199195|NCT04388111|Analgesics|analgesics|mesh-ancestor
92199196|NCT04388111|Sensory System Agents|sensory system agents|mesh-ancestor
92199197|NCT04388111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199198|NCT03309137|Chlorhexidine|chlorhexidine|mesh-list
92199199|NCT03309137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92199201|NCT03309137|Disinfectants|disinfectants|mesh-ancestor
92199202|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
92199203|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
92199204|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
92199205|NCT01881087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199206|NCT01881087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199207|NCT01881087|Sensory System Agents|sensory system agents|mesh-ancestor
92199208|NCT01881087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199209|NCT01944423|Cycloserine|cycloserine|mesh-list
92199210|NCT01944423|Nicotine|nicotine|mesh-list
92199211|NCT01944423|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92199213|NCT01944423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199214|NCT01944423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199215|NCT01944423|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92199216|NCT01944423|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92199217|NCT01944423|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199218|NCT01944423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199219|NCT01944423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199220|NCT01944423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92199221|NCT01944423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199222|NCT01944423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92199223|NCT01944423|Antitubercular Agents|antitubercular agents|mesh-ancestor
92199224|NCT01944423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199225|NCT01944423|Antimetabolites|antimetabolites|mesh-ancestor
92199226|NCT05305313|Propofol|propofol|mesh-list
92199227|NCT05305313|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92199228|NCT05305313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199229|NCT05305313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199230|NCT05305313|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92199231|NCT05305313|Anesthetics, General|anesthetics, general|mesh-ancestor
92199232|NCT05305313|Anesthetics|anesthetics|mesh-ancestor
92199233|NCT00600925|Gentamicins|gentamicins|mesh-list
92199234|NCT00600925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199235|NCT00600925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199236|NCT00600925|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92199237|NCT00600925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199238|NCT00600925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199239|NCT02338973|Interferons|interferons|mesh-list
92199240|NCT02338973|Interferon-gamma|interferon-gamma|mesh-list
92199241|NCT02338973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199242|NCT02338973|Antiviral Agents|antiviral agents|mesh-ancestor
92199243|NCT02338973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199244|NCT00601627|Gemcitabine|gemcitabine|mesh-list
92199245|NCT00601627|Fluorouracil|fluorouracil|mesh-list
92199246|NCT00601627|Capecitabine|capecitabine|mesh-list
92199247|NCT00601627|Panitumumab|panitumumab|mesh-list
92199248|NCT00601627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92199249|NCT00601627|Antimetabolites|antimetabolites|mesh-ancestor
92199250|NCT00601627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199251|NCT00601627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199252|NCT00601627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199253|NCT00601627|Immunologic Factors|immunologic factors|mesh-ancestor
91940014|NCT02483078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92199254|NCT00601627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199255|NCT00601627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92199256|NCT01947153|Metformin|metformin|mesh-list
92199257|NCT01947153|Linagliptin|linagliptin|mesh-list
92199258|NCT01947153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199259|NCT01947153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199260|NCT01947153|Incretins|incretins|mesh-ancestor
92199261|NCT01947153|Hormones|hormones|mesh-ancestor
92199262|NCT01947153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199263|NCT01947153|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92199264|NCT01947153|Protease Inhibitors|protease inhibitors|mesh-ancestor
92199265|NCT01947153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199266|NCT01947153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199267|NCT02476409|Tolvaptan|tolvaptan|mesh-list
92199268|NCT02476409|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92199269|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199271|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199272|NCT01269853|Bevacizumab|bevacizumab|mesh-list
92199273|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92199274|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199275|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92199276|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92199277|NCT01269853|Growth Substances|growth substances|mesh-ancestor
92199278|NCT01269853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199279|NCT01269853|Growth Inhibitors|growth inhibitors|mesh-ancestor
92199280|NCT02993575|Floxacillin|floxacillin|mesh-list
92199281|NCT02993575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199282|NCT02993575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199283|NCT00603187|Acyline|acyline|mesh-list
92199284|NCT00603187|Hormone Antagonists|hormone antagonists|mesh-ancestor
92199285|NCT00603187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199286|NCT00603187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199287|NCT01886937|Phentermine|phentermine|mesh-list
92199288|NCT01886937|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92199289|NCT01886937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199290|NCT01886937|Appetite Depressants|appetite depressants|mesh-ancestor
92199291|NCT01886937|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92199292|NCT01886937|Sympathomimetics|sympathomimetics|mesh-ancestor
92199293|NCT01886937|Autonomic Agents|autonomic agents|mesh-ancestor
92199294|NCT01886937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199295|NCT01886937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92199296|NCT01886937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199297|NCT01886937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199298|NCT02993341|Tranexamic Acid|tranexamic acid|mesh-list
92199299|NCT02993341|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92199300|NCT02993341|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92199301|NCT02993341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199302|NCT02993341|Hemostatics|hemostatics|mesh-ancestor
92199303|NCT02993341|Coagulants|coagulants|mesh-ancestor
92199304|NCT01219075|Phytoestrogens|phytoestrogens|mesh-list
92199305|NCT01219075|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92199306|NCT01219075|Estrogens|estrogens|mesh-ancestor
92199307|NCT01219075|Hormones|hormones|mesh-ancestor
92199308|NCT01219075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199309|NCT01219075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199310|NCT00086684|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
92199311|NCT00086684|Anticoagulants|anticoagulants|mesh-ancestor
92199312|NCT02987907|Dexamethasone|dexamethasone|mesh-list
92199313|NCT02987907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199314|NCT02987907|Antiemetics|antiemetics|mesh-ancestor
92199315|NCT02987907|Autonomic Agents|autonomic agents|mesh-ancestor
92199316|NCT02987907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199317|NCT02987907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199318|NCT02987907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199319|NCT02987907|Glucocorticoids|glucocorticoids|mesh-ancestor
92199320|NCT02987907|Hormones|hormones|mesh-ancestor
92199321|NCT02987907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199322|NCT02987907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92199323|NCT02987907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199324|NCT01887171|Tacrolimus|tacrolimus|mesh-list
92199325|NCT01887171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199326|NCT01887171|Immunologic Factors|immunologic factors|mesh-ancestor
92199327|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199328|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92199329|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199330|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199331|NCT00713479|Varenicline|varenicline|mesh-list
92199332|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92199333|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92199334|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199335|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199336|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199337|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199338|NCT03467750|Ketorolac|ketorolac|mesh-list
92199339|NCT03467750|Morphine|morphine|mesh-list
92199340|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92199341|NCT03467750|Narcotics|narcotics|mesh-ancestor
92199342|NCT03467750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199343|NCT03467750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199344|NCT03467750|Analgesics|analgesics|mesh-ancestor
92199345|NCT03467750|Sensory System Agents|sensory system agents|mesh-ancestor
92199346|NCT03467750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199347|NCT03467750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92199348|NCT03467750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199349|NCT03467750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199350|NCT03467750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92199351|NCT03467750|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92199352|NCT03467750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199353|NCT03467750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199354|NCT04402580|Mycophenolic Acid|mycophenolic acid|mesh-list
92199355|NCT04402580|Rituximab|rituximab|mesh-list
92199356|NCT04402580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92199357|NCT04402580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199358|NCT04402580|Immunologic Factors|immunologic factors|mesh-ancestor
92199359|NCT04402580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199360|NCT04402580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92199361|NCT04402580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92199362|NCT04402580|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92199363|NCT04402580|Antitubercular Agents|antitubercular agents|mesh-ancestor
92199364|NCT04402580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199365|NCT04402580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199366|NCT04402580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199367|NCT04402580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199368|NCT01887327|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92199369|NCT01887327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199370|NCT01887327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199371|NCT02987751|Insulin|insulin|mesh-list
92199372|NCT02987751|Insulin Glargine|insulin glargine|mesh-list
92199373|NCT02987751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199374|NCT02987751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199375|NCT04385719|Remdesivir|remdesivir|mesh-list
92199376|NCT04385719|Antimetabolites|antimetabolites|mesh-ancestor
92199377|NCT04385719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199378|NCT04385719|Antiviral Agents|antiviral agents|mesh-ancestor
92199379|NCT04385719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199380|NCT00082628|Hormones|hormones|mesh-list
92199381|NCT00082628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199382|NCT00082628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199383|NCT01275859|Letrozole|letrozole|mesh-list
92199384|NCT01275859|Lapatinib|lapatinib|mesh-list
92199385|NCT01275859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199386|NCT01275859|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92199387|NCT01275859|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92199388|NCT01275859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199389|NCT01275859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199390|NCT01275859|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92199391|NCT01275859|Hormone Antagonists|hormone antagonists|mesh-ancestor
92199392|NCT01275859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199393|NCT01275859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199394|NCT01275859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199396|NCT01950039|Glycine|glycine|mesh-list
92199397|NCT01950039|Glycine Agents|glycine agents|mesh-ancestor
92199398|NCT01950039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199399|NCT01950039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199400|NCT01950039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199401|NCT01950039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199402|NCT01950039|Lipotropic Agents|lipotropic agents|mesh-ancestor
92199403|NCT01950039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92199404|NCT01950039|Antimetabolites|antimetabolites|mesh-ancestor
92199405|NCT01950039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92199406|NCT01275937|Esomeprazole|esomeprazole|mesh-list
92199407|NCT01275937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92199408|NCT01275937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199409|NCT01275937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92199410|NCT01275937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199411|NCT01275937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199412|NCT02990455|Nicotine|nicotine|mesh-list
92199413|NCT02990455|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92199415|NCT02990455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199416|NCT02990455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199417|NCT02990455|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92199418|NCT02990455|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92199419|NCT02990455|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199420|NCT02990455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199421|NCT02990455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199422|NCT01889667|Insulin|insulin|mesh-list
92199423|NCT01889667|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92199424|NCT01889667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199425|NCT01889667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199426|NCT01276015|Botulinum Toxins|botulinum toxins|mesh-list
92199427|NCT01276015|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92199428|NCT01276015|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92199429|NCT01276015|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92199430|NCT01276015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199431|NCT01276015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199432|NCT01276015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199433|NCT01276015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199434|NCT01276015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199435|NCT01276015|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92199436|NCT01276015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199437|NCT02130635|Nemiralisib|nemiralisib|mesh-list
92199438|NCT02130635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199439|NCT02130635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199440|NCT02130635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199441|NCT01276093|Amiodarone|amiodarone|mesh-list
92199442|NCT01276093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92199443|NCT01276093|Vasodilator Agents|vasodilator agents|mesh-ancestor
92199444|NCT01276093|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92199445|NCT01276093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199446|NCT01276093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199447|NCT01276093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92199448|NCT01276093|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92199449|NCT01276093|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92199450|NCT01276093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199451|NCT01276093|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92199452|NCT01276093|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92199453|NCT01276093|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92199454|NCT00557973|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
92199455|NCT00557973|Baclofen|baclofen|mesh-list
92199456|NCT00557973|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92199457|NCT00557973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199458|NCT00557973|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92199459|NCT00557973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199460|NCT00557973|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92199461|NCT00557973|GABA Agonists|gaba agonists|mesh-ancestor
92199462|NCT00557973|GABA Agents|gaba agents|mesh-ancestor
92199463|NCT00557973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199464|NCT00557973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199465|NCT00726739|Aldesleukin|aldesleukin|mesh-list
92199466|NCT00726739|Interleukin-2|interleukin-2|mesh-list
92199467|NCT00726739|Vaccines|vaccines|mesh-list
92199468|NCT00726739|Immunologic Factors|immunologic factors|mesh-ancestor
92199469|NCT00726739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199470|NCT00726739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199471|NCT00726739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199472|NCT00726739|Analgesics|analgesics|mesh-ancestor
92199473|NCT00726739|Sensory System Agents|sensory system agents|mesh-ancestor
92199474|NCT00726739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199475|NCT00726739|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92199476|NCT00726739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92199477|NCT00726739|Antiviral Agents|antiviral agents|mesh-ancestor
92199478|NCT00726739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199479|NCT00569309|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92199480|NCT00569309|Immunologic Factors|immunologic factors|mesh-ancestor
92199481|NCT00569309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199482|NCT00569855|Phenoxybenzamine|phenoxybenzamine|mesh-list
92199483|NCT00569855|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92199484|NCT00569855|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92199485|NCT00569855|Adrenergic Agents|adrenergic agents|mesh-ancestor
92199486|NCT00569855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199487|NCT00569855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199488|NCT00569855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199489|NCT00569855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92199490|NCT00569855|Vasodilator Agents|vasodilator agents|mesh-ancestor
92199491|NCT02991781|Varenicline|varenicline|mesh-list
92199492|NCT02991781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92199493|NCT02991781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92199494|NCT02991781|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199495|NCT02991781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199496|NCT02991781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199497|NCT02991781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199499|NCT01893801|Cisplatin|cisplatin|mesh-list
92199500|NCT01893801|Gemcitabine|gemcitabine|mesh-list
92199501|NCT01893801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92199502|NCT01893801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199503|NCT01893801|Tubulin Modulators|tubulin modulators|mesh-ancestor
92199504|NCT01893801|Antimitotic Agents|antimitotic agents|mesh-ancestor
92199505|NCT01893801|Mitosis Modulators|mitosis modulators|mesh-ancestor
92199506|NCT01893801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199507|NCT01893801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92199508|NCT01893801|Antimetabolites|antimetabolites|mesh-ancestor
92199509|NCT00570089|Ranolazine|ranolazine|mesh-list
92199510|NCT00570089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92199511|NCT00570089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199512|NCT00570089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199513|NCT00727597|Efavirenz|efavirenz|mesh-list
92199514|NCT00727597|Fosamprenavir|fosamprenavir|mesh-list
92199515|NCT00727597|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92199516|NCT00727597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92199517|NCT00727597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199518|NCT00727597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199519|NCT00727597|Antiviral Agents|antiviral agents|mesh-ancestor
92199520|NCT00727597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199521|NCT00727597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92199522|NCT00727597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92199523|NCT00727597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92199524|NCT00727597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92199525|NCT00727597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92199526|NCT00727597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92199527|NCT00727597|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92199528|NCT00727597|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92199529|NCT00727597|Protease Inhibitors|protease inhibitors|mesh-ancestor
92199530|NCT00727597|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92199531|NCT00727597|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92199532|NCT00571259|Gentamicins|gentamicins|mesh-list
92199533|NCT00571259|Heparin|heparin|mesh-list
92199534|NCT00571259|Citric Acid|citric acid|mesh-list
92199535|NCT00571259|Sodium Citrate|sodium citrate|mesh-list
92199536|NCT00571259|Anticoagulants|anticoagulants|mesh-ancestor
92199537|NCT00571259|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92199538|NCT00571259|Chelating Agents|chelating agents|mesh-ancestor
92199539|NCT00571259|Sequestering Agents|sequestering agents|mesh-ancestor
92199540|NCT00571259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199541|NCT00571259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92199542|NCT00571259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92199543|NCT00571259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199544|NCT00571259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199545|NCT00571259|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92199546|NCT00571259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199547|NCT01893879|Ketoprofen|ketoprofen|mesh-list
92199548|NCT01893879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92199549|NCT01893879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199550|NCT01893879|Analgesics|analgesics|mesh-ancestor
92199551|NCT01893879|Sensory System Agents|sensory system agents|mesh-ancestor
92199552|NCT01893879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199553|NCT01893879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199554|NCT01893879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199555|NCT01893879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92199556|NCT01893879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92199557|NCT01893879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199558|NCT01893879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199559|NCT01894503|Mometasone Furoate|mometasone furoate|mesh-list
92199560|NCT01894503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199561|NCT01894503|Dermatologic Agents|dermatologic agents|mesh-ancestor
92199562|NCT01894503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92199563|NCT00571493|Cytarabine|cytarabine|mesh-list
92199564|NCT00571493|Etoposide|etoposide|mesh-list
92199565|NCT00571493|Bortezomib|bortezomib|mesh-list
92199566|NCT00571493|Melphalan|melphalan|mesh-list
92199567|NCT00571493|Carmustine|carmustine|mesh-list
92199568|NCT00571493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92199570|NCT00571493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92199571|NCT00571493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92199572|NCT00571493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199573|NCT00571493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199574|NCT00571493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92199575|NCT00571493|Antimetabolites|antimetabolites|mesh-ancestor
92199576|NCT00571493|Antiviral Agents|antiviral agents|mesh-ancestor
92199577|NCT00571493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199578|NCT00571493|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199579|NCT00571493|Immunologic Factors|immunologic factors|mesh-ancestor
92199580|NCT00571493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199581|NCT00571493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92199582|NCT00571493|Alkylating Agents|alkylating agents|mesh-ancestor
92199583|NCT00571493|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92199584|NCT00571961|Ritonavir|ritonavir|mesh-list
92199585|NCT00571961|Lopinavir|lopinavir|mesh-list
92199586|NCT00571961|Buprenorphine|buprenorphine|mesh-list
92199587|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92199588|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92199589|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92199590|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199591|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199592|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92199593|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92199594|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
92199595|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199596|NCT00571961|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92199597|NCT00571961|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92199598|NCT00571961|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92199599|NCT00571961|Narcotics|narcotics|mesh-ancestor
92199600|NCT00571961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199601|NCT00571961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199602|NCT00571961|Analgesics|analgesics|mesh-ancestor
92199603|NCT00571961|Sensory System Agents|sensory system agents|mesh-ancestor
92199604|NCT00571961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199605|NCT00571961|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92199606|NCT00572117|Topiramate|topiramate|mesh-list
92199607|NCT00572117|Anticonvulsants|anticonvulsants|mesh-ancestor
92199608|NCT00572117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92199609|NCT00572117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199610|NCT01895127|Immunoglobulins|immunoglobulins|mesh-list
92199611|NCT01895127|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92199612|NCT01895127|Antibodies|antibodies|mesh-list
92199613|NCT01895127|Eculizumab|eculizumab|mesh-list
92199614|NCT01895127|Immunologic Factors|immunologic factors|mesh-ancestor
92199615|NCT01895127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199616|NCT01895127|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92199617|NCT01895127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199618|NCT01953081|Metoclopramide|metoclopramide|mesh-list
92199619|NCT01953081|Antiemetics|antiemetics|mesh-ancestor
92199620|NCT01953081|Autonomic Agents|autonomic agents|mesh-ancestor
92199621|NCT01953081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199622|NCT01953081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199623|NCT01953081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199624|NCT01953081|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92199625|NCT01953081|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92199626|NCT01953081|Dopamine Agents|dopamine agents|mesh-ancestor
92199627|NCT01953081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199628|NCT01953081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199630|NCT00572897|Melphalan|melphalan|mesh-list
92199631|NCT00572897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199632|NCT00572897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199633|NCT00572897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92199634|NCT00572897|Immunologic Factors|immunologic factors|mesh-ancestor
92199635|NCT00572897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199636|NCT00572897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92199637|NCT00572897|Alkylating Agents|alkylating agents|mesh-ancestor
92199638|NCT00572897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92199639|NCT01276717|Vorinostat|vorinostat|mesh-list
92199640|NCT01276717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199641|NCT01276717|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92199642|NCT01276717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199643|NCT01276717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199644|NCT02991157|Nimodipine|nimodipine|mesh-list
92199645|NCT02991157|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92199646|NCT02991157|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92199647|NCT02991157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199648|NCT02991157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199649|NCT02991157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92199650|NCT02991157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199651|NCT02991157|Vasodilator Agents|vasodilator agents|mesh-ancestor
92199652|NCT04386499|Folic Acid|folic acid|mesh-list
92199653|NCT04386499|Resveratrol|resveratrol|mesh-list
92199654|NCT04386499|Hematinics|hematinics|mesh-ancestor
92199655|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
92199656|NCT04386499|Vitamins|vitamins|mesh-ancestor
92199657|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
92199658|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199659|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
92199660|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199661|NCT04386499|Protective Agents|protective agents|mesh-ancestor
92199662|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199663|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92199664|NCT00573287|Risperidone|risperidone|mesh-list
92199665|NCT00573287|Clozapine|clozapine|mesh-list
92199666|NCT00573287|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92199667|NCT00573287|Serotonin Agents|serotonin agents|mesh-ancestor
92199668|NCT00573287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199669|NCT00573287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199670|NCT00573287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199671|NCT00573287|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92199672|NCT00573287|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92199673|NCT00573287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199674|NCT00573287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92199675|NCT00573287|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92199676|NCT00573287|Dopamine Agents|dopamine agents|mesh-ancestor
92199677|NCT00573287|GABA Antagonists|gaba antagonists|mesh-ancestor
92199678|NCT00573287|GABA Agents|gaba agents|mesh-ancestor
92199679|NCT01896921|Raltegravir Potassium|raltegravir potassium|mesh-list
92199680|NCT01896921|Dolutegravir|dolutegravir|mesh-list
92199681|NCT01896921|Maraviroc|maraviroc|mesh-list
92199682|NCT01896921|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92199683|NCT01896921|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92199684|NCT01896921|Antiviral Agents|antiviral agents|mesh-ancestor
92199685|NCT01896921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199686|NCT01896921|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92199687|NCT01896921|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92199688|NCT01896921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199689|NCT01896921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199690|NCT01896921|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92199692|NCT01896921|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92199693|NCT00749749|Bupivacaine|bupivacaine|mesh-list
92199694|NCT00749749|Anesthetics, Local|anesthetics, local|mesh-ancestor
92199695|NCT00749749|Anesthetics|anesthetics|mesh-ancestor
92199696|NCT00749749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199697|NCT00749749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199698|NCT00749749|Sensory System Agents|sensory system agents|mesh-ancestor
92199699|NCT00749749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199701|NCT02991937|Piperacillin|piperacillin|mesh-list
92199702|NCT02991937|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92199703|NCT02991937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199704|NCT02991937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199705|NCT02991937|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92199706|NCT02991937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199707|NCT02991937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199708|NCT00420667|Enoxaparin|enoxaparin|mesh-list
92199709|NCT00420667|Anticoagulants|anticoagulants|mesh-ancestor
92199710|NCT00420667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92199711|NCT00420667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92199712|NCT00420667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199713|NCT01277107|Zaleplon|zaleplon|mesh-list
92199714|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
92199715|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92199716|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199717|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199718|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
92199719|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
92199720|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199721|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199722|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
92199723|NCT01277185|Calcium|calcium|mesh-list
92199724|NCT01277185|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92199725|NCT01277185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199726|NCT01277185|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92199727|NCT01274533|Lenalidomide|lenalidomide|mesh-list
92199728|NCT01274533|Immunologic Factors|immunologic factors|mesh-ancestor
92199729|NCT01274533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199730|NCT01274533|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92199731|NCT01274533|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92199732|NCT01274533|Growth Substances|growth substances|mesh-ancestor
92199733|NCT01274533|Growth Inhibitors|growth inhibitors|mesh-ancestor
92199734|NCT01274533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199735|NCT01277497|Calcium|calcium|mesh-list
92199736|NCT01277497|Sevelamer|sevelamer|mesh-list
92199737|NCT01277497|Calcium acetate|calcium acetate|mesh-list
92199738|NCT01277497|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92199739|NCT01277497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199740|NCT01277497|Chelating Agents|chelating agents|mesh-ancestor
92199741|NCT01277497|Sequestering Agents|sequestering agents|mesh-ancestor
92199742|NCT01277497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199743|NCT05735535|Antiviral Agents|antiviral agents|mesh-list
92199744|NCT05735535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199745|NCT01270087|Adalimumab|adalimumab|mesh-list
92199746|NCT01270087|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92199747|NCT01270087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199748|NCT01270087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92199749|NCT01958073|Estradiol|estradiol|mesh-list
92199750|NCT01958073|Estrogens|estrogens|mesh-list
92199751|NCT01958073|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92199752|NCT01958073|Hormones|hormones|mesh-ancestor
92199753|NCT01958073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199754|NCT01958073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199755|NCT01270165|Telbivudine|telbivudine|mesh-list
92199756|NCT01270165|Antiviral Agents|antiviral agents|mesh-ancestor
92199757|NCT01270165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199758|NCT01270165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92199759|NCT01270165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199760|NCT01270165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199761|NCT05740215|Lenvatinib|lenvatinib|mesh-list
92199762|NCT05740215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199763|NCT05740215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199764|NCT05740215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199765|NCT05740215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199766|NCT01277731|Methylprednisolone|methylprednisolone|mesh-list
92199767|NCT01277731|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92199768|NCT01277731|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92199769|NCT01277731|Prednisolone|prednisolone|mesh-list
92199770|NCT01277731|Prednisolone acetate|prednisolone acetate|mesh-list
92199771|NCT01277731|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92199772|NCT01277731|Prednisolone phosphate|prednisolone phosphate|mesh-list
92199773|NCT01277731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199774|NCT01277731|Antiemetics|antiemetics|mesh-ancestor
92199775|NCT01277731|Autonomic Agents|autonomic agents|mesh-ancestor
92199776|NCT01277731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199777|NCT01277731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199778|NCT01277731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199779|NCT01277731|Glucocorticoids|glucocorticoids|mesh-ancestor
92199780|NCT01277731|Hormones|hormones|mesh-ancestor
92199781|NCT01277731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199782|NCT01277731|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92199783|NCT01277731|Protective Agents|protective agents|mesh-ancestor
92199784|NCT01277731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92199785|NCT01277731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199786|NCT01898403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92199787|NCT05735379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92199788|NCT05735379|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92199789|NCT05735379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199790|NCT05735379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199791|NCT05735379|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199792|NCT05735379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199793|NCT05735379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199795|NCT00751777|Immunologic Factors|immunologic factors|mesh-ancestor
92199796|NCT00751777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199797|NCT01902459|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92199799|NCT01902459|Coagulants|coagulants|mesh-ancestor
92199800|NCT01274611|Botulinum Toxins|botulinum toxins|mesh-list
92199801|NCT01274611|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92199802|NCT01274611|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92199803|NCT01274611|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92199804|NCT01274611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199805|NCT01274611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199806|NCT01274611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92199807|NCT01274611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199808|NCT01274611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199809|NCT01274611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92199810|NCT01274611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199811|NCT05735145|Paclitaxel|paclitaxel|mesh-list
92199812|NCT05735145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92199813|NCT05735145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92199814|NCT05735145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199815|NCT05735145|Tubulin Modulators|tubulin modulators|mesh-ancestor
92199816|NCT05735145|Antimitotic Agents|antimitotic agents|mesh-ancestor
92199817|NCT05735145|Mitosis Modulators|mitosis modulators|mesh-ancestor
92199818|NCT05735145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199819|NCT01903005|Buprenorphine|buprenorphine|mesh-list
92199820|NCT01903005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92199821|NCT01903005|Naloxone|naloxone|mesh-list
92199822|NCT01903005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92199823|NCT01903005|Narcotics|narcotics|mesh-ancestor
92199824|NCT01903005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199825|NCT01903005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199826|NCT01903005|Analgesics|analgesics|mesh-ancestor
92199827|NCT01903005|Sensory System Agents|sensory system agents|mesh-ancestor
92199828|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199829|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92199830|NCT00614029|Sumatriptan|sumatriptan|mesh-list
92199831|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92199832|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92199833|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92199834|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
92199835|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199836|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199837|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199838|NCT01905423|Albendazole|albendazole|mesh-list
92199839|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
92199840|NCT01905423|Piperazine|piperazine|mesh-list
92199841|NCT01905423|Mebendazole|mebendazole|mesh-list
92199842|NCT01905423|Piperazine citrate|piperazine citrate|mesh-list
92199843|NCT01905423|Citric Acid|citric acid|mesh-list
92199844|NCT01905423|Sodium Citrate|sodium citrate|mesh-list
92199845|NCT01905423|DMP 777|dmp 777|mesh-list
92199846|NCT01905423|Anticoagulants|anticoagulants|mesh-ancestor
92199847|NCT01905423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92199848|NCT01905423|Chelating Agents|chelating agents|mesh-ancestor
92199849|NCT01905423|Sequestering Agents|sequestering agents|mesh-ancestor
92199850|NCT01905423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199851|NCT01905423|Anthelmintics|anthelmintics|mesh-ancestor
92199852|NCT01905423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92199853|NCT01905423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199854|NCT01905423|Anticestodal Agents|anticestodal agents|mesh-ancestor
92199855|NCT01905423|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92199856|NCT01905423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92199857|NCT01905423|Tubulin Modulators|tubulin modulators|mesh-ancestor
92199858|NCT01905423|Antimitotic Agents|antimitotic agents|mesh-ancestor
92199859|NCT01905423|Mitosis Modulators|mitosis modulators|mesh-ancestor
92199860|NCT01905423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199861|NCT01905423|Filaricides|filaricides|mesh-ancestor
92199862|NCT01905423|Antinematodal Agents|antinematodal agents|mesh-ancestor
92199863|NCT01905423|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92199864|NCT01905423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199865|NCT05734911|Niraparib|niraparib|mesh-list
92199866|NCT05734911|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92199867|NCT05734911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199868|NCT05734911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199870|NCT01906515|Chrysarobin|chrysarobin|mesh-list
92199871|NCT01906515|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92199872|NCT01906515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199873|NCT01906515|Analgesics|analgesics|mesh-ancestor
92199874|NCT01906515|Sensory System Agents|sensory system agents|mesh-ancestor
92199875|NCT01906515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199876|NCT01906515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199877|NCT01906515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199878|NCT01906515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92199879|NCT00730483|Doxorubicin|doxorubicin|mesh-list
92199880|NCT00730483|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92199881|NCT00730483|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92199882|NCT00730483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199883|NCT00730483|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92199884|NCT00730483|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92199885|NCT00730483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199886|NCT00730483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199887|NCT01907607|Palbociclib|palbociclib|mesh-list
92199888|NCT01907607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199889|NCT01907607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199890|NCT01907607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199891|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199892|NCT00753337|Cobalt|cobalt|mesh-list
92199893|NCT00753337|Trace Elements|trace elements|mesh-ancestor
92199894|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
92199895|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199896|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
92199897|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92199898|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
92199899|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
92199900|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199901|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199902|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92199903|NCT01911351|Analgesics|analgesics|mesh-ancestor
92199904|NCT01911351|Sensory System Agents|sensory system agents|mesh-ancestor
92199905|NCT01911351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199906|NCT04385407|Ribavirin|ribavirin|mesh-list
92199907|NCT04385407|Sofosbuvir|sofosbuvir|mesh-list
92199908|NCT04385407|Simeprevir|simeprevir|mesh-list
92199909|NCT04385407|Antimetabolites|antimetabolites|mesh-ancestor
92199910|NCT04385407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199911|NCT04385407|Antiviral Agents|antiviral agents|mesh-ancestor
92199912|NCT04385407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199913|NCT04385407|Protease Inhibitors|protease inhibitors|mesh-ancestor
92199914|NCT04385407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199915|NCT00573989|Pemetrexed|pemetrexed|mesh-list
92199916|NCT00573989|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92199917|NCT00573989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199918|NCT00573989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92199919|NCT00573989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199920|NCT00573989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92199921|NCT00573989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92199922|NCT00573989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92199923|NCT02286921|Methyltestosterone|methyltestosterone|mesh-list
92199924|NCT02286921|Testosterone|testosterone|mesh-list
92199925|NCT02286921|Testosterone undecanoate|testosterone undecanoate|mesh-list
92199926|NCT02286921|Testosterone enanthate|testosterone enanthate|mesh-list
92199927|NCT02286921|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92199928|NCT02286921|Androgens|androgens|mesh-ancestor
92199929|NCT02286921|Hormones|hormones|mesh-ancestor
92199930|NCT02286921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199931|NCT02286921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199932|NCT02286921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92199933|NCT02286921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199934|NCT02286921|Anabolic Agents|anabolic agents|mesh-ancestor
92199935|NCT00574067|Buprenorphine|buprenorphine|mesh-list
92199936|NCT00574067|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92199937|NCT00574067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92199938|NCT00574067|Narcotics|narcotics|mesh-ancestor
92199939|NCT00574067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199940|NCT00574067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199941|NCT00574067|Analgesics|analgesics|mesh-ancestor
92199942|NCT00574067|Sensory System Agents|sensory system agents|mesh-ancestor
92199944|NCT00574067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92199945|NCT05734443|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92199946|NCT05734443|Luteolytic Agents|luteolytic agents|mesh-ancestor
92199947|NCT05734443|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92199948|NCT05734443|Contraceptive Agents|contraceptive agents|mesh-ancestor
92199949|NCT05734443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92199950|NCT05734443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199951|NCT05734443|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92199952|NCT05734443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92199953|NCT05734443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199954|NCT01913535|Aticaprant|aticaprant|mesh-list
92199955|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92199956|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199957|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
92199958|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199959|NCT01914159|Ranibizumab|ranibizumab|mesh-list
92199960|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92199961|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92199962|NCT01914159|Growth Substances|growth substances|mesh-ancestor
92199963|NCT01914159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199964|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
92199965|NCT01914159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199966|NCT00576251|Tobramycin|tobramycin|mesh-list
92199967|NCT00576251|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92199968|NCT00576251|Dexamethasone|dexamethasone|mesh-list
92199969|NCT00576251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92199970|NCT00576251|Antiemetics|antiemetics|mesh-ancestor
92199971|NCT00576251|Autonomic Agents|autonomic agents|mesh-ancestor
92199972|NCT00576251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92199973|NCT00576251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199974|NCT00576251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92199975|NCT00576251|Glucocorticoids|glucocorticoids|mesh-ancestor
92199976|NCT00576251|Hormones|hormones|mesh-ancestor
92199977|NCT00576251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92199978|NCT00576251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92199979|NCT00576251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92199980|NCT00576251|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92199981|NCT00576251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199982|NCT00576251|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92199983|NCT00576251|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92199984|NCT00578279|Ethanol|ethanol|mesh-list
92199985|NCT00578279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92199986|NCT00578279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92199987|NCT00578279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92199988|NCT00578279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199989|NCT00578669|Fluoxetine|fluoxetine|mesh-list
92199990|NCT00578669|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92199991|NCT00578669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92199992|NCT00578669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92199993|NCT00578669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92199994|NCT00578669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92199995|NCT00578669|Serotonin Agents|serotonin agents|mesh-ancestor
92199996|NCT00578669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92199997|NCT00578669|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92199998|NCT00578669|Antidepressive Agents|antidepressive agents|mesh-ancestor
92199999|NCT00578669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92200000|NCT00578669|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92200001|NCT00578669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92200002|NCT00578669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200003|NCT00578903|Cyclophosphamide|cyclophosphamide|mesh-list
92200004|NCT00578903|Methotrexate|methotrexate|mesh-list
92200005|NCT00578903|Alemtuzumab|alemtuzumab|mesh-list
92200007|NCT00578903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200008|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
92200009|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200010|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200011|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200012|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
92200013|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200014|NCT00578903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200015|NCT00578903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92200016|NCT00578903|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92200017|NCT00578903|Abortifacient Agents|abortifacient agents|mesh-ancestor
92200018|NCT00578903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92200019|NCT00578903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92200020|NCT00578903|Antimetabolites|antimetabolites|mesh-ancestor
92200021|NCT00578903|Dermatologic Agents|dermatologic agents|mesh-ancestor
92200022|NCT00578903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200023|NCT00578903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92200024|NCT00578903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92200025|NCT00578903|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92200026|NCT00578903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200027|NCT01918761|Pemetrexed|pemetrexed|mesh-list
92200028|NCT01918761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200029|NCT01918761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200030|NCT01918761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200031|NCT01918761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92200032|NCT01918761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92200033|NCT00579137|Fludarabine|fludarabine|mesh-list
92200034|NCT00579137|Alemtuzumab|alemtuzumab|mesh-list
92200035|NCT00579137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200036|NCT00579137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200037|NCT00580073|Leucovorin|leucovorin|mesh-list
92200038|NCT00580073|Fluorouracil|fluorouracil|mesh-list
92200039|NCT00580073|Oxaliplatin|oxaliplatin|mesh-list
92200041|NCT00580073|Antimetabolites|antimetabolites|mesh-ancestor
92200042|NCT00580073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200043|NCT00580073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92200044|NCT00580073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200045|NCT00580073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200047|NCT00580073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200048|NCT00580073|Antidotes|antidotes|mesh-ancestor
92200049|NCT00580073|Protective Agents|protective agents|mesh-ancestor
92200051|NCT00580073|Vitamins|vitamins|mesh-ancestor
92200052|NCT00580073|Micronutrients|micronutrients|mesh-ancestor
92200053|NCT00580073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200055|NCT00580151|Analgesics|analgesics|mesh-ancestor
92200056|NCT00580151|Sensory System Agents|sensory system agents|mesh-ancestor
92200057|NCT00580151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200058|NCT00580151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200059|NCT00580151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92200060|NCT00580151|Sympatholytics|sympatholytics|mesh-ancestor
92200061|NCT00580151|Autonomic Agents|autonomic agents|mesh-ancestor
92200062|NCT00580151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92200063|NCT00580151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92200064|NCT00580151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92200065|NCT00580151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200067|NCT00580151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200068|NCT01919697|Plecanatide|plecanatide|mesh-list
92200069|NCT01919697|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92200070|NCT01919697|Enzyme Activators|enzyme activators|mesh-ancestor
92200071|NCT01919697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200072|NCT01919697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200073|NCT00580229|Prednisone|prednisone|mesh-list
92200074|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200075|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
92200076|NCT00580229|Hormones|hormones|mesh-ancestor
92322338|NCT00000506|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92322339|NCT00000506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92322340|NCT00000506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322341|NCT00000506|Serotonin Agents|serotonin agents|mesh-ancestor
92322343|NCT00000512|Nicotinic Acids|nicotinic acids|mesh-list
92322344|NCT00000512|Lovastatin|lovastatin|mesh-list
92322345|NCT00000512|L 647318|l 647318|mesh-list
92322346|NCT00000512|Dihydromevinolin|dihydromevinolin|mesh-list
92322347|NCT00000512|Colestipol|colestipol|mesh-list
92322348|NCT00000512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92322349|NCT00000512|Antimetabolites|antimetabolites|mesh-ancestor
92322350|NCT00000512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322351|NCT00000512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92408647|NCT05962957|Dopamine Agents|dopamine agents|mesh-ancestor
92322352|NCT00000512|Vasodilator Agents|vasodilator agents|mesh-ancestor
92322354|NCT00000512|Vitamins|vitamins|mesh-ancestor
92322355|NCT00000512|Micronutrients|micronutrients|mesh-ancestor
92322356|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322357|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92322358|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92322359|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322360|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
92322361|NCT00380822|Miglitol|miglitol|mesh-list
92322362|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200077|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200078|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200079|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200080|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200081|NCT00580853|Bupropion|bupropion|mesh-list
92200082|NCT00580853|Varenicline|varenicline|mesh-list
92200083|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92200084|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
92200085|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92200087|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92200088|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200089|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200090|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
92200091|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200093|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92200094|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92200095|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335549|NCT04731558|Enoxaparin|enoxaparin|mesh-list
92200096|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92200097|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92200098|NCT00580853|Cholinergic Agents|cholinergic agents|mesh-ancestor
92200100|NCT05739045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200101|NCT05739045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200102|NCT05739045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92200103|NCT05739045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200105|NCT00604019|Norepinephrine|norepinephrine|mesh-list
92200106|NCT00604019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92200107|NCT00604019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92200108|NCT00604019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200109|NCT00604019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200110|NCT00604019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200111|NCT00604019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200112|NCT00604019|Sympathomimetics|sympathomimetics|mesh-ancestor
92200113|NCT00604019|Autonomic Agents|autonomic agents|mesh-ancestor
92200114|NCT00604019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200115|NCT00604019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92200116|NCT00604019|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92200117|NCT00604019|Dopamine Agents|dopamine agents|mesh-ancestor
92200118|NCT00604019|Protective Agents|protective agents|mesh-ancestor
92200119|NCT01922115|Trospium chloride|trospium chloride|mesh-list
92200120|NCT01922115|Parasympatholytics|parasympatholytics|mesh-ancestor
92200121|NCT01922115|Autonomic Agents|autonomic agents|mesh-ancestor
92200122|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200123|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200124|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92200125|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92200126|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
92200127|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200128|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200129|NCT01922115|Urological Agents|urological agents|mesh-ancestor
92200131|NCT00081770|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92200132|NCT00081770|Interferon-alpha|interferon-alpha|mesh-list
92200133|NCT00081770|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92200134|NCT00081770|Antimetabolites|antimetabolites|mesh-ancestor
92200135|NCT00081770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200136|NCT00081770|Antiviral Agents|antiviral agents|mesh-ancestor
92200137|NCT00081770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200138|NCT00081770|Immunologic Factors|immunologic factors|mesh-ancestor
92200139|NCT00081770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200140|NCT05731323|Cycloserine|cycloserine|mesh-list
92200141|NCT05731323|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92200142|NCT05731323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200143|NCT05731323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92200144|NCT05731323|Antitubercular Agents|antitubercular agents|mesh-ancestor
92200145|NCT05731323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92200146|NCT05731323|Antimetabolites|antimetabolites|mesh-ancestor
92200147|NCT05731323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200148|NCT00605423|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92200149|NCT00605423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200150|NCT00605423|Glucocorticoids|glucocorticoids|mesh-ancestor
92200151|NCT00605423|Hormones|hormones|mesh-ancestor
92200152|NCT00605423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200153|NCT00605423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200155|NCT01923129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92200156|NCT01923129|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92200157|NCT01923129|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92200158|NCT01923129|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92200159|NCT01923129|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200160|NCT01923129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200161|NCT01923129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200162|NCT01923129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200163|NCT00581867|Insulin|insulin|mesh-list
92200164|NCT00581867|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92200165|NCT00581867|Insulin Aspart|insulin aspart|mesh-list
92200166|NCT00581867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92200167|NCT00581867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200168|NCT01925469|Benzocaine|benzocaine|mesh-list
92200169|NCT01925469|Anesthetics, Local|anesthetics, local|mesh-ancestor
92200171|NCT01925469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200172|NCT01925469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200173|NCT01925469|Sensory System Agents|sensory system agents|mesh-ancestor
92200174|NCT01925469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200176|NCT01925781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92200178|NCT01925781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200179|NCT01925781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200180|NCT01925781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92081541|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92200181|NCT01925781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92200182|NCT01925781|Cholinergic Agents|cholinergic agents|mesh-ancestor
92200183|NCT01925781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200184|NCT01925781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200185|NCT01927887|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92200186|NCT01927887|Hematinics|hematinics|mesh-ancestor
92200187|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92200188|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92200189|NCT00081458|Teduglutide|teduglutide|mesh-list
92200190|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200191|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92200192|NCT00081458|Protective Agents|protective agents|mesh-ancestor
92200193|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200196|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
92200197|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200198|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200199|NCT00610727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200200|NCT00610727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92200201|NCT00610727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92200202|NCT00610727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200203|NCT00610727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92200204|NCT00610727|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92200205|NCT00610727|Dopamine Agents|dopamine agents|mesh-ancestor
92200206|NCT00610727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200207|NCT00610727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200208|NCT01929291|Vaccines|vaccines|mesh-list
92200209|NCT01929291|Immunologic Factors|immunologic factors|mesh-ancestor
92200210|NCT01929291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200211|NCT01929759|Tenofovir|tenofovir|mesh-list
92200212|NCT01929759|Emtricitabine|emtricitabine|mesh-list
92200213|NCT01929759|Cobicistat|cobicistat|mesh-list
92322363|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322364|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92322365|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322366|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92322367|NCT00000542|Amlodipine|amlodipine|mesh-list
92322368|NCT00000542|Lisinopril|lisinopril|mesh-list
92322369|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
92322370|NCT00000542|Doxazosin|doxazosin|mesh-list
92322371|NCT00000542|Pravastatin|pravastatin|mesh-list
92322372|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92322373|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92322374|NCT00000542|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92322375|NCT00000542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322376|NCT00000542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322377|NCT00000542|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92322378|NCT00000542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322379|NCT00000542|Vasodilator Agents|vasodilator agents|mesh-ancestor
92322380|NCT00000542|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92322381|NCT00000542|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92322382|NCT00000542|Antimetabolites|antimetabolites|mesh-ancestor
92322383|NCT00000542|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92322384|NCT00000542|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92322385|NCT00000542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322386|NCT00000542|Protease Inhibitors|protease inhibitors|mesh-ancestor
92322387|NCT00000542|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92322388|NCT00000542|Protective Agents|protective agents|mesh-ancestor
92322389|NCT00000542|Diuretics|diuretics|mesh-ancestor
92322390|NCT00000542|Natriuretic Agents|natriuretic agents|mesh-ancestor
92322391|NCT00000542|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92322392|NCT00000542|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92322393|NCT00000542|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92322394|NCT00000542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92322395|NCT00000542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92322396|NCT00000542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322397|NCT00002120|Leucovorin|leucovorin|mesh-list
92322398|NCT00002120|Trimethoprim|trimethoprim|mesh-list
92322399|NCT00002120|Dapsone|dapsone|mesh-list
92322400|NCT00002120|Sulfamethoxazole|sulfamethoxazole|mesh-list
92322401|NCT00002120|Trimetrexate|trimetrexate|mesh-list
92322402|NCT00002120|Calcium|calcium|mesh-list
92322403|NCT00002120|Levoleucovorin|levoleucovorin|mesh-list
92322404|NCT00002120|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92322405|NCT00002120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322407|NCT00002120|Protective Agents|protective agents|mesh-ancestor
92322408|NCT00002120|Vitamin B Complex|vitamin b complex|mesh-ancestor
92322410|NCT00002120|Micronutrients|micronutrients|mesh-ancestor
92322411|NCT00002120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92322412|NCT00002120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322413|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
92322414|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92322415|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92322416|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92322417|NCT00002120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322418|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322419|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92322420|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92322421|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322423|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92322424|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
92322425|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92322426|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
92322427|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322428|NCT00002126|Lenograstim|lenograstim|mesh-list
92322429|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92322430|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
92322431|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322432|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92322433|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92322434|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322435|NCT03189433|Dantrolene|dantrolene|mesh-list
92322436|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92322437|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322438|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92322439|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322440|NCT00002132|Itraconazole|itraconazole|mesh-list
92322441|NCT00002132|Fluconazole|fluconazole|mesh-list
92322442|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
92322443|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322444|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92322445|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322446|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322447|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322448|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92322449|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327635|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91919452|NCT02581202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322450|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322451|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322452|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92322453|NCT00002132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92322454|NCT00002132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92322455|NCT00002144|Foscarnet|foscarnet|mesh-list
92322456|NCT00002144|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92322457|NCT00002144|Antiviral Agents|antiviral agents|mesh-ancestor
92322458|NCT00002144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322459|NCT00002144|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322460|NCT00002144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322461|NCT00002144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322462|NCT00002144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322463|NCT00000578|Beclomethasone|beclomethasone|mesh-list
92322464|NCT00000578|Theophylline|theophylline|mesh-list
92322465|NCT00000578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92322466|NCT00000578|Glucocorticoids|glucocorticoids|mesh-ancestor
92322467|NCT00000578|Hormones|hormones|mesh-ancestor
92322468|NCT00000578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322469|NCT00000578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322470|NCT00000578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92322471|NCT00000578|Respiratory System Agents|respiratory system agents|mesh-ancestor
92322472|NCT00000578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92322473|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
92322474|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322475|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92322476|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322477|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322478|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
92322479|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92322480|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92322481|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
92322482|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322483|NCT03774745|Mifepristone|mifepristone|mesh-list
92322484|NCT03774745|Progesterone|progesterone|mesh-list
92322485|NCT03774745|Progestins|progestins|mesh-ancestor
92322487|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322488|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322489|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92322490|NCT03774745|Abortifacient Agents|abortifacient agents|mesh-ancestor
92322491|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92322492|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92322494|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92322495|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
92322496|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92322497|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92322498|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
92322499|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
92322500|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92322501|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92322502|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
92322503|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92322504|NCT00000584|Antibodies|antibodies|mesh-list
92322505|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
92322506|NCT00000584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322507|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
92322508|NCT00000590|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92322509|NCT00000590|Antibodies|antibodies|mesh-list
92322510|NCT00000590|Immunologic Factors|immunologic factors|mesh-ancestor
92322511|NCT00000590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322512|NCT00000614|Warfarin|warfarin|mesh-list
92322513|NCT00000614|Anticoagulants|anticoagulants|mesh-ancestor
92322514|NCT02973464|Valganciclovir|valganciclovir|mesh-list
92322515|NCT02973464|Ganciclovir|ganciclovir|mesh-list
92322516|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92322517|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
92322518|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322519|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322520|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322521|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322522|NCT00000626|Doxorubicin|doxorubicin|mesh-list
92322523|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92322526|NCT00000626|Vinblastine|vinblastine|mesh-list
92322527|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92322528|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322529|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92322530|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92322531|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322532|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322533|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92322534|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
92322535|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92322536|NCT00000626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92322537|NCT00000626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92322538|NCT00000626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92322539|NCT03109873|Metformin|metformin|mesh-list
92322540|NCT03109873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92322541|NCT03109873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322542|NCT04713254|Metoprolol|metoprolol|mesh-list
92322543|NCT04713254|Midazolam|midazolam|mesh-list
92322544|NCT04713254|Bupropion|bupropion|mesh-list
92322545|NCT04713254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92322546|NCT04713254|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92322547|NCT04713254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92322548|NCT04713254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322549|NCT04713254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92322550|NCT04713254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92322551|NCT04713254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92322552|NCT04713254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92322553|NCT04713254|Anesthetics, General|anesthetics, general|mesh-ancestor
92322555|NCT04713254|GABA Modulators|gaba modulators|mesh-ancestor
92322556|NCT04713254|GABA Agents|gaba agents|mesh-ancestor
92322557|NCT04713254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322558|NCT04713254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322559|NCT04713254|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92322560|NCT04713254|Antidepressive Agents|antidepressive agents|mesh-ancestor
92322561|NCT04713254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92322562|NCT04713254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92322563|NCT04713254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322565|NCT04713254|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92322566|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322567|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322568|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92322569|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92322570|NCT04713254|Sympatholytics|sympatholytics|mesh-ancestor
92322571|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
92322572|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322573|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92322574|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92322575|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92322577|NCT00002156|Ganciclovir|ganciclovir|mesh-list
92200214|NCT01929759|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92200217|NCT01929759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200218|NCT01929759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92200219|NCT01929759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92200220|NCT01929759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200221|NCT01929759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200222|NCT01929759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92200223|NCT01929759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92200224|NCT01929759|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92200225|NCT01929759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92200226|NCT01929759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92200228|NCT03437330|Empagliflozin|empagliflozin|mesh-list
92200229|NCT03437330|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92200230|NCT03437330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200231|NCT03437330|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92200232|NCT03437330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200233|NCT01271803|Vemurafenib|vemurafenib|mesh-list
92200234|NCT01271803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200235|NCT01271803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92200236|NCT01271803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322578|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92200237|NCT01271803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200238|NCT00585377|Bevacizumab|bevacizumab|mesh-list
92200239|NCT00585377|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92200240|NCT00585377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200241|NCT00585377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200242|NCT00585377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92200243|NCT00585377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92200244|NCT00585377|Growth Substances|growth substances|mesh-ancestor
92200245|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200246|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
92200247|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92200248|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200249|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200250|NCT00080288|Modafinil|modafinil|mesh-list
92200251|NCT00080288|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92200252|NCT00080288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200253|NCT00080288|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92200254|NCT00080288|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92200255|NCT00080288|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92200256|NCT00080288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200257|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
92200258|NCT00610883|Methotrexate|methotrexate|mesh-list
92200259|NCT00610883|Asparaginase|asparaginase|mesh-list
92200260|NCT00610883|Daunorubicin|daunorubicin|mesh-list
92200261|NCT00610883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200262|NCT00610883|Immunologic Factors|immunologic factors|mesh-ancestor
92200263|NCT00610883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200264|NCT00610883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200265|NCT00610883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200266|NCT00610883|Alkylating Agents|alkylating agents|mesh-ancestor
92200267|NCT00610883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200268|NCT00610883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200269|NCT00610883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92200270|NCT00610883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92200271|NCT00610883|Abortifacient Agents|abortifacient agents|mesh-ancestor
92200272|NCT00610883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92200273|NCT00610883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92200275|NCT00610883|Dermatologic Agents|dermatologic agents|mesh-ancestor
92200276|NCT00610883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200277|NCT00610883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92200278|NCT00610883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92200279|NCT00610883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92200280|NCT00610883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92200281|NCT00610883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92200283|NCT03084380|Fludarabine|fludarabine|mesh-list
92200284|NCT03084380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200285|NCT03084380|Immunologic Factors|immunologic factors|mesh-ancestor
92200286|NCT03084380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200287|NCT03084380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200288|NCT03084380|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200289|NCT03084380|Alkylating Agents|alkylating agents|mesh-ancestor
92200290|NCT03084380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200291|NCT03084380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200292|NCT03084380|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92200293|NCT00084344|Afimoxifene|afimoxifene|mesh-list
92200294|NCT00084344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200295|NCT00084344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92200296|NCT00084344|Hormone Antagonists|hormone antagonists|mesh-ancestor
92200297|NCT00084344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200298|NCT00084344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200299|NCT00084344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92200300|NCT00084344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92200301|NCT00611351|Mycophenolic Acid|mycophenolic acid|mesh-list
92200302|NCT00611351|Cyclophosphamide|cyclophosphamide|mesh-list
92200303|NCT00611351|Busulfan|busulfan|mesh-list
92200304|NCT00611351|Tacrolimus|tacrolimus|mesh-list
92200305|NCT00611351|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92200306|NCT00611351|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200307|NCT00611351|Immunologic Factors|immunologic factors|mesh-ancestor
92200308|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200309|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200310|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200311|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
92200312|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200313|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200314|NCT00611351|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92200315|NCT00611351|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92200316|NCT00611351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200317|NCT00611351|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92200318|NCT00611351|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92200319|NCT00611351|Antitubercular Agents|antitubercular agents|mesh-ancestor
92200320|NCT00611351|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92200321|NCT00611351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200322|NCT00611897|Acetylcysteine|acetylcysteine|mesh-list
92200323|NCT00611897|Ketamine|ketamine|mesh-list
92200324|NCT00611897|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92200325|NCT00611897|Analgesics|analgesics|mesh-ancestor
92200326|NCT00611897|Sensory System Agents|sensory system agents|mesh-ancestor
92200327|NCT00611897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200328|NCT00611897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200329|NCT00611897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92200330|NCT00611897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92200331|NCT00611897|Anesthetics, General|anesthetics, general|mesh-ancestor
92200332|NCT00611897|Anesthetics|anesthetics|mesh-ancestor
92200333|NCT00611897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200334|NCT00611897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92200335|NCT00611897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92200336|NCT00611897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200337|NCT00611897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200338|NCT00611897|Antiviral Agents|antiviral agents|mesh-ancestor
92200339|NCT00611897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200340|NCT00611897|Expectorants|expectorants|mesh-ancestor
92200341|NCT00611897|Respiratory System Agents|respiratory system agents|mesh-ancestor
92200342|NCT00611897|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92200343|NCT00611897|Antioxidants|antioxidants|mesh-ancestor
92200344|NCT00611897|Protective Agents|protective agents|mesh-ancestor
92200345|NCT00611897|Antidotes|antidotes|mesh-ancestor
92200346|NCT05711823|Dexamethasone|dexamethasone|mesh-list
92200347|NCT05711823|Dexamethasone acetate|dexamethasone acetate|mesh-list
92200348|NCT05711823|Aprepitant|aprepitant|mesh-list
92200349|NCT05711823|Granisetron|granisetron|mesh-list
92200350|NCT05711823|BB 1101|bb 1101|mesh-list
92200351|NCT05711823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200352|NCT05711823|Antiemetics|antiemetics|mesh-ancestor
92200353|NCT05711823|Autonomic Agents|autonomic agents|mesh-ancestor
92200354|NCT05711823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200355|NCT05711823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200356|NCT05711823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200357|NCT05711823|Glucocorticoids|glucocorticoids|mesh-ancestor
92200358|NCT05711823|Hormones|hormones|mesh-ancestor
92200359|NCT05711823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200360|NCT05711823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200361|NCT05711823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200362|NCT05711823|Protease Inhibitors|protease inhibitors|mesh-ancestor
92200363|NCT05711823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200364|NCT05711823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200365|NCT05711823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92335622|NCT04730856|Anticoagulants|anticoagulants|mesh-ancestor
92200366|NCT05711823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200367|NCT05711823|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92200368|NCT05711823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92200369|NCT05711823|Serotonin Agents|serotonin agents|mesh-ancestor
92200370|NCT03080324|Fentanyl|fentanyl|mesh-list
92200371|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92200372|NCT03080324|Narcotics|narcotics|mesh-ancestor
92200373|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200374|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200375|NCT03080324|Analgesics|analgesics|mesh-ancestor
92200376|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
92200377|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200378|NCT03080324|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92200379|NCT03080324|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92200380|NCT03080324|Anesthetics, General|anesthetics, general|mesh-ancestor
92200381|NCT03080324|Anesthetics|anesthetics|mesh-ancestor
92200382|NCT03083834|Cosyntropin|cosyntropin|mesh-list
92200383|NCT03083834|Hormones|hormones|mesh-ancestor
92200384|NCT03083834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200385|NCT03083834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200386|NCT03404180|Dexmedetomidine|dexmedetomidine|mesh-list
92200387|NCT03404180|Propofol|propofol|mesh-list
91940035|NCT00730639|Nivolumab|nivolumab|mesh-list
92200388|NCT03404180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92200389|NCT03404180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200390|NCT03404180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200391|NCT03404180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92200392|NCT03404180|Analgesics|analgesics|mesh-ancestor
92200393|NCT03404180|Sensory System Agents|sensory system agents|mesh-ancestor
92200394|NCT03404180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200395|NCT03404180|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92200396|NCT03404180|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92200397|NCT03404180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92200398|NCT03404180|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200399|NCT03404180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322582|NCT00002156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92200400|NCT03404180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200401|NCT03404180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92200403|NCT03404180|Anesthetics|anesthetics|mesh-ancestor
92200404|NCT02780609|Dexamethasone|dexamethasone|mesh-list
92200405|NCT02780609|Melphalan|melphalan|mesh-list
92200407|NCT02780609|Aprepitant|aprepitant|mesh-list
92200408|NCT02780609|Antiemetics|antiemetics|mesh-list
92200409|NCT02780609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92322583|NCT00002156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200411|NCT02780609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200412|NCT02780609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200413|NCT02780609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200415|NCT02780609|Hormones|hormones|mesh-ancestor
92200416|NCT02780609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200417|NCT02780609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200418|NCT02780609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200419|NCT02780609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200420|NCT02780609|Alkylating Agents|alkylating agents|mesh-ancestor
92200421|NCT02780609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200422|NCT02780609|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92200423|NCT02780609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200424|NCT02780609|Immunologic Factors|immunologic factors|mesh-ancestor
92200425|NCT02780609|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92200426|NCT02780609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200427|NCT03086096|Irinotecan|irinotecan|mesh-list
92200428|NCT03086096|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92200429|NCT03086096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92200431|NCT03086096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200432|NCT03086096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200433|NCT03402152|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92200434|NCT03402152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92200435|NCT03402152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92200436|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200437|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200438|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92200439|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92200440|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92200441|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92200442|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200443|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200444|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200445|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92200446|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92200448|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92200449|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92200450|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
92200452|NCT05346146|Gemcitabine|gemcitabine|mesh-list
92200453|NCT05346146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92200454|NCT05346146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200456|NCT05346146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92200457|NCT05346146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92200458|NCT05346146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200475|NCT01271725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92200476|NCT01271725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200477|NCT01271725|Tubulin Modulators|tubulin modulators|mesh-ancestor
92200478|NCT01271725|Antimitotic Agents|antimitotic agents|mesh-ancestor
92200479|NCT01271725|Mitosis Modulators|mitosis modulators|mesh-ancestor
92200480|NCT01271725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200481|NCT01271725|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92200482|NCT01271725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200484|NCT00587483|Amiodarone|amiodarone|mesh-list
92200486|NCT00587483|Anesthetics|anesthetics|mesh-ancestor
92200487|NCT00587483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200488|NCT00587483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200489|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
92200490|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200491|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92200492|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92200493|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92200494|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200495|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200496|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
92200497|NCT00587483|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92200498|NCT00587483|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91912432|NCT02088671|Desflurane|desflurane|mesh-list
92200506|NCT03401060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200507|NCT01270321|Everolimus|everolimus|mesh-list
92200508|NCT01270321|Pasireotide|pasireotide|mesh-list
91912731|NCT02090933|Analgesics|analgesics|mesh-ancestor
92200510|NCT01270321|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91912878|NCT00358163|Paclitaxel|paclitaxel|mesh-list
92200511|NCT01270321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913027|NCT02099357|Vitamins|vitamins|mesh-ancestor
92200513|NCT01270321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200514|NCT01270321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91913861|NCT02607800|Sofosbuvir|sofosbuvir|mesh-list
92200515|NCT01270321|Immunologic Factors|immunologic factors|mesh-ancestor
91913928|NCT04847024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92200516|NCT01270321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914076|NCT02429193|Prednisone|prednisone|mesh-list
92200517|NCT01270321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914378|NCT04842968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914468|NCT03185871|Celecoxib|celecoxib|mesh-list
91914602|NCT02426697|Analgesics|analgesics|mesh-ancestor
91914755|NCT04770272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914829|NCT02426229|Anticoagulants|anticoagulants|mesh-ancestor
91915204|NCT02604212|Tenofovir|tenofovir|mesh-list
91915281|NCT02789111|Alvimopan|alvimopan|mesh-list
91915428|NCT02123381|Cetuximab|cetuximab|mesh-list
91915499|NCT02124317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91915574|NCT02118311|Immunologic Factors|immunologic factors|mesh-ancestor
92200519|NCT01270321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915797|NCT04797338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915945|NCT02128685|Hormones|hormones|mesh-ancestor
91916095|NCT02136875|Autonomic Agents|autonomic agents|mesh-ancestor
92200521|NCT03400826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91916355|NCT03962114|Niacin|niacin|mesh-list
92200522|NCT03400826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92200523|NCT03400826|Antimetabolites|antimetabolites|mesh-ancestor
91916471|NCT04792034|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92200524|NCT03400826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916543|NCT02783729|GABA Agonists|gaba agonists|mesh-ancestor
92200525|NCT03400826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92200526|NCT03400826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91917073|NCT05611268|Pentoxifylline|pentoxifylline|mesh-list
92200527|NCT03400826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200528|NCT01271023|Insulin|insulin|mesh-list
92200529|NCT01271023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92200530|NCT01271023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200531|NCT03086486|Linezolid|linezolid|mesh-list
92200532|NCT03086486|Bedaquiline|bedaquiline|mesh-list
92200533|NCT03086486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92200534|NCT03086486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200535|NCT03086486|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92200536|NCT03086486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200537|NCT03086486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200538|NCT03086486|Antitubercular Agents|antitubercular agents|mesh-ancestor
92200539|NCT02287779|Volixibat|volixibat|mesh-list
92200540|NCT02287779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91917751|NCT05546060|Hormones|hormones|mesh-ancestor
91918278|NCT04425824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200542|NCT00732901|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91918446|NCT02417337|Ibuprofen|ibuprofen|mesh-list
91918510|NCT02164825|Morphine|morphine|mesh-list
92200543|NCT00732901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92200544|NCT00732901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117126|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92200545|NCT00732901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200546|NCT00732901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200547|NCT00732901|Serotonin Agents|serotonin agents|mesh-ancestor
91918953|NCT02401425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919026|NCT03169413|Adenosine|adenosine|mesh-list
92200549|NCT03083210|Lanreotide|lanreotide|mesh-list
91919331|NCT02757625|Analgesics|analgesics|mesh-ancestor
92200550|NCT03083210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919786|NCT02176213|Hormones|hormones|mesh-ancestor
92200551|NCT00616109|Sunitinib|sunitinib|mesh-list
91920072|NCT05532254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92200552|NCT00616109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200553|NCT00616109|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92200554|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92200555|NCT00616109|Growth Substances|growth substances|mesh-ancestor
92200556|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200557|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
91920158|NCT04099355|Hormones|hormones|mesh-ancestor
91920305|NCT02179567|Bevacizumab|bevacizumab|mesh-list
92200558|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920382|NCT02179645|Celecoxib|celecoxib|mesh-list
92200559|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920592|NCT05526794|Analgesics|analgesics|mesh-list
91920739|NCT02180425|Adapalene|adapalene|mesh-list
91920813|NCT05520944|Histamine Agents|histamine agents|mesh-ancestor
91920883|NCT02184247|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91920960|NCT02184637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91921188|NCT04766996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200560|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921641|NCT05502068|Vitamin D|vitamin d|mesh-list
91921711|NCT02195089|Vaccines|vaccines|mesh-list
91921860|NCT02206555|Antiviral Agents|antiviral agents|mesh-ancestor
91922317|NCT02220829|Silodosin|silodosin|mesh-list
91922391|NCT02205931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91922392|NCT02205931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922393|NCT02205931|GABA Agents|gaba agents|mesh-ancestor
91922394|NCT02205931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922395|NCT02205931|Antimanic Agents|antimanic agents|mesh-ancestor
91922468|NCT05503706|Trace Elements|trace elements|mesh-ancestor
91922619|NCT02231281|Protease Inhibitors|protease inhibitors|mesh-ancestor
92200561|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92200562|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
92200563|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200564|NCT00249769|Vaccines|vaccines|mesh-list
92200565|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
92200566|NCT00249769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200567|NCT03434678|Fentanyl|fentanyl|mesh-list
92200568|NCT03434678|Bupivacaine|bupivacaine|mesh-list
92200569|NCT03434678|Propofol|propofol|mesh-list
92200570|NCT03434678|Rocuronium|rocuronium|mesh-list
92200571|NCT03434678|Anesthetics, Local|anesthetics, local|mesh-ancestor
91923123|NCT03167385|Apatinib|apatinib|mesh-list
91923199|NCT02146547|Aripiprazole|aripiprazole|mesh-list
91923435|NCT03699956|Etoposide|etoposide|mesh-list
92200573|NCT03434678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923499|NCT03106389|Oxytocics|oxytocics|mesh-ancestor
91923645|NCT02224105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92200574|NCT03434678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923942|NCT03659929|Dopamine Agents|dopamine agents|mesh-ancestor
92200575|NCT03434678|Sensory System Agents|sensory system agents|mesh-ancestor
92200576|NCT03434678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924244|NCT04300244|Nivolumab|nivolumab|mesh-list
92200577|NCT03434678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92200578|NCT03434678|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92200579|NCT03434678|Anesthetics, General|anesthetics, general|mesh-ancestor
92200580|NCT03434678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92200581|NCT03434678|Narcotics|narcotics|mesh-ancestor
92200582|NCT03434678|Analgesics|analgesics|mesh-ancestor
92200583|NCT03434678|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92200584|NCT03434678|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91924693|NCT02233777|Pregabalin|pregabalin|mesh-list
92200585|NCT03434678|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91924985|NCT01474135|Travoprost|travoprost|mesh-list
92200586|NCT03434678|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91925138|NCT02853500|Doxorubicin|doxorubicin|mesh-list
92200588|NCT05445921|Anesthetics, Local|anesthetics, local|mesh-ancestor
91925431|NCT02151305|Remifentanil|remifentanil|mesh-list
92200589|NCT05445921|Anesthetics|anesthetics|mesh-ancestor
91925582|NCT02269969|Tobramycin|tobramycin|mesh-list
92200590|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925735|NCT05014581|Sympathomimetics|sympathomimetics|mesh-ancestor
91925893|NCT02441660|Capsaicin|capsaicin|mesh-list
91926186|NCT03542825|Chelating Agents|chelating agents|mesh-ancestor
92200591|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926565|NCT02159027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92200592|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
91927616|NCT00629551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200593|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200596|NCT03389750|Oxycodone|oxycodone|mesh-list
91927915|NCT00485563|Hematinics|hematinics|mesh-ancestor
91928142|NCT05309421|Pembrolizumab|pembrolizumab|mesh-list
92200597|NCT03389750|Hydromorphone|hydromorphone|mesh-list
91928216|NCT02741713|Anesthetics|anesthetics|mesh-ancestor
92200598|NCT03389750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92200599|NCT03389750|Narcotics|narcotics|mesh-ancestor
92200600|NCT03389750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200601|NCT03389750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200602|NCT03389750|Analgesics|analgesics|mesh-ancestor
92200603|NCT03389750|Sensory System Agents|sensory system agents|mesh-ancestor
92200604|NCT03389750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200605|NCT03389750|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92200606|NCT03837873|Cytarabine|cytarabine|mesh-list
92200607|NCT03837873|Dexamethasone|dexamethasone|mesh-list
92200609|NCT03837873|Rituximab|rituximab|mesh-list
92200610|NCT03837873|Doxorubicin|doxorubicin|mesh-list
92200611|NCT03837873|Etoposide|etoposide|mesh-list
92200612|NCT03837873|Vincristine|vincristine|mesh-list
92200613|NCT03837873|Lenalidomide|lenalidomide|mesh-list
91929622|NCT02389179|Vitamin D|vitamin d|mesh-list
92200614|NCT03837873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92200615|NCT03837873|Immunologic Factors|immunologic factors|mesh-ancestor
92200616|NCT03837873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200617|NCT03837873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200618|NCT03837873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92200619|NCT03837873|Alkylating Agents|alkylating agents|mesh-ancestor
91930442|NCT02198027|Bupivacaine|bupivacaine|mesh-list
91930664|NCT02368197|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930741|NCT03105765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92200620|NCT03837873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931038|NCT05790941|Vasodilator Agents|vasodilator agents|mesh-ancestor
92200621|NCT03837873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931261|NCT05316831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931262|NCT05308056|Anesthetics|anesthetics|mesh-list
91931263|NCT05308056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931488|NCT04352777|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91931635|NCT03363763|Sirolimus|sirolimus|mesh-list
92200622|NCT03837873|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91932240|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
91932469|NCT04467931|Metoprolol|metoprolol|mesh-list
92200623|NCT03837873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932564|NCT04467931|Antioxidants|antioxidants|mesh-ancestor
92200624|NCT03837873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200625|NCT03837873|Antiemetics|antiemetics|mesh-ancestor
92200626|NCT03837873|Autonomic Agents|autonomic agents|mesh-ancestor
91933226|NCT02294617|Nicotine|nicotine|mesh-list
92200627|NCT03837873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933447|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
92200628|NCT03837873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200629|NCT03837873|Glucocorticoids|glucocorticoids|mesh-ancestor
92200631|NCT03837873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200632|NCT03837873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200633|NCT03837873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92200634|NCT03837873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92200635|NCT03837873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92200636|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200637|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92335655|NCT02111850|Alkylating Agents|alkylating agents|mesh-ancestor
92200638|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92200639|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
92200640|NCT03837873|Antiviral Agents|antiviral agents|mesh-ancestor
92200641|NCT03837873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200642|NCT03837873|Tubulin Modulators|tubulin modulators|mesh-ancestor
92200643|NCT03837873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92200644|NCT03837873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92200645|NCT03837873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92200646|NCT03837873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92200647|NCT03837873|Growth Substances|growth substances|mesh-ancestor
92200648|NCT03837873|Growth Inhibitors|growth inhibitors|mesh-ancestor
92200649|NCT03082742|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92200650|NCT03082742|Furosemide|furosemide|mesh-list
92200651|NCT03082742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92200652|NCT03082742|Diuretics|diuretics|mesh-ancestor
92200653|NCT03082742|Natriuretic Agents|natriuretic agents|mesh-ancestor
92200654|NCT03082742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200655|NCT03082742|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92200656|NCT03082742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200657|NCT03082742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200658|NCT03082742|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92200659|NCT05434533|Tranexamic Acid|tranexamic acid|mesh-list
92200660|NCT05434533|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92200661|NCT05434533|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92200662|NCT05434533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200664|NCT05434533|Coagulants|coagulants|mesh-ancestor
92200665|NCT03432650|Dexamethasone|dexamethasone|mesh-list
92200666|NCT03432650|Bupivacaine|bupivacaine|mesh-list
92200667|NCT03432650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200668|NCT03432650|Antiemetics|antiemetics|mesh-ancestor
92200669|NCT03432650|Autonomic Agents|autonomic agents|mesh-ancestor
92200670|NCT03432650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200671|NCT03432650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200672|NCT03432650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200673|NCT03432650|Glucocorticoids|glucocorticoids|mesh-ancestor
92200674|NCT03432650|Hormones|hormones|mesh-ancestor
92200675|NCT03432650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200676|NCT03432650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200677|NCT03432650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200678|NCT03432650|Anesthetics, Local|anesthetics, local|mesh-ancestor
92200679|NCT03432650|Anesthetics|anesthetics|mesh-ancestor
92200680|NCT03432650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200681|NCT03432650|Sensory System Agents|sensory system agents|mesh-ancestor
92200682|NCT00248833|Vaccines|vaccines|mesh-list
92200683|NCT00248833|Immunologic Factors|immunologic factors|mesh-ancestor
92200684|NCT00248833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200685|NCT00668525|Dexetimide|dexetimide|mesh-list
92200686|NCT00668525|Citalopram|citalopram|mesh-list
92200687|NCT00668525|Escitalopram|escitalopram|mesh-list
92200688|NCT00668525|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92200689|NCT00668525|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92200690|NCT00668525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200691|NCT00668525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200692|NCT00668525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200693|NCT00668525|Serotonin Agents|serotonin agents|mesh-ancestor
92200694|NCT00668525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200695|NCT00668525|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92200696|NCT00668525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92200697|NCT00668525|Parasympatholytics|parasympatholytics|mesh-ancestor
92200698|NCT00668525|Autonomic Agents|autonomic agents|mesh-ancestor
92200699|NCT00668525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200700|NCT00668525|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92200701|NCT00668525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92200702|NCT00668525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92200703|NCT00668525|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92200704|NCT00668525|Antidepressive Agents|antidepressive agents|mesh-ancestor
92200706|NCT05736549|Dexamethasone|dexamethasone|mesh-list
92200707|NCT05736549|Methylprednisolone|methylprednisolone|mesh-list
92200708|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92200709|NCT05736549|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92200710|NCT05736549|Prednisolone|prednisolone|mesh-list
92200711|NCT05736549|Prednisolone acetate|prednisolone acetate|mesh-list
92200712|NCT05736549|Dexamethasone acetate|dexamethasone acetate|mesh-list
92200713|NCT05736549|Bupivacaine|bupivacaine|mesh-list
92200714|NCT05736549|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92200715|NCT05736549|Prednisolone phosphate|prednisolone phosphate|mesh-list
92200716|NCT05736549|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92200717|NCT05736549|BB 1101|bb 1101|mesh-list
92200718|NCT05736549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200719|NCT05736549|Antiemetics|antiemetics|mesh-ancestor
92200720|NCT05736549|Autonomic Agents|autonomic agents|mesh-ancestor
92200721|NCT05736549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200722|NCT05736549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200723|NCT05736549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200724|NCT05736549|Glucocorticoids|glucocorticoids|mesh-ancestor
92200725|NCT05736549|Hormones|hormones|mesh-ancestor
92200726|NCT05736549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200727|NCT05736549|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200728|NCT05736549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200729|NCT05736549|Anesthetics, Local|anesthetics, local|mesh-ancestor
92200730|NCT05736549|Anesthetics|anesthetics|mesh-ancestor
92200731|NCT05736549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200732|NCT05736549|Sensory System Agents|sensory system agents|mesh-ancestor
92200733|NCT05736549|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92200734|NCT05736549|Protective Agents|protective agents|mesh-ancestor
92200735|NCT05736549|Protease Inhibitors|protease inhibitors|mesh-ancestor
92200736|NCT05736549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200737|NCT05736549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200738|NCT05688488|Curcumin|curcumin|mesh-list
92200739|NCT05688488|Mitomycins|mitomycins|mesh-list
92200740|NCT05688488|Mitomycin|mitomycin|mesh-list
92200741|NCT05688488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92200742|NCT05688488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200743|NCT05688488|Alkylating Agents|alkylating agents|mesh-ancestor
92200744|NCT05688488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200745|NCT05688488|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92200746|NCT05688488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200747|NCT05688488|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92200748|NCT05688488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92200749|NCT05688488|Analgesics|analgesics|mesh-ancestor
92200750|NCT05688488|Sensory System Agents|sensory system agents|mesh-ancestor
92200751|NCT05688488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200752|NCT05688488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200753|NCT05688488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200754|NCT05688488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200755|NCT00669383|Betamethasone|betamethasone|mesh-list
92200756|NCT00669383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200757|NCT00669383|Glucocorticoids|glucocorticoids|mesh-ancestor
92200758|NCT00669383|Hormones|hormones|mesh-ancestor
92200759|NCT00669383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200760|NCT00669383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200761|NCT00669383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92200762|NCT00669383|Respiratory System Agents|respiratory system agents|mesh-ancestor
92200763|NCT00733993|Caffeine|caffeine|mesh-list
92200764|NCT00733993|Amphetamine|amphetamine|mesh-list
92200765|NCT00733993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92200766|NCT00733993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200767|NCT00733993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92200768|NCT00733993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200769|NCT00733993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200770|NCT00733993|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92200771|NCT00733993|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92200772|NCT00733993|Purinergic Agents|purinergic agents|mesh-ancestor
92200773|NCT00733993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200774|NCT00733993|Sympathomimetics|sympathomimetics|mesh-ancestor
92200775|NCT00733993|Autonomic Agents|autonomic agents|mesh-ancestor
92200776|NCT00733993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200777|NCT00733993|Dopamine Agents|dopamine agents|mesh-ancestor
92200778|NCT00733993|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200779|NCT00733993|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92200780|NCT00733993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92200781|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200782|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92200783|NCT01271257|Misoprostol|misoprostol|mesh-list
92200784|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92200785|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
92200786|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92200787|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200788|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92200789|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200790|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
92200791|NCT03082352|Metoprolol|metoprolol|mesh-list
92200792|NCT03082352|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92200793|NCT03082352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92200794|NCT03082352|Sympatholytics|sympatholytics|mesh-ancestor
92200795|NCT03082352|Autonomic Agents|autonomic agents|mesh-ancestor
92200796|NCT03082352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200797|NCT03082352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200798|NCT03082352|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92200799|NCT03082352|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92200800|NCT03082352|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92200801|NCT03082352|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200802|NCT03082352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200803|NCT03082352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200804|NCT03431168|Azithromycin|azithromycin|mesh-list
92200805|NCT03431168|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92200806|NCT03431168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92200807|NCT03431168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200808|NCT03431168|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92200809|NCT03431168|Antimalarials|antimalarials|mesh-ancestor
92200810|NCT03431168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92200812|NCT05737563|Capecitabine|capecitabine|mesh-list
92200813|NCT05737563|Irinotecan|irinotecan|mesh-list
92200814|NCT05737563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92200815|NCT05737563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92200816|NCT05737563|Antimetabolites|antimetabolites|mesh-ancestor
92200817|NCT05737563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200818|NCT05737563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200819|NCT05737563|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92200820|NCT05737563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92200821|NCT05737563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200822|NCT05737563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200823|NCT03398252|Doxazosin|doxazosin|mesh-list
92200824|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92200825|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92200826|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92200827|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92200828|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200829|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200830|NCT03398252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200831|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200833|NCT02285283|Antifungal Agents|antifungal agents|mesh-ancestor
92200834|NCT02285283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200835|NCT02285283|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92200836|NCT02285283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92200837|NCT02285283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200838|NCT02285283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200839|NCT02285283|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92200841|NCT02285283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200842|NCT02285283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200843|NCT02285283|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92200845|NCT05688098|Irbesartan|irbesartan|mesh-list
92200846|NCT05688098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92200847|NCT05688098|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92200848|NCT05688098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92200849|NCT05688098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200850|NCT05688098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92200851|NCT05688098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200852|NCT05688098|Vasodilator Agents|vasodilator agents|mesh-ancestor
92200853|NCT05688098|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92200854|NCT05688098|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92200855|NCT03429140|Hyaluronic Acid|hyaluronic acid|mesh-list
92200856|NCT03429140|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92200857|NCT03429140|Immunologic Factors|immunologic factors|mesh-ancestor
92200858|NCT03429140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200859|NCT03429140|Viscosupplements|viscosupplements|mesh-ancestor
92200860|NCT03429140|Protective Agents|protective agents|mesh-ancestor
92200861|NCT03081494|Spartalizumab|spartalizumab|mesh-list
92200862|NCT03081494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92200863|NCT03081494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200864|NCT03081494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92200865|NCT03081494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200866|NCT03081728|Acetaminophen|acetaminophen|mesh-list
92200867|NCT03081728|Diclofenac|diclofenac|mesh-list
92200868|NCT03081728|Ropivacaine|ropivacaine|mesh-list
92200869|NCT03081728|Anesthetics, Local|anesthetics, local|mesh-ancestor
92200870|NCT03081728|Anesthetics|anesthetics|mesh-ancestor
92200871|NCT03081728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200872|NCT03081728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200873|NCT03081728|Sensory System Agents|sensory system agents|mesh-ancestor
92200874|NCT03081728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200875|NCT03081728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92200876|NCT03081728|Analgesics|analgesics|mesh-ancestor
92200877|NCT03081728|Antipyretics|antipyretics|mesh-ancestor
92200878|NCT03081728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92200879|NCT03081728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200880|NCT03081728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200881|NCT03081728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92200882|NCT03081728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200883|NCT03081728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200884|NCT05651217|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92200885|NCT05651217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92200886|NCT05688020|Epinephrine|epinephrine|mesh-list
92200887|NCT05688020|Tranexamic Acid|tranexamic acid|mesh-list
92200888|NCT05688020|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92200889|NCT05688020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92200890|NCT05688020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200891|NCT05688020|Hemostatics|hemostatics|mesh-ancestor
92200892|NCT05688020|Coagulants|coagulants|mesh-ancestor
92200893|NCT05688020|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92200894|NCT05688020|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92200895|NCT05688020|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200896|NCT05688020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200897|NCT05688020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200898|NCT05688020|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92200899|NCT05688020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92200900|NCT05688020|Autonomic Agents|autonomic agents|mesh-ancestor
92200901|NCT05688020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335681|NCT02084082|Metformin|metformin|mesh-list
92200902|NCT05688020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92200903|NCT05688020|Respiratory System Agents|respiratory system agents|mesh-ancestor
92200905|NCT05688020|Sympathomimetics|sympathomimetics|mesh-ancestor
92200906|NCT05688020|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92200907|NCT00618917|Manganese|manganese|mesh-list
92200908|NCT00618917|Paclitaxel|paclitaxel|mesh-list
92200909|NCT00618917|Carboplatin|carboplatin|mesh-list
92200910|NCT00618917|Superoxide Dismutase|superoxide dismutase|mesh-list
92200911|NCT00618917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92200912|NCT00618917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200913|NCT00618917|Tubulin Modulators|tubulin modulators|mesh-ancestor
92200914|NCT00618917|Antimitotic Agents|antimitotic agents|mesh-ancestor
92200915|NCT00618917|Mitosis Modulators|mitosis modulators|mesh-ancestor
92200916|NCT00618917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200917|NCT00618917|Trace Elements|trace elements|mesh-ancestor
92200918|NCT00618917|Micronutrients|micronutrients|mesh-ancestor
92200919|NCT00618917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200921|NCT00618917|Antioxidants|antioxidants|mesh-ancestor
92200922|NCT00618917|Protective Agents|protective agents|mesh-ancestor
92200923|NCT05736081|Dexamethasone|dexamethasone|mesh-list
92200924|NCT05736081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200925|NCT05736081|Antiemetics|antiemetics|mesh-ancestor
92200926|NCT05736081|Autonomic Agents|autonomic agents|mesh-ancestor
92200927|NCT05736081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200928|NCT05736081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200929|NCT05736081|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92200930|NCT05736081|Glucocorticoids|glucocorticoids|mesh-ancestor
92200931|NCT05736081|Hormones|hormones|mesh-ancestor
92200932|NCT05736081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200933|NCT05736081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92200934|NCT05736081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92200935|NCT00619073|Aspirin|aspirin|mesh-list
92200936|NCT00619073|Clopidogrel|clopidogrel|mesh-list
92200937|NCT00619073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92200938|NCT00619073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92200939|NCT00619073|Analgesics|analgesics|mesh-ancestor
92200940|NCT00619073|Sensory System Agents|sensory system agents|mesh-ancestor
92200941|NCT00619073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92200942|NCT00619073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200943|NCT00619073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200944|NCT00619073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92200945|NCT00619073|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92200946|NCT00619073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92200947|NCT00619073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200948|NCT00619073|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92200949|NCT00619073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92200950|NCT00619073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200951|NCT00619073|Antipyretics|antipyretics|mesh-ancestor
92200952|NCT00619073|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92200953|NCT00619073|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92200954|NCT00619073|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92200955|NCT00619073|Purinergic Agents|purinergic agents|mesh-ancestor
92200956|NCT00619073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92200957|NCT00670241|Betamethasone|betamethasone|mesh-list
92200958|NCT00670241|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
92200959|NCT00670241|Calcipotriene|calcipotriene|mesh-list
92200960|NCT00670241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92200961|NCT00670241|Glucocorticoids|glucocorticoids|mesh-ancestor
92200963|NCT00670241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92200964|NCT00670241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200965|NCT00670241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92200966|NCT00670241|Respiratory System Agents|respiratory system agents|mesh-ancestor
92200967|NCT00670241|Dermatologic Agents|dermatologic agents|mesh-ancestor
92200968|NCT03088670|Metformin|metformin|mesh-list
92200969|NCT03088670|Vildagliptin|vildagliptin|mesh-list
92200970|NCT03088670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92200971|NCT03088670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200972|NCT03088670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92200973|NCT03088670|Protease Inhibitors|protease inhibitors|mesh-ancestor
92200974|NCT03088670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92200975|NCT03088670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200976|NCT03088358|Enoxaparin|enoxaparin|mesh-list
92200977|NCT03088358|Anticoagulants|anticoagulants|mesh-ancestor
92200978|NCT03088358|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92200979|NCT03088358|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92200980|NCT03088358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200981|NCT03396068|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92200982|NCT03396068|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92200983|NCT03396068|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92200984|NCT03396068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92200985|NCT03396068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92200986|NCT03396068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92200987|NCT03396068|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92200988|NCT03396068|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92200989|NCT03396068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92200990|NCT03396068|Adrenergic Agents|adrenergic agents|mesh-ancestor
92200991|NCT03396068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933905|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92200992|NCT03396068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92200993|NCT03396068|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92200994|NCT03396068|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92200996|NCT03396068|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92200997|NCT03396068|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92200998|NCT03396068|Dopamine Agents|dopamine agents|mesh-ancestor
92200999|NCT00620945|Phenoxybenzamine|phenoxybenzamine|mesh-list
92201000|NCT00620945|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92201001|NCT00620945|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92201002|NCT00620945|Adrenergic Agents|adrenergic agents|mesh-ancestor
92201003|NCT00620945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201004|NCT00620945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201005|NCT00620945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201006|NCT00620945|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92201007|NCT00620945|Vasodilator Agents|vasodilator agents|mesh-ancestor
92201008|NCT00621179|Leuprolide|leuprolide|mesh-list
92201009|NCT00621179|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92201010|NCT00621179|Fertility Agents|fertility agents|mesh-ancestor
92201011|NCT00621179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92201012|NCT00621179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201013|NCT00621179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92201014|NCT00621179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201015|NCT00247273|Risedronic Acid|risedronic acid|mesh-list
92201016|NCT00247273|Etidronic Acid|etidronic acid|mesh-list
92201017|NCT00247273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92201018|NCT00247273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201019|NCT00247273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201020|NCT00247273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92201021|NCT00247273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201022|NCT00247273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92201023|NCT05056233|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92201024|NCT05056233|Lubricant Eye Drops|lubricant eye drops|mesh-list
92201025|NCT05056233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92201026|NCT03382106|Sildenafil Citrate|sildenafil citrate|mesh-list
92201027|NCT03382106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92201028|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92201029|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92201031|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201032|NCT03382106|Urological Agents|urological agents|mesh-ancestor
92201033|NCT00622895|Mycophenolic Acid|mycophenolic acid|mesh-list
92201034|NCT00622895|Fludarabine|fludarabine|mesh-list
92201035|NCT00622895|Fludarabine phosphate|fludarabine phosphate|mesh-list
92201036|NCT00622895|Tacrolimus|tacrolimus|mesh-list
92201037|NCT00622895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201038|NCT00622895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201039|NCT00622895|Antimetabolites|antimetabolites|mesh-ancestor
92201040|NCT00622895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201041|NCT00622895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201042|NCT00622895|Immunologic Factors|immunologic factors|mesh-ancestor
92201043|NCT00622895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201044|NCT00622895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92201045|NCT00622895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201046|NCT00622895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201047|NCT00622895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92201048|NCT00622895|Antitubercular Agents|antitubercular agents|mesh-ancestor
92201049|NCT00622895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92201050|NCT00622895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201052|NCT00672737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92201053|NCT00672737|Narcotics|narcotics|mesh-ancestor
92201054|NCT00672737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201055|NCT00672737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201056|NCT00672737|Analgesics|analgesics|mesh-ancestor
92201057|NCT00672737|Sensory System Agents|sensory system agents|mesh-ancestor
92201058|NCT00672737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201059|NCT00673127|Ketoconazole|ketoconazole|mesh-list
92201060|NCT00673127|Hydrocortisone|hydrocortisone|mesh-list
92201061|NCT00673127|Dutasteride|dutasteride|mesh-list
92201062|NCT00673127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201063|NCT00673127|Antifungal Agents|antifungal agents|mesh-ancestor
92201064|NCT00673127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201065|NCT00673127|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92201066|NCT00673127|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92201067|NCT00673127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201068|NCT00673127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201069|NCT00673127|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92201070|NCT00673127|Hormone Antagonists|hormone antagonists|mesh-ancestor
92201071|NCT00673127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201072|NCT00673127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201073|NCT00673127|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92201074|NCT00673127|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92201075|NCT00246259|Risperidone|risperidone|mesh-list
92201076|NCT00246259|Antipsychotic Agents|antipsychotic agents|mesh-list
92201077|NCT00246259|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92201078|NCT00246259|Serotonin Agents|serotonin agents|mesh-ancestor
92201079|NCT00246259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201080|NCT00246259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201081|NCT00246259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201082|NCT00246259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92201083|NCT00246259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201084|NCT00246259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201085|NCT00246259|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92201086|NCT00246259|Dopamine Agents|dopamine agents|mesh-ancestor
92201087|NCT00673439|PENTA|penta|mesh-list
92201088|NCT00673439|Warfarin|warfarin|mesh-list
92201089|NCT00673439|Fondaparinux|fondaparinux|mesh-list
92201090|NCT00673439|Anticoagulants|anticoagulants|mesh-ancestor
92201091|NCT00673439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92201092|NCT00673439|Antithrombins|antithrombins|mesh-ancestor
92201093|NCT00673439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92201094|NCT00673439|Protease Inhibitors|protease inhibitors|mesh-ancestor
92201095|NCT00673439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201096|NCT00673439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201097|NCT00673439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92201098|NCT00673439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92201099|NCT03316118|Bupivacaine|bupivacaine|mesh-list
92201100|NCT03316118|Anesthetics, Local|anesthetics, local|mesh-ancestor
92201101|NCT03316118|Anesthetics|anesthetics|mesh-ancestor
92201102|NCT03316118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201103|NCT03316118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201104|NCT03316118|Sensory System Agents|sensory system agents|mesh-ancestor
92201105|NCT03316118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201107|NCT03029013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201108|NCT03029013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201109|NCT03029013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201110|NCT03029013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201111|NCT00674219|Memantine|memantine|mesh-list
92201112|NCT00674219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92201113|NCT00674219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92201114|NCT00674219|Dopamine Agents|dopamine agents|mesh-ancestor
92201115|NCT00674219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201116|NCT00674219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201117|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201118|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92201119|NCT00674219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92201120|NCT00246025|Dabigatran|dabigatran|mesh-list
92201121|NCT00246025|Antithrombins|antithrombins|mesh-ancestor
92201122|NCT00246025|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92201123|NCT00246025|Protease Inhibitors|protease inhibitors|mesh-ancestor
92201124|NCT00246025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201125|NCT00246025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201126|NCT00246025|Anticoagulants|anticoagulants|mesh-ancestor
92201127|NCT03311594|Ethanol|ethanol|mesh-list
92201128|NCT03311594|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92201129|NCT03311594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201130|NCT03311594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201131|NCT03311594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201132|NCT05069051|Belimumab|belimumab|mesh-list
92201133|NCT05069051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201134|NCT05069051|Immunologic Factors|immunologic factors|mesh-ancestor
92201135|NCT05069051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201136|NCT00624923|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92201137|NCT00624923|Sodium Salicylate|sodium salicylate|mesh-list
92201138|NCT00624923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92201139|NCT00624923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92201140|NCT00624923|Analgesics|analgesics|mesh-ancestor
92201141|NCT00624923|Sensory System Agents|sensory system agents|mesh-ancestor
92201142|NCT00624923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201143|NCT00624923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201144|NCT00624923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201145|NCT00624923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92201146|NCT00624923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92201147|NCT00624923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201148|NCT00624923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201149|NCT05593653|Suvorexant|suvorexant|mesh-list
92201150|NCT05593653|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92201151|NCT05593653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92201152|NCT05593653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201153|NCT05593653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201154|NCT05593653|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92201155|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201156|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201157|NCT04954287|Vaccines|vaccines|mesh-list
92201158|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
92201159|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201160|NCT00735787|Adalimumab|adalimumab|mesh-list
92201161|NCT00735787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92201162|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201163|NCT00735787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92201164|NCT00628589|Loxapine|loxapine|mesh-list
92201165|NCT00628589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92201166|NCT00628589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92201167|NCT00628589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201168|NCT00628589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201169|NCT00628589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201170|NCT00628589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92201171|NCT00628589|Dopamine Agents|dopamine agents|mesh-ancestor
92201172|NCT00628589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335721|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
92201173|NCT00628589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201174|NCT03375242|Crizotinib|crizotinib|mesh-list
92201175|NCT03375242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201176|NCT03375242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201177|NCT03375242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201178|NCT03375242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201179|NCT01271569|Fospropofol|fospropofol|mesh-list
92201180|NCT01271569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92201181|NCT01271569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201182|NCT01271569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201183|NCT05686772|Dopamine|dopamine|mesh-list
92201184|NCT05686772|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92201185|NCT05686772|Sympathomimetics|sympathomimetics|mesh-ancestor
92201186|NCT05686772|Autonomic Agents|autonomic agents|mesh-ancestor
92201187|NCT05686772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201188|NCT05686772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201189|NCT05686772|Dopamine Agents|dopamine agents|mesh-ancestor
92201190|NCT05686772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201191|NCT05686772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201192|NCT05686772|Protective Agents|protective agents|mesh-ancestor
92201194|NCT04771871|Cyclophosphamide|cyclophosphamide|mesh-list
92201195|NCT04771871|Carboplatin|carboplatin|mesh-list
92201196|NCT04771871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92201197|NCT04771871|Epirubicin|epirubicin|mesh-list
92201198|NCT04771871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92201199|NCT04771871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201200|NCT04771871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92201201|NCT04771871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92201202|NCT04771871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92201203|NCT04771871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201204|NCT04771871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201205|NCT04771871|Immunologic Factors|immunologic factors|mesh-ancestor
92201206|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201207|NCT04771871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92201208|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201209|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
92201210|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92201211|NCT04771871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201212|NCT04771871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92201213|NCT04771871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92201214|NCT04771871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201215|NCT04386577|Vitamin D|vitamin d|mesh-list
92201216|NCT04386577|Cholecalciferol|cholecalciferol|mesh-list
92201217|NCT04386577|Vitamins|vitamins|mesh-ancestor
92201218|NCT04386577|Micronutrients|micronutrients|mesh-ancestor
92201219|NCT04386577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201220|NCT04386577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92201221|NCT04386577|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92201222|NCT04270669|RC28-E protein|rc28-e protein|mesh-list
92201223|NCT04270669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92201224|NCT04270669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92201225|NCT04270669|Growth Substances|growth substances|mesh-ancestor
92201226|NCT04270669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201227|NCT04270669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92201228|NCT04270669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201229|NCT05680454|Vaccines|vaccines|mesh-list
92201230|NCT05680454|Immunologic Factors|immunologic factors|mesh-ancestor
92201231|NCT05680454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201232|NCT04928703|Ketamine|ketamine|mesh-list
92201233|NCT04928703|Analgesics|analgesics|mesh-ancestor
92201234|NCT04928703|Sensory System Agents|sensory system agents|mesh-ancestor
92201235|NCT04928703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201236|NCT04928703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201237|NCT04928703|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92201238|NCT04928703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92201239|NCT04928703|Anesthetics, General|anesthetics, general|mesh-ancestor
92201240|NCT04928703|Anesthetics|anesthetics|mesh-ancestor
92201241|NCT04928703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201242|NCT04928703|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92201243|NCT04928703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92201244|NCT04928703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201245|NCT04928703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201246|NCT04278950|Povidone-Iodine|povidone-iodine|mesh-list
92201247|NCT04278950|Povidone|povidone|mesh-list
92201248|NCT04278950|Plasma Substitutes|plasma substitutes|mesh-ancestor
92201249|NCT04278950|Blood Substitutes|blood substitutes|mesh-ancestor
92201250|NCT04278950|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92201251|NCT04278950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201253|NCT00755755|Ulipristal acetate|ulipristal acetate|mesh-list
92201254|NCT00755755|Trace Elements|trace elements|mesh-ancestor
92201255|NCT00755755|Micronutrients|micronutrients|mesh-ancestor
92201256|NCT00755755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201257|NCT00755755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92201258|NCT00755755|Contraceptive Agents|contraceptive agents|mesh-ancestor
92201259|NCT00755755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92201260|NCT00755755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92201262|NCT05686616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92201263|NCT05686616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201264|NCT05686616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92201265|NCT05686616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201266|NCT00674765|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92201267|NCT00674765|Antidepressive Agents|antidepressive agents|mesh-ancestor
92201268|NCT00674765|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201269|NCT00674765|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92201270|NCT00674765|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92201271|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201272|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201273|NCT05567601|Doxorubicin|doxorubicin|mesh-list
92201274|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92201275|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201276|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201277|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92201278|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92201279|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201280|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201281|NCT00755911|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92201282|NCT00755911|Hemostatics|hemostatics|mesh-ancestor
92201283|NCT00755911|Coagulants|coagulants|mesh-ancestor
92201284|NCT00737737|Morphine|morphine|mesh-list
92201285|NCT00737737|Oxycodone|oxycodone|mesh-list
92201286|NCT00737737|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92201288|NCT00737737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201289|NCT00737737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201290|NCT00737737|Analgesics|analgesics|mesh-ancestor
92201291|NCT00737737|Sensory System Agents|sensory system agents|mesh-ancestor
92201292|NCT00737737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201293|NCT05199051|Cytarabine|cytarabine|mesh-list
92201294|NCT05199051|Gemtuzumab|gemtuzumab|mesh-list
92201295|NCT05199051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201296|NCT05199051|Antimetabolites|antimetabolites|mesh-ancestor
92201297|NCT05199051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201298|NCT05199051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201299|NCT05199051|Antiviral Agents|antiviral agents|mesh-ancestor
92201300|NCT05199051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201301|NCT05199051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201302|NCT05199051|Immunologic Factors|immunologic factors|mesh-ancestor
92201303|NCT05199051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201304|NCT05199051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92201305|NCT05199051|Immunotoxins|immunotoxins|mesh-ancestor
92201306|NCT05199051|Immunoconjugates|immunoconjugates|mesh-ancestor
92201307|NCT00245011|Ifosfamide|ifosfamide|mesh-list
92201308|NCT00245011|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92201309|NCT00245011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201310|NCT00245011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201311|NCT00245011|Alkylating Agents|alkylating agents|mesh-ancestor
92201312|NCT00245011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201313|NCT00245011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201314|NCT00245011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92201315|NCT00245011|Analgesics|analgesics|mesh-ancestor
92201316|NCT00245011|Sensory System Agents|sensory system agents|mesh-ancestor
92201317|NCT00245011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201318|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
92201319|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92201320|NCT05539053|Antiviral Agents|antiviral agents|mesh-ancestor
92201321|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201322|NCT05539053|Expectorants|expectorants|mesh-ancestor
92201323|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
92201324|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92201325|NCT05539053|Antioxidants|antioxidants|mesh-ancestor
92201326|NCT05539053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201327|NCT05539053|Protective Agents|protective agents|mesh-ancestor
92201328|NCT05539053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201329|NCT05539053|Antidotes|antidotes|mesh-ancestor
92201330|NCT00629525|Everolimus|everolimus|mesh-list
92201331|NCT00629525|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92201332|NCT00629525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201333|NCT00629525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201334|NCT00629525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201335|NCT00629525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201336|NCT00629525|Immunologic Factors|immunologic factors|mesh-ancestor
92201337|NCT00629525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201338|NCT00629525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201339|NCT00244855|Dexamethasone|dexamethasone|mesh-list
92201340|NCT00244855|Rituximab|rituximab|mesh-list
92201341|NCT00244855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92201342|NCT00244855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201343|NCT00244855|Immunologic Factors|immunologic factors|mesh-ancestor
92201344|NCT00244855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201345|NCT00244855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92201346|NCT00244855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201347|NCT00244855|Antiemetics|antiemetics|mesh-ancestor
92201348|NCT00244855|Autonomic Agents|autonomic agents|mesh-ancestor
92201349|NCT00244855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201350|NCT00244855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92201351|NCT00244855|Glucocorticoids|glucocorticoids|mesh-ancestor
92201352|NCT00244855|Hormones|hormones|mesh-ancestor
92201353|NCT00244855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201354|NCT00244855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92201355|NCT00737893|Epoetin Alfa|epoetin alfa|mesh-list
92201356|NCT00737893|Hematinics|hematinics|mesh-ancestor
92201357|NCT00631319|Hydromorphone|hydromorphone|mesh-list
92201358|NCT00631319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92201359|NCT00631319|Narcotics|narcotics|mesh-ancestor
92201360|NCT00631319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201361|NCT00631319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201362|NCT00631319|Analgesics|analgesics|mesh-ancestor
92335754|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
92201363|NCT00631319|Sensory System Agents|sensory system agents|mesh-ancestor
92201364|NCT00631319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201365|NCT00244621|Candesartan|candesartan|mesh-list
92201366|NCT00244621|Candesartan cilexetil|candesartan cilexetil|mesh-list
92201367|NCT00244621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92201368|NCT00244621|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92201369|NCT00244621|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92201370|NCT00244621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201371|NCT00680225|Ranibizumab|ranibizumab|mesh-list
92201372|NCT00680225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92201373|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92201374|NCT00680225|Growth Substances|growth substances|mesh-ancestor
92201375|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201376|NCT00680225|Growth Inhibitors|growth inhibitors|mesh-ancestor
92201377|NCT00680225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201378|NCT04603391|Cannabidiol|cannabidiol|mesh-list
92201379|NCT04603391|Methylphenidate|methylphenidate|mesh-list
92201380|NCT04603391|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92201381|NCT04603391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201382|NCT04603391|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92201383|NCT04603391|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92201384|NCT04603391|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201385|NCT04603391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201386|NCT04603391|Dopamine Agents|dopamine agents|mesh-ancestor
92201387|NCT04603391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201388|NCT04603391|Anticonvulsants|anticonvulsants|mesh-ancestor
92201389|NCT00738049|Darusentan|darusentan|mesh-list
92201390|NCT00738049|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92201391|NCT00738049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201392|NCT02291133|Bleomycin|bleomycin|mesh-list
92201393|NCT02291133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201394|NCT02291133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201395|NCT00680459|Ethanol|ethanol|mesh-list
92201396|NCT00680459|Heparin|heparin|mesh-list
92201397|NCT00680459|Anticoagulants|anticoagulants|mesh-list
92201398|NCT00680459|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92201399|NCT00680459|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92201400|NCT00680459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201401|NCT00680459|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92201402|NCT00680459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201403|NCT00680459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201404|NCT00680459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201405|NCT00632411|Nicotine|nicotine|mesh-list
92201406|NCT00632411|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92201408|NCT00632411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201409|NCT00632411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201410|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92201411|NCT00632411|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92201412|NCT00632411|Cholinergic Agents|cholinergic agents|mesh-ancestor
92201413|NCT00632411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201414|NCT00632411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201415|NCT05685836|Bevacizumab|bevacizumab|mesh-list
92201416|NCT05685836|89Zr-bevacizumab|89zr-bevacizumab|mesh-list
92201417|NCT05685836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92201418|NCT05685836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201419|NCT05685836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92201420|NCT05685836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92201421|NCT05685836|Growth Substances|growth substances|mesh-ancestor
92201422|NCT05685836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201423|NCT05685836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92201424|NCT05685836|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92201425|NCT05685836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201426|NCT00632489|Capecitabine|capecitabine|mesh-list
92201427|NCT00632489|Lapatinib|lapatinib|mesh-list
92201428|NCT00632489|Panobinostat|panobinostat|mesh-list
92201429|NCT00632489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201430|NCT00632489|Antimetabolites|antimetabolites|mesh-ancestor
92201431|NCT00632489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201432|NCT00632489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201433|NCT00632489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201434|NCT00632489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201435|NCT00632489|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92201436|NCT05096481|Temozolomide|temozolomide|mesh-list
92201437|NCT05096481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201439|NCT05096481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201440|NCT05096481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201441|NCT05074875|Carbon Monoxide|carbon monoxide|mesh-list
92201442|NCT05074875|Antimetabolites|antimetabolites|mesh-ancestor
92201443|NCT05074875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201444|NCT05074875|Gasotransmitters|gasotransmitters|mesh-ancestor
92201445|NCT05074875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201446|NCT05074875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201447|NCT01798979|Midazolam|midazolam|mesh-list
92201448|NCT01798979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92201449|NCT01798979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92201450|NCT01798979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201451|NCT01798979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201452|NCT01798979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92201453|NCT01798979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92201454|NCT01798979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201455|NCT01798979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92201456|NCT01798979|Anesthetics, General|anesthetics, general|mesh-ancestor
92201457|NCT01798979|Anesthetics|anesthetics|mesh-ancestor
92201458|NCT01798979|GABA Modulators|gaba modulators|mesh-ancestor
92201459|NCT01798979|GABA Agents|gaba agents|mesh-ancestor
92201460|NCT01798979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201461|NCT01798979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201462|NCT00738361|Paclitaxel|paclitaxel|mesh-list
92201463|NCT00738361|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92201464|NCT00738361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92201465|NCT00738361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201466|NCT00738361|Tubulin Modulators|tubulin modulators|mesh-ancestor
92201467|NCT00738361|Antimitotic Agents|antimitotic agents|mesh-ancestor
92201468|NCT00738361|Mitosis Modulators|mitosis modulators|mesh-ancestor
92201469|NCT00738361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201470|NCT01279213|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92201471|NCT01279213|Clozapine|clozapine|mesh-list
92201472|NCT01279213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92201473|NCT01279213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92201474|NCT01279213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201475|NCT01279213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201476|NCT01279213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201477|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92201478|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92201479|NCT01279213|Serotonin Agents|serotonin agents|mesh-ancestor
92201480|NCT01279213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201481|NCT01279213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201482|NCT01279213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92201483|NCT01279213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92201484|NCT01279213|Dopamine Agents|dopamine agents|mesh-ancestor
92201485|NCT01279213|GABA Antagonists|gaba antagonists|mesh-ancestor
92201486|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
92201488|NCT00634283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92201489|NCT00634283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92201490|NCT00634283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201491|NCT00634283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201492|NCT00634283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201493|NCT00634283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201494|NCT00634283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92201495|NCT00634283|Antidepressive Agents|antidepressive agents|mesh-ancestor
92201496|NCT00634283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201497|NCT01279291|Paclitaxel|paclitaxel|mesh-list
92201498|NCT01279291|Carboplatin|carboplatin|mesh-list
92201499|NCT01279291|Gemcitabine|gemcitabine|mesh-list
92201500|NCT01279291|Doxorubicin|doxorubicin|mesh-list
92201501|NCT01279291|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92201502|NCT01279291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92201503|NCT01279291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201504|NCT01279291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92201505|NCT01279291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92201506|NCT01279291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92201507|NCT01279291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201508|NCT01279291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201509|NCT01279291|Antimetabolites|antimetabolites|mesh-ancestor
92201510|NCT01279291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201511|NCT01279291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92201512|NCT01279291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92201513|NCT01279291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201514|NCT04367883|Amantadine|amantadine|mesh-list
92201515|NCT04367883|Histamine Antagonists|histamine antagonists|mesh-list
92201516|NCT04367883|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92201517|NCT04367883|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92201518|NCT04367883|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92201519|NCT04367883|Antiviral Agents|antiviral agents|mesh-ancestor
92201520|NCT04367883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201521|NCT04367883|Dopamine Agents|dopamine agents|mesh-ancestor
92201522|NCT04367883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201523|NCT04367883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201524|NCT04367883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201525|NCT04367883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92201526|NCT04367883|Analgesics|analgesics|mesh-ancestor
92201527|NCT04367883|Sensory System Agents|sensory system agents|mesh-ancestor
92201528|NCT04367883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201529|NCT04367883|Histamine Agents|histamine agents|mesh-ancestor
92201530|NCT04329039|Somatostatin|somatostatin|mesh-list
92201531|NCT04329039|Hormones|hormones|mesh-ancestor
92201532|NCT04329039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201533|NCT04329039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201534|NCT00635609|Doxycycline|doxycycline|mesh-list
92201535|NCT00635609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92201536|NCT00635609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201537|NCT00635609|Antimalarials|antimalarials|mesh-ancestor
92201538|NCT00635609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92201539|NCT00635609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92201540|NCT04347902|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92201541|NCT04347902|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92201542|NCT04347902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92201543|NCT03298802|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92201544|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92201545|NCT03298802|Diuretics|diuretics|mesh-ancestor
92201546|NCT03298802|Natriuretic Agents|natriuretic agents|mesh-ancestor
92201547|NCT03298802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201548|NCT03298802|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92201549|NCT03298802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201550|NCT03298802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201551|NCT03066843|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92201552|NCT03066843|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92201553|NCT03066843|Dermatologic Agents|dermatologic agents|mesh-ancestor
92201554|NCT05315336|Antibodies|antibodies|mesh-list
92201555|NCT05315336|Immunologic Factors|immunologic factors|mesh-ancestor
92201556|NCT05315336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201558|NCT04746495|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92201559|NCT04746495|Hormone Antagonists|hormone antagonists|mesh-ancestor
92201560|NCT04746495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201561|NCT04746495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201562|NCT04746495|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92201563|NCT04746495|Diuretics|diuretics|mesh-ancestor
92201564|NCT04746495|Natriuretic Agents|natriuretic agents|mesh-ancestor
92201565|NCT04746495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92201566|NCT03347786|Verapamil|verapamil|mesh-list
92201567|NCT03347786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92201568|NCT03347786|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92201569|NCT03347786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201570|NCT03347786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201571|NCT03347786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92201572|NCT03347786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201573|NCT03347786|Vasodilator Agents|vasodilator agents|mesh-ancestor
92201574|NCT03288974|Pomalidomide|pomalidomide|mesh-list
92201575|NCT03288974|Immunologic Factors|immunologic factors|mesh-ancestor
92201576|NCT03288974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201577|NCT03288974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92201578|NCT03288974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92201579|NCT03288974|Growth Substances|growth substances|mesh-ancestor
92201580|NCT03288974|Growth Inhibitors|growth inhibitors|mesh-ancestor
92201581|NCT03288974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201582|NCT03286634|Cytarabine|cytarabine|mesh-list
92201583|NCT03286634|Prednisolone|prednisolone|mesh-list
92201584|NCT03286634|Hydrocortisone|hydrocortisone|mesh-list
92201585|NCT03286634|Cyclophosphamide|cyclophosphamide|mesh-list
92201586|NCT03286634|Methotrexate|methotrexate|mesh-list
92201587|NCT03286634|Vincristine|vincristine|mesh-list
92201588|NCT03286634|Daunorubicin|daunorubicin|mesh-list
92201589|NCT03286634|Asparaginase|asparaginase|mesh-list
92201590|NCT03286634|Epirubicin|epirubicin|mesh-list
92201591|NCT03286634|Mercaptopurine|mercaptopurine|mesh-list
92201592|NCT03286634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201593|NCT03286634|Immunologic Factors|immunologic factors|mesh-ancestor
92201594|NCT03286634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201595|NCT03286634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92201596|NCT03286634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201597|NCT03286634|Alkylating Agents|alkylating agents|mesh-ancestor
92201598|NCT03286634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201599|NCT03286634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201600|NCT03286634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92201601|NCT03286634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92201602|NCT03286634|Abortifacient Agents|abortifacient agents|mesh-ancestor
92201603|NCT03286634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92201604|NCT03286634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201605|NCT03286634|Antimetabolites|antimetabolites|mesh-ancestor
92201606|NCT03286634|Dermatologic Agents|dermatologic agents|mesh-ancestor
92201607|NCT03286634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201608|NCT03286634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92201609|NCT03286634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92201610|NCT03286634|Antiviral Agents|antiviral agents|mesh-ancestor
92201611|NCT03286634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201612|NCT03286634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92201613|NCT03286634|Tubulin Modulators|tubulin modulators|mesh-ancestor
92201614|NCT03286634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92201615|NCT03286634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92201616|NCT03286634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201617|NCT03286634|Glucocorticoids|glucocorticoids|mesh-ancestor
92201618|NCT03286634|Hormones|hormones|mesh-ancestor
92201619|NCT03286634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201620|NCT03286634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92201621|NCT03286634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201622|NCT03286634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92201623|NCT03286634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92201624|NCT03286556|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92201625|NCT03286556|Autoantibodies|autoantibodies|mesh-list
92201626|NCT03286556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201627|NCT03286556|Immunologic Factors|immunologic factors|mesh-ancestor
92201628|NCT03286556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201629|NCT05000294|Atezolizumab|atezolizumab|mesh-list
92201630|NCT05000294|Tivozanib|tivozanib|mesh-list
92201631|NCT05000294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92201632|NCT05000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201633|NCT05000294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92201634|NCT05000294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201635|NCT05000294|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201636|NCT05000294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201637|NCT00637247|Gemcitabine|gemcitabine|mesh-list
92201638|NCT00637247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201639|NCT00637247|Antimetabolites|antimetabolites|mesh-ancestor
92201640|NCT00637247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201641|NCT00637247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201642|NCT04998032|Metformin|metformin|mesh-list
92201643|NCT04998032|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92201644|NCT04998032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201645|NCT04388033|Temozolomide|temozolomide|mesh-list
92201646|NCT04388033|Interleukin-12|interleukin-12|mesh-list
92201647|NCT04388033|Vaccines|vaccines|mesh-list
92201648|NCT04388033|Immunologic Factors|immunologic factors|mesh-ancestor
92201649|NCT04388033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201650|NCT04388033|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201651|NCT04388033|Alkylating Agents|alkylating agents|mesh-ancestor
92201652|NCT04388033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201653|NCT04388033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201654|NCT04388033|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92201655|NCT04388033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92201656|NCT04388033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92201658|NCT04388033|Growth Inhibitors|growth inhibitors|mesh-ancestor
92201659|NCT03267680|Indomethacin|indomethacin|mesh-list
92201660|NCT03267680|Cyclophosphamide|cyclophosphamide|mesh-list
92201661|NCT03267680|Omeprazole|omeprazole|mesh-list
92201662|NCT03267680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201663|NCT03267680|Immunologic Factors|immunologic factors|mesh-ancestor
92201664|NCT03267680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201665|NCT03267680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92201666|NCT03267680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201667|NCT03267680|Alkylating Agents|alkylating agents|mesh-ancestor
92201668|NCT03267680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201669|NCT03267680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201670|NCT03267680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92201671|NCT03267680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92201672|NCT03267680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92201673|NCT03267680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92201674|NCT03267680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201675|NCT03267680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92201676|NCT03267680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92201677|NCT03267680|Analgesics|analgesics|mesh-ancestor
92201678|NCT03267680|Sensory System Agents|sensory system agents|mesh-ancestor
92201679|NCT03267680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201680|NCT03267680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201681|NCT03267680|Gout Suppressants|gout suppressants|mesh-ancestor
92201682|NCT03267680|Tocolytic Agents|tocolytic agents|mesh-ancestor
92201683|NCT03267680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92201684|NCT03267680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92201685|NCT02980731|Venetoclax|venetoclax|mesh-list
92201686|NCT02980731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201687|NCT05564390|Cytarabine|cytarabine|mesh-list
92201688|NCT05564390|Azacitidine|azacitidine|mesh-list
92201689|NCT05564390|Daunorubicin|daunorubicin|mesh-list
92201690|NCT05564390|Venetoclax|venetoclax|mesh-list
92201691|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201692|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
92201693|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201694|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201695|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
92201696|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201697|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201698|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
92201699|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201700|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201701|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201702|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92201703|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92201705|NCT04725591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92201706|NCT04725591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201708|NCT02980497|Listerine|listerine|mesh-list
92201709|NCT02980497|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92201710|NCT02980497|Sodium Fluoride|sodium fluoride|mesh-list
92201711|NCT02980497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201712|NCT02980497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201713|NCT02980497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201714|NCT02980497|Cariostatic Agents|cariostatic agents|mesh-ancestor
92201715|NCT02980497|Protective Agents|protective agents|mesh-ancestor
92201716|NCT02652429|Nitric Oxide|nitric oxide|mesh-list
92201717|NCT02652429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92201718|NCT02652429|Autonomic Agents|autonomic agents|mesh-ancestor
92201719|NCT02652429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201720|NCT02652429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201721|NCT02652429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92201722|NCT02652429|Respiratory System Agents|respiratory system agents|mesh-ancestor
92201723|NCT02652429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92201724|NCT02652429|Antioxidants|antioxidants|mesh-ancestor
92201725|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201726|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201727|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92201728|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
92201729|NCT02652429|Gasotransmitters|gasotransmitters|mesh-ancestor
92201730|NCT02652429|Protective Agents|protective agents|mesh-ancestor
92201731|NCT02294253|Buprenorphine|buprenorphine|mesh-list
91933911|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
92201732|NCT02294253|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92201733|NCT02294253|Naloxone|naloxone|mesh-list
92201734|NCT02294253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92201735|NCT02294253|Narcotics|narcotics|mesh-ancestor
92201736|NCT02294253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201737|NCT02294253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201738|NCT02294253|Analgesics|analgesics|mesh-ancestor
92201739|NCT02294253|Sensory System Agents|sensory system agents|mesh-ancestor
92201740|NCT02294253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201741|NCT02294253|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92201742|NCT00684983|Capecitabine|capecitabine|mesh-list
92201743|NCT00684983|Lapatinib|lapatinib|mesh-list
92201744|NCT00684983|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92201745|NCT00684983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201746|NCT00684983|Antimetabolites|antimetabolites|mesh-ancestor
92201747|NCT00684983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201748|NCT00684983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201749|NCT00684983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201750|NCT00684983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201751|NCT00684983|Immunologic Factors|immunologic factors|mesh-ancestor
92201752|NCT00684983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201753|NCT03339596|Epoetin Alfa|epoetin alfa|mesh-list
92201754|NCT03339596|Hematinics|hematinics|mesh-ancestor
92201755|NCT00638651|Imiquimod|imiquimod|mesh-list
92201756|NCT00638651|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92201757|NCT00638651|Immunologic Factors|immunologic factors|mesh-ancestor
92201758|NCT00638651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201759|NCT00638651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201760|NCT00638651|Interferon Inducers|interferon inducers|mesh-ancestor
92201761|NCT02584647|Sirolimus|sirolimus|mesh-list
92201762|NCT02584647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92201763|NCT02584647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201764|NCT02584647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92201765|NCT02584647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201766|NCT02584647|Antifungal Agents|antifungal agents|mesh-ancestor
92201767|NCT02584647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201768|NCT02584647|Immunologic Factors|immunologic factors|mesh-ancestor
92201769|NCT02584647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201770|NCT00685139|Zonisamide|zonisamide|mesh-list
92201771|NCT00685139|Anticonvulsants|anticonvulsants|mesh-ancestor
92201772|NCT00685139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92201773|NCT00685139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201774|NCT00685139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201775|NCT00685139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92201776|NCT00685139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201777|NCT00685295|Fentanyl|fentanyl|mesh-list
92201778|NCT00685295|Oxycodone|oxycodone|mesh-list
92201779|NCT00685295|Lansoprazole|lansoprazole|mesh-list
92201780|NCT00685295|Dexlansoprazole|dexlansoprazole|mesh-list
92201781|NCT00685295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92201782|NCT00685295|Narcotics|narcotics|mesh-ancestor
92201783|NCT00685295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201784|NCT00685295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201785|NCT00685295|Analgesics|analgesics|mesh-ancestor
92201786|NCT00685295|Sensory System Agents|sensory system agents|mesh-ancestor
92201787|NCT00685295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201788|NCT00685295|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92201789|NCT00685295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92201790|NCT00685295|Anesthetics, General|anesthetics, general|mesh-ancestor
92201791|NCT00685295|Anesthetics|anesthetics|mesh-ancestor
92201792|NCT00685295|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92201793|NCT00685295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92201794|NCT00685295|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92201795|NCT00685295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201796|NCT00685295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201797|NCT00686231|Lidocaine|lidocaine|mesh-list
92201798|NCT00686231|Nitroglycerin|nitroglycerin|mesh-list
92201799|NCT00686231|Anesthetics, Local|anesthetics, local|mesh-ancestor
92201800|NCT00686231|Anesthetics|anesthetics|mesh-ancestor
92201801|NCT00686231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201802|NCT00686231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201803|NCT00686231|Sensory System Agents|sensory system agents|mesh-ancestor
92201804|NCT00686231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201805|NCT00686231|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92201806|NCT00686231|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92201807|NCT00686231|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92201808|NCT00686231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201809|NCT00686231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201810|NCT00686231|Vasodilator Agents|vasodilator agents|mesh-ancestor
92201811|NCT05278208|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92201812|NCT05278208|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92201813|NCT05278208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201814|NCT03335774|Hydrocortisone|hydrocortisone|mesh-list
92201815|NCT03335774|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92201816|NCT03335774|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92201817|NCT03335774|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92201818|NCT03335774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201819|NCT03335540|Nivolumab|nivolumab|mesh-list
92201820|NCT03335540|Ipilimumab|ipilimumab|mesh-list
92201821|NCT03335540|Relatlimab|relatlimab|mesh-list
92201822|NCT03335540|Linrodostat|linrodostat|mesh-list
92201823|NCT03335540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92201824|NCT03335540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201825|NCT03335540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92201826|NCT03335540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201827|NCT03335540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201828|NCT00643097|Temozolomide|temozolomide|mesh-list
92201829|NCT00643097|Sargramostim|sargramostim|mesh-list
92201830|NCT00643097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92201831|NCT00643097|Alkylating Agents|alkylating agents|mesh-ancestor
92201832|NCT00643097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201833|NCT00643097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201834|NCT00643097|Immunologic Factors|immunologic factors|mesh-ancestor
92201835|NCT00643097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201836|NCT03333668|Guanfacine|guanfacine|mesh-list
92201837|NCT03333668|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92201838|NCT03333668|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92201839|NCT03333668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201840|NCT03333668|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92201841|NCT03333668|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92201842|NCT03333668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201843|NCT03333668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201845|NCT03333668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201846|NCT03333668|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92201847|NCT03333668|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92201848|NCT03333668|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92201849|NCT03333668|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92201850|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
92201851|NCT03280160|Ofatumumab|ofatumumab|mesh-list
92201852|NCT03280160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201853|NCT04683315|Paclitaxel|paclitaxel|mesh-list
92201854|NCT04683315|Gemcitabine|gemcitabine|mesh-list
92201855|NCT04683315|Fluorouracil|fluorouracil|mesh-list
92201856|NCT04683315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92201858|NCT04683315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92201859|NCT04683315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92201860|NCT04683315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92201861|NCT04683315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201862|NCT04683315|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92201863|NCT04683315|Antimetabolites|antimetabolites|mesh-ancestor
92201864|NCT04683315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92201865|NCT04683315|Immunologic Factors|immunologic factors|mesh-ancestor
92201866|NCT04683315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201867|NCT05502146|Norepinephrine|norepinephrine|mesh-list
92201868|NCT05502146|Bupivacaine|bupivacaine|mesh-list
92201869|NCT05502146|Anesthetics, Local|anesthetics, local|mesh-ancestor
92201870|NCT05502146|Anesthetics|anesthetics|mesh-ancestor
92201871|NCT05502146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201872|NCT05502146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201873|NCT05502146|Sensory System Agents|sensory system agents|mesh-ancestor
92201874|NCT05502146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201875|NCT05502146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92201876|NCT05502146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92201877|NCT05502146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92201878|NCT05502146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201879|NCT05502146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201880|NCT05502146|Sympathomimetics|sympathomimetics|mesh-ancestor
92201881|NCT05502146|Autonomic Agents|autonomic agents|mesh-ancestor
92201882|NCT05502146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92201883|NCT04027361|Amphetamine|amphetamine|mesh-list
92201884|NCT04027361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92201885|NCT04027361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201886|NCT04027361|Sympathomimetics|sympathomimetics|mesh-ancestor
92201887|NCT04027361|Autonomic Agents|autonomic agents|mesh-ancestor
92201888|NCT04027361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201889|NCT04027361|Dopamine Agents|dopamine agents|mesh-ancestor
92201890|NCT04027361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201891|NCT04027361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201892|NCT04027361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92201893|NCT04027361|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92201894|NCT04027361|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92201895|NCT04027361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201896|NCT04027361|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92201897|NCT04682847|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92201898|NCT04682847|Hematinics|hematinics|mesh-ancestor
92201899|NCT04682847|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92201900|NCT04682847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92201901|NCT04011839|Levobupivacaine|levobupivacaine|mesh-list
92201902|NCT04011839|Anesthetics, Local|anesthetics, local|mesh-ancestor
92201903|NCT04011839|Anesthetics|anesthetics|mesh-ancestor
92201904|NCT04011839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201905|NCT04011839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201906|NCT04011839|Sensory System Agents|sensory system agents|mesh-ancestor
92201907|NCT04011839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201909|NCT03793439|Tofacitinib|tofacitinib|mesh-list
92201910|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201912|NCT03793439|Hormones|hormones|mesh-ancestor
92201913|NCT03793439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201914|NCT03793439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201915|NCT03793439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92201916|NCT03793439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92201917|NCT03793439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92201918|NCT03793439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92201919|NCT03793439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201920|NCT03793439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201921|NCT00687167|Zonisamide|zonisamide|mesh-list
92201922|NCT00687167|Anticonvulsants|anticonvulsants|mesh-ancestor
92201923|NCT00687167|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92201924|NCT00687167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201925|NCT00687167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201926|NCT00687167|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92201927|NCT00687167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201928|NCT00687713|Bupropion|bupropion|mesh-list
92201929|NCT00687713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92201930|NCT00687713|Antidepressive Agents|antidepressive agents|mesh-ancestor
92201931|NCT00687713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92201932|NCT00687713|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92201933|NCT00687713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92201934|NCT00687713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92201935|NCT00687713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201936|NCT00687713|Dopamine Agents|dopamine agents|mesh-ancestor
92201937|NCT00687713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201938|NCT00687713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201939|NCT00687713|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92201940|NCT00687713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92201941|NCT00687713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201942|NCT02304159|Ribavirin|ribavirin|mesh-list
92201943|NCT02304159|Sofosbuvir|sofosbuvir|mesh-list
92201944|NCT02304159|Antimetabolites|antimetabolites|mesh-ancestor
92201945|NCT02304159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201946|NCT02304159|Antiviral Agents|antiviral agents|mesh-ancestor
92201947|NCT02304159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92201948|NCT02143973|Nalbuphine|nalbuphine|mesh-list
92201949|NCT02143973|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92201951|NCT02143973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92201952|NCT02143973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201953|NCT02143973|Analgesics|analgesics|mesh-ancestor
92201954|NCT02143973|Sensory System Agents|sensory system agents|mesh-ancestor
92201955|NCT02143973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201956|NCT03028701|Budesonide|budesonide|mesh-list
92201957|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
92201958|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92201959|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92201960|NCT03028701|Autonomic Agents|autonomic agents|mesh-ancestor
92201961|NCT03028701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201962|NCT03028701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201963|NCT03028701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92201964|NCT03028701|Respiratory System Agents|respiratory system agents|mesh-ancestor
92201965|NCT03028701|Glucocorticoids|glucocorticoids|mesh-ancestor
92201966|NCT03028701|Hormones|hormones|mesh-ancestor
92201967|NCT03028701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92201968|NCT03028701|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92201969|NCT03028701|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92201970|NCT03028701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92201971|NCT03028701|Adrenergic Agents|adrenergic agents|mesh-ancestor
92201972|NCT03028701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201973|NCT03028701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201974|NCT03686696|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92201975|NCT03686696|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92201976|NCT03686696|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92201977|NCT03686696|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92201978|NCT03686696|Adrenergic Agents|adrenergic agents|mesh-ancestor
92201979|NCT03686696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201980|NCT03686696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201981|NCT03686696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201982|NCT03686696|Protease Inhibitors|protease inhibitors|mesh-ancestor
92201983|NCT03686696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92201984|NCT02267655|Nitric Oxide|nitric oxide|mesh-list
92201985|NCT02267655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92201986|NCT02267655|Autonomic Agents|autonomic agents|mesh-ancestor
92201987|NCT02267655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92201988|NCT02267655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92201989|NCT02267655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92201990|NCT02267655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92201991|NCT02267655|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92201992|NCT02267655|Antioxidants|antioxidants|mesh-ancestor
92201993|NCT02267655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92201994|NCT02267655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92201995|NCT02267655|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92201996|NCT02267655|Vasodilator Agents|vasodilator agents|mesh-ancestor
92201997|NCT02267655|Gasotransmitters|gasotransmitters|mesh-ancestor
92201998|NCT02267655|Protective Agents|protective agents|mesh-ancestor
92201999|NCT02209545|Pyridoxine|pyridoxine|mesh-list
92202000|NCT02209545|Vitamin B 6|vitamin b 6|mesh-list
92202001|NCT02209545|Misoprostol|misoprostol|mesh-list
92202002|NCT02209545|Vitamins|vitamins|mesh-ancestor
92202004|NCT02209545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202005|NCT02209545|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92202006|NCT02209545|Abortifacient Agents|abortifacient agents|mesh-ancestor
92202007|NCT02209545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92202008|NCT02209545|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92202009|NCT02209545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202010|NCT02209545|Oxytocics|oxytocics|mesh-ancestor
92202011|NCT02209545|Vitamin B Complex|vitamin b complex|mesh-ancestor
92202012|NCT04858958|Aflutinib|aflutinib|mesh-list
92202013|NCT04858958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92202014|NCT04858958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202015|NCT04858958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202016|NCT00690833|Desonide|desonide|mesh-list
92202017|NCT00690833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202018|NCT03686306|Sildenafil Citrate|sildenafil citrate|mesh-list
92202019|NCT03686306|Vasodilator Agents|vasodilator agents|mesh-ancestor
92202020|NCT03686306|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92202021|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92202022|NCT03686306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202023|NCT03686306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202025|NCT04078269|Immunomodulating Agents|immunomodulating agents|mesh-list
92202026|NCT04078269|Immunologic Factors|immunologic factors|mesh-ancestor
92335825|NCT02079636|Pemetrexed|pemetrexed|mesh-list
92202027|NCT04078269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202029|NCT00644657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92202030|NCT00644657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92202031|NCT00644657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92202032|NCT00644657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92202033|NCT00644657|Purinergic Agents|purinergic agents|mesh-ancestor
92202034|NCT00644657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202035|NCT00644657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202036|NCT00644657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202037|NCT04613024|Topiramate|topiramate|mesh-list
92202038|NCT04613024|Gabapentin|gabapentin|mesh-list
92202039|NCT04613024|Analgesics|analgesics|mesh-ancestor
92202040|NCT04613024|Sensory System Agents|sensory system agents|mesh-ancestor
92202041|NCT04613024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202042|NCT04613024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202043|NCT04613024|Anticonvulsants|anticonvulsants|mesh-ancestor
92202044|NCT04613024|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92202045|NCT04613024|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92202046|NCT04613024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202047|NCT04613024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92202048|NCT04613024|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92202049|NCT04613024|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92202050|NCT04613024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202051|NCT04613024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202052|NCT04613024|Antimanic Agents|antimanic agents|mesh-ancestor
92202053|NCT04613024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92202054|NCT01933815|Bevacizumab|bevacizumab|mesh-list
92202055|NCT01933815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202056|NCT01933815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202057|NCT01933815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92202058|NCT01933815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92202059|NCT01933815|Growth Substances|growth substances|mesh-ancestor
92202060|NCT01933815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202061|NCT01933815|Growth Inhibitors|growth inhibitors|mesh-ancestor
92202062|NCT04606316|Nivolumab|nivolumab|mesh-list
92202063|NCT04606316|Ipilimumab|ipilimumab|mesh-list
92202064|NCT04606316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202065|NCT04606316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202066|NCT04606316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92202067|NCT04606316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202068|NCT03480971|Tempol|tempol|mesh-list
92202069|NCT03480971|TEMPO|tempo|mesh-list
92202070|NCT03480971|Antioxidants|antioxidants|mesh-ancestor
92202071|NCT03480971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202072|NCT03480971|Protective Agents|protective agents|mesh-ancestor
92202073|NCT03480971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202074|NCT03480971|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92202075|NCT03480971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202076|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92202077|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92202078|NCT00646763|Lenograstim|lenograstim|mesh-list
92202079|NCT00646763|Sargramostim|sargramostim|mesh-list
92202080|NCT00646763|Mitogens|mitogens|mesh-list
92202081|NCT00646763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92202082|NCT00646763|Immunologic Factors|immunologic factors|mesh-ancestor
92202083|NCT00646763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202084|NCT00646763|Mitosis Modulators|mitosis modulators|mesh-ancestor
92202085|NCT00646763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202086|NCT03237572|Pembrolizumab|pembrolizumab|mesh-list
92202087|NCT03237572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202088|NCT03237572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202089|NCT03237572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92202090|NCT03237572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202091|NCT02986347|Epinephrine|epinephrine|mesh-list
92202092|NCT02986347|Racepinephrine|racepinephrine|mesh-list
92202093|NCT02986347|Anesthetics|anesthetics|mesh-list
92202094|NCT02986347|Epinephryl borate|epinephryl borate|mesh-list
92202095|NCT02986347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202096|NCT02986347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202097|NCT02986347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202098|NCT02986347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202099|NCT02986347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202100|NCT02986347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202101|NCT02986347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202102|NCT02986347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92202103|NCT02986347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92202104|NCT02986347|Autonomic Agents|autonomic agents|mesh-ancestor
92202105|NCT02986347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202106|NCT02986347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92202107|NCT02986347|Respiratory System Agents|respiratory system agents|mesh-ancestor
92202108|NCT02986347|Mydriatics|mydriatics|mesh-ancestor
92202109|NCT02986347|Sympathomimetics|sympathomimetics|mesh-ancestor
92202110|NCT02986347|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92202111|NCT00649961|Melatonin|melatonin|mesh-list
92202112|NCT00649961|Antioxidants|antioxidants|mesh-ancestor
92202113|NCT00649961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202114|NCT00649961|Protective Agents|protective agents|mesh-ancestor
92202115|NCT00649961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202116|NCT00649961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202117|NCT03235232|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92202118|NCT03235232|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92202119|NCT03235232|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92202120|NCT03235232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92202121|NCT03235232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92202122|NCT03235232|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202123|NCT03235232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202124|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202125|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202126|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202127|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202128|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202129|NCT01781637|Omalizumab|omalizumab|mesh-list
92202130|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92202131|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92202132|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92202133|NCT00652145|Mesalamine|mesalamine|mesh-list
92202134|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202135|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202136|NCT00652145|Analgesics|analgesics|mesh-ancestor
92202137|NCT00652145|Sensory System Agents|sensory system agents|mesh-ancestor
92202138|NCT00652145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202139|NCT00652145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202140|NCT00652145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202141|NCT00652145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202142|NCT03231722|Leucovorin|leucovorin|mesh-list
92202143|NCT03231722|Fluorouracil|fluorouracil|mesh-list
92202144|NCT03231722|Oxaliplatin|oxaliplatin|mesh-list
92202145|NCT03231722|Irinotecan|irinotecan|mesh-list
92202146|NCT03231722|Panitumumab|panitumumab|mesh-list
92202147|NCT03231722|Levoleucovorin|levoleucovorin|mesh-list
92202148|NCT03231722|Antimetabolites|antimetabolites|mesh-ancestor
92202149|NCT03231722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202150|NCT03231722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92202151|NCT03231722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202152|NCT03231722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92202153|NCT03231722|Immunologic Factors|immunologic factors|mesh-ancestor
92202154|NCT03231722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202155|NCT03231722|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92202156|NCT03231722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92202157|NCT03231722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202158|NCT03231722|Antidotes|antidotes|mesh-ancestor
92202159|NCT03231722|Protective Agents|protective agents|mesh-ancestor
92202160|NCT03231722|Vitamin B Complex|vitamin b complex|mesh-ancestor
92202161|NCT03231722|Vitamins|vitamins|mesh-ancestor
92202162|NCT03231722|Micronutrients|micronutrients|mesh-ancestor
92202163|NCT03231722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202164|NCT02298933|Eculizumab|eculizumab|mesh-list
92202165|NCT02298933|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92202166|NCT02298933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92202167|NCT02298933|Immunologic Factors|immunologic factors|mesh-ancestor
92202168|NCT02298933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202169|NCT02959775|Vaccines|vaccines|mesh-list
92202170|NCT02959775|Immunologic Factors|immunologic factors|mesh-ancestor
92202171|NCT02959775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202172|NCT04761848|Cilostazol|cilostazol|mesh-list
92202173|NCT04761848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92202174|NCT04761848|Autonomic Agents|autonomic agents|mesh-ancestor
92202175|NCT04761848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202176|NCT04761848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202177|NCT04761848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92202178|NCT04761848|Respiratory System Agents|respiratory system agents|mesh-ancestor
92202179|NCT04761848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92202180|NCT04761848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92202181|NCT04761848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202182|NCT04761848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92202183|NCT04761848|Vasodilator Agents|vasodilator agents|mesh-ancestor
92202184|NCT04761848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92202185|NCT04761848|Protective Agents|protective agents|mesh-ancestor
92202186|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92202187|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92202188|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202189|NCT03277196|Ivacaftor|ivacaftor|mesh-list
92202190|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92202191|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202192|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202193|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92202194|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
92202195|NCT04278248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202196|NCT04056962|Tacrolimus|tacrolimus|mesh-list
92202197|NCT04056962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92202198|NCT04056962|Immunologic Factors|immunologic factors|mesh-ancestor
92202199|NCT04056962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202200|NCT04056962|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92202201|NCT04056962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202202|NCT04056962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202203|NCT00693485|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92202204|NCT00693485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92202205|NCT00693485|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202206|NCT00693485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202207|NCT00693485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202208|NCT00693485|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202209|NCT00693485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202210|NCT00693485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202211|NCT00693485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202212|NCT00693719|Irinotecan|irinotecan|mesh-list
92202213|NCT00693719|Etoposide|etoposide|mesh-list
92202214|NCT00693719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92202215|NCT00693719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92202216|NCT00693719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202217|NCT00693719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202218|NCT00693719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202219|NCT00693719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92202220|NCT00693719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92202221|NCT00653861|Lidocaine|lidocaine|mesh-list
92202222|NCT00653861|Anesthetics, Local|anesthetics, local|mesh-ancestor
92202223|NCT00653861|Anesthetics|anesthetics|mesh-ancestor
92202224|NCT00653861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202225|NCT00653861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202226|NCT00653861|Sensory System Agents|sensory system agents|mesh-ancestor
92202227|NCT00653861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202228|NCT00653861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92202229|NCT00653861|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92202230|NCT00653861|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92202231|NCT00653861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202232|NCT00653861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202233|NCT00654329|Fentanyl|fentanyl|mesh-list
92202234|NCT00654329|Dexmedetomidine|dexmedetomidine|mesh-list
92202235|NCT00654329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92202236|NCT00654329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202237|NCT00654329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202238|NCT00654329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202239|NCT00654329|Analgesics|analgesics|mesh-ancestor
92202240|NCT00654329|Sensory System Agents|sensory system agents|mesh-ancestor
92202241|NCT00654329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202242|NCT00654329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202243|NCT00654329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202244|NCT00654329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202245|NCT00654329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202246|NCT00654329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202247|NCT00654329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202248|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92202249|NCT00654329|Narcotics|narcotics|mesh-ancestor
92202250|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92202251|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92202252|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
92202253|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
92202254|NCT00695435|Tobramycin|tobramycin|mesh-list
92202255|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92202256|NCT00695435|Dexamethasone|dexamethasone|mesh-list
92202257|NCT00695435|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92202258|NCT00695435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202259|NCT00695435|Antiemetics|antiemetics|mesh-ancestor
92202260|NCT00695435|Autonomic Agents|autonomic agents|mesh-ancestor
92202261|NCT00695435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202262|NCT00695435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202263|NCT00695435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202264|NCT00695435|Glucocorticoids|glucocorticoids|mesh-ancestor
92202265|NCT00695435|Hormones|hormones|mesh-ancestor
92202266|NCT00695435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202267|NCT00695435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92202268|NCT00695435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202269|NCT00695435|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92202270|NCT00695435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92202271|NCT00695435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202272|NCT00654953|Gabapentin|gabapentin|mesh-list
92202273|NCT00654953|Sertraline|sertraline|mesh-list
92202274|NCT00654953|Analgesics|analgesics|mesh-ancestor
92202275|NCT00654953|Sensory System Agents|sensory system agents|mesh-ancestor
92202276|NCT00654953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202277|NCT00654953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202278|NCT00654953|Anticonvulsants|anticonvulsants|mesh-ancestor
92202279|NCT00654953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92202280|NCT00654953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92202281|NCT00654953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202282|NCT00654953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92202283|NCT00654953|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92202284|NCT00654953|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92202285|NCT00654953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202286|NCT00654953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202287|NCT00654953|Antimanic Agents|antimanic agents|mesh-ancestor
92202288|NCT00654953|Antidepressive Agents|antidepressive agents|mesh-ancestor
92202289|NCT00654953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92202290|NCT00654953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92202291|NCT00654953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202292|NCT00654953|Serotonin Agents|serotonin agents|mesh-ancestor
92202294|NCT01790165|Antifungal Agents|antifungal agents|mesh-ancestor
92202295|NCT01790165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202296|NCT01790165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202297|NCT01790165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202298|NCT02299089|Octreotide|octreotide|mesh-list
92202299|NCT02299089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202300|NCT02299089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92202301|NCT02299089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202303|NCT00655811|Antipruritics|antipruritics|mesh-ancestor
92202304|NCT00655811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202305|NCT00655811|Sensory System Agents|sensory system agents|mesh-ancestor
92202306|NCT00655811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202307|NCT00655811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202308|NCT03931551|Trastuzumab|trastuzumab|mesh-list
92202309|NCT03931551|Olaparib|olaparib|mesh-list
92202310|NCT03931551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202311|NCT03931551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202312|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92202313|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202314|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202315|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92202316|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92202317|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92202318|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202319|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202321|NCT00696293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202322|NCT00696293|Analgesics|analgesics|mesh-ancestor
92202323|NCT00696293|Sensory System Agents|sensory system agents|mesh-ancestor
92202324|NCT00696293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202325|NCT00696293|Antidepressive Agents|antidepressive agents|mesh-ancestor
92202326|NCT00696293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92202327|NCT00696293|Dopamine Agents|dopamine agents|mesh-ancestor
92202328|NCT00696449|Adapalene|adapalene|mesh-list
92202329|NCT00696449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202330|NCT00696449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202331|NCT00696449|Analgesics|analgesics|mesh-ancestor
92202332|NCT00696449|Sensory System Agents|sensory system agents|mesh-ancestor
92202333|NCT00696449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202334|NCT00696449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202335|NCT00696449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202336|NCT00696449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202337|NCT00696449|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202338|NCT03916263|Metformin|metformin|mesh-list
92202339|NCT03916263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92202340|NCT03916263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202341|NCT00696761|Alfuzosin|alfuzosin|mesh-list
92202342|NCT00696761|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92202343|NCT00696761|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92202344|NCT00696761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92202345|NCT00696761|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202346|NCT00696761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202347|NCT00696761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202348|NCT00696761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202349|NCT00696761|Urological Agents|urological agents|mesh-ancestor
92202350|NCT00656201|Progesterone|progesterone|mesh-list
92202351|NCT00656201|Progestins|progestins|mesh-ancestor
92202353|NCT00656201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202354|NCT00656201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202355|NCT00759291|Acipimox|acipimox|mesh-list
92202356|NCT00759291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202357|NCT00759291|Antimetabolites|antimetabolites|mesh-ancestor
92202358|NCT00759291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202359|NCT00759291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202360|NCT00756405|Antioxidants|antioxidants|mesh-list
92202361|NCT00756405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202362|NCT00756405|Protective Agents|protective agents|mesh-ancestor
92202363|NCT00756405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202364|NCT00697541|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92202365|NCT00697541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92202366|NCT00697541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92202367|NCT00697541|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92202368|NCT00697541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202369|NCT00697541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202370|NCT00697541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202371|NCT00697541|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202372|NCT00697541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202373|NCT00697541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202374|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202375|NCT03889275|Durvalumab|durvalumab|mesh-list
92202376|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202377|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202378|NCT00657917|Gentamicins|gentamicins|mesh-list
92202379|NCT00657917|Paromomycin|paromomycin|mesh-list
92202380|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92202381|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202382|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92202383|NCT00657917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202384|NCT00657917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202385|NCT00657917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92202386|NCT00657917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92202387|NCT01959945|Hemagglutinins|hemagglutinins|mesh-list
92202388|NCT01959945|Vaccines|vaccines|mesh-list
92202389|NCT01959945|Immunologic Factors|immunologic factors|mesh-ancestor
92202390|NCT01959945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202392|NCT01959945|Coagulants|coagulants|mesh-ancestor
92202393|NCT00700661|Montelukast|montelukast|mesh-list
92202394|NCT00700661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92202395|NCT00700661|Respiratory System Agents|respiratory system agents|mesh-ancestor
92202396|NCT00700661|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92202397|NCT00700661|Hormone Antagonists|hormone antagonists|mesh-ancestor
92202398|NCT00700661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202399|NCT00700661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202400|NCT00700661|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92202401|NCT00700661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92202402|NCT00700661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202403|NCT00652847|Ezetimibe|ezetimibe|mesh-list
92202404|NCT00652847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202405|NCT00652847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202406|NCT00652847|Antimetabolites|antimetabolites|mesh-ancestor
92202407|NCT00652847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202408|NCT00652847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202409|NCT00652301|Simvastatin|simvastatin|mesh-list
92202410|NCT00652301|Ezetimibe|ezetimibe|mesh-list
92202411|NCT00652301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202412|NCT00652301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202413|NCT00652301|Antimetabolites|antimetabolites|mesh-ancestor
92202414|NCT00652301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202415|NCT00652301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202416|NCT00652301|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92202417|NCT00652301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202418|NCT01961271|Buprenorphine|buprenorphine|mesh-list
92202419|NCT01961271|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92202420|NCT01961271|Narcotics|narcotics|mesh-ancestor
92202421|NCT01961271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202422|NCT01961271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202423|NCT01961271|Analgesics|analgesics|mesh-ancestor
92202424|NCT01961271|Sensory System Agents|sensory system agents|mesh-ancestor
92202425|NCT01961271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202426|NCT01961271|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92202427|NCT01963143|gamma-Globulins|gamma-globulins|mesh-list
92202428|NCT01963143|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92202429|NCT01963143|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92202430|NCT01963143|Immunologic Factors|immunologic factors|mesh-ancestor
92202431|NCT01963143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202432|NCT03822351|Durvalumab|durvalumab|mesh-list
92202433|NCT03822351|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92202434|NCT03822351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202435|NCT03822351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202436|NCT03822351|Immunologic Factors|immunologic factors|mesh-ancestor
92202437|NCT03822351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202438|NCT01963845|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92202439|NCT01963845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92202440|NCT01963845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202441|NCT01963845|Incretins|incretins|mesh-ancestor
92202442|NCT01963845|Hormones|hormones|mesh-ancestor
92202443|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202444|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92202445|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
92202446|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202447|NCT01963845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202448|NCT00658619|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92202449|NCT00658619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92202450|NCT00658619|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202451|NCT00658619|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202452|NCT00658619|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202453|NCT00658619|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202454|NCT00658619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202455|NCT00658619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202456|NCT00658619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202457|NCT01966419|Phenylacetic acid|phenylacetic acid|mesh-list
92202458|NCT01966419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92202459|NCT01966419|Antimetabolites|antimetabolites|mesh-ancestor
92202460|NCT01966419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933921|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
92202461|NCT01966419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202462|NCT01966809|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92202463|NCT01966809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202464|NCT01966809|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202465|NCT01966809|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92202466|NCT04575584|Molnupiravir|molnupiravir|mesh-list
92202467|NCT04575584|Antiviral Agents|antiviral agents|mesh-ancestor
92202468|NCT04575584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202469|NCT04277702|Montelukast|montelukast|mesh-list
92202470|NCT04277702|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92202471|NCT04277702|Respiratory System Agents|respiratory system agents|mesh-ancestor
92202472|NCT04277702|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92202473|NCT04277702|Hormone Antagonists|hormone antagonists|mesh-ancestor
92202474|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202475|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202476|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92202477|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92202478|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202479|NCT00699491|Sirolimus|sirolimus|mesh-list
92202480|NCT00699491|Temsirolimus|temsirolimus|mesh-list
92202481|NCT00699491|MTOR Inhibitors|mtor inhibitors|mesh-list
92202482|NCT00699491|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92202483|NCT00699491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92202484|NCT00699491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202485|NCT00699491|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92202486|NCT00699491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202487|NCT00699491|Antifungal Agents|antifungal agents|mesh-ancestor
92202488|NCT00699491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92202489|NCT00699491|Immunologic Factors|immunologic factors|mesh-ancestor
92202490|NCT00699491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202491|NCT00699491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92202492|NCT00699491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202493|NCT00699491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202494|NCT04493216|Dolutegravir|dolutegravir|mesh-list
92202495|NCT04493216|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92202496|NCT04493216|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92202497|NCT04493216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202498|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202499|NCT04493216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92202500|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92202501|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
92202502|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202503|NCT03721965|Prednisone|prednisone|mesh-list
92202504|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
92202505|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202506|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
92202507|NCT03721965|Hormones|hormones|mesh-ancestor
92202508|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202509|NCT03721965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202510|NCT03721965|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92202511|NCT03721965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202512|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
92202513|NCT03721965|Autonomic Agents|autonomic agents|mesh-ancestor
92202514|NCT03721965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202515|NCT03721965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202516|NCT03721965|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92202517|NCT03721965|Protective Agents|protective agents|mesh-ancestor
92202518|NCT04399148|Ketotifen|ketotifen|mesh-list
92202519|NCT04399148|Aprepitant|aprepitant|mesh-list
92202520|NCT04399148|Desloratadine|desloratadine|mesh-list
92202521|NCT04399148|Antiemetics|antiemetics|mesh-ancestor
92202522|NCT04399148|Autonomic Agents|autonomic agents|mesh-ancestor
92202523|NCT04399148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202524|NCT04399148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202525|NCT04399148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202526|NCT04399148|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92202527|NCT04399148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202528|NCT04399148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202529|NCT04399148|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92202530|NCT04399148|Cholinergic Agents|cholinergic agents|mesh-ancestor
92202531|NCT04399148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92202532|NCT04399148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92202533|NCT04399148|Histamine Antagonists|histamine antagonists|mesh-ancestor
92202534|NCT04399148|Histamine Agents|histamine agents|mesh-ancestor
92202535|NCT04399148|Antipruritics|antipruritics|mesh-ancestor
92202536|NCT04399148|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202537|NCT04399148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92202538|NCT04672382|Morphine|morphine|mesh-list
92202539|NCT04672382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92202540|NCT04672382|Narcotics|narcotics|mesh-ancestor
92202541|NCT04672382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202542|NCT04672382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202543|NCT04672382|Analgesics|analgesics|mesh-ancestor
92202544|NCT04672382|Sensory System Agents|sensory system agents|mesh-ancestor
92202545|NCT04672382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202546|NCT00699803|Prednisone|prednisone|mesh-list
92202547|NCT00699803|Prednisolone acetate|prednisolone acetate|mesh-list
92202548|NCT00699803|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92202549|NCT00699803|Methylprednisolone|methylprednisolone|mesh-list
92202550|NCT00699803|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92202551|NCT00699803|Prednisolone|prednisolone|mesh-list
92202552|NCT00699803|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92202553|NCT00699803|Prednisolone phosphate|prednisolone phosphate|mesh-list
92202554|NCT00699803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202555|NCT00699803|Glucocorticoids|glucocorticoids|mesh-ancestor
92202556|NCT00699803|Hormones|hormones|mesh-ancestor
92202557|NCT00699803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202558|NCT00699803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202559|NCT00699803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92202560|NCT00699803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202562|NCT00699803|Autonomic Agents|autonomic agents|mesh-ancestor
92202563|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202564|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202565|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92202566|NCT00699803|Protective Agents|protective agents|mesh-ancestor
92202567|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
92202568|NCT01967433|Promethazine|promethazine|mesh-list
92202569|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92202570|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92202571|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202572|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202573|NCT01967433|Anesthetics, Local|anesthetics, local|mesh-ancestor
92202574|NCT01967433|Anesthetics|anesthetics|mesh-ancestor
92202575|NCT01967433|Sensory System Agents|sensory system agents|mesh-ancestor
92202576|NCT01967433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202577|NCT01967433|Antiemetics|antiemetics|mesh-ancestor
92202578|NCT01967433|Autonomic Agents|autonomic agents|mesh-ancestor
92202579|NCT01967433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202580|NCT01967433|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92202581|NCT01967433|Histamine Antagonists|histamine antagonists|mesh-ancestor
92202582|NCT01967433|Histamine Agents|histamine agents|mesh-ancestor
92202583|NCT01967433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202584|NCT01967433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202585|NCT01967433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92202586|NCT01967433|Antipruritics|antipruritics|mesh-ancestor
92202587|NCT01967433|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202588|NCT00551447|Simvastatin|simvastatin|mesh-list
92202589|NCT00551447|Ezetimibe|ezetimibe|mesh-list
92202590|NCT00551447|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202591|NCT00551447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202592|NCT00551447|Antimetabolites|antimetabolites|mesh-ancestor
92202593|NCT00551447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202594|NCT00551447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202595|NCT00551447|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92202596|NCT00551447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202598|NCT01968057|Cyclosporins|cyclosporins|mesh-list
92202599|NCT01968057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202600|NCT01968057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202601|NCT01968057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92202602|NCT01968057|Immunologic Factors|immunologic factors|mesh-ancestor
92202603|NCT01968057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202604|NCT01968057|Antifungal Agents|antifungal agents|mesh-ancestor
92202605|NCT01968057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202606|NCT01968057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202607|NCT01968057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202608|NCT01968057|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92202609|NCT01968135|Contraceptive Agents|contraceptive agents|mesh-list
92202610|NCT01968135|Contraceptives, Oral|contraceptives, oral|mesh-list
92202611|NCT01968135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92202612|NCT01968135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92202613|NCT01968135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202614|NCT01968135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92202615|NCT00658697|Bevacizumab|bevacizumab|mesh-list
92202616|NCT00658697|Docetaxel|docetaxel|mesh-list
92202617|NCT00658697|Bicalutamide|bicalutamide|mesh-list
92202618|NCT00658697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202619|NCT00658697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202620|NCT00658697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92202621|NCT00658697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92202622|NCT00658697|Growth Substances|growth substances|mesh-ancestor
92202623|NCT00658697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202624|NCT00658697|Growth Inhibitors|growth inhibitors|mesh-ancestor
92202625|NCT00658697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92202626|NCT00658697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92202627|NCT00658697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92202628|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202629|NCT00658697|Androgen Antagonists|androgen antagonists|mesh-ancestor
92202630|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
92202631|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202632|NCT03873116|Berotralstat|berotralstat|mesh-list
92202633|NCT03873116|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92202634|NCT03873116|Protease Inhibitors|protease inhibitors|mesh-ancestor
92202635|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202636|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202637|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
92202638|NCT04399226|Ketamine|ketamine|mesh-list
92202639|NCT04399226|Propofol|propofol|mesh-list
92202640|NCT04399226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92202641|NCT04399226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202642|NCT04399226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202643|NCT04399226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202644|NCT04399226|Analgesics|analgesics|mesh-ancestor
92202645|NCT04399226|Sensory System Agents|sensory system agents|mesh-ancestor
92202646|NCT04399226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202647|NCT04399226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202648|NCT04399226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202649|NCT04399226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202650|NCT04399226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202651|NCT04399226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202652|NCT04399226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202653|NCT04399226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92202654|NCT04399226|Anesthetics, General|anesthetics, general|mesh-ancestor
92202655|NCT04399226|Anesthetics|anesthetics|mesh-ancestor
92202656|NCT04399226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92202657|NCT04399226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92202658|NCT04399226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92202659|NCT00659165|Insulin|insulin|mesh-list
92202660|NCT00659165|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92202661|NCT00659165|Insulin Glargine|insulin glargine|mesh-list
92202662|NCT00659165|Insulin Detemir|insulin detemir|mesh-list
92202663|NCT00659165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92202664|NCT00659165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202665|NCT00542087|Diclofenac|diclofenac|mesh-list
92202666|NCT00542087|Etoricoxib|etoricoxib|mesh-list
92202667|NCT00542087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202668|NCT00542087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202669|NCT00542087|Analgesics|analgesics|mesh-ancestor
92202670|NCT00542087|Sensory System Agents|sensory system agents|mesh-ancestor
92202671|NCT00542087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202672|NCT00542087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202673|NCT00542087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202674|NCT00542087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202675|NCT00542087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92202676|NCT00542087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202677|NCT00542087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202678|NCT00542087|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92202680|NCT00541697|Simvastatin|simvastatin|mesh-list
92202681|NCT00541697|Ezetimibe|ezetimibe|mesh-list
92202682|NCT00541697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202683|NCT00541697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202684|NCT00541697|Antimetabolites|antimetabolites|mesh-ancestor
92202685|NCT00541697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202686|NCT00541697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202687|NCT00541697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92202688|NCT00541697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202690|NCT03223376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92202691|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92202692|NCT03223376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202693|NCT03223376|Tubulin Modulators|tubulin modulators|mesh-ancestor
92202694|NCT03223376|Antimitotic Agents|antimitotic agents|mesh-ancestor
92202695|NCT03223376|Mitosis Modulators|mitosis modulators|mesh-ancestor
92202696|NCT03223376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202697|NCT00395603|Atorvastatin|atorvastatin|mesh-list
92202698|NCT00395603|Simvastatin|simvastatin|mesh-list
92202699|NCT00395603|Ezetimibe|ezetimibe|mesh-list
92202700|NCT00395603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202701|NCT00395603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202702|NCT00395603|Antimetabolites|antimetabolites|mesh-ancestor
92202703|NCT00395603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202704|NCT00395603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202705|NCT00395603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92202706|NCT00395603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202707|NCT00659633|Lidocaine|lidocaine|mesh-list
92202708|NCT00659633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92202710|NCT00659633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92202711|NCT00659633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202712|NCT00659633|Sensory System Agents|sensory system agents|mesh-ancestor
92202713|NCT00659633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202714|NCT00659633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92202715|NCT00659633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92202716|NCT00659633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92202717|NCT00659633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202718|NCT00659633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202719|NCT00328523|Ezetimibe|ezetimibe|mesh-list
92202720|NCT00328523|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202721|NCT00328523|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202722|NCT00328523|Antimetabolites|antimetabolites|mesh-ancestor
92202723|NCT00328523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202724|NCT00328523|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202725|NCT00701675|Sertraline|sertraline|mesh-list
92202726|NCT00701675|Antidepressive Agents|antidepressive agents|mesh-ancestor
92202727|NCT00701675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92202728|NCT00701675|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92202729|NCT00701675|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92202730|NCT00701675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202731|NCT00701675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202732|NCT00701675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202733|NCT00701675|Serotonin Agents|serotonin agents|mesh-ancestor
92202734|NCT00701675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202735|NCT04639310|Ezogabine|ezogabine|mesh-list
92202736|NCT04639310|Anticonvulsants|anticonvulsants|mesh-ancestor
92202737|NCT04639310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202738|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202739|NCT03246074|Paclitaxel|paclitaxel|mesh-list
92202740|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92202741|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202742|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
92202743|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
92202744|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
92202745|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202746|NCT02300727|Curcumin|curcumin|mesh-list
92202747|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202748|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202749|NCT02300727|Analgesics|analgesics|mesh-ancestor
92202750|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
92202751|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202752|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202753|NCT02300727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202754|NCT02300727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202755|NCT02300727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202756|NCT02300727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202757|NCT02300727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202758|NCT00250445|Diclofenac|diclofenac|mesh-list
92202759|NCT00250445|Etoricoxib|etoricoxib|mesh-list
92202760|NCT00250445|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202761|NCT00250445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202762|NCT00250445|Analgesics|analgesics|mesh-ancestor
92202763|NCT00250445|Sensory System Agents|sensory system agents|mesh-ancestor
92202764|NCT00250445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202765|NCT00250445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202766|NCT00250445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202767|NCT00250445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202768|NCT00250445|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92335926|NCT02043366|Flurbiprofen|flurbiprofen|mesh-list
92202769|NCT00250445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202770|NCT00250445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202771|NCT00250445|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92202773|NCT00242489|Etoricoxib|etoricoxib|mesh-list
92202774|NCT00242489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202775|NCT00242489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202776|NCT00242489|Analgesics|analgesics|mesh-ancestor
92202777|NCT00242489|Sensory System Agents|sensory system agents|mesh-ancestor
92202778|NCT00242489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202779|NCT00242489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202780|NCT00242489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202781|NCT00242489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202782|NCT00242489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92202783|NCT00242489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202784|NCT00242489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202785|NCT00242489|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92202786|NCT00659945|Ondansetron|ondansetron|mesh-list
92202787|NCT00659945|Aprepitant|aprepitant|mesh-list
92202788|NCT00659945|Antiemetics|antiemetics|mesh-ancestor
92202789|NCT00659945|Autonomic Agents|autonomic agents|mesh-ancestor
92202790|NCT00659945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202791|NCT00659945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202792|NCT00659945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202793|NCT00659945|Antipruritics|antipruritics|mesh-ancestor
92202794|NCT00659945|Dermatologic Agents|dermatologic agents|mesh-ancestor
92202795|NCT00659945|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92202796|NCT00659945|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92202797|NCT00659945|Serotonin Agents|serotonin agents|mesh-ancestor
92202798|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202799|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202800|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92202801|NCT04387565|Vanadium|vanadium|mesh-list
92202802|NCT04387565|Trace Elements|trace elements|mesh-ancestor
92202803|NCT04387565|Micronutrients|micronutrients|mesh-ancestor
92202804|NCT04387565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202805|NCT02141555|Misoprostol|misoprostol|mesh-list
92202806|NCT02141555|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92202807|NCT02141555|Abortifacient Agents|abortifacient agents|mesh-ancestor
92202808|NCT02141555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92202809|NCT02141555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202810|NCT02141555|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92202811|NCT02141555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202812|NCT02141555|Oxytocics|oxytocics|mesh-ancestor
92202813|NCT01799057|Metformin|metformin|mesh-list
92202814|NCT01799057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92202815|NCT01799057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202816|NCT00588965|Propranolol|propranolol|mesh-list
92202817|NCT00588965|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92202818|NCT00588965|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92202819|NCT00588965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202820|NCT00588965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202821|NCT00588965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202822|NCT00588965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202823|NCT00588965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92202824|NCT00588965|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92202825|NCT00588965|Vasodilator Agents|vasodilator agents|mesh-ancestor
92202827|NCT00702299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92202828|NCT00702299|Cisplatin|cisplatin|mesh-list
92202829|NCT00702299|Pemetrexed|pemetrexed|mesh-list
92202830|NCT00702299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92202831|NCT00702299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202833|NCT00702299|Antimitotic Agents|antimitotic agents|mesh-ancestor
92202834|NCT00702299|Mitosis Modulators|mitosis modulators|mesh-ancestor
92202835|NCT00702299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202836|NCT00702299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202837|NCT00702299|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92202838|NCT00702299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92202839|NCT00661583|Ranibizumab|ranibizumab|mesh-list
92202840|NCT00661583|Mitomycins|mitomycins|mesh-list
92202841|NCT00661583|Mitomycin|mitomycin|mesh-list
92202842|NCT00661583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92202843|NCT00661583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92202844|NCT00661583|Growth Substances|growth substances|mesh-ancestor
92202845|NCT00661583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202846|NCT00661583|Growth Inhibitors|growth inhibitors|mesh-ancestor
92202847|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202848|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92202849|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
92202850|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202851|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92202852|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202854|NCT00661895|Atenolol|atenolol|mesh-list
92202855|NCT00661895|Amlodipine|amlodipine|mesh-list
92202856|NCT00661895|Valsartan|valsartan|mesh-list
92202857|NCT00661895|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92202858|NCT00661895|Clonidine|clonidine|mesh-list
92202859|NCT00661895|Lisinopril|lisinopril|mesh-list
92202860|NCT00661895|Doxazosin|doxazosin|mesh-list
92202861|NCT00661895|Hydralazine|hydralazine|mesh-list
92202862|NCT00661895|Nifedipine|nifedipine|mesh-list
92202863|NCT00661895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92202864|NCT00661895|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92202865|NCT00661895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92202866|NCT00661895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202867|NCT00661895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92202868|NCT00661895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202869|NCT00661895|Vasodilator Agents|vasodilator agents|mesh-ancestor
92202870|NCT00661895|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92202871|NCT00661895|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92202872|NCT00661895|Diuretics|diuretics|mesh-ancestor
92202873|NCT00661895|Natriuretic Agents|natriuretic agents|mesh-ancestor
92202874|NCT00661895|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92202875|NCT00661895|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92202876|NCT00661895|Sympatholytics|sympatholytics|mesh-ancestor
92202877|NCT00661895|Autonomic Agents|autonomic agents|mesh-ancestor
92202878|NCT00661895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92202879|NCT00661895|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92202880|NCT00661895|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92202881|NCT00661895|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92202882|NCT00661895|Adrenergic Agents|adrenergic agents|mesh-ancestor
92202883|NCT00661895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92202884|NCT00661895|Analgesics|analgesics|mesh-ancestor
92202885|NCT00661895|Sensory System Agents|sensory system agents|mesh-ancestor
92202886|NCT00661895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92202887|NCT00661895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92202888|NCT00661895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92202889|NCT00661895|Tocolytic Agents|tocolytic agents|mesh-ancestor
92202890|NCT00661895|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92202891|NCT00661895|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92202892|NCT00661895|Protease Inhibitors|protease inhibitors|mesh-ancestor
92202893|NCT00661895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202894|NCT00661895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92202895|NCT00661895|Protective Agents|protective agents|mesh-ancestor
92202896|NCT00661895|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92202897|NCT00661895|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92202898|NCT02312258|Ixazomib|ixazomib|mesh-list
92202899|NCT02312258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202900|NCT02312258|Protease Inhibitors|protease inhibitors|mesh-ancestor
92202901|NCT02312258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202902|NCT02312258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202903|NCT02301039|Pembrolizumab|pembrolizumab|mesh-list
92202904|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202905|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202906|NCT02301039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92202907|NCT02301039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202909|NCT00662675|Pancreatin|pancreatin|mesh-list
92202910|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92202911|NCT00591305|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92202912|NCT00591305|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92202913|NCT00591305|Protective Agents|protective agents|mesh-ancestor
92202914|NCT00591305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202915|NCT00591305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202916|NCT01799603|Simeprevir|simeprevir|mesh-list
92202917|NCT01799603|Antiviral Agents|antiviral agents|mesh-ancestor
92202918|NCT01799603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202919|NCT01799603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92202920|NCT01799603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202921|NCT01799603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202923|NCT03816176|Antifungal Agents|antifungal agents|mesh-ancestor
92202924|NCT03816176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92202925|NCT00666029|Atorvastatin|atorvastatin|mesh-list
92202926|NCT00666029|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92202927|NCT00666029|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92202928|NCT00666029|Antimetabolites|antimetabolites|mesh-ancestor
92202929|NCT00666029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202930|NCT00666029|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92202931|NCT00666029|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92202932|NCT00666029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202933|NCT04372940|Tranexamic Acid|tranexamic acid|mesh-list
92202934|NCT04372940|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92202935|NCT04372940|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92202936|NCT04372940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202937|NCT04372940|Hemostatics|hemostatics|mesh-ancestor
92202938|NCT04372940|Coagulants|coagulants|mesh-ancestor
92202939|NCT00592475|Conivaptan|conivaptan|mesh-list
92202940|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92202941|NCT00592475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202942|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
92202943|NCT00592475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202944|NCT03221426|Leucovorin|leucovorin|mesh-list
92202945|NCT03221426|Docetaxel|docetaxel|mesh-list
92202946|NCT03221426|Pembrolizumab|pembrolizumab|mesh-list
92202947|NCT03221426|Fluorouracil|fluorouracil|mesh-list
92202948|NCT03221426|Capecitabine|capecitabine|mesh-list
92202949|NCT03221426|Oxaliplatin|oxaliplatin|mesh-list
92202950|NCT03221426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92202951|NCT03221426|Tubulin Modulators|tubulin modulators|mesh-ancestor
92202952|NCT03221426|Antimitotic Agents|antimitotic agents|mesh-ancestor
92202953|NCT03221426|Mitosis Modulators|mitosis modulators|mesh-ancestor
92202954|NCT03221426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202955|NCT03221426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92202956|NCT03221426|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92202957|NCT03221426|Antimetabolites|antimetabolites|mesh-ancestor
92202958|NCT03221426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92202959|NCT03221426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92202960|NCT03221426|Immunologic Factors|immunologic factors|mesh-ancestor
92202961|NCT03221426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202962|NCT03221426|Antidotes|antidotes|mesh-ancestor
92202963|NCT03221426|Protective Agents|protective agents|mesh-ancestor
92202964|NCT03221426|Vitamin B Complex|vitamin b complex|mesh-ancestor
92202965|NCT03221426|Vitamins|vitamins|mesh-ancestor
92202966|NCT03221426|Micronutrients|micronutrients|mesh-ancestor
92202967|NCT01989195|Manganese|manganese|mesh-list
92202968|NCT01989195|Trace Elements|trace elements|mesh-ancestor
92202969|NCT01989195|Micronutrients|micronutrients|mesh-ancestor
92202970|NCT01989195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202971|NCT00592943|Modafinil|modafinil|mesh-list
92202972|NCT00592943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92202973|NCT00592943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202974|NCT00592943|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92202975|NCT00592943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92202976|NCT00592943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92202977|NCT00592943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202978|NCT01973205|Aspirin|aspirin|mesh-list
92202979|NCT01973205|Acetaminophen|acetaminophen|mesh-list
92202980|NCT01973205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92202981|NCT01973205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92202982|NCT01973205|Analgesics|analgesics|mesh-ancestor
92202983|NCT01973205|Sensory System Agents|sensory system agents|mesh-ancestor
92335941|NCT02043366|Anesthetics|anesthetics|mesh-ancestor
92202985|NCT01973205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92202986|NCT01973205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92202987|NCT01973205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92202988|NCT01973205|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92202989|NCT01973205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92202990|NCT01973205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92202991|NCT01973205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92202992|NCT01973205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92202993|NCT01973205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92202995|NCT01990677|Eplerenone|eplerenone|mesh-list
92202996|NCT01990677|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92202997|NCT01990677|Hormone Antagonists|hormone antagonists|mesh-ancestor
92202998|NCT01990677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92202999|NCT01990677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203000|NCT01990677|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92203001|NCT01990677|Diuretics|diuretics|mesh-ancestor
92203002|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
92203003|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92203004|NCT00593645|Cytarabine|cytarabine|mesh-list
92203005|NCT00593645|Clofarabine|clofarabine|mesh-list
92203006|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
92203007|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92203008|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203009|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
92203010|NCT00593645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203011|NCT00593645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203012|NCT00593645|Antiviral Agents|antiviral agents|mesh-ancestor
92203013|NCT00593645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203014|NCT00593645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203015|NCT00593645|Immunologic Factors|immunologic factors|mesh-ancestor
92203016|NCT00593645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203017|NCT03194126|Misoprostol|misoprostol|mesh-list
92203018|NCT03194126|Mifepristone|mifepristone|mesh-list
92203019|NCT03194126|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92203020|NCT03194126|Abortifacient Agents|abortifacient agents|mesh-ancestor
92203021|NCT03194126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92203022|NCT03194126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203023|NCT03194126|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92203024|NCT03194126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92203025|NCT03194126|Oxytocics|oxytocics|mesh-ancestor
92203026|NCT03194126|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92203027|NCT03194126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92203028|NCT03194126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92203029|NCT03194126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92203030|NCT03194126|Contraceptive Agents|contraceptive agents|mesh-ancestor
92203031|NCT03194126|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92203032|NCT03194126|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92203033|NCT03194126|Hormone Antagonists|hormone antagonists|mesh-ancestor
92203034|NCT03194126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203035|NCT03194126|Luteolytic Agents|luteolytic agents|mesh-ancestor
92203036|NCT03194126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92203037|NCT03194126|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92203038|NCT03219086|Bupivacaine|bupivacaine|mesh-list
92203039|NCT03219086|Prilocaine|prilocaine|mesh-list
92203040|NCT03219086|Anesthetics|anesthetics|mesh-list
92203041|NCT03219086|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203042|NCT03219086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203043|NCT03219086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203044|NCT03219086|Sensory System Agents|sensory system agents|mesh-ancestor
92203046|NCT02998385|Cisplatin|cisplatin|mesh-list
92203047|NCT02998385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203048|NCT04398290|Nitric Oxide|nitric oxide|mesh-list
92203049|NCT04398290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92203050|NCT04398290|Autonomic Agents|autonomic agents|mesh-ancestor
92203051|NCT04398290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203052|NCT04398290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203053|NCT04398290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92203054|NCT04398290|Respiratory System Agents|respiratory system agents|mesh-ancestor
92203055|NCT04398290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92203056|NCT04398290|Antioxidants|antioxidants|mesh-ancestor
92203057|NCT04398290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203058|NCT04398290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203059|NCT04398290|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92203060|NCT04398290|Vasodilator Agents|vasodilator agents|mesh-ancestor
92203061|NCT04398290|Gasotransmitters|gasotransmitters|mesh-ancestor
92203062|NCT04398290|Protective Agents|protective agents|mesh-ancestor
92203063|NCT04397510|Heparin|heparin|mesh-list
92203064|NCT04397510|Anticoagulants|anticoagulants|mesh-ancestor
92203065|NCT04397510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92203066|NCT04397510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92203067|NCT04397510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203068|NCT00704717|Ribavirin|ribavirin|mesh-list
92203069|NCT00704717|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92203070|NCT00704717|Interferon-alpha|interferon-alpha|mesh-list
92203071|NCT00704717|Antimetabolites|antimetabolites|mesh-ancestor
92203072|NCT00704717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203073|NCT00704717|Antiviral Agents|antiviral agents|mesh-ancestor
92203074|NCT00704717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203075|NCT00704717|Immunologic Factors|immunologic factors|mesh-ancestor
92203076|NCT00704717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203077|NCT03708224|Atezolizumab|atezolizumab|mesh-list
92203078|NCT03708224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92203079|NCT03708224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203080|NCT03708224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203081|NCT03708224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203082|NCT03632642|Floxacillin|floxacillin|mesh-list
92203083|NCT03632642|Penicillin G|penicillin g|mesh-list
92203084|NCT03632642|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92203085|NCT03632642|Penicillin G Procaine|penicillin g procaine|mesh-list
92203086|NCT03632642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92203087|NCT03632642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203088|NCT00594425|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92203089|NCT00594425|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92203090|NCT00594425|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92203091|NCT00594425|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203092|NCT04317404|Triamcinolone|triamcinolone|mesh-list
92203093|NCT04317404|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92203094|NCT04317404|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92203095|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92203096|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203097|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
92203098|NCT04317404|Hormones|hormones|mesh-ancestor
92203099|NCT04317404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203100|NCT04317404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203101|NCT04317404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203102|NCT04317404|Immunologic Factors|immunologic factors|mesh-ancestor
92203103|NCT04317404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203104|NCT04317404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203105|NCT04399070|Ketamine|ketamine|mesh-list
92203106|NCT04399070|Esketamine|esketamine|mesh-list
92203107|NCT04399070|Analgesics|analgesics|mesh-ancestor
92203108|NCT04399070|Sensory System Agents|sensory system agents|mesh-ancestor
92203109|NCT04399070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203110|NCT04399070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203111|NCT04399070|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92203112|NCT04399070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92203113|NCT04399070|Anesthetics, General|anesthetics, general|mesh-ancestor
92203114|NCT04399070|Anesthetics|anesthetics|mesh-ancestor
92203115|NCT04399070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203116|NCT04399070|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92203117|NCT04399070|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92203118|NCT04399070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203119|NCT04399070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203120|NCT04399070|Antidepressive Agents|antidepressive agents|mesh-ancestor
92203121|NCT04399070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92203122|NCT00667589|Fluocinonide|fluocinonide|mesh-list
92203123|NCT00667589|Tazarotene|tazarotene|mesh-list
92203124|NCT00667589|Emollients|emollients|mesh-list
92203125|NCT00667589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203126|NCT00667589|Keratolytic Agents|keratolytic agents|mesh-ancestor
92203127|NCT00667589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203128|NCT00667589|Glucocorticoids|glucocorticoids|mesh-ancestor
92203129|NCT00667589|Hormones|hormones|mesh-ancestor
92203130|NCT00667589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203131|NCT00667589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203132|NCT00667589|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92203133|NCT00667745|Lithium Carbonate|lithium carbonate|mesh-list
92203134|NCT00667745|Antidepressive Agents|antidepressive agents|mesh-ancestor
92203135|NCT00667745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92203136|NCT00667745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203137|NCT00667745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203138|NCT00667745|Antimanic Agents|antimanic agents|mesh-ancestor
92203139|NCT00667745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92203140|NCT00667745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203141|NCT00667745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203142|NCT03173612|Cytarabine|cytarabine|mesh-list
92203143|NCT03173612|Etoposide|etoposide|mesh-list
92203144|NCT03173612|Mitoxantrone|mitoxantrone|mesh-list
92203145|NCT03173612|Idarubicin|idarubicin|mesh-list
92203146|NCT03173612|Dasatinib|dasatinib|mesh-list
92203147|NCT03173612|Aclacinomycins|aclacinomycins|mesh-list
92203148|NCT03173612|Lenograstim|lenograstim|mesh-list
92203149|NCT03173612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92203150|NCT03173612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203151|NCT03173612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203152|NCT03173612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203153|NCT03173612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203154|NCT03173612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203155|NCT03173612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203156|NCT03173612|Antimetabolites|antimetabolites|mesh-ancestor
92203157|NCT03173612|Antiviral Agents|antiviral agents|mesh-ancestor
92203158|NCT03173612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203159|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203160|NCT03173612|Immunologic Factors|immunologic factors|mesh-ancestor
92203161|NCT03173612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203162|NCT03173612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92203163|NCT03173612|Analgesics|analgesics|mesh-ancestor
92203164|NCT03173612|Sensory System Agents|sensory system agents|mesh-ancestor
92203165|NCT03173612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203166|NCT03173612|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92203167|NCT03173612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92203168|NCT00595361|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92203169|NCT00595361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92203170|NCT00595361|Autonomic Agents|autonomic agents|mesh-ancestor
92203171|NCT00595361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203172|NCT00595361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203173|NCT00595361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92203174|NCT00595361|Respiratory System Agents|respiratory system agents|mesh-ancestor
92203175|NCT00595361|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92203176|NCT00595361|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92203177|NCT00595361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92203178|NCT00595361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92203179|NCT00595361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203180|NCT00595361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203181|NCT00596453|Ciprofloxacin|ciprofloxacin|mesh-list
92203182|NCT00596453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92203183|NCT00596453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203184|NCT00596453|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203185|NCT00596453|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203186|NCT00596453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203187|NCT00596453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203188|NCT00596453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203189|NCT00596453|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92203190|NCT00596453|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92203191|NCT00705107|Ribavirin|ribavirin|mesh-list
92203192|NCT00705107|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92203193|NCT00705107|Interferon-alpha|interferon-alpha|mesh-list
92203194|NCT00705107|Antimetabolites|antimetabolites|mesh-ancestor
92335957|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203195|NCT00705107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203196|NCT00705107|Antiviral Agents|antiviral agents|mesh-ancestor
92203197|NCT00705107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203198|NCT00705107|Immunologic Factors|immunologic factors|mesh-ancestor
92203199|NCT00705107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203200|NCT00240331|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92203201|NCT00240331|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92203202|NCT00240331|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92203203|NCT00240331|Antimetabolites|antimetabolites|mesh-ancestor
92203204|NCT00240331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203205|NCT00240331|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92203206|NCT00240331|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92203207|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203208|NCT00240097|Carboplatin|carboplatin|mesh-list
92203209|NCT00240097|Oxaliplatin|oxaliplatin|mesh-list
92203210|NCT00240097|Irinotecan|irinotecan|mesh-list
92203211|NCT00240097|Etoposide|etoposide|mesh-list
92203212|NCT00240097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203213|NCT00240097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92203214|NCT00240097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203215|NCT00240097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203216|NCT00240097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203217|NCT00240097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92203218|NCT00240097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203219|NCT04270487|Octylonium|octylonium|mesh-list
92203220|NCT04270487|Bromides|bromides|mesh-list
92203221|NCT04270487|Anticonvulsants|anticonvulsants|mesh-ancestor
92203222|NCT04270487|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92203223|NCT04270487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92203224|NCT04270487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203225|NCT04270487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92203226|NCT04270487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203227|NCT04270487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92203228|NCT04270487|Parasympatholytics|parasympatholytics|mesh-ancestor
92203229|NCT04270487|Autonomic Agents|autonomic agents|mesh-ancestor
92203230|NCT04270487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203231|NCT04270487|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92203232|NCT04270487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92203233|NCT04270487|Cholinergic Agents|cholinergic agents|mesh-ancestor
92203234|NCT04270487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203235|NCT00739999|Atorvastatin|atorvastatin|mesh-list
92203236|NCT00739999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92203237|NCT00739999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92203238|NCT00739999|Antimetabolites|antimetabolites|mesh-ancestor
92203239|NCT00739999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203240|NCT00739999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92203241|NCT00739999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92203242|NCT00739999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203243|NCT02997995|Durvalumab|durvalumab|mesh-list
92203244|NCT02997995|Tremelimumab|tremelimumab|mesh-list
92203245|NCT02997995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203246|NCT02997995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203247|NCT03620162|Vaccines|vaccines|mesh-list
92203248|NCT03620162|Immunologic Factors|immunologic factors|mesh-ancestor
92203249|NCT03620162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203250|NCT00742573|Antidepressive Agents|antidepressive agents|mesh-list
92203251|NCT00742573|Bupropion|bupropion|mesh-list
92203252|NCT00742573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92203253|NCT00742573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92203254|NCT00742573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92203255|NCT00742573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203256|NCT00742573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203257|NCT00742573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203258|NCT00742573|Dopamine Agents|dopamine agents|mesh-ancestor
92203259|NCT00742573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92203260|NCT00742573|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92203261|NCT00742573|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92203262|NCT00742573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92203263|NCT00742573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203264|NCT03809923|Lidocaine|lidocaine|mesh-list
92203265|NCT03809923|Dexmedetomidine|dexmedetomidine|mesh-list
92203266|NCT03809923|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203267|NCT03809923|Anesthetics|anesthetics|mesh-ancestor
92203268|NCT03809923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203269|NCT03809923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203270|NCT03809923|Sensory System Agents|sensory system agents|mesh-ancestor
92203271|NCT03809923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203272|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92203273|NCT03809923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92203274|NCT03809923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92203275|NCT03809923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92203276|NCT03809923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203277|NCT03809923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92203278|NCT03809923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92203279|NCT03809923|Analgesics|analgesics|mesh-ancestor
92203280|NCT03809923|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92203281|NCT03809923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92203282|NCT03809923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92203283|NCT03809923|Adrenergic Agents|adrenergic agents|mesh-ancestor
92203284|NCT03809923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203285|NCT00719329|Chlorhexidine|chlorhexidine|mesh-list
92203286|NCT00719329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92203287|NCT00719329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203288|NCT00719329|Disinfectants|disinfectants|mesh-ancestor
92203289|NCT00602225|Cytarabine|cytarabine|mesh-list
92203290|NCT00602225|Clofarabine|clofarabine|mesh-list
92203291|NCT00602225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203292|NCT00602225|Antimetabolites|antimetabolites|mesh-ancestor
92203293|NCT00602225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203294|NCT00602225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203295|NCT00602225|Antiviral Agents|antiviral agents|mesh-ancestor
92203296|NCT00602225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203297|NCT00602225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203298|NCT00602225|Immunologic Factors|immunologic factors|mesh-ancestor
92203299|NCT00602225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203300|NCT00602771|Etoposide|etoposide|mesh-list
92203301|NCT00602771|Etoposide phosphate|etoposide phosphate|mesh-list
92203302|NCT00602771|Tipifarnib|tipifarnib|mesh-list
92203303|NCT00602771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92203304|NCT00602771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203305|NCT00602771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203306|NCT00602771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203307|NCT00602771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203308|NCT00602771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203309|NCT00744211|Sitaxsentan|sitaxsentan|mesh-list
92203310|NCT00744211|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92203311|NCT00744211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203312|NCT02997371|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92203313|NCT02997371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203314|NCT04248998|Metformin|metformin|mesh-list
92203315|NCT04248998|Paclitaxel|paclitaxel|mesh-list
92203316|NCT04248998|Cyclophosphamide|cyclophosphamide|mesh-list
92203317|NCT04248998|Doxorubicin|doxorubicin|mesh-list
92203318|NCT04248998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92203319|NCT04248998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203320|NCT04248998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92203321|NCT04248998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92203322|NCT04248998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92203323|NCT04248998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203324|NCT04248998|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203325|NCT04248998|Immunologic Factors|immunologic factors|mesh-ancestor
92203326|NCT04248998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203327|NCT04248998|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203328|NCT04248998|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92203329|NCT04248998|Alkylating Agents|alkylating agents|mesh-ancestor
92203330|NCT04248998|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92203331|NCT04248998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92203332|NCT04248998|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92203333|NCT04248998|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203334|NCT04248998|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203335|NCT04248998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203336|NCT00714233|Metformin|metformin|mesh-list
92203337|NCT00714233|Contraceptive Agents|contraceptive agents|mesh-list
92203338|NCT00714233|Contraceptives, Oral|contraceptives, oral|mesh-list
92203339|NCT00714233|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92203340|NCT00714233|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92203341|NCT00714233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92203342|NCT00714233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203343|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92203344|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92203345|NCT00746395|Lubiprostone|lubiprostone|mesh-list
92203346|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92203347|NCT00746395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92203348|NCT00746395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203349|NCT04205786|Vitamin B 12|vitamin b 12|mesh-list
92203350|NCT04205786|Hydroxocobalamin|hydroxocobalamin|mesh-list
92203351|NCT04205786|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92203352|NCT04205786|Vitamins|vitamins|mesh-ancestor
92203353|NCT04205786|Micronutrients|micronutrients|mesh-ancestor
92203354|NCT04205786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203355|NCT04205786|Vitamin B Complex|vitamin b complex|mesh-ancestor
92203356|NCT04205786|Hematinics|hematinics|mesh-ancestor
92203357|NCT04205786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92203358|NCT04205786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203359|NCT04205786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203360|NCT04205786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92203361|NCT04205786|Hormone Antagonists|hormone antagonists|mesh-ancestor
92203362|NCT04205786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203363|NCT00719966|Letrozole|letrozole|mesh-list
92203364|NCT00719966|Anastrozole|anastrozole|mesh-list
92203365|NCT00719966|Exemestane|exemestane|mesh-list
92203366|NCT00719966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203367|NCT00719966|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92203368|NCT00719966|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92203369|NCT00719966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203370|NCT00719966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203371|NCT00719966|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92203372|NCT00719966|Hormone Antagonists|hormone antagonists|mesh-ancestor
92203373|NCT00719966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203374|NCT00719966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203375|NCT00719966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92203376|NCT01276067|Donepezil|donepezil|mesh-list
92203377|NCT01276067|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92203378|NCT01276067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203379|NCT01276067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203380|NCT01276067|Cholinergic Agents|cholinergic agents|mesh-ancestor
92203381|NCT01276067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203382|NCT01276067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203383|NCT01276067|Nootropic Agents|nootropic agents|mesh-ancestor
92203385|NCT04183868|Glimepiride|glimepiride|mesh-list
92203386|NCT04183868|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92203387|NCT04183868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203388|NCT04183868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92203389|NCT04183868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203390|NCT04183868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92203391|NCT04183868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203392|NCT04183868|Immunologic Factors|immunologic factors|mesh-ancestor
92203393|NCT02997215|Lidocaine|lidocaine|mesh-list
92203394|NCT02997215|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203395|NCT02997215|Anesthetics|anesthetics|mesh-ancestor
92203396|NCT02997215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203397|NCT02997215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203398|NCT02997215|Sensory System Agents|sensory system agents|mesh-ancestor
92335970|NCT01622088|Dopamine Agents|dopamine agents|mesh-ancestor
92203399|NCT02997215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203400|NCT02997215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92203401|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92203402|NCT02997215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92203403|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92203404|NCT02997215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203405|NCT02990507|Methyltestosterone|methyltestosterone|mesh-list
92203406|NCT02990507|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92203407|NCT02990507|Testosterone|testosterone|mesh-list
92203408|NCT02990507|Testosterone undecanoate|testosterone undecanoate|mesh-list
92203409|NCT02990507|Testosterone enanthate|testosterone enanthate|mesh-list
92203410|NCT02990507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92203411|NCT02990507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203412|NCT02990507|Anabolic Agents|anabolic agents|mesh-ancestor
92203413|NCT02990507|Hormones|hormones|mesh-ancestor
92203414|NCT02990507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203415|NCT02990507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203416|NCT02990507|Androgens|androgens|mesh-ancestor
92203417|NCT03331484|Rivaroxaban|rivaroxaban|mesh-list
92203418|NCT03331484|Ticagrelor|ticagrelor|mesh-list
92203419|NCT03331484|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92203420|NCT03331484|Antithrombins|antithrombins|mesh-ancestor
92203421|NCT03331484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92203422|NCT03331484|Protease Inhibitors|protease inhibitors|mesh-ancestor
92203423|NCT03331484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203424|NCT03331484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203425|NCT03331484|Anticoagulants|anticoagulants|mesh-ancestor
92203426|NCT03331484|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92203427|NCT03331484|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92203428|NCT03331484|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92203429|NCT03331484|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92203430|NCT03331484|Purinergic Agents|purinergic agents|mesh-ancestor
92203431|NCT03331484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203432|NCT03331484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203434|NCT00721513|Fluorouracil|fluorouracil|mesh-list
92203435|NCT00721513|Cetuximab|cetuximab|mesh-list
92203436|NCT00721513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203437|NCT00721513|Tubulin Modulators|tubulin modulators|mesh-ancestor
92203438|NCT00721513|Antimitotic Agents|antimitotic agents|mesh-ancestor
92203439|NCT00721513|Mitosis Modulators|mitosis modulators|mesh-ancestor
92203440|NCT00721513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203441|NCT00721513|Antimetabolites|antimetabolites|mesh-ancestor
92203442|NCT00721513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203443|NCT00721513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203444|NCT00721513|Immunologic Factors|immunologic factors|mesh-ancestor
91919528|NCT02173093|Interleukin-2|interleukin-2|mesh-list
92203445|NCT00721513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203446|NCT00721513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203447|NCT00706121|Vitamins|vitamins|mesh-list
92203448|NCT00706121|Vitamin E|vitamin e|mesh-list
92203449|NCT00706121|Tocopherols|tocopherols|mesh-list
92203450|NCT00706121|Tocotrienols|tocotrienols|mesh-list
92203451|NCT00706121|alpha-Tocopherol|alpha-tocopherol|mesh-list
92203452|NCT00706121|Selenium|selenium|mesh-list
92203453|NCT00706121|Micronutrients|micronutrients|mesh-ancestor
92203454|NCT00706121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203455|NCT00706121|Antioxidants|antioxidants|mesh-ancestor
92203456|NCT00706121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203457|NCT00706121|Protective Agents|protective agents|mesh-ancestor
92203458|NCT00706121|Trace Elements|trace elements|mesh-ancestor
92203459|NCT00746863|Bupivacaine|bupivacaine|mesh-list
92203460|NCT00746863|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203461|NCT00746863|Anesthetics|anesthetics|mesh-ancestor
92203462|NCT00746863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203463|NCT00746863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203464|NCT00746863|Sensory System Agents|sensory system agents|mesh-ancestor
92203465|NCT00746863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203466|NCT04385563|Docetaxel|docetaxel|mesh-list
92203467|NCT04385563|Trastuzumab|trastuzumab|mesh-list
92203468|NCT04385563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203469|NCT04385563|Tubulin Modulators|tubulin modulators|mesh-ancestor
92203470|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
92203471|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
92203472|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203473|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203474|NCT03568838|Enoxaparin|enoxaparin|mesh-list
92203475|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
92203476|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92203477|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92203478|NCT03568838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203479|NCT00726713|Vitamin B 12|vitamin b 12|mesh-list
92203480|NCT00726713|Vitamin B Complex|vitamin b complex|mesh-ancestor
92203481|NCT00726713|Vitamins|vitamins|mesh-ancestor
92203482|NCT00726713|Micronutrients|micronutrients|mesh-ancestor
92203483|NCT00726713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203484|NCT00759187|Chlorhexidine|chlorhexidine|mesh-list
92203485|NCT00759187|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92203486|NCT00759187|Triclosan|triclosan|mesh-list
92203487|NCT00759187|Fluorides|fluorides|mesh-list
92203488|NCT00759187|Sodium Fluoride|sodium fluoride|mesh-list
92203489|NCT00759187|Fluorophosphate|fluorophosphate|mesh-list
92203490|NCT00759187|Cariostatic Agents|cariostatic agents|mesh-ancestor
92203491|NCT00759187|Protective Agents|protective agents|mesh-ancestor
92203492|NCT00759187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203493|NCT00759187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92203494|NCT00759187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203495|NCT00759187|Disinfectants|disinfectants|mesh-ancestor
92203496|NCT00759187|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203497|NCT00759187|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92203498|NCT00759187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92203499|NCT00759187|Antimetabolites|antimetabolites|mesh-ancestor
92203500|NCT00759187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203501|NCT00759187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92203502|NCT03085940|Hydroxychloroquine|hydroxychloroquine|mesh-list
92203503|NCT03085940|Antimalarials|antimalarials|mesh-ancestor
92203504|NCT03085940|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92203505|NCT03085940|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92203506|NCT03085940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203507|NCT03085940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203508|NCT03085940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203509|NCT03085940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203510|NCT01279915|Linaclotide|linaclotide|mesh-list
92203511|NCT01279915|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92203512|NCT01279915|Enzyme Activators|enzyme activators|mesh-ancestor
92203513|NCT01279915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203514|NCT01279915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92203515|NCT03809455|Fentanyl|fentanyl|mesh-list
92203516|NCT03809455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92203517|NCT03809455|Narcotics|narcotics|mesh-ancestor
92203518|NCT03809455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203519|NCT03809455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203520|NCT03809455|Analgesics|analgesics|mesh-ancestor
92203521|NCT03809455|Sensory System Agents|sensory system agents|mesh-ancestor
92203522|NCT03809455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203523|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92203524|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92203525|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
92203526|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
92203527|NCT03618134|Durvalumab|durvalumab|mesh-list
92203528|NCT03618134|Ipilimumab|ipilimumab|mesh-list
92203530|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
92203531|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92203532|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
92203533|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203534|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203535|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
92203536|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203537|NCT03618134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92203538|NCT03618134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203539|NCT02997059|Fluconazole|fluconazole|mesh-list
92203540|NCT02997059|Antifungal Agents|antifungal agents|mesh-ancestor
92203541|NCT02997059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203542|NCT02997059|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92203543|NCT02997059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92203544|NCT02997059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203545|NCT02997059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203546|NCT02997059|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92203547|NCT02997059|Hormone Antagonists|hormone antagonists|mesh-ancestor
92203548|NCT02997059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203549|NCT02997059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203550|NCT02997059|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92203551|NCT02997059|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92203553|NCT00759811|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92203554|NCT00759811|Abortifacient Agents|abortifacient agents|mesh-ancestor
92203555|NCT00759811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92203556|NCT00759811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203557|NCT00759811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203558|NCT00759811|Antimetabolites|antimetabolites|mesh-ancestor
92203559|NCT00759811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203560|NCT00759811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203561|NCT00759811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203562|NCT00759811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203563|NCT00759811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92203564|NCT00759811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203565|NCT00759811|Immunologic Factors|immunologic factors|mesh-ancestor
92203566|NCT00759811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203567|NCT00759811|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92203569|NCT03085628|Oxytocics|oxytocics|mesh-ancestor
92203570|NCT03085628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92203571|NCT03085628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203572|NCT01276613|Gemcitabine|gemcitabine|mesh-list
92203573|NCT01276613|Losartan|losartan|mesh-list
92203574|NCT01276613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203575|NCT01276613|Antimetabolites|antimetabolites|mesh-ancestor
92203576|NCT01276613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203577|NCT01276613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203578|NCT01276613|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92203579|NCT01276613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92203580|NCT01276613|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92203581|NCT01276613|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92203582|NCT02428205|Propranolol|propranolol|mesh-list
92203583|NCT02428205|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92203584|NCT02428205|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92203585|NCT02428205|Adrenergic Agents|adrenergic agents|mesh-ancestor
92203586|NCT02428205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203587|NCT02428205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203588|NCT02428205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203589|NCT02428205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92203590|NCT02428205|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92203591|NCT02428205|Vasodilator Agents|vasodilator agents|mesh-ancestor
92203592|NCT01276691|Aspirin|aspirin|mesh-list
92203593|NCT01276691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92203594|NCT01276691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92203595|NCT01276691|Analgesics|analgesics|mesh-ancestor
92203596|NCT01276691|Sensory System Agents|sensory system agents|mesh-ancestor
92203597|NCT01276691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203598|NCT01276691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203599|NCT01276691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203601|NCT01276691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92203602|NCT01276691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92203603|NCT01276691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203604|NCT01276691|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92203605|NCT01276691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92203606|NCT01276691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203607|NCT01276691|Antipyretics|antipyretics|mesh-ancestor
92203608|NCT03081416|Diphenhydramine|diphenhydramine|mesh-list
92203609|NCT03081416|Dexamethasone|dexamethasone|mesh-list
92203610|NCT03081416|Ketorolac|ketorolac|mesh-list
92203611|NCT03081416|Ketamine|ketamine|mesh-list
92203612|NCT03081416|Metoclopramide|metoclopramide|mesh-list
92203613|NCT03081416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203614|NCT03081416|Antiemetics|antiemetics|mesh-ancestor
92203615|NCT03081416|Autonomic Agents|autonomic agents|mesh-ancestor
92203616|NCT03081416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203617|NCT03081416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335984|NCT02059434|LAS190792|las190792|mesh-list
92203618|NCT03081416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92203619|NCT03081416|Glucocorticoids|glucocorticoids|mesh-ancestor
92203620|NCT03081416|Hormones|hormones|mesh-ancestor
92203621|NCT03081416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203622|NCT03081416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92203623|NCT03081416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203624|NCT03081416|Analgesics|analgesics|mesh-ancestor
92203625|NCT03081416|Sensory System Agents|sensory system agents|mesh-ancestor
92203626|NCT03081416|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92203627|NCT03081416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92203628|NCT03081416|Anesthetics, General|anesthetics, general|mesh-ancestor
92203629|NCT03081416|Anesthetics|anesthetics|mesh-ancestor
92203630|NCT03081416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203631|NCT03081416|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92203632|NCT03081416|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92203633|NCT03081416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203634|NCT03081416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203635|NCT03081416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92203636|NCT03081416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92203637|NCT03081416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203638|NCT03081416|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92203639|NCT03081416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203640|NCT03081416|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92203641|NCT03081416|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92203642|NCT03081416|Dopamine Agents|dopamine agents|mesh-ancestor
92203643|NCT03081416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92203644|NCT03081416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92203645|NCT03081416|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203646|NCT03081416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92203647|NCT03081416|Histamine Antagonists|histamine antagonists|mesh-ancestor
92203648|NCT03081416|Histamine Agents|histamine agents|mesh-ancestor
92203649|NCT03081416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92203650|NCT00706589|Aripiprazole|aripiprazole|mesh-list
92203651|NCT00706589|Antidepressive Agents|antidepressive agents|mesh-ancestor
92203652|NCT00706589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92203653|NCT00706589|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92203654|NCT00706589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92203655|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203656|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203657|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
92203658|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
92203659|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203660|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203661|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92203662|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92203663|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
92203664|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92203665|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92203666|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92203667|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92203668|NCT01276769|Paclitaxel|paclitaxel|mesh-list
92203669|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92203670|NCT01276769|Carboplatin|carboplatin|mesh-list
92203671|NCT01276769|Epirubicin|epirubicin|mesh-list
91920297|NCT02182375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92203672|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92203673|NCT01276769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203674|NCT01276769|Tubulin Modulators|tubulin modulators|mesh-ancestor
92203675|NCT01276769|Antimitotic Agents|antimitotic agents|mesh-ancestor
92203676|NCT01276769|Mitosis Modulators|mitosis modulators|mesh-ancestor
92203677|NCT01276769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203678|NCT01276769|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92203679|NCT01276769|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203680|NCT01276769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203681|NCT01276769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203683|NCT01279681|Bevacizumab|bevacizumab|mesh-list
92203684|NCT01279681|Fluorouracil|fluorouracil|mesh-list
92203685|NCT01279681|Capecitabine|capecitabine|mesh-list
92203686|NCT01279681|Oxaliplatin|oxaliplatin|mesh-list
92203688|NCT01279681|Levoleucovorin|levoleucovorin|mesh-list
92203689|NCT01279681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203690|NCT01279681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203691|NCT01279681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92203692|NCT01279681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92203693|NCT01279681|Growth Substances|growth substances|mesh-ancestor
92203694|NCT01279681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203695|NCT01279681|Growth Inhibitors|growth inhibitors|mesh-ancestor
92203696|NCT01279681|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92203697|NCT01279681|Antimetabolites|antimetabolites|mesh-ancestor
92203698|NCT01279681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203699|NCT01279681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203700|NCT01279681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203701|NCT01279681|Immunologic Factors|immunologic factors|mesh-ancestor
92203702|NCT01279681|Antidotes|antidotes|mesh-ancestor
92203703|NCT01279681|Protective Agents|protective agents|mesh-ancestor
92203704|NCT01279681|Vitamin B Complex|vitamin b complex|mesh-ancestor
92203705|NCT01279681|Vitamins|vitamins|mesh-ancestor
92203706|NCT01279681|Micronutrients|micronutrients|mesh-ancestor
92203707|NCT01276925|Bupivacaine|bupivacaine|mesh-list
92203708|NCT01276925|Ropivacaine|ropivacaine|mesh-list
92203709|NCT01276925|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203710|NCT01276925|Anesthetics|anesthetics|mesh-ancestor
92203711|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203712|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203713|NCT01276925|Sensory System Agents|sensory system agents|mesh-ancestor
92203714|NCT01276925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203715|NCT00728507|Moxifloxacin|moxifloxacin|mesh-list
92203716|NCT00728507|Rifampin|rifampin|mesh-list
92203717|NCT00728507|Isoniazid|isoniazid|mesh-list
92203718|NCT00728507|Pyrazinamide|pyrazinamide|mesh-list
92203719|NCT00728507|Ethambutol|ethambutol|mesh-list
92203720|NCT00728507|Rifapentine|rifapentine|mesh-list
92203721|NCT00728507|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92203722|NCT00728507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203723|NCT00728507|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92203724|NCT00728507|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92203725|NCT00728507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203726|NCT00728507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203727|NCT00728507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203728|NCT00728507|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92203729|NCT00728507|Antitubercular Agents|antitubercular agents|mesh-ancestor
92203730|NCT00728507|Leprostatic Agents|leprostatic agents|mesh-ancestor
92203731|NCT00728507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92203732|NCT00728507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92203733|NCT00728507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92203734|NCT00728507|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92203735|NCT00728507|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92203736|NCT00728507|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92203737|NCT00728507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92203738|NCT00728507|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92203739|NCT00728507|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92203740|NCT00728507|Antimetabolites|antimetabolites|mesh-ancestor
92203741|NCT00728507|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92203742|NCT01279057|Fluticasone|fluticasone|mesh-list
92203743|NCT01279057|Xhance|xhance|mesh-list
92203744|NCT01279057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203745|NCT01279057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92203746|NCT01279057|Autonomic Agents|autonomic agents|mesh-ancestor
92203747|NCT01279057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203748|NCT01279057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203749|NCT01279057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92203750|NCT01279057|Respiratory System Agents|respiratory system agents|mesh-ancestor
92203751|NCT01279057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203752|NCT01279057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92203753|NCT04384783|Hormones|hormones|mesh-list
92203754|NCT04384783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203755|NCT04384783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203756|NCT03186326|Bevacizumab|bevacizumab|mesh-list
92203757|NCT03186326|Cetuximab|cetuximab|mesh-list
92203758|NCT03186326|Avelumab|avelumab|mesh-list
92203759|NCT03186326|Panitumumab|panitumumab|mesh-list
92203760|NCT03186326|Aflibercept|aflibercept|mesh-list
92203761|NCT03186326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203762|NCT03186326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203763|NCT03186326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92203764|NCT03186326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92203765|NCT03186326|Growth Substances|growth substances|mesh-ancestor
92203766|NCT03186326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203767|NCT03186326|Growth Inhibitors|growth inhibitors|mesh-ancestor
92203768|NCT02999633|Acetaminophen|acetaminophen|mesh-list
92203769|NCT02999633|Diphenhydramine|diphenhydramine|mesh-list
92203770|NCT02999633|Promethazine|promethazine|mesh-list
92203771|NCT02999633|Dexamethasone|dexamethasone|mesh-list
92203772|NCT02999633|Dexamethasone acetate|dexamethasone acetate|mesh-list
92203773|NCT02999633|Ranitidine|ranitidine|mesh-list
92203774|NCT02999633|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92203775|NCT02999633|BB 1101|bb 1101|mesh-list
92203776|NCT02999633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203777|NCT02999633|Antiemetics|antiemetics|mesh-ancestor
92203778|NCT02999633|Autonomic Agents|autonomic agents|mesh-ancestor
92203779|NCT02999633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203780|NCT02999633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203781|NCT02999633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92203782|NCT02999633|Glucocorticoids|glucocorticoids|mesh-ancestor
92203783|NCT02999633|Hormones|hormones|mesh-ancestor
92203784|NCT02999633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203785|NCT02999633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92203786|NCT02999633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203787|NCT02999633|Protease Inhibitors|protease inhibitors|mesh-ancestor
92203788|NCT02999633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203789|NCT02999633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203790|NCT02999633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92203791|NCT02999633|Analgesics|analgesics|mesh-ancestor
92203792|NCT02999633|Sensory System Agents|sensory system agents|mesh-ancestor
92203793|NCT02999633|Antipyretics|antipyretics|mesh-ancestor
92203794|NCT02999633|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92203795|NCT02999633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92203796|NCT02999633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203797|NCT02999633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203798|NCT02999633|Anesthetics|anesthetics|mesh-ancestor
92203799|NCT02999633|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92203800|NCT02999633|Histamine Antagonists|histamine antagonists|mesh-ancestor
92203801|NCT02999633|Histamine Agents|histamine agents|mesh-ancestor
92203802|NCT02999633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203803|NCT02999633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92203804|NCT02999633|Antipruritics|antipruritics|mesh-ancestor
92203805|NCT02999633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203806|NCT02999633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92203807|NCT02999633|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92203808|NCT04749797|Bupivacaine|bupivacaine|mesh-list
92203809|NCT04749797|Anesthetics, Local|anesthetics, local|mesh-ancestor
92203810|NCT04749797|Anesthetics|anesthetics|mesh-ancestor
92203811|NCT04749797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92203812|NCT04749797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203813|NCT04749797|Sensory System Agents|sensory system agents|mesh-ancestor
92203814|NCT04749797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203816|NCT02991599|Immunologic Factors|immunologic factors|mesh-ancestor
92203817|NCT02991599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203818|NCT02996513|Vitamin A|vitamin a|mesh-list
92203819|NCT02996513|Vitamins|vitamins|mesh-ancestor
92203820|NCT02996513|Micronutrients|micronutrients|mesh-ancestor
92203821|NCT02996513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203822|NCT04276688|Interferons|interferons|mesh-list
92203823|NCT04276688|Ritonavir|ritonavir|mesh-list
92203824|NCT04276688|Ribavirin|ribavirin|mesh-list
92203825|NCT04276688|Lopinavir|lopinavir|mesh-list
92203826|NCT04276688|Interferon-beta|interferon-beta|mesh-list
92203827|NCT04276688|Interferon beta-1b|interferon beta-1b|mesh-list
92203828|NCT04276688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203829|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
92203830|NCT04276688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203831|NCT04276688|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92203832|NCT04276688|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92203833|NCT04276688|Protease Inhibitors|protease inhibitors|mesh-ancestor
92203834|NCT04276688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203835|NCT04276688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203836|NCT04276688|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92203837|NCT04276688|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92203838|NCT04276688|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92203839|NCT04276688|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92203840|NCT04276688|Antimetabolites|antimetabolites|mesh-ancestor
92203841|NCT04276688|Immunologic Factors|immunologic factors|mesh-ancestor
92203842|NCT04276688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203843|NCT04276688|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92203845|NCT01277627|Nevirapine|nevirapine|mesh-list
92203846|NCT01277627|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92203847|NCT01277627|Protease Inhibitors|protease inhibitors|mesh-list
92203848|NCT01277627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92203849|NCT01277627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92203850|NCT01277627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203851|NCT01277627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203852|NCT01277627|Antiviral Agents|antiviral agents|mesh-ancestor
92203853|NCT01277627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203854|NCT01277627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92203855|NCT01277627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92203856|NCT01277627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92203857|NCT01277627|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92203858|NCT01277627|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92203859|NCT01277627|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92203860|NCT01277627|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92203861|NCT01277627|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92203862|NCT01277627|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92203863|NCT05241470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92203864|NCT05241470|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92203865|NCT01270451|Insulin|insulin|mesh-list
92203866|NCT01270451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92203867|NCT01270451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203868|NCT00706979|Nicotine|nicotine|mesh-list
92203869|NCT00706979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92203870|NCT00706979|Autonomic Agents|autonomic agents|mesh-ancestor
92203871|NCT00706979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203872|NCT00706979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203873|NCT00706979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92203874|NCT00706979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92203875|NCT00706979|Cholinergic Agents|cholinergic agents|mesh-ancestor
92203876|NCT00706979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203877|NCT00706979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203879|NCT01278017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92203880|NCT01278017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92203881|NCT00716963|Fluticasone|fluticasone|mesh-list
92203882|NCT00716963|Xhance|xhance|mesh-list
92203883|NCT00716963|Budesonide|budesonide|mesh-list
92203884|NCT00716963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203885|NCT00716963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92203886|NCT00716963|Autonomic Agents|autonomic agents|mesh-ancestor
92203887|NCT00716963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203888|NCT00716963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203889|NCT00716963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92203890|NCT00716963|Respiratory System Agents|respiratory system agents|mesh-ancestor
92203891|NCT00716963|Dermatologic Agents|dermatologic agents|mesh-ancestor
92203892|NCT00716963|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92203893|NCT00716963|Glucocorticoids|glucocorticoids|mesh-ancestor
92203894|NCT00716963|Hormones|hormones|mesh-ancestor
92203895|NCT00716963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92203896|NCT01270997|Etanercept|etanercept|mesh-list
92203897|NCT01270997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92203898|NCT01270997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92203899|NCT01270997|Analgesics|analgesics|mesh-ancestor
92203900|NCT01270997|Sensory System Agents|sensory system agents|mesh-ancestor
92203901|NCT01270997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203902|NCT01270997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203903|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203904|NCT01270997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203905|NCT01270997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92203906|NCT01270997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203907|NCT01270997|Immunologic Factors|immunologic factors|mesh-ancestor
92203908|NCT01278745|Rituximab|rituximab|mesh-list
92203909|NCT01278745|Tacrolimus|tacrolimus|mesh-list
92203910|NCT01278745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203911|NCT01278745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203912|NCT01278745|Immunologic Factors|immunologic factors|mesh-ancestor
92203913|NCT01278745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203914|NCT01278745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203915|NCT01278745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92203916|NCT01278745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92203917|NCT01278745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203918|NCT01278745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203919|NCT02995655|Azacitidine|azacitidine|mesh-list
92203920|NCT02995655|Heparin|heparin|mesh-list
92203921|NCT02995655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92203922|NCT02995655|Antimetabolites|antimetabolites|mesh-ancestor
92203923|NCT02995655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203924|NCT02995655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203925|NCT02995655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203926|NCT02995655|Anticoagulants|anticoagulants|mesh-ancestor
92203927|NCT02995655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92203928|NCT02995655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92203929|NCT01271153|Dobutamine|dobutamine|mesh-list
92203930|NCT01271153|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92203931|NCT01271153|Sympathomimetics|sympathomimetics|mesh-ancestor
92203932|NCT01271153|Autonomic Agents|autonomic agents|mesh-ancestor
92203933|NCT01271153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203934|NCT01271153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203935|NCT01271153|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92203936|NCT01271153|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92203937|NCT01271153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92203938|NCT01271153|Adrenergic Agents|adrenergic agents|mesh-ancestor
92203939|NCT01271153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203940|NCT01271153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203941|NCT01271153|Protective Agents|protective agents|mesh-ancestor
92203942|NCT03809065|Labetalol|labetalol|mesh-list
92203943|NCT03809065|Nitroglycerin|nitroglycerin|mesh-list
92203944|NCT03809065|Vasodilator Agents|vasodilator agents|mesh-ancestor
92203945|NCT03809065|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92203946|NCT03809065|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92203947|NCT03809065|Adrenergic Agents|adrenergic agents|mesh-ancestor
92203948|NCT03809065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203949|NCT03809065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203950|NCT03809065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203951|NCT03809065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92203952|NCT03809065|Sympathomimetics|sympathomimetics|mesh-ancestor
92203953|NCT03809065|Autonomic Agents|autonomic agents|mesh-ancestor
92203954|NCT03809065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203955|NCT03809065|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92203956|NCT03809065|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92203957|NCT03006926|Pembrolizumab|pembrolizumab|mesh-list
92203958|NCT03006926|Lenvatinib|lenvatinib|mesh-list
92203959|NCT03006926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92203960|NCT03006926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203961|NCT03006926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92203962|NCT03006926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203963|NCT03006926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92203964|NCT03006926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203965|NCT02995187|Apatinib|apatinib|mesh-list
92203966|NCT02995187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203967|NCT02995187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92203968|NCT02995187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92203969|NCT02995187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203970|NCT01272089|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92203971|NCT01272089|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92203972|NCT01272089|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92203973|NCT01272089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92203974|NCT01272089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92203975|NCT01272089|Analgesics|analgesics|mesh-ancestor
92203976|NCT01272089|Sensory System Agents|sensory system agents|mesh-ancestor
92203977|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92203978|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92203979|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92203980|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92203981|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92203982|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92203983|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92203984|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
92203985|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
92203986|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92203987|NCT01272089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92203988|NCT00748657|Bevacizumab|bevacizumab|mesh-list
92203989|NCT00748657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92203990|NCT00748657|Endothelial Growth Factors|endothelial growth factors|mesh-list
92203991|NCT00748657|Antibodies|antibodies|mesh-list
92203992|NCT00748657|Immunoglobulins|immunoglobulins|mesh-list
92203993|NCT00748657|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92203994|NCT00748657|Immunoglobulin G|immunoglobulin g|mesh-list
92203995|NCT00748657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92203996|NCT00748657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92203997|NCT00748657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92203998|NCT00748657|Growth Substances|growth substances|mesh-ancestor
92203999|NCT00748657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204000|NCT00748657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92204001|NCT00748657|Immunologic Factors|immunologic factors|mesh-ancestor
92204002|NCT02994953|Avelumab|avelumab|mesh-list
92204003|NCT02994953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92204004|NCT02994953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204005|NCT02994953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204006|NCT02994953|Immunologic Factors|immunologic factors|mesh-ancestor
92204007|NCT02994953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204008|NCT01273051|Capecitabine|capecitabine|mesh-list
92204009|NCT01273051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92204010|NCT01273051|Antimetabolites|antimetabolites|mesh-ancestor
92204011|NCT01273051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204012|NCT01273051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204013|NCT02994875|Acetylcysteine|acetylcysteine|mesh-list
92204014|NCT02994875|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92204015|NCT02994875|Antiviral Agents|antiviral agents|mesh-ancestor
92204016|NCT02994875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204017|NCT02994875|Expectorants|expectorants|mesh-ancestor
92204018|NCT02994875|Respiratory System Agents|respiratory system agents|mesh-ancestor
92204019|NCT02994875|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92204020|NCT02994875|Antioxidants|antioxidants|mesh-ancestor
92204021|NCT02994875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204022|NCT02994875|Protective Agents|protective agents|mesh-ancestor
92204023|NCT02994875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204025|NCT03809143|Buprenorphine|buprenorphine|mesh-list
92204026|NCT03809143|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204027|NCT03809143|Narcotics|narcotics|mesh-ancestor
92204028|NCT03809143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204029|NCT03809143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204030|NCT03809143|Analgesics|analgesics|mesh-ancestor
92204031|NCT03809143|Sensory System Agents|sensory system agents|mesh-ancestor
92204032|NCT03809143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204033|NCT03809143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92204034|NCT02390960|Sildenafil Citrate|sildenafil citrate|mesh-list
92204035|NCT02390960|Vasodilator Agents|vasodilator agents|mesh-ancestor
92204036|NCT02390960|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92204037|NCT02390960|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92204038|NCT02390960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204039|NCT02390960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204040|NCT02390960|Urological Agents|urological agents|mesh-ancestor
92204041|NCT00720473|Lamotrigine|lamotrigine|mesh-list
92204042|NCT00720473|Anticonvulsants|anticonvulsants|mesh-ancestor
92204043|NCT00720473|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92204044|NCT00720473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92204045|NCT00720473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204046|NCT00720473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92204047|NCT00720473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204048|NCT00720473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92204049|NCT00720473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92204050|NCT00720473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204051|NCT00720473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92204052|NCT00720473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92204053|NCT00637832|Prednisolone|prednisolone|mesh-list
92204054|NCT00637832|Cyclophosphamide|cyclophosphamide|mesh-list
92204055|NCT00637832|Rituximab|rituximab|mesh-list
92204056|NCT00637832|Doxorubicin|doxorubicin|mesh-list
92204057|NCT00637832|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92204058|NCT00637832|Vincristine|vincristine|mesh-list
92204059|NCT00637832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204060|NCT00637832|Immunologic Factors|immunologic factors|mesh-ancestor
92204061|NCT00637832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204062|NCT00637832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204063|NCT00637832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204064|NCT00637832|Alkylating Agents|alkylating agents|mesh-ancestor
92204065|NCT00637832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204066|NCT00637832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204067|NCT00637832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92204068|NCT00637832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204069|NCT00637832|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92204070|NCT00637832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92204071|NCT00637832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92204072|NCT00637832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204073|NCT00637832|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92204074|NCT00637832|Tubulin Modulators|tubulin modulators|mesh-ancestor
92204075|NCT00637832|Antimitotic Agents|antimitotic agents|mesh-ancestor
92204076|NCT00637832|Mitosis Modulators|mitosis modulators|mesh-ancestor
92204077|NCT00637832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204078|NCT00637832|Glucocorticoids|glucocorticoids|mesh-ancestor
92204079|NCT00637832|Hormones|hormones|mesh-ancestor
92204080|NCT00637832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204081|NCT00637832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204082|NCT00720629|Methotrexate|methotrexate|mesh-list
92204083|NCT00720629|Tacrolimus|tacrolimus|mesh-list
92204084|NCT00720629|Thymoglobulin|thymoglobulin|mesh-list
92204085|NCT00720629|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92204086|NCT00720629|Visilizumab|visilizumab|mesh-list
92204087|NCT00720629|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92204088|NCT00720629|Abortifacient Agents|abortifacient agents|mesh-ancestor
92204089|NCT00720629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204090|NCT00720629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204091|NCT00720629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92204092|NCT00720629|Antimetabolites|antimetabolites|mesh-ancestor
92204093|NCT00720629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204094|NCT00720629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204095|NCT00720629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92204096|NCT00720629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204097|NCT00720629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92204098|NCT00720629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204099|NCT00720629|Immunologic Factors|immunologic factors|mesh-ancestor
92204100|NCT00720629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204101|NCT00720629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92204102|NCT00720629|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92204103|NCT01276327|Pioglitazone|pioglitazone|mesh-list
92204104|NCT01276327|Linagliptin|linagliptin|mesh-list
92204105|NCT01276327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204106|NCT01276327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204107|NCT01276327|Incretins|incretins|mesh-ancestor
92204109|NCT01276327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204110|NCT01276327|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92204111|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92204112|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204113|NCT01276327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204114|NCT05245760|Paclitaxel|paclitaxel|mesh-list
92204115|NCT05245760|Carboplatin|carboplatin|mesh-list
92204116|NCT05245760|Tislelizumab|tislelizumab|mesh-list
92204117|NCT05245760|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92204118|NCT05245760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204119|NCT05245760|Tubulin Modulators|tubulin modulators|mesh-ancestor
92204120|NCT05245760|Antimitotic Agents|antimitotic agents|mesh-ancestor
92204121|NCT05245760|Mitosis Modulators|mitosis modulators|mesh-ancestor
92204122|NCT05245760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204123|NCT05245760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204124|NCT02674958|Aspirin|aspirin|mesh-list
92204125|NCT02674958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92204126|NCT02674958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204127|NCT02674958|Analgesics|analgesics|mesh-ancestor
92204128|NCT02674958|Sensory System Agents|sensory system agents|mesh-ancestor
92204129|NCT02674958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204130|NCT02674958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204131|NCT02674958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204132|NCT02674958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204133|NCT02674958|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92204134|NCT02674958|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92204135|NCT02674958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204136|NCT02674958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92204137|NCT02674958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92204138|NCT02674958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204139|NCT02674958|Antipyretics|antipyretics|mesh-ancestor
92204140|NCT00760435|Infliximab|infliximab|mesh-list
92204141|NCT00760435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92204142|NCT00760435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204143|NCT00760435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92204144|NCT00760435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204145|NCT00760435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204146|NCT03808129|Lidocaine|lidocaine|mesh-list
92204147|NCT03808129|Bupivacaine|bupivacaine|mesh-list
92204148|NCT03808129|Anesthetics, Local|anesthetics, local|mesh-ancestor
92204149|NCT03808129|Anesthetics|anesthetics|mesh-ancestor
92204150|NCT03808129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204151|NCT03808129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204152|NCT03808129|Sensory System Agents|sensory system agents|mesh-ancestor
92204153|NCT03808129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204154|NCT03808129|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92204155|NCT03808129|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92204156|NCT03808129|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92204157|NCT03808129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92204158|NCT03808129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204159|NCT00749125|Escitalopram|escitalopram|mesh-list
92204160|NCT00749125|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92204161|NCT00749125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92204162|NCT00749125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92204163|NCT00749125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204164|NCT00749125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204165|NCT00749125|Serotonin Agents|serotonin agents|mesh-ancestor
92204166|NCT00749125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204167|NCT02144675|Cytarabine|cytarabine|mesh-list
92204168|NCT02144675|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
92204170|NCT02144675|Idarubicin|idarubicin|mesh-list
92204171|NCT02144675|Choline|choline|mesh-list
92204172|NCT02144675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92204173|NCT02144675|Antimetabolites|antimetabolites|mesh-ancestor
92336033|NCT02017860|Everolimus|everolimus|mesh-list
92204174|NCT02144675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204175|NCT02144675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204176|NCT02144675|Antiviral Agents|antiviral agents|mesh-ancestor
92204177|NCT02144675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204178|NCT02144675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204179|NCT02144675|Immunologic Factors|immunologic factors|mesh-ancestor
92204180|NCT02144675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204181|NCT02144675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92204182|NCT02144675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92204183|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92204184|NCT02144675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204185|NCT02144675|Lipotropic Agents|lipotropic agents|mesh-ancestor
92204186|NCT02144675|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92204187|NCT02144675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204188|NCT02144675|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92204189|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
92204190|NCT02144675|Analgesics|analgesics|mesh-ancestor
92204191|NCT02144675|Sensory System Agents|sensory system agents|mesh-ancestor
92204192|NCT02144675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204193|NCT02144675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92204194|NCT02144675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204196|NCT02144675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204197|NCT02144675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92204198|NCT00749515|Deferasirox|deferasirox|mesh-list
92204199|NCT00749515|Deferoxamine|deferoxamine|mesh-list
92204200|NCT00749515|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92204201|NCT00749515|Chelating Agents|chelating agents|mesh-ancestor
92204202|NCT00749515|Sequestering Agents|sequestering agents|mesh-ancestor
92204203|NCT00749515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204204|NCT00749515|Siderophores|siderophores|mesh-ancestor
92204205|NCT01272557|Doxorubicin|doxorubicin|mesh-list
92204206|NCT01272557|Sorafenib|sorafenib|mesh-list
92204207|NCT01272557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92204208|NCT01272557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204209|NCT01272557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92204210|NCT01272557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92204211|NCT01272557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204212|NCT01272557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204213|NCT01272557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92204214|NCT00639002|Dexamethasone|dexamethasone|mesh-list
92204215|NCT00639002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204216|NCT00639002|Antiemetics|antiemetics|mesh-ancestor
92204217|NCT00639002|Autonomic Agents|autonomic agents|mesh-ancestor
92204218|NCT00639002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204219|NCT00639002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204220|NCT00639002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204221|NCT00639002|Glucocorticoids|glucocorticoids|mesh-ancestor
92204222|NCT00639002|Hormones|hormones|mesh-ancestor
92204223|NCT00639002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204224|NCT00639002|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204225|NCT00639002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204226|NCT00761137|Tropicamide|tropicamide|mesh-list
92204227|NCT00761137|Mydriatics|mydriatics|mesh-ancestor
92204228|NCT00761137|Autonomic Agents|autonomic agents|mesh-ancestor
92204229|NCT00761137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204230|NCT00761137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204231|NCT00761137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92204232|NCT00761137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92204233|NCT00761137|Cholinergic Agents|cholinergic agents|mesh-ancestor
92204234|NCT00761137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204235|NCT00761137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204236|NCT02145247|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92204237|NCT02145247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204238|NCT02145247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204239|NCT01273493|Dexamethasone|dexamethasone|mesh-list
92204240|NCT01273493|Trabectedin|trabectedin|mesh-list
92204241|NCT01273493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204242|NCT01273493|Antiemetics|antiemetics|mesh-ancestor
92204243|NCT01273493|Autonomic Agents|autonomic agents|mesh-ancestor
92204244|NCT01273493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204245|NCT01273493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204246|NCT01273493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204247|NCT01273493|Glucocorticoids|glucocorticoids|mesh-ancestor
92204248|NCT01273493|Hormones|hormones|mesh-ancestor
92204249|NCT01273493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204250|NCT01273493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204251|NCT01273493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204252|NCT01273493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204253|NCT01273493|Alkylating Agents|alkylating agents|mesh-ancestor
92204254|NCT01273493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204255|NCT00638456|Budesonide|budesonide|mesh-list
92204256|NCT00638456|Lansoprazole|lansoprazole|mesh-list
92204257|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
92204258|NCT00638456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204259|NCT00638456|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92204260|NCT00638456|Autonomic Agents|autonomic agents|mesh-ancestor
92204261|NCT00638456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204262|NCT00638456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204263|NCT00638456|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92204264|NCT00638456|Respiratory System Agents|respiratory system agents|mesh-ancestor
92204266|NCT00638456|Hormones|hormones|mesh-ancestor
92204267|NCT00638456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204268|NCT00638456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92204269|NCT00638456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204270|NCT00638456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92204271|NCT00638456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204272|NCT00638456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204273|NCT01273571|Metformin|metformin|mesh-list
92204274|NCT01273571|Canagliflozin|canagliflozin|mesh-list
92204275|NCT01273571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204276|NCT01273571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204277|NCT01273571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92204278|NCT01273571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204279|NCT02147899|Secnidazole|secnidazole|mesh-list
92204280|NCT02147899|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92204281|NCT02147899|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92204282|NCT02147899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204283|NCT02565992|Pembrolizumab|pembrolizumab|mesh-list
92204284|NCT02565992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204285|NCT02565992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204286|NCT02565992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92204287|NCT02565992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204288|NCT03132116|Gentamicins|gentamicins|mesh-list
92204289|NCT03132116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92204290|NCT03132116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204291|NCT03132116|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92204292|NCT03132116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204293|NCT03132116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204294|NCT00762619|Triclosan|triclosan|mesh-list
92204295|NCT00762619|Fluorides|fluorides|mesh-list
92204296|NCT00762619|Cariostatic Agents|cariostatic agents|mesh-ancestor
92204297|NCT00762619|Protective Agents|protective agents|mesh-ancestor
92204298|NCT00762619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204299|NCT00762619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92204300|NCT00762619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204301|NCT00762619|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92204302|NCT00762619|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92204303|NCT00762619|Antimetabolites|antimetabolites|mesh-ancestor
92204304|NCT00762619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204305|NCT00762619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92204306|NCT00735449|Timolol|timolol|mesh-list
92204307|NCT00735449|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92204308|NCT00735449|Latanoprost|latanoprost|mesh-list
92204309|NCT00735449|Maleic acid|maleic acid|mesh-list
92204310|NCT00735449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204311|NCT00735449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204312|NCT00735449|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92204313|NCT00735449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92204314|NCT00735449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92204315|NCT00735449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204316|NCT00735449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204317|NCT00735449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92204318|NCT00735449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92204320|NCT00735449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92204321|NCT00735449|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92204322|NCT00735449|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92204323|NCT00735449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92204324|NCT01273831|Cisatracurium|cisatracurium|mesh-list
92204325|NCT01273831|Atracurium|atracurium|mesh-list
92204326|NCT01273831|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92204327|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92204328|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204329|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204330|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92204331|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92204332|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92204333|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
92204334|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204335|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204337|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92204338|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92204339|NCT00735917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204340|NCT00735917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204341|NCT00735917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204342|NCT00736073|Aprepitant|aprepitant|mesh-list
92204343|NCT00736073|Antiemetics|antiemetics|mesh-ancestor
92204344|NCT00736073|Autonomic Agents|autonomic agents|mesh-ancestor
92204345|NCT00736073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204346|NCT00736073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204347|NCT00736073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204348|NCT00736073|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92204349|NCT00736073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204350|NCT00736073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204351|NCT00736229|Exenatide|exenatide|mesh-list
92204352|NCT00736229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204353|NCT00736229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204354|NCT00736229|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92204355|NCT00736229|Incretins|incretins|mesh-ancestor
92204356|NCT00736229|Hormones|hormones|mesh-ancestor
92204357|NCT00736229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204358|NCT00737243|Paclitaxel|paclitaxel|mesh-list
92204359|NCT00737243|Bevacizumab|bevacizumab|mesh-list
92204360|NCT00737243|Carboplatin|carboplatin|mesh-list
92204361|NCT00737243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92204362|NCT00737243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92204363|NCT00737243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204364|NCT00737243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92204365|NCT00737243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92204366|NCT00737243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92204367|NCT00737243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204368|NCT00737243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204369|NCT00737243|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92204370|NCT00737243|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92204371|NCT00737243|Growth Substances|growth substances|mesh-ancestor
92204372|NCT00737243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204373|NCT00737243|Growth Inhibitors|growth inhibitors|mesh-ancestor
92204374|NCT00737243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92204375|NCT00737243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204376|NCT00707759|Mycophenolic Acid|mycophenolic acid|mesh-list
92204377|NCT00707759|Prednisone|prednisone|mesh-list
92204378|NCT00707759|Prednisolone|prednisolone|mesh-list
92204379|NCT00707759|Tacrolimus|tacrolimus|mesh-list
92204380|NCT00707759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204381|NCT00707759|Glucocorticoids|glucocorticoids|mesh-ancestor
92204382|NCT00707759|Hormones|hormones|mesh-ancestor
92204383|NCT00707759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204384|NCT00707759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204385|NCT00707759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204386|NCT00707759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204387|NCT00707759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204388|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
92204389|NCT00707759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92204390|NCT00707759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336048|NCT04720716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204391|NCT00707759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204392|NCT00707759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92204393|NCT00707759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92204394|NCT00707759|Antitubercular Agents|antitubercular agents|mesh-ancestor
92204395|NCT00707759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92204396|NCT00707759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204398|NCT01273727|Dexamethasone acetate|dexamethasone acetate|mesh-list
92204399|NCT01273727|BB 1101|bb 1101|mesh-list
92204400|NCT01273727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204401|NCT01273727|Antiemetics|antiemetics|mesh-ancestor
92204402|NCT01273727|Autonomic Agents|autonomic agents|mesh-ancestor
92204403|NCT01273727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204404|NCT01273727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204405|NCT01273727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204406|NCT01273727|Glucocorticoids|glucocorticoids|mesh-ancestor
92204407|NCT01273727|Hormones|hormones|mesh-ancestor
92204408|NCT01273727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204409|NCT01273727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204410|NCT01273727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204411|NCT01273727|Protease Inhibitors|protease inhibitors|mesh-ancestor
92204412|NCT01273727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204413|NCT01273727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204414|NCT00708071|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92204415|NCT00708071|Thrombin|thrombin|mesh-list
92204416|NCT00708071|Aprotinin|aprotinin|mesh-list
92204417|NCT00708071|Hemostatics|hemostatics|mesh-ancestor
92204418|NCT00708071|Coagulants|coagulants|mesh-ancestor
92204419|NCT00708071|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92204420|NCT00708071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92204421|NCT00708071|Protease Inhibitors|protease inhibitors|mesh-ancestor
92204422|NCT00708071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204423|NCT00708071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204424|NCT02994485|Simvastatin|simvastatin|mesh-list
92204425|NCT02994485|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92204426|NCT02994485|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92204427|NCT02994485|Antimetabolites|antimetabolites|mesh-ancestor
92204428|NCT02994485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204429|NCT02994485|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92204430|NCT02994485|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92204431|NCT02994485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204432|NCT02994173|Ketamine|ketamine|mesh-list
92204433|NCT02994173|Oxycodone|oxycodone|mesh-list
92204434|NCT02994173|Esketamine|esketamine|mesh-list
92204435|NCT02994173|Analgesics|analgesics|mesh-ancestor
92204436|NCT02994173|Sensory System Agents|sensory system agents|mesh-ancestor
92204437|NCT02994173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204438|NCT02994173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204439|NCT02994173|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92204440|NCT02994173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92204441|NCT02994173|Anesthetics, General|anesthetics, general|mesh-ancestor
92204442|NCT02994173|Anesthetics|anesthetics|mesh-ancestor
92204443|NCT02994173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204444|NCT02994173|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92204445|NCT02994173|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92204446|NCT02994173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204447|NCT02994173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204448|NCT02994173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204449|NCT02994173|Narcotics|narcotics|mesh-ancestor
92204450|NCT02994173|Antidepressive Agents|antidepressive agents|mesh-ancestor
92204451|NCT02994173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92204452|NCT00723749|Buprenorphine|buprenorphine|mesh-list
92204453|NCT00723749|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92204454|NCT00723749|Naloxone|naloxone|mesh-list
92204455|NCT00723749|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204456|NCT00723749|Narcotics|narcotics|mesh-ancestor
92204457|NCT00723749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204458|NCT00723749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204459|NCT00723749|Analgesics|analgesics|mesh-ancestor
92204460|NCT00723749|Sensory System Agents|sensory system agents|mesh-ancestor
92204461|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204462|NCT00723749|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92204463|NCT00723827|Temozolomide|temozolomide|mesh-list
92204464|NCT00723827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204465|NCT00723827|Alkylating Agents|alkylating agents|mesh-ancestor
92204466|NCT00723827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204467|NCT00723827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204468|NCT02993861|Anticonvulsants|anticonvulsants|mesh-list
92204469|NCT00779311|Bevacizumab|bevacizumab|mesh-list
92204470|NCT00779311|Sorafenib|sorafenib|mesh-list
92204471|NCT00779311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204472|NCT00779311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204473|NCT00779311|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92204474|NCT00779311|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92204475|NCT00779311|Growth Substances|growth substances|mesh-ancestor
91933994|NCT02229617|Androgens|androgens|mesh-ancestor
92204476|NCT00779311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204477|NCT00779311|Growth Inhibitors|growth inhibitors|mesh-ancestor
92204478|NCT00779311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92204479|NCT00779311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204480|NCT00779311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204481|NCT01274039|Acetazolamide|acetazolamide|mesh-list
92204482|NCT01274039|Anticonvulsants|anticonvulsants|mesh-ancestor
92204483|NCT01274039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92204484|NCT01274039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204485|NCT01274039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204486|NCT01274039|Diuretics|diuretics|mesh-ancestor
92204487|NCT01274039|Natriuretic Agents|natriuretic agents|mesh-ancestor
92204488|NCT01274039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204489|NCT01274195|Busulfan|busulfan|mesh-list
92204490|NCT01274195|Alkylating Agents|alkylating agents|mesh-ancestor
92204491|NCT01274195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204492|NCT01274195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204493|NCT01274195|Immunologic Factors|immunologic factors|mesh-ancestor
92204494|NCT01274195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204495|NCT01274195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204496|NCT01274195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204497|NCT01274195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92204498|NCT00779701|Insulin|insulin|mesh-list
92204499|NCT00779701|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204500|NCT00779701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204501|NCT00738023|Rosiglitazone|rosiglitazone|mesh-list
92204502|NCT00738023|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92204503|NCT00738023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204504|NCT00738023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204505|NCT00738023|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92204506|NCT00738023|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92204507|NCT00738023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92204508|NCT03809221|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92204509|NCT03809221|Hormones|hormones|mesh-list
91920527|NCT02177539|Oxymetazoline|oxymetazoline|mesh-list
92204510|NCT03809221|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92204511|NCT03809221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204512|NCT03809221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204513|NCT03809221|Luteolytic Agents|luteolytic agents|mesh-ancestor
92204514|NCT03809221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92204515|NCT03809221|Contraceptive Agents|contraceptive agents|mesh-ancestor
92204516|NCT03809221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204517|NCT03809221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92204518|NCT03809221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204519|NCT03809221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204520|NCT02993159|Tamoxifen|tamoxifen|mesh-list
92204521|NCT02993159|Afimoxifene|afimoxifene|mesh-list
92204522|NCT02993159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92204523|NCT02993159|Hormone Antagonists|hormone antagonists|mesh-ancestor
92204524|NCT02993159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204525|NCT02993159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204526|NCT02993159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204527|NCT02993159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204528|NCT02993159|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92204529|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92204530|NCT02993159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92204531|NCT00723931|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92204532|NCT00723931|Antiviral Agents|antiviral agents|mesh-ancestor
92204533|NCT00723931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204534|NCT00740129|Zoledronic Acid|zoledronic acid|mesh-list
92204535|NCT00740129|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92204536|NCT00740129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204537|NCT00762853|Triclosan|triclosan|mesh-list
92204538|NCT00762853|Fluorides|fluorides|mesh-list
92204539|NCT00762853|Cariostatic Agents|cariostatic agents|mesh-ancestor
92204540|NCT00762853|Protective Agents|protective agents|mesh-ancestor
92204541|NCT00762853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204542|NCT00762853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92204543|NCT00762853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204544|NCT00762853|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92204546|NCT00762853|Antimetabolites|antimetabolites|mesh-ancestor
91934004|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
92204547|NCT00762853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204548|NCT00762853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92204550|NCT00724009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92204551|NCT00724009|Antimetabolites|antimetabolites|mesh-ancestor
92204552|NCT00724009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204553|NCT00724009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204554|NCT01279499|Remifentanil|remifentanil|mesh-list
92204555|NCT01279499|Propofol|propofol|mesh-list
92204556|NCT01279499|Sevoflurane|sevoflurane|mesh-list
92204557|NCT01279499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92204558|NCT01279499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204559|NCT01279499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204560|NCT01279499|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92204561|NCT01279499|Anesthetics, General|anesthetics, general|mesh-ancestor
92204562|NCT01279499|Anesthetics|anesthetics|mesh-ancestor
92204563|NCT01279499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92204564|NCT01279499|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92204565|NCT01279499|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204566|NCT01279499|Narcotics|narcotics|mesh-ancestor
92204567|NCT01279499|Analgesics|analgesics|mesh-ancestor
92204568|NCT01279499|Sensory System Agents|sensory system agents|mesh-ancestor
92204569|NCT01279499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204570|NCT02992925|Vaccines|vaccines|mesh-list
92204571|NCT02992925|Immunologic Factors|immunologic factors|mesh-ancestor
92204572|NCT02992925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204573|NCT00780715|Metformin|metformin|mesh-list
92204574|NCT00780715|Pioglitazone|pioglitazone|mesh-list
92204575|NCT00780715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92204576|NCT00780715|Gliclazide|gliclazide|mesh-list
92204577|NCT00780715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204578|NCT00780715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204579|NCT00780715|Incretins|incretins|mesh-ancestor
92204580|NCT00780715|Hormones|hormones|mesh-ancestor
92204581|NCT00780715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204582|NCT00780715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92204583|NCT00780715|Protease Inhibitors|protease inhibitors|mesh-ancestor
92204584|NCT00780715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204585|NCT00780715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204586|NCT05318443|Paclitaxel|paclitaxel|mesh-list
92204587|NCT05318443|Carboplatin|carboplatin|mesh-list
92204588|NCT05318443|Bevacizumab|bevacizumab|mesh-list
92204589|NCT05318443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92204590|NCT05318443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204591|NCT05318443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92204592|NCT05318443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92204593|NCT05318443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92204594|NCT05318443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204595|NCT05318443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204596|NCT05318443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92204597|NCT05318443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92204598|NCT05318443|Growth Substances|growth substances|mesh-ancestor
92204599|NCT05318443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204600|NCT05318443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92204601|NCT00740831|Leuprolide|leuprolide|mesh-list
92204602|NCT00740831|Ulipristal acetate|ulipristal acetate|mesh-list
92204603|NCT00740831|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92204604|NCT00740831|Fertility Agents|fertility agents|mesh-ancestor
92204605|NCT00740831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204606|NCT00740831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204607|NCT00740831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204608|NCT00740831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204609|NCT00740831|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92204610|NCT00740831|Contraceptive Agents|contraceptive agents|mesh-ancestor
92204611|NCT00740831|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92204612|NCT01275287|Eculizumab|eculizumab|mesh-list
92204613|NCT01275287|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92204614|NCT01275287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204615|NCT01275287|Immunologic Factors|immunologic factors|mesh-ancestor
92204616|NCT01275287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204617|NCT01275443|Rilpivirine|rilpivirine|mesh-list
92204618|NCT01275443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92204619|NCT01275443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92204620|NCT01275443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204621|NCT01275443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204622|NCT01275443|Antiviral Agents|antiviral agents|mesh-ancestor
92204623|NCT01275443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204624|NCT01275443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92204625|NCT01275443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92204626|NCT01274221|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92204627|NCT01274221|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92204628|NCT01274221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204629|NCT01274221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92204630|NCT01274221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92204631|NCT01274221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92204632|NCT01274221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204633|NCT01274221|Dopamine Agents|dopamine agents|mesh-ancestor
92204634|NCT01274221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204635|NCT00741455|Cyclosporine|cyclosporine|mesh-list
92204636|NCT00741455|Cyclophosphamide|cyclophosphamide|mesh-list
92204637|NCT00741455|Methotrexate|methotrexate|mesh-list
92204638|NCT00741455|Fludarabine|fludarabine|mesh-list
92204639|NCT00741455|Cyclosporins|cyclosporins|mesh-list
92204640|NCT00741455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204641|NCT00741455|Immunologic Factors|immunologic factors|mesh-ancestor
92204642|NCT00741455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204643|NCT00741455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204644|NCT00741455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204645|NCT00741455|Alkylating Agents|alkylating agents|mesh-ancestor
92204646|NCT00741455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204647|NCT00741455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204648|NCT00741455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92204649|NCT00741455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92204650|NCT00741455|Abortifacient Agents|abortifacient agents|mesh-ancestor
92204651|NCT00741455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204652|NCT00741455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92204653|NCT00741455|Antimetabolites|antimetabolites|mesh-ancestor
92204654|NCT00741455|Dermatologic Agents|dermatologic agents|mesh-ancestor
92204655|NCT00741455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204656|NCT00741455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92204657|NCT00741455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92204658|NCT00741455|Antifungal Agents|antifungal agents|mesh-ancestor
92204659|NCT00741455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204660|NCT00741455|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92204661|NCT00742313|Hemostatics|hemostatics|mesh-list
92204662|NCT00742313|Coagulants|coagulants|mesh-ancestor
92204663|NCT00742469|Rifaximin|rifaximin|mesh-list
92204664|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92204665|NCT00742469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204666|NCT00742469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204667|NCT01275599|Buprenorphine|buprenorphine|mesh-list
92204668|NCT01275599|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92204669|NCT01275599|Naloxone|naloxone|mesh-list
92204670|NCT01275599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204671|NCT01275599|Narcotics|narcotics|mesh-ancestor
92204672|NCT01275599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204673|NCT01275599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204674|NCT01275599|Analgesics|analgesics|mesh-ancestor
92204675|NCT01275599|Sensory System Agents|sensory system agents|mesh-ancestor
92204676|NCT01275599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204677|NCT01275599|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92204678|NCT02992457|Interferons|interferons|mesh-list
92204679|NCT02992457|Ribavirin|ribavirin|mesh-list
92204680|NCT02992457|Interferon-alpha|interferon-alpha|mesh-list
92204681|NCT02992457|Interferon alpha-2|interferon alpha-2|mesh-list
92204682|NCT02992457|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92204683|NCT02992457|Sofosbuvir|sofosbuvir|mesh-list
92204684|NCT02992457|Ledipasvir|ledipasvir|mesh-list
92204685|NCT02992457|Simeprevir|simeprevir|mesh-list
92204686|NCT02992457|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92204687|NCT02992457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204688|NCT02992457|Antiviral Agents|antiviral agents|mesh-ancestor
92204689|NCT02992457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204690|NCT02992457|Antimetabolites|antimetabolites|mesh-ancestor
92204691|NCT02992457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204692|NCT02992457|Immunologic Factors|immunologic factors|mesh-ancestor
92204693|NCT02992457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204694|NCT02992457|Protease Inhibitors|protease inhibitors|mesh-ancestor
92204695|NCT02992457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204696|NCT00782821|Rituximab|rituximab|mesh-list
92204697|NCT00782821|Bortezomib|bortezomib|mesh-list
92204698|NCT00782821|Thymoglobulin|thymoglobulin|mesh-list
92204699|NCT00782821|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92204700|NCT00782821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204701|NCT00782821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204702|NCT00782821|Immunologic Factors|immunologic factors|mesh-ancestor
92204703|NCT00782821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204704|NCT00782821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204705|NCT00782821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204706|NCT00743093|Acetaminophen|acetaminophen|mesh-list
92204707|NCT00743093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204708|NCT00743093|Analgesics|analgesics|mesh-ancestor
92204709|NCT00743093|Sensory System Agents|sensory system agents|mesh-ancestor
92204710|NCT00743093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204711|NCT00743093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204712|NCT00743093|Antipyretics|antipyretics|mesh-ancestor
92204713|NCT03805945|Dexmedetomidine|dexmedetomidine|mesh-list
92204714|NCT03805945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92204715|NCT03805945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204716|NCT03805945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204717|NCT03805945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204718|NCT03805945|Analgesics|analgesics|mesh-ancestor
92204719|NCT03805945|Sensory System Agents|sensory system agents|mesh-ancestor
92204720|NCT03805945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204721|NCT03805945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92204722|NCT03805945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92204723|NCT03805945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92204724|NCT03805945|Adrenergic Agents|adrenergic agents|mesh-ancestor
92204725|NCT03805945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204726|NCT03805945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204727|NCT04270019|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92204728|NCT04270019|Laxatives|laxatives|mesh-ancestor
92204729|NCT04270019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204730|NCT02992301|Alirocumab|alirocumab|mesh-list
92204731|NCT02992301|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92204732|NCT02992301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92204733|NCT02992301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92204734|NCT02992301|Antimetabolites|antimetabolites|mesh-ancestor
92204735|NCT02992301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204736|NCT02992301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92204737|NCT02992301|Protease Inhibitors|protease inhibitors|mesh-ancestor
92204738|NCT02992301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204739|NCT02992301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92204740|NCT00743717|Cobalt|cobalt|mesh-list
92204741|NCT00743717|Trace Elements|trace elements|mesh-ancestor
92204742|NCT00743717|Micronutrients|micronutrients|mesh-ancestor
92204743|NCT00743717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204744|NCT00744965|Glyburide|glyburide|mesh-list
92336072|NCT04678362|Avelumab|avelumab|mesh-list
92204745|NCT00744965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204746|NCT00744965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204747|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
92204748|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
92204749|NCT00763867|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92204750|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92204751|NCT00763867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204752|NCT00763867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204753|NCT00763867|Urological Agents|urological agents|mesh-ancestor
92204754|NCT00711347|Hyaluronic Acid|hyaluronic acid|mesh-list
92204755|NCT00711347|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92204756|NCT00711347|Immunologic Factors|immunologic factors|mesh-ancestor
92204757|NCT00711347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204758|NCT00711347|Viscosupplements|viscosupplements|mesh-ancestor
92204759|NCT00711347|Protective Agents|protective agents|mesh-ancestor
92204760|NCT01276223|Fluprednisolone|fluprednisolone|mesh-list
92204762|NCT01276223|Glucocorticoids|glucocorticoids|mesh-ancestor
92204763|NCT01276223|Hormones|hormones|mesh-ancestor
92204764|NCT01276223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204765|NCT01276223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204766|NCT01276223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204767|NCT00784225|Vitamins|vitamins|mesh-list
92204768|NCT00784225|Vitamin E|vitamin e|mesh-list
92204769|NCT00784225|Tocopherols|tocopherols|mesh-list
92204770|NCT00784225|Tocotrienols|tocotrienols|mesh-list
92204771|NCT00784225|alpha-Tocopherol|alpha-tocopherol|mesh-list
92204772|NCT00784225|Selenium|selenium|mesh-list
92204773|NCT00784225|Micronutrients|micronutrients|mesh-ancestor
92204774|NCT00784225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204775|NCT00784225|Antioxidants|antioxidants|mesh-ancestor
92204776|NCT00784225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204777|NCT00784225|Protective Agents|protective agents|mesh-ancestor
92204778|NCT00784225|Trace Elements|trace elements|mesh-ancestor
92204779|NCT02991911|MEDI3726|medi3726|mesh-list
92204780|NCT02991911|Immunoconjugates|immunoconjugates|mesh-ancestor
92204781|NCT02991911|Immunologic Factors|immunologic factors|mesh-ancestor
92204782|NCT02991911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204783|NCT01275131|Insulin Aspart|insulin aspart|mesh-list
92204784|NCT01275131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92204785|NCT01275131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204786|NCT01273805|Hydroxychloroquine|hydroxychloroquine|mesh-list
92204787|NCT01273805|Antimalarials|antimalarials|mesh-ancestor
92204788|NCT01273805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92204789|NCT01273805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92204790|NCT01273805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204791|NCT01273805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204792|NCT01273805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204793|NCT01273805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204794|NCT01273181|Aldesleukin|aldesleukin|mesh-list
92204795|NCT01273181|Cyclophosphamide|cyclophosphamide|mesh-list
92204796|NCT01273181|Fludarabine|fludarabine|mesh-list
92204797|NCT01273181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204798|NCT01273181|Immunologic Factors|immunologic factors|mesh-ancestor
92204799|NCT01273181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204800|NCT01273181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204801|NCT01273181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204802|NCT01273181|Alkylating Agents|alkylating agents|mesh-ancestor
92204803|NCT01273181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204804|NCT01273181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204805|NCT01273181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92204806|NCT01273181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92204807|NCT01273181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92204808|NCT01273181|Antiviral Agents|antiviral agents|mesh-ancestor
92204809|NCT01273181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204811|NCT01272947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92204812|NCT01272947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204813|NCT01272947|Analgesics|analgesics|mesh-ancestor
92204814|NCT01272947|Sensory System Agents|sensory system agents|mesh-ancestor
91920528|NCT02177539|Tropicamide|tropicamide|mesh-list
92204815|NCT01272947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204816|NCT01272947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204817|NCT01272947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204818|NCT01272947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204819|NCT01272947|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92204820|NCT01272947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204821|NCT01272947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204822|NCT01279343|Misoprostol|misoprostol|mesh-list
92204823|NCT01279343|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92204824|NCT01279343|Abortifacient Agents|abortifacient agents|mesh-ancestor
92204825|NCT01279343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204826|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204827|NCT01279343|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92204828|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204829|NCT01279343|Oxytocics|oxytocics|mesh-ancestor
92204830|NCT01278797|Amlodipine|amlodipine|mesh-list
92204831|NCT01278797|Telmisartan|telmisartan|mesh-list
92204832|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92204833|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92204834|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92204835|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92204836|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204837|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92204838|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204839|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
92204840|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92204841|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92204842|NCT01272635|Azithromycin|azithromycin|mesh-list
92204843|NCT01272635|Prednisolone|prednisolone|mesh-list
92204844|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92204845|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
92204846|NCT01272635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92204847|NCT01272635|Prednisolone acetate|prednisolone acetate|mesh-list
92204848|NCT01272635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92204849|NCT01272635|Prednisolone phosphate|prednisolone phosphate|mesh-list
92204851|NCT01272635|Glucocorticoids|glucocorticoids|mesh-ancestor
92204852|NCT01272635|Hormones|hormones|mesh-ancestor
92204853|NCT01272635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204854|NCT01272635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204855|NCT01272635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204856|NCT01272635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204857|NCT01272635|Antiemetics|antiemetics|mesh-ancestor
92204858|NCT01272635|Autonomic Agents|autonomic agents|mesh-ancestor
92204859|NCT01272635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204860|NCT01272635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204861|NCT01272635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92204862|NCT01272635|Protective Agents|protective agents|mesh-ancestor
92204863|NCT01272635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92204864|NCT01272635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204865|NCT04387097|Remifentanil|remifentanil|mesh-list
92204866|NCT04387097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204868|NCT04387097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204869|NCT04387097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204870|NCT04387097|Analgesics|analgesics|mesh-ancestor
92204871|NCT04387097|Sensory System Agents|sensory system agents|mesh-ancestor
92204872|NCT04387097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204873|NCT01270841|Enclomiphene|enclomiphene|mesh-list
92204874|NCT01270841|Clomiphene|clomiphene|mesh-list
92204875|NCT01270841|Zuclomiphene|zuclomiphene|mesh-list
92204876|NCT01270841|Testosterone|testosterone|mesh-list
92204877|NCT01270841|Androgens|androgens|mesh-ancestor
92204878|NCT01270841|Hormones|hormones|mesh-ancestor
92204879|NCT01270841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204880|NCT01270841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204881|NCT01270841|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92204882|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
92204883|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92204884|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
92204885|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92204886|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92204887|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92204888|NCT01278407|Donepezil|donepezil|mesh-list
92204889|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92204890|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117127|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
92204891|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204892|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
92204893|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204894|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204895|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
92204896|NCT01278173|Vigabatrin|vigabatrin|mesh-list
92204897|NCT01278173|Anticonvulsants|anticonvulsants|mesh-ancestor
92204898|NCT01278173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204899|NCT01278173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204900|NCT01278173|GABA Agents|gaba agents|mesh-ancestor
92204901|NCT01278173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92204902|NCT01278173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204903|NCT00784303|Lenvatinib|lenvatinib|mesh-list
92204904|NCT00784303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204905|NCT00784303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92204906|NCT00784303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204907|NCT00784303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204908|NCT00750815|Dexamethasone|dexamethasone|mesh-list
92204909|NCT00750815|Cyclophosphamide|cyclophosphamide|mesh-list
92204910|NCT00750815|Doxorubicin|doxorubicin|mesh-list
92204911|NCT00750815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92204912|NCT00750815|Bortezomib|bortezomib|mesh-list
92204913|NCT00750815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204914|NCT00750815|Immunologic Factors|immunologic factors|mesh-ancestor
92204915|NCT00750815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204916|NCT00750815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204917|NCT00750815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92204918|NCT00750815|Alkylating Agents|alkylating agents|mesh-ancestor
92204919|NCT00750815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204920|NCT00750815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204921|NCT00750815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92204922|NCT00750815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204923|NCT00750815|Antiemetics|antiemetics|mesh-ancestor
92204924|NCT00750815|Autonomic Agents|autonomic agents|mesh-ancestor
91934007|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
92204925|NCT00750815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204927|NCT00750815|Glucocorticoids|glucocorticoids|mesh-ancestor
92204928|NCT00750815|Hormones|hormones|mesh-ancestor
92204929|NCT00750815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92204930|NCT00750815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92204931|NCT00750815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92204932|NCT00750815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92204933|NCT00750815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92204934|NCT00750815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204935|NCT00784849|Methylene Blue|methylene blue|mesh-list
92204936|NCT00784849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92204937|NCT00784849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204938|NCT01277861|Fentanyl|fentanyl|mesh-list
92204939|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92204941|NCT01277861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92204942|NCT01277861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204943|NCT01277861|Analgesics|analgesics|mesh-ancestor
92204944|NCT01277861|Sensory System Agents|sensory system agents|mesh-ancestor
92204945|NCT01277861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204946|NCT01277861|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92204947|NCT01277861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92204948|NCT01277861|Anesthetics, General|anesthetics, general|mesh-ancestor
92204949|NCT01277861|Anesthetics|anesthetics|mesh-ancestor
92204950|NCT00786487|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92204951|NCT00786487|Glycerol|glycerol|mesh-list
92204952|NCT00786487|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92336085|NCT04678050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204953|NCT00786487|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92204954|NCT00786487|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92204955|NCT00786487|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92204956|NCT00786487|Protective Agents|protective agents|mesh-ancestor
92204957|NCT00786487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204958|NCT03805633|Pancrelipase|pancrelipase|mesh-list
92204959|NCT03805633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204960|NCT01276847|Etanercept|etanercept|mesh-list
92204961|NCT01276847|Ustekinumab|ustekinumab|mesh-list
92204962|NCT01276847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92204963|NCT01276847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204964|NCT01276847|Analgesics|analgesics|mesh-ancestor
92204965|NCT01276847|Sensory System Agents|sensory system agents|mesh-ancestor
92204966|NCT01276847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204967|NCT01276847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204968|NCT01276847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92204969|NCT01276847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92204970|NCT01276847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92204971|NCT01276847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204972|NCT01276847|Immunologic Factors|immunologic factors|mesh-ancestor
92204973|NCT01276847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92204974|NCT00945269|Aldesleukin|aldesleukin|mesh-list
92204975|NCT00945269|Interleukin-2|interleukin-2|mesh-list
92204976|NCT00945269|Denileukin diftitox|denileukin diftitox|mesh-list
92204977|NCT00945269|Immunotoxins|immunotoxins|mesh-list
92204978|NCT00945269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204979|NCT00945269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92204980|NCT00945269|Analgesics|analgesics|mesh-ancestor
92204981|NCT00945269|Sensory System Agents|sensory system agents|mesh-ancestor
92204982|NCT00945269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92204983|NCT00945269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92204984|NCT00945269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92204985|NCT00945269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92204986|NCT00945269|Antiviral Agents|antiviral agents|mesh-ancestor
92204987|NCT00945269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92204988|NCT00945269|Immunoconjugates|immunoconjugates|mesh-ancestor
92204989|NCT00945269|Immunologic Factors|immunologic factors|mesh-ancestor
92204990|NCT01272791|Gemcitabine|gemcitabine|mesh-list
92204991|NCT01272791|Bavituximab|bavituximab|mesh-list
92204992|NCT01272791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92204993|NCT01272791|Antimetabolites|antimetabolites|mesh-ancestor
92204994|NCT01272791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92204995|NCT01272791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92204996|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92204997|NCT00765661|Tacrolimus|tacrolimus|mesh-list
92204998|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92204999|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
92205000|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205001|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92205002|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205003|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205004|NCT00765895|Nortriptyline|nortriptyline|mesh-list
92205005|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92205006|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
92205007|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205008|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92205009|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92205010|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205011|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205012|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205013|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205014|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205015|NCT01276457|Cyclosporine|cyclosporine|mesh-list
92205017|NCT01276457|Cyclosporins|cyclosporins|mesh-list
92205018|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205019|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205020|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205021|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
92205022|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205023|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
92205024|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205025|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92205026|NCT01276457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205027|NCT01276457|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92205028|NCT01276457|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92205029|NCT01276457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205030|NCT01276457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205031|NCT03804931|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92205033|NCT03804931|Mesalamine|mesalamine|mesh-list
92205034|NCT03804931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205035|NCT03804931|Glucocorticoids|glucocorticoids|mesh-ancestor
92205036|NCT03804931|Hormones|hormones|mesh-ancestor
92205037|NCT03804931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205038|NCT03804931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205039|NCT03804931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92205040|NCT03804931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205041|NCT03804931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205042|NCT03804931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205043|NCT03804931|Analgesics|analgesics|mesh-ancestor
92205044|NCT03804931|Sensory System Agents|sensory system agents|mesh-ancestor
92205045|NCT03804931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205046|NCT03804931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205047|NCT03804931|Antitubercular Agents|antitubercular agents|mesh-ancestor
92205048|NCT03804931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92205049|NCT03804931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205050|NCT02991131|Linezolid|linezolid|mesh-list
92205051|NCT02991131|Tedizolid|tedizolid|mesh-list
92205052|NCT02991131|Tedizolid phosphate|tedizolid phosphate|mesh-list
92205053|NCT02991131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92205054|NCT02991131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205055|NCT02991131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92205056|NCT02991131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205057|NCT02991131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205058|NCT00748865|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92205059|NCT00748865|Lubricant Eye Drops|lubricant eye drops|mesh-list
92205060|NCT00748865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92205061|NCT00766753|Vaccines|vaccines|mesh-list
92205062|NCT00766753|Immunologic Factors|immunologic factors|mesh-ancestor
92205063|NCT00766753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205064|NCT00767767|Thiopental|thiopental|mesh-list
92205065|NCT00767767|Propofol|propofol|mesh-list
92205066|NCT00767767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92205067|NCT00767767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205068|NCT00767767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205069|NCT00767767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92205070|NCT00767767|Anesthetics, General|anesthetics, general|mesh-ancestor
92205071|NCT00767767|Anesthetics|anesthetics|mesh-ancestor
92205072|NCT00767767|Anticonvulsants|anticonvulsants|mesh-ancestor
92205073|NCT00767767|GABA Modulators|gaba modulators|mesh-ancestor
92205074|NCT00767767|GABA Agents|gaba agents|mesh-ancestor
92205075|NCT00767767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205076|NCT00767767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205077|NCT00761345|Gemcitabine|gemcitabine|mesh-list
92205078|NCT00761345|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92205079|NCT00761345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92205080|NCT00761345|Antimetabolites|antimetabolites|mesh-ancestor
92205081|NCT00761345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205082|NCT00761345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205083|NCT00761345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205084|NCT00761345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205085|NCT00762515|Triclosan|triclosan|mesh-list
92205086|NCT00762515|Fluorides|fluorides|mesh-list
92205087|NCT00762515|Cariostatic Agents|cariostatic agents|mesh-ancestor
92205088|NCT00762515|Protective Agents|protective agents|mesh-ancestor
92205089|NCT00762515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205090|NCT00762515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92205091|NCT00762515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205092|NCT00762515|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92205093|NCT00762515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92205094|NCT00762515|Antimetabolites|antimetabolites|mesh-ancestor
92205095|NCT00762515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205096|NCT00762515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92205097|NCT03806933|Botulinum Toxins|botulinum toxins|mesh-list
92205098|NCT03806933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92205099|NCT03806933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92205100|NCT03806933|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92205101|NCT03806933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92205102|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205103|NCT03806933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205104|NCT03806933|Cholinergic Agents|cholinergic agents|mesh-ancestor
92205105|NCT03806933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205106|NCT03806933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205107|NCT03806933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92205108|NCT03806933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205109|NCT00753935|Aspirin|aspirin|mesh-list
92205110|NCT00753935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205111|NCT00753935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205112|NCT00753935|Analgesics|analgesics|mesh-ancestor
92205113|NCT00753935|Sensory System Agents|sensory system agents|mesh-ancestor
92205114|NCT00753935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205115|NCT00753935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205116|NCT00753935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205117|NCT00753935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205118|NCT00753935|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92205119|NCT00753935|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92205120|NCT00753935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205121|NCT00753935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92205122|NCT00753935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92205123|NCT00753935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205124|NCT00753935|Antipyretics|antipyretics|mesh-ancestor
92205125|NCT00779285|Doxorubicin|doxorubicin|mesh-list
92205126|NCT00779285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92205127|NCT00779285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92205128|NCT00779285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205129|NCT00779285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92205130|NCT00779285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92205131|NCT00779285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205132|NCT00779285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205133|NCT00786643|Leucovorin|leucovorin|mesh-list
92205134|NCT00786643|Interferons|interferons|mesh-list
92205135|NCT00786643|Interferon-gamma|interferon-gamma|mesh-list
92205136|NCT00786643|Bevacizumab|bevacizumab|mesh-list
92205137|NCT00786643|Fluorouracil|fluorouracil|mesh-list
92205138|NCT00786643|Levoleucovorin|levoleucovorin|mesh-list
92205139|NCT00786643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205140|NCT00786643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205141|NCT00786643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92205142|NCT00786643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92205143|NCT00786643|Growth Substances|growth substances|mesh-ancestor
92205144|NCT00786643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205145|NCT00786643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92205146|NCT00786643|Antimetabolites|antimetabolites|mesh-ancestor
92205147|NCT00786643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205148|NCT00786643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92205149|NCT00786643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205150|NCT00786643|Immunologic Factors|immunologic factors|mesh-ancestor
92205151|NCT00786643|Antiviral Agents|antiviral agents|mesh-ancestor
92205152|NCT00786643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205154|NCT00786643|Protective Agents|protective agents|mesh-ancestor
92205155|NCT00786643|Vitamin B Complex|vitamin b complex|mesh-ancestor
92205156|NCT00786643|Vitamins|vitamins|mesh-ancestor
92205157|NCT00786643|Micronutrients|micronutrients|mesh-ancestor
92205159|NCT01276379|Folic Acid|folic acid|mesh-list
92205160|NCT01276379|Fluorouracil|fluorouracil|mesh-list
92205161|NCT01276379|Oxaliplatin|oxaliplatin|mesh-list
92205162|NCT01276379|Irinotecan|irinotecan|mesh-list
92205163|NCT01276379|Cetuximab|cetuximab|mesh-list
92205164|NCT01276379|Levoleucovorin|levoleucovorin|mesh-list
92205165|NCT01276379|Antimetabolites|antimetabolites|mesh-ancestor
92205166|NCT01276379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205167|NCT01276379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92205168|NCT01276379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205169|NCT01276379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205170|NCT01276379|Immunologic Factors|immunologic factors|mesh-ancestor
92205171|NCT01276379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205172|NCT01276379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92205173|NCT01276379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92205174|NCT01276379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205175|NCT01276379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205176|NCT01276379|Antidotes|antidotes|mesh-ancestor
92205177|NCT01276379|Protective Agents|protective agents|mesh-ancestor
92205178|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
92205179|NCT01276379|Vitamins|vitamins|mesh-ancestor
92205180|NCT01276379|Micronutrients|micronutrients|mesh-ancestor
92205181|NCT01276379|Hematinics|hematinics|mesh-ancestor
92205182|NCT01275547|Midazolam|midazolam|mesh-list
92205183|NCT01275547|Ketamine|ketamine|mesh-list
92205184|NCT01275547|Morphine|morphine|mesh-list
92205185|NCT01275547|Esketamine|esketamine|mesh-list
92205186|NCT01275547|Analgesics|analgesics|mesh-ancestor
92205187|NCT01275547|Sensory System Agents|sensory system agents|mesh-ancestor
92205188|NCT01275547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205189|NCT01275547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205190|NCT01275547|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92205191|NCT01275547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92205192|NCT01275547|Anesthetics, General|anesthetics, general|mesh-ancestor
92205193|NCT01275547|Anesthetics|anesthetics|mesh-ancestor
92205194|NCT01275547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205195|NCT01275547|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92205196|NCT01275547|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92205197|NCT01275547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205198|NCT01275547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205199|NCT01275547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92205200|NCT01275547|Narcotics|narcotics|mesh-ancestor
92205201|NCT01275547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92205202|NCT01275547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92205203|NCT01275547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92205204|NCT01275547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92205205|NCT01275547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205206|NCT01275547|GABA Modulators|gaba modulators|mesh-ancestor
92205207|NCT01275547|GABA Agents|gaba agents|mesh-ancestor
92205208|NCT01275547|Antidepressive Agents|antidepressive agents|mesh-ancestor
92205209|NCT00789685|Interferons|interferons|mesh-list
92205210|NCT00789685|Interferon-beta|interferon-beta|mesh-list
92205212|NCT00789685|Antiviral Agents|antiviral agents|mesh-ancestor
92205213|NCT00789685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205214|NCT00789685|Immunologic Factors|immunologic factors|mesh-ancestor
92205215|NCT00789685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205216|NCT03804229|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92205217|NCT03804229|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92205218|NCT03804229|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92205219|NCT03804229|Protective Agents|protective agents|mesh-ancestor
92205220|NCT03804229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205222|NCT02149303|Antithrombins|antithrombins|mesh-ancestor
92205223|NCT02149303|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92205224|NCT02149303|Protease Inhibitors|protease inhibitors|mesh-ancestor
92205225|NCT02149303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205226|NCT02149303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205227|NCT02149303|Anticoagulants|anticoagulants|mesh-ancestor
92205228|NCT03803449|Fentanyl|fentanyl|mesh-list
92205229|NCT03803449|Midazolam|midazolam|mesh-list
92205230|NCT03803449|Propofol|propofol|mesh-list
92205231|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92205232|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205233|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205234|NCT03803449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92205235|NCT03803449|Anesthetics, General|anesthetics, general|mesh-ancestor
92205236|NCT03803449|Anesthetics|anesthetics|mesh-ancestor
92205237|NCT03803449|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92205238|NCT03803449|Narcotics|narcotics|mesh-ancestor
92205239|NCT03803449|Analgesics|analgesics|mesh-ancestor
92205240|NCT03803449|Sensory System Agents|sensory system agents|mesh-ancestor
92205241|NCT03803449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205242|NCT03803449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92205243|NCT03803449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92205244|NCT03803449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92205245|NCT03803449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205246|NCT03803449|GABA Modulators|gaba modulators|mesh-ancestor
92205247|NCT03803449|GABA Agents|gaba agents|mesh-ancestor
92205248|NCT03803449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205249|NCT03803449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205250|NCT03803839|Clodronic Acid|clodronic acid|mesh-list
92205251|NCT03803839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92205252|NCT03803839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205253|NCT00789997|Levofloxacin|levofloxacin|mesh-list
92205254|NCT00789997|Prednisone|prednisone|mesh-list
92205255|NCT00789997|Etanercept|etanercept|mesh-list
92205256|NCT00789997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205257|NCT00789997|Glucocorticoids|glucocorticoids|mesh-ancestor
92205258|NCT00789997|Hormones|hormones|mesh-ancestor
92205259|NCT00789997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205260|NCT00789997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205261|NCT00789997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92205262|NCT00789997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205263|NCT00789997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205264|NCT00789997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205265|NCT00789997|Analgesics|analgesics|mesh-ancestor
92205266|NCT00789997|Sensory System Agents|sensory system agents|mesh-ancestor
92205267|NCT00789997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205268|NCT00789997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205269|NCT00789997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205270|NCT00789997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205271|NCT00789997|Immunologic Factors|immunologic factors|mesh-ancestor
92205272|NCT00789997|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92205273|NCT00789997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205274|NCT00789997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92205275|NCT00789997|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92205276|NCT00789997|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92205277|NCT00789997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205278|NCT00789997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205279|NCT00789997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92205280|NCT00789997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92205281|NCT00771745|Thymoglobulin|thymoglobulin|mesh-list
92205282|NCT00771745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92205283|NCT00771745|Immunologic Factors|immunologic factors|mesh-ancestor
92205284|NCT00771745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205285|NCT00771745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205286|NCT03803215|Theophylline|theophylline|mesh-list
92205287|NCT03803215|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92205288|NCT03803215|Autonomic Agents|autonomic agents|mesh-ancestor
92205289|NCT03803215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205290|NCT03803215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205291|NCT03803215|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92205292|NCT03803215|Respiratory System Agents|respiratory system agents|mesh-ancestor
92205293|NCT03803215|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92205294|NCT03803215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205295|NCT03803215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205296|NCT03803215|Vasodilator Agents|vasodilator agents|mesh-ancestor
92205297|NCT03803215|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92205298|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92205299|NCT03803215|Purinergic Agents|purinergic agents|mesh-ancestor
92205300|NCT03803215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205301|NCT00790855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92205302|NCT00790855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92205303|NCT00790855|Alkylating Agents|alkylating agents|mesh-ancestor
92205304|NCT00790855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205305|NCT00790855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205306|NCT03802747|Durvalumab|durvalumab|mesh-list
92205307|NCT03802747|Tremelimumab|tremelimumab|mesh-list
92205308|NCT03802747|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92205309|NCT03802747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205310|NCT03802747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205311|NCT03802747|Immunologic Factors|immunologic factors|mesh-ancestor
92205312|NCT03802747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205313|NCT00791323|Ketorolac|ketorolac|mesh-list
92205314|NCT00791323|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92205315|NCT00791323|Lubricant Eye Drops|lubricant eye drops|mesh-list
92205316|NCT00791323|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92205317|NCT00791323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205318|NCT00791323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205319|NCT00791323|Analgesics|analgesics|mesh-ancestor
92205320|NCT00791323|Sensory System Agents|sensory system agents|mesh-ancestor
92205321|NCT00791323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205322|NCT00791323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205323|NCT00791323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205324|NCT00791323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205325|NCT00791323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92205326|NCT00791323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205327|NCT00791323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205328|NCT00772915|Dexamethasone|dexamethasone|mesh-list
92205329|NCT00772915|Lenalidomide|lenalidomide|mesh-list
92205330|NCT00772915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205331|NCT00772915|Antiemetics|antiemetics|mesh-ancestor
92205332|NCT00772915|Autonomic Agents|autonomic agents|mesh-ancestor
92205333|NCT00772915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205334|NCT00772915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205335|NCT00772915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205336|NCT00772915|Glucocorticoids|glucocorticoids|mesh-ancestor
92205337|NCT00772915|Hormones|hormones|mesh-ancestor
92205338|NCT00772915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205339|NCT00772915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92205340|NCT00772915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205341|NCT00772915|Immunologic Factors|immunologic factors|mesh-ancestor
92205342|NCT00772915|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92205343|NCT00772915|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92205344|NCT00772915|Growth Substances|growth substances|mesh-ancestor
92205345|NCT00772915|Growth Inhibitors|growth inhibitors|mesh-ancestor
92205346|NCT05497453|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92205347|NCT05497453|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92205348|NCT05497453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205349|NCT05497453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205350|NCT05497453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205351|NCT05497453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205352|NCT05497453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205354|NCT03801733|Atorvastatin|atorvastatin|mesh-list
92205355|NCT03801733|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92205356|NCT03801733|Simvastatin|simvastatin|mesh-list
92205357|NCT03801733|Pravastatin|pravastatin|mesh-list
92205358|NCT03801733|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92205359|NCT03801733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92205360|NCT03801733|Antimetabolites|antimetabolites|mesh-ancestor
92205361|NCT03801733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205362|NCT03801733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92205363|NCT03801733|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92205364|NCT03801733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205365|NCT03801733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205366|NCT03801733|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205367|NCT03801733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205369|NCT03801733|Sensory System Agents|sensory system agents|mesh-ancestor
92205370|NCT03801733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205371|NCT03801733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205372|NCT03801733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205373|NCT03801733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205374|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205375|NCT00775411|Dexamethasone|dexamethasone|mesh-list
92205376|NCT00775411|Ranibizumab|ranibizumab|mesh-list
92205377|NCT00775411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205378|NCT00775411|Antiemetics|antiemetics|mesh-ancestor
92205379|NCT00775411|Autonomic Agents|autonomic agents|mesh-ancestor
92205380|NCT00775411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205381|NCT00775411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205382|NCT00775411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205384|NCT00775411|Hormones|hormones|mesh-ancestor
92205385|NCT00775411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205386|NCT00775411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92205387|NCT00775411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205388|NCT00775411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92205389|NCT00775411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92205390|NCT00775411|Growth Substances|growth substances|mesh-ancestor
92205391|NCT00775411|Growth Inhibitors|growth inhibitors|mesh-ancestor
92205393|NCT03801499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205394|NCT03801499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205395|NCT03801499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205396|NCT03801499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205397|NCT00808405|Acyclovir|acyclovir|mesh-list
92205398|NCT00808405|Antiviral Agents|antiviral agents|mesh-ancestor
92205399|NCT00808405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205400|NCT00775645|Acetylcarnitine|acetylcarnitine|mesh-list
92205401|NCT00775645|Vitamin B Complex|vitamin b complex|mesh-ancestor
92205402|NCT00775645|Vitamins|vitamins|mesh-ancestor
92205403|NCT00775645|Micronutrients|micronutrients|mesh-ancestor
92205404|NCT00775645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205405|NCT00775645|Nootropic Agents|nootropic agents|mesh-ancestor
92205406|NCT01974687|Itraconazole|itraconazole|mesh-list
92205407|NCT01974687|Uprifosbuvir|uprifosbuvir|mesh-list
92205408|NCT01974687|Antifungal Agents|antifungal agents|mesh-ancestor
92205409|NCT01974687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205410|NCT01974687|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92205411|NCT01974687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92205412|NCT01974687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205413|NCT01974687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205414|NCT01974687|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92205415|NCT01974687|Hormone Antagonists|hormone antagonists|mesh-ancestor
92205416|NCT01974687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205417|NCT01974687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205418|NCT01974687|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92205419|NCT01974687|Antiviral Agents|antiviral agents|mesh-ancestor
92205420|NCT00795145|Moxifloxacin|moxifloxacin|mesh-list
92205421|NCT00795145|Linezolid|linezolid|mesh-list
92205422|NCT00795145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92205423|NCT00795145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205424|NCT00795145|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92205425|NCT00795145|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92205426|NCT00795145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205427|NCT00795145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205428|NCT00795145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205429|NCT00795145|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92205430|NCT03801187|Chlorhexidine|chlorhexidine|mesh-list
92205431|NCT03801187|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92205432|NCT03801187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205433|NCT03801187|Disinfectants|disinfectants|mesh-ancestor
92205434|NCT00809185|Everolimus|everolimus|mesh-list
92205435|NCT00809185|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92205436|NCT00809185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205437|NCT00809185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205438|NCT00809185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205439|NCT00809185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205440|NCT00809185|Immunologic Factors|immunologic factors|mesh-ancestor
92205441|NCT00809185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205442|NCT00809185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205444|NCT03800953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205445|NCT03800953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205446|NCT00795769|Ondansetron|ondansetron|mesh-list
92205447|NCT00795769|Antiemetics|antiemetics|mesh-ancestor
92205448|NCT00795769|Autonomic Agents|autonomic agents|mesh-ancestor
92205449|NCT00795769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205450|NCT00795769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205451|NCT00795769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205452|NCT00795769|Antipruritics|antipruritics|mesh-ancestor
92205453|NCT00795769|Dermatologic Agents|dermatologic agents|mesh-ancestor
92205454|NCT00795769|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92205455|NCT00795769|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92205456|NCT00795769|Serotonin Agents|serotonin agents|mesh-ancestor
92205457|NCT00795769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336124|NCT02037984|Immunologic Factors|immunologic factors|mesh-ancestor
92205458|NCT00795769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205459|NCT01975935|Amlexanox|amlexanox|mesh-list
92205460|NCT01975935|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92205461|NCT02305017|Acetaminophen|acetaminophen|mesh-list
92205462|NCT02305017|Opicapone|opicapone|mesh-list
92205463|NCT02305017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205464|NCT02305017|Analgesics|analgesics|mesh-ancestor
92205465|NCT02305017|Sensory System Agents|sensory system agents|mesh-ancestor
92205466|NCT02305017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205467|NCT02305017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205468|NCT02305017|Antipyretics|antipyretics|mesh-ancestor
92205469|NCT02305017|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92205470|NCT02305017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205471|NCT02305017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205472|NCT02305017|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92205473|NCT02305017|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92205474|NCT01976871|Rotigotine|rotigotine|mesh-list
92205475|NCT01976871|Dopamine Agonists|dopamine agonists|mesh-ancestor
92205476|NCT01976871|Dopamine Agents|dopamine agents|mesh-ancestor
92205477|NCT01976871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205478|NCT01976871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205479|NCT01976871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205480|NCT03602781|Nitric Oxide|nitric oxide|mesh-list
92205481|NCT03602781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92205482|NCT03602781|Autonomic Agents|autonomic agents|mesh-ancestor
92205483|NCT03602781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205484|NCT03602781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205485|NCT03602781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92205486|NCT03602781|Respiratory System Agents|respiratory system agents|mesh-ancestor
92205487|NCT03602781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92205488|NCT03602781|Antioxidants|antioxidants|mesh-ancestor
92205489|NCT03602781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205490|NCT03602781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205491|NCT03602781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92205492|NCT03602781|Vasodilator Agents|vasodilator agents|mesh-ancestor
92205493|NCT03602781|Gasotransmitters|gasotransmitters|mesh-ancestor
92205494|NCT03602781|Protective Agents|protective agents|mesh-ancestor
92205495|NCT02280239|Acetaminophen|acetaminophen|mesh-list
92205496|NCT02280239|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205497|NCT02280239|Analgesics|analgesics|mesh-ancestor
92205498|NCT02280239|Sensory System Agents|sensory system agents|mesh-ancestor
92205499|NCT02280239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205500|NCT02280239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205501|NCT02280239|Antipyretics|antipyretics|mesh-ancestor
92205503|NCT01993875|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91920529|NCT02177539|Cyclopentolate|cyclopentolate|mesh-list
92205504|NCT01993875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205505|NCT01993875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205506|NCT00796705|Adalimumab|adalimumab|mesh-list
92205507|NCT00796705|Etanercept|etanercept|mesh-list
92205508|NCT00796705|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92205509|NCT00796705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205510|NCT00796705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205511|NCT00796705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205512|NCT00796705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205513|NCT00796705|Analgesics|analgesics|mesh-ancestor
92205514|NCT00796705|Sensory System Agents|sensory system agents|mesh-ancestor
92205515|NCT00796705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205516|NCT00796705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205517|NCT00796705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205518|NCT00796705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205519|NCT00796705|Immunologic Factors|immunologic factors|mesh-ancestor
92205520|NCT00809809|Zinc|zinc|mesh-list
92205521|NCT00809809|Trace Elements|trace elements|mesh-ancestor
92205522|NCT00809809|Micronutrients|micronutrients|mesh-ancestor
92205523|NCT00809809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205524|NCT00248651|Amitriptyline|amitriptyline|mesh-list
92205525|NCT00248651|Escitalopram|escitalopram|mesh-list
92205526|NCT00248651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92205527|NCT00248651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92205528|NCT00248651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205529|NCT00248651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205530|NCT00248651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205531|NCT00248651|Serotonin Agents|serotonin agents|mesh-ancestor
92205532|NCT00248651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205533|NCT00248651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205534|NCT00248651|Antidepressive Agents|antidepressive agents|mesh-ancestor
92205535|NCT00248651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205536|NCT00248651|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92205537|NCT00248651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205538|NCT00248651|Analgesics|analgesics|mesh-ancestor
92205539|NCT00248651|Sensory System Agents|sensory system agents|mesh-ancestor
92205540|NCT00248651|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92205541|NCT00248651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205542|NCT03800797|Loxoprofen|loxoprofen|mesh-list
92205543|NCT03800797|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205544|NCT03800797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205545|NCT03800797|Analgesics|analgesics|mesh-ancestor
92205546|NCT03800797|Sensory System Agents|sensory system agents|mesh-ancestor
92205547|NCT03800797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205548|NCT03800797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205549|NCT03800797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205550|NCT03800797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205551|NCT04383067|Aldesleukin|aldesleukin|mesh-list
92205552|NCT04383067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205553|NCT04383067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92205554|NCT04383067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92205555|NCT04383067|Antiviral Agents|antiviral agents|mesh-ancestor
92205556|NCT04383067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205557|NCT01994109|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92205558|NCT01994109|Botulinum Toxins|botulinum toxins|mesh-list
92205559|NCT01994109|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92205560|NCT01994109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205561|NCT01994109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205562|NCT01994109|Cholinergic Agents|cholinergic agents|mesh-ancestor
92205563|NCT01994109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205564|NCT01994109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205565|NCT01994109|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92205566|NCT00248495|Pemetrexed|pemetrexed|mesh-list
92205567|NCT00248495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205568|NCT00248495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934040|NCT03446807|Droxidopa|droxidopa|mesh-list
92205569|NCT00248495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205570|NCT00248495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92205571|NCT00248495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92205572|NCT04739371|Insulin|insulin|mesh-list
92205573|NCT04739371|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92205574|NCT04739371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92205575|NCT04739371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205577|NCT03809767|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92205578|NCT03809767|Immunologic Factors|immunologic factors|mesh-ancestor
92205579|NCT03809767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205580|NCT03800641|Dexmedetomidine|dexmedetomidine|mesh-list
92205581|NCT03800641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92205582|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205583|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205584|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205585|NCT03800641|Analgesics|analgesics|mesh-ancestor
92205586|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
92205587|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205588|NCT03800641|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92205589|NCT03800641|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92205590|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92205591|NCT03800641|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205592|NCT03800641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205593|NCT03800641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205594|NCT03807011|Fentanyl|fentanyl|mesh-list
92205595|NCT03807011|Remifentanil|remifentanil|mesh-list
92205596|NCT03807011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92205597|NCT03807011|Narcotics|narcotics|mesh-ancestor
92205598|NCT03807011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205599|NCT03807011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205600|NCT03807011|Analgesics|analgesics|mesh-ancestor
92205601|NCT03807011|Sensory System Agents|sensory system agents|mesh-ancestor
92205602|NCT03807011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205603|NCT03807011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92205604|NCT03807011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92205605|NCT03807011|Anesthetics, General|anesthetics, general|mesh-ancestor
92205606|NCT03807011|Anesthetics|anesthetics|mesh-ancestor
92205607|NCT02986503|Cisplatin|cisplatin|mesh-list
92205608|NCT02986503|Doxorubicin|doxorubicin|mesh-list
92205609|NCT02986503|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92205610|NCT02986503|Methotrexate|methotrexate|mesh-list
92205611|NCT02986503|Ifosfamide|ifosfamide|mesh-list
92205612|NCT02986503|Isophosphamide mustard|isophosphamide mustard|mesh-list
92205613|NCT02986503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205614|NCT02986503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92205615|NCT02986503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92205616|NCT02986503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92205617|NCT02986503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205618|NCT02986503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205619|NCT02986503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92205620|NCT02986503|Abortifacient Agents|abortifacient agents|mesh-ancestor
92205621|NCT02986503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92205622|NCT02986503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205623|NCT02986503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92205624|NCT02986503|Antimetabolites|antimetabolites|mesh-ancestor
92205625|NCT02986503|Dermatologic Agents|dermatologic agents|mesh-ancestor
92205626|NCT02986503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92205627|NCT02986503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205628|NCT02986503|Immunologic Factors|immunologic factors|mesh-ancestor
92205629|NCT02986503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205630|NCT02986503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92205631|NCT02986503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92205632|NCT02986503|Alkylating Agents|alkylating agents|mesh-ancestor
92205633|NCT01978743|Raltegravir Potassium|raltegravir potassium|mesh-list
92205634|NCT01978743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92205635|NCT01978743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92205636|NCT01978743|Antiviral Agents|antiviral agents|mesh-ancestor
92205637|NCT01978743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205638|NCT01978743|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92205639|NCT01978743|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92205640|NCT01978743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205641|NCT01978743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205642|NCT00763061|Timolol|timolol|mesh-list
92205643|NCT00763061|Travoprost|travoprost|mesh-list
92205644|NCT00763061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92205646|NCT00763061|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92205647|NCT00763061|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92205648|NCT00763061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205649|NCT00763061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205650|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205651|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205652|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92205653|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92205654|NCT03806335|Anesthetics|anesthetics|mesh-list
92205655|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205656|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205657|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
92205658|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92205659|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205660|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205661|NCT03806777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205662|NCT03806777|Analgesics|analgesics|mesh-ancestor
92205663|NCT03806777|Sensory System Agents|sensory system agents|mesh-ancestor
92205664|NCT03806777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205665|NCT03806777|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92205666|NCT03806777|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92205667|NCT03806777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92205668|NCT03806777|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205669|NCT03806777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205670|NCT03806777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205671|NCT03806387|Alemtuzumab|alemtuzumab|mesh-list
92205672|NCT03806387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205673|NCT03806387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205674|NCT00754247|Vitamin E|vitamin e|mesh-list
92205675|NCT00754247|Hydrocortisone|hydrocortisone|mesh-list
92205676|NCT00754247|Vitamins|vitamins|mesh-ancestor
92205677|NCT00754247|Micronutrients|micronutrients|mesh-ancestor
92205678|NCT00754247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205679|NCT00754247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205680|NCT00754247|Antioxidants|antioxidants|mesh-ancestor
92205681|NCT00754247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205682|NCT00754247|Protective Agents|protective agents|mesh-ancestor
92205684|NCT02305329|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92205685|NCT02305329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205686|NCT02305329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205687|NCT02305329|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92205688|NCT02305329|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92205689|NCT01979445|Clopidogrel|clopidogrel|mesh-list
92205690|NCT01979445|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92205691|NCT01979445|Cangrelor|cangrelor|mesh-list
92205692|NCT01979445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92205693|NCT01979445|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92205694|NCT01979445|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92205695|NCT01979445|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92205696|NCT01979445|Purinergic Agents|purinergic agents|mesh-ancestor
92205697|NCT01979445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205698|NCT01979445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205699|NCT01979445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205700|NCT03802565|Tolperisone|tolperisone|mesh-list
92205701|NCT03802565|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92205702|NCT03802565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205703|NCT03802565|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92205704|NCT03802565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205705|NCT04382443|Colchicine|colchicine|mesh-list
92205706|NCT04382443|Gout Suppressants|gout suppressants|mesh-ancestor
91934054|NCT02229773|Pravastatin|pravastatin|mesh-list
92205708|NCT04382443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92205709|NCT04382443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92205710|NCT04382443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92205711|NCT04382443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205712|NCT04382443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205713|NCT04633213|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92205714|NCT04633213|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92205716|NCT01981863|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92205717|NCT01981863|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92205718|NCT01981863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205719|NCT01981863|Hemostatics|hemostatics|mesh-ancestor
92205720|NCT01981863|Coagulants|coagulants|mesh-ancestor
92205721|NCT00245765|Certolizumab Pegol|certolizumab pegol|mesh-list
92205722|NCT00245765|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92205723|NCT00245765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205724|NCT00245765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205725|NCT00245765|Immunologic Factors|immunologic factors|mesh-ancestor
92205726|NCT00245765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205727|NCT00245765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205728|NCT01995045|Triamcinolone|triamcinolone|mesh-list
92205729|NCT01995045|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92205730|NCT01995045|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92205731|NCT01995045|Bupivacaine|bupivacaine|mesh-list
92205732|NCT01995045|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92205733|NCT01995045|Anesthetics, Local|anesthetics, local|mesh-ancestor
92205734|NCT01995045|Anesthetics|anesthetics|mesh-ancestor
92205735|NCT01995045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205736|NCT01995045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205737|NCT01995045|Sensory System Agents|sensory system agents|mesh-ancestor
92205738|NCT01995045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205739|NCT01995045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205740|NCT01995045|Glucocorticoids|glucocorticoids|mesh-ancestor
92205741|NCT01995045|Hormones|hormones|mesh-ancestor
92205742|NCT01995045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205743|NCT01995045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205744|NCT01995045|Immunologic Factors|immunologic factors|mesh-ancestor
92205745|NCT01995045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205746|NCT01995045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205747|NCT04894123|Trifluridine|trifluridine|mesh-list
92205748|NCT04894123|Oxaliplatin|oxaliplatin|mesh-list
92205749|NCT04894123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205750|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
92205751|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205752|NCT04894123|Antiviral Agents|antiviral agents|mesh-ancestor
92205753|NCT04894123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205754|NCT01982643|Naltrexone|naltrexone|mesh-list
92205755|NCT01982643|Bupropion|bupropion|mesh-list
92205756|NCT01982643|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92205757|NCT01982643|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92205758|NCT01982643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205759|NCT01982643|Sensory System Agents|sensory system agents|mesh-ancestor
92205760|NCT01982643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205761|NCT01982643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92205762|NCT01982643|Antidepressive Agents|antidepressive agents|mesh-ancestor
92205763|NCT01982643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205764|NCT01982643|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92205765|NCT01982643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92205766|NCT01982643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205767|NCT01982643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205768|NCT01982643|Dopamine Agents|dopamine agents|mesh-ancestor
92205769|NCT01982643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205770|NCT01982643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92205771|NCT01982643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92205772|NCT01982643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205773|NCT01996839|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92205774|NCT01996839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92205776|NCT00797797|Levomilnacipran|levomilnacipran|mesh-list
92205777|NCT00797797|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92205778|NCT00797797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92205779|NCT00797797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205780|NCT00797797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205781|NCT00797797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205782|NCT00797797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205783|NCT00797797|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205785|NCT00797797|Sensory System Agents|sensory system agents|mesh-ancestor
92205786|NCT00797797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205787|NCT00797797|Antidepressive Agents|antidepressive agents|mesh-ancestor
92205788|NCT00797797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205789|NCT03496233|Grazoprevir|grazoprevir|mesh-list
92205790|NCT03496233|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92205791|NCT03496233|Antiviral Agents|antiviral agents|mesh-ancestor
92205792|NCT03496233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205793|NCT04482673|Vitamin D|vitamin d|mesh-list
92205794|NCT04482673|Ergocalciferols|ergocalciferols|mesh-list
92205795|NCT04482673|Cholecalciferol|cholecalciferol|mesh-list
92205796|NCT04482673|Vitamins|vitamins|mesh-list
92205797|NCT04482673|Micronutrients|micronutrients|mesh-ancestor
92205798|NCT04482673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205799|NCT04482673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92205800|NCT04482673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92205801|NCT00245063|Cediranib|cediranib|mesh-list
92205802|NCT00245063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205803|NCT00245063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920530|NCT02177539|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92205804|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205805|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205806|NCT02151487|Dexamethasone|dexamethasone|mesh-list
92336159|NCT02036502|Dexamethasone|dexamethasone|mesh-list
92205807|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
92205808|NCT02151487|Clonidine|clonidine|mesh-list
92205809|NCT02151487|Ropivacaine|ropivacaine|mesh-list
92205810|NCT02151487|BB 1101|bb 1101|mesh-list
92205811|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205812|NCT02151487|Antiemetics|antiemetics|mesh-ancestor
92205813|NCT02151487|Autonomic Agents|autonomic agents|mesh-ancestor
92205814|NCT02151487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205815|NCT02151487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205816|NCT02151487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92205817|NCT02151487|Glucocorticoids|glucocorticoids|mesh-ancestor
92205818|NCT02151487|Hormones|hormones|mesh-ancestor
92205819|NCT02151487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205820|NCT02151487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92205821|NCT02151487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205822|NCT02151487|Protease Inhibitors|protease inhibitors|mesh-ancestor
92205823|NCT02151487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205824|NCT02151487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205825|NCT02151487|Anesthetics, Local|anesthetics, local|mesh-ancestor
92205826|NCT02151487|Anesthetics|anesthetics|mesh-ancestor
92205827|NCT02151487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205828|NCT02151487|Sensory System Agents|sensory system agents|mesh-ancestor
92205829|NCT02151487|Analgesics|analgesics|mesh-ancestor
92205830|NCT02151487|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92205832|NCT02151487|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92205833|NCT02151487|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92205834|NCT02151487|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92205835|NCT02151487|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205836|NCT02151487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205837|NCT05318339|Trastuzumab|trastuzumab|mesh-list
92205838|NCT05318339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92205839|NCT05318339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205840|NCT04703335|Anti-Infective Agents|anti-infective agents|mesh-list
92205841|NCT04703335|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92205842|NCT00764309|Dasatinib|dasatinib|mesh-list
92205843|NCT00764309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205844|NCT00764309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205845|NCT00764309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205846|NCT00764309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205847|NCT02151877|Nitric Oxide|nitric oxide|mesh-list
92205848|NCT02151877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92205849|NCT02151877|Autonomic Agents|autonomic agents|mesh-ancestor
92205850|NCT02151877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205851|NCT02151877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205852|NCT02151877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92205853|NCT02151877|Respiratory System Agents|respiratory system agents|mesh-ancestor
92205854|NCT02151877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92205855|NCT02151877|Antioxidants|antioxidants|mesh-ancestor
92205856|NCT02151877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205857|NCT02151877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205858|NCT02151877|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92205859|NCT02151877|Vasodilator Agents|vasodilator agents|mesh-ancestor
92205860|NCT02151877|Gasotransmitters|gasotransmitters|mesh-ancestor
92205861|NCT02151877|Protective Agents|protective agents|mesh-ancestor
92205862|NCT03970837|Tofacitinib|tofacitinib|mesh-list
92205863|NCT03970837|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92205864|NCT03970837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205865|NCT03970837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205866|NCT03970837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205867|NCT00798577|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92205868|NCT00798577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92205870|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92205871|NCT00799435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205872|NCT00799435|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92205873|NCT00799435|Incretins|incretins|mesh-ancestor
92205874|NCT00799435|Hormones|hormones|mesh-ancestor
92205875|NCT00799435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205876|NCT04329091|Dexmedetomidine|dexmedetomidine|mesh-list
92205877|NCT04329091|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92205878|NCT04329091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205879|NCT04329091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205880|NCT04329091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205881|NCT04329091|Analgesics|analgesics|mesh-ancestor
92205882|NCT04329091|Sensory System Agents|sensory system agents|mesh-ancestor
92205883|NCT04329091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205884|NCT04329091|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92205885|NCT04329091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92205886|NCT04329091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92205887|NCT04329091|Adrenergic Agents|adrenergic agents|mesh-ancestor
92205888|NCT04329091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205889|NCT04329091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205890|NCT04382209|Meperidine|meperidine|mesh-list
92205891|NCT04382209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92205892|NCT04382209|Narcotics|narcotics|mesh-ancestor
92205893|NCT04382209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92205894|NCT04382209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205895|NCT04382209|Analgesics|analgesics|mesh-ancestor
92205896|NCT04382209|Sensory System Agents|sensory system agents|mesh-ancestor
92205897|NCT04382209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205898|NCT04382209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92205899|NCT04634071|Bupropion|bupropion|mesh-list
92205900|NCT04634071|Nicotine|nicotine|mesh-list
92205901|NCT04634071|Varenicline|varenicline|mesh-list
92205902|NCT04634071|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92205903|NCT04634071|Autonomic Agents|autonomic agents|mesh-ancestor
92205904|NCT04634071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205905|NCT04634071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205906|NCT04634071|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92205907|NCT04634071|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92205908|NCT04634071|Cholinergic Agents|cholinergic agents|mesh-ancestor
92205909|NCT04634071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92205910|NCT04634071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205911|NCT04634071|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92205912|NCT04634071|Antidepressive Agents|antidepressive agents|mesh-ancestor
92205913|NCT04634071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92205914|NCT04634071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92205915|NCT04634071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92205916|NCT04634071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92205917|NCT04634071|Dopamine Agents|dopamine agents|mesh-ancestor
92205918|NCT04634071|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92205919|NCT04634071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92205920|NCT04634071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205922|NCT03417921|Gemcitabine|gemcitabine|mesh-list
92205923|NCT03417921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92205924|NCT03417921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205925|NCT03417921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92205926|NCT03417921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92205927|NCT03417921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92205928|NCT03417921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205929|NCT03417921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92205930|NCT03417921|Antimetabolites|antimetabolites|mesh-ancestor
92205931|NCT03378297|Aspirin|aspirin|mesh-list
92205932|NCT03378297|Metformin|metformin|mesh-list
92205933|NCT03378297|Letrozole|letrozole|mesh-list
92205934|NCT03378297|Olaparib|olaparib|mesh-list
92205935|NCT03378297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92205936|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205937|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205938|NCT03378297|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92205939|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92205940|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205941|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205942|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92205943|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
92205944|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92205945|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92205946|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92205947|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92205948|NCT03378297|Analgesics|analgesics|mesh-ancestor
92205949|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
92205950|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92205951|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92205952|NCT03378297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205953|NCT03378297|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92205954|NCT03378297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92205955|NCT03378297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92205956|NCT03378297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92205957|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
92205958|NCT03367689|Olaparib|olaparib|mesh-list
92205959|NCT03367689|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92205960|NCT03367689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205961|NCT03367689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205962|NCT03367689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205963|NCT00243659|Factor VIII|factor viii|mesh-list
92205964|NCT00243659|Coagulants|coagulants|mesh-ancestor
92205965|NCT00814177|Warfarin|warfarin|mesh-list
92205966|NCT00814177|Anticoagulants|anticoagulants|mesh-ancestor
92205967|NCT00243347|Cediranib|cediranib|mesh-list
92205968|NCT00243347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205969|NCT00243347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92205970|NCT00243347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92205971|NCT00243347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205972|NCT03364491|Tranexamic Acid|tranexamic acid|mesh-list
92205973|NCT03364491|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92205974|NCT03364491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92205975|NCT03364491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205976|NCT03364491|Hemostatics|hemostatics|mesh-ancestor
92205977|NCT03364491|Coagulants|coagulants|mesh-ancestor
92205978|NCT04294069|Azithromycin|azithromycin|mesh-list
92205979|NCT04294069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92205980|NCT04294069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92205981|NCT01997229|Eculizumab|eculizumab|mesh-list
92205982|NCT01997229|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92205983|NCT01997229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205984|NCT01997229|Immunologic Factors|immunologic factors|mesh-ancestor
92205985|NCT01997229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205986|NCT00800839|Cyclophosphamide|cyclophosphamide|mesh-list
92205987|NCT00800839|Busulfan|busulfan|mesh-list
92205988|NCT00800839|Fludarabine|fludarabine|mesh-list
92205989|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
92205990|NCT00800839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92205991|NCT00800839|Immunologic Factors|immunologic factors|mesh-ancestor
92205992|NCT00800839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92205993|NCT00800839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92205994|NCT00800839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92205995|NCT00800839|Alkylating Agents|alkylating agents|mesh-ancestor
92205996|NCT00800839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92205997|NCT00800839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92205998|NCT00800839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92205999|NCT00800839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92206000|NCT00800839|Antimetabolites|antimetabolites|mesh-ancestor
92206001|NCT00814255|Adalimumab|adalimumab|mesh-list
92206002|NCT00814255|Losartan|losartan|mesh-list
92206003|NCT00814255|Lisinopril|lisinopril|mesh-list
92206004|NCT00814255|Atorvastatin|atorvastatin|mesh-list
92206005|NCT00814255|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92206006|NCT00814255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92206007|NCT00814255|Antimetabolites|antimetabolites|mesh-ancestor
92206008|NCT00814255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206009|NCT00814255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206010|NCT00814255|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92206011|NCT00814255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206012|NCT00814255|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92206013|NCT00814255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206014|NCT00814255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206015|NCT00814255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92206016|NCT00814255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92206017|NCT00814255|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92206018|NCT00814255|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92206019|NCT00814255|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92206020|NCT00814255|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206021|NCT00814255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92206022|NCT00814255|Protective Agents|protective agents|mesh-ancestor
92206023|NCT00814255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206024|NCT02000973|Lidocaine|lidocaine|mesh-list
92206025|NCT02000973|Bupivacaine|bupivacaine|mesh-list
92206026|NCT02000973|Ropivacaine|ropivacaine|mesh-list
92206027|NCT02000973|Anesthetics, Local|anesthetics, local|mesh-ancestor
92206028|NCT02000973|Anesthetics|anesthetics|mesh-ancestor
92206029|NCT02000973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206030|NCT02000973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206031|NCT02000973|Sensory System Agents|sensory system agents|mesh-ancestor
92206032|NCT02000973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206033|NCT02000973|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92206034|NCT02000973|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92206035|NCT02000973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92206036|NCT02000973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206037|NCT02000973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206038|NCT02002767|Velpatasvir|velpatasvir|mesh-list
92206039|NCT02002767|Antiviral Agents|antiviral agents|mesh-ancestor
92206040|NCT02002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206041|NCT01985685|Thiamine|thiamine|mesh-list
92206042|NCT01985685|Vitamin B Complex|vitamin b complex|mesh-ancestor
92206043|NCT01985685|Vitamins|vitamins|mesh-ancestor
92206044|NCT01985685|Micronutrients|micronutrients|mesh-ancestor
92206045|NCT01985685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206046|NCT00815347|Bosentan|bosentan|mesh-list
92206047|NCT00815347|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92206048|NCT00815347|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92206049|NCT00815347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206051|NCT01985763|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92206052|NCT01985763|Protective Agents|protective agents|mesh-ancestor
92206053|NCT01985763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206054|NCT01985763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206055|NCT01985763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92206056|NCT01985763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336191|NCT02056626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92206057|NCT01985763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206058|NCT01985763|Phytoestrogens|phytoestrogens|mesh-ancestor
92206059|NCT01985763|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92206060|NCT01985763|Estrogens|estrogens|mesh-ancestor
92206061|NCT01985763|Hormones|hormones|mesh-ancestor
92206062|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206063|NCT02061969|Insulin Glargine|insulin glargine|mesh-list
92206064|NCT02061969|Linagliptin|linagliptin|mesh-list
92206065|NCT02061969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92206066|NCT02061969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206067|NCT02061969|Incretins|incretins|mesh-ancestor
92206068|NCT02061969|Hormones|hormones|mesh-ancestor
92206069|NCT02061969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206070|NCT02061969|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92206071|NCT02061969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206072|NCT02061969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206073|NCT02061969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206074|NCT02003625|Meloxicam|meloxicam|mesh-list
92206075|NCT02003625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92206076|NCT02003625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206077|NCT02003625|Analgesics|analgesics|mesh-ancestor
92206078|NCT02003625|Sensory System Agents|sensory system agents|mesh-ancestor
92206079|NCT02003625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206080|NCT02003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206081|NCT02003625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206082|NCT02003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206083|NCT02003625|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92206084|NCT02003625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92206085|NCT02003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206086|NCT02003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206087|NCT04037683|Misoprostol|misoprostol|mesh-list
92206088|NCT04037683|Oxytocin|oxytocin|mesh-list
92206089|NCT04037683|Oxytocics|oxytocics|mesh-ancestor
92206090|NCT04037683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92206091|NCT04037683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206092|NCT04037683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92206093|NCT04037683|Abortifacient Agents|abortifacient agents|mesh-ancestor
92206094|NCT04037683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92206095|NCT04037683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206096|NCT04251247|Fibrin fragment D|fibrin fragment d|mesh-list
92206097|NCT04251247|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92206098|NCT04251247|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92206099|NCT04251247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206100|NCT04251247|Hemostatics|hemostatics|mesh-ancestor
92206101|NCT04251247|Coagulants|coagulants|mesh-ancestor
92206102|NCT02396511|Bevacizumab|bevacizumab|mesh-list
92206103|NCT02396511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92206104|NCT02396511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206105|NCT02396511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92206106|NCT02396511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92206107|NCT02396511|Growth Substances|growth substances|mesh-ancestor
92206108|NCT02396511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206109|NCT02396511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92206110|NCT00816829|Fenofibrate|fenofibrate|mesh-list
92206111|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92206112|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
91934092|NCT02298205|Beclomethasone|beclomethasone|mesh-list
92206113|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206114|NCT00816829|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206116|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
92206117|NCT02062359|Fludarabine|fludarabine|mesh-list
92206118|NCT02062359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92206119|NCT02062359|Immunologic Factors|immunologic factors|mesh-ancestor
92206120|NCT02062359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206121|NCT02062359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206122|NCT02062359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92206123|NCT02062359|Alkylating Agents|alkylating agents|mesh-ancestor
92206124|NCT02062359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206125|NCT02062359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206126|NCT02062359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92206127|NCT02062359|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92206128|NCT02062359|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92206129|NCT02062359|Antiviral Agents|antiviral agents|mesh-ancestor
92206130|NCT02062359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206132|NCT02397291|Vitamin B Complex|vitamin b complex|mesh-ancestor
92206133|NCT02397291|Vitamins|vitamins|mesh-ancestor
92206134|NCT02397291|Micronutrients|micronutrients|mesh-ancestor
92206135|NCT02397291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206136|NCT00816907|Metformin|metformin|mesh-list
92206137|NCT00816907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92206138|NCT00816907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206139|NCT00817219|Betamethasone|betamethasone|mesh-list
92206140|NCT00817219|Betamethasone Valerate|betamethasone valerate|mesh-list
92206141|NCT00817219|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92206142|NCT00817219|Betamethasone benzoate|betamethasone benzoate|mesh-list
92206143|NCT00817219|Calcipotriene|calcipotriene|mesh-list
92206144|NCT00817219|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92206145|NCT00817219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206146|NCT00817219|Glucocorticoids|glucocorticoids|mesh-ancestor
92206147|NCT00817219|Hormones|hormones|mesh-ancestor
92206148|NCT00817219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206149|NCT00817219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206150|NCT00817219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92206151|NCT00817219|Respiratory System Agents|respiratory system agents|mesh-ancestor
92206152|NCT00817219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206153|NCT00817843|Simvastatin|simvastatin|mesh-list
92206154|NCT00817843|Ezetimibe|ezetimibe|mesh-list
92206155|NCT00817843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92206156|NCT00817843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92206157|NCT00817843|Antimetabolites|antimetabolites|mesh-ancestor
92206158|NCT00817843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206159|NCT00817843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206160|NCT00817843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92206161|NCT00817843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206162|NCT00817999|Clopidogrel|clopidogrel|mesh-list
92206163|NCT00817999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92206164|NCT00817999|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92206165|NCT00817999|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92206166|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92206167|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
92206168|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206169|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206170|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206171|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92206172|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92206173|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206174|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
92206175|NCT02008617|Bupivacaine|bupivacaine|mesh-list
92206176|NCT02008617|Anesthetics, Local|anesthetics, local|mesh-ancestor
92206177|NCT02008617|Anesthetics|anesthetics|mesh-ancestor
92206178|NCT02008617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206179|NCT02008617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206181|NCT02008617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206182|NCT03839251|Aripiprazole|aripiprazole|mesh-list
92206183|NCT03839251|Antidepressive Agents|antidepressive agents|mesh-ancestor
92206184|NCT03839251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92206185|NCT03839251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92206186|NCT03839251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92206187|NCT03839251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206188|NCT03839251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206189|NCT03839251|Dopamine Agonists|dopamine agonists|mesh-ancestor
92206190|NCT03839251|Dopamine Agents|dopamine agents|mesh-ancestor
92206191|NCT03839251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206192|NCT03839251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206193|NCT03839251|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92206194|NCT03839251|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92206195|NCT03839251|Serotonin Agents|serotonin agents|mesh-ancestor
92206196|NCT03839251|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92206197|NCT03839251|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92206198|NCT03839251|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92206200|NCT00819403|Simvastatin|simvastatin|mesh-list
92206201|NCT00819403|Ezetimibe|ezetimibe|mesh-list
92206202|NCT00819403|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92206203|NCT00819403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92206204|NCT00819403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92206205|NCT00819403|Antimetabolites|antimetabolites|mesh-ancestor
92206206|NCT00819403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206207|NCT00819403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206208|NCT00819403|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92206209|NCT00819403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206210|NCT02010021|Letrozole|letrozole|mesh-list
92206211|NCT02010021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206212|NCT02010021|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92206213|NCT02010021|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92206214|NCT02010021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206215|NCT02010021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206216|NCT02010021|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92206217|NCT02010021|Hormone Antagonists|hormone antagonists|mesh-ancestor
92206218|NCT02010021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206219|NCT02010021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206220|NCT02062905|Dexamethasone|dexamethasone|mesh-list
92206221|NCT02062905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206222|NCT02062905|Antiemetics|antiemetics|mesh-ancestor
92206223|NCT02062905|Autonomic Agents|autonomic agents|mesh-ancestor
92206224|NCT02062905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206225|NCT02062905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206226|NCT02062905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206227|NCT02062905|Glucocorticoids|glucocorticoids|mesh-ancestor
92206228|NCT02062905|Hormones|hormones|mesh-ancestor
92206229|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206230|NCT02062905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92206231|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206232|NCT00820573|Metformin|metformin|mesh-list
92206233|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92206234|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92206235|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206236|NCT00820573|Incretins|incretins|mesh-ancestor
92206237|NCT00820573|Hormones|hormones|mesh-ancestor
92206238|NCT00820573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206239|NCT00820573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92206240|NCT00820573|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206241|NCT00820573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206242|NCT00820573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206243|NCT05217355|Botulinum Toxins|botulinum toxins|mesh-list
92206244|NCT05217355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92206245|NCT05217355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92206246|NCT05217355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92206247|NCT05217355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206248|NCT05217355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206249|NCT05217355|Cholinergic Agents|cholinergic agents|mesh-ancestor
92206250|NCT05217355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206251|NCT05217355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206253|NCT05217355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206254|NCT02010645|Decitabine|decitabine|mesh-list
92206255|NCT02010645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92206256|NCT02010645|Antimetabolites|antimetabolites|mesh-ancestor
92206257|NCT02010645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206258|NCT02010645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206259|NCT02010645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206261|NCT02065479|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92206262|NCT02065479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92206263|NCT02065479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92206264|NCT02065479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92206265|NCT02065479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92206266|NCT02065479|Purinergic Agents|purinergic agents|mesh-ancestor
92206267|NCT02065479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206268|NCT02065479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206269|NCT02065479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206270|NCT05236621|Dexamethasone|dexamethasone|mesh-list
92206271|NCT05236621|Pomalidomide|pomalidomide|mesh-list
92206272|NCT05236621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206273|NCT05236621|Antiemetics|antiemetics|mesh-ancestor
92206274|NCT05236621|Autonomic Agents|autonomic agents|mesh-ancestor
92206275|NCT05236621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206276|NCT05236621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206277|NCT05236621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206278|NCT05236621|Glucocorticoids|glucocorticoids|mesh-ancestor
92206279|NCT05236621|Hormones|hormones|mesh-ancestor
92206280|NCT05236621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206281|NCT05236621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92206282|NCT05236621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206283|NCT05236621|Immunologic Factors|immunologic factors|mesh-ancestor
92206284|NCT05236621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92206285|NCT05236621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92206286|NCT05236621|Growth Substances|growth substances|mesh-ancestor
92206287|NCT05236621|Growth Inhibitors|growth inhibitors|mesh-ancestor
92206288|NCT02066727|Dexmedetomidine|dexmedetomidine|mesh-list
92206289|NCT02066727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92206290|NCT02066727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206291|NCT02066727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206292|NCT02066727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206293|NCT02066727|Analgesics|analgesics|mesh-ancestor
92206294|NCT02066727|Sensory System Agents|sensory system agents|mesh-ancestor
92206295|NCT02066727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206296|NCT02066727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92206297|NCT02066727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92206298|NCT02066727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92206299|NCT02066727|Adrenergic Agents|adrenergic agents|mesh-ancestor
92206300|NCT02066727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206301|NCT02066727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206302|NCT04349241|Favipiravir|favipiravir|mesh-list
92206303|NCT04349241|Antiviral Agents|antiviral agents|mesh-ancestor
92206304|NCT04349241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206305|NCT02812615|Micronutrients|micronutrients|mesh-list
92206306|NCT02812615|Trace Elements|trace elements|mesh-list
92206307|NCT02812615|Albendazole|albendazole|mesh-list
92206308|NCT02812615|Pyrantel|pyrantel|mesh-list
92206309|NCT02812615|Pyrantel Pamoate|pyrantel pamoate|mesh-list
92206310|NCT02812615|Anthelmintics|anthelmintics|mesh-ancestor
92206311|NCT02812615|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92206312|NCT02812615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206313|NCT02812615|Anticestodal Agents|anticestodal agents|mesh-ancestor
92206314|NCT02812615|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92206315|NCT02812615|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92206316|NCT02812615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92206317|NCT02812615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92206318|NCT02812615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92206319|NCT02812615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206320|NCT02812615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206321|NCT02812615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206322|NCT02812615|Antinematodal Agents|antinematodal agents|mesh-ancestor
92206323|NCT02812615|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92206324|NCT02812615|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92206325|NCT02812615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92206326|NCT02812615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206327|NCT02665117|Chlorthalidone|chlorthalidone|mesh-list
92206328|NCT02665117|Magnesium citrate|magnesium citrate|mesh-list
92206329|NCT02665117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206330|NCT02665117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92206331|NCT02665117|Diuretics|diuretics|mesh-ancestor
92206332|NCT02665117|Natriuretic Agents|natriuretic agents|mesh-ancestor
92206333|NCT02665117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206334|NCT02665117|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92206335|NCT02665117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206336|NCT02665117|Cathartics|cathartics|mesh-ancestor
92206337|NCT02665117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206338|NCT02151253|Modafinil|modafinil|mesh-list
92206339|NCT02151253|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92206340|NCT02151253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206341|NCT02151253|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92206342|NCT02151253|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92206343|NCT02151253|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92206344|NCT02151253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206345|NCT02069847|Budesonide|budesonide|mesh-list
92206346|NCT02069847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206347|NCT02069847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92206348|NCT02069847|Autonomic Agents|autonomic agents|mesh-ancestor
92206349|NCT02069847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206350|NCT02069847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206351|NCT02069847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92206352|NCT02069847|Respiratory System Agents|respiratory system agents|mesh-ancestor
92206353|NCT02069847|Glucocorticoids|glucocorticoids|mesh-ancestor
92206354|NCT02069847|Hormones|hormones|mesh-ancestor
92206355|NCT02069847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206356|NCT02070237|Enoxaparin|enoxaparin|mesh-list
92206357|NCT02070237|Anticoagulants|anticoagulants|mesh-ancestor
92206358|NCT02070237|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92206359|NCT02070237|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92206360|NCT02070237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206361|NCT02071095|Poly I-C|poly i-c|mesh-list
92206362|NCT02071095|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92206364|NCT02071095|Interferon Inducers|interferon inducers|mesh-ancestor
92206365|NCT02071095|Immunologic Factors|immunologic factors|mesh-ancestor
92206366|NCT02071095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206367|NCT02071095|Laxatives|laxatives|mesh-ancestor
92206368|NCT02071095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206369|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
92206370|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206371|NCT02348359|Ranibizumab|ranibizumab|mesh-list
92206372|NCT02348359|Aflibercept|aflibercept|mesh-list
92206373|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206374|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92206375|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92206376|NCT02348359|Growth Substances|growth substances|mesh-ancestor
92206377|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206378|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92206379|NCT02406885|Apixaban|apixaban|mesh-list
92206380|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92206381|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
92206382|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92206383|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206384|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206385|NCT02406885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206386|NCT02406885|Anticoagulants|anticoagulants|mesh-ancestor
92206387|NCT02408445|Methyltestosterone|methyltestosterone|mesh-list
92206388|NCT02408445|Testosterone|testosterone|mesh-list
92206389|NCT02408445|Testosterone undecanoate|testosterone undecanoate|mesh-list
92206390|NCT02408445|Testosterone enanthate|testosterone enanthate|mesh-list
92206391|NCT02408445|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92206392|NCT02408445|Androgens|androgens|mesh-ancestor
92206393|NCT02408445|Hormones|hormones|mesh-ancestor
92206394|NCT02408445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206395|NCT02408445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206396|NCT02408445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92206397|NCT02408445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206398|NCT02408445|Anabolic Agents|anabolic agents|mesh-ancestor
92206399|NCT00388921|Vitamin A|vitamin a|mesh-list
92206400|NCT00388921|Vitamins|vitamins|mesh-ancestor
92206401|NCT00388921|Micronutrients|micronutrients|mesh-ancestor
92206402|NCT00388921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206403|NCT02016885|Glycopyrrolate|glycopyrrolate|mesh-list
92206404|NCT02016885|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92206405|NCT02016885|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92206406|NCT02016885|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92206407|NCT02016885|Cholinergic Agents|cholinergic agents|mesh-ancestor
92408659|NCT05962957|Antioxidants|antioxidants|mesh-ancestor
92206408|NCT02016885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206409|NCT02016885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206410|NCT02016885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206411|NCT05139121|Contraceptive Agents|contraceptive agents|mesh-list
92206412|NCT05139121|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92206413|NCT05139121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206414|NCT00142285|Zinc Sulfate|zinc sulfate|mesh-list
92206415|NCT00142285|Astringents|astringents|mesh-ancestor
92206416|NCT00142285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206417|NCT00142285|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206418|NCT02342379|Bevacizumab|bevacizumab|mesh-list
92206419|NCT02342379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92206420|NCT02342379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206421|NCT02342379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92206422|NCT02342379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92206423|NCT02342379|Growth Substances|growth substances|mesh-ancestor
92206424|NCT02342379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206425|NCT02342379|Growth Inhibitors|growth inhibitors|mesh-ancestor
92206426|NCT02019069|Cytarabine|cytarabine|mesh-list
92206427|NCT02019069|Daunorubicin|daunorubicin|mesh-list
92206428|NCT02019069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92206429|NCT02019069|Antimetabolites|antimetabolites|mesh-ancestor
92206430|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206431|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206432|NCT02019069|Antiviral Agents|antiviral agents|mesh-ancestor
92206433|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206434|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92206435|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
92206436|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206437|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92206438|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92206439|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92206440|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206441|NCT00821821|Edaravone|edaravone|mesh-list
92206442|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92206443|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
92206444|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206445|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92206446|NCT00821821|Protective Agents|protective agents|mesh-ancestor
92206447|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206448|NCT00816751|Lidocaine|lidocaine|mesh-list
92206449|NCT00816751|Vasopressins|vasopressins|mesh-list
92206450|NCT00816751|Arginine Vasopressin|arginine vasopressin|mesh-list
92206451|NCT00816751|Anesthetics, Local|anesthetics, local|mesh-ancestor
92206452|NCT00816751|Anesthetics|anesthetics|mesh-ancestor
92206453|NCT00816751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206454|NCT00816751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206455|NCT00816751|Sensory System Agents|sensory system agents|mesh-ancestor
92206456|NCT00816751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206457|NCT00816751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92206458|NCT00816751|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92206459|NCT00816751|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92206460|NCT00816751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206461|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206462|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
92206463|NCT00816751|Coagulants|coagulants|mesh-ancestor
92206464|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92206465|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92206466|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
92206467|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
92206468|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92206469|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92206470|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92206471|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206472|NCT00822523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206473|NCT00822523|Cholinergic Agents|cholinergic agents|mesh-ancestor
92206474|NCT00822523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206475|NCT00822523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336240|NCT02034006|Ranibizumab|ranibizumab|mesh-list
92206476|NCT00822523|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92206477|NCT00822523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206480|NCT02410707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92206481|NCT02410707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206482|NCT02410707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206483|NCT02410707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92206484|NCT02410707|Anesthetics, General|anesthetics, general|mesh-ancestor
92206486|NCT02410707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92206487|NCT02410707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206488|NCT02410707|Analgesics|analgesics|mesh-ancestor
92206489|NCT02410707|Sensory System Agents|sensory system agents|mesh-ancestor
92206490|NCT02410707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206491|NCT02343081|Temozolomide|temozolomide|mesh-list
92206492|NCT02343081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92206493|NCT02343081|Alkylating Agents|alkylating agents|mesh-ancestor
92206494|NCT02343081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206495|NCT02343081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206496|NCT00823303|Calcitriol|calcitriol|mesh-list
92206497|NCT00823303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92206498|NCT00823303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206499|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92206500|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206501|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206502|NCT00823303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92206503|NCT00823303|Vitamins|vitamins|mesh-ancestor
92206504|NCT00823303|Micronutrients|micronutrients|mesh-ancestor
92206505|NCT00823303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92206506|NCT00823459|Everolimus|everolimus|mesh-list
92206507|NCT00823459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92206508|NCT00823459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92206509|NCT00823459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206510|NCT00823459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206511|NCT00823459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92206512|NCT00823459|Immunologic Factors|immunologic factors|mesh-ancestor
92206513|NCT00823459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206514|NCT00823459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206515|NCT00825565|Allantoin|allantoin|mesh-list
92206516|NCT00825565|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206517|NCT00803647|Leucovorin|leucovorin|mesh-list
92206518|NCT00803647|Fluorouracil|fluorouracil|mesh-list
92206519|NCT00803647|Oxaliplatin|oxaliplatin|mesh-list
92206520|NCT00803647|Cetuximab|cetuximab|mesh-list
92206521|NCT00803647|Antimetabolites|antimetabolites|mesh-ancestor
92206522|NCT00803647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206523|NCT00803647|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92206524|NCT00803647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206525|NCT00803647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92206526|NCT00803647|Immunologic Factors|immunologic factors|mesh-ancestor
92206527|NCT00803647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206528|NCT00803647|Antidotes|antidotes|mesh-ancestor
92206529|NCT00803647|Protective Agents|protective agents|mesh-ancestor
92206530|NCT00803647|Vitamin B Complex|vitamin b complex|mesh-ancestor
92206531|NCT00803647|Vitamins|vitamins|mesh-ancestor
92206532|NCT00803647|Micronutrients|micronutrients|mesh-ancestor
92206533|NCT00803647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92206534|NCT00827983|Progesterone|progesterone|mesh-list
92206535|NCT00827983|Progestins|progestins|mesh-ancestor
92206536|NCT00827983|Hormones|hormones|mesh-ancestor
92206537|NCT00827983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206538|NCT00827983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206539|NCT02346903|Capsaicin|capsaicin|mesh-list
92206540|NCT02346903|Antipruritics|antipruritics|mesh-ancestor
92206541|NCT02346903|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206542|NCT02346903|Sensory System Agents|sensory system agents|mesh-ancestor
92206543|NCT02346903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206544|NCT02346903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206545|NCT02347605|Nicotine|nicotine|mesh-list
92206546|NCT02347605|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92206547|NCT02347605|Autonomic Agents|autonomic agents|mesh-ancestor
92206548|NCT02347605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206549|NCT02347605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206550|NCT02347605|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92206551|NCT02347605|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92206552|NCT02347605|Cholinergic Agents|cholinergic agents|mesh-ancestor
92206553|NCT02347605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206554|NCT02347605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206555|NCT02153671|Vaccines|vaccines|mesh-list
92206556|NCT02153671|Immunologic Factors|immunologic factors|mesh-ancestor
92206557|NCT02153671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206559|NCT02413203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92206560|NCT02413203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206561|NCT02413203|Analgesics|analgesics|mesh-ancestor
92206562|NCT02413203|Sensory System Agents|sensory system agents|mesh-ancestor
92206563|NCT02413203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206564|NCT02413203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206565|NCT02413203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206566|NCT02413203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206567|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92206568|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92206569|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206570|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206571|NCT02153983|Colchicine|colchicine|mesh-list
92206572|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
92206573|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206574|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
92206575|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
92206576|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
92206577|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206578|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206579|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
92206580|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92206581|NCT02348775|Glycine|glycine|mesh-list
92206582|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
92206583|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206584|NCT02348775|Expectorants|expectorants|mesh-ancestor
92206585|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
92206586|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92206587|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
92206588|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206589|NCT02348775|Protective Agents|protective agents|mesh-ancestor
92206590|NCT02348775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206591|NCT02348775|Antidotes|antidotes|mesh-ancestor
92206592|NCT02348775|Glycine Agents|glycine agents|mesh-ancestor
92206593|NCT02348775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206594|NCT00828061|Prednisone|prednisone|mesh-list
92206595|NCT00828061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206596|NCT00828061|Glucocorticoids|glucocorticoids|mesh-ancestor
92206597|NCT00828061|Hormones|hormones|mesh-ancestor
92206598|NCT00828061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206599|NCT00828061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206600|NCT00828061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92206601|NCT00828061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206603|NCT00849121|Immunologic Factors|immunologic factors|mesh-ancestor
92206604|NCT00849121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206605|NCT02023125|Esomeprazole|esomeprazole|mesh-list
92206606|NCT02023125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92206607|NCT02023125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206608|NCT02023125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92206609|NCT02023125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206610|NCT02023125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206611|NCT02349477|Gabapentin|gabapentin|mesh-list
92206612|NCT02349477|Analgesics|analgesics|mesh-ancestor
92206613|NCT02349477|Sensory System Agents|sensory system agents|mesh-ancestor
92206614|NCT02349477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206615|NCT02349477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206616|NCT02349477|Anticonvulsants|anticonvulsants|mesh-ancestor
92206617|NCT02349477|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92206618|NCT02349477|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92206619|NCT02349477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206620|NCT02349477|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92206621|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92206622|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92206623|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206624|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206625|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
92206626|NCT00828295|Palonosetron|palonosetron|mesh-list
92206627|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
92206628|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
92206629|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206630|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206631|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206632|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92206634|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
92206635|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206636|NCT00828295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206637|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
92206638|NCT02350569|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92206639|NCT02350569|Ledipasvir|ledipasvir|mesh-list
92206640|NCT02350569|Antiviral Agents|antiviral agents|mesh-ancestor
92206641|NCT02350569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206642|NCT02351115|Alprazolam|alprazolam|mesh-list
92206643|NCT02351115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92206644|NCT02351115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206645|NCT02351115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206646|NCT02351115|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92206647|NCT02351115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92206648|NCT02351115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92206649|NCT02351115|GABA Modulators|gaba modulators|mesh-ancestor
92206650|NCT02351115|GABA Agents|gaba agents|mesh-ancestor
92206651|NCT02351115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206652|NCT02351115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206653|NCT02025075|Rocuronium|rocuronium|mesh-list
92206654|NCT02025075|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92206655|NCT02025075|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92206656|NCT02025075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92206657|NCT02025075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206658|NCT02025075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206659|NCT00242567|Zoledronic Acid|zoledronic acid|mesh-list
92206660|NCT00242567|Androgens|androgens|mesh-list
92206661|NCT00242567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92206662|NCT00242567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206663|NCT00242567|Hormones|hormones|mesh-ancestor
92206664|NCT00242567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206665|NCT00241631|Fluticasone|fluticasone|mesh-list
92206667|NCT00241631|Theophylline|theophylline|mesh-list
92206668|NCT00241631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206669|NCT00241631|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92206670|NCT00241631|Autonomic Agents|autonomic agents|mesh-ancestor
92206671|NCT00241631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206672|NCT00241631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206673|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92206674|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
92206675|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206676|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92206677|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92206678|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206679|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206680|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
92206681|NCT00241631|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92206682|NCT00241631|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92206683|NCT00241631|Purinergic Agents|purinergic agents|mesh-ancestor
92206684|NCT00241631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206685|NCT02351739|Pembrolizumab|pembrolizumab|mesh-list
92206686|NCT02351739|Acalabrutinib|acalabrutinib|mesh-list
92206687|NCT02351739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92206688|NCT02351739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206689|NCT02351739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92206690|NCT02351739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206692|NCT00240071|Bevacizumab|bevacizumab|mesh-list
92206693|NCT00240071|Letrozole|letrozole|mesh-list
92206694|NCT00240071|Exemestane|exemestane|mesh-list
92206695|NCT00240071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92206696|NCT00240071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206697|NCT00240071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92206698|NCT00240071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92206699|NCT00240071|Growth Substances|growth substances|mesh-ancestor
92206700|NCT00240071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206701|NCT00240071|Growth Inhibitors|growth inhibitors|mesh-ancestor
92206702|NCT00240071|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92206703|NCT00240071|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92206704|NCT00240071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934104|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206705|NCT00240071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206706|NCT00240071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92206707|NCT00240071|Hormone Antagonists|hormone antagonists|mesh-ancestor
92206708|NCT00240071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92206709|NCT00240071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92206710|NCT00240071|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92206711|NCT00240071|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92206712|NCT00240071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92206713|NCT02352363|Levodopa|levodopa|mesh-list
92206714|NCT02352363|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92206715|NCT02352363|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92206716|NCT02352363|Dopamine Agents|dopamine agents|mesh-ancestor
92206717|NCT02352363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206718|NCT02352363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206719|NCT02352363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206720|NCT00765947|Amlodipine|amlodipine|mesh-list
92206721|NCT00765947|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92206722|NCT00765947|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92206723|NCT00765947|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92206724|NCT00765947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206725|NCT00765947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206726|NCT00765947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92206727|NCT00765947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206728|NCT00765947|Vasodilator Agents|vasodilator agents|mesh-ancestor
92206729|NCT00765947|Diuretics|diuretics|mesh-ancestor
92206730|NCT00765947|Natriuretic Agents|natriuretic agents|mesh-ancestor
92206731|NCT00765947|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92206732|NCT05743907|Dapagliflozin|dapagliflozin|mesh-list
92206733|NCT05743907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92206734|NCT05743907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206735|NCT05743907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92206736|NCT05743907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206737|NCT00766649|Sirolimus|sirolimus|mesh-list
92206738|NCT00766649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92206739|NCT00766649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206740|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92206741|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206742|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
92206743|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92206744|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
92206745|NCT00766649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206746|NCT02352831|Capecitabine|capecitabine|mesh-list
92206747|NCT02352831|Tosedostat|tosedostat|mesh-list
92206748|NCT02352831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92206749|NCT02352831|Antimetabolites|antimetabolites|mesh-ancestor
92206750|NCT02352831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206751|NCT02352831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206752|NCT02352831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206753|NCT02353299|Zolpidem|zolpidem|mesh-list
92206754|NCT02353299|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92206755|NCT02353299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92206756|NCT02353299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206757|NCT02353299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206758|NCT02353299|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92206760|NCT02353299|GABA Agents|gaba agents|mesh-ancestor
92206761|NCT02353299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206762|NCT02353299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206763|NCT00756977|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92206764|NCT00756977|Laxatives|laxatives|mesh-ancestor
92206765|NCT00756977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206766|NCT03808961|Vitamins|vitamins|mesh-list
92206767|NCT03808961|Niacin|niacin|mesh-list
92206768|NCT03808961|Niacinamide|niacinamide|mesh-list
92206769|NCT03808961|Nicotinic Acids|nicotinic acids|mesh-list
92206770|NCT03808961|Vitamin B Complex|vitamin b complex|mesh-list
92206771|NCT03808961|Micronutrients|micronutrients|mesh-ancestor
92206772|NCT03808961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206773|NCT03808961|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92206774|NCT03808961|Antimetabolites|antimetabolites|mesh-ancestor
92206775|NCT03808961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206776|NCT03808961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92206777|NCT03808961|Vasodilator Agents|vasodilator agents|mesh-ancestor
92206778|NCT00783965|Tazarotene|tazarotene|mesh-list
92206779|NCT00783965|Dermatologic Agents|dermatologic agents|mesh-ancestor
92206780|NCT00783965|Keratolytic Agents|keratolytic agents|mesh-ancestor
92206781|NCT02354859|Gallium nitrate|gallium nitrate|mesh-list
92206782|NCT02354859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92206783|NCT02354859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206784|NCT02354859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206785|NCT00421551|Ritonavir|ritonavir|mesh-list
92206786|NCT00421551|Darunavir|darunavir|mesh-list
92206787|NCT00421551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92206788|NCT00421551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92206789|NCT00421551|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206790|NCT00421551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206791|NCT00421551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206792|NCT00421551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92206793|NCT00421551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92206794|NCT00421551|Antiviral Agents|antiviral agents|mesh-ancestor
92206795|NCT00421551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206796|NCT00421551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92206797|NCT00421551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92206798|NCT02356107|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92206799|NCT02356107|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92206800|NCT02356107|Antidepressive Agents|antidepressive agents|mesh-ancestor
92206801|NCT02356107|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92206802|NCT00767507|Cangrelor|cangrelor|mesh-list
92206803|NCT00767507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92206804|NCT00767507|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92206805|NCT00767507|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92206806|NCT00767507|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92206807|NCT00767507|Purinergic Agents|purinergic agents|mesh-ancestor
92206808|NCT00767507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206809|NCT00767507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206810|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206811|NCT02029755|Anesthetics|anesthetics|mesh-list
92206812|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
92206813|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206814|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206815|NCT02029755|Sensory System Agents|sensory system agents|mesh-ancestor
92206816|NCT02029755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206817|NCT03804749|Suramin|suramin|mesh-list
92206818|NCT03804749|Antinematodal Agents|antinematodal agents|mesh-ancestor
92206819|NCT03804749|Anthelmintics|anthelmintics|mesh-ancestor
92206820|NCT03804749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92206821|NCT03804749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206822|NCT03804749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206823|NCT03804749|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92206824|NCT03804749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92206825|NCT02312739|Ketorolac|ketorolac|mesh-list
92206826|NCT02312739|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92206827|NCT02312739|Nitrous Oxide|nitrous oxide|mesh-list
92206829|NCT02312739|Lorazepam|lorazepam|mesh-list
92206830|NCT02312739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92206831|NCT02312739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206832|NCT02312739|Sensory System Agents|sensory system agents|mesh-ancestor
92206833|NCT02312739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206834|NCT02312739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206835|NCT02312739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206836|NCT02312739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206837|NCT02312739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92206838|NCT02312739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206839|NCT02312739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206840|NCT02312739|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92206841|NCT02312739|Anesthetics, General|anesthetics, general|mesh-ancestor
92206842|NCT02312739|Anesthetics|anesthetics|mesh-ancestor
92206843|NCT02312739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206844|NCT02312739|Anticonvulsants|anticonvulsants|mesh-ancestor
92206845|NCT02312739|Antiemetics|antiemetics|mesh-ancestor
92206846|NCT02312739|Autonomic Agents|autonomic agents|mesh-ancestor
92206847|NCT02312739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206848|NCT02312739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92206849|NCT02312739|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92206850|NCT02312739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92206851|NCT02312739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92206852|NCT02312739|GABA Modulators|gaba modulators|mesh-ancestor
92206853|NCT02312739|GABA Agents|gaba agents|mesh-ancestor
92206854|NCT02312739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206855|NCT02351037|Azacitidine|azacitidine|mesh-list
92206856|NCT02351037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92206857|NCT02351037|Antimetabolites|antimetabolites|mesh-ancestor
92206858|NCT02351037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206859|NCT02351037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206860|NCT02351037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206861|NCT05718609|Amoxicillin|amoxicillin|mesh-list
92206862|NCT05718609|Clarithromycin|clarithromycin|mesh-list
92206863|NCT05718609|Furazolidone|furazolidone|mesh-list
92206864|NCT05718609|Rabeprazole|rabeprazole|mesh-list
92206865|NCT05718609|Bismuth|bismuth|mesh-list
92206866|NCT05718609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92206867|NCT05718609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92206868|NCT05718609|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92206869|NCT05718609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206870|NCT05718609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206871|NCT05718609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92206872|NCT05718609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92206873|NCT05718609|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92206874|NCT05718609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92206875|NCT05718609|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92206876|NCT05718609|Antacids|antacids|mesh-ancestor
92206877|NCT05718609|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92206878|NCT05718609|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92206879|NCT05718609|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92206880|NCT05718609|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92206881|NCT05718609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92206882|NCT05718609|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92206884|NCT02359305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206885|NCT02359305|Analgesics|analgesics|mesh-ancestor
92206886|NCT02359305|Sensory System Agents|sensory system agents|mesh-ancestor
92206887|NCT02359305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206888|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206889|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
92206890|NCT02360319|Aripiprazole|aripiprazole|mesh-list
92206891|NCT02360319|Antipsychotic Agents|antipsychotic agents|mesh-list
92206892|NCT02360319|Antidepressive Agents|antidepressive agents|mesh-ancestor
92206893|NCT02360319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92206894|NCT02360319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92206895|NCT02360319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92206896|NCT02360319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206897|NCT02360319|Dopamine Agonists|dopamine agonists|mesh-ancestor
92206898|NCT02360319|Dopamine Agents|dopamine agents|mesh-ancestor
92206899|NCT02360319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206900|NCT02360319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206901|NCT02360319|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92206902|NCT02360319|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92206903|NCT02360319|Serotonin Agents|serotonin agents|mesh-ancestor
92206904|NCT02360319|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92206905|NCT02360319|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92206906|NCT02360319|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92206907|NCT02360319|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92206908|NCT05718531|Aspirin|aspirin|mesh-list
92206909|NCT05718531|Rivaroxaban|rivaroxaban|mesh-list
92206910|NCT05718531|Clopidogrel|clopidogrel|mesh-list
92206911|NCT05718531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92206912|NCT05718531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206913|NCT05718531|Analgesics|analgesics|mesh-ancestor
92206914|NCT05718531|Sensory System Agents|sensory system agents|mesh-ancestor
92206915|NCT05718531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206916|NCT05718531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206917|NCT05718531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92206918|NCT05718531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206919|NCT05718531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92206920|NCT05718531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92206921|NCT05718531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206922|NCT05718531|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92206923|NCT05718531|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92206924|NCT05718531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206925|NCT05718531|Antipyretics|antipyretics|mesh-ancestor
92206926|NCT05718531|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92206927|NCT05718531|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92206928|NCT05718531|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92206929|NCT05718531|Purinergic Agents|purinergic agents|mesh-ancestor
92206930|NCT05718531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206931|NCT05718531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92206932|NCT05718531|Antithrombins|antithrombins|mesh-ancestor
92206933|NCT05718531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92206934|NCT05718531|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206935|NCT05718531|Anticoagulants|anticoagulants|mesh-ancestor
92206936|NCT02360631|Varenicline|varenicline|mesh-list
92206937|NCT02360631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92206938|NCT02360631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92206939|NCT02360631|Cholinergic Agents|cholinergic agents|mesh-ancestor
92206940|NCT02360631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92206941|NCT02360631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206942|NCT02360631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206943|NCT00355095|Epoetin Alfa|epoetin alfa|mesh-list
92206944|NCT00355095|Hematinics|hematinics|mesh-ancestor
92206945|NCT02366871|Enoxaparin|enoxaparin|mesh-list
92206946|NCT02366871|Apixaban|apixaban|mesh-list
92206947|NCT02366871|Anticoagulants|anticoagulants|mesh-ancestor
92206948|NCT02366871|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92206949|NCT02366871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92206950|NCT02366871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206951|NCT02366871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92206952|NCT02366871|Antithrombins|antithrombins|mesh-ancestor
92206953|NCT02366871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92206954|NCT02366871|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206955|NCT02366871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206956|NCT02368431|Zonisamide|zonisamide|mesh-list
92206957|NCT02368431|Anticonvulsants|anticonvulsants|mesh-ancestor
92206958|NCT02368431|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92206959|NCT02368431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92206960|NCT02368431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206961|NCT02368431|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92206962|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206963|NCT03836651|Antioxidants|antioxidants|mesh-list
92206964|NCT03836651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206965|NCT03836651|Protective Agents|protective agents|mesh-ancestor
92206966|NCT03836651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206967|NCT02037555|Antithrombins|antithrombins|mesh-list
92206968|NCT02037555|Antithrombin III|antithrombin iii|mesh-list
92206969|NCT02037555|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92206970|NCT02037555|Protease Inhibitors|protease inhibitors|mesh-ancestor
92206971|NCT02037555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92206972|NCT02037555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92206973|NCT02037555|Anticoagulants|anticoagulants|mesh-ancestor
92206974|NCT03804359|Rituximab|rituximab|mesh-list
92206975|NCT03804359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92206976|NCT03804359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92206977|NCT03804359|Immunologic Factors|immunologic factors|mesh-ancestor
92206978|NCT03804359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206979|NCT03804359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92206980|NCT02369211|Acetaminophen|acetaminophen|mesh-list
92206981|NCT02369211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92206982|NCT02369211|Analgesics|analgesics|mesh-ancestor
92206983|NCT02369211|Sensory System Agents|sensory system agents|mesh-ancestor
92206984|NCT02369211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92206985|NCT02369211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206986|NCT02369211|Antipyretics|antipyretics|mesh-ancestor
92206987|NCT02038023|Iron|iron|mesh-list
92206988|NCT02038023|Dextrans|dextrans|mesh-list
92206989|NCT02038023|Iron-Dextran Complex|iron-dextran complex|mesh-list
92206990|NCT02038023|Trace Elements|trace elements|mesh-ancestor
92206991|NCT02038023|Micronutrients|micronutrients|mesh-ancestor
92206992|NCT02038023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92206993|NCT02038023|Anticoagulants|anticoagulants|mesh-ancestor
92206994|NCT02038023|Plasma Substitutes|plasma substitutes|mesh-ancestor
92206995|NCT02038023|Blood Substitutes|blood substitutes|mesh-ancestor
92206996|NCT02038023|Hematinics|hematinics|mesh-ancestor
92206997|NCT04384133|Nitric Oxide|nitric oxide|mesh-list
92206998|NCT04384133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92206999|NCT04384133|Autonomic Agents|autonomic agents|mesh-ancestor
92207000|NCT04384133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207001|NCT04384133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207002|NCT04384133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92207003|NCT04384133|Respiratory System Agents|respiratory system agents|mesh-ancestor
92207004|NCT04384133|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92207005|NCT04384133|Antioxidants|antioxidants|mesh-ancestor
92207006|NCT04384133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207007|NCT04384133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207008|NCT04384133|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92207009|NCT04384133|Vasodilator Agents|vasodilator agents|mesh-ancestor
92207010|NCT04384133|Gasotransmitters|gasotransmitters|mesh-ancestor
92207011|NCT04384133|Protective Agents|protective agents|mesh-ancestor
92207012|NCT02038179|Allopurinol|allopurinol|mesh-list
92207013|NCT02038179|Antimetabolites|antimetabolites|mesh-ancestor
92207014|NCT02038179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207015|NCT02038179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207016|NCT02038179|Gout Suppressants|gout suppressants|mesh-ancestor
92207017|NCT02038179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207018|NCT02038179|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92207019|NCT02038179|Antioxidants|antioxidants|mesh-ancestor
92207020|NCT02038179|Protective Agents|protective agents|mesh-ancestor
92207021|NCT02038179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207022|NCT02369835|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92207024|NCT02369835|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92207025|NCT02369835|Disinfectants|disinfectants|mesh-ancestor
92207026|NCT02369835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207027|NCT00768521|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92207028|NCT00768521|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92207029|NCT00768521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92207030|NCT00768521|Cholinergic Agents|cholinergic agents|mesh-ancestor
92207031|NCT00768521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207032|NCT00768521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207033|NCT00768521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207034|NCT00768521|Urological Agents|urological agents|mesh-ancestor
92207036|NCT00768599|Antifungal Agents|antifungal agents|mesh-ancestor
92207037|NCT00768599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207038|NCT00768599|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92207039|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92207041|NCT00768599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207042|NCT00768599|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92207043|NCT00768599|Hormone Antagonists|hormone antagonists|mesh-ancestor
92207044|NCT00768599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207045|NCT00768599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207046|NCT02370693|Mycophenolic Acid|mycophenolic acid|mesh-list
92207047|NCT02370693|Bortezomib|bortezomib|mesh-list
92207048|NCT02370693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92207049|NCT02370693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207050|NCT02370693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92207051|NCT02370693|Antitubercular Agents|antitubercular agents|mesh-ancestor
92207052|NCT02370693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92207053|NCT02370693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207055|NCT02370693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207056|NCT02039115|Prednisone|prednisone|mesh-list
92207057|NCT02039115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207058|NCT02039115|Glucocorticoids|glucocorticoids|mesh-ancestor
92207059|NCT02039115|Hormones|hormones|mesh-ancestor
92207060|NCT02039115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207061|NCT02039115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207062|NCT02039115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92207063|NCT02039115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207064|NCT00759473|Cycloserine|cycloserine|mesh-list
92207065|NCT00759473|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92207066|NCT00759473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207067|NCT00759473|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92207068|NCT00759473|Antitubercular Agents|antitubercular agents|mesh-ancestor
92207069|NCT00759473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92207070|NCT00759473|Antimetabolites|antimetabolites|mesh-ancestor
92207071|NCT00759473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207072|NCT00759707|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92207073|NCT00759707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207074|NCT00759707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207075|NCT03809273|Trimetazidine|trimetazidine|mesh-list
92207076|NCT03809273|Vasodilator Agents|vasodilator agents|mesh-ancestor
92207077|NCT04384991|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92207078|NCT04384991|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92207080|NCT00354627|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92207081|NCT00354627|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92207082|NCT00354627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207083|NCT00354627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207084|NCT00354627|Antiviral Agents|antiviral agents|mesh-ancestor
92207085|NCT00354627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207086|NCT00770861|Nebivolol|nebivolol|mesh-list
92207087|NCT00770861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92207088|NCT00770861|Vasodilator Agents|vasodilator agents|mesh-ancestor
92207089|NCT00770861|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92207090|NCT00770861|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92207091|NCT00770861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92207092|NCT00770861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92207093|NCT00770861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207094|NCT00770861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207095|NCT00770861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207096|NCT03808805|Aprepitant|aprepitant|mesh-list
92207097|NCT03808805|Fosaprepitant|fosaprepitant|mesh-list
92207098|NCT03808805|Hydroxyzine|hydroxyzine|mesh-list
92207099|NCT03808805|Antiemetics|antiemetics|mesh-ancestor
92207100|NCT03808805|Autonomic Agents|autonomic agents|mesh-ancestor
92207101|NCT03808805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207102|NCT03808805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207103|NCT03808805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207104|NCT03808805|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92207105|NCT03808805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207106|NCT03808805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207107|NCT03808805|Antipruritics|antipruritics|mesh-ancestor
92207108|NCT03808805|Dermatologic Agents|dermatologic agents|mesh-ancestor
92207109|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92207110|NCT03808805|Histamine Antagonists|histamine antagonists|mesh-ancestor
92207111|NCT03808805|Histamine Agents|histamine agents|mesh-ancestor
92207112|NCT03803267|Fentanyl|fentanyl|mesh-list
92207113|NCT03803267|Propofol|propofol|mesh-list
92207114|NCT03803267|Atracurium|atracurium|mesh-list
92207115|NCT03803267|Anesthetics|anesthetics|mesh-ancestor
92207116|NCT03803267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207117|NCT03803267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207118|NCT03803267|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92207119|NCT03803267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207120|NCT03803267|Anesthetics, General|anesthetics, general|mesh-ancestor
92207121|NCT03803267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207122|NCT03803267|Narcotics|narcotics|mesh-ancestor
92207123|NCT03803267|Analgesics|analgesics|mesh-ancestor
92207124|NCT03803267|Sensory System Agents|sensory system agents|mesh-ancestor
92207125|NCT03803267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207126|NCT03803267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92207127|NCT03803267|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92207128|NCT03803267|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92207129|NCT03803267|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92207130|NCT03803267|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92207131|NCT03803267|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92207132|NCT03803267|Cholinergic Agents|cholinergic agents|mesh-ancestor
92207133|NCT03803267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207134|NCT03803267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207135|NCT00787943|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92207136|NCT00787943|Dermatologic Agents|dermatologic agents|mesh-ancestor
92207137|NCT03808649|Mannitol|mannitol|mesh-list
92207138|NCT03808649|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92207139|NCT03808649|Diuretics|diuretics|mesh-ancestor
92207140|NCT03808649|Natriuretic Agents|natriuretic agents|mesh-ancestor
92207141|NCT03808649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207142|NCT00788255|Oxytocin|oxytocin|mesh-list
92207143|NCT00788255|Oxytocics|oxytocics|mesh-ancestor
92207144|NCT00788255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92207145|NCT00788255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207146|NCT02379195|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92207147|NCT02379195|Cyclophosphamide|cyclophosphamide|mesh-list
92207148|NCT02379195|Fludarabine|fludarabine|mesh-list
92207149|NCT02379195|Interleukin-2|interleukin-2|mesh-list
92207150|NCT02379195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92207151|NCT02379195|Immunologic Factors|immunologic factors|mesh-ancestor
92207152|NCT02379195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207153|NCT02379195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207154|NCT02379195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92207155|NCT02379195|Alkylating Agents|alkylating agents|mesh-ancestor
92207156|NCT02379195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207157|NCT02379195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207158|NCT02379195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92207159|NCT02379195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207161|NCT02379195|Sensory System Agents|sensory system agents|mesh-ancestor
92207162|NCT02379195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207163|NCT02379195|Antiviral Agents|antiviral agents|mesh-ancestor
92207164|NCT02379195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207165|NCT00771875|Acetaminophen|acetaminophen|mesh-list
92207166|NCT00771875|Diphenhydramine|diphenhydramine|mesh-list
92207167|NCT00771875|Methylprednisolone|methylprednisolone|mesh-list
92207168|NCT00771875|Rituximab|rituximab|mesh-list
92207169|NCT00771875|Bortezomib|bortezomib|mesh-list
92207170|NCT00771875|Thymoglobulin|thymoglobulin|mesh-list
92207171|NCT00771875|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92207172|NCT00771875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92207173|NCT00771875|Histamine Antagonists|histamine antagonists|mesh-list
91920531|NCT02177539|Mydriatics|mydriatics|mesh-ancestor
92207174|NCT00771875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207175|NCT00771875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207176|NCT00771875|Immunologic Factors|immunologic factors|mesh-ancestor
92207177|NCT00771875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207178|NCT00771875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207179|NCT00771875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207180|NCT00771875|Analgesics|analgesics|mesh-ancestor
92207181|NCT00771875|Sensory System Agents|sensory system agents|mesh-ancestor
92207182|NCT00771875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207183|NCT00771875|Antipyretics|antipyretics|mesh-ancestor
92207184|NCT00771875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207185|NCT00771875|Antiemetics|antiemetics|mesh-ancestor
92207186|NCT00771875|Autonomic Agents|autonomic agents|mesh-ancestor
92207187|NCT00771875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207188|NCT00771875|Glucocorticoids|glucocorticoids|mesh-ancestor
92207189|NCT00771875|Hormones|hormones|mesh-ancestor
92207190|NCT00771875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207191|NCT00771875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92207192|NCT00771875|Protective Agents|protective agents|mesh-ancestor
92207193|NCT00771875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92207194|NCT00771875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92207195|NCT00771875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92207196|NCT00771875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207197|NCT00771875|Anesthetics, Local|anesthetics, local|mesh-ancestor
92207198|NCT00771875|Anesthetics|anesthetics|mesh-ancestor
92207199|NCT00771875|Histamine Agents|histamine agents|mesh-ancestor
92207200|NCT00771875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207201|NCT00771875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207202|NCT00771875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92207203|NCT00760019|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92207204|NCT00760019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92207205|NCT00760019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207206|NCT00760019|Analgesics|analgesics|mesh-ancestor
92207207|NCT00760019|Sensory System Agents|sensory system agents|mesh-ancestor
92207208|NCT00760019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207209|NCT00760019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207210|NCT00760019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207211|NCT00760019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207212|NCT00789113|Lamotrigine|lamotrigine|mesh-list
92207213|NCT00789113|Anticonvulsants|anticonvulsants|mesh-ancestor
92207214|NCT00789113|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92207215|NCT00789113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92207216|NCT00789113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207217|NCT00789113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92207218|NCT00789113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207219|NCT00789113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92207220|NCT00789113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92207221|NCT00789113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207222|NCT00789113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207223|NCT00789113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92207224|NCT03808259|Ketamine|ketamine|mesh-list
92207225|NCT03808259|Esketamine|esketamine|mesh-list
92207226|NCT03808259|Analgesics|analgesics|mesh-ancestor
92207227|NCT03808259|Sensory System Agents|sensory system agents|mesh-ancestor
92207228|NCT03808259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207229|NCT03808259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207230|NCT03808259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92207231|NCT03808259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207232|NCT03808259|Anesthetics, General|anesthetics, general|mesh-ancestor
92207233|NCT03808259|Anesthetics|anesthetics|mesh-ancestor
92207234|NCT03808259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207235|NCT03808259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92207236|NCT03808259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92207237|NCT03808259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207238|NCT03808259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207239|NCT03808259|Antidepressive Agents|antidepressive agents|mesh-ancestor
92207240|NCT03808259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207241|NCT02051595|Vancomycin|vancomycin|mesh-list
92207242|NCT02051595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92207243|NCT02051595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207244|NCT05742503|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92207245|NCT05742503|Medroxyprogesterone|medroxyprogesterone|mesh-list
92207246|NCT05742503|Etonogestrel|etonogestrel|mesh-list
92207247|NCT05742503|Norgestrel|norgestrel|mesh-list
92207248|NCT05742503|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92207249|NCT05742503|Contraceptive Agents|contraceptive agents|mesh-ancestor
92207250|NCT05742503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92207251|NCT05742503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207252|NCT05742503|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92207253|NCT05742503|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92207254|NCT05742503|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92207255|NCT05742503|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92207256|NCT05742503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92207257|NCT05742503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207258|NCT05742503|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92207260|NCT02388321|Ketamine|ketamine|mesh-list
92207261|NCT02388321|Analgesics|analgesics|mesh-ancestor
92207262|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
92207263|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207264|NCT02388321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207265|NCT02388321|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92207266|NCT02388321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207267|NCT02388321|Anesthetics, General|anesthetics, general|mesh-ancestor
92207268|NCT02388321|Anesthetics|anesthetics|mesh-ancestor
92207269|NCT02388321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207270|NCT02388321|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92207271|NCT02388321|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92207272|NCT02388321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207273|NCT02388321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207274|NCT02388321|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207275|NCT02388321|Narcotics|narcotics|mesh-ancestor
92207276|NCT02388321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92207277|NCT05742425|Bevacizumab|bevacizumab|mesh-list
92207278|NCT05742425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207279|NCT05742425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207280|NCT05742425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92207281|NCT05742425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92207282|NCT05742425|Growth Substances|growth substances|mesh-ancestor
92207283|NCT05742425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207284|NCT05742425|Growth Inhibitors|growth inhibitors|mesh-ancestor
92207285|NCT02313675|Acetaminophen|acetaminophen|mesh-list
92207286|NCT02313675|Ketorolac|ketorolac|mesh-list
92207287|NCT02313675|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92207288|NCT02313675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207289|NCT02313675|Analgesics|analgesics|mesh-ancestor
92207290|NCT02313675|Sensory System Agents|sensory system agents|mesh-ancestor
92207291|NCT02313675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207292|NCT02313675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207293|NCT02313675|Antipyretics|antipyretics|mesh-ancestor
92207294|NCT02313675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92207295|NCT02313675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207296|NCT02313675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207297|NCT02313675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92207298|NCT02313675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207299|NCT02313675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207300|NCT05568797|Vaccines|vaccines|mesh-list
92207301|NCT05568797|Immunologic Factors|immunologic factors|mesh-ancestor
92207302|NCT05568797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207304|NCT03801629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207305|NCT03801629|Narcotics|narcotics|mesh-ancestor
92207306|NCT03801629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207307|NCT03801629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207308|NCT03801629|Analgesics|analgesics|mesh-ancestor
92207309|NCT03801629|Sensory System Agents|sensory system agents|mesh-ancestor
92207310|NCT03801629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207311|NCT05741021|Paclitaxel|paclitaxel|mesh-list
92207312|NCT05741021|Carboplatin|carboplatin|mesh-list
92207313|NCT05741021|Pemetrexed|pemetrexed|mesh-list
92207314|NCT05741021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92207315|NCT05741021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207316|NCT05741021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92207317|NCT05741021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92207318|NCT05741021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92207319|NCT05741021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207320|NCT05741021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207321|NCT05741021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92207322|NCT05741021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92207323|NCT04383977|Etoposide|etoposide|mesh-list
92207324|NCT04383977|Apatinib|apatinib|mesh-list
92207325|NCT04383977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92207326|NCT04383977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336308|NCT02006706|Abortifacient Agents|abortifacient agents|mesh-ancestor
92207327|NCT04383977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92207328|NCT04383977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92207329|NCT04383977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207330|NCT04383977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207331|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207332|NCT02389959|Bevacizumab|bevacizumab|mesh-list
92207333|NCT02389959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207334|NCT02389959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207335|NCT02389959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92207336|NCT02389959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92207337|NCT02389959|Growth Substances|growth substances|mesh-ancestor
92207338|NCT02389959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207339|NCT02389959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92207341|NCT00775931|Busulfan|busulfan|mesh-list
92207342|NCT00775931|Fludarabine|fludarabine|mesh-list
92207343|NCT00775931|Fludarabine phosphate|fludarabine phosphate|mesh-list
92207344|NCT00775931|Alemtuzumab|alemtuzumab|mesh-list
92207345|NCT00775931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92207346|NCT00775931|Immunologic Factors|immunologic factors|mesh-ancestor
92207347|NCT00775931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207348|NCT00775931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207349|NCT00775931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92207350|NCT00775931|Alkylating Agents|alkylating agents|mesh-ancestor
92207351|NCT00775931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207352|NCT00775931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207353|NCT00775931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92207354|NCT00775931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92207355|NCT00775931|Antimetabolites|antimetabolites|mesh-ancestor
92207356|NCT00775931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207357|NCT02052141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92207358|NCT02052141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92207359|NCT02052141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92207360|NCT02052141|Immunologic Factors|immunologic factors|mesh-ancestor
92207361|NCT02052141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207362|NCT05734235|Vitamins|vitamins|mesh-list
92207363|NCT05734235|Vitamin E|vitamin e|mesh-list
92207364|NCT05734235|Micronutrients|micronutrients|mesh-ancestor
92207365|NCT05734235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207366|NCT05734235|Antioxidants|antioxidants|mesh-ancestor
92207367|NCT05734235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207368|NCT05734235|Protective Agents|protective agents|mesh-ancestor
92207369|NCT05732129|Irinotecan|irinotecan|mesh-list
92207370|NCT05732129|Fluzoparib|fluzoparib|mesh-list
92207371|NCT05732129|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92207372|NCT05732129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92207373|NCT05732129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207374|NCT05732129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207375|NCT05732129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207376|NCT05732129|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92207378|NCT02394951|Analgesics|analgesics|mesh-ancestor
92207379|NCT02394951|Sensory System Agents|sensory system agents|mesh-ancestor
92207380|NCT02394951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207381|NCT02394951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207382|NCT02394951|Anticonvulsants|anticonvulsants|mesh-ancestor
92207383|NCT02394951|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92207384|NCT02394951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92207385|NCT02394951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207386|NCT02394951|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92207387|NCT02394951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92207388|NCT02394951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92207389|NCT02394951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207390|NCT02394951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207391|NCT03838367|Leronlimab|leronlimab|mesh-list
92207392|NCT03838367|Carboplatin|carboplatin|mesh-list
92207393|NCT03838367|HIV Antibodies|hiv antibodies|mesh-list
92207394|NCT03838367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207395|NCT03838367|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92207396|NCT03838367|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92207397|NCT03838367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207398|NCT03838367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92207399|NCT03838367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92207400|NCT03838367|Antiviral Agents|antiviral agents|mesh-ancestor
92207401|NCT03838367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207402|NCT03838367|Immunologic Factors|immunologic factors|mesh-ancestor
92207403|NCT03838367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207404|NCT00354861|Aluminum sulfate|aluminum sulfate|mesh-list
92207405|NCT00354861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92207406|NCT00354861|Immunologic Factors|immunologic factors|mesh-ancestor
92207407|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207408|NCT04345445|Methylprednisolone|methylprednisolone|mesh-list
92207409|NCT04345445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92207410|NCT04345445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92207411|NCT04345445|Prednisolone|prednisolone|mesh-list
92207412|NCT04345445|Prednisolone acetate|prednisolone acetate|mesh-list
92207413|NCT04345445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92207414|NCT04345445|Prednisolone phosphate|prednisolone phosphate|mesh-list
92207415|NCT04345445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207417|NCT04345445|Autonomic Agents|autonomic agents|mesh-ancestor
92207418|NCT04345445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207419|NCT04345445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207420|NCT04345445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207421|NCT04345445|Glucocorticoids|glucocorticoids|mesh-ancestor
92207422|NCT04345445|Hormones|hormones|mesh-ancestor
92207423|NCT04345445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207424|NCT04345445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92207425|NCT04345445|Protective Agents|protective agents|mesh-ancestor
92207426|NCT04345445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92207427|NCT04345445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207428|NCT00354939|Insulin Glargine|insulin glargine|mesh-list
92207429|NCT00354939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92207430|NCT00354939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207431|NCT05713877|Melatonin|melatonin|mesh-list
92207432|NCT05713877|Antioxidants|antioxidants|mesh-ancestor
92207433|NCT05713877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207434|NCT05713877|Protective Agents|protective agents|mesh-ancestor
92207435|NCT05713877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207436|NCT05713877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207437|NCT00795275|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92207438|NCT00795275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92207439|NCT00795275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207440|NCT00795275|Incretins|incretins|mesh-ancestor
92207441|NCT00795275|Hormones|hormones|mesh-ancestor
92207442|NCT00795275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207443|NCT00795275|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92207444|NCT00795275|Protease Inhibitors|protease inhibitors|mesh-ancestor
92207445|NCT00795275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207446|NCT00795275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207447|NCT00777335|Panobinostat|panobinostat|mesh-list
92207448|NCT00777335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207449|NCT00777335|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92207450|NCT00777335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336316|NCT02006706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92207451|NCT00777335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207452|NCT04896645|Albuterol|albuterol|mesh-list
92207453|NCT04896645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92207454|NCT04896645|Autonomic Agents|autonomic agents|mesh-ancestor
92207455|NCT04896645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207456|NCT04896645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207457|NCT04896645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92207458|NCT04896645|Respiratory System Agents|respiratory system agents|mesh-ancestor
92207459|NCT04896645|Tocolytic Agents|tocolytic agents|mesh-ancestor
92207460|NCT04896645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92207461|NCT04896645|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92207462|NCT04896645|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92207463|NCT04896645|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92207464|NCT04896645|Adrenergic Agents|adrenergic agents|mesh-ancestor
92207465|NCT04896645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207466|NCT04896645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207468|NCT05644587|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92207469|NCT05644587|Naloxone|naloxone|mesh-list
92207470|NCT05644587|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207471|NCT05644587|Narcotics|narcotics|mesh-ancestor
92207472|NCT05644587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207473|NCT05644587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207474|NCT05644587|Analgesics|analgesics|mesh-ancestor
92207475|NCT05644587|Sensory System Agents|sensory system agents|mesh-ancestor
92207476|NCT05644587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207477|NCT05644587|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92207478|NCT00355407|Darbepoetin alfa|darbepoetin alfa|mesh-list
92207479|NCT00355407|Hematinics|hematinics|mesh-ancestor
92207480|NCT00355251|Atorvastatin|atorvastatin|mesh-list
92207481|NCT00355251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92207482|NCT00355251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92207483|NCT00355251|Antimetabolites|antimetabolites|mesh-ancestor
92207484|NCT00355251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207485|NCT00355251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92207486|NCT00355251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92207487|NCT00355251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207488|NCT03832127|Fludarabine|fludarabine|mesh-list
92207489|NCT03832127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207490|NCT04876131|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92207491|NCT04876131|Gentamicins|gentamicins|mesh-list
92207493|NCT04876131|Penicillin G|penicillin g|mesh-list
92207494|NCT04876131|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92207495|NCT04876131|Penicillin G Procaine|penicillin g procaine|mesh-list
92207496|NCT04876131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207497|NCT04876131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92207498|NCT04876131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207499|NCT04876131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207500|NCT04825275|Posaconazole|posaconazole|mesh-list
92207501|NCT04825275|Antifungal Agents|antifungal agents|mesh-ancestor
92207502|NCT04825275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207503|NCT04825275|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92207504|NCT04825275|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92207505|NCT04825275|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92207506|NCT04825275|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92207507|NCT04825275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92207508|NCT04825275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207509|NCT04825275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207510|NCT04825275|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92207511|NCT04825275|Hormone Antagonists|hormone antagonists|mesh-ancestor
92207512|NCT04825275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207513|NCT04825275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207514|NCT00791219|Itraconazole|itraconazole|mesh-list
92207515|NCT00791219|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92207516|NCT00791219|Antifungal Agents|antifungal agents|mesh-ancestor
92207517|NCT00791219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207518|NCT00791219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92207519|NCT00791219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92207520|NCT00791219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207521|NCT00791219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207522|NCT00791219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92207523|NCT00791219|Hormone Antagonists|hormone antagonists|mesh-ancestor
92207524|NCT00791219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207525|NCT00791219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207526|NCT00791219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92207527|NCT04818489|Colchicine|colchicine|mesh-list
92207528|NCT04818489|Gout Suppressants|gout suppressants|mesh-ancestor
92207529|NCT04818489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207530|NCT04818489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92207531|NCT04818489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92207532|NCT04818489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92207533|NCT04818489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207534|NCT04818489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207535|NCT00797459|Hyaluronic Acid|hyaluronic acid|mesh-list
92207536|NCT00797459|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92207537|NCT00797459|Immunologic Factors|immunologic factors|mesh-ancestor
92207538|NCT00797459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207540|NCT00797459|Protective Agents|protective agents|mesh-ancestor
92207541|NCT04807101|Midazolam|midazolam|mesh-list
92207542|NCT04807101|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92207543|NCT04807101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92207544|NCT04807101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207545|NCT04807101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207546|NCT04807101|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92207547|NCT04807101|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92207548|NCT04807101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207549|NCT04807101|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207550|NCT04807101|Anesthetics, General|anesthetics, general|mesh-ancestor
92207551|NCT04807101|Anesthetics|anesthetics|mesh-ancestor
92207552|NCT04807101|GABA Modulators|gaba modulators|mesh-ancestor
92207553|NCT04807101|GABA Agents|gaba agents|mesh-ancestor
92207554|NCT04807101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207555|NCT04807101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207556|NCT00355953|Genistein|genistein|mesh-list
92207557|NCT00355953|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92207558|NCT00355953|Protective Agents|protective agents|mesh-ancestor
92207559|NCT00355953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207560|NCT00355953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207561|NCT00355953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207562|NCT00355953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207563|NCT00355953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207564|NCT00355953|Phytoestrogens|phytoestrogens|mesh-ancestor
92207565|NCT00355953|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92207566|NCT00355953|Estrogens|estrogens|mesh-ancestor
92207567|NCT00355953|Hormones|hormones|mesh-ancestor
92207568|NCT00355953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207569|NCT05419193|Propranolol|propranolol|mesh-list
92207570|NCT05419193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92207571|NCT05419193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92207572|NCT05419193|Adrenergic Agents|adrenergic agents|mesh-ancestor
92207573|NCT05419193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207574|NCT05419193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207575|NCT05419193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207576|NCT05419193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92207577|NCT05419193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92207578|NCT05419193|Vasodilator Agents|vasodilator agents|mesh-ancestor
92207579|NCT05416073|Sufentanil|sufentanil|mesh-list
92207580|NCT05416073|Esketamine|esketamine|mesh-list
92207581|NCT05416073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207582|NCT05416073|Narcotics|narcotics|mesh-ancestor
92207583|NCT05416073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207584|NCT05416073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207585|NCT05416073|Analgesics|analgesics|mesh-ancestor
92336345|NCT02006628|Cannabidiol|cannabidiol|mesh-list
92207586|NCT05416073|Sensory System Agents|sensory system agents|mesh-ancestor
92207587|NCT05416073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207588|NCT05416073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92207589|NCT05416073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207590|NCT05416073|Anesthetics, General|anesthetics, general|mesh-ancestor
92207591|NCT05416073|Anesthetics|anesthetics|mesh-ancestor
92207592|NCT05416073|Antidepressive Agents|antidepressive agents|mesh-ancestor
92207593|NCT05416073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207594|NCT05664971|Paclitaxel|paclitaxel|mesh-list
92207595|NCT05664971|Etoposide|etoposide|mesh-list
92207596|NCT05664971|Docetaxel|docetaxel|mesh-list
92207597|NCT05664971|Carboplatin|carboplatin|mesh-list
92207598|NCT05664971|Pemetrexed|pemetrexed|mesh-list
92207599|NCT05664971|Antibodies|antibodies|mesh-list
92207600|NCT05664971|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92207601|NCT05664971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92207602|NCT05664971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207603|NCT05664971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92207604|NCT05664971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92207605|NCT05664971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92207606|NCT05664971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207607|NCT05664971|Immunologic Factors|immunologic factors|mesh-ancestor
92207608|NCT05664971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207609|NCT05664971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92207610|NCT05664971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92207611|NCT05664971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207612|NCT05664971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92207613|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92207614|NCT05590299|Immunomodulating Agents|immunomodulating agents|mesh-list
92207615|NCT05590299|Immunologic Factors|immunologic factors|mesh-list
92207616|NCT05590299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207617|NCT04812509|Denosumab|denosumab|mesh-list
92207618|NCT04812509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92207619|NCT04812509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207620|NCT05446623|Sufentanil|sufentanil|mesh-list
92207621|NCT05446623|Dexmedetomidine|dexmedetomidine|mesh-list
92207622|NCT05446623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92207623|NCT05446623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207624|NCT05446623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207625|NCT05446623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207626|NCT05446623|Analgesics|analgesics|mesh-ancestor
92207627|NCT05446623|Sensory System Agents|sensory system agents|mesh-ancestor
92207628|NCT05446623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207629|NCT05446623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92207630|NCT05446623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92207631|NCT05446623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92207632|NCT05446623|Adrenergic Agents|adrenergic agents|mesh-ancestor
92207633|NCT05446623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207634|NCT05446623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207635|NCT05446623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207636|NCT05446623|Narcotics|narcotics|mesh-ancestor
92207637|NCT05446623|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92207638|NCT05446623|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207639|NCT05446623|Anesthetics, General|anesthetics, general|mesh-ancestor
92207640|NCT05446623|Anesthetics|anesthetics|mesh-ancestor
92207641|NCT00792077|Lenalidomide|lenalidomide|mesh-list
92207642|NCT00792077|Immunologic Factors|immunologic factors|mesh-ancestor
92207643|NCT00792077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207644|NCT00792077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92207645|NCT00792077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92207646|NCT00792077|Growth Substances|growth substances|mesh-ancestor
92207647|NCT00792077|Growth Inhibitors|growth inhibitors|mesh-ancestor
92207648|NCT00792077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207649|NCT02979015|Alirocumab|alirocumab|mesh-list
92207650|NCT02979015|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92207651|NCT02979015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92207652|NCT02979015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92207653|NCT02979015|Antimetabolites|antimetabolites|mesh-ancestor
92207654|NCT02979015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207655|NCT02979015|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92336355|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
92207656|NCT02979015|Protease Inhibitors|protease inhibitors|mesh-ancestor
92207657|NCT02979015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207658|NCT02979015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92207659|NCT00799643|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92207661|NCT00799643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92207662|NCT00799643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207663|NCT00799643|Analgesics|analgesics|mesh-ancestor
92207664|NCT00799643|Sensory System Agents|sensory system agents|mesh-ancestor
92207665|NCT00799643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207666|NCT00799643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207667|NCT00799643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207668|NCT00799643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207669|NCT00799643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92207670|NCT00799643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207671|NCT00799643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207673|NCT03835013|Glucagon|glucagon|mesh-list
92207674|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92207675|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92207676|NCT03835013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207677|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92207678|NCT03835013|Incretins|incretins|mesh-ancestor
92207679|NCT03835013|Hormones|hormones|mesh-ancestor
92207680|NCT03835013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207681|NCT03835013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207682|NCT05555823|Repaglinide|repaglinide|mesh-list
92207683|NCT05555823|Celecoxib|celecoxib|mesh-list
92207684|NCT05555823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92207685|NCT05555823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207686|NCT05555823|Analgesics|analgesics|mesh-ancestor
92207687|NCT05555823|Sensory System Agents|sensory system agents|mesh-ancestor
92207688|NCT05555823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207689|NCT05555823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207690|NCT05555823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207691|NCT05555823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207692|NCT05555823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92207693|NCT05555823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92207694|NCT05555823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207695|NCT05555823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207696|NCT05555823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92207697|NCT00800345|Topotecan|topotecan|mesh-list
92207698|NCT00800345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92207699|NCT00800345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92207700|NCT00800345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117128|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92207701|NCT00800345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207702|NCT00800345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207703|NCT03806751|Acetazolamide|acetazolamide|mesh-list
92207704|NCT03806751|Anticonvulsants|anticonvulsants|mesh-ancestor
92207705|NCT03806751|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92207706|NCT03806751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207707|NCT03806751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207708|NCT03806751|Diuretics|diuretics|mesh-ancestor
92207709|NCT03806751|Natriuretic Agents|natriuretic agents|mesh-ancestor
92207710|NCT03806751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207711|NCT04383275|Capecitabine|capecitabine|mesh-list
92207712|NCT04383275|Trastuzumab|trastuzumab|mesh-list
92207713|NCT04383275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92207714|NCT04383275|Antimetabolites|antimetabolites|mesh-ancestor
92207715|NCT04383275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207716|NCT04383275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207717|NCT04383275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207718|NCT03973229|Estradiol|estradiol|mesh-list
92207719|NCT03973229|Estrogens|estrogens|mesh-ancestor
92207720|NCT03973229|Hormones|hormones|mesh-ancestor
92207721|NCT03973229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207722|NCT03973229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207723|NCT03782103|Ethanol|ethanol|mesh-list
92207724|NCT03782103|Chlorhexidine|chlorhexidine|mesh-list
92207725|NCT03782103|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92207726|NCT03782103|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92207727|NCT03782103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207728|NCT03782103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207729|NCT03782103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207730|NCT03782103|Disinfectants|disinfectants|mesh-ancestor
92207731|NCT03782103|Dermatologic Agents|dermatologic agents|mesh-ancestor
92207732|NCT05319015|Pembrolizumab|pembrolizumab|mesh-list
92207733|NCT05319015|Lenvatinib|lenvatinib|mesh-list
92207734|NCT05319015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207735|NCT05319015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207736|NCT05319015|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92207737|NCT05319015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207738|NCT05319015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207739|NCT05319015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207740|NCT00810719|Gemcitabine|gemcitabine|mesh-list
92207741|NCT00810719|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92207742|NCT00810719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92207743|NCT00810719|Antimetabolites|antimetabolites|mesh-ancestor
92207744|NCT00810719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207745|NCT00810719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207746|NCT00810719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207747|NCT00810719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207748|NCT03761277|Morphine|morphine|mesh-list
92207749|NCT03761277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207750|NCT03761277|Narcotics|narcotics|mesh-ancestor
92207751|NCT03761277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207752|NCT03761277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207753|NCT03761277|Analgesics|analgesics|mesh-ancestor
92207754|NCT03761277|Sensory System Agents|sensory system agents|mesh-ancestor
92207755|NCT03761277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207756|NCT00810797|Exemestane|exemestane|mesh-list
92207757|NCT00810797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207758|NCT00810797|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92207759|NCT00810797|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92207760|NCT00810797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207761|NCT00810797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207762|NCT00810797|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92207763|NCT00810797|Hormone Antagonists|hormone antagonists|mesh-ancestor
92207764|NCT00810797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207765|NCT00810797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207766|NCT04340505|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92207767|NCT04340505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207768|NCT04340505|Glucocorticoids|glucocorticoids|mesh-ancestor
92207769|NCT04340505|Hormones|hormones|mesh-ancestor
92207770|NCT04340505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207771|NCT04340505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207772|NCT04724447|Valganciclovir|valganciclovir|mesh-list
92207773|NCT04724447|Antiviral Agents|antiviral agents|mesh-ancestor
92207774|NCT04724447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207775|NCT04693715|RNS60|rns60|mesh-list
92207776|NCT04693715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92207777|NCT04693715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207778|NCT04693715|Analgesics|analgesics|mesh-ancestor
92207779|NCT04693715|Sensory System Agents|sensory system agents|mesh-ancestor
92207780|NCT04693715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207781|NCT04693715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207782|NCT04693715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207783|NCT04693715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207784|NCT04693715|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92207785|NCT00355641|Ropinirole|ropinirole|mesh-list
92207786|NCT00355641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92207787|NCT00355641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92207788|NCT00355641|Dopamine Agonists|dopamine agonists|mesh-ancestor
92207789|NCT00355641|Dopamine Agents|dopamine agents|mesh-ancestor
92207790|NCT00355641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207791|NCT00355641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207792|NCT00355641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207793|NCT05268237|Liraglutide|liraglutide|mesh-list
92207794|NCT05268237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92207795|NCT05268237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207796|NCT05268237|Incretins|incretins|mesh-ancestor
92207797|NCT05268237|Hormones|hormones|mesh-ancestor
92207798|NCT05268237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207799|NCT00356733|Epoetin Alfa|epoetin alfa|mesh-list
92207800|NCT00356733|Hematinics|hematinics|mesh-ancestor
92207801|NCT04591925|Insulin|insulin|mesh-list
92207802|NCT04591925|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92207803|NCT04591925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92207804|NCT04591925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207805|NCT04542473|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92207806|NCT04542473|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92207807|NCT04542473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207808|NCT04290689|Botulinum Toxins|botulinum toxins|mesh-list
92207809|NCT04290689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92207810|NCT04290689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92207811|NCT04290689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92207812|NCT04290689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92207813|NCT04290689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207814|NCT04290689|Cholinergic Agents|cholinergic agents|mesh-ancestor
92207815|NCT04290689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207816|NCT04290689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207817|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92207818|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207819|NCT00801827|Fallypride|fallypride|mesh-list
92207820|NCT00801827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92207821|NCT00801827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92207822|NCT00801827|Dopamine Agents|dopamine agents|mesh-ancestor
92207823|NCT00801827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207824|NCT00801827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207825|NCT00801827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207826|NCT04112823|Dexamethasone|dexamethasone|mesh-list
92207827|NCT04112823|Dexamethasone acetate|dexamethasone acetate|mesh-list
92207828|NCT04112823|BB 1101|bb 1101|mesh-list
92207829|NCT04112823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207830|NCT04112823|Antiemetics|antiemetics|mesh-ancestor
92207831|NCT04112823|Autonomic Agents|autonomic agents|mesh-ancestor
92207832|NCT04112823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207833|NCT04112823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207835|NCT04112823|Glucocorticoids|glucocorticoids|mesh-ancestor
92207836|NCT04112823|Hormones|hormones|mesh-ancestor
92207837|NCT04112823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92207838|NCT04112823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92207839|NCT04112823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207840|NCT04112823|Protease Inhibitors|protease inhibitors|mesh-ancestor
92207841|NCT04112823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207842|NCT04112823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207843|NCT00802685|Ibuprofen|ibuprofen|mesh-list
92207844|NCT00802685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92207845|NCT00802685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207846|NCT00802685|Analgesics|analgesics|mesh-ancestor
92207847|NCT00802685|Sensory System Agents|sensory system agents|mesh-ancestor
92207848|NCT00802685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207849|NCT00802685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207850|NCT00802685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92207851|NCT00802685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92207852|NCT00802685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92207853|NCT00802685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207854|NCT00802685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207855|NCT03496623|Treprostinil|treprostinil|mesh-list
92207856|NCT03496623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92207857|NCT03496623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92207858|NCT00802919|Varenicline|varenicline|mesh-list
92207859|NCT00802919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92207860|NCT00802919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92207861|NCT00802919|Cholinergic Agents|cholinergic agents|mesh-ancestor
92207862|NCT00802919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207863|NCT00802919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207864|NCT00802919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207865|NCT04467905|Etripamil|etripamil|mesh-list
92207866|NCT04467905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92207867|NCT04467905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92207868|NCT04467905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207869|NCT04467905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92207870|NCT04467905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207871|NCT00803543|Valacyclovir|valacyclovir|mesh-list
92207872|NCT00803543|Antiviral Agents|antiviral agents|mesh-ancestor
92207873|NCT00803543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207874|NCT04099641|Pembrolizumab|pembrolizumab|mesh-list
92207875|NCT04099641|Bavituximab|bavituximab|mesh-list
92207876|NCT04099641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92207877|NCT04099641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207878|NCT04099641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92207879|NCT04099641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207880|NCT05051735|Acetaminophen|acetaminophen|mesh-list
92207881|NCT05051735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207882|NCT05051735|Analgesics|analgesics|mesh-ancestor
92207883|NCT05051735|Sensory System Agents|sensory system agents|mesh-ancestor
92207884|NCT05051735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207885|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207886|NCT05051735|Antipyretics|antipyretics|mesh-ancestor
92207887|NCT04098237|Pancrelipase|pancrelipase|mesh-list
92207888|NCT04098237|Pancreatin|pancreatin|mesh-list
92207889|NCT04098237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207890|NCT04095221|Irinotecan|irinotecan|mesh-list
92207891|NCT04095221|Prexasertib|prexasertib|mesh-list
92207892|NCT04095221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92207893|NCT04095221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92207894|NCT04095221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207895|NCT04095221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207896|NCT04095221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207897|NCT04095221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207898|NCT03357627|Venetoclax|venetoclax|mesh-list
92207899|NCT03357627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207900|NCT04923113|Amoxicillin|amoxicillin|mesh-list
92207901|NCT04923113|Minocycline|minocycline|mesh-list
92207902|NCT04923113|Rabeprazole|rabeprazole|mesh-list
92207903|NCT04923113|Bismuth|bismuth|mesh-list
92207904|NCT04923113|Antibodies|antibodies|mesh-list
92207905|NCT04923113|Immunologic Factors|immunologic factors|mesh-ancestor
92207906|NCT04923113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207908|NCT04923113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207909|NCT04923113|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92207910|NCT04923113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207911|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92207912|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207913|NCT04923113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207914|NCT04923113|Antacids|antacids|mesh-ancestor
92207915|NCT03250923|Acemannan|acemannan|mesh-list
92207916|NCT03250923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92207917|NCT03250923|Immunologic Factors|immunologic factors|mesh-ancestor
92207918|NCT03250923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207919|NCT03250923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207920|NCT03250923|Antiviral Agents|antiviral agents|mesh-ancestor
92207921|NCT03250923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207922|NCT03250923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92207923|NCT00805493|Riluzole|riluzole|mesh-list
92207924|NCT00805493|Anticonvulsants|anticonvulsants|mesh-ancestor
92207925|NCT00805493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92207926|NCT00805493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92207927|NCT00805493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207928|NCT00805493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207929|NCT00805493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207930|NCT00805493|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92207931|NCT00805493|Protective Agents|protective agents|mesh-ancestor
92207932|NCT03236649|Sorafenib|sorafenib|mesh-list
92207933|NCT03236649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207934|NCT03236649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207935|NCT03236649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207936|NCT03236649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207937|NCT00807209|Fentanyl|fentanyl|mesh-list
92207938|NCT00807209|Bupivacaine|bupivacaine|mesh-list
92207939|NCT00807209|Anesthetics, Local|anesthetics, local|mesh-ancestor
92207940|NCT00807209|Anesthetics|anesthetics|mesh-ancestor
92207941|NCT00807209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207942|NCT00807209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207943|NCT00807209|Sensory System Agents|sensory system agents|mesh-ancestor
92207944|NCT00807209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207945|NCT00807209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92207947|NCT00807209|Analgesics|analgesics|mesh-ancestor
92207948|NCT00807209|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92207949|NCT00807209|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92207950|NCT00807209|Anesthetics, General|anesthetics, general|mesh-ancestor
92207951|NCT03220035|Vemurafenib|vemurafenib|mesh-list
92207952|NCT03220035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207953|NCT03220035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92207954|NCT03220035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207955|NCT03220035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207956|NCT00807989|Lamotrigine|lamotrigine|mesh-list
92207957|NCT00807989|Carbamazepine|carbamazepine|mesh-list
92207958|NCT00807989|Valproic Acid|valproic acid|mesh-list
92207959|NCT00807989|Anticonvulsants|anticonvulsants|mesh-ancestor
92207960|NCT00807989|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92207961|NCT00807989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92207962|NCT00807989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207963|NCT00807989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92207964|NCT00807989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92207965|NCT00807989|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92207966|NCT00807989|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92207967|NCT00807989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92207968|NCT00807989|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92207969|NCT00807989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92207970|NCT00807989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207971|NCT00807989|GABA Agents|gaba agents|mesh-ancestor
92207972|NCT00807989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92207973|NCT00807989|Antimanic Agents|antimanic agents|mesh-ancestor
92207974|NCT00807989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92207975|NCT00807989|Analgesics|analgesics|mesh-ancestor
92207976|NCT00807989|Sensory System Agents|sensory system agents|mesh-ancestor
92207977|NCT00807989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92207978|NCT00807989|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92207979|NCT00807989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92207980|NCT05111392|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92207981|NCT00843713|Raltegravir Potassium|raltegravir potassium|mesh-list
92207982|NCT00843713|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92207983|NCT00843713|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92207984|NCT00843713|Antiviral Agents|antiviral agents|mesh-ancestor
92207985|NCT00843713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92207986|NCT00843713|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92207987|NCT00843713|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92207988|NCT00843713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207989|NCT00843713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207990|NCT04845490|Mitomycins|mitomycins|mesh-list
92207991|NCT04845490|Mitomycin|mitomycin|mesh-list
92207992|NCT04845490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92207993|NCT04845490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92207994|NCT04845490|Alkylating Agents|alkylating agents|mesh-ancestor
92207995|NCT04845490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92207996|NCT04845490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92207997|NCT04845490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92207998|NCT00357045|Paroxetine|paroxetine|mesh-list
92207999|NCT00357045|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92208000|NCT00357045|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208001|NCT00357045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208002|NCT00357045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208003|NCT00357045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208004|NCT00357045|Serotonin Agents|serotonin agents|mesh-ancestor
92208005|NCT00357045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208006|NCT00357045|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92208007|NCT00357045|Antidepressive Agents|antidepressive agents|mesh-ancestor
92208008|NCT00357045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208009|NCT00357045|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92208010|NCT00357045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92208011|NCT00357045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208012|NCT04819360|Solifenacin Succinate|solifenacin succinate|mesh-list
92208013|NCT04819360|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92208014|NCT04819360|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92208015|NCT04819360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208016|NCT04819360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208017|NCT04819360|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92208018|NCT04819360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208019|NCT04819360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208020|NCT04819360|Cholinergic Agents|cholinergic agents|mesh-ancestor
92208021|NCT04819360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208022|NCT04819360|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92208023|NCT04819360|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92208024|NCT04819360|Urological Agents|urological agents|mesh-ancestor
92208025|NCT00357123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92208026|NCT00357123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92208027|NCT00357123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92208028|NCT00357123|Antimetabolites|antimetabolites|mesh-ancestor
92208029|NCT00357123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208030|NCT00357123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92208031|NCT00357123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92208032|NCT00357123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208033|NCT04436458|Niclosamide|niclosamide|mesh-list
92208034|NCT04436458|Anticestodal Agents|anticestodal agents|mesh-ancestor
92208035|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92208036|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
92208037|NCT04436458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92208038|NCT04436458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208039|NCT04436458|Antinematodal Agents|antinematodal agents|mesh-ancestor
92208040|NCT03834753|Bevacizumab|bevacizumab|mesh-list
92208041|NCT03834753|Ranibizumab|ranibizumab|mesh-list
92208042|NCT03834753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208043|NCT03834753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208044|NCT03834753|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92208045|NCT03834753|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92208046|NCT03834753|Growth Substances|growth substances|mesh-ancestor
92208047|NCT03834753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208048|NCT03834753|Growth Inhibitors|growth inhibitors|mesh-ancestor
92208050|NCT00845039|Cetuximab|cetuximab|mesh-list
92208051|NCT00845039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92208052|NCT00845039|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92208053|NCT00845039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92208054|NCT00845039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208055|NCT00845039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208057|NCT00845039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208058|NCT00845039|Immunologic Factors|immunologic factors|mesh-ancestor
92208059|NCT00845039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208060|NCT00845195|Azelastine|azelastine|mesh-list
92208061|NCT00845195|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92208062|NCT00845195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92208063|NCT00845195|Autonomic Agents|autonomic agents|mesh-ancestor
92208064|NCT00845195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208065|NCT00845195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208066|NCT00845195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92208067|NCT00845195|Respiratory System Agents|respiratory system agents|mesh-ancestor
92208068|NCT00845195|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92208069|NCT00845195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208070|NCT00845195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208071|NCT00845195|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92208072|NCT00845195|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92208073|NCT00845195|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92208074|NCT00845195|Histamine Antagonists|histamine antagonists|mesh-ancestor
92208075|NCT00845195|Histamine Agents|histamine agents|mesh-ancestor
92208076|NCT00845195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208077|NCT00845195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92208078|NCT00845195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208079|NCT00845195|Analgesics|analgesics|mesh-ancestor
92208080|NCT00845195|Sensory System Agents|sensory system agents|mesh-ancestor
92208081|NCT00845195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208082|NCT00845195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208084|NCT00845507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92208085|NCT00845507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208086|NCT00845507|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92208087|NCT00845507|Incretins|incretins|mesh-ancestor
92208088|NCT00845507|Hormones|hormones|mesh-ancestor
91934154|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208089|NCT00845507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208090|NCT03761914|Pembrolizumab|pembrolizumab|mesh-list
92208091|NCT03761914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208092|NCT03761914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208093|NCT03761914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92208094|NCT03761914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208095|NCT00845663|Certolizumab Pegol|certolizumab pegol|mesh-list
92208096|NCT00845663|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92208097|NCT00845663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208098|NCT00845663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208099|NCT00845663|Immunologic Factors|immunologic factors|mesh-ancestor
92208100|NCT00845663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208101|NCT00845663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208102|NCT03500380|Capecitabine|capecitabine|mesh-list
92208103|NCT03500380|Lapatinib|lapatinib|mesh-list
92208104|NCT03500380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208105|NCT03500380|Antimetabolites|antimetabolites|mesh-ancestor
92208106|NCT03500380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208107|NCT03500380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208108|NCT03500380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92208109|NCT03500380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208110|NCT00534430|Cyclosporine|cyclosporine|mesh-list
92208111|NCT00534430|Mycophenolic Acid|mycophenolic acid|mesh-list
92208112|NCT00534430|Etoposide|etoposide|mesh-list
92208113|NCT00534430|Busulfan|busulfan|mesh-list
92208114|NCT00534430|Cyclosporins|cyclosporins|mesh-list
92208115|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92208116|NCT00534430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208117|NCT00534430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92208118|NCT00534430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92208119|NCT00534430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208120|NCT00534430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208121|NCT00534430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208122|NCT00534430|Immunologic Factors|immunologic factors|mesh-ancestor
92208123|NCT00534430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208124|NCT00534430|Antifungal Agents|antifungal agents|mesh-ancestor
92208125|NCT00534430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208126|NCT00534430|Dermatologic Agents|dermatologic agents|mesh-ancestor
92208127|NCT00534430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208128|NCT00534430|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92208129|NCT00534430|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92208130|NCT00534430|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92208131|NCT00534430|Antitubercular Agents|antitubercular agents|mesh-ancestor
92208132|NCT00534430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208133|NCT00534430|Alkylating Agents|alkylating agents|mesh-ancestor
92208134|NCT00534430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92208135|NCT00534430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92208136|NCT03092895|Apatinib|apatinib|mesh-list
92208137|NCT03092895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208138|NCT03092895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92208139|NCT03092895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208140|NCT03092895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208141|NCT03839771|Ivosidenib|ivosidenib|mesh-list
92208142|NCT03839771|Glycine|glycine|mesh-list
92208143|NCT03839771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208144|NCT03839771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208145|NCT03839771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208146|NCT03839771|Glycine Agents|glycine agents|mesh-ancestor
92208147|NCT03839771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208148|NCT03839771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208149|NCT02593396|Bupropion|bupropion|mesh-list
92208150|NCT02593396|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92208151|NCT02593396|Antidepressive Agents|antidepressive agents|mesh-ancestor
92208152|NCT02593396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208153|NCT02593396|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92117129|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
92208154|NCT02593396|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208155|NCT02593396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208156|NCT02593396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208157|NCT02593396|Dopamine Agents|dopamine agents|mesh-ancestor
92208158|NCT02593396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208159|NCT02593396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208160|NCT02593396|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92208161|NCT02593396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92208162|NCT02593396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208163|NCT00848783|Capecitabine|capecitabine|mesh-list
92208164|NCT00848783|Irinotecan|irinotecan|mesh-list
92208165|NCT00848783|Floxuridine|floxuridine|mesh-list
92208166|NCT00848783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208167|NCT00848783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208168|NCT00848783|Antimetabolites|antimetabolites|mesh-ancestor
92208169|NCT00848783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208170|NCT00848783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92208171|NCT00848783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92208172|NCT00848783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208173|NCT05372536|Cytarabine|cytarabine|mesh-list
92208174|NCT05372536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208175|NCT05372536|Antimetabolites|antimetabolites|mesh-ancestor
92208176|NCT05372536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208177|NCT05372536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208178|NCT05372536|Antiviral Agents|antiviral agents|mesh-ancestor
92208179|NCT05372536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208180|NCT05372536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208181|NCT05372536|Immunologic Factors|immunologic factors|mesh-ancestor
92208182|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208183|NCT00849251|Dexamethasone|dexamethasone|mesh-list
92208184|NCT00849251|Cyclophosphamide|cyclophosphamide|mesh-list
92208185|NCT00849251|Doxorubicin|doxorubicin|mesh-list
92208186|NCT00849251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92208187|NCT00849251|Bortezomib|bortezomib|mesh-list
92208188|NCT00849251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208189|NCT00849251|Immunologic Factors|immunologic factors|mesh-ancestor
92208190|NCT00849251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208191|NCT00849251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208192|NCT00849251|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92208193|NCT00849251|Alkylating Agents|alkylating agents|mesh-ancestor
92208194|NCT00849251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208195|NCT00849251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208196|NCT00849251|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92208197|NCT00849251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208198|NCT00849251|Antiemetics|antiemetics|mesh-ancestor
92208199|NCT00849251|Autonomic Agents|autonomic agents|mesh-ancestor
92208200|NCT00849251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208201|NCT00849251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92208202|NCT00849251|Glucocorticoids|glucocorticoids|mesh-ancestor
92208203|NCT00849251|Hormones|hormones|mesh-ancestor
92208204|NCT00849251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208205|NCT00849251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92208206|NCT00849251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92208207|NCT00849251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92208208|NCT00849251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92208209|NCT00849251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208210|NCT00850889|Lidocaine|lidocaine|mesh-list
92208211|NCT00850889|Hyaluronic Acid|hyaluronic acid|mesh-list
92208212|NCT00850889|Anesthetics, Local|anesthetics, local|mesh-ancestor
92208213|NCT00850889|Anesthetics|anesthetics|mesh-ancestor
92208214|NCT00850889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208215|NCT00850889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208216|NCT00850889|Sensory System Agents|sensory system agents|mesh-ancestor
92208217|NCT00850889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208218|NCT00850889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92208219|NCT00850889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92336400|NCT02047734|Interferon-beta|interferon-beta|mesh-list
92208221|NCT00850889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208222|NCT00850889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208223|NCT00850889|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92208224|NCT00850889|Immunologic Factors|immunologic factors|mesh-ancestor
92208225|NCT00850889|Viscosupplements|viscosupplements|mesh-ancestor
92208226|NCT00850889|Protective Agents|protective agents|mesh-ancestor
92208227|NCT05254288|Chlorhexidine|chlorhexidine|mesh-list
92208228|NCT05254288|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92208229|NCT05254288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208230|NCT05254288|Disinfectants|disinfectants|mesh-ancestor
92208231|NCT00851357|Nicotine|nicotine|mesh-list
92208232|NCT00851357|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92208233|NCT00851357|Autonomic Agents|autonomic agents|mesh-ancestor
92208234|NCT00851357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934156|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92208235|NCT00851357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208236|NCT00851357|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92208237|NCT00851357|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92208238|NCT00851357|Cholinergic Agents|cholinergic agents|mesh-ancestor
92208239|NCT00851357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208240|NCT00851357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208242|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92208243|NCT05105074|Narcotics|narcotics|mesh-ancestor
92208244|NCT05105074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208245|NCT05105074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208246|NCT05105074|Analgesics|analgesics|mesh-ancestor
92208247|NCT05105074|Sensory System Agents|sensory system agents|mesh-ancestor
92208248|NCT05105074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208249|NCT00364702|Methylphenidate|methylphenidate|mesh-list
92208250|NCT00364702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92208251|NCT00364702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208252|NCT00364702|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92208253|NCT00364702|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208254|NCT00364702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208255|NCT00364702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208256|NCT00364702|Dopamine Agents|dopamine agents|mesh-ancestor
92208257|NCT00364702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208258|NCT00852761|Clobetasol|clobetasol|mesh-list
92208259|NCT00852761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208260|NCT00852761|Glucocorticoids|glucocorticoids|mesh-ancestor
92208261|NCT00852761|Hormones|hormones|mesh-ancestor
92208262|NCT00852761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208263|NCT00852761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208264|NCT03839537|Nitric Oxide|nitric oxide|mesh-list
92208265|NCT03839537|Carbon Monoxide|carbon monoxide|mesh-list
92208266|NCT03839537|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92208267|NCT03839537|Autonomic Agents|autonomic agents|mesh-ancestor
92208268|NCT03839537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208269|NCT03839537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208270|NCT03839537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92208271|NCT03839537|Respiratory System Agents|respiratory system agents|mesh-ancestor
92208272|NCT03839537|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92208273|NCT03839537|Antioxidants|antioxidants|mesh-ancestor
92208274|NCT03839537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208275|NCT03839537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208276|NCT03839537|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92208277|NCT03839537|Vasodilator Agents|vasodilator agents|mesh-ancestor
92208278|NCT03839537|Gasotransmitters|gasotransmitters|mesh-ancestor
92208279|NCT03839537|Protective Agents|protective agents|mesh-ancestor
92208280|NCT03839537|Antimetabolites|antimetabolites|mesh-ancestor
92208281|NCT04082806|Trazodone|trazodone|mesh-list
92208282|NCT04082806|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92208283|NCT04082806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92208284|NCT04082806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208285|NCT04082806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208286|NCT04082806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208287|NCT04082806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92336402|NCT02047734|Ozanimod|ozanimod|mesh-list
92208288|NCT04082806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208289|NCT04082806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208290|NCT04082806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208291|NCT04082806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208292|NCT04082806|Serotonin Agents|serotonin agents|mesh-ancestor
92208293|NCT04082806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92208294|NCT04082806|Antidepressive Agents|antidepressive agents|mesh-ancestor
92208295|NCT05635786|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92208296|NCT05635786|Tenecteplase|tenecteplase|mesh-list
92208297|NCT05635786|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92208298|NCT05635786|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92208299|NCT05635786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208301|NCT00365950|Anticoagulants|anticoagulants|mesh-ancestor
92208302|NCT02487797|Oxytocin|oxytocin|mesh-list
92208303|NCT02487797|Oxytocics|oxytocics|mesh-ancestor
92208304|NCT02487797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92208305|NCT02487797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208306|NCT01733693|Buprenorphine|buprenorphine|mesh-list
92208307|NCT01733693|Methadone|methadone|mesh-list
92208308|NCT01733693|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92208309|NCT01733693|Narcotics|narcotics|mesh-ancestor
92208310|NCT01733693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208311|NCT01733693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208313|NCT01733693|Sensory System Agents|sensory system agents|mesh-ancestor
92208314|NCT01733693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208315|NCT01733693|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92208316|NCT01733693|Antitussive Agents|antitussive agents|mesh-ancestor
92208317|NCT01733693|Respiratory System Agents|respiratory system agents|mesh-ancestor
92208318|NCT00855413|Ritonavir|ritonavir|mesh-list
92208319|NCT00855413|Darunavir|darunavir|mesh-list
92208320|NCT00855413|Etravirine|etravirine|mesh-list
92208321|NCT00855413|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92208322|NCT00855413|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92208323|NCT00855413|Protease Inhibitors|protease inhibitors|mesh-ancestor
92208324|NCT00855413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208325|NCT00855413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208326|NCT00855413|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92208327|NCT00855413|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92208328|NCT00855413|Antiviral Agents|antiviral agents|mesh-ancestor
92208329|NCT00855413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208330|NCT00855413|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92208331|NCT00855413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92208332|NCT00855413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92208333|NCT00855413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92208334|NCT05599984|Carboplatin|carboplatin|mesh-list
92208335|NCT05599984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208336|NCT00816101|Anti-Infective Agents|anti-infective agents|mesh-list
92208337|NCT00816101|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92208338|NCT00366262|Naproxen|naproxen|mesh-list
92208339|NCT00366262|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92208340|NCT00366262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208341|NCT00366262|Analgesics|analgesics|mesh-ancestor
92208342|NCT00366262|Sensory System Agents|sensory system agents|mesh-ancestor
92208343|NCT00366262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208344|NCT00366262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208345|NCT00366262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208346|NCT00366262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208347|NCT00366262|Gout Suppressants|gout suppressants|mesh-ancestor
92208348|NCT00366262|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92208349|NCT00366262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208350|NCT00366262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208351|NCT00818363|Bupivacaine|bupivacaine|mesh-list
92208352|NCT00818363|Anesthetics, Local|anesthetics, local|mesh-ancestor
92208353|NCT00818363|Anesthetics|anesthetics|mesh-ancestor
92208354|NCT00818363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208355|NCT00818363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208356|NCT00818363|Sensory System Agents|sensory system agents|mesh-ancestor
92208357|NCT00818363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208358|NCT00828841|Paclitaxel|paclitaxel|mesh-list
92208359|NCT00828841|Carboplatin|carboplatin|mesh-list
92208360|NCT00828841|Gemcitabine|gemcitabine|mesh-list
92208361|NCT00828841|Cetuximab|cetuximab|mesh-list
92208362|NCT00828841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92208363|NCT00828841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208365|NCT00828841|Antimitotic Agents|antimitotic agents|mesh-ancestor
92208366|NCT00828841|Mitosis Modulators|mitosis modulators|mesh-ancestor
92208367|NCT00828841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208368|NCT00828841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208369|NCT00828841|Antimetabolites|antimetabolites|mesh-ancestor
92208370|NCT00828841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208371|NCT05445310|Aflutinib|aflutinib|mesh-list
92208372|NCT05445310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92208373|NCT05445310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208374|NCT05445310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208375|NCT00858689|Minocycline|minocycline|mesh-list
92208376|NCT00858689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208377|NCT00858689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208378|NCT00821795|Insulin|insulin|mesh-list
92208379|NCT00821795|Insulin Aspart|insulin aspart|mesh-list
92208380|NCT00821795|Protamines|protamines|mesh-list
92208381|NCT00821795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92208382|NCT00821795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208383|NCT00821795|Heparin Antagonists|heparin antagonists|mesh-ancestor
92208384|NCT00821795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208386|NCT00833365|Ibuprofen|ibuprofen|mesh-list
92208387|NCT00833365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92208388|NCT00833365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208389|NCT00833365|Analgesics|analgesics|mesh-ancestor
92208390|NCT00833365|Sensory System Agents|sensory system agents|mesh-ancestor
92208391|NCT00833365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208392|NCT00833365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208393|NCT00833365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208394|NCT00833365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208395|NCT00833365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92208396|NCT00833365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208397|NCT00833365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208398|NCT00821951|Vorinostat|vorinostat|mesh-list
92208399|NCT00821951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208400|NCT00821951|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92208401|NCT00821951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208402|NCT00821951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208403|NCT00852631|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92208404|NCT00852631|Antidepressive Agents|antidepressive agents|mesh-ancestor
92208405|NCT00852631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208406|NCT00852631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92208407|NCT00852631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92208408|NCT00852631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208409|NCT00852631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208410|NCT00860015|Gemcitabine|gemcitabine|mesh-list
92208411|NCT00860015|Pemetrexed|pemetrexed|mesh-list
92208412|NCT00860015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208413|NCT00860015|Antimetabolites|antimetabolites|mesh-ancestor
92208414|NCT00860015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208415|NCT00860015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208416|NCT00860015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208417|NCT00860015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92208418|NCT00860015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92208419|NCT00853333|Midazolam|midazolam|mesh-list
92208420|NCT00853333|Dexmedetomidine|dexmedetomidine|mesh-list
92208421|NCT00853333|Propofol|propofol|mesh-list
92208422|NCT00853333|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92208423|NCT00853333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208424|NCT00853333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208425|NCT00853333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208426|NCT00853333|Analgesics|analgesics|mesh-ancestor
92208427|NCT00853333|Sensory System Agents|sensory system agents|mesh-ancestor
92208428|NCT00853333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208429|NCT00853333|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92208430|NCT00853333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92208431|NCT00853333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92208432|NCT00853333|Adrenergic Agents|adrenergic agents|mesh-ancestor
92208433|NCT00853333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208434|NCT00853333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208435|NCT00853333|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92208436|NCT00853333|Anesthetics, General|anesthetics, general|mesh-ancestor
92208437|NCT00853333|Anesthetics|anesthetics|mesh-ancestor
92208438|NCT00853333|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92208439|NCT00853333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92208440|NCT00853333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92208441|NCT00853333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208442|NCT00853333|GABA Modulators|gaba modulators|mesh-ancestor
92208443|NCT00853333|GABA Agents|gaba agents|mesh-ancestor
92208444|NCT00822107|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92208445|NCT00822107|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92208446|NCT00822107|Diuretics|diuretics|mesh-ancestor
92208447|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
92208448|NCT00822107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208449|NCT00822107|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92208450|NCT00822107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208451|NCT00822107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208452|NCT05236907|Midazolam|midazolam|mesh-list
92208453|NCT05236907|Melatonin|melatonin|mesh-list
92208454|NCT05236907|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92208455|NCT05236907|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92208456|NCT05236907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934160|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208457|NCT05236907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208458|NCT05236907|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92208459|NCT05236907|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92208460|NCT05236907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208461|NCT05236907|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92208462|NCT05236907|Anesthetics, General|anesthetics, general|mesh-ancestor
92208464|NCT05236907|GABA Modulators|gaba modulators|mesh-ancestor
92208465|NCT05236907|GABA Agents|gaba agents|mesh-ancestor
92208466|NCT05236907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208467|NCT05236907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208468|NCT05236907|Antioxidants|antioxidants|mesh-ancestor
92208469|NCT05236907|Protective Agents|protective agents|mesh-ancestor
92208470|NCT05217706|Ketamine|ketamine|mesh-list
92208471|NCT05217706|Analgesics|analgesics|mesh-ancestor
92208472|NCT05217706|Sensory System Agents|sensory system agents|mesh-ancestor
92208473|NCT05217706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208474|NCT05217706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208475|NCT05217706|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92208476|NCT05217706|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92208477|NCT05217706|Anesthetics, General|anesthetics, general|mesh-ancestor
92208478|NCT05217706|Anesthetics|anesthetics|mesh-ancestor
92208479|NCT05217706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208480|NCT05217706|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92208481|NCT05217706|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92208482|NCT05217706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208483|NCT05217706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208484|NCT00833443|Bupropion|bupropion|mesh-list
92208485|NCT00833443|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92208486|NCT00833443|Antidepressive Agents|antidepressive agents|mesh-ancestor
92208487|NCT00833443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208488|NCT00833443|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92208489|NCT00833443|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208490|NCT00833443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208491|NCT00833443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208492|NCT00833443|Dopamine Agents|dopamine agents|mesh-ancestor
92208493|NCT00833443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208494|NCT00833443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208495|NCT00833443|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92208496|NCT00833443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92208497|NCT00833443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208498|NCT05207722|Aldesleukin|aldesleukin|mesh-list
92208499|NCT05207722|Cyclophosphamide|cyclophosphamide|mesh-list
92208500|NCT05207722|Pembrolizumab|pembrolizumab|mesh-list
92208501|NCT05207722|Trastuzumab|trastuzumab|mesh-list
92208502|NCT05207722|Fludarabine|fludarabine|mesh-list
92208503|NCT05207722|Interleukin-2|interleukin-2|mesh-list
92208504|NCT05207722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208505|NCT05207722|Immunologic Factors|immunologic factors|mesh-ancestor
92208506|NCT05207722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208507|NCT05207722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208508|NCT05207722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92208509|NCT05207722|Alkylating Agents|alkylating agents|mesh-ancestor
92208510|NCT05207722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208511|NCT05207722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208512|NCT05207722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92208513|NCT05207722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208514|NCT05207722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92208515|NCT05207722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208516|NCT05207722|Analgesics|analgesics|mesh-ancestor
92208517|NCT05207722|Sensory System Agents|sensory system agents|mesh-ancestor
92208518|NCT05207722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208519|NCT05207722|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92208520|NCT05207722|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92208521|NCT05207722|Antiviral Agents|antiviral agents|mesh-ancestor
92208522|NCT05207722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208523|NCT00860171|Iodine|iodine|mesh-list
92208524|NCT00860171|Cadexomer iodine|cadexomer iodine|mesh-list
92208525|NCT00860171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92208526|NCT00860171|Antibodies|antibodies|mesh-list
92208527|NCT00860171|Immunoglobulins|immunoglobulins|mesh-list
92208528|NCT00860171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92208529|NCT00860171|Immunologic Factors|immunologic factors|mesh-ancestor
92208530|NCT00860171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208531|NCT00860171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208532|NCT00860171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92208533|NCT00860171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208534|NCT00860171|Trace Elements|trace elements|mesh-ancestor
92208535|NCT00860171|Micronutrients|micronutrients|mesh-ancestor
92208537|NCT00366418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208538|NCT00366418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208539|NCT00366418|Immunologic Factors|immunologic factors|mesh-ancestor
92208540|NCT00366418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208541|NCT00366418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208542|NCT00823043|Timolol|timolol|mesh-list
92208543|NCT00823043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208544|NCT00823043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92208545|NCT00823043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92208546|NCT00823043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92208547|NCT00823043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208548|NCT00823043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208549|NCT00823043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92208550|NCT00823043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92208551|NCT00862745|Fesoterodine|fesoterodine|mesh-list
92208552|NCT00862745|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92208553|NCT00862745|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92208554|NCT00862745|Cholinergic Agents|cholinergic agents|mesh-ancestor
92208555|NCT00862745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208556|NCT00862745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208557|NCT00862745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208558|NCT00862745|Urological Agents|urological agents|mesh-ancestor
92208559|NCT02150759|Fentanyl|fentanyl|mesh-list
92208560|NCT02150759|Dexmedetomidine|dexmedetomidine|mesh-list
92208561|NCT02150759|Ketamine|ketamine|mesh-list
92208562|NCT02150759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92208563|NCT02150759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208564|NCT02150759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208565|NCT02150759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208566|NCT02150759|Analgesics|analgesics|mesh-ancestor
92208567|NCT02150759|Sensory System Agents|sensory system agents|mesh-ancestor
92208568|NCT02150759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208569|NCT02150759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92208570|NCT02150759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92208571|NCT02150759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92208572|NCT02150759|Adrenergic Agents|adrenergic agents|mesh-ancestor
92208573|NCT02150759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208574|NCT02150759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208575|NCT02150759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92208576|NCT02150759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92208577|NCT02150759|Anesthetics, General|anesthetics, general|mesh-ancestor
92208578|NCT02150759|Anesthetics|anesthetics|mesh-ancestor
92336414|NCT01994850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208579|NCT02150759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92208580|NCT02150759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92208581|NCT02150759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92208582|NCT02150759|Narcotics|narcotics|mesh-ancestor
92208583|NCT02150759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92208584|NCT04991350|Bevacizumab|bevacizumab|mesh-list
92208585|NCT04991350|Ranibizumab|ranibizumab|mesh-list
92208586|NCT04991350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208587|NCT04991350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208588|NCT04991350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92208589|NCT04991350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92208590|NCT04991350|Growth Substances|growth substances|mesh-ancestor
92208591|NCT04991350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208592|NCT04991350|Growth Inhibitors|growth inhibitors|mesh-ancestor
92208593|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92208594|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
92208595|NCT00857545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208596|NCT04952194|Levodopa|levodopa|mesh-list
92208597|NCT04952194|Carbidopa|carbidopa|mesh-list
92208598|NCT04952194|Entacapone|entacapone|mesh-list
92208599|NCT04952194|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92208600|NCT04952194|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92208601|NCT04952194|Dopamine Agents|dopamine agents|mesh-ancestor
92208602|NCT04952194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208603|NCT04952194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208604|NCT04952194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208605|NCT04952194|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92208606|NCT04952194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208607|NCT04952194|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92208608|NCT00835159|Rivastigmine|rivastigmine|mesh-list
92208609|NCT00835159|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92208610|NCT00835159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208611|NCT00835159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208612|NCT00835159|Cholinergic Agents|cholinergic agents|mesh-ancestor
92208613|NCT00835159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208614|NCT00835159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208615|NCT00835159|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92208617|NCT04860856|Ropivacaine|ropivacaine|mesh-list
92208618|NCT04860856|Anesthetics, Local|anesthetics, local|mesh-ancestor
92208619|NCT04860856|Anesthetics|anesthetics|mesh-ancestor
92208620|NCT04860856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208621|NCT04860856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208622|NCT04860856|Sensory System Agents|sensory system agents|mesh-ancestor
92208623|NCT04860856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208624|NCT00827099|Mycophenolic Acid|mycophenolic acid|mesh-list
92208625|NCT00827099|Fludarabine|fludarabine|mesh-list
92208626|NCT00827099|Fludarabine phosphate|fludarabine phosphate|mesh-list
92208627|NCT00827099|Melphalan|melphalan|mesh-list
92208628|NCT00827099|Tacrolimus|tacrolimus|mesh-list
92208629|NCT00827099|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92208630|NCT00827099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208631|NCT00827099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208632|NCT00827099|Antimetabolites|antimetabolites|mesh-ancestor
92208633|NCT00827099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208634|NCT00827099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208635|NCT00827099|Immunologic Factors|immunologic factors|mesh-ancestor
92208636|NCT00827099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208637|NCT00827099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92208638|NCT00827099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208639|NCT00827099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92208640|NCT00827099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92208642|NCT00827099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208643|NCT00827099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208644|NCT00827099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92208645|NCT00827099|Alkylating Agents|alkylating agents|mesh-ancestor
92208646|NCT00827099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92208647|NCT00366652|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92208648|NCT00366652|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92208649|NCT00366652|Desipramine|desipramine|mesh-list
92336421|NCT01994382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208650|NCT00366652|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92208651|NCT00366652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208652|NCT00366652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208653|NCT00366652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208654|NCT00366652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208655|NCT00366652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208657|NCT00366652|Sensory System Agents|sensory system agents|mesh-ancestor
92208658|NCT00366652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208659|NCT00366652|Antidepressive Agents|antidepressive agents|mesh-ancestor
92208660|NCT00366652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92208661|NCT00366652|Dopamine Agents|dopamine agents|mesh-ancestor
92208662|NCT00366652|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92208663|NCT00366652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208664|NCT00366652|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92208665|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92208666|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
92208667|NCT00366730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92208668|NCT00366730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208669|NCT02617888|Bismuth|bismuth|mesh-list
92208670|NCT02617888|Antacids|antacids|mesh-ancestor
92208671|NCT02617888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208672|NCT02617888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92208673|NCT02620774|Tazobactam|tazobactam|mesh-list
92208674|NCT02620774|Ceftolozane|ceftolozane|mesh-list
92208675|NCT02620774|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92208676|NCT02620774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208677|NCT02620774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208678|NCT02620774|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92208679|NCT02620774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208680|NCT02620774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208681|NCT02620774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92208682|NCT02625298|Pemetrexed|pemetrexed|mesh-list
92208683|NCT02625298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208684|NCT02625298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208685|NCT02625298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208686|NCT02625298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92208687|NCT02625298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92208688|NCT00858013|Glimepiride|glimepiride|mesh-list
92208689|NCT00858013|Nateglinide|nateglinide|mesh-list
92208690|NCT00858013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92208691|NCT00858013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92208692|NCT00858013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208693|NCT00858013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208694|NCT00858013|Immunologic Factors|immunologic factors|mesh-ancestor
92208695|NCT02626156|Methyl salicylate|methyl salicylate|mesh-list
92208696|NCT02626156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208697|NCT00835861|Insulin|insulin|mesh-list
92208698|NCT00835861|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92208699|NCT00835861|Metformin|metformin|mesh-list
92208700|NCT00835861|Insulin, Isophane|insulin, isophane|mesh-list
92208701|NCT00835861|Isophane Insulin, Human|isophane insulin, human|mesh-list
92208702|NCT00835861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92208703|NCT00835861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208704|NCT00804973|Sumatriptan|sumatriptan|mesh-list
92208705|NCT00804973|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92208706|NCT00804973|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92208707|NCT00804973|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92208708|NCT00804973|Serotonin Agents|serotonin agents|mesh-ancestor
92208709|NCT00804973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208710|NCT00804973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208711|NCT00804973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208712|NCT02628106|Alprostadil|alprostadil|mesh-list
92208713|NCT02628106|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92208714|NCT02628106|Vasodilator Agents|vasodilator agents|mesh-ancestor
92208715|NCT02628106|Urological Agents|urological agents|mesh-ancestor
92208716|NCT02629354|Ibuprofen|ibuprofen|mesh-list
92208717|NCT02629354|Caffeine|caffeine|mesh-list
92208718|NCT02629354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92208719|NCT02629354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92208720|NCT02629354|Analgesics|analgesics|mesh-ancestor
92208721|NCT02629354|Sensory System Agents|sensory system agents|mesh-ancestor
92208722|NCT02629354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208723|NCT02629354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208724|NCT02629354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208725|NCT02629354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208726|NCT02629354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92208727|NCT02629354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208728|NCT02629354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208729|NCT02629354|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92208730|NCT02629354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92208731|NCT02629354|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92208732|NCT02629354|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92208733|NCT02629354|Purinergic Agents|purinergic agents|mesh-ancestor
92208734|NCT02629354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208736|NCT02834247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208737|NCT02834247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208738|NCT02834247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92208739|NCT02834247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208740|NCT00859027|Risedronic Acid|risedronic acid|mesh-list
92208741|NCT00859027|Etidronic Acid|etidronic acid|mesh-list
92208742|NCT00859027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92208743|NCT00859027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208744|NCT00859027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208745|NCT00859027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92208746|NCT00859027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208747|NCT00859027|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92208748|NCT02630992|Amoxicillin|amoxicillin|mesh-list
92208749|NCT02630992|Clavulanic Acid|clavulanic acid|mesh-list
92208750|NCT02630992|Clavulanic Acids|clavulanic acids|mesh-list
92208751|NCT02630992|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92208753|NCT02630992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208754|NCT02630992|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92208755|NCT02630992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208756|NCT02630992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208757|NCT00836407|Ipilimumab|ipilimumab|mesh-list
92208758|NCT00836407|Vaccines|vaccines|mesh-list
92208759|NCT00836407|Immunologic Factors|immunologic factors|mesh-ancestor
92208760|NCT00836407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208761|NCT00836407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92208762|NCT00836407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208763|NCT00836407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92208764|NCT00836407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208765|NCT02631772|Ribavirin|ribavirin|mesh-list
92208766|NCT02631772|Sofosbuvir|sofosbuvir|mesh-list
92208767|NCT02631772|Ledipasvir|ledipasvir|mesh-list
92208768|NCT02631772|Antimetabolites|antimetabolites|mesh-ancestor
92208769|NCT02631772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208770|NCT02631772|Antiviral Agents|antiviral agents|mesh-ancestor
92208771|NCT02631772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208772|NCT02633488|Metformin|metformin|mesh-list
92208773|NCT02633488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92208774|NCT02633488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208775|NCT00859339|Gemcitabine|gemcitabine|mesh-list
92208776|NCT00859339|Sunitinib|sunitinib|mesh-list
92208777|NCT00859339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208778|NCT00859339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208779|NCT00859339|Antimetabolites|antimetabolites|mesh-ancestor
92208780|NCT00859339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208781|NCT00859339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92208782|NCT00859339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92208783|NCT00859339|Growth Substances|growth substances|mesh-ancestor
92208784|NCT00859339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208785|NCT00859339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92208786|NCT00859339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92208787|NCT00859339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208789|NCT00859495|Pemetrexed|pemetrexed|mesh-list
92208790|NCT00859495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208791|NCT00859495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92208792|NCT00859495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92336432|NCT01994226|Analgesics|analgesics|mesh-ancestor
92208793|NCT00859495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92208794|NCT00859495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208795|NCT00859495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208796|NCT00859495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92208797|NCT00859495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92208798|NCT00355719|Ritonavir|ritonavir|mesh-list
92208799|NCT00355719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92208800|NCT00355719|Nevirapine|nevirapine|mesh-list
92208801|NCT00355719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92208802|NCT00355719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92208803|NCT00355719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92208804|NCT00355719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208805|NCT00355719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208806|NCT00355719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92208807|NCT00355719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92208808|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
92208809|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208810|NCT00355719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92208811|NCT00355719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92208812|NCT00355719|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92208813|NCT00355719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92208814|NCT00355719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92208815|NCT00355719|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92208816|NCT00859651|Vitamin D|vitamin d|mesh-list
92208817|NCT00859651|Cholecalciferol|cholecalciferol|mesh-list
92208818|NCT00859651|Vitamins|vitamins|mesh-ancestor
92208819|NCT00859651|Micronutrients|micronutrients|mesh-ancestor
92208820|NCT00859651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208821|NCT00859651|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92208822|NCT00859651|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92208823|NCT02633956|Atorvastatin|atorvastatin|mesh-list
92208824|NCT02633956|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92208826|NCT02633956|Antimetabolites|antimetabolites|mesh-ancestor
92208827|NCT02633956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208828|NCT02633956|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92208829|NCT02633956|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92208830|NCT02633956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920532|NCT02177539|Autonomic Agents|autonomic agents|mesh-ancestor
92208831|NCT00836641|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92208832|NCT00836641|Immunologic Factors|immunologic factors|mesh-ancestor
92208833|NCT00836641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208834|NCT00806221|Emollients|emollients|mesh-list
92208835|NCT00806221|Dermatologic Agents|dermatologic agents|mesh-ancestor
92208836|NCT02635828|Promethazine|promethazine|mesh-list
92208837|NCT02635828|Diphenhydramine|diphenhydramine|mesh-list
92208838|NCT02635828|Dexamethasone|dexamethasone|mesh-list
92208839|NCT02635828|Palonosetron|palonosetron|mesh-list
92208840|NCT02635828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208841|NCT02635828|Antiemetics|antiemetics|mesh-ancestor
92208842|NCT02635828|Autonomic Agents|autonomic agents|mesh-ancestor
92208843|NCT02635828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208844|NCT02635828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208845|NCT02635828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92208846|NCT02635828|Glucocorticoids|glucocorticoids|mesh-ancestor
92208847|NCT02635828|Hormones|hormones|mesh-ancestor
92208848|NCT02635828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208849|NCT02635828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92208850|NCT02635828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208851|NCT02635828|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92208852|NCT02635828|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92208853|NCT02635828|Serotonin Agents|serotonin agents|mesh-ancestor
92208854|NCT02635828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208855|NCT02635828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208856|NCT02635828|Antipruritics|antipruritics|mesh-ancestor
92208857|NCT02635828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92208858|NCT02635828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92208859|NCT02635828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92208860|NCT02635828|Histamine Agents|histamine agents|mesh-ancestor
92208861|NCT02635828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92208862|NCT02635828|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92208863|NCT02635828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92208864|NCT02635828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208865|NCT02635828|Anesthetics, Local|anesthetics, local|mesh-ancestor
92208866|NCT02635828|Anesthetics|anesthetics|mesh-ancestor
92208867|NCT02635828|Sensory System Agents|sensory system agents|mesh-ancestor
92208868|NCT02638168|Methylphenidate|methylphenidate|mesh-list
92208869|NCT02638168|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92208870|NCT02638168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208871|NCT02638168|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92208872|NCT02638168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208873|NCT02638168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208874|NCT02638168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208875|NCT02638168|Dopamine Agents|dopamine agents|mesh-ancestor
92208876|NCT02638168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208877|NCT00837031|Gemcitabine|gemcitabine|mesh-list
92208878|NCT00837031|Lenalidomide|lenalidomide|mesh-list
92208879|NCT00837031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92208880|NCT00837031|Antimetabolites|antimetabolites|mesh-ancestor
92208881|NCT00837031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208882|NCT00837031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208883|NCT00837031|Immunologic Factors|immunologic factors|mesh-ancestor
92208884|NCT00837031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208885|NCT00837031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92208886|NCT00837031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92208887|NCT00837031|Growth Substances|growth substances|mesh-ancestor
92208888|NCT00837031|Growth Inhibitors|growth inhibitors|mesh-ancestor
92208889|NCT02973880|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92208890|NCT02973880|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92208891|NCT04344483|Lidocaine|lidocaine|mesh-list
92208892|NCT04344483|Epinephrine|epinephrine|mesh-list
92208893|NCT04344483|Racepinephrine|racepinephrine|mesh-list
92208894|NCT04344483|Epinephryl borate|epinephryl borate|mesh-list
92208895|NCT04344483|Anesthetics, Local|anesthetics, local|mesh-ancestor
92208896|NCT04344483|Anesthetics|anesthetics|mesh-ancestor
92208897|NCT04344483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208898|NCT04344483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208899|NCT04344483|Sensory System Agents|sensory system agents|mesh-ancestor
92208900|NCT04344483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208901|NCT04344483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92208902|NCT04344483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92208903|NCT04344483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92208904|NCT04344483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117278|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92208905|NCT04344483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208906|NCT04344483|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92208908|NCT04344483|Adrenergic Agents|adrenergic agents|mesh-ancestor
92208909|NCT04344483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208910|NCT04344483|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92208911|NCT04344483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92208912|NCT04344483|Autonomic Agents|autonomic agents|mesh-ancestor
92208913|NCT04344483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92208914|NCT04344483|Respiratory System Agents|respiratory system agents|mesh-ancestor
92208915|NCT04344483|Mydriatics|mydriatics|mesh-ancestor
92208916|NCT04344483|Sympathomimetics|sympathomimetics|mesh-ancestor
92208917|NCT04344483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92208918|NCT02154763|Ropivacaine|ropivacaine|mesh-list
92208919|NCT02154763|Anesthetics, Local|anesthetics, local|mesh-ancestor
92208920|NCT02154763|Anesthetics|anesthetics|mesh-ancestor
92208921|NCT02154763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92208922|NCT02154763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208923|NCT02154763|Sensory System Agents|sensory system agents|mesh-ancestor
92208924|NCT02154763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208925|NCT02641522|Siltuximab|siltuximab|mesh-list
92208926|NCT02641522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208927|NCT04964427|Methylphenidate|methylphenidate|mesh-list
92208928|NCT04964427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92208929|NCT04964427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208930|NCT04964427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92208931|NCT04964427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92208932|NCT04964427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92208933|NCT04964427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208934|NCT04964427|Dopamine Agents|dopamine agents|mesh-ancestor
92208935|NCT04964427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208936|NCT00357669|Brivaracetam|brivaracetam|mesh-list
92208937|NCT00357669|Anticonvulsants|anticonvulsants|mesh-ancestor
92208938|NCT00357747|Docetaxel|docetaxel|mesh-list
92208939|NCT00357747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208940|NCT00357747|Tubulin Modulators|tubulin modulators|mesh-ancestor
92208941|NCT00357747|Antimitotic Agents|antimitotic agents|mesh-ancestor
92208942|NCT00357747|Mitosis Modulators|mitosis modulators|mesh-ancestor
92208943|NCT00357747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208944|NCT00863551|Trospium chloride|trospium chloride|mesh-list
92208945|NCT00863551|Parasympatholytics|parasympatholytics|mesh-ancestor
92208946|NCT00863551|Autonomic Agents|autonomic agents|mesh-ancestor
92208947|NCT00863551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92208948|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208949|NCT00863551|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92208950|NCT00863551|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92208951|NCT00863551|Cholinergic Agents|cholinergic agents|mesh-ancestor
92208952|NCT00863551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92208953|NCT00863551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208954|NCT00863551|Urological Agents|urological agents|mesh-ancestor
92208955|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
92208956|NCT03838575|Gentamicins|gentamicins|mesh-list
92208957|NCT03838575|Anti-Infective Agents|anti-infective agents|mesh-list
92208958|NCT03838575|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92208959|NCT03838575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92208960|NCT03838575|Disinfectants|disinfectants|mesh-ancestor
92208961|NCT03838575|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92208962|NCT03838575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208963|NCT03838575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208964|NCT03540355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92208965|NCT03540355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92208966|NCT03540355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92208967|NCT03540355|Antimetabolites|antimetabolites|mesh-ancestor
92208968|NCT03540355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208969|NCT03540355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92208970|NCT03540355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92208971|NCT03540355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92208972|NCT04339816|Azithromycin|azithromycin|mesh-list
92208974|NCT04339816|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92208975|NCT04339816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92208976|NCT04339816|Antimalarials|antimalarials|mesh-ancestor
92208977|NCT04339816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92208978|NCT04339816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92208979|NCT04339816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117279|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
92208980|NCT04339816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92208981|NCT04339816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92208982|NCT05588908|Betamethasone|betamethasone|mesh-list
92208983|NCT05588908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92208984|NCT05588908|Antibodies|antibodies|mesh-list
92208985|NCT05588908|Immunoglobulins|immunoglobulins|mesh-list
92208986|NCT05588908|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92208987|NCT05588908|Immunologic Factors|immunologic factors|mesh-ancestor
92208988|NCT05588908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92208989|NCT05588908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92208990|NCT05588908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92208991|NCT05588908|Glucocorticoids|glucocorticoids|mesh-ancestor
92208992|NCT05588908|Hormones|hormones|mesh-ancestor
92208993|NCT05588908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92208994|NCT05588908|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92208995|NCT05588908|Respiratory System Agents|respiratory system agents|mesh-ancestor
92208996|NCT05588830|Belimumab|belimumab|mesh-list
92208997|NCT05588830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92208998|NCT05588830|Immunologic Factors|immunologic factors|mesh-ancestor
92208999|NCT05588830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209000|NCT04740190|Carboplatin|carboplatin|mesh-list
92209001|NCT04740190|Talazoparib|talazoparib|mesh-list
92209002|NCT04740190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209003|NCT04740190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92209004|NCT04740190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209005|NCT04740190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209006|NCT00865969|Belinostat|belinostat|mesh-list
92209007|NCT00865969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209008|NCT00865969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92209009|NCT00865969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209010|NCT00865969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209011|NCT05588518|Propolis|propolis|mesh-list
92209012|NCT05588518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209013|NCT00866749|Cytarabine|cytarabine|mesh-list
92209014|NCT00866749|Cyclophosphamide|cyclophosphamide|mesh-list
92209015|NCT00866749|Doxorubicin|doxorubicin|mesh-list
92209016|NCT00866749|Methotrexate|methotrexate|mesh-list
92209017|NCT00866749|Vincristine|vincristine|mesh-list
92209018|NCT00866749|Daunorubicin|daunorubicin|mesh-list
92209019|NCT00866749|Asparaginase|asparaginase|mesh-list
92209020|NCT00866749|Mercaptopurine|mercaptopurine|mesh-list
92209021|NCT00866749|Thioguanine|thioguanine|mesh-list
92209022|NCT00866749|Pegaspargase|pegaspargase|mesh-list
92209023|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209024|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
92209025|NCT00866749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209026|NCT00866749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209027|NCT00866749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92209028|NCT00866749|Alkylating Agents|alkylating agents|mesh-ancestor
92209029|NCT00866749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209030|NCT00866749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209031|NCT00866749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92209032|NCT00866749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92209033|NCT00866749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92209034|NCT00866749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92209035|NCT00866749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209036|NCT00866749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92209037|NCT00866749|Abortifacient Agents|abortifacient agents|mesh-ancestor
92209038|NCT00866749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92209039|NCT00866749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92209040|NCT00866749|Antimetabolites|antimetabolites|mesh-ancestor
92209041|NCT00866749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92209042|NCT00866749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92209043|NCT00866749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92209044|NCT00866749|Antiviral Agents|antiviral agents|mesh-ancestor
92209045|NCT00866749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209046|NCT00866749|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92209048|NCT00866749|Antimitotic Agents|antimitotic agents|mesh-ancestor
92209049|NCT00866749|Mitosis Modulators|mitosis modulators|mesh-ancestor
92209050|NCT00866905|Cyclophosphamide|cyclophosphamide|mesh-list
92209051|NCT00866905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209052|NCT00866905|Immunologic Factors|immunologic factors|mesh-ancestor
92209053|NCT00866905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209054|NCT00866905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209055|NCT00866905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92209056|NCT00866905|Alkylating Agents|alkylating agents|mesh-ancestor
92209057|NCT00866905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209058|NCT00866905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209059|NCT00866905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92209060|NCT05587426|Iproplatin|iproplatin|mesh-list
92209061|NCT05587426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209063|NCT00867139|Ribavirin|ribavirin|mesh-list
92209064|NCT00867139|Zanamivir|zanamivir|mesh-list
92209065|NCT00867139|Amantadine|amantadine|mesh-list
92209066|NCT00867139|Thiazole-4-carboxamide adenine dinucleotide|thiazole-4-carboxamide adenine dinucleotide|mesh-list
92209067|NCT00867139|Antiviral Agents|antiviral agents|mesh-ancestor
92209068|NCT00867139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209069|NCT00867139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209070|NCT00867139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209071|NCT00867139|Antimetabolites|antimetabolites|mesh-ancestor
92209072|NCT00867139|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92209073|NCT00867139|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92209074|NCT00867139|Dopamine Agents|dopamine agents|mesh-ancestor
92209075|NCT00867139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336446|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
92209076|NCT00867139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209077|NCT00867139|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92209078|NCT00867139|Analgesics|analgesics|mesh-ancestor
92209079|NCT00867139|Sensory System Agents|sensory system agents|mesh-ancestor
92209080|NCT00867139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209081|NCT05342818|Ondansetron|ondansetron|mesh-list
92209082|NCT05342818|Metoclopramide|metoclopramide|mesh-list
92209083|NCT05342818|Neostigmine|neostigmine|mesh-list
92209084|NCT05342818|Antiemetics|antiemetics|mesh-ancestor
92209085|NCT05342818|Autonomic Agents|autonomic agents|mesh-ancestor
92209086|NCT05342818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209087|NCT05342818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209088|NCT05342818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92209089|NCT05342818|Antipruritics|antipruritics|mesh-ancestor
92209090|NCT05342818|Dermatologic Agents|dermatologic agents|mesh-ancestor
92209091|NCT05342818|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92209092|NCT05342818|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92209093|NCT05342818|Serotonin Agents|serotonin agents|mesh-ancestor
92209094|NCT05342818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209095|NCT05342818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209096|NCT05342818|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92209097|NCT05342818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209098|NCT05342818|Cholinergic Agents|cholinergic agents|mesh-ancestor
92209099|NCT05342818|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92209100|NCT05342818|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92209101|NCT05342818|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92209102|NCT05342818|Dopamine Agents|dopamine agents|mesh-ancestor
92209103|NCT00867217|Vitamin D|vitamin d|mesh-list
92209104|NCT00867217|Ergocalciferols|ergocalciferols|mesh-list
92209105|NCT00867217|Cholecalciferol|cholecalciferol|mesh-list
92209106|NCT00867217|Vitamins|vitamins|mesh-list
92209107|NCT00867217|Letrozole|letrozole|mesh-list
92209108|NCT00867217|Micronutrients|micronutrients|mesh-ancestor
92209109|NCT00867217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209110|NCT00867217|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92209111|NCT00867217|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92209112|NCT00867217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209113|NCT00867217|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92209114|NCT00867217|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92209115|NCT00867217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209116|NCT00867217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209117|NCT00867217|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92209118|NCT00867217|Hormone Antagonists|hormone antagonists|mesh-ancestor
92209119|NCT00867217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92209120|NCT00867451|Melatonin|melatonin|mesh-list
92209121|NCT00867451|Antioxidants|antioxidants|mesh-ancestor
92209122|NCT00867451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209123|NCT00867451|Protective Agents|protective agents|mesh-ancestor
92209124|NCT00867451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209125|NCT00867451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209126|NCT00867529|Rituximab|rituximab|mesh-list
92209127|NCT00867529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209128|NCT00867529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209129|NCT00867529|Immunologic Factors|immunologic factors|mesh-ancestor
92209130|NCT00867529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209131|NCT00867529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209132|NCT05197270|Aflibercept|aflibercept|mesh-list
92209133|NCT05197270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92209134|NCT05197270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92209135|NCT05197270|Growth Substances|growth substances|mesh-ancestor
92209136|NCT05197270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209137|NCT05197270|Growth Inhibitors|growth inhibitors|mesh-ancestor
92209138|NCT05197270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209139|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
92209140|NCT05028946|Immunologic Factors|immunologic factors|mesh-ancestor
92209141|NCT05028946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209142|NCT05028946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209143|NCT00889915|Methylphenidate|methylphenidate|mesh-list
92209144|NCT00889915|Amphetamine|amphetamine|mesh-list
92336458|NCT02023866|Cysteamine|cysteamine|mesh-list
92209145|NCT00889915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92209146|NCT00889915|Adderall|adderall|mesh-list
92209147|NCT00889915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92209148|NCT00889915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209149|NCT00889915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92209150|NCT00889915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92209151|NCT00889915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92209152|NCT00889915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209153|NCT00889915|Dopamine Agents|dopamine agents|mesh-ancestor
92209154|NCT00889915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209155|NCT00889915|Sympathomimetics|sympathomimetics|mesh-ancestor
92209156|NCT00889915|Autonomic Agents|autonomic agents|mesh-ancestor
92209157|NCT00889915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209158|NCT00889915|Adrenergic Agents|adrenergic agents|mesh-ancestor
92209159|NCT00889915|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92209160|NCT00841087|Insulin|insulin|mesh-list
92209161|NCT00841087|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92209162|NCT00841087|Insulin Aspart|insulin aspart|mesh-list
92209163|NCT00841087|Insulin Detemir|insulin detemir|mesh-list
92209164|NCT00841087|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209165|NCT00841087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209166|NCT02685436|Domperidone|domperidone|mesh-list
92209167|NCT02685436|Omeprazole|omeprazole|mesh-list
92209168|NCT02685436|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92209169|NCT02685436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92209170|NCT02685436|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92209171|NCT02685436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209172|NCT02685436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209173|NCT02685436|Antiemetics|antiemetics|mesh-ancestor
92209174|NCT02685436|Autonomic Agents|autonomic agents|mesh-ancestor
92209175|NCT02685436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209176|NCT02685436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209177|NCT02685436|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92209178|NCT02685436|Dopamine Agents|dopamine agents|mesh-ancestor
92209179|NCT02685436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209180|NCT00841555|Temozolomide|temozolomide|mesh-list
92209181|NCT00841555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92209182|NCT00841555|Alkylating Agents|alkylating agents|mesh-ancestor
92209183|NCT00841555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209184|NCT00841555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209185|NCT00842023|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92209186|NCT00842023|Nitroglycerin|nitroglycerin|mesh-list
92209187|NCT00842023|Vasodilator Agents|vasodilator agents|mesh-ancestor
92209188|NCT00842023|Natriuretic Agents|natriuretic agents|mesh-ancestor
92209189|NCT00842023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209190|NCT00868309|Antivenins|antivenins|mesh-list
92209191|NCT00868309|Immunologic Factors|immunologic factors|mesh-ancestor
92209192|NCT00868309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209193|NCT00368134|Vildagliptin|vildagliptin|mesh-list
92209194|NCT00368134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209195|NCT00368134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209196|NCT00368134|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92209197|NCT00368134|Protease Inhibitors|protease inhibitors|mesh-ancestor
92209198|NCT00368134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209199|NCT00368134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209200|NCT02697292|Immunoglobulins|immunoglobulins|mesh-list
92209201|NCT02697292|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92209202|NCT02697292|Antibodies|antibodies|mesh-list
92209203|NCT02697292|gamma-Globulins|gamma-globulins|mesh-list
92209204|NCT02697292|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92209205|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
92209206|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209207|NCT02700334|Dapagliflozin|dapagliflozin|mesh-list
91920764|NCT02183467|Incretins|incretins|mesh-ancestor
92209208|NCT02700334|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92209209|NCT02700334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209210|NCT02700334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209211|NCT02700334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209212|NCT00868699|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92209213|NCT00868699|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92209214|NCT00868699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92209215|NCT00868699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209216|NCT00868699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209217|NCT00868699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92209218|NCT00868699|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92209219|NCT00868699|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92209220|NCT00868699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92209221|NCT00868699|Adrenergic Agents|adrenergic agents|mesh-ancestor
92209222|NCT00868699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209223|NCT00868699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209224|NCT00868699|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92209225|NCT00868699|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92209226|NCT00868699|Serotonin Agents|serotonin agents|mesh-ancestor
92209227|NCT00868699|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92209228|NCT00868699|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92209229|NCT00868699|Dopamine Agents|dopamine agents|mesh-ancestor
92209230|NCT02701582|Phenylephrine|phenylephrine|mesh-list
92209231|NCT02701582|Epinephrine|epinephrine|mesh-list
92209232|NCT02701582|Oxymetazoline|oxymetazoline|mesh-list
92209233|NCT02701582|Synephrine|synephrine|mesh-list
92209234|NCT02701582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92209235|NCT02701582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92209236|NCT02701582|Adrenergic Agents|adrenergic agents|mesh-ancestor
92209237|NCT02701582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209238|NCT02701582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209239|NCT02701582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209240|NCT02701582|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92209241|NCT02701582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92209242|NCT02701582|Autonomic Agents|autonomic agents|mesh-ancestor
92209243|NCT02701582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209244|NCT02701582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92209245|NCT02701582|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209246|NCT02701582|Mydriatics|mydriatics|mesh-ancestor
92209247|NCT02701582|Sympathomimetics|sympathomimetics|mesh-ancestor
92209248|NCT02701582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92209249|NCT02701582|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92209250|NCT02701582|Nasal Decongestants|nasal decongestants|mesh-ancestor
92209251|NCT02701582|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92209252|NCT02701582|Protective Agents|protective agents|mesh-ancestor
92209253|NCT00869791|Levodopa|levodopa|mesh-list
92209254|NCT00869791|Carbidopa|carbidopa|mesh-list
92209255|NCT00869791|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92209256|NCT00869791|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92209257|NCT00869791|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92209258|NCT00869791|Dopamine Agents|dopamine agents|mesh-ancestor
92209259|NCT00869791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209260|NCT00869791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209261|NCT00869791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209262|NCT00869791|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92209263|NCT00869791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209264|NCT00869791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92209265|NCT00869791|Immunologic Factors|immunologic factors|mesh-ancestor
92209266|NCT00869791|Dopamine Agonists|dopamine agonists|mesh-ancestor
92209267|NCT02704702|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92209268|NCT02704702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92209270|NCT02704702|Antimetabolites|antimetabolites|mesh-ancestor
92209271|NCT02704702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209272|NCT02704702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92209273|NCT02704702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92209274|NCT02704702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209275|NCT00895531|Morphine|morphine|mesh-list
92209276|NCT00895531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92209277|NCT00895531|Narcotics|narcotics|mesh-ancestor
92209278|NCT00895531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209279|NCT00895531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209280|NCT00895531|Analgesics|analgesics|mesh-ancestor
92209281|NCT00895531|Sensory System Agents|sensory system agents|mesh-ancestor
92336465|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
92209282|NCT00895531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209284|NCT03215875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92209285|NCT03215875|Diuretics|diuretics|mesh-ancestor
92209286|NCT03215875|Natriuretic Agents|natriuretic agents|mesh-ancestor
92209287|NCT03215875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209288|NCT03215875|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92209289|NCT03215875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92209290|NCT03215875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209292|NCT02710630|Antithrombins|antithrombins|mesh-ancestor
92209293|NCT02710630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92209294|NCT02710630|Protease Inhibitors|protease inhibitors|mesh-ancestor
92209295|NCT02710630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209296|NCT02710630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209297|NCT02710630|Anticoagulants|anticoagulants|mesh-ancestor
92209298|NCT02715700|Methadone|methadone|mesh-list
92209299|NCT02715700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92209300|NCT02715700|Narcotics|narcotics|mesh-ancestor
92209301|NCT02715700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209302|NCT02715700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209303|NCT02715700|Analgesics|analgesics|mesh-ancestor
92209304|NCT02715700|Sensory System Agents|sensory system agents|mesh-ancestor
92209305|NCT02715700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209306|NCT02715700|Antitussive Agents|antitussive agents|mesh-ancestor
92209307|NCT02715700|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209308|NCT00338377|Cyclophosphamide|cyclophosphamide|mesh-list
92209309|NCT00338377|Fludarabine|fludarabine|mesh-list
92209310|NCT00338377|Fludarabine phosphate|fludarabine phosphate|mesh-list
92209311|NCT00338377|Interleukin-2|interleukin-2|mesh-list
92209312|NCT00338377|Mesna|mesna|mesh-list
92209313|NCT00338377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209314|NCT00338377|Immunologic Factors|immunologic factors|mesh-ancestor
92209315|NCT00338377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209316|NCT00338377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209317|NCT00338377|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92209318|NCT00338377|Alkylating Agents|alkylating agents|mesh-ancestor
92209319|NCT00338377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209320|NCT00338377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209321|NCT00338377|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92209322|NCT00338377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92209323|NCT00338377|Antimetabolites|antimetabolites|mesh-ancestor
92209324|NCT00338377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92209325|NCT00338377|Analgesics|analgesics|mesh-ancestor
92209326|NCT00338377|Sensory System Agents|sensory system agents|mesh-ancestor
92209327|NCT00338377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209328|NCT00338377|Protective Agents|protective agents|mesh-ancestor
92209329|NCT00895921|Olanzapine|olanzapine|mesh-list
92209330|NCT00895921|Aripiprazole|aripiprazole|mesh-list
92209331|NCT00895921|Antiemetics|antiemetics|mesh-ancestor
92209332|NCT00895921|Autonomic Agents|autonomic agents|mesh-ancestor
92209333|NCT00895921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209334|NCT00895921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209335|NCT00895921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92209336|NCT00895921|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92209337|NCT00895921|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92209338|NCT00895921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209339|NCT00895921|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92209340|NCT00895921|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92209341|NCT00895921|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92209342|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92209343|NCT00895921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209345|NCT00895921|Serotonin Agents|serotonin agents|mesh-ancestor
92209346|NCT00895921|Antidepressive Agents|antidepressive agents|mesh-ancestor
92209347|NCT00895921|Dopamine Agonists|dopamine agonists|mesh-ancestor
92209348|NCT00895921|Dopamine Agents|dopamine agents|mesh-ancestor
92209349|NCT00895921|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92209350|NCT00895921|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92209351|NCT00895921|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92209352|NCT00895921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92209353|NCT00895921|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92209354|NCT00895921|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92209355|NCT05315479|Meloxicam|meloxicam|mesh-list
92209356|NCT05315479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92209357|NCT05315479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92209358|NCT05315479|Analgesics|analgesics|mesh-ancestor
92209359|NCT05315479|Sensory System Agents|sensory system agents|mesh-ancestor
92209360|NCT05315479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209361|NCT05315479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209362|NCT05315479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92209363|NCT05315479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209364|NCT05315479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92209365|NCT05315479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92209366|NCT05315479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209367|NCT05315479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209368|NCT00883675|Carboplatin|carboplatin|mesh-list
92209369|NCT00883675|Docetaxel|docetaxel|mesh-list
92209370|NCT00883675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209371|NCT00883675|Tubulin Modulators|tubulin modulators|mesh-ancestor
92209372|NCT00883675|Antimitotic Agents|antimitotic agents|mesh-ancestor
92209373|NCT00883675|Mitosis Modulators|mitosis modulators|mesh-ancestor
92209374|NCT00883675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209376|NCT03215407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92209377|NCT03215407|Glucocorticoids|glucocorticoids|mesh-ancestor
92209378|NCT03215407|Hormones|hormones|mesh-ancestor
92209379|NCT03215407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92209380|NCT03215407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209381|NCT03215407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92209382|NCT03215407|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209383|NCT05310331|Paclitaxel|paclitaxel|mesh-list
92209384|NCT05310331|Antibodies|antibodies|mesh-list
92209385|NCT05310331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92209386|NCT05310331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209387|NCT05310331|Tubulin Modulators|tubulin modulators|mesh-ancestor
92209388|NCT05310331|Antimitotic Agents|antimitotic agents|mesh-ancestor
92209389|NCT05310331|Mitosis Modulators|mitosis modulators|mesh-ancestor
92209390|NCT05310331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209391|NCT05310331|Immunologic Factors|immunologic factors|mesh-ancestor
92209392|NCT05310331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209393|NCT00885079|Rebamipide|rebamipide|mesh-list
92209394|NCT00885079|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92209395|NCT00885079|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92209396|NCT00885079|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92209397|NCT00885079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92209398|NCT00885079|Antioxidants|antioxidants|mesh-ancestor
92209399|NCT00885079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209400|NCT00885079|Protective Agents|protective agents|mesh-ancestor
92209401|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209402|NCT00885079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209403|NCT00896779|Ranibizumab|ranibizumab|mesh-list
92209404|NCT00896779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92209405|NCT00896779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92209406|NCT00896779|Growth Substances|growth substances|mesh-ancestor
92209407|NCT00896779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209408|NCT00896779|Growth Inhibitors|growth inhibitors|mesh-ancestor
92209409|NCT00896779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209410|NCT03214939|Immunomodulating Agents|immunomodulating agents|mesh-list
92209411|NCT03214939|Immunologic Factors|immunologic factors|mesh-ancestor
92209412|NCT03214939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209413|NCT03376477|Lenalidomide|lenalidomide|mesh-list
92209414|NCT03376477|Molgramostim|molgramostim|mesh-list
92209415|NCT03376477|Vaccines|vaccines|mesh-list
92209416|NCT03376477|Sargramostim|sargramostim|mesh-list
92209417|NCT03376477|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92209418|NCT03376477|Immunologic Factors|immunologic factors|mesh-ancestor
92209419|NCT03376477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209421|NCT03376477|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92209422|NCT03376477|Growth Substances|growth substances|mesh-ancestor
92209423|NCT03376477|Growth Inhibitors|growth inhibitors|mesh-ancestor
92209424|NCT03376477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209425|NCT02726620|Lidocaine|lidocaine|mesh-list
92209426|NCT02726620|Atropine|atropine|mesh-list
92209427|NCT02726620|Terlipressin|terlipressin|mesh-list
92209428|NCT02726620|Phenylephrine|phenylephrine|mesh-list
92209429|NCT02726620|Dobutamine|dobutamine|mesh-list
92209430|NCT02726620|Dopamine|dopamine|mesh-list
92209431|NCT02726620|Milrinone|milrinone|mesh-list
92209432|NCT02726620|Isoproterenol|isoproterenol|mesh-list
92209433|NCT02726620|Vasopressins|vasopressins|mesh-list
92209434|NCT02726620|Epinephrine|epinephrine|mesh-list
92209435|NCT02726620|Norepinephrine|norepinephrine|mesh-list
92209436|NCT02726620|Ephedrine|ephedrine|mesh-list
92209437|NCT02726620|Glycopyrrolate|glycopyrrolate|mesh-list
92209438|NCT02726620|Bupivacaine|bupivacaine|mesh-list
92209439|NCT02726620|Ropivacaine|ropivacaine|mesh-list
92209440|NCT02726620|Levobupivacaine|levobupivacaine|mesh-list
92209441|NCT02726620|Tetracaine|tetracaine|mesh-list
92209442|NCT02726620|Prilocaine|prilocaine|mesh-list
92209443|NCT02726620|Mepivacaine|mepivacaine|mesh-list
92209444|NCT02726620|Benzocaine|benzocaine|mesh-list
92209445|NCT02726620|Chloroprocaine|chloroprocaine|mesh-list
92209446|NCT02726620|Procaine|procaine|mesh-list
92209447|NCT02726620|Anesthetics|anesthetics|mesh-list
92209448|NCT02726620|Propofol|propofol|mesh-list
92209449|NCT02726620|Sevoflurane|sevoflurane|mesh-list
92209450|NCT02726620|Desflurane|desflurane|mesh-list
92209451|NCT02726620|Isoflurane|isoflurane|mesh-list
92209452|NCT02726620|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92209453|NCT02726620|Plasma-lyte 148|plasma-lyte 148|mesh-list
92209454|NCT02726620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92209455|NCT02726620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209456|NCT02726620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209457|NCT02726620|Sensory System Agents|sensory system agents|mesh-ancestor
92209458|NCT02726620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209459|NCT02726620|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92209460|NCT02726620|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92209461|NCT02726620|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92209462|NCT02726620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92209463|NCT02726620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209464|NCT02726620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92209465|NCT02726620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92209466|NCT02726620|Anesthetics, General|anesthetics, general|mesh-ancestor
92209467|NCT02726620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92209468|NCT02726620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92209469|NCT02726620|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92209470|NCT02726620|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92209471|NCT02726620|Adrenergic Agents|adrenergic agents|mesh-ancestor
92209472|NCT02726620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209473|NCT02726620|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92209474|NCT02726620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92209475|NCT02726620|Autonomic Agents|autonomic agents|mesh-ancestor
92209476|NCT02726620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92209477|NCT02726620|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209478|NCT02726620|Mydriatics|mydriatics|mesh-ancestor
92209479|NCT02726620|Sympathomimetics|sympathomimetics|mesh-ancestor
92209480|NCT02726620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92209481|NCT02726620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92209482|NCT02726620|Nasal Decongestants|nasal decongestants|mesh-ancestor
92209483|NCT02726620|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92209484|NCT02726620|Protective Agents|protective agents|mesh-ancestor
92209485|NCT02726620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92209486|NCT02726620|Parasympatholytics|parasympatholytics|mesh-ancestor
92209487|NCT02726620|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92209488|NCT02726620|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92209489|NCT02726620|Cholinergic Agents|cholinergic agents|mesh-ancestor
92209490|NCT02726620|Hemostatics|hemostatics|mesh-ancestor
92209491|NCT02726620|Coagulants|coagulants|mesh-ancestor
92209492|NCT02726620|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92209493|NCT02726620|Natriuretic Agents|natriuretic agents|mesh-ancestor
92209494|NCT02726620|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92209495|NCT02726620|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92209496|NCT02726620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92209497|NCT02726620|Dopamine Agents|dopamine agents|mesh-ancestor
92209498|NCT02726620|Vasodilator Agents|vasodilator agents|mesh-ancestor
92209499|NCT02726620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92209500|NCT02726620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92209501|NCT02726620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209502|NCT02726620|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92209503|NCT00887575|Paclitaxel|paclitaxel|mesh-list
92209504|NCT00887575|Carboplatin|carboplatin|mesh-list
92209505|NCT00887575|Sunitinib|sunitinib|mesh-list
92209506|NCT00887575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92209507|NCT00887575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209508|NCT00887575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92209509|NCT00887575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92209510|NCT00887575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92209511|NCT00887575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209512|NCT00887575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92209513|NCT00887575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92209514|NCT00887575|Growth Substances|growth substances|mesh-ancestor
92209515|NCT00887575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209516|NCT00887575|Growth Inhibitors|growth inhibitors|mesh-ancestor
92209517|NCT00887575|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92209518|NCT00887575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209519|NCT03352843|Primaquine|primaquine|mesh-list
92209520|NCT03352843|Antimalarials|antimalarials|mesh-ancestor
92209521|NCT03352843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92209522|NCT03352843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92209523|NCT03352843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209524|NCT03238027|Durvalumab|durvalumab|mesh-list
92209525|NCT03238027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209526|NCT03238027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209528|NCT00887653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92209529|NCT00887653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92209530|NCT00887653|Antiviral Agents|antiviral agents|mesh-ancestor
92209531|NCT00887653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209532|NCT00887653|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92209533|NCT00887653|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92209534|NCT00887653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209535|NCT00887653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209536|NCT00887965|Denosumab|denosumab|mesh-list
92209537|NCT00887965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92209538|NCT00887965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209539|NCT02729038|Gepotidacin|gepotidacin|mesh-list
92209540|NCT02729038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92209541|NCT02729038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209542|NCT02729038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209543|NCT02729038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209544|NCT05311813|Hydroxychloroquine|hydroxychloroquine|mesh-list
92209545|NCT05311813|Enoxaparin|enoxaparin|mesh-list
92209546|NCT05311813|Antimalarials|antimalarials|mesh-ancestor
92209547|NCT05311813|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92209548|NCT05311813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92209549|NCT05311813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209550|NCT05311813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209551|NCT05311813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209552|NCT05311813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209553|NCT05311813|Anticoagulants|anticoagulants|mesh-ancestor
92209554|NCT05311813|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92209555|NCT05311813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92209556|NCT03214627|Iron|iron|mesh-list
92209557|NCT03214627|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92209558|NCT03214627|Hematinics|hematinics|mesh-list
92209559|NCT03214627|Trace Elements|trace elements|mesh-ancestor
92209560|NCT03214627|Micronutrients|micronutrients|mesh-ancestor
92209561|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209562|NCT00888511|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92209563|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209564|NCT00888511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92209565|NCT00888511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209566|NCT00888511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209567|NCT03214393|Antibodies|antibodies|mesh-list
92209568|NCT03214393|Immunologic Factors|immunologic factors|mesh-ancestor
92209569|NCT03214393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209570|NCT00888979|Nicotine|nicotine|mesh-list
92209571|NCT00888979|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92209572|NCT00888979|Autonomic Agents|autonomic agents|mesh-ancestor
92209573|NCT00888979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209574|NCT00888979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209575|NCT00888979|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92209576|NCT00888979|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92209577|NCT00888979|Cholinergic Agents|cholinergic agents|mesh-ancestor
92209578|NCT00888979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209579|NCT00888979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209580|NCT03214159|Ritonavir|ritonavir|mesh-list
92209581|NCT03214159|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92209582|NCT03214159|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92209583|NCT03214159|Protease Inhibitors|protease inhibitors|mesh-ancestor
92209584|NCT03214159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209585|NCT03214159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209586|NCT03214159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92209587|NCT03214159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92209588|NCT03214159|Antiviral Agents|antiviral agents|mesh-ancestor
92209589|NCT03214159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209590|NCT03214159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92209591|NCT03214159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92209592|NCT02737072|Durvalumab|durvalumab|mesh-list
92209593|NCT02737072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209594|NCT02737072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209595|NCT05446480|Desloratadine|desloratadine|mesh-list
92209596|NCT05446480|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92209597|NCT05446480|Cholinergic Agents|cholinergic agents|mesh-ancestor
92209598|NCT05446480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209599|NCT05446480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209600|NCT05446480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209601|NCT05446480|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92209602|NCT05446480|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92209603|NCT05446480|Histamine Antagonists|histamine antagonists|mesh-ancestor
92209604|NCT05446480|Histamine Agents|histamine agents|mesh-ancestor
92209605|NCT03213145|Rifampin|rifampin|mesh-list
92209606|NCT03213145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92209607|NCT03213145|Antitubercular Agents|antitubercular agents|mesh-ancestor
92209608|NCT03213145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92209609|NCT03213145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209610|NCT03213145|Leprostatic Agents|leprostatic agents|mesh-ancestor
92209611|NCT03213145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92209612|NCT03213145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209613|NCT03213145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209614|NCT03213145|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92209615|NCT03213145|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92209616|NCT03213145|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92209617|NCT03213145|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92209618|NCT03213145|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92209619|NCT03213145|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92209620|NCT02722564|Ethanol|ethanol|mesh-list
92209621|NCT02722564|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92209622|NCT02722564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209623|NCT02722564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209624|NCT02722564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209625|NCT05446090|Nitric Oxide|nitric oxide|mesh-list
92209626|NCT05446090|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92209627|NCT05446090|Autonomic Agents|autonomic agents|mesh-ancestor
92209628|NCT05446090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209629|NCT05446090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209630|NCT05446090|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92209631|NCT05446090|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209632|NCT05446090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92209633|NCT05446090|Antioxidants|antioxidants|mesh-ancestor
92209634|NCT05446090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209635|NCT05446090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209636|NCT05446090|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92209637|NCT05446090|Vasodilator Agents|vasodilator agents|mesh-ancestor
92209638|NCT05446090|Gasotransmitters|gasotransmitters|mesh-ancestor
92209639|NCT05446090|Protective Agents|protective agents|mesh-ancestor
92209640|NCT05444998|Paclitaxel|paclitaxel|mesh-list
92209641|NCT05444998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92209642|NCT05444998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209643|NCT05444998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92209645|NCT05444998|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934175|NCT03146325|Antacids|antacids|mesh-ancestor
92209646|NCT05444998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209647|NCT05444842|Insulin|insulin|mesh-list
92209648|NCT05444842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92209649|NCT05444842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209650|NCT05444842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209651|NCT04381741|Antibodies|antibodies|mesh-list
92209652|NCT04381741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92209653|NCT04381741|Immunologic Factors|immunologic factors|mesh-ancestor
92209654|NCT04381741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209655|NCT05444452|Sirolimus|sirolimus|mesh-list
92209656|NCT05444452|Everolimus|everolimus|mesh-list
92209657|NCT05444452|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92209658|NCT05444452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92209659|NCT05444452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209660|NCT05444452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209661|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209662|NCT05444452|Immunologic Factors|immunologic factors|mesh-ancestor
92209663|NCT05444452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209664|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209665|NCT05444452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92209666|NCT05444452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209667|NCT05444452|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92209668|NCT05444452|Antifungal Agents|antifungal agents|mesh-ancestor
92209669|NCT05444374|Bevacizumab|bevacizumab|mesh-list
92209670|NCT05444374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209671|NCT05444374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209672|NCT05444374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92209673|NCT05444374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92209674|NCT05444374|Growth Substances|growth substances|mesh-ancestor
92209675|NCT05444374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209676|NCT05444374|Growth Inhibitors|growth inhibitors|mesh-ancestor
92209678|NCT05444218|Metronidazole|metronidazole|mesh-list
92209679|NCT05444218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92209680|NCT05444218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209681|NCT05444218|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92209682|NCT05444218|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92209683|NCT01830361|Midostaurin|midostaurin|mesh-list
92209684|NCT01830361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209685|NCT01830361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92209686|NCT01830361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209687|NCT01830361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209688|NCT01830517|Losartan|losartan|mesh-list
92209689|NCT01830517|Amlodipine|amlodipine|mesh-list
92209690|NCT01830517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92209691|NCT01830517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92209692|NCT01830517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92209693|NCT01830517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209694|NCT01830517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92209695|NCT01830517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209696|NCT01830517|Vasodilator Agents|vasodilator agents|mesh-ancestor
92209697|NCT01830517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92209698|NCT01830517|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92209699|NCT01830517|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92209700|NCT03212833|Insulin|insulin|mesh-list
92209701|NCT03212833|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209702|NCT03212833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209703|NCT05443360|Calcium, Dietary|calcium, dietary|mesh-list
92209704|NCT05443360|Calcium Carbonate|calcium carbonate|mesh-list
92209705|NCT05443360|Calcium|calcium|mesh-list
92209706|NCT05443360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92209707|NCT05443360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209708|NCT05443360|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92209709|NCT05443360|Antacids|antacids|mesh-ancestor
92209710|NCT05443360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209711|NCT05443360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92209712|NCT05443282|Hormones|hormones|mesh-list
92209713|NCT05443282|Estradiol|estradiol|mesh-list
92209714|NCT05443282|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92209715|NCT05443282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92209717|NCT05443282|Estrogens|estrogens|mesh-ancestor
92209718|NCT00904345|Cetuximab|cetuximab|mesh-list
92209719|NCT00904345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209720|NCT00904345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209721|NCT05442736|Ciprofloxacin|ciprofloxacin|mesh-list
92209722|NCT05442736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92209723|NCT05442736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209724|NCT05442736|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92209725|NCT05442736|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92209726|NCT05442736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209727|NCT05442736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209728|NCT05442736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209729|NCT05442736|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92209730|NCT05442736|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92209731|NCT01830829|Tamsulosin|tamsulosin|mesh-list
92209732|NCT01830829|Dutasteride|dutasteride|mesh-list
92209733|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92209734|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92209735|NCT01830829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92209736|NCT01830829|Adrenergic Agents|adrenergic agents|mesh-ancestor
92209737|NCT01830829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209738|NCT01830829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209739|NCT01830829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209740|NCT01830829|Urological Agents|urological agents|mesh-ancestor
92209741|NCT01830829|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92209742|NCT01830829|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92209743|NCT01830829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209744|NCT01830829|Hormone Antagonists|hormone antagonists|mesh-ancestor
92209745|NCT01830829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92209746|NCT03212755|Immunoglobulins|immunoglobulins|mesh-list
92209747|NCT03212755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92209748|NCT03212755|Antibodies|antibodies|mesh-list
92209749|NCT03212755|Immunoglobulin G|immunoglobulin g|mesh-list
92209750|NCT03212755|Immunologic Factors|immunologic factors|mesh-ancestor
92209751|NCT03212755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209752|NCT05437822|Tranexamic Acid|tranexamic acid|mesh-list
92209753|NCT05437822|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92209754|NCT05437822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92209755|NCT05437822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209756|NCT05437822|Hemostatics|hemostatics|mesh-ancestor
92209757|NCT05437822|Coagulants|coagulants|mesh-ancestor
92209758|NCT03212599|Disulfiram|disulfiram|mesh-list
92209759|NCT03212599|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92209760|NCT03212599|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92209761|NCT03212599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209762|NCT03212599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209763|NCT03212053|Hemostatics|hemostatics|mesh-list
92209764|NCT03212053|Coagulants|coagulants|mesh-ancestor
92209765|NCT05447026|Anti-Infective Agents|anti-infective agents|mesh-list
92209766|NCT05447026|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92209767|NCT05311189|Trastuzumab|trastuzumab|mesh-list
92209768|NCT05311189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209769|NCT05311189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209770|NCT00369772|Darbepoetin alfa|darbepoetin alfa|mesh-list
92209771|NCT00369772|Hematinics|hematinics|mesh-ancestor
92209772|NCT03211897|Midazolam|midazolam|mesh-list
92209773|NCT03211897|Haloperidol|haloperidol|mesh-list
92209774|NCT03211897|Olanzapine|olanzapine|mesh-list
92209775|NCT03211897|Haloperidol decanoate|haloperidol decanoate|mesh-list
92209776|NCT03211897|Ziprasidone|ziprasidone|mesh-list
92209777|NCT03211897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92209778|NCT03211897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92209779|NCT03211897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209780|NCT03211897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209781|NCT03211897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92209782|NCT03211897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92209783|NCT03211897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92209784|NCT03211897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92209785|NCT03211897|Anesthetics, General|anesthetics, general|mesh-ancestor
92209786|NCT03211897|Anesthetics|anesthetics|mesh-ancestor
92209787|NCT03211897|GABA Modulators|gaba modulators|mesh-ancestor
92209788|NCT03211897|GABA Agents|gaba agents|mesh-ancestor
92209789|NCT03211897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209790|NCT03211897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209791|NCT03211897|Antiemetics|antiemetics|mesh-ancestor
92209792|NCT03211897|Autonomic Agents|autonomic agents|mesh-ancestor
92209793|NCT03211897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209794|NCT03211897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92209795|NCT03211897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92209796|NCT03211897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92209797|NCT03211897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92209798|NCT03211897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92209799|NCT03211897|Serotonin Agents|serotonin agents|mesh-ancestor
92209800|NCT03211897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92209801|NCT03211897|Dopamine Agents|dopamine agents|mesh-ancestor
92209802|NCT03211897|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92209803|NCT03211897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92209804|NCT01831687|Etodolac|etodolac|mesh-list
92209805|NCT01831687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92209806|NCT01831687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92209807|NCT01831687|Analgesics|analgesics|mesh-ancestor
92209808|NCT01831687|Sensory System Agents|sensory system agents|mesh-ancestor
92209809|NCT01831687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209810|NCT01831687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209811|NCT01831687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92209812|NCT01831687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209813|NCT01831687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92209814|NCT01831687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92209815|NCT01831687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209816|NCT01831687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209817|NCT05441254|Paclitaxel|paclitaxel|mesh-list
92209818|NCT05441254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92209819|NCT05441254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209821|NCT05441254|Antimitotic Agents|antimitotic agents|mesh-ancestor
92209822|NCT05441254|Mitosis Modulators|mitosis modulators|mesh-ancestor
92209823|NCT05441254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209824|NCT00369148|Nateglinide|nateglinide|mesh-list
92209825|NCT00369148|Mitiglinide|mitiglinide|mesh-list
92209826|NCT00369148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209827|NCT00369148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209828|NCT03816982|Bupivacaine|bupivacaine|mesh-list
92209829|NCT03816982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92209830|NCT03816982|Anesthetics|anesthetics|mesh-ancestor
92209831|NCT03816982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209832|NCT03816982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209833|NCT03816982|Sensory System Agents|sensory system agents|mesh-ancestor
92209834|NCT03816982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209835|NCT01832467|Cetuximab|cetuximab|mesh-list
92209836|NCT01832467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92209837|NCT01832467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209838|NCT03211351|Dextrans|dextrans|mesh-list
92209839|NCT03211351|Anticoagulants|anticoagulants|mesh-ancestor
92209840|NCT03211351|Plasma Substitutes|plasma substitutes|mesh-ancestor
92209841|NCT03211351|Blood Substitutes|blood substitutes|mesh-ancestor
92209842|NCT01832623|Vitamin D|vitamin d|mesh-list
92209843|NCT01832623|Vitamins|vitamins|mesh-ancestor
92209844|NCT01832623|Micronutrients|micronutrients|mesh-ancestor
92209845|NCT01832623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209846|NCT01832623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92209847|NCT03211195|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92209848|NCT03211195|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92209849|NCT03211195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209850|NCT03211195|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209851|NCT03211195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209852|NCT02470390|Fentanyl|fentanyl|mesh-list
92209853|NCT02470390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92209854|NCT02470390|Narcotics|narcotics|mesh-ancestor
92209855|NCT02470390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934177|NCT02233049|Everolimus|everolimus|mesh-list
92209856|NCT02470390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209857|NCT02470390|Analgesics|analgesics|mesh-ancestor
92209858|NCT02470390|Sensory System Agents|sensory system agents|mesh-ancestor
92209859|NCT02470390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209860|NCT02470390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92209861|NCT02470390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92209862|NCT02470390|Anesthetics, General|anesthetics, general|mesh-ancestor
92209863|NCT02470390|Anesthetics|anesthetics|mesh-ancestor
92209864|NCT00363532|Calcitonin|calcitonin|mesh-list
92209865|NCT00363532|Salmon calcitonin|salmon calcitonin|mesh-list
92209866|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92209867|NCT00363532|Katacalcin|katacalcin|mesh-list
92209868|NCT00363532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92209869|NCT00363532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209870|NCT00363532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92209871|NCT00363532|Vasodilator Agents|vasodilator agents|mesh-ancestor
92209872|NCT00363610|Pegaspargase|pegaspargase|mesh-list
92209873|NCT00363610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209874|NCT00363688|Penicillins|penicillins|mesh-list
92209875|NCT00363688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92209876|NCT00363688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209877|NCT01832935|Insulin|insulin|mesh-list
92209878|NCT01832935|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92209879|NCT01832935|Insulin Glargine|insulin glargine|mesh-list
92209880|NCT01832935|Isophane Insulin, Human|isophane insulin, human|mesh-list
92209881|NCT01832935|Insulin, Isophane|insulin, isophane|mesh-list
92209882|NCT01832935|Isophane insulin, beef|isophane insulin, beef|mesh-list
92209883|NCT01832935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209884|NCT01832935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209885|NCT03216733|Sirolimus|sirolimus|mesh-list
92209886|NCT03216733|Temsirolimus|temsirolimus|mesh-list
92209887|NCT03216733|MTOR Inhibitors|mtor inhibitors|mesh-list
92209888|NCT03216733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92209889|NCT03216733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209890|NCT03216733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92209891|NCT03216733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209892|NCT03216733|Antifungal Agents|antifungal agents|mesh-ancestor
92209893|NCT03216733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209894|NCT03216733|Immunologic Factors|immunologic factors|mesh-ancestor
92209895|NCT03216733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209896|NCT03216733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92209897|NCT03216733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209898|NCT03216733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209899|NCT03216343|Chiauranib|chiauranib|mesh-list
92209900|NCT03216343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209901|NCT03216343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92209902|NCT03216343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209903|NCT03216343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209904|NCT04380181|Milrinone|milrinone|mesh-list
92209905|NCT04380181|Epinephrine|epinephrine|mesh-list
92209906|NCT04380181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92209907|NCT04380181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92209908|NCT04380181|Adrenergic Agents|adrenergic agents|mesh-ancestor
92209909|NCT04380181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209910|NCT04380181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209911|NCT04380181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209912|NCT04380181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92209913|NCT04380181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92209914|NCT04380181|Autonomic Agents|autonomic agents|mesh-ancestor
92209915|NCT04380181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209916|NCT04380181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92209917|NCT04380181|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209918|NCT04380181|Mydriatics|mydriatics|mesh-ancestor
92209919|NCT04380181|Sympathomimetics|sympathomimetics|mesh-ancestor
92209920|NCT04380181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92209921|NCT04380181|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92209922|NCT04380181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92209923|NCT04380181|Vasodilator Agents|vasodilator agents|mesh-ancestor
92209924|NCT04380181|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92209925|NCT04380181|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92209926|NCT04380181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336509|NCT01967550|Diclofenac|diclofenac|mesh-list
92209927|NCT04380181|Protective Agents|protective agents|mesh-ancestor
92209928|NCT01833559|Insulin|insulin|mesh-list
92209929|NCT01833559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92209930|NCT01833559|Isophane Insulin, Human|isophane insulin, human|mesh-list
92209931|NCT01833559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209932|NCT01833559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209933|NCT05394142|Metformin|metformin|mesh-list
92209934|NCT05394142|Pioglitazone|pioglitazone|mesh-list
92209935|NCT05394142|Spironolactone|spironolactone|mesh-list
92209936|NCT05394142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92209937|NCT05394142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209938|NCT05394142|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92209939|NCT05394142|Hormone Antagonists|hormone antagonists|mesh-ancestor
92209940|NCT05394142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92209941|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92209942|NCT05394142|Diuretics|diuretics|mesh-ancestor
92209943|NCT05394142|Natriuretic Agents|natriuretic agents|mesh-ancestor
92209944|NCT00901225|Plerixafor|plerixafor|mesh-list
92209945|NCT00901225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92209946|NCT00901225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92209947|NCT00901225|Antiviral Agents|antiviral agents|mesh-ancestor
92209948|NCT00901225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92209949|NCT01833715|Morphine|morphine|mesh-list
92209950|NCT01833715|Methadone|methadone|mesh-list
92209951|NCT01833715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92209952|NCT01833715|Narcotics|narcotics|mesh-ancestor
92209953|NCT01833715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92209954|NCT01833715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209955|NCT01833715|Analgesics|analgesics|mesh-ancestor
92209956|NCT01833715|Sensory System Agents|sensory system agents|mesh-ancestor
92209957|NCT01833715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92209958|NCT01833715|Antitussive Agents|antitussive agents|mesh-ancestor
92209959|NCT01833715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92209960|NCT05393050|Methotrexate|methotrexate|mesh-list
92209961|NCT05393050|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92209962|NCT05393050|Abortifacient Agents|abortifacient agents|mesh-ancestor
92209963|NCT05393050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92209964|NCT05393050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209965|NCT05393050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92209966|NCT05393050|Antimetabolites|antimetabolites|mesh-ancestor
92209967|NCT05393050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209968|NCT05393050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209969|NCT05393050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92209970|NCT05393050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209971|NCT05393050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92209972|NCT05393050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92209973|NCT05393050|Immunologic Factors|immunologic factors|mesh-ancestor
92209974|NCT05393050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92209975|NCT05393050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92209977|NCT03166228|Glycine Agents|glycine agents|mesh-ancestor
92209978|NCT03166228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92209979|NCT03166228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209980|NCT03166228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209981|NCT01833793|Levonorgestrel|levonorgestrel|mesh-list
92209982|NCT01833793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92209983|NCT01833793|Contraceptive Agents|contraceptive agents|mesh-ancestor
92209984|NCT01833793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92209985|NCT01833793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92209986|NCT01833793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92209987|NCT01833793|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92209988|NCT01833793|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92209989|NCT03154996|Topotecan|topotecan|mesh-list
92209990|NCT03154996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92209991|NCT03154996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92209992|NCT03154996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92209993|NCT03154996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209994|NCT03154996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92209995|NCT02475070|Dapagliflozin|dapagliflozin|mesh-list
92209996|NCT02475070|Vildagliptin|vildagliptin|mesh-list
92209997|NCT02475070|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92209998|NCT02475070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92209999|NCT02475070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92210000|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210001|NCT02475070|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92210002|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92210003|NCT02475070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210004|NCT00902161|Propranolol|propranolol|mesh-list
92210005|NCT00902161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92210006|NCT00902161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92210007|NCT00902161|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210008|NCT00902161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210009|NCT00902161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210010|NCT00902161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210011|NCT00902161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92210012|NCT00902161|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210013|NCT00902161|Vasodilator Agents|vasodilator agents|mesh-ancestor
92210014|NCT01834183|Gemcitabine|gemcitabine|mesh-list
92210015|NCT01834183|Tivozanib|tivozanib|mesh-list
92210016|NCT01834183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92210017|NCT01834183|Antimetabolites|antimetabolites|mesh-ancestor
92210018|NCT01834183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210019|NCT01834183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210020|NCT01834183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92210021|NCT01834183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210022|NCT02478580|Modafinil|modafinil|mesh-list
92210023|NCT02478580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92210024|NCT02478580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210025|NCT02478580|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92210026|NCT02478580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92210027|NCT02478580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92210028|NCT02478580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210029|NCT03210493|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92210030|NCT03210493|Antiviral Agents|antiviral agents|mesh-ancestor
92210031|NCT03210493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210032|NCT03210025|Methyldopa|methyldopa|mesh-list
92210033|NCT03210025|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210034|NCT03210025|Sympatholytics|sympatholytics|mesh-ancestor
92210035|NCT03210025|Autonomic Agents|autonomic agents|mesh-ancestor
92210036|NCT03210025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210037|NCT03210025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210038|NCT03210025|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92210039|NCT03210025|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92210040|NCT03210025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92210041|NCT03210025|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210042|NCT03210025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117280|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92210043|NCT03210025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210044|NCT03219853|Selenium|selenium|mesh-list
92210045|NCT03219853|Antioxidants|antioxidants|mesh-ancestor
92210046|NCT03219853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210047|NCT03219853|Protective Agents|protective agents|mesh-ancestor
92210048|NCT03219853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210049|NCT03219853|Trace Elements|trace elements|mesh-ancestor
92210050|NCT03219853|Micronutrients|micronutrients|mesh-ancestor
92210051|NCT05330884|BCG Vaccine|bcg vaccine|mesh-list
92210052|NCT05330884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92210053|NCT05330884|Immunologic Factors|immunologic factors|mesh-ancestor
92210054|NCT05330884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210055|NCT02480998|Vaccines|vaccines|mesh-list
92210056|NCT02480998|Immunologic Factors|immunologic factors|mesh-ancestor
92210057|NCT02480998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210058|NCT00905515|Cyclosporine|cyclosporine|mesh-list
92210059|NCT00905515|Tacrolimus|tacrolimus|mesh-list
92210060|NCT00905515|Cyclosporins|cyclosporins|mesh-list
92210061|NCT00905515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210062|NCT00905515|Immunologic Factors|immunologic factors|mesh-ancestor
92210063|NCT00905515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210064|NCT00905515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92210065|NCT00905515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210066|NCT00905515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210067|NCT00905515|Antifungal Agents|antifungal agents|mesh-ancestor
92210068|NCT00905515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210069|NCT00905515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210070|NCT00905515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210071|NCT03215797|Phenylephrine|phenylephrine|mesh-list
92210072|NCT03215797|Oxymetazoline|oxymetazoline|mesh-list
92210073|NCT03215797|Norepinephrine|norepinephrine|mesh-list
92210074|NCT03215797|Adrenergic Agonists|adrenergic agonists|mesh-list
92210075|NCT03215797|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92210076|NCT03215797|Mydriatics|mydriatics|mesh-ancestor
92210077|NCT03215797|Autonomic Agents|autonomic agents|mesh-ancestor
92210078|NCT03215797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210079|NCT03215797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210080|NCT03215797|Sympathomimetics|sympathomimetics|mesh-ancestor
92210081|NCT03215797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92210082|NCT03215797|Nasal Decongestants|nasal decongestants|mesh-ancestor
92210083|NCT03215797|Respiratory System Agents|respiratory system agents|mesh-ancestor
92210084|NCT03215797|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92210085|NCT03215797|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92210086|NCT03215797|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210087|NCT03215797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210088|NCT03215797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210089|NCT03215797|Protective Agents|protective agents|mesh-ancestor
92210090|NCT02485834|Docetaxel|docetaxel|mesh-list
92210091|NCT02485834|Capecitabine|capecitabine|mesh-list
92210092|NCT02485834|Irinotecan|irinotecan|mesh-list
92210093|NCT02485834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210094|NCT02485834|Tubulin Modulators|tubulin modulators|mesh-ancestor
92210095|NCT02485834|Antimitotic Agents|antimitotic agents|mesh-ancestor
92210096|NCT02485834|Mitosis Modulators|mitosis modulators|mesh-ancestor
92210097|NCT02485834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210098|NCT02485834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92210099|NCT02485834|Antimetabolites|antimetabolites|mesh-ancestor
92210100|NCT02485834|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92210101|NCT02485834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92210102|NCT02485834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210103|NCT01834885|Fluticasone|fluticasone|mesh-list
92210104|NCT01834885|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92210105|NCT01834885|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92210106|NCT01834885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210107|NCT01834885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92210108|NCT01834885|Autonomic Agents|autonomic agents|mesh-ancestor
92210109|NCT01834885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210110|NCT01834885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210111|NCT01834885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92210112|NCT01834885|Respiratory System Agents|respiratory system agents|mesh-ancestor
92210113|NCT01834885|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210114|NCT01834885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92210115|NCT01834885|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92210116|NCT01834885|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92210117|NCT01834885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92210118|NCT01834885|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210119|NCT01834885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210120|NCT01834885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210122|NCT01834885|Hormones|hormones|mesh-ancestor
92210123|NCT01834885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210124|NCT01834885|Sympathomimetics|sympathomimetics|mesh-ancestor
92210125|NCT01834963|Interferons|interferons|mesh-list
92210126|NCT01834963|Interferon-alpha|interferon-alpha|mesh-list
92210127|NCT01834963|Cisplatin|cisplatin|mesh-list
92210128|NCT01834963|Fluorouracil|fluorouracil|mesh-list
92210129|NCT01834963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210130|NCT01834963|Antimetabolites|antimetabolites|mesh-ancestor
92210131|NCT01834963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210132|NCT01834963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92210133|NCT01834963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210134|NCT01834963|Immunologic Factors|immunologic factors|mesh-ancestor
92210135|NCT01834963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210136|NCT01834963|Antiviral Agents|antiviral agents|mesh-ancestor
92210137|NCT01834963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210138|NCT04380103|Bevacizumab|bevacizumab|mesh-list
92210139|NCT04380103|Capecitabine|capecitabine|mesh-list
92210140|NCT04380103|Oxaliplatin|oxaliplatin|mesh-list
92210142|NCT04380103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92210143|NCT04380103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210144|NCT04380103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92210145|NCT04380103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92210146|NCT04380103|Growth Substances|growth substances|mesh-ancestor
92210147|NCT04380103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210148|NCT04380103|Growth Inhibitors|growth inhibitors|mesh-ancestor
92210149|NCT04380103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92210150|NCT04380103|Antimetabolites|antimetabolites|mesh-ancestor
92210151|NCT04380103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210152|NCT04380103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92210153|NCT04380103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92210154|NCT04380103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210155|NCT01954966|Progesterone|progesterone|mesh-list
92210156|NCT01954966|Progestins|progestins|mesh-ancestor
92210157|NCT01954966|Hormones|hormones|mesh-ancestor
92210158|NCT01954966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210160|NCT01835353|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92210161|NCT01835353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210162|NCT03836599|Allopurinol|allopurinol|mesh-list
92210163|NCT03836599|Verinurad|verinurad|mesh-list
92210164|NCT03836599|Antimetabolites|antimetabolites|mesh-ancestor
92210165|NCT03836599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210166|NCT03836599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210167|NCT03836599|Gout Suppressants|gout suppressants|mesh-ancestor
92210168|NCT03836599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210169|NCT03836599|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92210170|NCT03836599|Antioxidants|antioxidants|mesh-ancestor
92210171|NCT03836599|Protective Agents|protective agents|mesh-ancestor
92210172|NCT03836599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210173|NCT01839097|Prednisone|prednisone|mesh-list
92210174|NCT01839097|Cyclophosphamide|cyclophosphamide|mesh-list
92210175|NCT01839097|Doxorubicin|doxorubicin|mesh-list
92210176|NCT01839097|Vincristine|vincristine|mesh-list
92210177|NCT01839097|Belinostat|belinostat|mesh-list
92210178|NCT01839097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210179|NCT01839097|Immunologic Factors|immunologic factors|mesh-ancestor
92210180|NCT01839097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210181|NCT01839097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210182|NCT01839097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92210183|NCT01839097|Alkylating Agents|alkylating agents|mesh-ancestor
92210184|NCT01839097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210185|NCT01839097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210186|NCT01839097|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92210187|NCT01839097|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92210188|NCT01839097|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92210189|NCT01839097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92210190|NCT01839097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210191|NCT01839097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210192|NCT01839097|Glucocorticoids|glucocorticoids|mesh-ancestor
92210193|NCT01839097|Hormones|hormones|mesh-ancestor
92210194|NCT01839097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210195|NCT01839097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92210196|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92210197|NCT01839097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92210198|NCT01839097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92210199|NCT01839097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92210200|NCT01839097|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92210201|NCT01835665|Nimodipine|nimodipine|mesh-list
92210202|NCT01835665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210203|NCT01835665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92210204|NCT01835665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92210205|NCT01835665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210206|NCT01835665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92210207|NCT01835665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210208|NCT01835665|Vasodilator Agents|vasodilator agents|mesh-ancestor
92210209|NCT01839175|Vaccines|vaccines|mesh-list
92210210|NCT01839175|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92210211|NCT01839175|Immunologic Factors|immunologic factors|mesh-ancestor
92336529|NCT01989156|Menthol|menthol|mesh-list
92210212|NCT01839175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210214|NCT01839253|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92210215|NCT01839253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92210216|NCT01839253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210217|NCT01839253|Sympatholytics|sympatholytics|mesh-ancestor
92210218|NCT01839253|Autonomic Agents|autonomic agents|mesh-ancestor
92210219|NCT01839253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210220|NCT01839253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210221|NCT01839253|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92210222|NCT01839253|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92210223|NCT01839253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92210224|NCT01839253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210225|NCT01839253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210226|NCT01839253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210227|NCT01839253|Protease Inhibitors|protease inhibitors|mesh-ancestor
92210228|NCT01839253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210229|NCT01836289|Cyclophosphamide|cyclophosphamide|mesh-list
92210230|NCT01836289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210231|NCT01836289|Immunologic Factors|immunologic factors|mesh-ancestor
92210232|NCT01836289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210233|NCT01836289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210234|NCT01836289|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92210235|NCT01836289|Alkylating Agents|alkylating agents|mesh-ancestor
92210236|NCT01836289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210237|NCT01836289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210238|NCT01836289|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92210239|NCT01839643|Meloxicam|meloxicam|mesh-list
92210240|NCT01839643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92210241|NCT01839643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92210242|NCT01839643|Analgesics|analgesics|mesh-ancestor
92210243|NCT01839643|Sensory System Agents|sensory system agents|mesh-ancestor
92210244|NCT01839643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210245|NCT01839643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210246|NCT01839643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210247|NCT01839643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210248|NCT01839643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92210249|NCT01839643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92210250|NCT01839643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210251|NCT01839643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210252|NCT04380025|Pycnogenols|pycnogenols|mesh-list
92210253|NCT04380025|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92210254|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
92210255|NCT04380025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210257|NCT04380025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210258|NCT04380025|Protective Agents|protective agents|mesh-ancestor
92210259|NCT04380025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210260|NCT01836679|Paclitaxel|paclitaxel|mesh-list
92210261|NCT01836679|Carboplatin|carboplatin|mesh-list
92210262|NCT01836679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92210263|NCT01836679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210264|NCT01836679|Tubulin Modulators|tubulin modulators|mesh-ancestor
92210265|NCT01836679|Antimitotic Agents|antimitotic agents|mesh-ancestor
92210266|NCT01836679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92210267|NCT01836679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210268|NCT00369538|Losartan|losartan|mesh-list
92210269|NCT00369538|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92210270|NCT00369538|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92210271|NCT00369538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210272|NCT00369538|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92210273|NCT00369538|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92210274|NCT00369538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210275|NCT00369538|Diuretics|diuretics|mesh-ancestor
92210276|NCT00369538|Natriuretic Agents|natriuretic agents|mesh-ancestor
92210277|NCT00369538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210278|NCT00369538|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92210279|NCT00369538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92210280|NCT02489734|Sevoflurane|sevoflurane|mesh-list
92210281|NCT02489734|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210283|NCT02489734|Anesthetics, General|anesthetics, general|mesh-ancestor
92210284|NCT02489734|Anesthetics|anesthetics|mesh-ancestor
92210285|NCT02489734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210286|NCT02489734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210287|NCT02490670|Cephalexin|cephalexin|mesh-list
92210288|NCT02490670|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92210289|NCT02490670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210290|NCT01836757|Dimethyl sulfone|dimethyl sulfone|mesh-list
92210291|NCT01836757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210292|NCT05451472|Calcium|calcium|mesh-list
92210293|NCT05451472|Parathyroid Hormone|parathyroid hormone|mesh-list
92210294|NCT05451472|Hormones|hormones|mesh-list
92210295|NCT05451472|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92210296|NCT05451472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210297|NCT05451472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210298|NCT03218059|Methotrexate|methotrexate|mesh-list
92210299|NCT03218059|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92210300|NCT03218059|Abortifacient Agents|abortifacient agents|mesh-ancestor
92210301|NCT03218059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92210302|NCT03218059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210303|NCT03218059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92210304|NCT03218059|Antimetabolites|antimetabolites|mesh-ancestor
92210305|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210306|NCT03218059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210307|NCT03218059|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210308|NCT03218059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210309|NCT03218059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92210310|NCT03218059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210311|NCT03218059|Immunologic Factors|immunologic factors|mesh-ancestor
92210312|NCT03218059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210313|NCT03218059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92210314|NCT01839955|Quinacrine|quinacrine|mesh-list
92210315|NCT01839955|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92210316|NCT01839955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210317|NCT01839955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92210318|NCT01839955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210319|NCT01839955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210320|NCT01839955|Anticestodal Agents|anticestodal agents|mesh-ancestor
92210321|NCT01839955|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92210322|NCT01839955|Anthelmintics|anthelmintics|mesh-ancestor
92210323|NCT01839955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92210324|NCT01839955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210325|NCT01839955|Antimalarials|antimalarials|mesh-ancestor
92210326|NCT01839955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92210327|NCT01839955|Antinematodal Agents|antinematodal agents|mesh-ancestor
92210329|NCT02494102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92210330|NCT02494102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210331|NCT02494102|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92210332|NCT02494102|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92210333|NCT02494102|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92210334|NCT02494102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210335|NCT00894517|Botulinum Toxins|botulinum toxins|mesh-list
92210336|NCT00894517|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92210337|NCT00894517|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92210338|NCT00894517|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92210339|NCT00894517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92210340|NCT00894517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210341|NCT00894517|Cholinergic Agents|cholinergic agents|mesh-ancestor
92210342|NCT00894517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210343|NCT00894517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210345|NCT00894517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210346|NCT01838395|Cytarabine|cytarabine|mesh-list
92210347|NCT01838395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92210348|NCT01838395|Antimetabolites|antimetabolites|mesh-ancestor
92210349|NCT01838395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210350|NCT01838395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210351|NCT01838395|Antiviral Agents|antiviral agents|mesh-ancestor
92210352|NCT01838395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210353|NCT01838395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210354|NCT01838395|Immunologic Factors|immunologic factors|mesh-ancestor
92210355|NCT01838395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210356|NCT00422578|Tadalafil|tadalafil|mesh-list
92210357|NCT00422578|Vasodilator Agents|vasodilator agents|mesh-ancestor
92210358|NCT00422578|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92210359|NCT00422578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92210360|NCT00422578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210361|NCT00422578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210362|NCT00422578|Urological Agents|urological agents|mesh-ancestor
92210363|NCT02494180|Fentanyl|fentanyl|mesh-list
92210364|NCT02494180|Midazolam|midazolam|mesh-list
92210365|NCT02494180|Diazepam|diazepam|mesh-list
92210366|NCT02494180|Meperidine|meperidine|mesh-list
92210367|NCT02494180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92210368|NCT02494180|Narcotics|narcotics|mesh-ancestor
92210369|NCT02494180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210370|NCT02494180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210371|NCT02494180|Analgesics|analgesics|mesh-ancestor
92210372|NCT02494180|Sensory System Agents|sensory system agents|mesh-ancestor
92210373|NCT02494180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210374|NCT02494180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92210375|NCT02494180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92210376|NCT02494180|Anesthetics, General|anesthetics, general|mesh-ancestor
92210377|NCT02494180|Anesthetics|anesthetics|mesh-ancestor
92210378|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92210379|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92210380|NCT02494180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92210381|NCT02494180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92210382|NCT02494180|GABA Modulators|gaba modulators|mesh-ancestor
92210383|NCT02494180|GABA Agents|gaba agents|mesh-ancestor
92210384|NCT02494180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210385|NCT02494180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210386|NCT02494180|Anticonvulsants|anticonvulsants|mesh-ancestor
92210387|NCT02494180|Antiemetics|antiemetics|mesh-ancestor
92210388|NCT02494180|Autonomic Agents|autonomic agents|mesh-ancestor
92210389|NCT02494180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210390|NCT02494180|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92210391|NCT02494180|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92210392|NCT02494336|Ropivacaine|ropivacaine|mesh-list
92210393|NCT02494336|Anesthetics, Local|anesthetics, local|mesh-ancestor
92210394|NCT02494336|Anesthetics|anesthetics|mesh-ancestor
92210395|NCT02494336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210396|NCT02494336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210397|NCT02494336|Sensory System Agents|sensory system agents|mesh-ancestor
92210398|NCT02494336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210399|NCT02495038|Rocuronium|rocuronium|mesh-list
92210400|NCT02495038|Atracurium|atracurium|mesh-list
92210401|NCT02495038|Cisatracurium|cisatracurium|mesh-list
92210402|NCT02495038|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92210403|NCT02495038|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92210404|NCT02495038|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92210405|NCT02495038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210406|NCT02495038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210407|NCT02495038|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92210408|NCT02495038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92210409|NCT02495038|Cholinergic Agents|cholinergic agents|mesh-ancestor
92210410|NCT02495038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210411|NCT02495038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210412|NCT04956484|Belimumab|belimumab|mesh-list
92210413|NCT04956484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210414|NCT04956484|Immunologic Factors|immunologic factors|mesh-ancestor
92210415|NCT04956484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210416|NCT05450458|Sorbitol|sorbitol|mesh-list
92210417|NCT05450458|Hyaluronic Acid|hyaluronic acid|mesh-list
92210418|NCT05450458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92210419|NCT05450458|Immunologic Factors|immunologic factors|mesh-ancestor
92210420|NCT05450458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210421|NCT05450458|Viscosupplements|viscosupplements|mesh-ancestor
92210422|NCT05450458|Protective Agents|protective agents|mesh-ancestor
92210423|NCT05450458|Cathartics|cathartics|mesh-ancestor
92210424|NCT05450458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210425|NCT01720615|Remifentanil|remifentanil|mesh-list
92210426|NCT01720615|Propofol|propofol|mesh-list
92210427|NCT01720615|Sevoflurane|sevoflurane|mesh-list
92210428|NCT01720615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92210429|NCT01720615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210430|NCT01720615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210431|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92210432|NCT01720615|Anesthetics, General|anesthetics, general|mesh-ancestor
92210433|NCT01720615|Anesthetics|anesthetics|mesh-ancestor
92210434|NCT01720615|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210435|NCT01720615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92210436|NCT01720615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92210437|NCT01720615|Narcotics|narcotics|mesh-ancestor
92210438|NCT01720615|Analgesics|analgesics|mesh-ancestor
92210439|NCT01720615|Sensory System Agents|sensory system agents|mesh-ancestor
92210440|NCT01720615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210441|NCT01837927|Glycopyrrolate|glycopyrrolate|mesh-list
92210442|NCT01837927|Tiotropium Bromide|tiotropium bromide|mesh-list
92210443|NCT01837927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92210444|NCT01837927|Autonomic Agents|autonomic agents|mesh-ancestor
92210445|NCT01837927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210446|NCT01837927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210447|NCT01837927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92210448|NCT01837927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92210449|NCT01837927|Parasympatholytics|parasympatholytics|mesh-ancestor
92210450|NCT01837927|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92210451|NCT01837927|Cholinergic Agents|cholinergic agents|mesh-ancestor
92210452|NCT01837927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210453|NCT01837927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210454|NCT01837927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92210455|NCT01837927|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92210456|NCT01838083|Insulin Glargine|insulin glargine|mesh-list
92210457|NCT01838083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92210458|NCT01838083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210459|NCT02504554|Vancomycin|vancomycin|mesh-list
92210460|NCT02504554|Omeprazole|omeprazole|mesh-list
92210461|NCT02504554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92210462|NCT02504554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210463|NCT02504554|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92210464|NCT02504554|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210465|NCT02504554|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92210466|NCT02504554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210467|NCT02504554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210468|NCT01838473|Lobeline|lobeline|mesh-list
92210469|NCT01838473|Nicotine|nicotine|mesh-list
92210470|NCT01838473|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92210471|NCT01838473|Autonomic Agents|autonomic agents|mesh-ancestor
92210472|NCT01838473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210473|NCT01838473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210474|NCT01838473|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92210475|NCT01838473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92210476|NCT01838473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92210477|NCT01838473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210478|NCT01838473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210479|NCT01838473|Respiratory System Agents|respiratory system agents|mesh-ancestor
92210480|NCT04937452|Rotigotine|rotigotine|mesh-list
92210481|NCT04937452|Dopamine Agonists|dopamine agonists|mesh-ancestor
92210482|NCT04937452|Dopamine Agents|dopamine agents|mesh-ancestor
92210483|NCT04937452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210484|NCT04937452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210485|NCT04937452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210486|NCT01838707|Fentanyl|fentanyl|mesh-list
92210487|NCT01838707|Morphine|morphine|mesh-list
92210488|NCT01838707|Bupivacaine|bupivacaine|mesh-list
92210489|NCT01838707|Anesthetics, Local|anesthetics, local|mesh-ancestor
92210490|NCT01838707|Anesthetics|anesthetics|mesh-ancestor
92210491|NCT01838707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210492|NCT01838707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210493|NCT01838707|Sensory System Agents|sensory system agents|mesh-ancestor
92336550|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
92210494|NCT01838707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210495|NCT01838707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92210496|NCT01838707|Narcotics|narcotics|mesh-ancestor
92210497|NCT01838707|Analgesics|analgesics|mesh-ancestor
92210498|NCT01838707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92210499|NCT01838707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92210500|NCT01838707|Anesthetics, General|anesthetics, general|mesh-ancestor
92210501|NCT02506114|Ipilimumab|ipilimumab|mesh-list
92210502|NCT02506114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92210503|NCT02506114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210504|NCT02506114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92210505|NCT02506114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210506|NCT05449366|Paclitaxel|paclitaxel|mesh-list
92210507|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92210508|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92210509|NCT05449366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210510|NCT05449366|Tubulin Modulators|tubulin modulators|mesh-ancestor
92210511|NCT05449366|Antimitotic Agents|antimitotic agents|mesh-ancestor
92210512|NCT05449366|Mitosis Modulators|mitosis modulators|mesh-ancestor
92210513|NCT05449366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210514|NCT04920994|Bupivacaine|bupivacaine|mesh-list
92210515|NCT04920994|Anesthetics, Local|anesthetics, local|mesh-ancestor
92210516|NCT04920994|Anesthetics|anesthetics|mesh-ancestor
92210517|NCT04920994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210518|NCT04920994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210519|NCT04920994|Sensory System Agents|sensory system agents|mesh-ancestor
92210520|NCT04920994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210521|NCT02506660|Dexamethasone|dexamethasone|mesh-list
92210522|NCT02506660|Dexamethasone acetate|dexamethasone acetate|mesh-list
92210523|NCT02506660|Bupivacaine|bupivacaine|mesh-list
92210524|NCT02506660|BB 1101|bb 1101|mesh-list
92210525|NCT02506660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210526|NCT02506660|Antiemetics|antiemetics|mesh-ancestor
92210527|NCT02506660|Autonomic Agents|autonomic agents|mesh-ancestor
92210528|NCT02506660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210529|NCT02506660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210530|NCT02506660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210532|NCT02506660|Hormones|hormones|mesh-ancestor
92210533|NCT02506660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210534|NCT02506660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92210535|NCT02506660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210536|NCT02506660|Protease Inhibitors|protease inhibitors|mesh-ancestor
92210537|NCT02506660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210538|NCT02506660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210539|NCT02506660|Anesthetics, Local|anesthetics, local|mesh-ancestor
92210540|NCT02506660|Anesthetics|anesthetics|mesh-ancestor
92210541|NCT02506660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210542|NCT02506660|Sensory System Agents|sensory system agents|mesh-ancestor
92210543|NCT02509624|Selonsertib|selonsertib|mesh-list
92210544|NCT02509624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92210545|NCT02509624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210546|NCT02509624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210547|NCT01726075|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92210548|NCT01726075|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92210549|NCT01726075|Somatostatin|somatostatin|mesh-list
92210550|NCT01726075|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92210551|NCT01726075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210552|NCT01726075|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92210553|NCT01726075|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92210554|NCT01726075|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92210555|NCT01726075|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210556|NCT01726075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210557|NCT01726075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210558|NCT01726075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210559|NCT01726075|Hormones|hormones|mesh-ancestor
92210560|NCT01726075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210561|NCT00369694|Terlipressin|terlipressin|mesh-list
92210562|NCT00369694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210563|NCT00369694|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92210564|NCT01721707|Latanoprost|latanoprost|mesh-list
92210565|NCT01721707|Brinzolamide|brinzolamide|mesh-list
92210566|NCT01721707|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92210567|NCT01721707|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92210568|NCT01721707|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92210569|NCT01721707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210570|NCT01721707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210571|NCT05448586|Analgesics, Opioid|analgesics, opioid|mesh-list
92210572|NCT05448586|Narcotics|narcotics|mesh-ancestor
92210573|NCT05448586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210574|NCT05448586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210575|NCT05448586|Analgesics|analgesics|mesh-ancestor
92210576|NCT05448586|Sensory System Agents|sensory system agents|mesh-ancestor
92210577|NCT05448586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210578|NCT01726465|Acetylcysteine|acetylcysteine|mesh-list
92210579|NCT01726465|Methylprednisolone|methylprednisolone|mesh-list
92210580|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92210581|NCT01726465|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92210582|NCT01726465|Prednisolone|prednisolone|mesh-list
92210583|NCT01726465|Prednisolone acetate|prednisolone acetate|mesh-list
92210584|NCT01726465|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92210585|NCT01726465|Prednisolone phosphate|prednisolone phosphate|mesh-list
92210586|NCT01726465|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92210587|NCT01726465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210588|NCT01726465|Antiemetics|antiemetics|mesh-ancestor
92210589|NCT01726465|Autonomic Agents|autonomic agents|mesh-ancestor
92210590|NCT01726465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210591|NCT01726465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210592|NCT01726465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210593|NCT01726465|Glucocorticoids|glucocorticoids|mesh-ancestor
92210594|NCT01726465|Hormones|hormones|mesh-ancestor
92210595|NCT01726465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210596|NCT01726465|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92210597|NCT01726465|Protective Agents|protective agents|mesh-ancestor
92210598|NCT01726465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92210599|NCT01726465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210600|NCT01726465|Antiviral Agents|antiviral agents|mesh-ancestor
92210601|NCT01726465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210602|NCT01726465|Expectorants|expectorants|mesh-ancestor
92210603|NCT01726465|Respiratory System Agents|respiratory system agents|mesh-ancestor
92210604|NCT01726465|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92210605|NCT01726465|Antioxidants|antioxidants|mesh-ancestor
92210606|NCT01726465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210607|NCT01726465|Antidotes|antidotes|mesh-ancestor
92210608|NCT01720303|Insulin|insulin|mesh-list
92210609|NCT01720303|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92210610|NCT01720303|Repaglinide|repaglinide|mesh-list
92210611|NCT01720303|Isophane Insulin, Human|isophane insulin, human|mesh-list
92210612|NCT01720303|Insulin, Isophane|insulin, isophane|mesh-list
92210613|NCT01720303|Isophane insulin, beef|isophane insulin, beef|mesh-list
92210614|NCT01720303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92210615|NCT01720303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210616|NCT02733042|Rituximab|rituximab|mesh-list
92210617|NCT02733042|Durvalumab|durvalumab|mesh-list
92210618|NCT02733042|Lenalidomide|lenalidomide|mesh-list
92210619|NCT02733042|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92210620|NCT02733042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92210621|NCT02733042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210622|NCT02733042|Immunologic Factors|immunologic factors|mesh-ancestor
92210623|NCT02733042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210624|NCT02733042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210625|NCT02733042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92210626|NCT02733042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92210627|NCT02733042|Growth Substances|growth substances|mesh-ancestor
92210628|NCT02733042|Growth Inhibitors|growth inhibitors|mesh-ancestor
92210629|NCT02733042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92210630|NCT02733042|Alkylating Agents|alkylating agents|mesh-ancestor
92210631|NCT02733042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210632|NCT00912301|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92210633|NCT00912301|Cathartics|cathartics|mesh-ancestor
92210634|NCT00912301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210636|NCT04850638|Diuretics|diuretics|mesh-ancestor
92210637|NCT04850638|Natriuretic Agents|natriuretic agents|mesh-ancestor
92210638|NCT04850638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210639|NCT04850638|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92210640|NCT04850638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92210641|NCT04850638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210642|NCT01726777|Vitamin D|vitamin d|mesh-list
92210643|NCT01726777|Ergocalciferols|ergocalciferols|mesh-list
92210644|NCT01726777|Cholecalciferol|cholecalciferol|mesh-list
92210645|NCT01726777|Vitamins|vitamins|mesh-list
92210646|NCT01726777|Micronutrients|micronutrients|mesh-ancestor
92210647|NCT01726777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210648|NCT01726777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92210649|NCT01726777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92210650|NCT05532306|Ribavirin|ribavirin|mesh-list
92210651|NCT05532306|Antimetabolites|antimetabolites|mesh-ancestor
92210652|NCT05532306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210653|NCT05532306|Antiviral Agents|antiviral agents|mesh-ancestor
92210654|NCT05532306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210655|NCT05602038|Morphine|morphine|mesh-list
92210656|NCT05602038|Bupivacaine|bupivacaine|mesh-list
92210657|NCT05602038|Anesthetics, Local|anesthetics, local|mesh-ancestor
92210658|NCT05602038|Anesthetics|anesthetics|mesh-ancestor
92210659|NCT05602038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210660|NCT05602038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210661|NCT05602038|Sensory System Agents|sensory system agents|mesh-ancestor
92210662|NCT05602038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210663|NCT05602038|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92210664|NCT05602038|Narcotics|narcotics|mesh-ancestor
92210665|NCT05602038|Analgesics|analgesics|mesh-ancestor
92210666|NCT01722409|Dexmedetomidine|dexmedetomidine|mesh-list
92210667|NCT01722409|Sevoflurane|sevoflurane|mesh-list
92210668|NCT01722409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92210669|NCT01722409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210670|NCT01722409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210671|NCT01722409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92210672|NCT01722409|Analgesics|analgesics|mesh-ancestor
92210673|NCT01722409|Sensory System Agents|sensory system agents|mesh-ancestor
92210674|NCT01722409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210675|NCT01722409|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92210676|NCT01722409|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92210677|NCT01722409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92210678|NCT01722409|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210679|NCT01722409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210680|NCT01722409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210681|NCT01722409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210682|NCT01722409|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92210683|NCT01722409|Anesthetics, General|anesthetics, general|mesh-ancestor
92210684|NCT01722409|Anesthetics|anesthetics|mesh-ancestor
92210685|NCT04307238|Anesthetics|anesthetics|mesh-list
92210686|NCT04307238|Propofol|propofol|mesh-list
92210687|NCT04307238|Sevoflurane|sevoflurane|mesh-list
92210688|NCT04307238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210689|NCT04307238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210690|NCT04307238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92210691|NCT04307238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92210692|NCT04307238|Anesthetics, General|anesthetics, general|mesh-ancestor
92210693|NCT04307238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210694|NCT04307238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92210695|NCT01726933|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92210696|NCT01726933|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210697|NCT01726933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210698|NCT01726933|Immunologic Factors|immunologic factors|mesh-ancestor
92210699|NCT01726933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210700|NCT01727401|PENTA|penta|mesh-list
92210701|NCT01727401|Fondaparinux|fondaparinux|mesh-list
92210702|NCT01727401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92210703|NCT01727401|Antithrombins|antithrombins|mesh-ancestor
92336571|NCT01946412|Ivacaftor|ivacaftor|mesh-list
92210704|NCT01727401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92210705|NCT01727401|Protease Inhibitors|protease inhibitors|mesh-ancestor
92210706|NCT01727401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210707|NCT01727401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210708|NCT01727401|Anticoagulants|anticoagulants|mesh-ancestor
92210709|NCT01727401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92210710|NCT01727401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92210711|NCT02513212|Fluorides|fluorides|mesh-list
92210712|NCT02513212|Tin Fluorides|tin fluorides|mesh-list
92210713|NCT02513212|Cariostatic Agents|cariostatic agents|mesh-ancestor
92210714|NCT02513212|Protective Agents|protective agents|mesh-ancestor
92210715|NCT02513212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210716|NCT02513446|Itraconazole|itraconazole|mesh-list
92210717|NCT02513446|Antifungal Agents|antifungal agents|mesh-ancestor
92210718|NCT02513446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210719|NCT02513446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92210720|NCT02513446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92210721|NCT02513446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210722|NCT02513446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210723|NCT02513446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92210724|NCT02513446|Hormone Antagonists|hormone antagonists|mesh-ancestor
92210725|NCT02513446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210726|NCT02513446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210727|NCT02513446|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92210728|NCT00363844|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92210729|NCT00363844|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92210730|NCT00363844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210731|NCT00363844|Incretins|incretins|mesh-ancestor
92210732|NCT00363844|Hormones|hormones|mesh-ancestor
92210733|NCT00363844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210734|NCT00363844|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92210735|NCT00363844|Protease Inhibitors|protease inhibitors|mesh-ancestor
92210736|NCT00363844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210737|NCT00363844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210738|NCT04687800|Dexamethasone|dexamethasone|mesh-list
92210739|NCT04687800|Difluprednate|difluprednate|mesh-list
92210740|NCT04687800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210741|NCT04687800|Antiemetics|antiemetics|mesh-ancestor
92210742|NCT04687800|Autonomic Agents|autonomic agents|mesh-ancestor
92210743|NCT04687800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210744|NCT04687800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210745|NCT04687800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210746|NCT04687800|Glucocorticoids|glucocorticoids|mesh-ancestor
92210747|NCT04687800|Hormones|hormones|mesh-ancestor
92210748|NCT04687800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934197|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92210749|NCT04687800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92210750|NCT04687800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210752|NCT00864383|Rifampin|rifampin|mesh-list
92210753|NCT00864383|Isoniazid|isoniazid|mesh-list
92210754|NCT00864383|Pyrazinamide|pyrazinamide|mesh-list
92210755|NCT00864383|Ethambutol|ethambutol|mesh-list
92210756|NCT00864383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92210757|NCT00864383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210758|NCT00864383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92210759|NCT00864383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92210760|NCT00864383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210761|NCT00864383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210762|NCT00864383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210763|NCT00864383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92210764|NCT00864383|Antitubercular Agents|antitubercular agents|mesh-ancestor
92210765|NCT00864383|Leprostatic Agents|leprostatic agents|mesh-ancestor
92210766|NCT00864383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92210767|NCT00864383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92210768|NCT00864383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92210769|NCT00864383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92210770|NCT00864383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92210771|NCT00864383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92210772|NCT00864383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92210773|NCT00864383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92210774|NCT00864383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92210775|NCT00864383|Antimetabolites|antimetabolites|mesh-ancestor
92210776|NCT00864383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92210777|NCT05532072|Sirolimus|sirolimus|mesh-list
92210778|NCT05532072|Methylprednisolone|methylprednisolone|mesh-list
92210779|NCT05532072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92210780|NCT05532072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92210781|NCT05532072|Prednisolone|prednisolone|mesh-list
92210782|NCT05532072|Prednisolone acetate|prednisolone acetate|mesh-list
92210783|NCT05532072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92210784|NCT05532072|Prednisolone phosphate|prednisolone phosphate|mesh-list
92210785|NCT05532072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92210786|NCT05532072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210787|NCT05532072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92210788|NCT05532072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210789|NCT05532072|Antifungal Agents|antifungal agents|mesh-ancestor
92210790|NCT05532072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210791|NCT05532072|Immunologic Factors|immunologic factors|mesh-ancestor
92210792|NCT05532072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210793|NCT05532072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210794|NCT05532072|Antiemetics|antiemetics|mesh-ancestor
92210795|NCT05532072|Autonomic Agents|autonomic agents|mesh-ancestor
92210796|NCT05532072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210797|NCT05532072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92210798|NCT05532072|Glucocorticoids|glucocorticoids|mesh-ancestor
92210799|NCT05532072|Hormones|hormones|mesh-ancestor
92210800|NCT05532072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210801|NCT05532072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92210802|NCT05532072|Protective Agents|protective agents|mesh-ancestor
92210803|NCT05532072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92210804|NCT00864539|Vitamin D|vitamin d|mesh-list
92210805|NCT00864539|Calcium|calcium|mesh-list
92210806|NCT00864539|Vitamins|vitamins|mesh-ancestor
92210807|NCT00864539|Micronutrients|micronutrients|mesh-ancestor
92210808|NCT00864539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210809|NCT00864539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92210810|NCT00864539|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92210811|NCT00827255|Cyclosporine|cyclosporine|mesh-list
92210812|NCT00827255|Cyclosporins|cyclosporins|mesh-list
92210813|NCT00827255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210814|NCT00827255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210815|NCT00827255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210816|NCT00827255|Immunologic Factors|immunologic factors|mesh-ancestor
92210817|NCT00827255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210818|NCT00827255|Antifungal Agents|antifungal agents|mesh-ancestor
92210819|NCT00827255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210820|NCT00827255|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210821|NCT00827255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210822|NCT00827255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92210823|NCT04458610|Rituximab|rituximab|mesh-list
92210824|NCT04458610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92210825|NCT04458610|Zanubrutinib|zanubrutinib|mesh-list
92210826|NCT04458610|Antibodies|antibodies|mesh-list
92210827|NCT04458610|Immunoglobulins|immunoglobulins|mesh-list
92210828|NCT04458610|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92210829|NCT04458610|Immunologic Factors|immunologic factors|mesh-ancestor
92210830|NCT04458610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210831|NCT04458610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210832|NCT04458610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210833|NCT04458610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92210834|NCT04458610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210835|NCT04458610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210836|NCT02153489|Bromides|bromides|mesh-list
92210838|NCT04627012|Pembrolizumab|pembrolizumab|mesh-list
92210839|NCT04627012|Tislelizumab|tislelizumab|mesh-list
92210840|NCT04627012|Lenvatinib|lenvatinib|mesh-list
92210841|NCT04627012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92210842|NCT04627012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210843|NCT04627012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92210844|NCT04627012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210845|NCT04627012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92210846|NCT04627012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210847|NCT00866879|Sirolimus|sirolimus|mesh-list
92210848|NCT00866879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92210849|NCT00866879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92210850|NCT00866879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92210851|NCT00866879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210852|NCT00866879|Antifungal Agents|antifungal agents|mesh-ancestor
92210853|NCT00866879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210854|NCT00866879|Immunologic Factors|immunologic factors|mesh-ancestor
92210855|NCT00866879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210856|NCT02311920|Nivolumab|nivolumab|mesh-list
92210857|NCT02311920|Ipilimumab|ipilimumab|mesh-list
92210858|NCT02311920|Temozolomide|temozolomide|mesh-list
92210859|NCT02311920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92210860|NCT02311920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210861|NCT02311920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92210862|NCT02311920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210863|NCT02311920|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92210864|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
92210865|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
92210866|NCT02153723|(T,G)-A-L|(t,g)-a-l|mesh-list
92210867|NCT02153723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92210868|NCT02153723|Immunologic Factors|immunologic factors|mesh-ancestor
92210869|NCT02153723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210870|NCT02153723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92210871|NCT02153723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210872|NCT00828191|Progesterone|progesterone|mesh-list
92210873|NCT00828191|Progestins|progestins|mesh-ancestor
92210874|NCT00828191|Hormones|hormones|mesh-ancestor
92210875|NCT00828191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210876|NCT00828191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210877|NCT00867659|Cetrorelix|cetrorelix|mesh-list
92210878|NCT00867659|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92210879|NCT00867659|Fertility Agents|fertility agents|mesh-ancestor
92210880|NCT00867659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92210881|NCT00867659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210882|NCT00867659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92210883|NCT00867659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92210884|NCT05531058|Vaccines|vaccines|mesh-list
92210885|NCT05531058|Immunologic Factors|immunologic factors|mesh-ancestor
92210886|NCT05531058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210887|NCT00828347|Alfacalcidol|alfacalcidol|mesh-list
92210888|NCT00828347|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92210889|NCT00828347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92210890|NCT00828347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210891|NCT00828347|Vitamins|vitamins|mesh-ancestor
92210892|NCT00828347|Micronutrients|micronutrients|mesh-ancestor
92210893|NCT02939872|Aspirin|aspirin|mesh-list
92210894|NCT02939872|Clopidogrel|clopidogrel|mesh-list
92210895|NCT02939872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92210896|NCT02939872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92210897|NCT02939872|Analgesics|analgesics|mesh-ancestor
92210898|NCT02939872|Sensory System Agents|sensory system agents|mesh-ancestor
92210899|NCT02939872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210900|NCT02939872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210901|NCT02939872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210902|NCT02939872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210903|NCT02939872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92210904|NCT02939872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92210905|NCT02939872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210906|NCT02939872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92210907|NCT02939872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92210908|NCT02939872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210910|NCT02939872|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92210911|NCT02939872|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92210912|NCT02939872|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92210913|NCT02939872|Purinergic Agents|purinergic agents|mesh-ancestor
92210914|NCT02939872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210916|NCT00829049|Tazarotene|tazarotene|mesh-list
92210917|NCT00829049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92210918|NCT00829049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92210919|NCT00829049|Analgesics|analgesics|mesh-ancestor
92210920|NCT00829049|Sensory System Agents|sensory system agents|mesh-ancestor
92210921|NCT00829049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210922|NCT00829049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210923|NCT00829049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92210924|NCT00829049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92210925|NCT00829049|Dermatologic Agents|dermatologic agents|mesh-ancestor
92210926|NCT00829049|Keratolytic Agents|keratolytic agents|mesh-ancestor
92210927|NCT02859064|Lanreotide|lanreotide|mesh-list
92210928|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210929|NCT04303702|Oxytocin|oxytocin|mesh-list
92210930|NCT04303702|Oxytocics|oxytocics|mesh-ancestor
92210931|NCT04303702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92210932|NCT04303702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210933|NCT01727557|Anesthetics|anesthetics|mesh-list
92210934|NCT01727557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210935|NCT01727557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210936|NCT04529044|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92210937|NCT04529044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210938|NCT04529044|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92210939|NCT00913003|Lidocaine|lidocaine|mesh-list
92210940|NCT00913003|Anesthetics, Local|anesthetics, local|mesh-ancestor
92210941|NCT00913003|Anesthetics|anesthetics|mesh-ancestor
92210942|NCT00913003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92210943|NCT00913003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210944|NCT00913003|Sensory System Agents|sensory system agents|mesh-ancestor
92210945|NCT00913003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210946|NCT00913003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92210947|NCT00913003|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92210948|NCT00913003|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92210949|NCT00913003|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92210950|NCT00913003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210951|NCT00869141|Timolol|timolol|mesh-list
92210953|NCT00869141|Dorzolamide|dorzolamide|mesh-list
92210954|NCT00869141|Brinzolamide|brinzolamide|mesh-list
92210955|NCT00869141|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92210956|NCT00869141|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92210957|NCT00869141|Adrenergic Agents|adrenergic agents|mesh-ancestor
92210958|NCT00869141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92210959|NCT00869141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210960|NCT00869141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210961|NCT00869141|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92210962|NCT00869141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92210963|NCT00869141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92210964|NCT00869141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92210965|NCT00869141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92210966|NCT00869141|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92210967|NCT00869141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210968|NCT01722799|Paclitaxel|paclitaxel|mesh-list
92210969|NCT01722799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92210970|NCT01722799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210971|NCT01722799|Tubulin Modulators|tubulin modulators|mesh-ancestor
92210972|NCT01722799|Antimitotic Agents|antimitotic agents|mesh-ancestor
92210973|NCT01722799|Mitosis Modulators|mitosis modulators|mesh-ancestor
92210974|NCT01722799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210975|NCT04260022|Blinatumomab|blinatumomab|mesh-list
92210976|NCT04260022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210977|NCT01606176|Nabiximols|nabiximols|mesh-list
92210978|NCT01606176|Analgesics|analgesics|mesh-ancestor
92210979|NCT01606176|Sensory System Agents|sensory system agents|mesh-ancestor
92210980|NCT01606176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92210981|NCT01606176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210982|NCT00913081|Quercetin|quercetin|mesh-list
92210983|NCT00913081|Antioxidants|antioxidants|mesh-ancestor
92336592|NCT01986114|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92210984|NCT00913081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92210985|NCT00913081|Protective Agents|protective agents|mesh-ancestor
92210986|NCT00913081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210987|NCT04077424|Hemagglutinins|hemagglutinins|mesh-list
92210988|NCT04077424|Vaccines|vaccines|mesh-list
92210989|NCT04077424|Immunologic Factors|immunologic factors|mesh-ancestor
92210990|NCT04077424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92210991|NCT04077424|Agglutinins|agglutinins|mesh-ancestor
92210992|NCT04077424|Coagulants|coagulants|mesh-ancestor
92210993|NCT01727869|Cetuximab|cetuximab|mesh-list
92210994|NCT01727869|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92210995|NCT01727869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92210996|NCT01727869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92210997|NCT01727869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92210998|NCT01727869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92210999|NCT01727869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211000|NCT00371020|Heparin|heparin|mesh-list
92211001|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92211002|NCT00371020|Tinzaparin|tinzaparin|mesh-list
92211003|NCT00371020|Dalteparin|dalteparin|mesh-list
92211004|NCT00371020|Anticoagulants|anticoagulants|mesh-ancestor
92211005|NCT00371020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92211006|NCT00371020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92211007|NCT00371020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211008|NCT04476628|Budesonide|budesonide|mesh-list
92211009|NCT04476628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211010|NCT04476628|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92211011|NCT04476628|Autonomic Agents|autonomic agents|mesh-ancestor
92211012|NCT04476628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211013|NCT04476628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211014|NCT04476628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92211015|NCT04476628|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211016|NCT04476628|Glucocorticoids|glucocorticoids|mesh-ancestor
92211017|NCT04476628|Hormones|hormones|mesh-ancestor
92211018|NCT04476628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211019|NCT01728181|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92211020|NCT01728181|Tivozanib|tivozanib|mesh-list
92211021|NCT01728181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211022|NCT01728181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92211023|NCT01728181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211024|NCT01728181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211025|NCT04378231|Amoxicillin|amoxicillin|mesh-list
92211026|NCT04378231|Clavulanic Acid|clavulanic acid|mesh-list
92211027|NCT04378231|Clavulanic Acids|clavulanic acids|mesh-list
92211028|NCT04378231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92211029|NCT04378231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211030|NCT04378231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211031|NCT04378231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92211032|NCT04378231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921074|NCT04411706|Antimetabolites|antimetabolites|mesh-ancestor
92211033|NCT04378231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211034|NCT04475302|BCG Vaccine|bcg vaccine|mesh-list
92211035|NCT04475302|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211036|NCT04475302|Immunologic Factors|immunologic factors|mesh-ancestor
92211037|NCT04475302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211038|NCT01728571|Vitamin D|vitamin d|mesh-list
92211039|NCT01728571|Ergocalciferols|ergocalciferols|mesh-list
92211040|NCT01728571|Cholecalciferol|cholecalciferol|mesh-list
92211041|NCT01728571|Vitamins|vitamins|mesh-list
92211042|NCT01728571|Micronutrients|micronutrients|mesh-ancestor
92211043|NCT01728571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211044|NCT01728571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92211045|NCT01728571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92211046|NCT00832637|Gemcitabine|gemcitabine|mesh-list
92211047|NCT00832637|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92211048|NCT00832637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211049|NCT00832637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92211050|NCT00832637|Antimetabolites|antimetabolites|mesh-ancestor
92211051|NCT00832637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211052|NCT00832637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92211053|NCT00832637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211054|NCT03408457|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92211055|NCT03408457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211056|NCT00370240|Ropivacaine|ropivacaine|mesh-list
92211057|NCT00370240|Anesthetics, Local|anesthetics, local|mesh-ancestor
92211058|NCT00370240|Anesthetics|anesthetics|mesh-ancestor
92211059|NCT00370240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211060|NCT00370240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211061|NCT00370240|Sensory System Agents|sensory system agents|mesh-ancestor
92211062|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211063|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
92211064|NCT03408145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211065|NCT03408145|Immunologic Factors|immunologic factors|mesh-ancestor
92211066|NCT03408145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211067|NCT03408145|Viscosupplements|viscosupplements|mesh-ancestor
92211068|NCT03408145|Protective Agents|protective agents|mesh-ancestor
92211069|NCT02475772|Cisplatin|cisplatin|mesh-list
92211070|NCT02475772|Doxorubicin|doxorubicin|mesh-list
92211071|NCT02475772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92211072|NCT02475772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211073|NCT02475772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92211074|NCT02475772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92211075|NCT02475772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92211076|NCT02475772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211077|NCT02475772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211078|NCT00915655|Ritonavir|ritonavir|mesh-list
92211079|NCT00915655|Darunavir|darunavir|mesh-list
92211080|NCT00915655|Lamivudine|lamivudine|mesh-list
92211081|NCT00915655|Zidovudine|zidovudine|mesh-list
92211082|NCT00915655|Abacavir|abacavir|mesh-list
92211083|NCT00915655|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92211084|NCT00915655|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92211085|NCT00915655|Protease Inhibitors|protease inhibitors|mesh-ancestor
92211086|NCT00915655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211087|NCT00915655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211088|NCT00915655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92211089|NCT00915655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92211090|NCT00915655|Antiviral Agents|antiviral agents|mesh-ancestor
92211091|NCT00915655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211092|NCT00915655|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92211093|NCT00915655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92211094|NCT00915655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92211095|NCT00915655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92211096|NCT00915655|Antimetabolites|antimetabolites|mesh-ancestor
92211097|NCT03835507|Epoetin Alfa|epoetin alfa|mesh-list
92211098|NCT03835507|Hematinics|hematinics|mesh-ancestor
92211099|NCT05524974|Paclitaxel|paclitaxel|mesh-list
92211100|NCT05524974|Oxaliplatin|oxaliplatin|mesh-list
92211101|NCT05524974|Apatinib|apatinib|mesh-list
92211102|NCT05524974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92211103|NCT05524974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211104|NCT05524974|Tubulin Modulators|tubulin modulators|mesh-ancestor
92211105|NCT05524974|Antimitotic Agents|antimitotic agents|mesh-ancestor
92211106|NCT05524974|Mitosis Modulators|mitosis modulators|mesh-ancestor
92211107|NCT05524974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211108|NCT05524974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92211109|NCT05524974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211110|NCT00870467|Adalimumab|adalimumab|mesh-list
92211111|NCT00870467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92211112|NCT00870467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211113|NCT00870467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211114|NCT00370318|Acetaminophen|acetaminophen|mesh-list
92211115|NCT00370318|Vaccines|vaccines|mesh-list
92211116|NCT00370318|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92211117|NCT00370318|Immunologic Factors|immunologic factors|mesh-ancestor
92211118|NCT00370318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211119|NCT00370318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211120|NCT00370318|Analgesics|analgesics|mesh-ancestor
92211121|NCT00370318|Sensory System Agents|sensory system agents|mesh-ancestor
92211122|NCT00370318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211123|NCT00370318|Antipyretics|antipyretics|mesh-ancestor
92211124|NCT01728961|Lumefantrine|lumefantrine|mesh-list
92211126|NCT01728961|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92211127|NCT01728961|Antimalarials|antimalarials|mesh-ancestor
92211128|NCT01728961|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92211129|NCT01728961|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92211130|NCT01728961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211131|NCT01723501|Chlorhexidine|chlorhexidine|mesh-list
92211132|NCT01723501|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92211133|NCT01723501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211134|NCT01723501|Disinfectants|disinfectants|mesh-ancestor
92211135|NCT00872027|Escitalopram|escitalopram|mesh-list
92211136|NCT00872027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92211137|NCT00872027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92211138|NCT00872027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92211139|NCT00872027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211140|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211141|NCT00872027|Serotonin Agents|serotonin agents|mesh-ancestor
92211142|NCT00872027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211143|NCT01854814|Mycophenolic Acid|mycophenolic acid|mesh-list
92211144|NCT01854814|Losartan|losartan|mesh-list
92211145|NCT01854814|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92211146|NCT01854814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211147|NCT01854814|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92211148|NCT01854814|Antitubercular Agents|antitubercular agents|mesh-ancestor
92211149|NCT01854814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211150|NCT01854814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211151|NCT01854814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211152|NCT01854814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211153|NCT01854814|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92211154|NCT01854814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92211155|NCT01854814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92211156|NCT01854814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92211157|NCT01723657|Gemtuzumab|gemtuzumab|mesh-list
92211158|NCT01723657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211159|NCT01723657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211160|NCT01723657|Immunotoxins|immunotoxins|mesh-ancestor
92211161|NCT01723657|Immunoconjugates|immunoconjugates|mesh-ancestor
92211162|NCT01723657|Immunologic Factors|immunologic factors|mesh-ancestor
92211163|NCT01723657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211164|NCT02576652|Tetracycline|tetracycline|mesh-list
92211165|NCT02576652|Demeclocycline|demeclocycline|mesh-list
92211166|NCT02576652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211167|NCT02576652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211168|NCT02576652|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92211169|NCT02576652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211170|NCT02576652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211171|NCT01743742|Vitamins|vitamins|mesh-list
92211172|NCT01743742|Vitamin E|vitamin e|mesh-list
92211173|NCT01743742|Micronutrients|micronutrients|mesh-ancestor
92211174|NCT01743742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211175|NCT01743742|Antioxidants|antioxidants|mesh-ancestor
92211176|NCT01743742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211177|NCT01743742|Protective Agents|protective agents|mesh-ancestor
92211178|NCT01723735|Ezetimibe|ezetimibe|mesh-list
92211179|NCT01723735|Alirocumab|alirocumab|mesh-list
92211181|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92211182|NCT01723735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92211183|NCT01723735|Antimetabolites|antimetabolites|mesh-ancestor
92211184|NCT01723735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211185|NCT01723735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92211186|NCT01723735|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92211187|NCT01723735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92211188|NCT01723735|Protease Inhibitors|protease inhibitors|mesh-ancestor
92211189|NCT01723735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211191|NCT00872729|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92211192|NCT00872729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211193|NCT04640376|Acetaminophen|acetaminophen|mesh-list
92211194|NCT04640376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211195|NCT04640376|Analgesics|analgesics|mesh-ancestor
92211196|NCT04640376|Sensory System Agents|sensory system agents|mesh-ancestor
92211197|NCT04640376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211198|NCT04640376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211199|NCT04640376|Antipyretics|antipyretics|mesh-ancestor
92211200|NCT00832871|Mifepristone|mifepristone|mesh-list
92211201|NCT00832871|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92211202|NCT00832871|Abortifacient Agents|abortifacient agents|mesh-ancestor
92211203|NCT00832871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92211204|NCT00832871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211205|NCT00832871|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92211206|NCT00832871|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92211207|NCT00832871|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92211208|NCT00832871|Contraceptive Agents|contraceptive agents|mesh-ancestor
92211209|NCT00832871|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92211210|NCT00832871|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92211211|NCT00832871|Hormone Antagonists|hormone antagonists|mesh-ancestor
92211212|NCT00832871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211213|NCT00832871|Luteolytic Agents|luteolytic agents|mesh-ancestor
92211214|NCT00832871|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92211215|NCT00832871|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92211216|NCT05530200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92211217|NCT05530200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211218|NCT05530200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211219|NCT05530200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211220|NCT01729663|Interferons|interferons|mesh-list
92211221|NCT01729663|Interferon-alpha|interferon-alpha|mesh-list
92211222|NCT01729663|Interferon alpha-2|interferon alpha-2|mesh-list
92211223|NCT01729663|Molgramostim|molgramostim|mesh-list
92211224|NCT01729663|Sargramostim|sargramostim|mesh-list
92211225|NCT01729663|BCG Vaccine|bcg vaccine|mesh-list
92211226|NCT01729663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211227|NCT01729663|Antiviral Agents|antiviral agents|mesh-ancestor
92211228|NCT01729663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211229|NCT01729663|Immunologic Factors|immunologic factors|mesh-ancestor
92211230|NCT01729663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211231|NCT01729663|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211232|NCT05530122|Adalimumab|adalimumab|mesh-list
92211233|NCT05530122|Infliximab|infliximab|mesh-list
92211234|NCT05530122|Golimumab|golimumab|mesh-list
92211235|NCT05530122|Ustekinumab|ustekinumab|mesh-list
92211236|NCT05530122|Vedolizumab|vedolizumab|mesh-list
92211237|NCT05530122|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92211238|NCT05530122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211239|NCT05530122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211240|NCT05530122|Dermatologic Agents|dermatologic agents|mesh-ancestor
92211241|NCT05530122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92211242|NCT05530122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211243|NCT05530122|Immunologic Factors|immunologic factors|mesh-ancestor
92211244|NCT05530122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211245|NCT05208840|Ocrelizumab|ocrelizumab|mesh-list
92211246|NCT05208840|Immunologic Factors|immunologic factors|mesh-ancestor
92211247|NCT05208840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211248|NCT03407599|Insulin Aspart|insulin aspart|mesh-list
92211249|NCT03407599|Insulin, Long-Acting|insulin, long-acting|mesh-list
92211250|NCT03407599|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92211251|NCT03407599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92211252|NCT03407599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211253|NCT05529888|Isotretinoin|isotretinoin|mesh-list
92211254|NCT05529888|Dermatologic Agents|dermatologic agents|mesh-ancestor
92211255|NCT02444741|Pembrolizumab|pembrolizumab|mesh-list
92211256|NCT02444741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211257|NCT02444741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211258|NCT02444741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92211259|NCT02444741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211260|NCT05518578|Huperzine A|huperzine a|mesh-list
92211261|NCT05518578|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92211262|NCT05518578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921149|NCT02187133|Immunologic Factors|immunologic factors|mesh-ancestor
92211263|NCT05518578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211264|NCT05518578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92211265|NCT05518578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211266|NCT05518578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211267|NCT05518578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92211268|NCT05518578|Protective Agents|protective agents|mesh-ancestor
92211269|NCT05518500|Vaccines|vaccines|mesh-list
92211270|NCT05518500|Immunologic Factors|immunologic factors|mesh-ancestor
92211271|NCT05518500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211272|NCT03058978|Etonogestrel|etonogestrel|mesh-list
92211273|NCT03058978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92211274|NCT03058978|Contraceptive Agents|contraceptive agents|mesh-ancestor
92211275|NCT03058978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92211276|NCT03058978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211277|NCT03058978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92211278|NCT00212134|Dipivefrin|dipivefrin|mesh-list
92211279|NCT00212134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92211280|NCT00212134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211281|NCT00212134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211282|NCT00212134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211283|NCT00212134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211284|NCT00913627|Ibuprofen|ibuprofen|mesh-list
92211285|NCT00913627|Naproxen|naproxen|mesh-list
92211286|NCT00913627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92211287|NCT00913627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211288|NCT00913627|Analgesics|analgesics|mesh-ancestor
92211289|NCT00913627|Sensory System Agents|sensory system agents|mesh-ancestor
92211290|NCT00913627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211291|NCT00913627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211292|NCT00913627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211293|NCT00913627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211294|NCT00913627|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92211295|NCT00913627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211296|NCT00913627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211297|NCT00913627|Gout Suppressants|gout suppressants|mesh-ancestor
92211298|NCT04297176|Vancomycin|vancomycin|mesh-list
92211299|NCT04297176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211300|NCT04297176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211301|NCT02425306|Cyclophosphamide|cyclophosphamide|mesh-list
92211302|NCT02425306|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92211303|NCT02425306|Poly ICLC|poly iclc|mesh-list
92211304|NCT02425306|Immunologic Factors|immunologic factors|mesh-ancestor
92211305|NCT02425306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211306|NCT02425306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211307|NCT02425306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211308|NCT02425306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92211309|NCT02425306|Alkylating Agents|alkylating agents|mesh-ancestor
92211310|NCT02425306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211311|NCT02425306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211312|NCT02425306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92211313|NCT02425306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211314|NCT02425306|Interferon Inducers|interferon inducers|mesh-ancestor
92211315|NCT04052698|Factor VIII|factor viii|mesh-list
92211316|NCT04052698|Coagulants|coagulants|mesh-ancestor
92211317|NCT05523102|Acetaminophen|acetaminophen|mesh-list
92211318|NCT05523102|Ketorolac|ketorolac|mesh-list
92211319|NCT05523102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211320|NCT05523102|Analgesics|analgesics|mesh-ancestor
92211321|NCT05523102|Sensory System Agents|sensory system agents|mesh-ancestor
92211322|NCT05523102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211323|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211324|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
92211325|NCT05523102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92211326|NCT05523102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211327|NCT05523102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211328|NCT05523102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92211329|NCT05523102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211330|NCT05523102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211331|NCT03407209|Anesthetics|anesthetics|mesh-list
92211332|NCT03407209|Anesthetics, Local|anesthetics, local|mesh-list
92211333|NCT03407209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211334|NCT03407209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211335|NCT03407209|Sensory System Agents|sensory system agents|mesh-ancestor
92336618|NCT01945242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211336|NCT03407209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211337|NCT04141020|Sirolimus|sirolimus|mesh-list
92211338|NCT04141020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211339|NCT04141020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211340|NCT04141020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92211341|NCT04141020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211342|NCT04141020|Antifungal Agents|antifungal agents|mesh-ancestor
92211343|NCT04141020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211344|NCT04141020|Immunologic Factors|immunologic factors|mesh-ancestor
92211345|NCT04141020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211346|NCT03999268|Insulin|insulin|mesh-list
92211347|NCT03999268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92211348|NCT03999268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211349|NCT05517330|Tislelizumab|tislelizumab|mesh-list
92211350|NCT05517330|Afatinib|afatinib|mesh-list
92211351|NCT05517330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211352|NCT05517330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211353|NCT05517330|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92211354|NCT05517330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211355|NCT05517330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211356|NCT05517174|Vaccines|vaccines|mesh-list
92211357|NCT05517174|Immunologic Factors|immunologic factors|mesh-ancestor
92211358|NCT05517174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211359|NCT01729897|Fentanyl|fentanyl|mesh-list
92211360|NCT01729897|Propofol|propofol|mesh-list
92211361|NCT01729897|Etomidate|etomidate|mesh-list
92211362|NCT01729897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92211363|NCT01729897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211364|NCT01729897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211365|NCT01729897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92211366|NCT01729897|Anesthetics, General|anesthetics, general|mesh-ancestor
92211367|NCT01729897|Anesthetics|anesthetics|mesh-ancestor
92211368|NCT01729897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92211369|NCT01729897|Narcotics|narcotics|mesh-ancestor
92211370|NCT01729897|Analgesics|analgesics|mesh-ancestor
92211371|NCT01729897|Sensory System Agents|sensory system agents|mesh-ancestor
92211372|NCT01729897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211373|NCT01729897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92211374|NCT01048177|Lidocaine|lidocaine|mesh-list
92211375|NCT01048177|Heparin|heparin|mesh-list
92211376|NCT01048177|Anesthetics, Local|anesthetics, local|mesh-ancestor
92211377|NCT01048177|Anesthetics|anesthetics|mesh-ancestor
92211378|NCT01048177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211379|NCT01048177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211380|NCT01048177|Sensory System Agents|sensory system agents|mesh-ancestor
92211381|NCT01048177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211382|NCT01048177|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92211383|NCT01048177|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92211384|NCT01048177|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92211385|NCT01048177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92211386|NCT01048177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211387|NCT01048177|Anticoagulants|anticoagulants|mesh-ancestor
92211388|NCT01048177|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92211389|NCT01048177|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92211390|NCT02740582|Tolcapone|tolcapone|mesh-list
92211391|NCT02740582|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92211392|NCT02740582|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92211393|NCT02740582|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92211394|NCT02740582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211395|NCT02740582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211396|NCT05453266|Tranexamic Acid|tranexamic acid|mesh-list
92211397|NCT05453266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92211398|NCT05453266|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92211399|NCT05453266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92211400|NCT05453266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211401|NCT05453266|Hemostatics|hemostatics|mesh-ancestor
92211402|NCT05453266|Coagulants|coagulants|mesh-ancestor
92211403|NCT02740660|Caffeine|caffeine|mesh-list
92211404|NCT02740660|Albuterol|albuterol|mesh-list
92211405|NCT02740660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92211406|NCT02740660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211407|NCT02740660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92211408|NCT02740660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211409|NCT02740660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211410|NCT02740660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92211411|NCT02740660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92211412|NCT02740660|Purinergic Agents|purinergic agents|mesh-ancestor
92211413|NCT02740660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211414|NCT02740660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92211415|NCT02740660|Autonomic Agents|autonomic agents|mesh-ancestor
92211416|NCT02740660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211417|NCT02740660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92211418|NCT02740660|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211419|NCT02740660|Tocolytic Agents|tocolytic agents|mesh-ancestor
92211420|NCT02740660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92211421|NCT02740660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92211422|NCT02740660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92211423|NCT02740660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92211424|NCT02740660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211426|NCT05516862|Salicylates|salicylates|mesh-list
92211427|NCT05516862|Methyl salicylate|methyl salicylate|mesh-list
92211428|NCT05516862|Menthol|menthol|mesh-list
92211429|NCT05516862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92211430|NCT05516862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211431|NCT05516862|Antipruritics|antipruritics|mesh-ancestor
92211432|NCT05516862|Dermatologic Agents|dermatologic agents|mesh-ancestor
92211433|NCT05516862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92211434|NCT05516862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211435|NCT05516862|Analgesics|analgesics|mesh-ancestor
92211436|NCT05516862|Sensory System Agents|sensory system agents|mesh-ancestor
92211437|NCT05516862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211438|NCT05516862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211439|NCT05516862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211440|NCT05516862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211441|NCT05516862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92211442|NCT05516862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211443|NCT05516862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211444|NCT03929068|Levodopa|levodopa|mesh-list
92211445|NCT03929068|Carbidopa|carbidopa|mesh-list
92211446|NCT03929068|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92211447|NCT03929068|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92211448|NCT03929068|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92211449|NCT03929068|Dopamine Agents|dopamine agents|mesh-ancestor
92211450|NCT03929068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211451|NCT03929068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211452|NCT03929068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211453|NCT03929068|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92211454|NCT03929068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211455|NCT03929068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211456|NCT03929068|Immunologic Factors|immunologic factors|mesh-ancestor
92211457|NCT03929068|Dopamine Agonists|dopamine agonists|mesh-ancestor
92211458|NCT05516784|Clopidogrel|clopidogrel|mesh-list
92211459|NCT05516784|Ticagrelor|ticagrelor|mesh-list
92211460|NCT05516784|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92211461|NCT05516784|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92211462|NCT05516784|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92211463|NCT05516784|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92211464|NCT05516784|Purinergic Agents|purinergic agents|mesh-ancestor
92211465|NCT05516784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211466|NCT05516784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211467|NCT05516784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211468|NCT02571972|Timolol|timolol|mesh-list
92211469|NCT02571972|Dorzolamide|dorzolamide|mesh-list
92211470|NCT02571972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92211471|NCT02571972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92211472|NCT02571972|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211473|NCT02571972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211474|NCT02571972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211475|NCT02571972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211476|NCT02571972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92211477|NCT02571972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92211478|NCT02571972|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92211479|NCT02571972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211480|NCT03700138|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92211481|NCT03700138|Immunologic Factors|immunologic factors|mesh-ancestor
92211482|NCT03700138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211484|NCT04996134|Antiemetics|antiemetics|mesh-ancestor
92211485|NCT04996134|Autonomic Agents|autonomic agents|mesh-ancestor
92211486|NCT04996134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211487|NCT04996134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211488|NCT04996134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92211489|NCT04996134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92211490|NCT04996134|Dopamine Agents|dopamine agents|mesh-ancestor
92211491|NCT04996134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211492|NCT04996134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211493|NCT00371332|Minocycline|minocycline|mesh-list
92211494|NCT00371332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211495|NCT00371332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211496|NCT00842075|Pramlintide|pramlintide|mesh-list
92211497|NCT00842075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92211498|NCT00842075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211500|NCT00879359|Bevacizumab|bevacizumab|mesh-list
92211501|NCT00879359|Carboplatin|carboplatin|mesh-list
92211502|NCT00879359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92211503|NCT00879359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211504|NCT00879359|Tubulin Modulators|tubulin modulators|mesh-ancestor
92211505|NCT00879359|Antimitotic Agents|antimitotic agents|mesh-ancestor
92211506|NCT00879359|Mitosis Modulators|mitosis modulators|mesh-ancestor
92211507|NCT00879359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211508|NCT00879359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211509|NCT00879359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92211510|NCT00879359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92211511|NCT00879359|Growth Substances|growth substances|mesh-ancestor
92211512|NCT00879359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211513|NCT00879359|Growth Inhibitors|growth inhibitors|mesh-ancestor
92211514|NCT00880919|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92211515|NCT00880919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92211516|NCT00880919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92211517|NCT00880919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92211518|NCT00880919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92211519|NCT00880919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211520|NCT00880919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211521|NCT00880997|Doxazosin|doxazosin|mesh-list
92211522|NCT00880997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92211523|NCT00880997|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92211524|NCT00880997|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92211525|NCT00880997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92211526|NCT00880997|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211527|NCT00880997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211528|NCT00880997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211529|NCT00880997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211530|NCT05527548|Alendronate|alendronate|mesh-list
92211531|NCT05527548|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92211532|NCT05527548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211533|NCT00883103|Lidocaine|lidocaine|mesh-list
92211534|NCT00883103|Anesthetics, Local|anesthetics, local|mesh-ancestor
92211535|NCT00883103|Anesthetics|anesthetics|mesh-ancestor
92211536|NCT00883103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211537|NCT00883103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211538|NCT00883103|Sensory System Agents|sensory system agents|mesh-ancestor
92211539|NCT00883103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211540|NCT00883103|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92211541|NCT00883103|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92211542|NCT00883103|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92211543|NCT00883103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336637|NCT01962948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211544|NCT00883103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211545|NCT02742532|Oxytocin|oxytocin|mesh-list
92211546|NCT02742532|Oxytocics|oxytocics|mesh-ancestor
92211547|NCT02742532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92211548|NCT02742532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211549|NCT05521386|Caffeine|caffeine|mesh-list
92211550|NCT05521386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92211551|NCT05521386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211552|NCT05521386|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92211553|NCT05521386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211554|NCT05521386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211555|NCT05521386|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92211556|NCT05521386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92211557|NCT05521386|Purinergic Agents|purinergic agents|mesh-ancestor
92211558|NCT05521386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211559|NCT00370630|Triamcinolone|triamcinolone|mesh-list
92211560|NCT00370630|Bevacizumab|bevacizumab|mesh-list
92211561|NCT00370630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211562|NCT00370630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211563|NCT00370630|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92211564|NCT00370630|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92211565|NCT00370630|Growth Substances|growth substances|mesh-ancestor
92211566|NCT00370630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211567|NCT00370630|Growth Inhibitors|growth inhibitors|mesh-ancestor
92211568|NCT00370630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211569|NCT00370630|Glucocorticoids|glucocorticoids|mesh-ancestor
92211570|NCT00370630|Hormones|hormones|mesh-ancestor
92211571|NCT00370630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211572|NCT04984980|Bevacizumab|bevacizumab|mesh-list
92211573|NCT04984980|Gemcitabine|gemcitabine|mesh-list
92211574|NCT04984980|Oxaliplatin|oxaliplatin|mesh-list
92211575|NCT04984980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211576|NCT04984980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211577|NCT04984980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92211578|NCT04984980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92211579|NCT04984980|Growth Substances|growth substances|mesh-ancestor
92211580|NCT04984980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211581|NCT04984980|Growth Inhibitors|growth inhibitors|mesh-ancestor
92211582|NCT04984980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92211583|NCT04984980|Antimetabolites|antimetabolites|mesh-ancestor
92211584|NCT04984980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211585|NCT00370786|Bevacizumab|bevacizumab|mesh-list
92211586|NCT00370786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211587|NCT00370786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211588|NCT00370786|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92211589|NCT00370786|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92211590|NCT00370786|Growth Substances|growth substances|mesh-ancestor
92211591|NCT00370786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211592|NCT00370786|Growth Inhibitors|growth inhibitors|mesh-ancestor
92211593|NCT04981158|Anesthetics|anesthetics|mesh-list
92211594|NCT04981158|Anesthetics, General|anesthetics, general|mesh-list
92211595|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211596|NCT04981158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211597|NCT03437356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92211598|NCT03387670|Simvastatin|simvastatin|mesh-list
92211599|NCT03387670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92211600|NCT03387670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92211601|NCT03387670|Antimetabolites|antimetabolites|mesh-ancestor
92211602|NCT03387670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211603|NCT03387670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92211604|NCT03387670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92211605|NCT03387670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211606|NCT04979832|Metronidazole|metronidazole|mesh-list
92211607|NCT04979832|Fosfomycin|fosfomycin|mesh-list
92211608|NCT04979832|Molgramostim|molgramostim|mesh-list
92211609|NCT04979832|Sargramostim|sargramostim|mesh-list
92211610|NCT04979832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211611|NCT04979832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211612|NCT04979832|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92211613|NCT04979832|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92211614|NCT04979832|Immunologic Factors|immunologic factors|mesh-ancestor
92211615|NCT04979832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211616|NCT04979832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211618|NCT05521152|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92211619|NCT05521152|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92211620|NCT05521152|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211621|NCT05521152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211622|NCT05521152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211623|NCT05521152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211624|NCT05521152|Sympathomimetics|sympathomimetics|mesh-ancestor
92211625|NCT05521152|Autonomic Agents|autonomic agents|mesh-ancestor
92211626|NCT05521152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211627|NCT05521152|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92211628|NCT02740114|Oxycodone|oxycodone|mesh-list
92211629|NCT02740114|Bupivacaine|bupivacaine|mesh-list
92211630|NCT02740114|Anesthetics, Local|anesthetics, local|mesh-ancestor
92211631|NCT02740114|Anesthetics|anesthetics|mesh-ancestor
92211632|NCT02740114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211633|NCT02740114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211634|NCT02740114|Sensory System Agents|sensory system agents|mesh-ancestor
92211635|NCT02740114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211636|NCT02740114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92211637|NCT02740114|Narcotics|narcotics|mesh-ancestor
92211638|NCT02740114|Analgesics|analgesics|mesh-ancestor
92211639|NCT00371410|Triamcinolone|triamcinolone|mesh-list
92211640|NCT00371410|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92211641|NCT00371410|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92211642|NCT00371410|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92211643|NCT00371410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211644|NCT00371410|Glucocorticoids|glucocorticoids|mesh-ancestor
92211645|NCT00371410|Hormones|hormones|mesh-ancestor
92211646|NCT00371410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211647|NCT00371410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211648|NCT00371410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211649|NCT00371410|Immunologic Factors|immunologic factors|mesh-ancestor
92211650|NCT00371410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211651|NCT00371410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211653|NCT04659616|Daunorubicin|daunorubicin|mesh-list
92211654|NCT04659616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92211655|NCT04659616|Antimetabolites|antimetabolites|mesh-ancestor
92211656|NCT04659616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211657|NCT04659616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211658|NCT04659616|Antiviral Agents|antiviral agents|mesh-ancestor
92211659|NCT04659616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211660|NCT04659616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211661|NCT04659616|Immunologic Factors|immunologic factors|mesh-ancestor
92211662|NCT04659616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211663|NCT04659616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92211664|NCT04659616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92211665|NCT04659616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92211666|NCT04659616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211667|NCT04295850|Aspirin|aspirin|mesh-list
92211668|NCT04295850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92211669|NCT04295850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211670|NCT04295850|Analgesics|analgesics|mesh-ancestor
92211671|NCT04295850|Sensory System Agents|sensory system agents|mesh-ancestor
92211672|NCT04295850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211673|NCT04295850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211674|NCT04295850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211675|NCT04295850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211676|NCT04295850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92211677|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92336647|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92211678|NCT04295850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211679|NCT04295850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92211680|NCT04295850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92211681|NCT04295850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211683|NCT02166905|Poly I-C|poly i-c|mesh-list
92211684|NCT02166905|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92211685|NCT02166905|Poly ICLC|poly iclc|mesh-list
92211686|NCT02166905|Interferon Inducers|interferon inducers|mesh-ancestor
92211687|NCT02166905|Immunologic Factors|immunologic factors|mesh-ancestor
92211688|NCT02166905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211689|NCT02166905|Laxatives|laxatives|mesh-ancestor
92211690|NCT02166905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92211691|NCT02166905|Antiviral Agents|antiviral agents|mesh-ancestor
92211692|NCT02166905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211693|NCT02743078|Bevacizumab|bevacizumab|mesh-list
92211694|NCT02743078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211695|NCT02743078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211696|NCT02743078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92211697|NCT02743078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92211698|NCT02743078|Growth Substances|growth substances|mesh-ancestor
92211699|NCT02743078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211700|NCT02743078|Growth Inhibitors|growth inhibitors|mesh-ancestor
92211701|NCT03323398|Durvalumab|durvalumab|mesh-list
92211702|NCT03323398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211703|NCT03323398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211704|NCT00890981|Denosumab|denosumab|mesh-list
92211705|NCT00890981|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92211706|NCT00890981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211708|NCT05515770|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92211709|NCT05515770|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92211710|NCT05515770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211711|NCT05515770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211712|NCT05515770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92211713|NCT05515770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92211714|NCT05515770|Antiviral Agents|antiviral agents|mesh-ancestor
92211715|NCT05515770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211716|NCT04480138|Interferons|interferons|mesh-list
92211717|NCT04480138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211718|NCT04480138|Antiviral Agents|antiviral agents|mesh-ancestor
92211719|NCT04480138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211720|NCT00371488|Lapatinib|lapatinib|mesh-list
92211721|NCT00371488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211722|NCT00371488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92211723|NCT00371488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211724|NCT00371488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211725|NCT00883415|Darbepoetin alfa|darbepoetin alfa|mesh-list
92211726|NCT00883415|Hematinics|hematinics|mesh-ancestor
92211727|NCT04337632|Paclitaxel|paclitaxel|mesh-list
92211728|NCT04337632|Carboplatin|carboplatin|mesh-list
92211729|NCT04337632|Doxorubicin|doxorubicin|mesh-list
92211730|NCT04337632|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92211731|NCT04337632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92211732|NCT04337632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211733|NCT04337632|Tubulin Modulators|tubulin modulators|mesh-ancestor
92211734|NCT04337632|Antimitotic Agents|antimitotic agents|mesh-ancestor
92211735|NCT04337632|Mitosis Modulators|mitosis modulators|mesh-ancestor
92211736|NCT04337632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211737|NCT04337632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92211738|NCT04337632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92211739|NCT04337632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92211740|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211741|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92211742|NCT05349058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211743|NCT05349058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211744|NCT05349058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211745|NCT05348980|Phenylephrine|phenylephrine|mesh-list
92211746|NCT05348980|Oxymetazoline|oxymetazoline|mesh-list
92211747|NCT05348980|Synephrine|synephrine|mesh-list
92211748|NCT05348980|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92211749|NCT05348980|Mydriatics|mydriatics|mesh-ancestor
92211750|NCT05348980|Autonomic Agents|autonomic agents|mesh-ancestor
92211751|NCT05348980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211752|NCT05348980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211753|NCT05348980|Sympathomimetics|sympathomimetics|mesh-ancestor
92211754|NCT05348980|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92211755|NCT05348980|Nasal Decongestants|nasal decongestants|mesh-ancestor
92211756|NCT05348980|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211757|NCT05348980|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92211758|NCT05348980|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92211759|NCT05348980|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92211760|NCT05348980|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211761|NCT05348980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211762|NCT05348980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211763|NCT05348980|Protective Agents|protective agents|mesh-ancestor
92211764|NCT00884585|Cyclosporine|cyclosporine|mesh-list
92211765|NCT00884585|Cyclosporins|cyclosporins|mesh-list
92211766|NCT00884585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211767|NCT00884585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211768|NCT00884585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211769|NCT00884585|Immunologic Factors|immunologic factors|mesh-ancestor
92211770|NCT00884585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211771|NCT00884585|Antifungal Agents|antifungal agents|mesh-ancestor
92211772|NCT00884585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211773|NCT00884585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92211774|NCT00884585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211775|NCT00884585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92211776|NCT00884897|Oxytocin|oxytocin|mesh-list
92211777|NCT00884897|Oxytocics|oxytocics|mesh-ancestor
92211778|NCT00884897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92211779|NCT00884897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211780|NCT03216473|Botulinum Toxins|botulinum toxins|mesh-list
92211781|NCT03216473|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92211782|NCT03216473|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92211783|NCT03216473|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92211784|NCT03216473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92211785|NCT03216473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211786|NCT03216473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92211787|NCT03216473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211788|NCT03216473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211789|NCT03216473|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92211790|NCT03216473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211791|NCT03384563|Dexmedetomidine|dexmedetomidine|mesh-list
92211792|NCT03384563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92211793|NCT03384563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211794|NCT03384563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211795|NCT03384563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211797|NCT03384563|Sensory System Agents|sensory system agents|mesh-ancestor
92211798|NCT03384563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211799|NCT03384563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92211800|NCT03384563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92211801|NCT03384563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92211802|NCT03384563|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211803|NCT03384563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211804|NCT03384563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211805|NCT04946526|Mechlorethamine|mechlorethamine|mesh-list
92211806|NCT04946526|Alkylating Agents|alkylating agents|mesh-ancestor
92211807|NCT04946526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211808|NCT04946526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92211809|NCT04946526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211810|NCT02748070|Fluticasone|fluticasone|mesh-list
92211811|NCT02748070|Prednisone|prednisone|mesh-list
92211812|NCT02748070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211813|NCT02748070|Glucocorticoids|glucocorticoids|mesh-ancestor
92211814|NCT02748070|Hormones|hormones|mesh-ancestor
92336661|NCT04665648|Nicorandil|nicorandil|mesh-list
92211815|NCT02748070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211816|NCT02748070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211817|NCT02748070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92211818|NCT02748070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211819|NCT02748070|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92211820|NCT02748070|Autonomic Agents|autonomic agents|mesh-ancestor
92211821|NCT02748070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211822|NCT02748070|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92211823|NCT02748070|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211824|NCT02748070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92211825|NCT02748070|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92211826|NCT05311709|Sotorasib|sotorasib|mesh-list
92211827|NCT05311709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92211828|NCT05311709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211829|NCT05311709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211830|NCT05311709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211831|NCT05310383|Tislelizumab|tislelizumab|mesh-list
92211832|NCT05310383|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211833|NCT05310383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211834|NCT05310305|Antibodies|antibodies|mesh-list
92211835|NCT05310305|Immunologic Factors|immunologic factors|mesh-ancestor
92211836|NCT05310305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211837|NCT05149638|Cosyntropin|cosyntropin|mesh-list
92211838|NCT05149638|Hormones|hormones|mesh-ancestor
92211839|NCT05149638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211840|NCT05149638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211841|NCT05519670|Niraparib|niraparib|mesh-list
92211842|NCT05519670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92211843|NCT05519670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211844|NCT05519670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211845|NCT05519670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211846|NCT05519592|Ropivacaine|ropivacaine|mesh-list
92211847|NCT05519592|Anesthetics, Local|anesthetics, local|mesh-ancestor
92211848|NCT05519592|Anesthetics|anesthetics|mesh-ancestor
92211849|NCT05519592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211850|NCT05519592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211851|NCT05519592|Sensory System Agents|sensory system agents|mesh-ancestor
92211852|NCT05519592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211853|NCT05519514|Budesonide|budesonide|mesh-list
92211854|NCT05519514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211855|NCT05519514|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92211856|NCT05519514|Autonomic Agents|autonomic agents|mesh-ancestor
92211857|NCT05519514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211858|NCT05519514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211859|NCT05519514|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92211860|NCT05519514|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211861|NCT05519514|Glucocorticoids|glucocorticoids|mesh-ancestor
92211862|NCT05519514|Hormones|hormones|mesh-ancestor
92211863|NCT05519514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92211864|NCT02756572|Cytarabine|cytarabine|mesh-list
92211865|NCT02756572|Cyclosporine|cyclosporine|mesh-list
92211866|NCT02756572|Mycophenolic Acid|mycophenolic acid|mesh-list
92211867|NCT02756572|Sirolimus|sirolimus|mesh-list
92211868|NCT02756572|Fludarabine|fludarabine|mesh-list
92211869|NCT02756572|Fludarabine phosphate|fludarabine phosphate|mesh-list
92211870|NCT02756572|Melphalan|melphalan|mesh-list
92211871|NCT02756572|Mechlorethamine|mechlorethamine|mesh-list
92211872|NCT02756572|Mitoxantrone|mitoxantrone|mesh-list
92211873|NCT02756572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92211874|NCT02756572|Cladribine|cladribine|mesh-list
92211875|NCT02756572|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92211876|NCT02756572|Cyclosporins|cyclosporins|mesh-list
92211877|NCT02756572|Lenograstim|lenograstim|mesh-list
92211878|NCT02756572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211879|NCT02756572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92211880|NCT02756572|Antimetabolites|antimetabolites|mesh-ancestor
92211881|NCT02756572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211882|NCT02756572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92211883|NCT02756572|Immunologic Factors|immunologic factors|mesh-ancestor
92211884|NCT02756572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211885|NCT02756572|Antiviral Agents|antiviral agents|mesh-ancestor
92211886|NCT02756572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92211887|NCT02756572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211888|NCT02756572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211889|NCT02756572|Antifungal Agents|antifungal agents|mesh-ancestor
92211890|NCT02756572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92211891|NCT02756572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211892|NCT02756572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92211893|NCT02756572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92211894|NCT02756572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92211895|NCT02756572|Antitubercular Agents|antitubercular agents|mesh-ancestor
92211896|NCT02756572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92211897|NCT02756572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92211898|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
92211899|NCT02756572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92211900|NCT02756572|Analgesics|analgesics|mesh-ancestor
92211901|NCT02756572|Sensory System Agents|sensory system agents|mesh-ancestor
92211902|NCT02756572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211903|NCT02756572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92211904|NCT02756572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92211905|NCT01049035|Vaccines|vaccines|mesh-list
92211906|NCT01049035|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92211907|NCT01049035|Immunologic Factors|immunologic factors|mesh-ancestor
92211908|NCT01049035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211909|NCT05131698|Lenvatinib|lenvatinib|mesh-list
92211910|NCT05131698|Tislelizumab|tislelizumab|mesh-list
92211911|NCT05131698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211912|NCT05131698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92211913|NCT05131698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211914|NCT05131698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211915|NCT05131698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92211916|NCT01724983|Fentanyl|fentanyl|mesh-list
92211917|NCT01724983|Ketamine|ketamine|mesh-list
92211918|NCT01724983|Analgesics|analgesics|mesh-ancestor
92211919|NCT01724983|Sensory System Agents|sensory system agents|mesh-ancestor
92211920|NCT01724983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211921|NCT01724983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211922|NCT01724983|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92211923|NCT01724983|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92211924|NCT01724983|Anesthetics, General|anesthetics, general|mesh-ancestor
92211925|NCT01724983|Anesthetics|anesthetics|mesh-ancestor
92211926|NCT01724983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211927|NCT01724983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92211928|NCT01724983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92211929|NCT01724983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211930|NCT01724983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211931|NCT01724983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92211932|NCT01724983|Narcotics|narcotics|mesh-ancestor
92211933|NCT01724983|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92211934|NCT02973958|Acetaminophen|acetaminophen|mesh-list
92211935|NCT02973958|Ibuprofen|ibuprofen|mesh-list
92211936|NCT02973958|Ketorolac|ketorolac|mesh-list
92211937|NCT02973958|Bupivacaine|bupivacaine|mesh-list
92211938|NCT02973958|Sevoflurane|sevoflurane|mesh-list
92211939|NCT02973958|Anesthetics, Local|anesthetics, local|mesh-ancestor
92211940|NCT02973958|Anesthetics|anesthetics|mesh-ancestor
92211941|NCT02973958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211942|NCT02973958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211943|NCT02973958|Sensory System Agents|sensory system agents|mesh-ancestor
92211944|NCT02973958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211945|NCT02973958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92211946|NCT02973958|Analgesics|analgesics|mesh-ancestor
92211947|NCT02973958|Antipyretics|antipyretics|mesh-ancestor
92211948|NCT02973958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92211949|NCT02973958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92211950|NCT02973958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211951|NCT02973958|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92211952|NCT02973958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92211953|NCT02973958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211954|NCT02973958|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92211955|NCT02973958|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92211956|NCT02973958|Anesthetics, General|anesthetics, general|mesh-ancestor
92211957|NCT01048333|Formoterol Fumarate|formoterol fumarate|mesh-list
92211958|NCT01048333|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92211959|NCT01048333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92211961|NCT01048333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211962|NCT01048333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211963|NCT01048333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92211964|NCT01048333|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211965|NCT01048333|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92211966|NCT01048333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92211967|NCT01048333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92211968|NCT01048333|Adrenergic Agents|adrenergic agents|mesh-ancestor
92211969|NCT01048333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92211970|NCT01048333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211971|NCT05513976|Febuxostat|febuxostat|mesh-list
92211972|NCT05513976|Gout Suppressants|gout suppressants|mesh-ancestor
92211973|NCT05513976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92211974|NCT04335526|Cholestyramine Resin|cholestyramine resin|mesh-list
92211975|NCT04335526|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92211976|NCT04335526|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92211977|NCT04335526|Antimetabolites|antimetabolites|mesh-ancestor
92211978|NCT04335526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92211979|NCT04335526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92211980|NCT05348434|Ether|ether|mesh-list
92211981|NCT05348434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92211982|NCT05348434|Anesthetics, General|anesthetics, general|mesh-ancestor
92211983|NCT05348434|Anesthetics|anesthetics|mesh-ancestor
92211984|NCT05348434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92211985|NCT05348434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211986|NCT05519202|Oxaliplatin|oxaliplatin|mesh-list
92211987|NCT05519202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92211988|NCT02281383|BCG Vaccine|bcg vaccine|mesh-list
92211989|NCT02281383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92211990|NCT02281383|Immunologic Factors|immunologic factors|mesh-ancestor
92211991|NCT02281383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211992|NCT01047553|Formoterol Fumarate|formoterol fumarate|mesh-list
92211993|NCT01047553|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92211994|NCT01047553|Autonomic Agents|autonomic agents|mesh-ancestor
92211995|NCT01047553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92211996|NCT01047553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92211997|NCT01047553|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92211998|NCT01047553|Respiratory System Agents|respiratory system agents|mesh-ancestor
92211999|NCT01047553|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92212000|NCT01047553|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92212001|NCT01047553|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92212002|NCT01047553|Adrenergic Agents|adrenergic agents|mesh-ancestor
92212003|NCT01047553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212004|NCT01047553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212005|NCT02760862|Hydrocortisone|hydrocortisone|mesh-list
92212006|NCT02760862|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92212007|NCT02760862|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92212008|NCT02760862|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92212009|NCT02760862|Mannitol|mannitol|mesh-list
92212010|NCT02760862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212011|NCT02760862|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92212012|NCT02760862|Diuretics|diuretics|mesh-ancestor
92212013|NCT02760862|Natriuretic Agents|natriuretic agents|mesh-ancestor
92212014|NCT02760862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212015|NCT05720637|Serotonin|serotonin|mesh-list
92212016|NCT05720637|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92212017|NCT05720637|Serotonin Agents|serotonin agents|mesh-ancestor
92212018|NCT05720637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940215|NCT03496519|Trabectedin|trabectedin|mesh-list
92212019|NCT05720637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212020|NCT05720637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212021|NCT05720559|Folic Acid|folic acid|mesh-list
92212022|NCT05720559|Vitamin A|vitamin a|mesh-list
92212023|NCT05720559|Metronidazole|metronidazole|mesh-list
92212024|NCT05720559|Capecitabine|capecitabine|mesh-list
92212025|NCT05720559|Oxaliplatin|oxaliplatin|mesh-list
92212026|NCT05720559|Cetuximab|cetuximab|mesh-list
92212027|NCT05720559|Vitamins|vitamins|mesh-ancestor
92212028|NCT05720559|Micronutrients|micronutrients|mesh-ancestor
92212029|NCT05720559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336679|NCT01942590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92212030|NCT05720559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212031|NCT05720559|Antimetabolites|antimetabolites|mesh-ancestor
92212032|NCT05720559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212033|NCT05720559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212034|NCT05720559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212035|NCT05720559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212036|NCT05720559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212037|NCT05720559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92212038|NCT05720559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92212039|NCT05720559|Hematinics|hematinics|mesh-ancestor
92212040|NCT05720559|Vitamin B Complex|vitamin b complex|mesh-ancestor
92212041|NCT02761252|Montelukast|montelukast|mesh-list
92212042|NCT02761252|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92212044|NCT02761252|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92212045|NCT02761252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92212046|NCT02761252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212047|NCT02761252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212048|NCT02761252|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92212049|NCT02761252|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92212050|NCT02761252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212051|NCT05714475|Pancrelipase|pancrelipase|mesh-list
92212052|NCT05714475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212053|NCT01047007|Cisplatin|cisplatin|mesh-list
92212054|NCT01047007|Adavosertib|adavosertib|mesh-list
92212055|NCT01047007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212056|NCT01047007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212057|NCT01047007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212058|NCT05443984|Esomeprazole|esomeprazole|mesh-list
92212059|NCT05443984|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92212060|NCT05443984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212061|NCT05443984|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92212062|NCT05443984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212063|NCT05443984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212064|NCT01725607|Dexmedetomidine|dexmedetomidine|mesh-list
92212065|NCT01725607|Anesthetics|anesthetics|mesh-list
92212066|NCT01725607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212067|NCT01725607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212068|NCT01725607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92212069|NCT01725607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212070|NCT01725607|Analgesics|analgesics|mesh-ancestor
92212071|NCT01725607|Sensory System Agents|sensory system agents|mesh-ancestor
92212072|NCT01725607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212073|NCT01725607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92212074|NCT01725607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92212075|NCT01725607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92212076|NCT01725607|Adrenergic Agents|adrenergic agents|mesh-ancestor
92212077|NCT01725607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212078|NCT01725607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212079|NCT03304379|Celecoxib|celecoxib|mesh-list
92212080|NCT03304379|Diclofenac|diclofenac|mesh-list
92212081|NCT03304379|Fasinumab|fasinumab|mesh-list
92212082|NCT03304379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92212083|NCT03304379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212084|NCT03304379|Analgesics|analgesics|mesh-ancestor
92212085|NCT03304379|Sensory System Agents|sensory system agents|mesh-ancestor
92212086|NCT03304379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212087|NCT03304379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212088|NCT03304379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212089|NCT03304379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212090|NCT03304379|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92212091|NCT03304379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92212092|NCT03304379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934206|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212093|NCT03304379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212094|NCT00915967|Vancomycin|vancomycin|mesh-list
92212095|NCT00915967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212096|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212097|NCT01044745|Mycophenolic Acid|mycophenolic acid|mesh-list
92212098|NCT01044745|Cyclophosphamide|cyclophosphamide|mesh-list
92212099|NCT01044745|Busulfan|busulfan|mesh-list
92212100|NCT01044745|Rituximab|rituximab|mesh-list
92212101|NCT01044745|Fludarabine|fludarabine|mesh-list
92212102|NCT01044745|Fludarabine phosphate|fludarabine phosphate|mesh-list
92212103|NCT01044745|Tacrolimus|tacrolimus|mesh-list
92212104|NCT01044745|Thymoglobulin|thymoglobulin|mesh-list
92212105|NCT01044745|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92212106|NCT01044745|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92212107|NCT01044745|Immunologic Factors|immunologic factors|mesh-ancestor
92212108|NCT01044745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212109|NCT01044745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212110|NCT01044745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92212111|NCT01044745|Alkylating Agents|alkylating agents|mesh-ancestor
92212112|NCT01044745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212113|NCT01044745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212114|NCT01044745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92212115|NCT01044745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212116|NCT01044745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212117|NCT01044745|Antimetabolites|antimetabolites|mesh-ancestor
92212118|NCT01044745|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92212119|NCT01044745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212120|NCT01044745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92212121|NCT01044745|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92212122|NCT01044745|Antitubercular Agents|antitubercular agents|mesh-ancestor
92212123|NCT01044745|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212124|NCT01044745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212125|NCT02766244|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92212126|NCT02766244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212127|NCT05031078|Lidocaine|lidocaine|mesh-list
92212128|NCT05031078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212129|NCT05031078|Anesthetics, Local|anesthetics, local|mesh-ancestor
92212130|NCT05031078|Anesthetics|anesthetics|mesh-ancestor
92212131|NCT05031078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212132|NCT05031078|Sensory System Agents|sensory system agents|mesh-ancestor
92212133|NCT05031078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212134|NCT05031078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92212135|NCT05031078|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92212136|NCT05031078|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92212137|NCT05031078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212138|NCT05031078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212139|NCT03270059|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92212140|NCT03270059|Hematinics|hematinics|mesh-ancestor
92212141|NCT03270059|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92212142|NCT03270059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92212143|NCT05513664|Osimertinib|osimertinib|mesh-list
92212144|NCT05513664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212145|NCT05513664|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92212146|NCT05513664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212147|NCT05513664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212148|NCT03216395|Epinephrine|epinephrine|mesh-list
92212149|NCT03216395|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92212150|NCT03216395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92212151|NCT03216395|Adrenergic Agents|adrenergic agents|mesh-ancestor
92212152|NCT03216395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212153|NCT03216395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212154|NCT03216395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212155|NCT03216395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92212156|NCT03216395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92212157|NCT03216395|Autonomic Agents|autonomic agents|mesh-ancestor
92212158|NCT03216395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212159|NCT03216395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92212160|NCT03216395|Respiratory System Agents|respiratory system agents|mesh-ancestor
92212161|NCT03216395|Mydriatics|mydriatics|mesh-ancestor
92212162|NCT03216395|Sympathomimetics|sympathomimetics|mesh-ancestor
92212163|NCT03216395|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92212164|NCT02767492|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92212165|NCT02767492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212166|NCT02767492|Glucocorticoids|glucocorticoids|mesh-ancestor
92212167|NCT02767492|Hormones|hormones|mesh-ancestor
92212168|NCT02767492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212169|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212170|NCT02767492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92212171|NCT02767492|Immunologic Factors|immunologic factors|mesh-ancestor
92212173|NCT01044433|Lapatinib|lapatinib|mesh-list
92212174|NCT01044433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212175|NCT01044433|Antimetabolites|antimetabolites|mesh-ancestor
92212176|NCT01044433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212177|NCT01044433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212178|NCT01044433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92212179|NCT01044433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212180|NCT03400969|Glycerol|glycerol|mesh-list
92212181|NCT03400969|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92212182|NCT03400969|Protective Agents|protective agents|mesh-ancestor
92212183|NCT03400969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212184|NCT04633278|Pembrolizumab|pembrolizumab|mesh-list
92212185|NCT04633278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212186|NCT04633278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212187|NCT04633278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92212188|NCT04633278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212189|NCT05518812|Carboprost|carboprost|mesh-list
92212190|NCT05518812|Carboprost tromethamine|carboprost tromethamine|mesh-list
92212191|NCT05518812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92212192|NCT05518812|Abortifacient Agents|abortifacient agents|mesh-ancestor
92212193|NCT05518812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92212194|NCT05518812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212195|NCT05518812|Oxytocics|oxytocics|mesh-ancestor
92212196|NCT04334512|Vitamin D|vitamin d|mesh-list
92212197|NCT04334512|Vitamins|vitamins|mesh-list
92212198|NCT04334512|Azithromycin|azithromycin|mesh-list
92212199|NCT04334512|Hydroxychloroquine|hydroxychloroquine|mesh-list
92212200|NCT04334512|Micronutrients|micronutrients|mesh-ancestor
92212201|NCT04334512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212202|NCT04334512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92212203|NCT04334512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212204|NCT04334512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212205|NCT04334512|Antimalarials|antimalarials|mesh-ancestor
92212206|NCT04334512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92212207|NCT04334512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92212208|NCT04334512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212209|NCT04334512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212210|NCT04334512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212211|NCT01043185|Lesogaberan|lesogaberan|mesh-list
92212212|NCT01043185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212213|NCT01043185|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92212214|NCT01043185|GABA Agonists|gaba agonists|mesh-ancestor
92212215|NCT01043185|GABA Agents|gaba agents|mesh-ancestor
92212216|NCT01043185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212217|NCT01043185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212218|NCT01043185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212219|NCT01042093|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92212220|NCT01042093|Clonidine|clonidine|mesh-list
92212221|NCT01042093|Epinephrine|epinephrine|mesh-list
92212222|NCT01042093|Ropivacaine|ropivacaine|mesh-list
92212223|NCT01042093|Anesthetics, Local|anesthetics, local|mesh-ancestor
92212224|NCT01042093|Anesthetics|anesthetics|mesh-ancestor
92212225|NCT01042093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212226|NCT01042093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212227|NCT01042093|Sensory System Agents|sensory system agents|mesh-ancestor
92212228|NCT01042093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212229|NCT01042093|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92212230|NCT01042093|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92212231|NCT01042093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92212232|NCT01042093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212233|NCT01042093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212234|NCT01042093|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92212235|NCT01042093|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92212236|NCT01042093|Autonomic Agents|autonomic agents|mesh-ancestor
92212237|NCT01042093|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92212238|NCT01042093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92212239|NCT01042093|Mydriatics|mydriatics|mesh-ancestor
92212240|NCT01042093|Sympathomimetics|sympathomimetics|mesh-ancestor
92212241|NCT01042093|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92212242|NCT01042093|Analgesics|analgesics|mesh-ancestor
92212243|NCT01042093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92212244|NCT01042093|Sympatholytics|sympatholytics|mesh-ancestor
92212245|NCT01042093|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92212246|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92212247|NCT01042093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212248|NCT01042093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212249|NCT01042093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212250|NCT01042093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92212251|NCT01042093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212252|NCT03400735|Cefdinir|cefdinir|mesh-list
92212253|NCT03400735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212254|NCT03400735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212255|NCT04737928|Latanoprost|latanoprost|mesh-list
92212256|NCT04737928|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92212257|NCT04737928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92212259|NCT01041859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92212260|NCT01041859|Narcotics|narcotics|mesh-ancestor
92212261|NCT01041859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212262|NCT01041859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212263|NCT01041859|Analgesics|analgesics|mesh-ancestor
92212264|NCT01041859|Sensory System Agents|sensory system agents|mesh-ancestor
92212265|NCT01041859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212266|NCT01041859|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92212267|NCT01041859|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92212268|NCT01041859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212269|NCT01041859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212270|NCT01041859|Adrenergic Agents|adrenergic agents|mesh-ancestor
92212271|NCT01041859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212272|NCT03405805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92212273|NCT03405805|Immunologic Factors|immunologic factors|mesh-ancestor
92212274|NCT03405805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212275|NCT00371878|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92212276|NCT00371878|Immunologic Factors|immunologic factors|mesh-ancestor
92212277|NCT00371878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212278|NCT03400423|Caffeine|caffeine|mesh-list
92212279|NCT03400423|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92212280|NCT03400423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212281|NCT03400423|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92212282|NCT03400423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212283|NCT03400423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212284|NCT03400423|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92212285|NCT03400423|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92212286|NCT03400423|Purinergic Agents|purinergic agents|mesh-ancestor
92212287|NCT03400423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212288|NCT01040845|Colchicine|colchicine|mesh-list
92212289|NCT01040845|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92212290|NCT01040845|Norethindrone|norethindrone|mesh-list
92212291|NCT01040845|Norethindrone Acetate|norethindrone acetate|mesh-list
92212292|NCT01040845|Estradiol|estradiol|mesh-list
92212293|NCT01040845|Estrogens|estrogens|mesh-ancestor
92212294|NCT01040845|Hormones|hormones|mesh-ancestor
92212295|NCT01040845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212296|NCT01040845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212297|NCT01040845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92212298|NCT01040845|Contraceptive Agents|contraceptive agents|mesh-ancestor
92212299|NCT01040845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92212300|NCT01040845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92212301|NCT01040845|Gout Suppressants|gout suppressants|mesh-ancestor
92212302|NCT01040845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212303|NCT01040845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92212304|NCT01040845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92212305|NCT01040845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92212306|NCT01040845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212307|NCT01040845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212308|NCT01040845|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92212309|NCT01040845|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92212310|NCT01040845|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92212311|NCT00371956|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92212312|NCT00371956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92212313|NCT00371956|Hormone Antagonists|hormone antagonists|mesh-ancestor
92212314|NCT00371956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212315|NCT00371956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212316|NCT00371956|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92212317|NCT00371956|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92212318|NCT00371956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92212319|NCT01040689|Tiotropium Bromide|tiotropium bromide|mesh-list
92212320|NCT01040689|Olodaterol|olodaterol|mesh-list
92212321|NCT01040689|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92212322|NCT01040689|Autonomic Agents|autonomic agents|mesh-ancestor
92212323|NCT01040689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212324|NCT01040689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212325|NCT01040689|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92212326|NCT01040689|Respiratory System Agents|respiratory system agents|mesh-ancestor
92212327|NCT01040689|Parasympatholytics|parasympatholytics|mesh-ancestor
92212328|NCT01040689|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92212329|NCT01040689|Cholinergic Agents|cholinergic agents|mesh-ancestor
92212330|NCT01040689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212331|NCT01040689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212332|NCT00372658|Lidocaine|lidocaine|mesh-list
92212333|NCT00372658|Anesthetics, Local|anesthetics, local|mesh-ancestor
92212334|NCT00372658|Anesthetics|anesthetics|mesh-ancestor
92212335|NCT00372658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212336|NCT00372658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212337|NCT00372658|Sensory System Agents|sensory system agents|mesh-ancestor
92212338|NCT00372658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212339|NCT00372658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92212340|NCT00372658|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92212341|NCT00372658|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92212342|NCT00372658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212343|NCT00372658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212344|NCT03400189|Sulthiame|sulthiame|mesh-list
92212345|NCT03400189|Anticonvulsants|anticonvulsants|mesh-ancestor
92212346|NCT04098874|Bupropion|bupropion|mesh-list
92212347|NCT04098874|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92212348|NCT04098874|Antidepressive Agents|antidepressive agents|mesh-ancestor
92212349|NCT04098874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92212350|NCT04098874|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92212351|NCT04098874|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92212352|NCT04098874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212353|NCT04098874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212354|NCT04098874|Dopamine Agents|dopamine agents|mesh-ancestor
92212355|NCT04098874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212356|NCT04098874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212357|NCT04098874|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92212358|NCT04098874|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92212359|NCT04098874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212360|NCT01043029|Pioglitazone|pioglitazone|mesh-list
92212361|NCT01043029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92212362|NCT01043029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212364|NCT04282954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92212365|NCT04282954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212366|NCT04282954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92212367|NCT04282954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212368|NCT04282954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212369|NCT05337436|Calcium|calcium|mesh-list
92212370|NCT05337436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92212371|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212372|NCT04755712|Sufentanil|sufentanil|mesh-list
92212373|NCT04755712|Morphine|morphine|mesh-list
92212374|NCT04755712|Bupivacaine|bupivacaine|mesh-list
92212375|NCT04755712|Anesthetics, Local|anesthetics, local|mesh-ancestor
92212376|NCT04755712|Anesthetics|anesthetics|mesh-ancestor
92212377|NCT04755712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212378|NCT04755712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212379|NCT04755712|Sensory System Agents|sensory system agents|mesh-ancestor
92212380|NCT04755712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212381|NCT04755712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92212382|NCT04755712|Narcotics|narcotics|mesh-ancestor
92212383|NCT04755712|Analgesics|analgesics|mesh-ancestor
92212384|NCT04755712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92212385|NCT04755712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92212386|NCT04755712|Anesthetics, General|anesthetics, general|mesh-ancestor
92212387|NCT04751812|Analgesics, Opioid|analgesics, opioid|mesh-list
92212389|NCT04751812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212390|NCT04751812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212391|NCT04751812|Analgesics|analgesics|mesh-ancestor
92212392|NCT04751812|Sensory System Agents|sensory system agents|mesh-ancestor
92212393|NCT04751812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212394|NCT00372736|Docetaxel|docetaxel|mesh-list
92212395|NCT00372736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212396|NCT00372736|Tubulin Modulators|tubulin modulators|mesh-ancestor
92212397|NCT00372736|Antimitotic Agents|antimitotic agents|mesh-ancestor
92212398|NCT00372736|Mitosis Modulators|mitosis modulators|mesh-ancestor
92212399|NCT00372736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212400|NCT02415712|Fomepizole|fomepizole|mesh-list
92212401|NCT02415712|Antidotes|antidotes|mesh-ancestor
92212402|NCT02415712|Protective Agents|protective agents|mesh-ancestor
92212403|NCT02415712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212404|NCT02415712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212405|NCT02415712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212406|NCT05456698|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92212407|NCT05456698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212408|NCT05456698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212409|NCT05456698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92212410|NCT05456698|Immunotoxins|immunotoxins|mesh-ancestor
92212411|NCT05456698|Immunoconjugates|immunoconjugates|mesh-ancestor
92212412|NCT05456698|Immunologic Factors|immunologic factors|mesh-ancestor
92212413|NCT05456698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212414|NCT02973724|Remifentanil|remifentanil|mesh-list
92212415|NCT02973724|Propofol|propofol|mesh-list
92212416|NCT02973724|Anesthetics|anesthetics|mesh-ancestor
92212417|NCT02973724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212418|NCT02973724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212419|NCT02973724|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92212420|NCT02973724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92212421|NCT02973724|Anesthetics, General|anesthetics, general|mesh-ancestor
92212422|NCT02973724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92212423|NCT02973724|Narcotics|narcotics|mesh-ancestor
92212424|NCT02973724|Analgesics|analgesics|mesh-ancestor
92212425|NCT02973724|Sensory System Agents|sensory system agents|mesh-ancestor
92212426|NCT02973724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212427|NCT05456542|Dexamethasone|dexamethasone|mesh-list
92212428|NCT05456542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212429|NCT05456542|Antiemetics|antiemetics|mesh-ancestor
92212430|NCT05456542|Autonomic Agents|autonomic agents|mesh-ancestor
92212431|NCT05456542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212432|NCT05456542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212433|NCT05456542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212434|NCT05456542|Glucocorticoids|glucocorticoids|mesh-ancestor
92212435|NCT05456542|Hormones|hormones|mesh-ancestor
92336724|NCT01984164|Protease Inhibitors|protease inhibitors|mesh-ancestor
92212436|NCT05456542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212437|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92212438|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212439|NCT05455918|Paclitaxel|paclitaxel|mesh-list
92212440|NCT05455918|Ifosfamide|ifosfamide|mesh-list
92212441|NCT05455918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92212442|NCT05455918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212443|NCT05455918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92212444|NCT05455918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92212445|NCT05455918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92212446|NCT05455918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212447|NCT05455918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92212448|NCT05455918|Alkylating Agents|alkylating agents|mesh-ancestor
92212449|NCT00889187|Capecitabine|capecitabine|mesh-list
92212450|NCT00889187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212451|NCT00889187|Antimetabolites|antimetabolites|mesh-ancestor
92212452|NCT00889187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212453|NCT00889187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212454|NCT04334824|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92212455|NCT04334824|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92212456|NCT04334824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92212457|NCT04334824|Diuretics|diuretics|mesh-ancestor
92212458|NCT04334824|Natriuretic Agents|natriuretic agents|mesh-ancestor
92212459|NCT04334824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212460|NCT04334824|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92212461|NCT04334824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212462|NCT04334824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212464|NCT04334824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212465|NCT05314127|Fluorouracil|fluorouracil|mesh-list
92212466|NCT05314127|Imiquimod|imiquimod|mesh-list
92212467|NCT05314127|Tazarotene|tazarotene|mesh-list
92212468|NCT05314127|Petrolatum|petrolatum|mesh-list
92212469|NCT05314127|Antimetabolites|antimetabolites|mesh-ancestor
92212470|NCT05314127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212471|NCT05314127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212472|NCT05314127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212473|NCT05314127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92212474|NCT05314127|Immunologic Factors|immunologic factors|mesh-ancestor
92212475|NCT05314127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212476|NCT05314127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92212477|NCT05314127|Interferon Inducers|interferon inducers|mesh-ancestor
92212478|NCT05314127|Dermatologic Agents|dermatologic agents|mesh-ancestor
92212479|NCT05314127|Keratolytic Agents|keratolytic agents|mesh-ancestor
92212480|NCT05314127|Emollients|emollients|mesh-ancestor
92212481|NCT03130127|Terlipressin|terlipressin|mesh-list
92212482|NCT03130127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92212483|NCT03130127|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92212484|NCT04225078|Moxifloxacin|moxifloxacin|mesh-list
92212485|NCT04225078|Loperamide|loperamide|mesh-list
92212486|NCT04225078|Antidiarrheals|antidiarrheals|mesh-list
92212487|NCT04225078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212488|NCT04225078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212489|NCT04225078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92212490|NCT04225078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92212491|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212492|NCT04225078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212493|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212494|NCT04225078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212495|NCT00373048|Mefloquine|mefloquine|mesh-list
92212496|NCT00373048|Antimalarials|antimalarials|mesh-ancestor
92212497|NCT00373048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92212498|NCT00373048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92212499|NCT00373048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212500|NCT00372892|Rituximab|rituximab|mesh-list
92212501|NCT00372892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212502|NCT00372892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212503|NCT00372892|Immunologic Factors|immunologic factors|mesh-ancestor
92212504|NCT00372892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212505|NCT00372892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212506|NCT00895817|Fluticasone|fluticasone|mesh-list
92212507|NCT00895817|Esomeprazole|esomeprazole|mesh-list
92336729|NCT01983774|Esomeprazole|esomeprazole|mesh-list
92212508|NCT00895817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212509|NCT00895817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92212510|NCT00895817|Autonomic Agents|autonomic agents|mesh-ancestor
92212511|NCT00895817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212512|NCT00895817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212513|NCT00895817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92212514|NCT00895817|Respiratory System Agents|respiratory system agents|mesh-ancestor
92212515|NCT00895817|Dermatologic Agents|dermatologic agents|mesh-ancestor
92212516|NCT00895817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92212517|NCT00895817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92212518|NCT00895817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212519|NCT00895817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92212520|NCT00895817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212521|NCT00895817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212522|NCT03020303|Spironolactone|spironolactone|mesh-list
92212523|NCT03020303|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92212524|NCT03020303|Hormone Antagonists|hormone antagonists|mesh-ancestor
92212525|NCT03020303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212526|NCT03020303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212527|NCT03020303|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92212528|NCT03020303|Diuretics|diuretics|mesh-ancestor
92212529|NCT03020303|Natriuretic Agents|natriuretic agents|mesh-ancestor
92212530|NCT04825522|Vancomycin|vancomycin|mesh-list
92212531|NCT04825522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212532|NCT04825522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212533|NCT00373204|Motexafin gadolinium|motexafin gadolinium|mesh-list
92212534|NCT00373204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212535|NCT00373204|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92212536|NCT00373204|Dermatologic Agents|dermatologic agents|mesh-ancestor
92212537|NCT00373282|Triamcinolone|triamcinolone|mesh-list
92212538|NCT00373282|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92212540|NCT00373282|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92212541|NCT00373282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212542|NCT00373282|Glucocorticoids|glucocorticoids|mesh-ancestor
92212543|NCT00373282|Hormones|hormones|mesh-ancestor
92212544|NCT00373282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212545|NCT00373282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212546|NCT00373282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92212547|NCT00373282|Immunologic Factors|immunologic factors|mesh-ancestor
92212548|NCT00373282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212549|NCT00373282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212550|NCT04033354|Paclitaxel|paclitaxel|mesh-list
92212551|NCT04033354|Carboplatin|carboplatin|mesh-list
92212552|NCT04033354|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92212553|NCT04033354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212554|NCT04033354|Tubulin Modulators|tubulin modulators|mesh-ancestor
92212555|NCT04033354|Antimitotic Agents|antimitotic agents|mesh-ancestor
92212556|NCT04033354|Mitosis Modulators|mitosis modulators|mesh-ancestor
92212557|NCT04033354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212558|NCT04382027|Vitamins|vitamins|mesh-list
92212559|NCT04382027|Vitamin K|vitamin k|mesh-list
92212560|NCT04382027|Vitamin K 2|vitamin k 2|mesh-list
92212561|NCT04382027|Micronutrients|micronutrients|mesh-ancestor
92212562|NCT04382027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212563|NCT04382027|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92212564|NCT04382027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92212565|NCT04382027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212566|NCT04382027|Hemostatics|hemostatics|mesh-ancestor
92212567|NCT04382027|Coagulants|coagulants|mesh-ancestor
92212568|NCT00896441|Citalopram|citalopram|mesh-list
92212569|NCT00896441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92212570|NCT00896441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92212571|NCT00896441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212572|NCT00896441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212573|NCT00896441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212574|NCT00896441|Serotonin Agents|serotonin agents|mesh-ancestor
92212575|NCT00896441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212576|NCT00896441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92212577|NCT00896441|Antidepressive Agents|antidepressive agents|mesh-ancestor
92212578|NCT00896441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92212579|NCT02790515|Sirolimus|sirolimus|mesh-list
92212580|NCT02790515|Cyclophosphamide|cyclophosphamide|mesh-list
92212581|NCT02790515|Melphalan|melphalan|mesh-list
92212582|NCT02790515|Mechlorethamine|mechlorethamine|mesh-list
92212583|NCT02790515|Thiotepa|thiotepa|mesh-list
92212584|NCT02790515|Rituximab|rituximab|mesh-list
92212585|NCT02790515|Fludarabine|fludarabine|mesh-list
92212586|NCT02790515|Blinatumomab|blinatumomab|mesh-list
92212587|NCT02790515|Tacrolimus|tacrolimus|mesh-list
92212588|NCT02790515|Thymoglobulin|thymoglobulin|mesh-list
92212589|NCT02790515|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92212590|NCT02790515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92212591|NCT02790515|Immunologic Factors|immunologic factors|mesh-ancestor
92212592|NCT02790515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212593|NCT02790515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212594|NCT02790515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92212595|NCT02790515|Alkylating Agents|alkylating agents|mesh-ancestor
92212596|NCT02790515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212597|NCT02790515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212598|NCT02790515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92212599|NCT02790515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212600|NCT02790515|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92212601|NCT02790515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212602|NCT02790515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212603|NCT02790515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212604|NCT02790515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92212605|NCT02790515|Antifungal Agents|antifungal agents|mesh-ancestor
92212606|NCT03400111|Acetaminophen|acetaminophen|mesh-list
92212607|NCT03400111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212608|NCT03400111|Analgesics|analgesics|mesh-ancestor
92212609|NCT03400111|Sensory System Agents|sensory system agents|mesh-ancestor
92212610|NCT03400111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212611|NCT03400111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212612|NCT03400111|Antipyretics|antipyretics|mesh-ancestor
92212613|NCT03404791|Gemcitabine|gemcitabine|mesh-list
92212614|NCT03404791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212616|NCT03404791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212617|NCT03404791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212619|NCT00918931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212620|NCT00918931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212621|NCT03404011|Glycerol|glycerol|mesh-list
92212622|NCT03404011|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92212623|NCT03404011|Protective Agents|protective agents|mesh-ancestor
91921456|NCT02188615|Tubulin Modulators|tubulin modulators|mesh-ancestor
92212624|NCT03404011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212625|NCT01830491|Aspirin|aspirin|mesh-list
92212626|NCT01830491|Clopidogrel|clopidogrel|mesh-list
92212627|NCT01830491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92212628|NCT01830491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212629|NCT01830491|Analgesics|analgesics|mesh-ancestor
92212630|NCT01830491|Sensory System Agents|sensory system agents|mesh-ancestor
92212631|NCT01830491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212632|NCT01830491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212633|NCT01830491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212634|NCT01830491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212635|NCT01830491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92212636|NCT01830491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92212637|NCT01830491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212638|NCT01830491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92212639|NCT01830491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92212640|NCT01830491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212641|NCT01830491|Antipyretics|antipyretics|mesh-ancestor
92212642|NCT01830491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92212643|NCT01830491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92212644|NCT01830491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92212645|NCT01830491|Purinergic Agents|purinergic agents|mesh-ancestor
92212646|NCT01830491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212647|NCT02778880|Fentanyl|fentanyl|mesh-list
92212648|NCT02778880|Ketamine|ketamine|mesh-list
92212649|NCT02778880|Analgesics|analgesics|mesh-ancestor
92212650|NCT02778880|Sensory System Agents|sensory system agents|mesh-ancestor
92212651|NCT02778880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212652|NCT02778880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212653|NCT02778880|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92212654|NCT02778880|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92212655|NCT02778880|Anesthetics, General|anesthetics, general|mesh-ancestor
92212656|NCT02778880|Anesthetics|anesthetics|mesh-ancestor
92212657|NCT02778880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212658|NCT02778880|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92212659|NCT02778880|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92212660|NCT02778880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212661|NCT02778880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212662|NCT02778880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92212663|NCT02778880|Narcotics|narcotics|mesh-ancestor
92212664|NCT02778880|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92212665|NCT05310929|Labetalol|labetalol|mesh-list
92212666|NCT05310929|Nitroglycerin|nitroglycerin|mesh-list
92212667|NCT05310929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92212668|NCT05310929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92212669|NCT05310929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92212670|NCT05310929|Adrenergic Agents|adrenergic agents|mesh-ancestor
92212671|NCT05310929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212672|NCT05310929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212673|NCT05310929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212674|NCT05310929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92212675|NCT05310929|Sympathomimetics|sympathomimetics|mesh-ancestor
92212676|NCT05310929|Autonomic Agents|autonomic agents|mesh-ancestor
92212677|NCT05310929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212678|NCT05310929|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92212679|NCT05310929|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92212680|NCT00891995|Insulin|insulin|mesh-list
92212681|NCT00891995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92212682|NCT00891995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212684|NCT02781454|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92212685|NCT02781454|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92212686|NCT02781454|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92212687|NCT02781454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212688|NCT02781454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212690|NCT00892697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92212691|NCT00892697|Antimetabolites|antimetabolites|mesh-ancestor
92212692|NCT00892697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212693|NCT00892697|Antiviral Agents|antiviral agents|mesh-ancestor
92212694|NCT00892697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212695|NCT02155465|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92212696|NCT02155465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212697|NCT02155465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92212698|NCT02155465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921457|NCT02188615|Antimitotic Agents|antimitotic agents|mesh-ancestor
92212699|NCT02155465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212700|NCT01831193|Curcumin|curcumin|mesh-list
92212701|NCT01831193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92212702|NCT01831193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212703|NCT01831193|Analgesics|analgesics|mesh-ancestor
92212704|NCT01831193|Sensory System Agents|sensory system agents|mesh-ancestor
92212705|NCT01831193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212706|NCT01831193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212707|NCT01831193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212708|NCT01831193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212709|NCT01831193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212710|NCT01831193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212711|NCT01831193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212712|NCT01831505|Prednisolone|prednisolone|mesh-list
92212713|NCT01831505|Rituximab|rituximab|mesh-list
92212714|NCT01831505|Doxorubicin|doxorubicin|mesh-list
92212715|NCT01831505|Vincristine|vincristine|mesh-list
92212716|NCT01831505|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92212717|NCT01831505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212718|NCT01831505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212719|NCT01831505|Immunologic Factors|immunologic factors|mesh-ancestor
92212720|NCT01831505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212721|NCT01831505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212722|NCT01831505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92212723|NCT01831505|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92212724|NCT01831505|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92212725|NCT01831505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212726|NCT01831505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212727|NCT01831505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92212728|NCT01831505|Tubulin Modulators|tubulin modulators|mesh-ancestor
92212729|NCT01831505|Antimitotic Agents|antimitotic agents|mesh-ancestor
92212730|NCT01831505|Mitosis Modulators|mitosis modulators|mesh-ancestor
92212731|NCT01831505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212732|NCT01831505|Glucocorticoids|glucocorticoids|mesh-ancestor
92212734|NCT01831505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212735|NCT01831505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92212736|NCT01831505|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92212737|NCT01831505|Alkylating Agents|alkylating agents|mesh-ancestor
92212738|NCT02781610|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92212739|NCT02781610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212740|NCT03214055|Mannitol|mannitol|mesh-list
92212741|NCT03214055|Diuretics|diuretics|mesh-list
92212742|NCT03214055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92212743|NCT03214055|Natriuretic Agents|natriuretic agents|mesh-ancestor
92212744|NCT03214055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212745|NCT03405337|Factor VIII|factor viii|mesh-list
92212746|NCT03405337|Coagulants|coagulants|mesh-ancestor
92212747|NCT01831661|Metformin|metformin|mesh-list
92212748|NCT01831661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92212749|NCT01831661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212750|NCT05311085|Nicotine|nicotine|mesh-list
92212751|NCT05311085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92212752|NCT05311085|Autonomic Agents|autonomic agents|mesh-ancestor
92212753|NCT05311085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212754|NCT05311085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212755|NCT05311085|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92212756|NCT05311085|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92212757|NCT05311085|Cholinergic Agents|cholinergic agents|mesh-ancestor
92212758|NCT05311085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212759|NCT05311085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212760|NCT03400267|Acetaminophen|acetaminophen|mesh-list
92212762|NCT03400267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92212764|NCT03400267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212765|NCT03400267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212766|NCT03400267|Analgesics|analgesics|mesh-ancestor
92212767|NCT03400267|Sensory System Agents|sensory system agents|mesh-ancestor
92212768|NCT03400267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212769|NCT03400267|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92212770|NCT03400267|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92212771|NCT03400267|Anesthetics, General|anesthetics, general|mesh-ancestor
92212772|NCT03400267|Anesthetics|anesthetics|mesh-ancestor
92212773|NCT03400267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212774|NCT03400267|Antipyretics|antipyretics|mesh-ancestor
92212775|NCT01832051|Trastuzumab|trastuzumab|mesh-list
92212776|NCT01832051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92212777|NCT01832051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212778|NCT01832129|Vitamins|vitamins|mesh-list
92212779|NCT01832129|Hydroxocobalamin|hydroxocobalamin|mesh-list
92212780|NCT01832129|Vitamin B 12|vitamin b 12|mesh-list
92212781|NCT01832129|Vitamin B Complex|vitamin b complex|mesh-list
92212782|NCT01832129|Micronutrients|micronutrients|mesh-ancestor
92212783|NCT01832129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212784|NCT01832129|Hematinics|hematinics|mesh-ancestor
92212785|NCT03219359|Methylprednisolone|methylprednisolone|mesh-list
92212786|NCT03219359|Cyclophosphamide|cyclophosphamide|mesh-list
92212787|NCT03219359|Vedolizumab|vedolizumab|mesh-list
92212788|NCT03219359|Thymoglobulin|thymoglobulin|mesh-list
92212789|NCT03219359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92212790|NCT03219359|Immunologic Factors|immunologic factors|mesh-ancestor
92212791|NCT03219359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212792|NCT03219359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212793|NCT03219359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92212794|NCT03219359|Alkylating Agents|alkylating agents|mesh-ancestor
92212795|NCT03219359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212796|NCT03219359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212797|NCT03219359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92212798|NCT03219359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212799|NCT03219359|Antiemetics|antiemetics|mesh-ancestor
92212800|NCT03219359|Autonomic Agents|autonomic agents|mesh-ancestor
92212801|NCT03219359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212802|NCT03219359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212803|NCT03219359|Glucocorticoids|glucocorticoids|mesh-ancestor
92212804|NCT03219359|Hormones|hormones|mesh-ancestor
92212805|NCT03219359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212806|NCT03219359|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92212807|NCT03219359|Protective Agents|protective agents|mesh-ancestor
92212808|NCT04380857|Dexamethasone|dexamethasone|mesh-list
92212809|NCT04380857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212810|NCT04380857|Antiemetics|antiemetics|mesh-ancestor
92212811|NCT04380857|Autonomic Agents|autonomic agents|mesh-ancestor
92212812|NCT04380857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212813|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212814|NCT04380857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212815|NCT04380857|Glucocorticoids|glucocorticoids|mesh-ancestor
92212816|NCT04380857|Hormones|hormones|mesh-ancestor
92212817|NCT04380857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92212818|NCT04380857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92212819|NCT04380857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212820|NCT02903446|Denosumab|denosumab|mesh-list
92212821|NCT02903446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92212822|NCT02903446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212823|NCT01832285|Fluvoxamine|fluvoxamine|mesh-list
92212824|NCT01832285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92212825|NCT01832285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92212826|NCT01832285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212827|NCT01832285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212828|NCT01832285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92212829|NCT01832285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92212830|NCT01832285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92212831|NCT01832285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212832|NCT01832285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212833|NCT01832285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212834|NCT01832285|Serotonin Agents|serotonin agents|mesh-ancestor
92212835|NCT01832285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92212836|NCT01832285|Antidepressive Agents|antidepressive agents|mesh-ancestor
92212837|NCT01832285|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92212838|NCT01832285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92212839|NCT01832285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212840|NCT01832285|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92212842|NCT01832363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92212843|NCT01832363|Anesthetics, General|anesthetics, general|mesh-ancestor
92212844|NCT01832363|Anesthetics|anesthetics|mesh-ancestor
92212845|NCT01832363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212846|NCT01832363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212847|NCT02903836|Moxifloxacin|moxifloxacin|mesh-list
92212848|NCT02903836|Nafithromycin|nafithromycin|mesh-list
92212849|NCT02903836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212850|NCT02903836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212851|NCT02903836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92212852|NCT02903836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92212853|NCT02903836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212854|NCT02903836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336763|NCT01939314|Bupivacaine|bupivacaine|mesh-list
92212855|NCT02903836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212856|NCT02903836|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92212857|NCT00014911|Sirolimus|sirolimus|mesh-list
92212858|NCT00014911|Pentamidine|pentamidine|mesh-list
92212859|NCT00014911|Trimethoprim|trimethoprim|mesh-list
92212860|NCT00014911|Sulfamethoxazole|sulfamethoxazole|mesh-list
92212861|NCT00014911|Ganciclovir|ganciclovir|mesh-list
92212862|NCT00014911|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92212863|NCT00014911|Tacrolimus|tacrolimus|mesh-list
92212864|NCT00014911|Daclizumab|daclizumab|mesh-list
92212865|NCT00014911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92212866|NCT00014911|Immunologic Factors|immunologic factors|mesh-ancestor
92212867|NCT00014911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212868|NCT00014911|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92212869|NCT00014911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212870|NCT00014911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212871|NCT00014911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92212872|NCT00014911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212873|NCT00014911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92212874|NCT00014911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212875|NCT00014911|Antifungal Agents|antifungal agents|mesh-ancestor
92212876|NCT00014911|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92212877|NCT00014911|Antimalarials|antimalarials|mesh-ancestor
92212878|NCT00014911|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92212879|NCT00014911|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92212880|NCT00014911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92212881|NCT00014911|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92212882|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92212883|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92212884|NCT00014911|Antiviral Agents|antiviral agents|mesh-ancestor
92212885|NCT00014911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92212886|NCT00014911|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92212887|NCT01832675|Bupivacaine|bupivacaine|mesh-list
92212888|NCT01832675|Anesthetics, Local|anesthetics, local|mesh-ancestor
92212889|NCT01832675|Anesthetics|anesthetics|mesh-ancestor
92212890|NCT01832675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212891|NCT01832675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212892|NCT01832675|Sensory System Agents|sensory system agents|mesh-ancestor
92212893|NCT01832675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212894|NCT03213587|Apatinib|apatinib|mesh-list
92212895|NCT03213587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212896|NCT03213587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92212897|NCT03213587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212898|NCT03213587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212899|NCT00013897|Lamivudine|lamivudine|mesh-list
92212900|NCT00013897|Zidovudine|zidovudine|mesh-list
92212901|NCT00013897|Efavirenz|efavirenz|mesh-list
92212902|NCT00013897|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92212903|NCT00013897|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92212904|NCT00013897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92212905|NCT00013897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92212906|NCT00013897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212907|NCT00013897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212908|NCT00013897|Antiviral Agents|antiviral agents|mesh-ancestor
92212909|NCT00013897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212910|NCT00013897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92212911|NCT00013897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92212912|NCT00013897|Antimetabolites|antimetabolites|mesh-ancestor
92212913|NCT00013897|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92212914|NCT00013897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92212915|NCT00013897|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92212916|NCT00013897|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92212917|NCT00013897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92212918|NCT00013897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92212919|NCT00013897|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92212920|NCT00013897|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92212921|NCT00013897|Protease Inhibitors|protease inhibitors|mesh-ancestor
92212922|NCT03219983|Bupivacaine|bupivacaine|mesh-list
92212923|NCT03219983|Ropivacaine|ropivacaine|mesh-list
92212924|NCT03219983|Anesthetics, Local|anesthetics, local|mesh-ancestor
92212925|NCT03219983|Anesthetics|anesthetics|mesh-ancestor
92212926|NCT03219983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212927|NCT03219983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212928|NCT03219983|Sensory System Agents|sensory system agents|mesh-ancestor
92212929|NCT03219983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212930|NCT04347577|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92212931|NCT04347577|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92212932|NCT04347577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92212933|NCT04347577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92212934|NCT04347577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212935|NCT04347577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212936|NCT04347577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212937|NCT04347577|Analgesics|analgesics|mesh-ancestor
92212938|NCT04347577|Sensory System Agents|sensory system agents|mesh-ancestor
92212939|NCT04347577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212940|NCT04347577|Antidepressive Agents|antidepressive agents|mesh-ancestor
92212941|NCT04347577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92212942|NCT04347577|Dopamine Agents|dopamine agents|mesh-ancestor
92212943|NCT02240017|Carboplatin|carboplatin|mesh-list
92212944|NCT02240017|Gemcitabine|gemcitabine|mesh-list
92212945|NCT02240017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212946|NCT02240017|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92212947|NCT02240017|Antimetabolites|antimetabolites|mesh-ancestor
92212948|NCT02240017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212949|NCT00899717|Salicylic Acid|salicylic acid|mesh-list
92212950|NCT00899717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92212951|NCT00899717|Antifungal Agents|antifungal agents|mesh-ancestor
92212952|NCT00899717|Keratolytic Agents|keratolytic agents|mesh-ancestor
92212953|NCT00899717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92212954|NCT03219593|Apatinib|apatinib|mesh-list
92212955|NCT03219593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212956|NCT03219593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92212957|NCT03219593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212958|NCT03219593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212959|NCT04375267|Olaparib|olaparib|mesh-list
92212960|NCT04375267|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92212961|NCT04375267|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92212962|NCT04375267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212963|NCT04375267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212964|NCT04375267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92212965|NCT04375267|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92212966|NCT03836807|Ketoprofen|ketoprofen|mesh-list
92212967|NCT03836807|Ketoprofen lysine|ketoprofen lysine|mesh-list
92212968|NCT03836807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92212969|NCT03836807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92212970|NCT03836807|Analgesics|analgesics|mesh-ancestor
92212971|NCT03836807|Sensory System Agents|sensory system agents|mesh-ancestor
92212972|NCT03836807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212973|NCT03836807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212974|NCT03836807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92212975|NCT03836807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92212976|NCT03836807|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92212977|NCT03836807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92212978|NCT03836807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212979|NCT02240173|Haloperidol|haloperidol|mesh-list
92212980|NCT02240173|Haloperidol decanoate|haloperidol decanoate|mesh-list
92212981|NCT02240173|Antiemetics|antiemetics|mesh-ancestor
92212982|NCT02240173|Autonomic Agents|autonomic agents|mesh-ancestor
92212983|NCT02240173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92212984|NCT02240173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92212985|NCT02240173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92212987|NCT02240173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92212988|NCT02240173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92212989|NCT02240173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92212990|NCT02240173|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92212991|NCT02240173|Dopamine Agents|dopamine agents|mesh-ancestor
92212992|NCT02240173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92212993|NCT02240173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92212994|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92212995|NCT02240641|Antihypertensive Agents|antihypertensive agents|mesh-list
92212997|NCT02240641|Diuretics|diuretics|mesh-list
92212998|NCT02240641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92212999|NCT02240641|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92213000|NCT02240641|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92213001|NCT02240641|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92213002|NCT02240641|Natriuretic Agents|natriuretic agents|mesh-ancestor
92213003|NCT02240641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213004|NCT02240641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92213005|NCT02240641|Adrenergic Agents|adrenergic agents|mesh-ancestor
92213006|NCT02240641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213007|NCT02240641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213008|NCT02240641|Protease Inhibitors|protease inhibitors|mesh-ancestor
92213009|NCT02240641|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92213010|NCT02240641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213011|NCT02240641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92213012|NCT03219671|Nivolumab|nivolumab|mesh-list
92213013|NCT03219671|Ipilimumab|ipilimumab|mesh-list
92213014|NCT03219671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213015|NCT03219671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213016|NCT03219671|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92213017|NCT03219671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213018|NCT03404635|Rivaroxaban|rivaroxaban|mesh-list
92213019|NCT03404635|Apixaban|apixaban|mesh-list
92213020|NCT03404635|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92213021|NCT03404635|Antithrombins|antithrombins|mesh-ancestor
92213022|NCT03404635|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92213023|NCT03404635|Protease Inhibitors|protease inhibitors|mesh-ancestor
92213024|NCT03404635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213025|NCT03404635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213026|NCT03404635|Anticoagulants|anticoagulants|mesh-ancestor
92213027|NCT01832987|Trimethoprim|trimethoprim|mesh-list
92213028|NCT01832987|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92213029|NCT01832987|Sulfamethoxazole|sulfamethoxazole|mesh-list
92213030|NCT01832987|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92213031|NCT01832987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213032|NCT01832987|Antimalarials|antimalarials|mesh-ancestor
92213033|NCT01832987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92213034|NCT01832987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92213035|NCT01832987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92213036|NCT01832987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213037|NCT01832987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213038|NCT01832987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92213039|NCT01832987|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92213040|NCT01832987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92213041|NCT01832987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213042|NCT03404479|Celecoxib|celecoxib|mesh-list
92213043|NCT03404479|Diacerein|diacerein|mesh-list
92213044|NCT03404479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92213045|NCT03404479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213047|NCT03404479|Sensory System Agents|sensory system agents|mesh-ancestor
92213048|NCT03404479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213049|NCT03404479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213050|NCT03404479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213051|NCT03404479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213052|NCT03404479|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92213053|NCT03404479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92213054|NCT03404479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213055|NCT03404479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213056|NCT04380467|Vitamin D|vitamin d|mesh-list
92213057|NCT04380467|Cholecalciferol|cholecalciferol|mesh-list
92213058|NCT04380467|Vitamins|vitamins|mesh-ancestor
92213059|NCT04380467|Micronutrients|micronutrients|mesh-ancestor
92213060|NCT04380467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213061|NCT04380467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92213062|NCT04380467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92213063|NCT03218657|Cyclosporine|cyclosporine|mesh-list
92213064|NCT03218657|Levamisole|levamisole|mesh-list
92213065|NCT03218657|Cyclosporins|cyclosporins|mesh-list
92213066|NCT03218657|Androgens|androgens|mesh-list
92213067|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213068|NCT03218657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213069|NCT03218657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213070|NCT03218657|Immunologic Factors|immunologic factors|mesh-ancestor
92213071|NCT03218657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213072|NCT03218657|Antifungal Agents|antifungal agents|mesh-ancestor
92213073|NCT03218657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213074|NCT03218657|Dermatologic Agents|dermatologic agents|mesh-ancestor
92213075|NCT03218657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213076|NCT03218657|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92213077|NCT03218657|Hormones|hormones|mesh-ancestor
92213078|NCT03218657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213079|NCT03218657|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92213080|NCT03218657|Antinematodal Agents|antinematodal agents|mesh-ancestor
92213081|NCT03218657|Anthelmintics|anthelmintics|mesh-ancestor
92213082|NCT03218657|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92213083|NCT02240719|Everolimus|everolimus|mesh-list
92213084|NCT02240719|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92213085|NCT02240719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92213086|NCT02240719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92213087|NCT02240719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213088|NCT02240719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213089|NCT02240719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213090|NCT02240719|Immunologic Factors|immunologic factors|mesh-ancestor
92213091|NCT02240719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213092|NCT02240719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213093|NCT02240719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92213094|NCT02240719|Alkylating Agents|alkylating agents|mesh-ancestor
92213095|NCT01833299|Sorafenib|sorafenib|mesh-list
92213096|NCT01833299|Chlorotrianisene|chlorotrianisene|mesh-list
92213097|NCT01833299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213098|NCT01833299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92213099|NCT01833299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213100|NCT01833299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213101|NCT01833299|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92213102|NCT01833299|Estrogens|estrogens|mesh-ancestor
92213103|NCT01833299|Hormones|hormones|mesh-ancestor
92213104|NCT01833299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213105|NCT01833299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213106|NCT01833299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92213107|NCT03213041|Carboplatin|carboplatin|mesh-list
92213108|NCT03213041|Pembrolizumab|pembrolizumab|mesh-list
92213109|NCT03213041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213110|NCT03213041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213111|NCT03213041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92213112|NCT03213041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213113|NCT02240875|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92213114|NCT02240875|Antiviral Agents|antiviral agents|mesh-ancestor
92213115|NCT02240875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213116|NCT01833611|Entecavir|entecavir|mesh-list
92213117|NCT01833611|Antiviral Agents|antiviral agents|mesh-ancestor
92213118|NCT01833611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213120|NCT02240953|Anticoagulants|anticoagulants|mesh-ancestor
92213121|NCT03212729|Anti-Infective Agents|anti-infective agents|mesh-list
92213122|NCT03212729|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92213123|NCT02241031|Oprelvekin|oprelvekin|mesh-list
92213124|NCT02241031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213125|NCT03212807|Lenalidomide|lenalidomide|mesh-list
92213126|NCT03212807|Durvalumab|durvalumab|mesh-list
92213127|NCT03212807|Immunologic Factors|immunologic factors|mesh-ancestor
92213128|NCT03212807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213129|NCT03212807|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92213130|NCT03212807|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92213131|NCT03212807|Growth Substances|growth substances|mesh-ancestor
92213132|NCT03212807|Growth Inhibitors|growth inhibitors|mesh-ancestor
92213133|NCT03212807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213134|NCT03212807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213135|NCT04373941|Lenograstim|lenograstim|mesh-list
92213136|NCT04373941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92213137|NCT04373941|Immunologic Factors|immunologic factors|mesh-ancestor
92213138|NCT04373941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213139|NCT01833767|Cyclophosphamide|cyclophosphamide|mesh-list
92213140|NCT01833767|Interleukin-2|interleukin-2|mesh-list
92213141|NCT01833767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213142|NCT01833767|Immunologic Factors|immunologic factors|mesh-ancestor
92213143|NCT01833767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213144|NCT01833767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213145|NCT01833767|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92213146|NCT01833767|Alkylating Agents|alkylating agents|mesh-ancestor
92213147|NCT01833767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213148|NCT01833767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213149|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92213150|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213151|NCT01833767|Analgesics|analgesics|mesh-ancestor
92213152|NCT01833767|Sensory System Agents|sensory system agents|mesh-ancestor
91921458|NCT02188615|Mitosis Modulators|mitosis modulators|mesh-ancestor
92213153|NCT01833767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213154|NCT03213353|Acetaminophen|acetaminophen|mesh-list
92213155|NCT03213353|Phenylpropanolamine|phenylpropanolamine|mesh-list
92213156|NCT03213353|Phenylephrine|phenylephrine|mesh-list
92213157|NCT03213353|Oxymetazoline|oxymetazoline|mesh-list
92213158|NCT03213353|Guaifenesin|guaifenesin|mesh-list
92213159|NCT03213353|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92213160|NCT03213353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213161|NCT03213353|Analgesics|analgesics|mesh-ancestor
92213162|NCT03213353|Sensory System Agents|sensory system agents|mesh-ancestor
92213163|NCT03213353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213164|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213165|NCT03213353|Antipyretics|antipyretics|mesh-ancestor
92213166|NCT03213353|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92213167|NCT03213353|Mydriatics|mydriatics|mesh-ancestor
92213168|NCT03213353|Autonomic Agents|autonomic agents|mesh-ancestor
92213169|NCT03213353|Sympathomimetics|sympathomimetics|mesh-ancestor
92213170|NCT03213353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92213171|NCT03213353|Nasal Decongestants|nasal decongestants|mesh-ancestor
92213172|NCT03213353|Respiratory System Agents|respiratory system agents|mesh-ancestor
92213173|NCT03213353|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92213174|NCT03213353|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92213175|NCT03213353|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92213176|NCT03213353|Adrenergic Agents|adrenergic agents|mesh-ancestor
92213177|NCT03213353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213178|NCT03213353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213179|NCT03213353|Protective Agents|protective agents|mesh-ancestor
92213180|NCT03213353|Expectorants|expectorants|mesh-ancestor
92213181|NCT03213353|Appetite Depressants|appetite depressants|mesh-ancestor
92213182|NCT03213353|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92213183|NCT01834235|Paclitaxel|paclitaxel|mesh-list
92213184|NCT01834235|Gemcitabine|gemcitabine|mesh-list
92213185|NCT01834235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92213186|NCT01834235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213187|NCT01834235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92213188|NCT01834235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92213189|NCT01834235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92213190|NCT01834235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213191|NCT01834235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92213192|NCT01834235|Antimetabolites|antimetabolites|mesh-ancestor
92213193|NCT03211871|Dexmedetomidine|dexmedetomidine|mesh-list
92213194|NCT03211871|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92213195|NCT03211871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213196|NCT03211871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213197|NCT03211871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213198|NCT03211871|Analgesics|analgesics|mesh-ancestor
92213199|NCT03211871|Sensory System Agents|sensory system agents|mesh-ancestor
92213200|NCT03211871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213201|NCT03211871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92213202|NCT03211871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92213203|NCT03211871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92213204|NCT03211871|Adrenergic Agents|adrenergic agents|mesh-ancestor
92213205|NCT03211871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213206|NCT03211871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213207|NCT03838133|Bupivacaine|bupivacaine|mesh-list
92213208|NCT03838133|Ropivacaine|ropivacaine|mesh-list
92213209|NCT03838133|Anesthetics, Local|anesthetics, local|mesh-ancestor
92213210|NCT03838133|Anesthetics|anesthetics|mesh-ancestor
92213211|NCT03838133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213212|NCT03838133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213213|NCT03838133|Sensory System Agents|sensory system agents|mesh-ancestor
92213214|NCT03838133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213215|NCT03217409|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92213216|NCT03217409|Ezetimibe|ezetimibe|mesh-list
92213217|NCT03217409|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92213218|NCT03217409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92213219|NCT03217409|Antimetabolites|antimetabolites|mesh-ancestor
92213220|NCT03217409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213221|NCT03217409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92213222|NCT03217409|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92213223|NCT03217409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213224|NCT00895193|Aspirin|aspirin|mesh-list
92213225|NCT00895193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92213226|NCT00895193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213227|NCT00895193|Analgesics|analgesics|mesh-ancestor
92213228|NCT00895193|Sensory System Agents|sensory system agents|mesh-ancestor
92336842|NCT01959672|Vitamins|vitamins|mesh-ancestor
92213229|NCT00895193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213230|NCT00895193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213231|NCT00895193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213232|NCT00895193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213233|NCT00895193|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92213234|NCT00895193|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92213235|NCT00895193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213236|NCT00895193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92213237|NCT00895193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92213238|NCT00895193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213239|NCT00895193|Antipyretics|antipyretics|mesh-ancestor
92213240|NCT01834547|Caffeine|caffeine|mesh-list
92213241|NCT01834547|Methylphenidate|methylphenidate|mesh-list
92213242|NCT01834547|Modafinil|modafinil|mesh-list
92213243|NCT01834547|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92213244|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213245|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92213246|NCT01834547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213247|NCT01834547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213248|NCT01834547|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92213249|NCT01834547|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92213250|NCT01834547|Purinergic Agents|purinergic agents|mesh-ancestor
92213251|NCT01834547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213252|NCT01834547|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92213253|NCT01834547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92213254|NCT01834547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213255|NCT01834547|Dopamine Agents|dopamine agents|mesh-ancestor
92213256|NCT01834547|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92213257|NCT01834547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92213258|NCT01834547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92213260|NCT03216941|Olanzapine|olanzapine|mesh-list
92213261|NCT03216941|Analgesics|analgesics|mesh-ancestor
92213262|NCT03216941|Sensory System Agents|sensory system agents|mesh-ancestor
92213263|NCT03216941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213264|NCT03216941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213265|NCT03216941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92213266|NCT03216941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92213267|NCT03216941|Anesthetics, General|anesthetics, general|mesh-ancestor
92213268|NCT03216941|Anesthetics|anesthetics|mesh-ancestor
92213269|NCT03216941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213270|NCT03216941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92213271|NCT03216941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92213272|NCT03216941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213273|NCT03216941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213274|NCT03216941|Antiemetics|antiemetics|mesh-ancestor
92213275|NCT03216941|Autonomic Agents|autonomic agents|mesh-ancestor
92213276|NCT03216941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92213277|NCT03216941|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92213278|NCT03216941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92213280|NCT03216941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92213281|NCT03216941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92213282|NCT03216941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213283|NCT03216941|Serotonin Agents|serotonin agents|mesh-ancestor
92213284|NCT03216707|Capsaicin|capsaicin|mesh-list
92213285|NCT03216707|Antipruritics|antipruritics|mesh-ancestor
92213286|NCT03216707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92213287|NCT03216707|Sensory System Agents|sensory system agents|mesh-ancestor
92213288|NCT03216707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213289|NCT03216707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213290|NCT01838993|Lidocaine|lidocaine|mesh-list
92213291|NCT01838993|Anesthetics, Local|anesthetics, local|mesh-ancestor
92213292|NCT01838993|Anesthetics|anesthetics|mesh-ancestor
92213293|NCT01838993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213294|NCT01838993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213295|NCT01838993|Sensory System Agents|sensory system agents|mesh-ancestor
92213296|NCT01838993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213297|NCT01838993|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92213298|NCT01838993|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92213299|NCT01838993|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92213300|NCT01838993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213301|NCT01838993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213302|NCT03211013|Oxytocin|oxytocin|mesh-list
92213303|NCT03211013|Oxytocics|oxytocics|mesh-ancestor
92213304|NCT03211013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92213305|NCT03211013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213306|NCT01835561|Thalidomide|thalidomide|mesh-list
92213307|NCT01835561|Pomalidomide|pomalidomide|mesh-list
92213308|NCT01835561|Immunologic Factors|immunologic factors|mesh-ancestor
92213309|NCT01835561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213310|NCT01835561|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92213311|NCT01835561|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92213312|NCT01835561|Growth Substances|growth substances|mesh-ancestor
92213313|NCT01835561|Growth Inhibitors|growth inhibitors|mesh-ancestor
92213314|NCT01835561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213315|NCT01835561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213316|NCT01835561|Leprostatic Agents|leprostatic agents|mesh-ancestor
92213317|NCT01835561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213318|NCT01835561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213319|NCT01835639|Vitamin D|vitamin d|mesh-list
92213320|NCT01835639|Cholecalciferol|cholecalciferol|mesh-list
92213321|NCT01835639|Vitamins|vitamins|mesh-ancestor
92213322|NCT01835639|Micronutrients|micronutrients|mesh-ancestor
92213323|NCT01835639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213324|NCT01835639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92213325|NCT01835639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92213326|NCT01839149|Oxytocin|oxytocin|mesh-list
92213327|NCT01839149|Oxytocics|oxytocics|mesh-ancestor
92213328|NCT01839149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92213329|NCT01839149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213330|NCT01839383|Dialysis Solutions|dialysis solutions|mesh-list
92213331|NCT01839383|Calcium|calcium|mesh-list
92213332|NCT01839383|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92213333|NCT01839383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213334|NCT01839383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92213335|NCT00901199|Deferasirox|deferasirox|mesh-list
92213336|NCT00901199|Deferoxamine|deferoxamine|mesh-list
92213337|NCT00901199|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92213338|NCT00901199|Chelating Agents|chelating agents|mesh-ancestor
92213339|NCT00901199|Sequestering Agents|sequestering agents|mesh-ancestor
92213340|NCT00901199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213341|NCT00901199|Siderophores|siderophores|mesh-ancestor
92213342|NCT01836341|Carboplatin|carboplatin|mesh-list
92213343|NCT01836341|Pemetrexed|pemetrexed|mesh-list
92213344|NCT01836341|Afatinib|afatinib|mesh-list
92213345|NCT01836341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213346|NCT01836341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213347|NCT01836341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213348|NCT01836341|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92213349|NCT01836341|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92213350|NCT01836341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92213351|NCT00906503|Dexamethasone|dexamethasone|mesh-list
92213352|NCT00906503|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92213353|NCT00906503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213354|NCT00906503|Antiemetics|antiemetics|mesh-ancestor
92213356|NCT00906503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213357|NCT00906503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213358|NCT00906503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92213359|NCT00906503|Glucocorticoids|glucocorticoids|mesh-ancestor
92213360|NCT00906503|Hormones|hormones|mesh-ancestor
92336865|NCT04650282|Lidocaine|lidocaine|mesh-list
92213361|NCT00906503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213362|NCT00906503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92213363|NCT00906503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213364|NCT00906503|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92213365|NCT00906503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213366|NCT01836575|Carboplatin|carboplatin|mesh-list
92213367|NCT01836575|Pemetrexed|pemetrexed|mesh-list
92213368|NCT01836575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213369|NCT01836575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213370|NCT01836575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213371|NCT01836575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92213372|NCT01836575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92213373|NCT01836653|Bevacizumab|bevacizumab|mesh-list
92213374|NCT01836653|Cetuximab|cetuximab|mesh-list
92213375|NCT01836653|Fluorouracil|fluorouracil|mesh-list
92213376|NCT01836653|Oxaliplatin|oxaliplatin|mesh-list
92213377|NCT01836653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213378|NCT01836653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213379|NCT01836653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92213380|NCT01836653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92213381|NCT01836653|Growth Substances|growth substances|mesh-ancestor
92213382|NCT01836653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213383|NCT01836653|Growth Inhibitors|growth inhibitors|mesh-ancestor
92213384|NCT01836653|Antimetabolites|antimetabolites|mesh-ancestor
92213385|NCT01836653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213386|NCT01836653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92213387|NCT01836653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213388|NCT01836653|Immunologic Factors|immunologic factors|mesh-ancestor
92213389|NCT03836885|Apremilast|apremilast|mesh-list
92213390|NCT03836885|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92213391|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213392|NCT03836885|Analgesics|analgesics|mesh-ancestor
92213393|NCT03836885|Sensory System Agents|sensory system agents|mesh-ancestor
92213394|NCT03836885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213395|NCT03836885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213396|NCT03836885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213397|NCT03836885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213398|NCT03836885|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92213399|NCT03836885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92213400|NCT03836885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213401|NCT03836885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213402|NCT01837043|Cyclosporine|cyclosporine|mesh-list
92213403|NCT01837043|Abatacept|abatacept|mesh-list
92213404|NCT01837043|Tacrolimus|tacrolimus|mesh-list
92213405|NCT01837043|Cyclosporins|cyclosporins|mesh-list
92213406|NCT01837043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92213407|NCT01837043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213408|NCT01837043|Immunologic Factors|immunologic factors|mesh-ancestor
92213409|NCT01837043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213410|NCT01837043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213411|NCT01837043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213412|NCT01837043|Antifungal Agents|antifungal agents|mesh-ancestor
92213413|NCT01837043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213414|NCT01837043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92213415|NCT01837043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213416|NCT01837043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92213417|NCT01837043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213418|NCT01837043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213419|NCT01839773|Paclitaxel|paclitaxel|mesh-list
92213420|NCT01839773|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92213421|NCT01839773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92213422|NCT01839773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213423|NCT01839773|Tubulin Modulators|tubulin modulators|mesh-ancestor
92213424|NCT01839773|Antimitotic Agents|antimitotic agents|mesh-ancestor
92213425|NCT01839773|Mitosis Modulators|mitosis modulators|mesh-ancestor
92213426|NCT01839773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213427|NCT00909155|Fluoxetine|fluoxetine|mesh-list
92213428|NCT00909155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92213430|NCT00909155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92213431|NCT00909155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336869|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213432|NCT00909155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213433|NCT00909155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213434|NCT00909155|Serotonin Agents|serotonin agents|mesh-ancestor
92213435|NCT00909155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213436|NCT00909155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92213437|NCT00909155|Antidepressive Agents|antidepressive agents|mesh-ancestor
92213438|NCT00909155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92213439|NCT00909155|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92213440|NCT00909155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92213441|NCT00909155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213442|NCT00909155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92213443|NCT01839851|Glucocorticoids|glucocorticoids|mesh-list
92213445|NCT01839851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213446|NCT01839851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213447|NCT01839929|Tacrolimus|tacrolimus|mesh-list
92213448|NCT01839929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213449|NCT01839929|Immunologic Factors|immunologic factors|mesh-ancestor
92213450|NCT01839929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213451|NCT01839929|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92213452|NCT01839929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213453|NCT01839929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213454|NCT04373083|Cemiplimab|cemiplimab|mesh-list
92213455|NCT04373083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213456|NCT04373083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213457|NCT03210545|Betamethasone|betamethasone|mesh-list
92213458|NCT03210545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213459|NCT03210545|Glucocorticoids|glucocorticoids|mesh-ancestor
92213460|NCT03210545|Hormones|hormones|mesh-ancestor
92213461|NCT03210545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213462|NCT03210545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213463|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92213464|NCT03210545|Respiratory System Agents|respiratory system agents|mesh-ancestor
92213465|NCT04372849|Insulin|insulin|mesh-list
92213466|NCT04372849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92213467|NCT04372849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213468|NCT03403777|Avelumab|avelumab|mesh-list
92213469|NCT03403777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213470|NCT03403777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213471|NCT02241421|Amoxicillin|amoxicillin|mesh-list
92213472|NCT02241421|Vancomycin|vancomycin|mesh-list
92213473|NCT02241421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213474|NCT02241421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213475|NCT01837199|Amoxicillin|amoxicillin|mesh-list
92213476|NCT01837199|Metronidazole|metronidazole|mesh-list
92213477|NCT01837199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213478|NCT01837199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213479|NCT01837199|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92213480|NCT01837199|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92213481|NCT00926185|Lifitegrast|lifitegrast|mesh-list
92213482|NCT00926185|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92213483|NCT00926185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92213484|NCT02241499|Fluorouracil|fluorouracil|mesh-list
92213485|NCT02241499|Oxaliplatin|oxaliplatin|mesh-list
92213486|NCT02241499|Antimetabolites|antimetabolites|mesh-ancestor
92213487|NCT02241499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213488|NCT02241499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92213489|NCT02241499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213490|NCT02241499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213491|NCT02241499|Immunologic Factors|immunologic factors|mesh-ancestor
92213492|NCT02241499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213493|NCT01837667|Docetaxel|docetaxel|mesh-list
92213494|NCT01837667|LB100|lb100|mesh-list
92213495|NCT01837667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213496|NCT01837667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92213497|NCT01837667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92213498|NCT01837667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92213499|NCT01837667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213500|NCT01837667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213501|NCT03833947|Dexamethasone|dexamethasone|mesh-list
92213502|NCT03833947|Lidocaine|lidocaine|mesh-list
92213503|NCT03833947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213505|NCT03833947|Autonomic Agents|autonomic agents|mesh-ancestor
92213506|NCT03833947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213507|NCT03833947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213508|NCT03833947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92213509|NCT03833947|Glucocorticoids|glucocorticoids|mesh-ancestor
92213510|NCT03833947|Hormones|hormones|mesh-ancestor
92213511|NCT03833947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213512|NCT03833947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92213513|NCT03833947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213514|NCT03833947|Anesthetics, Local|anesthetics, local|mesh-ancestor
92213515|NCT03833947|Anesthetics|anesthetics|mesh-ancestor
92213516|NCT03833947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213517|NCT03833947|Sensory System Agents|sensory system agents|mesh-ancestor
92213518|NCT03833947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92213519|NCT03833947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92213520|NCT03833947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92213521|NCT03833947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213522|NCT03833947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213523|NCT03219437|Methotrexate|methotrexate|mesh-list
92213524|NCT03219437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92213525|NCT03219437|Abortifacient Agents|abortifacient agents|mesh-ancestor
92213526|NCT03219437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92213527|NCT03219437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213528|NCT03219437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92213529|NCT03219437|Antimetabolites|antimetabolites|mesh-ancestor
92213530|NCT03219437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213531|NCT03219437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213532|NCT03219437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92213533|NCT03219437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213534|NCT03219437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92213535|NCT03219437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213536|NCT03219437|Immunologic Factors|immunologic factors|mesh-ancestor
92213537|NCT03219437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213538|NCT03219437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92213539|NCT03212963|Clobetasol|clobetasol|mesh-list
92213540|NCT03212963|Halobetasol|halobetasol|mesh-list
92213541|NCT03212963|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92213542|NCT03212963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213543|NCT03212963|Glucocorticoids|glucocorticoids|mesh-ancestor
92213544|NCT03212963|Hormones|hormones|mesh-ancestor
92213545|NCT03212963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213546|NCT03212963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213547|NCT03218969|Ecopipam|ecopipam|mesh-list
92213548|NCT03218969|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92213549|NCT03218969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92213550|NCT03218969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213551|NCT03218969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213552|NCT03218969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92213553|NCT03218969|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92213554|NCT03218969|Dopamine Agents|dopamine agents|mesh-ancestor
92213555|NCT03218969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213556|NCT03218969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213557|NCT01830101|Temozolomide|temozolomide|mesh-list
92213558|NCT01830101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92213559|NCT01830101|Alkylating Agents|alkylating agents|mesh-ancestor
92213560|NCT01830101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213561|NCT01830101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213562|NCT01830335|Indomethacin|indomethacin|mesh-list
92213563|NCT01830335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92213564|NCT01830335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213565|NCT01830335|Analgesics|analgesics|mesh-ancestor
92213566|NCT01830335|Sensory System Agents|sensory system agents|mesh-ancestor
92213567|NCT01830335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213568|NCT01830335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213569|NCT01830335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213570|NCT01830335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213571|NCT01830335|Gout Suppressants|gout suppressants|mesh-ancestor
92213572|NCT01830335|Tocolytic Agents|tocolytic agents|mesh-ancestor
92213573|NCT01830335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92213574|NCT01830335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92213575|NCT01830335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213576|NCT01830335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213578|NCT00926263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92213579|NCT00926263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213580|NCT00926263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213581|NCT00926263|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92213582|NCT00926263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92213583|NCT00926263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213584|NCT00926263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213585|NCT00926263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213586|NCT00926263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213587|NCT00926263|Immunologic Factors|immunologic factors|mesh-ancestor
92213588|NCT02242279|Tiotropium Bromide|tiotropium bromide|mesh-list
92213589|NCT02242279|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92213590|NCT02242279|Autonomic Agents|autonomic agents|mesh-ancestor
92213591|NCT02242279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213592|NCT02242279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213593|NCT02242279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92213594|NCT02242279|Respiratory System Agents|respiratory system agents|mesh-ancestor
92213595|NCT02242279|Parasympatholytics|parasympatholytics|mesh-ancestor
92213596|NCT02242279|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92213597|NCT02242279|Cholinergic Agents|cholinergic agents|mesh-ancestor
92213598|NCT02242279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213599|NCT02242279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213600|NCT04371757|Doxazosin|doxazosin|mesh-list
92213601|NCT04371757|Adrenergic Agents|adrenergic agents|mesh-list
92213602|NCT04371757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92213603|NCT04371757|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92213604|NCT04371757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92213605|NCT04371757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92213606|NCT04371757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213607|NCT04371757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213608|NCT04371757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213609|NCT04371601|Oseltamivir|oseltamivir|mesh-list
92213610|NCT04371601|Hormones|hormones|mesh-list
92213611|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213612|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213613|NCT04371601|Antiviral Agents|antiviral agents|mesh-ancestor
92213614|NCT04371601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213615|NCT04371601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213616|NCT04371601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213618|NCT04371523|Antimalarials|antimalarials|mesh-ancestor
92213619|NCT04371523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92213620|NCT04371523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92213621|NCT04371523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213622|NCT04371523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213623|NCT04371523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213624|NCT04371523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213625|NCT02242357|Telmisartan|telmisartan|mesh-list
92213626|NCT02242357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92213627|NCT02242357|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92213628|NCT02242357|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92213629|NCT02242357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213630|NCT03409835|Ramosetron|ramosetron|mesh-list
92213631|NCT03409835|Antiemetics|antiemetics|mesh-ancestor
92213632|NCT03409835|Autonomic Agents|autonomic agents|mesh-ancestor
92213633|NCT03409835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213634|NCT03409835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213635|NCT03409835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92213636|NCT03409835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92213637|NCT03409835|Serotonin Agents|serotonin agents|mesh-ancestor
92213638|NCT03409835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213639|NCT03409835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213640|NCT02242513|Lidocaine|lidocaine|mesh-list
92213641|NCT02242513|Anesthetics, Local|anesthetics, local|mesh-ancestor
92213642|NCT02242513|Anesthetics|anesthetics|mesh-ancestor
92213643|NCT02242513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336877|NCT01937364|Baclofen|baclofen|mesh-list
92213644|NCT02242513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213645|NCT02242513|Sensory System Agents|sensory system agents|mesh-ancestor
92213646|NCT02242513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213647|NCT02242513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92213648|NCT02242513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92213649|NCT02242513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92213650|NCT02242513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213651|NCT02242513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213652|NCT03409679|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92213653|NCT03409679|Murepavadin|murepavadin|mesh-list
92213654|NCT03409679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213655|NCT04371367|Avdoralimab|avdoralimab|mesh-list
92213656|NCT04371367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213657|NCT04371367|Antiviral Agents|antiviral agents|mesh-ancestor
92213658|NCT04371367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213659|NCT02242591|Ropivacaine|ropivacaine|mesh-list
92213660|NCT02242591|Anesthetics, Local|anesthetics, local|mesh-ancestor
92213661|NCT02242591|Anesthetics|anesthetics|mesh-ancestor
92213662|NCT02242591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213663|NCT02242591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213664|NCT02242591|Sensory System Agents|sensory system agents|mesh-ancestor
92213665|NCT02242591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213666|NCT02982577|Pilocarpine|pilocarpine|mesh-list
92213667|NCT02982577|Miotics|miotics|mesh-ancestor
92213668|NCT02982577|Autonomic Agents|autonomic agents|mesh-ancestor
92213669|NCT02982577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213670|NCT02982577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213671|NCT02982577|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92213672|NCT02982577|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92213673|NCT02982577|Cholinergic Agents|cholinergic agents|mesh-ancestor
92213674|NCT02982577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213675|NCT02982577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213676|NCT01726205|Pregabalin|pregabalin|mesh-list
92213677|NCT01726205|Ropivacaine|ropivacaine|mesh-list
92213678|NCT01726205|Anesthetics, Local|anesthetics, local|mesh-ancestor
92213679|NCT01726205|Anesthetics|anesthetics|mesh-ancestor
92213680|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213681|NCT01726205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213682|NCT01726205|Sensory System Agents|sensory system agents|mesh-ancestor
92213683|NCT01726205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213684|NCT01726205|Analgesics|analgesics|mesh-ancestor
92213685|NCT01726205|Anticonvulsants|anticonvulsants|mesh-ancestor
92213686|NCT01726205|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92213687|NCT01726205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213688|NCT01726205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213689|NCT01726205|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92213690|NCT01726205|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92213691|NCT01726205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92213692|NCT01726205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92213694|NCT02242825|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92213695|NCT02242825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92213696|NCT02242825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92213697|NCT02242825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92213698|NCT02242825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213699|NCT02242825|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92213700|NCT02242825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213701|NCT02242825|Diuretics|diuretics|mesh-ancestor
92213702|NCT02242825|Natriuretic Agents|natriuretic agents|mesh-ancestor
92213703|NCT02242825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213704|NCT04370977|Artesunate|artesunate|mesh-list
92213705|NCT04370977|Lumefantrine|lumefantrine|mesh-list
92213706|NCT04370977|Artemether|artemether|mesh-list
92213707|NCT04370977|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92213708|NCT04370977|Amodiaquine|amodiaquine|mesh-list
92213709|NCT04370977|Antimalarials|antimalarials|mesh-ancestor
92213710|NCT04370977|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92213711|NCT04370977|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92213712|NCT04370977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213713|NCT04370977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213714|NCT04370977|Antiviral Agents|antiviral agents|mesh-ancestor
92213715|NCT04370977|Schistosomicides|schistosomicides|mesh-ancestor
92213716|NCT04370977|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92213717|NCT04370977|Anthelmintics|anthelmintics|mesh-ancestor
92213718|NCT01726283|Riboflavin|riboflavin|mesh-list
92213719|NCT01726283|Vitamin B Complex|vitamin b complex|mesh-ancestor
92213720|NCT01726283|Vitamins|vitamins|mesh-ancestor
92213721|NCT01726283|Micronutrients|micronutrients|mesh-ancestor
92213722|NCT01726283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213723|NCT01726283|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92213724|NCT01726283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92213725|NCT04370431|Edaravone|edaravone|mesh-list
92213726|NCT04370431|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92213727|NCT04370431|Antioxidants|antioxidants|mesh-ancestor
92213728|NCT04370431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213729|NCT04370431|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92213730|NCT04370431|Protective Agents|protective agents|mesh-ancestor
92213731|NCT04370431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213732|NCT02245165|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92213733|NCT02245165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213734|NCT02245165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213736|NCT03835871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213737|NCT03835871|Glucocorticoids|glucocorticoids|mesh-ancestor
92213738|NCT03835871|Hormones|hormones|mesh-ancestor
92213739|NCT03835871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213740|NCT03835871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213741|NCT03835871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92213742|NCT03835871|Respiratory System Agents|respiratory system agents|mesh-ancestor
92213743|NCT03402295|Thalidomide|thalidomide|mesh-list
92213744|NCT03402295|Dexamethasone|dexamethasone|mesh-list
92213745|NCT03402295|Cyclophosphamide|cyclophosphamide|mesh-list
92213746|NCT03402295|Bortezomib|bortezomib|mesh-list
92213747|NCT03402295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213748|NCT03402295|Immunologic Factors|immunologic factors|mesh-ancestor
92213749|NCT03402295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213750|NCT03402295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921532|NCT03535519|Abortifacient Agents|abortifacient agents|mesh-ancestor
92213751|NCT03402295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92213752|NCT03402295|Alkylating Agents|alkylating agents|mesh-ancestor
92213753|NCT03402295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213754|NCT03402295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213755|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92213756|NCT03402295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213757|NCT03402295|Antiemetics|antiemetics|mesh-ancestor
92213758|NCT03402295|Autonomic Agents|autonomic agents|mesh-ancestor
92213759|NCT03402295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213760|NCT03402295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92213761|NCT03402295|Glucocorticoids|glucocorticoids|mesh-ancestor
92213762|NCT03402295|Hormones|hormones|mesh-ancestor
92213763|NCT03402295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213764|NCT03402295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92213765|NCT03402295|Leprostatic Agents|leprostatic agents|mesh-ancestor
92213766|NCT03402295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213767|NCT03402295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213768|NCT03402295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92213769|NCT03402295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92213770|NCT03402295|Growth Substances|growth substances|mesh-ancestor
92213771|NCT03402295|Growth Inhibitors|growth inhibitors|mesh-ancestor
92213772|NCT02243839|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92213773|NCT02243839|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92213774|NCT02243839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213775|NCT02244073|Insulin|insulin|mesh-list
92213776|NCT02244073|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92213777|NCT02244073|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92213778|NCT02244073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213779|NCT02244151|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92213780|NCT02244151|Luteolytic Agents|luteolytic agents|mesh-ancestor
92213781|NCT02244151|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92213782|NCT02244151|Contraceptive Agents|contraceptive agents|mesh-ancestor
92213783|NCT02244151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92213784|NCT02244151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213785|NCT02244151|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92213786|NCT02244151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92213787|NCT02244151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213788|NCT03401827|Paclitaxel|paclitaxel|mesh-list
92213789|NCT03401827|Gemcitabine|gemcitabine|mesh-list
92213790|NCT03401827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92213791|NCT03401827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213792|NCT03401827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92213793|NCT03401827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92213794|NCT03401827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92213795|NCT03401827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213796|NCT03401827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92213797|NCT03401827|Antimetabolites|antimetabolites|mesh-ancestor
92213798|NCT00909545|Isradipine|isradipine|mesh-list
92213799|NCT00909545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92213800|NCT00909545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92213801|NCT00909545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213802|NCT00909545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213803|NCT00909545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92213804|NCT00909545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213805|NCT00909545|Vasodilator Agents|vasodilator agents|mesh-ancestor
92213806|NCT02244229|Tamsulosin|tamsulosin|mesh-list
92213807|NCT02244229|Finasteride|finasteride|mesh-list
92213808|NCT02244229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92213809|NCT02244229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92213810|NCT02244229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92213811|NCT02244229|Adrenergic Agents|adrenergic agents|mesh-ancestor
92213812|NCT02244229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213813|NCT02244229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213814|NCT02244229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213815|NCT02244229|Urological Agents|urological agents|mesh-ancestor
92213816|NCT02244229|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92213817|NCT02244229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92213818|NCT02244229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213819|NCT02244229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92213820|NCT02244229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213821|NCT02157103|Bevacizumab|bevacizumab|mesh-list
92213822|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213823|NCT02157103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213824|NCT02157103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92213825|NCT02157103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92213826|NCT02157103|Growth Substances|growth substances|mesh-ancestor
92213827|NCT02157103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213828|NCT02157103|Growth Inhibitors|growth inhibitors|mesh-ancestor
92213829|NCT00924001|Aldesleukin|aldesleukin|mesh-list
92213830|NCT00924001|Cyclophosphamide|cyclophosphamide|mesh-list
92213831|NCT00924001|Fludarabine|fludarabine|mesh-list
92213832|NCT00924001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92213833|NCT00924001|Immunologic Factors|immunologic factors|mesh-ancestor
92213834|NCT00924001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213835|NCT00924001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213836|NCT00924001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92213837|NCT00924001|Alkylating Agents|alkylating agents|mesh-ancestor
92213838|NCT00924001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213839|NCT00924001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213840|NCT00924001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92213841|NCT00924001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92213842|NCT00924001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92213843|NCT00924001|Antiviral Agents|antiviral agents|mesh-ancestor
92213844|NCT00924001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213845|NCT02244307|Adrenergic Agents|adrenergic agents|mesh-list
92213846|NCT02244307|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92213847|NCT02244307|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92213848|NCT02244307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213849|NCT02244307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213850|NCT02244307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213852|NCT03401593|Midazolam|midazolam|mesh-list
92213853|NCT03401593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92213854|NCT03401593|Narcotics|narcotics|mesh-ancestor
92213855|NCT03401593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213856|NCT03401593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213857|NCT03401593|Analgesics|analgesics|mesh-ancestor
92213858|NCT03401593|Sensory System Agents|sensory system agents|mesh-ancestor
92213859|NCT03401593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213860|NCT03401593|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92213861|NCT03401593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92213862|NCT03401593|Anesthetics, General|anesthetics, general|mesh-ancestor
92213863|NCT03401593|Anesthetics|anesthetics|mesh-ancestor
92213864|NCT03401593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92213865|NCT03401593|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92213866|NCT03401593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92213867|NCT03401593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92213868|NCT03401593|GABA Modulators|gaba modulators|mesh-ancestor
92213869|NCT03401593|GABA Agents|gaba agents|mesh-ancestor
92213870|NCT03401593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213871|NCT03401593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213872|NCT03401515|Propranolol|propranolol|mesh-list
92213873|NCT03401515|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92213874|NCT03401515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92213875|NCT03401515|Adrenergic Agents|adrenergic agents|mesh-ancestor
92213876|NCT03401515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213877|NCT03401515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213878|NCT03401515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213879|NCT03401515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92213880|NCT03401515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92213881|NCT03401515|Vasodilator Agents|vasodilator agents|mesh-ancestor
92213882|NCT01726829|Pancrelipase|pancrelipase|mesh-list
92213884|NCT01726829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92213885|NCT03834233|Nivolumab|nivolumab|mesh-list
92213886|NCT03834233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213887|NCT03834233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213888|NCT03834233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92213889|NCT03834233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213890|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
92213891|NCT04367155|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92213892|NCT04367155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92213893|NCT04367155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213894|NCT04367155|Hemostatics|hemostatics|mesh-ancestor
92213895|NCT04367155|Coagulants|coagulants|mesh-ancestor
92213896|NCT01727453|Warfarin|warfarin|mesh-list
92213897|NCT01727453|Anticoagulants|anticoagulants|mesh-ancestor
92213898|NCT01727531|Chloroquine|chloroquine|mesh-list
92213899|NCT01727531|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92213900|NCT01727531|Amebicides|amebicides|mesh-ancestor
92213901|NCT01727531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92213902|NCT01727531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92213903|NCT01727531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213904|NCT01727531|Antimalarials|antimalarials|mesh-ancestor
92213905|NCT01727531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92213906|NCT01727531|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92213907|NCT01727531|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92213908|NCT01727531|Analgesics|analgesics|mesh-ancestor
92213909|NCT01727531|Sensory System Agents|sensory system agents|mesh-ancestor
92213910|NCT01727531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213911|NCT01727531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213912|NCT01727531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92213913|NCT01727531|Filaricides|filaricides|mesh-ancestor
92213914|NCT01727531|Antinematodal Agents|antinematodal agents|mesh-ancestor
92213915|NCT01727531|Anthelmintics|anthelmintics|mesh-ancestor
92213916|NCT01721135|Moxifloxacin|moxifloxacin|mesh-list
92213917|NCT01721135|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92213918|NCT01721135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92213919|NCT01721135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213920|NCT01721135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92213921|NCT01721135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92213922|NCT01721135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213923|NCT01721135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213924|NCT01721135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213925|NCT01721135|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92213926|NCT01721135|Contraceptive Agents|contraceptive agents|mesh-ancestor
92213927|NCT01721135|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92213928|NCT01721135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213929|NCT01721135|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92213930|NCT01721135|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92213931|NCT01721135|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92213933|NCT00929071|Anesthetics, Local|anesthetics, local|mesh-list
92213934|NCT00929071|Anesthetics|anesthetics|mesh-list
92213935|NCT00929071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92213936|NCT00929071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213937|NCT00929071|Sensory System Agents|sensory system agents|mesh-ancestor
92213938|NCT00929071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92213939|NCT00929071|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92213940|NCT00929071|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92213941|NCT00929071|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92213942|NCT00929071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213943|NCT00929071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213945|NCT01721525|Paclitaxel|paclitaxel|mesh-list
92213946|NCT01721525|Carboplatin|carboplatin|mesh-list
92213947|NCT01721525|Afatinib|afatinib|mesh-list
92213948|NCT01721525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92213949|NCT01721525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213950|NCT01721525|Tubulin Modulators|tubulin modulators|mesh-ancestor
92213951|NCT01721525|Antimitotic Agents|antimitotic agents|mesh-ancestor
92213952|NCT01721525|Mitosis Modulators|mitosis modulators|mesh-ancestor
92213953|NCT01721525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213954|NCT01721525|Antimetabolites|antimetabolites|mesh-ancestor
92213955|NCT01721525|Antiviral Agents|antiviral agents|mesh-ancestor
92213956|NCT01721525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92213957|NCT01721525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92213958|NCT01721525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92213959|NCT01727843|Tranexamic Acid|tranexamic acid|mesh-list
92213960|NCT01727843|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92213961|NCT01727843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92213962|NCT01727843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213963|NCT01727843|Hemostatics|hemostatics|mesh-ancestor
92213964|NCT01727843|Coagulants|coagulants|mesh-ancestor
92213966|NCT01721915|Vitamins|vitamins|mesh-ancestor
92213967|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
92213968|NCT01721915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213969|NCT01721915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92213970|NCT04357483|Thrombin|thrombin|mesh-list
92213971|NCT04357483|Hemostatics|hemostatics|mesh-ancestor
92213972|NCT04357483|Coagulants|coagulants|mesh-ancestor
92213973|NCT01721993|Zoledronic Acid|zoledronic acid|mesh-list
92213974|NCT01721993|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92213975|NCT01721993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213976|NCT04366609|Methylphenidate|methylphenidate|mesh-list
92213977|NCT04366609|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92213978|NCT04366609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213979|NCT04366609|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92213980|NCT04366609|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92213981|NCT04366609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92213982|NCT04366609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213983|NCT04366609|Dopamine Agents|dopamine agents|mesh-ancestor
92213984|NCT04366609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92213985|NCT03407105|Ipilimumab|ipilimumab|mesh-list
92213986|NCT03407105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92213987|NCT03407105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92213988|NCT03407105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92213989|NCT03407105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92213990|NCT01722227|Liraglutide|liraglutide|mesh-list
92213991|NCT01722227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92213992|NCT01722227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92213993|NCT01722227|Incretins|incretins|mesh-ancestor
92213994|NCT01722227|Hormones|hormones|mesh-ancestor
92213995|NCT01722227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92213996|NCT01722305|Dexamethasone|dexamethasone|mesh-list
92213997|NCT01722305|Dexamethasone acetate|dexamethasone acetate|mesh-list
92213998|NCT01722305|Pomalidomide|pomalidomide|mesh-list
92213999|NCT01722305|Ichthammol|ichthammol|mesh-list
92214000|NCT01722305|BB 1101|bb 1101|mesh-list
92214001|NCT01722305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214002|NCT01722305|Antiemetics|antiemetics|mesh-ancestor
92214003|NCT01722305|Autonomic Agents|autonomic agents|mesh-ancestor
92214004|NCT01722305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214005|NCT01722305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214006|NCT01722305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214007|NCT01722305|Glucocorticoids|glucocorticoids|mesh-ancestor
92214008|NCT01722305|Hormones|hormones|mesh-ancestor
92214009|NCT01722305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214010|NCT01722305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92214011|NCT01722305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214012|NCT01722305|Protease Inhibitors|protease inhibitors|mesh-ancestor
92214013|NCT01722305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214014|NCT01722305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214015|NCT01722305|Immunologic Factors|immunologic factors|mesh-ancestor
92214016|NCT01722305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214017|NCT01722305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92214018|NCT01722305|Growth Substances|growth substances|mesh-ancestor
92214019|NCT01722305|Growth Inhibitors|growth inhibitors|mesh-ancestor
92214020|NCT01722305|Dermatologic Agents|dermatologic agents|mesh-ancestor
92214021|NCT04365517|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92214022|NCT04365517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214023|NCT04365517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214024|NCT04365517|Incretins|incretins|mesh-ancestor
92214025|NCT04365517|Hormones|hormones|mesh-ancestor
92214026|NCT04365517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214027|NCT04365517|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92214028|NCT04365517|Protease Inhibitors|protease inhibitors|mesh-ancestor
92214029|NCT04365517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214030|NCT04365517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214031|NCT03406871|Nivolumab|nivolumab|mesh-list
92214032|NCT03406871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214033|NCT03406871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214034|NCT03406871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92214035|NCT03406871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214037|NCT04357093|Grape Seed Extract|grape seed extract|mesh-list
92214038|NCT04357093|Fluorides|fluorides|mesh-list
92214039|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
92214040|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
92214041|NCT04357093|Protective Agents|protective agents|mesh-ancestor
92214042|NCT04357093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214043|NCT04357093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92214044|NCT04357093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214045|NCT04357093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92214046|NCT04357093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214047|NCT04357093|Antioxidants|antioxidants|mesh-ancestor
92214048|NCT04357093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214049|NCT03406793|Iron|iron|mesh-list
92214050|NCT03406793|Zinc|zinc|mesh-list
92214051|NCT03406793|Trace Elements|trace elements|mesh-ancestor
92214052|NCT03406793|Micronutrients|micronutrients|mesh-ancestor
92214053|NCT03406793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214054|NCT04365127|Progesterone|progesterone|mesh-list
92214055|NCT04365127|Progestins|progestins|mesh-ancestor
92214056|NCT04365127|Hormones|hormones|mesh-ancestor
92214057|NCT04365127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214058|NCT04365127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214059|NCT00929383|Hemostatics|hemostatics|mesh-list
92214060|NCT00929383|Coagulants|coagulants|mesh-ancestor
92214061|NCT01722539|Pyrimethamine|pyrimethamine|mesh-list
92214062|NCT01722539|Piperaquine|piperaquine|mesh-list
92214063|NCT01722539|Sulfadoxine|sulfadoxine|mesh-list
92214064|NCT01722539|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92214065|NCT01722539|Albendazole|albendazole|mesh-list
92214066|NCT01722539|Praziquantel|praziquantel|mesh-list
92214067|NCT01722539|Antimalarials|antimalarials|mesh-ancestor
92214068|NCT01722539|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92214069|NCT01722539|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92214070|NCT01722539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214071|NCT01722539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92214072|NCT01722539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214073|NCT01722539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214074|NCT01722539|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92214075|NCT01722539|Anthelmintics|anthelmintics|mesh-ancestor
92214076|NCT01722539|Anticestodal Agents|anticestodal agents|mesh-ancestor
92214077|NCT01722539|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92214078|NCT01722539|Tubulin Modulators|tubulin modulators|mesh-ancestor
92214079|NCT01722539|Antimitotic Agents|antimitotic agents|mesh-ancestor
92214080|NCT01722539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92214081|NCT01722539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214082|NCT03406403|Anesthetics|anesthetics|mesh-list
92214083|NCT03406403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214084|NCT03406403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214085|NCT03406169|Sildenafil Citrate|sildenafil citrate|mesh-list
92214086|NCT03406169|Pentoxifylline|pentoxifylline|mesh-list
92214087|NCT03406169|Vasodilator Agents|vasodilator agents|mesh-ancestor
92214088|NCT03406169|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92214089|NCT03406169|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92214090|NCT03406169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214091|NCT03406169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214092|NCT03406169|Urological Agents|urological agents|mesh-ancestor
92214093|NCT03406169|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92214094|NCT03406169|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92214095|NCT03406169|Protective Agents|protective agents|mesh-ancestor
92214096|NCT03406169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214097|NCT03406169|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92214098|NCT03406169|Antioxidants|antioxidants|mesh-ancestor
92214099|NCT04357015|Tranexamic Acid|tranexamic acid|mesh-list
92214100|NCT04357015|Carbetocin|carbetocin|mesh-list
92214101|NCT04357015|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92214102|NCT04357015|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92214103|NCT04357015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214104|NCT04357015|Hemostatics|hemostatics|mesh-ancestor
92214105|NCT04357015|Coagulants|coagulants|mesh-ancestor
92214106|NCT04357015|Oxytocics|oxytocics|mesh-ancestor
92214107|NCT04357015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92214108|NCT04357015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214109|NCT04364893|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92214110|NCT04364893|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92214111|NCT04364893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92214112|NCT04364893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214113|NCT04364893|Protease Inhibitors|protease inhibitors|mesh-ancestor
92214114|NCT03406091|Plerixafor|plerixafor|mesh-list
92214115|NCT03406091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92214116|NCT03406091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92214117|NCT03406091|Antiviral Agents|antiviral agents|mesh-ancestor
92214118|NCT03406091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214119|NCT04364815|Hydroxychloroquine|hydroxychloroquine|mesh-list
92214120|NCT04364815|Antimalarials|antimalarials|mesh-ancestor
92214121|NCT04364815|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92214122|NCT04364815|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92214123|NCT04364815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214124|NCT04364815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214125|NCT04364815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214126|NCT04364815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214127|NCT04673383|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92214128|NCT04673383|Hallucinogens|hallucinogens|mesh-ancestor
92214129|NCT04673383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214130|NCT04673383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92214131|NCT04673383|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92214132|NCT04673383|Serotonin Agents|serotonin agents|mesh-ancestor
92214133|NCT04673383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214134|NCT04673383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214135|NCT04673383|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92214136|NCT02245243|Delafloxacin|delafloxacin|mesh-list
92214137|NCT02245243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214138|NCT01728935|Tenofovir|tenofovir|mesh-list
92214139|NCT01728935|Antiviral Agents|antiviral agents|mesh-ancestor
92214140|NCT01728935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214141|NCT01728935|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92214142|NCT01728935|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92214143|NCT01728935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214144|NCT01728935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214145|NCT01728935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92214146|NCT01728935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92214147|NCT03833999|Ondansetron|ondansetron|mesh-list
92214148|NCT03833999|Lactulose|lactulose|mesh-list
92214149|NCT03833999|Antiemetics|antiemetics|mesh-ancestor
92214150|NCT03833999|Autonomic Agents|autonomic agents|mesh-ancestor
92214151|NCT03833999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214152|NCT03833999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214153|NCT03833999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214154|NCT03833999|Antipruritics|antipruritics|mesh-ancestor
92214155|NCT03833999|Dermatologic Agents|dermatologic agents|mesh-ancestor
92214156|NCT03833999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92214157|NCT03833999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92214158|NCT03833999|Serotonin Agents|serotonin agents|mesh-ancestor
92214159|NCT03833999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214160|NCT03833999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214161|NCT04379219|Methotrexate|methotrexate|mesh-list
92214162|NCT04379219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92214163|NCT04379219|Abortifacient Agents|abortifacient agents|mesh-ancestor
92214164|NCT04379219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92214165|NCT04379219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214167|NCT04379219|Antimetabolites|antimetabolites|mesh-ancestor
92214168|NCT04379219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214169|NCT04379219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214170|NCT04379219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92214171|NCT04379219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214172|NCT04379219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92214173|NCT04379219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214174|NCT04379219|Immunologic Factors|immunologic factors|mesh-ancestor
92214175|NCT04379219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214176|NCT04379219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92214177|NCT04347031|Azithromycin|azithromycin|mesh-list
92214178|NCT04347031|Hydroxychloroquine|hydroxychloroquine|mesh-list
92214179|NCT04347031|Mefloquine|mefloquine|mesh-list
92214180|NCT04347031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92214181|NCT04347031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214182|NCT04347031|Antimalarials|antimalarials|mesh-ancestor
92214183|NCT04347031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92214184|NCT04347031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92214185|NCT04347031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214186|NCT04347031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214187|NCT04347031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214188|NCT02906566|Vitamin A|vitamin a|mesh-list
92214189|NCT02906566|Vitamins|vitamins|mesh-ancestor
92214190|NCT02906566|Micronutrients|micronutrients|mesh-ancestor
92214191|NCT02906566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214192|NCT00913133|Desirudin|desirudin|mesh-list
92214193|NCT00913133|Anticoagulants|anticoagulants|mesh-ancestor
92214194|NCT00913133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92214195|NCT00913133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92214196|NCT00913133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214197|NCT00373126|Nicotine|nicotine|mesh-list
92214198|NCT00373126|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92214200|NCT00373126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214201|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214202|NCT00373126|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92214203|NCT00373126|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92214204|NCT00373126|Cholinergic Agents|cholinergic agents|mesh-ancestor
92214206|NCT00373126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214207|NCT04378283|Lidocaine|lidocaine|mesh-list
92214208|NCT04378283|Epinephrine|epinephrine|mesh-list
92214209|NCT04378283|Tetracaine|tetracaine|mesh-list
92214210|NCT04378283|Anesthetics|anesthetics|mesh-list
92214211|NCT04378283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92214212|NCT04378283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214213|NCT04378283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214214|NCT04378283|Sensory System Agents|sensory system agents|mesh-ancestor
92214215|NCT04378283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214216|NCT04378283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92214217|NCT04378283|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92214218|NCT04378283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92214219|NCT04378283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92214220|NCT04378283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214221|NCT04378283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92214222|NCT04378283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92214223|NCT04378283|Adrenergic Agents|adrenergic agents|mesh-ancestor
92214224|NCT04378283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214225|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92214226|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92214227|NCT04378283|Autonomic Agents|autonomic agents|mesh-ancestor
92214228|NCT04378283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92214229|NCT04378283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92214230|NCT04378283|Mydriatics|mydriatics|mesh-ancestor
92214231|NCT04378283|Sympathomimetics|sympathomimetics|mesh-ancestor
92214232|NCT04378283|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92214233|NCT04355845|Sumatriptan|sumatriptan|mesh-list
92214234|NCT04355845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92214235|NCT04355845|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92214236|NCT04355845|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92214237|NCT04355845|Serotonin Agents|serotonin agents|mesh-ancestor
92214238|NCT04355845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214239|NCT04355845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214240|NCT04355845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214241|NCT02789410|Morphine|morphine|mesh-list
92214242|NCT02789410|Hydromorphone|hydromorphone|mesh-list
92214243|NCT02789410|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92214244|NCT02789410|Narcotics|narcotics|mesh-ancestor
92214245|NCT02789410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214246|NCT02789410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214247|NCT02789410|Analgesics|analgesics|mesh-ancestor
92214248|NCT02789410|Sensory System Agents|sensory system agents|mesh-ancestor
92214249|NCT02789410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214250|NCT01729481|Leucovorin|leucovorin|mesh-list
92214251|NCT01729481|Folic Acid|folic acid|mesh-list
92214252|NCT01729481|Gemcitabine|gemcitabine|mesh-list
92214253|NCT01729481|Oxaliplatin|oxaliplatin|mesh-list
92214254|NCT01729481|Irinotecan|irinotecan|mesh-list
92214255|NCT01729481|Levoleucovorin|levoleucovorin|mesh-list
92214256|NCT01729481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92214257|NCT01729481|Antimetabolites|antimetabolites|mesh-ancestor
92214258|NCT01729481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214259|NCT01729481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214260|NCT01729481|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92214261|NCT01729481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92214262|NCT01729481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214263|NCT01729481|Antidotes|antidotes|mesh-ancestor
92214264|NCT01729481|Protective Agents|protective agents|mesh-ancestor
92214265|NCT01729481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214266|NCT01729481|Vitamin B Complex|vitamin b complex|mesh-ancestor
92214267|NCT01729481|Vitamins|vitamins|mesh-ancestor
92214268|NCT01729481|Micronutrients|micronutrients|mesh-ancestor
92214269|NCT01729481|Hematinics|hematinics|mesh-ancestor
92214270|NCT00939211|Tiotropium Bromide|tiotropium bromide|mesh-list
92214271|NCT00939211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92214272|NCT00939211|Autonomic Agents|autonomic agents|mesh-ancestor
92214273|NCT00939211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336938|NCT01979016|Emollients|emollients|mesh-list
92214274|NCT00939211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214275|NCT00939211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92214276|NCT00939211|Respiratory System Agents|respiratory system agents|mesh-ancestor
92214277|NCT00939211|Parasympatholytics|parasympatholytics|mesh-ancestor
92214278|NCT00939211|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92214279|NCT00939211|Cholinergic Agents|cholinergic agents|mesh-ancestor
92214280|NCT00939211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214281|NCT00939211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214283|NCT02793154|rGLP-1 protein|rglp-1 protein|mesh-list
92214284|NCT02793154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214285|NCT02793154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214286|NCT02793154|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92214287|NCT02793154|Incretins|incretins|mesh-ancestor
92214288|NCT02793154|Hormones|hormones|mesh-ancestor
92214289|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214290|NCT01723553|Corticosterone|corticosterone|mesh-list
92214291|NCT01723553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214292|NCT02907268|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92214293|NCT02907268|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92214294|NCT02907268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92214295|NCT02907268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214296|NCT02907268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214297|NCT02907268|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92214298|NCT02907268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92214299|NCT02907268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214300|NCT02907268|Cholinergic Agents|cholinergic agents|mesh-ancestor
92214301|NCT02907268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214302|NCT02909140|Lidocaine|lidocaine|mesh-list
92214303|NCT02909140|Phenylephrine|phenylephrine|mesh-list
92214304|NCT02909140|Epinephrine|epinephrine|mesh-list
92214305|NCT02909140|Oxymetazoline|oxymetazoline|mesh-list
92214306|NCT02909140|Cyclopentolate|cyclopentolate|mesh-list
92214307|NCT02909140|Anesthetics, Local|anesthetics, local|mesh-ancestor
92214308|NCT02909140|Anesthetics|anesthetics|mesh-ancestor
92214309|NCT02909140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214310|NCT02909140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214311|NCT02909140|Sensory System Agents|sensory system agents|mesh-ancestor
92214312|NCT02909140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214313|NCT02909140|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92214314|NCT02909140|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92214315|NCT02909140|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92214316|NCT02909140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92214317|NCT02909140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214318|NCT02909140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92214319|NCT02909140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92214320|NCT02909140|Adrenergic Agents|adrenergic agents|mesh-ancestor
92214321|NCT02909140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214322|NCT02909140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92214323|NCT02909140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92214324|NCT02909140|Autonomic Agents|autonomic agents|mesh-ancestor
92214325|NCT02909140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92214326|NCT02909140|Respiratory System Agents|respiratory system agents|mesh-ancestor
92214327|NCT02909140|Mydriatics|mydriatics|mesh-ancestor
92214328|NCT02909140|Sympathomimetics|sympathomimetics|mesh-ancestor
92214329|NCT02909140|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92214330|NCT02909140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92214331|NCT02909140|Nasal Decongestants|nasal decongestants|mesh-ancestor
92214332|NCT02909140|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92214333|NCT02909140|Protective Agents|protective agents|mesh-ancestor
92214334|NCT02909140|Parasympatholytics|parasympatholytics|mesh-ancestor
92214335|NCT02909140|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92214336|NCT02909140|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92214337|NCT02909140|Cholinergic Agents|cholinergic agents|mesh-ancestor
92214338|NCT01724879|Dasatinib|dasatinib|mesh-list
92214339|NCT01724879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214340|NCT01724879|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92214341|NCT01724879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214342|NCT01724879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214344|NCT02793856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214345|NCT02793856|Immunologic Factors|immunologic factors|mesh-ancestor
92214346|NCT02793856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214347|NCT02793856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214348|NCT02793856|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92214349|NCT02793856|Alkylating Agents|alkylating agents|mesh-ancestor
92214350|NCT02793856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214351|NCT02793856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214352|NCT02793856|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92214353|NCT03403985|Calcium|calcium|mesh-list
92214354|NCT03403985|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92214355|NCT03403985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214356|NCT04364425|Triamcinolone|triamcinolone|mesh-list
92214357|NCT04364425|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92214358|NCT04364425|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92214359|NCT04364425|Lidocaine|lidocaine|mesh-list
92214360|NCT04364425|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92214361|NCT04364425|Anesthetics, Local|anesthetics, local|mesh-ancestor
92214362|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
92214363|NCT04364425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214364|NCT04364425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214365|NCT04364425|Sensory System Agents|sensory system agents|mesh-ancestor
92214366|NCT04364425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214367|NCT04364425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92214368|NCT04364425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92214369|NCT04364425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92214370|NCT04364425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92214371|NCT04364425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214372|NCT04364425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214373|NCT04364425|Glucocorticoids|glucocorticoids|mesh-ancestor
92214374|NCT04364425|Hormones|hormones|mesh-ancestor
92214375|NCT04364425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214376|NCT04364425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214377|NCT04364425|Immunologic Factors|immunologic factors|mesh-ancestor
92214378|NCT04364425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214379|NCT02911324|Nabilone|nabilone|mesh-list
92214380|NCT02911324|Antiemetics|antiemetics|mesh-ancestor
92214381|NCT02911324|Autonomic Agents|autonomic agents|mesh-ancestor
92214382|NCT02911324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214383|NCT02911324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214384|NCT02911324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214385|NCT02911324|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92214386|NCT02911324|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92214387|NCT02911324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214388|NCT02911324|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92214389|NCT01729403|Metformin|metformin|mesh-list
92214391|NCT01729403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214392|NCT04281667|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92214393|NCT04281667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214394|NCT04355455|Citalopram|citalopram|mesh-list
92214395|NCT04355455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92214396|NCT04355455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92214397|NCT04355455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92214398|NCT04355455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214399|NCT04355455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214400|NCT04355455|Serotonin Agents|serotonin agents|mesh-ancestor
92214401|NCT04355455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214402|NCT04355455|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92214403|NCT04355455|Antidepressive Agents|antidepressive agents|mesh-ancestor
92214404|NCT04355455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92214405|NCT00913913|Bevacizumab|bevacizumab|mesh-list
92214406|NCT00913913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214407|NCT00913913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214408|NCT00913913|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214409|NCT00913913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92214411|NCT00913913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214412|NCT00913913|Growth Inhibitors|growth inhibitors|mesh-ancestor
92214413|NCT00373594|Rituximab|rituximab|mesh-list
92214414|NCT00373594|Fludarabine|fludarabine|mesh-list
92214415|NCT00373594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214416|NCT00373594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214417|NCT00373594|Immunologic Factors|immunologic factors|mesh-ancestor
92214418|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214419|NCT00373594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214420|NCT03403829|Gemcitabine|gemcitabine|mesh-list
92214421|NCT03403829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92214422|NCT03403829|Antimetabolites|antimetabolites|mesh-ancestor
92214423|NCT03403829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214424|NCT03403829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214425|NCT04364113|Benzocaine|benzocaine|mesh-list
92214426|NCT04364113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92214427|NCT04364113|Anesthetics|anesthetics|mesh-ancestor
92214428|NCT04364113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214429|NCT04364113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214430|NCT04364113|Sensory System Agents|sensory system agents|mesh-ancestor
92214431|NCT04364113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214432|NCT03403595|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
92214433|NCT03403595|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92214434|NCT03403595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214435|NCT03197194|Aspirin|aspirin|mesh-list
92214436|NCT03197194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92214437|NCT03197194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92214438|NCT03197194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92214439|NCT03197194|Analgesics|analgesics|mesh-ancestor
92214440|NCT03197194|Sensory System Agents|sensory system agents|mesh-ancestor
92214441|NCT03197194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214442|NCT03197194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214443|NCT03197194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214444|NCT03197194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214445|NCT03197194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92214446|NCT03197194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92214447|NCT03197194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214448|NCT03197194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92214449|NCT03197194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92214450|NCT03197194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214451|NCT03197194|Antipyretics|antipyretics|mesh-ancestor
92214452|NCT03834935|Pimecrolimus|pimecrolimus|mesh-list
92214453|NCT03834935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92214454|NCT03834935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92214455|NCT03834935|Analgesics|analgesics|mesh-ancestor
92214456|NCT03834935|Sensory System Agents|sensory system agents|mesh-ancestor
92214457|NCT03834935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214458|NCT03834935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214459|NCT03834935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214460|NCT03834935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214461|NCT03834935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92214462|NCT03834935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214464|NCT03834935|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92214465|NCT03834935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214466|NCT03834935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214467|NCT02796352|Interleukin-2|interleukin-2|mesh-list
92214468|NCT02796352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214469|NCT02796352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92214470|NCT02796352|Analgesics|analgesics|mesh-ancestor
92214471|NCT02796352|Sensory System Agents|sensory system agents|mesh-ancestor
92214472|NCT02796352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214473|NCT02796352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214474|NCT00939367|Zolpidem|zolpidem|mesh-list
92214475|NCT00939367|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92214476|NCT00939367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92214477|NCT00939367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336955|NCT01934556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214478|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214479|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92214480|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
92214481|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
92214482|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214483|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214484|NCT03168880|Paclitaxel|paclitaxel|mesh-list
92214485|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92214486|NCT03168880|Carboplatin|carboplatin|mesh-list
92214487|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92214488|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214489|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
92214490|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
92214491|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
92214492|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214493|NCT04347187|Anticoagulants|anticoagulants|mesh-list
92214494|NCT00920075|Alendronate|alendronate|mesh-list
92214495|NCT00920075|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92214496|NCT00920075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214497|NCT04364035|Vesatolimod|vesatolimod|mesh-list
92214498|NCT04364035|Antiviral Agents|antiviral agents|mesh-ancestor
92214499|NCT04364035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214500|NCT03403439|Itraconazole|itraconazole|mesh-list
92214501|NCT03403439|Antifungal Agents|antifungal agents|mesh-ancestor
92214502|NCT03403439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214503|NCT03403439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92214504|NCT03403439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92214505|NCT03403439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214506|NCT03403439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214507|NCT03403439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92214508|NCT03403439|Hormone Antagonists|hormone antagonists|mesh-ancestor
92214509|NCT03403439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214510|NCT03403439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214511|NCT03403439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92214512|NCT04346797|Eculizumab|eculizumab|mesh-list
92214513|NCT04346797|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92214514|NCT04346797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214515|NCT04346797|Immunologic Factors|immunologic factors|mesh-ancestor
92214516|NCT04346797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214517|NCT04364581|Letrozole|letrozole|mesh-list
92214518|NCT04364581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214519|NCT04364581|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92214520|NCT04364581|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92214521|NCT04364581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214522|NCT04364581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214523|NCT04364581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92214524|NCT04364581|Hormone Antagonists|hormone antagonists|mesh-ancestor
92214525|NCT04364581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214526|NCT04364581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214527|NCT01049009|Metoprolol|metoprolol|mesh-list
92214528|NCT01049009|Nebivolol|nebivolol|mesh-list
92214529|NCT01049009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92214530|NCT01049009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92214531|NCT01049009|Sympatholytics|sympatholytics|mesh-ancestor
92214532|NCT01049009|Autonomic Agents|autonomic agents|mesh-ancestor
92214533|NCT01049009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214534|NCT01049009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214535|NCT01049009|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92214536|NCT01049009|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92214537|NCT01049009|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92214538|NCT01049009|Adrenergic Agents|adrenergic agents|mesh-ancestor
92214539|NCT01049009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214540|NCT01049009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214541|NCT01049009|Vasodilator Agents|vasodilator agents|mesh-ancestor
92214542|NCT01049009|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92214543|NCT01049009|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92214544|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92214545|NCT02850874|Gemcitabine|gemcitabine|mesh-list
92214546|NCT02850874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92214547|NCT02850874|Antimetabolites|antimetabolites|mesh-ancestor
92214548|NCT02850874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214549|NCT02850874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214550|NCT01047683|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92214551|NCT01047683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92214553|NCT02920918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92214554|NCT02920918|Canagliflozin|canagliflozin|mesh-list
92214555|NCT02920918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214556|NCT02920918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214557|NCT02920918|Incretins|incretins|mesh-ancestor
92214558|NCT02920918|Hormones|hormones|mesh-ancestor
92214559|NCT02920918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214560|NCT02920918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92214561|NCT02920918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92214562|NCT02920918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214563|NCT02920918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214564|NCT02920918|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92214565|NCT03403049|Gemcitabine|gemcitabine|mesh-list
92214566|NCT03403049|Capecitabine|capecitabine|mesh-list
92214567|NCT03403049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92214568|NCT03403049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214569|NCT03403049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92214570|NCT03403049|Antimetabolites|antimetabolites|mesh-ancestor
92214571|NCT03403049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214572|NCT03403049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92214573|NCT03403049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214575|NCT00944047|Cyclophosphamide|cyclophosphamide|mesh-list
92214576|NCT00944047|Doxorubicin|doxorubicin|mesh-list
92214577|NCT00944047|Trastuzumab|trastuzumab|mesh-list
92214578|NCT00944047|Mitogens|mitogens|mesh-list
92214579|NCT00944047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92214580|NCT00944047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214581|NCT00944047|Tubulin Modulators|tubulin modulators|mesh-ancestor
92214582|NCT00944047|Antimitotic Agents|antimitotic agents|mesh-ancestor
92214583|NCT00944047|Mitosis Modulators|mitosis modulators|mesh-ancestor
92214584|NCT00944047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214585|NCT00944047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214586|NCT00944047|Immunologic Factors|immunologic factors|mesh-ancestor
92214587|NCT00944047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214588|NCT00944047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214589|NCT00944047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92214590|NCT00944047|Alkylating Agents|alkylating agents|mesh-ancestor
92214591|NCT00944047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92214592|NCT00944047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92214593|NCT00944047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92214594|NCT00944047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92214595|NCT00944047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214596|NCT00944047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214597|NCT02921386|Methyltestosterone|methyltestosterone|mesh-list
92214598|NCT02921386|Testosterone|testosterone|mesh-list
92214599|NCT02921386|Testosterone undecanoate|testosterone undecanoate|mesh-list
92214600|NCT02921386|Testosterone enanthate|testosterone enanthate|mesh-list
92214601|NCT02921386|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92214602|NCT02921386|Androgens|androgens|mesh-ancestor
92214603|NCT02921386|Hormones|hormones|mesh-ancestor
92214604|NCT02921386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214605|NCT02921386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214606|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92214607|NCT02921386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214608|NCT02921386|Anabolic Agents|anabolic agents|mesh-ancestor
92214609|NCT03402815|Maraviroc|maraviroc|mesh-list
92214610|NCT03402815|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92214611|NCT03402815|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92214612|NCT03402815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214613|NCT03402815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92214614|NCT03402815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92214615|NCT03402815|Antiviral Agents|antiviral agents|mesh-ancestor
92214616|NCT03402815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214617|NCT03402815|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92214618|NCT02245555|Tamsulosin|tamsulosin|mesh-list
92214619|NCT02245555|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92214620|NCT02245555|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92214621|NCT02245555|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92214622|NCT02245555|Adrenergic Agents|adrenergic agents|mesh-ancestor
92214623|NCT02245555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214624|NCT02245555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214625|NCT02245555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214626|NCT02245555|Urological Agents|urological agents|mesh-ancestor
92214627|NCT04354441|Hydroxychloroquine|hydroxychloroquine|mesh-list
92214628|NCT04354441|Antimalarials|antimalarials|mesh-ancestor
92214629|NCT04354441|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92214630|NCT04354441|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92214631|NCT04354441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214632|NCT04354441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214633|NCT04354441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214634|NCT04354441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214635|NCT02802514|Exenatide|exenatide|mesh-list
92214636|NCT02802514|rGLP-1 protein|rglp-1 protein|mesh-list
92214637|NCT02802514|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92214638|NCT02802514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214639|NCT02802514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214640|NCT02802514|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92214641|NCT02802514|Incretins|incretins|mesh-ancestor
92214642|NCT02802514|Hormones|hormones|mesh-ancestor
92214643|NCT02802514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214644|NCT00944671|Calcium, Dietary|calcium, dietary|mesh-list
92214645|NCT00944671|Calcium Carbonate|calcium carbonate|mesh-list
92214646|NCT00944671|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92214647|NCT00944671|Famotidine|famotidine|mesh-list
92214648|NCT00944671|Calcium|calcium|mesh-list
92214649|NCT00944671|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92214650|NCT00944671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214651|NCT00944671|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92214652|NCT00944671|Antacids|antacids|mesh-ancestor
92214653|NCT00944671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214654|NCT00944671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214655|NCT00944671|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92214656|NCT00944671|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92214657|NCT00944671|Histamine Antagonists|histamine antagonists|mesh-ancestor
92214658|NCT00944671|Histamine Agents|histamine agents|mesh-ancestor
92214659|NCT00944671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214660|NCT00944749|Cyclosporine|cyclosporine|mesh-list
92214661|NCT00944749|Cyclosporins|cyclosporins|mesh-list
92214662|NCT00944749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117281|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214663|NCT00944749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214664|NCT00944749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214665|NCT00944749|Immunologic Factors|immunologic factors|mesh-ancestor
92214666|NCT00944749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214667|NCT00944749|Antifungal Agents|antifungal agents|mesh-ancestor
92214668|NCT00944749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214669|NCT00944749|Dermatologic Agents|dermatologic agents|mesh-ancestor
92214670|NCT00944749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214671|NCT00944749|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92214672|NCT01047293|Leucovorin|leucovorin|mesh-list
92214673|NCT01047293|Bevacizumab|bevacizumab|mesh-list
92214674|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
92214675|NCT01047293|Everolimus|everolimus|mesh-list
92214676|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214677|NCT01047293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214678|NCT01047293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214679|NCT01047293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92214680|NCT01047293|Growth Substances|growth substances|mesh-ancestor
92214681|NCT01047293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214682|NCT01047293|Growth Inhibitors|growth inhibitors|mesh-ancestor
92214683|NCT01047293|Antidotes|antidotes|mesh-ancestor
92214684|NCT01047293|Protective Agents|protective agents|mesh-ancestor
92214685|NCT01047293|Vitamin B Complex|vitamin b complex|mesh-ancestor
92214686|NCT01047293|Vitamins|vitamins|mesh-ancestor
92214687|NCT01047293|Micronutrients|micronutrients|mesh-ancestor
92214688|NCT01047293|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92214689|NCT01047293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92214690|NCT01047293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214691|NCT01047293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214692|NCT01047293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214693|NCT01047293|Immunologic Factors|immunologic factors|mesh-ancestor
92214694|NCT01045967|Lansoprazole|lansoprazole|mesh-list
92214695|NCT01045967|Dexlansoprazole|dexlansoprazole|mesh-list
92214696|NCT01045967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92214697|NCT01045967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214698|NCT01045967|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92214699|NCT01045967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214700|NCT01045967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214701|NCT02808052|Minocycline|minocycline|mesh-list
92214702|NCT02808052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92214703|NCT02808052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214704|NCT02924350|Fluorides|fluorides|mesh-list
92214705|NCT02924350|Tin Fluorides|tin fluorides|mesh-list
92214706|NCT02924350|Fluorophosphate|fluorophosphate|mesh-list
92214707|NCT02924350|Cariostatic Agents|cariostatic agents|mesh-ancestor
92214708|NCT02924350|Protective Agents|protective agents|mesh-ancestor
92214709|NCT02924350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214710|NCT02344498|Tenofovir|tenofovir|mesh-list
92214711|NCT02344498|Antiviral Agents|antiviral agents|mesh-ancestor
92214712|NCT02344498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214713|NCT02344498|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92214714|NCT02344498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92214715|NCT02344498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214716|NCT02344498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214717|NCT02344498|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92214718|NCT02344498|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92214719|NCT00945139|Bevacizumab|bevacizumab|mesh-list
92214720|NCT00945139|Doxorubicin|doxorubicin|mesh-list
92214721|NCT00945139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214722|NCT00945139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214723|NCT00945139|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214724|NCT00945139|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92214725|NCT00945139|Growth Substances|growth substances|mesh-ancestor
92214726|NCT00945139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214727|NCT00945139|Growth Inhibitors|growth inhibitors|mesh-ancestor
92214728|NCT00945139|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92214729|NCT00945139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92214730|NCT00945139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92214731|NCT00945139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214732|NCT00945139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214733|NCT02812342|Tofacitinib|tofacitinib|mesh-list
92214734|NCT02812342|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92214735|NCT02812342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92214736|NCT02812342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214737|NCT02812342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214738|NCT03871465|Triamcinolone|triamcinolone|mesh-list
91921609|NCT03534037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214739|NCT03871465|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92214740|NCT03871465|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92214741|NCT03871465|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92214742|NCT03871465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214743|NCT03871465|Glucocorticoids|glucocorticoids|mesh-ancestor
92214744|NCT03871465|Hormones|hormones|mesh-ancestor
92214745|NCT03871465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214746|NCT03871465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214747|NCT03871465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214748|NCT03871465|Immunologic Factors|immunologic factors|mesh-ancestor
92214749|NCT03871465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214750|NCT03871465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214751|NCT00931489|Ranibizumab|ranibizumab|mesh-list
92214752|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214753|NCT00931489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92214754|NCT00931489|Growth Substances|growth substances|mesh-ancestor
92214755|NCT00931489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214756|NCT00931489|Growth Inhibitors|growth inhibitors|mesh-ancestor
92214757|NCT00931489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214759|NCT04363255|Carboplatin|carboplatin|mesh-list
92214760|NCT04363255|Etoposide|etoposide|mesh-list
92214761|NCT04363255|Etoposide phosphate|etoposide phosphate|mesh-list
92214762|NCT04363255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214763|NCT04363255|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92214764|NCT04363255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92214765|NCT04363255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92214766|NCT04363255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214767|NCT04363255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214768|NCT00945295|Botulinum Toxins|botulinum toxins|mesh-list
92214769|NCT00945295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92214770|NCT00945295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92214771|NCT00945295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92214772|NCT00945295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92214773|NCT00945295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214774|NCT00945295|Cholinergic Agents|cholinergic agents|mesh-ancestor
92214775|NCT00945295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214776|NCT00945295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214777|NCT00945295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92214778|NCT00945295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214779|NCT03490825|Melatonin|melatonin|mesh-list
92214780|NCT03490825|Antioxidants|antioxidants|mesh-ancestor
92214781|NCT03490825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214782|NCT03490825|Protective Agents|protective agents|mesh-ancestor
92214783|NCT03490825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214784|NCT03490825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214785|NCT04362943|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92214786|NCT04362943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214787|NCT03317899|Lenograstim|lenograstim|mesh-list
92214788|NCT03317899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92214789|NCT03317899|Immunologic Factors|immunologic factors|mesh-ancestor
92214790|NCT03317899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214791|NCT04353505|Dexamethasone|dexamethasone|mesh-list
92214792|NCT04353505|Ketorolac|ketorolac|mesh-list
92214793|NCT04353505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214794|NCT04353505|Antiemetics|antiemetics|mesh-ancestor
92214795|NCT04353505|Autonomic Agents|autonomic agents|mesh-ancestor
92214796|NCT04353505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214797|NCT04353505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214798|NCT04353505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214799|NCT04353505|Glucocorticoids|glucocorticoids|mesh-ancestor
92214800|NCT04353505|Hormones|hormones|mesh-ancestor
92214801|NCT04353505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214802|NCT04353505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92214803|NCT04353505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214804|NCT04353505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92214805|NCT04353505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92214806|NCT04353505|Analgesics|analgesics|mesh-ancestor
92214807|NCT04353505|Sensory System Agents|sensory system agents|mesh-ancestor
92214808|NCT04353505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214809|NCT04353505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92214810|NCT04353505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214811|NCT04353505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214812|NCT02929927|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92214813|NCT02929927|Eusol|eusol|mesh-list
92214814|NCT02929927|Disinfectants|disinfectants|mesh-ancestor
92214815|NCT02929927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214816|NCT02427451|Venetoclax|venetoclax|mesh-list
92214817|NCT02427451|Obinutuzumab|obinutuzumab|mesh-list
92214818|NCT02427451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214819|NCT02427451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214820|NCT04362241|Prednisolone|prednisolone|mesh-list
92214821|NCT04362241|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92214823|NCT04362241|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92214824|NCT04362241|Prednisolone acetate|prednisolone acetate|mesh-list
92214825|NCT04362241|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92214826|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
92214827|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214828|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
92214829|NCT04362241|Hormones|hormones|mesh-ancestor
92214830|NCT04362241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214831|NCT04362241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214832|NCT04362241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92214833|NCT04362241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214834|NCT04362241|Antiemetics|antiemetics|mesh-ancestor
92214835|NCT04362241|Autonomic Agents|autonomic agents|mesh-ancestor
92214836|NCT04362241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214837|NCT04362241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92214838|NCT04362241|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92214839|NCT04362241|Protective Agents|protective agents|mesh-ancestor
92214840|NCT01384513|Mycophenolic Acid|mycophenolic acid|mesh-list
92214841|NCT01384513|Cyclophosphamide|cyclophosphamide|mesh-list
92214842|NCT01384513|Busulfan|busulfan|mesh-list
92214843|NCT01384513|Fludarabine|fludarabine|mesh-list
92214844|NCT01384513|Fludarabine phosphate|fludarabine phosphate|mesh-list
92214845|NCT01384513|Tacrolimus|tacrolimus|mesh-list
92214846|NCT01384513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92214847|NCT01384513|Immunologic Factors|immunologic factors|mesh-ancestor
92214848|NCT01384513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214849|NCT01384513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214850|NCT01384513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92214851|NCT01384513|Alkylating Agents|alkylating agents|mesh-ancestor
92214852|NCT01384513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214853|NCT01384513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214854|NCT01384513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92214855|NCT01384513|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92214856|NCT01384513|Antimetabolites|antimetabolites|mesh-ancestor
92214857|NCT01384513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214858|NCT01384513|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92214859|NCT01384513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214860|NCT01384513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92214861|NCT01384513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92214862|NCT01384513|Antitubercular Agents|antitubercular agents|mesh-ancestor
92214863|NCT01384513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92214864|NCT03035617|Bupivacaine|bupivacaine|mesh-list
92214865|NCT03035617|Anesthetics, Local|anesthetics, local|mesh-ancestor
92214866|NCT03035617|Anesthetics|anesthetics|mesh-ancestor
92214867|NCT03035617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214868|NCT03035617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214869|NCT03035617|Sensory System Agents|sensory system agents|mesh-ancestor
92214870|NCT03035617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214871|NCT02933320|Rituximab|rituximab|mesh-list
92214872|NCT02933320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214873|NCT02933320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214874|NCT02933320|Immunologic Factors|immunologic factors|mesh-ancestor
92214875|NCT02933320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214876|NCT02933320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214877|NCT05563675|Cholinergic Agents|cholinergic agents|mesh-list
92214878|NCT05563675|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92214879|NCT05563675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92214880|NCT05563675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214881|NCT05563675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214882|NCT05563675|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92214883|NCT05555251|Trastuzumab|trastuzumab|mesh-list
92214884|NCT05555251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214885|NCT05555251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214886|NCT03035305|Pyrimethamine|pyrimethamine|mesh-list
92214887|NCT03035305|Sulfadoxine|sulfadoxine|mesh-list
92336994|NCT01957644|Azacitidine|azacitidine|mesh-list
92214888|NCT03035305|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92214889|NCT03035305|Amodiaquine|amodiaquine|mesh-list
92214890|NCT03035305|Antimalarials|antimalarials|mesh-ancestor
92214891|NCT03035305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92214892|NCT03035305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92214893|NCT03035305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214894|NCT03035305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92214895|NCT03035305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214896|NCT03035305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214897|NCT03035305|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92214898|NCT03034759|Insulin|insulin|mesh-list
92214899|NCT03034759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214900|NCT03034759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214901|NCT02158273|Fenofibrate|fenofibrate|mesh-list
92214902|NCT02158273|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92214903|NCT02158273|Antimetabolites|antimetabolites|mesh-ancestor
92214904|NCT02158273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214905|NCT02158273|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92214906|NCT02819284|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92214907|NCT02819284|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92214909|NCT04361461|Hydroxychloroquine|hydroxychloroquine|mesh-list
92214910|NCT04361461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92214911|NCT04361461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214912|NCT04361461|Antimalarials|antimalarials|mesh-ancestor
92214913|NCT04361461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92214914|NCT04361461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92214915|NCT04361461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214916|NCT04361461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214917|NCT04361461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92214918|NCT03002506|Tazobactam|tazobactam|mesh-list
92214919|NCT03002506|Ceftolozane|ceftolozane|mesh-list
92214920|NCT03002506|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92214921|NCT03002506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92214922|NCT03002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214923|NCT03002506|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92214924|NCT03002506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214925|NCT03002506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214926|NCT03002506|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92214927|NCT02822950|Ceftazidime|ceftazidime|mesh-list
92214928|NCT02822950|Avibactam|avibactam|mesh-list
92214929|NCT02822950|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92214930|NCT02822950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92214931|NCT02822950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92214932|NCT02822950|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92214933|NCT02822950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214934|NCT02822950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214935|NCT02935738|Prednisolone|prednisolone|mesh-list
92214936|NCT02935738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92214937|NCT02935738|Glucocorticoids|glucocorticoids|mesh-ancestor
92214939|NCT02935738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92214940|NCT02935738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214941|NCT02935738|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92214942|NCT02935738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214943|NCT05435677|Insulin|insulin|mesh-list
92214944|NCT05435677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92214945|NCT05435677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214946|NCT00939991|Bevacizumab|bevacizumab|mesh-list
92214947|NCT00939991|Temozolomide|temozolomide|mesh-list
92214948|NCT00939991|Vorinostat|vorinostat|mesh-list
92214949|NCT00939991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92214950|NCT00939991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214951|NCT00939991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92214952|NCT00939991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92214953|NCT00939991|Growth Substances|growth substances|mesh-ancestor
92214954|NCT00939991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214955|NCT00939991|Growth Inhibitors|growth inhibitors|mesh-ancestor
92214956|NCT00939991|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92214957|NCT00939991|Alkylating Agents|alkylating agents|mesh-ancestor
92214958|NCT00939991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214959|NCT00939991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92214960|NCT00939991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214961|NCT04361305|Tadalafil|tadalafil|mesh-list
92214962|NCT04361305|Vasodilator Agents|vasodilator agents|mesh-ancestor
92214963|NCT04361305|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92214964|NCT04361305|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92214965|NCT04361305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92214966|NCT04361305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92214967|NCT04361305|Urological Agents|urological agents|mesh-ancestor
92214968|NCT02245321|Ferrous gluconate|ferrous gluconate|mesh-list
92214969|NCT02245321|Hematinics|hematinics|mesh-ancestor
92214970|NCT04361149|Capsaicin|capsaicin|mesh-list
92214971|NCT04361149|Antipruritics|antipruritics|mesh-ancestor
92214972|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92214973|NCT04361149|Sensory System Agents|sensory system agents|mesh-ancestor
92214974|NCT04361149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214975|NCT04361149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214976|NCT05332483|Megestrol|megestrol|mesh-list
92214977|NCT05332483|Megestrol Acetate|megestrol acetate|mesh-list
92214978|NCT05332483|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92214979|NCT05332483|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92214980|NCT05332483|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92214981|NCT05332483|Contraceptive Agents|contraceptive agents|mesh-ancestor
92214982|NCT05332483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92214983|NCT05332483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214984|NCT05332483|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92214985|NCT05332483|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92214986|NCT05332483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92214987|NCT05332483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92214988|NCT05332483|Appetite Stimulants|appetite stimulants|mesh-ancestor
92214989|NCT05332483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92214991|NCT03033589|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92214992|NCT03033589|Anesthetics, Local|anesthetics, local|mesh-ancestor
92214993|NCT03033589|Anesthetics|anesthetics|mesh-ancestor
92214994|NCT03033589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92214995|NCT03033589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92214996|NCT03033589|Sensory System Agents|sensory system agents|mesh-ancestor
92214997|NCT03033589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92214998|NCT00947167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92214999|NCT00947167|Pertuzumab|pertuzumab|mesh-list
92215000|NCT00947167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215001|NCT00947167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92215002|NCT00947167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215003|NCT00947167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215004|NCT00947167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92215005|NCT04360759|Hydroxychloroquine|hydroxychloroquine|mesh-list
92215006|NCT04360759|Chloroquine|chloroquine|mesh-list
92215007|NCT04360759|Antimalarials|antimalarials|mesh-ancestor
92215008|NCT04360759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92215009|NCT04360759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92215010|NCT04360759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215011|NCT04360759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215012|NCT04360759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215013|NCT04360759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215014|NCT04360759|Amebicides|amebicides|mesh-ancestor
92215015|NCT00940771|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92215016|NCT00940771|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92215017|NCT00940771|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92215018|NCT00940771|Protease Inhibitors|protease inhibitors|mesh-ancestor
92215019|NCT00940771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215020|NCT00940771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215021|NCT00940771|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92215022|NCT00940771|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92215023|NCT00940771|Antiviral Agents|antiviral agents|mesh-ancestor
92215024|NCT00940771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215025|NCT03033355|Botulinum Toxins|botulinum toxins|mesh-list
92215026|NCT03033355|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92215027|NCT03033355|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92215028|NCT03033355|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92215029|NCT03033355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337008|NCT01930890|Mycophenolic Acid|mycophenolic acid|mesh-list
92215030|NCT03033355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215032|NCT03033355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215033|NCT03033355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215034|NCT03033355|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92215035|NCT03033355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215037|NCT03033121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215038|NCT03033121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215039|NCT03033199|Dexamethasone|dexamethasone|mesh-list
92215040|NCT03033199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215041|NCT03033199|Antiemetics|antiemetics|mesh-ancestor
92215042|NCT03033199|Autonomic Agents|autonomic agents|mesh-ancestor
92215043|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215044|NCT03033199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215045|NCT03033199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215046|NCT03033199|Glucocorticoids|glucocorticoids|mesh-ancestor
92215047|NCT03033199|Hormones|hormones|mesh-ancestor
92215048|NCT03033199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215049|NCT03033199|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92215050|NCT03033199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215051|NCT00940927|Albuterol|albuterol|mesh-list
92215052|NCT00940927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92215053|NCT00940927|Autonomic Agents|autonomic agents|mesh-ancestor
91934232|NCT02293525|Morphine|morphine|mesh-list
92215054|NCT00940927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215055|NCT00940927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215056|NCT00940927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92215057|NCT00940927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215058|NCT00940927|Tocolytic Agents|tocolytic agents|mesh-ancestor
92215059|NCT00940927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92215060|NCT00940927|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92215061|NCT00940927|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92215062|NCT00940927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215063|NCT00940927|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215064|NCT00940927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215065|NCT00940927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215066|NCT00934375|Donepezil|donepezil|mesh-list
92215067|NCT00934375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92215068|NCT00934375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215069|NCT00934375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215070|NCT00934375|Cholinergic Agents|cholinergic agents|mesh-ancestor
92215071|NCT00934375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215072|NCT00934375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215073|NCT00934375|Nootropic Agents|nootropic agents|mesh-ancestor
92215074|NCT03002974|Triamcinolone|triamcinolone|mesh-list
92215075|NCT03002974|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92215076|NCT03002974|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92215077|NCT03002974|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92215078|NCT03002974|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92215079|NCT03002974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215080|NCT03002974|Glucocorticoids|glucocorticoids|mesh-ancestor
92215081|NCT03002974|Hormones|hormones|mesh-ancestor
92215082|NCT03002974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215083|NCT03002974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215084|NCT03002974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92215085|NCT03002974|Immunologic Factors|immunologic factors|mesh-ancestor
92215086|NCT03002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215087|NCT03002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215088|NCT03002974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215089|NCT02245477|Mitogens|mitogens|mesh-list
92215090|NCT02245477|Endothelial Growth Factors|endothelial growth factors|mesh-list
92215091|NCT02245477|Mitosis Modulators|mitosis modulators|mesh-ancestor
92215092|NCT02245477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215093|NCT02245477|Growth Substances|growth substances|mesh-ancestor
92215094|NCT02245477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215095|NCT02825212|Sofosbuvir|sofosbuvir|mesh-list
92215096|NCT02825212|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92215097|NCT02825212|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92215098|NCT02825212|Ledipasvir|ledipasvir|mesh-list
92215099|NCT02825212|Velpatasvir|velpatasvir|mesh-list
92215100|NCT02825212|Antiviral Agents|antiviral agents|mesh-ancestor
92215101|NCT02825212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215102|NCT00373672|Modafinil|modafinil|mesh-list
92215103|NCT00373672|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92215104|NCT00373672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215105|NCT00373672|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92215106|NCT00373672|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92215107|NCT00373672|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92215108|NCT00373672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215109|NCT04941703|Magnesium citrate|magnesium citrate|mesh-list
92215110|NCT04941703|Cathartics|cathartics|mesh-ancestor
92215111|NCT04941703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215112|NCT04359823|Lovastatin|lovastatin|mesh-list
92215113|NCT04359823|L 647318|l 647318|mesh-list
92215114|NCT04359823|Dihydromevinolin|dihydromevinolin|mesh-list
92215115|NCT04359823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92215116|NCT04359823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92215117|NCT04359823|Antimetabolites|antimetabolites|mesh-ancestor
92215118|NCT04359823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215119|NCT04359823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92215120|NCT04359823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92215121|NCT04359823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215122|NCT03008590|Naltrexone|naltrexone|mesh-list
92215123|NCT03008590|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92215124|NCT03008590|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92215125|NCT03008590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215126|NCT03008590|Sensory System Agents|sensory system agents|mesh-ancestor
92215127|NCT03008590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215129|NCT04359511|Hydrocortisone|hydrocortisone|mesh-list
92215130|NCT04359511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215131|NCT04359511|Glucocorticoids|glucocorticoids|mesh-ancestor
92215132|NCT04359511|Hormones|hormones|mesh-ancestor
92215133|NCT04359511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215134|NCT04359511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215135|NCT04359511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92215136|NCT04359511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215137|NCT03032419|Vaccines|vaccines|mesh-list
92215138|NCT03032419|Immunologic Factors|immunologic factors|mesh-ancestor
92215139|NCT03032419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215140|NCT00373906|Bortezomib|bortezomib|mesh-list
92215141|NCT00373906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215142|NCT00955513|Diclofenac|diclofenac|mesh-list
92215143|NCT00955513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92215144|NCT00955513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215145|NCT00955513|Analgesics|analgesics|mesh-ancestor
92215146|NCT00955513|Sensory System Agents|sensory system agents|mesh-ancestor
92215147|NCT00955513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215148|NCT00955513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215149|NCT00955513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215150|NCT00955513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215151|NCT00955513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92215152|NCT00955513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215153|NCT00955513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215154|NCT00935311|Acetaminophen|acetaminophen|mesh-list
92215155|NCT00935311|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92215156|NCT00935311|Hydrocodone|hydrocodone|mesh-list
92215157|NCT00935311|Oxycodone|oxycodone|mesh-list
92215158|NCT00935311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215159|NCT00935311|Analgesics|analgesics|mesh-ancestor
92215160|NCT00935311|Sensory System Agents|sensory system agents|mesh-ancestor
92215161|NCT00935311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337015|NCT01930890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215162|NCT00935311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215163|NCT00935311|Antipyretics|antipyretics|mesh-ancestor
92215164|NCT00935311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92215165|NCT00935311|Narcotics|narcotics|mesh-ancestor
92215166|NCT00935311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215167|NCT00935311|Antitussive Agents|antitussive agents|mesh-ancestor
92215168|NCT00935311|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215169|NCT00935311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92215170|NCT00935311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215171|NCT00935311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215173|NCT02946034|Antimetabolites|antimetabolites|mesh-ancestor
92215174|NCT02946034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215175|NCT02946034|Antiviral Agents|antiviral agents|mesh-ancestor
92215176|NCT02946034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215177|NCT00955747|Tagatose|tagatose|mesh-list
92215178|NCT00955747|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92215179|NCT00955747|Chelating Agents|chelating agents|mesh-ancestor
92215180|NCT00955747|Sequestering Agents|sequestering agents|mesh-ancestor
92215181|NCT00955747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215182|NCT02946892|Carvedilol|carvedilol|mesh-list
92215183|NCT02946892|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92215184|NCT02946892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92215185|NCT02946892|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215186|NCT02946892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215187|NCT02946892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408677|NCT05962671|Analgesics|analgesics|mesh-ancestor
92215188|NCT02946892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215189|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92215190|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
92215191|NCT02946892|Protective Agents|protective agents|mesh-ancestor
92215192|NCT02946892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92215193|NCT02946892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215194|NCT02946892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92215195|NCT02946892|Vasodilator Agents|vasodilator agents|mesh-ancestor
92215196|NCT02946892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92215197|NCT02946892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92215198|NCT03402191|Sildenafil Citrate|sildenafil citrate|mesh-list
92215199|NCT03402191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92215200|NCT03402191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91934234|NCT02293525|Ropivacaine|ropivacaine|mesh-list
92215201|NCT03402191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92215202|NCT03402191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215203|NCT03402191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215204|NCT03402191|Urological Agents|urological agents|mesh-ancestor
92215205|NCT03402113|Midazolam|midazolam|mesh-list
92215206|NCT03402113|Dexmedetomidine|dexmedetomidine|mesh-list
92215207|NCT03402113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92215208|NCT03402113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215209|NCT03402113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215210|NCT03402113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215211|NCT03402113|Analgesics|analgesics|mesh-ancestor
92215212|NCT03402113|Sensory System Agents|sensory system agents|mesh-ancestor
92215213|NCT03402113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215214|NCT03402113|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92215215|NCT03402113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92215216|NCT03402113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215217|NCT03402113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215218|NCT03402113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215219|NCT03402113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215220|NCT03402113|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92215221|NCT03402113|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92215222|NCT03402113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92215223|NCT03402113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215224|NCT03402113|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92215225|NCT03402113|Anesthetics, General|anesthetics, general|mesh-ancestor
92215226|NCT03402113|Anesthetics|anesthetics|mesh-ancestor
92215227|NCT03402113|GABA Modulators|gaba modulators|mesh-ancestor
92215228|NCT03402113|GABA Agents|gaba agents|mesh-ancestor
92215229|NCT01725113|Calcitriol|calcitriol|mesh-list
92215230|NCT01725113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92215231|NCT01725113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215232|NCT01725113|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92215233|NCT01725113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215234|NCT01725113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215235|NCT01725113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92215236|NCT01725113|Vitamins|vitamins|mesh-ancestor
92215237|NCT01725113|Micronutrients|micronutrients|mesh-ancestor
92215238|NCT01725113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92215239|NCT03031405|Oxytocin|oxytocin|mesh-list
92215240|NCT03031405|Oxytocics|oxytocics|mesh-ancestor
92215241|NCT03031405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92215242|NCT03031405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215243|NCT03031249|Cytarabine|cytarabine|mesh-list
92215244|NCT03031249|Tretinoin|tretinoin|mesh-list
92215245|NCT03031249|Arsenic Trioxide|arsenic trioxide|mesh-list
92215246|NCT03031249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92215247|NCT03031249|Antimetabolites|antimetabolites|mesh-ancestor
92215248|NCT03031249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215249|NCT03031249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215250|NCT03031249|Antiviral Agents|antiviral agents|mesh-ancestor
92215251|NCT03031249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215252|NCT03031249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92215253|NCT03031249|Immunologic Factors|immunologic factors|mesh-ancestor
92215254|NCT03031249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215255|NCT03031249|Keratolytic Agents|keratolytic agents|mesh-ancestor
92215256|NCT03031249|Dermatologic Agents|dermatologic agents|mesh-ancestor
92215257|NCT02980315|Immunomodulating Agents|immunomodulating agents|mesh-list
92215258|NCT02980315|Immunologic Factors|immunologic factors|mesh-ancestor
92215259|NCT02980315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215260|NCT01042535|Tryptophan|tryptophan|mesh-list
92215261|NCT01042535|Vaccines|vaccines|mesh-list
92215262|NCT01042535|Immunologic Factors|immunologic factors|mesh-ancestor
92215263|NCT01042535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215264|NCT01042535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92215265|NCT01042535|Antidepressive Agents|antidepressive agents|mesh-ancestor
92215266|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215267|NCT03031327|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92215268|NCT03031327|Hyaluronic Acid|hyaluronic acid|mesh-list
92215269|NCT03031327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92215270|NCT03031327|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92215271|NCT03031327|Immunologic Factors|immunologic factors|mesh-ancestor
92215272|NCT03031327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215273|NCT03031327|Viscosupplements|viscosupplements|mesh-ancestor
92215274|NCT03031327|Protective Agents|protective agents|mesh-ancestor
92215275|NCT03401957|Cetuximab|cetuximab|mesh-list
92215276|NCT03401957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92215277|NCT03401957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215278|NCT04358965|Misoprostol|misoprostol|mesh-list
92215279|NCT04358965|Tranexamic Acid|tranexamic acid|mesh-list
92215280|NCT04358965|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92215281|NCT04358965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92215282|NCT04358965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215283|NCT04358965|Hemostatics|hemostatics|mesh-ancestor
92215284|NCT04358965|Coagulants|coagulants|mesh-ancestor
92215285|NCT04358965|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92215286|NCT04358965|Abortifacient Agents|abortifacient agents|mesh-ancestor
92215287|NCT04358965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92215288|NCT04358965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215289|NCT04358965|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92215290|NCT04358965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215291|NCT04358965|Oxytocics|oxytocics|mesh-ancestor
92215293|NCT01041287|Nebivolol|nebivolol|mesh-list
92215294|NCT01041287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92215295|NCT01041287|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92215296|NCT01041287|Sympatholytics|sympatholytics|mesh-ancestor
92215297|NCT01041287|Autonomic Agents|autonomic agents|mesh-ancestor
92215298|NCT01041287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215299|NCT01041287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215300|NCT01041287|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92215301|NCT01041287|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92215302|NCT01041287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92215303|NCT01041287|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215304|NCT01041287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215305|NCT01041287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215306|NCT01041287|Vasodilator Agents|vasodilator agents|mesh-ancestor
92215307|NCT01041287|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92215308|NCT01041287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92215309|NCT01041287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215310|NCT03016741|Prednisone|prednisone|mesh-list
92215311|NCT03016741|Abiraterone Acetate|abiraterone acetate|mesh-list
92215312|NCT03016741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215313|NCT03016741|Glucocorticoids|glucocorticoids|mesh-ancestor
92215315|NCT03016741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215316|NCT03016741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215317|NCT03016741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92215318|NCT03016741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215319|NCT03016741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92215320|NCT03016741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215321|NCT03016741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215322|NCT03016741|Hormone Antagonists|hormone antagonists|mesh-ancestor
92215323|NCT03016741|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92215324|NCT01042925|Paclitaxel|paclitaxel|mesh-list
92215325|NCT01042925|Trastuzumab|trastuzumab|mesh-list
92215326|NCT01042925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92215327|NCT01042925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215328|NCT01042925|Tubulin Modulators|tubulin modulators|mesh-ancestor
92215329|NCT01042925|Antimitotic Agents|antimitotic agents|mesh-ancestor
92215330|NCT01042925|Mitosis Modulators|mitosis modulators|mesh-ancestor
92215331|NCT01042925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215332|NCT01042925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92215333|NCT03400709|Acetylcysteine|acetylcysteine|mesh-list
92215334|NCT03400709|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92215335|NCT03400709|Antiviral Agents|antiviral agents|mesh-ancestor
92215336|NCT03400709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215337|NCT03400709|Expectorants|expectorants|mesh-ancestor
92408678|NCT05962671|Sensory System Agents|sensory system agents|mesh-ancestor
92215338|NCT03400709|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215339|NCT03400709|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92215340|NCT03400709|Antioxidants|antioxidants|mesh-ancestor
92215341|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215342|NCT03400709|Protective Agents|protective agents|mesh-ancestor
92215343|NCT03400709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215344|NCT03400709|Antidotes|antidotes|mesh-ancestor
92215345|NCT02049957|Fulvestrant|fulvestrant|mesh-list
92215346|NCT02049957|Exemestane|exemestane|mesh-list
92215347|NCT02049957|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92215348|NCT02049957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215349|NCT02049957|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92215350|NCT02049957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92215351|NCT02049957|Hormone Antagonists|hormone antagonists|mesh-ancestor
92215352|NCT02049957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215353|NCT02049957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215355|NCT02049957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92215356|NCT02049957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215357|NCT02049957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215358|NCT03030937|Irinotecan|irinotecan|mesh-list
92215359|NCT03030937|Apatinib|apatinib|mesh-list
92215360|NCT03030937|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92215361|NCT03030937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92215362|NCT03030937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215363|NCT03030937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215364|NCT03030937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215365|NCT03030937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92215366|NCT00950365|Pemetrexed|pemetrexed|mesh-list
92215367|NCT00950365|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92215368|NCT00950365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215370|NCT00950365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215371|NCT00950365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92215372|NCT00950365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92215373|NCT00950365|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92215374|NCT01908465|Ebastine|ebastine|mesh-list
92215375|NCT01908465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92215376|NCT01908465|Histamine Antagonists|histamine antagonists|mesh-ancestor
92215377|NCT01908465|Histamine Agents|histamine agents|mesh-ancestor
92215378|NCT01908465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215379|NCT01908465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215380|NCT01908465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215381|NCT00950833|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92215382|NCT00950833|Immunologic Factors|immunologic factors|mesh-ancestor
92215383|NCT00950833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215384|NCT02246023|Propofol|propofol|mesh-list
92215385|NCT02246023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92215386|NCT02246023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215387|NCT02246023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408943|NCT05959720|Cytarabine|cytarabine|mesh-list
92215388|NCT02246023|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92215389|NCT02246023|Anesthetics, General|anesthetics, general|mesh-ancestor
92409190|NCT05894239|Taxane|taxane|mesh-list
92215390|NCT02246023|Anesthetics|anesthetics|mesh-ancestor
92215391|NCT00924053|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92215392|NCT00924053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215393|NCT00924053|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92215394|NCT00924053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409610|NCT05669482|Paclitaxel|paclitaxel|mesh-list
92215395|NCT00357825|Reboxetine|reboxetine|mesh-list
92409685|NCT05653401|Analgesics|analgesics|mesh-ancestor
92409850|NCT05603104|GABA Agents|gaba agents|mesh-ancestor
92215396|NCT00357825|Antidepressive Agents|antidepressive agents|mesh-ancestor
92410072|NCT05498233|Pyridoxine|pyridoxine|mesh-list
92215397|NCT00357825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215398|NCT00357825|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92410283|NCT05328908|Antiviral Agents|antiviral agents|mesh-ancestor
92410361|NCT05282121|Empagliflozin|empagliflozin|mesh-list
92410436|NCT05259839|Hormones|hormones|mesh-ancestor
92410519|NCT05179512|Glucocorticoids|glucocorticoids|mesh-ancestor
92215399|NCT00357825|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92410595|NCT05099198|Glimepiride|glimepiride|mesh-list
92215400|NCT00357825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92410735|NCT04997811|Valproic Acid|valproic acid|mesh-list
92215401|NCT00357825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410811|NCT04971304|Lenograstim|lenograstim|mesh-list
92410885|NCT04925284|Nivolumab|nivolumab|mesh-list
92215402|NCT00357825|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215403|NCT00357825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215404|NCT00357825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411112|NCT04749641|Vaccines|vaccines|mesh-list
92215405|NCT03400241|Bromides|bromides|mesh-list
92215406|NCT03400241|Tiotropium Bromide|tiotropium bromide|mesh-list
92215407|NCT03400241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92215408|NCT03400241|Autonomic Agents|autonomic agents|mesh-ancestor
92215409|NCT03400241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215410|NCT03400241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215411|NCT03400241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92411624|NCT04126070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92215412|NCT03400241|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215413|NCT03400241|Parasympatholytics|parasympatholytics|mesh-ancestor
92215414|NCT03400241|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92215415|NCT03400241|Cholinergic Agents|cholinergic agents|mesh-ancestor
92215416|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411847|NCT03900637|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92215417|NCT03400241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215418|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
92215419|NCT05706987|Lidocaine|lidocaine|mesh-list
92412141|NCT03440567|Avelumab|avelumab|mesh-list
92215420|NCT05706987|Anesthetics, Local|anesthetics, local|mesh-ancestor
92215421|NCT05706987|Anesthetics|anesthetics|mesh-ancestor
92412448|NCT02757859|Pancreatin|pancreatin|mesh-list
92215422|NCT05706987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215423|NCT05706987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412762|NCT01614197|Cytarabine|cytarabine|mesh-list
92215424|NCT05706987|Sensory System Agents|sensory system agents|mesh-ancestor
92215425|NCT05706987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215426|NCT05706987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92215427|NCT05706987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92215428|NCT05706987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92215429|NCT05706987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215430|NCT05706987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215431|NCT00729573|Tenofovir|tenofovir|mesh-list
92215432|NCT00729573|Emtricitabine|emtricitabine|mesh-list
92215433|NCT00729573|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92215434|NCT00729573|Antiviral Agents|antiviral agents|mesh-ancestor
92215435|NCT00729573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215436|NCT00729573|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92215437|NCT00729573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92215438|NCT00729573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215439|NCT00729573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215440|NCT00729573|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92215441|NCT00729573|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92215442|NCT02951182|Ivacaftor|ivacaftor|mesh-list
92215443|NCT02951182|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92215444|NCT02951182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215445|NCT02951182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215446|NCT03403205|Choline|choline|mesh-list
92215447|NCT03403205|Lipotropic Agents|lipotropic agents|mesh-ancestor
92215448|NCT03403205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92215449|NCT03403205|Antimetabolites|antimetabolites|mesh-ancestor
92215450|NCT03403205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215451|NCT03403205|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215452|NCT03403205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92215453|NCT03403205|Nootropic Agents|nootropic agents|mesh-ancestor
92215454|NCT02959359|Ribavirin|ribavirin|mesh-list
92215455|NCT02959359|Sofosbuvir|sofosbuvir|mesh-list
92215456|NCT02959359|Ledipasvir|ledipasvir|mesh-list
92215457|NCT02959359|Antimetabolites|antimetabolites|mesh-ancestor
92215458|NCT02959359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215459|NCT02959359|Antiviral Agents|antiviral agents|mesh-ancestor
92215460|NCT02959359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215461|NCT02829034|Ranolazine|ranolazine|mesh-list
92215462|NCT02829034|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92215463|NCT02829034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215464|NCT02829034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215465|NCT00924209|Bevacizumab|bevacizumab|mesh-list
92215466|NCT00924209|Gemcitabine|gemcitabine|mesh-list
92215467|NCT00924209|Etoposide|etoposide|mesh-list
92215468|NCT00924209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92215469|NCT00924209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215470|NCT00924209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92215471|NCT00924209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92215472|NCT00924209|Growth Substances|growth substances|mesh-ancestor
92215473|NCT00924209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215474|NCT00924209|Growth Inhibitors|growth inhibitors|mesh-ancestor
92215475|NCT00924209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92215476|NCT00924209|Antimetabolites|antimetabolites|mesh-ancestor
92215477|NCT00924209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215478|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92215479|NCT00924209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92215480|NCT00924209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92215481|NCT00924209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215482|NCT05719467|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92215483|NCT05719467|Parasympatholytics|parasympatholytics|mesh-ancestor
92215484|NCT05719467|Autonomic Agents|autonomic agents|mesh-ancestor
92215485|NCT05719467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215486|NCT05719467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215487|NCT05719467|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92215488|NCT05719467|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92215489|NCT05719467|Cholinergic Agents|cholinergic agents|mesh-ancestor
92215490|NCT05719467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215491|NCT05719467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215492|NCT03408119|Vitamin D|vitamin d|mesh-list
92215493|NCT03408119|Calcium|calcium|mesh-list
92215494|NCT03408119|Vitamins|vitamins|mesh-ancestor
92215495|NCT03408119|Micronutrients|micronutrients|mesh-ancestor
92215496|NCT03408119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215497|NCT03408119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92215498|NCT03408119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92215499|NCT03405155|Nivolumab|nivolumab|mesh-list
92215500|NCT03405155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92215501|NCT03405155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215502|NCT03405155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92337053|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92215503|NCT03405155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215504|NCT04374929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92215505|NCT04374929|Glucocorticoids|glucocorticoids|mesh-list
92215506|NCT04374929|Hormones|hormones|mesh-ancestor
92215507|NCT04374929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215508|NCT04374929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215509|NCT05717361|Lidocaine|lidocaine|mesh-list
92215510|NCT05717361|Ketamine|ketamine|mesh-list
92215511|NCT05717361|Remifentanil|remifentanil|mesh-list
92215512|NCT05717361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92215513|NCT05717361|Anesthetics|anesthetics|mesh-ancestor
92215514|NCT05717361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215515|NCT05717361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215516|NCT05717361|Sensory System Agents|sensory system agents|mesh-ancestor
92215517|NCT05717361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215518|NCT05717361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92215519|NCT05717361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92215520|NCT05717361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92215521|NCT05717361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215522|NCT05717361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215523|NCT05717361|Analgesics|analgesics|mesh-ancestor
92215524|NCT05717361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92215525|NCT05717361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92215526|NCT05717361|Anesthetics, General|anesthetics, general|mesh-ancestor
92215527|NCT05717361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92215528|NCT05717361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92215529|NCT05717361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215530|NCT05717361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92215532|NCT02951884|Bupivacaine|bupivacaine|mesh-list
92215533|NCT02951884|Anesthetics, Local|anesthetics, local|mesh-ancestor
92215534|NCT02951884|Anesthetics|anesthetics|mesh-ancestor
92215535|NCT02951884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215536|NCT02951884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215537|NCT02951884|Sensory System Agents|sensory system agents|mesh-ancestor
92215538|NCT02951884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215539|NCT05574387|Metformin|metformin|mesh-list
92215540|NCT05574387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92215541|NCT05574387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215542|NCT02978001|Glycerol|glycerol|mesh-list
92215543|NCT02978001|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92215544|NCT02978001|Protective Agents|protective agents|mesh-ancestor
92215545|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215546|NCT02978313|Cetuximab|cetuximab|mesh-list
92215547|NCT02978313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92215548|NCT02978313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215549|NCT00014495|Cytarabine|cytarabine|mesh-list
92215550|NCT00014495|Bismuth|bismuth|mesh-list
92215551|NCT00014495|Antibodies|antibodies|mesh-list
92215552|NCT00014495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92215553|NCT00014495|Immunologic Factors|immunologic factors|mesh-ancestor
92215554|NCT00014495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936803|NCT02264171|Tamsulosin|tamsulosin|mesh-list
92215555|NCT00014495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92215556|NCT00014495|Antimetabolites|antimetabolites|mesh-ancestor
92215557|NCT00014495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215558|NCT00014495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215559|NCT00014495|Antiviral Agents|antiviral agents|mesh-ancestor
92215560|NCT00014495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215561|NCT00014495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92215562|NCT00014495|Antacids|antacids|mesh-ancestor
92215563|NCT00014495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215564|NCT05566041|Carboplatin|carboplatin|mesh-list
92215565|NCT05566041|Etoposide|etoposide|mesh-list
92215566|NCT05566041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215567|NCT05566041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92215568|NCT05566041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92215569|NCT05566041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92215570|NCT05566041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215571|NCT05566041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215572|NCT04374071|Methylprednisolone|methylprednisolone|mesh-list
92215573|NCT04374071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92337059|NCT01928940|Dabrafenib|dabrafenib|mesh-list
92215574|NCT04374071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92215575|NCT04374071|Prednisolone|prednisolone|mesh-list
92215576|NCT04374071|Prednisolone acetate|prednisolone acetate|mesh-list
92215577|NCT04374071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92215578|NCT04374071|Prednisolone phosphate|prednisolone phosphate|mesh-list
92215579|NCT04374071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215580|NCT04374071|Antiemetics|antiemetics|mesh-ancestor
92215581|NCT04374071|Autonomic Agents|autonomic agents|mesh-ancestor
92215582|NCT04374071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215583|NCT04374071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215584|NCT04374071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215585|NCT04374071|Glucocorticoids|glucocorticoids|mesh-ancestor
92215586|NCT04374071|Hormones|hormones|mesh-ancestor
92215587|NCT04374071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215588|NCT04374071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92215589|NCT04374071|Protective Agents|protective agents|mesh-ancestor
92215590|NCT04374071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92215591|NCT04374071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215592|NCT00357981|Contraceptive Agents|contraceptive agents|mesh-list
92215593|NCT00357981|Ortho Evra|ortho evra|mesh-list
92215594|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92215595|NCT00357981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215596|NCT00357981|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92215597|NCT03030703|Inositol|inositol|mesh-list
92215598|NCT03030703|Vitamin B Complex|vitamin b complex|mesh-ancestor
92215599|NCT03030703|Vitamins|vitamins|mesh-ancestor
92215600|NCT03030703|Micronutrients|micronutrients|mesh-ancestor
92215601|NCT03030703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215602|NCT02157623|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92215603|NCT02157623|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92215604|NCT02157623|Dermatologic Agents|dermatologic agents|mesh-ancestor
92215605|NCT03030469|Analgesics, Opioid|analgesics, opioid|mesh-list
92215606|NCT03030469|Analgesics|analgesics|mesh-list
92215607|NCT03030469|Narcotics|narcotics|mesh-ancestor
92215608|NCT03030469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215609|NCT03030469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215610|NCT03030469|Sensory System Agents|sensory system agents|mesh-ancestor
92215611|NCT03030469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215612|NCT00952081|Clevidipine|clevidipine|mesh-list
92215613|NCT00952081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92215614|NCT00952081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215615|NCT00952081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215616|NCT00952081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92215617|NCT00952081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215619|NCT05716347|Immunologic Factors|immunologic factors|mesh-ancestor
92215620|NCT05716347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215621|NCT02959840|Ondansetron|ondansetron|mesh-list
92215622|NCT02959840|Metoclopramide|metoclopramide|mesh-list
92215623|NCT02959840|Antiemetics|antiemetics|mesh-ancestor
92215624|NCT02959840|Autonomic Agents|autonomic agents|mesh-ancestor
92215625|NCT02959840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215626|NCT02959840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215627|NCT02959840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215628|NCT02959840|Antipruritics|antipruritics|mesh-ancestor
92215629|NCT02959840|Dermatologic Agents|dermatologic agents|mesh-ancestor
92215630|NCT02959840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92215631|NCT02959840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92215632|NCT02959840|Serotonin Agents|serotonin agents|mesh-ancestor
92215633|NCT02959840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215634|NCT02959840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215635|NCT02959840|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92215636|NCT02959840|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92215637|NCT02959840|Dopamine Agents|dopamine agents|mesh-ancestor
92215638|NCT04358341|Doxorubicin|doxorubicin|mesh-list
92215639|NCT04358341|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92215640|NCT04358341|Fluorouracil|fluorouracil|mesh-list
92215641|NCT04358341|Irinotecan|irinotecan|mesh-list
92215642|NCT04358341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337066|NCT01975272|Iron|iron|mesh-list
92215643|NCT04358341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215644|NCT04358341|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92215645|NCT04358341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92215646|NCT04358341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215647|NCT04358341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215648|NCT04358341|Antimetabolites|antimetabolites|mesh-ancestor
92215649|NCT04358341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92215650|NCT04358341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92215651|NCT04358341|Immunologic Factors|immunologic factors|mesh-ancestor
92215652|NCT04358341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215653|NCT04358341|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92215654|NCT02978547|Metformin|metformin|mesh-list
92215655|NCT02978547|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92215656|NCT02978547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215657|NCT02959996|Bupivacaine|bupivacaine|mesh-list
92215658|NCT02959996|Anesthetics, Local|anesthetics, local|mesh-ancestor
92215659|NCT02959996|Anesthetics|anesthetics|mesh-ancestor
92215660|NCT02959996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215661|NCT02959996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215662|NCT02959996|Sensory System Agents|sensory system agents|mesh-ancestor
92215663|NCT02959996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215664|NCT00929981|Methylprednisolone|methylprednisolone|mesh-list
92215665|NCT00929981|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92215666|NCT00929981|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92215667|NCT00929981|Prednisolone|prednisolone|mesh-list
92215668|NCT00929981|Prednisolone acetate|prednisolone acetate|mesh-list
92215669|NCT00929981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92215670|NCT00929981|Prednisolone phosphate|prednisolone phosphate|mesh-list
92215671|NCT00929981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215672|NCT00929981|Antiemetics|antiemetics|mesh-ancestor
92215673|NCT00929981|Autonomic Agents|autonomic agents|mesh-ancestor
92215674|NCT00929981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215675|NCT00929981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215676|NCT00929981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215677|NCT00929981|Glucocorticoids|glucocorticoids|mesh-ancestor
92215678|NCT00929981|Hormones|hormones|mesh-ancestor
92215679|NCT00929981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92215680|NCT00929981|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92215681|NCT00929981|Protective Agents|protective agents|mesh-ancestor
92215682|NCT00929981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92215683|NCT00929981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215684|NCT00961441|Levetiracetam|levetiracetam|mesh-list
92215685|NCT00961441|Anticonvulsants|anticonvulsants|mesh-ancestor
92215686|NCT00961441|Nootropic Agents|nootropic agents|mesh-ancestor
92215687|NCT02961946|Nitroglycerin|nitroglycerin|mesh-list
92215688|NCT02961946|Vasodilator Agents|vasodilator agents|mesh-ancestor
92215689|NCT02240459|Fesoterodine|fesoterodine|mesh-list
92215690|NCT02240459|Oxybutynin|oxybutynin|mesh-list
92215691|NCT02240459|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92215692|NCT02240459|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92215693|NCT02240459|Cholinergic Agents|cholinergic agents|mesh-ancestor
92215694|NCT02240459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215695|NCT02240459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215696|NCT02240459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215697|NCT02240459|Urological Agents|urological agents|mesh-ancestor
92215698|NCT02240459|Parasympatholytics|parasympatholytics|mesh-ancestor
92215699|NCT02240459|Autonomic Agents|autonomic agents|mesh-ancestor
92215700|NCT02240459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215701|NCT02240537|Sargramostim|sargramostim|mesh-list
92215702|NCT02240537|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92215703|NCT02240537|Immunologic Factors|immunologic factors|mesh-ancestor
92215704|NCT02240537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215705|NCT02240537|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92215706|NCT00962065|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92215707|NCT00962065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92215708|NCT00962065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215709|NCT00962065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92215710|NCT00962065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215712|NCT02240927|Warfarin|warfarin|mesh-list
92215713|NCT02240927|Enoxaparin sodium|enoxaparin sodium|mesh-list
92215714|NCT02240927|Anticoagulants|anticoagulants|mesh-ancestor
92215715|NCT02240927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92215716|NCT02240927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92215717|NCT02240927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215718|NCT03038308|Ropinirole|ropinirole|mesh-list
92215719|NCT03038308|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92215720|NCT03038308|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92215721|NCT03038308|Dopamine Agonists|dopamine agonists|mesh-ancestor
92215722|NCT03038308|Dopamine Agents|dopamine agents|mesh-ancestor
92215723|NCT03038308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215724|NCT03038308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215725|NCT03038308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215726|NCT04358497|Ibuprofen|ibuprofen|mesh-list
92215727|NCT04358497|Polidocanol|polidocanol|mesh-list
92215728|NCT04358497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92215729|NCT04358497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215730|NCT04358497|Analgesics|analgesics|mesh-ancestor
92215731|NCT04358497|Sensory System Agents|sensory system agents|mesh-ancestor
92215732|NCT04358497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215733|NCT04358497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215734|NCT04358497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215735|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215736|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92215737|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215738|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215739|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92215740|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92215741|NCT02851108|Primaquine|primaquine|mesh-list
92215742|NCT02851108|Phenothiazine|phenothiazine|mesh-list
92215743|NCT02851108|Methylene Blue|methylene blue|mesh-list
92215744|NCT02851108|Antimalarials|antimalarials|mesh-ancestor
92215745|NCT02851108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92215746|NCT02851108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92215747|NCT02851108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215748|NCT02851108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215749|NCT02851108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215750|NCT00930293|Dexetimide|dexetimide|mesh-list
92215751|NCT00930293|Citalopram|citalopram|mesh-list
92215752|NCT00930293|Escitalopram|escitalopram|mesh-list
92215753|NCT00930293|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92215754|NCT00930293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92215755|NCT00930293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215756|NCT00930293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215757|NCT00930293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215758|NCT00930293|Serotonin Agents|serotonin agents|mesh-ancestor
92215759|NCT00930293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215760|NCT00930293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92215761|NCT00930293|Antidepressive Agents|antidepressive agents|mesh-ancestor
92215762|NCT00930293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215763|NCT00930293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92215764|NCT00930293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92215765|NCT00930293|Parasympatholytics|parasympatholytics|mesh-ancestor
92215766|NCT00930293|Autonomic Agents|autonomic agents|mesh-ancestor
92215767|NCT00930293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215768|NCT00930293|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92215769|NCT00930293|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92215770|NCT00930293|Cholinergic Agents|cholinergic agents|mesh-ancestor
92215771|NCT02855086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92215772|NCT02855086|Cetuximab|cetuximab|mesh-list
92215773|NCT02855086|Antibodies|antibodies|mesh-list
92215774|NCT02855086|Immunoglobulins|immunoglobulins|mesh-list
92215775|NCT02855086|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92215776|NCT02855086|Immunologic Factors|immunologic factors|mesh-ancestor
92215777|NCT02855086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215778|NCT02855086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215779|NCT05368857|Afamelanotide|afamelanotide|mesh-list
92215780|NCT05368857|Dermatologic Agents|dermatologic agents|mesh-ancestor
92215782|NCT04347005|Febuxostat|febuxostat|mesh-list
92215783|NCT04347005|Antimetabolites|antimetabolites|mesh-ancestor
92215784|NCT04347005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215785|NCT04347005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215786|NCT04347005|Gout Suppressants|gout suppressants|mesh-ancestor
92215787|NCT04347005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215788|NCT04347005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92215789|NCT04347005|Antioxidants|antioxidants|mesh-ancestor
92215790|NCT04347005|Protective Agents|protective agents|mesh-ancestor
91934242|NCT02293525|Anesthetics, Local|anesthetics, local|mesh-ancestor
92215791|NCT04347005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215793|NCT00358293|Analgesics|analgesics|mesh-ancestor
92215794|NCT00358293|Sensory System Agents|sensory system agents|mesh-ancestor
92215795|NCT00358293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215796|NCT00358293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215797|NCT00358293|Anticonvulsants|anticonvulsants|mesh-ancestor
92215798|NCT00358293|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92215799|NCT00358293|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92215800|NCT00358293|Parasympatholytics|parasympatholytics|mesh-ancestor
92215801|NCT00358293|Autonomic Agents|autonomic agents|mesh-ancestor
92215802|NCT00358293|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92215803|NCT00358293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92215804|NCT00358293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215805|NCT00358293|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215806|NCT00358293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215807|NCT00358293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215808|NCT02241083|Dopamine|dopamine|mesh-list
92215809|NCT02241083|Norepinephrine|norepinephrine|mesh-list
92215810|NCT02241083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92215811|NCT02241083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215812|NCT02241083|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215813|NCT02241083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215814|NCT02241083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215815|NCT02241083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215816|NCT02241083|Sympathomimetics|sympathomimetics|mesh-ancestor
92215817|NCT02241083|Autonomic Agents|autonomic agents|mesh-ancestor
92215818|NCT02241083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215819|NCT02241083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92215820|NCT02241083|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92215821|NCT02241083|Dopamine Agents|dopamine agents|mesh-ancestor
92215822|NCT02241083|Protective Agents|protective agents|mesh-ancestor
92215823|NCT04372589|Heparin|heparin|mesh-list
92215824|NCT04372589|Anticoagulants|anticoagulants|mesh-ancestor
92215825|NCT04372589|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92215826|NCT04372589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92215827|NCT04372589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215828|NCT04364399|Vaccines|vaccines|mesh-list
92215829|NCT04364399|Immunologic Factors|immunologic factors|mesh-ancestor
92215830|NCT04364399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215831|NCT02982551|Insulin|insulin|mesh-list
92215832|NCT02982551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92215833|NCT02982551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215834|NCT02965924|Phenylephrine|phenylephrine|mesh-list
92215835|NCT02965924|Oxymetazoline|oxymetazoline|mesh-list
92215836|NCT02965924|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92215837|NCT02965924|Mydriatics|mydriatics|mesh-ancestor
92215838|NCT02965924|Autonomic Agents|autonomic agents|mesh-ancestor
92215839|NCT02965924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215840|NCT02965924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215841|NCT02965924|Sympathomimetics|sympathomimetics|mesh-ancestor
92215842|NCT02965924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92215843|NCT02965924|Nasal Decongestants|nasal decongestants|mesh-ancestor
92215844|NCT02965924|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215845|NCT02965924|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92215846|NCT02965924|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92215847|NCT02965924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215848|NCT02965924|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215849|NCT02965924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215850|NCT02965924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215851|NCT02965924|Protective Agents|protective agents|mesh-ancestor
92215852|NCT04364321|Diazepam|diazepam|mesh-list
92215853|NCT04364321|Clonazepam|clonazepam|mesh-list
92215854|NCT04364321|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92215855|NCT04364321|Anticonvulsants|anticonvulsants|mesh-ancestor
92215856|NCT04364321|Antiemetics|antiemetics|mesh-ancestor
92215857|NCT04364321|Autonomic Agents|autonomic agents|mesh-ancestor
92215858|NCT04364321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215859|NCT04364321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215860|NCT04364321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92215861|NCT04364321|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92215862|NCT04364321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215863|NCT04364321|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92215864|NCT04364321|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92215865|NCT04364321|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92215866|NCT04364321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92215867|NCT04364321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215868|NCT04364321|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92215869|NCT04364321|Anesthetics, General|anesthetics, general|mesh-ancestor
92215871|NCT04364321|GABA Modulators|gaba modulators|mesh-ancestor
92215872|NCT04364321|GABA Agents|gaba agents|mesh-ancestor
92215873|NCT04364321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215874|NCT04364321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215875|NCT03039088|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92215876|NCT03039088|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92215877|NCT03039088|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215878|NCT03039088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215879|NCT03039088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215880|NCT03039088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215881|NCT05528913|Benralizumab|benralizumab|mesh-list
92215882|NCT05528913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92215883|NCT05528913|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215884|NCT04364009|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92215885|NCT04364009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215886|NCT04371965|Povidone-Iodine|povidone-iodine|mesh-list
92215887|NCT04371965|Povidone|povidone|mesh-list
92215888|NCT04371965|Plasma Substitutes|plasma substitutes|mesh-ancestor
92215889|NCT04371965|Blood Substitutes|blood substitutes|mesh-ancestor
92215890|NCT04371965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92215891|NCT04371965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215892|NCT02959125|Micronutrients|micronutrients|mesh-list
92215893|NCT02959125|Trace Elements|trace elements|mesh-list
92215894|NCT02959125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215895|NCT02972554|Propranolol|propranolol|mesh-list
92215896|NCT02972554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92215897|NCT02972554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92215898|NCT02972554|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215899|NCT02972554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215900|NCT02972554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215901|NCT02972554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215902|NCT02972554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92215903|NCT02972554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92215904|NCT02972554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92215905|NCT02241941|Daptomycin|daptomycin|mesh-list
92215906|NCT02241941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92215907|NCT02241941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215908|NCT00359151|Celecoxib|celecoxib|mesh-list
92215909|NCT00359151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92215910|NCT00359151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215912|NCT00359151|Sensory System Agents|sensory system agents|mesh-ancestor
92215913|NCT00359151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215914|NCT00359151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215915|NCT00359151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92215916|NCT00359151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92215917|NCT00359151|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92215918|NCT00359151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92215919|NCT00359151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215920|NCT00359151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215921|NCT02242097|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92215922|NCT02242097|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92215923|NCT02242097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92215924|NCT02242097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215925|NCT00374686|Valganciclovir|valganciclovir|mesh-list
92215926|NCT00374686|Antiviral Agents|antiviral agents|mesh-ancestor
92215927|NCT00374686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92215928|NCT04371575|Carbamazepine|carbamazepine|mesh-list
92215929|NCT04371575|Oxcarbazepine|oxcarbazepine|mesh-list
92215930|NCT04371575|Anticonvulsants|anticonvulsants|mesh-ancestor
92215931|NCT04371575|Antimanic Agents|antimanic agents|mesh-ancestor
92215932|NCT04371575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92215933|NCT04371575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215934|NCT04371575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215935|NCT04371575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215936|NCT04371575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92215937|NCT04371575|Analgesics|analgesics|mesh-ancestor
92215938|NCT04371575|Sensory System Agents|sensory system agents|mesh-ancestor
92215939|NCT04371575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215940|NCT04371575|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92215941|NCT04371575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92215942|NCT04371575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215943|NCT04371575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92215944|NCT04371575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92215945|NCT04371575|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92215946|NCT00359229|Zolpidem|zolpidem|mesh-list
92215947|NCT00359229|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92215948|NCT00359229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92215949|NCT00359229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215950|NCT00359229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215951|NCT00359229|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92215952|NCT00359229|GABA Agonists|gaba agonists|mesh-ancestor
92215953|NCT00359229|GABA Agents|gaba agents|mesh-ancestor
92215954|NCT00359229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215955|NCT00359229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215956|NCT04371341|Bupivacaine|bupivacaine|mesh-list
92215957|NCT04371341|Anesthetics, Local|anesthetics, local|mesh-ancestor
92215958|NCT04371341|Anesthetics|anesthetics|mesh-ancestor
92215959|NCT04371341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215960|NCT04371341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215961|NCT04371341|Sensory System Agents|sensory system agents|mesh-ancestor
92215962|NCT04371341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215963|NCT00374764|Risperidone|risperidone|mesh-list
92215964|NCT00374764|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92215965|NCT00374764|Serotonin Agents|serotonin agents|mesh-ancestor
92215966|NCT00374764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215967|NCT00374764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215968|NCT00374764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215969|NCT00374764|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92215970|NCT00374764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92215971|NCT00374764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92215972|NCT00374764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92215973|NCT00374764|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92215974|NCT00374764|Dopamine Agents|dopamine agents|mesh-ancestor
92215975|NCT04371185|Ustekinumab|ustekinumab|mesh-list
92215976|NCT04371185|Dermatologic Agents|dermatologic agents|mesh-ancestor
92215977|NCT01005355|Ramucirumab|ramucirumab|mesh-list
92215978|NCT01005355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92215979|NCT02242253|Tiotropium Bromide|tiotropium bromide|mesh-list
92337101|NCT03888755|Analgesics|analgesics|mesh-ancestor
92215981|NCT02242253|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92215982|NCT02242253|Autonomic Agents|autonomic agents|mesh-ancestor
92215983|NCT02242253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92215984|NCT02242253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92215985|NCT02242253|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92215986|NCT02242253|Respiratory System Agents|respiratory system agents|mesh-ancestor
92215987|NCT02242253|Parasympatholytics|parasympatholytics|mesh-ancestor
92215988|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92215989|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
92215990|NCT02242253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92215991|NCT02242253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92215992|NCT02242253|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92215993|NCT02242253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92215994|NCT02242253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92215995|NCT02242253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92215996|NCT05285943|Betamethasone|betamethasone|mesh-list
92215997|NCT05285943|Betamethasone Valerate|betamethasone valerate|mesh-list
92215998|NCT05285943|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92215999|NCT05285943|Betamethasone benzoate|betamethasone benzoate|mesh-list
92216000|NCT05285943|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92216001|NCT05285943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216002|NCT05285943|Glucocorticoids|glucocorticoids|mesh-ancestor
92216003|NCT05285943|Hormones|hormones|mesh-ancestor
92216004|NCT05285943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216005|NCT05285943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216006|NCT05285943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92216007|NCT05285943|Respiratory System Agents|respiratory system agents|mesh-ancestor
92216008|NCT03030001|Antibodies|antibodies|mesh-list
92216009|NCT03030001|Immunologic Factors|immunologic factors|mesh-ancestor
92216010|NCT03030001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216011|NCT02242331|Telmisartan|telmisartan|mesh-list
92216012|NCT02242331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92216013|NCT02242331|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92216014|NCT02242331|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92216015|NCT02242331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216016|NCT05495061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92216017|NCT05495061|Latanoprost|latanoprost|mesh-list
92216018|NCT05495061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92216019|NCT03030157|Pirarubicin|pirarubicin|mesh-list
92216020|NCT03030157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216021|NCT00359385|Alendronate|alendronate|mesh-list
92216022|NCT00359385|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92216023|NCT00359385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216024|NCT03029455|Ivacaftor|ivacaftor|mesh-list
92216025|NCT03029455|VX-659|vx-659|mesh-list
92216026|NCT03029455|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92216027|NCT03029455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216028|NCT03029455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216029|NCT02245789|Remifentanil|remifentanil|mesh-list
92216030|NCT02245789|Propofol|propofol|mesh-list
92216031|NCT02245789|Anesthetics|anesthetics|mesh-ancestor
92216032|NCT02245789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216033|NCT02245789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216034|NCT02245789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92216035|NCT02245789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92216036|NCT02245789|Anesthetics, General|anesthetics, general|mesh-ancestor
92216037|NCT02245789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92216038|NCT02245789|Narcotics|narcotics|mesh-ancestor
92216039|NCT02245789|Analgesics|analgesics|mesh-ancestor
92216040|NCT02245789|Sensory System Agents|sensory system agents|mesh-ancestor
92216041|NCT02245789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216042|NCT04370015|Hydroxychloroquine|hydroxychloroquine|mesh-list
92216043|NCT04370015|Antimalarials|antimalarials|mesh-ancestor
92216044|NCT04370015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92216045|NCT04370015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92216046|NCT04370015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216047|NCT04370015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216048|NCT04370015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216049|NCT04370015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216050|NCT01006369|Hydroxychloroquine|hydroxychloroquine|mesh-list
92216051|NCT01006369|Antimalarials|antimalarials|mesh-ancestor
92216052|NCT01006369|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92216053|NCT01006369|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92216054|NCT01006369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216055|NCT01006369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216056|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216057|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216058|NCT02242877|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92216059|NCT02242877|Telmisartan|telmisartan|mesh-list
92216060|NCT02242877|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92216061|NCT02242877|Diuretics|diuretics|mesh-ancestor
92216062|NCT02242877|Natriuretic Agents|natriuretic agents|mesh-ancestor
92216063|NCT02242877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216064|NCT02242877|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92216065|NCT02242877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216066|NCT02242877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216067|NCT02242877|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92216068|NCT02242877|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92216069|NCT01007071|Hormones|hormones|mesh-list
92216070|NCT01007071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216071|NCT01007071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216073|NCT05475639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92216074|NCT05475639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216075|NCT05475639|Analgesics|analgesics|mesh-ancestor
92216076|NCT05475639|Sensory System Agents|sensory system agents|mesh-ancestor
92216077|NCT05475639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216078|NCT05475639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216079|NCT05475639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216080|NCT05475639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216081|NCT05475639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92216082|NCT05475639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921610|NCT03534037|Uricosuric Agents|uricosuric agents|mesh-ancestor
92216083|NCT05475639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216084|NCT02242955|Diazepam|diazepam|mesh-list
92216085|NCT02242955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92216086|NCT02242955|Anticonvulsants|anticonvulsants|mesh-ancestor
92216087|NCT02242955|Antiemetics|antiemetics|mesh-ancestor
92216088|NCT02242955|Autonomic Agents|autonomic agents|mesh-ancestor
92216089|NCT02242955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216090|NCT02242955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216091|NCT02242955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216092|NCT02242955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92216093|NCT02242955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216094|NCT02242955|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92216095|NCT02242955|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92216096|NCT02242955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92216097|NCT02242955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92216098|NCT02242955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216099|NCT02242955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92216100|NCT02242955|Anesthetics, General|anesthetics, general|mesh-ancestor
92216101|NCT02242955|Anesthetics|anesthetics|mesh-ancestor
92216102|NCT02242955|GABA Modulators|gaba modulators|mesh-ancestor
92216103|NCT02242955|GABA Agents|gaba agents|mesh-ancestor
92216104|NCT02242955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216105|NCT02242955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216106|NCT02984644|Dapagliflozin|dapagliflozin|mesh-list
92216107|NCT02984644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92216108|NCT02984644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216109|NCT02984644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92216110|NCT02984644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216111|NCT01008319|Citric Acid|citric acid|mesh-list
92216112|NCT01008319|Sodium Citrate|sodium citrate|mesh-list
92216114|NCT01008319|Enclomiphene|enclomiphene|mesh-list
92216115|NCT01008319|Zuclomiphene|zuclomiphene|mesh-list
92216116|NCT01008319|Anticoagulants|anticoagulants|mesh-ancestor
92216117|NCT01008319|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92216118|NCT01008319|Chelating Agents|chelating agents|mesh-ancestor
92216119|NCT01008319|Sequestering Agents|sequestering agents|mesh-ancestor
92216120|NCT01008319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216121|NCT01008319|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92216122|NCT01008319|Hormone Antagonists|hormone antagonists|mesh-ancestor
92216123|NCT01008319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216124|NCT01008319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216125|NCT01008319|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92216126|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
92216127|NCT01008319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92216128|NCT01008319|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92216129|NCT01008319|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92216130|NCT04369391|Moxifloxacin|moxifloxacin|mesh-list
92216131|NCT04369391|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216132|NCT04369391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216133|NCT04369391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92216134|NCT04369391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92216135|NCT04369391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216136|NCT04369391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216137|NCT04369391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216138|NCT00358683|Certolizumab Pegol|certolizumab pegol|mesh-list
92216139|NCT00358683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92216140|NCT00358683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216141|NCT00358683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92216143|NCT00358683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216144|NCT00358683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216145|NCT00967369|Carboplatin|carboplatin|mesh-list
92216146|NCT00967369|Etoposide|etoposide|mesh-list
92216147|NCT00967369|Etoposide phosphate|etoposide phosphate|mesh-list
92216148|NCT00967369|Bortezomib|bortezomib|mesh-list
92216149|NCT00967369|Ifosfamide|ifosfamide|mesh-list
92216150|NCT00967369|Isophosphamide mustard|isophosphamide mustard|mesh-list
92216151|NCT00967369|Podophyllotoxin|podophyllotoxin|mesh-list
92216152|NCT00967369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216153|NCT00967369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92216154|NCT00967369|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92216155|NCT00967369|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92216156|NCT00967369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216157|NCT00967369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216158|NCT00967369|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92216159|NCT00967369|Alkylating Agents|alkylating agents|mesh-ancestor
92216160|NCT00967369|Keratolytic Agents|keratolytic agents|mesh-ancestor
92216161|NCT00967369|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216162|NCT00967369|Tubulin Modulators|tubulin modulators|mesh-ancestor
92216163|NCT00967369|Antimitotic Agents|antimitotic agents|mesh-ancestor
92216164|NCT00967369|Mitosis Modulators|mitosis modulators|mesh-ancestor
92216166|NCT02245295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216167|NCT02245295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216168|NCT05238207|Psyllium|psyllium|mesh-list
92216169|NCT05238207|Cathartics|cathartics|mesh-ancestor
92216170|NCT05238207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216171|NCT02880514|Mometasone Furoate|mometasone furoate|mesh-list
92216172|NCT02880514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216173|NCT02880514|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216174|NCT02880514|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92216175|NCT00968071|Decitabine|decitabine|mesh-list
92216176|NCT00968071|Gemtuzumab|gemtuzumab|mesh-list
92216177|NCT00968071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92216178|NCT00968071|Antimetabolites|antimetabolites|mesh-ancestor
92216179|NCT00968071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216180|NCT00968071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216181|NCT00968071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216182|NCT00968071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216183|NCT00968071|Immunotoxins|immunotoxins|mesh-ancestor
92216184|NCT00968071|Immunoconjugates|immunoconjugates|mesh-ancestor
92216185|NCT00968071|Immunologic Factors|immunologic factors|mesh-ancestor
92216186|NCT00968071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216187|NCT00971737|Cyclophosphamide|cyclophosphamide|mesh-list
92216188|NCT00971737|Trastuzumab|trastuzumab|mesh-list
92216189|NCT00971737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92216190|NCT00971737|Immunologic Factors|immunologic factors|mesh-ancestor
92216191|NCT00971737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216192|NCT00971737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216193|NCT00971737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92216194|NCT00971737|Alkylating Agents|alkylating agents|mesh-ancestor
92216195|NCT00971737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216196|NCT00971737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216197|NCT00971737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92216198|NCT00971737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216199|NCT04368377|Aspirin|aspirin|mesh-list
92216201|NCT04368377|Tirofiban|tirofiban|mesh-list
92216202|NCT04368377|Fondaparinux|fondaparinux|mesh-list
92216203|NCT04368377|Clopidogrel|clopidogrel|mesh-list
92216204|NCT04368377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92216205|NCT04368377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92216206|NCT04368377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92216207|NCT04368377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92216208|NCT04368377|Purinergic Agents|purinergic agents|mesh-ancestor
92216209|NCT04368377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216210|NCT04368377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216211|NCT04368377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216212|NCT04368377|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92216214|NCT04368377|Analgesics|analgesics|mesh-ancestor
92216215|NCT04368377|Sensory System Agents|sensory system agents|mesh-ancestor
92216216|NCT04368377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216217|NCT04368377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216218|NCT04368377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216219|NCT04368377|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92216220|NCT04368377|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92216221|NCT04368377|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92216222|NCT04368377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216223|NCT04368377|Antipyretics|antipyretics|mesh-ancestor
92216224|NCT04368377|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92216225|NCT04368377|Antithrombins|antithrombins|mesh-ancestor
92216226|NCT04368377|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92216227|NCT04368377|Protease Inhibitors|protease inhibitors|mesh-ancestor
92216228|NCT04368377|Anticoagulants|anticoagulants|mesh-ancestor
92216229|NCT04361513|Triamcinolone|triamcinolone|mesh-list
92216230|NCT04361513|Bupivacaine|bupivacaine|mesh-list
92216231|NCT04361513|Anesthetics, Local|anesthetics, local|mesh-ancestor
92216232|NCT04361513|Anesthetics|anesthetics|mesh-ancestor
92216233|NCT04361513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216234|NCT04361513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216235|NCT04361513|Sensory System Agents|sensory system agents|mesh-ancestor
92216236|NCT04361513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216237|NCT04361513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216238|NCT04361513|Glucocorticoids|glucocorticoids|mesh-ancestor
92216240|NCT04361513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216242|NCT05595993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92216243|NCT05595993|Autonomic Agents|autonomic agents|mesh-ancestor
92216244|NCT05595993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216245|NCT05595993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216246|NCT05595993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92216247|NCT05595993|Respiratory System Agents|respiratory system agents|mesh-ancestor
92216248|NCT05595993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92216249|NCT05595993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92216250|NCT05595993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216251|NCT05595993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92216252|NCT05595993|Vasodilator Agents|vasodilator agents|mesh-ancestor
92216253|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92216254|NCT05595993|Protective Agents|protective agents|mesh-ancestor
92216255|NCT05595993|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92216256|NCT05595993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92216257|NCT05595993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337141|NCT00377975|Ephedrine|ephedrine|mesh-list
92216258|NCT05593341|Analgesics, Opioid|analgesics, opioid|mesh-list
92216259|NCT05593341|Narcotics|narcotics|mesh-ancestor
92216260|NCT05593341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216261|NCT05593341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216262|NCT05593341|Analgesics|analgesics|mesh-ancestor
92216263|NCT05593341|Sensory System Agents|sensory system agents|mesh-ancestor
92216264|NCT05593341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216265|NCT00972205|Paclitaxel|paclitaxel|mesh-list
92216266|NCT00972205|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92216267|NCT00972205|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92216268|NCT00972205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216269|NCT00972205|Tubulin Modulators|tubulin modulators|mesh-ancestor
92216270|NCT00972205|Antimitotic Agents|antimitotic agents|mesh-ancestor
92216271|NCT00972205|Mitosis Modulators|mitosis modulators|mesh-ancestor
92216272|NCT00972205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216273|NCT00972205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92216274|NCT00928421|Polidocanol|polidocanol|mesh-list
92216275|NCT00928421|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92216276|NCT00928421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92216277|NCT03051256|Methadone|methadone|mesh-list
92216278|NCT03051256|D-methadone|d-methadone|mesh-list
92216279|NCT03051256|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92216280|NCT03051256|Narcotics|narcotics|mesh-ancestor
92216281|NCT03051256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216282|NCT03051256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216283|NCT03051256|Analgesics|analgesics|mesh-ancestor
92216284|NCT03051256|Sensory System Agents|sensory system agents|mesh-ancestor
92216285|NCT03051256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216286|NCT03051256|Antitussive Agents|antitussive agents|mesh-ancestor
92216287|NCT03051256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92216288|NCT03051256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216289|NCT00932321|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92216290|NCT00932321|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92216291|NCT00932321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92216292|NCT00932321|Norethindrone|norethindrone|mesh-list
92216293|NCT00932321|Norethindrone Acetate|norethindrone acetate|mesh-list
92216295|NCT00932321|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92216296|NCT00932321|Estrogens|estrogens|mesh-ancestor
92216297|NCT00932321|Hormones|hormones|mesh-ancestor
92216298|NCT00932321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216299|NCT00932321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216300|NCT00932321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92216301|NCT00932321|Contraceptive Agents|contraceptive agents|mesh-ancestor
92216302|NCT00932321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92216303|NCT00932321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92216304|NCT00932321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92216305|NCT00932321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92216306|NCT00932321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92216307|NCT05445609|Nivolumab|nivolumab|mesh-list
92216308|NCT05445609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216309|NCT05445609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216310|NCT05445609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92216311|NCT05445609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216312|NCT01011829|Varenicline|varenicline|mesh-list
92216313|NCT01011829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92216314|NCT01011829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92216315|NCT01011829|Cholinergic Agents|cholinergic agents|mesh-ancestor
92216316|NCT01011829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216317|NCT01011829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216318|NCT01011829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216319|NCT00932477|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92216320|NCT00932477|Lubricant Eye Drops|lubricant eye drops|mesh-list
92216321|NCT00932477|Glycerol|glycerol|mesh-list
92216322|NCT00932477|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92216323|NCT00932477|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92216324|NCT00932477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92216325|NCT00932477|Protective Agents|protective agents|mesh-ancestor
92216326|NCT00932477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216327|NCT00932477|Laxatives|laxatives|mesh-ancestor
92216328|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216329|NCT00972439|Contraceptive Agents|contraceptive agents|mesh-list
92216330|NCT00972439|Norinyl|norinyl|mesh-list
92216331|NCT00972439|Contraceptives, Oral|contraceptives, oral|mesh-list
92337142|NCT00377975|Caffeine|caffeine|mesh-list
92216332|NCT00972439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92216333|NCT00972439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216334|NCT00972439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92216335|NCT00972439|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92216336|NCT00972439|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92216337|NCT00972439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92216338|NCT00358371|Floxacillin|floxacillin|mesh-list
92216339|NCT00358371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216340|NCT00358371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216341|NCT02989714|Nivolumab|nivolumab|mesh-list
92216342|NCT02989714|Interleukin-2|interleukin-2|mesh-list
92216343|NCT02989714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216344|NCT02989714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216345|NCT02989714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92216346|NCT02989714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216347|NCT02989714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216348|NCT02989714|Analgesics|analgesics|mesh-ancestor
92216349|NCT02989714|Sensory System Agents|sensory system agents|mesh-ancestor
92216350|NCT02989714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216351|NCT02989714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216352|NCT04361279|Rituximab|rituximab|mesh-list
92216353|NCT04361279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216354|NCT04361279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216355|NCT04361279|Immunologic Factors|immunologic factors|mesh-ancestor
92216356|NCT04361279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216357|NCT04361279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216358|NCT05585229|Psilocybin|psilocybin|mesh-list
92216359|NCT05585229|Hallucinogens|hallucinogens|mesh-ancestor
92216360|NCT05585229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216361|NCT05585229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216362|NCT05582499|Paclitaxel|paclitaxel|mesh-list
92216363|NCT05582499|Cyclophosphamide|cyclophosphamide|mesh-list
92216364|NCT05582499|Carboplatin|carboplatin|mesh-list
92216365|NCT05582499|Trastuzumab|trastuzumab|mesh-list
92216366|NCT05582499|Letrozole|letrozole|mesh-list
92216367|NCT05582499|Epirubicin|epirubicin|mesh-list
92216368|NCT05582499|Pertuzumab|pertuzumab|mesh-list
92216369|NCT05582499|Goserelin|goserelin|mesh-list
92216370|NCT05582499|Fluzoparib|fluzoparib|mesh-list
92216371|NCT05582499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92216372|NCT05582499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216373|NCT05582499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92216374|NCT05582499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92216375|NCT05582499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92216376|NCT05582499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216377|NCT05582499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92216378|NCT05582499|Immunologic Factors|immunologic factors|mesh-ancestor
92216379|NCT05582499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216380|NCT05582499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216381|NCT05582499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92216382|NCT05582499|Alkylating Agents|alkylating agents|mesh-ancestor
92216383|NCT05582499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92216384|NCT05582499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216385|NCT05582499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92216386|NCT05582499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92216387|NCT05582499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216388|NCT05582499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92216389|NCT05582499|Hormone Antagonists|hormone antagonists|mesh-ancestor
92095897|NCT03233139|Cemiplimab|cemiplimab|mesh-list
92216390|NCT05582499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216391|NCT05582499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92216392|NCT05582499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92216393|NCT05582499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92216394|NCT05582499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92216395|NCT05582499|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92216396|NCT02881996|Acetaminophen|acetaminophen|mesh-list
92216397|NCT02881996|Ketorolac|ketorolac|mesh-list
92216398|NCT02881996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216399|NCT02881996|Analgesics|analgesics|mesh-ancestor
92216400|NCT02881996|Sensory System Agents|sensory system agents|mesh-ancestor
92216401|NCT02881996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216402|NCT02881996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216403|NCT02881996|Antipyretics|antipyretics|mesh-ancestor
92216404|NCT02881996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92216405|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216406|NCT02881996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216407|NCT02881996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92216408|NCT02881996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216409|NCT02881996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216410|NCT04367831|Heparin|heparin|mesh-list
92216411|NCT04367831|Calcium heparin|calcium heparin|mesh-list
92216412|NCT04367831|Enoxaparin|enoxaparin|mesh-list
92216413|NCT04367831|Enoxaparin sodium|enoxaparin sodium|mesh-list
92216414|NCT04367831|Anticoagulants|anticoagulants|mesh-ancestor
92216415|NCT04367831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92216416|NCT04367831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92216417|NCT04367831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216418|NCT03051646|Aspirin|aspirin|mesh-list
92216419|NCT03051646|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92216420|NCT03051646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216421|NCT03051646|Analgesics|analgesics|mesh-ancestor
92216422|NCT03051646|Sensory System Agents|sensory system agents|mesh-ancestor
92216423|NCT03051646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216424|NCT03051646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216425|NCT03051646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216426|NCT03051646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216427|NCT03051646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92216428|NCT03051646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92216429|NCT03051646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216430|NCT03051646|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92216431|NCT03051646|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92216433|NCT03051646|Antipyretics|antipyretics|mesh-ancestor
92216435|NCT04344405|Vitamins|vitamins|mesh-ancestor
92216436|NCT04344405|Micronutrients|micronutrients|mesh-ancestor
92216437|NCT04344405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216438|NCT04344405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92216439|NCT05187429|Nivolumab|nivolumab|mesh-list
92216440|NCT05187429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216441|NCT05187429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216442|NCT05187429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92216443|NCT05187429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216444|NCT02993302|Alfacalcidol|alfacalcidol|mesh-list
92216445|NCT02993302|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92216446|NCT02993302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92216447|NCT02993302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216448|NCT02993302|Vitamins|vitamins|mesh-ancestor
92216449|NCT02993302|Micronutrients|micronutrients|mesh-ancestor
92216450|NCT00359853|Norfloxacin|norfloxacin|mesh-list
92216451|NCT00359853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216452|NCT00359853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216453|NCT00359853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92216454|NCT00359853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92216455|NCT00359853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216456|NCT00359853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216457|NCT00359853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216458|NCT00359853|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92216459|NCT00359853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92216461|NCT05168709|Immunologic Factors|immunologic factors|mesh-ancestor
92216462|NCT05168709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216463|NCT04367051|Spironolactone|spironolactone|mesh-list
92216464|NCT04367051|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92216465|NCT04367051|Hormone Antagonists|hormone antagonists|mesh-ancestor
91921611|NCT03533959|Alirocumab|alirocumab|mesh-list
92216466|NCT04367051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216467|NCT04367051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216468|NCT04367051|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92216469|NCT04367051|Diuretics|diuretics|mesh-ancestor
92216471|NCT03111316|Dinoprostone|dinoprostone|mesh-list
92216472|NCT03111316|Oxytocics|oxytocics|mesh-ancestor
92216473|NCT03111316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92216474|NCT03111316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216475|NCT03054844|Lidocaine|lidocaine|mesh-list
92216476|NCT03054844|Midazolam|midazolam|mesh-list
92216477|NCT03054844|Anesthetics, Local|anesthetics, local|mesh-ancestor
92216478|NCT03054844|Anesthetics|anesthetics|mesh-ancestor
92216479|NCT03054844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216480|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216481|NCT03054844|Sensory System Agents|sensory system agents|mesh-ancestor
92216482|NCT03054844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216483|NCT03054844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92216484|NCT03054844|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92216485|NCT03054844|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92216486|NCT03054844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216487|NCT03054844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216488|NCT03054844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92216489|NCT03054844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92216490|NCT03054844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92216491|NCT03054844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92216492|NCT03054844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216493|NCT03054844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92216494|NCT03054844|Anesthetics, General|anesthetics, general|mesh-ancestor
92216495|NCT03054844|GABA Modulators|gaba modulators|mesh-ancestor
92216496|NCT03054844|GABA Agents|gaba agents|mesh-ancestor
92216497|NCT03054844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216498|NCT05405595|Pembrolizumab|pembrolizumab|mesh-list
92216499|NCT05405595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216500|NCT05405595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216501|NCT05405595|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92216502|NCT05405595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216503|NCT00359697|Mannitol|mannitol|mesh-list
92216504|NCT00359697|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92216505|NCT00359697|Diuretics|diuretics|mesh-ancestor
92216506|NCT00359697|Natriuretic Agents|natriuretic agents|mesh-ancestor
92216507|NCT00359697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216508|NCT03111628|Omalizumab|omalizumab|mesh-list
92216509|NCT03111628|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92216510|NCT03111628|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92216511|NCT03111628|Respiratory System Agents|respiratory system agents|mesh-ancestor
92216512|NCT05120505|Metformin|metformin|mesh-list
92216513|NCT05120505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92216514|NCT05120505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216515|NCT02977533|Acyclovir|acyclovir|mesh-list
92216516|NCT02977533|Antiviral Agents|antiviral agents|mesh-ancestor
92216517|NCT02977533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216518|NCT01012297|Bevacizumab|bevacizumab|mesh-list
92216519|NCT01012297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92216520|NCT01012297|Gemcitabine|gemcitabine|mesh-list
92216521|NCT01012297|Docetaxel|docetaxel|mesh-list
92216522|NCT01012297|Endothelial Growth Factors|endothelial growth factors|mesh-list
92216523|NCT01012297|Antibodies|antibodies|mesh-list
92216524|NCT01012297|Immunoglobulins|immunoglobulins|mesh-list
92216525|NCT01012297|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92216526|NCT01012297|Lenograstim|lenograstim|mesh-list
92216527|NCT01012297|Immunoglobulin G|immunoglobulin g|mesh-list
92216528|NCT01012297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216529|NCT01012297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92216530|NCT01012297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92216531|NCT01012297|Growth Substances|growth substances|mesh-ancestor
92216532|NCT01012297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216533|NCT01012297|Growth Inhibitors|growth inhibitors|mesh-ancestor
92216534|NCT01012297|Immunologic Factors|immunologic factors|mesh-ancestor
92216535|NCT01012297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92216536|NCT01012297|Antimetabolites|antimetabolites|mesh-ancestor
92216537|NCT01012297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216538|NCT01012297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92216539|NCT01012297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92216540|NCT01012297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92216541|NCT01012297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92216542|NCT00923117|Sunitinib|sunitinib|mesh-list
92216543|NCT00923117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216544|NCT00923117|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92216545|NCT00923117|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92216546|NCT00923117|Growth Substances|growth substances|mesh-ancestor
92216547|NCT00923117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216548|NCT00923117|Growth Inhibitors|growth inhibitors|mesh-ancestor
92216549|NCT00923117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92216550|NCT00923117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216551|NCT00923117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216553|NCT03054922|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92216554|NCT03054922|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92216555|NCT02977611|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92216556|NCT02977611|Hematinics|hematinics|mesh-ancestor
92216557|NCT04360655|Antibodies|antibodies|mesh-list
92216558|NCT04360655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92216559|NCT04360655|Immunologic Factors|immunologic factors|mesh-ancestor
92216560|NCT04360655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216561|NCT00375232|Montelukast|montelukast|mesh-list
92216562|NCT00375232|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92216563|NCT00375232|Respiratory System Agents|respiratory system agents|mesh-ancestor
92216564|NCT00375232|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92216565|NCT00375232|Hormone Antagonists|hormone antagonists|mesh-ancestor
92216566|NCT00375232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216567|NCT00375232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216568|NCT00375232|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92216569|NCT00375232|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92216570|NCT00375232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216571|NCT00975637|Brodalumab|brodalumab|mesh-list
92216572|NCT00975637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92216573|NCT00975637|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216574|NCT00975637|Immunologic Factors|immunologic factors|mesh-ancestor
92216575|NCT00975637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216576|NCT02244437|Acetaminophen|acetaminophen|mesh-list
92216577|NCT02244437|Ibuprofen|ibuprofen|mesh-list
92216578|NCT02244437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216579|NCT02244437|Analgesics|analgesics|mesh-ancestor
92216580|NCT02244437|Sensory System Agents|sensory system agents|mesh-ancestor
92216581|NCT02244437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216582|NCT02244437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216583|NCT02244437|Antipyretics|antipyretics|mesh-ancestor
92216584|NCT02244437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92216585|NCT02244437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216586|NCT02244437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216587|NCT02244437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92216588|NCT02244437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216589|NCT02244437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216590|NCT03023527|Dexamethasone|dexamethasone|mesh-list
92216591|NCT03023527|Nivolumab|nivolumab|mesh-list
92216592|NCT03023527|Pomalidomide|pomalidomide|mesh-list
92216593|NCT03023527|Elotuzumab|elotuzumab|mesh-list
92216594|NCT03023527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216595|NCT03023527|Antiemetics|antiemetics|mesh-ancestor
92216596|NCT03023527|Autonomic Agents|autonomic agents|mesh-ancestor
92216597|NCT03023527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216598|NCT03023527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216599|NCT03023527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216600|NCT03023527|Glucocorticoids|glucocorticoids|mesh-ancestor
92216601|NCT03023527|Hormones|hormones|mesh-ancestor
92216602|NCT03023527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216603|NCT03023527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92216604|NCT03023527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216605|NCT03023527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216606|NCT03023527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92216607|NCT03023527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216608|NCT03023527|Immunologic Factors|immunologic factors|mesh-ancestor
92216609|NCT03023527|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92216610|NCT03023527|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92216611|NCT03023527|Growth Substances|growth substances|mesh-ancestor
92216612|NCT03023527|Growth Inhibitors|growth inhibitors|mesh-ancestor
92216613|NCT04878627|Cannabidiol|cannabidiol|mesh-list
92216614|NCT04878627|Anticonvulsants|anticonvulsants|mesh-ancestor
92216615|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
92216616|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92216617|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216618|NCT02244515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216619|NCT02244515|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216620|NCT02244515|Analgesics|analgesics|mesh-ancestor
92216621|NCT02244515|Sensory System Agents|sensory system agents|mesh-ancestor
92216622|NCT02244515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216623|NCT02244515|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92216624|NCT02244515|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92216625|NCT02244515|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92216626|NCT02244515|Adrenergic Agents|adrenergic agents|mesh-ancestor
92216627|NCT02244515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216628|NCT02244515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216629|NCT04360031|Mycophenolic Acid|mycophenolic acid|mesh-list
92216631|NCT04360031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92216632|NCT04360031|Immunologic Factors|immunologic factors|mesh-ancestor
92216633|NCT04360031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216634|NCT04360031|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92216635|NCT04360031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216636|NCT04360031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216637|NCT04360031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92216638|NCT04360031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216639|NCT04360031|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92216640|NCT04360031|Antitubercular Agents|antitubercular agents|mesh-ancestor
92216641|NCT04360031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216642|NCT04360031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216643|NCT04366739|Chlorpromazine|chlorpromazine|mesh-list
92216644|NCT04366739|Antiemetics|antiemetics|mesh-ancestor
92216645|NCT04366739|Autonomic Agents|autonomic agents|mesh-ancestor
92216646|NCT04366739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216647|NCT04366739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216648|NCT04366739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216649|NCT04366739|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92216650|NCT04366739|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92216651|NCT04366739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216652|NCT04366739|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216653|NCT04366739|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92216654|NCT04366739|Dopamine Agents|dopamine agents|mesh-ancestor
92216655|NCT04366739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216656|NCT04366739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216657|NCT03023059|Levodopa|levodopa|mesh-list
92216658|NCT03023059|Carbidopa|carbidopa|mesh-list
92216659|NCT03023059|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92216660|NCT03023059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92216661|NCT03023059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92216662|NCT03023059|Dopamine Agents|dopamine agents|mesh-ancestor
92216663|NCT03023059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216664|NCT03023059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216665|NCT03023059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216666|NCT03023059|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92216667|NCT03023059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216668|NCT03023059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92216669|NCT03023059|Immunologic Factors|immunologic factors|mesh-ancestor
92216670|NCT03023059|Dopamine Agonists|dopamine agonists|mesh-ancestor
92216671|NCT02244827|Levonadifloxacin|levonadifloxacin|mesh-list
92216672|NCT02244827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92216673|NCT02244827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216674|NCT02244827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216675|NCT02244827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216676|NCT02244827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216677|NCT04359485|Glycolic acid|glycolic acid|mesh-list
92216678|NCT04359485|Keratolytic Agents|keratolytic agents|mesh-ancestor
92216679|NCT04359485|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216680|NCT02976987|Cidofovir|cidofovir|mesh-list
92216681|NCT02976987|Antiviral Agents|antiviral agents|mesh-ancestor
92216682|NCT02976987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216683|NCT02976987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216684|NCT02976987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216685|NCT02244281|Tamsulosin|tamsulosin|mesh-list
92216686|NCT02244281|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92216687|NCT02244281|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92216688|NCT02244281|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92216689|NCT02244281|Adrenergic Agents|adrenergic agents|mesh-ancestor
92216690|NCT02244281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216691|NCT02244281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216692|NCT02244281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216693|NCT02244281|Urological Agents|urological agents|mesh-ancestor
92216694|NCT00361413|Alefacept|alefacept|mesh-list
92216695|NCT00361413|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216696|NCT00361413|Immunologic Factors|immunologic factors|mesh-ancestor
92216697|NCT00361413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216698|NCT03062488|Acetaminophen|acetaminophen|mesh-list
92216699|NCT03062488|Fentanyl|fentanyl|mesh-list
92216700|NCT03062488|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92216701|NCT03062488|Narcotics|narcotics|mesh-ancestor
92216702|NCT03062488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216703|NCT03062488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216704|NCT03062488|Analgesics|analgesics|mesh-ancestor
92216705|NCT03062488|Sensory System Agents|sensory system agents|mesh-ancestor
92216706|NCT03062488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216707|NCT03062488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92216708|NCT03062488|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92216709|NCT03062488|Anesthetics, General|anesthetics, general|mesh-ancestor
92216710|NCT03062488|Anesthetics|anesthetics|mesh-ancestor
92216711|NCT03062488|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216712|NCT03062488|Antipyretics|antipyretics|mesh-ancestor
92216713|NCT00936299|Bupropion|bupropion|mesh-list
92216714|NCT00936299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92216715|NCT00936299|Antidepressive Agents|antidepressive agents|mesh-ancestor
92216716|NCT00936299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216717|NCT00936299|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92216718|NCT00936299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92216719|NCT00936299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216720|NCT00936299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216721|NCT00936299|Dopamine Agents|dopamine agents|mesh-ancestor
92216722|NCT00936299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216723|NCT00936299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216724|NCT00936299|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92216725|NCT00936299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92216726|NCT00936299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216727|NCT04375943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92216728|NCT04375943|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92216729|NCT04375943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216730|NCT04375943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216731|NCT03117634|Aflibercept|aflibercept|mesh-list
92216732|NCT03117634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92216733|NCT03117634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92216734|NCT03117634|Growth Substances|growth substances|mesh-ancestor
92216735|NCT03117634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216736|NCT03117634|Growth Inhibitors|growth inhibitors|mesh-ancestor
92216737|NCT03117634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216739|NCT00937235|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92216740|NCT00937235|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92216741|NCT00937235|Cholinergic Agents|cholinergic agents|mesh-ancestor
92216742|NCT00937235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216743|NCT00937235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216744|NCT00937235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216745|NCT01014403|Enoxaparin|enoxaparin|mesh-list
92216746|NCT01014403|Anticoagulants|anticoagulants|mesh-ancestor
92216747|NCT01014403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92216748|NCT01014403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92216749|NCT01014403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216750|NCT05405608|Ondansetron|ondansetron|mesh-list
92216751|NCT05405608|Antiemetics|antiemetics|mesh-ancestor
92216752|NCT05405608|Autonomic Agents|autonomic agents|mesh-ancestor
92216753|NCT05405608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216754|NCT05405608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216755|NCT05405608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216756|NCT05405608|Antipruritics|antipruritics|mesh-ancestor
92216757|NCT05405608|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216758|NCT05405608|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92216759|NCT05405608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92216760|NCT05405608|Serotonin Agents|serotonin agents|mesh-ancestor
92216761|NCT05405608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216762|NCT05405608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216763|NCT01014871|Botulinum Toxins|botulinum toxins|mesh-list
92216764|NCT01014871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92216765|NCT01014871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92216766|NCT01014871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92216767|NCT01014871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216768|NCT01014871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216769|NCT01014871|Cholinergic Agents|cholinergic agents|mesh-ancestor
92216770|NCT01014871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216771|NCT01014871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216772|NCT01014871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92216773|NCT01014871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216774|NCT00375466|Tranexamic Acid|tranexamic acid|mesh-list
92216775|NCT00375466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92216776|NCT00375466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92216777|NCT00375466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216778|NCT00375466|Hemostatics|hemostatics|mesh-ancestor
92216779|NCT00375466|Coagulants|coagulants|mesh-ancestor
92216781|NCT00976183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216782|NCT00976183|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92216783|NCT00976183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216784|NCT00976183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216785|NCT04357535|Angiotensin II|angiotensin ii|mesh-list
92216786|NCT04357535|Giapreza|giapreza|mesh-list
92216787|NCT04357535|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92216788|NCT04357535|Angiotensinogen|angiotensinogen|mesh-list
92216789|NCT04357535|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92216790|NCT04357535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92216791|NCT04357535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216792|NCT04357535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92216793|NCT04357535|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92216794|NCT04357535|Protease Inhibitors|protease inhibitors|mesh-ancestor
92216795|NCT01015807|Clonidine|clonidine|mesh-list
92216796|NCT01015807|Bupivacaine|bupivacaine|mesh-list
92216797|NCT01015807|Anesthetics, Local|anesthetics, local|mesh-ancestor
92216798|NCT01015807|Anesthetics|anesthetics|mesh-ancestor
92216799|NCT01015807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216800|NCT01015807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216801|NCT01015807|Sensory System Agents|sensory system agents|mesh-ancestor
92216802|NCT01015807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216803|NCT01015807|Analgesics|analgesics|mesh-ancestor
92216804|NCT01015807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92216805|NCT01015807|Sympatholytics|sympatholytics|mesh-ancestor
92216806|NCT01015807|Autonomic Agents|autonomic agents|mesh-ancestor
92216807|NCT01015807|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92216808|NCT01015807|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92216809|NCT01015807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92216810|NCT01015807|Adrenergic Agents|adrenergic agents|mesh-ancestor
92216811|NCT01015807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216812|NCT01015807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216813|NCT01575925|Thalidomide|thalidomide|mesh-list
92216814|NCT01575925|Dexamethasone|dexamethasone|mesh-list
92216815|NCT01575925|Dexamethasone acetate|dexamethasone acetate|mesh-list
92216816|NCT01575925|Pomalidomide|pomalidomide|mesh-list
92216818|NCT01575925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216819|NCT01575925|Antiemetics|antiemetics|mesh-ancestor
92216820|NCT01575925|Autonomic Agents|autonomic agents|mesh-ancestor
92216821|NCT01575925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216822|NCT01575925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216823|NCT01575925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216824|NCT01575925|Glucocorticoids|glucocorticoids|mesh-ancestor
92216825|NCT01575925|Hormones|hormones|mesh-ancestor
92216826|NCT01575925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92216827|NCT01575925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92216828|NCT01575925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216829|NCT01575925|Protease Inhibitors|protease inhibitors|mesh-ancestor
92216830|NCT01575925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216831|NCT01575925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216832|NCT01575925|Immunologic Factors|immunologic factors|mesh-ancestor
92216833|NCT01575925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92216834|NCT01575925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92216835|NCT01575925|Growth Substances|growth substances|mesh-ancestor
92216836|NCT01575925|Growth Inhibitors|growth inhibitors|mesh-ancestor
92216837|NCT01575925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92216838|NCT01575925|Leprostatic Agents|leprostatic agents|mesh-ancestor
92216839|NCT01575925|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216840|NCT01575925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216841|NCT00936377|Dexmedetomidine|dexmedetomidine|mesh-list
92216842|NCT00936377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92216843|NCT00936377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216844|NCT00936377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216845|NCT00936377|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216846|NCT00936377|Analgesics|analgesics|mesh-ancestor
92216847|NCT00936377|Sensory System Agents|sensory system agents|mesh-ancestor
92216848|NCT00936377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216849|NCT00936377|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92216850|NCT00936377|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92216851|NCT00936377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92216852|NCT00936377|Adrenergic Agents|adrenergic agents|mesh-ancestor
92216853|NCT00936377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216854|NCT00936377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216855|NCT04471233|Pregabalin|pregabalin|mesh-list
92216856|NCT04471233|Analgesics|analgesics|mesh-ancestor
92216857|NCT04471233|Sensory System Agents|sensory system agents|mesh-ancestor
92216858|NCT04471233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216859|NCT04471233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216860|NCT04471233|Anticonvulsants|anticonvulsants|mesh-ancestor
92216861|NCT04471233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92216862|NCT04471233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216863|NCT04471233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216864|NCT04471233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92216865|NCT04471233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92216866|NCT04471233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92216867|NCT04471233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216868|NCT04471233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216869|NCT04359095|Tenofovir|tenofovir|mesh-list
92216870|NCT04359095|Emtricitabine|emtricitabine|mesh-list
92216871|NCT04359095|Colchicine|colchicine|mesh-list
92216872|NCT04359095|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92216873|NCT04359095|Antiviral Agents|antiviral agents|mesh-ancestor
92216874|NCT04359095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216875|NCT04359095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92216876|NCT04359095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92216877|NCT04359095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216878|NCT04359095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216879|NCT04359095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92216880|NCT04359095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92216881|NCT04359095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92216882|NCT04359095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92216883|NCT04359095|Antimetabolites|antimetabolites|mesh-ancestor
92216884|NCT04359095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92216885|NCT04359095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92216886|NCT04359095|Gout Suppressants|gout suppressants|mesh-ancestor
92216887|NCT04359095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216888|NCT04359095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92216889|NCT04359095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92216890|NCT04359095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92216891|NCT04359095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216892|NCT02163421|Vedolizumab|vedolizumab|mesh-list
92216893|NCT02163421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216894|NCT02982395|Ethanol|ethanol|mesh-list
92216895|NCT02982395|Docetaxel|docetaxel|mesh-list
92216896|NCT02982395|Mitomycins|mitomycins|mesh-list
92216897|NCT02982395|Mitomycin|mitomycin|mesh-list
92216898|NCT02982395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216899|NCT02982395|Tubulin Modulators|tubulin modulators|mesh-ancestor
92216900|NCT02982395|Antimitotic Agents|antimitotic agents|mesh-ancestor
92216901|NCT02982395|Mitosis Modulators|mitosis modulators|mesh-ancestor
92216902|NCT02982395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216903|NCT02982395|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92216904|NCT02982395|Alkylating Agents|alkylating agents|mesh-ancestor
92216905|NCT02982395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92216906|NCT02982395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216907|NCT02982395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92216908|NCT02982395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216909|NCT02982395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92216910|NCT02982395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216911|NCT02982005|Brodalumab|brodalumab|mesh-list
92216912|NCT02982005|Dermatologic Agents|dermatologic agents|mesh-ancestor
92216913|NCT04736836|Rifaximin|rifaximin|mesh-list
92216914|NCT04736836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92216915|NCT04736836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216916|NCT04736836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92216917|NCT03126370|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92216918|NCT03126370|Emtricitabine|emtricitabine|mesh-list
92216919|NCT03126370|Tenofovir|tenofovir|mesh-list
92216920|NCT03126370|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92216921|NCT03126370|Protease Inhibitors|protease inhibitors|mesh-list
92216922|NCT03126370|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92216923|NCT03126370|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92216924|NCT03126370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216925|NCT03126370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216926|NCT03126370|Antiviral Agents|antiviral agents|mesh-ancestor
92216927|NCT03126370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216928|NCT03126370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92216929|NCT03126370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92216930|NCT03126370|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92216931|NCT04467801|Ipatasertib|ipatasertib|mesh-list
92337212|NCT01340885|Rivastigmine|rivastigmine|mesh-list
92216932|NCT04467801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216933|NCT04467801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92216934|NCT04467801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216935|NCT04467801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216936|NCT01019707|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92216937|NCT01019707|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92216938|NCT01019707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92216939|NCT01019707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216940|NCT01019707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216941|NCT01019707|Adrenergic Agents|adrenergic agents|mesh-ancestor
92216942|NCT01019707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216943|NCT01019707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216944|NCT00979615|Azelastine|azelastine|mesh-list
92216945|NCT00979615|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92216946|NCT00979615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92216947|NCT00979615|Autonomic Agents|autonomic agents|mesh-ancestor
92216948|NCT00979615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92216949|NCT00979615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216950|NCT00979615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92216951|NCT00979615|Respiratory System Agents|respiratory system agents|mesh-ancestor
92216952|NCT00979615|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92216953|NCT00979615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216954|NCT00979615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216955|NCT00979615|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92216956|NCT00979615|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92216957|NCT00979615|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92216958|NCT00979615|Histamine Antagonists|histamine antagonists|mesh-ancestor
92216959|NCT00979615|Histamine Agents|histamine agents|mesh-ancestor
92216960|NCT00979615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216961|NCT00979615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92216962|NCT00979615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92216963|NCT00979615|Analgesics|analgesics|mesh-ancestor
92216964|NCT00979615|Sensory System Agents|sensory system agents|mesh-ancestor
92216965|NCT00979615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92216966|NCT00979615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92216967|NCT03126682|Bupropion|bupropion|mesh-list
92216968|NCT03126682|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92216969|NCT03126682|Antidepressive Agents|antidepressive agents|mesh-ancestor
92216970|NCT03126682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92216971|NCT03126682|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92216972|NCT03126682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92216973|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92216974|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216975|NCT03126682|Dopamine Agents|dopamine agents|mesh-ancestor
92216976|NCT03126682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92216977|NCT03126682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92216978|NCT03126682|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92216979|NCT03126682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92216980|NCT03126682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216981|NCT05236738|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92216982|NCT05236738|Cobicistat|cobicistat|mesh-list
92216983|NCT05236738|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92216984|NCT05236738|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92216985|NCT05236738|Protease Inhibitors|protease inhibitors|mesh-ancestor
92216986|NCT05236738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92216987|NCT05236738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92216988|NCT05236738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92216989|NCT05236738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92216990|NCT05236738|Antiviral Agents|antiviral agents|mesh-ancestor
92216991|NCT05236738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92216992|NCT05236738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92216993|NCT05236738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92216994|NCT00980395|Rituximab|rituximab|mesh-list
92216995|NCT00980395|Bortezomib|bortezomib|mesh-list
92216996|NCT00980395|Cladribine|cladribine|mesh-list
92216997|NCT00980395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92216998|NCT00980395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92216999|NCT00980395|Immunologic Factors|immunologic factors|mesh-ancestor
92217000|NCT00980395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217001|NCT00980395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217002|NCT00980395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217004|NCT02976597|Bupivacaine|bupivacaine|mesh-list
92217005|NCT02976597|Anesthetics, Local|anesthetics, local|mesh-ancestor
92217006|NCT02976597|Anesthetics|anesthetics|mesh-ancestor
92217007|NCT02976597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217008|NCT02976597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217009|NCT02976597|Sensory System Agents|sensory system agents|mesh-ancestor
92217010|NCT02976597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217011|NCT02976597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92217012|NCT02976597|Narcotics|narcotics|mesh-ancestor
92217013|NCT02976597|Analgesics|analgesics|mesh-ancestor
92217014|NCT03020329|Paclitaxel|paclitaxel|mesh-list
92217015|NCT03020329|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92217016|NCT03020329|Cisplatin|cisplatin|mesh-list
92217017|NCT03020329|Fluorouracil|fluorouracil|mesh-list
92217018|NCT03020329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92217019|NCT03020329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217020|NCT03020329|Tubulin Modulators|tubulin modulators|mesh-ancestor
92217021|NCT03020329|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217022|NCT03020329|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217023|NCT03020329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217024|NCT03020329|Antimetabolites|antimetabolites|mesh-ancestor
92217025|NCT03020329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92217026|NCT03020329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217027|NCT03020329|Immunologic Factors|immunologic factors|mesh-ancestor
92217028|NCT03020329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217029|NCT04791579|Ciprofloxacin|ciprofloxacin|mesh-list
92217030|NCT04791579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92217031|NCT04791579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217032|NCT04791579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92217033|NCT04791579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92217034|NCT04791579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217035|NCT04791579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217036|NCT04791579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217037|NCT04791579|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92217038|NCT04791579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92217039|NCT00980785|Ramipril|ramipril|mesh-list
92217040|NCT00980785|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92217041|NCT00980785|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217042|NCT00980785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217043|NCT00980785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217044|NCT00980785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217046|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
92217047|NCT04772547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217048|NCT04772547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217049|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
92217050|NCT04772547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217051|NCT04772547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217052|NCT05028153|Azithromycin|azithromycin|mesh-list
92217053|NCT05028153|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92217054|NCT05028153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217055|NCT03126760|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92217056|NCT03126760|Hormones|hormones|mesh-ancestor
92217057|NCT03126760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217058|NCT03126760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217059|NCT05026905|Leucovorin|leucovorin|mesh-list
92217060|NCT05026905|Paclitaxel|paclitaxel|mesh-list
92217061|NCT05026905|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92217062|NCT05026905|Gemcitabine|gemcitabine|mesh-list
92217063|NCT05026905|Oxaliplatin|oxaliplatin|mesh-list
92217064|NCT05026905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92217065|NCT05026905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217066|NCT05026905|Tubulin Modulators|tubulin modulators|mesh-ancestor
92217067|NCT05026905|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217068|NCT05026905|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217069|NCT05026905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217070|NCT05026905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92217071|NCT05026905|Antimetabolites|antimetabolites|mesh-ancestor
92217072|NCT05026905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337226|NCT01326923|Cetuximab|cetuximab|mesh-list
92217073|NCT05026905|Antidotes|antidotes|mesh-ancestor
92217074|NCT05026905|Protective Agents|protective agents|mesh-ancestor
92217075|NCT05026905|Vitamin B Complex|vitamin b complex|mesh-ancestor
92217076|NCT05026905|Vitamins|vitamins|mesh-ancestor
92217077|NCT05026905|Micronutrients|micronutrients|mesh-ancestor
92217078|NCT00982189|Lisinopril|lisinopril|mesh-list
92217079|NCT00982189|Pravastatin|pravastatin|mesh-list
92217080|NCT00982189|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92217081|NCT00982189|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92217082|NCT00982189|Antimetabolites|antimetabolites|mesh-ancestor
92217083|NCT00982189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217084|NCT00982189|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92217085|NCT00982189|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92217086|NCT00982189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217087|NCT00982189|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92217088|NCT00982189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217089|NCT00982189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217090|NCT00982189|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92217091|NCT00982189|Protective Agents|protective agents|mesh-ancestor
92217092|NCT00982189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217093|NCT05017545|Abatacept|abatacept|mesh-list
92217094|NCT05017545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92217095|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217096|NCT05017545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217097|NCT05017545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217098|NCT05017545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217099|NCT05017545|Immunologic Factors|immunologic factors|mesh-ancestor
92217100|NCT05017545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217101|NCT05017545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217102|NCT03128008|Paclitaxel|paclitaxel|mesh-list
92217103|NCT03128008|Carboplatin|carboplatin|mesh-list
92217104|NCT03128008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92217105|NCT03128008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217106|NCT03128008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92217107|NCT03128008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217108|NCT03128008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217109|NCT03128008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217110|NCT05017311|Escitalopram|escitalopram|mesh-list
92217111|NCT05017311|Brexpiprazole|brexpiprazole|mesh-list
92217112|NCT05017311|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92217113|NCT05017311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92217114|NCT05017311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217115|NCT05017311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217116|NCT05017311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217117|NCT05017311|Serotonin Agents|serotonin agents|mesh-ancestor
92217118|NCT05017311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217119|NCT05017311|Dopamine Agonists|dopamine agonists|mesh-ancestor
92217120|NCT05017311|Dopamine Agents|dopamine agents|mesh-ancestor
92217121|NCT00360087|Bosentan|bosentan|mesh-list
92217122|NCT00360087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217123|NCT00360087|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92217124|NCT00360087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217125|NCT00982423|Furosemide|furosemide|mesh-list
92217126|NCT00982423|Diuretics|diuretics|mesh-ancestor
92217127|NCT00982423|Natriuretic Agents|natriuretic agents|mesh-ancestor
92217128|NCT00982423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217129|NCT00982423|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92217130|NCT00982423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217131|NCT00982423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217132|NCT04719819|Anesthetics|anesthetics|mesh-list
92217133|NCT04719819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217134|NCT04719819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217135|NCT02981719|Gemcitabine|gemcitabine|mesh-list
92217136|NCT02981719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92217137|NCT02981719|Antimetabolites|antimetabolites|mesh-ancestor
92217138|NCT02981719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217139|NCT02981719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217140|NCT03073876|Donepezil|donepezil|mesh-list
92217141|NCT03073876|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92217142|NCT03073876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217143|NCT03073876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217144|NCT03073876|Cholinergic Agents|cholinergic agents|mesh-ancestor
92217145|NCT03073876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217146|NCT03073876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217147|NCT03073876|Nootropic Agents|nootropic agents|mesh-ancestor
92217148|NCT04718961|Volixibat|volixibat|mesh-list
92217149|NCT04718961|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92217150|NCT03130738|Miconazole|miconazole|mesh-list
92217151|NCT03130738|Clotrimazole|clotrimazole|mesh-list
92217152|NCT03130738|Antifungal Agents|antifungal agents|mesh-ancestor
92217153|NCT03130738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217154|NCT03130738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92217155|NCT03130738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92217156|NCT03130738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217157|NCT03130738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217158|NCT03130738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92217159|NCT03130738|Hormone Antagonists|hormone antagonists|mesh-ancestor
92217160|NCT03130738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217161|NCT03130738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217162|NCT03130738|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92217163|NCT03130738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92217164|NCT03130738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92217165|NCT04996251|Bupivacaine|bupivacaine|mesh-list
92217166|NCT04996251|Anesthetics, Local|anesthetics, local|mesh-ancestor
92217167|NCT04996251|Anesthetics|anesthetics|mesh-ancestor
92217168|NCT04996251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217169|NCT04996251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217170|NCT04996251|Sensory System Agents|sensory system agents|mesh-ancestor
92217171|NCT04996251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217172|NCT00984139|Vaccines|vaccines|mesh-list
92217173|NCT00984139|Immunologic Factors|immunologic factors|mesh-ancestor
92217174|NCT00984139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217175|NCT04672395|Vaccines|vaccines|mesh-list
92217176|NCT04672395|1018 oligonucleotide|1018 oligonucleotide|mesh-list
92217177|NCT04672395|Immunologic Factors|immunologic factors|mesh-ancestor
92217178|NCT04672395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217179|NCT04672395|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92217180|NCT00985543|Ritonavir|ritonavir|mesh-list
92217181|NCT00985543|Lopinavir|lopinavir|mesh-list
92217182|NCT00985543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92217183|NCT00985543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92217184|NCT00985543|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217185|NCT00985543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217186|NCT00985543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217187|NCT00985543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92217188|NCT00985543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92217189|NCT00985543|Antiviral Agents|antiviral agents|mesh-ancestor
92217191|NCT00985543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92217192|NCT00985543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92217193|NCT05394415|Paclitaxel|paclitaxel|mesh-list
92217194|NCT05394415|Carboplatin|carboplatin|mesh-list
92217195|NCT05394415|Tislelizumab|tislelizumab|mesh-list
92217196|NCT05394415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92217197|NCT05394415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217198|NCT05394415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92217199|NCT05394415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217200|NCT05394415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217201|NCT05394415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217202|NCT05394415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217203|NCT04352959|Betadex|betadex|mesh-list
92217204|NCT04352959|Sequestering Agents|sequestering agents|mesh-ancestor
92217205|NCT04352959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217206|NCT00360945|Temozolomide|temozolomide|mesh-list
92217207|NCT00360945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217208|NCT00360945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92217209|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
92337235|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
92217210|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217211|NCT03019237|Omalizumab|omalizumab|mesh-list
92217212|NCT03019237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92217213|NCT03019237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92217214|NCT03019237|Respiratory System Agents|respiratory system agents|mesh-ancestor
92217215|NCT00361023|Losartan|losartan|mesh-list
92217216|NCT00361023|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92217217|NCT00361023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92117282|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92217218|NCT00361023|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92217219|NCT00361023|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92217220|NCT00361023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217222|NCT03019081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92217223|NCT03019081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92217224|NCT03019081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217225|NCT03019081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217226|NCT03019081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217227|NCT03019081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217228|NCT03019081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92217229|NCT03019081|Autonomic Agents|autonomic agents|mesh-ancestor
92217230|NCT03019081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217231|NCT03019081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92217232|NCT03019081|Respiratory System Agents|respiratory system agents|mesh-ancestor
92217233|NCT03019081|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92217234|NCT03019081|Sympathomimetics|sympathomimetics|mesh-ancestor
92217235|NCT03019081|Protective Agents|protective agents|mesh-ancestor
92217236|NCT00986401|Metformin|metformin|mesh-list
92217237|NCT00986401|Trospium chloride|trospium chloride|mesh-list
92217238|NCT00986401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92217239|NCT00986401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217240|NCT00986401|Parasympatholytics|parasympatholytics|mesh-ancestor
92217241|NCT00986401|Autonomic Agents|autonomic agents|mesh-ancestor
92217242|NCT00986401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217243|NCT00986401|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92217244|NCT00986401|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92217245|NCT00986401|Cholinergic Agents|cholinergic agents|mesh-ancestor
92217246|NCT00986401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217247|NCT00986401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217248|NCT00986401|Urological Agents|urological agents|mesh-ancestor
92217249|NCT00375076|Enoxaparin|enoxaparin|mesh-list
92217250|NCT00375076|Anticoagulants|anticoagulants|mesh-ancestor
92217251|NCT00375076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92217252|NCT00375076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92217253|NCT00375076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217255|NCT00987415|Antimetabolites|antimetabolites|mesh-ancestor
92217256|NCT00987415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217257|NCT00987415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217258|NCT00987415|Gout Suppressants|gout suppressants|mesh-ancestor
92217259|NCT00987415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217260|NCT00987415|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92217261|NCT00987415|Antioxidants|antioxidants|mesh-ancestor
92217262|NCT00987415|Protective Agents|protective agents|mesh-ancestor
92217263|NCT00987415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217264|NCT04807504|Ropivacaine|ropivacaine|mesh-list
92217265|NCT04807504|Anesthetics, Local|anesthetics, local|mesh-ancestor
92217266|NCT04807504|Anesthetics|anesthetics|mesh-ancestor
92217267|NCT04807504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217268|NCT04807504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217269|NCT04807504|Sensory System Agents|sensory system agents|mesh-ancestor
92217270|NCT04807504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217271|NCT04771156|Ketorolac|ketorolac|mesh-list
92217272|NCT04771156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92217273|NCT04771156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92217274|NCT04771156|Analgesics|analgesics|mesh-ancestor
92217275|NCT04771156|Sensory System Agents|sensory system agents|mesh-ancestor
92217276|NCT04771156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217277|NCT04771156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217278|NCT04771156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217279|NCT04771156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217280|NCT04771156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92337240|NCT03855059|Hormones|hormones|mesh-ancestor
92217281|NCT04771156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217282|NCT04771156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217284|NCT04707118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92217285|NCT04707118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92217286|NCT04707118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217287|NCT04707118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92217288|NCT04707118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217289|NCT04707118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217290|NCT04707118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217291|NCT03086356|Dabigatran|dabigatran|mesh-list
92217292|NCT03086356|Antithrombins|antithrombins|mesh-ancestor
92217293|NCT03086356|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92217294|NCT03086356|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217295|NCT03086356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217296|NCT03086356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217297|NCT03086356|Anticoagulants|anticoagulants|mesh-ancestor
92217298|NCT03140254|Chlorhexidine|chlorhexidine|mesh-list
92217299|NCT03140254|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92217300|NCT03140254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92217301|NCT03140254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217302|NCT03140254|Disinfectants|disinfectants|mesh-ancestor
92217303|NCT03140254|Dermatologic Agents|dermatologic agents|mesh-ancestor
92217304|NCT03140722|Epoetin Alfa|epoetin alfa|mesh-list
92217305|NCT03140722|Hematinics|hematinics|mesh-ancestor
92217306|NCT00982345|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92217307|NCT00982345|Antidepressive Agents|antidepressive agents|mesh-ancestor
92217308|NCT00982345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92217309|NCT00982345|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92217310|NCT00982345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92217311|NCT00982345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217312|NCT00982345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217313|NCT00375622|Tamoxifen|tamoxifen|mesh-list
92217314|NCT00375622|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92217315|NCT00375622|Hormone Antagonists|hormone antagonists|mesh-ancestor
92217316|NCT00375622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217317|NCT00375622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217318|NCT00375622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92217319|NCT00375622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217320|NCT00375622|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92217321|NCT00375622|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92217322|NCT00375622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92217323|NCT03087604|Lidocaine|lidocaine|mesh-list
92217324|NCT03087604|Epinephrine|epinephrine|mesh-list
92217325|NCT03087604|Anesthetics, Local|anesthetics, local|mesh-ancestor
92217326|NCT03087604|Anesthetics|anesthetics|mesh-ancestor
92217327|NCT03087604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217328|NCT03087604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217329|NCT03087604|Sensory System Agents|sensory system agents|mesh-ancestor
92217330|NCT03087604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217331|NCT03087604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92217332|NCT03087604|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92217333|NCT03087604|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92217334|NCT03087604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217335|NCT03087604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217336|NCT03087604|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92217337|NCT03087604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92217338|NCT03087604|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217339|NCT03087604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217340|NCT03087604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92217341|NCT03087604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92217342|NCT03087604|Autonomic Agents|autonomic agents|mesh-ancestor
92217343|NCT03087604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92217344|NCT03087604|Respiratory System Agents|respiratory system agents|mesh-ancestor
92217345|NCT03087604|Mydriatics|mydriatics|mesh-ancestor
92217346|NCT03087604|Sympathomimetics|sympathomimetics|mesh-ancestor
92217347|NCT03087604|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92217348|NCT00987727|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92217349|NCT00987727|Hyaluronic Acid|hyaluronic acid|mesh-list
92217350|NCT00987727|Glycerol|glycerol|mesh-list
92217351|NCT00987727|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92217352|NCT00987727|Immunologic Factors|immunologic factors|mesh-ancestor
92217353|NCT00987727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217354|NCT00987727|Viscosupplements|viscosupplements|mesh-ancestor
92217355|NCT00987727|Protective Agents|protective agents|mesh-ancestor
92217356|NCT00987727|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92217357|NCT00987727|Laxatives|laxatives|mesh-ancestor
92217358|NCT00987727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217359|NCT02160535|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92217360|NCT02160535|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92217361|NCT02160535|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92217362|NCT02160535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217363|NCT02160535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217364|NCT02160535|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92217365|NCT02160535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217366|NCT02160535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217367|NCT02160535|Cholinergic Agents|cholinergic agents|mesh-ancestor
92217368|NCT02160535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217369|NCT04913337|Pembrolizumab|pembrolizumab|mesh-list
92217370|NCT04913337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217371|NCT04913337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217372|NCT04913337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92217373|NCT04913337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217374|NCT05386459|Interferons|interferons|mesh-list
92217375|NCT05386459|Interferon-gamma|interferon-gamma|mesh-list
92217376|NCT05386459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217377|NCT05386459|Antiviral Agents|antiviral agents|mesh-ancestor
92217378|NCT05386459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217379|NCT03018535|Methylprednisolone|methylprednisolone|mesh-list
92217380|NCT03018535|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92217381|NCT03018535|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92217382|NCT03018535|Prednisolone|prednisolone|mesh-list
92217383|NCT03018535|Prednisolone acetate|prednisolone acetate|mesh-list
92217384|NCT03018535|Cyclophosphamide|cyclophosphamide|mesh-list
92217385|NCT03018535|Rituximab|rituximab|mesh-list
92217386|NCT03018535|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92217387|NCT03018535|Prednisolone phosphate|prednisolone phosphate|mesh-list
92217388|NCT03018535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217389|NCT03018535|Immunologic Factors|immunologic factors|mesh-ancestor
92217390|NCT03018535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217391|NCT03018535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217392|NCT03018535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92217393|NCT03018535|Alkylating Agents|alkylating agents|mesh-ancestor
92217394|NCT03018535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217395|NCT03018535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217396|NCT03018535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92217397|NCT03018535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217398|NCT03018535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217399|NCT03018535|Antiemetics|antiemetics|mesh-ancestor
92217400|NCT03018535|Autonomic Agents|autonomic agents|mesh-ancestor
92217401|NCT03018535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217402|NCT03018535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217403|NCT03018535|Glucocorticoids|glucocorticoids|mesh-ancestor
92217405|NCT03018535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217406|NCT03018535|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92217407|NCT03018535|Protective Agents|protective agents|mesh-ancestor
92217408|NCT03018535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92217409|NCT04890873|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92217410|NCT04890873|Antacids|antacids|mesh-ancestor
92217411|NCT04890873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217412|NCT04890873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217413|NCT04889547|Dexamethasone|dexamethasone|mesh-list
92217414|NCT04889547|Dexamethasone acetate|dexamethasone acetate|mesh-list
92217415|NCT04889547|BB 1101|bb 1101|mesh-list
92217416|NCT04889547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217417|NCT04889547|Antiemetics|antiemetics|mesh-ancestor
92217418|NCT04889547|Autonomic Agents|autonomic agents|mesh-ancestor
92217419|NCT04889547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217420|NCT04889547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217421|NCT04889547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217422|NCT04889547|Glucocorticoids|glucocorticoids|mesh-ancestor
92217423|NCT04889547|Hormones|hormones|mesh-ancestor
92217424|NCT04889547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217425|NCT04889547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92217426|NCT04889547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217427|NCT04889547|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217428|NCT04889547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217429|NCT04889547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217430|NCT00989911|Bosentan|bosentan|mesh-list
92217431|NCT00989911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217432|NCT00989911|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92217433|NCT00989911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217434|NCT02977065|Atorvastatin|atorvastatin|mesh-list
92217435|NCT02977065|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92217436|NCT02977065|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92217437|NCT02977065|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92217438|NCT02977065|Antimetabolites|antimetabolites|mesh-ancestor
92217439|NCT02977065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217440|NCT02977065|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92217441|NCT02977065|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92217442|NCT02977065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217443|NCT03146806|Ketamine|ketamine|mesh-list
92217444|NCT03146806|Analgesics|analgesics|mesh-ancestor
92217445|NCT03146806|Sensory System Agents|sensory system agents|mesh-ancestor
92217446|NCT03146806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217447|NCT03146806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217448|NCT03146806|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92217449|NCT03146806|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92217450|NCT03146806|Anesthetics, General|anesthetics, general|mesh-ancestor
92217451|NCT03146806|Anesthetics|anesthetics|mesh-ancestor
92217452|NCT03146806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217453|NCT03146806|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92217454|NCT03146806|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92217455|NCT03146806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217456|NCT03146806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217457|NCT04706806|Acetic Acid|acetic acid|mesh-list
92217458|NCT04706806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92217459|NCT04706806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217460|NCT02975583|Vorapaxar|vorapaxar|mesh-list
92217461|NCT02975583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92217462|NCT03953235|Nivolumab|nivolumab|mesh-list
92217463|NCT03953235|Ipilimumab|ipilimumab|mesh-list
92217464|NCT03953235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217465|NCT03953235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217466|NCT03953235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92217467|NCT03953235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217468|NCT03095638|Dolutegravir|dolutegravir|mesh-list
92217469|NCT03095638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92217470|NCT03095638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92217471|NCT03095638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217472|NCT03095638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217473|NCT03095638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92217474|NCT03095638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92217475|NCT03095638|Antiviral Agents|antiviral agents|mesh-ancestor
92217476|NCT03095638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217477|NCT04458688|Ocrelizumab|ocrelizumab|mesh-list
92217478|NCT04458688|Immunologic Factors|immunologic factors|mesh-ancestor
92217479|NCT04458688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217480|NCT04450108|Nitric Oxide|nitric oxide|mesh-list
92217481|NCT04450108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92217482|NCT04450108|Autonomic Agents|autonomic agents|mesh-ancestor
92217483|NCT04450108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217484|NCT04450108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217485|NCT04450108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92217486|NCT04450108|Respiratory System Agents|respiratory system agents|mesh-ancestor
92217487|NCT04450108|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92217488|NCT04450108|Antioxidants|antioxidants|mesh-ancestor
92217489|NCT04450108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217490|NCT04450108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217491|NCT04450108|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92217492|NCT04450108|Vasodilator Agents|vasodilator agents|mesh-ancestor
92217493|NCT04450108|Gasotransmitters|gasotransmitters|mesh-ancestor
92217494|NCT04450108|Protective Agents|protective agents|mesh-ancestor
92217495|NCT03891849|Octreotide|octreotide|mesh-list
92217496|NCT03891849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217497|NCT03891849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92217498|NCT03891849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217499|NCT04341831|Teicoplanin|teicoplanin|mesh-list
92217500|NCT04341831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92217501|NCT04341831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217502|NCT00361959|Fluticasone|fluticasone|mesh-list
92217503|NCT00361959|Xhance|xhance|mesh-list
92217504|NCT00361959|Bromides|bromides|mesh-list
92217505|NCT00361959|Tiotropium Bromide|tiotropium bromide|mesh-list
92217506|NCT00361959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92217507|NCT00361959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217508|NCT00361959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92217509|NCT00361959|Autonomic Agents|autonomic agents|mesh-ancestor
92217510|NCT00361959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217511|NCT00361959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217512|NCT00361959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92217513|NCT00361959|Respiratory System Agents|respiratory system agents|mesh-ancestor
92217514|NCT00361959|Dermatologic Agents|dermatologic agents|mesh-ancestor
92217515|NCT00361959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92217516|NCT00361959|Parasympatholytics|parasympatholytics|mesh-ancestor
92217517|NCT00361959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92217518|NCT00361959|Cholinergic Agents|cholinergic agents|mesh-ancestor
92217519|NCT00361959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217520|NCT00361959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217521|NCT00361959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92217522|NCT00361959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92217523|NCT00361959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92217524|NCT00361959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217525|NCT00361959|Anticonvulsants|anticonvulsants|mesh-ancestor
92217526|NCT03158116|Aztreonam|aztreonam|mesh-list
92217527|NCT03158116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92217528|NCT03158116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217529|NCT03096730|Sufentanil|sufentanil|mesh-list
92217530|NCT03096730|Dexmedetomidine|dexmedetomidine|mesh-list
92217531|NCT03096730|Remifentanil|remifentanil|mesh-list
92217532|NCT03096730|Dsuvia|dsuvia|mesh-list
92217533|NCT03096730|Nalmefene|nalmefene|mesh-list
92217534|NCT03096730|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92217535|NCT03096730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217536|NCT03096730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217537|NCT03096730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92217538|NCT03096730|Analgesics|analgesics|mesh-ancestor
92217539|NCT03096730|Sensory System Agents|sensory system agents|mesh-ancestor
92217540|NCT03096730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217541|NCT03096730|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92217542|NCT03096730|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92217543|NCT03096730|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92217544|NCT03096730|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217545|NCT03096730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217546|NCT03096730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217547|NCT03096730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92217548|NCT03096730|Narcotics|narcotics|mesh-ancestor
92217549|NCT03096730|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92217550|NCT03096730|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92217551|NCT03096730|Anesthetics, General|anesthetics, general|mesh-ancestor
92217552|NCT03096730|Anesthetics|anesthetics|mesh-ancestor
92217553|NCT03096730|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92217554|NCT00362037|Irbesartan|irbesartan|mesh-list
92217555|NCT00362037|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217556|NCT00362037|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92217557|NCT00362037|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92217558|NCT00362037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217560|NCT03161158|Natriuretic Agents|natriuretic agents|mesh-ancestor
92217561|NCT03161158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217562|NCT03161938|Dexamethasone|dexamethasone|mesh-list
92217563|NCT03161938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217565|NCT03161938|Autonomic Agents|autonomic agents|mesh-ancestor
92217566|NCT03161938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217567|NCT03161938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217568|NCT03161938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217569|NCT03161938|Glucocorticoids|glucocorticoids|mesh-ancestor
92217570|NCT03161938|Hormones|hormones|mesh-ancestor
92217571|NCT03161938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217572|NCT03161938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92217573|NCT03161938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217574|NCT03321045|Trastuzumab|trastuzumab|mesh-list
92217575|NCT03321045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217576|NCT03321045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217577|NCT00989989|Ranibizumab|ranibizumab|mesh-list
92217578|NCT00989989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92217579|NCT00989989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92217580|NCT00989989|Growth Substances|growth substances|mesh-ancestor
92217581|NCT00989989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217582|NCT00989989|Growth Inhibitors|growth inhibitors|mesh-ancestor
92217583|NCT00989989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217584|NCT03802773|Cyclophosphamide|cyclophosphamide|mesh-list
92217585|NCT03802773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217586|NCT03802773|Immunologic Factors|immunologic factors|mesh-ancestor
92217587|NCT03802773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217588|NCT03802773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217589|NCT03802773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92217590|NCT03802773|Alkylating Agents|alkylating agents|mesh-ancestor
92217591|NCT03802773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217592|NCT03802773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217593|NCT03802773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92217594|NCT03018301|Ketamine|ketamine|mesh-list
92217595|NCT03018301|Analgesics|analgesics|mesh-ancestor
92217596|NCT03018301|Sensory System Agents|sensory system agents|mesh-ancestor
92217597|NCT03018301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217598|NCT03018301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217599|NCT03018301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92217600|NCT03018301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92217601|NCT03018301|Anesthetics, General|anesthetics, general|mesh-ancestor
92217602|NCT03018301|Anesthetics|anesthetics|mesh-ancestor
92217603|NCT03018301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217604|NCT03018301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92217605|NCT03018301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92217606|NCT03018301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217607|NCT03018301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217608|NCT00990769|Anesthetics|anesthetics|mesh-list
92217609|NCT00990769|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217610|NCT00990769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217611|NCT00991081|Bupropion|bupropion|mesh-list
92217612|NCT00991081|Nicotine|nicotine|mesh-list
92217613|NCT00991081|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92217614|NCT00991081|Autonomic Agents|autonomic agents|mesh-ancestor
92217615|NCT00991081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217616|NCT00991081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217617|NCT00991081|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92217618|NCT00991081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92217619|NCT00991081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92217620|NCT00991081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217621|NCT00991081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217622|NCT00991081|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92217623|NCT00991081|Antidepressive Agents|antidepressive agents|mesh-ancestor
92217624|NCT00991081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92217625|NCT00991081|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92217626|NCT00991081|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92337269|NCT02708849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92217627|NCT00991081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217628|NCT00991081|Dopamine Agents|dopamine agents|mesh-ancestor
92217629|NCT00991081|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92217630|NCT00991081|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92217631|NCT00991081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217632|NCT03168022|Amitriptyline|amitriptyline|mesh-list
92217633|NCT03168022|Cyclobenzaprine|cyclobenzaprine|mesh-list
92217634|NCT03168022|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92217635|NCT03168022|Antidepressive Agents|antidepressive agents|mesh-ancestor
92217637|NCT03168022|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92217638|NCT03168022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217639|NCT03168022|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92217640|NCT03168022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217641|NCT03168022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92217642|NCT03168022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217643|NCT03168022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92217644|NCT03168022|Analgesics|analgesics|mesh-ancestor
92217645|NCT03168022|Sensory System Agents|sensory system agents|mesh-ancestor
92217646|NCT03168022|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92217647|NCT03168022|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92217648|NCT03168022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217649|NCT03168022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217650|NCT03168022|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217651|NCT03168022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217652|NCT03102190|Verapamil|verapamil|mesh-list
92217653|NCT03102190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92217654|NCT03102190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92217655|NCT03102190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217656|NCT03102190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217657|NCT03102190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92217658|NCT03102190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217659|NCT03102190|Vasodilator Agents|vasodilator agents|mesh-ancestor
92217660|NCT03254667|Brodalumab|brodalumab|mesh-list
92217661|NCT03254667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92217662|NCT03102736|Nitroprusside|nitroprusside|mesh-list
92217663|NCT03102736|Ketamine|ketamine|mesh-list
92217664|NCT03102736|Analgesics|analgesics|mesh-ancestor
92217665|NCT03102736|Sensory System Agents|sensory system agents|mesh-ancestor
92217666|NCT03102736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217667|NCT03102736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217668|NCT03102736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92217669|NCT03102736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92217670|NCT03102736|Anesthetics, General|anesthetics, general|mesh-ancestor
92217671|NCT03102736|Anesthetics|anesthetics|mesh-ancestor
92217672|NCT03102736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217673|NCT03102736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92217674|NCT03102736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92217675|NCT03102736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217676|NCT03102736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217677|NCT03102736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217678|NCT03102736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92217679|NCT03102736|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92217680|NCT03743103|Nitroprusside|nitroprusside|mesh-list
92217681|NCT03743103|Esmolol|esmolol|mesh-list
92217682|NCT03743103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217683|NCT03743103|Vasodilator Agents|vasodilator agents|mesh-ancestor
92217684|NCT03743103|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92217685|NCT03743103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217686|NCT03743103|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92217687|NCT03743103|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92217688|NCT03743103|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92217689|NCT03743103|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217690|NCT03743103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217691|NCT03743103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217692|NCT04049266|Aflibercept|aflibercept|mesh-list
92217693|NCT04049266|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92217694|NCT04049266|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92217695|NCT04049266|Growth Substances|growth substances|mesh-ancestor
92217697|NCT04049266|Growth Inhibitors|growth inhibitors|mesh-ancestor
92217698|NCT04049266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217699|NCT03217071|Pembrolizumab|pembrolizumab|mesh-list
92217700|NCT03217071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217701|NCT03217071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217702|NCT03217071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92217703|NCT03217071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217704|NCT01502917|Antibodies|antibodies|mesh-list
92217705|NCT01502917|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92217706|NCT01502917|Immunologic Factors|immunologic factors|mesh-ancestor
92217707|NCT01502917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217708|NCT00362505|Clevudine|clevudine|mesh-list
92217710|NCT00362505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217711|NCT00993187|Metformin|metformin|mesh-list
92217712|NCT00993187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92217713|NCT00993187|Glimepiride|glimepiride|mesh-list
92217714|NCT00993187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92217715|NCT00993187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217716|NCT00993187|Incretins|incretins|mesh-ancestor
92217717|NCT00993187|Hormones|hormones|mesh-ancestor
92217718|NCT00993187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217719|NCT00993187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92217720|NCT00993187|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217721|NCT00993187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217722|NCT00993187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217723|NCT00993187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92217725|NCT00993187|Immunologic Factors|immunologic factors|mesh-ancestor
92217726|NCT03173170|Itraconazole|itraconazole|mesh-list
92217727|NCT03173170|Antifungal Agents|antifungal agents|mesh-ancestor
92217728|NCT03173170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217729|NCT03173170|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92217730|NCT03173170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92217731|NCT03173170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217732|NCT03173170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217733|NCT03173170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92217734|NCT03173170|Hormone Antagonists|hormone antagonists|mesh-ancestor
92217735|NCT03173170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217736|NCT03173170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217737|NCT03173170|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92217738|NCT03106870|Insulin|insulin|mesh-list
92217739|NCT03106870|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92217740|NCT03106870|Metformin|metformin|mesh-list
92217741|NCT03106870|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
92217742|NCT03106870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92217743|NCT03106870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217744|NCT00375310|Gemcitabine|gemcitabine|mesh-list
92217745|NCT00375310|Sorafenib|sorafenib|mesh-list
92217746|NCT00375310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92217747|NCT00375310|Antimetabolites|antimetabolites|mesh-ancestor
92117283|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92217748|NCT00375310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217749|NCT00375310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217750|NCT00375310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92217751|NCT00375310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217752|NCT03670953|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92217753|NCT03670953|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92217754|NCT03670953|Immunologic Factors|immunologic factors|mesh-ancestor
92217755|NCT03670953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217756|NCT03670953|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92217757|NCT03670953|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92217758|NCT03670953|Dopamine Agonists|dopamine agonists|mesh-ancestor
92217759|NCT03670953|Dopamine Agents|dopamine agents|mesh-ancestor
92217760|NCT03670953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217761|NCT03670953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217762|NCT04736914|Zanubrutinib|zanubrutinib|mesh-list
92217763|NCT04736914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217764|NCT04736914|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92217765|NCT04736914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217766|NCT04736914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217767|NCT00993655|Paclitaxel|paclitaxel|mesh-list
92217768|NCT00993655|Carboplatin|carboplatin|mesh-list
92217769|NCT00993655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92217770|NCT00993655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217771|NCT00993655|Tubulin Modulators|tubulin modulators|mesh-ancestor
92217772|NCT00993655|Antimitotic Agents|antimitotic agents|mesh-ancestor
92217773|NCT00993655|Mitosis Modulators|mitosis modulators|mesh-ancestor
92217774|NCT00993655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217775|NCT00362583|Fentanyl|fentanyl|mesh-list
92217776|NCT00362583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92217777|NCT00362583|Narcotics|narcotics|mesh-ancestor
92217778|NCT00362583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217779|NCT00362583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217780|NCT00362583|Analgesics|analgesics|mesh-ancestor
92217781|NCT00362583|Sensory System Agents|sensory system agents|mesh-ancestor
92217782|NCT00362583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217783|NCT00362583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92217784|NCT00362583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92217785|NCT00362583|Anesthetics, General|anesthetics, general|mesh-ancestor
92217786|NCT00362583|Anesthetics|anesthetics|mesh-ancestor
92217787|NCT00657241|Valsartan|valsartan|mesh-list
92217788|NCT00657241|Carvedilol|carvedilol|mesh-list
92217789|NCT00657241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217790|NCT00657241|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92217791|NCT00657241|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92217792|NCT00657241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217793|NCT00657241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92217794|NCT00657241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92217795|NCT00657241|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217796|NCT00657241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217797|NCT00657241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217798|NCT00657241|Antioxidants|antioxidants|mesh-ancestor
92217799|NCT00657241|Protective Agents|protective agents|mesh-ancestor
92217800|NCT00657241|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92217801|NCT00657241|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217802|NCT00657241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92217803|NCT00657241|Vasodilator Agents|vasodilator agents|mesh-ancestor
92217804|NCT00657241|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92217805|NCT00657241|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92217807|NCT04342065|Pregabalin|pregabalin|mesh-list
92217808|NCT04342065|Analgesics|analgesics|mesh-ancestor
92217809|NCT04342065|Sensory System Agents|sensory system agents|mesh-ancestor
92217810|NCT04342065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217811|NCT04342065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217812|NCT04342065|Anticonvulsants|anticonvulsants|mesh-ancestor
92217813|NCT04342065|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92217814|NCT04342065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217815|NCT04342065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217816|NCT04342065|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92217817|NCT04342065|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92217818|NCT04342065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92217819|NCT04342065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217820|NCT04342065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92217821|NCT04342065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92217822|NCT04342065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92217823|NCT04342065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217824|NCT04342065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217825|NCT04342065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92217826|NCT04342065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92217827|NCT04342065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217828|NCT03179410|Avelumab|avelumab|mesh-list
92217829|NCT03179410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217830|NCT03179410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217831|NCT00478465|Valganciclovir|valganciclovir|mesh-list
92217832|NCT00478465|Antiviral Agents|antiviral agents|mesh-ancestor
92217833|NCT00478465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217834|NCT00421785|Acetylcysteine|acetylcysteine|mesh-list
92217835|NCT00421785|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92217836|NCT00421785|Antiviral Agents|antiviral agents|mesh-ancestor
92217837|NCT00421785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217838|NCT00421785|Expectorants|expectorants|mesh-ancestor
92217839|NCT00421785|Respiratory System Agents|respiratory system agents|mesh-ancestor
92217840|NCT00421785|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92217841|NCT00421785|Antioxidants|antioxidants|mesh-ancestor
92217842|NCT00421785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217843|NCT00421785|Protective Agents|protective agents|mesh-ancestor
92217844|NCT00421785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217845|NCT00421785|Antidotes|antidotes|mesh-ancestor
92217846|NCT02519348|Bevacizumab|bevacizumab|mesh-list
92217847|NCT02519348|Durvalumab|durvalumab|mesh-list
92217848|NCT02519348|Tremelimumab|tremelimumab|mesh-list
92217849|NCT02519348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217850|NCT02519348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217851|NCT02519348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92217852|NCT02519348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92217853|NCT02519348|Growth Substances|growth substances|mesh-ancestor
92217854|NCT02519348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217855|NCT02519348|Growth Inhibitors|growth inhibitors|mesh-ancestor
92217856|NCT00421863|Amlodipine|amlodipine|mesh-list
92217857|NCT00421863|Telmisartan|telmisartan|mesh-list
92217858|NCT00421863|Clonidine|clonidine|mesh-list
92217859|NCT00421863|Ramipril|ramipril|mesh-list
92217860|NCT00421863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92217861|NCT00421863|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92217862|NCT00421863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217863|NCT00421863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217864|NCT00421863|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92217865|NCT00421863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217866|NCT00421863|Vasodilator Agents|vasodilator agents|mesh-ancestor
92217867|NCT00421863|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92217868|NCT00421863|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92217870|NCT00421863|Sensory System Agents|sensory system agents|mesh-ancestor
92217871|NCT00421863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217872|NCT00421863|Sympatholytics|sympatholytics|mesh-ancestor
92217873|NCT00421863|Autonomic Agents|autonomic agents|mesh-ancestor
92217874|NCT00421863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92217875|NCT00421863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92217876|NCT00421863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92217877|NCT00421863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217878|NCT00421863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217879|NCT00421863|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92217880|NCT00421863|Protease Inhibitors|protease inhibitors|mesh-ancestor
92217881|NCT00421863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217882|NCT00636818|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92217883|NCT00636818|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92217884|NCT00636818|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92217885|NCT00636818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217886|NCT00636818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217887|NCT00636818|Adrenergic Agents|adrenergic agents|mesh-ancestor
92217888|NCT00636818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92217889|NCT00636818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217890|NCT05363722|Bevacizumab|bevacizumab|mesh-list
92217891|NCT05363722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217892|NCT05363722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217893|NCT05363722|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92217894|NCT05363722|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92217895|NCT05363722|Growth Substances|growth substances|mesh-ancestor
92217896|NCT05363722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217897|NCT05363722|Growth Inhibitors|growth inhibitors|mesh-ancestor
92217898|NCT01922492|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92217899|NCT01922492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217900|NCT03127137|Triamcinolone|triamcinolone|mesh-list
92217901|NCT03127137|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92217902|NCT03127137|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92217903|NCT03127137|Lidocaine|lidocaine|mesh-list
92217904|NCT03127137|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92217906|NCT03127137|Anesthetics|anesthetics|mesh-ancestor
92217907|NCT03127137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92217908|NCT03127137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217909|NCT03127137|Sensory System Agents|sensory system agents|mesh-ancestor
92217910|NCT03127137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217911|NCT03127137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92217912|NCT03127137|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92217913|NCT03127137|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92217914|NCT03127137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92217915|NCT03127137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217916|NCT03127137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217917|NCT03127137|Glucocorticoids|glucocorticoids|mesh-ancestor
92217918|NCT03127137|Hormones|hormones|mesh-ancestor
92217919|NCT03127137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217920|NCT03127137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217921|NCT03127137|Immunologic Factors|immunologic factors|mesh-ancestor
92217922|NCT03127137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217923|NCT03122847|Methylprednisolone|methylprednisolone|mesh-list
92217924|NCT03122847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92217925|NCT03122847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92217926|NCT03122847|Prednisolone|prednisolone|mesh-list
92217927|NCT03122847|Prednisolone acetate|prednisolone acetate|mesh-list
92217928|NCT03122847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92217929|NCT03122847|Prednisolone phosphate|prednisolone phosphate|mesh-list
92217930|NCT03122847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92217931|NCT03122847|Antiemetics|antiemetics|mesh-ancestor
92217932|NCT03122847|Autonomic Agents|autonomic agents|mesh-ancestor
92217933|NCT03122847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92217934|NCT03122847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217935|NCT03122847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92217936|NCT03122847|Glucocorticoids|glucocorticoids|mesh-ancestor
92217937|NCT03122847|Hormones|hormones|mesh-ancestor
92217938|NCT03122847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92217939|NCT03122847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92217940|NCT03122847|Protective Agents|protective agents|mesh-ancestor
92217941|NCT03122847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92217942|NCT03122847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217943|NCT04342221|Hydroxychloroquine|hydroxychloroquine|mesh-list
92217944|NCT04342221|Antimalarials|antimalarials|mesh-ancestor
92217945|NCT04342221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92217946|NCT04342221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92217947|NCT04342221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217948|NCT04342221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217949|NCT04342221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217950|NCT04342221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217951|NCT03525028|Metformin|metformin|mesh-list
92217952|NCT03525028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92217953|NCT03525028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217954|NCT00636194|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92217955|NCT00754312|Entinostat|entinostat|mesh-list
92217956|NCT00754312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217957|NCT00754312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92217958|NCT00754312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92217959|NCT00754312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217960|NCT03623373|Cytarabine|cytarabine|mesh-list
92217961|NCT03623373|Rituximab|rituximab|mesh-list
92217962|NCT03623373|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92217963|NCT03623373|Acalabrutinib|acalabrutinib|mesh-list
92217964|NCT03623373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92217965|NCT03623373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217966|NCT03623373|Immunologic Factors|immunologic factors|mesh-ancestor
92217967|NCT03623373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217968|NCT03623373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217969|NCT03623373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92217970|NCT03623373|Antimetabolites|antimetabolites|mesh-ancestor
92217971|NCT03623373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217972|NCT03623373|Antiviral Agents|antiviral agents|mesh-ancestor
92217973|NCT03623373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92217974|NCT03623373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217975|NCT03623373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92217976|NCT03623373|Alkylating Agents|alkylating agents|mesh-ancestor
92217978|NCT03505762|Cortisone|cortisone|mesh-list
92217979|NCT03505762|Cyclophosphamide|cyclophosphamide|mesh-list
92217980|NCT03505762|Rituximab|rituximab|mesh-list
92217981|NCT03505762|Doxorubicin|doxorubicin|mesh-list
92217982|NCT03505762|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92217983|NCT03505762|Vincristine|vincristine|mesh-list
92217984|NCT03505762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92217985|NCT03505762|Antibodies|antibodies|mesh-list
92217986|NCT03505762|Immunoglobulins|immunoglobulins|mesh-list
92217987|NCT03505762|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92217988|NCT03505762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92217989|NCT03505762|Immunologic Factors|immunologic factors|mesh-ancestor
92217990|NCT03505762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92217991|NCT03505762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92217992|NCT03505762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92217993|NCT03505762|Alkylating Agents|alkylating agents|mesh-ancestor
92217994|NCT03505762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92217995|NCT03505762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92217996|NCT03505762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92217997|NCT03505762|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92217998|NCT03505762|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92217999|NCT03505762|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92218000|NCT03505762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218001|NCT03505762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218002|NCT03505762|Glucocorticoids|glucocorticoids|mesh-ancestor
92218003|NCT03505762|Hormones|hormones|mesh-ancestor
92218004|NCT03505762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218005|NCT03505762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92218006|NCT03505762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92218007|NCT03505762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218008|NCT03505762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218009|NCT03505762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218010|NCT04736524|Antibodies|antibodies|mesh-list
92218011|NCT04736524|Immunologic Factors|immunologic factors|mesh-ancestor
92218012|NCT04736524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218013|NCT00362661|Hydrocortisone|hydrocortisone|mesh-list
92218014|NCT00362661|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92218015|NCT00362661|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92218016|NCT00362661|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92218017|NCT00362661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218018|NCT03410446|Ketamine|ketamine|mesh-list
92218019|NCT03410446|Analgesics|analgesics|mesh-ancestor
92218020|NCT03410446|Sensory System Agents|sensory system agents|mesh-ancestor
92218021|NCT03410446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218022|NCT03410446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218023|NCT03410446|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92218024|NCT03410446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92218025|NCT03410446|Anesthetics, General|anesthetics, general|mesh-ancestor
92218026|NCT03410446|Anesthetics|anesthetics|mesh-ancestor
92218027|NCT03410446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218028|NCT03410446|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92218029|NCT03410446|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92218030|NCT03410446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218031|NCT03410446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218032|NCT03617445|Vancomycin|vancomycin|mesh-list
92218033|NCT03617445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218034|NCT03617445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218035|NCT00375388|Metformin|metformin|mesh-list
92218036|NCT00375388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92218037|NCT00375388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218038|NCT00375778|Memantine|memantine|mesh-list
92218039|NCT00375778|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92218040|NCT00375778|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92218041|NCT00375778|Dopamine Agents|dopamine agents|mesh-ancestor
92218042|NCT00375778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218043|NCT00375778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218044|NCT00375778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218045|NCT00375778|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92218046|NCT00375778|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92218047|NCT00994123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92218048|NCT00994123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218049|NCT00994123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218050|NCT00994123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218051|NCT00994123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218052|NCT03001726|Docetaxel|docetaxel|mesh-list
92218053|NCT03001726|Oxaliplatin|oxaliplatin|mesh-list
92218054|NCT03001726|Tegafur|tegafur|mesh-list
92218055|NCT03001726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218056|NCT03001726|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218057|NCT03001726|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218058|NCT03001726|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218059|NCT03001726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218060|NCT03001726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92218061|NCT03001726|Antimetabolites|antimetabolites|mesh-ancestor
92218062|NCT04697329|Levobupivacaine|levobupivacaine|mesh-list
92218063|NCT04697329|Anesthetics, Local|anesthetics, local|mesh-ancestor
92218064|NCT04697329|Anesthetics|anesthetics|mesh-ancestor
92218065|NCT04697329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218066|NCT04697329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218067|NCT04697329|Sensory System Agents|sensory system agents|mesh-ancestor
92218068|NCT04697329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218069|NCT03577431|Cyclophosphamide|cyclophosphamide|mesh-list
92218070|NCT03577431|Everolimus|everolimus|mesh-list
92218071|NCT03577431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218072|NCT03577431|Immunologic Factors|immunologic factors|mesh-ancestor
92218073|NCT03577431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218074|NCT03577431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92218075|NCT03577431|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92218076|NCT03577431|Alkylating Agents|alkylating agents|mesh-ancestor
92218077|NCT03577431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218078|NCT03577431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218079|NCT03577431|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92218080|NCT03577431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92218081|NCT03577431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218082|NCT03577431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218083|NCT04444843|Mycophenolic Acid|mycophenolic acid|mesh-list
92218084|NCT04444843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92218085|NCT04444843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218087|NCT04444843|Antitubercular Agents|antitubercular agents|mesh-ancestor
92218088|NCT04444843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218089|NCT04444843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218090|NCT04444843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218091|NCT04444843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218092|NCT04353193|Octreotide|octreotide|mesh-list
92218093|NCT04353193|Terlipressin|terlipressin|mesh-list
92218094|NCT04353193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92218095|NCT04353193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92218096|NCT04353193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218097|NCT04353193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92218098|NCT04353193|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92218099|NCT01023841|Bimatoprost|bimatoprost|mesh-list
92218100|NCT01023841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92218101|NCT01023841|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92218102|NCT01023841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92218103|NCT00635648|Caspofungin|caspofungin|mesh-list
92218104|NCT00635648|Antifungal Agents|antifungal agents|mesh-ancestor
92218105|NCT00635648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218106|NCT00635648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218107|NCT00635648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218108|NCT05240456|Solifenacin Succinate|solifenacin succinate|mesh-list
92218109|NCT05240456|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92218110|NCT05240456|Adrenergic Agents|adrenergic agents|mesh-list
92218111|NCT05240456|Adrenergic Agonists|adrenergic agonists|mesh-list
92337314|NCT01216631|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92218112|NCT05240456|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-list
92218113|NCT05240456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92218114|NCT05240456|Cholinergic Agents|cholinergic agents|mesh-ancestor
92218115|NCT05240456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218116|NCT05240456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218117|NCT05240456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218118|NCT05240456|Urological Agents|urological agents|mesh-ancestor
92218119|NCT05240456|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92218121|NCT03574779|Bevacizumab|bevacizumab|mesh-list
92218122|NCT03574779|Carboplatin|carboplatin|mesh-list
92218123|NCT03574779|Niraparib|niraparib|mesh-list
92218124|NCT03574779|Dostarlimab|dostarlimab|mesh-list
92218125|NCT03574779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92218126|NCT03574779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218127|NCT03574779|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218128|NCT03574779|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218129|NCT03574779|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218130|NCT03574779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218131|NCT03574779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92218132|NCT03574779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92218133|NCT03574779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92218134|NCT03574779|Growth Substances|growth substances|mesh-ancestor
92218135|NCT03574779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218136|NCT03574779|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218137|NCT03574779|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92218138|NCT03574779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218139|NCT04341883|Paclitaxel|paclitaxel|mesh-list
92218140|NCT04341883|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92218141|NCT04341883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92218142|NCT04341883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218143|NCT04341883|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218144|NCT04341883|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218145|NCT04341883|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218146|NCT04341883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218147|NCT00995761|Cisplatin|cisplatin|mesh-list
92218148|NCT00995761|Docetaxel|docetaxel|mesh-list
92218149|NCT00995761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218150|NCT00995761|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218152|NCT00995761|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218153|NCT00995761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218154|NCT00362271|Aripiprazole|aripiprazole|mesh-list
92218155|NCT00362271|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92218156|NCT00362271|Antidepressive Agents|antidepressive agents|mesh-ancestor
92218157|NCT00362271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92218158|NCT00362271|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92218159|NCT00362271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92218160|NCT00362271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218161|NCT00362271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218162|NCT00362271|Dopamine Agonists|dopamine agonists|mesh-ancestor
92218164|NCT00362271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218165|NCT00362271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218166|NCT00362271|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92218167|NCT00362271|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92218168|NCT00362271|Serotonin Agents|serotonin agents|mesh-ancestor
92218169|NCT00362271|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92218170|NCT00362271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92218171|NCT00362271|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92218172|NCT00362271|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92218173|NCT00362271|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92218174|NCT00362271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92218175|NCT00362271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218176|NCT00362271|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92218177|NCT00635102|Cycloserine|cycloserine|mesh-list
92218178|NCT00635102|Glycine|glycine|mesh-list
92218179|NCT00635102|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92218180|NCT00635102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218181|NCT00635102|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92218182|NCT00635102|Antitubercular Agents|antitubercular agents|mesh-ancestor
92218183|NCT00635102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218185|NCT00635102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218186|NCT00635102|Glycine Agents|glycine agents|mesh-ancestor
92218187|NCT00635102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218188|NCT00635102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218189|NCT03041883|Riboflavin|riboflavin|mesh-list
92218190|NCT03041883|Vitamin B Complex|vitamin b complex|mesh-ancestor
92218191|NCT03041883|Vitamins|vitamins|mesh-ancestor
92218192|NCT03041883|Micronutrients|micronutrients|mesh-ancestor
92218193|NCT03041883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218194|NCT03041883|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92218195|NCT03041883|Dermatologic Agents|dermatologic agents|mesh-ancestor
92218196|NCT03034005|Budesonide|budesonide|mesh-list
92218197|NCT03034005|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218198|NCT03034005|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92218199|NCT03034005|Autonomic Agents|autonomic agents|mesh-ancestor
92218200|NCT03034005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218201|NCT03034005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218202|NCT03034005|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92218203|NCT03034005|Respiratory System Agents|respiratory system agents|mesh-ancestor
92218204|NCT03034005|Glucocorticoids|glucocorticoids|mesh-ancestor
92218205|NCT03034005|Hormones|hormones|mesh-ancestor
92218206|NCT03034005|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218207|NCT04296916|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92218208|NCT04296916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92218209|NCT00635024|Melphalan|melphalan|mesh-list
92218210|NCT00635024|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92218211|NCT00635024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92218212|NCT00635024|Alkylating Agents|alkylating agents|mesh-ancestor
92218213|NCT00635024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218214|NCT00635024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218215|NCT00635024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92218216|NCT00635024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218217|NCT00635024|Immunologic Factors|immunologic factors|mesh-ancestor
92218218|NCT00635024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218219|NCT03182920|Lasmiditan|lasmiditan|mesh-list
92218220|NCT03182920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92218221|NCT03182920|Serotonin Agents|serotonin agents|mesh-ancestor
92218222|NCT03182920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218223|NCT03182920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218224|NCT03182920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218225|NCT05406388|Fentanyl|fentanyl|mesh-list
92218226|NCT05406388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218227|NCT05406388|Narcotics|narcotics|mesh-ancestor
92218228|NCT05406388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218229|NCT05406388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218230|NCT05406388|Analgesics|analgesics|mesh-ancestor
92218231|NCT05406388|Sensory System Agents|sensory system agents|mesh-ancestor
92218232|NCT05406388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218233|NCT05406388|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92218234|NCT05406388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92218235|NCT05406388|Anesthetics, General|anesthetics, general|mesh-ancestor
92218236|NCT05406388|Anesthetics|anesthetics|mesh-ancestor
92218237|NCT03485547|Venetoclax|venetoclax|mesh-list
92218238|NCT03485547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218239|NCT03187678|Selexipag|selexipag|mesh-list
92218240|NCT03187678|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92218241|NCT03192826|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92218242|NCT03192826|Lubricant Eye Drops|lubricant eye drops|mesh-list
92218243|NCT03192826|Dipivefrin|dipivefrin|mesh-list
92218244|NCT03192826|Brinzolamide|brinzolamide|mesh-list
92218245|NCT03192826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92218246|NCT03192826|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92218247|NCT03192826|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92218248|NCT03192826|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92218249|NCT03192826|Adrenergic Agents|adrenergic agents|mesh-ancestor
92218250|NCT03192826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218251|NCT03192826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218252|NCT03192826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218253|NCT03192826|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92218254|NCT03192826|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92218255|NCT03192826|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92218256|NCT03192826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218257|NCT03287674|Cyclophosphamide|cyclophosphamide|mesh-list
92218258|NCT03287674|Nivolumab|nivolumab|mesh-list
92218259|NCT03287674|Fludarabine|fludarabine|mesh-list
92218260|NCT03287674|Fludarabine phosphate|fludarabine phosphate|mesh-list
92218261|NCT03287674|Ipilimumab|ipilimumab|mesh-list
92218262|NCT03287674|Interleukin-2|interleukin-2|mesh-list
92218263|NCT03287674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218264|NCT03287674|Immunologic Factors|immunologic factors|mesh-ancestor
92218265|NCT03287674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218266|NCT03287674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92218267|NCT03287674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92218268|NCT03287674|Alkylating Agents|alkylating agents|mesh-ancestor
92218269|NCT03287674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218270|NCT03287674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218271|NCT03287674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92218272|NCT03287674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92218273|NCT03287674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92218274|NCT03287674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92218275|NCT03287674|Antimetabolites|antimetabolites|mesh-ancestor
92218276|NCT03287674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218277|NCT03287674|Analgesics|analgesics|mesh-ancestor
91940407|NCT02812667|Nivolumab|nivolumab|mesh-list
92218278|NCT03287674|Sensory System Agents|sensory system agents|mesh-ancestor
92218279|NCT03287674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218280|NCT00634244|Cytarabine|cytarabine|mesh-list
92218281|NCT00634244|Sirolimus|sirolimus|mesh-list
92218282|NCT00634244|Carboplatin|carboplatin|mesh-list
92218283|NCT00634244|Etoposide|etoposide|mesh-list
92218284|NCT00634244|Etoposide phosphate|etoposide phosphate|mesh-list
92218285|NCT00634244|Topotecan|topotecan|mesh-list
92218286|NCT00634244|Mitoxantrone|mitoxantrone|mesh-list
92218287|NCT00634244|Alvocidib|alvocidib|mesh-list
92218288|NCT00634244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218289|NCT00634244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92218290|NCT00634244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92218291|NCT00634244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92218292|NCT00634244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218293|NCT00634244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218294|NCT00634244|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92218295|NCT00634244|Antimetabolites|antimetabolites|mesh-ancestor
92218296|NCT00634244|Antiviral Agents|antiviral agents|mesh-ancestor
92218297|NCT00634244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218298|NCT00634244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218299|NCT00634244|Immunologic Factors|immunologic factors|mesh-ancestor
91934269|NCT03949673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218300|NCT00634244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218301|NCT00634244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218302|NCT00634244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92218303|NCT00634244|Antifungal Agents|antifungal agents|mesh-ancestor
92218304|NCT00634244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218305|NCT00634244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92218306|NCT00634244|Analgesics|analgesics|mesh-ancestor
92218307|NCT00634244|Sensory System Agents|sensory system agents|mesh-ancestor
92218309|NCT00634244|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218310|NCT00634244|Growth Substances|growth substances|mesh-ancestor
92218311|NCT01922804|Vitamins|vitamins|mesh-list
92218312|NCT01922804|Micronutrients|micronutrients|mesh-ancestor
92218313|NCT01922804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218314|NCT03289858|Bupivacaine|bupivacaine|mesh-list
92218315|NCT03289858|Anesthetics, Local|anesthetics, local|mesh-ancestor
92218316|NCT03289858|Anesthetics|anesthetics|mesh-ancestor
92218317|NCT03289858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218318|NCT03289858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218319|NCT03289858|Sensory System Agents|sensory system agents|mesh-ancestor
92218320|NCT03289858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218321|NCT03418714|Salvinorin A|salvinorin a|mesh-list
92218322|NCT03418714|Hallucinogens|hallucinogens|mesh-ancestor
92218323|NCT03418714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218324|NCT03418714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92218326|NCT03421210|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92218327|NCT03421210|Autonomic Agents|autonomic agents|mesh-ancestor
92218328|NCT03421210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218329|NCT03421210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218330|NCT03421210|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92218331|NCT03421210|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92218332|NCT03421210|Cholinergic Agents|cholinergic agents|mesh-ancestor
92218333|NCT03421210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218334|NCT03421210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218335|NCT03294850|Cholic Acids|cholic acids|mesh-list
92218336|NCT03294850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92218337|NCT00996931|Lenalidomide|lenalidomide|mesh-list
92218338|NCT00996931|Immunologic Factors|immunologic factors|mesh-ancestor
92218339|NCT00996931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218340|NCT00996931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92218341|NCT00996931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92218342|NCT00996931|Growth Substances|growth substances|mesh-ancestor
92218343|NCT00996931|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218344|NCT00996931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218345|NCT00634088|Capecitabine|capecitabine|mesh-list
92218346|NCT00634088|Lapatinib|lapatinib|mesh-list
92218347|NCT00634088|Epothilones|epothilones|mesh-list
92218348|NCT00634088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92218349|NCT00634088|Antimetabolites|antimetabolites|mesh-ancestor
92218350|NCT00634088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218351|NCT00634088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218352|NCT00634088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218353|NCT00634088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218354|NCT00634088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218355|NCT00634088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218356|NCT00634088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218357|NCT03428230|Acetaminophen|acetaminophen|mesh-list
92218358|NCT03428230|Chloroprocaine|chloroprocaine|mesh-list
92218359|NCT03428230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92218360|NCT03428230|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218361|NCT03428230|Analgesics|analgesics|mesh-ancestor
92218362|NCT03428230|Sensory System Agents|sensory system agents|mesh-ancestor
92218363|NCT03428230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218364|NCT03428230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218365|NCT03428230|Antipyretics|antipyretics|mesh-ancestor
92218366|NCT03428230|Anesthetics, Local|anesthetics, local|mesh-ancestor
92218367|NCT03428230|Anesthetics|anesthetics|mesh-ancestor
92218368|NCT03428230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218369|NCT03296800|Bexagliflozin|bexagliflozin|mesh-list
92218370|NCT03296800|Rifampin|rifampin|mesh-list
92218371|NCT03296800|Probenecid|probenecid|mesh-list
92218372|NCT03296800|Verapamil|verapamil|mesh-list
92218373|NCT03296800|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92218374|NCT03296800|Antitubercular Agents|antitubercular agents|mesh-ancestor
92218375|NCT03296800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218376|NCT03296800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218377|NCT03296800|Leprostatic Agents|leprostatic agents|mesh-ancestor
92218378|NCT03296800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92218379|NCT03296800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218380|NCT03296800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218381|NCT03296800|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92218382|NCT03296800|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92218383|NCT03296800|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92218384|NCT03296800|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92218385|NCT03296800|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92218386|NCT03296800|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92218387|NCT03296800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92218388|NCT03296800|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92218389|NCT03296800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218390|NCT03296800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92218391|NCT03296800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218393|NCT03296800|Uricosuric Agents|uricosuric agents|mesh-ancestor
92218394|NCT03296800|Gout Suppressants|gout suppressants|mesh-ancestor
92218396|NCT03296800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92218398|NCT00634010|Methadone|methadone|mesh-list
92218399|NCT00634010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218400|NCT00634010|Narcotics|narcotics|mesh-ancestor
92218401|NCT00634010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218402|NCT00634010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218403|NCT00634010|Analgesics|analgesics|mesh-ancestor
92218404|NCT00634010|Sensory System Agents|sensory system agents|mesh-ancestor
92218405|NCT00634010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218406|NCT00634010|Antitussive Agents|antitussive agents|mesh-ancestor
92218407|NCT00634010|Respiratory System Agents|respiratory system agents|mesh-ancestor
92218408|NCT00633932|Esomeprazole|esomeprazole|mesh-list
92218409|NCT00633932|Omeprazole|omeprazole|mesh-list
92218410|NCT00633932|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92218411|NCT00633932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92218412|NCT00633932|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92218413|NCT00633932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218414|NCT00633932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218415|NCT01028677|Oxytocin|oxytocin|mesh-list
92218416|NCT01028677|Oxytocics|oxytocics|mesh-ancestor
92218417|NCT01028677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92218418|NCT01028677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218419|NCT03302416|Hydrocortisone|hydrocortisone|mesh-list
92218420|NCT03302416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218421|NCT01000285|Raltegravir Potassium|raltegravir potassium|mesh-list
92218422|NCT01000285|Prednisone|prednisone|mesh-list
92218423|NCT01000285|Cyclophosphamide|cyclophosphamide|mesh-list
92218424|NCT01000285|Doxorubicin|doxorubicin|mesh-list
92218425|NCT01000285|Etoposide|etoposide|mesh-list
92218426|NCT01000285|Vincristine|vincristine|mesh-list
92218427|NCT01000285|Bortezomib|bortezomib|mesh-list
92218428|NCT01000285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218429|NCT01000285|Immunologic Factors|immunologic factors|mesh-ancestor
92218430|NCT01000285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218431|NCT01000285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92218432|NCT01000285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92218433|NCT01000285|Alkylating Agents|alkylating agents|mesh-ancestor
92218434|NCT01000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218435|NCT01000285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218436|NCT01000285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92218437|NCT01000285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92218438|NCT01000285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92218439|NCT01000285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92218440|NCT01000285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218441|NCT01000285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218442|NCT01000285|Glucocorticoids|glucocorticoids|mesh-ancestor
92218443|NCT01000285|Hormones|hormones|mesh-ancestor
92218444|NCT01000285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218445|NCT01000285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92218446|NCT01000285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92218447|NCT01000285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218448|NCT01000285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218449|NCT01000285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218450|NCT01000285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92218451|NCT01000285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92218452|NCT01000285|Antiviral Agents|antiviral agents|mesh-ancestor
92218453|NCT01000285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218454|NCT01000285|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92218455|NCT01000285|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92218457|NCT01000987|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92218458|NCT01000987|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92218459|NCT01000987|Cholinergic Agents|cholinergic agents|mesh-ancestor
92218460|NCT01000987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218461|NCT01000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218462|NCT01000987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218464|NCT00633464|Epothilones|epothilones|mesh-list
92218465|NCT00633464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92218466|NCT00633464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218467|NCT00633464|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218468|NCT00633464|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218469|NCT00633464|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218470|NCT00633464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218471|NCT03437044|Clopidogrel|clopidogrel|mesh-list
92218472|NCT03437044|Ticagrelor|ticagrelor|mesh-list
92218473|NCT03437044|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92218474|NCT03437044|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92218475|NCT03437044|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92218476|NCT03437044|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92218477|NCT03437044|Purinergic Agents|purinergic agents|mesh-ancestor
92218478|NCT03437044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218479|NCT03437044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218480|NCT03437044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218481|NCT01923194|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92218482|NCT01923194|Hormones|hormones|mesh-ancestor
92218483|NCT01923194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218484|NCT01923194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218485|NCT03303196|Pancrelipase|pancrelipase|mesh-list
92218486|NCT03303196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92218487|NCT00633152|Linezolid|linezolid|mesh-list
92218488|NCT00633152|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92218489|NCT00633152|Cephalosporins|cephalosporins|mesh-list
92218490|NCT00633152|Aztreonam|aztreonam|mesh-list
92218491|NCT00633152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218492|NCT00633152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218493|NCT00633152|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92218494|NCT00633152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218495|NCT00633152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218496|NCT01030783|Sorafenib|sorafenib|mesh-list
92218497|NCT01030783|Tivozanib|tivozanib|mesh-list
92218498|NCT01030783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218499|NCT01030783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218500|NCT01030783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218501|NCT01030783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218502|NCT00633074|Vaccines|vaccines|mesh-list
92218503|NCT00633074|Immunologic Factors|immunologic factors|mesh-ancestor
92218504|NCT00633074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218505|NCT03304054|Amifampridine|amifampridine|mesh-list
92218506|NCT03304054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92218507|NCT03304054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218508|NCT03304054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218509|NCT03304054|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92218510|NCT03304054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218511|NCT03304054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218512|NCT01929278|Clindamycin|clindamycin|mesh-list
92218513|NCT01929278|Clindamycin palmitate|clindamycin palmitate|mesh-list
92218514|NCT01929278|Clindamycin phosphate|clindamycin phosphate|mesh-list
92218515|NCT01929278|Tretinoin|tretinoin|mesh-list
92218516|NCT01929278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218517|NCT01929278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218518|NCT01929278|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92218519|NCT01929278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218520|NCT01929278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218521|NCT01929278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218522|NCT01929278|Keratolytic Agents|keratolytic agents|mesh-ancestor
92218523|NCT01929278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92218524|NCT03210376|Neostigmine|neostigmine|mesh-list
92218525|NCT03210376|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92218526|NCT03210376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218527|NCT03210376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218528|NCT03210376|Cholinergic Agents|cholinergic agents|mesh-ancestor
92218529|NCT03210376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218530|NCT03210376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218531|NCT03210376|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92218532|NCT03210376|Autonomic Agents|autonomic agents|mesh-ancestor
92218533|NCT03210376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218534|NCT01929512|Metformin|metformin|mesh-list
92218535|NCT01929512|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92218536|NCT01929512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92218537|NCT01929512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218538|NCT01929512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92218539|NCT01929512|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92218540|NCT01929512|Antimetabolites|antimetabolites|mesh-ancestor
92218541|NCT01929512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218542|NCT01929512|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92218543|NCT01929512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92218544|NCT01929512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218545|NCT03211234|Ranibizumab|ranibizumab|mesh-list
92218546|NCT03211234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92218547|NCT03211234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92218548|NCT03211234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92218549|NCT03211234|Growth Substances|growth substances|mesh-ancestor
92218550|NCT03211234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218551|NCT03211234|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218552|NCT03211234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218553|NCT03105518|Acetaminophen|acetaminophen|mesh-list
92218554|NCT03105518|Fentanyl|fentanyl|mesh-list
92218555|NCT03105518|Oxycodone|oxycodone|mesh-list
92218556|NCT03105518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218557|NCT03105518|Narcotics|narcotics|mesh-ancestor
92218558|NCT03105518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218559|NCT03105518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218560|NCT03105518|Analgesics|analgesics|mesh-ancestor
92218561|NCT03105518|Sensory System Agents|sensory system agents|mesh-ancestor
92218562|NCT03105518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218563|NCT03105518|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92218564|NCT03105518|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92218565|NCT03105518|Anesthetics, General|anesthetics, general|mesh-ancestor
92218566|NCT03105518|Anesthetics|anesthetics|mesh-ancestor
92218567|NCT03105518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218568|NCT03105518|Antipyretics|antipyretics|mesh-ancestor
92218569|NCT01929668|Ascorbic Acid|ascorbic acid|mesh-list
92218570|NCT01929668|Antioxidants|antioxidants|mesh-ancestor
92218571|NCT01929668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218572|NCT01929668|Protective Agents|protective agents|mesh-ancestor
92218573|NCT01929668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218574|NCT01929668|Vitamins|vitamins|mesh-ancestor
92218575|NCT01929668|Micronutrients|micronutrients|mesh-ancestor
92218576|NCT01929746|Daclizumab|daclizumab|mesh-list
92218577|NCT01929746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218578|NCT01929746|Immunologic Factors|immunologic factors|mesh-ancestor
92218579|NCT01929746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218580|NCT03506048|Lenvatinib|lenvatinib|mesh-list
92218581|NCT03506048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218582|NCT03506048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218583|NCT03506048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218584|NCT03506048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218585|NCT02161705|Ropivacaine|ropivacaine|mesh-list
92218586|NCT02161705|Anesthetics, Local|anesthetics, local|mesh-ancestor
92218587|NCT02161705|Anesthetics|anesthetics|mesh-ancestor
92218588|NCT02161705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218589|NCT02161705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218590|NCT02161705|Sensory System Agents|sensory system agents|mesh-ancestor
92218591|NCT02161705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218592|NCT01929824|Nitric Oxide|nitric oxide|mesh-list
92218593|NCT01929824|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92218594|NCT01929824|Autonomic Agents|autonomic agents|mesh-ancestor
92218595|NCT01929824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218596|NCT01929824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218597|NCT01929824|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92218598|NCT01929824|Respiratory System Agents|respiratory system agents|mesh-ancestor
92218599|NCT01929824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92218600|NCT01929824|Antioxidants|antioxidants|mesh-ancestor
92218601|NCT01929824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218602|NCT01929824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218603|NCT01929824|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92218604|NCT01929824|Vasodilator Agents|vasodilator agents|mesh-ancestor
92218605|NCT01929824|Gasotransmitters|gasotransmitters|mesh-ancestor
92218606|NCT01929824|Protective Agents|protective agents|mesh-ancestor
92218607|NCT01031953|Fosaprepitant|fosaprepitant|mesh-list
92218608|NCT01031953|Aprepitant|aprepitant|mesh-list
92218609|NCT01031953|Antiemetics|antiemetics|mesh-ancestor
92218610|NCT01031953|Autonomic Agents|autonomic agents|mesh-ancestor
92218611|NCT01031953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218612|NCT01031953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218613|NCT01031953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92218614|NCT01031953|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92218615|NCT01031953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218616|NCT01031953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218617|NCT01923584|Ubiquinone|ubiquinone|mesh-list
92218618|NCT01923584|Micronutrients|micronutrients|mesh-ancestor
92218619|NCT01923584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218620|NCT00630344|Everolimus|everolimus|mesh-list
92218621|NCT00630344|Bicalutamide|bicalutamide|mesh-list
92218622|NCT00630344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92218623|NCT00630344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218624|NCT00630344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218625|NCT00630344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218626|NCT00630344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218627|NCT00630344|Immunologic Factors|immunologic factors|mesh-ancestor
92218628|NCT00630344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218629|NCT00630344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218630|NCT00630344|Androgen Antagonists|androgen antagonists|mesh-ancestor
92218631|NCT00630344|Hormone Antagonists|hormone antagonists|mesh-ancestor
92218632|NCT00630344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218633|NCT01923818|Aspirin|aspirin|mesh-list
92218634|NCT01923818|Rivaroxaban|rivaroxaban|mesh-list
92218635|NCT01923818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92218636|NCT01923818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218637|NCT01923818|Analgesics|analgesics|mesh-ancestor
92218638|NCT01923818|Sensory System Agents|sensory system agents|mesh-ancestor
92218639|NCT01923818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218640|NCT01923818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218641|NCT01923818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218642|NCT01923818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92218643|NCT01923818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92218644|NCT01923818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92218645|NCT01923818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218646|NCT01923818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92218647|NCT01923818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92218648|NCT01923818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218649|NCT01923818|Antipyretics|antipyretics|mesh-ancestor
92218650|NCT01923818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92218651|NCT01923818|Antithrombins|antithrombins|mesh-ancestor
92218652|NCT01923818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92218653|NCT01923818|Protease Inhibitors|protease inhibitors|mesh-ancestor
92218654|NCT01923818|Anticoagulants|anticoagulants|mesh-ancestor
92218655|NCT02169115|Omalizumab|omalizumab|mesh-list
92218656|NCT02169115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92218657|NCT02169115|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92218658|NCT02169115|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92218659|NCT02169115|Respiratory System Agents|respiratory system agents|mesh-ancestor
92218660|NCT02169115|Immunologic Factors|immunologic factors|mesh-ancestor
92218661|NCT02169115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218662|NCT00376792|Docetaxel|docetaxel|mesh-list
92218663|NCT00376792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218664|NCT00376792|Tubulin Modulators|tubulin modulators|mesh-ancestor
92218665|NCT00376792|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218666|NCT00376792|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218667|NCT00376792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218668|NCT00635882|Mometasone Furoate|mometasone furoate|mesh-list
92218669|NCT00635882|Formoterol Fumarate|formoterol fumarate|mesh-list
92218670|NCT00635882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92218671|NCT00635882|Autonomic Agents|autonomic agents|mesh-ancestor
92218672|NCT00635882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218673|NCT00635882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218674|NCT00635882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92218676|NCT00635882|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92218677|NCT00635882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92218678|NCT00635882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92218679|NCT00635882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92218680|NCT00635882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218681|NCT00635882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218682|NCT00635882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218683|NCT00635882|Dermatologic Agents|dermatologic agents|mesh-ancestor
92218684|NCT00635882|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92218685|NCT03316378|Ropivacaine|ropivacaine|mesh-list
92218686|NCT03316378|Anesthetics, Local|anesthetics, local|mesh-ancestor
92218687|NCT03316378|Anesthetics|anesthetics|mesh-ancestor
92218688|NCT03316378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218689|NCT03316378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218690|NCT03316378|Sensory System Agents|sensory system agents|mesh-ancestor
92218691|NCT03316378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218692|NCT00637130|Travoprost|travoprost|mesh-list
92218693|NCT00637130|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92218694|NCT00637130|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92218695|NCT00637130|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92218696|NCT02847559|Bevacizumab|bevacizumab|mesh-list
92218697|NCT02847559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92218698|NCT02847559|Endothelial Growth Factors|endothelial growth factors|mesh-list
92218699|NCT02847559|Antibodies|antibodies|mesh-list
92218700|NCT02847559|Immunoglobulins|immunoglobulins|mesh-list
92218701|NCT02847559|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92218702|NCT02847559|Immunoglobulin G|immunoglobulin g|mesh-list
92218703|NCT02847559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218704|NCT02847559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92218705|NCT02847559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92218706|NCT02847559|Growth Substances|growth substances|mesh-ancestor
92218707|NCT02847559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218708|NCT02847559|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218709|NCT02847559|Immunologic Factors|immunologic factors|mesh-ancestor
92218710|NCT00637052|Filanesib|filanesib|mesh-list
92218711|NCT00637052|Antimitotic Agents|antimitotic agents|mesh-ancestor
92218712|NCT00637052|Mitosis Modulators|mitosis modulators|mesh-ancestor
92218713|NCT00637052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218714|NCT00637052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218715|NCT01921868|Acetylcarnitine|acetylcarnitine|mesh-list
92218716|NCT01921868|Vitamin B Complex|vitamin b complex|mesh-ancestor
92218717|NCT01921868|Vitamins|vitamins|mesh-ancestor
92218718|NCT01921868|Micronutrients|micronutrients|mesh-ancestor
92218719|NCT01921868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218720|NCT01921868|Nootropic Agents|nootropic agents|mesh-ancestor
92218721|NCT02150785|Streptokinase|streptokinase|mesh-list
92218722|NCT02150785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92218723|NCT02150785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92218724|NCT02150785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218725|NCT01926158|Denosumab|denosumab|mesh-list
92218726|NCT01926158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92218727|NCT01926158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218728|NCT03445390|Acetaminophen|acetaminophen|mesh-list
92218729|NCT03445390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218730|NCT03445390|Analgesics|analgesics|mesh-ancestor
92218731|NCT03445390|Sensory System Agents|sensory system agents|mesh-ancestor
92218732|NCT03445390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218733|NCT03445390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218734|NCT03445390|Antipyretics|antipyretics|mesh-ancestor
92218735|NCT00981890|Sunitinib|sunitinib|mesh-list
92218736|NCT00981890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218737|NCT00981890|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92218738|NCT00981890|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92218739|NCT00981890|Growth Substances|growth substances|mesh-ancestor
92218740|NCT00981890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218741|NCT00981890|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218742|NCT00981890|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92218743|NCT00981890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218744|NCT00981890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218745|NCT03221764|Amiodarone|amiodarone|mesh-list
92218746|NCT03221764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92218747|NCT03221764|Vasodilator Agents|vasodilator agents|mesh-ancestor
92218748|NCT03221764|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92218749|NCT03221764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218750|NCT03221764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218751|NCT03221764|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92218752|NCT03221764|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92218753|NCT03221764|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92218754|NCT03221764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218755|NCT03221764|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92218756|NCT03221764|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92218757|NCT03221764|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92218759|NCT03122444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92218760|NCT03122444|Antidepressive Agents|antidepressive agents|mesh-ancestor
92218761|NCT03122444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92218762|NCT03122444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92218763|NCT03122444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92218764|NCT03122444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218765|NCT03122444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218766|NCT03122444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92218767|NCT03122444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218768|NCT03122444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218769|NCT02169427|Opicapone|opicapone|mesh-list
92218770|NCT02169427|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92218771|NCT02169427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218772|NCT02169427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218773|NCT02169427|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92218774|NCT02169427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92218775|NCT03454048|Pyrimethamine|pyrimethamine|mesh-list
92218776|NCT03454048|Piperaquine|piperaquine|mesh-list
92218777|NCT03454048|Sulfadoxine|sulfadoxine|mesh-list
92218778|NCT03454048|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92218779|NCT03454048|Atovaquone|atovaquone|mesh-list
92218780|NCT03454048|Proguanil|proguanil|mesh-list
92218781|NCT03454048|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92218782|NCT03454048|Antimalarials|antimalarials|mesh-ancestor
92218783|NCT03454048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92218784|NCT03454048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92218785|NCT03454048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218786|NCT03454048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92218787|NCT03454048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218788|NCT03454048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218789|NCT03454048|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92218790|NCT03454048|Antimetabolites|antimetabolites|mesh-ancestor
92218791|NCT04396184|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92218792|NCT04396184|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92218793|NCT04396184|Dermatologic Agents|dermatologic agents|mesh-ancestor
92218794|NCT01924286|Prednisone|prednisone|mesh-list
92218795|NCT01924286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218796|NCT01924286|Glucocorticoids|glucocorticoids|mesh-ancestor
92218797|NCT01924286|Hormones|hormones|mesh-ancestor
92218798|NCT01924286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218799|NCT01924286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218800|NCT01924286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92218801|NCT01924286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218802|NCT03455218|Nitric Oxide|nitric oxide|mesh-list
92218803|NCT03455218|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92218804|NCT03455218|Autonomic Agents|autonomic agents|mesh-ancestor
92218805|NCT03455218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218806|NCT03455218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218807|NCT03455218|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92218808|NCT03455218|Respiratory System Agents|respiratory system agents|mesh-ancestor
92218809|NCT03455218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92218810|NCT03455218|Antioxidants|antioxidants|mesh-ancestor
92218811|NCT03455218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218812|NCT03455218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218813|NCT03455218|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92218814|NCT03455218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92218815|NCT03455218|Gasotransmitters|gasotransmitters|mesh-ancestor
92218816|NCT03455218|Protective Agents|protective agents|mesh-ancestor
92218817|NCT01050907|Miltefosine|miltefosine|mesh-list
92218818|NCT01050907|Antifungal Agents|antifungal agents|mesh-ancestor
92218819|NCT01050907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218820|NCT01050907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218821|NCT01050907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92218822|NCT01050907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92218823|NCT01924520|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92218824|NCT01924520|Antidepressive Agents|antidepressive agents|mesh-ancestor
92218825|NCT01924520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92218826|NCT01924520|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92218827|NCT01924520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92218828|NCT01924520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218829|NCT01924520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218830|NCT04433845|Psilocybin|psilocybin|mesh-list
92218831|NCT04433845|Hallucinogens|hallucinogens|mesh-ancestor
92218832|NCT04433845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218833|NCT04433845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92218834|NCT01920386|Acetaminophen|acetaminophen|mesh-list
92218835|NCT01920386|Tramadol|tramadol|mesh-list
92218836|NCT01920386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218837|NCT01920386|Analgesics|analgesics|mesh-ancestor
92218838|NCT01920386|Sensory System Agents|sensory system agents|mesh-ancestor
92218839|NCT01920386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218840|NCT01920386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218841|NCT01920386|Antipyretics|antipyretics|mesh-ancestor
92218842|NCT01920386|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218843|NCT01920386|Narcotics|narcotics|mesh-ancestor
92218844|NCT01920386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218845|NCT03460990|Ivacaftor|ivacaftor|mesh-list
92218846|NCT03460990|VX-659|vx-659|mesh-list
92218847|NCT03460990|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92218848|NCT03460990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218849|NCT03460990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218850|NCT01924832|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92218851|NCT01924832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92218852|NCT01924832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218853|NCT01924832|Immunologic Factors|immunologic factors|mesh-ancestor
92218854|NCT01924832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218855|NCT01920542|Dexmedetomidine|dexmedetomidine|mesh-list
92218856|NCT01920542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92218857|NCT01920542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218858|NCT01920542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218859|NCT01920542|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218860|NCT01920542|Analgesics|analgesics|mesh-ancestor
92218861|NCT01920542|Sensory System Agents|sensory system agents|mesh-ancestor
92218862|NCT01920542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218863|NCT01920542|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92218864|NCT01920542|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92218865|NCT01920542|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92218866|NCT01920542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92218867|NCT01920542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218868|NCT01920542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218869|NCT03319810|gamma-Globulins|gamma-globulins|mesh-list
92218870|NCT03319810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92218871|NCT03319810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92218872|NCT03319810|Immunologic Factors|immunologic factors|mesh-ancestor
92218873|NCT03319810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218874|NCT01052701|Ribavirin|ribavirin|mesh-list
92218875|NCT01052701|Abacavir|abacavir|mesh-list
92218876|NCT01052701|Antimetabolites|antimetabolites|mesh-ancestor
92218877|NCT01052701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218878|NCT01052701|Antiviral Agents|antiviral agents|mesh-ancestor
92218879|NCT01052701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218880|NCT01052701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92218881|NCT01052701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92218882|NCT01052701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218883|NCT01052701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92218884|NCT01052701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92218885|NCT01921010|Niacin|niacin|mesh-list
92218886|NCT01921010|Nicotinic Acids|nicotinic acids|mesh-list
92218887|NCT01921010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92218888|NCT01921010|Antimetabolites|antimetabolites|mesh-ancestor
92218889|NCT01921010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218890|NCT01921010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92218891|NCT01921010|Vasodilator Agents|vasodilator agents|mesh-ancestor
92218892|NCT01921010|Vitamin B Complex|vitamin b complex|mesh-ancestor
92218893|NCT01921010|Vitamins|vitamins|mesh-ancestor
92218894|NCT01921010|Micronutrients|micronutrients|mesh-ancestor
92218895|NCT01921010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218896|NCT03115424|Liraglutide|liraglutide|mesh-list
92218897|NCT03115424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92218898|NCT03115424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218900|NCT03115424|Hormones|hormones|mesh-ancestor
92218901|NCT03115424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92218902|NCT03325816|Nivolumab|nivolumab|mesh-list
92218903|NCT03325816|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92218904|NCT03325816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92218905|NCT03325816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218906|NCT03325816|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92218907|NCT03325816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218908|NCT03325816|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92218909|NCT00986570|Botulinum Toxins|botulinum toxins|mesh-list
92218910|NCT00986570|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92218911|NCT00986570|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92218912|NCT00986570|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92218913|NCT00986570|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218914|NCT00986570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218915|NCT00986570|Cholinergic Agents|cholinergic agents|mesh-ancestor
92218916|NCT00986570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218917|NCT00986570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218918|NCT00986570|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92218919|NCT00986570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218920|NCT00986258|Tapentadol|tapentadol|mesh-list
92218921|NCT00986258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218922|NCT00986258|Narcotics|narcotics|mesh-ancestor
92218923|NCT00986258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218924|NCT00986258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218925|NCT00986258|Analgesics|analgesics|mesh-ancestor
92218926|NCT00986258|Sensory System Agents|sensory system agents|mesh-ancestor
92218927|NCT00986258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218928|NCT00986258|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92218929|NCT00986258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92337414|NCT00378911|Sunitinib|sunitinib|mesh-list
92218930|NCT00986258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92218931|NCT00986258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218932|NCT00986258|Adrenergic Agents|adrenergic agents|mesh-ancestor
92218933|NCT00986258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218935|NCT00986180|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218936|NCT00986180|Narcotics|narcotics|mesh-ancestor
92218937|NCT00986180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218938|NCT00986180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218939|NCT00986180|Analgesics|analgesics|mesh-ancestor
92218940|NCT00986180|Sensory System Agents|sensory system agents|mesh-ancestor
92218941|NCT00986180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218942|NCT01056601|Bortezomib|bortezomib|mesh-list
92218943|NCT01056601|Panobinostat|panobinostat|mesh-list
92218944|NCT01056601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218945|NCT01056601|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92218946|NCT01056601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92218947|NCT01056601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218948|NCT03014947|Adalimumab|adalimumab|mesh-list
92218949|NCT03014947|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92218950|NCT03014947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218951|NCT03014947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92218952|NCT01057225|Thalidomide|thalidomide|mesh-list
92218953|NCT01057225|Dexamethasone|dexamethasone|mesh-list
92218954|NCT01057225|Cyclophosphamide|cyclophosphamide|mesh-list
92218955|NCT01057225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92218956|NCT01057225|Immunologic Factors|immunologic factors|mesh-ancestor
92218957|NCT01057225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218958|NCT01057225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92218959|NCT01057225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92218960|NCT01057225|Alkylating Agents|alkylating agents|mesh-ancestor
92218961|NCT01057225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218962|NCT01057225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92218963|NCT01057225|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92218964|NCT01057225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92218965|NCT01057225|Antiemetics|antiemetics|mesh-ancestor
92218966|NCT01057225|Autonomic Agents|autonomic agents|mesh-ancestor
92218967|NCT01057225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218968|NCT01057225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92218969|NCT01057225|Glucocorticoids|glucocorticoids|mesh-ancestor
92218970|NCT01057225|Hormones|hormones|mesh-ancestor
92218971|NCT01057225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934276|NCT02350179|Hemostatics|hemostatics|mesh-ancestor
92218972|NCT01057225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92218973|NCT01057225|Leprostatic Agents|leprostatic agents|mesh-ancestor
92218974|NCT01057225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218975|NCT01057225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92218976|NCT01057225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92218977|NCT01057225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92218978|NCT01057225|Growth Substances|growth substances|mesh-ancestor
92218979|NCT01057225|Growth Inhibitors|growth inhibitors|mesh-ancestor
92218980|NCT01057381|Dexmedetomidine|dexmedetomidine|mesh-list
92218982|NCT01057381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92218983|NCT01057381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92218984|NCT01057381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92218985|NCT01057381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92218986|NCT01057381|Analgesics|analgesics|mesh-ancestor
92218987|NCT01057381|Sensory System Agents|sensory system agents|mesh-ancestor
92218988|NCT01057381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92218989|NCT01057381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92218990|NCT01057381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92218991|NCT01057381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92218992|NCT01057381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92218993|NCT01057381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92218994|NCT01057381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92218995|NCT01057381|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92218996|NCT01057381|Narcotics|narcotics|mesh-ancestor
92218997|NCT00986102|Doripenem|doripenem|mesh-list
92218998|NCT00986102|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92218999|NCT00986102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219000|NCT01058239|Rituximab|rituximab|mesh-list
92219001|NCT01058239|Bortezomib|bortezomib|mesh-list
92219002|NCT01058239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219003|NCT01058239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219004|NCT01058239|Immunologic Factors|immunologic factors|mesh-ancestor
92219005|NCT01058239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219006|NCT01058239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219007|NCT01058941|Thioctic Acid|thioctic acid|mesh-list
92219008|NCT01058941|Antioxidants|antioxidants|mesh-ancestor
92219009|NCT01058941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219010|NCT01058941|Protective Agents|protective agents|mesh-ancestor
92219011|NCT01058941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219012|NCT01058941|Vitamin B Complex|vitamin b complex|mesh-ancestor
92219013|NCT01058941|Vitamins|vitamins|mesh-ancestor
92219014|NCT01058941|Micronutrients|micronutrients|mesh-ancestor
92219015|NCT00985946|Panobinostat|panobinostat|mesh-list
92219016|NCT00985946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219017|NCT00985946|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92219018|NCT00985946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219019|NCT00985946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219020|NCT02170519|Iloprost|iloprost|mesh-list
92219021|NCT02170519|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92219022|NCT02170519|Vasodilator Agents|vasodilator agents|mesh-ancestor
92219023|NCT00985712|Insulin Lispro|insulin lispro|mesh-list
92219024|NCT00985712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92219025|NCT00985712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219026|NCT04275284|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92219027|NCT04275284|Immunologic Factors|immunologic factors|mesh-ancestor
92219028|NCT04275284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219029|NCT01924910|Vitamin D|vitamin d|mesh-list
92219030|NCT01924910|Cholecalciferol|cholecalciferol|mesh-list
92219031|NCT01924910|Vitamins|vitamins|mesh-ancestor
92219032|NCT01924910|Micronutrients|micronutrients|mesh-ancestor
92219033|NCT01924910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219034|NCT01924910|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92219035|NCT01924910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92219036|NCT04395638|Vitamin D|vitamin d|mesh-list
92219037|NCT04395638|Ergocalciferols|ergocalciferols|mesh-list
92219038|NCT04395638|Cholecalciferol|cholecalciferol|mesh-list
92219039|NCT04395638|Vitamins|vitamins|mesh-list
92219040|NCT04395638|Micronutrients|micronutrients|mesh-ancestor
92219041|NCT04395638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219042|NCT04395638|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92219043|NCT04395638|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92219044|NCT04347980|Hydroxychloroquine|hydroxychloroquine|mesh-list
92219045|NCT04347980|Dexamethasone|dexamethasone|mesh-list
92219046|NCT04347980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219047|NCT04347980|Antiemetics|antiemetics|mesh-ancestor
91934277|NCT02350179|Coagulants|coagulants|mesh-ancestor
92219048|NCT04347980|Autonomic Agents|autonomic agents|mesh-ancestor
92219049|NCT04347980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219050|NCT04347980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219051|NCT04347980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219052|NCT04347980|Glucocorticoids|glucocorticoids|mesh-ancestor
92219053|NCT04347980|Hormones|hormones|mesh-ancestor
92219054|NCT04347980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219055|NCT04347980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219056|NCT04347980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219057|NCT04347980|Antimalarials|antimalarials|mesh-ancestor
92219058|NCT04347980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92219059|NCT04347980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92219060|NCT04347980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219061|NCT04347980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219062|NCT04347980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219063|NCT04347980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219064|NCT01925300|Bisoprolol|bisoprolol|mesh-list
92219065|NCT01925300|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92219067|NCT01925300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92219068|NCT01925300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219069|NCT01925300|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92219070|NCT01925300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92219071|NCT01925300|Antimetabolites|antimetabolites|mesh-ancestor
92219072|NCT01925300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219073|NCT01925300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92219074|NCT01925300|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92219075|NCT01925300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219076|NCT01925300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92219077|NCT01925300|Sympatholytics|sympatholytics|mesh-ancestor
92219078|NCT01925300|Autonomic Agents|autonomic agents|mesh-ancestor
92219079|NCT01925300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219080|NCT01925300|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92219081|NCT01925300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92219082|NCT01925300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92219083|NCT01925300|Adrenergic Agents|adrenergic agents|mesh-ancestor
92219084|NCT01925300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219085|NCT01921946|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92219086|NCT01921946|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92219087|NCT01921946|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92219088|NCT01921946|Antimetabolites|antimetabolites|mesh-ancestor
92219089|NCT01921946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219090|NCT01921946|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92219091|NCT01921946|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92219092|NCT01921946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219093|NCT01925378|Nelfinavir|nelfinavir|mesh-list
92219094|NCT01925378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92219095|NCT01925378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92219096|NCT01925378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219097|NCT01925378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219098|NCT01925378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219099|NCT01925378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92219100|NCT01925378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92219101|NCT01925378|Antiviral Agents|antiviral agents|mesh-ancestor
92219102|NCT01925378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219103|NCT01925456|Fesoterodine|fesoterodine|mesh-list
92219104|NCT01925456|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92219106|NCT01925456|Cholinergic Agents|cholinergic agents|mesh-ancestor
92219107|NCT01925456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219108|NCT01925456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219109|NCT01925456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219110|NCT01925456|Urological Agents|urological agents|mesh-ancestor
92219111|NCT02255799|Donepezil|donepezil|mesh-list
92219112|NCT02255799|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92219113|NCT02255799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219114|NCT02255799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219115|NCT02255799|Cholinergic Agents|cholinergic agents|mesh-ancestor
92219116|NCT02255799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219117|NCT02255799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219118|NCT02255799|Nootropic Agents|nootropic agents|mesh-ancestor
92219119|NCT02226159|Dexamethasone|dexamethasone|mesh-list
92219120|NCT02226159|Dexamethasone acetate|dexamethasone acetate|mesh-list
92219122|NCT02226159|BB 1101|bb 1101|mesh-list
92219123|NCT02226159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219124|NCT02226159|Antiemetics|antiemetics|mesh-ancestor
92219125|NCT02226159|Autonomic Agents|autonomic agents|mesh-ancestor
92219126|NCT02226159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219127|NCT02226159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219128|NCT02226159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219129|NCT02226159|Glucocorticoids|glucocorticoids|mesh-ancestor
92219130|NCT02226159|Hormones|hormones|mesh-ancestor
92219131|NCT02226159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219132|NCT02226159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219133|NCT02226159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219134|NCT02226159|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219135|NCT02226159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219136|NCT02226159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219137|NCT02226159|Anesthetics, Local|anesthetics, local|mesh-ancestor
92219138|NCT02226159|Anesthetics|anesthetics|mesh-ancestor
92219139|NCT02226159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219140|NCT02226159|Sensory System Agents|sensory system agents|mesh-ancestor
92219141|NCT02226159|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92219142|NCT02226159|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92219143|NCT02226159|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92219144|NCT02226159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92219145|NCT03241030|Acetaminophen|acetaminophen|mesh-list
92219146|NCT03241030|Ibuprofen|ibuprofen|mesh-list
92219147|NCT03241030|Sucralfate|sucralfate|mesh-list
92219148|NCT03241030|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219149|NCT03241030|Analgesics|analgesics|mesh-ancestor
92219150|NCT03241030|Sensory System Agents|sensory system agents|mesh-ancestor
92219151|NCT03241030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219152|NCT03241030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219153|NCT03241030|Antipyretics|antipyretics|mesh-ancestor
92219154|NCT03241030|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219155|NCT03241030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219156|NCT03241030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219157|NCT03241030|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219158|NCT03241030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219159|NCT03241030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219160|NCT03241030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92219161|NCT03241030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219162|NCT02184195|Olaparib|olaparib|mesh-list
92219163|NCT02184195|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92219164|NCT02184195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219165|NCT02184195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219166|NCT02184195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219167|NCT03241810|Fulvestrant|fulvestrant|mesh-list
92219168|NCT03241810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219169|NCT03241810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219170|NCT03241810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92219171|NCT03241810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92219172|NCT03241810|Hormone Antagonists|hormone antagonists|mesh-ancestor
92219173|NCT03241810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219174|NCT03241810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219175|NCT02129751|Bupropion|bupropion|mesh-list
92219176|NCT02129751|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92219177|NCT02129751|Antidepressive Agents|antidepressive agents|mesh-ancestor
92219178|NCT02129751|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92219179|NCT02129751|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92219180|NCT02129751|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92219181|NCT02129751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92219182|NCT02129751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219183|NCT02129751|Dopamine Agents|dopamine agents|mesh-ancestor
92219184|NCT02129751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219185|NCT02129751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219186|NCT02129751|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92219187|NCT02129751|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92219188|NCT02129751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219189|NCT03242590|Methyltestosterone|methyltestosterone|mesh-list
92219190|NCT03242590|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92219191|NCT03242590|Testosterone|testosterone|mesh-list
91921612|NCT03533959|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92219192|NCT03242590|Testosterone undecanoate|testosterone undecanoate|mesh-list
92219193|NCT03242590|Testosterone enanthate|testosterone enanthate|mesh-list
92219194|NCT03242590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219195|NCT03242590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219196|NCT03242590|Anabolic Agents|anabolic agents|mesh-ancestor
92219197|NCT03242590|Hormones|hormones|mesh-ancestor
92219198|NCT03242590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219199|NCT03242590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219200|NCT03242590|Androgens|androgens|mesh-ancestor
92219201|NCT03247738|Cangrelor|cangrelor|mesh-list
92219202|NCT03247738|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92219203|NCT03247738|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92219204|NCT03247738|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92219205|NCT03247738|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92219206|NCT03247738|Purinergic Agents|purinergic agents|mesh-ancestor
92219207|NCT03247738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219208|NCT03247738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219209|NCT03247738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219210|NCT03345160|Immunomodulating Agents|immunomodulating agents|mesh-list
92219211|NCT03345160|Immunologic Factors|immunologic factors|mesh-ancestor
92219212|NCT03345160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219213|NCT01567605|Lidocaine|lidocaine|mesh-list
92219214|NCT01567605|Anesthetics, Local|anesthetics, local|mesh-ancestor
92219215|NCT01567605|Anesthetics|anesthetics|mesh-ancestor
92219216|NCT01567605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219217|NCT01567605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219218|NCT01567605|Sensory System Agents|sensory system agents|mesh-ancestor
92219219|NCT01567605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219220|NCT01567605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92219221|NCT01567605|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92219222|NCT01567605|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92219223|NCT01567605|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92219224|NCT01567605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219225|NCT02604537|Ketorolac|ketorolac|mesh-list
92219226|NCT02604537|Betamethasone|betamethasone|mesh-list
92219227|NCT02604537|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219228|NCT02604537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219229|NCT02604537|Analgesics|analgesics|mesh-ancestor
92219230|NCT02604537|Sensory System Agents|sensory system agents|mesh-ancestor
92219231|NCT02604537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219232|NCT02604537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219233|NCT02604537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219234|NCT02604537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219235|NCT02604537|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219236|NCT02604537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219237|NCT02604537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219238|NCT02604537|Glucocorticoids|glucocorticoids|mesh-ancestor
92219239|NCT02604537|Hormones|hormones|mesh-ancestor
92219240|NCT02604537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219241|NCT02604537|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92219242|NCT02604537|Respiratory System Agents|respiratory system agents|mesh-ancestor
92219243|NCT01384773|Riboflavin|riboflavin|mesh-list
92219244|NCT01384773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92219245|NCT01384773|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92219246|NCT01384773|Vitamin B Complex|vitamin b complex|mesh-ancestor
92219247|NCT01384773|Vitamins|vitamins|mesh-ancestor
92219248|NCT01384773|Micronutrients|micronutrients|mesh-ancestor
92219249|NCT01384773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219250|NCT01384773|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92219251|NCT01384773|Dermatologic Agents|dermatologic agents|mesh-ancestor
92219252|NCT01063075|Carboplatin|carboplatin|mesh-list
92219253|NCT01063075|Cetuximab|cetuximab|mesh-list
92219254|NCT01063075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219255|NCT01063075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219256|NCT01341405|Celecoxib|celecoxib|mesh-list
92219257|NCT01341405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219258|NCT01341405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219259|NCT01341405|Analgesics|analgesics|mesh-ancestor
92219260|NCT01341405|Sensory System Agents|sensory system agents|mesh-ancestor
92219261|NCT01341405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219262|NCT01341405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219263|NCT01341405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219264|NCT01341405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934280|NCT02233205|Antimetabolites|antimetabolites|mesh-ancestor
92219265|NCT01341405|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92219266|NCT01341405|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219267|NCT01341405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337441|NCT02499887|Prednisone|prednisone|mesh-list
92219268|NCT01341405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219270|NCT05136157|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92219271|NCT05136157|Insulin, Short-Acting|insulin, short-acting|mesh-list
92219272|NCT05136157|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92219273|NCT05136157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219274|NCT01921790|Dexamethasone|dexamethasone|mesh-list
92219275|NCT01921790|Gemcitabine|gemcitabine|mesh-list
92219276|NCT01921790|Oxaliplatin|oxaliplatin|mesh-list
92219277|NCT01921790|Bevacizumab|bevacizumab|mesh-list
92219278|NCT01921790|Pegaspargase|pegaspargase|mesh-list
92219279|NCT01921790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219280|NCT01921790|Antiemetics|antiemetics|mesh-ancestor
92219281|NCT01921790|Autonomic Agents|autonomic agents|mesh-ancestor
92219282|NCT01921790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219283|NCT01921790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219284|NCT01921790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219285|NCT01921790|Glucocorticoids|glucocorticoids|mesh-ancestor
92219286|NCT01921790|Hormones|hormones|mesh-ancestor
92219287|NCT01921790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219288|NCT01921790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219289|NCT01921790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219290|NCT01921790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92219291|NCT01921790|Antimetabolites|antimetabolites|mesh-ancestor
92219292|NCT01921790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219293|NCT01921790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219294|NCT01921790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92219295|NCT01921790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92219296|NCT01921790|Growth Substances|growth substances|mesh-ancestor
92219297|NCT01921790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92219298|NCT02153541|Antipyrine|antipyrine|mesh-list
92219299|NCT02153541|Benzocaine|benzocaine|mesh-list
92219300|NCT02153541|Glycerol|glycerol|mesh-list
92219301|NCT02153541|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92219302|NCT02153541|Protective Agents|protective agents|mesh-ancestor
92219303|NCT02153541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219304|NCT02153541|Anesthetics, Local|anesthetics, local|mesh-ancestor
92219305|NCT02153541|Anesthetics|anesthetics|mesh-ancestor
92219306|NCT02153541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219307|NCT02153541|Sensory System Agents|sensory system agents|mesh-ancestor
92219308|NCT02153541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219309|NCT02153541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219310|NCT02153541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219311|NCT02153541|Analgesics|analgesics|mesh-ancestor
92219312|NCT02153541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219313|NCT02153541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219314|NCT03487276|Vilobelimab|vilobelimab|mesh-list
92219315|NCT03487276|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92219316|NCT03487276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92219317|NCT03487276|Immunologic Factors|immunologic factors|mesh-ancestor
92219318|NCT03487276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219319|NCT03489850|Ibudilast|ibudilast|mesh-list
92219320|NCT03489850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92219321|NCT03489850|Autonomic Agents|autonomic agents|mesh-ancestor
92219322|NCT03489850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219324|NCT03489850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92219325|NCT03489850|Respiratory System Agents|respiratory system agents|mesh-ancestor
92219326|NCT03489850|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92219327|NCT03489850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219328|NCT03489850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219329|NCT03489850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92219330|NCT03489850|Vasodilator Agents|vasodilator agents|mesh-ancestor
92219331|NCT03490942|Glucagon|glucagon|mesh-list
92219332|NCT03490942|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92219333|NCT03490942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219334|NCT03490942|Hormones|hormones|mesh-ancestor
92219335|NCT03490942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219336|NCT03490942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219337|NCT03490942|Incretins|incretins|mesh-ancestor
92219338|NCT00376870|Pioglitazone|pioglitazone|mesh-list
92219340|NCT00376870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219341|NCT03015025|Acenocoumarol|acenocoumarol|mesh-list
92219342|NCT03015025|Anticoagulants|anticoagulants|mesh-ancestor
92219343|NCT03256162|Midazolam|midazolam|mesh-list
92219344|NCT03256162|Ketamine|ketamine|mesh-list
92219345|NCT03256162|Analgesics|analgesics|mesh-ancestor
92219346|NCT03256162|Sensory System Agents|sensory system agents|mesh-ancestor
92219347|NCT03256162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219348|NCT03256162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219349|NCT03256162|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92219350|NCT03256162|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92219351|NCT03256162|Anesthetics, General|anesthetics, general|mesh-ancestor
92219352|NCT03256162|Anesthetics|anesthetics|mesh-ancestor
92219353|NCT03256162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219354|NCT03256162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92219355|NCT03256162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92219356|NCT03256162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219357|NCT03256162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219358|NCT03256162|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92219359|NCT03256162|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92219360|NCT03256162|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92219361|NCT03256162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92219362|NCT03256162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92219363|NCT03256162|GABA Modulators|gaba modulators|mesh-ancestor
92219364|NCT03256162|GABA Agents|gaba agents|mesh-ancestor
92219365|NCT03493828|Bupivacaine|bupivacaine|mesh-list
92219366|NCT03493828|Anesthetics, Local|anesthetics, local|mesh-ancestor
92219367|NCT03493828|Anesthetics|anesthetics|mesh-ancestor
92219368|NCT03493828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219369|NCT03493828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219370|NCT03493828|Sensory System Agents|sensory system agents|mesh-ancestor
92219371|NCT03493828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219372|NCT03496324|Ibuprofen|ibuprofen|mesh-list
92219373|NCT03496324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219374|NCT03496324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219375|NCT03496324|Analgesics|analgesics|mesh-ancestor
92219376|NCT03496324|Sensory System Agents|sensory system agents|mesh-ancestor
92219377|NCT03496324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219378|NCT03496324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219379|NCT03496324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219380|NCT03496324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219381|NCT03496324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219382|NCT03496324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219383|NCT03496324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219384|NCT03354598|Ciprofloxacin|ciprofloxacin|mesh-list
92219385|NCT03354598|Probenecid|probenecid|mesh-list
92219386|NCT03354598|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219387|NCT03354598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219388|NCT03354598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92219389|NCT03354598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92219390|NCT03354598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219391|NCT03354598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219392|NCT03354598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219393|NCT03354598|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92219394|NCT03354598|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92219395|NCT03354598|Uricosuric Agents|uricosuric agents|mesh-ancestor
92219396|NCT03354598|Gout Suppressants|gout suppressants|mesh-ancestor
92219397|NCT03354598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219398|NCT02169895|Opicapone|opicapone|mesh-list
92219399|NCT02169895|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92219400|NCT02169895|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92219401|NCT02169895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219402|NCT02169895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219403|NCT02169895|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92219404|NCT02169895|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92219405|NCT02169895|Dopamine Agents|dopamine agents|mesh-ancestor
92219406|NCT02169895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337463|NCT02504099|Ritonavir|ritonavir|mesh-list
92219407|NCT02169895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219408|NCT01072669|Ambrisentan|ambrisentan|mesh-list
92219409|NCT01072669|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92219410|NCT03014713|Flurbiprofen|flurbiprofen|mesh-list
92219411|NCT03014713|Dexmedetomidine|dexmedetomidine|mesh-list
92219412|NCT03014713|Dezocine|dezocine|mesh-list
92219413|NCT03014713|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92219414|NCT03014713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219415|NCT03014713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219416|NCT03014713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219417|NCT03014713|Analgesics|analgesics|mesh-ancestor
92219418|NCT03014713|Sensory System Agents|sensory system agents|mesh-ancestor
92219419|NCT03014713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219420|NCT03014713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92219421|NCT03014713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92219422|NCT03014713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92219423|NCT03014713|Adrenergic Agents|adrenergic agents|mesh-ancestor
92219424|NCT03014713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219425|NCT03014713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219426|NCT03014713|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92219427|NCT03014713|Narcotics|narcotics|mesh-ancestor
92219428|NCT03014713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219429|NCT03014713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219430|NCT03014713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219431|NCT03014713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219432|NCT03014713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219433|NCT01074463|Pramipexole|pramipexole|mesh-list
92219434|NCT01074463|Antioxidants|antioxidants|mesh-ancestor
92219435|NCT01074463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219436|NCT01074463|Protective Agents|protective agents|mesh-ancestor
92219437|NCT01074463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219438|NCT01074463|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92219439|NCT01074463|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92219440|NCT01074463|Dopamine Agonists|dopamine agonists|mesh-ancestor
92219441|NCT01074463|Dopamine Agents|dopamine agents|mesh-ancestor
92219442|NCT01074463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219443|NCT01075087|Ropivacaine|ropivacaine|mesh-list
92219444|NCT01075087|Anesthetics, Local|anesthetics, local|mesh-ancestor
92219445|NCT01075087|Anesthetics|anesthetics|mesh-ancestor
92219446|NCT01075087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219447|NCT01075087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219448|NCT01075087|Sensory System Agents|sensory system agents|mesh-ancestor
92219449|NCT01075087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219450|NCT01075399|Imidazole|imidazole|mesh-list
92219451|NCT01075399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219452|NCT01075399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219453|NCT03835819|Pembrolizumab|pembrolizumab|mesh-list
92219454|NCT03835819|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92219455|NCT03835819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219456|NCT03835819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219457|NCT03835819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92219458|NCT03835819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219459|NCT03835819|Immunoconjugates|immunoconjugates|mesh-ancestor
92219460|NCT03835819|Immunologic Factors|immunologic factors|mesh-ancestor
92219461|NCT03835819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219462|NCT03358576|Amoxicillin|amoxicillin|mesh-list
92219463|NCT03358576|Metronidazole|metronidazole|mesh-list
92219464|NCT03358576|Ciprofloxacin|ciprofloxacin|mesh-list
92219465|NCT03358576|Clavulanic Acid|clavulanic acid|mesh-list
92219466|NCT03358576|Clavulanic Acids|clavulanic acids|mesh-list
92219467|NCT03358576|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92219468|NCT03358576|Ertapenem|ertapenem|mesh-list
92219469|NCT03358576|Lactams|lactams|mesh-list
92219470|NCT03358576|Probenecid|probenecid|mesh-list
92219471|NCT03358576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219472|NCT03358576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219473|NCT03358576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92219474|NCT03358576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92219475|NCT03358576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92219476|NCT03358576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92219477|NCT03358576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219478|NCT03358576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219479|NCT03358576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219480|NCT03358576|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92219481|NCT03358576|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92219482|NCT03358576|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92219483|NCT03358576|Uricosuric Agents|uricosuric agents|mesh-ancestor
92219484|NCT03358576|Gout Suppressants|gout suppressants|mesh-ancestor
92219485|NCT03358576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219486|NCT03822013|Miglustat|miglustat|mesh-list
92219488|NCT03822013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219489|NCT03822013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92219490|NCT03822013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92219491|NCT03822013|Antiviral Agents|antiviral agents|mesh-ancestor
92219492|NCT03822013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921768|NCT03534505|Anesthetics|anesthetics|mesh-ancestor
92219493|NCT03822013|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92219494|NCT03822013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92219495|NCT03822013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219496|NCT00376324|Tigecycline|tigecycline|mesh-list
92219497|NCT00376324|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219498|NCT00376324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219499|NCT00376324|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92219500|NCT00376324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219501|NCT00376324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219502|NCT00376480|Methylprednisolone|methylprednisolone|mesh-list
92219503|NCT00376480|Fludarabine|fludarabine|mesh-list
92219504|NCT00376480|Fludarabine phosphate|fludarabine phosphate|mesh-list
92219505|NCT00376480|Thiotepa|thiotepa|mesh-list
92219506|NCT00376480|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92219507|NCT00376480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219508|NCT00376480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92219509|NCT00376480|Antimetabolites|antimetabolites|mesh-ancestor
92219510|NCT00376480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219511|NCT00376480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92219512|NCT00376480|Immunologic Factors|immunologic factors|mesh-ancestor
92219513|NCT00376480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219514|NCT00376480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219515|NCT00376480|Antiemetics|antiemetics|mesh-ancestor
92219516|NCT00376480|Autonomic Agents|autonomic agents|mesh-ancestor
92219517|NCT00376480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219518|NCT00376480|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219519|NCT00376480|Glucocorticoids|glucocorticoids|mesh-ancestor
92219521|NCT00376480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219522|NCT00376480|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92219523|NCT00376480|Protective Agents|protective agents|mesh-ancestor
92219524|NCT00376480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92219525|NCT00376480|Alkylating Agents|alkylating agents|mesh-ancestor
92219526|NCT00376480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92219527|NCT03016039|Curcumin|curcumin|mesh-list
92219528|NCT03016039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219529|NCT03016039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219530|NCT03016039|Analgesics|analgesics|mesh-ancestor
92219531|NCT03016039|Sensory System Agents|sensory system agents|mesh-ancestor
92219532|NCT03016039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219533|NCT03016039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219534|NCT03016039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219535|NCT03016039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219536|NCT03016039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219537|NCT03016039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219538|NCT03016039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219539|NCT03753919|Durvalumab|durvalumab|mesh-list
92219540|NCT03753919|Tremelimumab|tremelimumab|mesh-list
92219541|NCT03753919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219542|NCT03753919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219543|NCT03498196|Avelumab|avelumab|mesh-list
92219544|NCT03498196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219545|NCT03498196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219546|NCT03500302|Evolocumab|evolocumab|mesh-list
92219547|NCT03500302|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92219548|NCT03500302|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92219549|NCT03500302|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92219550|NCT03500302|Antimetabolites|antimetabolites|mesh-ancestor
92219551|NCT03500302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219552|NCT03500302|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92219553|NCT03500302|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219554|NCT03500302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219555|NCT03500302|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92219556|NCT03501550|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92219557|NCT03501550|Antiviral Agents|antiviral agents|mesh-ancestor
92219558|NCT03501550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219560|NCT03503578|Sevoflurane|sevoflurane|mesh-list
92219561|NCT03503578|Analgesics|analgesics|mesh-ancestor
92219562|NCT03503578|Sensory System Agents|sensory system agents|mesh-ancestor
92219563|NCT03503578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219564|NCT03503578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219565|NCT03503578|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92219566|NCT03503578|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92219567|NCT03503578|Anesthetics, General|anesthetics, general|mesh-ancestor
92219568|NCT03503578|Anesthetics|anesthetics|mesh-ancestor
92219569|NCT03503578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219570|NCT03503578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92219571|NCT03503578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92219572|NCT03503578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219573|NCT03503578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219574|NCT03503578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92219575|NCT03503578|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92219576|NCT03270514|Bupivacaine|bupivacaine|mesh-list
92219577|NCT03270514|Anesthetics, Local|anesthetics, local|mesh-ancestor
92219578|NCT03270514|Anesthetics|anesthetics|mesh-ancestor
92219579|NCT03270514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219580|NCT03270514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219581|NCT03270514|Sensory System Agents|sensory system agents|mesh-ancestor
92219582|NCT03270514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219583|NCT02178241|Gemcitabine|gemcitabine|mesh-list
92219584|NCT02178241|Halichondrin B|halichondrin b|mesh-list
92219585|NCT02178241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92219586|NCT02178241|Antimetabolites|antimetabolites|mesh-ancestor
92219587|NCT02178241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219588|NCT02178241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219589|NCT02178241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92219590|NCT02178241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92219591|NCT02178241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92219592|NCT03015727|Docetaxel|docetaxel|mesh-list
92219593|NCT03015727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219594|NCT03015727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92219595|NCT03015727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92219596|NCT03015727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92219597|NCT03015727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219598|NCT03539731|Piperazine|piperazine|mesh-list
92219599|NCT03539731|Antinematodal Agents|antinematodal agents|mesh-ancestor
92219600|NCT03539731|Anthelmintics|anthelmintics|mesh-ancestor
92219601|NCT03539731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92219602|NCT03539731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219603|NCT01077973|Ibuprofen|ibuprofen|mesh-list
92219604|NCT01077973|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219605|NCT01077973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219606|NCT01077973|Analgesics|analgesics|mesh-ancestor
92219607|NCT01077973|Sensory System Agents|sensory system agents|mesh-ancestor
92219608|NCT01077973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219609|NCT01077973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219610|NCT01077973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219611|NCT01077973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219612|NCT01077973|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219613|NCT01077973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219614|NCT01077973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219615|NCT02973646|Tenofovir|tenofovir|mesh-list
92219617|NCT02973646|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92219618|NCT02973646|Antiviral Agents|antiviral agents|mesh-ancestor
92219619|NCT02973646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219620|NCT02973646|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92219621|NCT02973646|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92219622|NCT02973646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219623|NCT02973646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219624|NCT02973646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92219625|NCT02973646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92219627|NCT01078363|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92219628|NCT01078363|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219629|NCT01078363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219630|NCT01078363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219631|NCT01078363|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92219632|NCT03371836|Clobazam|clobazam|mesh-list
92219633|NCT03371836|Anticonvulsants|anticonvulsants|mesh-ancestor
92219634|NCT03371836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92219635|NCT03371836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92219636|NCT03371836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219637|NCT03371836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219638|NCT03371836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92219639|NCT03371836|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92219640|NCT03371836|GABA Agonists|gaba agonists|mesh-ancestor
92219641|NCT03371836|GABA Agents|gaba agents|mesh-ancestor
92219642|NCT03371836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219643|NCT03371836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219644|NCT01078753|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92219645|NCT01078753|Hemostatics|hemostatics|mesh-ancestor
92219646|NCT01078753|Coagulants|coagulants|mesh-ancestor
92219647|NCT01078753|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92219648|NCT01078753|Natriuretic Agents|natriuretic agents|mesh-ancestor
92219649|NCT01078753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219650|NCT03372382|Acetaminophen|acetaminophen|mesh-list
92219651|NCT03372382|Ibuprofen|ibuprofen|mesh-list
92219652|NCT03372382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219653|NCT03372382|Analgesics|analgesics|mesh-ancestor
92219654|NCT03372382|Sensory System Agents|sensory system agents|mesh-ancestor
92219655|NCT03372382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219656|NCT03372382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219657|NCT03372382|Antipyretics|antipyretics|mesh-ancestor
92219658|NCT03372382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92219659|NCT03372382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219660|NCT03372382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219661|NCT03372382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92219662|NCT03372382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219663|NCT03372382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219664|NCT03373162|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92219665|NCT03373162|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92219666|NCT03373162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92219667|NCT03373162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219668|NCT03373162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219669|NCT03373162|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92219670|NCT03373162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92219671|NCT03373162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219672|NCT03373162|Cholinergic Agents|cholinergic agents|mesh-ancestor
92219673|NCT03373162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219675|NCT03374176|Metronidazole|metronidazole|mesh-list
92219676|NCT03374176|Clindamycin|clindamycin|mesh-list
92219677|NCT03374176|Clindamycin palmitate|clindamycin palmitate|mesh-list
92219678|NCT03374176|Clindamycin phosphate|clindamycin phosphate|mesh-list
92219679|NCT03374176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219680|NCT03374176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219681|NCT03374176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92219682|NCT03374176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92219683|NCT03374176|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92219684|NCT03374176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219685|NCT03374176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219686|NCT03281200|Nintedanib|nintedanib|mesh-list
92219687|NCT03281200|Antineoplastic Agents|antineoplastic agents|mesh-list
92219688|NCT03281200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-list
92219689|NCT03281200|Immunomodulating Agents|immunomodulating agents|mesh-list
92219690|NCT03281200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337482|NCT01094561|Secretin|secretin|mesh-list
92219691|NCT03281200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219692|NCT03281200|Immunologic Factors|immunologic factors|mesh-ancestor
92219693|NCT03281200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219695|NCT03378076|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92219696|NCT03378076|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92219697|NCT03378076|FX006|fx006|mesh-list
92219698|NCT03378076|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92219699|NCT03378076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219700|NCT03378076|Glucocorticoids|glucocorticoids|mesh-ancestor
92219701|NCT03378076|Hormones|hormones|mesh-ancestor
92219702|NCT03378076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219703|NCT03378076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219704|NCT03378076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92219705|NCT03378076|Immunologic Factors|immunologic factors|mesh-ancestor
92219706|NCT03378076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219707|NCT03378076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219708|NCT03520348|Pantothenic Acid|pantothenic acid|mesh-list
92219709|NCT03520348|Vitamin B Complex|vitamin b complex|mesh-ancestor
92219710|NCT03520348|Vitamins|vitamins|mesh-ancestor
92219711|NCT03520348|Micronutrients|micronutrients|mesh-ancestor
92219712|NCT03520348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219713|NCT03380026|Triamcinolone|triamcinolone|mesh-list
92219714|NCT03380026|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92219715|NCT03380026|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92219716|NCT03380026|Mechlorethamine|mechlorethamine|mesh-list
92219717|NCT03380026|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92219718|NCT03380026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219719|NCT03380026|Glucocorticoids|glucocorticoids|mesh-ancestor
92219720|NCT03380026|Hormones|hormones|mesh-ancestor
92219721|NCT03380026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219722|NCT03380026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219723|NCT03380026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92219724|NCT03380026|Immunologic Factors|immunologic factors|mesh-ancestor
92219725|NCT03380026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219726|NCT03380026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219727|NCT03380026|Alkylating Agents|alkylating agents|mesh-ancestor
92219728|NCT03380026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92219729|NCT03380026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219730|NCT01079143|Cyclosporine|cyclosporine|mesh-list
92219731|NCT01079143|Mycophenolic Acid|mycophenolic acid|mesh-list
92219732|NCT01079143|Everolimus|everolimus|mesh-list
92219733|NCT01079143|Cyclosporins|cyclosporins|mesh-list
92219734|NCT01079143|Basiliximab|basiliximab|mesh-list
92219735|NCT01079143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219736|NCT01079143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219737|NCT01079143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92219738|NCT01079143|Immunologic Factors|immunologic factors|mesh-ancestor
92219739|NCT01079143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219740|NCT01079143|Antifungal Agents|antifungal agents|mesh-ancestor
92219741|NCT01079143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219742|NCT01079143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92219743|NCT01079143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92219744|NCT01079143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92219745|NCT01079143|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92219746|NCT01079143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92219747|NCT01079143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219748|NCT01079143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92219749|NCT01079143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92219750|NCT01079143|Antitubercular Agents|antitubercular agents|mesh-ancestor
92219751|NCT01079143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219752|NCT03381742|Clopidogrel|clopidogrel|mesh-list
92219753|NCT03381742|Ticagrelor|ticagrelor|mesh-list
92219754|NCT03381742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92219755|NCT03381742|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92219756|NCT03381742|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92219757|NCT03381742|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92219758|NCT03381742|Purinergic Agents|purinergic agents|mesh-ancestor
92219759|NCT03381742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337487|NCT01074437|Prednisolone|prednisolone|mesh-list
92219760|NCT03381742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219761|NCT03381742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219762|NCT04735042|Dapagliflozin|dapagliflozin|mesh-list
92219763|NCT04735042|Empagliflozin|empagliflozin|mesh-list
92219764|NCT04735042|Linagliptin|linagliptin|mesh-list
92219765|NCT04735042|Saxagliptin|saxagliptin|mesh-list
92219766|NCT04735042|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92219767|NCT04735042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219768|NCT04735042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92219769|NCT04735042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219770|NCT04735042|Incretins|incretins|mesh-ancestor
92219772|NCT04735042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219773|NCT04735042|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92219774|NCT04735042|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219775|NCT04735042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219776|NCT04681339|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92219777|NCT04681339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92219778|NCT04681339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219779|NCT04681339|Antitubercular Agents|antitubercular agents|mesh-ancestor
92219780|NCT00376012|Rifampin|rifampin|mesh-list
92219781|NCT00376012|Isoniazid|isoniazid|mesh-list
92219782|NCT00376012|Pyrazinamide|pyrazinamide|mesh-list
92219783|NCT00376012|Ethambutol|ethambutol|mesh-list
92219784|NCT00376012|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92219785|NCT00376012|Antitubercular Agents|antitubercular agents|mesh-ancestor
92219786|NCT00376012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219787|NCT00376012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219788|NCT00376012|Leprostatic Agents|leprostatic agents|mesh-ancestor
92219789|NCT00376012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92219790|NCT00376012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219791|NCT00376012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219792|NCT00376012|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92219793|NCT00376012|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92219794|NCT00376012|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92219795|NCT00376012|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92219796|NCT00376012|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91922375|NCT02205931|Anticonvulsants|anticonvulsants|mesh-list
92219797|NCT00376012|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92219798|NCT00376012|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92219799|NCT00376012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92219800|NCT00376012|Antimetabolites|antimetabolites|mesh-ancestor
92219801|NCT00376012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92219802|NCT02171611|Dabigatran|dabigatran|mesh-list
92219803|NCT02171611|Antithrombins|antithrombins|mesh-ancestor
92219804|NCT02171611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92219805|NCT02171611|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219806|NCT02171611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219807|NCT02171611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219808|NCT02171611|Anticoagulants|anticoagulants|mesh-ancestor
92219809|NCT01083667|Pyrimethamine|pyrimethamine|mesh-list
92219810|NCT01083667|Antimalarials|antimalarials|mesh-ancestor
92219811|NCT01083667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92219812|NCT01083667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92219813|NCT01083667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219814|NCT01083667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92219815|NCT01083667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219816|NCT01083667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219817|NCT00942305|Brincidofovir|brincidofovir|mesh-list
92219818|NCT00942305|Antiviral Agents|antiviral agents|mesh-ancestor
92219819|NCT00942305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219820|NCT01084759|Etoposide|etoposide|mesh-list
92219821|NCT01084759|Methyltestosterone|methyltestosterone|mesh-list
92219822|NCT01084759|Testosterone|testosterone|mesh-list
92219823|NCT01084759|Testosterone undecanoate|testosterone undecanoate|mesh-list
92219824|NCT01084759|Testosterone enanthate|testosterone enanthate|mesh-list
92219825|NCT01084759|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92219826|NCT01084759|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92219827|NCT01084759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219828|NCT01084759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92219830|NCT01084759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219831|NCT01084759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219833|NCT01084759|Hormones|hormones|mesh-ancestor
92219834|NCT01084759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219835|NCT01084759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219836|NCT01084759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219837|NCT01084759|Anabolic Agents|anabolic agents|mesh-ancestor
92219839|NCT01110187|Fosphenytoin|fosphenytoin|mesh-list
92219840|NCT01110187|Anticonvulsants|anticonvulsants|mesh-ancestor
92219841|NCT01110187|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92219842|NCT01110187|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92219843|NCT01110187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92219844|NCT01110187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219845|NCT04357301|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92219846|NCT01110421|Amoxicillin|amoxicillin|mesh-list
92219847|NCT01110421|Clavulanic Acid|clavulanic acid|mesh-list
92219848|NCT01110421|Clavulanic Acids|clavulanic acids|mesh-list
92219849|NCT01110421|Cefepime|cefepime|mesh-list
92219850|NCT01110421|Doripenem|doripenem|mesh-list
92219851|NCT01110421|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92219852|NCT01110421|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219853|NCT01110421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219854|NCT01110421|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92219855|NCT01110421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219856|NCT01110421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219857|NCT04358627|Dexmedetomidine|dexmedetomidine|mesh-list
92219858|NCT04358627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92219859|NCT04358627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219860|NCT04358627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219861|NCT04358627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92219862|NCT04358627|Analgesics|analgesics|mesh-ancestor
92219863|NCT04358627|Sensory System Agents|sensory system agents|mesh-ancestor
92219864|NCT04358627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219865|NCT04358627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92219866|NCT04358627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92219867|NCT04358627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92219868|NCT04358627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92219869|NCT04358627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219870|NCT04358627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219871|NCT04356677|Ribavirin|ribavirin|mesh-list
92219872|NCT04356677|Antimetabolites|antimetabolites|mesh-ancestor
92219873|NCT04356677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219874|NCT04356677|Antiviral Agents|antiviral agents|mesh-ancestor
92219875|NCT04356677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219876|NCT04356833|Plasminogen|plasminogen|mesh-list
92219877|NCT04356833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92219878|NCT04356833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92219879|NCT04356833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92219880|NCT04356833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219881|NCT05620277|Tocopherols|tocopherols|mesh-list
92219882|NCT05620277|Vitamin E|vitamin e|mesh-list
92219883|NCT05620277|alpha-Tocopherol|alpha-tocopherol|mesh-list
92219884|NCT05620277|Antioxidants|antioxidants|mesh-ancestor
92219885|NCT05620277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219886|NCT05620277|Protective Agents|protective agents|mesh-ancestor
92219887|NCT05620277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219888|NCT05620277|Vitamins|vitamins|mesh-ancestor
92219889|NCT05620277|Micronutrients|micronutrients|mesh-ancestor
92219890|NCT01110499|Bimatoprost|bimatoprost|mesh-list
92219891|NCT01110499|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92219892|NCT01110499|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92219893|NCT01110499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92219894|NCT02174419|Nalbuphine|nalbuphine|mesh-list
92219895|NCT02174419|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92219896|NCT02174419|Narcotics|narcotics|mesh-ancestor
92219897|NCT02174419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219898|NCT02174419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219899|NCT02174419|Analgesics|analgesics|mesh-ancestor
92219900|NCT02174419|Sensory System Agents|sensory system agents|mesh-ancestor
92219901|NCT02174419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219902|NCT05620589|Amoxicillin|amoxicillin|mesh-list
92219903|NCT05620589|Tetracycline|tetracycline|mesh-list
92219904|NCT05620589|Esomeprazole|esomeprazole|mesh-list
92219905|NCT05620589|Bismuth|bismuth|mesh-list
92219906|NCT05620589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219907|NCT05620589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219908|NCT05620589|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92219909|NCT05620589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92219910|NCT05620589|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92219911|NCT05620589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219912|NCT05620589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219913|NCT05620589|Antacids|antacids|mesh-ancestor
92219914|NCT05620589|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92219915|NCT01086475|Cycloserine|cycloserine|mesh-list
92219916|NCT01086475|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92219917|NCT01086475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92219918|NCT01086475|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92219919|NCT01086475|Antitubercular Agents|antitubercular agents|mesh-ancestor
92219920|NCT01086475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92219921|NCT01086475|Antimetabolites|antimetabolites|mesh-ancestor
92219922|NCT01086475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219923|NCT01112683|Memantine|memantine|mesh-list
92219924|NCT01112683|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92219925|NCT01112683|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92219926|NCT01112683|Dopamine Agents|dopamine agents|mesh-ancestor
92219927|NCT01112683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219928|NCT01112683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219929|NCT01112683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219930|NCT01112683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92219931|NCT01112683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92219932|NCT02245373|Antidepressive Agents|antidepressive agents|mesh-list
92219933|NCT02245373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92219934|NCT04355273|Heparin|heparin|mesh-list
92219935|NCT04355273|Calcium heparin|calcium heparin|mesh-list
92219936|NCT04355273|Anticoagulants|anticoagulants|mesh-ancestor
92219937|NCT04355273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92219938|NCT04355273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92219939|NCT04355273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219940|NCT04355429|Captopril|captopril|mesh-list
92219941|NCT04355429|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92219942|NCT04355429|Protease Inhibitors|protease inhibitors|mesh-ancestor
92219943|NCT04355429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219944|NCT04355429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219945|NCT04355429|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92219946|NCT01114555|Bevacizumab|bevacizumab|mesh-list
92219947|NCT01114555|Irinotecan|irinotecan|mesh-list
92219948|NCT01114555|Temozolomide|temozolomide|mesh-list
92219949|NCT01114555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92219950|NCT01114555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92219951|NCT01114555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92219952|NCT01114555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92219953|NCT01114555|Growth Substances|growth substances|mesh-ancestor
92219954|NCT01114555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219955|NCT01114555|Growth Inhibitors|growth inhibitors|mesh-ancestor
92219956|NCT01114555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92219957|NCT01114555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92219958|NCT01114555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92219959|NCT01114555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219960|NCT01114555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92219961|NCT01114555|Alkylating Agents|alkylating agents|mesh-ancestor
92219963|NCT02673931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92219964|NCT02673931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219965|NCT02673931|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92219966|NCT02673931|Incretins|incretins|mesh-ancestor
92219967|NCT02673931|Hormones|hormones|mesh-ancestor
92219968|NCT02673931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219969|NCT01115101|Pirinitramide|pirinitramide|mesh-list
92219970|NCT01115101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92219971|NCT01115101|Narcotics|narcotics|mesh-ancestor
92219972|NCT01115101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92219973|NCT01115101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219974|NCT01115101|Analgesics|analgesics|mesh-ancestor
92219975|NCT01115101|Sensory System Agents|sensory system agents|mesh-ancestor
92219976|NCT01115101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92219978|NCT02245529|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92219979|NCT02245529|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92219980|NCT02245529|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92219981|NCT02245529|Adrenergic Agents|adrenergic agents|mesh-ancestor
92219982|NCT02245529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92219983|NCT02245529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92219984|NCT02245529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219985|NCT02245529|Urological Agents|urological agents|mesh-ancestor
92219987|NCT00947765|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92219988|NCT00947765|Methylprednisolone|methylprednisolone|mesh-list
92219989|NCT00947765|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92219990|NCT00947765|Prednisolone acetate|prednisolone acetate|mesh-list
92219991|NCT00947765|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92219992|NCT00947765|Prednisolone phosphate|prednisolone phosphate|mesh-list
92219993|NCT00947765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92219994|NCT00947765|Glucocorticoids|glucocorticoids|mesh-ancestor
92219995|NCT00947765|Hormones|hormones|mesh-ancestor
92219996|NCT00947765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92219997|NCT00947765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92219998|NCT00947765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92219999|NCT00947765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220000|NCT00947765|Antiemetics|antiemetics|mesh-ancestor
92220001|NCT00947765|Autonomic Agents|autonomic agents|mesh-ancestor
92220002|NCT00947765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220003|NCT00947765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220004|NCT00947765|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92220005|NCT00947765|Protective Agents|protective agents|mesh-ancestor
92220006|NCT01089517|Ranibizumab|ranibizumab|mesh-list
92220007|NCT01089517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92220008|NCT01089517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92220009|NCT01089517|Growth Substances|growth substances|mesh-ancestor
92220010|NCT01089517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220011|NCT01089517|Growth Inhibitors|growth inhibitors|mesh-ancestor
92220012|NCT01089517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220013|NCT04311515|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92220014|NCT04311515|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92220015|NCT04311515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220016|NCT01089595|Imatinib Mesylate|imatinib mesylate|mesh-list
92220017|NCT01089595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220018|NCT01089595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92220019|NCT01089595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220020|NCT01089595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220021|NCT04354961|Paclitaxel|paclitaxel|mesh-list
92220022|NCT04354961|Carboplatin|carboplatin|mesh-list
92220023|NCT04354961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92220024|NCT04354961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220025|NCT04354961|Tubulin Modulators|tubulin modulators|mesh-ancestor
92220026|NCT04354961|Antimitotic Agents|antimitotic agents|mesh-ancestor
92220027|NCT04354961|Mitosis Modulators|mitosis modulators|mesh-ancestor
92117284|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92220028|NCT04354961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220029|NCT01089751|Trospium chloride|trospium chloride|mesh-list
92220030|NCT01089751|Parasympatholytics|parasympatholytics|mesh-ancestor
92220031|NCT01089751|Autonomic Agents|autonomic agents|mesh-ancestor
92220032|NCT01089751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220033|NCT01089751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220034|NCT01089751|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92220035|NCT01089751|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92220036|NCT01089751|Cholinergic Agents|cholinergic agents|mesh-ancestor
92220037|NCT01089751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220038|NCT01089751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220039|NCT01089751|Urological Agents|urological agents|mesh-ancestor
92220041|NCT03032315|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92220042|NCT03032315|Telmisartan|telmisartan|mesh-list
92220043|NCT03032315|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92220044|NCT03032315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92220045|NCT03032315|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92220046|NCT03032315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92220047|NCT03032315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220048|NCT03032315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92220049|NCT03032315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220050|NCT03032315|Vasodilator Agents|vasodilator agents|mesh-ancestor
92220051|NCT03032315|Diuretics|diuretics|mesh-ancestor
92220052|NCT03032315|Natriuretic Agents|natriuretic agents|mesh-ancestor
92220053|NCT03032315|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92220054|NCT03032315|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92220055|NCT03032315|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92220056|NCT01090921|Bortezomib|bortezomib|mesh-list
92220057|NCT01090921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220058|NCT03537274|Interferons|interferons|mesh-list
92220059|NCT03537274|Interferon-alpha|interferon-alpha|mesh-list
92220060|NCT03537274|Interferon alpha-2|interferon alpha-2|mesh-list
92220061|NCT03537274|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92220062|NCT03537274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220063|NCT03537274|Antiviral Agents|antiviral agents|mesh-ancestor
92220064|NCT03537274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220065|NCT03537274|Immunologic Factors|immunologic factors|mesh-ancestor
92220066|NCT03537274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220067|NCT00939653|Cytarabine|cytarabine|mesh-list
92220068|NCT00939653|Cyclophosphamide|cyclophosphamide|mesh-list
92220069|NCT00939653|Etoposide|etoposide|mesh-list
92220070|NCT00939653|Clofarabine|clofarabine|mesh-list
92220071|NCT00939653|Lenograstim|lenograstim|mesh-list
92220072|NCT00939653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92220073|NCT00939653|Immunologic Factors|immunologic factors|mesh-ancestor
92220074|NCT00939653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220075|NCT00939653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220076|NCT00939653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220077|NCT00939653|Alkylating Agents|alkylating agents|mesh-ancestor
92220078|NCT00939653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220079|NCT00939653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220080|NCT00939653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92220081|NCT00939653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92220082|NCT00939653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92220083|NCT00939653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92220084|NCT00939653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220085|NCT00939653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220086|NCT00939653|Antimetabolites|antimetabolites|mesh-ancestor
92220087|NCT00939653|Antiviral Agents|antiviral agents|mesh-ancestor
92220088|NCT00939653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220089|NCT00939653|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92220090|NCT04355039|Dexamethasone|dexamethasone|mesh-list
92220091|NCT04355039|Pomalidomide|pomalidomide|mesh-list
92220092|NCT04355039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220093|NCT04355039|Antiemetics|antiemetics|mesh-ancestor
92220094|NCT04355039|Autonomic Agents|autonomic agents|mesh-ancestor
92220095|NCT04355039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220096|NCT04355039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220097|NCT04355039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220098|NCT04355039|Glucocorticoids|glucocorticoids|mesh-ancestor
92220099|NCT04355039|Hormones|hormones|mesh-ancestor
92220100|NCT04355039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220101|NCT04355039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220102|NCT04355039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220103|NCT04355039|Immunologic Factors|immunologic factors|mesh-ancestor
92220104|NCT04355039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92220105|NCT04355039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92220106|NCT04355039|Growth Substances|growth substances|mesh-ancestor
92220107|NCT04355039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92220108|NCT02524405|Corticosterone|corticosterone|mesh-list
92220109|NCT02524405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220110|NCT03014323|Galantamine|galantamine|mesh-list
92220111|NCT03014323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92220112|NCT03014323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220113|NCT03014323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220115|NCT03014323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220116|NCT03014323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220117|NCT03014323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92220118|NCT03014323|Autonomic Agents|autonomic agents|mesh-ancestor
92220119|NCT03014323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220120|NCT03014323|Nootropic Agents|nootropic agents|mesh-ancestor
92220122|NCT03393208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92220123|NCT03393208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220124|NCT01092559|Nitric Oxide|nitric oxide|mesh-list
92220125|NCT01092559|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92220126|NCT01092559|Autonomic Agents|autonomic agents|mesh-ancestor
92220127|NCT01092559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220128|NCT01092559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220129|NCT01092559|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92220130|NCT01092559|Respiratory System Agents|respiratory system agents|mesh-ancestor
92220131|NCT01092559|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92220132|NCT01092559|Antioxidants|antioxidants|mesh-ancestor
92220133|NCT01092559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220134|NCT01092559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220135|NCT01092559|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92220136|NCT01092559|Vasodilator Agents|vasodilator agents|mesh-ancestor
92220137|NCT01092559|Gasotransmitters|gasotransmitters|mesh-ancestor
92220138|NCT01092559|Protective Agents|protective agents|mesh-ancestor
92220140|NCT03587428|Trace Elements|trace elements|mesh-ancestor
92220141|NCT03587428|Micronutrients|micronutrients|mesh-ancestor
92220142|NCT03587428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220143|NCT03398278|Oxycodone|oxycodone|mesh-list
92220144|NCT03398278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220145|NCT03398278|Narcotics|narcotics|mesh-ancestor
92220146|NCT03398278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220147|NCT03398278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220148|NCT03398278|Analgesics|analgesics|mesh-ancestor
92220149|NCT03398278|Sensory System Agents|sensory system agents|mesh-ancestor
92220150|NCT03398278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220151|NCT03593902|Methylprednisolone|methylprednisolone|mesh-list
92220152|NCT03593902|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92220153|NCT03593902|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92220154|NCT03593902|Prednisolone|prednisolone|mesh-list
92220155|NCT03593902|Prednisolone acetate|prednisolone acetate|mesh-list
92220156|NCT03593902|Cyclophosphamide|cyclophosphamide|mesh-list
92220157|NCT03593902|Rituximab|rituximab|mesh-list
92220158|NCT03593902|Fludarabine|fludarabine|mesh-list
92220159|NCT03593902|Thymoglobulin|thymoglobulin|mesh-list
92220160|NCT03593902|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92220161|NCT03593902|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92220162|NCT03593902|Prednisolone phosphate|prednisolone phosphate|mesh-list
92220163|NCT03593902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92220164|NCT03593902|Immunologic Factors|immunologic factors|mesh-ancestor
92220165|NCT03593902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220166|NCT03593902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220167|NCT03593902|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220168|NCT03593902|Alkylating Agents|alkylating agents|mesh-ancestor
92220169|NCT03593902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220170|NCT03593902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220171|NCT03593902|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92220172|NCT03593902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220173|NCT03593902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220174|NCT03593902|Antiemetics|antiemetics|mesh-ancestor
92220175|NCT03593902|Autonomic Agents|autonomic agents|mesh-ancestor
92220176|NCT03593902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220177|NCT03593902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220178|NCT03593902|Glucocorticoids|glucocorticoids|mesh-ancestor
92220179|NCT03593902|Hormones|hormones|mesh-ancestor
92220180|NCT03593902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220181|NCT03593902|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92220182|NCT03593902|Protective Agents|protective agents|mesh-ancestor
92220183|NCT03593902|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220184|NCT00948935|Gemcitabine|gemcitabine|mesh-list
92220185|NCT00948935|Irinotecan|irinotecan|mesh-list
92220186|NCT00948935|Panitumumab|panitumumab|mesh-list
92220187|NCT00948935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220188|NCT00948935|Antimetabolites|antimetabolites|mesh-ancestor
92220189|NCT00948935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220191|NCT00948935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92220192|NCT00948935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92220193|NCT00948935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220194|NCT00948935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220195|NCT04354805|Chlorpromazine|chlorpromazine|mesh-list
92220196|NCT04354805|Antiemetics|antiemetics|mesh-ancestor
92220197|NCT04354805|Autonomic Agents|autonomic agents|mesh-ancestor
92220198|NCT04354805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220199|NCT04354805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220200|NCT04354805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220201|NCT04354805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92220202|NCT04354805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92220203|NCT04354805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220204|NCT04354805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92220205|NCT04354805|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92220206|NCT04354805|Dopamine Agents|dopamine agents|mesh-ancestor
92220207|NCT04354805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220208|NCT04354805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220209|NCT03944681|Droperidol|droperidol|mesh-list
92220210|NCT03944681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92220212|NCT03944681|Autonomic Agents|autonomic agents|mesh-ancestor
92220213|NCT03944681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220214|NCT03944681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220215|NCT03944681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220216|NCT03944681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92220217|NCT03944681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92220218|NCT03944681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220219|NCT03944681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92220220|NCT03944681|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92220221|NCT03944681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92220222|NCT03944681|Dopamine Agents|dopamine agents|mesh-ancestor
92220223|NCT03944681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220224|NCT03944681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337547|NCT01009931|Choline magnesium trisalicylate|choline magnesium trisalicylate|mesh-list
92337548|NCT01009931|Choline|choline|mesh-list
92220225|NCT03935555|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
92220226|NCT03935555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220227|NCT03031691|Trifluridine|trifluridine|mesh-list
92220228|NCT03031691|Antimetabolites|antimetabolites|mesh-ancestor
92220229|NCT03031691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220230|NCT03031691|Antiviral Agents|antiviral agents|mesh-ancestor
92220231|NCT03031691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220232|NCT01093183|Cyclophosphamide|cyclophosphamide|mesh-list
92220233|NCT01093183|Lenalidomide|lenalidomide|mesh-list
92220234|NCT01093183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92220235|NCT01093183|Immunologic Factors|immunologic factors|mesh-ancestor
92220236|NCT01093183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220237|NCT01093183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220238|NCT01093183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220239|NCT01093183|Alkylating Agents|alkylating agents|mesh-ancestor
92220240|NCT01093183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220241|NCT01093183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220242|NCT01093183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92220243|NCT01093183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92220244|NCT01093183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92220245|NCT01093183|Growth Substances|growth substances|mesh-ancestor
92220246|NCT01093183|Growth Inhibitors|growth inhibitors|mesh-ancestor
92220247|NCT02430103|Goserelin|goserelin|mesh-list
92220248|NCT02430103|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220249|NCT02430103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220250|NCT03031535|Octreotide|octreotide|mesh-list
92220251|NCT03031535|Hormones|hormones|mesh-list
92220252|NCT03031535|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92220253|NCT03031535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220254|NCT03031535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220255|NCT03031535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220256|NCT03031535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220257|NCT03031535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220258|NCT01093417|Vitamin D|vitamin d|mesh-list
92220259|NCT01093417|Vitamins|vitamins|mesh-ancestor
92220260|NCT01093417|Micronutrients|micronutrients|mesh-ancestor
92220261|NCT01093417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220262|NCT01093417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92220263|NCT01093651|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92220264|NCT01093651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92220265|NCT01093651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220266|NCT01093651|Incretins|incretins|mesh-ancestor
92220267|NCT01093651|Hormones|hormones|mesh-ancestor
92220268|NCT01093651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220269|NCT01093651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92220270|NCT01093651|Protease Inhibitors|protease inhibitors|mesh-ancestor
92220271|NCT01093651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220272|NCT01093651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220273|NCT00362895|Tobramycin|tobramycin|mesh-list
92220274|NCT00362895|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92220275|NCT00362895|Dexamethasone|dexamethasone|mesh-list
92220276|NCT00362895|Dexamethasone acetate|dexamethasone acetate|mesh-list
92220277|NCT00362895|BB 1101|bb 1101|mesh-list
92220278|NCT00362895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220279|NCT00362895|Antiemetics|antiemetics|mesh-ancestor
92220280|NCT00362895|Autonomic Agents|autonomic agents|mesh-ancestor
92220281|NCT00362895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220282|NCT00362895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220283|NCT00362895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220285|NCT00362895|Hormones|hormones|mesh-ancestor
92220286|NCT00362895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220287|NCT00362895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220288|NCT00362895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220289|NCT00362895|Protease Inhibitors|protease inhibitors|mesh-ancestor
92220290|NCT00362895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220291|NCT00362895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220292|NCT00362895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92220293|NCT00362895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220294|NCT00362895|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92220295|NCT00362895|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92220296|NCT04744623|Mycophenolic Acid|mycophenolic acid|mesh-list
92220297|NCT04744623|Dapsone|dapsone|mesh-list
92220298|NCT04744623|Prednisolone|prednisolone|mesh-list
92220299|NCT04744623|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92220300|NCT04744623|Methylprednisolone|methylprednisolone|mesh-list
92220301|NCT04744623|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92220302|NCT04744623|Prednisolone acetate|prednisolone acetate|mesh-list
92220303|NCT04744623|Triamcinolone|triamcinolone|mesh-list
92220304|NCT04744623|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92220305|NCT04744623|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92220306|NCT04744623|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92220307|NCT04744623|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92220308|NCT04744623|Prednisolone phosphate|prednisolone phosphate|mesh-list
92220309|NCT04744623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92220310|NCT04744623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220311|NCT04744623|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92220312|NCT04744623|Antitubercular Agents|antitubercular agents|mesh-ancestor
92220313|NCT04744623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92220314|NCT04744623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220315|NCT04744623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220316|NCT04744623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220317|NCT04744623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220318|NCT04744623|Glucocorticoids|glucocorticoids|mesh-ancestor
92220319|NCT04744623|Hormones|hormones|mesh-ancestor
92220320|NCT04744623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220321|NCT04744623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220322|NCT04744623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220323|NCT04744623|Antiemetics|antiemetics|mesh-ancestor
92220324|NCT04744623|Autonomic Agents|autonomic agents|mesh-ancestor
92220325|NCT04744623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220326|NCT04744623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220327|NCT04744623|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92220328|NCT04744623|Protective Agents|protective agents|mesh-ancestor
92220329|NCT04744623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92220330|NCT04744623|Immunologic Factors|immunologic factors|mesh-ancestor
92220331|NCT04744623|Antimalarials|antimalarials|mesh-ancestor
92220332|NCT04744623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92220333|NCT04744623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92220334|NCT04744623|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92220335|NCT04744623|Leprostatic Agents|leprostatic agents|mesh-ancestor
92220337|NCT00939731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220338|NCT00939731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92220339|NCT00939731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220340|NCT00939731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220341|NCT00633945|Lenalidomide|lenalidomide|mesh-list
92220342|NCT00633945|Immunologic Factors|immunologic factors|mesh-ancestor
92220343|NCT00633945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220344|NCT00633945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92220345|NCT00633945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92220346|NCT00633945|Growth Substances|growth substances|mesh-ancestor
92220347|NCT00633945|Growth Inhibitors|growth inhibitors|mesh-ancestor
92220348|NCT00633945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220349|NCT03609047|Paclitaxel|paclitaxel|mesh-list
92220350|NCT03609047|Docetaxel|docetaxel|mesh-list
92220351|NCT03609047|Cyclophosphamide|cyclophosphamide|mesh-list
92220352|NCT03609047|Doxorubicin|doxorubicin|mesh-list
92220353|NCT03609047|Epirubicin|epirubicin|mesh-list
92220354|NCT03609047|Palbociclib|palbociclib|mesh-list
92220355|NCT03609047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92220356|NCT03609047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220357|NCT03609047|Tubulin Modulators|tubulin modulators|mesh-ancestor
92220358|NCT03609047|Antimitotic Agents|antimitotic agents|mesh-ancestor
92220359|NCT03609047|Mitosis Modulators|mitosis modulators|mesh-ancestor
92220360|NCT03609047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220362|NCT03609047|Immunologic Factors|immunologic factors|mesh-ancestor
92220363|NCT03609047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220364|NCT03609047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220365|NCT03609047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220366|NCT03609047|Alkylating Agents|alkylating agents|mesh-ancestor
92220367|NCT03609047|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92220368|NCT03609047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92220369|NCT03609047|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92220370|NCT03609047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92220371|NCT03609047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220372|NCT03609047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92220374|NCT01118845|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92220375|NCT01118845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220376|NCT01118845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220377|NCT01118845|Immunologic Factors|immunologic factors|mesh-ancestor
92220378|NCT01118845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220379|NCT01118845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220380|NCT01118845|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220381|NCT01118845|Alkylating Agents|alkylating agents|mesh-ancestor
92220382|NCT01118845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220383|NCT01130077|Poly ICLC|poly iclc|mesh-list
92220384|NCT01130077|Interferon Inducers|interferon inducers|mesh-ancestor
92220385|NCT01130077|Immunologic Factors|immunologic factors|mesh-ancestor
92220386|NCT01130077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220387|NCT03162731|Nivolumab|nivolumab|mesh-list
92220388|NCT03162731|Ipilimumab|ipilimumab|mesh-list
92220389|NCT03162731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220390|NCT03162731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220391|NCT03162731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92220392|NCT03162731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220393|NCT03030911|Fentanyl|fentanyl|mesh-list
92220394|NCT03030911|Midazolam|midazolam|mesh-list
92220395|NCT03030911|Dexmedetomidine|dexmedetomidine|mesh-list
92220396|NCT03030911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92220397|NCT03030911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220398|NCT03030911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220399|NCT03030911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220400|NCT03030911|Analgesics|analgesics|mesh-ancestor
92220401|NCT03030911|Sensory System Agents|sensory system agents|mesh-ancestor
92220402|NCT03030911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220403|NCT03030911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92220404|NCT03030911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92220406|NCT03030911|Adrenergic Agents|adrenergic agents|mesh-ancestor
92220407|NCT03030911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220408|NCT03030911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220409|NCT03030911|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220410|NCT03030911|Narcotics|narcotics|mesh-ancestor
92220411|NCT03030911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92220412|NCT03030911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92220413|NCT03030911|Anesthetics, General|anesthetics, general|mesh-ancestor
92220414|NCT03030911|Anesthetics|anesthetics|mesh-ancestor
92220415|NCT03030911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92220416|NCT03030911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92220417|NCT03030911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92220418|NCT03030911|GABA Modulators|gaba modulators|mesh-ancestor
92220419|NCT03030911|GABA Agents|gaba agents|mesh-ancestor
92220420|NCT01120405|Sevoflurane|sevoflurane|mesh-list
92220421|NCT01120405|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92220422|NCT01120405|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92220423|NCT01120405|Anesthetics, General|anesthetics, general|mesh-ancestor
92220424|NCT01120405|Anesthetics|anesthetics|mesh-ancestor
92220425|NCT01120405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220426|NCT01120405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220427|NCT03013387|Octreotide|octreotide|mesh-list
92220428|NCT03013387|Edotreotide|edotreotide|mesh-list
92337584|NCT03792191|Narcotics|narcotics|mesh-ancestor
92220429|NCT03013387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220430|NCT03013387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220431|NCT03013387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220432|NCT03013387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92220433|NCT03013387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220435|NCT01782989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92220436|NCT01782989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220437|NCT01782989|Antimalarials|antimalarials|mesh-ancestor
92220438|NCT01782989|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92220439|NCT01782989|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92220440|NCT01120639|Temozolomide|temozolomide|mesh-list
92220441|NCT01120639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220442|NCT01120639|Alkylating Agents|alkylating agents|mesh-ancestor
92220443|NCT01120639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220444|NCT01120639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220445|NCT01095757|Plerixafor|plerixafor|mesh-list
92220446|NCT01095757|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92220447|NCT01095757|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92220448|NCT01095757|Antiviral Agents|antiviral agents|mesh-ancestor
92220449|NCT01095757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220450|NCT03549598|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92220451|NCT03549598|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92220452|NCT03549598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220453|NCT02245451|Ritonavir|ritonavir|mesh-list
92220454|NCT02245451|Tipranavir|tipranavir|mesh-list
92220455|NCT02245451|Methadone|methadone|mesh-list
92220456|NCT02245451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92220457|NCT02245451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92220458|NCT02245451|Protease Inhibitors|protease inhibitors|mesh-ancestor
92220459|NCT02245451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220460|NCT02245451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220461|NCT02245451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92220462|NCT02245451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92220463|NCT02245451|Antiviral Agents|antiviral agents|mesh-ancestor
92220464|NCT02245451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220465|NCT02245451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92220466|NCT02245451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92220467|NCT02245451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220468|NCT02245451|Narcotics|narcotics|mesh-ancestor
92220469|NCT02245451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220470|NCT02245451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220471|NCT02245451|Analgesics|analgesics|mesh-ancestor
92220472|NCT02245451|Sensory System Agents|sensory system agents|mesh-ancestor
92220473|NCT02245451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220474|NCT02245451|Antitussive Agents|antitussive agents|mesh-ancestor
92220475|NCT02245451|Respiratory System Agents|respiratory system agents|mesh-ancestor
92220476|NCT01096771|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92220477|NCT01096771|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92220478|NCT01096771|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92220479|NCT01096771|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92220480|NCT00951899|Metformin|metformin|mesh-list
92220481|NCT00951899|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92220482|NCT00951899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92220483|NCT00951899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220484|NCT00951899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92220485|NCT00951899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92220486|NCT00951899|Antimetabolites|antimetabolites|mesh-ancestor
92117285|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
92220487|NCT00951899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220488|NCT00951899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92220489|NCT01097395|Ribavirin|ribavirin|mesh-list
92220491|NCT01097395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220492|NCT01097395|Antiviral Agents|antiviral agents|mesh-ancestor
92220493|NCT01097395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220494|NCT00467987|Testosterone|testosterone|mesh-list
92220495|NCT00467987|Androgens|androgens|mesh-ancestor
92220496|NCT00467987|Hormones|hormones|mesh-ancestor
92220497|NCT00467987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220498|NCT00467987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220499|NCT00433589|Tamoxifen|tamoxifen|mesh-list
92220500|NCT00433589|Docetaxel|docetaxel|mesh-list
92220501|NCT00433589|Capecitabine|capecitabine|mesh-list
92220502|NCT00433589|Letrozole|letrozole|mesh-list
92220503|NCT00433589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220504|NCT00433589|Tubulin Modulators|tubulin modulators|mesh-ancestor
92220505|NCT00433589|Antimitotic Agents|antimitotic agents|mesh-ancestor
92220506|NCT00433589|Mitosis Modulators|mitosis modulators|mesh-ancestor
92220507|NCT00433589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220508|NCT00433589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220509|NCT00433589|Antimetabolites|antimetabolites|mesh-ancestor
92220510|NCT00433589|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92220511|NCT00433589|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92220512|NCT00433589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220513|NCT00433589|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92220514|NCT00433589|Hormone Antagonists|hormone antagonists|mesh-ancestor
92220515|NCT00433589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220516|NCT00433589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220517|NCT00433589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220518|NCT00433589|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92220519|NCT00433589|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92220520|NCT00433589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92220521|NCT03013075|Morphine|morphine|mesh-list
92220522|NCT03013075|Bupivacaine|bupivacaine|mesh-list
92220523|NCT03013075|Anesthetics|anesthetics|mesh-list
92220524|NCT03013075|Anesthetics, General|anesthetics, general|mesh-list
92220525|NCT03013075|Anesthetics, Local|anesthetics, local|mesh-ancestor
92220526|NCT03013075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220527|NCT03013075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220528|NCT03013075|Sensory System Agents|sensory system agents|mesh-ancestor
92220529|NCT03013075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220530|NCT03013075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220531|NCT03013075|Narcotics|narcotics|mesh-ancestor
92220532|NCT03013075|Analgesics|analgesics|mesh-ancestor
92220533|NCT03030677|Lidocaine|lidocaine|mesh-list
92220534|NCT03030677|Anesthetics, Local|anesthetics, local|mesh-ancestor
92220535|NCT03030677|Anesthetics|anesthetics|mesh-ancestor
92220536|NCT03030677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220537|NCT03030677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220538|NCT03030677|Sensory System Agents|sensory system agents|mesh-ancestor
92220539|NCT03030677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220540|NCT03030677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92220541|NCT03030677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92220542|NCT03030677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92220543|NCT03030677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92220544|NCT03030677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220545|NCT01122901|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92220546|NCT01122901|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92220547|NCT01122901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220548|NCT01122901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220549|NCT01097785|Simvastatin|simvastatin|mesh-list
92220550|NCT01097785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92220551|NCT01097785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92220552|NCT01097785|Antimetabolites|antimetabolites|mesh-ancestor
92220553|NCT01097785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220554|NCT01097785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92220555|NCT01097785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92220556|NCT01097785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220557|NCT03030287|Paclitaxel|paclitaxel|mesh-list
92220558|NCT03030287|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92220559|NCT03030287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92220560|NCT03030287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220561|NCT03030287|Tubulin Modulators|tubulin modulators|mesh-ancestor
92220562|NCT03030287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92220563|NCT03030287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92220564|NCT03030287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220565|NCT03030287|Immunologic Factors|immunologic factors|mesh-ancestor
92337598|NCT00983645|Tacrolimus|tacrolimus|mesh-list
92220566|NCT03030287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220568|NCT03035357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220569|NCT00940589|Melatonin|melatonin|mesh-list
92220570|NCT00940589|Antioxidants|antioxidants|mesh-ancestor
92220571|NCT00940589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220572|NCT00940589|Protective Agents|protective agents|mesh-ancestor
92220573|NCT00940589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220574|NCT00940589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220575|NCT02574078|Paclitaxel|paclitaxel|mesh-list
92220576|NCT02574078|Docetaxel|docetaxel|mesh-list
92220577|NCT02574078|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92220578|NCT02574078|Bevacizumab|bevacizumab|mesh-list
92220579|NCT02574078|Carboplatin|carboplatin|mesh-list
92220580|NCT02574078|Gemcitabine|gemcitabine|mesh-list
92220581|NCT02574078|Nivolumab|nivolumab|mesh-list
92220582|NCT02574078|Pemetrexed|pemetrexed|mesh-list
92220583|NCT02574078|Crizotinib|crizotinib|mesh-list
92220584|NCT02574078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92220585|NCT02574078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220586|NCT02574078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92220587|NCT02574078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92220588|NCT02574078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92220589|NCT02574078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220590|NCT02574078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220591|NCT02574078|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92220592|NCT02574078|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92220593|NCT02574078|Growth Substances|growth substances|mesh-ancestor
92220594|NCT02574078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220595|NCT02574078|Growth Inhibitors|growth inhibitors|mesh-ancestor
92220596|NCT02574078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220597|NCT02574078|Antimetabolites|antimetabolites|mesh-ancestor
92220598|NCT02574078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92220599|NCT02574078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220600|NCT02574078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92220601|NCT02574078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92220602|NCT02574078|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92220603|NCT03605914|Acetaminophen|acetaminophen|mesh-list
92220604|NCT03605914|Diclofenac|diclofenac|mesh-list
92220605|NCT03605914|Hydrocodone|hydrocodone|mesh-list
92220606|NCT03605914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220607|NCT03605914|Analgesics|analgesics|mesh-ancestor
92220608|NCT03605914|Sensory System Agents|sensory system agents|mesh-ancestor
92220609|NCT03605914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220610|NCT03605914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220611|NCT03605914|Antipyretics|antipyretics|mesh-ancestor
92220612|NCT03605914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92220613|NCT03605914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220614|NCT03605914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220615|NCT03605914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92220616|NCT03605914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220617|NCT03605914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220618|NCT03605914|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220619|NCT03605914|Narcotics|narcotics|mesh-ancestor
92220620|NCT03605914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220621|NCT03605914|Antitussive Agents|antitussive agents|mesh-ancestor
92220622|NCT03605914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92220623|NCT04353479|Decitabine|decitabine|mesh-list
92220624|NCT04353479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92220625|NCT04353479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220626|NCT04353479|Antimetabolites|antimetabolites|mesh-ancestor
92220627|NCT04353479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220628|NCT04353479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220629|NCT04353479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220630|NCT04353479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220631|NCT03608488|Vitamin D|vitamin d|mesh-list
92220632|NCT03608488|Vitamins|vitamins|mesh-ancestor
92220633|NCT03608488|Micronutrients|micronutrients|mesh-ancestor
92220634|NCT03608488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220635|NCT03608488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92220636|NCT03035045|Acetaminophen|acetaminophen|mesh-list
92220637|NCT03035045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220638|NCT03035045|Analgesics|analgesics|mesh-ancestor
92220639|NCT03035045|Sensory System Agents|sensory system agents|mesh-ancestor
92220640|NCT03035045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220641|NCT03035045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220642|NCT03035045|Antipyretics|antipyretics|mesh-ancestor
92220643|NCT03034733|Dexamethasone|dexamethasone|mesh-list
92220644|NCT03034733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220645|NCT03034733|Antiemetics|antiemetics|mesh-ancestor
92220646|NCT03034733|Autonomic Agents|autonomic agents|mesh-ancestor
92220647|NCT03034733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220648|NCT03034733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220649|NCT03034733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220650|NCT03034733|Glucocorticoids|glucocorticoids|mesh-ancestor
92220651|NCT03034733|Hormones|hormones|mesh-ancestor
92220652|NCT03034733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220653|NCT03034733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220654|NCT03034733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220655|NCT05512416|Letrozole|letrozole|mesh-list
92220656|NCT05512416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220657|NCT05512416|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92220658|NCT05512416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92220659|NCT05512416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220660|NCT05512416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220661|NCT05512416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92220662|NCT05512416|Hormone Antagonists|hormone antagonists|mesh-ancestor
92220663|NCT05512416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220664|NCT05512416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220665|NCT04290624|Listerine|listerine|mesh-list
92220666|NCT04290624|Fluorides|fluorides|mesh-list
92220667|NCT04290624|Sodium Fluoride|sodium fluoride|mesh-list
92220668|NCT04290624|Tin Fluorides|tin fluorides|mesh-list
92220669|NCT04290624|Cariostatic Agents|cariostatic agents|mesh-ancestor
92220670|NCT04290624|Protective Agents|protective agents|mesh-ancestor
92220671|NCT04290624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220672|NCT04290624|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92220673|NCT04290624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220674|NCT03403504|Oxycodone|oxycodone|mesh-list
92220675|NCT03403504|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220676|NCT03403504|Narcotics|narcotics|mesh-ancestor
92220677|NCT03403504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220678|NCT03403504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220679|NCT03403504|Analgesics|analgesics|mesh-ancestor
92220680|NCT03403504|Sensory System Agents|sensory system agents|mesh-ancestor
92220681|NCT03403504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220682|NCT05512728|Midazolam|midazolam|mesh-list
92220683|NCT05512728|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92220684|NCT05512728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92220685|NCT05512728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220686|NCT05512728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220687|NCT05512728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92220688|NCT05512728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92220689|NCT05512728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92220690|NCT05512728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92220691|NCT05512728|Anesthetics, General|anesthetics, general|mesh-ancestor
92220692|NCT05512728|Anesthetics|anesthetics|mesh-ancestor
92220693|NCT05512728|GABA Modulators|gaba modulators|mesh-ancestor
92220694|NCT05512728|GABA Agents|gaba agents|mesh-ancestor
92220695|NCT05512728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220696|NCT05512728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220697|NCT02565810|Adalimumab|adalimumab|mesh-list
92220698|NCT02565810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92220699|NCT02565810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220700|NCT02565810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220701|NCT00940901|Sildenafil Citrate|sildenafil citrate|mesh-list
92220702|NCT00940901|Vasodilator Agents|vasodilator agents|mesh-ancestor
92220703|NCT00940901|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92220704|NCT00940901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92220705|NCT00940901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220706|NCT00940901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220707|NCT00940901|Urological Agents|urological agents|mesh-ancestor
92220708|NCT04353713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92220709|NCT04353713|Laxatives|laxatives|mesh-ancestor
92220710|NCT04353713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220711|NCT04900038|Lamivudine|lamivudine|mesh-list
92220712|NCT04900038|Dolutegravir|dolutegravir|mesh-list
92220713|NCT04900038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92220714|NCT04900038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92220715|NCT04900038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220716|NCT04900038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220718|NCT04900038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220719|NCT04900038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92220720|NCT04900038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92220721|NCT04900038|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92220722|NCT04900038|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92220723|NCT03565666|Insulin|insulin|mesh-list
92220724|NCT03565666|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92220725|NCT03565666|Insulin Lispro|insulin lispro|mesh-list
92220726|NCT03565666|Insulin Aspart|insulin aspart|mesh-list
92220727|NCT03565666|Pancrelipase|pancrelipase|mesh-list
92220728|NCT03565666|Pancreatin|pancreatin|mesh-list
92220729|NCT03565666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92220730|NCT03565666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220731|NCT03565666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220732|NCT03620890|Protamines|protamines|mesh-list
92220733|NCT03620890|Heparin Antagonists|heparin antagonists|mesh-ancestor
92220734|NCT03620890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220735|NCT03620890|Coagulants|coagulants|mesh-ancestor
92220736|NCT05507112|Capecitabine|capecitabine|mesh-list
92220737|NCT05507112|Tislelizumab|tislelizumab|mesh-list
92220738|NCT05507112|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92220739|NCT05507112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220740|NCT05507112|Antimetabolites|antimetabolites|mesh-ancestor
92220741|NCT05507112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220742|NCT05507112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220743|NCT05507112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220744|NCT05511948|Hydroquinone|hydroquinone|mesh-list
92220745|NCT05511948|Antioxidants|antioxidants|mesh-ancestor
92220746|NCT05511948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220747|NCT05511948|Protective Agents|protective agents|mesh-ancestor
92220748|NCT05511948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220749|NCT05511948|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92220750|NCT00952133|Dexamethasone|dexamethasone|mesh-list
92220751|NCT00952133|Dexamethasone acetate|dexamethasone acetate|mesh-list
92220752|NCT00952133|Palonosetron|palonosetron|mesh-list
92220753|NCT00952133|BB 1101|bb 1101|mesh-list
92220754|NCT00952133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220755|NCT00952133|Antiemetics|antiemetics|mesh-ancestor
92220756|NCT00952133|Autonomic Agents|autonomic agents|mesh-ancestor
92220757|NCT00952133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220758|NCT00952133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220759|NCT00952133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92220760|NCT00952133|Glucocorticoids|glucocorticoids|mesh-ancestor
92220761|NCT00952133|Hormones|hormones|mesh-ancestor
92220762|NCT00952133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92220763|NCT00952133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92220764|NCT00952133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220765|NCT00952133|Protease Inhibitors|protease inhibitors|mesh-ancestor
92220766|NCT00952133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220767|NCT00952133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220768|NCT00952133|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92220769|NCT00952133|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92220770|NCT00952133|Serotonin Agents|serotonin agents|mesh-ancestor
92220771|NCT00952133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220772|NCT05042375|Pembrolizumab|pembrolizumab|mesh-list
92220773|NCT05042375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92220774|NCT05042375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220775|NCT05042375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92220776|NCT05042375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220777|NCT05506566|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92220778|NCT05506566|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92220779|NCT05506566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220780|NCT03023189|Tranexamic Acid|tranexamic acid|mesh-list
92220781|NCT03023189|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92220782|NCT03023189|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92220783|NCT03023189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220784|NCT03023189|Hemostatics|hemostatics|mesh-ancestor
92220785|NCT03023189|Coagulants|coagulants|mesh-ancestor
92220786|NCT02561832|Cyclophosphamide|cyclophosphamide|mesh-list
92220787|NCT02561832|Carboplatin|carboplatin|mesh-list
92220788|NCT02561832|Olaparib|olaparib|mesh-list
92220789|NCT02561832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92220790|NCT02561832|Immunologic Factors|immunologic factors|mesh-ancestor
92220791|NCT02561832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220792|NCT02561832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220793|NCT02561832|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92220794|NCT02561832|Alkylating Agents|alkylating agents|mesh-ancestor
92220795|NCT02561832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220796|NCT02561832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220797|NCT02561832|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92220798|NCT02561832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92220799|NCT02561832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220800|NCT02982161|Celecoxib|celecoxib|mesh-list
92220801|NCT02982161|Tramadol|tramadol|mesh-list
92220802|NCT02982161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92220803|NCT02982161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220804|NCT02982161|Analgesics|analgesics|mesh-ancestor
92220805|NCT02982161|Sensory System Agents|sensory system agents|mesh-ancestor
91934312|NCT02298985|Analgesics|analgesics|mesh-ancestor
92220806|NCT02982161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220807|NCT02982161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220808|NCT02982161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220809|NCT02982161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220810|NCT02982161|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92220811|NCT02982161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92220812|NCT02982161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220813|NCT02982161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220814|NCT02982161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220815|NCT02982161|Narcotics|narcotics|mesh-ancestor
92220816|NCT02982161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220818|NCT05506488|Quercetin|quercetin|mesh-list
92220819|NCT05506488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220820|NCT05506488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92220821|NCT05506488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220822|NCT05506488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220823|NCT05506488|Antioxidants|antioxidants|mesh-ancestor
92220824|NCT05506488|Protective Agents|protective agents|mesh-ancestor
92220825|NCT05506488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220826|NCT00942149|Daptomycin|daptomycin|mesh-list
92220827|NCT00942149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92220828|NCT00942149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220829|NCT03023111|Miltefosine|miltefosine|mesh-list
92220830|NCT03023111|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92220831|NCT03023111|Molgramostim|molgramostim|mesh-list
92220832|NCT03023111|Sargramostim|sargramostim|mesh-list
92220833|NCT03023111|Immunologic Factors|immunologic factors|mesh-ancestor
92220834|NCT03023111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220835|NCT03023111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220836|NCT03023111|Antifungal Agents|antifungal agents|mesh-ancestor
92220837|NCT03023111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220838|NCT03023111|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92220839|NCT03023111|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92220840|NCT03022253|Acetaminophen|acetaminophen|mesh-list
92220841|NCT03022253|Ibuprofen|ibuprofen|mesh-list
92220842|NCT03022253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92220843|NCT03022253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220844|NCT03022253|Analgesics|analgesics|mesh-ancestor
92220845|NCT03022253|Sensory System Agents|sensory system agents|mesh-ancestor
92220846|NCT03022253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220847|NCT03022253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220848|NCT03022253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220849|NCT03022253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220850|NCT03022253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92220851|NCT03022253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220852|NCT03022253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220853|NCT03022253|Antipyretics|antipyretics|mesh-ancestor
92220854|NCT01037881|Pimecrolimus|pimecrolimus|mesh-list
92220855|NCT01037881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92220856|NCT01037881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92220857|NCT01037881|Analgesics|analgesics|mesh-ancestor
92220858|NCT01037881|Sensory System Agents|sensory system agents|mesh-ancestor
92220859|NCT01037881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220860|NCT01037881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220861|NCT01037881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92220862|NCT01037881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92220863|NCT01037881|Dermatologic Agents|dermatologic agents|mesh-ancestor
92220864|NCT01037881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92220865|NCT01037881|Immunologic Factors|immunologic factors|mesh-ancestor
92220866|NCT01037881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92220867|NCT01037881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220868|NCT01037881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220870|NCT03017807|Immunologic Factors|immunologic factors|mesh-ancestor
92220871|NCT03017807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220872|NCT03017729|Botulinum Toxins|botulinum toxins|mesh-list
92220873|NCT03017729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92220874|NCT03017729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92220875|NCT03017729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92220876|NCT03017729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92220877|NCT03017729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220878|NCT03017729|Cholinergic Agents|cholinergic agents|mesh-ancestor
92220879|NCT03017729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220880|NCT03017729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220881|NCT03017729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92220882|NCT03017729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220884|NCT03017495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92220885|NCT03017495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92220886|NCT03017495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220887|NCT03017495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220888|NCT03017495|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92220889|NCT03017495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92220890|NCT03017495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92220891|NCT03017495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92220892|NCT03017495|Anesthetics, General|anesthetics, general|mesh-ancestor
92220893|NCT03017495|Anesthetics|anesthetics|mesh-ancestor
92220894|NCT03017495|GABA Modulators|gaba modulators|mesh-ancestor
92220895|NCT03017495|GABA Agents|gaba agents|mesh-ancestor
92220896|NCT03017495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220897|NCT03017495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220898|NCT01039207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92220899|NCT01039207|Rilotumumab|rilotumumab|mesh-list
92220900|NCT01039207|Antibodies|antibodies|mesh-list
92220901|NCT01039207|Immunoglobulins|immunoglobulins|mesh-list
92220902|NCT01039207|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92220903|NCT01039207|Immunologic Factors|immunologic factors|mesh-ancestor
92220904|NCT01039207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220905|NCT01039207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220906|NCT02981615|Levofloxacin|levofloxacin|mesh-list
92220907|NCT02981615|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92220908|NCT02981615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220909|NCT02981615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92220910|NCT02981615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92220911|NCT02981615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92220912|NCT02981615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220913|NCT02981615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220914|NCT02981615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220915|NCT02981615|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92220916|NCT02981615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92220917|NCT01125163|Iron|iron|mesh-list
92220918|NCT01125163|Trace Elements|trace elements|mesh-ancestor
92220919|NCT01125163|Micronutrients|micronutrients|mesh-ancestor
92220920|NCT01125163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220921|NCT03019991|Ritonavir|ritonavir|mesh-list
92220922|NCT03019991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92220923|NCT03019991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92220924|NCT03019991|Protease Inhibitors|protease inhibitors|mesh-ancestor
92220925|NCT03019991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92220926|NCT03019991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220927|NCT03019991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92220928|NCT03019991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92220929|NCT03019991|Antiviral Agents|antiviral agents|mesh-ancestor
92220930|NCT03019991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92220931|NCT03019991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92220932|NCT03019991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92220933|NCT05307835|Molgramostim|molgramostim|mesh-list
92220934|NCT05307835|Sargramostim|sargramostim|mesh-list
92220935|NCT05307835|Immunologic Factors|immunologic factors|mesh-ancestor
92220936|NCT05307835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220937|NCT05307835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220938|NCT00947297|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92220939|NCT00947297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92220940|NCT03019835|Neostigmine|neostigmine|mesh-list
92220941|NCT03019835|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92220942|NCT03019835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117362|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92220943|NCT03019835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220944|NCT03019835|Cholinergic Agents|cholinergic agents|mesh-ancestor
92220945|NCT03019835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220946|NCT03019835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220947|NCT03019835|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92220948|NCT03019835|Autonomic Agents|autonomic agents|mesh-ancestor
92220949|NCT03019835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220950|NCT00955877|Morphine|morphine|mesh-list
92220951|NCT00955877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92220952|NCT00955877|Narcotics|narcotics|mesh-ancestor
92220953|NCT00955877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220954|NCT00955877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220955|NCT00955877|Analgesics|analgesics|mesh-ancestor
92220956|NCT00955877|Sensory System Agents|sensory system agents|mesh-ancestor
92220957|NCT00955877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220959|NCT03960658|Analgesics|analgesics|mesh-ancestor
92220960|NCT03960658|Sensory System Agents|sensory system agents|mesh-ancestor
92220961|NCT03960658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220962|NCT03960658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220963|NCT03960658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92220964|NCT03960658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92220965|NCT03960658|Anesthetics, General|anesthetics, general|mesh-ancestor
92220966|NCT03960658|Anesthetics|anesthetics|mesh-ancestor
92220967|NCT03960658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92220968|NCT03960658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92220969|NCT03960658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92220970|NCT03960658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220971|NCT03960658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220972|NCT01005407|Vaccines|vaccines|mesh-list
92220973|NCT01005407|Immunologic Factors|immunologic factors|mesh-ancestor
92220974|NCT01005407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220975|NCT03633448|Phenylpropanolamine|phenylpropanolamine|mesh-list
92220976|NCT03633448|Guaifenesin|guaifenesin|mesh-list
92220977|NCT03633448|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92220978|NCT03633448|Expectorants|expectorants|mesh-ancestor
92220979|NCT03633448|Respiratory System Agents|respiratory system agents|mesh-ancestor
92220980|NCT03633448|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92220981|NCT03633448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92220982|NCT03633448|Adrenergic Agents|adrenergic agents|mesh-ancestor
92220983|NCT03633448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92220984|NCT03633448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92220985|NCT03633448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92220986|NCT03633448|Appetite Depressants|appetite depressants|mesh-ancestor
92220987|NCT03633448|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92220988|NCT03633448|Sympathomimetics|sympathomimetics|mesh-ancestor
92220989|NCT03633448|Autonomic Agents|autonomic agents|mesh-ancestor
92220990|NCT03633448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92220991|NCT03633448|Nasal Decongestants|nasal decongestants|mesh-ancestor
92220992|NCT03633448|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92220994|NCT05313958|Sorafenib|sorafenib|mesh-list
92220995|NCT05313958|Mitoxantrone|mitoxantrone|mesh-list
92220996|NCT05313958|Idarubicin|idarubicin|mesh-list
92220997|NCT05313958|Cladribine|cladribine|mesh-list
92220998|NCT05313958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92220999|NCT05313958|Antimetabolites|antimetabolites|mesh-ancestor
92221000|NCT05313958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221001|NCT05313958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221002|NCT05313958|Antiviral Agents|antiviral agents|mesh-ancestor
92221003|NCT05313958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221004|NCT05313958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221005|NCT05313958|Immunologic Factors|immunologic factors|mesh-ancestor
92221006|NCT05313958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221007|NCT05313958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92221008|NCT05313958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221009|NCT05313958|Analgesics|analgesics|mesh-ancestor
92221010|NCT05313958|Sensory System Agents|sensory system agents|mesh-ancestor
92221011|NCT05313958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221012|NCT05313958|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92221013|NCT05313958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92221014|NCT05313958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92221015|NCT01006655|Beclomethasone|beclomethasone|mesh-list
92221016|NCT01006655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221017|NCT01006655|Glucocorticoids|glucocorticoids|mesh-ancestor
92221019|NCT01006655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922376|NCT02205931|Clobazam|clobazam|mesh-list
92221020|NCT01006655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221021|NCT01006655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92221022|NCT01006655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92221023|NCT03633526|Ivacaftor|ivacaftor|mesh-list
92221025|NCT03633526|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92221026|NCT03633526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221027|NCT03633526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221028|NCT01007591|Hydrocortisone|hydrocortisone|mesh-list
92221029|NCT01007591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221030|NCT03019523|Caffeine|caffeine|mesh-list
92221031|NCT03019523|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92221032|NCT03019523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221033|NCT03019523|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92221034|NCT03019523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221035|NCT03019523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221036|NCT03019523|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92221037|NCT03019523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92221038|NCT03019523|Purinergic Agents|purinergic agents|mesh-ancestor
92221039|NCT03019523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221040|NCT01008059|Alfentanil|alfentanil|mesh-list
92221041|NCT01008059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92221042|NCT01008059|Narcotics|narcotics|mesh-ancestor
92221043|NCT01008059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221044|NCT01008059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221045|NCT01008059|Analgesics|analgesics|mesh-ancestor
92221046|NCT01008059|Sensory System Agents|sensory system agents|mesh-ancestor
92221047|NCT01008059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337650|NCT02075021|Paclitaxel|paclitaxel|mesh-list
92221048|NCT01008059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221049|NCT01008059|Anesthetics, General|anesthetics, general|mesh-ancestor
92221050|NCT01008059|Anesthetics|anesthetics|mesh-ancestor
92221051|NCT01009619|Azithromycin|azithromycin|mesh-list
92221052|NCT01009619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92221053|NCT01009619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221054|NCT01010009|Resveratrol|resveratrol|mesh-list
92221055|NCT01010009|Antioxidants|antioxidants|mesh-ancestor
92221056|NCT01010009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221057|NCT01010009|Protective Agents|protective agents|mesh-ancestor
92221058|NCT01010009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221059|NCT01010009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221060|NCT01010009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92221061|NCT04467424|Lidocaine|lidocaine|mesh-list
92221062|NCT04467424|Ketamine|ketamine|mesh-list
92221063|NCT04467424|Propofol|propofol|mesh-list
92221064|NCT04467424|Anesthetics, Local|anesthetics, local|mesh-ancestor
92221065|NCT04467424|Anesthetics|anesthetics|mesh-ancestor
92221066|NCT04467424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221067|NCT04467424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221068|NCT04467424|Sensory System Agents|sensory system agents|mesh-ancestor
92221069|NCT04467424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221070|NCT04467424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92221071|NCT04467424|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92221072|NCT04467424|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92221073|NCT04467424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221074|NCT04467424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221075|NCT04467424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92221076|NCT04467424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221077|NCT04467424|Anesthetics, General|anesthetics, general|mesh-ancestor
92221078|NCT04467424|Analgesics|analgesics|mesh-ancestor
92221079|NCT04467424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92221080|NCT04467424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92221081|NCT04467424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92221082|NCT04467424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221083|NCT03016715|Sirolimus|sirolimus|mesh-list
92221084|NCT03016715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92221085|NCT03016715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221086|NCT03016715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92221087|NCT03016715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221088|NCT03016715|Antifungal Agents|antifungal agents|mesh-ancestor
92221089|NCT03016715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221090|NCT03016715|Immunologic Factors|immunologic factors|mesh-ancestor
92221091|NCT03016715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221093|NCT00377104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221094|NCT00377104|Growth Inhibitors|growth inhibitors|mesh-ancestor
92081536|NCT01426347|Vitamin D|vitamin d|mesh-list
92221095|NCT00377104|Growth Substances|growth substances|mesh-ancestor
92221096|NCT00377104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221097|NCT00377104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92221098|NCT00377104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221099|NCT00377104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221100|NCT03016793|Puerarin|puerarin|mesh-list
92221101|NCT03016793|Vasodilator Agents|vasodilator agents|mesh-ancestor
92221102|NCT03928522|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92221103|NCT03928522|Vancomycin|vancomycin|mesh-list
92221104|NCT03928522|Tobramycin|tobramycin|mesh-list
92221105|NCT03928522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221106|NCT01010399|Ritonavir|ritonavir|mesh-list
92221107|NCT01010399|Fosamprenavir|fosamprenavir|mesh-list
92221108|NCT01010399|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92221109|NCT01010399|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92221110|NCT01010399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92221111|NCT01010399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221112|NCT01010399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221113|NCT01010399|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92221114|NCT01010399|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92221115|NCT01010399|Antiviral Agents|antiviral agents|mesh-ancestor
92221116|NCT01010399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221117|NCT01010399|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92221118|NCT01010399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92221119|NCT03638908|Fluoxetine|fluoxetine|mesh-list
92221120|NCT03638908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92221121|NCT03638908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92221122|NCT03638908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221123|NCT03638908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221124|NCT03638908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221125|NCT03638908|Serotonin Agents|serotonin agents|mesh-ancestor
92221126|NCT03638908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221127|NCT03638908|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92221128|NCT03638908|Antidepressive Agents|antidepressive agents|mesh-ancestor
92221129|NCT03638908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92221130|NCT03638908|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92221131|NCT03638908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92221132|NCT03638908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221133|NCT01041781|Celecoxib|celecoxib|mesh-list
92221134|NCT01041781|Carboplatin|carboplatin|mesh-list
92221135|NCT01041781|Gemcitabine|gemcitabine|mesh-list
92221136|NCT01041781|Pemetrexed|pemetrexed|mesh-list
92221137|NCT01041781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221138|NCT01041781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92221139|NCT01041781|Antimetabolites|antimetabolites|mesh-ancestor
92221140|NCT01041781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221141|NCT01041781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221142|NCT01041781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92221143|NCT01041781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92221144|NCT01041781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221145|NCT01041781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221146|NCT01041781|Analgesics|analgesics|mesh-ancestor
92221147|NCT01041781|Sensory System Agents|sensory system agents|mesh-ancestor
92221148|NCT01041781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221149|NCT01041781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221150|NCT01041781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221151|NCT01041781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221152|NCT01041781|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92221153|NCT01041781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92221154|NCT01010477|Nicotine|nicotine|mesh-list
92221155|NCT01010477|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92221156|NCT01010477|Autonomic Agents|autonomic agents|mesh-ancestor
92221157|NCT01010477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221158|NCT01010477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221159|NCT01010477|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92221160|NCT01010477|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92221161|NCT01010477|Cholinergic Agents|cholinergic agents|mesh-ancestor
92221162|NCT01010477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221163|NCT01010477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221164|NCT03921190|Anesthetics|anesthetics|mesh-list
92221165|NCT03921190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221166|NCT03921190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221167|NCT00953849|Calcitriol|calcitriol|mesh-list
92221168|NCT00953849|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92221169|NCT00953849|Vitamin D|vitamin d|mesh-list
92221170|NCT00953849|Celecoxib|celecoxib|mesh-list
92221171|NCT00953849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221172|NCT00953849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221173|NCT00953849|Analgesics|analgesics|mesh-ancestor
92221174|NCT00953849|Sensory System Agents|sensory system agents|mesh-ancestor
92221175|NCT00953849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221176|NCT00953849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221177|NCT00953849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221178|NCT00953849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221179|NCT00953849|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92221180|NCT00953849|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92221181|NCT00953849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221182|NCT00953849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221183|NCT00953849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92221184|NCT00953849|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92221185|NCT00953849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221186|NCT00953849|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92221187|NCT00953849|Vitamins|vitamins|mesh-ancestor
92221188|NCT00953849|Micronutrients|micronutrients|mesh-ancestor
92221189|NCT00953849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92221191|NCT04425850|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92221192|NCT04425850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221193|NCT03639766|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92221194|NCT03639766|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92221195|NCT03639766|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92221196|NCT03639766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221197|NCT03639766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221198|NCT03639766|Cholinergic Agents|cholinergic agents|mesh-ancestor
92221199|NCT03639766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221200|NCT03639766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221201|NCT03639766|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92221202|NCT03639766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221203|NCT01042795|Sunitinib|sunitinib|mesh-list
92221204|NCT01042795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221205|NCT01042795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92221206|NCT01042795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92221207|NCT01042795|Growth Substances|growth substances|mesh-ancestor
92221208|NCT01042795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221209|NCT01042795|Growth Inhibitors|growth inhibitors|mesh-ancestor
92221210|NCT01042795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92221211|NCT01042795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221212|NCT01042795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221213|NCT03644212|Vitamin D|vitamin d|mesh-list
92221214|NCT03644212|Cholecalciferol|cholecalciferol|mesh-list
92221215|NCT03644212|Vitamins|vitamins|mesh-list
92221216|NCT03644212|Micronutrients|micronutrients|mesh-ancestor
92221217|NCT03644212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221218|NCT03644212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92221219|NCT03644212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92221220|NCT03906448|Temozolomide|temozolomide|mesh-list
92221221|NCT03906448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92221222|NCT03906448|Alkylating Agents|alkylating agents|mesh-ancestor
92221223|NCT03906448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221224|NCT03906448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221225|NCT01011413|Efavirenz|efavirenz|mesh-list
92221226|NCT01011413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92221227|NCT01011413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92221228|NCT01011413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221229|NCT01011413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221230|NCT01011413|Antiviral Agents|antiviral agents|mesh-ancestor
92221231|NCT01011413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221232|NCT01011413|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92221233|NCT01011413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92221234|NCT01011413|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92221235|NCT01011413|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92221236|NCT01011413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92221237|NCT01011413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92221238|NCT03889444|Dexamethasone|dexamethasone|mesh-list
92221239|NCT03889444|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221240|NCT03889444|Antiemetics|antiemetics|mesh-ancestor
92221241|NCT03889444|Autonomic Agents|autonomic agents|mesh-ancestor
92221242|NCT03889444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221243|NCT03889444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221244|NCT03889444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221245|NCT03889444|Glucocorticoids|glucocorticoids|mesh-ancestor
92221246|NCT03889444|Hormones|hormones|mesh-ancestor
92221247|NCT03889444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221248|NCT03889444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92221249|NCT03889444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221250|NCT01104025|Dexamethasone|dexamethasone|mesh-list
92221251|NCT01104025|Hydrocortisone|hydrocortisone|mesh-list
92221253|NCT01104025|Etoposide|etoposide|mesh-list
92221254|NCT01104025|Thymoglobulin|thymoglobulin|mesh-list
92221255|NCT01104025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221256|NCT01104025|Antiemetics|antiemetics|mesh-ancestor
92221257|NCT01104025|Autonomic Agents|autonomic agents|mesh-ancestor
92221258|NCT01104025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337664|NCT02057237|Mitotane|mitotane|mesh-list
92221259|NCT01104025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221261|NCT01104025|Glucocorticoids|glucocorticoids|mesh-ancestor
92221262|NCT01104025|Hormones|hormones|mesh-ancestor
92221263|NCT01104025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221264|NCT01104025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92221265|NCT01104025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221266|NCT01104025|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92221267|NCT01104025|Abortifacient Agents|abortifacient agents|mesh-ancestor
92221268|NCT01104025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92221269|NCT01104025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92221270|NCT01104025|Antimetabolites|antimetabolites|mesh-ancestor
92221271|NCT01104025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221272|NCT01104025|Dermatologic Agents|dermatologic agents|mesh-ancestor
92221273|NCT01104025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221274|NCT01104025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92221275|NCT01104025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221276|NCT01104025|Immunologic Factors|immunologic factors|mesh-ancestor
92221277|NCT01104025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221278|NCT01104025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92221279|NCT01104025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92221280|NCT01104025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92221281|NCT01104025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92221282|NCT03649750|Guaifenesin|guaifenesin|mesh-list
92221283|NCT03649750|Expectorants|expectorants|mesh-ancestor
92221284|NCT03649750|Respiratory System Agents|respiratory system agents|mesh-ancestor
92221285|NCT04343092|Ivermectin|ivermectin|mesh-list
92221286|NCT04343092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92221287|NCT04343092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221288|NCT01105117|Epoprostenol|epoprostenol|mesh-list
92221289|NCT01105117|Tezosentan|tezosentan|mesh-list
92221290|NCT01105117|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92221291|NCT01105117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92221292|NCT01105117|Vasodilator Agents|vasodilator agents|mesh-ancestor
92221293|NCT03885154|Dihydroergotamine|dihydroergotamine|mesh-list
92221294|NCT03885154|Valproic Acid|valproic acid|mesh-list
92221295|NCT03885154|Anticonvulsants|anticonvulsants|mesh-ancestor
92221296|NCT03885154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221297|NCT03885154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221298|NCT03885154|GABA Agents|gaba agents|mesh-ancestor
92221299|NCT03885154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221300|NCT03885154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221301|NCT03885154|Antimanic Agents|antimanic agents|mesh-ancestor
92221302|NCT03885154|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92221303|NCT03885154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221304|NCT03885154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92221305|NCT03885154|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92221306|NCT03885154|Dopamine Agonists|dopamine agonists|mesh-ancestor
92221307|NCT03885154|Dopamine Agents|dopamine agents|mesh-ancestor
92221308|NCT03885154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221309|NCT03885154|Analgesics|analgesics|mesh-ancestor
92221310|NCT03885154|Sensory System Agents|sensory system agents|mesh-ancestor
92221311|NCT03885154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221312|NCT01106833|Sirolimus|sirolimus|mesh-list
92221313|NCT01106833|Prednisone|prednisone|mesh-list
92221314|NCT01106833|Temsirolimus|temsirolimus|mesh-list
92221315|NCT01106833|MTOR Inhibitors|mtor inhibitors|mesh-list
92221316|NCT01106833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92221317|NCT01106833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221318|NCT01106833|Glucocorticoids|glucocorticoids|mesh-ancestor
92221319|NCT01106833|Hormones|hormones|mesh-ancestor
92221320|NCT01106833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221321|NCT01106833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221322|NCT01106833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92221323|NCT01106833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221324|NCT01106833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92221325|NCT01106833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221326|NCT01106833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92221328|NCT01106833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221329|NCT01106833|Immunologic Factors|immunologic factors|mesh-ancestor
92221330|NCT01106833|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92221331|NCT01106833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221332|NCT01106833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221333|NCT00957047|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92221334|NCT00957047|Anticonvulsants|anticonvulsants|mesh-ancestor
92221335|NCT00957047|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92221336|NCT00957047|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92221337|NCT00957047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221338|NCT00957047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221340|NCT00957359|Psilocybin|psilocybin|mesh-list
92221341|NCT00957359|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92221342|NCT00957359|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92221343|NCT00957359|Antimetabolites|antimetabolites|mesh-ancestor
92221344|NCT00957359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221345|NCT00957359|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92221346|NCT00957359|Vasodilator Agents|vasodilator agents|mesh-ancestor
92221347|NCT00957359|Vitamin B Complex|vitamin b complex|mesh-ancestor
92221348|NCT00957359|Vitamins|vitamins|mesh-ancestor
92221349|NCT00957359|Micronutrients|micronutrients|mesh-ancestor
92221350|NCT00957359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221351|NCT00957359|Hallucinogens|hallucinogens|mesh-ancestor
92221352|NCT00957359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92221353|NCT00957359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92221354|NCT00957359|Serotonin Agents|serotonin agents|mesh-ancestor
92221355|NCT00957359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221356|NCT00957359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92221357|NCT00957593|Oxytocin|oxytocin|mesh-list
92221358|NCT00957593|Oxytocics|oxytocics|mesh-ancestor
92221359|NCT00957593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92221360|NCT00957593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221361|NCT00957671|Hormones|hormones|mesh-list
92221362|NCT00957671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221363|NCT00957671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221364|NCT04322968|Ketorolac|ketorolac|mesh-list
92221365|NCT04322968|Ketamine|ketamine|mesh-list
92221366|NCT04322968|Analgesics|analgesics|mesh-ancestor
92221367|NCT04322968|Sensory System Agents|sensory system agents|mesh-ancestor
92221368|NCT04322968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221369|NCT04322968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221370|NCT04322968|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92221371|NCT04322968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221372|NCT04322968|Anesthetics, General|anesthetics, general|mesh-ancestor
92221373|NCT04322968|Anesthetics|anesthetics|mesh-ancestor
92221374|NCT04322968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221375|NCT04322968|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92221376|NCT04322968|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92221377|NCT04322968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221378|NCT04322968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221379|NCT04322968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221380|NCT04322968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221381|NCT04322968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221382|NCT04322968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221383|NCT04322968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92221384|NCT04322968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221385|NCT03018899|Anesthetics|anesthetics|mesh-list
92221386|NCT03018899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221387|NCT03018899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221388|NCT00958919|Naloxone|naloxone|mesh-list
92221389|NCT00958919|Endorphins|endorphins|mesh-list
92221390|NCT00958919|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92221391|NCT00958919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221392|NCT00958919|Sensory System Agents|sensory system agents|mesh-ancestor
92221393|NCT00958919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221394|NCT00958919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221395|NCT00958919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221396|NCT04323592|Methylprednisolone|methylprednisolone|mesh-list
92221397|NCT04323592|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92221398|NCT04323592|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92221400|NCT04323592|Prednisolone acetate|prednisolone acetate|mesh-list
92221401|NCT04323592|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92221402|NCT04323592|Prednisolone phosphate|prednisolone phosphate|mesh-list
92221403|NCT04323592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221404|NCT04323592|Antiemetics|antiemetics|mesh-ancestor
92221405|NCT04323592|Autonomic Agents|autonomic agents|mesh-ancestor
92221406|NCT04323592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221407|NCT04323592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221408|NCT04323592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221409|NCT04323592|Glucocorticoids|glucocorticoids|mesh-ancestor
92221410|NCT04323592|Hormones|hormones|mesh-ancestor
92221411|NCT04323592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221412|NCT04323592|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92221413|NCT04323592|Protective Agents|protective agents|mesh-ancestor
92221414|NCT04323592|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92221415|NCT04323592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221416|NCT01047241|Sufentanil|sufentanil|mesh-list
92221417|NCT01047241|Ketamine|ketamine|mesh-list
92221418|NCT01047241|Analgesics|analgesics|mesh-ancestor
92221419|NCT01047241|Sensory System Agents|sensory system agents|mesh-ancestor
92221420|NCT01047241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221421|NCT01047241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221422|NCT01047241|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92221423|NCT01047241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221424|NCT01047241|Anesthetics, General|anesthetics, general|mesh-ancestor
92221425|NCT01047241|Anesthetics|anesthetics|mesh-ancestor
92221426|NCT01047241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221427|NCT01047241|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92221428|NCT01047241|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92221429|NCT01047241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221430|NCT01047241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221431|NCT01047241|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92221432|NCT01047241|Narcotics|narcotics|mesh-ancestor
92221433|NCT01047241|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92221434|NCT01012661|Lidocaine|lidocaine|mesh-list
92221435|NCT01012661|Anesthetics, Local|anesthetics, local|mesh-ancestor
92221436|NCT01012661|Anesthetics|anesthetics|mesh-ancestor
92221437|NCT01012661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221438|NCT01012661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221439|NCT01012661|Sensory System Agents|sensory system agents|mesh-ancestor
92221440|NCT01012661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221441|NCT01012661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92221442|NCT01012661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92221443|NCT01012661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92221444|NCT01012661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221445|NCT01012661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221446|NCT03655444|Nivolumab|nivolumab|mesh-list
92221447|NCT03655444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92221448|NCT03655444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221449|NCT03655444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92221450|NCT03655444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221451|NCT03018977|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92221452|NCT03018977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221453|NCT03018977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221454|NCT03018821|Tenofovir|tenofovir|mesh-list
92221455|NCT03018821|Entecavir|entecavir|mesh-list
92221456|NCT03018821|Antiviral Agents|antiviral agents|mesh-ancestor
92221457|NCT03018821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221458|NCT03018821|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92221459|NCT03018821|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92221460|NCT03018821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221461|NCT03018821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221462|NCT03018821|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92221463|NCT03018821|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92221465|NCT03866434|Omeprazole|omeprazole|mesh-list
92221466|NCT03866434|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92221467|NCT03866434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221468|NCT03866434|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92221469|NCT03866434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117363|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92221470|NCT03866434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221471|NCT03866434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92221472|NCT03866434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92221473|NCT03866434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92221474|NCT00962039|Citalopram|citalopram|mesh-list
92221475|NCT00962039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92221476|NCT00962039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92221477|NCT00962039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221478|NCT00962039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221479|NCT00962039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221480|NCT00962039|Serotonin Agents|serotonin agents|mesh-ancestor
92221481|NCT00962039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221482|NCT00962039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92221483|NCT00962039|Antidepressive Agents|antidepressive agents|mesh-ancestor
92221484|NCT00962039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92221485|NCT03375385|Dexmedetomidine|dexmedetomidine|mesh-list
92221486|NCT03375385|Propofol|propofol|mesh-list
92221487|NCT03375385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92221488|NCT03375385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221489|NCT03375385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221490|NCT03375385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221491|NCT03375385|Analgesics|analgesics|mesh-ancestor
92221492|NCT03375385|Sensory System Agents|sensory system agents|mesh-ancestor
92221493|NCT03375385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221494|NCT03375385|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92221495|NCT03375385|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92221496|NCT03375385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92221497|NCT03375385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92221498|NCT03375385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221499|NCT03375385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221500|NCT03375385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221501|NCT03375385|Anesthetics, General|anesthetics, general|mesh-ancestor
92221502|NCT03375385|Anesthetics|anesthetics|mesh-ancestor
92221503|NCT03018665|Metformin|metformin|mesh-list
92221504|NCT03018665|Exenatide|exenatide|mesh-list
92221505|NCT03018665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92221506|NCT03018665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221507|NCT03018665|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92221508|NCT03018665|Incretins|incretins|mesh-ancestor
92221509|NCT03018665|Hormones|hormones|mesh-ancestor
92221510|NCT03018665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221511|NCT03012763|Acetaminophen|acetaminophen|mesh-list
92221512|NCT03012763|Fexofenadine|fexofenadine|mesh-list
92221513|NCT03012763|Sulfasalazine|sulfasalazine|mesh-list
92221514|NCT03012763|Valsartan|valsartan|mesh-list
92221515|NCT03012763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221516|NCT03012763|Analgesics|analgesics|mesh-ancestor
92221517|NCT03012763|Sensory System Agents|sensory system agents|mesh-ancestor
92221518|NCT03012763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221519|NCT03012763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221520|NCT03012763|Antipyretics|antipyretics|mesh-ancestor
92221521|NCT03012763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92221522|NCT03012763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92221523|NCT03012763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92221524|NCT03012763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221525|NCT03012763|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92221526|NCT03012763|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92221527|NCT03012763|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92221528|NCT03012763|Histamine Antagonists|histamine antagonists|mesh-ancestor
92221529|NCT03012763|Histamine Agents|histamine agents|mesh-ancestor
92221530|NCT03012763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221531|NCT03012763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221532|NCT03012763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221533|NCT03012763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221534|NCT03012763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221535|NCT03012763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221536|NCT03012607|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92221537|NCT03012607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92221538|NCT03012607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92221539|NCT03012607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221540|NCT03012607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221542|NCT03012607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221543|NCT03012607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92221544|NCT03012607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92221545|NCT01048879|Oseltamivir|oseltamivir|mesh-list
92221547|NCT01048879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92221548|NCT01048879|Antiviral Agents|antiviral agents|mesh-ancestor
92221549|NCT01048879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221550|NCT01048879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221551|NCT01048879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221552|NCT04290676|Dexamethasone|dexamethasone|mesh-list
92221553|NCT04290676|Dexamethasone acetate|dexamethasone acetate|mesh-list
92221554|NCT04290676|BB 1101|bb 1101|mesh-list
92221555|NCT04290676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221556|NCT04290676|Antiemetics|antiemetics|mesh-ancestor
92221557|NCT04290676|Autonomic Agents|autonomic agents|mesh-ancestor
92221558|NCT04290676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221559|NCT04290676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221560|NCT04290676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221561|NCT04290676|Glucocorticoids|glucocorticoids|mesh-ancestor
92221562|NCT04290676|Hormones|hormones|mesh-ancestor
92221563|NCT04290676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221564|NCT04290676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92221565|NCT04290676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221566|NCT04290676|Protease Inhibitors|protease inhibitors|mesh-ancestor
92221567|NCT04290676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221568|NCT04290676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221569|NCT03112993|Neostigmine|neostigmine|mesh-list
92221570|NCT03112993|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92221571|NCT03112993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221572|NCT03112993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221573|NCT03112993|Cholinergic Agents|cholinergic agents|mesh-ancestor
92221574|NCT03112993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221575|NCT03112993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221576|NCT03112993|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92221577|NCT03112993|Autonomic Agents|autonomic agents|mesh-ancestor
92221578|NCT03112993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221579|NCT03670030|Sirolimus|sirolimus|mesh-list
92221580|NCT03670030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92221581|NCT03670030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221582|NCT03670030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92221583|NCT03670030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221584|NCT03670030|Antifungal Agents|antifungal agents|mesh-ancestor
92221585|NCT03670030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221586|NCT03670030|Immunologic Factors|immunologic factors|mesh-ancestor
92221587|NCT03670030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221588|NCT03859960|Insulin|insulin|mesh-list
92221589|NCT03859960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92221590|NCT03859960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92221591|NCT03859960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221592|NCT03857230|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92221593|NCT03857230|Hormones|hormones|mesh-ancestor
92221594|NCT03857230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221595|NCT03857230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221596|NCT02181127|Glucagon|glucagon|mesh-list
92221597|NCT02181127|Pancrelipase|pancrelipase|mesh-list
92221598|NCT02181127|Pancreatin|pancreatin|mesh-list
92221599|NCT02181127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221600|NCT02181127|Hormones|hormones|mesh-ancestor
92221601|NCT02181127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221602|NCT02181127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221603|NCT04332094|Azithromycin|azithromycin|mesh-list
92221604|NCT04332094|Hydroxychloroquine|hydroxychloroquine|mesh-list
92221605|NCT04332094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92221606|NCT04332094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221607|NCT04332094|Antimalarials|antimalarials|mesh-ancestor
92221608|NCT04332094|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92221609|NCT04332094|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92221610|NCT04332094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221611|NCT04332094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221612|NCT04332094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221614|NCT05314270|Trace Elements|trace elements|mesh-ancestor
92221615|NCT05314270|Micronutrients|micronutrients|mesh-ancestor
92221616|NCT05314270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221617|NCT01167829|Testosterone|testosterone|mesh-list
92221618|NCT01167829|Acyline|acyline|mesh-list
92221619|NCT01167829|Androgens|androgens|mesh-ancestor
92221620|NCT01167829|Hormones|hormones|mesh-ancestor
92221621|NCT01167829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221622|NCT01167829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221624|NCT02066623|Everolimus|everolimus|mesh-list
92221625|NCT02066623|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92221626|NCT02066623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92221627|NCT02066623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221628|NCT02066623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221629|NCT02066623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221630|NCT02066623|Immunologic Factors|immunologic factors|mesh-ancestor
92221631|NCT02066623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221632|NCT02066623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221633|NCT04974151|Folic Acid|folic acid|mesh-list
92221634|NCT04974151|Amlodipine|amlodipine|mesh-list
92221635|NCT04974151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92221636|NCT04974151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92221637|NCT04974151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221638|NCT04974151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221639|NCT04974151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92221640|NCT04974151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221641|NCT04974151|Vasodilator Agents|vasodilator agents|mesh-ancestor
92221642|NCT04974151|Hematinics|hematinics|mesh-ancestor
92221643|NCT04974151|Vitamin B Complex|vitamin b complex|mesh-ancestor
92221644|NCT04974151|Vitamins|vitamins|mesh-ancestor
92221645|NCT04974151|Micronutrients|micronutrients|mesh-ancestor
92221646|NCT01924819|Leucovorin|leucovorin|mesh-list
92221647|NCT01924819|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92221648|NCT01924819|Cisplatin|cisplatin|mesh-list
92221649|NCT01924819|Docetaxel|docetaxel|mesh-list
92221650|NCT01924819|Fluorouracil|fluorouracil|mesh-list
92221651|NCT01924819|Capecitabine|capecitabine|mesh-list
92221652|NCT01924819|Oxaliplatin|oxaliplatin|mesh-list
92221653|NCT01924819|Epirubicin|epirubicin|mesh-list
92221654|NCT01924819|Levoleucovorin|levoleucovorin|mesh-list
92221655|NCT01924819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221656|NCT01924819|Tubulin Modulators|tubulin modulators|mesh-ancestor
92221657|NCT01924819|Antimitotic Agents|antimitotic agents|mesh-ancestor
92221658|NCT01924819|Mitosis Modulators|mitosis modulators|mesh-ancestor
92221659|NCT01924819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221660|NCT01924819|Antimetabolites|antimetabolites|mesh-ancestor
92221661|NCT01924819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92221662|NCT01924819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221663|NCT01924819|Immunologic Factors|immunologic factors|mesh-ancestor
92221664|NCT01924819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221665|NCT01924819|Antidotes|antidotes|mesh-ancestor
92221666|NCT01924819|Protective Agents|protective agents|mesh-ancestor
92221667|NCT01924819|Vitamin B Complex|vitamin b complex|mesh-ancestor
92221668|NCT01924819|Vitamins|vitamins|mesh-ancestor
92221669|NCT01924819|Micronutrients|micronutrients|mesh-ancestor
92221670|NCT01924819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92221671|NCT01924819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92221672|NCT01924819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92221673|NCT01924819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221674|NCT01168687|Levetiracetam|levetiracetam|mesh-list
92221675|NCT01168687|Anticonvulsants|anticonvulsants|mesh-ancestor
92221676|NCT01168687|Nootropic Agents|nootropic agents|mesh-ancestor
92221677|NCT03685396|Hemostatics|hemostatics|mesh-list
92221678|NCT03685396|Coagulants|coagulants|mesh-ancestor
92221679|NCT01126255|Clobetasol|clobetasol|mesh-list
92221680|NCT01126255|Progesterone|progesterone|mesh-list
92221681|NCT01126255|Progestins|progestins|mesh-ancestor
92221682|NCT01126255|Hormones|hormones|mesh-ancestor
92221683|NCT01126255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221684|NCT01126255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221686|NCT01126255|Glucocorticoids|glucocorticoids|mesh-ancestor
92221687|NCT04198948|Gliclazide|gliclazide|mesh-list
92221688|NCT04198948|Omeprazole|omeprazole|mesh-list
92221689|NCT04198948|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92221690|NCT04198948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221691|NCT04198948|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92221692|NCT04198948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221693|NCT04198948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221694|NCT04198948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92221695|NCT04198948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221696|NCT01169467|Dexmedetomidine|dexmedetomidine|mesh-list
92221697|NCT01169467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92221698|NCT01169467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221700|NCT01169467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221701|NCT01169467|Analgesics|analgesics|mesh-ancestor
92221702|NCT01169467|Sensory System Agents|sensory system agents|mesh-ancestor
92221703|NCT01169467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922377|NCT02205931|Ethosuximide|ethosuximide|mesh-list
92221704|NCT01169467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92221705|NCT01169467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92221706|NCT01169467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92221707|NCT01169467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92221708|NCT01169467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221709|NCT01169467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221711|NCT04822363|Clopidogrel|clopidogrel|mesh-list
92221712|NCT04822363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221713|NCT04822363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221714|NCT04822363|Analgesics|analgesics|mesh-ancestor
92221715|NCT04822363|Sensory System Agents|sensory system agents|mesh-ancestor
92221716|NCT04822363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221717|NCT04822363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221718|NCT04822363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221719|NCT04822363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221720|NCT04822363|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92221721|NCT04822363|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92221722|NCT04822363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221723|NCT04822363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92221724|NCT04822363|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92221725|NCT04822363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221726|NCT04822363|Antipyretics|antipyretics|mesh-ancestor
92221727|NCT04822363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92221728|NCT04822363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92221729|NCT04822363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92221730|NCT04822363|Purinergic Agents|purinergic agents|mesh-ancestor
92221731|NCT04822363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221732|NCT01170247|Ketamine|ketamine|mesh-list
92221733|NCT01170247|Analgesics|analgesics|mesh-ancestor
92221734|NCT01170247|Sensory System Agents|sensory system agents|mesh-ancestor
92221735|NCT01170247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221736|NCT01170247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221737|NCT01170247|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92221738|NCT01170247|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221739|NCT01170247|Anesthetics, General|anesthetics, general|mesh-ancestor
92221740|NCT01170247|Anesthetics|anesthetics|mesh-ancestor
92221741|NCT01170247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221742|NCT01170247|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92221743|NCT01170247|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92221744|NCT01170247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221745|NCT01170247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221746|NCT01126099|Prazosin|prazosin|mesh-list
92221747|NCT01126099|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92221748|NCT01126099|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92221749|NCT01126099|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92221750|NCT01126099|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92221751|NCT01126099|Adrenergic Agents|adrenergic agents|mesh-ancestor
92221752|NCT01126099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221753|NCT01126099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221754|NCT01126099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221755|NCT01170715|Etanercept|etanercept|mesh-list
92221756|NCT01170715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221757|NCT01170715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221758|NCT01170715|Analgesics|analgesics|mesh-ancestor
92221759|NCT01170715|Sensory System Agents|sensory system agents|mesh-ancestor
92221760|NCT01170715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221761|NCT01170715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221762|NCT01170715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221763|NCT01170715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934321|NCT02298985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92221765|NCT01170715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221766|NCT01170715|Immunologic Factors|immunologic factors|mesh-ancestor
92221767|NCT03809182|Fentanyl|fentanyl|mesh-list
92221768|NCT03809182|Dexmedetomidine|dexmedetomidine|mesh-list
92221769|NCT03809182|Morphine|morphine|mesh-list
92221770|NCT03809182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92221771|NCT03809182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221772|NCT03809182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221773|NCT03809182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221774|NCT03809182|Analgesics|analgesics|mesh-ancestor
92221775|NCT03809182|Sensory System Agents|sensory system agents|mesh-ancestor
92221776|NCT03809182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221777|NCT03809182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92221778|NCT03809182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92221779|NCT03809182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92221780|NCT03809182|Adrenergic Agents|adrenergic agents|mesh-ancestor
92221781|NCT03809182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221782|NCT03809182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221783|NCT03809182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92221784|NCT03809182|Narcotics|narcotics|mesh-ancestor
92221785|NCT03809182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92221786|NCT03809182|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221787|NCT03809182|Anesthetics, General|anesthetics, general|mesh-ancestor
92221788|NCT03809182|Anesthetics|anesthetics|mesh-ancestor
92221789|NCT01170949|Miltefosine|miltefosine|mesh-list
92221790|NCT01170949|Antifungal Agents|antifungal agents|mesh-ancestor
92221791|NCT01170949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221792|NCT01170949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221793|NCT01170949|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92221794|NCT01170949|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92221795|NCT03805672|Enoxaparin|enoxaparin|mesh-list
92221796|NCT03805672|Enoxaparin sodium|enoxaparin sodium|mesh-list
92221797|NCT03805672|Anticoagulants|anticoagulants|mesh-ancestor
92221798|NCT03805672|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92221799|NCT03805672|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92221800|NCT03805672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221801|NCT03802864|Bupivacaine|bupivacaine|mesh-list
92221802|NCT03802864|Anesthetics, Local|anesthetics, local|mesh-ancestor
92221803|NCT03802864|Anesthetics|anesthetics|mesh-ancestor
92221804|NCT03802864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221805|NCT03802864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221806|NCT03802864|Sensory System Agents|sensory system agents|mesh-ancestor
92221807|NCT03802864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221808|NCT03797872|Sulfasalazine|sulfasalazine|mesh-list
92221809|NCT03797872|Methylprednisolone|methylprednisolone|mesh-list
92337714|NCT01978535|Iron|iron|mesh-list
92221810|NCT03797872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92221811|NCT03797872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92221813|NCT03797872|Prednisolone acetate|prednisolone acetate|mesh-list
92221814|NCT03797872|Triamcinolone|triamcinolone|mesh-list
92221815|NCT03797872|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92221816|NCT03797872|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92221817|NCT03797872|Methotrexate|methotrexate|mesh-list
92221818|NCT03797872|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92221819|NCT03797872|Leflunomide|leflunomide|mesh-list
92221820|NCT03797872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92221821|NCT03797872|Prednisolone phosphate|prednisolone phosphate|mesh-list
92221822|NCT03797872|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92221823|NCT03797872|Abortifacient Agents|abortifacient agents|mesh-ancestor
92221824|NCT03797872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92221825|NCT03797872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221826|NCT03797872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92221827|NCT03797872|Antimetabolites|antimetabolites|mesh-ancestor
92221828|NCT03797872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221829|NCT03797872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221830|NCT03797872|Dermatologic Agents|dermatologic agents|mesh-ancestor
92221831|NCT03797872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221832|NCT03797872|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92221833|NCT03797872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221834|NCT03797872|Immunologic Factors|immunologic factors|mesh-ancestor
92221835|NCT03797872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221836|NCT03797872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92221837|NCT03797872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92221838|NCT03797872|Antiemetics|antiemetics|mesh-ancestor
92221839|NCT03797872|Autonomic Agents|autonomic agents|mesh-ancestor
92221840|NCT03797872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221841|NCT03797872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221843|NCT03797872|Hormones|hormones|mesh-ancestor
92221844|NCT03797872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92221845|NCT03797872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92221846|NCT03797872|Protective Agents|protective agents|mesh-ancestor
92221847|NCT03797872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92221848|NCT03797872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221849|NCT03797872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92221850|NCT03797872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221851|NCT03797872|Analgesics|analgesics|mesh-ancestor
92221852|NCT03797872|Sensory System Agents|sensory system agents|mesh-ancestor
92221853|NCT01127581|Dinoprostone|dinoprostone|mesh-list
92221854|NCT01127581|Oxytocics|oxytocics|mesh-ancestor
92221855|NCT01127581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92221856|NCT01127581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221857|NCT00377728|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
92221858|NCT00377728|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92221859|NCT00377728|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92221860|NCT00377728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221861|NCT00377728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221862|NCT04498351|Magnesium Sulfate|magnesium sulfate|mesh-list
92221863|NCT04498351|Dexmedetomidine|dexmedetomidine|mesh-list
92221864|NCT04498351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92221865|NCT04498351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221866|NCT04498351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221867|NCT04498351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92221868|NCT04498351|Analgesics|analgesics|mesh-ancestor
92221869|NCT04498351|Sensory System Agents|sensory system agents|mesh-ancestor
92221870|NCT04498351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221871|NCT04498351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92221872|NCT04498351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92221873|NCT04498351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92221874|NCT04498351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92221875|NCT04498351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221876|NCT04498351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221877|NCT04498351|Anesthetics|anesthetics|mesh-ancestor
92337727|NCT00379067|Tamsulosin|tamsulosin|mesh-list
92221878|NCT04498351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92221879|NCT04498351|Anticonvulsants|anticonvulsants|mesh-ancestor
92221880|NCT04498351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92221881|NCT04498351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221882|NCT04498351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92221883|NCT04498351|Tocolytic Agents|tocolytic agents|mesh-ancestor
92221884|NCT04498351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92221885|NCT02186665|Calcitriol|calcitriol|mesh-list
92221886|NCT02186665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92221887|NCT02186665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221888|NCT02186665|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92221889|NCT02186665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221890|NCT02186665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221891|NCT02186665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92221892|NCT02186665|Vitamins|vitamins|mesh-ancestor
92221893|NCT02186665|Micronutrients|micronutrients|mesh-ancestor
92221894|NCT02186665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92221895|NCT01172197|Ropivacaine|ropivacaine|mesh-list
92221896|NCT01172197|Levobupivacaine|levobupivacaine|mesh-list
92221897|NCT01172197|Anesthetics, Local|anesthetics, local|mesh-ancestor
92221898|NCT01172197|Anesthetics|anesthetics|mesh-ancestor
92221899|NCT01172197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221900|NCT01172197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221901|NCT01172197|Sensory System Agents|sensory system agents|mesh-ancestor
92221902|NCT01172197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92221903|NCT04141930|Baloxavir|baloxavir|mesh-list
92221904|NCT04141930|Antiviral Agents|antiviral agents|mesh-ancestor
92221905|NCT04141930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92221906|NCT04141930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92221907|NCT04141930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221908|NCT04138498|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92221909|NCT04138498|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92221910|NCT04138498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221911|NCT04138498|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92221912|NCT04138498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92221913|NCT04138498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221914|NCT04138498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221915|NCT04138498|Dopamine Agents|dopamine agents|mesh-ancestor
92221916|NCT04138498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221917|NCT03746002|Metolazone|metolazone|mesh-list
92221918|NCT03746002|Furosemide|furosemide|mesh-list
92221919|NCT03746002|Diuretics|diuretics|mesh-ancestor
92221920|NCT03746002|Natriuretic Agents|natriuretic agents|mesh-ancestor
92221921|NCT03746002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221922|NCT03746002|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92221923|NCT03746002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221924|NCT03746002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221925|NCT03746002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92221926|NCT03746002|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92221927|NCT04089982|Varenicline|varenicline|mesh-list
92221928|NCT04089982|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92221929|NCT04089982|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92221930|NCT04089982|Cholinergic Agents|cholinergic agents|mesh-ancestor
92221931|NCT04089982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92221932|NCT04089982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221933|NCT04089982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221934|NCT03783130|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92221935|NCT03783130|Aluminum sulfate|aluminum sulfate|mesh-list
92221936|NCT03783130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92221937|NCT03783130|Immunologic Factors|immunologic factors|mesh-ancestor
92221938|NCT03783130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221939|NCT03783130|Antacids|antacids|mesh-ancestor
92221940|NCT03783130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221941|NCT03783130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92221942|NCT00984542|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92221943|NCT00984542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92221944|NCT00984542|Alkylating Agents|alkylating agents|mesh-ancestor
92221945|NCT00984542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221946|NCT00984542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221947|NCT00983918|Propofol|propofol|mesh-list
92221948|NCT00983918|Sevoflurane|sevoflurane|mesh-list
92221949|NCT00983918|Desflurane|desflurane|mesh-list
92221950|NCT00983918|Isoflurane|isoflurane|mesh-list
92221951|NCT00983918|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92221952|NCT00983918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92221953|NCT00983918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221954|NCT00983918|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92221955|NCT00983918|Anesthetics, General|anesthetics, general|mesh-ancestor
92221956|NCT00983918|Anesthetics|anesthetics|mesh-ancestor
92221957|NCT00983918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92221958|NCT00983918|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92221959|NCT01926236|Leucovorin|leucovorin|mesh-list
92221960|NCT01926236|Folic Acid|folic acid|mesh-list
92221961|NCT01926236|Fluorouracil|fluorouracil|mesh-list
92221962|NCT01926236|Oxaliplatin|oxaliplatin|mesh-list
92221963|NCT01926236|Levoleucovorin|levoleucovorin|mesh-list
92221964|NCT01926236|Antimetabolites|antimetabolites|mesh-ancestor
92221965|NCT01926236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221966|NCT01926236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92221967|NCT01926236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221968|NCT01926236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92221969|NCT01926236|Immunologic Factors|immunologic factors|mesh-ancestor
92221970|NCT01926236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221971|NCT01926236|Antidotes|antidotes|mesh-ancestor
92221972|NCT01926236|Protective Agents|protective agents|mesh-ancestor
92221973|NCT01926236|Vitamin B Complex|vitamin b complex|mesh-ancestor
92221974|NCT01926236|Vitamins|vitamins|mesh-ancestor
92221975|NCT01926236|Micronutrients|micronutrients|mesh-ancestor
92221976|NCT01926236|Hematinics|hematinics|mesh-ancestor
92221977|NCT00983528|Alemtuzumab|alemtuzumab|mesh-list
92221978|NCT00983528|Clofarabine|clofarabine|mesh-list
92221979|NCT00983528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92221980|NCT00983528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221981|NCT00983528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92221982|NCT00983528|Antimetabolites|antimetabolites|mesh-ancestor
92221983|NCT00983528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221984|NCT00983372|Colchicine|colchicine|mesh-list
92221985|NCT00983372|Diltiazem|diltiazem|mesh-list
92221986|NCT00983372|Gout Suppressants|gout suppressants|mesh-ancestor
92221987|NCT00983372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92221988|NCT00983372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92221990|NCT00983372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92221991|NCT00983372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92221992|NCT00983372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92221993|NCT00983372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92221994|NCT00983372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92221995|NCT00983372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92221996|NCT00983372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92221997|NCT00983372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92221998|NCT00983372|Vasodilator Agents|vasodilator agents|mesh-ancestor
92221999|NCT01173211|Vaccines|vaccines|mesh-list
92222000|NCT01173211|Immunologic Factors|immunologic factors|mesh-ancestor
92222001|NCT01173211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222002|NCT00983294|Azithromycin|azithromycin|mesh-list
92222003|NCT00983294|Colchicine|colchicine|mesh-list
92222004|NCT00983294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222005|NCT00983294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222006|NCT00983294|Gout Suppressants|gout suppressants|mesh-ancestor
92222007|NCT00983294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222008|NCT00983294|Tubulin Modulators|tubulin modulators|mesh-ancestor
92222009|NCT00983294|Antimitotic Agents|antimitotic agents|mesh-ancestor
92222010|NCT00983294|Mitosis Modulators|mitosis modulators|mesh-ancestor
92222011|NCT00983294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222012|NCT00983294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222013|NCT01926392|Sulfadiazine|sulfadiazine|mesh-list
92222014|NCT01926392|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92222015|NCT01926392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222016|NCT01926392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222017|NCT01926392|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92222018|NCT01926392|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92222019|NCT01926392|Coccidiostats|coccidiostats|mesh-ancestor
92222020|NCT01926392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92222021|NCT05601830|Cytarabine|cytarabine|mesh-list
92222022|NCT05601830|Cyclophosphamide|cyclophosphamide|mesh-list
92222023|NCT05601830|Fludarabine|fludarabine|mesh-list
92222024|NCT05601830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222025|NCT05601830|Immunologic Factors|immunologic factors|mesh-ancestor
92222026|NCT05601830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222027|NCT05601830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222028|NCT05601830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92222029|NCT05601830|Alkylating Agents|alkylating agents|mesh-ancestor
92222030|NCT05601830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222031|NCT05601830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222032|NCT05601830|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92222033|NCT05601830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222034|NCT05601830|Antimetabolites|antimetabolites|mesh-ancestor
92222035|NCT05601830|Antiviral Agents|antiviral agents|mesh-ancestor
92222036|NCT05601830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222038|NCT00982280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92222039|NCT00982280|Narcotics|narcotics|mesh-ancestor
92222040|NCT00982280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222041|NCT00982280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222042|NCT00982280|Analgesics|analgesics|mesh-ancestor
92222043|NCT00982280|Sensory System Agents|sensory system agents|mesh-ancestor
92222044|NCT00982280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222045|NCT00982280|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92222046|NCT00982280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92222047|NCT00982280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92222048|NCT00982280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222049|NCT00982280|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222050|NCT00982280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222051|NCT01175395|Triamcinolone|triamcinolone|mesh-list
92222052|NCT01175395|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92222053|NCT01175395|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92222054|NCT01175395|Ranibizumab|ranibizumab|mesh-list
92222055|NCT01175395|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92222056|NCT01175395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222057|NCT01175395|Glucocorticoids|glucocorticoids|mesh-ancestor
92222058|NCT01175395|Hormones|hormones|mesh-ancestor
92222059|NCT01175395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222060|NCT01175395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222061|NCT01175395|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222062|NCT01175395|Immunologic Factors|immunologic factors|mesh-ancestor
92222063|NCT01175395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222064|NCT01175395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222065|NCT01175395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222066|NCT01175395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222067|NCT01175395|Growth Substances|growth substances|mesh-ancestor
92222068|NCT01175395|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222069|NCT01175395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222070|NCT03011905|Acetaminophen|acetaminophen|mesh-list
92222071|NCT03011905|Dexamethasone|dexamethasone|mesh-list
92222072|NCT03011905|Etoricoxib|etoricoxib|mesh-list
92222073|NCT03011905|Oxycodone|oxycodone|mesh-list
92222074|NCT03011905|Ropivacaine|ropivacaine|mesh-list
92222075|NCT03011905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222076|NCT03011905|Antiemetics|antiemetics|mesh-ancestor
92222077|NCT03011905|Autonomic Agents|autonomic agents|mesh-ancestor
92222078|NCT03011905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222079|NCT03011905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222080|NCT03011905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222081|NCT03011905|Glucocorticoids|glucocorticoids|mesh-ancestor
92222082|NCT03011905|Hormones|hormones|mesh-ancestor
92222083|NCT03011905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222084|NCT03011905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92222085|NCT03011905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222086|NCT03011905|Anesthetics, Local|anesthetics, local|mesh-ancestor
92222087|NCT03011905|Anesthetics|anesthetics|mesh-ancestor
92222088|NCT03011905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222089|NCT03011905|Sensory System Agents|sensory system agents|mesh-ancestor
92222090|NCT03011905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92222091|NCT03011905|Analgesics|analgesics|mesh-ancestor
92337742|NCT01938833|Paclitaxel|paclitaxel|mesh-list
92222093|NCT03011905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92222094|NCT03011905|Narcotics|narcotics|mesh-ancestor
92222095|NCT03011905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92222096|NCT03011905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222097|NCT03011905|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92222098|NCT03011905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92222099|NCT03011905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222100|NCT03011905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222101|NCT01926548|Imatinib Mesylate|imatinib mesylate|mesh-list
92222102|NCT01926548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222103|NCT01926548|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222104|NCT01926548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222105|NCT01926548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222106|NCT01176955|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92222107|NCT01176955|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222108|NCT00980798|Hydromorphone|hydromorphone|mesh-list
92222109|NCT00980798|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92222110|NCT00980798|Narcotics|narcotics|mesh-ancestor
92222111|NCT00980798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222112|NCT00980798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222113|NCT00980798|Analgesics|analgesics|mesh-ancestor
92222114|NCT00980798|Sensory System Agents|sensory system agents|mesh-ancestor
92222115|NCT00980798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222116|NCT01177189|Thioctic Acid|thioctic acid|mesh-list
92222117|NCT01177189|Vitamins|vitamins|mesh-ancestor
92222118|NCT01177189|Micronutrients|micronutrients|mesh-ancestor
92222119|NCT01177189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222120|NCT01177189|Antioxidants|antioxidants|mesh-ancestor
92222121|NCT01177189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222122|NCT01177189|Protective Agents|protective agents|mesh-ancestor
92222123|NCT01177189|Vitamin B Complex|vitamin b complex|mesh-ancestor
92222124|NCT01926860|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92222125|NCT01926860|Immunologic Factors|immunologic factors|mesh-ancestor
92222126|NCT01926860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222127|NCT01177735|Pomalidomide|pomalidomide|mesh-list
92222128|NCT01177735|Immunologic Factors|immunologic factors|mesh-ancestor
92222129|NCT01177735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222130|NCT01177735|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222131|NCT01177735|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222132|NCT01177735|Growth Substances|growth substances|mesh-ancestor
92222133|NCT01177735|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222134|NCT01177735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222135|NCT01135069|Tretinoin|tretinoin|mesh-list
92222136|NCT01135069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222137|NCT01135069|Keratolytic Agents|keratolytic agents|mesh-ancestor
92222138|NCT01135069|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222139|NCT01178281|Thalidomide|thalidomide|mesh-list
92222140|NCT01178281|Pomalidomide|pomalidomide|mesh-list
92222141|NCT01178281|Immunologic Factors|immunologic factors|mesh-ancestor
92222142|NCT01178281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222143|NCT01178281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222144|NCT01178281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222145|NCT01178281|Growth Substances|growth substances|mesh-ancestor
92222146|NCT01178281|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222147|NCT01178281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222148|NCT01178281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222149|NCT01178281|Leprostatic Agents|leprostatic agents|mesh-ancestor
92222150|NCT01178281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222151|NCT01178281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222152|NCT01178827|Mandelic Acids|mandelic acids|mesh-list
92222153|NCT01178827|Oxybutynin|oxybutynin|mesh-list
92222154|NCT01178827|Trospium chloride|trospium chloride|mesh-list
92222155|NCT01178827|Parasympatholytics|parasympatholytics|mesh-ancestor
92081538|NCT01426347|Vitamins|vitamins|mesh-ancestor
92222156|NCT01178827|Autonomic Agents|autonomic agents|mesh-ancestor
92222157|NCT01178827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222158|NCT01178827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222159|NCT01178827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92222160|NCT01178827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92222161|NCT01178827|Cholinergic Agents|cholinergic agents|mesh-ancestor
92222163|NCT01178827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222164|NCT01178827|Urological Agents|urological agents|mesh-ancestor
92222165|NCT01178827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92222166|NCT01178827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222167|NCT01135537|Thymoglobulin|thymoglobulin|mesh-list
92222168|NCT01135537|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92222169|NCT01135537|Immunologic Factors|immunologic factors|mesh-ancestor
92222170|NCT01135537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222171|NCT01135537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222172|NCT02181517|Ranibizumab|ranibizumab|mesh-list
92222173|NCT02181517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222174|NCT02181517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222175|NCT02181517|Growth Substances|growth substances|mesh-ancestor
92222176|NCT02181517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222177|NCT02181517|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222178|NCT02181517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222179|NCT03010267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92222180|NCT03010267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92222181|NCT03010267|Hormone Antagonists|hormone antagonists|mesh-ancestor
92222182|NCT03010267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222183|NCT03010267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222184|NCT03010267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92222185|NCT03010267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92222186|NCT03010267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92222187|NCT01181323|Vaccines|vaccines|mesh-list
92222188|NCT01181323|Immunologic Factors|immunologic factors|mesh-ancestor
92222189|NCT01181323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222190|NCT03872947|Leucovorin|leucovorin|mesh-list
92222191|NCT03872947|Bevacizumab|bevacizumab|mesh-list
92222192|NCT03872947|Carboplatin|carboplatin|mesh-list
92222193|NCT03872947|Gemcitabine|gemcitabine|mesh-list
92222194|NCT03872947|Pembrolizumab|pembrolizumab|mesh-list
92222195|NCT03872947|Nivolumab|nivolumab|mesh-list
92222196|NCT03872947|Irinotecan|irinotecan|mesh-list
92222197|NCT03872947|Topotecan|topotecan|mesh-list
92222198|NCT03872947|Imiquimod|imiquimod|mesh-list
92222199|NCT03872947|Ramucirumab|ramucirumab|mesh-list
92222200|NCT03872947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222201|NCT03872947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222202|NCT03872947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222203|NCT03872947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222204|NCT03872947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222205|NCT03872947|Growth Substances|growth substances|mesh-ancestor
92222206|NCT03872947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222207|NCT03872947|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222208|NCT03872947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222209|NCT03872947|Antimetabolites|antimetabolites|mesh-ancestor
92222210|NCT03872947|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92222211|NCT03872947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92222213|NCT03872947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222214|NCT03872947|Antidotes|antidotes|mesh-ancestor
92222215|NCT03872947|Protective Agents|protective agents|mesh-ancestor
92222216|NCT03872947|Vitamin B Complex|vitamin b complex|mesh-ancestor
92222217|NCT03872947|Vitamins|vitamins|mesh-ancestor
92222218|NCT03872947|Micronutrients|micronutrients|mesh-ancestor
92222219|NCT03872947|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92222220|NCT03872947|Immunologic Factors|immunologic factors|mesh-ancestor
92222221|NCT03872947|Interferon Inducers|interferon inducers|mesh-ancestor
92222222|NCT02246881|Factor VIII|factor viii|mesh-list
92222223|NCT02246881|Coagulants|coagulants|mesh-ancestor
92222224|NCT00980330|Ribavirin|ribavirin|mesh-list
92222225|NCT00980330|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92222226|NCT00980330|Interferon alpha-2|interferon alpha-2|mesh-list
92222227|NCT00980330|Simeprevir|simeprevir|mesh-list
92222228|NCT00980330|Antimetabolites|antimetabolites|mesh-ancestor
92222229|NCT00980330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222230|NCT00980330|Antiviral Agents|antiviral agents|mesh-ancestor
92222231|NCT00980330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222233|NCT00980330|Protease Inhibitors|protease inhibitors|mesh-ancestor
92222234|NCT00980330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222235|NCT01138735|Adapalene|adapalene|mesh-list
92222236|NCT01138735|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92222237|NCT01138735|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92222238|NCT01138735|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222239|NCT01138735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92222240|NCT01138735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92222241|NCT01138735|Analgesics|analgesics|mesh-ancestor
92222242|NCT01138735|Sensory System Agents|sensory system agents|mesh-ancestor
92222243|NCT01138735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222244|NCT01138735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222245|NCT01138735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222246|NCT01138735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222247|NCT00980174|Denosumab|denosumab|mesh-list
92222248|NCT00980174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92222249|NCT00980174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222250|NCT03064568|Misoprostol|misoprostol|mesh-list
92222251|NCT03064568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92222252|NCT03064568|Abortifacient Agents|abortifacient agents|mesh-ancestor
92222253|NCT03064568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92222254|NCT03064568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222255|NCT03064568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92222256|NCT03064568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222257|NCT03064568|Oxytocics|oxytocics|mesh-ancestor
92222258|NCT01138969|Esomeprazole|esomeprazole|mesh-list
92222259|NCT01138969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92222260|NCT01138969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222261|NCT01138969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92222262|NCT01138969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222263|NCT01138969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222264|NCT01139515|Eletriptan|eletriptan|mesh-list
92222265|NCT01139515|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92222266|NCT01139515|Serotonin Agents|serotonin agents|mesh-ancestor
92222267|NCT01139515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222268|NCT01139515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222269|NCT01139515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222270|NCT00987272|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92222271|NCT00987272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92222272|NCT00987272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92222273|NCT00987272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92222274|NCT00987272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92222275|NCT00987272|Analgesics|analgesics|mesh-ancestor
92222276|NCT00987272|Sensory System Agents|sensory system agents|mesh-ancestor
92222277|NCT00987272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222278|NCT00987272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222279|NCT00987272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222280|NCT00987272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222281|NCT00987272|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92222282|NCT00987272|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92222283|NCT00987272|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92222284|NCT00987272|Histamine Antagonists|histamine antagonists|mesh-ancestor
92222285|NCT00987272|Histamine Agents|histamine agents|mesh-ancestor
92222287|NCT00987272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222288|NCT03709459|Doxycycline|doxycycline|mesh-list
92222289|NCT03709459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222290|NCT03709459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222291|NCT03709459|Antimalarials|antimalarials|mesh-ancestor
92222292|NCT03709459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92222293|NCT03709459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92222294|NCT00986882|Ibuprofen|ibuprofen|mesh-list
92222295|NCT00986882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92222296|NCT00986882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92222297|NCT00986882|Analgesics|analgesics|mesh-ancestor
92222298|NCT00986882|Sensory System Agents|sensory system agents|mesh-ancestor
92222299|NCT00986882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337760|NCT01893359|Micronutrients|micronutrients|mesh-ancestor
92222300|NCT00986882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222301|NCT00986882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222302|NCT00986882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222303|NCT00986882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92222304|NCT00986882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222305|NCT00986882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222306|NCT00981656|Fluorouracil|fluorouracil|mesh-list
92222307|NCT00981656|Mitomycins|mitomycins|mesh-list
92222308|NCT00981656|Mitomycin|mitomycin|mesh-list
92222309|NCT00981656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222310|NCT00981656|Antimetabolites|antimetabolites|mesh-ancestor
92222311|NCT00981656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222312|NCT00981656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222313|NCT00981656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222314|NCT00981656|Immunologic Factors|immunologic factors|mesh-ancestor
92222315|NCT00981656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222316|NCT00981656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92222317|NCT00981656|Alkylating Agents|alkylating agents|mesh-ancestor
92222318|NCT00981656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92222319|NCT00981656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222320|NCT04395170|Immunoglobulins|immunoglobulins|mesh-list
92222321|NCT04395170|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92222322|NCT04395170|Antibodies|antibodies|mesh-list
92222323|NCT04395170|Immunologic Factors|immunologic factors|mesh-ancestor
92222324|NCT04395170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222325|NCT01927328|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92222326|NCT01927328|Hematinics|hematinics|mesh-ancestor
92222327|NCT04552808|Yimitasvir|yimitasvir|mesh-list
92222328|NCT04552808|Antiviral Agents|antiviral agents|mesh-ancestor
92222329|NCT04552808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222330|NCT01927406|Timolol|timolol|mesh-list
92222331|NCT01927406|Bimatoprost|bimatoprost|mesh-list
92222332|NCT01927406|Travoprost|travoprost|mesh-list
92222333|NCT01927406|Latanoprost|latanoprost|mesh-list
92222334|NCT01927406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222335|NCT01927406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92222336|NCT01927406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92222337|NCT01927406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222338|NCT01927406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222339|NCT01927406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222340|NCT01927406|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92222341|NCT01927406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92222342|NCT01927406|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92222343|NCT01927406|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92222344|NCT01182493|Insulin|insulin|mesh-list
92222345|NCT01182493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92222346|NCT01182493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222347|NCT01927484|Methotrexate|methotrexate|mesh-list
92222348|NCT01927484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92222349|NCT01927484|Abortifacient Agents|abortifacient agents|mesh-ancestor
92222350|NCT01927484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92222351|NCT01927484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222352|NCT01927484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222353|NCT01927484|Antimetabolites|antimetabolites|mesh-ancestor
92222354|NCT01927484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222355|NCT01927484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222356|NCT01927484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222357|NCT01927484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222358|NCT01927484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92222359|NCT01927484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222360|NCT01927484|Immunologic Factors|immunologic factors|mesh-ancestor
92222361|NCT01927484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222362|NCT01927484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92222363|NCT05607446|Montelukast|montelukast|mesh-list
92222364|NCT05607446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92222365|NCT05607446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92222366|NCT05607446|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92222367|NCT05607446|Hormone Antagonists|hormone antagonists|mesh-ancestor
92222368|NCT05607446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222369|NCT05607446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222370|NCT05607446|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92222371|NCT05607446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92222372|NCT05607446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222374|NCT02185339|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92222376|NCT02185339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92222377|NCT02185339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222378|NCT02185339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222379|NCT03831464|Metformin|metformin|mesh-list
92222380|NCT03831464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92222381|NCT03831464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222382|NCT01928498|Paclitaxel|paclitaxel|mesh-list
92222383|NCT01928498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92222384|NCT01928498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222385|NCT01928498|Tubulin Modulators|tubulin modulators|mesh-ancestor
92222386|NCT01928498|Antimitotic Agents|antimitotic agents|mesh-ancestor
92222387|NCT01928498|Mitosis Modulators|mitosis modulators|mesh-ancestor
92117364|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222388|NCT01928498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222389|NCT04558502|Amoxicillin|amoxicillin|mesh-list
92222390|NCT04558502|Clarithromycin|clarithromycin|mesh-list
92222391|NCT04558502|Minocycline|minocycline|mesh-list
92222392|NCT04558502|Esomeprazole|esomeprazole|mesh-list
92222393|NCT04558502|Bismuth|bismuth|mesh-list
92222394|NCT04558502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222395|NCT04558502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222396|NCT04558502|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92222397|NCT04558502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222398|NCT04558502|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92222399|NCT04558502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222400|NCT04558502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222401|NCT04558502|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92222402|NCT04558502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92222403|NCT04558502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92222404|NCT04558502|Antacids|antacids|mesh-ancestor
92222405|NCT01218997|Naltrexone|naltrexone|mesh-list
92222406|NCT01218997|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92222407|NCT01218997|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92222408|NCT01218997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222409|NCT01218997|Sensory System Agents|sensory system agents|mesh-ancestor
92222410|NCT01218997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222411|NCT01219777|Paclitaxel|paclitaxel|mesh-list
92222412|NCT01219777|Bevacizumab|bevacizumab|mesh-list
92222413|NCT01219777|Carboplatin|carboplatin|mesh-list
92222414|NCT01219777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92222415|NCT01219777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222416|NCT01219777|Tubulin Modulators|tubulin modulators|mesh-ancestor
92222417|NCT01219777|Antimitotic Agents|antimitotic agents|mesh-ancestor
92222418|NCT01219777|Mitosis Modulators|mitosis modulators|mesh-ancestor
92222419|NCT01219777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222420|NCT01219777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222421|NCT01219777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222422|NCT01219777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222423|NCT01219777|Growth Substances|growth substances|mesh-ancestor
92222424|NCT01219777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222425|NCT01219777|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222426|NCT05603156|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92222427|NCT05603156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222428|NCT05603156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222429|NCT05603156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92222430|NCT05603156|Immunotoxins|immunotoxins|mesh-ancestor
92222431|NCT05603156|Immunoconjugates|immunoconjugates|mesh-ancestor
92222432|NCT05603156|Immunologic Factors|immunologic factors|mesh-ancestor
92222433|NCT05603156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222435|NCT04759742|Anesthetics, Local|anesthetics, local|mesh-ancestor
92222436|NCT04759742|Anesthetics|anesthetics|mesh-ancestor
92222437|NCT04759742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222438|NCT04759742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222439|NCT04759742|Sensory System Agents|sensory system agents|mesh-ancestor
92222440|NCT04759742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222441|NCT01928888|Famotidine|famotidine|mesh-list
92222442|NCT01928888|Hydrotalcite|hydrotalcite|mesh-list
92222443|NCT01928888|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92222444|NCT01928888|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222445|NCT01928888|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92222446|NCT01928888|Histamine Antagonists|histamine antagonists|mesh-ancestor
92222448|NCT01928888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222449|NCT01928888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222450|NCT01928888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222451|NCT01928888|Antacids|antacids|mesh-ancestor
92222452|NCT04556084|Blinatumomab|blinatumomab|mesh-list
92222453|NCT04556084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222454|NCT04394234|Warfarin|warfarin|mesh-list
92222455|NCT04394234|Anticoagulants|anticoagulants|mesh-list
92222456|NCT02569710|Simeprevir|simeprevir|mesh-list
92222457|NCT02569710|Odalasvir|odalasvir|mesh-list
92222458|NCT02569710|Antiviral Agents|antiviral agents|mesh-ancestor
92222459|NCT02569710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222460|NCT02569710|Protease Inhibitors|protease inhibitors|mesh-ancestor
92222461|NCT02569710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222462|NCT02569710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222463|NCT04550624|Pembrolizumab|pembrolizumab|mesh-list
92222464|NCT04550624|Lenvatinib|lenvatinib|mesh-list
92222465|NCT04550624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222466|NCT04550624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222467|NCT04550624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92222468|NCT04550624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222469|NCT04550624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222470|NCT04550624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222471|NCT04550546|Nystatin|nystatin|mesh-list
92222472|NCT04550546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222473|NCT04550546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222474|NCT04550546|Antifungal Agents|antifungal agents|mesh-ancestor
92222475|NCT04550546|Ionophores|ionophores|mesh-ancestor
92222476|NCT04550546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92222477|NCT04550546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222478|NCT02984072|Menthol|menthol|mesh-list
92222479|NCT02984072|Antipruritics|antipruritics|mesh-ancestor
92222480|NCT02984072|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222481|NCT04589832|Entrectinib|entrectinib|mesh-list
92222482|NCT04589832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222483|NCT04589832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222484|NCT04589832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222485|NCT05506410|Cytarabine|cytarabine|mesh-list
92222486|NCT05506410|Prednisone|prednisone|mesh-list
92222487|NCT05506410|Rituximab|rituximab|mesh-list
92222488|NCT05506410|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92222489|NCT05506410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222490|NCT05506410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222491|NCT05506410|Immunologic Factors|immunologic factors|mesh-ancestor
92222492|NCT05506410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222493|NCT05506410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222494|NCT05506410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222495|NCT05506410|Glucocorticoids|glucocorticoids|mesh-ancestor
92222496|NCT05506410|Hormones|hormones|mesh-ancestor
92222497|NCT05506410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222498|NCT05506410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92222499|NCT05506410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222500|NCT05506410|Antimetabolites|antimetabolites|mesh-ancestor
92222501|NCT05506410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222502|NCT05506410|Antiviral Agents|antiviral agents|mesh-ancestor
92222503|NCT05506410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222504|NCT05506410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222505|NCT05506410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92222506|NCT05506410|Alkylating Agents|alkylating agents|mesh-ancestor
92222507|NCT05506332|Venetoclax|venetoclax|mesh-list
92222508|NCT05506332|Mercaptopurine|mercaptopurine|mesh-list
92222509|NCT05506332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222510|NCT05506332|Antimetabolites|antimetabolites|mesh-ancestor
92222511|NCT05506332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222512|NCT05506332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222513|NCT05506332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222514|NCT05506332|Immunologic Factors|immunologic factors|mesh-ancestor
92222515|NCT05506332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222516|NCT05506332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92222517|NCT05506332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222518|NCT01927874|Bupivacaine|bupivacaine|mesh-list
92222519|NCT01927874|Anesthetics, Local|anesthetics, local|mesh-ancestor
92222520|NCT01927874|Anesthetics|anesthetics|mesh-ancestor
92222521|NCT01927874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222522|NCT01927874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222523|NCT01927874|Sensory System Agents|sensory system agents|mesh-ancestor
92222524|NCT01927874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222525|NCT05604638|Tenecteplase|tenecteplase|mesh-list
92222527|NCT05604638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92222528|NCT05604638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92222529|NCT05604638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222530|NCT05604638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92222531|NCT03033758|Budesonide|budesonide|mesh-list
92222532|NCT03033758|Formoterol Fumarate|formoterol fumarate|mesh-list
92222533|NCT03033758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222534|NCT03033758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92222535|NCT03033758|Autonomic Agents|autonomic agents|mesh-ancestor
92222536|NCT03033758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222537|NCT03033758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222538|NCT03033758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92222539|NCT03033758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92222540|NCT03033758|Glucocorticoids|glucocorticoids|mesh-ancestor
92222541|NCT03033758|Hormones|hormones|mesh-ancestor
92117441|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92222542|NCT03033758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222543|NCT03033758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92222544|NCT03033758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92222545|NCT03033758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92222546|NCT03033758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222547|NCT03033758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222548|NCT03033758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222549|NCT01016483|Gemcitabine|gemcitabine|mesh-list
92222550|NCT01016483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222551|NCT01016483|Antimetabolites|antimetabolites|mesh-ancestor
92222552|NCT01016483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222553|NCT01016483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222554|NCT02569476|Obinutuzumab|obinutuzumab|mesh-list
92222555|NCT02569476|Zanubrutinib|zanubrutinib|mesh-list
92222556|NCT02569476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222557|NCT02569476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222558|NCT02569476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222559|NCT02569476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222560|NCT02569476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222561|NCT00955253|Guanfacine|guanfacine|mesh-list
92222562|NCT00955253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92222563|NCT00955253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92222564|NCT00955253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92222565|NCT00955253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92222566|NCT00955253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222567|NCT00955253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222568|NCT00955253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222569|NCT00955253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222570|NCT04394390|Vitamin D|vitamin d|mesh-list
92222571|NCT04394390|Ergocalciferols|ergocalciferols|mesh-list
92222572|NCT04394390|Cholecalciferol|cholecalciferol|mesh-list
92222573|NCT04394390|Vitamins|vitamins|mesh-list
92222574|NCT04394390|Micronutrients|micronutrients|mesh-ancestor
92222575|NCT04394390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222576|NCT04394390|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92222577|NCT04394390|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92222578|NCT04120454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92222579|NCT04120454|Pembrolizumab|pembrolizumab|mesh-list
92222580|NCT04120454|Ramucirumab|ramucirumab|mesh-list
92222581|NCT04120454|Antibodies|antibodies|mesh-list
92222582|NCT04120454|Immunoglobulins|immunoglobulins|mesh-list
92222583|NCT04120454|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92222584|NCT04120454|Lexatumumab|lexatumumab|mesh-list
92222585|NCT04120454|Immunologic Factors|immunologic factors|mesh-ancestor
92222586|NCT04120454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222587|NCT04120454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222588|NCT04120454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92222589|NCT04120454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222590|NCT01017653|Irinotecan|irinotecan|mesh-list
92222591|NCT01017653|Panitumumab|panitumumab|mesh-list
92222592|NCT01017653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92222593|NCT01017653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92222594|NCT01017653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222595|NCT01017653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222596|NCT01017653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222597|NCT01017653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222598|NCT00966641|Naproxen|naproxen|mesh-list
92222599|NCT00966641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92222600|NCT00966641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92222601|NCT00966641|Analgesics|analgesics|mesh-ancestor
92222602|NCT00966641|Sensory System Agents|sensory system agents|mesh-ancestor
92222603|NCT00966641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222604|NCT00966641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222605|NCT00966641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222606|NCT00966641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222607|NCT00966641|Gout Suppressants|gout suppressants|mesh-ancestor
92222608|NCT00966641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92222609|NCT00966641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222610|NCT00966641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222611|NCT00970073|Mycophenolic Acid|mycophenolic acid|mesh-list
92222612|NCT00970073|Tacrolimus|tacrolimus|mesh-list
92222613|NCT00970073|Thymoglobulin|thymoglobulin|mesh-list
92222614|NCT00970073|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92222615|NCT00970073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222616|NCT00970073|Immunologic Factors|immunologic factors|mesh-ancestor
92222617|NCT00970073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222618|NCT00970073|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92222619|NCT00970073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222620|NCT00970073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222621|NCT00970073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92222622|NCT00970073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222623|NCT00970073|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92222624|NCT00970073|Antitubercular Agents|antitubercular agents|mesh-ancestor
92222625|NCT00970073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222626|NCT00970073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222627|NCT00971633|Ondansetron|ondansetron|mesh-list
92222628|NCT00971633|Antiemetics|antiemetics|mesh-ancestor
92222629|NCT00971633|Autonomic Agents|autonomic agents|mesh-ancestor
92222630|NCT00971633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222631|NCT00971633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222632|NCT00971633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222633|NCT00971633|Antipruritics|antipruritics|mesh-ancestor
92222634|NCT00971633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222635|NCT00971633|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92222636|NCT00971633|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92222637|NCT00971633|Serotonin Agents|serotonin agents|mesh-ancestor
92222638|NCT00971633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222639|NCT00971633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222640|NCT05511246|Ethanol|ethanol|mesh-list
92222641|NCT05511246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92222642|NCT05511246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222643|NCT05511246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222644|NCT05511246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222645|NCT00971789|Sirolimus|sirolimus|mesh-list
92222646|NCT00971789|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92222647|NCT00971789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222648|NCT00971789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222649|NCT00971789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92222650|NCT00971789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222651|NCT00971789|Antifungal Agents|antifungal agents|mesh-ancestor
92222652|NCT00971789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222653|NCT00971789|Immunologic Factors|immunologic factors|mesh-ancestor
92222654|NCT00971789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222655|NCT00971789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222656|NCT00971789|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92222657|NCT05510778|Charcoal|charcoal|mesh-list
92222658|NCT05510778|Antidotes|antidotes|mesh-ancestor
92222659|NCT05510778|Protective Agents|protective agents|mesh-ancestor
92222660|NCT05510778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222661|NCT00972335|Bevacizumab|bevacizumab|mesh-list
92222662|NCT00972335|Everolimus|everolimus|mesh-list
92222663|NCT00972335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222664|NCT00972335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222665|NCT00972335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92222666|NCT00972335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92222667|NCT00972335|Growth Substances|growth substances|mesh-ancestor
92222668|NCT00972335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222669|NCT00972335|Growth Inhibitors|growth inhibitors|mesh-ancestor
92222670|NCT00972335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92222671|NCT00972335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222672|NCT00972335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222673|NCT00972335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222674|NCT00972335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222675|NCT00972335|Immunologic Factors|immunologic factors|mesh-ancestor
92222676|NCT02337530|Carboplatin|carboplatin|mesh-list
92222677|NCT02337530|Pemetrexed|pemetrexed|mesh-list
92222678|NCT02337530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222679|NCT02337530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222680|NCT02337530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222681|NCT02337530|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92222682|NCT02337530|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92222683|NCT03341156|Thrombin|thrombin|mesh-list
92222684|NCT03341156|Hemostatics|hemostatics|mesh-ancestor
92222685|NCT03341156|Coagulants|coagulants|mesh-ancestor
92222686|NCT04122560|Fluconazole|fluconazole|mesh-list
92222687|NCT04122560|Antifungal Agents|antifungal agents|mesh-ancestor
92222688|NCT04122560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222689|NCT04122560|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92117442|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
92222690|NCT04122560|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92222691|NCT04122560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222692|NCT04122560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222693|NCT04122560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92222694|NCT04122560|Hormone Antagonists|hormone antagonists|mesh-ancestor
92222695|NCT04122560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222696|NCT04122560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222697|NCT04122560|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92222698|NCT04122560|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92222699|NCT02569242|Paclitaxel|paclitaxel|mesh-list
92222700|NCT02569242|Docetaxel|docetaxel|mesh-list
92222701|NCT02569242|Nivolumab|nivolumab|mesh-list
92222702|NCT02569242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92222703|NCT02569242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222704|NCT02569242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92222705|NCT02569242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92222706|NCT02569242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92222707|NCT02569242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222708|NCT02569242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222709|NCT02569242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92222710|NCT04124588|Hemostatics|hemostatics|mesh-list
92222711|NCT04124588|Coagulants|coagulants|mesh-ancestor
92222712|NCT05501340|Molgramostim|molgramostim|mesh-list
92222713|NCT05501340|Sargramostim|sargramostim|mesh-list
92222714|NCT05501340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222715|NCT05501340|Immunologic Factors|immunologic factors|mesh-ancestor
92222716|NCT05501340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222717|NCT00972725|Chloroquine|chloroquine|mesh-list
92222718|NCT00972725|Amebicides|amebicides|mesh-ancestor
92222719|NCT00972725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92222720|NCT00972725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92222721|NCT00972725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222722|NCT00972725|Antimalarials|antimalarials|mesh-ancestor
92222723|NCT00972725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222724|NCT05600660|Rituximab|rituximab|mesh-list
92222725|NCT05600660|Methotrexate|methotrexate|mesh-list
92222726|NCT05600660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222727|NCT05600660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222728|NCT05600660|Immunologic Factors|immunologic factors|mesh-ancestor
92222729|NCT05600660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222730|NCT05600660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92222731|NCT05600660|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92222732|NCT05600660|Abortifacient Agents|abortifacient agents|mesh-ancestor
92222733|NCT05600660|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92222734|NCT05600660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222736|NCT05600660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222737|NCT05600660|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222738|NCT05600660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222739|NCT05600660|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92222740|NCT05600660|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92222741|NCT05600660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92222742|NCT00972959|Zoledronic Acid|zoledronic acid|mesh-list
92222743|NCT00972959|Dexamethasone|dexamethasone|mesh-list
92222745|NCT00972959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222746|NCT00972959|Antiemetics|antiemetics|mesh-ancestor
92222747|NCT00972959|Autonomic Agents|autonomic agents|mesh-ancestor
92222748|NCT00972959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222749|NCT00972959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222750|NCT00972959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222751|NCT00972959|Glucocorticoids|glucocorticoids|mesh-ancestor
92222752|NCT00972959|Hormones|hormones|mesh-ancestor
92222753|NCT00972959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222754|NCT00972959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92222755|NCT00972959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222756|NCT00972959|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92222757|NCT05609240|Cefuroxime|cefuroxime|mesh-list
92222758|NCT05609240|Cefuroxime axetil|cefuroxime axetil|mesh-list
92222759|NCT05609240|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222760|NCT05609240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222761|NCT00973739|Lapatinib|lapatinib|mesh-list
92222762|NCT00973739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222763|NCT00973739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222764|NCT00973739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222765|NCT00973739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222766|NCT00974051|Insulin|insulin|mesh-list
92222767|NCT00974051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92222768|NCT00974051|Terbutaline|terbutaline|mesh-list
92222769|NCT00974051|Adrenergic Agonists|adrenergic agonists|mesh-list
92222770|NCT00974051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92222771|NCT00974051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222772|NCT00974051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92222773|NCT00974051|Autonomic Agents|autonomic agents|mesh-ancestor
92222774|NCT00974051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222775|NCT00974051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92222776|NCT00974051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92222777|NCT00974051|Sympathomimetics|sympathomimetics|mesh-ancestor
92222778|NCT00974051|Tocolytic Agents|tocolytic agents|mesh-ancestor
92222779|NCT00974051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92222780|NCT00974051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92222781|NCT00974051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92222782|NCT00974051|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222783|NCT00974051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222784|NCT00974051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222785|NCT03017963|Sodium thiosulfate|sodium thiosulfate|mesh-list
92222786|NCT03017963|Antidotes|antidotes|mesh-ancestor
92222787|NCT03017963|Protective Agents|protective agents|mesh-ancestor
92222788|NCT03017963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222789|NCT03017963|Antioxidants|antioxidants|mesh-ancestor
92222790|NCT03017963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222791|NCT03017963|Antitubercular Agents|antitubercular agents|mesh-ancestor
92222792|NCT03017963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222793|NCT03017963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222794|NCT03017963|Chelating Agents|chelating agents|mesh-ancestor
92222795|NCT03017963|Sequestering Agents|sequestering agents|mesh-ancestor
92222796|NCT03018353|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92222797|NCT03018353|Antiviral Agents|antiviral agents|mesh-ancestor
92222798|NCT03018353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222799|NCT00977171|Droxidopa|droxidopa|mesh-list
92222800|NCT00977171|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92222801|NCT00977171|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92222802|NCT04129424|Insulin|insulin|mesh-list
92222803|NCT04129424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92222804|NCT04129424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222806|NCT00955487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92222807|NCT00955487|Autonomic Agents|autonomic agents|mesh-ancestor
92222808|NCT00955487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222809|NCT00955487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222810|NCT00955487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92222811|NCT00955487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92222812|NCT00955487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92222814|NCT00955487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222815|NCT00955487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222816|NCT00955487|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92222817|NCT00955487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92222818|NCT00955487|Gasotransmitters|gasotransmitters|mesh-ancestor
92222819|NCT00955487|Protective Agents|protective agents|mesh-ancestor
92222820|NCT04120922|Calcium Carbonate|calcium carbonate|mesh-list
92222821|NCT04120922|Calcium|calcium|mesh-list
92222822|NCT04120922|Sevelamer|sevelamer|mesh-list
92222823|NCT04120922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92222824|NCT04120922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222825|NCT04120922|Antacids|antacids|mesh-ancestor
92222826|NCT04120922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222827|NCT04120922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92222828|NCT04120922|Chelating Agents|chelating agents|mesh-ancestor
92222829|NCT04120922|Sequestering Agents|sequestering agents|mesh-ancestor
92222830|NCT01663740|Valganciclovir|valganciclovir|mesh-list
92222831|NCT01663740|Antiviral Agents|antiviral agents|mesh-ancestor
92222832|NCT01663740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222833|NCT02984228|Hyaluronic Acid|hyaluronic acid|mesh-list
92222834|NCT02984228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92222835|NCT02984228|Immunologic Factors|immunologic factors|mesh-ancestor
92222836|NCT02984228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222837|NCT02984228|Viscosupplements|viscosupplements|mesh-ancestor
92222838|NCT02984228|Protective Agents|protective agents|mesh-ancestor
92222839|NCT00979121|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92222840|NCT00979121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92222841|NCT00979121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92222842|NCT00979121|Antimetabolites|antimetabolites|mesh-ancestor
92222843|NCT00979121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222844|NCT00979121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92222845|NCT00979121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92222846|NCT00979121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222847|NCT03828032|Mannitol|mannitol|mesh-list
92222848|NCT03828032|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92222849|NCT03828032|Diuretics|diuretics|mesh-ancestor
92222850|NCT03828032|Natriuretic Agents|natriuretic agents|mesh-ancestor
92222851|NCT03828032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222852|NCT03827876|Calcitriol|calcitriol|mesh-list
92222853|NCT03827876|Betamethasone|betamethasone|mesh-list
92222854|NCT03827876|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92222855|NCT03827876|Calcipotriene|calcipotriene|mesh-list
92222856|NCT03827876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92222857|NCT03827876|Glucocorticoids|glucocorticoids|mesh-ancestor
92222858|NCT03827876|Hormones|hormones|mesh-ancestor
92222859|NCT03827876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92222860|NCT03827876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222861|NCT03827876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92222862|NCT03827876|Respiratory System Agents|respiratory system agents|mesh-ancestor
92222863|NCT03827876|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92222864|NCT03827876|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92222865|NCT03827876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92222866|NCT03827876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222867|NCT03827876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92222868|NCT03827876|Vitamins|vitamins|mesh-ancestor
92222869|NCT03827876|Micronutrients|micronutrients|mesh-ancestor
92222870|NCT03827876|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92222871|NCT03827876|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222872|NCT03898934|Vitamin D|vitamin d|mesh-list
92222873|NCT03898934|Vitamins|vitamins|mesh-ancestor
92222874|NCT03898934|Micronutrients|micronutrients|mesh-ancestor
92222875|NCT03898934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222876|NCT03898934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92222877|NCT04128800|Apatinib|apatinib|mesh-list
92222878|NCT04128800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934337|NCT02345187|Micronutrients|micronutrients|mesh-list
92222879|NCT04128800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222880|NCT04128800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222881|NCT04128800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222883|NCT04129112|Anesthetics|anesthetics|mesh-ancestor
92222884|NCT04129112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92222885|NCT04129112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222886|NCT04129112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92222887|NCT04129112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92222888|NCT04129112|Anesthetics, General|anesthetics, general|mesh-ancestor
92222889|NCT01608893|Metoprolol|metoprolol|mesh-list
92222890|NCT01608893|Carvedilol|carvedilol|mesh-list
92222891|NCT01608893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92222892|NCT01608893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92222893|NCT01608893|Sympatholytics|sympatholytics|mesh-ancestor
92222894|NCT01608893|Autonomic Agents|autonomic agents|mesh-ancestor
92222895|NCT01608893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222896|NCT01608893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222897|NCT01608893|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92222898|NCT01608893|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92222899|NCT01608893|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92222900|NCT01608893|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222901|NCT01608893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222902|NCT01608893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222903|NCT01608893|Antioxidants|antioxidants|mesh-ancestor
92222904|NCT01608893|Protective Agents|protective agents|mesh-ancestor
92222905|NCT01608893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92222906|NCT01608893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92222907|NCT01608893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92337834|NCT00716807|Analgesics|analgesics|mesh-ancestor
92222908|NCT01608893|Vasodilator Agents|vasodilator agents|mesh-ancestor
92222909|NCT01608893|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92222910|NCT01608893|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92222911|NCT04128878|Sotalol|sotalol|mesh-list
92222912|NCT04128878|Dofetilide|dofetilide|mesh-list
92222913|NCT04128878|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92222914|NCT04128878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92222915|NCT04128878|Adrenergic Agents|adrenergic agents|mesh-ancestor
92222916|NCT04128878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92222917|NCT04128878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222918|NCT04128878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222919|NCT04128878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92222920|NCT04128878|Sympatholytics|sympatholytics|mesh-ancestor
92222921|NCT04128878|Autonomic Agents|autonomic agents|mesh-ancestor
92222922|NCT04128878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222923|NCT04128878|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92222924|NCT04128878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92222925|NCT00979745|Afamelanotide|afamelanotide|mesh-list
92222926|NCT00979745|Dermatologic Agents|dermatologic agents|mesh-ancestor
92222927|NCT00042341|Clofarabine|clofarabine|mesh-list
92222928|NCT00042341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222929|NCT00042341|Antimetabolites|antimetabolites|mesh-ancestor
92222930|NCT00042341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222931|NCT00042341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222932|NCT00980681|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92222933|NCT00980681|Chelating Agents|chelating agents|mesh-ancestor
92222934|NCT00980681|Sequestering Agents|sequestering agents|mesh-ancestor
92222935|NCT00980681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222936|NCT04759196|Topiramate|topiramate|mesh-list
92222937|NCT04759196|Levetiracetam|levetiracetam|mesh-list
92222938|NCT04759196|Anticonvulsants|anticonvulsants|mesh-ancestor
92222939|NCT04759196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92222940|NCT04759196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222941|NCT04759196|Nootropic Agents|nootropic agents|mesh-ancestor
92222942|NCT04128254|Apixaban|apixaban|mesh-list
92222943|NCT04128254|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92222944|NCT04128254|Antithrombins|antithrombins|mesh-ancestor
92222945|NCT04128254|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92222946|NCT04128254|Protease Inhibitors|protease inhibitors|mesh-ancestor
92222947|NCT04128254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222948|NCT04128254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222949|NCT04128254|Anticoagulants|anticoagulants|mesh-ancestor
92222950|NCT04128020|Nivolumab|nivolumab|mesh-list
92222951|NCT04128020|Azacitidine|azacitidine|mesh-list
92222952|NCT04128020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92222953|NCT04128020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222954|NCT04128020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92222955|NCT04128020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222956|NCT04128020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222957|NCT04128020|Antimetabolites|antimetabolites|mesh-ancestor
92222958|NCT04128020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222960|NCT03827642|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92222961|NCT03827642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222962|NCT03827642|Sensory System Agents|sensory system agents|mesh-ancestor
92222963|NCT03827642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92222964|NCT05510310|Oxytocin|oxytocin|mesh-list
92222965|NCT05510310|Oxytocics|oxytocics|mesh-ancestor
92222966|NCT05510310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92222967|NCT05510310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222968|NCT00981227|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92222969|NCT00981227|Anticonvulsants|anticonvulsants|mesh-ancestor
92222970|NCT00981227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92222971|NCT00981227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92222972|NCT00981227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92222973|NCT00981227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222974|NCT01022567|Ertapenem|ertapenem|mesh-list
92222975|NCT01022567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92222976|NCT01022567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92222977|NCT04411524|Capecitabine|capecitabine|mesh-list
92222978|NCT04411524|Irinotecan|irinotecan|mesh-list
92222979|NCT04411524|Antibodies|antibodies|mesh-list
92222980|NCT04411524|Immunologic Factors|immunologic factors|mesh-ancestor
92222981|NCT04411524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92222982|NCT04411524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92222983|NCT04411524|Antimetabolites|antimetabolites|mesh-ancestor
92222984|NCT04411524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222985|NCT04411524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222986|NCT04411524|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92222987|NCT04411524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92222988|NCT04411524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222989|NCT04127396|Sorafenib|sorafenib|mesh-list
92222990|NCT04127396|Lenvatinib|lenvatinib|mesh-list
92222991|NCT04127396|Chlorotrianisene|chlorotrianisene|mesh-list
92222992|NCT04127396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92222993|NCT04127396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92222994|NCT04127396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92222995|NCT04127396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92222996|NCT04127396|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92222997|NCT04127396|Estrogens|estrogens|mesh-ancestor
92222998|NCT04127396|Hormones|hormones|mesh-ancestor
92222999|NCT04127396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223000|NCT04127396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223001|NCT04127396|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223002|NCT04120064|Cholecalciferol|cholecalciferol|mesh-list
92223003|NCT04120064|Vitamin D|vitamin d|mesh-list
92223004|NCT04120064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92223005|NCT04120064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223006|NCT04120064|Vitamins|vitamins|mesh-ancestor
92223007|NCT04120064|Micronutrients|micronutrients|mesh-ancestor
92223008|NCT04120064|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92223009|NCT00982007|Ferric Compounds|ferric compounds|mesh-list
92223010|NCT00982007|Hematinics|hematinics|mesh-ancestor
92223011|NCT04814940|Menotropins|menotropins|mesh-list
92223012|NCT04814940|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92223013|NCT04814940|Fertility Agents|fertility agents|mesh-ancestor
92223014|NCT04814940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92223015|NCT04814940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223016|NCT05042934|Irinotecan|irinotecan|mesh-list
92223017|NCT05042934|Camptothecin|camptothecin|mesh-list
92223018|NCT05042934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92223019|NCT05042934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92223020|NCT05042934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223021|NCT05042934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223022|NCT05042934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223023|NCT05042934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92223024|NCT05505006|Folic Acid|folic acid|mesh-list
92223025|NCT05505006|Vitamin B 12|vitamin b 12|mesh-list
92223026|NCT05505006|Hematinics|hematinics|mesh-ancestor
92223027|NCT05505006|Vitamin B Complex|vitamin b complex|mesh-ancestor
92223029|NCT05505006|Micronutrients|micronutrients|mesh-ancestor
92223030|NCT05505006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223031|NCT03826706|Pyrithione zinc|pyrithione zinc|mesh-list
92223032|NCT03826706|Keratolytic Agents|keratolytic agents|mesh-ancestor
92223033|NCT03826706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92223034|NCT02979548|Ondansetron|ondansetron|mesh-list
92223035|NCT02979548|Aprepitant|aprepitant|mesh-list
92223036|NCT02979548|Metoclopramide|metoclopramide|mesh-list
92223037|NCT02979548|Antiemetics|antiemetics|mesh-ancestor
92223038|NCT02979548|Autonomic Agents|autonomic agents|mesh-ancestor
92223039|NCT02979548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223040|NCT02979548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337860|NCT00669461|Lubiprostone|lubiprostone|mesh-list
92223041|NCT02979548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223042|NCT02979548|Antipruritics|antipruritics|mesh-ancestor
92223043|NCT02979548|Dermatologic Agents|dermatologic agents|mesh-ancestor
92223044|NCT02979548|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92223045|NCT02979548|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92223046|NCT02979548|Serotonin Agents|serotonin agents|mesh-ancestor
92223047|NCT02979548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223048|NCT02979548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223049|NCT02979548|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92223050|NCT02979548|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92223051|NCT02979548|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92223052|NCT02979548|Dopamine Agents|dopamine agents|mesh-ancestor
92223053|NCT03821246|Atezolizumab|atezolizumab|mesh-list
92223054|NCT03821246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92223055|NCT03821246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92223056|NCT03821246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223057|NCT03821246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223058|NCT03821246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223059|NCT03821246|Immunologic Factors|immunologic factors|mesh-ancestor
92223060|NCT03821246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223061|NCT03826316|Nalbuphine|nalbuphine|mesh-list
92223062|NCT03826316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92223063|NCT03826316|Narcotics|narcotics|mesh-ancestor
92223064|NCT03826316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223065|NCT03826316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223066|NCT03826316|Analgesics|analgesics|mesh-ancestor
92223067|NCT03826316|Sensory System Agents|sensory system agents|mesh-ancestor
92223068|NCT03826316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223069|NCT04393610|Lidocaine|lidocaine|mesh-list
92223070|NCT04393610|Magnesium Sulfate|magnesium sulfate|mesh-list
92223071|NCT04393610|Fentanyl|fentanyl|mesh-list
92223072|NCT04393610|Anesthetics, Local|anesthetics, local|mesh-ancestor
92223073|NCT04393610|Anesthetics|anesthetics|mesh-ancestor
92223074|NCT04393610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223075|NCT04393610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223076|NCT04393610|Sensory System Agents|sensory system agents|mesh-ancestor
92223077|NCT04393610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223078|NCT04393610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92223079|NCT04393610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92223080|NCT04393610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92223081|NCT04393610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92223082|NCT04393610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223083|NCT04393610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92223084|NCT04393610|Narcotics|narcotics|mesh-ancestor
92223085|NCT04393610|Analgesics|analgesics|mesh-ancestor
92223086|NCT04393610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92223087|NCT04393610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92223088|NCT04393610|Anesthetics, General|anesthetics, general|mesh-ancestor
92223089|NCT04393610|Anticonvulsants|anticonvulsants|mesh-ancestor
92223090|NCT04393610|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92223091|NCT04393610|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92223092|NCT04393610|Tocolytic Agents|tocolytic agents|mesh-ancestor
92223093|NCT04393610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92223094|NCT03820466|Aspirin|aspirin|mesh-list
92223095|NCT03820466|Atorvastatin|atorvastatin|mesh-list
92223096|NCT03820466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223097|NCT03820466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223098|NCT03820466|Analgesics|analgesics|mesh-ancestor
92223099|NCT03820466|Sensory System Agents|sensory system agents|mesh-ancestor
92223100|NCT03820466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223101|NCT03820466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223102|NCT03820466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223103|NCT03820466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223104|NCT03820466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92223105|NCT03820466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92223106|NCT03820466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223107|NCT03820466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92223108|NCT03820466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92223109|NCT03820466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223110|NCT03820466|Antipyretics|antipyretics|mesh-ancestor
92223111|NCT03820466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92223112|NCT03820466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92223113|NCT03820466|Antimetabolites|antimetabolites|mesh-ancestor
92223115|NCT03820466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92223116|NCT03826004|Clemastine|clemastine|mesh-list
92223117|NCT03826004|Antipruritics|antipruritics|mesh-ancestor
92223118|NCT03826004|Dermatologic Agents|dermatologic agents|mesh-ancestor
92223119|NCT03826004|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92223120|NCT03826004|Histamine Antagonists|histamine antagonists|mesh-ancestor
92223121|NCT03826004|Histamine Agents|histamine agents|mesh-ancestor
92223122|NCT03826004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223123|NCT03826004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223124|NCT03826004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223125|NCT03826004|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92223127|NCT02338076|Emollients|emollients|mesh-ancestor
92223128|NCT02338076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92223129|NCT02978534|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92223130|NCT02978534|Antidepressive Agents|antidepressive agents|mesh-ancestor
92223131|NCT02978534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92223132|NCT02978534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92223133|NCT02978534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92223134|NCT02978534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223135|NCT02978534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223136|NCT01222117|Plasminogen|plasminogen|mesh-list
92223137|NCT01222117|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92223138|NCT01222117|Fibrinolysin|fibrinolysin|mesh-list
92223139|NCT01222117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92223140|NCT01222117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92223141|NCT01222117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223142|NCT03825380|Bimatoprost|bimatoprost|mesh-list
92223143|NCT03825380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92223144|NCT01222195|Lenalidomide|lenalidomide|mesh-list
92223145|NCT01222195|Darbepoetin alfa|darbepoetin alfa|mesh-list
92223146|NCT01222195|Immunologic Factors|immunologic factors|mesh-ancestor
92223147|NCT01222195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117443|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
92223148|NCT01222195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92223149|NCT01222195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223150|NCT01222195|Growth Substances|growth substances|mesh-ancestor
92223151|NCT01222195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223152|NCT01222195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223153|NCT01222195|Hematinics|hematinics|mesh-ancestor
92223154|NCT01222273|Vitamin D|vitamin d|mesh-list
92223155|NCT01222273|Cholecalciferol|cholecalciferol|mesh-list
92223156|NCT01222273|Vitamins|vitamins|mesh-ancestor
92223157|NCT01222273|Micronutrients|micronutrients|mesh-ancestor
92223158|NCT01222273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223159|NCT01222273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92223160|NCT01222273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92223161|NCT03161912|Aflibercept|aflibercept|mesh-list
92223162|NCT03161912|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92223163|NCT03161912|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223164|NCT03161912|Growth Substances|growth substances|mesh-ancestor
92223165|NCT03161912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223166|NCT03161912|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223167|NCT03161912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223168|NCT01222585|Metronidazole|metronidazole|mesh-list
92223169|NCT01222585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337871|NCT03248141|Factor VIII|factor viii|mesh-list
92223170|NCT01222585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92223171|NCT01222585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92223172|NCT01222585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92223173|NCT04126382|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92223174|NCT04126382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223175|NCT03829592|Misoprostol|misoprostol|mesh-list
92223176|NCT03829592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92223177|NCT03829592|Abortifacient Agents|abortifacient agents|mesh-ancestor
92223178|NCT03829592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92223179|NCT03829592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223180|NCT03829592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92223181|NCT03829592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223183|NCT01142323|Fenofibrate|fenofibrate|mesh-list
92223184|NCT01142323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92223185|NCT01142323|Antimetabolites|antimetabolites|mesh-ancestor
92223186|NCT01142323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223187|NCT01142323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92223188|NCT01142947|Beclomethasone|beclomethasone|mesh-list
92223189|NCT01142947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223190|NCT01142947|Glucocorticoids|glucocorticoids|mesh-ancestor
92223191|NCT01142947|Hormones|hormones|mesh-ancestor
92223192|NCT01142947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223193|NCT01142947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223194|NCT01142947|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92223195|NCT01142947|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223197|NCT02972294|Tranexamic Acid|tranexamic acid|mesh-list
92223198|NCT02972294|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92223199|NCT02972294|Ferric Compounds|ferric compounds|mesh-list
92223200|NCT02972294|Trace Elements|trace elements|mesh-ancestor
92223201|NCT02972294|Micronutrients|micronutrients|mesh-ancestor
92223202|NCT02972294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223203|NCT02972294|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92223204|NCT02972294|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92223205|NCT02972294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223206|NCT02972294|Hemostatics|hemostatics|mesh-ancestor
92223207|NCT02972294|Coagulants|coagulants|mesh-ancestor
92223208|NCT02972294|Hematinics|hematinics|mesh-ancestor
92223209|NCT02969798|Metformin|metformin|mesh-list
92223210|NCT02969798|Pioglitazone|pioglitazone|mesh-list
92223211|NCT02969798|Dapagliflozin|dapagliflozin|mesh-list
92223212|NCT02969798|Saxagliptin|saxagliptin|mesh-list
92223213|NCT02969798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92223214|NCT02969798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223215|NCT02969798|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92223216|NCT02969798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223217|NCT02969798|Incretins|incretins|mesh-ancestor
92223218|NCT02969798|Hormones|hormones|mesh-ancestor
92223219|NCT02969798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223220|NCT02969798|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92223221|NCT02969798|Protease Inhibitors|protease inhibitors|mesh-ancestor
92223222|NCT02969798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223223|NCT02983214|Cilostazol|cilostazol|mesh-list
92223224|NCT02983214|Clopidogrel|clopidogrel|mesh-list
92223225|NCT02983214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92223226|NCT02983214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92223227|NCT02983214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92223228|NCT02983214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92223229|NCT02983214|Purinergic Agents|purinergic agents|mesh-ancestor
92223230|NCT02983214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223231|NCT02983214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223232|NCT02983214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223233|NCT02983214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92223234|NCT02983214|Autonomic Agents|autonomic agents|mesh-ancestor
92223235|NCT02983214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223236|NCT02983214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92223237|NCT02983214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223238|NCT02983214|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92223239|NCT02983214|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92223240|NCT02983214|Vasodilator Agents|vasodilator agents|mesh-ancestor
92223241|NCT02983214|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92223242|NCT02983214|Protective Agents|protective agents|mesh-ancestor
92223243|NCT02983214|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92223244|NCT02983214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92223245|NCT02983214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223246|NCT03825068|Anesthetics|anesthetics|mesh-list
92223247|NCT03825068|Anesthetics, General|anesthetics, general|mesh-list
92223248|NCT03825068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223249|NCT03825068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223250|NCT03824834|Morphine|morphine|mesh-list
92223251|NCT03824834|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92223252|NCT03824834|Narcotics|narcotics|mesh-ancestor
92223253|NCT03824834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223254|NCT03824834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223255|NCT03824834|Analgesics|analgesics|mesh-ancestor
92223256|NCT03824834|Sensory System Agents|sensory system agents|mesh-ancestor
92223257|NCT03824834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223258|NCT03829124|Ketamine|ketamine|mesh-list
92223259|NCT03829124|Propofol|propofol|mesh-list
92223260|NCT03829124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92223261|NCT03829124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223262|NCT03829124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223263|NCT03829124|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92223264|NCT03829124|Anesthetics, General|anesthetics, general|mesh-ancestor
92223265|NCT03829124|Anesthetics|anesthetics|mesh-ancestor
92223266|NCT03829124|Analgesics|analgesics|mesh-ancestor
92223267|NCT03829124|Sensory System Agents|sensory system agents|mesh-ancestor
92223268|NCT03829124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223269|NCT03829124|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92223270|NCT03829124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92223271|NCT03829124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92223272|NCT03829124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223273|NCT03829124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223274|NCT02965976|Botulinum Toxins|botulinum toxins|mesh-list
92223275|NCT02965976|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92223276|NCT02965976|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92223277|NCT02965976|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92223278|NCT02965976|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92223279|NCT02965976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92223280|NCT02965976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223281|NCT02965976|Cholinergic Agents|cholinergic agents|mesh-ancestor
92223282|NCT02965976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223283|NCT02965976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223284|NCT02965976|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92223285|NCT02965976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223286|NCT03047330|Leuprolide|leuprolide|mesh-list
92223287|NCT03047330|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92223288|NCT03047330|Fertility Agents|fertility agents|mesh-ancestor
92223289|NCT03047330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92223290|NCT03047330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223291|NCT03047330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223292|NCT03047330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223293|NCT04393220|Bevacizumab|bevacizumab|mesh-list
92223294|NCT04393220|Nivolumab|nivolumab|mesh-list
92223295|NCT04393220|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223296|NCT04393220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223297|NCT04393220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92223298|NCT04393220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223299|NCT04393220|Growth Substances|growth substances|mesh-ancestor
92223300|NCT04393220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223301|NCT04393220|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223302|NCT04393220|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92223303|NCT04393220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223304|NCT01025453|Sirolimus|sirolimus|mesh-list
92223305|NCT01025453|Sorafenib|sorafenib|mesh-list
92223306|NCT01025453|Temsirolimus|temsirolimus|mesh-list
92223307|NCT01025453|MTOR Inhibitors|mtor inhibitors|mesh-list
92223308|NCT01025453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223309|NCT01025453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92223310|NCT01025453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223311|NCT01025453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223312|NCT01025453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92223313|NCT01025453|Immunologic Factors|immunologic factors|mesh-ancestor
92223314|NCT01025453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223315|NCT01025453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92223316|NCT01025453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223317|NCT01025453|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92223318|NCT01025453|Antifungal Agents|antifungal agents|mesh-ancestor
92223319|NCT05394233|Bevacizumab|bevacizumab|mesh-list
92223320|NCT05394233|Tislelizumab|tislelizumab|mesh-list
92223321|NCT05394233|Pemetrexed|pemetrexed|mesh-list
92223322|NCT05394233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223323|NCT05394233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223324|NCT05394233|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92223325|NCT05394233|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223326|NCT05394233|Growth Substances|growth substances|mesh-ancestor
92223327|NCT05394233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223328|NCT05394233|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223329|NCT05394233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223330|NCT05394233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223331|NCT05394233|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92223332|NCT05394233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92223333|NCT03823976|Anesthetics|anesthetics|mesh-list
92223334|NCT03823976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223335|NCT03823976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223337|NCT00982553|Raltegravir Potassium|raltegravir potassium|mesh-list
92223338|NCT00982553|Antimetabolites|antimetabolites|mesh-ancestor
92223339|NCT00982553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223340|NCT00982553|Antiviral Agents|antiviral agents|mesh-ancestor
92223341|NCT00982553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223342|NCT00982553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92223343|NCT00982553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92223344|NCT00982553|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92223345|NCT00982553|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92223346|NCT00982553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223347|NCT02943590|Atorvastatin|atorvastatin|mesh-list
92223348|NCT02943590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92223349|NCT02943590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92223350|NCT02943590|Antimetabolites|antimetabolites|mesh-ancestor
92223351|NCT02943590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223352|NCT02943590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92223353|NCT02943590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92223354|NCT02943590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223356|NCT02939300|Ipilimumab|ipilimumab|mesh-list
92223357|NCT02939300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223358|NCT02939300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223359|NCT02939300|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92223360|NCT02939300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223361|NCT04392128|Azithromycin|azithromycin|mesh-list
92223362|NCT04392128|Hydroxychloroquine|hydroxychloroquine|mesh-list
92223363|NCT04392128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92223364|NCT04392128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223365|NCT04392128|Antimalarials|antimalarials|mesh-ancestor
92223366|NCT04392128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92223367|NCT04392128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92223368|NCT04392128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223369|NCT04392128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223370|NCT04392128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223371|NCT02891954|Canagliflozin|canagliflozin|mesh-list
92223372|NCT02891954|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92223373|NCT02891954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223374|NCT02891954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92223375|NCT02891954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223376|NCT02565186|Lasmiditan|lasmiditan|mesh-list
92223377|NCT02565186|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92223378|NCT02565186|Serotonin Agents|serotonin agents|mesh-ancestor
92223379|NCT02565186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223380|NCT02565186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223381|NCT02565186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223382|NCT04694586|Rifampin|rifampin|mesh-list
92223383|NCT04694586|Isoniazid|isoniazid|mesh-list
92223384|NCT04694586|Pyrazinamide|pyrazinamide|mesh-list
92223385|NCT04694586|Ethambutol|ethambutol|mesh-list
92223386|NCT04694586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92223387|NCT04694586|Antitubercular Agents|antitubercular agents|mesh-ancestor
92223388|NCT04694586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92223389|NCT04694586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223390|NCT04694586|Leprostatic Agents|leprostatic agents|mesh-ancestor
92223391|NCT04694586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92223392|NCT04694586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223393|NCT04694586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223394|NCT04694586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92223395|NCT04694586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92223396|NCT04694586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92223397|NCT04694586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92223398|NCT04694586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92223399|NCT04694586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92223400|NCT04694586|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92223401|NCT04694586|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92223403|NCT04694586|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92223404|NCT04274816|Tremelimumab|tremelimumab|mesh-list
92223405|NCT04274816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223406|NCT03252938|Avelumab|avelumab|mesh-list
92223407|NCT03252938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223408|NCT03252938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223409|NCT05509374|Dexamethasone|dexamethasone|mesh-list
92223410|NCT05509374|Pomalidomide|pomalidomide|mesh-list
92223411|NCT05509374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223412|NCT05509374|Antiemetics|antiemetics|mesh-ancestor
92223413|NCT05509374|Autonomic Agents|autonomic agents|mesh-ancestor
92223414|NCT05509374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223415|NCT05509374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223416|NCT05509374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223417|NCT05509374|Glucocorticoids|glucocorticoids|mesh-ancestor
92223418|NCT05509374|Hormones|hormones|mesh-ancestor
92223419|NCT05509374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223420|NCT05509374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223421|NCT05509374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223422|NCT05509374|Immunologic Factors|immunologic factors|mesh-ancestor
92223423|NCT05509374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92223424|NCT05509374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223425|NCT05509374|Growth Substances|growth substances|mesh-ancestor
92223426|NCT05509374|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223428|NCT04124822|Piroxicam|piroxicam|mesh-list
92223429|NCT04124822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223430|NCT04124822|Glucocorticoids|glucocorticoids|mesh-ancestor
92223431|NCT04124822|Hormones|hormones|mesh-ancestor
92223432|NCT04124822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223433|NCT04124822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223434|NCT04124822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223436|NCT04124822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223437|NCT04124822|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223438|NCT04124822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223439|NCT04124822|Analgesics|analgesics|mesh-ancestor
92223440|NCT04124822|Sensory System Agents|sensory system agents|mesh-ancestor
92223441|NCT04124822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223442|NCT04124822|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92223443|NCT04124822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223444|NCT04124822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223445|NCT05504694|Ofatumumab|ofatumumab|mesh-list
92223446|NCT05504694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223447|NCT02854670|Capsaicin|capsaicin|mesh-list
92223448|NCT02854670|Antipruritics|antipruritics|mesh-ancestor
92223449|NCT02854670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92223450|NCT02854670|Sensory System Agents|sensory system agents|mesh-ancestor
92223451|NCT02854670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223452|NCT02854670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223453|NCT02937272|Paclitaxel|paclitaxel|mesh-list
92223454|NCT02937272|Gemcitabine|gemcitabine|mesh-list
92223455|NCT02937272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92223456|NCT02937272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223457|NCT02937272|Tubulin Modulators|tubulin modulators|mesh-ancestor
92223458|NCT02937272|Antimitotic Agents|antimitotic agents|mesh-ancestor
92223459|NCT02937272|Mitosis Modulators|mitosis modulators|mesh-ancestor
92223460|NCT02937272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223461|NCT02937272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92223462|NCT02937272|Antimetabolites|antimetabolites|mesh-ancestor
92223463|NCT03519308|Paclitaxel|paclitaxel|mesh-list
92223464|NCT03519308|Gemcitabine|gemcitabine|mesh-list
92223465|NCT03519308|Nivolumab|nivolumab|mesh-list
92223466|NCT03519308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92223467|NCT03519308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223468|NCT03519308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92223469|NCT03519308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92223470|NCT03519308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92223471|NCT03519308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223472|NCT03519308|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92223473|NCT03519308|Antimetabolites|antimetabolites|mesh-ancestor
92223474|NCT03519308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223475|NCT03519308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92223477|NCT03821714|Hydrocortisone|hydrocortisone|mesh-list
92223478|NCT03821714|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92223479|NCT03821714|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92223480|NCT03821714|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92223481|NCT03821714|Glucocorticoids|glucocorticoids|mesh-list
92223482|NCT03821714|Micronutrients|micronutrients|mesh-ancestor
92223483|NCT03821714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223484|NCT03821714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223485|NCT03821714|Hormones|hormones|mesh-ancestor
92223486|NCT03821714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223487|NCT02565108|Cannabidiol|cannabidiol|mesh-list
92223488|NCT02565108|Clobazam|clobazam|mesh-list
92223489|NCT02565108|Anticonvulsants|anticonvulsants|mesh-ancestor
92223490|NCT02565108|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92223491|NCT02565108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92223492|NCT02565108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223493|NCT02565108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223494|NCT02565108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92223495|NCT02565108|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92223496|NCT02565108|GABA Agonists|gaba agonists|mesh-ancestor
92223497|NCT02565108|GABA Agents|gaba agents|mesh-ancestor
92223498|NCT02565108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223499|NCT02565108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223500|NCT03821168|Bevacizumab|bevacizumab|mesh-list
92223501|NCT03821168|Epoetin Alfa|epoetin alfa|mesh-list
92223502|NCT03821168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223503|NCT03821168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223504|NCT03821168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92337925|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
92223505|NCT03821168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223506|NCT03821168|Growth Substances|growth substances|mesh-ancestor
92223507|NCT03821168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223508|NCT03821168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223509|NCT03821168|Hematinics|hematinics|mesh-ancestor
92223511|NCT01454180|Gemcitabine|gemcitabine|mesh-list
92223512|NCT01454180|Capecitabine|capecitabine|mesh-list
92223513|NCT01454180|Fluorouracil|fluorouracil|mesh-list
92223514|NCT01454180|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92223515|NCT01454180|Oxaliplatin|oxaliplatin|mesh-list
92223516|NCT01454180|Folfirinox|folfirinox|mesh-list
92223517|NCT01454180|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92223518|NCT01454180|Antimetabolites|antimetabolites|mesh-ancestor
92223519|NCT01454180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223520|NCT01454180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223521|NCT01454180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92223522|NCT01454180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223523|NCT01454180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92223524|NCT01454180|Immunologic Factors|immunologic factors|mesh-ancestor
92223525|NCT01454180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223526|NCT01454180|Antidotes|antidotes|mesh-ancestor
92223527|NCT01454180|Protective Agents|protective agents|mesh-ancestor
92223528|NCT01454180|Vitamin B Complex|vitamin b complex|mesh-ancestor
92223529|NCT01454180|Vitamins|vitamins|mesh-ancestor
92223530|NCT01454180|Micronutrients|micronutrients|mesh-ancestor
92223531|NCT02564952|Cannabidiol|cannabidiol|mesh-list
92223532|NCT02564952|Clobazam|clobazam|mesh-list
92223533|NCT02564952|Anticonvulsants|anticonvulsants|mesh-ancestor
92223534|NCT02564952|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92223535|NCT02564952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92223536|NCT02564952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223537|NCT02564952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223538|NCT02564952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92223539|NCT02564952|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92223540|NCT02564952|GABA Agonists|gaba agonists|mesh-ancestor
92223541|NCT02564952|GABA Agents|gaba agents|mesh-ancestor
92223542|NCT02564952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223543|NCT02564952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223545|NCT05564286|Fosaprepitant|fosaprepitant|mesh-list
92223546|NCT05564286|Aprepitant|aprepitant|mesh-list
92223547|NCT05564286|Tropisetron|tropisetron|mesh-list
92223548|NCT05564286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223549|NCT05564286|Antiemetics|antiemetics|mesh-ancestor
92223550|NCT05564286|Autonomic Agents|autonomic agents|mesh-ancestor
92223551|NCT05564286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223552|NCT05564286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223553|NCT05564286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223554|NCT05564286|Glucocorticoids|glucocorticoids|mesh-ancestor
92223555|NCT05564286|Hormones|hormones|mesh-ancestor
92223556|NCT05564286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223557|NCT05564286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223558|NCT05564286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223559|NCT05564286|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92223560|NCT05564286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223561|NCT05564286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223562|NCT05564286|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92223563|NCT05564286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92223564|NCT05564286|Serotonin Agents|serotonin agents|mesh-ancestor
92223565|NCT01454804|Trastuzumab|trastuzumab|mesh-list
92223566|NCT01454804|Lapatinib|lapatinib|mesh-list
92223567|NCT01454804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223568|NCT01454804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223569|NCT01454804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92223570|NCT01454804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223571|NCT01454804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223572|NCT03820622|Paclitaxel|paclitaxel|mesh-list
92223573|NCT03820622|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92223574|NCT03820622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92223575|NCT03820622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223576|NCT03820622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92223577|NCT03820622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92223579|NCT03820622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223580|NCT05504382|Naproxen|naproxen|mesh-list
92223581|NCT05504382|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223582|NCT05504382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223583|NCT05504382|Analgesics|analgesics|mesh-ancestor
92223584|NCT05504382|Sensory System Agents|sensory system agents|mesh-ancestor
92223585|NCT05504382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223586|NCT05504382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223587|NCT05504382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223588|NCT05504382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223589|NCT05504382|Gout Suppressants|gout suppressants|mesh-ancestor
92223590|NCT05504382|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92223591|NCT05504382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223592|NCT05504382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223593|NCT03823040|Oxiconazole|oxiconazole|mesh-list
92223594|NCT03823040|Antifungal Agents|antifungal agents|mesh-ancestor
92223595|NCT03823040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223596|NCT02566902|Albuterol|albuterol|mesh-list
92223597|NCT02566902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92223598|NCT02566902|Autonomic Agents|autonomic agents|mesh-ancestor
92223599|NCT02566902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223600|NCT02566902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223601|NCT02566902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92223602|NCT02566902|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223603|NCT02566902|Tocolytic Agents|tocolytic agents|mesh-ancestor
92223604|NCT02566902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92223605|NCT02566902|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92223606|NCT02566902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92223607|NCT02566902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92223608|NCT02566902|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922378|NCT02205931|Stiripentol|stiripentol|mesh-list
92223609|NCT02566902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223610|NCT02566902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223611|NCT05508516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92223612|NCT05508516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92223613|NCT05508516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92223614|NCT05508516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92223615|NCT05508516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223616|NCT05508516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223617|NCT05508516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223618|NCT05508516|Analgesics|analgesics|mesh-ancestor
92223619|NCT05508516|Sensory System Agents|sensory system agents|mesh-ancestor
92223620|NCT05508516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223621|NCT05508516|Antidepressive Agents|antidepressive agents|mesh-ancestor
92223622|NCT05508516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92223623|NCT05508516|Dopamine Agents|dopamine agents|mesh-ancestor
92223624|NCT02902484|Nintedanib|nintedanib|mesh-list
92223625|NCT02902484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223626|NCT02902484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92223627|NCT02902484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223628|NCT02902484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223629|NCT01455506|Fludarabine|fludarabine|mesh-list
92223630|NCT01455506|Busulfan|busulfan|mesh-list
92223631|NCT01455506|Decitabine|decitabine|mesh-list
92223632|NCT01455506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223633|NCT01455506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92223634|NCT01455506|Antimetabolites|antimetabolites|mesh-ancestor
92223635|NCT01455506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223636|NCT01455506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92223637|NCT01455506|Immunologic Factors|immunologic factors|mesh-ancestor
92223638|NCT01455506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223639|NCT01455506|Alkylating Agents|alkylating agents|mesh-ancestor
92223640|NCT01455506|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92223641|NCT01455506|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92223642|NCT01455506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223643|NCT02564796|Iron|iron|mesh-list
92223644|NCT02564796|Epoetin Alfa|epoetin alfa|mesh-list
92223645|NCT02564796|Trace Elements|trace elements|mesh-ancestor
92223646|NCT02564796|Micronutrients|micronutrients|mesh-ancestor
92223647|NCT02564796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223648|NCT02564796|Hematinics|hematinics|mesh-ancestor
92223649|NCT05563350|Midazolam|midazolam|mesh-list
92223650|NCT05563350|Omeprazole|omeprazole|mesh-list
92223651|NCT05563350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92223652|NCT05563350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92223653|NCT05563350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223654|NCT05563350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223655|NCT05563350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92223656|NCT05563350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92223657|NCT05563350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92223658|NCT05563350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92223659|NCT05563350|Anesthetics, General|anesthetics, general|mesh-ancestor
92223660|NCT05563350|Anesthetics|anesthetics|mesh-ancestor
92223661|NCT05563350|GABA Modulators|gaba modulators|mesh-ancestor
92223662|NCT05563350|GABA Agents|gaba agents|mesh-ancestor
92223663|NCT05563350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223664|NCT05563350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223665|NCT05563350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92223666|NCT05563350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223667|NCT05563350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92223668|NCT05563350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223669|NCT04273100|Lenvatinib|lenvatinib|mesh-list
92223670|NCT04273100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223671|NCT04273100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92223672|NCT04273100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223673|NCT04273100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223674|NCT02564718|Rivaroxaban|rivaroxaban|mesh-list
92223675|NCT02564718|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92223676|NCT02564718|Antithrombins|antithrombins|mesh-ancestor
92223677|NCT02564718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92223678|NCT02564718|Protease Inhibitors|protease inhibitors|mesh-ancestor
92223679|NCT02564718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223680|NCT02564718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223681|NCT02564718|Anticoagulants|anticoagulants|mesh-ancestor
92223682|NCT01453946|Budesonide|budesonide|mesh-list
92223683|NCT01453946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223684|NCT01453946|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92223685|NCT01453946|Autonomic Agents|autonomic agents|mesh-ancestor
92223686|NCT01453946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223687|NCT01453946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223688|NCT01453946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92223689|NCT01453946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223690|NCT01453946|Glucocorticoids|glucocorticoids|mesh-ancestor
92223692|NCT01453946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223693|NCT01455896|Exenatide|exenatide|mesh-list
92223694|NCT01455896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92223695|NCT01455896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223696|NCT01455896|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92223697|NCT01455896|Incretins|incretins|mesh-ancestor
92223698|NCT01455896|Hormones|hormones|mesh-ancestor
92223699|NCT01455896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223700|NCT05562882|Daratumumab|daratumumab|mesh-list
92223701|NCT05562882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223702|NCT05560542|Dexamethasone|dexamethasone|mesh-list
92223704|NCT05560542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223705|NCT05560542|Antiemetics|antiemetics|mesh-ancestor
92223706|NCT05560542|Autonomic Agents|autonomic agents|mesh-ancestor
92223707|NCT05560542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223708|NCT05560542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223709|NCT05560542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223710|NCT05560542|Glucocorticoids|glucocorticoids|mesh-ancestor
92223711|NCT05560542|Hormones|hormones|mesh-ancestor
92223712|NCT05560542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223713|NCT05560542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223714|NCT05560542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223715|NCT05560542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92223716|NCT05560542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92223717|NCT05560542|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92223718|NCT05560542|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92223719|NCT05560542|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223720|NCT05560542|Mydriatics|mydriatics|mesh-ancestor
92223721|NCT05560542|Parasympatholytics|parasympatholytics|mesh-ancestor
92223722|NCT05560542|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92223723|NCT05560542|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92223724|NCT05560542|Cholinergic Agents|cholinergic agents|mesh-ancestor
92223725|NCT05560542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223726|NCT05560542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223727|NCT01455974|Dialysis Solutions|dialysis solutions|mesh-list
92223728|NCT01455974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92223729|NCT05560308|Trastuzumab|trastuzumab|mesh-list
92223730|NCT05560308|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92223731|NCT05560308|Maytansine|maytansine|mesh-list
92223732|NCT05560308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223733|NCT05560308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223734|NCT05560308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223735|NCT05560308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92223736|NCT05560308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92223737|NCT05560308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92223738|NCT05560308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92223739|NCT05560308|Immunotoxins|immunotoxins|mesh-ancestor
92223740|NCT05560308|Immunoconjugates|immunoconjugates|mesh-ancestor
92223741|NCT05560308|Immunologic Factors|immunologic factors|mesh-ancestor
92223742|NCT05560308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223743|NCT01456208|Norepinephrine|norepinephrine|mesh-list
92223744|NCT01456208|Angiotensin II|angiotensin ii|mesh-list
92223745|NCT01456208|Giapreza|giapreza|mesh-list
92223746|NCT01456208|Angiotensinogen|angiotensinogen|mesh-list
92223747|NCT01456208|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92223748|NCT01456208|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92223749|NCT01456208|Adrenergic Agents|adrenergic agents|mesh-ancestor
92223750|NCT01456208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223751|NCT01456208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223752|NCT01456208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223753|NCT01456208|Sympathomimetics|sympathomimetics|mesh-ancestor
92223754|NCT01456208|Autonomic Agents|autonomic agents|mesh-ancestor
92223755|NCT01456208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223756|NCT01456208|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92223757|NCT01456208|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92223758|NCT01456208|Protease Inhibitors|protease inhibitors|mesh-ancestor
92223760|NCT05436522|Propofol|propofol|mesh-list
92223761|NCT05436522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92223762|NCT05436522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223763|NCT05436522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223764|NCT05436522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92223765|NCT05436522|Anesthetics, General|anesthetics, general|mesh-ancestor
92223766|NCT05436522|Anesthetics|anesthetics|mesh-ancestor
92223767|NCT03780010|Paclitaxel|paclitaxel|mesh-list
92223768|NCT03780010|Carboplatin|carboplatin|mesh-list
92223769|NCT03780010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92223770|NCT03780010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223771|NCT03780010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92223772|NCT03780010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92223773|NCT03780010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92223774|NCT03780010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223775|NCT03826550|Diclofenac|diclofenac|mesh-list
92223776|NCT03826550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223777|NCT03826550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223778|NCT03826550|Analgesics|analgesics|mesh-ancestor
92223779|NCT03826550|Sensory System Agents|sensory system agents|mesh-ancestor
92223780|NCT03826550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223781|NCT03826550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223782|NCT03826550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223783|NCT03826550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223784|NCT03826550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92223785|NCT03826550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223786|NCT03826550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223787|NCT03827018|Prednisone|prednisone|mesh-list
92223789|NCT03827018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223790|NCT03827018|Glucocorticoids|glucocorticoids|mesh-ancestor
92223791|NCT03827018|Hormones|hormones|mesh-ancestor
92223792|NCT03827018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223793|NCT03827018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223794|NCT03827018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223795|NCT03827018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223796|NCT03827018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223797|NCT05325762|Dexmedetomidine|dexmedetomidine|mesh-list
92223798|NCT05325762|Propofol|propofol|mesh-list
92223799|NCT05325762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92223800|NCT05325762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223801|NCT05325762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223802|NCT05325762|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223804|NCT05325762|Sensory System Agents|sensory system agents|mesh-ancestor
92223805|NCT05325762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223806|NCT05325762|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92223807|NCT05325762|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92223808|NCT05325762|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92223809|NCT05325762|Adrenergic Agents|adrenergic agents|mesh-ancestor
92223810|NCT05325762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223811|NCT05325762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223812|NCT05325762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92223813|NCT05325762|Anesthetics, General|anesthetics, general|mesh-ancestor
92223814|NCT05325762|Anesthetics|anesthetics|mesh-ancestor
92223815|NCT04391582|Sulfadiazine|sulfadiazine|mesh-list
92223816|NCT04391582|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92223817|NCT04391582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92223818|NCT04391582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223819|NCT04391582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92223820|NCT04391582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92223821|NCT04391582|Coccidiostats|coccidiostats|mesh-ancestor
92223822|NCT04391582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92223823|NCT05498064|Ensartinib|ensartinib|mesh-list
92223824|NCT05498064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223825|NCT05498064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92223826|NCT05498064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223827|NCT05498064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223828|NCT03767062|Topiramate|topiramate|mesh-list
92223829|NCT03767062|Anticonvulsants|anticonvulsants|mesh-ancestor
92223830|NCT03767062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92223831|NCT03767062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223832|NCT01456364|Ticagrelor|ticagrelor|mesh-list
92223833|NCT01456364|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92223834|NCT01456364|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92223835|NCT01456364|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92223836|NCT01456364|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92223837|NCT01456364|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92223838|NCT01456364|Purinergic Agents|purinergic agents|mesh-ancestor
92223839|NCT01456364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223840|NCT01456364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223841|NCT01456364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223842|NCT04281420|Niacin|niacin|mesh-list
92223843|NCT04281420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92223844|NCT04281420|Antimetabolites|antimetabolites|mesh-ancestor
92223845|NCT04281420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223846|NCT04281420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92223847|NCT04281420|Vasodilator Agents|vasodilator agents|mesh-ancestor
92223848|NCT04281420|Vitamin B Complex|vitamin b complex|mesh-ancestor
92223849|NCT04281420|Vitamins|vitamins|mesh-ancestor
92223850|NCT04281420|Micronutrients|micronutrients|mesh-ancestor
92223851|NCT04281420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223852|NCT03765502|Glucagon|glucagon|mesh-list
92223853|NCT03765502|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92223854|NCT03765502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337953|NCT00608465|Diuretics|diuretics|mesh-ancestor
92223856|NCT03765502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223857|NCT03765502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223859|NCT04447716|Rituximab|rituximab|mesh-list
92223860|NCT04447716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92223861|NCT04447716|Lenalidomide|lenalidomide|mesh-list
92223862|NCT04447716|Venetoclax|venetoclax|mesh-list
92223863|NCT04447716|Piperidine|piperidine|mesh-list
92223864|NCT04447716|Antibodies|antibodies|mesh-list
92223865|NCT04447716|Immunoglobulins|immunoglobulins|mesh-list
92223866|NCT04447716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92223867|NCT04447716|Immunologic Factors|immunologic factors|mesh-ancestor
92223868|NCT04447716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223869|NCT04447716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223870|NCT04447716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223871|NCT04447716|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92223872|NCT04447716|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92223873|NCT04447716|Growth Substances|growth substances|mesh-ancestor
92223874|NCT04447716|Growth Inhibitors|growth inhibitors|mesh-ancestor
92223875|NCT04447716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223876|NCT04447716|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92223877|NCT04447716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92223878|NCT04447716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92223879|NCT05285124|Melatonin|melatonin|mesh-list
92223880|NCT05285124|Antioxidants|antioxidants|mesh-ancestor
92223881|NCT05285124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223882|NCT05285124|Protective Agents|protective agents|mesh-ancestor
92223883|NCT05285124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223884|NCT05285124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223885|NCT01450046|Vitamin E|vitamin e|mesh-list
92223886|NCT01450046|Tocopherols|tocopherols|mesh-list
92223887|NCT01450046|Tocotrienols|tocotrienols|mesh-list
92223888|NCT01450046|Vitamins|vitamins|mesh-ancestor
92223889|NCT01450046|Micronutrients|micronutrients|mesh-ancestor
92223890|NCT01450046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223891|NCT01450046|Antioxidants|antioxidants|mesh-ancestor
92223892|NCT01450046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223893|NCT01450046|Protective Agents|protective agents|mesh-ancestor
92223894|NCT05497596|Vitamin D|vitamin d|mesh-list
92223895|NCT05497596|Vitamins|vitamins|mesh-ancestor
92223896|NCT05497596|Micronutrients|micronutrients|mesh-ancestor
92223897|NCT05497596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223898|NCT05497596|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92223899|NCT01450124|Boswellic acid|boswellic acid|mesh-list
92223900|NCT01450124|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223901|NCT01450124|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223902|NCT01450124|Analgesics|analgesics|mesh-ancestor
92223903|NCT01450124|Sensory System Agents|sensory system agents|mesh-ancestor
92223904|NCT01450124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223905|NCT01450124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223906|NCT01450124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223907|NCT01450124|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223908|NCT05243862|Atezolizumab|atezolizumab|mesh-list
92223909|NCT05243862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92223910|NCT05243862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223911|NCT05243862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223912|NCT05243862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223913|NCT03751124|Norethindrone|norethindrone|mesh-list
92223914|NCT03751124|Norethindrone Acetate|norethindrone acetate|mesh-list
92223915|NCT03751124|Estradiol|estradiol|mesh-list
92223916|NCT03751124|Relugolix|relugolix|mesh-list
92223917|NCT03751124|Estrogens|estrogens|mesh-ancestor
92223918|NCT03751124|Hormones|hormones|mesh-ancestor
92117522|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92223919|NCT03751124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223920|NCT03751124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223921|NCT03751124|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92223922|NCT03751124|Contraceptive Agents|contraceptive agents|mesh-ancestor
92223923|NCT03751124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92223924|NCT03751124|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92223925|NCT03751124|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92223926|NCT03751124|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92337959|NCT00608777|Hormones|hormones|mesh-ancestor
92223927|NCT03751124|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92223928|NCT03751124|Androgen Antagonists|androgen antagonists|mesh-ancestor
92223929|NCT03751124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92223930|NCT02563548|Pembrolizumab|pembrolizumab|mesh-list
92223931|NCT02563548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92223932|NCT02563548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223933|NCT02563548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92223934|NCT02563548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223935|NCT01450358|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92223936|NCT01450358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223938|NCT04081324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92223939|NCT04081324|Serotonin Agents|serotonin agents|mesh-ancestor
92223940|NCT04081324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223941|NCT04081324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223942|NCT04081324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223943|NCT04042324|Heparin|heparin|mesh-list
92223944|NCT04042324|Calcium heparin|calcium heparin|mesh-list
92223945|NCT04042324|Anticoagulants|anticoagulants|mesh-ancestor
92223946|NCT04042324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223947|NCT04042324|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92223948|NCT04042324|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92223949|NCT04391660|Ethanol|ethanol|mesh-list
92223950|NCT04391660|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92223951|NCT04391660|Eusol|eusol|mesh-list
92223952|NCT04391660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92223953|NCT04391660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92223954|NCT04391660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92223955|NCT04391660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223956|NCT04391660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223957|NCT04391660|Disinfectants|disinfectants|mesh-ancestor
92223958|NCT04842422|Imiquimod|imiquimod|mesh-list
92223959|NCT04842422|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92223960|NCT04842422|Immunologic Factors|immunologic factors|mesh-ancestor
92223961|NCT04842422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223962|NCT04842422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223963|NCT04842422|Interferon Inducers|interferon inducers|mesh-ancestor
92223964|NCT04066426|Acetaminophen|acetaminophen|mesh-list
92223965|NCT04066426|Dexamethasone|dexamethasone|mesh-list
92223966|NCT04066426|Naproxen|naproxen|mesh-list
92223967|NCT04066426|Codeine|codeine|mesh-list
92223968|NCT04066426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92223969|NCT04066426|Antiemetics|antiemetics|mesh-ancestor
92223970|NCT04066426|Autonomic Agents|autonomic agents|mesh-ancestor
92223971|NCT04066426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92223972|NCT04066426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92223973|NCT04066426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92223974|NCT04066426|Glucocorticoids|glucocorticoids|mesh-ancestor
92223975|NCT04066426|Hormones|hormones|mesh-ancestor
92223976|NCT04066426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92223977|NCT04066426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92223978|NCT04066426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92223979|NCT04066426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92223980|NCT04066426|Analgesics|analgesics|mesh-ancestor
92223981|NCT04066426|Sensory System Agents|sensory system agents|mesh-ancestor
92223983|NCT04066426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92223984|NCT04066426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92223985|NCT04066426|Gout Suppressants|gout suppressants|mesh-ancestor
92223986|NCT04066426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92223987|NCT04066426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92223988|NCT04066426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223989|NCT04066426|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92223990|NCT04066426|Narcotics|narcotics|mesh-ancestor
92223991|NCT04066426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92223992|NCT04066426|Antitussive Agents|antitussive agents|mesh-ancestor
92223993|NCT04066426|Respiratory System Agents|respiratory system agents|mesh-ancestor
92223994|NCT01450514|Pipamperone|pipamperone|mesh-list
92223995|NCT01450514|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92223996|NCT01450514|Serotonin Agents|serotonin agents|mesh-ancestor
92223997|NCT01450514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92223998|NCT01450514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92223999|NCT01450514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224000|NCT01450514|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92224001|NCT01450514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92224002|NCT01450514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224003|NCT01450514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224004|NCT04758728|Epinephrine|epinephrine|mesh-list
92224005|NCT04758728|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92224006|NCT04758728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92224007|NCT04758728|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224008|NCT04758728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224009|NCT04758728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224010|NCT04758728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224011|NCT04758728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92224012|NCT04758728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92224013|NCT04758728|Autonomic Agents|autonomic agents|mesh-ancestor
92224014|NCT04758728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224015|NCT04758728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92224016|NCT04758728|Respiratory System Agents|respiratory system agents|mesh-ancestor
92224017|NCT04758728|Mydriatics|mydriatics|mesh-ancestor
92224018|NCT04758728|Sympathomimetics|sympathomimetics|mesh-ancestor
92224019|NCT04758728|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92224020|NCT02559570|Linaclotide|linaclotide|mesh-list
92224021|NCT02559570|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92224022|NCT02559570|Enzyme Activators|enzyme activators|mesh-ancestor
92224023|NCT02559570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224024|NCT02559570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224025|NCT04051684|Ropivacaine|ropivacaine|mesh-list
92224026|NCT04051684|Anesthetics, Local|anesthetics, local|mesh-ancestor
92224027|NCT04051684|Anesthetics|anesthetics|mesh-ancestor
92224028|NCT04051684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224029|NCT04051684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224030|NCT04051684|Sensory System Agents|sensory system agents|mesh-ancestor
92224031|NCT04051684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224032|NCT04840862|Rifabutin|rifabutin|mesh-list
92224033|NCT04840862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92224034|NCT04840862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224035|NCT04840862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92224036|NCT04840862|Antitubercular Agents|antitubercular agents|mesh-ancestor
92224037|NCT04840238|Cholecalciferol|cholecalciferol|mesh-list
92224038|NCT04840238|Vitamin D|vitamin d|mesh-list
92224039|NCT04840238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92224040|NCT04840238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224041|NCT04840238|Vitamins|vitamins|mesh-ancestor
92224042|NCT04840238|Micronutrients|micronutrients|mesh-ancestor
92224043|NCT04840238|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92224044|NCT03829618|Lidocaine|lidocaine|mesh-list
92224045|NCT03829618|Anesthetics, Local|anesthetics, local|mesh-ancestor
92224046|NCT03829618|Anesthetics|anesthetics|mesh-ancestor
92224047|NCT03829618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224048|NCT03829618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224049|NCT03829618|Sensory System Agents|sensory system agents|mesh-ancestor
92224050|NCT03829618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224051|NCT03829618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92224052|NCT03829618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92224053|NCT03829618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92224054|NCT03829618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92224055|NCT03829618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224056|NCT04272788|Infliximab|infliximab|mesh-list
92224057|NCT04272788|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92224058|NCT04272788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224059|NCT04272788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224060|NCT04272788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224061|NCT04272788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224062|NCT01457690|Tocopherols|tocopherols|mesh-list
92224063|NCT01457690|Vitamin E|vitamin e|mesh-list
92224064|NCT01457690|Tocotrienols|tocotrienols|mesh-list
92224065|NCT01457690|alpha-Tocopherol|alpha-tocopherol|mesh-list
92224066|NCT01457690|Antioxidants|antioxidants|mesh-ancestor
92337968|NCT00379457|Carboplatin|carboplatin|mesh-list
92224067|NCT01457690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224068|NCT01457690|Protective Agents|protective agents|mesh-ancestor
92224069|NCT01457690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224070|NCT01457690|Vitamins|vitamins|mesh-ancestor
92224071|NCT01457690|Micronutrients|micronutrients|mesh-ancestor
92224072|NCT05497206|Metronidazole|metronidazole|mesh-list
92224073|NCT05497206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224074|NCT05497206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92224075|NCT05497206|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92224076|NCT05497206|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92224077|NCT01451060|Ephedrine|ephedrine|mesh-list
92224078|NCT01451060|Metaraminol|metaraminol|mesh-list
92224079|NCT01451060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92224080|NCT01451060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224081|NCT01451060|Sympathomimetics|sympathomimetics|mesh-ancestor
92224082|NCT01451060|Autonomic Agents|autonomic agents|mesh-ancestor
92224083|NCT01451060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224084|NCT01451060|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92224085|NCT01451060|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224086|NCT01451060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224087|NCT01451060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224088|NCT01451060|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92224089|NCT01451060|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92224090|NCT01451060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92224091|NCT04904562|Angiotensin II|angiotensin ii|mesh-list
92224092|NCT04904562|Giapreza|giapreza|mesh-list
92224093|NCT04904562|Angiotensinogen|angiotensinogen|mesh-list
92224094|NCT04904562|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92224095|NCT04904562|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92224096|NCT04904562|Protease Inhibitors|protease inhibitors|mesh-ancestor
92224097|NCT04904562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224098|NCT04904562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224099|NCT01143181|Brincidofovir|brincidofovir|mesh-list
92224100|NCT01143181|Antiviral Agents|antiviral agents|mesh-ancestor
92224101|NCT01143181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224102|NCT01451294|Phenylephrine|phenylephrine|mesh-list
92224103|NCT01451294|Oxymetazoline|oxymetazoline|mesh-list
92224104|NCT01451294|Ephedrine|ephedrine|mesh-list
92224105|NCT01451294|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92224106|NCT01451294|Mydriatics|mydriatics|mesh-ancestor
92224107|NCT01451294|Autonomic Agents|autonomic agents|mesh-ancestor
92224108|NCT01451294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224109|NCT01451294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224110|NCT01451294|Sympathomimetics|sympathomimetics|mesh-ancestor
92224111|NCT01451294|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92224112|NCT01451294|Nasal Decongestants|nasal decongestants|mesh-ancestor
92224113|NCT01451294|Respiratory System Agents|respiratory system agents|mesh-ancestor
92224114|NCT01451294|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92224115|NCT01451294|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92224116|NCT01451294|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92224117|NCT01451294|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224118|NCT01451294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224119|NCT01451294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224120|NCT01451294|Protective Agents|protective agents|mesh-ancestor
92224121|NCT01451294|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92224122|NCT01187017|Cyclophosphamide|cyclophosphamide|mesh-list
92224123|NCT01187017|Fludarabine|fludarabine|mesh-list
92224124|NCT01187017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92224125|NCT01187017|Immunologic Factors|immunologic factors|mesh-ancestor
92224126|NCT01187017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224127|NCT01187017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224128|NCT01187017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92224129|NCT01187017|Alkylating Agents|alkylating agents|mesh-ancestor
92224130|NCT01187017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224131|NCT01187017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224132|NCT01187017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92224133|NCT00378118|Antibodies|antibodies|mesh-list
92224134|NCT00378118|Immunoglobulins|immunoglobulins|mesh-list
92224135|NCT00378118|HIV Antibodies|hiv antibodies|mesh-list
92224136|NCT00378118|Immunologic Factors|immunologic factors|mesh-ancestor
92224137|NCT00378118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224138|NCT01224145|Bupivacaine|bupivacaine|mesh-list
92224139|NCT01224145|Anesthetics, Local|anesthetics, local|mesh-ancestor
92224140|NCT01224145|Anesthetics|anesthetics|mesh-ancestor
92224141|NCT01224145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224142|NCT01224145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224143|NCT01224145|Sensory System Agents|sensory system agents|mesh-ancestor
92224144|NCT01224145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224145|NCT01451840|Lidocaine|lidocaine|mesh-list
92224146|NCT01451840|Remifentanil|remifentanil|mesh-list
92224147|NCT01451840|Anesthetics, Local|anesthetics, local|mesh-ancestor
92224148|NCT01451840|Anesthetics|anesthetics|mesh-ancestor
92224149|NCT01451840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224150|NCT01451840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224151|NCT01451840|Sensory System Agents|sensory system agents|mesh-ancestor
92224152|NCT01451840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224153|NCT01451840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92224154|NCT01451840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92224155|NCT01451840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92224156|NCT01451840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92224157|NCT01451840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224158|NCT01451840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92224159|NCT01451840|Narcotics|narcotics|mesh-ancestor
92224160|NCT01451840|Analgesics|analgesics|mesh-ancestor
92224161|NCT01451918|Resveratrol|resveratrol|mesh-list
92224162|NCT01451918|Antioxidants|antioxidants|mesh-ancestor
92224163|NCT01451918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224164|NCT01451918|Protective Agents|protective agents|mesh-ancestor
92224165|NCT01451918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224166|NCT01451918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224167|NCT01451918|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92224168|NCT00378196|Ranibizumab|ranibizumab|mesh-list
92224169|NCT00378196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92224170|NCT00378196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92224171|NCT00378196|Growth Substances|growth substances|mesh-ancestor
92224172|NCT00378196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224173|NCT00378196|Growth Inhibitors|growth inhibitors|mesh-ancestor
92224174|NCT00378196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224175|NCT01188109|Gemcitabine|gemcitabine|mesh-list
92224176|NCT01188109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224177|NCT01188109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92224178|NCT01188109|Antimetabolites|antimetabolites|mesh-ancestor
92224179|NCT01188109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224180|NCT01458236|Beraprost|beraprost|mesh-list
92224181|NCT01458236|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92224182|NCT01458236|Vasodilator Agents|vasodilator agents|mesh-ancestor
92224183|NCT01146457|Morphine|morphine|mesh-list
92224184|NCT01146457|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92224185|NCT01146457|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92224186|NCT01146457|Narcotics|narcotics|mesh-ancestor
92224187|NCT01146457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224188|NCT01146457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224189|NCT01146457|Analgesics|analgesics|mesh-ancestor
92224190|NCT01146457|Sensory System Agents|sensory system agents|mesh-ancestor
92224191|NCT01146457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224192|NCT04031430|Antihypertensive Agents|antihypertensive agents|mesh-list
92224193|NCT02886962|Vitamin K|vitamin k|mesh-list
92224194|NCT02886962|Vitamins|vitamins|mesh-ancestor
92224195|NCT02886962|Micronutrients|micronutrients|mesh-ancestor
92224196|NCT02886962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224197|NCT02886962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92224198|NCT02886962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92224199|NCT02886962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224200|NCT02886962|Hemostatics|hemostatics|mesh-ancestor
92224201|NCT02886962|Coagulants|coagulants|mesh-ancestor
92224202|NCT05495958|Vitamin D|vitamin d|mesh-list
92224203|NCT05495958|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92224204|NCT05495958|Vitamins|vitamins|mesh-ancestor
92224205|NCT05495958|Micronutrients|micronutrients|mesh-ancestor
92224206|NCT05495958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224207|NCT05495958|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92224208|NCT05495958|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92224210|NCT04011592|Analgesics|analgesics|mesh-ancestor
92224211|NCT04011592|Sensory System Agents|sensory system agents|mesh-ancestor
92224212|NCT04011592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224213|NCT04011592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224214|NCT04011592|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92224215|NCT04011592|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92224216|NCT04011592|Anesthetics, General|anesthetics, general|mesh-ancestor
92224217|NCT04011592|Anesthetics|anesthetics|mesh-ancestor
92224218|NCT04011592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224219|NCT04011592|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92224220|NCT04011592|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92224221|NCT04011592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117523|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92224222|NCT04011592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224223|NCT01458470|Memantine|memantine|mesh-list
92224224|NCT01458470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92224225|NCT01458470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92224226|NCT01458470|Dopamine Agents|dopamine agents|mesh-ancestor
92224227|NCT01458470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224228|NCT01458470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224229|NCT01458470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224230|NCT01458470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92224231|NCT01458470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92224233|NCT05025488|Interferon Inducers|interferon inducers|mesh-ancestor
92224234|NCT05025488|Immunologic Factors|immunologic factors|mesh-ancestor
92224235|NCT05025488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224236|NCT01452542|Eliglustat|eliglustat|mesh-list
92224237|NCT01452542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224238|NCT01452542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224239|NCT01458548|Rituximab|rituximab|mesh-list
92224240|NCT01458548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224241|NCT01458548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224242|NCT01458548|Immunologic Factors|immunologic factors|mesh-ancestor
92224243|NCT01458548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224244|NCT01458548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224245|NCT05027204|Docetaxel|docetaxel|mesh-list
92224246|NCT05027204|Nivolumab|nivolumab|mesh-list
92224247|NCT05027204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224248|NCT05027204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92224249|NCT05027204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92224250|NCT05027204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92224251|NCT05027204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224252|NCT05027204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224253|NCT05027204|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224254|NCT01458626|Mirtazapine|mirtazapine|mesh-list
92224255|NCT01458626|Paroxetine|paroxetine|mesh-list
92224256|NCT01458626|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92224257|NCT01458626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92224258|NCT01458626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92224259|NCT01458626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224260|NCT01458626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224261|NCT01458626|Serotonin Agents|serotonin agents|mesh-ancestor
92224262|NCT01458626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224263|NCT01458626|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92224264|NCT01458626|Antidepressive Agents|antidepressive agents|mesh-ancestor
92224265|NCT01458626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224266|NCT01458626|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92224267|NCT01458626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92224268|NCT01458626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224269|NCT01458626|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92224270|NCT01458626|Histamine Antagonists|histamine antagonists|mesh-ancestor
92224271|NCT01458626|Histamine Agents|histamine agents|mesh-ancestor
92224272|NCT01458626|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92224273|NCT01458626|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92224274|NCT01458626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224275|NCT01458626|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92224276|NCT01458626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92224277|NCT01458626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92224278|NCT01458626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224279|NCT01458626|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92224280|NCT01458626|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92224281|NCT01458626|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92224282|NCT00377806|Diclofenac|diclofenac|mesh-list
92224283|NCT00377806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92224284|NCT00377806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224285|NCT00377806|Analgesics|analgesics|mesh-ancestor
92224286|NCT00377806|Sensory System Agents|sensory system agents|mesh-ancestor
92224287|NCT00377806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224288|NCT00377806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224289|NCT00377806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224290|NCT00377806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224291|NCT00377806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92224292|NCT00377806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224293|NCT00377806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224294|NCT05495724|Tislelizumab|tislelizumab|mesh-list
92224295|NCT05495724|Disitamab vedotin|disitamab vedotin|mesh-list
92224296|NCT05495724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224297|NCT05495724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224298|NCT05495724|Immunoconjugates|immunoconjugates|mesh-ancestor
92224299|NCT05495724|Immunologic Factors|immunologic factors|mesh-ancestor
92224300|NCT05495724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224302|NCT02559414|Clopidogrel|clopidogrel|mesh-list
92224303|NCT02559414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92224304|NCT02559414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224305|NCT02559414|Analgesics|analgesics|mesh-ancestor
92224306|NCT02559414|Sensory System Agents|sensory system agents|mesh-ancestor
92224307|NCT02559414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224308|NCT02559414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224309|NCT02559414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224310|NCT02559414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224311|NCT02559414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92224312|NCT02559414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92224313|NCT02559414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224314|NCT02559414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92224315|NCT02559414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92224316|NCT02559414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224317|NCT02559414|Antipyretics|antipyretics|mesh-ancestor
92224318|NCT02559414|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92224319|NCT02559414|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92224320|NCT02559414|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92224321|NCT02559414|Purinergic Agents|purinergic agents|mesh-ancestor
92224322|NCT02559414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224323|NCT03527264|Nivolumab|nivolumab|mesh-list
92224324|NCT03527264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224325|NCT03527264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224326|NCT03527264|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224327|NCT03527264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224328|NCT04713904|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92224329|NCT04713904|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92224330|NCT04713904|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92224332|NCT04713904|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92224333|NCT04713904|Estrogens|estrogens|mesh-ancestor
92224334|NCT04713904|Hormones|hormones|mesh-ancestor
92224335|NCT04713904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224336|NCT04713904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224337|NCT04713904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92224338|NCT04713904|Contraceptive Agents|contraceptive agents|mesh-ancestor
92224339|NCT04713904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92224340|NCT04713904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92224341|NCT04713904|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92224342|NCT04713904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92224343|NCT03995680|Mebendazole|mebendazole|mesh-list
92224344|NCT03995680|Piperazine|piperazine|mesh-list
92224345|NCT03995680|Piperazine citrate|piperazine citrate|mesh-list
92224346|NCT03995680|DMP 777|dmp 777|mesh-list
92224347|NCT03995680|Antinematodal Agents|antinematodal agents|mesh-ancestor
92224348|NCT03995680|Anthelmintics|anthelmintics|mesh-ancestor
92224349|NCT03995680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92224350|NCT03995680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224351|NCT03995680|Tubulin Modulators|tubulin modulators|mesh-ancestor
92224352|NCT03995680|Antimitotic Agents|antimitotic agents|mesh-ancestor
92224353|NCT03995680|Mitosis Modulators|mitosis modulators|mesh-ancestor
92224354|NCT03995680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224355|NCT03995680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224356|NCT03995680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224357|NCT01452698|Lansoprazole|lansoprazole|mesh-list
92224358|NCT01452698|Dexlansoprazole|dexlansoprazole|mesh-list
92224359|NCT01452698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92224360|NCT01452698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224361|NCT01452698|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92224362|NCT01452698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224363|NCT01452698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224364|NCT05029856|Vaccines|vaccines|mesh-list
92224365|NCT05029856|Immunologic Factors|immunologic factors|mesh-ancestor
92224366|NCT05029856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224367|NCT05490342|Antibodies|antibodies|mesh-list
92224368|NCT05490342|Myeloma Proteins|myeloma proteins|mesh-list
92224369|NCT05490342|Paraproteins|paraproteins|mesh-list
92224370|NCT05490342|Immunologic Factors|immunologic factors|mesh-ancestor
92224371|NCT05490342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224372|NCT05495100|Azacitidine|azacitidine|mesh-list
92224373|NCT05495100|Mitoxantrone|mitoxantrone|mesh-list
92224374|NCT05495100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92224375|NCT05495100|Antimetabolites|antimetabolites|mesh-ancestor
92224376|NCT05495100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224378|NCT05495100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224379|NCT05495100|Analgesics|analgesics|mesh-ancestor
92224380|NCT05495100|Sensory System Agents|sensory system agents|mesh-ancestor
92224381|NCT05495100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224382|NCT05495100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224383|NCT05495100|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92224384|NCT05495100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92224385|NCT03325114|Chlorthalidone|chlorthalidone|mesh-list
92224386|NCT03325114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92224387|NCT03325114|Diuretics|diuretics|mesh-ancestor
92224388|NCT03325114|Natriuretic Agents|natriuretic agents|mesh-ancestor
92224389|NCT03325114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224390|NCT03325114|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92224391|NCT03325114|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92224392|NCT03325114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224393|NCT01453400|Aspirin|aspirin|mesh-list
92224394|NCT01453400|Acetaminophen|acetaminophen|mesh-list
92224395|NCT01453400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92224396|NCT01453400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224397|NCT01453400|Analgesics|analgesics|mesh-ancestor
92224398|NCT01453400|Sensory System Agents|sensory system agents|mesh-ancestor
92224399|NCT01453400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224400|NCT01453400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224401|NCT01453400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224402|NCT01453400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224403|NCT01453400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92224404|NCT01453400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92224405|NCT01453400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224406|NCT01453400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92224407|NCT01453400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92224408|NCT01453400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224409|NCT01453400|Antipyretics|antipyretics|mesh-ancestor
92224411|NCT05025644|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92224412|NCT05025644|Sympathomimetics|sympathomimetics|mesh-ancestor
92224413|NCT05025644|Autonomic Agents|autonomic agents|mesh-ancestor
92224414|NCT05025644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338002|NCT01629329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224415|NCT05025644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224416|NCT05025644|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92224417|NCT05025644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92224418|NCT05025644|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92224419|NCT05025644|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224420|NCT05025644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224421|NCT05025644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224422|NCT05025644|Protective Agents|protective agents|mesh-ancestor
92224423|NCT05494710|Bleomycin|bleomycin|mesh-list
92224424|NCT05494710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92224425|NCT05494710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224426|NCT03810066|Osimertinib|osimertinib|mesh-list
92224427|NCT03810066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224428|NCT03810066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92224429|NCT03810066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224430|NCT03810066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224431|NCT03992482|Immunoglobulins|immunoglobulins|mesh-list
92224432|NCT03992482|Antibodies|antibodies|mesh-list
92224433|NCT03992482|gamma-Globulins|gamma-globulins|mesh-list
92224434|NCT03992482|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92224435|NCT03992482|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92224436|NCT03992482|Immunologic Factors|immunologic factors|mesh-ancestor
92224437|NCT03992482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224438|NCT00377494|Vaccines|vaccines|mesh-list
92224439|NCT00377494|Immunologic Factors|immunologic factors|mesh-ancestor
92224440|NCT00377494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224441|NCT01459250|Agomelatine|agomelatine|mesh-list
92224442|NCT01459250|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92224443|NCT01459250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224444|NCT01459250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224445|NCT04303156|Islatravir|islatravir|mesh-list
92224446|NCT04303156|Antiviral Agents|antiviral agents|mesh-ancestor
92224447|NCT04303156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224448|NCT04303156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224449|NCT04303156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224450|NCT04303156|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92224451|NCT04303156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92224452|NCT04303156|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92224453|NCT04390334|Efavirenz|efavirenz|mesh-list
92224454|NCT04390334|Famotidine|famotidine|mesh-list
92224455|NCT04390334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92224456|NCT04390334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92224457|NCT04390334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224458|NCT04390334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224459|NCT04390334|Antiviral Agents|antiviral agents|mesh-ancestor
92224460|NCT04390334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224461|NCT04390334|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92224462|NCT04390334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92224463|NCT04390334|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92224464|NCT04390334|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92224465|NCT04390334|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92224466|NCT04390334|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92224467|NCT04390334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92224468|NCT04390334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224469|NCT04390334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92224470|NCT04390334|Histamine Antagonists|histamine antagonists|mesh-ancestor
92224471|NCT04390334|Histamine Agents|histamine agents|mesh-ancestor
92224472|NCT04390334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224473|NCT04390334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224474|NCT02880020|Nivolumab|nivolumab|mesh-list
92224475|NCT02880020|Ipilimumab|ipilimumab|mesh-list
92224476|NCT02880020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224477|NCT02880020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224478|NCT02880020|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224479|NCT02880020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990553|NCT04517357|Apatinib|apatinib|mesh-list
92224480|NCT03150160|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92224482|NCT03150160|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92224483|NCT03150160|Brinzolamide|brinzolamide|mesh-list
92224484|NCT03150160|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92224485|NCT03150160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92224486|NCT03150160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92224487|NCT03150160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92224489|NCT03150160|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224490|NCT03150160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224491|NCT03150160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224492|NCT03150160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224493|NCT03150160|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92224494|NCT03150160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224495|NCT01459406|Levan|levan|mesh-list
92224496|NCT01459406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224497|NCT05489952|Iron|iron|mesh-list
92224498|NCT05489952|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92224499|NCT05489952|Trace Elements|trace elements|mesh-ancestor
92224500|NCT05489952|Micronutrients|micronutrients|mesh-ancestor
92224501|NCT05489952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224502|NCT05489952|Hematinics|hematinics|mesh-ancestor
92224503|NCT01459640|Hyaluronic Acid|hyaluronic acid|mesh-list
92224504|NCT01459640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92224505|NCT01459640|Immunologic Factors|immunologic factors|mesh-ancestor
92224506|NCT01459640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224507|NCT01459640|Viscosupplements|viscosupplements|mesh-ancestor
92224508|NCT01459640|Protective Agents|protective agents|mesh-ancestor
92224509|NCT04257396|Carbon Fiber|carbon fiber|mesh-list
92224510|NCT04257396|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92224511|NCT04257396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224512|NCT01500772|Ribavirin|ribavirin|mesh-list
92224513|NCT01500772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92224514|NCT01500772|Antimetabolites|antimetabolites|mesh-ancestor
92224515|NCT01500772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224516|NCT01500772|Antiviral Agents|antiviral agents|mesh-ancestor
92224517|NCT01500772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224518|NCT04272476|Fluoxetine|fluoxetine|mesh-list
92224519|NCT04272476|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92224520|NCT04272476|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92224521|NCT04272476|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92224522|NCT04272476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224523|NCT04272476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224524|NCT04272476|Serotonin Agents|serotonin agents|mesh-ancestor
92224525|NCT04272476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224526|NCT04272476|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92224528|NCT04272476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224529|NCT04272476|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92224530|NCT04272476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92224531|NCT04272476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224532|NCT03984838|Dolutegravir|dolutegravir|mesh-list
92224533|NCT03984838|Rilpivirine|rilpivirine|mesh-list
92224534|NCT03984838|Dolutegravir, rilpivirine drug combination|dolutegravir, rilpivirine drug combination|mesh-list
92224535|NCT03984838|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92224536|NCT03984838|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92224537|NCT03984838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224538|NCT03984838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224539|NCT03984838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92224540|NCT03984838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92224541|NCT03984838|Antiviral Agents|antiviral agents|mesh-ancestor
92224542|NCT03984838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224543|NCT03984838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92224544|NCT03984838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92224545|NCT02994576|Atezolizumab|atezolizumab|mesh-list
92224546|NCT02994576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224547|NCT02994576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224548|NCT02994576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224549|NCT02994576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224550|NCT01890902|Ketoprofen|ketoprofen|mesh-list
92224551|NCT01890902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92224552|NCT01890902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224553|NCT01890902|Analgesics|analgesics|mesh-ancestor
92224554|NCT01890902|Sensory System Agents|sensory system agents|mesh-ancestor
92224555|NCT01890902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224556|NCT01890902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224557|NCT01890902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224558|NCT01890902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224559|NCT01890902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92224560|NCT01890902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224561|NCT01890902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224562|NCT04423926|Prednisolone|prednisolone|mesh-list
92224563|NCT04423926|Cyclophosphamide|cyclophosphamide|mesh-list
92224564|NCT04423926|Doxorubicin|doxorubicin|mesh-list
92224565|NCT04423926|Vincristine|vincristine|mesh-list
92224566|NCT04423926|Lenalidomide|lenalidomide|mesh-list
92224567|NCT04423926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92224568|NCT04423926|Immunologic Factors|immunologic factors|mesh-ancestor
92224569|NCT04423926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224570|NCT04423926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224571|NCT04423926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92224572|NCT04423926|Alkylating Agents|alkylating agents|mesh-ancestor
92224573|NCT04423926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224574|NCT04423926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224575|NCT04423926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92224576|NCT04423926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92224577|NCT04423926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92224578|NCT04423926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92224579|NCT04423926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224580|NCT04423926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92224581|NCT04423926|Tubulin Modulators|tubulin modulators|mesh-ancestor
92224582|NCT04423926|Antimitotic Agents|antimitotic agents|mesh-ancestor
92224583|NCT04423926|Mitosis Modulators|mitosis modulators|mesh-ancestor
92224584|NCT04423926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92224585|NCT04423926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92224586|NCT04423926|Growth Substances|growth substances|mesh-ancestor
92224587|NCT04423926|Growth Inhibitors|growth inhibitors|mesh-ancestor
92224588|NCT04423926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224589|NCT04423926|Glucocorticoids|glucocorticoids|mesh-ancestor
92224590|NCT04423926|Hormones|hormones|mesh-ancestor
92224591|NCT04423926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224592|NCT04423926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92224593|NCT03979066|Atezolizumab|atezolizumab|mesh-list
92224594|NCT03979066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224595|NCT03979066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224596|NCT03979066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224597|NCT03979066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224598|NCT03968848|Acalabrutinib|acalabrutinib|mesh-list
92224599|NCT03968848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224600|NCT05489406|Dolutegravir|dolutegravir|mesh-list
92224601|NCT05489406|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92224602|NCT05489406|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92224603|NCT05489406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224604|NCT05489406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224605|NCT05489406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92224606|NCT05489406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92224607|NCT05489406|Antiviral Agents|antiviral agents|mesh-ancestor
92224608|NCT05489406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224609|NCT01479010|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92224610|NCT01479010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224611|NCT01472692|Febuxostat|febuxostat|mesh-list
92224612|NCT01472692|Gout Suppressants|gout suppressants|mesh-ancestor
92224613|NCT01472692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224614|NCT00378820|Caseins|caseins|mesh-list
92224615|NCT00378820|Chelating Agents|chelating agents|mesh-ancestor
92224616|NCT00378820|Sequestering Agents|sequestering agents|mesh-ancestor
92224617|NCT00378820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224618|NCT02558400|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92224619|NCT02558400|Latanoprost|latanoprost|mesh-list
92224620|NCT02558400|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92224621|NCT04758260|Antioxidants|antioxidants|mesh-list
92224622|NCT04758260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224623|NCT04758260|Protective Agents|protective agents|mesh-ancestor
92224624|NCT04758260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224625|NCT01446250|Ribavirin|ribavirin|mesh-list
92224626|NCT01446250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92224627|NCT01446250|Antimetabolites|antimetabolites|mesh-ancestor
92224628|NCT01446250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224629|NCT01446250|Antiviral Agents|antiviral agents|mesh-ancestor
92224630|NCT01446250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224632|NCT05493618|Pembrolizumab|pembrolizumab|mesh-list
92224633|NCT05493618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224634|NCT05493618|Antiemetics|antiemetics|mesh-ancestor
92224635|NCT05493618|Autonomic Agents|autonomic agents|mesh-ancestor
92224636|NCT05493618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224637|NCT05493618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224638|NCT05493618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224639|NCT05493618|Glucocorticoids|glucocorticoids|mesh-ancestor
92224640|NCT05493618|Hormones|hormones|mesh-ancestor
92224641|NCT05493618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224642|NCT05493618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92224643|NCT05493618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224644|NCT05493618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224645|NCT05493618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224646|NCT05493618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224647|NCT00379600|Rosiglitazone|rosiglitazone|mesh-list
92224648|NCT00379600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92224649|NCT00379600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224650|NCT04139304|Prednisone|prednisone|mesh-list
92224651|NCT04139304|Cortisone|cortisone|mesh-list
92224652|NCT04139304|Cyclophosphamide|cyclophosphamide|mesh-list
92224653|NCT04139304|Doxorubicin|doxorubicin|mesh-list
92224654|NCT04139304|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92224655|NCT04139304|Etoposide|etoposide|mesh-list
92224656|NCT04139304|Vincristine|vincristine|mesh-list
92224657|NCT04139304|Etoposide phosphate|etoposide phosphate|mesh-list
92224658|NCT04139304|Daunorubicin|daunorubicin|mesh-list
92224659|NCT04139304|Daratumumab|daratumumab|mesh-list
92224660|NCT04139304|Podophyllotoxin|podophyllotoxin|mesh-list
92224661|NCT04139304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92224662|NCT04139304|Immunologic Factors|immunologic factors|mesh-ancestor
92224663|NCT04139304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224664|NCT04139304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224665|NCT04139304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92224666|NCT04139304|Alkylating Agents|alkylating agents|mesh-ancestor
92224667|NCT04139304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224668|NCT04139304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224669|NCT04139304|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92224670|NCT04139304|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92224671|NCT04139304|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92224672|NCT04139304|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92224673|NCT04139304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224674|NCT04139304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224675|NCT04139304|Glucocorticoids|glucocorticoids|mesh-ancestor
92224676|NCT04139304|Hormones|hormones|mesh-ancestor
92224677|NCT04139304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224678|NCT04139304|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92224679|NCT04139304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92224680|NCT04139304|Tubulin Modulators|tubulin modulators|mesh-ancestor
92224681|NCT04139304|Antimitotic Agents|antimitotic agents|mesh-ancestor
92224682|NCT04139304|Mitosis Modulators|mitosis modulators|mesh-ancestor
92224683|NCT04139304|Keratolytic Agents|keratolytic agents|mesh-ancestor
92224684|NCT04139304|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224685|NCT05020574|Cephalexin|cephalexin|mesh-list
92224686|NCT05020574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92224687|NCT05020574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224688|NCT02936206|Tamoxifen|tamoxifen|mesh-list
92224689|NCT02936206|Fulvestrant|fulvestrant|mesh-list
92224690|NCT02936206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92224691|NCT02936206|Hormone Antagonists|hormone antagonists|mesh-ancestor
92224692|NCT02936206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224693|NCT02936206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224694|NCT02936206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92224695|NCT02936206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224696|NCT02936206|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92224697|NCT02936206|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92224698|NCT02936206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92224699|NCT02936206|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92224700|NCT01891526|Tretinoin|tretinoin|mesh-list
92224701|NCT01891526|Alitretinoin|alitretinoin|mesh-list
92224702|NCT01891526|Isotretinoin|isotretinoin|mesh-list
92224703|NCT01891526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224704|NCT01891526|Keratolytic Agents|keratolytic agents|mesh-ancestor
92224705|NCT01891526|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224706|NCT01406860|Diphenhydramine|diphenhydramine|mesh-list
92224707|NCT01406860|Promethazine|promethazine|mesh-list
92224708|NCT01406860|Droperidol|droperidol|mesh-list
92224709|NCT01406860|Metoclopramide|metoclopramide|mesh-list
92224710|NCT01406860|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92224711|NCT01406860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92224712|NCT01406860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224713|NCT01406860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224714|NCT01406860|Anesthetics, Local|anesthetics, local|mesh-ancestor
92224715|NCT01406860|Anesthetics|anesthetics|mesh-ancestor
92224716|NCT01406860|Sensory System Agents|sensory system agents|mesh-ancestor
92224717|NCT01406860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224718|NCT01406860|Antiemetics|antiemetics|mesh-ancestor
92224719|NCT01406860|Autonomic Agents|autonomic agents|mesh-ancestor
92224720|NCT01406860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224721|NCT01406860|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92224722|NCT01406860|Histamine Antagonists|histamine antagonists|mesh-ancestor
92224723|NCT01406860|Histamine Agents|histamine agents|mesh-ancestor
92224724|NCT01406860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224725|NCT01406860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224726|NCT01406860|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92224727|NCT01406860|Antipruritics|antipruritics|mesh-ancestor
92224728|NCT01406860|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224729|NCT01406860|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92224730|NCT01406860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92224731|NCT01406860|Dopamine Agents|dopamine agents|mesh-ancestor
92224732|NCT01406860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92224733|NCT01406860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92224734|NCT01406860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92224735|NCT01406860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224736|NCT04138212|Paclitaxel|paclitaxel|mesh-list
92224737|NCT04138212|Cisplatin|cisplatin|mesh-list
92224738|NCT04138212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92224739|NCT04138212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224740|NCT04138212|Tubulin Modulators|tubulin modulators|mesh-ancestor
92224741|NCT04138212|Antimitotic Agents|antimitotic agents|mesh-ancestor
92224742|NCT04138212|Mitosis Modulators|mitosis modulators|mesh-ancestor
92224743|NCT04138212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224744|NCT02773576|Risperidone|risperidone|mesh-list
92224745|NCT02773576|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92224747|NCT02773576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224748|NCT02773576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224749|NCT02773576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224750|NCT02773576|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92224751|NCT02773576|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91940587|NCT00774761|Xhance|xhance|mesh-list
92224752|NCT02773576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224753|NCT02773576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224754|NCT02773576|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92224755|NCT02773576|Dopamine Agents|dopamine agents|mesh-ancestor
92224756|NCT05022758|Warfarin|warfarin|mesh-list
92224757|NCT05022758|Rivaroxaban|rivaroxaban|mesh-list
92224758|NCT05022758|Anticoagulants|anticoagulants|mesh-ancestor
92338038|NCT00423059|Bevacizumab|bevacizumab|mesh-list
92224759|NCT05022758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92224760|NCT05022758|Antithrombins|antithrombins|mesh-ancestor
92224761|NCT05022758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92224762|NCT05022758|Protease Inhibitors|protease inhibitors|mesh-ancestor
92224763|NCT05022758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224764|NCT05022758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224765|NCT05021978|Pramoxine|pramoxine|mesh-list
92224766|NCT05021978|Anesthetics, Local|anesthetics, local|mesh-ancestor
92224767|NCT05021978|Anesthetics|anesthetics|mesh-ancestor
92224768|NCT05021978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224769|NCT05021978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224770|NCT05021978|Sensory System Agents|sensory system agents|mesh-ancestor
92224771|NCT05021978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224772|NCT04280406|Azithromycin|azithromycin|mesh-list
92224773|NCT04280406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92224774|NCT04280406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224775|NCT05599828|Sotorasib|sotorasib|mesh-list
92224776|NCT05599828|Omeprazole|omeprazole|mesh-list
92224777|NCT05599828|Famotidine|famotidine|mesh-list
92224778|NCT05599828|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92224779|NCT05599828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224780|NCT05599828|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92224781|NCT05599828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224782|NCT05599828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224783|NCT05599828|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92224784|NCT05599828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92224785|NCT05599828|Histamine Agents|histamine agents|mesh-ancestor
92224786|NCT05599828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224787|NCT05599828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224788|NCT05599828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92224789|NCT05599828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224790|NCT05599828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224791|NCT01350232|Cytarabine|cytarabine|mesh-list
92224792|NCT01350232|Cyclophosphamide|cyclophosphamide|mesh-list
92224793|NCT01350232|Rituximab|rituximab|mesh-list
92224794|NCT01350232|Fludarabine|fludarabine|mesh-list
92224795|NCT01350232|Bortezomib|bortezomib|mesh-list
92224796|NCT01350232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92224797|NCT01350232|Immunologic Factors|immunologic factors|mesh-ancestor
92224798|NCT01350232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224799|NCT01350232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92224800|NCT01350232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92224801|NCT01350232|Alkylating Agents|alkylating agents|mesh-ancestor
92224802|NCT01350232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224803|NCT01350232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224804|NCT01350232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92224805|NCT01350232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224806|NCT01350232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92224807|NCT01350232|Antimetabolites|antimetabolites|mesh-ancestor
92224808|NCT01350232|Antiviral Agents|antiviral agents|mesh-ancestor
92224809|NCT01350232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224810|NCT05493228|Dexmedetomidine|dexmedetomidine|mesh-list
92224811|NCT05493228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92224812|NCT05493228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224813|NCT05493228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224814|NCT05493228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224815|NCT05493228|Analgesics|analgesics|mesh-ancestor
92224816|NCT05493228|Sensory System Agents|sensory system agents|mesh-ancestor
92224817|NCT05493228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224818|NCT05493228|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92224819|NCT05493228|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92224821|NCT05493228|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224822|NCT05493228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224823|NCT05493228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224824|NCT02758132|Denosumab|denosumab|mesh-list
92224825|NCT02758132|Prednisone|prednisone|mesh-list
92224826|NCT02758132|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224827|NCT02758132|Glucocorticoids|glucocorticoids|mesh-ancestor
92224828|NCT02758132|Hormones|hormones|mesh-ancestor
92224829|NCT02758132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224830|NCT02758132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224831|NCT02758132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92224832|NCT02758132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224833|NCT02758132|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92224835|NCT01891916|Chelating Agents|chelating agents|mesh-ancestor
92224836|NCT01891916|Sequestering Agents|sequestering agents|mesh-ancestor
92224837|NCT01891916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224838|NCT01313416|Gemcitabine|gemcitabine|mesh-list
92224839|NCT01313416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92224840|NCT01313416|Antimetabolites|antimetabolites|mesh-ancestor
92224841|NCT01313416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224842|NCT01313416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224843|NCT05599360|Gemtuzumab|gemtuzumab|mesh-list
92224844|NCT05599360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92224845|NCT05599360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224846|NCT05599360|Immunotoxins|immunotoxins|mesh-ancestor
92224847|NCT05599360|Immunoconjugates|immunoconjugates|mesh-ancestor
92224848|NCT05599360|Immunologic Factors|immunologic factors|mesh-ancestor
92224849|NCT05599360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224850|NCT05499234|Acetaminophen|acetaminophen|mesh-list
92224851|NCT05499234|Meperidine|meperidine|mesh-list
92224852|NCT05499234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224853|NCT05499234|Analgesics|analgesics|mesh-ancestor
92224854|NCT05499234|Sensory System Agents|sensory system agents|mesh-ancestor
92224855|NCT05499234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224856|NCT05499234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224858|NCT05499234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92224859|NCT05499234|Narcotics|narcotics|mesh-ancestor
92224860|NCT05499234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224861|NCT05499234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92224862|NCT01269034|Insulin|insulin|mesh-list
92224863|NCT01269034|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92224864|NCT01269034|Exenatide|exenatide|mesh-list
92224865|NCT01269034|Insulin Glargine|insulin glargine|mesh-list
92224866|NCT01269034|Insulin Detemir|insulin detemir|mesh-list
92224867|NCT01269034|Insulin, Long-Acting|insulin, long-acting|mesh-list
92224868|NCT01269034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92224869|NCT01269034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224870|NCT01269034|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92224871|NCT01269034|Incretins|incretins|mesh-ancestor
92224872|NCT01269034|Hormones|hormones|mesh-ancestor
92224873|NCT01269034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224874|NCT05599126|Lorazepam|lorazepam|mesh-list
92224875|NCT05599126|Mianserin|mianserin|mesh-list
92224876|NCT05599126|Anticonvulsants|anticonvulsants|mesh-ancestor
92224877|NCT05599126|Antiemetics|antiemetics|mesh-ancestor
92224878|NCT05599126|Autonomic Agents|autonomic agents|mesh-ancestor
92224879|NCT05599126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224880|NCT05599126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224881|NCT05599126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92224882|NCT05599126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92224883|NCT05599126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224884|NCT05599126|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92224885|NCT05599126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92224886|NCT05599126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224887|NCT05599126|GABA Modulators|gaba modulators|mesh-ancestor
92224888|NCT05599126|GABA Agents|gaba agents|mesh-ancestor
92224889|NCT05599126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224890|NCT05599126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224891|NCT05599126|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92224892|NCT05599126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92224893|NCT05599126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92224894|NCT05599126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92224895|NCT05599126|Histamine Antagonists|histamine antagonists|mesh-ancestor
92224896|NCT05599126|Histamine Agents|histamine agents|mesh-ancestor
92224897|NCT05599126|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92224898|NCT05599126|Serotonin Agents|serotonin agents|mesh-ancestor
92224899|NCT05599126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92224900|NCT05599126|Antidepressive Agents|antidepressive agents|mesh-ancestor
92224901|NCT01892150|Sunscreening Agents|sunscreening agents|mesh-list
92224902|NCT01892150|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92224903|NCT01892150|Protective Agents|protective agents|mesh-ancestor
92338047|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92224904|NCT01892150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224905|NCT01892150|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224906|NCT02663752|Deferasirox|deferasirox|mesh-list
92224907|NCT02663752|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92224908|NCT02663752|Chelating Agents|chelating agents|mesh-ancestor
92224909|NCT02663752|Sequestering Agents|sequestering agents|mesh-ancestor
92224910|NCT02663752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224911|NCT01253668|Antibodies|antibodies|mesh-list
92224912|NCT01253668|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92224913|NCT01253668|Immunologic Factors|immunologic factors|mesh-ancestor
92224914|NCT01253668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224915|NCT01890200|Ribavirin|ribavirin|mesh-list
92224916|NCT01890200|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92224917|NCT01890200|Antimetabolites|antimetabolites|mesh-ancestor
92224918|NCT01890200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224919|NCT01890200|Antiviral Agents|antiviral agents|mesh-ancestor
92224920|NCT01890200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92224921|NCT01662648|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92224922|NCT01662648|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92224923|NCT01662648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92224924|NCT01662648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92224925|NCT01662648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224926|NCT01662648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92224927|NCT01662648|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92224928|NCT01662648|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92224929|NCT01662648|Serotonin Agents|serotonin agents|mesh-ancestor
92224930|NCT01662648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224931|NCT01662648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224932|NCT01662648|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92224934|NCT01662648|Dopamine Agents|dopamine agents|mesh-ancestor
92224935|NCT05586620|Mitomycins|mitomycins|mesh-list
92224936|NCT05586620|Mitomycin|mitomycin|mesh-list
92224937|NCT05586620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92224938|NCT05586620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224939|NCT05586620|Alkylating Agents|alkylating agents|mesh-ancestor
92224940|NCT05586620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224941|NCT05586620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92224942|NCT05586620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224943|NCT01893788|Eplerenone|eplerenone|mesh-list
92224944|NCT01893788|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92224945|NCT01893788|Hormone Antagonists|hormone antagonists|mesh-ancestor
92224946|NCT01893788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224947|NCT01893788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224948|NCT01893788|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92224949|NCT01893788|Diuretics|diuretics|mesh-ancestor
92224950|NCT01893788|Natriuretic Agents|natriuretic agents|mesh-ancestor
92224951|NCT01893788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92224952|NCT01231750|Capsaicin|capsaicin|mesh-list
92224953|NCT01231750|Antipruritics|antipruritics|mesh-ancestor
92224954|NCT01231750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224955|NCT01231750|Sensory System Agents|sensory system agents|mesh-ancestor
92224956|NCT01231750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224957|NCT01231750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224958|NCT05488860|Triamcinolone|triamcinolone|mesh-list
92224959|NCT05488860|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92224960|NCT05488860|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92224961|NCT05488860|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92224962|NCT05488860|Photosensitizing Agents|photosensitizing agents|mesh-list
92224963|NCT05488860|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92224964|NCT05488860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92224965|NCT05488860|Glucocorticoids|glucocorticoids|mesh-ancestor
92224966|NCT05488860|Hormones|hormones|mesh-ancestor
92338053|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224967|NCT05488860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92224968|NCT05488860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224969|NCT05488860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92224971|NCT05488860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224972|NCT05488860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224973|NCT05488860|Dermatologic Agents|dermatologic agents|mesh-ancestor
92224974|NCT02549716|Acetaminophen|acetaminophen|mesh-list
92224975|NCT02549716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92224976|NCT02549716|Analgesics|analgesics|mesh-ancestor
92224977|NCT02549716|Sensory System Agents|sensory system agents|mesh-ancestor
92224978|NCT02549716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92224979|NCT02549716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224980|NCT02549716|Antipyretics|antipyretics|mesh-ancestor
92224981|NCT01207726|Azacitidine|azacitidine|mesh-list
92224982|NCT01207726|Entinostat|entinostat|mesh-list
92224983|NCT01207726|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92224984|NCT01207726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92224985|NCT01207726|Antimetabolites|antimetabolites|mesh-ancestor
92224986|NCT01207726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224987|NCT01207726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92224988|NCT01207726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92224989|NCT02534038|Quinidine|quinidine|mesh-list
92224990|NCT02534038|Dextromethorphan|dextromethorphan|mesh-list
92224991|NCT02534038|Antitussive Agents|antitussive agents|mesh-ancestor
92224992|NCT02534038|Respiratory System Agents|respiratory system agents|mesh-ancestor
92224993|NCT02534038|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92224994|NCT02534038|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92224995|NCT02534038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92224996|NCT02534038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92224997|NCT02534038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92224998|NCT02534038|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92224999|NCT02534038|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92225000|NCT02534038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225001|NCT02534038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92225002|NCT02534038|Antimalarials|antimalarials|mesh-ancestor
92225003|NCT02534038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92225004|NCT02534038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92225005|NCT02534038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225006|NCT02534038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225007|NCT02534038|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92225008|NCT02534038|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92225009|NCT02534038|Cholinergic Agents|cholinergic agents|mesh-ancestor
92225010|NCT02534038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92225011|NCT02534038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92225012|NCT02534038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225013|NCT02534038|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92225014|NCT02534038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92225016|NCT01202110|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92225017|NCT01202110|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92225018|NCT01202110|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225019|NCT01202110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225020|NCT01202110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225021|NCT01202110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225022|NCT01202110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92225023|NCT01202110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92225024|NCT01202110|Vasodilator Agents|vasodilator agents|mesh-ancestor
92225025|NCT02556918|Insulin|insulin|mesh-list
92225026|NCT02556918|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92225027|NCT02556918|Insulin Glargine|insulin glargine|mesh-list
92225028|NCT02556918|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92225029|NCT02556918|Insulin Aspart|insulin aspart|mesh-list
92225030|NCT02556918|Insulin Lispro|insulin lispro|mesh-list
92225031|NCT02556918|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92225032|NCT02556918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225033|NCT02556918|Incretins|incretins|mesh-ancestor
92225034|NCT02556918|Hormones|hormones|mesh-ancestor
92225035|NCT02556918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225036|NCT02556918|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92225037|NCT02556918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92225038|NCT02556918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225039|NCT02556918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225040|NCT00379756|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92225041|NCT00379756|Vasodilator Agents|vasodilator agents|mesh-ancestor
92225042|NCT00379756|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92225043|NCT00379756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92225044|NCT00379756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225045|NCT00379756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225046|NCT00379756|Urological Agents|urological agents|mesh-ancestor
92225047|NCT02518750|Cytarabine|cytarabine|mesh-list
92225048|NCT02518750|Dexamethasone|dexamethasone|mesh-list
92225049|NCT02518750|Hydrocortisone|hydrocortisone|mesh-list
92225050|NCT02518750|Cyclophosphamide|cyclophosphamide|mesh-list
92225051|NCT02518750|Methotrexate|methotrexate|mesh-list
92225052|NCT02518750|Etoposide|etoposide|mesh-list
92225053|NCT02518750|Vincristine|vincristine|mesh-list
92225054|NCT02518750|Bortezomib|bortezomib|mesh-list
92225055|NCT02518750|Asparaginase|asparaginase|mesh-list
92225056|NCT02518750|Mitoxantrone|mitoxantrone|mesh-list
92225057|NCT02518750|Mercaptopurine|mercaptopurine|mesh-list
92225058|NCT02518750|Clofarabine|clofarabine|mesh-list
92225059|NCT02518750|Panobinostat|panobinostat|mesh-list
92225060|NCT02518750|Pegaspargase|pegaspargase|mesh-list
92225061|NCT02518750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92225062|NCT02518750|Immunologic Factors|immunologic factors|mesh-ancestor
92225063|NCT02518750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225065|NCT02518750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92225066|NCT02518750|Alkylating Agents|alkylating agents|mesh-ancestor
92225067|NCT02518750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225068|NCT02518750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225069|NCT02518750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92225070|NCT02518750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225071|NCT02518750|Antiemetics|antiemetics|mesh-ancestor
92225072|NCT02518750|Autonomic Agents|autonomic agents|mesh-ancestor
92225073|NCT02518750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225074|NCT02518750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225075|NCT02518750|Glucocorticoids|glucocorticoids|mesh-ancestor
92225076|NCT02518750|Hormones|hormones|mesh-ancestor
92225077|NCT02518750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225078|NCT02518750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225079|NCT02518750|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92225080|NCT02518750|Abortifacient Agents|abortifacient agents|mesh-ancestor
92225081|NCT02518750|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92225082|NCT02518750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92225083|NCT02518750|Antimetabolites|antimetabolites|mesh-ancestor
92225084|NCT02518750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92225085|NCT02518750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225086|NCT02518750|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92225087|NCT02518750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92225088|NCT02518750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92225089|NCT02518750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92225090|NCT02518750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92225092|NCT02518750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225093|NCT02518750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225094|NCT02518750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225095|NCT02518750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225096|NCT02518750|Analgesics|analgesics|mesh-ancestor
92225097|NCT02518750|Sensory System Agents|sensory system agents|mesh-ancestor
92225098|NCT02518750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92225099|NCT01194856|Ritonavir|ritonavir|mesh-list
92225100|NCT01194856|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92225101|NCT01194856|Efavirenz|efavirenz|mesh-list
92225102|NCT01194856|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92225103|NCT01194856|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92225104|NCT01194856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92225105|NCT01194856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225106|NCT01194856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225107|NCT01194856|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92225108|NCT01194856|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92225109|NCT01194856|Antiviral Agents|antiviral agents|mesh-ancestor
92225110|NCT01194856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225111|NCT01194856|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92225112|NCT01194856|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92225113|NCT01194856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92225114|NCT01194856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92225115|NCT01194856|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92225116|NCT01194856|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92225117|NCT01194856|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92225118|NCT01194856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92225119|NCT01194856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92225120|NCT01182610|Paclitaxel|paclitaxel|mesh-list
92225121|NCT01182610|Carboplatin|carboplatin|mesh-list
92225122|NCT01182610|Fluorouracil|fluorouracil|mesh-list
92225123|NCT01182610|Panitumumab|panitumumab|mesh-list
92225124|NCT01182610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92225125|NCT01182610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225126|NCT01182610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225127|NCT01182610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225128|NCT01182610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225129|NCT01182610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225130|NCT01182610|Antimetabolites|antimetabolites|mesh-ancestor
92225131|NCT01182610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92225132|NCT01182610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92225133|NCT01182610|Immunologic Factors|immunologic factors|mesh-ancestor
92225134|NCT01182610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225135|NCT01182610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225136|NCT05491902|Flutemetamol|flutemetamol|mesh-list
92225137|NCT05491902|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92225138|NCT05491902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225139|NCT05485896|Pembrolizumab|pembrolizumab|mesh-list
92225140|NCT05485896|Lenvatinib|lenvatinib|mesh-list
92225141|NCT05485896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225142|NCT05485896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225143|NCT05485896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92225144|NCT05485896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225145|NCT05485896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92225146|NCT05485896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225147|NCT05526430|Harmine|harmine|mesh-list
92225148|NCT05526430|Hallucinogens|hallucinogens|mesh-ancestor
92225149|NCT05526430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225150|NCT05526430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92225151|NCT05526430|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92225152|NCT05526430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225153|NCT05526430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225154|NCT05507398|Metformin|metformin|mesh-list
92225155|NCT05507398|Atorvastatin|atorvastatin|mesh-list
92225157|NCT05507398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225158|NCT05507398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92225159|NCT05507398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92225160|NCT05507398|Antimetabolites|antimetabolites|mesh-ancestor
92225161|NCT05507398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225162|NCT05507398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92225163|NCT05507398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92225164|NCT05507398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225165|NCT05487300|Levodopa|levodopa|mesh-list
92225166|NCT05487300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92225167|NCT05487300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92225168|NCT05487300|Dopamine Agents|dopamine agents|mesh-ancestor
92225169|NCT05487300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225170|NCT05487300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225171|NCT05487300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225172|NCT01147042|Interferons|interferons|mesh-list
92225173|NCT01147042|Interferon-gamma|interferon-gamma|mesh-list
92225174|NCT01147042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225175|NCT01147042|Antiviral Agents|antiviral agents|mesh-ancestor
92225176|NCT01147042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225177|NCT05485272|Fluorides|fluorides|mesh-list
92225178|NCT05485272|Cariostatic Agents|cariostatic agents|mesh-ancestor
92225179|NCT05485272|Protective Agents|protective agents|mesh-ancestor
92225180|NCT05485272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225181|NCT01108666|Nelfinavir|nelfinavir|mesh-list
92225182|NCT01108666|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92225183|NCT01108666|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92225184|NCT01108666|Protease Inhibitors|protease inhibitors|mesh-ancestor
92225185|NCT01108666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225186|NCT01108666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225187|NCT01108666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92225188|NCT01108666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92225189|NCT01108666|Antiviral Agents|antiviral agents|mesh-ancestor
92225190|NCT01108666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225191|NCT02317276|Triamcinolone|triamcinolone|mesh-list
92225192|NCT02317276|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92225194|NCT02317276|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92225195|NCT02317276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225196|NCT02317276|Glucocorticoids|glucocorticoids|mesh-ancestor
92225197|NCT02317276|Hormones|hormones|mesh-ancestor
92225198|NCT02317276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225199|NCT02317276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225200|NCT02317276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92225201|NCT02317276|Immunologic Factors|immunologic factors|mesh-ancestor
92225202|NCT02317276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225203|NCT02317276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225204|NCT01662492|Botulinum Toxins|botulinum toxins|mesh-list
92225205|NCT01662492|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92225206|NCT01662492|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92225207|NCT01662492|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92225208|NCT01662492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225209|NCT01662492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225211|NCT01662492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225212|NCT01662492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225213|NCT01662492|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92225214|NCT01662492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225215|NCT00378976|Valacyclovir|valacyclovir|mesh-list
92225216|NCT00378976|Antiviral Agents|antiviral agents|mesh-ancestor
92225217|NCT00378976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225218|NCT05342974|Misoprostol|misoprostol|mesh-list
92225219|NCT05342974|Atorvastatin|atorvastatin|mesh-list
92225220|NCT05342974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92225221|NCT05342974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92225222|NCT05342974|Antimetabolites|antimetabolites|mesh-ancestor
92225223|NCT05342974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225224|NCT05342974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92225225|NCT05342974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92225226|NCT05342974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225227|NCT05342974|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92225228|NCT05342974|Abortifacient Agents|abortifacient agents|mesh-ancestor
92225229|NCT05342974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92225230|NCT05342974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225231|NCT05342974|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92225232|NCT05342974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225233|NCT05342974|Oxytocics|oxytocics|mesh-ancestor
92225234|NCT02297230|Paclitaxel|paclitaxel|mesh-list
92225235|NCT02297230|Capecitabine|capecitabine|mesh-list
92225236|NCT02297230|Trastuzumab|trastuzumab|mesh-list
92225237|NCT02297230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92225238|NCT02297230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225239|NCT02297230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225240|NCT02297230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225241|NCT02297230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225242|NCT02297230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225243|NCT02297230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92225244|NCT02297230|Antimetabolites|antimetabolites|mesh-ancestor
92225245|NCT02297230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225246|NCT02282332|Ticagrelor|ticagrelor|mesh-list
92225247|NCT02282332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92225248|NCT02282332|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92225249|NCT02282332|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92225250|NCT02282332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92225251|NCT02282332|Purinergic Agents|purinergic agents|mesh-ancestor
92225252|NCT02282332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225253|NCT02282332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225254|NCT02282332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225255|NCT02287636|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92225256|NCT02287636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92225257|NCT02287636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225258|NCT05486988|Antineoplastic Agents|antineoplastic agents|mesh-list
92225259|NCT02253394|Ambrisentan|ambrisentan|mesh-list
92225260|NCT02253394|Spironolactone|spironolactone|mesh-list
92225261|NCT02253394|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92225262|NCT02253394|Hormone Antagonists|hormone antagonists|mesh-ancestor
91934357|NCT05624801|Vitamins|vitamins|mesh-ancestor
92225263|NCT02253394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225264|NCT02253394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225265|NCT02253394|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92225266|NCT02253394|Diuretics|diuretics|mesh-ancestor
92225267|NCT02253394|Natriuretic Agents|natriuretic agents|mesh-ancestor
92225268|NCT02253394|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92225269|NCT05479032|Amantadine|amantadine|mesh-list
92225270|NCT05479032|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92225271|NCT05479032|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92225272|NCT05479032|Antiviral Agents|antiviral agents|mesh-ancestor
92225273|NCT05479032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225274|NCT05479032|Dopamine Agents|dopamine agents|mesh-ancestor
92225275|NCT05479032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225276|NCT05479032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225277|NCT05479032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225278|NCT05479032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92225279|NCT05479032|Analgesics|analgesics|mesh-ancestor
92225280|NCT05479032|Sensory System Agents|sensory system agents|mesh-ancestor
92225281|NCT05479032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225282|NCT02236546|Deoxyglucose|deoxyglucose|mesh-list
92225283|NCT02236546|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92225284|NCT02236546|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92225285|NCT02236546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225286|NCT02236546|Antimetabolites|antimetabolites|mesh-ancestor
92225287|NCT02236546|Antiviral Agents|antiviral agents|mesh-ancestor
92225288|NCT02236546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225289|NCT05484648|Dexamethasone|dexamethasone|mesh-list
92225290|NCT05484648|Dexmedetomidine|dexmedetomidine|mesh-list
92225291|NCT05484648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92338111|NCT00528437|Thiotepa|thiotepa|mesh-list
92225292|NCT05484648|Antiemetics|antiemetics|mesh-ancestor
92225293|NCT05484648|Autonomic Agents|autonomic agents|mesh-ancestor
92225294|NCT05484648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225295|NCT05484648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225296|NCT05484648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225297|NCT05484648|Glucocorticoids|glucocorticoids|mesh-ancestor
92225298|NCT05484648|Hormones|hormones|mesh-ancestor
92225299|NCT05484648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225300|NCT05484648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225301|NCT05484648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225302|NCT05484648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92225303|NCT05484648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225304|NCT05484648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92225305|NCT05484648|Analgesics|analgesics|mesh-ancestor
92225306|NCT05484648|Sensory System Agents|sensory system agents|mesh-ancestor
92225307|NCT05484648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92225308|NCT05484648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92225310|NCT05484648|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225311|NCT05484648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225312|NCT05484648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225313|NCT05478954|Pyrimethamine|pyrimethamine|mesh-list
92225314|NCT05478954|Sulfadoxine|sulfadoxine|mesh-list
92225315|NCT05478954|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92225316|NCT05478954|Amodiaquine|amodiaquine|mesh-list
92225317|NCT05478954|Antimalarials|antimalarials|mesh-ancestor
92225318|NCT05478954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92225319|NCT05478954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92225320|NCT05478954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225321|NCT05478954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92225322|NCT05478954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225323|NCT05478954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225324|NCT05478954|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92225325|NCT02137096|Carboplatin|carboplatin|mesh-list
92225326|NCT02137096|Etoposide|etoposide|mesh-list
92225327|NCT02137096|Ifosfamide|ifosfamide|mesh-list
92225328|NCT02137096|Etoposide phosphate|etoposide phosphate|mesh-list
92225329|NCT02137096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225330|NCT02137096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92225331|NCT02137096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92225332|NCT02137096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92225333|NCT02137096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225334|NCT02137096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225335|NCT02137096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92225336|NCT02137096|Alkylating Agents|alkylating agents|mesh-ancestor
92225337|NCT02130622|Promethazine|promethazine|mesh-list
92225338|NCT02130622|Diphenhydramine|diphenhydramine|mesh-list
92225339|NCT02130622|Antipruritics|antipruritics|mesh-ancestor
92225340|NCT02130622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92225341|NCT02130622|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92225342|NCT02130622|Histamine Antagonists|histamine antagonists|mesh-ancestor
92225343|NCT02130622|Histamine Agents|histamine agents|mesh-ancestor
92225344|NCT02130622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225345|NCT02130622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225346|NCT02130622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225347|NCT02130622|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92225348|NCT02130622|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92225349|NCT02130622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92225350|NCT02130622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225351|NCT02130622|Anesthetics, Local|anesthetics, local|mesh-ancestor
92225353|NCT02130622|Sensory System Agents|sensory system agents|mesh-ancestor
92225354|NCT02130622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225355|NCT02130622|Antiemetics|antiemetics|mesh-ancestor
92225356|NCT02130622|Autonomic Agents|autonomic agents|mesh-ancestor
92225357|NCT02130622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225358|NCT02134912|Pemetrexed|pemetrexed|mesh-list
92225359|NCT02134912|Crizotinib|crizotinib|mesh-list
92338124|NCT00000743|Zidovudine|zidovudine|mesh-list
92225360|NCT02134912|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92225361|NCT02134912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225362|NCT02134912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940937|NCT00728351|Metformin|metformin|mesh-list
92225363|NCT02134912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225364|NCT02134912|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92225365|NCT02134912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92225366|NCT02134912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92225367|NCT02094352|Ketamine|ketamine|mesh-list
92225368|NCT02094352|Analgesics|analgesics|mesh-ancestor
92225369|NCT02094352|Sensory System Agents|sensory system agents|mesh-ancestor
92225370|NCT02094352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225371|NCT02094352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225372|NCT02094352|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92225373|NCT02094352|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92225374|NCT02094352|Anesthetics, General|anesthetics, general|mesh-ancestor
92225375|NCT02094352|Anesthetics|anesthetics|mesh-ancestor
92225376|NCT02094352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225377|NCT02094352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92225378|NCT02094352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92225379|NCT02094352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225380|NCT02094352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225381|NCT05478876|Immunomodulating Agents|immunomodulating agents|mesh-list
92225382|NCT05478876|Immunologic Factors|immunologic factors|mesh-ancestor
92225383|NCT05478876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225384|NCT01188421|Clonidine|clonidine|mesh-list
92225385|NCT01188421|Buprenorphine|buprenorphine|mesh-list
92225386|NCT01188421|Tramadol|tramadol|mesh-list
92225387|NCT01188421|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92225388|NCT01188421|Naloxone|naloxone|mesh-list
92225389|NCT01188421|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92225390|NCT01188421|Narcotics|narcotics|mesh-ancestor
92225391|NCT01188421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225392|NCT01188421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225393|NCT01188421|Analgesics|analgesics|mesh-ancestor
92225394|NCT01188421|Sensory System Agents|sensory system agents|mesh-ancestor
92225395|NCT01188421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225396|NCT01188421|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92225397|NCT01188421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92225398|NCT01188421|Sympatholytics|sympatholytics|mesh-ancestor
92225399|NCT01188421|Autonomic Agents|autonomic agents|mesh-ancestor
92225400|NCT01188421|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92225401|NCT01188421|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92225402|NCT01188421|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92225403|NCT01188421|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225404|NCT01188421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225405|NCT01188421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225406|NCT01006018|Pioglitazone|pioglitazone|mesh-list
92225407|NCT01006018|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92225408|NCT01006018|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92225409|NCT01006018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225410|NCT01006018|Incretins|incretins|mesh-ancestor
92225411|NCT01006018|Hormones|hormones|mesh-ancestor
92225412|NCT01006018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225413|NCT01006018|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92225414|NCT01006018|Protease Inhibitors|protease inhibitors|mesh-ancestor
92225415|NCT01006018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225416|NCT01006018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225417|NCT00996502|Prednisone|prednisone|mesh-list
92225418|NCT00996502|Bevacizumab|bevacizumab|mesh-list
92225419|NCT00996502|Docetaxel|docetaxel|mesh-list
92225420|NCT00996502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92225421|NCT00996502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225422|NCT00996502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225423|NCT00996502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92225424|NCT00996502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92225426|NCT00996502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225428|NCT00996502|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225429|NCT00996502|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225430|NCT00996502|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225431|NCT00996502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225432|NCT00996502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225433|NCT00996502|Glucocorticoids|glucocorticoids|mesh-ancestor
92225434|NCT00996502|Hormones|hormones|mesh-ancestor
92225435|NCT00996502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225436|NCT00996502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225437|NCT00996502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92225438|NCT00996502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225439|NCT00984490|Metformin|metformin|mesh-list
92225440|NCT00984490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92225441|NCT00984490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225442|NCT05484024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92225443|NCT05484024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225444|NCT05484024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225445|NCT05484024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225446|NCT02027272|Dexamethasone|dexamethasone|mesh-list
92225447|NCT02027272|Glucocorticoids|glucocorticoids|mesh-list
92225448|NCT02027272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225449|NCT02027272|Antiemetics|antiemetics|mesh-ancestor
92225450|NCT02027272|Autonomic Agents|autonomic agents|mesh-ancestor
92225451|NCT02027272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225452|NCT02027272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225453|NCT02027272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225454|NCT02027272|Hormones|hormones|mesh-ancestor
92225455|NCT02027272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225456|NCT02027272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225457|NCT02027272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225458|NCT05475444|Ciprofloxacin|ciprofloxacin|mesh-list
92225459|NCT05475444|Chitosan|chitosan|mesh-list
92225460|NCT05475444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92225461|NCT05475444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225462|NCT05475444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92225463|NCT05475444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92225464|NCT05475444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225465|NCT05475444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225466|NCT05475444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225467|NCT05475444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92225468|NCT05475444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92225469|NCT05475444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92225470|NCT05475444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92225471|NCT05475444|Antimetabolites|antimetabolites|mesh-ancestor
92225472|NCT05475444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92225473|NCT05475444|Chelating Agents|chelating agents|mesh-ancestor
92225474|NCT05475444|Sequestering Agents|sequestering agents|mesh-ancestor
92225475|NCT05475444|Hemostatics|hemostatics|mesh-ancestor
92225476|NCT05475444|Coagulants|coagulants|mesh-ancestor
92225477|NCT03472092|Amitriptyline|amitriptyline|mesh-list
92225478|NCT03472092|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92225479|NCT03472092|Antidepressive Agents|antidepressive agents|mesh-ancestor
92225480|NCT03472092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92225481|NCT03472092|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92225482|NCT03472092|Analgesics|analgesics|mesh-ancestor
92225483|NCT03472092|Sensory System Agents|sensory system agents|mesh-ancestor
92225484|NCT03472092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225485|NCT03472092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225486|NCT03472092|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92225487|NCT03472092|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92225488|NCT03472092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225489|NCT03472092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225490|NCT03472092|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225491|NCT03472092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225492|NCT01996852|Sildenafil Citrate|sildenafil citrate|mesh-list
92225493|NCT01996852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225494|NCT01996852|Vasodilator Agents|vasodilator agents|mesh-ancestor
92225495|NCT01996852|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92225496|NCT01996852|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92225497|NCT01996852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225498|NCT01996852|Urological Agents|urological agents|mesh-ancestor
92225499|NCT05478330|Flutamide|flutamide|mesh-list
92225500|NCT05478330|Androgen Antagonists|androgen antagonists|mesh-ancestor
92225501|NCT05478330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92225502|NCT05478330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225503|NCT05478330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225504|NCT05478330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225505|NCT05478330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225506|NCT00978874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92225507|NCT00978874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92225508|NCT00978874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225509|NCT04331626|Gemcitabine|gemcitabine|mesh-list
92225510|NCT04331626|Nivolumab|nivolumab|mesh-list
92225511|NCT04331626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92225512|NCT04331626|Antimetabolites|antimetabolites|mesh-ancestor
92225513|NCT04331626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225514|NCT04331626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225515|NCT04331626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225516|NCT04331626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92225517|NCT03699540|Ethanol|ethanol|mesh-list
92225518|NCT03699540|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92225519|NCT03699540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225520|NCT03699540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225521|NCT03699540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225522|NCT00970606|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92225523|NCT00970606|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92225524|NCT00970606|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92225525|NCT00970606|Antimetabolites|antimetabolites|mesh-ancestor
92225526|NCT00970606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225527|NCT00970606|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92225528|NCT00970606|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92225529|NCT00970606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225530|NCT01973062|Rituximab|rituximab|mesh-list
92225531|NCT01973062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92225532|NCT01973062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225533|NCT01973062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225534|NCT01973062|Immunologic Factors|immunologic factors|mesh-ancestor
92225535|NCT01973062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225536|NCT01973062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92225537|NCT03661320|Gemcitabine|gemcitabine|mesh-list
92225538|NCT03661320|Nivolumab|nivolumab|mesh-list
92225539|NCT03661320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225540|NCT03661320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92225541|NCT03661320|Antimetabolites|antimetabolites|mesh-ancestor
92225542|NCT03661320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225543|NCT03661320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225544|NCT03661320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92225545|NCT00981370|Deferasirox|deferasirox|mesh-list
92225546|NCT00981370|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92225547|NCT00981370|Chelating Agents|chelating agents|mesh-ancestor
92225548|NCT00981370|Sequestering Agents|sequestering agents|mesh-ancestor
92225549|NCT00981370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225550|NCT00979810|Alovudine|alovudine|mesh-list
92225551|NCT00979810|Antiviral Agents|antiviral agents|mesh-ancestor
92225552|NCT00979810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225553|NCT04549116|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92225554|NCT04549116|Progesterone|progesterone|mesh-list
92225556|NCT04549116|Hormones|hormones|mesh-ancestor
92225557|NCT04549116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225558|NCT04549116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225559|NCT00947284|Nalbuphine|nalbuphine|mesh-list
92225560|NCT00947284|Naloxone|naloxone|mesh-list
92225561|NCT00947284|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92225562|NCT00947284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225563|NCT00947284|Sensory System Agents|sensory system agents|mesh-ancestor
92225564|NCT00947284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225565|NCT00947284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92225566|NCT00947284|Narcotics|narcotics|mesh-ancestor
92225567|NCT00947284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225568|NCT00947284|Analgesics|analgesics|mesh-ancestor
92225569|NCT00932152|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92225570|NCT00932152|Bevacizumab|bevacizumab|mesh-list
92225571|NCT00932152|Fulvestrant|fulvestrant|mesh-list
92225572|NCT00932152|Anastrozole|anastrozole|mesh-list
92225573|NCT00932152|Analgesics|analgesics|mesh-list
92225574|NCT00932152|Antiemetics|antiemetics|mesh-list
92225575|NCT00932152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225576|NCT00932152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225577|NCT00932152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92225578|NCT00932152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92225579|NCT00932152|Growth Substances|growth substances|mesh-ancestor
92225580|NCT00932152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225581|NCT00932152|Growth Inhibitors|growth inhibitors|mesh-ancestor
92225582|NCT00932152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225583|NCT00932152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225584|NCT00932152|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92225585|NCT00932152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92225586|NCT00932152|Hormone Antagonists|hormone antagonists|mesh-ancestor
92225587|NCT00932152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225588|NCT00932152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92225589|NCT00932152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92225590|NCT00932152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225591|NCT00932152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225592|NCT00932152|Sensory System Agents|sensory system agents|mesh-ancestor
92225593|NCT00932152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225594|NCT00932152|Autonomic Agents|autonomic agents|mesh-ancestor
92225595|NCT00932152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225596|NCT01916590|Bupivacaine|bupivacaine|mesh-list
92225597|NCT01916590|Anesthetics, Local|anesthetics, local|mesh-ancestor
92225598|NCT01916590|Anesthetics|anesthetics|mesh-ancestor
92225599|NCT01916590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225600|NCT01916590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225601|NCT01916590|Sensory System Agents|sensory system agents|mesh-ancestor
92225602|NCT01916590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225603|NCT01890694|Tolvaptan|tolvaptan|mesh-list
92225604|NCT01890694|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92225605|NCT01890694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225606|NCT01890694|Natriuretic Agents|natriuretic agents|mesh-ancestor
92225607|NCT01890694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225609|NCT05474898|Analgesics|analgesics|mesh-ancestor
92225610|NCT05474898|Sensory System Agents|sensory system agents|mesh-ancestor
92225611|NCT05474898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225612|NCT05474898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225613|NCT05474898|Anesthetics|anesthetics|mesh-ancestor
92225614|NCT05474898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225615|NCT05474898|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92225616|NCT05474898|Anticonvulsants|anticonvulsants|mesh-ancestor
92225617|NCT05474898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92225618|NCT05474898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225619|NCT05474898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225620|NCT05474898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92225621|NCT05474898|Tocolytic Agents|tocolytic agents|mesh-ancestor
92225622|NCT05474898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92225623|NCT03428958|Leucovorin|leucovorin|mesh-list
92225624|NCT03428958|Bevacizumab|bevacizumab|mesh-list
92225625|NCT03428958|Cetuximab|cetuximab|mesh-list
92225626|NCT03428958|Panitumumab|panitumumab|mesh-list
92225627|NCT03428958|Oxaliplatin|oxaliplatin|mesh-list
92225628|NCT03428958|Irinotecan|irinotecan|mesh-list
92225629|NCT03428958|Levoleucovorin|levoleucovorin|mesh-list
92225630|NCT03428958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225631|NCT03428958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225632|NCT03428958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92225633|NCT03428958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92225635|NCT03428958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225637|NCT03428958|Antidotes|antidotes|mesh-ancestor
92225638|NCT03428958|Protective Agents|protective agents|mesh-ancestor
92225639|NCT03428958|Vitamin B Complex|vitamin b complex|mesh-ancestor
92225640|NCT03428958|Vitamins|vitamins|mesh-ancestor
92225641|NCT03428958|Micronutrients|micronutrients|mesh-ancestor
92225642|NCT03428958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92225643|NCT03428958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92225644|NCT03428958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225645|NCT03428958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225646|NCT01844206|Morphine|morphine|mesh-list
92225647|NCT01844206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92225648|NCT01844206|Narcotics|narcotics|mesh-ancestor
92225649|NCT01844206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225650|NCT01844206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225651|NCT01844206|Analgesics|analgesics|mesh-ancestor
92225652|NCT01844206|Sensory System Agents|sensory system agents|mesh-ancestor
92225653|NCT01844206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225654|NCT03626454|Norepinephrine|norepinephrine|mesh-list
92225655|NCT03626454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92225656|NCT03626454|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92225657|NCT03626454|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92225658|NCT03626454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225659|NCT03626454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225660|NCT03626454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225661|NCT03626454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225662|NCT03626454|Sympathomimetics|sympathomimetics|mesh-ancestor
92225663|NCT03626454|Autonomic Agents|autonomic agents|mesh-ancestor
92225664|NCT03626454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225665|NCT03626454|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92225666|NCT01830790|Sildenafil Citrate|sildenafil citrate|mesh-list
92225667|NCT01830790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225668|NCT01830790|Vasodilator Agents|vasodilator agents|mesh-ancestor
92225669|NCT01830790|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92225670|NCT01830790|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92225671|NCT01830790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225672|NCT01830790|Urological Agents|urological agents|mesh-ancestor
92225673|NCT01662102|Rituximab|rituximab|mesh-list
92225674|NCT01662102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225675|NCT01662102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225676|NCT01662102|Immunologic Factors|immunologic factors|mesh-ancestor
92225677|NCT01662102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225678|NCT01662102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92225679|NCT03950076|Edoxaban|edoxaban|mesh-list
92225680|NCT03950076|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92225681|NCT03950076|Antithrombins|antithrombins|mesh-ancestor
92225682|NCT03950076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92225683|NCT03950076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92225684|NCT03950076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225685|NCT03950076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225686|NCT03950076|Anticoagulants|anticoagulants|mesh-ancestor
92225687|NCT05292976|Albuterol|albuterol|mesh-list
92225688|NCT05292976|Methacholine Chloride|methacholine chloride|mesh-list
92225689|NCT05292976|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92225690|NCT05292976|Autonomic Agents|autonomic agents|mesh-ancestor
92225691|NCT05292976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225692|NCT05292976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225693|NCT05292976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92225694|NCT05292976|Respiratory System Agents|respiratory system agents|mesh-ancestor
92225695|NCT05292976|Tocolytic Agents|tocolytic agents|mesh-ancestor
92225696|NCT05292976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92225697|NCT05292976|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92225698|NCT05292976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92225699|NCT05292976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92225700|NCT05292976|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225701|NCT05292976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338157|NCT00456989|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225702|NCT05292976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225703|NCT05292976|Miotics|miotics|mesh-ancestor
92225705|NCT05292976|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92225706|NCT05292976|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92225707|NCT05292976|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92225708|NCT05292976|Cholinergic Agents|cholinergic agents|mesh-ancestor
92225709|NCT00850720|Hydrocortisone|hydrocortisone|mesh-list
92225710|NCT00850720|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92225711|NCT00850720|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92225712|NCT00850720|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92225713|NCT00850720|Vasopressins|vasopressins|mesh-list
92225714|NCT00850720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225715|NCT00850720|Hemostatics|hemostatics|mesh-ancestor
92225716|NCT00850720|Coagulants|coagulants|mesh-ancestor
92225717|NCT00850720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92225718|NCT00850720|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92225719|NCT00850720|Natriuretic Agents|natriuretic agents|mesh-ancestor
92225720|NCT00850720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225721|NCT00843310|Dexamethasone|dexamethasone|mesh-list
92225722|NCT00843310|Lenalidomide|lenalidomide|mesh-list
92225723|NCT00843310|Melphalan|melphalan|mesh-list
92225724|NCT00843310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225725|NCT00843310|Antiemetics|antiemetics|mesh-ancestor
92225726|NCT00843310|Autonomic Agents|autonomic agents|mesh-ancestor
92225727|NCT00843310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225728|NCT00843310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225729|NCT00843310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92225730|NCT00843310|Glucocorticoids|glucocorticoids|mesh-ancestor
92225731|NCT00843310|Hormones|hormones|mesh-ancestor
92225732|NCT00843310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225733|NCT00843310|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225734|NCT00843310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225735|NCT00843310|Immunologic Factors|immunologic factors|mesh-ancestor
92225736|NCT00843310|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92225737|NCT00843310|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92225738|NCT00843310|Growth Substances|growth substances|mesh-ancestor
92225739|NCT00843310|Growth Inhibitors|growth inhibitors|mesh-ancestor
92225740|NCT00843310|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92225741|NCT00843310|Alkylating Agents|alkylating agents|mesh-ancestor
91922379|NCT02205931|Nitrazepam|nitrazepam|mesh-list
92225742|NCT00843310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225743|NCT00843310|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92225744|NCT00843310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92225745|NCT00809458|Vitamin E|vitamin e|mesh-list
92225746|NCT00809458|Tocopherols|tocopherols|mesh-list
92225747|NCT00809458|Tocotrienols|tocotrienols|mesh-list
92225748|NCT00809458|alpha-Tocopherol|alpha-tocopherol|mesh-list
92225749|NCT00809458|Vitamins|vitamins|mesh-ancestor
92225750|NCT00809458|Micronutrients|micronutrients|mesh-ancestor
92225751|NCT00809458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225752|NCT00809458|Antioxidants|antioxidants|mesh-ancestor
92225753|NCT00809458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225754|NCT00809458|Protective Agents|protective agents|mesh-ancestor
92225755|NCT01701622|Febuxostat|febuxostat|mesh-list
92225756|NCT01701622|Gout Suppressants|gout suppressants|mesh-ancestor
92225757|NCT01701622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92225758|NCT00786682|Hydroxychloroquine|hydroxychloroquine|mesh-list
92225759|NCT00786682|Docetaxel|docetaxel|mesh-list
92225760|NCT00786682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225761|NCT00786682|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225762|NCT00786682|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225763|NCT00786682|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225764|NCT00786682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225765|NCT00786682|Antimalarials|antimalarials|mesh-ancestor
92225766|NCT00786682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92225767|NCT00786682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92225768|NCT00786682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225769|NCT00786682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225770|NCT00786682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92225771|NCT01675960|Gabapentin|gabapentin|mesh-list
92225772|NCT01675960|Analgesics|analgesics|mesh-ancestor
92225773|NCT01675960|Sensory System Agents|sensory system agents|mesh-ancestor
92225774|NCT01675960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225775|NCT01675960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225777|NCT01675960|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92225778|NCT01675960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91934365|NCT05255211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92225779|NCT01675960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225780|NCT01675960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92225781|NCT01675960|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92225782|NCT01675960|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92225783|NCT01675960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225784|NCT01675960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225785|NCT01675960|Antimanic Agents|antimanic agents|mesh-ancestor
92225786|NCT01607320|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92225787|NCT01607320|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92225788|NCT01607320|Clomiphene|clomiphene|mesh-list
92225789|NCT01607320|Medroxyprogesterone|medroxyprogesterone|mesh-list
92225790|NCT01607320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92225791|NCT01607320|Hormone Antagonists|hormone antagonists|mesh-ancestor
92225792|NCT01607320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225793|NCT01607320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225794|NCT01607320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92225795|NCT01607320|Fertility Agents|fertility agents|mesh-ancestor
92225796|NCT01607320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92225797|NCT01607320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92225798|NCT01607320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92225799|NCT01607320|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92225800|NCT01607320|Contraceptive Agents|contraceptive agents|mesh-ancestor
92225801|NCT01607320|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92225802|NCT01607320|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92225803|NCT01607320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92225804|NCT01607320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225805|NCT01607320|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92225806|NCT01607320|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92225807|NCT01607320|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92225808|NCT01607320|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92225809|NCT01606150|Lidocaine|lidocaine|mesh-list
92225810|NCT01606150|Anesthetics, Local|anesthetics, local|mesh-ancestor
92225811|NCT01606150|Anesthetics|anesthetics|mesh-ancestor
92225812|NCT01606150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225813|NCT01606150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225814|NCT01606150|Sensory System Agents|sensory system agents|mesh-ancestor
92225815|NCT01606150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225816|NCT01606150|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92225817|NCT01606150|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92225818|NCT01606150|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92225819|NCT01606150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225820|NCT01606150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225821|NCT01602016|Leucovorin|leucovorin|mesh-list
92225822|NCT01602016|Folic Acid|folic acid|mesh-list
92225823|NCT01602016|Levoleucovorin|levoleucovorin|mesh-list
92225824|NCT01602016|Antidotes|antidotes|mesh-ancestor
92225825|NCT01602016|Protective Agents|protective agents|mesh-ancestor
92225826|NCT01602016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225827|NCT01602016|Vitamin B Complex|vitamin b complex|mesh-ancestor
92225828|NCT01602016|Vitamins|vitamins|mesh-ancestor
92225829|NCT01602016|Micronutrients|micronutrients|mesh-ancestor
92225830|NCT01602016|Hematinics|hematinics|mesh-ancestor
92225831|NCT00731770|Fluticasone|fluticasone|mesh-list
92225833|NCT00731770|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92225834|NCT00731770|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92225835|NCT00731770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225836|NCT00731770|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92225837|NCT00731770|Autonomic Agents|autonomic agents|mesh-ancestor
92225838|NCT00731770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225839|NCT00731770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225840|NCT00731770|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92225841|NCT00731770|Respiratory System Agents|respiratory system agents|mesh-ancestor
92225842|NCT00731770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92225843|NCT00731770|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92225844|NCT00731770|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92225845|NCT00731770|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92225846|NCT00731770|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92225847|NCT00731770|Adrenergic Agents|adrenergic agents|mesh-ancestor
92225848|NCT00731770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225849|NCT00731770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225850|NCT00731770|Glucocorticoids|glucocorticoids|mesh-ancestor
92225851|NCT00731770|Hormones|hormones|mesh-ancestor
92225852|NCT00731770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92225853|NCT00731770|Sympathomimetics|sympathomimetics|mesh-ancestor
92225854|NCT00719914|Eptifibatide|eptifibatide|mesh-list
92225855|NCT00719914|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92225857|NCT01566370|Anticonvulsants|anticonvulsants|mesh-ancestor
92225858|NCT01566370|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92225859|NCT01566370|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225860|NCT01566370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225861|NCT01566370|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92225862|NCT01566370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225863|NCT03414684|Carboplatin|carboplatin|mesh-list
92225864|NCT03414684|Nivolumab|nivolumab|mesh-list
92225865|NCT03414684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225866|NCT03414684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225867|NCT03414684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92225868|NCT03414684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225869|NCT01558492|Paclitaxel|paclitaxel|mesh-list
92225870|NCT01558492|Carboplatin|carboplatin|mesh-list
92225871|NCT01558492|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92225872|NCT01558492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225873|NCT01558492|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225874|NCT01558492|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225875|NCT01558492|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225876|NCT01558492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225877|NCT03579472|Halichondrin B|halichondrin b|mesh-list
92225878|NCT03579472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225879|NCT03579472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225880|NCT03579472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92225881|NCT03579472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92225882|NCT03579472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92225883|NCT05286190|Bupivacaine|bupivacaine|mesh-list
92225884|NCT05286190|Anesthetics, Local|anesthetics, local|mesh-ancestor
92225885|NCT05286190|Anesthetics|anesthetics|mesh-ancestor
92225886|NCT05286190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225887|NCT05286190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225888|NCT05286190|Sensory System Agents|sensory system agents|mesh-ancestor
92225889|NCT05286190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225890|NCT03399552|Avelumab|avelumab|mesh-list
92225891|NCT03399552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92225892|NCT03399552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225893|NCT00691444|Melatonin|melatonin|mesh-list
92225894|NCT00691444|Antioxidants|antioxidants|mesh-ancestor
92225895|NCT00691444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225896|NCT00691444|Protective Agents|protective agents|mesh-ancestor
92225897|NCT00691444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225898|NCT00691444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225899|NCT05477004|Ketamine|ketamine|mesh-list
92225900|NCT05477004|Analgesics|analgesics|mesh-ancestor
92225901|NCT05477004|Sensory System Agents|sensory system agents|mesh-ancestor
92225902|NCT05477004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225903|NCT05477004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225904|NCT05477004|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92225905|NCT05477004|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92225906|NCT05477004|Anesthetics, General|anesthetics, general|mesh-ancestor
92225907|NCT05477004|Anesthetics|anesthetics|mesh-ancestor
92225908|NCT05477004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225909|NCT05477004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92225910|NCT05477004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92225911|NCT05477004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225912|NCT05477004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225913|NCT05482464|Caseins|caseins|mesh-list
92225914|NCT05482464|Chelating Agents|chelating agents|mesh-ancestor
92225916|NCT05482464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225917|NCT01530880|Acetaminophen|acetaminophen|mesh-list
92225918|NCT01530880|Ibuprofen|ibuprofen|mesh-list
92225919|NCT01530880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92225920|NCT01530880|Analgesics|analgesics|mesh-ancestor
92225921|NCT01530880|Sensory System Agents|sensory system agents|mesh-ancestor
92225922|NCT01530880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225923|NCT01530880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934369|NCT03514381|Ifosfamide|ifosfamide|mesh-list
92225925|NCT01530880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92225926|NCT01530880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92225927|NCT01530880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92225928|NCT01530880|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92225929|NCT01530880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225930|NCT01530880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225931|NCT05482074|Olaparib|olaparib|mesh-list
92225932|NCT05482074|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92225933|NCT05482074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225934|NCT05482074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225935|NCT05482074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92225936|NCT00678574|Fluoxetine|fluoxetine|mesh-list
92225937|NCT00678574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92225938|NCT00678574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92225939|NCT00678574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92225940|NCT00678574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225941|NCT00678574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225942|NCT00678574|Serotonin Agents|serotonin agents|mesh-ancestor
92225943|NCT00678574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225944|NCT00678574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92225945|NCT00678574|Antidepressive Agents|antidepressive agents|mesh-ancestor
92225946|NCT00678574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92225947|NCT00678574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92225948|NCT00678574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92225949|NCT00678574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225950|NCT01475500|Dimercaprol|dimercaprol|mesh-list
92225951|NCT01475500|Chelating Agents|chelating agents|mesh-ancestor
92225952|NCT01475500|Sequestering Agents|sequestering agents|mesh-ancestor
92225953|NCT01475500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225954|NCT02551692|Nicotine|nicotine|mesh-list
92225955|NCT02551692|Varenicline|varenicline|mesh-list
92225956|NCT02551692|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92225957|NCT02551692|Autonomic Agents|autonomic agents|mesh-ancestor
92225958|NCT02551692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225959|NCT02551692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225960|NCT02551692|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92225961|NCT02551692|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92225962|NCT02551692|Cholinergic Agents|cholinergic agents|mesh-ancestor
92225963|NCT02551692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225964|NCT02551692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225965|NCT00542542|Fentanyl|fentanyl|mesh-list
92225966|NCT00542542|Midazolam|midazolam|mesh-list
92225967|NCT00542542|Propofol|propofol|mesh-list
92225968|NCT00542542|Ropivacaine|ropivacaine|mesh-list
92225969|NCT00542542|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92225970|NCT00542542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92225971|NCT00542542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92225972|NCT00542542|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92225973|NCT00542542|Anesthetics, General|anesthetics, general|mesh-ancestor
92225974|NCT00542542|Anesthetics|anesthetics|mesh-ancestor
92225975|NCT00542542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92225976|NCT00542542|Sensory System Agents|sensory system agents|mesh-ancestor
92225977|NCT00542542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92225978|NCT00542542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92225979|NCT00542542|Narcotics|narcotics|mesh-ancestor
92225980|NCT00542542|Analgesics|analgesics|mesh-ancestor
92225981|NCT00542542|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92225982|NCT00542542|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92225983|NCT00542542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92225984|NCT00542542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92225985|NCT00542542|GABA Modulators|gaba modulators|mesh-ancestor
92225986|NCT00542542|GABA Agents|gaba agents|mesh-ancestor
92225987|NCT00542542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92225988|NCT00542542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92225989|NCT05471544|Pyrimethamine|pyrimethamine|mesh-list
92225990|NCT05471544|Sulfadoxine|sulfadoxine|mesh-list
92225991|NCT05471544|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92225992|NCT05471544|Amodiaquine|amodiaquine|mesh-list
92225993|NCT05471544|Antimalarials|antimalarials|mesh-ancestor
92225994|NCT05471544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92225995|NCT05471544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92225996|NCT05471544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92225997|NCT05471544|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92225998|NCT05471544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92225999|NCT05471544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226000|NCT05471544|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92226001|NCT03333486|Cyclophosphamide|cyclophosphamide|mesh-list
92226002|NCT03333486|Fludarabine|fludarabine|mesh-list
92226003|NCT03333486|Fludarabine phosphate|fludarabine phosphate|mesh-list
92226004|NCT03333486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226005|NCT03333486|Immunologic Factors|immunologic factors|mesh-ancestor
92226006|NCT03333486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226007|NCT03333486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226008|NCT03333486|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92226009|NCT03333486|Alkylating Agents|alkylating agents|mesh-ancestor
92226010|NCT03333486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226011|NCT03333486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226012|NCT03333486|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92226013|NCT03333486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226014|NCT03333486|Antimetabolites|antimetabolites|mesh-ancestor
92226015|NCT02598778|Chlorhexidine|chlorhexidine|mesh-list
92226016|NCT02598778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92226018|NCT02598778|Fluorides|fluorides|mesh-list
92226019|NCT02598778|Sodium Fluoride|sodium fluoride|mesh-list
92226020|NCT02598778|Cariostatic Agents|cariostatic agents|mesh-ancestor
92226021|NCT02598778|Protective Agents|protective agents|mesh-ancestor
92226022|NCT02598778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226023|NCT02598778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92226024|NCT02598778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226025|NCT02598778|Disinfectants|disinfectants|mesh-ancestor
92226026|NCT02598778|Dermatologic Agents|dermatologic agents|mesh-ancestor
92226027|NCT00642382|Hyaluronic Acid|hyaluronic acid|mesh-list
92226028|NCT00642382|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92226029|NCT00642382|Immunologic Factors|immunologic factors|mesh-ancestor
92226030|NCT00642382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226031|NCT00642382|Viscosupplements|viscosupplements|mesh-ancestor
92226032|NCT00642382|Protective Agents|protective agents|mesh-ancestor
92226033|NCT05476380|Paclitaxel|paclitaxel|mesh-list
92226034|NCT05476380|Cisplatin|cisplatin|mesh-list
92226035|NCT05476380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92226036|NCT05476380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226037|NCT05476380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92226038|NCT05476380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92226039|NCT05476380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92226040|NCT05476380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226041|NCT00634972|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92226042|NCT00634972|Ketorolac|ketorolac|mesh-list
92226043|NCT00634972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92226044|NCT00634972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92226045|NCT00634972|Analgesics|analgesics|mesh-ancestor
92226046|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
92226047|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226048|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226049|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92226050|NCT00634972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226051|NCT00634972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92226052|NCT00634972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226053|NCT00634972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226054|NCT00529282|Vancomycin|vancomycin|mesh-list
92226055|NCT00529282|Cefepime|cefepime|mesh-list
92226056|NCT00529282|Ceftobiprole|ceftobiprole|mesh-list
92226057|NCT00529282|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92226058|NCT00529282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226059|NCT00529282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226061|NCT00623974|Calcitriol|calcitriol|mesh-list
92226062|NCT00623974|Calcium|calcium|mesh-list
92226063|NCT00623974|Parathyroid Hormone|parathyroid hormone|mesh-list
92226064|NCT00623974|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92226065|NCT00623974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226066|NCT00623974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92226067|NCT00623974|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92226068|NCT00623974|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92226069|NCT00623974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226070|NCT00623974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92226071|NCT00623974|Vitamins|vitamins|mesh-ancestor
92226072|NCT00623974|Micronutrients|micronutrients|mesh-ancestor
92226073|NCT02550288|Atorvastatin|atorvastatin|mesh-list
92226074|NCT02550288|Ezetimibe|ezetimibe|mesh-list
92226075|NCT02550288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92226076|NCT02550288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92226077|NCT02550288|Antimetabolites|antimetabolites|mesh-ancestor
92226078|NCT02550288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226079|NCT02550288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92226080|NCT02550288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92226081|NCT02550288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226082|NCT00380146|Pyrimethamine|pyrimethamine|mesh-list
92226083|NCT00380146|Sulfadoxine|sulfadoxine|mesh-list
92226084|NCT00380146|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92226085|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
92226086|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92226087|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92226088|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226089|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92226090|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226091|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226092|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92226093|NCT00496756|Sorafenib|sorafenib|mesh-list
92226094|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226095|NCT00496756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92226096|NCT00496756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226097|NCT00496756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226098|NCT00500890|Cyclophosphamide|cyclophosphamide|mesh-list
92226099|NCT00500890|Carboplatin|carboplatin|mesh-list
92226100|NCT00500890|Etoposide|etoposide|mesh-list
92226101|NCT00500890|Vincristine|vincristine|mesh-list
92226102|NCT00500890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226103|NCT00500890|Immunologic Factors|immunologic factors|mesh-ancestor
92226104|NCT00500890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226105|NCT00500890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226106|NCT00500890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92226107|NCT00500890|Alkylating Agents|alkylating agents|mesh-ancestor
92226108|NCT00500890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226109|NCT00500890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226110|NCT00500890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92226111|NCT00500890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92226112|NCT00500890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92226113|NCT00500890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92226114|NCT00500890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226115|NCT00500890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92226116|NCT00500890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92226117|NCT00500890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92226118|NCT00000736|Zidovudine|zidovudine|mesh-list
92226119|NCT00000736|Antimetabolites|antimetabolites|mesh-ancestor
92226120|NCT00000736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226121|NCT00000736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226122|NCT00000736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226123|NCT00000736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226124|NCT00000736|Antiviral Agents|antiviral agents|mesh-ancestor
92226125|NCT00000736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226127|NCT00000736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226128|NCT00379522|Vasopressins|vasopressins|mesh-list
92226129|NCT00379522|Arginine Vasopressin|arginine vasopressin|mesh-list
92226130|NCT00379522|Hemostatics|hemostatics|mesh-ancestor
92226131|NCT00379522|Coagulants|coagulants|mesh-ancestor
92226132|NCT00379522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92226133|NCT00379522|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92226134|NCT00379522|Natriuretic Agents|natriuretic agents|mesh-ancestor
92226135|NCT00379522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226136|NCT00421954|Ziprasidone|ziprasidone|mesh-list
92226137|NCT00421954|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92226138|NCT00421954|Serotonin Agents|serotonin agents|mesh-ancestor
92226139|NCT00421954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226140|NCT00421954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226141|NCT00421954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226142|NCT00421954|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92226143|NCT00421954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92226144|NCT00421954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226145|NCT00421954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92226146|NCT00421954|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92226147|NCT00421954|Dopamine Agents|dopamine agents|mesh-ancestor
92226148|NCT01662336|Ritonavir|ritonavir|mesh-list
92226150|NCT01662336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92226151|NCT01662336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92226152|NCT01662336|Protease Inhibitors|protease inhibitors|mesh-ancestor
92226153|NCT01662336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226154|NCT01662336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226155|NCT01662336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226156|NCT01662336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226157|NCT01662336|Antiviral Agents|antiviral agents|mesh-ancestor
92226158|NCT01662336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226159|NCT01662336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92226160|NCT01662336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92226161|NCT00000766|Ganciclovir|ganciclovir|mesh-list
92226162|NCT00000766|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92226163|NCT00000766|Foscarnet|foscarnet|mesh-list
92226164|NCT00000766|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92226165|NCT00000766|Antiviral Agents|antiviral agents|mesh-ancestor
92226166|NCT00000766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226167|NCT00000766|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226168|NCT00000766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226169|NCT00000766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226170|NCT00000766|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226171|NCT00000772|Ribavirin|ribavirin|mesh-list
92226172|NCT00000772|Didanosine|didanosine|mesh-list
92226173|NCT00000772|Antimetabolites|antimetabolites|mesh-ancestor
92226174|NCT00000772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226175|NCT00000772|Antiviral Agents|antiviral agents|mesh-ancestor
92226176|NCT00000772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226177|NCT00000772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226178|NCT00000772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226179|NCT00000772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226180|NCT00000772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226181|NCT00000772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226182|NCT00572260|Daptomycin|daptomycin|mesh-list
92226183|NCT00572260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226184|NCT00572260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226185|NCT00000778|Pyridoxine|pyridoxine|mesh-list
92226186|NCT00000778|Vitamin B 6|vitamin b 6|mesh-list
92226187|NCT00000778|Levofloxacin|levofloxacin|mesh-list
92226188|NCT00000778|Isoniazid|isoniazid|mesh-list
92226189|NCT00000778|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92226190|NCT00000778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226191|NCT00000778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226192|NCT00000778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92226193|NCT00000778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92226194|NCT00000778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226195|NCT00000778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226196|NCT00000778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226197|NCT00000778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92226198|NCT00000778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92226199|NCT00000778|Antitubercular Agents|antitubercular agents|mesh-ancestor
92226200|NCT00000778|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92226201|NCT00000778|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92226202|NCT00000778|Antimetabolites|antimetabolites|mesh-ancestor
92226203|NCT00000778|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92226204|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
92226205|NCT00000778|Vitamins|vitamins|mesh-ancestor
92226206|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
92226207|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226208|NCT00000796|Pyridoxine|pyridoxine|mesh-list
92226209|NCT00000796|Vitamin B 6|vitamin b 6|mesh-list
92226210|NCT00000796|Levofloxacin|levofloxacin|mesh-list
92226211|NCT00000796|Cycloserine|cycloserine|mesh-list
92226212|NCT00000796|Rifampin|rifampin|mesh-list
92226213|NCT00000796|Isoniazid|isoniazid|mesh-list
92226214|NCT00000796|Amikacin|amikacin|mesh-list
92226215|NCT00000796|Pyrazinamide|pyrazinamide|mesh-list
92226216|NCT00000796|Ethambutol|ethambutol|mesh-list
92226217|NCT00000796|Clofazimine|clofazimine|mesh-list
92226218|NCT00000796|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92226219|NCT00000796|Streptomycin|streptomycin|mesh-list
92226220|NCT00000796|Ethionamide|ethionamide|mesh-list
92226221|NCT00000796|Capreomycin|capreomycin|mesh-list
92226222|NCT00000796|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92226223|NCT00000796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226224|NCT00000796|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226225|NCT00000796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92226226|NCT00000796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92226227|NCT00000796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226228|NCT00000796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226229|NCT00000796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226230|NCT00000796|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92226231|NCT00000796|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92226232|NCT00000796|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92226233|NCT00000796|Antitubercular Agents|antitubercular agents|mesh-ancestor
92226234|NCT00000796|Leprostatic Agents|leprostatic agents|mesh-ancestor
92226235|NCT00000796|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226236|NCT00000796|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92226237|NCT00000796|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92226238|NCT00000796|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92226239|NCT00000796|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92226240|NCT00000796|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92226241|NCT00000796|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92226242|NCT00000796|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92226243|NCT00000796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92226244|NCT00000796|Antimetabolites|antimetabolites|mesh-ancestor
92226245|NCT00000796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92226246|NCT00000796|Vitamin B Complex|vitamin b complex|mesh-ancestor
92226247|NCT00000796|Vitamins|vitamins|mesh-ancestor
92226248|NCT00000796|Micronutrients|micronutrients|mesh-ancestor
92226249|NCT00000796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226250|NCT00000796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92226251|NCT00000796|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92226252|NCT00000802|Dapsone|dapsone|mesh-list
92226253|NCT00000802|Atovaquone|atovaquone|mesh-list
92226254|NCT00000802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226255|NCT00000802|Antimalarials|antimalarials|mesh-ancestor
92226256|NCT00000802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92226257|NCT00000802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92226258|NCT00000802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92226259|NCT00000802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226260|NCT00000802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226261|NCT00000802|Leprostatic Agents|leprostatic agents|mesh-ancestor
92226262|NCT00000802|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226263|NCT02389946|Sirolimus|sirolimus|mesh-list
92226264|NCT02389946|Everolimus|everolimus|mesh-list
92226265|NCT02389946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92226266|NCT02389946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92226267|NCT02389946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226268|NCT02389946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226269|NCT02389946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226270|NCT02389946|Immunologic Factors|immunologic factors|mesh-ancestor
92226271|NCT02389946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226272|NCT02389946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226273|NCT02389946|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226274|NCT02389946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226275|NCT02389946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92226276|NCT02389946|Antifungal Agents|antifungal agents|mesh-ancestor
92226277|NCT00245128|Imatinib Mesylate|imatinib mesylate|mesh-list
91940958|NCT00615251|Hormones|hormones|mesh-ancestor
92226278|NCT00245128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226279|NCT00245128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92226280|NCT00245128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226281|NCT00245128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226283|NCT00268450|Bevacizumab|bevacizumab|mesh-list
92226284|NCT00268450|Gemcitabine|gemcitabine|mesh-list
92226285|NCT00268450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92226286|NCT00268450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226287|NCT00268450|Tubulin Modulators|tubulin modulators|mesh-ancestor
92226288|NCT00268450|Antimitotic Agents|antimitotic agents|mesh-ancestor
92226289|NCT00268450|Mitosis Modulators|mitosis modulators|mesh-ancestor
92226290|NCT00268450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226291|NCT00268450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934378|NCT02343393|Hydralazine|hydralazine|mesh-list
92226292|NCT00268450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92226293|NCT00268450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92226295|NCT00268450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226296|NCT00268450|Growth Inhibitors|growth inhibitors|mesh-ancestor
92226297|NCT00268450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226298|NCT00268450|Antimetabolites|antimetabolites|mesh-ancestor
92226300|NCT00000808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226301|NCT00000808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226302|NCT00000808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226303|NCT00000808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226304|NCT00000808|Antiviral Agents|antiviral agents|mesh-ancestor
92226305|NCT00000808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226306|NCT00000808|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226307|NCT00000808|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226308|NCT00000808|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92226309|NCT00000808|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92226310|NCT01892384|BI 409306|bi 409306|mesh-list
92226311|NCT01892384|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92226312|NCT01892384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226313|NCT01892384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226314|NCT00000814|Zidovudine|zidovudine|mesh-list
92226315|NCT00000814|Nevirapine|nevirapine|mesh-list
92226316|NCT00000814|Didanosine|didanosine|mesh-list
92226317|NCT00000814|Antimetabolites|antimetabolites|mesh-ancestor
92226318|NCT00000814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226319|NCT00000814|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226320|NCT00000814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226321|NCT00000814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226322|NCT00000814|Antiviral Agents|antiviral agents|mesh-ancestor
92226323|NCT00000814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226324|NCT00000814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226325|NCT00000814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226326|NCT00000814|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92226327|NCT00000814|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92226328|NCT02661932|Letrozole|letrozole|mesh-list
92226329|NCT02661932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226330|NCT02661932|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92226331|NCT02661932|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92226332|NCT02661932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226333|NCT02661932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226334|NCT02661932|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92226335|NCT02661932|Hormone Antagonists|hormone antagonists|mesh-ancestor
92226336|NCT02661932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226337|NCT02661932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226338|NCT02658890|Nivolumab|nivolumab|mesh-list
92226339|NCT02658890|Ipilimumab|ipilimumab|mesh-list
92226340|NCT02658890|Linrodostat|linrodostat|mesh-list
92226341|NCT02658890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92226342|NCT02658890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226343|NCT02658890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92226344|NCT02658890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226345|NCT02658890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226346|NCT00177970|Immunoglobulins|immunoglobulins|mesh-list
92226347|NCT00177970|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92226348|NCT00177970|Antibodies|antibodies|mesh-list
92226349|NCT00177970|Immunoglobulin G|immunoglobulin g|mesh-list
92226350|NCT00177970|gamma-Globulins|gamma-globulins|mesh-list
92226351|NCT00177970|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92226352|NCT00177970|Immunologic Factors|immunologic factors|mesh-ancestor
92226353|NCT00177970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226354|NCT01892618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92226355|NCT01892618|Immunologic Factors|immunologic factors|mesh-ancestor
92226356|NCT01892618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226357|NCT00088972|Celecoxib|celecoxib|mesh-list
92226358|NCT00088972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92226359|NCT00088972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92226360|NCT00088972|Analgesics|analgesics|mesh-ancestor
92226361|NCT00088972|Sensory System Agents|sensory system agents|mesh-ancestor
92226362|NCT00088972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226363|NCT00088972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934382|NCT02343393|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92226364|NCT00088972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92226365|NCT00088972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226366|NCT00088972|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92226367|NCT00088972|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92226368|NCT00088972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226369|NCT00088972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226370|NCT00089128|Gemcitabine|gemcitabine|mesh-list
92226371|NCT00089128|Irinotecan|irinotecan|mesh-list
92226372|NCT00089128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226373|NCT00089128|Antimetabolites|antimetabolites|mesh-ancestor
92226374|NCT00089128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226375|NCT00089128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226376|NCT00089128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92226377|NCT00089128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92226378|NCT00089128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226379|NCT00000838|Lamivudine|lamivudine|mesh-list
92226380|NCT00000838|Zidovudine|zidovudine|mesh-list
92226381|NCT00000838|Didanosine|didanosine|mesh-list
92226382|NCT00000838|Stavudine|stavudine|mesh-list
92226383|NCT00000838|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226384|NCT00000838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226385|NCT00000838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226386|NCT00000838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226387|NCT00000838|Antiviral Agents|antiviral agents|mesh-ancestor
92226388|NCT00000838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226389|NCT00000838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226390|NCT00000838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226391|NCT00000838|Antimetabolites|antimetabolites|mesh-ancestor
92226392|NCT00001768|Immunoglobulins|immunoglobulins|mesh-list
92226393|NCT00001768|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92226394|NCT00001768|Antibodies|antibodies|mesh-list
92226395|NCT00001768|gamma-Globulins|gamma-globulins|mesh-list
92226396|NCT00001768|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92226397|NCT00001768|Immunologic Factors|immunologic factors|mesh-ancestor
92226398|NCT00001768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226399|NCT00000844|Interferons|interferons|mesh-list
92226400|NCT00000844|Interferon-alpha|interferon-alpha|mesh-list
92226401|NCT00000844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226402|NCT00000844|Antiviral Agents|antiviral agents|mesh-ancestor
92226403|NCT00000844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226404|NCT00000844|Immunologic Factors|immunologic factors|mesh-ancestor
92226405|NCT00000844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226406|NCT00014560|Antibodies|antibodies|mesh-list
92226407|NCT00014560|Sargramostim|sargramostim|mesh-list
92226408|NCT00014560|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92226409|NCT00014560|Immunologic Factors|immunologic factors|mesh-ancestor
92226410|NCT00014560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226411|NCT00020722|Cyclophosphamide|cyclophosphamide|mesh-list
92226412|NCT00020722|Ifosfamide|ifosfamide|mesh-list
92226413|NCT00020722|Thiotepa|thiotepa|mesh-list
92226414|NCT00020722|Carboplatin|carboplatin|mesh-list
92226415|NCT00020722|Etoposide|etoposide|mesh-list
92226416|NCT00020722|Etoposide phosphate|etoposide phosphate|mesh-list
92226417|NCT00020722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226418|NCT00020722|Immunologic Factors|immunologic factors|mesh-ancestor
92226419|NCT00020722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226420|NCT00020722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226421|NCT00020722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92226422|NCT00020722|Alkylating Agents|alkylating agents|mesh-ancestor
92226423|NCT00020722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226424|NCT00020722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226425|NCT00020722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92226426|NCT00020722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92226427|NCT00020722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91940965|NCT05647642|Midazolam|midazolam|mesh-list
92226428|NCT00020722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92226429|NCT00020722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226430|NCT02649764|Cytarabine|cytarabine|mesh-list
92226431|NCT02649764|Fludarabine|fludarabine|mesh-list
92226432|NCT02649764|Fludarabine phosphate|fludarabine phosphate|mesh-list
92226433|NCT02649764|Prexasertib|prexasertib|mesh-list
92226434|NCT02649764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226435|NCT02649764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226436|NCT02649764|Antimetabolites|antimetabolites|mesh-ancestor
92226437|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934383|NCT02343393|Diuretics|diuretics|mesh-ancestor
92226438|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226439|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
92226440|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226441|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
92226442|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226443|NCT02649764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92226444|NCT02649764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226445|NCT04051996|Decitabine|decitabine|mesh-list
92226446|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226447|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
92226448|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226449|NCT04051996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226450|NCT04051996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226451|NCT02126878|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92226452|NCT02126878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92226453|NCT02126878|Glucocorticoids|glucocorticoids|mesh-ancestor
92226454|NCT02126878|Hormones|hormones|mesh-ancestor
92226455|NCT02126878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226456|NCT02126878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226457|NCT02126878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226458|NCT02126878|Immunologic Factors|immunologic factors|mesh-ancestor
92226459|NCT02634008|Ritonavir|ritonavir|mesh-list
92226460|NCT02634008|Ribavirin|ribavirin|mesh-list
92226461|NCT02634008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92226462|NCT02634008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92226463|NCT02634008|Protease Inhibitors|protease inhibitors|mesh-ancestor
92226464|NCT02634008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226465|NCT02634008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226466|NCT02634008|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226467|NCT02634008|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226468|NCT02634008|Antiviral Agents|antiviral agents|mesh-ancestor
92226469|NCT02634008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226470|NCT02634008|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92226471|NCT02634008|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92226472|NCT02634008|Antimetabolites|antimetabolites|mesh-ancestor
92226473|NCT00000850|Indinavir|indinavir|mesh-list
92226474|NCT00000850|Sargramostim|sargramostim|mesh-list
92226475|NCT00000850|Immunologic Factors|immunologic factors|mesh-ancestor
92226476|NCT00000850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226477|NCT00000850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92226478|NCT00000850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92226480|NCT00000850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226481|NCT00000850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226482|NCT00000850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226483|NCT00000850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226484|NCT00000850|Antiviral Agents|antiviral agents|mesh-ancestor
92226485|NCT00000850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226486|NCT00000856|Ganciclovir|ganciclovir|mesh-list
92226487|NCT00000856|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92226488|NCT00000856|Foscarnet|foscarnet|mesh-list
92226489|NCT00000856|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92226490|NCT00000856|Antiviral Agents|antiviral agents|mesh-ancestor
92226491|NCT00000856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226492|NCT00000856|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226493|NCT00000856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226494|NCT00000856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226495|NCT00000856|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226496|NCT00001810|Voriconazole|voriconazole|mesh-list
92226497|NCT00001810|Antifungal Agents|antifungal agents|mesh-ancestor
92226498|NCT00001810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226499|NCT00001810|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92226500|NCT00001810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92226501|NCT00001810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226502|NCT00001810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226503|NCT00001810|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92226504|NCT00001810|Hormone Antagonists|hormone antagonists|mesh-ancestor
92226505|NCT00001810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226506|NCT00001810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226507|NCT00001810|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92226508|NCT00000862|Zidovudine|zidovudine|mesh-list
92226509|NCT00000862|Antimetabolites|antimetabolites|mesh-ancestor
91934386|NCT02343393|Vasodilator Agents|vasodilator agents|mesh-ancestor
92226510|NCT00000862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226511|NCT00000862|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226512|NCT00000862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226513|NCT00000862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226514|NCT00000862|Antiviral Agents|antiviral agents|mesh-ancestor
92226515|NCT00000862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226516|NCT00000862|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226517|NCT00000862|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226519|NCT02344472|Vinorelbine|vinorelbine|mesh-list
92226520|NCT02344472|Docetaxel|docetaxel|mesh-list
92226521|NCT02344472|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92226522|NCT02344472|Capecitabine|capecitabine|mesh-list
92226523|NCT02344472|Trastuzumab|trastuzumab|mesh-list
92226524|NCT02344472|Letrozole|letrozole|mesh-list
92226525|NCT02344472|Fulvestrant|fulvestrant|mesh-list
92226526|NCT02344472|Pertuzumab|pertuzumab|mesh-list
92226527|NCT02344472|Anastrozole|anastrozole|mesh-list
92226528|NCT02344472|Exemestane|exemestane|mesh-list
92226529|NCT02344472|Goserelin|goserelin|mesh-list
92226530|NCT02344472|Leuprolide|leuprolide|mesh-list
92226531|NCT02344472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92226532|NCT02344472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226533|NCT02344472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92226534|NCT02344472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92226535|NCT02344472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92226536|NCT02344472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226537|NCT02344472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226538|NCT02344472|Antimetabolites|antimetabolites|mesh-ancestor
92226539|NCT02344472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92226540|NCT02344472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92226541|NCT02344472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92226542|NCT02344472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226543|NCT02344472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92226544|NCT02344472|Hormone Antagonists|hormone antagonists|mesh-ancestor
92226545|NCT02344472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226546|NCT02344472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226547|NCT02344472|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92226548|NCT02344472|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92226549|NCT02344472|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92226550|NCT02344472|Fertility Agents|fertility agents|mesh-ancestor
92226551|NCT02344472|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92226552|NCT02338232|Telmisartan|telmisartan|mesh-list
92226553|NCT02338232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92226554|NCT02338232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92226555|NCT02338232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92226556|NCT02338232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226557|NCT01780636|Botulinum Toxins|botulinum toxins|mesh-list
92226558|NCT01780636|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92226559|NCT01780636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92226560|NCT01780636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226561|NCT01780636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92226562|NCT01780636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226563|NCT01780636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226564|NCT00000868|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92226565|NCT00000868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92226566|NCT00000868|Immunologic Factors|immunologic factors|mesh-ancestor
92226567|NCT00000868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226568|NCT00000868|Antacids|antacids|mesh-ancestor
92226569|NCT00000868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226570|NCT00000868|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92226571|NCT05586464|Bismuth|bismuth|mesh-list
92226572|NCT05586464|Antacids|antacids|mesh-ancestor
92226573|NCT05586464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226574|NCT05586464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92226575|NCT01561378|Insulin Aspart|insulin aspart|mesh-list
92226576|NCT01561378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92226577|NCT01561378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226578|NCT02627846|Lidocaine|lidocaine|mesh-list
92226579|NCT02627846|Epinephrine|epinephrine|mesh-list
92226580|NCT02627846|Racepinephrine|racepinephrine|mesh-list
92226581|NCT02627846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92226582|NCT02627846|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
92226583|NCT02627846|Epinephryl borate|epinephryl borate|mesh-list
92226585|NCT02627846|Anesthetics|anesthetics|mesh-ancestor
92226586|NCT02627846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226587|NCT02627846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226588|NCT02627846|Sensory System Agents|sensory system agents|mesh-ancestor
92226589|NCT02627846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226590|NCT02627846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92226591|NCT02627846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92226592|NCT02627846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92226593|NCT02627846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92226594|NCT02627846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226595|NCT02627846|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92226596|NCT02627846|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92226597|NCT02627846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92226598|NCT02627846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226599|NCT02627846|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92226600|NCT02627846|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92226601|NCT02627846|Autonomic Agents|autonomic agents|mesh-ancestor
92226602|NCT02627846|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92226603|NCT02627846|Respiratory System Agents|respiratory system agents|mesh-ancestor
92226604|NCT02627846|Mydriatics|mydriatics|mesh-ancestor
92226605|NCT02627846|Sympathomimetics|sympathomimetics|mesh-ancestor
92226606|NCT02627846|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92226607|NCT02627846|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92226608|NCT02608268|Decitabine|decitabine|mesh-list
92226609|NCT02608268|Spartalizumab|spartalizumab|mesh-list
92226610|NCT02608268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226611|NCT02608268|Antimetabolites|antimetabolites|mesh-ancestor
92226612|NCT02608268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226613|NCT02608268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226614|NCT02608268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226615|NCT02608268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92226616|NCT02608268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92226617|NCT00000880|Cyclosporine|cyclosporine|mesh-list
92226618|NCT00000880|Cyclosporins|cyclosporins|mesh-list
92226619|NCT00000880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226620|NCT00000880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226621|NCT00000880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226622|NCT00000880|Immunologic Factors|immunologic factors|mesh-ancestor
92226623|NCT00000880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226624|NCT00000880|Antifungal Agents|antifungal agents|mesh-ancestor
92226625|NCT00000880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226626|NCT00000880|Dermatologic Agents|dermatologic agents|mesh-ancestor
92226627|NCT00000880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226628|NCT00000880|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92226630|NCT02308280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226631|NCT02795156|Afatinib|afatinib|mesh-list
92226632|NCT02795156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226633|NCT02795156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92226634|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226635|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226636|NCT02279654|Lenalidomide|lenalidomide|mesh-list
92226637|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
92226638|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226639|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92226640|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92226641|NCT02279654|Growth Substances|growth substances|mesh-ancestor
92226642|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
92226643|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226644|NCT02780024|Metformin|metformin|mesh-list
92226645|NCT02780024|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92226646|NCT02780024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226647|NCT02268656|Propofol|propofol|mesh-list
92226648|NCT02268656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92226649|NCT02268656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226650|NCT02268656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226651|NCT02268656|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92226652|NCT02268656|Anesthetics, General|anesthetics, general|mesh-ancestor
92226653|NCT02268656|Anesthetics|anesthetics|mesh-ancestor
92226654|NCT02564978|Minocycline|minocycline|mesh-list
92226655|NCT02564978|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92226656|NCT02564978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226657|NCT02554890|Valsartan|valsartan|mesh-list
92226658|NCT02554890|Enalapril|enalapril|mesh-list
92226659|NCT02554890|Enalaprilat|enalaprilat|mesh-list
92226660|NCT02554890|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92226661|NCT02554890|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92226662|NCT02554890|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92226663|NCT02554890|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92226664|NCT02554890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226665|NCT02554890|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92226666|NCT02554890|Protease Inhibitors|protease inhibitors|mesh-ancestor
92226667|NCT02554890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226668|NCT00001864|Atropine|atropine|mesh-list
92226669|NCT00001864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92226670|NCT00001864|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92226671|NCT00001864|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92226672|NCT00001864|Autonomic Agents|autonomic agents|mesh-ancestor
92226673|NCT00001864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226674|NCT00001864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226675|NCT00001864|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92226676|NCT00001864|Respiratory System Agents|respiratory system agents|mesh-ancestor
92226677|NCT00001864|Mydriatics|mydriatics|mesh-ancestor
92226678|NCT00001864|Parasympatholytics|parasympatholytics|mesh-ancestor
92226679|NCT00001864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92226680|NCT00001864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92226681|NCT00001864|Cholinergic Agents|cholinergic agents|mesh-ancestor
92226682|NCT00001864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226683|NCT00001864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226684|NCT02229656|Olaparib|olaparib|mesh-list
92226685|NCT02229656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92226686|NCT02229656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226687|NCT02229656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226688|NCT02229656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226690|NCT00001870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92226691|NCT00001870|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92226692|NCT00001870|Cholinergic Agents|cholinergic agents|mesh-ancestor
92226693|NCT00001870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226694|NCT00001870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226695|NCT00001870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226696|NCT03252600|Dexamethasone|dexamethasone|mesh-list
92226697|NCT03252600|Dexamethasone acetate|dexamethasone acetate|mesh-list
92226698|NCT03252600|Cyclophosphamide|cyclophosphamide|mesh-list
92226699|NCT03252600|Lenalidomide|lenalidomide|mesh-list
92226700|NCT03252600|Elotuzumab|elotuzumab|mesh-list
92226701|NCT03252600|Ichthammol|ichthammol|mesh-list
92226702|NCT03252600|BB 1101|bb 1101|mesh-list
92226703|NCT03252600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226704|NCT03252600|Immunologic Factors|immunologic factors|mesh-ancestor
92226705|NCT03252600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226706|NCT03252600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92226707|NCT03252600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92226708|NCT03252600|Alkylating Agents|alkylating agents|mesh-ancestor
92226709|NCT03252600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226710|NCT03252600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226711|NCT03252600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92226712|NCT03252600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92226713|NCT03252600|Antiemetics|antiemetics|mesh-ancestor
92226714|NCT03252600|Autonomic Agents|autonomic agents|mesh-ancestor
92226715|NCT03252600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226716|NCT03252600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92226717|NCT03252600|Glucocorticoids|glucocorticoids|mesh-ancestor
92226718|NCT03252600|Hormones|hormones|mesh-ancestor
92226719|NCT03252600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226721|NCT03252600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92226722|NCT03252600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92226723|NCT03252600|Growth Substances|growth substances|mesh-ancestor
92226724|NCT03252600|Growth Inhibitors|growth inhibitors|mesh-ancestor
92226725|NCT03252600|Protease Inhibitors|protease inhibitors|mesh-ancestor
92226726|NCT03252600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226727|NCT03252600|Dermatologic Agents|dermatologic agents|mesh-ancestor
92226728|NCT02749526|Tegafur|tegafur|mesh-list
92226729|NCT02749526|Endostar protein|endostar protein|mesh-list
92226730|NCT02749526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226731|NCT02749526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226732|NCT02749526|Antimetabolites|antimetabolites|mesh-ancestor
92226733|NCT02749526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226734|NCT02749526|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92226735|NCT02749526|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92226736|NCT02749526|Growth Substances|growth substances|mesh-ancestor
92226737|NCT02749526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226738|NCT02749526|Growth Inhibitors|growth inhibitors|mesh-ancestor
92226740|NCT00000916|Zidovudine|zidovudine|mesh-list
92226741|NCT00000916|Didanosine|didanosine|mesh-list
92226742|NCT00000916|Stavudine|stavudine|mesh-list
92226743|NCT00000916|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92226744|NCT00000916|Indinavir|indinavir|mesh-list
92226745|NCT00000916|Hydroxyurea|hydroxyurea|mesh-list
92226746|NCT00000916|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226747|NCT00000916|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226748|NCT00000916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226749|NCT00000916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226750|NCT00000916|Antiviral Agents|antiviral agents|mesh-ancestor
92226751|NCT00000916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226752|NCT00000916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226753|NCT00000916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226754|NCT00000916|Antimetabolites|antimetabolites|mesh-ancestor
92226755|NCT00000916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226756|NCT00000916|Antisickling Agents|antisickling agents|mesh-ancestor
92226757|NCT00000916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92226758|NCT00000916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92226759|NCT00000916|Protease Inhibitors|protease inhibitors|mesh-ancestor
92226760|NCT02548364|Vitamin D|vitamin d|mesh-list
92226761|NCT02548364|Calcifediol|calcifediol|mesh-list
92226762|NCT02548364|Vitamins|vitamins|mesh-ancestor
92226763|NCT02548364|Micronutrients|micronutrients|mesh-ancestor
92226764|NCT02548364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226765|NCT02548364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92226766|NCT00000130|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92226767|NCT00000130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226768|NCT02221310|Gemtuzumab|gemtuzumab|mesh-list
92226769|NCT02221310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92226770|NCT02221310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226771|NCT02221310|Immunotoxins|immunotoxins|mesh-ancestor
92226772|NCT02221310|Immunoconjugates|immunoconjugates|mesh-ancestor
92226773|NCT02221310|Immunologic Factors|immunologic factors|mesh-ancestor
92226774|NCT02221310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226775|NCT00000160|Xenon|xenon|mesh-list
92226776|NCT00000160|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92226777|NCT00000160|Anesthetics, General|anesthetics, general|mesh-ancestor
92226778|NCT00000160|Anesthetics|anesthetics|mesh-ancestor
92226779|NCT00000160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226780|NCT00000160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226781|NCT00000178|Prednisone|prednisone|mesh-list
92226782|NCT00000178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92226783|NCT00000178|Glucocorticoids|glucocorticoids|mesh-ancestor
92226784|NCT00000178|Hormones|hormones|mesh-ancestor
92226785|NCT00000178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92226786|NCT00000178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226787|NCT00000178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92226788|NCT00000178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226789|NCT05480280|Leucovorin|leucovorin|mesh-list
92226790|NCT05480280|Fluorouracil|fluorouracil|mesh-list
92226791|NCT05480280|Oxaliplatin|oxaliplatin|mesh-list
92226792|NCT05480280|Calcium|calcium|mesh-list
92226793|NCT05480280|Levoleucovorin|levoleucovorin|mesh-list
92226794|NCT05480280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92226795|NCT05480280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226796|NCT05480280|Antimetabolites|antimetabolites|mesh-ancestor
92226797|NCT05480280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226798|NCT05480280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92226799|NCT05480280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226800|NCT05480280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92226801|NCT05480280|Immunologic Factors|immunologic factors|mesh-ancestor
92226802|NCT05480280|Antidotes|antidotes|mesh-ancestor
92226803|NCT05480280|Protective Agents|protective agents|mesh-ancestor
92226804|NCT05480280|Vitamin B Complex|vitamin b complex|mesh-ancestor
92226805|NCT05480280|Vitamins|vitamins|mesh-ancestor
92226806|NCT05480280|Micronutrients|micronutrients|mesh-ancestor
92226808|NCT00001906|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92226809|NCT00001906|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92226810|NCT00001906|Immunologic Factors|immunologic factors|mesh-ancestor
92226811|NCT00001906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226812|NCT00001906|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92226813|NCT00001906|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92226814|NCT00001906|Growth Substances|growth substances|mesh-ancestor
92226815|NCT00001906|Growth Inhibitors|growth inhibitors|mesh-ancestor
92226816|NCT00001906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226818|NCT00001906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226819|NCT00001906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92226820|NCT00000196|Naltrexone|naltrexone|mesh-list
92226821|NCT00000196|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92226822|NCT00000196|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92226823|NCT00000196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226824|NCT00000196|Sensory System Agents|sensory system agents|mesh-ancestor
92226825|NCT00000196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226826|NCT00000946|polysaccharide-K|polysaccharide-k|mesh-list
92226827|NCT00000946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92226828|NCT00000946|Immunologic Factors|immunologic factors|mesh-ancestor
92226829|NCT00000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226830|NCT00000946|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92226831|NCT00000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226832|NCT00000946|Antiviral Agents|antiviral agents|mesh-ancestor
92226833|NCT00000946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226834|NCT00000946|Interferon Inducers|interferon inducers|mesh-ancestor
92226835|NCT00000946|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92226836|NCT00000946|Protective Agents|protective agents|mesh-ancestor
92226838|NCT02543346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92226839|NCT02543346|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92226840|NCT02543346|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92226841|NCT02543346|Histamine Antagonists|histamine antagonists|mesh-ancestor
92226842|NCT02543346|Histamine Agents|histamine agents|mesh-ancestor
92226843|NCT02543346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226844|NCT02543346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226845|NCT02543346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226846|NCT04390100|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92226847|NCT04390100|Hyaluronic Acid|hyaluronic acid|mesh-list
92226848|NCT04390100|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92226849|NCT04390100|Immunologic Factors|immunologic factors|mesh-ancestor
92226850|NCT04390100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226851|NCT04390100|Viscosupplements|viscosupplements|mesh-ancestor
92226852|NCT04390100|Protective Agents|protective agents|mesh-ancestor
92226853|NCT04390100|Hemostatics|hemostatics|mesh-ancestor
92226854|NCT04390100|Coagulants|coagulants|mesh-ancestor
92226855|NCT00000202|Buprenorphine|buprenorphine|mesh-list
92226856|NCT00000202|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92226857|NCT00000202|Narcotics|narcotics|mesh-ancestor
92226858|NCT00000202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226859|NCT00000202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226860|NCT00000202|Analgesics|analgesics|mesh-ancestor
92226861|NCT00000202|Sensory System Agents|sensory system agents|mesh-ancestor
92226862|NCT00000202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226863|NCT00000202|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92226864|NCT00000208|Buprenorphine|buprenorphine|mesh-list
92226865|NCT00000208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92226866|NCT00000208|Narcotics|narcotics|mesh-ancestor
92226867|NCT00000208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226868|NCT00000208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226869|NCT00000208|Analgesics|analgesics|mesh-ancestor
92226870|NCT00000208|Sensory System Agents|sensory system agents|mesh-ancestor
92226871|NCT00000208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226872|NCT00000208|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92226873|NCT00001930|Amantadine|amantadine|mesh-list
92226874|NCT00001930|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92226875|NCT00001930|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92226876|NCT00001930|Antiviral Agents|antiviral agents|mesh-ancestor
92226877|NCT00001930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226878|NCT00001930|Dopamine Agents|dopamine agents|mesh-ancestor
92226879|NCT00001930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226880|NCT00001930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226881|NCT00001930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226882|NCT00001930|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92226884|NCT00001930|Sensory System Agents|sensory system agents|mesh-ancestor
92226885|NCT00001930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226886|NCT00000964|Foscarnet|foscarnet|mesh-list
92226887|NCT00000964|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92226888|NCT00000964|Ranitidine|ranitidine|mesh-list
92226889|NCT00000964|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92226890|NCT00000964|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92226891|NCT00000964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92226892|NCT00000964|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92226893|NCT00000964|Histamine Antagonists|histamine antagonists|mesh-ancestor
92226894|NCT00000964|Histamine Agents|histamine agents|mesh-ancestor
92226895|NCT00000964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226896|NCT00000964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226897|NCT00000964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226898|NCT00000964|Antiviral Agents|antiviral agents|mesh-ancestor
92226899|NCT00000964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226900|NCT00000964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226901|NCT00000964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226902|NCT00000964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226903|NCT00000976|Zidovudine|zidovudine|mesh-list
92226904|NCT00000976|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92226905|NCT00000976|Antimetabolites|antimetabolites|mesh-ancestor
92226906|NCT00000976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338247|NCT00281879|Cytarabine|cytarabine|mesh-list
92226907|NCT00000976|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226908|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226909|NCT00000976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226911|NCT00000976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226912|NCT00000976|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226913|NCT00000976|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226914|NCT00000976|Immunologic Factors|immunologic factors|mesh-ancestor
92226915|NCT00000976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226916|NCT00000226|Buprenorphine|buprenorphine|mesh-list
92226917|NCT00000226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92226918|NCT00000226|Narcotics|narcotics|mesh-ancestor
92226919|NCT00000226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226920|NCT00000226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226921|NCT00000226|Analgesics|analgesics|mesh-ancestor
92226922|NCT00000226|Sensory System Agents|sensory system agents|mesh-ancestor
92226923|NCT00000226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226924|NCT00000226|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92226925|NCT00000982|Zidovudine|zidovudine|mesh-list
92226926|NCT00000982|Didanosine|didanosine|mesh-list
92226927|NCT00000982|Antimetabolites|antimetabolites|mesh-ancestor
92226928|NCT00000982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226929|NCT00000982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226930|NCT00000982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226931|NCT00000982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226932|NCT00000982|Antiviral Agents|antiviral agents|mesh-ancestor
92226933|NCT00000982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226934|NCT00000982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226935|NCT00000982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226936|NCT02549196|Donepezil|donepezil|mesh-list
92226937|NCT02549196|Solifenacin Succinate|solifenacin succinate|mesh-list
92226938|NCT02549196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92226939|NCT02549196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226940|NCT02549196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226941|NCT02549196|Cholinergic Agents|cholinergic agents|mesh-ancestor
92226942|NCT02549196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226943|NCT02549196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226944|NCT02549196|Nootropic Agents|nootropic agents|mesh-ancestor
92226945|NCT02549196|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92226946|NCT02549196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92226947|NCT02549196|Urological Agents|urological agents|mesh-ancestor
92226948|NCT00000988|Stavudine|stavudine|mesh-list
92226949|NCT00000988|Antimetabolites|antimetabolites|mesh-ancestor
92226950|NCT00000988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226951|NCT00000988|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226952|NCT00000988|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226953|NCT00000988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226954|NCT00000988|Antiviral Agents|antiviral agents|mesh-ancestor
92226955|NCT00000988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226956|NCT00000988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226957|NCT00000988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226958|NCT00000232|Buprenorphine|buprenorphine|mesh-list
92226959|NCT00000232|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92226961|NCT00000232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226962|NCT00000232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226963|NCT00000232|Analgesics|analgesics|mesh-ancestor
92226964|NCT00000232|Sensory System Agents|sensory system agents|mesh-ancestor
92226965|NCT00000232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226966|NCT00000232|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92226967|NCT00000238|Buprenorphine|buprenorphine|mesh-list
92226968|NCT00000238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92226969|NCT00000238|Narcotics|narcotics|mesh-ancestor
92226970|NCT00000238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92226971|NCT00000238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226972|NCT00000238|Analgesics|analgesics|mesh-ancestor
92338255|NCT00281879|Methotrexate|methotrexate|mesh-list
92226973|NCT00000238|Sensory System Agents|sensory system agents|mesh-ancestor
92226974|NCT00000238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92226975|NCT00000238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92226976|NCT00000244|Dynorphins|dynorphins|mesh-list
92226977|NCT00000244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92226978|NCT00000244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226979|NCT00000244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226980|NCT00000994|Zidovudine|zidovudine|mesh-list
92226981|NCT00000994|Antimetabolites|antimetabolites|mesh-ancestor
92226982|NCT00000994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92226983|NCT00000994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226984|NCT00000994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226985|NCT00000994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92226986|NCT00000994|Antiviral Agents|antiviral agents|mesh-ancestor
92226987|NCT00000994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92226988|NCT00000994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92226989|NCT00000994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92226990|NCT00001006|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92226991|NCT00001006|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92226992|NCT00001006|Immunologic Factors|immunologic factors|mesh-ancestor
92226993|NCT00001006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92226994|NCT00001006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92226995|NCT00001006|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92226996|NCT00001006|Protective Agents|protective agents|mesh-ancestor
92226997|NCT00001006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92226998|NCT00001006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92226999|NCT00001006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227000|NCT00001006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227001|NCT00001006|Antiviral Agents|antiviral agents|mesh-ancestor
92227002|NCT00001006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227003|NCT00001954|Etanercept|etanercept|mesh-list
92227004|NCT00001954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92227005|NCT00001954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227006|NCT00001954|Analgesics|analgesics|mesh-ancestor
92227007|NCT00001954|Sensory System Agents|sensory system agents|mesh-ancestor
92227008|NCT00001954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227009|NCT00001954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227010|NCT00001954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227011|NCT00001954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92227012|NCT00001954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227013|NCT00001954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92227014|NCT00001954|Immunologic Factors|immunologic factors|mesh-ancestor
92227015|NCT02904954|Durvalumab|durvalumab|mesh-list
92227016|NCT02904954|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92227017|NCT02904954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92227018|NCT02904954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227019|NCT02904954|Immunologic Factors|immunologic factors|mesh-ancestor
92227020|NCT02904954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227021|NCT00000250|Nitrous Oxide|nitrous oxide|mesh-list
92227022|NCT00000250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92227023|NCT00000250|Anesthetics, General|anesthetics, general|mesh-ancestor
92227024|NCT00000250|Anesthetics|anesthetics|mesh-ancestor
92227025|NCT00000250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227026|NCT00000250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227027|NCT00000250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227028|NCT00000250|Analgesics|analgesics|mesh-ancestor
92227029|NCT00000250|Sensory System Agents|sensory system agents|mesh-ancestor
92227030|NCT00000250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227031|NCT03244020|Aspirin|aspirin|mesh-list
92227032|NCT03244020|Enoxaparin|enoxaparin|mesh-list
92227033|NCT03244020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92227034|NCT03244020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227035|NCT03244020|Analgesics|analgesics|mesh-ancestor
92227036|NCT03244020|Sensory System Agents|sensory system agents|mesh-ancestor
92227037|NCT03244020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227038|NCT03244020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227039|NCT03244020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227040|NCT03244020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92227041|NCT03244020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92227042|NCT03244020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92227043|NCT03244020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227044|NCT03244020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92227045|NCT03244020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92227046|NCT03244020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227047|NCT03244020|Antipyretics|antipyretics|mesh-ancestor
92227048|NCT03244020|Anticoagulants|anticoagulants|mesh-ancestor
92227049|NCT00000262|Nitrous Oxide|nitrous oxide|mesh-list
92227050|NCT00000262|Sevoflurane|sevoflurane|mesh-list
92227051|NCT00000262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92227052|NCT00000262|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92227053|NCT00000262|Anesthetics, General|anesthetics, general|mesh-ancestor
92227054|NCT00000262|Anesthetics|anesthetics|mesh-ancestor
92227055|NCT00000262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227056|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227057|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227058|NCT00000262|Analgesics|analgesics|mesh-ancestor
92227059|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
92227060|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227061|NCT00001024|Zidovudine|zidovudine|mesh-list
92227062|NCT00001024|Didanosine|didanosine|mesh-list
92227063|NCT00001024|Antimetabolites|antimetabolites|mesh-ancestor
92227064|NCT00001024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227065|NCT00001024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227066|NCT00001024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227067|NCT00001024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227068|NCT00001024|Antiviral Agents|antiviral agents|mesh-ancestor
92227069|NCT00001024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227070|NCT00001024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227071|NCT00001024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227072|NCT00000268|Bupropion|bupropion|mesh-list
92227073|NCT00000268|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92227074|NCT00000268|Antidepressive Agents|antidepressive agents|mesh-ancestor
92227075|NCT00000268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227076|NCT00000268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92227077|NCT00000268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227078|NCT00000268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227079|NCT00000268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227080|NCT00000268|Dopamine Agents|dopamine agents|mesh-ancestor
92227081|NCT00000268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227082|NCT00000268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227083|NCT00000268|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92227084|NCT00000268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227085|NCT00000268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227086|NCT02847624|Tolvaptan|tolvaptan|mesh-list
92227087|NCT02847624|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92227088|NCT02847624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227089|NCT02847624|Natriuretic Agents|natriuretic agents|mesh-ancestor
92227090|NCT02847624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227091|NCT00001042|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92227092|NCT00001042|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92227093|NCT00001042|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
92227094|NCT00001042|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92227095|NCT00001042|Immunologic Factors|immunologic factors|mesh-ancestor
92227096|NCT00001042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227097|NCT00001042|Antacids|antacids|mesh-ancestor
92227098|NCT00001042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227099|NCT00001042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227100|NCT00982865|Niacinamide|niacinamide|mesh-list
92227101|NCT00982865|Vitamin B Complex|vitamin b complex|mesh-ancestor
92227102|NCT00982865|Vitamins|vitamins|mesh-ancestor
92227103|NCT00982865|Micronutrients|micronutrients|mesh-ancestor
92227104|NCT00982865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227105|NCT00001054|Valacyclovir|valacyclovir|mesh-list
92227107|NCT00001054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227108|NCT02521844|Pembrolizumab|pembrolizumab|mesh-list
92227109|NCT02521844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92227110|NCT02521844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227111|NCT02521844|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92227112|NCT02521844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227113|NCT01226719|Leucovorin|leucovorin|mesh-list
92227114|NCT01226719|Fluorouracil|fluorouracil|mesh-list
92227115|NCT01226719|Oxaliplatin|oxaliplatin|mesh-list
92227116|NCT01226719|Irinotecan|irinotecan|mesh-list
92227117|NCT01226719|Panitumumab|panitumumab|mesh-list
92227118|NCT01226719|Antimetabolites|antimetabolites|mesh-ancestor
92227119|NCT01226719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227120|NCT01226719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92227121|NCT01226719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227122|NCT01226719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92227124|NCT01226719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227125|NCT01226719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92227126|NCT01226719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92227127|NCT01226719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227128|NCT01226719|Antidotes|antidotes|mesh-ancestor
92227129|NCT01226719|Protective Agents|protective agents|mesh-ancestor
92227130|NCT01226719|Vitamin B Complex|vitamin b complex|mesh-ancestor
92227131|NCT01226719|Vitamins|vitamins|mesh-ancestor
92227132|NCT01226719|Micronutrients|micronutrients|mesh-ancestor
92227133|NCT01226719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92227134|NCT00001072|polysaccharide-K|polysaccharide-k|mesh-list
92227135|NCT00001072|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92227136|NCT00001072|Immunologic Factors|immunologic factors|mesh-ancestor
92227137|NCT00001072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227138|NCT00001072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92227139|NCT00001072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227140|NCT00001072|Antiviral Agents|antiviral agents|mesh-ancestor
92227141|NCT00001072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227142|NCT00001072|Interferon Inducers|interferon inducers|mesh-ancestor
92227143|NCT00001072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92227144|NCT00001072|Protective Agents|protective agents|mesh-ancestor
92227145|NCT04331470|Ritonavir|ritonavir|mesh-list
92227146|NCT04331470|Lopinavir|lopinavir|mesh-list
92227147|NCT04331470|Chloroquine|chloroquine|mesh-list
92227148|NCT04331470|Levamisole|levamisole|mesh-list
92227149|NCT04331470|Hydroxychloroquine|hydroxychloroquine|mesh-list
92227150|NCT04331470|Budesonide|budesonide|mesh-list
92227151|NCT04331470|Formoterol Fumarate|formoterol fumarate|mesh-list
92227152|NCT04331470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92227153|NCT04331470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92227154|NCT04331470|Protease Inhibitors|protease inhibitors|mesh-ancestor
92227155|NCT04331470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227156|NCT04331470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227157|NCT04331470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227158|NCT04331470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227159|NCT04331470|Antiviral Agents|antiviral agents|mesh-ancestor
92227160|NCT04331470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227161|NCT04331470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92227162|NCT04331470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227163|NCT04331470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227164|NCT04331470|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92227165|NCT04331470|Autonomic Agents|autonomic agents|mesh-ancestor
92227166|NCT04331470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227167|NCT04331470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227168|NCT04331470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92227169|NCT04331470|Respiratory System Agents|respiratory system agents|mesh-ancestor
92227170|NCT04331470|Glucocorticoids|glucocorticoids|mesh-ancestor
92227171|NCT04331470|Hormones|hormones|mesh-ancestor
92227172|NCT04331470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227173|NCT04331470|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92227174|NCT04331470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92227175|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92227176|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
92227177|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227178|NCT04331470|Amebicides|amebicides|mesh-ancestor
92227179|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227180|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227181|NCT04331470|Antimalarials|antimalarials|mesh-ancestor
92227182|NCT04331470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92227183|NCT04331470|Antinematodal Agents|antinematodal agents|mesh-ancestor
92227184|NCT04331470|Anthelmintics|anthelmintics|mesh-ancestor
92227185|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92227186|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
92227187|NCT00001090|Sargramostim|sargramostim|mesh-list
92227188|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
92227189|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227190|NCT01147627|Insulin|insulin|mesh-list
92227191|NCT01147627|Pioglitazone|pioglitazone|mesh-list
92227192|NCT01147627|Exenatide|exenatide|mesh-list
92227193|NCT01147627|Insulin Lispro|insulin lispro|mesh-list
92227194|NCT01147627|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92227195|NCT01147627|Protamines|protamines|mesh-list
92227196|NCT01147627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92227197|NCT01147627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227198|NCT01147627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92227200|NCT01147627|Hormones|hormones|mesh-ancestor
92227201|NCT01147627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227202|NCT01147627|Heparin Antagonists|heparin antagonists|mesh-ancestor
92227203|NCT01147627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227204|NCT01147627|Coagulants|coagulants|mesh-ancestor
92227205|NCT02548962|Dexamethasone|dexamethasone|mesh-list
92227206|NCT02548962|Pomalidomide|pomalidomide|mesh-list
92227207|NCT02548962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227208|NCT02548962|Antiemetics|antiemetics|mesh-ancestor
92227209|NCT02548962|Autonomic Agents|autonomic agents|mesh-ancestor
92227210|NCT02548962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227211|NCT02548962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227212|NCT02548962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227213|NCT02548962|Glucocorticoids|glucocorticoids|mesh-ancestor
92227214|NCT02548962|Hormones|hormones|mesh-ancestor
92227215|NCT02548962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227216|NCT02548962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92227217|NCT02548962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227218|NCT02548962|Immunologic Factors|immunologic factors|mesh-ancestor
92227219|NCT02548962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92227220|NCT02548962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92227221|NCT02548962|Growth Substances|growth substances|mesh-ancestor
92227222|NCT02548962|Growth Inhibitors|growth inhibitors|mesh-ancestor
92227223|NCT00000274|Flupenthixol|flupenthixol|mesh-list
92227224|NCT00000274|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92227225|NCT00000274|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92227226|NCT00000274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92227227|NCT00000274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227228|NCT00000274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227229|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227230|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92227231|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
92227232|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227233|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227234|NCT02743598|Liraglutide|liraglutide|mesh-list
92227235|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92227236|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227237|NCT02743598|Incretins|incretins|mesh-ancestor
92227238|NCT02743598|Hormones|hormones|mesh-ancestor
92227239|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227240|NCT00000280|Nimodipine|nimodipine|mesh-list
92227241|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92227242|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92227243|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227244|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227245|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92227246|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227247|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
92227248|NCT00000286|Nefazodone|nefazodone|mesh-list
92227249|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92227250|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227251|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227252|NCT00000286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227253|NCT00000286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227254|NCT00000286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227255|NCT00000286|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92227256|NCT00000286|Antidepressive Agents|antidepressive agents|mesh-ancestor
92227257|NCT00000286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227258|NCT00000286|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92227259|NCT00000286|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92227260|NCT00000286|Serotonin Agents|serotonin agents|mesh-ancestor
92227261|NCT01188577|Epinephrine|epinephrine|mesh-list
92227262|NCT01188577|Racepinephrine|racepinephrine|mesh-list
92227263|NCT01188577|Epinephryl borate|epinephryl borate|mesh-list
92227264|NCT01188577|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92227265|NCT01188577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92227266|NCT01188577|Adrenergic Agents|adrenergic agents|mesh-ancestor
92227267|NCT01188577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227268|NCT01188577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227269|NCT01188577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227270|NCT01188577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91940986|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
92227271|NCT01188577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92227272|NCT01188577|Autonomic Agents|autonomic agents|mesh-ancestor
92227273|NCT01188577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227274|NCT01188577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92227275|NCT01188577|Respiratory System Agents|respiratory system agents|mesh-ancestor
92227276|NCT01188577|Mydriatics|mydriatics|mesh-ancestor
92227277|NCT01188577|Sympathomimetics|sympathomimetics|mesh-ancestor
92227278|NCT01188577|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92227279|NCT02507336|Thalidomide|thalidomide|mesh-list
92227280|NCT02507336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92227281|NCT02507336|Immunologic Factors|immunologic factors|mesh-ancestor
92227282|NCT02507336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227283|NCT02507336|Leprostatic Agents|leprostatic agents|mesh-ancestor
92227284|NCT02507336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227285|NCT02507336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227286|NCT02507336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92227287|NCT02507336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92227288|NCT02507336|Growth Substances|growth substances|mesh-ancestor
92227289|NCT02507336|Growth Inhibitors|growth inhibitors|mesh-ancestor
92227290|NCT02507336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227291|NCT00000292|Cocaine|cocaine|mesh-list
92227292|NCT00000292|Anesthetics, Local|anesthetics, local|mesh-ancestor
92227293|NCT00000292|Anesthetics|anesthetics|mesh-ancestor
92227294|NCT00000292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227295|NCT00000292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227296|NCT00000292|Sensory System Agents|sensory system agents|mesh-ancestor
92227297|NCT00000292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227298|NCT00000292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92227299|NCT00000292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92227300|NCT00000292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227301|NCT00000292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227302|NCT00000292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227303|NCT00000292|Dopamine Agents|dopamine agents|mesh-ancestor
92227304|NCT00000292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227305|NCT00000298|Buprenorphine|buprenorphine|mesh-list
92227306|NCT00000298|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92227307|NCT00000298|Naloxone|naloxone|mesh-list
92227308|NCT00000298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92227309|NCT00000298|Narcotics|narcotics|mesh-ancestor
92227310|NCT00000298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227311|NCT00000298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227312|NCT00000298|Analgesics|analgesics|mesh-ancestor
92227313|NCT00000298|Sensory System Agents|sensory system agents|mesh-ancestor
92227314|NCT00000298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227315|NCT00000298|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92227316|NCT00000304|Amphetamine|amphetamine|mesh-list
92227317|NCT00000304|Dextroamphetamine|dextroamphetamine|mesh-list
92227318|NCT00000304|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92227319|NCT00000304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227320|NCT00000304|Sympathomimetics|sympathomimetics|mesh-ancestor
92227321|NCT00000304|Autonomic Agents|autonomic agents|mesh-ancestor
92227322|NCT00000304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227323|NCT00000304|Dopamine Agents|dopamine agents|mesh-ancestor
92227324|NCT00000304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338287|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92227325|NCT00000304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227326|NCT00000304|Adrenergic Agents|adrenergic agents|mesh-ancestor
92227327|NCT00000304|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92227328|NCT00000304|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227329|NCT00000304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227330|NCT00000304|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92227333|NCT02548650|Vorapaxar|vorapaxar|mesh-list
92227334|NCT02548650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92227335|NCT02548650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227336|NCT02548650|Analgesics|analgesics|mesh-ancestor
92227337|NCT02548650|Sensory System Agents|sensory system agents|mesh-ancestor
92227338|NCT02548650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227339|NCT02548650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227340|NCT02548650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227341|NCT02548650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92227342|NCT02548650|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92227343|NCT02548650|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92227344|NCT02548650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227345|NCT02548650|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92227346|NCT02548650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92227347|NCT02548650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227348|NCT02548650|Antipyretics|antipyretics|mesh-ancestor
92227349|NCT02548650|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92227350|NCT02548650|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92227351|NCT02548650|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92227352|NCT02548650|Purinergic Agents|purinergic agents|mesh-ancestor
92227353|NCT02548650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227354|NCT00000310|Risperidone|risperidone|mesh-list
92227355|NCT00000310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92227356|NCT00000310|Serotonin Agents|serotonin agents|mesh-ancestor
92227357|NCT00000310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227358|NCT00000310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227359|NCT00000310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227360|NCT00000310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92227361|NCT00000310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92227362|NCT00000310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227363|NCT00000310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227364|NCT00000310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92227365|NCT00000310|Dopamine Agents|dopamine agents|mesh-ancestor
92227366|NCT02734004|Bevacizumab|bevacizumab|mesh-list
92227367|NCT02734004|Durvalumab|durvalumab|mesh-list
92227368|NCT02734004|Olaparib|olaparib|mesh-list
92227369|NCT02734004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92227370|NCT02734004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227371|NCT02734004|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92227372|NCT02734004|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92227373|NCT02734004|Growth Substances|growth substances|mesh-ancestor
92227374|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227375|NCT02734004|Growth Inhibitors|growth inhibitors|mesh-ancestor
92227376|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92227377|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227378|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227379|NCT01227655|Levodopa|levodopa|mesh-list
92227380|NCT01227655|Carbidopa|carbidopa|mesh-list
92227381|NCT01227655|Opicapone|opicapone|mesh-list
92227382|NCT01227655|Benserazide|benserazide|mesh-list
92227383|NCT01227655|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92227384|NCT01227655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92227385|NCT01227655|Dopamine Agents|dopamine agents|mesh-ancestor
92227386|NCT01227655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227387|NCT01227655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227388|NCT01227655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227389|NCT01227655|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92227390|NCT01227655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227391|NCT01227655|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92227392|NCT00000316|Cocaine|cocaine|mesh-list
92227393|NCT00000316|Anesthetics, Local|anesthetics, local|mesh-ancestor
92227394|NCT00000316|Anesthetics|anesthetics|mesh-ancestor
92227395|NCT00000316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227396|NCT00000316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227397|NCT00000316|Sensory System Agents|sensory system agents|mesh-ancestor
92227398|NCT00000316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227399|NCT00000316|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92227400|NCT00000316|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92227401|NCT00000316|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227402|NCT00000316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934394|NCT03896009|Analgesics|analgesics|mesh-ancestor
92227403|NCT00000316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227404|NCT00000316|Dopamine Agents|dopamine agents|mesh-ancestor
92227405|NCT00000316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227406|NCT05459532|Molnupiravir|molnupiravir|mesh-list
92227407|NCT05459532|Antiviral Agents|antiviral agents|mesh-ancestor
92227408|NCT05459532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227409|NCT00001990|Atovaquone|atovaquone|mesh-list
92227410|NCT00001990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227411|NCT00001990|Antimalarials|antimalarials|mesh-ancestor
92227412|NCT00001990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227413|NCT00001990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227414|NCT00001990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227415|NCT00001990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227416|NCT01026623|Sirolimus|sirolimus|mesh-list
92227417|NCT01026623|Temsirolimus|temsirolimus|mesh-list
92227418|NCT01026623|MTOR Inhibitors|mtor inhibitors|mesh-list
92227419|NCT01026623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92227420|NCT01026623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227421|NCT01026623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227422|NCT01026623|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92227423|NCT01026623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227424|NCT01026623|Antifungal Agents|antifungal agents|mesh-ancestor
92227425|NCT01026623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92227426|NCT01026623|Immunologic Factors|immunologic factors|mesh-ancestor
92227427|NCT01026623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227428|NCT01026623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92227429|NCT01026623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227430|NCT01026623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227431|NCT00001996|Atovaquone|atovaquone|mesh-list
92227432|NCT00001996|Pentamidine|pentamidine|mesh-list
92227433|NCT00001996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227434|NCT00001996|Antimalarials|antimalarials|mesh-ancestor
92227435|NCT00001996|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227436|NCT00001996|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227437|NCT00001996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227438|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227439|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
92227440|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92227441|NCT02725424|Docetaxel|docetaxel|mesh-list
92227442|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
92227443|NCT02725424|Trastuzumab|trastuzumab|mesh-list
92227444|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227445|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
92227446|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
92227447|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
92227448|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227449|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92227450|NCT01189279|Bimatoprost|bimatoprost|mesh-list
92227451|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92227452|NCT00001108|Ritonavir|ritonavir|mesh-list
92227453|NCT00001108|Nelfinavir|nelfinavir|mesh-list
92227454|NCT00001108|Saquinavir|saquinavir|mesh-list
92227455|NCT00001108|Lamivudine|lamivudine|mesh-list
92227456|NCT00001108|Nevirapine|nevirapine|mesh-list
92227457|NCT00001108|Didanosine|didanosine|mesh-list
92227458|NCT00001108|Stavudine|stavudine|mesh-list
92227459|NCT00001108|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92227460|NCT00001108|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92227461|NCT00001108|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338301|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92227462|NCT00001108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227463|NCT00001108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227464|NCT00001108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227465|NCT00001108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227466|NCT00001108|Antiviral Agents|antiviral agents|mesh-ancestor
92227467|NCT00001108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227468|NCT00001108|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92227469|NCT00001108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227470|NCT00001108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227471|NCT00001108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227472|NCT00001108|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92227473|NCT00001108|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92227474|NCT00001108|Antimetabolites|antimetabolites|mesh-ancestor
92227475|NCT02157974|Exenatide|exenatide|mesh-list
92227476|NCT02157974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92227477|NCT02157974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227478|NCT02157974|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92227479|NCT02157974|Incretins|incretins|mesh-ancestor
92227480|NCT02157974|Hormones|hormones|mesh-ancestor
92227481|NCT02157974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227482|NCT00000328|Analgesics, Opioid|analgesics, opioid|mesh-list
92227483|NCT00000328|Narcotics|narcotics|mesh-ancestor
92227484|NCT00000328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227485|NCT00000328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227486|NCT00000328|Analgesics|analgesics|mesh-ancestor
92227487|NCT00000328|Sensory System Agents|sensory system agents|mesh-ancestor
92227488|NCT00000328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227489|NCT00380224|Olanzapine|olanzapine|mesh-list
92227490|NCT00380224|Antiemetics|antiemetics|mesh-ancestor
92227491|NCT00380224|Autonomic Agents|autonomic agents|mesh-ancestor
92227492|NCT00380224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227493|NCT00380224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227494|NCT00380224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227495|NCT00380224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92227496|NCT00380224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92227497|NCT00380224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227498|NCT00380224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227499|NCT00380224|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92227500|NCT00380224|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227501|NCT00380224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227502|NCT00380224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227503|NCT00380224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227504|NCT00380224|Serotonin Agents|serotonin agents|mesh-ancestor
92227505|NCT00002002|Leucovorin|leucovorin|mesh-list
92227506|NCT00002002|Trimethoprim|trimethoprim|mesh-list
92227507|NCT00002002|Sulfamethoxazole|sulfamethoxazole|mesh-list
92227508|NCT00002002|Calcium|calcium|mesh-list
92227509|NCT00002002|Levoleucovorin|levoleucovorin|mesh-list
92227510|NCT00002002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92227511|NCT00002002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227512|NCT00002002|Antidotes|antidotes|mesh-ancestor
92227513|NCT00002002|Protective Agents|protective agents|mesh-ancestor
92227514|NCT00002002|Vitamin B Complex|vitamin b complex|mesh-ancestor
92227515|NCT00002002|Vitamins|vitamins|mesh-ancestor
92227516|NCT00002002|Micronutrients|micronutrients|mesh-ancestor
92227517|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92227518|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227519|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
92227520|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227521|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227522|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92227523|NCT00002002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227524|NCT00002002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227525|NCT00002002|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92227526|NCT00002002|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92227527|NCT00002002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227528|NCT02535000|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92338308|NCT05091203|Vitamin D|vitamin d|mesh-list
92227529|NCT02535000|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92227530|NCT02535000|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227531|NCT02535000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227532|NCT02535000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227533|NCT02535000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227534|NCT02535000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227536|NCT02535000|Sensory System Agents|sensory system agents|mesh-ancestor
92227537|NCT02535000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227538|NCT02535000|Antidepressive Agents|antidepressive agents|mesh-ancestor
92227539|NCT02535000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227540|NCT02535000|Dopamine Agents|dopamine agents|mesh-ancestor
92227541|NCT00380380|Vildagliptin|vildagliptin|mesh-list
92227542|NCT00380380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92227543|NCT00380380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227544|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92227545|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
92227546|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227547|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227548|NCT01228903|Allopurinol|allopurinol|mesh-list
92227549|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
92227550|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227551|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227552|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
92227553|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92227554|NCT01228903|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92227555|NCT01228903|Antioxidants|antioxidants|mesh-ancestor
92227556|NCT01228903|Protective Agents|protective agents|mesh-ancestor
92227557|NCT01228903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227558|NCT01189747|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92227559|NCT01189747|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92227560|NCT01189747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92227561|NCT01189747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227562|NCT01189747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227563|NCT01189747|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92227564|NCT01189747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227565|NCT01189747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227566|NCT01189747|Cholinergic Agents|cholinergic agents|mesh-ancestor
92227567|NCT01189747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227568|NCT00001126|Cidofovir|cidofovir|mesh-list
92227569|NCT00001126|Antiviral Agents|antiviral agents|mesh-ancestor
92227570|NCT00001126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227571|NCT00001126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227572|NCT00001126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227573|NCT00002008|Sargramostim|sargramostim|mesh-list
92227574|NCT00002008|Immunologic Factors|immunologic factors|mesh-ancestor
92227575|NCT00002008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227576|NCT00001132|Abacavir|abacavir|mesh-list
92227577|NCT00001132|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227578|NCT00001132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227579|NCT00001132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227580|NCT00001132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227581|NCT00001132|Antiviral Agents|antiviral agents|mesh-ancestor
92227582|NCT00001132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227583|NCT00001132|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227584|NCT00001132|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227585|NCT01149733|Tamsulosin|tamsulosin|mesh-list
92227586|NCT01149733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92227587|NCT01149733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92227588|NCT01149733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92227589|NCT01149733|Adrenergic Agents|adrenergic agents|mesh-ancestor
92227590|NCT01149733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227591|NCT01149733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227592|NCT01149733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227593|NCT01149733|Urological Agents|urological agents|mesh-ancestor
92227594|NCT02498912|Cyclophosphamide|cyclophosphamide|mesh-list
92227595|NCT02498912|Fludarabine|fludarabine|mesh-list
92227596|NCT02498912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92227597|NCT02498912|Immunologic Factors|immunologic factors|mesh-ancestor
92227598|NCT02498912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227599|NCT02498912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92227600|NCT02498912|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92227601|NCT02498912|Alkylating Agents|alkylating agents|mesh-ancestor
92227602|NCT02498912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227603|NCT02498912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227604|NCT02498912|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92227605|NCT00002014|Zidovudine|zidovudine|mesh-list
92227606|NCT00002014|Didanosine|didanosine|mesh-list
92227607|NCT00002014|Antimetabolites|antimetabolites|mesh-ancestor
92227608|NCT00002014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227609|NCT00002014|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227610|NCT00002014|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227611|NCT00002014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227612|NCT00002014|Antiviral Agents|antiviral agents|mesh-ancestor
92227613|NCT00002014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227614|NCT00002014|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227615|NCT00002014|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227616|NCT00000334|Buprenorphine|buprenorphine|mesh-list
92227617|NCT00000334|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92227618|NCT00000334|Narcotics|narcotics|mesh-ancestor
92227619|NCT00000334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227620|NCT00000334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227621|NCT00000334|Analgesics|analgesics|mesh-ancestor
92227622|NCT00000334|Sensory System Agents|sensory system agents|mesh-ancestor
92227623|NCT00000334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227625|NCT00000340|Pemoline|pemoline|mesh-list
92227626|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92227627|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227628|NCT00002020|Zidovudine|zidovudine|mesh-list
92227629|NCT00002020|Antimetabolites|antimetabolites|mesh-ancestor
92227630|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227631|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227632|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227633|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227634|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
92227635|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227636|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227637|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227638|NCT00002026|Acyclovir|acyclovir|mesh-list
92227639|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
92227640|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227641|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
92227642|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
92227643|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
92227644|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92227645|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92227646|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922380|NCT02205931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92227647|NCT00000352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227648|NCT00000352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227650|NCT00002032|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227651|NCT00002032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227652|NCT00002032|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92227653|NCT00002032|Antitubercular Agents|antitubercular agents|mesh-ancestor
92227654|NCT01229527|Meperidine|meperidine|mesh-list
92227655|NCT01229527|Remifentanil|remifentanil|mesh-list
92227656|NCT01229527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92227657|NCT01229527|Narcotics|narcotics|mesh-ancestor
92227658|NCT01229527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92227659|NCT01229527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227660|NCT01229527|Analgesics|analgesics|mesh-ancestor
92227661|NCT01229527|Sensory System Agents|sensory system agents|mesh-ancestor
92227662|NCT01229527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227663|NCT01229527|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92227664|NCT02723162|Acetylcysteine|acetylcysteine|mesh-list
92227665|NCT02723162|Varenicline|varenicline|mesh-list
92227666|NCT02723162|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92227667|NCT02723162|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92227668|NCT02723162|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92227669|NCT02723162|Cholinergic Agents|cholinergic agents|mesh-ancestor
92227670|NCT02723162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227671|NCT02723162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227672|NCT02723162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227674|NCT02723162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227675|NCT02723162|Expectorants|expectorants|mesh-ancestor
92227676|NCT02723162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92227677|NCT02723162|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92227678|NCT02723162|Antioxidants|antioxidants|mesh-ancestor
92227679|NCT02723162|Protective Agents|protective agents|mesh-ancestor
92227680|NCT02723162|Antidotes|antidotes|mesh-ancestor
92227681|NCT00000358|Lofexidine|lofexidine|mesh-list
92227682|NCT00000358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92227683|NCT00000358|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92227684|NCT00000358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227685|NCT00000358|Sensory System Agents|sensory system agents|mesh-ancestor
92227686|NCT00000358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227687|NCT00000358|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92227688|NCT00000358|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92227689|NCT00000358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92227690|NCT00000358|Adrenergic Agents|adrenergic agents|mesh-ancestor
92227691|NCT00000358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227692|NCT00000358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227693|NCT00000376|Desipramine|desipramine|mesh-list
92227694|NCT00000376|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92227695|NCT00000376|Antidepressive Agents|antidepressive agents|mesh-ancestor
92227696|NCT00000376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92227697|NCT00000376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227698|NCT00000376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227699|NCT00000376|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92227700|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92227701|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227702|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92227703|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227704|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227705|NCT02143388|Cisplatin|cisplatin|mesh-list
92227706|NCT02143388|Capecitabine|capecitabine|mesh-list
92227707|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227708|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92227709|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
92227710|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227711|NCT00001228|Interferons|interferons|mesh-list
92227712|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227713|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
92227714|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227715|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92227717|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92227718|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
92227719|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92227720|NCT02483936|Diuretics|diuretics|mesh-ancestor
92227721|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
92227722|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227723|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92227724|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227725|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227726|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92227727|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92227728|NCT00002038|Fluconazole|fluconazole|mesh-list
92227729|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
92227730|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227731|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92227732|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227733|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227734|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227735|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92227736|NCT00002038|Hormone Antagonists|hormone antagonists|mesh-ancestor
92227737|NCT00002038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227738|NCT00002038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227739|NCT00002038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92227740|NCT00002038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92227741|NCT01894334|Edaravone|edaravone|mesh-list
92227742|NCT01894334|Tranexamic Acid|tranexamic acid|mesh-list
92227743|NCT01894334|Urinastatin|urinastatin|mesh-list
92227744|NCT01894334|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92227745|NCT01894334|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92227746|NCT01894334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227747|NCT01894334|Hemostatics|hemostatics|mesh-ancestor
92227748|NCT01894334|Coagulants|coagulants|mesh-ancestor
92227749|NCT01894334|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92227750|NCT01894334|Antioxidants|antioxidants|mesh-ancestor
92227751|NCT01894334|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92227752|NCT01894334|Protective Agents|protective agents|mesh-ancestor
92227753|NCT01894334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227754|NCT01894334|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92227755|NCT01894334|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92227756|NCT01894334|Protease Inhibitors|protease inhibitors|mesh-ancestor
92227757|NCT01894334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227758|NCT00002044|Zidovudine|zidovudine|mesh-list
92227759|NCT00002044|Antimetabolites|antimetabolites|mesh-ancestor
92227760|NCT00002044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227761|NCT00002044|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227762|NCT00002044|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227763|NCT00002044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227764|NCT00002044|Antiviral Agents|antiviral agents|mesh-ancestor
92227765|NCT00002044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227766|NCT00002044|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227767|NCT00002044|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227768|NCT00001282|Zidovudine|zidovudine|mesh-list
92227769|NCT00001282|Interleukin-2|interleukin-2|mesh-list
92227770|NCT00001282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227771|NCT00001282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227773|NCT00001282|Sensory System Agents|sensory system agents|mesh-ancestor
92227774|NCT00001282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227775|NCT00001282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227776|NCT00001282|Antimetabolites|antimetabolites|mesh-ancestor
92227777|NCT00001282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227778|NCT00001282|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227779|NCT00001282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227780|NCT00001282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227781|NCT00001282|Antiviral Agents|antiviral agents|mesh-ancestor
92227782|NCT00001282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227783|NCT00001282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227784|NCT00001282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227786|NCT01150981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92227787|NCT01150981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227788|NCT00001300|Doxorubicin|doxorubicin|mesh-list
92227789|NCT00001300|Ifosfamide|ifosfamide|mesh-list
92227790|NCT00001300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92227791|NCT00001300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227792|NCT00001300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92227793|NCT00001300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92227794|NCT00001300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227795|NCT00001300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227796|NCT00001300|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92227797|NCT00001300|Alkylating Agents|alkylating agents|mesh-ancestor
92227798|NCT00000400|Alendronate|alendronate|mesh-list
92227799|NCT00000400|Teriparatide|teriparatide|mesh-list
92227800|NCT00000400|Hormones|hormones|mesh-list
92227801|NCT00000400|Parathyroid Hormone|parathyroid hormone|mesh-list
92227802|NCT00000400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227803|NCT00000400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227804|NCT00000400|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92227805|NCT00000400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92227806|NCT01195597|Nicotine|nicotine|mesh-list
92227807|NCT01195597|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92227808|NCT01195597|Autonomic Agents|autonomic agents|mesh-ancestor
92227809|NCT01195597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227810|NCT01195597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227811|NCT01195597|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92227813|NCT01195597|Cholinergic Agents|cholinergic agents|mesh-ancestor
92227814|NCT01195597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92227815|NCT01195597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227816|NCT00002050|Thymopentin|thymopentin|mesh-list
92227817|NCT00002050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92227818|NCT00002050|Immunologic Factors|immunologic factors|mesh-ancestor
92227819|NCT00002050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227820|NCT04389866|Hyaluronic Acid|hyaluronic acid|mesh-list
92227821|NCT04389866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92227822|NCT04389866|Immunologic Factors|immunologic factors|mesh-ancestor
92227823|NCT04389866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227824|NCT04389866|Viscosupplements|viscosupplements|mesh-ancestor
92227825|NCT04389866|Protective Agents|protective agents|mesh-ancestor
92227826|NCT00000412|Alendronate|alendronate|mesh-list
92227827|NCT00000412|Calcitriol|calcitriol|mesh-list
92227828|NCT00000412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92227829|NCT00000412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227830|NCT00000412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92227831|NCT00000412|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92227832|NCT00000412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92227833|NCT00000412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227834|NCT00000412|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92227835|NCT00000412|Vitamins|vitamins|mesh-ancestor
92227836|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
92227837|NCT00002056|Pentamidine|pentamidine|mesh-list
92227838|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
92227839|NCT00002056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227840|NCT00002056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227841|NCT00002056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227842|NCT00002056|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92227843|NCT03110562|Dexamethasone|dexamethasone|mesh-list
92227844|NCT03110562|Bortezomib|bortezomib|mesh-list
92227845|NCT03110562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227846|NCT03110562|Antiemetics|antiemetics|mesh-ancestor
92227847|NCT03110562|Autonomic Agents|autonomic agents|mesh-ancestor
92227848|NCT03110562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227849|NCT03110562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227850|NCT03110562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227851|NCT03110562|Glucocorticoids|glucocorticoids|mesh-ancestor
92227852|NCT03110562|Hormones|hormones|mesh-ancestor
92227853|NCT03110562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227854|NCT03110562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92227855|NCT03110562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227856|NCT00380614|Lamivudine|lamivudine|mesh-list
92227857|NCT00380614|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227858|NCT00380614|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227859|NCT00380614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227860|NCT00380614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227861|NCT00380614|Antiviral Agents|antiviral agents|mesh-ancestor
92227862|NCT00380614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227863|NCT00380614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227864|NCT00380614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227865|NCT00000430|Alendronate|alendronate|mesh-list
92227866|NCT00000430|Estrogens|estrogens|mesh-list
92227867|NCT00000430|Progestins|progestins|mesh-list
92227868|NCT00000430|Hormones|hormones|mesh-ancestor
92227869|NCT00000430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227870|NCT00000430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227871|NCT00000430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92227872|NCT00380770|Lamivudine|lamivudine|mesh-list
92227873|NCT00380770|Stavudine|stavudine|mesh-list
92227874|NCT00380770|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
92227875|NCT00380770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227876|NCT00380770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227877|NCT00380770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227878|NCT00380770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227879|NCT00380770|Antiviral Agents|antiviral agents|mesh-ancestor
92227880|NCT00380770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227881|NCT00380770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92227882|NCT00380770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92227883|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
92227884|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
92227885|NCT01231399|Leucovorin|leucovorin|mesh-list
92227886|NCT01231399|Fluorouracil|fluorouracil|mesh-list
92227887|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
92227888|NCT01231399|Everolimus|everolimus|mesh-list
92227889|NCT01231399|Calcium|calcium|mesh-list
92227890|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
92227891|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92227892|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227893|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92227894|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
92227895|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227896|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92227897|NCT01231399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227898|NCT01231399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92227899|NCT01231399|Immunologic Factors|immunologic factors|mesh-ancestor
92227900|NCT01231399|Antidotes|antidotes|mesh-ancestor
92227901|NCT01231399|Protective Agents|protective agents|mesh-ancestor
92227902|NCT01231399|Vitamin B Complex|vitamin b complex|mesh-ancestor
92227903|NCT01231399|Vitamins|vitamins|mesh-ancestor
92227904|NCT01231399|Micronutrients|micronutrients|mesh-ancestor
92227905|NCT01231399|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92227906|NCT01231399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92227907|NCT01231399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227908|NCT00002062|Spiramycin|spiramycin|mesh-list
92227909|NCT00002062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227910|NCT00002062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227911|NCT00002062|Coccidiostats|coccidiostats|mesh-ancestor
92227912|NCT00002062|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227913|NCT00002062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227914|NCT01231633|Dexamethasone|dexamethasone|mesh-list
92227915|NCT01231633|Bevacizumab|bevacizumab|mesh-list
92227916|NCT01231633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92227917|NCT01231633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227918|NCT01231633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92227919|NCT01231633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92227920|NCT01231633|Growth Substances|growth substances|mesh-ancestor
92227921|NCT01231633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227922|NCT01231633|Growth Inhibitors|growth inhibitors|mesh-ancestor
92227923|NCT01231633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92227924|NCT01231633|Antiemetics|antiemetics|mesh-ancestor
92227925|NCT01231633|Autonomic Agents|autonomic agents|mesh-ancestor
92227926|NCT01231633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227927|NCT01231633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92227928|NCT01231633|Glucocorticoids|glucocorticoids|mesh-ancestor
92227929|NCT01231633|Hormones|hormones|mesh-ancestor
92227930|NCT01231633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227931|NCT01231633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92227932|NCT00000442|Naltrexone|naltrexone|mesh-list
92227933|NCT00000442|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92227934|NCT00000442|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92227935|NCT00000442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227936|NCT00000442|Sensory System Agents|sensory system agents|mesh-ancestor
92227937|NCT00000442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227938|NCT00002068|Fluconazole|fluconazole|mesh-list
92227939|NCT00002068|Amphotericin B|amphotericin b|mesh-list
92227940|NCT00002068|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92227941|NCT00002068|Antifungal Agents|antifungal agents|mesh-ancestor
92227942|NCT00002068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227943|NCT00002068|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92227944|NCT00002068|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227945|NCT00002068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227946|NCT00002068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227947|NCT00002068|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92227948|NCT00002068|Hormone Antagonists|hormone antagonists|mesh-ancestor
92227949|NCT00002068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227950|NCT00002068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227951|NCT00002068|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92227952|NCT00002068|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92227953|NCT00002068|Amebicides|amebicides|mesh-ancestor
92227954|NCT00002068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227955|NCT00002068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227956|NCT00002068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227957|NCT00000448|Naltrexone|naltrexone|mesh-list
92227958|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92227959|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92227960|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227961|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
92227962|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227963|NCT00001318|Interferons|interferons|mesh-list
92227964|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
92227965|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227966|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
92227967|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227968|NCT00002074|Fluconazole|fluconazole|mesh-list
92227969|NCT00002074|Amphotericin B|amphotericin b|mesh-list
92227970|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92227971|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
92227972|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92227973|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92227974|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92227975|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92227976|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227977|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92227978|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
92227979|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92227980|NCT00002074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227981|NCT00002074|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92227982|NCT00002074|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92227984|NCT00002074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92227985|NCT00002074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92227986|NCT00002074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92227987|NCT00001354|Zidovudine|zidovudine|mesh-list
92227988|NCT00001354|Interleukin-2|interleukin-2|mesh-list
92227989|NCT00001354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92227990|NCT00001354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92227991|NCT00001354|Analgesics|analgesics|mesh-ancestor
92227992|NCT00001354|Sensory System Agents|sensory system agents|mesh-ancestor
92227993|NCT00001354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92227994|NCT00001354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92227995|NCT00001354|Antimetabolites|antimetabolites|mesh-ancestor
92227996|NCT00001354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92227997|NCT00001354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92227998|NCT00001354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92227999|NCT00001354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228000|NCT00001354|Antiviral Agents|antiviral agents|mesh-ancestor
92228001|NCT00001354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228002|NCT00001354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228003|NCT00001354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228004|NCT00000454|Nicotine|nicotine|mesh-list
92228005|NCT00000454|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92228006|NCT00000454|Autonomic Agents|autonomic agents|mesh-ancestor
92228007|NCT00000454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228008|NCT00000454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228009|NCT00000454|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92228010|NCT00000454|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92228011|NCT00000454|Cholinergic Agents|cholinergic agents|mesh-ancestor
92228012|NCT00000454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92228013|NCT00000454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228014|NCT00002080|Rifabutin|rifabutin|mesh-list
92228015|NCT00002080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228016|NCT00002080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228017|NCT00002080|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92228018|NCT00002080|Antitubercular Agents|antitubercular agents|mesh-ancestor
92228019|NCT00000484|Chlorothiazide|chlorothiazide|mesh-list
92228020|NCT00000484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92228021|NCT00000484|Diuretics|diuretics|mesh-ancestor
92228023|NCT00000484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228024|NCT00000484|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92338345|NCT00000839|Antimetabolites|antimetabolites|mesh-ancestor
92228025|NCT00000484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92228026|NCT00000484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228027|NCT00000496|Aspirin|aspirin|mesh-list
92228028|NCT00000496|Dipyridamole|dipyridamole|mesh-list
92228029|NCT00000496|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92228030|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92228031|NCT00000496|Analgesics|analgesics|mesh-ancestor
92228032|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
92228033|NCT00000496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228034|NCT00000496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228035|NCT00000496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92228036|NCT00000496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228037|NCT00000496|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92228038|NCT00000496|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92228039|NCT00000496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228040|NCT00000496|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92228041|NCT00000496|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92228042|NCT00000496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228043|NCT00000496|Antipyretics|antipyretics|mesh-ancestor
92228044|NCT00000496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92228045|NCT00000496|Vasodilator Agents|vasodilator agents|mesh-ancestor
92228046|NCT00002086|Interferons|interferons|mesh-list
92228047|NCT00002086|Interferon-alpha|interferon-alpha|mesh-list
92228048|NCT00002086|Zidovudine|zidovudine|mesh-list
92228049|NCT00002086|Zalcitabine|zalcitabine|mesh-list
92228050|NCT00002086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228051|NCT00002086|Antiviral Agents|antiviral agents|mesh-ancestor
92228052|NCT00002086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228053|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
92228054|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228055|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
92228056|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228057|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228058|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228059|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228060|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228061|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228062|NCT01151449|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92228063|NCT01151449|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92228064|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228065|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228066|NCT00001384|Paclitaxel|paclitaxel|mesh-list
92228067|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
92228068|NCT00001384|Doxorubicin|doxorubicin|mesh-list
92228069|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92228070|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92228071|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228072|NCT00001384|Tubulin Modulators|tubulin modulators|mesh-ancestor
92228073|NCT00001384|Antimitotic Agents|antimitotic agents|mesh-ancestor
92228074|NCT00001384|Mitosis Modulators|mitosis modulators|mesh-ancestor
92228075|NCT00001384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228076|NCT00001384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228077|NCT00001384|Immunologic Factors|immunologic factors|mesh-ancestor
92228078|NCT00001384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228079|NCT00001384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228080|NCT00001384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92228081|NCT00001384|Alkylating Agents|alkylating agents|mesh-ancestor
92228082|NCT00001384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92228083|NCT00001384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92228084|NCT00001384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92228085|NCT00001384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92228086|NCT00001384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228087|NCT01151761|Cisplatin|cisplatin|mesh-list
92228088|NCT01151761|Carboplatin|carboplatin|mesh-list
92228089|NCT01151761|Gemcitabine|gemcitabine|mesh-list
92228090|NCT01151761|Fluorouracil|fluorouracil|mesh-list
92228091|NCT01151761|Capecitabine|capecitabine|mesh-list
92228092|NCT01151761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228093|NCT01151761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228094|NCT01151761|Antimetabolites|antimetabolites|mesh-ancestor
92338350|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
92228095|NCT01151761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228096|NCT01151761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228097|NCT01151761|Immunologic Factors|immunologic factors|mesh-ancestor
92228098|NCT01151761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228100|NCT00002092|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92228101|NCT00002092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228102|NCT00002092|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92228103|NCT00002092|Histamine Antagonists|histamine antagonists|mesh-ancestor
92228104|NCT00002092|Histamine Agents|histamine agents|mesh-ancestor
92228105|NCT00002092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92228106|NCT00002092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228107|NCT00002092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228108|NCT00002092|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92228109|NCT00002092|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92228110|NCT00002092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228111|NCT00002098|Didanosine|didanosine|mesh-list
92228112|NCT00002098|Lentinan|lentinan|mesh-list
92228113|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
92228114|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228115|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228116|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228117|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228119|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228120|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228121|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228122|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92228123|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
92228124|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228125|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228126|NCT02705300|Leucovorin|leucovorin|mesh-list
92228127|NCT02705300|Tocotrienols|tocotrienols|mesh-list
92228128|NCT02705300|Vitamin E|vitamin e|mesh-list
92228129|NCT02705300|Tocopherols|tocopherols|mesh-list
92228130|NCT02705300|Fluorouracil|fluorouracil|mesh-list
92228131|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
92228132|NCT02705300|Irinotecan|irinotecan|mesh-list
92228133|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
92228134|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228135|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
92228136|NCT02705300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228137|NCT02705300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228138|NCT02705300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228139|NCT02705300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228140|NCT02705300|Immunologic Factors|immunologic factors|mesh-ancestor
92228141|NCT02705300|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92228142|NCT02705300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92228143|NCT02705300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228144|NCT02705300|Antidotes|antidotes|mesh-ancestor
92228145|NCT02705300|Protective Agents|protective agents|mesh-ancestor
92228146|NCT02705300|Vitamin B Complex|vitamin b complex|mesh-ancestor
92228147|NCT02705300|Vitamins|vitamins|mesh-ancestor
92228148|NCT02705300|Micronutrients|micronutrients|mesh-ancestor
92228149|NCT02705300|Antioxidants|antioxidants|mesh-ancestor
92228150|NCT01196377|Albuterol|albuterol|mesh-list
92228151|NCT01196377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92228152|NCT01196377|Autonomic Agents|autonomic agents|mesh-ancestor
92228153|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228154|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228155|NCT01196377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92228156|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
92228157|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
92228158|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228159|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92228160|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92228161|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92228162|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
92228163|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92228164|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228165|NCT00001426|Paclitaxel|paclitaxel|mesh-list
92228166|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
92228167|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92228168|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228169|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
92228170|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
92228171|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
92228172|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228173|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228174|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
92228175|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228176|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228177|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92228178|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
92228179|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92228181|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228182|NCT00002104|Thalidomide|thalidomide|mesh-list
92228183|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228184|NCT00002104|Immunologic Factors|immunologic factors|mesh-ancestor
92228185|NCT00002104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228186|NCT00002104|Leprostatic Agents|leprostatic agents|mesh-ancestor
92228187|NCT00002104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228188|NCT00002104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228189|NCT00002104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92228190|NCT00002104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92228191|NCT00002104|Growth Substances|growth substances|mesh-ancestor
92228192|NCT00002104|Growth Inhibitors|growth inhibitors|mesh-ancestor
92228193|NCT00002104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228194|NCT00001438|Interferon alpha-2|interferon alpha-2|mesh-list
92228196|NCT00001438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228197|NCT00001438|Keratolytic Agents|keratolytic agents|mesh-ancestor
92228198|NCT00001438|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228199|NCT00001438|Antiviral Agents|antiviral agents|mesh-ancestor
92228200|NCT00001438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228201|NCT00001444|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92228202|NCT00001444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228203|NCT00001444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92228204|NCT00001444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228205|NCT00001444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228206|NCT00000574|Ibuprofen|ibuprofen|mesh-list
92228207|NCT00000574|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92228208|NCT00000574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92228209|NCT00000574|Analgesics|analgesics|mesh-ancestor
92228210|NCT00000574|Sensory System Agents|sensory system agents|mesh-ancestor
92228211|NCT00000574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228212|NCT00000574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228213|NCT00000574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92228214|NCT00000574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228215|NCT00000574|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92228216|NCT00000574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228217|NCT00000574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228218|NCT00002110|Zidovudine|zidovudine|mesh-list
92228219|NCT00002110|Cysteamine|cysteamine|mesh-list
92228220|NCT00002110|Antimetabolites|antimetabolites|mesh-ancestor
92228221|NCT00002110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228222|NCT00002110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228223|NCT00002110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228224|NCT00002110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228225|NCT00002110|Antiviral Agents|antiviral agents|mesh-ancestor
92228226|NCT00002110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228227|NCT00002110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228228|NCT00002110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228229|NCT00002110|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92228230|NCT00001450|Paclitaxel|paclitaxel|mesh-list
92228231|NCT00001450|Cisplatin|cisplatin|mesh-list
92228232|NCT00001450|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92228233|NCT00001450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228234|NCT00001450|Tubulin Modulators|tubulin modulators|mesh-ancestor
92228235|NCT00001450|Antimitotic Agents|antimitotic agents|mesh-ancestor
92228236|NCT00001450|Mitosis Modulators|mitosis modulators|mesh-ancestor
92228237|NCT00001450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228238|NCT00000580|Immunoglobulins|immunoglobulins|mesh-list
92338358|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228239|NCT00000580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92228240|NCT00000580|Antibodies|antibodies|mesh-list
92228241|NCT00000580|gamma-Globulins|gamma-globulins|mesh-list
92228242|NCT00000580|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92228243|NCT00000580|Immunologic Factors|immunologic factors|mesh-ancestor
92228244|NCT00000580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228245|NCT00002116|Cidofovir|cidofovir|mesh-list
92228246|NCT00002116|Antiviral Agents|antiviral agents|mesh-ancestor
92228247|NCT00002116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228248|NCT00002116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228249|NCT00002116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228250|NCT00001498|Leucovorin|leucovorin|mesh-list
92228251|NCT00001498|Paclitaxel|paclitaxel|mesh-list
92228252|NCT00001498|Cyclophosphamide|cyclophosphamide|mesh-list
92228254|NCT00001498|Fluorouracil|fluorouracil|mesh-list
92228255|NCT00001498|Methotrexate|methotrexate|mesh-list
92228256|NCT00001498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92228257|NCT00001498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228258|NCT00001498|Tubulin Modulators|tubulin modulators|mesh-ancestor
92228259|NCT00001498|Antimitotic Agents|antimitotic agents|mesh-ancestor
92228260|NCT00001498|Mitosis Modulators|mitosis modulators|mesh-ancestor
92228261|NCT00001498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228262|NCT00001498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228263|NCT00001498|Immunologic Factors|immunologic factors|mesh-ancestor
92228264|NCT00001498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228265|NCT00001498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228266|NCT00001498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92228267|NCT00001498|Alkylating Agents|alkylating agents|mesh-ancestor
92228268|NCT00001498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92228269|NCT00001498|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92228270|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92228271|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92228272|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228273|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
92228274|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228275|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92228276|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
92228277|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228278|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228279|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92228280|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228281|NCT00001498|Antidotes|antidotes|mesh-ancestor
92228282|NCT00001498|Protective Agents|protective agents|mesh-ancestor
92228283|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
92228284|NCT00001498|Vitamins|vitamins|mesh-ancestor
92228285|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
92228286|NCT00001504|Tretinoin|tretinoin|mesh-list
92228287|NCT00001504|Alitretinoin|alitretinoin|mesh-list
92228288|NCT00001504|Isotretinoin|isotretinoin|mesh-list
92228289|NCT00001504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228290|NCT00001504|Keratolytic Agents|keratolytic agents|mesh-ancestor
92228291|NCT00001504|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228292|NCT02688140|Cytarabine|cytarabine|mesh-list
92228293|NCT02688140|Methotrexate|methotrexate|mesh-list
92228294|NCT02688140|Mercaptopurine|mercaptopurine|mesh-list
92228295|NCT02688140|Mitoxantrone|mitoxantrone|mesh-list
92228296|NCT02688140|Idarubicin|idarubicin|mesh-list
92228297|NCT02688140|Tretinoin|tretinoin|mesh-list
92228298|NCT02688140|Arsenic Trioxide|arsenic trioxide|mesh-list
92228299|NCT02688140|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92228300|NCT02688140|Abortifacient Agents|abortifacient agents|mesh-ancestor
92228301|NCT02688140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228302|NCT02688140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228303|NCT02688140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228304|NCT02688140|Antimetabolites|antimetabolites|mesh-ancestor
92228305|NCT02688140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228306|NCT02688140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228307|NCT02688140|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228308|NCT02688140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228309|NCT02688140|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92228310|NCT02688140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228311|NCT02688140|Immunologic Factors|immunologic factors|mesh-ancestor
92228312|NCT02688140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228313|NCT02688140|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228314|NCT02688140|Antiviral Agents|antiviral agents|mesh-ancestor
92228315|NCT02688140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228316|NCT02688140|Analgesics|analgesics|mesh-ancestor
92228317|NCT02688140|Sensory System Agents|sensory system agents|mesh-ancestor
92228318|NCT02688140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228319|NCT02688140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92228320|NCT02688140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92228321|NCT02688140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92228322|NCT02688140|Keratolytic Agents|keratolytic agents|mesh-ancestor
92228323|NCT00002122|Azithromycin|azithromycin|mesh-list
92228325|NCT00002122|Fluconazole|fluconazole|mesh-list
92228326|NCT00002122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228328|NCT00002122|Antifungal Agents|antifungal agents|mesh-ancestor
92228329|NCT00002122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92228330|NCT00002122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92228331|NCT00002122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228332|NCT00002122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228333|NCT00002122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92228334|NCT00002122|Hormone Antagonists|hormone antagonists|mesh-ancestor
92117524|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92228335|NCT00002122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92228336|NCT00002122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228337|NCT00002122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92228338|NCT00002122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92228339|NCT00002122|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92228340|NCT00002122|Antitubercular Agents|antitubercular agents|mesh-ancestor
92228341|NCT05456334|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92228342|NCT05456334|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92228343|NCT05456334|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228344|NCT00001534|Losartan|losartan|mesh-list
92228345|NCT00001534|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92228346|NCT00001534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92228347|NCT00001534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92228348|NCT00001534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92228349|NCT00001534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228350|NCT01027559|Sertraline|sertraline|mesh-list
92228351|NCT01027559|Antidepressive Agents|antidepressive agents|mesh-ancestor
92228352|NCT01027559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92228353|NCT01027559|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92228354|NCT01027559|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92228355|NCT01027559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92228356|NCT01027559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228357|NCT01027559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92228358|NCT01027559|Serotonin Agents|serotonin agents|mesh-ancestor
92228359|NCT01027559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228360|NCT00002128|Adefovir|adefovir|mesh-list
92228361|NCT00002128|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92228362|NCT00002128|Antiviral Agents|antiviral agents|mesh-ancestor
92228363|NCT00002128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228364|NCT00002128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228365|NCT00002128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228366|NCT00002128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228367|NCT00002128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228368|NCT00001570|Vinblastine|vinblastine|mesh-list
92228369|NCT00001570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92228370|NCT00001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228371|NCT00001570|Tubulin Modulators|tubulin modulators|mesh-ancestor
92228372|NCT00001570|Antimitotic Agents|antimitotic agents|mesh-ancestor
92228373|NCT00001570|Mitosis Modulators|mitosis modulators|mesh-ancestor
92228374|NCT00001570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228376|NCT00000628|L-697661|l-697661|mesh-list
92228377|NCT00000628|Antimetabolites|antimetabolites|mesh-ancestor
92228378|NCT00000628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228379|NCT00000628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228380|NCT00000628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228381|NCT00000628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228382|NCT00000628|Antiviral Agents|antiviral agents|mesh-ancestor
92228383|NCT00000628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228384|NCT00000628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228385|NCT00000628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228386|NCT00000634|Nevirapine|nevirapine|mesh-list
92228387|NCT00000634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228388|NCT00000634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228389|NCT00000634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228390|NCT00000634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228391|NCT00000634|Antiviral Agents|antiviral agents|mesh-ancestor
92228392|NCT00000634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228393|NCT00000634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228394|NCT00000634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228395|NCT00000634|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92228396|NCT00000634|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92228397|NCT01661790|Bevacizumab|bevacizumab|mesh-list
92228398|NCT01661790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92228399|NCT01661790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228400|NCT01661790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92228401|NCT01661790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92228402|NCT01661790|Growth Substances|growth substances|mesh-ancestor
92228403|NCT01661790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228404|NCT01661790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92228406|NCT00002134|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92228407|NCT00002134|Antiviral Agents|antiviral agents|mesh-ancestor
92228408|NCT00002134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228409|NCT00002134|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228410|NCT00002134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228411|NCT00002134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228412|NCT00985907|Bortezomib|bortezomib|mesh-list
92228413|NCT00985907|Melphalan|melphalan|mesh-list
92228414|NCT00985907|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92228415|NCT00985907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228416|NCT00985907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92228417|NCT00985907|Alkylating Agents|alkylating agents|mesh-ancestor
92228418|NCT00985907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228419|NCT00985907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92228420|NCT00985907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228421|NCT00985907|Immunologic Factors|immunologic factors|mesh-ancestor
92228422|NCT00985907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228423|NCT00985907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92228424|NCT00002140|Azithromycin|azithromycin|mesh-list
92228425|NCT00002140|Clarithromycin|clarithromycin|mesh-list
92228426|NCT00002140|Ethambutol|ethambutol|mesh-list
92228427|NCT00002140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228428|NCT00002140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228429|NCT00002140|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92228430|NCT00002140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228431|NCT00002140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228432|NCT00002140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92228433|NCT00002140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92228434|NCT00002140|Antitubercular Agents|antitubercular agents|mesh-ancestor
92228435|NCT00000658|Leucovorin|leucovorin|mesh-list
92228436|NCT00000658|Cytarabine|cytarabine|mesh-list
92228437|NCT00000658|Dexamethasone|dexamethasone|mesh-list
92228438|NCT00000658|Cyclophosphamide|cyclophosphamide|mesh-list
92228439|NCT00000658|Doxorubicin|doxorubicin|mesh-list
92228440|NCT00000658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92228441|NCT00000658|Methotrexate|methotrexate|mesh-list
92228442|NCT00000658|Vincristine|vincristine|mesh-list
92228443|NCT00000658|Bleomycin|bleomycin|mesh-list
92228444|NCT00000658|Allopurinol|allopurinol|mesh-list
92228445|NCT00000658|Sargramostim|sargramostim|mesh-list
92228446|NCT00000658|Levoleucovorin|levoleucovorin|mesh-list
92228447|NCT00000658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228448|NCT00000658|Immunologic Factors|immunologic factors|mesh-ancestor
92228449|NCT00000658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228451|NCT00000658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92228452|NCT00000658|Alkylating Agents|alkylating agents|mesh-ancestor
92228453|NCT00000658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228454|NCT00000658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228455|NCT00000658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92228456|NCT00000658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92228457|NCT00000658|Antiemetics|antiemetics|mesh-ancestor
92228458|NCT00000658|Autonomic Agents|autonomic agents|mesh-ancestor
92228459|NCT00000658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228460|NCT00000658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228461|NCT00000658|Glucocorticoids|glucocorticoids|mesh-ancestor
92228462|NCT00000658|Hormones|hormones|mesh-ancestor
92228463|NCT00000658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92228464|NCT00000658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92228465|NCT00000658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92228466|NCT00000658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92228467|NCT00000658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92228468|NCT00000658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228469|NCT00000658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92228470|NCT00000658|Abortifacient Agents|abortifacient agents|mesh-ancestor
92228471|NCT00000658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228472|NCT00000658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228473|NCT00000658|Antimetabolites|antimetabolites|mesh-ancestor
92228474|NCT00000658|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228475|NCT00000658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92228476|NCT00000658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228477|NCT00000658|Antiviral Agents|antiviral agents|mesh-ancestor
92228478|NCT00000658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228479|NCT00000658|Antidotes|antidotes|mesh-ancestor
92228480|NCT00000658|Protective Agents|protective agents|mesh-ancestor
92228481|NCT00000658|Vitamin B Complex|vitamin b complex|mesh-ancestor
92228482|NCT00000658|Vitamins|vitamins|mesh-ancestor
92228483|NCT00000658|Micronutrients|micronutrients|mesh-ancestor
92228484|NCT00000658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92228485|NCT00000658|Tubulin Modulators|tubulin modulators|mesh-ancestor
92228486|NCT00000658|Antimitotic Agents|antimitotic agents|mesh-ancestor
92228487|NCT00000658|Mitosis Modulators|mitosis modulators|mesh-ancestor
92228488|NCT00000658|Gout Suppressants|gout suppressants|mesh-ancestor
92228489|NCT00000658|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92228490|NCT00000658|Antioxidants|antioxidants|mesh-ancestor
92228491|NCT02684474|HBOC 201|hboc 201|mesh-list
92228492|NCT02684474|Blood Substitutes|blood substitutes|mesh-ancestor
92228493|NCT01027793|Tretinoin|tretinoin|mesh-list
92228494|NCT01027793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228495|NCT01027793|Keratolytic Agents|keratolytic agents|mesh-ancestor
92228496|NCT01027793|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228497|NCT00002146|Foscarnet|foscarnet|mesh-list
92228498|NCT00002146|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92228499|NCT00002146|Magnesium Sulfate|magnesium sulfate|mesh-list
92228500|NCT00002146|Analgesics|analgesics|mesh-ancestor
92228501|NCT00002146|Sensory System Agents|sensory system agents|mesh-ancestor
92228502|NCT00002146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228503|NCT00002146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228504|NCT00002146|Anesthetics|anesthetics|mesh-ancestor
92228505|NCT00002146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92228506|NCT00002146|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92228507|NCT00002146|Anticonvulsants|anticonvulsants|mesh-ancestor
92228508|NCT00002146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92228509|NCT00002146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92228510|NCT00002146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228511|NCT00002146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92228512|NCT00002146|Tocolytic Agents|tocolytic agents|mesh-ancestor
92228513|NCT00002146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228514|NCT00002146|Antiviral Agents|antiviral agents|mesh-ancestor
92228515|NCT00002146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228516|NCT00002146|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228517|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228518|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228519|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
92228520|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91934407|NCT02344875|Dotinurad|dotinurad|mesh-list
92228521|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92228522|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228523|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
92228524|NCT04389554|Coagulants|coagulants|mesh-ancestor
92228525|NCT03051516|Vaccines|vaccines|mesh-list
92228526|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
92228527|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228528|NCT01029587|Eculizumab|eculizumab|mesh-list
92228529|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92228530|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228531|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
92228532|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228533|NCT00000664|Zidovudine|zidovudine|mesh-list
92228534|NCT00000664|Interleukin-2|interleukin-2|mesh-list
92228535|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228536|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92228537|NCT00000664|Analgesics|analgesics|mesh-ancestor
92228538|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
92228539|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228540|NCT00000664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228541|NCT00000664|Antimetabolites|antimetabolites|mesh-ancestor
92228542|NCT00000664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228543|NCT00000664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228544|NCT00000664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228545|NCT00000664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228546|NCT00000664|Antiviral Agents|antiviral agents|mesh-ancestor
92228547|NCT00000664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228548|NCT00000664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228549|NCT00000664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228550|NCT00000670|Zidovudine|zidovudine|mesh-list
92228552|NCT00000670|Antimetabolites|antimetabolites|mesh-ancestor
92228553|NCT00000670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228554|NCT00000670|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228555|NCT00000670|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228556|NCT00000670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228557|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
92228558|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228559|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228560|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228561|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
92228562|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
92228563|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228564|NCT02020070|Ipilimumab|ipilimumab|mesh-list
92228565|NCT02020070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92228566|NCT02020070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228567|NCT02020070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92228568|NCT02020070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228569|NCT00002158|Nitazoxanide|nitazoxanide|mesh-list
92228570|NCT00002158|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92228571|NCT00002158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228572|NCT00000694|Interferons|interferons|mesh-list
92228573|NCT00000694|Interferon-alpha|interferon-alpha|mesh-list
92228574|NCT00000694|Interferon alpha-2|interferon alpha-2|mesh-list
92228575|NCT00000694|Zidovudine|zidovudine|mesh-list
92228576|NCT00000694|Sargramostim|sargramostim|mesh-list
92228577|NCT00000694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228578|NCT00000694|Antiviral Agents|antiviral agents|mesh-ancestor
92228579|NCT00000694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228580|NCT00000694|Immunologic Factors|immunologic factors|mesh-ancestor
92228581|NCT00000694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228582|NCT00000694|Antimetabolites|antimetabolites|mesh-ancestor
92228583|NCT00000694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228584|NCT00000694|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228585|NCT00000694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228586|NCT00000694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228587|NCT00000694|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228588|NCT00000694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228589|NCT01894412|Etanercept|etanercept|mesh-list
92228590|NCT01894412|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92228591|NCT01894412|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92228592|NCT01894412|Analgesics|analgesics|mesh-ancestor
92228593|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
92228594|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228595|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228596|NCT01894412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92228597|NCT01894412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228598|NCT01894412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228599|NCT01894412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228600|NCT01894412|Immunologic Factors|immunologic factors|mesh-ancestor
92228602|NCT00000700|Antimetabolites|antimetabolites|mesh-ancestor
92228603|NCT00000700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228604|NCT00000700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228605|NCT00000700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228606|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228607|NCT00000700|Antiviral Agents|antiviral agents|mesh-ancestor
92228608|NCT00000700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228609|NCT00000700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228610|NCT00000700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228611|NCT00002164|Nelfinavir|nelfinavir|mesh-list
92228612|NCT00002164|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92228613|NCT00002164|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92228614|NCT00002164|Protease Inhibitors|protease inhibitors|mesh-ancestor
92228615|NCT00002164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228616|NCT00002164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228617|NCT00002164|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228618|NCT00002164|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228619|NCT00002164|Antiviral Agents|antiviral agents|mesh-ancestor
92228620|NCT00002164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228621|NCT00000706|Zidovudine|zidovudine|mesh-list
92228622|NCT00000706|Quinine|quinine|mesh-list
92228623|NCT00000706|Probenecid|probenecid|mesh-list
92228624|NCT00000706|Antimetabolites|antimetabolites|mesh-ancestor
92228625|NCT00000706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228626|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228627|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228628|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228629|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
92228630|NCT00000706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228631|NCT00000706|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228632|NCT00000706|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228633|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
92228634|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92228635|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92228636|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92228637|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228638|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92228639|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228640|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92228641|NCT00000706|Analgesics|analgesics|mesh-ancestor
92228642|NCT00000706|Sensory System Agents|sensory system agents|mesh-ancestor
92228643|NCT00000706|Uricosuric Agents|uricosuric agents|mesh-ancestor
92228644|NCT00000706|Gout Suppressants|gout suppressants|mesh-ancestor
92228645|NCT00000706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92228646|NCT00988325|Oseltamivir|oseltamivir|mesh-list
92228647|NCT00988325|Antiviral Agents|antiviral agents|mesh-ancestor
92228648|NCT00988325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228649|NCT00988325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228650|NCT00988325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228651|NCT00002296|Inosine Pranobex|inosine pranobex|mesh-list
92228652|NCT00002296|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92228653|NCT00002296|Immunologic Factors|immunologic factors|mesh-ancestor
92228654|NCT00002296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228655|NCT00002296|Antiviral Agents|antiviral agents|mesh-ancestor
92228656|NCT00002296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228657|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
92228658|NCT00002302|Hematinics|hematinics|mesh-ancestor
92228659|NCT00002170|Nelfinavir|nelfinavir|mesh-list
92228660|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92228661|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92228662|NCT00002170|Protease Inhibitors|protease inhibitors|mesh-ancestor
92228663|NCT00002170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228664|NCT00002170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228665|NCT00002170|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228666|NCT00002170|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228668|NCT00002170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228669|NCT00002308|Stavudine|stavudine|mesh-list
92228670|NCT00002308|Antimetabolites|antimetabolites|mesh-ancestor
92228671|NCT00002308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228672|NCT00002308|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228673|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228674|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228676|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228677|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228678|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228679|NCT00000724|Leucovorin|leucovorin|mesh-list
92228680|NCT00000724|Trimetrexate|trimetrexate|mesh-list
92228681|NCT00000724|Calcium|calcium|mesh-list
92228682|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
92228683|NCT00000724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92228684|NCT00000724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228685|NCT00000724|Antidotes|antidotes|mesh-ancestor
92228686|NCT00000724|Protective Agents|protective agents|mesh-ancestor
92228687|NCT00000724|Vitamin B Complex|vitamin b complex|mesh-ancestor
92228688|NCT00000724|Vitamins|vitamins|mesh-ancestor
92228689|NCT00000724|Micronutrients|micronutrients|mesh-ancestor
92228690|NCT00000724|Antifungal Agents|antifungal agents|mesh-ancestor
92228691|NCT00000724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228692|NCT00000724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228693|NCT00000724|Antimetabolites|antimetabolites|mesh-ancestor
92228694|NCT00000724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228695|NCT00000724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228696|NCT00000724|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92228697|NCT00000724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228698|NCT00000730|Leucovorin|leucovorin|mesh-list
92228699|NCT00000730|Trimethoprim|trimethoprim|mesh-list
92228700|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92228701|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
92228702|NCT00000730|Pentamidine|pentamidine|mesh-list
92228703|NCT00000730|Trimetrexate|trimetrexate|mesh-list
92228704|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
92228705|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
92228706|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228707|NCT00000730|Antidotes|antidotes|mesh-ancestor
92228708|NCT00000730|Protective Agents|protective agents|mesh-ancestor
92228709|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
92228710|NCT00000730|Vitamins|vitamins|mesh-ancestor
92228711|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
92228712|NCT00000730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92228713|NCT00000730|Antiemetics|antiemetics|mesh-ancestor
92228714|NCT00000730|Autonomic Agents|autonomic agents|mesh-ancestor
92228715|NCT00000730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228716|NCT00000730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228717|NCT00000730|Glucocorticoids|glucocorticoids|mesh-ancestor
92228718|NCT00000730|Hormones|hormones|mesh-ancestor
92228719|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92228720|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92228721|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228722|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92228723|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228724|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
92228725|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92228726|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92228727|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92228728|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228729|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228730|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92228731|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92228732|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92228733|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
92228734|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92228735|NCT00000730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228736|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228737|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
92228738|NCT00002176|Nelfinavir|nelfinavir|mesh-list
92228739|NCT00002176|Didanosine|didanosine|mesh-list
92228740|NCT00002176|Stavudine|stavudine|mesh-list
92228741|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
92228742|NCT00002176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228743|NCT00002176|Antisickling Agents|antisickling agents|mesh-ancestor
92228744|NCT00002176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228745|NCT00002176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228746|NCT00002176|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228747|NCT00002176|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92228748|NCT00002176|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92228749|NCT00002176|Protease Inhibitors|protease inhibitors|mesh-ancestor
92228750|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228751|NCT00002176|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228752|NCT00002176|Antiviral Agents|antiviral agents|mesh-ancestor
92228753|NCT00002176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228754|NCT00002176|Antimetabolites|antimetabolites|mesh-ancestor
92228755|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228756|NCT01990196|Dasatinib|dasatinib|mesh-list
92228757|NCT01990196|Trametinib|trametinib|mesh-list
92228758|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228759|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92228760|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228761|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228762|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
92228763|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92228764|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228765|NCT00002182|Megestrol|megestrol|mesh-list
92228766|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
92228767|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92228768|NCT00002182|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92228769|NCT00002182|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92228770|NCT00002182|Contraceptive Agents|contraceptive agents|mesh-ancestor
92228771|NCT00002182|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228772|NCT00002182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228773|NCT00002182|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92228774|NCT00002182|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92228775|NCT00002182|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92228776|NCT00002182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228777|NCT00002182|Appetite Stimulants|appetite stimulants|mesh-ancestor
92228778|NCT00002182|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92228779|NCT00002320|Lamivudine|lamivudine|mesh-list
92228780|NCT00002320|Zidovudine|zidovudine|mesh-list
92228781|NCT00002320|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228782|NCT00002320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228783|NCT00002320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228784|NCT00002320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228785|NCT00002320|Antiviral Agents|antiviral agents|mesh-ancestor
92228786|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228787|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228788|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228789|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
92228790|NCT02167217|Prednisolone|prednisolone|mesh-list
92228791|NCT02167217|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92228792|NCT02167217|Methylprednisolone|methylprednisolone|mesh-list
92228793|NCT02167217|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92228794|NCT02167217|Prednisolone acetate|prednisolone acetate|mesh-list
92228795|NCT02167217|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92228796|NCT02167217|Prednisolone phosphate|prednisolone phosphate|mesh-list
92117525|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
92228797|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92228798|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
92228799|NCT02167217|Hormones|hormones|mesh-ancestor
92228800|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92228801|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228802|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92228803|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228804|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
92228805|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
92228806|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228807|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228808|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92228809|NCT02167217|Protective Agents|protective agents|mesh-ancestor
92228810|NCT00002326|Zidovudine|zidovudine|mesh-list
92228811|NCT00002326|Adefovir|adefovir|mesh-list
92228813|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228814|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228815|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228816|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228817|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
92228818|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228819|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228820|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228821|NCT01152697|Haloperidol|haloperidol|mesh-list
92228822|NCT01152697|Haloperidol decanoate|haloperidol decanoate|mesh-list
92228823|NCT01152697|Antiemetics|antiemetics|mesh-ancestor
92228824|NCT01152697|Autonomic Agents|autonomic agents|mesh-ancestor
92228825|NCT01152697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228826|NCT01152697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228827|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228829|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92228830|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92228831|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92228832|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92228833|NCT01152697|Dopamine Agents|dopamine agents|mesh-ancestor
92228834|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92228835|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228836|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92228837|NCT00002188|Alitretinoin|alitretinoin|mesh-list
92228838|NCT00002188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228839|NCT00002188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92228840|NCT00002332|Thymopentin|thymopentin|mesh-list
92228841|NCT00002332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92228842|NCT00002332|Immunologic Factors|immunologic factors|mesh-ancestor
92228843|NCT00002332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228844|NCT05571644|Leucovorin|leucovorin|mesh-list
92228845|NCT05571644|Fluorouracil|fluorouracil|mesh-list
92228846|NCT05571644|Oxaliplatin|oxaliplatin|mesh-list
92228847|NCT05571644|Irinotecan|irinotecan|mesh-list
92228848|NCT05571644|Levoleucovorin|levoleucovorin|mesh-list
92228849|NCT05571644|Antimetabolites|antimetabolites|mesh-ancestor
92228850|NCT05571644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228851|NCT05571644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92228852|NCT05571644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228853|NCT05571644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92228854|NCT05571644|Immunologic Factors|immunologic factors|mesh-ancestor
92228855|NCT05571644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228856|NCT05571644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92228857|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92228858|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228859|NCT05571644|Antidotes|antidotes|mesh-ancestor
92228860|NCT05571644|Protective Agents|protective agents|mesh-ancestor
92228861|NCT05571644|Vitamin B Complex|vitamin b complex|mesh-ancestor
92228862|NCT05571644|Vitamins|vitamins|mesh-ancestor
92228863|NCT05571644|Micronutrients|micronutrients|mesh-ancestor
92228864|NCT03011281|Tofacitinib|tofacitinib|mesh-list
92228865|NCT03011281|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92228866|NCT03011281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92228867|NCT03011281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228868|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228869|NCT00002194|Clarithromycin|clarithromycin|mesh-list
92228870|NCT00002194|Erythromycin|erythromycin|mesh-list
92228871|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
92228872|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92228873|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
92228874|NCT00002194|Nevirapine|nevirapine|mesh-list
92228875|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228876|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228877|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92228878|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228879|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228880|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92228881|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92228882|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338411|NCT04941833|Progestins|progestins|mesh-ancestor
92228883|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228884|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
92228885|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228886|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228887|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92228888|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92228889|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92228890|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
92228891|NCT04756622|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92228892|NCT04756622|Antiviral Agents|antiviral agents|mesh-ancestor
92228893|NCT04756622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228894|NCT04756622|Expectorants|expectorants|mesh-ancestor
92228895|NCT04756622|Respiratory System Agents|respiratory system agents|mesh-ancestor
92228896|NCT04756622|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92228897|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
92228898|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228899|NCT04756622|Protective Agents|protective agents|mesh-ancestor
92228900|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228901|NCT04756622|Antidotes|antidotes|mesh-ancestor
92228902|NCT00002344|Azithromycin|azithromycin|mesh-list
92228903|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92228904|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228905|NCT01198327|Ranibizumab|ranibizumab|mesh-list
92228906|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92228907|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92228908|NCT01198327|Growth Substances|growth substances|mesh-ancestor
92228909|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228910|NCT01198327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92228911|NCT01198327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228912|NCT00002200|Abacavir|abacavir|mesh-list
92228913|NCT00002200|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228914|NCT00002200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228915|NCT00002200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228916|NCT00002200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228917|NCT00002200|Antiviral Agents|antiviral agents|mesh-ancestor
92228918|NCT00002200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228919|NCT00002200|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228920|NCT00002200|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228921|NCT00002356|Fomivirsen|fomivirsen|mesh-list
92228922|NCT00002356|Antiviral Agents|antiviral agents|mesh-ancestor
92228923|NCT00002356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228924|NCT00994175|Pioglitazone|pioglitazone|mesh-list
92228925|NCT00994175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92228926|NCT00994175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228927|NCT00002206|Adefovir|adefovir|mesh-list
92228928|NCT00002206|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92228929|NCT00002206|Antiviral Agents|antiviral agents|mesh-ancestor
92228930|NCT00002206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228931|NCT00002206|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228932|NCT00002206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228933|NCT00002206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228934|NCT00002206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228935|NCT02403986|Lidocaine|lidocaine|mesh-list
92228936|NCT02403986|Anesthetics, Local|anesthetics, local|mesh-ancestor
92228937|NCT02403986|Anesthetics|anesthetics|mesh-ancestor
92228938|NCT02403986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92228939|NCT02403986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228940|NCT02403986|Sensory System Agents|sensory system agents|mesh-ancestor
92228941|NCT02403986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228942|NCT02403986|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92228943|NCT02403986|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92228944|NCT02403986|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92228945|NCT02403986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92228946|NCT02403986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228948|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92228949|NCT00002362|Emtricitabine|emtricitabine|mesh-list
92228950|NCT00002362|Efavirenz|efavirenz|mesh-list
92228951|NCT00002362|Abacavir|abacavir|mesh-list
92228952|NCT00002362|Stavudine|stavudine|mesh-list
92228953|NCT00002362|Antiviral Agents|antiviral agents|mesh-ancestor
92228954|NCT00002362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228955|NCT00002362|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228956|NCT00002362|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228958|NCT00002362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228959|NCT00002362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228960|NCT00002362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228961|NCT00002362|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92228962|NCT00002362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92228963|NCT00002362|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92228964|NCT00002362|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92228965|NCT00002362|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92228966|NCT00002362|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92228967|NCT00002362|Antimetabolites|antimetabolites|mesh-ancestor
92228969|NCT02168309|Nifedipine|nifedipine|mesh-list
92228970|NCT02168309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92228971|NCT02168309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92228972|NCT02168309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228973|NCT02168309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92228974|NCT02168309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92228975|NCT02168309|Vasodilator Agents|vasodilator agents|mesh-ancestor
92228976|NCT02168309|Tocolytic Agents|tocolytic agents|mesh-ancestor
92228977|NCT02168309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92228978|NCT02168309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92228979|NCT02168309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92228980|NCT02168309|Adrenergic Agents|adrenergic agents|mesh-ancestor
92228981|NCT02168309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92228982|NCT02168309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92228983|NCT02168309|Sympathomimetics|sympathomimetics|mesh-ancestor
92228984|NCT02168309|Autonomic Agents|autonomic agents|mesh-ancestor
92228985|NCT02168309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92228986|NCT02168309|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92228987|NCT02168309|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92228988|NCT00002368|Lamivudine|lamivudine|mesh-list
92228989|NCT00002368|Nevirapine|nevirapine|mesh-list
92228990|NCT00002368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92228991|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92228992|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92228993|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92228994|NCT00002368|Antiviral Agents|antiviral agents|mesh-ancestor
92228995|NCT00002368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92228996|NCT00002368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92228997|NCT00002368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92228998|NCT00002368|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92228999|NCT00002368|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92229000|NCT01199965|Dihydroergotamine|dihydroergotamine|mesh-list
92229001|NCT01199965|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92229002|NCT01199965|Dopamine Agonists|dopamine agonists|mesh-ancestor
92229003|NCT01199965|Dopamine Agents|dopamine agents|mesh-ancestor
92229004|NCT01199965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229005|NCT01199965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229006|NCT01199965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229007|NCT01199965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229008|NCT01199965|Analgesics|analgesics|mesh-ancestor
92229009|NCT01199965|Sensory System Agents|sensory system agents|mesh-ancestor
92229010|NCT01199965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229011|NCT00995501|Insulin|insulin|mesh-list
92229012|NCT00995501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92229013|NCT00995501|Dexamethasone|dexamethasone|mesh-list
92229014|NCT00995501|Dexamethasone acetate|dexamethasone acetate|mesh-list
92229015|NCT00995501|Anesthetics|anesthetics|mesh-list
92229016|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
92229017|NCT00995501|BB 1101|bb 1101|mesh-list
92229018|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92229019|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229020|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229021|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
92229022|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
92229023|NCT00995501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338427|NCT00521885|Antithrombins|antithrombins|mesh-ancestor
92229024|NCT00995501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92229025|NCT00995501|Glucocorticoids|glucocorticoids|mesh-ancestor
92117526|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92229027|NCT00995501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229028|NCT00995501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92229029|NCT00995501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229030|NCT00995501|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229031|NCT00995501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229032|NCT00995501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229033|NCT00995501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92229034|NCT00995501|Cathartics|cathartics|mesh-ancestor
92229035|NCT00002374|Ritonavir|ritonavir|mesh-list
92229036|NCT00002374|Nelfinavir|nelfinavir|mesh-list
92229037|NCT00002374|Saquinavir|saquinavir|mesh-list
92229038|NCT00002374|Stavudine|stavudine|mesh-list
92229039|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229040|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229041|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229042|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229043|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229044|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229045|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229046|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
92229047|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229048|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92229049|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229050|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
92229051|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229052|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229054|NCT00002380|Saquinavir|saquinavir|mesh-list
92229055|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229056|NCT00002380|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229057|NCT00002380|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229058|NCT00002380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229059|NCT00002380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229060|NCT00002380|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229061|NCT00002380|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229062|NCT00002380|Antiviral Agents|antiviral agents|mesh-ancestor
92229063|NCT00002380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229064|NCT00002380|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92229065|NCT00002380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229066|NCT00002386|Lamivudine|lamivudine|mesh-list
92229067|NCT00002386|Zidovudine|zidovudine|mesh-list
92229068|NCT00002386|Didanosine|didanosine|mesh-list
92229069|NCT00002386|Stavudine|stavudine|mesh-list
92229070|NCT00002386|Zalcitabine|zalcitabine|mesh-list
92229071|NCT00002386|Indinavir|indinavir|mesh-list
92229072|NCT00002386|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229073|NCT00002386|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229074|NCT00002386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229075|NCT00002386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229076|NCT00002386|Antiviral Agents|antiviral agents|mesh-ancestor
92229077|NCT00002386|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229078|NCT00002386|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229079|NCT00002386|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229080|NCT00002386|Antimetabolites|antimetabolites|mesh-ancestor
92229081|NCT00002386|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229082|NCT00002386|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229083|NCT00002386|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229084|NCT01942694|Vitamin D|vitamin d|mesh-list
92229085|NCT01942694|Cholecalciferol|cholecalciferol|mesh-list
92229086|NCT01942694|Vitamins|vitamins|mesh-ancestor
92229087|NCT01942694|Micronutrients|micronutrients|mesh-ancestor
92229088|NCT01942694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229089|NCT01942694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92229090|NCT01942694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229091|NCT01153711|Ketoconazole|ketoconazole|mesh-list
92229092|NCT01153711|Antifungal Agents|antifungal agents|mesh-ancestor
92229093|NCT01153711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229094|NCT01153711|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92229095|NCT01153711|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229096|NCT01153711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229097|NCT01153711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229098|NCT01153711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92229099|NCT01153711|Hormone Antagonists|hormone antagonists|mesh-ancestor
92229100|NCT01153711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229101|NCT01153711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229102|NCT01153711|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92229103|NCT02168855|Nicotine|nicotine|mesh-list
92229104|NCT02168855|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92229105|NCT02168855|Autonomic Agents|autonomic agents|mesh-ancestor
92229106|NCT02168855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229107|NCT02168855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229108|NCT02168855|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92229109|NCT02168855|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92229110|NCT02168855|Cholinergic Agents|cholinergic agents|mesh-ancestor
92229111|NCT02168855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229112|NCT02168855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229113|NCT05751850|Leucovorin|leucovorin|mesh-list
92229114|NCT05751850|Paclitaxel|paclitaxel|mesh-list
92229115|NCT05751850|Gemcitabine|gemcitabine|mesh-list
92229116|NCT05751850|Fluorouracil|fluorouracil|mesh-list
92229117|NCT05751850|Oxaliplatin|oxaliplatin|mesh-list
92229118|NCT05751850|Calcium|calcium|mesh-list
92229119|NCT05751850|Levoleucovorin|levoleucovorin|mesh-list
92229120|NCT05751850|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229121|NCT05751850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229122|NCT05751850|Tubulin Modulators|tubulin modulators|mesh-ancestor
92229123|NCT05751850|Antimitotic Agents|antimitotic agents|mesh-ancestor
92229124|NCT05751850|Mitosis Modulators|mitosis modulators|mesh-ancestor
92229125|NCT05751850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229126|NCT05751850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229127|NCT05751850|Antimetabolites|antimetabolites|mesh-ancestor
92229128|NCT05751850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229129|NCT05751850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229130|NCT05751850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229131|NCT05751850|Immunologic Factors|immunologic factors|mesh-ancestor
92229132|NCT05751850|Antidotes|antidotes|mesh-ancestor
92229133|NCT05751850|Protective Agents|protective agents|mesh-ancestor
92229134|NCT05751850|Vitamin B Complex|vitamin b complex|mesh-ancestor
92229135|NCT05751850|Vitamins|vitamins|mesh-ancestor
92229136|NCT05751850|Micronutrients|micronutrients|mesh-ancestor
92229137|NCT01938248|Aspirin|aspirin|mesh-list
92229138|NCT01938248|Apixaban|apixaban|mesh-list
92229139|NCT01938248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92229140|NCT01938248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229141|NCT01938248|Analgesics|analgesics|mesh-ancestor
92229142|NCT01938248|Sensory System Agents|sensory system agents|mesh-ancestor
92229143|NCT01938248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229144|NCT01938248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229145|NCT01938248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229146|NCT01938248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229147|NCT01938248|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92229148|NCT01938248|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92229149|NCT01938248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229150|NCT01938248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92229151|NCT01938248|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92229152|NCT01938248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229153|NCT01938248|Antipyretics|antipyretics|mesh-ancestor
92229154|NCT01938248|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92229155|NCT01938248|Antithrombins|antithrombins|mesh-ancestor
92229156|NCT01938248|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92229157|NCT01938248|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229158|NCT01938248|Anticoagulants|anticoagulants|mesh-ancestor
92229159|NCT00002230|Efavirenz|efavirenz|mesh-list
92229160|NCT00002230|Didanosine|didanosine|mesh-list
92229161|NCT00002230|Stavudine|stavudine|mesh-list
92229162|NCT00002230|Hydroxyurea|hydroxyurea|mesh-list
92229163|NCT00002230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229164|NCT00002230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229165|NCT00002230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229166|NCT00002230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229167|NCT00002230|Antiviral Agents|antiviral agents|mesh-ancestor
92229168|NCT00002230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229169|NCT00002230|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92229170|NCT00002230|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229171|NCT00002230|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92229172|NCT00002230|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92229173|NCT00002230|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92229174|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92229175|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229176|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
92229177|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
92229178|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229179|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229180|NCT03009877|Fentanyl|fentanyl|mesh-list
92229181|NCT03009877|Midazolam|midazolam|mesh-list
92229182|NCT03009877|Propofol|propofol|mesh-list
92229183|NCT03009877|Rocuronium|rocuronium|mesh-list
92229184|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92229185|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92229186|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229187|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92229188|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
92229189|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
92229190|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92229191|NCT03009877|Narcotics|narcotics|mesh-ancestor
92229192|NCT03009877|Analgesics|analgesics|mesh-ancestor
92229193|NCT03009877|Sensory System Agents|sensory system agents|mesh-ancestor
92229194|NCT03009877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229195|NCT03009877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92229196|NCT03009877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92229197|NCT03009877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92229198|NCT03009877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92229199|NCT03009877|GABA Modulators|gaba modulators|mesh-ancestor
92229200|NCT03009877|GABA Agents|gaba agents|mesh-ancestor
92229201|NCT03009877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229202|NCT03009877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229203|NCT03009877|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92229204|NCT03009877|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92229206|NCT00002392|Thalidomide|thalidomide|mesh-list
92229207|NCT00002392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229208|NCT00002392|Immunologic Factors|immunologic factors|mesh-ancestor
92229209|NCT00002392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229210|NCT00002392|Leprostatic Agents|leprostatic agents|mesh-ancestor
92229211|NCT00002392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92229212|NCT00002392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229213|NCT00002392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92229214|NCT00002392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92229215|NCT00002392|Growth Substances|growth substances|mesh-ancestor
92229216|NCT00002392|Growth Inhibitors|growth inhibitors|mesh-ancestor
92229217|NCT00002392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229218|NCT00002398|Adefovir|adefovir|mesh-list
92229219|NCT00002398|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92229220|NCT00002398|Antiviral Agents|antiviral agents|mesh-ancestor
92229221|NCT00002398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229222|NCT00002398|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229223|NCT00002398|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229224|NCT00002398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229225|NCT00002398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229226|NCT00997139|Polymyxins|polymyxins|mesh-list
92229227|NCT00997139|Neomycin|neomycin|mesh-list
92229228|NCT00997139|Bacitracin|bacitracin|mesh-list
92229229|NCT00997139|Polymyxin B|polymyxin b|mesh-list
92229230|NCT00997139|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
92229231|NCT00997139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92229232|NCT00997139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229233|NCT00997139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92229234|NCT00997139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229235|NCT00997139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229236|NCT00997139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92229237|NCT00002236|Zidovudine|zidovudine|mesh-list
92229238|NCT00002236|Delavirdine|delavirdine|mesh-list
92229239|NCT00002236|Indinavir|indinavir|mesh-list
92229240|NCT00002236|Antimetabolites|antimetabolites|mesh-ancestor
92229241|NCT00002236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229242|NCT00002236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229243|NCT00002236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229244|NCT00002236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229245|NCT00002236|Antiviral Agents|antiviral agents|mesh-ancestor
92229246|NCT00002236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229247|NCT00002236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229248|NCT00002236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229249|NCT00002236|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229250|NCT00002236|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229251|NCT00002236|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229253|NCT01241539|Antithrombins|antithrombins|mesh-ancestor
92229254|NCT01241539|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92229255|NCT01241539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229256|NCT01241539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229257|NCT01241539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229258|NCT01241539|Anticoagulants|anticoagulants|mesh-ancestor
92229259|NCT04998617|Curcumin|curcumin|mesh-list
92229260|NCT04998617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92229261|NCT04998617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229262|NCT04998617|Analgesics|analgesics|mesh-ancestor
92229263|NCT04998617|Sensory System Agents|sensory system agents|mesh-ancestor
92229264|NCT04998617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229265|NCT04998617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229266|NCT04998617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229267|NCT04998617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229268|NCT04998617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229269|NCT04998617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229270|NCT04998617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229271|NCT00002404|Valacyclovir|valacyclovir|mesh-list
92229272|NCT00002404|Antiviral Agents|antiviral agents|mesh-ancestor
92229273|NCT00002404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229274|NCT05593757|Quinidine|quinidine|mesh-list
92229275|NCT05593757|Verapamil|verapamil|mesh-list
92229276|NCT05593757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92229277|NCT05593757|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92229278|NCT05593757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92229279|NCT05593757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229280|NCT05593757|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229281|NCT05593757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229282|NCT05593757|Vasodilator Agents|vasodilator agents|mesh-ancestor
92229283|NCT05593757|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92229284|NCT05593757|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92229285|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92229286|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229287|NCT05593757|Antimalarials|antimalarials|mesh-ancestor
92229288|NCT05593757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92229289|NCT05593757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92229290|NCT05593757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229291|NCT05593757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229292|NCT05593757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92229293|NCT05593757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92229294|NCT05593757|Cholinergic Agents|cholinergic agents|mesh-ancestor
92229295|NCT05593757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92229296|NCT05593757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92229297|NCT05593757|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92229298|NCT05593757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229299|NCT01242241|Propofol|propofol|mesh-list
92229300|NCT01242241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92229301|NCT01242241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92229302|NCT01242241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229303|NCT01242241|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92229304|NCT01242241|Anesthetics, General|anesthetics, general|mesh-ancestor
92229305|NCT01242241|Anesthetics|anesthetics|mesh-ancestor
92229306|NCT02393690|Iodine|iodine|mesh-list
92229307|NCT02393690|Cadexomer iodine|cadexomer iodine|mesh-list
92229308|NCT02393690|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92229309|NCT02393690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229310|NCT02393690|Trace Elements|trace elements|mesh-ancestor
92229311|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
92229312|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229313|NCT01200433|Dexmedetomidine|dexmedetomidine|mesh-list
92229314|NCT01200433|Propofol|propofol|mesh-list
92229315|NCT01200433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92229316|NCT01200433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92229317|NCT01200433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229318|NCT01200433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229319|NCT01200433|Analgesics|analgesics|mesh-ancestor
92229320|NCT01200433|Sensory System Agents|sensory system agents|mesh-ancestor
92229321|NCT01200433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229322|NCT01200433|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92229323|NCT01200433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92229324|NCT01200433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92229325|NCT01200433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92229326|NCT01200433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229327|NCT01200433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229328|NCT01200433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92229329|NCT01200433|Anesthetics, General|anesthetics, general|mesh-ancestor
92229330|NCT01200433|Anesthetics|anesthetics|mesh-ancestor
92229331|NCT00002410|Lamivudine|lamivudine|mesh-list
92229332|NCT00002410|Zidovudine|zidovudine|mesh-list
92229333|NCT00002410|Indinavir|indinavir|mesh-list
92229334|NCT00002410|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229335|NCT00002410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229336|NCT00002410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229337|NCT00002410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229338|NCT00002410|Antiviral Agents|antiviral agents|mesh-ancestor
92229339|NCT00002410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229340|NCT00002410|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229341|NCT00002410|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229342|NCT00002410|Antimetabolites|antimetabolites|mesh-ancestor
92229343|NCT00002410|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229344|NCT00002410|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229345|NCT00002410|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229346|NCT01243333|Deoxyglucose|deoxyglucose|mesh-list
92229347|NCT01243333|Alovudine|alovudine|mesh-list
92229348|NCT01243333|Dideoxynucleosides|dideoxynucleosides|mesh-list
92229349|NCT01243333|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92229350|NCT01243333|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92229351|NCT01243333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229353|NCT01243333|Antiviral Agents|antiviral agents|mesh-ancestor
92229354|NCT01243333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229355|NCT01243333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229356|NCT01243333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229357|NCT01243333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229358|NCT01924052|Calcitonin|calcitonin|mesh-list
92229359|NCT01924052|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92229360|NCT01924052|Katacalcin|katacalcin|mesh-list
92229361|NCT01924052|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229362|NCT01924052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229363|NCT01924052|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92229364|NCT01924052|Vasodilator Agents|vasodilator agents|mesh-ancestor
92229365|NCT00002416|Lamivudine|lamivudine|mesh-list
92229366|NCT00002416|Emtricitabine|emtricitabine|mesh-list
92229367|NCT00002416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229368|NCT00002416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229369|NCT00002416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229370|NCT00002416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229371|NCT00002416|Antiviral Agents|antiviral agents|mesh-ancestor
92229372|NCT00002416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229373|NCT00002416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229374|NCT00002416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229375|NCT00002254|Alovudine|alovudine|mesh-list
92229376|NCT00002254|Antiviral Agents|antiviral agents|mesh-ancestor
92229377|NCT00002254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229378|NCT01897454|Calcium, Dietary|calcium, dietary|mesh-list
92229379|NCT01897454|Leucovorin|leucovorin|mesh-list
92229380|NCT01897454|Folic Acid|folic acid|mesh-list
92229381|NCT01897454|Gemcitabine|gemcitabine|mesh-list
92229382|NCT01897454|Fluorouracil|fluorouracil|mesh-list
92229383|NCT01897454|Oxaliplatin|oxaliplatin|mesh-list
92229384|NCT01897454|Irinotecan|irinotecan|mesh-list
92229385|NCT01897454|Camptothecin|camptothecin|mesh-list
92229386|NCT01897454|Calcium|calcium|mesh-list
92229387|NCT01897454|Levoleucovorin|levoleucovorin|mesh-list
92229388|NCT01897454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229389|NCT01897454|Antimetabolites|antimetabolites|mesh-ancestor
92229390|NCT01897454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229391|NCT01897454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229392|NCT01897454|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229393|NCT01897454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229394|NCT01897454|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92229395|NCT01897454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229397|NCT01897454|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92229398|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92229399|NCT01897454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229401|NCT01897454|Protective Agents|protective agents|mesh-ancestor
92229402|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
92229403|NCT01897454|Vitamins|vitamins|mesh-ancestor
92229404|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
92229405|NCT01897454|Hematinics|hematinics|mesh-ancestor
92229406|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229407|NCT01243567|Timolol|timolol|mesh-list
92229408|NCT01243567|Bimatoprost|bimatoprost|mesh-list
92229409|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92229410|NCT01243567|Latanoprost|latanoprost|mesh-list
92229411|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92229412|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92229413|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92229414|NCT01243567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92229415|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229416|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229417|NCT01243567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229418|NCT01243567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92229419|NCT01243567|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92229420|NCT01001195|Bimatoprost|bimatoprost|mesh-list
92229421|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92229422|NCT01001195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92229423|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92229424|NCT00381472|Ropinirole|ropinirole|mesh-list
92229425|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92229426|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92229427|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
92229428|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
92229429|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229430|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229431|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229432|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92229433|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92229434|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92229435|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92229436|NCT01460654|Alendronate|alendronate|mesh-list
92229437|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
92229438|NCT01460654|Testosterone|testosterone|mesh-list
92229439|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
92229440|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
92229441|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92229442|NCT01460654|Androgens|androgens|mesh-ancestor
92229443|NCT01460654|Hormones|hormones|mesh-ancestor
92229444|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229445|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229446|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92229447|NCT01460654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229448|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
92229449|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92229450|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
92229451|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92229452|NCT01001975|Protective Agents|protective agents|mesh-ancestor
92229453|NCT01001975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229454|NCT01001975|Dermatologic Agents|dermatologic agents|mesh-ancestor
92229455|NCT01459484|Cisplatin|cisplatin|mesh-list
92229456|NCT01459484|Doxorubicin|doxorubicin|mesh-list
92229457|NCT01459484|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92229458|NCT01459484|Methotrexate|methotrexate|mesh-list
92229459|NCT01459484|Ifosfamide|ifosfamide|mesh-list
92229460|NCT01459484|Mifamurtide|mifamurtide|mesh-list
92229461|NCT01459484|Acetylmuramyl-Alanyl-Isoglutamine|acetylmuramyl-alanyl-isoglutamine|mesh-list
92229462|NCT01459484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229463|NCT01459484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92229464|NCT01459484|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92229465|NCT01459484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92229466|NCT01459484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229467|NCT01459484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229468|NCT01459484|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92229469|NCT01459484|Abortifacient Agents|abortifacient agents|mesh-ancestor
92229470|NCT01459484|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92229471|NCT01459484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229472|NCT01459484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229473|NCT01459484|Antimetabolites|antimetabolites|mesh-ancestor
92229475|NCT01459484|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92229476|NCT01459484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229477|NCT01459484|Immunologic Factors|immunologic factors|mesh-ancestor
92229478|NCT01459484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229479|NCT01459484|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229480|NCT01459484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92229481|NCT01459484|Alkylating Agents|alkylating agents|mesh-ancestor
92229482|NCT01459484|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92229483|NCT00002260|Alovudine|alovudine|mesh-list
92229484|NCT00002260|Antiviral Agents|antiviral agents|mesh-ancestor
92229485|NCT00002260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229486|NCT01444040|Travoprost|travoprost|mesh-list
92229487|NCT01444040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92229488|NCT00002266|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92229489|NCT00002266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92229490|NCT00002266|Immunologic Factors|immunologic factors|mesh-ancestor
92229491|NCT00002266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229492|NCT00002266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229493|NCT00002266|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92229494|NCT00002266|Protective Agents|protective agents|mesh-ancestor
92229495|NCT00002266|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229496|NCT00002266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229497|NCT00002266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229498|NCT00002266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229499|NCT00002266|Antiviral Agents|antiviral agents|mesh-ancestor
92229500|NCT00002266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229501|NCT05751304|Dexmedetomidine|dexmedetomidine|mesh-list
92229502|NCT05751304|Ketamine|ketamine|mesh-list
92229503|NCT05751304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92229504|NCT05751304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92229505|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229506|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229507|NCT05751304|Analgesics|analgesics|mesh-ancestor
92229508|NCT05751304|Sensory System Agents|sensory system agents|mesh-ancestor
92229509|NCT05751304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229510|NCT05751304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92229511|NCT05751304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92229512|NCT05751304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92229513|NCT05751304|Adrenergic Agents|adrenergic agents|mesh-ancestor
92229514|NCT05751304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229515|NCT05751304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229516|NCT05751304|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92229517|NCT05751304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92229518|NCT05751304|Anesthetics, General|anesthetics, general|mesh-ancestor
92229519|NCT05751304|Anesthetics|anesthetics|mesh-ancestor
92229520|NCT05751304|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92229521|NCT05751304|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92229522|NCT01202071|Rabeprazole|rabeprazole|mesh-list
92229523|NCT01202071|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92229524|NCT01202071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92229525|NCT01202071|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92229526|NCT01202071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229527|NCT01202071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229528|NCT00002428|Vaccines|vaccines|mesh-list
92229529|NCT00002428|Immunologic Factors|immunologic factors|mesh-ancestor
92229530|NCT00002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229531|NCT01422746|Metformin|metformin|mesh-list
92229532|NCT01422746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92229533|NCT01422746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229534|NCT00002272|Foscarnet|foscarnet|mesh-list
92229535|NCT00002272|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92229536|NCT00002272|Antiviral Agents|antiviral agents|mesh-ancestor
92229537|NCT00002272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229538|NCT00002272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229539|NCT00002272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229540|NCT00002272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229541|NCT00002272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229542|NCT01002755|Lenalidomide|lenalidomide|mesh-list
92229543|NCT01002755|Ofatumumab|ofatumumab|mesh-list
92229544|NCT01002755|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92229545|NCT01002755|Immunologic Factors|immunologic factors|mesh-ancestor
92229546|NCT01002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229548|NCT01002755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92229549|NCT01002755|Growth Substances|growth substances|mesh-ancestor
92229550|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
92229551|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229552|NCT00002434|Leucovorin|leucovorin|mesh-list
92229553|NCT00002434|Trimetrexate|trimetrexate|mesh-list
92229554|NCT00002434|Calcium|calcium|mesh-list
92229555|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
92229556|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229557|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229558|NCT00002434|Antidotes|antidotes|mesh-ancestor
92229559|NCT00002434|Protective Agents|protective agents|mesh-ancestor
92229560|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
92229561|NCT00002434|Vitamins|vitamins|mesh-ancestor
92229562|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
92229563|NCT00002434|Antifungal Agents|antifungal agents|mesh-ancestor
92229564|NCT00002434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229565|NCT00002434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229566|NCT00002434|Antimetabolites|antimetabolites|mesh-ancestor
92229567|NCT00002434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229568|NCT00002434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229569|NCT00002434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92229570|NCT00002434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229571|NCT00002278|Diclazuril|diclazuril|mesh-list
92229572|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
92229573|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92229574|NCT00002278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92229575|NCT00002278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229576|NCT01885130|Dimenhydrinate|dimenhydrinate|mesh-list
92229577|NCT01885130|Antiemetics|antiemetics|mesh-ancestor
92229578|NCT01885130|Autonomic Agents|autonomic agents|mesh-ancestor
92229579|NCT01885130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229580|NCT01885130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229581|NCT01885130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92229582|NCT01885130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92229583|NCT01885130|Histamine Antagonists|histamine antagonists|mesh-ancestor
92229584|NCT01885130|Histamine Agents|histamine agents|mesh-ancestor
92229585|NCT01885130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229586|NCT01885130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229587|NCT01003301|Omalizumab|omalizumab|mesh-list
92229588|NCT01003301|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92229589|NCT01003301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92229590|NCT01003301|Respiratory System Agents|respiratory system agents|mesh-ancestor
92229591|NCT00002440|Ritonavir|ritonavir|mesh-list
92229593|NCT00002440|Indinavir|indinavir|mesh-list
92229594|NCT00002440|Saquinavir|saquinavir|mesh-list
92229595|NCT00002440|Amprenavir|amprenavir|mesh-list
92229596|NCT00002440|Abacavir|abacavir|mesh-list
92229597|NCT00002440|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229598|NCT00002440|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229599|NCT00002440|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229600|NCT00002440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229601|NCT00002440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229602|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229603|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229604|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
92229605|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229606|NCT00002440|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92229607|NCT00002440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229608|NCT00002440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229609|NCT00002440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229610|NCT00002440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92229611|NCT00002440|Antitubercular Agents|antitubercular agents|mesh-ancestor
92229612|NCT00002440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92229613|NCT01421810|Dexamethasone|dexamethasone|mesh-list
92229614|NCT01421810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229615|NCT01421810|Antiemetics|antiemetics|mesh-ancestor
92229616|NCT01421810|Autonomic Agents|autonomic agents|mesh-ancestor
92229617|NCT01421810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229618|NCT01421810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229619|NCT01421810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92229620|NCT01421810|Glucocorticoids|glucocorticoids|mesh-ancestor
92229622|NCT01421810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229623|NCT01421810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92229624|NCT01421810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229625|NCT00002284|Zidovudine|zidovudine|mesh-list
92229626|NCT00002284|Antimetabolites|antimetabolites|mesh-ancestor
92229627|NCT00002284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229628|NCT00002284|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229629|NCT00002284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229630|NCT00002284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229631|NCT00002284|Antiviral Agents|antiviral agents|mesh-ancestor
92229632|NCT00002284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229633|NCT00002284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229634|NCT00002284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229635|NCT01243957|Fluoxetine|fluoxetine|mesh-list
92229636|NCT01243957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92229637|NCT01243957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92229638|NCT01243957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92229639|NCT01243957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229640|NCT01243957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229641|NCT01243957|Serotonin Agents|serotonin agents|mesh-ancestor
92229642|NCT01243957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229643|NCT01243957|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92229644|NCT01243957|Antidepressive Agents|antidepressive agents|mesh-ancestor
92229645|NCT01243957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92229646|NCT01243957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92229647|NCT01243957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229648|NCT01243957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229649|NCT00002446|Fluconazole|fluconazole|mesh-list
92229650|NCT00002446|Posaconazole|posaconazole|mesh-list
92229651|NCT00002446|Antifungal Agents|antifungal agents|mesh-ancestor
92229652|NCT00002446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229653|NCT00002446|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92229654|NCT00002446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92229655|NCT00002446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229656|NCT00002446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229657|NCT00002446|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92229658|NCT00002446|Hormone Antagonists|hormone antagonists|mesh-ancestor
92229659|NCT00002446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229660|NCT00002446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338483|NCT00000161|Vitamin E|vitamin e|mesh-list
92229661|NCT00002446|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92229662|NCT00002446|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92229663|NCT00002446|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92229664|NCT00002446|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92229665|NCT00002446|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92229666|NCT01884740|Bevacizumab|bevacizumab|mesh-list
92229667|NCT01884740|Cetuximab|cetuximab|mesh-list
92229668|NCT01884740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92229669|NCT01884740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229670|NCT01884740|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92229671|NCT01884740|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92229672|NCT01884740|Growth Substances|growth substances|mesh-ancestor
92229673|NCT01884740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229674|NCT01884740|Growth Inhibitors|growth inhibitors|mesh-ancestor
92229675|NCT00002290|Zidovudine|zidovudine|mesh-list
92229676|NCT00002290|Acyclovir|acyclovir|mesh-list
92229677|NCT00002290|Antimetabolites|antimetabolites|mesh-ancestor
92229678|NCT00002290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229679|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92229680|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229681|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229682|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
92229683|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229684|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92229685|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229686|NCT01003769|Acetic Acid|acetic acid|mesh-list
92229687|NCT01003769|Lenalidomide|lenalidomide|mesh-list
92229688|NCT01003769|Retinol acetate|retinol acetate|mesh-list
92229689|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
92229690|NCT01003769|Gossypol|gossypol|mesh-list
92229691|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
92229692|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229693|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92229694|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92229695|NCT01003769|Growth Substances|growth substances|mesh-ancestor
92229696|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
92229697|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229698|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92229699|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229700|NCT01003769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92229701|NCT01003769|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92229702|NCT01003769|Protective Agents|protective agents|mesh-ancestor
92229703|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92229704|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
92229705|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92229706|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229707|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92229708|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92229709|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92229710|NCT00002452|Indinavir|indinavir|mesh-list
92229711|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92229712|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92229713|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229714|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229715|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229716|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91941067|NCT03483181|Enoxaparin|enoxaparin|mesh-list
92229717|NCT00002452|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92229718|NCT00002452|Antiviral Agents|antiviral agents|mesh-ancestor
92229719|NCT00002452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229720|NCT01004393|Bromides|bromides|mesh-list
92229721|NCT01004393|Methylnaltrexone|methylnaltrexone|mesh-list
92229722|NCT01004393|Anticonvulsants|anticonvulsants|mesh-ancestor
92229723|NCT01004393|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92229724|NCT01004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229725|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
92229726|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229727|NCT00002458|Antibodies|antibodies|mesh-list
92229728|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92229729|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
92229730|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229731|NCT00002470|Interferons|interferons|mesh-list
92229732|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
92229733|NCT00002470|Fluorouracil|fluorouracil|mesh-list
92229734|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
92338489|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229735|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229736|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229737|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229738|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229739|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
92229740|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229741|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
92229742|NCT00002470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229743|NCT00002476|Leucovorin|leucovorin|mesh-list
92229745|NCT00002476|Fluorouracil|fluorouracil|mesh-list
92229746|NCT00002476|Methotrexate|methotrexate|mesh-list
92229747|NCT00002476|Vincristine|vincristine|mesh-list
92229748|NCT00002476|Bleomycin|bleomycin|mesh-list
92229749|NCT00002476|Calcium|calcium|mesh-list
92229750|NCT00002476|Levoleucovorin|levoleucovorin|mesh-list
92229751|NCT00002476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92229752|NCT00002476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229753|NCT00002476|Antimetabolites|antimetabolites|mesh-ancestor
92229754|NCT00002476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229755|NCT00002476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229756|NCT00002476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229757|NCT00002476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229758|NCT00002476|Immunologic Factors|immunologic factors|mesh-ancestor
92229759|NCT00002476|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92229760|NCT00002476|Abortifacient Agents|abortifacient agents|mesh-ancestor
92229761|NCT00002476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92229762|NCT00002476|Dermatologic Agents|dermatologic agents|mesh-ancestor
92229763|NCT00002476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229764|NCT00002476|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92229765|NCT00002476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229766|NCT00002476|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229767|NCT00002476|Antidotes|antidotes|mesh-ancestor
92229768|NCT00002476|Protective Agents|protective agents|mesh-ancestor
92229769|NCT00002476|Vitamin B Complex|vitamin b complex|mesh-ancestor
92229770|NCT00002476|Vitamins|vitamins|mesh-ancestor
92229771|NCT00002476|Micronutrients|micronutrients|mesh-ancestor
92229772|NCT00002476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229773|NCT00002476|Tubulin Modulators|tubulin modulators|mesh-ancestor
92229774|NCT00002476|Antimitotic Agents|antimitotic agents|mesh-ancestor
92229775|NCT00002476|Mitosis Modulators|mitosis modulators|mesh-ancestor
92229776|NCT00002476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92229777|NCT00002476|Trace Elements|trace elements|mesh-ancestor
92229778|NCT01876628|Clindamycin|clindamycin|mesh-list
92229779|NCT01876628|Clindamycin palmitate|clindamycin palmitate|mesh-list
92229780|NCT01876628|Clindamycin phosphate|clindamycin phosphate|mesh-list
92229781|NCT01876628|Floxacillin|floxacillin|mesh-list
92229782|NCT01876628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92229783|NCT01876628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229784|NCT01876628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92229785|NCT01876628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229786|NCT01876628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229787|NCT01004705|Aspirin|aspirin|mesh-list
92229788|NCT01004705|Ramipril|ramipril|mesh-list
92229789|NCT01004705|Simvastatin|simvastatin|mesh-list
92229790|NCT01004705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92229791|NCT01004705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92229792|NCT01004705|Antimetabolites|antimetabolites|mesh-ancestor
92229793|NCT01004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229794|NCT01004705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91923145|NCT02228473|Glycopyrrolate|glycopyrrolate|mesh-list
92229795|NCT01004705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92229796|NCT01004705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229797|NCT01004705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92229798|NCT01004705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229799|NCT01004705|Analgesics|analgesics|mesh-ancestor
92229800|NCT01004705|Sensory System Agents|sensory system agents|mesh-ancestor
92229801|NCT01004705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229802|NCT01004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229803|NCT01004705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229805|NCT01004705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92229806|NCT01004705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92229807|NCT01004705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92229808|NCT01004705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92229809|NCT01004705|Antipyretics|antipyretics|mesh-ancestor
92229810|NCT01004705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92229811|NCT01004705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229812|NCT01004705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92229813|NCT00002482|Cyclophosphamide|cyclophosphamide|mesh-list
92229814|NCT00002482|Muromonab-CD3|muromonab-cd3|mesh-list
92229815|NCT00002482|Antibodies|antibodies|mesh-list
92229816|NCT00002482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229817|NCT00002482|Immunologic Factors|immunologic factors|mesh-ancestor
92229818|NCT00002482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229819|NCT00002482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229820|NCT00002482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92229821|NCT00002482|Alkylating Agents|alkylating agents|mesh-ancestor
92229822|NCT00002482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229823|NCT00002482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229824|NCT00002482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92229825|NCT01004939|PENTA|penta|mesh-list
92229826|NCT01004939|Fondaparinux|fondaparinux|mesh-list
92229827|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92229828|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
92229829|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92229830|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229831|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229832|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229833|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
92229834|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92229835|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92229836|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
92229837|NCT05750758|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92229838|NCT05750758|Antithrombins|antithrombins|mesh-ancestor
92229839|NCT05750758|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92229840|NCT05750758|Protease Inhibitors|protease inhibitors|mesh-ancestor
92229841|NCT05750758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229842|NCT05750758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229843|NCT05750758|Anticoagulants|anticoagulants|mesh-ancestor
92229844|NCT00002488|Cyclophosphamide|cyclophosphamide|mesh-list
92229845|NCT00002488|Etoposide|etoposide|mesh-list
92229846|NCT00002488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229847|NCT00002488|Immunologic Factors|immunologic factors|mesh-ancestor
92229848|NCT00002488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229849|NCT00002488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229850|NCT00002488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92229851|NCT00002488|Alkylating Agents|alkylating agents|mesh-ancestor
92229852|NCT00002488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229853|NCT00002488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229854|NCT00002488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92229855|NCT00002488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229856|NCT00002488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92229857|NCT00002488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92229858|NCT00002488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229859|NCT01245595|Aminophylline|aminophylline|mesh-list
92229860|NCT01245595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92229861|NCT01245595|Autonomic Agents|autonomic agents|mesh-ancestor
92229862|NCT01245595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229863|NCT01245595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229864|NCT01245595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92229865|NCT01245595|Respiratory System Agents|respiratory system agents|mesh-ancestor
92229866|NCT01245595|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92229867|NCT01245595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92229868|NCT01245595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229869|NCT01245595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923296|NCT04440267|Daunorubicin|daunorubicin|mesh-list
92229870|NCT01245595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92229871|NCT01245595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92229872|NCT01245595|Purinergic Agents|purinergic agents|mesh-ancestor
92229873|NCT01245595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229874|NCT01245595|Protective Agents|protective agents|mesh-ancestor
92229875|NCT01864772|Cetuximab|cetuximab|mesh-list
92229876|NCT01864772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92229877|NCT01864772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229878|NCT00002494|Leucovorin|leucovorin|mesh-list
92229880|NCT00002494|Cytarabine|cytarabine|mesh-list
92229881|NCT00002494|Dexamethasone|dexamethasone|mesh-list
92229882|NCT00002494|Prednisone|prednisone|mesh-list
92229883|NCT00002494|Hydrocortisone|hydrocortisone|mesh-list
92229884|NCT00002494|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92229885|NCT00002494|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92229886|NCT00002494|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92229887|NCT00002494|Cyclophosphamide|cyclophosphamide|mesh-list
92229888|NCT00002494|Ifosfamide|ifosfamide|mesh-list
92229889|NCT00002494|Doxorubicin|doxorubicin|mesh-list
92229890|NCT00002494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92229891|NCT00002494|Methotrexate|methotrexate|mesh-list
92229892|NCT00002494|Etoposide|etoposide|mesh-list
92229893|NCT00002494|Vincristine|vincristine|mesh-list
92229894|NCT00002494|Levoleucovorin|levoleucovorin|mesh-list
92229895|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92229896|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
92229897|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229898|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92229899|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92229900|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
92229901|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229902|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229903|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92229904|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229905|NCT00002494|Antiemetics|antiemetics|mesh-ancestor
92229906|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
92229907|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229908|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92229909|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
92229910|NCT00002494|Hormones|hormones|mesh-ancestor
92229911|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92229912|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92229913|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92229914|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92229915|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92229916|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229917|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92229918|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
92229919|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92229920|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92229921|NCT00002494|Antimetabolites|antimetabolites|mesh-ancestor
92229922|NCT00002494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92229923|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92229924|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92229925|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92229926|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
92229927|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229929|NCT00002494|Protective Agents|protective agents|mesh-ancestor
92229930|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
92229931|NCT00002494|Vitamins|vitamins|mesh-ancestor
92229932|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
92229933|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92229934|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92229935|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92229936|NCT00002494|Trace Elements|trace elements|mesh-ancestor
92229937|NCT00002506|Interferons|interferons|mesh-list
92229938|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
92229939|NCT00002506|Isotretinoin|isotretinoin|mesh-list
92229940|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229941|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
92338501|NCT00000161|Antipyretics|antipyretics|mesh-ancestor
92229942|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229943|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
92229944|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229945|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
92229946|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
92229947|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92229948|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229949|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92229950|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
92229951|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92229952|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229953|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229954|NCT01895894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229955|NCT02165111|Botulinum Toxins|botulinum toxins|mesh-list
92229956|NCT02165111|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92229957|NCT02165111|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92229958|NCT02165111|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92229959|NCT02165111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92229960|NCT02165111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229961|NCT02165111|Cholinergic Agents|cholinergic agents|mesh-ancestor
92229962|NCT02165111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92229963|NCT02165111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229964|NCT02165111|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92229965|NCT02165111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229966|NCT03866837|Micronutrients|micronutrients|mesh-list
92229967|NCT03866837|Trace Elements|trace elements|mesh-list
92229968|NCT03866837|Lactoferrin|lactoferrin|mesh-list
92229969|NCT03866837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229970|NCT03866837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229971|NCT05750446|Riociguat|riociguat|mesh-list
92229972|NCT05750446|Enzyme Activators|enzyme activators|mesh-ancestor
92229973|NCT05750446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229974|NCT05750290|Irinotecan|irinotecan|mesh-list
92229975|NCT05750290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92229976|NCT05750290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92229977|NCT05750290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92229978|NCT05750290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229979|NCT05750290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229980|NCT03845621|Salicylic Acid|salicylic acid|mesh-list
92229981|NCT03845621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92229983|NCT03845621|Keratolytic Agents|keratolytic agents|mesh-ancestor
92229984|NCT03845621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92229985|NCT04456517|Ranolazine|ranolazine|mesh-list
92229986|NCT04456517|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92229987|NCT04456517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92229988|NCT04456517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92229989|NCT01840046|Interleukin-2|interleukin-2|mesh-list
92229990|NCT01840046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92229991|NCT01840046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92229992|NCT01840046|Analgesics|analgesics|mesh-ancestor
92229993|NCT01840046|Sensory System Agents|sensory system agents|mesh-ancestor
92229994|NCT01840046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92229995|NCT01840046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92229996|NCT00437216|Clobetasol|clobetasol|mesh-list
92229997|NCT00437216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92229998|NCT00437216|Glucocorticoids|glucocorticoids|mesh-ancestor
92229999|NCT00437216|Hormones|hormones|mesh-ancestor
92230000|NCT00437216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230001|NCT00437216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230002|NCT00002524|Leucovorin|leucovorin|mesh-list
92230003|NCT00002524|Cytarabine|cytarabine|mesh-list
92230004|NCT00002524|Zidovudine|zidovudine|mesh-list
92230005|NCT00002524|Trimethoprim|trimethoprim|mesh-list
92230006|NCT00002524|Sulfamethoxazole|sulfamethoxazole|mesh-list
92230007|NCT00002524|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92338514|NCT00000935|Antibodies|antibodies|mesh-list
92230008|NCT00002524|Pentamidine|pentamidine|mesh-list
92230009|NCT00002524|Prednisone|prednisone|mesh-list
92230010|NCT00002524|Methylprednisolone|methylprednisolone|mesh-list
92230011|NCT00002524|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92230012|NCT00002524|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92230013|NCT00002524|Prednisolone|prednisolone|mesh-list
92230014|NCT00002524|Prednisolone acetate|prednisolone acetate|mesh-list
92230015|NCT00002524|Cyclophosphamide|cyclophosphamide|mesh-list
92230016|NCT00002524|Ifosfamide|ifosfamide|mesh-list
92230017|NCT00002524|Doxorubicin|doxorubicin|mesh-list
92230018|NCT00002524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92230019|NCT00002524|Fluorouracil|fluorouracil|mesh-list
92230020|NCT00002524|Methotrexate|methotrexate|mesh-list
92230021|NCT00002524|Etoposide|etoposide|mesh-list
92230022|NCT00002524|Vincristine|vincristine|mesh-list
92230023|NCT00002524|Bleomycin|bleomycin|mesh-list
92230024|NCT00002524|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92230025|NCT00002524|Prednisolone phosphate|prednisolone phosphate|mesh-list
92230026|NCT00002524|Levoleucovorin|levoleucovorin|mesh-list
92230027|NCT00002524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230028|NCT00002524|Immunologic Factors|immunologic factors|mesh-ancestor
92230029|NCT00002524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230030|NCT00002524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230031|NCT00002524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230032|NCT00002524|Alkylating Agents|alkylating agents|mesh-ancestor
92230033|NCT00002524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230034|NCT00002524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230035|NCT00002524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230036|NCT00002524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230037|NCT00002524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230038|NCT00002524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230039|NCT00002524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230040|NCT00002524|Antimetabolites|antimetabolites|mesh-ancestor
92230041|NCT00002524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230042|NCT00002524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230043|NCT00002524|Glucocorticoids|glucocorticoids|mesh-ancestor
92230044|NCT00002524|Hormones|hormones|mesh-ancestor
92230045|NCT00002524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230046|NCT00002524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230047|NCT00002524|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92230048|NCT00002524|Abortifacient Agents|abortifacient agents|mesh-ancestor
92230049|NCT00002524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230050|NCT00002524|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230051|NCT00002524|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92230052|NCT00002524|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230053|NCT00002524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230054|NCT00002524|Antiviral Agents|antiviral agents|mesh-ancestor
92230055|NCT00002524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230056|NCT00002524|Antidotes|antidotes|mesh-ancestor
92230057|NCT00002524|Protective Agents|protective agents|mesh-ancestor
92230058|NCT00002524|Vitamin B Complex|vitamin b complex|mesh-ancestor
92230060|NCT00002524|Micronutrients|micronutrients|mesh-ancestor
92230061|NCT00002524|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230062|NCT00002524|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230063|NCT00002524|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230064|NCT00002524|Antiemetics|antiemetics|mesh-ancestor
92230065|NCT00002524|Autonomic Agents|autonomic agents|mesh-ancestor
92230066|NCT00002524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230067|NCT00002524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230068|NCT00002524|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92230069|NCT00002524|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92230070|NCT00002524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92230071|NCT00002524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92230072|NCT00002524|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92230073|NCT00002524|Antimalarials|antimalarials|mesh-ancestor
92230074|NCT00002524|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92230075|NCT00002524|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92230076|NCT00002524|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92230077|NCT00002524|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92230078|NCT00002524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92230079|NCT00002524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92230080|NCT00002524|Antifungal Agents|antifungal agents|mesh-ancestor
92230081|NCT00002524|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92230083|NCT00002536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230084|NCT00002536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230085|NCT00002536|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230086|NCT00002536|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230087|NCT00002536|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230088|NCT00002536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230089|NCT01203319|Vaccines|vaccines|mesh-list
92230090|NCT01203319|Immunologic Factors|immunologic factors|mesh-ancestor
92230091|NCT01203319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230092|NCT01344200|Celecoxib|celecoxib|mesh-list
92230093|NCT01344200|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92230094|NCT01344200|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230095|NCT01344200|Analgesics|analgesics|mesh-ancestor
92230096|NCT01344200|Sensory System Agents|sensory system agents|mesh-ancestor
92230097|NCT01344200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230098|NCT01344200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230099|NCT01344200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230100|NCT01344200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230101|NCT01344200|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92230102|NCT01344200|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92230103|NCT01344200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230104|NCT01344200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230106|NCT01204255|Promethazine|promethazine|mesh-list
92230107|NCT01204255|Lorazepam|lorazepam|mesh-list
92230108|NCT01204255|Haloperidol|haloperidol|mesh-list
92230109|NCT01204255|Haloperidol decanoate|haloperidol decanoate|mesh-list
92230110|NCT01204255|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92230111|NCT01204255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92230112|NCT01204255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92230113|NCT01204255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230114|NCT01204255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92230115|NCT01204255|Anesthetics|anesthetics|mesh-ancestor
92230116|NCT01204255|Sensory System Agents|sensory system agents|mesh-ancestor
92230117|NCT01204255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230118|NCT01204255|Antiemetics|antiemetics|mesh-ancestor
92230119|NCT01204255|Autonomic Agents|autonomic agents|mesh-ancestor
92230120|NCT01204255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230121|NCT01204255|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92230122|NCT01204255|Histamine Antagonists|histamine antagonists|mesh-ancestor
92230123|NCT01204255|Histamine Agents|histamine agents|mesh-ancestor
92230124|NCT01204255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230125|NCT01204255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230126|NCT01204255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92230127|NCT01204255|Antipruritics|antipruritics|mesh-ancestor
92230128|NCT01204255|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230129|NCT01204255|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92230130|NCT01204255|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92230131|NCT01204255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92230132|NCT01204255|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92230133|NCT01204255|Dopamine Agents|dopamine agents|mesh-ancestor
92230134|NCT01204255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92230135|NCT01204255|Anticonvulsants|anticonvulsants|mesh-ancestor
92230136|NCT01204255|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92230137|NCT01204255|GABA Modulators|gaba modulators|mesh-ancestor
92230138|NCT01204255|GABA Agents|gaba agents|mesh-ancestor
92230139|NCT00002542|Tamoxifen|tamoxifen|mesh-list
92230140|NCT00002542|Cyclophosphamide|cyclophosphamide|mesh-list
92230141|NCT00002542|Doxorubicin|doxorubicin|mesh-list
92230142|NCT00002542|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92230143|NCT00002542|Fluorouracil|fluorouracil|mesh-list
92230144|NCT00002542|Methotrexate|methotrexate|mesh-list
92230145|NCT00002542|Epirubicin|epirubicin|mesh-list
92230146|NCT00002542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230147|NCT00002542|Immunologic Factors|immunologic factors|mesh-ancestor
92230148|NCT00002542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230149|NCT00002542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230150|NCT00002542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230151|NCT00002542|Alkylating Agents|alkylating agents|mesh-ancestor
92230152|NCT00002542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230153|NCT00002542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230154|NCT00002542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230155|NCT00002542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230156|NCT00002542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230157|NCT00002542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230158|NCT00002542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230159|NCT00002542|Antimetabolites|antimetabolites|mesh-ancestor
92230160|NCT00002542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230161|NCT00002542|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92230162|NCT00002542|Abortifacient Agents|abortifacient agents|mesh-ancestor
92230163|NCT00002542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230164|NCT00002542|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230165|NCT00002542|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92230166|NCT00002542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230167|NCT00002542|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92230168|NCT00002542|Hormone Antagonists|hormone antagonists|mesh-ancestor
92230169|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230170|NCT00002542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230171|NCT00002542|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92230172|NCT00002542|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92230173|NCT00002542|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92230174|NCT01156597|Pioglitazone|pioglitazone|mesh-list
92230175|NCT01156597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92230176|NCT01156597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230178|NCT01823198|Fludarabine|fludarabine|mesh-list
92230179|NCT01823198|Fludarabine phosphate|fludarabine phosphate|mesh-list
92230181|NCT01823198|Interleukin-2|interleukin-2|mesh-list
92230182|NCT01823198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230183|NCT01823198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230184|NCT01823198|Antimetabolites|antimetabolites|mesh-ancestor
92230185|NCT01823198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230186|NCT01823198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230187|NCT01823198|Immunologic Factors|immunologic factors|mesh-ancestor
92230188|NCT01823198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230189|NCT01823198|Alkylating Agents|alkylating agents|mesh-ancestor
92230190|NCT01823198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230191|NCT01823198|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230192|NCT01823198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230193|NCT01823198|Analgesics|analgesics|mesh-ancestor
92230194|NCT01823198|Sensory System Agents|sensory system agents|mesh-ancestor
92230195|NCT01823198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230196|NCT01823198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92230197|NCT01823198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92230198|NCT01823198|Antiviral Agents|antiviral agents|mesh-ancestor
92230199|NCT01823198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230200|NCT05750056|Lidocaine|lidocaine|mesh-list
92230201|NCT05750056|Sufentanil|sufentanil|mesh-list
92230202|NCT05750056|Dsuvia|dsuvia|mesh-list
92230203|NCT05750056|Propofol|propofol|mesh-list
92230204|NCT05750056|Anesthetics, Local|anesthetics, local|mesh-ancestor
92230205|NCT05750056|Anesthetics|anesthetics|mesh-ancestor
92230206|NCT05750056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92230207|NCT05750056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230208|NCT05750056|Sensory System Agents|sensory system agents|mesh-ancestor
92230209|NCT05750056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230210|NCT05750056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92230211|NCT05750056|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92230212|NCT05750056|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92230213|NCT05750056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92230214|NCT05750056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230215|NCT05750056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92230216|NCT05750056|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92230217|NCT05750056|Anesthetics, General|anesthetics, general|mesh-ancestor
92230218|NCT05750056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92230219|NCT05750056|Narcotics|narcotics|mesh-ancestor
92230220|NCT05750056|Analgesics|analgesics|mesh-ancestor
92230221|NCT05750056|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92230222|NCT03011125|Dexlansoprazole|dexlansoprazole|mesh-list
92230223|NCT03011125|Lansoprazole|lansoprazole|mesh-list
92230224|NCT03011125|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92230225|NCT03011125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230226|NCT03011125|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92230227|NCT03011125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230228|NCT03011125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230229|NCT05749900|Gemcitabine|gemcitabine|mesh-list
92230231|NCT05749900|Trastuzumab|trastuzumab|mesh-list
92230232|NCT05749900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230233|NCT05749900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230234|NCT05749900|Antimetabolites|antimetabolites|mesh-ancestor
92230235|NCT05749900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230236|NCT05749900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92230237|NCT05749900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92230238|NCT03442751|Riboflavin|riboflavin|mesh-list
92230239|NCT03442751|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92230240|NCT03442751|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92230241|NCT03442751|Vitamin B Complex|vitamin b complex|mesh-ancestor
92230242|NCT03442751|Vitamins|vitamins|mesh-ancestor
92230243|NCT03442751|Micronutrients|micronutrients|mesh-ancestor
92230244|NCT03442751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230245|NCT03442751|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92230246|NCT03442751|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230247|NCT05749666|Prednisolone|prednisolone|mesh-list
92230248|NCT05749666|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92230249|NCT05749666|Methylprednisolone|methylprednisolone|mesh-list
92230250|NCT05749666|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92230251|NCT05749666|Prednisolone acetate|prednisolone acetate|mesh-list
92230252|NCT05749666|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92230253|NCT05749666|Prednisolone phosphate|prednisolone phosphate|mesh-list
92230255|NCT05749666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230256|NCT05749666|Glucocorticoids|glucocorticoids|mesh-ancestor
92230257|NCT05749666|Hormones|hormones|mesh-ancestor
92230258|NCT05749666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230259|NCT05749666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230260|NCT05749666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941080|NCT02356588|Narcotics|narcotics|mesh-ancestor
92230261|NCT05749666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230262|NCT05749666|Antiemetics|antiemetics|mesh-ancestor
92230263|NCT05749666|Autonomic Agents|autonomic agents|mesh-ancestor
92230264|NCT05749666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230265|NCT05749666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230266|NCT05749666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92230267|NCT05749666|Protective Agents|protective agents|mesh-ancestor
92230268|NCT05749666|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92230269|NCT05749666|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92230270|NCT05749666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230271|NCT05749666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230272|NCT05449535|Omalizumab|omalizumab|mesh-list
92230273|NCT05449535|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92230274|NCT05449535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92230275|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
92230276|NCT05749276|Daratumumab|daratumumab|mesh-list
92230277|NCT05749276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230278|NCT05749042|Cisplatin|cisplatin|mesh-list
92230279|NCT05749042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230280|NCT02940509|Magnesium Sulfate|magnesium sulfate|mesh-list
92230281|NCT02940509|Ketamine|ketamine|mesh-list
92230282|NCT02940509|Analgesics|analgesics|mesh-ancestor
92230283|NCT02940509|Sensory System Agents|sensory system agents|mesh-ancestor
92230284|NCT02940509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230285|NCT02940509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230286|NCT02940509|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92230287|NCT02940509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92230288|NCT02940509|Anesthetics, General|anesthetics, general|mesh-ancestor
92230289|NCT02940509|Anesthetics|anesthetics|mesh-ancestor
92230290|NCT02940509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92230291|NCT02940509|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92230292|NCT02940509|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92230293|NCT02940509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230294|NCT02940509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230295|NCT02940509|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92230296|NCT02940509|Anticonvulsants|anticonvulsants|mesh-ancestor
92230297|NCT02940509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92230298|NCT02940509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92230299|NCT02940509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92230300|NCT02940509|Tocolytic Agents|tocolytic agents|mesh-ancestor
92230301|NCT02940509|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230302|NCT02530697|Miltefosine|miltefosine|mesh-list
92230303|NCT02530697|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92230304|NCT02530697|Pentoxifylline|pentoxifylline|mesh-list
92230305|NCT02530697|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92230306|NCT02530697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230307|NCT02530697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230308|NCT02530697|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92230309|NCT02530697|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92230310|NCT02530697|Protective Agents|protective agents|mesh-ancestor
92230311|NCT02530697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230312|NCT02530697|Vasodilator Agents|vasodilator agents|mesh-ancestor
92230313|NCT02530697|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92230314|NCT02530697|Antioxidants|antioxidants|mesh-ancestor
92230315|NCT02530697|Antifungal Agents|antifungal agents|mesh-ancestor
92230316|NCT02530697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230317|NCT02530697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230318|NCT02530697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92230319|NCT02530697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92230320|NCT02170649|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92230321|NCT02170649|Anticonvulsants|anticonvulsants|mesh-ancestor
92230322|NCT02170649|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92230323|NCT02170649|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92230324|NCT02170649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92230325|NCT02170649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230327|NCT04094207|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92230328|NCT04094207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230329|NCT04094207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230330|NCT04094207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92230331|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92230332|NCT04094207|Protective Agents|protective agents|mesh-ancestor
92230333|NCT04094207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230334|NCT04094207|Vasodilator Agents|vasodilator agents|mesh-ancestor
92230335|NCT04094207|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92230336|NCT04094207|Antioxidants|antioxidants|mesh-ancestor
92230337|NCT02144831|Aspirin|aspirin|mesh-list
92230338|NCT02144831|Clopidogrel|clopidogrel|mesh-list
92230339|NCT02144831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92230340|NCT02144831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230341|NCT02144831|Analgesics|analgesics|mesh-ancestor
92230342|NCT02144831|Sensory System Agents|sensory system agents|mesh-ancestor
92230343|NCT02144831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230344|NCT02144831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230345|NCT02144831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230346|NCT02144831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230347|NCT02144831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92230348|NCT02144831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92230349|NCT02144831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230350|NCT02144831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92230351|NCT02144831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92230352|NCT02144831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230353|NCT02144831|Antipyretics|antipyretics|mesh-ancestor
92230354|NCT02144831|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92230355|NCT02144831|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92230356|NCT02144831|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92230357|NCT02144831|Purinergic Agents|purinergic agents|mesh-ancestor
92230358|NCT02144831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230361|NCT05276219|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92230362|NCT05276219|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92230363|NCT05276219|Diuretics|diuretics|mesh-ancestor
92230364|NCT05276219|Natriuretic Agents|natriuretic agents|mesh-ancestor
92230365|NCT05276219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230366|NCT05276219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92230367|NCT05276219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92230368|NCT05276219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230369|NCT05276219|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92230370|NCT05276219|Vasodilator Agents|vasodilator agents|mesh-ancestor
92230371|NCT05276219|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92230372|NCT05232461|Ciprofloxacin|ciprofloxacin|mesh-list
92230373|NCT05232461|Celecoxib|celecoxib|mesh-list
92230374|NCT05232461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92230375|NCT05232461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230376|NCT05232461|Analgesics|analgesics|mesh-ancestor
92230377|NCT05232461|Sensory System Agents|sensory system agents|mesh-ancestor
92230378|NCT05232461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230379|NCT05232461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230380|NCT05232461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230381|NCT05232461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230382|NCT05232461|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92230383|NCT05232461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92230384|NCT05232461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230385|NCT05232461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230386|NCT05232461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92230387|NCT05232461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230388|NCT05232461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230389|NCT05232461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230390|NCT05232461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230391|NCT05232461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92230392|NCT05232461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92230393|NCT01804790|Capecitabine|capecitabine|mesh-list
92230394|NCT01804790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230395|NCT01804790|Antimetabolites|antimetabolites|mesh-ancestor
92230396|NCT01804790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230397|NCT01804790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230398|NCT05623774|Imatinib Mesylate|imatinib mesylate|mesh-list
92230399|NCT05623774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230400|NCT05623774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92230401|NCT05623774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230402|NCT05623774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230403|NCT01313702|Atenolol|atenolol|mesh-list
92230404|NCT01313702|Lisinopril|lisinopril|mesh-list
92230405|NCT01313702|Simvastatin|simvastatin|mesh-list
92230406|NCT01313702|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92230407|NCT01313702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92230408|NCT01313702|Antimetabolites|antimetabolites|mesh-ancestor
92230409|NCT01313702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230410|NCT01313702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91923297|NCT04440267|Asparaginase|asparaginase|mesh-list
92230411|NCT01313702|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92230412|NCT01313702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230413|NCT01313702|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92230415|NCT01313702|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92230416|NCT01313702|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92230417|NCT01313702|Protective Agents|protective agents|mesh-ancestor
92230418|NCT01313702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230419|NCT01313702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92230420|NCT01313702|Sympatholytics|sympatholytics|mesh-ancestor
92230421|NCT01313702|Autonomic Agents|autonomic agents|mesh-ancestor
92230422|NCT01313702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230423|NCT01313702|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92230424|NCT01313702|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92230425|NCT01313702|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92230426|NCT01313702|Adrenergic Agents|adrenergic agents|mesh-ancestor
92230427|NCT01313702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230428|NCT04868708|Paclitaxel|paclitaxel|mesh-list
92230429|NCT04868708|Bevacizumab|bevacizumab|mesh-list
92230430|NCT04868708|Carboplatin|carboplatin|mesh-list
92230431|NCT04868708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230432|NCT04868708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230433|NCT04868708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230434|NCT04868708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230435|NCT04868708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230436|NCT04868708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230437|NCT04868708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92230438|NCT04868708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92230439|NCT04868708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92230440|NCT04868708|Growth Substances|growth substances|mesh-ancestor
92230441|NCT04868708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230442|NCT04868708|Growth Inhibitors|growth inhibitors|mesh-ancestor
92230443|NCT05732272|Bupropion|bupropion|mesh-list
92230444|NCT05732272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92230445|NCT05732272|Antidepressive Agents|antidepressive agents|mesh-ancestor
92230446|NCT05732272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92230447|NCT05732272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92230448|NCT05732272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92230449|NCT05732272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92230450|NCT05732272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230451|NCT05732272|Dopamine Agents|dopamine agents|mesh-ancestor
92230452|NCT05732272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230453|NCT05732272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338579|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
92230454|NCT05732272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92230455|NCT05732272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92230456|NCT05732272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230457|NCT05513872|Nicotine|nicotine|mesh-list
92230458|NCT05513872|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92230459|NCT05513872|Autonomic Agents|autonomic agents|mesh-ancestor
92230460|NCT05513872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230461|NCT05513872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230462|NCT05513872|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92230463|NCT05513872|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92230464|NCT05513872|Cholinergic Agents|cholinergic agents|mesh-ancestor
92230465|NCT05513872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230466|NCT05513872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230467|NCT05445856|Fentanyl|fentanyl|mesh-list
92230468|NCT05445856|Methadone|methadone|mesh-list
92230469|NCT05445856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92230470|NCT05445856|Narcotics|narcotics|mesh-ancestor
92230471|NCT05445856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92230472|NCT05445856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230473|NCT05445856|Analgesics|analgesics|mesh-ancestor
92230474|NCT05445856|Sensory System Agents|sensory system agents|mesh-ancestor
92230475|NCT05445856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230476|NCT05445856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92230477|NCT05445856|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92230478|NCT05445856|Anesthetics, General|anesthetics, general|mesh-ancestor
92230479|NCT05445856|Anesthetics|anesthetics|mesh-ancestor
92230480|NCT05445856|Antitussive Agents|antitussive agents|mesh-ancestor
92230481|NCT05445856|Respiratory System Agents|respiratory system agents|mesh-ancestor
92230482|NCT00382330|Ciclopirox|ciclopirox|mesh-list
92230483|NCT00382330|Antifungal Agents|antifungal agents|mesh-ancestor
92230484|NCT00382330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230485|NCT05520892|Immunoglobulins|immunoglobulins|mesh-list
92230486|NCT05520892|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92230487|NCT05520892|Antibodies|antibodies|mesh-list
92230488|NCT05520892|gamma-Globulins|gamma-globulins|mesh-list
92230489|NCT05520892|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92230490|NCT05520892|Immunologic Factors|immunologic factors|mesh-ancestor
92230491|NCT05520892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230492|NCT05397964|Calcium|calcium|mesh-list
92230493|NCT05397964|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92230494|NCT05397964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230495|NCT00002548|Interferons|interferons|mesh-list
92230496|NCT00002548|Interferon-alpha|interferon-alpha|mesh-list
92230497|NCT00002548|Dexamethasone|dexamethasone|mesh-list
92230499|NCT00002548|Cyclophosphamide|cyclophosphamide|mesh-list
92230500|NCT00002548|Melphalan|melphalan|mesh-list
92230501|NCT00002548|Carmustine|carmustine|mesh-list
92230502|NCT00002548|Doxorubicin|doxorubicin|mesh-list
92230503|NCT00002548|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92230504|NCT00002548|Vincristine|vincristine|mesh-list
92230505|NCT00002548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230506|NCT00002548|Immunologic Factors|immunologic factors|mesh-ancestor
92230507|NCT00002548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230508|NCT00002548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230509|NCT00002548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230510|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
92230511|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230512|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230513|NCT00002548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230514|NCT00002548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230515|NCT00002548|Antiemetics|antiemetics|mesh-ancestor
92230516|NCT00002548|Autonomic Agents|autonomic agents|mesh-ancestor
92230517|NCT00002548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230518|NCT00002548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230519|NCT00002548|Glucocorticoids|glucocorticoids|mesh-ancestor
92230520|NCT00002548|Hormones|hormones|mesh-ancestor
92230521|NCT00002548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230522|NCT00002548|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230523|NCT00002548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230524|NCT00002548|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230525|NCT00002548|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230526|NCT00002548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230527|NCT00002548|Antiviral Agents|antiviral agents|mesh-ancestor
92230528|NCT00002548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230529|NCT00002548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230530|NCT00002548|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230531|NCT00002548|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230532|NCT00002548|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230533|NCT02087306|Brincidofovir|brincidofovir|mesh-list
92230534|NCT02087306|Antiviral Agents|antiviral agents|mesh-ancestor
92230535|NCT02087306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230536|NCT00002554|Cyclophosphamide|cyclophosphamide|mesh-list
92230537|NCT00002554|Busulfan|busulfan|mesh-list
92230538|NCT00002554|Methotrexate|methotrexate|mesh-list
92230539|NCT00002554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230540|NCT00002554|Immunologic Factors|immunologic factors|mesh-ancestor
92230541|NCT00002554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230542|NCT00002554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230543|NCT00002554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230544|NCT00002554|Alkylating Agents|alkylating agents|mesh-ancestor
92230545|NCT00002554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230546|NCT00002554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230547|NCT00002554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230548|NCT00002554|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92230549|NCT00002554|Abortifacient Agents|abortifacient agents|mesh-ancestor
92230550|NCT00002554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230551|NCT00002554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230552|NCT00002554|Antimetabolites|antimetabolites|mesh-ancestor
92230553|NCT00002554|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230554|NCT00002554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230555|NCT00002554|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92230556|NCT00002554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230558|NCT00002560|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92230559|NCT00002560|Sargramostim|sargramostim|mesh-list
92230560|NCT00002560|Immunologic Factors|immunologic factors|mesh-ancestor
92230561|NCT00002560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230563|NCT00254384|Docetaxel|docetaxel|mesh-list
92230564|NCT00254384|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91923298|NCT04440267|Mercaptopurine|mercaptopurine|mesh-list
92230565|NCT00254384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230566|NCT00254384|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230567|NCT00254384|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230568|NCT00254384|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230569|NCT00254384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230570|NCT00254384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92230571|NCT00254384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230572|NCT00002566|Cyclophosphamide|cyclophosphamide|mesh-list
92230573|NCT00002566|Ifosfamide|ifosfamide|mesh-list
92230574|NCT00002566|Carboplatin|carboplatin|mesh-list
92230575|NCT00002566|Etoposide|etoposide|mesh-list
92230576|NCT00002566|Vinblastine|vinblastine|mesh-list
92230577|NCT00002566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230578|NCT00002566|Immunologic Factors|immunologic factors|mesh-ancestor
92230579|NCT00002566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230580|NCT00002566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230581|NCT00002566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230582|NCT00002566|Alkylating Agents|alkylating agents|mesh-ancestor
92230583|NCT00002566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230584|NCT00002566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230585|NCT00002566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230586|NCT00002566|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230587|NCT00002566|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230588|NCT00002566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230589|NCT00002566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230590|NCT00002566|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230591|NCT00002566|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230592|NCT00002566|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230593|NCT00002572|Aldesleukin|aldesleukin|mesh-list
92230594|NCT00002572|Muromonab-CD3|muromonab-cd3|mesh-list
92230595|NCT00002572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230596|NCT00002572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92230597|NCT00002572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92230598|NCT00002572|Antiviral Agents|antiviral agents|mesh-ancestor
92230599|NCT00002572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230600|NCT00002572|Immunologic Factors|immunologic factors|mesh-ancestor
92230601|NCT00002572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230602|NCT00002572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230603|NCT00002578|Leucovorin|leucovorin|mesh-list
92230604|NCT00002578|Cytarabine|cytarabine|mesh-list
92230605|NCT00002578|Methotrexate|methotrexate|mesh-list
92230606|NCT00002578|Gallium nitrate|gallium nitrate|mesh-list
92230607|NCT00002578|Calcium|calcium|mesh-list
92230608|NCT00002578|Levoleucovorin|levoleucovorin|mesh-list
92230609|NCT00002578|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92230610|NCT00002578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230611|NCT00002578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92230612|NCT00002578|Abortifacient Agents|abortifacient agents|mesh-ancestor
92230613|NCT00002578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230614|NCT00002578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230615|NCT00002578|Antimetabolites|antimetabolites|mesh-ancestor
92230616|NCT00002578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230617|NCT00002578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230618|NCT00002578|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230619|NCT00002578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230620|NCT00002578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92230621|NCT00002578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230622|NCT00002578|Immunologic Factors|immunologic factors|mesh-ancestor
92230623|NCT00002578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230624|NCT00002578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230625|NCT00002578|Antiviral Agents|antiviral agents|mesh-ancestor
92230626|NCT00002578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230627|NCT00002578|Antidotes|antidotes|mesh-ancestor
92230628|NCT00002578|Protective Agents|protective agents|mesh-ancestor
92230629|NCT00002578|Vitamin B Complex|vitamin b complex|mesh-ancestor
92230630|NCT00002578|Vitamins|vitamins|mesh-ancestor
92230631|NCT00002578|Micronutrients|micronutrients|mesh-ancestor
92230632|NCT00002590|Leucovorin|leucovorin|mesh-list
92230633|NCT00002590|Cytarabine|cytarabine|mesh-list
92230635|NCT00002590|Cyclophosphamide|cyclophosphamide|mesh-list
92230636|NCT00002590|Doxorubicin|doxorubicin|mesh-list
92230637|NCT00002590|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92230638|NCT00002590|Methotrexate|methotrexate|mesh-list
92230639|NCT00002590|Etoposide|etoposide|mesh-list
92230640|NCT00002590|Vincristine|vincristine|mesh-list
92230641|NCT00002590|Daunorubicin|daunorubicin|mesh-list
92230642|NCT00002590|Asparaginase|asparaginase|mesh-list
92230643|NCT00002590|Pegaspargase|pegaspargase|mesh-list
92230644|NCT00002590|Thioguanine|thioguanine|mesh-list
92230645|NCT00002590|Levoleucovorin|levoleucovorin|mesh-list
91923532|NCT02229955|Cyclosporins|cyclosporins|mesh-list
92230646|NCT00002590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230647|NCT00002590|Immunologic Factors|immunologic factors|mesh-ancestor
92230648|NCT00002590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230649|NCT00002590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230650|NCT00002590|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230651|NCT00002590|Alkylating Agents|alkylating agents|mesh-ancestor
92230652|NCT00002590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230653|NCT00002590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230654|NCT00002590|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230655|NCT00002590|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230656|NCT00002590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230657|NCT00002590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230658|NCT00002590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230659|NCT00002590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230660|NCT00002590|Glucocorticoids|glucocorticoids|mesh-ancestor
92230661|NCT00002590|Hormones|hormones|mesh-ancestor
92230662|NCT00002590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230663|NCT00002590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230664|NCT00002590|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92230665|NCT00002590|Abortifacient Agents|abortifacient agents|mesh-ancestor
92230666|NCT00002590|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230667|NCT00002590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230668|NCT00002590|Antimetabolites|antimetabolites|mesh-ancestor
92230669|NCT00002590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230670|NCT00002590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92230671|NCT00002590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230672|NCT00002590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230673|NCT00002590|Antiviral Agents|antiviral agents|mesh-ancestor
92230674|NCT00002590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230675|NCT00002590|Antidotes|antidotes|mesh-ancestor
92230676|NCT00002590|Protective Agents|protective agents|mesh-ancestor
92230677|NCT00002590|Vitamin B Complex|vitamin b complex|mesh-ancestor
92230678|NCT00002590|Vitamins|vitamins|mesh-ancestor
92230679|NCT00002590|Micronutrients|micronutrients|mesh-ancestor
92230680|NCT00002590|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230681|NCT00002590|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230682|NCT00002590|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230683|NCT00002596|Cyclophosphamide|cyclophosphamide|mesh-list
92230684|NCT00002596|Carboplatin|carboplatin|mesh-list
92230685|NCT00002596|Etoposide|etoposide|mesh-list
92230686|NCT00002596|Bleomycin|bleomycin|mesh-list
92230687|NCT00002596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230688|NCT00002596|Immunologic Factors|immunologic factors|mesh-ancestor
92230689|NCT00002596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230690|NCT00002596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230691|NCT00002596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230692|NCT00002596|Alkylating Agents|alkylating agents|mesh-ancestor
92230693|NCT00002596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230694|NCT00002596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230695|NCT00002596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230696|NCT00002596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230697|NCT00002596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230698|NCT00002596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230699|NCT00002596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230700|NCT00002596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230701|NCT00199082|Cytarabine|cytarabine|mesh-list
92230702|NCT00199082|Dexamethasone|dexamethasone|mesh-list
92230703|NCT00199082|Prednisolone|prednisolone|mesh-list
92230704|NCT00199082|Cyclophosphamide|cyclophosphamide|mesh-list
92230705|NCT00199082|Ifosfamide|ifosfamide|mesh-list
92230706|NCT00199082|Rituximab|rituximab|mesh-list
92230707|NCT00199082|Methotrexate|methotrexate|mesh-list
92230708|NCT00199082|Vincristine|vincristine|mesh-list
92230709|NCT00199082|Doxorubicin|doxorubicin|mesh-list
92230711|NCT00199082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230712|NCT00199082|Immunologic Factors|immunologic factors|mesh-ancestor
92230713|NCT00199082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230714|NCT00199082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230715|NCT00199082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230716|NCT00199082|Alkylating Agents|alkylating agents|mesh-ancestor
92230717|NCT00199082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230718|NCT00199082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230719|NCT00199082|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230720|NCT00199082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92230721|NCT00199082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230722|NCT00199082|Antiemetics|antiemetics|mesh-ancestor
92230723|NCT00199082|Autonomic Agents|autonomic agents|mesh-ancestor
92230724|NCT00199082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230725|NCT00199082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230726|NCT00199082|Glucocorticoids|glucocorticoids|mesh-ancestor
92230727|NCT00199082|Hormones|hormones|mesh-ancestor
92230728|NCT00199082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230729|NCT00199082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230730|NCT00199082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92230731|NCT00199082|Abortifacient Agents|abortifacient agents|mesh-ancestor
92230732|NCT00199082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230733|NCT00199082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230734|NCT00199082|Antimetabolites|antimetabolites|mesh-ancestor
92230735|NCT00199082|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230736|NCT00199082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230737|NCT00199082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92230738|NCT00199082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230739|NCT00199082|Antiviral Agents|antiviral agents|mesh-ancestor
92230740|NCT00199082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230741|NCT00199082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230742|NCT00199082|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230743|NCT00199082|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230744|NCT00199082|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230745|NCT00199082|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230746|NCT00199082|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230747|NCT00199082|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230748|NCT00194090|Celecoxib|celecoxib|mesh-list
92230749|NCT00194090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92230750|NCT00194090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230751|NCT00194090|Analgesics|analgesics|mesh-ancestor
92230752|NCT00194090|Sensory System Agents|sensory system agents|mesh-ancestor
92230753|NCT00194090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230754|NCT00194090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230755|NCT00194090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230756|NCT00194090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230757|NCT00194090|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92230758|NCT00194090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92230759|NCT00194090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230760|NCT00194090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230761|NCT00002608|Tamoxifen|tamoxifen|mesh-list
92230762|NCT00002608|Doxorubicin|doxorubicin|mesh-list
92230763|NCT00002608|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92230764|NCT00002608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230765|NCT00002608|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92230766|NCT00002608|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230767|NCT00002608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230768|NCT00002608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230769|NCT00002608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230770|NCT00002608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92230771|NCT00002608|Hormone Antagonists|hormone antagonists|mesh-ancestor
92230772|NCT00002608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230773|NCT00002608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230774|NCT00002608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230775|NCT00002608|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92230776|NCT00002608|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92230777|NCT00002608|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92230779|NCT00002620|Carmustine|carmustine|mesh-list
92230780|NCT00002620|Mitolactol|mitolactol|mesh-list
92230781|NCT00002620|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230782|NCT00002620|Alkylating Agents|alkylating agents|mesh-ancestor
92230783|NCT00002620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230784|NCT00002620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230785|NCT00002620|Trace Elements|trace elements|mesh-ancestor
92230786|NCT00002620|Micronutrients|micronutrients|mesh-ancestor
92230787|NCT00002620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230788|NCT04160000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92230789|NCT00002638|Cytarabine|cytarabine|mesh-list
92230790|NCT00002638|Cyclophosphamide|cyclophosphamide|mesh-list
92230791|NCT00002638|Carmustine|carmustine|mesh-list
92230792|NCT00002638|Etoposide|etoposide|mesh-list
92230793|NCT00002638|Sargramostim|sargramostim|mesh-list
92230794|NCT00002638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230795|NCT00002638|Immunologic Factors|immunologic factors|mesh-ancestor
92230796|NCT00002638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230797|NCT00002638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230798|NCT00002638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230799|NCT00002638|Alkylating Agents|alkylating agents|mesh-ancestor
92230800|NCT00002638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230801|NCT00002638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230802|NCT00002638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230803|NCT00002638|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230804|NCT00002638|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230805|NCT00002638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230806|NCT00002638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230807|NCT00002638|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230808|NCT00002638|Antimetabolites|antimetabolites|mesh-ancestor
92230809|NCT00002638|Antiviral Agents|antiviral agents|mesh-ancestor
92230810|NCT00002638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230811|NCT05120362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92230812|NCT05120362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92230813|NCT05120362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230814|NCT05120362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230815|NCT01896440|Ondansetron|ondansetron|mesh-list
92230816|NCT01896440|Antiemetics|antiemetics|mesh-ancestor
92230817|NCT01896440|Autonomic Agents|autonomic agents|mesh-ancestor
92230818|NCT01896440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230819|NCT01896440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230820|NCT01896440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230821|NCT01896440|Antipruritics|antipruritics|mesh-ancestor
92230822|NCT01896440|Dermatologic Agents|dermatologic agents|mesh-ancestor
92230823|NCT01896440|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92230824|NCT01896440|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92230825|NCT01896440|Serotonin Agents|serotonin agents|mesh-ancestor
92230826|NCT01896440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230827|NCT01896440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230829|NCT00002656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230830|NCT00002662|Paclitaxel|paclitaxel|mesh-list
92230831|NCT00002662|Docetaxel|docetaxel|mesh-list
92230832|NCT00002662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230833|NCT00002662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230834|NCT00002662|Tubulin Modulators|tubulin modulators|mesh-ancestor
92230835|NCT00002662|Antimitotic Agents|antimitotic agents|mesh-ancestor
92230836|NCT00002662|Mitosis Modulators|mitosis modulators|mesh-ancestor
92230837|NCT00002662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230838|NCT00054314|IDN 5109|idn 5109|mesh-list
92230839|NCT00054314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230840|NCT01743950|Bevacizumab|bevacizumab|mesh-list
92230841|NCT01743950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92230842|NCT01743950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230843|NCT01743950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92230844|NCT01743950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92230845|NCT01743950|Growth Substances|growth substances|mesh-ancestor
92230846|NCT01743950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230847|NCT01743950|Growth Inhibitors|growth inhibitors|mesh-ancestor
92230848|NCT00002674|Cytarabine|cytarabine|mesh-list
92230849|NCT00002674|Etoposide|etoposide|mesh-list
92230850|NCT00002674|Mitoxantrone|mitoxantrone|mesh-list
92230851|NCT00002674|Hydroxyurea|hydroxyurea|mesh-list
92230852|NCT00002674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92230853|NCT00002674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230854|NCT00002674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92230855|NCT00002674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92230856|NCT00002674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230857|NCT00002674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230858|NCT00002674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230859|NCT00002674|Antimetabolites|antimetabolites|mesh-ancestor
92230860|NCT00002674|Antiviral Agents|antiviral agents|mesh-ancestor
92230861|NCT00002674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92230862|NCT00002674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230863|NCT00002674|Immunologic Factors|immunologic factors|mesh-ancestor
92230864|NCT00002674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230865|NCT00002674|Analgesics|analgesics|mesh-ancestor
92230866|NCT00002674|Sensory System Agents|sensory system agents|mesh-ancestor
92230867|NCT00002674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230868|NCT00002674|Antisickling Agents|antisickling agents|mesh-ancestor
92230869|NCT00002674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92230870|NCT01743872|Dextrans|dextrans|mesh-list
92230871|NCT01743872|Anticoagulants|anticoagulants|mesh-ancestor
92230872|NCT01743872|Plasma Substitutes|plasma substitutes|mesh-ancestor
92230873|NCT01743872|Blood Substitutes|blood substitutes|mesh-ancestor
92230874|NCT00002680|Tamoxifen|tamoxifen|mesh-list
92230875|NCT00002680|Cyclophosphamide|cyclophosphamide|mesh-list
92230876|NCT00002680|Melphalan|melphalan|mesh-list
92230877|NCT00002680|Thiotepa|thiotepa|mesh-list
92230878|NCT00002680|Megestrol|megestrol|mesh-list
92230879|NCT00002680|Megestrol Acetate|megestrol acetate|mesh-list
92230880|NCT00002680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230881|NCT00002680|Immunologic Factors|immunologic factors|mesh-ancestor
92230882|NCT00002680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230883|NCT00002680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230884|NCT00002680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92230885|NCT00002680|Alkylating Agents|alkylating agents|mesh-ancestor
92230886|NCT00002680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230887|NCT00002680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230888|NCT00002680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92230889|NCT00002680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92230890|NCT00002680|Hormone Antagonists|hormone antagonists|mesh-ancestor
92230891|NCT00002680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230892|NCT00002680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230893|NCT00002680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92230894|NCT00002680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92230895|NCT00002680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92230896|NCT00002680|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92230897|NCT00002680|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92230898|NCT00002680|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92230899|NCT00002680|Contraceptive Agents|contraceptive agents|mesh-ancestor
92230900|NCT00002680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230901|NCT00002680|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92230902|NCT00002680|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92230903|NCT00002680|Appetite Stimulants|appetite stimulants|mesh-ancestor
92230904|NCT00002680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92230905|NCT00002692|Leucovorin|leucovorin|mesh-list
92230906|NCT00002692|Fluorouracil|fluorouracil|mesh-list
92230907|NCT00002692|Calcium|calcium|mesh-list
92230908|NCT00002692|Levoleucovorin|levoleucovorin|mesh-list
92230909|NCT00002692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92230910|NCT00002692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230911|NCT00002692|Antimetabolites|antimetabolites|mesh-ancestor
92338686|NCT03121001|Sirolimus|sirolimus|mesh-list
92230912|NCT00002692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230913|NCT00002692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92230914|NCT00002692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230915|NCT00002692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92230916|NCT00002692|Immunologic Factors|immunologic factors|mesh-ancestor
92230917|NCT00002692|Antidotes|antidotes|mesh-ancestor
92230918|NCT00002692|Protective Agents|protective agents|mesh-ancestor
92230919|NCT00002692|Vitamin B Complex|vitamin b complex|mesh-ancestor
92230921|NCT00002692|Micronutrients|micronutrients|mesh-ancestor
92230922|NCT05293210|Dexamethasone|dexamethasone|mesh-list
92230923|NCT05293210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230924|NCT05293210|Antiemetics|antiemetics|mesh-ancestor
92230925|NCT05293210|Autonomic Agents|autonomic agents|mesh-ancestor
92230926|NCT05293210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230927|NCT05293210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230928|NCT05293210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92230929|NCT05293210|Glucocorticoids|glucocorticoids|mesh-ancestor
92230930|NCT05293210|Hormones|hormones|mesh-ancestor
92230931|NCT05293210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230932|NCT05293210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230933|NCT05293210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230934|NCT01895348|Dexmedetomidine|dexmedetomidine|mesh-list
92230935|NCT01895348|Remifentanil|remifentanil|mesh-list
92230936|NCT01895348|Propofol|propofol|mesh-list
92230937|NCT01895348|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92230938|NCT01895348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92230939|NCT01895348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230940|NCT01895348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230941|NCT01895348|Analgesics|analgesics|mesh-ancestor
92230942|NCT01895348|Sensory System Agents|sensory system agents|mesh-ancestor
92230943|NCT01895348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230944|NCT01895348|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92230945|NCT01895348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92230946|NCT01895348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92230947|NCT01895348|Adrenergic Agents|adrenergic agents|mesh-ancestor
92230948|NCT01895348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92230949|NCT01895348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230950|NCT01895348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92230951|NCT01895348|Anesthetics, General|anesthetics, general|mesh-ancestor
92230952|NCT01895348|Anesthetics|anesthetics|mesh-ancestor
92230953|NCT01895348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92230954|NCT01895348|Narcotics|narcotics|mesh-ancestor
92230955|NCT04194554|Leuprolide|leuprolide|mesh-list
92230956|NCT04194554|Abiraterone Acetate|abiraterone acetate|mesh-list
92230957|NCT04194554|Niraparib|niraparib|mesh-list
92230958|NCT04194554|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92230959|NCT04194554|Fertility Agents|fertility agents|mesh-ancestor
92230960|NCT04194554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92230961|NCT04194554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230962|NCT04194554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92230963|NCT04194554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92230964|NCT04194554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92230965|NCT04194554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230966|NCT04194554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230967|NCT04194554|Hormone Antagonists|hormone antagonists|mesh-ancestor
92230968|NCT04194554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92230969|NCT04194554|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92230970|NCT04194554|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92230972|NCT05073718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92230973|NCT05073718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230974|NCT05073718|Analgesics|analgesics|mesh-ancestor
92230975|NCT05073718|Sensory System Agents|sensory system agents|mesh-ancestor
92230976|NCT05073718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230977|NCT05073718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230978|NCT05073718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92230979|NCT05073718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92230980|NCT05073718|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92230981|NCT05073718|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92230982|NCT05073718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92230983|NCT05073718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92230984|NCT05073718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92230985|NCT05073718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92230986|NCT05073718|Antipyretics|antipyretics|mesh-ancestor
92230987|NCT04784000|Carbamazepine|carbamazepine|mesh-list
92230988|NCT04784000|Anticonvulsants|anticonvulsants|mesh-ancestor
92230989|NCT04784000|Antimanic Agents|antimanic agents|mesh-ancestor
92230990|NCT04784000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92230991|NCT04784000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92230992|NCT04784000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92230993|NCT04784000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92230994|NCT04784000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92230995|NCT04784000|Analgesics|analgesics|mesh-ancestor
92230996|NCT04784000|Sensory System Agents|sensory system agents|mesh-ancestor
92230997|NCT04784000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92230998|NCT04784000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92230999|NCT04784000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92231000|NCT04784000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231001|NCT04784000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92231002|NCT04784000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92231003|NCT05271292|Chiauranib|chiauranib|mesh-list
92231004|NCT05271292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231005|NCT05271292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92231006|NCT05271292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231007|NCT05271292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231008|NCT05266846|Bevacizumab|bevacizumab|mesh-list
92231009|NCT05266846|Pembrolizumab|pembrolizumab|mesh-list
92231010|NCT05266846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231011|NCT05266846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231012|NCT05266846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92231013|NCT05266846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92231014|NCT05266846|Growth Substances|growth substances|mesh-ancestor
92231015|NCT05266846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231016|NCT05266846|Growth Inhibitors|growth inhibitors|mesh-ancestor
92231017|NCT05266846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92231018|NCT05266846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231020|NCT01113476|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92231021|NCT01113476|Bevacizumab|bevacizumab|mesh-list
92231022|NCT01113476|Gemcitabine|gemcitabine|mesh-list
92231023|NCT01113476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92231024|NCT01113476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231025|NCT01113476|Tubulin Modulators|tubulin modulators|mesh-ancestor
92231026|NCT01113476|Antimitotic Agents|antimitotic agents|mesh-ancestor
92231027|NCT01113476|Mitosis Modulators|mitosis modulators|mesh-ancestor
92231028|NCT01113476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231029|NCT01113476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231030|NCT01113476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92231031|NCT01113476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92231032|NCT01113476|Growth Substances|growth substances|mesh-ancestor
92231033|NCT01113476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231034|NCT01113476|Growth Inhibitors|growth inhibitors|mesh-ancestor
92231035|NCT01113476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231036|NCT01113476|Antimetabolites|antimetabolites|mesh-ancestor
92231037|NCT01107236|Naproxen|naproxen|mesh-list
92231038|NCT01107236|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92231039|NCT01107236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92231040|NCT01107236|Analgesics|analgesics|mesh-ancestor
92231041|NCT01107236|Sensory System Agents|sensory system agents|mesh-ancestor
92231042|NCT01107236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231043|NCT01107236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231044|NCT01107236|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231045|NCT01107236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231046|NCT01107236|Gout Suppressants|gout suppressants|mesh-ancestor
92231047|NCT01107236|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92231048|NCT01107236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231049|NCT01107236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231050|NCT00002704|Leucovorin|leucovorin|mesh-list
92231051|NCT00002704|Cytarabine|cytarabine|mesh-list
92231052|NCT00002704|Dexamethasone|dexamethasone|mesh-list
92231053|NCT00002704|Hydrocortisone|hydrocortisone|mesh-list
92231054|NCT00002704|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92231055|NCT00002704|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92231056|NCT00002704|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92231057|NCT00002704|Cyclophosphamide|cyclophosphamide|mesh-list
92231058|NCT00002704|Thiotepa|thiotepa|mesh-list
92231059|NCT00002704|Methotrexate|methotrexate|mesh-list
92231060|NCT00002704|Etoposide|etoposide|mesh-list
92231061|NCT00002704|Vincristine|vincristine|mesh-list
92231062|NCT00002704|Daunorubicin|daunorubicin|mesh-list
92231063|NCT00002704|Asparaginase|asparaginase|mesh-list
92231064|NCT00002704|Mercaptopurine|mercaptopurine|mesh-list
92231065|NCT00002704|Levoleucovorin|levoleucovorin|mesh-list
92231066|NCT00002704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231067|NCT00002704|Immunologic Factors|immunologic factors|mesh-ancestor
92231068|NCT00002704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231069|NCT00002704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231070|NCT00002704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231071|NCT00002704|Alkylating Agents|alkylating agents|mesh-ancestor
92231072|NCT00002704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231073|NCT00002704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231074|NCT00002704|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92231075|NCT00002704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231076|NCT00002704|Antiemetics|antiemetics|mesh-ancestor
92231077|NCT00002704|Autonomic Agents|autonomic agents|mesh-ancestor
92231078|NCT00002704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231079|NCT00002704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231080|NCT00002704|Glucocorticoids|glucocorticoids|mesh-ancestor
92231081|NCT00002704|Hormones|hormones|mesh-ancestor
92231082|NCT00002704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231083|NCT00002704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231084|NCT00002704|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92231085|NCT00002704|Abortifacient Agents|abortifacient agents|mesh-ancestor
92231086|NCT00002704|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231087|NCT00002704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231088|NCT00002704|Antimetabolites|antimetabolites|mesh-ancestor
92231089|NCT00002704|Dermatologic Agents|dermatologic agents|mesh-ancestor
92231090|NCT00002704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231091|NCT00002704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92231092|NCT00002704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92231093|NCT00002704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92231094|NCT00002704|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231095|NCT00002704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231096|NCT00002704|Antiviral Agents|antiviral agents|mesh-ancestor
92231097|NCT00002704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231098|NCT00002704|Antidotes|antidotes|mesh-ancestor
92231099|NCT00002704|Protective Agents|protective agents|mesh-ancestor
92231100|NCT00002704|Vitamin B Complex|vitamin b complex|mesh-ancestor
92231102|NCT00002704|Micronutrients|micronutrients|mesh-ancestor
92231103|NCT00002704|Tubulin Modulators|tubulin modulators|mesh-ancestor
92231104|NCT00002704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92231105|NCT00002704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92231106|NCT00002704|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231107|NCT00002716|Leucovorin|leucovorin|mesh-list
92231108|NCT00002716|Dexamethasone|dexamethasone|mesh-list
92231109|NCT00002716|Fluorouracil|fluorouracil|mesh-list
92231110|NCT00002716|Floxuridine|floxuridine|mesh-list
92231111|NCT00002716|Calcium|calcium|mesh-list
92231112|NCT00002716|Levoleucovorin|levoleucovorin|mesh-list
92231113|NCT00002716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231114|NCT00002716|Antiemetics|antiemetics|mesh-ancestor
92231115|NCT00002716|Autonomic Agents|autonomic agents|mesh-ancestor
92231117|NCT00002716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231118|NCT00002716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231119|NCT00002716|Glucocorticoids|glucocorticoids|mesh-ancestor
92231120|NCT00002716|Hormones|hormones|mesh-ancestor
92231121|NCT00002716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231122|NCT00002716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231123|NCT00002716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231124|NCT00002716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92231125|NCT00002716|Antimetabolites|antimetabolites|mesh-ancestor
92231126|NCT00002716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231127|NCT00002716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231128|NCT00002716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231129|NCT00002716|Immunologic Factors|immunologic factors|mesh-ancestor
92231130|NCT00002716|Antidotes|antidotes|mesh-ancestor
92231131|NCT00002716|Protective Agents|protective agents|mesh-ancestor
92231132|NCT00002716|Vitamin B Complex|vitamin b complex|mesh-ancestor
92231133|NCT00002716|Vitamins|vitamins|mesh-ancestor
92231134|NCT00002716|Micronutrients|micronutrients|mesh-ancestor
92231135|NCT02533674|Gemcitabine|gemcitabine|mesh-list
92231136|NCT02533674|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231137|NCT02533674|Antimetabolites|antimetabolites|mesh-ancestor
92231138|NCT02533674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231139|NCT02533674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231140|NCT00002722|Leucovorin|leucovorin|mesh-list
92231141|NCT00002722|Fluorouracil|fluorouracil|mesh-list
92231142|NCT00002722|Calcium|calcium|mesh-list
92231143|NCT00002722|Levoleucovorin|levoleucovorin|mesh-list
92231144|NCT00002722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231145|NCT00002722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92231146|NCT00002722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231147|NCT00002722|Antimetabolites|antimetabolites|mesh-ancestor
92231148|NCT00002722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231149|NCT00002722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231150|NCT00002722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231151|NCT00002722|Immunologic Factors|immunologic factors|mesh-ancestor
92231152|NCT00002722|Antidotes|antidotes|mesh-ancestor
92231153|NCT00002722|Protective Agents|protective agents|mesh-ancestor
92231154|NCT00002722|Vitamin B Complex|vitamin b complex|mesh-ancestor
92231155|NCT00002722|Vitamins|vitamins|mesh-ancestor
92231156|NCT00002722|Micronutrients|micronutrients|mesh-ancestor
92231157|NCT00002734|Interferons|interferons|mesh-list
92231158|NCT00002734|Interferon-alpha|interferon-alpha|mesh-list
92231159|NCT00002734|Paclitaxel|paclitaxel|mesh-list
92231160|NCT00002734|Topotecan|topotecan|mesh-list
92231161|NCT00002734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92231162|NCT00002734|Antibodies|antibodies|mesh-list
92231163|NCT00002734|Immunoglobulins|immunoglobulins|mesh-list
92231164|NCT00002734|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92231165|NCT00002734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92231166|NCT00002734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231167|NCT00002734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92231168|NCT00002734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92231169|NCT00002734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92231170|NCT00002734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231171|NCT00002734|Immunologic Factors|immunologic factors|mesh-ancestor
92231172|NCT00002734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231173|NCT00002734|Antiviral Agents|antiviral agents|mesh-ancestor
92231174|NCT00002734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231175|NCT00002734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92231176|NCT00002734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231177|NCT00002734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231178|NCT04783610|Ethanol|ethanol|mesh-list
92231179|NCT04783610|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92231180|NCT04783610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231181|NCT04783610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231182|NCT04783610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231184|NCT00002740|Cyclophosphamide|cyclophosphamide|mesh-list
92231185|NCT00002740|Carboplatin|carboplatin|mesh-list
92231186|NCT00002740|Doxorubicin|doxorubicin|mesh-list
92231187|NCT00002740|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92231188|NCT00002740|Etoposide|etoposide|mesh-list
92231189|NCT00002740|Vincristine|vincristine|mesh-list
92231190|NCT00002740|Lenograstim|lenograstim|mesh-list
92231191|NCT00002740|Mesna|mesna|mesh-list
92231192|NCT00002740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231193|NCT00002740|Immunologic Factors|immunologic factors|mesh-ancestor
92231194|NCT00002740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231195|NCT00002740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231196|NCT00002740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231197|NCT00002740|Alkylating Agents|alkylating agents|mesh-ancestor
92231198|NCT00002740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231199|NCT00002740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231200|NCT00002740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92231201|NCT00002740|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231202|NCT00002740|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231203|NCT00002740|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231204|NCT00002740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231205|NCT00002740|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92231206|NCT00002740|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92231207|NCT00002740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92231208|NCT00002740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92231209|NCT00002740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92231210|NCT00002740|Protective Agents|protective agents|mesh-ancestor
92231211|NCT00002740|Trace Elements|trace elements|mesh-ancestor
92231212|NCT00002740|Micronutrients|micronutrients|mesh-ancestor
92231213|NCT00002746|Aldesleukin|aldesleukin|mesh-list
92231214|NCT00002746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231215|NCT00002746|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92231216|NCT00002746|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92231217|NCT00002746|Antiviral Agents|antiviral agents|mesh-ancestor
92231218|NCT00002746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231219|NCT01049945|Dexamethasone|dexamethasone|mesh-list
92231220|NCT01049945|Lenalidomide|lenalidomide|mesh-list
92231221|NCT01049945|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92231222|NCT01049945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231223|NCT01049945|Antiemetics|antiemetics|mesh-ancestor
92231224|NCT01049945|Autonomic Agents|autonomic agents|mesh-ancestor
92231225|NCT01049945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231226|NCT01049945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231227|NCT01049945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231228|NCT01049945|Glucocorticoids|glucocorticoids|mesh-ancestor
92231230|NCT01049945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231231|NCT01049945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231232|NCT01049945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231233|NCT01049945|Immunologic Factors|immunologic factors|mesh-ancestor
92231234|NCT01049945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92231235|NCT01049945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92231236|NCT01049945|Growth Substances|growth substances|mesh-ancestor
92231237|NCT01049945|Growth Inhibitors|growth inhibitors|mesh-ancestor
92231238|NCT01049945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231239|NCT01049945|Alkylating Agents|alkylating agents|mesh-ancestor
92231240|NCT01049945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231241|NCT00002752|Antibodies|antibodies|mesh-list
92231242|NCT00002752|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92231243|NCT00002752|Immunologic Factors|immunologic factors|mesh-ancestor
92231244|NCT00002752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231245|NCT01050647|Castor Oil|castor oil|mesh-list
92231246|NCT01050647|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92231247|NCT01050647|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92231248|NCT01050647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92231249|NCT01050647|Hormone Antagonists|hormone antagonists|mesh-ancestor
92231250|NCT01050647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231251|NCT01050647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231252|NCT01050647|Progestins|progestins|mesh-ancestor
92231253|NCT01050647|Hormones|hormones|mesh-ancestor
92231254|NCT01050647|Cathartics|cathartics|mesh-ancestor
92231255|NCT01050647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231256|NCT04825678|Erenumab|erenumab|mesh-list
92231257|NCT04825678|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92231258|NCT04825678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231259|NCT04825678|Analgesics|analgesics|mesh-ancestor
92231260|NCT04825678|Sensory System Agents|sensory system agents|mesh-ancestor
92231261|NCT04825678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231262|NCT04825678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231263|NCT00002764|Doxorubicin|doxorubicin|mesh-list
92231264|NCT00002764|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92231266|NCT00002764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231267|NCT00002764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231268|NCT00002764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231269|NCT00002764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231270|NCT00002764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231271|NCT00002764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231272|NCT00002764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231273|NCT00002764|Alkylating Agents|alkylating agents|mesh-ancestor
92231274|NCT01688492|Ipilimumab|ipilimumab|mesh-list
92231275|NCT01688492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231276|NCT01688492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231277|NCT01688492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92231278|NCT01688492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231279|NCT05167175|Prednisone|prednisone|mesh-list
92231280|NCT05167175|Olaparib|olaparib|mesh-list
92231281|NCT05167175|Abiraterone Acetate|abiraterone acetate|mesh-list
92231282|NCT05167175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231283|NCT05167175|Glucocorticoids|glucocorticoids|mesh-ancestor
92231284|NCT05167175|Hormones|hormones|mesh-ancestor
92231285|NCT05167175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231286|NCT05167175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231287|NCT05167175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231288|NCT05167175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231289|NCT05167175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92231290|NCT05167175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231291|NCT05167175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231292|NCT05167175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92231293|NCT05167175|Hormone Antagonists|hormone antagonists|mesh-ancestor
92231294|NCT05167175|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92231295|NCT00002788|Dexamethasone|dexamethasone|mesh-list
92231296|NCT00002788|Cyclophosphamide|cyclophosphamide|mesh-list
92231297|NCT00002788|Etoposide|etoposide|mesh-list
92231298|NCT00002788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231299|NCT00002788|Immunologic Factors|immunologic factors|mesh-ancestor
92231300|NCT00002788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231301|NCT00002788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231302|NCT00002788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231303|NCT00002788|Alkylating Agents|alkylating agents|mesh-ancestor
92231304|NCT00002788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231305|NCT00002788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231306|NCT00002788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92231307|NCT00002788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231308|NCT00002788|Antiemetics|antiemetics|mesh-ancestor
92231309|NCT00002788|Autonomic Agents|autonomic agents|mesh-ancestor
92231310|NCT00002788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231311|NCT00002788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231312|NCT00002788|Glucocorticoids|glucocorticoids|mesh-ancestor
92231313|NCT00002788|Hormones|hormones|mesh-ancestor
92231314|NCT00002788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231315|NCT00002788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231316|NCT00002788|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92231317|NCT00002788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231318|NCT00002788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231319|NCT00002788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231320|NCT04352933|Hydroxychloroquine|hydroxychloroquine|mesh-list
92231321|NCT04352933|Antimalarials|antimalarials|mesh-ancestor
92231322|NCT04352933|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92231323|NCT04352933|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92231324|NCT04352933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231325|NCT04352933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231326|NCT04352933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231327|NCT04352933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231328|NCT04783792|Ascorbic Acid|ascorbic acid|mesh-list
92231329|NCT04783792|Antioxidants|antioxidants|mesh-ancestor
92231330|NCT04783792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231331|NCT04783792|Protective Agents|protective agents|mesh-ancestor
92231332|NCT04783792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231333|NCT04783792|Vitamins|vitamins|mesh-ancestor
92231334|NCT04783792|Micronutrients|micronutrients|mesh-ancestor
92231335|NCT05002816|Elotuzumab|elotuzumab|mesh-list
92231336|NCT05002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231337|NCT01676402|Vaccines|vaccines|mesh-list
92231338|NCT01676402|Immunologic Factors|immunologic factors|mesh-ancestor
92231339|NCT01676402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231340|NCT01052831|Naltrexone|naltrexone|mesh-list
92231341|NCT01052831|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92231342|NCT01052831|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92231343|NCT01052831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231344|NCT01052831|Sensory System Agents|sensory system agents|mesh-ancestor
92231345|NCT01052831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231346|NCT04330300|Losartan|losartan|mesh-list
92231347|NCT04330300|Verapamil|verapamil|mesh-list
92231348|NCT04330300|Felodipine|felodipine|mesh-list
92231349|NCT04330300|Amlodipine|amlodipine|mesh-list
92231350|NCT04330300|Valsartan|valsartan|mesh-list
92231351|NCT04330300|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92231352|NCT04330300|Telmisartan|telmisartan|mesh-list
92231353|NCT04330300|Candesartan|candesartan|mesh-list
92231354|NCT04330300|Ramipril|ramipril|mesh-list
92231355|NCT04330300|Olmesartan|olmesartan|mesh-list
92231356|NCT04330300|Enalapril|enalapril|mesh-list
92231357|NCT04330300|Lisinopril|lisinopril|mesh-list
92231358|NCT04330300|Irbesartan|irbesartan|mesh-list
92231359|NCT04330300|Chlorthalidone|chlorthalidone|mesh-list
92231360|NCT04330300|Perindopril|perindopril|mesh-list
92231361|NCT04330300|Diltiazem|diltiazem|mesh-list
92231362|NCT04330300|Benazepril|benazepril|mesh-list
92231363|NCT04330300|Captopril|captopril|mesh-list
92231364|NCT04330300|Indapamide|indapamide|mesh-list
92231365|NCT04330300|Nicardipine|nicardipine|mesh-list
92231366|NCT04330300|Nimodipine|nimodipine|mesh-list
92231367|NCT04330300|Quinapril|quinapril|mesh-list
92231368|NCT04330300|Metolazone|metolazone|mesh-list
92231369|NCT04330300|Trandolapril|trandolapril|mesh-list
92231370|NCT04330300|Fosinopril|fosinopril|mesh-list
92231371|NCT04330300|Eprosartan|eprosartan|mesh-list
92231372|NCT04330300|Nitrendipine|nitrendipine|mesh-list
92231373|NCT04330300|Bendroflumethiazide|bendroflumethiazide|mesh-list
92231374|NCT04330300|Chlorothiazide|chlorothiazide|mesh-list
92231375|NCT04330300|Nifedipine|nifedipine|mesh-list
92231376|NCT04330300|Calcium Channel Blockers|calcium channel blockers|mesh-list
92231377|NCT04330300|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92231378|NCT04330300|Diuretics|diuretics|mesh-list
92231379|NCT04330300|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92231380|NCT04330300|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92231381|NCT04330300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231382|NCT04330300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92231383|NCT04330300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92231384|NCT04330300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231385|NCT04330300|Vasodilator Agents|vasodilator agents|mesh-ancestor
92231386|NCT04330300|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92231387|NCT04330300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92231388|NCT04330300|Natriuretic Agents|natriuretic agents|mesh-ancestor
92231389|NCT04330300|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92231390|NCT04330300|Protease Inhibitors|protease inhibitors|mesh-ancestor
92231391|NCT04330300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231392|NCT04330300|Tocolytic Agents|tocolytic agents|mesh-ancestor
92231393|NCT04330300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231394|NCT04330300|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92231395|NCT04330300|Protective Agents|protective agents|mesh-ancestor
92231396|NCT04330300|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92231397|NCT04352855|Tazobactam|tazobactam|mesh-list
92231398|NCT04352855|Ceftolozane|ceftolozane|mesh-list
92231399|NCT04352855|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92231400|NCT04352855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92231401|NCT04352855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231402|NCT04352855|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92231403|NCT04352855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231404|NCT04352855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231405|NCT04352855|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92231406|NCT04782128|RC28-E protein|rc28-e protein|mesh-list
92231407|NCT04782128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92231408|NCT04782128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92231409|NCT04782128|Growth Substances|growth substances|mesh-ancestor
92231410|NCT04782128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231411|NCT04782128|Growth Inhibitors|growth inhibitors|mesh-ancestor
92231412|NCT04782128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231413|NCT00995150|Levonorgestrel|levonorgestrel|mesh-list
92231414|NCT00995150|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92231415|NCT00995150|Contraceptive Agents|contraceptive agents|mesh-ancestor
92231416|NCT00995150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231417|NCT00995150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231418|NCT00995150|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92231419|NCT00995150|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92231420|NCT00995150|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92231421|NCT00382642|Ondansetron|ondansetron|mesh-list
92231422|NCT00382642|Antiemetics|antiemetics|mesh-ancestor
92231423|NCT00382642|Autonomic Agents|autonomic agents|mesh-ancestor
92231424|NCT00382642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231425|NCT00382642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231426|NCT00382642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231427|NCT00382642|Antipruritics|antipruritics|mesh-ancestor
92231428|NCT00382642|Dermatologic Agents|dermatologic agents|mesh-ancestor
92231429|NCT00382642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92231430|NCT00382642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92231431|NCT00382642|Serotonin Agents|serotonin agents|mesh-ancestor
92231432|NCT00382642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231433|NCT00382642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231434|NCT01054079|Cinacalcet|cinacalcet|mesh-list
92231435|NCT01054079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92231436|NCT01054079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231437|NCT01054079|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92231438|NCT01054079|Hormone Antagonists|hormone antagonists|mesh-ancestor
92231439|NCT01054079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231440|NCT01054625|Zalutumumab|zalutumumab|mesh-list
92231441|NCT01054625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231442|NCT01054625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231443|NCT02544750|Cannabidiol|cannabidiol|mesh-list
92231444|NCT02544750|Anticonvulsants|anticonvulsants|mesh-ancestor
92231445|NCT01662050|Cytarabine|cytarabine|mesh-list
92231447|NCT01662050|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92231448|NCT01662050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231449|NCT01662050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231450|NCT01662050|Immunologic Factors|immunologic factors|mesh-ancestor
92231451|NCT01662050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231452|NCT01662050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231453|NCT01662050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231454|NCT01662050|Antimetabolites|antimetabolites|mesh-ancestor
92231455|NCT01662050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231456|NCT01662050|Antiviral Agents|antiviral agents|mesh-ancestor
92231457|NCT01662050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231458|NCT01662050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231459|NCT01662050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231460|NCT01662050|Alkylating Agents|alkylating agents|mesh-ancestor
92231461|NCT04748848|Azacitidine|azacitidine|mesh-list
92231463|NCT04748848|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
92231464|NCT04748848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231465|NCT04748848|Antimetabolites|antimetabolites|mesh-ancestor
92231466|NCT04748848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231467|NCT04748848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231468|NCT04748848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231469|NCT02171195|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92231470|NCT02171195|Anticonvulsants|anticonvulsants|mesh-ancestor
92231471|NCT02171195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92231472|NCT02171195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92231473|NCT02171195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92231474|NCT02171195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231475|NCT01620788|Losartan|losartan|mesh-list
92231476|NCT01620788|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92231477|NCT01620788|Indapamide|indapamide|mesh-list
92231478|NCT01620788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92231479|NCT01620788|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92231480|NCT01620788|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92231481|NCT01620788|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92231482|NCT01620788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231483|NCT01620788|Diuretics|diuretics|mesh-ancestor
92231484|NCT01620788|Natriuretic Agents|natriuretic agents|mesh-ancestor
92231485|NCT01620788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231486|NCT01620788|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92231487|NCT01620788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92231488|NCT03014843|Bromides|bromides|mesh-list
92231489|NCT03014843|Naloxone|naloxone|mesh-list
92231490|NCT03014843|Methylnaltrexone|methylnaltrexone|mesh-list
92231491|NCT03014843|Anticonvulsants|anticonvulsants|mesh-ancestor
92231492|NCT03014843|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92231493|NCT03014843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231494|NCT03014843|Sensory System Agents|sensory system agents|mesh-ancestor
92231495|NCT03014843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231496|NCT05081375|Enoxaparin|enoxaparin|mesh-list
92231497|NCT05081375|Anticoagulants|anticoagulants|mesh-ancestor
92231498|NCT05081375|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92231499|NCT05081375|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92231500|NCT05081375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231501|NCT04755062|Micronutrients|micronutrients|mesh-list
92231502|NCT04755062|Trace Elements|trace elements|mesh-list
92231503|NCT04755062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231504|NCT03852797|Ketamine|ketamine|mesh-list
92231505|NCT03852797|Propofol|propofol|mesh-list
92231506|NCT03852797|Etomidate|etomidate|mesh-list
92231507|NCT03852797|Oxytocin|oxytocin|mesh-list
92231508|NCT03852797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92231509|NCT03852797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231510|NCT03852797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231511|NCT03852797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92231512|NCT03852797|Anesthetics, General|anesthetics, general|mesh-ancestor
92231513|NCT03852797|Anesthetics|anesthetics|mesh-ancestor
92231514|NCT03852797|Analgesics|analgesics|mesh-ancestor
92231515|NCT03852797|Sensory System Agents|sensory system agents|mesh-ancestor
92231516|NCT03852797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231517|NCT03852797|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92231518|NCT03852797|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92231519|NCT03852797|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92231520|NCT03852797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231521|NCT03852797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231522|NCT03852797|Oxytocics|oxytocics|mesh-ancestor
92231523|NCT03852797|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231525|NCT01055171|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92231526|NCT01055171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92231527|NCT01055171|Adrenergic Agents|adrenergic agents|mesh-ancestor
92231528|NCT01055171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231529|NCT01055171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231530|NCT01055171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231531|NCT01055171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92231532|NCT01055171|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92231533|NCT01055171|Vasodilator Agents|vasodilator agents|mesh-ancestor
92231534|NCT01057277|Everolimus|everolimus|mesh-list
92231535|NCT01057277|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92231536|NCT01057277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92231537|NCT01057277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338751|NCT00001061|Ganciclovir|ganciclovir|mesh-list
92231538|NCT01057277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231539|NCT01057277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231540|NCT01057277|Immunologic Factors|immunologic factors|mesh-ancestor
92231541|NCT01057277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231542|NCT01057277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231543|NCT00866840|Riluzole|riluzole|mesh-list
92231544|NCT00866840|Anticonvulsants|anticonvulsants|mesh-ancestor
92231545|NCT00866840|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92231546|NCT00866840|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92231547|NCT00866840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231548|NCT00866840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231549|NCT00866840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231550|NCT00866840|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92231551|NCT00866840|Protective Agents|protective agents|mesh-ancestor
92231552|NCT04349722|Scopolamine|scopolamine|mesh-list
92231553|NCT04349722|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92231554|NCT04349722|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92231555|NCT04349722|Antiemetics|antiemetics|mesh-ancestor
92231556|NCT04349722|Autonomic Agents|autonomic agents|mesh-ancestor
92231557|NCT04349722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231558|NCT04349722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231559|NCT04349722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231560|NCT04349722|Mydriatics|mydriatics|mesh-ancestor
92231561|NCT04349722|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92231562|NCT04349722|Cholinergic Agents|cholinergic agents|mesh-ancestor
92231563|NCT04349722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231564|NCT04349722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231565|NCT04349722|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92231566|NCT04349722|Parasympatholytics|parasympatholytics|mesh-ancestor
92231567|NCT01058993|Plerixafor|plerixafor|mesh-list
92231568|NCT01058993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92231569|NCT01058993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92231570|NCT01058993|Antiviral Agents|antiviral agents|mesh-ancestor
92231571|NCT01058993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231572|NCT04652518|Pirfenidone|pirfenidone|mesh-list
92231573|NCT04652518|Analgesics|analgesics|mesh-ancestor
92231574|NCT04652518|Sensory System Agents|sensory system agents|mesh-ancestor
92231575|NCT04652518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231576|NCT04652518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231577|NCT04652518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92231578|NCT04652518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92231579|NCT04652518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231580|NCT04652518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231581|NCT04652518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231582|NCT01059305|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92231583|NCT01059305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231584|NCT01059305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92231585|NCT01059305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231586|NCT01059305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231587|NCT04650490|Immunomodulating Agents|immunomodulating agents|mesh-list
92231588|NCT04650490|Immunologic Factors|immunologic factors|mesh-ancestor
91934447|NCT02344641|Exenatide|exenatide|mesh-list
92231589|NCT04650490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231590|NCT03850379|Ciprofloxacin|ciprofloxacin|mesh-list
92231591|NCT03850379|Levofloxacin|levofloxacin|mesh-list
92231592|NCT03850379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92231593|NCT03850379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231594|NCT03850379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231595|NCT03850379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231596|NCT03850379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231597|NCT03850379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231598|NCT03850379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231599|NCT03850379|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92231600|NCT03850379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92231601|NCT03850379|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92231602|NCT03014687|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92231603|NCT03014687|Cefdinir|cefdinir|mesh-list
92231604|NCT03014687|Cephalosporins|cephalosporins|mesh-list
92231605|NCT03014687|Trimethoprim|trimethoprim|mesh-list
92231606|NCT03014687|Sulfamethoxazole|sulfamethoxazole|mesh-list
92231607|NCT03014687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231608|NCT03014687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92231609|NCT03014687|Antimalarials|antimalarials|mesh-ancestor
92231610|NCT03014687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92231611|NCT03014687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92231612|NCT03014687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92231613|NCT03014687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231614|NCT03014687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231615|NCT03014687|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92231616|NCT03014687|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92231617|NCT03014687|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92231618|NCT04199572|Acetaminophen|acetaminophen|mesh-list
92231619|NCT04199572|Diclofenac|diclofenac|mesh-list
92231620|NCT04199572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92231621|NCT04199572|Analgesics|analgesics|mesh-ancestor
92231622|NCT04199572|Sensory System Agents|sensory system agents|mesh-ancestor
92231623|NCT04199572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231624|NCT04199572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231625|NCT04199572|Antipyretics|antipyretics|mesh-ancestor
92231626|NCT04199572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92231627|NCT04199572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231628|NCT04199572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231629|NCT04199572|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92231630|NCT04199572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231631|NCT04199572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231632|NCT00383032|Mifepristone|mifepristone|mesh-list
92231633|NCT00383032|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92231634|NCT00383032|Abortifacient Agents|abortifacient agents|mesh-ancestor
92231635|NCT00383032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231636|NCT00383032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231637|NCT00383032|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92231638|NCT00383032|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92231639|NCT00383032|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92231640|NCT00383032|Contraceptive Agents|contraceptive agents|mesh-ancestor
92231641|NCT00383032|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92231642|NCT00383032|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92231643|NCT00383032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92231644|NCT00383032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231645|NCT00383032|Luteolytic Agents|luteolytic agents|mesh-ancestor
92231646|NCT00383032|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92231647|NCT00383032|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92231648|NCT02169479|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92231649|NCT02169479|Opicapone|opicapone|mesh-list
92231650|NCT02169479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92231651|NCT02169479|Immunologic Factors|immunologic factors|mesh-ancestor
92231652|NCT02169479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231653|NCT02169479|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92231654|NCT02169479|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92231655|NCT02169479|Dopamine Agonists|dopamine agonists|mesh-ancestor
92231657|NCT02169479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231658|NCT02169479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231659|NCT02169479|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92231660|NCT02169479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231661|NCT04302454|Leuprolide|leuprolide|mesh-list
92231662|NCT04302454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92231663|NCT04302454|Fertility Agents|fertility agents|mesh-ancestor
92231664|NCT04302454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231665|NCT04302454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231666|NCT04302454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231667|NCT04302454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231668|NCT01059851|Suvorexant|suvorexant|mesh-list
92231669|NCT01059851|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92231670|NCT01059851|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92231671|NCT01059851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231672|NCT01059851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231673|NCT01059851|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92231674|NCT01059851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231675|NCT01059851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231676|NCT02169869|Levonorgestrel|levonorgestrel|mesh-list
92231677|NCT02169869|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92231678|NCT02169869|Contraceptive Agents|contraceptive agents|mesh-ancestor
92231679|NCT02169869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231680|NCT02169869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231681|NCT02169869|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92231682|NCT02169869|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92231683|NCT02169869|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92231684|NCT01059929|Fentanyl|fentanyl|mesh-list
92231685|NCT01059929|Midazolam|midazolam|mesh-list
92231686|NCT01059929|Dexmedetomidine|dexmedetomidine|mesh-list
92231687|NCT01059929|Propofol|propofol|mesh-list
92231688|NCT01059929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92231689|NCT01059929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231690|NCT01059929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231691|NCT01059929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92231692|NCT01059929|Analgesics|analgesics|mesh-ancestor
92231693|NCT01059929|Sensory System Agents|sensory system agents|mesh-ancestor
92231694|NCT01059929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231695|NCT01059929|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92231696|NCT01059929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92231697|NCT01059929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92231698|NCT01059929|Adrenergic Agents|adrenergic agents|mesh-ancestor
92231699|NCT01059929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231700|NCT01059929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231701|NCT01059929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92231702|NCT01059929|Anesthetics, General|anesthetics, general|mesh-ancestor
92231703|NCT01059929|Anesthetics|anesthetics|mesh-ancestor
92231704|NCT01059929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92231705|NCT01059929|Narcotics|narcotics|mesh-ancestor
92231706|NCT01059929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92231707|NCT01059929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92231708|NCT01059929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92231709|NCT01059929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92231710|NCT01059929|GABA Modulators|gaba modulators|mesh-ancestor
92231711|NCT01059929|GABA Agents|gaba agents|mesh-ancestor
92231712|NCT04828031|Vitamin D|vitamin d|mesh-list
92231713|NCT04828031|Vitamins|vitamins|mesh-ancestor
92231714|NCT04828031|Micronutrients|micronutrients|mesh-ancestor
92231715|NCT04828031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231716|NCT04828031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92231717|NCT04162522|Escitalopram|escitalopram|mesh-list
92231718|NCT04162522|Brexpiprazole|brexpiprazole|mesh-list
92231719|NCT04162522|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92231720|NCT04162522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92231721|NCT04162522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92231722|NCT04162522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231723|NCT04162522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231724|NCT04162522|Serotonin Agents|serotonin agents|mesh-ancestor
92231725|NCT04162522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231726|NCT04162522|Dopamine Agonists|dopamine agonists|mesh-ancestor
92231727|NCT04162522|Dopamine Agents|dopamine agents|mesh-ancestor
92231728|NCT04896658|Dexamethasone|dexamethasone|mesh-list
92231729|NCT04896658|Cyclophosphamide|cyclophosphamide|mesh-list
92231730|NCT04896658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231731|NCT04896658|Immunologic Factors|immunologic factors|mesh-ancestor
92231732|NCT04896658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231733|NCT04896658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231734|NCT04896658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231735|NCT04896658|Alkylating Agents|alkylating agents|mesh-ancestor
92231736|NCT04896658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231737|NCT04896658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231738|NCT04896658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92231739|NCT04896658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231740|NCT04896658|Antiemetics|antiemetics|mesh-ancestor
92231741|NCT04896658|Autonomic Agents|autonomic agents|mesh-ancestor
92231742|NCT04896658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231743|NCT04896658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231744|NCT04896658|Glucocorticoids|glucocorticoids|mesh-ancestor
92231745|NCT04896658|Hormones|hormones|mesh-ancestor
92231746|NCT04896658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231747|NCT04896658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231748|NCT01062269|Cholestyramine Resin|cholestyramine resin|mesh-list
92231749|NCT01062269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92231750|NCT01062269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92231751|NCT01062269|Antimetabolites|antimetabolites|mesh-ancestor
92231752|NCT01062269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231753|NCT01062269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92231754|NCT04156828|Dexamethasone|dexamethasone|mesh-list
92231755|NCT04156828|Dexamethasone acetate|dexamethasone acetate|mesh-list
92231756|NCT04156828|Rituximab|rituximab|mesh-list
92231757|NCT04156828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92231758|NCT04156828|Carboplatin|carboplatin|mesh-list
92231759|NCT04156828|Gemcitabine|gemcitabine|mesh-list
92231760|NCT04156828|Antibodies|antibodies|mesh-list
92231761|NCT04156828|Immunoglobulins|immunoglobulins|mesh-list
92231762|NCT04156828|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92231763|NCT04156828|Lenograstim|lenograstim|mesh-list
92231764|NCT04156828|BB 1101|bb 1101|mesh-list
92231765|NCT04156828|Immunologic Factors|immunologic factors|mesh-ancestor
92231766|NCT04156828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231767|NCT04156828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231768|NCT04156828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231769|NCT04156828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231770|NCT04156828|Antiemetics|antiemetics|mesh-ancestor
92231771|NCT04156828|Autonomic Agents|autonomic agents|mesh-ancestor
92231772|NCT04156828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231773|NCT04156828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231774|NCT04156828|Glucocorticoids|glucocorticoids|mesh-ancestor
92231775|NCT04156828|Hormones|hormones|mesh-ancestor
92231776|NCT04156828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231777|NCT04156828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231778|NCT04156828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231779|NCT04156828|Antimetabolites|antimetabolites|mesh-ancestor
92231780|NCT04156828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231781|NCT04156828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92231782|NCT04156828|Protease Inhibitors|protease inhibitors|mesh-ancestor
92231783|NCT04156828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231784|NCT01063049|Bisacodyl|bisacodyl|mesh-list
92231785|NCT01063049|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92231786|NCT01063049|Cathartics|cathartics|mesh-ancestor
92231787|NCT01063049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231788|NCT01063049|Laxatives|laxatives|mesh-ancestor
92231789|NCT04883242|Dexamethasone|dexamethasone|mesh-list
92231790|NCT04883242|Dexamethasone acetate|dexamethasone acetate|mesh-list
92231791|NCT04883242|Pomalidomide|pomalidomide|mesh-list
92231792|NCT04883242|Ichthammol|ichthammol|mesh-list
92231793|NCT04883242|BB 1101|bb 1101|mesh-list
92231794|NCT04883242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91923533|NCT02229955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231795|NCT04883242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231796|NCT04883242|Antiemetics|antiemetics|mesh-ancestor
92231797|NCT04883242|Autonomic Agents|autonomic agents|mesh-ancestor
92338793|NCT00001079|Androgens|androgens|mesh-ancestor
92231798|NCT04883242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231799|NCT04883242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231800|NCT04883242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231801|NCT04883242|Glucocorticoids|glucocorticoids|mesh-ancestor
92231802|NCT04883242|Hormones|hormones|mesh-ancestor
92231803|NCT04883242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231804|NCT04883242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231805|NCT04883242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231806|NCT04883242|Protease Inhibitors|protease inhibitors|mesh-ancestor
92231807|NCT04883242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231808|NCT04883242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231809|NCT04883242|Immunologic Factors|immunologic factors|mesh-ancestor
92231810|NCT04883242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92231811|NCT04883242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92231812|NCT04883242|Growth Substances|growth substances|mesh-ancestor
92231813|NCT04883242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92231814|NCT04883242|Dermatologic Agents|dermatologic agents|mesh-ancestor
92231815|NCT04104178|Clindamycin|clindamycin|mesh-list
92231816|NCT04104178|Clindamycin palmitate|clindamycin palmitate|mesh-list
92231817|NCT04104178|Clindamycin phosphate|clindamycin phosphate|mesh-list
92231818|NCT04104178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92231819|NCT04104178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231820|NCT04104178|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92231821|NCT04104178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231822|NCT04104178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231823|NCT03661138|Upadacitinib|upadacitinib|mesh-list
92231824|NCT03661138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92231825|NCT03661138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92231826|NCT03661138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231827|NCT03661138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231828|NCT03661138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231829|NCT04588792|Furosemide|furosemide|mesh-list
92231830|NCT04588792|Diuretics|diuretics|mesh-ancestor
92231831|NCT04588792|Natriuretic Agents|natriuretic agents|mesh-ancestor
92231832|NCT04588792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231833|NCT04588792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92231834|NCT04588792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92231835|NCT04588792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231836|NCT04081792|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92231837|NCT04081792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231838|NCT04075396|Lazertinib|lazertinib|mesh-list
92231839|NCT04075396|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92231840|NCT04075396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231841|NCT04075396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231842|NCT04038970|Methotrexate|methotrexate|mesh-list
92231843|NCT04038970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92231844|NCT04038970|Abortifacient Agents|abortifacient agents|mesh-ancestor
92231845|NCT04038970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92231846|NCT04038970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231847|NCT04038970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92231848|NCT04038970|Antimetabolites|antimetabolites|mesh-ancestor
92231849|NCT04038970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231850|NCT04038970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231851|NCT04038970|Dermatologic Agents|dermatologic agents|mesh-ancestor
92231852|NCT04038970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231853|NCT04038970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92231854|NCT04038970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231855|NCT04038970|Immunologic Factors|immunologic factors|mesh-ancestor
92231856|NCT04038970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231857|NCT04038970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92231858|NCT02181738|Doxorubicin|doxorubicin|mesh-list
92231859|NCT02181738|Nivolumab|nivolumab|mesh-list
92231860|NCT02181738|Dacarbazine|dacarbazine|mesh-list
92231861|NCT02181738|Vinblastine|vinblastine|mesh-list
92231862|NCT02181738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231863|NCT02181738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231864|NCT02181738|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231865|NCT02181738|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231866|NCT02181738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941117|NCT05647330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231867|NCT02181738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231868|NCT02181738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231869|NCT02181738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92231870|NCT02181738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231871|NCT02181738|Alkylating Agents|alkylating agents|mesh-ancestor
92231872|NCT02181738|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92231873|NCT02181738|Tubulin Modulators|tubulin modulators|mesh-ancestor
92231874|NCT02181738|Antimitotic Agents|antimitotic agents|mesh-ancestor
92231875|NCT02181738|Mitosis Modulators|mitosis modulators|mesh-ancestor
92231877|NCT05426304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92231878|NCT05426304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231879|NCT05426304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231880|NCT03955198|Durvalumab|durvalumab|mesh-list
92231881|NCT03955198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92231882|NCT03955198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231883|NCT04494958|Palbociclib|palbociclib|mesh-list
92231884|NCT04494958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231885|NCT04494958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92231886|NCT04494958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231887|NCT04494958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231888|NCT00382954|Bortezomib|bortezomib|mesh-list
92231889|NCT00382954|Idarubicin|idarubicin|mesh-list
92231890|NCT00382954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231891|NCT00382954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231892|NCT00382954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231893|NCT00382954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231894|NCT00382954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231895|NCT00382954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231896|NCT01246063|Dexamethasone|dexamethasone|mesh-list
92231897|NCT01246063|Doxorubicin|doxorubicin|mesh-list
92231898|NCT01246063|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92231899|NCT01246063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231900|NCT01246063|Antiemetics|antiemetics|mesh-ancestor
92231901|NCT01246063|Autonomic Agents|autonomic agents|mesh-ancestor
92231902|NCT01246063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231903|NCT01246063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231904|NCT01246063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231905|NCT01246063|Glucocorticoids|glucocorticoids|mesh-ancestor
92231906|NCT01246063|Hormones|hormones|mesh-ancestor
92231907|NCT01246063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231908|NCT01246063|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231909|NCT01246063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231910|NCT01246063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231911|NCT01246063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231912|NCT01246063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231913|NCT01246063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231914|NCT01246063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231915|NCT03836014|Dexamethasone|dexamethasone|mesh-list
92231916|NCT03836014|Dexamethasone acetate|dexamethasone acetate|mesh-list
92231917|NCT03836014|Lenalidomide|lenalidomide|mesh-list
92231918|NCT03836014|Daratumumab|daratumumab|mesh-list
92231919|NCT03836014|BB 1101|bb 1101|mesh-list
92231920|NCT03836014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92231921|NCT03836014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231922|NCT03836014|Antiemetics|antiemetics|mesh-ancestor
92231923|NCT03836014|Autonomic Agents|autonomic agents|mesh-ancestor
92231924|NCT03836014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231925|NCT03836014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231926|NCT03836014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92231928|NCT03836014|Hormones|hormones|mesh-ancestor
92231929|NCT03836014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92231930|NCT03836014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92231931|NCT03836014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231932|NCT03836014|Protease Inhibitors|protease inhibitors|mesh-ancestor
92231933|NCT03836014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231934|NCT03836014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231935|NCT03836014|Immunologic Factors|immunologic factors|mesh-ancestor
92231936|NCT03836014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92231937|NCT03836014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92231938|NCT03836014|Growth Substances|growth substances|mesh-ancestor
92231939|NCT03836014|Growth Inhibitors|growth inhibitors|mesh-ancestor
92231940|NCT01205503|Cyclophosphamide|cyclophosphamide|mesh-list
92231941|NCT01205503|Doxorubicin|doxorubicin|mesh-list
92231942|NCT01205503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92231943|NCT01205503|Immunologic Factors|immunologic factors|mesh-ancestor
92231944|NCT01205503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231945|NCT01205503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231946|NCT01205503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92231947|NCT01205503|Alkylating Agents|alkylating agents|mesh-ancestor
92231948|NCT01205503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231949|NCT01205503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92231950|NCT01205503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92231951|NCT01205503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92231952|NCT01205503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92231953|NCT01205503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92231954|NCT01205503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231955|NCT03187834|Amoxicillin|amoxicillin|mesh-list
92231956|NCT03187834|Azithromycin|azithromycin|mesh-list
92231957|NCT03187834|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92231958|NCT03187834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92231959|NCT03187834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92231960|NCT03187834|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92231961|NCT03187834|Antimalarials|antimalarials|mesh-ancestor
92231962|NCT03187834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92231963|NCT03187834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92231964|NCT01206595|Bupivacaine|bupivacaine|mesh-list
92231965|NCT01206595|Anesthetics, Local|anesthetics, local|mesh-ancestor
92231966|NCT01206595|Anesthetics|anesthetics|mesh-ancestor
92231967|NCT01206595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92231968|NCT01206595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231969|NCT01206595|Sensory System Agents|sensory system agents|mesh-ancestor
92231970|NCT01206595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231971|NCT04385992|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92231972|NCT04385992|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92231973|NCT04385992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231975|NCT01158703|Clopidogrel|clopidogrel|mesh-list
92231976|NCT01158703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92231977|NCT01158703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92231978|NCT01158703|Analgesics|analgesics|mesh-ancestor
92231979|NCT01158703|Sensory System Agents|sensory system agents|mesh-ancestor
92231980|NCT01158703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92231981|NCT01158703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92231982|NCT01158703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92231983|NCT01158703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92231984|NCT01158703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92231985|NCT01158703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92231986|NCT01158703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92231987|NCT01158703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92231988|NCT01158703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92231989|NCT01158703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92231990|NCT01158703|Antipyretics|antipyretics|mesh-ancestor
92231991|NCT01158703|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92231992|NCT01158703|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92231993|NCT01158703|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92231994|NCT01158703|Purinergic Agents|purinergic agents|mesh-ancestor
92231995|NCT01158703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92231996|NCT03009643|Nitric Oxide|nitric oxide|mesh-list
92231997|NCT03009643|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92231998|NCT03009643|Autonomic Agents|autonomic agents|mesh-ancestor
92231999|NCT03009643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232000|NCT03009643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232001|NCT03009643|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92232002|NCT03009643|Respiratory System Agents|respiratory system agents|mesh-ancestor
92232003|NCT03009643|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92232004|NCT03009643|Antioxidants|antioxidants|mesh-ancestor
92232005|NCT03009643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232006|NCT03009643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232007|NCT03009643|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92232008|NCT03009643|Vasodilator Agents|vasodilator agents|mesh-ancestor
92232009|NCT03009643|Gasotransmitters|gasotransmitters|mesh-ancestor
92232010|NCT03009643|Protective Agents|protective agents|mesh-ancestor
92232011|NCT04275232|Plasminogen|plasminogen|mesh-list
92232012|NCT04275232|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92232013|NCT04275232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92232014|NCT04275232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232015|NCT01207765|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92232016|NCT01207765|Immunologic Factors|immunologic factors|mesh-ancestor
91941119|NCT05647330|Amebicides|amebicides|mesh-ancestor
92232017|NCT01207765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232018|NCT03786796|Olaparib|olaparib|mesh-list
92232019|NCT03786796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92232020|NCT03786796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232021|NCT03786796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232022|NCT03786796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232023|NCT03779854|Vidarabine|vidarabine|mesh-list
92232024|NCT03779854|Cyclophosphamide|cyclophosphamide|mesh-list
92232025|NCT03779854|Busulfan|busulfan|mesh-list
92232026|NCT03779854|Thiotepa|thiotepa|mesh-list
92232027|NCT03779854|Methotrexate|methotrexate|mesh-list
92232028|NCT03779854|Fludarabine|fludarabine|mesh-list
92232029|NCT03779854|Fludarabine phosphate|fludarabine phosphate|mesh-list
92232030|NCT03779854|Tacrolimus|tacrolimus|mesh-list
92232031|NCT03779854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232032|NCT03779854|Immunologic Factors|immunologic factors|mesh-ancestor
92232033|NCT03779854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232034|NCT03779854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232035|NCT03779854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232036|NCT03779854|Alkylating Agents|alkylating agents|mesh-ancestor
92232037|NCT03779854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232038|NCT03779854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232039|NCT03779854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92232040|NCT03779854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92232041|NCT03779854|Abortifacient Agents|abortifacient agents|mesh-ancestor
92232042|NCT03779854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232043|NCT03779854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232044|NCT03779854|Antimetabolites|antimetabolites|mesh-ancestor
92232045|NCT03779854|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232046|NCT03779854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232047|NCT03779854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92232048|NCT03779854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232049|NCT03779854|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92232050|NCT03779854|Antiviral Agents|antiviral agents|mesh-ancestor
92232051|NCT03779854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232053|NCT03089866|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92232054|NCT03089866|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92232055|NCT03089866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232056|NCT03089866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232057|NCT03089866|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92232058|NCT03089866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92232059|NCT03089866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92232060|NCT03089866|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92232061|NCT03089866|Anesthetics, General|anesthetics, general|mesh-ancestor
92232062|NCT03089866|Anesthetics|anesthetics|mesh-ancestor
92232064|NCT03089866|GABA Agents|gaba agents|mesh-ancestor
92232065|NCT03089866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232066|NCT03089866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232067|NCT00002890|Lintuzumab|lintuzumab|mesh-list
92232068|NCT00002890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92232069|NCT00002890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232070|NCT00002896|Leucovorin|leucovorin|mesh-list
92232072|NCT00002896|Fluorouracil|fluorouracil|mesh-list
92232073|NCT00002896|Calcium|calcium|mesh-list
92232074|NCT00002896|Levoleucovorin|levoleucovorin|mesh-list
92232075|NCT00002896|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92232076|NCT00002896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232078|NCT00002896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232079|NCT00002896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232080|NCT00002896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232081|NCT00002896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232082|NCT00002896|Immunologic Factors|immunologic factors|mesh-ancestor
92232083|NCT00002896|Antidotes|antidotes|mesh-ancestor
92232084|NCT00002896|Protective Agents|protective agents|mesh-ancestor
92232085|NCT00002896|Vitamin B Complex|vitamin b complex|mesh-ancestor
92232086|NCT00002896|Vitamins|vitamins|mesh-ancestor
92232087|NCT00002896|Micronutrients|micronutrients|mesh-ancestor
92232088|NCT00002896|Trace Elements|trace elements|mesh-ancestor
92232089|NCT01249027|Everolimus|everolimus|mesh-list
92232090|NCT01249027|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92232091|NCT01249027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92232092|NCT01249027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232093|NCT01249027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232094|NCT01249027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232095|NCT01249027|Immunologic Factors|immunologic factors|mesh-ancestor
92232096|NCT01249027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232097|NCT01249027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232098|NCT00002902|Irinotecan|irinotecan|mesh-list
92232099|NCT00002902|Raltitrexed|raltitrexed|mesh-list
92232100|NCT00002902|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92232101|NCT00002902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232102|NCT00002902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232103|NCT00002902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232104|NCT00002902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232105|NCT00002902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232106|NCT00002902|Antimetabolites|antimetabolites|mesh-ancestor
92232107|NCT00002902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92232108|NCT02992756|Mitogens|mitogens|mesh-list
92232109|NCT02992756|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232110|NCT02992756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232111|NCT01250899|Vitamin D|vitamin d|mesh-list
92232112|NCT01250899|Vitamins|vitamins|mesh-ancestor
92232113|NCT01250899|Micronutrients|micronutrients|mesh-ancestor
92232114|NCT01250899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232115|NCT01250899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92232116|NCT01212445|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92232117|NCT01212445|Laxatives|laxatives|mesh-list
92232118|NCT01212445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92232119|NCT00002908|Vincristine|vincristine|mesh-list
92232120|NCT00002908|Bryostatin 1|bryostatin 1|mesh-list
92232121|NCT00002908|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232122|NCT00002908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232123|NCT00002908|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232124|NCT00002908|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232125|NCT00002908|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232126|NCT00002908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232127|NCT00002908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92232128|NCT00002908|Immunologic Factors|immunologic factors|mesh-ancestor
92232129|NCT00002908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232130|NCT00002920|Tamoxifen|tamoxifen|mesh-list
92232131|NCT00002920|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92232132|NCT00002920|Medroxyprogesterone|medroxyprogesterone|mesh-list
92232133|NCT00002920|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92232134|NCT00002920|Hormone Antagonists|hormone antagonists|mesh-ancestor
92232135|NCT00002920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232136|NCT00002920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232137|NCT00002920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232138|NCT00002920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232139|NCT00002920|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92232140|NCT00002920|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92232141|NCT00002920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92338825|NCT00001091|Nevirapine|nevirapine|mesh-list
92232142|NCT00002920|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92232143|NCT00002920|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92232144|NCT00002920|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92232145|NCT00002920|Contraceptive Agents|contraceptive agents|mesh-ancestor
92232146|NCT00002920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232147|NCT00002920|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92232148|NCT00002920|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92232149|NCT00002920|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92232150|NCT01250977|Donepezil|donepezil|mesh-list
92232151|NCT01250977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92232152|NCT01250977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232153|NCT01250977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232154|NCT01250977|Cholinergic Agents|cholinergic agents|mesh-ancestor
92232155|NCT01250977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232156|NCT01250977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232157|NCT01250977|Nootropic Agents|nootropic agents|mesh-ancestor
92232158|NCT01161121|Adenosine|adenosine|mesh-list
92232159|NCT01161121|Regadenoson|regadenoson|mesh-list
92232160|NCT01161121|Analgesics|analgesics|mesh-ancestor
92232161|NCT01161121|Sensory System Agents|sensory system agents|mesh-ancestor
92232162|NCT01161121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232163|NCT01161121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232164|NCT01161121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92232165|NCT01161121|Vasodilator Agents|vasodilator agents|mesh-ancestor
92232166|NCT01161121|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92232167|NCT01161121|Purinergic Agonists|purinergic agonists|mesh-ancestor
92232168|NCT01161121|Purinergic Agents|purinergic agents|mesh-ancestor
92232169|NCT01161121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232170|NCT01161121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232171|NCT01161121|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92232172|NCT03010579|Epoetin Alfa|epoetin alfa|mesh-list
92232173|NCT03010579|Ferrous succinate|ferrous succinate|mesh-list
92232174|NCT03010579|Hematinics|hematinics|mesh-list
92232175|NCT01214083|Acetylcysteine|acetylcysteine|mesh-list
92232176|NCT01214083|Naltrexone|naltrexone|mesh-list
92232177|NCT01214083|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92232178|NCT01214083|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92232179|NCT01214083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92232180|NCT01214083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232181|NCT01214083|Sensory System Agents|sensory system agents|mesh-ancestor
92232182|NCT01214083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232183|NCT01214083|Antiviral Agents|antiviral agents|mesh-ancestor
92232184|NCT01214083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232185|NCT01214083|Expectorants|expectorants|mesh-ancestor
92232186|NCT01214083|Respiratory System Agents|respiratory system agents|mesh-ancestor
92232187|NCT01214083|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92232188|NCT01214083|Antioxidants|antioxidants|mesh-ancestor
92232189|NCT01214083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232190|NCT01214083|Protective Agents|protective agents|mesh-ancestor
92232191|NCT01214083|Antidotes|antidotes|mesh-ancestor
92232192|NCT01254877|Ondansetron|ondansetron|mesh-list
92232193|NCT01254877|Antiemetics|antiemetics|mesh-ancestor
92232194|NCT01254877|Autonomic Agents|autonomic agents|mesh-ancestor
92232195|NCT01254877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232196|NCT01254877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232198|NCT01254877|Antipruritics|antipruritics|mesh-ancestor
92232199|NCT01254877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232200|NCT01254877|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92232201|NCT01254877|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92232202|NCT01254877|Serotonin Agents|serotonin agents|mesh-ancestor
92232203|NCT01254877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232204|NCT01254877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232205|NCT02189317|Bupivacaine|bupivacaine|mesh-list
92232206|NCT02189317|Anesthetics, Local|anesthetics, local|mesh-ancestor
92232207|NCT02189317|Anesthetics|anesthetics|mesh-ancestor
92232208|NCT02189317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232209|NCT02189317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232210|NCT02189317|Sensory System Agents|sensory system agents|mesh-ancestor
92232211|NCT02189317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232212|NCT03713944|Bevacizumab|bevacizumab|mesh-list
92232213|NCT03713944|Atezolizumab|atezolizumab|mesh-list
92232214|NCT03713944|Carboplatin|carboplatin|mesh-list
92232215|NCT03713944|Pemetrexed|pemetrexed|mesh-list
92232216|NCT03713944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92232217|NCT03713944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232218|NCT03713944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92232219|NCT03713944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92232220|NCT03713944|Growth Substances|growth substances|mesh-ancestor
92232221|NCT03713944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232222|NCT03713944|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232223|NCT03713944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232224|NCT03713944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232225|NCT03713944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92232226|NCT03713944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232227|NCT03713944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92232228|NCT01214161|Lidocaine|lidocaine|mesh-list
92232229|NCT01214161|Anesthetics, Local|anesthetics, local|mesh-ancestor
92232230|NCT01214161|Anesthetics|anesthetics|mesh-ancestor
92232231|NCT01214161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232232|NCT01214161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232233|NCT01214161|Sensory System Agents|sensory system agents|mesh-ancestor
92232234|NCT01214161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232235|NCT01214161|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92232236|NCT01214161|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92232237|NCT01214161|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92232238|NCT01214161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92232239|NCT01214161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232240|NCT02945800|Paclitaxel|paclitaxel|mesh-list
92232241|NCT02945800|Gemcitabine|gemcitabine|mesh-list
92232242|NCT02945800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232243|NCT02945800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232244|NCT02945800|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232245|NCT02945800|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232246|NCT02945800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232247|NCT02945800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232248|NCT02945800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232249|NCT02945800|Antimetabolites|antimetabolites|mesh-ancestor
92232250|NCT02981329|Metformin|metformin|mesh-list
92232251|NCT02981329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92232252|NCT02981329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232253|NCT00383656|Hormones|hormones|mesh-list
92232254|NCT00383656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232255|NCT00383656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232256|NCT01214317|Mitoxantrone|mitoxantrone|mesh-list
92232257|NCT01214317|Analgesics|analgesics|mesh-ancestor
92232258|NCT01214317|Sensory System Agents|sensory system agents|mesh-ancestor
92232259|NCT01214317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232260|NCT01214317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232261|NCT01214317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232262|NCT01214317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232263|NCT01214317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232264|NCT01214317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232265|NCT01214317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232266|NCT00383812|Bevacizumab|bevacizumab|mesh-list
92232267|NCT00383812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92232268|NCT00383812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232269|NCT00383812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92232270|NCT00383812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92232271|NCT00383812|Growth Substances|growth substances|mesh-ancestor
92232272|NCT00383812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232273|NCT00383812|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232274|NCT02189629|Trifarotene|trifarotene|mesh-list
92232275|NCT02189629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232276|NCT00002926|Cytarabine|cytarabine|mesh-list
92232277|NCT00002926|Etoposide|etoposide|mesh-list
92232278|NCT00002926|Idarubicin|idarubicin|mesh-list
92232279|NCT00002926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232280|NCT00002926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232281|NCT00002926|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232282|NCT00002926|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232283|NCT00002926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232284|NCT00002926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232285|NCT00002926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232287|NCT00002926|Antiviral Agents|antiviral agents|mesh-ancestor
92232288|NCT00002926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232289|NCT00002926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232290|NCT00002926|Immunologic Factors|immunologic factors|mesh-ancestor
92232291|NCT00002926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232292|NCT00002926|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92232294|NCT01281007|Famciclovir|famciclovir|mesh-list
92232295|NCT01281007|Antiviral Agents|antiviral agents|mesh-ancestor
92232296|NCT01281007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232297|NCT01281007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232298|NCT01281007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232299|NCT01281007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232300|NCT02898610|Colchicine|colchicine|mesh-list
92232301|NCT02898610|Gout Suppressants|gout suppressants|mesh-ancestor
92232302|NCT02898610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232303|NCT02898610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232304|NCT02898610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232305|NCT02898610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232306|NCT02898610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232307|NCT02898610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232308|NCT01281475|Levodopa|levodopa|mesh-list
92232309|NCT01281475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92232310|NCT01281475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92232311|NCT01281475|Dopamine Agents|dopamine agents|mesh-ancestor
92232312|NCT01281475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232313|NCT01281475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232314|NCT01281475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232315|NCT00002932|Cisplatin|cisplatin|mesh-list
92232316|NCT00002932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232317|NCT01572662|Methotrexate|methotrexate|mesh-list
92232318|NCT01572662|Fludarabine phosphate|fludarabine phosphate|mesh-list
92232319|NCT01572662|Fludarabine|fludarabine|mesh-list
92232320|NCT01572662|Busulfan|busulfan|mesh-list
92232321|NCT01572662|Tacrolimus|tacrolimus|mesh-list
92232322|NCT01572662|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92232323|NCT01572662|Abortifacient Agents|abortifacient agents|mesh-ancestor
92232324|NCT01572662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232325|NCT01572662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232326|NCT01572662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232328|NCT01572662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232329|NCT01572662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232330|NCT01572662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232331|NCT01572662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232332|NCT01572662|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92232333|NCT01572662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232334|NCT01572662|Immunologic Factors|immunologic factors|mesh-ancestor
92232335|NCT01572662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232336|NCT01572662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232337|NCT01572662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92232338|NCT01572662|Alkylating Agents|alkylating agents|mesh-ancestor
92232339|NCT01572662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232340|NCT01572662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92232341|NCT02822092|Risperidone|risperidone|mesh-list
92232342|NCT02822092|Aripiprazole|aripiprazole|mesh-list
92232343|NCT02822092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92232344|NCT02822092|Serotonin Agents|serotonin agents|mesh-ancestor
92232345|NCT02822092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232346|NCT02822092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232347|NCT02822092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232348|NCT02822092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92232349|NCT02822092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92232350|NCT02822092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232351|NCT02822092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92232352|NCT02822092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92232353|NCT02822092|Dopamine Agents|dopamine agents|mesh-ancestor
92232354|NCT02822092|Antidepressive Agents|antidepressive agents|mesh-ancestor
92232355|NCT02822092|Dopamine Agonists|dopamine agonists|mesh-ancestor
92232356|NCT02822092|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92232357|NCT02822092|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92232358|NCT02822092|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92232359|NCT02822092|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92232360|NCT01258153|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92232362|NCT01258153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92232363|NCT01258153|Autonomic Agents|autonomic agents|mesh-ancestor
92232364|NCT01258153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232365|NCT01258153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232366|NCT01258153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92232367|NCT01258153|Respiratory System Agents|respiratory system agents|mesh-ancestor
92232369|NCT01555268|Trebananib|trebananib|mesh-list
92232370|NCT01555268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232372|NCT01555268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232373|NCT01555268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232374|NCT01555268|Antiviral Agents|antiviral agents|mesh-ancestor
92232375|NCT01555268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232376|NCT01555268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232377|NCT01555268|Immunologic Factors|immunologic factors|mesh-ancestor
92232378|NCT01555268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232379|NCT01555268|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92232380|NCT01555268|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92232381|NCT01555268|Growth Substances|growth substances|mesh-ancestor
92232382|NCT01555268|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232383|NCT00840944|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92232384|NCT00840944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232385|NCT00840944|Luteolytic Agents|luteolytic agents|mesh-ancestor
92232386|NCT00840944|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92232387|NCT00840944|Contraceptive Agents|contraceptive agents|mesh-ancestor
92232388|NCT00840944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232389|NCT00840944|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92232390|NCT00840944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232391|NCT00840944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232392|NCT04781270|Bevacizumab|bevacizumab|mesh-list
92232393|NCT04781270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92232394|NCT04781270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232395|NCT04781270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92232396|NCT04781270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92232397|NCT04781270|Growth Substances|growth substances|mesh-ancestor
92232398|NCT04781270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232399|NCT04781270|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232400|NCT00003394|Paclitaxel|paclitaxel|mesh-list
92232401|NCT00003394|Carboplatin|carboplatin|mesh-list
92232402|NCT00003394|Leuprolide|leuprolide|mesh-list
92232403|NCT00003394|Goserelin|goserelin|mesh-list
92232404|NCT00003394|Estramustine|estramustine|mesh-list
92232405|NCT00003394|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232406|NCT00003394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232407|NCT00003394|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232408|NCT00003394|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232409|NCT00003394|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232410|NCT00003394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232411|NCT00003394|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92232412|NCT00003394|Fertility Agents|fertility agents|mesh-ancestor
92232413|NCT00003394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232414|NCT00003394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232415|NCT00003394|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232416|NCT00003394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232417|NCT00003394|Alkylating Agents|alkylating agents|mesh-ancestor
92232418|NCT00003400|Melphalan|melphalan|mesh-list
92232419|NCT00003400|Vinorelbine|vinorelbine|mesh-list
92232420|NCT00003400|Carmustine|carmustine|mesh-list
92232421|NCT00003400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232422|NCT00003400|Immunologic Factors|immunologic factors|mesh-ancestor
92232423|NCT00003400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232424|NCT00003400|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232425|NCT00003400|Alkylating Agents|alkylating agents|mesh-ancestor
92232426|NCT00003400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232427|NCT00003400|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92232428|NCT00003400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232429|NCT00003400|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232430|NCT00003400|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232431|NCT00003400|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232432|NCT00003400|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232433|NCT04348370|Vaccines|vaccines|mesh-list
92232434|NCT04348370|BCG Vaccine|bcg vaccine|mesh-list
92232435|NCT04348370|Immunologic Factors|immunologic factors|mesh-ancestor
92232436|NCT04348370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232437|NCT04348370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92232438|NCT00002944|Carboplatin|carboplatin|mesh-list
92232439|NCT00002944|Vincristine|vincristine|mesh-list
92232440|NCT00002944|Thioguanine|thioguanine|mesh-list
92232441|NCT00002944|Lomustine|lomustine|mesh-list
92232442|NCT00002944|Procarbazine|procarbazine|mesh-list
92232443|NCT00002944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232444|NCT00002944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232445|NCT00002944|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232446|NCT00002944|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232447|NCT00002944|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232448|NCT00002944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232449|NCT00002944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232450|NCT00002944|Antimetabolites|antimetabolites|mesh-ancestor
92232451|NCT00002944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232452|NCT00002944|Alkylating Agents|alkylating agents|mesh-ancestor
92232453|NCT04778072|Iron|iron|mesh-list
92232454|NCT04778072|Trace Elements|trace elements|mesh-ancestor
92232455|NCT04778072|Micronutrients|micronutrients|mesh-ancestor
92232456|NCT04778072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232457|NCT00002950|Topotecan|topotecan|mesh-list
92232458|NCT00002950|Sargramostim|sargramostim|mesh-list
92232459|NCT00002950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92232460|NCT00002950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232461|NCT00002950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232462|NCT00002950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232463|NCT00002950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232464|NCT00002950|Immunologic Factors|immunologic factors|mesh-ancestor
92232465|NCT00002950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232466|NCT00777140|Deferoxamine|deferoxamine|mesh-list
92232467|NCT00777140|Siderophores|siderophores|mesh-ancestor
92232468|NCT00777140|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92232469|NCT00777140|Chelating Agents|chelating agents|mesh-ancestor
92232470|NCT00777140|Sequestering Agents|sequestering agents|mesh-ancestor
92232471|NCT00777140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232472|NCT00003406|Carboplatin|carboplatin|mesh-list
92232473|NCT00003406|Docetaxel|docetaxel|mesh-list
92232474|NCT00003406|Ifosfamide|ifosfamide|mesh-list
92232475|NCT00003406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232476|NCT00003406|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232477|NCT00003406|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232478|NCT00003406|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232479|NCT00003406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232480|NCT00003406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232481|NCT00003406|Alkylating Agents|alkylating agents|mesh-ancestor
92232482|NCT00003412|Interleukin-12|interleukin-12|mesh-list
92232483|NCT00003412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92232484|NCT00003412|Immunologic Factors|immunologic factors|mesh-ancestor
92232485|NCT00003412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232486|NCT00003412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92232487|NCT00003412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92232488|NCT00003412|Growth Substances|growth substances|mesh-ancestor
92232489|NCT00003412|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232490|NCT00003412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232491|NCT04780958|Vitamin A|vitamin a|mesh-list
92232492|NCT04780958|Vitamins|vitamins|mesh-ancestor
92232493|NCT04780958|Micronutrients|micronutrients|mesh-ancestor
92232494|NCT04780958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232495|NCT00002968|Edrecolomab|edrecolomab|mesh-list
92232496|NCT00002968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92232497|NCT00002968|Immunologic Factors|immunologic factors|mesh-ancestor
92232498|NCT00002968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232499|NCT04780412|Alprostadil|alprostadil|mesh-list
92232500|NCT04780412|Misoprostol|misoprostol|mesh-list
92232501|NCT04780412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92232502|NCT04780412|Abortifacient Agents|abortifacient agents|mesh-ancestor
92232503|NCT04780412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232504|NCT04780412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232505|NCT04780412|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92232506|NCT04780412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92232508|NCT04780412|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92232509|NCT04780412|Vasodilator Agents|vasodilator agents|mesh-ancestor
92232510|NCT04780412|Urological Agents|urological agents|mesh-ancestor
92232511|NCT00002974|Carboplatin|carboplatin|mesh-list
92232512|NCT00002974|Etoposide|etoposide|mesh-list
92232513|NCT00002974|Ifosfamide|ifosfamide|mesh-list
92232514|NCT00002974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232515|NCT00002974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232516|NCT00002974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232517|NCT00002974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232518|NCT00002974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232519|NCT00002974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232520|NCT00002974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232521|NCT00002974|Alkylating Agents|alkylating agents|mesh-ancestor
92232522|NCT00754364|Carboplatin|carboplatin|mesh-list
92232523|NCT00754364|Gemcitabine|gemcitabine|mesh-list
92232524|NCT00754364|Pemetrexed|pemetrexed|mesh-list
92232525|NCT00754364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232526|NCT00754364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232527|NCT00754364|Antimetabolites|antimetabolites|mesh-ancestor
92232528|NCT00754364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232529|NCT00754364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232530|NCT00754364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92232531|NCT00754364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232532|NCT02612896|Praziquantel|praziquantel|mesh-list
92232533|NCT02612896|Anthelmintics|anthelmintics|mesh-ancestor
92232534|NCT02612896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92232535|NCT02612896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232536|NCT00002980|Decitabine|decitabine|mesh-list
92232537|NCT00002980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232538|NCT00002980|Antimetabolites|antimetabolites|mesh-ancestor
92232539|NCT00002980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232540|NCT00002980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232541|NCT00002980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232542|NCT00002986|Topotecan|topotecan|mesh-list
92232543|NCT00002986|Carmustine|carmustine|mesh-list
92232544|NCT00002986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92232545|NCT00002986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232546|NCT00002986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232547|NCT00002986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232548|NCT00002986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232549|NCT00002986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232551|NCT00003418|Tamoxifen|tamoxifen|mesh-list
92232552|NCT00003418|Exemestane|exemestane|mesh-list
92232553|NCT00003418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232554|NCT00003418|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92232555|NCT00003418|Hormone Antagonists|hormone antagonists|mesh-ancestor
92232556|NCT00003418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232557|NCT00003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232558|NCT00003418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232559|NCT00003418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232560|NCT00003418|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92232561|NCT00003418|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92232562|NCT00003418|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92232563|NCT00003418|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92232564|NCT00003418|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92232565|NCT00003418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232566|NCT04777838|Amitriptyline|amitriptyline|mesh-list
92232567|NCT04777838|Citalopram|citalopram|mesh-list
92232568|NCT04777838|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92232569|NCT04777838|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92232570|NCT04777838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92232571|NCT04777838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232572|NCT04777838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232573|NCT04777838|Serotonin Agents|serotonin agents|mesh-ancestor
92232574|NCT04777838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232575|NCT04777838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92232576|NCT04777838|Antidepressive Agents|antidepressive agents|mesh-ancestor
92232577|NCT04777838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92232578|NCT04777838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232579|NCT04777838|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92232580|NCT04777838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92232581|NCT04777838|Analgesics|analgesics|mesh-ancestor
92232582|NCT04777838|Sensory System Agents|sensory system agents|mesh-ancestor
92232584|NCT04777838|Adrenergic Agents|adrenergic agents|mesh-ancestor
92232585|NCT00003424|Tamoxifen|tamoxifen|mesh-list
92232586|NCT00003424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92232587|NCT00003424|Hormone Antagonists|hormone antagonists|mesh-ancestor
92232588|NCT00003424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232589|NCT00003424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232590|NCT00003424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232591|NCT00003424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232592|NCT00003424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92232593|NCT00003424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92232594|NCT00003424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92232595|NCT00002998|Gemcitabine|gemcitabine|mesh-list
92232596|NCT00002998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232597|NCT00002998|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232598|NCT00002998|Antimetabolites|antimetabolites|mesh-ancestor
92232599|NCT00002998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232600|NCT00003004|Paclitaxel|paclitaxel|mesh-list
92232601|NCT00003004|Alvocidib|alvocidib|mesh-list
92232602|NCT00003004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232603|NCT00003004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232604|NCT00003004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232605|NCT00003004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232606|NCT00003004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232607|NCT00003004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232608|NCT00003004|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232609|NCT00003004|Growth Substances|growth substances|mesh-ancestor
92232610|NCT00003004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232611|NCT00003004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92232612|NCT00003004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232613|NCT04776512|Bupivacaine|bupivacaine|mesh-list
92232614|NCT04776512|Anesthetics, Local|anesthetics, local|mesh-ancestor
92232615|NCT04776512|Anesthetics|anesthetics|mesh-ancestor
92232616|NCT04776512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232617|NCT04776512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232618|NCT04776512|Sensory System Agents|sensory system agents|mesh-ancestor
92232619|NCT04776512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232620|NCT04776590|Tislelizumab|tislelizumab|mesh-list
91934474|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92232621|NCT04776590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92232622|NCT04776590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232623|NCT00003436|Cytarabine|cytarabine|mesh-list
92232624|NCT00003436|Hydrocortisone|hydrocortisone|mesh-list
92232625|NCT00003436|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92232626|NCT00003436|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92232627|NCT00003436|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92232628|NCT00003436|Methotrexate|methotrexate|mesh-list
92232629|NCT00003436|Etoposide|etoposide|mesh-list
92232630|NCT00003436|Daunorubicin|daunorubicin|mesh-list
92232631|NCT00003436|Asparaginase|asparaginase|mesh-list
92232632|NCT00003436|Mitoxantrone|mitoxantrone|mesh-list
92232633|NCT00003436|Amsacrine|amsacrine|mesh-list
92232634|NCT00003436|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92232635|NCT00003436|Abortifacient Agents|abortifacient agents|mesh-ancestor
92232636|NCT00003436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232637|NCT00003436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232638|NCT00003436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232639|NCT00003436|Antimetabolites|antimetabolites|mesh-ancestor
92232640|NCT00003436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232641|NCT00003436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232642|NCT00003436|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232643|NCT00003436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232644|NCT00003436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92232645|NCT00003436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232646|NCT00003436|Immunologic Factors|immunologic factors|mesh-ancestor
92232647|NCT00003436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232648|NCT00003436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92232649|NCT00003436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232650|NCT00003436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232651|NCT00003436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232653|NCT00003436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232654|NCT00003436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92232655|NCT00003436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92232656|NCT00003436|Analgesics|analgesics|mesh-ancestor
92232657|NCT00003436|Sensory System Agents|sensory system agents|mesh-ancestor
92232658|NCT00003436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232659|NCT02432378|Celecoxib|celecoxib|mesh-list
92232660|NCT02432378|Cisplatin|cisplatin|mesh-list
92232661|NCT02432378|Vaccines|vaccines|mesh-list
92232662|NCT02432378|Immunologic Factors|immunologic factors|mesh-ancestor
92232663|NCT02432378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232664|NCT02432378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232665|NCT02432378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92232666|NCT02432378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92232667|NCT02432378|Analgesics|analgesics|mesh-ancestor
92232668|NCT02432378|Sensory System Agents|sensory system agents|mesh-ancestor
92232669|NCT02432378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232670|NCT02432378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92232671|NCT02432378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232672|NCT02432378|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92232673|NCT02432378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92232674|NCT02432378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232675|NCT02432378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232676|NCT00003466|Temozolomide|temozolomide|mesh-list
92232677|NCT00003466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232678|NCT00003466|Alkylating Agents|alkylating agents|mesh-ancestor
92232679|NCT00003466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232680|NCT00003466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232681|NCT00003478|Antibodies|antibodies|mesh-list
92232682|NCT00003478|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92232683|NCT00003478|Immunologic Factors|immunologic factors|mesh-ancestor
92232684|NCT00003478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232685|NCT00003016|Tamoxifen|tamoxifen|mesh-list
92232686|NCT00003016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92232687|NCT00003016|Hormone Antagonists|hormone antagonists|mesh-ancestor
92232688|NCT00003016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232689|NCT00003016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232690|NCT00003016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232691|NCT00003016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232692|NCT00003016|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92232693|NCT00003016|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92232694|NCT00003016|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92232695|NCT00003022|Antibodies|antibodies|mesh-list
92232696|NCT00003022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92232697|NCT00003022|Immunologic Factors|immunologic factors|mesh-ancestor
92232698|NCT00003022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232699|NCT01258387|Mitogens|mitogens|mesh-list
92232700|NCT01258387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232701|NCT01258387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232702|NCT00003484|Irinotecan|irinotecan|mesh-list
92232703|NCT00003484|Carmustine|carmustine|mesh-list
92232704|NCT00003484|Antibodies|antibodies|mesh-list
92232705|NCT00003484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92232706|NCT00003484|Immunologic Factors|immunologic factors|mesh-ancestor
92232707|NCT00003484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232708|NCT00003484|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92232709|NCT00003484|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232710|NCT00003484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232711|NCT00003484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232712|NCT00003484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232713|NCT00003484|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232714|NCT00003484|Alkylating Agents|alkylating agents|mesh-ancestor
92232716|NCT00003490|Cyclophosphamide|cyclophosphamide|mesh-list
92232717|NCT00003490|Vincristine|vincristine|mesh-list
92232718|NCT00003490|Sargramostim|sargramostim|mesh-list
92232719|NCT00003490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232720|NCT00003490|Immunologic Factors|immunologic factors|mesh-ancestor
92232721|NCT00003490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232722|NCT00003490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232723|NCT00003490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232724|NCT00003490|Alkylating Agents|alkylating agents|mesh-ancestor
92232725|NCT00003490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232726|NCT00003490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232727|NCT00003490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92232728|NCT00003490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92232729|NCT00003490|Glucocorticoids|glucocorticoids|mesh-ancestor
92232730|NCT00003490|Hormones|hormones|mesh-ancestor
92232731|NCT00003490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232732|NCT00003490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232733|NCT00003490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232734|NCT00003490|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232735|NCT00003490|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232736|NCT00003490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232737|NCT00003034|Doxorubicin|doxorubicin|mesh-list
92232738|NCT00003034|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92232739|NCT00003034|Ranpirnase|ranpirnase|mesh-list
92232740|NCT00003034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92232741|NCT00003034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232742|NCT00003034|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232743|NCT00003034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232744|NCT00003034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232745|NCT00003034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232746|NCT00003034|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92232747|NCT00383890|Dexmedetomidine|dexmedetomidine|mesh-list
92232748|NCT00383890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92232749|NCT00383890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232750|NCT00383890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232751|NCT00383890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92232752|NCT00383890|Analgesics|analgesics|mesh-ancestor
92232753|NCT00383890|Sensory System Agents|sensory system agents|mesh-ancestor
92232754|NCT00383890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232755|NCT00383890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92232756|NCT00383890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92232757|NCT00383890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92232758|NCT00383890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92232759|NCT00383890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232760|NCT00383890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232761|NCT00003046|Interleukin-12|interleukin-12|mesh-list
92232762|NCT00003046|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92232763|NCT00003046|Immunologic Factors|immunologic factors|mesh-ancestor
92232764|NCT00003046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232765|NCT00003046|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92232766|NCT00003046|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92232767|NCT00003046|Growth Substances|growth substances|mesh-ancestor
92232768|NCT00003046|Growth Inhibitors|growth inhibitors|mesh-ancestor
92232769|NCT00003046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232770|NCT00003052|Doxorubicin|doxorubicin|mesh-list
92232771|NCT00003052|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92232772|NCT00003052|Etoposide|etoposide|mesh-list
92232773|NCT00003052|Ifosfamide|ifosfamide|mesh-list
92232774|NCT00003052|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92232775|NCT00003052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232776|NCT00003052|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232777|NCT00003052|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232778|NCT00003052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232779|NCT00003052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232780|NCT00003052|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232781|NCT00003052|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232782|NCT00003052|Alkylating Agents|alkylating agents|mesh-ancestor
92232783|NCT00003058|Troglitazone|troglitazone|mesh-list
92232784|NCT00003058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92232785|NCT00003058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232786|NCT04775732|Infliximab|infliximab|mesh-list
92232787|NCT04775732|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92232788|NCT04775732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92232789|NCT04775732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232790|NCT04775732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92232791|NCT04775732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232792|NCT04754750|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92232793|NCT04754750|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92232794|NCT04754750|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92232795|NCT04754750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232796|NCT04754750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232797|NCT04754750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92232798|NCT04754750|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92232799|NCT04754750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92232800|NCT04754750|Serotonin Agents|serotonin agents|mesh-ancestor
92232801|NCT04754750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232802|NCT04754750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232803|NCT04754750|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92232804|NCT04754750|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92232805|NCT04754750|Dopamine Agents|dopamine agents|mesh-ancestor
92232806|NCT00003064|Paclitaxel|paclitaxel|mesh-list
92232807|NCT00003064|Etoposide|etoposide|mesh-list
92232808|NCT00003064|Carboplatin|carboplatin|mesh-list
92232809|NCT00003064|Topotecan|topotecan|mesh-list
92232810|NCT00003064|Thiotepa|thiotepa|mesh-list
92232811|NCT00003064|Etoposide phosphate|etoposide phosphate|mesh-list
92232812|NCT00003064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232813|NCT00003064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232814|NCT00003064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232815|NCT00003064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232816|NCT00003064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232817|NCT00003064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232818|NCT00003064|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232819|NCT00003064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232820|NCT00003064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232821|NCT00003064|Immunologic Factors|immunologic factors|mesh-ancestor
92232822|NCT00003064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232823|NCT00003064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92232824|NCT00003064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232825|NCT00003064|Alkylating Agents|alkylating agents|mesh-ancestor
92232826|NCT00003064|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92232827|NCT00003064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232828|NCT00003544|Irinotecan|irinotecan|mesh-list
92232829|NCT00003544|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92232830|NCT00003544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232831|NCT00003544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232832|NCT00003544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232833|NCT00003544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232834|NCT03475394|Chlorhexidine|chlorhexidine|mesh-list
92232835|NCT03475394|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92232836|NCT03475394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232837|NCT03475394|Disinfectants|disinfectants|mesh-ancestor
92232838|NCT01269424|Temozolomide|temozolomide|mesh-list
92232839|NCT01269424|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92232840|NCT01269424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232841|NCT01269424|Alkylating Agents|alkylating agents|mesh-ancestor
92232842|NCT01269424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232843|NCT01269424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232845|NCT03395912|Anesthetics|anesthetics|mesh-list
92232846|NCT03395912|Anesthetics, Local|anesthetics, local|mesh-list
92232847|NCT03395912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232848|NCT03395912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232849|NCT03395912|Sensory System Agents|sensory system agents|mesh-ancestor
92232850|NCT03395912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232852|NCT00384436|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92232853|NCT00384436|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92232854|NCT00384436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92232855|NCT00384436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232856|NCT00384436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232857|NCT00384436|Serotonin Agents|serotonin agents|mesh-ancestor
92232858|NCT00384436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232859|NCT00003562|Carboplatin|carboplatin|mesh-list
92232860|NCT00003562|Docetaxel|docetaxel|mesh-list
92232861|NCT00003562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232862|NCT00003562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232863|NCT00003562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232864|NCT00003562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232865|NCT00003562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232866|NCT04775576|Anesthetics|anesthetics|mesh-list
92232867|NCT04775576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232868|NCT04775576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232869|NCT00003568|Aldesleukin|aldesleukin|mesh-list
92232870|NCT00003568|Freund's Adjuvant|freund's adjuvant|mesh-list
92232871|NCT00003568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232872|NCT00003568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92232873|NCT00003568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92232874|NCT00003568|Antiviral Agents|antiviral agents|mesh-ancestor
92232875|NCT00003568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232876|NCT00003568|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92232877|NCT00003568|Immunologic Factors|immunologic factors|mesh-ancestor
92232878|NCT00003568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232879|NCT00003070|Enalapril|enalapril|mesh-list
92232880|NCT00003070|Enalaprilat|enalaprilat|mesh-list
92232881|NCT00003070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232882|NCT00003070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232883|NCT00003070|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92232884|NCT00003070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92232885|NCT00003070|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92232886|NCT00003076|Eflornithine|eflornithine|mesh-list
92232887|NCT00003076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232888|NCT00003076|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92232889|NCT00003076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92232890|NCT00003076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92232891|NCT00003076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232892|NCT00003076|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92232893|NCT00003076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232894|NCT00003076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232895|NCT01896518|Nicotine|nicotine|mesh-list
92232896|NCT01896518|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92232897|NCT01896518|Autonomic Agents|autonomic agents|mesh-ancestor
92232898|NCT01896518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92232899|NCT01896518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232900|NCT01896518|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92232901|NCT01896518|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92232902|NCT01896518|Cholinergic Agents|cholinergic agents|mesh-ancestor
92232903|NCT01896518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232904|NCT01896518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232905|NCT00003082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92232906|NCT00003082|Antibodies|antibodies|mesh-list
92232907|NCT00003082|Immunoglobulins|immunoglobulins|mesh-list
92232908|NCT00003082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92232909|NCT00003082|Immunologic Factors|immunologic factors|mesh-ancestor
92232910|NCT00003082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232911|NCT00003082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232912|NCT00003088|Paclitaxel|paclitaxel|mesh-list
92232913|NCT00003088|Cyclophosphamide|cyclophosphamide|mesh-list
92232914|NCT00003088|Doxorubicin|doxorubicin|mesh-list
92232915|NCT00003088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92232916|NCT00003088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92232917|NCT00003088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232918|NCT00003088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232919|NCT00003088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232920|NCT00003088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232921|NCT00003088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232922|NCT00003088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232923|NCT00003088|Immunologic Factors|immunologic factors|mesh-ancestor
92232924|NCT00003088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232925|NCT00003088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92232926|NCT00003088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92232927|NCT00003088|Alkylating Agents|alkylating agents|mesh-ancestor
92232928|NCT00003088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92232929|NCT00003088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92232930|NCT00003088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92232931|NCT00003088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92232932|NCT00003088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232933|NCT04775030|Salicylic Acid|salicylic acid|mesh-list
92232934|NCT04775030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232935|NCT04775030|Antifungal Agents|antifungal agents|mesh-ancestor
92232936|NCT04775030|Keratolytic Agents|keratolytic agents|mesh-ancestor
92232937|NCT04775030|Dermatologic Agents|dermatologic agents|mesh-ancestor
92232938|NCT05423210|Atezolizumab|atezolizumab|mesh-list
92232939|NCT05423210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92232940|NCT05423210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232941|NCT05423210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92232943|NCT00755560|Albendazole|albendazole|mesh-list
92232944|NCT00755560|Anthelmintics|anthelmintics|mesh-ancestor
92232945|NCT00755560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92232946|NCT00755560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232947|NCT00755560|Anticestodal Agents|anticestodal agents|mesh-ancestor
92232948|NCT00755560|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92232949|NCT00755560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92232950|NCT00755560|Tubulin Modulators|tubulin modulators|mesh-ancestor
92232951|NCT00755560|Antimitotic Agents|antimitotic agents|mesh-ancestor
92232952|NCT00755560|Mitosis Modulators|mitosis modulators|mesh-ancestor
92232953|NCT00755560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232954|NCT00755560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232955|NCT05405894|Zoledronic Acid|zoledronic acid|mesh-list
92232956|NCT05405894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92232957|NCT05405894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232958|NCT00003118|Fluorouracil|fluorouracil|mesh-list
92232959|NCT00003118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232960|NCT00003118|Antimetabolites|antimetabolites|mesh-ancestor
92232961|NCT00003118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232962|NCT00003118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92232963|NCT00003118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92232964|NCT00003118|Immunologic Factors|immunologic factors|mesh-ancestor
92232965|NCT00003118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232966|NCT00003124|Leuprolide|leuprolide|mesh-list
92232967|NCT00003124|Flutamide|flutamide|mesh-list
92232968|NCT00003124|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92232969|NCT00003124|Fertility Agents|fertility agents|mesh-ancestor
92232970|NCT00003124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92232971|NCT00003124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232972|NCT00003124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92232973|NCT00003124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92232974|NCT00003124|Androgen Antagonists|androgen antagonists|mesh-ancestor
92232975|NCT00003124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92232976|NCT00003124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92232977|NCT00003580|Amifostine|amifostine|mesh-list
92232978|NCT00003580|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92232979|NCT00003580|Protective Agents|protective agents|mesh-ancestor
92232980|NCT00003580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232981|NCT00056498|Risperidone|risperidone|mesh-list
92232982|NCT00056498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92232983|NCT00056498|Serotonin Agents|serotonin agents|mesh-ancestor
92232984|NCT00056498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92232985|NCT00056498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92232986|NCT00056498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92232987|NCT00056498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92232988|NCT00056498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92232989|NCT00056498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92232990|NCT00056498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92232991|NCT00056498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92232992|NCT00056498|Dopamine Agents|dopamine agents|mesh-ancestor
92232993|NCT04330144|Hydroxychloroquine|hydroxychloroquine|mesh-list
92232994|NCT04330144|Antimalarials|antimalarials|mesh-ancestor
92232995|NCT04330144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92232996|NCT04330144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92232997|NCT04330144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92232998|NCT04330144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92232999|NCT04330144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233000|NCT04330144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233001|NCT00003130|Paclitaxel|paclitaxel|mesh-list
92233002|NCT00003130|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233003|NCT00003130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233004|NCT00003130|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233005|NCT00003130|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233006|NCT00003130|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233007|NCT00003130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233008|NCT00058370|Vincristine|vincristine|mesh-list
92233009|NCT00058370|Lomustine|lomustine|mesh-list
92233010|NCT00058370|Antibodies|antibodies|mesh-list
92233011|NCT00058370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92233012|NCT00058370|Immunologic Factors|immunologic factors|mesh-ancestor
92233014|NCT00058370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233015|NCT00058370|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233016|NCT00058370|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233017|NCT00058370|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233018|NCT00058370|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233019|NCT00058370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233020|NCT00058370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233021|NCT00058370|Alkylating Agents|alkylating agents|mesh-ancestor
92233022|NCT00059228|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92233024|NCT00059228|Estradiol|estradiol|mesh-list
92233025|NCT00059228|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92233026|NCT00059228|Estrogens|estrogens|mesh-ancestor
92233027|NCT00059228|Hormones|hormones|mesh-ancestor
92233028|NCT00059228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233029|NCT00059228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233030|NCT00059228|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92233031|NCT00059228|Contraceptive Agents|contraceptive agents|mesh-ancestor
92233032|NCT00059228|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92233033|NCT00059228|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92233034|NCT00060008|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92233035|NCT00060008|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92233036|NCT00060008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233038|NCT00062738|Nortriptyline|nortriptyline|mesh-list
92233039|NCT00062738|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92233040|NCT00062738|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92233041|NCT00062738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92233042|NCT00062738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233043|NCT00062738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92233044|NCT00062738|Serotonin Agents|serotonin agents|mesh-ancestor
92233045|NCT00062738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233046|NCT00062738|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92233047|NCT00062738|Antidepressive Agents|antidepressive agents|mesh-ancestor
92233048|NCT00062738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92233049|NCT00062738|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92233050|NCT00062738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92233051|NCT00062738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233052|NCT00062738|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92233053|NCT00062738|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92233054|NCT00062738|Adrenergic Agents|adrenergic agents|mesh-ancestor
92233055|NCT00063362|Lamotrigine|lamotrigine|mesh-list
92233056|NCT00063362|Valproic Acid|valproic acid|mesh-list
92233057|NCT00063362|Lithium Carbonate|lithium carbonate|mesh-list
92233058|NCT00063362|Antidepressive Agents|antidepressive agents|mesh-ancestor
92233059|NCT00063362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92233060|NCT00063362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233061|NCT00063362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233062|NCT00063362|Antimanic Agents|antimanic agents|mesh-ancestor
92233063|NCT00063362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92233064|NCT00063362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92233065|NCT00063362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233066|NCT00063362|Anticonvulsants|anticonvulsants|mesh-ancestor
92233067|NCT00063362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92233068|NCT00063362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92233069|NCT00063362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92233070|NCT00063362|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92233071|NCT00063362|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92233072|NCT00063362|GABA Agents|gaba agents|mesh-ancestor
92233073|NCT00063362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92233074|NCT00064844|Nicotine|nicotine|mesh-list
92233075|NCT00064844|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92233076|NCT00064844|Autonomic Agents|autonomic agents|mesh-ancestor
92233077|NCT00064844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233078|NCT00064844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233079|NCT00064844|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92233080|NCT00064844|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92233081|NCT00064844|Cholinergic Agents|cholinergic agents|mesh-ancestor
92233083|NCT00064844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233084|NCT02668562|Ticagrelor|ticagrelor|mesh-list
92233085|NCT02668562|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92233086|NCT02668562|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92233087|NCT02668562|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92233088|NCT02668562|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92233089|NCT02668562|Purinergic Agents|purinergic agents|mesh-ancestor
92233090|NCT02668562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92233091|NCT02668562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233092|NCT02668562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233093|NCT00067028|Cytarabine|cytarabine|mesh-list
92233094|NCT00067028|Clofarabine|clofarabine|mesh-list
92233095|NCT00067028|Idarubicin|idarubicin|mesh-list
92233096|NCT00067028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233097|NCT00067028|Antimetabolites|antimetabolites|mesh-ancestor
92233098|NCT00067028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233099|NCT00067028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233100|NCT00067028|Antiviral Agents|antiviral agents|mesh-ancestor
92233101|NCT00067028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233102|NCT00067028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233103|NCT00067028|Immunologic Factors|immunologic factors|mesh-ancestor
92233104|NCT00067028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233105|NCT00067028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233106|NCT00067028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233107|NCT00067028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233108|NCT00067028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233109|NCT00067808|Decitabine|decitabine|mesh-list
92233110|NCT00067808|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233111|NCT00067808|Antimetabolites|antimetabolites|mesh-ancestor
92233112|NCT00067808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233113|NCT00067808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233114|NCT00067808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233115|NCT05174312|Diuretics|diuretics|mesh-list
92233116|NCT05174312|Natriuretic Agents|natriuretic agents|mesh-ancestor
92233117|NCT05174312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233118|NCT00493870|Cyclophosphamide|cyclophosphamide|mesh-list
92233119|NCT00493870|Docetaxel|docetaxel|mesh-list
92233120|NCT00493870|Doxorubicin|doxorubicin|mesh-list
92233121|NCT00493870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233122|NCT00493870|Immunologic Factors|immunologic factors|mesh-ancestor
92233123|NCT00493870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233124|NCT00493870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233125|NCT00493870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233126|NCT00493870|Alkylating Agents|alkylating agents|mesh-ancestor
92233127|NCT00493870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233128|NCT00493870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233129|NCT00493870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233130|NCT00493870|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233131|NCT00493870|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233132|NCT00493870|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233133|NCT00493870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233134|NCT00493870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233135|NCT00493870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233136|NCT00493870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233137|NCT03287336|Tranexamic Acid|tranexamic acid|mesh-list
92233138|NCT03287336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92233139|NCT03287336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92233140|NCT03287336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233141|NCT03287336|Hemostatics|hemostatics|mesh-ancestor
92233142|NCT03287336|Coagulants|coagulants|mesh-ancestor
92233143|NCT00003136|Cyclophosphamide|cyclophosphamide|mesh-list
92233144|NCT00003136|Carboplatin|carboplatin|mesh-list
92233145|NCT00003136|Amifostine|amifostine|mesh-list
92233146|NCT00003136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233147|NCT00003136|Immunologic Factors|immunologic factors|mesh-ancestor
92233148|NCT00003136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233149|NCT00003136|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233150|NCT00003136|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233151|NCT00003136|Alkylating Agents|alkylating agents|mesh-ancestor
92233152|NCT00003136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233153|NCT00003136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233154|NCT00003136|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233155|NCT00003136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92233156|NCT00003136|Protective Agents|protective agents|mesh-ancestor
92233157|NCT00003598|Tretinoin|tretinoin|mesh-list
92233158|NCT00003598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233159|NCT00003598|Keratolytic Agents|keratolytic agents|mesh-ancestor
92233160|NCT00003598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92233161|NCT00003604|Aldesleukin|aldesleukin|mesh-list
92233162|NCT00003604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233163|NCT00003604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92233164|NCT00003604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92233165|NCT00003604|Antiviral Agents|antiviral agents|mesh-ancestor
91923687|NCT02230735|Epinephryl borate|epinephryl borate|mesh-list
92233166|NCT00003604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233167|NCT00002794|Carboplatin|carboplatin|mesh-list
92233168|NCT00002794|Vincristine|vincristine|mesh-list
92233169|NCT00002794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233170|NCT00002794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233171|NCT00002794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233172|NCT00002794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233173|NCT00002794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233174|NCT00002794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233176|NCT00003610|Antipruritics|antipruritics|mesh-ancestor
92233177|NCT00003610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92233178|NCT00003610|Sensory System Agents|sensory system agents|mesh-ancestor
92233179|NCT00003610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233180|NCT00003610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233181|NCT00003616|Irinotecan|irinotecan|mesh-list
92233182|NCT00003616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92233183|NCT00003616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233184|NCT00003616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233185|NCT00003616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233186|NCT00003616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233187|NCT01063829|Letermovir|letermovir|mesh-list
92233188|NCT01063829|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92233189|NCT01063829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233190|NCT01063829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233191|NCT01063829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233192|NCT01063829|Antiviral Agents|antiviral agents|mesh-ancestor
92233193|NCT01063829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233194|NCT00072566|Cyclophosphamide|cyclophosphamide|mesh-list
92233195|NCT00072566|Bevacizumab|bevacizumab|mesh-list
92233196|NCT00072566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92233197|NCT00072566|Antibodies|antibodies|mesh-list
92233198|NCT00072566|Immunoglobulins|immunoglobulins|mesh-list
92233199|NCT00072566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92233200|NCT00072566|Immunoglobulin G|immunoglobulin g|mesh-list
92233201|NCT00072566|Endothelial Growth Factors|endothelial growth factors|mesh-list
92233202|NCT00072566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233203|NCT00072566|Immunologic Factors|immunologic factors|mesh-ancestor
92233204|NCT00072566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233205|NCT00072566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233206|NCT00072566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233207|NCT00072566|Alkylating Agents|alkylating agents|mesh-ancestor
92233208|NCT00072566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233209|NCT00072566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233210|NCT00072566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233211|NCT00072566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92233212|NCT00072566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92233213|NCT00072566|Growth Substances|growth substances|mesh-ancestor
92233214|NCT00072566|Growth Inhibitors|growth inhibitors|mesh-ancestor
92233216|NCT00003622|Vinorelbine|vinorelbine|mesh-list
92233217|NCT00003622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233218|NCT00003622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233219|NCT00003622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233220|NCT00003622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233221|NCT00003622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233222|NCT00003622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233223|NCT00003148|Aldesleukin|aldesleukin|mesh-list
92233224|NCT00003148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233225|NCT00003148|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92233226|NCT00003148|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92233227|NCT00003148|Antiviral Agents|antiviral agents|mesh-ancestor
92233228|NCT00003148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233229|NCT00384046|Testosterone|testosterone|mesh-list
92233230|NCT00384046|Androgens|androgens|mesh-ancestor
92233231|NCT00384046|Hormones|hormones|mesh-ancestor
92233232|NCT00384046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233233|NCT00384046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233234|NCT00002800|Cytarabine|cytarabine|mesh-list
92233235|NCT00002800|Etoposide|etoposide|mesh-list
92233236|NCT00002800|Idarubicin|idarubicin|mesh-list
92233237|NCT00002800|Lintuzumab|lintuzumab|mesh-list
92233238|NCT00002800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233239|NCT00002800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233240|NCT00002800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233241|NCT00002800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233242|NCT00002800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233243|NCT00002800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233244|NCT00002800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233245|NCT00002800|Antimetabolites|antimetabolites|mesh-ancestor
92233246|NCT00002800|Antiviral Agents|antiviral agents|mesh-ancestor
92233247|NCT00002800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233248|NCT00002800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233249|NCT00002800|Immunologic Factors|immunologic factors|mesh-ancestor
92233250|NCT00002800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233251|NCT00002800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233252|NCT00002800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92233253|NCT05061992|Lactulose|lactulose|mesh-list
92233254|NCT05061992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92233255|NCT00002806|Vincristine|vincristine|mesh-list
92233256|NCT00002806|Lomustine|lomustine|mesh-list
92233257|NCT00002806|Procarbazine|procarbazine|mesh-list
92233258|NCT00002806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233259|NCT00002806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233260|NCT00002806|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233261|NCT00002806|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233262|NCT00002806|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233263|NCT00002806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233264|NCT00002806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233265|NCT00002806|Alkylating Agents|alkylating agents|mesh-ancestor
92233266|NCT00003160|Paclitaxel|paclitaxel|mesh-list
92233267|NCT00003160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233268|NCT00003160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233269|NCT00003160|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233270|NCT00003160|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233271|NCT00003160|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233272|NCT00003160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233273|NCT00002812|Cytarabine|cytarabine|mesh-list
92233274|NCT00002812|Dexamethasone|dexamethasone|mesh-list
92233275|NCT00002812|Prednisone|prednisone|mesh-list
92233276|NCT00002812|Cyclophosphamide|cyclophosphamide|mesh-list
92233277|NCT00002812|Doxorubicin|doxorubicin|mesh-list
92233278|NCT00002812|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92233279|NCT00002812|Methotrexate|methotrexate|mesh-list
92233280|NCT00002812|Vincristine|vincristine|mesh-list
92233281|NCT00002812|Daunorubicin|daunorubicin|mesh-list
92233283|NCT00002812|Mercaptopurine|mercaptopurine|mesh-list
92233284|NCT00002812|Idarubicin|idarubicin|mesh-list
92233285|NCT00002812|Pegaspargase|pegaspargase|mesh-list
92233286|NCT00002812|Thioguanine|thioguanine|mesh-list
92233287|NCT00002812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233288|NCT00002812|Immunologic Factors|immunologic factors|mesh-ancestor
92233289|NCT00002812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233290|NCT00002812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233291|NCT00002812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233292|NCT00002812|Alkylating Agents|alkylating agents|mesh-ancestor
92233293|NCT00002812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233294|NCT00002812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233295|NCT00002812|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233296|NCT00002812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92233297|NCT00002812|Antiemetics|antiemetics|mesh-ancestor
92233298|NCT00002812|Autonomic Agents|autonomic agents|mesh-ancestor
92233299|NCT00002812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233300|NCT00002812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92233301|NCT00002812|Glucocorticoids|glucocorticoids|mesh-ancestor
92233302|NCT00002812|Hormones|hormones|mesh-ancestor
92233303|NCT00002812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233304|NCT00002812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92233305|NCT00002812|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233306|NCT00002812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233307|NCT00002812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233308|NCT00002812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233309|NCT00002812|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92233310|NCT00002812|Abortifacient Agents|abortifacient agents|mesh-ancestor
92233311|NCT00002812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92233312|NCT00002812|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233313|NCT00002812|Antimetabolites|antimetabolites|mesh-ancestor
92233314|NCT00002812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92233315|NCT00002812|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92233316|NCT00002812|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233317|NCT00002812|Antiviral Agents|antiviral agents|mesh-ancestor
92233318|NCT00002812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233319|NCT00002812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233320|NCT00002812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233321|NCT00002812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233322|NCT00002812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233323|NCT01258855|Aldesleukin|aldesleukin|mesh-list
92233324|NCT01258855|Aflibercept|aflibercept|mesh-list
92233325|NCT01258855|Interleukin-2|interleukin-2|mesh-list
92233326|NCT01258855|Endothelial Growth Factors|endothelial growth factors|mesh-list
92233327|NCT01258855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92233328|NCT01258855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92233329|NCT01258855|Growth Substances|growth substances|mesh-ancestor
92233330|NCT01258855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233331|NCT01258855|Growth Inhibitors|growth inhibitors|mesh-ancestor
92233332|NCT01258855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233333|NCT01258855|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92233335|NCT01258855|Sensory System Agents|sensory system agents|mesh-ancestor
92233336|NCT01258855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233337|NCT01258855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92233338|NCT01258855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92233339|NCT01258855|Antiviral Agents|antiviral agents|mesh-ancestor
92233340|NCT01258855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233341|NCT00003166|Vincristine|vincristine|mesh-list
92233342|NCT00003166|Bryostatin 1|bryostatin 1|mesh-list
92233343|NCT00003166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92338922|NCT00000335|Narcotics|narcotics|mesh-ancestor
92233344|NCT00003166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233345|NCT00003166|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233346|NCT00003166|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233347|NCT00003166|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233348|NCT00003166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233349|NCT00003166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92233350|NCT00003166|Immunologic Factors|immunologic factors|mesh-ancestor
92233351|NCT00003166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233352|NCT00003172|Interferons|interferons|mesh-list
92233353|NCT00003172|Interferon-alpha|interferon-alpha|mesh-list
92233354|NCT00003172|Docetaxel|docetaxel|mesh-list
92233356|NCT00003172|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92233357|NCT00003172|Fluorouracil|fluorouracil|mesh-list
92233358|NCT00003172|Hydroxyurea|hydroxyurea|mesh-list
92233359|NCT00003172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233360|NCT00003172|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233361|NCT00003172|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233362|NCT00003172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233363|NCT00003172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233364|NCT00003172|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233365|NCT00003172|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233366|NCT00003172|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233367|NCT00003172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233368|NCT00003172|Antimetabolites|antimetabolites|mesh-ancestor
92233369|NCT00003172|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233370|NCT00003172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233371|NCT00003172|Immunologic Factors|immunologic factors|mesh-ancestor
92233372|NCT00003172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233373|NCT00003172|Antiviral Agents|antiviral agents|mesh-ancestor
92233374|NCT00003172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233375|NCT00003172|Antisickling Agents|antisickling agents|mesh-ancestor
92233376|NCT00003172|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233377|NCT00003634|Oregovomab|oregovomab|mesh-list
92233378|NCT00003634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92233379|NCT00003634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233380|NCT02191033|Nicotine|nicotine|mesh-list
92233381|NCT02191033|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92233382|NCT02191033|Autonomic Agents|autonomic agents|mesh-ancestor
92233383|NCT02191033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233384|NCT02191033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233385|NCT02191033|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92233386|NCT02191033|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92233387|NCT02191033|Cholinergic Agents|cholinergic agents|mesh-ancestor
92233388|NCT02191033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92233389|NCT02191033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233390|NCT00002818|Cytarabine|cytarabine|mesh-list
92233391|NCT00002818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233392|NCT00002818|Antimetabolites|antimetabolites|mesh-ancestor
92233393|NCT00002818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233394|NCT00002818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233395|NCT00002818|Antiviral Agents|antiviral agents|mesh-ancestor
92233396|NCT00002818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233397|NCT00002818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233398|NCT00002818|Immunologic Factors|immunologic factors|mesh-ancestor
92233399|NCT00002818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233400|NCT00003640|Doxorubicin|doxorubicin|mesh-list
92233401|NCT00003640|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92233402|NCT00003640|Methotrexate|methotrexate|mesh-list
92233403|NCT00003640|Vinblastine|vinblastine|mesh-list
92233404|NCT00003640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233405|NCT00003640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233406|NCT00003640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233407|NCT00003640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233408|NCT00003640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233409|NCT00003640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233410|NCT00003640|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92233411|NCT00003640|Abortifacient Agents|abortifacient agents|mesh-ancestor
92233412|NCT00003640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92233413|NCT00003640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233414|NCT00003640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92338928|NCT00000341|Buprenorphine|buprenorphine|mesh-list
92233415|NCT00003640|Antimetabolites|antimetabolites|mesh-ancestor
92233416|NCT00003640|Dermatologic Agents|dermatologic agents|mesh-ancestor
92233417|NCT00003640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92233418|NCT00003640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233419|NCT00003640|Immunologic Factors|immunologic factors|mesh-ancestor
92233420|NCT00003640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233421|NCT00003640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233422|NCT00003640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233423|NCT00003640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233424|NCT00003640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233425|NCT00003640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233426|NCT00002824|Ganciclovir|ganciclovir|mesh-list
92233427|NCT00002824|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92233428|NCT00002824|Antiviral Agents|antiviral agents|mesh-ancestor
92233429|NCT00002824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233430|NCT00002824|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233431|NCT00002824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233432|NCT00002824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233433|NCT00003178|Idarubicin|idarubicin|mesh-list
92233434|NCT00003178|Cladribine|cladribine|mesh-list
92233435|NCT00003178|Lenograstim|lenograstim|mesh-list
92233436|NCT00003178|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92233437|NCT00003178|Immunologic Factors|immunologic factors|mesh-ancestor
92233438|NCT00003178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233439|NCT00003178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233440|NCT00003178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233441|NCT00003178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233442|NCT00003178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233443|NCT00003178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233444|NCT00003178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233445|NCT00003178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233446|NCT01260649|Ketamine|ketamine|mesh-list
92233447|NCT01260649|Anesthetics|anesthetics|mesh-list
92233448|NCT01260649|Analgesics|analgesics|mesh-ancestor
92233449|NCT01260649|Sensory System Agents|sensory system agents|mesh-ancestor
92233450|NCT01260649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233451|NCT01260649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233452|NCT01260649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92233453|NCT01260649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92233454|NCT01260649|Anesthetics, General|anesthetics, general|mesh-ancestor
92233455|NCT01260649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92233456|NCT01260649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92233457|NCT01260649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92233458|NCT01260649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92233459|NCT01260649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233460|NCT01260883|Ketorolac|ketorolac|mesh-list
92233461|NCT01260883|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92233462|NCT01260883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92233463|NCT01260883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92233464|NCT01260883|Analgesics|analgesics|mesh-ancestor
92233465|NCT01260883|Sensory System Agents|sensory system agents|mesh-ancestor
92233466|NCT01260883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233467|NCT01260883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233468|NCT01260883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92233469|NCT01260883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233470|NCT01260883|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92233471|NCT01260883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233472|NCT01260883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233473|NCT00076622|Antidepressive Agents|antidepressive agents|mesh-list
92233474|NCT00076622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92233475|NCT00423202|Ambrisentan|ambrisentan|mesh-list
92233476|NCT00423202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92233477|NCT00003184|Vaccines|vaccines|mesh-list
92233478|NCT00003184|Sargramostim|sargramostim|mesh-list
92233479|NCT00003184|BCG Vaccine|bcg vaccine|mesh-list
92233480|NCT00003184|Immunologic Factors|immunologic factors|mesh-ancestor
92233481|NCT00003184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233482|NCT00003184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92233484|NCT00003190|Etoposide|etoposide|mesh-list
92233485|NCT00003190|Daunorubicin|daunorubicin|mesh-list
92233486|NCT00003190|Etoposide phosphate|etoposide phosphate|mesh-list
92233487|NCT00003190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233488|NCT00003190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233489|NCT00003190|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233490|NCT00003190|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233491|NCT00003190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233492|NCT00003190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233493|NCT00003190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233494|NCT00003190|Antimetabolites|antimetabolites|mesh-ancestor
92233495|NCT00003190|Antiviral Agents|antiviral agents|mesh-ancestor
92233496|NCT00003190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233497|NCT00003190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233498|NCT00003190|Immunologic Factors|immunologic factors|mesh-ancestor
92233499|NCT00003190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233500|NCT00003190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233501|NCT00003652|Fluorouracil|fluorouracil|mesh-list
92233502|NCT00003652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233503|NCT00003652|Antimetabolites|antimetabolites|mesh-ancestor
92233504|NCT00003652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233505|NCT00003652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233506|NCT00003652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233507|NCT00003652|Immunologic Factors|immunologic factors|mesh-ancestor
92233508|NCT00003652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233509|NCT04773236|Lidocaine|lidocaine|mesh-list
92233510|NCT04773236|Anesthetics, Local|anesthetics, local|mesh-ancestor
92233511|NCT04773236|Anesthetics|anesthetics|mesh-ancestor
92233512|NCT04773236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92233513|NCT04773236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233514|NCT04773236|Sensory System Agents|sensory system agents|mesh-ancestor
92233515|NCT04773236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233516|NCT04773236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92233517|NCT04773236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92233518|NCT04773236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92233519|NCT04773236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92233520|NCT04773236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233521|NCT00003658|Cyclophosphamide|cyclophosphamide|mesh-list
92233522|NCT00003658|Rituximab|rituximab|mesh-list
92233523|NCT00003658|Pentostatin|pentostatin|mesh-list
92233524|NCT00003658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233525|NCT00003658|Immunologic Factors|immunologic factors|mesh-ancestor
92233526|NCT00003658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233527|NCT00003658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233528|NCT00003658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233529|NCT00003658|Alkylating Agents|alkylating agents|mesh-ancestor
92233530|NCT00003658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233531|NCT00003658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233532|NCT00003658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233533|NCT00003658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92233534|NCT00003658|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92233535|NCT00003658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233536|NCT00002836|Cyclophosphamide|cyclophosphamide|mesh-list
92233537|NCT00002836|Thiotepa|thiotepa|mesh-list
92233538|NCT00002836|Carmustine|carmustine|mesh-list
92233539|NCT00002836|Cisplatin|cisplatin|mesh-list
92233540|NCT00002836|Etoposide|etoposide|mesh-list
92233541|NCT00002836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233542|NCT00002836|Immunologic Factors|immunologic factors|mesh-ancestor
92233543|NCT00002836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233544|NCT00002836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233545|NCT00002836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233546|NCT00002836|Alkylating Agents|alkylating agents|mesh-ancestor
92233547|NCT00002836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233548|NCT00002836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233549|NCT00002836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233550|NCT00002836|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233551|NCT00002836|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233552|NCT00002836|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233553|NCT00002836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233555|NCT00003664|Interferon-alpha|interferon-alpha|mesh-list
92233556|NCT00003664|Aldesleukin|aldesleukin|mesh-list
92233557|NCT00003664|Gemcitabine|gemcitabine|mesh-list
92233558|NCT00003664|Fluorouracil|fluorouracil|mesh-list
92233559|NCT00003664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233560|NCT00003664|Antimetabolites|antimetabolites|mesh-ancestor
92233561|NCT00003664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233562|NCT00003664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233563|NCT00003664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233564|NCT00003664|Immunologic Factors|immunologic factors|mesh-ancestor
92233565|NCT00003664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233566|NCT00003664|Antiviral Agents|antiviral agents|mesh-ancestor
92233567|NCT00003664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233568|NCT00003664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92233569|NCT00003664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92233570|NCT00003196|Cyclosporine|cyclosporine|mesh-list
92233571|NCT00003196|Mycophenolic Acid|mycophenolic acid|mesh-list
92233572|NCT00003196|Cyclosporins|cyclosporins|mesh-list
92233573|NCT00003196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233574|NCT00003196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233575|NCT00003196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233576|NCT00003196|Immunologic Factors|immunologic factors|mesh-ancestor
92233577|NCT00003196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233578|NCT00003196|Antifungal Agents|antifungal agents|mesh-ancestor
92233579|NCT00003196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233580|NCT00003196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92233581|NCT00003196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233582|NCT00003196|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92233583|NCT00003196|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233584|NCT00003196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233585|NCT00003196|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92233586|NCT00003196|Antitubercular Agents|antitubercular agents|mesh-ancestor
92233587|NCT00003196|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92233588|NCT00003202|Gemcitabine|gemcitabine|mesh-list
92233589|NCT00003202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233590|NCT00003202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233591|NCT00003202|Antimetabolites|antimetabolites|mesh-ancestor
92233592|NCT00003202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233593|NCT00002854|Paclitaxel|paclitaxel|mesh-list
92233594|NCT00002854|Etoposide|etoposide|mesh-list
92233595|NCT00002854|Cyclophosphamide|cyclophosphamide|mesh-list
92233596|NCT00002854|Carboplatin|carboplatin|mesh-list
92233597|NCT00002854|Ifosfamide|ifosfamide|mesh-list
92233598|NCT00002854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233599|NCT00002854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233600|NCT00002854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233601|NCT00002854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233602|NCT00002854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233603|NCT00002854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233604|NCT00002854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233605|NCT00002854|Immunologic Factors|immunologic factors|mesh-ancestor
92233606|NCT00002854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233607|NCT00002854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233608|NCT00002854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233609|NCT00002854|Alkylating Agents|alkylating agents|mesh-ancestor
92233610|NCT00002854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233611|NCT00002854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233612|NCT00002854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233613|NCT00002854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233614|NCT02308202|Perindopril|perindopril|mesh-list
92233615|NCT02308202|Doxazosin|doxazosin|mesh-list
92233616|NCT02308202|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92233617|NCT02308202|Protease Inhibitors|protease inhibitors|mesh-ancestor
92233618|NCT02308202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233619|NCT02308202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233620|NCT02308202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92233621|NCT02308202|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92233622|NCT02308202|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92233623|NCT02308202|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92233624|NCT02308202|Adrenergic Agents|adrenergic agents|mesh-ancestor
92233625|NCT02308202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92233626|NCT02308202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233628|NCT00003214|Cyclophosphamide|cyclophosphamide|mesh-list
92233629|NCT00003214|Carboplatin|carboplatin|mesh-list
92233630|NCT00003214|Doxorubicin|doxorubicin|mesh-list
92233631|NCT00003214|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92233632|NCT00003214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233633|NCT00003214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233634|NCT00003214|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233635|NCT00003214|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233636|NCT00003214|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233637|NCT00003214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233638|NCT00003214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233639|NCT00003214|Immunologic Factors|immunologic factors|mesh-ancestor
92233640|NCT00003214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233641|NCT00003214|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233642|NCT00003214|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233643|NCT00003214|Alkylating Agents|alkylating agents|mesh-ancestor
92233644|NCT00003214|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233645|NCT00003214|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233646|NCT00003214|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233647|NCT00003214|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233648|NCT00003214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233649|NCT00384592|Esomeprazole|esomeprazole|mesh-list
92233650|NCT00384592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92233651|NCT00384592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92233652|NCT00384592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92233653|NCT00384592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233654|NCT00384592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233655|NCT00003220|Bryostatin 1|bryostatin 1|mesh-list
92233656|NCT00003220|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92233657|NCT00003220|Immunologic Factors|immunologic factors|mesh-ancestor
92233658|NCT00003220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233659|NCT00003220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233660|NCT00002866|Docetaxel|docetaxel|mesh-list
92233661|NCT00002866|Epirubicin|epirubicin|mesh-list
92233662|NCT00002866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233663|NCT00002866|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233664|NCT00002866|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233665|NCT00002866|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233666|NCT00002866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233667|NCT00002866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233668|NCT00002866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233669|NCT00002866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233670|NCT00002866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233671|NCT00003232|Clodronic Acid|clodronic acid|mesh-list
92233672|NCT00003232|Prednisone|prednisone|mesh-list
92233673|NCT00003232|Mitoxantrone|mitoxantrone|mesh-list
92233674|NCT00003232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92233675|NCT00003232|Glucocorticoids|glucocorticoids|mesh-ancestor
92233676|NCT00003232|Hormones|hormones|mesh-ancestor
92233677|NCT00003232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233678|NCT00003232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233679|NCT00003232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92233680|NCT00003232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233681|NCT00003232|Analgesics|analgesics|mesh-ancestor
92233682|NCT00003232|Sensory System Agents|sensory system agents|mesh-ancestor
92233683|NCT00003232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233684|NCT00003232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233685|NCT00003232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233686|NCT00003232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233687|NCT00003232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233688|NCT00003232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92233689|NCT00003238|Perillyl alcohol|perillyl alcohol|mesh-list
92233690|NCT00003238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233691|NCT00003238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233692|NCT00003238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233693|NCT00002884|Fluorouracil|fluorouracil|mesh-list
92233695|NCT00002884|Antimetabolites|antimetabolites|mesh-ancestor
92233696|NCT00002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233697|NCT00002884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233698|NCT00002884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233699|NCT00002884|Immunologic Factors|immunologic factors|mesh-ancestor
92233700|NCT00002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233701|NCT00003682|Methylprednisolone|methylprednisolone|mesh-list
92233702|NCT00003682|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92233703|NCT00003682|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92233704|NCT00003682|Prednisolone|prednisolone|mesh-list
92233705|NCT00003682|Prednisolone acetate|prednisolone acetate|mesh-list
92233706|NCT00003682|Doxorubicin|doxorubicin|mesh-list
92233707|NCT00003682|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92233708|NCT00003682|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92233709|NCT00003682|Prednisolone phosphate|prednisolone phosphate|mesh-list
92233710|NCT00003682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233711|NCT00003682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233712|NCT00003682|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233713|NCT00003682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233714|NCT00003682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233715|NCT00003682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233716|NCT00003682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92233717|NCT00003682|Antiemetics|antiemetics|mesh-ancestor
92233718|NCT00003682|Autonomic Agents|autonomic agents|mesh-ancestor
92233719|NCT00003682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92233720|NCT00003682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233721|NCT00003682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92233722|NCT00003682|Glucocorticoids|glucocorticoids|mesh-ancestor
92233723|NCT00003682|Hormones|hormones|mesh-ancestor
92233724|NCT00003682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233725|NCT00003682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92233726|NCT00003682|Protective Agents|protective agents|mesh-ancestor
92233727|NCT00003682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92233728|NCT00003688|Dactinomycin|dactinomycin|mesh-list
92233729|NCT00003688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92233730|NCT00003688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233731|NCT00003688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233732|NCT00003688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233733|NCT00003688|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92233734|NCT00003688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233735|NCT00003688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233736|NCT00003688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233737|NCT00083174|Exemestane|exemestane|mesh-list
92233738|NCT00083174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233739|NCT00083174|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92233740|NCT00083174|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92233741|NCT00083174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233742|NCT00083174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233743|NCT00083174|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92233744|NCT00083174|Hormone Antagonists|hormone antagonists|mesh-ancestor
92233745|NCT00083174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233746|NCT00083174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233747|NCT00003934|Cytarabine|cytarabine|mesh-list
92233748|NCT00003934|Methotrexate|methotrexate|mesh-list
92233749|NCT00003934|Mercaptopurine|mercaptopurine|mesh-list
92233750|NCT00003934|Daunorubicin|daunorubicin|mesh-list
92233751|NCT00003934|Arsenic Trioxide|arsenic trioxide|mesh-list
92233752|NCT00003934|Tretinoin|tretinoin|mesh-list
92233753|NCT00003934|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92233754|NCT00003934|Abortifacient Agents|abortifacient agents|mesh-ancestor
92233755|NCT00003934|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92233756|NCT00003934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233757|NCT00003934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233758|NCT00003934|Antimetabolites|antimetabolites|mesh-ancestor
92233759|NCT00003934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233760|NCT00003934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233761|NCT00003934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92338962|NCT00000353|Naloxone|naloxone|mesh-list
92233762|NCT00003934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233763|NCT00003934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92233764|NCT00003934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233765|NCT00003934|Immunologic Factors|immunologic factors|mesh-ancestor
92233766|NCT00003934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233767|NCT00003934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233768|NCT00003934|Antiviral Agents|antiviral agents|mesh-ancestor
92233769|NCT00003934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233770|NCT00003934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233771|NCT00003934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233772|NCT00003934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233773|NCT00003934|Keratolytic Agents|keratolytic agents|mesh-ancestor
92233774|NCT00003694|Cytarabine|cytarabine|mesh-list
92233775|NCT00003694|Homoharringtonine|homoharringtonine|mesh-list
92233776|NCT00003694|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233777|NCT00003694|Antimetabolites|antimetabolites|mesh-ancestor
91923765|NCT01358864|Antiviral Agents|antiviral agents|mesh-ancestor
92233778|NCT00003694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233779|NCT00003694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233780|NCT00003694|Antiviral Agents|antiviral agents|mesh-ancestor
92233781|NCT00003694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233782|NCT00003694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233783|NCT00003694|Immunologic Factors|immunologic factors|mesh-ancestor
92233784|NCT00003694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233785|NCT00003694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233786|NCT00003694|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92233787|NCT00003694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233788|NCT00003250|Fenretinide|fenretinide|mesh-list
92233789|NCT00003250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233790|NCT00003250|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92233791|NCT00003250|Protective Agents|protective agents|mesh-ancestor
92233792|NCT00003250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233793|NCT00003256|Alvocidib|alvocidib|mesh-list
92233794|NCT00003256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233795|NCT00003256|Growth Inhibitors|growth inhibitors|mesh-ancestor
92233796|NCT00003256|Growth Substances|growth substances|mesh-ancestor
92233797|NCT00003256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233798|NCT00003256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92233799|NCT00003256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233800|NCT00003256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233801|NCT00003946|Danazol|danazol|mesh-list
92233802|NCT00003946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92233803|NCT00003946|Hormone Antagonists|hormone antagonists|mesh-ancestor
92233804|NCT00003946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233805|NCT00003946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233806|NCT04679480|Cemiplimab|cemiplimab|mesh-list
92233807|NCT04679480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92233808|NCT04679480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233809|NCT00003262|Prednisone|prednisone|mesh-list
92233810|NCT00003262|Doxorubicin|doxorubicin|mesh-list
92233811|NCT00003262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92233812|NCT00003262|Epirubicin|epirubicin|mesh-list
92233813|NCT00003262|Bleomycin|bleomycin|mesh-list
92233814|NCT00003262|Etoposide|etoposide|mesh-list
92233815|NCT00003262|Vincristine|vincristine|mesh-list
92233816|NCT00003262|Vinblastine|vinblastine|mesh-list
92233817|NCT00003262|Mechlorethamine|mechlorethamine|mesh-list
92233818|NCT00003262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233819|NCT00003262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233820|NCT00003262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233821|NCT00003262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233822|NCT00003262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233823|NCT00003262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233824|NCT00003262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92233825|NCT00003262|Glucocorticoids|glucocorticoids|mesh-ancestor
92233826|NCT00003262|Hormones|hormones|mesh-ancestor
92233827|NCT00003262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233828|NCT00003262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233829|NCT00003262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92233830|NCT00003262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233831|NCT00003262|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233832|NCT00003262|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233833|NCT00003262|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233834|NCT00003262|Alkylating Agents|alkylating agents|mesh-ancestor
92233835|NCT00003262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233836|NCT00003700|Leucovorin|leucovorin|mesh-list
92233837|NCT00003700|Cytarabine|cytarabine|mesh-list
92233838|NCT00003700|Prednisone|prednisone|mesh-list
92233839|NCT00003700|Cyclophosphamide|cyclophosphamide|mesh-list
92233840|NCT00003700|Methotrexate|methotrexate|mesh-list
92233841|NCT00003700|Vincristine|vincristine|mesh-list
92233842|NCT00003700|Daunorubicin|daunorubicin|mesh-list
92233843|NCT00003700|Asparaginase|asparaginase|mesh-list
92233844|NCT00003700|Mercaptopurine|mercaptopurine|mesh-list
92233845|NCT00003700|Allopurinol|allopurinol|mesh-list
92233846|NCT00003700|Levoleucovorin|levoleucovorin|mesh-list
92233847|NCT00003700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233848|NCT00003700|Immunologic Factors|immunologic factors|mesh-ancestor
92233849|NCT00003700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233850|NCT00003700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233851|NCT00003700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233852|NCT00003700|Alkylating Agents|alkylating agents|mesh-ancestor
92233853|NCT00003700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233854|NCT00003700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233855|NCT00003700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92233856|NCT00003700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92233857|NCT00003700|Glucocorticoids|glucocorticoids|mesh-ancestor
92233859|NCT00003700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92233860|NCT00003700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92233861|NCT00003700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92233862|NCT00003700|Abortifacient Agents|abortifacient agents|mesh-ancestor
92233863|NCT00003700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92233864|NCT00003700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233865|NCT00003700|Antimetabolites|antimetabolites|mesh-ancestor
92233866|NCT00003700|Dermatologic Agents|dermatologic agents|mesh-ancestor
92233867|NCT00003700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233868|NCT00003700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92233869|NCT00003700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233870|NCT00003700|Antiviral Agents|antiviral agents|mesh-ancestor
92233871|NCT00003700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233872|NCT00003700|Antidotes|antidotes|mesh-ancestor
92233873|NCT00003700|Protective Agents|protective agents|mesh-ancestor
92233874|NCT00003700|Vitamin B Complex|vitamin b complex|mesh-ancestor
92233875|NCT00003700|Vitamins|vitamins|mesh-ancestor
92233876|NCT00003700|Micronutrients|micronutrients|mesh-ancestor
92233877|NCT00003700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233878|NCT00003700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233879|NCT00003700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233880|NCT00003700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233881|NCT00003700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233882|NCT00003700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233883|NCT00003700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233884|NCT00003700|Gout Suppressants|gout suppressants|mesh-ancestor
92233885|NCT00003700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92233886|NCT00003700|Antioxidants|antioxidants|mesh-ancestor
92233887|NCT00003706|Pemetrexed|pemetrexed|mesh-list
92233888|NCT00003706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233889|NCT00003706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233890|NCT00003706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233891|NCT00003706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92233892|NCT00003706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233893|NCT00003958|Dactinomycin|dactinomycin|mesh-list
92233894|NCT00003958|Cactinomycin|cactinomycin|mesh-list
92233895|NCT00003958|Cyclophosphamide|cyclophosphamide|mesh-list
92233896|NCT00003958|Vincristine|vincristine|mesh-list
92233897|NCT00003958|Topotecan|topotecan|mesh-list
92233898|NCT00003958|Sargramostim|sargramostim|mesh-list
92233899|NCT00003958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233900|NCT00003958|Immunologic Factors|immunologic factors|mesh-ancestor
92233901|NCT00003958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233902|NCT00003958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233903|NCT00003958|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233904|NCT00003958|Alkylating Agents|alkylating agents|mesh-ancestor
92233905|NCT00003958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233906|NCT00003958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233907|NCT00003958|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92338964|NCT00000353|Narcotics|narcotics|mesh-ancestor
92233908|NCT00003958|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92233909|NCT00003958|Tubulin Modulators|tubulin modulators|mesh-ancestor
92233910|NCT00003958|Antimitotic Agents|antimitotic agents|mesh-ancestor
92233911|NCT00003958|Mitosis Modulators|mitosis modulators|mesh-ancestor
92233912|NCT00003958|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92233913|NCT00003958|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233914|NCT00003958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233915|NCT00003958|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92233916|NCT00003958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233917|NCT00003958|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233918|NCT00003958|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92233919|NCT00003958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92233920|NCT00003712|Sirolimus|sirolimus|mesh-list
92233921|NCT00003712|Temsirolimus|temsirolimus|mesh-list
92233922|NCT00003712|MTOR Inhibitors|mtor inhibitors|mesh-list
92233923|NCT00003712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92233924|NCT00003712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233925|NCT00003712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233926|NCT00003712|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233927|NCT00003712|Immunologic Factors|immunologic factors|mesh-ancestor
92233928|NCT00003712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233929|NCT00003712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233930|NCT00003712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92233931|NCT00003712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233932|NCT00003712|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233933|NCT00003712|Antifungal Agents|antifungal agents|mesh-ancestor
92233934|NCT00003268|Cytarabine|cytarabine|mesh-list
92233935|NCT00003268|Idarubicin|idarubicin|mesh-list
92233936|NCT00003268|Amifostine|amifostine|mesh-list
92233937|NCT00003268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92233938|NCT00003268|Antimetabolites|antimetabolites|mesh-ancestor
92233939|NCT00003268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233940|NCT00003268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233941|NCT00003268|Antiviral Agents|antiviral agents|mesh-ancestor
92233942|NCT00003268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233943|NCT00003268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233944|NCT00003268|Immunologic Factors|immunologic factors|mesh-ancestor
92233945|NCT00003268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233946|NCT00003268|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92233947|NCT00003268|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92233948|NCT00003268|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233949|NCT00003268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233950|NCT00003268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92233951|NCT00003268|Protective Agents|protective agents|mesh-ancestor
92233952|NCT00083720|Cetuximab|cetuximab|mesh-list
92233953|NCT00083720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92233954|NCT00083720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233955|NCT00003274|Sargramostim|sargramostim|mesh-list
92233956|NCT00003274|Freund's Adjuvant|freund's adjuvant|mesh-list
92233957|NCT00003274|Immunologic Factors|immunologic factors|mesh-ancestor
92233958|NCT00003274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233959|NCT00003274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92233960|NCT00003280|Rituximab|rituximab|mesh-list
92233961|NCT00003280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92233962|NCT00003280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233963|NCT00003280|Immunologic Factors|immunologic factors|mesh-ancestor
92233964|NCT00003280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233965|NCT00003280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92233966|NCT00384124|Imiquimod|imiquimod|mesh-list
92233967|NCT00384124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92233968|NCT00384124|Immunologic Factors|immunologic factors|mesh-ancestor
92233969|NCT00384124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233970|NCT00384124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233971|NCT00384124|Interferon Inducers|interferon inducers|mesh-ancestor
92233972|NCT00003718|Temozolomide|temozolomide|mesh-list
92233973|NCT00003718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92233974|NCT00003718|Alkylating Agents|alkylating agents|mesh-ancestor
92233975|NCT00003718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233976|NCT00003718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233977|NCT00003970|Irinotecan|irinotecan|mesh-list
92233978|NCT00003970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92233979|NCT00003970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92233980|NCT00003970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92233981|NCT00003970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92233982|NCT00003970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233983|NCT00085436|Interferons|interferons|mesh-list
92233984|NCT00085436|Interferon-alpha|interferon-alpha|mesh-list
92233985|NCT00085436|Interferon alpha-2|interferon alpha-2|mesh-list
92233986|NCT00085436|Aldesleukin|aldesleukin|mesh-list
92233987|NCT00085436|Vaccines|vaccines|mesh-list
92233988|NCT00085436|Immunologic Factors|immunologic factors|mesh-ancestor
92233989|NCT00085436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233990|NCT00085436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92233991|NCT00085436|Antiviral Agents|antiviral agents|mesh-ancestor
92233992|NCT00085436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92233993|NCT00085436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92233995|NCT00384202|Tacrolimus|tacrolimus|mesh-list
92233996|NCT00384202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92233997|NCT00384202|Immunologic Factors|immunologic factors|mesh-ancestor
92233998|NCT00384202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92233999|NCT00384202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92234000|NCT00384202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234001|NCT00384202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234002|NCT00086138|Sertraline|sertraline|mesh-list
92234003|NCT00086138|Antidepressive Agents|antidepressive agents|mesh-ancestor
92234004|NCT00086138|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92234005|NCT00086138|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92234006|NCT00086138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91924373|NCT02558894|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234007|NCT00086138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92234008|NCT00086138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234009|NCT00086138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92234010|NCT00086138|Serotonin Agents|serotonin agents|mesh-ancestor
92234011|NCT00086138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234012|NCT04329130|Lenalidomide|lenalidomide|mesh-list
92234013|NCT04329130|Immunologic Factors|immunologic factors|mesh-ancestor
92234014|NCT04329130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234015|NCT04329130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92234016|NCT04329130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92234017|NCT04329130|Growth Substances|growth substances|mesh-ancestor
92234018|NCT04329130|Growth Inhibitors|growth inhibitors|mesh-ancestor
92234019|NCT04329130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234020|NCT00384280|Rifampin|rifampin|mesh-list
92234021|NCT00384280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92234022|NCT00384280|Antitubercular Agents|antitubercular agents|mesh-ancestor
92234023|NCT00384280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92234024|NCT00384280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234025|NCT00384280|Leprostatic Agents|leprostatic agents|mesh-ancestor
92234026|NCT00384280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92234027|NCT00384280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234028|NCT00384280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234029|NCT00384280|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92234030|NCT00384280|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92234031|NCT00384280|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92234032|NCT00384280|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92234033|NCT00384280|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92234034|NCT00384280|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92234035|NCT00003976|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92234036|NCT00003976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234037|NCT00003976|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92234038|NCT00003976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234039|NCT00003976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234040|NCT00003730|Fluorouracil|fluorouracil|mesh-list
92234041|NCT00003730|Vinorelbine|vinorelbine|mesh-list
92234042|NCT00003730|Antimetabolites|antimetabolites|mesh-ancestor
92234043|NCT00003730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234044|NCT00003730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234045|NCT00003730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234046|NCT00003730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234047|NCT00003730|Immunologic Factors|immunologic factors|mesh-ancestor
92234048|NCT00003730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234049|NCT00003730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234050|NCT00003730|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234051|NCT00003730|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234052|NCT00003730|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234053|NCT01881308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92234054|NCT01881308|Antirheumatic Agents|antirheumatic agents|mesh-list
92234055|NCT01881308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234056|NCT00003292|Ifosfamide|ifosfamide|mesh-list
92234057|NCT00003292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234058|NCT00003292|Alkylating Agents|alkylating agents|mesh-ancestor
92234059|NCT00003292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234060|NCT00003292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234061|NCT00088634|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92234062|NCT00088634|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92234063|NCT00088634|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92234064|NCT00088634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92234065|NCT00088634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234066|NCT00088634|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92234067|NCT00088634|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92234068|NCT00088634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92234069|NCT00088634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92234070|NCT00088634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92234071|NCT00088634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92234072|NCT00088634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234073|NCT00088634|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92234074|NCT00088634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92234075|NCT00088634|Serotonin Agents|serotonin agents|mesh-ancestor
92234076|NCT00088634|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92234077|NCT00088634|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92234078|NCT00088634|Dopamine Agents|dopamine agents|mesh-ancestor
92234079|NCT00003736|Motexafin gadolinium|motexafin gadolinium|mesh-list
92234080|NCT00003736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234081|NCT00003736|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92234082|NCT00003736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92234084|NCT00003994|Fluorouracil|fluorouracil|mesh-list
92234085|NCT00003994|Vincristine|vincristine|mesh-list
92234087|NCT00003994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234088|NCT00003994|Antimetabolites|antimetabolites|mesh-ancestor
92234089|NCT00003994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234090|NCT00003994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234091|NCT00003994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234092|NCT00003994|Immunologic Factors|immunologic factors|mesh-ancestor
92234093|NCT00003994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234094|NCT00003994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234095|NCT00003994|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234096|NCT00003994|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234097|NCT00003994|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234098|NCT00003994|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92234099|NCT00003994|Protective Agents|protective agents|mesh-ancestor
92234100|NCT00003742|Paclitaxel|paclitaxel|mesh-list
92234101|NCT00003742|Irinotecan|irinotecan|mesh-list
92234102|NCT00003742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234103|NCT00003742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234104|NCT00003742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234105|NCT00003742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234106|NCT00003742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234107|NCT00003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234108|NCT00003742|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234109|NCT00003742|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234110|NCT00003742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234111|NCT00003304|Temozolomide|temozolomide|mesh-list
92234112|NCT00003304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234113|NCT00003304|Alkylating Agents|alkylating agents|mesh-ancestor
92234114|NCT00003304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234115|NCT00003304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234116|NCT00004006|Cyclophosphamide|cyclophosphamide|mesh-list
92234117|NCT00004006|Carboplatin|carboplatin|mesh-list
92234118|NCT00004006|Doxorubicin|doxorubicin|mesh-list
92338982|NCT00001865|Daclizumab|daclizumab|mesh-list
92234119|NCT00004006|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234120|NCT00004006|Etoposide|etoposide|mesh-list
92234121|NCT00004006|Topotecan|topotecan|mesh-list
92234122|NCT00004006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234123|NCT00004006|Immunologic Factors|immunologic factors|mesh-ancestor
92234124|NCT00004006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234125|NCT00004006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234126|NCT00004006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234127|NCT00004006|Alkylating Agents|alkylating agents|mesh-ancestor
92234128|NCT00004006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234129|NCT00004006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234130|NCT00004006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234131|NCT00004006|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234132|NCT00004006|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234133|NCT00004006|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234134|NCT00004006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234135|NCT00004006|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234136|NCT00004006|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234137|NCT00003316|Gemcitabine|gemcitabine|mesh-list
92234138|NCT00003316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234139|NCT00003316|Antimetabolites|antimetabolites|mesh-ancestor
92234140|NCT00003316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234141|NCT00003316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234142|NCT00089024|Leucovorin|leucovorin|mesh-list
92234143|NCT00089024|Gemcitabine|gemcitabine|mesh-list
92234144|NCT00089024|Fluorouracil|fluorouracil|mesh-list
92234145|NCT00089024|Oxaliplatin|oxaliplatin|mesh-list
92234146|NCT00089024|Calcium|calcium|mesh-list
92234147|NCT00089024|Levoleucovorin|levoleucovorin|mesh-list
92234148|NCT00089024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234149|NCT00089024|Antimetabolites|antimetabolites|mesh-ancestor
92234150|NCT00089024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234151|NCT00089024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234152|NCT00089024|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92234153|NCT00089024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234154|NCT00089024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234155|NCT00089024|Immunologic Factors|immunologic factors|mesh-ancestor
92234156|NCT00089024|Antidotes|antidotes|mesh-ancestor
92234157|NCT00089024|Protective Agents|protective agents|mesh-ancestor
92234158|NCT00089024|Vitamin B Complex|vitamin b complex|mesh-ancestor
92234160|NCT00089024|Micronutrients|micronutrients|mesh-ancestor
92234161|NCT00003322|Paclitaxel|paclitaxel|mesh-list
92234162|NCT00003322|Cisplatin|cisplatin|mesh-list
92234163|NCT00003322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234164|NCT00003322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234165|NCT00003322|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234166|NCT00003322|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234167|NCT00003322|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234168|NCT00003322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234169|NCT00519818|Hydrocortisone|hydrocortisone|mesh-list
92234170|NCT00519818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92234171|NCT00519818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92234172|NCT00519818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92234173|NCT00519818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234174|NCT00003748|Irinotecan|irinotecan|mesh-list
92234175|NCT00003748|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234176|NCT00003748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234177|NCT00003748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234178|NCT00003748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234179|NCT00003748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234180|NCT00089102|Gemcitabine|gemcitabine|mesh-list
92234181|NCT00089102|Irinotecan|irinotecan|mesh-list
92234182|NCT00089102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234183|NCT00089102|Antimetabolites|antimetabolites|mesh-ancestor
92234184|NCT00089102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234185|NCT00089102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234186|NCT00089102|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234187|NCT00089102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234188|NCT00089102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234189|NCT00004012|Capecitabine|capecitabine|mesh-list
92234190|NCT00004012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234191|NCT00004012|Antimetabolites|antimetabolites|mesh-ancestor
92234192|NCT00004012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234193|NCT00004012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234195|NCT00003754|Cyclophosphamide|cyclophosphamide|mesh-list
92234196|NCT00003754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234197|NCT00003754|Immunologic Factors|immunologic factors|mesh-ancestor
92234198|NCT00003754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234199|NCT00003754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234200|NCT00003754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234201|NCT00003754|Alkylating Agents|alkylating agents|mesh-ancestor
92234202|NCT00003754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234203|NCT00003754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234204|NCT00003754|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234205|NCT00003754|Leprostatic Agents|leprostatic agents|mesh-ancestor
92234206|NCT00003754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92234207|NCT00003754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234208|NCT00003754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92234209|NCT00003754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92234210|NCT00003754|Growth Substances|growth substances|mesh-ancestor
92234211|NCT00003754|Growth Inhibitors|growth inhibitors|mesh-ancestor
92234212|NCT00003328|Porfiromycin|porfiromycin|mesh-list
92234213|NCT00003328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234214|NCT00003328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234215|NCT00004024|Aldesleukin|aldesleukin|mesh-list
92234216|NCT00004024|Sargramostim|sargramostim|mesh-list
92234217|NCT00004024|Muromonab-CD3|muromonab-cd3|mesh-list
92234218|NCT00004024|Immunologic Factors|immunologic factors|mesh-ancestor
92234219|NCT00004024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234220|NCT00004024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234221|NCT00004024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92234222|NCT00004024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92234223|NCT00004024|Antiviral Agents|antiviral agents|mesh-ancestor
92234224|NCT00004024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234225|NCT00004024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234227|NCT00003334|Doxorubicin|doxorubicin|mesh-list
92234228|NCT00003334|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234229|NCT00003334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234230|NCT00003334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234231|NCT00003334|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234232|NCT00003334|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234233|NCT00003334|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234234|NCT00003334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234235|NCT00003334|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234236|NCT00003334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234237|NCT00003334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234238|NCT00003334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234240|NCT00093782|Temsirolimus|temsirolimus|mesh-list
92234241|NCT00093782|MTOR Inhibitors|mtor inhibitors|mesh-list
92234242|NCT00093782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92234243|NCT00093782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234244|NCT00093782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234245|NCT00093782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234246|NCT00093782|Immunologic Factors|immunologic factors|mesh-ancestor
92234247|NCT00093782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234248|NCT00093782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234249|NCT00093782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92234250|NCT00093782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234251|NCT00093782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234252|NCT00093782|Antifungal Agents|antifungal agents|mesh-ancestor
92234253|NCT00003760|Irofulven|irofulven|mesh-list
92234254|NCT00003760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234255|NCT00003760|Alkylating Agents|alkylating agents|mesh-ancestor
92234256|NCT00003760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234257|NCT00003760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234258|NCT04771754|Dolutegravir|dolutegravir|mesh-list
92234259|NCT04771754|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92234260|NCT04771754|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92234261|NCT04771754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234262|NCT04771754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234263|NCT04771754|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92234264|NCT04771754|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92234265|NCT04771754|Antiviral Agents|antiviral agents|mesh-ancestor
92234266|NCT04771754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234267|NCT00003766|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92234268|NCT00003766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234269|NCT00003766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234270|NCT00003766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234271|NCT00004030|Doxorubicin|doxorubicin|mesh-list
92234272|NCT00004030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234273|NCT00004030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234274|NCT00004030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234275|NCT00004030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234276|NCT00004030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234277|NCT00004030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234278|NCT00004030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234279|NCT04389320|Hydroxychloroquine|hydroxychloroquine|mesh-list
92234280|NCT04389320|Antimalarials|antimalarials|mesh-ancestor
92234281|NCT04389320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92234282|NCT04389320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92234283|NCT04389320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234284|NCT04389320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234285|NCT04389320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234286|NCT04389320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234287|NCT00003340|Cyclophosphamide|cyclophosphamide|mesh-list
92234288|NCT00003340|Topotecan|topotecan|mesh-list
92234289|NCT00003340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234290|NCT00003340|Immunologic Factors|immunologic factors|mesh-ancestor
92234291|NCT00003340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234292|NCT00003340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234293|NCT00003340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234294|NCT00003340|Alkylating Agents|alkylating agents|mesh-ancestor
92234295|NCT00003340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234296|NCT00003340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234297|NCT00003340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234298|NCT00003340|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234299|NCT00003340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234300|NCT00003340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234301|NCT00004036|Cyclophosphamide|cyclophosphamide|mesh-list
92234302|NCT00004036|Carboplatin|carboplatin|mesh-list
92234303|NCT00004036|Sargramostim|sargramostim|mesh-list
92234304|NCT00004036|Amifostine|amifostine|mesh-list
92234305|NCT00004036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234306|NCT00004036|Immunologic Factors|immunologic factors|mesh-ancestor
92234307|NCT00004036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234308|NCT00004036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234309|NCT00004036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234310|NCT00004036|Alkylating Agents|alkylating agents|mesh-ancestor
92234311|NCT00004036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234312|NCT00004036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234313|NCT00004036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234314|NCT00004036|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92234315|NCT00004036|Protective Agents|protective agents|mesh-ancestor
92234316|NCT00003346|Acetaminophen|acetaminophen|mesh-list
92234317|NCT00003346|Acetylcysteine|acetylcysteine|mesh-list
92234319|NCT00003346|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92234320|NCT00003346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92234321|NCT00003346|Analgesics|analgesics|mesh-ancestor
92234322|NCT00003346|Sensory System Agents|sensory system agents|mesh-ancestor
92234323|NCT00003346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234324|NCT00003346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234325|NCT00003346|Antipyretics|antipyretics|mesh-ancestor
92234326|NCT00003346|Antiviral Agents|antiviral agents|mesh-ancestor
92234327|NCT00003346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234328|NCT00003346|Expectorants|expectorants|mesh-ancestor
92234329|NCT00003346|Respiratory System Agents|respiratory system agents|mesh-ancestor
91991528|NCT02395783|Antioxidants|antioxidants|mesh-ancestor
92234330|NCT00003346|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92234332|NCT00003346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234333|NCT00003346|Protective Agents|protective agents|mesh-ancestor
92234334|NCT00003346|Antidotes|antidotes|mesh-ancestor
92234335|NCT00003346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234336|NCT00003346|Alkylating Agents|alkylating agents|mesh-ancestor
92234337|NCT00003346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234338|NCT00096122|Cytarabine|cytarabine|mesh-list
92234339|NCT00096122|Idarubicin|idarubicin|mesh-list
92234340|NCT00096122|Tipifarnib|tipifarnib|mesh-list
92234341|NCT00096122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234342|NCT00096122|Antimetabolites|antimetabolites|mesh-ancestor
92234343|NCT00096122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234344|NCT00096122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234345|NCT00096122|Antiviral Agents|antiviral agents|mesh-ancestor
92234346|NCT00096122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234347|NCT00096122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234348|NCT00096122|Immunologic Factors|immunologic factors|mesh-ancestor
92234349|NCT00096122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234350|NCT00096122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234351|NCT00096122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234352|NCT00096122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234353|NCT00096122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234354|NCT00003778|Dolastatin 10|dolastatin 10|mesh-list
92234355|NCT00003778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234356|NCT00003778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234357|NCT00003778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234358|NCT00003778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234359|NCT00003778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234360|NCT00004042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92234361|NCT00004042|Antibodies|antibodies|mesh-list
92234362|NCT00004042|Immunoglobulins|immunoglobulins|mesh-list
92234363|NCT00004042|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234364|NCT00004042|Immunologic Factors|immunologic factors|mesh-ancestor
92234365|NCT00004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234366|NCT00004042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234367|NCT00003784|Prednisone|prednisone|mesh-list
92234368|NCT00003784|Cyclophosphamide|cyclophosphamide|mesh-list
92234370|NCT00003784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234371|NCT00003784|Vincristine|vincristine|mesh-list
92234372|NCT00003784|Tositumomab I-131|tositumomab i-131|mesh-list
92234373|NCT00003784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234374|NCT00003784|Immunologic Factors|immunologic factors|mesh-ancestor
92234375|NCT00003784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234376|NCT00003784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234377|NCT00003784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234378|NCT00003784|Alkylating Agents|alkylating agents|mesh-ancestor
92234379|NCT00003784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234380|NCT00003784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234381|NCT00003784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234382|NCT00003784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234383|NCT00003784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234384|NCT00003784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234385|NCT00003784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234386|NCT00003784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234387|NCT00003784|Glucocorticoids|glucocorticoids|mesh-ancestor
92234388|NCT00003784|Hormones|hormones|mesh-ancestor
92234389|NCT00003784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234390|NCT00003784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92234391|NCT00003784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234392|NCT00003784|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234393|NCT00003784|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234394|NCT00003784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234395|NCT00003352|Cyclophosphamide|cyclophosphamide|mesh-list
92234396|NCT00003352|Docetaxel|docetaxel|mesh-list
92234397|NCT00003352|Doxorubicin|doxorubicin|mesh-list
92234398|NCT00003352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234399|NCT00003352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234400|NCT00003352|Immunologic Factors|immunologic factors|mesh-ancestor
92234401|NCT00003352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234402|NCT00003352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234403|NCT00003352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234404|NCT00003352|Alkylating Agents|alkylating agents|mesh-ancestor
92234405|NCT00003352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234406|NCT00003352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234407|NCT00003352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234408|NCT00003352|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234409|NCT00003352|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234410|NCT00003352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234411|NCT00003352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234412|NCT00003352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234413|NCT00003352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234414|NCT00003352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234415|NCT00004048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92234416|NCT00004048|Doxorubicin|doxorubicin|mesh-list
92234417|NCT00004048|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234418|NCT00004048|Antibodies|antibodies|mesh-list
92234419|NCT00004048|Immunoglobulins|immunoglobulins|mesh-list
92234420|NCT00004048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234421|NCT00004048|Immunologic Factors|immunologic factors|mesh-ancestor
92234422|NCT00004048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234423|NCT00004048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234424|NCT00004048|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234425|NCT00004048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234426|NCT00004048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234427|NCT00004048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234428|NCT00004048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234429|NCT00003358|Gemcitabine|gemcitabine|mesh-list
92234430|NCT00003358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234431|NCT00003358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234432|NCT00003358|Antimetabolites|antimetabolites|mesh-ancestor
92234433|NCT00003358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234434|NCT00004060|Exatecan|exatecan|mesh-list
92234435|NCT00004060|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234436|NCT00004060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234437|NCT00004060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234438|NCT00004060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234439|NCT00004060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234440|NCT00384826|Paclitaxel|paclitaxel|mesh-list
92234441|NCT00384826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92234442|NCT00384826|Carboplatin|carboplatin|mesh-list
92234443|NCT00384826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234444|NCT00384826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234445|NCT00384826|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234446|NCT00384826|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234447|NCT00384826|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234448|NCT00384826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234449|NCT00384826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92234450|NCT00384826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234451|NCT00003364|Cyclophosphamide|cyclophosphamide|mesh-list
92234452|NCT00003364|Doxorubicin|doxorubicin|mesh-list
92234453|NCT00003364|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234454|NCT00003364|Etoposide|etoposide|mesh-list
92234455|NCT00003364|Vincristine|vincristine|mesh-list
92234456|NCT00003364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234457|NCT00003364|Immunologic Factors|immunologic factors|mesh-ancestor
92234458|NCT00003364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234459|NCT00003364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234460|NCT00003364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234461|NCT00003364|Alkylating Agents|alkylating agents|mesh-ancestor
92234462|NCT00003364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234463|NCT00003364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234464|NCT00003364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234465|NCT00003364|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234466|NCT00003364|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234467|NCT00003364|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234468|NCT00003364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234469|NCT00003364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234470|NCT00003364|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234471|NCT00003364|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234472|NCT00003364|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234473|NCT00004066|Gemcitabine|gemcitabine|mesh-list
92234474|NCT00004066|Docetaxel|docetaxel|mesh-list
92234475|NCT00004066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234476|NCT00004066|Antimetabolites|antimetabolites|mesh-ancestor
92234477|NCT00004066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234478|NCT00004066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234479|NCT00004066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234480|NCT00004066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234481|NCT00004066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234482|NCT00003370|Irofulven|irofulven|mesh-list
92234483|NCT00003370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234484|NCT00003370|Alkylating Agents|alkylating agents|mesh-ancestor
92234485|NCT00003370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234486|NCT00003370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234487|NCT00003382|Gemcitabine|gemcitabine|mesh-list
92234488|NCT00003382|Topotecan|topotecan|mesh-list
92234489|NCT00003382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234490|NCT00003382|Antimetabolites|antimetabolites|mesh-ancestor
92234491|NCT00003382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234492|NCT00003382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234493|NCT00003382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234494|NCT00003382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234495|NCT00003382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234496|NCT00004834|Imipramine|imipramine|mesh-list
92234497|NCT00004834|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92234498|NCT00004834|Antidepressive Agents|antidepressive agents|mesh-ancestor
92234499|NCT00004834|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92234500|NCT00004834|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92234501|NCT00004834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92234502|NCT00004834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92234503|NCT00004834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234504|NCT00004834|Adrenergic Agents|adrenergic agents|mesh-ancestor
92234505|NCT00004834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92234506|NCT00004834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234507|NCT00004840|Hormones|hormones|mesh-list
92234508|NCT00004840|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
91934537|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234509|NCT00004840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234510|NCT00004840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234511|NCT00004852|Lamivudine|lamivudine|mesh-list
92234512|NCT00004852|Zidovudine|zidovudine|mesh-list
92234513|NCT00004852|Efavirenz|efavirenz|mesh-list
92234514|NCT00004852|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92234515|NCT00004852|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92234516|NCT00004852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234517|NCT00004852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234518|NCT00004852|Antiviral Agents|antiviral agents|mesh-ancestor
92234519|NCT00004852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234520|NCT00004852|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92234521|NCT00004852|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92234522|NCT00004852|Antimetabolites|antimetabolites|mesh-ancestor
92234523|NCT00004852|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92234524|NCT00004852|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92234525|NCT00004852|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92234526|NCT00004852|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92234527|NCT00004852|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92234528|NCT00004852|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92234529|NCT00004858|Genistein|genistein|mesh-list
92234530|NCT00004858|Immunoconjugates|immunoconjugates|mesh-list
92234531|NCT00004858|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92234532|NCT00004858|Protective Agents|protective agents|mesh-ancestor
92234533|NCT00004858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234534|NCT00004858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234535|NCT00004858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92234536|NCT00004858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234537|NCT00004858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234538|NCT00004858|Phytoestrogens|phytoestrogens|mesh-ancestor
92234539|NCT00004858|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92234540|NCT00004858|Estrogens|estrogens|mesh-ancestor
92234541|NCT00004858|Hormones|hormones|mesh-ancestor
92234542|NCT00004858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234543|NCT00004858|Immunologic Factors|immunologic factors|mesh-ancestor
92234544|NCT00004864|Docetaxel|docetaxel|mesh-list
92234545|NCT00004864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234546|NCT00004864|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234547|NCT00004864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234548|NCT00004864|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234549|NCT00004864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234550|NCT00003796|Irofulven|irofulven|mesh-list
92234551|NCT00003796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234552|NCT00003796|Alkylating Agents|alkylating agents|mesh-ancestor
92234553|NCT00003796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234554|NCT00003796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234555|NCT00003802|NSC 366140|nsc 366140|mesh-list
92234556|NCT00003802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234557|NCT02972866|Budesonide|budesonide|mesh-list
92234558|NCT02972866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234559|NCT02972866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92234560|NCT02972866|Autonomic Agents|autonomic agents|mesh-ancestor
92234561|NCT02972866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234562|NCT02972866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234563|NCT02972866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92234564|NCT02972866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92234565|NCT02972866|Glucocorticoids|glucocorticoids|mesh-ancestor
92234566|NCT02972866|Hormones|hormones|mesh-ancestor
92234567|NCT02972866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234568|NCT00003814|Eflornithine|eflornithine|mesh-list
92234569|NCT00003814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234570|NCT00003814|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92234571|NCT00003814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92234572|NCT00003814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92234573|NCT00003814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234574|NCT00003814|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92234575|NCT00003814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234576|NCT00003814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234577|NCT00003832|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
92234578|NCT00003832|5-bromouridine|5-bromouridine|mesh-list
92234579|NCT00003832|Antimetabolites|antimetabolites|mesh-ancestor
92234580|NCT00003832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234581|NCT00003832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234582|NCT00003832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234583|NCT00003832|Antiviral Agents|antiviral agents|mesh-ancestor
92234584|NCT00003832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234585|NCT00003850|Thalidomide|thalidomide|mesh-list
92234586|NCT00003850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234587|NCT00003850|Immunologic Factors|immunologic factors|mesh-ancestor
92234588|NCT00003850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234589|NCT00003850|Leprostatic Agents|leprostatic agents|mesh-ancestor
92234590|NCT00003850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92234591|NCT00003850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234592|NCT00003850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92234593|NCT00003850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92234594|NCT00003850|Growth Substances|growth substances|mesh-ancestor
92234595|NCT00003850|Growth Inhibitors|growth inhibitors|mesh-ancestor
92234596|NCT00003850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234597|NCT00004072|Carmustine|carmustine|mesh-list
92234598|NCT00004072|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92234599|NCT00004072|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234600|NCT00004072|Alkylating Agents|alkylating agents|mesh-ancestor
92234601|NCT00004072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234602|NCT00004072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234603|NCT00004072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234604|NCT00004078|Irinotecan|irinotecan|mesh-list
92234605|NCT00004078|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234606|NCT00004078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234607|NCT00004078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234608|NCT00004078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234609|NCT00004078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234610|NCT00003856|Temoporfin|temoporfin|mesh-list
92234611|NCT00003856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234612|NCT00003856|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92234613|NCT00003856|Dermatologic Agents|dermatologic agents|mesh-ancestor
92234614|NCT00014222|Paclitaxel|paclitaxel|mesh-list
92234615|NCT00014222|Cyclophosphamide|cyclophosphamide|mesh-list
92234616|NCT00014222|Doxorubicin|doxorubicin|mesh-list
92234617|NCT00014222|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234618|NCT00014222|Fluorouracil|fluorouracil|mesh-list
92234619|NCT00014222|Epirubicin|epirubicin|mesh-list
92234620|NCT00014222|Epoetin Alfa|epoetin alfa|mesh-list
92234621|NCT00014222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234622|NCT00014222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234623|NCT00014222|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234624|NCT00014222|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234625|NCT00014222|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234626|NCT00014222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234627|NCT00014222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234628|NCT00014222|Immunologic Factors|immunologic factors|mesh-ancestor
92234629|NCT00014222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234630|NCT00014222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234631|NCT00014222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234632|NCT00014222|Alkylating Agents|alkylating agents|mesh-ancestor
92234633|NCT00014222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234634|NCT00014222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234635|NCT00014222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234636|NCT00014222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234637|NCT00014222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234638|NCT00014222|Antimetabolites|antimetabolites|mesh-ancestor
92234639|NCT00014222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234640|NCT00014222|Hematinics|hematinics|mesh-ancestor
92234641|NCT00004870|Irinotecan|irinotecan|mesh-list
92234642|NCT00004870|Oblimersen|oblimersen|mesh-list
92234643|NCT00004870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234644|NCT00004870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234645|NCT00004870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234646|NCT00004870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234647|NCT00004870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234648|NCT00004084|Epratuzumab|epratuzumab|mesh-list
92234649|NCT00004084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92234650|NCT00004084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234651|NCT00004876|Thalidomide|thalidomide|mesh-list
92234652|NCT00004876|Carboplatin|carboplatin|mesh-list
92234653|NCT00004876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234654|NCT00004876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234655|NCT00004876|Immunologic Factors|immunologic factors|mesh-ancestor
92234656|NCT00004876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234657|NCT00004876|Leprostatic Agents|leprostatic agents|mesh-ancestor
92234658|NCT00004876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92234659|NCT00004876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234660|NCT00004876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92234661|NCT00004876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92234662|NCT00004876|Growth Substances|growth substances|mesh-ancestor
92234663|NCT00004876|Growth Inhibitors|growth inhibitors|mesh-ancestor
92234664|NCT00003862|Leucovorin|leucovorin|mesh-list
92234665|NCT00003862|Paclitaxel|paclitaxel|mesh-list
92234666|NCT00003862|Fluorouracil|fluorouracil|mesh-list
92234668|NCT00003862|Levoleucovorin|levoleucovorin|mesh-list
92234669|NCT00003862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234670|NCT00003862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234671|NCT00003862|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234672|NCT00003862|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234673|NCT00003862|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234674|NCT00003862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234675|NCT00003862|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92234676|NCT00003862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234677|NCT00003862|Antimetabolites|antimetabolites|mesh-ancestor
92234678|NCT00003862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234679|NCT00003862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234680|NCT00003862|Immunologic Factors|immunologic factors|mesh-ancestor
92234681|NCT00003862|Antidotes|antidotes|mesh-ancestor
92234682|NCT00003862|Protective Agents|protective agents|mesh-ancestor
92234683|NCT00003862|Vitamin B Complex|vitamin b complex|mesh-ancestor
92234685|NCT00003862|Micronutrients|micronutrients|mesh-ancestor
92234686|NCT00003868|Cyclophosphamide|cyclophosphamide|mesh-list
92234687|NCT00003868|Methotrexate|methotrexate|mesh-list
92234688|NCT00003868|Antibodies|antibodies|mesh-list
92234689|NCT00003868|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234690|NCT00003868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234691|NCT00003868|Immunologic Factors|immunologic factors|mesh-ancestor
92234692|NCT00003868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234693|NCT00003868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234694|NCT00003868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234695|NCT00003868|Alkylating Agents|alkylating agents|mesh-ancestor
92234696|NCT00003868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234697|NCT00003868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234698|NCT00003868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234699|NCT00003868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92234700|NCT00003868|Abortifacient Agents|abortifacient agents|mesh-ancestor
92234701|NCT00003868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92234702|NCT00003868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234703|NCT00003868|Antimetabolites|antimetabolites|mesh-ancestor
92234704|NCT00003868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92234705|NCT00003868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234706|NCT00003868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92234707|NCT00003868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92234708|NCT00003874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92234709|NCT00003874|Antibodies|antibodies|mesh-list
92234710|NCT00003874|Immunoglobulins|immunoglobulins|mesh-list
92234711|NCT00003874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234712|NCT00003874|Immunologic Factors|immunologic factors|mesh-ancestor
92234713|NCT00003874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234714|NCT00003874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234715|NCT00004090|Gemcitabine|gemcitabine|mesh-list
92234716|NCT00004090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234717|NCT00004090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234718|NCT00004090|Antimetabolites|antimetabolites|mesh-ancestor
92234719|NCT00004090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234720|NCT00004102|Leucovorin|leucovorin|mesh-list
92234721|NCT00004102|Fluorouracil|fluorouracil|mesh-list
92234722|NCT00004102|Oxaliplatin|oxaliplatin|mesh-list
92234723|NCT00004102|Calcium|calcium|mesh-list
92234724|NCT00004102|Levoleucovorin|levoleucovorin|mesh-list
92234725|NCT00004102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92234726|NCT00004102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234728|NCT00004102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234729|NCT00004102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234730|NCT00004102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234731|NCT00004102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234732|NCT00004102|Immunologic Factors|immunologic factors|mesh-ancestor
92234733|NCT00004102|Antidotes|antidotes|mesh-ancestor
92234734|NCT00004102|Protective Agents|protective agents|mesh-ancestor
92234735|NCT00004102|Vitamin B Complex|vitamin b complex|mesh-ancestor
92234736|NCT00004102|Vitamins|vitamins|mesh-ancestor
92234737|NCT00004102|Micronutrients|micronutrients|mesh-ancestor
92234738|NCT00003880|Paclitaxel|paclitaxel|mesh-list
92234739|NCT00003880|Carboplatin|carboplatin|mesh-list
92234740|NCT00003880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234741|NCT00003880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234742|NCT00003880|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234743|NCT00003880|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234744|NCT00003880|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234745|NCT00003880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234746|NCT00004108|Exatecan|exatecan|mesh-list
92234747|NCT00004108|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92234748|NCT00004108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234749|NCT00004108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234750|NCT00004108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234751|NCT00004108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234752|NCT00004900|Cyclophosphamide|cyclophosphamide|mesh-list
92234753|NCT00004900|Thiotepa|thiotepa|mesh-list
92234754|NCT00004900|Carboplatin|carboplatin|mesh-list
92234755|NCT00004900|Etoposide|etoposide|mesh-list
92234756|NCT00004900|Anastrozole|anastrozole|mesh-list
92234757|NCT00004900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234758|NCT00004900|Immunologic Factors|immunologic factors|mesh-ancestor
92234759|NCT00004900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234760|NCT00004900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234761|NCT00004900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234762|NCT00004900|Alkylating Agents|alkylating agents|mesh-ancestor
92234763|NCT00004900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234764|NCT00004900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234765|NCT00004900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234766|NCT00004900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234767|NCT00004900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234768|NCT00004900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234769|NCT00004900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234770|NCT00004900|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92234771|NCT00004900|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92234772|NCT00004900|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92234773|NCT00004900|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92234774|NCT00004900|Hormone Antagonists|hormone antagonists|mesh-ancestor
92234775|NCT00004900|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234776|NCT00004114|Cytarabine|cytarabine|mesh-list
92234777|NCT00004114|Cyclophosphamide|cyclophosphamide|mesh-list
92234778|NCT00004114|Fludarabine|fludarabine|mesh-list
92234779|NCT00004114|Fludarabine phosphate|fludarabine phosphate|mesh-list
92234780|NCT00004114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234781|NCT00004114|Immunologic Factors|immunologic factors|mesh-ancestor
92234782|NCT00004114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234783|NCT00004114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234784|NCT00004114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234785|NCT00004114|Alkylating Agents|alkylating agents|mesh-ancestor
92234786|NCT00004114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234787|NCT00004114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234788|NCT00004114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234789|NCT00004114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234790|NCT00004114|Antimetabolites|antimetabolites|mesh-ancestor
92234791|NCT00004114|Antiviral Agents|antiviral agents|mesh-ancestor
92234792|NCT00004114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234793|NCT00004906|Pamidronate|pamidronate|mesh-list
92234794|NCT00004906|Cyclophosphamide|cyclophosphamide|mesh-list
92234795|NCT00004906|Thiotepa|thiotepa|mesh-list
92234796|NCT00004906|Carboplatin|carboplatin|mesh-list
92234797|NCT00004906|Docetaxel|docetaxel|mesh-list
92234798|NCT00004906|Doxorubicin|doxorubicin|mesh-list
92234799|NCT00004906|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92234800|NCT00004906|Etoposide|etoposide|mesh-list
92234801|NCT00004906|Anastrozole|anastrozole|mesh-list
92234802|NCT00004906|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234803|NCT00004906|Immunologic Factors|immunologic factors|mesh-ancestor
92234804|NCT00004906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234805|NCT00004906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934542|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
92234806|NCT00004906|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234807|NCT00004906|Alkylating Agents|alkylating agents|mesh-ancestor
92234808|NCT00004906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234809|NCT00004906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234810|NCT00004906|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234811|NCT00004906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92234812|NCT00004906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92234813|NCT00004906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92234814|NCT00004906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92234815|NCT00004906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234816|NCT00004906|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234817|NCT00004906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234818|NCT00004906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234819|NCT00004906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92234820|NCT00004906|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92234821|NCT00004906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92234822|NCT00004906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92234823|NCT00004906|Hormone Antagonists|hormone antagonists|mesh-ancestor
92234824|NCT00004906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234825|NCT00004906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92234827|NCT00004918|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92234828|NCT00004918|Immunologic Factors|immunologic factors|mesh-ancestor
92234829|NCT00004918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234830|NCT00004918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92234831|NCT00003892|ISIS 5132|isis 5132|mesh-list
92234832|NCT00003892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234833|NCT00003892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234834|NCT00003892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234835|NCT00004132|Cyclophosphamide|cyclophosphamide|mesh-list
92234836|NCT00004132|Ifosfamide|ifosfamide|mesh-list
92234837|NCT00004132|Etoposide|etoposide|mesh-list
92234838|NCT00004132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234839|NCT00004132|Immunologic Factors|immunologic factors|mesh-ancestor
92234840|NCT00004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234841|NCT00004132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234842|NCT00004132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945337|NCT03529097|Morphine|morphine|mesh-list
92234843|NCT00004132|Alkylating Agents|alkylating agents|mesh-ancestor
92234844|NCT00004132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234845|NCT00004132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234846|NCT00004132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234847|NCT00004132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234848|NCT00004132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234849|NCT00004132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234850|NCT00004132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234851|NCT00004138|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92234852|NCT00004138|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92234853|NCT00004138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234854|NCT05776940|Dexamethasone|dexamethasone|mesh-list
92234855|NCT05776940|Dexamethasone acetate|dexamethasone acetate|mesh-list
92234856|NCT05776940|Bortezomib|bortezomib|mesh-list
92234857|NCT05776940|Daratumumab|daratumumab|mesh-list
92234858|NCT05776940|BB 1101|bb 1101|mesh-list
92234859|NCT05776940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92234860|NCT05776940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234861|NCT05776940|Antiemetics|antiemetics|mesh-ancestor
92234862|NCT05776940|Autonomic Agents|autonomic agents|mesh-ancestor
92234863|NCT05776940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234864|NCT05776940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234865|NCT05776940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92234866|NCT05776940|Glucocorticoids|glucocorticoids|mesh-ancestor
92234867|NCT05776940|Hormones|hormones|mesh-ancestor
92234868|NCT05776940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92234869|NCT05776940|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92234870|NCT05776940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234871|NCT05776940|Protease Inhibitors|protease inhibitors|mesh-ancestor
92234872|NCT05776940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234873|NCT05776940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234874|NCT05776940|Immunologic Factors|immunologic factors|mesh-ancestor
92234875|NCT05776862|Ursolic acid|ursolic acid|mesh-list
92234876|NCT05776862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234877|NCT05776862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234878|NCT05776862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234879|NCT05776862|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92234880|NCT05776862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234881|NCT05776862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234882|NCT05776862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92234883|NCT05776862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92234884|NCT05776862|Analgesics|analgesics|mesh-ancestor
92234885|NCT05776862|Sensory System Agents|sensory system agents|mesh-ancestor
92234886|NCT05776862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234887|NCT05776862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234888|NCT05776862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234889|NCT05776862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234890|NCT05776758|Cisplatin|cisplatin|mesh-list
92234891|NCT05776758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234892|NCT05776407|Cyclophosphamide|cyclophosphamide|mesh-list
92234893|NCT05776407|Fludarabine|fludarabine|mesh-list
92234894|NCT05776407|Etoposide|etoposide|mesh-list
92234895|NCT05776407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92234896|NCT05776407|Immunologic Factors|immunologic factors|mesh-ancestor
92234897|NCT05776407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234898|NCT05776407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234899|NCT05776407|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92234900|NCT05776407|Alkylating Agents|alkylating agents|mesh-ancestor
92234901|NCT05776407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234902|NCT05776407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234903|NCT05776407|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92234904|NCT05776407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92234905|NCT05776407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92234906|NCT05776407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92234907|NCT05776407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234908|NCT05776212|Fluorides|fluorides|mesh-list
92234909|NCT05776212|Cariostatic Agents|cariostatic agents|mesh-ancestor
92234910|NCT05776212|Protective Agents|protective agents|mesh-ancestor
92234911|NCT05776212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234912|NCT05776186|Bupivacaine|bupivacaine|mesh-list
92234913|NCT05776186|Anesthetics, Local|anesthetics, local|mesh-ancestor
92234914|NCT05776186|Anesthetics|anesthetics|mesh-ancestor
92234915|NCT05776186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92234916|NCT05776186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234917|NCT05776186|Sensory System Agents|sensory system agents|mesh-ancestor
92234918|NCT05776186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234919|NCT05776043|Dapagliflozin|dapagliflozin|mesh-list
92234920|NCT05776043|Empagliflozin|empagliflozin|mesh-list
92234921|NCT05776043|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92234922|NCT05776043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234923|NCT05776043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92234924|NCT05776043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234925|NCT05776030|Methamphetamine|methamphetamine|mesh-list
92234926|NCT05776030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92234927|NCT05776030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234928|NCT05776030|Sympathomimetics|sympathomimetics|mesh-ancestor
92234929|NCT05776030|Autonomic Agents|autonomic agents|mesh-ancestor
92234930|NCT05776030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234931|NCT05776030|Dopamine Agents|dopamine agents|mesh-ancestor
92234932|NCT05776030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92234933|NCT05776030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234934|NCT05776030|Adrenergic Agents|adrenergic agents|mesh-ancestor
92234935|NCT05776030|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92234936|NCT05776030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92234937|NCT05776030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92234938|NCT05776030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92234939|NCT05775965|Aspirin|aspirin|mesh-list
92234940|NCT05775965|Rivaroxaban|rivaroxaban|mesh-list
92234941|NCT05775965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92234942|NCT05775965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92234943|NCT05775965|Analgesics|analgesics|mesh-ancestor
92234945|NCT05775965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234946|NCT05775965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234947|NCT05775965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92234948|NCT05775965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92234949|NCT05775965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92234950|NCT05775965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92234951|NCT05775965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234952|NCT05775965|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92234953|NCT05775965|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92234954|NCT05775965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92234955|NCT05775965|Antipyretics|antipyretics|mesh-ancestor
92234956|NCT05775965|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92234957|NCT05775965|Antithrombins|antithrombins|mesh-ancestor
92234958|NCT05775965|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92234959|NCT05775965|Protease Inhibitors|protease inhibitors|mesh-ancestor
92234960|NCT05775965|Anticoagulants|anticoagulants|mesh-ancestor
92234961|NCT05775939|Deoxyglucose|deoxyglucose|mesh-list
92234962|NCT05775939|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92234963|NCT05775939|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92234964|NCT05775939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234965|NCT05775939|Antimetabolites|antimetabolites|mesh-ancestor
92234966|NCT05775939|Antiviral Agents|antiviral agents|mesh-ancestor
92234967|NCT05775939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92234968|NCT05775900|Capecitabine|capecitabine|mesh-list
92234969|NCT05775900|Cetuximab|cetuximab|mesh-list
92234970|NCT05775900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92234971|NCT05775900|Antimetabolites|antimetabolites|mesh-ancestor
92234972|NCT05775900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234973|NCT05775900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234974|NCT05775900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92234975|NCT05775874|Tislelizumab|tislelizumab|mesh-list
92234976|NCT05775874|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92234977|NCT05775874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92234978|NCT05775874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92234979|NCT05775874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234980|NCT05775861|Dexmedetomidine|dexmedetomidine|mesh-list
92234981|NCT05775861|Ropivacaine|ropivacaine|mesh-list
92234982|NCT05775861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92234983|NCT05775861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92234984|NCT05775861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92234985|NCT05775861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92234986|NCT05775861|Analgesics|analgesics|mesh-ancestor
92234987|NCT05775861|Sensory System Agents|sensory system agents|mesh-ancestor
92234988|NCT05775861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92234989|NCT05775861|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92234990|NCT05775861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92234991|NCT05775861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92234992|NCT05775861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92234993|NCT05775861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92234994|NCT05775861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92234995|NCT05775861|Anesthetics, Local|anesthetics, local|mesh-ancestor
92234996|NCT05775861|Anesthetics|anesthetics|mesh-ancestor
92234997|NCT05775770|Insulin|insulin|mesh-list
92234998|NCT05775770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92234999|NCT05775770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235000|NCT05775731|Hemostatics|hemostatics|mesh-list
92235001|NCT05775731|Coagulants|coagulants|mesh-ancestor
92235002|NCT05775705|Antibodies|antibodies|mesh-list
92235003|NCT05775705|Immunologic Factors|immunologic factors|mesh-ancestor
92235004|NCT05775705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235005|NCT05775692|Fluconazole|fluconazole|mesh-list
92235006|NCT05775692|Antifungal Agents|antifungal agents|mesh-ancestor
92235007|NCT05775692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235008|NCT05775692|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92235009|NCT05775692|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92235010|NCT05775692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235011|NCT05775692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235012|NCT05775692|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92235013|NCT05775692|Hormone Antagonists|hormone antagonists|mesh-ancestor
92235014|NCT05775692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235015|NCT05775692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235016|NCT05775692|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92235017|NCT05775692|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92235019|NCT05775536|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92235020|NCT05775536|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92235021|NCT05775536|Analgesics|analgesics|mesh-ancestor
92235022|NCT05775536|Sensory System Agents|sensory system agents|mesh-ancestor
92235023|NCT05775536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235024|NCT05775536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235025|NCT05775536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235026|NCT05775536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92235027|NCT05775536|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92235028|NCT05775536|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92235029|NCT05775536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235030|NCT05775536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92235031|NCT05775536|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92235032|NCT05775536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235034|NCT00004126|Paclitaxel|paclitaxel|mesh-list
92235035|NCT00004126|Oxaliplatin|oxaliplatin|mesh-list
92235036|NCT00004126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235037|NCT00004126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235038|NCT00004126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235039|NCT00004126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235040|NCT00004126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235041|NCT00004126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235042|NCT05774964|Folic Acid|folic acid|mesh-list
92235043|NCT05774964|Vitamin A|vitamin a|mesh-list
92235044|NCT05774964|Metronidazole|metronidazole|mesh-list
92235045|NCT05774964|Oxaliplatin|oxaliplatin|mesh-list
92235046|NCT05774964|Cetuximab|cetuximab|mesh-list
92235047|NCT05774964|Tegafur|tegafur|mesh-list
92235048|NCT05774964|Vitamins|vitamins|mesh-ancestor
92235049|NCT05774964|Micronutrients|micronutrients|mesh-ancestor
92235050|NCT05774964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235051|NCT05774964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235052|NCT05774964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235053|NCT05774964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235054|NCT05774964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92235055|NCT05774964|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92235056|NCT05774964|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92235057|NCT05774964|Hematinics|hematinics|mesh-ancestor
92235058|NCT05774964|Vitamin B Complex|vitamin b complex|mesh-ancestor
92235059|NCT05774964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235060|NCT05774964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235061|NCT05774964|Antimetabolites|antimetabolites|mesh-ancestor
92235062|NCT05774691|Heparin|heparin|mesh-list
92235063|NCT05774691|Calcium heparin|calcium heparin|mesh-list
92235064|NCT05774691|Protamines|protamines|mesh-list
92235065|NCT05774691|Anticoagulants|anticoagulants|mesh-ancestor
92235066|NCT05774691|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92235067|NCT05774691|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92235068|NCT05774691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235069|NCT05774691|Heparin Antagonists|heparin antagonists|mesh-ancestor
92235070|NCT05774691|Coagulants|coagulants|mesh-ancestor
92235071|NCT05773976|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92235072|NCT05773976|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92235073|NCT05773963|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92235074|NCT05773963|Lubricant Eye Drops|lubricant eye drops|mesh-list
92235075|NCT05773963|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92235076|NCT05773950|Fosaprepitant|fosaprepitant|mesh-list
92235077|NCT05773950|Aprepitant|aprepitant|mesh-list
92235078|NCT05773950|Antiemetics|antiemetics|mesh-ancestor
92235079|NCT05773950|Autonomic Agents|autonomic agents|mesh-ancestor
92235080|NCT05773950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235081|NCT05773950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235082|NCT05773950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235083|NCT05773950|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92235084|NCT05773950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235085|NCT05773950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235087|NCT05773222|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92235088|NCT05773222|Antithrombins|antithrombins|mesh-ancestor
92235089|NCT05773222|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92235090|NCT05773222|Protease Inhibitors|protease inhibitors|mesh-ancestor
92235091|NCT05773222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235092|NCT05773222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235093|NCT05773222|Anticoagulants|anticoagulants|mesh-ancestor
92235094|NCT05638594|Carboplatin|carboplatin|mesh-list
92235095|NCT05638594|Docetaxel|docetaxel|mesh-list
92235096|NCT05638594|Trastuzumab|trastuzumab|mesh-list
92235097|NCT05638594|Letrozole|letrozole|mesh-list
92235099|NCT05638594|Hormones|hormones|mesh-list
92235100|NCT05638594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235101|NCT05638594|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235102|NCT05638594|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235103|NCT05638594|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235104|NCT05638594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235105|NCT05638594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235106|NCT05638594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235107|NCT05638594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235108|NCT05638594|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92235109|NCT05638594|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92235110|NCT05638594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235111|NCT05638594|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92235112|NCT05638594|Hormone Antagonists|hormone antagonists|mesh-ancestor
92235113|NCT05635227|Dexamethasone|dexamethasone|mesh-list
92235114|NCT05635227|Olanzapine|olanzapine|mesh-list
92235115|NCT05635227|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92235116|NCT05635227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235117|NCT05635227|Antiemetics|antiemetics|mesh-ancestor
92235118|NCT05635227|Autonomic Agents|autonomic agents|mesh-ancestor
92235119|NCT05635227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235120|NCT05635227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235121|NCT05635227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235122|NCT05635227|Glucocorticoids|glucocorticoids|mesh-ancestor
92235123|NCT05635227|Hormones|hormones|mesh-ancestor
92235124|NCT05635227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235125|NCT05635227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235126|NCT05635227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235127|NCT05635227|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92235128|NCT05635227|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92235129|NCT05635227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235130|NCT05635227|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92235131|NCT05635227|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92235132|NCT05635227|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92235133|NCT05635227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92235134|NCT05635227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235135|NCT05635227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235136|NCT05635227|Serotonin Agents|serotonin agents|mesh-ancestor
92235137|NCT05607147|Antibodies|antibodies|mesh-list
92235138|NCT05607147|Immunologic Factors|immunologic factors|mesh-ancestor
92235139|NCT05607147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235140|NCT05519254|Lactoferrin|lactoferrin|mesh-list
92235141|NCT05519254|Muramidase|muramidase|mesh-list
92235142|NCT05519254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235143|NCT05493475|Fentanyl|fentanyl|mesh-list
92235144|NCT05493475|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92235145|NCT05493475|Narcotics|narcotics|mesh-ancestor
92235146|NCT05493475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235147|NCT05493475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235148|NCT05493475|Analgesics|analgesics|mesh-ancestor
92235149|NCT05493475|Sensory System Agents|sensory system agents|mesh-ancestor
92235150|NCT05493475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235151|NCT05493475|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92235152|NCT05493475|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92235153|NCT05493475|Anesthetics, General|anesthetics, general|mesh-ancestor
92235154|NCT05493475|Anesthetics|anesthetics|mesh-ancestor
92235155|NCT05463341|Fentanyl|fentanyl|mesh-list
92235156|NCT05463341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92235157|NCT05463341|Narcotics|narcotics|mesh-ancestor
92235158|NCT05463341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235159|NCT05463341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235160|NCT05463341|Analgesics|analgesics|mesh-ancestor
92235161|NCT05463341|Sensory System Agents|sensory system agents|mesh-ancestor
92235162|NCT05463341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235163|NCT05463341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92235164|NCT05463341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92235165|NCT05463341|Anesthetics, General|anesthetics, general|mesh-ancestor
92235167|NCT05429970|Etodolac|etodolac|mesh-list
92235168|NCT05429970|Propofol|propofol|mesh-list
92235169|NCT05429970|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92235170|NCT05429970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235171|NCT05429970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235172|NCT05429970|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92235173|NCT05429970|Anesthetics, General|anesthetics, general|mesh-ancestor
92235174|NCT05429970|Anesthetics|anesthetics|mesh-ancestor
92235175|NCT05429970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92235176|NCT05429970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92235177|NCT05429970|Analgesics|analgesics|mesh-ancestor
92235178|NCT05429970|Sensory System Agents|sensory system agents|mesh-ancestor
92235179|NCT05429970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235180|NCT05429970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235181|NCT05429970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92235182|NCT05429970|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92235183|NCT05429970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92235184|NCT05429970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235185|NCT05429970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235186|NCT05376904|Ropivacaine|ropivacaine|mesh-list
92235187|NCT05376904|Anesthetics, Local|anesthetics, local|mesh-ancestor
92235188|NCT05376904|Anesthetics|anesthetics|mesh-ancestor
92235189|NCT05376904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235190|NCT05376904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235191|NCT05376904|Sensory System Agents|sensory system agents|mesh-ancestor
92235192|NCT05376904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235193|NCT05329740|Methylprednisolone|methylprednisolone|mesh-list
92235194|NCT05329740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92235195|NCT05329740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92235196|NCT05329740|Prednisolone|prednisolone|mesh-list
92235197|NCT05329740|Prednisolone acetate|prednisolone acetate|mesh-list
92235198|NCT05329740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92235199|NCT05329740|Prednisolone phosphate|prednisolone phosphate|mesh-list
92235200|NCT05329740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235201|NCT05329740|Antiemetics|antiemetics|mesh-ancestor
92235202|NCT05329740|Autonomic Agents|autonomic agents|mesh-ancestor
92235203|NCT05329740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235204|NCT05329740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235205|NCT05329740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235206|NCT05329740|Glucocorticoids|glucocorticoids|mesh-ancestor
92235207|NCT05329740|Hormones|hormones|mesh-ancestor
92235208|NCT05329740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235209|NCT05329740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92235210|NCT05329740|Protective Agents|protective agents|mesh-ancestor
92235211|NCT05329740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235212|NCT05329740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235213|NCT05298670|Metformin|metformin|mesh-list
92235214|NCT05298670|Interferons|interferons|mesh-list
92235215|NCT05298670|Interferon-beta|interferon-beta|mesh-list
92235216|NCT05298670|Interferon beta-1a|interferon beta-1a|mesh-list
92235217|NCT05298670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92235218|NCT05298670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235219|NCT05298670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235220|NCT05298670|Antiviral Agents|antiviral agents|mesh-ancestor
92235221|NCT05298670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235222|NCT05298670|Immunologic Factors|immunologic factors|mesh-ancestor
92235223|NCT05298670|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92235224|NCT05297851|Riboflavin|riboflavin|mesh-list
92235225|NCT05297851|Niacinamide|niacinamide|mesh-list
92235226|NCT05297851|Niacin|niacin|mesh-list
92235227|NCT05297851|Nicotinic Acids|nicotinic acids|mesh-list
92235228|NCT05297851|Vitamin B Complex|vitamin b complex|mesh-ancestor
92235229|NCT05297851|Vitamins|vitamins|mesh-ancestor
92235230|NCT05297851|Micronutrients|micronutrients|mesh-ancestor
92235231|NCT05297851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235232|NCT05297851|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92235233|NCT05297851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92235234|NCT05297851|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92235235|NCT05297851|Antimetabolites|antimetabolites|mesh-ancestor
92235236|NCT05297851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235237|NCT05297851|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92235238|NCT05297851|Vasodilator Agents|vasodilator agents|mesh-ancestor
92235239|NCT05271318|Pembrolizumab|pembrolizumab|mesh-list
92235240|NCT05271318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235241|NCT05271318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235242|NCT05271318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235243|NCT05271318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235244|NCT05252598|Psilocybin|psilocybin|mesh-list
92235245|NCT05252598|Hallucinogens|hallucinogens|mesh-ancestor
92235246|NCT05252598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235247|NCT05252598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92235248|NCT05223829|Brexanolone|brexanolone|mesh-list
92235249|NCT05223829|Neurosteroids|neurosteroids|mesh-ancestor
92235250|NCT05223829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235251|NCT05223829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235252|NCT05223829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235253|NCT05223829|GABA Modulators|gaba modulators|mesh-ancestor
92235254|NCT05223829|GABA Agents|gaba agents|mesh-ancestor
92235255|NCT05180006|Bevacizumab|bevacizumab|mesh-list
92235256|NCT05180006|Trastuzumab|trastuzumab|mesh-list
92235257|NCT05180006|Atezolizumab|atezolizumab|mesh-list
92235258|NCT05180006|Pertuzumab|pertuzumab|mesh-list
92235259|NCT05180006|Ipatasertib|ipatasertib|mesh-list
92235260|NCT05180006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235261|NCT05180006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235262|NCT05180006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92235263|NCT05180006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92235264|NCT05180006|Growth Substances|growth substances|mesh-ancestor
92235265|NCT05180006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235266|NCT05180006|Growth Inhibitors|growth inhibitors|mesh-ancestor
92235267|NCT05180006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235268|NCT05180006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235269|NCT05180006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92235270|NCT05180006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235271|NCT05148884|Befiradol|befiradol|mesh-list
92235272|NCT05148884|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92235273|NCT05148884|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92235274|NCT05148884|Serotonin Agents|serotonin agents|mesh-ancestor
92235275|NCT05148884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235276|NCT05148884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235277|NCT05148884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235278|NCT05144854|Capecitabine|capecitabine|mesh-list
92235279|NCT05144854|Tegafur|tegafur|mesh-list
92235280|NCT05144854|Oxaliplatin|oxaliplatin|mesh-list
92235281|NCT05144854|Nivolumab|nivolumab|mesh-list
92235282|NCT05144854|Ipilimumab|ipilimumab|mesh-list
92235283|NCT05144854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235284|NCT05144854|Antimetabolites|antimetabolites|mesh-ancestor
92235285|NCT05144854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235286|NCT05144854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235287|NCT05144854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235289|NCT05099666|Doxorubicin|doxorubicin|mesh-list
92235290|NCT05099666|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92235291|NCT05099666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235292|NCT05099666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235293|NCT05099666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235294|NCT05099666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235295|NCT05099666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235296|NCT05042817|Sufentanil|sufentanil|mesh-list
92235297|NCT05042817|Morphine|morphine|mesh-list
92235298|NCT05042817|Prilocaine|prilocaine|mesh-list
92235299|NCT05042817|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92235300|NCT05042817|Narcotics|narcotics|mesh-ancestor
92235301|NCT05042817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235302|NCT05042817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235303|NCT05042817|Analgesics|analgesics|mesh-ancestor
92235304|NCT05042817|Sensory System Agents|sensory system agents|mesh-ancestor
92235305|NCT05042817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235306|NCT05042817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92235307|NCT05042817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92235308|NCT05042817|Anesthetics, General|anesthetics, general|mesh-ancestor
92235309|NCT05042817|Anesthetics|anesthetics|mesh-ancestor
92235310|NCT05042817|Anesthetics, Local|anesthetics, local|mesh-ancestor
92235311|NCT05042505|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92235312|NCT05042505|Dapagliflozin|dapagliflozin|mesh-list
92235313|NCT05042505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92235314|NCT05042505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235315|NCT05042505|Incretins|incretins|mesh-ancestor
92235316|NCT05042505|Hormones|hormones|mesh-ancestor
92235317|NCT05042505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235318|NCT05042505|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92235319|NCT05042505|Protease Inhibitors|protease inhibitors|mesh-ancestor
92235320|NCT05042505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235321|NCT05042505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235322|NCT05042505|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92235323|NCT04914234|Metoprolol|metoprolol|mesh-list
92235324|NCT04914234|Atenolol|atenolol|mesh-list
92235325|NCT04914234|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92235326|NCT04914234|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92235327|NCT04914234|Sympatholytics|sympatholytics|mesh-ancestor
92235328|NCT04914234|Autonomic Agents|autonomic agents|mesh-ancestor
92235329|NCT04914234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235330|NCT04914234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235331|NCT04914234|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92235332|NCT04914234|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92235333|NCT04914234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92235334|NCT04914234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92235335|NCT04914234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235336|NCT04914234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235337|NCT04895566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92235338|NCT04895566|Antibodies|antibodies|mesh-list
92235339|NCT04895566|Immunoglobulins|immunoglobulins|mesh-list
92235340|NCT04895566|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92235341|NCT04895566|Immunologic Factors|immunologic factors|mesh-ancestor
92235342|NCT04895566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235343|NCT04895566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235344|NCT04779320|Vedolizumab|vedolizumab|mesh-list
92235345|NCT04779320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235346|NCT04779307|Vedolizumab|vedolizumab|mesh-list
92235347|NCT04779307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235348|NCT04762199|Osimertinib|osimertinib|mesh-list
92235349|NCT04762199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235350|NCT04762199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92235351|NCT04762199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235352|NCT04762199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235353|NCT04737187|Trifluridine|trifluridine|mesh-list
92235354|NCT04737187|Bevacizumab|bevacizumab|mesh-list
92235355|NCT04737187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235356|NCT04737187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235357|NCT04737187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92235358|NCT04737187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92235359|NCT04737187|Growth Substances|growth substances|mesh-ancestor
92235360|NCT04737187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235361|NCT04737187|Growth Inhibitors|growth inhibitors|mesh-ancestor
92235362|NCT04737187|Antimetabolites|antimetabolites|mesh-ancestor
92235363|NCT04737187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235364|NCT04737187|Antiviral Agents|antiviral agents|mesh-ancestor
92235365|NCT04737187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235366|NCT04733157|Tranexamic Acid|tranexamic acid|mesh-list
92235367|NCT04733157|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92235368|NCT04733157|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92235369|NCT04733157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235370|NCT04733157|Hemostatics|hemostatics|mesh-ancestor
92235371|NCT04733157|Coagulants|coagulants|mesh-ancestor
92235372|NCT04723147|Levodopa|levodopa|mesh-list
92235373|NCT04723147|Carbidopa|carbidopa|mesh-list
92235374|NCT04723147|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92339094|NCT04713761|Carboplatin|carboplatin|mesh-list
92235375|NCT04723147|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92235376|NCT04723147|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92235377|NCT04723147|Dopamine Agents|dopamine agents|mesh-ancestor
92235378|NCT04723147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117527|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92235379|NCT04723147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235380|NCT04723147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235381|NCT04723147|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92235382|NCT04723147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235383|NCT04723147|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92235384|NCT04723147|Immunologic Factors|immunologic factors|mesh-ancestor
92235385|NCT04723147|Dopamine Agonists|dopamine agonists|mesh-ancestor
92235386|NCT04662710|Leucovorin|leucovorin|mesh-list
92235387|NCT04662710|Pembrolizumab|pembrolizumab|mesh-list
92235388|NCT04662710|Capecitabine|capecitabine|mesh-list
92235389|NCT04662710|Oxaliplatin|oxaliplatin|mesh-list
92235390|NCT04662710|Lenvatinib|lenvatinib|mesh-list
92235391|NCT04662710|Levoleucovorin|levoleucovorin|mesh-list
92235392|NCT04662710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235393|NCT04662710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235394|NCT04662710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235395|NCT04662710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235396|NCT04662710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235397|NCT04662710|Antimetabolites|antimetabolites|mesh-ancestor
92235398|NCT04662710|Antidotes|antidotes|mesh-ancestor
92235399|NCT04662710|Protective Agents|protective agents|mesh-ancestor
92235400|NCT04662710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235401|NCT04662710|Vitamin B Complex|vitamin b complex|mesh-ancestor
92235403|NCT04662710|Micronutrients|micronutrients|mesh-ancestor
92235404|NCT04662710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92235405|NCT04662710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235406|NCT04659174|Xanomeline|xanomeline|mesh-list
92235407|NCT04659174|Trospium chloride|trospium chloride|mesh-list
92235408|NCT04659174|Parasympatholytics|parasympatholytics|mesh-ancestor
92235409|NCT04659174|Autonomic Agents|autonomic agents|mesh-ancestor
92235410|NCT04659174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235411|NCT04659174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235412|NCT04659174|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92235413|NCT04659174|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92235414|NCT04659174|Cholinergic Agents|cholinergic agents|mesh-ancestor
92235415|NCT04659174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235416|NCT04659174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235417|NCT04659174|Urological Agents|urological agents|mesh-ancestor
92235418|NCT04659174|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92235419|NCT04659174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92235420|NCT04659174|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92235421|NCT04659174|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92235422|NCT04653662|Carbamide Peroxide|carbamide peroxide|mesh-list
92235423|NCT04653662|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92235424|NCT04653662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235425|NCT04643405|Paclitaxel|paclitaxel|mesh-list
92235426|NCT04643405|Gemcitabine|gemcitabine|mesh-list
92235427|NCT04643405|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235428|NCT04643405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235429|NCT04643405|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235430|NCT04643405|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235431|NCT04643405|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235432|NCT04643405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235433|NCT04643405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235434|NCT04643405|Antimetabolites|antimetabolites|mesh-ancestor
92235435|NCT04633122|Sunitinib|sunitinib|mesh-list
92235436|NCT04633122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235437|NCT04633122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92235438|NCT04633122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92235439|NCT04633122|Growth Substances|growth substances|mesh-ancestor
92235440|NCT04633122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235441|NCT04633122|Growth Inhibitors|growth inhibitors|mesh-ancestor
92235442|NCT04633122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92235443|NCT04633122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235444|NCT04633122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235446|NCT04569747|Trastuzumab|trastuzumab|mesh-list
92235447|NCT04569747|Pertuzumab|pertuzumab|mesh-list
92235448|NCT04569747|Letrozole|letrozole|mesh-list
92235449|NCT04569747|Anastrozole|anastrozole|mesh-list
92235450|NCT04569747|Leuprolide|leuprolide|mesh-list
92235451|NCT04569747|Exemestane|exemestane|mesh-list
92235452|NCT04569747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235453|NCT04569747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235454|NCT04569747|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92235455|NCT04569747|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92235456|NCT04569747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235457|NCT04569747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235458|NCT04569747|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92235459|NCT04569747|Hormone Antagonists|hormone antagonists|mesh-ancestor
92235460|NCT04569747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235461|NCT04569747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235462|NCT04569747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235463|NCT04569747|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92235464|NCT04569747|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92235465|NCT04569747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92235466|NCT04569747|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92235467|NCT04569747|Fertility Agents|fertility agents|mesh-ancestor
92235468|NCT04569747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92235469|NCT04543942|Ethanol|ethanol|mesh-list
92235470|NCT04543942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92235471|NCT04543942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235472|NCT04543942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235473|NCT04543942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235474|NCT04538950|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92235475|NCT04538950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235476|NCT04531046|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92235477|NCT04531046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235478|NCT04531046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235479|NCT04500158|Lidocaine|lidocaine|mesh-list
92235480|NCT04500158|Anesthetics, Local|anesthetics, local|mesh-ancestor
92235481|NCT04500158|Anesthetics|anesthetics|mesh-ancestor
92235482|NCT04500158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235483|NCT04500158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235484|NCT04500158|Sensory System Agents|sensory system agents|mesh-ancestor
92235485|NCT04500158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235486|NCT04500158|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92235487|NCT04500158|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92235488|NCT04500158|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92235489|NCT04500158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92235490|NCT04500158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235491|NCT04439279|Trametinib|trametinib|mesh-list
92235492|NCT04439279|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92235493|NCT04439279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235494|NCT04439279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92235495|NCT04439279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235496|NCT04439279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235497|NCT04439279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92235498|NCT04439279|Protective Agents|protective agents|mesh-ancestor
92235499|NCT04439279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235500|NCT04439279|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92235501|NCT04439279|Antioxidants|antioxidants|mesh-ancestor
92235502|NCT04439201|Palbociclib|palbociclib|mesh-list
92235503|NCT04439201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235504|NCT04439201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92235505|NCT04439201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235506|NCT04439201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235507|NCT04304755|Zoledronic Acid|zoledronic acid|mesh-list
92235508|NCT04304755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92235509|NCT04304755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235510|NCT04273165|Etravirine|etravirine|mesh-list
92235511|NCT04273165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92235512|NCT04273165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92235513|NCT04273165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235514|NCT04273165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235516|NCT04273165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235517|NCT04179968|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92235518|NCT04179968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92235519|NCT04179968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235521|NCT04140526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235522|NCT04140526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235523|NCT04140526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235524|NCT04140526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235525|NCT04041128|Olaparib|olaparib|mesh-list
92235526|NCT04041128|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92235527|NCT04041128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235528|NCT04041128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235529|NCT04041128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235530|NCT04030962|Lifitegrast|lifitegrast|mesh-list
92235531|NCT04030962|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92235532|NCT04030962|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92235533|NCT03951753|Tirzepatide|tirzepatide|mesh-list
92235534|NCT03951753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92235535|NCT03951753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235536|NCT03951753|Incretins|incretins|mesh-ancestor
92235537|NCT03951753|Hormones|hormones|mesh-ancestor
92235538|NCT03951753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235539|NCT03947671|Acetaminophen|acetaminophen|mesh-list
92235540|NCT03947671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92235541|NCT03947671|Analgesics|analgesics|mesh-ancestor
92235542|NCT03947671|Sensory System Agents|sensory system agents|mesh-ancestor
91934553|NCT02342145|Cyclosporine|cyclosporine|mesh-list
92235543|NCT03947671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235544|NCT03947671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235545|NCT03947671|Antipyretics|antipyretics|mesh-ancestor
92235546|NCT03941964|Azacitidine|azacitidine|mesh-list
92235547|NCT03941964|Decitabine|decitabine|mesh-list
92235548|NCT03941964|Venetoclax|venetoclax|mesh-list
92235549|NCT03941964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235550|NCT03941964|Antimetabolites|antimetabolites|mesh-ancestor
92235551|NCT03941964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235552|NCT03941964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235553|NCT03941964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235554|NCT03837509|Daratumumab|daratumumab|mesh-list
92235555|NCT03837509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235556|NCT03808077|Rocuronium|rocuronium|mesh-list
92235557|NCT03808077|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92235558|NCT03808077|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92235559|NCT03808077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92235560|NCT03808077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235561|NCT03808077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235562|NCT03630705|Vaccines|vaccines|mesh-list
92235563|NCT03630705|Immunologic Factors|immunologic factors|mesh-ancestor
92235564|NCT03630705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235565|NCT03603184|Paclitaxel|paclitaxel|mesh-list
92235566|NCT03603184|Carboplatin|carboplatin|mesh-list
92235567|NCT03603184|Atezolizumab|atezolizumab|mesh-list
92235568|NCT03603184|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235569|NCT03603184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235570|NCT03603184|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235571|NCT03603184|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235572|NCT03603184|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235573|NCT03603184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235574|NCT03603184|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235575|NCT03603184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235576|NCT03586999|Nivolumab|nivolumab|mesh-list
92235577|NCT03586999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235578|NCT03586999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235579|NCT03586999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235580|NCT03586999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235581|NCT03507452|BAY 2287411|bay 2287411|mesh-list
92235582|NCT03507452|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92235583|NCT03507452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235585|NCT03493490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92235586|NCT03493490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92235588|NCT03493490|Sensory System Agents|sensory system agents|mesh-ancestor
92235589|NCT03493490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235590|NCT03493490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235591|NCT03493490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235592|NCT03493490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92235593|NCT03493490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92235594|NCT03493490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235595|NCT03493490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235596|NCT03377491|Paclitaxel|paclitaxel|mesh-list
92235597|NCT03377491|Gemcitabine|gemcitabine|mesh-list
92235598|NCT03377491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235599|NCT03377491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235600|NCT03377491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235601|NCT03377491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235602|NCT03377491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235603|NCT03377491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235604|NCT03377491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235605|NCT03377491|Antimetabolites|antimetabolites|mesh-ancestor
92235606|NCT03298087|Leuprolide|leuprolide|mesh-list
92235607|NCT03298087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92235608|NCT03298087|Fertility Agents|fertility agents|mesh-ancestor
92235609|NCT03298087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92235610|NCT03298087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235611|NCT03298087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235612|NCT03298087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235613|NCT03297359|Dalteparin|dalteparin|mesh-list
92235614|NCT03297359|Tinzaparin|tinzaparin|mesh-list
92235615|NCT03297359|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92235617|NCT03297359|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92235618|NCT03297359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92235619|NCT03297359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235620|NCT03189719|Pembrolizumab|pembrolizumab|mesh-list
92235621|NCT03189719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235622|NCT03189719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235623|NCT03189719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235624|NCT03189719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235625|NCT02889081|Vitamin D|vitamin d|mesh-list
92235626|NCT02889081|Vitamins|vitamins|mesh-ancestor
92235627|NCT02889081|Micronutrients|micronutrients|mesh-ancestor
92235628|NCT02889081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235629|NCT02889081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92235630|NCT02856594|Dexmedetomidine|dexmedetomidine|mesh-list
92235631|NCT02856594|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92235632|NCT02856594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235633|NCT02856594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235634|NCT02856594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92235635|NCT02856594|Analgesics|analgesics|mesh-ancestor
92235636|NCT02856594|Sensory System Agents|sensory system agents|mesh-ancestor
92235637|NCT02856594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235638|NCT02856594|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92235639|NCT02856594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92235640|NCT02856594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92235641|NCT02856594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92235642|NCT02856594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235643|NCT02856594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235644|NCT02840539|Cytarabine|cytarabine|mesh-list
92235645|NCT02840539|Dexamethasone|dexamethasone|mesh-list
92235646|NCT02840539|Dexamethasone acetate|dexamethasone acetate|mesh-list
92235647|NCT02840539|Bortezomib|bortezomib|mesh-list
92235648|NCT02840539|BB 1101|bb 1101|mesh-list
92235649|NCT02840539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235650|NCT02840539|Antiemetics|antiemetics|mesh-ancestor
92235651|NCT02840539|Autonomic Agents|autonomic agents|mesh-ancestor
92235652|NCT02840539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235653|NCT02840539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235654|NCT02840539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235655|NCT02840539|Glucocorticoids|glucocorticoids|mesh-ancestor
92235656|NCT02840539|Hormones|hormones|mesh-ancestor
92235657|NCT02840539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235658|NCT02840539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235659|NCT02840539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235660|NCT02840539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92235661|NCT02840539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235662|NCT02840539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235663|NCT02840539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235664|NCT02840539|Antimetabolites|antimetabolites|mesh-ancestor
92235665|NCT02840539|Antiviral Agents|antiviral agents|mesh-ancestor
92235666|NCT02840539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235667|NCT02840539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235669|NCT02453594|Pembrolizumab|pembrolizumab|mesh-list
92235670|NCT02453594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235671|NCT02453594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235672|NCT02453594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92235673|NCT02453594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235674|NCT02342782|Cytarabine|cytarabine|mesh-list
92235675|NCT02342782|Etoposide|etoposide|mesh-list
92235676|NCT02342782|Melphalan|melphalan|mesh-list
92235677|NCT02342782|Carmustine|carmustine|mesh-list
92235678|NCT02342782|Basiliximab|basiliximab|mesh-list
92235679|NCT02342782|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235680|NCT02342782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235681|NCT02342782|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235682|NCT02342782|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235683|NCT02342782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117528|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
92235684|NCT02342782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235685|NCT02342782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235686|NCT02342782|Antimetabolites|antimetabolites|mesh-ancestor
92235687|NCT02342782|Antiviral Agents|antiviral agents|mesh-ancestor
92235688|NCT02342782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235689|NCT02342782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235690|NCT02342782|Immunologic Factors|immunologic factors|mesh-ancestor
92235691|NCT02342782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235692|NCT02342782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92235693|NCT02342782|Alkylating Agents|alkylating agents|mesh-ancestor
92235694|NCT02342782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92235695|NCT02291055|Durvalumab|durvalumab|mesh-list
92235696|NCT02291055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235697|NCT02291055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235698|NCT02112864|Dexamethasone|dexamethasone|mesh-list
92235699|NCT02112864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235700|NCT02112864|Antiemetics|antiemetics|mesh-ancestor
92235701|NCT02112864|Autonomic Agents|autonomic agents|mesh-ancestor
92235702|NCT02112864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235703|NCT02112864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235704|NCT02112864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235705|NCT02112864|Glucocorticoids|glucocorticoids|mesh-ancestor
92235706|NCT02112864|Hormones|hormones|mesh-ancestor
92235707|NCT02112864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235708|NCT02112864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235709|NCT02112864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235710|NCT02106988|Dexamethasone|dexamethasone|mesh-list
92235711|NCT02106988|Carboplatin|carboplatin|mesh-list
92235712|NCT02106988|Etoposide|etoposide|mesh-list
92235713|NCT02106988|Ifosfamide|ifosfamide|mesh-list
92235714|NCT02106988|Etoposide phosphate|etoposide phosphate|mesh-list
92235715|NCT02106988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235716|NCT02106988|Antiemetics|antiemetics|mesh-ancestor
92235717|NCT02106988|Autonomic Agents|autonomic agents|mesh-ancestor
92235718|NCT02106988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235719|NCT02106988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235720|NCT02106988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235721|NCT02106988|Glucocorticoids|glucocorticoids|mesh-ancestor
92235722|NCT02106988|Hormones|hormones|mesh-ancestor
92339117|NCT04331327|Mitogens|mitogens|mesh-list
92235723|NCT02106988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235724|NCT02106988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235725|NCT02106988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235726|NCT02106988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235727|NCT02106988|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235728|NCT02106988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235729|NCT02106988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235730|NCT02106988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235731|NCT02106988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92235732|NCT02106988|Alkylating Agents|alkylating agents|mesh-ancestor
92235733|NCT01237457|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92235734|NCT01237457|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92235735|NCT01237457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235736|NCT00723697|Buprenorphine|buprenorphine|mesh-list
92235737|NCT00723697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92235738|NCT00723697|Narcotics|narcotics|mesh-ancestor
92235739|NCT00723697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235740|NCT00723697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235741|NCT00723697|Analgesics|analgesics|mesh-ancestor
92235742|NCT00723697|Sensory System Agents|sensory system agents|mesh-ancestor
92235743|NCT00723697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235744|NCT00723697|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92235745|NCT00684073|Buprenorphine|buprenorphine|mesh-list
92235746|NCT00684073|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92235747|NCT00684073|Naloxone|naloxone|mesh-list
92235748|NCT00684073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92235749|NCT00684073|Narcotics|narcotics|mesh-ancestor
92235750|NCT00684073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235751|NCT00684073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235752|NCT00684073|Analgesics|analgesics|mesh-ancestor
92235753|NCT00684073|Sensory System Agents|sensory system agents|mesh-ancestor
92235754|NCT00684073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235755|NCT00684073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92235756|NCT00603109|Rimonabant|rimonabant|mesh-list
92235757|NCT00603109|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92235758|NCT00603109|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92235759|NCT00603109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92235760|NCT00603109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235761|NCT00603109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235762|NCT00603109|Hormones|hormones|mesh-ancestor
92235763|NCT00603109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235764|NCT00603109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235765|NCT00199095|Cytarabine|cytarabine|mesh-list
92235766|NCT00199095|Dexamethasone|dexamethasone|mesh-list
92235767|NCT00199095|Cyclophosphamide|cyclophosphamide|mesh-list
92235768|NCT00199095|Ifosfamide|ifosfamide|mesh-list
92235769|NCT00199095|Methotrexate|methotrexate|mesh-list
92235770|NCT00199095|Vincristine|vincristine|mesh-list
92235771|NCT00199095|Doxorubicin|doxorubicin|mesh-list
92235772|NCT00199095|Mercaptopurine|mercaptopurine|mesh-list
92235773|NCT00199095|Idarubicin|idarubicin|mesh-list
92235774|NCT00199095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235775|NCT00199095|Immunologic Factors|immunologic factors|mesh-ancestor
92235776|NCT00199095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235777|NCT00199095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92235778|NCT00199095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92235779|NCT00199095|Alkylating Agents|alkylating agents|mesh-ancestor
92235780|NCT00199095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235781|NCT00199095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235782|NCT00199095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92235783|NCT00199095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235784|NCT00199095|Antiemetics|antiemetics|mesh-ancestor
92235785|NCT00199095|Autonomic Agents|autonomic agents|mesh-ancestor
92235786|NCT00199095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235787|NCT00199095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235788|NCT00199095|Glucocorticoids|glucocorticoids|mesh-ancestor
92235790|NCT00199095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235791|NCT00199095|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235792|NCT00199095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92235793|NCT00199095|Abortifacient Agents|abortifacient agents|mesh-ancestor
92235794|NCT00199095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92235795|NCT00199095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235796|NCT00199095|Antimetabolites|antimetabolites|mesh-ancestor
92235797|NCT00199095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92235798|NCT00199095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235799|NCT00199095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92235800|NCT00199095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92235801|NCT00199095|Antiviral Agents|antiviral agents|mesh-ancestor
92235802|NCT00199095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235803|NCT00199095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235804|NCT00199095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235805|NCT00199095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235806|NCT00199095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235807|NCT00199095|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92235808|NCT00199095|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235809|NCT00199095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235810|NCT00199056|Cytarabine|cytarabine|mesh-list
92235811|NCT00199056|Dexamethasone|dexamethasone|mesh-list
92235812|NCT00199056|Prednisolone|prednisolone|mesh-list
92235813|NCT00199056|Cyclophosphamide|cyclophosphamide|mesh-list
92235814|NCT00199056|Ifosfamide|ifosfamide|mesh-list
92235815|NCT00199056|Methotrexate|methotrexate|mesh-list
92235816|NCT00199056|Fludarabine|fludarabine|mesh-list
92235817|NCT00199056|Vincristine|vincristine|mesh-list
92235818|NCT00199056|Doxorubicin|doxorubicin|mesh-list
92235819|NCT00199056|Daunorubicin|daunorubicin|mesh-list
92235820|NCT00199056|Asparaginase|asparaginase|mesh-list
92235821|NCT00199056|Mercaptopurine|mercaptopurine|mesh-list
92235823|NCT00199056|Thioguanine|thioguanine|mesh-list
92235824|NCT00199056|Vindesine|vindesine|mesh-list
92235825|NCT00199056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235826|NCT00199056|Immunologic Factors|immunologic factors|mesh-ancestor
92235827|NCT00199056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235828|NCT00199056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92235829|NCT00199056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92235830|NCT00199056|Alkylating Agents|alkylating agents|mesh-ancestor
92235831|NCT00199056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235832|NCT00199056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235833|NCT00199056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92235834|NCT00199056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235835|NCT00199056|Antiemetics|antiemetics|mesh-ancestor
92235836|NCT00199056|Autonomic Agents|autonomic agents|mesh-ancestor
92235837|NCT00199056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235838|NCT00199056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235839|NCT00199056|Glucocorticoids|glucocorticoids|mesh-ancestor
92235840|NCT00199056|Hormones|hormones|mesh-ancestor
92235841|NCT00199056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235842|NCT00199056|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235843|NCT00199056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92235844|NCT00199056|Abortifacient Agents|abortifacient agents|mesh-ancestor
92235845|NCT00199056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92235846|NCT00199056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235847|NCT00199056|Antimetabolites|antimetabolites|mesh-ancestor
92235848|NCT00199056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92235849|NCT00199056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235850|NCT00199056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92235851|NCT00199056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92235852|NCT00199056|Antiviral Agents|antiviral agents|mesh-ancestor
92235853|NCT00199056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235854|NCT00199056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235855|NCT00199056|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235856|NCT00199056|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235857|NCT00199056|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235858|NCT00199056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92235859|NCT00199056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235860|NCT00199056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235861|NCT00199030|Alemtuzumab|alemtuzumab|mesh-list
92235862|NCT00199030|Cladribine|cladribine|mesh-list
92235863|NCT00199030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235864|NCT00199030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235865|NCT00199030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235866|NCT00199030|Immunologic Factors|immunologic factors|mesh-ancestor
92235867|NCT00199030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235868|NCT00198978|Cytarabine|cytarabine|mesh-list
92235869|NCT00198978|Dexamethasone|dexamethasone|mesh-list
92235870|NCT00198978|Prednisolone|prednisolone|mesh-list
92235871|NCT00198978|Cyclophosphamide|cyclophosphamide|mesh-list
92235872|NCT00198978|Rituximab|rituximab|mesh-list
92235873|NCT00198978|Methotrexate|methotrexate|mesh-list
92235874|NCT00198978|Vincristine|vincristine|mesh-list
92235875|NCT00198978|Asparaginase|asparaginase|mesh-list
92235876|NCT00198978|Mercaptopurine|mercaptopurine|mesh-list
92235877|NCT00198978|Idarubicin|idarubicin|mesh-list
92235878|NCT00198978|Lenograstim|lenograstim|mesh-list
92235879|NCT00198978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235880|NCT00198978|Immunologic Factors|immunologic factors|mesh-ancestor
92235881|NCT00198978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235882|NCT00198978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92235883|NCT00198978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92235884|NCT00198978|Alkylating Agents|alkylating agents|mesh-ancestor
92235885|NCT00198978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235886|NCT00198978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235887|NCT00198978|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92235888|NCT00198978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92235889|NCT00198978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92235890|NCT00198978|Antiemetics|antiemetics|mesh-ancestor
92235891|NCT00198978|Autonomic Agents|autonomic agents|mesh-ancestor
92235892|NCT00198978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235893|NCT00198978|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235894|NCT00198978|Glucocorticoids|glucocorticoids|mesh-ancestor
92235895|NCT00198978|Hormones|hormones|mesh-ancestor
92235896|NCT00198978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92235897|NCT00198978|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92235898|NCT00198978|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92235899|NCT00198978|Abortifacient Agents|abortifacient agents|mesh-ancestor
92235900|NCT00198978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92235901|NCT00198978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235902|NCT00198978|Antimetabolites|antimetabolites|mesh-ancestor
92235903|NCT00198978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92235904|NCT00198978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235905|NCT00198978|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92235906|NCT00198978|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92235907|NCT00198978|Antiviral Agents|antiviral agents|mesh-ancestor
92235908|NCT00198978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235909|NCT00198978|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235910|NCT00198978|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235911|NCT00198978|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235912|NCT00198978|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235913|NCT00198978|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92235914|NCT00198978|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92235915|NCT00198978|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235916|NCT00198978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235917|NCT00109395|Midazolam|midazolam|mesh-list
92235918|NCT00109395|Lorazepam|lorazepam|mesh-list
92235919|NCT00109395|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92235920|NCT00109395|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92235921|NCT00109395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92235922|NCT00109395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235923|NCT00109395|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92235924|NCT00109395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92235925|NCT00109395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92235926|NCT00109395|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92235927|NCT00109395|Anesthetics, General|anesthetics, general|mesh-ancestor
92235928|NCT00109395|Anesthetics|anesthetics|mesh-ancestor
92235929|NCT00109395|GABA Modulators|gaba modulators|mesh-ancestor
92235931|NCT00109395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92235932|NCT00109395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235933|NCT00109395|Anticonvulsants|anticonvulsants|mesh-ancestor
92235934|NCT00109395|Antiemetics|antiemetics|mesh-ancestor
92235935|NCT00109395|Autonomic Agents|autonomic agents|mesh-ancestor
92235936|NCT00109395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92235937|NCT00109395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92235938|NCT01215643|Ribavirin|ribavirin|mesh-list
92235939|NCT01215643|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92235940|NCT01215643|Antimetabolites|antimetabolites|mesh-ancestor
92235941|NCT01215643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235942|NCT01215643|Antiviral Agents|antiviral agents|mesh-ancestor
92235943|NCT01215643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92235944|NCT00004924|Paclitaxel|paclitaxel|mesh-list
92235945|NCT00004924|Irinotecan|irinotecan|mesh-list
92235946|NCT00004924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92235947|NCT00004924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235948|NCT00004924|Tubulin Modulators|tubulin modulators|mesh-ancestor
92235949|NCT00004924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92235950|NCT00004924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92235951|NCT00004924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235952|NCT00004924|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92235953|NCT00004924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235954|NCT00004924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235955|NCT00004144|Gemcitabine|gemcitabine|mesh-list
92235956|NCT00004144|Bryostatin 1|bryostatin 1|mesh-list
92235957|NCT00004144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235958|NCT00004144|Antimetabolites|antimetabolites|mesh-ancestor
92235959|NCT00004144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235960|NCT00004144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235961|NCT00004144|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92235962|NCT00004144|Immunologic Factors|immunologic factors|mesh-ancestor
92235963|NCT00004144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235964|NCT00004150|Leucovorin|leucovorin|mesh-list
92235965|NCT00004150|Fluorouracil|fluorouracil|mesh-list
92235966|NCT00004150|Calcium|calcium|mesh-list
92235967|NCT00004150|Levoleucovorin|levoleucovorin|mesh-list
92235968|NCT00004150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92235969|NCT00004150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92235970|NCT00004150|Antimetabolites|antimetabolites|mesh-ancestor
92235971|NCT00004150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235972|NCT00004150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235973|NCT00004150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235974|NCT00004150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92235975|NCT00004150|Immunologic Factors|immunologic factors|mesh-ancestor
92235977|NCT00004150|Protective Agents|protective agents|mesh-ancestor
92235978|NCT00004150|Vitamin B Complex|vitamin b complex|mesh-ancestor
92235979|NCT00004150|Vitamins|vitamins|mesh-ancestor
92235980|NCT00004150|Micronutrients|micronutrients|mesh-ancestor
92235981|NCT00004930|Doxorubicin|doxorubicin|mesh-list
92235982|NCT00004930|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92235983|NCT00004930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92235984|NCT00004930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235985|NCT00004930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92235986|NCT00004930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92235987|NCT00004930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92235988|NCT00004930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235989|NCT00003928|Gemcitabine|gemcitabine|mesh-list
92235990|NCT00003928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92235991|NCT00003928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92235992|NCT00003928|Antimetabolites|antimetabolites|mesh-ancestor
92235993|NCT00003928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92235994|NCT00004162|Doxorubicin|doxorubicin|mesh-list
92235995|NCT00004162|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92235996|NCT00004162|Methotrexate|methotrexate|mesh-list
92235997|NCT00004162|Vincristine|vincristine|mesh-list
92235998|NCT00004162|Sargramostim|sargramostim|mesh-list
92235999|NCT00004162|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92236000|NCT00004162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236001|NCT00004162|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236002|NCT00004162|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236004|NCT00004162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236005|NCT00004162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92236006|NCT00004162|Abortifacient Agents|abortifacient agents|mesh-ancestor
92236007|NCT00004162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236008|NCT00004162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236009|NCT00004162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236010|NCT00004162|Antimetabolites|antimetabolites|mesh-ancestor
92236011|NCT00004162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236012|NCT00004162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92236013|NCT00004162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236014|NCT00004162|Immunologic Factors|immunologic factors|mesh-ancestor
92236015|NCT00004162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236016|NCT00004162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236017|NCT00004162|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236018|NCT00004162|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236019|NCT00004162|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236020|NCT00004162|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236021|NCT00004984|Insulin|insulin|mesh-list
92236022|NCT00004984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92236023|NCT00004984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92236024|NCT00004984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236025|NCT00004174|Paclitaxel|paclitaxel|mesh-list
92236026|NCT00004174|Cyclophosphamide|cyclophosphamide|mesh-list
92236027|NCT00004174|Thiotepa|thiotepa|mesh-list
92236028|NCT00004174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236029|NCT00004174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236030|NCT00004174|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236031|NCT00004174|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236032|NCT00004174|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236033|NCT00004174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236034|NCT00004174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236035|NCT00004174|Immunologic Factors|immunologic factors|mesh-ancestor
92236036|NCT00004174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236037|NCT00004174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236038|NCT00004174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236039|NCT00004174|Alkylating Agents|alkylating agents|mesh-ancestor
92236040|NCT00004174|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92236041|NCT01284517|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92236042|NCT01284517|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92236043|NCT01284517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92236044|NCT01284517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92236045|NCT01284517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236046|NCT01284517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92236047|NCT01284517|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92236048|NCT01284517|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92236049|NCT01284517|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92236050|NCT01284517|Adrenergic Agents|adrenergic agents|mesh-ancestor
92236051|NCT01284517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236052|NCT01284517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236053|NCT01284517|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92236054|NCT01284517|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92236055|NCT01284517|Serotonin Agents|serotonin agents|mesh-ancestor
92236056|NCT01284517|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92236057|NCT01284517|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92236058|NCT01284517|Dopamine Agents|dopamine agents|mesh-ancestor
92236059|NCT00004990|Dexamethasone|dexamethasone|mesh-list
92236060|NCT00004990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236061|NCT00004990|Antiemetics|antiemetics|mesh-ancestor
92236062|NCT00004990|Autonomic Agents|autonomic agents|mesh-ancestor
92236063|NCT00004990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236064|NCT00004990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236065|NCT00004990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236066|NCT00004990|Glucocorticoids|glucocorticoids|mesh-ancestor
92236067|NCT00004990|Hormones|hormones|mesh-ancestor
92236068|NCT00004990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236069|NCT00004990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236070|NCT00004990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236072|NCT01216735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236073|NCT01216735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92236074|NCT01216735|Autonomic Agents|autonomic agents|mesh-ancestor
92236075|NCT01216735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236076|NCT01216735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236077|NCT01216735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92236078|NCT01216735|Respiratory System Agents|respiratory system agents|mesh-ancestor
92236079|NCT01216735|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236080|NCT01216735|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92236081|NCT00004186|Carboplatin|carboplatin|mesh-list
92236082|NCT00004186|Etoposide|etoposide|mesh-list
92236083|NCT00004186|Topotecan|topotecan|mesh-list
92236084|NCT00004186|Ifosfamide|ifosfamide|mesh-list
92236085|NCT00004186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236086|NCT00004186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236087|NCT00004186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236088|NCT00004186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236089|NCT00004186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236090|NCT00004186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236091|NCT00004186|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92236092|NCT00004186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236093|NCT00004186|Alkylating Agents|alkylating agents|mesh-ancestor
92236094|NCT00004192|Cytarabine|cytarabine|mesh-list
92236095|NCT00004192|Methylprednisolone|methylprednisolone|mesh-list
92236096|NCT00004192|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92236097|NCT00004192|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92236098|NCT00004192|Prednisolone|prednisolone|mesh-list
92236099|NCT00004192|Prednisolone acetate|prednisolone acetate|mesh-list
92236100|NCT00004192|Etoposide|etoposide|mesh-list
92236101|NCT00004192|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92236102|NCT00004192|Prednisolone phosphate|prednisolone phosphate|mesh-list
92236103|NCT00004192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236104|NCT00004192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236105|NCT00004192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236106|NCT00004192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236107|NCT00004192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236108|NCT00004192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236109|NCT00004192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236110|NCT00004192|Antimetabolites|antimetabolites|mesh-ancestor
92236111|NCT00004192|Antiviral Agents|antiviral agents|mesh-ancestor
92236112|NCT00004192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236113|NCT00004192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236115|NCT00004192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236116|NCT00004192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236117|NCT00004192|Antiemetics|antiemetics|mesh-ancestor
92236118|NCT00004192|Autonomic Agents|autonomic agents|mesh-ancestor
92236119|NCT00004192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236120|NCT00004192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236121|NCT00004192|Glucocorticoids|glucocorticoids|mesh-ancestor
92236123|NCT00004192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236124|NCT00004192|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92236125|NCT00004192|Protective Agents|protective agents|mesh-ancestor
92236126|NCT00004192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236127|NCT00005002|Lamivudine|lamivudine|mesh-list
92236128|NCT00005002|Zidovudine|zidovudine|mesh-list
92236129|NCT00005002|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92236130|NCT00005002|Nelfinavir|nelfinavir|mesh-list
92236131|NCT00005002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92236132|NCT00005002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236133|NCT00005002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236134|NCT00005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236135|NCT00005002|Antiviral Agents|antiviral agents|mesh-ancestor
92236136|NCT00005002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236137|NCT00005002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236138|NCT00005002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236139|NCT00005002|Antimetabolites|antimetabolites|mesh-ancestor
92236140|NCT00005002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92236141|NCT00005002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92236142|NCT00005002|Protease Inhibitors|protease inhibitors|mesh-ancestor
92236143|NCT00004198|Sargramostim|sargramostim|mesh-list
92236144|NCT00004198|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92236146|NCT00004198|Immunologic Factors|immunologic factors|mesh-ancestor
92236147|NCT00004198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236148|NCT00004198|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92236149|NCT01264705|Sorafenib|sorafenib|mesh-list
92236150|NCT01264705|Bavituximab|bavituximab|mesh-list
92236151|NCT01264705|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92236152|NCT01264705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236153|NCT01264705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236154|NCT01264705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236155|NCT01264705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236156|NCT01264705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92236157|NCT01264705|Immunologic Factors|immunologic factors|mesh-ancestor
92236158|NCT01264705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236160|NCT00004204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236161|NCT00004204|Alkylating Agents|alkylating agents|mesh-ancestor
92236162|NCT00004204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236163|NCT00004204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236164|NCT01217515|Diltiazem|diltiazem|mesh-list
92236165|NCT01217515|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92236166|NCT01217515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92236167|NCT01217515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236168|NCT01217515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236169|NCT01217515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92236170|NCT01217515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236171|NCT01217515|Vasodilator Agents|vasodilator agents|mesh-ancestor
92236172|NCT00005014|Risperidone|risperidone|mesh-list
92236173|NCT00005014|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92236174|NCT00005014|Serotonin Agents|serotonin agents|mesh-ancestor
92236175|NCT00005014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236176|NCT00005014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236177|NCT00005014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236178|NCT00005014|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92236179|NCT00005014|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92236180|NCT00005014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92236181|NCT00005014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92236182|NCT00005014|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92236183|NCT00005014|Dopamine Agents|dopamine agents|mesh-ancestor
92236184|NCT03009799|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92236185|NCT03009799|Laxatives|laxatives|mesh-ancestor
92236186|NCT03009799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236187|NCT00005026|Paclitaxel|paclitaxel|mesh-list
92236188|NCT00005026|Carboplatin|carboplatin|mesh-list
92236189|NCT00005026|Topotecan|topotecan|mesh-list
92236190|NCT00005026|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236191|NCT00005026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236192|NCT00005026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236194|NCT00005026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236195|NCT00005026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236196|NCT00005026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92236197|NCT00005026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236198|NCT00005026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236199|NCT00016718|Emtricitabine|emtricitabine|mesh-list
92236200|NCT00016718|Efavirenz|efavirenz|mesh-list
92236201|NCT00016718|Didanosine|didanosine|mesh-list
92236202|NCT00016718|Antiviral Agents|antiviral agents|mesh-ancestor
92236203|NCT00016718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236204|NCT00016718|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92236205|NCT00016718|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236206|NCT00016718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236207|NCT00016718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236208|NCT00016718|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236209|NCT00016718|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236210|NCT00016718|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92236211|NCT00016718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92236212|NCT00016718|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92236213|NCT00016718|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92236214|NCT00016718|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92236215|NCT00016718|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92236216|NCT00016718|Antimetabolites|antimetabolites|mesh-ancestor
92236217|NCT00004216|Ciprofloxacin|ciprofloxacin|mesh-list
92236218|NCT00004216|Ceftriaxone|ceftriaxone|mesh-list
92236219|NCT00004216|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92236221|NCT00004216|Trimethoprim|trimethoprim|mesh-list
92236222|NCT00004216|Sulfamethoxazole|sulfamethoxazole|mesh-list
92236223|NCT00004216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92236224|NCT00004216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236225|NCT00004216|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236226|NCT00004216|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236227|NCT00004216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236228|NCT00004216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236229|NCT00004216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236230|NCT00004216|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92236231|NCT00004216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92236232|NCT00004216|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92236234|NCT00004216|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92236235|NCT00004216|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92236236|NCT00004216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92236237|NCT00004216|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92236238|NCT00004216|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92236239|NCT00005032|Paclitaxel|paclitaxel|mesh-list
92236240|NCT00005032|Oblimersen|oblimersen|mesh-list
92236241|NCT00005032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236242|NCT00005032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236243|NCT00005032|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236244|NCT00005032|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236245|NCT00005032|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236246|NCT00005032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236247|NCT00005038|Aldesleukin|aldesleukin|mesh-list
92236248|NCT00005038|Histamine|histamine|mesh-list
92236249|NCT00005038|Histamine phosphate|histamine phosphate|mesh-list
92236250|NCT00005038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236251|NCT00005038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236252|NCT00005038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236253|NCT00005038|Antiviral Agents|antiviral agents|mesh-ancestor
92236254|NCT00005038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236255|NCT00005038|Histamine Agonists|histamine agonists|mesh-ancestor
92236256|NCT00005038|Histamine Agents|histamine agents|mesh-ancestor
92236257|NCT00005038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236258|NCT00005038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236259|NCT00005038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236260|NCT00019682|Aldesleukin|aldesleukin|mesh-list
92236261|NCT00019682|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92236262|NCT00019682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236263|NCT00019682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236264|NCT00019682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236265|NCT00019682|Antiviral Agents|antiviral agents|mesh-ancestor
92236266|NCT00019682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236267|NCT00019682|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92236268|NCT00019682|Immunologic Factors|immunologic factors|mesh-ancestor
92236269|NCT00019682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236270|NCT00005050|Fluorouracil|fluorouracil|mesh-list
92236271|NCT00005050|Oxaliplatin|oxaliplatin|mesh-list
92236272|NCT00005050|Eniluracil|eniluracil|mesh-list
92236273|NCT00005050|Antimetabolites|antimetabolites|mesh-ancestor
92236274|NCT00005050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236275|NCT00005050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236276|NCT00005050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236277|NCT00005050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236278|NCT00005050|Immunologic Factors|immunologic factors|mesh-ancestor
92236279|NCT00005050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236280|NCT00005050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236281|NCT00005578|Prednisone|prednisone|mesh-list
92236282|NCT00005578|Cyclophosphamide|cyclophosphamide|mesh-list
92236283|NCT00005578|Doxorubicin|doxorubicin|mesh-list
92236284|NCT00005578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92236285|NCT00005578|Etoposide|etoposide|mesh-list
92236286|NCT00005578|Vincristine|vincristine|mesh-list
92236287|NCT00005578|Bleomycin|bleomycin|mesh-list
92236288|NCT00005578|Dexrazoxane|dexrazoxane|mesh-list
92236289|NCT00005578|Razoxane|razoxane|mesh-list
92236290|NCT00005578|Lenograstim|lenograstim|mesh-list
92236291|NCT00005578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236292|NCT00005578|Immunologic Factors|immunologic factors|mesh-ancestor
92236293|NCT00005578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236294|NCT00005578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236295|NCT00005578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236296|NCT00005578|Alkylating Agents|alkylating agents|mesh-ancestor
92236297|NCT00005578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236298|NCT00005578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236299|NCT00005578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92236300|NCT00005578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92236301|NCT00005578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236302|NCT00005578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236303|NCT00005578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236304|NCT00005578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236305|NCT00005578|Glucocorticoids|glucocorticoids|mesh-ancestor
92236307|NCT00005578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236308|NCT00005578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236309|NCT00005578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236310|NCT00005578|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92236311|NCT00005578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236312|NCT00005578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236313|NCT00005578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236314|NCT00005578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92236315|NCT00005578|Protective Agents|protective agents|mesh-ancestor
92236316|NCT00022490|Cytarabine|cytarabine|mesh-list
92236317|NCT00022490|Imatinib Mesylate|imatinib mesylate|mesh-list
92236318|NCT00022490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236319|NCT00022490|Antimetabolites|antimetabolites|mesh-ancestor
92236320|NCT00022490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236321|NCT00022490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236322|NCT00022490|Antiviral Agents|antiviral agents|mesh-ancestor
92236323|NCT00022490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236324|NCT00022490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236325|NCT00022490|Immunologic Factors|immunologic factors|mesh-ancestor
92236326|NCT00022490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236327|NCT00022490|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236328|NCT00022490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236329|NCT00386230|Zidovudine|zidovudine|mesh-list
92236330|NCT00386230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236331|NCT00386230|Antimetabolites|antimetabolites|mesh-ancestor
92236332|NCT00386230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92236333|NCT00386230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236334|NCT00386230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236335|NCT00386230|Antiviral Agents|antiviral agents|mesh-ancestor
92236336|NCT00386230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236337|NCT00386230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236338|NCT00386230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236339|NCT00097448|Prednisone|prednisone|mesh-list
92236340|NCT00097448|Methylprednisolone|methylprednisolone|mesh-list
92236341|NCT00097448|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92236342|NCT00097448|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92236343|NCT00097448|Prednisolone|prednisolone|mesh-list
92236344|NCT00097448|Prednisolone acetate|prednisolone acetate|mesh-list
92236345|NCT00097448|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92236346|NCT00097448|Prednisolone phosphate|prednisolone phosphate|mesh-list
92236347|NCT00097448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236348|NCT00097448|Glucocorticoids|glucocorticoids|mesh-ancestor
92236349|NCT00097448|Hormones|hormones|mesh-ancestor
92236350|NCT00097448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236351|NCT00097448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236352|NCT00097448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236353|NCT00097448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236354|NCT00097448|Antiemetics|antiemetics|mesh-ancestor
92236355|NCT00097448|Autonomic Agents|autonomic agents|mesh-ancestor
92236356|NCT00097448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236357|NCT00097448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236358|NCT00097448|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92236359|NCT00097448|Protective Agents|protective agents|mesh-ancestor
92236360|NCT00004246|Fludarabine|fludarabine|mesh-list
92236361|NCT00004246|Fludarabine phosphate|fludarabine phosphate|mesh-list
92236362|NCT00004246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236363|NCT00004246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236364|NCT00004246|Antimetabolites|antimetabolites|mesh-ancestor
92236365|NCT00004246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236366|NCT00004246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236367|NCT00004246|Immunologic Factors|immunologic factors|mesh-ancestor
92236368|NCT00004246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236370|NCT00028262|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92236371|NCT00028262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236372|NCT00005056|Bryostatin 1|bryostatin 1|mesh-list
92236373|NCT00005056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92236374|NCT00005056|Immunologic Factors|immunologic factors|mesh-ancestor
92236375|NCT00005056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236376|NCT00005056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236377|NCT00004252|Leucovorin|leucovorin|mesh-list
92236378|NCT00004252|Fluorouracil|fluorouracil|mesh-list
92236379|NCT00004252|Calcium|calcium|mesh-list
92236380|NCT00004252|Levoleucovorin|levoleucovorin|mesh-list
92236381|NCT00004252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92236382|NCT00004252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236383|NCT00004252|Antimetabolites|antimetabolites|mesh-ancestor
92236384|NCT00004252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236385|NCT00004252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236386|NCT00004252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236387|NCT00004252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236388|NCT00004252|Immunologic Factors|immunologic factors|mesh-ancestor
92236389|NCT00004252|Antidotes|antidotes|mesh-ancestor
92236390|NCT00004252|Protective Agents|protective agents|mesh-ancestor
92236391|NCT00004252|Vitamin B Complex|vitamin b complex|mesh-ancestor
92236392|NCT00004252|Vitamins|vitamins|mesh-ancestor
92236393|NCT00004252|Micronutrients|micronutrients|mesh-ancestor
92236394|NCT00005590|Levofloxacin|levofloxacin|mesh-list
92236395|NCT00005590|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92236396|NCT00005590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236397|NCT00005590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92236398|NCT00005590|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236399|NCT00005590|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236400|NCT00005590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236401|NCT00005590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236402|NCT00005590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236403|NCT00005590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92236404|NCT00005590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92236405|NCT00005596|Leucovorin|leucovorin|mesh-list
92236406|NCT00005596|Cytarabine|cytarabine|mesh-list
92236407|NCT00005596|Dexamethasone|dexamethasone|mesh-list
92236408|NCT00005596|Cyclophosphamide|cyclophosphamide|mesh-list
92236409|NCT00005596|Methotrexate|methotrexate|mesh-list
92236410|NCT00005596|Vincristine|vincristine|mesh-list
92236411|NCT00005596|Daunorubicin|daunorubicin|mesh-list
92236412|NCT00005596|Mercaptopurine|mercaptopurine|mesh-list
92236413|NCT00005596|Pegaspargase|pegaspargase|mesh-list
92236414|NCT00005596|Thioguanine|thioguanine|mesh-list
92236415|NCT00005596|Levoleucovorin|levoleucovorin|mesh-list
92236416|NCT00005596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236417|NCT00005596|Immunologic Factors|immunologic factors|mesh-ancestor
92236418|NCT00005596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236419|NCT00005596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236420|NCT00005596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236421|NCT00005596|Alkylating Agents|alkylating agents|mesh-ancestor
92236422|NCT00005596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236423|NCT00005596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339180|NCT00000623|Siderophores|siderophores|mesh-ancestor
92236424|NCT00005596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92236425|NCT00005596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236427|NCT00005596|Autonomic Agents|autonomic agents|mesh-ancestor
92236428|NCT00005596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236429|NCT00005596|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236430|NCT00005596|Glucocorticoids|glucocorticoids|mesh-ancestor
92236431|NCT00005596|Hormones|hormones|mesh-ancestor
92236432|NCT00005596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236433|NCT00005596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236434|NCT00005596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92236435|NCT00005596|Abortifacient Agents|abortifacient agents|mesh-ancestor
92236436|NCT00005596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236437|NCT00005596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236438|NCT00005596|Antimetabolites|antimetabolites|mesh-ancestor
92236439|NCT00005596|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236440|NCT00005596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236441|NCT00005596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92236442|NCT00005596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236443|NCT00005596|Antiviral Agents|antiviral agents|mesh-ancestor
92236444|NCT00005596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236445|NCT00005596|Antidotes|antidotes|mesh-ancestor
92236446|NCT00005596|Protective Agents|protective agents|mesh-ancestor
92236447|NCT00005596|Vitamin B Complex|vitamin b complex|mesh-ancestor
92236448|NCT00005596|Vitamins|vitamins|mesh-ancestor
92236449|NCT00005596|Micronutrients|micronutrients|mesh-ancestor
92236450|NCT00005596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236451|NCT00005596|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236452|NCT00005596|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236453|NCT00005596|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236454|NCT00005596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92236455|NCT00005596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236456|NCT00005596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236457|NCT00005068|Leucovorin|leucovorin|mesh-list
92236458|NCT00005068|Fluorouracil|fluorouracil|mesh-list
92236459|NCT00005068|Oxaliplatin|oxaliplatin|mesh-list
92236460|NCT00005068|Irinotecan|irinotecan|mesh-list
92236461|NCT00005068|Calcium|calcium|mesh-list
92236462|NCT00005068|Levoleucovorin|levoleucovorin|mesh-list
92236463|NCT00005068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92236464|NCT00005068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236465|NCT00005068|Antimetabolites|antimetabolites|mesh-ancestor
92236466|NCT00005068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236467|NCT00005068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236468|NCT00005068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236469|NCT00005068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236470|NCT00005068|Immunologic Factors|immunologic factors|mesh-ancestor
92236471|NCT00005068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92236472|NCT00005068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236473|NCT00005068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236474|NCT00005068|Antidotes|antidotes|mesh-ancestor
92236475|NCT00005068|Protective Agents|protective agents|mesh-ancestor
92236476|NCT00005068|Vitamin B Complex|vitamin b complex|mesh-ancestor
92236477|NCT00005068|Vitamins|vitamins|mesh-ancestor
92236478|NCT00005068|Micronutrients|micronutrients|mesh-ancestor
92236479|NCT00004264|Docetaxel|docetaxel|mesh-list
92236480|NCT00004264|Amifostine|amifostine|mesh-list
92236481|NCT00004264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236482|NCT00004264|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236483|NCT00004264|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236484|NCT00004264|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236485|NCT00004264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236486|NCT00004264|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92236487|NCT00004264|Protective Agents|protective agents|mesh-ancestor
92236488|NCT00004264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236489|NCT00005074|Alvocidib|alvocidib|mesh-list
92236490|NCT00005074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236491|NCT00005074|Growth Inhibitors|growth inhibitors|mesh-ancestor
92236492|NCT00005074|Growth Substances|growth substances|mesh-ancestor
92236493|NCT00005074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236494|NCT00005074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236495|NCT00005074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339191|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236496|NCT00005074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236497|NCT00005602|Carboplatin|carboplatin|mesh-list
92236498|NCT00005602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236500|NCT00004276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236501|NCT00004276|Immunologic Factors|immunologic factors|mesh-ancestor
92236502|NCT00004276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236503|NCT00004276|Leprostatic Agents|leprostatic agents|mesh-ancestor
92236504|NCT00004276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92236505|NCT00004276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236506|NCT00004276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92236507|NCT00004276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92236508|NCT00004276|Growth Substances|growth substances|mesh-ancestor
92236509|NCT00004276|Growth Inhibitors|growth inhibitors|mesh-ancestor
92236510|NCT00004276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236511|NCT00004288|Olsalazine|olsalazine|mesh-list
92236512|NCT00004288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92236513|NCT00004288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92236514|NCT00004288|Analgesics|analgesics|mesh-ancestor
92236515|NCT00004288|Sensory System Agents|sensory system agents|mesh-ancestor
92236516|NCT00004288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236517|NCT00004288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236518|NCT00004288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236519|NCT00004288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236520|NCT00004288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236521|NCT00005086|Gemcitabine|gemcitabine|mesh-list
92236522|NCT00005086|Docetaxel|docetaxel|mesh-list
92236523|NCT00005086|Methotrexate|methotrexate|mesh-list
92236524|NCT00005086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236525|NCT00005086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236526|NCT00005086|Antimetabolites|antimetabolites|mesh-ancestor
92236527|NCT00005086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236528|NCT00005086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236529|NCT00005086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236530|NCT00005086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236531|NCT00005086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92236532|NCT00005086|Abortifacient Agents|abortifacient agents|mesh-ancestor
92236533|NCT00005086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236534|NCT00005086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236535|NCT00005086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236536|NCT00005086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236537|NCT00005086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92236538|NCT00005086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236539|NCT00005086|Immunologic Factors|immunologic factors|mesh-ancestor
92236540|NCT00005086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236541|NCT00005086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236542|NCT00005614|Gemcitabine|gemcitabine|mesh-list
92236543|NCT00005614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92236544|NCT00005614|Antimetabolites|antimetabolites|mesh-ancestor
92236545|NCT00005614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236546|NCT00005614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236547|NCT00101036|Lapatinib|lapatinib|mesh-list
92236548|NCT00101036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236549|NCT00101036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236550|NCT00101036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236551|NCT00101036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236552|NCT00004300|Bromocriptine|bromocriptine|mesh-list
92236553|NCT00004300|Sertraline|sertraline|mesh-list
92236554|NCT00004300|Antidepressive Agents|antidepressive agents|mesh-ancestor
92236555|NCT00004300|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92236556|NCT00004300|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92236557|NCT00004300|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92236558|NCT00004300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236559|NCT00004300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236560|NCT00004300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236561|NCT00004300|Serotonin Agents|serotonin agents|mesh-ancestor
92236562|NCT00004300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236563|NCT00004300|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92236564|NCT00004300|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92236565|NCT00004300|Hormone Antagonists|hormone antagonists|mesh-ancestor
92236566|NCT00004300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236567|NCT00004300|Dopamine Agonists|dopamine agonists|mesh-ancestor
92236568|NCT00004300|Dopamine Agents|dopamine agents|mesh-ancestor
92236569|NCT00005626|Irinotecan|irinotecan|mesh-list
92236570|NCT00005626|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92236571|NCT00005626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236572|NCT00005626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236573|NCT00005626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236574|NCT00005626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236575|NCT00005092|Cyclophosphamide|cyclophosphamide|mesh-list
92236576|NCT00005092|Thiotepa|thiotepa|mesh-list
92236577|NCT00005092|Methoxsalen|methoxsalen|mesh-list
92236578|NCT00005092|Furocoumarins|furocoumarins|mesh-list
92236579|NCT00005092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236580|NCT00005092|Immunologic Factors|immunologic factors|mesh-ancestor
92236581|NCT00005092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236582|NCT00005092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236583|NCT00005092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236584|NCT00005092|Alkylating Agents|alkylating agents|mesh-ancestor
92236585|NCT00005092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236586|NCT00005092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236587|NCT00005092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92236588|NCT00005092|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92236589|NCT00005092|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236590|NCT00005638|Irinotecan|irinotecan|mesh-list
92236591|NCT00005638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236592|NCT00005638|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92236593|NCT00005638|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236594|NCT00005638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236595|NCT00005638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236596|NCT00005104|Metformin|metformin|mesh-list
92236597|NCT00005104|Clomiphene|clomiphene|mesh-list
92236598|NCT00005104|Enclomiphene|enclomiphene|mesh-list
92236599|NCT00005104|Zuclomiphene|zuclomiphene|mesh-list
92236600|NCT00005104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92236601|NCT00005104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236602|NCT00005104|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92236603|NCT00005104|Hormone Antagonists|hormone antagonists|mesh-ancestor
92236604|NCT00005104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236605|NCT00005104|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92236606|NCT00005104|Fertility Agents|fertility agents|mesh-ancestor
92236607|NCT00005104|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236608|NCT00005104|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91924456|NCT04046887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236609|NCT00005104|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92236610|NCT00005110|Albuterol|albuterol|mesh-list
92236611|NCT00005110|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92236612|NCT00005110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92236613|NCT00005110|Autonomic Agents|autonomic agents|mesh-ancestor
92236614|NCT00005110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236615|NCT00005110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236616|NCT00005110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92236617|NCT00005110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92236618|NCT00005110|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92236619|NCT00005110|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92236620|NCT00005110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92236621|NCT00005110|Adrenergic Agents|adrenergic agents|mesh-ancestor
92236622|NCT00005110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236623|NCT00005110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236624|NCT00005110|Tocolytic Agents|tocolytic agents|mesh-ancestor
92236625|NCT00005110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236626|NCT00004330|Hormones|hormones|mesh-list
92236627|NCT00004330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236628|NCT00004330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236629|NCT00005668|Itraconazole|itraconazole|mesh-list
92236630|NCT00005668|Antifungal Agents|antifungal agents|mesh-ancestor
92236631|NCT00005668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236632|NCT00005668|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92236633|NCT00005668|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92236634|NCT00005668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236635|NCT00005668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236636|NCT00005668|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92236637|NCT00005668|Hormone Antagonists|hormone antagonists|mesh-ancestor
92236638|NCT00005668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236639|NCT00005668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236640|NCT00005668|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92236641|NCT00030992|Diphenhydramine|diphenhydramine|mesh-list
92236642|NCT00030992|Promethazine|promethazine|mesh-list
92236643|NCT00030992|Ranitidine|ranitidine|mesh-list
92236644|NCT00030992|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92236645|NCT00030992|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92236646|NCT00030992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92236647|NCT00030992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92236648|NCT00030992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236649|NCT00030992|Anesthetics, Local|anesthetics, local|mesh-ancestor
92236651|NCT00030992|Sensory System Agents|sensory system agents|mesh-ancestor
92236652|NCT00030992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236653|NCT00030992|Antiemetics|antiemetics|mesh-ancestor
92236654|NCT00030992|Autonomic Agents|autonomic agents|mesh-ancestor
92236655|NCT00030992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92236656|NCT00030992|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92236657|NCT00030992|Histamine Antagonists|histamine antagonists|mesh-ancestor
92236659|NCT00030992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236660|NCT00030992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236661|NCT00030992|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92236662|NCT00030992|Antipruritics|antipruritics|mesh-ancestor
92236663|NCT00030992|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236664|NCT00030992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92236665|NCT00030992|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92236666|NCT00004360|Chlorothiazide|chlorothiazide|mesh-list
92236667|NCT00004360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92236668|NCT00004360|Diuretics|diuretics|mesh-ancestor
92236669|NCT00004360|Natriuretic Agents|natriuretic agents|mesh-ancestor
92236670|NCT00004360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236671|NCT00004360|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92236672|NCT00004360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236673|NCT00004360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236674|NCT00385450|Nelfinavir|nelfinavir|mesh-list
92236675|NCT00385450|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92236676|NCT00385450|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92236677|NCT00385450|Protease Inhibitors|protease inhibitors|mesh-ancestor
92236678|NCT00385450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236679|NCT00385450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236680|NCT00385450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236681|NCT00385450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236682|NCT00385450|Antiviral Agents|antiviral agents|mesh-ancestor
92236683|NCT00385450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236684|NCT00004390|Morphine|morphine|mesh-list
92236685|NCT00004390|Methadone|methadone|mesh-list
92236686|NCT00004390|Nortriptyline|nortriptyline|mesh-list
92236687|NCT00004390|Desipramine|desipramine|mesh-list
92236688|NCT00004390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92236689|NCT00004390|Narcotics|narcotics|mesh-ancestor
92236690|NCT00004390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92236691|NCT00004390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236692|NCT00004390|Analgesics|analgesics|mesh-ancestor
92236693|NCT00004390|Sensory System Agents|sensory system agents|mesh-ancestor
92236694|NCT00004390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236695|NCT00004390|Antitussive Agents|antitussive agents|mesh-ancestor
92236696|NCT00004390|Respiratory System Agents|respiratory system agents|mesh-ancestor
92236697|NCT00004390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92236698|NCT00004390|Antidepressive Agents|antidepressive agents|mesh-ancestor
92236699|NCT00004390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92236700|NCT00004390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92236701|NCT00004390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92236702|NCT00004390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236703|NCT00004390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236704|NCT00004390|Adrenergic Agents|adrenergic agents|mesh-ancestor
92236705|NCT00004390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236706|NCT00004390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236707|NCT00004396|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92236708|NCT00004396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236709|NCT00004396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236710|NCT00004402|Calcitriol|calcitriol|mesh-list
92236711|NCT00004402|Interferons|interferons|mesh-list
92236712|NCT00004402|Interferon-gamma|interferon-gamma|mesh-list
92236713|NCT00004402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236714|NCT00004402|Antiviral Agents|antiviral agents|mesh-ancestor
92236715|NCT00004402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236716|NCT00004402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92236717|NCT00004402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236718|NCT00004402|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92236719|NCT00004402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236720|NCT00004402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236721|NCT00004402|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92236722|NCT00004402|Vitamins|vitamins|mesh-ancestor
92236723|NCT00004402|Micronutrients|micronutrients|mesh-ancestor
92236724|NCT00004402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92236725|NCT00004420|Evening primrose oil|evening primrose oil|mesh-list
92236726|NCT00004420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92236727|NCT00004420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92236729|NCT00004420|Sensory System Agents|sensory system agents|mesh-ancestor
92236730|NCT00004420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236731|NCT00004420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236732|NCT00004420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236733|NCT00004420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236734|NCT00004420|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92236735|NCT00004420|Antimetabolites|antimetabolites|mesh-ancestor
92236736|NCT00004420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236737|NCT00004420|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92236738|NCT00004420|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236739|NCT00004426|Leuprolide|leuprolide|mesh-list
92236740|NCT00004426|Hormones|hormones|mesh-list
92236741|NCT00004426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236742|NCT00004426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236743|NCT00004426|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92236744|NCT00004426|Fertility Agents|fertility agents|mesh-ancestor
92236745|NCT00004426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236746|NCT00004426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236747|NCT00004426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236749|NCT00004438|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92236750|NCT00004438|Fertility Agents|fertility agents|mesh-ancestor
92236751|NCT00004438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92236752|NCT00004438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236753|NCT00004438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236754|NCT00004438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236755|NCT01217749|Ofatumumab|ofatumumab|mesh-list
92236756|NCT01217749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236757|NCT02197273|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92236758|NCT02197273|Epinephrine|epinephrine|mesh-list
92236759|NCT02197273|Fentanyl|fentanyl|mesh-list
92236760|NCT02197273|Morphine|morphine|mesh-list
92236761|NCT02197273|Bupivacaine|bupivacaine|mesh-list
92236762|NCT02197273|Ropivacaine|ropivacaine|mesh-list
92236763|NCT02197273|Anesthetics, Local|anesthetics, local|mesh-ancestor
92236764|NCT02197273|Anesthetics|anesthetics|mesh-ancestor
92236765|NCT02197273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92236766|NCT02197273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236767|NCT02197273|Sensory System Agents|sensory system agents|mesh-ancestor
92236768|NCT02197273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236769|NCT02197273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92236770|NCT02197273|Narcotics|narcotics|mesh-ancestor
92236771|NCT02197273|Analgesics|analgesics|mesh-ancestor
92236772|NCT02197273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92236773|NCT02197273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92236774|NCT02197273|Anesthetics, General|anesthetics, general|mesh-ancestor
92236775|NCT02197273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92236776|NCT02197273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92236777|NCT02197273|Adrenergic Agents|adrenergic agents|mesh-ancestor
92236778|NCT02197273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236779|NCT02197273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236780|NCT02197273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92236781|NCT02197273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92236782|NCT02197273|Autonomic Agents|autonomic agents|mesh-ancestor
92236783|NCT02197273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92236784|NCT02197273|Respiratory System Agents|respiratory system agents|mesh-ancestor
92236785|NCT02197273|Mydriatics|mydriatics|mesh-ancestor
92236786|NCT02197273|Sympathomimetics|sympathomimetics|mesh-ancestor
92236787|NCT02197273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92236788|NCT02197273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92236789|NCT02197273|Glucocorticoids|glucocorticoids|mesh-ancestor
92236790|NCT02197273|Hormones|hormones|mesh-ancestor
92236791|NCT02197273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236792|NCT02197273|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92236793|NCT02197273|Protective Agents|protective agents|mesh-ancestor
92236794|NCT02197273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92236795|NCT02197273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236796|NCT00004444|Paromomycin|paromomycin|mesh-list
92236797|NCT00004444|Streptomycin|streptomycin|mesh-list
92236798|NCT00004444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92236799|NCT00004444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236800|NCT00004444|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92236801|NCT00004444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92236802|NCT00004444|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92236803|NCT00004444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236804|NCT00004444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236805|NCT00004450|Interferons|interferons|mesh-list
92236806|NCT00004450|Interferon-beta|interferon-beta|mesh-list
92236807|NCT00004450|Thalidomide|thalidomide|mesh-list
92236808|NCT00004450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236809|NCT00004450|Antiviral Agents|antiviral agents|mesh-ancestor
92236810|NCT00004450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236811|NCT00004450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236812|NCT00004450|Immunologic Factors|immunologic factors|mesh-ancestor
92236813|NCT00004450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236814|NCT00004450|Leprostatic Agents|leprostatic agents|mesh-ancestor
92236815|NCT00004450|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92236816|NCT00004450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92236817|NCT00004450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92236818|NCT00004450|Growth Substances|growth substances|mesh-ancestor
92236819|NCT00004450|Growth Inhibitors|growth inhibitors|mesh-ancestor
92236820|NCT00004468|Calcitriol|calcitriol|mesh-list
92236821|NCT00004468|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92236822|NCT00004468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236823|NCT00004468|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92236824|NCT00004468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236825|NCT00004468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236826|NCT00004468|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92236827|NCT00004468|Vitamins|vitamins|mesh-ancestor
92236828|NCT00004468|Micronutrients|micronutrients|mesh-ancestor
92236829|NCT00004468|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92236830|NCT01288807|Milnacipran|milnacipran|mesh-list
92236831|NCT01288807|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92236832|NCT01288807|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92236833|NCT01288807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236834|NCT01288807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236835|NCT01288807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236836|NCT01288807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236837|NCT01288807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92236838|NCT01288807|Analgesics|analgesics|mesh-ancestor
92236839|NCT01288807|Sensory System Agents|sensory system agents|mesh-ancestor
92236840|NCT01288807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236841|NCT00005764|Lamivudine|lamivudine|mesh-list
92236842|NCT00005764|Zidovudine|zidovudine|mesh-list
92236843|NCT00005764|Abacavir|abacavir|mesh-list
92236844|NCT00005764|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92236845|NCT00005764|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92236846|NCT00005764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236847|NCT00005764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236848|NCT00005764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236849|NCT00005764|Antiviral Agents|antiviral agents|mesh-ancestor
92236850|NCT00005764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236851|NCT00005764|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92236852|NCT00005764|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92236853|NCT00005764|Antimetabolites|antimetabolites|mesh-ancestor
92236854|NCT01289275|Nicotine|nicotine|mesh-list
92236855|NCT01289275|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92236856|NCT01289275|Autonomic Agents|autonomic agents|mesh-ancestor
92236857|NCT01289275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236858|NCT01289275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236859|NCT01289275|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92236860|NCT01289275|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92236861|NCT01289275|Cholinergic Agents|cholinergic agents|mesh-ancestor
92236862|NCT01289275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236863|NCT01289275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236864|NCT00004474|Cyclophosphamide|cyclophosphamide|mesh-list
92236865|NCT00004474|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92236866|NCT00004474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92236867|NCT00004474|Immunologic Factors|immunologic factors|mesh-ancestor
92236868|NCT00004474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236869|NCT00004474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92236870|NCT00004474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236872|NCT00004474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236873|NCT00004474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236874|NCT00004474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92236875|NCT00004480|Botulinum Toxins|botulinum toxins|mesh-list
92236876|NCT00004480|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92236877|NCT00004480|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92236878|NCT00004480|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92236879|NCT00004480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236880|NCT00004480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236881|NCT00004480|Cholinergic Agents|cholinergic agents|mesh-ancestor
92236882|NCT00004480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236883|NCT00004480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236884|NCT00004480|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92236885|NCT00004480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236886|NCT00004486|Fluoxetine|fluoxetine|mesh-list
92236887|NCT00004486|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92236888|NCT00004486|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92236889|NCT00004486|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92236890|NCT00004486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236891|NCT00004486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236893|NCT00004486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236894|NCT00004486|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92236895|NCT00004486|Antidepressive Agents|antidepressive agents|mesh-ancestor
92236896|NCT00004486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92236897|NCT00004486|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92236898|NCT00004486|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92236899|NCT00004486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236900|NCT00004492|Clotrimazole|clotrimazole|mesh-list
92236901|NCT00004492|Miconazole|miconazole|mesh-list
92236902|NCT00004492|Hydroxyurea|hydroxyurea|mesh-list
92236903|NCT00004492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236904|NCT00004492|Antisickling Agents|antisickling agents|mesh-ancestor
92236905|NCT00004492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236906|NCT00004492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236907|NCT00004492|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92236908|NCT00004492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92236909|NCT00004492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92236910|NCT00004492|Antifungal Agents|antifungal agents|mesh-ancestor
92236911|NCT00004492|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92236912|NCT00004492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92236913|NCT00004492|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92236914|NCT00004492|Hormone Antagonists|hormone antagonists|mesh-ancestor
92236915|NCT00004492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92236916|NCT00004492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236917|NCT00004492|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92236918|NCT00004492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92236919|NCT00005776|Nitric Oxide|nitric oxide|mesh-list
92236920|NCT00005776|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92236921|NCT00005776|Autonomic Agents|autonomic agents|mesh-ancestor
92236922|NCT00005776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92236923|NCT00005776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236924|NCT00005776|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92236925|NCT00005776|Respiratory System Agents|respiratory system agents|mesh-ancestor
92236926|NCT00005776|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92236927|NCT00005776|Antioxidants|antioxidants|mesh-ancestor
92236928|NCT00005776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236929|NCT00005776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236930|NCT00005776|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92236931|NCT00005776|Vasodilator Agents|vasodilator agents|mesh-ancestor
92236932|NCT00005776|Gasotransmitters|gasotransmitters|mesh-ancestor
92236933|NCT00005776|Protective Agents|protective agents|mesh-ancestor
92236934|NCT00005782|Lenograstim|lenograstim|mesh-list
92236935|NCT00005782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92236936|NCT00005782|Immunologic Factors|immunologic factors|mesh-ancestor
92236937|NCT00005782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236938|NCT01290913|Omalizumab|omalizumab|mesh-list
92236939|NCT01290913|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92236940|NCT01290913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92236941|NCT01290913|Respiratory System Agents|respiratory system agents|mesh-ancestor
92236942|NCT00004552|Acamprosate|acamprosate|mesh-list
92236943|NCT00004552|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92236944|NCT00101660|Dasatinib|dasatinib|mesh-list
92236945|NCT00101660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236946|NCT00101660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236947|NCT00101660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236948|NCT00101660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236949|NCT01267279|Zoledronic Acid|zoledronic acid|mesh-list
92236950|NCT01267279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92236951|NCT01267279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236952|NCT00005800|Docetaxel|docetaxel|mesh-list
92236953|NCT00005800|Doxorubicin|doxorubicin|mesh-list
92236954|NCT00005800|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92236955|NCT00005800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236956|NCT00005800|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236957|NCT00005800|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236958|NCT00005800|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236959|NCT00005800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236960|NCT00005800|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92236961|NCT00005800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92236962|NCT00005800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92236963|NCT00005800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236964|NCT00004564|Clopidogrel|clopidogrel|mesh-list
92236965|NCT00004564|Atorvastatin|atorvastatin|mesh-list
92236966|NCT00004564|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92236967|NCT00004564|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92236968|NCT00004564|Antimetabolites|antimetabolites|mesh-ancestor
92236969|NCT00004564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236970|NCT00004564|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92236971|NCT00004564|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92236972|NCT00004564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236973|NCT00004564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92236974|NCT00004564|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92236975|NCT00004564|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92236976|NCT00004564|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92236977|NCT00004564|Purinergic Agents|purinergic agents|mesh-ancestor
92236978|NCT00004564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92236979|NCT00004564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92236980|NCT01268527|Calcipotriene|calcipotriene|mesh-list
92236981|NCT01268527|Dermatologic Agents|dermatologic agents|mesh-ancestor
92236982|NCT00005806|Paclitaxel|paclitaxel|mesh-list
92236983|NCT00005806|Carboplatin|carboplatin|mesh-list
92236984|NCT00005806|Gefitinib|gefitinib|mesh-list
92236985|NCT00005806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92236986|NCT00005806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236987|NCT00005806|Tubulin Modulators|tubulin modulators|mesh-ancestor
92236988|NCT00005806|Antimitotic Agents|antimitotic agents|mesh-ancestor
92236989|NCT00005806|Mitosis Modulators|mitosis modulators|mesh-ancestor
92236990|NCT00005806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236991|NCT00005806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92236992|NCT00005806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92236993|NCT00005812|Temozolomide|temozolomide|mesh-list
92236994|NCT00005812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92236995|NCT00005812|Alkylating Agents|alkylating agents|mesh-ancestor
92236996|NCT00005812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92236997|NCT00005812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92236998|NCT01270555|Bupropion|bupropion|mesh-list
92236999|NCT01270555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92237000|NCT01270555|Antidepressive Agents|antidepressive agents|mesh-ancestor
92237001|NCT01270555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92237002|NCT01270555|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92237003|NCT01270555|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92237004|NCT01270555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92237005|NCT01270555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237007|NCT01270555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237008|NCT01270555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237009|NCT01270555|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92237010|NCT01270555|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92237011|NCT01270555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237012|NCT00004582|Ritonavir|ritonavir|mesh-list
92237013|NCT00004582|Lopinavir|lopinavir|mesh-list
92237014|NCT00004582|Efavirenz|efavirenz|mesh-list
92237015|NCT00004582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92237016|NCT00004582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92237017|NCT00004582|Protease Inhibitors|protease inhibitors|mesh-ancestor
92237018|NCT00004582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237019|NCT00004582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237020|NCT00004582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92237021|NCT00004582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92237022|NCT00004582|Antiviral Agents|antiviral agents|mesh-ancestor
92237023|NCT00004582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237024|NCT00004582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92237025|NCT00004582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92237026|NCT00004582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92237027|NCT00004582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92237028|NCT00004582|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91934569|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237029|NCT00004582|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92237030|NCT00004582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92237031|NCT00004582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92237032|NCT00004582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92237034|NCT00004690|Cariostatic Agents|cariostatic agents|mesh-ancestor
92237035|NCT00004690|Protective Agents|protective agents|mesh-ancestor
92237036|NCT00004690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237037|NCT00004696|Morphine|morphine|mesh-list
92237038|NCT00004696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92237039|NCT00004696|Narcotics|narcotics|mesh-ancestor
92237040|NCT00004696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237041|NCT00004696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237042|NCT00004696|Analgesics|analgesics|mesh-ancestor
92237043|NCT00004696|Sensory System Agents|sensory system agents|mesh-ancestor
92237044|NCT00004696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237045|NCT00004744|Immunoglobulins|immunoglobulins|mesh-list
92237046|NCT00004744|Antibodies|antibodies|mesh-list
92237047|NCT00004744|gamma-Globulins|gamma-globulins|mesh-list
92237048|NCT00004744|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92237049|NCT00004744|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92237050|NCT00004744|Immunologic Factors|immunologic factors|mesh-ancestor
92237051|NCT00004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237052|NCT01292005|Pentoxifylline|pentoxifylline|mesh-list
92237053|NCT01292005|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92237054|NCT01292005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237055|NCT01292005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237056|NCT01292005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92237057|NCT01292005|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92237058|NCT01292005|Protective Agents|protective agents|mesh-ancestor
92237059|NCT01292005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237060|NCT01292005|Vasodilator Agents|vasodilator agents|mesh-ancestor
92237061|NCT01292005|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92237062|NCT01292005|Antioxidants|antioxidants|mesh-ancestor
92237063|NCT00004762|Cladribine|cladribine|mesh-list
92237064|NCT00004762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237065|NCT00004762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237066|NCT00004762|Immunologic Factors|immunologic factors|mesh-ancestor
92237067|NCT00004762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237068|NCT00004786|Iloprost|iloprost|mesh-list
92237069|NCT00004786|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92237070|NCT00004786|Vasodilator Agents|vasodilator agents|mesh-ancestor
92237071|NCT01272583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92237072|NCT01272583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237073|NCT01272583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237074|NCT01272583|Incretins|incretins|mesh-ancestor
92237075|NCT01272583|Hormones|hormones|mesh-ancestor
92237076|NCT01272583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237077|NCT01272583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92237078|NCT01272583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92237079|NCT01272583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237080|NCT01272583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237082|NCT00004804|Interferon-alpha|interferon-alpha|mesh-list
92237083|NCT00004804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237084|NCT00004804|Antiviral Agents|antiviral agents|mesh-ancestor
92237085|NCT00004804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237086|NCT00004804|Immunologic Factors|immunologic factors|mesh-ancestor
92237087|NCT00004804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237088|NCT00386074|Fe(III)-EDTA|fe(iii)-edta|mesh-list
92237089|NCT00386074|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92237090|NCT00386074|Chelating Agents|chelating agents|mesh-ancestor
92237091|NCT00386074|Sequestering Agents|sequestering agents|mesh-ancestor
92237092|NCT00386074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237093|NCT00004810|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92237094|NCT00004810|Antitubercular Agents|antitubercular agents|mesh-ancestor
92237095|NCT00004810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92237096|NCT00004810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237097|NCT00004816|Antibodies|antibodies|mesh-list
92237098|NCT00004816|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92237099|NCT00004816|Immunologic Factors|immunologic factors|mesh-ancestor
92237100|NCT00004816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237101|NCT01341301|Mycophenolic Acid|mycophenolic acid|mesh-list
92237102|NCT01341301|Cyclophosphamide|cyclophosphamide|mesh-list
92237103|NCT01341301|Tacrolimus|tacrolimus|mesh-list
92237104|NCT01341301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237105|NCT01341301|Immunologic Factors|immunologic factors|mesh-ancestor
92237106|NCT01341301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237107|NCT01341301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237108|NCT01341301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92237109|NCT01341301|Alkylating Agents|alkylating agents|mesh-ancestor
92237110|NCT01341301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237111|NCT01341301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237112|NCT01341301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92237113|NCT01341301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92237114|NCT01341301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237115|NCT01341301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237116|NCT01341301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92237117|NCT01341301|Antitubercular Agents|antitubercular agents|mesh-ancestor
92237118|NCT01341301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92237119|NCT01341301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237120|NCT01273207|Cyclosporine|cyclosporine|mesh-list
92237121|NCT01273207|Cyclosporins|cyclosporins|mesh-list
92237122|NCT01273207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237123|NCT01273207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237124|NCT01273207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237125|NCT01273207|Immunologic Factors|immunologic factors|mesh-ancestor
92237126|NCT01273207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237127|NCT01273207|Antifungal Agents|antifungal agents|mesh-ancestor
92237128|NCT01273207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237129|NCT01273207|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237130|NCT01273207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237131|NCT01273207|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92237132|NCT01342549|Naltrexone|naltrexone|mesh-list
92237133|NCT01342549|Valproic Acid|valproic acid|mesh-list
92237134|NCT01342549|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92237135|NCT01342549|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92237136|NCT01342549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237137|NCT01342549|Sensory System Agents|sensory system agents|mesh-ancestor
92237138|NCT01342549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237139|NCT01342549|Anticonvulsants|anticonvulsants|mesh-ancestor
92237140|NCT01342549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237141|NCT01342549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237142|NCT01342549|GABA Agents|gaba agents|mesh-ancestor
92237143|NCT01342549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237144|NCT01342549|Antimanic Agents|antimanic agents|mesh-ancestor
92237145|NCT01342549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92237146|NCT01342549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237148|NCT01295515|Interferons|interferons|mesh-list
92237149|NCT01295515|Interferon-alpha|interferon-alpha|mesh-list
92237150|NCT01295515|Interferon alpha-2|interferon alpha-2|mesh-list
92237151|NCT01295515|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92237152|NCT01295515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237153|NCT01295515|Antiviral Agents|antiviral agents|mesh-ancestor
92237154|NCT01295515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237155|NCT01295515|Immunologic Factors|immunologic factors|mesh-ancestor
92237156|NCT01295515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237157|NCT01277341|Bepotastine besilate|bepotastine besilate|mesh-list
92237158|NCT01277341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92237159|NCT00101816|Dasatinib|dasatinib|mesh-list
92237160|NCT00101816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237161|NCT00101816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92237162|NCT00101816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237163|NCT00101816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237164|NCT00102518|Aripiprazole|aripiprazole|mesh-list
92237165|NCT00102518|Antidepressive Agents|antidepressive agents|mesh-ancestor
92237166|NCT00102518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92237167|NCT00102518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92237168|NCT00102518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92237169|NCT00102518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237170|NCT00102518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237171|NCT00102518|Dopamine Agonists|dopamine agonists|mesh-ancestor
92237172|NCT00102518|Dopamine Agents|dopamine agents|mesh-ancestor
92237173|NCT00102518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237174|NCT00102518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237175|NCT00102518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92237176|NCT00102518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92237177|NCT00102518|Serotonin Agents|serotonin agents|mesh-ancestor
92237178|NCT00102518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92237179|NCT00102518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92237180|NCT00102518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92237181|NCT00102518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92237183|NCT00103376|Androgens|androgens|mesh-list
92237184|NCT00103376|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92237185|NCT00103376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237186|NCT00103376|Hormones|hormones|mesh-ancestor
92237187|NCT00103376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237188|NCT00103376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237189|NCT00103376|Androgen Antagonists|androgen antagonists|mesh-ancestor
92237190|NCT00103376|Hormone Antagonists|hormone antagonists|mesh-ancestor
92237191|NCT00042224|Clozapine|clozapine|mesh-list
92237192|NCT00042224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92237193|NCT00042224|Serotonin Agents|serotonin agents|mesh-ancestor
92237194|NCT00042224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237195|NCT00042224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237196|NCT00042224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237197|NCT00042224|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92237198|NCT00042224|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92237199|NCT00042224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237200|NCT00042224|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92237201|NCT00042224|GABA Antagonists|gaba antagonists|mesh-ancestor
92237202|NCT00042224|GABA Agents|gaba agents|mesh-ancestor
92237203|NCT01296763|Irinotecan|irinotecan|mesh-list
92237204|NCT01296763|Olaparib|olaparib|mesh-list
92237205|NCT01296763|Mitomycins|mitomycins|mesh-list
92237206|NCT01296763|Mitomycin|mitomycin|mesh-list
92237207|NCT01296763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237208|NCT01296763|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92237209|NCT01296763|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92237210|NCT01296763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237211|NCT01296763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237212|NCT01296763|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91924457|NCT04046887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92237213|NCT01296763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237214|NCT01296763|Alkylating Agents|alkylating agents|mesh-ancestor
92237215|NCT01296763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92237217|NCT01349491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92237218|NCT01349491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92237219|NCT01349491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237220|NCT01280695|Pioglitazone|pioglitazone|mesh-list
92237221|NCT01280695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237222|NCT01280695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237223|NCT00103844|Imatinib Mesylate|imatinib mesylate|mesh-list
92237224|NCT00103844|Dasatinib|dasatinib|mesh-list
92237225|NCT00103844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237226|NCT00103844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92237227|NCT00103844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237228|NCT00103844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237229|NCT01402375|Acetaminophen|acetaminophen|mesh-list
92237230|NCT01402375|Oxycodone|oxycodone|mesh-list
92237231|NCT01402375|Hydrocodone|hydrocodone|mesh-list
92237232|NCT01402375|Codeine|codeine|mesh-list
92237233|NCT01402375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92237234|NCT01402375|Analgesics|analgesics|mesh-ancestor
92237235|NCT01402375|Sensory System Agents|sensory system agents|mesh-ancestor
92237236|NCT01402375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237237|NCT01402375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237238|NCT01402375|Antipyretics|antipyretics|mesh-ancestor
92237239|NCT01402375|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92237240|NCT01402375|Narcotics|narcotics|mesh-ancestor
92237241|NCT01402375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237242|NCT01402375|Antitussive Agents|antitussive agents|mesh-ancestor
92237244|NCT01302379|Metformin|metformin|mesh-list
92237245|NCT01302379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237246|NCT01302379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237247|NCT01351753|Metformin|metformin|mesh-list
92237248|NCT01351753|Topiramate|topiramate|mesh-list
92237249|NCT01351753|Orlistat|orlistat|mesh-list
92237250|NCT01351753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237251|NCT01351753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237252|NCT01351753|Anticonvulsants|anticonvulsants|mesh-ancestor
92237253|NCT01351753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237254|NCT01351753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237255|NCT01351753|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92237256|NCT01351753|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92237257|NCT00104858|Cyclosporine|cyclosporine|mesh-list
92237258|NCT00104858|Mycophenolic Acid|mycophenolic acid|mesh-list
92237259|NCT00104858|Rituximab|rituximab|mesh-list
92237260|NCT00104858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92237261|NCT00104858|Fludarabine|fludarabine|mesh-list
92237262|NCT00104858|Fludarabine phosphate|fludarabine phosphate|mesh-list
92237263|NCT00104858|Antibodies|antibodies|mesh-list
92237264|NCT00104858|Immunoglobulins|immunoglobulins|mesh-list
92237265|NCT00104858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92237266|NCT00104858|Cyclosporins|cyclosporins|mesh-list
92237267|NCT00104858|Immunologic Factors|immunologic factors|mesh-ancestor
92237268|NCT00104858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237269|NCT00104858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237270|NCT00104858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237271|NCT00104858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92237272|NCT00104858|Antimetabolites|antimetabolites|mesh-ancestor
92237273|NCT00104858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237274|NCT00104858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237275|NCT00104858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237276|NCT00104858|Antifungal Agents|antifungal agents|mesh-ancestor
92237277|NCT00104858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237278|NCT00104858|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237279|NCT00104858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92237280|NCT00104858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237281|NCT00104858|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92237282|NCT00104858|Antitubercular Agents|antitubercular agents|mesh-ancestor
92237283|NCT00104858|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92237284|NCT01407523|Levetiracetam|levetiracetam|mesh-list
92237285|NCT01407523|Anticonvulsants|anticonvulsants|mesh-ancestor
92237286|NCT01407523|Nootropic Agents|nootropic agents|mesh-ancestor
92237287|NCT00047060|Cyclosporine|cyclosporine|mesh-list
92237288|NCT00047060|Fludarabine|fludarabine|mesh-list
92237289|NCT00047060|Alemtuzumab|alemtuzumab|mesh-list
92237290|NCT00047060|Cyclosporins|cyclosporins|mesh-list
92237291|NCT00047060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237292|NCT00047060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237293|NCT00047060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237294|NCT00047060|Immunologic Factors|immunologic factors|mesh-ancestor
92237295|NCT00047060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237296|NCT00047060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237297|NCT00047060|Antifungal Agents|antifungal agents|mesh-ancestor
92237298|NCT00047060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237299|NCT00047060|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237300|NCT00047060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237301|NCT00047060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92237302|NCT00047060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237303|NCT01304407|Calcium|calcium|mesh-list
92237304|NCT01304407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92237305|NCT01304407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237306|NCT00106106|Acamprosate|acamprosate|mesh-list
92237307|NCT00106106|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92237308|NCT01304641|Atorvastatin|atorvastatin|mesh-list
92237309|NCT01304641|Simvastatin|simvastatin|mesh-list
92237310|NCT01304641|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92237311|NCT01304641|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92237312|NCT01304641|Antimetabolites|antimetabolites|mesh-ancestor
92237313|NCT01304641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237314|NCT01304641|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92237315|NCT01304641|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92237316|NCT01304641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237317|NCT04753112|Valsartan|valsartan|mesh-list
92237318|NCT04753112|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92237319|NCT04753112|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92237320|NCT04753112|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92237321|NCT04753112|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92237322|NCT04753112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237324|NCT01409239|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92237325|NCT01409239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237326|NCT01409239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237327|NCT00108524|Orlistat|orlistat|mesh-list
92237328|NCT00108524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237329|NCT00108524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237330|NCT00108524|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92237331|NCT00108524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92237332|NCT00052442|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92237333|NCT00052442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237334|NCT00052442|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92237335|NCT00052442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237336|NCT00052442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237337|NCT01410409|Acetaminophen|acetaminophen|mesh-list
92237338|NCT01410409|Pantoprazole|pantoprazole|mesh-list
92237339|NCT01410409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92237340|NCT01410409|Analgesics|analgesics|mesh-ancestor
92237341|NCT01410409|Sensory System Agents|sensory system agents|mesh-ancestor
92237342|NCT01410409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237343|NCT01410409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237344|NCT01410409|Antipyretics|antipyretics|mesh-ancestor
92237345|NCT01410409|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92237346|NCT01410409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92237347|NCT01410409|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92237348|NCT01410409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237349|NCT01410409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237350|NCT01410565|Apaziquone|apaziquone|mesh-list
92237351|NCT01410565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237352|NCT01357135|Metformin|metformin|mesh-list
92237353|NCT01357135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92237354|NCT01357135|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92237355|NCT01357135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237356|NCT01357135|Incretins|incretins|mesh-ancestor
92237357|NCT01357135|Hormones|hormones|mesh-ancestor
92237358|NCT01357135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237359|NCT01357135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92237360|NCT01357135|Protease Inhibitors|protease inhibitors|mesh-ancestor
92237361|NCT01357135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237362|NCT01357135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237363|NCT02324335|Brilacidin|brilacidin|mesh-list
92237364|NCT02324335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237365|NCT01411501|Mosapride|mosapride|mesh-list
92237366|NCT01411501|Citric Acid|citric acid|mesh-list
92237367|NCT01411501|Sodium Citrate|sodium citrate|mesh-list
92237368|NCT01411501|Anticoagulants|anticoagulants|mesh-ancestor
92237369|NCT01411501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92237370|NCT01411501|Chelating Agents|chelating agents|mesh-ancestor
92237371|NCT01411501|Sequestering Agents|sequestering agents|mesh-ancestor
92237372|NCT01411501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237373|NCT01411501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92237374|NCT01411501|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92237375|NCT01411501|Serotonin Agents|serotonin agents|mesh-ancestor
92237376|NCT01411501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237377|NCT01411501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237378|NCT01310179|Fludarabine|fludarabine|mesh-list
92237379|NCT01310179|Fludarabine phosphate|fludarabine phosphate|mesh-list
92237380|NCT01310179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237381|NCT01310179|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92237382|NCT01310179|Antimetabolites|antimetabolites|mesh-ancestor
92237383|NCT01310179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237384|NCT01310179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237385|NCT01310179|Immunologic Factors|immunologic factors|mesh-ancestor
92237386|NCT01310179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237387|NCT01412281|Vaccines|vaccines|mesh-list
92237388|NCT01412281|Immunologic Factors|immunologic factors|mesh-ancestor
92237389|NCT01412281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237390|NCT01359007|Leucovorin|leucovorin|mesh-list
92237391|NCT01359007|Oxaliplatin|oxaliplatin|mesh-list
92237392|NCT01359007|Irinotecan|irinotecan|mesh-list
92237393|NCT01359007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237394|NCT01359007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92237395|NCT01359007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92237396|NCT01359007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237397|NCT01359007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237398|NCT01359007|Antidotes|antidotes|mesh-ancestor
92237399|NCT01359007|Protective Agents|protective agents|mesh-ancestor
92237400|NCT01359007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237401|NCT01359007|Vitamin B Complex|vitamin b complex|mesh-ancestor
92237402|NCT01359007|Vitamins|vitamins|mesh-ancestor
92237403|NCT01359007|Micronutrients|micronutrients|mesh-ancestor
92237404|NCT01414153|Bevacizumab|bevacizumab|mesh-list
92237406|NCT01414153|Aflibercept|aflibercept|mesh-list
92237407|NCT01414153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92237408|NCT01414153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237409|NCT01414153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237410|NCT01414153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92237411|NCT01414153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92237412|NCT01414153|Growth Substances|growth substances|mesh-ancestor
92237413|NCT01414153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237414|NCT01414153|Growth Inhibitors|growth inhibitors|mesh-ancestor
92237415|NCT01414153|Immunologic Factors|immunologic factors|mesh-ancestor
92237416|NCT01311895|Hydromorphone|hydromorphone|mesh-list
92237417|NCT01311895|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92237418|NCT01311895|Narcotics|narcotics|mesh-ancestor
92237419|NCT01311895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237420|NCT01311895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237421|NCT01311895|Analgesics|analgesics|mesh-ancestor
92237422|NCT01311895|Sensory System Agents|sensory system agents|mesh-ancestor
92237423|NCT01311895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237424|NCT01362127|Cisplatin|cisplatin|mesh-list
92237425|NCT01362127|Carboplatin|carboplatin|mesh-list
92237426|NCT01362127|Oxaliplatin|oxaliplatin|mesh-list
92237427|NCT01362127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237428|NCT01362205|Dexmedetomidine|dexmedetomidine|mesh-list
92237429|NCT01362205|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92237430|NCT01362205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237431|NCT01362205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237432|NCT01362205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92237433|NCT01362205|Analgesics|analgesics|mesh-ancestor
92237434|NCT01362205|Sensory System Agents|sensory system agents|mesh-ancestor
92237435|NCT01362205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237436|NCT01362205|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92237437|NCT01362205|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92237438|NCT01362205|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92237439|NCT01362205|Adrenergic Agents|adrenergic agents|mesh-ancestor
92237440|NCT01362205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237441|NCT01362205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237443|NCT00052910|Fluorouracil|fluorouracil|mesh-list
92237444|NCT00052910|Epirubicin|epirubicin|mesh-list
92237445|NCT00052910|Calcium|calcium|mesh-list
92237446|NCT00052910|Levoleucovorin|levoleucovorin|mesh-list
92237447|NCT00052910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237448|NCT00052910|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92237449|NCT00052910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237450|NCT00052910|Antimetabolites|antimetabolites|mesh-ancestor
92237451|NCT00052910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237452|NCT00052910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92237453|NCT00052910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237454|NCT00052910|Immunologic Factors|immunologic factors|mesh-ancestor
92237455|NCT00052910|Antidotes|antidotes|mesh-ancestor
92237456|NCT00052910|Protective Agents|protective agents|mesh-ancestor
92237457|NCT00052910|Vitamin B Complex|vitamin b complex|mesh-ancestor
92237458|NCT00052910|Vitamins|vitamins|mesh-ancestor
92237459|NCT00052910|Micronutrients|micronutrients|mesh-ancestor
92237460|NCT00052910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237461|NCT00052910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92237462|NCT00052910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92237463|NCT00052910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237464|NCT01363843|Leucovorin|leucovorin|mesh-list
92237465|NCT01363843|Oxaliplatin|oxaliplatin|mesh-list
92237466|NCT01363843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237467|NCT01363843|Antidotes|antidotes|mesh-ancestor
92237468|NCT01363843|Protective Agents|protective agents|mesh-ancestor
92237469|NCT01363843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237470|NCT01363843|Vitamin B Complex|vitamin b complex|mesh-ancestor
92237471|NCT01363843|Vitamins|vitamins|mesh-ancestor
92237472|NCT01363843|Micronutrients|micronutrients|mesh-ancestor
92237474|NCT02092298|Cisplatin|cisplatin|mesh-list
92237475|NCT02092298|Mitomycins|mitomycins|mesh-list
92237476|NCT02092298|Mitomycin|mitomycin|mesh-list
92237477|NCT02092298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237478|NCT02092298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237479|NCT02092298|Alkylating Agents|alkylating agents|mesh-ancestor
92237480|NCT02092298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237481|NCT02092298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92237482|NCT02092298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237483|NCT02092298|Antidotes|antidotes|mesh-ancestor
92237484|NCT02092298|Protective Agents|protective agents|mesh-ancestor
92237485|NCT02092298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237486|NCT02092298|Antioxidants|antioxidants|mesh-ancestor
92237487|NCT02092298|Antitubercular Agents|antitubercular agents|mesh-ancestor
92237488|NCT02092298|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92237489|NCT02092298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237490|NCT02092298|Chelating Agents|chelating agents|mesh-ancestor
92237491|NCT02092298|Sequestering Agents|sequestering agents|mesh-ancestor
92237492|NCT02568566|Vaccines|vaccines|mesh-list
92237493|NCT02568566|Immunologic Factors|immunologic factors|mesh-ancestor
92237494|NCT02568566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237495|NCT00151814|Olmesartan|olmesartan|mesh-list
92237496|NCT00151814|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92237497|NCT00151814|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92237498|NCT00151814|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92237499|NCT00151814|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92237500|NCT00151814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237501|NCT00153842|Bexarotene|bexarotene|mesh-list
92237502|NCT00153842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237503|NCT01314001|Nicotine|nicotine|mesh-list
92237504|NCT01314001|Varenicline|varenicline|mesh-list
92237505|NCT01314001|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92237506|NCT01314001|Autonomic Agents|autonomic agents|mesh-ancestor
92237507|NCT01314001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339323|NCT00000695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237508|NCT01314001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237509|NCT01314001|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92237510|NCT01314001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92237511|NCT01314001|Cholinergic Agents|cholinergic agents|mesh-ancestor
92237512|NCT01314001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237513|NCT01314001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237514|NCT01363999|Atorvastatin|atorvastatin|mesh-list
92237515|NCT01363999|Dalcetrapib|dalcetrapib|mesh-list
92237516|NCT01363999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92237517|NCT01363999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92237518|NCT01363999|Antimetabolites|antimetabolites|mesh-ancestor
92237519|NCT01363999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237520|NCT01363999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92237521|NCT01363999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92237522|NCT01363999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237524|NCT00257894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237525|NCT00257894|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92237526|NCT00257894|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92237527|NCT00257894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237528|NCT00257894|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92237529|NCT00257894|GABA Agonists|gaba agonists|mesh-ancestor
92237530|NCT00257894|GABA Agents|gaba agents|mesh-ancestor
92237531|NCT00257894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237532|NCT00257894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237533|NCT00258128|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92237534|NCT00258128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92237535|NCT00258128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92237536|NCT00258128|Analgesics|analgesics|mesh-ancestor
92237537|NCT00258128|Sensory System Agents|sensory system agents|mesh-ancestor
92237538|NCT00258128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237539|NCT00258128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237540|NCT00258128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92237541|NCT00258128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237542|NCT01364623|Methyltestosterone|methyltestosterone|mesh-list
92237543|NCT01364623|Testosterone|testosterone|mesh-list
92237544|NCT01364623|Testosterone undecanoate|testosterone undecanoate|mesh-list
92237545|NCT01364623|Testosterone enanthate|testosterone enanthate|mesh-list
92237546|NCT01364623|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92237547|NCT01364623|Androgens|androgens|mesh-ancestor
92237548|NCT01364623|Hormones|hormones|mesh-ancestor
92237549|NCT01364623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237550|NCT01364623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237551|NCT01364623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92237552|NCT01364623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237553|NCT01364623|Anabolic Agents|anabolic agents|mesh-ancestor
92237554|NCT00258206|Cyclophosphamide|cyclophosphamide|mesh-list
92237555|NCT00258206|Rituximab|rituximab|mesh-list
92237556|NCT00258206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237557|NCT00258206|Immunologic Factors|immunologic factors|mesh-ancestor
92237558|NCT00258206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237559|NCT00258206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237560|NCT00258206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92237561|NCT00258206|Alkylating Agents|alkylating agents|mesh-ancestor
92237562|NCT00258206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237563|NCT00258206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237564|NCT00258206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92237565|NCT00258206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237566|NCT01063907|Bortezomib|bortezomib|mesh-list
92237567|NCT01063907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237568|NCT01316263|Olaratumab|olaratumab|mesh-list
92237569|NCT01316263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237570|NCT03015857|Phenylephrine|phenylephrine|mesh-list
92237571|NCT03015857|Oxymetazoline|oxymetazoline|mesh-list
92237572|NCT03015857|Norepinephrine|norepinephrine|mesh-list
92237573|NCT03015857|Fentanyl|fentanyl|mesh-list
92237574|NCT03015857|Bupivacaine|bupivacaine|mesh-list
92237575|NCT03015857|Anesthetics, Local|anesthetics, local|mesh-ancestor
92237576|NCT03015857|Anesthetics|anesthetics|mesh-ancestor
92237577|NCT03015857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237578|NCT03015857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237579|NCT03015857|Sensory System Agents|sensory system agents|mesh-ancestor
92237580|NCT03015857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237581|NCT03015857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92237582|NCT03015857|Narcotics|narcotics|mesh-ancestor
92237583|NCT03015857|Analgesics|analgesics|mesh-ancestor
92237584|NCT03015857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92237585|NCT03015857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92237586|NCT03015857|Anesthetics, General|anesthetics, general|mesh-ancestor
92237587|NCT03015857|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92237588|NCT03015857|Mydriatics|mydriatics|mesh-ancestor
92237589|NCT03015857|Autonomic Agents|autonomic agents|mesh-ancestor
92237591|NCT03015857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92237592|NCT03015857|Nasal Decongestants|nasal decongestants|mesh-ancestor
92237593|NCT03015857|Respiratory System Agents|respiratory system agents|mesh-ancestor
92237594|NCT03015857|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92237595|NCT03015857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92237596|NCT03015857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92237597|NCT03015857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92237598|NCT03015857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237599|NCT03015857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237600|NCT03015857|Protective Agents|protective agents|mesh-ancestor
92237601|NCT03295487|Estrogens|estrogens|mesh-list
92237602|NCT03295487|Hormones|hormones|mesh-ancestor
92237603|NCT03295487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237604|NCT03295487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237605|NCT03016091|Pembrolizumab|pembrolizumab|mesh-list
92237606|NCT03016091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237607|NCT03016091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237608|NCT03016091|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92237609|NCT03016091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237610|NCT03015701|Mifepristone|mifepristone|mesh-list
92237611|NCT03015701|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92237612|NCT03015701|Abortifacient Agents|abortifacient agents|mesh-ancestor
92237613|NCT03015701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92237614|NCT03015701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237615|NCT03015701|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92237616|NCT03015701|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92237617|NCT03015701|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92237618|NCT03015701|Contraceptive Agents|contraceptive agents|mesh-ancestor
92237619|NCT03015701|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92237620|NCT03015701|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92237621|NCT03015701|Hormone Antagonists|hormone antagonists|mesh-ancestor
92237622|NCT03015701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237623|NCT03015701|Luteolytic Agents|luteolytic agents|mesh-ancestor
92237624|NCT03015701|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92237625|NCT03015701|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92237627|NCT03047135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92237628|NCT03047135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237629|NCT03047135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237630|NCT03047135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237631|NCT04780061|Vitamin D|vitamin d|mesh-list
92237632|NCT04780061|Cholecalciferol|cholecalciferol|mesh-list
92237633|NCT04780061|Vitamins|vitamins|mesh-list
92237634|NCT04780061|Vitamin K|vitamin k|mesh-list
92237636|NCT04780061|Micronutrients|micronutrients|mesh-ancestor
92237637|NCT04780061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237638|NCT04780061|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92237639|NCT04780061|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92237640|NCT04780061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237641|NCT04780061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92237642|NCT04780061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92237643|NCT04780061|Hemostatics|hemostatics|mesh-ancestor
92237644|NCT04780061|Coagulants|coagulants|mesh-ancestor
92237645|NCT02172755|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92237646|NCT02172755|Anticonvulsants|anticonvulsants|mesh-ancestor
92237647|NCT02172755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92237648|NCT02172755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92237649|NCT02172755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92237650|NCT02172755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237651|NCT02973737|Capecitabine|capecitabine|mesh-list
92237652|NCT02973737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92237653|NCT02973737|Antimetabolites|antimetabolites|mesh-ancestor
92237654|NCT02973737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237655|NCT02973737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237656|NCT02872025|Pembrolizumab|pembrolizumab|mesh-list
92237657|NCT02872025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237658|NCT02872025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237659|NCT02872025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92237660|NCT02872025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237661|NCT02762669|Oxytocin|oxytocin|mesh-list
92237662|NCT02762669|Oxytocics|oxytocics|mesh-ancestor
92237663|NCT02762669|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92237664|NCT02762669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237665|NCT01072643|Dexmedetomidine|dexmedetomidine|mesh-list
92237666|NCT01072643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92237667|NCT01072643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237668|NCT01072643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237669|NCT01072643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92237670|NCT01072643|Analgesics|analgesics|mesh-ancestor
92237671|NCT01072643|Sensory System Agents|sensory system agents|mesh-ancestor
92237672|NCT01072643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237673|NCT01072643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92237674|NCT01072643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92237675|NCT01072643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92237676|NCT01072643|Adrenergic Agents|adrenergic agents|mesh-ancestor
92237677|NCT01072643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237678|NCT01072643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237679|NCT01076231|Etoposide|etoposide|mesh-list
92237680|NCT01076231|Etoposide phosphate|etoposide phosphate|mesh-list
92237681|NCT01076231|Podophyllotoxin|podophyllotoxin|mesh-list
92237682|NCT01076231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237683|NCT01076231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92237684|NCT01076231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92237685|NCT01076231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92237686|NCT01076231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237687|NCT01076231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237688|NCT01076231|Keratolytic Agents|keratolytic agents|mesh-ancestor
92237689|NCT01076231|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237690|NCT01076231|Tubulin Modulators|tubulin modulators|mesh-ancestor
92237691|NCT01076231|Antimitotic Agents|antimitotic agents|mesh-ancestor
92237692|NCT01076231|Mitosis Modulators|mitosis modulators|mesh-ancestor
92237693|NCT00117962|Carboplatin|carboplatin|mesh-list
92237694|NCT00117962|Pemetrexed|pemetrexed|mesh-list
92237695|NCT00117962|Cetuximab|cetuximab|mesh-list
92237696|NCT00117962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237697|NCT00117962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237698|NCT00117962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237699|NCT00117962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92237700|NCT00117962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92237701|NCT00117962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237702|NCT00118274|Cyclophosphamide|cyclophosphamide|mesh-list
92237704|NCT00118274|Freund's Adjuvant|freund's adjuvant|mesh-list
92237705|NCT00118274|Immunologic Factors|immunologic factors|mesh-ancestor
92237706|NCT00118274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237707|NCT00118274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237708|NCT00118274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237709|NCT00118274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92237710|NCT00118274|Alkylating Agents|alkylating agents|mesh-ancestor
92237711|NCT00118274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237712|NCT00118274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237713|NCT00118274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92237714|NCT00118274|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92237715|NCT01898000|Chlorhexidine|chlorhexidine|mesh-list
92339340|NCT00000713|Antiviral Agents|antiviral agents|mesh-ancestor
92237716|NCT01898000|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92237717|NCT01898000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237718|NCT01898000|Disinfectants|disinfectants|mesh-ancestor
92237719|NCT00166166|Fluconazole|fluconazole|mesh-list
92237720|NCT00166166|Nitroprusside|nitroprusside|mesh-list
92237721|NCT00166166|Tetraethylammonium|tetraethylammonium|mesh-list
92237722|NCT00166166|Acetylcholine|acetylcholine|mesh-list
92237724|NCT00166166|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92237725|NCT00166166|Kininogens|kininogens|mesh-list
92237726|NCT00166166|Antifungal Agents|antifungal agents|mesh-ancestor
92237727|NCT00166166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237728|NCT00166166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92237729|NCT00166166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92237730|NCT00166166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237731|NCT00166166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237732|NCT00166166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92237733|NCT00166166|Hormone Antagonists|hormone antagonists|mesh-ancestor
92237734|NCT00166166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237735|NCT00166166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237736|NCT00166166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92237737|NCT00166166|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92237738|NCT00166166|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92237739|NCT00166166|Vasodilator Agents|vasodilator agents|mesh-ancestor
92237740|NCT00166166|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92237741|NCT00166166|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92237742|NCT00166166|Cholinergic Agents|cholinergic agents|mesh-ancestor
92237743|NCT00166166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237744|NCT00166166|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92237745|NCT00166166|Protease Inhibitors|protease inhibitors|mesh-ancestor
92237746|NCT00166166|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92237747|NCT00166166|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92237748|NCT00118352|Cyclosporine|cyclosporine|mesh-list
92237749|NCT00118352|Mycophenolic Acid|mycophenolic acid|mesh-list
92237750|NCT00118352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92237751|NCT00118352|Alemtuzumab|alemtuzumab|mesh-list
92237752|NCT00118352|Fludarabine|fludarabine|mesh-list
92237753|NCT00118352|Fludarabine phosphate|fludarabine phosphate|mesh-list
92237754|NCT00118352|Antibodies|antibodies|mesh-list
92237755|NCT00118352|Immunoglobulins|immunoglobulins|mesh-list
92237756|NCT00118352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92237757|NCT00118352|Cyclosporins|cyclosporins|mesh-list
92237758|NCT00118352|Immunologic Factors|immunologic factors|mesh-ancestor
92237759|NCT00118352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237760|NCT00118352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237761|NCT00118352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92237762|NCT00118352|Antimetabolites|antimetabolites|mesh-ancestor
92237763|NCT00118352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237764|NCT00118352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237765|NCT00118352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237766|NCT00118352|Antifungal Agents|antifungal agents|mesh-ancestor
92237767|NCT00118352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237768|NCT00118352|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237769|NCT00118352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237770|NCT00118352|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92237771|NCT00118352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237772|NCT00118352|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92237773|NCT00118352|Antitubercular Agents|antitubercular agents|mesh-ancestor
92237774|NCT00118352|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92237775|NCT01111331|Empagliflozin|empagliflozin|mesh-list
92237776|NCT01111331|Warfarin|warfarin|mesh-list
92237777|NCT01111331|Anticoagulants|anticoagulants|mesh-ancestor
92237778|NCT01111331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92237779|NCT01111331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237780|NCT01111331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237781|NCT01111331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237782|NCT00167102|Alefacept|alefacept|mesh-list
92237783|NCT00167102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237784|NCT00167102|Immunologic Factors|immunologic factors|mesh-ancestor
92237785|NCT00167102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237786|NCT01859819|Cytarabine|cytarabine|mesh-list
92237787|NCT01859819|Rituximab|rituximab|mesh-list
92237788|NCT01859819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237789|NCT01859819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237790|NCT01859819|Immunologic Factors|immunologic factors|mesh-ancestor
92237791|NCT01859819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237792|NCT01859819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237793|NCT01859819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92237794|NCT01859819|Antimetabolites|antimetabolites|mesh-ancestor
92237795|NCT01859819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237796|NCT01859819|Antiviral Agents|antiviral agents|mesh-ancestor
92237797|NCT01859819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237798|NCT01859819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237800|NCT01795313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92237801|NCT01795313|Immunologic Factors|immunologic factors|mesh-ancestor
92237802|NCT01795313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237803|NCT01795313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237804|NCT01795313|Interferon Inducers|interferon inducers|mesh-ancestor
92237805|NCT02176031|Methylprednisolone|methylprednisolone|mesh-list
92237806|NCT02176031|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92237807|NCT02176031|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92237808|NCT02176031|Prednisolone|prednisolone|mesh-list
92237809|NCT02176031|Prednisolone acetate|prednisolone acetate|mesh-list
92237810|NCT02176031|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92237811|NCT02176031|Prednisolone phosphate|prednisolone phosphate|mesh-list
92237812|NCT02176031|Natalizumab|natalizumab|mesh-list
92237813|NCT02176031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92237814|NCT02176031|Antiemetics|antiemetics|mesh-ancestor
92237815|NCT02176031|Autonomic Agents|autonomic agents|mesh-ancestor
92237816|NCT02176031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237817|NCT02176031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237818|NCT02176031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92237819|NCT02176031|Glucocorticoids|glucocorticoids|mesh-ancestor
92237820|NCT02176031|Hormones|hormones|mesh-ancestor
92237821|NCT02176031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237822|NCT02176031|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92237823|NCT02176031|Protective Agents|protective agents|mesh-ancestor
92237824|NCT02176031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92237825|NCT02176031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237826|NCT02176031|Immunologic Factors|immunologic factors|mesh-ancestor
92237827|NCT03013361|Bupivacaine|bupivacaine|mesh-list
92237828|NCT03013361|Ropivacaine|ropivacaine|mesh-list
92237829|NCT03013361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92237830|NCT03013361|Anesthetics|anesthetics|mesh-ancestor
92237831|NCT03013361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237832|NCT03013361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237833|NCT03013361|Sensory System Agents|sensory system agents|mesh-ancestor
92237834|NCT03013361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237835|NCT01077401|Ranibizumab|ranibizumab|mesh-list
92237836|NCT01077401|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92237837|NCT01077401|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92237838|NCT01077401|Growth Substances|growth substances|mesh-ancestor
92237839|NCT01077401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237840|NCT01077401|Growth Inhibitors|growth inhibitors|mesh-ancestor
92237841|NCT01077401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237842|NCT01316341|Empagliflozin|empagliflozin|mesh-list
92237843|NCT01316341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92237844|NCT01316341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237845|NCT01316341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237846|NCT01316341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237847|NCT01112735|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92237848|NCT01112735|Hemostatics|hemostatics|mesh-ancestor
92237849|NCT01112735|Coagulants|coagulants|mesh-ancestor
92237850|NCT03014297|Everolimus|everolimus|mesh-list
92237851|NCT03014297|Fosbretabulin|fosbretabulin|mesh-list
92237852|NCT03014297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92237853|NCT03014297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92237854|NCT03014297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237855|NCT03014297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237856|NCT03014297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237857|NCT03014297|Immunologic Factors|immunologic factors|mesh-ancestor
92237858|NCT03014297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237859|NCT03014297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237860|NCT03014297|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92237862|NCT01034111|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92237863|NCT01034111|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237864|NCT01034111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237866|NCT01034111|Hormones|hormones|mesh-ancestor
92237867|NCT01034111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92237868|NCT01034111|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92237869|NCT01034111|Protease Inhibitors|protease inhibitors|mesh-ancestor
92237870|NCT01034111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237871|NCT01034111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237872|NCT01114997|Lidocaine|lidocaine|mesh-list
92237873|NCT01114997|Esmolol|esmolol|mesh-list
92237874|NCT01114997|Anesthetics, Local|anesthetics, local|mesh-ancestor
92237875|NCT01114997|Anesthetics|anesthetics|mesh-ancestor
92237876|NCT01114997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237877|NCT01114997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237878|NCT01114997|Sensory System Agents|sensory system agents|mesh-ancestor
92237879|NCT01114997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237880|NCT01114997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92237881|NCT01114997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92237882|NCT01114997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92237883|NCT01114997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92237884|NCT01114997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237885|NCT01114997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92237886|NCT01114997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92237887|NCT01114997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92237888|NCT01114997|Adrenergic Agents|adrenergic agents|mesh-ancestor
92237889|NCT01114997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92237890|NCT00118742|Cyclosporine|cyclosporine|mesh-list
92237891|NCT00118742|Sirolimus|sirolimus|mesh-list
92237892|NCT00118742|Mycophenolic Acid|mycophenolic acid|mesh-list
92237893|NCT00118742|Tacrolimus|tacrolimus|mesh-list
92237894|NCT00118742|Cyclosporins|cyclosporins|mesh-list
92237895|NCT00118742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237896|NCT00118742|Immunologic Factors|immunologic factors|mesh-ancestor
92237897|NCT00118742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237898|NCT00118742|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92237899|NCT00118742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237900|NCT00118742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237901|NCT00118742|Antifungal Agents|antifungal agents|mesh-ancestor
92237902|NCT00118742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92237903|NCT00118742|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237904|NCT00118742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237905|NCT00118742|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92237906|NCT00118742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237907|NCT00118742|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92237908|NCT00118742|Antitubercular Agents|antitubercular agents|mesh-ancestor
92237909|NCT00118742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92237910|NCT01317667|Vaccines|vaccines|mesh-list
92237911|NCT01317667|Immunologic Factors|immunologic factors|mesh-ancestor
92237912|NCT01317667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237913|NCT00167180|Cyclophosphamide|cyclophosphamide|mesh-list
92237914|NCT00167180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92237915|NCT00167180|Immunologic Factors|immunologic factors|mesh-ancestor
92237916|NCT00167180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237917|NCT00167180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237918|NCT00167180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92237919|NCT00167180|Alkylating Agents|alkylating agents|mesh-ancestor
92237920|NCT00167180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237921|NCT00167180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237922|NCT00167180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92237923|NCT01317901|Rituximab|rituximab|mesh-list
92237924|NCT01317901|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92237925|NCT01317901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92237926|NCT01317901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237927|NCT01317901|Immunologic Factors|immunologic factors|mesh-ancestor
92237928|NCT01317901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237929|NCT01317901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237930|NCT01317901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92237931|NCT01317901|Alkylating Agents|alkylating agents|mesh-ancestor
92237932|NCT01317901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237934|NCT03008551|Empagliflozin|empagliflozin|mesh-list
92237935|NCT03008551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237936|NCT03008551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237937|NCT03008551|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92237938|NCT03008551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237939|NCT01366885|Vitamin D|vitamin d|mesh-list
92237940|NCT01366885|Cholecalciferol|cholecalciferol|mesh-list
92237941|NCT01366885|Vitamins|vitamins|mesh-ancestor
92237942|NCT01366885|Micronutrients|micronutrients|mesh-ancestor
92237943|NCT01366885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237944|NCT01366885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92237945|NCT01366885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92237946|NCT01899170|Carfentanil|carfentanil|mesh-list
92237947|NCT01899170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92237948|NCT01899170|Narcotics|narcotics|mesh-ancestor
92237949|NCT01899170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92237950|NCT01899170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237951|NCT01899170|Analgesics|analgesics|mesh-ancestor
92237952|NCT01899170|Sensory System Agents|sensory system agents|mesh-ancestor
92237953|NCT01899170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237954|NCT01425229|Bosentan|bosentan|mesh-list
92237955|NCT01425229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92237956|NCT01425229|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92237957|NCT01425229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237958|NCT00258362|Carboplatin|carboplatin|mesh-list
92237959|NCT00258362|Docetaxel|docetaxel|mesh-list
92237960|NCT00258362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237961|NCT00258362|Tubulin Modulators|tubulin modulators|mesh-ancestor
92237962|NCT00258362|Antimitotic Agents|antimitotic agents|mesh-ancestor
92237963|NCT00258362|Mitosis Modulators|mitosis modulators|mesh-ancestor
92237964|NCT00258362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237965|NCT00258830|Vaccines|vaccines|mesh-list
92237966|NCT00258830|Immunologic Factors|immunologic factors|mesh-ancestor
92237967|NCT00258830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237968|NCT02539368|Infliximab|infliximab|mesh-list
92237969|NCT02539368|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92237970|NCT02539368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92237971|NCT02539368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92237972|NCT02539368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92237973|NCT02539368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92237974|NCT01425307|Hydroxyurea|hydroxyurea|mesh-list
92237975|NCT01425307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237976|NCT01425307|Antisickling Agents|antisickling agents|mesh-ancestor
92237977|NCT01425307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92237978|NCT01425307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92237979|NCT01425307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92237980|NCT01035749|Vaccines|vaccines|mesh-list
92237981|NCT01035749|Immunologic Factors|immunologic factors|mesh-ancestor
92237982|NCT01035749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237983|NCT00123110|Metformin|metformin|mesh-list
92237984|NCT00123110|Leuprolide|leuprolide|mesh-list
92237985|NCT00123110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92237986|NCT00123110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237987|NCT00123110|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92237988|NCT00123110|Fertility Agents|fertility agents|mesh-ancestor
92237989|NCT00123110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92237990|NCT00123110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92237991|NCT00123110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92237992|NCT01425853|Celecoxib|celecoxib|mesh-list
92237993|NCT01425853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92237994|NCT01425853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92237995|NCT01425853|Analgesics|analgesics|mesh-ancestor
92237996|NCT01425853|Sensory System Agents|sensory system agents|mesh-ancestor
92237997|NCT01425853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92237998|NCT01425853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92237999|NCT01425853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238000|NCT01425853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238001|NCT01425853|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92238002|NCT01425853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92238003|NCT01425853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238004|NCT01425853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238005|NCT01426867|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92238006|NCT01426867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92238008|NCT01426867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92238009|NCT01426867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92238010|NCT01426867|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92238011|NCT01426867|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92238012|NCT01426867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92238013|NCT01426867|Adrenergic Agents|adrenergic agents|mesh-ancestor
92238014|NCT01426867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238015|NCT01426867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238016|NCT01426867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238017|NCT01426867|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92238018|NCT01426867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238019|NCT00168428|Botulinum Toxins|botulinum toxins|mesh-list
92238020|NCT00168428|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92238021|NCT00168428|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92238022|NCT00168428|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92238023|NCT00168428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92238024|NCT00168428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238025|NCT00168428|Cholinergic Agents|cholinergic agents|mesh-ancestor
92238026|NCT00168428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238027|NCT00168428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238028|NCT00168428|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92238029|NCT00168428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238030|NCT01427881|Cyclosporine|cyclosporine|mesh-list
92238031|NCT01427881|Cyclophosphamide|cyclophosphamide|mesh-list
92238032|NCT01427881|Busulfan|busulfan|mesh-list
92238033|NCT01427881|Fludarabine|fludarabine|mesh-list
92238034|NCT01427881|Fludarabine phosphate|fludarabine phosphate|mesh-list
92238035|NCT01427881|Cyclosporins|cyclosporins|mesh-list
92238036|NCT01427881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238037|NCT01427881|Immunologic Factors|immunologic factors|mesh-ancestor
92238038|NCT01427881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238039|NCT01427881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238040|NCT01427881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238041|NCT01427881|Alkylating Agents|alkylating agents|mesh-ancestor
92238042|NCT01427881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238043|NCT01427881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238044|NCT01427881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238045|NCT01427881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238046|NCT01427881|Antimetabolites|antimetabolites|mesh-ancestor
92238047|NCT01427881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238048|NCT01427881|Antifungal Agents|antifungal agents|mesh-ancestor
92238049|NCT01427881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238050|NCT01427881|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238051|NCT01427881|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92238052|NCT02112734|Vitamin D|vitamin d|mesh-list
92238053|NCT02112734|Ergocalciferols|ergocalciferols|mesh-list
92238054|NCT02112734|Cholecalciferol|cholecalciferol|mesh-list
92238055|NCT02112734|Vitamins|vitamins|mesh-list
92238056|NCT02112734|Micronutrients|micronutrients|mesh-ancestor
91924615|NCT01573351|Protease Inhibitors|protease inhibitors|mesh-ancestor
92238057|NCT02112734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238058|NCT02112734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92238059|NCT02112734|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92238060|NCT01319773|Cyclosporine|cyclosporine|mesh-list
92238061|NCT01319773|Cyclosporins|cyclosporins|mesh-list
92238062|NCT01319773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238063|NCT01319773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238064|NCT01319773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238065|NCT01319773|Immunologic Factors|immunologic factors|mesh-ancestor
92238066|NCT01319773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238067|NCT01319773|Antifungal Agents|antifungal agents|mesh-ancestor
92238068|NCT01319773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238069|NCT01319773|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238070|NCT01319773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238071|NCT01319773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92238072|NCT01319851|Alefacept|alefacept|mesh-list
92238073|NCT01319851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238074|NCT01319851|Immunologic Factors|immunologic factors|mesh-ancestor
92238075|NCT01319851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238076|NCT04351867|Docetaxel|docetaxel|mesh-list
92238077|NCT04351867|Capecitabine|capecitabine|mesh-list
92238078|NCT04351867|Oxaliplatin|oxaliplatin|mesh-list
92238079|NCT04351867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238080|NCT04351867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92238081|NCT04351867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92238082|NCT04351867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92238083|NCT04351867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238084|NCT04351867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238085|NCT04351867|Antimetabolites|antimetabolites|mesh-ancestor
92238086|NCT00262730|Temozolomide|temozolomide|mesh-list
92238087|NCT00262730|Poly ICLC|poly iclc|mesh-list
92238088|NCT00262730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238089|NCT00262730|Alkylating Agents|alkylating agents|mesh-ancestor
92238090|NCT00262730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238091|NCT00262730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238092|NCT00262730|Interferon Inducers|interferon inducers|mesh-ancestor
92238093|NCT00262730|Immunologic Factors|immunologic factors|mesh-ancestor
92238094|NCT00262730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238095|NCT04262934|Vitamin D|vitamin d|mesh-list
92238096|NCT04262934|Cholecalciferol|cholecalciferol|mesh-list
92238097|NCT04262934|Vitamins|vitamins|mesh-ancestor
92238098|NCT04262934|Micronutrients|micronutrients|mesh-ancestor
92238099|NCT04262934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238100|NCT04262934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92238101|NCT04262934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92238102|NCT00262964|Niacin|niacin|mesh-list
92238103|NCT00262964|Fenofibrate|fenofibrate|mesh-list
92238104|NCT00262964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92238105|NCT00262964|Antimetabolites|antimetabolites|mesh-ancestor
92238106|NCT00262964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238107|NCT00262964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92238108|NCT00262964|Vasodilator Agents|vasodilator agents|mesh-ancestor
92238109|NCT00262964|Vitamin B Complex|vitamin b complex|mesh-ancestor
92238110|NCT00262964|Vitamins|vitamins|mesh-ancestor
92238111|NCT00262964|Micronutrients|micronutrients|mesh-ancestor
92238112|NCT00262964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238113|NCT00124514|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92238114|NCT00124514|Luteolytic Agents|luteolytic agents|mesh-ancestor
92238115|NCT00124514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92238116|NCT00124514|Contraceptive Agents|contraceptive agents|mesh-ancestor
92238117|NCT00124514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92238118|NCT00124514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238119|NCT00124514|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92238120|NCT00124514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238121|NCT00124514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238122|NCT01899248|Sevoflurane|sevoflurane|mesh-list
92238123|NCT01899248|Desflurane|desflurane|mesh-list
92238124|NCT01899248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92238125|NCT01899248|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92238126|NCT01899248|Anesthetics, General|anesthetics, general|mesh-ancestor
92238127|NCT01899248|Anesthetics|anesthetics|mesh-ancestor
92238128|NCT01899248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238129|NCT01899248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238130|NCT01322815|Leucovorin|leucovorin|mesh-list
92238131|NCT01322815|Fluorouracil|fluorouracil|mesh-list
92238132|NCT01322815|Oxaliplatin|oxaliplatin|mesh-list
92238133|NCT01322815|Irinotecan|irinotecan|mesh-list
92238134|NCT01322815|Bevacizumab|bevacizumab|mesh-list
92238135|NCT01322815|Levoleucovorin|levoleucovorin|mesh-list
92238136|NCT01322815|Antimetabolites|antimetabolites|mesh-ancestor
92238137|NCT01322815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238138|NCT01322815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238139|NCT01322815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238140|NCT01322815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238141|NCT01322815|Immunologic Factors|immunologic factors|mesh-ancestor
92238142|NCT01322815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238143|NCT01322815|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92238144|NCT01322815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92238145|NCT01322815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238146|NCT01322815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238147|NCT01322815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92238148|NCT01322815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92238149|NCT01322815|Growth Substances|growth substances|mesh-ancestor
92238150|NCT01322815|Growth Inhibitors|growth inhibitors|mesh-ancestor
92238151|NCT01322815|Antidotes|antidotes|mesh-ancestor
92238152|NCT01322815|Protective Agents|protective agents|mesh-ancestor
92238153|NCT01322815|Vitamin B Complex|vitamin b complex|mesh-ancestor
92238154|NCT01322815|Vitamins|vitamins|mesh-ancestor
92238155|NCT01322815|Micronutrients|micronutrients|mesh-ancestor
92238156|NCT00176228|Lamotrigine|lamotrigine|mesh-list
92238157|NCT00176228|Anticonvulsants|anticonvulsants|mesh-ancestor
92238158|NCT00176228|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92238159|NCT00176228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92238160|NCT00176228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238161|NCT00176228|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92238162|NCT00176228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238163|NCT00176228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92238164|NCT00176228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92238165|NCT00176228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238166|NCT00176228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92238167|NCT00176228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92238168|NCT00176306|Levofloxacin|levofloxacin|mesh-list
92238169|NCT00176306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92238170|NCT00176306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238171|NCT00176306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92238172|NCT00176306|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92238173|NCT00176306|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92238174|NCT00176306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238175|NCT00176306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238176|NCT00176306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238177|NCT00176306|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92238178|NCT00176306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92238179|NCT01429987|Plecanatide|plecanatide|mesh-list
92238180|NCT01429987|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92238181|NCT01429987|Enzyme Activators|enzyme activators|mesh-ancestor
92238182|NCT01429987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238183|NCT01429987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238184|NCT00265616|Pentobarbital|pentobarbital|mesh-list
92238185|NCT00265616|Thiopental|thiopental|mesh-list
92238186|NCT00265616|Propofol|propofol|mesh-list
92238187|NCT00265616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92238188|NCT00265616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238189|NCT00265616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238190|NCT00265616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92238191|NCT00265616|Anesthetics, General|anesthetics, general|mesh-ancestor
92238192|NCT00265616|Anesthetics|anesthetics|mesh-ancestor
92238193|NCT00265616|Anticonvulsants|anticonvulsants|mesh-ancestor
92238194|NCT00265616|GABA Modulators|gaba modulators|mesh-ancestor
92238195|NCT00265616|GABA Agents|gaba agents|mesh-ancestor
92238196|NCT00265616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081546|NCT04415983|Metronidazole|metronidazole|mesh-list
92238197|NCT00265616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238198|NCT00265616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92238199|NCT00176852|Vidarabine|vidarabine|mesh-list
92238200|NCT00176852|Cyclophosphamide|cyclophosphamide|mesh-list
92238201|NCT00176852|Busulfan|busulfan|mesh-list
92238202|NCT00176852|Fludarabine|fludarabine|mesh-list
92238203|NCT00176852|Fludarabine phosphate|fludarabine phosphate|mesh-list
92238204|NCT00176852|Alemtuzumab|alemtuzumab|mesh-list
92238205|NCT00176852|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92238206|NCT00176852|Lenograstim|lenograstim|mesh-list
92238207|NCT00176852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238208|NCT00176852|Immunologic Factors|immunologic factors|mesh-ancestor
92238209|NCT00176852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238210|NCT00176852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238211|NCT00176852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238212|NCT00176852|Alkylating Agents|alkylating agents|mesh-ancestor
92238213|NCT00176852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238214|NCT00176852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238215|NCT00176852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238216|NCT00176852|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238217|NCT00176852|Antimetabolites|antimetabolites|mesh-ancestor
92238218|NCT00176852|Antiviral Agents|antiviral agents|mesh-ancestor
92238219|NCT00176852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238220|NCT00176852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92238221|NCT00176852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238222|NCT01323517|Dactinomycin|dactinomycin|mesh-list
92238223|NCT01323517|Ipilimumab|ipilimumab|mesh-list
92238224|NCT01323517|Melphalan|melphalan|mesh-list
92238225|NCT01323517|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238226|NCT01323517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238227|NCT01323517|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92238228|NCT01323517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238229|NCT01323517|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238230|NCT01323517|Alkylating Agents|alkylating agents|mesh-ancestor
92238231|NCT01323517|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238233|NCT01323517|Immunologic Factors|immunologic factors|mesh-ancestor
92238234|NCT01323517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238235|NCT01323517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92238236|NCT01323517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238237|NCT01323517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92238238|NCT01323517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92238239|NCT01323517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238240|NCT01323517|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92238241|NCT01323595|Celecoxib|celecoxib|mesh-list
92238242|NCT01323595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92238243|NCT01323595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92238244|NCT01323595|Analgesics|analgesics|mesh-ancestor
92238245|NCT01323595|Sensory System Agents|sensory system agents|mesh-ancestor
92238246|NCT01323595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238247|NCT01323595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238248|NCT01323595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238249|NCT01323595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238250|NCT01323595|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92238251|NCT01323595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92238252|NCT01323595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238253|NCT01323595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238254|NCT01376557|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92238255|NCT01376557|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92238256|NCT01376557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238257|NCT01376557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92238258|NCT01376557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238259|NCT01431391|Leuprolide|leuprolide|mesh-list
92238260|NCT01431391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92238261|NCT01431391|Fertility Agents|fertility agents|mesh-ancestor
92238262|NCT01431391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92238263|NCT01431391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238264|NCT01431391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238265|NCT01431391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238266|NCT03009097|Atorvastatin|atorvastatin|mesh-list
92238267|NCT03009097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92238268|NCT03009097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92238269|NCT03009097|Antimetabolites|antimetabolites|mesh-ancestor
92238270|NCT03009097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238271|NCT03009097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92238272|NCT03009097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92238273|NCT03009097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238274|NCT01325311|Vitamin D|vitamin d|mesh-list
92238275|NCT01325311|Cholecalciferol|cholecalciferol|mesh-list
92238276|NCT01325311|Genistein|genistein|mesh-list
92238277|NCT01325311|Vitamins|vitamins|mesh-ancestor
92238278|NCT01325311|Micronutrients|micronutrients|mesh-ancestor
92238279|NCT01325311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238280|NCT01325311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92238281|NCT01325311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92238282|NCT01325311|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92238283|NCT01325311|Protective Agents|protective agents|mesh-ancestor
92238284|NCT01325311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238285|NCT01325311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92238286|NCT01325311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238287|NCT01325311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238288|NCT01325311|Phytoestrogens|phytoestrogens|mesh-ancestor
92238289|NCT01325311|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92238290|NCT01325311|Estrogens|estrogens|mesh-ancestor
92238291|NCT01325311|Hormones|hormones|mesh-ancestor
92238292|NCT01325311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238293|NCT01432015|Aprepitant|aprepitant|mesh-list
92238294|NCT01432015|Fosaprepitant|fosaprepitant|mesh-list
92238295|NCT01432015|Antiemetics|antiemetics|mesh-ancestor
92238296|NCT01432015|Autonomic Agents|autonomic agents|mesh-ancestor
92238297|NCT01432015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238298|NCT01432015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238299|NCT01432015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238300|NCT01432015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92238301|NCT01432015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238302|NCT01432015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238304|NCT01080677|Caffeine|caffeine|mesh-list
92238305|NCT01080677|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92238306|NCT01080677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238307|NCT01080677|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92238308|NCT01080677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238309|NCT01080677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238310|NCT01080677|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92238311|NCT01080677|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92238312|NCT01080677|Purinergic Agents|purinergic agents|mesh-ancestor
92238313|NCT01080677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238314|NCT01080677|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92238315|NCT01080677|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92238316|NCT01080677|Adrenergic Agents|adrenergic agents|mesh-ancestor
92238317|NCT01080677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92238318|NCT01080677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92238319|NCT01080677|Vasodilator Agents|vasodilator agents|mesh-ancestor
92238320|NCT01378273|Epoetin Alfa|epoetin alfa|mesh-list
92238321|NCT01378273|Hematinics|hematinics|mesh-ancestor
92238322|NCT01432405|Pioglitazone|pioglitazone|mesh-list
92238323|NCT01432405|Exenatide|exenatide|mesh-list
92238324|NCT01432405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92238325|NCT01432405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238326|NCT01432405|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92238327|NCT01432405|Incretins|incretins|mesh-ancestor
92238328|NCT01432405|Hormones|hormones|mesh-ancestor
92238329|NCT01432405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238330|NCT01432561|Cysteamine|cysteamine|mesh-list
92238331|NCT01432561|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92339406|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238332|NCT01432561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238334|NCT01116401|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92238335|NCT01116401|Fertility Agents|fertility agents|mesh-ancestor
92238336|NCT01116401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92238337|NCT01116401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238338|NCT01116401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238339|NCT01116401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238340|NCT03008317|Chromium|chromium|mesh-list
92238341|NCT03008317|Trace Elements|trace elements|mesh-ancestor
92238342|NCT03008317|Micronutrients|micronutrients|mesh-ancestor
92238343|NCT03008317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238344|NCT01433107|Terbinafine|terbinafine|mesh-list
92238345|NCT01433107|Antifungal Agents|antifungal agents|mesh-ancestor
92238346|NCT01433107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238347|NCT01433107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238348|NCT01433107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238349|NCT01082939|Cyclophosphamide|cyclophosphamide|mesh-list
92238350|NCT01082939|Rituximab|rituximab|mesh-list
92238351|NCT01082939|Fludarabine|fludarabine|mesh-list
92238352|NCT01082939|Fludarabine phosphate|fludarabine phosphate|mesh-list
92238353|NCT01082939|Alemtuzumab|alemtuzumab|mesh-list
92238354|NCT01082939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238355|NCT01082939|Immunologic Factors|immunologic factors|mesh-ancestor
92238356|NCT01082939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238357|NCT01082939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238358|NCT01082939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238359|NCT01082939|Alkylating Agents|alkylating agents|mesh-ancestor
92238360|NCT01082939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238361|NCT01082939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238362|NCT01082939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238363|NCT01082939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238364|NCT01082939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238365|NCT01082939|Antimetabolites|antimetabolites|mesh-ancestor
92238366|NCT01381471|Fluticasone|fluticasone|mesh-list
92238367|NCT01381471|Xhance|xhance|mesh-list
92238368|NCT01381471|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92238369|NCT01381471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238370|NCT01381471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92238371|NCT01381471|Autonomic Agents|autonomic agents|mesh-ancestor
92238372|NCT01381471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238373|NCT01381471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238374|NCT01381471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92238375|NCT01381471|Respiratory System Agents|respiratory system agents|mesh-ancestor
92238376|NCT01381471|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238377|NCT01381471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92238378|NCT01381471|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92238379|NCT01381471|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92238380|NCT01381471|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92238381|NCT01381471|Adrenergic Agents|adrenergic agents|mesh-ancestor
92238382|NCT01381471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238383|NCT01381471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238384|NCT05422092|Pioglitazone|pioglitazone|mesh-list
92238385|NCT05422092|Canagliflozin|canagliflozin|mesh-list
92238386|NCT05422092|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92238387|NCT05422092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238388|NCT05422092|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92238389|NCT05422092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238390|NCT05448456|Tranexamic Acid|tranexamic acid|mesh-list
92238391|NCT05448456|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92238392|NCT05448456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92238393|NCT05448456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238394|NCT05448456|Hemostatics|hemostatics|mesh-ancestor
92238395|NCT05448456|Coagulants|coagulants|mesh-ancestor
92238397|NCT05448378|Vitamin B Complex|vitamin b complex|mesh-ancestor
92238398|NCT05448378|Vitamins|vitamins|mesh-ancestor
92238399|NCT05448378|Micronutrients|micronutrients|mesh-ancestor
92238400|NCT05448378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238401|NCT01434121|Ascorbic Acid|ascorbic acid|mesh-list
92238402|NCT01434121|Vitamins|vitamins|mesh-ancestor
92238403|NCT01434121|Micronutrients|micronutrients|mesh-ancestor
92238404|NCT01434121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238405|NCT01434121|Antioxidants|antioxidants|mesh-ancestor
92238406|NCT01434121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238407|NCT01434121|Protective Agents|protective agents|mesh-ancestor
92238408|NCT01381861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92238409|NCT01381861|Immunologic Factors|immunologic factors|mesh-ancestor
92238410|NCT01381861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238411|NCT01040819|Pioglitazone|pioglitazone|mesh-list
92238412|NCT01040819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92238413|NCT01040819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238414|NCT01041209|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92238415|NCT01041209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238416|NCT01084265|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92238417|NCT01084265|Hormones|hormones|mesh-list
92238418|NCT01084265|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92238419|NCT01084265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238420|NCT01084265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238421|NCT01084265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92238422|NCT01084499|Letrozole|letrozole|mesh-list
92238423|NCT01084499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238424|NCT01084499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92238425|NCT01084499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92238426|NCT01084499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238427|NCT01084499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238428|NCT01084499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92238429|NCT01084499|Hormone Antagonists|hormone antagonists|mesh-ancestor
92238430|NCT01084499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238431|NCT01084499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238432|NCT01118273|Diphenhydramine|diphenhydramine|mesh-list
92238433|NCT01118273|Promethazine|promethazine|mesh-list
92238434|NCT01118273|Ibuprofen|ibuprofen|mesh-list
92238435|NCT01118273|Naproxen|naproxen|mesh-list
92238436|NCT01118273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238437|NCT01118273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92238438|NCT01118273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92238439|NCT01118273|Analgesics|analgesics|mesh-ancestor
92238440|NCT01118273|Sensory System Agents|sensory system agents|mesh-ancestor
92238441|NCT01118273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238442|NCT01118273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238443|NCT01118273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238444|NCT01118273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238445|NCT01118273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92238446|NCT01118273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238447|NCT01118273|Gout Suppressants|gout suppressants|mesh-ancestor
92238448|NCT01118273|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92238449|NCT01118273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92238450|NCT01118273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238451|NCT01118273|Anesthetics, Local|anesthetics, local|mesh-ancestor
92238452|NCT01118273|Anesthetics|anesthetics|mesh-ancestor
92238453|NCT01118273|Antiemetics|antiemetics|mesh-ancestor
92238455|NCT01118273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238456|NCT01118273|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92238457|NCT01118273|Histamine Antagonists|histamine antagonists|mesh-ancestor
92238458|NCT01118273|Histamine Agents|histamine agents|mesh-ancestor
92238459|NCT01118273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238460|NCT01118273|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92238461|NCT01118273|Antipruritics|antipruritics|mesh-ancestor
92238462|NCT01118273|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238463|NCT01085903|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92238464|NCT01085903|Modafinil|modafinil|mesh-list
92238465|NCT01085903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92238466|NCT01085903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238467|NCT01085903|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92238468|NCT01085903|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92238469|NCT01085903|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92238470|NCT01085903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238471|NCT01118741|Disulfiram|disulfiram|mesh-list
92238472|NCT01118741|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92238473|NCT01118741|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92238474|NCT01118741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238475|NCT01118741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238476|NCT01439815|Fluticasone|fluticasone|mesh-list
92238477|NCT01439815|Xhance|xhance|mesh-list
92238478|NCT01439815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238479|NCT01439815|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92238480|NCT01439815|Autonomic Agents|autonomic agents|mesh-ancestor
92238481|NCT01439815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238482|NCT01439815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238483|NCT01439815|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92238484|NCT01439815|Respiratory System Agents|respiratory system agents|mesh-ancestor
92238485|NCT01439815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238486|NCT01439815|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92238487|NCT01332253|Ibuprofen|ibuprofen|mesh-list
92238488|NCT01332253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92238489|NCT01332253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92238490|NCT01332253|Analgesics|analgesics|mesh-ancestor
92238491|NCT01332253|Sensory System Agents|sensory system agents|mesh-ancestor
92238492|NCT01332253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238493|NCT01332253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238494|NCT01332253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238495|NCT01332253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238496|NCT01332253|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92238497|NCT01332253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238498|NCT01332253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238499|NCT01332721|Bevacizumab|bevacizumab|mesh-list
92238500|NCT01332721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238501|NCT01332721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238502|NCT01332721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92238503|NCT01332721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92238504|NCT01332721|Growth Substances|growth substances|mesh-ancestor
92238505|NCT01332721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238506|NCT01332721|Growth Inhibitors|growth inhibitors|mesh-ancestor
92238507|NCT01384591|Acetylcysteine|acetylcysteine|mesh-list
92238508|NCT01384591|Losartan|losartan|mesh-list
92238509|NCT01384591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92238510|NCT01384591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92238511|NCT01384591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92238512|NCT01384591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92238513|NCT01384591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92238514|NCT01384591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238515|NCT01384591|Antiviral Agents|antiviral agents|mesh-ancestor
92238516|NCT01384591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238517|NCT01384591|Expectorants|expectorants|mesh-ancestor
92238518|NCT01384591|Respiratory System Agents|respiratory system agents|mesh-ancestor
92238519|NCT01384591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92238520|NCT01384591|Antioxidants|antioxidants|mesh-ancestor
92238521|NCT01384591|Protective Agents|protective agents|mesh-ancestor
92238522|NCT01384591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238523|NCT01384591|Antidotes|antidotes|mesh-ancestor
92238524|NCT01086605|Pixantrone|pixantrone|mesh-list
92238525|NCT01086605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92238526|NCT01086605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92238527|NCT01086605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238528|NCT01086605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238530|NCT00265850|Leucovorin|leucovorin|mesh-list
92238531|NCT00265850|Folic Acid|folic acid|mesh-list
92238532|NCT00265850|Bevacizumab|bevacizumab|mesh-list
92238533|NCT00265850|Cetuximab|cetuximab|mesh-list
92238534|NCT00265850|Fluorouracil|fluorouracil|mesh-list
92238535|NCT00265850|Oxaliplatin|oxaliplatin|mesh-list
92238536|NCT00265850|Irinotecan|irinotecan|mesh-list
92238537|NCT00265850|Levoleucovorin|levoleucovorin|mesh-list
92238538|NCT00265850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238539|NCT00265850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238540|NCT00265850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92238541|NCT00265850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92238542|NCT00265850|Growth Substances|growth substances|mesh-ancestor
92238543|NCT00265850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238544|NCT00265850|Growth Inhibitors|growth inhibitors|mesh-ancestor
92238546|NCT00265850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238547|NCT00265850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238548|NCT00265850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238549|NCT00265850|Immunologic Factors|immunologic factors|mesh-ancestor
92238550|NCT00265850|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92238551|NCT00265850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92238552|NCT00265850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238553|NCT00265850|Antidotes|antidotes|mesh-ancestor
92238554|NCT00265850|Protective Agents|protective agents|mesh-ancestor
92238555|NCT00265850|Vitamin B Complex|vitamin b complex|mesh-ancestor
92238556|NCT00265850|Vitamins|vitamins|mesh-ancestor
92238557|NCT00265850|Micronutrients|micronutrients|mesh-ancestor
92238558|NCT00265850|Hematinics|hematinics|mesh-ancestor
92238559|NCT00125372|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92238560|NCT00125372|Bexarotene|bexarotene|mesh-list
92238561|NCT00125372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238562|NCT00125372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92238563|NCT00125372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238564|NCT00125372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238565|NCT00125528|Cycloserine|cycloserine|mesh-list
92238566|NCT00125528|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92238567|NCT00125528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238568|NCT00125528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92238569|NCT00125528|Antitubercular Agents|antitubercular agents|mesh-ancestor
92238570|NCT00125528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92238571|NCT00125528|Antimetabolites|antimetabolites|mesh-ancestor
92238572|NCT00125528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238573|NCT01390909|Oxcarbazepine|oxcarbazepine|mesh-list
92238574|NCT01390909|Anticonvulsants|anticonvulsants|mesh-list
92238575|NCT01390909|Lactitol|lactitol|mesh-list
92238576|NCT01390909|Cathartics|cathartics|mesh-ancestor
92238577|NCT01390909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238578|NCT01390909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238579|NCT01390909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92238580|NCT01390909|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92238581|NCT01390909|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92238582|NCT01390909|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92238583|NCT01390909|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92238584|NCT01042145|Dexamethasone|dexamethasone|mesh-list
92238585|NCT01042145|Prednisone|prednisone|mesh-list
92238586|NCT01042145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238587|NCT01042145|Antiemetics|antiemetics|mesh-ancestor
92238588|NCT01042145|Autonomic Agents|autonomic agents|mesh-ancestor
92238589|NCT01042145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238590|NCT01042145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238591|NCT01042145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238592|NCT01042145|Glucocorticoids|glucocorticoids|mesh-ancestor
92238593|NCT01042145|Hormones|hormones|mesh-ancestor
92238594|NCT01042145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238595|NCT01042145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238596|NCT01042145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238597|NCT01043393|Desoximetasone|desoximetasone|mesh-list
92238598|NCT01043393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238599|NCT01043393|Glucocorticoids|glucocorticoids|mesh-ancestor
92238600|NCT01043393|Hormones|hormones|mesh-ancestor
92238601|NCT01043393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238602|NCT01043393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238603|NCT01087931|Bupivacaine|bupivacaine|mesh-list
92238604|NCT01087931|Anesthetics, Local|anesthetics, local|mesh-ancestor
92238605|NCT01087931|Anesthetics|anesthetics|mesh-ancestor
92238606|NCT01087931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238607|NCT01087931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238608|NCT01087931|Sensory System Agents|sensory system agents|mesh-ancestor
92238609|NCT01087931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238610|NCT01336933|Prednisone|prednisone|mesh-list
92238611|NCT01336933|Cyclophosphamide|cyclophosphamide|mesh-list
92238612|NCT01336933|Etoposide|etoposide|mesh-list
92238613|NCT01336933|Vincristine|vincristine|mesh-list
92238614|NCT01336933|Etoposide phosphate|etoposide phosphate|mesh-list
92238615|NCT01336933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238616|NCT01336933|Immunologic Factors|immunologic factors|mesh-ancestor
92238617|NCT01336933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238618|NCT01336933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238619|NCT01336933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238620|NCT01336933|Alkylating Agents|alkylating agents|mesh-ancestor
92238621|NCT01336933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238622|NCT01336933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238623|NCT01336933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238624|NCT01336933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238625|NCT01336933|Glucocorticoids|glucocorticoids|mesh-ancestor
92238627|NCT01336933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238628|NCT01336933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238629|NCT01336933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92238630|NCT01336933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92238631|NCT01336933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92238632|NCT01336933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238633|NCT01336933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92238634|NCT01336933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92238635|NCT01336933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92238636|NCT03009409|Ketamine|ketamine|mesh-list
92238637|NCT03009409|Analgesics|analgesics|mesh-ancestor
92238638|NCT03009409|Sensory System Agents|sensory system agents|mesh-ancestor
92238639|NCT03009409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238640|NCT03009409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238641|NCT03009409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92238642|NCT03009409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92238643|NCT03009409|Anesthetics, General|anesthetics, general|mesh-ancestor
92238644|NCT03009409|Anesthetics|anesthetics|mesh-ancestor
92238645|NCT03009409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238646|NCT03009409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92238647|NCT03009409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92238648|NCT03009409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924616|NCT01573351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238649|NCT03009409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238650|NCT00176930|Cyclophosphamide|cyclophosphamide|mesh-list
92238651|NCT00176930|Busulfan|busulfan|mesh-list
92238652|NCT00176930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238653|NCT00176930|Immunologic Factors|immunologic factors|mesh-ancestor
92238654|NCT00176930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238655|NCT00176930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238656|NCT00176930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238657|NCT00176930|Alkylating Agents|alkylating agents|mesh-ancestor
92238658|NCT00176930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238659|NCT00176930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238660|NCT00176930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238661|NCT01473745|Daminozide|daminozide|mesh-list
92238662|NCT01473745|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92238663|NCT01473745|Growth Substances|growth substances|mesh-ancestor
92238664|NCT01473745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238665|NCT00178178|Bupivacaine|bupivacaine|mesh-list
92238666|NCT00178178|Anesthetics, Local|anesthetics, local|mesh-ancestor
92238667|NCT00178178|Anesthetics|anesthetics|mesh-ancestor
92238668|NCT00178178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238669|NCT00178178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238670|NCT00178178|Sensory System Agents|sensory system agents|mesh-ancestor
92238671|NCT00178178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238672|NCT01441843|Lorazepam|lorazepam|mesh-list
92238673|NCT01441843|Anticonvulsants|anticonvulsants|mesh-ancestor
92238674|NCT01441843|Antiemetics|antiemetics|mesh-ancestor
92238675|NCT01441843|Autonomic Agents|autonomic agents|mesh-ancestor
92238676|NCT01441843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238677|NCT01441843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238678|NCT01441843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238679|NCT01441843|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92238680|NCT01441843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238681|NCT01441843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92238682|NCT01441843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92238683|NCT01441843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92238684|NCT01441843|GABA Modulators|gaba modulators|mesh-ancestor
92238685|NCT01441843|GABA Agents|gaba agents|mesh-ancestor
92238686|NCT01441843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238687|NCT01441843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238688|NCT00178646|Botulinum Toxins|botulinum toxins|mesh-list
92238689|NCT00178646|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92238690|NCT00178646|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92238691|NCT00178646|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92238692|NCT00178646|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92238693|NCT00178646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238694|NCT00178646|Cholinergic Agents|cholinergic agents|mesh-ancestor
92238695|NCT00178646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238696|NCT00178646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238697|NCT00178646|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92238698|NCT00178646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238699|NCT01089569|Insulin Glargine|insulin glargine|mesh-list
92238701|NCT01089569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92238702|NCT01089569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238703|NCT01089569|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92238704|NCT01089569|Incretins|incretins|mesh-ancestor
92238705|NCT01089569|Hormones|hormones|mesh-ancestor
92238706|NCT01089569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238707|NCT00128180|Methylprednisolone|methylprednisolone|mesh-list
92238708|NCT00128180|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92238709|NCT00128180|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92238710|NCT00128180|Prednisolone|prednisolone|mesh-list
92238711|NCT00128180|Prednisolone acetate|prednisolone acetate|mesh-list
92238712|NCT00128180|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92238713|NCT00128180|Prednisolone phosphate|prednisolone phosphate|mesh-list
92238714|NCT00128180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238715|NCT00128180|Antiemetics|antiemetics|mesh-ancestor
92238716|NCT00128180|Autonomic Agents|autonomic agents|mesh-ancestor
92238717|NCT00128180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238718|NCT00128180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238719|NCT00128180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238720|NCT00128180|Glucocorticoids|glucocorticoids|mesh-ancestor
92238721|NCT00128180|Hormones|hormones|mesh-ancestor
92238722|NCT00128180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238723|NCT00128180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92238724|NCT00128180|Protective Agents|protective agents|mesh-ancestor
92238725|NCT00128180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238726|NCT00128180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238727|NCT01121939|Bevacizumab|bevacizumab|mesh-list
92238728|NCT01121939|Pertuzumab|pertuzumab|mesh-list
92238729|NCT01121939|Octreotide|octreotide|mesh-list
92238730|NCT01121939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238731|NCT01121939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238732|NCT01121939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92238733|NCT01121939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92238734|NCT01121939|Growth Substances|growth substances|mesh-ancestor
92238735|NCT01121939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238736|NCT01121939|Growth Inhibitors|growth inhibitors|mesh-ancestor
92238737|NCT01121939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238738|NCT01121939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238739|NCT03013751|Udenafil|udenafil|mesh-list
92238740|NCT03013751|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92238741|NCT03013751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92238742|NCT03013751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238743|NCT03013751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238744|NCT01897844|Somatostatin|somatostatin|mesh-list
92238745|NCT01897844|Hormones|hormones|mesh-ancestor
92238746|NCT01897844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238747|NCT01897844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238748|NCT00131378|Hormones|hormones|mesh-list
92238749|NCT00131378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238750|NCT00131378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238751|NCT01445821|Methylprednisolone|methylprednisolone|mesh-list
92238752|NCT01445821|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92238753|NCT01445821|Cyclophosphamide|cyclophosphamide|mesh-list
92238754|NCT01445821|Fludarabine|fludarabine|mesh-list
92238755|NCT01445821|Thymoglobulin|thymoglobulin|mesh-list
92238756|NCT01445821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238757|NCT01445821|Immunologic Factors|immunologic factors|mesh-ancestor
92238758|NCT01445821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238759|NCT01445821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92238760|NCT01445821|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92238761|NCT01445821|Alkylating Agents|alkylating agents|mesh-ancestor
92238762|NCT01445821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238763|NCT01445821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238764|NCT01445821|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92238765|NCT01445821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238766|NCT01445821|Antiemetics|antiemetics|mesh-ancestor
92238767|NCT01445821|Autonomic Agents|autonomic agents|mesh-ancestor
92238768|NCT01445821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238769|NCT01445821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92238770|NCT01445821|Glucocorticoids|glucocorticoids|mesh-ancestor
92238771|NCT01445821|Hormones|hormones|mesh-ancestor
92238772|NCT01445821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238773|NCT01445821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92238774|NCT01445821|Protective Agents|protective agents|mesh-ancestor
92238775|NCT01445821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92238776|NCT00182000|Cycloserine|cycloserine|mesh-list
92238777|NCT00182000|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92238778|NCT00182000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238779|NCT00182000|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92238780|NCT00182000|Antitubercular Agents|antitubercular agents|mesh-ancestor
92238781|NCT00182000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92238782|NCT00182000|Antimetabolites|antimetabolites|mesh-ancestor
92238783|NCT00182000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238784|NCT01092923|Sevoflurane|sevoflurane|mesh-list
92238785|NCT01092923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92238786|NCT01092923|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92238787|NCT01092923|Anesthetics, General|anesthetics, general|mesh-ancestor
92238788|NCT01092923|Anesthetics|anesthetics|mesh-ancestor
92238789|NCT01092923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238790|NCT01092923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238791|NCT03013439|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92238792|NCT03013439|Hematinics|hematinics|mesh-ancestor
92238793|NCT00131456|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92238794|NCT00131456|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92238795|NCT00131456|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92238796|NCT00131456|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081555|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238797|NCT00131456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238798|NCT00131456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238799|NCT00131456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238800|NCT00131456|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92238801|NCT00131456|Antidepressive Agents|antidepressive agents|mesh-ancestor
92238802|NCT00131456|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92238803|NCT01093469|Decanoic acid|decanoic acid|mesh-list
92238804|NCT01093469|Petrolatum|petrolatum|mesh-list
92238805|NCT01093469|Emollients|emollients|mesh-ancestor
92238806|NCT01093469|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238807|NCT01093469|Antifungal Agents|antifungal agents|mesh-ancestor
92238808|NCT01093469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238809|NCT02543658|Neostigmine|neostigmine|mesh-list
92238810|NCT02543658|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92238811|NCT02543658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238812|NCT02543658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238813|NCT02543658|Cholinergic Agents|cholinergic agents|mesh-ancestor
92238814|NCT02543658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238815|NCT02543658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238816|NCT02543658|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92238817|NCT02543658|Autonomic Agents|autonomic agents|mesh-ancestor
92238818|NCT02543658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238820|NCT00183092|Anticestodal Agents|anticestodal agents|mesh-ancestor
92238821|NCT00183092|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92238822|NCT00183092|Anthelmintics|anthelmintics|mesh-ancestor
92238823|NCT00183092|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92238824|NCT00183092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238825|NCT00183092|Antimalarials|antimalarials|mesh-ancestor
92238826|NCT00183092|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92238827|NCT00183092|Antinematodal Agents|antinematodal agents|mesh-ancestor
92238828|NCT00183092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238829|NCT00183092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238830|NCT00183092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238831|NCT00132002|Vorinostat|vorinostat|mesh-list
92238832|NCT00132002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238833|NCT00132002|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92238834|NCT00132002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238835|NCT00132002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238836|NCT00183794|Gemcitabine|gemcitabine|mesh-list
92238837|NCT00183794|Docetaxel|docetaxel|mesh-list
92238838|NCT00183794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92238839|NCT00183794|Antimetabolites|antimetabolites|mesh-ancestor
92238840|NCT00183794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238841|NCT00183794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238842|NCT00183794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92238843|NCT00183794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92238844|NCT00183794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92238845|NCT00270296|Ritonavir|ritonavir|mesh-list
92238846|NCT00270296|Lopinavir|lopinavir|mesh-list
92238847|NCT00270296|Lamivudine|lamivudine|mesh-list
92238848|NCT00270296|Zidovudine|zidovudine|mesh-list
92238849|NCT00270296|Nevirapine|nevirapine|mesh-list
92238850|NCT00270296|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92238851|NCT00270296|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92238852|NCT00270296|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92238853|NCT00270296|Protease Inhibitors|protease inhibitors|mesh-ancestor
92238854|NCT00270296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238855|NCT00270296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238856|NCT00270296|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92238857|NCT00270296|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92238858|NCT00270296|Antiviral Agents|antiviral agents|mesh-ancestor
92238859|NCT00270296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238860|NCT00270296|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92238861|NCT00270296|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92238862|NCT00270296|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92238863|NCT00270296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92238864|NCT00270296|Antimetabolites|antimetabolites|mesh-ancestor
92238865|NCT00270296|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92238866|NCT00270296|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92238867|NCT01047527|Nicotine|nicotine|mesh-list
92238868|NCT01047527|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92238869|NCT01047527|Autonomic Agents|autonomic agents|mesh-ancestor
92238870|NCT01047527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238871|NCT01047527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238872|NCT01047527|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92238873|NCT01047527|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92238874|NCT01047527|Cholinergic Agents|cholinergic agents|mesh-ancestor
92238875|NCT01047527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238876|NCT01047527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238877|NCT03013127|Pembrolizumab|pembrolizumab|mesh-list
92238878|NCT03013127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92238879|NCT03013127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92238880|NCT03013127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92238881|NCT03013127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238882|NCT01048697|Ethambutol|ethambutol|mesh-list
92238883|NCT01048697|Antitubercular Agents|antitubercular agents|mesh-ancestor
92238884|NCT01048697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92238885|NCT01048697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92238886|NCT01049243|Fluocinonide|fluocinonide|mesh-list
92238887|NCT01049243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238888|NCT01049243|Glucocorticoids|glucocorticoids|mesh-ancestor
92238889|NCT01049243|Hormones|hormones|mesh-ancestor
92238890|NCT01049243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238891|NCT01049243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238893|NCT03013205|Triamcinolone|triamcinolone|mesh-list
92238894|NCT03013205|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92238895|NCT03013205|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92238896|NCT03013205|Lidocaine|lidocaine|mesh-list
92238897|NCT03013205|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92238898|NCT03013205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92238899|NCT03013205|Glucocorticoids|glucocorticoids|mesh-ancestor
92238900|NCT03013205|Hormones|hormones|mesh-ancestor
92238901|NCT03013205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238902|NCT03013205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238903|NCT03013205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238904|NCT03013205|Immunologic Factors|immunologic factors|mesh-ancestor
92238905|NCT03013205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92238906|NCT03013205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238907|NCT03013205|Anesthetics, Local|anesthetics, local|mesh-ancestor
92238908|NCT03013205|Anesthetics|anesthetics|mesh-ancestor
92238909|NCT03013205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238910|NCT03013205|Sensory System Agents|sensory system agents|mesh-ancestor
92238911|NCT03013205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238912|NCT03013205|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92238913|NCT03013205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92238914|NCT03013205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92238915|NCT03013205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92238917|NCT01094717|Acitretin|acitretin|mesh-list
92238918|NCT01094717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238919|NCT01094717|Keratolytic Agents|keratolytic agents|mesh-ancestor
92238920|NCT01095497|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92238921|NCT01095497|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92238922|NCT01095497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238923|NCT01095497|Immunologic Factors|immunologic factors|mesh-ancestor
92238924|NCT01095497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238925|NCT01095887|Eculizumab|eculizumab|mesh-list
92238926|NCT01095887|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92238927|NCT01095887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238928|NCT01095887|Immunologic Factors|immunologic factors|mesh-ancestor
92238929|NCT01095887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238930|NCT05307731|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92238931|NCT05307731|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92238932|NCT05307731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238933|NCT05307731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92238934|NCT05307731|Immunologic Factors|immunologic factors|mesh-ancestor
92238935|NCT05307731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238936|NCT03110315|Suvorexant|suvorexant|mesh-list
92238937|NCT03110315|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92238938|NCT03110315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92238939|NCT03110315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238940|NCT03110315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238941|NCT03110315|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92238942|NCT03110315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238943|NCT03110315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238944|NCT05307341|Sufentanil|sufentanil|mesh-list
92238945|NCT05307341|Dsuvia|dsuvia|mesh-list
92238946|NCT05307341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92238947|NCT05307341|Narcotics|narcotics|mesh-ancestor
91932440|NCT04972123|Adrenergic Agents|adrenergic agents|mesh-ancestor
92238948|NCT05307341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238949|NCT05307341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238950|NCT05307341|Analgesics|analgesics|mesh-ancestor
92238951|NCT05307341|Sensory System Agents|sensory system agents|mesh-ancestor
92238952|NCT05307341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238953|NCT05307341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92238954|NCT05307341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92238955|NCT05307341|Anesthetics, General|anesthetics, general|mesh-ancestor
92238956|NCT05307341|Anesthetics|anesthetics|mesh-ancestor
92238957|NCT01100255|Ketamine|ketamine|mesh-list
92238958|NCT01100255|Analgesics|analgesics|mesh-ancestor
92238959|NCT01100255|Sensory System Agents|sensory system agents|mesh-ancestor
92238960|NCT01100255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92238961|NCT01100255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238962|NCT01100255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92238963|NCT01100255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92238964|NCT01100255|Anesthetics, General|anesthetics, general|mesh-ancestor
92238965|NCT01100255|Anesthetics|anesthetics|mesh-ancestor
92238966|NCT01100255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92238967|NCT01100255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92238968|NCT01100255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92238969|NCT01100255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92238970|NCT01100255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238971|NCT03012347|Sunscreening Agents|sunscreening agents|mesh-list
92238972|NCT03012347|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92238973|NCT03012347|Protective Agents|protective agents|mesh-ancestor
92238974|NCT03012347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238975|NCT03012347|Dermatologic Agents|dermatologic agents|mesh-ancestor
92238976|NCT01100723|Vitamin D|vitamin d|mesh-list
92238977|NCT01100723|Calcitriol|calcitriol|mesh-list
92238978|NCT01100723|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92238980|NCT01100723|Vitamins|vitamins|mesh-ancestor
92238981|NCT01100723|Micronutrients|micronutrients|mesh-ancestor
92238982|NCT01100723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238983|NCT01100723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92238984|NCT01100723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92238985|NCT01100723|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92238986|NCT01100723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92238987|NCT01100723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92238988|NCT01100723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92238989|NCT01100723|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92238990|NCT01100723|Hormone Antagonists|hormone antagonists|mesh-ancestor
92238991|NCT01100723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238992|NCT05306405|Misoprostol|misoprostol|mesh-list
92238993|NCT05306405|Estradiol|estradiol|mesh-list
92238994|NCT05306405|Estrogens|estrogens|mesh-ancestor
92238995|NCT05306405|Hormones|hormones|mesh-ancestor
92238996|NCT05306405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92238997|NCT05306405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92238998|NCT05306405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92238999|NCT05306405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92239000|NCT05306405|Abortifacient Agents|abortifacient agents|mesh-ancestor
92239001|NCT05306405|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92239002|NCT05306405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239003|NCT05306405|Oxytocics|oxytocics|mesh-ancestor
92239004|NCT04352621|Ketamine|ketamine|mesh-list
92239005|NCT04352621|Analgesics|analgesics|mesh-ancestor
92239006|NCT04352621|Sensory System Agents|sensory system agents|mesh-ancestor
92239007|NCT04352621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239008|NCT04352621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239009|NCT04352621|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92239010|NCT04352621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92239011|NCT04352621|Anesthetics, General|anesthetics, general|mesh-ancestor
92239012|NCT04352621|Anesthetics|anesthetics|mesh-ancestor
92239013|NCT04352621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239014|NCT04352621|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92239015|NCT04352621|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92239016|NCT04352621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239017|NCT04352621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239018|NCT02246855|Immunoglobulins|immunoglobulins|mesh-list
92239019|NCT02246855|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92239020|NCT02246855|Antibodies|antibodies|mesh-list
92239021|NCT02246855|Immunologic Factors|immunologic factors|mesh-ancestor
92239022|NCT02246855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239023|NCT05272397|Methylphenidate|methylphenidate|mesh-list
92239024|NCT05272397|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92239025|NCT05272397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239026|NCT05272397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92239027|NCT05272397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92239028|NCT05272397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239029|NCT05272397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239030|NCT05272397|Dopamine Agents|dopamine agents|mesh-ancestor
92239031|NCT05272397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239032|NCT00185900|Magnesium Sulfate|magnesium sulfate|mesh-list
92239033|NCT00185900|Nifedipine|nifedipine|mesh-list
92239034|NCT00185900|Analgesics|analgesics|mesh-ancestor
92239035|NCT00185900|Sensory System Agents|sensory system agents|mesh-ancestor
92239036|NCT00185900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239037|NCT00185900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239038|NCT00185900|Anesthetics|anesthetics|mesh-ancestor
92239039|NCT00185900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239040|NCT00185900|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92239041|NCT00185900|Anticonvulsants|anticonvulsants|mesh-ancestor
92239042|NCT00185900|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92239043|NCT00185900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239044|NCT00185900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239045|NCT00185900|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239046|NCT00185900|Tocolytic Agents|tocolytic agents|mesh-ancestor
92239047|NCT00185900|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92239048|NCT00185900|Vasodilator Agents|vasodilator agents|mesh-ancestor
92239049|NCT00186056|Mifepristone|mifepristone|mesh-list
92239050|NCT00186056|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92239051|NCT00186056|Abortifacient Agents|abortifacient agents|mesh-ancestor
92239052|NCT00186056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92239053|NCT00186056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239054|NCT00186056|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92239055|NCT00186056|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92239056|NCT00186056|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92239057|NCT00186056|Contraceptive Agents|contraceptive agents|mesh-ancestor
92239058|NCT00186056|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92239059|NCT00186056|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92239060|NCT00186056|Hormone Antagonists|hormone antagonists|mesh-ancestor
92239061|NCT00186056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239062|NCT00186056|Luteolytic Agents|luteolytic agents|mesh-ancestor
92239063|NCT00186056|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92239064|NCT00186056|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92239065|NCT00186446|Bupropion|bupropion|mesh-list
92239066|NCT00186446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92239067|NCT00186446|Antidepressive Agents|antidepressive agents|mesh-ancestor
92239068|NCT00186446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239069|NCT00186446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92239070|NCT00186446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92239071|NCT00186446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239072|NCT00186446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239073|NCT00186446|Dopamine Agents|dopamine agents|mesh-ancestor
92239074|NCT00186446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239075|NCT00186446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239076|NCT00186446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92239077|NCT00186446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92239078|NCT00186446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239079|NCT00136760|Bupropion|bupropion|mesh-list
92239080|NCT00136760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92239081|NCT00136760|Antidepressive Agents|antidepressive agents|mesh-ancestor
92239082|NCT00136760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239083|NCT00136760|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92239084|NCT00136760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92239085|NCT00136760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239086|NCT00136760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239087|NCT00136760|Dopamine Agents|dopamine agents|mesh-ancestor
92239088|NCT00136760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239089|NCT00136760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239090|NCT00136760|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92239091|NCT00136760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92239092|NCT00136760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239093|NCT00189098|Trimethoprim|trimethoprim|mesh-list
92239094|NCT00189098|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92239095|NCT00189098|Sulfamethoxazole|sulfamethoxazole|mesh-list
92239096|NCT00189098|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92239097|NCT00189098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239098|NCT00189098|Antimalarials|antimalarials|mesh-ancestor
92239099|NCT00189098|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92239100|NCT00189098|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92239101|NCT00189098|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92239102|NCT00189098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239103|NCT00189098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239104|NCT00189098|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92239105|NCT00189098|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92239106|NCT00189098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92239107|NCT00189098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239108|NCT00145418|Docetaxel|docetaxel|mesh-list
92239109|NCT00145418|Oxaliplatin|oxaliplatin|mesh-list
92239110|NCT00145418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239111|NCT00145418|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239112|NCT00145418|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239113|NCT00145418|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239114|NCT00145418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239115|NCT04751318|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92239116|NCT04751318|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92239117|NCT04751318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92239118|NCT04751318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239119|NCT04751318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239120|NCT04751318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239121|NCT04751318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239123|NCT04751318|Sensory System Agents|sensory system agents|mesh-ancestor
92239124|NCT04751318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239125|NCT04751318|Antidepressive Agents|antidepressive agents|mesh-ancestor
92239126|NCT04751318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239127|NCT04751318|Dopamine Agents|dopamine agents|mesh-ancestor
92239128|NCT01107665|Paclitaxel|paclitaxel|mesh-list
92239129|NCT01107665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92239130|NCT01107665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239131|NCT01107665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239132|NCT01107665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239133|NCT01107665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239134|NCT01107665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239135|NCT03012659|Contraceptive Agents|contraceptive agents|mesh-list
92239136|NCT03012659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92239137|NCT03012659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239138|NCT01447225|Carboplatin|carboplatin|mesh-list
92239139|NCT01447225|Gemcitabine|gemcitabine|mesh-list
92239140|NCT01447225|Pemetrexed|pemetrexed|mesh-list
92239141|NCT01447225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239142|NCT01447225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92239143|NCT01447225|Antimetabolites|antimetabolites|mesh-ancestor
92239144|NCT01447225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239145|NCT01447225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239146|NCT01447225|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92239147|NCT01447225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92239148|NCT01447849|Lubiprostone|lubiprostone|mesh-list
92239149|NCT01447849|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92239150|NCT01447849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239151|NCT01447849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239153|NCT00277394|Tinzaparin|tinzaparin|mesh-list
92239154|NCT00277394|Anticoagulants|anticoagulants|mesh-ancestor
92239155|NCT00277394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92239156|NCT00277394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92239157|NCT00277394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239158|NCT01450189|Tenofovir|tenofovir|mesh-list
92239159|NCT01450189|Emtricitabine|emtricitabine|mesh-list
92239160|NCT01450189|Raltegravir Potassium|raltegravir potassium|mesh-list
92239161|NCT01450189|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92239162|NCT01450189|Antiviral Agents|antiviral agents|mesh-ancestor
92239163|NCT01450189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239164|NCT01450189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92239165|NCT01450189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92239166|NCT01450189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239167|NCT01450189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239168|NCT01450189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92239169|NCT01450189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92239170|NCT01450189|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92239171|NCT01450189|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92239172|NCT00278876|Imatinib Mesylate|imatinib mesylate|mesh-list
92239173|NCT00278876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239174|NCT00278876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239175|NCT00278876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239176|NCT00278876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239177|NCT01474213|Dexmedetomidine|dexmedetomidine|mesh-list
92239178|NCT01474213|Remifentanil|remifentanil|mesh-list
92239179|NCT01474213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92239180|NCT01474213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239181|NCT01474213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239182|NCT01474213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92239183|NCT01474213|Analgesics|analgesics|mesh-ancestor
92239184|NCT01474213|Sensory System Agents|sensory system agents|mesh-ancestor
92239185|NCT01474213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239186|NCT01474213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92239187|NCT01474213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92239188|NCT01474213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92239189|NCT01474213|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239190|NCT01474213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239191|NCT01474213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239192|NCT01474213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92239193|NCT01474213|Narcotics|narcotics|mesh-ancestor
92239194|NCT00147212|Trabectedin|trabectedin|mesh-list
92239195|NCT00147212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92239196|NCT00147212|Alkylating Agents|alkylating agents|mesh-ancestor
92239197|NCT00147212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239198|NCT00147212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239199|NCT01474915|Promethazine|promethazine|mesh-list
92239200|NCT01474915|Diphenhydramine|diphenhydramine|mesh-list
92239201|NCT01474915|Dexamethasone|dexamethasone|mesh-list
92239202|NCT01474915|Ondansetron|ondansetron|mesh-list
92239204|NCT01474915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239205|NCT01474915|Antiemetics|antiemetics|mesh-ancestor
92239206|NCT01474915|Autonomic Agents|autonomic agents|mesh-ancestor
92239207|NCT01474915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239208|NCT01474915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239209|NCT01474915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239210|NCT01474915|Glucocorticoids|glucocorticoids|mesh-ancestor
92239211|NCT01474915|Hormones|hormones|mesh-ancestor
92239212|NCT01474915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239213|NCT01474915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92239214|NCT01474915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239215|NCT01474915|Antipruritics|antipruritics|mesh-ancestor
92239216|NCT01474915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92239217|NCT01474915|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92239218|NCT01474915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92239219|NCT01474915|Serotonin Agents|serotonin agents|mesh-ancestor
92239220|NCT01474915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239221|NCT01474915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239222|NCT01474915|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92239223|NCT01474915|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92239224|NCT01474915|Histamine Antagonists|histamine antagonists|mesh-ancestor
92239225|NCT01474915|Histamine Agents|histamine agents|mesh-ancestor
92239226|NCT01474915|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92239227|NCT01474915|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92239228|NCT01474915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92239229|NCT01474915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239230|NCT01474915|Anesthetics, Local|anesthetics, local|mesh-ancestor
92239231|NCT01474915|Anesthetics|anesthetics|mesh-ancestor
92239232|NCT01474915|Sensory System Agents|sensory system agents|mesh-ancestor
92239233|NCT01899794|Mandelic Acids|mandelic acids|mesh-list
92239234|NCT01899794|Oxybutynin|oxybutynin|mesh-list
92239235|NCT01899794|Parasympatholytics|parasympatholytics|mesh-ancestor
92239236|NCT01899794|Autonomic Agents|autonomic agents|mesh-ancestor
92239237|NCT01899794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239238|NCT01899794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239239|NCT01899794|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92239240|NCT01899794|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92239241|NCT01899794|Cholinergic Agents|cholinergic agents|mesh-ancestor
92239242|NCT01899794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239243|NCT01899794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239244|NCT01899794|Urological Agents|urological agents|mesh-ancestor
92239245|NCT01899794|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92239246|NCT01899794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239247|NCT01391299|Botulinum Toxins|botulinum toxins|mesh-list
92239248|NCT01391299|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92239249|NCT01391299|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92239250|NCT01391299|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92239251|NCT01391299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239252|NCT01391299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239253|NCT01391299|Cholinergic Agents|cholinergic agents|mesh-ancestor
92239254|NCT01391299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239255|NCT01391299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239256|NCT01391299|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92239257|NCT01391299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239258|NCT02099084|Teduglutide|teduglutide|mesh-list
92239259|NCT02099084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239260|NCT02099084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92239261|NCT02099084|Protective Agents|protective agents|mesh-ancestor
92239262|NCT02099084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239263|NCT00281918|Cyclophosphamide|cyclophosphamide|mesh-list
92239265|NCT00281918|Fludarabine|fludarabine|mesh-list
92239266|NCT00281918|Fludarabine phosphate|fludarabine phosphate|mesh-list
92239267|NCT00281918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92239268|NCT00281918|Immunologic Factors|immunologic factors|mesh-ancestor
92239269|NCT00281918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239270|NCT00281918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239271|NCT00281918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92239272|NCT00281918|Alkylating Agents|alkylating agents|mesh-ancestor
92239273|NCT00281918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239274|NCT00281918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239275|NCT00281918|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92239276|NCT00281918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239277|NCT00281918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92239278|NCT00281918|Antimetabolites|antimetabolites|mesh-ancestor
92239279|NCT00201734|Paclitaxel|paclitaxel|mesh-list
92239280|NCT00201734|Carboplatin|carboplatin|mesh-list
92239281|NCT00201734|Capecitabine|capecitabine|mesh-list
92239282|NCT00201734|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92239283|NCT00201734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239284|NCT00201734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239285|NCT00201734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239286|NCT00201734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239287|NCT00201734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239288|NCT00201734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92239289|NCT00201734|Antimetabolites|antimetabolites|mesh-ancestor
92239290|NCT00203216|Levetiracetam|levetiracetam|mesh-list
92239291|NCT00203216|Anticonvulsants|anticonvulsants|mesh-ancestor
92239292|NCT00203216|Nootropic Agents|nootropic agents|mesh-ancestor
92239293|NCT05156060|Ketamine|ketamine|mesh-list
92239294|NCT05156060|Gabapentin|gabapentin|mesh-list
92239295|NCT05156060|Analgesics|analgesics|mesh-ancestor
92239296|NCT05156060|Sensory System Agents|sensory system agents|mesh-ancestor
92239297|NCT05156060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239298|NCT05156060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239299|NCT05156060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92239300|NCT05156060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92239301|NCT05156060|Anesthetics, General|anesthetics, general|mesh-ancestor
92239302|NCT05156060|Anesthetics|anesthetics|mesh-ancestor
92239303|NCT05156060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239304|NCT05156060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92239306|NCT05156060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239307|NCT05156060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239308|NCT05156060|Anticonvulsants|anticonvulsants|mesh-ancestor
92239309|NCT05156060|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92239310|NCT05156060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92239311|NCT05156060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239312|NCT05156060|Antimanic Agents|antimanic agents|mesh-ancestor
92239313|NCT00206336|Topiramate|topiramate|mesh-list
92239314|NCT00206336|Anticonvulsants|anticonvulsants|mesh-ancestor
92239315|NCT00206336|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92239316|NCT00206336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239317|NCT00210470|Zinc|zinc|mesh-list
92239318|NCT00210470|Indomethacin|indomethacin|mesh-list
92239319|NCT00210470|Cyclophosphamide|cyclophosphamide|mesh-list
92239320|NCT00210470|Omeprazole|omeprazole|mesh-list
92239321|NCT00210470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92239322|NCT00210470|Immunologic Factors|immunologic factors|mesh-ancestor
92239323|NCT00210470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239324|NCT00210470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239325|NCT00210470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92239326|NCT00210470|Alkylating Agents|alkylating agents|mesh-ancestor
92239327|NCT00210470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239328|NCT00210470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239329|NCT00210470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92239330|NCT00210470|Trace Elements|trace elements|mesh-ancestor
92239331|NCT00210470|Micronutrients|micronutrients|mesh-ancestor
92239332|NCT00210470|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92239333|NCT00210470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239334|NCT00210470|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92239335|NCT00210470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239336|NCT00210470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92239337|NCT00210470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92239338|NCT00210470|Analgesics|analgesics|mesh-ancestor
92239339|NCT00210470|Sensory System Agents|sensory system agents|mesh-ancestor
92239340|NCT00210470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239341|NCT00210470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239343|NCT00210470|Tocolytic Agents|tocolytic agents|mesh-ancestor
92239344|NCT00210470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92239345|NCT00210470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92239346|NCT01108445|Everolimus|everolimus|mesh-list
92239348|NCT01108445|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92239349|NCT01108445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239350|NCT01108445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239351|NCT01108445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239352|NCT01108445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92239353|NCT01108445|Immunologic Factors|immunologic factors|mesh-ancestor
92239354|NCT01108445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239355|NCT01108445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239356|NCT01108445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92239357|NCT01108445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92239358|NCT01108445|Growth Substances|growth substances|mesh-ancestor
92239359|NCT01108445|Growth Inhibitors|growth inhibitors|mesh-ancestor
92239360|NCT01108757|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92239361|NCT01108757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92239362|NCT01108757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239363|NCT01108757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239364|NCT01108757|Antimalarials|antimalarials|mesh-ancestor
92239365|NCT01108757|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92239366|NCT01108757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92239367|NCT04352153|Febuxostat|febuxostat|mesh-list
92239368|NCT04352153|Citric Acid|citric acid|mesh-list
92239369|NCT04352153|Anticoagulants|anticoagulants|mesh-ancestor
92239370|NCT04352153|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92239371|NCT04352153|Chelating Agents|chelating agents|mesh-ancestor
92239372|NCT04352153|Sequestering Agents|sequestering agents|mesh-ancestor
92239373|NCT04352153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239374|NCT04352153|Gout Suppressants|gout suppressants|mesh-ancestor
92239375|NCT04352153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239376|NCT05215067|Docetaxel|docetaxel|mesh-list
92239377|NCT05215067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239378|NCT05215067|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239379|NCT05215067|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239380|NCT05215067|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239381|NCT05215067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239382|NCT01162733|Vancomycin|vancomycin|mesh-list
92239383|NCT01162733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239384|NCT01162733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239385|NCT02530242|Carbon Monoxide|carbon monoxide|mesh-list
92239386|NCT02530242|Antimetabolites|antimetabolites|mesh-ancestor
92239387|NCT02530242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239388|NCT02530242|Gasotransmitters|gasotransmitters|mesh-ancestor
92239389|NCT02530242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239390|NCT02530242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239391|NCT05410860|Etripamil|etripamil|mesh-list
92239392|NCT05410860|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92239393|NCT05410860|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239394|NCT05410860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239395|NCT05410860|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239396|NCT05410860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239397|NCT01131065|Immunoglobulins|immunoglobulins|mesh-list
92239398|NCT01131065|Antibodies|antibodies|mesh-list
92239399|NCT01131065|gamma-Globulins|gamma-globulins|mesh-list
92239400|NCT01131065|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92239401|NCT01131065|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92239402|NCT01131065|Immunologic Factors|immunologic factors|mesh-ancestor
92239403|NCT01131065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239404|NCT01165541|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92239405|NCT01165541|Mirtazapine|mirtazapine|mesh-list
92239406|NCT01165541|Antidepressive Agents|antidepressive agents|mesh-ancestor
92239407|NCT01165541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239408|NCT01165541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92239409|NCT01165541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92239410|NCT01165541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239411|NCT01165541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239412|NCT01165541|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92239413|NCT01165541|Histamine Antagonists|histamine antagonists|mesh-ancestor
92239415|NCT01165541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239416|NCT01165541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239417|NCT01165541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92239418|NCT01165541|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92239419|NCT01165541|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92239420|NCT01165541|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92239421|NCT01165541|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239422|NCT01165541|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92239423|NCT01165541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92239424|NCT01165541|Serotonin Agents|serotonin agents|mesh-ancestor
92239425|NCT01165541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92239426|NCT00284180|Trastuzumab|trastuzumab|mesh-list
92239427|NCT00284180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239428|NCT00284180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239429|NCT04087460|Vaccines|vaccines|mesh-list
92239430|NCT04087460|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92239431|NCT04087460|Immunologic Factors|immunologic factors|mesh-ancestor
92239432|NCT04087460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239433|NCT05031806|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92239434|NCT05031806|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92239435|NCT01899404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92239436|NCT01899404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92339509|NCT00002093|Bleomycin|bleomycin|mesh-list
92239437|NCT01899404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239439|NCT00287222|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92239440|NCT00287222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239441|NCT00287222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239442|NCT00287222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92239443|NCT00287222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92239444|NCT00287222|Growth Substances|growth substances|mesh-ancestor
92239445|NCT00287222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239446|NCT00287222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92239447|NCT00287222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239448|NCT00287222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239449|NCT00287222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239450|NCT00218426|Naltrexone|naltrexone|mesh-list
92239451|NCT00218426|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92239452|NCT00218426|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92239453|NCT00218426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239454|NCT00218426|Sensory System Agents|sensory system agents|mesh-ancestor
92239455|NCT00218426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239456|NCT01134575|Rituximab|rituximab|mesh-list
92239457|NCT01134575|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92239458|NCT01134575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239459|NCT01134575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239460|NCT01134575|Immunologic Factors|immunologic factors|mesh-ancestor
92239461|NCT01134575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239462|NCT01134575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239463|NCT01134575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92239464|NCT01134575|Immunotoxins|immunotoxins|mesh-ancestor
92239465|NCT01134575|Immunoconjugates|immunoconjugates|mesh-ancestor
92239466|NCT01790672|Ethanol|ethanol|mesh-list
92239467|NCT01790672|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92239468|NCT01790672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239469|NCT01790672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239470|NCT01790672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239471|NCT00223262|Lamotrigine|lamotrigine|mesh-list
92239472|NCT00223262|Anticonvulsants|anticonvulsants|mesh-ancestor
92239473|NCT00223262|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92239474|NCT00223262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239475|NCT00223262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239476|NCT00223262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239477|NCT00223262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239478|NCT00223262|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92239479|NCT00223262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92239480|NCT00223262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239481|NCT00223262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239482|NCT00223262|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92239483|NCT00290654|Tamoxifen|tamoxifen|mesh-list
92239484|NCT00290654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92239485|NCT00290654|Hormone Antagonists|hormone antagonists|mesh-ancestor
92239486|NCT00290654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239487|NCT00290654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239488|NCT00290654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92239489|NCT00290654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239490|NCT00290654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92239492|NCT00290654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92239493|NCT00290810|Bevacizumab|bevacizumab|mesh-list
92239494|NCT00290810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92239495|NCT00290810|Antibodies|antibodies|mesh-list
92239496|NCT00290810|Immunoglobulins|immunoglobulins|mesh-list
92239497|NCT00290810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92239498|NCT00290810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239499|NCT00290810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92239500|NCT00290810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92239501|NCT00290810|Growth Substances|growth substances|mesh-ancestor
92239502|NCT00290810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239503|NCT00290810|Growth Inhibitors|growth inhibitors|mesh-ancestor
92239504|NCT00290810|Immunologic Factors|immunologic factors|mesh-ancestor
92239505|NCT04042142|Glucagon|glucagon|mesh-list
92239506|NCT04042142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239507|NCT04042142|Hormones|hormones|mesh-ancestor
92239508|NCT04042142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239509|NCT04042142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239510|NCT01138475|Cholecalciferol|cholecalciferol|mesh-list
92239511|NCT01138475|Vitamin D|vitamin d|mesh-list
92239512|NCT01138475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239513|NCT01138475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239514|NCT01138475|Vitamins|vitamins|mesh-ancestor
92239515|NCT01138475|Micronutrients|micronutrients|mesh-ancestor
92239516|NCT01138475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92239517|NCT00293540|Tamoxifen|tamoxifen|mesh-list
92239518|NCT00293540|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92239519|NCT00293540|Hormone Antagonists|hormone antagonists|mesh-ancestor
92239520|NCT00293540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239521|NCT00293540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339547|NCT00002333|Saquinavir|saquinavir|mesh-list
92239522|NCT00293540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92239523|NCT00293540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239524|NCT00293540|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92239525|NCT00293540|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92239526|NCT00293540|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92239527|NCT03012113|Mirabegron|mirabegron|mesh-list
92239528|NCT03012113|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92239529|NCT03012113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92239530|NCT03012113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92239531|NCT03012113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239532|NCT03012113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239533|NCT03012113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239534|NCT03012113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239535|NCT03012113|Urological Agents|urological agents|mesh-ancestor
92239536|NCT01139801|Misoprostol|misoprostol|mesh-list
92239537|NCT01139801|Oxytocin|oxytocin|mesh-list
92239538|NCT01139801|Oxytocics|oxytocics|mesh-ancestor
92239539|NCT01139801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92239540|NCT01139801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239541|NCT01139801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92239542|NCT01139801|Abortifacient Agents|abortifacient agents|mesh-ancestor
92239543|NCT01139801|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92239544|NCT01139801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239545|NCT00294632|Rituximab|rituximab|mesh-list
92239546|NCT00294632|Lenalidomide|lenalidomide|mesh-list
92239547|NCT00294632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239548|NCT00294632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239549|NCT00294632|Immunologic Factors|immunologic factors|mesh-ancestor
92239550|NCT00294632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239551|NCT00294632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239552|NCT00294632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92239553|NCT00294632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92239554|NCT00294632|Growth Substances|growth substances|mesh-ancestor
91934592|NCT02349399|Hormones|hormones|mesh-ancestor
92239555|NCT00294632|Growth Inhibitors|growth inhibitors|mesh-ancestor
92239557|NCT01898624|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92239558|NCT01898624|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92239559|NCT01898624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92239560|NCT01898624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239561|NCT01898624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239562|NCT01898624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339576|NCT00002105|Doxorubicin|doxorubicin|mesh-list
92239563|NCT01898624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239564|NCT01898624|Urological Agents|urological agents|mesh-ancestor
92239565|NCT01140191|Gentamicins|gentamicins|mesh-list
92239566|NCT01140191|Paromomycin|paromomycin|mesh-list
92239567|NCT01140191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239568|NCT01140191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239569|NCT01140191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92239570|NCT01140191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239571|NCT01140191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239572|NCT01140191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92239573|NCT01140191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92239574|NCT01141049|Gabapentin|gabapentin|mesh-list
92239575|NCT01141049|Analgesics|analgesics|mesh-ancestor
92239576|NCT01141049|Sensory System Agents|sensory system agents|mesh-ancestor
92239577|NCT01141049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239578|NCT01141049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239579|NCT01141049|Anticonvulsants|anticonvulsants|mesh-ancestor
92239580|NCT01141049|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92239581|NCT01141049|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92239582|NCT01141049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239583|NCT01141049|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239584|NCT01141049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92239585|NCT01141049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92239586|NCT01141049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239587|NCT01141049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239588|NCT01141049|Antimanic Agents|antimanic agents|mesh-ancestor
92239589|NCT01141595|Verapamil|verapamil|mesh-list
92239590|NCT01141595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92239591|NCT01141595|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92239592|NCT01141595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239593|NCT01141595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239594|NCT01141595|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239595|NCT01141595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239596|NCT01141595|Vasodilator Agents|vasodilator agents|mesh-ancestor
92239597|NCT01167569|Ascorbic Acid|ascorbic acid|mesh-list
92239598|NCT01167569|Vitamins|vitamins|mesh-ancestor
92239599|NCT01167569|Micronutrients|micronutrients|mesh-ancestor
92239600|NCT01167569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239601|NCT01167569|Antioxidants|antioxidants|mesh-ancestor
92239602|NCT01167569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239603|NCT01167569|Protective Agents|protective agents|mesh-ancestor
92239604|NCT00296192|Rotigotine|rotigotine|mesh-list
92239605|NCT00296192|Dopamine Agonists|dopamine agonists|mesh-ancestor
92239606|NCT00296192|Dopamine Agents|dopamine agents|mesh-ancestor
92239607|NCT00296192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239608|NCT00296192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239609|NCT00296192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239610|NCT04312139|Lincomycin|lincomycin|mesh-list
92239611|NCT04312139|Calcium|calcium|mesh-list
92239612|NCT04312139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239613|NCT04312139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239614|NCT04312139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239615|NCT04312139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239616|NCT04312139|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92239617|NCT04312139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239618|NCT04312139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239619|NCT00297596|Oxaliplatin|oxaliplatin|mesh-list
92239620|NCT00297596|Trastuzumab|trastuzumab|mesh-list
92239621|NCT00297596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239622|NCT00297596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239623|NCT01144637|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92339668|NCT05752409|Ketamine|ketamine|mesh-list
92239624|NCT01144637|Antiviral Agents|antiviral agents|mesh-ancestor
92239625|NCT01144637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239626|NCT00298610|Artesunate|artesunate|mesh-list
92239627|NCT00298610|Atovaquone|atovaquone|mesh-list
92239629|NCT00298610|Quinidine|quinidine|mesh-list
92239630|NCT00298610|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92239631|NCT00298610|Antimalarials|antimalarials|mesh-ancestor
92239632|NCT00298610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92239633|NCT00298610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92239634|NCT00298610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239635|NCT00298610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239637|NCT00298610|Schistosomicides|schistosomicides|mesh-ancestor
92239638|NCT00298610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92239639|NCT00298610|Anthelmintics|anthelmintics|mesh-ancestor
92239640|NCT00298610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239641|NCT00298610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239642|NCT00298610|Antimetabolites|antimetabolites|mesh-ancestor
92239643|NCT00298610|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92239644|NCT00298610|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92239645|NCT00298610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239646|NCT00298610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239647|NCT00298610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239648|NCT00298610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92239649|NCT00298610|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92239650|NCT00298610|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92239651|NCT00298610|Cholinergic Agents|cholinergic agents|mesh-ancestor
92239652|NCT00298610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92239653|NCT00298610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92239654|NCT00298610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239655|NCT00298610|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92239656|NCT00298610|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92239657|NCT01144949|Silodosin|silodosin|mesh-list
92239658|NCT01144949|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92239659|NCT01144949|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92239660|NCT01144949|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92239661|NCT01144949|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239662|NCT01144949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239663|NCT01144949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239664|NCT01144949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239665|NCT01144949|Urological Agents|urological agents|mesh-ancestor
92239666|NCT00215930|Carboplatin|carboplatin|mesh-list
92239667|NCT00215930|Gemcitabine|gemcitabine|mesh-list
92239668|NCT00215930|Docetaxel|docetaxel|mesh-list
92239669|NCT00215930|Vinorelbine|vinorelbine|mesh-list
92239670|NCT00215930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239671|NCT00215930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92239672|NCT00215930|Antimetabolites|antimetabolites|mesh-ancestor
92239673|NCT00215930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239674|NCT00215930|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239675|NCT00215930|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239676|NCT00215930|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239677|NCT00215930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92239678|NCT01145183|Doxazosin|doxazosin|mesh-list
92239679|NCT01145183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92239680|NCT01145183|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92239681|NCT01145183|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92239682|NCT01145183|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92239683|NCT01145183|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239684|NCT01145183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239685|NCT01145183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239686|NCT01145183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239687|NCT00230126|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92239688|NCT00230126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239689|NCT00230126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239690|NCT00230126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239691|NCT00230126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239692|NCT04128722|Sirolimus|sirolimus|mesh-list
92339738|NCT00002375|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92239693|NCT04128722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239694|NCT04128722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239695|NCT04128722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92239696|NCT04128722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239697|NCT04128722|Antifungal Agents|antifungal agents|mesh-ancestor
92239698|NCT04128722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92239699|NCT04128722|Immunologic Factors|immunologic factors|mesh-ancestor
92239700|NCT04128722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239701|NCT01169519|Sildenafil Citrate|sildenafil citrate|mesh-list
92239702|NCT01169519|Vasodilator Agents|vasodilator agents|mesh-ancestor
92239703|NCT01169519|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92239704|NCT01169519|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92239705|NCT01169519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239706|NCT01169519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239707|NCT01169519|Urological Agents|urological agents|mesh-ancestor
92239708|NCT04071977|Antioxidants|antioxidants|mesh-list
92239709|NCT04071977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239710|NCT04071977|Protective Agents|protective agents|mesh-ancestor
92239711|NCT04071977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239712|NCT02101190|Opicapone|opicapone|mesh-list
92239713|NCT02101190|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92239714|NCT02101190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239715|NCT02101190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239717|NCT02101190|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92239718|NCT01170533|Omeprazole|omeprazole|mesh-list
92239719|NCT01170533|Pantoprazole|pantoprazole|mesh-list
92239720|NCT01170533|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92239721|NCT01170533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92239722|NCT01170533|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92239723|NCT01170533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239724|NCT01170533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239725|NCT01147601|Timolol|timolol|mesh-list
92239726|NCT01147601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92339797|NCT00002399|Fluconazole|fluconazole|mesh-list
92239727|NCT01147601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92239728|NCT01147601|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239729|NCT01147601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239730|NCT01147601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239731|NCT01147601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239732|NCT01147601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92239733|NCT01147601|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92239735|NCT03011645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92239736|NCT03011645|Serotonin Agents|serotonin agents|mesh-ancestor
92239737|NCT03011645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239738|NCT03011645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239739|NCT03011645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239740|NCT03011645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92239741|NCT03011645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92239742|NCT03011645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239743|NCT03011645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92239744|NCT03011645|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92239745|NCT03011645|Dopamine Agents|dopamine agents|mesh-ancestor
92239746|NCT01149785|Ketoconazole|ketoconazole|mesh-list
92239747|NCT01149785|Crizotinib|crizotinib|mesh-list
92239748|NCT01149785|Antifungal Agents|antifungal agents|mesh-ancestor
92239749|NCT01149785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239750|NCT01149785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92239751|NCT01149785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92239752|NCT01149785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239753|NCT01149785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239754|NCT01149785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92239755|NCT01149785|Hormone Antagonists|hormone antagonists|mesh-ancestor
92239756|NCT01149785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239757|NCT01149785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239758|NCT01149785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92239759|NCT01149785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239760|NCT01149785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239761|NCT02182115|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92239762|NCT02182115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239763|NCT03011567|Acetaminophen|acetaminophen|mesh-list
92239764|NCT03011567|Ibuprofen|ibuprofen|mesh-list
92239765|NCT03011567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92239766|NCT03011567|Analgesics|analgesics|mesh-ancestor
92239767|NCT03011567|Sensory System Agents|sensory system agents|mesh-ancestor
92239768|NCT03011567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239769|NCT03011567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239770|NCT03011567|Antipyretics|antipyretics|mesh-ancestor
92239771|NCT03011567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92239772|NCT03011567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239773|NCT03011567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239774|NCT03011567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92239775|NCT03011567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239776|NCT03011567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239777|NCT01173029|Antihypertensive Agents|antihypertensive agents|mesh-list
92239778|NCT01173029|Calcium Channel Blockers|calcium channel blockers|mesh-list
92239779|NCT01173029|Diuretics|diuretics|mesh-list
92239780|NCT01173029|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92239781|NCT01173029|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92239782|NCT01173029|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92239783|NCT01173029|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92239784|NCT01173029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239785|NCT01173029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239786|NCT01173029|Natriuretic Agents|natriuretic agents|mesh-ancestor
92239787|NCT01173029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239788|NCT01173029|Protease Inhibitors|protease inhibitors|mesh-ancestor
92239789|NCT01173029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239790|NCT01173029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92239791|NCT01173029|Hormone Antagonists|hormone antagonists|mesh-ancestor
92239792|NCT01173029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239793|NCT01173029|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92239794|NCT01174823|Bepotastine besilate|bepotastine besilate|mesh-list
92239795|NCT01174823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92239796|NCT01174823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92239797|NCT01174823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92239798|NCT03886649|Venetoclax|venetoclax|mesh-list
92239799|NCT03886649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239800|NCT01151813|Varenicline|varenicline|mesh-list
92239801|NCT01151813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92239802|NCT01151813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92239803|NCT01151813|Cholinergic Agents|cholinergic agents|mesh-ancestor
92239804|NCT01151813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239805|NCT01151813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239806|NCT01151813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239807|NCT03877991|Cannabidiol|cannabidiol|mesh-list
92239808|NCT03877991|Anticonvulsants|anticonvulsants|mesh-ancestor
92239809|NCT03835949|Atezolizumab|atezolizumab|mesh-list
92239810|NCT03835949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92239811|NCT03835949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239812|NCT03835949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239813|NCT03835949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239814|NCT01177709|Metformin|metformin|mesh-list
92239815|NCT01177709|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92239816|NCT01177709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239817|NCT01179113|Esmolol|esmolol|mesh-list
92239818|NCT01179113|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92239819|NCT01179113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92239820|NCT01179113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92239821|NCT01179113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92239822|NCT01179113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239823|NCT01179113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239824|NCT01179113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239825|NCT01152515|Remifentanil|remifentanil|mesh-list
92239826|NCT01152515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92239827|NCT01152515|Narcotics|narcotics|mesh-ancestor
92239828|NCT01152515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239829|NCT01152515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239830|NCT01152515|Analgesics|analgesics|mesh-ancestor
92239831|NCT01152515|Sensory System Agents|sensory system agents|mesh-ancestor
92239832|NCT01152515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239833|NCT03011177|Linagliptin|linagliptin|mesh-list
92239834|NCT03011177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92239835|NCT03011177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239836|NCT03011177|Incretins|incretins|mesh-ancestor
92239837|NCT03011177|Hormones|hormones|mesh-ancestor
92239838|NCT03011177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239839|NCT03011177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92239840|NCT03011177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92239841|NCT03011177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239842|NCT03011177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239843|NCT03465527|Prednisolone|prednisolone|mesh-list
92239844|NCT03465527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239845|NCT03465527|Glucocorticoids|glucocorticoids|mesh-ancestor
92239846|NCT03465527|Hormones|hormones|mesh-ancestor
92239847|NCT03465527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92239848|NCT03465527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239849|NCT03465527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92239850|NCT03465527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239851|NCT03418805|Ibuprofen|ibuprofen|mesh-list
92239852|NCT03418805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92239853|NCT03418805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92239854|NCT03418805|Analgesics|analgesics|mesh-ancestor
92239855|NCT03418805|Sensory System Agents|sensory system agents|mesh-ancestor
92239856|NCT03418805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239857|NCT03418805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239858|NCT03418805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239859|NCT03418805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239860|NCT03418805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92239861|NCT03418805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239862|NCT03418805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239863|NCT01156571|Clopidogrel|clopidogrel|mesh-list
92239864|NCT01156571|Cangrelor|cangrelor|mesh-list
92239865|NCT01156571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92239866|NCT01156571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92239867|NCT01156571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92239868|NCT01156571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92239869|NCT01156571|Purinergic Agents|purinergic agents|mesh-ancestor
92239870|NCT01156571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239871|NCT01156571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239872|NCT01156571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239873|NCT01220687|Nitric Oxide|nitric oxide|mesh-list
92239874|NCT01220687|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92239875|NCT01220687|Autonomic Agents|autonomic agents|mesh-ancestor
92239876|NCT01220687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239877|NCT01220687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239878|NCT01220687|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92239879|NCT01220687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92239880|NCT01220687|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92239881|NCT01220687|Antioxidants|antioxidants|mesh-ancestor
92239882|NCT01220687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239883|NCT01220687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239884|NCT01220687|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92239885|NCT01220687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92239886|NCT01220687|Gasotransmitters|gasotransmitters|mesh-ancestor
92239887|NCT01220687|Protective Agents|protective agents|mesh-ancestor
92239888|NCT03010865|Butyric Acid|butyric acid|mesh-list
92239889|NCT03010865|Histamine Antagonists|histamine antagonists|mesh-ancestor
92239890|NCT03010865|Histamine Agents|histamine agents|mesh-ancestor
92239891|NCT03010865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92239892|NCT03010865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239893|NCT03010865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239894|NCT01157429|Cycloserine|cycloserine|mesh-list
92239895|NCT01157429|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92239896|NCT01157429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92239897|NCT01157429|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92239898|NCT01157429|Antitubercular Agents|antitubercular agents|mesh-ancestor
92239899|NCT01157429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92239900|NCT01157429|Antimetabolites|antimetabolites|mesh-ancestor
92239901|NCT01157429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239903|NCT00234884|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92239904|NCT00234884|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239905|NCT00234884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239906|NCT01602666|Carboplatin|carboplatin|mesh-list
92239908|NCT01602666|Etoposide phosphate|etoposide phosphate|mesh-list
92239909|NCT01602666|Ifosfamide|ifosfamide|mesh-list
92239910|NCT01602666|Isophosphamide mustard|isophosphamide mustard|mesh-list
92239911|NCT01602666|Podophyllotoxin|podophyllotoxin|mesh-list
92239912|NCT01602666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239913|NCT01602666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92239914|NCT01602666|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92239915|NCT01602666|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92239916|NCT01602666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239917|NCT01602666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239918|NCT01602666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92239919|NCT01602666|Alkylating Agents|alkylating agents|mesh-ancestor
92239920|NCT01602666|Keratolytic Agents|keratolytic agents|mesh-ancestor
92239921|NCT01602666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92239922|NCT01602666|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239923|NCT01602666|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239924|NCT01602666|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239925|NCT05442060|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92239926|NCT05442060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239927|NCT05442060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239928|NCT05442060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239929|NCT05442060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239930|NCT05441592|Tranexamic Acid|tranexamic acid|mesh-list
92239931|NCT05441592|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92239932|NCT05441592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92239933|NCT05441592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239935|NCT05441592|Coagulants|coagulants|mesh-ancestor
92239936|NCT05415462|Vaccines|vaccines|mesh-list
92239937|NCT05415462|Immunologic Factors|immunologic factors|mesh-ancestor
92239938|NCT05415462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239939|NCT00300482|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92239940|NCT00300482|Calcium|calcium|mesh-list
92239941|NCT00300482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92239942|NCT00300482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239943|NCT00300482|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92239944|NCT00300482|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92239945|NCT00300482|Antimetabolites|antimetabolites|mesh-ancestor
92239946|NCT00300482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239947|NCT00300482|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92239948|NCT00300482|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92239949|NCT00300482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239950|NCT05439876|Melatonin|melatonin|mesh-list
92239951|NCT05439876|Antioxidants|antioxidants|mesh-ancestor
92239952|NCT05439876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239953|NCT05439876|Protective Agents|protective agents|mesh-ancestor
92239954|NCT05439876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239955|NCT05439876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239957|NCT00301028|Carboplatin|carboplatin|mesh-list
92239958|NCT00301028|Cetuximab|cetuximab|mesh-list
92239959|NCT00301028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92239960|NCT00301028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239961|NCT00301028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92239962|NCT00301028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92239963|NCT00301028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92239964|NCT00301028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239965|NCT00301028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92239966|NCT00301418|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92239967|NCT00301418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239968|NCT00301418|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92239969|NCT00301418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239970|NCT00301418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239971|NCT05414838|Vitamin D|vitamin d|mesh-list
92239972|NCT05414838|Curcumin|curcumin|mesh-list
92239973|NCT05414838|Vitamins|vitamins|mesh-ancestor
92239974|NCT05414838|Micronutrients|micronutrients|mesh-ancestor
92239975|NCT05414838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239976|NCT05414838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92239977|NCT05414838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92239978|NCT05414838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92239979|NCT05414838|Analgesics|analgesics|mesh-ancestor
92239980|NCT05414838|Sensory System Agents|sensory system agents|mesh-ancestor
92239981|NCT05414838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239982|NCT05414838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92239983|NCT05414838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92239984|NCT05414838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92239985|NCT05414838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92239986|NCT05414838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92239987|NCT05414214|Anesthetics|anesthetics|mesh-list
92239988|NCT05414214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239989|NCT05414214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239990|NCT05014230|Analgesics, Opioid|analgesics, opioid|mesh-list
92239991|NCT05014230|Narcotics|narcotics|mesh-ancestor
92239992|NCT05014230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92239993|NCT05014230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92239994|NCT05014230|Analgesics|analgesics|mesh-ancestor
92239995|NCT05014230|Sensory System Agents|sensory system agents|mesh-ancestor
92339912|NCT00002453|Tenofovir|tenofovir|mesh-list
92239996|NCT05014230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92239997|NCT01896284|Aflibercept|aflibercept|mesh-list
92239998|NCT01896284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92239999|NCT01896284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92240000|NCT01896284|Growth Substances|growth substances|mesh-ancestor
92240001|NCT01896284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240002|NCT01896284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92240003|NCT01896284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240004|NCT05438160|Coal Tar|coal tar|mesh-list
92240005|NCT05438160|Keratolytic Agents|keratolytic agents|mesh-ancestor
92240006|NCT05438160|Dermatologic Agents|dermatologic agents|mesh-ancestor
92240007|NCT03954990|Metronidazole|metronidazole|mesh-list
92240009|NCT03954990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240010|NCT03954990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92240011|NCT03954990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92240012|NCT01478581|Dexamethasone|dexamethasone|mesh-list
92240013|NCT01478581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240014|NCT01478581|Antiemetics|antiemetics|mesh-ancestor
92240015|NCT01478581|Autonomic Agents|autonomic agents|mesh-ancestor
92240016|NCT01478581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240017|NCT01478581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240018|NCT01478581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240019|NCT01478581|Glucocorticoids|glucocorticoids|mesh-ancestor
92240020|NCT01478581|Hormones|hormones|mesh-ancestor
92240021|NCT01478581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240022|NCT01478581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92240023|NCT01478581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240024|NCT00239642|Iron|iron|mesh-list
92240025|NCT00239642|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92240026|NCT00239642|Trace Elements|trace elements|mesh-ancestor
92240027|NCT00239642|Micronutrients|micronutrients|mesh-ancestor
92240028|NCT00239642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240029|NCT00239642|Hematinics|hematinics|mesh-ancestor
92240030|NCT01351896|Lenalidomide|lenalidomide|mesh-list
92240031|NCT01351896|Vaccines|vaccines|mesh-list
92240032|NCT01351896|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92240033|NCT01351896|Immunologic Factors|immunologic factors|mesh-ancestor
92240034|NCT01351896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240035|NCT01351896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92240036|NCT01351896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92240037|NCT01351896|Growth Substances|growth substances|mesh-ancestor
92240038|NCT01351896|Growth Inhibitors|growth inhibitors|mesh-ancestor
92240039|NCT01351896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240040|NCT00241904|Propranolol|propranolol|mesh-list
92240041|NCT00241904|Metoprolol|metoprolol|mesh-list
92240042|NCT00241904|Atenolol|atenolol|mesh-list
92240043|NCT00241904|Lisinopril|lisinopril|mesh-list
92240044|NCT00241904|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92240045|NCT00241904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92240046|NCT00241904|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92240047|NCT00241904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92240048|NCT00241904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92240049|NCT00241904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240050|NCT00241904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240051|NCT00241904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339921|NCT00002465|Megestrol|megestrol|mesh-list
92240052|NCT00241904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92240053|NCT00241904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92240054|NCT00241904|Vasodilator Agents|vasodilator agents|mesh-ancestor
92240055|NCT00241904|Sympatholytics|sympatholytics|mesh-ancestor
92240056|NCT00241904|Autonomic Agents|autonomic agents|mesh-ancestor
92240057|NCT00241904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240058|NCT00241904|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92240059|NCT00241904|Protease Inhibitors|protease inhibitors|mesh-ancestor
92240060|NCT00241904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240061|NCT00241904|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92240062|NCT00241904|Protective Agents|protective agents|mesh-ancestor
92240063|NCT01791296|Dexmedetomidine|dexmedetomidine|mesh-list
92240064|NCT01791296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92240065|NCT01791296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240066|NCT01791296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240067|NCT01791296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240068|NCT01791296|Analgesics|analgesics|mesh-ancestor
92240069|NCT01791296|Sensory System Agents|sensory system agents|mesh-ancestor
92240070|NCT01791296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240071|NCT01791296|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92240072|NCT01791296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92240073|NCT01791296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92240074|NCT01791296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92240075|NCT01791296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240076|NCT01791296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240077|NCT01479127|Silicon|silicon|mesh-list
92240078|NCT01479127|Levodopa|levodopa|mesh-list
92240080|NCT01479127|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92240081|NCT01479127|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92240082|NCT01479127|Dopamine Agents|dopamine agents|mesh-ancestor
92240083|NCT01479127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240084|NCT01479127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240085|NCT01479127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240086|NCT01479127|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92240087|NCT01479127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240088|NCT01479127|Trace Elements|trace elements|mesh-ancestor
92240089|NCT01479127|Micronutrients|micronutrients|mesh-ancestor
92240090|NCT03917966|Docetaxel|docetaxel|mesh-list
92240091|NCT03917966|Apatinib|apatinib|mesh-list
92240092|NCT03917966|Nedaplatin|nedaplatin|mesh-list
92240093|NCT03917966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240094|NCT03917966|Tubulin Modulators|tubulin modulators|mesh-ancestor
92240095|NCT03917966|Antimitotic Agents|antimitotic agents|mesh-ancestor
92240096|NCT03917966|Mitosis Modulators|mitosis modulators|mesh-ancestor
92240097|NCT03917966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240098|NCT03917966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92240099|NCT03917966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240100|NCT00243152|Lamotrigine|lamotrigine|mesh-list
92240101|NCT00243152|Anticonvulsants|anticonvulsants|mesh-list
92240102|NCT00243152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92240103|NCT00243152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92240104|NCT00243152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240105|NCT00243152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92240106|NCT00243152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240107|NCT00243152|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92240108|NCT00243152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92240109|NCT00243152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240110|NCT00243152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92240111|NCT00243152|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92240112|NCT01453075|Valacyclovir|valacyclovir|mesh-list
92240113|NCT01453075|Antiviral Agents|antiviral agents|mesh-ancestor
92240114|NCT01453075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240115|NCT01791374|Rilotumumab|rilotumumab|mesh-list
92240116|NCT01791374|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92240117|NCT01791374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240118|NCT01791374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240119|NCT01791374|Immunologic Factors|immunologic factors|mesh-ancestor
92240120|NCT01791374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240121|NCT03783416|Ixazomib|ixazomib|mesh-list
92240122|NCT03783416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240123|NCT03783416|Protease Inhibitors|protease inhibitors|mesh-ancestor
92240124|NCT03783416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240125|NCT03783416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240126|NCT00248534|Methylprednisolone|methylprednisolone|mesh-list
92240127|NCT00248534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92240128|NCT00248534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92240130|NCT00248534|Prednisolone acetate|prednisolone acetate|mesh-list
92240131|NCT00248534|Rituximab|rituximab|mesh-list
92240132|NCT00248534|Temozolomide|temozolomide|mesh-list
92240133|NCT00248534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92240134|NCT00248534|Prednisolone phosphate|prednisolone phosphate|mesh-list
92240135|NCT00248534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240136|NCT00248534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240137|NCT00248534|Immunologic Factors|immunologic factors|mesh-ancestor
92240138|NCT00248534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240139|NCT00248534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240140|NCT00248534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92240141|NCT00248534|Alkylating Agents|alkylating agents|mesh-ancestor
92240142|NCT00248534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240143|NCT00248534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240144|NCT00248534|Antiemetics|antiemetics|mesh-ancestor
92240145|NCT00248534|Autonomic Agents|autonomic agents|mesh-ancestor
92240146|NCT00248534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240147|NCT00248534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240148|NCT00248534|Glucocorticoids|glucocorticoids|mesh-ancestor
92240149|NCT00248534|Hormones|hormones|mesh-ancestor
92240150|NCT00248534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240151|NCT00248534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92240152|NCT00248534|Protective Agents|protective agents|mesh-ancestor
92240153|NCT00248534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92240154|NCT00248612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92240155|NCT00248612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92240156|NCT00248612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92240157|NCT00248612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92240158|NCT00248612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240159|NCT00248612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240160|NCT00248612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240161|NCT00248612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92240162|NCT00248612|Antidepressive Agents|antidepressive agents|mesh-ancestor
92240163|NCT00248612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92240164|NCT05266820|Thalidomide|thalidomide|mesh-list
92240165|NCT05266820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240166|NCT05266820|Immunologic Factors|immunologic factors|mesh-ancestor
92240167|NCT05266820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240168|NCT05266820|Leprostatic Agents|leprostatic agents|mesh-ancestor
92240169|NCT05266820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240170|NCT05266820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240171|NCT05266820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92240172|NCT05266820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92240173|NCT05266820|Growth Substances|growth substances|mesh-ancestor
92240174|NCT05266820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92240175|NCT05266820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240176|NCT03549650|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
92240177|NCT03549650|Anticoagulants|anticoagulants|mesh-ancestor
92240178|NCT01454791|Diclofenac|diclofenac|mesh-list
92240179|NCT01454791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92240180|NCT01454791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240181|NCT01454791|Analgesics|analgesics|mesh-ancestor
92240182|NCT01454791|Sensory System Agents|sensory system agents|mesh-ancestor
92240183|NCT01454791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240184|NCT01454791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240185|NCT01454791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240186|NCT01454791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240187|NCT01454791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92240188|NCT01454791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240189|NCT01454791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240190|NCT02099006|Ketoprofen|ketoprofen|mesh-list
92240191|NCT02099006|Ketamine|ketamine|mesh-list
92240192|NCT02099006|Gabapentin|gabapentin|mesh-list
92240193|NCT02099006|Amitriptyline|amitriptyline|mesh-list
92240194|NCT02099006|Baclofen|baclofen|mesh-list
92240195|NCT02099006|Loperamide|loperamide|mesh-list
92340102|NCT00002165|Nelfinavir|nelfinavir|mesh-list
92240196|NCT02099006|Antidiarrheals|antidiarrheals|mesh-list
92240197|NCT02099006|Analgesics|analgesics|mesh-ancestor
92240198|NCT02099006|Sensory System Agents|sensory system agents|mesh-ancestor
92240199|NCT02099006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240200|NCT02099006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240201|NCT02099006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92240203|NCT02099006|Anesthetics, General|anesthetics, general|mesh-ancestor
92240204|NCT02099006|Anesthetics|anesthetics|mesh-ancestor
92240205|NCT02099006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240206|NCT02099006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92240207|NCT02099006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92240208|NCT02099006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240209|NCT02099006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240210|NCT02099006|Anticonvulsants|anticonvulsants|mesh-ancestor
92240211|NCT02099006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92240212|NCT02099006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92240213|NCT02099006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92240214|NCT02099006|Antimanic Agents|antimanic agents|mesh-ancestor
92240215|NCT02099006|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92240216|NCT02099006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92240217|NCT02099006|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92240218|NCT02099006|GABA Agonists|gaba agonists|mesh-ancestor
92240219|NCT02099006|GABA Agents|gaba agents|mesh-ancestor
92240220|NCT02099006|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92240221|NCT02099006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240222|NCT02099006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240223|NCT02099006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240224|NCT02099006|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92240225|NCT02099006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240226|NCT02099006|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92240227|NCT02099006|Antidepressive Agents|antidepressive agents|mesh-ancestor
92240228|NCT02099006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92240229|NCT02099006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92340103|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92240230|NCT02099006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92240231|NCT02099006|Adrenergic Agents|adrenergic agents|mesh-ancestor
92240232|NCT02099006|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240233|NCT05266274|Azacitidine|azacitidine|mesh-list
92240234|NCT05266274|Antibodies|antibodies|mesh-list
92240235|NCT05266274|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92240236|NCT05266274|Immunologic Factors|immunologic factors|mesh-ancestor
92240237|NCT05266274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240238|NCT05266274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92240240|NCT05266274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240241|NCT05266274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240242|NCT05266274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240243|NCT05266196|Cyclophosphamide|cyclophosphamide|mesh-list
92240244|NCT05266196|Topotecan|topotecan|mesh-list
92240245|NCT05266196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240246|NCT05266196|Immunologic Factors|immunologic factors|mesh-ancestor
92240247|NCT05266196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240248|NCT05266196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240249|NCT05266196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92240250|NCT05266196|Alkylating Agents|alkylating agents|mesh-ancestor
92240251|NCT05266196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240252|NCT05266196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240253|NCT05266196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92240254|NCT05266196|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92240255|NCT05266196|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92240256|NCT05266196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240257|NCT05265962|Decitabine|decitabine|mesh-list
92240258|NCT05265962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92240259|NCT05265962|Antimetabolites|antimetabolites|mesh-ancestor
92240260|NCT05265962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240261|NCT05265962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240262|NCT05265962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240263|NCT00324896|Eszopiclone|eszopiclone|mesh-list
92240264|NCT00324896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92240265|NCT00324896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240266|NCT00324896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240267|NCT01479517|Tetracaine|tetracaine|mesh-list
92240268|NCT01479517|Anesthetics, Local|anesthetics, local|mesh-ancestor
92240269|NCT01479517|Anesthetics|anesthetics|mesh-ancestor
92240270|NCT01479517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240271|NCT01479517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240272|NCT01479517|Sensory System Agents|sensory system agents|mesh-ancestor
92240273|NCT01479517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240274|NCT01480219|Voriconazole|voriconazole|mesh-list
92240276|NCT01480219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240277|NCT01480219|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92240278|NCT01480219|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92240279|NCT01480219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240280|NCT01480219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240281|NCT01480219|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92240282|NCT01480219|Hormone Antagonists|hormone antagonists|mesh-ancestor
92240283|NCT01480219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240284|NCT01480219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240285|NCT01480219|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92240286|NCT01480297|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92240287|NCT01480297|Sodium Salicylate|sodium salicylate|mesh-list
92240288|NCT01480297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92240289|NCT01480297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240290|NCT01480297|Analgesics|analgesics|mesh-ancestor
92240291|NCT01480297|Sensory System Agents|sensory system agents|mesh-ancestor
92240292|NCT01480297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924617|NCT02685033|Dalbavancin|dalbavancin|mesh-list
92240293|NCT01480297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240294|NCT01480297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240295|NCT01480297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240296|NCT01480297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92240297|NCT01480297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240298|NCT01480297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240299|NCT01480843|Insulin Glargine|insulin glargine|mesh-list
92240300|NCT01480843|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92240301|NCT01480843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240302|NCT01392703|Dasatinib|dasatinib|mesh-list
92240303|NCT01392703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240304|NCT01392703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92240305|NCT01392703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240306|NCT01392703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240307|NCT01392859|Levocetirizine|levocetirizine|mesh-list
92240308|NCT01392859|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92240309|NCT01392859|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92240310|NCT01392859|Histamine Antagonists|histamine antagonists|mesh-ancestor
92240312|NCT01392859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240313|NCT01392859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240314|NCT01392859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240315|NCT01457521|Ibuprofen|ibuprofen|mesh-list
92240316|NCT01457521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92240317|NCT01457521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240318|NCT01457521|Analgesics|analgesics|mesh-ancestor
92240319|NCT01457521|Sensory System Agents|sensory system agents|mesh-ancestor
92240320|NCT01457521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240321|NCT01457521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240322|NCT01457521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240323|NCT01457521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240324|NCT01457521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92240325|NCT01457521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240326|NCT01457521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240327|NCT00325442|Treprostinil|treprostinil|mesh-list
92240328|NCT00325442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92240329|NCT01393717|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92240330|NCT01393717|Antibodies|antibodies|mesh-list
92240331|NCT01393717|Immunoglobulins|immunoglobulins|mesh-list
92240332|NCT01393717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92240333|NCT01393717|Immunoconjugates|immunoconjugates|mesh-list
92240334|NCT01393717|Immunologic Factors|immunologic factors|mesh-ancestor
92240335|NCT01393717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240336|NCT01393717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240337|NCT01393717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240338|NCT01393717|Immunotoxins|immunotoxins|mesh-ancestor
92240339|NCT01460875|Interferons|interferons|mesh-list
92240340|NCT01460875|Interferon-alpha|interferon-alpha|mesh-list
92240341|NCT01460875|Interferon alpha-2|interferon alpha-2|mesh-list
92240342|NCT01460875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240343|NCT01460875|Antiviral Agents|antiviral agents|mesh-ancestor
92240344|NCT01460875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240345|NCT01460875|Immunologic Factors|immunologic factors|mesh-ancestor
92240346|NCT01460875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240347|NCT01481545|Leucovorin|leucovorin|mesh-list
92240348|NCT01481545|Bevacizumab|bevacizumab|mesh-list
92240349|NCT01481545|Fluorouracil|fluorouracil|mesh-list
92240350|NCT01481545|Oxaliplatin|oxaliplatin|mesh-list
92240351|NCT01481545|Raltitrexed|raltitrexed|mesh-list
92240352|NCT01481545|Levoleucovorin|levoleucovorin|mesh-list
92240353|NCT01481545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240354|NCT01481545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240355|NCT01481545|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92240356|NCT01481545|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92240358|NCT01481545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240359|NCT01481545|Growth Inhibitors|growth inhibitors|mesh-ancestor
92240360|NCT01481545|Antimetabolites|antimetabolites|mesh-ancestor
92240361|NCT01481545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240362|NCT01481545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92240363|NCT01481545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240364|NCT01481545|Immunologic Factors|immunologic factors|mesh-ancestor
92240365|NCT01481545|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92240366|NCT01481545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240367|NCT01481545|Antidotes|antidotes|mesh-ancestor
92240368|NCT01481545|Protective Agents|protective agents|mesh-ancestor
92240369|NCT01481545|Vitamin B Complex|vitamin b complex|mesh-ancestor
92240370|NCT01481545|Vitamins|vitamins|mesh-ancestor
92240371|NCT01481545|Micronutrients|micronutrients|mesh-ancestor
92240372|NCT01482091|Fentanyl|fentanyl|mesh-list
92240373|NCT01482091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92240374|NCT01482091|Narcotics|narcotics|mesh-ancestor
92240375|NCT01482091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240376|NCT01482091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240377|NCT01482091|Analgesics|analgesics|mesh-ancestor
92240378|NCT01482091|Sensory System Agents|sensory system agents|mesh-ancestor
92240379|NCT01482091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240380|NCT01482091|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92240381|NCT01482091|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92240382|NCT01482091|Anesthetics, General|anesthetics, general|mesh-ancestor
92240383|NCT01482091|Anesthetics|anesthetics|mesh-ancestor
92240384|NCT00327392|Fospropofol|fospropofol|mesh-list
92240385|NCT00327392|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92240386|NCT00327392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240387|NCT00327392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240389|NCT01791608|Zinc Sulfate|zinc sulfate|mesh-list
92240390|NCT01791608|Trace Elements|trace elements|mesh-ancestor
92240391|NCT01791608|Micronutrients|micronutrients|mesh-ancestor
92240392|NCT01791608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240393|NCT01791608|Astringents|astringents|mesh-ancestor
92240394|NCT01791608|Dermatologic Agents|dermatologic agents|mesh-ancestor
92240395|NCT04346030|Triamcinolone|triamcinolone|mesh-list
92240396|NCT04346030|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92240397|NCT04346030|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92240398|NCT04346030|Lidocaine|lidocaine|mesh-list
92240399|NCT04346030|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92240400|NCT04346030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92240401|NCT04346030|Anesthetics|anesthetics|mesh-ancestor
92240402|NCT04346030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240403|NCT04346030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240404|NCT04346030|Sensory System Agents|sensory system agents|mesh-ancestor
92240405|NCT04346030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240406|NCT04346030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92240407|NCT04346030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92240408|NCT04346030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92240409|NCT04346030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92240410|NCT04346030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240411|NCT04346030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240412|NCT04346030|Glucocorticoids|glucocorticoids|mesh-ancestor
92240413|NCT04346030|Hormones|hormones|mesh-ancestor
92240414|NCT04346030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240415|NCT04346030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240416|NCT04346030|Immunologic Factors|immunologic factors|mesh-ancestor
92240417|NCT04346030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240418|NCT05075330|Analgesics, Opioid|analgesics, opioid|mesh-list
92240419|NCT05075330|Narcotics|narcotics|mesh-ancestor
92240420|NCT05075330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240421|NCT05075330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240422|NCT05075330|Analgesics|analgesics|mesh-ancestor
92240423|NCT05075330|Sensory System Agents|sensory system agents|mesh-ancestor
92240424|NCT05075330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240425|NCT02108288|Carteolol|carteolol|mesh-list
92240426|NCT02108288|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92240427|NCT02108288|Latanoprost|latanoprost|mesh-list
92240428|NCT02108288|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92240429|NCT02108288|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92240430|NCT02108288|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92240431|NCT02108288|Adrenergic Agents|adrenergic agents|mesh-ancestor
92240432|NCT02108288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240433|NCT02108288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240434|NCT02108288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240435|NCT02108288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92240436|NCT02108288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92240437|NCT02108288|Sympatholytics|sympatholytics|mesh-ancestor
92240438|NCT02108288|Autonomic Agents|autonomic agents|mesh-ancestor
92240439|NCT02108288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240440|NCT02106494|Dexamethasone|dexamethasone|mesh-list
92240441|NCT02106494|Ondansetron|ondansetron|mesh-list
92240442|NCT02106494|Fosaprepitant|fosaprepitant|mesh-list
92240443|NCT02106494|Aprepitant|aprepitant|mesh-list
92240444|NCT02106494|Granisetron|granisetron|mesh-list
92240445|NCT02106494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240446|NCT02106494|Antiemetics|antiemetics|mesh-ancestor
92240447|NCT02106494|Autonomic Agents|autonomic agents|mesh-ancestor
92240448|NCT02106494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240449|NCT02106494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240450|NCT02106494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240451|NCT02106494|Glucocorticoids|glucocorticoids|mesh-ancestor
92240452|NCT02106494|Hormones|hormones|mesh-ancestor
92240453|NCT02106494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240454|NCT02106494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92240455|NCT02106494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240456|NCT02106494|Antipruritics|antipruritics|mesh-ancestor
92240457|NCT02106494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92240458|NCT02106494|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92240459|NCT02106494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92240460|NCT02106494|Serotonin Agents|serotonin agents|mesh-ancestor
92240461|NCT02106494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240462|NCT02106494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240463|NCT02106494|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92240464|NCT00335504|Sulindac|sulindac|mesh-list
92240466|NCT00335504|Calcium|calcium|mesh-list
92240467|NCT00335504|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92240468|NCT00335504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240469|NCT00335504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92240470|NCT00335504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92240471|NCT00335504|Antimetabolites|antimetabolites|mesh-ancestor
92240472|NCT00335504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240473|NCT00335504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92240474|NCT00335504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92240475|NCT00335504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240476|NCT00335504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92240477|NCT00335504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240478|NCT00335504|Analgesics|analgesics|mesh-ancestor
92240479|NCT00335504|Sensory System Agents|sensory system agents|mesh-ancestor
92240480|NCT00335504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240481|NCT00335504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240482|NCT00335504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240483|NCT00335504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240484|NCT00335504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92240485|NCT01183169|Ribavirin|ribavirin|mesh-list
92240486|NCT01183169|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92240487|NCT01183169|Antimetabolites|antimetabolites|mesh-ancestor
92240488|NCT01183169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240489|NCT01183169|Antiviral Agents|antiviral agents|mesh-ancestor
92240490|NCT01183169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240491|NCT01183481|Aprepitant|aprepitant|mesh-list
92240492|NCT01183481|Granisetron|granisetron|mesh-list
92240493|NCT01183481|Antiemetics|antiemetics|mesh-ancestor
92240494|NCT01183481|Autonomic Agents|autonomic agents|mesh-ancestor
92240495|NCT01183481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240496|NCT01183481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240497|NCT01183481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240498|NCT01183481|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92240499|NCT01183481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240500|NCT01183481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240501|NCT01183481|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92240502|NCT01183481|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92240504|NCT01183559|Paclitaxel|paclitaxel|mesh-list
92240505|NCT01183559|Carboplatin|carboplatin|mesh-list
92240506|NCT01183559|Fluorouracil|fluorouracil|mesh-list
92240507|NCT01183559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92240508|NCT01183559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240509|NCT01183559|Tubulin Modulators|tubulin modulators|mesh-ancestor
92240510|NCT01183559|Antimitotic Agents|antimitotic agents|mesh-ancestor
92240511|NCT01183559|Mitosis Modulators|mitosis modulators|mesh-ancestor
92240512|NCT01183559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240513|NCT01183559|Antimetabolites|antimetabolites|mesh-ancestor
92240514|NCT01183559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92240515|NCT01183559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240516|NCT01183559|Immunologic Factors|immunologic factors|mesh-ancestor
92240517|NCT01183559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240518|NCT01184417|Phenobarbital|phenobarbital|mesh-list
92240519|NCT01184417|Anticonvulsants|anticonvulsants|mesh-ancestor
92240520|NCT01184417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92240521|NCT01184417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240522|NCT01184417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240523|NCT01184417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91925155|NCT01188187|Hormones|hormones|mesh-ancestor
92240524|NCT01184417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92240525|NCT01184417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240526|NCT01184417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240527|NCT01184417|GABA Modulators|gaba modulators|mesh-ancestor
92240528|NCT01184417|GABA Agents|gaba agents|mesh-ancestor
92240529|NCT01184417|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92240530|NCT01184417|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92240531|NCT01184417|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92240532|NCT01159067|Deferasirox|deferasirox|mesh-list
92240533|NCT01159067|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92240534|NCT01159067|Chelating Agents|chelating agents|mesh-ancestor
92240535|NCT01159067|Sequestering Agents|sequestering agents|mesh-ancestor
92240536|NCT01159067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240537|NCT01222091|Propranolol|propranolol|mesh-list
92240538|NCT01222091|Remifentanil|remifentanil|mesh-list
92240539|NCT01222091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92240540|NCT01222091|Narcotics|narcotics|mesh-ancestor
92240541|NCT01222091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240542|NCT01222091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240543|NCT01222091|Analgesics|analgesics|mesh-ancestor
92240544|NCT01222091|Sensory System Agents|sensory system agents|mesh-ancestor
92240545|NCT01222091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240546|NCT01222091|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92240547|NCT01222091|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92240548|NCT01222091|Adrenergic Agents|adrenergic agents|mesh-ancestor
92240549|NCT01222091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240550|NCT01222091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240551|NCT01222091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92240552|NCT01222091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92240553|NCT01222091|Vasodilator Agents|vasodilator agents|mesh-ancestor
92240554|NCT01225055|Teriparatide|teriparatide|mesh-list
92240555|NCT01225055|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92240556|NCT01225055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240557|NCT01225055|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92240558|NCT01336140|Aminophylline|aminophylline|mesh-list
92240559|NCT01336140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92240560|NCT01336140|Autonomic Agents|autonomic agents|mesh-ancestor
92240561|NCT01336140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240562|NCT01336140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240563|NCT01336140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92240564|NCT01336140|Respiratory System Agents|respiratory system agents|mesh-ancestor
92240565|NCT01336140|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92240566|NCT01336140|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92240567|NCT01336140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240568|NCT01336140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240569|NCT01336140|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92240570|NCT01336140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92240571|NCT01336140|Purinergic Agents|purinergic agents|mesh-ancestor
92240572|NCT01336140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240573|NCT01336140|Protective Agents|protective agents|mesh-ancestor
92240575|NCT01184885|Cyclophosphamide|cyclophosphamide|mesh-list
92240576|NCT01184885|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92240577|NCT01184885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240578|NCT01184885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240579|NCT01184885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240580|NCT01184885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240581|NCT01184885|Antifungal Agents|antifungal agents|mesh-ancestor
92240582|NCT01184885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240583|NCT01184885|Immunologic Factors|immunologic factors|mesh-ancestor
92240584|NCT01184885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240585|NCT01184885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240586|NCT01184885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92240587|NCT01184885|Alkylating Agents|alkylating agents|mesh-ancestor
92240588|NCT01184885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92240589|NCT01187381|Trastuzumab|trastuzumab|mesh-list
92240590|NCT01187381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240591|NCT01187381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240592|NCT01225289|Vitamin A|vitamin a|mesh-list
92240593|NCT01225289|Retinol palmitate|retinol palmitate|mesh-list
92240594|NCT01225289|Vitamins|vitamins|mesh-ancestor
92240595|NCT01225289|Micronutrients|micronutrients|mesh-ancestor
92240596|NCT01225289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240597|NCT01225289|Antioxidants|antioxidants|mesh-ancestor
92240598|NCT01225289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240599|NCT01225289|Protective Agents|protective agents|mesh-ancestor
92240600|NCT01225289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92240601|NCT01225289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240602|NCT01161563|Leuprolide|leuprolide|mesh-list
92240603|NCT01161563|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92240604|NCT01161563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92240605|NCT01161563|Fertility Agents|fertility agents|mesh-ancestor
92240606|NCT01161563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92240607|NCT01161563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240608|NCT01161563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92240609|NCT01161563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240610|NCT01161563|Luteolytic Agents|luteolytic agents|mesh-ancestor
92240611|NCT01161563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92240612|NCT01161563|Contraceptive Agents|contraceptive agents|mesh-ancestor
92240613|NCT01161563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92240614|NCT01189409|Sennosides|sennosides|mesh-list
92240615|NCT01189409|Laxatives|laxatives|mesh-ancestor
92240616|NCT01189409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240617|NCT03010475|Furosemide|furosemide|mesh-list
92240618|NCT03010475|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92240619|NCT03010475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92240620|NCT03010475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92240621|NCT03010475|Antimetabolites|antimetabolites|mesh-ancestor
92240622|NCT03010475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240623|NCT03010475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92240624|NCT03010475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92240625|NCT03010475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240626|NCT03010475|Diuretics|diuretics|mesh-ancestor
92240627|NCT03010475|Natriuretic Agents|natriuretic agents|mesh-ancestor
92240628|NCT03010475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240629|NCT03010475|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92240630|NCT03010475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92240631|NCT02191865|Nintedanib|nintedanib|mesh-list
92240632|NCT02191865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240633|NCT02191865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92240634|NCT02191865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240635|NCT02191865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240636|NCT04352465|Methotrexate|methotrexate|mesh-list
92240637|NCT04352465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92240638|NCT04352465|Abortifacient Agents|abortifacient agents|mesh-ancestor
92240639|NCT04352465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92240640|NCT04352465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240641|NCT04352465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92240642|NCT04352465|Antimetabolites|antimetabolites|mesh-ancestor
92240643|NCT04352465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240645|NCT04352465|Dermatologic Agents|dermatologic agents|mesh-ancestor
92240646|NCT04352465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240647|NCT04352465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92240648|NCT04352465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240649|NCT04352465|Immunologic Factors|immunologic factors|mesh-ancestor
92240650|NCT04352465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240651|NCT04352465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92240652|NCT01191749|Alemtuzumab|alemtuzumab|mesh-list
92240653|NCT01191749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240654|NCT01191749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240655|NCT00343460|Dexamethasone|dexamethasone|mesh-list
92240656|NCT00343460|Palonosetron|palonosetron|mesh-list
92240657|NCT00343460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240658|NCT00343460|Antiemetics|antiemetics|mesh-ancestor
92240659|NCT00343460|Autonomic Agents|autonomic agents|mesh-ancestor
92240660|NCT00343460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240661|NCT00343460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240662|NCT00343460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240663|NCT00343460|Glucocorticoids|glucocorticoids|mesh-ancestor
92240664|NCT00343460|Hormones|hormones|mesh-ancestor
92240665|NCT00343460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240666|NCT00343460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92240667|NCT00343460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240668|NCT00343460|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92240669|NCT00343460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92240670|NCT00343460|Serotonin Agents|serotonin agents|mesh-ancestor
92240671|NCT00343460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240672|NCT00343460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240673|NCT04934696|Contraceptive Agents|contraceptive agents|mesh-list
92240674|NCT04934696|Contraceptives, Oral|contraceptives, oral|mesh-list
92240675|NCT04934696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92240676|NCT04934696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240677|NCT04934696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92240678|NCT01192139|Metformin|metformin|mesh-list
92240679|NCT01192139|Saxagliptin|saxagliptin|mesh-list
92240680|NCT01192139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92240681|NCT01192139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240682|NCT01192139|Incretins|incretins|mesh-ancestor
92240683|NCT01192139|Hormones|hormones|mesh-ancestor
92240684|NCT01192139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240685|NCT01192139|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92240686|NCT01192139|Protease Inhibitors|protease inhibitors|mesh-ancestor
92240687|NCT01192139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240688|NCT01192139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240689|NCT04892186|Inositol|inositol|mesh-list
92240690|NCT04892186|Metformin|metformin|mesh-list
92240691|NCT04892186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92240692|NCT04892186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240693|NCT04892186|Vitamin B Complex|vitamin b complex|mesh-ancestor
92240694|NCT04892186|Vitamins|vitamins|mesh-ancestor
92240695|NCT04892186|Micronutrients|micronutrients|mesh-ancestor
92240696|NCT01229423|Bimatoprost|bimatoprost|mesh-list
92240697|NCT01229423|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92240698|NCT01229891|Vitamin D|vitamin d|mesh-list
92240699|NCT01229891|Ergocalciferols|ergocalciferols|mesh-list
92240700|NCT01229891|Cholecalciferol|cholecalciferol|mesh-list
92240701|NCT01229891|Vitamins|vitamins|mesh-list
92240702|NCT01229891|Micronutrients|micronutrients|mesh-ancestor
92240703|NCT01229891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240704|NCT01229891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92240705|NCT01229891|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92240706|NCT01283555|Tenofovir|tenofovir|mesh-list
92240707|NCT01283555|Antiviral Agents|antiviral agents|mesh-ancestor
92240708|NCT01283555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240709|NCT01283555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92240710|NCT01283555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92240711|NCT01283555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934614|NCT03737123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92340553|NCT00002627|Alkylating Agents|alkylating agents|mesh-ancestor
92240712|NCT01283555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240714|NCT01283555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92240715|NCT01194089|Nicotine|nicotine|mesh-list
92240716|NCT01194089|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92240717|NCT01194089|Autonomic Agents|autonomic agents|mesh-ancestor
92240718|NCT01194089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240719|NCT01194089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240720|NCT01194089|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92240721|NCT01194089|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92240722|NCT01194089|Cholinergic Agents|cholinergic agents|mesh-ancestor
92240723|NCT01194089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240724|NCT01194089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240725|NCT01650350|Naltrexone|naltrexone|mesh-list
92240726|NCT01650350|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92240727|NCT01650350|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92240728|NCT01650350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240729|NCT01650350|Sensory System Agents|sensory system agents|mesh-ancestor
92240730|NCT01650350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240731|NCT00349388|Mesalamine|mesalamine|mesh-list
92240732|NCT00349388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92240733|NCT00349388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92240734|NCT00349388|Analgesics|analgesics|mesh-ancestor
92240735|NCT00349388|Sensory System Agents|sensory system agents|mesh-ancestor
92240736|NCT00349388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240737|NCT00349388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240738|NCT00349388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240739|NCT00349388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240740|NCT00349778|Cyclophosphamide|cyclophosphamide|mesh-list
92240741|NCT00349778|Melphalan|melphalan|mesh-list
92240742|NCT00349778|Carmustine|carmustine|mesh-list
92240743|NCT00349778|Etoposide|etoposide|mesh-list
92240744|NCT00349778|Etoposide phosphate|etoposide phosphate|mesh-list
92240745|NCT00349778|Lenograstim|lenograstim|mesh-list
92240746|NCT00349778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240747|NCT00349778|Immunologic Factors|immunologic factors|mesh-ancestor
92240748|NCT00349778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240749|NCT00349778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925306|NCT01156753|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
92240750|NCT00349778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92240751|NCT00349778|Alkylating Agents|alkylating agents|mesh-ancestor
92240752|NCT00349778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240753|NCT00349778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240754|NCT00349778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92240755|NCT00349778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92240756|NCT00349778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92240757|NCT00349778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92240758|NCT00349778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240759|NCT00349778|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92240760|NCT00305084|Doxorubicin|doxorubicin|mesh-list
92240761|NCT00305084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92240762|NCT00305084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240763|NCT00305084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92240764|NCT00305084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92240765|NCT00305084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240766|NCT00305084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240767|NCT00305162|Clopidogrel|clopidogrel|mesh-list
92240768|NCT00305162|Cangrelor|cangrelor|mesh-list
92240769|NCT00305162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92240770|NCT00305162|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92240771|NCT00305162|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92240772|NCT00305162|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92240773|NCT00305162|Purinergic Agents|purinergic agents|mesh-ancestor
92240774|NCT00305162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240775|NCT00305162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240776|NCT00305162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240777|NCT00351416|Letrozole|letrozole|mesh-list
92240778|NCT00351416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92240779|NCT00351416|LHRH, N-Ac-2-Nal(1)-4-Cl-Phe(2)-3-Pal(3)-Arg(5)-Glu(6)-AlaNH2(10)-|lhrh, n-ac-2-nal(1)-4-cl-phe(2)-3-pal(3)-arg(5)-glu(6)-alanh2(10)-|mesh-list
92240780|NCT00351416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240781|NCT00351416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92240782|NCT00351416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240783|NCT00351416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240784|NCT00351416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92240785|NCT00351416|Hormone Antagonists|hormone antagonists|mesh-ancestor
92240786|NCT00351416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240787|NCT00351416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240788|NCT00305942|Carboplatin|carboplatin|mesh-list
92240790|NCT00305942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240791|NCT00305942|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92240792|NCT00305942|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92240793|NCT00305942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240794|NCT00305942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240795|NCT00352976|Mycophenolic Acid|mycophenolic acid|mesh-list
92240796|NCT00352976|Sirolimus|sirolimus|mesh-list
92240797|NCT00352976|Cyclophosphamide|cyclophosphamide|mesh-list
92240798|NCT00352976|Fludarabine|fludarabine|mesh-list
92240799|NCT00352976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240800|NCT00352976|Immunologic Factors|immunologic factors|mesh-ancestor
92240801|NCT00352976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240802|NCT00352976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240803|NCT00352976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92240804|NCT00352976|Alkylating Agents|alkylating agents|mesh-ancestor
92240805|NCT00352976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240806|NCT00352976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240807|NCT00352976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92240808|NCT00352976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92240809|NCT00352976|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92240810|NCT00352976|Antitubercular Agents|antitubercular agents|mesh-ancestor
92240811|NCT00352976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240812|NCT00352976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240813|NCT00352976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240814|NCT00352976|Antifungal Agents|antifungal agents|mesh-ancestor
92240815|NCT00306488|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92240817|NCT00306488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92240818|NCT00306488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240819|NCT00306488|Protective Agents|protective agents|mesh-ancestor
92240820|NCT00306488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240821|NCT01793636|Everolimus|everolimus|mesh-list
92240822|NCT01793636|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92240823|NCT01793636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92240824|NCT01793636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240825|NCT01793636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240826|NCT01793636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240827|NCT01793636|Immunologic Factors|immunologic factors|mesh-ancestor
92240828|NCT01793636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240829|NCT01793636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240830|NCT00353522|Dalcetrapib|dalcetrapib|mesh-list
92240832|NCT00353522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92240833|NCT00353522|Antimetabolites|antimetabolites|mesh-ancestor
92240834|NCT00353522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240835|NCT00353522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92240836|NCT00310076|Thalidomide|thalidomide|mesh-list
92240837|NCT00310076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92240838|NCT00310076|Immunologic Factors|immunologic factors|mesh-ancestor
92240839|NCT00310076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240840|NCT00310076|Leprostatic Agents|leprostatic agents|mesh-ancestor
92240841|NCT00310076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240842|NCT00310076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240843|NCT00310076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92240844|NCT00310076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92240845|NCT00310076|Growth Substances|growth substances|mesh-ancestor
92240846|NCT00310076|Growth Inhibitors|growth inhibitors|mesh-ancestor
92240847|NCT00310076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240848|NCT00353834|Insulin|insulin|mesh-list
92240849|NCT00353834|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92240850|NCT00353834|Insulin Glargine|insulin glargine|mesh-list
92240851|NCT00353834|Exenatide|exenatide|mesh-list
92240852|NCT00353834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92240853|NCT00353834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240854|NCT00353834|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92240855|NCT00353834|Incretins|incretins|mesh-ancestor
92240856|NCT00353834|Hormones|hormones|mesh-ancestor
91934621|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240857|NCT00353834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92240858|NCT05344404|Niacinamide|niacinamide|mesh-list
92240859|NCT05344404|Niacin|niacin|mesh-list
92240860|NCT05344404|Nicotinic Acids|nicotinic acids|mesh-list
92240861|NCT05344404|Vitamin B Complex|vitamin b complex|mesh-ancestor
92240862|NCT05344404|Vitamins|vitamins|mesh-ancestor
92240863|NCT05344404|Micronutrients|micronutrients|mesh-ancestor
92240864|NCT05344404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240865|NCT05344404|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92240866|NCT05344404|Antimetabolites|antimetabolites|mesh-ancestor
92240867|NCT05344404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240868|NCT05344404|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92240869|NCT05344404|Vasodilator Agents|vasodilator agents|mesh-ancestor
92240870|NCT00354224|Capecitabine|capecitabine|mesh-list
92240871|NCT00354224|Oxaliplatin|oxaliplatin|mesh-list
92240872|NCT00354224|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92240873|NCT00354224|Antimetabolites|antimetabolites|mesh-ancestor
92240874|NCT00354224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240875|NCT00354224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240876|NCT01792388|Vitamin D|vitamin d|mesh-list
92240877|NCT01792388|Vitamins|vitamins|mesh-ancestor
92240878|NCT01792388|Micronutrients|micronutrients|mesh-ancestor
92240879|NCT01792388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240880|NCT01792388|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92240881|NCT05395104|Midazolam|midazolam|mesh-list
92240882|NCT05395104|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92340674|NCT00002675|Alkylating Agents|alkylating agents|mesh-ancestor
92240883|NCT05395104|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92240884|NCT05395104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240885|NCT05395104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240886|NCT05395104|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92240887|NCT05395104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92240888|NCT05395104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92240889|NCT05395104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92240890|NCT05395104|Anesthetics, General|anesthetics, general|mesh-ancestor
92240891|NCT05395104|Anesthetics|anesthetics|mesh-ancestor
92240892|NCT05395104|GABA Modulators|gaba modulators|mesh-ancestor
92240893|NCT05395104|GABA Agents|gaba agents|mesh-ancestor
92240894|NCT05395104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240895|NCT05395104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240896|NCT01793870|Carvedilol|carvedilol|mesh-list
92240897|NCT01793870|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92240898|NCT01793870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92240899|NCT01793870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92240900|NCT01793870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240901|NCT01793870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240902|NCT01793870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240903|NCT01793870|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92240904|NCT01793870|Antioxidants|antioxidants|mesh-ancestor
92240905|NCT01793870|Protective Agents|protective agents|mesh-ancestor
92240906|NCT01793870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92240907|NCT01793870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92240908|NCT01793870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92240909|NCT01793870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92240910|NCT01793870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92240911|NCT01793870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92240912|NCT01793948|Metformin|metformin|mesh-list
92240913|NCT01793948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92240914|NCT01793948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240915|NCT00310466|Immunomodulating Agents|immunomodulating agents|mesh-list
92240916|NCT00310466|Immunologic Factors|immunologic factors|mesh-ancestor
92240917|NCT00310466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240918|NCT00355394|Metoclopramide|metoclopramide|mesh-list
92240919|NCT00355394|Antiemetics|antiemetics|mesh-ancestor
92240920|NCT00355394|Autonomic Agents|autonomic agents|mesh-ancestor
92240921|NCT00355394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240922|NCT00355394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240923|NCT00355394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240924|NCT00355394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92240925|NCT00355394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92240926|NCT00355394|Dopamine Agents|dopamine agents|mesh-ancestor
92240927|NCT00355394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240928|NCT00355394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240929|NCT00311246|Adalimumab|adalimumab|mesh-list
92240930|NCT00311246|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92240931|NCT00311246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92240932|NCT00311246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92240934|NCT02105324|Pancreatin|pancreatin|mesh-list
92240935|NCT02105324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240936|NCT02105558|Anesthetics|anesthetics|mesh-list
92240937|NCT02105558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92240938|NCT02105558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240939|NCT02106962|Bacitracin|bacitracin|mesh-list
92240940|NCT02106962|Tranexamic Acid|tranexamic acid|mesh-list
92240941|NCT02106962|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92240942|NCT02106962|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92240943|NCT02106962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240944|NCT02106962|Hemostatics|hemostatics|mesh-ancestor
92240945|NCT02106962|Coagulants|coagulants|mesh-ancestor
92240946|NCT02106962|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92240947|NCT02106962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240948|NCT02106962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240949|NCT00315146|Pioglitazone|pioglitazone|mesh-list
92240950|NCT00315146|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92240951|NCT00315146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240952|NCT01792700|Amoxicillin|amoxicillin|mesh-list
92240953|NCT01792700|Moxifloxacin|moxifloxacin|mesh-list
92240954|NCT01792700|Metronidazole|metronidazole|mesh-list
92240955|NCT01792700|Tetracycline|tetracycline|mesh-list
92240956|NCT01792700|Esomeprazole|esomeprazole|mesh-list
92240957|NCT01792700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92240958|NCT01792700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92240959|NCT01792700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92240960|NCT01792700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92240961|NCT01792700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240962|NCT01792700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240963|NCT01792700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240964|NCT01792700|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92240965|NCT01792700|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92240966|NCT01792700|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92240967|NCT01792700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92240968|NCT01792700|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92240969|NCT01792700|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92240970|NCT00315302|Atropine|atropine|mesh-list
92240971|NCT00315302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92240972|NCT00315302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92240973|NCT00315302|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92240974|NCT00315302|Autonomic Agents|autonomic agents|mesh-ancestor
92240975|NCT00315302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92240976|NCT00315302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92240977|NCT00315302|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92240978|NCT00315302|Respiratory System Agents|respiratory system agents|mesh-ancestor
92240980|NCT00315302|Parasympatholytics|parasympatholytics|mesh-ancestor
92240981|NCT00315302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92240982|NCT00315302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92240983|NCT00315302|Cholinergic Agents|cholinergic agents|mesh-ancestor
92240984|NCT00315302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92240985|NCT00315302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240986|NCT00316862|Irinotecan|irinotecan|mesh-list
92240987|NCT00316862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240988|NCT00316862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92240989|NCT00316862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92240990|NCT00316862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240991|NCT00316862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92240992|NCT00317720|Trastuzumab|trastuzumab|mesh-list
92240993|NCT00317720|Everolimus|everolimus|mesh-list
92240994|NCT00317720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92240995|NCT00317720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92240996|NCT00317720|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92240997|NCT00317720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92240998|NCT00317720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92240999|NCT00317720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241000|NCT00317720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241001|NCT00317720|Immunologic Factors|immunologic factors|mesh-ancestor
92241002|NCT00317720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241003|NCT00357032|Belinostat|belinostat|mesh-list
92241004|NCT00357032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241005|NCT00357032|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92241006|NCT00357032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241007|NCT00357032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241008|NCT00357734|Gefitinib|gefitinib|mesh-list
92241009|NCT00357734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241010|NCT00357734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241011|NCT00357734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241012|NCT00357734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241013|NCT00318812|Iron|iron|mesh-list
92241014|NCT00318812|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92241015|NCT00318812|Trace Elements|trace elements|mesh-ancestor
92241016|NCT00318812|Micronutrients|micronutrients|mesh-ancestor
92241017|NCT00318812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241018|NCT00318812|Hematinics|hematinics|mesh-ancestor
92241019|NCT00362882|Docetaxel|docetaxel|mesh-list
92241020|NCT00362882|Bortezomib|bortezomib|mesh-list
92241021|NCT00362882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241022|NCT00362882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92241023|NCT00362882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92241024|NCT00362882|Mitosis Modulators|mitosis modulators|mesh-ancestor
92241025|NCT00362882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241026|NCT00365144|Bevacizumab|bevacizumab|mesh-list
92241027|NCT00365144|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92241028|NCT00365144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241029|NCT00365144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241030|NCT00365144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92241031|NCT00365144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92241032|NCT00365144|Growth Substances|growth substances|mesh-ancestor
92241033|NCT00365144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241034|NCT00365144|Growth Inhibitors|growth inhibitors|mesh-ancestor
92241035|NCT00365144|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241036|NCT00365144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241037|NCT00365144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241038|NCT05339022|Coal Tar|coal tar|mesh-list
92241039|NCT05339022|Keratolytic Agents|keratolytic agents|mesh-ancestor
92241040|NCT05339022|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241041|NCT00366626|Naltrexone|naltrexone|mesh-list
92241042|NCT00366626|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92241043|NCT00366626|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92241044|NCT00366626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241045|NCT00366626|Sensory System Agents|sensory system agents|mesh-ancestor
92241046|NCT00366626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241047|NCT00367016|Omalizumab|omalizumab|mesh-list
92241048|NCT00367016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92241049|NCT00367016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92340809|NCT00002765|Immunotoxins|immunotoxins|mesh-list
92241050|NCT00367016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92241052|NCT04422678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241053|NCT04422678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241054|NCT04422678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241055|NCT04422678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241056|NCT00573378|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92241057|NCT00573378|Antiviral Agents|antiviral agents|mesh-ancestor
92241058|NCT00573378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241059|NCT05334654|Enoxaparin|enoxaparin|mesh-list
92241060|NCT05334654|Enoxaparin sodium|enoxaparin sodium|mesh-list
92241062|NCT05334654|Anticoagulants|anticoagulants|mesh-ancestor
92241063|NCT05334654|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92241064|NCT05334654|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92241065|NCT05334654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241066|NCT05334654|Antithrombins|antithrombins|mesh-ancestor
92241067|NCT05334654|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92241068|NCT05334654|Protease Inhibitors|protease inhibitors|mesh-ancestor
92241069|NCT05334654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241070|NCT03561584|Sulfasalazine|sulfasalazine|mesh-list
92241071|NCT03561584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241072|NCT03561584|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92241073|NCT03561584|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92241074|NCT03561584|Analgesics|analgesics|mesh-ancestor
92241075|NCT03561584|Sensory System Agents|sensory system agents|mesh-ancestor
92241076|NCT03561584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241077|NCT03561584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241078|NCT03561584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241079|NCT03561584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241080|NCT03561584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92241081|NCT00369512|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92241082|NCT00369512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241083|NCT00369512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241084|NCT00369512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241085|NCT00369512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241086|NCT00324272|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92241087|NCT00324272|Hemostatics|hemostatics|mesh-ancestor
92241088|NCT00324272|Coagulants|coagulants|mesh-ancestor
92241089|NCT00369590|Aflibercept|aflibercept|mesh-list
92241090|NCT00369590|Endothelial Growth Factors|endothelial growth factors|mesh-list
92241091|NCT00369590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92241092|NCT00369590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92340852|NCT00002783|Leucovorin|leucovorin|mesh-list
92241093|NCT00369590|Growth Substances|growth substances|mesh-ancestor
92241094|NCT00369590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241095|NCT00369590|Growth Inhibitors|growth inhibitors|mesh-ancestor
92241096|NCT00369590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241097|NCT03932136|Sulforaphane|sulforaphane|mesh-list
92241098|NCT03932136|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92241099|NCT03932136|Protective Agents|protective agents|mesh-ancestor
92241100|NCT03932136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241101|NCT03932136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241102|NCT00324350|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92241103|NCT00324350|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92241104|NCT00324350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241105|NCT00324350|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92241106|NCT00324350|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92241107|NCT00324350|Antimetabolites|antimetabolites|mesh-ancestor
92241108|NCT00324350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241109|NCT00324350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241110|NCT00324350|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92241111|NCT00390182|Gemcitabine|gemcitabine|mesh-list
92241112|NCT00390182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92241113|NCT00390182|Antimetabolites|antimetabolites|mesh-ancestor
92241114|NCT00390182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241115|NCT00390182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241116|NCT05366868|Metformin|metformin|mesh-list
92241117|NCT05366868|Vildagliptin|vildagliptin|mesh-list
92241118|NCT05366868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92241119|NCT05366868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241120|NCT05366868|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92241121|NCT05366868|Protease Inhibitors|protease inhibitors|mesh-ancestor
92241122|NCT05366868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241123|NCT05366868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241124|NCT05610774|Dexmedetomidine|dexmedetomidine|mesh-list
92241125|NCT05610774|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92241126|NCT05610774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241127|NCT05610774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241128|NCT05610774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92241129|NCT05610774|Analgesics|analgesics|mesh-ancestor
92241130|NCT05610774|Sensory System Agents|sensory system agents|mesh-ancestor
92241131|NCT05610774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241132|NCT05610774|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92241133|NCT05610774|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92241134|NCT05610774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92241135|NCT05610774|Adrenergic Agents|adrenergic agents|mesh-ancestor
92241136|NCT05610774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241137|NCT05610774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241138|NCT00369746|Citalopram|citalopram|mesh-list
92241139|NCT00369746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92241140|NCT00369746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92241141|NCT00369746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92241142|NCT00369746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241143|NCT00369746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241144|NCT00369746|Serotonin Agents|serotonin agents|mesh-ancestor
92241145|NCT00369746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241146|NCT00369746|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92241147|NCT00369746|Antidepressive Agents|antidepressive agents|mesh-ancestor
92241148|NCT00369746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241149|NCT00392054|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92241150|NCT02525874|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92241151|NCT02525874|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241152|NCT02525874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241153|NCT02525874|Immunologic Factors|immunologic factors|mesh-ancestor
92241154|NCT02525874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241156|NCT05329428|Ergocalciferols|ergocalciferols|mesh-list
92241157|NCT05329428|Cholecalciferol|cholecalciferol|mesh-list
92241159|NCT05329428|Micronutrients|micronutrients|mesh-ancestor
92241160|NCT05329428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241161|NCT05329428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91993406|NCT03163849|Sofosbuvir|sofosbuvir|mesh-list
92241162|NCT05329428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92241163|NCT01794572|Melphalan|melphalan|mesh-list
92241164|NCT01794572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241165|NCT01794572|Alkylating Agents|alkylating agents|mesh-ancestor
92241166|NCT01794572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241167|NCT01794572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241168|NCT01794572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92241169|NCT01794572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241170|NCT01794572|Immunologic Factors|immunologic factors|mesh-ancestor
92241171|NCT01794572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241172|NCT05385432|Mycophenolic Acid|mycophenolic acid|mesh-list
92241173|NCT05385432|Tacrolimus|tacrolimus|mesh-list
92241174|NCT05385432|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92241175|NCT05385432|Basiliximab|basiliximab|mesh-list
92241176|NCT05385432|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92241177|NCT05385432|Thymoglobulin|thymoglobulin|mesh-list
92241178|NCT05385432|Immunologic Factors|immunologic factors|mesh-ancestor
92241179|NCT05385432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241180|NCT05385432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92241181|NCT05385432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241182|NCT05385432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241183|NCT05385432|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92241184|NCT05385432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241185|NCT05385432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92241186|NCT05385432|Antitubercular Agents|antitubercular agents|mesh-ancestor
92241187|NCT05385432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241188|NCT05385432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241189|NCT00392444|Sunitinib|sunitinib|mesh-list
92241190|NCT00392444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241191|NCT00392444|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92241192|NCT00392444|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92241193|NCT00392444|Growth Substances|growth substances|mesh-ancestor
92241194|NCT00392444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241195|NCT00392444|Growth Inhibitors|growth inhibitors|mesh-ancestor
92241196|NCT00392444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241197|NCT00392444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241198|NCT00392444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241199|NCT02528214|Prednisone|prednisone|mesh-list
92241200|NCT02528214|Prednisolone|prednisolone|mesh-list
92241201|NCT02528214|Albuterol|albuterol|mesh-list
92241202|NCT02528214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241203|NCT02528214|Glucocorticoids|glucocorticoids|mesh-ancestor
92241204|NCT02528214|Hormones|hormones|mesh-ancestor
91925307|NCT01156753|Immunoconjugates|immunoconjugates|mesh-ancestor
92241205|NCT02528214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241206|NCT02528214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241207|NCT02528214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92241208|NCT02528214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241209|NCT02528214|Autonomic Agents|autonomic agents|mesh-ancestor
92241210|NCT02528214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241212|NCT02528214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92241213|NCT02528214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92241214|NCT02528214|Tocolytic Agents|tocolytic agents|mesh-ancestor
92241215|NCT02528214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92241216|NCT02528214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92241217|NCT02528214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92241218|NCT02528214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92241219|NCT02528214|Adrenergic Agents|adrenergic agents|mesh-ancestor
92241220|NCT02528214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241221|NCT02528214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241222|NCT00392678|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92241223|NCT00392678|Sodium Salicylate|sodium salicylate|mesh-list
92241224|NCT00392678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92241225|NCT00392678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92241226|NCT00392678|Analgesics|analgesics|mesh-ancestor
92241227|NCT00392678|Sensory System Agents|sensory system agents|mesh-ancestor
92241228|NCT00392678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241229|NCT00392678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241230|NCT00392678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241231|NCT00392678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241232|NCT00392678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92241233|NCT00392678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241234|NCT00392678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241235|NCT05902299|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92241236|NCT05902299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241237|NCT05902260|Immunomodulating Agents|immunomodulating agents|mesh-list
92241238|NCT05902260|Immunologic Factors|immunologic factors|mesh-ancestor
92241239|NCT05902260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241240|NCT05902221|Amoxicillin|amoxicillin|mesh-list
92241241|NCT05902221|Moxifloxacin|moxifloxacin|mesh-list
92241242|NCT05902221|Rifampin|rifampin|mesh-list
92241243|NCT05902221|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92241244|NCT05902221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241245|NCT05902221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241246|NCT05902221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92241247|NCT05902221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92241248|NCT05902221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241249|NCT05902221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241250|NCT05902221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241251|NCT05902221|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92241252|NCT05902221|Contraceptive Agents|contraceptive agents|mesh-ancestor
92241253|NCT05902221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92241254|NCT05902221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241255|NCT05902221|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92241256|NCT05902221|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92241257|NCT05902221|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92241258|NCT05902221|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92241259|NCT05902221|Antitubercular Agents|antitubercular agents|mesh-ancestor
92241260|NCT05902221|Leprostatic Agents|leprostatic agents|mesh-ancestor
92241261|NCT05902221|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92241262|NCT05902221|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92241263|NCT05902221|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92241264|NCT05902221|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92241265|NCT05902221|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92241266|NCT05902221|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92241267|NCT05902221|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92241268|NCT05902208|Antiviral Agents|antiviral agents|mesh-list
92241269|NCT05902208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241270|NCT05902169|Carboplatin|carboplatin|mesh-list
92241271|NCT05902169|Temozolomide|temozolomide|mesh-list
92241272|NCT05902169|Lomustine|lomustine|mesh-list
92241273|NCT05902169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241274|NCT05902169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241275|NCT05902169|Alkylating Agents|alkylating agents|mesh-ancestor
92241276|NCT05902169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241277|NCT05902078|Calcitriol|calcitriol|mesh-list
92241278|NCT05902078|Eldecalcitol|eldecalcitol|mesh-list
92241279|NCT05902078|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92241280|NCT05902078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241281|NCT05902078|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92241283|NCT05902078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241284|NCT05902078|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92241285|NCT05902078|Vitamins|vitamins|mesh-ancestor
92241286|NCT05902078|Micronutrients|micronutrients|mesh-ancestor
92241287|NCT05902078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92241288|NCT05901935|Capecitabine|capecitabine|mesh-list
92241289|NCT05901935|Trastuzumab|trastuzumab|mesh-list
92241290|NCT05901935|Vinorelbine|vinorelbine|mesh-list
92241291|NCT05901935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92241292|NCT05901935|Antimetabolites|antimetabolites|mesh-ancestor
92241293|NCT05901935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241294|NCT05901935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241295|NCT05901935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241296|NCT05901935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92241297|NCT05901935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92241298|NCT05901935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92241299|NCT05901935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92241300|NCT05901766|Micronutrients|micronutrients|mesh-list
92241301|NCT05901766|Trace Elements|trace elements|mesh-list
92241302|NCT05901766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241303|NCT05901701|Salicylic Acid|salicylic acid|mesh-list
92241304|NCT05901701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241305|NCT05901701|Antifungal Agents|antifungal agents|mesh-ancestor
92241306|NCT05901701|Keratolytic Agents|keratolytic agents|mesh-ancestor
92241307|NCT05901701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241308|NCT05901571|Dexetimide|dexetimide|mesh-list
92241309|NCT05901571|Citalopram|citalopram|mesh-list
92241310|NCT05901571|Escitalopram|escitalopram|mesh-list
92241311|NCT05901571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92241312|NCT05901571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92241313|NCT05901571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92241314|NCT05901571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241315|NCT05901571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241316|NCT05901571|Serotonin Agents|serotonin agents|mesh-ancestor
92241317|NCT05901571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241318|NCT05901571|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92241319|NCT05901571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92241320|NCT05901571|Parasympatholytics|parasympatholytics|mesh-ancestor
92241321|NCT05901571|Autonomic Agents|autonomic agents|mesh-ancestor
92241322|NCT05901571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241323|NCT05901571|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92241324|NCT05901571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92241325|NCT05901571|Cholinergic Agents|cholinergic agents|mesh-ancestor
92241326|NCT05901571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92241327|NCT05901571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92241328|NCT05901571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241329|NCT05901545|Panitumumab|panitumumab|mesh-list
92241330|NCT05901545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241331|NCT05901545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241332|NCT05901454|Vaccines|vaccines|mesh-list
92241333|NCT05901454|Immunologic Factors|immunologic factors|mesh-ancestor
92241334|NCT05901454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241335|NCT05901441|Sufentanil|sufentanil|mesh-list
92241336|NCT05901441|Hydromorphone|hydromorphone|mesh-list
92241337|NCT05901441|Ropivacaine|ropivacaine|mesh-list
92241338|NCT05901441|Anesthetics, Local|anesthetics, local|mesh-ancestor
92241339|NCT05901441|Anesthetics|anesthetics|mesh-ancestor
92241340|NCT05901441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241341|NCT05901441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241342|NCT05901441|Sensory System Agents|sensory system agents|mesh-ancestor
92241343|NCT05901441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241344|NCT05901441|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92241345|NCT05901441|Narcotics|narcotics|mesh-ancestor
92241346|NCT05901441|Analgesics|analgesics|mesh-ancestor
92241347|NCT05901441|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92241348|NCT05901441|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92241349|NCT05901441|Anesthetics, General|anesthetics, general|mesh-ancestor
92241350|NCT05901389|Lidocaine|lidocaine|mesh-list
92241351|NCT05901389|Anesthetics, Local|anesthetics, local|mesh-ancestor
92241352|NCT05901389|Anesthetics|anesthetics|mesh-ancestor
92241353|NCT05901389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241354|NCT05901389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241355|NCT05901389|Sensory System Agents|sensory system agents|mesh-ancestor
92241356|NCT05901389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241357|NCT05901389|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92241358|NCT05901389|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92241359|NCT05901389|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92241360|NCT05901389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92241361|NCT05901389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241363|NCT05901194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241364|NCT05901194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241365|NCT05901194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241366|NCT05901194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241367|NCT05901051|Amoxicillin|amoxicillin|mesh-list
92241368|NCT05901051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241369|NCT05901051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241370|NCT05901012|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92241371|NCT05901012|Hallucinogens|hallucinogens|mesh-ancestor
92241372|NCT05901012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241373|NCT05901012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241374|NCT05901012|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92241375|NCT05901012|Serotonin Agents|serotonin agents|mesh-ancestor
92241376|NCT05901012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241377|NCT05901012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241378|NCT05901012|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92241379|NCT05900921|Paclitaxel|paclitaxel|mesh-list
92241380|NCT05900921|Carboplatin|carboplatin|mesh-list
92241381|NCT05900921|Tislelizumab|tislelizumab|mesh-list
92241382|NCT05900921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92241383|NCT05900921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241384|NCT05900921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92241385|NCT05900921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92241386|NCT05900921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92241387|NCT05900921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241388|NCT05900921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241389|NCT05900895|Olaparib|olaparib|mesh-list
92241390|NCT05900895|Estradiol|estradiol|mesh-list
92241391|NCT05900895|Estrogens|estrogens|mesh-ancestor
92241392|NCT05900895|Hormones|hormones|mesh-ancestor
92241393|NCT05900895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241394|NCT05900895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241395|NCT05900895|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92241396|NCT05900895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241397|NCT05900895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241398|NCT05900895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241399|NCT05900882|Dexamethasone|dexamethasone|mesh-list
92241400|NCT05900882|Lenalidomide|lenalidomide|mesh-list
92241401|NCT05900882|Bortezomib|bortezomib|mesh-list
92241402|NCT05900882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241403|NCT05900882|Antiemetics|antiemetics|mesh-ancestor
92241404|NCT05900882|Autonomic Agents|autonomic agents|mesh-ancestor
92241405|NCT05900882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241406|NCT05900882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241407|NCT05900882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92241408|NCT05900882|Glucocorticoids|glucocorticoids|mesh-ancestor
92241409|NCT05900882|Hormones|hormones|mesh-ancestor
92241410|NCT05900882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241411|NCT05900882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92241412|NCT05900882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241413|NCT05900882|Immunologic Factors|immunologic factors|mesh-ancestor
92241414|NCT05900882|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92241415|NCT05900882|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92241416|NCT05900882|Growth Substances|growth substances|mesh-ancestor
92241417|NCT05900882|Growth Inhibitors|growth inhibitors|mesh-ancestor
92241418|NCT05899699|Adapalene|adapalene|mesh-list
92241419|NCT05899699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92241420|NCT05899699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92241421|NCT05899699|Analgesics|analgesics|mesh-ancestor
92241422|NCT05899699|Sensory System Agents|sensory system agents|mesh-ancestor
92241423|NCT05899699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241424|NCT05899699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241425|NCT05899699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241426|NCT05899699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241427|NCT05899699|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241428|NCT05899608|Pembrolizumab|pembrolizumab|mesh-list
92241429|NCT05899608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241430|NCT05899608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241431|NCT05899608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92241432|NCT05899608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241434|NCT05898854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92241435|NCT05898854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241436|NCT05897151|Anesthetics|anesthetics|mesh-list
92241437|NCT05897151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241438|NCT05897151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241439|NCT05897138|Lenvatinib|lenvatinib|mesh-list
92241440|NCT05897138|Tislelizumab|tislelizumab|mesh-list
92340910|NCT00382343|Sulfamethoxazole|sulfamethoxazole|mesh-list
92241441|NCT05897138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241442|NCT05897138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241443|NCT05897138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241444|NCT05897138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241445|NCT05897138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241446|NCT05895162|Fluconazole|fluconazole|mesh-list
92241447|NCT05895162|Antifungal Agents|antifungal agents|mesh-ancestor
92241448|NCT05895162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241449|NCT05895162|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92241450|NCT05895162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92241451|NCT05895162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241452|NCT05895162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241453|NCT05895162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92241454|NCT05895162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92241455|NCT05895162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241456|NCT05895162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241457|NCT05895162|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92241458|NCT05895162|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92241460|NCT05894603|Nirmatrelvir|nirmatrelvir|mesh-list
92241461|NCT05894603|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92241462|NCT05894603|Molnupiravir|molnupiravir|mesh-list
92241463|NCT05894603|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92241464|NCT05894603|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92241465|NCT05894603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92241466|NCT05894603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241467|NCT05894603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241468|NCT05894603|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92241469|NCT05894603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92241470|NCT05894603|Antiviral Agents|antiviral agents|mesh-ancestor
92241471|NCT05894603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241472|NCT05894603|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92241473|NCT05894603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92241474|NCT05886335|Cyclophosphamide|cyclophosphamide|mesh-list
92241475|NCT05886335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241476|NCT05886335|Immunologic Factors|immunologic factors|mesh-ancestor
92241477|NCT05886335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241478|NCT05886335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241479|NCT05886335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241480|NCT05886335|Alkylating Agents|alkylating agents|mesh-ancestor
92241481|NCT05886335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241482|NCT05886335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241483|NCT05886335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92241484|NCT05877326|Anesthetics|anesthetics|mesh-list
92241485|NCT05877326|Propofol|propofol|mesh-list
92241486|NCT05877326|Sevoflurane|sevoflurane|mesh-list
92241487|NCT05877326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241488|NCT05877326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241489|NCT05877326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92241490|NCT05877326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92241491|NCT05877326|Anesthetics, General|anesthetics, general|mesh-ancestor
92241492|NCT05877326|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92241493|NCT05877326|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92241494|NCT05844332|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92241495|NCT05844332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92241496|NCT05844332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241497|NCT05837000|Magnesium Sulfate|magnesium sulfate|mesh-list
92241498|NCT05837000|Dexmedetomidine|dexmedetomidine|mesh-list
92241499|NCT05837000|Ketamine|ketamine|mesh-list
92241500|NCT05837000|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92241501|NCT05837000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241502|NCT05837000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241503|NCT05837000|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92241504|NCT05837000|Analgesics|analgesics|mesh-ancestor
92241505|NCT05837000|Sensory System Agents|sensory system agents|mesh-ancestor
92241506|NCT05837000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241507|NCT05837000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92241508|NCT05837000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92241509|NCT05837000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92241510|NCT05837000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92241511|NCT05837000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241512|NCT05837000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241513|NCT05837000|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92241514|NCT05837000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92241515|NCT05837000|Anesthetics, General|anesthetics, general|mesh-ancestor
92241516|NCT05837000|Anesthetics|anesthetics|mesh-ancestor
92241517|NCT05837000|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92241518|NCT05837000|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92241519|NCT05837000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92241520|NCT05837000|Anticonvulsants|anticonvulsants|mesh-ancestor
92241521|NCT05837000|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92241522|NCT05837000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92241523|NCT05837000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92241524|NCT05837000|Tocolytic Agents|tocolytic agents|mesh-ancestor
92241525|NCT05837000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92241526|NCT05834036|Amoxicillin|amoxicillin|mesh-list
92241527|NCT05834036|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241528|NCT05834036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241529|NCT05833139|Itraconazole|itraconazole|mesh-list
92241530|NCT05833139|Antifungal Agents|antifungal agents|mesh-ancestor
92241531|NCT05833139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241532|NCT05833139|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92241533|NCT05833139|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92241534|NCT05833139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241535|NCT05833139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241536|NCT05833139|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92241537|NCT05833139|Hormone Antagonists|hormone antagonists|mesh-ancestor
92241538|NCT05833139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241539|NCT05833139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241540|NCT05833139|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92241541|NCT05821296|Methamphetamine|methamphetamine|mesh-list
92241542|NCT05821296|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92241543|NCT05821296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241544|NCT05821296|Sympathomimetics|sympathomimetics|mesh-ancestor
92241545|NCT05821296|Autonomic Agents|autonomic agents|mesh-ancestor
92241546|NCT05821296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241547|NCT05821296|Dopamine Agents|dopamine agents|mesh-ancestor
92241548|NCT05821296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241549|NCT05821296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241550|NCT05821296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92241551|NCT05821296|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92241552|NCT05821296|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92241553|NCT05821296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92241554|NCT05821296|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92241555|NCT05810597|Tirzepatide|tirzepatide|mesh-list
92241556|NCT05810597|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92241557|NCT05810597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241558|NCT05810597|Incretins|incretins|mesh-ancestor
92241560|NCT05810597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241561|NCT05785767|Cemiplimab|cemiplimab|mesh-list
92241562|NCT05785767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241563|NCT05785767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241564|NCT05736861|Ivermectin|ivermectin|mesh-list
92241565|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92241566|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241567|NCT05728372|Copper|copper|mesh-list
92241568|NCT05728372|Pembrolizumab|pembrolizumab|mesh-list
92241569|NCT05728372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241570|NCT05728372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241571|NCT05728372|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92241572|NCT05728372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241573|NCT05728372|Trace Elements|trace elements|mesh-ancestor
92241574|NCT05728372|Micronutrients|micronutrients|mesh-ancestor
92241575|NCT05728372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241576|NCT05707273|Cyclophosphamide|cyclophosphamide|mesh-list
92241577|NCT05707273|Fludarabine|fludarabine|mesh-list
92241578|NCT05707273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241579|NCT05707273|Immunologic Factors|immunologic factors|mesh-ancestor
92241580|NCT05707273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241581|NCT05707273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241582|NCT05707273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241583|NCT05707273|Alkylating Agents|alkylating agents|mesh-ancestor
92241584|NCT05707273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241585|NCT05707273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241586|NCT05707273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92241587|NCT05705856|Ustekinumab|ustekinumab|mesh-list
92241588|NCT05705856|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241589|NCT05672173|Cyclophosphamide|cyclophosphamide|mesh-list
92241590|NCT05672173|Nivolumab|nivolumab|mesh-list
92241591|NCT05672173|Fludarabine|fludarabine|mesh-list
92241592|NCT05672173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241593|NCT05672173|Immunologic Factors|immunologic factors|mesh-ancestor
92241594|NCT05672173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241595|NCT05672173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241596|NCT05672173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241597|NCT05672173|Alkylating Agents|alkylating agents|mesh-ancestor
92241598|NCT05672173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241599|NCT05672173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241600|NCT05672173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92241601|NCT05672173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241602|NCT05672173|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92241603|NCT05661643|Temozolomide|temozolomide|mesh-list
92241604|NCT05661643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241605|NCT05661643|Alkylating Agents|alkylating agents|mesh-ancestor
92241606|NCT05661643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241607|NCT05661643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241608|NCT05660941|Insulin Lispro|insulin lispro|mesh-list
92241609|NCT05660941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92241610|NCT05660941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241611|NCT05659056|Paclitaxel|paclitaxel|mesh-list
92241612|NCT05659056|Trastuzumab|trastuzumab|mesh-list
92241613|NCT05659056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92241614|NCT05659056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241615|NCT05659056|Tubulin Modulators|tubulin modulators|mesh-ancestor
92241616|NCT05659056|Antimitotic Agents|antimitotic agents|mesh-ancestor
92241617|NCT05659056|Mitosis Modulators|mitosis modulators|mesh-ancestor
92241618|NCT05659056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241619|NCT05659056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241620|NCT05654649|Dexamethasone|dexamethasone|mesh-list
92241621|NCT05654649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241622|NCT05654649|Antiemetics|antiemetics|mesh-ancestor
92241623|NCT05654649|Autonomic Agents|autonomic agents|mesh-ancestor
92241624|NCT05654649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241625|NCT05654649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241626|NCT05654649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92241627|NCT05654649|Glucocorticoids|glucocorticoids|mesh-ancestor
92241628|NCT05654649|Hormones|hormones|mesh-ancestor
92241629|NCT05654649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241630|NCT05654649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92241631|NCT05654649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241632|NCT05649748|Treprostinil|treprostinil|mesh-list
92241633|NCT05649748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92241634|NCT05629234|Osimertinib|osimertinib|mesh-list
92241635|NCT05629234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241636|NCT05629234|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241637|NCT05629234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241638|NCT05629234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241639|NCT05570825|Pembrolizumab|pembrolizumab|mesh-list
92241640|NCT05570825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241641|NCT05570825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241642|NCT05570825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92241643|NCT05570825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241644|NCT05567315|Anesthetics|anesthetics|mesh-list
92241646|NCT05567315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241647|NCT05567315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241648|NCT05567315|Sensory System Agents|sensory system agents|mesh-ancestor
92241649|NCT05567315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241650|NCT05556681|Sirolimus|sirolimus|mesh-list
92241651|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241652|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241653|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92241654|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241655|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
92241656|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241657|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
92241658|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241659|NCT05547386|Edetic Acid|edetic acid|mesh-list
92241660|NCT05547386|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92241661|NCT05547386|Chelating Agents|chelating agents|mesh-ancestor
92241662|NCT05547386|Sequestering Agents|sequestering agents|mesh-ancestor
92241663|NCT05547386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241664|NCT05547386|Anticoagulants|anticoagulants|mesh-ancestor
92241665|NCT05547386|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92241666|NCT05547386|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92241667|NCT05519111|Dronabinol|dronabinol|mesh-list
92241668|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
92241669|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241670|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241671|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92241672|NCT05519111|Analgesics|analgesics|mesh-ancestor
92241673|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
92241674|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241675|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92241676|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92241677|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241678|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241679|NCT05519111|Hormones|hormones|mesh-ancestor
92241680|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241681|NCT05492994|Carbon Monoxide|carbon monoxide|mesh-list
92241682|NCT05492994|Antimetabolites|antimetabolites|mesh-ancestor
92241683|NCT05492994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241684|NCT05492994|Gasotransmitters|gasotransmitters|mesh-ancestor
92241685|NCT05492994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241686|NCT05492994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241687|NCT05463133|Sirolimus|sirolimus|mesh-list
92241688|NCT05463133|Cyclophosphamide|cyclophosphamide|mesh-list
92241689|NCT05463133|Busulfan|busulfan|mesh-list
92241690|NCT05463133|Alemtuzumab|alemtuzumab|mesh-list
92241691|NCT05463133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241692|NCT05463133|Immunologic Factors|immunologic factors|mesh-ancestor
92241693|NCT05463133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241694|NCT05463133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241695|NCT05463133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241696|NCT05463133|Alkylating Agents|alkylating agents|mesh-ancestor
92241697|NCT05463133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241698|NCT05463133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241699|NCT05463133|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92241700|NCT05463133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241701|NCT05463133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241702|NCT05463133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92241703|NCT05463133|Antifungal Agents|antifungal agents|mesh-ancestor
92241704|NCT05463133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241705|NCT05438602|Ritonavir|ritonavir|mesh-list
92241706|NCT05438602|Nirmatrelvir|nirmatrelvir|mesh-list
92241707|NCT05438602|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92241708|NCT05438602|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92241709|NCT05438602|Protease Inhibitors|protease inhibitors|mesh-ancestor
92241710|NCT05438602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241711|NCT05438602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241712|NCT05438602|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92241713|NCT05438602|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92241714|NCT05438602|Antiviral Agents|antiviral agents|mesh-ancestor
92241715|NCT05438602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241716|NCT05438602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92241717|NCT05438602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92241718|NCT05436418|Sirolimus|sirolimus|mesh-list
92241719|NCT05436418|Cyclophosphamide|cyclophosphamide|mesh-list
92241720|NCT05436418|Melphalan|melphalan|mesh-list
92241721|NCT05436418|Fludarabine|fludarabine|mesh-list
92241722|NCT05436418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241723|NCT05436418|Immunologic Factors|immunologic factors|mesh-ancestor
92241724|NCT05436418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241725|NCT05436418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241726|NCT05436418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92241727|NCT05436418|Alkylating Agents|alkylating agents|mesh-ancestor
92241728|NCT05436418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241729|NCT05436418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241730|NCT05436418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92241731|NCT05436418|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92241732|NCT05436418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241733|NCT05436418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241734|NCT05436418|Antifungal Agents|antifungal agents|mesh-ancestor
92241735|NCT05427474|Propranolol|propranolol|mesh-list
92241736|NCT05427474|Gabapentin|gabapentin|mesh-list
92241737|NCT05427474|Analgesics|analgesics|mesh-ancestor
92241738|NCT05427474|Sensory System Agents|sensory system agents|mesh-ancestor
92241739|NCT05427474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241740|NCT05427474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241741|NCT05427474|Anticonvulsants|anticonvulsants|mesh-ancestor
92241742|NCT05427474|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92241743|NCT05427474|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92241744|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241745|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241746|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92241747|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92241748|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241749|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241750|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
92241751|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92241752|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92241753|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
92241754|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92241755|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92241756|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
92241757|NCT05418647|Dialysis Solutions|dialysis solutions|mesh-list
92241758|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92241760|NCT05376579|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92241761|NCT05376579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241762|NCT05376579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241763|NCT05376579|Immunologic Factors|immunologic factors|mesh-ancestor
92241764|NCT05376579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241765|NCT05340673|Petrolatum|petrolatum|mesh-list
92241766|NCT05340673|Mineral Oil|mineral oil|mesh-list
92241767|NCT05340673|Emollients|emollients|mesh-ancestor
92241768|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241769|NCT05320406|Leuprolide|leuprolide|mesh-list
92241770|NCT05320406|Relugolix|relugolix|mesh-list
92241771|NCT05320406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92241772|NCT05320406|Fertility Agents|fertility agents|mesh-ancestor
92241773|NCT05320406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92241774|NCT05320406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241775|NCT05320406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92241776|NCT05320406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241777|NCT05320406|Androgen Antagonists|androgen antagonists|mesh-ancestor
92241778|NCT05320406|Hormone Antagonists|hormone antagonists|mesh-ancestor
92241779|NCT05320406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241780|NCT05312151|Psilocybin|psilocybin|mesh-list
92241781|NCT05312151|Hallucinogens|hallucinogens|mesh-ancestor
92241782|NCT05312151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241783|NCT05312151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241784|NCT05307198|Capecitabine|capecitabine|mesh-list
92241785|NCT05307198|Oxaliplatin|oxaliplatin|mesh-list
92241786|NCT05307198|Antibodies|antibodies|mesh-list
92241787|NCT05307198|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92241788|NCT05307198|Immunologic Factors|immunologic factors|mesh-ancestor
92241789|NCT05307198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241790|NCT05307198|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92241791|NCT05307198|Antimetabolites|antimetabolites|mesh-ancestor
92340931|NCT05749445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92241792|NCT05307198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241793|NCT05307198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241794|NCT05299073|Denosumab|denosumab|mesh-list
92241795|NCT05299073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92241796|NCT05299073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241797|NCT05243290|Niacinamide|niacinamide|mesh-list
92241798|NCT05243290|Niacin|niacin|mesh-list
92241799|NCT05243290|Nicotinic Acids|nicotinic acids|mesh-list
92241800|NCT05243290|Vitamin B Complex|vitamin b complex|mesh-ancestor
92241802|NCT05243290|Micronutrients|micronutrients|mesh-ancestor
92241803|NCT05243290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241804|NCT05243290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92241805|NCT05243290|Antimetabolites|antimetabolites|mesh-ancestor
92241806|NCT05243290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241807|NCT05243290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92241808|NCT05243290|Vasodilator Agents|vasodilator agents|mesh-ancestor
92241809|NCT05221398|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92241810|NCT05221398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241811|NCT05221398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241812|NCT05221398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241813|NCT05213221|Lenvatinib|lenvatinib|mesh-list
92241814|NCT05213221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241815|NCT05213221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241816|NCT05213221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241817|NCT05213221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241818|NCT05213208|Propofol|propofol|mesh-list
92241819|NCT05213208|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92241820|NCT05213208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241821|NCT05213208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241822|NCT05213208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92241823|NCT05213208|Anesthetics, General|anesthetics, general|mesh-ancestor
92241824|NCT05213208|Anesthetics|anesthetics|mesh-ancestor
92241825|NCT05212337|Denosumab|denosumab|mesh-list
92241826|NCT05212337|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92241827|NCT05212337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241828|NCT05189223|Buprenorphine|buprenorphine|mesh-list
92241829|NCT05189223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92241830|NCT05189223|Narcotics|narcotics|mesh-ancestor
92241831|NCT05189223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241832|NCT05189223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241833|NCT05189223|Analgesics|analgesics|mesh-ancestor
92241834|NCT05189223|Sensory System Agents|sensory system agents|mesh-ancestor
92241835|NCT05189223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241836|NCT05189223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92241837|NCT05123040|Prednisone|prednisone|mesh-list
92241838|NCT05123040|Methylprednisolone|methylprednisolone|mesh-list
92241839|NCT05123040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241840|NCT05123040|Glucocorticoids|glucocorticoids|mesh-ancestor
92241841|NCT05123040|Hormones|hormones|mesh-ancestor
92241842|NCT05123040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92241843|NCT05123040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241844|NCT05123040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92241845|NCT05123040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241846|NCT05123040|Antiemetics|antiemetics|mesh-ancestor
92241847|NCT05123040|Autonomic Agents|autonomic agents|mesh-ancestor
92241848|NCT05123040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241849|NCT05123040|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92241850|NCT05123040|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92241851|NCT05123040|Protective Agents|protective agents|mesh-ancestor
92241852|NCT05096702|Primaquine|primaquine|mesh-list
92241853|NCT05096702|Tafenoquine|tafenoquine|mesh-list
92241854|NCT05096702|Antimalarials|antimalarials|mesh-ancestor
92241855|NCT05096702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92241856|NCT05096702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92241857|NCT05096702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241858|NCT05017454|Mometasone Furoate|mometasone furoate|mesh-list
92241859|NCT05017454|Valproic Acid|valproic acid|mesh-list
92241860|NCT05017454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241861|NCT05017454|Dermatologic Agents|dermatologic agents|mesh-ancestor
92241862|NCT05017454|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92241863|NCT05017454|Anticonvulsants|anticonvulsants|mesh-ancestor
92241864|NCT05017454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241865|NCT05017454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241866|NCT05017454|GABA Agents|gaba agents|mesh-ancestor
92241867|NCT05017454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241868|NCT05017454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241869|NCT05017454|Antimanic Agents|antimanic agents|mesh-ancestor
92241870|NCT05017454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92241871|NCT05017454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241872|NCT05017454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92241873|NCT05013424|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92241874|NCT05013424|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92241875|NCT05013424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92241876|NCT05013424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241877|NCT05013424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932446|NCT02322892|Vitamins|vitamins|mesh-ancestor
92241878|NCT05013424|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92241879|NCT05013424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92241880|NCT05013424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241881|NCT05013424|Cholinergic Agents|cholinergic agents|mesh-ancestor
92241882|NCT05013424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241883|NCT04999215|Choline|choline|mesh-list
92241884|NCT04999215|Lipotropic Agents|lipotropic agents|mesh-ancestor
92241885|NCT04999215|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92241886|NCT04999215|Antimetabolites|antimetabolites|mesh-ancestor
92241887|NCT04999215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241888|NCT04999215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92241890|NCT04999215|Nootropic Agents|nootropic agents|mesh-ancestor
92241891|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
92241892|NCT04991025|Carboplatin|carboplatin|mesh-list
92241893|NCT04991025|Gemcitabine|gemcitabine|mesh-list
92241894|NCT04991025|Nivolumab|nivolumab|mesh-list
92241895|NCT04991025|Pemetrexed|pemetrexed|mesh-list
92241896|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241897|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92241898|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
92241899|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241900|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92241901|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92241902|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241903|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92241904|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92241905|NCT04991025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92241906|NCT04991025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92241907|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92241908|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
92241909|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241910|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92241911|NCT04935658|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92241912|NCT04935658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241913|NCT04935658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241914|NCT04930315|Apatinib|apatinib|mesh-list
92241915|NCT04930315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241916|NCT04930315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92241917|NCT04930315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241918|NCT04930315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241919|NCT04887857|Azacitidine|azacitidine|mesh-list
92241920|NCT04887857|Venetoclax|venetoclax|mesh-list
92241922|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92241923|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
92241924|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241925|NCT04887857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92241926|NCT04887857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241927|NCT04855266|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92241928|NCT04855266|Hematinics|hematinics|mesh-ancestor
92241929|NCT04832399|Natalizumab|natalizumab|mesh-list
92241930|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
92241931|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241932|NCT04821310|Pantoprazole|pantoprazole|mesh-list
92241933|NCT04821310|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92241934|NCT04821310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92241935|NCT04821310|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92241936|NCT04821310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241937|NCT04821310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241939|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
92241940|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92241941|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92241942|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241943|NCT04757662|Tadalafil|tadalafil|mesh-list
92241944|NCT04757662|Vasodilator Agents|vasodilator agents|mesh-ancestor
92241945|NCT04757662|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92241946|NCT04757662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92241947|NCT04757662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241948|NCT04757662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241949|NCT04757662|Urological Agents|urological agents|mesh-ancestor
92241950|NCT04756050|Epinephrine|epinephrine|mesh-list
92241951|NCT04756050|Racepinephrine|racepinephrine|mesh-list
92241952|NCT04756050|Bupivacaine|bupivacaine|mesh-list
92241953|NCT04756050|Prilocaine|prilocaine|mesh-list
92241954|NCT04756050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92241955|NCT04756050|Epinephryl borate|epinephryl borate|mesh-list
92241956|NCT04756050|Anesthetics, Local|anesthetics, local|mesh-ancestor
92241957|NCT04756050|Anesthetics|anesthetics|mesh-ancestor
92241958|NCT04756050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92241959|NCT04756050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241960|NCT04756050|Sensory System Agents|sensory system agents|mesh-ancestor
92241961|NCT04756050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92241962|NCT04756050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92241963|NCT04756050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92241964|NCT04756050|Adrenergic Agents|adrenergic agents|mesh-ancestor
92241965|NCT04756050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241966|NCT04756050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241967|NCT04756050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92241968|NCT04756050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92241969|NCT04756050|Autonomic Agents|autonomic agents|mesh-ancestor
92241970|NCT04756050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92241971|NCT04756050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92241972|NCT04756050|Mydriatics|mydriatics|mesh-ancestor
92241973|NCT04756050|Sympathomimetics|sympathomimetics|mesh-ancestor
92241974|NCT04756050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92241975|NCT04731103|Lamivudine|lamivudine|mesh-list
92241976|NCT04731103|Zidovudine|zidovudine|mesh-list
92241977|NCT04731103|Abacavir|abacavir|mesh-list
92241978|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
92241979|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92241980|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92241981|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92241982|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241983|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
92241984|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241985|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92241986|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92241987|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
92241988|NCT04716712|Azithromycin|azithromycin|mesh-list
92241989|NCT04716712|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92241990|NCT04716712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92241991|NCT04683640|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92241992|NCT04683640|GABA Agents|gaba agents|mesh-ancestor
92241993|NCT04683640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92241994|NCT04683640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92241995|NCT04683640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92241996|NCT04680221|Bupivacaine|bupivacaine|mesh-list
92241997|NCT04680221|Anesthetics, Local|anesthetics, local|mesh-ancestor
92241998|NCT04680221|Anesthetics|anesthetics|mesh-ancestor
92241999|NCT04680221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242000|NCT04680221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242001|NCT04680221|Sensory System Agents|sensory system agents|mesh-ancestor
92242002|NCT04680221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242003|NCT04668144|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92242004|NCT04668144|Cangrelor|cangrelor|mesh-list
92242005|NCT04668144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92242006|NCT04668144|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92242007|NCT04668144|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92242008|NCT04668144|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92242009|NCT04668144|Purinergic Agents|purinergic agents|mesh-ancestor
92242010|NCT04668144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242011|NCT04668144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242012|NCT04668144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242013|NCT04667078|Cangrelor|cangrelor|mesh-list
92242014|NCT04667078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92242015|NCT04667078|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92242016|NCT04667078|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92242017|NCT04667078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92242018|NCT04667078|Purinergic Agents|purinergic agents|mesh-ancestor
92242019|NCT04667078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242020|NCT04667078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242021|NCT04667078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242022|NCT04663997|Docetaxel|docetaxel|mesh-list
92242023|NCT04663997|177Lu-PSMA-617|177lu-psma-617|mesh-list
92242024|NCT04663997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242025|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
92242026|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
92242027|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
92242028|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242029|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92242030|NCT04650581|Fulvestrant|fulvestrant|mesh-list
92242031|NCT04650581|Ipatasertib|ipatasertib|mesh-list
92242032|NCT04650581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242033|NCT04650581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242034|NCT04650581|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92242035|NCT04650581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92242036|NCT04650581|Hormone Antagonists|hormone antagonists|mesh-ancestor
92242037|NCT04650581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242038|NCT04650581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242039|NCT04650581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242040|NCT04650581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242041|NCT04650581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242042|NCT04644796|Bupivacaine|bupivacaine|mesh-list
92242043|NCT04644796|Anesthetics, Local|anesthetics, local|mesh-ancestor
92242044|NCT04644796|Anesthetics|anesthetics|mesh-ancestor
92242045|NCT04644796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242046|NCT04644796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242047|NCT04644796|Sensory System Agents|sensory system agents|mesh-ancestor
92242048|NCT04644796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242049|NCT04639414|Empagliflozin|empagliflozin|mesh-list
92242050|NCT04639414|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92242051|NCT04639414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242052|NCT04639414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242053|NCT04639414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242055|NCT04623541|Cyclophosphamide|cyclophosphamide|mesh-list
92242056|NCT04623541|Rituximab|rituximab|mesh-list
92242057|NCT04623541|Doxorubicin|doxorubicin|mesh-list
92242058|NCT04623541|Vincristine|vincristine|mesh-list
92242059|NCT04623541|Lenalidomide|lenalidomide|mesh-list
92242060|NCT04623541|Venetoclax|venetoclax|mesh-list
92242061|NCT04623541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242062|NCT04623541|Immunologic Factors|immunologic factors|mesh-ancestor
92242063|NCT04623541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242064|NCT04623541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242065|NCT04623541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242066|NCT04623541|Alkylating Agents|alkylating agents|mesh-ancestor
92242067|NCT04623541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242068|NCT04623541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242069|NCT04623541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92242070|NCT04623541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242071|NCT04623541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92242072|NCT04623541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92242073|NCT04623541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92242074|NCT04623541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242075|NCT04623541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242077|NCT04623541|Hormones|hormones|mesh-ancestor
92242078|NCT04623541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242080|NCT04623541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92242081|NCT04623541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92242082|NCT04623541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92242083|NCT04623541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92242084|NCT04623541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242085|NCT04623541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242086|NCT04623541|Growth Substances|growth substances|mesh-ancestor
92242087|NCT04623541|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242088|NCT04621929|Topiramate|topiramate|mesh-list
92242089|NCT04621929|Phentermine|phentermine|mesh-list
92242090|NCT04621929|Allopurinol|allopurinol|mesh-list
92242091|NCT04621929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242092|NCT04621929|Anticonvulsants|anticonvulsants|mesh-ancestor
92242093|NCT04621929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242094|NCT04621929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242095|NCT04621929|Antimetabolites|antimetabolites|mesh-ancestor
92242096|NCT04621929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242097|NCT04621929|Gout Suppressants|gout suppressants|mesh-ancestor
92242098|NCT04621929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242099|NCT04621929|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92242100|NCT04621929|Antioxidants|antioxidants|mesh-ancestor
92242101|NCT04621929|Protective Agents|protective agents|mesh-ancestor
92242102|NCT04621929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92242103|NCT04621929|Appetite Depressants|appetite depressants|mesh-ancestor
92242104|NCT04621929|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92242105|NCT04621929|Sympathomimetics|sympathomimetics|mesh-ancestor
92242106|NCT04621929|Autonomic Agents|autonomic agents|mesh-ancestor
92242107|NCT04621929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242108|NCT04621929|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242109|NCT04621929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242110|NCT04593927|Siponimod|siponimod|mesh-list
92242111|NCT04593927|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92242112|NCT04593927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242113|NCT04593927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242114|NCT04593927|Immunologic Factors|immunologic factors|mesh-ancestor
92242115|NCT04593927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242116|NCT04572763|Venetoclax|venetoclax|mesh-list
92242117|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242118|NCT04568161|Cyclophosphamide|cyclophosphamide|mesh-list
92242119|NCT04568161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242120|NCT04568161|Immunologic Factors|immunologic factors|mesh-ancestor
92242121|NCT04568161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242122|NCT04568161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242123|NCT04568161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242124|NCT04568161|Alkylating Agents|alkylating agents|mesh-ancestor
92242125|NCT04568161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242126|NCT04568161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242127|NCT04568161|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92242128|NCT04556370|Norepinephrine|norepinephrine|mesh-list
92242129|NCT04556370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92242130|NCT04556370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242131|NCT04556370|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242132|NCT04556370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242133|NCT04556370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242134|NCT04556370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242135|NCT04556370|Sympathomimetics|sympathomimetics|mesh-ancestor
92242136|NCT04556370|Autonomic Agents|autonomic agents|mesh-ancestor
92242137|NCT04556370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242138|NCT04556370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92242139|NCT04553692|Leucovorin|leucovorin|mesh-list
92242140|NCT04553692|Bevacizumab|bevacizumab|mesh-list
92242141|NCT04553692|Gemcitabine|gemcitabine|mesh-list
92242142|NCT04553692|Docetaxel|docetaxel|mesh-list
92242143|NCT04553692|Fluorouracil|fluorouracil|mesh-list
92242144|NCT04553692|Irinotecan|irinotecan|mesh-list
92242145|NCT04553692|Azacitidine|azacitidine|mesh-list
92242146|NCT04553692|Venetoclax|venetoclax|mesh-list
92242147|NCT04553692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242148|NCT04553692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242149|NCT04553692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242150|NCT04553692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242151|NCT04553692|Growth Substances|growth substances|mesh-ancestor
92242152|NCT04553692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242153|NCT04553692|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242154|NCT04553692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92242155|NCT04553692|Antimetabolites|antimetabolites|mesh-ancestor
92242156|NCT04553692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242157|NCT04553692|Tubulin Modulators|tubulin modulators|mesh-ancestor
92242158|NCT04553692|Antimitotic Agents|antimitotic agents|mesh-ancestor
92242159|NCT04553692|Mitosis Modulators|mitosis modulators|mesh-ancestor
92242160|NCT04553692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242161|NCT04553692|Immunologic Factors|immunologic factors|mesh-ancestor
92242162|NCT04553692|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92242163|NCT04553692|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92242164|NCT04553692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242165|NCT04553692|Antidotes|antidotes|mesh-ancestor
92242166|NCT04553692|Protective Agents|protective agents|mesh-ancestor
92242167|NCT04553692|Vitamin B Complex|vitamin b complex|mesh-ancestor
92242168|NCT04553692|Vitamins|vitamins|mesh-ancestor
92242169|NCT04553692|Micronutrients|micronutrients|mesh-ancestor
92242170|NCT04535882|polysaccharide-K|polysaccharide-k|mesh-list
92242171|NCT04535882|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92242172|NCT04535882|Immunologic Factors|immunologic factors|mesh-ancestor
92242173|NCT04535882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242174|NCT04535882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92242175|NCT04535882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242176|NCT04535882|Antiviral Agents|antiviral agents|mesh-ancestor
92242177|NCT04535882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242178|NCT04535882|Interferon Inducers|interferon inducers|mesh-ancestor
92242179|NCT04535882|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92242180|NCT04535882|Protective Agents|protective agents|mesh-ancestor
92242181|NCT04535687|Fluzoparib|fluzoparib|mesh-list
92242182|NCT04535687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92242183|NCT04535687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242184|NCT04535687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242185|NCT04535687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242186|NCT04527887|Dexamethasone|dexamethasone|mesh-list
92242187|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242188|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
92242189|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
92242190|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242191|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242192|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92242193|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
92242194|NCT04527887|Hormones|hormones|mesh-ancestor
92242195|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242196|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242197|NCT04527887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242198|NCT04474847|Abatacept|abatacept|mesh-list
92242199|NCT04474847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242200|NCT04474847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242201|NCT04474847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242202|NCT04474847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242203|NCT04474847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242204|NCT04474847|Immunologic Factors|immunologic factors|mesh-ancestor
92242205|NCT04474847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340972|NCT05522465|Prednisone|prednisone|mesh-list
92242206|NCT04474847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242207|NCT04458831|Dexamethasone|dexamethasone|mesh-list
92242208|NCT04458831|Pomalidomide|pomalidomide|mesh-list
92242209|NCT04458831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242210|NCT04458831|Antiemetics|antiemetics|mesh-ancestor
92242211|NCT04458831|Autonomic Agents|autonomic agents|mesh-ancestor
92242212|NCT04458831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242213|NCT04458831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242214|NCT04458831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92242215|NCT04458831|Glucocorticoids|glucocorticoids|mesh-ancestor
92242216|NCT04458831|Hormones|hormones|mesh-ancestor
92242217|NCT04458831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242218|NCT04458831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242219|NCT04458831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242220|NCT04458831|Immunologic Factors|immunologic factors|mesh-ancestor
92242221|NCT04458831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242222|NCT04458831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242223|NCT04458831|Growth Substances|growth substances|mesh-ancestor
92242224|NCT04458831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242225|NCT04436926|Analgesics, Opioid|analgesics, opioid|mesh-list
92242226|NCT04436926|Narcotics|narcotics|mesh-ancestor
92242227|NCT04436926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242228|NCT04436926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242229|NCT04436926|Analgesics|analgesics|mesh-ancestor
92242230|NCT04436926|Sensory System Agents|sensory system agents|mesh-ancestor
92242231|NCT04436926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242232|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
92242233|NCT04423055|Etonogestrel|etonogestrel|mesh-list
92242234|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92242235|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242236|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92242237|NCT04423055|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92242238|NCT04418401|Antibodies|antibodies|mesh-list
92242239|NCT04418401|Immunologic Factors|immunologic factors|mesh-ancestor
92242240|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242241|NCT04407754|Inositol|inositol|mesh-list
92242242|NCT04407754|Vitamin B Complex|vitamin b complex|mesh-ancestor
92242243|NCT04407754|Vitamins|vitamins|mesh-ancestor
92242244|NCT04407754|Micronutrients|micronutrients|mesh-ancestor
92242245|NCT04407754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242246|NCT04385602|Dexmedetomidine|dexmedetomidine|mesh-list
92242247|NCT04385602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92242248|NCT04385602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242249|NCT04385602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242250|NCT04385602|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92242251|NCT04385602|Analgesics|analgesics|mesh-ancestor
92242252|NCT04385602|Sensory System Agents|sensory system agents|mesh-ancestor
92242253|NCT04385602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242254|NCT04385602|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92242255|NCT04385602|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92242256|NCT04385602|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242257|NCT04385602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242258|NCT04385602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242259|NCT04385602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242260|NCT04379713|Vaccines|vaccines|mesh-list
92242261|NCT04379713|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92242262|NCT04379713|Immunologic Factors|immunologic factors|mesh-ancestor
92242263|NCT04379713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242264|NCT04323280|Dexamethasone|dexamethasone|mesh-list
92242265|NCT04323280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242266|NCT04323280|Antiemetics|antiemetics|mesh-ancestor
92242267|NCT04323280|Autonomic Agents|autonomic agents|mesh-ancestor
92242268|NCT04323280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242269|NCT04323280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242270|NCT04323280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92242271|NCT04323280|Glucocorticoids|glucocorticoids|mesh-ancestor
92242272|NCT04323280|Hormones|hormones|mesh-ancestor
92242273|NCT04323280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242274|NCT04323280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242275|NCT04323280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242276|NCT04218773|Phenylephrine|phenylephrine|mesh-list
92242277|NCT04218773|Oxymetazoline|oxymetazoline|mesh-list
92242278|NCT04218773|Norepinephrine|norepinephrine|mesh-list
92242279|NCT04218773|Synephrine|synephrine|mesh-list
92242280|NCT04218773|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92242281|NCT04218773|Mydriatics|mydriatics|mesh-ancestor
92242282|NCT04218773|Autonomic Agents|autonomic agents|mesh-ancestor
92242283|NCT04218773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242284|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242285|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
92242286|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92242287|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
92242288|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92242289|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92242290|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92242291|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242292|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242293|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242294|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242295|NCT04218773|Protective Agents|protective agents|mesh-ancestor
92242296|NCT04217447|Aspirin|aspirin|mesh-list
92242297|NCT04217447|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92242298|NCT04217447|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92242299|NCT04217447|Analgesics|analgesics|mesh-ancestor
92242300|NCT04217447|Sensory System Agents|sensory system agents|mesh-ancestor
92242301|NCT04217447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242302|NCT04217447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242303|NCT04217447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242304|NCT04217447|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242305|NCT04217447|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92242306|NCT04217447|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92242307|NCT04217447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242308|NCT04217447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92242309|NCT04217447|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92242310|NCT04217447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242311|NCT04217447|Antipyretics|antipyretics|mesh-ancestor
92242312|NCT04206787|Afatinib|afatinib|mesh-list
92242313|NCT04206787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242314|NCT04206787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242315|NCT04206787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242316|NCT04206787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242317|NCT04126031|Ceftazidime|ceftazidime|mesh-list
92242318|NCT04126031|Avibactam|avibactam|mesh-list
92242319|NCT04126031|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92242320|NCT04126031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92242321|NCT04126031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242322|NCT04126031|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92242323|NCT04126031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242324|NCT04126031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242325|NCT04100824|Nimodipine|nimodipine|mesh-list
92242326|NCT04100824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92242327|NCT04100824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92242328|NCT04100824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92340993|NCT05204147|Antibodies|antibodies|mesh-list
92242329|NCT04100824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117529|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92242330|NCT04100824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92242332|NCT04100824|Vasodilator Agents|vasodilator agents|mesh-ancestor
92242333|NCT04088851|Metformin|metformin|mesh-list
92242334|NCT04088851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242335|NCT04088851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242336|NCT04074265|Ketorolac|ketorolac|mesh-list
92242337|NCT04074265|Epinephrine|epinephrine|mesh-list
92242338|NCT04074265|Ropivacaine|ropivacaine|mesh-list
92242339|NCT04074265|Anesthetics, Local|anesthetics, local|mesh-ancestor
92242340|NCT04074265|Anesthetics|anesthetics|mesh-ancestor
92242341|NCT04074265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242342|NCT04074265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242343|NCT04074265|Sensory System Agents|sensory system agents|mesh-ancestor
92242344|NCT04074265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242345|NCT04074265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92242346|NCT04074265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242347|NCT04074265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242348|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242349|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242350|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92242351|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92242352|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
92242353|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92242354|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
92242355|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
92242356|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
92242357|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92242358|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92242359|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92242360|NCT04074265|Analgesics|analgesics|mesh-ancestor
92242361|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242362|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242363|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92242364|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242365|NCT04058067|Aflibercept|aflibercept|mesh-list
92242366|NCT04058067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242367|NCT04058067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242368|NCT04058067|Growth Substances|growth substances|mesh-ancestor
92242369|NCT04058067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242370|NCT04058067|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242371|NCT04058067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242372|NCT04007744|Pembrolizumab|pembrolizumab|mesh-list
92242373|NCT04007744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242374|NCT04007744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242375|NCT04007744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242376|NCT04007744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242377|NCT03998735|Lobeline|lobeline|mesh-list
92242378|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92242379|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
92242380|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242381|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242382|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92242383|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92242384|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
92242385|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242386|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242387|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
92242388|NCT03993327|Iodine|iodine|mesh-list
92242389|NCT03993327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92242390|NCT03993327|Antibodies|antibodies|mesh-list
92242391|NCT03993327|Immunoglobulins|immunoglobulins|mesh-list
92341009|NCT04824053|Trace Elements|trace elements|mesh-ancestor
92242392|NCT03993327|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92242393|NCT03993327|Immunologic Factors|immunologic factors|mesh-ancestor
92242394|NCT03993327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242395|NCT03993327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242396|NCT03993327|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92242397|NCT03993327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242398|NCT03993327|Trace Elements|trace elements|mesh-ancestor
92242399|NCT03993327|Micronutrients|micronutrients|mesh-ancestor
92242400|NCT03983057|Antibodies|antibodies|mesh-list
92242401|NCT03983057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92242402|NCT03983057|Immunologic Factors|immunologic factors|mesh-ancestor
92242403|NCT03983057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242404|NCT03933215|Cladribine|cladribine|mesh-list
92242405|NCT03933215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242406|NCT03933215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242407|NCT03933215|Immunologic Factors|immunologic factors|mesh-ancestor
92242408|NCT03933215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242409|NCT03932643|TIC10 compound|tic10 compound|mesh-list
92242410|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242411|NCT03879135|Factor VIII|factor viii|mesh-list
92242412|NCT03879135|Coagulants|coagulants|mesh-ancestor
92242413|NCT03802799|Cannabidiol|cannabidiol|mesh-list
92242414|NCT03802799|Anticonvulsants|anticonvulsants|mesh-ancestor
92242415|NCT03789110|Nivolumab|nivolumab|mesh-list
92242416|NCT03789110|Ipilimumab|ipilimumab|mesh-list
92242417|NCT03789110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242418|NCT03789110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242419|NCT03789110|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242420|NCT03789110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242421|NCT03759028|Acetaminophen|acetaminophen|mesh-list
92242422|NCT03759028|Ibuprofen|ibuprofen|mesh-list
92242423|NCT03759028|Oxycodone|oxycodone|mesh-list
92242424|NCT03759028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92242425|NCT03759028|Analgesics|analgesics|mesh-ancestor
92242426|NCT03759028|Sensory System Agents|sensory system agents|mesh-ancestor
92242427|NCT03759028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242428|NCT03759028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242429|NCT03759028|Antipyretics|antipyretics|mesh-ancestor
92242430|NCT03759028|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92242431|NCT03759028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242432|NCT03759028|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242433|NCT03759028|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92242434|NCT03759028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242435|NCT03759028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242436|NCT03759028|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92242437|NCT03759028|Narcotics|narcotics|mesh-ancestor
92242438|NCT03759028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242439|NCT03716921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92242440|NCT03716921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92242441|NCT03716921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242442|NCT03716921|Antitubercular Agents|antitubercular agents|mesh-ancestor
92242443|NCT03693560|Metformin|metformin|mesh-list
92242444|NCT03693560|Glimepiride|glimepiride|mesh-list
92242445|NCT03693560|Vildagliptin|vildagliptin|mesh-list
92242446|NCT03693560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242447|NCT03693560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242448|NCT03693560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92242449|NCT03693560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242450|NCT03693560|Immunologic Factors|immunologic factors|mesh-ancestor
92242451|NCT03693560|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92242452|NCT03693560|Protease Inhibitors|protease inhibitors|mesh-ancestor
92242453|NCT03693560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242454|NCT03693560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242455|NCT03675893|Metformin|metformin|mesh-list
92242456|NCT03675893|Letrozole|letrozole|mesh-list
92242457|NCT03675893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242458|NCT03675893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242459|NCT03675893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242460|NCT03675893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92341018|NCT04811339|Antidiarrheals|antidiarrheals|mesh-ancestor
92242461|NCT03675893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92242462|NCT03675893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242463|NCT03675893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242464|NCT03675893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92242465|NCT03675893|Hormone Antagonists|hormone antagonists|mesh-ancestor
92242466|NCT03675893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242467|NCT03624062|Insulin|insulin|mesh-list
92242468|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242469|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242470|NCT03574090|Amoxicillin|amoxicillin|mesh-list
92242471|NCT03574090|Clavulanic Acid|clavulanic acid|mesh-list
92242472|NCT03574090|Clavulanic Acids|clavulanic acids|mesh-list
92242473|NCT03574090|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92242474|NCT03574090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92242475|NCT03574090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242476|NCT03574090|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92242477|NCT03574090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242478|NCT03574090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242480|NCT03522246|Rucaparib|rucaparib|mesh-list
92242481|NCT03522246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242482|NCT03522246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242483|NCT03522246|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91934642|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
92242484|NCT03522246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242485|NCT03522246|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92242486|NCT03522246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242488|NCT03504397|Folic Acid|folic acid|mesh-list
92242489|NCT03504397|Fluorouracil|fluorouracil|mesh-list
92242490|NCT03504397|Oxaliplatin|oxaliplatin|mesh-list
92242491|NCT03504397|Levoleucovorin|levoleucovorin|mesh-list
92242492|NCT03504397|Antimetabolites|antimetabolites|mesh-ancestor
92242493|NCT03504397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242494|NCT03504397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92242495|NCT03504397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242496|NCT03504397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242497|NCT03504397|Immunologic Factors|immunologic factors|mesh-ancestor
92242498|NCT03504397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242499|NCT03504397|Antidotes|antidotes|mesh-ancestor
92242500|NCT03504397|Protective Agents|protective agents|mesh-ancestor
92242501|NCT03504397|Vitamin B Complex|vitamin b complex|mesh-ancestor
92242502|NCT03504397|Vitamins|vitamins|mesh-ancestor
92242503|NCT03504397|Micronutrients|micronutrients|mesh-ancestor
92242504|NCT03504397|Hematinics|hematinics|mesh-ancestor
92242505|NCT03498716|Paclitaxel|paclitaxel|mesh-list
92242506|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
92242507|NCT03498716|Doxorubicin|doxorubicin|mesh-list
92242508|NCT03498716|Atezolizumab|atezolizumab|mesh-list
92242509|NCT03498716|Epirubicin|epirubicin|mesh-list
92242510|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92242511|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242512|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
92242513|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
92242514|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
92242515|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242516|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242517|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
92242518|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242519|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242520|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242521|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
92242522|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92242523|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92242524|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92242525|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92242526|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242527|NCT03498716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242528|NCT03498716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242529|NCT03429543|Empagliflozin|empagliflozin|mesh-list
92242530|NCT03429543|Linagliptin|linagliptin|mesh-list
92242531|NCT03429543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92242532|NCT03429543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242533|NCT03429543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242534|NCT03429543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242535|NCT03429543|Incretins|incretins|mesh-ancestor
92242536|NCT03429543|Hormones|hormones|mesh-ancestor
92242537|NCT03429543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242538|NCT03429543|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92242539|NCT03429543|Protease Inhibitors|protease inhibitors|mesh-ancestor
92242540|NCT03429543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242541|NCT03417544|Trastuzumab|trastuzumab|mesh-list
92242542|NCT03417544|Atezolizumab|atezolizumab|mesh-list
92242543|NCT03417544|Pertuzumab|pertuzumab|mesh-list
92242544|NCT03417544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242545|NCT03417544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242546|NCT03417544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242547|NCT03417544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242548|NCT03363464|Empagliflozin|empagliflozin|mesh-list
92242549|NCT03363464|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92242550|NCT03363464|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92242551|NCT03363464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242552|NCT03363464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242553|NCT03363464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242554|NCT03363464|Protease Inhibitors|protease inhibitors|mesh-ancestor
92242555|NCT03363464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242557|NCT03309878|Mogamulizumab|mogamulizumab|mesh-list
92242558|NCT03309878|Immunoglobulins|immunoglobulins|mesh-list
92242559|NCT03309878|Immunoglobulin G|immunoglobulin g|mesh-list
92242560|NCT03309878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242561|NCT03309878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242562|NCT03309878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242563|NCT03309878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242564|NCT03309878|Immunologic Factors|immunologic factors|mesh-ancestor
92242565|NCT03309878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242566|NCT03297606|Nivolumab|nivolumab|mesh-list
92242567|NCT03297606|Trastuzumab|trastuzumab|mesh-list
92242568|NCT03297606|Ipilimumab|ipilimumab|mesh-list
92242569|NCT03297606|Pertuzumab|pertuzumab|mesh-list
92242570|NCT03297606|Sunitinib|sunitinib|mesh-list
92242571|NCT03297606|Dasatinib|dasatinib|mesh-list
92242572|NCT03297606|Olaparib|olaparib|mesh-list
92242573|NCT03297606|Palbociclib|palbociclib|mesh-list
92242574|NCT03297606|Temsirolimus|temsirolimus|mesh-list
92242575|NCT03297606|Axitinib|axitinib|mesh-list
92242576|NCT03297606|Vemurafenib|vemurafenib|mesh-list
92242577|NCT03297606|Crizotinib|crizotinib|mesh-list
92242578|NCT03297606|Tucatinib|tucatinib|mesh-list
92242579|NCT03297606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242580|NCT03297606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242581|NCT03297606|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242582|NCT03297606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242583|NCT03297606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242584|NCT03297606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242585|NCT03297606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242586|NCT03297606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242587|NCT03297606|Growth Substances|growth substances|mesh-ancestor
92242588|NCT03297606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242589|NCT03297606|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242590|NCT03297606|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92242591|NCT03297606|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92242592|NCT03297606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242593|NCT03297606|Immunologic Factors|immunologic factors|mesh-ancestor
92242594|NCT03233204|Olaparib|olaparib|mesh-list
92242595|NCT03233204|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92242596|NCT03233204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242597|NCT03233204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242598|NCT03233204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242599|NCT03179930|Pembrolizumab|pembrolizumab|mesh-list
92242600|NCT03179930|Entinostat|entinostat|mesh-list
92242601|NCT03179930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242602|NCT03179930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242603|NCT03179930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242604|NCT03179930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242605|NCT03179930|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92242606|NCT03179930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242607|NCT03113851|Molgramostim|molgramostim|mesh-list
92242608|NCT03113851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242609|NCT03043313|Trastuzumab|trastuzumab|mesh-list
92242610|NCT03043313|Tucatinib|tucatinib|mesh-list
92242611|NCT03043313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242612|NCT03043313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242613|NCT03043313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242614|NCT03043313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242615|NCT03043313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242616|NCT02972840|Rituximab|rituximab|mesh-list
92242617|NCT02972840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92242618|NCT02972840|Acalabrutinib|acalabrutinib|mesh-list
92242619|NCT02972840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242620|NCT02972840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242621|NCT02972840|Immunologic Factors|immunologic factors|mesh-ancestor
92242622|NCT02972840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242623|NCT02972840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242624|NCT02972840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242625|NCT02972840|Alkylating Agents|alkylating agents|mesh-ancestor
92242626|NCT02972840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242627|NCT02903381|Dexamethasone|dexamethasone|mesh-list
92242628|NCT02903381|Nivolumab|nivolumab|mesh-list
92242629|NCT02903381|Lenalidomide|lenalidomide|mesh-list
92242630|NCT02903381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242631|NCT02903381|Antiemetics|antiemetics|mesh-ancestor
92242632|NCT02903381|Autonomic Agents|autonomic agents|mesh-ancestor
92242633|NCT02903381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242634|NCT02903381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242635|NCT02903381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92242636|NCT02903381|Glucocorticoids|glucocorticoids|mesh-ancestor
92242637|NCT02903381|Hormones|hormones|mesh-ancestor
92242638|NCT02903381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242639|NCT02903381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242640|NCT02903381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242641|NCT02903381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242642|NCT02903381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242643|NCT02903381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242644|NCT02903381|Immunologic Factors|immunologic factors|mesh-ancestor
92242645|NCT02903381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242646|NCT02903381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242647|NCT02903381|Growth Substances|growth substances|mesh-ancestor
92242648|NCT02903381|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242649|NCT02811133|Inositol|inositol|mesh-list
92242650|NCT02811133|Vitamin B Complex|vitamin b complex|mesh-ancestor
92242651|NCT02811133|Vitamins|vitamins|mesh-ancestor
92242652|NCT02811133|Micronutrients|micronutrients|mesh-ancestor
92242653|NCT02811133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242654|NCT02744391|Levodopa|levodopa|mesh-list
92242655|NCT02744391|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92242656|NCT02744391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92242657|NCT02744391|Dopamine Agents|dopamine agents|mesh-ancestor
92242658|NCT02744391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242659|NCT02744391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242660|NCT02744391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242661|NCT02618577|Edoxaban|edoxaban|mesh-list
92242662|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92242663|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
92242664|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92242665|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92242666|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242667|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242668|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
92242669|NCT02607722|Nintedanib|nintedanib|mesh-list
92242670|NCT02607722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242671|NCT02607722|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242672|NCT02607722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242673|NCT02607722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242674|NCT02462837|Mirabegron|mirabegron|mesh-list
92242675|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92242676|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92242677|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242678|NCT02462837|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242679|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242680|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242681|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242682|NCT02462837|Urological Agents|urological agents|mesh-ancestor
92242683|NCT02436707|Dexamethasone|dexamethasone|mesh-list
92242684|NCT02436707|Cyclophosphamide|cyclophosphamide|mesh-list
92242685|NCT02436707|Rituximab|rituximab|mesh-list
92242686|NCT02436707|Gemcitabine|gemcitabine|mesh-list
92242687|NCT02436707|Etoposide|etoposide|mesh-list
92242688|NCT02436707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242689|NCT02436707|Immunologic Factors|immunologic factors|mesh-ancestor
92242690|NCT02436707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242691|NCT02436707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242692|NCT02436707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242693|NCT02436707|Alkylating Agents|alkylating agents|mesh-ancestor
92242694|NCT02436707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242695|NCT02436707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242696|NCT02436707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92242697|NCT02436707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242698|NCT02436707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242699|NCT02436707|Antiemetics|antiemetics|mesh-ancestor
92242700|NCT02436707|Autonomic Agents|autonomic agents|mesh-ancestor
92242701|NCT02436707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242702|NCT02436707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92242703|NCT02436707|Glucocorticoids|glucocorticoids|mesh-ancestor
92242704|NCT02436707|Hormones|hormones|mesh-ancestor
92242705|NCT02436707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242706|NCT02436707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242707|NCT02436707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92242708|NCT02436707|Antimetabolites|antimetabolites|mesh-ancestor
92242709|NCT02436707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92242710|NCT02436707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92117530|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242711|NCT02436707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92242712|NCT02436707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242713|NCT02346201|Methylphenidate|methylphenidate|mesh-list
92242714|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92242715|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242716|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92242717|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92242718|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92242719|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242720|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
92242721|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242722|NCT02331134|Lenograstim|lenograstim|mesh-list
92242723|NCT02331134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92242724|NCT02331134|Immunologic Factors|immunologic factors|mesh-ancestor
92242725|NCT02331134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242726|NCT02078427|BAX 855|bax 855|mesh-list
92242727|NCT02078427|Coagulants|coagulants|mesh-ancestor
92242728|NCT02042378|Rucaparib|rucaparib|mesh-list
92242729|NCT02042378|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92242730|NCT02042378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242731|NCT02042378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242732|NCT02042378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242733|NCT02019706|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92242734|NCT02019706|Dopamine Agents|dopamine agents|mesh-ancestor
92242735|NCT02019706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242736|NCT02019706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242737|NCT02019706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242738|NCT01866930|Interferons|interferons|mesh-list
92242739|NCT01866930|Ribavirin|ribavirin|mesh-list
92242740|NCT01866930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242741|NCT01866930|Antiviral Agents|antiviral agents|mesh-ancestor
92242742|NCT01866930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242743|NCT01866930|Antimetabolites|antimetabolites|mesh-ancestor
92242744|NCT01866930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242745|NCT01682187|Lomustine|lomustine|mesh-list
92242746|NCT01682187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242747|NCT01682187|Alkylating Agents|alkylating agents|mesh-ancestor
92242748|NCT01682187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242749|NCT01682187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242750|NCT01621568|Sunitinib|sunitinib|mesh-list
92242751|NCT01621568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242752|NCT01621568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92242753|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92242754|NCT01621568|Growth Substances|growth substances|mesh-ancestor
92242755|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242756|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
92242757|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242758|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242759|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242760|NCT01366612|Vidarabine|vidarabine|mesh-list
92242761|NCT01366612|Fludarabine|fludarabine|mesh-list
92242762|NCT01366612|Fludarabine phosphate|fludarabine phosphate|mesh-list
92242763|NCT01366612|Busulfan|busulfan|mesh-list
92242764|NCT01366612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242765|NCT01366612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92242766|NCT01366612|Antimetabolites|antimetabolites|mesh-ancestor
92242767|NCT01366612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242768|NCT01366612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242769|NCT01366612|Immunologic Factors|immunologic factors|mesh-ancestor
92242770|NCT01366612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242772|NCT01366612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242773|NCT01366612|Alkylating Agents|alkylating agents|mesh-ancestor
92242774|NCT01366612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92242775|NCT01366612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92242776|NCT00813293|Sorafenib|sorafenib|mesh-list
92242777|NCT00813293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242778|NCT00813293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242779|NCT00813293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242780|NCT00813293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242782|NCT00777036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242783|NCT00777036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92242784|NCT00777036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242785|NCT00777036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242786|NCT00481091|Navitoclax|navitoclax|mesh-list
92242787|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242788|NCT00003641|Interferons|interferons|mesh-list
92242789|NCT00003641|Interferon-alpha|interferon-alpha|mesh-list
92242790|NCT00003641|Interferon alpha-2|interferon alpha-2|mesh-list
92242791|NCT00003641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242792|NCT00003641|Antiviral Agents|antiviral agents|mesh-ancestor
92242793|NCT00003641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242794|NCT00003641|Immunologic Factors|immunologic factors|mesh-ancestor
92242795|NCT00003641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242796|NCT00392834|Leucovorin|leucovorin|mesh-list
92242797|NCT00392834|Cytarabine|cytarabine|mesh-list
92242798|NCT00392834|Hydrocortisone|hydrocortisone|mesh-list
92242799|NCT00392834|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92242800|NCT00392834|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92242801|NCT00392834|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92242802|NCT00392834|Cyclophosphamide|cyclophosphamide|mesh-list
92242803|NCT00392834|Ifosfamide|ifosfamide|mesh-list
92242804|NCT00392834|Rituximab|rituximab|mesh-list
92242805|NCT00392834|Doxorubicin|doxorubicin|mesh-list
92242806|NCT00392834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92242807|NCT00392834|Methotrexate|methotrexate|mesh-list
92242808|NCT00392834|Etoposide|etoposide|mesh-list
92242809|NCT00392834|Vincristine|vincristine|mesh-list
92242810|NCT00392834|Levoleucovorin|levoleucovorin|mesh-list
92242811|NCT00392834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242812|NCT00392834|Immunologic Factors|immunologic factors|mesh-ancestor
92242813|NCT00392834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242814|NCT00392834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242815|NCT00392834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341109|NCT05015621|Leucovorin|leucovorin|mesh-list
92242816|NCT00392834|Alkylating Agents|alkylating agents|mesh-ancestor
92242817|NCT00392834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242818|NCT00392834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242819|NCT00392834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92242820|NCT00392834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242821|NCT00392834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92242822|NCT00392834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92242823|NCT00392834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92242824|NCT00392834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242825|NCT00392834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92242826|NCT00392834|Abortifacient Agents|abortifacient agents|mesh-ancestor
92242827|NCT00392834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92242828|NCT00392834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92242829|NCT00392834|Antimetabolites|antimetabolites|mesh-ancestor
92242830|NCT00392834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92242831|NCT00392834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92242832|NCT00392834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92242833|NCT00392834|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92242834|NCT00392834|Antiviral Agents|antiviral agents|mesh-ancestor
92242835|NCT00392834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242837|NCT00392834|Protective Agents|protective agents|mesh-ancestor
92242838|NCT00392834|Vitamin B Complex|vitamin b complex|mesh-ancestor
92242839|NCT00392834|Vitamins|vitamins|mesh-ancestor
92242840|NCT00392834|Micronutrients|micronutrients|mesh-ancestor
92242841|NCT00392834|Tubulin Modulators|tubulin modulators|mesh-ancestor
92242842|NCT00392834|Antimitotic Agents|antimitotic agents|mesh-ancestor
92242843|NCT00392834|Mitosis Modulators|mitosis modulators|mesh-ancestor
92242844|NCT00392834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242845|NCT00393380|Teriparatide|teriparatide|mesh-list
92242846|NCT00393380|Hormones|hormones|mesh-list
92242847|NCT00393380|Parathyroid Hormone|parathyroid hormone|mesh-list
92242848|NCT00393380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242849|NCT00393380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242850|NCT00393380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92242851|NCT00393380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92242852|NCT05361642|Lidocaine|lidocaine|mesh-list
92242853|NCT05361642|Dexmedetomidine|dexmedetomidine|mesh-list
92242854|NCT05361642|Bupivacaine|bupivacaine|mesh-list
92242855|NCT05361642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92242856|NCT05361642|Anesthetics|anesthetics|mesh-ancestor
92242857|NCT05361642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242858|NCT05361642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242859|NCT05361642|Sensory System Agents|sensory system agents|mesh-ancestor
92242860|NCT05361642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242861|NCT05361642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92242862|NCT05361642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92242863|NCT05361642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92242864|NCT05361642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92242865|NCT05361642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242866|NCT05361642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92242867|NCT05361642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92242868|NCT05361642|Analgesics|analgesics|mesh-ancestor
92242869|NCT05361642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92242870|NCT05361642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92242871|NCT05361642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242872|NCT05361642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242873|NCT05361642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242874|NCT00395876|Tenecteplase|tenecteplase|mesh-list
92242875|NCT00395876|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92242876|NCT00395876|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92242877|NCT00395876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242878|NCT02662634|Paclitaxel|paclitaxel|mesh-list
92242879|NCT02662634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92242880|NCT02662634|Cisplatin|cisplatin|mesh-list
92242881|NCT02662634|Carboplatin|carboplatin|mesh-list
92242882|NCT02662634|Pemetrexed|pemetrexed|mesh-list
92242883|NCT02662634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92242884|NCT02662634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242886|NCT02662634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92242887|NCT02662634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92242888|NCT02662634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242889|NCT02662634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242890|NCT02662634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92242891|NCT02662634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92242892|NCT00396032|Tenecteplase|tenecteplase|mesh-list
92242893|NCT00396032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92242894|NCT00396032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92242895|NCT00396032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242896|NCT02277782|Fentanyl|fentanyl|mesh-list
92242897|NCT02277782|Hydromorphone|hydromorphone|mesh-list
92242898|NCT02277782|Bupivacaine|bupivacaine|mesh-list
92242899|NCT02277782|Anesthetics, Local|anesthetics, local|mesh-ancestor
92242900|NCT02277782|Anesthetics|anesthetics|mesh-ancestor
92242901|NCT02277782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92242902|NCT02277782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242903|NCT02277782|Sensory System Agents|sensory system agents|mesh-ancestor
92242904|NCT02277782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242905|NCT02277782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92242906|NCT02277782|Narcotics|narcotics|mesh-ancestor
92242907|NCT02277782|Analgesics|analgesics|mesh-ancestor
92242908|NCT02277782|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92242909|NCT02277782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92242910|NCT02277782|Anesthetics, General|anesthetics, general|mesh-ancestor
92242911|NCT05287100|Midodrine|midodrine|mesh-list
92242912|NCT05287100|Sympathomimetics|sympathomimetics|mesh-ancestor
92242913|NCT05287100|Autonomic Agents|autonomic agents|mesh-ancestor
92242914|NCT05287100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242915|NCT05287100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242916|NCT05287100|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92242917|NCT05287100|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92242918|NCT05287100|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92242919|NCT05287100|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92242920|NCT05287100|Adrenergic Agents|adrenergic agents|mesh-ancestor
92242921|NCT05287100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92242922|NCT05287100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242923|NCT02271230|Vitamin D|vitamin d|mesh-list
92242924|NCT02271230|Ergocalciferols|ergocalciferols|mesh-list
92242925|NCT02271230|Cholecalciferol|cholecalciferol|mesh-list
92242926|NCT02271230|Vitamins|vitamins|mesh-list
92242927|NCT02271230|Micronutrients|micronutrients|mesh-ancestor
92242928|NCT02271230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242929|NCT02271230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92242930|NCT02271230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92242931|NCT05321706|Dapagliflozin|dapagliflozin|mesh-list
92242932|NCT05321706|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92242933|NCT05321706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242934|NCT05321706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242935|NCT05321706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242937|NCT05514990|Dexamethasone acetate|dexamethasone acetate|mesh-list
92242938|NCT05514990|Pembrolizumab|pembrolizumab|mesh-list
92242939|NCT05514990|Bortezomib|bortezomib|mesh-list
92242940|NCT05514990|Ichthammol|ichthammol|mesh-list
92242941|NCT05514990|BB 1101|bb 1101|mesh-list
92242942|NCT05514990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242943|NCT05514990|Antiemetics|antiemetics|mesh-ancestor
92242944|NCT05514990|Autonomic Agents|autonomic agents|mesh-ancestor
92242945|NCT05514990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242946|NCT05514990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242947|NCT05514990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92242948|NCT05514990|Glucocorticoids|glucocorticoids|mesh-ancestor
92242949|NCT05514990|Hormones|hormones|mesh-ancestor
92341136|NCT05289167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92242950|NCT05514990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92242951|NCT05514990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92242952|NCT05514990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242954|NCT05514990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242955|NCT05514990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242956|NCT05514990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242957|NCT05514990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242958|NCT05514990|Dermatologic Agents|dermatologic agents|mesh-ancestor
92242959|NCT05354778|Hydrocortisone|hydrocortisone|mesh-list
92242960|NCT05354778|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92242961|NCT05354778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242962|NCT00396266|Plerixafor|plerixafor|mesh-list
92242963|NCT00396266|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92242964|NCT00396266|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92242965|NCT00396266|Antiviral Agents|antiviral agents|mesh-ancestor
92242966|NCT00396266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92242967|NCT04271384|Nivolumab|nivolumab|mesh-list
92242968|NCT04271384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242969|NCT04271384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242970|NCT04271384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92242971|NCT04271384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242972|NCT05610384|Ibuprofen|ibuprofen|mesh-list
92242973|NCT05610384|Ketorolac|ketorolac|mesh-list
92242974|NCT05610384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92242975|NCT05610384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92242976|NCT05610384|Analgesics|analgesics|mesh-ancestor
92242977|NCT05610384|Sensory System Agents|sensory system agents|mesh-ancestor
92242978|NCT05610384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92242979|NCT05610384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242980|NCT05610384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92242981|NCT05610384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92242982|NCT05610384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92242983|NCT05610384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242984|NCT05610384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242985|NCT03570632|Metformin|metformin|mesh-list
92242986|NCT03570632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92242987|NCT03570632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92242988|NCT00397904|Irinotecan|irinotecan|mesh-list
92242989|NCT00397904|Cetuximab|cetuximab|mesh-list
92242990|NCT00397904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92242991|NCT00397904|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92242992|NCT00397904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92242993|NCT00397904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92242994|NCT00397904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92242995|NCT00397904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92242996|NCT00398918|Zonisamide|zonisamide|mesh-list
92242997|NCT00398918|Anticonvulsants|anticonvulsants|mesh-ancestor
92242998|NCT00398918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92242999|NCT00398918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243000|NCT00398918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243001|NCT00398918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92243002|NCT00398918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243003|NCT05380752|Tecovirimat|tecovirimat|mesh-list
92243004|NCT05380752|Antiviral Agents|antiviral agents|mesh-ancestor
92243005|NCT05380752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243006|NCT00401414|Warfarin|warfarin|mesh-list
92243007|NCT00401414|Anticoagulants|anticoagulants|mesh-ancestor
92243008|NCT00370838|Clonidine|clonidine|mesh-list
92243009|NCT00370838|Levetiracetam|levetiracetam|mesh-list
92243010|NCT00370838|Analgesics|analgesics|mesh-ancestor
92243011|NCT00370838|Sensory System Agents|sensory system agents|mesh-ancestor
92243012|NCT00370838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243013|NCT00370838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243014|NCT00370838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243015|NCT00370838|Sympatholytics|sympatholytics|mesh-ancestor
92243016|NCT00370838|Autonomic Agents|autonomic agents|mesh-ancestor
92243017|NCT00370838|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92243018|NCT00370838|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92243019|NCT00370838|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92243020|NCT00370838|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243021|NCT00370838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243022|NCT00370838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243023|NCT00370838|Anticonvulsants|anticonvulsants|mesh-ancestor
92243024|NCT00370838|Nootropic Agents|nootropic agents|mesh-ancestor
92243025|NCT01795430|Etoposide|etoposide|mesh-list
92243026|NCT01795430|Etoposide phosphate|etoposide phosphate|mesh-list
92243027|NCT01795430|Melphalan|melphalan|mesh-list
92243028|NCT01795430|Busulfan|busulfan|mesh-list
92243029|NCT01795430|Topotecan|topotecan|mesh-list
92243030|NCT01795430|Ifosfamide|ifosfamide|mesh-list
92243031|NCT01795430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92243032|NCT01795430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243033|NCT01795430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92243034|NCT01795430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92243035|NCT01795430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243036|NCT01795430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243037|NCT01795430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92243038|NCT01795430|Alkylating Agents|alkylating agents|mesh-ancestor
92243039|NCT01795430|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92243040|NCT01795430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243041|NCT01795430|Immunologic Factors|immunologic factors|mesh-ancestor
92243042|NCT01795430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243043|NCT01795430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92243044|NCT04750382|Gemcitabine|gemcitabine|mesh-list
92243045|NCT04750382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243046|NCT04750382|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92243047|NCT04750382|Antimetabolites|antimetabolites|mesh-ancestor
92243048|NCT04750382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243049|NCT00401882|Metoprolol|metoprolol|mesh-list
92243050|NCT00401882|Epinephrine|epinephrine|mesh-list
92243051|NCT00401882|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92243052|NCT00401882|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92243053|NCT00401882|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243054|NCT00401882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243055|NCT00401882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243056|NCT00401882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243057|NCT00401882|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92243058|NCT00401882|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92243059|NCT00401882|Autonomic Agents|autonomic agents|mesh-ancestor
92243060|NCT00401882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243061|NCT00401882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92243062|NCT00401882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243064|NCT00401882|Sympathomimetics|sympathomimetics|mesh-ancestor
92243065|NCT00401882|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92243066|NCT00401882|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92243067|NCT00401882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243068|NCT00401882|Sympatholytics|sympatholytics|mesh-ancestor
92243069|NCT00401882|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92243070|NCT00401882|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92243071|NCT00401882|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92243072|NCT00373334|Nizatidine|nizatidine|mesh-list
92243073|NCT00373334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92243074|NCT00373334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243075|NCT00373334|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92243076|NCT00373334|Histamine Antagonists|histamine antagonists|mesh-ancestor
92243077|NCT00373334|Histamine Agents|histamine agents|mesh-ancestor
92243078|NCT00373334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243079|NCT00373334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243080|NCT00373334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243081|NCT04749914|Dabigatran|dabigatran|mesh-list
92243082|NCT04749914|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92243083|NCT04749914|Lasmiditan|lasmiditan|mesh-list
92243084|NCT04749914|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92243085|NCT04749914|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92243086|NCT04749914|Antimetabolites|antimetabolites|mesh-ancestor
92341153|NCT00382499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243087|NCT04749914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243088|NCT04749914|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92243089|NCT04749914|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92243091|NCT04749914|Antithrombins|antithrombins|mesh-ancestor
92243092|NCT04749914|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92243093|NCT04749914|Protease Inhibitors|protease inhibitors|mesh-ancestor
92243094|NCT04749914|Anticoagulants|anticoagulants|mesh-ancestor
92243095|NCT04749914|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92243096|NCT04749914|Serotonin Agents|serotonin agents|mesh-ancestor
92243097|NCT04749914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243098|NCT04749914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243099|NCT00402194|Losartan|losartan|mesh-list
92243100|NCT00402194|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92243101|NCT00402194|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243102|NCT00402194|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92243103|NCT00402194|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92243104|NCT00402194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243105|NCT05305404|Dexamethasone|dexamethasone|mesh-list
92243106|NCT05305404|Dexamethasone acetate|dexamethasone acetate|mesh-list
92243107|NCT05305404|BB 1101|bb 1101|mesh-list
92243108|NCT05305404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243109|NCT05305404|Antiemetics|antiemetics|mesh-ancestor
92243110|NCT05305404|Autonomic Agents|autonomic agents|mesh-ancestor
92243111|NCT05305404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243112|NCT05305404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243113|NCT05305404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243114|NCT05305404|Glucocorticoids|glucocorticoids|mesh-ancestor
92243115|NCT05305404|Hormones|hormones|mesh-ancestor
92243116|NCT05305404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92243117|NCT05305404|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92243118|NCT05305404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243119|NCT05305404|Protease Inhibitors|protease inhibitors|mesh-ancestor
92243120|NCT05305404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243121|NCT05305404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243122|NCT00402896|Mitogens|mitogens|mesh-list
92243123|NCT00402896|Endothelial Growth Factors|endothelial growth factors|mesh-list
92243124|NCT00402896|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92243125|NCT00402896|Mitosis Modulators|mitosis modulators|mesh-ancestor
92243126|NCT00402896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243127|NCT00402896|Growth Substances|growth substances|mesh-ancestor
92243128|NCT00402896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243129|NCT00402896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243130|NCT00402896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243131|NCT05268120|Doxycycline|doxycycline|mesh-list
92243132|NCT05268120|Rifampin|rifampin|mesh-list
92243133|NCT05268120|Trimethoprim|trimethoprim|mesh-list
92243134|NCT05268120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92243135|NCT05268120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243137|NCT05268120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92243138|NCT05268120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92243139|NCT05268120|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92243140|NCT05268120|Antitubercular Agents|antitubercular agents|mesh-ancestor
92243141|NCT05268120|Leprostatic Agents|leprostatic agents|mesh-ancestor
92243142|NCT05268120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92243143|NCT05268120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243144|NCT05268120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243145|NCT05268120|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92243146|NCT05268120|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92243147|NCT05268120|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92243148|NCT05268120|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92243149|NCT05268120|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92243150|NCT05268120|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92243151|NCT05268120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92243152|NCT05268120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92243153|NCT05268120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92243154|NCT05268120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92243155|NCT05268120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92243156|NCT00405704|Trimethoprim|trimethoprim|mesh-list
92243157|NCT00405704|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92243158|NCT00405704|Sulfamethoxazole|sulfamethoxazole|mesh-list
92243159|NCT00405704|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92243160|NCT00405704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243161|NCT00405704|Antimalarials|antimalarials|mesh-ancestor
92243162|NCT00405704|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92243163|NCT00405704|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92243164|NCT00405704|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92243165|NCT00405704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243166|NCT00405704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243167|NCT00405704|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92243168|NCT00405704|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92243169|NCT00405704|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92243170|NCT00405704|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92243172|NCT01657266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92243173|NCT01657266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92243174|NCT01657266|Analgesics|analgesics|mesh-ancestor
92243175|NCT01657266|Sensory System Agents|sensory system agents|mesh-ancestor
92243176|NCT01657266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243177|NCT01657266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243178|NCT01657266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243179|NCT01657266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92243180|NCT00375830|Diphosphonates|diphosphonates|mesh-list
92243181|NCT00375830|Methylene diphosphonate|methylene diphosphonate|mesh-list
92243182|NCT00375830|Listerine|listerine|mesh-list
92243183|NCT00375830|Deoxyglucose|deoxyglucose|mesh-list
92243184|NCT00375830|Fluorides|fluorides|mesh-list
92243185|NCT00375830|Sodium Fluoride|sodium fluoride|mesh-list
92243186|NCT00375830|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92243187|NCT00375830|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92243188|NCT00375830|Cariostatic Agents|cariostatic agents|mesh-ancestor
92243189|NCT00375830|Protective Agents|protective agents|mesh-ancestor
92243190|NCT00375830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243191|NCT00375830|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92243192|NCT00375830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243193|NCT00375830|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92243194|NCT00375830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243195|NCT00375830|Antimetabolites|antimetabolites|mesh-ancestor
92243196|NCT00375830|Antiviral Agents|antiviral agents|mesh-ancestor
92243197|NCT00375830|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92243198|NCT05286008|Dexamethasone|dexamethasone|mesh-list
92243199|NCT05286008|Ropivacaine|ropivacaine|mesh-list
92243200|NCT05286008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243201|NCT05286008|Antiemetics|antiemetics|mesh-ancestor
92243202|NCT05286008|Autonomic Agents|autonomic agents|mesh-ancestor
92243203|NCT05286008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243204|NCT05286008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243205|NCT05286008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243206|NCT05286008|Glucocorticoids|glucocorticoids|mesh-ancestor
92243207|NCT05286008|Hormones|hormones|mesh-ancestor
92243208|NCT05286008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92243209|NCT05286008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92243210|NCT05286008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243211|NCT05286008|Anesthetics, Local|anesthetics, local|mesh-ancestor
92243212|NCT05286008|Anesthetics|anesthetics|mesh-ancestor
92243213|NCT05286008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243214|NCT05286008|Sensory System Agents|sensory system agents|mesh-ancestor
92243215|NCT05302284|Carboplatin|carboplatin|mesh-list
92243216|NCT05302284|Gemcitabine|gemcitabine|mesh-list
92243217|NCT05302284|Disitamab vedotin|disitamab vedotin|mesh-list
92243218|NCT05302284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243219|NCT05302284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92243220|NCT05302284|Antimetabolites|antimetabolites|mesh-ancestor
92243221|NCT05302284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243222|NCT05302284|Immunoconjugates|immunoconjugates|mesh-ancestor
92243223|NCT05302284|Immunologic Factors|immunologic factors|mesh-ancestor
92243224|NCT05302284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243226|NCT05263284|Adenosine|adenosine|mesh-list
92243227|NCT05263284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243228|NCT05263284|Analgesics|analgesics|mesh-ancestor
92243229|NCT05263284|Sensory System Agents|sensory system agents|mesh-ancestor
92243230|NCT05263284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243231|NCT05263284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243232|NCT05263284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92243233|NCT05263284|Vasodilator Agents|vasodilator agents|mesh-ancestor
92243234|NCT05263284|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92243235|NCT05263284|Purinergic Agonists|purinergic agonists|mesh-ancestor
92243236|NCT05263284|Purinergic Agents|purinergic agents|mesh-ancestor
92243237|NCT05263284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243238|NCT05263284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243239|NCT05300802|Dexmedetomidine|dexmedetomidine|mesh-list
92243240|NCT05300802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92243241|NCT05300802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243242|NCT05300802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243243|NCT05300802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92243244|NCT05300802|Analgesics|analgesics|mesh-ancestor
92243245|NCT05300802|Sensory System Agents|sensory system agents|mesh-ancestor
92243246|NCT05300802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243247|NCT05300802|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92243248|NCT05300802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92243249|NCT05300802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92243250|NCT05300802|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243251|NCT05300802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243252|NCT05300802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243253|NCT05299476|Bevacizumab|bevacizumab|mesh-list
92243254|NCT05299476|Tislelizumab|tislelizumab|mesh-list
92243255|NCT05299476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243256|NCT05299476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243257|NCT05299476|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92243258|NCT05299476|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92243259|NCT05299476|Growth Substances|growth substances|mesh-ancestor
92243260|NCT05299476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243261|NCT05299476|Growth Inhibitors|growth inhibitors|mesh-ancestor
92243262|NCT00405938|Bevacizumab|bevacizumab|mesh-list
92243263|NCT00405938|Fulvestrant|fulvestrant|mesh-list
92243264|NCT00405938|Anastrozole|anastrozole|mesh-list
92243265|NCT00405938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243266|NCT00405938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243267|NCT00405938|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92243268|NCT00405938|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92243269|NCT00405938|Growth Substances|growth substances|mesh-ancestor
92243270|NCT00405938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243271|NCT00405938|Growth Inhibitors|growth inhibitors|mesh-ancestor
92243272|NCT00405938|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92243273|NCT00405938|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92243274|NCT00405938|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92243275|NCT00405938|Hormone Antagonists|hormone antagonists|mesh-ancestor
92243276|NCT00405938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92243277|NCT00405938|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92243278|NCT00405938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92243279|NCT00405938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243280|NCT00405938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243281|NCT05299398|Trazodone|trazodone|mesh-list
92243282|NCT05299398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92243283|NCT05299398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92243284|NCT05299398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243285|NCT05299398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243286|NCT05299398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243287|NCT05299398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92243288|NCT05299398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92243289|NCT05299398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243290|NCT05299398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243291|NCT05299398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243292|NCT05299398|Serotonin Agents|serotonin agents|mesh-ancestor
92243293|NCT05299398|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92243294|NCT05299398|Antidepressive Agents|antidepressive agents|mesh-ancestor
92243295|NCT01793480|Methadone|methadone|mesh-list
92243296|NCT01793480|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92243297|NCT01793480|Narcotics|narcotics|mesh-ancestor
92243298|NCT01793480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243299|NCT01793480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243300|NCT01793480|Analgesics|analgesics|mesh-ancestor
92243301|NCT01793480|Sensory System Agents|sensory system agents|mesh-ancestor
92243302|NCT01793480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243303|NCT01793480|Antitussive Agents|antitussive agents|mesh-ancestor
92243304|NCT01793480|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243305|NCT05299086|Fluticasone|fluticasone|mesh-list
92243307|NCT05299086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243308|NCT05299086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92243309|NCT05299086|Autonomic Agents|autonomic agents|mesh-ancestor
92243310|NCT05299086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243311|NCT05299086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243312|NCT05299086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92243313|NCT05299086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243314|NCT05299086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92243315|NCT05299086|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92243316|NCT05299008|Bethanechol|bethanechol|mesh-list
92243317|NCT05299008|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92243318|NCT05299008|Autonomic Agents|autonomic agents|mesh-ancestor
92243319|NCT05299008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243320|NCT05299008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243321|NCT05299008|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92243322|NCT05299008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92243323|NCT05299008|Cholinergic Agents|cholinergic agents|mesh-ancestor
92243324|NCT05299008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243325|NCT05299008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243327|NCT05258292|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92243328|NCT05258292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243329|NCT00378326|Tacrolimus|tacrolimus|mesh-list
92243330|NCT00378326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243331|NCT00378326|Immunologic Factors|immunologic factors|mesh-ancestor
92243332|NCT00378326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243333|NCT00378326|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92243334|NCT00378326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243335|NCT00378326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243336|NCT05256264|Ketamine|ketamine|mesh-list
92243337|NCT05256264|Analgesics|analgesics|mesh-ancestor
92243338|NCT05256264|Sensory System Agents|sensory system agents|mesh-ancestor
92243340|NCT05256264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243341|NCT05256264|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92243342|NCT05256264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92243343|NCT05256264|Anesthetics, General|anesthetics, general|mesh-ancestor
92243344|NCT05256264|Anesthetics|anesthetics|mesh-ancestor
92243345|NCT05256264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243346|NCT05256264|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92243347|NCT05256264|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92243348|NCT05256264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243349|NCT05256264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243350|NCT00379574|Prednisolone|prednisolone|mesh-list
92243351|NCT00379574|Cyclophosphamide|cyclophosphamide|mesh-list
92243352|NCT00379574|Doxorubicin|doxorubicin|mesh-list
92243353|NCT00379574|Vincristine|vincristine|mesh-list
92243354|NCT00379574|Bortezomib|bortezomib|mesh-list
92243355|NCT00379574|Lenograstim|lenograstim|mesh-list
92243356|NCT00379574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243357|NCT00379574|Immunologic Factors|immunologic factors|mesh-ancestor
92243358|NCT00379574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243359|NCT00379574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92243360|NCT00379574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92243361|NCT00379574|Alkylating Agents|alkylating agents|mesh-ancestor
92243362|NCT00379574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243363|NCT00379574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243364|NCT00379574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92243365|NCT00379574|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92243366|NCT00379574|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92243367|NCT00379574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92243368|NCT00379574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243369|NCT00379574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92243370|NCT00379574|Tubulin Modulators|tubulin modulators|mesh-ancestor
92243371|NCT00379574|Antimitotic Agents|antimitotic agents|mesh-ancestor
92243372|NCT00379574|Mitosis Modulators|mitosis modulators|mesh-ancestor
92243373|NCT00379574|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243374|NCT00379574|Glucocorticoids|glucocorticoids|mesh-ancestor
92243376|NCT00379574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92243377|NCT00379574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92243378|NCT00379574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92243379|NCT05256108|Oxycodone|oxycodone|mesh-list
92243380|NCT05256108|Tramadol|tramadol|mesh-list
92243381|NCT05256108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92243382|NCT05256108|Narcotics|narcotics|mesh-ancestor
92243383|NCT05256108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243384|NCT05256108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243385|NCT05256108|Analgesics|analgesics|mesh-ancestor
92243386|NCT05256108|Sensory System Agents|sensory system agents|mesh-ancestor
92243387|NCT05256108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243388|NCT00407654|Aflibercept|aflibercept|mesh-list
92243389|NCT00407654|Endothelial Growth Factors|endothelial growth factors|mesh-list
92243390|NCT00407654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92243391|NCT00407654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92243392|NCT00407654|Growth Substances|growth substances|mesh-ancestor
92243393|NCT00407654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243394|NCT00407654|Growth Inhibitors|growth inhibitors|mesh-ancestor
92243395|NCT00407654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243396|NCT05484492|Calcium|calcium|mesh-list
92243397|NCT05484492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92243398|NCT05484492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243399|NCT00407888|Paclitaxel|paclitaxel|mesh-list
92243400|NCT00407888|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92243401|NCT00407888|Cyclophosphamide|cyclophosphamide|mesh-list
92243402|NCT00407888|Doxorubicin|doxorubicin|mesh-list
92243403|NCT00407888|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92243404|NCT00407888|Trastuzumab|trastuzumab|mesh-list
92243405|NCT00407888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92243406|NCT00407888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243407|NCT00407888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92243408|NCT00407888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92243409|NCT00407888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92243410|NCT00407888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243411|NCT00407888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243412|NCT00407888|Immunologic Factors|immunologic factors|mesh-ancestor
92243413|NCT00407888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243414|NCT00407888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92243415|NCT00407888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92243416|NCT00407888|Alkylating Agents|alkylating agents|mesh-ancestor
92243417|NCT00407888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92243418|NCT00407888|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92243419|NCT00407888|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92243420|NCT00407888|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92243421|NCT00407888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243422|NCT00407888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243423|NCT00407966|Cytarabine|cytarabine|mesh-list
92243424|NCT00407966|Mitoxantrone|mitoxantrone|mesh-list
92243425|NCT00407966|Alvocidib|alvocidib|mesh-list
92243426|NCT00407966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92243427|NCT00407966|Antimetabolites|antimetabolites|mesh-ancestor
92243428|NCT00407966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243429|NCT00407966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243430|NCT00407966|Antiviral Agents|antiviral agents|mesh-ancestor
92243431|NCT00407966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243432|NCT00407966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243433|NCT00407966|Immunologic Factors|immunologic factors|mesh-ancestor
92243434|NCT00407966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243435|NCT00407966|Analgesics|analgesics|mesh-ancestor
92243436|NCT00407966|Sensory System Agents|sensory system agents|mesh-ancestor
92243437|NCT00407966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243438|NCT00407966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92243439|NCT00407966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92243440|NCT00407966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243441|NCT00407966|Growth Inhibitors|growth inhibitors|mesh-ancestor
92243442|NCT00407966|Growth Substances|growth substances|mesh-ancestor
92243443|NCT00407966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243444|NCT00408200|Sotalol|sotalol|mesh-list
92243445|NCT00408200|Flecainide|flecainide|mesh-list
92243446|NCT00408200|Propafenone|propafenone|mesh-list
92243447|NCT00408200|Dofetilide|dofetilide|mesh-list
92243448|NCT00408200|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92243449|NCT00408200|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92243450|NCT00408200|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243451|NCT00408200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243452|NCT00408200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243453|NCT00408200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243454|NCT00408200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92243455|NCT00408200|Sympatholytics|sympatholytics|mesh-ancestor
92243456|NCT00408200|Autonomic Agents|autonomic agents|mesh-ancestor
92243457|NCT00408200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243458|NCT00408200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92243459|NCT00408200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92243460|NCT00408200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243461|NCT00408200|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92243462|NCT05255406|Aflutinib|aflutinib|mesh-list
92243463|NCT05255406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243464|NCT05255406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243465|NCT05255406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243466|NCT05250050|Amoxicillin|amoxicillin|mesh-list
92243467|NCT05250050|Metronidazole|metronidazole|mesh-list
92243468|NCT05250050|Clarithromycin|clarithromycin|mesh-list
92243469|NCT05250050|Levofloxacin|levofloxacin|mesh-list
92243470|NCT05250050|Tetracycline|tetracycline|mesh-list
92243471|NCT05250050|Potassium Citrate|potassium citrate|mesh-list
92243472|NCT05250050|Esomeprazole|esomeprazole|mesh-list
92243473|NCT05250050|Bismuth|bismuth|mesh-list
92243474|NCT05250050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243475|NCT05250050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92243476|NCT05250050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243477|NCT05250050|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92243478|NCT05250050|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92243479|NCT05250050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92243480|NCT05250050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243481|NCT05250050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92243482|NCT05250050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243483|NCT05250050|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92243484|NCT05250050|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92243485|NCT05250050|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92243486|NCT05250050|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92243487|NCT05250050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92243488|NCT05250050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92243489|NCT05250050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243490|NCT05250050|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92243491|NCT05250050|Antacids|antacids|mesh-ancestor
92243492|NCT05250050|Diuretics|diuretics|mesh-ancestor
92243493|NCT05250050|Natriuretic Agents|natriuretic agents|mesh-ancestor
92243494|NCT05250050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243495|NCT05250050|Expectorants|expectorants|mesh-ancestor
92243496|NCT05250050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243497|NCT05499390|Pembrolizumab|pembrolizumab|mesh-list
92243498|NCT05499390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243499|NCT05499390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243500|NCT05499390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92243501|NCT05499390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243502|NCT05294328|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92243503|NCT05294328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92243504|NCT05294328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92243505|NCT05294328|Aceclidine|aceclidine|mesh-list
92243506|NCT05294328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243507|NCT05294328|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92243508|NCT05294328|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92243509|NCT05294328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92243510|NCT05294328|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243511|NCT05294328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243512|NCT05294328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243513|NCT05294328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243514|NCT05294328|Miotics|miotics|mesh-ancestor
92243515|NCT05294328|Autonomic Agents|autonomic agents|mesh-ancestor
92243516|NCT05294328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243517|NCT05294328|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92243518|NCT05254236|Vaccines|vaccines|mesh-list
92243519|NCT05254236|Immunologic Factors|immunologic factors|mesh-ancestor
92243520|NCT05254236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243522|NCT05292690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92243523|NCT05292690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243524|NCT05292690|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92243525|NCT05292690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243526|NCT05292690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243527|NCT05292690|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92243528|NCT05292690|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92243529|NCT05292690|Purinergic Agents|purinergic agents|mesh-ancestor
92243530|NCT05292690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243531|NCT00382148|Omalizumab|omalizumab|mesh-list
92243532|NCT00382148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92243533|NCT00382148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92243534|NCT00382148|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243535|NCT05292066|Pregabalin|pregabalin|mesh-list
92243536|NCT05292066|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92243537|NCT05292066|Analgesics|analgesics|mesh-ancestor
92243538|NCT05292066|Sensory System Agents|sensory system agents|mesh-ancestor
92243539|NCT05292066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243540|NCT05292066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243541|NCT05292066|Anticonvulsants|anticonvulsants|mesh-ancestor
92243542|NCT05292066|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92243543|NCT05292066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243544|NCT05292066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243545|NCT05292066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92243546|NCT05292066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92243547|NCT05292066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92243548|NCT05292066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243549|NCT05292066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243550|NCT05292066|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92243551|NCT05292066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92243552|NCT05292066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243553|NCT05292066|Antidepressive Agents|antidepressive agents|mesh-ancestor
92243554|NCT05292066|Dopamine Agents|dopamine agents|mesh-ancestor
92243555|NCT04270994|Misoprostol|misoprostol|mesh-list
92243556|NCT04270994|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92243557|NCT04270994|Abortifacient Agents|abortifacient agents|mesh-ancestor
92243558|NCT04270994|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92243559|NCT04270994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243560|NCT04270994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92243561|NCT04270994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243562|NCT04270994|Oxytocics|oxytocics|mesh-ancestor
92243564|NCT02111798|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92243565|NCT02111798|Antidepressive Agents|antidepressive agents|mesh-ancestor
92243566|NCT02111798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243567|NCT02111798|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92243568|NCT02111798|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92243569|NCT02111798|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243570|NCT02111798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243571|NCT02111798|Dopamine Agents|dopamine agents|mesh-ancestor
92243572|NCT02111798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243573|NCT02111798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243574|NCT02111798|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92243575|NCT02111798|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92243576|NCT02111798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243577|NCT05290662|Cyclophosphamide|cyclophosphamide|mesh-list
92243578|NCT05290662|Fludarabine|fludarabine|mesh-list
92243579|NCT05290662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243580|NCT05290662|Immunologic Factors|immunologic factors|mesh-ancestor
92243581|NCT05290662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243582|NCT05290662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92243583|NCT05290662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92243584|NCT05290662|Alkylating Agents|alkylating agents|mesh-ancestor
92243585|NCT05290662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243586|NCT05290662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243587|NCT05290662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92243588|NCT05143502|Fluticasone|fluticasone|mesh-list
92243590|NCT05143502|Prednisolone|prednisolone|mesh-list
92243591|NCT05143502|Montelukast|montelukast|mesh-list
92243592|NCT05143502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934662|NCT03647111|Crizotinib|crizotinib|mesh-list
92243593|NCT05143502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92243594|NCT05143502|Autonomic Agents|autonomic agents|mesh-ancestor
92243595|NCT05143502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243596|NCT05143502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243597|NCT05143502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92243598|NCT05143502|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243599|NCT05143502|Dermatologic Agents|dermatologic agents|mesh-ancestor
92243600|NCT05143502|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92243601|NCT05143502|Glucocorticoids|glucocorticoids|mesh-ancestor
92243602|NCT05143502|Hormones|hormones|mesh-ancestor
92243603|NCT05143502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92243604|NCT05143502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92243605|NCT05143502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243606|NCT05143502|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92243607|NCT05143502|Hormone Antagonists|hormone antagonists|mesh-ancestor
92243608|NCT05143502|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92243609|NCT05143502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92243610|NCT05143502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243611|NCT05290116|Apatinib|apatinib|mesh-list
92243612|NCT05290116|Tislelizumab|tislelizumab|mesh-list
92243613|NCT05290116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243614|NCT05290116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243615|NCT05290116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243616|NCT05290116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243617|NCT05290116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243618|NCT00409292|Everolimus|everolimus|mesh-list
92243619|NCT00409292|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92243620|NCT00409292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243621|NCT00409292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243622|NCT00409292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243623|NCT00409292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243624|NCT00409292|Immunologic Factors|immunologic factors|mesh-ancestor
92243625|NCT00409292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243626|NCT00409292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243628|NCT05246046|Tiotropium Bromide|tiotropium bromide|mesh-list
92243629|NCT05246046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92243630|NCT05246046|Autonomic Agents|autonomic agents|mesh-ancestor
92243631|NCT05246046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243632|NCT05246046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243633|NCT05246046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92243634|NCT05246046|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243635|NCT05246046|Parasympatholytics|parasympatholytics|mesh-ancestor
92243636|NCT05246046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92243637|NCT05246046|Cholinergic Agents|cholinergic agents|mesh-ancestor
92243638|NCT05246046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243639|NCT05246046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243640|NCT05246046|Anticonvulsants|anticonvulsants|mesh-ancestor
92243641|NCT00383942|Misoprostol|misoprostol|mesh-list
92243642|NCT00383942|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92243643|NCT00383942|Abortifacient Agents|abortifacient agents|mesh-ancestor
92243644|NCT00383942|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92243645|NCT00383942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243646|NCT00383942|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92243647|NCT00383942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243648|NCT00383942|Oxytocics|oxytocics|mesh-ancestor
92243649|NCT05288400|Amlodipine|amlodipine|mesh-list
92243650|NCT05288400|Bisoprolol|bisoprolol|mesh-list
92243651|NCT05288400|Perindopril|perindopril|mesh-list
92243652|NCT05288400|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243653|NCT05288400|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92243654|NCT05288400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243655|NCT05288400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243656|NCT05288400|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92243657|NCT05288400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243658|NCT05288400|Vasodilator Agents|vasodilator agents|mesh-ancestor
92243659|NCT05288400|Sympatholytics|sympatholytics|mesh-ancestor
92243660|NCT05288400|Autonomic Agents|autonomic agents|mesh-ancestor
92243661|NCT05288400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243662|NCT05288400|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92243663|NCT05288400|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92243664|NCT05288400|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92243665|NCT05288400|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243666|NCT05288400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243667|NCT05288400|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92243668|NCT05288400|Protease Inhibitors|protease inhibitors|mesh-ancestor
92243669|NCT05288400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243670|NCT05474040|Morphine|morphine|mesh-list
92243671|NCT05474040|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92243672|NCT05474040|Narcotics|narcotics|mesh-ancestor
92243673|NCT05474040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243674|NCT05474040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243675|NCT05474040|Analgesics|analgesics|mesh-ancestor
92243676|NCT05474040|Sensory System Agents|sensory system agents|mesh-ancestor
92243677|NCT05474040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243678|NCT00410150|Albuterol|albuterol|mesh-list
92243679|NCT00410150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92243680|NCT00410150|Autonomic Agents|autonomic agents|mesh-ancestor
92243681|NCT00410150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243682|NCT00410150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243683|NCT00410150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92243684|NCT00410150|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243685|NCT00410150|Tocolytic Agents|tocolytic agents|mesh-ancestor
92243686|NCT00410150|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92243687|NCT00410150|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92243688|NCT00410150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92243689|NCT00410150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92243690|NCT00410150|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243691|NCT00410150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243692|NCT00410150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243693|NCT00385268|Acamprosate|acamprosate|mesh-list
92243694|NCT00385268|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92243695|NCT05287464|Pembrolizumab|pembrolizumab|mesh-list
92243696|NCT05287464|Nivolumab|nivolumab|mesh-list
92243697|NCT05287464|Ipilimumab|ipilimumab|mesh-list
92243698|NCT05287464|Atezolizumab|atezolizumab|mesh-list
92243700|NCT05287464|Lenvatinib|lenvatinib|mesh-list
92243701|NCT05287464|Axitinib|axitinib|mesh-list
92243702|NCT05287464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243703|NCT05287464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243704|NCT05287464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92243705|NCT05287464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243706|NCT05287464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243707|NCT05287464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243708|NCT01657500|Gentamicins|gentamicins|mesh-list
92243709|NCT01657500|Dextrans|dextrans|mesh-list
92243710|NCT01657500|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92243711|NCT01657500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92243712|NCT01657500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243713|NCT01657500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92243714|NCT01657500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243715|NCT01657500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243716|NCT01657500|Anticoagulants|anticoagulants|mesh-ancestor
92243717|NCT01657500|Plasma Substitutes|plasma substitutes|mesh-ancestor
92243718|NCT01657500|Blood Substitutes|blood substitutes|mesh-ancestor
92243719|NCT00411086|Rituximab|rituximab|mesh-list
92243720|NCT00411086|Molgramostim|molgramostim|mesh-list
92243721|NCT00411086|Sargramostim|sargramostim|mesh-list
92243722|NCT00411086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243723|NCT00411086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243724|NCT00411086|Immunologic Factors|immunologic factors|mesh-ancestor
92243725|NCT00411086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243726|NCT00411086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92243727|NCT01658904|Melphalan|melphalan|mesh-list
92243728|NCT01658904|Immunologic Factors|immunologic factors|mesh-ancestor
92243729|NCT01658904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243730|NCT01658904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92243731|NCT01658904|Alkylating Agents|alkylating agents|mesh-ancestor
92243732|NCT01658904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243733|NCT01658904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243734|NCT01658904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92243735|NCT01658904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243736|NCT05238948|Midazolam|midazolam|mesh-list
92243737|NCT05238948|CKD-506|ckd-506|mesh-list
92243738|NCT05238948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92243739|NCT05238948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92243740|NCT05238948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934663|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243741|NCT05238948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243742|NCT05238948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92243743|NCT05238948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92243744|NCT05238948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243745|NCT05238948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92243746|NCT05238948|Anesthetics, General|anesthetics, general|mesh-ancestor
92243747|NCT05238948|Anesthetics|anesthetics|mesh-ancestor
92243748|NCT05238948|GABA Modulators|gaba modulators|mesh-ancestor
92243749|NCT05238948|GABA Agents|gaba agents|mesh-ancestor
92243750|NCT05238948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243751|NCT05238948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243752|NCT05238948|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92243753|NCT05238948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243754|NCT00385580|Dasatinib|dasatinib|mesh-list
92243755|NCT00385580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243756|NCT00385580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92243757|NCT00385580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243758|NCT00385580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243759|NCT05236530|Metformin|metformin|mesh-list
92243760|NCT05236530|Repaglinide|repaglinide|mesh-list
92243761|NCT05236530|Lumefantrine|lumefantrine|mesh-list
92243762|NCT05236530|Dolutegravir|dolutegravir|mesh-list
92243763|NCT05236530|Midazolam|midazolam|mesh-list
92243764|NCT05236530|Dextromethorphan|dextromethorphan|mesh-list
92243765|NCT05236530|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92243766|NCT05236530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92243767|NCT05236530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243768|NCT05236530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92243769|NCT05236530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92341227|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92243770|NCT05236530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243772|NCT05236530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92243773|NCT05236530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243774|NCT05236530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92243775|NCT05236530|Anesthetics, General|anesthetics, general|mesh-ancestor
92243776|NCT05236530|Anesthetics|anesthetics|mesh-ancestor
92243777|NCT05236530|GABA Modulators|gaba modulators|mesh-ancestor
92243778|NCT05236530|GABA Agents|gaba agents|mesh-ancestor
92243779|NCT05236530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243780|NCT05236530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243781|NCT05236530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92243782|NCT05236530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92243783|NCT05236530|Antimetabolites|antimetabolites|mesh-ancestor
92243784|NCT05236530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92243785|NCT05236530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92243786|NCT05236530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243787|NCT05236530|Antimalarials|antimalarials|mesh-ancestor
92243788|NCT05236530|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92243789|NCT05236530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92243790|NCT05236530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243791|NCT05236530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92243792|NCT05236530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92243793|NCT05236530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92243794|NCT05236530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92243795|NCT05236530|Antiviral Agents|antiviral agents|mesh-ancestor
92243796|NCT05236530|Antitussive Agents|antitussive agents|mesh-ancestor
92243797|NCT05236530|Respiratory System Agents|respiratory system agents|mesh-ancestor
92243798|NCT05236530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92243799|NCT05236530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92243800|NCT00455702|Cycloserine|cycloserine|mesh-list
92243801|NCT00455702|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92243802|NCT00455702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243803|NCT00455702|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92243804|NCT00455702|Antitubercular Agents|antitubercular agents|mesh-ancestor
92243805|NCT00455702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92243806|NCT00455702|Antimetabolites|antimetabolites|mesh-ancestor
92243807|NCT00455702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243808|NCT00456014|Desipramine|desipramine|mesh-list
92243809|NCT00456014|Escitalopram|escitalopram|mesh-list
92243810|NCT00456014|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92243811|NCT00456014|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92243812|NCT00456014|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243813|NCT00456014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243814|NCT00456014|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243815|NCT00456014|Serotonin Agents|serotonin agents|mesh-ancestor
92243816|NCT00456014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243817|NCT00456014|Antidepressive Agents|antidepressive agents|mesh-ancestor
92243818|NCT00456014|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243819|NCT00456014|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92243820|NCT00456014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243821|NCT00456014|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92243822|NCT00456014|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243823|NCT05235516|Cisplatin|cisplatin|mesh-list
92243824|NCT05235516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243825|NCT00411398|Memantine|memantine|mesh-list
92243826|NCT00411398|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92243827|NCT00411398|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92243828|NCT00411398|Dopamine Agents|dopamine agents|mesh-ancestor
92243829|NCT00411398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243830|NCT00411398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243831|NCT00411398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243832|NCT00411398|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92243833|NCT00411398|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92243834|NCT05231694|Mitogens|mitogens|mesh-list
92243835|NCT05231694|Mitosis Modulators|mitosis modulators|mesh-ancestor
92243836|NCT05231694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243837|NCT00457730|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92243838|NCT00457730|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92243839|NCT00457730|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92243840|NCT00457730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92243841|NCT00457730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243842|NCT00457730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243843|NCT00457730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243845|NCT00457730|Sensory System Agents|sensory system agents|mesh-ancestor
92243846|NCT00457730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243847|NCT00457730|Antidepressive Agents|antidepressive agents|mesh-ancestor
92243848|NCT00457730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243849|NCT00457730|Dopamine Agents|dopamine agents|mesh-ancestor
92243850|NCT00458822|Dexamethasone|dexamethasone|mesh-list
92243851|NCT00458822|Bortezomib|bortezomib|mesh-list
92243852|NCT00458822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243853|NCT00458822|Antiemetics|antiemetics|mesh-ancestor
92243854|NCT00458822|Autonomic Agents|autonomic agents|mesh-ancestor
92243855|NCT00458822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243856|NCT00458822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243857|NCT00458822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92243858|NCT00458822|Glucocorticoids|glucocorticoids|mesh-ancestor
92243859|NCT00458822|Hormones|hormones|mesh-ancestor
92243860|NCT00458822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92243861|NCT00458822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92243862|NCT00458822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243863|NCT00389168|Atenolol|atenolol|mesh-list
92243864|NCT00389168|Irbesartan|irbesartan|mesh-list
92243865|NCT00389168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243866|NCT00389168|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92243867|NCT00389168|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92243868|NCT00389168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243869|NCT00389168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92243870|NCT00389168|Sympatholytics|sympatholytics|mesh-ancestor
92243871|NCT00389168|Autonomic Agents|autonomic agents|mesh-ancestor
92243872|NCT00389168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243873|NCT00389168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243874|NCT00389168|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92243875|NCT00389168|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92243876|NCT00389168|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92243877|NCT00389168|Adrenergic Agents|adrenergic agents|mesh-ancestor
92243878|NCT00389168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243879|NCT00462020|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92243880|NCT00462020|Metronidazole|metronidazole|mesh-list
92243881|NCT00462020|Ceftriaxone|ceftriaxone|mesh-list
92243882|NCT00462020|Clavulanic Acids|clavulanic acids|mesh-list
92243883|NCT00462020|Clavulanic Acid|clavulanic acid|mesh-list
92243884|NCT00462020|Ampicillin|ampicillin|mesh-list
92243885|NCT00462020|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92243886|NCT00462020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243887|NCT00462020|Antitubercular Agents|antitubercular agents|mesh-ancestor
92243889|NCT00462020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92243890|NCT00462020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243891|NCT00462020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243892|NCT00462020|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92243893|NCT05177718|Natalizumab|natalizumab|mesh-list
92243894|NCT05177718|Immunologic Factors|immunologic factors|mesh-ancestor
92243895|NCT05177718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243896|NCT00414206|Mecamylamine|mecamylamine|mesh-list
92243897|NCT00414206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92243898|NCT00414206|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92243899|NCT00414206|Autonomic Agents|autonomic agents|mesh-ancestor
92243900|NCT00414206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243901|NCT00414206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243902|NCT00414206|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92243903|NCT00414206|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92243904|NCT00414206|Cholinergic Agents|cholinergic agents|mesh-ancestor
92243905|NCT00414206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243906|NCT00414206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243907|NCT05480046|Risperidone|risperidone|mesh-list
92243908|NCT05480046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92243909|NCT05480046|Serotonin Agents|serotonin agents|mesh-ancestor
92243910|NCT05480046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243911|NCT05480046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243913|NCT05480046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92243914|NCT05480046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92243915|NCT05480046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243916|NCT05480046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243917|NCT05480046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92243919|NCT04241640|Nefopam|nefopam|mesh-list
92243920|NCT04241640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92243921|NCT04241640|Analgesics|analgesics|mesh-ancestor
92243922|NCT04241640|Sensory System Agents|sensory system agents|mesh-ancestor
92243923|NCT04241640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243924|NCT04241640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243925|NCT00462332|Vidarabine|vidarabine|mesh-list
92243926|NCT00462332|Fludarabine|fludarabine|mesh-list
92243927|NCT00462332|Fludarabine phosphate|fludarabine phosphate|mesh-list
92243928|NCT00462332|Alemtuzumab|alemtuzumab|mesh-list
92243929|NCT00462332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243930|NCT00462332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92243931|NCT00462332|Antimetabolites|antimetabolites|mesh-ancestor
92243932|NCT00462332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243933|NCT00462332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243934|NCT00462332|Immunologic Factors|immunologic factors|mesh-ancestor
92243935|NCT00462332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243936|NCT00462332|Antiviral Agents|antiviral agents|mesh-ancestor
92243937|NCT00462332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243938|NCT00462332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92243939|NCT00462644|Fentanyl|fentanyl|mesh-list
92243940|NCT00462644|Midazolam|midazolam|mesh-list
92243941|NCT00462644|Etomidate|etomidate|mesh-list
92243942|NCT00462644|Succinylcholine|succinylcholine|mesh-list
92243943|NCT00462644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92243944|NCT00462644|Narcotics|narcotics|mesh-ancestor
92243945|NCT00462644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92243946|NCT00462644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243947|NCT00462644|Analgesics|analgesics|mesh-ancestor
92243948|NCT00462644|Sensory System Agents|sensory system agents|mesh-ancestor
92243949|NCT00462644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243950|NCT00462644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92243951|NCT00462644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92243952|NCT00462644|Anesthetics, General|anesthetics, general|mesh-ancestor
92243953|NCT00462644|Anesthetics|anesthetics|mesh-ancestor
92243954|NCT00462644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92243955|NCT00462644|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92243956|NCT00462644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92243957|NCT00462644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92243958|NCT00462644|GABA Modulators|gaba modulators|mesh-ancestor
92243959|NCT00462644|GABA Agents|gaba agents|mesh-ancestor
92243960|NCT00462644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92243961|NCT00462644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243962|NCT00462644|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92243964|NCT00462644|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92243965|NCT00462722|Ibuprofen|ibuprofen|mesh-list
92243966|NCT00462722|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92243967|NCT00462722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92243968|NCT00462722|Analgesics|analgesics|mesh-ancestor
92243969|NCT00462722|Sensory System Agents|sensory system agents|mesh-ancestor
92243970|NCT00462722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92243971|NCT00462722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243972|NCT00462722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92243973|NCT00462722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92243974|NCT00462722|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92243975|NCT00462722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243976|NCT00462722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243977|NCT05272254|Povidone-Iodine|povidone-iodine|mesh-list
92243978|NCT05272254|Povidone|povidone|mesh-list
92243979|NCT05272254|Plasma Substitutes|plasma substitutes|mesh-ancestor
92243980|NCT05272254|Blood Substitutes|blood substitutes|mesh-ancestor
92243981|NCT05272254|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92243982|NCT05272254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243983|NCT00528398|Cytarabine|cytarabine|mesh-list
92243984|NCT00528398|Idarubicin|idarubicin|mesh-list
92243985|NCT00528398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341408|NCT03058289|Pembrolizumab|pembrolizumab|mesh-list
92243986|NCT00528398|Antimetabolites|antimetabolites|mesh-ancestor
92243987|NCT00528398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92243988|NCT00528398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92243989|NCT00528398|Antiviral Agents|antiviral agents|mesh-ancestor
92243990|NCT00528398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92243991|NCT00528398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92243992|NCT00528398|Immunologic Factors|immunologic factors|mesh-ancestor
92243993|NCT00528398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92243994|NCT00528398|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92243995|NCT00528398|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92243996|NCT00528398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92243997|NCT00528398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92243998|NCT00528788|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92243999|NCT00528788|Vitamins|vitamins|mesh-ancestor
92244000|NCT00528788|Micronutrients|micronutrients|mesh-ancestor
92244001|NCT00528788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244002|NCT00528788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92244003|NCT00414518|Ritonavir|ritonavir|mesh-list
92244004|NCT00414518|Lopinavir|lopinavir|mesh-list
92244005|NCT00414518|Tenofovir|tenofovir|mesh-list
92244006|NCT00414518|Emtricitabine|emtricitabine|mesh-list
92244007|NCT00414518|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92244008|NCT00414518|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92244009|NCT00414518|Protease Inhibitors|protease inhibitors|mesh-ancestor
92244010|NCT00414518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244011|NCT00414518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244012|NCT00414518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92244013|NCT00414518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92244014|NCT00414518|Antiviral Agents|antiviral agents|mesh-ancestor
92244015|NCT00414518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244016|NCT00414518|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92244017|NCT00414518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92244018|NCT00414518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92244019|NCT00414518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92244020|NCT01795664|Fluticasone|fluticasone|mesh-list
92244021|NCT01795664|Xhance|xhance|mesh-list
92244022|NCT01795664|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92244023|NCT01795664|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92244024|NCT01795664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244025|NCT01795664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92244026|NCT01795664|Autonomic Agents|autonomic agents|mesh-ancestor
92244027|NCT01795664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244028|NCT01795664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244029|NCT01795664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92244030|NCT01795664|Respiratory System Agents|respiratory system agents|mesh-ancestor
92244031|NCT01795664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92244032|NCT01795664|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92244033|NCT01795664|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92244034|NCT01795664|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92244035|NCT01795664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92244036|NCT01795664|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244037|NCT01795664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244038|NCT01795664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244040|NCT01795664|Hormones|hormones|mesh-ancestor
92244041|NCT01795664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244042|NCT01795664|Sympathomimetics|sympathomimetics|mesh-ancestor
92244043|NCT05271084|Pentoxifylline|pentoxifylline|mesh-list
92244044|NCT05271084|Dexetimide|dexetimide|mesh-list
92244045|NCT05271084|Citalopram|citalopram|mesh-list
92244046|NCT05271084|Escitalopram|escitalopram|mesh-list
92244047|NCT05271084|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92244048|NCT05271084|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92244049|NCT05271084|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244050|NCT05271084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244051|NCT05271084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244052|NCT05271084|Serotonin Agents|serotonin agents|mesh-ancestor
92244053|NCT05271084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244054|NCT05271084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92244055|NCT05271084|Antidepressive Agents|antidepressive agents|mesh-ancestor
92244056|NCT05271084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244057|NCT05271084|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92244058|NCT05271084|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92244059|NCT05271084|Parasympatholytics|parasympatholytics|mesh-ancestor
92244060|NCT05271084|Autonomic Agents|autonomic agents|mesh-ancestor
92244061|NCT05271084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244062|NCT05271084|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92244063|NCT05271084|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92244064|NCT05271084|Cholinergic Agents|cholinergic agents|mesh-ancestor
92244065|NCT05271084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92244066|NCT05271084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244067|NCT05271084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92244068|NCT05271084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92244069|NCT05271084|Protective Agents|protective agents|mesh-ancestor
92244070|NCT05271084|Vasodilator Agents|vasodilator agents|mesh-ancestor
92244071|NCT05271084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92244072|NCT05271084|Antioxidants|antioxidants|mesh-ancestor
92244073|NCT00531518|Lamotrigine|lamotrigine|mesh-list
92244074|NCT00531518|Aripiprazole|aripiprazole|mesh-list
92244075|NCT00531518|Bupropion|bupropion|mesh-list
92244076|NCT00531518|Fluoxetine|fluoxetine|mesh-list
92244077|NCT00531518|Sertraline|sertraline|mesh-list
92244078|NCT00531518|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92244079|NCT00531518|Antidepressive Agents|antidepressive agents|mesh-ancestor
92244080|NCT00531518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244081|NCT00531518|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92244082|NCT00531518|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92244083|NCT00531518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117531|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92244084|NCT00531518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244085|NCT00531518|Dopamine Agents|dopamine agents|mesh-ancestor
92244086|NCT00531518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244087|NCT00531518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244088|NCT00531518|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92244089|NCT00531518|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92244090|NCT00531518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244091|NCT00531518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244092|NCT00531518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244093|NCT00531518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244094|NCT00531518|Dopamine Agonists|dopamine agonists|mesh-ancestor
92244095|NCT00531518|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92244096|NCT00531518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92244097|NCT00531518|Serotonin Agents|serotonin agents|mesh-ancestor
92244098|NCT00531518|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92244099|NCT00531518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92244100|NCT00531518|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92244101|NCT00531518|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92244102|NCT00531518|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92244103|NCT00531518|Anticonvulsants|anticonvulsants|mesh-ancestor
92244104|NCT00531518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92244105|NCT00531518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92244106|NCT00531518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92244107|NCT00533546|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92244108|NCT00533546|Protein C|protein c|mesh-list
92244109|NCT00533546|Anticoagulants|anticoagulants|mesh-ancestor
92244110|NCT00533546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92244112|NCT00533546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244113|NCT00533546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244114|NCT00534794|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92244115|NCT00534794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92244116|NCT00534794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244117|NCT00534794|Analgesics|analgesics|mesh-ancestor
92244118|NCT00534794|Sensory System Agents|sensory system agents|mesh-ancestor
92244119|NCT00534794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244120|NCT00534794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244121|NCT00534794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244122|NCT00534794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244123|NCT00534794|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92244124|NCT00534794|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92244125|NCT00534794|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92244126|NCT00534794|Histamine Antagonists|histamine antagonists|mesh-ancestor
92244127|NCT00534794|Histamine Agents|histamine agents|mesh-ancestor
92244128|NCT00534794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244129|NCT00534794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244130|NCT01658436|Dactolisib|dactolisib|mesh-list
92244131|NCT01658436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244132|NCT05168280|Dexmedetomidine|dexmedetomidine|mesh-list
92244133|NCT05168280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92244134|NCT05168280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244135|NCT05168280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244136|NCT05168280|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244138|NCT05168280|Sensory System Agents|sensory system agents|mesh-ancestor
92244139|NCT05168280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244140|NCT05168280|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92244141|NCT05168280|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92244142|NCT05168280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92244143|NCT05168280|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244144|NCT05168280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244145|NCT05168280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244146|NCT05053854|Talazoparib|talazoparib|mesh-list
92244147|NCT05053854|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92244148|NCT05053854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244149|NCT05053854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244150|NCT05053854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244151|NCT00464204|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92244152|NCT00464204|Plasma Substitutes|plasma substitutes|mesh-ancestor
92244153|NCT00464204|Blood Substitutes|blood substitutes|mesh-ancestor
92244154|NCT00464438|Moxifloxacin|moxifloxacin|mesh-list
92244155|NCT00464438|Gatifloxacin|gatifloxacin|mesh-list
92244156|NCT00464438|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92244157|NCT00464438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244158|NCT00464438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244159|NCT00464438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92244160|NCT00464438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92244161|NCT00464438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244162|NCT00464438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244163|NCT00464438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244164|NCT00464438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92244165|NCT00465530|Gentamicins|gentamicins|mesh-list
92244166|NCT00465530|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244167|NCT00465530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244168|NCT00465530|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92244169|NCT00465530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244170|NCT00465530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244171|NCT00466310|Risperidone|risperidone|mesh-list
92244172|NCT00466310|Aripiprazole|aripiprazole|mesh-list
92244173|NCT00466310|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92244174|NCT00466310|Serotonin Agents|serotonin agents|mesh-ancestor
92244175|NCT00466310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244176|NCT00466310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244177|NCT00466310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244178|NCT00466310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244179|NCT00466310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244180|NCT00466310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244181|NCT00466310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244182|NCT00466310|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92244184|NCT00466310|Antidepressive Agents|antidepressive agents|mesh-ancestor
92244185|NCT00466310|Dopamine Agonists|dopamine agonists|mesh-ancestor
92244186|NCT00466310|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92244187|NCT00466310|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92244188|NCT00466310|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92244189|NCT00466310|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92244190|NCT03463460|Pembrolizumab|pembrolizumab|mesh-list
92244191|NCT03463460|Sunitinib|sunitinib|mesh-list
92244192|NCT03463460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244193|NCT03463460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244194|NCT03463460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92244195|NCT03463460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244196|NCT03463460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92244197|NCT03463460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92244198|NCT03463460|Growth Substances|growth substances|mesh-ancestor
92244199|NCT03463460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244200|NCT03463460|Growth Inhibitors|growth inhibitors|mesh-ancestor
92244201|NCT03463460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92244202|NCT03463460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244203|NCT00535652|Ertapenem|ertapenem|mesh-list
92244204|NCT00535652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244205|NCT00535652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244206|NCT00418028|Capecitabine|capecitabine|mesh-list
92244207|NCT00418028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92244208|NCT00418028|Antimetabolites|antimetabolites|mesh-ancestor
92244209|NCT00418028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244210|NCT00418028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244211|NCT00537290|Rituximab|rituximab|mesh-list
92244212|NCT00537290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244213|NCT00537290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244214|NCT00537290|Immunologic Factors|immunologic factors|mesh-ancestor
92244215|NCT00537290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244216|NCT00537290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244217|NCT00538304|Bimatoprost|bimatoprost|mesh-list
92244218|NCT00538304|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92244219|NCT00538304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92244220|NCT00538304|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92244221|NCT00538616|Dexmedetomidine|dexmedetomidine|mesh-list
92244222|NCT00538616|Propofol|propofol|mesh-list
92244223|NCT00538616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92244224|NCT00538616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244225|NCT00538616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244226|NCT00538616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244227|NCT00538616|Analgesics|analgesics|mesh-ancestor
92244228|NCT00538616|Sensory System Agents|sensory system agents|mesh-ancestor
92244229|NCT00538616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244230|NCT00538616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92244231|NCT00538616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92244232|NCT00538616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92244233|NCT00538616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244234|NCT00538616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244235|NCT00538616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244236|NCT00538616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92244237|NCT00538616|Anesthetics, General|anesthetics, general|mesh-ancestor
92244238|NCT00538616|Anesthetics|anesthetics|mesh-ancestor
92244239|NCT00469274|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92244240|NCT00469274|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92244241|NCT00469274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244242|NCT00469274|Antitubercular Agents|antitubercular agents|mesh-ancestor
92244243|NCT05157126|Gentamicins|gentamicins|mesh-list
92244244|NCT05157126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244245|NCT05157126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244246|NCT05157126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92244247|NCT05157126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244248|NCT05157126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244249|NCT00469508|Modafinil|modafinil|mesh-list
92244250|NCT00469508|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92244251|NCT00469508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244252|NCT00469508|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92244253|NCT00469508|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92244254|NCT00469508|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92244255|NCT00469508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244258|NCT05096832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244259|NCT00470600|Ibuprofen|ibuprofen|mesh-list
92244260|NCT00470600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92244261|NCT00470600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244262|NCT00470600|Analgesics|analgesics|mesh-ancestor
92244263|NCT00470600|Sensory System Agents|sensory system agents|mesh-ancestor
92244264|NCT00470600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244265|NCT00470600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244266|NCT00470600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244267|NCT00470600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244268|NCT00470600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92244269|NCT00470600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244270|NCT00470600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244271|NCT00471068|Timolol|timolol|mesh-list
92244272|NCT00471068|Travoprost|travoprost|mesh-list
92244273|NCT00471068|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92244274|NCT00471068|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92244275|NCT00471068|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244276|NCT00471068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244277|NCT00471068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244278|NCT00471068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244279|NCT00471068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92244280|NCT00471068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92244282|NCT00471380|Travoprost|travoprost|mesh-list
92244283|NCT00471380|Dorzolamide|dorzolamide|mesh-list
92244284|NCT00471380|Brinzolamide|brinzolamide|mesh-list
92244285|NCT00471380|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92244286|NCT00471380|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92244287|NCT00471380|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244288|NCT00471380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244289|NCT00471380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244290|NCT00471380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244291|NCT00471380|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92244292|NCT00471380|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92244293|NCT00471380|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92244294|NCT00471380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244295|NCT00471848|Thymoglobulin|thymoglobulin|mesh-list
92244296|NCT00471848|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92244297|NCT00471848|Immunologic Factors|immunologic factors|mesh-ancestor
92244298|NCT00471848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244299|NCT00471848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244300|NCT00538850|Fentanyl|fentanyl|mesh-list
92244301|NCT00538850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92244302|NCT00538850|Narcotics|narcotics|mesh-ancestor
92244303|NCT00538850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244304|NCT00538850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244305|NCT00538850|Analgesics|analgesics|mesh-ancestor
92244306|NCT00538850|Sensory System Agents|sensory system agents|mesh-ancestor
92244307|NCT00538850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244308|NCT00538850|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92244309|NCT00538850|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92244310|NCT00538850|Anesthetics, General|anesthetics, general|mesh-ancestor
92244311|NCT00538850|Anesthetics|anesthetics|mesh-ancestor
92244312|NCT00418262|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92244313|NCT00418262|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92244314|NCT00418262|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92244315|NCT00418262|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244316|NCT00418262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244317|NCT00418262|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244318|NCT00418262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244319|NCT00418262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244320|NCT00418574|Abagovomab|abagovomab|mesh-list
92244321|NCT00418574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244322|NCT00418574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244323|NCT00473642|Ranibizumab|ranibizumab|mesh-list
92244324|NCT00473642|Verteporfin|verteporfin|mesh-list
92244325|NCT00473642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92244326|NCT00473642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92244327|NCT00473642|Growth Substances|growth substances|mesh-ancestor
92244328|NCT00473642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244329|NCT00473642|Growth Inhibitors|growth inhibitors|mesh-ancestor
92244330|NCT00473642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244331|NCT00473642|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92244332|NCT00473642|Dermatologic Agents|dermatologic agents|mesh-ancestor
92244333|NCT00539942|PENTA|penta|mesh-list
92244334|NCT00539942|Fondaparinux|fondaparinux|mesh-list
92244335|NCT00539942|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92244336|NCT00539942|Antithrombins|antithrombins|mesh-ancestor
92244337|NCT00539942|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92244338|NCT00539942|Protease Inhibitors|protease inhibitors|mesh-ancestor
92244339|NCT00539942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244340|NCT00539942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244341|NCT00539942|Anticoagulants|anticoagulants|mesh-ancestor
92244342|NCT00539942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92244343|NCT00539942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92244344|NCT00419666|Calcitriol|calcitriol|mesh-list
92244345|NCT00419666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92244346|NCT00419666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244347|NCT00419666|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92244348|NCT00419666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244349|NCT00419666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244350|NCT00419666|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92244351|NCT00419666|Vitamins|vitamins|mesh-ancestor
92244352|NCT00419666|Micronutrients|micronutrients|mesh-ancestor
92244353|NCT00419666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92244354|NCT00540722|Acetic Acid|acetic acid|mesh-list
92244355|NCT00540722|Retinol acetate|retinol acetate|mesh-list
92244357|NCT00540722|Gossypol|gossypol|mesh-list
92244358|NCT00540722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244359|NCT00540722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244360|NCT00540722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92244361|NCT00540722|Immunologic Factors|immunologic factors|mesh-ancestor
92244362|NCT00540722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244363|NCT00540722|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92244364|NCT00540722|Protective Agents|protective agents|mesh-ancestor
92244365|NCT00540722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244366|NCT00540722|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92244367|NCT00540722|Contraceptive Agents|contraceptive agents|mesh-ancestor
92244368|NCT00540722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92244369|NCT00540722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92244370|NCT00540722|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92244371|NCT00540722|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92244372|NCT00540722|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92244373|NCT00542750|Acetylcysteine|acetylcysteine|mesh-list
92244374|NCT00542750|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92244375|NCT00542750|Antiviral Agents|antiviral agents|mesh-ancestor
92244376|NCT00542750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244377|NCT00542750|Expectorants|expectorants|mesh-ancestor
92244378|NCT00542750|Respiratory System Agents|respiratory system agents|mesh-ancestor
92244379|NCT00542750|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92244380|NCT00542750|Antioxidants|antioxidants|mesh-ancestor
92244381|NCT00542750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244382|NCT00542750|Protective Agents|protective agents|mesh-ancestor
92244383|NCT00542750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244384|NCT00542750|Antidotes|antidotes|mesh-ancestor
92244385|NCT00475904|Gabapentin|gabapentin|mesh-list
92244386|NCT00475904|Analgesics|analgesics|mesh-ancestor
92244387|NCT00475904|Sensory System Agents|sensory system agents|mesh-ancestor
92244388|NCT00475904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244389|NCT00475904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244390|NCT00475904|Anticonvulsants|anticonvulsants|mesh-ancestor
92244391|NCT00475904|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92244392|NCT00475904|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244393|NCT00475904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244394|NCT00475904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244395|NCT00475904|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92244396|NCT00475904|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92244397|NCT00475904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244398|NCT00475904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244399|NCT00475904|Antimanic Agents|antimanic agents|mesh-ancestor
92244400|NCT00420992|Naltrexone|naltrexone|mesh-list
92244401|NCT00420992|Morphine|morphine|mesh-list
92244402|NCT00420992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92244404|NCT00420992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244405|NCT00420992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244406|NCT00420992|Analgesics|analgesics|mesh-ancestor
92244407|NCT00420992|Sensory System Agents|sensory system agents|mesh-ancestor
92244408|NCT00420992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244409|NCT00420992|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92244410|NCT00420992|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92244411|NCT00423878|Olanzapine|olanzapine|mesh-list
92244412|NCT00423878|Risperidone|risperidone|mesh-list
92244413|NCT00423878|Aripiprazole|aripiprazole|mesh-list
92244414|NCT00423878|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92244415|NCT00423878|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92244416|NCT00423878|Serotonin Agents|serotonin agents|mesh-ancestor
92244417|NCT00423878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244418|NCT00423878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244419|NCT00423878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244420|NCT00423878|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244421|NCT00423878|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244422|NCT00423878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244423|NCT00423878|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244424|NCT00423878|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92244425|NCT00423878|Dopamine Agents|dopamine agents|mesh-ancestor
92244426|NCT00423878|Antiemetics|antiemetics|mesh-ancestor
92244427|NCT00423878|Autonomic Agents|autonomic agents|mesh-ancestor
92244428|NCT00423878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244429|NCT00423878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244430|NCT00423878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92244431|NCT00423878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92244432|NCT00423878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244433|NCT00423878|Antidepressive Agents|antidepressive agents|mesh-ancestor
92244434|NCT00423878|Dopamine Agonists|dopamine agonists|mesh-ancestor
92244435|NCT00423878|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92244436|NCT00423878|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92244437|NCT00423878|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92244438|NCT00423878|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92244439|NCT00480740|Dexmedetomidine|dexmedetomidine|mesh-list
92244440|NCT00480740|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92244441|NCT00480740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244442|NCT00480740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244443|NCT00480740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244444|NCT00480740|Analgesics|analgesics|mesh-ancestor
92244445|NCT00480740|Sensory System Agents|sensory system agents|mesh-ancestor
92244446|NCT00480740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244447|NCT00480740|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92244448|NCT00480740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92244449|NCT00480740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92244450|NCT00480740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92244451|NCT00480740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244452|NCT00480740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244453|NCT00424502|Rituximab|rituximab|mesh-list
92244454|NCT00424502|Methotrexate|methotrexate|mesh-list
92244455|NCT00424502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244456|NCT00424502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244457|NCT00424502|Immunologic Factors|immunologic factors|mesh-ancestor
92244458|NCT00424502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244459|NCT00424502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244460|NCT00424502|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92244461|NCT00424502|Abortifacient Agents|abortifacient agents|mesh-ancestor
92244462|NCT00424502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92244463|NCT00424502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92244464|NCT00424502|Antimetabolites|antimetabolites|mesh-ancestor
92244465|NCT00424502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244466|NCT00424502|Dermatologic Agents|dermatologic agents|mesh-ancestor
92244467|NCT00424502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244468|NCT00424502|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92244469|NCT00424502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244470|NCT00424502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92244471|NCT00425672|Interleukin-2|interleukin-2|mesh-list
91934675|NCT02232581|Alovudine|alovudine|mesh-list
92244472|NCT00425672|Denileukin diftitox|denileukin diftitox|mesh-list
92244473|NCT00425672|Immunotoxins|immunotoxins|mesh-list
92244474|NCT00425672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244475|NCT00425672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244476|NCT00425672|Analgesics|analgesics|mesh-ancestor
92244477|NCT00425672|Sensory System Agents|sensory system agents|mesh-ancestor
92244478|NCT00425672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244479|NCT00425672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244480|NCT00425672|Immunoconjugates|immunoconjugates|mesh-ancestor
92244481|NCT00425672|Immunologic Factors|immunologic factors|mesh-ancestor
92244482|NCT00544076|Sildenafil Citrate|sildenafil citrate|mesh-list
92244483|NCT00544076|Alprostadil|alprostadil|mesh-list
92244484|NCT00544076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244485|NCT00544076|Vasodilator Agents|vasodilator agents|mesh-ancestor
92244486|NCT00544076|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92244487|NCT00544076|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92244488|NCT00544076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244489|NCT00544076|Urological Agents|urological agents|mesh-ancestor
92244490|NCT00544076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92244491|NCT00544778|Doxorubicin|doxorubicin|mesh-list
92244492|NCT00544778|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92244493|NCT00544778|Dexrazoxane|dexrazoxane|mesh-list
92244494|NCT00544778|Irinotecan|irinotecan|mesh-list
92244495|NCT00544778|Ifosfamide|ifosfamide|mesh-list
92244496|NCT00544778|Razoxane|razoxane|mesh-list
92244497|NCT00544778|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92244498|NCT00544778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244499|NCT00544778|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92244500|NCT00544778|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92244501|NCT00544778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244502|NCT00544778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244503|NCT00544778|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92244504|NCT00544778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244505|NCT00544778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92244506|NCT00544778|Alkylating Agents|alkylating agents|mesh-ancestor
92244507|NCT00544778|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92244508|NCT00544778|Protective Agents|protective agents|mesh-ancestor
92244509|NCT00544778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92244510|NCT00544778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92244511|NCT00484874|Tositumomab I-131|tositumomab i-131|mesh-list
92244512|NCT00484874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244514|NCT00486824|Nifedipine|nifedipine|mesh-list
92244515|NCT00486824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92244516|NCT00486824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244517|NCT00486824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244518|NCT00486824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92341602|NCT00383357|Zolpidem|zolpidem|mesh-list
92244519|NCT00486824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244520|NCT00486824|Vasodilator Agents|vasodilator agents|mesh-ancestor
92244521|NCT00486824|Tocolytic Agents|tocolytic agents|mesh-ancestor
92244522|NCT00486824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92244523|NCT00486824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92244524|NCT00486824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244525|NCT00486824|Analgesics|analgesics|mesh-ancestor
92244526|NCT00486824|Sensory System Agents|sensory system agents|mesh-ancestor
92244527|NCT00486824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244528|NCT00486824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244529|NCT00486824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244530|NCT00486824|Gout Suppressants|gout suppressants|mesh-ancestor
92244531|NCT00486824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92244532|NCT00486824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244533|NCT00489086|Tazarotene|tazarotene|mesh-list
92244534|NCT00489086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92244535|NCT00489086|Keratolytic Agents|keratolytic agents|mesh-ancestor
92244536|NCT00489866|Aripiprazole|aripiprazole|mesh-list
92244537|NCT00489866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92244538|NCT00489866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244539|NCT00489866|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244540|NCT00489866|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244541|NCT00489866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244542|NCT00489866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244543|NCT00489866|Dopamine Agonists|dopamine agonists|mesh-ancestor
92244544|NCT00489866|Dopamine Agents|dopamine agents|mesh-ancestor
92244545|NCT00489866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244546|NCT00489866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244547|NCT00489866|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92244548|NCT00489866|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92244550|NCT00489866|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92244551|NCT00489866|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92244552|NCT00489866|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92244553|NCT00489866|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92244555|NCT00546104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244556|NCT00546104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92244557|NCT00546104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244558|NCT00546104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244559|NCT00546728|Metformin|metformin|mesh-list
92244560|NCT00546728|Exenatide|exenatide|mesh-list
92244561|NCT00546728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92244562|NCT00546728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244563|NCT00546728|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92244564|NCT00546728|Incretins|incretins|mesh-ancestor
92244565|NCT00546728|Hormones|hormones|mesh-ancestor
92244566|NCT00546728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244567|NCT00547586|Bromides|bromides|mesh-list
92244568|NCT00547586|Methylnaltrexone|methylnaltrexone|mesh-list
92244569|NCT00547586|Anticonvulsants|anticonvulsants|mesh-ancestor
92244570|NCT00547586|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92244571|NCT00547586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244572|NCT00547586|Sensory System Agents|sensory system agents|mesh-ancestor
92244573|NCT00547586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244574|NCT00548132|Chlorhexidine|chlorhexidine|mesh-list
92244575|NCT00548132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92244576|NCT00548132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244577|NCT00548132|Disinfectants|disinfectants|mesh-ancestor
92244578|NCT00490100|Mecasermin|mecasermin|mesh-list
92244579|NCT00490100|Growth Substances|growth substances|mesh-ancestor
92244580|NCT00490100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244582|NCT00490802|Oxytocics|oxytocics|mesh-ancestor
92244583|NCT00490802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92244584|NCT00490802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244585|NCT00550394|Topiramate|topiramate|mesh-list
92244586|NCT00550394|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92244587|NCT00550394|Antidepressive Agents|antidepressive agents|mesh-ancestor
92244588|NCT00550394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244589|NCT00550394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244590|NCT00550394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244591|NCT00550394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244592|NCT00550394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244593|NCT00550394|Anticonvulsants|anticonvulsants|mesh-ancestor
92244594|NCT00550394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92244595|NCT00550862|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92244596|NCT00550862|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92244597|NCT00550862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244598|NCT00551174|Ibandronic Acid|ibandronic acid|mesh-list
92244599|NCT00551174|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92244600|NCT00551174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244601|NCT00492206|Cetuximab|cetuximab|mesh-list
92244602|NCT00492206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244603|NCT00492206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244604|NCT00431132|Estradiol|estradiol|mesh-list
92244605|NCT00431132|Estrogens|estrogens|mesh-ancestor
92244606|NCT00431132|Hormones|hormones|mesh-ancestor
92244607|NCT00431132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244608|NCT00431132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244609|NCT00493064|Niacin|niacin|mesh-list
92244610|NCT00493064|Nicotinic Acids|nicotinic acids|mesh-list
92244611|NCT00493064|Niacinamide|niacinamide|mesh-list
92244612|NCT00493064|Prednisolone|prednisolone|mesh-list
92244613|NCT00493064|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92244614|NCT00493064|Methylprednisolone|methylprednisolone|mesh-list
92244615|NCT00493064|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92244616|NCT00493064|Prednisolone acetate|prednisolone acetate|mesh-list
92244617|NCT00493064|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92244618|NCT00493064|Prednisolone phosphate|prednisolone phosphate|mesh-list
92244619|NCT00493064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244620|NCT00493064|Glucocorticoids|glucocorticoids|mesh-ancestor
92244621|NCT00493064|Hormones|hormones|mesh-ancestor
92244622|NCT00493064|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244623|NCT00493064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244624|NCT00493064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92244626|NCT00493064|Antiemetics|antiemetics|mesh-ancestor
92244627|NCT00493064|Autonomic Agents|autonomic agents|mesh-ancestor
92244628|NCT00493064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244629|NCT00493064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244630|NCT00493064|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92244631|NCT00493064|Protective Agents|protective agents|mesh-ancestor
92244632|NCT00493064|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92244633|NCT00493064|Antimetabolites|antimetabolites|mesh-ancestor
92244634|NCT00493064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244635|NCT00493064|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92244636|NCT00493064|Vasodilator Agents|vasodilator agents|mesh-ancestor
92244637|NCT00493064|Vitamin B Complex|vitamin b complex|mesh-ancestor
92244638|NCT00493064|Vitamins|vitamins|mesh-ancestor
92244639|NCT00493064|Micronutrients|micronutrients|mesh-ancestor
92244640|NCT00552422|Domperidone|domperidone|mesh-list
92244641|NCT00552422|Antiemetics|antiemetics|mesh-ancestor
92244642|NCT00552422|Autonomic Agents|autonomic agents|mesh-ancestor
92244643|NCT00552422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244644|NCT00552422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244645|NCT00552422|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244646|NCT00552422|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92244647|NCT00552422|Dopamine Agents|dopamine agents|mesh-ancestor
92244648|NCT00552422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244649|NCT00552422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244650|NCT00432458|Zoledronic Acid|zoledronic acid|mesh-list
92244651|NCT00432458|Thalidomide|thalidomide|mesh-list
92244652|NCT00432458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244653|NCT00432458|Immunologic Factors|immunologic factors|mesh-ancestor
92244654|NCT00432458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244655|NCT00432458|Leprostatic Agents|leprostatic agents|mesh-ancestor
92244656|NCT00432458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244657|NCT00432458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244658|NCT00432458|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92244659|NCT00432458|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92244660|NCT00432458|Growth Substances|growth substances|mesh-ancestor
92244661|NCT00432458|Growth Inhibitors|growth inhibitors|mesh-ancestor
92244662|NCT00432458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244663|NCT00432458|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92244665|NCT00433550|Oxaliplatin|oxaliplatin|mesh-list
92244666|NCT00433550|Irinotecan|irinotecan|mesh-list
92244667|NCT00433550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92244668|NCT00433550|Antimetabolites|antimetabolites|mesh-ancestor
92244669|NCT00433550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244670|NCT00433550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244671|NCT00433550|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92244672|NCT00433550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92244673|NCT00433550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244674|NCT02208037|Mycophenolic Acid|mycophenolic acid|mesh-list
92244675|NCT02208037|Maraviroc|maraviroc|mesh-list
92244676|NCT02208037|Cyclophosphamide|cyclophosphamide|mesh-list
92244677|NCT02208037|Methotrexate|methotrexate|mesh-list
92244678|NCT02208037|Bortezomib|bortezomib|mesh-list
92244679|NCT02208037|Tacrolimus|tacrolimus|mesh-list
92244680|NCT02208037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244681|NCT02208037|Immunologic Factors|immunologic factors|mesh-ancestor
92244682|NCT02208037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244683|NCT02208037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244684|NCT02208037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92244685|NCT02208037|Alkylating Agents|alkylating agents|mesh-ancestor
92244686|NCT02208037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244687|NCT02208037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244688|NCT02208037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92244689|NCT02208037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92244690|NCT02208037|Abortifacient Agents|abortifacient agents|mesh-ancestor
92244691|NCT02208037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92244692|NCT02208037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92244693|NCT02208037|Antimetabolites|antimetabolites|mesh-ancestor
92244694|NCT02208037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92244695|NCT02208037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244696|NCT02208037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92244697|NCT02208037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92244698|NCT02208037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92244699|NCT02208037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92244700|NCT02208037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92244701|NCT02208037|Antitubercular Agents|antitubercular agents|mesh-ancestor
92244702|NCT02208037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92244703|NCT02208037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244704|NCT02208037|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92244705|NCT02208037|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92244706|NCT02208037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92244707|NCT02208037|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92244708|NCT02208037|Antiviral Agents|antiviral agents|mesh-ancestor
92244709|NCT02208037|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92244710|NCT03007927|Dexamethasone|dexamethasone|mesh-list
92244711|NCT03007927|Bupivacaine|bupivacaine|mesh-list
92244712|NCT03007927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244713|NCT03007927|Antiemetics|antiemetics|mesh-ancestor
92244714|NCT03007927|Autonomic Agents|autonomic agents|mesh-ancestor
92244715|NCT03007927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244716|NCT03007927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244717|NCT03007927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244718|NCT03007927|Glucocorticoids|glucocorticoids|mesh-ancestor
92244719|NCT03007927|Hormones|hormones|mesh-ancestor
92244720|NCT03007927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244721|NCT03007927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92244722|NCT03007927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244723|NCT03007927|Anesthetics, Local|anesthetics, local|mesh-ancestor
92244724|NCT03007927|Anesthetics|anesthetics|mesh-ancestor
92244725|NCT03007927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244726|NCT03007927|Sensory System Agents|sensory system agents|mesh-ancestor
92244727|NCT05041842|Trastuzumab|trastuzumab|mesh-list
92244728|NCT05041842|Pertuzumab|pertuzumab|mesh-list
92244729|NCT05041842|Tucatinib|tucatinib|mesh-list
92244730|NCT05041842|Hormones|hormones|mesh-list
92244731|NCT05041842|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244732|NCT05041842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341634|NCT00003101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92244733|NCT05041842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244734|NCT05041842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244735|NCT05041842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92244736|NCT05041842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244737|NCT05041842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244738|NCT05150496|Vaccines|vaccines|mesh-list
92244739|NCT05150496|Immunologic Factors|immunologic factors|mesh-ancestor
92244740|NCT05150496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244741|NCT00496340|Rituximab|rituximab|mesh-list
92244742|NCT00496340|Busulfan|busulfan|mesh-list
92244743|NCT00496340|Pentostatin|pentostatin|mesh-list
92244744|NCT00496340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244745|NCT00496340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244746|NCT00496340|Immunologic Factors|immunologic factors|mesh-ancestor
92244747|NCT00496340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244748|NCT00496340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244749|NCT00496340|Alkylating Agents|alkylating agents|mesh-ancestor
92244750|NCT00496340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244751|NCT00496340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244752|NCT00496340|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92244753|NCT00496340|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92244754|NCT00496340|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92244755|NCT00496340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244756|NCT05090358|Canagliflozin|canagliflozin|mesh-list
92244757|NCT05090358|Fulvestrant|fulvestrant|mesh-list
92244758|NCT05090358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92244759|NCT05090358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244760|NCT05090358|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92244761|NCT05090358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92244762|NCT05090358|Hormone Antagonists|hormone antagonists|mesh-ancestor
92244763|NCT05090358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244764|NCT05090358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117532|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
92244765|NCT05090358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92244766|NCT05090358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244767|NCT05090358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92244768|NCT00496808|Trastuzumab|trastuzumab|mesh-list
92244769|NCT00496808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244770|NCT00496808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244771|NCT05148078|Anesthetics|anesthetics|mesh-list
92244772|NCT05148078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244773|NCT05148078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244774|NCT01795820|Ticagrelor|ticagrelor|mesh-list
92244775|NCT01795820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92244776|NCT01795820|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92244777|NCT01795820|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92244778|NCT01795820|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92244779|NCT01795820|Purinergic Agents|purinergic agents|mesh-ancestor
92244780|NCT01795820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244781|NCT01795820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244782|NCT01795820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244783|NCT01484041|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92244784|NCT01484041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92244785|NCT01484041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244786|NCT01484041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244787|NCT01484041|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92244788|NCT01484041|Hormone Antagonists|hormone antagonists|mesh-ancestor
92244789|NCT01484041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244790|NCT01484041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244791|NCT00555152|Lapatinib|lapatinib|mesh-list
92244792|NCT00555152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244793|NCT00555152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92244794|NCT00555152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244795|NCT00555152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244796|NCT01461499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92244797|NCT01461499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244798|NCT00555464|Prednisone|prednisone|mesh-list
92244799|NCT00555464|Prednisolone|prednisolone|mesh-list
92244800|NCT00555464|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92244801|NCT00555464|Methylprednisolone|methylprednisolone|mesh-list
92244802|NCT00555464|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92244803|NCT00555464|Prednisolone acetate|prednisolone acetate|mesh-list
92244804|NCT00555464|Vincristine|vincristine|mesh-list
92244805|NCT00555464|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92244806|NCT00555464|Prednisolone phosphate|prednisolone phosphate|mesh-list
92244807|NCT00555464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244808|NCT00555464|Glucocorticoids|glucocorticoids|mesh-ancestor
92244809|NCT00555464|Hormones|hormones|mesh-ancestor
92244810|NCT00555464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244811|NCT00555464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244812|NCT00555464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92244813|NCT00555464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244814|NCT00555464|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92244815|NCT00555464|Tubulin Modulators|tubulin modulators|mesh-ancestor
92244816|NCT00555464|Antimitotic Agents|antimitotic agents|mesh-ancestor
92244817|NCT00555464|Mitosis Modulators|mitosis modulators|mesh-ancestor
92244818|NCT00555464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244819|NCT00555464|Antiemetics|antiemetics|mesh-ancestor
92244820|NCT00555464|Autonomic Agents|autonomic agents|mesh-ancestor
92244821|NCT00555464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244822|NCT00555464|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244823|NCT00555464|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92244824|NCT00555464|Protective Agents|protective agents|mesh-ancestor
92244825|NCT01795976|Cyclophosphamide|cyclophosphamide|mesh-list
92244826|NCT01795976|Fludarabine|fludarabine|mesh-list
92244827|NCT01795976|Interleukin-2|interleukin-2|mesh-list
92244828|NCT01795976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244829|NCT01795976|Immunologic Factors|immunologic factors|mesh-ancestor
92244830|NCT01795976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244831|NCT01795976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244832|NCT01795976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92244833|NCT01795976|Alkylating Agents|alkylating agents|mesh-ancestor
92244834|NCT01795976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244835|NCT01795976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941440|NCT00581477|Droxidopa|droxidopa|mesh-list
92244836|NCT01795976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92244837|NCT01795976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244838|NCT01795976|Analgesics|analgesics|mesh-ancestor
92244839|NCT01795976|Sensory System Agents|sensory system agents|mesh-ancestor
92244840|NCT01795976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244841|NCT01461733|Amiodarone|amiodarone|mesh-list
92244842|NCT01461733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92244843|NCT01461733|Vasodilator Agents|vasodilator agents|mesh-ancestor
92244844|NCT01461733|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92244845|NCT01461733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244846|NCT01461733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244847|NCT01461733|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92244848|NCT01461733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92244849|NCT01461733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92244850|NCT01461733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244851|NCT01461733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92244852|NCT01461733|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92244853|NCT01461733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92244854|NCT01462279|Thiamine|thiamine|mesh-list
92244856|NCT01462279|Vitamins|vitamins|mesh-ancestor
92244857|NCT01462279|Micronutrients|micronutrients|mesh-ancestor
92244858|NCT01462279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244859|NCT00435812|Vaccines|vaccines|mesh-list
92244860|NCT00435812|Immunologic Factors|immunologic factors|mesh-ancestor
92244861|NCT00435812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244862|NCT05081466|Vitamin D|vitamin d|mesh-list
92244863|NCT05081466|Calcium|calcium|mesh-list
92244864|NCT05081466|Vitamins|vitamins|mesh-ancestor
92244865|NCT05081466|Micronutrients|micronutrients|mesh-ancestor
92244866|NCT05081466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244867|NCT05081466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92244868|NCT05081466|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92244869|NCT01464229|Iloperidone|iloperidone|mesh-list
92244870|NCT01464229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244871|NCT01464229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244872|NCT01464229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244873|NCT01464229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244874|NCT01464229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244875|NCT00556478|Lidocaine|lidocaine|mesh-list
92244876|NCT00556478|Prilocaine|prilocaine|mesh-list
92244877|NCT00556478|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92244878|NCT00556478|Anesthetics, Local|anesthetics, local|mesh-ancestor
92244879|NCT00556478|Anesthetics|anesthetics|mesh-ancestor
92244880|NCT00556478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244881|NCT00556478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244882|NCT00556478|Sensory System Agents|sensory system agents|mesh-ancestor
92244883|NCT00556478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244884|NCT00556478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92244885|NCT00556478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92244886|NCT00556478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92244887|NCT00556478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92244888|NCT00556478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244889|NCT00556478|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92244890|NCT00500240|Insulin|insulin|mesh-list
92244891|NCT00500240|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92244892|NCT00500240|Insulin Glargine|insulin glargine|mesh-list
92244893|NCT00500240|Insulin Aspart|insulin aspart|mesh-list
92244894|NCT00500240|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92244895|NCT00500240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244896|NCT01469767|Fluocinonide|fluocinonide|mesh-list
92244897|NCT01469767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244898|NCT01469767|Glucocorticoids|glucocorticoids|mesh-ancestor
92244899|NCT01469767|Hormones|hormones|mesh-ancestor
92244900|NCT01469767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92244901|NCT01469767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244902|NCT01469767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92244904|NCT05029596|Calcium heparin|calcium heparin|mesh-list
92244905|NCT05029596|Anticoagulants|anticoagulants|mesh-ancestor
92244906|NCT05029596|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92244907|NCT05029596|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92244908|NCT05029596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244909|NCT03246620|Diazepam|diazepam|mesh-list
92244910|NCT03246620|Haloperidol|haloperidol|mesh-list
92244911|NCT03246620|Olanzapine|olanzapine|mesh-list
92244912|NCT03246620|Haloperidol decanoate|haloperidol decanoate|mesh-list
92244913|NCT03246620|Antiemetics|antiemetics|mesh-ancestor
92244914|NCT03246620|Autonomic Agents|autonomic agents|mesh-ancestor
92244915|NCT03246620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244916|NCT03246620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244917|NCT03246620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244918|NCT03246620|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92244919|NCT03246620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92244920|NCT03246620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92244921|NCT03246620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92244922|NCT03246620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92244923|NCT03246620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92244924|NCT03246620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92341662|NCT00003113|Alkylating Agents|alkylating agents|mesh-ancestor
92244925|NCT03246620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244926|NCT03246620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244927|NCT03246620|Serotonin Agents|serotonin agents|mesh-ancestor
92244928|NCT03246620|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92244929|NCT03246620|Dopamine Agents|dopamine agents|mesh-ancestor
92244930|NCT03246620|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92244931|NCT03246620|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92244932|NCT03246620|Anticonvulsants|anticonvulsants|mesh-ancestor
92244933|NCT03246620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92244934|NCT03246620|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92244935|NCT03246620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92244936|NCT03246620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92244937|NCT03246620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92244938|NCT03246620|Anesthetics, General|anesthetics, general|mesh-ancestor
92244939|NCT03246620|Anesthetics|anesthetics|mesh-ancestor
92244940|NCT03246620|GABA Modulators|gaba modulators|mesh-ancestor
92244941|NCT03246620|GABA Agents|gaba agents|mesh-ancestor
92244942|NCT05080218|Adalimumab|adalimumab|mesh-list
92244943|NCT05080218|Golimumab|golimumab|mesh-list
92244944|NCT05080218|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92244945|NCT05080218|Etanercept|etanercept|mesh-list
92244946|NCT05080218|Abatacept|abatacept|mesh-list
92244947|NCT05080218|Upadacitinib|upadacitinib|mesh-list
92244948|NCT05080218|Ixekizumab|ixekizumab|mesh-list
92244949|NCT05080218|Tofacitinib|tofacitinib|mesh-list
92244950|NCT05080218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244951|NCT05080218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244952|NCT05080218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92244953|NCT05080218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244954|NCT05080218|Analgesics|analgesics|mesh-ancestor
92244955|NCT05080218|Sensory System Agents|sensory system agents|mesh-ancestor
92244956|NCT05080218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244957|NCT05080218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244958|NCT05080218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92244959|NCT05080218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92244960|NCT05080218|Immunologic Factors|immunologic factors|mesh-ancestor
92244961|NCT05080218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92244962|NCT05080218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244963|NCT05080218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92244964|NCT05080218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244965|NCT05080218|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92244966|NCT05080218|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92244967|NCT05080218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244968|NCT05080218|Dermatologic Agents|dermatologic agents|mesh-ancestor
92244970|NCT01470859|Carbidopa|carbidopa|mesh-list
92244971|NCT01470859|Pramipexole|pramipexole|mesh-list
92244972|NCT01470859|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92244973|NCT01470859|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92244974|NCT01470859|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92244975|NCT01470859|Dopamine Agents|dopamine agents|mesh-ancestor
92244976|NCT01470859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92244977|NCT01470859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92244978|NCT01470859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244979|NCT01470859|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92244980|NCT01470859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92244981|NCT01470859|Antioxidants|antioxidants|mesh-ancestor
92244982|NCT01470859|Protective Agents|protective agents|mesh-ancestor
92244983|NCT01470859|Dopamine Agonists|dopamine agonists|mesh-ancestor
92244984|NCT01470859|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92244985|NCT01470859|Immunologic Factors|immunologic factors|mesh-ancestor
92244986|NCT00436046|Interferons|interferons|mesh-list
92244987|NCT00436046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92244988|NCT00436046|Antiviral Agents|antiviral agents|mesh-ancestor
92244989|NCT00436046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92244990|NCT01471639|Ketorolac|ketorolac|mesh-list
92341667|NCT00003113|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92244991|NCT01471639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92244992|NCT01471639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92244993|NCT01471639|Analgesics|analgesics|mesh-ancestor
92244994|NCT01471639|Sensory System Agents|sensory system agents|mesh-ancestor
92244995|NCT01471639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92244996|NCT01471639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92244997|NCT01471639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92244998|NCT01471639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92244999|NCT01471639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92245000|NCT01471639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245001|NCT01471639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245002|NCT05622656|Dexmedetomidine|dexmedetomidine|mesh-list
92245003|NCT05622656|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92245004|NCT05622656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245005|NCT05622656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245006|NCT05622656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245007|NCT05622656|Analgesics|analgesics|mesh-ancestor
92245008|NCT05622656|Sensory System Agents|sensory system agents|mesh-ancestor
92245009|NCT05622656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245010|NCT05622656|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92245011|NCT05622656|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92245012|NCT05622656|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92245013|NCT05622656|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245014|NCT05622656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245015|NCT05622656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245016|NCT05079126|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92245017|NCT05079126|Antioxidants|antioxidants|mesh-ancestor
92245018|NCT05079126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245019|NCT05079126|Protective Agents|protective agents|mesh-ancestor
92245020|NCT05079126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245021|NCT05079126|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92245022|NCT05079126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245023|NCT05140278|Artesunate|artesunate|mesh-list
92245024|NCT05140278|Antimalarials|antimalarials|mesh-ancestor
92245025|NCT05140278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92245026|NCT05140278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92245027|NCT05140278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245028|NCT05140278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245030|NCT05140278|Schistosomicides|schistosomicides|mesh-ancestor
92245031|NCT05140278|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92245032|NCT05140278|Anthelmintics|anthelmintics|mesh-ancestor
92245033|NCT00436904|Rituximab|rituximab|mesh-list
92245034|NCT00436904|Alemtuzumab|alemtuzumab|mesh-list
92245035|NCT00436904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245036|NCT00436904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245037|NCT00436904|Immunologic Factors|immunologic factors|mesh-ancestor
92245038|NCT00436904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245039|NCT00436904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245040|NCT00438854|Dasatinib|dasatinib|mesh-list
92245041|NCT00438854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245042|NCT00438854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92245043|NCT00438854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245044|NCT00438854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245045|NCT01485055|Infliximab|infliximab|mesh-list
92245046|NCT01485055|Basiliximab|basiliximab|mesh-list
92245047|NCT01485055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92245048|NCT01485055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245049|NCT01485055|Dermatologic Agents|dermatologic agents|mesh-ancestor
92245050|NCT01485055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245051|NCT01485055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245052|NCT01485055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245053|NCT01485055|Immunologic Factors|immunologic factors|mesh-ancestor
92245054|NCT01485055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245055|NCT05028348|Dexamethasone|dexamethasone|mesh-list
92245056|NCT05028348|Pomalidomide|pomalidomide|mesh-list
92245057|NCT05028348|Elotuzumab|elotuzumab|mesh-list
92245058|NCT05028348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245059|NCT05028348|Antiemetics|antiemetics|mesh-ancestor
92245060|NCT05028348|Autonomic Agents|autonomic agents|mesh-ancestor
92245061|NCT05028348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245062|NCT05028348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245063|NCT05028348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245064|NCT05028348|Glucocorticoids|glucocorticoids|mesh-ancestor
92245065|NCT05028348|Hormones|hormones|mesh-ancestor
92117533|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92245066|NCT05028348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245067|NCT05028348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245068|NCT05028348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245069|NCT05028348|Immunologic Factors|immunologic factors|mesh-ancestor
92245070|NCT05028348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92245071|NCT05028348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92245072|NCT05028348|Growth Substances|growth substances|mesh-ancestor
92245073|NCT05028348|Growth Inhibitors|growth inhibitors|mesh-ancestor
92245074|NCT01486615|Melatonin|melatonin|mesh-list
92245075|NCT01486615|Alprazolam|alprazolam|mesh-list
92245076|NCT01486615|Azaperone|azaperone|mesh-list
92245077|NCT01486615|Antioxidants|antioxidants|mesh-ancestor
92245078|NCT01486615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245079|NCT01486615|Protective Agents|protective agents|mesh-ancestor
92245080|NCT01486615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245081|NCT01486615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245082|NCT01486615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92245083|NCT01486615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92245084|NCT01486615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92245085|NCT01486615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92245086|NCT01486615|GABA Modulators|gaba modulators|mesh-ancestor
92245087|NCT01486615|GABA Agents|gaba agents|mesh-ancestor
92245088|NCT01486615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245089|NCT01486615|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92245090|NCT01486615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92245091|NCT01486615|Dopamine Agents|dopamine agents|mesh-ancestor
92245092|NCT00503750|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92245093|NCT00503750|Vinorelbine|vinorelbine|mesh-list
92245094|NCT00503750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245095|NCT00503750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92245096|NCT00503750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92245097|NCT00503750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92245098|NCT00503750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92245099|NCT00503750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245100|NCT05077332|Celecoxib|celecoxib|mesh-list
92245101|NCT05077332|Famotidine|famotidine|mesh-list
92245102|NCT05077332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92245103|NCT05077332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245104|NCT05077332|Analgesics|analgesics|mesh-ancestor
92245105|NCT05077332|Sensory System Agents|sensory system agents|mesh-ancestor
92245106|NCT05077332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245107|NCT05077332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245108|NCT05077332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245110|NCT05077332|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92245111|NCT05077332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92245112|NCT05077332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245113|NCT05077332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245114|NCT05077332|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92245115|NCT05077332|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245116|NCT05077332|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92245117|NCT05077332|Histamine Antagonists|histamine antagonists|mesh-ancestor
92245118|NCT05077332|Histamine Agents|histamine agents|mesh-ancestor
92245119|NCT05077332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245120|NCT05076006|PF-06700841|pf-06700841|mesh-list
92245121|NCT05076006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92245122|NCT05076006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245123|NCT05076006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245124|NCT00439946|Treprostinil|treprostinil|mesh-list
92245125|NCT00439946|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92245127|NCT04227678|Anticoagulants|anticoagulants|mesh-ancestor
92245128|NCT04227678|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92245129|NCT04227678|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92245130|NCT04227678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245131|NCT00508118|Nicardipine|nicardipine|mesh-list
92245132|NCT00508118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92245133|NCT00508118|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92245134|NCT00508118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245135|NCT00508118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245136|NCT00508118|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92245137|NCT00508118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245138|NCT00508118|Vasodilator Agents|vasodilator agents|mesh-ancestor
92245139|NCT05139030|Bupivacaine|bupivacaine|mesh-list
92245140|NCT05139030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92245141|NCT05139030|Anesthetics|anesthetics|mesh-ancestor
91941453|NCT02282267|Gefitinib|gefitinib|mesh-list
92245142|NCT05139030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245143|NCT05139030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245144|NCT05139030|Sensory System Agents|sensory system agents|mesh-ancestor
92245145|NCT05139030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245146|NCT00440180|Anastrozole|anastrozole|mesh-list
92245147|NCT00440180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245148|NCT00440180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245149|NCT00440180|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92245150|NCT00440180|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92245151|NCT00440180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245152|NCT00440180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245153|NCT00440180|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92245154|NCT00440180|Hormone Antagonists|hormone antagonists|mesh-ancestor
92245155|NCT00440180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245156|NCT00440180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245157|NCT05021484|Felzartamab|felzartamab|mesh-list
92245158|NCT05021484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245159|NCT05021484|Immunologic Factors|immunologic factors|mesh-ancestor
92245160|NCT05021484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245161|NCT05021094|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92245162|NCT05021094|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92245164|NCT05021094|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92245165|NCT05021094|Dydrogesterone|dydrogesterone|mesh-list
92245166|NCT05021094|Estrogens|estrogens|mesh-ancestor
92245167|NCT05021094|Hormones|hormones|mesh-ancestor
92245168|NCT05021094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245169|NCT05021094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245170|NCT05021094|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92245171|NCT05021094|Contraceptive Agents|contraceptive agents|mesh-ancestor
92245172|NCT05021094|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92245173|NCT05021094|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92245174|NCT05021094|Progestins|progestins|mesh-ancestor
92245175|NCT01364298|Pregabalin|pregabalin|mesh-list
92245176|NCT01364298|Gabapentin|gabapentin|mesh-list
92245177|NCT01364298|Analgesics|analgesics|mesh-ancestor
92245178|NCT01364298|Sensory System Agents|sensory system agents|mesh-ancestor
92245179|NCT01364298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245180|NCT01364298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245181|NCT01364298|Anticonvulsants|anticonvulsants|mesh-ancestor
92245182|NCT01364298|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92245183|NCT01364298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245184|NCT01364298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245185|NCT01364298|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92245186|NCT01364298|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92245187|NCT01364298|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92245188|NCT01364298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245189|NCT01364298|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92245190|NCT01364298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92245191|NCT01364298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92245192|NCT01364298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245193|NCT01364298|Antimanic Agents|antimanic agents|mesh-ancestor
92245194|NCT04421742|Beclomethasone|beclomethasone|mesh-list
92245195|NCT04421742|Formoterol Fumarate|formoterol fumarate|mesh-list
92245196|NCT04421742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92245197|NCT04421742|Autonomic Agents|autonomic agents|mesh-ancestor
92245198|NCT04421742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245199|NCT04421742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245200|NCT04421742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92245201|NCT04421742|Respiratory System Agents|respiratory system agents|mesh-ancestor
92245202|NCT04421742|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92245203|NCT04421742|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92245204|NCT04421742|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92245205|NCT04421742|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245206|NCT04421742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245207|NCT04421742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245208|NCT04421742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245211|NCT04421742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245212|NCT01488019|Formoterol Fumarate|formoterol fumarate|mesh-list
92245213|NCT01488019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92245214|NCT01488019|Autonomic Agents|autonomic agents|mesh-ancestor
92245215|NCT01488019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245216|NCT01488019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245217|NCT01488019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92245218|NCT01488019|Respiratory System Agents|respiratory system agents|mesh-ancestor
92245219|NCT01488019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92245220|NCT01488019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92245221|NCT01488019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92245222|NCT01488019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245223|NCT01488019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245224|NCT01488019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245225|NCT01488409|Acipimox|acipimox|mesh-list
92245226|NCT01488409|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92245227|NCT01488409|Antimetabolites|antimetabolites|mesh-ancestor
92245228|NCT01488409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245229|NCT01488409|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92245230|NCT01488877|Spironolactone|spironolactone|mesh-list
92245231|NCT01488877|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92245232|NCT01488877|Hormone Antagonists|hormone antagonists|mesh-ancestor
92245233|NCT01488877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245234|NCT01488877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245235|NCT01488877|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92245236|NCT01488877|Diuretics|diuretics|mesh-ancestor
92245237|NCT01488877|Natriuretic Agents|natriuretic agents|mesh-ancestor
92245238|NCT01364922|Acetaminophen|acetaminophen|mesh-list
92245239|NCT01364922|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92245240|NCT01364922|Hydrocodone|hydrocodone|mesh-list
92245241|NCT01364922|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245242|NCT01364922|Analgesics|analgesics|mesh-ancestor
92245243|NCT01364922|Sensory System Agents|sensory system agents|mesh-ancestor
92245244|NCT01364922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245245|NCT01364922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245246|NCT01364922|Antipyretics|antipyretics|mesh-ancestor
92245247|NCT01364922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92245248|NCT01364922|Narcotics|narcotics|mesh-ancestor
92245249|NCT01364922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245250|NCT01364922|Antitussive Agents|antitussive agents|mesh-ancestor
92245251|NCT01364922|Respiratory System Agents|respiratory system agents|mesh-ancestor
92245252|NCT01364922|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92245253|NCT01364922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245254|NCT01364922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245255|NCT01489969|Melatonin|melatonin|mesh-list
92245256|NCT01489969|Antioxidants|antioxidants|mesh-ancestor
92245257|NCT01489969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245258|NCT01489969|Protective Agents|protective agents|mesh-ancestor
92245259|NCT01489969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245260|NCT01489969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245261|NCT00509288|Aldesleukin|aldesleukin|mesh-list
92245262|NCT00509288|Cyclophosphamide|cyclophosphamide|mesh-list
92245263|NCT00509288|Fludarabine|fludarabine|mesh-list
92245264|NCT00509288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245265|NCT00509288|Immunologic Factors|immunologic factors|mesh-ancestor
92245266|NCT00509288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245267|NCT00509288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245268|NCT00509288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92245269|NCT00509288|Alkylating Agents|alkylating agents|mesh-ancestor
92245270|NCT00509288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245271|NCT00509288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245272|NCT00509288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92245273|NCT00509288|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92245274|NCT00509288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92245275|NCT00509288|Antiviral Agents|antiviral agents|mesh-ancestor
92245276|NCT00509288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245277|NCT00442364|Polidocanol|polidocanol|mesh-list
92245278|NCT00442364|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92245279|NCT00442364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92245280|NCT00510224|Octreotide|octreotide|mesh-list
92245281|NCT00510224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245282|NCT00510224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245283|NCT00510224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245284|NCT05070156|Vaccines|vaccines|mesh-list
92245285|NCT05070156|Immunologic Factors|immunologic factors|mesh-ancestor
92245286|NCT05070156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245287|NCT00511706|Dexamethasone|dexamethasone|mesh-list
92245288|NCT00511706|Ranibizumab|ranibizumab|mesh-list
92245289|NCT00511706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245290|NCT00511706|Antiemetics|antiemetics|mesh-ancestor
92245291|NCT00511706|Autonomic Agents|autonomic agents|mesh-ancestor
92245292|NCT00511706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245293|NCT00511706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245294|NCT00511706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245295|NCT00511706|Glucocorticoids|glucocorticoids|mesh-ancestor
92245296|NCT00511706|Hormones|hormones|mesh-ancestor
92245297|NCT00511706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245298|NCT00511706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245299|NCT00511706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245300|NCT00511706|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92245301|NCT00511706|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92245302|NCT00511706|Growth Substances|growth substances|mesh-ancestor
92245303|NCT00511706|Growth Inhibitors|growth inhibitors|mesh-ancestor
92245304|NCT05067894|Vaccines|vaccines|mesh-list
92245305|NCT05067894|Immunologic Factors|immunologic factors|mesh-ancestor
92245306|NCT05067894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245307|NCT01493947|Metronidazole|metronidazole|mesh-list
92245308|NCT01493947|Ivermectin|ivermectin|mesh-list
92245309|NCT01493947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245310|NCT01493947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92245311|NCT01493947|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92245312|NCT01493947|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92245313|NCT00445484|Lenalidomide|lenalidomide|mesh-list
92245314|NCT00445484|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92245315|NCT00445484|Immunologic Factors|immunologic factors|mesh-ancestor
92245316|NCT00445484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245317|NCT00445484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92245318|NCT00445484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92245319|NCT00445484|Growth Substances|growth substances|mesh-ancestor
92245320|NCT00445484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92245321|NCT00445484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245322|NCT01495585|Lonafarnib|lonafarnib|mesh-list
92245323|NCT01495585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245324|NCT01495585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245325|NCT00446264|Sirolimus|sirolimus|mesh-list
92245326|NCT00446264|Tacrolimus|tacrolimus|mesh-list
92245327|NCT00446264|Daclizumab|daclizumab|mesh-list
92245328|NCT00446264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245329|NCT00446264|Immunologic Factors|immunologic factors|mesh-ancestor
92245330|NCT00446264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245331|NCT00446264|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92245332|NCT00446264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245333|NCT00446264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245334|NCT00446264|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92245335|NCT00446264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245336|NCT00446264|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92245337|NCT00446264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245338|NCT00446264|Antifungal Agents|antifungal agents|mesh-ancestor
92245340|NCT01495819|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92245341|NCT01495819|Autonomic Agents|autonomic agents|mesh-ancestor
92245342|NCT01495819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245343|NCT01495819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245344|NCT01495819|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92245345|NCT01495819|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92245346|NCT01495819|Cholinergic Agents|cholinergic agents|mesh-ancestor
92245347|NCT01495819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245348|NCT01495819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245349|NCT04214886|Cyclophosphamide|cyclophosphamide|mesh-list
92245351|NCT04214886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245352|NCT04214886|Immunologic Factors|immunologic factors|mesh-ancestor
92245353|NCT04214886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245354|NCT04214886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245355|NCT04214886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92245356|NCT04214886|Alkylating Agents|alkylating agents|mesh-ancestor
92245357|NCT04214886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245358|NCT04214886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245359|NCT04214886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92391732|NCT01725204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391733|NCT01725360|Montelukast|montelukast|mesh-list
92391734|NCT01725360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92391735|NCT01725360|Respiratory System Agents|respiratory system agents|mesh-ancestor
92391736|NCT01725360|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92391737|NCT01725360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92391738|NCT01725360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391739|NCT01725360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391740|NCT01725360|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92391741|NCT01725360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92391742|NCT01725360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391743|NCT01725672|Metformin|metformin|mesh-list
92391744|NCT01725672|Glimepiride|glimepiride|mesh-list
92391745|NCT01725672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391746|NCT01725672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391747|NCT01725672|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92391748|NCT01725672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391749|NCT01725672|Immunologic Factors|immunologic factors|mesh-ancestor
92391750|NCT01725906|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92391751|NCT01725906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92391752|NCT01725906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391753|NCT01725906|Antitubercular Agents|antitubercular agents|mesh-ancestor
92391754|NCT01726530|Fentanyl|fentanyl|mesh-list
92391755|NCT01726530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92391756|NCT01726530|Narcotics|narcotics|mesh-ancestor
92391757|NCT01726530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391758|NCT01726530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391759|NCT01726530|Analgesics|analgesics|mesh-ancestor
92391760|NCT01726530|Sensory System Agents|sensory system agents|mesh-ancestor
92391761|NCT01726530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391762|NCT01726530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92391763|NCT01726530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92391764|NCT01726530|Anesthetics, General|anesthetics, general|mesh-ancestor
92391765|NCT01726530|Anesthetics|anesthetics|mesh-ancestor
92391766|NCT01726686|Ropivacaine|ropivacaine|mesh-list
92391767|NCT01726686|Anesthetics, Local|anesthetics, local|mesh-ancestor
92391768|NCT01726686|Anesthetics|anesthetics|mesh-ancestor
92391769|NCT01726686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391770|NCT01726686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391771|NCT01726686|Sensory System Agents|sensory system agents|mesh-ancestor
92391772|NCT01726686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391773|NCT01726764|Metformin|metformin|mesh-list
92245361|NCT00512876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245362|NCT00512876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245363|NCT00512876|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92245364|NCT00512876|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92245365|NCT00512876|Growth Substances|growth substances|mesh-ancestor
92245366|NCT00512876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245367|NCT00512876|Growth Inhibitors|growth inhibitors|mesh-ancestor
92245368|NCT05127876|Ephedrine|ephedrine|mesh-list
92245369|NCT05127876|Pseudoephedrine|pseudoephedrine|mesh-list
92245370|NCT05127876|Ondansetron|ondansetron|mesh-list
92245371|NCT05127876|Antiemetics|antiemetics|mesh-ancestor
92245372|NCT05127876|Autonomic Agents|autonomic agents|mesh-ancestor
92245373|NCT05127876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245374|NCT05127876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245375|NCT05127876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245376|NCT05127876|Antipruritics|antipruritics|mesh-ancestor
92245377|NCT05127876|Dermatologic Agents|dermatologic agents|mesh-ancestor
92245378|NCT05127876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92245379|NCT05127876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92245380|NCT05127876|Serotonin Agents|serotonin agents|mesh-ancestor
92245381|NCT05127876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245382|NCT05127876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245383|NCT05127876|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92245384|NCT05127876|Sympathomimetics|sympathomimetics|mesh-ancestor
92245385|NCT05127876|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92245386|NCT05127876|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245387|NCT05127876|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92245388|NCT05127876|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92245389|NCT05127876|Respiratory System Agents|respiratory system agents|mesh-ancestor
92245390|NCT05127876|Nasal Decongestants|nasal decongestants|mesh-ancestor
92245391|NCT01496131|Cyclophosphamide|cyclophosphamide|mesh-list
92245392|NCT01496131|Goserelin|goserelin|mesh-list
92245393|NCT01496131|Immunologic Factors|immunologic factors|mesh-ancestor
92245394|NCT01496131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245395|NCT01496131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245396|NCT01496131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245397|NCT01496131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92245398|NCT01496131|Alkylating Agents|alkylating agents|mesh-ancestor
92245399|NCT01496131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245400|NCT01496131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245401|NCT01496131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92245402|NCT01496131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245403|NCT02520726|Sertraline|sertraline|mesh-list
92245404|NCT02520726|Antidepressive Agents|antidepressive agents|mesh-ancestor
92245405|NCT02520726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92245406|NCT02520726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92245407|NCT02520726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92245408|NCT02520726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245409|NCT02520726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245410|NCT02520726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245411|NCT02520726|Serotonin Agents|serotonin agents|mesh-ancestor
92245412|NCT02520726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245413|NCT00450242|Lidocaine|lidocaine|mesh-list
92245414|NCT00450242|Anesthetics, Local|anesthetics, local|mesh-ancestor
92245415|NCT00450242|Anesthetics|anesthetics|mesh-ancestor
92245416|NCT00450242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245417|NCT00450242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245418|NCT00450242|Sensory System Agents|sensory system agents|mesh-ancestor
92245419|NCT00450242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245420|NCT00450242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92245421|NCT00450242|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92245422|NCT00450242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92245423|NCT00450242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245424|NCT00450242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245425|NCT00517010|Ranibizumab|ranibizumab|mesh-list
92341709|NCT00003401|Dexamethasone|dexamethasone|mesh-list
92245426|NCT00517010|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92245427|NCT00517010|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92245428|NCT00517010|Growth Substances|growth substances|mesh-ancestor
92245429|NCT00517010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245430|NCT00517010|Growth Inhibitors|growth inhibitors|mesh-ancestor
92245431|NCT00517010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245432|NCT00517556|Contraceptive Agents|contraceptive agents|mesh-list
92245433|NCT00517556|Contraceptives, Oral|contraceptives, oral|mesh-list
92245434|NCT00517556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92245435|NCT00517556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245436|NCT00517556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92245437|NCT00519584|Bupivacaine|bupivacaine|mesh-list
92245438|NCT00519584|Ropivacaine|ropivacaine|mesh-list
92245439|NCT00519584|Anesthetics, Local|anesthetics, local|mesh-ancestor
92245440|NCT00519584|Anesthetics|anesthetics|mesh-ancestor
92245441|NCT00519584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245442|NCT00519584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245443|NCT00519584|Sensory System Agents|sensory system agents|mesh-ancestor
92245444|NCT00519584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245445|NCT05122884|Milrinone|milrinone|mesh-list
92245446|NCT05122884|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92245447|NCT05122884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92245448|NCT05122884|Vasodilator Agents|vasodilator agents|mesh-ancestor
92245449|NCT05122884|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92245450|NCT05122884|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92245451|NCT05122884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245452|NCT05122884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245453|NCT05122884|Protective Agents|protective agents|mesh-ancestor
92245454|NCT05122884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245455|NCT00520286|Modafinil|modafinil|mesh-list
92245456|NCT00520286|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92245457|NCT00520286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245458|NCT00520286|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92245459|NCT00520286|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92245460|NCT00520286|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92245461|NCT00520286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245462|NCT01796288|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92245463|NCT01796288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245464|NCT01796288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92245465|NCT01796288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245466|NCT01796288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245467|NCT01395043|Epinephrine|epinephrine|mesh-list
92245468|NCT01395043|Bupivacaine|bupivacaine|mesh-list
92245469|NCT01395043|Anesthetics, Local|anesthetics, local|mesh-ancestor
92245470|NCT01395043|Anesthetics|anesthetics|mesh-ancestor
92245471|NCT01395043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245472|NCT01395043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245473|NCT01395043|Sensory System Agents|sensory system agents|mesh-ancestor
92245474|NCT01395043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245475|NCT01395043|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92245476|NCT01395043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92245477|NCT01395043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245478|NCT01395043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245479|NCT01395043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245480|NCT01395043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92245481|NCT01395043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92245482|NCT01395043|Autonomic Agents|autonomic agents|mesh-ancestor
92245483|NCT01395043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92245484|NCT01395043|Respiratory System Agents|respiratory system agents|mesh-ancestor
92245485|NCT01395043|Mydriatics|mydriatics|mesh-ancestor
92245486|NCT01395043|Sympathomimetics|sympathomimetics|mesh-ancestor
92245487|NCT01395043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92245488|NCT00521456|Ketorolac|ketorolac|mesh-list
92245489|NCT00521456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92245490|NCT00521456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92245491|NCT00521456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92245492|NCT00521456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245493|NCT00521456|Analgesics|analgesics|mesh-ancestor
92245494|NCT00521456|Sensory System Agents|sensory system agents|mesh-ancestor
92245495|NCT00521456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245496|NCT00521456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245497|NCT00521456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245498|NCT00521456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245499|NCT00521456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92245500|NCT00521456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245501|NCT00521456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245502|NCT01796366|Insulin|insulin|mesh-list
92245503|NCT01796366|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92245504|NCT01796366|Insulin Glargine|insulin glargine|mesh-list
92245505|NCT01796366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92245506|NCT01796366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245507|NCT03326180|Bupivacaine|bupivacaine|mesh-list
92245508|NCT03326180|Anesthetics, Local|anesthetics, local|mesh-ancestor
92245509|NCT03326180|Anesthetics|anesthetics|mesh-ancestor
92245510|NCT03326180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245511|NCT03326180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245512|NCT03326180|Sensory System Agents|sensory system agents|mesh-ancestor
92245513|NCT03326180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245514|NCT01498549|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92245515|NCT01498549|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92245516|NCT01498549|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92245517|NCT01498549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245518|NCT01498549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245519|NCT01498549|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245520|NCT01498549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245521|NCT01498549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245522|NCT01796444|Hormones|hormones|mesh-list
92245523|NCT01796444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245524|NCT01796444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245525|NCT01542541|Rifaximin|rifaximin|mesh-list
92245526|NCT01542541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92245527|NCT01542541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245528|NCT01542541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245529|NCT00524264|Ketorolac|ketorolac|mesh-list
92245530|NCT00524264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92245531|NCT00524264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245532|NCT00524264|Analgesics|analgesics|mesh-ancestor
92245533|NCT00524264|Sensory System Agents|sensory system agents|mesh-ancestor
92245534|NCT00524264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245535|NCT00524264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245536|NCT00524264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245537|NCT00524264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245538|NCT00524264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92245539|NCT00524264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245540|NCT00524264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245541|NCT00452426|Analgesics, Opioid|analgesics, opioid|mesh-list
92245542|NCT00452426|Narcotics|narcotics|mesh-ancestor
92245543|NCT00452426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245544|NCT00452426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245545|NCT00452426|Analgesics|analgesics|mesh-ancestor
92245546|NCT00452426|Sensory System Agents|sensory system agents|mesh-ancestor
92245547|NCT00452426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245548|NCT05117814|Zanubrutinib|zanubrutinib|mesh-list
92245549|NCT05117814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245550|NCT05117814|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92245551|NCT05117814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245552|NCT05117814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245553|NCT00524342|Oprelvekin|oprelvekin|mesh-list
92245554|NCT00524342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245555|NCT00524576|Vaccines|vaccines|mesh-list
92245556|NCT00524576|Immunologic Factors|immunologic factors|mesh-ancestor
92245557|NCT00524576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245558|NCT04950660|Caffeine|caffeine|mesh-list
92245559|NCT04950660|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92245560|NCT04950660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245561|NCT04950660|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92245562|NCT04950660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245563|NCT04950660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245564|NCT04950660|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92245565|NCT04950660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92245566|NCT04950660|Purinergic Agents|purinergic agents|mesh-ancestor
92245567|NCT04950660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245568|NCT02516202|Estradiol|estradiol|mesh-list
92245569|NCT02516202|Estrogens|estrogens|mesh-ancestor
92245570|NCT02516202|Hormones|hormones|mesh-ancestor
92245571|NCT02516202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245572|NCT02516202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245573|NCT00526058|Clotrimazole|clotrimazole|mesh-list
92245574|NCT00526058|Miconazole|miconazole|mesh-list
92245575|NCT00526058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92245576|NCT00526058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245577|NCT00526058|Antifungal Agents|antifungal agents|mesh-ancestor
92245578|NCT00526058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92245579|NCT00526058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92245580|NCT00526058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245581|NCT00526058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245582|NCT00526058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92245583|NCT00526058|Hormone Antagonists|hormone antagonists|mesh-ancestor
92245584|NCT00526058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245585|NCT00526058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934715|NCT02341365|Vitamins|vitamins|mesh-ancestor
92245586|NCT00526058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92245587|NCT00526058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92245588|NCT00526292|Cyclophosphamide|cyclophosphamide|mesh-list
92245589|NCT00526292|Fludarabine|fludarabine|mesh-list
92245590|NCT00526292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245591|NCT00526292|Immunologic Factors|immunologic factors|mesh-ancestor
92245592|NCT00526292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245593|NCT00526292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245594|NCT00526292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92245595|NCT00526292|Alkylating Agents|alkylating agents|mesh-ancestor
92245596|NCT00526292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245597|NCT00526292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245598|NCT00526292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92245599|NCT02124044|Asunaprevir|asunaprevir|mesh-list
92245600|NCT02124044|Protease Inhibitors|protease inhibitors|mesh-ancestor
92245601|NCT02124044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245602|NCT02124044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245603|NCT01502761|Magnesium Sulfate|magnesium sulfate|mesh-list
92245604|NCT01502761|Analgesics|analgesics|mesh-ancestor
92245605|NCT01502761|Sensory System Agents|sensory system agents|mesh-ancestor
92245606|NCT01502761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245607|NCT01502761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245608|NCT01502761|Anesthetics|anesthetics|mesh-ancestor
92245609|NCT01502761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245610|NCT01502761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92245611|NCT01502761|Anticonvulsants|anticonvulsants|mesh-ancestor
92245612|NCT01502761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92245613|NCT01502761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245614|NCT01502761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245615|NCT01502761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92245616|NCT01502761|Tocolytic Agents|tocolytic agents|mesh-ancestor
92245617|NCT01502761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92245618|NCT01504477|Bortezomib|bortezomib|mesh-list
92245619|NCT01504477|Panitumumab|panitumumab|mesh-list
92245620|NCT01504477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245621|NCT01504477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245622|NCT02124512|Rifaximin|rifaximin|mesh-list
92245623|NCT02124512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92245624|NCT02124512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245625|NCT02124512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245626|NCT01504711|Fosaprepitant|fosaprepitant|mesh-list
92245627|NCT01504711|Aprepitant|aprepitant|mesh-list
92245628|NCT01504711|Antiemetics|antiemetics|mesh-ancestor
92245629|NCT01504711|Autonomic Agents|autonomic agents|mesh-ancestor
92245630|NCT01504711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245631|NCT01504711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245632|NCT01504711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245633|NCT01504711|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92245634|NCT01504711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245635|NCT01504711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245636|NCT02209519|Metronidazole|metronidazole|mesh-list
92245637|NCT02209519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245638|NCT02209519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92245639|NCT02209519|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92245640|NCT02209519|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92245641|NCT02129660|Glycopyrrolate|glycopyrrolate|mesh-list
92245642|NCT02129660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92245643|NCT02129660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92245644|NCT02129660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92245645|NCT02129660|Cholinergic Agents|cholinergic agents|mesh-ancestor
92245646|NCT02129660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245647|NCT02129660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245648|NCT02129660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245649|NCT04946370|Pembrolizumab|pembrolizumab|mesh-list
92245650|NCT04946370|Androgens|androgens|mesh-list
92245651|NCT04946370|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92245652|NCT04946370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245653|NCT04946370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245654|NCT04946370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92245655|NCT04946370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245657|NCT04946370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245658|NCT04946370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245659|NCT04946370|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92245660|NCT01505179|Ranolazine|ranolazine|mesh-list
92245661|NCT01505179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92245662|NCT01505179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245663|NCT01505179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245664|NCT01797848|Ribavirin|ribavirin|mesh-list
92245665|NCT01797848|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92245666|NCT01797848|Antimetabolites|antimetabolites|mesh-ancestor
92245667|NCT01797848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245668|NCT01797848|Antiviral Agents|antiviral agents|mesh-ancestor
92245669|NCT01797848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245670|NCT01398943|Antioxidants|antioxidants|mesh-list
92245671|NCT01398943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245672|NCT01398943|Protective Agents|protective agents|mesh-ancestor
92245673|NCT01398943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245674|NCT01550341|Buprenorphine|buprenorphine|mesh-list
92245675|NCT01550341|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92245676|NCT01550341|Naloxone|naloxone|mesh-list
92245677|NCT01550341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92245678|NCT01550341|Narcotics|narcotics|mesh-ancestor
92245679|NCT01550341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245680|NCT01550341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245681|NCT01550341|Analgesics|analgesics|mesh-ancestor
92245682|NCT01550341|Sensory System Agents|sensory system agents|mesh-ancestor
92245683|NCT01550341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245684|NCT01550341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92245685|NCT02125292|Mesalamine|mesalamine|mesh-list
92245686|NCT02125292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92245687|NCT02125292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245688|NCT02125292|Analgesics|analgesics|mesh-ancestor
92245689|NCT02125292|Sensory System Agents|sensory system agents|mesh-ancestor
92245690|NCT02125292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245691|NCT02125292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245692|NCT02125292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245693|NCT02125292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245694|NCT05079698|177Lu-PSMA-617|177lu-psma-617|mesh-list
92245695|NCT05079698|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92117534|NCT03257124|Osimertinib|osimertinib|mesh-list
92245696|NCT05079698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245697|NCT01653912|Paclitaxel|paclitaxel|mesh-list
92245698|NCT01653912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92245699|NCT01653912|Carboplatin|carboplatin|mesh-list
92341744|NCT00003125|Vaccines|vaccines|mesh-list
92245700|NCT01653912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92245702|NCT01653912|Tubulin Modulators|tubulin modulators|mesh-ancestor
92245703|NCT01653912|Antimitotic Agents|antimitotic agents|mesh-ancestor
92245704|NCT01653912|Mitosis Modulators|mitosis modulators|mesh-ancestor
92245705|NCT01653912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245706|NCT04132388|Adalimumab|adalimumab|mesh-list
92245707|NCT04132388|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92245708|NCT04132388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245709|NCT04132388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245710|NCT02514174|Afatinib|afatinib|mesh-list
92245711|NCT02514174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245712|NCT02514174|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92245713|NCT02514174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245714|NCT02514174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245715|NCT02132468|Fosbretabulin|fosbretabulin|mesh-list
92245716|NCT02132468|Combretastatin|combretastatin|mesh-list
92245717|NCT02132468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92245718|NCT02132468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245719|NCT02132468|Tubulin Modulators|tubulin modulators|mesh-ancestor
92245720|NCT02132468|Antimitotic Agents|antimitotic agents|mesh-ancestor
92245721|NCT02132468|Mitosis Modulators|mitosis modulators|mesh-ancestor
92245722|NCT02132468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245723|NCT01508455|Fentanyl|fentanyl|mesh-list
92245724|NCT01508455|Midazolam|midazolam|mesh-list
92245725|NCT01508455|Dexmedetomidine|dexmedetomidine|mesh-list
92245726|NCT01508455|Morphine|morphine|mesh-list
92245727|NCT01508455|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92245728|NCT01508455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245729|NCT01508455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245730|NCT01508455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245731|NCT01508455|Analgesics|analgesics|mesh-ancestor
92245732|NCT01508455|Sensory System Agents|sensory system agents|mesh-ancestor
92245733|NCT01508455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245734|NCT01508455|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92245735|NCT01508455|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92245736|NCT01508455|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92245737|NCT01508455|Adrenergic Agents|adrenergic agents|mesh-ancestor
92245738|NCT01508455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245739|NCT01508455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245740|NCT01508455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92245741|NCT01508455|Narcotics|narcotics|mesh-ancestor
92245742|NCT01508455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92245743|NCT01508455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92245744|NCT01508455|Anesthetics, General|anesthetics, general|mesh-ancestor
92245745|NCT01508455|Anesthetics|anesthetics|mesh-ancestor
92245746|NCT01508455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92245747|NCT01508455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92245748|NCT01508455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92245749|NCT01508455|GABA Modulators|gaba modulators|mesh-ancestor
92245750|NCT01508455|GABA Agents|gaba agents|mesh-ancestor
92245752|NCT03095612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245753|NCT03095612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92245754|NCT03095612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92245755|NCT03095612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92245756|NCT03095612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245757|NCT01509625|Fulvestrant|fulvestrant|mesh-list
92245758|NCT01509625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245759|NCT01509625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245760|NCT01509625|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92245761|NCT01509625|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92245762|NCT01509625|Hormone Antagonists|hormone antagonists|mesh-ancestor
92245763|NCT01509625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245764|NCT01509625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245765|NCT02482428|Imiquimod|imiquimod|mesh-list
92245766|NCT02482428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92245767|NCT02482428|Immunologic Factors|immunologic factors|mesh-ancestor
92245768|NCT02482428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245769|NCT02482428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245770|NCT02482428|Interferon Inducers|interferon inducers|mesh-ancestor
92245771|NCT01510327|Aspirin|aspirin|mesh-list
92245772|NCT01510327|Everolimus|everolimus|mesh-list
92245773|NCT01510327|Ticlopidine|ticlopidine|mesh-list
92245774|NCT01510327|Clopidogrel|clopidogrel|mesh-list
92245775|NCT01510327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92245776|NCT01510327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92245777|NCT01510327|Analgesics|analgesics|mesh-ancestor
92245778|NCT01510327|Sensory System Agents|sensory system agents|mesh-ancestor
92245779|NCT01510327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245780|NCT01510327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245781|NCT01510327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245782|NCT01510327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245783|NCT01510327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92245784|NCT01510327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92245785|NCT01510327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245786|NCT01510327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92245787|NCT01510327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92245788|NCT01510327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245789|NCT01510327|Antipyretics|antipyretics|mesh-ancestor
92245790|NCT01510327|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92245791|NCT01510327|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92245792|NCT01510327|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245793|NCT01510327|Immunologic Factors|immunologic factors|mesh-ancestor
92245794|NCT01510327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245795|NCT01510327|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92245796|NCT01510327|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92245798|NCT01510327|Purinergic Agents|purinergic agents|mesh-ancestor
92245799|NCT01510327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245800|NCT01510327|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92245801|NCT01510327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92245802|NCT01401595|Dexetimide|dexetimide|mesh-list
92245803|NCT01401595|Citalopram|citalopram|mesh-list
92245804|NCT01401595|Escitalopram|escitalopram|mesh-list
92245805|NCT01401595|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92245806|NCT01401595|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92245807|NCT01401595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245808|NCT01401595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245809|NCT01401595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245810|NCT01401595|Serotonin Agents|serotonin agents|mesh-ancestor
92245811|NCT01401595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245812|NCT01401595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92245813|NCT01401595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92245814|NCT01401595|Parasympatholytics|parasympatholytics|mesh-ancestor
92245815|NCT01401595|Autonomic Agents|autonomic agents|mesh-ancestor
92245816|NCT01401595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245817|NCT01401595|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92245818|NCT01401595|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92245819|NCT01401595|Cholinergic Agents|cholinergic agents|mesh-ancestor
92245820|NCT01401595|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92245821|NCT01401595|Antidepressive Agents|antidepressive agents|mesh-ancestor
92245822|NCT01401595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92245823|NCT01511809|Ritonavir|ritonavir|mesh-list
92245824|NCT01511809|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92245825|NCT01511809|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92245826|NCT01511809|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92245827|NCT01511809|Protease Inhibitors|protease inhibitors|mesh-ancestor
92245828|NCT01511809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245829|NCT01511809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245830|NCT01511809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92245831|NCT01511809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92245832|NCT01511809|Antiviral Agents|antiviral agents|mesh-ancestor
92245833|NCT01511809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245834|NCT01511809|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92245835|NCT01511809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92245836|NCT02480712|Sofosbuvir|sofosbuvir|mesh-list
92245837|NCT02480712|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92245838|NCT02480712|Velpatasvir|velpatasvir|mesh-list
92245839|NCT02480712|Antiviral Agents|antiviral agents|mesh-ancestor
92245840|NCT02480712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245841|NCT03916094|Trastuzumab|trastuzumab|mesh-list
92245842|NCT03916094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245843|NCT03916094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245844|NCT04986852|Pembrolizumab|pembrolizumab|mesh-list
92245845|NCT04986852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245846|NCT04986852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245847|NCT04986852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92245848|NCT04986852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245849|NCT00115700|Prednisolone|prednisolone|mesh-list
92245850|NCT00115700|Cyclophosphamide|cyclophosphamide|mesh-list
92245851|NCT00115700|Rituximab|rituximab|mesh-list
92245852|NCT00115700|Vincristine|vincristine|mesh-list
92245853|NCT00115700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245854|NCT00115700|Immunologic Factors|immunologic factors|mesh-ancestor
92245855|NCT00115700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245856|NCT00115700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245857|NCT00115700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92245858|NCT00115700|Alkylating Agents|alkylating agents|mesh-ancestor
92245859|NCT00115700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245860|NCT00115700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245861|NCT00115700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92245862|NCT00115700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245863|NCT00115700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92245864|NCT00115700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92245865|NCT00115700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92245866|NCT00115700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92245867|NCT00115700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245868|NCT00115700|Glucocorticoids|glucocorticoids|mesh-ancestor
92245869|NCT00115700|Hormones|hormones|mesh-ancestor
92245870|NCT00115700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245871|NCT00115700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245872|NCT01553539|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92245873|NCT01553539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92245874|NCT01553539|Vasodilator Agents|vasodilator agents|mesh-ancestor
92245875|NCT03243890|Vitamin D|vitamin d|mesh-list
92245876|NCT03243890|Vitamin K 2|vitamin k 2|mesh-list
92245877|NCT03243890|Vitamin K|vitamin k|mesh-list
92245878|NCT03243890|Menaquinone 7|menaquinone 7|mesh-list
92245879|NCT03243890|Vitamins|vitamins|mesh-ancestor
92245880|NCT03243890|Micronutrients|micronutrients|mesh-ancestor
92245881|NCT03243890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245882|NCT03243890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92245883|NCT03243890|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92245884|NCT03243890|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92245885|NCT03243890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245886|NCT03243890|Hemostatics|hemostatics|mesh-ancestor
92245887|NCT03243890|Coagulants|coagulants|mesh-ancestor
92245888|NCT00560612|Paroxetine|paroxetine|mesh-list
92245889|NCT00560612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92245890|NCT00560612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92245891|NCT00560612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92245892|NCT00560612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245893|NCT00560612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92245894|NCT00560612|Serotonin Agents|serotonin agents|mesh-ancestor
92245895|NCT00560612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245896|NCT00560612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92245897|NCT00560612|Antidepressive Agents|antidepressive agents|mesh-ancestor
92245898|NCT00560612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92245899|NCT00560612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92245900|NCT00560612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92245901|NCT00560612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245902|NCT01556347|Rituximab|rituximab|mesh-list
92245903|NCT01556347|Bortezomib|bortezomib|mesh-list
92245904|NCT01556347|Thymoglobulin|thymoglobulin|mesh-list
92245905|NCT01556347|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92245906|NCT01556347|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92245907|NCT01556347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245908|NCT01556347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245909|NCT01556347|Immunologic Factors|immunologic factors|mesh-ancestor
92245910|NCT01556347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245911|NCT01556347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245912|NCT01556347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245913|NCT00561002|Vaccines|vaccines|mesh-list
92245914|NCT00561002|Immunologic Factors|immunologic factors|mesh-ancestor
92245915|NCT00561002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245916|NCT03236792|Dexamethasone|dexamethasone|mesh-list
92245917|NCT03236792|Cyclophosphamide|cyclophosphamide|mesh-list
92245918|NCT03236792|Ixazomib|ixazomib|mesh-list
92245919|NCT03236792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92245920|NCT03236792|Immunologic Factors|immunologic factors|mesh-ancestor
92245921|NCT03236792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245922|NCT03236792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245923|NCT03236792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92245924|NCT03236792|Alkylating Agents|alkylating agents|mesh-ancestor
92245925|NCT03236792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245926|NCT03236792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245927|NCT03236792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92245928|NCT03236792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92245929|NCT03236792|Antiemetics|antiemetics|mesh-ancestor
92245930|NCT03236792|Autonomic Agents|autonomic agents|mesh-ancestor
92245931|NCT03236792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245932|NCT03236792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92245933|NCT03236792|Glucocorticoids|glucocorticoids|mesh-ancestor
92245934|NCT03236792|Hormones|hormones|mesh-ancestor
92245935|NCT03236792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245936|NCT03236792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92245937|NCT03236792|Protease Inhibitors|protease inhibitors|mesh-ancestor
92245938|NCT03236792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92245939|NCT03725384|Ascorbic Acid|ascorbic acid|mesh-list
92245940|NCT03725384|Iron|iron|mesh-list
92245941|NCT03725384|Vitamins|vitamins|mesh-ancestor
92245942|NCT03725384|Micronutrients|micronutrients|mesh-ancestor
92245943|NCT03725384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245944|NCT03725384|Trace Elements|trace elements|mesh-ancestor
92245945|NCT03725384|Antioxidants|antioxidants|mesh-ancestor
92245946|NCT03725384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245947|NCT03725384|Protective Agents|protective agents|mesh-ancestor
92245948|NCT01556425|Naltrexone|naltrexone|mesh-list
92245949|NCT01556425|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92245950|NCT01556425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92245951|NCT01556425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245952|NCT01556425|Sensory System Agents|sensory system agents|mesh-ancestor
92391774|NCT01726764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92245953|NCT01556425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245954|NCT01798628|Abiraterone Acetate|abiraterone acetate|mesh-list
92245955|NCT01798628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245956|NCT01798628|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92245957|NCT01798628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341768|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245958|NCT01798628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245959|NCT01798628|Hormone Antagonists|hormone antagonists|mesh-ancestor
92245960|NCT01798628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92245961|NCT01798628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245962|NCT01798628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92245963|NCT03143270|Nivolumab|nivolumab|mesh-list
92245964|NCT03143270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245965|NCT03143270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245966|NCT03143270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92245967|NCT03143270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92245968|NCT00562328|Rituximab|rituximab|mesh-list
92245969|NCT00562328|Alemtuzumab|alemtuzumab|mesh-list
92245970|NCT00562328|Sargramostim|sargramostim|mesh-list
92245971|NCT00562328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92245972|NCT00562328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92245973|NCT00562328|Immunologic Factors|immunologic factors|mesh-ancestor
92245974|NCT00562328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245975|NCT00562328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92245976|NCT01514149|Metformin|metformin|mesh-list
92245977|NCT01514149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92245978|NCT01514149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245979|NCT05566093|Ethanol|ethanol|mesh-list
92245980|NCT05566093|Polidocanol|polidocanol|mesh-list
92245981|NCT05566093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92245982|NCT05566093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92245983|NCT05566093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245984|NCT05566093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245985|NCT05566093|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92245986|NCT05566093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92245987|NCT01558063|Ketamine|ketamine|mesh-list
92245988|NCT01558063|Analgesics|analgesics|mesh-ancestor
92245989|NCT01558063|Sensory System Agents|sensory system agents|mesh-ancestor
92245990|NCT01558063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92245991|NCT01558063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92245992|NCT01558063|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92245993|NCT01558063|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92245994|NCT01558063|Anesthetics, General|anesthetics, general|mesh-ancestor
92245995|NCT01558063|Anesthetics|anesthetics|mesh-ancestor
92245996|NCT01558063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92245997|NCT01558063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92245998|NCT01558063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92245999|NCT01558063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246000|NCT01558063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246001|NCT03641846|Tadalafil|tadalafil|mesh-list
92246002|NCT03641846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92246003|NCT03641846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92246004|NCT03641846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92246005|NCT03641846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246006|NCT03641846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246007|NCT03641846|Urological Agents|urological agents|mesh-ancestor
92246008|NCT03474458|Doxycycline|doxycycline|mesh-list
92246009|NCT03474458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92246010|NCT03474458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246011|NCT03474458|Antimalarials|antimalarials|mesh-ancestor
92246012|NCT03474458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92246013|NCT03474458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246014|NCT01516957|Brodalumab|brodalumab|mesh-list
92246015|NCT01516957|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92246016|NCT01516957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92246017|NCT01516957|Immunologic Factors|immunologic factors|mesh-ancestor
92246018|NCT01516957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246019|NCT01519063|Naltrexone|naltrexone|mesh-list
92246020|NCT01519063|Memantine|memantine|mesh-list
92246021|NCT01519063|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92246022|NCT01519063|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92246023|NCT01519063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246024|NCT01519063|Sensory System Agents|sensory system agents|mesh-ancestor
92246025|NCT01519063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246026|NCT01519063|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92246027|NCT01519063|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92246028|NCT01519063|Dopamine Agents|dopamine agents|mesh-ancestor
92246029|NCT01519063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246030|NCT01519063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246031|NCT01519063|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92246032|NCT01519063|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92246033|NCT01559857|Pioglitazone|pioglitazone|mesh-list
92246034|NCT01559857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92246035|NCT01559857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246036|NCT05565625|Sunscreening Agents|sunscreening agents|mesh-list
92246037|NCT05565625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92246038|NCT05565625|Protective Agents|protective agents|mesh-ancestor
92246039|NCT05565625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246040|NCT05565625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92246041|NCT00754208|Methylphenidate|methylphenidate|mesh-list
92246042|NCT00754208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92246043|NCT00754208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246044|NCT00754208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92246045|NCT00754208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92246046|NCT00754208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246047|NCT00754208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246048|NCT00754208|Dopamine Agents|dopamine agents|mesh-ancestor
92246049|NCT00754208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246050|NCT01562041|Ranolazine|ranolazine|mesh-list
92246051|NCT01562041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92246052|NCT01562041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246053|NCT01562041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246054|NCT00634166|Anti-Infective Agents|anti-infective agents|mesh-list
92246055|NCT00634166|Amphotericin B|amphotericin b|mesh-list
92246056|NCT00634166|Clotrimazole|clotrimazole|mesh-list
92246057|NCT00634166|Miconazole|miconazole|mesh-list
92246058|NCT00634166|Bacitracin|bacitracin|mesh-list
92246059|NCT00634166|Mafenide|mafenide|mesh-list
92246060|NCT00634166|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92246061|NCT00634166|Antifungal Agents|antifungal agents|mesh-list
92246062|NCT00634166|Amebicides|amebicides|mesh-ancestor
92246063|NCT00634166|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92246064|NCT00634166|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246065|NCT00634166|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92246066|NCT00634166|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92246067|NCT00634166|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92246068|NCT00634166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246069|NCT00634166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246070|NCT00634166|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92246071|NCT00634166|Hormone Antagonists|hormone antagonists|mesh-ancestor
92246072|NCT00634166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92246073|NCT00634166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246074|NCT00634166|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92246075|NCT00634166|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92246076|NCT00634166|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92246077|NCT00565370|Capecitabine|capecitabine|mesh-list
92246078|NCT00565370|Sorafenib|sorafenib|mesh-list
92246079|NCT00565370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246080|NCT00565370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92246081|NCT00565370|Antimetabolites|antimetabolites|mesh-ancestor
92246082|NCT00565370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246083|NCT00565370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92246084|NCT00565370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246085|NCT03303950|Cyclophosphamide|cyclophosphamide|mesh-list
92246087|NCT03303950|Fludarabine|fludarabine|mesh-list
92246088|NCT03303950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246089|NCT03303950|Immunologic Factors|immunologic factors|mesh-ancestor
92246090|NCT03303950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246091|NCT03303950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246092|NCT03303950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92246093|NCT03303950|Alkylating Agents|alkylating agents|mesh-ancestor
92246094|NCT03303950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246095|NCT03303950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246096|NCT03303950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92246098|NCT01563055|Chlorambucil|chlorambucil|mesh-list
92246099|NCT01563055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246100|NCT01563055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92246101|NCT01563055|Alkylating Agents|alkylating agents|mesh-ancestor
92246102|NCT01563055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246103|NCT00565916|Estradiol|estradiol|mesh-list
92246104|NCT00565916|Estrogens|estrogens|mesh-list
92246105|NCT00565916|Progesterone|progesterone|mesh-list
92246106|NCT00565916|Hormones|hormones|mesh-ancestor
92246107|NCT00565916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92246108|NCT00565916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246109|NCT00565916|Progestins|progestins|mesh-ancestor
92246110|NCT03258320|Docetaxel|docetaxel|mesh-list
92246111|NCT03258320|Mitoxantrone|mitoxantrone|mesh-list
92246112|NCT03258320|Satraplatin|satraplatin|mesh-list
92246113|NCT03258320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246114|NCT03258320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92246115|NCT03258320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92246116|NCT03258320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92246117|NCT03258320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246118|NCT03258320|Analgesics|analgesics|mesh-ancestor
92246119|NCT03258320|Sensory System Agents|sensory system agents|mesh-ancestor
92246120|NCT03258320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246121|NCT03258320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246122|NCT03258320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92246123|NCT03258320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92246124|NCT03258320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246125|NCT01797926|Losartan|losartan|mesh-list
92246126|NCT01797926|Amlodipine|amlodipine|mesh-list
92246127|NCT01797926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92246128|NCT01797926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92246129|NCT01797926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246130|NCT01797926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246131|NCT01797926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92246132|NCT01797926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246133|NCT01797926|Vasodilator Agents|vasodilator agents|mesh-ancestor
92246134|NCT01797926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92246135|NCT01797926|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92246136|NCT01797926|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92246137|NCT03008083|Clopidogrel|clopidogrel|mesh-list
92246138|NCT03008083|Ticagrelor|ticagrelor|mesh-list
92246139|NCT03008083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92246140|NCT03008083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92246141|NCT03008083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92246142|NCT03008083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92246143|NCT03008083|Purinergic Agents|purinergic agents|mesh-ancestor
92246144|NCT03008083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246145|NCT03008083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246146|NCT03008083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246147|NCT05559398|Glenzocimab|glenzocimab|mesh-list
92246148|NCT05559398|Anticoagulants|anticoagulants|mesh-ancestor
92246149|NCT00566150|Levetiracetam|levetiracetam|mesh-list
92246150|NCT00566150|Anticonvulsants|anticonvulsants|mesh-ancestor
92246151|NCT00566150|Nootropic Agents|nootropic agents|mesh-ancestor
92246152|NCT00566540|Paclitaxel|paclitaxel|mesh-list
92246153|NCT00566540|Cisplatin|cisplatin|mesh-list
92246154|NCT00566540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92246155|NCT00566540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246156|NCT00566540|Tubulin Modulators|tubulin modulators|mesh-ancestor
92246157|NCT00566540|Antimitotic Agents|antimitotic agents|mesh-ancestor
92246158|NCT00566540|Mitosis Modulators|mitosis modulators|mesh-ancestor
92246159|NCT00566540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246160|NCT00567008|Varenicline|varenicline|mesh-list
92246161|NCT00567008|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92246162|NCT00567008|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92246163|NCT00567008|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246164|NCT00567008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246165|NCT00567008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246166|NCT00567008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246167|NCT00567320|Varenicline|varenicline|mesh-list
92246168|NCT00567320|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92246169|NCT00567320|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92246170|NCT00567320|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246171|NCT00567320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246172|NCT00567320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246173|NCT00567320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246174|NCT01522417|Tirofiban|tirofiban|mesh-list
92246175|NCT01522417|Eptifibatide|eptifibatide|mesh-list
92246176|NCT01522417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92246177|NCT01522417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92246178|NCT01522417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246179|NCT01522417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92246180|NCT00568022|Capecitabine|capecitabine|mesh-list
92246181|NCT00568022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92246182|NCT00568022|Antimetabolites|antimetabolites|mesh-ancestor
92246183|NCT00568022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246184|NCT00568022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246185|NCT01522963|Nicotine|nicotine|mesh-list
92246186|NCT01522963|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92246187|NCT01522963|Autonomic Agents|autonomic agents|mesh-ancestor
92246188|NCT01522963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246189|NCT01522963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246190|NCT01522963|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92246191|NCT01522963|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92246192|NCT01522963|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246193|NCT01522963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246194|NCT01522963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246195|NCT03094286|Durvalumab|durvalumab|mesh-list
92246196|NCT03094286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92246197|NCT03094286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246198|NCT03071666|Vitamin B 12|vitamin b 12|mesh-list
92246199|NCT03071666|Vitamins|vitamins|mesh-ancestor
92246200|NCT03071666|Micronutrients|micronutrients|mesh-ancestor
92246201|NCT03071666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246202|NCT03071666|Vitamin B Complex|vitamin b complex|mesh-ancestor
92246203|NCT05533580|Sufentanil|sufentanil|mesh-list
92246204|NCT05533580|Dsuvia|dsuvia|mesh-list
92246205|NCT05533580|Propofol|propofol|mesh-list
92246206|NCT05533580|Cisatracurium|cisatracurium|mesh-list
92246207|NCT05533580|Atracurium|atracurium|mesh-list
92246208|NCT05533580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92246209|NCT05533580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246210|NCT05533580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246211|NCT05533580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92246212|NCT05533580|Anesthetics, General|anesthetics, general|mesh-ancestor
92246213|NCT05533580|Anesthetics|anesthetics|mesh-ancestor
92246214|NCT05533580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92246215|NCT05533580|Narcotics|narcotics|mesh-ancestor
92246216|NCT05533580|Analgesics|analgesics|mesh-ancestor
92246217|NCT05533580|Sensory System Agents|sensory system agents|mesh-ancestor
92246218|NCT05533580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246219|NCT05533580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92246220|NCT05533580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92246221|NCT05533580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92246222|NCT05533580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92246223|NCT05533580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92246224|NCT05533580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92246225|NCT05533580|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246226|NCT05533580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246227|NCT05533580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246228|NCT02129426|Midazolam|midazolam|mesh-list
92246229|NCT02129426|Dexmedetomidine|dexmedetomidine|mesh-list
92246230|NCT02129426|Ketamine|ketamine|mesh-list
92246231|NCT02129426|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92246232|NCT02129426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246233|NCT02129426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246234|NCT02129426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92246235|NCT02129426|Analgesics|analgesics|mesh-ancestor
92246236|NCT02129426|Sensory System Agents|sensory system agents|mesh-ancestor
92246237|NCT02129426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246238|NCT02129426|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92246239|NCT02129426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92246240|NCT02129426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92246241|NCT02129426|Adrenergic Agents|adrenergic agents|mesh-ancestor
92246242|NCT02129426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246243|NCT02129426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246244|NCT02129426|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92246245|NCT02129426|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92246246|NCT02129426|Anesthetics, General|anesthetics, general|mesh-ancestor
92246248|NCT02129426|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92246249|NCT02129426|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92246250|NCT02129426|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92246251|NCT02129426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92246252|NCT02129426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92246253|NCT02129426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92246254|NCT02129426|GABA Modulators|gaba modulators|mesh-ancestor
92246255|NCT02129426|GABA Agents|gaba agents|mesh-ancestor
92246256|NCT01523821|Protease Inhibitors|protease inhibitors|mesh-list
92246257|NCT01523821|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92246258|NCT01523821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246259|NCT01523821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246260|NCT01523821|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92246261|NCT01523821|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92246262|NCT05409716|Hemostatics|hemostatics|mesh-list
92246263|NCT05409716|Coagulants|coagulants|mesh-ancestor
92246264|NCT05395910|Paclitaxel|paclitaxel|mesh-list
92246265|NCT05395910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92246266|NCT05395910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246267|NCT05395910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92246268|NCT05395910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92246269|NCT05395910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92246270|NCT05395910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246271|NCT05389046|Dexetimide|dexetimide|mesh-list
92246272|NCT05389046|Aripiprazole|aripiprazole|mesh-list
92246273|NCT05389046|Citalopram|citalopram|mesh-list
92246274|NCT05389046|Escitalopram|escitalopram|mesh-list
92246275|NCT05389046|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92246276|NCT05389046|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92246277|NCT05389046|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246278|NCT05389046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246279|NCT05389046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246280|NCT05389046|Serotonin Agents|serotonin agents|mesh-ancestor
92341844|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92246281|NCT05389046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246282|NCT05389046|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92246283|NCT05389046|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92246284|NCT05389046|Parasympatholytics|parasympatholytics|mesh-ancestor
92246285|NCT05389046|Autonomic Agents|autonomic agents|mesh-ancestor
92246286|NCT05389046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246287|NCT05389046|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92246288|NCT05389046|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92246289|NCT05389046|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246290|NCT05389046|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92246291|NCT05389046|Antidepressive Agents|antidepressive agents|mesh-ancestor
92246292|NCT05389046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92246293|NCT05389046|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92246294|NCT05389046|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92246295|NCT05389046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246296|NCT05389046|Dopamine Agonists|dopamine agonists|mesh-ancestor
92246297|NCT05389046|Dopamine Agents|dopamine agents|mesh-ancestor
92246298|NCT05389046|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92246299|NCT05389046|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92246300|NCT05389046|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92246301|NCT05389046|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92246302|NCT05389046|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92246303|NCT05389046|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92246304|NCT01566409|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92246305|NCT01566409|Laxatives|laxatives|mesh-ancestor
92246306|NCT01566409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246307|NCT02184416|Everolimus|everolimus|mesh-list
92246308|NCT02184416|Temsirolimus|temsirolimus|mesh-list
92246309|NCT02184416|Sorafenib|sorafenib|mesh-list
92246310|NCT02184416|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92246311|NCT02184416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92246312|NCT02184416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246313|NCT02184416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246314|NCT02184416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246315|NCT02184416|Immunologic Factors|immunologic factors|mesh-ancestor
92246316|NCT02184416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246317|NCT02184416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246318|NCT01568905|Nicotine|nicotine|mesh-list
92246319|NCT01568905|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92246320|NCT01568905|Autonomic Agents|autonomic agents|mesh-ancestor
92246321|NCT01568905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246322|NCT01568905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246323|NCT01568905|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92246324|NCT01568905|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92246325|NCT01568905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246326|NCT01568905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246327|NCT01568905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246328|NCT01569451|Rituximab|rituximab|mesh-list
92246329|NCT01569451|Glatiramer Acetate|glatiramer acetate|mesh-list
92246330|NCT01569451|(T,G)-A-L|(t,g)-a-l|mesh-list
92246331|NCT01569451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92246332|NCT01569451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246333|NCT01569451|Immunologic Factors|immunologic factors|mesh-ancestor
92246334|NCT01569451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246335|NCT01569451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246336|NCT01569451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92246337|NCT01569451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246338|NCT02132936|Calcipotriene|calcipotriene|mesh-list
92246339|NCT02132936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92246340|NCT01528891|Dexmedetomidine|dexmedetomidine|mesh-list
92246341|NCT01528891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92246342|NCT01528891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246343|NCT01528891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246344|NCT01528891|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92246345|NCT01528891|Analgesics|analgesics|mesh-ancestor
92246346|NCT01528891|Sensory System Agents|sensory system agents|mesh-ancestor
92246347|NCT01528891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246348|NCT01528891|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92246349|NCT01528891|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92246350|NCT01528891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92246351|NCT01528891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92246352|NCT01528891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246353|NCT01528891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246354|NCT01529203|Botulinum Toxins|botulinum toxins|mesh-list
92246355|NCT01529203|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92246356|NCT01529203|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92246357|NCT01529203|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92246358|NCT01529203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246359|NCT01529203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246360|NCT01529203|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246361|NCT01529203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246362|NCT01529203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246363|NCT01529203|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92246364|NCT01529203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246365|NCT01529827|Mycophenolic Acid|mycophenolic acid|mesh-list
92246366|NCT01529827|Methotrexate|methotrexate|mesh-list
92246367|NCT01529827|Fludarabine phosphate|fludarabine phosphate|mesh-list
92246368|NCT01529827|Fludarabine|fludarabine|mesh-list
92246369|NCT01529827|Melphalan|melphalan|mesh-list
92246370|NCT01529827|Tacrolimus|tacrolimus|mesh-list
92246371|NCT01529827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92246372|NCT01529827|Abortifacient Agents|abortifacient agents|mesh-ancestor
92246373|NCT01529827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92246374|NCT01529827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246375|NCT01529827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92246376|NCT01529827|Antimetabolites|antimetabolites|mesh-ancestor
92246377|NCT01529827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246378|NCT01529827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246379|NCT01529827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92246380|NCT01529827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246381|NCT01529827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92246382|NCT01529827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246383|NCT01529827|Immunologic Factors|immunologic factors|mesh-ancestor
92246384|NCT01529827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246385|NCT01529827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92246386|NCT01529827|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92246387|NCT01529827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92246388|NCT01529827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92246389|NCT01529827|Antitubercular Agents|antitubercular agents|mesh-ancestor
92246390|NCT01529827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92246391|NCT01529827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246392|NCT01529827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92246393|NCT01529827|Alkylating Agents|alkylating agents|mesh-ancestor
92246394|NCT01529827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92246395|NCT01571557|Dexamethasone|dexamethasone|mesh-list
92246396|NCT01571557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246397|NCT01571557|Antiemetics|antiemetics|mesh-ancestor
92246398|NCT01571557|Autonomic Agents|autonomic agents|mesh-ancestor
92246399|NCT01571557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246400|NCT01571557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246401|NCT01571557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246402|NCT01571557|Glucocorticoids|glucocorticoids|mesh-ancestor
92246403|NCT01571557|Hormones|hormones|mesh-ancestor
92246404|NCT01571557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92246405|NCT01571557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92246406|NCT01571557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246407|NCT00569660|Azacitidine|azacitidine|mesh-list
92246408|NCT00569660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92246409|NCT00569660|Antimetabolites|antimetabolites|mesh-ancestor
92246410|NCT00569660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246411|NCT00569660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246412|NCT00569660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246413|NCT01573273|Oxytocin|oxytocin|mesh-list
92246414|NCT01573273|Oxytocics|oxytocics|mesh-ancestor
92246415|NCT01573273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92246416|NCT01573273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246417|NCT00572234|Bupropion|bupropion|mesh-list
92246418|NCT00572234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92246419|NCT00572234|Antidepressive Agents|antidepressive agents|mesh-ancestor
92246420|NCT00572234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92246421|NCT00572234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92246422|NCT00572234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92246423|NCT00572234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246424|NCT00572234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246425|NCT00572234|Dopamine Agents|dopamine agents|mesh-ancestor
92246426|NCT00572234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246427|NCT00572234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246428|NCT00572234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92246429|NCT00572234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92246430|NCT00572234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246431|NCT00572468|Simvastatin|simvastatin|mesh-list
92246432|NCT00572468|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92246433|NCT00572468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92246434|NCT00572468|Antimetabolites|antimetabolites|mesh-ancestor
92246435|NCT00572468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246436|NCT00572468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92246437|NCT00572468|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92246438|NCT00572468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246439|NCT02339246|Tacrolimus|tacrolimus|mesh-list
92246440|NCT02339246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246441|NCT02339246|Immunologic Factors|immunologic factors|mesh-ancestor
92246442|NCT02339246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246443|NCT02339246|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92246444|NCT02339246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246445|NCT02339246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246446|NCT00572936|Timolol|timolol|mesh-list
92246447|NCT00572936|Dorzolamide|dorzolamide|mesh-list
92246448|NCT00572936|Latanoprost|latanoprost|mesh-list
92246449|NCT00572936|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92246450|NCT00572936|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92246451|NCT00572936|Adrenergic Agents|adrenergic agents|mesh-ancestor
92246452|NCT00572936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246453|NCT00572936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246454|NCT00572936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246455|NCT00572936|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92246456|NCT00572936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92246457|NCT00572936|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92246458|NCT00572936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92246459|NCT00572936|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92246460|NCT00572936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246461|NCT05085626|Fluzoparib|fluzoparib|mesh-list
91934729|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246462|NCT05085626|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92246464|NCT05085626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246465|NCT05085626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246466|NCT05041946|Methylphenidate|methylphenidate|mesh-list
92246467|NCT05041946|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92246468|NCT05041946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246469|NCT05041946|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92246470|NCT05041946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92246471|NCT05041946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246472|NCT05041946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246473|NCT05041946|Dopamine Agents|dopamine agents|mesh-ancestor
92246474|NCT05041946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246475|NCT05092412|Carboplatin|carboplatin|mesh-list
92246476|NCT05092412|Etoposide|etoposide|mesh-list
92246478|NCT05092412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246479|NCT05092412|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92246480|NCT05092412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92246481|NCT05092412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92246482|NCT05092412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246483|NCT05092412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246484|NCT05092412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92246486|NCT00574340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246487|NCT05004896|Midazolam|midazolam|mesh-list
92246488|NCT05004896|Ketamine|ketamine|mesh-list
92246489|NCT05004896|Analgesics|analgesics|mesh-ancestor
92246490|NCT05004896|Sensory System Agents|sensory system agents|mesh-ancestor
92246491|NCT05004896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246492|NCT05004896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246493|NCT05004896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92246494|NCT05004896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92246495|NCT05004896|Anesthetics, General|anesthetics, general|mesh-ancestor
92246496|NCT05004896|Anesthetics|anesthetics|mesh-ancestor
92246497|NCT05004896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246498|NCT05004896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92246499|NCT05004896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92246500|NCT05004896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246501|NCT05004896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246502|NCT05004896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92246503|NCT05004896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92246504|NCT05004896|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92246505|NCT05004896|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92246506|NCT05004896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92246507|NCT05004896|GABA Modulators|gaba modulators|mesh-ancestor
92246508|NCT05004896|GABA Agents|gaba agents|mesh-ancestor
92246509|NCT00576680|Temozolomide|temozolomide|mesh-list
92246510|NCT00576680|Everolimus|everolimus|mesh-list
92246511|NCT00576680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92246512|NCT00576680|Alkylating Agents|alkylating agents|mesh-ancestor
92246513|NCT00576680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246514|NCT00576680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246515|NCT00576680|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92246516|NCT00576680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92246517|NCT00576680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246518|NCT00576680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246519|NCT00576680|Immunologic Factors|immunologic factors|mesh-ancestor
92246520|NCT00576680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246521|NCT04866602|Atovaquone|atovaquone|mesh-list
92246522|NCT04866602|Proguanil|proguanil|mesh-list
92246523|NCT04866602|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92246524|NCT04866602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246525|NCT04866602|Antimalarials|antimalarials|mesh-ancestor
92246526|NCT04866602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92246527|NCT04866602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246528|NCT04866602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246529|NCT04866602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246530|NCT04866602|Antimetabolites|antimetabolites|mesh-ancestor
92246531|NCT04730648|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92246532|NCT04730648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92246533|NCT04730648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92246534|NCT04730648|Antimetabolites|antimetabolites|mesh-ancestor
91934731|NCT02341209|Doxycycline|doxycycline|mesh-list
92246535|NCT04730648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246536|NCT04730648|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92246537|NCT04730648|Protease Inhibitors|protease inhibitors|mesh-ancestor
92246538|NCT04730648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246539|NCT04730648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92246540|NCT00578552|Gabapentin|gabapentin|mesh-list
92246541|NCT00578552|Analgesics|analgesics|mesh-ancestor
92246542|NCT00578552|Sensory System Agents|sensory system agents|mesh-ancestor
92246543|NCT00578552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246544|NCT00578552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246545|NCT00578552|Anticonvulsants|anticonvulsants|mesh-ancestor
92246546|NCT00578552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92246547|NCT00578552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92246548|NCT00578552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246549|NCT00578552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92246550|NCT00578552|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92246551|NCT00578552|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92246552|NCT00578552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246553|NCT00578552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246554|NCT00578552|Antimanic Agents|antimanic agents|mesh-ancestor
92246555|NCT01532089|Bevacizumab|bevacizumab|mesh-list
92246556|NCT01532089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92246557|NCT01532089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92246558|NCT01532089|Endothelial Growth Factors|endothelial growth factors|mesh-list
92246559|NCT01532089|Antibodies|antibodies|mesh-list
92246560|NCT01532089|Immunoglobulins|immunoglobulins|mesh-list
92246561|NCT01532089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92246562|NCT01532089|Immunoglobulin G|immunoglobulin g|mesh-list
92246563|NCT01532089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246564|NCT01532089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92246565|NCT01532089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92246566|NCT01532089|Growth Substances|growth substances|mesh-ancestor
92246567|NCT01532089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246568|NCT01532089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92246569|NCT01532089|Immunologic Factors|immunologic factors|mesh-ancestor
92246570|NCT01532089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92246571|NCT01532089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246572|NCT01532089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246573|NCT00579878|Hydroxychloroquine|hydroxychloroquine|mesh-list
92246574|NCT00579878|Sulfasalazine|sulfasalazine|mesh-list
92246575|NCT00579878|Methotrexate|methotrexate|mesh-list
92246576|NCT00579878|Leflunomide|leflunomide|mesh-list
92246577|NCT00579878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92246578|NCT00579878|Abortifacient Agents|abortifacient agents|mesh-ancestor
92246579|NCT00579878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92246580|NCT00579878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246581|NCT00579878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92246582|NCT00579878|Antimetabolites|antimetabolites|mesh-ancestor
92246583|NCT00579878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246584|NCT00579878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246585|NCT00579878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92246586|NCT00579878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246587|NCT00579878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92246588|NCT00579878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246589|NCT00579878|Immunologic Factors|immunologic factors|mesh-ancestor
92246590|NCT00579878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246591|NCT00579878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92246592|NCT00579878|Antimalarials|antimalarials|mesh-ancestor
92246593|NCT00579878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92246594|NCT00579878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246595|NCT00579878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941486|NCT03480997|Tocolytic Agents|tocolytic agents|mesh-ancestor
92246596|NCT00579878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92246597|NCT00579878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92246598|NCT00579878|Analgesics|analgesics|mesh-ancestor
92246599|NCT00579878|Sensory System Agents|sensory system agents|mesh-ancestor
92246600|NCT00579878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246601|NCT00579878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246602|NCT00579878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246603|NCT01533259|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92246604|NCT01533259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92246605|NCT01533259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92246606|NCT01533259|Antiviral Agents|antiviral agents|mesh-ancestor
92246607|NCT01533259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246608|NCT05246072|Ivermectin|ivermectin|mesh-list
92246609|NCT05246072|Colchicine|colchicine|mesh-list
92246610|NCT05246072|Gout Suppressants|gout suppressants|mesh-ancestor
92246611|NCT05246072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246612|NCT05246072|Tubulin Modulators|tubulin modulators|mesh-ancestor
92246613|NCT05246072|Antimitotic Agents|antimitotic agents|mesh-ancestor
92246614|NCT05246072|Mitosis Modulators|mitosis modulators|mesh-ancestor
92246615|NCT05246072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246616|NCT05246072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246617|NCT05246072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246618|NCT05246072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246619|NCT02135432|Ivacaftor|ivacaftor|mesh-list
92246620|NCT02135432|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92246621|NCT02135432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246622|NCT02135432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246623|NCT05245994|Carboplatin|carboplatin|mesh-list
92246624|NCT05245994|Etoposide|etoposide|mesh-list
92246625|NCT05245994|Durvalumab|durvalumab|mesh-list
92246626|NCT05245994|Olaparib|olaparib|mesh-list
92246627|NCT05245994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246628|NCT05245994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92246629|NCT05245994|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92246630|NCT05245994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92246631|NCT05245994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246632|NCT05245994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246633|NCT05245994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92246634|NCT05245994|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92246635|NCT05245604|Cyclosporine|cyclosporine|mesh-list
92246636|NCT05245604|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92246637|NCT05245604|Cyclosporins|cyclosporins|mesh-list
92246638|NCT05245604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246639|NCT05245604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246640|NCT05245604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246641|NCT05245604|Immunologic Factors|immunologic factors|mesh-ancestor
92246642|NCT05245604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246643|NCT05245604|Antifungal Agents|antifungal agents|mesh-ancestor
92246644|NCT05245604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246645|NCT05245604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92246646|NCT05245604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246647|NCT05245604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92246648|NCT05245604|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92246649|NCT05245448|Tetrandrine|tetrandrine|mesh-list
92246650|NCT05245448|Antimalarials|antimalarials|mesh-ancestor
92246651|NCT05245448|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92246652|NCT05245448|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246653|NCT05245448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246654|NCT05245448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92246655|NCT05245448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246656|NCT05245448|Antiviral Agents|antiviral agents|mesh-ancestor
92246657|NCT05245448|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92246658|NCT05245448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246659|NCT05245448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246660|NCT05245448|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92246661|NCT05245448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246662|NCT05245448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246663|NCT05245448|Immunologic Factors|immunologic factors|mesh-ancestor
92246664|NCT00581048|Vitamin E|vitamin e|mesh-list
92246665|NCT00581048|Tocopherols|tocopherols|mesh-list
92246666|NCT00581048|alpha-Tocopherol|alpha-tocopherol|mesh-list
92246667|NCT00581048|Vitamins|vitamins|mesh-ancestor
92246668|NCT00581048|Micronutrients|micronutrients|mesh-ancestor
92246669|NCT00581048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246670|NCT00581048|Antioxidants|antioxidants|mesh-ancestor
92246671|NCT00581048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246672|NCT00581048|Protective Agents|protective agents|mesh-ancestor
92246673|NCT01798472|Cimetidine|cimetidine|mesh-list
92246674|NCT01798472|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92246675|NCT01798472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246676|NCT01798472|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92246677|NCT01798472|Histamine Antagonists|histamine antagonists|mesh-ancestor
92246678|NCT01798472|Histamine Agents|histamine agents|mesh-ancestor
92246679|NCT01798472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246680|NCT01798472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246681|NCT01798472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246682|NCT01798472|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92246683|NCT01798472|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92246684|NCT01798472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246686|NCT01579513|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92246687|NCT01579513|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92246688|NCT01579513|Prednisolone|prednisolone|mesh-list
92246689|NCT01579513|Prednisolone acetate|prednisolone acetate|mesh-list
92246690|NCT01579513|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92246691|NCT01579513|Prednisolone phosphate|prednisolone phosphate|mesh-list
92246692|NCT01579513|Glucocorticoids|glucocorticoids|mesh-list
92246693|NCT01579513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246694|NCT01579513|Antiemetics|antiemetics|mesh-ancestor
92246695|NCT01579513|Autonomic Agents|autonomic agents|mesh-ancestor
92246696|NCT01579513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246697|NCT01579513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246698|NCT01579513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246699|NCT01579513|Hormones|hormones|mesh-ancestor
92246700|NCT01579513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92246701|NCT01579513|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92246702|NCT01579513|Protective Agents|protective agents|mesh-ancestor
92246703|NCT01579513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92246704|NCT01579513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246705|NCT01534897|Dabrafenib|dabrafenib|mesh-list
92246706|NCT01534897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246707|NCT01534897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92246708|NCT01534897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246709|NCT01534897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246710|NCT05121350|Epirubicin|epirubicin|mesh-list
92246711|NCT05121350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92246712|NCT05121350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246713|NCT05121350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92246714|NCT05121350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92246715|NCT05121350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246716|NCT05121350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246717|NCT00583622|Bevacizumab|bevacizumab|mesh-list
92246718|NCT00583622|Carboplatin|carboplatin|mesh-list
92246719|NCT00583622|Gemcitabine|gemcitabine|mesh-list
92246720|NCT00583622|Docetaxel|docetaxel|mesh-list
92246721|NCT00583622|Melphalan|melphalan|mesh-list
92246722|NCT00583622|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92246723|NCT00583622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246724|NCT00583622|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92246725|NCT00583622|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92246726|NCT00583622|Growth Substances|growth substances|mesh-ancestor
92246727|NCT00583622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246728|NCT00583622|Growth Inhibitors|growth inhibitors|mesh-ancestor
92246729|NCT00583622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92246730|NCT00583622|Antimetabolites|antimetabolites|mesh-ancestor
92246731|NCT00583622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246732|NCT00583622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92246733|NCT00583622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92246734|NCT00583622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92246735|NCT00583622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92246736|NCT00583622|Alkylating Agents|alkylating agents|mesh-ancestor
92246737|NCT00583622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92246738|NCT00583622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246739|NCT00583622|Immunologic Factors|immunologic factors|mesh-ancestor
92246740|NCT00583700|Vitamin E|vitamin e|mesh-list
92246741|NCT00583700|Pentoxifylline|pentoxifylline|mesh-list
92246742|NCT00583700|Vitamins|vitamins|mesh-ancestor
92246743|NCT00583700|Micronutrients|micronutrients|mesh-ancestor
92246744|NCT00583700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246746|NCT00583700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246747|NCT00583700|Protective Agents|protective agents|mesh-ancestor
92246748|NCT00583700|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92246749|NCT00583700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246750|NCT00583700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92246751|NCT00583700|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92246752|NCT00583700|Vasodilator Agents|vasodilator agents|mesh-ancestor
92246753|NCT00583700|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92246754|NCT05540743|Adalimumab|adalimumab|mesh-list
91934734|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
92246755|NCT05540743|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92246756|NCT05540743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246757|NCT05540743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246758|NCT01537315|Hydroxychloroquine|hydroxychloroquine|mesh-list
92246759|NCT01537315|Antimalarials|antimalarials|mesh-ancestor
92246760|NCT01537315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92246761|NCT01537315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92246762|NCT01537315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246763|NCT01537315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246764|NCT01537315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246765|NCT01537315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246767|NCT04257188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246768|NCT04257188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246769|NCT04224428|Fexofenadine|fexofenadine|mesh-list
92246770|NCT04224428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92246771|NCT04224428|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92246772|NCT04224428|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92246773|NCT04224428|Histamine Antagonists|histamine antagonists|mesh-ancestor
92246774|NCT04224428|Histamine Agents|histamine agents|mesh-ancestor
92246775|NCT04224428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246776|NCT04224428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246777|NCT04224428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246778|NCT04224194|Adalimumab|adalimumab|mesh-list
92246779|NCT04224194|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92246780|NCT04224194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246781|NCT04224194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246782|NCT00584948|Memantine|memantine|mesh-list
92246783|NCT00584948|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92246784|NCT00584948|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92246785|NCT00584948|Dopamine Agents|dopamine agents|mesh-ancestor
92246786|NCT00584948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246787|NCT00584948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246788|NCT00584948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246789|NCT00584948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92246790|NCT00584948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92246791|NCT00605072|Metoprolol|metoprolol|mesh-list
92246792|NCT00605072|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92246793|NCT00605072|Candesartan|candesartan|mesh-list
92246794|NCT00605072|Candesartan cilexetil|candesartan cilexetil|mesh-list
92246795|NCT00605072|Lisinopril|lisinopril|mesh-list
92246796|NCT00605072|Nifedipine|nifedipine|mesh-list
92246797|NCT00605072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92246798|NCT00605072|Diuretics|diuretics|mesh-ancestor
92246799|NCT00605072|Natriuretic Agents|natriuretic agents|mesh-ancestor
92246800|NCT00605072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246801|NCT00605072|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92246802|NCT00605072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246803|NCT00605072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246804|NCT00605072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92246805|NCT00605072|Sympatholytics|sympatholytics|mesh-ancestor
92246806|NCT00605072|Autonomic Agents|autonomic agents|mesh-ancestor
92246807|NCT00605072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341914|NCT00003449|Tubulin Modulators|tubulin modulators|mesh-ancestor
92246808|NCT00605072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92246809|NCT00605072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92246810|NCT00605072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92246811|NCT00605072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92246812|NCT00605072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246813|NCT00605072|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92246814|NCT00605072|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92246815|NCT00605072|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92246816|NCT00605072|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92246817|NCT00605072|Vasodilator Agents|vasodilator agents|mesh-ancestor
92246818|NCT00605072|Tocolytic Agents|tocolytic agents|mesh-ancestor
92246819|NCT00605072|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925308|NCT01156753|Immunologic Factors|immunologic factors|mesh-ancestor
92246820|NCT00605072|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92246821|NCT00605072|Protease Inhibitors|protease inhibitors|mesh-ancestor
92246822|NCT00605072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246823|NCT00605072|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92246824|NCT00605072|Protective Agents|protective agents|mesh-ancestor
92246825|NCT00585104|Simendan|simendan|mesh-list
92246826|NCT00585104|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92246827|NCT00585104|Vasodilator Agents|vasodilator agents|mesh-ancestor
92246828|NCT00585104|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92246829|NCT00585104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92246830|NCT00585104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246831|NCT00585104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246832|NCT00585104|Protective Agents|protective agents|mesh-ancestor
92246833|NCT00585104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246835|NCT00585182|Anticoagulants|anticoagulants|mesh-ancestor
92246836|NCT00585182|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92246837|NCT00585182|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92246838|NCT00585182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246839|NCT00585650|Etanercept|etanercept|mesh-list
92246840|NCT00585650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92246841|NCT00585650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92246842|NCT00585650|Analgesics|analgesics|mesh-ancestor
92246843|NCT00585650|Sensory System Agents|sensory system agents|mesh-ancestor
92246844|NCT00585650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246845|NCT00585650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246846|NCT00585650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246847|NCT00585650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246848|NCT00585650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246849|NCT00585650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246850|NCT00585650|Immunologic Factors|immunologic factors|mesh-ancestor
92246851|NCT04856228|Lidocaine|lidocaine|mesh-list
92246852|NCT04856228|Anesthetics, Local|anesthetics, local|mesh-ancestor
92246853|NCT04856228|Anesthetics|anesthetics|mesh-ancestor
92246854|NCT04856228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246855|NCT04856228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246856|NCT04856228|Sensory System Agents|sensory system agents|mesh-ancestor
92246857|NCT04856228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246858|NCT04856228|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92246859|NCT04856228|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92246860|NCT04856228|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92246861|NCT04856228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92246862|NCT04856228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246863|NCT00605384|Tenofovir|tenofovir|mesh-list
92246864|NCT00605384|Lamivudine|lamivudine|mesh-list
92246865|NCT00605384|Entecavir|entecavir|mesh-list
92246867|NCT00605384|Antiviral Agents|antiviral agents|mesh-ancestor
92246868|NCT00605384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246869|NCT00605384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92246870|NCT00605384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92246871|NCT00605384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246872|NCT00605384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246873|NCT00605384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92246874|NCT00605384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92246875|NCT00586196|Donepezil|donepezil|mesh-list
92246876|NCT00586196|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92246877|NCT00586196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92246878|NCT00586196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246879|NCT00586196|Cholinergic Agents|cholinergic agents|mesh-ancestor
92246880|NCT00586196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246881|NCT00586196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246882|NCT00586196|Nootropic Agents|nootropic agents|mesh-ancestor
92246883|NCT00605696|Insulin|insulin|mesh-list
92246884|NCT00605696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92246885|NCT00605696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246886|NCT00587132|Secretin|secretin|mesh-list
92246887|NCT00587132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246888|NCT00587132|Hormones|hormones|mesh-ancestor
92246889|NCT00587132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92246890|NCT00587132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246891|NCT00587678|Simvastatin|simvastatin|mesh-list
92246892|NCT00587678|Ezetimibe|ezetimibe|mesh-list
92246893|NCT00587678|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92246894|NCT00587678|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92246895|NCT00587678|Antimetabolites|antimetabolites|mesh-ancestor
92246896|NCT00587678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246897|NCT00587678|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91934739|NCT02349165|Vitamins|vitamins|mesh-ancestor
92246898|NCT00587678|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92246900|NCT02138006|Insulin|insulin|mesh-list
92246901|NCT02138006|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92246902|NCT02138006|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92246903|NCT02138006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246904|NCT04545008|Acetylcysteine|acetylcysteine|mesh-list
92246905|NCT04545008|Famotidine|famotidine|mesh-list
92246906|NCT04545008|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92246907|NCT04545008|Antiviral Agents|antiviral agents|mesh-ancestor
92246908|NCT04545008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92246909|NCT04545008|Expectorants|expectorants|mesh-ancestor
92246910|NCT04545008|Respiratory System Agents|respiratory system agents|mesh-ancestor
92246911|NCT04545008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92246912|NCT04545008|Antioxidants|antioxidants|mesh-ancestor
92246913|NCT04545008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246914|NCT04545008|Protective Agents|protective agents|mesh-ancestor
92246915|NCT04545008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246916|NCT04545008|Antidotes|antidotes|mesh-ancestor
92246917|NCT04545008|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92246918|NCT04545008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246919|NCT04545008|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92246920|NCT04545008|Histamine Antagonists|histamine antagonists|mesh-ancestor
92246921|NCT04545008|Histamine Agents|histamine agents|mesh-ancestor
92246922|NCT04545008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246923|NCT04527770|Dexamethasone|dexamethasone|mesh-list
92246924|NCT04527770|Midazolam|midazolam|mesh-list
92246925|NCT04527770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246926|NCT04527770|Antiemetics|antiemetics|mesh-ancestor
92246927|NCT04527770|Autonomic Agents|autonomic agents|mesh-ancestor
92246928|NCT04527770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246929|NCT04527770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246930|NCT04527770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92246931|NCT04527770|Glucocorticoids|glucocorticoids|mesh-ancestor
92246932|NCT04527770|Hormones|hormones|mesh-ancestor
92246933|NCT04527770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92246934|NCT04527770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92246935|NCT04527770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246936|NCT04527770|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92246937|NCT04527770|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92246938|NCT04527770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92246939|NCT04527770|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92246940|NCT04527770|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92246941|NCT04527770|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92246942|NCT04527770|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92246943|NCT04527770|Anesthetics, General|anesthetics, general|mesh-ancestor
92246944|NCT04527770|Anesthetics|anesthetics|mesh-ancestor
92246945|NCT04527770|GABA Modulators|gaba modulators|mesh-ancestor
92246946|NCT04527770|GABA Agents|gaba agents|mesh-ancestor
92246947|NCT04527770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246948|NCT04527770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246949|NCT01798940|Pioglitazone|pioglitazone|mesh-list
92246950|NCT01798940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92246951|NCT01798940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246952|NCT00609128|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92246953|NCT00609128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92246954|NCT00609128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92246955|NCT00609128|Analgesics|analgesics|mesh-ancestor
92246956|NCT00609128|Sensory System Agents|sensory system agents|mesh-ancestor
92246957|NCT00609128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92246958|NCT00609128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246959|NCT00609128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92246960|NCT00609128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246961|NCT00609128|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92246962|NCT00609128|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92246963|NCT00609128|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92246964|NCT00609128|Histamine Antagonists|histamine antagonists|mesh-ancestor
92246965|NCT00609128|Histamine Agents|histamine agents|mesh-ancestor
92246966|NCT00609128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92246967|NCT00609128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246968|NCT00668564|Cyclophosphamide|cyclophosphamide|mesh-list
92246969|NCT00668564|Busulfan|busulfan|mesh-list
92246970|NCT00668564|Alemtuzumab|alemtuzumab|mesh-list
92246971|NCT00668564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92246972|NCT00668564|Immunologic Factors|immunologic factors|mesh-ancestor
92246973|NCT00668564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246974|NCT00668564|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92246975|NCT00668564|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92246976|NCT00668564|Alkylating Agents|alkylating agents|mesh-ancestor
92246977|NCT00668564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92246978|NCT00668564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246979|NCT00668564|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92246980|NCT00668564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92246982|NCT00610688|Ergocalciferols|ergocalciferols|mesh-list
92246983|NCT00610688|Cholecalciferol|cholecalciferol|mesh-list
92246984|NCT00610688|Vitamins|vitamins|mesh-list
92246985|NCT00610688|Micronutrients|micronutrients|mesh-ancestor
92246986|NCT00610688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246987|NCT00610688|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92246988|NCT00610688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92246989|NCT00669578|Pomalidomide|pomalidomide|mesh-list
92246990|NCT00669578|Immunologic Factors|immunologic factors|mesh-ancestor
92246991|NCT00669578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92246992|NCT00669578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92246993|NCT00669578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92246994|NCT00669578|Growth Substances|growth substances|mesh-ancestor
92246995|NCT00669578|Growth Inhibitors|growth inhibitors|mesh-ancestor
92246996|NCT00669578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92246997|NCT02137382|Pancrelipase|pancrelipase|mesh-list
92246998|NCT02137382|Pancreatin|pancreatin|mesh-list
92246999|NCT02137382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247000|NCT00611468|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92247001|NCT00611468|Topotecan|topotecan|mesh-list
92247002|NCT00611468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247003|NCT00611468|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247004|NCT00611468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247005|NCT00611468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247006|NCT00611468|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92247007|NCT00611468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92247008|NCT00670202|Fasudil|fasudil|mesh-list
92247009|NCT00670202|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92247010|NCT00670202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247011|NCT00670202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247012|NCT00670202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92341945|NCT00002813|Vinorelbine|vinorelbine|mesh-list
92247013|NCT00670202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247014|NCT00670202|Vasodilator Agents|vasodilator agents|mesh-ancestor
92247015|NCT00670202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247016|NCT00670202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247017|NCT00670982|Bevacizumab|bevacizumab|mesh-list
92247018|NCT00670982|Trastuzumab|trastuzumab|mesh-list
92247019|NCT00670982|Vinorelbine|vinorelbine|mesh-list
92247020|NCT00670982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92247021|NCT00670982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247022|NCT00670982|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247023|NCT00670982|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247024|NCT00670982|Growth Substances|growth substances|mesh-ancestor
92247025|NCT00670982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247026|NCT00670982|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247027|NCT00670982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92247028|NCT00670982|Tubulin Modulators|tubulin modulators|mesh-ancestor
92247029|NCT00670982|Antimitotic Agents|antimitotic agents|mesh-ancestor
92247030|NCT00670982|Mitosis Modulators|mitosis modulators|mesh-ancestor
92247031|NCT00670982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247032|NCT00612560|Anastrozole|anastrozole|mesh-list
92247033|NCT00612560|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92247034|NCT00612560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247035|NCT00612560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92247036|NCT00612560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92247037|NCT00612560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247038|NCT00612560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247039|NCT00612560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92247040|NCT00612560|Hormone Antagonists|hormone antagonists|mesh-ancestor
92247041|NCT00612560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247042|NCT00612560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247043|NCT00612716|Cyclophosphamide|cyclophosphamide|mesh-list
92247045|NCT00612716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92247046|NCT00612716|Immunologic Factors|immunologic factors|mesh-ancestor
92247047|NCT00612716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247048|NCT00612716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247049|NCT00612716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92247050|NCT00612716|Alkylating Agents|alkylating agents|mesh-ancestor
92247051|NCT00612716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247052|NCT00612716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247053|NCT00612716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92247054|NCT04220684|Cytarabine|cytarabine|mesh-list
92247055|NCT04220684|Fludarabine|fludarabine|mesh-list
92247056|NCT04220684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247057|NCT04220684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92247058|NCT04220684|Antimetabolites|antimetabolites|mesh-ancestor
92247059|NCT04220684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247060|NCT04220684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92247061|NCT04220684|Immunologic Factors|immunologic factors|mesh-ancestor
92247062|NCT04220684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247063|NCT04220684|Antiviral Agents|antiviral agents|mesh-ancestor
92247064|NCT04220684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247065|NCT00613028|Bevacizumab|bevacizumab|mesh-list
92247066|NCT00613028|Etoposide|etoposide|mesh-list
92247067|NCT00613028|Temozolomide|temozolomide|mesh-list
92247068|NCT00613028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92247069|NCT00613028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247070|NCT00613028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247071|NCT00613028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247072|NCT00613028|Growth Substances|growth substances|mesh-ancestor
92247073|NCT00613028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247074|NCT00613028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247075|NCT00613028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92247076|NCT00613028|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92247077|NCT00613028|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92247078|NCT00613028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247079|NCT00613028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341948|NCT00002813|Tubulin Modulators|tubulin modulators|mesh-ancestor
92247080|NCT00613028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92247081|NCT00613028|Alkylating Agents|alkylating agents|mesh-ancestor
92247083|NCT01799798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92247084|NCT01799798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247085|NCT00614198|Caseins|caseins|mesh-list
92247086|NCT00614198|Chelating Agents|chelating agents|mesh-ancestor
92247087|NCT00614198|Sequestering Agents|sequestering agents|mesh-ancestor
92247088|NCT00614198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247089|NCT00616772|Choline|choline|mesh-list
92247090|NCT00616772|Atorvastatin|atorvastatin|mesh-list
92247091|NCT00616772|Fenofibric acid|fenofibric acid|mesh-list
92247092|NCT00616772|Fenofibrate|fenofibrate|mesh-list
92247093|NCT00616772|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92247094|NCT00616772|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92247095|NCT00616772|Antimetabolites|antimetabolites|mesh-ancestor
92247096|NCT00616772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247097|NCT00616772|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92247098|NCT00616772|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92247099|NCT00616772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247100|NCT00616772|Lipotropic Agents|lipotropic agents|mesh-ancestor
92247101|NCT00616772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247102|NCT00616772|Nootropic Agents|nootropic agents|mesh-ancestor
92247103|NCT00672854|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92247104|NCT00672854|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92247105|NCT00672854|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92247106|NCT00672854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92247107|NCT00672932|Raltegravir Potassium|raltegravir potassium|mesh-list
92247108|NCT00672932|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92247109|NCT00672932|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92247110|NCT00672932|Antiviral Agents|antiviral agents|mesh-ancestor
92247111|NCT00672932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247112|NCT00672932|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92247113|NCT00672932|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92247114|NCT00672932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247115|NCT00672932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247116|NCT02513550|Ixekizumab|ixekizumab|mesh-list
92247117|NCT02513550|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247118|NCT00673712|Analgesics, Opioid|analgesics, opioid|mesh-list
92247119|NCT00673712|Narcotics|narcotics|mesh-ancestor
92247120|NCT00673712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247121|NCT00673712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247122|NCT00673712|Analgesics|analgesics|mesh-ancestor
92247123|NCT00673712|Sensory System Agents|sensory system agents|mesh-ancestor
92247124|NCT00673712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247125|NCT04062032|Aspirin|aspirin|mesh-list
92247126|NCT04062032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92247127|NCT04062032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247128|NCT04062032|Analgesics|analgesics|mesh-ancestor
92247129|NCT04062032|Sensory System Agents|sensory system agents|mesh-ancestor
92247130|NCT04062032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247131|NCT04062032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247132|NCT04062032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247133|NCT04062032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247134|NCT04062032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92247135|NCT04062032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92247136|NCT04062032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247137|NCT04062032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92247138|NCT04062032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92247139|NCT04062032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247140|NCT04062032|Antipyretics|antipyretics|mesh-ancestor
92247141|NCT00617396|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92247142|NCT00617396|Antidepressive Agents|antidepressive agents|mesh-ancestor
92247143|NCT00617396|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92247144|NCT00617396|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92247145|NCT00617396|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92247146|NCT00617396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247147|NCT00617396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247148|NCT03722966|Nicotine|nicotine|mesh-list
92247149|NCT03722966|Varenicline|varenicline|mesh-list
92247150|NCT03722966|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92247151|NCT03722966|Autonomic Agents|autonomic agents|mesh-ancestor
92247152|NCT03722966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247153|NCT03722966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247154|NCT03722966|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92247155|NCT03722966|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92247156|NCT03722966|Cholinergic Agents|cholinergic agents|mesh-ancestor
92247157|NCT03722966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247158|NCT03722966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247159|NCT01581541|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
92247160|NCT01581541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247161|NCT01582477|Bupivacaine|bupivacaine|mesh-list
92247162|NCT01582477|Anesthetics, Local|anesthetics, local|mesh-ancestor
92247163|NCT01582477|Anesthetics|anesthetics|mesh-ancestor
92247164|NCT01582477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247165|NCT01582477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247166|NCT01582477|Sensory System Agents|sensory system agents|mesh-ancestor
92247167|NCT01582477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247168|NCT03001687|Vitamin D|vitamin d|mesh-list
92247169|NCT03001687|Vitamins|vitamins|mesh-ancestor
92247170|NCT03001687|Micronutrients|micronutrients|mesh-ancestor
92247171|NCT03001687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247172|NCT03001687|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92247173|NCT03001609|Abivertinib|abivertinib|mesh-list
92247174|NCT03001609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247175|NCT03001609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247176|NCT03001609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247177|NCT03007381|Ketorolac|ketorolac|mesh-list
92247178|NCT03007381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92247179|NCT03007381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92247180|NCT03007381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247181|NCT03007381|Analgesics|analgesics|mesh-ancestor
92247182|NCT03007381|Sensory System Agents|sensory system agents|mesh-ancestor
92247183|NCT03007381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247184|NCT03007381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247185|NCT03007381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247186|NCT03007381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247187|NCT03007381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92247188|NCT03007381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247189|NCT03007381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247190|NCT01585129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92247191|NCT01585129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92247192|NCT01585129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247193|NCT01585129|Antitubercular Agents|antitubercular agents|mesh-ancestor
92247195|NCT01585207|Anticonvulsants|anticonvulsants|mesh-ancestor
92247196|NCT01585207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247197|NCT01585207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247198|NCT01585207|GABA Agents|gaba agents|mesh-ancestor
92247199|NCT01585207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247200|NCT01585207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247201|NCT03007303|Olanzapine|olanzapine|mesh-list
92247202|NCT03007303|Risperidone|risperidone|mesh-list
92247203|NCT03007303|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92247204|NCT03007303|Ziprasidone|ziprasidone|mesh-list
92247205|NCT03007303|Antipsychotic Agents|antipsychotic agents|mesh-list
92247206|NCT03007303|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92247207|NCT03007303|Serotonin Agents|serotonin agents|mesh-ancestor
92247208|NCT03007303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247209|NCT03007303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247210|NCT03007303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247211|NCT03007303|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92247212|NCT03007303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247213|NCT03007303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92247214|NCT03007303|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92247215|NCT03007303|Dopamine Agents|dopamine agents|mesh-ancestor
92247216|NCT03007303|Antiemetics|antiemetics|mesh-ancestor
92247217|NCT03007303|Autonomic Agents|autonomic agents|mesh-ancestor
92247218|NCT03007303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247219|NCT03007303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247220|NCT03007303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92247221|NCT03007303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92247222|NCT03007303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247223|NCT03007303|Antidepressive Agents|antidepressive agents|mesh-ancestor
92247225|NCT01585441|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92247226|NCT01585441|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92247227|NCT01585441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247228|NCT01585441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247229|NCT01585441|Hormone Antagonists|hormone antagonists|mesh-ancestor
92247230|NCT01585441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247231|NCT01585441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247232|NCT01585441|Urological Agents|urological agents|mesh-ancestor
92247233|NCT00617942|Paclitaxel|paclitaxel|mesh-list
92247234|NCT00617942|Carboplatin|carboplatin|mesh-list
92247235|NCT00617942|Trastuzumab|trastuzumab|mesh-list
92247236|NCT00617942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92247237|NCT00617942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247238|NCT00617942|Tubulin Modulators|tubulin modulators|mesh-ancestor
92247239|NCT00617942|Antimitotic Agents|antimitotic agents|mesh-ancestor
92247240|NCT00617942|Mitosis Modulators|mitosis modulators|mesh-ancestor
92247241|NCT00617942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247242|NCT00617942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92247243|NCT00618332|Mometasone Furoate|mometasone furoate|mesh-list
92247244|NCT00618332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247245|NCT00618332|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247246|NCT00618332|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92247247|NCT01588561|Nicotine|nicotine|mesh-list
92247248|NCT01588561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92247249|NCT01588561|Autonomic Agents|autonomic agents|mesh-ancestor
92247250|NCT01588561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247251|NCT01588561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247252|NCT01588561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92247253|NCT01588561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92247254|NCT01588561|Cholinergic Agents|cholinergic agents|mesh-ancestor
92247255|NCT01588561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247256|NCT01588561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247257|NCT00619190|Aripiprazole|aripiprazole|mesh-list
92247258|NCT00619190|Antidepressive Agents|antidepressive agents|mesh-ancestor
92247259|NCT00619190|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92247260|NCT00619190|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92247261|NCT00619190|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92247262|NCT00619190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247263|NCT00619190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247264|NCT00619190|Dopamine Agonists|dopamine agonists|mesh-ancestor
92247265|NCT00619190|Dopamine Agents|dopamine agents|mesh-ancestor
92247267|NCT00619190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247268|NCT00619190|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92247269|NCT00619190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92247270|NCT00619190|Serotonin Agents|serotonin agents|mesh-ancestor
92247271|NCT00619190|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92247272|NCT00619190|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92247273|NCT00619190|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92247274|NCT00619190|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92247275|NCT01589263|Tamsulosin|tamsulosin|mesh-list
92247276|NCT01589263|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92247277|NCT01589263|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92247278|NCT01589263|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92247279|NCT01589263|Adrenergic Agents|adrenergic agents|mesh-ancestor
92247280|NCT01589263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247281|NCT01589263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247282|NCT01589263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247283|NCT01589263|Urological Agents|urological agents|mesh-ancestor
92247284|NCT01590979|Ranolazine|ranolazine|mesh-list
92247285|NCT01590979|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92247286|NCT01590979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247287|NCT01590979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247289|NCT00619970|Lactulose|lactulose|mesh-list
92247290|NCT00619970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247291|NCT00619970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92247292|NCT00619970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247293|NCT01591837|Vaccines|vaccines|mesh-list
92247294|NCT01591837|Immunologic Factors|immunologic factors|mesh-ancestor
92247295|NCT01591837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247296|NCT01592851|Fluorides|fluorides|mesh-list
92247297|NCT01592851|Tin Fluorides|tin fluorides|mesh-list
92247298|NCT01592851|Fluorophosphate|fluorophosphate|mesh-list
92247299|NCT01592851|Cariostatic Agents|cariostatic agents|mesh-ancestor
92247300|NCT01592851|Protective Agents|protective agents|mesh-ancestor
92247301|NCT01592851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247302|NCT00675584|Budesonide|budesonide|mesh-list
92247303|NCT00675584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247304|NCT00675584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92247305|NCT00675584|Autonomic Agents|autonomic agents|mesh-ancestor
92247306|NCT00675584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247307|NCT00675584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247308|NCT00675584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92247309|NCT00675584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92247310|NCT00675584|Glucocorticoids|glucocorticoids|mesh-ancestor
92247311|NCT00675584|Hormones|hormones|mesh-ancestor
92247312|NCT00675584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247313|NCT03376646|Paclitaxel|paclitaxel|mesh-list
92247314|NCT03376646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92247315|NCT03376646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247316|NCT03376646|Tubulin Modulators|tubulin modulators|mesh-ancestor
92247317|NCT03376646|Antimitotic Agents|antimitotic agents|mesh-ancestor
92247318|NCT03376646|Mitosis Modulators|mitosis modulators|mesh-ancestor
92247319|NCT03376646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247320|NCT00676364|Lidocaine|lidocaine|mesh-list
92247321|NCT00676364|Anesthetics, Local|anesthetics, local|mesh-list
92247322|NCT00676364|Anesthetics|anesthetics|mesh-list
92247323|NCT00676364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247324|NCT00676364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247325|NCT00676364|Sensory System Agents|sensory system agents|mesh-ancestor
92247326|NCT00676364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247327|NCT00676364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92247328|NCT00676364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92247329|NCT00676364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92247330|NCT00676364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247331|NCT00676364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247332|NCT00676676|Testosterone|testosterone|mesh-list
92247333|NCT00676676|Androgens|androgens|mesh-ancestor
92247334|NCT00676676|Hormones|hormones|mesh-ancestor
92247335|NCT00676676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247336|NCT00676676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247337|NCT00621530|Ketorolac|ketorolac|mesh-list
92247338|NCT00621530|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92247339|NCT00621530|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92247340|NCT00621530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247341|NCT00621530|Analgesics|analgesics|mesh-ancestor
92247342|NCT00621530|Sensory System Agents|sensory system agents|mesh-ancestor
92247343|NCT00621530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247344|NCT00621530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247345|NCT00621530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247346|NCT00621530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247347|NCT00621530|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92247348|NCT00621530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247349|NCT00621530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247350|NCT02513472|Pembrolizumab|pembrolizumab|mesh-list
92247351|NCT02513472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92247352|NCT02513472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247353|NCT02513472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92247354|NCT02513472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247355|NCT00621686|Bevacizumab|bevacizumab|mesh-list
92247356|NCT00621686|Sorafenib|sorafenib|mesh-list
92247357|NCT00621686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92247358|NCT00621686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247359|NCT00621686|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247360|NCT00621686|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247361|NCT00621686|Growth Substances|growth substances|mesh-ancestor
92247362|NCT00621686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247363|NCT00621686|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247364|NCT00621686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247365|NCT00621686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247366|NCT00621686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247367|NCT02924714|Imatinib Mesylate|imatinib mesylate|mesh-list
92247368|NCT02924714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247369|NCT02924714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247370|NCT02924714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391775|NCT01726764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247371|NCT02924714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247372|NCT00678470|Alefacept|alefacept|mesh-list
92247373|NCT00678470|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247374|NCT00678470|Immunologic Factors|immunologic factors|mesh-ancestor
92247375|NCT00678470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247376|NCT00623012|Sirolimus|sirolimus|mesh-list
92247377|NCT00623012|Tacrolimus|tacrolimus|mesh-list
92247378|NCT00623012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92247379|NCT00623012|Immunologic Factors|immunologic factors|mesh-ancestor
92247380|NCT00623012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247381|NCT00623012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92247382|NCT00623012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247383|NCT00623012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247384|NCT00623012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92247385|NCT00623012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247386|NCT00623012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92247387|NCT00623012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247388|NCT00623012|Antifungal Agents|antifungal agents|mesh-ancestor
92247389|NCT02592356|Lenvatinib|lenvatinib|mesh-list
92247390|NCT02592356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247391|NCT02592356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247392|NCT02592356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247393|NCT02592356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247394|NCT02446964|Mycophenolic Acid|mycophenolic acid|mesh-list
92247395|NCT02446964|Cyclophosphamide|cyclophosphamide|mesh-list
92247396|NCT02446964|Fludarabine|fludarabine|mesh-list
92247397|NCT02446964|Fludarabine phosphate|fludarabine phosphate|mesh-list
92247398|NCT02446964|Tacrolimus|tacrolimus|mesh-list
92247399|NCT02446964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92247400|NCT02446964|Immunologic Factors|immunologic factors|mesh-ancestor
92247401|NCT02446964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247402|NCT02446964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247403|NCT02446964|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92247404|NCT02446964|Alkylating Agents|alkylating agents|mesh-ancestor
92247405|NCT02446964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247406|NCT02446964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247407|NCT02446964|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92247408|NCT02446964|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92247409|NCT02446964|Antimetabolites|antimetabolites|mesh-ancestor
92247410|NCT02446964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92247411|NCT02446964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247412|NCT02446964|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92247413|NCT02446964|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92247414|NCT02446964|Antitubercular Agents|antitubercular agents|mesh-ancestor
92247415|NCT02446964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92247416|NCT02446964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247417|NCT01799954|Vaccines|vaccines|mesh-list
92247418|NCT01799954|Immunologic Factors|immunologic factors|mesh-ancestor
92247419|NCT01799954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247420|NCT00623714|Fluticasone|fluticasone|mesh-list
92247422|NCT00623714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247423|NCT00623714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92247424|NCT00623714|Autonomic Agents|autonomic agents|mesh-ancestor
92247425|NCT00623714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247426|NCT00623714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247427|NCT00623714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92247428|NCT00623714|Respiratory System Agents|respiratory system agents|mesh-ancestor
92247429|NCT00623714|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247430|NCT00623714|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92247431|NCT02174822|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92247432|NCT02174822|Paroxetine|paroxetine|mesh-list
92247433|NCT02174822|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92247434|NCT02174822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92247435|NCT02174822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247436|NCT02174822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247437|NCT02174822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247438|NCT02174822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247439|NCT02174822|Analgesics|analgesics|mesh-ancestor
92247440|NCT02174822|Sensory System Agents|sensory system agents|mesh-ancestor
92247441|NCT02174822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247442|NCT02174822|Antidepressive Agents|antidepressive agents|mesh-ancestor
92247443|NCT02174822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92247444|NCT02174822|Dopamine Agents|dopamine agents|mesh-ancestor
92247445|NCT02174822|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92247446|NCT02174822|Serotonin Agents|serotonin agents|mesh-ancestor
92247447|NCT02174822|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92247448|NCT02174822|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92247449|NCT02174822|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92247450|NCT02174822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247451|NCT00624416|Prednisolone|prednisolone|mesh-list
92247452|NCT00624416|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92247453|NCT00624416|Methylprednisolone|methylprednisolone|mesh-list
92247454|NCT00624416|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92247455|NCT00624416|Prednisolone acetate|prednisolone acetate|mesh-list
92247456|NCT00624416|Cortisone|cortisone|mesh-list
92247457|NCT00624416|Isoproterenol|isoproterenol|mesh-list
92247458|NCT00624416|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92247459|NCT00624416|Prednisolone phosphate|prednisolone phosphate|mesh-list
92247460|NCT00624416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247461|NCT00624416|Glucocorticoids|glucocorticoids|mesh-ancestor
92247462|NCT00624416|Hormones|hormones|mesh-ancestor
92247463|NCT00624416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247464|NCT00624416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247465|NCT00624416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92247466|NCT00624416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247467|NCT00624416|Antiemetics|antiemetics|mesh-ancestor
92247468|NCT00624416|Autonomic Agents|autonomic agents|mesh-ancestor
92247469|NCT00624416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247470|NCT00624416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247471|NCT00624416|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92247472|NCT00624416|Protective Agents|protective agents|mesh-ancestor
92247473|NCT00624416|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92247474|NCT00624416|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92247475|NCT00624416|Adrenergic Agents|adrenergic agents|mesh-ancestor
92247476|NCT00624416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247477|NCT00624416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247478|NCT00624416|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92247479|NCT00624416|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92247480|NCT00624416|Respiratory System Agents|respiratory system agents|mesh-ancestor
92247481|NCT00624416|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92247482|NCT00624416|Sympathomimetics|sympathomimetics|mesh-ancestor
92247483|NCT01872260|Letrozole|letrozole|mesh-list
92247484|NCT01872260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247485|NCT01872260|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92247486|NCT01872260|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92247487|NCT01872260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247488|NCT01872260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247489|NCT01872260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92247490|NCT01872260|Hormone Antagonists|hormone antagonists|mesh-ancestor
92247491|NCT01872260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247492|NCT01872260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247493|NCT00626210|Modafinil|modafinil|mesh-list
92247494|NCT00626210|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92247495|NCT00626210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247496|NCT00626210|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92247497|NCT00626210|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92247498|NCT00626210|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92247499|NCT00626210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247501|NCT00653276|Ezetimibe|ezetimibe|mesh-list
92247502|NCT00653276|Cyclosporins|cyclosporins|mesh-list
92247503|NCT00653276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247504|NCT00653276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247505|NCT00653276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92247506|NCT00653276|Immunologic Factors|immunologic factors|mesh-ancestor
92247507|NCT00653276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247508|NCT00653276|Antifungal Agents|antifungal agents|mesh-ancestor
92247509|NCT00653276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247510|NCT00653276|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247511|NCT00653276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247512|NCT00653276|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92247513|NCT00653276|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92247514|NCT00653276|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92247515|NCT00653276|Antimetabolites|antimetabolites|mesh-ancestor
92247516|NCT00653276|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92247517|NCT00683852|Aripiprazole|aripiprazole|mesh-list
92247518|NCT00683852|Antidepressive Agents|antidepressive agents|mesh-ancestor
92247519|NCT00683852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92247520|NCT00683852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92247521|NCT00683852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92247522|NCT00683852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247523|NCT00683852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247524|NCT00683852|Dopamine Agonists|dopamine agonists|mesh-ancestor
92247525|NCT00683852|Dopamine Agents|dopamine agents|mesh-ancestor
92247526|NCT00683852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247527|NCT00683852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247528|NCT00683852|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92247529|NCT00683852|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92247530|NCT00683852|Serotonin Agents|serotonin agents|mesh-ancestor
92247531|NCT00683852|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92247532|NCT00683852|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92247533|NCT00683852|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92247534|NCT00683852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92247535|NCT03006835|Clopidogrel|clopidogrel|mesh-list
92247536|NCT03006835|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92247537|NCT03006835|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92247538|NCT03006835|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92247539|NCT03006835|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92247540|NCT03006835|Purinergic Agents|purinergic agents|mesh-ancestor
92247541|NCT03006835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247542|NCT03006835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247543|NCT03006835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247544|NCT03006757|Titanium dioxide|titanium dioxide|mesh-list
92247545|NCT03006757|Sunscreening Agents|sunscreening agents|mesh-ancestor
92247546|NCT03006757|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92247547|NCT03006757|Protective Agents|protective agents|mesh-ancestor
92247548|NCT03006757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247549|NCT03006757|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247550|NCT03006757|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92247551|NCT05566405|Anesthetics|anesthetics|mesh-list
92247552|NCT05566405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247553|NCT05566405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247554|NCT03000127|Testosterone|testosterone|mesh-list
92247555|NCT03000127|Androgens|androgens|mesh-ancestor
92341985|NCT00002831|Prednisolone|prednisolone|mesh-list
92247557|NCT03000127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247558|NCT03000127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247560|NCT02999815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92247562|NCT02999815|Antitoxins|antitoxins|mesh-list
92247563|NCT02999815|Immunologic Factors|immunologic factors|mesh-ancestor
92247564|NCT02999815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247565|NCT05134363|Dexmedetomidine|dexmedetomidine|mesh-list
92247566|NCT05134363|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92247567|NCT05134363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247568|NCT05134363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247569|NCT05134363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247570|NCT05134363|Analgesics|analgesics|mesh-ancestor
92247572|NCT05134363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247573|NCT05134363|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92247574|NCT05134363|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92247575|NCT05134363|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92247576|NCT05134363|Adrenergic Agents|adrenergic agents|mesh-ancestor
92247577|NCT05134363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247578|NCT05134363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247579|NCT03006679|Meropenem|meropenem|mesh-list
92247580|NCT03006679|Tazobactam|tazobactam|mesh-list
92247581|NCT03006679|Piperacillin|piperacillin|mesh-list
92247582|NCT03006679|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92247583|NCT03006679|Vaborbactam|vaborbactam|mesh-list
92247584|NCT03006679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92247585|NCT03006679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247586|NCT03006679|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92247587|NCT03006679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247588|NCT03006679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247589|NCT03006445|Dotinurad|dotinurad|mesh-list
92247590|NCT03006445|Uricosuric Agents|uricosuric agents|mesh-ancestor
92247591|NCT03006445|Gout Suppressants|gout suppressants|mesh-ancestor
92247592|NCT03006445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247593|NCT03006211|Nitric Oxide|nitric oxide|mesh-list
92247594|NCT03006211|Nitrous Oxide|nitrous oxide|mesh-list
92247595|NCT03006211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92247596|NCT03006211|Anesthetics, General|anesthetics, general|mesh-ancestor
92247597|NCT03006211|Anesthetics|anesthetics|mesh-ancestor
92247598|NCT03006211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247599|NCT03006211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247600|NCT03006211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247601|NCT03006211|Analgesics|analgesics|mesh-ancestor
92247602|NCT03006211|Sensory System Agents|sensory system agents|mesh-ancestor
92247603|NCT03006211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247604|NCT03006211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92247605|NCT03006211|Autonomic Agents|autonomic agents|mesh-ancestor
92247606|NCT03006211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92247607|NCT03006211|Respiratory System Agents|respiratory system agents|mesh-ancestor
92247608|NCT03006211|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92247609|NCT03006211|Antioxidants|antioxidants|mesh-ancestor
92247610|NCT03006211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247611|NCT03006211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247612|NCT03006211|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92247613|NCT03006211|Vasodilator Agents|vasodilator agents|mesh-ancestor
92247614|NCT03006211|Gasotransmitters|gasotransmitters|mesh-ancestor
92247615|NCT03006211|Protective Agents|protective agents|mesh-ancestor
92247617|NCT02248051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247618|NCT02247505|Tadalafil|tadalafil|mesh-list
92247619|NCT02247505|Tamsulosin|tamsulosin|mesh-list
92247620|NCT02247505|Vasodilator Agents|vasodilator agents|mesh-ancestor
92247621|NCT02247505|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92247622|NCT02247505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92247623|NCT02247505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247624|NCT02247505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247625|NCT02247505|Urological Agents|urological agents|mesh-ancestor
92247626|NCT02247505|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92247627|NCT02247505|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92247628|NCT02247505|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92247629|NCT02247505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92247630|NCT02247505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247631|NCT02247505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247633|NCT04707625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247634|NCT04707625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247635|NCT04707625|Growth Substances|growth substances|mesh-ancestor
92247636|NCT04707625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247637|NCT04707625|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247638|NCT04707625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247639|NCT02248129|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92247641|NCT02248129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92247642|NCT02248129|Diuretics|diuretics|mesh-ancestor
92247643|NCT02248129|Natriuretic Agents|natriuretic agents|mesh-ancestor
92247644|NCT02248129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247645|NCT02248129|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92247646|NCT02248129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247647|NCT02248129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247648|NCT02248129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92247649|NCT02248129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92247650|NCT02248207|Pramipexole|pramipexole|mesh-list
92247651|NCT02248207|Antioxidants|antioxidants|mesh-ancestor
92247652|NCT02248207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247653|NCT02248207|Protective Agents|protective agents|mesh-ancestor
92247654|NCT02248207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247655|NCT02248207|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92247656|NCT02248207|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92247657|NCT02248207|Dopamine Agonists|dopamine agonists|mesh-ancestor
92247658|NCT02248207|Dopamine Agents|dopamine agents|mesh-ancestor
92247659|NCT02248207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247660|NCT00683930|Mycophenolic Acid|mycophenolic acid|mesh-list
92247661|NCT00683930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92247662|NCT00683930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247663|NCT00683930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92247664|NCT00683930|Antitubercular Agents|antitubercular agents|mesh-ancestor
92247665|NCT00683930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92247666|NCT00683930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247667|NCT00683930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247668|NCT00683930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247669|NCT00684242|Lenalidomide|lenalidomide|mesh-list
92247670|NCT00684242|Immunologic Factors|immunologic factors|mesh-ancestor
92247671|NCT00684242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247672|NCT00684242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247673|NCT00684242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247674|NCT00684242|Growth Substances|growth substances|mesh-ancestor
92247675|NCT00684242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247676|NCT00684242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247677|NCT00651560|Simvastatin|simvastatin|mesh-list
92247679|NCT00651560|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92247680|NCT00651560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92247681|NCT00651560|Antimetabolites|antimetabolites|mesh-ancestor
92247682|NCT00651560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247683|NCT00651560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92247684|NCT00651560|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92247685|NCT00651560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247686|NCT00684554|Buprenorphine|buprenorphine|mesh-list
92247687|NCT00684554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92247688|NCT00684554|Narcotics|narcotics|mesh-ancestor
92247689|NCT00684554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92247690|NCT00684554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247691|NCT00684554|Analgesics|analgesics|mesh-ancestor
92247692|NCT00684554|Sensory System Agents|sensory system agents|mesh-ancestor
92247693|NCT00684554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247694|NCT00684554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92247695|NCT00551876|Simvastatin|simvastatin|mesh-list
92247697|NCT00551876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92247698|NCT00551876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92247699|NCT00551876|Antimetabolites|antimetabolites|mesh-ancestor
92247700|NCT00551876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247701|NCT00551876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92342000|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
92247702|NCT00551876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92247703|NCT00551876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247704|NCT04451863|Caryophyllene|caryophyllene|mesh-list
92247705|NCT04451863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247706|NCT04451863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247707|NCT04451863|Analgesics|analgesics|mesh-ancestor
92247708|NCT04451863|Sensory System Agents|sensory system agents|mesh-ancestor
92247709|NCT04451863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247710|NCT04451863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92247711|NCT04451863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247712|NCT04451863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247713|NCT00628394|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92247714|NCT00628394|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92247715|NCT00628394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92247716|NCT00628394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247717|NCT00628394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247719|NCT00628394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247720|NCT00628394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247721|NCT00251576|Heparin|heparin|mesh-list
92247722|NCT00251576|Calcium heparin|calcium heparin|mesh-list
92247723|NCT00251576|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92247724|NCT00251576|Tinzaparin|tinzaparin|mesh-list
92247725|NCT00251576|Dalteparin|dalteparin|mesh-list
92247726|NCT00251576|Tirofiban|tirofiban|mesh-list
92247727|NCT00251576|Simvastatin|simvastatin|mesh-list
92247728|NCT00251576|Anticoagulants|anticoagulants|mesh-ancestor
92247729|NCT00251576|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92247730|NCT00251576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92247731|NCT00251576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247732|NCT00251576|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92247733|NCT00251576|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92247734|NCT00251576|Antimetabolites|antimetabolites|mesh-ancestor
92247735|NCT00251576|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92247736|NCT00251576|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92247737|NCT00251576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247738|NCT00251576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92247739|NCT04387604|Ranibizumab|ranibizumab|mesh-list
92247740|NCT04387604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247741|NCT04387604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247742|NCT04387604|Growth Substances|growth substances|mesh-ancestor
92247743|NCT04387604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247744|NCT04387604|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247745|NCT04387604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247746|NCT03005665|Acetazolamide|acetazolamide|mesh-list
92247747|NCT03005665|Anticonvulsants|anticonvulsants|mesh-ancestor
92247748|NCT03005665|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92247749|NCT03005665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247750|NCT03005665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247751|NCT03005665|Diuretics|diuretics|mesh-ancestor
92247752|NCT03005665|Natriuretic Agents|natriuretic agents|mesh-ancestor
92247753|NCT03005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247754|NCT00628628|Rasburicase|rasburicase|mesh-list
92247755|NCT00628628|Gout Suppressants|gout suppressants|mesh-ancestor
92247756|NCT00628628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247757|NCT04386811|Calcitriol|calcitriol|mesh-list
92247758|NCT04386811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92247759|NCT04386811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247760|NCT04386811|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92247761|NCT04386811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247762|NCT04386811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247763|NCT04386811|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92247764|NCT04386811|Vitamins|vitamins|mesh-ancestor
92247765|NCT04386811|Micronutrients|micronutrients|mesh-ancestor
92247766|NCT04386811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92247767|NCT04357873|Pembrolizumab|pembrolizumab|mesh-list
92247768|NCT04357873|Vorinostat|vorinostat|mesh-list
92247769|NCT04357873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92247770|NCT04357873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247771|NCT04357873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92247772|NCT04357873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247773|NCT04357873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92247774|NCT04357873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247775|NCT00630734|Ritonavir|ritonavir|mesh-list
92247776|NCT00630734|Darunavir|darunavir|mesh-list
92247777|NCT00630734|Pravastatin|pravastatin|mesh-list
92247778|NCT00630734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92247779|NCT00630734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92247780|NCT00630734|Protease Inhibitors|protease inhibitors|mesh-ancestor
92247781|NCT00630734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247782|NCT00630734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247783|NCT00630734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92247784|NCT00630734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92247785|NCT00630734|Antiviral Agents|antiviral agents|mesh-ancestor
92247786|NCT00630734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247787|NCT00630734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92247788|NCT00630734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92247789|NCT00630734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92247790|NCT00630734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92247791|NCT00630734|Antimetabolites|antimetabolites|mesh-ancestor
92247792|NCT00630734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92247793|NCT00630734|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92247794|NCT05644249|Doxorubicin|doxorubicin|mesh-list
92247795|NCT05644249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247796|NCT05644249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92247797|NCT05644249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92247798|NCT05644249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92247799|NCT05644249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247800|NCT05644249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247801|NCT00686582|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92247802|NCT00686582|Antiviral Agents|antiviral agents|mesh-ancestor
92247803|NCT00686582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247804|NCT00631358|Dexamethasone|dexamethasone|mesh-list
92247805|NCT00631358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247806|NCT00631358|Antiemetics|antiemetics|mesh-ancestor
92247807|NCT00631358|Autonomic Agents|autonomic agents|mesh-ancestor
92247808|NCT00631358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247809|NCT00631358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247810|NCT00631358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247811|NCT00631358|Glucocorticoids|glucocorticoids|mesh-ancestor
92247813|NCT00631358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247814|NCT00631358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92247815|NCT00631358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247816|NCT02248753|Metoprolol|metoprolol|mesh-list
92247817|NCT02248753|Digoxin|digoxin|mesh-list
92247818|NCT02248753|Amiodarone|amiodarone|mesh-list
92247819|NCT02248753|Verapamil|verapamil|mesh-list
92247820|NCT02248753|Flecainide|flecainide|mesh-list
92247821|NCT02248753|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92247822|NCT02248753|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92247823|NCT02248753|Sympatholytics|sympatholytics|mesh-ancestor
92247824|NCT02248753|Autonomic Agents|autonomic agents|mesh-ancestor
92247825|NCT02248753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247826|NCT02248753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247827|NCT02248753|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92247828|NCT02248753|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92247829|NCT02248753|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92247830|NCT02248753|Adrenergic Agents|adrenergic agents|mesh-ancestor
92247831|NCT02248753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247832|NCT02248753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247833|NCT02248753|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92247834|NCT02248753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247835|NCT02248753|Protective Agents|protective agents|mesh-ancestor
92247836|NCT02248753|Vasodilator Agents|vasodilator agents|mesh-ancestor
92247837|NCT02248753|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92247838|NCT02248753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92247839|NCT02248753|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92247840|NCT02248753|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92247841|NCT02248753|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92247842|NCT02248753|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92247843|NCT02248753|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92247844|NCT02248753|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92247845|NCT02248753|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92247846|NCT02248753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92247847|NCT02248753|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92247848|NCT00687674|Dexamethasone|dexamethasone|mesh-list
92247849|NCT00687674|Lenalidomide|lenalidomide|mesh-list
92247850|NCT00687674|Sorafenib|sorafenib|mesh-list
92247851|NCT00687674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247853|NCT00687674|Autonomic Agents|autonomic agents|mesh-ancestor
92247854|NCT00687674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247855|NCT00687674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247856|NCT00687674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247857|NCT00687674|Glucocorticoids|glucocorticoids|mesh-ancestor
92247858|NCT00687674|Hormones|hormones|mesh-ancestor
92247859|NCT00687674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247860|NCT00687674|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92247861|NCT00687674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247862|NCT00687674|Immunologic Factors|immunologic factors|mesh-ancestor
92247863|NCT00687674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92247864|NCT00687674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92247865|NCT00687674|Growth Substances|growth substances|mesh-ancestor
92247866|NCT00687674|Growth Inhibitors|growth inhibitors|mesh-ancestor
92247867|NCT00687674|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92247868|NCT00687674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247869|NCT00687674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247871|NCT00687908|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92247872|NCT00687908|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247873|NCT00687908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92247874|NCT00687908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247875|NCT00687908|Analgesics|analgesics|mesh-ancestor
92247876|NCT00687908|Sensory System Agents|sensory system agents|mesh-ancestor
92247877|NCT00687908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247878|NCT00687908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247879|NCT00687908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247880|NCT00687908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247881|NCT00689078|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92247882|NCT00689078|Prednisolone|prednisolone|mesh-list
92247883|NCT00689078|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92247884|NCT00689078|Methylprednisolone|methylprednisolone|mesh-list
92247885|NCT00689078|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92247886|NCT00689078|Prednisolone acetate|prednisolone acetate|mesh-list
92247887|NCT00689078|Lubricant Eye Drops|lubricant eye drops|mesh-list
92247888|NCT00689078|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92247889|NCT00689078|Prednisolone phosphate|prednisolone phosphate|mesh-list
92247890|NCT00689078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247891|NCT00689078|Glucocorticoids|glucocorticoids|mesh-ancestor
92247892|NCT00689078|Hormones|hormones|mesh-ancestor
92247893|NCT00689078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247894|NCT00689078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247895|NCT00689078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92247896|NCT00689078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247897|NCT00689078|Antiemetics|antiemetics|mesh-ancestor
92247898|NCT00689078|Autonomic Agents|autonomic agents|mesh-ancestor
92247899|NCT00689078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247900|NCT00689078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92247901|NCT00689078|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92247902|NCT00689078|Protective Agents|protective agents|mesh-ancestor
92247903|NCT00689078|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92247904|NCT00689078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92247905|NCT00689078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92247906|NCT05568979|Vaccines|vaccines|mesh-list
92247907|NCT05568979|Immunologic Factors|immunologic factors|mesh-ancestor
92247908|NCT05568979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247909|NCT03005353|Clotrimazole|clotrimazole|mesh-list
92247910|NCT03005353|Miconazole|miconazole|mesh-list
92247911|NCT03005353|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92247912|NCT03005353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342017|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
92247913|NCT03005353|Antifungal Agents|antifungal agents|mesh-ancestor
92247914|NCT03005353|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92247915|NCT03005353|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92247916|NCT03005353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247917|NCT03005353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247918|NCT03005353|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92247919|NCT03005353|Hormone Antagonists|hormone antagonists|mesh-ancestor
92247920|NCT03005353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92247921|NCT03005353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247922|NCT03005353|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92247923|NCT03005353|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92247924|NCT00588536|Leucovorin|leucovorin|mesh-list
92247925|NCT00588536|Methotrexate|methotrexate|mesh-list
92247927|NCT00588536|Calcium|calcium|mesh-list
92247928|NCT00588536|Levoleucovorin|levoleucovorin|mesh-list
92247929|NCT00588536|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92247930|NCT00588536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247931|NCT00588536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92247932|NCT00588536|Abortifacient Agents|abortifacient agents|mesh-ancestor
92247933|NCT00588536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92247934|NCT00588536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92247935|NCT00588536|Antimetabolites|antimetabolites|mesh-ancestor
92247936|NCT00588536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247937|NCT00588536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247938|NCT00588536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92247939|NCT00588536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247940|NCT00588536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92247941|NCT00588536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92247942|NCT00588536|Immunologic Factors|immunologic factors|mesh-ancestor
92247943|NCT00588536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92247944|NCT00588536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92247945|NCT00588536|Antidotes|antidotes|mesh-ancestor
92247946|NCT00588536|Protective Agents|protective agents|mesh-ancestor
92247947|NCT00588536|Vitamin B Complex|vitamin b complex|mesh-ancestor
92247948|NCT00588536|Vitamins|vitamins|mesh-ancestor
92247949|NCT00588536|Micronutrients|micronutrients|mesh-ancestor
92247950|NCT03977233|Leucovorin|leucovorin|mesh-list
92247951|NCT03977233|Oxaliplatin|oxaliplatin|mesh-list
92247952|NCT03977233|Irinotecan|irinotecan|mesh-list
92247953|NCT03977233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92247954|NCT03977233|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92247955|NCT03977233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92247956|NCT03977233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247957|NCT03977233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247958|NCT03977233|Antidotes|antidotes|mesh-ancestor
92247959|NCT03977233|Protective Agents|protective agents|mesh-ancestor
92247960|NCT03977233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247961|NCT03977233|Vitamin B Complex|vitamin b complex|mesh-ancestor
92247962|NCT03977233|Vitamins|vitamins|mesh-ancestor
92247963|NCT03977233|Micronutrients|micronutrients|mesh-ancestor
92247964|NCT03951649|Acetaminophen|acetaminophen|mesh-list
92247965|NCT03951649|Caffeine|caffeine|mesh-list
92247966|NCT03951649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92247967|NCT03951649|Analgesics|analgesics|mesh-ancestor
92247968|NCT03951649|Sensory System Agents|sensory system agents|mesh-ancestor
92247969|NCT03951649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92247970|NCT03951649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92247971|NCT03951649|Antipyretics|antipyretics|mesh-ancestor
92247972|NCT03951649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92247973|NCT03951649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92247974|NCT03951649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247975|NCT03951649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247976|NCT03951649|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92247977|NCT03951649|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92247978|NCT03951649|Purinergic Agents|purinergic agents|mesh-ancestor
92247979|NCT03951649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92247980|NCT00590018|Hydrocortisone|hydrocortisone|mesh-list
92247981|NCT00590018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92247982|NCT02219503|Ritonavir|ritonavir|mesh-list
92247983|NCT02219503|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92247984|NCT02219503|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92247985|NCT02219503|Protease Inhibitors|protease inhibitors|mesh-ancestor
92247986|NCT02219503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92247987|NCT02219503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92247988|NCT02219503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92247989|NCT02219503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92247990|NCT02219503|Antiviral Agents|antiviral agents|mesh-ancestor
92247991|NCT02219503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247992|NCT02219503|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92247993|NCT02219503|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92247994|NCT00592124|Tenofovir|tenofovir|mesh-list
92247995|NCT00592124|Antiviral Agents|antiviral agents|mesh-ancestor
92247996|NCT00592124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92247997|NCT00592124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92247998|NCT00592124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92247999|NCT00592124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248000|NCT00592124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248001|NCT00592124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92248002|NCT00592124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92248003|NCT02221219|Indomethacin|indomethacin|mesh-list
92248004|NCT02221219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92248005|NCT02221219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92248006|NCT02221219|Analgesics|analgesics|mesh-ancestor
92248007|NCT02221219|Sensory System Agents|sensory system agents|mesh-ancestor
92248008|NCT02221219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248009|NCT02221219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248010|NCT02221219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248011|NCT02221219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248012|NCT02221219|Gout Suppressants|gout suppressants|mesh-ancestor
92248013|NCT02221219|Tocolytic Agents|tocolytic agents|mesh-ancestor
92248014|NCT02221219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92248015|NCT02221219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92248016|NCT02221219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248017|NCT02221219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248018|NCT00593450|Bevacizumab|bevacizumab|mesh-list
92248019|NCT00593450|Ranibizumab|ranibizumab|mesh-list
92248020|NCT00593450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248021|NCT00593450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248022|NCT00593450|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248023|NCT00593450|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248024|NCT00593450|Growth Substances|growth substances|mesh-ancestor
92248025|NCT00593450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248026|NCT00593450|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248027|NCT00631748|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92248028|NCT00631748|Antidepressive Agents|antidepressive agents|mesh-ancestor
92248029|NCT00631748|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248030|NCT00631748|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92248031|NCT00631748|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248032|NCT00631748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248033|NCT00631748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248034|NCT00594230|Panobinostat|panobinostat|mesh-list
92248035|NCT00594230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248036|NCT00594230|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92248037|NCT00594230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248038|NCT00594230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248039|NCT00594308|Cyclosporine|cyclosporine|mesh-list
92248041|NCT00594308|Cyclophosphamide|cyclophosphamide|mesh-list
92248042|NCT00594308|Fludarabine|fludarabine|mesh-list
92248043|NCT00594308|Cyclosporins|cyclosporins|mesh-list
92248044|NCT00594308|Basiliximab|basiliximab|mesh-list
92248045|NCT00594308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248046|NCT00594308|Immunologic Factors|immunologic factors|mesh-ancestor
92248047|NCT00594308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248048|NCT00594308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248049|NCT00594308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92248050|NCT00594308|Alkylating Agents|alkylating agents|mesh-ancestor
92248051|NCT00594308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248052|NCT00594308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248053|NCT00594308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92248054|NCT00594308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248055|NCT00594308|Antifungal Agents|antifungal agents|mesh-ancestor
92248056|NCT00594308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248057|NCT00594308|Dermatologic Agents|dermatologic agents|mesh-ancestor
92248058|NCT00594308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92248059|NCT00594308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92248060|NCT00594308|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92248061|NCT00594308|Antitubercular Agents|antitubercular agents|mesh-ancestor
92248062|NCT00594308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92248063|NCT02137538|Letrozole|letrozole|mesh-list
92248064|NCT02137538|Anastrozole|anastrozole|mesh-list
92248065|NCT02137538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248066|NCT02137538|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92248067|NCT02137538|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92248068|NCT02137538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248069|NCT02137538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248070|NCT02137538|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92248071|NCT02137538|Hormone Antagonists|hormone antagonists|mesh-ancestor
92248072|NCT02137538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248073|NCT02137538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248074|NCT02137538|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92248075|NCT00595556|Zonisamide|zonisamide|mesh-list
92248077|NCT00595556|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92248078|NCT00595556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248079|NCT00595556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248080|NCT00595556|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92248081|NCT00595556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248082|NCT00595790|Vaccines|vaccines|mesh-list
92248083|NCT00595790|Immunologic Factors|immunologic factors|mesh-ancestor
92248084|NCT00595790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248085|NCT00595946|Lubiprostone|lubiprostone|mesh-list
92248086|NCT00595946|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92248087|NCT00595946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248088|NCT00595946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248089|NCT00597038|Dasatinib|dasatinib|mesh-list
92248090|NCT00597038|Dacarbazine|dacarbazine|mesh-list
92248091|NCT00597038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248092|NCT00597038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92248093|NCT00597038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248094|NCT00597038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248095|NCT00597038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92248096|NCT00597038|Alkylating Agents|alkylating agents|mesh-ancestor
92248097|NCT00597428|Lubiprostone|lubiprostone|mesh-list
92248098|NCT00597428|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92248099|NCT00597428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248100|NCT00597428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248101|NCT00597818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92248102|NCT00597818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92248103|NCT00597818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92248104|NCT00597818|Analgesics|analgesics|mesh-ancestor
92248105|NCT00597818|Sensory System Agents|sensory system agents|mesh-ancestor
92248106|NCT00597818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248107|NCT00597818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248108|NCT00597818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248109|NCT00597896|Pramipexole|pramipexole|mesh-list
92248110|NCT00597896|Antioxidants|antioxidants|mesh-ancestor
92248111|NCT00597896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248112|NCT00597896|Protective Agents|protective agents|mesh-ancestor
92248113|NCT00597896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248114|NCT00597896|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92248115|NCT00597896|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92248116|NCT00597896|Dopamine Agonists|dopamine agonists|mesh-ancestor
92248117|NCT00597896|Dopamine Agents|dopamine agents|mesh-ancestor
92248118|NCT00597896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248119|NCT01790282|Estradiol|estradiol|mesh-list
92248120|NCT01790282|Progesterone|progesterone|mesh-list
92248121|NCT01790282|Estrogens|estrogens|mesh-ancestor
92248122|NCT01790282|Hormones|hormones|mesh-ancestor
92248123|NCT01790282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248124|NCT01790282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248125|NCT01790282|Progestins|progestins|mesh-ancestor
92248126|NCT03843541|Acetylcysteine|acetylcysteine|mesh-list
92248127|NCT03843541|Ambroxol|ambroxol|mesh-list
92248128|NCT03843541|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92248129|NCT03843541|Antiviral Agents|antiviral agents|mesh-ancestor
92248130|NCT03843541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248131|NCT03843541|Expectorants|expectorants|mesh-ancestor
92248132|NCT03843541|Respiratory System Agents|respiratory system agents|mesh-ancestor
92248133|NCT03843541|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92248134|NCT03843541|Antioxidants|antioxidants|mesh-ancestor
92248135|NCT03843541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248136|NCT03843541|Protective Agents|protective agents|mesh-ancestor
92248137|NCT03843541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248138|NCT03843541|Antidotes|antidotes|mesh-ancestor
92248139|NCT00639158|Choline|choline|mesh-list
92248140|NCT00639158|Atorvastatin|atorvastatin|mesh-list
92248141|NCT00639158|Ezetimibe|ezetimibe|mesh-list
92248142|NCT00639158|Fenofibric acid|fenofibric acid|mesh-list
92248143|NCT00639158|Fenofibrate|fenofibrate|mesh-list
92248144|NCT00639158|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92248145|NCT00639158|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92248146|NCT00639158|Antimetabolites|antimetabolites|mesh-ancestor
92248147|NCT00639158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248148|NCT00639158|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92248149|NCT00639158|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92248151|NCT00639158|Lipotropic Agents|lipotropic agents|mesh-ancestor
92248152|NCT00639158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92248153|NCT00639158|Nootropic Agents|nootropic agents|mesh-ancestor
92248154|NCT02248987|Antipsychotic Agents|antipsychotic agents|mesh-list
92248155|NCT02248987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248156|NCT02248987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248157|NCT02248987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248158|NCT02248987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248159|NCT00692978|Fluticasone|fluticasone|mesh-list
92248160|NCT00692978|Xhance|xhance|mesh-list
92248161|NCT00692978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248162|NCT00692978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92248163|NCT00692978|Autonomic Agents|autonomic agents|mesh-ancestor
92248164|NCT00692978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248165|NCT00692978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248166|NCT00692978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92248167|NCT00692978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92248168|NCT00692978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92248169|NCT00692978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92248170|NCT00601718|Rituximab|rituximab|mesh-list
92248171|NCT00601718|Carboplatin|carboplatin|mesh-list
92248172|NCT00601718|Etoposide|etoposide|mesh-list
92248173|NCT00601718|Etoposide phosphate|etoposide phosphate|mesh-list
92248174|NCT00601718|Ifosfamide|ifosfamide|mesh-list
92248175|NCT00601718|Vorinostat|vorinostat|mesh-list
92248176|NCT00601718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248177|NCT00601718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248178|NCT00601718|Immunologic Factors|immunologic factors|mesh-ancestor
92248179|NCT00601718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248180|NCT00601718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248181|NCT00601718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92248182|NCT00601718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92248183|NCT00601718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92248184|NCT00601718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248185|NCT00601718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248186|NCT00601718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92248187|NCT00601718|Alkylating Agents|alkylating agents|mesh-ancestor
92248188|NCT00601718|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92248189|NCT00601796|Cyclophosphamide|cyclophosphamide|mesh-list
92248190|NCT00601796|Tretinoin|tretinoin|mesh-list
92248191|NCT00601796|Vaccines|vaccines|mesh-list
92248192|NCT00601796|Immunologic Factors|immunologic factors|mesh-ancestor
92248193|NCT00601796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248194|NCT00601796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248195|NCT00601796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248196|NCT00601796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92248197|NCT00601796|Alkylating Agents|alkylating agents|mesh-ancestor
92248198|NCT00601796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248199|NCT00601796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248200|NCT00601796|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92248201|NCT00601796|Keratolytic Agents|keratolytic agents|mesh-ancestor
92248202|NCT00601796|Dermatologic Agents|dermatologic agents|mesh-ancestor
92248203|NCT00693992|Sunitinib|sunitinib|mesh-list
92248204|NCT00693992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248205|NCT00693992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248206|NCT00693992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248207|NCT00693992|Growth Substances|growth substances|mesh-ancestor
92248208|NCT00693992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248209|NCT00693992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248210|NCT00693992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92248211|NCT00693992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248212|NCT00693992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248213|NCT00645710|Gemcitabine|gemcitabine|mesh-list
92248214|NCT00645710|Floxuridine|floxuridine|mesh-list
92248215|NCT00645710|Antibodies|antibodies|mesh-list
92248216|NCT00645710|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92248217|NCT00645710|Immunologic Factors|immunologic factors|mesh-ancestor
92248218|NCT00645710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248219|NCT00645710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92248220|NCT00645710|Antimetabolites|antimetabolites|mesh-ancestor
92248221|NCT00645710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248222|NCT00645710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248223|NCT00603044|Fluticasone|fluticasone|mesh-list
92248224|NCT00603044|Xhance|xhance|mesh-list
92248226|NCT00603044|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92248227|NCT00603044|Autonomic Agents|autonomic agents|mesh-ancestor
92248228|NCT00603044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248229|NCT00603044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248230|NCT00603044|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92248231|NCT00603044|Respiratory System Agents|respiratory system agents|mesh-ancestor
92248232|NCT00603044|Dermatologic Agents|dermatologic agents|mesh-ancestor
92248233|NCT00603044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92248234|NCT00646646|Midazolam|midazolam|mesh-list
92248235|NCT00646646|Dexmedetomidine|dexmedetomidine|mesh-list
92248236|NCT00646646|Propofol|propofol|mesh-list
92248237|NCT00646646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92248238|NCT00646646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248239|NCT00646646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248240|NCT00646646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92248241|NCT00646646|Analgesics|analgesics|mesh-ancestor
92248242|NCT00646646|Sensory System Agents|sensory system agents|mesh-ancestor
92248243|NCT00646646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248244|NCT00646646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92248245|NCT00646646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92248246|NCT00646646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92248247|NCT00646646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92248248|NCT00646646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248249|NCT00646646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248250|NCT00646646|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92248251|NCT00646646|Anesthetics, General|anesthetics, general|mesh-ancestor
92248252|NCT00646646|Anesthetics|anesthetics|mesh-ancestor
92248253|NCT00646646|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92248254|NCT00646646|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92248255|NCT00646646|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248256|NCT00646646|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248257|NCT00646646|GABA Modulators|gaba modulators|mesh-ancestor
92248258|NCT00646646|GABA Agents|gaba agents|mesh-ancestor
92248259|NCT02998424|Propofol|propofol|mesh-list
92248260|NCT02998424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92248261|NCT02998424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248262|NCT02998424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248263|NCT02998424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92248264|NCT02998424|Anesthetics, General|anesthetics, general|mesh-ancestor
92248265|NCT02998424|Anesthetics|anesthetics|mesh-ancestor
92248266|NCT00696488|Fluorouracil|fluorouracil|mesh-list
92248267|NCT00696488|Antimetabolites|antimetabolites|mesh-ancestor
92248268|NCT00696488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248269|NCT00696488|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92248270|NCT00696488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248271|NCT00696488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248272|NCT00696488|Immunologic Factors|immunologic factors|mesh-ancestor
92248273|NCT00696488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248274|NCT00648908|4-Aminopyridine|4-aminopyridine|mesh-list
92248275|NCT00648908|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92248276|NCT00648908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248277|NCT00648908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248278|NCT00650078|Prednisone|prednisone|mesh-list
92248279|NCT00650078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248280|NCT00650078|Glucocorticoids|glucocorticoids|mesh-ancestor
92248281|NCT00650078|Hormones|hormones|mesh-ancestor
92248282|NCT00650078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248283|NCT00650078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248284|NCT00650078|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92248285|NCT00650078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248286|NCT01799486|Adefovir|adefovir|mesh-list
92248287|NCT01799486|Telbivudine|telbivudine|mesh-list
92248288|NCT01799486|Antiviral Agents|antiviral agents|mesh-ancestor
92248289|NCT01799486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248290|NCT01799486|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92248291|NCT01799486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92248292|NCT01799486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248293|NCT01799486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248294|NCT00650546|Exenatide|exenatide|mesh-list
92248295|NCT00650546|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92248296|NCT00650546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248297|NCT00650546|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92248298|NCT00650546|Incretins|incretins|mesh-ancestor
92248299|NCT00650546|Hormones|hormones|mesh-ancestor
92248300|NCT00650546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248301|NCT01386710|Bevacizumab|bevacizumab|mesh-list
92248302|NCT01386710|Carboplatin|carboplatin|mesh-list
92248303|NCT01386710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248304|NCT01386710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248305|NCT01386710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248306|NCT01386710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248307|NCT01386710|Growth Substances|growth substances|mesh-ancestor
92248308|NCT01386710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248309|NCT01386710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248310|NCT00650858|Plasminogen|plasminogen|mesh-list
92248311|NCT00650858|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92248312|NCT00650858|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92248313|NCT00650858|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92248314|NCT00650858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248315|NCT00651482|Bevacizumab|bevacizumab|mesh-list
92248316|NCT00651482|Everolimus|everolimus|mesh-list
92248317|NCT00651482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248318|NCT00651482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248319|NCT00651482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248320|NCT00651482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248321|NCT00651482|Growth Substances|growth substances|mesh-ancestor
92248322|NCT00651482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248323|NCT00651482|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248324|NCT00651482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92248325|NCT00651482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92248326|NCT00651482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248327|NCT00651482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248328|NCT00651482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248329|NCT00651482|Immunologic Factors|immunologic factors|mesh-ancestor
92248330|NCT00654836|Bevacizumab|bevacizumab|mesh-list
92248331|NCT00654836|Carboplatin|carboplatin|mesh-list
92248332|NCT00654836|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92248333|NCT00654836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248334|NCT00654836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248335|NCT00654836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248336|NCT00654836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248337|NCT00654836|Growth Substances|growth substances|mesh-ancestor
92248338|NCT00654836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248339|NCT00654836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248340|NCT02997800|Labetalol|labetalol|mesh-list
92248341|NCT02997800|Fentanyl|fentanyl|mesh-list
92248342|NCT02997800|Esmolol|esmolol|mesh-list
92248343|NCT02997800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92248344|NCT02997800|Narcotics|narcotics|mesh-ancestor
92248345|NCT02997800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248346|NCT02997800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248347|NCT02997800|Analgesics|analgesics|mesh-ancestor
92248348|NCT02997800|Sensory System Agents|sensory system agents|mesh-ancestor
92248349|NCT02997800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248350|NCT02997800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92248351|NCT02997800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92248352|NCT02997800|Anesthetics, General|anesthetics, general|mesh-ancestor
92248353|NCT02997800|Anesthetics|anesthetics|mesh-ancestor
92248354|NCT02997800|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92248355|NCT02997800|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92248356|NCT02997800|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92248357|NCT02997800|Adrenergic Agents|adrenergic agents|mesh-ancestor
92248358|NCT02997800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248359|NCT02997800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248360|NCT02997800|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92248361|NCT02997800|Sympathomimetics|sympathomimetics|mesh-ancestor
92248362|NCT02997800|Autonomic Agents|autonomic agents|mesh-ancestor
92248363|NCT02997800|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92248364|NCT02997800|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92248365|NCT00701636|Daptomycin|daptomycin|mesh-list
92248366|NCT00701636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92248367|NCT00701636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248368|NCT00701714|Epoetin Alfa|epoetin alfa|mesh-list
92248369|NCT00701714|Hematinics|hematinics|mesh-ancestor
92248370|NCT00655538|Dalcetrapib|dalcetrapib|mesh-list
92248371|NCT00655538|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92248372|NCT00655538|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92248373|NCT00655538|Antimetabolites|antimetabolites|mesh-ancestor
92248374|NCT00655538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248375|NCT00655538|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92248376|NCT00656630|Naltrexone|naltrexone|mesh-list
92248377|NCT00656630|Acamprosate|acamprosate|mesh-list
92248378|NCT00656630|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92248379|NCT00656630|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92248380|NCT00656630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248381|NCT00656630|Sensory System Agents|sensory system agents|mesh-ancestor
92248382|NCT00656630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248383|NCT01362998|Fentanyl|fentanyl|mesh-list
92248384|NCT01362998|Morphine|morphine|mesh-list
92248385|NCT01362998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92248386|NCT01362998|Narcotics|narcotics|mesh-ancestor
92248387|NCT01362998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248388|NCT01362998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248389|NCT01362998|Analgesics|analgesics|mesh-ancestor
92248390|NCT01362998|Sensory System Agents|sensory system agents|mesh-ancestor
92248391|NCT01362998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248392|NCT01362998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92248393|NCT01362998|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92248394|NCT01362998|Anesthetics, General|anesthetics, general|mesh-ancestor
92248395|NCT01362998|Anesthetics|anesthetics|mesh-ancestor
92248396|NCT04387526|Sofosbuvir|sofosbuvir|mesh-list
92248397|NCT04387526|Antiviral Agents|antiviral agents|mesh-ancestor
92248398|NCT04387526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248399|NCT00658112|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92248400|NCT00658112|Dermatologic Agents|dermatologic agents|mesh-ancestor
92248401|NCT02997332|Docetaxel|docetaxel|mesh-list
92248402|NCT02997332|Fluorouracil|fluorouracil|mesh-list
92248403|NCT02997332|Durvalumab|durvalumab|mesh-list
92248404|NCT02997332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248405|NCT02997332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92248406|NCT02997332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92248407|NCT02997332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92248408|NCT02997332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248409|NCT02997332|Antimetabolites|antimetabolites|mesh-ancestor
92248410|NCT02997332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92248411|NCT02997332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248412|NCT02997332|Immunologic Factors|immunologic factors|mesh-ancestor
92248413|NCT02997332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248414|NCT02997332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248415|NCT04345094|Hydroquinone|hydroquinone|mesh-list
92248416|NCT04345094|Antioxidants|antioxidants|mesh-ancestor
92248417|NCT04345094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248418|NCT04345094|Protective Agents|protective agents|mesh-ancestor
92248419|NCT04345094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248420|NCT04345094|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92248421|NCT00702884|Sunitinib|sunitinib|mesh-list
92248422|NCT00702884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248423|NCT00702884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248424|NCT00702884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248425|NCT00702884|Growth Substances|growth substances|mesh-ancestor
92248426|NCT00702884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248427|NCT00702884|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248428|NCT00702884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92248429|NCT00702884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248430|NCT00702884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248431|NCT00703508|Metformin|metformin|mesh-list
92248432|NCT00703508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92248433|NCT00703508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248434|NCT01284335|Gemcitabine|gemcitabine|mesh-list
92248435|NCT01284335|Docetaxel|docetaxel|mesh-list
92248436|NCT01284335|Temozolomide|temozolomide|mesh-list
92248437|NCT01284335|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92248438|NCT01284335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248439|NCT01284335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92248440|NCT01284335|Antimetabolites|antimetabolites|mesh-ancestor
92248441|NCT01284335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248442|NCT01284335|Tubulin Modulators|tubulin modulators|mesh-ancestor
92248443|NCT01284335|Antimitotic Agents|antimitotic agents|mesh-ancestor
92248444|NCT01284335|Mitosis Modulators|mitosis modulators|mesh-ancestor
92248445|NCT01284335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92248446|NCT01284335|Alkylating Agents|alkylating agents|mesh-ancestor
92248447|NCT01284335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92248448|NCT01284335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248449|NCT01194479|Formoterol Fumarate|formoterol fumarate|mesh-list
92248450|NCT01194479|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92248451|NCT01194479|Autonomic Agents|autonomic agents|mesh-ancestor
92248452|NCT01194479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248453|NCT01194479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248454|NCT01194479|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92248455|NCT01194479|Respiratory System Agents|respiratory system agents|mesh-ancestor
92248456|NCT01194479|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92248457|NCT01194479|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92248458|NCT01194479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92248459|NCT01194479|Adrenergic Agents|adrenergic agents|mesh-ancestor
92248460|NCT01194479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248461|NCT01194479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248462|NCT01230593|Tobramycin|tobramycin|mesh-list
92248463|NCT01230593|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
92248464|NCT01230593|Dexamethasone|dexamethasone|mesh-list
92248465|NCT01230593|Dexamethasone acetate|dexamethasone acetate|mesh-list
92248466|NCT01230593|BB 1101|bb 1101|mesh-list
92248467|NCT01230593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248468|NCT01230593|Antiemetics|antiemetics|mesh-ancestor
92248469|NCT01230593|Autonomic Agents|autonomic agents|mesh-ancestor
92248470|NCT01230593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248471|NCT01230593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248472|NCT01230593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92248473|NCT01230593|Glucocorticoids|glucocorticoids|mesh-ancestor
92248474|NCT01230593|Hormones|hormones|mesh-ancestor
92248475|NCT01230593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248476|NCT01230593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92248477|NCT01230593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248478|NCT01230593|Protease Inhibitors|protease inhibitors|mesh-ancestor
92248479|NCT01230593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248480|NCT01230593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248481|NCT01230593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92248482|NCT01230593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248483|NCT01230593|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92248484|NCT01230593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92248485|NCT01195025|Chrysarobin|chrysarobin|mesh-list
92248486|NCT01195025|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92248487|NCT01195025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92248488|NCT01195025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92248489|NCT01195025|Analgesics|analgesics|mesh-ancestor
92248490|NCT01195025|Sensory System Agents|sensory system agents|mesh-ancestor
92248491|NCT01195025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248492|NCT01195025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248493|NCT01195025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248494|NCT01195025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248495|NCT01195025|Plasma Substitutes|plasma substitutes|mesh-ancestor
92248496|NCT01195025|Blood Substitutes|blood substitutes|mesh-ancestor
92248498|NCT00703664|Vorinostat|vorinostat|mesh-list
92248499|NCT00703664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248500|NCT00703664|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92248501|NCT00703664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248502|NCT00703664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248503|NCT00658736|Triamcinolone|triamcinolone|mesh-list
92248504|NCT00658736|Bupivacaine|bupivacaine|mesh-list
92248505|NCT00658736|Anesthetics, Local|anesthetics, local|mesh-ancestor
92248506|NCT00658736|Anesthetics|anesthetics|mesh-ancestor
92248507|NCT00658736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248508|NCT00658736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248509|NCT00658736|Sensory System Agents|sensory system agents|mesh-ancestor
92248510|NCT00658736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248511|NCT00658736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248512|NCT00658736|Glucocorticoids|glucocorticoids|mesh-ancestor
92248513|NCT00658736|Hormones|hormones|mesh-ancestor
92248514|NCT00658736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248515|NCT00659360|Saracatinib|saracatinib|mesh-list
92248516|NCT00659360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248517|NCT00659360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248518|NCT00659360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248519|NCT01197833|Polidocanol|polidocanol|mesh-list
92248520|NCT01197833|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92248521|NCT01197833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92248522|NCT04270370|Atorvastatin|atorvastatin|mesh-list
92248523|NCT04270370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92248524|NCT04270370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92248525|NCT04270370|Antimetabolites|antimetabolites|mesh-ancestor
92248526|NCT04270370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248527|NCT04270370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92248528|NCT04270370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92248529|NCT04270370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248530|NCT01288781|Acetazolamide|acetazolamide|mesh-list
92248531|NCT01288781|Anticonvulsants|anticonvulsants|mesh-ancestor
92248532|NCT01288781|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92248533|NCT01288781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248534|NCT01288781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248535|NCT01288781|Diuretics|diuretics|mesh-ancestor
92248536|NCT01288781|Natriuretic Agents|natriuretic agents|mesh-ancestor
92248537|NCT01288781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248538|NCT02990078|Sildenafil Citrate|sildenafil citrate|mesh-list
92248539|NCT02990078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248540|NCT02990078|Vasodilator Agents|vasodilator agents|mesh-ancestor
92248541|NCT02990078|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92248542|NCT02990078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92248543|NCT02990078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248544|NCT02990078|Urological Agents|urological agents|mesh-ancestor
92248545|NCT01288859|Curcumin|curcumin|mesh-list
92248546|NCT01288859|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92248547|NCT01288859|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92248548|NCT01288859|Analgesics|analgesics|mesh-ancestor
92248549|NCT01288859|Sensory System Agents|sensory system agents|mesh-ancestor
92248550|NCT01288859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248551|NCT01288859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248552|NCT01288859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248553|NCT01288859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248554|NCT01288859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248555|NCT01288859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248556|NCT01288859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248557|NCT01235195|Sertraline|sertraline|mesh-list
92248558|NCT01235195|Antidepressive Agents|antidepressive agents|mesh-ancestor
92248559|NCT01235195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248560|NCT01235195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92248561|NCT01235195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92248562|NCT01235195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248563|NCT01235195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248564|NCT01235195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248565|NCT01235195|Serotonin Agents|serotonin agents|mesh-ancestor
92248566|NCT01235195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248567|NCT02996942|Factor VIII|factor viii|mesh-list
92248568|NCT02996942|Coagulants|coagulants|mesh-ancestor
92248569|NCT01199237|Glycopyrrolate|glycopyrrolate|mesh-list
92248570|NCT01199237|Sevoflurane|sevoflurane|mesh-list
92248571|NCT01199237|Desflurane|desflurane|mesh-list
92248572|NCT01199237|Rocuronium|rocuronium|mesh-list
92248573|NCT01199237|Neostigmine|neostigmine|mesh-list
92248574|NCT01199237|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92248575|NCT01199237|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92248576|NCT01199237|Anesthetics, General|anesthetics, general|mesh-ancestor
92248577|NCT01199237|Anesthetics|anesthetics|mesh-ancestor
92248578|NCT01199237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248579|NCT01199237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248580|NCT01199237|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92248581|NCT01199237|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92248582|NCT01199237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92248583|NCT01199237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248584|NCT01199237|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92248585|NCT01199237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248586|NCT01199237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248587|NCT01199237|Cholinergic Agents|cholinergic agents|mesh-ancestor
92248588|NCT01199237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248589|NCT01199237|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92248591|NCT01199237|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92248592|NCT01199237|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92248593|NCT01199237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92248594|NCT01235897|Paclitaxel|paclitaxel|mesh-list
92248595|NCT01235897|Trastuzumab|trastuzumab|mesh-list
92248596|NCT01235897|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92248597|NCT01235897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248598|NCT01235897|Tubulin Modulators|tubulin modulators|mesh-ancestor
92248599|NCT01235897|Antimitotic Agents|antimitotic agents|mesh-ancestor
92248600|NCT01235897|Mitosis Modulators|mitosis modulators|mesh-ancestor
92248601|NCT01235897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248602|NCT01235897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248603|NCT01236053|Gabapentin|gabapentin|mesh-list
92248604|NCT01236053|Analgesics|analgesics|mesh-ancestor
92248605|NCT01236053|Sensory System Agents|sensory system agents|mesh-ancestor
92248606|NCT01236053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248607|NCT01236053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248608|NCT01236053|Anticonvulsants|anticonvulsants|mesh-ancestor
92248609|NCT01236053|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92248610|NCT01236053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248611|NCT01236053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248612|NCT01236053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248613|NCT01236053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92248614|NCT01236053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92248615|NCT01236053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248616|NCT01236053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248617|NCT01236053|Antimanic Agents|antimanic agents|mesh-ancestor
92248618|NCT00703976|Bevacizumab|bevacizumab|mesh-list
92248619|NCT00703976|Cetuximab|cetuximab|mesh-list
92248620|NCT00703976|Pemetrexed|pemetrexed|mesh-list
92248621|NCT00703976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92248622|NCT00703976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248623|NCT00703976|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92248624|NCT00703976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92248625|NCT00703976|Growth Substances|growth substances|mesh-ancestor
92248626|NCT00703976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248627|NCT00703976|Growth Inhibitors|growth inhibitors|mesh-ancestor
92248628|NCT00703976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248629|NCT00703976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248630|NCT00703976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92248631|NCT00703976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92248632|NCT00661544|Ascorbic Acid|ascorbic acid|mesh-list
92248633|NCT00661544|Melphalan|melphalan|mesh-list
92248634|NCT00661544|Arsenic Trioxide|arsenic trioxide|mesh-list
92248635|NCT00661544|Vitamins|vitamins|mesh-ancestor
92248636|NCT00661544|Micronutrients|micronutrients|mesh-ancestor
92248637|NCT00661544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248638|NCT00661544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92248639|NCT00661544|Alkylating Agents|alkylating agents|mesh-ancestor
92248640|NCT00661544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248641|NCT00661544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248642|NCT00661544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92248643|NCT00661544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248644|NCT00661544|Immunologic Factors|immunologic factors|mesh-ancestor
92248645|NCT00661544|Antioxidants|antioxidants|mesh-ancestor
92248646|NCT00661544|Protective Agents|protective agents|mesh-ancestor
92248647|NCT00706550|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92248648|NCT00706550|Immunologic Factors|immunologic factors|mesh-ancestor
92248649|NCT00706550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248650|NCT02979392|Paclitaxel|paclitaxel|mesh-list
92248651|NCT02979392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92248652|NCT02979392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248653|NCT02979392|Tubulin Modulators|tubulin modulators|mesh-ancestor
92248654|NCT02979392|Antimitotic Agents|antimitotic agents|mesh-ancestor
92248655|NCT02979392|Mitosis Modulators|mitosis modulators|mesh-ancestor
92248656|NCT02979392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248657|NCT02999906|Treprostinil|treprostinil|mesh-list
92248658|NCT02999906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92248659|NCT01238471|Propranolol|propranolol|mesh-list
92248661|NCT01238471|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92248662|NCT01238471|Adrenergic Agents|adrenergic agents|mesh-ancestor
92248663|NCT01238471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934755|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248664|NCT01238471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248665|NCT01238471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248666|NCT01238471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92248667|NCT01238471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92248668|NCT01238471|Vasodilator Agents|vasodilator agents|mesh-ancestor
92248669|NCT00664430|Calcitriol|calcitriol|mesh-list
92248670|NCT00664430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92248671|NCT00664430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248672|NCT00664430|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92248673|NCT00664430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248674|NCT00664430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248675|NCT00664430|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92248676|NCT00664430|Vitamins|vitamins|mesh-ancestor
92248677|NCT00664430|Micronutrients|micronutrients|mesh-ancestor
92248678|NCT00664430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92248679|NCT01292447|Lidocaine|lidocaine|mesh-list
92248680|NCT01292447|Anesthetics, Local|anesthetics, local|mesh-ancestor
92248681|NCT01292447|Anesthetics|anesthetics|mesh-ancestor
92248682|NCT01292447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248683|NCT01292447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248684|NCT01292447|Sensory System Agents|sensory system agents|mesh-ancestor
92248685|NCT01292447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248686|NCT01292447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92248687|NCT01292447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92248688|NCT01292447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92248689|NCT01292447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248690|NCT01292447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248691|NCT00704912|Orlistat|orlistat|mesh-list
92248692|NCT00704912|Contraceptive Agents|contraceptive agents|mesh-list
92248693|NCT00704912|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92248694|NCT00704912|Contraceptives, Oral|contraceptives, oral|mesh-list
92248695|NCT00704912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92248696|NCT00704912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248697|NCT00704912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92248698|NCT00704912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248699|NCT00704912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248700|NCT00704912|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92248701|NCT00704912|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92248702|NCT00704912|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92248703|NCT00704912|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92248704|NCT00704912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92248705|NCT00704912|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92248706|NCT00704912|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92248707|NCT02195921|Antiemetics|antiemetics|mesh-list
92248708|NCT02195921|Autonomic Agents|autonomic agents|mesh-ancestor
92248709|NCT02195921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248710|NCT02195921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248711|NCT02195921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92248712|NCT02189213|Sertraline|sertraline|mesh-list
92248713|NCT02189213|Antidepressive Agents|antidepressive agents|mesh-ancestor
92248714|NCT02189213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248715|NCT02189213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92248716|NCT02189213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92248717|NCT02189213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248718|NCT02189213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248719|NCT02189213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248720|NCT02189213|Serotonin Agents|serotonin agents|mesh-ancestor
92248721|NCT02189213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248722|NCT01241903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92248723|NCT01241903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92248724|NCT01241903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92248725|NCT01241903|Antimetabolites|antimetabolites|mesh-ancestor
92248726|NCT01241903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248727|NCT01241903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92248728|NCT01241903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92248729|NCT01241903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248730|NCT00666848|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92248731|NCT00666848|Enalapril|enalapril|mesh-list
92248732|NCT00666848|Enalaprilat|enalaprilat|mesh-list
92248733|NCT00666848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92248734|NCT00666848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248735|NCT00666848|Incretins|incretins|mesh-ancestor
92248736|NCT00666848|Hormones|hormones|mesh-ancestor
92248737|NCT00666848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248738|NCT00666848|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92248739|NCT00666848|Protease Inhibitors|protease inhibitors|mesh-ancestor
92248740|NCT00666848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248741|NCT00666848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248742|NCT00666848|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92248743|NCT00666848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92248744|NCT01287377|Nicotine|nicotine|mesh-list
92248745|NCT01287377|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92248746|NCT01287377|Autonomic Agents|autonomic agents|mesh-ancestor
92248747|NCT01287377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248748|NCT01287377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248749|NCT01287377|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92248750|NCT01287377|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92248751|NCT01287377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92248752|NCT01287377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248753|NCT01287377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248754|NCT01511042|Norepinephrine|norepinephrine|mesh-list
92248755|NCT01511042|Angiotensin II|angiotensin ii|mesh-list
92248756|NCT01511042|Giapreza|giapreza|mesh-list
92248757|NCT01511042|Angiotensinogen|angiotensinogen|mesh-list
92248758|NCT01511042|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92248759|NCT01511042|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92248760|NCT01511042|Adrenergic Agents|adrenergic agents|mesh-ancestor
92248761|NCT01511042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248762|NCT01511042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248763|NCT01511042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248764|NCT01511042|Sympathomimetics|sympathomimetics|mesh-ancestor
92248765|NCT01511042|Autonomic Agents|autonomic agents|mesh-ancestor
92248766|NCT01511042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248767|NCT01511042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92248768|NCT01511042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92248769|NCT01511042|Protease Inhibitors|protease inhibitors|mesh-ancestor
92248770|NCT01511042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248771|NCT00667004|Ecabet|ecabet|mesh-list
92248772|NCT00667004|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92248773|NCT00667004|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92248774|NCT00667004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248775|NCT00667004|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92248776|NCT00667004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92248777|NCT00667004|Protease Inhibitors|protease inhibitors|mesh-ancestor
92248778|NCT00667004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248779|NCT00667004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248780|NCT00667004|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92248781|NCT00667004|Protective Agents|protective agents|mesh-ancestor
92248782|NCT00667004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248784|NCT01204853|Sitaxsentan|sitaxsentan|mesh-list
92248785|NCT01204853|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92248786|NCT01204853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248787|NCT01028846|Diazoxide|diazoxide|mesh-list
92248788|NCT01028846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92248789|NCT01028846|Vasodilator Agents|vasodilator agents|mesh-ancestor
92248790|NCT04386122|Loxoprofen|loxoprofen|mesh-list
92248791|NCT04386122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92248792|NCT04386122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92248793|NCT04386122|Analgesics|analgesics|mesh-ancestor
92248794|NCT04386122|Sensory System Agents|sensory system agents|mesh-ancestor
92248795|NCT04386122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248796|NCT04386122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248797|NCT04386122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248798|NCT04386122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248799|NCT03009461|Sorafenib|sorafenib|mesh-list
92248800|NCT03009461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248801|NCT03009461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92248802|NCT03009461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248803|NCT03009461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248804|NCT02990702|Bupivacaine|bupivacaine|mesh-list
92248805|NCT02990702|Anesthetics, Local|anesthetics, local|mesh-ancestor
92248806|NCT02990702|Anesthetics|anesthetics|mesh-ancestor
92248807|NCT02990702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248808|NCT02990702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248809|NCT02990702|Sensory System Agents|sensory system agents|mesh-ancestor
92248810|NCT02990702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248811|NCT02995304|Midazolam|midazolam|mesh-list
92248812|NCT02995304|Morphine|morphine|mesh-list
92248813|NCT02995304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92248814|NCT02995304|Narcotics|narcotics|mesh-ancestor
92248815|NCT02995304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248816|NCT02995304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248817|NCT02995304|Analgesics|analgesics|mesh-ancestor
92248818|NCT02995304|Sensory System Agents|sensory system agents|mesh-ancestor
92248819|NCT02995304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248820|NCT02995304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92248821|NCT02995304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92248822|NCT02995304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92248823|NCT02995304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248824|NCT02995304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248825|NCT02995304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92248826|NCT02995304|Anesthetics, General|anesthetics, general|mesh-ancestor
92248827|NCT02995304|Anesthetics|anesthetics|mesh-ancestor
92248828|NCT02995304|GABA Modulators|gaba modulators|mesh-ancestor
92248829|NCT02995304|GABA Agents|gaba agents|mesh-ancestor
92248830|NCT02995304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248831|NCT02995304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248832|NCT02990858|Leronlimab|leronlimab|mesh-list
92248833|NCT02990858|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92248834|NCT02990858|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92248835|NCT02990858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248836|NCT02990858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92248837|NCT02990858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92248838|NCT02990858|Antiviral Agents|antiviral agents|mesh-ancestor
92248839|NCT02990858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248840|NCT00725504|Lidocaine|lidocaine|mesh-list
92248841|NCT00725504|Anesthetics, Local|anesthetics, local|mesh-ancestor
92248842|NCT00725504|Anesthetics|anesthetics|mesh-ancestor
92248843|NCT00725504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248844|NCT00725504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248845|NCT00725504|Sensory System Agents|sensory system agents|mesh-ancestor
92248846|NCT00725504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248847|NCT00725504|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92248848|NCT00725504|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92248849|NCT00725504|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92248850|NCT00725504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248851|NCT00725504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248852|NCT03830684|Baicalein|baicalein|mesh-list
92248854|NCT03830684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248855|NCT03830684|Protective Agents|protective agents|mesh-ancestor
92248856|NCT03830684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248857|NCT03830684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248858|NCT03830684|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
92248859|NCT03830684|Hormone Antagonists|hormone antagonists|mesh-ancestor
92248860|NCT03830684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248861|NCT02990546|Midodrine|midodrine|mesh-list
92248862|NCT02990546|Sympathomimetics|sympathomimetics|mesh-ancestor
92248863|NCT02990546|Autonomic Agents|autonomic agents|mesh-ancestor
92248864|NCT02990546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248865|NCT02990546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248866|NCT02990546|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92248867|NCT02990546|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92248868|NCT02990546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92248869|NCT02990546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92248870|NCT02990546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92248871|NCT02990546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248872|NCT02990546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248873|NCT00727064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92248874|NCT00727064|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92248875|NCT00727064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92248876|NCT00727064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92248877|NCT00727064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92248878|NCT00727064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248879|NCT00727064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248880|NCT00727064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248881|NCT00727064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92248882|NCT00727064|Antidepressive Agents|antidepressive agents|mesh-ancestor
92248883|NCT00727064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248884|NCT01294163|Propofol|propofol|mesh-list
92248885|NCT01294163|Sevoflurane|sevoflurane|mesh-list
92248886|NCT01294163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92248887|NCT01294163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248888|NCT01294163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248889|NCT01294163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92248890|NCT01294163|Anesthetics, General|anesthetics, general|mesh-ancestor
92248891|NCT01294163|Anesthetics|anesthetics|mesh-ancestor
92248892|NCT01294163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92248893|NCT01294163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92248894|NCT01294319|Dexamethasone|dexamethasone|mesh-list
92248895|NCT01294319|Dexamethasone acetate|dexamethasone acetate|mesh-list
92248896|NCT01294319|Spironolactone|spironolactone|mesh-list
92248897|NCT01294319|Mifepristone|mifepristone|mesh-list
92248898|NCT01294319|BB 1101|bb 1101|mesh-list
92248899|NCT01294319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248900|NCT01294319|Antiemetics|antiemetics|mesh-ancestor
92248901|NCT01294319|Autonomic Agents|autonomic agents|mesh-ancestor
92248902|NCT01294319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248903|NCT01294319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248904|NCT01294319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92248905|NCT01294319|Glucocorticoids|glucocorticoids|mesh-ancestor
92248906|NCT01294319|Hormones|hormones|mesh-ancestor
92248907|NCT01294319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92248908|NCT01294319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92248909|NCT01294319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248910|NCT01294319|Protease Inhibitors|protease inhibitors|mesh-ancestor
92248911|NCT01294319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248912|NCT01294319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248913|NCT01294319|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92248914|NCT01294319|Hormone Antagonists|hormone antagonists|mesh-ancestor
92248915|NCT01294319|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92248916|NCT01294319|Diuretics|diuretics|mesh-ancestor
92248917|NCT01294319|Natriuretic Agents|natriuretic agents|mesh-ancestor
92248918|NCT01294319|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92248919|NCT01294319|Abortifacient Agents|abortifacient agents|mesh-ancestor
92248920|NCT01294319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92248921|NCT01294319|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92248922|NCT01294319|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92248923|NCT01294319|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92248924|NCT01294319|Contraceptive Agents|contraceptive agents|mesh-ancestor
92248925|NCT01294319|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92248926|NCT01294319|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92248927|NCT01294319|Luteolytic Agents|luteolytic agents|mesh-ancestor
92248928|NCT01294319|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92248929|NCT01294319|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92248930|NCT00727298|Infliximab|infliximab|mesh-list
92248931|NCT00727298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92248932|NCT00727298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92248933|NCT00727298|Dermatologic Agents|dermatologic agents|mesh-ancestor
92248934|NCT00727298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92248935|NCT00727298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92248936|NCT02990312|Sirolimus|sirolimus|mesh-list
92248937|NCT02990312|Maraviroc|maraviroc|mesh-list
92248938|NCT02990312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92248939|NCT02990312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248940|NCT02990312|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92248941|NCT02990312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248942|NCT02990312|Antifungal Agents|antifungal agents|mesh-ancestor
92248943|NCT02990312|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92248944|NCT02990312|Immunologic Factors|immunologic factors|mesh-ancestor
92248945|NCT02990312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248946|NCT02990312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248947|NCT02990312|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92248948|NCT02990312|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92248949|NCT02990312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92248950|NCT02990312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92248951|NCT02990312|Antiviral Agents|antiviral agents|mesh-ancestor
92248952|NCT02990312|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92248953|NCT01295879|Vitamin D|vitamin d|mesh-list
92248954|NCT01295879|Ergocalciferols|ergocalciferols|mesh-list
92248955|NCT01295879|Vitamins|vitamins|mesh-ancestor
92248956|NCT01295879|Micronutrients|micronutrients|mesh-ancestor
92248957|NCT01295879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248958|NCT01295879|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92248959|NCT01295879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92248960|NCT01244633|Ecopipam|ecopipam|mesh-list
92248961|NCT01244633|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92248962|NCT01244633|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248963|NCT01244633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248964|NCT01244633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248965|NCT01244633|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248966|NCT01244633|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92248967|NCT01244633|Dopamine Agents|dopamine agents|mesh-ancestor
92248968|NCT01244633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248969|NCT01244633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248970|NCT01296191|Moxifloxacin|moxifloxacin|mesh-list
92248971|NCT01296191|Besifloxacin|besifloxacin|mesh-list
92248972|NCT01296191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92248973|NCT01296191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92248974|NCT01296191|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92248975|NCT01296191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92248976|NCT01296191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92248977|NCT01296191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92248978|NCT01296191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92248979|NCT01244711|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92248980|NCT01244711|Antidepressive Agents|antidepressive agents|mesh-ancestor
92248981|NCT01244711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248982|NCT01244711|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92248983|NCT01244711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92248984|NCT01244711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248985|NCT01244711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248986|NCT01210079|Gabapentin|gabapentin|mesh-list
92248987|NCT01210079|Analgesics|analgesics|mesh-ancestor
92248988|NCT01210079|Sensory System Agents|sensory system agents|mesh-ancestor
92248989|NCT01210079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92248990|NCT01210079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92248991|NCT01210079|Anticonvulsants|anticonvulsants|mesh-ancestor
92248992|NCT01210079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92248994|NCT01210079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92248995|NCT01210079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92248996|NCT01210079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92248997|NCT01210079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92248998|NCT01210079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92248999|NCT01210079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249000|NCT01210079|Antimanic Agents|antimanic agents|mesh-ancestor
92249001|NCT01245647|Naltrexone|naltrexone|mesh-list
92249002|NCT01245647|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92249003|NCT01245647|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92249004|NCT01245647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249005|NCT01245647|Sensory System Agents|sensory system agents|mesh-ancestor
92249006|NCT01245647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249007|NCT00708110|Dolutegravir|dolutegravir|mesh-list
92249008|NCT00708110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92249009|NCT00708110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92249010|NCT00708110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249011|NCT00708110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249012|NCT00708110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92249013|NCT00708110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92249014|NCT00708110|Antiviral Agents|antiviral agents|mesh-ancestor
92249015|NCT00708110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249016|NCT01296815|Bevacizumab|bevacizumab|mesh-list
92249017|NCT01296815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249018|NCT01296815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249019|NCT01296815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92249020|NCT01296815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92249021|NCT01296815|Growth Substances|growth substances|mesh-ancestor
92249022|NCT01296815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249023|NCT01296815|Growth Inhibitors|growth inhibitors|mesh-ancestor
92249024|NCT01276262|Contraceptive Agents|contraceptive agents|mesh-list
91934761|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92249025|NCT01276262|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92249026|NCT01276262|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92249027|NCT01276262|Contraceptives, Oral|contraceptives, oral|mesh-list
92249028|NCT01276262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92249029|NCT01276262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249030|NCT01276262|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92249031|NCT01276262|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92249032|NCT01276262|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92249033|NCT01276262|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92249034|NCT01276262|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92249035|NCT01276262|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92249036|NCT01276262|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92249037|NCT01276262|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92249038|NCT01276496|Paclitaxel|paclitaxel|mesh-list
92249039|NCT01276496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92249040|NCT01276496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92249041|NCT01276496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249042|NCT01276496|Tubulin Modulators|tubulin modulators|mesh-ancestor
92249043|NCT01276496|Antimitotic Agents|antimitotic agents|mesh-ancestor
92249044|NCT01276496|Mitosis Modulators|mitosis modulators|mesh-ancestor
92249045|NCT01276496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249046|NCT01297595|Crizotinib|crizotinib|mesh-list
92249047|NCT01297595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249048|NCT01297595|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249049|NCT01297595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249050|NCT01297595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249051|NCT02992418|Vaccines|vaccines|mesh-list
92249052|NCT02992418|Immunologic Factors|immunologic factors|mesh-ancestor
92249053|NCT02992418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249054|NCT01276730|Interferons|interferons|mesh-list
92249056|NCT01276730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249057|NCT01276730|Antiviral Agents|antiviral agents|mesh-ancestor
92249058|NCT01276730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249059|NCT01276730|Keratolytic Agents|keratolytic agents|mesh-ancestor
92249060|NCT01276730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92249061|NCT01298063|Afatinib|afatinib|mesh-list
92249062|NCT01298063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249063|NCT01298063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249064|NCT01298063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249065|NCT01298063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249066|NCT02999594|Tramadol|tramadol|mesh-list
92249067|NCT02999594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92249068|NCT02999594|Narcotics|narcotics|mesh-ancestor
92249069|NCT02999594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249070|NCT02999594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249071|NCT02999594|Analgesics|analgesics|mesh-ancestor
92249072|NCT02999594|Sensory System Agents|sensory system agents|mesh-ancestor
92249073|NCT02999594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249074|NCT01298219|Lubiprostone|lubiprostone|mesh-list
92249075|NCT01298219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92249076|NCT01298219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249077|NCT01298219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249078|NCT01276886|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92249079|NCT01276886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249080|NCT02322242|Dexamethasone|dexamethasone|mesh-list
92249081|NCT02322242|Dexamethasone acetate|dexamethasone acetate|mesh-list
92249082|NCT02322242|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92249083|NCT02322242|BB 1101|bb 1101|mesh-list
92249084|NCT02322242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249085|NCT02322242|Antiemetics|antiemetics|mesh-ancestor
92249086|NCT02322242|Autonomic Agents|autonomic agents|mesh-ancestor
92391776|NCT01726920|Naproxen|naproxen|mesh-list
92249087|NCT02322242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249088|NCT02322242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249089|NCT02322242|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249090|NCT02322242|Glucocorticoids|glucocorticoids|mesh-ancestor
92249091|NCT02322242|Hormones|hormones|mesh-ancestor
92249092|NCT02322242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249093|NCT02322242|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249094|NCT02322242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249095|NCT02322242|Protease Inhibitors|protease inhibitors|mesh-ancestor
92249096|NCT02322242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249097|NCT02322242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249098|NCT01211873|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92249100|NCT01211873|Sequestering Agents|sequestering agents|mesh-ancestor
92249101|NCT01211873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249102|NCT02993588|Melatonin|melatonin|mesh-list
92249103|NCT02993588|Antioxidants|antioxidants|mesh-ancestor
92249104|NCT02993588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249105|NCT02993588|Protective Agents|protective agents|mesh-ancestor
92249106|NCT02993588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249107|NCT02993588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249108|NCT01270178|Entecavir|entecavir|mesh-list
92249109|NCT01270178|Antiviral Agents|antiviral agents|mesh-ancestor
92249110|NCT01270178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249111|NCT01270412|Mitogens|mitogens|mesh-list
92249112|NCT01270412|Hyaluronic Acid|hyaluronic acid|mesh-list
92249113|NCT01270412|Mitosis Modulators|mitosis modulators|mesh-ancestor
92249114|NCT01270412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249115|NCT01270412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92249116|NCT01270412|Immunologic Factors|immunologic factors|mesh-ancestor
92249117|NCT01270412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249118|NCT01270412|Viscosupplements|viscosupplements|mesh-ancestor
92249119|NCT01270412|Protective Agents|protective agents|mesh-ancestor
92249120|NCT02992496|Midazolam|midazolam|mesh-list
92249121|NCT02992496|Ketamine|ketamine|mesh-list
92249122|NCT02992496|Analgesics|analgesics|mesh-ancestor
92249123|NCT02992496|Sensory System Agents|sensory system agents|mesh-ancestor
92249124|NCT02992496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249125|NCT02992496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249126|NCT02992496|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92249127|NCT02992496|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92249128|NCT02992496|Anesthetics, General|anesthetics, general|mesh-ancestor
92249129|NCT02992496|Anesthetics|anesthetics|mesh-ancestor
92249130|NCT02992496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249131|NCT02992496|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92249132|NCT02992496|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92249133|NCT02992496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249134|NCT02992496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249135|NCT02992496|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92249136|NCT02992496|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92249137|NCT02992496|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92249138|NCT02992496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92249139|NCT02992496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249140|NCT02992496|GABA Modulators|gaba modulators|mesh-ancestor
92249141|NCT02992496|GABA Agents|gaba agents|mesh-ancestor
92249142|NCT00729482|Everolimus|everolimus|mesh-list
92249143|NCT00729482|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92249144|NCT00729482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249145|NCT00729482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249146|NCT00729482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249147|NCT00729482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92249148|NCT00729482|Immunologic Factors|immunologic factors|mesh-ancestor
92249149|NCT00729482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249150|NCT00729482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249151|NCT01270490|Interferons|interferons|mesh-list
92249152|NCT01270490|Interferon-gamma|interferon-gamma|mesh-list
92249153|NCT01270490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249154|NCT01270490|Antiviral Agents|antiviral agents|mesh-ancestor
92249155|NCT01270490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249156|NCT01278056|Deferasirox|deferasirox|mesh-list
92249157|NCT01278056|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92249158|NCT01278056|Chelating Agents|chelating agents|mesh-ancestor
92249159|NCT01278056|Sequestering Agents|sequestering agents|mesh-ancestor
92249160|NCT01278056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249161|NCT02992652|Allopurinol|allopurinol|mesh-list
92249162|NCT02992652|Antimetabolites|antimetabolites|mesh-ancestor
92249163|NCT02992652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249164|NCT02992652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249165|NCT02992652|Gout Suppressants|gout suppressants|mesh-ancestor
92249166|NCT02992652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249167|NCT02992652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92249168|NCT02992652|Antioxidants|antioxidants|mesh-ancestor
92249169|NCT02992652|Protective Agents|protective agents|mesh-ancestor
92249170|NCT02992652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249172|NCT01270724|Gemcitabine|gemcitabine|mesh-list
92249173|NCT01270724|Oxaliplatin|oxaliplatin|mesh-list
92249174|NCT01270724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92249175|NCT01270724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249176|NCT01270724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92249177|NCT01270724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92249178|NCT01270724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92249179|NCT01270724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249180|NCT01270724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92249181|NCT01270724|Antimetabolites|antimetabolites|mesh-ancestor
92249182|NCT00709826|Gemcitabine|gemcitabine|mesh-list
92249183|NCT00709826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92249184|NCT00709826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92249185|NCT00709826|Antimetabolites|antimetabolites|mesh-ancestor
92249186|NCT00709826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249187|NCT00709826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249188|NCT00709826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249189|NCT00709826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249190|NCT01271114|Terlipressin|terlipressin|mesh-list
92249191|NCT01271114|Norepinephrine|norepinephrine|mesh-list
92249192|NCT01271114|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92249193|NCT01271114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92249194|NCT01271114|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249195|NCT01271114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249196|NCT01271114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249197|NCT01271114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249198|NCT01271114|Sympathomimetics|sympathomimetics|mesh-ancestor
92249199|NCT01271114|Autonomic Agents|autonomic agents|mesh-ancestor
92249200|NCT01271114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249201|NCT01271114|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92249202|NCT01271114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92249203|NCT02992340|Gemcitabine|gemcitabine|mesh-list
92249204|NCT02992340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249205|NCT02992340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92249206|NCT02992340|Antimetabolites|antimetabolites|mesh-ancestor
92249207|NCT02992340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249208|NCT00711464|Modafinil|modafinil|mesh-list
92249209|NCT00711464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92249210|NCT00711464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249211|NCT00711464|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92249212|NCT00711464|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92249213|NCT00711464|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92249214|NCT00711464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249215|NCT01278290|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92249216|NCT01278290|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92249217|NCT01278290|Luteolytic Agents|luteolytic agents|mesh-ancestor
92249218|NCT01278290|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92249219|NCT01278290|Contraceptive Agents|contraceptive agents|mesh-ancestor
92249220|NCT01278290|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92249221|NCT01278290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249222|NCT01278290|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92249223|NCT01278290|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249224|NCT01278290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249225|NCT01278290|Hormones|hormones|mesh-ancestor
92249226|NCT01278290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249227|NCT01278446|Caseins|caseins|mesh-list
92249228|NCT01278446|Chelating Agents|chelating agents|mesh-ancestor
92249229|NCT01278446|Sequestering Agents|sequestering agents|mesh-ancestor
92117535|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249230|NCT01278446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249231|NCT02339558|Nivolumab|nivolumab|mesh-list
92249232|NCT02339558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249233|NCT02339558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249234|NCT02339558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92249235|NCT02339558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249236|NCT00731198|Drotaverin|drotaverin|mesh-list
92249237|NCT00731198|Scopolamine|scopolamine|mesh-list
92249238|NCT00731198|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92249239|NCT00731198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92249240|NCT00731198|Antiemetics|antiemetics|mesh-ancestor
92249241|NCT00731198|Autonomic Agents|autonomic agents|mesh-ancestor
91934765|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249242|NCT00731198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249243|NCT00731198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249245|NCT00731198|Mydriatics|mydriatics|mesh-ancestor
92249246|NCT00731198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92249247|NCT00731198|Cholinergic Agents|cholinergic agents|mesh-ancestor
92249248|NCT00731198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249249|NCT00731198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249250|NCT00731198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92249251|NCT00731198|Parasympatholytics|parasympatholytics|mesh-ancestor
92249252|NCT00731198|Analgesics|analgesics|mesh-ancestor
92249253|NCT00731198|Sensory System Agents|sensory system agents|mesh-ancestor
92249254|NCT00731198|Vasodilator Agents|vasodilator agents|mesh-ancestor
92249255|NCT01278602|Rituximab|rituximab|mesh-list
92249256|NCT01278602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249257|NCT01278602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249258|NCT01278602|Immunologic Factors|immunologic factors|mesh-ancestor
92249259|NCT01278602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249260|NCT01278602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249261|NCT00712244|Hyaluronic Acid|hyaluronic acid|mesh-list
92249262|NCT00712244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92249263|NCT00712244|Immunologic Factors|immunologic factors|mesh-ancestor
92249264|NCT00712244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249266|NCT00712244|Protective Agents|protective agents|mesh-ancestor
92249267|NCT02991950|Parnaparin|parnaparin|mesh-list
92249268|NCT02991950|Anticoagulants|anticoagulants|mesh-ancestor
92249269|NCT02991950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92249270|NCT02991950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92249271|NCT02991950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249272|NCT01271582|Leucovorin|leucovorin|mesh-list
92249273|NCT01271582|Irinotecan|irinotecan|mesh-list
92249274|NCT01271582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92249275|NCT01271582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92249276|NCT01271582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249277|NCT01271582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249278|NCT01271582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249279|NCT01271582|Antidotes|antidotes|mesh-ancestor
92249280|NCT01271582|Protective Agents|protective agents|mesh-ancestor
92249281|NCT01271582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249282|NCT01271582|Vitamin B Complex|vitamin b complex|mesh-ancestor
92249283|NCT01271582|Vitamins|vitamins|mesh-ancestor
92249284|NCT01271582|Micronutrients|micronutrients|mesh-ancestor
92249285|NCT01271660|Pregabalin|pregabalin|mesh-list
92249286|NCT01271660|Analgesics|analgesics|mesh-ancestor
92249287|NCT01271660|Sensory System Agents|sensory system agents|mesh-ancestor
92249288|NCT01271660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249289|NCT01271660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249290|NCT01271660|Anticonvulsants|anticonvulsants|mesh-ancestor
92249291|NCT01271660|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92249292|NCT01271660|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249293|NCT01271660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249294|NCT01271660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92249295|NCT01271660|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92249296|NCT01271660|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92249297|NCT01271660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249298|NCT01271660|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249299|NCT00731588|Biotin|biotin|mesh-list
92249300|NCT00731588|Vitamin B Complex|vitamin b complex|mesh-ancestor
92249301|NCT00731588|Vitamins|vitamins|mesh-ancestor
92249302|NCT00731588|Micronutrients|micronutrients|mesh-ancestor
92249303|NCT00731588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249304|NCT01271894|Efavirenz|efavirenz|mesh-list
92249305|NCT01271894|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92249306|NCT01271894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92249307|NCT01271894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249308|NCT01271894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249309|NCT01271894|Antiviral Agents|antiviral agents|mesh-ancestor
92249310|NCT01271894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391777|NCT01726920|Naratriptan|naratriptan|mesh-list
92249311|NCT01271894|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92249312|NCT01271894|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92249313|NCT01271894|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92249314|NCT01271894|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92249315|NCT01271894|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92249316|NCT01271894|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92249318|NCT01278758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249319|NCT00717626|Factor VIII|factor viii|mesh-list
92249320|NCT00717626|Coagulants|coagulants|mesh-ancestor
92249321|NCT01272128|Interferons|interferons|mesh-list
92249322|NCT01272128|Interferon-beta|interferon-beta|mesh-list
92249323|NCT01272128|Interferon beta-1a|interferon beta-1a|mesh-list
92249324|NCT01272128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249325|NCT01272128|Antiviral Agents|antiviral agents|mesh-ancestor
92249326|NCT01272128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249327|NCT01272128|Immunologic Factors|immunologic factors|mesh-ancestor
92249328|NCT01272128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249329|NCT01272128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92249330|NCT00719186|Letrozole|letrozole|mesh-list
92249331|NCT00719186|Clomiphene|clomiphene|mesh-list
92249332|NCT00719186|Enclomiphene|enclomiphene|mesh-list
92249333|NCT00719186|Zuclomiphene|zuclomiphene|mesh-list
92249334|NCT00719186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249335|NCT00719186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249336|NCT00719186|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92249337|NCT00719186|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92249338|NCT00719186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249339|NCT00719186|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92249340|NCT00719186|Hormone Antagonists|hormone antagonists|mesh-ancestor
92249341|NCT00719186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249342|NCT00719186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249343|NCT00719186|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92249344|NCT00719186|Fertility Agents|fertility agents|mesh-ancestor
92249345|NCT00719186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92249346|NCT00719186|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92249347|NCT00719186|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92249348|NCT00721136|Heparin|heparin|mesh-list
92249349|NCT00721136|Warfarin|warfarin|mesh-list
92249350|NCT00721136|Anticoagulants|anticoagulants|mesh-ancestor
92249351|NCT00721136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92249352|NCT00721136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92249353|NCT00721136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249354|NCT00737204|Modafinil|modafinil|mesh-list
92249355|NCT00737204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92249356|NCT00737204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249357|NCT00737204|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92249358|NCT00737204|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92249359|NCT00737204|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92249360|NCT00737204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249361|NCT00722072|Sorafenib|sorafenib|mesh-list
92249362|NCT00722072|Fulvestrant|fulvestrant|mesh-list
92249363|NCT00722072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249364|NCT00722072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249365|NCT00722072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249366|NCT00722072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249367|NCT00722072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249368|NCT00722072|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92249369|NCT00722072|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92249370|NCT00722072|Hormone Antagonists|hormone antagonists|mesh-ancestor
92249371|NCT00722072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249372|NCT00722072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249373|NCT01275170|Imipenem|imipenem|mesh-list
92249374|NCT01275170|Relebactam|relebactam|mesh-list
92249375|NCT01275170|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92249376|NCT01275170|Midazolam|midazolam|mesh-list
92249377|NCT01275170|Caffeine|caffeine|mesh-list
92249378|NCT01275170|Omeprazole|omeprazole|mesh-list
92249379|NCT01275170|Cilastatin|cilastatin|mesh-list
92249380|NCT01275170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91941583|NCT05944341|Lidocaine|lidocaine|mesh-list
92249381|NCT01275170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92249382|NCT01275170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249383|NCT01275170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249384|NCT01275170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92249385|NCT01275170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92249386|NCT01275170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249387|NCT01275170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92249388|NCT01275170|Anesthetics, General|anesthetics, general|mesh-ancestor
92249389|NCT01275170|Anesthetics|anesthetics|mesh-ancestor
92249390|NCT01275170|GABA Modulators|gaba modulators|mesh-ancestor
92249392|NCT01275170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249393|NCT01275170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249394|NCT01275170|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92249395|NCT01275170|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92249396|NCT01275170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249397|NCT01275170|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92249398|NCT01275170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92249399|NCT01275170|Purinergic Agents|purinergic agents|mesh-ancestor
92249400|NCT01275170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92249401|NCT01275170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249402|NCT01275170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92342177|NCT00003941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249403|NCT01275170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92249404|NCT01275170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249405|NCT01275170|Protease Inhibitors|protease inhibitors|mesh-ancestor
92249406|NCT01275170|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92249408|NCT04385654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249409|NCT04385654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249410|NCT04385654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249411|NCT04385654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249412|NCT01273064|Interferons|interferons|mesh-list
92249413|NCT01273064|Ribavirin|ribavirin|mesh-list
92249414|NCT01273064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249415|NCT01273064|Antiviral Agents|antiviral agents|mesh-ancestor
92249416|NCT01273064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249417|NCT01273064|Antimetabolites|antimetabolites|mesh-ancestor
92249418|NCT01273064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249419|NCT01272986|Immunoglobulin G|immunoglobulin g|mesh-list
92249420|NCT01272986|Immunologic Factors|immunologic factors|mesh-ancestor
92249421|NCT01272986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249422|NCT01272908|Rituximab|rituximab|mesh-list
92249423|NCT01272908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249424|NCT01272908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249425|NCT01272908|Immunologic Factors|immunologic factors|mesh-ancestor
92249426|NCT01272908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249427|NCT01272908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249428|NCT01271504|Sorafenib|sorafenib|mesh-list
92249429|NCT01271504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249430|NCT01271504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249431|NCT01271504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249432|NCT01271504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249433|NCT02144714|Adalimumab|adalimumab|mesh-list
92249434|NCT02144714|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92249435|NCT02144714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249436|NCT02144714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249437|NCT00741026|Olanzapine|olanzapine|mesh-list
92249438|NCT00741026|Antiemetics|antiemetics|mesh-ancestor
92249439|NCT00741026|Autonomic Agents|autonomic agents|mesh-ancestor
92249440|NCT00741026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249441|NCT00741026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249442|NCT00741026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249443|NCT00741026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92249444|NCT00741026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92249445|NCT00741026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249446|NCT00741026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249447|NCT00741026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92249448|NCT00741026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92249449|NCT00741026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249450|NCT00741026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249451|NCT00741026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249452|NCT00741026|Serotonin Agents|serotonin agents|mesh-ancestor
92249453|NCT00741104|Infliximab|infliximab|mesh-list
92249454|NCT00741104|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92249455|NCT00741104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249456|NCT00741104|Dermatologic Agents|dermatologic agents|mesh-ancestor
92249457|NCT00741104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249458|NCT00741104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249459|NCT01273298|Bisoprolol|bisoprolol|mesh-list
92249460|NCT01273298|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92249461|NCT01273298|Sympatholytics|sympatholytics|mesh-ancestor
92249462|NCT01273298|Autonomic Agents|autonomic agents|mesh-ancestor
92249463|NCT01273298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249464|NCT01273298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249465|NCT01273298|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92249466|NCT01273298|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92249467|NCT01273298|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92249468|NCT01273298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249469|NCT01273298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92342181|NCT00003941|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92249470|NCT01273298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249471|NCT01270802|Tenofovir|tenofovir|mesh-list
92249472|NCT01270802|Emtricitabine|emtricitabine|mesh-list
92249473|NCT01270802|Efavirenz|efavirenz|mesh-list
92249474|NCT01270802|Raltegravir Potassium|raltegravir potassium|mesh-list
92249475|NCT01270802|Antiviral Agents|antiviral agents|mesh-ancestor
92249476|NCT01270802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249477|NCT01270802|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92249478|NCT01270802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92249479|NCT01270802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249480|NCT01270802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249481|NCT01270802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92249482|NCT01270802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92249483|NCT01270802|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92249484|NCT01270802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92249485|NCT01270802|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92249486|NCT01270802|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92249487|NCT01270802|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92249488|NCT01270802|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92249489|NCT01270802|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92249490|NCT01270802|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92249491|NCT01273454|Hydromorphone|hydromorphone|mesh-list
92249492|NCT01273454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92249493|NCT01273454|Narcotics|narcotics|mesh-ancestor
92249494|NCT01273454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249495|NCT01273454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249497|NCT01273454|Sensory System Agents|sensory system agents|mesh-ancestor
92249498|NCT01273454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249499|NCT01270256|Budesonide|budesonide|mesh-list
92249500|NCT01270256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249501|NCT01270256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92249502|NCT01270256|Autonomic Agents|autonomic agents|mesh-ancestor
92249503|NCT01270256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249504|NCT01270256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249505|NCT01270256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92249506|NCT01270256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92249507|NCT01270256|Glucocorticoids|glucocorticoids|mesh-ancestor
92249508|NCT01270256|Hormones|hormones|mesh-ancestor
92249509|NCT01270256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249510|NCT01279694|Prednisone|prednisone|mesh-list
92249511|NCT01279694|Melphalan|melphalan|mesh-list
92249512|NCT01279694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249513|NCT01279694|Glucocorticoids|glucocorticoids|mesh-ancestor
92249514|NCT01279694|Hormones|hormones|mesh-ancestor
92249515|NCT01279694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249516|NCT01279694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249517|NCT01279694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249518|NCT01279694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249519|NCT01279694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92249520|NCT01279694|Alkylating Agents|alkylating agents|mesh-ancestor
92249521|NCT01279694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249522|NCT01279694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92249523|NCT01279694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92249524|NCT01279694|Immunologic Factors|immunologic factors|mesh-ancestor
92249525|NCT01273532|Tapentadol|tapentadol|mesh-list
92249526|NCT01273532|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92249527|NCT01273532|Narcotics|narcotics|mesh-ancestor
92249528|NCT01273532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249529|NCT01273532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249530|NCT01273532|Analgesics|analgesics|mesh-ancestor
92249531|NCT01273532|Sensory System Agents|sensory system agents|mesh-ancestor
92249532|NCT01273532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249533|NCT01273532|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92249534|NCT01273532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92249535|NCT01273532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92342191|NCT00003569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92249536|NCT01273532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249537|NCT01273532|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249538|NCT01273532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249540|NCT00744380|Dexmedetomidine|dexmedetomidine|mesh-list
92249541|NCT00744380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92249542|NCT00744380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249543|NCT00744380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249544|NCT00744380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92249545|NCT00744380|Analgesics|analgesics|mesh-ancestor
92249546|NCT00744380|Sensory System Agents|sensory system agents|mesh-ancestor
92249547|NCT00744380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249548|NCT00744380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92249549|NCT00744380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92249550|NCT00744380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92249551|NCT00744380|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249552|NCT00744380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249553|NCT00744380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249554|NCT00744380|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92249555|NCT00744380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92249556|NCT00744380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92249557|NCT00744380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249558|NCT00744380|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92249559|NCT00744380|Anesthetics, General|anesthetics, general|mesh-ancestor
92249560|NCT00744380|Anesthetics|anesthetics|mesh-ancestor
92249561|NCT00744380|GABA Modulators|gaba modulators|mesh-ancestor
92249562|NCT00744380|GABA Agents|gaba agents|mesh-ancestor
92249563|NCT00744692|Fludarabine|fludarabine|mesh-list
92249564|NCT00744692|Melphalan|melphalan|mesh-list
92249565|NCT00744692|Thiotepa|thiotepa|mesh-list
92249566|NCT00744692|Hydroxyurea|hydroxyurea|mesh-list
92249567|NCT00744692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249568|NCT00744692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249569|NCT00744692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92249570|NCT00744692|Immunologic Factors|immunologic factors|mesh-ancestor
92249571|NCT00744692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249572|NCT00744692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92249573|NCT00744692|Alkylating Agents|alkylating agents|mesh-ancestor
92249574|NCT00744692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92249575|NCT00744692|Antisickling Agents|antisickling agents|mesh-ancestor
92249576|NCT00744692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249577|NCT00744692|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92249578|NCT00744848|Epinephrine|epinephrine|mesh-list
92249579|NCT00744848|Bupivacaine|bupivacaine|mesh-list
92249580|NCT00744848|Anesthetics, Local|anesthetics, local|mesh-ancestor
92249581|NCT00744848|Anesthetics|anesthetics|mesh-ancestor
92249582|NCT00744848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249583|NCT00744848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249584|NCT00744848|Sensory System Agents|sensory system agents|mesh-ancestor
92249585|NCT00744848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249586|NCT00744848|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92249587|NCT00744848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92249588|NCT00744848|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249589|NCT00744848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249590|NCT00744848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249591|NCT00744848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92249592|NCT00744848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92249593|NCT00744848|Autonomic Agents|autonomic agents|mesh-ancestor
92249594|NCT00744848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92249595|NCT00744848|Respiratory System Agents|respiratory system agents|mesh-ancestor
92249596|NCT00744848|Mydriatics|mydriatics|mesh-ancestor
92249597|NCT00744848|Sympathomimetics|sympathomimetics|mesh-ancestor
92249598|NCT00744848|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92249599|NCT03830606|Paclitaxel|paclitaxel|mesh-list
92249600|NCT03830606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92249601|NCT03830606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249602|NCT03830606|Tubulin Modulators|tubulin modulators|mesh-ancestor
92249603|NCT03830606|Antimitotic Agents|antimitotic agents|mesh-ancestor
92249604|NCT03830606|Mitosis Modulators|mitosis modulators|mesh-ancestor
92249605|NCT03830606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249607|NCT01278134|Ribavirin|ribavirin|mesh-list
92249608|NCT01278134|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92249609|NCT01278134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92249610|NCT01278134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92249611|NCT01278134|Protease Inhibitors|protease inhibitors|mesh-ancestor
92249612|NCT01278134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249613|NCT01278134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249614|NCT01278134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92249615|NCT01278134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92249616|NCT01278134|Antiviral Agents|antiviral agents|mesh-ancestor
92249617|NCT01278134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249618|NCT01278134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92249619|NCT01278134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92249620|NCT01278134|Antimetabolites|antimetabolites|mesh-ancestor
92249621|NCT01273844|Bortezomib|bortezomib|mesh-list
92249622|NCT01273844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249623|NCT01271348|Etoricoxib|etoricoxib|mesh-list
92249624|NCT01271348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92249625|NCT01271348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92249626|NCT01271348|Analgesics|analgesics|mesh-ancestor
92249627|NCT01271348|Sensory System Agents|sensory system agents|mesh-ancestor
92249628|NCT01271348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249629|NCT01271348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249630|NCT01271348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249631|NCT01271348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249632|NCT01271348|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92249633|NCT01271348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92249634|NCT01271348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249635|NCT01271348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249636|NCT04385264|Hydroxychloroquine|hydroxychloroquine|mesh-list
92249637|NCT04385264|Mannitol|mannitol|mesh-list
92249638|NCT04385264|Antimalarials|antimalarials|mesh-ancestor
92249639|NCT04385264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92249640|NCT04385264|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92249641|NCT04385264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249643|NCT04385264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249644|NCT04385264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249645|NCT04385264|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92249646|NCT04385264|Diuretics|diuretics|mesh-ancestor
92249647|NCT04385264|Natriuretic Agents|natriuretic agents|mesh-ancestor
92249648|NCT04385264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249649|NCT00746954|Acetazolamide|acetazolamide|mesh-list
92249650|NCT00746954|Buspirone|buspirone|mesh-list
92249651|NCT00746954|Anticonvulsants|anticonvulsants|mesh-ancestor
92249652|NCT00746954|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92249653|NCT00746954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249654|NCT00746954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249655|NCT00746954|Diuretics|diuretics|mesh-ancestor
92249656|NCT00746954|Natriuretic Agents|natriuretic agents|mesh-ancestor
92249657|NCT00746954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249658|NCT00746954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92249659|NCT00746954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92249660|NCT00746954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249661|NCT00746954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249662|NCT00746954|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92249663|NCT00746954|Serotonin Agents|serotonin agents|mesh-ancestor
92249664|NCT00746954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249665|NCT00752102|Calcitriol|calcitriol|mesh-list
92249666|NCT00752102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92249667|NCT00752102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249668|NCT00752102|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92249669|NCT00752102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249670|NCT00752102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249671|NCT00752102|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92249672|NCT00752102|Vitamins|vitamins|mesh-ancestor
92249673|NCT00752102|Micronutrients|micronutrients|mesh-ancestor
92249674|NCT00752102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92249675|NCT00723632|Ribavirin|ribavirin|mesh-list
92249676|NCT00723632|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92249677|NCT00723632|Antimetabolites|antimetabolites|mesh-ancestor
92249678|NCT00723632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249679|NCT00723632|Antiviral Agents|antiviral agents|mesh-ancestor
92249680|NCT00723632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249681|NCT01279616|Mycophenolic Acid|mycophenolic acid|mesh-list
92249682|NCT01279616|Cyclophosphamide|cyclophosphamide|mesh-list
92249683|NCT01279616|Busulfan|busulfan|mesh-list
92249684|NCT01279616|Rituximab|rituximab|mesh-list
92249685|NCT01279616|Fludarabine|fludarabine|mesh-list
92249686|NCT01279616|Fludarabine phosphate|fludarabine phosphate|mesh-list
92249687|NCT01279616|Tacrolimus|tacrolimus|mesh-list
92249689|NCT01279616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92249690|NCT01279616|Immunologic Factors|immunologic factors|mesh-ancestor
92249691|NCT01279616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249692|NCT01279616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249693|NCT01279616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92249694|NCT01279616|Alkylating Agents|alkylating agents|mesh-ancestor
92249695|NCT01279616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249696|NCT01279616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249697|NCT01279616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92249698|NCT01279616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249699|NCT01279616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92249700|NCT01279616|Antimetabolites|antimetabolites|mesh-ancestor
92249701|NCT01279616|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92249702|NCT01279616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249703|NCT01279616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92249704|NCT01279616|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92249705|NCT01279616|Antitubercular Agents|antitubercular agents|mesh-ancestor
92249706|NCT01279616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92249707|NCT01279616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249708|NCT01275638|Prednisolone|prednisolone|mesh-list
92249709|NCT01275638|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92249711|NCT01275638|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92249712|NCT01275638|Prednisolone acetate|prednisolone acetate|mesh-list
92249713|NCT01275638|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92249714|NCT01275638|Prednisolone phosphate|prednisolone phosphate|mesh-list
92249715|NCT01275638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249716|NCT01275638|Glucocorticoids|glucocorticoids|mesh-ancestor
92249717|NCT01275638|Hormones|hormones|mesh-ancestor
92249718|NCT01275638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249719|NCT01275638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249720|NCT01275638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249721|NCT01275638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249722|NCT01275638|Antiemetics|antiemetics|mesh-ancestor
92249723|NCT01275638|Autonomic Agents|autonomic agents|mesh-ancestor
92249724|NCT01275638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249725|NCT01275638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249726|NCT01275638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92249727|NCT01275638|Protective Agents|protective agents|mesh-ancestor
92249728|NCT00724568|Dexamethasone|dexamethasone|mesh-list
92249729|NCT00724568|Lenalidomide|lenalidomide|mesh-list
92249730|NCT00724568|Bortezomib|bortezomib|mesh-list
92249731|NCT00724568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249732|NCT00724568|Antiemetics|antiemetics|mesh-ancestor
92249733|NCT00724568|Autonomic Agents|autonomic agents|mesh-ancestor
92249734|NCT00724568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249735|NCT00724568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249736|NCT00724568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249737|NCT00724568|Glucocorticoids|glucocorticoids|mesh-ancestor
92249738|NCT00724568|Hormones|hormones|mesh-ancestor
92249739|NCT00724568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249740|NCT00724568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249741|NCT00724568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249742|NCT00724568|Immunologic Factors|immunologic factors|mesh-ancestor
92342210|NCT00003953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92249743|NCT00724568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92249744|NCT00724568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92249745|NCT00724568|Growth Substances|growth substances|mesh-ancestor
92249746|NCT00724568|Growth Inhibitors|growth inhibitors|mesh-ancestor
92249747|NCT01274000|Ramosetron|ramosetron|mesh-list
92249748|NCT01274000|Antiemetics|antiemetics|mesh-ancestor
92249749|NCT01274000|Autonomic Agents|autonomic agents|mesh-ancestor
92249750|NCT01274000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249751|NCT01274000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249752|NCT01274000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249753|NCT01274000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92249754|NCT01274000|Serotonin Agents|serotonin agents|mesh-ancestor
92249755|NCT01274000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249756|NCT01274000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249757|NCT04272320|Bupivacaine|bupivacaine|mesh-list
92249758|NCT04272320|Anesthetics, Local|anesthetics, local|mesh-ancestor
92249759|NCT04272320|Anesthetics|anesthetics|mesh-ancestor
92249760|NCT04272320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92249761|NCT04272320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249762|NCT04272320|Sensory System Agents|sensory system agents|mesh-ancestor
92249763|NCT04272320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249764|NCT01277744|Cisplatin|cisplatin|mesh-list
92249765|NCT01277744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249766|NCT01277822|Losartan|losartan|mesh-list
92249767|NCT01277822|Amlodipine|amlodipine|mesh-list
92249768|NCT01277822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92249769|NCT01277822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92249770|NCT01277822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249771|NCT01277822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249772|NCT01277822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92249773|NCT01277822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249774|NCT01277822|Vasodilator Agents|vasodilator agents|mesh-ancestor
92249775|NCT01277822|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92249776|NCT01277822|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92249777|NCT01277822|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92249778|NCT00249002|Paclitaxel|paclitaxel|mesh-list
92249779|NCT00249002|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92249780|NCT00249002|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92249781|NCT00249002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249783|NCT00249002|Antimitotic Agents|antimitotic agents|mesh-ancestor
92249784|NCT00249002|Mitosis Modulators|mitosis modulators|mesh-ancestor
92249785|NCT00249002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249786|NCT00748826|Infliximab|infliximab|mesh-list
92249787|NCT00748826|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92249788|NCT00748826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249789|NCT00748826|Dermatologic Agents|dermatologic agents|mesh-ancestor
92249790|NCT00748826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249791|NCT00748826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92249792|NCT00246740|Doxycycline|doxycycline|mesh-list
92249793|NCT00246740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92249794|NCT00246740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249795|NCT00246740|Antimalarials|antimalarials|mesh-ancestor
92249796|NCT00246740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92249797|NCT00246740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92249798|NCT01274624|Leucovorin|leucovorin|mesh-list
92249799|NCT01274624|Bevacizumab|bevacizumab|mesh-list
92249800|NCT01274624|Fluorouracil|fluorouracil|mesh-list
92249801|NCT01274624|Irinotecan|irinotecan|mesh-list
92249802|NCT01274624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249803|NCT01274624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249804|NCT01274624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92249805|NCT01274624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92249806|NCT01274624|Growth Substances|growth substances|mesh-ancestor
92249807|NCT01274624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249808|NCT01274624|Growth Inhibitors|growth inhibitors|mesh-ancestor
92249809|NCT01274624|Antimetabolites|antimetabolites|mesh-ancestor
92249810|NCT01274624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249811|NCT01274624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92249812|NCT01274624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92249813|NCT01274624|Immunologic Factors|immunologic factors|mesh-ancestor
92249814|NCT01274624|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92249815|NCT01274624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92249816|NCT01274624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249817|NCT01274624|Antidotes|antidotes|mesh-ancestor
92249818|NCT01274624|Protective Agents|protective agents|mesh-ancestor
92249819|NCT01274624|Vitamin B Complex|vitamin b complex|mesh-ancestor
92249820|NCT01274624|Vitamins|vitamins|mesh-ancestor
92249821|NCT01274624|Micronutrients|micronutrients|mesh-ancestor
92249822|NCT00761930|Listerine|listerine|mesh-list
92249823|NCT00761930|Triclosan|triclosan|mesh-list
92249824|NCT00761930|Fluorides|fluorides|mesh-list
92249825|NCT00761930|Sodium Fluoride|sodium fluoride|mesh-list
92249826|NCT00761930|Cariostatic Agents|cariostatic agents|mesh-ancestor
92249827|NCT00761930|Protective Agents|protective agents|mesh-ancestor
92249828|NCT00761930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249829|NCT00761930|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92249830|NCT00761930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249831|NCT00761930|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92249832|NCT00761930|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92249833|NCT00761930|Antimetabolites|antimetabolites|mesh-ancestor
92249834|NCT00761930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249835|NCT00761930|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92249836|NCT00245102|Sorafenib|sorafenib|mesh-list
92249837|NCT00245102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249838|NCT00245102|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249839|NCT00245102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249840|NCT00245102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249841|NCT01275014|Dexamethasone|dexamethasone|mesh-list
92249842|NCT01275014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92249843|NCT01275014|Antiemetics|antiemetics|mesh-ancestor
92249844|NCT01275014|Autonomic Agents|autonomic agents|mesh-ancestor
92249845|NCT01275014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249846|NCT01275014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249847|NCT01275014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249848|NCT01275014|Glucocorticoids|glucocorticoids|mesh-ancestor
92249849|NCT01275014|Hormones|hormones|mesh-ancestor
92249850|NCT01275014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249851|NCT01275014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92249852|NCT01275014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249853|NCT01275248|Ondansetron|ondansetron|mesh-list
92249854|NCT01275248|Antiemetics|antiemetics|mesh-ancestor
92249855|NCT01275248|Autonomic Agents|autonomic agents|mesh-ancestor
92249856|NCT01275248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249857|NCT01275248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249858|NCT01275248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249859|NCT01275248|Antipruritics|antipruritics|mesh-ancestor
92249860|NCT01275248|Dermatologic Agents|dermatologic agents|mesh-ancestor
92249861|NCT01275248|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92249862|NCT01275248|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92249863|NCT01275248|Serotonin Agents|serotonin agents|mesh-ancestor
92249864|NCT01275248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249865|NCT01275248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249866|NCT00756236|Metoprolol|metoprolol|mesh-list
92249867|NCT00756236|Esmolol|esmolol|mesh-list
92249868|NCT00756236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92249869|NCT00756236|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92249870|NCT00756236|Sympatholytics|sympatholytics|mesh-ancestor
92249871|NCT00756236|Autonomic Agents|autonomic agents|mesh-ancestor
92249872|NCT00756236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249873|NCT00756236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249874|NCT00756236|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92249875|NCT00756236|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92249876|NCT00756236|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92249877|NCT00756236|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249878|NCT00756236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249879|NCT00756236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249880|NCT00762320|Ritonavir|ritonavir|mesh-list
92249881|NCT00762320|Lopinavir|lopinavir|mesh-list
92249882|NCT00762320|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92249883|NCT00762320|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92249884|NCT00762320|Protease Inhibitors|protease inhibitors|mesh-ancestor
92249885|NCT00762320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249886|NCT00762320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249887|NCT00762320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92342223|NCT00003953|Dermatologic Agents|dermatologic agents|mesh-ancestor
92249888|NCT00762320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92249889|NCT00762320|Antiviral Agents|antiviral agents|mesh-ancestor
92249890|NCT00762320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249891|NCT00762320|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92249892|NCT00762320|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92249893|NCT00244712|Tenofovir|tenofovir|mesh-list
92249894|NCT00244712|Lamivudine|lamivudine|mesh-list
92249895|NCT00244712|Emtricitabine|emtricitabine|mesh-list
92249896|NCT00244712|Abacavir|abacavir|mesh-list
92249897|NCT00244712|Antiviral Agents|antiviral agents|mesh-ancestor
92249898|NCT00244712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249899|NCT00244712|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92249900|NCT00244712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92249901|NCT00244712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249902|NCT00244712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249903|NCT00244712|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92249904|NCT00244712|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92249905|NCT00725270|Mifepristone|mifepristone|mesh-list
92249906|NCT00725270|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92249907|NCT00725270|Abortifacient Agents|abortifacient agents|mesh-ancestor
92249908|NCT00725270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92249909|NCT00725270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249910|NCT00725270|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92249911|NCT00725270|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92249912|NCT00725270|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92249913|NCT00725270|Contraceptive Agents|contraceptive agents|mesh-ancestor
92249914|NCT00725270|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92249915|NCT00725270|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92249916|NCT00725270|Hormone Antagonists|hormone antagonists|mesh-ancestor
92249917|NCT00725270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92249918|NCT00725270|Luteolytic Agents|luteolytic agents|mesh-ancestor
92249919|NCT00725270|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92249920|NCT00725270|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92249922|NCT00243932|Coenzyme Q10|coenzyme q10|mesh-list
92249923|NCT00243932|Micronutrients|micronutrients|mesh-ancestor
92249924|NCT00243932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249926|NCT00243386|Factor VIII|factor viii|mesh-list
92249927|NCT00243386|Coagulants|coagulants|mesh-ancestor
92249928|NCT03807362|CC-11050|cc-11050|mesh-list
92249929|NCT03807362|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92249930|NCT03807362|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92249931|NCT03807362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249932|NCT03807362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249933|NCT01275560|Metronidazole|metronidazole|mesh-list
92249934|NCT01275560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249935|NCT01275560|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92249936|NCT01275560|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92249937|NCT01275560|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92249938|NCT00762710|Prazosin|prazosin|mesh-list
92249939|NCT00762710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92249940|NCT00762710|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92249941|NCT00762710|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92249942|NCT00762710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92249943|NCT00762710|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249944|NCT00762710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249945|NCT00762710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249946|NCT00762710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249947|NCT00756548|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92249948|NCT00756548|Laxatives|laxatives|mesh-ancestor
92249949|NCT00756548|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92249950|NCT00243074|Cediranib|cediranib|mesh-list
92249951|NCT00243074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249952|NCT00243074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249953|NCT00243074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249954|NCT00243074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92249955|NCT00241358|Plerixafor|plerixafor|mesh-list
92249956|NCT00241358|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92249957|NCT00241358|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92249958|NCT00241358|Antiviral Agents|antiviral agents|mesh-ancestor
92249959|NCT00241358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92249960|NCT00778310|Methylphenidate|methylphenidate|mesh-list
92249962|NCT00778310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249963|NCT00778310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92249964|NCT00778310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92249965|NCT00778310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249966|NCT00778310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249967|NCT00778310|Dopamine Agents|dopamine agents|mesh-ancestor
92249968|NCT00778310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249969|NCT03801278|Bemarituzumab|bemarituzumab|mesh-list
92249970|NCT03801278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92249971|NCT03801278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92249972|NCT01247285|Fluoxetine|fluoxetine|mesh-list
92249973|NCT01247285|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92249974|NCT01247285|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92249975|NCT01247285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92249976|NCT01247285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249977|NCT01247285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249978|NCT01247285|Serotonin Agents|serotonin agents|mesh-ancestor
92249979|NCT01247285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249980|NCT01247285|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92249981|NCT01247285|Antidepressive Agents|antidepressive agents|mesh-ancestor
92249982|NCT01247285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92249983|NCT01247285|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91934773|NCT04771923|Hemostatics|hemostatics|mesh-ancestor
92249984|NCT01247285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92249985|NCT01247285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92249986|NCT03806582|Norepinephrine|norepinephrine|mesh-list
92249987|NCT03806582|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92249988|NCT03806582|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92249989|NCT03806582|Adrenergic Agents|adrenergic agents|mesh-ancestor
92249990|NCT03806582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92249991|NCT03806582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92249992|NCT03806582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92249993|NCT03806582|Sympathomimetics|sympathomimetics|mesh-ancestor
92249994|NCT03806582|Autonomic Agents|autonomic agents|mesh-ancestor
92249995|NCT03806582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92249996|NCT03806582|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92249997|NCT00779558|Heparin|heparin|mesh-list
92249998|NCT00779558|Calcium heparin|calcium heparin|mesh-list
92249999|NCT00779558|Anticoagulants|anticoagulants|mesh-ancestor
92250000|NCT00779558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92250001|NCT00779558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92250002|NCT00779558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250003|NCT00758342|Travoprost|travoprost|mesh-list
92250004|NCT00758342|Brinzolamide|brinzolamide|mesh-list
92250005|NCT00758342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92250006|NCT00758342|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92250007|NCT00758342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250008|NCT00758342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250009|NCT01301183|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92250010|NCT01301183|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92250011|NCT01301183|Estradiol|estradiol|mesh-list
92250012|NCT01301183|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92250013|NCT01301183|Mecasermin|mecasermin|mesh-list
92250014|NCT01301183|Estrogens|estrogens|mesh-ancestor
92250015|NCT01301183|Hormones|hormones|mesh-ancestor
92250016|NCT01301183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250017|NCT01301183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250018|NCT01301183|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92250019|NCT01301183|Contraceptive Agents|contraceptive agents|mesh-ancestor
92250020|NCT01301183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92250021|NCT01301183|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92250022|NCT01301183|Growth Substances|growth substances|mesh-ancestor
92250023|NCT00758420|Polidocanol|polidocanol|mesh-list
92250024|NCT00758420|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92250025|NCT00758420|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92342233|NCT00003959|Sargramostim|sargramostim|mesh-list
92250026|NCT01213043|Protease Inhibitors|protease inhibitors|mesh-list
92250027|NCT01213043|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92250028|NCT01213043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250029|NCT01213043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250030|NCT01213043|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92250031|NCT01213043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92250033|NCT01213199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250034|NCT01213199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250035|NCT01213199|Analgesics|analgesics|mesh-ancestor
92250036|NCT01213199|Sensory System Agents|sensory system agents|mesh-ancestor
92250037|NCT01213199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250038|NCT01213199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250039|NCT01213199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250040|NCT01213199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250041|NCT01213199|Dermatologic Agents|dermatologic agents|mesh-ancestor
92250042|NCT03809702|Pregabalin|pregabalin|mesh-list
92250043|NCT03809702|Analgesics|analgesics|mesh-ancestor
92250044|NCT03809702|Sensory System Agents|sensory system agents|mesh-ancestor
92250045|NCT03809702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250046|NCT03809702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250047|NCT03809702|Anticonvulsants|anticonvulsants|mesh-ancestor
92250048|NCT03809702|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92250049|NCT03809702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250050|NCT03809702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250051|NCT03809702|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92250052|NCT03809702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92250053|NCT03809702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92250054|NCT03809702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250055|NCT03809702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250056|NCT03806036|Vitamin D|vitamin d|mesh-list
92250057|NCT03806036|Clomiphene|clomiphene|mesh-list
92250058|NCT03806036|Enclomiphene|enclomiphene|mesh-list
92250059|NCT03806036|Zuclomiphene|zuclomiphene|mesh-list
92250060|NCT03806036|Vitamins|vitamins|mesh-ancestor
92250061|NCT03806036|Micronutrients|micronutrients|mesh-ancestor
92250062|NCT03806036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250063|NCT03806036|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92250064|NCT03806036|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92250065|NCT03806036|Hormone Antagonists|hormone antagonists|mesh-ancestor
92250066|NCT03806036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250067|NCT03806036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92250068|NCT03806036|Fertility Agents|fertility agents|mesh-ancestor
92250069|NCT03806036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92250070|NCT03806036|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92250071|NCT03806036|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92250073|NCT00780026|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92250074|NCT00780026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250075|NCT01214057|Remifentanil|remifentanil|mesh-list
92250076|NCT01214057|Propofol|propofol|mesh-list
92250077|NCT01214057|Sevoflurane|sevoflurane|mesh-list
92250078|NCT01214057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92250079|NCT01214057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250080|NCT01214057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250081|NCT01214057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92250082|NCT01214057|Anesthetics, General|anesthetics, general|mesh-ancestor
92250083|NCT01214057|Anesthetics|anesthetics|mesh-ancestor
92250084|NCT01214057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92250085|NCT01214057|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92250086|NCT01214057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92250087|NCT01214057|Narcotics|narcotics|mesh-ancestor
92250088|NCT01214057|Analgesics|analgesics|mesh-ancestor
92250089|NCT01214057|Sensory System Agents|sensory system agents|mesh-ancestor
92250090|NCT01214057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250091|NCT03809546|Dronabinol|dronabinol|mesh-list
92250092|NCT03809546|Hallucinogens|hallucinogens|mesh-ancestor
92250093|NCT03809546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250094|NCT03809546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250095|NCT03809546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250096|NCT03809546|Analgesics|analgesics|mesh-ancestor
92342236|NCT02972723|Metformin|metformin|mesh-list
92250098|NCT03809546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250099|NCT03809546|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92250100|NCT03809546|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92250101|NCT03809546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250102|NCT03809546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250103|NCT03809546|Hormones|hormones|mesh-ancestor
92250104|NCT03809546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250105|NCT03809312|Amoxicillin|amoxicillin|mesh-list
92250106|NCT03809312|Clavulanic Acids|clavulanic acids|mesh-list
92250107|NCT03809312|Clavulanic Acid|clavulanic acid|mesh-list
92250108|NCT03809312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250109|NCT03809312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250110|NCT03809312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250111|NCT03809312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250112|NCT03809312|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92250113|NCT01247363|Globalagliatin|globalagliatin|mesh-list
92250114|NCT01247363|Enzyme Activators|enzyme activators|mesh-ancestor
92250115|NCT01247363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250116|NCT00780494|Bevacizumab|bevacizumab|mesh-list
92250117|NCT00780494|Carboplatin|carboplatin|mesh-list
92250118|NCT00780494|Capecitabine|capecitabine|mesh-list
92250119|NCT00780494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92250120|NCT00780494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250121|NCT00780494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92250122|NCT00780494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92250123|NCT00780494|Growth Substances|growth substances|mesh-ancestor
92250124|NCT00780494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250125|NCT00780494|Growth Inhibitors|growth inhibitors|mesh-ancestor
92250126|NCT00780494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250127|NCT00780494|Antimetabolites|antimetabolites|mesh-ancestor
92250128|NCT00780494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250129|NCT00763412|Repaglinide|repaglinide|mesh-list
92250130|NCT00763412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92250131|NCT00763412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250132|NCT01302743|Metformin|metformin|mesh-list
92250133|NCT01302743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92250134|NCT01302743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250135|NCT00763490|Mycophenolic Acid|mycophenolic acid|mesh-list
92250136|NCT00763490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92250137|NCT00763490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250138|NCT00763490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92250139|NCT00763490|Antitubercular Agents|antitubercular agents|mesh-ancestor
92250140|NCT00763490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250141|NCT00763490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250142|NCT00763490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250143|NCT00763490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250144|NCT01214759|Tenofovir|tenofovir|mesh-list
92250145|NCT01214759|Emtricitabine|emtricitabine|mesh-list
92250146|NCT01214759|Raltegravir Potassium|raltegravir potassium|mesh-list
92250147|NCT01214759|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92250148|NCT01214759|Antiviral Agents|antiviral agents|mesh-ancestor
92250149|NCT01214759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250150|NCT01214759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92250151|NCT01214759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92250152|NCT01214759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250153|NCT01214759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250154|NCT01214759|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92250155|NCT01214759|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92250156|NCT01214759|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92250157|NCT01214759|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92250158|NCT00780962|Acetylcysteine|acetylcysteine|mesh-list
92250159|NCT00780962|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92250160|NCT00780962|Antiviral Agents|antiviral agents|mesh-ancestor
92250161|NCT00780962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250162|NCT00780962|Expectorants|expectorants|mesh-ancestor
92250163|NCT00780962|Respiratory System Agents|respiratory system agents|mesh-ancestor
92250164|NCT00780962|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92250165|NCT00780962|Antioxidants|antioxidants|mesh-ancestor
92250166|NCT00780962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250167|NCT00780962|Protective Agents|protective agents|mesh-ancestor
92250168|NCT00780962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250169|NCT00780962|Antidotes|antidotes|mesh-ancestor
92250170|NCT00764738|Ranibizumab|ranibizumab|mesh-list
92250171|NCT00764738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92250172|NCT00764738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92250173|NCT00764738|Growth Substances|growth substances|mesh-ancestor
92250174|NCT00764738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250175|NCT00764738|Growth Inhibitors|growth inhibitors|mesh-ancestor
92250176|NCT00764738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250177|NCT00781508|Sildenafil Citrate|sildenafil citrate|mesh-list
92250178|NCT00781508|Vasodilator Agents|vasodilator agents|mesh-ancestor
92250179|NCT00781508|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92250180|NCT00781508|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92250182|NCT00781508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250183|NCT00781508|Urological Agents|urological agents|mesh-ancestor
92250184|NCT03805568|Dexmedetomidine|dexmedetomidine|mesh-list
92250185|NCT03805568|Remifentanil|remifentanil|mesh-list
92250186|NCT03805568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92250187|NCT03805568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250188|NCT03805568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250189|NCT03805568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250190|NCT03805568|Analgesics|analgesics|mesh-ancestor
92250191|NCT03805568|Sensory System Agents|sensory system agents|mesh-ancestor
92250192|NCT03805568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250193|NCT03805568|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92250194|NCT03805568|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91934782|NCT04771923|Autonomic Agents|autonomic agents|mesh-ancestor
92250195|NCT03805568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92250196|NCT03805568|Adrenergic Agents|adrenergic agents|mesh-ancestor
92250197|NCT03805568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250198|NCT03805568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250199|NCT03805568|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92250200|NCT03805568|Narcotics|narcotics|mesh-ancestor
92250201|NCT00781898|Naltrexone|naltrexone|mesh-list
92250202|NCT00781898|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92250203|NCT00781898|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92250204|NCT00781898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250205|NCT00781898|Sensory System Agents|sensory system agents|mesh-ancestor
92250206|NCT00781898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250207|NCT00765128|Ketorolac|ketorolac|mesh-list
92250208|NCT00765128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250209|NCT00765128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250210|NCT00765128|Analgesics|analgesics|mesh-ancestor
92250211|NCT00765128|Sensory System Agents|sensory system agents|mesh-ancestor
92250212|NCT00765128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250213|NCT00765128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250214|NCT00765128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250215|NCT00765128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250216|NCT00765128|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92250217|NCT00765128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250218|NCT00765128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250219|NCT00765206|Omeprazole|omeprazole|mesh-list
92250220|NCT00765206|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92250221|NCT00765206|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92250222|NCT00765206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250223|NCT00765206|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92250224|NCT00765206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250225|NCT00765206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250226|NCT03809156|Ambrisentan|ambrisentan|mesh-list
92250227|NCT03809156|Riociguat|riociguat|mesh-list
92250228|NCT03809156|Enzyme Activators|enzyme activators|mesh-ancestor
92250229|NCT03809156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250230|NCT03809156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92250231|NCT03808844|Propofol|propofol|mesh-list
92250232|NCT03808844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92250233|NCT03808844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250234|NCT03808844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250235|NCT03808844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92250236|NCT03808844|Anesthetics, General|anesthetics, general|mesh-ancestor
92250237|NCT03808844|Anesthetics|anesthetics|mesh-ancestor
92250238|NCT03809078|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92250239|NCT03809078|Bombesin|bombesin|mesh-list
92250240|NCT03809078|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92250241|NCT03809078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250242|NCT03809078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250243|NCT03809078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250244|NCT05316428|Ethanol|ethanol|mesh-list
92250245|NCT05316428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92250246|NCT05316428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250247|NCT05316428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250248|NCT05316428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250249|NCT03805178|Abatacept|abatacept|mesh-list
92250250|NCT03805178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91934788|NCT04771923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92250251|NCT03805178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250252|NCT03805178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92250253|NCT03805178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250254|NCT03805178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250255|NCT03805178|Immunologic Factors|immunologic factors|mesh-ancestor
92250256|NCT03805178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250257|NCT03805178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250259|NCT01303835|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92250260|NCT01303835|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92250261|NCT01303835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250262|NCT01303835|Sensory System Agents|sensory system agents|mesh-ancestor
92250263|NCT01303835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250264|NCT01250717|Dexamethasone|dexamethasone|mesh-list
92250265|NCT01250717|Goserelin|goserelin|mesh-list
92250266|NCT01250717|Estramustine|estramustine|mesh-list
92250267|NCT01250717|Docetaxel|docetaxel|mesh-list
92250268|NCT01250717|Bicalutamide|bicalutamide|mesh-list
92250269|NCT01250717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250270|NCT01250717|Antiemetics|antiemetics|mesh-ancestor
92250271|NCT01250717|Autonomic Agents|autonomic agents|mesh-ancestor
92250272|NCT01250717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250273|NCT01250717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250274|NCT01250717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250275|NCT01250717|Glucocorticoids|glucocorticoids|mesh-ancestor
92250276|NCT01250717|Hormones|hormones|mesh-ancestor
92250277|NCT01250717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250278|NCT01250717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92250279|NCT01250717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250280|NCT01250717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92250281|NCT01250717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92250282|NCT01250717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92250283|NCT01250717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250284|NCT01250717|Androgen Antagonists|androgen antagonists|mesh-ancestor
92250285|NCT01250717|Hormone Antagonists|hormone antagonists|mesh-ancestor
92250286|NCT01250717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92250287|NCT01250717|Alkylating Agents|alkylating agents|mesh-ancestor
92250288|NCT03804866|Doxorubicin|doxorubicin|mesh-list
92250289|NCT03804866|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92250290|NCT03804866|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92250291|NCT03804866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250292|NCT03804866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92250293|NCT03804866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92250294|NCT03804866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250295|NCT03804866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250296|NCT01251575|Cyclosporine|cyclosporine|mesh-list
92250297|NCT01251575|Sirolimus|sirolimus|mesh-list
92250298|NCT01251575|Mycophenolic Acid|mycophenolic acid|mesh-list
92250299|NCT01251575|Fludarabine|fludarabine|mesh-list
92250300|NCT01251575|Fludarabine phosphate|fludarabine phosphate|mesh-list
92250301|NCT01251575|Cyclosporins|cyclosporins|mesh-list
92250302|NCT01251575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250303|NCT01251575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250304|NCT01251575|Antimetabolites|antimetabolites|mesh-ancestor
92250305|NCT01251575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250306|NCT01251575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250307|NCT01251575|Immunologic Factors|immunologic factors|mesh-ancestor
92250308|NCT01251575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250309|NCT01251575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250310|NCT01251575|Antifungal Agents|antifungal agents|mesh-ancestor
92250311|NCT01251575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250312|NCT01251575|Dermatologic Agents|dermatologic agents|mesh-ancestor
92250313|NCT01251575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250314|NCT01251575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92250315|NCT01251575|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92250316|NCT01251575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92250317|NCT01251575|Antitubercular Agents|antitubercular agents|mesh-ancestor
92250318|NCT01251575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250319|NCT00782756|Bevacizumab|bevacizumab|mesh-list
92250320|NCT00782756|Temozolomide|temozolomide|mesh-list
92250321|NCT00782756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92250322|NCT00782756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250323|NCT00782756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92250324|NCT00782756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92250325|NCT00782756|Growth Substances|growth substances|mesh-ancestor
92250326|NCT00782756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250327|NCT00782756|Growth Inhibitors|growth inhibitors|mesh-ancestor
92250328|NCT00782756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92250329|NCT00782756|Alkylating Agents|alkylating agents|mesh-ancestor
92250330|NCT00782756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250331|NCT03808142|Interferon beta-1b|interferon beta-1b|mesh-list
92250332|NCT03808142|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92250333|NCT03808142|Immunologic Factors|immunologic factors|mesh-ancestor
92250334|NCT03808142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250335|NCT01306175|Empagliflozin|empagliflozin|mesh-list
92250336|NCT01306175|Digoxin|digoxin|mesh-list
92250337|NCT01306175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92250338|NCT01306175|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92250339|NCT01306175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250340|NCT01306175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250341|NCT01306175|Protective Agents|protective agents|mesh-ancestor
92250342|NCT01306175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250343|NCT01306175|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92250344|NCT01306175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92250345|NCT01215929|Dextroamphetamine|dextroamphetamine|mesh-list
92250346|NCT01215929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92250347|NCT01215929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250348|NCT01215929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92250349|NCT01215929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92250350|NCT01215929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250351|NCT01215929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250352|NCT01215929|Dopamine Agents|dopamine agents|mesh-ancestor
92250353|NCT01215929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250354|NCT00767624|Antidepressive Agents|antidepressive agents|mesh-list
92250355|NCT00767624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250356|NCT01216241|Daptomycin|daptomycin|mesh-list
92250357|NCT01216241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250358|NCT01216241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250359|NCT01216397|Metformin|metformin|mesh-list
92250360|NCT01216397|Linagliptin|linagliptin|mesh-list
92250361|NCT01216397|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92250362|NCT01216397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250363|NCT01216397|Incretins|incretins|mesh-ancestor
92250365|NCT01216397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250366|NCT01216397|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92250367|NCT01216397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92250368|NCT01216397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250369|NCT01216397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250370|NCT04345406|Chloroquine|chloroquine|mesh-list
92250371|NCT04345406|Enalapril|enalapril|mesh-list
92250372|NCT04345406|Captopril|captopril|mesh-list
92250373|NCT04345406|Amebicides|amebicides|mesh-ancestor
92250374|NCT04345406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92250375|NCT04345406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92250376|NCT04345406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250377|NCT04345406|Antimalarials|antimalarials|mesh-ancestor
92250378|NCT04345406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250379|NCT04345406|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92250380|NCT04345406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92250381|NCT04345406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250382|NCT04345406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250383|NCT04345406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92250384|NCT05621174|Dextroamphetamine|dextroamphetamine|mesh-list
92250385|NCT05621174|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92250386|NCT05621174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250387|NCT05621174|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92250388|NCT05621174|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92250389|NCT05621174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250390|NCT05621174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250391|NCT05621174|Dopamine Agents|dopamine agents|mesh-ancestor
92250392|NCT05621174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250394|NCT01216943|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92250395|NCT01216943|Bimatoprost|bimatoprost|mesh-list
92250396|NCT01216943|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92250397|NCT01216943|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92250398|NCT01216943|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92250399|NCT01216943|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92250400|NCT01216943|Adrenergic Agents|adrenergic agents|mesh-ancestor
92250401|NCT01216943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250402|NCT01216943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250403|NCT01216943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250404|NCT01216943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92250405|NCT01216943|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92250406|NCT01216943|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92250407|NCT01216943|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92250408|NCT01216943|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92250409|NCT00783614|Aspirin|aspirin|mesh-list
92250410|NCT00783614|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92250411|NCT00783614|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250412|NCT00783614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250413|NCT00783614|Analgesics|analgesics|mesh-ancestor
92250414|NCT00783614|Sensory System Agents|sensory system agents|mesh-ancestor
92250415|NCT00783614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250416|NCT00783614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250417|NCT00783614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250418|NCT00783614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250419|NCT00783614|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92250420|NCT00783614|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92250421|NCT00783614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250422|NCT00783614|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92250423|NCT00783614|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92250424|NCT00783614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250425|NCT00783614|Antipyretics|antipyretics|mesh-ancestor
92250426|NCT00783614|Antiviral Agents|antiviral agents|mesh-ancestor
92250427|NCT00783614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250428|NCT01252745|Methyltestosterone|methyltestosterone|mesh-list
92250429|NCT01252745|Testosterone|testosterone|mesh-list
92250430|NCT01252745|Testosterone undecanoate|testosterone undecanoate|mesh-list
92250431|NCT01252745|Testosterone enanthate|testosterone enanthate|mesh-list
92250432|NCT01252745|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92250433|NCT01252745|Androgens|androgens|mesh-ancestor
92250434|NCT01252745|Hormones|hormones|mesh-ancestor
92250435|NCT01252745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250436|NCT01252745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250437|NCT01252745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92250438|NCT01252745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250440|NCT04278872|SJX-653|sjx-653|mesh-list
92250441|NCT04278872|Hormone Antagonists|hormone antagonists|mesh-ancestor
92342265|NCT00003575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92250442|NCT04278872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250443|NCT04278872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250444|NCT03807596|Hyaluronic Acid|hyaluronic acid|mesh-list
92250445|NCT03807596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92250446|NCT03807596|Immunologic Factors|immunologic factors|mesh-ancestor
92250447|NCT03807596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250448|NCT03807596|Viscosupplements|viscosupplements|mesh-ancestor
92250449|NCT03807596|Protective Agents|protective agents|mesh-ancestor
92250450|NCT01217411|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92250451|NCT01217411|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92250452|NCT01217411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250453|NCT01217411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250454|NCT01253525|Paclitaxel|paclitaxel|mesh-list
92250455|NCT01253525|Ramucirumab|ramucirumab|mesh-list
92250456|NCT01253525|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92250457|NCT01253525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250458|NCT01253525|Tubulin Modulators|tubulin modulators|mesh-ancestor
92250459|NCT01253525|Antimitotic Agents|antimitotic agents|mesh-ancestor
92250460|NCT01253525|Mitosis Modulators|mitosis modulators|mesh-ancestor
92250461|NCT01253525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250462|NCT05310968|Aspirin|aspirin|mesh-list
92250463|NCT05310968|Tirofiban|tirofiban|mesh-list
92250464|NCT05310968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250465|NCT05310968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250466|NCT05310968|Analgesics|analgesics|mesh-ancestor
92250467|NCT05310968|Sensory System Agents|sensory system agents|mesh-ancestor
92250468|NCT05310968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250469|NCT05310968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250470|NCT05310968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250471|NCT05310968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250472|NCT05310968|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92250473|NCT05310968|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92250474|NCT05310968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250475|NCT05310968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92250476|NCT05310968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92250477|NCT05310968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250478|NCT05310968|Antipyretics|antipyretics|mesh-ancestor
92250479|NCT00768716|Acetaminophen|acetaminophen|mesh-list
92250480|NCT00768716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250481|NCT00768716|Analgesics|analgesics|mesh-ancestor
92250482|NCT00768716|Sensory System Agents|sensory system agents|mesh-ancestor
92250483|NCT00768716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250484|NCT00768716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250485|NCT00768716|Antipyretics|antipyretics|mesh-ancestor
92250486|NCT05743634|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92250487|NCT05743634|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92250488|NCT05743634|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92250489|NCT05743634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250490|NCT05743634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250491|NCT05743634|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92250492|NCT05743634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250493|NCT05743634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250494|NCT05743634|Cholinergic Agents|cholinergic agents|mesh-ancestor
92250495|NCT05743634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250496|NCT05583188|Paclitaxel|paclitaxel|mesh-list
92250497|NCT05583188|Vinorelbine|vinorelbine|mesh-list
92250498|NCT05583188|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92250499|NCT05583188|Gemcitabine|gemcitabine|mesh-list
92250500|NCT05583188|Nivolumab|nivolumab|mesh-list
92250501|NCT05583188|Pemetrexed|pemetrexed|mesh-list
92250502|NCT05583188|Carboplatin|carboplatin|mesh-list
92250503|NCT05583188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92250504|NCT05583188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250505|NCT05583188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92250506|NCT05583188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92250507|NCT05583188|Mitosis Modulators|mitosis modulators|mesh-ancestor
92250508|NCT05583188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250509|NCT05583188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250510|NCT05583188|Antimetabolites|antimetabolites|mesh-ancestor
92250511|NCT05583188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92250512|NCT05583188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92250513|NCT05583188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250514|NCT05583188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92250515|NCT05583188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92250516|NCT01218971|Naltrexone|naltrexone|mesh-list
92250517|NCT01218971|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92250518|NCT01218971|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92250519|NCT01218971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250520|NCT01218971|Sensory System Agents|sensory system agents|mesh-ancestor
92250521|NCT01218971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250522|NCT01337687|Oxytocin|oxytocin|mesh-list
92250523|NCT01337687|Oxytocics|oxytocics|mesh-ancestor
92250524|NCT01337687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92250525|NCT01337687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250526|NCT04351919|Azithromycin|azithromycin|mesh-list
92250527|NCT04351919|Hydroxychloroquine|hydroxychloroquine|mesh-list
92250528|NCT04351919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250529|NCT04351919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250530|NCT04351919|Antimalarials|antimalarials|mesh-ancestor
92250531|NCT04351919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92250532|NCT04351919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92250533|NCT04351919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250534|NCT04351919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250535|NCT04351919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250536|NCT00769886|Ketotifen|ketotifen|mesh-list
92250537|NCT00769886|Naphazoline|naphazoline|mesh-list
92250538|NCT00769886|Antipruritics|antipruritics|mesh-ancestor
92250539|NCT00769886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92250540|NCT00769886|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92250541|NCT00769886|Histamine Antagonists|histamine antagonists|mesh-ancestor
92250542|NCT00769886|Histamine Agents|histamine agents|mesh-ancestor
92250543|NCT00769886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250544|NCT00769886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250545|NCT00769886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250546|NCT00769886|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92250547|NCT00769886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92250548|NCT00769886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92250549|NCT00769886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92250550|NCT00769886|Nasal Decongestants|nasal decongestants|mesh-ancestor
92250551|NCT00769886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92250552|NCT00769886|Respiratory System Agents|respiratory system agents|mesh-ancestor
92250553|NCT00794144|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92250554|NCT00794144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250555|NCT00794144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250556|NCT00794144|Analgesics|analgesics|mesh-ancestor
92250557|NCT00794144|Sensory System Agents|sensory system agents|mesh-ancestor
92250558|NCT00794144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250559|NCT00794144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250560|NCT00794144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250561|NCT00794144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250562|NCT00794144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92250563|NCT00794144|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92250564|NCT00794144|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92250565|NCT00794144|Histamine Antagonists|histamine antagonists|mesh-ancestor
92250566|NCT00794144|Histamine Agents|histamine agents|mesh-ancestor
92250567|NCT00794144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250568|NCT00794144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250569|NCT01309451|Dexamethasone|dexamethasone|mesh-list
92250570|NCT01309451|Bevacizumab|bevacizumab|mesh-list
92250571|NCT01309451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92250572|NCT01309451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250573|NCT01309451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92250574|NCT01309451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92342283|NCT00003209|Fluorouracil|fluorouracil|mesh-list
92250575|NCT01309451|Growth Substances|growth substances|mesh-ancestor
92250576|NCT01309451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250577|NCT01309451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92250578|NCT01309451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250579|NCT01309451|Antiemetics|antiemetics|mesh-ancestor
92250580|NCT01309451|Autonomic Agents|autonomic agents|mesh-ancestor
92250581|NCT01309451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250582|NCT01309451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250583|NCT01309451|Glucocorticoids|glucocorticoids|mesh-ancestor
92250584|NCT01309451|Hormones|hormones|mesh-ancestor
92250585|NCT01309451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250586|NCT01309451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92250587|NCT00771056|Hydroxychloroquine|hydroxychloroquine|mesh-list
92250588|NCT00771056|Antimalarials|antimalarials|mesh-ancestor
92250589|NCT00771056|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92250590|NCT00771056|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92250591|NCT00771056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250592|NCT00771056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250593|NCT00771056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250594|NCT00771056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250595|NCT00795002|Cytarabine|cytarabine|mesh-list
92250596|NCT00795002|Mitoxantrone|mitoxantrone|mesh-list
92250597|NCT00795002|Alvocidib|alvocidib|mesh-list
92250598|NCT00795002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250599|NCT00795002|Antimetabolites|antimetabolites|mesh-ancestor
92250600|NCT00795002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250601|NCT00795002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250602|NCT00795002|Antiviral Agents|antiviral agents|mesh-ancestor
92250603|NCT00795002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250604|NCT00795002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250605|NCT00795002|Immunologic Factors|immunologic factors|mesh-ancestor
92250606|NCT00795002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250607|NCT00795002|Analgesics|analgesics|mesh-ancestor
92250608|NCT00795002|Sensory System Agents|sensory system agents|mesh-ancestor
92250609|NCT00795002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250610|NCT00795002|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92250611|NCT00795002|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92250612|NCT00795002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250613|NCT00795002|Growth Inhibitors|growth inhibitors|mesh-ancestor
92250614|NCT00795002|Growth Substances|growth substances|mesh-ancestor
92250615|NCT00795002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92250617|NCT05742698|Antiemetics|antiemetics|mesh-ancestor
92250618|NCT05742698|Autonomic Agents|autonomic agents|mesh-ancestor
92250619|NCT05742698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250620|NCT05742698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250621|NCT05742698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250622|NCT05742698|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92250623|NCT05742698|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92250624|NCT05742698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250625|NCT05742698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250626|NCT03802838|Amisulpride|amisulpride|mesh-list
92250627|NCT03802838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92250628|NCT03802838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92250629|NCT03802838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250630|NCT03802838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250631|NCT03802838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250632|NCT03802838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92250633|NCT03802838|Dopamine Agents|dopamine agents|mesh-ancestor
92250634|NCT03802838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250635|NCT03802838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250636|NCT03802838|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92250637|NCT03802838|Antidepressive Agents|antidepressive agents|mesh-ancestor
92250638|NCT00772304|Azelastine|azelastine|mesh-list
92250639|NCT00772304|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92250640|NCT00772304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92342287|NCT00003209|Mitomycin|mitomycin|mesh-list
92250641|NCT00772304|Autonomic Agents|autonomic agents|mesh-ancestor
92250642|NCT00772304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250643|NCT00772304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250644|NCT00772304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92250645|NCT00772304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92250646|NCT00772304|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92250647|NCT00772304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250648|NCT00772304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250649|NCT00772304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92250650|NCT00772304|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92250651|NCT00772304|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92250652|NCT00772304|Histamine Antagonists|histamine antagonists|mesh-ancestor
92250653|NCT00772304|Histamine Agents|histamine agents|mesh-ancestor
92250654|NCT00772304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250655|NCT00772304|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250656|NCT00772304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250657|NCT00772304|Analgesics|analgesics|mesh-ancestor
92250658|NCT00772304|Sensory System Agents|sensory system agents|mesh-ancestor
92250659|NCT00772304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250660|NCT00772304|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250661|NCT01310231|Metformin|metformin|mesh-list
92250662|NCT01310231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92250663|NCT01310231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250664|NCT00789074|Varenicline|varenicline|mesh-list
92250665|NCT00789074|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92250666|NCT00789074|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92250667|NCT00789074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92250668|NCT00789074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250669|NCT00789074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250670|NCT00789074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250671|NCT01338857|Sorafenib|sorafenib|mesh-list
92250672|NCT01338857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250673|NCT01338857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92250674|NCT01338857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250675|NCT01338857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250676|NCT01339013|Anesthetics|anesthetics|mesh-list
92250677|NCT01339013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250678|NCT01339013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250679|NCT01339091|Vancomycin|vancomycin|mesh-list
92250680|NCT01339091|Linezolid|linezolid|mesh-list
92250681|NCT01339091|Dalbavancin|dalbavancin|mesh-list
92250682|NCT01339091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250683|NCT01339091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250684|NCT01339091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92250685|NCT01339091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250686|NCT01339091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250687|NCT01339247|Halofantrine|halofantrine|mesh-list
92250688|NCT01339247|Paroxetine|paroxetine|mesh-list
92250689|NCT01339247|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92250690|NCT01339247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92250691|NCT01339247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250692|NCT01339247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250693|NCT01339247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250694|NCT01339247|Serotonin Agents|serotonin agents|mesh-ancestor
92250695|NCT01339247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250696|NCT01339247|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92250697|NCT01339247|Antidepressive Agents|antidepressive agents|mesh-ancestor
92250698|NCT01339247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250699|NCT01339247|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92250700|NCT01339247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92250701|NCT01339247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250702|NCT01339247|Antimalarials|antimalarials|mesh-ancestor
92250703|NCT01339247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92250704|NCT01339247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92250705|NCT01339247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250706|NCT00772772|Vitamin D|vitamin d|mesh-list
92250708|NCT00772772|Cholecalciferol|cholecalciferol|mesh-list
92250709|NCT00772772|Vitamins|vitamins|mesh-list
92250710|NCT00772772|Micronutrients|micronutrients|mesh-ancestor
92250711|NCT00772772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250712|NCT00772772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92250713|NCT00772772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92250714|NCT00773474|Lonafarnib|lonafarnib|mesh-list
92250715|NCT00773474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250716|NCT00773474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250717|NCT01310855|Gefitinib|gefitinib|mesh-list
92250718|NCT01310855|Cediranib|cediranib|mesh-list
92250719|NCT01310855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250720|NCT01310855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250721|NCT01310855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250722|NCT01310855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92250723|NCT00773786|Formoterol Fumarate|formoterol fumarate|mesh-list
92250724|NCT00773786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92250725|NCT00773786|Autonomic Agents|autonomic agents|mesh-ancestor
92250726|NCT00773786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250727|NCT00773786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250728|NCT00773786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92250729|NCT00773786|Respiratory System Agents|respiratory system agents|mesh-ancestor
92250730|NCT00773786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92250731|NCT00773786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92250732|NCT00773786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92250733|NCT00773786|Adrenergic Agents|adrenergic agents|mesh-ancestor
92250734|NCT00773786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250735|NCT00773786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250736|NCT01258049|Artemether|artemether|mesh-list
92250737|NCT01258049|Quinine|quinine|mesh-list
92250738|NCT01258049|Antimalarials|antimalarials|mesh-ancestor
92250739|NCT01258049|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92250740|NCT01258049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92250741|NCT01258049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250742|NCT01258049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92250743|NCT01258049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250744|NCT01258049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92250745|NCT01258049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250746|NCT01258049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250747|NCT01258049|Analgesics|analgesics|mesh-ancestor
92250748|NCT01258049|Sensory System Agents|sensory system agents|mesh-ancestor
92250749|NCT03802214|Vedolizumab|vedolizumab|mesh-list
92250750|NCT03802214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250751|NCT03801746|Cyclosporine|cyclosporine|mesh-list
92250752|NCT03801746|Rifampin|rifampin|mesh-list
92250753|NCT03801746|Probenecid|probenecid|mesh-list
92250754|NCT03801746|Cyclosporins|cyclosporins|mesh-list
92250755|NCT03801746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250756|NCT03801746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250757|NCT03801746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250758|NCT03801746|Immunologic Factors|immunologic factors|mesh-ancestor
92250759|NCT03801746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250760|NCT03801746|Antifungal Agents|antifungal agents|mesh-ancestor
92250761|NCT03801746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250762|NCT03801746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92250763|NCT03801746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250764|NCT03801746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92250765|NCT03801746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92250766|NCT03801746|Antitubercular Agents|antitubercular agents|mesh-ancestor
92250767|NCT03801746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250768|NCT03801746|Leprostatic Agents|leprostatic agents|mesh-ancestor
92250769|NCT03801746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92250770|NCT03801746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92250771|NCT03801746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92250772|NCT03801746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92250773|NCT03801746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92250774|NCT03801746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92250775|NCT03801746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92250776|NCT03801746|Uricosuric Agents|uricosuric agents|mesh-ancestor
92250777|NCT03801746|Gout Suppressants|gout suppressants|mesh-ancestor
92250778|NCT03801668|Paclitaxel|paclitaxel|mesh-list
92250779|NCT03801668|Oxaliplatin|oxaliplatin|mesh-list
92250780|NCT03801668|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92250781|NCT03801668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92250782|NCT03801668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250783|NCT03801668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92250784|NCT03801668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92250785|NCT03801668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92250786|NCT03801668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250787|NCT05414006|Ketamine|ketamine|mesh-list
92250788|NCT05414006|Esketamine|esketamine|mesh-list
92250789|NCT05414006|Analgesics|analgesics|mesh-ancestor
92250790|NCT05414006|Sensory System Agents|sensory system agents|mesh-ancestor
92250791|NCT05414006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250792|NCT05414006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250793|NCT05414006|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92250794|NCT05414006|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92250795|NCT05414006|Anesthetics, General|anesthetics, general|mesh-ancestor
92250796|NCT05414006|Anesthetics|anesthetics|mesh-ancestor
92250797|NCT05414006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250798|NCT05414006|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92250799|NCT05414006|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92250800|NCT05414006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250801|NCT05414006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250802|NCT05414006|Antidepressive Agents|antidepressive agents|mesh-ancestor
92250803|NCT05414006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250804|NCT02199041|Mycophenolic Acid|mycophenolic acid|mesh-list
92250805|NCT02199041|Methylprednisolone|methylprednisolone|mesh-list
92250806|NCT02199041|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92250807|NCT02199041|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92250808|NCT02199041|Prednisolone|prednisolone|mesh-list
92250809|NCT02199041|Prednisolone acetate|prednisolone acetate|mesh-list
92250810|NCT02199041|Cyclophosphamide|cyclophosphamide|mesh-list
92250811|NCT02199041|Melphalan|melphalan|mesh-list
92250812|NCT02199041|Mechlorethamine|mechlorethamine|mesh-list
92250813|NCT02199041|Thiotepa|thiotepa|mesh-list
92250814|NCT02199041|Fludarabine|fludarabine|mesh-list
92250816|NCT02199041|Lenograstim|lenograstim|mesh-list
92250817|NCT02199041|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92250818|NCT02199041|Prednisolone phosphate|prednisolone phosphate|mesh-list
92250819|NCT02199041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250820|NCT02199041|Immunologic Factors|immunologic factors|mesh-ancestor
92250821|NCT02199041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250822|NCT02199041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250823|NCT02199041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92250824|NCT02199041|Alkylating Agents|alkylating agents|mesh-ancestor
92250825|NCT02199041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250826|NCT02199041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250827|NCT02199041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92250828|NCT02199041|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92250829|NCT02199041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250830|NCT02199041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92250831|NCT02199041|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92250832|NCT02199041|Antitubercular Agents|antitubercular agents|mesh-ancestor
92250833|NCT02199041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250834|NCT02199041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250835|NCT02199041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250836|NCT02199041|Antiemetics|antiemetics|mesh-ancestor
92250837|NCT02199041|Autonomic Agents|autonomic agents|mesh-ancestor
92250838|NCT02199041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250839|NCT02199041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250840|NCT02199041|Glucocorticoids|glucocorticoids|mesh-ancestor
92250841|NCT02199041|Hormones|hormones|mesh-ancestor
92250842|NCT02199041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92250843|NCT02199041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92250844|NCT02199041|Protective Agents|protective agents|mesh-ancestor
92250845|NCT02199041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92250846|NCT02199041|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92250847|NCT00789776|Mycophenolic Acid|mycophenolic acid|mesh-list
92250848|NCT00789776|Cyclophosphamide|cyclophosphamide|mesh-list
92250850|NCT00789776|Fludarabine phosphate|fludarabine phosphate|mesh-list
92250851|NCT00789776|Tacrolimus|tacrolimus|mesh-list
92250852|NCT00789776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250853|NCT00789776|Immunologic Factors|immunologic factors|mesh-ancestor
92250854|NCT00789776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250855|NCT00789776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250856|NCT00789776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92250857|NCT00789776|Alkylating Agents|alkylating agents|mesh-ancestor
92250858|NCT00789776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250859|NCT00789776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250860|NCT00789776|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92250861|NCT00789776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250862|NCT00789776|Antimetabolites|antimetabolites|mesh-ancestor
92250863|NCT00789776|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92250864|NCT00789776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250865|NCT00789776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92250866|NCT00789776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92250867|NCT00789776|Antitubercular Agents|antitubercular agents|mesh-ancestor
92250868|NCT00789776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92250869|NCT00789776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92250870|NCT03801590|Riboflavin|riboflavin|mesh-list
92250871|NCT03801590|Vitamin B Complex|vitamin b complex|mesh-ancestor
92250872|NCT03801590|Vitamins|vitamins|mesh-ancestor
92250873|NCT03801590|Micronutrients|micronutrients|mesh-ancestor
92250874|NCT03801590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250875|NCT03801590|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92250876|NCT03801590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92250877|NCT00775658|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92250878|NCT00775658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92250879|NCT00775658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92250880|NCT00775658|Analgesics|analgesics|mesh-ancestor
92250881|NCT00775658|Sensory System Agents|sensory system agents|mesh-ancestor
92250882|NCT00775658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250883|NCT00775658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250884|NCT00775658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92250885|NCT00775658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92250886|NCT00775658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92250887|NCT00775658|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92250888|NCT00775658|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92250889|NCT00775658|Histamine Antagonists|histamine antagonists|mesh-ancestor
92250890|NCT00775658|Histamine Agents|histamine agents|mesh-ancestor
92250891|NCT00775658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117536|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92250892|NCT00775658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250893|NCT02199197|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92250894|NCT02199197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250895|NCT00799604|Clevidipine|clevidipine|mesh-list
92250896|NCT00799604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92250897|NCT00799604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250898|NCT00799604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250899|NCT00799604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92250900|NCT00799604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250901|NCT01259063|Gemcitabine|gemcitabine|mesh-list
92250903|NCT01259063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92250904|NCT01259063|Antimetabolites|antimetabolites|mesh-ancestor
92250905|NCT01259063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250906|NCT01259063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250907|NCT01259063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92250908|NCT01259063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92250909|NCT01259063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250910|NCT01259063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92250911|NCT01259063|Immunologic Factors|immunologic factors|mesh-ancestor
92250912|NCT01259063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250913|NCT04383548|Immunoglobulins|immunoglobulins|mesh-list
92250914|NCT04383548|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92250915|NCT04383548|Antibodies|antibodies|mesh-list
92250916|NCT04383548|Immunologic Factors|immunologic factors|mesh-ancestor
92250918|NCT01313897|Bortezomib|bortezomib|mesh-list
92250919|NCT01313897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250920|NCT01341977|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92250921|NCT04351763|Amiodarone|amiodarone|mesh-list
92250922|NCT04351763|Verapamil|verapamil|mesh-list
92250923|NCT04351763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92250924|NCT04351763|Vasodilator Agents|vasodilator agents|mesh-ancestor
92250925|NCT04351763|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92250926|NCT04351763|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92250927|NCT04351763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250928|NCT04351763|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92250929|NCT04351763|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92250930|NCT04351763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92250931|NCT04351763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250932|NCT04351763|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92250933|NCT04351763|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92250934|NCT04351763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92250935|NCT04351763|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92250936|NCT04351763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92250937|NCT04351763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250938|NCT00801398|Oxymorphone|oxymorphone|mesh-list
92250939|NCT00801398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92250940|NCT00801398|Narcotics|narcotics|mesh-ancestor
92250941|NCT00801398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250942|NCT00801398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250943|NCT00801398|Analgesics|analgesics|mesh-ancestor
92250944|NCT00801398|Sensory System Agents|sensory system agents|mesh-ancestor
92250945|NCT00801398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250946|NCT00801398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92250947|NCT01342523|Nicotine|nicotine|mesh-list
92250948|NCT01342523|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92250949|NCT01342523|Autonomic Agents|autonomic agents|mesh-ancestor
92250950|NCT01342523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250951|NCT01342523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250952|NCT01342523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92250953|NCT01342523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92250954|NCT01342523|Cholinergic Agents|cholinergic agents|mesh-ancestor
92250955|NCT01342523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250956|NCT01342523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250957|NCT01342757|Temozolomide|temozolomide|mesh-list
92250958|NCT01342757|Vorinostat|vorinostat|mesh-list
92250959|NCT01342757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92250960|NCT01342757|Alkylating Agents|alkylating agents|mesh-ancestor
92250961|NCT01342757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250962|NCT01342757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250963|NCT01342757|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92250964|NCT01342757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92250965|NCT02199743|Haloperidol|haloperidol|mesh-list
92250966|NCT02199743|Haloperidol decanoate|haloperidol decanoate|mesh-list
92250967|NCT02199743|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92250968|NCT02199743|Perphenazine|perphenazine|mesh-list
92250969|NCT02199743|Antiemetics|antiemetics|mesh-ancestor
92250970|NCT02199743|Autonomic Agents|autonomic agents|mesh-ancestor
92250971|NCT02199743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92250972|NCT02199743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92250973|NCT02199743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92250974|NCT02199743|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92250975|NCT02199743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92250976|NCT02199743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92250977|NCT02199743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92250978|NCT02199743|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92250979|NCT02199743|Dopamine Agents|dopamine agents|mesh-ancestor
92250980|NCT02199743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92250981|NCT02199743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92250982|NCT02199743|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92250983|NCT02199743|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92250984|NCT02199743|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92250985|NCT02199743|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92250986|NCT02199743|Adrenergic Agents|adrenergic agents|mesh-ancestor
92250987|NCT02199743|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92250988|NCT02199743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92250989|NCT02199743|Serotonin Agents|serotonin agents|mesh-ancestor
92250990|NCT02199743|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92250991|NCT00776594|Bevacizumab|bevacizumab|mesh-list
92250992|NCT00776594|Bicalutamide|bicalutamide|mesh-list
92250993|NCT00776594|Androgens|androgens|mesh-list
92250994|NCT00776594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92250995|NCT00776594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92250996|NCT00776594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92250997|NCT00776594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92250998|NCT00776594|Growth Substances|growth substances|mesh-ancestor
92250999|NCT00776594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251000|NCT00776594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92251001|NCT00776594|Hormones|hormones|mesh-ancestor
92251002|NCT00776594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251003|NCT00776594|Androgen Antagonists|androgen antagonists|mesh-ancestor
92251004|NCT00776594|Hormone Antagonists|hormone antagonists|mesh-ancestor
92251005|NCT00777062|Naltrexone|naltrexone|mesh-list
92251006|NCT00777062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92251007|NCT00777062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92251008|NCT00777062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251009|NCT00777062|Sensory System Agents|sensory system agents|mesh-ancestor
92251010|NCT00777062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251011|NCT02193347|Temozolomide|temozolomide|mesh-list
92251012|NCT02193347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92251013|NCT02193347|Alkylating Agents|alkylating agents|mesh-ancestor
92251014|NCT02193347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251015|NCT02193347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251016|NCT01318577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92251017|NCT01318967|Furosemide|furosemide|mesh-list
92251018|NCT01318967|Diuretics|diuretics|mesh-ancestor
92251019|NCT01318967|Natriuretic Agents|natriuretic agents|mesh-ancestor
92251020|NCT01318967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251021|NCT01318967|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92251022|NCT01318967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251023|NCT01318967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251024|NCT01319045|Iloprost|iloprost|mesh-list
92251025|NCT01319045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92251026|NCT01319045|Vasodilator Agents|vasodilator agents|mesh-ancestor
92251027|NCT01348607|Methylphenidate|methylphenidate|mesh-list
92251028|NCT01348607|Modafinil|modafinil|mesh-list
92251029|NCT01348607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92251030|NCT01348607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251031|NCT01348607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92251032|NCT01348607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92251033|NCT01348607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251034|NCT01348607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251035|NCT01348607|Dopamine Agents|dopamine agents|mesh-ancestor
92251036|NCT01348607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251037|NCT01348607|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92251038|NCT01348607|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92251039|NCT01348607|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92251040|NCT01268111|Ergocalciferols|ergocalciferols|mesh-list
92251041|NCT01268111|Vitamin D|vitamin d|mesh-list
92251042|NCT01268111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251043|NCT01268111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251044|NCT01268111|Vitamins|vitamins|mesh-ancestor
92251045|NCT01268111|Micronutrients|micronutrients|mesh-ancestor
92251046|NCT01268111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92251047|NCT01349231|Ketamine|ketamine|mesh-list
92251048|NCT01349231|Analgesics|analgesics|mesh-ancestor
92251049|NCT01349231|Sensory System Agents|sensory system agents|mesh-ancestor
92251050|NCT01349231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251051|NCT01349231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251052|NCT01349231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92251053|NCT01349231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92251054|NCT01349231|Anesthetics, General|anesthetics, general|mesh-ancestor
92251055|NCT01349231|Anesthetics|anesthetics|mesh-ancestor
92251056|NCT01349231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251057|NCT01349231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92251058|NCT01349231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92251059|NCT01349231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251060|NCT01349231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251061|NCT01350245|Mycophenolic Acid|mycophenolic acid|mesh-list
92251062|NCT01350245|Cyclophosphamide|cyclophosphamide|mesh-list
92251063|NCT01350245|Tacrolimus|tacrolimus|mesh-list
92251064|NCT01350245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92251065|NCT01350245|Immunologic Factors|immunologic factors|mesh-ancestor
92251066|NCT01350245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251067|NCT01350245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251068|NCT01350245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92251069|NCT01350245|Alkylating Agents|alkylating agents|mesh-ancestor
92251070|NCT01350245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251071|NCT01350245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251072|NCT01350245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92251073|NCT01350245|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92251074|NCT01350245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251075|NCT01350245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92251076|NCT01350245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92251077|NCT01350245|Antitubercular Agents|antitubercular agents|mesh-ancestor
92251078|NCT01350245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92251079|NCT01350245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251080|NCT01321151|Resveratrol|resveratrol|mesh-list
92251081|NCT01321151|Antioxidants|antioxidants|mesh-ancestor
92251082|NCT01321151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251083|NCT01321151|Protective Agents|protective agents|mesh-ancestor
92251084|NCT01321151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251085|NCT01321151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251086|NCT01321151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92251087|NCT01350947|Azacitidine|azacitidine|mesh-list
92251088|NCT01350947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92251089|NCT01350947|Antimetabolites|antimetabolites|mesh-ancestor
92251090|NCT01350947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251091|NCT01350947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251092|NCT01350947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251094|NCT01269047|Pramlintide|pramlintide|mesh-list
92251095|NCT01269047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251096|NCT01269047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251097|NCT01269047|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92251098|NCT01269047|Incretins|incretins|mesh-ancestor
92251099|NCT01269047|Hormones|hormones|mesh-ancestor
92251100|NCT01269047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251101|NCT03800264|Hydrocortisone|hydrocortisone|mesh-list
92251102|NCT03800264|Bisoprolol|bisoprolol|mesh-list
92251103|NCT03800264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251104|NCT03800264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92251105|NCT03800264|Sympatholytics|sympatholytics|mesh-ancestor
92251106|NCT03800264|Autonomic Agents|autonomic agents|mesh-ancestor
92251107|NCT03800264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251108|NCT03800264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251109|NCT03800264|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92251110|NCT03800264|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92251111|NCT03800264|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92251113|NCT03800264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251114|NCT03800264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251115|NCT05287724|Acetylcysteine|acetylcysteine|mesh-list
92251116|NCT05287724|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92251117|NCT05287724|Antiviral Agents|antiviral agents|mesh-ancestor
92251118|NCT05287724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251119|NCT05287724|Expectorants|expectorants|mesh-ancestor
92251120|NCT05287724|Respiratory System Agents|respiratory system agents|mesh-ancestor
92251121|NCT05287724|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92251123|NCT05287724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251124|NCT05287724|Protective Agents|protective agents|mesh-ancestor
92251125|NCT05287724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251126|NCT05287724|Antidotes|antidotes|mesh-ancestor
92251127|NCT01321541|Rituximab|rituximab|mesh-list
92251128|NCT01321541|Gemcitabine|gemcitabine|mesh-list
92251129|NCT01321541|Pixantrone|pixantrone|mesh-list
92251130|NCT01321541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92251131|NCT01321541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251132|NCT01321541|Immunologic Factors|immunologic factors|mesh-ancestor
92251133|NCT01321541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251134|NCT01321541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251135|NCT01321541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92251136|NCT01321541|Antimetabolites|antimetabolites|mesh-ancestor
92251137|NCT01321541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251138|NCT01321541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92251139|NCT01321541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92251140|NCT01321541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251141|NCT03801434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92251142|NCT03801434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92251143|NCT03801434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251144|NCT03801434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251145|NCT05201612|Pembrolizumab|pembrolizumab|mesh-list
92251146|NCT05201612|Olaparib|olaparib|mesh-list
92251147|NCT05201612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92251148|NCT05201612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251149|NCT05201612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92251150|NCT05201612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251151|NCT05201612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92251152|NCT05201612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251153|NCT01271855|Glycerol|glycerol|mesh-list
92251154|NCT01271855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251155|NCT01271855|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92251156|NCT01271855|Protective Agents|protective agents|mesh-ancestor
92251157|NCT04865978|Warfarin|warfarin|mesh-list
92251158|NCT04865978|Apixaban|apixaban|mesh-list
92251159|NCT04865978|Anticoagulants|anticoagulants|mesh-ancestor
92251160|NCT04865978|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92251161|NCT04865978|Antithrombins|antithrombins|mesh-ancestor
92251162|NCT04865978|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92251163|NCT04865978|Protease Inhibitors|protease inhibitors|mesh-ancestor
92251164|NCT04865978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251165|NCT04865978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251166|NCT01354145|Celecoxib|celecoxib|mesh-list
92251167|NCT01354145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92251168|NCT01354145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251169|NCT01354145|Analgesics|analgesics|mesh-ancestor
92251170|NCT01354145|Sensory System Agents|sensory system agents|mesh-ancestor
92251171|NCT01354145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251172|NCT01354145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251173|NCT01354145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251174|NCT01354145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251175|NCT01354145|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92251176|NCT01354145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92251177|NCT01354145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251178|NCT01354145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251179|NCT05168462|Norepinephrine|norepinephrine|mesh-list
92251180|NCT05168462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92251181|NCT05168462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92251182|NCT05168462|Adrenergic Agents|adrenergic agents|mesh-ancestor
92251183|NCT05168462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251184|NCT05168462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251185|NCT05168462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251186|NCT05168462|Sympathomimetics|sympathomimetics|mesh-ancestor
92251187|NCT05168462|Autonomic Agents|autonomic agents|mesh-ancestor
92251188|NCT05168462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251189|NCT05168462|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92251190|NCT02196857|Azacitidine|azacitidine|mesh-list
92251191|NCT02196857|Sorafenib|sorafenib|mesh-list
91941616|NCT05944146|Dobutamine|dobutamine|mesh-list
92251192|NCT02196857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92251193|NCT02196857|Antimetabolites|antimetabolites|mesh-ancestor
92251194|NCT02196857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251195|NCT02196857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251196|NCT02196857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251197|NCT02196857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92251198|NCT01272245|Cytarabine|cytarabine|mesh-list
92251199|NCT01272245|Homoharringtonine|homoharringtonine|mesh-list
92251200|NCT01272245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92251201|NCT01272245|Antimetabolites|antimetabolites|mesh-ancestor
92251202|NCT01272245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251203|NCT01272245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251204|NCT01272245|Antiviral Agents|antiviral agents|mesh-ancestor
92251205|NCT01272245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251206|NCT01272245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92251207|NCT01272245|Immunologic Factors|immunologic factors|mesh-ancestor
92251208|NCT01272245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251209|NCT01272245|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92251210|NCT01272245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92251211|NCT01272245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251212|NCT00802100|Metformin|metformin|mesh-list
92251213|NCT00802100|Benztropine|benztropine|mesh-list
92251214|NCT00802100|Olanzapine|olanzapine|mesh-list
92251215|NCT00802100|Aripiprazole|aripiprazole|mesh-list
92251216|NCT00802100|Perphenazine|perphenazine|mesh-list
92251217|NCT00802100|Simvastatin|simvastatin|mesh-list
92251218|NCT00802100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251219|NCT00802100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251220|NCT00802100|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92251221|NCT00802100|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92251222|NCT00802100|Antimetabolites|antimetabolites|mesh-ancestor
92251223|NCT00802100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251224|NCT00802100|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92251225|NCT00802100|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92251226|NCT00802100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251227|NCT00802100|Antiemetics|antiemetics|mesh-ancestor
92251228|NCT00802100|Autonomic Agents|autonomic agents|mesh-ancestor
92251229|NCT00802100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251230|NCT00802100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251231|NCT00802100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92251232|NCT00802100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92251233|NCT00802100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251234|NCT00802100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92251235|NCT00802100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92251236|NCT00802100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92251237|NCT00802100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251238|NCT00802100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251239|NCT00802100|Serotonin Agents|serotonin agents|mesh-ancestor
92251240|NCT00802100|Antidepressive Agents|antidepressive agents|mesh-ancestor
92251241|NCT00802100|Dopamine Agonists|dopamine agonists|mesh-ancestor
92251242|NCT00802100|Dopamine Agents|dopamine agents|mesh-ancestor
92251243|NCT00802100|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92251244|NCT00802100|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92251245|NCT00802100|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92251246|NCT00802100|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92251247|NCT00802100|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92251248|NCT00802100|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92251249|NCT00802100|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92251250|NCT00802100|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92251251|NCT00802100|Parasympatholytics|parasympatholytics|mesh-ancestor
92251252|NCT00802100|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92251253|NCT00802100|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92251254|NCT00802100|Cholinergic Agents|cholinergic agents|mesh-ancestor
92251255|NCT00802100|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92251256|NCT00809276|Cyclophosphamide|cyclophosphamide|mesh-list
92251259|NCT00809276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92251260|NCT00809276|Immunologic Factors|immunologic factors|mesh-ancestor
92251261|NCT00809276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251262|NCT00809276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251263|NCT00809276|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92251264|NCT00809276|Alkylating Agents|alkylating agents|mesh-ancestor
92342348|NCT00003215|Alkylating Agents|alkylating agents|mesh-ancestor
92251265|NCT00809276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251266|NCT00809276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117537|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251267|NCT00809276|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92251269|NCT00802412|Anticonvulsants|anticonvulsants|mesh-ancestor
92251270|NCT00802412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251271|NCT00802412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251272|NCT01355705|Aspirin|aspirin|mesh-list
92251273|NCT01355705|Dexamethasone|dexamethasone|mesh-list
92251274|NCT01355705|Dexamethasone acetate|dexamethasone acetate|mesh-list
92251275|NCT01355705|Lenalidomide|lenalidomide|mesh-list
92251276|NCT01355705|Amrubicin|amrubicin|mesh-list
92251277|NCT01355705|BB 1101|bb 1101|mesh-list
92251278|NCT01355705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251279|NCT01355705|Antiemetics|antiemetics|mesh-ancestor
92251280|NCT01355705|Autonomic Agents|autonomic agents|mesh-ancestor
92251281|NCT01355705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251282|NCT01355705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251283|NCT01355705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251284|NCT01355705|Glucocorticoids|glucocorticoids|mesh-ancestor
92251285|NCT01355705|Hormones|hormones|mesh-ancestor
92251286|NCT01355705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251287|NCT01355705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92251288|NCT01355705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251289|NCT01355705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92251290|NCT01355705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251291|NCT01355705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251292|NCT01355705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92251293|NCT01355705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251294|NCT01355705|Analgesics|analgesics|mesh-ancestor
92251295|NCT01355705|Sensory System Agents|sensory system agents|mesh-ancestor
92251296|NCT01355705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251297|NCT01355705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92251298|NCT01355705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92251299|NCT01355705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92251300|NCT01355705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92251301|NCT01355705|Antipyretics|antipyretics|mesh-ancestor
92251302|NCT01355705|Immunologic Factors|immunologic factors|mesh-ancestor
92251303|NCT01355705|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92251304|NCT01355705|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92251305|NCT01355705|Growth Substances|growth substances|mesh-ancestor
92251306|NCT01355705|Growth Inhibitors|growth inhibitors|mesh-ancestor
92251307|NCT01327157|Salicylic Acid|salicylic acid|mesh-list
92251308|NCT01327157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251309|NCT01327157|Antifungal Agents|antifungal agents|mesh-ancestor
92251310|NCT01327157|Keratolytic Agents|keratolytic agents|mesh-ancestor
92251311|NCT01327157|Dermatologic Agents|dermatologic agents|mesh-ancestor
92251312|NCT00802880|Dacarbazine|dacarbazine|mesh-list
92251313|NCT00802880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92251314|NCT00802880|Alkylating Agents|alkylating agents|mesh-ancestor
92251315|NCT00802880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251316|NCT00802880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251317|NCT05118854|Cisplatin|cisplatin|mesh-list
92251318|NCT05118854|Carboplatin|carboplatin|mesh-list
92251319|NCT05118854|Pemetrexed|pemetrexed|mesh-list
92251320|NCT05118854|Sotorasib|sotorasib|mesh-list
92251321|NCT05118854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251322|NCT05118854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251323|NCT05118854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251324|NCT05118854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92251325|NCT05118854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92251326|NCT05118854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92251327|NCT05118854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92251328|NCT03839888|Atropine|atropine|mesh-list
92251329|NCT03839888|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92251330|NCT03839888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92251331|NCT03839888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92251332|NCT03839888|Autonomic Agents|autonomic agents|mesh-ancestor
92251333|NCT03839888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251334|NCT03839888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251335|NCT03839888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92342355|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251336|NCT03839888|Respiratory System Agents|respiratory system agents|mesh-ancestor
92251338|NCT03839888|Parasympatholytics|parasympatholytics|mesh-ancestor
92251339|NCT03839888|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92251340|NCT03839888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92251341|NCT03839888|Cholinergic Agents|cholinergic agents|mesh-ancestor
92251342|NCT03839888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251343|NCT03839888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251344|NCT05089526|Lidocaine|lidocaine|mesh-list
92251345|NCT05089526|Fentanyl|fentanyl|mesh-list
92251346|NCT05089526|Dexmedetomidine|dexmedetomidine|mesh-list
92251347|NCT05089526|Ketamine|ketamine|mesh-list
92251348|NCT05089526|Anesthetics, Local|anesthetics, local|mesh-ancestor
92251349|NCT05089526|Anesthetics|anesthetics|mesh-ancestor
92251350|NCT05089526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251351|NCT05089526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251352|NCT05089526|Sensory System Agents|sensory system agents|mesh-ancestor
92251353|NCT05089526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251354|NCT05089526|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92251355|NCT05089526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92251356|NCT05089526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92251357|NCT05089526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251358|NCT05089526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251359|NCT05089526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92251360|NCT05089526|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251361|NCT05089526|Analgesics|analgesics|mesh-ancestor
92251362|NCT05089526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92251363|NCT05089526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92251364|NCT05089526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92251365|NCT05089526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92251366|NCT05089526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251367|NCT05089526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92251368|NCT05089526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92251369|NCT05089526|Anesthetics, General|anesthetics, general|mesh-ancestor
92251370|NCT05089526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92251371|NCT05089526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92251372|NCT05089526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92251373|NCT05089526|Narcotics|narcotics|mesh-ancestor
92251374|NCT05089526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92251375|NCT04382846|Nitazoxanide|nitazoxanide|mesh-list
92251376|NCT04382846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92251377|NCT04382846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251378|NCT05032820|Lenalidomide|lenalidomide|mesh-list
92251379|NCT05032820|Immunologic Factors|immunologic factors|mesh-ancestor
92251380|NCT05032820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251381|NCT05032820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92251382|NCT05032820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92251383|NCT05032820|Growth Substances|growth substances|mesh-ancestor
92251384|NCT05032820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92251385|NCT05032820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251386|NCT01274897|Lactitol|lactitol|mesh-list
92251387|NCT01274897|Cathartics|cathartics|mesh-ancestor
92251388|NCT01274897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251389|NCT02323217|Isocarboxazid|isocarboxazid|mesh-list
92251390|NCT02323217|Idazoxan|idazoxan|mesh-list
92251391|NCT02323217|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92251392|NCT02323217|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92251393|NCT02323217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92251394|NCT02323217|Adrenergic Agents|adrenergic agents|mesh-ancestor
92251395|NCT02323217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251396|NCT02323217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251397|NCT02323217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251398|NCT02323217|Antidepressive Agents|antidepressive agents|mesh-ancestor
92251399|NCT02323217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92251400|NCT02323217|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92251401|NCT02323217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251402|NCT04382768|Ibuprofen|ibuprofen|mesh-list
92251403|NCT04382768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92251404|NCT04382768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251405|NCT04382768|Analgesics|analgesics|mesh-ancestor
92251406|NCT04382768|Sensory System Agents|sensory system agents|mesh-ancestor
92251407|NCT04382768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342357|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
92251408|NCT04382768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251409|NCT04382768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251410|NCT04382768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251411|NCT04382768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92251412|NCT04382768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251413|NCT04382768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251414|NCT03932162|Insulin|insulin|mesh-list
92251415|NCT03932162|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92251416|NCT03932162|Mitogens|mitogens|mesh-list
92251417|NCT03932162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251418|NCT03932162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251419|NCT03932162|Mitosis Modulators|mitosis modulators|mesh-ancestor
92251420|NCT03932162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251421|NCT04155164|Metformin|metformin|mesh-list
92251422|NCT04155164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251423|NCT04155164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251424|NCT00806078|Quinine|quinine|mesh-list
92251425|NCT00806078|Antimalarials|antimalarials|mesh-ancestor
92251426|NCT00806078|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92251427|NCT00806078|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92251428|NCT00806078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251429|NCT00806078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92251430|NCT00806078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251431|NCT00806078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92251432|NCT00806078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251433|NCT00806078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251434|NCT00806078|Analgesics|analgesics|mesh-ancestor
92251435|NCT00806078|Sensory System Agents|sensory system agents|mesh-ancestor
92251436|NCT00806234|Metformin|metformin|mesh-list
92251437|NCT00806234|Olanzapine|olanzapine|mesh-list
92251438|NCT00806234|Risperidone|risperidone|mesh-list
92251439|NCT00806234|Aripiprazole|aripiprazole|mesh-list
92251440|NCT00806234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92251441|NCT00806234|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92251442|NCT00806234|Ziprasidone|ziprasidone|mesh-list
92251443|NCT00806234|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92251444|NCT00806234|Asenapine|asenapine|mesh-list
92251445|NCT00806234|Iloperidone|iloperidone|mesh-list
92251446|NCT00806234|Perphenazine|perphenazine|mesh-list
92251447|NCT00806234|Fluoxetine|fluoxetine|mesh-list
92251448|NCT00806234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251449|NCT00806234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251450|NCT00806234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92251451|NCT00806234|Serotonin Agents|serotonin agents|mesh-ancestor
92251452|NCT00806234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251453|NCT00806234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251454|NCT00806234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92251455|NCT00806234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92251456|NCT00806234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251457|NCT00806234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92251458|NCT00806234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92251459|NCT00806234|Dopamine Agents|dopamine agents|mesh-ancestor
92251461|NCT00806234|Autonomic Agents|autonomic agents|mesh-ancestor
92251462|NCT00806234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251463|NCT00806234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251464|NCT00806234|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92251465|NCT00806234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92251466|NCT00806234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251467|NCT00806234|Antidepressive Agents|antidepressive agents|mesh-ancestor
92251468|NCT00806234|Dopamine Agonists|dopamine agonists|mesh-ancestor
92251469|NCT00806234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92251470|NCT00806234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92251471|NCT00806234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92251472|NCT00806234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92251473|NCT00806234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92251474|NCT00806234|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92251475|NCT00806234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92251476|NCT00806234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251477|NCT00806234|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92251478|NCT00806234|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92251479|NCT00806234|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92251480|NCT00806234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92251481|NCT04493138|Azacitidine|azacitidine|mesh-list
92251482|NCT04493138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92251484|NCT04493138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251485|NCT04493138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251486|NCT04493138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251487|NCT01275365|Methyltestosterone|methyltestosterone|mesh-list
92251488|NCT01275365|Testosterone|testosterone|mesh-list
92251489|NCT01275365|Testosterone undecanoate|testosterone undecanoate|mesh-list
92251490|NCT01275365|Testosterone enanthate|testosterone enanthate|mesh-list
92251491|NCT01275365|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92251492|NCT01275365|Androgens|androgens|mesh-ancestor
92251493|NCT01275365|Hormones|hormones|mesh-ancestor
92251494|NCT01275365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251495|NCT01275365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251496|NCT01275365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92251497|NCT01275365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251498|NCT01275365|Anabolic Agents|anabolic agents|mesh-ancestor
92251499|NCT00811850|Timolol|timolol|mesh-list
92251500|NCT00811850|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92251501|NCT00811850|Dorzolamide|dorzolamide|mesh-list
92251502|NCT00811850|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92251503|NCT00811850|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92251504|NCT00811850|Maleic acid|maleic acid|mesh-list
92251505|NCT00811850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251506|NCT00811850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251507|NCT00811850|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92251508|NCT00811850|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92251509|NCT00811850|Adrenergic Agents|adrenergic agents|mesh-ancestor
92251510|NCT00811850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251511|NCT00811850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251512|NCT00811850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92251513|NCT00811850|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92251514|NCT00811850|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92251515|NCT00811850|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92251516|NCT00811850|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92251517|NCT00811850|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92251518|NCT03678506|Apixaban|apixaban|mesh-list
92251519|NCT03678506|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92251520|NCT03678506|Antithrombins|antithrombins|mesh-ancestor
92251521|NCT03678506|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92251522|NCT03678506|Protease Inhibitors|protease inhibitors|mesh-ancestor
92251523|NCT03678506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251524|NCT03678506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251525|NCT03678506|Anticoagulants|anticoagulants|mesh-ancestor
92251526|NCT00844298|Cytarabine|cytarabine|mesh-list
92251527|NCT00844298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92251528|NCT00844298|Antimetabolites|antimetabolites|mesh-ancestor
92251529|NCT00844298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251530|NCT00844298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251531|NCT00844298|Antiviral Agents|antiviral agents|mesh-ancestor
92251532|NCT00844298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251533|NCT00844298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92251534|NCT00844298|Immunologic Factors|immunologic factors|mesh-ancestor
92251535|NCT00844298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251536|NCT01329185|Valganciclovir|valganciclovir|mesh-list
92251537|NCT01329185|Antiviral Agents|antiviral agents|mesh-ancestor
92251538|NCT01329185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251539|NCT01276301|Empagliflozin|empagliflozin|mesh-list
92251541|NCT01276301|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92251542|NCT01276301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251543|NCT01276301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251544|NCT01276301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251545|NCT01276301|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92251546|NCT01276301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92251547|NCT01276301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251548|NCT01276301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251549|NCT01276301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92251550|NCT00845000|Levodopa|levodopa|mesh-list
92251551|NCT00845000|Carbidopa|carbidopa|mesh-list
92251552|NCT00845000|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92251553|NCT00845000|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92251554|NCT00845000|Dopamine Agents|dopamine agents|mesh-ancestor
92251555|NCT00845000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251556|NCT00845000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251557|NCT00845000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251558|NCT00845000|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92251559|NCT00845000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251560|NCT01330043|Bupropion|bupropion|mesh-list
92251561|NCT01330043|Nicotine|nicotine|mesh-list
92251562|NCT01330043|Varenicline|varenicline|mesh-list
92251563|NCT01330043|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92251564|NCT01330043|Autonomic Agents|autonomic agents|mesh-ancestor
92251565|NCT01330043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251566|NCT01330043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251567|NCT01330043|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92251568|NCT01330043|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92251569|NCT01330043|Cholinergic Agents|cholinergic agents|mesh-ancestor
92251570|NCT01330043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251571|NCT01330043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251572|NCT01330043|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92251573|NCT01330043|Antidepressive Agents|antidepressive agents|mesh-ancestor
92251574|NCT01330043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92251575|NCT01330043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92251576|NCT01330043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92251577|NCT01330043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251578|NCT01330043|Dopamine Agents|dopamine agents|mesh-ancestor
92251579|NCT01330043|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92251580|NCT01330043|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92251581|NCT01330043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251582|NCT01330355|Gatifloxacin|gatifloxacin|mesh-list
92251583|NCT01330355|Besifloxacin|besifloxacin|mesh-list
92251584|NCT01330355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92251585|NCT01330355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251586|NCT01330355|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92251587|NCT01330355|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92251588|NCT01330355|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92251589|NCT01330355|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92251590|NCT01330355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251591|NCT01330355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251592|NCT01330355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251593|NCT02193815|Calcitriol|calcitriol|mesh-list
92251594|NCT02193815|Calcipotriene|calcipotriene|mesh-list
92251595|NCT02193815|Tofacitinib|tofacitinib|mesh-list
92251596|NCT02193815|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92251597|NCT02193815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92251598|NCT02193815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251599|NCT02193815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251600|NCT02193815|Dermatologic Agents|dermatologic agents|mesh-ancestor
92251601|NCT02193815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251602|NCT02193815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251603|NCT02193815|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92251604|NCT02193815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251605|NCT02193815|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92251607|NCT02193815|Micronutrients|micronutrients|mesh-ancestor
92251608|NCT02193815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92251609|NCT01277081|Acetaminophen|acetaminophen|mesh-list
92251610|NCT01277081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92342385|NCT00003215|Analgesics|analgesics|mesh-ancestor
92251611|NCT01277081|Analgesics|analgesics|mesh-ancestor
92251612|NCT01277081|Sensory System Agents|sensory system agents|mesh-ancestor
92251613|NCT01277081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251614|NCT01277081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251615|NCT01277081|Antipyretics|antipyretics|mesh-ancestor
92251616|NCT01361633|Cycloserine|cycloserine|mesh-list
92251617|NCT01361633|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92251618|NCT01361633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251619|NCT01361633|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92251620|NCT01361633|Antitubercular Agents|antitubercular agents|mesh-ancestor
92251621|NCT01361633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92251622|NCT01361633|Antimetabolites|antimetabolites|mesh-ancestor
92251623|NCT01361633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251624|NCT01331213|Pregabalin|pregabalin|mesh-list
92251625|NCT01331213|Analgesics|analgesics|mesh-ancestor
92251626|NCT01331213|Sensory System Agents|sensory system agents|mesh-ancestor
92251627|NCT01331213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251628|NCT01331213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251629|NCT01331213|Anticonvulsants|anticonvulsants|mesh-ancestor
92251630|NCT01331213|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92251631|NCT01331213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251632|NCT01331213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251633|NCT01331213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251635|NCT01331213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92251636|NCT01331213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251637|NCT01331213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92251638|NCT01332071|Metformin|metformin|mesh-list
92251639|NCT01332071|Rosiglitazone|rosiglitazone|mesh-list
92251640|NCT01332071|Maleic acid|maleic acid|mesh-list
92251641|NCT01332071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251642|NCT01332071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251643|NCT01332071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251644|NCT01332071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251645|NCT01277159|Dexamethasone|dexamethasone|mesh-list
92251646|NCT01277159|Dexamethasone acetate|dexamethasone acetate|mesh-list
92251647|NCT01277159|Buprenorphine|buprenorphine|mesh-list
92251648|NCT01277159|BB 1101|bb 1101|mesh-list
92251649|NCT01277159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251650|NCT01277159|Antiemetics|antiemetics|mesh-ancestor
92251651|NCT01277159|Autonomic Agents|autonomic agents|mesh-ancestor
92251652|NCT01277159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251653|NCT01277159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251654|NCT01277159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251655|NCT01277159|Glucocorticoids|glucocorticoids|mesh-ancestor
92251656|NCT01277159|Hormones|hormones|mesh-ancestor
92251657|NCT01277159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251658|NCT01277159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92251659|NCT01277159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251660|NCT01277159|Protease Inhibitors|protease inhibitors|mesh-ancestor
92251661|NCT01277159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251662|NCT01277159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251663|NCT01277159|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92251664|NCT01277159|Narcotics|narcotics|mesh-ancestor
92251665|NCT01277159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251666|NCT01277159|Analgesics|analgesics|mesh-ancestor
92251667|NCT01277159|Sensory System Agents|sensory system agents|mesh-ancestor
92251668|NCT01277159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92251669|NCT01362959|Nicotine|nicotine|mesh-list
92251670|NCT01362959|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92251671|NCT01362959|Autonomic Agents|autonomic agents|mesh-ancestor
92251672|NCT01362959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251673|NCT01362959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251674|NCT01362959|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92251675|NCT01362959|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92251676|NCT01362959|Cholinergic Agents|cholinergic agents|mesh-ancestor
92251677|NCT01362959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251678|NCT01362959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251679|NCT01332461|Fluticasone|fluticasone|mesh-list
92251680|NCT01332461|Xhance|xhance|mesh-list
92251681|NCT01332461|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92251682|NCT01332461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251683|NCT01332461|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92251684|NCT01332461|Autonomic Agents|autonomic agents|mesh-ancestor
92251685|NCT01332461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251686|NCT01332461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251687|NCT01332461|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92251688|NCT01332461|Respiratory System Agents|respiratory system agents|mesh-ancestor
92251689|NCT01332461|Dermatologic Agents|dermatologic agents|mesh-ancestor
92251690|NCT01332461|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92251691|NCT01332461|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92251692|NCT01332461|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92251693|NCT01332461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92251694|NCT01332461|Adrenergic Agents|adrenergic agents|mesh-ancestor
92251695|NCT01332461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251696|NCT01332461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251698|NCT01279187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251699|NCT01279187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251700|NCT01279187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92251701|NCT01280123|Pioglitazone|pioglitazone|mesh-list
92251702|NCT01280123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92251703|NCT01280123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251704|NCT03608696|Buprenorphine|buprenorphine|mesh-list
92251705|NCT03608696|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92251706|NCT03608696|Narcotics|narcotics|mesh-ancestor
92251707|NCT03608696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251708|NCT03608696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251709|NCT03608696|Analgesics|analgesics|mesh-ancestor
92251710|NCT03608696|Sensory System Agents|sensory system agents|mesh-ancestor
92251711|NCT03608696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251712|NCT03608696|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92251713|NCT01334723|Finasteride|finasteride|mesh-list
92251714|NCT01334723|Dutasteride|dutasteride|mesh-list
92251715|NCT01334723|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
92251716|NCT01334723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92251717|NCT01334723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251718|NCT01334723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251719|NCT01334723|Hormone Antagonists|hormone antagonists|mesh-ancestor
92251720|NCT01334723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251721|NCT01334723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251722|NCT01334723|Urological Agents|urological agents|mesh-ancestor
92251723|NCT04311710|Nivolumab|nivolumab|mesh-list
92251724|NCT04311710|Ipilimumab|ipilimumab|mesh-list
92251725|NCT04311710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92251726|NCT04311710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251727|NCT04311710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92251728|NCT04311710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251729|NCT01334957|Ibuprofen|ibuprofen|mesh-list
92251730|NCT01334957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92251731|NCT01334957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251732|NCT01334957|Analgesics|analgesics|mesh-ancestor
92251733|NCT01334957|Sensory System Agents|sensory system agents|mesh-ancestor
92251734|NCT01334957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251735|NCT01334957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251736|NCT01334957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251737|NCT01334957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251738|NCT01334957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92251739|NCT01334957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251740|NCT01334957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251741|NCT01402427|Verapamil|verapamil|mesh-list
92251742|NCT01402427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92251743|NCT01402427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92251744|NCT01402427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92251745|NCT01402427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251746|NCT01402427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251747|NCT01402427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251748|NCT01402427|Vasodilator Agents|vasodilator agents|mesh-ancestor
92251749|NCT03637400|Doxycycline|doxycycline|mesh-list
92251750|NCT03637400|Trimethoprim|trimethoprim|mesh-list
92251751|NCT03637400|Sulfamethoxazole|sulfamethoxazole|mesh-list
92251752|NCT03637400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92251753|NCT03637400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251754|NCT03637400|Antimalarials|antimalarials|mesh-ancestor
92342388|NCT00003995|Irinotecan|irinotecan|mesh-list
92251755|NCT03637400|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92251756|NCT03637400|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92251757|NCT03637400|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92251758|NCT03637400|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92251759|NCT03637400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251760|NCT03637400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251761|NCT03637400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92251762|NCT03637400|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92251763|NCT03637400|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92251764|NCT01365611|Fluticasone|fluticasone|mesh-list
92251766|NCT01365611|Ketorolac|ketorolac|mesh-list
92251767|NCT01365611|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92251768|NCT01365611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251769|NCT01365611|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92251770|NCT01365611|Autonomic Agents|autonomic agents|mesh-ancestor
92251771|NCT01365611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251772|NCT01365611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251773|NCT01365611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92251774|NCT01365611|Respiratory System Agents|respiratory system agents|mesh-ancestor
92251775|NCT01365611|Dermatologic Agents|dermatologic agents|mesh-ancestor
92251776|NCT01365611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92251777|NCT01365611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92251778|NCT01365611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92251779|NCT01365611|Analgesics|analgesics|mesh-ancestor
92251780|NCT01365611|Sensory System Agents|sensory system agents|mesh-ancestor
92251781|NCT01365611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92251782|NCT01365611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92251783|NCT01365611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251784|NCT01365611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251785|NCT01472549|Ethanol|ethanol|mesh-list
92251786|NCT01472549|Chlorhexidine|chlorhexidine|mesh-list
92251787|NCT01472549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92251788|NCT01472549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251789|NCT01472549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251790|NCT01472549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251791|NCT01472549|Disinfectants|disinfectants|mesh-ancestor
92251792|NCT00852644|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92251793|NCT00852644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92251794|NCT00852644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251795|NCT01404923|Mebeverine|mebeverine|mesh-list
92251796|NCT01404923|Alverine|alverine|mesh-list
92251797|NCT01404923|Parasympatholytics|parasympatholytics|mesh-list
92251798|NCT01404923|Autonomic Agents|autonomic agents|mesh-ancestor
92251799|NCT01404923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251800|NCT01404923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251801|NCT01404923|Anticonvulsants|anticonvulsants|mesh-ancestor
92251802|NCT01368263|Letrozole|letrozole|mesh-list
92251803|NCT01368263|Anastrozole|anastrozole|mesh-list
92251804|NCT01368263|Goserelin|goserelin|mesh-list
92251805|NCT01368263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251806|NCT01368263|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92251807|NCT01368263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92251808|NCT01368263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251809|NCT01368263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251810|NCT01368263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92251811|NCT01368263|Hormone Antagonists|hormone antagonists|mesh-ancestor
92251812|NCT01368263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251813|NCT01368263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251814|NCT01368263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92251816|NCT00815360|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92251817|NCT00815360|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92251818|NCT00815360|Ranibizumab|ranibizumab|mesh-list
92251819|NCT00815360|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92251820|NCT00815360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92251821|NCT00815360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92251822|NCT00815360|Growth Substances|growth substances|mesh-ancestor
92251823|NCT00815360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251824|NCT00815360|Growth Inhibitors|growth inhibitors|mesh-ancestor
92251825|NCT00815360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251826|NCT00815360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251827|NCT00815360|Glucocorticoids|glucocorticoids|mesh-ancestor
92251829|NCT00815360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251830|NCT00815360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92251831|NCT00815360|Immunologic Factors|immunologic factors|mesh-ancestor
92251832|NCT00815360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251833|NCT00815360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251835|NCT01474109|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92251836|NCT01474109|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92251837|NCT01474109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251838|NCT01474109|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92251839|NCT01405937|Ribavirin|ribavirin|mesh-list
92251840|NCT01405937|Antimetabolites|antimetabolites|mesh-ancestor
92251841|NCT01405937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251842|NCT01405937|Antiviral Agents|antiviral agents|mesh-ancestor
92251843|NCT01405937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251844|NCT01368653|Nicotine|nicotine|mesh-list
92251845|NCT01368653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92251846|NCT01368653|Autonomic Agents|autonomic agents|mesh-ancestor
92251847|NCT01368653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251848|NCT01368653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251849|NCT01368653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92251850|NCT01368653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92251851|NCT01368653|Cholinergic Agents|cholinergic agents|mesh-ancestor
92251852|NCT01368653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251853|NCT01368653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251854|NCT01407107|Nitroglycerin|nitroglycerin|mesh-list
92251855|NCT01407107|Vasodilator Agents|vasodilator agents|mesh-ancestor
92251857|NCT01368809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92251858|NCT01368809|Narcotics|narcotics|mesh-ancestor
92251859|NCT01368809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251860|NCT01368809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251861|NCT01368809|Analgesics|analgesics|mesh-ancestor
92251862|NCT01368809|Sensory System Agents|sensory system agents|mesh-ancestor
92251863|NCT01368809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251864|NCT01368809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92251865|NCT01368809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92251866|NCT01368809|Anesthetics, General|anesthetics, general|mesh-ancestor
92251867|NCT01368809|Anesthetics|anesthetics|mesh-ancestor
92251868|NCT01369745|Prednisone|prednisone|mesh-list
92251869|NCT01369745|Prednisolone|prednisolone|mesh-list
92251870|NCT01369745|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92251871|NCT01369745|Methylprednisolone|methylprednisolone|mesh-list
92251872|NCT01369745|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92251873|NCT01369745|Prednisolone acetate|prednisolone acetate|mesh-list
92251874|NCT01369745|Dipyridamole|dipyridamole|mesh-list
92251875|NCT01369745|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92251876|NCT01369745|Prednisolone phosphate|prednisolone phosphate|mesh-list
92251877|NCT01369745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251878|NCT01369745|Glucocorticoids|glucocorticoids|mesh-ancestor
92251879|NCT01369745|Hormones|hormones|mesh-ancestor
92251880|NCT01369745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251881|NCT01369745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251882|NCT01369745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92251883|NCT01369745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251885|NCT01369745|Autonomic Agents|autonomic agents|mesh-ancestor
92251886|NCT01369745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251887|NCT01369745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251888|NCT01369745|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92251889|NCT01369745|Protective Agents|protective agents|mesh-ancestor
92251890|NCT01369745|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92251891|NCT01369745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251892|NCT01369745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251893|NCT01369745|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92251894|NCT01369745|Vasodilator Agents|vasodilator agents|mesh-ancestor
92251896|NCT01475513|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92251897|NCT01475513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92251898|NCT01475513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251899|NCT01475513|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92251900|NCT01475513|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92251901|NCT01475513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251902|NCT01475513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251903|NCT01475513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251904|NCT01475513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92251905|NCT01475513|Contraceptive Agents|contraceptive agents|mesh-ancestor
92251906|NCT01475513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92251907|NCT01475513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251908|NCT01475513|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92251909|NCT01475513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92251910|NCT01475513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92251911|NCT01407575|Buprenorphine|buprenorphine|mesh-list
92251912|NCT01407575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92251913|NCT01407575|Narcotics|narcotics|mesh-ancestor
92251914|NCT01407575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251915|NCT01407575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251916|NCT01407575|Analgesics|analgesics|mesh-ancestor
92251917|NCT01407575|Sensory System Agents|sensory system agents|mesh-ancestor
92251918|NCT01407575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251919|NCT01407575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92251920|NCT01476449|Ranibizumab|ranibizumab|mesh-list
92251921|NCT01476449|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92251922|NCT01476449|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92251923|NCT01476449|Growth Substances|growth substances|mesh-ancestor
92251924|NCT01476449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251925|NCT01476449|Growth Inhibitors|growth inhibitors|mesh-ancestor
92251926|NCT01476449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251927|NCT01370369|Testosterone|testosterone|mesh-list
92251928|NCT01370369|Androgens|androgens|mesh-ancestor
92251929|NCT01370369|Hormones|hormones|mesh-ancestor
92251930|NCT01370369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251931|NCT01370369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251932|NCT01477463|Vitamin D|vitamin d|mesh-list
92251933|NCT01477463|Ergocalciferols|ergocalciferols|mesh-list
92251934|NCT01477463|Cholecalciferol|cholecalciferol|mesh-list
92251935|NCT01477463|Vitamins|vitamins|mesh-list
92251936|NCT01477463|Micronutrients|micronutrients|mesh-ancestor
92251937|NCT01477463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251938|NCT01477463|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92251939|NCT01477463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92251940|NCT02203565|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92251941|NCT02203565|Eusol|eusol|mesh-list
92251942|NCT02203565|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92251943|NCT02203565|Disinfectants|disinfectants|mesh-ancestor
92251944|NCT02203565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251945|NCT01375127|Tofacitinib|tofacitinib|mesh-list
92251946|NCT01375127|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92251947|NCT01375127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92251948|NCT01375127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251949|NCT01375127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251950|NCT00857714|Lapatinib|lapatinib|mesh-list
92251951|NCT00857714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251952|NCT00857714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92251953|NCT00857714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342416|NCT00003593|Immunologic Factors|immunologic factors|mesh-ancestor
92251954|NCT00857714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251956|NCT00858962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92251957|NCT00858962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92251958|NCT00858962|Antiviral Agents|antiviral agents|mesh-ancestor
92251959|NCT00858962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92251960|NCT00858962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92251961|NCT00858962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92251962|NCT00858962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92251963|NCT00858962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251964|NCT01376297|Dexamethasone|dexamethasone|mesh-list
92251965|NCT01376297|Aprepitant|aprepitant|mesh-list
92251966|NCT01376297|Palonosetron|palonosetron|mesh-list
92251967|NCT01376297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92251968|NCT01376297|Antiemetics|antiemetics|mesh-ancestor
92251969|NCT01376297|Autonomic Agents|autonomic agents|mesh-ancestor
92251970|NCT01376297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251971|NCT01376297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251972|NCT01376297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92251973|NCT01376297|Glucocorticoids|glucocorticoids|mesh-ancestor
92251974|NCT01376297|Hormones|hormones|mesh-ancestor
92251975|NCT01376297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251976|NCT01376297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92251977|NCT01376297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92251978|NCT01376297|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92251979|NCT01376297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92251980|NCT01376297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92251981|NCT01376297|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92251982|NCT01376297|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92251983|NCT01376297|Serotonin Agents|serotonin agents|mesh-ancestor
92251984|NCT00859040|Pasireotide|pasireotide|mesh-list
92251985|NCT00859040|Hormones|hormones|mesh-ancestor
92251986|NCT00859040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92251987|NCT00859040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251988|NCT02669186|Fentanyl|fentanyl|mesh-list
92251989|NCT02669186|Bupivacaine|bupivacaine|mesh-list
92251990|NCT02669186|Anesthetics, Local|anesthetics, local|mesh-ancestor
92251991|NCT02669186|Anesthetics|anesthetics|mesh-ancestor
92251992|NCT02669186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92251993|NCT02669186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92251994|NCT02669186|Sensory System Agents|sensory system agents|mesh-ancestor
92251995|NCT02669186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92251996|NCT02669186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92251997|NCT02669186|Narcotics|narcotics|mesh-ancestor
92251998|NCT02669186|Analgesics|analgesics|mesh-ancestor
92251999|NCT02669186|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92252000|NCT02669186|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92252001|NCT02669186|Anesthetics, General|anesthetics, general|mesh-ancestor
92252002|NCT00859508|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92252003|NCT00859508|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92252004|NCT00859508|Estradiol|estradiol|mesh-list
92252005|NCT00859508|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92252006|NCT00859508|Estrogens|estrogens|mesh-ancestor
92252007|NCT00859508|Hormones|hormones|mesh-ancestor
92252008|NCT00859508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252009|NCT00859508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252010|NCT00859508|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92252011|NCT00859508|Contraceptive Agents|contraceptive agents|mesh-ancestor
92252012|NCT00859508|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252013|NCT00859508|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92252014|NCT01377467|Denosumab|denosumab|mesh-list
92252015|NCT01377467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92252016|NCT01377467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252017|NCT02348762|Acetylcysteine|acetylcysteine|mesh-list
92252018|NCT02348762|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92252019|NCT02348762|Glycine|glycine|mesh-list
92252020|NCT02348762|Antiviral Agents|antiviral agents|mesh-ancestor
92252021|NCT02348762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252022|NCT02348762|Expectorants|expectorants|mesh-ancestor
92252023|NCT02348762|Respiratory System Agents|respiratory system agents|mesh-ancestor
92252024|NCT02348762|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92252025|NCT02348762|Antioxidants|antioxidants|mesh-ancestor
92252026|NCT02348762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252027|NCT02348762|Protective Agents|protective agents|mesh-ancestor
92252028|NCT02348762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252030|NCT02348762|Glycine Agents|glycine agents|mesh-ancestor
92252031|NCT02348762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252032|NCT01377623|Dexmedetomidine|dexmedetomidine|mesh-list
92252033|NCT01377623|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252034|NCT01377623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252035|NCT01377623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252036|NCT01377623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252037|NCT01377623|Analgesics|analgesics|mesh-ancestor
92252038|NCT01377623|Sensory System Agents|sensory system agents|mesh-ancestor
92252039|NCT01377623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252040|NCT01377623|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92252041|NCT01377623|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92252042|NCT01377623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92252043|NCT01377623|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252044|NCT01377623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252045|NCT01377623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252046|NCT01486043|Metformin|metformin|mesh-list
92252047|NCT01486043|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92252048|NCT01486043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252049|NCT01490723|Mycophenolic Acid|mycophenolic acid|mesh-list
92252050|NCT01490723|Rituximab|rituximab|mesh-list
92252051|NCT01490723|Methotrexate|methotrexate|mesh-list
92252052|NCT01490723|Fludarabine|fludarabine|mesh-list
92252053|NCT01490723|Fludarabine phosphate|fludarabine phosphate|mesh-list
92252054|NCT01490723|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92252055|NCT01490723|Tacrolimus|tacrolimus|mesh-list
92252056|NCT01490723|Thymoglobulin|thymoglobulin|mesh-list
92252057|NCT01490723|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92252058|NCT01490723|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92252059|NCT01490723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92252060|NCT01490723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252061|NCT01490723|Immunologic Factors|immunologic factors|mesh-ancestor
92252062|NCT01490723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252063|NCT01490723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252064|NCT01490723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92252065|NCT01490723|Abortifacient Agents|abortifacient agents|mesh-ancestor
92252066|NCT01490723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252067|NCT01490723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92252068|NCT01490723|Antimetabolites|antimetabolites|mesh-ancestor
92252069|NCT01490723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252070|NCT01490723|Dermatologic Agents|dermatologic agents|mesh-ancestor
92252071|NCT01490723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252072|NCT01490723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92252073|NCT01490723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252074|NCT01490723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92252075|NCT01490723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252076|NCT01490723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92252077|NCT01490723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92252078|NCT01490723|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92252079|NCT01490723|Antitubercular Agents|antitubercular agents|mesh-ancestor
92252080|NCT01490723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252081|NCT01490723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92252082|NCT01490723|Alkylating Agents|alkylating agents|mesh-ancestor
92252083|NCT01491113|Levetiracetam|levetiracetam|mesh-list
92252084|NCT01491113|Anticonvulsants|anticonvulsants|mesh-ancestor
92252085|NCT01491113|Nootropic Agents|nootropic agents|mesh-ancestor
92252086|NCT03839498|Axitinib|axitinib|mesh-list
92252087|NCT03839498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252088|NCT03839498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252089|NCT03839498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252090|NCT03839498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252091|NCT02252432|Ketamine|ketamine|mesh-list
92252092|NCT02252432|Methadone|methadone|mesh-list
92252093|NCT02252432|Analgesics|analgesics|mesh-ancestor
92252094|NCT02252432|Sensory System Agents|sensory system agents|mesh-ancestor
92252095|NCT02252432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252096|NCT02252432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252097|NCT02252432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92252098|NCT02252432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92252099|NCT02252432|Anesthetics, General|anesthetics, general|mesh-ancestor
92252100|NCT02252432|Anesthetics|anesthetics|mesh-ancestor
92252101|NCT02252432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252102|NCT02252432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92252103|NCT02252432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92252104|NCT02252432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117693|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252105|NCT02252432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252106|NCT02252432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92252107|NCT02252432|Narcotics|narcotics|mesh-ancestor
92252108|NCT02252432|Antitussive Agents|antitussive agents|mesh-ancestor
92252109|NCT02252432|Respiratory System Agents|respiratory system agents|mesh-ancestor
92252110|NCT01492673|Cyclophosphamide|cyclophosphamide|mesh-list
92252111|NCT01492673|Bevacizumab|bevacizumab|mesh-list
92252112|NCT01492673|Topotecan|topotecan|mesh-list
92252113|NCT01492673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252114|NCT01492673|Immunologic Factors|immunologic factors|mesh-ancestor
92252115|NCT01492673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252116|NCT01492673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252117|NCT01492673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92252118|NCT01492673|Alkylating Agents|alkylating agents|mesh-ancestor
92252119|NCT01492673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252120|NCT01492673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252121|NCT01492673|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92252122|NCT01492673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92252123|NCT01492673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92252124|NCT01492673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92252125|NCT01492673|Growth Substances|growth substances|mesh-ancestor
92252127|NCT01492673|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92252128|NCT01492673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92252129|NCT01492673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252130|NCT00818324|Rebamipide|rebamipide|mesh-list
92252131|NCT00818324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92252132|NCT00818324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252133|NCT00818324|Antioxidants|antioxidants|mesh-ancestor
92252134|NCT00818324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252135|NCT00818324|Protective Agents|protective agents|mesh-ancestor
92252136|NCT00818324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252137|NCT00818324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252138|NCT01419275|Xenon|xenon|mesh-list
92252139|NCT01419275|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92252140|NCT01419275|Anesthetics, General|anesthetics, general|mesh-ancestor
92252141|NCT01419275|Anesthetics|anesthetics|mesh-ancestor
92252142|NCT01419275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252143|NCT01419275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252144|NCT02155010|Dexmedetomidine|dexmedetomidine|mesh-list
92252145|NCT02155010|Bupivacaine|bupivacaine|mesh-list
92252146|NCT02155010|Anesthetics, Local|anesthetics, local|mesh-ancestor
92252147|NCT02155010|Anesthetics|anesthetics|mesh-ancestor
92252148|NCT02155010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252149|NCT02155010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252150|NCT02155010|Sensory System Agents|sensory system agents|mesh-ancestor
92252151|NCT02155010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252152|NCT02155010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252153|NCT02155010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252154|NCT02155010|Analgesics|analgesics|mesh-ancestor
92252155|NCT02155010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92252156|NCT02155010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92252157|NCT02155010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92252158|NCT02155010|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252159|NCT02155010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252160|NCT02155010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252162|NCT01495481|Dexmedetomidine|dexmedetomidine|mesh-list
92252163|NCT01495481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252164|NCT01495481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252165|NCT01495481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252166|NCT01495481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252167|NCT01495481|Analgesics|analgesics|mesh-ancestor
92252168|NCT01495481|Sensory System Agents|sensory system agents|mesh-ancestor
92252169|NCT01495481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252170|NCT01495481|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92252171|NCT01495481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92252172|NCT01495481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92252173|NCT01495481|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252174|NCT01495481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252175|NCT01495481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252176|NCT01495481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92252177|NCT01495481|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252178|NCT01495481|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92252179|NCT01495481|Purinergic Agonists|purinergic agonists|mesh-ancestor
92252180|NCT01495481|Purinergic Agents|purinergic agents|mesh-ancestor
92252181|NCT01379183|Erythromycin|erythromycin|mesh-list
92252182|NCT01379183|Erythromycin Estolate|erythromycin estolate|mesh-list
92252183|NCT01379183|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92252184|NCT01379183|Erythromycin stearate|erythromycin stearate|mesh-list
92252185|NCT01379183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252186|NCT01379183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252187|NCT01379183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252188|NCT01379183|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92252189|NCT01379183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252190|NCT01379183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252191|NCT01380197|Morphine|morphine|mesh-list
92252192|NCT01380197|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92252193|NCT01380197|Narcotics|narcotics|mesh-ancestor
92252194|NCT01380197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252195|NCT01380197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252196|NCT01380197|Analgesics|analgesics|mesh-ancestor
92252197|NCT01380197|Sensory System Agents|sensory system agents|mesh-ancestor
92252198|NCT01380197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252199|NCT00862784|Leucovorin|leucovorin|mesh-list
92252200|NCT00862784|Folic Acid|folic acid|mesh-list
92252201|NCT00862784|Oxaliplatin|oxaliplatin|mesh-list
92252202|NCT00862784|Fluorouracil|fluorouracil|mesh-list
92252203|NCT00862784|Ramucirumab|ramucirumab|mesh-list
92252204|NCT00862784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92252205|NCT00862784|Levoleucovorin|levoleucovorin|mesh-list
92252206|NCT00862784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252207|NCT00862784|Antimetabolites|antimetabolites|mesh-ancestor
92252208|NCT00862784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252209|NCT00862784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92252210|NCT00862784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252211|NCT00862784|Immunologic Factors|immunologic factors|mesh-ancestor
92252212|NCT00862784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252213|NCT00862784|Antidotes|antidotes|mesh-ancestor
92252214|NCT00862784|Protective Agents|protective agents|mesh-ancestor
92252215|NCT00862784|Vitamin B Complex|vitamin b complex|mesh-ancestor
92252216|NCT00862784|Vitamins|vitamins|mesh-ancestor
92252217|NCT00862784|Micronutrients|micronutrients|mesh-ancestor
92252218|NCT00862784|Hematinics|hematinics|mesh-ancestor
92252219|NCT00864032|Sorafenib|sorafenib|mesh-list
92252220|NCT00864032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252221|NCT00864032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252222|NCT00864032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252223|NCT00864032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252224|NCT00820664|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92252225|NCT00820664|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92252226|NCT00820664|Estradiol|estradiol|mesh-list
92252227|NCT00820664|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92252228|NCT00820664|Estrogens|estrogens|mesh-ancestor
92252229|NCT00820664|Hormones|hormones|mesh-ancestor
92252230|NCT00820664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252231|NCT00820664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252232|NCT00820664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92342432|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
92252233|NCT00820664|Contraceptive Agents|contraceptive agents|mesh-ancestor
92252234|NCT00820664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252236|NCT01380743|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
92252237|NCT01380743|Antiviral Agents|antiviral agents|mesh-ancestor
92252238|NCT01380743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252239|NCT01380743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252240|NCT01380743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252241|NCT01419977|Dalteparin|dalteparin|mesh-list
92252242|NCT01419977|Tinzaparin|tinzaparin|mesh-list
92252243|NCT01419977|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92252244|NCT01419977|Anticoagulants|anticoagulants|mesh-ancestor
92252245|NCT01419977|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92252246|NCT01419977|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92252247|NCT01419977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252248|NCT01499147|Vidarabine|vidarabine|mesh-list
92252249|NCT01499147|Fludarabine|fludarabine|mesh-list
92252250|NCT01499147|Fludarabine phosphate|fludarabine phosphate|mesh-list
92252251|NCT01499147|Melphalan|melphalan|mesh-list
92252252|NCT01499147|Busulfan|busulfan|mesh-list
92252253|NCT01499147|Thymoglobulin|thymoglobulin|mesh-list
92252254|NCT01499147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252255|NCT01499147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92252256|NCT01499147|Antimetabolites|antimetabolites|mesh-ancestor
92252257|NCT01499147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252258|NCT01499147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252259|NCT01499147|Immunologic Factors|immunologic factors|mesh-ancestor
92252260|NCT01499147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252261|NCT01499147|Antiviral Agents|antiviral agents|mesh-ancestor
92252262|NCT01499147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252263|NCT01499147|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92252264|NCT01499147|Alkylating Agents|alkylating agents|mesh-ancestor
92252265|NCT01499147|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92252266|NCT00823082|Antithrombins|antithrombins|mesh-list
92252267|NCT00823082|Antithrombin III|antithrombin iii|mesh-list
92252268|NCT00823082|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92252269|NCT00823082|Protease Inhibitors|protease inhibitors|mesh-ancestor
92252270|NCT00823082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252271|NCT00823082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252272|NCT00823082|Anticoagulants|anticoagulants|mesh-ancestor
92252273|NCT01382303|Pentoxifylline|pentoxifylline|mesh-list
92252274|NCT01382303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92252275|NCT01382303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252276|NCT01382303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252277|NCT01382303|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92252278|NCT01382303|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92252279|NCT01382303|Protective Agents|protective agents|mesh-ancestor
92252280|NCT01382303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252281|NCT01382303|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252282|NCT01382303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92252283|NCT01382303|Antioxidants|antioxidants|mesh-ancestor
92252284|NCT05236634|Tadalafil|tadalafil|mesh-list
92252285|NCT05236634|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92252286|NCT05236634|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92252287|NCT05236634|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252288|NCT05236634|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92252289|NCT05236634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252290|NCT05236634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252291|NCT05236634|Urological Agents|urological agents|mesh-ancestor
92252292|NCT05236634|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92252293|NCT05236634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252294|NCT05236634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252295|NCT05236634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252296|NCT01422161|Botulinum Toxins|botulinum toxins|mesh-list
92252297|NCT01422161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92252298|NCT01422161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92252299|NCT01422161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92252300|NCT01422161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252301|NCT01422161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92252302|NCT01422161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252303|NCT01422161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252304|NCT01422161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92252305|NCT01422161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252306|NCT05236166|Anticonvulsants|anticonvulsants|mesh-list
92252307|NCT01502813|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92252308|NCT01502813|Nootropic Agents|nootropic agents|mesh-ancestor
92252309|NCT00865202|Tryptophan|tryptophan|mesh-list
92252310|NCT00865202|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92252311|NCT00865202|Antidepressive Agents|antidepressive agents|mesh-ancestor
92252312|NCT00865202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92252313|NCT01424033|Acetylcysteine|acetylcysteine|mesh-list
92252314|NCT01424033|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92252315|NCT01424033|Antiviral Agents|antiviral agents|mesh-ancestor
92252316|NCT01424033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252317|NCT01424033|Expectorants|expectorants|mesh-ancestor
92252318|NCT01424033|Respiratory System Agents|respiratory system agents|mesh-ancestor
92252319|NCT01424033|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92252320|NCT01424033|Antioxidants|antioxidants|mesh-ancestor
92252321|NCT01424033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252322|NCT01424033|Protective Agents|protective agents|mesh-ancestor
92252323|NCT01424033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252324|NCT01424033|Antidotes|antidotes|mesh-ancestor
92252325|NCT01503749|Lenograstim|lenograstim|mesh-list
92252326|NCT01503749|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92252327|NCT01503749|Immunologic Factors|immunologic factors|mesh-ancestor
92252328|NCT01503749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252329|NCT00867932|Eculizumab|eculizumab|mesh-list
92252330|NCT00867932|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92252331|NCT00867932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252332|NCT00867932|Immunologic Factors|immunologic factors|mesh-ancestor
92252333|NCT00867932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252334|NCT00825266|Pioglitazone|pioglitazone|mesh-list
92252335|NCT00825266|Bosentan|bosentan|mesh-list
92252336|NCT00825266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92252337|NCT00825266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252338|NCT00825266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92252339|NCT00825266|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92252340|NCT00825266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252341|NCT01385189|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92252342|NCT01385189|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92252343|NCT01385189|Immunologic Factors|immunologic factors|mesh-ancestor
92252344|NCT01385189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252345|NCT01385189|Antacids|antacids|mesh-ancestor
92252346|NCT01385189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252347|NCT01385189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252348|NCT01386983|Finasteride|finasteride|mesh-list
92252349|NCT01386983|Dutasteride|dutasteride|mesh-list
92252350|NCT01386983|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92252351|NCT01386983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92252352|NCT01386983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252353|NCT01386983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252354|NCT01386983|Hormone Antagonists|hormone antagonists|mesh-ancestor
92252355|NCT01386983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252356|NCT01386983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252357|NCT01386983|Urological Agents|urological agents|mesh-ancestor
92252358|NCT01387139|Ketamine|ketamine|mesh-list
92252359|NCT01387139|Propofol|propofol|mesh-list
92252360|NCT01387139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252361|NCT01387139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252362|NCT01387139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342466|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
92252363|NCT01387139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92252364|NCT01387139|Anesthetics, General|anesthetics, general|mesh-ancestor
92252365|NCT01387139|Anesthetics|anesthetics|mesh-ancestor
92252366|NCT01387139|Analgesics|analgesics|mesh-ancestor
92252367|NCT01387139|Sensory System Agents|sensory system agents|mesh-ancestor
92252368|NCT01387139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252369|NCT01387139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92252370|NCT01387139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92252371|NCT01387139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92252372|NCT01387139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252373|NCT01387139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252374|NCT00870896|Tiotropium Bromide|tiotropium bromide|mesh-list
92252375|NCT00870896|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92252376|NCT00870896|Autonomic Agents|autonomic agents|mesh-ancestor
92252377|NCT00870896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252378|NCT00870896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252379|NCT00870896|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92252380|NCT00870896|Respiratory System Agents|respiratory system agents|mesh-ancestor
92252381|NCT00870896|Parasympatholytics|parasympatholytics|mesh-ancestor
92252382|NCT00870896|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92252383|NCT00870896|Cholinergic Agents|cholinergic agents|mesh-ancestor
92252384|NCT00870896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252385|NCT00870896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252386|NCT00825344|Etanercept|etanercept|mesh-list
92252387|NCT00825344|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92252388|NCT00825344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252389|NCT00825344|Analgesics|analgesics|mesh-ancestor
92252390|NCT00825344|Sensory System Agents|sensory system agents|mesh-ancestor
92252391|NCT00825344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252392|NCT00825344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252393|NCT00825344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92252394|NCT00825344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252395|NCT00825344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252396|NCT00825344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252397|NCT00825344|Immunologic Factors|immunologic factors|mesh-ancestor
92252398|NCT01426763|Complement C1s|complement c1s|mesh-list
92252399|NCT01426763|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92252400|NCT01426763|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92252401|NCT01426763|Immunologic Factors|immunologic factors|mesh-ancestor
92252402|NCT01426763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252403|NCT01426763|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92252404|NCT01426763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252405|NCT00825500|Loxapine|loxapine|mesh-list
92252406|NCT00825500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92252407|NCT00825500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92252408|NCT00825500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252409|NCT00825500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252410|NCT00825500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92252411|NCT00825500|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92252412|NCT00825500|Dopamine Agents|dopamine agents|mesh-ancestor
92252413|NCT00825500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252414|NCT00825500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252415|NCT01505933|Dexmedetomidine|dexmedetomidine|mesh-list
92252416|NCT01505933|Propofol|propofol|mesh-list
92252417|NCT01505933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252418|NCT01505933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252419|NCT01505933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252420|NCT01505933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252421|NCT01505933|Analgesics|analgesics|mesh-ancestor
91934881|NCT03507127|Varenicline|varenicline|mesh-list
92252422|NCT01505933|Sensory System Agents|sensory system agents|mesh-ancestor
92252423|NCT01505933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252424|NCT01505933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92252425|NCT01505933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92252427|NCT01505933|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252428|NCT01505933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252429|NCT01505933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252430|NCT01505933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92342470|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92252431|NCT01505933|Anesthetics, General|anesthetics, general|mesh-ancestor
92252432|NCT01505933|Anesthetics|anesthetics|mesh-ancestor
92252433|NCT00825734|Sorafenib|sorafenib|mesh-list
92252434|NCT00825734|Epothilones|epothilones|mesh-list
92252435|NCT00825734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252436|NCT00825734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252437|NCT00825734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252438|NCT00825734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252439|NCT00825734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92252440|NCT00825734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92252441|NCT00825734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92252442|NCT00872534|Aspirin|aspirin|mesh-list
92252443|NCT00872534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92252444|NCT00872534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252445|NCT00872534|Analgesics|analgesics|mesh-ancestor
92252446|NCT00872534|Sensory System Agents|sensory system agents|mesh-ancestor
92252447|NCT00872534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252448|NCT00872534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252449|NCT00872534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92252450|NCT00872534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252451|NCT00872534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92252452|NCT00872534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92252453|NCT00872534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252454|NCT00872534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92252455|NCT00872534|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92252456|NCT00872534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252457|NCT00872534|Antipyretics|antipyretics|mesh-ancestor
92252458|NCT02513160|Beclomethasone|beclomethasone|mesh-list
92252459|NCT02513160|Albuterol|albuterol|mesh-list
92252460|NCT02513160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92252461|NCT02513160|Autonomic Agents|autonomic agents|mesh-ancestor
92252462|NCT02513160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252463|NCT02513160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252464|NCT02513160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92252465|NCT02513160|Respiratory System Agents|respiratory system agents|mesh-ancestor
92252466|NCT02513160|Tocolytic Agents|tocolytic agents|mesh-ancestor
92252467|NCT02513160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252468|NCT02513160|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92252469|NCT02513160|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92252470|NCT02513160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92252471|NCT02513160|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252472|NCT02513160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252473|NCT02513160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252474|NCT02513160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92252475|NCT02513160|Glucocorticoids|glucocorticoids|mesh-ancestor
92252476|NCT02513160|Hormones|hormones|mesh-ancestor
92252477|NCT02513160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252478|NCT01507103|Cyclophosphamide|cyclophosphamide|mesh-list
92252479|NCT01507103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252480|NCT01507103|Immunologic Factors|immunologic factors|mesh-ancestor
92252481|NCT01507103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342476|NCT00004001|Tubulin Modulators|tubulin modulators|mesh-ancestor
92252482|NCT01507103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252483|NCT01507103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92252484|NCT01507103|Alkylating Agents|alkylating agents|mesh-ancestor
92252485|NCT01507103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252486|NCT01507103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252487|NCT01507103|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92252488|NCT02480010|Pertuzumab|pertuzumab|mesh-list
92252489|NCT02480010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92252490|NCT02480010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252491|NCT00876200|Minoxidil|minoxidil|mesh-list
92252492|NCT00876200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92252493|NCT00876200|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252494|NCT02512302|Glycopyrrolate|glycopyrrolate|mesh-list
92252495|NCT02512302|Bromides|bromides|mesh-list
92252496|NCT02512302|Charcoal|charcoal|mesh-list
92252497|NCT02512302|Anticonvulsants|anticonvulsants|mesh-ancestor
92252498|NCT02512302|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92252499|NCT02512302|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92252500|NCT02512302|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92252501|NCT02512302|Cholinergic Agents|cholinergic agents|mesh-ancestor
92252502|NCT02512302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252503|NCT02512302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252504|NCT02512302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252505|NCT02512302|Antidotes|antidotes|mesh-ancestor
92252506|NCT02512302|Protective Agents|protective agents|mesh-ancestor
92252507|NCT01507181|Midazolam|midazolam|mesh-list
92252508|NCT01507181|Ketamine|ketamine|mesh-list
92252509|NCT01507181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-list
92252510|NCT01507181|N-Methylaspartate|n-methylaspartate|mesh-list
92252511|NCT01507181|Analgesics|analgesics|mesh-ancestor
92252512|NCT01507181|Sensory System Agents|sensory system agents|mesh-ancestor
92252513|NCT01507181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252514|NCT01507181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252515|NCT01507181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92252516|NCT01507181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92252517|NCT01507181|Anesthetics, General|anesthetics, general|mesh-ancestor
92252518|NCT01507181|Anesthetics|anesthetics|mesh-ancestor
92252519|NCT01507181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252520|NCT01507181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92252521|NCT01507181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252522|NCT01507181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252523|NCT01507181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92252524|NCT01507181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252525|NCT01507181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92252526|NCT01507181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92252527|NCT01507181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92252528|NCT01507181|GABA Modulators|gaba modulators|mesh-ancestor
92252529|NCT01507181|GABA Agents|gaba agents|mesh-ancestor
92252530|NCT01507181|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92252531|NCT01428245|Estradiol|estradiol|mesh-list
92252532|NCT01428245|Estrogens|estrogens|mesh-list
92252533|NCT01428245|Progesterone|progesterone|mesh-list
92252534|NCT01428245|Hormones|hormones|mesh-ancestor
92252535|NCT01428245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252536|NCT01428245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252537|NCT01428245|Progestins|progestins|mesh-ancestor
92252539|NCT00877370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252540|NCT00877370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252541|NCT00877604|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92252542|NCT00877604|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92252543|NCT00877604|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252544|NCT00877604|Antiviral Agents|antiviral agents|mesh-ancestor
92252545|NCT00877604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252546|NCT01508117|Axitinib|axitinib|mesh-list
92252547|NCT01508117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252548|NCT01508117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252549|NCT01508117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252550|NCT01508117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252551|NCT00878228|Ondansetron|ondansetron|mesh-list
92252552|NCT00878228|Antiemetics|antiemetics|mesh-ancestor
92252553|NCT00878228|Autonomic Agents|autonomic agents|mesh-ancestor
92252554|NCT00878228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252555|NCT00878228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252556|NCT00878228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252557|NCT00878228|Antipruritics|antipruritics|mesh-ancestor
92252558|NCT00878228|Dermatologic Agents|dermatologic agents|mesh-ancestor
92252559|NCT00878228|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92252560|NCT00878228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92252561|NCT00878228|Serotonin Agents|serotonin agents|mesh-ancestor
92252562|NCT00878228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252563|NCT00878228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252564|NCT01391273|Bimatoprost|bimatoprost|mesh-list
92252565|NCT01391273|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92252566|NCT01391273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92252567|NCT01429259|Meropenem|meropenem|mesh-list
92252568|NCT01429259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252569|NCT01429259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252570|NCT05177198|Clindamycin|clindamycin|mesh-list
92252571|NCT05177198|Clindamycin palmitate|clindamycin palmitate|mesh-list
92252572|NCT05177198|Clindamycin phosphate|clindamycin phosphate|mesh-list
92252573|NCT05177198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252574|NCT05177198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252575|NCT05177198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92252576|NCT05177198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252577|NCT05177198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252578|NCT01392989|Cyclosporine|cyclosporine|mesh-list
92252579|NCT01392989|Mycophenolic Acid|mycophenolic acid|mesh-list
92252580|NCT01392989|Cyclosporins|cyclosporins|mesh-list
92252581|NCT01392989|Thymoglobulin|thymoglobulin|mesh-list
92252582|NCT01392989|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92252583|NCT01392989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252584|NCT01392989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252585|NCT01392989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252586|NCT01392989|Immunologic Factors|immunologic factors|mesh-ancestor
92252587|NCT01392989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252588|NCT01392989|Antifungal Agents|antifungal agents|mesh-ancestor
92252589|NCT01392989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252590|NCT01392989|Dermatologic Agents|dermatologic agents|mesh-ancestor
92252591|NCT01392989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252592|NCT01392989|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92252593|NCT01392989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92252594|NCT01392989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252595|NCT01392989|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92252596|NCT01392989|Antitubercular Agents|antitubercular agents|mesh-ancestor
92252597|NCT01392989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252598|NCT01393457|Levodopa|levodopa|mesh-list
92252599|NCT01393457|Carbidopa|carbidopa|mesh-list
92252600|NCT01393457|Ropinirole|ropinirole|mesh-list
92252601|NCT01393457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92252602|NCT01393457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92252603|NCT01393457|Dopamine Agents|dopamine agents|mesh-ancestor
92252604|NCT01393457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252605|NCT01393457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252606|NCT01393457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252607|NCT01393457|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92252608|NCT01393457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252609|NCT01393457|Dopamine Agonists|dopamine agonists|mesh-ancestor
92252610|NCT02518464|Ticagrelor|ticagrelor|mesh-list
92252611|NCT02518464|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92252612|NCT02518464|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92252613|NCT02518464|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92252614|NCT02518464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92252615|NCT02518464|Purinergic Agents|purinergic agents|mesh-ancestor
92252616|NCT02518464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252617|NCT02518464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252618|NCT02518464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252619|NCT02479230|Gemcitabine|gemcitabine|mesh-list
92252621|NCT02479230|Immunologic Factors|immunologic factors|mesh-ancestor
92252622|NCT02479230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252623|NCT02479230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92252624|NCT02479230|Antimetabolites|antimetabolites|mesh-ancestor
92252625|NCT02479230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252626|NCT02479230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252627|NCT04985136|Sorafenib|sorafenib|mesh-list
92252628|NCT04985136|Apatinib|apatinib|mesh-list
92252629|NCT04985136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252630|NCT04985136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252631|NCT04985136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252632|NCT04985136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252633|NCT04411446|Vitamin D|vitamin d|mesh-list
92252634|NCT04411446|Cholecalciferol|cholecalciferol|mesh-list
92252635|NCT04411446|Vitamins|vitamins|mesh-ancestor
92252636|NCT04411446|Micronutrients|micronutrients|mesh-ancestor
92252637|NCT04411446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252638|NCT04411446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92252639|NCT04411446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92252640|NCT01510379|Promethazine|promethazine|mesh-list
92252641|NCT01510379|Diphenhydramine|diphenhydramine|mesh-list
92252642|NCT01510379|Ondansetron|ondansetron|mesh-list
92252643|NCT01510379|Antiemetics|antiemetics|mesh-ancestor
92252644|NCT01510379|Autonomic Agents|autonomic agents|mesh-ancestor
92252645|NCT01510379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934885|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252646|NCT01510379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252647|NCT01510379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252648|NCT01510379|Antipruritics|antipruritics|mesh-ancestor
92252649|NCT01510379|Dermatologic Agents|dermatologic agents|mesh-ancestor
92252650|NCT01510379|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92252651|NCT01510379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92252652|NCT01510379|Serotonin Agents|serotonin agents|mesh-ancestor
92252653|NCT01510379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252654|NCT01510379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252655|NCT01510379|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92252656|NCT01510379|Histamine Antagonists|histamine antagonists|mesh-ancestor
92252657|NCT01510379|Histamine Agents|histamine agents|mesh-ancestor
92252658|NCT01510379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92252659|NCT01510379|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92252660|NCT01510379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252661|NCT01510379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252662|NCT01510379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92252663|NCT01510379|Anesthetics|anesthetics|mesh-ancestor
92252664|NCT01510379|Sensory System Agents|sensory system agents|mesh-ancestor
92252665|NCT01363986|Trastuzumab|trastuzumab|mesh-list
92252666|NCT01363986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92252667|NCT01363986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252668|NCT01510457|Milnacipran|milnacipran|mesh-list
92252669|NCT01510457|Levomilnacipran|levomilnacipran|mesh-list
92252670|NCT01510457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92252671|NCT01510457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92252672|NCT01510457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92252673|NCT01510457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252674|NCT01510457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252675|NCT01510457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252676|NCT01510457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252677|NCT01510457|Analgesics|analgesics|mesh-ancestor
92252678|NCT01510457|Sensory System Agents|sensory system agents|mesh-ancestor
92252679|NCT01510457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252680|NCT01510457|Antidepressive Agents|antidepressive agents|mesh-ancestor
92252681|NCT01510457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92252682|NCT02478372|Bupivacaine|bupivacaine|mesh-list
92252683|NCT02478372|Ropivacaine|ropivacaine|mesh-list
92252684|NCT02478372|Levobupivacaine|levobupivacaine|mesh-list
92252685|NCT02478372|Anesthetics, Local|anesthetics, local|mesh-ancestor
92252686|NCT02478372|Anesthetics|anesthetics|mesh-ancestor
92252687|NCT02478372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252688|NCT02478372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342515|NCT00004043|Calcitriol|calcitriol|mesh-list
92252690|NCT02478372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252691|NCT01511315|Ustekinumab|ustekinumab|mesh-list
92252692|NCT01511315|Dermatologic Agents|dermatologic agents|mesh-ancestor
92252693|NCT01654536|Ciclesonide|ciclesonide|mesh-list
92252694|NCT01654536|Glucocorticoids|glucocorticoids|mesh-ancestor
92252695|NCT01654536|Hormones|hormones|mesh-ancestor
92252696|NCT01654536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252697|NCT01654536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252698|NCT01654536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92252699|NCT01654380|Insulin Glargine|insulin glargine|mesh-list
92252700|NCT01654380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92252701|NCT01654380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252702|NCT02509026|Etanercept|etanercept|mesh-list
92252703|NCT02509026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92252704|NCT02509026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252705|NCT02509026|Analgesics|analgesics|mesh-ancestor
92252706|NCT02509026|Sensory System Agents|sensory system agents|mesh-ancestor
92252707|NCT02509026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252708|NCT02509026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252709|NCT02509026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92252710|NCT02509026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252711|NCT02509026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252712|NCT02509026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252713|NCT02509026|Immunologic Factors|immunologic factors|mesh-ancestor
92252715|NCT03439280|Pomalidomide|pomalidomide|mesh-list
92252716|NCT03439280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92252717|NCT03439280|Antiemetics|antiemetics|mesh-ancestor
92252718|NCT03439280|Autonomic Agents|autonomic agents|mesh-ancestor
92252719|NCT03439280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252720|NCT03439280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252721|NCT03439280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92252722|NCT03439280|Glucocorticoids|glucocorticoids|mesh-ancestor
92252723|NCT03439280|Hormones|hormones|mesh-ancestor
92252724|NCT03439280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252725|NCT03439280|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92252726|NCT03439280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252727|NCT03439280|Immunologic Factors|immunologic factors|mesh-ancestor
92252728|NCT03439280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92252729|NCT03439280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92252730|NCT03439280|Growth Substances|growth substances|mesh-ancestor
92252731|NCT03439280|Growth Inhibitors|growth inhibitors|mesh-ancestor
92252732|NCT00828074|Sorafenib|sorafenib|mesh-list
92252733|NCT00828074|Vinorelbine|vinorelbine|mesh-list
92252734|NCT00828074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252735|NCT00828074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252736|NCT00828074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252737|NCT00828074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252738|NCT00828074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92252739|NCT00828074|Tubulin Modulators|tubulin modulators|mesh-ancestor
92252740|NCT00828074|Antimitotic Agents|antimitotic agents|mesh-ancestor
92252741|NCT00828074|Mitosis Modulators|mitosis modulators|mesh-ancestor
92252742|NCT03434444|Propranolol|propranolol|mesh-list
92252743|NCT03434444|Oxytocin|oxytocin|mesh-list
92252744|NCT03434444|Oxytocics|oxytocics|mesh-ancestor
92252745|NCT03434444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252746|NCT03434444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252747|NCT03434444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92252748|NCT03434444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92252749|NCT03434444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252750|NCT03434444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252751|NCT03434444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252752|NCT03434444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92252753|NCT03434444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92252754|NCT03434444|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252755|NCT04382300|Thalidomide|thalidomide|mesh-list
92252756|NCT04382300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252757|NCT04382300|Immunologic Factors|immunologic factors|mesh-ancestor
92252758|NCT04382300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252759|NCT04382300|Leprostatic Agents|leprostatic agents|mesh-ancestor
92252760|NCT04382300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252761|NCT04382300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252762|NCT04382300|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92252763|NCT04382300|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92252764|NCT04382300|Growth Substances|growth substances|mesh-ancestor
92252765|NCT04382300|Growth Inhibitors|growth inhibitors|mesh-ancestor
92252766|NCT04382300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252767|NCT01430819|Vaccines|vaccines|mesh-list
92252768|NCT01430819|Immunologic Factors|immunologic factors|mesh-ancestor
92252769|NCT01430819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252770|NCT00828542|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92252771|NCT00828542|Medroxyprogesterone|medroxyprogesterone|mesh-list
92252772|NCT00828542|Desogestrel|desogestrel|mesh-list
92252773|NCT00828542|Etonogestrel|etonogestrel|mesh-list
92252774|NCT00828542|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92252775|NCT00828542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92252776|NCT00828542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92252777|NCT00828542|Contraceptive Agents|contraceptive agents|mesh-ancestor
92252778|NCT00828542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252779|NCT00828542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252780|NCT00828542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92252781|NCT00828542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92252782|NCT00828542|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92252783|NCT00828542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92252784|NCT00828542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252785|NCT00828542|Progestins|progestins|mesh-ancestor
92252786|NCT00828542|Hormones|hormones|mesh-ancestor
92252787|NCT00828542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252788|NCT01395329|Metoprolol|metoprolol|mesh-list
92252789|NCT01395329|Nebivolol|nebivolol|mesh-list
92252790|NCT01395329|Nitroprusside|nitroprusside|mesh-list
92252791|NCT01395329|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92252792|NCT01395329|BQ 788|bq 788|mesh-list
92252793|NCT01395329|Acetylcholine|acetylcholine|mesh-list
92252794|NCT01395329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92252795|NCT01395329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92252796|NCT01395329|Sympatholytics|sympatholytics|mesh-ancestor
92252797|NCT01395329|Autonomic Agents|autonomic agents|mesh-ancestor
92252798|NCT01395329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252799|NCT01395329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252800|NCT01395329|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92252801|NCT01395329|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92252802|NCT01395329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92252803|NCT01395329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252804|NCT01395329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252805|NCT01395329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252806|NCT01395329|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252807|NCT01395329|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92252808|NCT01395329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92252809|NCT01395329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92252810|NCT01395329|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92252811|NCT01395329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92252812|NCT01395329|Cholinergic Agents|cholinergic agents|mesh-ancestor
92252813|NCT01395329|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92252814|NCT01395329|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92252815|NCT00882206|Cytarabine|cytarabine|mesh-list
92252816|NCT00882206|Prednisone|prednisone|mesh-list
92252817|NCT00882206|Doxorubicin|doxorubicin|mesh-list
92252818|NCT00882206|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92252819|NCT00882206|Methotrexate|methotrexate|mesh-list
92252820|NCT00882206|Vincristine|vincristine|mesh-list
92252821|NCT00882206|Imatinib Mesylate|imatinib mesylate|mesh-list
92252822|NCT00882206|Decitabine|decitabine|mesh-list
92252823|NCT00882206|Asparaginase|asparaginase|mesh-list
92252824|NCT00882206|Vorinostat|vorinostat|mesh-list
92252825|NCT00882206|Pegaspargase|pegaspargase|mesh-list
92252826|NCT00882206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92252827|NCT00882206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252828|NCT00882206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92252829|NCT00882206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92252830|NCT00882206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252831|NCT00882206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252832|NCT00882206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92252833|NCT00882206|Glucocorticoids|glucocorticoids|mesh-ancestor
92252834|NCT00882206|Hormones|hormones|mesh-ancestor
92252835|NCT00882206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252836|NCT00882206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252837|NCT00882206|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92252838|NCT00882206|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92252839|NCT00882206|Abortifacient Agents|abortifacient agents|mesh-ancestor
92252840|NCT00882206|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92252841|NCT00882206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92252842|NCT00882206|Antimetabolites|antimetabolites|mesh-ancestor
92252843|NCT00882206|Dermatologic Agents|dermatologic agents|mesh-ancestor
92252844|NCT00882206|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92252845|NCT00882206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252846|NCT00882206|Immunologic Factors|immunologic factors|mesh-ancestor
92252847|NCT00882206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252848|NCT00882206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92252849|NCT00882206|Antiviral Agents|antiviral agents|mesh-ancestor
92252850|NCT00882206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252851|NCT00882206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92252852|NCT00882206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92252853|NCT00882206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92252854|NCT00882206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92252855|NCT00882206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252856|NCT00882206|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92252857|NCT00831272|Naltrexone|naltrexone|mesh-list
92252858|NCT00831272|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92252859|NCT00831272|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92252860|NCT00831272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252861|NCT00831272|Sensory System Agents|sensory system agents|mesh-ancestor
92252862|NCT00831272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252863|NCT00885092|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92252864|NCT01512251|Vemurafenib|vemurafenib|mesh-list
92252865|NCT01512251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252866|NCT01512251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252867|NCT01512251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252868|NCT01512251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252869|NCT00885638|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92252870|NCT00885638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92252871|NCT00885638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252872|NCT00885638|Incretins|incretins|mesh-ancestor
92252873|NCT00885638|Hormones|hormones|mesh-ancestor
92252874|NCT00885638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252875|NCT00885638|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92252876|NCT00885638|Protease Inhibitors|protease inhibitors|mesh-ancestor
92252877|NCT00885638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252878|NCT00885638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252879|NCT01512797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92252880|NCT01512797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92252881|NCT01512797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252882|NCT01512797|Incretins|incretins|mesh-ancestor
92252883|NCT01512797|Hormones|hormones|mesh-ancestor
92252884|NCT01512797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92252885|NCT01512797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92252886|NCT01512797|Protease Inhibitors|protease inhibitors|mesh-ancestor
92252887|NCT01512797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252888|NCT01512797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252889|NCT05620940|Naltrexone|naltrexone|mesh-list
92252890|NCT05620940|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92252891|NCT05620940|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92252892|NCT05620940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252893|NCT05620940|Sensory System Agents|sensory system agents|mesh-ancestor
92252894|NCT05620940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252895|NCT01395797|Pioglitazone|pioglitazone|mesh-list
92252896|NCT01395797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92252897|NCT01395797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252898|NCT05124704|Ropivacaine|ropivacaine|mesh-list
92252899|NCT05124704|Anesthetics, Local|anesthetics, local|mesh-ancestor
92252900|NCT05124704|Anesthetics|anesthetics|mesh-ancestor
92252901|NCT05124704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252902|NCT05124704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252903|NCT05124704|Sensory System Agents|sensory system agents|mesh-ancestor
92252904|NCT05124704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252905|NCT02203019|Fentanyl|fentanyl|mesh-list
92252906|NCT02203019|Dexmedetomidine|dexmedetomidine|mesh-list
92252907|NCT02203019|Propofol|propofol|mesh-list
92252908|NCT02203019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92252909|NCT02203019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92252910|NCT02203019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252911|NCT02203019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92252912|NCT02203019|Analgesics|analgesics|mesh-ancestor
92252913|NCT02203019|Sensory System Agents|sensory system agents|mesh-ancestor
92252914|NCT02203019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92252915|NCT02203019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92252916|NCT02203019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92252917|NCT02203019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92252918|NCT02203019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92252919|NCT02203019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92252920|NCT02203019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252921|NCT02203019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92252922|NCT02203019|Anesthetics, General|anesthetics, general|mesh-ancestor
92252923|NCT02203019|Anesthetics|anesthetics|mesh-ancestor
92252924|NCT02203019|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92252926|NCT02203019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92252927|NCT05000450|Cyclophosphamide|cyclophosphamide|mesh-list
92252928|NCT05000450|Fludarabine|fludarabine|mesh-list
92252929|NCT05000450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252930|NCT05000450|Immunologic Factors|immunologic factors|mesh-ancestor
92252931|NCT05000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252932|NCT05000450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252933|NCT05000450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92252934|NCT05000450|Alkylating Agents|alkylating agents|mesh-ancestor
92252935|NCT05000450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252936|NCT05000450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252937|NCT05000450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92252938|NCT00886262|Vasopressins|vasopressins|mesh-list
92252939|NCT00886262|Arginine Vasopressin|arginine vasopressin|mesh-list
92252940|NCT00886262|Hemostatics|hemostatics|mesh-ancestor
92252941|NCT00886262|Coagulants|coagulants|mesh-ancestor
92252942|NCT00886262|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92252943|NCT00886262|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92252944|NCT00886262|Natriuretic Agents|natriuretic agents|mesh-ancestor
92252945|NCT00886262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252946|NCT00887510|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92252947|NCT00887510|Trandolapril|trandolapril|mesh-list
92252948|NCT00887510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92252949|NCT00887510|Diuretics|diuretics|mesh-ancestor
92252950|NCT00887510|Natriuretic Agents|natriuretic agents|mesh-ancestor
92252951|NCT00887510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252952|NCT00887510|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92252953|NCT00887510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92252954|NCT00887510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252955|NCT00887510|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92252956|NCT00887510|Protease Inhibitors|protease inhibitors|mesh-ancestor
92252957|NCT00887510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252958|NCT01431989|Amoxicillin|amoxicillin|mesh-list
92252959|NCT01431989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252960|NCT01431989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252961|NCT03247088|Mycophenolic Acid|mycophenolic acid|mesh-list
92252962|NCT03247088|Cyclophosphamide|cyclophosphamide|mesh-list
92252963|NCT03247088|Busulfan|busulfan|mesh-list
92342544|NCT00004061|Alkylating Agents|alkylating agents|mesh-ancestor
92252964|NCT03247088|Fludarabine|fludarabine|mesh-list
92252965|NCT03247088|Sorafenib|sorafenib|mesh-list
92252966|NCT03247088|Tacrolimus|tacrolimus|mesh-list
92252967|NCT03247088|Lenograstim|lenograstim|mesh-list
92252968|NCT03247088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92252969|NCT03247088|Immunologic Factors|immunologic factors|mesh-ancestor
92252970|NCT03247088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92252971|NCT03247088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92252972|NCT03247088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92252973|NCT03247088|Alkylating Agents|alkylating agents|mesh-ancestor
92252974|NCT03247088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252975|NCT03247088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252976|NCT03247088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92252977|NCT03247088|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92252978|NCT03247088|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92252979|NCT03247088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252980|NCT03247088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92252981|NCT03247088|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92252982|NCT03247088|Antitubercular Agents|antitubercular agents|mesh-ancestor
92252983|NCT03247088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92252984|NCT03247088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92252985|NCT03247088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92252986|NCT01397591|Bortezomib|bortezomib|mesh-list
92252987|NCT01397591|Ofatumumab|ofatumumab|mesh-list
92252988|NCT01397591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92252989|NCT03855332|Cilostazol|cilostazol|mesh-list
92252990|NCT03855332|Sildenafil Citrate|sildenafil citrate|mesh-list
92252991|NCT03855332|Vasodilator Agents|vasodilator agents|mesh-ancestor
92252992|NCT03855332|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92252993|NCT03855332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92252994|NCT03855332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92252995|NCT03855332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92252996|NCT03855332|Urological Agents|urological agents|mesh-ancestor
92252997|NCT03855332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92252998|NCT03855332|Autonomic Agents|autonomic agents|mesh-ancestor
92252999|NCT03855332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253000|NCT03855332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253001|NCT03855332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92253002|NCT03855332|Respiratory System Agents|respiratory system agents|mesh-ancestor
92253003|NCT03855332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92253004|NCT03855332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92253005|NCT03855332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92253006|NCT03855332|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92253007|NCT03855332|Protective Agents|protective agents|mesh-ancestor
92253008|NCT03855332|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92253009|NCT02335580|Somatostatin|somatostatin|mesh-list
92253010|NCT02335580|Hormones|hormones|mesh-ancestor
92253011|NCT02335580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92253012|NCT02335580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253013|NCT02476968|Olaparib|olaparib|mesh-list
92253014|NCT02476968|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92253015|NCT02476968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253016|NCT02476968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253017|NCT02476968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253018|NCT01514513|Permethrin|permethrin|mesh-list
92253019|NCT01514513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253020|NCT01514513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253021|NCT04981860|Povidone-Iodine|povidone-iodine|mesh-list
92253022|NCT04981860|Povidone|povidone|mesh-list
92253023|NCT04981860|Plasma Substitutes|plasma substitutes|mesh-ancestor
92253024|NCT04981860|Blood Substitutes|blood substitutes|mesh-ancestor
92253025|NCT04981860|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92253026|NCT04981860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253027|NCT01432145|Methotrexate|methotrexate|mesh-list
92253028|NCT01432145|Mercaptopurine|mercaptopurine|mesh-list
92253029|NCT01432145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92253030|NCT01432145|Abortifacient Agents|abortifacient agents|mesh-ancestor
92253031|NCT01432145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92253032|NCT01432145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253033|NCT01432145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92253035|NCT01432145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253036|NCT01432145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253037|NCT01432145|Dermatologic Agents|dermatologic agents|mesh-ancestor
92253038|NCT01432145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253039|NCT01432145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92253040|NCT01432145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253041|NCT01432145|Immunologic Factors|immunologic factors|mesh-ancestor
92253042|NCT01432145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253043|NCT01432145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92253044|NCT04979520|Brodalumab|brodalumab|mesh-list
92253045|NCT04979520|Dermatologic Agents|dermatologic agents|mesh-ancestor
92253046|NCT01432379|Botulinum Toxins|botulinum toxins|mesh-list
92253047|NCT01432379|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92253048|NCT01432379|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92253049|NCT01432379|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92253050|NCT01432379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92253051|NCT01432379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253052|NCT01432379|Cholinergic Agents|cholinergic agents|mesh-ancestor
92253053|NCT01432379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253054|NCT01432379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253055|NCT01432379|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92253056|NCT01432379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253057|NCT02504892|Everolimus|everolimus|mesh-list
92253058|NCT02504892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92253059|NCT02504892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253060|NCT02504892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253061|NCT02504892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253062|NCT02504892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253063|NCT02504892|Immunologic Factors|immunologic factors|mesh-ancestor
92253064|NCT02504892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253065|NCT02504892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253066|NCT01432535|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92253067|NCT01432535|Antiviral Agents|antiviral agents|mesh-ancestor
92253068|NCT01432535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253069|NCT05946902|Mirabegron|mirabegron|mesh-list
92253070|NCT05946902|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92253071|NCT05946902|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92253072|NCT05946902|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92253073|NCT05946902|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92253074|NCT05946902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253075|NCT05946902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253076|NCT05946902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253077|NCT05946902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253078|NCT05946902|Urological Agents|urological agents|mesh-ancestor
92253079|NCT05946902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92253080|NCT05946902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92253081|NCT05946902|Cholinergic Agents|cholinergic agents|mesh-ancestor
92253082|NCT05946811|Macitentan|macitentan|mesh-list
92253083|NCT05946811|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92253084|NCT05946811|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92253085|NCT05946811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253086|NCT05946811|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92253087|NCT05946798|Insulin Aspart|insulin aspart|mesh-list
92253088|NCT05946798|Acetylcholine|acetylcholine|mesh-list
92253089|NCT05946798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253090|NCT05946798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253091|NCT05946798|Vasodilator Agents|vasodilator agents|mesh-ancestor
92253092|NCT05946798|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92253093|NCT05946798|Cholinergic Agents|cholinergic agents|mesh-ancestor
92253094|NCT05946798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253095|NCT05946798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253096|NCT05946785|Insulin Aspart|insulin aspart|mesh-list
92253097|NCT05946785|Acetylcholine|acetylcholine|mesh-list
92253098|NCT05946785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253099|NCT05946785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253100|NCT05946785|Vasodilator Agents|vasodilator agents|mesh-ancestor
92253101|NCT05946785|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92253102|NCT05946785|Cholinergic Agents|cholinergic agents|mesh-ancestor
92253103|NCT05946785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253104|NCT05946785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253105|NCT05946772|Cyclosporine|cyclosporine|mesh-list
92253106|NCT05946772|Cyclosporins|cyclosporins|mesh-list
92253107|NCT05946772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253108|NCT05946772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253109|NCT05946772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253110|NCT05946772|Immunologic Factors|immunologic factors|mesh-ancestor
92253111|NCT05946772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253112|NCT05946772|Antifungal Agents|antifungal agents|mesh-ancestor
92253113|NCT05946772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253114|NCT05946772|Dermatologic Agents|dermatologic agents|mesh-ancestor
92253115|NCT05946772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253116|NCT05946772|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92253117|NCT05946655|Metronidazole|metronidazole|mesh-list
92253119|NCT05946655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253120|NCT05946655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92253121|NCT05946655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92253122|NCT05946655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92253123|NCT05946655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92253124|NCT05946655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92253125|NCT05946655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92253126|NCT05946655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253127|NCT05946655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253128|NCT05946655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253129|NCT05946655|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92253130|NCT05946655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92253131|NCT05946642|Ivermectin|ivermectin|mesh-list
92253132|NCT05946642|Pyrimethamine|pyrimethamine|mesh-list
92253133|NCT05946642|Piperaquine|piperaquine|mesh-list
92253134|NCT05946642|Sulfadoxine|sulfadoxine|mesh-list
92253135|NCT05946642|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92253136|NCT05946642|Amodiaquine|amodiaquine|mesh-list
92253137|NCT05946642|Artenimol|artenimol|mesh-list
92253138|NCT05946642|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92253139|NCT05946642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253140|NCT05946642|Antimalarials|antimalarials|mesh-ancestor
92253141|NCT05946642|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92253142|NCT05946642|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92253143|NCT05946642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253144|NCT05946642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253145|NCT05946642|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92253146|NCT05946603|Fluorophosphate|fluorophosphate|mesh-list
92253147|NCT05946603|Cariostatic Agents|cariostatic agents|mesh-ancestor
92253148|NCT05946603|Protective Agents|protective agents|mesh-ancestor
92253149|NCT05946603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253150|NCT05946564|Pioglitazone|pioglitazone|mesh-list
92253151|NCT05946564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253152|NCT05946564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253153|NCT05946551|Cetirizine|cetirizine|mesh-list
92253154|NCT05946551|Naltrexone|naltrexone|mesh-list
92253155|NCT05946551|Famotidine|famotidine|mesh-list
92253156|NCT05946551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92253157|NCT05946551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92253158|NCT05946551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253159|NCT05946551|Sensory System Agents|sensory system agents|mesh-ancestor
92253160|NCT05946551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253161|NCT05946551|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92253162|NCT05946551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92253163|NCT05946551|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92253164|NCT05946551|Histamine Antagonists|histamine antagonists|mesh-ancestor
92253165|NCT05946551|Histamine Agents|histamine agents|mesh-ancestor
92253166|NCT05946551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253167|NCT05946551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253168|NCT05946551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92253169|NCT05946551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92253170|NCT05946551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92253171|NCT05946486|Rituximab|rituximab|mesh-list
92253172|NCT05946486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253173|NCT05946486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253174|NCT05946486|Immunologic Factors|immunologic factors|mesh-ancestor
92253175|NCT05946486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253176|NCT05946486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253177|NCT05946148|Empagliflozin|empagliflozin|mesh-list
92253178|NCT05946148|Dulaglutide|dulaglutide|mesh-list
92253179|NCT05946148|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92253180|NCT05946148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253181|NCT05946148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253182|NCT05946148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253183|NCT05946135|Lansoprazole|lansoprazole|mesh-list
92253184|NCT05946135|Dexlansoprazole|dexlansoprazole|mesh-list
92253185|NCT05946135|Fexuprazan|fexuprazan|mesh-list
92253186|NCT05946135|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92253187|NCT05946135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92253188|NCT05946135|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92253189|NCT05946135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253190|NCT05946135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253191|NCT05946122|Atorvastatin|atorvastatin|mesh-list
92253192|NCT05946122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92253193|NCT05946122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92253194|NCT05946122|Antimetabolites|antimetabolites|mesh-ancestor
92253195|NCT05946122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253196|NCT05946122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92253197|NCT05946122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92253198|NCT05946122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253199|NCT05946005|Povidone-Iodine|povidone-iodine|mesh-list
92253200|NCT05946005|Lidocaine|lidocaine|mesh-list
92253201|NCT05946005|Povidone|povidone|mesh-list
92253202|NCT05946005|Anesthetics, Local|anesthetics, local|mesh-ancestor
92253203|NCT05946005|Anesthetics|anesthetics|mesh-ancestor
92253204|NCT05946005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253205|NCT05946005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253206|NCT05946005|Sensory System Agents|sensory system agents|mesh-ancestor
92253207|NCT05946005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253208|NCT05946005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92253209|NCT05946005|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92253210|NCT05946005|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92253211|NCT05946005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92253212|NCT05946005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253213|NCT05946005|Plasma Substitutes|plasma substitutes|mesh-ancestor
92253214|NCT05946005|Blood Substitutes|blood substitutes|mesh-ancestor
92253215|NCT05946005|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92253216|NCT05946005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253218|NCT05945979|Vitamin B Complex|vitamin b complex|mesh-ancestor
92253219|NCT05945979|Vitamins|vitamins|mesh-ancestor
92253220|NCT05945979|Micronutrients|micronutrients|mesh-ancestor
92253221|NCT05945979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253222|NCT05945927|Trastuzumab|trastuzumab|mesh-list
92253223|NCT05945927|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92253224|NCT05945927|Maytansine|maytansine|mesh-list
92253225|NCT05945927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253226|NCT05945927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253227|NCT05945927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92253228|NCT05945927|Tubulin Modulators|tubulin modulators|mesh-ancestor
92253229|NCT05945927|Antimitotic Agents|antimitotic agents|mesh-ancestor
92253230|NCT05945927|Mitosis Modulators|mitosis modulators|mesh-ancestor
92253231|NCT05945927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253232|NCT05945927|Immunotoxins|immunotoxins|mesh-ancestor
92253233|NCT05945927|Immunoconjugates|immunoconjugates|mesh-ancestor
92253234|NCT05945927|Immunologic Factors|immunologic factors|mesh-ancestor
92253235|NCT05945927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253236|NCT05945901|Bevacizumab|bevacizumab|mesh-list
92253237|NCT05945901|Oxaliplatin|oxaliplatin|mesh-list
92253238|NCT05945901|Fluorouracil|fluorouracil|mesh-list
92253239|NCT05945901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253240|NCT05945901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253241|NCT05945901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92253242|NCT05945901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92253243|NCT05945901|Growth Substances|growth substances|mesh-ancestor
92253244|NCT05945901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253245|NCT05945901|Growth Inhibitors|growth inhibitors|mesh-ancestor
92253246|NCT05945901|Antimetabolites|antimetabolites|mesh-ancestor
92253247|NCT05945901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253248|NCT05945901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92253249|NCT05945901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253250|NCT05945901|Immunologic Factors|immunologic factors|mesh-ancestor
92253252|NCT05945875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253253|NCT05945875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253254|NCT05945823|Calcium, Dietary|calcium, dietary|mesh-list
92253255|NCT05945823|Leucovorin|leucovorin|mesh-list
92253256|NCT05945823|Pembrolizumab|pembrolizumab|mesh-list
92253257|NCT05945823|Oxaliplatin|oxaliplatin|mesh-list
92253258|NCT05945823|Futibatinib|futibatinib|mesh-list
92253259|NCT05945823|Calcium|calcium|mesh-list
92253260|NCT05945823|Levoleucovorin|levoleucovorin|mesh-list
92253261|NCT05945823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253262|NCT05945823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253263|NCT05945823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253264|NCT05945823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253265|NCT05945823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92253266|NCT05945823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253267|NCT05945823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92253268|NCT05945823|Antidotes|antidotes|mesh-ancestor
92253269|NCT05945823|Protective Agents|protective agents|mesh-ancestor
92253270|NCT05945823|Vitamin B Complex|vitamin b complex|mesh-ancestor
92253271|NCT05945823|Vitamins|vitamins|mesh-ancestor
92253272|NCT05945823|Micronutrients|micronutrients|mesh-ancestor
92253273|NCT05945797|Dexamethasone|dexamethasone|mesh-list
92253274|NCT05945797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92253275|NCT05945797|Antiemetics|antiemetics|mesh-ancestor
92253276|NCT05945797|Autonomic Agents|autonomic agents|mesh-ancestor
92253277|NCT05945797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253278|NCT05945797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253279|NCT05945797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92253280|NCT05945797|Glucocorticoids|glucocorticoids|mesh-ancestor
92253281|NCT05945797|Hormones|hormones|mesh-ancestor
92253282|NCT05945797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92253283|NCT05945797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92253284|NCT05945797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253285|NCT05945771|Grape Seed Extract|grape seed extract|mesh-list
92253286|NCT05945771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92253287|NCT05945771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253288|NCT05945771|Antioxidants|antioxidants|mesh-ancestor
92253289|NCT05945771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253290|NCT05945771|Protective Agents|protective agents|mesh-ancestor
92253291|NCT05945771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253292|NCT05945745|Immunomodulating Agents|immunomodulating agents|mesh-list
92253294|NCT05945745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253295|NCT05945732|Trastuzumab|trastuzumab|mesh-list
92253296|NCT05945732|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92253297|NCT05945732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253298|NCT05945732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253299|NCT05945732|Immunoconjugates|immunoconjugates|mesh-ancestor
92253300|NCT05945732|Immunologic Factors|immunologic factors|mesh-ancestor
92253301|NCT05945732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253302|NCT05945680|Tranexamic Acid|tranexamic acid|mesh-list
92253303|NCT05945680|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92253304|NCT05945680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92253305|NCT05945680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253306|NCT05945680|Hemostatics|hemostatics|mesh-ancestor
92253307|NCT05945680|Coagulants|coagulants|mesh-ancestor
92253308|NCT05945615|Phenylephrine|phenylephrine|mesh-list
92253309|NCT05945615|Oxymetazoline|oxymetazoline|mesh-list
92253310|NCT05945615|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92253311|NCT05945615|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92253312|NCT05945615|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253313|NCT05945615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253314|NCT05945615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253315|NCT05945615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253316|NCT05945615|Sympathomimetics|sympathomimetics|mesh-ancestor
92253317|NCT05945615|Autonomic Agents|autonomic agents|mesh-ancestor
92253318|NCT05945615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253319|NCT05945615|Nasal Decongestants|nasal decongestants|mesh-ancestor
92253320|NCT05945615|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92253321|NCT05945615|Respiratory System Agents|respiratory system agents|mesh-ancestor
92253322|NCT05945615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92253323|NCT05945615|Mydriatics|mydriatics|mesh-ancestor
92253324|NCT05945615|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92253325|NCT05945615|Protective Agents|protective agents|mesh-ancestor
92253326|NCT05945420|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92253327|NCT05945420|Hemostatics|hemostatics|mesh-ancestor
92253328|NCT05945420|Coagulants|coagulants|mesh-ancestor
92253329|NCT05945420|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92253330|NCT05945420|Natriuretic Agents|natriuretic agents|mesh-ancestor
92253331|NCT05945420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253332|NCT05945368|Trastuzumab|trastuzumab|mesh-list
92253334|NCT05945368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253335|NCT05945368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253337|NCT05945342|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92253338|NCT05945342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92253339|NCT05945342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92253340|NCT05945342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253341|NCT05945342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253342|NCT05945342|Serotonin Agents|serotonin agents|mesh-ancestor
92253343|NCT05945342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253344|NCT05945342|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92253345|NCT05945342|Antidepressive Agents|antidepressive agents|mesh-ancestor
92253346|NCT05945342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92253347|NCT05945342|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92253348|NCT05945342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92253349|NCT05945342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253350|NCT05945173|Ethanol|ethanol|mesh-list
92253351|NCT05945173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92253352|NCT05945173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253353|NCT05945173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253354|NCT05945173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253355|NCT05945160|Thioctic Acid|thioctic acid|mesh-list
92253356|NCT05945160|Ubiquinone|ubiquinone|mesh-list
92253357|NCT05945160|Coenzyme Q10|coenzyme q10|mesh-list
92253358|NCT05945160|Antioxidants|antioxidants|mesh-ancestor
92253359|NCT05945160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253360|NCT05945160|Protective Agents|protective agents|mesh-ancestor
92253361|NCT05945160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253362|NCT05945160|Vitamin B Complex|vitamin b complex|mesh-ancestor
92253363|NCT05945160|Vitamins|vitamins|mesh-ancestor
92253364|NCT05945160|Micronutrients|micronutrients|mesh-ancestor
92253365|NCT05945147|Midazolam|midazolam|mesh-list
92253366|NCT05945147|Ketamine|ketamine|mesh-list
92253367|NCT05945147|Analgesics|analgesics|mesh-ancestor
92253368|NCT05945147|Sensory System Agents|sensory system agents|mesh-ancestor
92253369|NCT05945147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253370|NCT05945147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253371|NCT05945147|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92253372|NCT05945147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92253373|NCT05945147|Anesthetics, General|anesthetics, general|mesh-ancestor
92253374|NCT05945147|Anesthetics|anesthetics|mesh-ancestor
92253375|NCT05945147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253376|NCT05945147|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92253377|NCT05945147|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92253378|NCT05945147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253379|NCT05945147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253380|NCT05945147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92253381|NCT05945147|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92253382|NCT05945147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92253383|NCT05945147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92253384|NCT05945147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92253385|NCT05945147|GABA Modulators|gaba modulators|mesh-ancestor
92253386|NCT05945147|GABA Agents|gaba agents|mesh-ancestor
92253387|NCT05944952|Buprenorphine|buprenorphine|mesh-list
92253388|NCT05944952|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92253389|NCT05944952|Naloxone|naloxone|mesh-list
92253390|NCT05944952|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92253391|NCT05944952|Narcotics|narcotics|mesh-ancestor
92253392|NCT05944952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253393|NCT05944952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253394|NCT05944952|Analgesics|analgesics|mesh-ancestor
92253395|NCT05944952|Sensory System Agents|sensory system agents|mesh-ancestor
92253396|NCT05944952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253397|NCT05944952|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92253398|NCT05944107|Heparin|heparin|mesh-list
92253399|NCT05944107|Anticoagulants|anticoagulants|mesh-ancestor
92253400|NCT05944107|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92253401|NCT05944107|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92253402|NCT05944107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253403|NCT05943496|Obinutuzumab|obinutuzumab|mesh-list
92253404|NCT05943496|Acalabrutinib|acalabrutinib|mesh-list
92253405|NCT05943496|Immunoglobulins|immunoglobulins|mesh-list
92253406|NCT05943496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92253407|NCT05943496|Immunologic Factors|immunologic factors|mesh-ancestor
92253408|NCT05943496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253409|NCT05943496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253410|NCT05943496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253411|NCT05943496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253412|NCT05943496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253413|NCT05943496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253414|NCT05943080|Epinephrine|epinephrine|mesh-list
92253415|NCT05943080|Racepinephrine|racepinephrine|mesh-list
92253416|NCT05943080|Bupivacaine|bupivacaine|mesh-list
92253417|NCT05943080|Epinephryl borate|epinephryl borate|mesh-list
92253418|NCT05943080|Anesthetics, Local|anesthetics, local|mesh-ancestor
92253419|NCT05943080|Anesthetics|anesthetics|mesh-ancestor
92253420|NCT05943080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253421|NCT05943080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253422|NCT05943080|Sensory System Agents|sensory system agents|mesh-ancestor
92253423|NCT05943080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253424|NCT05943080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92253425|NCT05943080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92253426|NCT05943080|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253427|NCT05943080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253428|NCT05943080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253429|NCT05943080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92253430|NCT05943080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92253431|NCT05943080|Autonomic Agents|autonomic agents|mesh-ancestor
92253432|NCT05943080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92253433|NCT05943080|Respiratory System Agents|respiratory system agents|mesh-ancestor
92253434|NCT05943080|Mydriatics|mydriatics|mesh-ancestor
92253435|NCT05943080|Sympathomimetics|sympathomimetics|mesh-ancestor
92253436|NCT05943080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92253437|NCT05938946|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92253438|NCT05929495|Metformin|metformin|mesh-list
92253439|NCT05929495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253440|NCT05929495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253441|NCT05928858|Calcium|calcium|mesh-list
92253442|NCT05928858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92253443|NCT05928858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253444|NCT05920642|Morphine|morphine|mesh-list
92253445|NCT05920642|Analgesics|analgesics|mesh-list
92253446|NCT05920642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92253447|NCT05920642|Narcotics|narcotics|mesh-ancestor
92253448|NCT05920642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253449|NCT05920642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253450|NCT05920642|Sensory System Agents|sensory system agents|mesh-ancestor
92253451|NCT05920642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253452|NCT05889468|Aspirin|aspirin|mesh-list
92253453|NCT05889468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92253454|NCT05889468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92253455|NCT05889468|Analgesics|analgesics|mesh-ancestor
92253456|NCT05889468|Sensory System Agents|sensory system agents|mesh-ancestor
92253457|NCT05889468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253458|NCT05889468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253459|NCT05889468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92253460|NCT05889468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253461|NCT05889468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92253462|NCT05889468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92253463|NCT05889468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253464|NCT05889468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92253465|NCT05889468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92253466|NCT05889468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253468|NCT05879120|Pembrolizumab|pembrolizumab|mesh-list
92253469|NCT05879120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253470|NCT05879120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253471|NCT05879120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253472|NCT05879120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253473|NCT05867147|Moxifloxacin|moxifloxacin|mesh-list
92253474|NCT05867147|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92253475|NCT05867147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92253476|NCT05867147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253477|NCT05867147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92253478|NCT05867147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92253479|NCT05867147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253480|NCT05867147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253481|NCT05867147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253482|NCT05867147|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92253483|NCT05867147|Contraceptive Agents|contraceptive agents|mesh-ancestor
92253484|NCT05867147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92253485|NCT05867147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253486|NCT05867147|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92253487|NCT05867147|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92253488|NCT05867147|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92253489|NCT05853367|Pembrolizumab|pembrolizumab|mesh-list
92253490|NCT05853367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253491|NCT05853367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253492|NCT05853367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253493|NCT05853367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253494|NCT05831176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92253495|NCT05831176|Immunologic Factors|immunologic factors|mesh-ancestor
92253496|NCT05831176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253497|NCT05827484|Losartan|losartan|mesh-list
92253498|NCT05827484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92253499|NCT05827484|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92253500|NCT05827484|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92253501|NCT05827484|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92253502|NCT05827484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253503|NCT05820841|Acalabrutinib|acalabrutinib|mesh-list
92253504|NCT05820841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253505|NCT05818085|Allopurinol|allopurinol|mesh-list
92253506|NCT05818085|Antimetabolites|antimetabolites|mesh-ancestor
92253507|NCT05818085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253508|NCT05818085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253509|NCT05818085|Gout Suppressants|gout suppressants|mesh-ancestor
92253510|NCT05818085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253511|NCT05818085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92253512|NCT05818085|Antioxidants|antioxidants|mesh-ancestor
92253513|NCT05818085|Protective Agents|protective agents|mesh-ancestor
92253514|NCT05818085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253515|NCT05806567|Belumosudil|belumosudil|mesh-list
92253516|NCT05806567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253517|NCT05806567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253518|NCT05806567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253519|NCT05786443|Empagliflozin|empagliflozin|mesh-list
92253520|NCT05786443|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92253521|NCT05786443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253522|NCT05786443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253523|NCT05786443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253524|NCT05753189|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92253525|NCT05753189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92253526|NCT05753189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92253527|NCT05753189|Aceclidine|aceclidine|mesh-list
92253528|NCT05753189|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92253529|NCT05753189|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92253530|NCT05753189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92253531|NCT05753189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92253532|NCT05753189|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253533|NCT05753189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253534|NCT05753189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253535|NCT05753189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253537|NCT05753189|Autonomic Agents|autonomic agents|mesh-ancestor
92253538|NCT05753189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253539|NCT05753189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92253540|NCT05750628|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92253541|NCT05750628|Antimalarials|antimalarials|mesh-ancestor
92253542|NCT05750628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92253543|NCT05750628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92253544|NCT05750628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253545|NCT05731518|Irinotecan|irinotecan|mesh-list
92253546|NCT05731518|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92253547|NCT05731518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92253548|NCT05731518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253549|NCT05731518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253550|NCT05731518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253551|NCT05728944|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92253552|NCT05728944|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92253553|NCT05728944|Aceclidine|aceclidine|mesh-list
92253554|NCT05728944|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92253555|NCT05728944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92253556|NCT05728944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92253557|NCT05728944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92253558|NCT05728944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92253559|NCT05728944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253560|NCT05728944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253561|NCT05728944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253562|NCT05728944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253563|NCT05728944|Miotics|miotics|mesh-ancestor
92253564|NCT05728944|Autonomic Agents|autonomic agents|mesh-ancestor
92253565|NCT05728944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253566|NCT05728944|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92253567|NCT05724108|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92253568|NCT05724108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253569|NCT05724108|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92253570|NCT05722561|Nicotine|nicotine|mesh-list
92253571|NCT05722561|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92253572|NCT05722561|Autonomic Agents|autonomic agents|mesh-ancestor
92253573|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253574|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253575|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92253576|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92253577|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
92253578|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253579|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253580|NCT05712278|Cytarabine|cytarabine|mesh-list
92253581|NCT05712278|Fludarabine|fludarabine|mesh-list
92253582|NCT05712278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253583|NCT05712278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92253584|NCT05712278|Antimetabolites|antimetabolites|mesh-ancestor
92253585|NCT05712278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253586|NCT05712278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253587|NCT05712278|Immunologic Factors|immunologic factors|mesh-ancestor
92253588|NCT05712278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253589|NCT05712278|Antiviral Agents|antiviral agents|mesh-ancestor
92253590|NCT05712278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253591|NCT05696795|Abrocitinib|abrocitinib|mesh-list
92253592|NCT05696795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253593|NCT05696795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253594|NCT05696795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253596|NCT05687123|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92342588|NCT00004091|Immunologic Factors|immunologic factors|mesh-ancestor
92342590|NCT00004097|Paclitaxel|paclitaxel|mesh-list
92253597|NCT05687123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253598|NCT05687123|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92253599|NCT05687123|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92253600|NCT05687123|Growth Substances|growth substances|mesh-ancestor
92253601|NCT05687123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253602|NCT05687123|Growth Inhibitors|growth inhibitors|mesh-ancestor
92253603|NCT05687123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253604|NCT05687123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253605|NCT05687123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253606|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92253607|NCT05687110|Novobiocin|novobiocin|mesh-list
92253608|NCT05687110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92253609|NCT05687110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253610|NCT05687110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253611|NCT05687110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253612|NCT05687110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92253614|NCT05683392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253615|NCT05683392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253616|NCT05674565|Magnesium Sulfate|magnesium sulfate|mesh-list
92253617|NCT05674565|Analgesics|analgesics|mesh-ancestor
92253618|NCT05674565|Sensory System Agents|sensory system agents|mesh-ancestor
92253619|NCT05674565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253620|NCT05674565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253621|NCT05674565|Anesthetics|anesthetics|mesh-ancestor
92253622|NCT05674565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253623|NCT05674565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92253624|NCT05674565|Anticonvulsants|anticonvulsants|mesh-ancestor
92253625|NCT05674565|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92253626|NCT05674565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92253627|NCT05674565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253628|NCT05674565|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92253629|NCT05674565|Tocolytic Agents|tocolytic agents|mesh-ancestor
92253630|NCT05674565|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92253631|NCT05669664|Leuprolide|leuprolide|mesh-list
92253632|NCT05669664|Androgen Antagonists|androgen antagonists|mesh-list
92253633|NCT05669664|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92253634|NCT05669664|Fertility Agents|fertility agents|mesh-ancestor
92253635|NCT05669664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92253636|NCT05669664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253637|NCT05669664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92253638|NCT05669664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253639|NCT05669664|Hormone Antagonists|hormone antagonists|mesh-ancestor
92253640|NCT05669664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92253641|NCT05664737|Luspatercept|luspatercept|mesh-list
92253642|NCT05664737|Hematinics|hematinics|mesh-ancestor
92253643|NCT05656027|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92253644|NCT05656027|Aceclidine|aceclidine|mesh-list
92253645|NCT05656027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92253646|NCT05656027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92253647|NCT05656027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92253648|NCT05656027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92253649|NCT05656027|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253650|NCT05656027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253651|NCT05656027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253652|NCT05656027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253653|NCT05656027|Miotics|miotics|mesh-ancestor
92253654|NCT05656027|Autonomic Agents|autonomic agents|mesh-ancestor
92253655|NCT05656027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253656|NCT05656027|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92253657|NCT05651711|KHK4083|khk4083|mesh-list
92253658|NCT05651711|Dermatologic Agents|dermatologic agents|mesh-ancestor
92253659|NCT05618925|Cyclophosphamide|cyclophosphamide|mesh-list
92253660|NCT05618925|Rituximab|rituximab|mesh-list
92253661|NCT05618925|Fludarabine|fludarabine|mesh-list
92253662|NCT05618925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253663|NCT05618925|Immunologic Factors|immunologic factors|mesh-ancestor
92253664|NCT05618925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342595|NCT00004097|Tubulin Modulators|tubulin modulators|mesh-ancestor
92253665|NCT05618925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253666|NCT05618925|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92253667|NCT05618925|Alkylating Agents|alkylating agents|mesh-ancestor
92253668|NCT05618925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253669|NCT05618925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253670|NCT05618925|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92253671|NCT05618925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253672|NCT05600894|Decitabine|decitabine|mesh-list
92253673|NCT05600894|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92253674|NCT05600894|Venetoclax|venetoclax|mesh-list
92253675|NCT05600894|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92253676|NCT05600894|Antimetabolites|antimetabolites|mesh-ancestor
92253677|NCT05600894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253678|NCT05600894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253679|NCT05600894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253680|NCT05554276|Antibodies|antibodies|mesh-list
92253681|NCT05554276|Immunologic Factors|immunologic factors|mesh-ancestor
92253682|NCT05554276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253683|NCT05531942|Aspirin|aspirin|mesh-list
92253684|NCT05531942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92253685|NCT05531942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92253686|NCT05531942|Analgesics|analgesics|mesh-ancestor
92253687|NCT05531942|Sensory System Agents|sensory system agents|mesh-ancestor
92253688|NCT05531942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253689|NCT05531942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253690|NCT05531942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92253691|NCT05531942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253692|NCT05531942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92253693|NCT05531942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92253694|NCT05531942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253695|NCT05531942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92253696|NCT05531942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92253697|NCT05531942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253698|NCT05531942|Antipyretics|antipyretics|mesh-ancestor
92253699|NCT05479916|Caseins|caseins|mesh-list
92253700|NCT05479916|Chelating Agents|chelating agents|mesh-ancestor
92253701|NCT05479916|Sequestering Agents|sequestering agents|mesh-ancestor
92253702|NCT05479916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253703|NCT05466279|Midazolam|midazolam|mesh-list
92253704|NCT05466279|Propofol|propofol|mesh-list
92253705|NCT05466279|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92253706|NCT05466279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253707|NCT05466279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253708|NCT05466279|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92253709|NCT05466279|Anesthetics, General|anesthetics, general|mesh-ancestor
92253710|NCT05466279|Anesthetics|anesthetics|mesh-ancestor
92253711|NCT05466279|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92253712|NCT05466279|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92253713|NCT05466279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92253714|NCT05466279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92253715|NCT05466279|GABA Modulators|gaba modulators|mesh-ancestor
92253716|NCT05466279|GABA Agents|gaba agents|mesh-ancestor
92253717|NCT05466279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253718|NCT05466279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253719|NCT05458856|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92253720|NCT05458856|Luteolytic Agents|luteolytic agents|mesh-ancestor
92253721|NCT05458856|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92253722|NCT05458856|Contraceptive Agents|contraceptive agents|mesh-ancestor
92253723|NCT05458856|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92253724|NCT05458856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253725|NCT05458856|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92253726|NCT05458856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92253727|NCT05458856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253728|NCT05451940|Hydroxyurea|hydroxyurea|mesh-list
92253729|NCT05451940|Epoetin Alfa|epoetin alfa|mesh-list
92253730|NCT05451940|Hematinics|hematinics|mesh-list
92253731|NCT05451940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253732|NCT05451940|Antisickling Agents|antisickling agents|mesh-ancestor
92253733|NCT05451940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253734|NCT05451940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253735|NCT05451940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92253736|NCT05447559|Cefazolin|cefazolin|mesh-list
92253737|NCT05447559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92253738|NCT05447559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253739|NCT05425420|Methadone|methadone|mesh-list
92253740|NCT05425420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92253741|NCT05425420|Narcotics|narcotics|mesh-ancestor
92253742|NCT05425420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253743|NCT05425420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253744|NCT05425420|Analgesics|analgesics|mesh-ancestor
92253745|NCT05425420|Sensory System Agents|sensory system agents|mesh-ancestor
92253746|NCT05425420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253747|NCT05425420|Antitussive Agents|antitussive agents|mesh-ancestor
92253748|NCT05425420|Respiratory System Agents|respiratory system agents|mesh-ancestor
92253749|NCT05422794|Paclitaxel|paclitaxel|mesh-list
92253750|NCT05422794|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92253751|NCT05422794|Pembrolizumab|pembrolizumab|mesh-list
92253752|NCT05422794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92253753|NCT05422794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253754|NCT05422794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92253755|NCT05422794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92253756|NCT05422794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92253757|NCT05422794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253758|NCT05422794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253759|NCT05422794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253760|NCT05422664|Lacosamide|lacosamide|mesh-list
92253761|NCT05422664|Anticonvulsants|anticonvulsants|mesh-ancestor
92253762|NCT05422664|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92253763|NCT05422664|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92253764|NCT05422664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92253765|NCT05422664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253766|NCT05411497|Cyclophosphamide|cyclophosphamide|mesh-list
92253767|NCT05411497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253768|NCT05411497|Immunologic Factors|immunologic factors|mesh-ancestor
92253769|NCT05411497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253770|NCT05411497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253771|NCT05411497|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92253772|NCT05411497|Alkylating Agents|alkylating agents|mesh-ancestor
92253773|NCT05411497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253774|NCT05411497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253775|NCT05411497|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92253776|NCT05411094|Durvalumab|durvalumab|mesh-list
92253777|NCT05411094|Olaparib|olaparib|mesh-list
92253778|NCT05411094|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92253779|NCT05411094|Immunoglobulins|immunoglobulins|mesh-list
92253780|NCT05411094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92253781|NCT05411094|Immunoglobulin G|immunoglobulin g|mesh-list
92253782|NCT05411094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253783|NCT05411094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253784|NCT05411094|Immunologic Factors|immunologic factors|mesh-ancestor
92253785|NCT05411094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253786|NCT05411094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253787|NCT05411094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253788|NCT05407961|Dulaglutide|dulaglutide|mesh-list
92253789|NCT05407961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253790|NCT05407961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253791|NCT05403086|Ketamine|ketamine|mesh-list
92253792|NCT05403086|Psilocybin|psilocybin|mesh-list
92253793|NCT05403086|Hallucinogens|hallucinogens|mesh-list
92253794|NCT05403086|Analgesics|analgesics|mesh-ancestor
92253795|NCT05403086|Sensory System Agents|sensory system agents|mesh-ancestor
92253796|NCT05403086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253797|NCT05403086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253798|NCT05403086|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92253799|NCT05403086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92253800|NCT05403086|Anesthetics, General|anesthetics, general|mesh-ancestor
92253801|NCT05403086|Anesthetics|anesthetics|mesh-ancestor
92253802|NCT05403086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253803|NCT05403086|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92253804|NCT05403086|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92253805|NCT05403086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253806|NCT05403086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253807|NCT05403086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92253808|NCT05400109|Cyclophosphamide|cyclophosphamide|mesh-list
92253809|NCT05400109|Fludarabine|fludarabine|mesh-list
92253810|NCT05400109|Fludarabine phosphate|fludarabine phosphate|mesh-list
92253811|NCT05400109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253812|NCT05400109|Immunologic Factors|immunologic factors|mesh-ancestor
92253813|NCT05400109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253814|NCT05400109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253815|NCT05400109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92253816|NCT05400109|Alkylating Agents|alkylating agents|mesh-ancestor
92253817|NCT05400109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253818|NCT05400109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253819|NCT05400109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92253820|NCT05400109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92253821|NCT05400109|Antimetabolites|antimetabolites|mesh-ancestor
92253822|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
92253823|NCT05388929|Methocarbamol|methocarbamol|mesh-list
92253824|NCT05388929|Narcotics|narcotics|mesh-ancestor
92253825|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253826|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253827|NCT05388929|Analgesics|analgesics|mesh-ancestor
92253828|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
92253829|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253830|NCT05388929|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92253831|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92253832|NCT05350202|Empagliflozin|empagliflozin|mesh-list
92253833|NCT05350202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92253834|NCT05350202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253835|NCT05350202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92253836|NCT05350202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253837|NCT05341583|Ensartinib|ensartinib|mesh-list
92253838|NCT05341583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253839|NCT05341583|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253840|NCT05341583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253841|NCT05341583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253842|NCT05269004|Ocrelizumab|ocrelizumab|mesh-list
92253843|NCT05269004|Immunologic Factors|immunologic factors|mesh-ancestor
92253844|NCT05269004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253845|NCT05256069|Propranolol|propranolol|mesh-list
92253846|NCT05256069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92253847|NCT05256069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92253848|NCT05256069|Adrenergic Agents|adrenergic agents|mesh-ancestor
92253849|NCT05256069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253850|NCT05256069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253851|NCT05256069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253852|NCT05256069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92253853|NCT05256069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92253854|NCT05256069|Vasodilator Agents|vasodilator agents|mesh-ancestor
92253855|NCT05218499|Doxorubicin|doxorubicin|mesh-list
92253856|NCT05218499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92253857|NCT05218499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253858|NCT05218499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92253859|NCT05218499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92253860|NCT05218499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253861|NCT05218499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253862|NCT05199571|Ofatumumab|ofatumumab|mesh-list
92253863|NCT05199571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253864|NCT05190315|Temozolomide|temozolomide|mesh-list
92253865|NCT05190315|Chlorpromazine|chlorpromazine|mesh-list
92253866|NCT05190315|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92253867|NCT05190315|Alkylating Agents|alkylating agents|mesh-ancestor
92253868|NCT05190315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253869|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253870|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
92253871|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
92253872|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92253873|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253874|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92253875|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92253876|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92253877|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253878|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92253879|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92253880|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
92253881|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253882|NCT05160805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92253883|NCT05160805|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92253884|NCT05155436|Amlodipine|amlodipine|mesh-list
92253885|NCT05155436|Telmisartan|telmisartan|mesh-list
92253886|NCT05155436|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92253887|NCT05155436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92253888|NCT05155436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92253889|NCT05155436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253890|NCT05155436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92253891|NCT05155436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253892|NCT05155436|Vasodilator Agents|vasodilator agents|mesh-ancestor
92253893|NCT05155436|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92253894|NCT05155436|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92253895|NCT05128487|Pembrolizumab|pembrolizumab|mesh-list
92253896|NCT05128487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253897|NCT05128487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253898|NCT05128487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253899|NCT05128487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253901|NCT05111626|Bemarituzumab|bemarituzumab|mesh-list
92253902|NCT05111626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253903|NCT05111626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253904|NCT05111626|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253905|NCT05111626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253907|NCT05103696|Etomidate|etomidate|mesh-list
92253908|NCT05103696|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92253909|NCT05103696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92253910|NCT05103696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253911|NCT05103696|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92253912|NCT05103696|Anesthetics, General|anesthetics, general|mesh-ancestor
92253913|NCT05103696|Anesthetics|anesthetics|mesh-ancestor
92253914|NCT05041309|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92253915|NCT05041309|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92253916|NCT05041309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253917|NCT05041309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253918|NCT05030311|Remibrutinib|remibrutinib|mesh-list
92253919|NCT05030311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92253920|NCT05030311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253921|NCT05030311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253922|NCT04984811|Atezolizumab|atezolizumab|mesh-list
92253923|NCT04984811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92253924|NCT04984811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253925|NCT04984811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92253926|NCT04984811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253927|NCT04981041|Clopidogrel|clopidogrel|mesh-list
92253928|NCT04981041|Ticagrelor|ticagrelor|mesh-list
92253929|NCT04981041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92253930|NCT04981041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92253931|NCT04981041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92253932|NCT04981041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92253933|NCT04981041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92253934|NCT04981041|Purinergic Agents|purinergic agents|mesh-ancestor
92253935|NCT04981041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92253936|NCT04981041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253937|NCT04981041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253938|NCT04915755|Niraparib|niraparib|mesh-list
92253939|NCT04915755|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92253940|NCT04915755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253941|NCT04915755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253942|NCT04915755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253943|NCT04898725|Vitamin D|vitamin d|mesh-list
92253944|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
92253945|NCT04898725|Vitamins|vitamins|mesh-ancestor
92253946|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
92253947|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253948|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92253949|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92253950|NCT04894435|Vaccines|vaccines|mesh-list
92253951|NCT04894435|Immunologic Factors|immunologic factors|mesh-ancestor
92253952|NCT04894435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253953|NCT04878432|Azacitidine|azacitidine|mesh-list
92253954|NCT04878432|Decitabine|decitabine|mesh-list
92253955|NCT04878432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92253956|NCT04878432|Antimetabolites|antimetabolites|mesh-ancestor
92253957|NCT04878432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253958|NCT04878432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253959|NCT04878432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253960|NCT04878211|Interferons|interferons|mesh-list
92253961|NCT04878211|Ofatumumab|ofatumumab|mesh-list
92253962|NCT04878211|Glatiramer Acetate|glatiramer acetate|mesh-list
92253963|NCT04878211|(T,G)-A-L|(t,g)-a-l|mesh-list
92253964|NCT04878211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92253965|NCT04878211|Antiviral Agents|antiviral agents|mesh-ancestor
92253966|NCT04878211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253967|NCT04878211|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92253968|NCT04878211|Immunologic Factors|immunologic factors|mesh-ancestor
92253969|NCT04878211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92253970|NCT04878211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92253971|NCT04878211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92253972|NCT04862975|Tenofovir|tenofovir|mesh-list
92253973|NCT04862975|Emtricitabine|emtricitabine|mesh-list
92253974|NCT04862975|Efavirenz|efavirenz|mesh-list
92253975|NCT04862975|Dolutegravir|dolutegravir|mesh-list
92253976|NCT04862975|Antiviral Agents|antiviral agents|mesh-ancestor
92253977|NCT04862975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92253978|NCT04862975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92253979|NCT04862975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92253980|NCT04862975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253981|NCT04862975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253982|NCT04862975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92253983|NCT04862975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92253984|NCT04862975|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92253985|NCT04862975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92253986|NCT04862975|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92253987|NCT04862975|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92253988|NCT04862975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92253989|NCT04862975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92253990|NCT04862975|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92253991|NCT04862975|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92253992|NCT04840550|Lansoprazole|lansoprazole|mesh-list
92253993|NCT04840550|Dexlansoprazole|dexlansoprazole|mesh-list
92253994|NCT04840550|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92253995|NCT04840550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92253996|NCT04840550|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92253997|NCT04840550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92253998|NCT04840550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92253999|NCT04789408|Cyclophosphamide|cyclophosphamide|mesh-list
92254000|NCT04789408|Fludarabine|fludarabine|mesh-list
92254001|NCT04789408|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254002|NCT04789408|Immunologic Factors|immunologic factors|mesh-ancestor
92254003|NCT04789408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254004|NCT04789408|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254005|NCT04789408|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254006|NCT04789408|Alkylating Agents|alkylating agents|mesh-ancestor
92254007|NCT04789408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254008|NCT04789408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254009|NCT04789408|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254010|NCT04788615|Interferons|interferons|mesh-list
92254011|NCT04788615|Interferon-beta|interferon-beta|mesh-list
92254012|NCT04788615|Interferon beta-1a|interferon beta-1a|mesh-list
92254013|NCT04788615|Teriflunomide|teriflunomide|mesh-list
92254014|NCT04788615|Ofatumumab|ofatumumab|mesh-list
92254015|NCT04788615|Glatiramer Acetate|glatiramer acetate|mesh-list
92254016|NCT04788615|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92254017|NCT04788615|(T,G)-A-L|(t,g)-a-l|mesh-list
92254018|NCT04788615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254019|NCT04788615|Antiviral Agents|antiviral agents|mesh-ancestor
92254020|NCT04788615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254021|NCT04788615|Immunologic Factors|immunologic factors|mesh-ancestor
92254022|NCT04788615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254023|NCT04788615|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92254024|NCT04788615|Dermatologic Agents|dermatologic agents|mesh-ancestor
92254025|NCT04788615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254026|NCT04788615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254027|NCT04788615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92254028|NCT04788615|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92254029|NCT04788615|Analgesics|analgesics|mesh-ancestor
92254030|NCT04788615|Sensory System Agents|sensory system agents|mesh-ancestor
92254031|NCT04788615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254032|NCT04788615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254033|NCT04762069|Lomustine|lomustine|mesh-list
92254034|NCT04762069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254035|NCT04762069|Alkylating Agents|alkylating agents|mesh-ancestor
92254036|NCT04762069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254037|NCT04762069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254038|NCT04756063|Ascorbic Acid|ascorbic acid|mesh-list
92254039|NCT04756063|Vitamins|vitamins|mesh-ancestor
92254040|NCT04756063|Micronutrients|micronutrients|mesh-ancestor
92254041|NCT04756063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254042|NCT04756063|Antioxidants|antioxidants|mesh-ancestor
92254043|NCT04756063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254044|NCT04756063|Protective Agents|protective agents|mesh-ancestor
92254045|NCT04747496|Edoxaban|edoxaban|mesh-list
92254046|NCT04747496|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92254047|NCT04747496|Antithrombins|antithrombins|mesh-ancestor
92254048|NCT04747496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92254049|NCT04747496|Protease Inhibitors|protease inhibitors|mesh-ancestor
92254050|NCT04747496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254051|NCT04747496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254053|NCT04744662|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92254054|NCT04744662|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92254055|NCT04736745|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92254056|NCT04736745|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92254057|NCT04736745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92254058|NCT04736745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254059|NCT04736745|Cholinergic Agents|cholinergic agents|mesh-ancestor
92254060|NCT04736745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254061|NCT04736745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254062|NCT04731844|Curcumin|curcumin|mesh-list
92254063|NCT04731844|Piperine|piperine|mesh-list
92254064|NCT04731844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92254065|NCT04731844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92254066|NCT04731844|Analgesics|analgesics|mesh-ancestor
92254067|NCT04731844|Sensory System Agents|sensory system agents|mesh-ancestor
92254068|NCT04731844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254069|NCT04731844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254070|NCT04731844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254071|NCT04731844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254072|NCT04731844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254073|NCT04731844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254074|NCT04731844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254075|NCT04731844|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92254076|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
92254077|NCT04660539|Azathioprine|azathioprine|mesh-list
92254078|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92254079|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254080|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92254081|NCT04660539|Antitubercular Agents|antitubercular agents|mesh-ancestor
92254082|NCT04660539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254083|NCT04660539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254084|NCT04660539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254085|NCT04660539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254086|NCT04660539|Antimetabolites|antimetabolites|mesh-ancestor
92254087|NCT04660539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342622|NCT00003239|Cytarabine|cytarabine|mesh-list
92254088|NCT04660539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254089|NCT04660539|Immunologic Factors|immunologic factors|mesh-ancestor
92254090|NCT04660539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254091|NCT04660539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254092|NCT04595370|Dapagliflozin|dapagliflozin|mesh-list
92254093|NCT04595370|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92254094|NCT04595370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254095|NCT04595370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92254096|NCT04595370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254097|NCT04521231|Blinatumomab|blinatumomab|mesh-list
92254098|NCT04521231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254099|NCT04520607|Lorecivivint|lorecivivint|mesh-list
92254100|NCT04520607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254101|NCT04512365|Dronabinol|dronabinol|mesh-list
92254102|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
92254103|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254104|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92254105|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92254106|NCT04512365|Analgesics|analgesics|mesh-ancestor
92254107|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
92254108|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254109|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92254110|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92254111|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254112|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254114|NCT04512365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254115|NCT04491942|Cisplatin|cisplatin|mesh-list
92254116|NCT04491942|Gemcitabine|gemcitabine|mesh-list
92254117|NCT04491942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254118|NCT04491942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92254119|NCT04491942|Antimetabolites|antimetabolites|mesh-ancestor
92254120|NCT04491942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254121|NCT04480853|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92254122|NCT04480853|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92254123|NCT04480853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254124|NCT04480853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254125|NCT04480853|Immunologic Factors|immunologic factors|mesh-ancestor
92254126|NCT04480853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254128|NCT04468984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254129|NCT04452214|Carboplatin|carboplatin|mesh-list
92254130|NCT04452214|Pembrolizumab|pembrolizumab|mesh-list
92254131|NCT04452214|Pemetrexed|pemetrexed|mesh-list
92254132|NCT04452214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254133|NCT04452214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254134|NCT04452214|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254135|NCT04452214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254136|NCT04452214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254137|NCT04452214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92254138|NCT04452214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92254139|NCT04438512|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92254140|NCT04438512|Hallucinogens|hallucinogens|mesh-ancestor
92254141|NCT04438512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254142|NCT04438512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92254143|NCT04438512|Serotonin Agents|serotonin agents|mesh-ancestor
92254144|NCT04438512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254145|NCT04438512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254146|NCT04438512|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92254147|NCT04438512|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92254148|NCT04438512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92254149|NCT04438512|Adrenergic Agents|adrenergic agents|mesh-ancestor
92254150|NCT04431258|Folfirinox|folfirinox|mesh-list
92254151|NCT04431258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254152|NCT04417621|Trametinib|trametinib|mesh-list
92254153|NCT04417621|Naporafenib|naporafenib|mesh-list
92254154|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254155|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254156|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254157|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254158|NCT04398719|Capsaicin|capsaicin|mesh-list
92254159|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
92254160|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
92254161|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
92254162|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254163|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254164|NCT04394624|Pembrolizumab|pembrolizumab|mesh-list
92254165|NCT04394624|Ramucirumab|ramucirumab|mesh-list
92254166|NCT04394624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254167|NCT04394624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254168|NCT04394624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254169|NCT04394624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254170|NCT04373317|Pimavanserin|pimavanserin|mesh-list
92254171|NCT04373317|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92254172|NCT04373317|Antidepressive Agents|antidepressive agents|mesh-ancestor
92254173|NCT04373317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92254174|NCT04373317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92254175|NCT04373317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92254176|NCT04373317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254177|NCT04373317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254178|NCT04373317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92254179|NCT04373317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92254180|NCT04373317|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92254181|NCT04373317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92254182|NCT04373317|Serotonin Agents|serotonin agents|mesh-ancestor
92254183|NCT04373317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254184|NCT04373317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254185|NCT04339270|Azithromycin|azithromycin|mesh-list
92254186|NCT04339270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254187|NCT04339270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254188|NCT04317105|Nivolumab|nivolumab|mesh-list
92254189|NCT04317105|Ipilimumab|ipilimumab|mesh-list
92254190|NCT04317105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254191|NCT04317105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254192|NCT04317105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254193|NCT04317105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254194|NCT04262193|Suvorexant|suvorexant|mesh-list
92254195|NCT04262193|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92254196|NCT04262193|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92254197|NCT04262193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254198|NCT04262193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254199|NCT04262193|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92254200|NCT04262193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254201|NCT04262193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254202|NCT04261439|Tislelizumab|tislelizumab|mesh-list
92254203|NCT04261439|Spartalizumab|spartalizumab|mesh-list
92254204|NCT04261439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254205|NCT04261439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254206|NCT04261439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254207|NCT04261439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254208|NCT04225598|Buprenorphine|buprenorphine|mesh-list
92254209|NCT04225598|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92254210|NCT04225598|Narcotics|narcotics|mesh-ancestor
92254211|NCT04225598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254212|NCT04225598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254213|NCT04225598|Analgesics|analgesics|mesh-ancestor
92254214|NCT04225598|Sensory System Agents|sensory system agents|mesh-ancestor
92254215|NCT04225598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254216|NCT04225598|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92254217|NCT04207944|Sulindac|sulindac|mesh-list
92254218|NCT04207944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92254219|NCT04207944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92254220|NCT04207944|Analgesics|analgesics|mesh-ancestor
92254221|NCT04207944|Sensory System Agents|sensory system agents|mesh-ancestor
92254222|NCT04207944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254223|NCT04207944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254224|NCT04207944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995144|NCT02003209|Docetaxel|docetaxel|mesh-list
92254225|NCT04207944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254226|NCT04207944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254227|NCT04207944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92254228|NCT04207944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254229|NCT04207944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254231|NCT04184622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92254232|NCT04184622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254233|NCT04184622|Incretins|incretins|mesh-ancestor
92254234|NCT04184622|Hormones|hormones|mesh-ancestor
92254235|NCT04184622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254236|NCT04179864|Prednisone|prednisone|mesh-list
92254237|NCT04179864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254238|NCT04179864|Glucocorticoids|glucocorticoids|mesh-ancestor
92254239|NCT04179864|Hormones|hormones|mesh-ancestor
92254240|NCT04179864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254241|NCT04179864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254242|NCT04179864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92254243|NCT04179864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254244|NCT04172532|Peposertib|peposertib|mesh-list
92254245|NCT04172532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254246|NCT04172532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254247|NCT04172532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254248|NCT04108156|Ranibizumab|ranibizumab|mesh-list
92254249|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92254250|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92254251|NCT04108156|Growth Substances|growth substances|mesh-ancestor
92254252|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254253|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
92254254|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254255|NCT04080427|Dronabinol|dronabinol|mesh-list
92254256|NCT04080427|Hallucinogens|hallucinogens|mesh-ancestor
92254257|NCT04080427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254258|NCT04080427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92254259|NCT04080427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92254260|NCT04080427|Analgesics|analgesics|mesh-ancestor
92254261|NCT04080427|Sensory System Agents|sensory system agents|mesh-ancestor
92254262|NCT04080427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254263|NCT04080427|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92254264|NCT04080427|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92254265|NCT04080427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254266|NCT04080427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254267|NCT04080427|Hormones|hormones|mesh-ancestor
92254268|NCT04080427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254269|NCT04071366|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92254270|NCT04071366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254271|NCT04071366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254272|NCT04032704|Pembrolizumab|pembrolizumab|mesh-list
92254273|NCT04032704|SGN-LIV1A|sgn-liv1a|mesh-list
92254274|NCT04032704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254275|NCT04032704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254276|NCT04032704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254277|NCT04032704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254278|NCT04032704|Immunoconjugates|immunoconjugates|mesh-ancestor
92254279|NCT04032704|Immunologic Factors|immunologic factors|mesh-ancestor
92254280|NCT04032704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254281|NCT03941262|Pembrolizumab|pembrolizumab|mesh-list
92254282|NCT03941262|Avelumab|avelumab|mesh-list
92254283|NCT03941262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254284|NCT03941262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254285|NCT03941262|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254286|NCT03941262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254287|NCT03933631|Ofloxacin|ofloxacin|mesh-list
92254288|NCT03933631|Prednisolone|prednisolone|mesh-list
92254289|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
92254290|NCT03933631|Pilocarpine|pilocarpine|mesh-list
92254291|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254292|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
92254293|NCT03933631|Hormones|hormones|mesh-ancestor
92117694|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
92254294|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254296|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92254297|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254298|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
92254299|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254300|NCT03933631|Miotics|miotics|mesh-ancestor
92254301|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92254302|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92254303|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
92254304|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254305|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254306|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92254307|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254308|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254309|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92254310|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92254311|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254312|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92254313|NCT03933631|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92254314|NCT03919435|Trimethoprim|trimethoprim|mesh-list
92254315|NCT03919435|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92254316|NCT03919435|Sulfamethoxazole|sulfamethoxazole|mesh-list
92254317|NCT03919435|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92254318|NCT03919435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254319|NCT03919435|Antimalarials|antimalarials|mesh-ancestor
91934926|NCT02307721|Naloxone|naloxone|mesh-list
92254320|NCT03919435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92254321|NCT03919435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92254322|NCT03919435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92254323|NCT03919435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254324|NCT03919435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254325|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92254326|NCT03919435|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92254327|NCT03919435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92254328|NCT03919435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254329|NCT03914625|Calcium, Dietary|calcium, dietary|mesh-list
92254331|NCT03914625|Folic Acid|folic acid|mesh-list
92254332|NCT03914625|Cytarabine|cytarabine|mesh-list
92254333|NCT03914625|Dexamethasone|dexamethasone|mesh-list
92254334|NCT03914625|Dexamethasone acetate|dexamethasone acetate|mesh-list
92254335|NCT03914625|Prednisone|prednisone|mesh-list
92254336|NCT03914625|Prednisolone|prednisolone|mesh-list
92254337|NCT03914625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92254338|NCT03914625|Methylprednisolone|methylprednisolone|mesh-list
92254339|NCT03914625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92254340|NCT03914625|Prednisolone acetate|prednisolone acetate|mesh-list
92254341|NCT03914625|Hydrocortisone|hydrocortisone|mesh-list
92254342|NCT03914625|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92254343|NCT03914625|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92254344|NCT03914625|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92254345|NCT03914625|Cortisone|cortisone|mesh-list
92254346|NCT03914625|Cyclophosphamide|cyclophosphamide|mesh-list
92254347|NCT03914625|Doxorubicin|doxorubicin|mesh-list
92254348|NCT03914625|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92254349|NCT03914625|Methotrexate|methotrexate|mesh-list
92254350|NCT03914625|Vincristine|vincristine|mesh-list
92254351|NCT03914625|Asparaginase|asparaginase|mesh-list
92254352|NCT03914625|Mercaptopurine|mercaptopurine|mesh-list
92254353|NCT03914625|Pegaspargase|pegaspargase|mesh-list
92254354|NCT03914625|Thioguanine|thioguanine|mesh-list
92254355|NCT03914625|Blinatumomab|blinatumomab|mesh-list
92254356|NCT03914625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92254357|NCT03914625|Muromonab-CD3|muromonab-cd3|mesh-list
92254358|NCT03914625|Antibodies|antibodies|mesh-list
92254359|NCT03914625|Immunoglobulins|immunoglobulins|mesh-list
92254360|NCT03914625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92254361|NCT03914625|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92254362|NCT03914625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92254363|NCT03914625|Prednisolone phosphate|prednisolone phosphate|mesh-list
92254364|NCT03914625|BB 1101|bb 1101|mesh-list
92254365|NCT03914625|Calcium|calcium|mesh-list
92254366|NCT03914625|2-Aminopurine|2-aminopurine|mesh-list
92254367|NCT03914625|Levoleucovorin|levoleucovorin|mesh-list
92254368|NCT03914625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254369|NCT03914625|Immunologic Factors|immunologic factors|mesh-ancestor
92254370|NCT03914625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254371|NCT03914625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254372|NCT03914625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254373|NCT03914625|Alkylating Agents|alkylating agents|mesh-ancestor
92254374|NCT03914625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254375|NCT03914625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254376|NCT03914625|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254377|NCT03914625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254378|NCT03914625|Antiemetics|antiemetics|mesh-ancestor
92254379|NCT03914625|Autonomic Agents|autonomic agents|mesh-ancestor
92254380|NCT03914625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254381|NCT03914625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92254382|NCT03914625|Glucocorticoids|glucocorticoids|mesh-ancestor
92254383|NCT03914625|Hormones|hormones|mesh-ancestor
92254384|NCT03914625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254385|NCT03914625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92254386|NCT03914625|Protease Inhibitors|protease inhibitors|mesh-ancestor
92254387|NCT03914625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254388|NCT03914625|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92254389|NCT03914625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92254390|NCT03914625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92254391|NCT03914625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92254392|NCT03914625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92254393|NCT03914625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92254394|NCT03914625|Abortifacient Agents|abortifacient agents|mesh-ancestor
92254395|NCT03914625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92254396|NCT03914625|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92254397|NCT03914625|Antimetabolites|antimetabolites|mesh-ancestor
92254398|NCT03914625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92254399|NCT03914625|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92254400|NCT03914625|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92254401|NCT03914625|Antiviral Agents|antiviral agents|mesh-ancestor
92254402|NCT03914625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254403|NCT03914625|Antidotes|antidotes|mesh-ancestor
92254404|NCT03914625|Protective Agents|protective agents|mesh-ancestor
92254405|NCT03914625|Vitamin B Complex|vitamin b complex|mesh-ancestor
92254406|NCT03914625|Vitamins|vitamins|mesh-ancestor
92254407|NCT03914625|Micronutrients|micronutrients|mesh-ancestor
92254408|NCT03914625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92254409|NCT03914625|Tubulin Modulators|tubulin modulators|mesh-ancestor
92254410|NCT03914625|Antimitotic Agents|antimitotic agents|mesh-ancestor
92254411|NCT03914625|Mitosis Modulators|mitosis modulators|mesh-ancestor
92254412|NCT03914625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92254414|NCT03911414|Inositol|inositol|mesh-list
92254415|NCT03911414|Acetylcysteine|acetylcysteine|mesh-list
92254416|NCT03911414|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92254417|NCT03911414|Antiviral Agents|antiviral agents|mesh-ancestor
92254418|NCT03911414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254419|NCT03911414|Expectorants|expectorants|mesh-ancestor
92254420|NCT03911414|Respiratory System Agents|respiratory system agents|mesh-ancestor
92254421|NCT03911414|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92254422|NCT03911414|Antioxidants|antioxidants|mesh-ancestor
92254423|NCT03911414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254424|NCT03911414|Protective Agents|protective agents|mesh-ancestor
92254425|NCT03911414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254426|NCT03911414|Antidotes|antidotes|mesh-ancestor
92254427|NCT03911414|Vitamin B Complex|vitamin b complex|mesh-ancestor
92254428|NCT03911414|Vitamins|vitamins|mesh-ancestor
92254429|NCT03911414|Micronutrients|micronutrients|mesh-ancestor
92254430|NCT03909334|Osimertinib|osimertinib|mesh-list
92254431|NCT03909334|Ramucirumab|ramucirumab|mesh-list
92254432|NCT03909334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254433|NCT03909334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254434|NCT03909334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254435|NCT03909334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254436|NCT03901001|Sirolimus|sirolimus|mesh-list
92254437|NCT03901001|Oseltamivir|oseltamivir|mesh-list
92254438|NCT03901001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254439|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254440|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92254441|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254442|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
92254443|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254444|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
92254445|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254446|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254447|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254448|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
92254449|NCT03900988|Acetylcysteine|acetylcysteine|mesh-list
92254450|NCT03900988|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92254451|NCT03900988|Antiviral Agents|antiviral agents|mesh-ancestor
92254452|NCT03900988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254453|NCT03900988|Expectorants|expectorants|mesh-ancestor
92254454|NCT03900988|Respiratory System Agents|respiratory system agents|mesh-ancestor
92254455|NCT03900988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92254456|NCT03900988|Antioxidants|antioxidants|mesh-ancestor
92254457|NCT03900988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254458|NCT03900988|Protective Agents|protective agents|mesh-ancestor
92254459|NCT03900988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254460|NCT03900988|Antidotes|antidotes|mesh-ancestor
92254461|NCT03900754|Oxytocin|oxytocin|mesh-list
92254462|NCT03900754|Oxytocics|oxytocics|mesh-ancestor
92254463|NCT03900754|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92254464|NCT03900754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254465|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
92254466|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92254467|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92254468|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254469|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92254470|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254471|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92254472|NCT03854474|Pembrolizumab|pembrolizumab|mesh-list
92254473|NCT03854474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254474|NCT03854474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254475|NCT03854474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254476|NCT03854474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254477|NCT03781414|Tacrolimus|tacrolimus|mesh-list
92254478|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254479|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
92254480|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254481|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92254482|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254483|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254484|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
92254485|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92254486|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
92254487|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92254488|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
92254489|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254490|NCT03740100|MTOR Inhibitors|mtor inhibitors|mesh-list
92254491|NCT03740100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254492|NCT03740100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254493|NCT03740100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254494|NCT03740100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254495|NCT03740100|Immunologic Factors|immunologic factors|mesh-ancestor
92254496|NCT03740100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254497|NCT03740100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254498|NCT03729869|Progesterone|progesterone|mesh-list
92254499|NCT03729869|Progestins|progestins|mesh-ancestor
92254500|NCT03729869|Hormones|hormones|mesh-ancestor
92254501|NCT03729869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254502|NCT03729869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254504|NCT03718065|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92254505|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92254506|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254507|NCT03718065|Sensory System Agents|sensory system agents|mesh-ancestor
92254508|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254509|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92254510|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92254511|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92254512|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
92254513|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254514|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254515|NCT03709680|Cyclophosphamide|cyclophosphamide|mesh-list
92254516|NCT03709680|Temozolomide|temozolomide|mesh-list
92254517|NCT03709680|Irinotecan|irinotecan|mesh-list
92254518|NCT03709680|Topotecan|topotecan|mesh-list
92254519|NCT03709680|Palbociclib|palbociclib|mesh-list
92254520|NCT03709680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254521|NCT03709680|Immunologic Factors|immunologic factors|mesh-ancestor
92254522|NCT03709680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254523|NCT03709680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254524|NCT03709680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254525|NCT03709680|Alkylating Agents|alkylating agents|mesh-ancestor
92117695|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
92254526|NCT03709680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254527|NCT03709680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254528|NCT03709680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254529|NCT03709680|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92254530|NCT03709680|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92254531|NCT03709680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254532|NCT03709680|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254533|NCT03706690|Durvalumab|durvalumab|mesh-list
92254534|NCT03706690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254535|NCT03706690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254536|NCT03603808|Vaccines|vaccines|mesh-list
92254537|NCT03603808|Immunologic Factors|immunologic factors|mesh-ancestor
92254538|NCT03603808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254539|NCT03599245|Ocrelizumab|ocrelizumab|mesh-list
92254540|NCT03599245|Immunologic Factors|immunologic factors|mesh-ancestor
92254541|NCT03599245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254542|NCT03532295|Bevacizumab|bevacizumab|mesh-list
92254543|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254544|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254545|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92254546|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92254547|NCT03532295|Growth Substances|growth substances|mesh-ancestor
92254548|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254549|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
92254550|NCT03456700|Sirolimus|sirolimus|mesh-list
92254551|NCT03456700|Auranofin|auranofin|mesh-list
92254552|NCT03456700|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254553|NCT03456700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254554|NCT03456700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92254555|NCT03456700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254556|NCT03456700|Antifungal Agents|antifungal agents|mesh-ancestor
92254557|NCT03456700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254558|NCT03456700|Immunologic Factors|immunologic factors|mesh-ancestor
92254559|NCT03456700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254560|NCT03456700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254561|NCT03401450|Bupivacaine|bupivacaine|mesh-list
92254562|NCT03401450|Anesthetics, Local|anesthetics, local|mesh-ancestor
92254563|NCT03401450|Anesthetics|anesthetics|mesh-ancestor
92254564|NCT03401450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254565|NCT03401450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254566|NCT03401450|Sensory System Agents|sensory system agents|mesh-ancestor
92254567|NCT03401450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254569|NCT03356483|Nicotinic Acids|nicotinic acids|mesh-list
92254570|NCT03356483|Psilocybin|psilocybin|mesh-list
92254571|NCT03356483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92254572|NCT03356483|Antimetabolites|antimetabolites|mesh-ancestor
92254573|NCT03356483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254574|NCT03356483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92254575|NCT03356483|Vasodilator Agents|vasodilator agents|mesh-ancestor
92254576|NCT03356483|Vitamin B Complex|vitamin b complex|mesh-ancestor
92254577|NCT03356483|Vitamins|vitamins|mesh-ancestor
92254578|NCT03356483|Micronutrients|micronutrients|mesh-ancestor
92254579|NCT03356483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254580|NCT03356483|Hallucinogens|hallucinogens|mesh-ancestor
92254581|NCT03356483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92254582|NCT03328026|Interferons|interferons|mesh-list
92254583|NCT03328026|Cyclophosphamide|cyclophosphamide|mesh-list
92254584|NCT03328026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254585|NCT03328026|Immunologic Factors|immunologic factors|mesh-ancestor
92254586|NCT03328026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254587|NCT03328026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254588|NCT03328026|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254589|NCT03328026|Alkylating Agents|alkylating agents|mesh-ancestor
92254590|NCT03328026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254591|NCT03328026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254592|NCT03328026|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254593|NCT03328026|Antiviral Agents|antiviral agents|mesh-ancestor
92254594|NCT03328026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254595|NCT03326063|Ifetroban|ifetroban|mesh-list
92254596|NCT03326063|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92254597|NCT03324984|Bupivacaine|bupivacaine|mesh-list
92254598|NCT03324984|Chloroprocaine|chloroprocaine|mesh-list
92254599|NCT03324984|Anesthetics, Local|anesthetics, local|mesh-ancestor
92254600|NCT03324984|Anesthetics|anesthetics|mesh-ancestor
92254601|NCT03324984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254602|NCT03324984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254603|NCT03324984|Sensory System Agents|sensory system agents|mesh-ancestor
92254604|NCT03324984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254605|NCT03310957|Pembrolizumab|pembrolizumab|mesh-list
92254606|NCT03310957|SGN-LIV1A|sgn-liv1a|mesh-list
92254607|NCT03310957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254608|NCT03310957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254609|NCT03310957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254610|NCT03310957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254611|NCT03310957|Immunoconjugates|immunoconjugates|mesh-ancestor
92254612|NCT03310957|Immunologic Factors|immunologic factors|mesh-ancestor
92254613|NCT03310957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254614|NCT03275857|Cisplatin|cisplatin|mesh-list
92254615|NCT03275857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254616|NCT03260712|Gemcitabine|gemcitabine|mesh-list
92254617|NCT03260712|Pembrolizumab|pembrolizumab|mesh-list
92254618|NCT03260712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254619|NCT03260712|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92254620|NCT03260712|Antimetabolites|antimetabolites|mesh-ancestor
91934938|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92254621|NCT03260712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254622|NCT03260712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254623|NCT03260712|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254624|NCT03177291|Pirfenidone|pirfenidone|mesh-list
92254625|NCT03177291|Paclitaxel|paclitaxel|mesh-list
92254626|NCT03177291|Carboplatin|carboplatin|mesh-list
92254627|NCT03177291|Pemetrexed|pemetrexed|mesh-list
92254628|NCT03177291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92254629|NCT03177291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254630|NCT03177291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92254631|NCT03177291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92254632|NCT03177291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92254633|NCT03177291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254634|NCT03177291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254635|NCT03177291|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92254636|NCT03177291|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92254637|NCT03177291|Analgesics|analgesics|mesh-ancestor
92254638|NCT03177291|Sensory System Agents|sensory system agents|mesh-ancestor
92254639|NCT03177291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254640|NCT03177291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254641|NCT03177291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92254642|NCT03177291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92254643|NCT03177291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254644|NCT03177291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254646|NCT03128359|Cyclophosphamide|cyclophosphamide|mesh-list
92254647|NCT03128359|Melphalan|melphalan|mesh-list
92254648|NCT03128359|Busulfan|busulfan|mesh-list
92254649|NCT03128359|Fludarabine|fludarabine|mesh-list
92254650|NCT03128359|Fludarabine phosphate|fludarabine phosphate|mesh-list
92254651|NCT03128359|Tacrolimus|tacrolimus|mesh-list
92254652|NCT03128359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254653|NCT03128359|Immunologic Factors|immunologic factors|mesh-ancestor
92254654|NCT03128359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254655|NCT03128359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254656|NCT03128359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342661|NCT00004127|Antidotes|antidotes|mesh-ancestor
92254657|NCT03128359|Alkylating Agents|alkylating agents|mesh-ancestor
92254658|NCT03128359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254659|NCT03128359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254660|NCT03128359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254661|NCT03128359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92254662|NCT03128359|Antimetabolites|antimetabolites|mesh-ancestor
92254663|NCT03128359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92254664|NCT03128359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254665|NCT03128359|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92254666|NCT03128359|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92254667|NCT03128359|Antitubercular Agents|antitubercular agents|mesh-ancestor
92254668|NCT03128359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254669|NCT03128359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254670|NCT03088813|Irinotecan|irinotecan|mesh-list
92254671|NCT03088813|Topotecan|topotecan|mesh-list
92254672|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92254673|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92254674|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254675|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254676|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254677|NCT02927769|Nivolumab|nivolumab|mesh-list
92254678|NCT02927769|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92254679|NCT02927769|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92254680|NCT02927769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254681|NCT02927769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254682|NCT02927769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92254683|NCT02927769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254684|NCT02927769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254685|NCT02927769|Alkylating Agents|alkylating agents|mesh-ancestor
92254686|NCT02927769|Immunotoxins|immunotoxins|mesh-ancestor
92254687|NCT02927769|Immunoconjugates|immunoconjugates|mesh-ancestor
92254688|NCT02927769|Immunologic Factors|immunologic factors|mesh-ancestor
92254689|NCT02927769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254690|NCT02764762|Adalimumab|adalimumab|mesh-list
92254691|NCT02764762|Methotrexate|methotrexate|mesh-list
92254692|NCT02764762|Vedolizumab|vedolizumab|mesh-list
92254693|NCT02764762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92254694|NCT02764762|Abortifacient Agents|abortifacient agents|mesh-ancestor
92254695|NCT02764762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92254696|NCT02764762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254697|NCT02764762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92254698|NCT02764762|Antimetabolites|antimetabolites|mesh-ancestor
92254699|NCT02764762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254700|NCT02764762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254701|NCT02764762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92254702|NCT02764762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254703|NCT02764762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92254704|NCT02764762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254705|NCT02764762|Immunologic Factors|immunologic factors|mesh-ancestor
92254706|NCT02764762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254707|NCT02764762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92254708|NCT02764762|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92254709|NCT02764762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254710|NCT02764762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92254711|NCT02666547|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92254712|NCT02666547|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92254713|NCT02666547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254715|NCT02654990|Bortezomib|bortezomib|mesh-list
92254716|NCT02654990|Panobinostat|panobinostat|mesh-list
92254717|NCT02654990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92254718|NCT02654990|Antiemetics|antiemetics|mesh-ancestor
92254719|NCT02654990|Autonomic Agents|autonomic agents|mesh-ancestor
92254720|NCT02654990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254721|NCT02654990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254722|NCT02654990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92254723|NCT02654990|Glucocorticoids|glucocorticoids|mesh-ancestor
92254724|NCT02654990|Hormones|hormones|mesh-ancestor
92254725|NCT02654990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254726|NCT02654990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342667|NCT00003251|Amifostine|amifostine|mesh-list
92254727|NCT02654990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254728|NCT02654990|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92254729|NCT02654990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254730|NCT02654990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254731|NCT02650401|Entrectinib|entrectinib|mesh-list
92254732|NCT02650401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254733|NCT02650401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254734|NCT02650401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254735|NCT02568267|Entrectinib|entrectinib|mesh-list
92254736|NCT02568267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254737|NCT02568267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254738|NCT02568267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254739|NCT02532257|Rituximab|rituximab|mesh-list
92254740|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92254741|NCT02532257|Lenalidomide|lenalidomide|mesh-list
92254742|NCT02532257|Antibodies|antibodies|mesh-list
92254743|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
92254744|NCT02532257|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92254745|NCT02532257|Immunologic Factors|immunologic factors|mesh-ancestor
92254746|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254747|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254748|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254749|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92254750|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92254751|NCT02532257|Growth Substances|growth substances|mesh-ancestor
92254752|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
92254753|NCT02521363|Taxane|taxane|mesh-list
92254754|NCT02521363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254755|NCT02407509|Everolimus|everolimus|mesh-list
92254756|NCT02407509|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92254757|NCT02407509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254758|NCT02407509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254759|NCT02407509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254760|NCT02407509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254761|NCT02407509|Immunologic Factors|immunologic factors|mesh-ancestor
92254762|NCT02407509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254763|NCT02407509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254764|NCT02340962|Interferons|interferons|mesh-list
92254765|NCT02340962|Ribavirin|ribavirin|mesh-list
92254766|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
92254767|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
92254768|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254769|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
92254770|NCT02340962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254771|NCT02340962|Antimetabolites|antimetabolites|mesh-ancestor
92254772|NCT02340962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254774|NCT02340962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254775|NCT02309645|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92254776|NCT02309645|Hemostatics|hemostatics|mesh-ancestor
92254777|NCT02309645|Coagulants|coagulants|mesh-ancestor
92254778|NCT02059499|Fluorouracil|fluorouracil|mesh-list
92254779|NCT02059499|Imiquimod|imiquimod|mesh-list
92254780|NCT02059499|Antimetabolites|antimetabolites|mesh-ancestor
92254781|NCT02059499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254782|NCT02059499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92254783|NCT02059499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254784|NCT02059499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254785|NCT02059499|Immunologic Factors|immunologic factors|mesh-ancestor
92254786|NCT02059499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254787|NCT02059499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92254788|NCT02059499|Interferon Inducers|interferon inducers|mesh-ancestor
92254789|NCT01750073|Paclitaxel|paclitaxel|mesh-list
92254790|NCT01750073|Cyclophosphamide|cyclophosphamide|mesh-list
92254792|NCT01750073|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342671|NCT00003251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92254793|NCT01750073|Trastuzumab|trastuzumab|mesh-list
92254794|NCT01750073|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92254795|NCT01750073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92254797|NCT01750073|Immunoglobulins|immunoglobulins|mesh-list
92254798|NCT01750073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92254799|NCT01750073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92254800|NCT01750073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254801|NCT01750073|Tubulin Modulators|tubulin modulators|mesh-ancestor
92254802|NCT01750073|Antimitotic Agents|antimitotic agents|mesh-ancestor
92254803|NCT01750073|Mitosis Modulators|mitosis modulators|mesh-ancestor
92254804|NCT01750073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254805|NCT01750073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254806|NCT01750073|Immunologic Factors|immunologic factors|mesh-ancestor
92254807|NCT01750073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254808|NCT01750073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254809|NCT01750073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254810|NCT01750073|Alkylating Agents|alkylating agents|mesh-ancestor
92254811|NCT01750073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254812|NCT01750073|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92254813|NCT01750073|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92254814|NCT01750073|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92254815|NCT01750073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254816|NCT01607879|Androgens|androgens|mesh-list
92254817|NCT01607879|Hormones|hormones|mesh-ancestor
92254818|NCT01607879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254819|NCT01607879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254820|NCT01582191|Everolimus|everolimus|mesh-list
92254821|NCT01582191|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92254822|NCT01582191|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254823|NCT01582191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254824|NCT01582191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254825|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254826|NCT01582191|Immunologic Factors|immunologic factors|mesh-ancestor
92254827|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254828|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254829|NCT01481974|Treprostinil|treprostinil|mesh-list
92254830|NCT01481974|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92254831|NCT01476787|Rituximab|rituximab|mesh-list
92254832|NCT01476787|Lenalidomide|lenalidomide|mesh-list
92254833|NCT01476787|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92254834|NCT01476787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92254835|NCT01476787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254836|NCT01476787|Immunologic Factors|immunologic factors|mesh-ancestor
92254837|NCT01476787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254838|NCT01476787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92254839|NCT01476787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92254840|NCT01476787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92254841|NCT01476787|Growth Substances|growth substances|mesh-ancestor
92254842|NCT01476787|Growth Inhibitors|growth inhibitors|mesh-ancestor
92254843|NCT01476787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254844|NCT01476787|Alkylating Agents|alkylating agents|mesh-ancestor
92254845|NCT01476787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254846|NCT01120249|Everolimus|everolimus|mesh-list
92254847|NCT01120249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92254848|NCT01120249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254849|NCT01120249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254850|NCT01120249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254851|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92254852|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
92254853|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254854|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254855|NCT00788125|Carboplatin|carboplatin|mesh-list
92254856|NCT00788125|Etoposide|etoposide|mesh-list
92254857|NCT00788125|Dasatinib|dasatinib|mesh-list
92254858|NCT00788125|Ifosfamide|ifosfamide|mesh-list
92254859|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
92254860|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254861|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92254862|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92254863|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342684|NCT00004139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92254864|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254865|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254866|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92254867|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92254868|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
92254869|NCT00676715|Interferons|interferons|mesh-list
92254870|NCT00676715|Interferon-beta|interferon-beta|mesh-list
92254871|NCT00676715|Ocrelizumab|ocrelizumab|mesh-list
92254872|NCT00676715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254873|NCT00676715|Antiviral Agents|antiviral agents|mesh-ancestor
92254874|NCT00676715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254875|NCT00676715|Immunologic Factors|immunologic factors|mesh-ancestor
92254876|NCT00676715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254877|NCT00579969|Timolol|timolol|mesh-list
92254878|NCT00579969|Latanoprost|latanoprost|mesh-list
92254879|NCT00579969|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92254880|NCT00579969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92254881|NCT00579969|Adrenergic Agents|adrenergic agents|mesh-ancestor
92254882|NCT00579969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254883|NCT00579969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254884|NCT00579969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254885|NCT00579969|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92254886|NCT00579969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92254887|NCT00579969|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92254888|NCT00579969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92254889|NCT00516373|Olaparib|olaparib|mesh-list
92254890|NCT00516373|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92254891|NCT00516373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254892|NCT00516373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254893|NCT00516373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254894|NCT00890162|Omalizumab|omalizumab|mesh-list
92254895|NCT00890162|Epinephrine|epinephrine|mesh-list
92254896|NCT00890162|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92254897|NCT00890162|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92254898|NCT00890162|Adrenergic Agents|adrenergic agents|mesh-ancestor
92254899|NCT00890162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254900|NCT00890162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254901|NCT00890162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254902|NCT00890162|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92254903|NCT00890162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92254904|NCT00890162|Autonomic Agents|autonomic agents|mesh-ancestor
92254905|NCT00890162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254906|NCT00890162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92254907|NCT00890162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92254908|NCT00890162|Mydriatics|mydriatics|mesh-ancestor
92254909|NCT00890162|Sympathomimetics|sympathomimetics|mesh-ancestor
92254910|NCT00890162|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92254911|NCT00890162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92254912|NCT01433081|Magnesium Sulfate|magnesium sulfate|mesh-list
92254913|NCT01433081|Analgesics|analgesics|mesh-ancestor
92254914|NCT01433081|Sensory System Agents|sensory system agents|mesh-ancestor
92254915|NCT01433081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254916|NCT01433081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254917|NCT01433081|Anesthetics|anesthetics|mesh-ancestor
92254918|NCT01433081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254919|NCT01433081|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92254920|NCT01433081|Anticonvulsants|anticonvulsants|mesh-ancestor
92254921|NCT01433081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92254922|NCT01433081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92254923|NCT01433081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254924|NCT01433081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92254925|NCT01433081|Tocolytic Agents|tocolytic agents|mesh-ancestor
92254926|NCT01433081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92254927|NCT00890396|Hydroxyurea|hydroxyurea|mesh-list
92254928|NCT00890396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254929|NCT00890396|Antisickling Agents|antisickling agents|mesh-ancestor
92254930|NCT00890396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254931|NCT00890396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254932|NCT00890396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92254933|NCT01401023|Tigecycline|tigecycline|mesh-list
92254934|NCT01401023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92254935|NCT01401023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92254936|NCT01401023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92254937|NCT01401023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254938|NCT01401023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254939|NCT01515995|Magnesium Sulfate|magnesium sulfate|mesh-list
92254940|NCT01515995|Analgesics|analgesics|mesh-ancestor
92254941|NCT01515995|Sensory System Agents|sensory system agents|mesh-ancestor
92254942|NCT01515995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254943|NCT01515995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254944|NCT01515995|Anesthetics|anesthetics|mesh-ancestor
92254945|NCT01515995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92254946|NCT01515995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92254947|NCT01515995|Anticonvulsants|anticonvulsants|mesh-ancestor
92254948|NCT01515995|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92254949|NCT01515995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92254950|NCT01515995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254951|NCT01515995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92254952|NCT01515995|Tocolytic Agents|tocolytic agents|mesh-ancestor
92254953|NCT01515995|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92254954|NCT01436045|Insulin glulisine|insulin glulisine|mesh-list
92254955|NCT01436045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92254956|NCT01436045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254957|NCT01519271|Rivastigmine|rivastigmine|mesh-list
92254958|NCT01519271|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92254959|NCT01519271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92254960|NCT01519271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254961|NCT01519271|Cholinergic Agents|cholinergic agents|mesh-ancestor
92254962|NCT01519271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254963|NCT01519271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254964|NCT01519271|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92254965|NCT01519271|Protective Agents|protective agents|mesh-ancestor
92254966|NCT01436279|Mifepristone|mifepristone|mesh-list
92254967|NCT01436279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92254968|NCT01436279|Abortifacient Agents|abortifacient agents|mesh-ancestor
92254969|NCT01436279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92254970|NCT01436279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254971|NCT01436279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92254972|NCT01436279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92254973|NCT01436279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92254974|NCT01436279|Contraceptive Agents|contraceptive agents|mesh-ancestor
92254975|NCT01436279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92254976|NCT01436279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92254977|NCT01436279|Hormone Antagonists|hormone antagonists|mesh-ancestor
92254978|NCT01436279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92254979|NCT01436279|Luteolytic Agents|luteolytic agents|mesh-ancestor
92254980|NCT01436279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92254981|NCT01436279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92254983|NCT02210195|Antiemetics|antiemetics|mesh-ancestor
92254984|NCT02210195|Autonomic Agents|autonomic agents|mesh-ancestor
92254985|NCT02210195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92254986|NCT02210195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92254987|NCT02210195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92254988|NCT02210195|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92342702|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92254989|NCT02210195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92254990|NCT02210195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254991|NCT01437449|Carboplatin|carboplatin|mesh-list
92254992|NCT01437449|Docetaxel|docetaxel|mesh-list
92254994|NCT01437449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92254995|NCT01437449|Tubulin Modulators|tubulin modulators|mesh-ancestor
92254996|NCT01437449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92254997|NCT01437449|Mitosis Modulators|mitosis modulators|mesh-ancestor
92254998|NCT01437449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92254999|NCT01437449|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255000|NCT00836888|Nivolumab|nivolumab|mesh-list
92255001|NCT00836888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255002|NCT00836888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255003|NCT00836888|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92255004|NCT00836888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255005|NCT02262026|Saracatinib|saracatinib|mesh-list
92255006|NCT02262026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255007|NCT02262026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255008|NCT02262026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255009|NCT00889226|Atorvastatin|atorvastatin|mesh-list
92255010|NCT00889226|Pitavastatin|pitavastatin|mesh-list
92255011|NCT00889226|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92255012|NCT00889226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92255013|NCT00889226|Antimetabolites|antimetabolites|mesh-ancestor
92255014|NCT00889226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255015|NCT00889226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92255016|NCT00889226|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92255017|NCT00889226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255019|NCT00837200|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92255020|NCT00837200|Asparaginase|asparaginase|mesh-list
92255021|NCT00837200|Pegaspargase|pegaspargase|mesh-list
92255022|NCT00837200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92255023|NCT00837200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255024|NCT00837200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92255025|NCT00837200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92255026|NCT00837200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255027|NCT00837200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255029|NCT00837512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92255030|NCT00837512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92255031|NCT00837512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255032|NCT00837590|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92255033|NCT00837590|Sodium Salicylate|sodium salicylate|mesh-list
92255034|NCT00837590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92255035|NCT00837590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92255036|NCT00837590|Analgesics|analgesics|mesh-ancestor
92255037|NCT00837590|Sensory System Agents|sensory system agents|mesh-ancestor
92255038|NCT00837590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255039|NCT00837590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255040|NCT00837590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255041|NCT00837590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255042|NCT00837590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92255043|NCT00837590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255044|NCT00837590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255045|NCT00891176|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92255046|NCT00891176|Immunologic Factors|immunologic factors|mesh-ancestor
92255047|NCT00891176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255048|NCT00839540|Caspofungin|caspofungin|mesh-list
92255049|NCT00839540|Micafungin|micafungin|mesh-list
92255050|NCT00839540|Antifungal Agents|antifungal agents|mesh-ancestor
92255051|NCT00839540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255052|NCT00839540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255053|NCT00839540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255054|NCT02966912|Magnesium Oxide|magnesium oxide|mesh-list
92255055|NCT02966912|Antacids|antacids|mesh-ancestor
91925384|NCT02269735|MK-2640|mk-2640|mesh-list
92255056|NCT02966912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255057|NCT02966912|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92255058|NCT02964182|Nicotine|nicotine|mesh-list
92255059|NCT02964182|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92255060|NCT02964182|Autonomic Agents|autonomic agents|mesh-ancestor
92255061|NCT02964182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255062|NCT02964182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255063|NCT02964182|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92255064|NCT02964182|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92255065|NCT02964182|Cholinergic Agents|cholinergic agents|mesh-ancestor
92255066|NCT02964182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255067|NCT02964182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255069|NCT01437605|Interferon Inducers|interferon inducers|mesh-ancestor
92255070|NCT01437605|Immunologic Factors|immunologic factors|mesh-ancestor
92255071|NCT01437605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255072|NCT01437605|Antiviral Agents|antiviral agents|mesh-ancestor
92255073|NCT01437605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255074|NCT01541735|Pantoprazole|pantoprazole|mesh-list
92255075|NCT01541735|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92255076|NCT01541735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92255077|NCT01541735|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92255078|NCT01541735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255079|NCT01541735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255080|NCT01541891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92255081|NCT01541891|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92255082|NCT01520207|Mannitol|mannitol|mesh-list
92255083|NCT01520207|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92255084|NCT01520207|Diuretics|diuretics|mesh-ancestor
92255085|NCT01520207|Natriuretic Agents|natriuretic agents|mesh-ancestor
92255086|NCT01520207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255087|NCT01203722|Mycophenolic Acid|mycophenolic acid|mesh-list
92255088|NCT01203722|Sirolimus|sirolimus|mesh-list
92255089|NCT01203722|Fludarabine|fludarabine|mesh-list
92255090|NCT01203722|Cyclophosphamide|cyclophosphamide|mesh-list
92255091|NCT01203722|Tacrolimus|tacrolimus|mesh-list
92255092|NCT01203722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255093|NCT01203722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255094|NCT01203722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255095|NCT01203722|Immunologic Factors|immunologic factors|mesh-ancestor
92255096|NCT01203722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255097|NCT01203722|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92255098|NCT01203722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255099|NCT01203722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255100|NCT01203722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255101|NCT01203722|Alkylating Agents|alkylating agents|mesh-ancestor
92255102|NCT01203722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92255103|NCT01203722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92255104|NCT01203722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92255105|NCT01203722|Antitubercular Agents|antitubercular agents|mesh-ancestor
92255106|NCT01203722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255107|NCT01203722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255108|NCT01203722|Antifungal Agents|antifungal agents|mesh-ancestor
92255109|NCT01520519|Rituximab|rituximab|mesh-list
92255110|NCT01520519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255111|NCT01520519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255112|NCT01520519|Immunologic Factors|immunologic factors|mesh-ancestor
92255113|NCT01520519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255114|NCT01520519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255115|NCT03008057|Vitamin D|vitamin d|mesh-list
92255116|NCT03008057|Ergocalciferols|ergocalciferols|mesh-list
92255117|NCT03008057|Cholecalciferol|cholecalciferol|mesh-list
92255118|NCT03008057|Vitamins|vitamins|mesh-list
92255119|NCT03008057|Micronutrients|micronutrients|mesh-ancestor
92255120|NCT03008057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255121|NCT03008057|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92255122|NCT03008057|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92255123|NCT01542125|Lidocaine|lidocaine|mesh-list
92255124|NCT01542125|Anesthetics, Local|anesthetics, local|mesh-ancestor
92255125|NCT01542125|Anesthetics|anesthetics|mesh-ancestor
92255126|NCT01542125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255127|NCT01542125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255128|NCT01542125|Sensory System Agents|sensory system agents|mesh-ancestor
92342716|NCT00003269|Sargramostim|sargramostim|mesh-list
92342717|NCT00003269|Amifostine|amifostine|mesh-list
92255129|NCT01542125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255130|NCT01542125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92255131|NCT01542125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92255132|NCT01542125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92255133|NCT01542125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255134|NCT01542125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255136|NCT03216668|Antioxidants|antioxidants|mesh-ancestor
92255137|NCT03216668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255138|NCT03216668|Protective Agents|protective agents|mesh-ancestor
92255139|NCT03216668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255140|NCT02548832|Bezafibrate|bezafibrate|mesh-list
92255141|NCT02548832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92255142|NCT02548832|Antimetabolites|antimetabolites|mesh-ancestor
92255143|NCT02548832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255144|NCT02548832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92255145|NCT03216278|Metformin|metformin|mesh-list
92255146|NCT03216278|Dapagliflozin|dapagliflozin|mesh-list
92255147|NCT03216278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92255148|NCT03216278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255149|NCT03216278|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92255150|NCT03216278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255151|NCT05310344|Paclitaxel|paclitaxel|mesh-list
92255152|NCT05310344|Bevacizumab|bevacizumab|mesh-list
92255153|NCT05310344|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92255154|NCT05310344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92255155|NCT05310344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255156|NCT05310344|Tubulin Modulators|tubulin modulators|mesh-ancestor
92255157|NCT05310344|Antimitotic Agents|antimitotic agents|mesh-ancestor
92255158|NCT05310344|Mitosis Modulators|mitosis modulators|mesh-ancestor
92255159|NCT05310344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255160|NCT05310344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255161|NCT05310344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92255162|NCT05310344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92255163|NCT05310344|Growth Substances|growth substances|mesh-ancestor
92255164|NCT05310344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255165|NCT05310344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92255166|NCT04381520|Antihypertensive Agents|antihypertensive agents|mesh-list
92255167|NCT00837902|Atenolol|atenolol|mesh-list
92255168|NCT00837902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92255169|NCT00837902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255170|NCT00837902|Sympatholytics|sympatholytics|mesh-ancestor
92255171|NCT00837902|Autonomic Agents|autonomic agents|mesh-ancestor
92255172|NCT00837902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255173|NCT00837902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255174|NCT00837902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92255175|NCT00837902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92255176|NCT00837902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92255177|NCT00837902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92255178|NCT00837902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255179|NCT00837902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255180|NCT04382144|Bupivacaine|bupivacaine|mesh-list
92255181|NCT04382144|Anesthetics, Local|anesthetics, local|mesh-ancestor
92255182|NCT04382144|Anesthetics|anesthetics|mesh-ancestor
92255183|NCT04382144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255184|NCT04382144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255185|NCT04382144|Sensory System Agents|sensory system agents|mesh-ancestor
92255186|NCT04382144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255187|NCT03215966|Tadalafil|tadalafil|mesh-list
92255188|NCT03215966|Macitentan|macitentan|mesh-list
92255189|NCT03215966|Vasodilator Agents|vasodilator agents|mesh-ancestor
92255190|NCT03215966|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92255191|NCT03215966|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92255192|NCT03215966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255193|NCT03215966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255194|NCT03215966|Urological Agents|urological agents|mesh-ancestor
92255195|NCT03215966|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92342723|NCT00003269|Alkylating Agents|alkylating agents|mesh-ancestor
92255196|NCT03215966|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92255197|NCT03215966|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92255198|NCT03215498|Insulin|insulin|mesh-list
92255199|NCT03215498|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92255200|NCT03215498|Insulin Aspart|insulin aspart|mesh-list
92255201|NCT03215498|Insulin, Long-Acting|insulin, long-acting|mesh-list
92255202|NCT03215498|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92255203|NCT03215498|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92255204|NCT03215498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255205|NCT01441037|Danazol|danazol|mesh-list
92255206|NCT01441037|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92255207|NCT01441037|Hormone Antagonists|hormone antagonists|mesh-ancestor
92255208|NCT01441037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92255209|NCT01441037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255210|NCT00891878|Capecitabine|capecitabine|mesh-list
92255211|NCT00891878|Sunitinib|sunitinib|mesh-list
92255212|NCT00891878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255213|NCT00891878|Antimetabolites|antimetabolites|mesh-ancestor
92255214|NCT00891878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255215|NCT00891878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255216|NCT00891878|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92255217|NCT00891878|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92255218|NCT00891878|Growth Substances|growth substances|mesh-ancestor
92255219|NCT00891878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255220|NCT00891878|Growth Inhibitors|growth inhibitors|mesh-ancestor
92255221|NCT00891878|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92255222|NCT00891878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255223|NCT01445873|Sitaxsentan|sitaxsentan|mesh-list
92255224|NCT01445873|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92255225|NCT01445873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255226|NCT03838328|Tranexamic Acid|tranexamic acid|mesh-list
92255227|NCT03838328|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92255228|NCT03838328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92255229|NCT03838328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255230|NCT03838328|Hemostatics|hemostatics|mesh-ancestor
92255231|NCT03838328|Coagulants|coagulants|mesh-ancestor
92255232|NCT01526213|Fexofenadine|fexofenadine|mesh-list
92255233|NCT01526213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92255234|NCT01526213|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92255235|NCT01526213|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92255236|NCT01526213|Histamine Antagonists|histamine antagonists|mesh-ancestor
92255237|NCT01526213|Histamine Agents|histamine agents|mesh-ancestor
92255238|NCT01526213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255239|NCT01526213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255240|NCT01526213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255241|NCT01549223|Misoprostol|misoprostol|mesh-list
92255243|NCT01549223|Carboprost|carboprost|mesh-list
92255244|NCT01549223|Carboprost tromethamine|carboprost tromethamine|mesh-list
92255245|NCT01549223|Methylergonovine|methylergonovine|mesh-list
92255246|NCT01549223|Maleic acid|maleic acid|mesh-list
92255247|NCT01549223|Oxytocics|oxytocics|mesh-ancestor
92255248|NCT01549223|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92255249|NCT01549223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255250|NCT01549223|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92255251|NCT01549223|Abortifacient Agents|abortifacient agents|mesh-ancestor
92255252|NCT01549223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92255253|NCT01549223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92255254|NCT01549223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255255|NCT01549223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255256|NCT00895934|Azacitidine|azacitidine|mesh-list
92255257|NCT00895934|Vorinostat|vorinostat|mesh-list
92255258|NCT00895934|Gemtuzumab|gemtuzumab|mesh-list
92255259|NCT00895934|Calicheamicins|calicheamicins|mesh-list
92255260|NCT00895934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255261|NCT00895934|Antimetabolites|antimetabolites|mesh-ancestor
92255262|NCT00895934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255263|NCT00895934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255264|NCT00895934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255265|NCT00895934|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92255266|NCT00895934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255268|NCT00895934|Immunoconjugates|immunoconjugates|mesh-ancestor
92255269|NCT00895934|Immunologic Factors|immunologic factors|mesh-ancestor
92255270|NCT00895934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255271|NCT00895934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92255272|NCT01550471|Ciclesonide|ciclesonide|mesh-list
92255273|NCT01550471|Beclomethasone|beclomethasone|mesh-list
92255274|NCT01550471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255275|NCT01550471|Glucocorticoids|glucocorticoids|mesh-ancestor
92255276|NCT01550471|Hormones|hormones|mesh-ancestor
92255277|NCT01550471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92255278|NCT01550471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255279|NCT01550471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92255280|NCT01550471|Respiratory System Agents|respiratory system agents|mesh-ancestor
92255281|NCT01550471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92255282|NCT00896012|Sirolimus|sirolimus|mesh-list
92255283|NCT00896012|Tacrolimus|tacrolimus|mesh-list
92255284|NCT00896012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255285|NCT00896012|Immunologic Factors|immunologic factors|mesh-ancestor
92255286|NCT00896012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255287|NCT00896012|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92255288|NCT00896012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255289|NCT00896012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255290|NCT00896012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255291|NCT00896012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255292|NCT00896012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92255293|NCT00896012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255294|NCT00896012|Antifungal Agents|antifungal agents|mesh-ancestor
92255295|NCT03215264|Hydroxychloroquine|hydroxychloroquine|mesh-list
92255296|NCT03215264|Entinostat|entinostat|mesh-list
92255297|NCT03215264|Antimalarials|antimalarials|mesh-ancestor
92255298|NCT03215264|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92255300|NCT03215264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255301|NCT03215264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255302|NCT03215264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255303|NCT03215264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255304|NCT03215264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255305|NCT03215264|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92255306|NCT01447511|Rifampin|rifampin|mesh-list
92255307|NCT01447511|Fluconazole|fluconazole|mesh-list
92255308|NCT01447511|Warfarin|warfarin|mesh-list
92255309|NCT01447511|Anticoagulants|anticoagulants|mesh-ancestor
92255310|NCT01447511|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92255311|NCT01447511|Antitubercular Agents|antitubercular agents|mesh-ancestor
92255312|NCT01447511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255313|NCT01447511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255314|NCT01447511|Leprostatic Agents|leprostatic agents|mesh-ancestor
92255315|NCT01447511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92255316|NCT01447511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255317|NCT01447511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255318|NCT01447511|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92255319|NCT01447511|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92255320|NCT01447511|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92255321|NCT01447511|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92255322|NCT01447511|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92255323|NCT01447511|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92255324|NCT01447511|Antifungal Agents|antifungal agents|mesh-ancestor
92255325|NCT01447511|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92255326|NCT01447511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92255327|NCT01447511|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92255328|NCT01447511|Hormone Antagonists|hormone antagonists|mesh-ancestor
92255329|NCT01447511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92255330|NCT01447511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255331|NCT01447511|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92255332|NCT01447511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92255333|NCT01831622|Methylphenidate|methylphenidate|mesh-list
92255335|NCT01831622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255336|NCT01831622|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92255337|NCT01831622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92255338|NCT01831622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255339|NCT01831622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255340|NCT01831622|Dopamine Agents|dopamine agents|mesh-ancestor
92255341|NCT01831622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255342|NCT04380818|Ritonavir|ritonavir|mesh-list
92255343|NCT04380818|Lopinavir|lopinavir|mesh-list
92255344|NCT04380818|Azithromycin|azithromycin|mesh-list
92255345|NCT04380818|Hydroxychloroquine|hydroxychloroquine|mesh-list
92255346|NCT04380818|Heparin|heparin|mesh-list
92255347|NCT04380818|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92255348|NCT04380818|Tinzaparin|tinzaparin|mesh-list
92255349|NCT04380818|Dalteparin|dalteparin|mesh-list
92255350|NCT04380818|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92255351|NCT04380818|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92255352|NCT04380818|Protease Inhibitors|protease inhibitors|mesh-ancestor
92255353|NCT04380818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255354|NCT04380818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255355|NCT04380818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91941718|NCT05943353|Antioxidants|antioxidants|mesh-ancestor
92255356|NCT04380818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92255357|NCT04380818|Antiviral Agents|antiviral agents|mesh-ancestor
92255358|NCT04380818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255359|NCT04380818|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92255360|NCT04380818|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92255361|NCT04380818|Anticoagulants|anticoagulants|mesh-ancestor
92255362|NCT04380818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92255363|NCT04380818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92255364|NCT04380818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255365|NCT04380818|Antimalarials|antimalarials|mesh-ancestor
92255366|NCT04380818|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92255367|NCT04380818|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92255368|NCT04380818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255369|NCT05312294|Vaccines|vaccines|mesh-list
92255370|NCT05312294|Immunologic Factors|immunologic factors|mesh-ancestor
92255371|NCT05312294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255372|NCT01550705|Isoniazid|isoniazid|mesh-list
92255373|NCT01550705|Antitubercular Agents|antitubercular agents|mesh-ancestor
92255374|NCT01550705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255375|NCT01550705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255376|NCT01550705|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92255377|NCT01550705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92255378|NCT01550705|Antimetabolites|antimetabolites|mesh-ancestor
92255379|NCT01550705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255380|NCT01550705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92255381|NCT01831700|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92255382|NCT01831700|Lisinopril|lisinopril|mesh-list
92255383|NCT01831700|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
92255384|NCT01831700|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255385|NCT01831700|Diuretics|diuretics|mesh-ancestor
92255386|NCT01831700|Natriuretic Agents|natriuretic agents|mesh-ancestor
92255387|NCT01831700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255388|NCT01831700|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92255389|NCT01831700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255390|NCT01831700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255391|NCT01831700|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92255392|NCT01831700|Protease Inhibitors|protease inhibitors|mesh-ancestor
92255393|NCT01831700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255394|NCT01831700|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92255395|NCT01831700|Protective Agents|protective agents|mesh-ancestor
92255396|NCT01531439|Naloxone|naloxone|mesh-list
92255397|NCT01531439|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92255398|NCT01531439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255399|NCT01531439|Sensory System Agents|sensory system agents|mesh-ancestor
92255400|NCT01531439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255401|NCT03214874|Torsemide|torsemide|mesh-list
92255402|NCT03214874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255403|NCT03214874|Diuretics|diuretics|mesh-ancestor
92255404|NCT03214874|Natriuretic Agents|natriuretic agents|mesh-ancestor
92255405|NCT03214874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255406|NCT03214874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92255407|NCT03214874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255408|NCT03214874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255409|NCT02504268|Methotrexate|methotrexate|mesh-list
92255410|NCT02504268|Abatacept|abatacept|mesh-list
92255411|NCT02504268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92255412|NCT02504268|Abortifacient Agents|abortifacient agents|mesh-ancestor
92255413|NCT02504268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92255414|NCT02504268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255415|NCT02504268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255416|NCT02504268|Antimetabolites|antimetabolites|mesh-ancestor
92255417|NCT02504268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255418|NCT02504268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255419|NCT02504268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92255420|NCT02504268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255421|NCT02504268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92255422|NCT02504268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255423|NCT02504268|Immunologic Factors|immunologic factors|mesh-ancestor
92255424|NCT02504268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255425|NCT02504268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92255426|NCT02504268|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92255427|NCT02504268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255429|NCT00904826|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92255430|NCT00904826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255431|NCT00904826|Immunologic Factors|immunologic factors|mesh-ancestor
92255432|NCT00904826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255433|NCT05311514|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92255434|NCT05311514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92255435|NCT01448525|Bimatoprost|bimatoprost|mesh-list
92255436|NCT01448525|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92255437|NCT01448525|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92255438|NCT01448525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255439|NCT01654302|Lidocaine|lidocaine|mesh-list
92255440|NCT01654302|Tetracaine|tetracaine|mesh-list
92255441|NCT01654302|Anesthetics, Local|anesthetics, local|mesh-ancestor
92255442|NCT01654302|Anesthetics|anesthetics|mesh-ancestor
92255443|NCT01654302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255444|NCT01654302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255445|NCT01654302|Sensory System Agents|sensory system agents|mesh-ancestor
92255446|NCT01654302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255447|NCT01654302|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92255448|NCT01654302|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92255449|NCT01654302|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92255450|NCT01654302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255451|NCT01654302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255452|NCT01832558|Eplerenone|eplerenone|mesh-list
92255453|NCT01832558|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92255454|NCT01832558|Hormone Antagonists|hormone antagonists|mesh-ancestor
92255455|NCT01832558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92255456|NCT01832558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255457|NCT01832558|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92255459|NCT01832558|Natriuretic Agents|natriuretic agents|mesh-ancestor
92255460|NCT01832558|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255461|NCT02476422|Ibuprofen|ibuprofen|mesh-list
92255462|NCT02476422|Diclofenac|diclofenac|mesh-list
92255463|NCT02476422|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92255464|NCT02476422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92255465|NCT02476422|Analgesics|analgesics|mesh-ancestor
92255466|NCT02476422|Sensory System Agents|sensory system agents|mesh-ancestor
92255467|NCT02476422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255468|NCT02476422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255469|NCT02476422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255470|NCT02476422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342746|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255472|NCT02476422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255473|NCT02476422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255474|NCT01450319|Cetuximab|cetuximab|mesh-list
92255475|NCT01450319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255476|NCT01450319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255477|NCT01552343|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92255478|NCT01552343|Hemostatics|hemostatics|mesh-ancestor
92255479|NCT01552343|Coagulants|coagulants|mesh-ancestor
92255480|NCT01552343|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92255481|NCT01552343|Natriuretic Agents|natriuretic agents|mesh-ancestor
92255482|NCT01552343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255483|NCT02475564|Resveratrol|resveratrol|mesh-list
92255484|NCT02475564|Antioxidants|antioxidants|mesh-ancestor
92255485|NCT02475564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255486|NCT02475564|Protective Agents|protective agents|mesh-ancestor
92255487|NCT02475564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255488|NCT02475564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255489|NCT02475564|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92255490|NCT00893984|Nebivolol|nebivolol|mesh-list
92255491|NCT00893984|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255492|NCT00893984|Vasodilator Agents|vasodilator agents|mesh-ancestor
92255493|NCT00893984|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92255494|NCT00893984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92255495|NCT00893984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92255496|NCT00893984|Adrenergic Agents|adrenergic agents|mesh-ancestor
92255497|NCT00893984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255498|NCT00893984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255499|NCT00893984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255500|NCT01832870|Ipilimumab|ipilimumab|mesh-list
92255501|NCT01832870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255502|NCT01832870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255503|NCT01832870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92255504|NCT01832870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255505|NCT01553201|Botulinum Toxins|botulinum toxins|mesh-list
92255506|NCT01553201|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92255507|NCT01553201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255508|NCT01553201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255509|NCT01553201|Cholinergic Agents|cholinergic agents|mesh-ancestor
92255510|NCT01553201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255511|NCT01553201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255512|NCT03214172|Rivaroxaban|rivaroxaban|mesh-list
92255513|NCT03214172|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92255514|NCT03214172|Antithrombins|antithrombins|mesh-ancestor
92255515|NCT03214172|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92255516|NCT03214172|Protease Inhibitors|protease inhibitors|mesh-ancestor
92255517|NCT03214172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255518|NCT03214172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255519|NCT03214172|Anticoagulants|anticoagulants|mesh-ancestor
92255520|NCT01832948|Leucovorin|leucovorin|mesh-list
92255521|NCT01832948|Folic Acid|folic acid|mesh-list
92255522|NCT01832948|Oxaliplatin|oxaliplatin|mesh-list
92255523|NCT01832948|Endostar protein|endostar protein|mesh-list
92255524|NCT01832948|Levoleucovorin|levoleucovorin|mesh-list
92255525|NCT01832948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255526|NCT01832948|Antidotes|antidotes|mesh-ancestor
92255527|NCT01832948|Protective Agents|protective agents|mesh-ancestor
92255528|NCT01832948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255529|NCT01832948|Vitamin B Complex|vitamin b complex|mesh-ancestor
92255530|NCT01832948|Vitamins|vitamins|mesh-ancestor
92255531|NCT01832948|Micronutrients|micronutrients|mesh-ancestor
92255532|NCT01832948|Hematinics|hematinics|mesh-ancestor
92255533|NCT01832948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92255534|NCT01832948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92255535|NCT01832948|Growth Substances|growth substances|mesh-ancestor
92255536|NCT01832948|Growth Inhibitors|growth inhibitors|mesh-ancestor
92255537|NCT01533077|Levodopa|levodopa|mesh-list
92255538|NCT01533077|Carbidopa|carbidopa|mesh-list
92255539|NCT01533077|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92255540|NCT01533077|Opicapone|opicapone|mesh-list
92255541|NCT01533077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92255542|NCT01533077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92255543|NCT01533077|Dopamine Agents|dopamine agents|mesh-ancestor
92342754|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
92255544|NCT01533077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255545|NCT01533077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255546|NCT01533077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255547|NCT01533077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92255548|NCT01533077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255549|NCT01533077|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92255550|NCT01533077|Immunologic Factors|immunologic factors|mesh-ancestor
92255551|NCT01533077|Dopamine Agonists|dopamine agonists|mesh-ancestor
92255552|NCT01533077|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92255553|NCT01534013|Insulin|insulin|mesh-list
92255554|NCT01534013|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92255555|NCT01534013|Pancrelipase|pancrelipase|mesh-list
92255556|NCT01534013|Pancreatin|pancreatin|mesh-list
92255557|NCT01534013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92255558|NCT01534013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255559|NCT01534013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92255560|NCT03211988|Entinostat|entinostat|mesh-list
92255561|NCT03211988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255562|NCT03211988|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92255563|NCT03211988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255564|NCT03211988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255566|NCT01833728|Propacetamol|propacetamol|mesh-list
92255567|NCT01833728|Nefopam|nefopam|mesh-list
92255568|NCT01833728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92255569|NCT01833728|Analgesics|analgesics|mesh-ancestor
92255570|NCT01833728|Sensory System Agents|sensory system agents|mesh-ancestor
92255571|NCT01833728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255572|NCT01833728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255573|NCT01833728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92255574|NCT01833728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255575|NCT01833728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255576|NCT01833728|Antipyretics|antipyretics|mesh-ancestor
92255577|NCT03213392|Anesthetics|anesthetics|mesh-list
92255578|NCT03213392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255579|NCT03213392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255580|NCT03219788|Remifentanil|remifentanil|mesh-list
92255581|NCT03219788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92255582|NCT03219788|Narcotics|narcotics|mesh-ancestor
92255583|NCT03219788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255584|NCT03219788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255585|NCT03219788|Analgesics|analgesics|mesh-ancestor
92255586|NCT03219788|Sensory System Agents|sensory system agents|mesh-ancestor
92255587|NCT03219788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255588|NCT03219710|Dexamethasone|dexamethasone|mesh-list
92255589|NCT03219710|Ondansetron|ondansetron|mesh-list
92255590|NCT03219710|Olanzapine|olanzapine|mesh-list
92255591|NCT03219710|Aprepitant|aprepitant|mesh-list
92255592|NCT03219710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255593|NCT03219710|Antiemetics|antiemetics|mesh-ancestor
92255594|NCT03219710|Autonomic Agents|autonomic agents|mesh-ancestor
92255595|NCT03219710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255596|NCT03219710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255597|NCT03219710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92255598|NCT03219710|Glucocorticoids|glucocorticoids|mesh-ancestor
92255599|NCT03219710|Hormones|hormones|mesh-ancestor
92255600|NCT03219710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92255601|NCT03219710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92255602|NCT03219710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255603|NCT03219710|Antipruritics|antipruritics|mesh-ancestor
92255604|NCT03219710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92255605|NCT03219710|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92255606|NCT03219710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92255607|NCT03219710|Serotonin Agents|serotonin agents|mesh-ancestor
92255608|NCT03219710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255609|NCT03219710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255610|NCT03219710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92255612|NCT03219710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255613|NCT03219710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92255614|NCT03219710|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92255615|NCT03219710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92342757|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255616|NCT03219710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255617|NCT03219710|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92255618|NCT01532141|Opicapone|opicapone|mesh-list
92255619|NCT01532141|Rasagiline|rasagiline|mesh-list
92255620|NCT01532141|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92255621|NCT01532141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255622|NCT01532141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255623|NCT01532141|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92255624|NCT01532141|Protective Agents|protective agents|mesh-ancestor
92255625|NCT01532141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255626|NCT01532141|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92255627|NCT01532141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92255628|NCT01532141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92255629|NCT00899600|Ketamine|ketamine|mesh-list
92255630|NCT00899600|Analgesics|analgesics|mesh-ancestor
92255631|NCT00899600|Sensory System Agents|sensory system agents|mesh-ancestor
92255632|NCT00899600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255633|NCT00899600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255634|NCT00899600|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92255635|NCT00899600|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92255636|NCT00899600|Anesthetics, General|anesthetics, general|mesh-ancestor
92255637|NCT00899600|Anesthetics|anesthetics|mesh-ancestor
92255638|NCT00899600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255639|NCT00899600|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92255640|NCT00899600|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92255641|NCT00899600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255642|NCT00899600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255643|NCT03219554|Palbociclib|palbociclib|mesh-list
92255644|NCT03219554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255645|NCT03219554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92255646|NCT03219554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255647|NCT03219554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255648|NCT01554371|Cyclophosphamide|cyclophosphamide|mesh-list
92255649|NCT01554371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255650|NCT01554371|Immunologic Factors|immunologic factors|mesh-ancestor
92255651|NCT01554371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255652|NCT01554371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255653|NCT01554371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255654|NCT01554371|Alkylating Agents|alkylating agents|mesh-ancestor
92255655|NCT01554371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255656|NCT01554371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255657|NCT01554371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92255659|NCT01451411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92255660|NCT01451411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255661|NCT01451411|Natriuretic Agents|natriuretic agents|mesh-ancestor
92255662|NCT01451411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255663|NCT03837938|Dipropizine|dipropizine|mesh-list
92255664|NCT03837938|Antitussive Agents|antitussive agents|mesh-ancestor
92255665|NCT03837938|Respiratory System Agents|respiratory system agents|mesh-ancestor
92255666|NCT01554683|Levetiracetam|levetiracetam|mesh-list
92255667|NCT01554683|Anticonvulsants|anticonvulsants|mesh-ancestor
92255668|NCT01554683|Nootropic Agents|nootropic agents|mesh-ancestor
92255669|NCT00905060|Temozolomide|temozolomide|mesh-list
92255670|NCT00905060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255671|NCT00905060|Alkylating Agents|alkylating agents|mesh-ancestor
92255672|NCT00905060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255673|NCT00905060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255674|NCT01535573|Dexetimide|dexetimide|mesh-list
92255675|NCT01535573|Citalopram|citalopram|mesh-list
92255676|NCT01535573|Escitalopram|escitalopram|mesh-list
92255677|NCT01535573|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92255678|NCT01535573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92255679|NCT01535573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255680|NCT01535573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255681|NCT01535573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255682|NCT01535573|Serotonin Agents|serotonin agents|mesh-ancestor
92255683|NCT01535573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342759|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
92255684|NCT01535573|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92255685|NCT01535573|Antidepressive Agents|antidepressive agents|mesh-ancestor
92255686|NCT01535573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92255687|NCT01535573|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92255688|NCT01535573|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92255689|NCT01535573|Parasympatholytics|parasympatholytics|mesh-ancestor
92255690|NCT01535573|Autonomic Agents|autonomic agents|mesh-ancestor
92255691|NCT01535573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255692|NCT01535573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92255693|NCT01535573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92255694|NCT01535573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92255695|NCT01834508|Entecavir|entecavir|mesh-list
92255696|NCT01834508|Adefovir|adefovir|mesh-list
92255697|NCT01834508|Antiviral Agents|antiviral agents|mesh-ancestor
92255698|NCT01834508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255699|NCT01834508|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92255700|NCT01834508|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92255701|NCT01834508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255702|NCT01834508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255703|NCT01537835|Anti-Infective Agents|anti-infective agents|mesh-list
92255704|NCT01537835|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92255705|NCT03213002|Capecitabine|capecitabine|mesh-list
92255706|NCT03213002|Temozolomide|temozolomide|mesh-list
92255707|NCT03213002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255708|NCT03213002|Antimetabolites|antimetabolites|mesh-ancestor
92255709|NCT03213002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255710|NCT03213002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255711|NCT03213002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255712|NCT03213002|Alkylating Agents|alkylating agents|mesh-ancestor
92255713|NCT01556633|Oseltamivir|oseltamivir|mesh-list
92255714|NCT01556633|Antiviral Agents|antiviral agents|mesh-ancestor
92255715|NCT01556633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255716|NCT01556633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255717|NCT01556633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255718|NCT03218852|Prednisone|prednisone|mesh-list
92255719|NCT03218852|Cyclophosphamide|cyclophosphamide|mesh-list
92255720|NCT03218852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255721|NCT03218852|Immunologic Factors|immunologic factors|mesh-ancestor
92255722|NCT03218852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255723|NCT03218852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934956|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
92255724|NCT03218852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255725|NCT03218852|Alkylating Agents|alkylating agents|mesh-ancestor
92255726|NCT03218852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255727|NCT03218852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255728|NCT03218852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92255729|NCT03218852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255730|NCT03218852|Glucocorticoids|glucocorticoids|mesh-ancestor
92255731|NCT03218852|Hormones|hormones|mesh-ancestor
92255732|NCT03218852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92255733|NCT03218852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92255734|NCT01834898|Oxycodone|oxycodone|mesh-list
92255735|NCT01834898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92255736|NCT01834898|Narcotics|narcotics|mesh-ancestor
92255737|NCT01834898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255738|NCT01834898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255739|NCT01834898|Analgesics|analgesics|mesh-ancestor
92255740|NCT01834898|Sensory System Agents|sensory system agents|mesh-ancestor
92255741|NCT01834898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255742|NCT01557959|Docetaxel|docetaxel|mesh-list
92255743|NCT01557959|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92255744|NCT01557959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255745|NCT01557959|Tubulin Modulators|tubulin modulators|mesh-ancestor
92255746|NCT01557959|Antimitotic Agents|antimitotic agents|mesh-ancestor
92255747|NCT01557959|Mitosis Modulators|mitosis modulators|mesh-ancestor
92255748|NCT01557959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255749|NCT01557959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92255750|NCT01557959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255751|NCT03212456|Analgesics, Opioid|analgesics, opioid|mesh-list
92255752|NCT03212456|Ropivacaine|ropivacaine|mesh-list
92342764|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
92255753|NCT03212456|Anesthetics, Local|anesthetics, local|mesh-ancestor
92255755|NCT03212456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255756|NCT03212456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255757|NCT03212456|Sensory System Agents|sensory system agents|mesh-ancestor
92255758|NCT03212456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255759|NCT03212456|Narcotics|narcotics|mesh-ancestor
92255760|NCT03212456|Analgesics|analgesics|mesh-ancestor
92255761|NCT03217838|Azacitidine|azacitidine|mesh-list
92255763|NCT03217838|Pyrazole|pyrazole|mesh-list
92255764|NCT03217838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255765|NCT03217838|Antimetabolites|antimetabolites|mesh-ancestor
92255766|NCT03217838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255767|NCT03217838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255768|NCT03217838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255769|NCT01558661|Axitinib|axitinib|mesh-list
92255770|NCT01558661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255771|NCT01558661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92255772|NCT01558661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255773|NCT01558661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255774|NCT01835288|Arsenic Trioxide|arsenic trioxide|mesh-list
92255775|NCT01835288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255776|NCT02502864|Cyclophosphamide|cyclophosphamide|mesh-list
92255777|NCT02502864|Docetaxel|docetaxel|mesh-list
92255778|NCT02502864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255779|NCT02502864|Immunologic Factors|immunologic factors|mesh-ancestor
92255780|NCT02502864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255781|NCT02502864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255782|NCT02502864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255783|NCT02502864|Alkylating Agents|alkylating agents|mesh-ancestor
92255784|NCT02502864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255785|NCT02502864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255786|NCT02502864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92255787|NCT02502864|Tubulin Modulators|tubulin modulators|mesh-ancestor
92255788|NCT02502864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92255789|NCT02502864|Mitosis Modulators|mitosis modulators|mesh-ancestor
92255790|NCT03217760|Hydrocortisone|hydrocortisone|mesh-list
92255791|NCT03217760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92255792|NCT03217292|Tramadol|tramadol|mesh-list
92255793|NCT03217292|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92255794|NCT03217292|Narcotics|narcotics|mesh-ancestor
92255795|NCT03217292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255796|NCT03217292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255797|NCT03217292|Analgesics|analgesics|mesh-ancestor
92255798|NCT03217292|Sensory System Agents|sensory system agents|mesh-ancestor
92255799|NCT03217292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255801|NCT03217448|Dabigatran|dabigatran|mesh-list
92255802|NCT03217448|Anticoagulants|anticoagulants|mesh-ancestor
92255803|NCT03217448|Antithrombins|antithrombins|mesh-ancestor
92255804|NCT03217448|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92255805|NCT03217448|Protease Inhibitors|protease inhibitors|mesh-ancestor
92255806|NCT03217448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255807|NCT03217448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255808|NCT01457573|Tamsulosin|tamsulosin|mesh-list
92255809|NCT01457573|Solifenacin Succinate|solifenacin succinate|mesh-list
92255810|NCT01457573|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92255811|NCT01457573|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92255812|NCT01457573|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92255813|NCT01457573|Adrenergic Agents|adrenergic agents|mesh-ancestor
92255814|NCT01457573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255815|NCT01457573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255816|NCT01457573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255817|NCT01457573|Urological Agents|urological agents|mesh-ancestor
92255818|NCT01457573|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92255819|NCT01457573|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92255820|NCT01457573|Cholinergic Agents|cholinergic agents|mesh-ancestor
92255821|NCT01560143|Tigecycline|tigecycline|mesh-list
92255822|NCT01560143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255823|NCT01560143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342771|NCT00384137|Tacrolimus|tacrolimus|mesh-list
92255824|NCT01560143|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92255825|NCT01560143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255826|NCT01560143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255827|NCT01836224|Terlipressin|terlipressin|mesh-list
92255828|NCT01836224|Norepinephrine|norepinephrine|mesh-list
92255829|NCT01836224|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255830|NCT01836224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92255831|NCT01836224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92255832|NCT01836224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92255833|NCT01836224|Adrenergic Agents|adrenergic agents|mesh-ancestor
92255834|NCT01836224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255835|NCT01836224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255836|NCT01836224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255837|NCT01836224|Sympathomimetics|sympathomimetics|mesh-ancestor
92255838|NCT01836224|Autonomic Agents|autonomic agents|mesh-ancestor
92255839|NCT01836224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255840|NCT01836536|Bevacizumab|bevacizumab|mesh-list
92255841|NCT01836536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255842|NCT01836536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255843|NCT01836536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92255844|NCT01836536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92255845|NCT01836536|Growth Substances|growth substances|mesh-ancestor
92255846|NCT01836536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255847|NCT01836536|Growth Inhibitors|growth inhibitors|mesh-ancestor
92255848|NCT03216980|Antioxidants|antioxidants|mesh-list
92255849|NCT03216980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255850|NCT03216980|Protective Agents|protective agents|mesh-ancestor
92255851|NCT03216980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255852|NCT00895232|Iron|iron|mesh-list
92255853|NCT00895232|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92255854|NCT00895232|Trace Elements|trace elements|mesh-ancestor
92255855|NCT00895232|Micronutrients|micronutrients|mesh-ancestor
92255856|NCT00895232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255857|NCT00895232|Hematinics|hematinics|mesh-ancestor
92255858|NCT03211052|Leuprolide|leuprolide|mesh-list
92255859|NCT03211052|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92255860|NCT03211052|Fertility Agents|fertility agents|mesh-ancestor
92255861|NCT03211052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92255862|NCT03211052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255863|NCT03211052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92255864|NCT03211052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255865|NCT01560923|Tryptophan|tryptophan|mesh-list
92255866|NCT01560923|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92255867|NCT01560923|Antidepressive Agents|antidepressive agents|mesh-ancestor
92255868|NCT01560923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92255869|NCT01839032|Vinorelbine|vinorelbine|mesh-list
92255870|NCT01839032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255871|NCT01839032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92255872|NCT01839032|Tubulin Modulators|tubulin modulators|mesh-ancestor
92255873|NCT01839032|Antimitotic Agents|antimitotic agents|mesh-ancestor
92255874|NCT01839032|Mitosis Modulators|mitosis modulators|mesh-ancestor
92255875|NCT01839032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255877|NCT01457885|Clofarabine|clofarabine|mesh-list
92255878|NCT01457885|Alkylating Agents|alkylating agents|mesh-ancestor
92255879|NCT01457885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255880|NCT01457885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255881|NCT01457885|Immunologic Factors|immunologic factors|mesh-ancestor
92255882|NCT01457885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255883|NCT01457885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255884|NCT01457885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255885|NCT01457885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92255886|NCT01457885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255887|NCT01457885|Antimetabolites|antimetabolites|mesh-ancestor
92255888|NCT01460225|Lubiprostone|lubiprostone|mesh-list
92255889|NCT01460225|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92255890|NCT01460225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255891|NCT01460225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255893|NCT01561469|Linezolid|linezolid|mesh-list
92255894|NCT01561469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92255895|NCT01561469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255896|NCT01561469|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92255897|NCT01561469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255898|NCT01561469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255899|NCT01561703|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92255900|NCT01561703|Amoxicillin|amoxicillin|mesh-list
92255901|NCT01561703|Azithromycin|azithromycin|mesh-list
92255902|NCT01561703|Clindamycin|clindamycin|mesh-list
92255903|NCT01561703|Clavulanic Acid|clavulanic acid|mesh-list
92255904|NCT01561703|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92255905|NCT01561703|Cephalexin|cephalexin|mesh-list
92255906|NCT01561703|Cefdinir|cefdinir|mesh-list
92255907|NCT01561703|Cefaclor|cefaclor|mesh-list
92255908|NCT01561703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92255909|NCT01561703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92255910|NCT01561703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92255911|NCT01561703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255912|NCT01561703|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92255914|NCT01839500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255915|NCT01839500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255916|NCT03210662|Pembrolizumab|pembrolizumab|mesh-list
92255917|NCT03210662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92255918|NCT03210662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255919|NCT03210662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92255920|NCT03210662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255921|NCT02501928|Fesoterodine|fesoterodine|mesh-list
92255922|NCT02501928|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92255923|NCT02501928|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92255924|NCT02501928|Cholinergic Agents|cholinergic agents|mesh-ancestor
92255925|NCT02501928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255926|NCT02501928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255927|NCT02501928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255928|NCT02501928|Urological Agents|urological agents|mesh-ancestor
92255929|NCT01839734|Lubiprostone|lubiprostone|mesh-list
92255930|NCT01839734|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92255931|NCT01839734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255932|NCT01839734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255933|NCT01462253|Cyclophosphamide|cyclophosphamide|mesh-list
92255934|NCT01462253|Clofarabine|clofarabine|mesh-list
92255935|NCT01462253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92255936|NCT01462253|Immunologic Factors|immunologic factors|mesh-ancestor
92255937|NCT01462253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255938|NCT01462253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92255939|NCT01462253|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92255941|NCT01462253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255942|NCT01462253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92255943|NCT01462253|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92255944|NCT01462253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92255945|NCT01462253|Antimetabolites|antimetabolites|mesh-ancestor
92255946|NCT01837394|Acetaminophen|acetaminophen|mesh-list
92255947|NCT01837394|Morphine|morphine|mesh-list
92255948|NCT01837394|Ondansetron|ondansetron|mesh-list
92255949|NCT01837394|Metoclopramide|metoclopramide|mesh-list
92255950|NCT01837394|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92255951|NCT01837394|Narcotics|narcotics|mesh-ancestor
92255952|NCT01837394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255953|NCT01837394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255954|NCT01837394|Analgesics|analgesics|mesh-ancestor
92255955|NCT01837394|Sensory System Agents|sensory system agents|mesh-ancestor
92255956|NCT01837394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255957|NCT01837394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92255958|NCT01837394|Antipyretics|antipyretics|mesh-ancestor
92255959|NCT01837394|Antiemetics|antiemetics|mesh-ancestor
92342781|NCT00003293|Procarbazine|procarbazine|mesh-list
92255960|NCT01837394|Autonomic Agents|autonomic agents|mesh-ancestor
92255961|NCT01837394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92255962|NCT01837394|Antipruritics|antipruritics|mesh-ancestor
92255963|NCT01837394|Dermatologic Agents|dermatologic agents|mesh-ancestor
92255964|NCT01837394|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92255965|NCT01837394|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92255966|NCT01837394|Serotonin Agents|serotonin agents|mesh-ancestor
92255967|NCT01837394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92255968|NCT01837394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255969|NCT01837394|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92255970|NCT01837394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92255971|NCT01837394|Dopamine Agents|dopamine agents|mesh-ancestor
92255972|NCT01462565|Epoprostenol|epoprostenol|mesh-list
92255973|NCT01462565|Tezosentan|tezosentan|mesh-list
92255974|NCT01462565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255975|NCT01462565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92255976|NCT01462565|Vasodilator Agents|vasodilator agents|mesh-ancestor
92255977|NCT01837628|Lidocaine|lidocaine|mesh-list
92255978|NCT01837628|Mineral Oil|mineral oil|mesh-list
92255979|NCT01837628|Anesthetics, Local|anesthetics, local|mesh-ancestor
92255980|NCT01837628|Anesthetics|anesthetics|mesh-ancestor
92255981|NCT01837628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92255982|NCT01837628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92255983|NCT01837628|Sensory System Agents|sensory system agents|mesh-ancestor
92255984|NCT01837628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92255986|NCT01837628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92255987|NCT01837628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92255988|NCT01837628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92255989|NCT01837628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255990|NCT01837628|Emollients|emollients|mesh-ancestor
92255991|NCT01837628|Dermatologic Agents|dermatologic agents|mesh-ancestor
92255992|NCT01462877|Fenofibrate|fenofibrate|mesh-list
92255993|NCT01462877|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92255994|NCT01462877|Antimetabolites|antimetabolites|mesh-ancestor
92255995|NCT01462877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92255996|NCT01462877|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92255997|NCT04972656|Ambrisentan|ambrisentan|mesh-list
92255998|NCT04972656|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92255999|NCT03210506|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92256000|NCT03210506|Antiviral Agents|antiviral agents|mesh-ancestor
92256001|NCT03210506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256002|NCT02500758|Chloroxylenol|chloroxylenol|mesh-list
92256003|NCT02500758|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92256004|NCT02500758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256005|NCT02500758|Disinfectants|disinfectants|mesh-ancestor
92256006|NCT02500758|Schistosomicides|schistosomicides|mesh-ancestor
92256007|NCT02500758|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92256008|NCT02500758|Anthelmintics|anthelmintics|mesh-ancestor
92256009|NCT02500758|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92256010|NCT01839812|Cosyntropin|cosyntropin|mesh-list
92256011|NCT01839812|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92256012|NCT01839812|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92256013|NCT01839812|beta-Endorphin|beta-endorphin|mesh-list
92256014|NCT01839812|Hormones|hormones|mesh-ancestor
91934969|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92256015|NCT01839812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92256016|NCT01839812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256017|NCT01839812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256018|NCT01839812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256019|NCT04939272|Venetoclax|venetoclax|mesh-list
92256020|NCT04939272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256021|NCT01839890|Paclitaxel|paclitaxel|mesh-list
92256022|NCT01839890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92256023|NCT01839890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256024|NCT01839890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92256025|NCT01839890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92256026|NCT01839890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92256027|NCT01839890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256028|NCT02205983|Acetaminophen|acetaminophen|mesh-list
92256029|NCT02205983|Hydromorphone|hydromorphone|mesh-list
92256030|NCT02205983|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256031|NCT02205983|Analgesics|analgesics|mesh-ancestor
92256032|NCT02205983|Sensory System Agents|sensory system agents|mesh-ancestor
92256033|NCT02205983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256034|NCT02205983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256035|NCT02205983|Antipyretics|antipyretics|mesh-ancestor
92256036|NCT02205983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92256037|NCT02205983|Narcotics|narcotics|mesh-ancestor
92256038|NCT02205983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256039|NCT01839968|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92256040|NCT01839968|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92256041|NCT03210038|Lidocaine|lidocaine|mesh-list
92256042|NCT03210038|Anesthetics, Local|anesthetics, local|mesh-ancestor
92256043|NCT03210038|Anesthetics|anesthetics|mesh-ancestor
92256044|NCT03210038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256045|NCT03210038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256046|NCT03210038|Sensory System Agents|sensory system agents|mesh-ancestor
92256047|NCT03210038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256048|NCT03210038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92256049|NCT03210038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92256050|NCT03210038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92256051|NCT03210038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256052|NCT03210038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256053|NCT02472756|Rituximab|rituximab|mesh-list
92256054|NCT02472756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92256055|NCT02472756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256056|NCT02472756|Immunologic Factors|immunologic factors|mesh-ancestor
92256057|NCT02472756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256058|NCT02472756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256059|NCT01464359|Cyclophosphamide|cyclophosphamide|mesh-list
92256061|NCT01464359|Fludarabine|fludarabine|mesh-list
92256062|NCT01464359|Interleukin-2|interleukin-2|mesh-list
92256063|NCT01464359|Allopurinol|allopurinol|mesh-list
92256064|NCT01464359|Levetiracetam|levetiracetam|mesh-list
92256065|NCT01464359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92256066|NCT01464359|Immunologic Factors|immunologic factors|mesh-ancestor
92256067|NCT01464359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256068|NCT01464359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256069|NCT01464359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92256070|NCT01464359|Alkylating Agents|alkylating agents|mesh-ancestor
92256071|NCT01464359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256072|NCT01464359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256073|NCT01464359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92256074|NCT01464359|Antimetabolites|antimetabolites|mesh-ancestor
92256075|NCT01464359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256076|NCT01464359|Analgesics|analgesics|mesh-ancestor
92256077|NCT01464359|Sensory System Agents|sensory system agents|mesh-ancestor
92256078|NCT01464359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256079|NCT01464359|Anticonvulsants|anticonvulsants|mesh-ancestor
92256080|NCT01464359|Nootropic Agents|nootropic agents|mesh-ancestor
92256081|NCT01464359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256082|NCT01464359|Gout Suppressants|gout suppressants|mesh-ancestor
92256083|NCT01464359|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92256084|NCT01464359|Antioxidants|antioxidants|mesh-ancestor
92256085|NCT01464359|Protective Agents|protective agents|mesh-ancestor
92256086|NCT04969224|Ivacaftor|ivacaftor|mesh-list
92256087|NCT04969224|Elexacaftor|elexacaftor|mesh-list
92256088|NCT04969224|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92342810|NCT00004205|Letrozole|letrozole|mesh-list
92256089|NCT04969224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256090|NCT04969224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256091|NCT01838252|Hyaluronic Acid|hyaluronic acid|mesh-list
92256092|NCT01838252|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92256093|NCT01838252|Immunologic Factors|immunologic factors|mesh-ancestor
92256094|NCT01838252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256095|NCT01838252|Viscosupplements|viscosupplements|mesh-ancestor
92256096|NCT01838252|Protective Agents|protective agents|mesh-ancestor
92256097|NCT01838330|Psyllium|psyllium|mesh-list
92256098|NCT01838330|Cathartics|cathartics|mesh-ancestor
92256099|NCT01838330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256100|NCT02498652|Allopurinol|allopurinol|mesh-list
92256101|NCT02498652|Verinurad|verinurad|mesh-list
92256102|NCT02498652|Antimetabolites|antimetabolites|mesh-ancestor
92256103|NCT02498652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256104|NCT02498652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256105|NCT02498652|Gout Suppressants|gout suppressants|mesh-ancestor
92256106|NCT02498652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256107|NCT02498652|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92256108|NCT02498652|Antioxidants|antioxidants|mesh-ancestor
92256109|NCT02498652|Protective Agents|protective agents|mesh-ancestor
92256110|NCT02498652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256111|NCT03213158|Ixazomib|ixazomib|mesh-list
92256112|NCT03213158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256113|NCT03213158|Protease Inhibitors|protease inhibitors|mesh-ancestor
92256114|NCT03213158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256115|NCT03213158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256116|NCT02498418|Rifaximin|rifaximin|mesh-list
92256117|NCT02498418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256118|NCT02498418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256119|NCT02498418|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256120|NCT03219476|Tamoxifen|tamoxifen|mesh-list
92256121|NCT03219476|Letrozole|letrozole|mesh-list
92256122|NCT03219476|Anastrozole|anastrozole|mesh-list
92256123|NCT03219476|Exemestane|exemestane|mesh-list
92256124|NCT03219476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256125|NCT03219476|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92256126|NCT03219476|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92256127|NCT03219476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256128|NCT03219476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256129|NCT03219476|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92256130|NCT03219476|Hormone Antagonists|hormone antagonists|mesh-ancestor
92256131|NCT03219476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92256132|NCT03219476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256133|NCT03219476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92256134|NCT03219476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92256135|NCT03219476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92256136|NCT03219476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92256137|NCT02472366|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92256138|NCT02472366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256139|NCT02472366|Glucocorticoids|glucocorticoids|mesh-ancestor
92256140|NCT02472366|Hormones|hormones|mesh-ancestor
92256141|NCT02472366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92256142|NCT02472366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256143|NCT01724606|Sorafenib|sorafenib|mesh-list
92256144|NCT01724606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256145|NCT01724606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92256146|NCT01724606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256147|NCT01724606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256148|NCT03219164|Aztreonam|aztreonam|mesh-list
92256149|NCT03219164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256150|NCT03219164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256151|NCT01720238|Lamivudine|lamivudine|mesh-list
92256152|NCT01720238|Adefovir|adefovir|mesh-list
92256153|NCT01720238|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92256154|NCT01720238|Entecavir|entecavir|mesh-list
92256155|NCT01720238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92256156|NCT01720238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92256157|NCT01720238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342815|NCT00004205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256158|NCT01720238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256159|NCT01720238|Antiviral Agents|antiviral agents|mesh-ancestor
92256160|NCT01720238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256161|NCT01720238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92256162|NCT01720238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92256164|NCT03836222|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92256165|NCT03836222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256166|NCT03836222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256167|NCT03836222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92256168|NCT03836222|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92256169|NCT03836222|Protective Agents|protective agents|mesh-ancestor
92256170|NCT03836222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256171|NCT03836222|Vasodilator Agents|vasodilator agents|mesh-ancestor
92256172|NCT03836222|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92256173|NCT03836222|Antioxidants|antioxidants|mesh-ancestor
92256174|NCT01830218|Anesthetics|anesthetics|mesh-list
92256175|NCT01830218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256176|NCT01830218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256177|NCT00910208|Morphine|morphine|mesh-list
92256178|NCT00910208|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92256179|NCT00910208|Narcotics|narcotics|mesh-ancestor
92256180|NCT00910208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256181|NCT00910208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256182|NCT00910208|Analgesics|analgesics|mesh-ancestor
92256183|NCT00910208|Sensory System Agents|sensory system agents|mesh-ancestor
92256184|NCT00910208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256185|NCT01566539|Vasopressins|vasopressins|mesh-list
92256186|NCT01566539|Arginine Vasopressin|arginine vasopressin|mesh-list
92256187|NCT01566539|Lorazepam|lorazepam|mesh-list
92256188|NCT01566539|Oxytocin|oxytocin|mesh-list
92256189|NCT01566539|Oxytocics|oxytocics|mesh-ancestor
92256190|NCT01566539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256191|NCT01566539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256192|NCT01566539|Anticonvulsants|anticonvulsants|mesh-ancestor
92256193|NCT01566539|Antiemetics|antiemetics|mesh-ancestor
92256194|NCT01566539|Autonomic Agents|autonomic agents|mesh-ancestor
92256195|NCT01566539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256196|NCT01566539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256197|NCT01566539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92256198|NCT01566539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256199|NCT01566539|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92256200|NCT01566539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92256201|NCT01566539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92256202|NCT01566539|GABA Modulators|gaba modulators|mesh-ancestor
92256203|NCT01566539|GABA Agents|gaba agents|mesh-ancestor
92256204|NCT01566539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256205|NCT01566539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256206|NCT01566539|Hemostatics|hemostatics|mesh-ancestor
92256207|NCT01566539|Coagulants|coagulants|mesh-ancestor
92256208|NCT01566539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92256209|NCT01566539|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92256210|NCT01566539|Natriuretic Agents|natriuretic agents|mesh-ancestor
92256211|NCT04967664|Capsaicin|capsaicin|mesh-list
92256212|NCT04967664|Antipruritics|antipruritics|mesh-ancestor
92256213|NCT04967664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92256214|NCT04967664|Sensory System Agents|sensory system agents|mesh-ancestor
92256215|NCT04967664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256216|NCT04967664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256217|NCT01725776|Milrinone|milrinone|mesh-list
92256218|NCT01725776|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92256219|NCT01725776|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92256220|NCT01725776|Vasodilator Agents|vasodilator agents|mesh-ancestor
92256221|NCT01725776|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92256222|NCT01725776|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92256223|NCT01725776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256224|NCT01725776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256225|NCT01725776|Protective Agents|protective agents|mesh-ancestor
92256226|NCT01725776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256227|NCT01830296|Morphine|morphine|mesh-list
92256228|NCT01830296|Remifentanil|remifentanil|mesh-list
92256229|NCT01830296|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92256231|NCT01830296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256232|NCT01830296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256233|NCT01830296|Analgesics|analgesics|mesh-ancestor
92256234|NCT01830296|Sensory System Agents|sensory system agents|mesh-ancestor
92256235|NCT01830296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256236|NCT05564819|Acetaminophen|acetaminophen|mesh-list
92256237|NCT05564819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256238|NCT05564819|Analgesics|analgesics|mesh-ancestor
92256239|NCT05564819|Sensory System Agents|sensory system agents|mesh-ancestor
92256240|NCT05564819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256241|NCT05564819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256242|NCT05564819|Antipyretics|antipyretics|mesh-ancestor
92256243|NCT01720394|Dinoprostone|dinoprostone|mesh-list
92256244|NCT01720394|Oxytocics|oxytocics|mesh-ancestor
92256245|NCT01720394|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256246|NCT01720394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256247|NCT01467947|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92256248|NCT01467947|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92256249|NCT01467947|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92256250|NCT01467947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92256251|NCT01467947|Immunologic Factors|immunologic factors|mesh-ancestor
92256252|NCT01467947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256253|NCT00910520|Botulinum Toxins|botulinum toxins|mesh-list
92256254|NCT00910520|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92256255|NCT00910520|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92256256|NCT00910520|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92256257|NCT00910520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256258|NCT00910520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256259|NCT00910520|Cholinergic Agents|cholinergic agents|mesh-ancestor
92256260|NCT00910520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256261|NCT00910520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256262|NCT00910520|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92256263|NCT00910520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256264|NCT01568255|Ergocalciferols|ergocalciferols|mesh-list
92256265|NCT01568255|Vitamin D|vitamin d|mesh-list
92256266|NCT01568255|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92256267|NCT01568255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256268|NCT01568255|Vitamins|vitamins|mesh-ancestor
92256269|NCT01568255|Micronutrients|micronutrients|mesh-ancestor
92256270|NCT01568255|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92256271|NCT01720628|Angiogenin|angiogenin|mesh-list
92256272|NCT01720628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92256273|NCT01720628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92256274|NCT01720628|Growth Substances|growth substances|mesh-ancestor
92256275|NCT01720628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256276|NCT01569191|Anti-Allergic Agents|anti-allergic agents|mesh-list
92256277|NCT01569191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92256278|NCT01569191|Lubricant Eye Drops|lubricant eye drops|mesh-list
92256279|NCT01569191|Epinastine|epinastine|mesh-list
92256280|NCT01569191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92256281|NCT01569191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92256282|NCT01569191|Histamine Antagonists|histamine antagonists|mesh-ancestor
92256283|NCT01569191|Histamine Agents|histamine agents|mesh-ancestor
92256284|NCT01569191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256285|NCT01569191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256286|NCT01569191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256287|NCT03409874|Diclofenac|diclofenac|mesh-list
92256288|NCT03409874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92256289|NCT03409874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256290|NCT03409874|Analgesics|analgesics|mesh-ancestor
92256291|NCT03409874|Sensory System Agents|sensory system agents|mesh-ancestor
92256292|NCT03409874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256293|NCT03409874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256294|NCT03409874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256295|NCT03409874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256296|NCT03409874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92256297|NCT03409874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256298|NCT03409874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256299|NCT01726088|Modafinil|modafinil|mesh-list
92256300|NCT01726088|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92256301|NCT01726088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256302|NCT01726088|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92256303|NCT01726088|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92256304|NCT01726088|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92256305|NCT01726088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256306|NCT01468337|Interferons|interferons|mesh-list
92256307|NCT01468337|Interferon-gamma|interferon-gamma|mesh-list
92256308|NCT01468337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256309|NCT01468337|Antiviral Agents|antiviral agents|mesh-ancestor
92256310|NCT01468337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256311|NCT00911612|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92256312|NCT00911612|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92256313|NCT00911612|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92256314|NCT00911612|Antimetabolites|antimetabolites|mesh-ancestor
92256315|NCT00911612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256316|NCT00911612|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92256317|NCT05562089|Paclitaxel|paclitaxel|mesh-list
92256318|NCT05562089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92256319|NCT05562089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256320|NCT05562089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92256321|NCT05562089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92256322|NCT05562089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92256323|NCT05562089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256324|NCT01726478|Oxytocin|oxytocin|mesh-list
92256325|NCT01726478|Oxytocics|oxytocics|mesh-ancestor
92256326|NCT01726478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256327|NCT01726478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256328|NCT04379492|Hydroxychloroquine|hydroxychloroquine|mesh-list
92256329|NCT04379492|Antimalarials|antimalarials|mesh-ancestor
92256330|NCT04379492|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92256331|NCT04379492|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92256332|NCT04379492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256333|NCT04379492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256334|NCT04379492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256335|NCT04379492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256336|NCT03409250|Ranibizumab|ranibizumab|mesh-list
92256337|NCT03409250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92256338|NCT03409250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92256339|NCT03409250|Growth Substances|growth substances|mesh-ancestor
92256340|NCT03409250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256341|NCT03409250|Growth Inhibitors|growth inhibitors|mesh-ancestor
92256342|NCT03409250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256343|NCT01569815|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92256344|NCT01569815|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92256345|NCT01569815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256346|NCT01469585|Doxycycline|doxycycline|mesh-list
92256347|NCT01469585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256348|NCT01469585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256349|NCT01469585|Antimalarials|antimalarials|mesh-ancestor
92256350|NCT01469585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92256351|NCT01469585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92256352|NCT01720940|Vancomycin|vancomycin|mesh-list
92256353|NCT01720940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256354|NCT01720940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256355|NCT00915590|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92256356|NCT00915590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256358|NCT01721798|Levonorgestrel|levonorgestrel|mesh-list
92256359|NCT01721798|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92256360|NCT01721798|Contraceptive Agents|contraceptive agents|mesh-ancestor
92256361|NCT01721798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256362|NCT01721798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256363|NCT01721798|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92256364|NCT01721798|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92256365|NCT01721798|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92256366|NCT01721798|Trace Elements|trace elements|mesh-ancestor
92256367|NCT01721798|Micronutrients|micronutrients|mesh-ancestor
92256368|NCT02497404|Fludarabine|fludarabine|mesh-list
92256369|NCT02497404|Azacitidine|azacitidine|mesh-list
92256371|NCT02497404|Alemtuzumab|alemtuzumab|mesh-list
92256372|NCT02497404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256373|NCT02497404|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92256374|NCT02497404|Antimetabolites|antimetabolites|mesh-ancestor
92256375|NCT02497404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256376|NCT02497404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92256377|NCT02497404|Immunologic Factors|immunologic factors|mesh-ancestor
92256378|NCT02497404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256379|NCT02497404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256380|NCT02497404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92256381|NCT02497404|Alkylating Agents|alkylating agents|mesh-ancestor
92256382|NCT02497404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92256383|NCT02497404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92256385|NCT01573169|Anticoagulants|anticoagulants|mesh-ancestor
92256386|NCT01573169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92256387|NCT01573169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92256388|NCT01573169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256389|NCT04205994|Tolcapone|tolcapone|mesh-list
92256390|NCT04205994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92256391|NCT04205994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92256392|NCT04205994|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92256393|NCT04205994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256394|NCT04205994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256395|NCT02218307|Mupirocin|mupirocin|mesh-list
92256396|NCT02218307|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256397|NCT02218307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256398|NCT02218307|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92256399|NCT02218307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256400|NCT02218307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256401|NCT01722110|Indomethacin|indomethacin|mesh-list
92256402|NCT01722110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92256403|NCT01722110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256404|NCT01722110|Analgesics|analgesics|mesh-ancestor
92256405|NCT01722110|Sensory System Agents|sensory system agents|mesh-ancestor
92256406|NCT01722110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256407|NCT01722110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256408|NCT01722110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256409|NCT01722110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256410|NCT01722110|Gout Suppressants|gout suppressants|mesh-ancestor
92256411|NCT01722110|Tocolytic Agents|tocolytic agents|mesh-ancestor
92256412|NCT01722110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256413|NCT01722110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92256414|NCT01722110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256415|NCT01722110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256416|NCT01573949|Metformin|metformin|mesh-list
92256417|NCT01573949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92256418|NCT01573949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256419|NCT01574183|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92256420|NCT01574183|Antidepressive Agents|antidepressive agents|mesh-ancestor
92256421|NCT01574183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92256422|NCT01574183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92256423|NCT01574183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92256424|NCT01574183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256425|NCT01574183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256426|NCT01574183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256427|NCT01574183|Serotonin Agents|serotonin agents|mesh-ancestor
92256428|NCT01574183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256429|NCT01574183|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92256430|NCT01574183|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92256431|NCT01574807|Lidocaine|lidocaine|mesh-list
92256432|NCT01574807|Mepivacaine|mepivacaine|mesh-list
92256433|NCT01574807|Anesthetics, Local|anesthetics, local|mesh-ancestor
92256434|NCT01574807|Anesthetics|anesthetics|mesh-ancestor
92256435|NCT01574807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256436|NCT01574807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256437|NCT01574807|Sensory System Agents|sensory system agents|mesh-ancestor
92256438|NCT01574807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256439|NCT01574807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92256440|NCT01574807|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92256441|NCT01574807|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92256442|NCT01574807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256443|NCT01574807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256444|NCT01575275|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92256445|NCT01575275|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92256446|NCT01575275|Dermatologic Agents|dermatologic agents|mesh-ancestor
92256448|NCT01728272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92256449|NCT01728272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92256450|NCT01728272|Sympatholytics|sympatholytics|mesh-ancestor
92256451|NCT01728272|Autonomic Agents|autonomic agents|mesh-ancestor
92256452|NCT01728272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256453|NCT01728272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256454|NCT01728272|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92256455|NCT01728272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92256456|NCT01728272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92256457|NCT01728272|Adrenergic Agents|adrenergic agents|mesh-ancestor
92256458|NCT01728272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256459|NCT01728272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256461|NCT03835286|Vitamins|vitamins|mesh-ancestor
92256462|NCT03835286|Micronutrients|micronutrients|mesh-ancestor
92256463|NCT03835286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256464|NCT03835286|Antioxidants|antioxidants|mesh-ancestor
92256465|NCT03835286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256466|NCT03835286|Protective Agents|protective agents|mesh-ancestor
92256467|NCT04377386|Vitamin D|vitamin d|mesh-list
92256468|NCT04377386|Ergocalciferols|ergocalciferols|mesh-list
92256469|NCT04377386|Cholecalciferol|cholecalciferol|mesh-list
92256470|NCT04377386|Vitamins|vitamins|mesh-list
92256471|NCT04377386|Micronutrients|micronutrients|mesh-ancestor
92256472|NCT04377386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256473|NCT04377386|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92256474|NCT04377386|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92256475|NCT01728740|Metformin|metformin|mesh-list
92256476|NCT01728740|Acarbose|acarbose|mesh-list
92256477|NCT01728740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92256478|NCT01728740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256479|NCT01728740|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92256480|NCT01728740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256481|NCT01728740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256482|NCT01728818|Gemcitabine|gemcitabine|mesh-list
92256483|NCT01728818|Afatinib|afatinib|mesh-list
92256484|NCT01728818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92256485|NCT01728818|Antimetabolites|antimetabolites|mesh-ancestor
92256486|NCT01728818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256487|NCT01728818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256488|NCT01728818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92256489|NCT01728818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256490|NCT03835520|Immunomodulating Agents|immunomodulating agents|mesh-list
92256491|NCT03835520|Immunologic Factors|immunologic factors|mesh-ancestor
92256492|NCT03835520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256493|NCT01728974|Anesthetics|anesthetics|mesh-list
92256494|NCT01728974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256495|NCT01728974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256496|NCT03407300|Docetaxel|docetaxel|mesh-list
92256497|NCT03407300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256498|NCT03407300|Tubulin Modulators|tubulin modulators|mesh-ancestor
92256499|NCT03407300|Antimitotic Agents|antimitotic agents|mesh-ancestor
92256500|NCT03407300|Mitosis Modulators|mitosis modulators|mesh-ancestor
92256501|NCT03407300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256502|NCT01722968|Paclitaxel|paclitaxel|mesh-list
92256503|NCT01722968|Bevacizumab|bevacizumab|mesh-list
92256504|NCT01722968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92256505|NCT01722968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256506|NCT01722968|Tubulin Modulators|tubulin modulators|mesh-ancestor
92256507|NCT01722968|Antimitotic Agents|antimitotic agents|mesh-ancestor
92256508|NCT01722968|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342846|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
92256509|NCT01722968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256510|NCT01722968|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92256511|NCT01722968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92256512|NCT01722968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92256513|NCT01722968|Growth Substances|growth substances|mesh-ancestor
92256514|NCT01722968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256515|NCT01722968|Growth Inhibitors|growth inhibitors|mesh-ancestor
92256516|NCT04379180|Bosentan|bosentan|mesh-list
92256517|NCT04379180|Sildenafil Citrate|sildenafil citrate|mesh-list
92256518|NCT04379180|Tadalafil|tadalafil|mesh-list
92256519|NCT04379180|Vasodilator Agents|vasodilator agents|mesh-ancestor
92256520|NCT04379180|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92256521|NCT04379180|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92256522|NCT04379180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256523|NCT04379180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256524|NCT04379180|Urological Agents|urological agents|mesh-ancestor
92256525|NCT04379180|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92256526|NCT04379180|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92256527|NCT01576523|Complement C1s|complement c1s|mesh-list
92256528|NCT01576523|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92256529|NCT01576523|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92256530|NCT01576523|Immunologic Factors|immunologic factors|mesh-ancestor
92256531|NCT01576523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256532|NCT01576523|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92256533|NCT01576523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92256535|NCT03406676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256536|NCT03406676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256537|NCT03001739|Urapidil|urapidil|mesh-list
92256538|NCT03001739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92256539|NCT03001739|Vasodilator Agents|vasodilator agents|mesh-ancestor
92256540|NCT03001739|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92256541|NCT03001739|Serotonin Agents|serotonin agents|mesh-ancestor
92256542|NCT03001739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256543|NCT03001739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256544|NCT03001739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256545|NCT03001739|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92256546|NCT03001739|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92256547|NCT03001739|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92256548|NCT03001739|Adrenergic Agents|adrenergic agents|mesh-ancestor
92256549|NCT03001661|Dinoprostone|dinoprostone|mesh-list
92256550|NCT03001661|Oxytocics|oxytocics|mesh-ancestor
92256551|NCT03001661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256552|NCT03001661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256553|NCT03006965|Factor VIII|factor viii|mesh-list
92256554|NCT03006965|BAX 855|bax 855|mesh-list
92256555|NCT03006965|Coagulants|coagulants|mesh-ancestor
92256556|NCT04379102|Anesthetics|anesthetics|mesh-list
92256557|NCT04379102|Anesthetics, Local|anesthetics, local|mesh-list
92256558|NCT04379102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256559|NCT04379102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256560|NCT04379102|Sensory System Agents|sensory system agents|mesh-ancestor
92256561|NCT04379102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256562|NCT02469246|Lamivudine|lamivudine|mesh-list
92256563|NCT02469246|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92256564|NCT02469246|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92256565|NCT02469246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256566|NCT02469246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256567|NCT02469246|Antiviral Agents|antiviral agents|mesh-ancestor
92256568|NCT02469246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256569|NCT02469246|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92256570|NCT02469246|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92256571|NCT01723202|Trametinib|trametinib|mesh-list
92256572|NCT01723202|Dabrafenib|dabrafenib|mesh-list
92256573|NCT01723202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256574|NCT01723202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92256575|NCT01723202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256576|NCT01723202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256577|NCT01578317|Vaccines|vaccines|mesh-list
92256578|NCT01578317|Immunologic Factors|immunologic factors|mesh-ancestor
92256579|NCT01578317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256581|NCT03830216|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92256582|NCT03830216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92256583|NCT03830216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256584|NCT01726946|Ribavirin|ribavirin|mesh-list
92256585|NCT01726946|Antimetabolites|antimetabolites|mesh-ancestor
92256586|NCT01726946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256587|NCT01726946|Antiviral Agents|antiviral agents|mesh-ancestor
92256588|NCT01726946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256589|NCT01723670|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
92256590|NCT01723670|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92256591|NCT01723670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256592|NCT01723670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256593|NCT01723748|Hormones|hormones|mesh-list
92256594|NCT01723748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92256595|NCT01723748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256596|NCT02469090|Apomorphine|apomorphine|mesh-list
92256597|NCT02469090|Emetics|emetics|mesh-ancestor
92256598|NCT02469090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256599|NCT02469090|Autonomic Agents|autonomic agents|mesh-ancestor
92256600|NCT02469090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256601|NCT02469090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256602|NCT02469090|Dopamine Agonists|dopamine agonists|mesh-ancestor
92256603|NCT02469090|Dopamine Agents|dopamine agents|mesh-ancestor
92256604|NCT02469090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256605|NCT02469090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256606|NCT02496000|Insulin|insulin|mesh-list
92256607|NCT02496000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92256608|NCT02496000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256609|NCT02517528|Ritonavir|ritonavir|mesh-list
92256610|NCT02517528|Ribavirin|ribavirin|mesh-list
92256611|NCT02517528|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92256612|NCT02517528|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92256613|NCT02517528|Protease Inhibitors|protease inhibitors|mesh-ancestor
92256614|NCT02517528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256615|NCT02517528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256617|NCT02517528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92256618|NCT02517528|Antiviral Agents|antiviral agents|mesh-ancestor
92256619|NCT02517528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256620|NCT02517528|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92256621|NCT02517528|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92256622|NCT02517528|Antimetabolites|antimetabolites|mesh-ancestor
92256623|NCT01727336|Axitinib|axitinib|mesh-list
92256624|NCT01727336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256625|NCT01727336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92256626|NCT01727336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256627|NCT01727336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256628|NCT01578707|Ofatumumab|ofatumumab|mesh-list
92256629|NCT01578707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256630|NCT03835442|Baclofen|baclofen|mesh-list
92256631|NCT03835442|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92256632|NCT03835442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256633|NCT03835442|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92256634|NCT03835442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256635|NCT03835442|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92256636|NCT03835442|GABA Agonists|gaba agonists|mesh-ancestor
92256638|NCT03835442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256639|NCT03835442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256640|NCT01722656|Aflibercept|aflibercept|mesh-list
92256641|NCT01722656|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92256642|NCT01722656|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92256643|NCT01722656|Growth Substances|growth substances|mesh-ancestor
92256644|NCT01722656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256645|NCT01722656|Growth Inhibitors|growth inhibitors|mesh-ancestor
92256646|NCT01722656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256647|NCT04963764|Amoxicillin|amoxicillin|mesh-list
92256648|NCT04963764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256649|NCT04963764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256650|NCT03405584|Amoxicillin|amoxicillin|mesh-list
92256651|NCT03405584|Potassium Citrate|potassium citrate|mesh-list
92256652|NCT03405584|Esomeprazole|esomeprazole|mesh-list
92256653|NCT03405584|Bismuth|bismuth|mesh-list
92256654|NCT03405584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256655|NCT03405584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92256656|NCT03405584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256657|NCT03405584|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92256658|NCT03405584|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256659|NCT03405584|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92256660|NCT03405584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256661|NCT03405584|Antacids|antacids|mesh-ancestor
92256662|NCT03405584|Diuretics|diuretics|mesh-ancestor
92256663|NCT03405584|Natriuretic Agents|natriuretic agents|mesh-ancestor
92256664|NCT03405584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256665|NCT03405584|Expectorants|expectorants|mesh-ancestor
92256666|NCT03405584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92256668|NCT03007121|Morphine|morphine|mesh-list
92256670|NCT03007121|Bupivacaine|bupivacaine|mesh-list
92256671|NCT03007121|Anesthetics, Local|anesthetics, local|mesh-ancestor
92256672|NCT03007121|Anesthetics|anesthetics|mesh-ancestor
92256673|NCT03007121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256674|NCT03007121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256675|NCT03007121|Sensory System Agents|sensory system agents|mesh-ancestor
92256676|NCT03007121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256677|NCT03007121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92256678|NCT03007121|Narcotics|narcotics|mesh-ancestor
92256679|NCT03007121|Analgesics|analgesics|mesh-ancestor
92256680|NCT03007121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92256681|NCT03007121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92256682|NCT03007121|Anesthetics, General|anesthetics, general|mesh-ancestor
92256684|NCT01725152|Neurosteroids|neurosteroids|mesh-ancestor
92256685|NCT01725152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256686|NCT01725152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256687|NCT01725152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256688|NCT01725152|GABA Modulators|gaba modulators|mesh-ancestor
92256689|NCT01725152|GABA Agents|gaba agents|mesh-ancestor
92256690|NCT02980913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92256691|NCT02980913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92256692|NCT02981303|Pembrolizumab|pembrolizumab|mesh-list
92256693|NCT02981303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92256694|NCT02981303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256695|NCT02981303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92256696|NCT02981303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256697|NCT02981459|Mirabegron|mirabegron|mesh-list
92256698|NCT02981459|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92256699|NCT02981459|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92256700|NCT02981459|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92256701|NCT02981459|Adrenergic Agents|adrenergic agents|mesh-ancestor
92256702|NCT02981459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256703|NCT02981459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256704|NCT02981459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256705|NCT02981459|Urological Agents|urological agents|mesh-ancestor
92256706|NCT01724138|Deferasirox|deferasirox|mesh-list
92256707|NCT01724138|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92256708|NCT01724138|Chelating Agents|chelating agents|mesh-ancestor
92256709|NCT01724138|Sequestering Agents|sequestering agents|mesh-ancestor
92256710|NCT01724138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256711|NCT03006809|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92256713|NCT03006809|Vancomycin|vancomycin|mesh-list
92256714|NCT03006809|Neomycin|neomycin|mesh-list
92256715|NCT03006809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256716|NCT03006809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92256717|NCT03006809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92256718|NCT03006809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92256719|NCT03006809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256720|NCT03006809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256721|NCT01580423|Aprepitant|aprepitant|mesh-list
92256722|NCT01580423|Antiemetics|antiemetics|mesh-ancestor
92256723|NCT01580423|Autonomic Agents|autonomic agents|mesh-ancestor
92256724|NCT01580423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256725|NCT01580423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256726|NCT01580423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256727|NCT01580423|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92256728|NCT01580423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256729|NCT01580423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256730|NCT01049984|Rasagiline|rasagiline|mesh-list
92256731|NCT01049984|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92256732|NCT01049984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256733|NCT01049984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256734|NCT01049984|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92256735|NCT01049984|Protective Agents|protective agents|mesh-ancestor
92256736|NCT01049984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256738|NCT03001271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92256739|NCT03001271|Vasodilator Agents|vasodilator agents|mesh-ancestor
92256740|NCT03001349|Octreotide|octreotide|mesh-list
92256741|NCT03001349|Edotreotide|edotreotide|mesh-list
92256742|NCT03001349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256743|NCT03001349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256744|NCT03001349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92256745|NCT03001349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256746|NCT03001349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92256747|NCT03001193|Oxytocin|oxytocin|mesh-list
92256748|NCT03001193|Oxytocics|oxytocics|mesh-ancestor
92256749|NCT03001193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92256750|NCT03001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256751|NCT01049360|Formoterol Fumarate|formoterol fumarate|mesh-list
92256752|NCT01049360|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92256753|NCT01049360|Autonomic Agents|autonomic agents|mesh-ancestor
92256754|NCT01049360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256755|NCT01049360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256756|NCT01049360|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92256757|NCT01049360|Respiratory System Agents|respiratory system agents|mesh-ancestor
92256758|NCT01049360|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92256759|NCT01049360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92256760|NCT01049360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92256761|NCT01049360|Adrenergic Agents|adrenergic agents|mesh-ancestor
92256762|NCT01049360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256763|NCT01049360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256764|NCT02494596|Capecitabine|capecitabine|mesh-list
92256765|NCT02494596|Pertuzumab|pertuzumab|mesh-list
92256766|NCT02494596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92256767|NCT02494596|Antimetabolites|antimetabolites|mesh-ancestor
92256768|NCT02494596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256769|NCT02494596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256770|NCT02494596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92256771|NCT01048502|Fenofibrate|fenofibrate|mesh-list
92256772|NCT01048502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92256773|NCT01048502|Antimetabolites|antimetabolites|mesh-ancestor
92256774|NCT01048502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256775|NCT01048502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92256776|NCT01583543|Olaparib|olaparib|mesh-list
92256777|NCT01583543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92256778|NCT01583543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256779|NCT01583543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256780|NCT01583543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256781|NCT01724372|Aripiprazole|aripiprazole|mesh-list
92256782|NCT01724372|Antipsychotic Agents|antipsychotic agents|mesh-list
92256783|NCT01724372|Fluoxetine|fluoxetine|mesh-list
92342877|NCT00003311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92256784|NCT01724372|Antidepressive Agents|antidepressive agents|mesh-list
92256785|NCT01724372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92256786|NCT01724372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92256787|NCT01724372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256788|NCT01724372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256789|NCT01724372|Dopamine Agonists|dopamine agonists|mesh-ancestor
92256790|NCT01724372|Dopamine Agents|dopamine agents|mesh-ancestor
92256791|NCT01724372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256792|NCT01724372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256793|NCT01724372|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92256794|NCT01724372|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92256795|NCT01724372|Serotonin Agents|serotonin agents|mesh-ancestor
92256796|NCT01724372|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92256797|NCT01724372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92256798|NCT01724372|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92256799|NCT01724372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92256800|NCT01724372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92256801|NCT01724372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92256802|NCT01724372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256803|NCT01724372|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92256804|NCT01724372|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92256805|NCT01724372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92256806|NCT01724372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256807|NCT02464410|Analgesics, Opioid|analgesics, opioid|mesh-list
92256808|NCT02464410|Narcotics|narcotics|mesh-ancestor
92256809|NCT02464410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256810|NCT02464410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256811|NCT02464410|Analgesics|analgesics|mesh-ancestor
92256812|NCT02464410|Sensory System Agents|sensory system agents|mesh-ancestor
92256813|NCT02464410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256814|NCT03006419|Thymoglobulin|thymoglobulin|mesh-list
92256815|NCT03006419|Basiliximab|basiliximab|mesh-list
92256816|NCT03006419|Immunologic Factors|immunologic factors|mesh-ancestor
92256817|NCT03006419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256818|NCT03006419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92256819|NCT03405272|Antibodies|antibodies|mesh-list
92256820|NCT03405272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92256821|NCT03405272|Immunologic Factors|immunologic factors|mesh-ancestor
92256822|NCT03405272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256823|NCT03405194|Efavirenz|efavirenz|mesh-list
92256824|NCT03405194|Cobicistat|cobicistat|mesh-list
92256825|NCT03405194|Elvitegravir|elvitegravir|mesh-list
92256826|NCT03405194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92256827|NCT03405194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92256828|NCT03405194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256829|NCT03405194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256830|NCT03405194|Antiviral Agents|antiviral agents|mesh-ancestor
92256831|NCT03405194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92256832|NCT03405194|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92256833|NCT03405194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92256834|NCT03405194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92256835|NCT03405194|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92256836|NCT03405194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92256837|NCT03405194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92256838|NCT03405194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92256839|NCT03405194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92256840|NCT03405194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92256841|NCT03405194|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92256842|NCT03006107|Piroxicam|piroxicam|mesh-list
92256843|NCT03006107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92256844|NCT03006107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256845|NCT03006107|Analgesics|analgesics|mesh-ancestor
92256846|NCT03006107|Sensory System Agents|sensory system agents|mesh-ancestor
92256847|NCT03006107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256848|NCT03006107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342881|NCT00003317|Paclitaxel|paclitaxel|mesh-list
92256849|NCT03006107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256850|NCT03006107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256851|NCT03006107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92256852|NCT03006107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256853|NCT03006107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256854|NCT01046396|Adapalene|adapalene|mesh-list
92256855|NCT01046396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92256856|NCT01046396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256857|NCT01046396|Analgesics|analgesics|mesh-ancestor
92256858|NCT01046396|Sensory System Agents|sensory system agents|mesh-ancestor
92256859|NCT01046396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256860|NCT01046396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256861|NCT01046396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256862|NCT01046396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256863|NCT01046396|Dermatologic Agents|dermatologic agents|mesh-ancestor
92256864|NCT01046084|Lansoprazole|lansoprazole|mesh-list
92256865|NCT01046084|Dexlansoprazole|dexlansoprazole|mesh-list
92256866|NCT01046084|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92256867|NCT01046084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92256868|NCT01046084|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92256869|NCT01046084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256870|NCT01046084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256871|NCT01045694|Triamcinolone|triamcinolone|mesh-list
92256872|NCT01045694|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92256873|NCT01045694|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92256874|NCT01045694|Lidocaine|lidocaine|mesh-list
92256875|NCT01045694|Botulinum Toxins|botulinum toxins|mesh-list
92256876|NCT01045694|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92256877|NCT01045694|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92256878|NCT01045694|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92256879|NCT01045694|Anesthetics, Local|anesthetics, local|mesh-ancestor
92256880|NCT01045694|Anesthetics|anesthetics|mesh-ancestor
92256881|NCT01045694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256882|NCT01045694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256883|NCT01045694|Sensory System Agents|sensory system agents|mesh-ancestor
92256884|NCT01045694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256885|NCT01045694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92256886|NCT01045694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92256887|NCT01045694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92256888|NCT01045694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256889|NCT01045694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256890|NCT01045694|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92256891|NCT01045694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92256892|NCT01045694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256893|NCT01045694|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92256894|NCT01045694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256895|NCT01045694|Glucocorticoids|glucocorticoids|mesh-ancestor
92256896|NCT01045694|Hormones|hormones|mesh-ancestor
92256897|NCT01045694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92256898|NCT01045694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92256899|NCT01045694|Immunologic Factors|immunologic factors|mesh-ancestor
92256900|NCT01045694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256901|NCT01586975|Aspirin|aspirin|mesh-list
92256902|NCT01586975|Clopidogrel|clopidogrel|mesh-list
92256903|NCT01586975|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92256904|NCT01586975|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92256905|NCT01586975|Analgesics|analgesics|mesh-ancestor
92256906|NCT01586975|Sensory System Agents|sensory system agents|mesh-ancestor
92256907|NCT01586975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256908|NCT01586975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256909|NCT01586975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92256910|NCT01586975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92256911|NCT01586975|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92256912|NCT01586975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92256913|NCT01586975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256914|NCT01586975|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92256915|NCT01586975|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92256916|NCT01586975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256917|NCT01586975|Antipyretics|antipyretics|mesh-ancestor
92256918|NCT01586975|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92342887|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
92256919|NCT01586975|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92256921|NCT01586975|Purinergic Agents|purinergic agents|mesh-ancestor
92256922|NCT01586975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256924|NCT03000413|Ketamine|ketamine|mesh-list
92256925|NCT03000413|Analgesics|analgesics|mesh-ancestor
92256926|NCT03000413|Sensory System Agents|sensory system agents|mesh-ancestor
92256927|NCT03000413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256928|NCT03000413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256929|NCT03000413|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92256930|NCT03000413|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92256931|NCT03000413|Anesthetics, General|anesthetics, general|mesh-ancestor
92256932|NCT03000413|Anesthetics|anesthetics|mesh-ancestor
92256933|NCT03000413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256934|NCT03000413|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92256935|NCT03000413|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92256936|NCT03000413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256937|NCT03000413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256938|NCT03000413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92256939|NCT03000413|Narcotics|narcotics|mesh-ancestor
92256940|NCT03000413|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92256941|NCT01724918|Lacosamide|lacosamide|mesh-list
92256942|NCT01724918|Anticonvulsants|anticonvulsants|mesh-ancestor
92256943|NCT01724918|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92256944|NCT01724918|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92256945|NCT01724918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256946|NCT01724918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256947|NCT01588457|Lamotrigine|lamotrigine|mesh-list
92256948|NCT01588457|Valproic Acid|valproic acid|mesh-list
92256949|NCT01588457|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92256950|NCT01588457|Lithium Carbonate|lithium carbonate|mesh-list
92256951|NCT01588457|Antidepressive Agents|antidepressive agents|mesh-ancestor
92256952|NCT01588457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92256953|NCT01588457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92256954|NCT01588457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92256955|NCT01588457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92256956|NCT01588457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256957|NCT01588457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256958|NCT01588457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256959|NCT01588457|Antimanic Agents|antimanic agents|mesh-ancestor
92256960|NCT01588457|Anticonvulsants|anticonvulsants|mesh-ancestor
92256961|NCT01588457|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92256962|NCT01588457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92256963|NCT01588457|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92256964|NCT01588457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92256965|NCT01588457|GABA Agents|gaba agents|mesh-ancestor
92256966|NCT01588457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256967|NCT03005639|Vemurafenib|vemurafenib|mesh-list
92256968|NCT03005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92256969|NCT03005639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92256970|NCT03005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934983|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256971|NCT03005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256973|NCT01590875|Analgesics|analgesics|mesh-ancestor
92256974|NCT01590875|Sensory System Agents|sensory system agents|mesh-ancestor
92256975|NCT01590875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92256976|NCT01590875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92256977|NCT01590875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92256978|NCT01590875|Vasodilator Agents|vasodilator agents|mesh-ancestor
92256979|NCT01590875|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92256980|NCT01590875|Purinergic Agonists|purinergic agonists|mesh-ancestor
92256981|NCT01590875|Purinergic Agents|purinergic agents|mesh-ancestor
92256982|NCT01590875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92256983|NCT01590875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256984|NCT03404414|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92256985|NCT03404414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92256986|NCT03404414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256987|NCT01725230|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92256988|NCT01725230|Simvastatin|simvastatin|mesh-list
92256989|NCT01725230|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92256990|NCT01725230|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92256991|NCT01725230|Antimetabolites|antimetabolites|mesh-ancestor
92256992|NCT01725230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92256993|NCT01725230|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92256994|NCT01725230|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92256995|NCT01725230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92256996|NCT01591733|Capecitabine|capecitabine|mesh-list
92256997|NCT01591733|Oxaliplatin|oxaliplatin|mesh-list
92256998|NCT01591733|Irinotecan|irinotecan|mesh-list
92256999|NCT01591733|Folfirinox|folfirinox|mesh-list
92257000|NCT01591733|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92257001|NCT01591733|Antimetabolites|antimetabolites|mesh-ancestor
92257002|NCT01591733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257003|NCT01591733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257004|NCT01591733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92257005|NCT01591733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257006|NCT01591733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257007|NCT03005405|Methamphetamine|methamphetamine|mesh-list
92257008|NCT03005405|Fluorides|fluorides|mesh-list
92257009|NCT03005405|Cariostatic Agents|cariostatic agents|mesh-ancestor
92257010|NCT03005405|Protective Agents|protective agents|mesh-ancestor
92257011|NCT03005405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257012|NCT03005405|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92257013|NCT03005405|Sympathomimetics|sympathomimetics|mesh-ancestor
92257014|NCT03005405|Autonomic Agents|autonomic agents|mesh-ancestor
92257015|NCT03005405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257016|NCT03005405|Dopamine Agents|dopamine agents|mesh-ancestor
92257017|NCT03005405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257018|NCT03005405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257019|NCT03005405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257020|NCT03005405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92257021|NCT03005405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92257022|NCT03005405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257023|NCT03005405|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92257024|NCT03005717|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92257025|NCT03005717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92257026|NCT03005717|Autonomic Agents|autonomic agents|mesh-ancestor
92257027|NCT03005717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257028|NCT03005717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257029|NCT03005717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92257030|NCT03005717|Respiratory System Agents|respiratory system agents|mesh-ancestor
92257031|NCT03005717|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92257032|NCT03005717|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92257033|NCT03005717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92257034|NCT03005717|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257035|NCT03005717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257036|NCT03005717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257037|NCT03005483|Gabapentin|gabapentin|mesh-list
92257038|NCT03005483|Analgesics|analgesics|mesh-ancestor
92257039|NCT03005483|Sensory System Agents|sensory system agents|mesh-ancestor
92257040|NCT03005483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257041|NCT03005483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257042|NCT03005483|Anticonvulsants|anticonvulsants|mesh-ancestor
92257043|NCT03005483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92257044|NCT03005483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92257045|NCT03005483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257046|NCT03005483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92257047|NCT03005483|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92257048|NCT03005483|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92257049|NCT03005483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257050|NCT03005483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257051|NCT03005483|Antimanic Agents|antimanic agents|mesh-ancestor
92257053|NCT01593215|Mydriatics|mydriatics|mesh-ancestor
92257054|NCT01593215|Autonomic Agents|autonomic agents|mesh-ancestor
92257055|NCT01593215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257056|NCT01593215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257057|NCT01593215|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92257058|NCT01593215|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92257059|NCT01593215|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92257060|NCT01593215|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257061|NCT01593215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257062|NCT01593215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257063|NCT01593215|Urological Agents|urological agents|mesh-ancestor
92257064|NCT05404919|Tenofovir|tenofovir|mesh-list
92257065|NCT05404919|Entecavir|entecavir|mesh-list
92257066|NCT05404919|Immunoglobulins|immunoglobulins|mesh-list
92257067|NCT05404919|Antibodies|antibodies|mesh-list
92257068|NCT05404919|gamma-Globulins|gamma-globulins|mesh-list
92257069|NCT05404919|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92257070|NCT05404919|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92257071|NCT05404919|Antiviral Agents|antiviral agents|mesh-ancestor
92257072|NCT05404919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257073|NCT05404919|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92257074|NCT05404919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92257075|NCT05404919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257076|NCT05404919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257077|NCT05404919|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92257078|NCT05404919|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92257079|NCT05404919|Immunologic Factors|immunologic factors|mesh-ancestor
92257080|NCT05404919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257081|NCT03005015|Doxorubicin|doxorubicin|mesh-list
92257082|NCT03005015|Lenvatinib|lenvatinib|mesh-list
92257083|NCT03005015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92257084|NCT03005015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257085|NCT03005015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92257086|NCT03005015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257087|NCT03005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257088|NCT03005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925385|NCT02269735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92257089|NCT03005015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92257090|NCT03005171|Lidocaine|lidocaine|mesh-list
92257091|NCT03005171|Bupivacaine|bupivacaine|mesh-list
92257092|NCT03005171|Anesthetics, Local|anesthetics, local|mesh-ancestor
92257093|NCT03005171|Anesthetics|anesthetics|mesh-ancestor
92257094|NCT03005171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257095|NCT03005171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257096|NCT03005171|Sensory System Agents|sensory system agents|mesh-ancestor
92257097|NCT03005171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257098|NCT03005171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92257099|NCT03005171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92257100|NCT03005171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92257101|NCT03005171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257102|NCT03005171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257103|NCT01041638|Vitamin A|vitamin a|mesh-list
92257104|NCT01041638|Aldesleukin|aldesleukin|mesh-list
92257105|NCT01041638|Interleukin-2|interleukin-2|mesh-list
92257106|NCT01041638|Tretinoin|tretinoin|mesh-list
92257107|NCT01041638|Dinutuximab|dinutuximab|mesh-list
92257108|NCT01041638|Isotretinoin|isotretinoin|mesh-list
92257109|NCT01041638|Sargramostim|sargramostim|mesh-list
92257110|NCT01041638|Vitamins|vitamins|mesh-ancestor
92257111|NCT01041638|Micronutrients|micronutrients|mesh-ancestor
92257112|NCT01041638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257113|NCT01041638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257114|NCT01041638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92257115|NCT01041638|Analgesics|analgesics|mesh-ancestor
92257116|NCT01041638|Sensory System Agents|sensory system agents|mesh-ancestor
92257117|NCT01041638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257118|NCT01041638|Immunologic Factors|immunologic factors|mesh-ancestor
92257120|NCT01041638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92257121|NCT01041638|Antiviral Agents|antiviral agents|mesh-ancestor
92257122|NCT01041638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342903|NCT00004217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257123|NCT01041638|Keratolytic Agents|keratolytic agents|mesh-ancestor
92257124|NCT01041638|Dermatologic Agents|dermatologic agents|mesh-ancestor
92257125|NCT03004625|Ribavirin|ribavirin|mesh-list
92257126|NCT03004625|Asunaprevir|asunaprevir|mesh-list
92257127|NCT03004625|Antimetabolites|antimetabolites|mesh-ancestor
92257128|NCT03004625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257129|NCT03004625|Antiviral Agents|antiviral agents|mesh-ancestor
92257130|NCT03004625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257131|NCT03004625|Protease Inhibitors|protease inhibitors|mesh-ancestor
92257132|NCT03004625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257133|NCT05566301|Clopidogrel|clopidogrel|mesh-list
92257134|NCT05566301|Ticagrelor|ticagrelor|mesh-list
92257135|NCT05566301|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92257136|NCT05566301|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92257137|NCT05566301|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92257138|NCT05566301|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92257139|NCT05566301|Purinergic Agents|purinergic agents|mesh-ancestor
92257140|NCT05566301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257141|NCT05566301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257142|NCT05566301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257143|NCT03404024|Mitogens|mitogens|mesh-list
92257144|NCT03404024|Mitosis Modulators|mitosis modulators|mesh-ancestor
92257145|NCT03404024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257146|NCT05131919|Pembrolizumab|pembrolizumab|mesh-list
92257147|NCT05131919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257148|NCT05131919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257149|NCT05131919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92257150|NCT05131919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257151|NCT01725542|Ribavirin|ribavirin|mesh-list
92257152|NCT01725542|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92257153|NCT01725542|Asunaprevir|asunaprevir|mesh-list
92257154|NCT01725542|Antimetabolites|antimetabolites|mesh-ancestor
92257155|NCT01725542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257156|NCT01725542|Antiviral Agents|antiviral agents|mesh-ancestor
92257157|NCT01725542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257158|NCT01725542|Protease Inhibitors|protease inhibitors|mesh-ancestor
92257159|NCT01725542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257160|NCT01725620|Etanercept|etanercept|mesh-list
92257161|NCT01725620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92257162|NCT01725620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92257163|NCT01725620|Analgesics|analgesics|mesh-ancestor
92257164|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
91941803|NCT05901714|Phenytoin|phenytoin|mesh-list
92257165|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257166|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257167|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92257168|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257169|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92257170|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257171|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
92257172|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
92257173|NCT01045460|Melphalan|melphalan|mesh-list
92257174|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257175|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
92257176|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257177|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257178|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92257179|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
92257180|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257181|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257182|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92257183|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92257184|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
92257185|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92257186|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92257187|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92257188|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257189|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257190|NCT05014919|Vortioxetine|vortioxetine|mesh-list
92257191|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92257192|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92257193|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92257194|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92257195|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257196|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257197|NCT05014919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92257198|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92257199|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257200|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257201|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257203|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92257204|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92257205|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92257206|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92257207|NCT05620862|Mitoxantrone|mitoxantrone|mesh-list
92257208|NCT05620862|Analgesics|analgesics|mesh-ancestor
92257209|NCT05620862|Sensory System Agents|sensory system agents|mesh-ancestor
92257210|NCT05620862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257211|NCT05620862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257212|NCT05620862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257213|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92257214|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257215|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257216|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257217|NCT03406286|Tolvaptan|tolvaptan|mesh-list
92257218|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92257219|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257220|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
92257221|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257222|NCT05672537|Gemcitabine|gemcitabine|mesh-list
92257223|NCT05672537|Durvalumab|durvalumab|mesh-list
92257224|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257225|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92257226|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
92257227|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257228|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257229|NCT03400592|Irinotecan|irinotecan|mesh-list
92257230|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
92257231|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92257232|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257233|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257234|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257235|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257236|NCT03400592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257237|NCT02218463|Estradiol|estradiol|mesh-list
92257238|NCT02218463|Estrogens|estrogens|mesh-ancestor
92257239|NCT02218463|Hormones|hormones|mesh-ancestor
92257240|NCT02218463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257241|NCT02218463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257242|NCT00919802|Oxytocin|oxytocin|mesh-list
92257243|NCT00919802|Oxytocics|oxytocics|mesh-ancestor
92257244|NCT00919802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92257245|NCT00919802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257246|NCT02222129|Bupivacaine|bupivacaine|mesh-list
92257247|NCT02222129|Anesthetics, Local|anesthetics, local|mesh-ancestor
92257248|NCT02222129|Anesthetics|anesthetics|mesh-ancestor
92257249|NCT02222129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257250|NCT02222129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257251|NCT02222129|Sensory System Agents|sensory system agents|mesh-ancestor
92257252|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257253|NCT03003611|Anesthetics|anesthetics|mesh-list
92257254|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257255|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257256|NCT03401294|Leucovorin|leucovorin|mesh-list
92342925|NCT00004235|Docetaxel|docetaxel|mesh-list
92257257|NCT03401294|Bevacizumab|bevacizumab|mesh-list
92257258|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
92257259|NCT03401294|Irinotecan|irinotecan|mesh-list
92257260|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257261|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257262|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92257263|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92257264|NCT03401294|Growth Substances|growth substances|mesh-ancestor
92257265|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257266|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
92257267|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92257268|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257269|NCT03401294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257270|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257271|NCT03401294|Antidotes|antidotes|mesh-ancestor
92257272|NCT03401294|Protective Agents|protective agents|mesh-ancestor
92257273|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
92257274|NCT03401294|Vitamins|vitamins|mesh-ancestor
92257275|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
92257276|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
92257277|NCT03402698|Vitamin D|vitamin d|mesh-list
92257278|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92257279|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257280|NCT03402698|Vitamins|vitamins|mesh-ancestor
92257281|NCT03402698|Micronutrients|micronutrients|mesh-ancestor
92257282|NCT03402698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92257283|NCT03406520|Chlorhexidine|chlorhexidine|mesh-list
92257284|NCT03406520|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92257285|NCT03406520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257286|NCT03406520|Disinfectants|disinfectants|mesh-ancestor
92257287|NCT02248181|Pramipexole|pramipexole|mesh-list
92257288|NCT02248181|Antioxidants|antioxidants|mesh-ancestor
92257289|NCT02248181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257290|NCT02248181|Protective Agents|protective agents|mesh-ancestor
92257291|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257292|NCT02248181|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92257293|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92257294|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
92257295|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
92257296|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257297|NCT03003143|Vigabatrin|vigabatrin|mesh-list
92257298|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
92257299|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257300|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257301|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
92257302|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257303|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257304|NCT02462928|Ranibizumab|ranibizumab|mesh-list
92257305|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92257306|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92257307|NCT02462928|Growth Substances|growth substances|mesh-ancestor
92257308|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257309|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
92257310|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257311|NCT03002831|Tegafur|tegafur|mesh-list
92257312|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92257313|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
92257314|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257315|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257316|NCT02248259|Itraconazole|itraconazole|mesh-list
92257317|NCT02248259|BI 409306|bi 409306|mesh-list
92257318|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
92257319|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257320|NCT02248259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92257321|NCT02248259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92257322|NCT02248259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257323|NCT02248259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257324|NCT02248259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92257325|NCT02248259|Hormone Antagonists|hormone antagonists|mesh-ancestor
92257326|NCT02248259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257327|NCT02248259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257328|NCT02248259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92257329|NCT02248259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92257331|NCT04526951|Tenecteplase|tenecteplase|mesh-list
92257332|NCT04526951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92257333|NCT04526951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92257335|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
92257336|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257337|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934987|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
92257339|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257340|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92257341|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92257342|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257343|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92257344|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92257345|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257346|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
92257347|NCT04956432|Allopurinol|allopurinol|mesh-list
92257348|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
92257349|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257350|NCT04956432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257351|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
92257352|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257353|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92257354|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
92257355|NCT04956432|Protective Agents|protective agents|mesh-ancestor
92257356|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257357|NCT02248415|Anesthetics|anesthetics|mesh-list
92257358|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257359|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257360|NCT02248571|Bevacizumab|bevacizumab|mesh-list
92257361|NCT02248571|Capecitabine|capecitabine|mesh-list
92257362|NCT02248571|Everolimus|everolimus|mesh-list
92257363|NCT02248571|Exemestane|exemestane|mesh-list
92257364|NCT02248571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257365|NCT02248571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257366|NCT02248571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92257367|NCT02248571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92257368|NCT02248571|Growth Substances|growth substances|mesh-ancestor
92257369|NCT02248571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257370|NCT02248571|Growth Inhibitors|growth inhibitors|mesh-ancestor
92257371|NCT02248571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92257372|NCT02248571|Antimetabolites|antimetabolites|mesh-ancestor
92257373|NCT02248571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257374|NCT02248571|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92257375|NCT02248571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92257376|NCT02248571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257377|NCT02248571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257378|NCT02248571|Immunologic Factors|immunologic factors|mesh-ancestor
92257379|NCT02248571|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92257380|NCT02248571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92257381|NCT02248571|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92257382|NCT02248571|Hormone Antagonists|hormone antagonists|mesh-ancestor
92257383|NCT02248571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257384|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92257385|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92257386|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257387|NCT03002675|Exenatide|exenatide|mesh-list
92257388|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92257389|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257390|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92257391|NCT03002675|Incretins|incretins|mesh-ancestor
92257392|NCT03002675|Hormones|hormones|mesh-ancestor
92257393|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257394|NCT02246270|Heparin|heparin|mesh-list
92257396|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
92257397|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92257398|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92257399|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257400|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92257401|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92257402|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92257403|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257404|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257405|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92257406|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257407|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257408|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
92257409|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257410|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
92257411|NCT04374188|Levofloxacin|levofloxacin|mesh-list
92257412|NCT04374188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92257413|NCT04374188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257414|NCT04374188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92257415|NCT04374188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257416|NCT04374188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257417|NCT04374188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257418|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257419|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92257420|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92257421|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92257422|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
92257423|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257424|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257425|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257426|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
92257427|NCT03401606|Remifentanil|remifentanil|mesh-list
92257428|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92257429|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257430|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257431|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92257432|NCT03401606|Analgesics|analgesics|mesh-ancestor
92257433|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
92257434|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257435|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92257436|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92257437|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92257438|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257439|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257440|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257441|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92257443|NCT02516592|Fluticasone|fluticasone|mesh-list
92257444|NCT02516592|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92257445|NCT02516592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342942|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257446|NCT02516592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92257447|NCT02516592|Autonomic Agents|autonomic agents|mesh-ancestor
92257449|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257450|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92257451|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
92257452|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
92257453|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92257454|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92257455|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92257456|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92257457|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257458|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257459|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257460|NCT03401372|Doxycycline|doxycycline|mesh-list
92257461|NCT03401372|Dexamethasone|dexamethasone|mesh-list
92257462|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
92257463|NCT03401372|Bortezomib|bortezomib|mesh-list
92257464|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257465|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
92257466|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257467|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257468|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92257469|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
92257470|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257471|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257472|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92257473|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92257474|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
92257475|NCT03401372|Autonomic Agents|autonomic agents|mesh-ancestor
92257476|NCT03401372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257477|NCT03401372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92257478|NCT03401372|Glucocorticoids|glucocorticoids|mesh-ancestor
92257479|NCT03401372|Hormones|hormones|mesh-ancestor
92257480|NCT03401372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257481|NCT03401372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92257482|NCT03401372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92257483|NCT03401372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257484|NCT03401372|Antimalarials|antimalarials|mesh-ancestor
92257485|NCT03401372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92257486|NCT03401372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92257487|NCT04934904|Ropivacaine|ropivacaine|mesh-list
92257488|NCT04934904|Anesthetics, Local|anesthetics, local|mesh-ancestor
92257489|NCT04934904|Anesthetics|anesthetics|mesh-ancestor
92257490|NCT04934904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257491|NCT04934904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257492|NCT04934904|Sensory System Agents|sensory system agents|mesh-ancestor
92257493|NCT04934904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257494|NCT02219321|Lidocaine|lidocaine|mesh-list
92257495|NCT02219321|Anesthetics, Local|anesthetics, local|mesh-ancestor
92257496|NCT02219321|Anesthetics|anesthetics|mesh-ancestor
92257497|NCT02219321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257498|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257499|NCT02219321|Sensory System Agents|sensory system agents|mesh-ancestor
92257500|NCT02219321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257501|NCT02219321|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92257502|NCT02219321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92257503|NCT02219321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92257504|NCT02219321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257505|NCT02219321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257506|NCT04955574|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92257507|NCT04955574|Metronidazole|metronidazole|mesh-list
92257508|NCT04955574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92257509|NCT04955574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257510|NCT04955574|Antitubercular Agents|antitubercular agents|mesh-ancestor
92342967|NCT00004253|Paclitaxel|paclitaxel|mesh-list
92257511|NCT04955574|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92257512|NCT04955574|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92257514|NCT04716335|Hallucinogens|hallucinogens|mesh-ancestor
92257515|NCT04716335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257516|NCT04716335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92257517|NCT04716335|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92257518|NCT04716335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257519|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257520|NCT04283669|Crizotinib|crizotinib|mesh-list
92257521|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257522|NCT04283669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92257523|NCT04283669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257524|NCT04283669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257525|NCT02221349|Listerine|listerine|mesh-list
92257526|NCT02221349|Fluorides|fluorides|mesh-list
92257527|NCT02221349|Sodium Fluoride|sodium fluoride|mesh-list
92257528|NCT02221349|Tin Fluorides|tin fluorides|mesh-list
92257529|NCT02221349|Cariostatic Agents|cariostatic agents|mesh-ancestor
92257530|NCT02221349|Protective Agents|protective agents|mesh-ancestor
92257531|NCT02221349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257532|NCT02221349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92257533|NCT02221349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257534|NCT02461758|Vaccines|vaccines|mesh-list
92257535|NCT02461758|Immunologic Factors|immunologic factors|mesh-ancestor
92257536|NCT02461758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257537|NCT02461290|Rituximab|rituximab|mesh-list
92257538|NCT02461290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257539|NCT02461290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257540|NCT02461290|Immunologic Factors|immunologic factors|mesh-ancestor
92257541|NCT02461290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257542|NCT02461290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257543|NCT04376528|Cyclosporine|cyclosporine|mesh-list
92257544|NCT04376528|Mycophenolic Acid|mycophenolic acid|mesh-list
92257545|NCT04376528|Cyclosporins|cyclosporins|mesh-list
92257546|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257547|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257548|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257549|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
92257550|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257551|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
92257552|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257553|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
92257554|NCT04376528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257555|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92257556|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92257557|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257558|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92257559|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
92257560|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92257562|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92257563|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257564|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92257565|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
92257566|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257567|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
92257568|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92257569|NCT04373018|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92257570|NCT04373018|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92257571|NCT04373018|Eusol|eusol|mesh-list
92257572|NCT04373018|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92257573|NCT04373018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257574|NCT04373018|Disinfectants|disinfectants|mesh-ancestor
92257575|NCT04373018|Dermatologic Agents|dermatologic agents|mesh-ancestor
92257576|NCT04934748|Phenylephrine|phenylephrine|mesh-list
92257577|NCT04934748|Oxymetazoline|oxymetazoline|mesh-list
92257578|NCT04934748|Norepinephrine|norepinephrine|mesh-list
92257579|NCT04934748|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92257580|NCT04934748|Mydriatics|mydriatics|mesh-ancestor
92257581|NCT04934748|Autonomic Agents|autonomic agents|mesh-ancestor
92257582|NCT04934748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257583|NCT04934748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257584|NCT04934748|Sympathomimetics|sympathomimetics|mesh-ancestor
92257585|NCT04934748|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92257586|NCT04934748|Nasal Decongestants|nasal decongestants|mesh-ancestor
92257587|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92257588|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92257589|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92257590|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92257591|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257592|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257593|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257594|NCT04934748|Protective Agents|protective agents|mesh-ancestor
92257596|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92257597|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257598|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
92257599|NCT02223065|Saxagliptin|saxagliptin|mesh-list
92257600|NCT02223065|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92257601|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257602|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92257603|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257604|NCT02223065|Incretins|incretins|mesh-ancestor
92257605|NCT02223065|Hormones|hormones|mesh-ancestor
92257606|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257607|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92257608|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
92257609|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257610|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92257611|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257612|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
92257613|NCT02241200|Hematinics|hematinics|mesh-ancestor
92257614|NCT02241278|Ketamine|ketamine|mesh-list
92257615|NCT02241278|Analgesics|analgesics|mesh-ancestor
92257616|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
92257617|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257618|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257619|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92257620|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92257621|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
92257622|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
92257623|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257624|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92257625|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92257626|NCT02241278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257627|NCT02241278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257628|NCT04347512|Azithromycin|azithromycin|mesh-list
92257629|NCT04347512|Hydroxychloroquine|hydroxychloroquine|mesh-list
92257630|NCT04347512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92257631|NCT04347512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257632|NCT04347512|Antimalarials|antimalarials|mesh-ancestor
92257633|NCT04347512|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92257634|NCT04347512|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92257635|NCT04347512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257636|NCT04347512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257637|NCT04347512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257638|NCT02460978|Dapagliflozin|dapagliflozin|mesh-list
92257639|NCT02460978|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92257640|NCT02460978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257641|NCT02460978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92257642|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257643|NCT04372316|Vitamin B 12|vitamin b 12|mesh-list
92257644|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
92257646|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
92257647|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257648|NCT02221739|Ipilimumab|ipilimumab|mesh-list
92257649|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257650|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257651|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92257652|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257653|NCT02241356|Methamphetamine|methamphetamine|mesh-list
92257654|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92257655|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257656|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
92342977|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257657|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
92257658|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257659|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
92257660|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257661|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257662|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257663|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92257664|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92257665|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257666|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92257667|NCT04365686|Propofol|propofol|mesh-list
92257668|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92257669|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257670|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257671|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92257672|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
92257673|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
92257674|NCT02241590|Entecavir|entecavir|mesh-list
92257675|NCT02241590|Antiviral Agents|antiviral agents|mesh-ancestor
92257676|NCT02241590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257677|NCT04083755|Ferric Compounds|ferric compounds|mesh-list
92257678|NCT04083755|Hematinics|hematinics|mesh-ancestor
92257679|NCT04372082|Hydroxychloroquine|hydroxychloroquine|mesh-list
92257680|NCT04372082|Niclosamide|niclosamide|mesh-list
92257681|NCT04372082|Diltiazem|diltiazem|mesh-list
92257682|NCT04372082|Antimalarials|antimalarials|mesh-ancestor
92257683|NCT04372082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92257684|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92257685|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257686|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257687|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257688|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257689|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92257690|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92257691|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257692|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91925539|NCT03164109|Protective Agents|protective agents|mesh-ancestor
92257693|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257694|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
92257695|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
92257696|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92257697|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
92257698|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
92257699|NCT05363111|Daratumumab|daratumumab|mesh-list
92257700|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92257701|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92257702|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257703|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
92257704|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257705|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
92257706|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
92257707|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257708|NCT02489448|Durvalumab|durvalumab|mesh-list
92257709|NCT02489448|Tremelimumab|tremelimumab|mesh-list
92257710|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257711|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257712|NCT00926588|Analgesics|analgesics|mesh-list
92257713|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
92257714|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257715|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257716|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
92257717|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
92257718|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92257719|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92257720|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257721|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257722|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257723|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92257724|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
92257725|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92257726|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257727|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92257728|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92257729|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342980|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
92257730|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257731|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257732|NCT04364906|Anesthetics|anesthetics|mesh-list
92257733|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257734|NCT04364906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257735|NCT04134845|Dantrolene|dantrolene|mesh-list
92257736|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92257737|NCT04134845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257738|NCT04134845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92257739|NCT04134845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257740|NCT02488980|Mefloquine|mefloquine|mesh-list
92257741|NCT02488980|Tafenoquine|tafenoquine|mesh-list
92257742|NCT02488980|Antimalarials|antimalarials|mesh-ancestor
92257743|NCT02488980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92257744|NCT02488980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92257745|NCT02488980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257746|NCT02227667|Durvalumab|durvalumab|mesh-list
92257747|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257748|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257749|NCT02242214|Misoprostol|misoprostol|mesh-list
92257750|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92257751|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
92257752|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92257753|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257754|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92257755|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92257756|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
92257757|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
92257758|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92257759|NCT02245256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257760|NCT02245256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257761|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92257762|NCT02245256|Analgesics|analgesics|mesh-ancestor
92257763|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
92257764|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257765|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92257767|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92257768|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257769|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257770|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257771|NCT05208983|Vaccines|vaccines|mesh-list
92257772|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
92257773|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257774|NCT02242292|Scopolamine|scopolamine|mesh-list
92257775|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92257776|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92257777|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
92257778|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
92257779|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257780|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257781|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92257782|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
92257783|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92257784|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
92257785|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257786|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257787|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92257788|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
92257790|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92257791|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92257792|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92257793|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257794|NCT04371146|Methylphenidate|methylphenidate|mesh-list
92257795|NCT04371146|Reboxetine|reboxetine|mesh-list
92257796|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92257797|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257798|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92257799|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92257800|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92257801|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257802|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
92257803|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257804|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
92257805|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92257806|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92257807|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257808|NCT01623479|Bimatoprost|bimatoprost|mesh-list
92257809|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92257810|NCT04347200|Anticoagulants|anticoagulants|mesh-list
92257811|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92257812|NCT04364516|Vitamin K|vitamin k|mesh-list
92257813|NCT04364516|Anticoagulants|anticoagulants|mesh-list
92257814|NCT04364516|Vitamins|vitamins|mesh-ancestor
92257815|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
92257816|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257817|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92257818|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92257819|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257820|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
92257821|NCT04364516|Coagulants|coagulants|mesh-ancestor
92257822|NCT01623869|Trebananib|trebananib|mesh-list
92257823|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92257824|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92257825|NCT01623869|Growth Substances|growth substances|mesh-ancestor
92257826|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257827|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
92257828|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257829|NCT02242838|Telmisartan|telmisartan|mesh-list
92257830|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92257831|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92257832|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92257833|NCT02242838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257834|NCT03207347|Niraparib|niraparib|mesh-list
92257835|NCT03207347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92257836|NCT03207347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257837|NCT03207347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257838|NCT03207347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257839|NCT02249039|Clonidine|clonidine|mesh-list
92257840|NCT02249039|Analgesics|analgesics|mesh-ancestor
92257841|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
92257842|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257843|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257844|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92257845|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
92257846|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
92257847|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92257848|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92257849|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92257850|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257851|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257852|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257853|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
92257854|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92257855|NCT04370288|Methylene Blue|methylene blue|mesh-list
92257856|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257857|NCT04370288|Antioxidants|antioxidants|mesh-ancestor
92257858|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257859|NCT04370288|Protective Agents|protective agents|mesh-ancestor
92257860|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
92257861|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257862|NCT04370288|Expectorants|expectorants|mesh-ancestor
92257863|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92257864|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92257865|NCT04370288|Antidotes|antidotes|mesh-ancestor
92257866|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257867|NCT02993705|Trabectedin|trabectedin|mesh-list
92257868|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92257869|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
92257870|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257871|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257873|NCT02243618|Polaprezinc|polaprezinc|mesh-list
92257874|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92257875|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92257876|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
92257877|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257878|NCT02243618|Protective Agents|protective agents|mesh-ancestor
92257879|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257880|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257881|NCT02243852|Hormones|hormones|mesh-list
92257882|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92257883|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257884|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
92257885|NCT03150329|Vorinostat|vorinostat|mesh-list
92257886|NCT03150329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257887|NCT03150329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257888|NCT03150329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92257889|NCT03150329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257890|NCT03150329|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92257891|NCT03150329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257892|NCT03102125|Regadenoson|regadenoson|mesh-list
92257893|NCT03102125|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92257894|NCT03102125|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92257895|NCT03102125|Purinergic Agonists|purinergic agonists|mesh-ancestor
92257896|NCT03102125|Purinergic Agents|purinergic agents|mesh-ancestor
92257897|NCT03102125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257898|NCT03102125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257899|NCT03102125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257900|NCT04369586|Meplazumab|meplazumab|mesh-list
92257901|NCT04369586|Antiviral Agents|antiviral agents|mesh-ancestor
92257902|NCT04369586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92257903|NCT02231177|Tiotropium Bromide|tiotropium bromide|mesh-list
92257904|NCT02231177|Olodaterol|olodaterol|mesh-list
92257905|NCT02231177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92257906|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
92257907|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257908|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257909|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92257910|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
92257911|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
92257912|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92257913|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
92257914|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257915|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257916|NCT03283007|Nintedanib|nintedanib|mesh-list
92257917|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257918|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92257919|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257920|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257921|NCT02244086|Bupivacaine|bupivacaine|mesh-list
92257922|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
92257923|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
92257924|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257925|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257926|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
91934998|NCT04463953|Hormones|hormones|mesh-ancestor
92257927|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257928|NCT01630109|Metoclopramide|metoclopramide|mesh-list
92257929|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
92257930|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
92257931|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257932|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257933|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92257934|NCT01630109|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92257935|NCT01630109|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92257936|NCT01630109|Dopamine Agents|dopamine agents|mesh-ancestor
92257937|NCT01630109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257938|NCT01630109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257939|NCT04367948|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92257940|NCT04367948|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92257941|NCT04367948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257942|NCT01632215|Gabapentin|gabapentin|mesh-list
92257943|NCT01632215|Anticonvulsants|anticonvulsants|mesh-list
92257944|NCT01632215|Analgesics|analgesics|mesh-ancestor
92257945|NCT01632215|Sensory System Agents|sensory system agents|mesh-ancestor
92257946|NCT01632215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92257947|NCT01632215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257948|NCT01632215|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92257949|NCT01632215|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92257950|NCT01632215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92257951|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92257952|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92257953|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92257954|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257955|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257956|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
92257957|NCT02244242|Tamsulosin|tamsulosin|mesh-list
92257958|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92257959|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92257960|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92257961|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257962|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257963|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257964|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257965|NCT02244242|Urological Agents|urological agents|mesh-ancestor
92257966|NCT03127631|Atorvastatin|atorvastatin|mesh-list
92257967|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92257968|NCT03127631|Simvastatin|simvastatin|mesh-list
92257969|NCT03127631|Pravastatin|pravastatin|mesh-list
92257970|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92257971|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92257972|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92257973|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
92257974|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257975|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92257976|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92257977|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92257978|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
92257979|NCT02244320|Tamsulosin|tamsulosin|mesh-list
92257980|NCT02244320|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92257981|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92257982|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92257983|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
92257984|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92257985|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92257986|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257987|NCT02244320|Urological Agents|urological agents|mesh-ancestor
92257988|NCT02244632|Bevacizumab|bevacizumab|mesh-list
92257989|NCT02244632|Fluorouracil|fluorouracil|mesh-list
92257990|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
92257991|NCT02244632|Irinotecan|irinotecan|mesh-list
91941839|NCT05866627|Famotidine|famotidine|mesh-list
92257992|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92257993|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92257994|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92257995|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92342998|NCT00003365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92257996|NCT02244632|Growth Substances|growth substances|mesh-ancestor
92257997|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92257998|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
92258000|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258001|NCT02244632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258002|NCT02244632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258003|NCT02244632|Immunologic Factors|immunologic factors|mesh-ancestor
92258004|NCT02244632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92258005|NCT02244632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92258006|NCT02244632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258008|NCT03060083|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92258009|NCT03060083|Autonomic Agents|autonomic agents|mesh-ancestor
92258010|NCT03060083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258011|NCT03060083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258012|NCT03060083|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92258013|NCT03060083|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92258014|NCT03060083|Cholinergic Agents|cholinergic agents|mesh-ancestor
92258015|NCT03060083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258016|NCT03060083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258017|NCT02244710|Clopidogrel|clopidogrel|mesh-list
92258018|NCT02244710|Ticagrelor|ticagrelor|mesh-list
92258019|NCT02244710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92258020|NCT02244710|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92258021|NCT02244710|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92258022|NCT02244710|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92258023|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
92258024|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258025|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258026|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258027|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
92258028|NCT04362332|Chloroquine|chloroquine|mesh-list
92258029|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92258030|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
92258031|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92258032|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92258033|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258034|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258035|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258036|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258037|NCT04362332|Amebicides|amebicides|mesh-ancestor
92258038|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92258039|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258040|NCT04362332|Analgesics|analgesics|mesh-ancestor
92258041|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
92258042|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258043|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258044|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258045|NCT04362332|Filaricides|filaricides|mesh-ancestor
92258046|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
92258047|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
92258048|NCT02308241|Ribavirin|ribavirin|mesh-list
92258049|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
92258050|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258051|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
92258052|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258053|NCT00932282|Omalizumab|omalizumab|mesh-list
92258054|NCT00932282|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92258055|NCT00932282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92258056|NCT00932282|Respiratory System Agents|respiratory system agents|mesh-ancestor
92258057|NCT02159495|Cyclophosphamide|cyclophosphamide|mesh-list
92258058|NCT02159495|Fludarabine|fludarabine|mesh-list
92258059|NCT02159495|Fludarabine phosphate|fludarabine phosphate|mesh-list
92258060|NCT02159495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258061|NCT02159495|Immunologic Factors|immunologic factors|mesh-ancestor
92258062|NCT02159495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258063|NCT02159495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258064|NCT02159495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92258065|NCT02159495|Alkylating Agents|alkylating agents|mesh-ancestor
92343015|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
91925540|NCT02152787|Propofol|propofol|mesh-list
92258066|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258067|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258068|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92258069|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258070|NCT02159495|Antimetabolites|antimetabolites|mesh-ancestor
92258071|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92258072|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92258073|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92258074|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258075|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258076|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
92258077|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258078|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92258079|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92258080|NCT02245022|Tenofovir|tenofovir|mesh-list
92258081|NCT02245022|Lamivudine|lamivudine|mesh-list
92258082|NCT02245022|Efavirenz|efavirenz|mesh-list
92258083|NCT02245022|Dolutegravir|dolutegravir|mesh-list
92258084|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
92258085|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258086|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92258087|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92258088|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258089|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258090|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92258091|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92258092|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92258093|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92258094|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92258095|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92258096|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92258097|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92258098|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92258099|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92258100|NCT02224313|Estradiol|estradiol|mesh-list
92258101|NCT02224313|Progesterone|progesterone|mesh-list
92258102|NCT02224313|Estrogens|estrogens|mesh-ancestor
92258103|NCT02224313|Hormones|hormones|mesh-ancestor
92258104|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258105|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258106|NCT02224313|Progestins|progestins|mesh-ancestor
92258107|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92258108|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
92258109|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258110|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
92258111|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258112|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258113|NCT02460198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92258114|NCT02460198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258115|NCT01633853|Vitamin D|vitamin d|mesh-list
92258116|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
92258117|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
92258118|NCT01633853|Vitamins|vitamins|mesh-list
92258119|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
92258120|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258121|NCT01633853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92258122|NCT01633853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92258123|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
92258124|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
92258125|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
92258126|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258128|NCT04376216|Prednisolone|prednisolone|mesh-list
92258129|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258130|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
92258131|NCT04376216|Hormones|hormones|mesh-ancestor
92258132|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258133|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258134|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343020|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258135|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258136|NCT02452320|Acetaminophen|acetaminophen|mesh-list
92258137|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258138|NCT02452320|Analgesics|analgesics|mesh-ancestor
92258139|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
92258140|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258141|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258142|NCT02452320|Antipyretics|antipyretics|mesh-ancestor
92258144|NCT02459964|Hydromorphone|hydromorphone|mesh-list
92258145|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92258147|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258148|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258149|NCT02459964|Analgesics|analgesics|mesh-ancestor
92258150|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
92258151|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258152|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92258153|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92258154|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
92258155|NCT02459964|Anesthetics|anesthetics|mesh-ancestor
92258157|NCT01635101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258158|NCT01635101|Analgesics|analgesics|mesh-ancestor
92258159|NCT01635101|Sensory System Agents|sensory system agents|mesh-ancestor
92258160|NCT01635101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258161|NCT01635101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258162|NCT01635101|Antipyretics|antipyretics|mesh-ancestor
92258163|NCT02087111|Interferons|interferons|mesh-list
92258164|NCT02087111|Ribavirin|ribavirin|mesh-list
92258165|NCT02087111|Interferon-alpha|interferon-alpha|mesh-list
92258166|NCT02087111|Interferon alpha-2|interferon alpha-2|mesh-list
92258167|NCT02087111|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92258168|NCT02087111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258170|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258171|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
92258172|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258173|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
92258174|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258175|NCT00932438|Leucovorin|leucovorin|mesh-list
92258176|NCT00932438|Bevacizumab|bevacizumab|mesh-list
92258177|NCT00932438|Fluorouracil|fluorouracil|mesh-list
92258178|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
92258179|NCT00932438|Irinotecan|irinotecan|mesh-list
92258180|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258181|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258182|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92258183|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92258184|NCT00932438|Growth Substances|growth substances|mesh-ancestor
92258185|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258186|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
92258187|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
92258188|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258189|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258190|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258191|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
92258192|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92258193|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92258194|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258195|NCT00932438|Antidotes|antidotes|mesh-ancestor
92258196|NCT00932438|Protective Agents|protective agents|mesh-ancestor
92258197|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
92258198|NCT00932438|Vitamins|vitamins|mesh-ancestor
92258199|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
92258200|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
92258201|NCT01869413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92258202|NCT01869413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92258203|NCT01869413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258204|NCT01869413|Hemostatics|hemostatics|mesh-ancestor
92258205|NCT01869413|Coagulants|coagulants|mesh-ancestor
92258206|NCT02982512|Dexmedetomidine|dexmedetomidine|mesh-list
92258207|NCT02982512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92258208|NCT02982512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258209|NCT02982512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258210|NCT02982512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92343027|NCT00004361|Calcium|calcium|mesh-list
92258211|NCT02982512|Analgesics|analgesics|mesh-ancestor
92258212|NCT02982512|Sensory System Agents|sensory system agents|mesh-ancestor
92258213|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258214|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92258215|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92258216|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92258217|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
92258218|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258219|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258220|NCT01555697|Memantine|memantine|mesh-list
92258221|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92258222|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92258223|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
92258225|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258226|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258227|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92258228|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92258229|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
92258230|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92258231|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258232|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258233|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
92258234|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258235|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258236|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
92258237|NCT02451930|Necitumumab|necitumumab|mesh-list
92258238|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258239|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258240|NCT02451930|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92258241|NCT02451930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258242|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
92258243|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92258244|NCT04358120|Immunologic Factors|immunologic factors|mesh-ancestor
92258245|NCT04358120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258246|NCT04358120|Viscosupplements|viscosupplements|mesh-ancestor
92258247|NCT04358120|Protective Agents|protective agents|mesh-ancestor
92258248|NCT00932828|Immunomodulating Agents|immunomodulating agents|mesh-list
92258249|NCT00932828|Immunologic Factors|immunologic factors|mesh-list
92258250|NCT00932828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258251|NCT00928694|Fenofibrate|fenofibrate|mesh-list
92258252|NCT00928694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92258253|NCT00928694|Antimetabolites|antimetabolites|mesh-ancestor
92258254|NCT00928694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258255|NCT00928694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92258256|NCT01639157|Buspirone|buspirone|mesh-list
92258257|NCT01639157|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92258258|NCT01639157|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92258259|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258260|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258261|NCT01639157|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92258262|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92258263|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
92258264|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258265|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258266|NCT02451696|Everolimus|everolimus|mesh-list
92258267|NCT02451696|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92258268|NCT02451696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92258269|NCT02451696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258270|NCT02451696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258271|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258272|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
92258273|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258274|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258275|NCT00928772|Midazolam|midazolam|mesh-list
92258276|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92258277|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92258278|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258279|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258280|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92258281|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92258282|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92258283|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92258284|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
92258285|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
92258286|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
92258287|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
92258288|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258289|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258290|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92258291|NCT02459418|Hormones|hormones|mesh-ancestor
92258292|NCT02459418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258293|NCT02459418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258294|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
92258295|NCT04361318|Nitazoxanide|nitazoxanide|mesh-list
92258296|NCT04361318|Antimalarials|antimalarials|mesh-ancestor
92258297|NCT04361318|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92258298|NCT04361318|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92258299|NCT04361318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258300|NCT04361318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258301|NCT04361318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258302|NCT04361318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258303|NCT00695279|Vaccines|vaccines|mesh-list
92258304|NCT00695279|Immunologic Factors|immunologic factors|mesh-ancestor
92258305|NCT00695279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258307|NCT04925076|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92258308|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258309|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258310|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258311|NCT01598207|Dronabinol|dronabinol|mesh-list
92258312|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
92258313|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258314|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92258315|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258316|NCT01598207|Analgesics|analgesics|mesh-ancestor
92258317|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
92258318|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258319|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92258320|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92258321|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258322|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258323|NCT01598207|Hormones|hormones|mesh-ancestor
92258324|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258325|NCT01640171|Ketorolac|ketorolac|mesh-list
92258326|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92258327|NCT01640171|Lidocaine|lidocaine|mesh-list
92258328|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
92258329|NCT01640171|Anesthetics|anesthetics|mesh-list
92258330|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
92258331|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258332|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258333|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
92258334|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258335|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92258336|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92258337|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92258338|NCT01640171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258339|NCT01640171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258340|NCT01640171|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92258341|NCT01640171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258342|NCT01640171|Analgesics|analgesics|mesh-ancestor
92258343|NCT01640171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258344|NCT01640171|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92258345|NCT01640171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258346|NCT04361474|Budesonide|budesonide|mesh-list
92258347|NCT04361474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258348|NCT04361474|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92258349|NCT04361474|Autonomic Agents|autonomic agents|mesh-ancestor
92258350|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343032|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
92258351|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258352|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92258353|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
92258354|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
92258355|NCT04361474|Hormones|hormones|mesh-ancestor
92258356|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258357|NCT04366622|Riociguat|riociguat|mesh-list
92258358|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
92258359|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258360|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
92258361|NCT02245334|Povidone|povidone|mesh-list
92258362|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
92258363|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
92258364|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92258365|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258366|NCT04762160|Rituximab|rituximab|mesh-list
92258367|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258368|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258369|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
92258370|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258371|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258372|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
92258373|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92258374|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92258375|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92258376|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
92258377|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258378|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258379|NCT02487498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258381|NCT04356872|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92258382|NCT04356872|Ifosfamide|ifosfamide|mesh-list
92258383|NCT04356872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92258384|NCT04356872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258385|NCT04356872|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92258386|NCT04356872|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92258387|NCT04356872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258388|NCT04356872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258389|NCT04356872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92258390|NCT04356872|Alkylating Agents|alkylating agents|mesh-ancestor
92258391|NCT02487108|Acetaminophen|acetaminophen|mesh-list
92258392|NCT02487108|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92258393|NCT02487108|Hydrocodone|hydrocodone|mesh-list
92258394|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258395|NCT02487108|Analgesics|analgesics|mesh-ancestor
92258396|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
92258397|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258398|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258399|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
92258400|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92258401|NCT02487108|Narcotics|narcotics|mesh-ancestor
92258402|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258403|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
92258404|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
92258405|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92258406|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258407|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258408|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
92258409|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92258410|NCT02487030|Ledipasvir|ledipasvir|mesh-list
92258411|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
92258412|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258413|NCT02486952|Prednisone|prednisone|mesh-list
92258414|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
92258415|NCT02486952|Rituximab|rituximab|mesh-list
92258416|NCT02486952|Vincristine|vincristine|mesh-list
92258417|NCT02486952|Doxorubicin|doxorubicin|mesh-list
92258418|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92258419|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258420|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
92258421|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258422|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258423|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92258424|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
92258425|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258426|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258427|NCT02486952|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92258428|NCT02486952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258429|NCT02486952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258430|NCT02486952|Glucocorticoids|glucocorticoids|mesh-ancestor
92258431|NCT02486952|Hormones|hormones|mesh-ancestor
92258432|NCT02486952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258433|NCT02486952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92258434|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92258435|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
92258436|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
92258437|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
92258438|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92258439|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92258440|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92258441|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258442|NCT02486796|Ubiquinone|ubiquinone|mesh-list
92258443|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
92258444|NCT02486796|Melatonin|melatonin|mesh-list
92258445|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
92258446|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258447|NCT02486796|Protective Agents|protective agents|mesh-ancestor
92258448|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258449|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258451|NCT02486796|Vitamins|vitamins|mesh-ancestor
92258452|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
92258453|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
92258454|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
92258455|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258457|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
92258458|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258459|NCT01641653|Midazolam|midazolam|mesh-list
92258460|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92258461|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92258462|NCT01641653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258463|NCT01641653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258464|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92258465|NCT01641653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92258466|NCT01641653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92258467|NCT01641653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92258468|NCT01641653|Anesthetics, General|anesthetics, general|mesh-ancestor
92258469|NCT01641653|Anesthetics|anesthetics|mesh-ancestor
92258470|NCT01641653|GABA Modulators|gaba modulators|mesh-ancestor
92258471|NCT01641653|GABA Agents|gaba agents|mesh-ancestor
92258472|NCT01641653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258473|NCT01641653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258474|NCT01600703|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92258475|NCT01600703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92258476|NCT01600703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258477|NCT01600703|Incretins|incretins|mesh-ancestor
92258478|NCT01600703|Hormones|hormones|mesh-ancestor
92258479|NCT01600703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258480|NCT01600703|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92258481|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
92258482|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258483|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258484|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
92258485|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92258486|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92258487|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92258488|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258489|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258490|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
92258491|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258492|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258493|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92258494|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258495|NCT01605539|Cannabidiol|cannabidiol|mesh-list
92258496|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
92258497|NCT02458638|Atezolizumab|atezolizumab|mesh-list
92258498|NCT02458638|Antibodies|antibodies|mesh-list
92258499|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
92258500|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258501|NCT02458638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92258502|NCT02458638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258503|NCT02458638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258504|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258505|NCT01607411|Fluorides|fluorides|mesh-list
92258506|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
92258507|NCT01607411|Protective Agents|protective agents|mesh-ancestor
92258508|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258509|NCT01691339|Vaccines|vaccines|mesh-list
92258510|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
92258511|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258512|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
92258513|NCT02233751|Testosterone|testosterone|mesh-list
92258514|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
92258515|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
92258516|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92258517|NCT02233751|Androgens|androgens|mesh-ancestor
92258518|NCT02233751|Hormones|hormones|mesh-ancestor
92258519|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258520|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258521|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92258522|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258523|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
92258524|NCT01607645|Cytarabine|cytarabine|mesh-list
92258525|NCT01607645|Decitabine|decitabine|mesh-list
92258526|NCT01607645|Azacitidine|azacitidine|mesh-list
92258527|NCT01607645|Idarubicin|idarubicin|mesh-list
92258528|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258529|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
92258530|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258531|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258532|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
92258533|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258534|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258535|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
92258536|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258537|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258538|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92258539|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92258540|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92258541|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92258542|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92258543|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
92258544|NCT01647581|Hormones|hormones|mesh-ancestor
92258545|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258546|NCT01647581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258547|NCT01647581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258548|NCT01647581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258549|NCT01608659|Botulinum Toxins|botulinum toxins|mesh-list
92258550|NCT01608659|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92258551|NCT01608659|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92258552|NCT01608659|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92258553|NCT01608659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258554|NCT01608659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258555|NCT01608659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92258556|NCT01608659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258557|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258558|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92258559|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258560|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
92258561|NCT01649609|Sirolimus|sirolimus|mesh-list
92258562|NCT01649609|Tacrolimus|tacrolimus|mesh-list
92258563|NCT01649609|Antimetabolites|antimetabolites|mesh-list
92258565|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
92258566|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258567|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92258568|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258569|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258570|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92258571|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258572|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92258573|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
92258574|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92258575|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258576|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
92258577|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92258578|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92258579|NCT02449902|Estradiol|estradiol|mesh-list
92258580|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92258581|NCT02449902|Estrogens|estrogens|mesh-ancestor
92258582|NCT02449902|Hormones|hormones|mesh-ancestor
92258583|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258584|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258585|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92258586|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
92258587|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92258588|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92258589|NCT02449044|Tolvaptan|tolvaptan|mesh-list
92258590|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92258591|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258592|NCT02449044|Natriuretic Agents|natriuretic agents|mesh-ancestor
92258593|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258594|NCT04942626|Capecitabine|capecitabine|mesh-list
92258595|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92258596|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92258597|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
92117696|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92258598|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258599|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258600|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258601|NCT04942470|Propolis|propolis|mesh-list
92258602|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258604|NCT02228681|Everolimus|everolimus|mesh-list
92258605|NCT02228681|Letrozole|letrozole|mesh-list
92258606|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92258607|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
92258608|NCT02228681|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92258609|NCT02228681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92258610|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258611|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258612|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258613|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
92258614|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258615|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258616|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92258617|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92258618|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92258619|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
92258620|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258621|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92258622|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92258623|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92258624|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92258625|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92258626|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92258627|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92258628|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
92343053|NCT00004397|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92258629|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92258630|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92343054|NCT00004397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258631|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92258632|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92258633|NCT00942578|Prednisone|prednisone|mesh-list
92258634|NCT00942578|Bevacizumab|bevacizumab|mesh-list
92258635|NCT00942578|Lenalidomide|lenalidomide|mesh-list
92258636|NCT00942578|Docetaxel|docetaxel|mesh-list
92258637|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258638|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258639|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92258640|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92258641|NCT00942578|Growth Substances|growth substances|mesh-ancestor
92258642|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258643|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
92258644|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92258645|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92258646|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92258647|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258648|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258649|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
92258650|NCT00942578|Hormones|hormones|mesh-ancestor
92258651|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258652|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92258653|NCT00942578|Immunologic Factors|immunologic factors|mesh-ancestor
92258654|NCT02229461|Aspirin|aspirin|mesh-list
92258655|NCT02229461|Naproxen|naproxen|mesh-list
92258656|NCT02229461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92258657|NCT02229461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92258658|NCT02229461|Analgesics|analgesics|mesh-ancestor
92258659|NCT02229461|Sensory System Agents|sensory system agents|mesh-ancestor
92258660|NCT02229461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258661|NCT02229461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258662|NCT02229461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258663|NCT02229461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92258664|NCT02229461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92258665|NCT02229461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92258666|NCT02229461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258667|NCT02229461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92258668|NCT02229461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92258669|NCT02229461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258670|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
92258671|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
92258672|NCT04641104|Thiamine|thiamine|mesh-list
92258673|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
92258674|NCT04641104|Vitamins|vitamins|mesh-ancestor
92258675|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
92258676|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258677|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
92258678|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92258679|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258680|NCT02237417|Aripiprazole|aripiprazole|mesh-list
92258681|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
92258682|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
92258683|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92258684|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92258685|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258686|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258687|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
92258688|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
92258689|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258690|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258691|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92258692|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92258693|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
92258694|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92258695|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92258696|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92258697|NCT02237417|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92258698|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
92343058|NCT00004883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258699|NCT04603898|Antioxidants|antioxidants|mesh-ancestor
92258700|NCT04603898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258701|NCT04603898|Protective Agents|protective agents|mesh-ancestor
92258702|NCT04603898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258703|NCT04603898|Vitamins|vitamins|mesh-ancestor
92258704|NCT04603898|Micronutrients|micronutrients|mesh-ancestor
92258705|NCT02245490|Tamsulosin|tamsulosin|mesh-list
92258706|NCT02245490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92258707|NCT02245490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92258708|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92258709|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
92258710|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258711|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258712|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258713|NCT02245490|Urological Agents|urological agents|mesh-ancestor
92258714|NCT04355936|Telmisartan|telmisartan|mesh-list
92258715|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92258716|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92258717|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92258718|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258719|NCT00934934|Anidulafungin|anidulafungin|mesh-list
92258720|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
92258721|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258722|NCT01651793|Caffeine|caffeine|mesh-list
92258723|NCT01651793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92258724|NCT01651793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258725|NCT01651793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92258726|NCT01651793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258727|NCT01651793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258728|NCT01651793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92258729|NCT01651793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92258730|NCT01651793|Purinergic Agents|purinergic agents|mesh-ancestor
92258732|NCT01652495|Methylprednisolone|methylprednisolone|mesh-list
92258733|NCT01652495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92258734|NCT01652495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92258735|NCT01652495|Prednisolone|prednisolone|mesh-list
92258736|NCT01652495|Prednisolone acetate|prednisolone acetate|mesh-list
92258737|NCT01652495|Triamcinolone|triamcinolone|mesh-list
92258738|NCT01652495|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92258739|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92258740|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92258741|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
92258742|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92258743|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258744|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
92258745|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
92258746|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258747|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258748|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92258749|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
92258750|NCT01652495|Hormones|hormones|mesh-ancestor
92258751|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258753|NCT01652495|Protective Agents|protective agents|mesh-ancestor
92258754|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92258755|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258756|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258757|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
92258758|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258759|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258760|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92258761|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
92258762|NCT00935792|Everolimus|everolimus|mesh-list
92258763|NCT00935792|Antibodies|antibodies|mesh-list
92258764|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
92258765|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92258766|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
92258767|NCT00935792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258768|NCT00935792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258769|NCT00935792|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92258770|NCT00935792|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92258771|NCT00935792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258772|NCT00935792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258773|NCT00935792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258774|NCT01699607|Amphetamine|amphetamine|mesh-list
92258775|NCT01699607|Dextroamphetamine|dextroamphetamine|mesh-list
92258776|NCT01699607|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92258777|NCT01699607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258778|NCT01699607|Sympathomimetics|sympathomimetics|mesh-ancestor
92258779|NCT01699607|Autonomic Agents|autonomic agents|mesh-ancestor
92258780|NCT01699607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258781|NCT01699607|Dopamine Agents|dopamine agents|mesh-ancestor
92258782|NCT01699607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258783|NCT01699607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258784|NCT01699607|Adrenergic Agents|adrenergic agents|mesh-ancestor
92258785|NCT01699607|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92258786|NCT01699607|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92258787|NCT01699607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258788|NCT01699607|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92258789|NCT04355468|Analgesics, Opioid|analgesics, opioid|mesh-list
92258790|NCT04355468|Anesthetics|anesthetics|mesh-list
92258791|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258792|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258793|NCT04355468|Narcotics|narcotics|mesh-ancestor
92258794|NCT04355468|Analgesics|analgesics|mesh-ancestor
92258795|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
92258796|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258797|NCT01653509|Acyclovir|acyclovir|mesh-list
92258798|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
92258799|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258800|NCT01614509|Triamcinolone|triamcinolone|mesh-list
92258801|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92258802|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92258803|NCT01614509|Bevacizumab|bevacizumab|mesh-list
92258804|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92258805|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258806|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258807|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92258808|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92258809|NCT01614509|Growth Substances|growth substances|mesh-ancestor
92258810|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258811|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
92258812|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92258813|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
92258815|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258816|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92258817|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
92258818|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258819|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258820|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92258821|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92258822|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258823|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258824|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92258825|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258826|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258828|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258830|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
92258831|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258832|NCT01654445|Tenecteplase|tenecteplase|mesh-list
92258833|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92258834|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92258835|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258836|NCT01703039|Riluzole|riluzole|mesh-list
92258837|NCT01703039|Sertraline|sertraline|mesh-list
92258838|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
92258839|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92258840|NCT01703039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92258841|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92258842|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258843|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258844|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258845|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
92258846|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258847|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
92258848|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92258849|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92258850|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92258851|NCT01703039|Protective Agents|protective agents|mesh-ancestor
92258852|NCT01656629|Vitamin D|vitamin d|mesh-list
92258853|NCT01656629|Alendronate|alendronate|mesh-list
92258854|NCT01656629|Teriparatide|teriparatide|mesh-list
92258855|NCT01656629|Calcium|calcium|mesh-list
92258856|NCT01656629|Vitamins|vitamins|mesh-ancestor
92258857|NCT01656629|Micronutrients|micronutrients|mesh-ancestor
92258858|NCT01656629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258859|NCT01656629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92258860|NCT01656629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92258861|NCT01703507|Ipilimumab|ipilimumab|mesh-list
92258862|NCT01703507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92258863|NCT01703507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258864|NCT01703507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92258865|NCT01703507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258866|NCT02158520|Paclitaxel|paclitaxel|mesh-list
92258867|NCT02158520|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92258868|NCT02158520|Bevacizumab|bevacizumab|mesh-list
92258869|NCT02158520|Ipilimumab|ipilimumab|mesh-list
92258870|NCT02158520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92258871|NCT02158520|Endothelial Growth Factors|endothelial growth factors|mesh-list
92258872|NCT02158520|Antibodies|antibodies|mesh-list
92258873|NCT02158520|Immunoglobulins|immunoglobulins|mesh-list
92258874|NCT02158520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92258875|NCT02158520|Immunoglobulin G|immunoglobulin g|mesh-list
92258876|NCT02158520|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92258877|NCT02158520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92258878|NCT02158520|Tubulin Modulators|tubulin modulators|mesh-ancestor
92258879|NCT02158520|Antimitotic Agents|antimitotic agents|mesh-ancestor
92258880|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
92258881|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258882|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92258883|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92258884|NCT02158520|Growth Substances|growth substances|mesh-ancestor
92258885|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258886|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
92258887|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
92258888|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92258889|NCT01704521|Ribavirin|ribavirin|mesh-list
92258890|NCT01704521|Antimetabolites|antimetabolites|mesh-ancestor
92258891|NCT01704521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258892|NCT01704521|Antiviral Agents|antiviral agents|mesh-ancestor
92258893|NCT01704521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258894|NCT01617083|Azithromycin|azithromycin|mesh-list
92258895|NCT01617083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92258896|NCT01617083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92258898|NCT04359524|Cholecalciferol|cholecalciferol|mesh-list
92258899|NCT04359524|Vitamins|vitamins|mesh-ancestor
92258900|NCT04359524|Micronutrients|micronutrients|mesh-ancestor
92258901|NCT04359524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258902|NCT04359524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92258903|NCT04359524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92258904|NCT01658657|Metoprolol|metoprolol|mesh-list
92258905|NCT01658657|Amlodipine|amlodipine|mesh-list
92258906|NCT01658657|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92258907|NCT01658657|Lisinopril|lisinopril|mesh-list
92258908|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
92258909|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92258910|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92258911|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92258912|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258913|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92258914|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258915|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
92258916|NCT01658657|Diuretics|diuretics|mesh-ancestor
92258917|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
92258918|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92258919|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92258920|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
92258921|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
92258922|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258923|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92258924|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92258925|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92258926|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
92258927|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258928|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92258929|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
92258930|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258931|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92258932|NCT01658657|Protective Agents|protective agents|mesh-ancestor
92258933|NCT04359212|Heparin|heparin|mesh-list
92258934|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92258935|NCT04359212|Tinzaparin|tinzaparin|mesh-list
92258936|NCT04359212|Dalteparin|dalteparin|mesh-list
92258938|NCT04359212|Fondaparinux|fondaparinux|mesh-list
92258939|NCT04359212|Anticoagulants|anticoagulants|mesh-ancestor
92258940|NCT04359212|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92258941|NCT04359212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92258942|NCT04359212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258943|NCT04359212|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92258944|NCT04359212|Antithrombins|antithrombins|mesh-ancestor
92258945|NCT04359212|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92258946|NCT04359212|Protease Inhibitors|protease inhibitors|mesh-ancestor
92258947|NCT04359212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258948|NCT01620047|Fentanyl|fentanyl|mesh-list
92258949|NCT01620047|Ropivacaine|ropivacaine|mesh-list
92258950|NCT01620047|Anesthetics, Local|anesthetics, local|mesh-ancestor
92258951|NCT01620047|Anesthetics|anesthetics|mesh-ancestor
92258952|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92258953|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258954|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
92258955|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92258956|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92258957|NCT01620047|Narcotics|narcotics|mesh-ancestor
92258958|NCT01620047|Analgesics|analgesics|mesh-ancestor
92258959|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92258960|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92258961|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
92258962|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92258963|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92258964|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258965|NCT00944450|Incretins|incretins|mesh-ancestor
92258966|NCT00944450|Hormones|hormones|mesh-ancestor
92343099|NCT00385307|Adrenergic Agents|adrenergic agents|mesh-ancestor
92258967|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92258968|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92258969|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
92258970|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258971|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258972|NCT03875144|Cisplatin|cisplatin|mesh-list
92258973|NCT03875144|Doxorubicin|doxorubicin|mesh-list
92258974|NCT03875144|Pemetrexed|pemetrexed|mesh-list
92258975|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117697|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92258976|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92258977|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92258978|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92258979|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92258980|NCT03875144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258981|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92258982|NCT03875144|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92258984|NCT01661621|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92258985|NCT01661621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92258986|NCT01661621|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92258987|NCT01661621|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92258988|NCT01661621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92258989|NCT01661621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92258990|NCT01661621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92258991|NCT01661621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92258992|NCT01661621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92258993|NCT01661621|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92258994|NCT01661621|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92258995|NCT01661621|Cholinergic Agents|cholinergic agents|mesh-ancestor
92258996|NCT01661621|Urological Agents|urological agents|mesh-ancestor
92258997|NCT01620593|Metformin|metformin|mesh-list
92258998|NCT01620593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92258999|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259000|NCT00939536|Zolpidem|zolpidem|mesh-list
92259001|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92259003|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259004|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259005|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92259006|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
92259007|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
92259008|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259009|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259010|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92259011|NCT04358354|Fluorouracil|fluorouracil|mesh-list
92259012|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
92259013|NCT04358354|Irinotecan|irinotecan|mesh-list
92259014|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
92259015|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259016|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259017|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259018|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259019|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
92259020|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259021|NCT04358354|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92259022|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92259023|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259024|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
92259025|NCT03516968|Vitamin D|vitamin d|mesh-list
92259026|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259027|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259028|NCT03516968|Vitamins|vitamins|mesh-ancestor
92259029|NCT03516968|Micronutrients|micronutrients|mesh-ancestor
92259030|NCT03516968|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92259031|NCT04355156|Axitinib|axitinib|mesh-list
92259032|NCT04355156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259033|NCT04355156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92259034|NCT04355156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259035|NCT04355156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259036|NCT03320018|Minocycline|minocycline|mesh-list
92259037|NCT03320018|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259038|NCT03320018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259039|NCT03032666|Sofosbuvir|sofosbuvir|mesh-list
92259040|NCT03032666|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92259042|NCT03032666|Antiviral Agents|antiviral agents|mesh-ancestor
92259043|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259044|NCT04354376|Telmisartan|telmisartan|mesh-list
92259045|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
92259046|NCT04354376|Diuretics|diuretics|mesh-list
92259047|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92259048|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92259049|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92259050|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92259051|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92259052|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259053|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
92259054|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259055|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259056|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92259057|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259058|NCT02777372|Sertraline|sertraline|mesh-list
92259059|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
92259060|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259061|NCT02777372|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92259062|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92259063|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259064|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259065|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259066|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
92259067|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259068|NCT01622543|Leucovorin|leucovorin|mesh-list
92259069|NCT01622543|Bevacizumab|bevacizumab|mesh-list
92259070|NCT01622543|Fluorouracil|fluorouracil|mesh-list
92259071|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
92259072|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259073|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259075|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92259076|NCT01622543|Growth Substances|growth substances|mesh-ancestor
92259077|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259078|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
92259079|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
92259080|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259081|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259082|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259083|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
92259084|NCT01622543|Antidotes|antidotes|mesh-ancestor
92259085|NCT01622543|Protective Agents|protective agents|mesh-ancestor
92259086|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
92259087|NCT01622543|Vitamins|vitamins|mesh-ancestor
92259088|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
92259089|NCT03032042|Azithromycin|azithromycin|mesh-list
92259090|NCT03032042|Albendazole|albendazole|mesh-list
92259091|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259092|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259093|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
92259094|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92259095|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
92259096|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92259097|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92259098|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92259099|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92259100|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92259101|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259102|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259103|NCT01623323|Fluticasone|fluticasone|mesh-list
92259104|NCT01623323|Xhance|xhance|mesh-list
92259105|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259106|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92259107|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
92259108|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259109|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259110|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92259111|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
92259112|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92343107|NCT00004901|Antimetabolites|antimetabolites|mesh-ancestor
92259113|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92259114|NCT01709747|Hydromorphone|hydromorphone|mesh-list
92259115|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92259116|NCT01709747|Narcotics|narcotics|mesh-ancestor
92259117|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259118|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259119|NCT01709747|Analgesics|analgesics|mesh-ancestor
92259120|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
92259121|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259123|NCT03031808|Rocuronium|rocuronium|mesh-list
92259124|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
92259125|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
91911974|NCT02145715|Antiemetics|antiemetics|mesh-ancestor
92259126|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259127|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259128|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
92259129|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259130|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92259131|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92259132|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92259133|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259134|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259135|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92259136|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92259137|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92259138|NCT01662791|Rifaximin|rifaximin|mesh-list
92259139|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259140|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259141|NCT01662791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259142|NCT03035084|Vitamin D|vitamin d|mesh-list
92259143|NCT03035084|Ergocalciferols|ergocalciferols|mesh-list
92259144|NCT03035084|Cholecalciferol|cholecalciferol|mesh-list
92259145|NCT03035084|Vitamins|vitamins|mesh-list
92259146|NCT03035084|Micronutrients|micronutrients|mesh-ancestor
92259147|NCT03035084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259148|NCT03035084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92259149|NCT03035084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259150|NCT03034850|Doxorubicin|doxorubicin|mesh-list
92259151|NCT03034850|Fluorouracil|fluorouracil|mesh-list
92259152|NCT03034850|Ifosfamide|ifosfamide|mesh-list
92259153|NCT03034850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92259154|NCT03034850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259155|NCT03034850|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92259156|NCT03034850|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92259157|NCT03034850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259158|NCT03034850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259159|NCT03034850|Antimetabolites|antimetabolites|mesh-ancestor
92259160|NCT03034850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259161|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259162|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
92259163|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259164|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92259165|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
92259166|NCT01663259|Cetuximab|cetuximab|mesh-list
92259167|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259168|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259169|NCT03031184|Mirtazapine|mirtazapine|mesh-list
92259170|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
92259171|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259172|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92259173|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
92259174|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
92259175|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259176|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259177|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259178|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92259179|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92259180|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259181|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92343110|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259182|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92259183|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92259184|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92259185|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92259186|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92259187|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
92259188|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92259189|NCT02238977|Bupropion|bupropion|mesh-list
92259190|NCT02238977|Fluoxetine|fluoxetine|mesh-list
92259191|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92259192|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
92259193|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259194|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92259195|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92259196|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259197|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259198|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
92259199|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259200|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259201|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92259202|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92259203|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259204|NCT02238977|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92259205|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
92259206|NCT03034382|Lidocaine|lidocaine|mesh-list
92259207|NCT03034382|Epinephrine|epinephrine|mesh-list
92259208|NCT03034382|Morphine|morphine|mesh-list
92259210|NCT03034382|Bupivacaine|bupivacaine|mesh-list
92259211|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
92259212|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
92259213|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259214|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259215|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
92259216|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259217|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92259218|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92259219|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92259220|NCT03034382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259221|NCT03034382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259222|NCT03034382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92259223|NCT03034382|Narcotics|narcotics|mesh-ancestor
92259224|NCT03034382|Analgesics|analgesics|mesh-ancestor
92259225|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92259226|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92259227|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
92259228|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259229|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92259230|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92259231|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
92259232|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92259233|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
92259234|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
92259235|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
92259236|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92259237|NCT01664741|Nicotine|nicotine|mesh-list
92259238|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92259239|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
92259240|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259241|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259242|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92259243|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92259244|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
92259245|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259246|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259247|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92259248|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92259249|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92259250|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259251|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
92259252|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92259253|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259254|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259255|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92259256|NCT03030950|Analgesics|analgesics|mesh-ancestor
92259257|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
92259258|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935016|NCT02348307|Dotinurad|dotinurad|mesh-list
92259259|NCT03030950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92259260|NCT03030950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92259261|NCT03030950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92259262|NCT03030950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92259263|NCT03030950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259264|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259265|NCT02022644|Irinotecan|irinotecan|mesh-list
92259266|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92259267|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92259268|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259269|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259270|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259271|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92259272|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259273|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92259274|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259275|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259276|NCT03030716|Proanthocyanidin|proanthocyanidin|mesh-list
92259277|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
92259278|NCT03030716|Procyanidin|procyanidin|mesh-list
92259279|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92259280|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259281|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
92259282|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259283|NCT03030716|Protective Agents|protective agents|mesh-ancestor
92259284|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259285|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92259286|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92259287|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259288|NCT04353362|Amoxicillin|amoxicillin|mesh-list
92259289|NCT04353362|Metronidazole|metronidazole|mesh-list
92259290|NCT04353362|Ofloxacin|ofloxacin|mesh-list
92259291|NCT04353362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259292|NCT04353362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259293|NCT04353362|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92259294|NCT04353362|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92259295|NCT04353362|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92259296|NCT04353362|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92259297|NCT04353362|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92259298|NCT04353362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259299|NCT04353362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259300|NCT04353362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259301|NCT04353362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92259302|NCT04353362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92259303|NCT00946478|Pimecrolimus|pimecrolimus|mesh-list
92259304|NCT00946478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92259305|NCT00946478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92259306|NCT00946478|Analgesics|analgesics|mesh-ancestor
92259307|NCT00946478|Sensory System Agents|sensory system agents|mesh-ancestor
92259308|NCT00946478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259309|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259310|NCT00946478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259311|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259312|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92259313|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259314|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
92259315|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92259316|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259317|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259318|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
92259319|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92259320|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259321|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92259322|NCT03033836|Dolutegravir|dolutegravir|mesh-list
92259323|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92259324|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92259325|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259326|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259327|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
92259328|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259329|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92259330|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92259331|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92259332|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92259333|NCT03030560|Lidocaine|lidocaine|mesh-list
92259334|NCT03030560|Anesthetics, Local|anesthetics, local|mesh-ancestor
92259335|NCT03030560|Anesthetics|anesthetics|mesh-ancestor
92259336|NCT03030560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259337|NCT03030560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259338|NCT03030560|Sensory System Agents|sensory system agents|mesh-ancestor
92259339|NCT03030560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259340|NCT03030560|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92259341|NCT03030560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92259342|NCT03030560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92259343|NCT03030560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259344|NCT03030560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259345|NCT03033368|Rilpivirine|rilpivirine|mesh-list
92259346|NCT03033368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92259347|NCT03033368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92259348|NCT03033368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259349|NCT03033368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259351|NCT03033368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259352|NCT03033368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92259353|NCT03033368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92259354|NCT03031262|Cytarabine|cytarabine|mesh-list
92259355|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259356|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
92259357|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259358|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259359|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
92259360|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259361|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259362|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
92259363|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259364|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
92259365|NCT03032978|Calcium|calcium|mesh-list
92259366|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259367|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259368|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92259369|NCT03030248|Vancomycin|vancomycin|mesh-list
92259370|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259371|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259372|NCT03028532|Clomiphene|clomiphene|mesh-list
92259373|NCT03028532|Enclomiphene|enclomiphene|mesh-list
92259374|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
92259375|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92259376|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
92259377|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259378|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259379|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92259380|NCT03028532|Fertility Agents|fertility agents|mesh-ancestor
92259381|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92259382|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92259383|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92259384|NCT03017768|Tryptophan|tryptophan|mesh-list
92259385|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92259386|NCT03017768|Antidepressive Agents|antidepressive agents|mesh-ancestor
92259387|NCT03017768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259388|NCT01006538|Ranibizumab|ranibizumab|mesh-list
92259389|NCT01006538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92259390|NCT01006538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92259391|NCT01006538|Growth Substances|growth substances|mesh-ancestor
92259392|NCT01006538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259393|NCT01006538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92259394|NCT01006538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259395|NCT03017222|Ondansetron|ondansetron|mesh-list
92259396|NCT03017222|Ramosetron|ramosetron|mesh-list
92259397|NCT03017222|Antiemetics|antiemetics|mesh-ancestor
92259398|NCT03017222|Autonomic Agents|autonomic agents|mesh-ancestor
92259399|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259400|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259401|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259402|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
92259403|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92259404|NCT03017222|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92259405|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92259406|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
92259407|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259408|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259409|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92259410|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92259411|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
92259412|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92259413|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
92259414|NCT01010282|Glycerol|glycerol|mesh-list
92259415|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92259416|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92259417|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92259418|NCT01010282|Protective Agents|protective agents|mesh-ancestor
92259419|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259420|NCT01010282|Laxatives|laxatives|mesh-ancestor
92259421|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259422|NCT03016988|Cytarabine|cytarabine|mesh-list
92259423|NCT03016988|Fludarabine|fludarabine|mesh-list
92259424|NCT03016988|Bortezomib|bortezomib|mesh-list
92259425|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259426|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259427|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
92259428|NCT03016988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259429|NCT03016988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259430|NCT03016988|Immunologic Factors|immunologic factors|mesh-ancestor
92259431|NCT03016988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259432|NCT03016988|Antiviral Agents|antiviral agents|mesh-ancestor
92259433|NCT03016988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259434|NCT03017066|Anesthetics|anesthetics|mesh-list
92259435|NCT03017066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259436|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259437|NCT03016832|Irbesartan|irbesartan|mesh-list
92259438|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92259439|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92259440|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92259441|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259442|NCT00955916|Cytarabine|cytarabine|mesh-list
92259443|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
92259444|NCT00955916|Cladribine|cladribine|mesh-list
92259445|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259446|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
92259447|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259448|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259449|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
92259450|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259451|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259452|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
92259453|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259454|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92259455|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259456|NCT01668017|Niacinamide|niacinamide|mesh-list
92259457|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
92259458|NCT01668017|Vitamins|vitamins|mesh-ancestor
92259459|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
92259460|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259461|NCT01010984|Doxorubicin|doxorubicin|mesh-list
92259462|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92259463|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259464|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92259465|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92259466|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259467|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259468|NCT05214599|Budesonide|budesonide|mesh-list
92259469|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259470|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92259471|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
92259472|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259473|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259474|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92259475|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
92259476|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
92259477|NCT05214599|Hormones|hormones|mesh-ancestor
92259478|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259479|NCT01011218|Modafinil|modafinil|mesh-list
92259480|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92259481|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259482|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92259483|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92259484|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92259485|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259486|NCT03023306|Antiemetics|antiemetics|mesh-list
92259487|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
92259488|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259489|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259490|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259491|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
92259492|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92259493|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259494|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92259495|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259496|NCT05184101|Heparin|heparin|mesh-list
92259497|NCT05184101|Calcium heparin|calcium heparin|mesh-list
92259498|NCT05184101|Anticoagulants|anticoagulants|mesh-ancestor
92259499|NCT05184101|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92259500|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92259501|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259503|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
92259504|NCT01014728|Propofol|propofol|mesh-list
92259505|NCT01014728|Sevoflurane|sevoflurane|mesh-list
92259506|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92259507|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259508|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259509|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92259510|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
92259511|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
92259512|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92259513|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92259514|NCT01015586|Lamotrigine|lamotrigine|mesh-list
92259515|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
92259516|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92259517|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259518|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259519|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259520|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259521|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92259522|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92259523|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259524|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259525|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92259526|NCT01680653|Glucagon|glucagon|mesh-list
92259527|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92343135|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
92259528|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259529|NCT01680653|Hormones|hormones|mesh-ancestor
92259530|NCT01680653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259531|NCT01680653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259532|NCT01680653|Incretins|incretins|mesh-ancestor
92259533|NCT02448810|Fluorouracil|fluorouracil|mesh-list
92259534|NCT02448810|Panitumumab|panitumumab|mesh-list
92259535|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
92259536|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259537|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259538|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259539|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259540|NCT02448810|Immunologic Factors|immunologic factors|mesh-ancestor
92259541|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259542|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259543|NCT01680887|Varenicline|varenicline|mesh-list
92259544|NCT01680887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92259545|NCT01680887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92259546|NCT01680887|Cholinergic Agents|cholinergic agents|mesh-ancestor
92259547|NCT01680887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259548|NCT01680887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259549|NCT01680887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259550|NCT01016678|Naproxen|naproxen|mesh-list
92259551|NCT01016678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92259552|NCT01016678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92259553|NCT01016678|Analgesics|analgesics|mesh-ancestor
92259554|NCT01016678|Sensory System Agents|sensory system agents|mesh-ancestor
92259555|NCT01016678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259556|NCT01016678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259557|NCT01016678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259558|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259559|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
92259560|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92259561|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259562|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259563|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92259564|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
92259565|NCT02457546|Coagulants|coagulants|mesh-ancestor
92259566|NCT01016834|Sumatriptan|sumatriptan|mesh-list
92259567|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92259568|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92259569|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92259570|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
92259571|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259572|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912431|NCT02088671|Propofol|propofol|mesh-list
92259574|NCT04923594|Mazindol|mazindol|mesh-list
92117698|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92259575|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92259576|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259577|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92259578|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92259579|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259580|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259581|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92259582|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259583|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92259584|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
92259585|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92259586|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
92259587|NCT00961532|Coagulants|coagulants|mesh-ancestor
92259588|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92259589|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
92259590|NCT00961532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259591|NCT02447718|Vaccines|vaccines|mesh-list
92259592|NCT02447718|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92259593|NCT02447718|Immunologic Factors|immunologic factors|mesh-ancestor
92259594|NCT02447718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259595|NCT03016442|Dinoprostone|dinoprostone|mesh-list
92259596|NCT03016442|Oxytocics|oxytocics|mesh-ancestor
92259597|NCT03016442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92259598|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259599|NCT01682135|Ramucirumab|ramucirumab|mesh-list
92259600|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259601|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
92259602|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92259603|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92259604|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
92259605|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259606|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92259607|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
92259608|NCT00963872|Fludarabine|fludarabine|mesh-list
92259609|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
92259610|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259611|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
92259612|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259613|NCT00963872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259614|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92259615|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
92259616|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259617|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259618|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92259619|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259620|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
92259621|NCT00964496|Thalidomide|thalidomide|mesh-list
92259622|NCT00964496|Ferrous succinate|ferrous succinate|mesh-list
92259623|NCT00964496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259624|NCT00964496|Immunologic Factors|immunologic factors|mesh-ancestor
92259625|NCT00964496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259626|NCT00964496|Leprostatic Agents|leprostatic agents|mesh-ancestor
92259627|NCT00964496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259628|NCT00964496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259629|NCT00964496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92259630|NCT00964496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92259631|NCT00964496|Growth Substances|growth substances|mesh-ancestor
92259632|NCT00964496|Growth Inhibitors|growth inhibitors|mesh-ancestor
92259633|NCT00964496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259634|NCT00964496|Hematinics|hematinics|mesh-ancestor
92259635|NCT01685411|Mycophenolic Acid|mycophenolic acid|mesh-list
92259636|NCT01685411|Cyclophosphamide|cyclophosphamide|mesh-list
92259637|NCT01685411|Busulfan|busulfan|mesh-list
92259638|NCT01685411|Allopurinol|allopurinol|mesh-list
92259639|NCT01685411|Levetiracetam|levetiracetam|mesh-list
92259640|NCT01685411|Tacrolimus|tacrolimus|mesh-list
92259641|NCT01685411|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92259642|NCT01685411|Lenograstim|lenograstim|mesh-list
92259643|NCT01685411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259644|NCT01685411|Immunologic Factors|immunologic factors|mesh-ancestor
92259645|NCT01685411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259646|NCT01685411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259647|NCT01685411|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92259648|NCT01685411|Alkylating Agents|alkylating agents|mesh-ancestor
92259649|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259650|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259651|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92259652|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92259653|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92259654|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259655|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92259656|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92259657|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
92259658|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92259659|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259661|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
92259662|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
92259663|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
92259664|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92259665|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
92259666|NCT01685411|Protective Agents|protective agents|mesh-ancestor
92259667|NCT02243813|Psilocybin|psilocybin|mesh-list
92259668|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
92259669|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259670|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259671|NCT02991209|Testosterone|testosterone|mesh-list
92259672|NCT02991209|Androgens|androgens|mesh-ancestor
92259673|NCT02991209|Hormones|hormones|mesh-ancestor
92259674|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259675|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259676|NCT03019562|Fentanyl|fentanyl|mesh-list
92259677|NCT03019562|Oxycodone|oxycodone|mesh-list
92259678|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92259679|NCT03019562|Narcotics|narcotics|mesh-ancestor
92259680|NCT03019562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259681|NCT03019562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259682|NCT03019562|Analgesics|analgesics|mesh-ancestor
92259683|NCT03019562|Sensory System Agents|sensory system agents|mesh-ancestor
92259684|NCT03019562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259685|NCT03019562|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92259686|NCT03019562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92259687|NCT03019562|Anesthetics, General|anesthetics, general|mesh-ancestor
92259688|NCT03019562|Anesthetics|anesthetics|mesh-ancestor
92259689|NCT00969878|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92259690|NCT00969878|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92259691|NCT00969878|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92259692|NCT00969878|Immunologic Factors|immunologic factors|mesh-ancestor
92259693|NCT00969878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259694|NCT00969878|Antacids|antacids|mesh-ancestor
92259695|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259696|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259697|NCT05677919|Venetoclax|venetoclax|mesh-list
92259698|NCT05677919|Pirtobrutinib|pirtobrutinib|mesh-list
92259699|NCT05677919|Pyrazole|pyrazole|mesh-list
92259700|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259701|NCT05677919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92259702|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259703|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259704|NCT00970814|Levetiracetam|levetiracetam|mesh-list
92259705|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
92259706|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
92259708|NCT02486406|Ribavirin|ribavirin|mesh-list
92259709|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92259710|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92259711|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92259712|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259713|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259714|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92259715|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92259716|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
92259717|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259718|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92259719|NCT02486406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92259720|NCT02486406|Antimetabolites|antimetabolites|mesh-ancestor
92259721|NCT01688609|Paclitaxel|paclitaxel|mesh-list
92259722|NCT01688609|Trastuzumab|trastuzumab|mesh-list
92259723|NCT01688609|Lapatinib|lapatinib|mesh-list
92259724|NCT01688609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92259725|NCT01688609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259726|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92259727|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92259728|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92259729|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259730|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259731|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92259732|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259733|NCT02485158|Dronabinol|dronabinol|mesh-list
92259734|NCT02485158|Amphetamine|amphetamine|mesh-list
92259735|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
92259736|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92259737|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259738|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
92259739|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
92259740|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259741|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
92259742|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259743|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259744|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92259745|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92259746|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92259747|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259748|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92259749|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
92259750|NCT02485158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92259751|NCT02485158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92259752|NCT02485158|Analgesics|analgesics|mesh-ancestor
92259753|NCT02485158|Sensory System Agents|sensory system agents|mesh-ancestor
92259754|NCT02485158|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92259755|NCT02485158|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92259756|NCT02485158|Hormones|hormones|mesh-ancestor
92259757|NCT02485158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259758|NCT02455518|Acetaminophen|acetaminophen|mesh-list
92259759|NCT02455518|Ibuprofen|ibuprofen|mesh-list
92259760|NCT02455518|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92259761|NCT02455518|Oxycodone|oxycodone|mesh-list
92259762|NCT02455518|Hydrocodone|hydrocodone|mesh-list
92259763|NCT02455518|Codeine|codeine|mesh-list
92259764|NCT02455518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92259765|NCT02455518|Analgesics|analgesics|mesh-ancestor
92259766|NCT02455518|Sensory System Agents|sensory system agents|mesh-ancestor
92259767|NCT02455518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259768|NCT02455518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259769|NCT02455518|Antipyretics|antipyretics|mesh-ancestor
92259770|NCT02455518|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92259771|NCT02455518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259772|NCT02455518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259773|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92259774|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259775|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259776|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92259777|NCT02455518|Narcotics|narcotics|mesh-ancestor
92259778|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259779|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
92259780|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
92259781|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92259783|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92259784|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92259785|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92259786|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
92259787|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259788|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259789|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259790|NCT03018626|Prednisone|prednisone|mesh-list
92259791|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
92259792|NCT03018626|Rituximab|rituximab|mesh-list
92259793|NCT03018626|Doxorubicin|doxorubicin|mesh-list
92259794|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92259795|NCT03018626|Etoposide|etoposide|mesh-list
92343156|NCT00004925|Trastuzumab|trastuzumab|mesh-list
92259796|NCT03018626|Vincristine|vincristine|mesh-list
92259797|NCT03018626|Bleomycin|bleomycin|mesh-list
92259798|NCT03018626|Vindesine|vindesine|mesh-list
92259799|NCT03018626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259800|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
92259801|NCT03018626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259802|NCT03018626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259803|NCT03018626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92259804|NCT03018626|Alkylating Agents|alkylating agents|mesh-ancestor
92259805|NCT03018626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259806|NCT03018626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259807|NCT03018626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92259808|NCT03018626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259809|NCT03018626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92259810|NCT03018626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92259811|NCT03018626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92259812|NCT03018626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259813|NCT03018626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259814|NCT03018626|Glucocorticoids|glucocorticoids|mesh-ancestor
92259815|NCT03018626|Hormones|hormones|mesh-ancestor
92259816|NCT03018626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259817|NCT03018626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92259818|NCT03018626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92259819|NCT03018626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92259820|NCT03018626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92259821|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92259822|NCT01689779|Vitamin D|vitamin d|mesh-list
92259823|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
92259824|NCT01689779|Vitamins|vitamins|mesh-ancestor
92259825|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
92259826|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259827|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92259828|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259829|NCT05388500|Paclitaxel|paclitaxel|mesh-list
92259830|NCT05388500|Trastuzumab|trastuzumab|mesh-list
92259831|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92259832|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259833|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
92259834|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
92259835|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
92259836|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259837|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259838|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92259839|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92259840|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
92259841|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259842|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259843|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92259844|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
92259845|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
92259846|NCT00974246|Hormones|hormones|mesh-ancestor
92259847|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259848|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
92259849|NCT00974480|Tretinoin|tretinoin|mesh-list
92259850|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259851|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
92259852|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
92259853|NCT00975650|Testosterone|testosterone|mesh-list
92259854|NCT00975650|Androgens|androgens|mesh-ancestor
92259855|NCT00975650|Hormones|hormones|mesh-ancestor
92259856|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259857|NCT00975650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259858|NCT00979940|Atorvastatin|atorvastatin|mesh-list
92259859|NCT00979940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92259860|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92259861|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
92259862|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259863|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92259864|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92259865|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259866|NCT03018236|Ethanol|ethanol|mesh-list
92259867|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
92259868|NCT03018236|Cocaine|cocaine|mesh-list
92259869|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92259870|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92259871|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259872|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92259873|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259874|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
92259875|NCT03018236|Expectorants|expectorants|mesh-ancestor
92259876|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
91912728|NCT02090933|Celecoxib|celecoxib|mesh-list
92259877|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92259878|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
92259879|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259880|NCT03018236|Protective Agents|protective agents|mesh-ancestor
92259881|NCT03018236|Antidotes|antidotes|mesh-ancestor
92259882|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
92259883|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
92259884|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
92259885|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259886|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92259887|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92259888|NCT03018236|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92259889|NCT03018236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92259890|NCT03018236|Dopamine Agents|dopamine agents|mesh-ancestor
92259891|NCT03018236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92259892|NCT02873195|Bevacizumab|bevacizumab|mesh-list
92259893|NCT02873195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92259894|NCT02873195|Atezolizumab|atezolizumab|mesh-list
92259895|NCT02873195|Capecitabine|capecitabine|mesh-list
92259896|NCT02873195|Endothelial Growth Factors|endothelial growth factors|mesh-list
92259897|NCT02873195|Antibodies|antibodies|mesh-list
92259898|NCT02873195|Immunoglobulins|immunoglobulins|mesh-list
92259899|NCT02873195|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92259900|NCT02873195|Immunoglobulin G|immunoglobulin g|mesh-list
92259901|NCT02873195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259902|NCT02873195|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92259903|NCT02873195|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92259904|NCT02873195|Growth Substances|growth substances|mesh-ancestor
92259905|NCT02873195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259906|NCT02873195|Growth Inhibitors|growth inhibitors|mesh-ancestor
92259907|NCT02873195|Immunologic Factors|immunologic factors|mesh-ancestor
92259908|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259909|NCT02873195|Antimetabolites|antimetabolites|mesh-ancestor
92259910|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259911|NCT02873195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92259912|NCT02659241|Adavosertib|adavosertib|mesh-list
92259913|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259914|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259915|NCT04337177|Temozolomide|temozolomide|mesh-list
92259916|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92259917|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
92259918|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259919|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259920|NCT00982592|Leucovorin|leucovorin|mesh-list
92259921|NCT00982592|Fluorouracil|fluorouracil|mesh-list
92259922|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
92259923|NCT00982592|Calcium|calcium|mesh-list
92259924|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
92259925|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92259926|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259927|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
92259928|NCT00982592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259929|NCT00982592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92259930|NCT00982592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259931|NCT00982592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259932|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
92259933|NCT00982592|Antidotes|antidotes|mesh-ancestor
92259934|NCT00982592|Protective Agents|protective agents|mesh-ancestor
92259935|NCT00982592|Vitamin B Complex|vitamin b complex|mesh-ancestor
92259936|NCT00982592|Vitamins|vitamins|mesh-ancestor
92259937|NCT00982592|Micronutrients|micronutrients|mesh-ancestor
92259938|NCT00983216|Ketoconazole|ketoconazole|mesh-list
92259939|NCT00983216|Colchicine|colchicine|mesh-list
92259940|NCT00983216|Gout Suppressants|gout suppressants|mesh-ancestor
92259941|NCT00983216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259942|NCT00983216|Tubulin Modulators|tubulin modulators|mesh-ancestor
92259943|NCT00983216|Antimitotic Agents|antimitotic agents|mesh-ancestor
92259944|NCT00983216|Mitosis Modulators|mitosis modulators|mesh-ancestor
92259945|NCT00983216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259946|NCT00983216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259947|NCT00983216|Antifungal Agents|antifungal agents|mesh-ancestor
92259948|NCT00983216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259949|NCT00983216|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92259950|NCT00983216|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92259951|NCT00983216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912814|NCT03045770|Vitamins|vitamins|mesh-ancestor
92259952|NCT00983216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92259953|NCT00983216|Hormone Antagonists|hormone antagonists|mesh-ancestor
92259954|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259955|NCT00983216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259956|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92259957|NCT01788020|Dexamethasone|dexamethasone|mesh-list
92259958|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
92259959|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
92259960|NCT01788020|Rituximab|rituximab|mesh-list
92259961|NCT01788020|Bortezomib|bortezomib|mesh-list
92259962|NCT01788020|BB 1101|bb 1101|mesh-list
92259963|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92259964|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
92259965|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259966|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92259967|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92259968|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
92259969|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259970|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259971|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92259972|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259973|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92259974|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
92259975|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
92259976|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92259977|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92259978|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
92259979|NCT01788020|Hormones|hormones|mesh-ancestor
92259980|NCT01788020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92259981|NCT01788020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92259982|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
92259983|NCT01788020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259984|NCT02435849|Tisagenlecleucel|tisagenlecleucel|mesh-list
92259985|NCT02435849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92259986|NCT02435849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92259987|NCT02249585|Iodine|iodine|mesh-list
92259988|NCT02249585|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92259989|NCT02249585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92259990|NCT02249585|Trace Elements|trace elements|mesh-ancestor
92259991|NCT02249585|Micronutrients|micronutrients|mesh-ancestor
92259992|NCT02249585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259993|NCT05478863|Caffeine|caffeine|mesh-list
92259994|NCT05478863|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92259995|NCT05478863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92259996|NCT05478863|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92259997|NCT05478863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92259998|NCT05478863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92259999|NCT05478863|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92260000|NCT05478863|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92260001|NCT05478863|Purinergic Agents|purinergic agents|mesh-ancestor
92260002|NCT05478863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260003|NCT01774487|Pentoxifylline|pentoxifylline|mesh-list
92260004|NCT01774487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92260005|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260006|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260007|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92260008|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92260009|NCT01774487|Protective Agents|protective agents|mesh-ancestor
92260010|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260011|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92260012|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92260013|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
92260014|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
92260015|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92260016|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260017|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260018|NCT04409600|Cholinergic Agents|cholinergic agents|mesh-ancestor
92260019|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260020|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260021|NCT02161484|Bupivacaine|bupivacaine|mesh-list
92260022|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
92260023|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
92260024|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260025|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912875|NCT02090153|Antimetabolites|antimetabolites|mesh-ancestor
92260027|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260028|NCT00988832|Infliximab|infliximab|mesh-list
92260029|NCT00988832|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92260030|NCT00988832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92260031|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92260032|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260033|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92260034|NCT01023776|Vaccines|vaccines|mesh-list
92260035|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
92260036|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260037|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
92260038|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92260039|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92260040|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92260041|NCT00989768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260042|NCT00989768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260043|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
92260044|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260045|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260046|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92260047|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260048|NCT00990236|Enoxaparin|enoxaparin|mesh-list
92260049|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
92260050|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
92260051|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92260052|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92260053|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260054|NCT01024010|Vidarabine|vidarabine|mesh-list
92260055|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
92260056|NCT01024010|Ofatumumab|ofatumumab|mesh-list
92260057|NCT01024010|Pentostatin|pentostatin|mesh-list
92260058|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92260059|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92260060|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
92260061|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260062|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92260063|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92260064|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
92260065|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260066|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260067|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92260068|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92260069|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260070|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
92260071|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
92260072|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260073|NCT02484690|Ranibizumab|ranibizumab|mesh-list
92260074|NCT02484690|Faricimab|faricimab|mesh-list
92260075|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92260076|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92260077|NCT02484690|Growth Substances|growth substances|mesh-ancestor
92260078|NCT02484690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260079|NCT02484690|Growth Inhibitors|growth inhibitors|mesh-ancestor
92260080|NCT02484690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260081|NCT01027598|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92260082|NCT01027598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260083|NCT01027598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92260084|NCT01027598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260085|NCT01027598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260086|NCT01654224|Vaccines|vaccines|mesh-list
92260087|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
92260088|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260089|NCT02447328|Fulvestrant|fulvestrant|mesh-list
92260090|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260091|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260092|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92260093|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92260094|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
92260095|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260096|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260097|NCT02447250|Albuterol|albuterol|mesh-list
92260098|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92260099|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
92260100|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260101|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260102|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92260103|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
92260104|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
92260105|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92117699|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92260106|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92260107|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92260108|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92260109|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
92260110|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260111|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260112|NCT00993200|Warfarin|warfarin|mesh-list
92260113|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
92260114|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92260115|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92260116|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92260117|NCT00993824|Antimetabolites|antimetabolites|mesh-ancestor
92260118|NCT00993824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260119|NCT00993824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92260120|NCT02447172|Gentamicins|gentamicins|mesh-list
92260121|NCT02447172|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92260122|NCT02447172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260123|NCT02447172|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92260124|NCT02447172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260125|NCT02447172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260126|NCT02163824|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92260127|NCT02163824|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92260128|NCT04200066|Tamoxifen|tamoxifen|mesh-list
92260129|NCT04200066|Temozolomide|temozolomide|mesh-list
92260130|NCT04200066|Maprotiline|maprotiline|mesh-list
92260131|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92260132|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
92260133|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260134|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260135|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92260136|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
92260137|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260138|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260139|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260140|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92260141|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92260142|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92260143|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92260144|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
92260146|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91935027|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
92260147|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92260148|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260150|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260151|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92260152|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92260153|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92260154|NCT02455050|Laxatives|laxatives|mesh-ancestor
92260155|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260157|NCT00994760|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92260158|NCT00994760|Narcotics|narcotics|mesh-ancestor
92260159|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260160|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260161|NCT00994760|Analgesics|analgesics|mesh-ancestor
92260162|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
92260163|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260164|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92260165|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92260166|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
92260167|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
92260168|NCT00995072|Metoprolol|metoprolol|mesh-list
92260169|NCT00995072|Nebivolol|nebivolol|mesh-list
92260170|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92260171|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92260172|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
92260173|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
92260174|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913026|NCT02099357|Vitamin D|vitamin d|mesh-list
92260175|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260176|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92260177|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92260178|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92260179|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92260180|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260181|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260182|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
92260183|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92260184|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92260185|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92260186|NCT01027910|Doxorubicin|doxorubicin|mesh-list
92260187|NCT01027910|Abexinostat|abexinostat|mesh-list
92260188|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92260189|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260190|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92260191|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92260192|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260193|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260194|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92260195|NCT01031420|Doxorubicin|doxorubicin|mesh-list
92260196|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92260197|NCT01031420|Methotrexate|methotrexate|mesh-list
92260198|NCT01031420|Vinblastine|vinblastine|mesh-list
92260199|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92260200|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260201|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92260202|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92260203|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260204|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260205|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92260206|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
92260207|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92260208|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260209|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92260210|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
92260211|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
92260212|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92260213|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92260214|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
92260215|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92260216|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92260217|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92260218|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92260219|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92260220|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92260222|NCT01031498|Palonosetron|palonosetron|mesh-list
92260223|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
92260224|NCT01031498|Autonomic Agents|autonomic agents|mesh-ancestor
92260225|NCT01031498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260226|NCT01031498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260227|NCT01031498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260228|NCT01031498|Antipruritics|antipruritics|mesh-ancestor
92260229|NCT01031498|Dermatologic Agents|dermatologic agents|mesh-ancestor
92260230|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92260231|NCT01031498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92260232|NCT01031498|Serotonin Agents|serotonin agents|mesh-ancestor
92260233|NCT01031498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260234|NCT01031498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260235|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
92260236|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
92260237|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92260238|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92260239|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260240|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260241|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92260242|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92260243|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260244|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260245|NCT03425006|Pembrolizumab|pembrolizumab|mesh-list
92260246|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92260247|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260248|NCT03425006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92260249|NCT03425006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260251|NCT00998426|Antibodies|antibodies|mesh-list
92260252|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
92260253|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92260254|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92260255|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
92260256|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
92260257|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260258|NCT00998582|Tenofovir|tenofovir|mesh-list
92260259|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
92260260|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260261|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92260262|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92260263|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260264|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260265|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92260266|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92260267|NCT02168660|Vitamin D|vitamin d|mesh-list
92260268|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
92260269|NCT02168660|Vitamins|vitamins|mesh-ancestor
92260270|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
92260271|NCT02168660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260272|NCT02168660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92260273|NCT02168660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260274|NCT01003106|Ranibizumab|ranibizumab|mesh-list
92260275|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92260276|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92260277|NCT01003106|Growth Substances|growth substances|mesh-ancestor
92260278|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260279|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92260280|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260281|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92260282|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
92260283|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343217|NCT00004583|Lopinavir|lopinavir|mesh-list
92260284|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
92260285|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92260286|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92260287|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92260288|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260289|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260290|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
92260291|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260292|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260293|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92260294|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260295|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
92260297|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260298|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260299|NCT01004354|Vitamins|vitamins|mesh-ancestor
92260300|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
92260301|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92260302|NCT02417064|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92260303|NCT02417064|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92260304|NCT02417064|Sertraline|sertraline|mesh-list
92260305|NCT02417064|Antidepressive Agents|antidepressive agents|mesh-list
92260306|NCT02417064|Esketamine|esketamine|mesh-list
92260307|NCT02417064|Escitalopram|escitalopram|mesh-list
92260308|NCT02417064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92260309|NCT02417064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92260310|NCT02417064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260311|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260312|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260313|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
92260314|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260315|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260316|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92260317|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92260318|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92260319|NCT02417064|Analgesics|analgesics|mesh-ancestor
92260320|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
92260321|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
92260322|NCT01004744|Anastrozole|anastrozole|mesh-list
92260323|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260324|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260325|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92260326|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92260327|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260328|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260329|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92260330|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92260331|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260332|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260333|NCT01005290|Ramipril|ramipril|mesh-list
92260334|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92260335|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
92260336|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260337|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260338|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92260339|NCT04478474|Ganciclovir|ganciclovir|mesh-list
92260340|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92260341|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
92260342|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260343|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92260344|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260345|NCT04478474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260346|NCT05592860|Insulin|insulin|mesh-list
92260347|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92260348|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260349|NCT01051778|Aspirin|aspirin|mesh-list
92343224|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260351|NCT01051778|Enoxaparin|enoxaparin|mesh-list
92260352|NCT01051778|Calcium heparin|calcium heparin|mesh-list
92260353|NCT01051778|Calcium|calcium|mesh-list
92260354|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260355|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260356|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92260357|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92260358|NCT01051778|Analgesics|analgesics|mesh-ancestor
92260359|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
92260360|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260361|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92260362|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92260363|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92260364|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91935030|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
92260365|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260366|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92260367|NCT01051778|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92260368|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260369|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
92260370|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
92260371|NCT02169440|Opicapone|opicapone|mesh-list
92260372|NCT02169440|Warfarin|warfarin|mesh-list
92260373|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
92260374|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92260375|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260376|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260377|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92260378|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92260379|NCT03015350|Sevoflurane|sevoflurane|mesh-list
92260380|NCT03015350|Desflurane|desflurane|mesh-list
92260381|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92260382|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92260383|NCT03015350|Anesthetics, General|anesthetics, general|mesh-ancestor
92260384|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
92260385|NCT03015350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260386|NCT03015350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260387|NCT01054742|Ribavirin|ribavirin|mesh-list
92260388|NCT01054742|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92260389|NCT01054742|Antimetabolites|antimetabolites|mesh-ancestor
92260390|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260391|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
92260392|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260393|NCT04171466|Metronidazole|metronidazole|mesh-list
92260394|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
92260395|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260396|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92260397|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92260398|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92260399|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92260400|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92260401|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260402|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260403|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260404|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92260405|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92260407|NCT02170376|Carbidopa|carbidopa|mesh-list
92260408|NCT02170376|Opicapone|opicapone|mesh-list
92260409|NCT02170376|Entacapone|entacapone|mesh-list
92260410|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92260411|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92260412|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
92260413|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260414|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260415|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260416|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92260417|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260418|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92260419|NCT02170532|Albuterol|albuterol|mesh-list
92260420|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92260421|NCT02170532|Autonomic Agents|autonomic agents|mesh-ancestor
92343232|NCT00004583|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92260422|NCT02170532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260423|NCT02170532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260424|NCT02170532|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92260425|NCT02170532|Respiratory System Agents|respiratory system agents|mesh-ancestor
92260427|NCT02170532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92260428|NCT02170532|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92260429|NCT02170532|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92260430|NCT02170532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92260431|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
92260432|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260433|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260434|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
92260435|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92260436|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
92260437|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
92260438|NCT02175212|Androgens|androgens|mesh-list
92260439|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92260440|NCT02175212|Hormones|hormones|mesh-ancestor
92260441|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260442|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260443|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
92260444|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260445|NCT02175212|Protective Agents|protective agents|mesh-ancestor
92260446|NCT02175212|Vitamins|vitamins|mesh-ancestor
92260447|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
92260448|NCT02175212|Estrogens|estrogens|mesh-ancestor
92260449|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260450|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260451|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
92260452|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
92260453|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92260454|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
92260455|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260456|NCT03014882|Expectorants|expectorants|mesh-ancestor
92260457|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92260458|NCT03014882|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92260459|NCT03014882|Antioxidants|antioxidants|mesh-ancestor
92260460|NCT03014882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260461|NCT03014882|Protective Agents|protective agents|mesh-ancestor
92260462|NCT03014882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260463|NCT03014882|Antidotes|antidotes|mesh-ancestor
92260464|NCT02171234|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92260465|NCT02171234|Anticonvulsants|anticonvulsants|mesh-ancestor
92260466|NCT02171234|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92260467|NCT02171234|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92260468|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260469|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260470|NCT01061528|Nicotine|nicotine|mesh-list
92260471|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92260472|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
91913339|NCT03554447|Antioxidants|antioxidants|mesh-ancestor
92260473|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260474|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260475|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92260476|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92260477|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
92260478|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260479|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260480|NCT01062230|Bortezomib|bortezomib|mesh-list
92260481|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260482|NCT01064882|Bimatoprost|bimatoprost|mesh-list
92260483|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92260484|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92260485|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92260486|NCT01065506|Nicotine|nicotine|mesh-list
92260487|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92260488|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
92260489|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260490|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260491|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92260492|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92260493|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
92260494|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260495|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260496|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92260497|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260498|NCT03817736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92260499|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260500|NCT03811886|Natalizumab|natalizumab|mesh-list
92260501|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
92260502|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260503|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92260504|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92260505|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92260506|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
92260507|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260508|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92260509|NCT01066520|Diclofenac|diclofenac|mesh-list
92260510|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92260511|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92260512|NCT01066520|Analgesics|analgesics|mesh-ancestor
92260513|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
92260514|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260515|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260516|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92260517|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92260518|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92260519|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260520|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260521|NCT03014804|Nivolumab|nivolumab|mesh-list
92260522|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92260523|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260524|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92260525|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260526|NCT05224388|Heparin|heparin|mesh-list
92260527|NCT05224388|Enoxaparin|enoxaparin|mesh-list
92260528|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
92260529|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92260530|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92260531|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260532|NCT03520790|Paclitaxel|paclitaxel|mesh-list
92260533|NCT03520790|Gemcitabine|gemcitabine|mesh-list
92260534|NCT03520790|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92260535|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260536|NCT03520790|Tubulin Modulators|tubulin modulators|mesh-ancestor
92260537|NCT03520790|Antimitotic Agents|antimitotic agents|mesh-ancestor
92260538|NCT03520790|Mitosis Modulators|mitosis modulators|mesh-ancestor
92260539|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260540|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92260541|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
92260542|NCT02416908|Cytarabine|cytarabine|mesh-list
92260543|NCT02416908|Plerixafor|plerixafor|mesh-list
92260544|NCT02416908|2'-deoxyadenosine|2'-deoxyadenosine|mesh-list
92260545|NCT02416908|Cladribine|cladribine|mesh-list
92260546|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92260547|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
92260548|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260549|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260550|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
92260551|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260552|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92260553|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
92260554|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260555|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92260556|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92260557|NCT01070810|Thiamine|thiamine|mesh-list
92260558|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
92260559|NCT01070810|Vitamins|vitamins|mesh-ancestor
92260560|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
92260561|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260562|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92260563|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92260564|NCT01071044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260565|NCT01071044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92260566|NCT01071044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92260567|NCT01071044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260568|NCT01071044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260569|NCT01071044|Dopamine Agents|dopamine agents|mesh-ancestor
92260570|NCT01071044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260571|NCT05150756|Lidocaine|lidocaine|mesh-list
92260572|NCT05150756|Morphine|morphine|mesh-list
92260573|NCT05150756|Anesthetics, Local|anesthetics, local|mesh-ancestor
92260574|NCT05150756|Anesthetics|anesthetics|mesh-ancestor
92260575|NCT05150756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260576|NCT05150756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260577|NCT05150756|Sensory System Agents|sensory system agents|mesh-ancestor
92260578|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260579|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92260580|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92260581|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92260582|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260583|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260584|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92260585|NCT05150756|Narcotics|narcotics|mesh-ancestor
92260586|NCT05150756|Analgesics|analgesics|mesh-ancestor
92260588|NCT01072136|Cefixime|cefixime|mesh-list
92260589|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92260590|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260591|NCT05135858|Methotrexate|methotrexate|mesh-list
92260592|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92260593|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
92260594|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92260595|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260596|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92260597|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
92260598|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260599|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260600|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
92260601|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260602|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92260603|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92260604|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
92260605|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92260606|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92260607|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
92260608|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92260609|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260610|NCT03012230|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92260611|NCT03012230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260612|NCT03005444|Enoxaparin|enoxaparin|mesh-list
92260613|NCT03005444|Nadroparin|nadroparin|mesh-list
92260614|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
92260615|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92260616|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
92260617|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92260618|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
92260619|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343251|NCT00004637|Micronutrients|micronutrients|mesh-ancestor
92260620|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260621|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
92260622|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92260623|NCT03005444|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92260624|NCT01076270|Plerixafor|plerixafor|mesh-list
92260625|NCT01076270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92260626|NCT01076270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92260627|NCT01076270|Antiviral Agents|antiviral agents|mesh-ancestor
92260628|NCT01076270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260629|NCT01076504|Carboplatin|carboplatin|mesh-list
92260630|NCT01076504|Amrubicin|amrubicin|mesh-list
92260631|NCT01076504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260632|NCT01076972|Ritonavir|ritonavir|mesh-list
92260633|NCT01076972|Lopinavir|lopinavir|mesh-list
92260634|NCT01076972|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92260635|NCT01076972|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92260636|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
92260637|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260638|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260639|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92260640|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92260641|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
92260642|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260643|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92260644|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92260645|NCT02174432|Nalbuphine|nalbuphine|mesh-list
92260646|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92260647|NCT02174432|Narcotics|narcotics|mesh-ancestor
92260648|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260649|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260650|NCT02174432|Analgesics|analgesics|mesh-ancestor
92260651|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
92260652|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260653|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
92260654|NCT02176382|Denosumab|denosumab|mesh-list
92260655|NCT02176382|Teriparatide|teriparatide|mesh-list
92260656|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92260657|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260658|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260659|NCT01077596|Bupropion|bupropion|mesh-list
92260660|NCT01077596|Antidepressive Agents|antidepressive agents|mesh-list
92260661|NCT01077596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
92260662|NCT01077596|Serotonin|serotonin|mesh-list
92260664|NCT01077596|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92260665|NCT01077596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92260666|NCT01077596|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92260667|NCT01077596|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92260668|NCT01077596|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260669|NCT01077596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260670|NCT01077596|Dopamine Agents|dopamine agents|mesh-ancestor
92260671|NCT01077596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260672|NCT01077596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260673|NCT01077596|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92260674|NCT01077596|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92260675|NCT01077596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260676|NCT01077596|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92260677|NCT01077596|Serotonin Agents|serotonin agents|mesh-ancestor
92260678|NCT03013712|Immunomodulating Agents|immunomodulating agents|mesh-list
92260679|NCT03013712|Immunologic Factors|immunologic factors|mesh-ancestor
92260680|NCT03013712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260682|NCT02740868|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92260683|NCT02740868|Anesthetics, General|anesthetics, general|mesh-ancestor
92260684|NCT02740868|Anesthetics|anesthetics|mesh-ancestor
92260685|NCT02740868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260686|NCT02740868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260687|NCT02414958|Empagliflozin|empagliflozin|mesh-list
92260688|NCT02414958|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92260689|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260690|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92260691|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260692|NCT03016208|Misoprostol|misoprostol|mesh-list
92260693|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92260694|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
92260695|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92260696|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913548|NCT03554915|Anesthetics|anesthetics|mesh-ancestor
92260697|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92260698|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260699|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
92260700|NCT03013790|Melatonin|melatonin|mesh-list
92260701|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
92260702|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260703|NCT03013790|Protective Agents|protective agents|mesh-ancestor
92260704|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260705|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260706|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92260707|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92260708|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92260709|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260710|NCT02485184|Propranolol|propranolol|mesh-list
92260711|NCT02485184|Warfarin|warfarin|mesh-list
92260712|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92260713|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
92260714|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92260715|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92260716|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260717|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260718|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260719|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92260720|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92260721|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
92260722|NCT03015818|Calcium|calcium|mesh-list
92260723|NCT03015818|Fluorides|fluorides|mesh-list
92260724|NCT03015818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260725|NCT03015818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260726|NCT03015818|Cariostatic Agents|cariostatic agents|mesh-ancestor
92260727|NCT03015818|Protective Agents|protective agents|mesh-ancestor
92260729|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92260730|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
92260731|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260732|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260733|NCT02452476|Poractant alfa|poractant alfa|mesh-list
92260735|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92260736|NCT01082588|Pravastatin|pravastatin|mesh-list
92260737|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92260738|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92260739|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
92260740|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260741|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92260742|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92260743|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260744|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
92260745|NCT02413398|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92260746|NCT02413398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260747|NCT02413398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92260748|NCT02413398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260749|NCT02441946|Anastrozole|anastrozole|mesh-list
92260750|NCT02441946|Loperamide|loperamide|mesh-list
92260751|NCT02441946|Antidiarrheals|antidiarrheals|mesh-list
92260752|NCT02441946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260753|NCT02441946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260754|NCT02441946|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92260755|NCT02441946|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92260756|NCT02441946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260757|NCT02441946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260758|NCT02441946|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92260759|NCT02441946|Hormone Antagonists|hormone antagonists|mesh-ancestor
92260760|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260761|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260762|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260763|NCT01083368|Sirolimus|sirolimus|mesh-list
92260764|NCT01083368|Bevacizumab|bevacizumab|mesh-list
92260765|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92260766|NCT01083368|Temsirolimus|temsirolimus|mesh-list
92260767|NCT01083368|MTOR Inhibitors|mtor inhibitors|mesh-list
92260768|NCT01083368|Antibodies|antibodies|mesh-list
92260769|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
92260770|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91913644|NCT03042182|Vaccines|vaccines|mesh-list
92260771|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260772|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92260773|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92260774|NCT01083368|Growth Substances|growth substances|mesh-ancestor
92260775|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260776|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
92260777|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
92260778|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92260779|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260780|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92260781|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
92260782|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92260783|NCT01083368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92260784|NCT01083368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260785|NCT01083368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260786|NCT02387580|Artefenomel|artefenomel|mesh-list
92260787|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
92260788|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92260789|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92260790|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260791|NCT02440854|Afatinib|afatinib|mesh-list
92260792|NCT02440854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260793|NCT02440854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92260794|NCT02440854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260795|NCT02440854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260796|NCT01084148|V0034CR|v0034cr|mesh-list
92260797|NCT01084148|Emollients|emollients|mesh-ancestor
92260798|NCT01084148|Dermatologic Agents|dermatologic agents|mesh-ancestor
92260799|NCT01085006|Tranexamic Acid|tranexamic acid|mesh-list
92260800|NCT01085006|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92260801|NCT01085006|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92260802|NCT01085006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260803|NCT01085006|Hemostatics|hemostatics|mesh-ancestor
92260804|NCT01085006|Coagulants|coagulants|mesh-ancestor
92260805|NCT01085786|Amoxicillin|amoxicillin|mesh-list
92260806|NCT01085786|Metronidazole|metronidazole|mesh-list
92260807|NCT01085786|Clarithromycin|clarithromycin|mesh-list
92260808|NCT01085786|Esomeprazole|esomeprazole|mesh-list
92260809|NCT01085786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92260810|NCT01085786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260811|NCT01085786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92260812|NCT01085786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92260813|NCT01085786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92260814|NCT01085786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260815|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92260816|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260817|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260818|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92260819|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92260820|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92260821|NCT02170220|Vortioxetine|vortioxetine|mesh-list
92260822|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
92260823|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92260824|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92260825|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92260826|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260827|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260828|NCT02170220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92260829|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92260830|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343270|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
92260831|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260832|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260833|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
92260834|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92260835|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92260836|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92260837|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92260839|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
92260840|NCT01037192|Vancomycin|vancomycin|mesh-list
92260841|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92260842|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260843|NCT02386098|Ritonavir|ritonavir|mesh-list
92260844|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92260845|NCT02386098|Tenofovir|tenofovir|mesh-list
91913704|NCT03192033|Hemostatics|hemostatics|mesh-list
92260846|NCT02386098|Dolutegravir|dolutegravir|mesh-list
92260847|NCT02386098|BMS-955176|bms-955176|mesh-list
92260848|NCT02386098|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92260849|NCT02386098|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92260850|NCT02386098|Protease Inhibitors|protease inhibitors|mesh-ancestor
92260851|NCT02386098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260852|NCT02386098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260853|NCT02386098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92260854|NCT02386098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92260855|NCT02386098|Antiviral Agents|antiviral agents|mesh-ancestor
92260856|NCT02386098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260857|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92260858|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92260859|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92260860|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92260861|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92260862|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92260863|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
92260864|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92260865|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
92260866|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
92260867|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260868|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260869|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260870|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92260871|NCT01089062|Analgesics|analgesics|mesh-ancestor
92260872|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
92260873|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260874|NCT02412618|Misoprostol|misoprostol|mesh-list
92260875|NCT02412618|Mifepristone|mifepristone|mesh-list
92260876|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92260877|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
92260878|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92260879|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260880|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92260881|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260882|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
92260883|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92260884|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92260885|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92260886|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92260887|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
92260888|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92260889|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92260890|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
92260891|NCT02412618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260892|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
92260893|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92260894|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92260895|NCT02179892|Acetaminophen|acetaminophen|mesh-list
92260896|NCT02179892|Dexamethasone|dexamethasone|mesh-list
92260897|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
92260898|NCT02179892|Bupivacaine|bupivacaine|mesh-list
92260899|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92260900|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
92260901|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
92260902|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260903|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260904|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260905|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
92260907|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92260908|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92260909|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260910|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
92260911|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
92260912|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260913|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
92260914|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92260915|NCT02179892|Analgesics|analgesics|mesh-ancestor
92260916|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
92260917|NCT01092338|Vitamin D|vitamin d|mesh-list
92260918|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
92260919|NCT01092338|Vitamins|vitamins|mesh-ancestor
92260920|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
91913777|NCT03041012|Romidepsin|romidepsin|mesh-list
92260921|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260922|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92260923|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260924|NCT01110434|Topiramate|topiramate|mesh-list
92260925|NCT01110434|Anticonvulsants|anticonvulsants|mesh-ancestor
92260926|NCT01110434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92260927|NCT01110434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260928|NCT01042496|Lamotrigine|lamotrigine|mesh-list
92260929|NCT01042496|Anticonvulsants|anticonvulsants|mesh-ancestor
92260930|NCT01042496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92117700|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92260931|NCT01042496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92260932|NCT01042496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260933|NCT01042496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92260934|NCT01042496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260935|NCT01042496|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92260936|NCT01042496|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92260937|NCT01042496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260938|NCT01042496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92260939|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92260940|NCT01111058|Everolimus|everolimus|mesh-list
92260941|NCT01111058|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92260942|NCT01111058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92260943|NCT01111058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260944|NCT01111058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260945|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92260946|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
92260947|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260948|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92260949|NCT01094522|Morphine|morphine|mesh-list
92260950|NCT01094522|Methadone|methadone|mesh-list
92260951|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92260952|NCT01094522|Narcotics|narcotics|mesh-ancestor
92260953|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260954|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260955|NCT01094522|Analgesics|analgesics|mesh-ancestor
92260956|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
92260957|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92260958|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
92260959|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
92260960|NCT02178800|Cabotegravir|cabotegravir|mesh-list
92260961|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92260962|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92260963|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92260964|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260965|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92260966|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92260967|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
92260968|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260969|NCT01044212|Psyllium|psyllium|mesh-list
92260970|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92260971|NCT01044212|Cathartics|cathartics|mesh-ancestor
92260972|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92260973|NCT01044212|Antidiarrheals|antidiarrheals|mesh-ancestor
92260974|NCT02174510|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92260975|NCT02174510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92260976|NCT02174510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92260977|NCT02174510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92260978|NCT02174510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92260979|NCT02174510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92260980|NCT02174510|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92260981|NCT02174510|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92260982|NCT02174510|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92260983|NCT02174510|Adrenergic Agents|adrenergic agents|mesh-ancestor
92260984|NCT02174510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92260985|NCT02174510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92260986|NCT02174510|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92260987|NCT02174510|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92260988|NCT02174510|Serotonin Agents|serotonin agents|mesh-ancestor
92260989|NCT02174510|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92260990|NCT02174510|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92260991|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
92260993|NCT00585195|Rifampin|rifampin|mesh-list
92260994|NCT00585195|Crizotinib|crizotinib|mesh-list
92260995|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
92260996|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92260997|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92260998|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92260999|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261000|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261001|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92261002|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
92261003|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261004|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261005|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92261006|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92261007|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
92261008|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261009|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
92261010|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92261011|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92261012|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92261013|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92261014|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92261015|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92261016|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92261017|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261018|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92261020|NCT01113398|Rilotumumab|rilotumumab|mesh-list
92261021|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261022|NCT01113398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261023|NCT01113398|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92261024|NCT01113398|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92261025|NCT01113398|Growth Substances|growth substances|mesh-ancestor
92261026|NCT01113398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261027|NCT01113398|Growth Inhibitors|growth inhibitors|mesh-ancestor
92261029|NCT03013556|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92261030|NCT03013556|Interferon-alpha|interferon-alpha|mesh-list
92261031|NCT03013556|Antiviral Agents|antiviral agents|mesh-ancestor
92261032|NCT03013556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261033|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92261034|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92261035|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261036|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261037|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92261038|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92261039|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
92261040|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261041|NCT01113632|Ofatumumab|ofatumumab|mesh-list
92261042|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261043|NCT00458835|Ciclesonide|ciclesonide|mesh-list
92343281|NCT00005039|Vaccines|vaccines|mesh-list
92261044|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
92261045|NCT00458835|Hormones|hormones|mesh-ancestor
92261046|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261047|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261048|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92261049|NCT01044758|Levetiracetam|levetiracetam|mesh-list
92261050|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
92261051|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
92261052|NCT01115582|Cholic Acids|cholic acids|mesh-list
92261053|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261054|NCT03013400|Ebselen|ebselen|mesh-list
92261055|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92261056|NCT03013400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92261057|NCT03013400|Analgesics|analgesics|mesh-ancestor
92261058|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
92261059|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261060|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261061|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92261062|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261063|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92261064|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261065|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
92261066|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261067|NCT03013400|Protective Agents|protective agents|mesh-ancestor
92261068|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92261069|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261070|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92261071|NCT02439138|Idelalisib|idelalisib|mesh-list
92261072|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261073|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261074|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261075|NCT01097642|Cetuximab|cetuximab|mesh-list
92261076|NCT01097642|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261077|NCT01097642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261078|NCT01048658|Sevoflurane|sevoflurane|mesh-list
92261079|NCT01048658|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91925772|NCT02157311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261080|NCT01048658|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92261081|NCT01048658|Anesthetics, General|anesthetics, general|mesh-ancestor
92261082|NCT01048658|Anesthetics|anesthetics|mesh-ancestor
92261083|NCT01048658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261084|NCT01048658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261085|NCT04341675|Sirolimus|sirolimus|mesh-list
92261087|NCT04341675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261088|NCT04341675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92261089|NCT04341675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261090|NCT04341675|Antifungal Agents|antifungal agents|mesh-ancestor
92261091|NCT04341675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261092|NCT04341675|Immunologic Factors|immunologic factors|mesh-ancestor
92261093|NCT04341675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261094|NCT02445807|Clobetasol|clobetasol|mesh-list
92261095|NCT02445807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92261096|NCT02445807|Glucocorticoids|glucocorticoids|mesh-ancestor
92261097|NCT02445807|Hormones|hormones|mesh-ancestor
92261098|NCT02445807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261099|NCT02445807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261100|NCT00362973|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92261101|NCT00362973|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92261102|NCT00362973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261104|NCT01116986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92261105|NCT01116986|Autonomic Agents|autonomic agents|mesh-ancestor
92261106|NCT01116986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261107|NCT01116986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261108|NCT01116986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92261109|NCT01116986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92261110|NCT01116986|Cholinergic Agents|cholinergic agents|mesh-ancestor
92261111|NCT01116986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343291|NCT00004685|Tocolytic Agents|tocolytic agents|mesh-ancestor
92261112|NCT01116986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261113|NCT01098500|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92261114|NCT01098500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92261115|NCT01098500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261116|NCT01098500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261117|NCT01099202|Epoetin Alfa|epoetin alfa|mesh-list
92261118|NCT01099202|Hematinics|hematinics|mesh-ancestor
92261119|NCT02448303|Pembrolizumab|pembrolizumab|mesh-list
92261120|NCT02448303|Acalabrutinib|acalabrutinib|mesh-list
92261121|NCT02448303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261122|NCT02448303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261123|NCT02448303|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92261124|NCT02448303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261125|NCT02415855|Dabigatran|dabigatran|mesh-list
92261126|NCT02415855|Antithrombins|antithrombins|mesh-ancestor
92261127|NCT02415855|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92261128|NCT02415855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92261129|NCT02415855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261130|NCT02415855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261131|NCT02415855|Anticoagulants|anticoagulants|mesh-ancestor
92261132|NCT00363285|Cyproterone Acetate|cyproterone acetate|mesh-list
92261133|NCT00363285|Hormones|hormones|mesh-list
92261134|NCT00363285|Cyproterone|cyproterone|mesh-list
92261135|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261136|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261137|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
92261138|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92261139|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261140|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92261141|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
92261142|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92261143|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
92261144|NCT02424357|Povidone|povidone|mesh-list
92261145|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92261146|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92261147|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
92261148|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
92261149|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92261150|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261151|NCT02425449|Succinylcholine|succinylcholine|mesh-list
92261152|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92261153|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92261154|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92261155|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261156|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261157|NCT02455167|Ribavirin|ribavirin|mesh-list
92261158|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
92261159|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
92261160|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261162|NCT02455167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261163|NCT02434497|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92261164|NCT02434497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92261165|NCT02434497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92261166|NCT02434497|Antimetabolites|antimetabolites|mesh-ancestor
92261167|NCT02434497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261168|NCT02434497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92261169|NCT02434497|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92261170|NCT02434497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261171|NCT02435901|Cyclosporine|cyclosporine|mesh-list
92261172|NCT02435901|Mycophenolic Acid|mycophenolic acid|mesh-list
92261173|NCT02435901|Fludarabine|fludarabine|mesh-list
92261174|NCT02435901|Melphalan|melphalan|mesh-list
92261175|NCT02435901|Alemtuzumab|alemtuzumab|mesh-list
92261176|NCT02435901|Tacrolimus|tacrolimus|mesh-list
92261177|NCT02435901|Cyclosporins|cyclosporins|mesh-list
92261179|NCT02435901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261180|NCT02435901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261181|NCT02435901|Immunologic Factors|immunologic factors|mesh-ancestor
92261182|NCT02435901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261183|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92261184|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261185|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
92261186|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261187|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92261188|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261189|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92261190|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92261191|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
92261192|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261193|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92261194|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
92261195|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92261196|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261197|NCT02437383|Propranolol|propranolol|mesh-list
92261198|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92261199|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92261200|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92261201|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261202|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261203|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261204|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92261205|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92261206|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
92261207|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
92261208|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92261209|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92261210|NCT02385708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261211|NCT02385708|Disinfectants|disinfectants|mesh-ancestor
92261212|NCT02385708|Dermatologic Agents|dermatologic agents|mesh-ancestor
92261213|NCT01099358|Fluorouracil|fluorouracil|mesh-list
92261214|NCT01099358|Cetuximab|cetuximab|mesh-list
92261215|NCT01099358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261216|NCT01099358|Antimetabolites|antimetabolites|mesh-ancestor
92261217|NCT01099358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261218|NCT01099358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92261219|NCT01099358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261220|NCT01099358|Immunologic Factors|immunologic factors|mesh-ancestor
92261221|NCT01099358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261222|NCT01099358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261223|NCT01118624|Vitamins|vitamins|mesh-list
92261224|NCT01118624|Folic Acid|folic acid|mesh-list
92261225|NCT01118624|Vitamin B 12|vitamin b 12|mesh-list
92261226|NCT01118624|Vitamin B Complex|vitamin b complex|mesh-list
92261227|NCT01118624|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92261228|NCT01118624|Aminopterin|aminopterin|mesh-list
92261229|NCT01118624|Micronutrients|micronutrients|mesh-ancestor
92261230|NCT01118624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261231|NCT01118624|Hematinics|hematinics|mesh-ancestor
92261232|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92261233|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261234|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261235|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261236|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
92261237|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
92261238|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261239|NCT02439879|Protective Agents|protective agents|mesh-ancestor
92261240|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261241|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
92261242|NCT02439879|Vitamins|vitamins|mesh-ancestor
92261243|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
92261244|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
92261245|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92261246|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261247|NCT01100606|Pancrelipase|pancrelipase|mesh-list
92261248|NCT01100606|Pancreatin|pancreatin|mesh-list
92261249|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261250|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
92261251|NCT03013010|Tegafur|tegafur|mesh-list
92261252|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261253|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92261254|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
92261255|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261256|NCT02518191|Goserelin|goserelin|mesh-list
92261257|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92261258|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261259|NCT01119794|Bortezomib|bortezomib|mesh-list
92261260|NCT01119794|Ofatumumab|ofatumumab|mesh-list
92261261|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261263|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261264|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261265|NCT01103414|Pioglitazone|pioglitazone|mesh-list
92261266|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92261267|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261268|NCT02180828|Fluconazole|fluconazole|mesh-list
92261269|NCT02180828|Clotrimazole|clotrimazole|mesh-list
92261270|NCT02180828|Miconazole|miconazole|mesh-list
92261271|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
92261272|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261273|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92261274|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92261275|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261276|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261277|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92261278|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
92261279|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261280|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261281|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92261282|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92261283|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92261284|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92261285|NCT02525523|Alicaforsen|alicaforsen|mesh-list
92261286|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261287|NCT02525523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261288|NCT02525523|Immunologic Factors|immunologic factors|mesh-ancestor
92261289|NCT02525523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261290|NCT02528409|Vortioxetine|vortioxetine|mesh-list
92261291|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
92261292|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92261293|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92261294|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92261295|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261296|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914158|NCT02429037|Cisplatin|cisplatin|mesh-list
92261297|NCT02528409|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92261298|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92261299|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92261300|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261301|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261302|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
92261303|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92261304|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92261305|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92261306|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92261307|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
92261308|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92261309|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92261310|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92261311|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
92261312|NCT02530281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261313|NCT02530281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261314|NCT02530281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261315|NCT03013634|Dexmedetomidine|dexmedetomidine|mesh-list
92261316|NCT03013634|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92261317|NCT03013634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261318|NCT03013634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261319|NCT03013634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92261320|NCT03013634|Analgesics|analgesics|mesh-ancestor
92261321|NCT03013634|Sensory System Agents|sensory system agents|mesh-ancestor
92261322|NCT03013634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261323|NCT03013634|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92261324|NCT03013634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92261325|NCT03013634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92261326|NCT03013634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92261327|NCT03013634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261328|NCT03013634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261330|NCT02980094|Vitamin E|vitamin e|mesh-list
92261331|NCT02980094|Tocopherols|tocopherols|mesh-list
92261332|NCT02980094|Tocotrienols|tocotrienols|mesh-list
92261333|NCT02980094|alpha-Tocopherol|alpha-tocopherol|mesh-list
92261334|NCT02980094|Selenium|selenium|mesh-list
92261335|NCT02980094|Antioxidants|antioxidants|mesh-list
92261336|NCT02980094|Micronutrients|micronutrients|mesh-ancestor
92261337|NCT02980094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261338|NCT02980094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261339|NCT02980094|Protective Agents|protective agents|mesh-ancestor
92261340|NCT02980094|Trace Elements|trace elements|mesh-ancestor
92261341|NCT03013322|Physostigmine|physostigmine|mesh-list
92261342|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92261343|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261344|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261345|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
92261346|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261347|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261348|NCT03013322|Miotics|miotics|mesh-ancestor
92261349|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
92261350|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261351|NCT02469597|Furosemide|furosemide|mesh-list
92261352|NCT02469597|Diuretics|diuretics|mesh-ancestor
92261353|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
92261354|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261355|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92261356|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92261357|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261358|NCT02183792|Furosemide|furosemide|mesh-list
92261359|NCT02183792|Tolvaptan|tolvaptan|mesh-list
92261360|NCT02183792|Diuretics|diuretics|mesh-ancestor
92261361|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
92261362|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261363|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92261364|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92261365|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261366|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92261367|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92261368|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91914253|NCT02428257|Ephedrine|ephedrine|mesh-list
92261369|NCT00363519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261370|NCT00363519|Incretins|incretins|mesh-ancestor
92261371|NCT00363519|Hormones|hormones|mesh-ancestor
92261372|NCT00363519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261373|NCT00363519|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92261374|NCT00363519|Protease Inhibitors|protease inhibitors|mesh-ancestor
92261375|NCT00363519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261376|NCT00363519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261377|NCT04743687|Zanubrutinib|zanubrutinib|mesh-list
92261378|NCT04743687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261379|NCT04743687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92261380|NCT04743687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261381|NCT04743687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261383|NCT02542761|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92261384|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261385|NCT02475837|Vorapaxar|vorapaxar|mesh-list
92261386|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92261387|NCT01124786|Gemcitabine|gemcitabine|mesh-list
92261388|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92261389|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
92261390|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261391|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261392|NCT01125098|Amoxicillin|amoxicillin|mesh-list
92261393|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
92261394|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92261395|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261396|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261397|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92261399|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261400|NCT02478489|Naltrexone|naltrexone|mesh-list
92261401|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92261402|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92261403|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261404|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
92261405|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261406|NCT02322320|Lenalidomide|lenalidomide|mesh-list
92261407|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
92261408|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261409|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92261410|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92261411|NCT02322320|Growth Substances|growth substances|mesh-ancestor
92261412|NCT02322320|Growth Inhibitors|growth inhibitors|mesh-ancestor
92261413|NCT02322320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261414|NCT05308160|Dapagliflozin|dapagliflozin|mesh-list
92261415|NCT05308160|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92261416|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261417|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92261418|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261419|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
92261420|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261421|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261422|NCT01127438|Fospropofol|fospropofol|mesh-list
92261423|NCT01127438|Propofol|propofol|mesh-list
92261424|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92261425|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261426|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261427|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92261428|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
92261429|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
92261430|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
92261431|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92261432|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261433|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261434|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92261435|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92261436|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261437|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261438|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261439|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92261440|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
92261441|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92261442|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261443|NCT05307614|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92261444|NCT05307614|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92261445|NCT05307614|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92261447|NCT02481219|Erythromycin Estolate|erythromycin estolate|mesh-list
92261448|NCT02481219|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92261449|NCT02481219|Erythromycin stearate|erythromycin stearate|mesh-list
92261450|NCT02481219|Metoclopramide|metoclopramide|mesh-list
92261452|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92261453|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
92261454|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
92261455|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261456|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261457|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261458|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92261459|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92261460|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
92261461|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261462|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261463|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261464|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261465|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92261466|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261467|NCT02481219|Cathartics|cathartics|mesh-ancestor
92261468|NCT02481219|Laxatives|laxatives|mesh-ancestor
92261469|NCT02481297|Rituximab|rituximab|mesh-list
92261470|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261471|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261472|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
92261473|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261474|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261475|NCT02481375|Iron|iron|mesh-list
92261476|NCT02481375|Trace Elements|trace elements|mesh-list
92261477|NCT02481375|Micronutrients|micronutrients|mesh-list
92261478|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261479|NCT01164098|Rituximab|rituximab|mesh-list
92261480|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261481|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261482|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
92261483|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261484|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261485|NCT01165112|Rituximab|rituximab|mesh-list
92261486|NCT01165112|Carboplatin|carboplatin|mesh-list
92261487|NCT01165112|Etoposide|etoposide|mesh-list
92261488|NCT01165112|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92261489|NCT01165112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261490|NCT01165112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261491|NCT01165112|Immunologic Factors|immunologic factors|mesh-ancestor
92261492|NCT01165112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261493|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261494|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92261495|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92261496|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92261497|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261498|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261499|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92261500|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
92261501|NCT01129778|Omeprazole|omeprazole|mesh-list
92261502|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92261503|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92261504|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92261505|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261506|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261507|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261508|NCT02556333|Tenofovir|tenofovir|mesh-list
92261509|NCT02556333|Emtricitabine|emtricitabine|mesh-list
92261510|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
92261511|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261512|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92261513|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92261514|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261515|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261516|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91914377|NCT04842968|Methylene Blue|methylene blue|mesh-list
92261517|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92261518|NCT01166126|Sirolimus|sirolimus|mesh-list
92261519|NCT01166126|Temsirolimus|temsirolimus|mesh-list
92261520|NCT01166126|MTOR Inhibitors|mtor inhibitors|mesh-list
92261521|NCT01166126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92261522|NCT01166126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261523|NCT01166126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261524|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261525|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
92261526|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261527|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261528|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261529|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261530|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92261531|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
92261532|NCT05306990|Atorvastatin|atorvastatin|mesh-list
92261533|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92261534|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92261535|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92261536|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
92261537|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261538|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92261539|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92261540|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261541|NCT02557035|Dexamethasone|dexamethasone|mesh-list
92261542|NCT02557035|Palonosetron|palonosetron|mesh-list
92261543|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92261544|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
92261545|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
92261546|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261547|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261548|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261549|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
92261550|NCT02557035|Hormones|hormones|mesh-ancestor
92261551|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261552|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92261553|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261554|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92261555|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92261556|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
92261557|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261558|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261559|NCT04341207|Azithromycin|azithromycin|mesh-list
92261560|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
92261561|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261562|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261563|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
92261564|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92261565|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92261566|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261567|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261568|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261569|NCT02411292|Enoxaparin|enoxaparin|mesh-list
92261570|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
92261571|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92261572|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92261573|NCT02411292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261574|NCT02486211|Amantadine|amantadine|mesh-list
92261575|NCT02486211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92261576|NCT02486211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92261577|NCT02486211|Antiviral Agents|antiviral agents|mesh-ancestor
92261578|NCT02486211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261579|NCT02486211|Dopamine Agents|dopamine agents|mesh-ancestor
92261580|NCT02486211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261581|NCT02486211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261582|NCT02486211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261583|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92261584|NCT02486211|Analgesics|analgesics|mesh-ancestor
92261585|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
92261586|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261587|NCT01167452|Trimethoprim|trimethoprim|mesh-list
92261588|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92261589|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
92261590|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92261591|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261592|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
92261593|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92261594|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92261595|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92261596|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261597|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261598|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92261599|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92261600|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92261601|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261602|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
92261603|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92261604|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261605|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261606|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92261607|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92261608|NCT02487225|Protective Agents|protective agents|mesh-ancestor
92261609|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261610|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
92261611|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92261612|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
92261613|NCT02384850|Leucovorin|leucovorin|mesh-list
92261614|NCT02384850|Folic Acid|folic acid|mesh-list
92261615|NCT02384850|Fluorouracil|fluorouracil|mesh-list
92261616|NCT02384850|Oxaliplatin|oxaliplatin|mesh-list
92261617|NCT02384850|Levoleucovorin|levoleucovorin|mesh-list
92261618|NCT02384850|Antimetabolites|antimetabolites|mesh-ancestor
92261619|NCT02384850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261620|NCT02384850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92261621|NCT02384850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261622|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261623|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
92261624|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261625|NCT02384850|Antidotes|antidotes|mesh-ancestor
92261626|NCT02384850|Protective Agents|protective agents|mesh-ancestor
92261627|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
92261628|NCT02384850|Vitamins|vitamins|mesh-ancestor
92261629|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
92261630|NCT02384850|Hematinics|hematinics|mesh-ancestor
92261631|NCT02558829|Insulin|insulin|mesh-list
92261632|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92261633|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92261634|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261635|NCT02487303|Acetaminophen|acetaminophen|mesh-list
92261636|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92261637|NCT02487303|Analgesics|analgesics|mesh-ancestor
92261638|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
92261639|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261640|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261641|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
92261642|NCT01168934|Crizotinib|crizotinib|mesh-list
92261643|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261644|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92261645|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261646|NCT01168934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261647|NCT05305508|Mannitol|mannitol|mesh-list
92261648|NCT05305508|Calcium Dobesilate|calcium dobesilate|mesh-list
92261649|NCT05305508|Calcium|calcium|mesh-list
92261650|NCT05305508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92261651|NCT05305508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261652|NCT05305508|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92261653|NCT05305508|Diuretics|diuretics|mesh-ancestor
92261654|NCT05305508|Natriuretic Agents|natriuretic agents|mesh-ancestor
92261655|NCT05305508|Hemostatics|hemostatics|mesh-ancestor
92261656|NCT05305508|Coagulants|coagulants|mesh-ancestor
92261657|NCT01170884|Timolol|timolol|mesh-list
92261658|NCT01170884|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92261659|NCT01170884|Bimatoprost|bimatoprost|mesh-list
92261660|NCT01170884|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92261661|NCT01170884|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92261662|NCT01170884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261663|NCT01170884|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92261664|NCT01170884|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92261665|NCT01170884|Adrenergic Agents|adrenergic agents|mesh-ancestor
92261666|NCT01170884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261667|NCT01170884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261668|NCT01170884|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92261669|NCT01170884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92261670|NCT01170884|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92261671|NCT01170884|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92261672|NCT01170884|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92261673|NCT01171118|Physostigmine|physostigmine|mesh-list
92261674|NCT01171118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92261675|NCT01171118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261676|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261677|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
92261678|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261679|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261681|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
92261682|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261683|NCT03011918|Vitamin D|vitamin d|mesh-list
92261684|NCT03011918|Vitamins|vitamins|mesh-ancestor
92261685|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
92261686|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261687|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92261688|NCT05296460|Dapsone|dapsone|mesh-list
92261689|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261690|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
92261691|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92261692|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92261693|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92261694|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261695|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261696|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
92261697|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261699|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92261700|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261701|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92261702|NCT01136798|Incretins|incretins|mesh-ancestor
92261703|NCT01136798|Hormones|hormones|mesh-ancestor
92261704|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261705|NCT01172522|Fexofenadine|fexofenadine|mesh-list
92261706|NCT01172522|Terfenadine|terfenadine|mesh-list
92261707|NCT01172522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92261708|NCT01172522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92261709|NCT01172522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92261710|NCT01172522|Histamine Antagonists|histamine antagonists|mesh-ancestor
92261711|NCT01172522|Histamine Agents|histamine agents|mesh-ancestor
92261712|NCT01172522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261713|NCT01172522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261714|NCT01172522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261715|NCT01172600|Nitrous Oxide|nitrous oxide|mesh-list
92261716|NCT01172600|Entonox|entonox|mesh-list
92261717|NCT01172600|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92261718|NCT01172600|Anesthetics, General|anesthetics, general|mesh-ancestor
92261719|NCT01172600|Anesthetics|anesthetics|mesh-ancestor
92261720|NCT01172600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261721|NCT01172600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261722|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92261723|NCT01172600|Analgesics|analgesics|mesh-ancestor
92261724|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
92261725|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261726|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92261727|NCT02246816|Opium|opium|mesh-list
92261728|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92343350|NCT00004733|Levodopa|levodopa|mesh-list
92261729|NCT02246816|Narcotics|narcotics|mesh-ancestor
92261730|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261731|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261732|NCT02246816|Analgesics|analgesics|mesh-ancestor
92261733|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
92261734|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261735|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
92261736|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261737|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
92261738|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
92261739|NCT01137890|Zonisamide|zonisamide|mesh-list
92261740|NCT01137890|Cocaine|cocaine|mesh-list
92261741|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
92261742|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92261743|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92261744|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914605|NCT02426697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92261745|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92261746|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261747|NCT01137890|Anesthetics, Local|anesthetics, local|mesh-ancestor
92261748|NCT01137890|Anesthetics|anesthetics|mesh-ancestor
92261749|NCT01137890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261750|NCT01137890|Sensory System Agents|sensory system agents|mesh-ancestor
92261751|NCT01137890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261752|NCT01137890|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92261753|NCT01137890|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92261754|NCT01137890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92261755|NCT01137890|Dopamine Agents|dopamine agents|mesh-ancestor
92261756|NCT01137890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261757|NCT01138124|Gabapentin|gabapentin|mesh-list
92261758|NCT01138124|Analgesics|analgesics|mesh-ancestor
92261759|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
92261760|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261761|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261762|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
92261763|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92261764|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92261765|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261766|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92261767|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92261768|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92261769|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261770|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261771|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
92261772|NCT02560779|Sorafenib|sorafenib|mesh-list
92261773|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261774|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92261775|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261776|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261777|NCT01138514|Clindamycin|clindamycin|mesh-list
92261778|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
92261779|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
92261780|NCT01138514|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92261781|NCT01138514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261782|NCT01138514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261783|NCT01138514|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92261784|NCT01138514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261785|NCT01138514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343362|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
92261786|NCT01138514|Dermatologic Agents|dermatologic agents|mesh-ancestor
92261788|NCT02561481|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92261789|NCT02561481|Protective Agents|protective agents|mesh-ancestor
92261790|NCT02561481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261791|NCT02561481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261792|NCT01173848|Cholecalciferol|cholecalciferol|mesh-list
92261793|NCT01173848|Vitamin D|vitamin d|mesh-list
92261794|NCT01173848|Ergocalciferols|ergocalciferols|mesh-list
92261795|NCT01173848|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92261796|NCT01173848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261797|NCT01173848|Vitamins|vitamins|mesh-ancestor
92261798|NCT01173848|Micronutrients|micronutrients|mesh-ancestor
92261799|NCT01173848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92261800|NCT01174082|Vaccines|vaccines|mesh-list
92261801|NCT01174082|Sargramostim|sargramostim|mesh-list
92261802|NCT01174082|Immunologic Factors|immunologic factors|mesh-ancestor
92261803|NCT01174082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261804|NCT01175798|Vitamin D|vitamin d|mesh-list
92261805|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
92261806|NCT01175798|Vitamins|vitamins|mesh-ancestor
92261807|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
92261808|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261809|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92261810|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92261811|NCT02246894|Factor VIII|factor viii|mesh-list
92261812|NCT02246894|Coagulants|coagulants|mesh-ancestor
92261813|NCT05177510|Mifepristone|mifepristone|mesh-list
92261814|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92261815|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
92261816|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92261817|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261818|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92261819|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92261820|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92261821|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
92261822|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92261823|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92261824|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
92261825|NCT05177510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261826|NCT05177510|Luteolytic Agents|luteolytic agents|mesh-ancestor
92261827|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92261828|NCT05177510|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92261829|NCT03011996|Amoxicillin|amoxicillin|mesh-list
92261830|NCT03011996|Clarithromycin|clarithromycin|mesh-list
92261831|NCT03011996|Pantoprazole|pantoprazole|mesh-list
92261832|NCT03011996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92261833|NCT03011996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261834|NCT03011996|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92261835|NCT03011996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117780|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261836|NCT03011996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261837|NCT03011996|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92261838|NCT03011996|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92261839|NCT03011996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92261840|NCT03011996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261841|NCT03011996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92261842|NCT01178216|Rituximab|rituximab|mesh-list
92261843|NCT01178216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261844|NCT01178216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261845|NCT01178216|Immunologic Factors|immunologic factors|mesh-ancestor
92343383|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
92261846|NCT01178216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261848|NCT01178528|Carvedilol|carvedilol|mesh-list
92261849|NCT01178528|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92261850|NCT01178528|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92261851|NCT01178528|Adrenergic Agents|adrenergic agents|mesh-ancestor
92261852|NCT01178528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261853|NCT01178528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261854|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261855|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92261856|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
92261857|NCT01178528|Protective Agents|protective agents|mesh-ancestor
92261858|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92261859|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92261860|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92261861|NCT01178528|Vasodilator Agents|vasodilator agents|mesh-ancestor
92261862|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92261863|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92261864|NCT02980250|Domperidone|domperidone|mesh-list
92261865|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
92261866|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
92261867|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261868|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261869|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261870|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92261871|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
92261872|NCT02980250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261873|NCT02980250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261874|NCT02491437|Progesterone|progesterone|mesh-list
92261875|NCT02491437|Dydrogesterone|dydrogesterone|mesh-list
92261876|NCT02491437|Progestins|progestins|mesh-ancestor
92261877|NCT02491437|Hormones|hormones|mesh-ancestor
92261878|NCT02491437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261879|NCT02491437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261880|NCT02383758|Bisacodyl|bisacodyl|mesh-list
92261881|NCT02383758|Glycerol|glycerol|mesh-list
92261882|NCT02383758|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92261883|NCT02383758|Protective Agents|protective agents|mesh-ancestor
92261884|NCT02383758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261885|NCT02383758|Cathartics|cathartics|mesh-ancestor
92261886|NCT02383758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261887|NCT02383758|Laxatives|laxatives|mesh-ancestor
92261888|NCT02492451|Progesterone|progesterone|mesh-list
92261889|NCT02492451|Progestins|progestins|mesh-ancestor
92261890|NCT02492451|Hormones|hormones|mesh-ancestor
92261891|NCT02492451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261892|NCT02492451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261893|NCT02410278|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92261894|NCT02410278|Montelukast|montelukast|mesh-list
92261895|NCT02410278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92261896|NCT02410278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92261897|NCT02410278|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92261898|NCT02410278|Hormone Antagonists|hormone antagonists|mesh-ancestor
92261899|NCT02410278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261900|NCT02410278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261901|NCT02410278|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92261902|NCT02410278|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92261903|NCT02410278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261904|NCT02410278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92261905|NCT02410278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261906|NCT02410278|Immunologic Factors|immunologic factors|mesh-ancestor
92261907|NCT01181258|Methylprednisolone|methylprednisolone|mesh-list
92261908|NCT01181258|Cyclophosphamide|cyclophosphamide|mesh-list
92261909|NCT01181258|Rituximab|rituximab|mesh-list
92261910|NCT01181258|Fludarabine|fludarabine|mesh-list
92261911|NCT01181258|Interleukin-2|interleukin-2|mesh-list
92261912|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261913|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
92261914|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261915|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92261916|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92261917|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
92261918|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261919|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261920|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92261921|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92261922|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92261924|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
92261925|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261926|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92261927|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
92261928|NCT01181258|Hormones|hormones|mesh-ancestor
92261929|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261930|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92261931|NCT01181258|Protective Agents|protective agents|mesh-ancestor
92261932|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92261933|NCT01181258|Analgesics|analgesics|mesh-ancestor
92261934|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
92261935|NCT02570139|Protective Agents|protective agents|mesh-list
92261936|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261937|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92261938|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
92261939|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92261940|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
92261941|NCT02410200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261942|NCT02409732|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92261943|NCT02409732|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92261944|NCT02409732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92261945|NCT02494713|Ketoconazole|ketoconazole|mesh-list
92261946|NCT02494713|Docetaxel|docetaxel|mesh-list
92261947|NCT02494713|Doxorubicin|doxorubicin|mesh-list
92261948|NCT02494713|Estramustine|estramustine|mesh-list
92261949|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261950|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
92261951|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
92261952|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
92261953|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261954|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92261955|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92261956|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92261957|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92261958|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
92261959|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92261960|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92261961|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92261962|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92261963|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
92261964|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92261965|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261966|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92261967|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92261968|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
92261969|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92261970|NCT02495103|Metformin|metformin|mesh-list
92261972|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261973|NCT02382276|Nalmefene|nalmefene|mesh-list
92261974|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92261975|NCT02382276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261976|NCT02382276|Sensory System Agents|sensory system agents|mesh-ancestor
92261977|NCT02382276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261978|NCT02571153|Ketamine|ketamine|mesh-list
92261979|NCT02571153|Analgesics|analgesics|mesh-ancestor
92261980|NCT02571153|Sensory System Agents|sensory system agents|mesh-ancestor
92261981|NCT02571153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92261982|NCT02571153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261983|NCT02571153|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92261984|NCT02571153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92261985|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
92261986|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
92261987|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92261988|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92261989|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92261990|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92261991|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261992|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92261993|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
92261994|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92261995|NCT04573322|Protective Agents|protective agents|mesh-ancestor
92261996|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92261997|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92261998|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92261999|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
92262000|NCT01143818|Testosterone|testosterone|mesh-list
92262001|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
92262002|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
92262003|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92262004|NCT01143818|Androgens|androgens|mesh-ancestor
92262005|NCT01143818|Hormones|hormones|mesh-ancestor
92262006|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262007|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262008|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262010|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
92262011|NCT02573181|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92262012|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
92262013|NCT02573181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262014|NCT02498769|Botulinum Toxins|botulinum toxins|mesh-list
92262015|NCT02498769|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92262016|NCT02498769|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92262017|NCT02498769|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92262018|NCT02498769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262019|NCT02498769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262020|NCT02498769|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262021|NCT02498769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262022|NCT02498769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262023|NCT02498769|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92262024|NCT02498769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262025|NCT01650558|Chloroquine|chloroquine|mesh-list
92262026|NCT01650558|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92262027|NCT01650558|Amebicides|amebicides|mesh-ancestor
92262028|NCT01650558|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92262029|NCT01650558|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92262030|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262031|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
92262032|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262033|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92262034|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262035|NCT02579343|Dexetimide|dexetimide|mesh-list
92262036|NCT02579343|Citalopram|citalopram|mesh-list
92262037|NCT02579343|Escitalopram|escitalopram|mesh-list
92262038|NCT02579343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92262039|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92262040|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262041|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262042|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262043|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
92262044|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262045|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92262046|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92262047|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
92262048|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
92262049|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262050|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92262051|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92262052|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262053|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92262054|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
92262055|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262056|NCT01144442|Paclitaxel|paclitaxel|mesh-list
92262057|NCT01144442|Carboplatin|carboplatin|mesh-list
92262058|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92262059|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262060|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
92262061|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
92262062|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
92262063|NCT01144442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262064|NCT02499081|Ixazomib|ixazomib|mesh-list
92262066|NCT02499081|Protease Inhibitors|protease inhibitors|mesh-ancestor
92262067|NCT02499081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262068|NCT02499081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262069|NCT02380248|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92262070|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92262071|NCT02501265|Nicotine|nicotine|mesh-list
92262072|NCT02501265|Varenicline|varenicline|mesh-list
92262073|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92262074|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
92262075|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262076|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262077|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92262078|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92262079|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262080|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262081|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262082|NCT02408016|Aldesleukin|aldesleukin|mesh-list
92262083|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
92262084|NCT02408016|Interleukin-2|interleukin-2|mesh-list
92262085|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262086|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
92262087|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262088|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262089|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262090|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
92262091|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262092|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262093|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92262094|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92262095|NCT02408016|Analgesics|analgesics|mesh-ancestor
92262096|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
92262097|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262098|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92262099|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92262100|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
92262101|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262102|NCT02579421|Progesterone|progesterone|mesh-list
92262103|NCT02579421|Progestins|progestins|mesh-ancestor
92262104|NCT02579421|Hormones|hormones|mesh-ancestor
92262105|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262106|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262107|NCT00422175|Siponimod|siponimod|mesh-list
92262108|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92262109|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262110|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262111|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
92262112|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262113|NCT01186250|Pioglitazone|pioglitazone|mesh-list
92262114|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92262115|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262116|NCT01186406|Bevacizumab|bevacizumab|mesh-list
92262117|NCT01186406|Temozolomide|temozolomide|mesh-list
92262118|NCT01186406|Carmustine|carmustine|mesh-list
92262119|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262120|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262121|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92262122|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92262123|NCT01186406|Growth Substances|growth substances|mesh-ancestor
92262124|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262125|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
92262126|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262127|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
92262128|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262129|NCT02407704|Lorazepam|lorazepam|mesh-list
92262130|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92262131|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92262132|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92262133|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262134|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262135|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262136|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262137|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92262138|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
92262139|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262140|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
92262141|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
92262142|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
92262143|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262144|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262145|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92262146|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262147|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92262148|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92262149|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
92262150|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
92262151|NCT02581839|Dexamethasone|dexamethasone|mesh-list
92262152|NCT02581839|Dexamethasone acetate|dexamethasone acetate|mesh-list
92262153|NCT02581839|Ondansetron|ondansetron|mesh-list
92262154|NCT02581839|BB 1101|bb 1101|mesh-list
92262155|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262156|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
92262157|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
92262158|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262159|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262160|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262161|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
92262162|NCT02581839|Hormones|hormones|mesh-ancestor
92262163|NCT02581839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262164|NCT02581839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262165|NCT02581839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262166|NCT02581839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92262167|NCT02581839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262168|NCT02581839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262169|NCT02581839|Antipruritics|antipruritics|mesh-ancestor
92262170|NCT02581839|Dermatologic Agents|dermatologic agents|mesh-ancestor
92262171|NCT02581839|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92262172|NCT02581839|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92262173|NCT02581839|Serotonin Agents|serotonin agents|mesh-ancestor
92262174|NCT02581839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262175|NCT02504775|Acetaminophen|acetaminophen|mesh-list
92262176|NCT02504775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92262177|NCT02504775|Analgesics|analgesics|mesh-ancestor
92262178|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
92262179|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262180|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262181|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
92262182|NCT02504931|Sertraline|sertraline|mesh-list
92262183|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
92262184|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262185|NCT02504931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92262186|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92262187|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262188|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262189|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262190|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
92262191|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262193|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92262194|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92262195|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262196|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
92262197|NCT02584725|Coagulants|coagulants|mesh-ancestor
92262198|NCT04423029|Nivolumab|nivolumab|mesh-list
92262199|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262200|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262201|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92262202|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262203|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92262204|NCT01186562|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92262205|NCT01186562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262207|NCT01186562|Hormones|hormones|mesh-ancestor
92262208|NCT01186562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262209|NCT01186562|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92262210|NCT01186562|Protease Inhibitors|protease inhibitors|mesh-ancestor
92262211|NCT01186562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925846|NCT04620135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92262212|NCT01186562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262213|NCT01187498|Oxybutynin|oxybutynin|mesh-list
92262214|NCT01187498|Parasympatholytics|parasympatholytics|mesh-ancestor
92262215|NCT01187498|Autonomic Agents|autonomic agents|mesh-ancestor
92262216|NCT01187498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262217|NCT01187498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262218|NCT01187498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92262219|NCT01187498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92262220|NCT01187498|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262221|NCT01187498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262222|NCT01187498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262223|NCT01187498|Urological Agents|urological agents|mesh-ancestor
92262224|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92262225|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
92262226|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92262227|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92262228|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92262229|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
92262230|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262231|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262232|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92262233|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92262234|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92262235|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262236|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262237|NCT01149434|Everolimus|everolimus|mesh-list
92262238|NCT01149434|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92262239|NCT01149434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262240|NCT01149434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262241|NCT01149434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262242|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262243|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
92262244|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262245|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262246|NCT01150760|Alvimopan|alvimopan|mesh-list
92262247|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262248|NCT01150838|Propofol|propofol|mesh-list
92262249|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92262250|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262251|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262252|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92262253|NCT01150838|Anesthetics, General|anesthetics, general|mesh-ancestor
92262254|NCT01150838|Anesthetics|anesthetics|mesh-ancestor
92262255|NCT01189292|Dexamethasone|dexamethasone|mesh-list
92262256|NCT01189292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262257|NCT01189292|Antiemetics|antiemetics|mesh-ancestor
92262258|NCT01189292|Autonomic Agents|autonomic agents|mesh-ancestor
92262259|NCT01189292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262260|NCT01189292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262262|NCT01189292|Glucocorticoids|glucocorticoids|mesh-ancestor
92262263|NCT01189292|Hormones|hormones|mesh-ancestor
92262264|NCT01189292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262265|NCT01189292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262266|NCT01189292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262267|NCT01189370|Sorafenib|sorafenib|mesh-list
92262268|NCT01189370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262269|NCT01189370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262270|NCT01189370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262271|NCT01189370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262272|NCT01189760|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92262273|NCT01189760|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92262274|NCT01189760|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92262275|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262276|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262277|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92262278|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262279|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262280|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262281|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262282|NCT03010202|Dexamethasone|dexamethasone|mesh-list
92262283|NCT03010202|Rituximab|rituximab|mesh-list
92262284|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262286|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
92262287|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262288|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262289|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262290|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
92262291|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
92262292|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262293|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262294|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
92262295|NCT03010202|Hormones|hormones|mesh-ancestor
92262296|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262297|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262298|NCT01191320|Enclomiphene|enclomiphene|mesh-list
92262299|NCT01191320|Clomiphene|clomiphene|mesh-list
92262300|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
92262301|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92262302|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
92262303|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262304|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262305|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92262306|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
92262307|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262308|NCT01191320|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92262309|NCT01191320|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92262310|NCT01151852|Imatinib Mesylate|imatinib mesylate|mesh-list
92262311|NCT01151852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262312|NCT01151852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262313|NCT01151852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262314|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262315|NCT01191398|Atropine|atropine|mesh-list
92262316|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
92262317|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92262318|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92262319|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92262320|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
92262321|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262322|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262323|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92262324|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
92262325|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
92262326|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
92262327|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92262328|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92262329|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262330|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262331|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262332|NCT01191476|Propofol|propofol|mesh-list
92262333|NCT01191476|Sevoflurane|sevoflurane|mesh-list
92262334|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92262335|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262336|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262337|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92262338|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
92262339|NCT01191476|Anesthetics|anesthetics|mesh-ancestor
92262340|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92262341|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92262342|NCT02508207|Ivacaftor|ivacaftor|mesh-list
92262343|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92262344|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262345|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262346|NCT02509065|Pancrelipase|pancrelipase|mesh-list
92262347|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262348|NCT01194674|Plasminogen|plasminogen|mesh-list
92262349|NCT01194674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92262350|NCT01194674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92262351|NCT01194674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262352|NCT02509767|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92262353|NCT02509767|Medroxyprogesterone|medroxyprogesterone|mesh-list
92262354|NCT02509767|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92262355|NCT02509767|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92262356|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92262357|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
92262358|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262359|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262360|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92262361|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92262362|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92262363|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262364|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262365|NCT01154192|Dexamethasone|dexamethasone|mesh-list
92262366|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92262367|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262368|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
92262369|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
92262370|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262371|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262372|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262373|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
92262374|NCT01154192|Hormones|hormones|mesh-ancestor
92262375|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262376|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262377|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262378|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262379|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
92262380|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262381|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262382|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92262383|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262384|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262385|NCT02511561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262386|NCT02511561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262387|NCT02511561|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92262388|NCT02511561|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92262389|NCT01195922|Sirolimus|sirolimus|mesh-list
92262390|NCT01195922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262391|NCT01195922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262392|NCT01195922|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92262393|NCT01195922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262394|NCT01195922|Antifungal Agents|antifungal agents|mesh-ancestor
92262395|NCT01195922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262396|NCT01195922|Immunologic Factors|immunologic factors|mesh-ancestor
92262397|NCT01195922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262398|NCT02512575|Prednisolone|prednisolone|mesh-list
92262399|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262400|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
92262401|NCT02512575|Hormones|hormones|mesh-ancestor
92262402|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262403|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262404|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262405|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343429|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262406|NCT01199744|Zanamivir|zanamivir|mesh-list
92262407|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
92262408|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262409|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262410|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262411|NCT03702374|Antioxidants|antioxidants|mesh-list
92262412|NCT03702374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262413|NCT03702374|Protective Agents|protective agents|mesh-ancestor
92262414|NCT03702374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262415|NCT02512809|Dexmedetomidine|dexmedetomidine|mesh-list
92262416|NCT02512809|Isoflurane|isoflurane|mesh-list
92262417|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92262418|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262419|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262420|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92262421|NCT02512809|Analgesics|analgesics|mesh-ancestor
92262422|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
92262423|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262424|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92262425|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92262426|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92262427|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
92262428|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262429|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262430|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92262431|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
92262432|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
92262433|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92262434|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92262435|NCT01202162|Sevoflurane|sevoflurane|mesh-list
92262436|NCT01202162|Desflurane|desflurane|mesh-list
92262437|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92262438|NCT01202162|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92262439|NCT01202162|Anesthetics, General|anesthetics, general|mesh-ancestor
92262440|NCT01202162|Anesthetics|anesthetics|mesh-ancestor
92262441|NCT01202162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262442|NCT01202162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262443|NCT01159262|Fentanyl|fentanyl|mesh-list
92262444|NCT01159262|Midazolam|midazolam|mesh-list
92262445|NCT01159262|Dexmedetomidine|dexmedetomidine|mesh-list
92262446|NCT01159262|Morphine|morphine|mesh-list
92262447|NCT01159262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92262448|NCT01159262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262449|NCT01159262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262450|NCT01159262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92262451|NCT01159262|Analgesics|analgesics|mesh-ancestor
92262452|NCT01159262|Sensory System Agents|sensory system agents|mesh-ancestor
92262453|NCT01159262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262454|NCT01159262|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92262455|NCT01159262|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92262456|NCT01159262|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92262457|NCT01159262|Adrenergic Agents|adrenergic agents|mesh-ancestor
92262458|NCT01159262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262459|NCT01159262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262460|NCT01159262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92262461|NCT01159262|Narcotics|narcotics|mesh-ancestor
92262462|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92262463|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92262464|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
92262465|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
92262466|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92262467|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92262468|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262469|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
92262470|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
92262471|NCT04378959|Lidocaine|lidocaine|mesh-list
92262472|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
92262473|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
92262474|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262475|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262476|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
92262477|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262478|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92262479|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92343434|NCT00004811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262480|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92262481|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262482|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262483|NCT03011060|Capecitabine|capecitabine|mesh-list
92262484|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92262485|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
92262486|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262487|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262488|NCT03010670|Oxytocin|oxytocin|mesh-list
92262489|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
92262490|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262491|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262492|NCT04377711|Ciclesonide|ciclesonide|mesh-list
92262493|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
92262494|NCT04377711|Hormones|hormones|mesh-ancestor
92262495|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262496|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262497|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92262498|NCT04366713|Capecitabine|capecitabine|mesh-list
92262499|NCT04366713|Loperamide|loperamide|mesh-list
92262500|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
92262501|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92262502|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
92262503|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262504|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262505|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262506|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
91925847|NCT02160275|Insulin|insulin|mesh-list
92262508|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262509|NCT02976441|Temozolomide|temozolomide|mesh-list
92262510|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262511|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
92262512|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262513|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262514|NCT00363753|Aspirin|aspirin|mesh-list
92262515|NCT00363753|Clopidogrel|clopidogrel|mesh-list
92262516|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92262517|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92262518|NCT00363753|Analgesics|analgesics|mesh-ancestor
92262519|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
92262520|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262521|NCT00363753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262522|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262523|NCT00363753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262524|NCT00363753|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92262525|NCT00363753|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92343435|NCT00004811|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92262526|NCT00363753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262527|NCT00363753|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92262528|NCT00363753|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92262529|NCT00363753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262530|NCT00363753|Antipyretics|antipyretics|mesh-ancestor
92262531|NCT00363753|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92262532|NCT00363753|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92262533|NCT00363753|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92262534|NCT00363753|Purinergic Agents|purinergic agents|mesh-ancestor
92262535|NCT00363753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262536|NCT02434770|Vaccines|vaccines|mesh-list
92262537|NCT02434770|Immunologic Factors|immunologic factors|mesh-ancestor
92262538|NCT02434770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262539|NCT01203644|Bupivacaine|bupivacaine|mesh-list
92262540|NCT01203644|Anesthetics, Local|anesthetics, local|mesh-ancestor
92262541|NCT01203644|Anesthetics|anesthetics|mesh-ancestor
92262542|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262543|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262544|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
92262545|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262546|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
92262547|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262548|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
92262549|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92262550|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92262551|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92262552|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92262553|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262554|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262555|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262556|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262557|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92262558|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
92262559|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262560|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92262561|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
92262562|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92262563|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92262564|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92262565|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915431|NCT02123615|Immunoglobulins|immunoglobulins|mesh-list
92262566|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
92262567|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92262568|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262569|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92262570|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262571|NCT00363909|Dexetimide|dexetimide|mesh-list
92262572|NCT00363909|Citalopram|citalopram|mesh-list
92262573|NCT00363909|Escitalopram|escitalopram|mesh-list
92262574|NCT00363909|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92262575|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92262576|NCT00363909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262577|NCT00363909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262578|NCT00363909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262579|NCT00363909|Serotonin Agents|serotonin agents|mesh-ancestor
92262580|NCT00363909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262581|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92262582|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
92262583|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262584|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92262585|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92262586|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
92262587|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
92262588|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262589|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92262590|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92262591|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
92262592|NCT01205828|Temozolomide|temozolomide|mesh-list
92262593|NCT01205828|Veliparib|veliparib|mesh-list
92262594|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262596|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262597|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262598|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92262599|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262600|NCT02515305|Clindamycin|clindamycin|mesh-list
92262601|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
92262602|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
92262603|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92262604|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262605|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262606|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92262607|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262608|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262609|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
92262610|NCT01206452|Prednisone|prednisone|mesh-list
92262611|NCT01206452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262612|NCT01206452|Glucocorticoids|glucocorticoids|mesh-ancestor
92262613|NCT01206452|Hormones|hormones|mesh-ancestor
92262614|NCT01206452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262615|NCT01206452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262616|NCT01206452|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262617|NCT01206452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262618|NCT01206608|Bupivacaine|bupivacaine|mesh-list
92262619|NCT01206608|Anesthetics, Local|anesthetics, local|mesh-ancestor
92262620|NCT01206608|Anesthetics|anesthetics|mesh-ancestor
92262621|NCT01206608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262622|NCT01206608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262623|NCT01206608|Sensory System Agents|sensory system agents|mesh-ancestor
92262624|NCT01206608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262625|NCT03010436|Benralizumab|benralizumab|mesh-list
92262626|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92262627|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
92262628|NCT02432040|Atorvastatin|atorvastatin|mesh-list
92262629|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92262630|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92262631|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
92262632|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262633|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92262634|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92262635|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262636|NCT02517021|Dexamethasone|dexamethasone|mesh-list
92262637|NCT02517021|Palonosetron|palonosetron|mesh-list
92262638|NCT02517021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262639|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
92262640|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
92262641|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262642|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262643|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262644|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
92262645|NCT02517021|Hormones|hormones|mesh-ancestor
92262646|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262647|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262648|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262649|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92262650|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92262651|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
92262652|NCT02517021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925848|NCT02160275|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92262653|NCT02517021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262654|NCT05859269|Methylprednisolone|methylprednisolone|mesh-list
92262655|NCT05859269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92262656|NCT05859269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92262657|NCT05859269|Prednisolone|prednisolone|mesh-list
92262658|NCT05859269|Prednisolone acetate|prednisolone acetate|mesh-list
92262659|NCT05859269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92262660|NCT05859269|Prednisolone phosphate|prednisolone phosphate|mesh-list
92262661|NCT05859269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262662|NCT05859269|Antiemetics|antiemetics|mesh-ancestor
92262663|NCT05859269|Autonomic Agents|autonomic agents|mesh-ancestor
92262664|NCT05859269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262665|NCT05859269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262666|NCT05859269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262668|NCT05859269|Hormones|hormones|mesh-ancestor
92262669|NCT05859269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262670|NCT05859269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92262671|NCT05859269|Protective Agents|protective agents|mesh-ancestor
92262672|NCT05859269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262673|NCT05859269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262674|NCT05859217|Atezolizumab|atezolizumab|mesh-list
92262675|NCT05859217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92262676|NCT05859217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262677|NCT05859217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262678|NCT05859217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262679|NCT05859126|Choline|choline|mesh-list
92262680|NCT05859126|Lipotropic Agents|lipotropic agents|mesh-ancestor
92262681|NCT05859126|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92262682|NCT05859126|Antimetabolites|antimetabolites|mesh-ancestor
92262683|NCT05859126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262684|NCT05859126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262685|NCT05859126|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92262686|NCT05859126|Nootropic Agents|nootropic agents|mesh-ancestor
92262687|NCT05858710|Doxorubicin|doxorubicin|mesh-list
92262688|NCT05858710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92262689|NCT05858710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262690|NCT05858710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92262691|NCT05858710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262692|NCT05858710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262693|NCT05858710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262694|NCT05858671|Fenugreek seed meal|fenugreek seed meal|mesh-list
92262695|NCT05858671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92262696|NCT05858671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262697|NCT05858645|Deucravacitinib|deucravacitinib|mesh-list
92262698|NCT05858645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92262699|NCT05858645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262700|NCT05858645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262701|NCT05858645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262702|NCT05858216|Chlorpheniramine|chlorpheniramine|mesh-list
92262703|NCT05858216|Antipruritics|antipruritics|mesh-ancestor
92262704|NCT05858216|Dermatologic Agents|dermatologic agents|mesh-ancestor
92262705|NCT05858216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92262706|NCT05858216|Histamine Antagonists|histamine antagonists|mesh-ancestor
92262707|NCT05858216|Histamine Agents|histamine agents|mesh-ancestor
92262708|NCT05858216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262709|NCT05858216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262710|NCT05858216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262711|NCT05858216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92262712|NCT05858177|Temozolomide|temozolomide|mesh-list
92262713|NCT05858177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262714|NCT05858177|Alkylating Agents|alkylating agents|mesh-ancestor
92262715|NCT05858177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262716|NCT05858177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262717|NCT05857982|Dexamethasone|dexamethasone|mesh-list
92262718|NCT05857982|Mitoxantrone|mitoxantrone|mesh-list
92262719|NCT05857982|Daratumumab|daratumumab|mesh-list
92262720|NCT05857982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262721|NCT05857982|Antiemetics|antiemetics|mesh-ancestor
92262722|NCT05857982|Autonomic Agents|autonomic agents|mesh-ancestor
92262723|NCT05857982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262724|NCT05857982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935054|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262725|NCT05857982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262728|NCT05857982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262729|NCT05857982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92262730|NCT05857982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262731|NCT05857982|Analgesics|analgesics|mesh-ancestor
92262732|NCT05857982|Sensory System Agents|sensory system agents|mesh-ancestor
92262733|NCT05857982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92262734|NCT05857982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262735|NCT05857982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262736|NCT05857982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262737|NCT05857891|Epoetin Alfa|epoetin alfa|mesh-list
92262738|NCT05857891|Hematinics|hematinics|mesh-ancestor
92262739|NCT05857748|Lifitegrast|lifitegrast|mesh-list
92262740|NCT05857748|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92262741|NCT05857748|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92262742|NCT05844618|Triamcinolone|triamcinolone|mesh-list
92262743|NCT05844618|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92262744|NCT05844618|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92262745|NCT05844618|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92262746|NCT05844618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92262747|NCT05844618|Glucocorticoids|glucocorticoids|mesh-ancestor
92262748|NCT05844618|Hormones|hormones|mesh-ancestor
92262749|NCT05844618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262750|NCT05844618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262751|NCT05844618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262752|NCT05844618|Immunologic Factors|immunologic factors|mesh-ancestor
92262753|NCT05844618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262754|NCT05844618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262755|NCT05836025|Sirolimus|sirolimus|mesh-list
92262756|NCT05836025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262757|NCT05836025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262758|NCT05836025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92262759|NCT05836025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262760|NCT05836025|Antifungal Agents|antifungal agents|mesh-ancestor
92262761|NCT05836025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262762|NCT05836025|Immunologic Factors|immunologic factors|mesh-ancestor
92262763|NCT05836025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262764|NCT05819853|Metformin|metformin|mesh-list
92262765|NCT05819853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92262766|NCT05819853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262767|NCT05796752|Memantine|memantine|mesh-list
92262768|NCT05796752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92262769|NCT05796752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92262770|NCT05796752|Dopamine Agents|dopamine agents|mesh-ancestor
92262771|NCT05796752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262772|NCT05796752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262773|NCT05796752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262774|NCT05796752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92262775|NCT05796752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92262776|NCT05794971|Irinotecan|irinotecan|mesh-list
92262777|NCT05794971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92262778|NCT05794971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262779|NCT05794971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262780|NCT05794971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262781|NCT05794971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262782|NCT05785195|Nitric Oxide|nitric oxide|mesh-list
92262783|NCT05785195|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92262784|NCT05785195|Autonomic Agents|autonomic agents|mesh-ancestor
92262785|NCT05785195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262786|NCT05785195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262787|NCT05785195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92262788|NCT05785195|Respiratory System Agents|respiratory system agents|mesh-ancestor
92262789|NCT05785195|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92262791|NCT05785195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262792|NCT05785195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262793|NCT05785195|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92262794|NCT05785195|Vasodilator Agents|vasodilator agents|mesh-ancestor
92262795|NCT05785195|Gasotransmitters|gasotransmitters|mesh-ancestor
92262796|NCT05785195|Protective Agents|protective agents|mesh-ancestor
92262797|NCT05735717|Rituximab|rituximab|mesh-list
92262798|NCT05735717|Fludarabine|fludarabine|mesh-list
92262799|NCT05735717|Melphalan|melphalan|mesh-list
92262800|NCT05735717|Busulfan|busulfan|mesh-list
92262801|NCT05735717|Levetiracetam|levetiracetam|mesh-list
92262802|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262803|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262804|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
92262805|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262806|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262807|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262808|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262809|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262810|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
92262811|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92262812|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
92262813|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
92262814|NCT05729282|Diazoxide|diazoxide|mesh-list
92262815|NCT05729282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92262816|NCT05729282|Vasodilator Agents|vasodilator agents|mesh-ancestor
92262817|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92262818|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
92262819|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262820|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262821|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92262822|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
92262823|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262824|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262825|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92262826|NCT05693675|Methadone|methadone|mesh-list
92262827|NCT05693675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92262828|NCT05693675|Narcotics|narcotics|mesh-ancestor
92262829|NCT05693675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262830|NCT05693675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262831|NCT05693675|Analgesics|analgesics|mesh-ancestor
92262832|NCT05693675|Sensory System Agents|sensory system agents|mesh-ancestor
92262833|NCT05693675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262834|NCT05693675|Antitussive Agents|antitussive agents|mesh-ancestor
92262835|NCT05693675|Respiratory System Agents|respiratory system agents|mesh-ancestor
92262836|NCT05655273|Tacrolimus|tacrolimus|mesh-list
92262837|NCT05655273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262838|NCT05655273|Immunologic Factors|immunologic factors|mesh-ancestor
92262839|NCT05655273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262840|NCT05655273|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92262841|NCT05655273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262842|NCT05655273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262843|NCT05642078|Vaccines|vaccines|mesh-list
92262844|NCT05642078|Immunologic Factors|immunologic factors|mesh-ancestor
92262845|NCT05642078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262846|NCT05624151|Magnesium Sulfate|magnesium sulfate|mesh-list
92262847|NCT05624151|Dexmedetomidine|dexmedetomidine|mesh-list
92262848|NCT05624151|Bupivacaine|bupivacaine|mesh-list
92262849|NCT05624151|Anesthetics, Local|anesthetics, local|mesh-ancestor
92262850|NCT05624151|Anesthetics|anesthetics|mesh-ancestor
92262851|NCT05624151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262852|NCT05624151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262853|NCT05624151|Sensory System Agents|sensory system agents|mesh-ancestor
92262854|NCT05624151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262855|NCT05624151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92262856|NCT05624151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92262857|NCT05624151|Analgesics|analgesics|mesh-ancestor
92262858|NCT05624151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92262859|NCT05624151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92262860|NCT05624151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92262861|NCT05624151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92262862|NCT05624151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262863|NCT05624151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262864|NCT05624151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92262865|NCT05624151|Anticonvulsants|anticonvulsants|mesh-ancestor
92262867|NCT05624151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92262868|NCT05624151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92262869|NCT05624151|Tocolytic Agents|tocolytic agents|mesh-ancestor
92262870|NCT05624151|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262871|NCT05620914|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92262872|NCT05620914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262873|NCT05620914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262874|NCT05588609|Abiraterone Acetate|abiraterone acetate|mesh-list
92262875|NCT05588609|Afatinib|afatinib|mesh-list
92262876|NCT05588609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262877|NCT05588609|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92262878|NCT05588609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262879|NCT05588609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262880|NCT05588609|Hormone Antagonists|hormone antagonists|mesh-ancestor
92117781|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262881|NCT05588609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92262882|NCT05588609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262883|NCT05588609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92262884|NCT05588609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262885|NCT05584007|Floxacillin|floxacillin|mesh-list
92262886|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262888|NCT05570292|Folic Acid|folic acid|mesh-list
92262889|NCT05570292|Domperidone|domperidone|mesh-list
92262890|NCT05570292|Hematinics|hematinics|mesh-ancestor
92262891|NCT05570292|Vitamin B Complex|vitamin b complex|mesh-ancestor
92262892|NCT05570292|Vitamins|vitamins|mesh-ancestor
92262893|NCT05570292|Micronutrients|micronutrients|mesh-ancestor
92262894|NCT05570292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262895|NCT05570292|Antiemetics|antiemetics|mesh-ancestor
92262896|NCT05570292|Autonomic Agents|autonomic agents|mesh-ancestor
92262897|NCT05570292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92262898|NCT05570292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92262899|NCT05570292|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92262900|NCT05570292|Dopamine Agents|dopamine agents|mesh-ancestor
92262901|NCT05570292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262902|NCT05570292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262903|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
92262904|NCT05554939|Mechlorethamine|mechlorethamine|mesh-list
92262905|NCT05554939|Doxorubicin|doxorubicin|mesh-list
92262906|NCT05554939|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92262907|NCT05554939|Fludarabine|fludarabine|mesh-list
92262908|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
92262909|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262910|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
92262911|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262912|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262913|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262914|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
92262915|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262916|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262917|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92262918|NCT05554939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92262919|NCT05554939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92262920|NCT05554939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262921|NCT05554939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262922|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92262923|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
92262924|NCT05545891|Aripiprazole|aripiprazole|mesh-list
92262925|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
92262926|NCT05545891|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92262927|NCT05545891|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92262928|NCT05545891|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92262929|NCT05545891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92262930|NCT05545891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262931|NCT05545891|Dopamine Agonists|dopamine agonists|mesh-ancestor
92262932|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
92262933|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92262934|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262935|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92262936|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92262937|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
92262938|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92262939|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92262940|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92262941|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92262942|NCT05535166|Cyclophosphamide|cyclophosphamide|mesh-list
92262943|NCT05535166|Carboplatin|carboplatin|mesh-list
92262944|NCT05535166|Methotrexate|methotrexate|mesh-list
92262945|NCT05535166|Etoposide|etoposide|mesh-list
92262946|NCT05535166|Vincristine|vincristine|mesh-list
92262947|NCT05535166|Topotecan|topotecan|mesh-list
92262948|NCT05535166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92262949|NCT05535166|Immunologic Factors|immunologic factors|mesh-ancestor
92262950|NCT05535166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262951|NCT05535166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92262952|NCT05535166|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92262954|NCT05535166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262955|NCT05535166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262956|NCT05535166|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92262957|NCT05535166|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92262958|NCT05535166|Abortifacient Agents|abortifacient agents|mesh-ancestor
92262959|NCT05535166|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92262960|NCT05535166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92262961|NCT05535166|Antimetabolites|antimetabolites|mesh-ancestor
92262962|NCT05535166|Dermatologic Agents|dermatologic agents|mesh-ancestor
92262963|NCT05535166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262964|NCT05535166|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92262965|NCT05535166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92262966|NCT05535166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92262967|NCT05535166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92262968|NCT05535166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262969|NCT05535166|Tubulin Modulators|tubulin modulators|mesh-ancestor
92262970|NCT05535166|Antimitotic Agents|antimitotic agents|mesh-ancestor
92262971|NCT05535166|Mitosis Modulators|mitosis modulators|mesh-ancestor
92262972|NCT05535166|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92262973|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
92262974|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92262975|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262976|NCT05533697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92262977|NCT05533697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262978|NCT05528458|Osimertinib|osimertinib|mesh-list
92262979|NCT05528458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262980|NCT05528458|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262981|NCT05528458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262982|NCT05528458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262983|NCT05493215|Imatinib Mesylate|imatinib mesylate|mesh-list
92262984|NCT05493215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262985|NCT05493215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92262986|NCT05493215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262987|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262988|NCT05478278|Moxifloxacin|moxifloxacin|mesh-list
92262990|NCT05478278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92262991|NCT05478278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92262992|NCT05478278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92262993|NCT05478278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92262994|NCT05478278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92262995|NCT05478278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92262996|NCT05478278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92262997|NCT05478278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92262998|NCT05478278|Hallucinogens|hallucinogens|mesh-ancestor
92262999|NCT05478278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92263000|NCT05467761|Psilocybin|psilocybin|mesh-list
92263001|NCT05467761|Hallucinogens|hallucinogens|mesh-ancestor
92263002|NCT05467761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263003|NCT05467761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92263004|NCT05440864|Durvalumab|durvalumab|mesh-list
92263005|NCT05440864|Tremelimumab|tremelimumab|mesh-list
92263006|NCT05440864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263007|NCT05440864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263008|NCT05418361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92263009|NCT05418361|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92263010|NCT05418361|Protease Inhibitors|protease inhibitors|mesh-ancestor
92263011|NCT05418361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263012|NCT05418361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263013|NCT05399498|Psilocybin|psilocybin|mesh-list
92263014|NCT05399498|Hallucinogens|hallucinogens|mesh-ancestor
92263015|NCT05399498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263016|NCT05399498|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92263017|NCT05379530|Anesthetics|anesthetics|mesh-list
92263018|NCT05379530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263019|NCT05379530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263020|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
92263021|NCT05282901|Lenvatinib|lenvatinib|mesh-list
92263022|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263023|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263024|NCT05282901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263025|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263026|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92263027|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263029|NCT05272605|Immunologic Factors|immunologic factors|mesh-ancestor
92263030|NCT05272605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263031|NCT05265286|Factor VIII|factor viii|mesh-list
92263032|NCT05265286|Coagulants|coagulants|mesh-ancestor
92263034|NCT05233202|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92263035|NCT05233202|Vasodilator Agents|vasodilator agents|mesh-ancestor
92263036|NCT05233202|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92263037|NCT05233202|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92263038|NCT05233202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263039|NCT05233202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263040|NCT05233202|Protective Agents|protective agents|mesh-ancestor
92263041|NCT05233202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263043|NCT05232123|Anticonvulsants|anticonvulsants|mesh-ancestor
92263044|NCT05229055|Ketamine|ketamine|mesh-list
92263045|NCT05229055|Analgesics|analgesics|mesh-ancestor
92263046|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
92263047|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263048|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263049|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92263050|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92263051|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
92263052|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
92263053|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263054|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92263055|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92263056|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263057|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263058|NCT05151471|Edaravone|edaravone|mesh-list
92263059|NCT05151471|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263060|NCT05151471|Antioxidants|antioxidants|mesh-ancestor
92263061|NCT05151471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263062|NCT05151471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92263063|NCT05151471|Protective Agents|protective agents|mesh-ancestor
92263064|NCT05151471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263065|NCT05009992|TIC10 compound|tic10 compound|mesh-list
92263066|NCT05009992|Dopamine|dopamine|mesh-list
92263067|NCT05009992|GDC-0084|gdc-0084|mesh-list
92263068|NCT05009992|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92263069|NCT05009992|Sympathomimetics|sympathomimetics|mesh-ancestor
92263070|NCT05009992|Autonomic Agents|autonomic agents|mesh-ancestor
92263071|NCT05009992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263072|NCT05009992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263073|NCT05009992|Dopamine Agents|dopamine agents|mesh-ancestor
92263074|NCT05009992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263075|NCT05009992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263076|NCT05009992|Protective Agents|protective agents|mesh-ancestor
92263077|NCT05009992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263078|NCT05009992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263079|NCT04992312|Glucagon|glucagon|mesh-list
92263080|NCT04992312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92263081|NCT04992312|Hormones|hormones|mesh-ancestor
92263082|NCT04992312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263083|NCT04992312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263084|NCT04986072|Nitroprusside|nitroprusside|mesh-list
92263085|NCT04986072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92263086|NCT04986072|Vasodilator Agents|vasodilator agents|mesh-ancestor
91915988|NCT03550781|Prednisone|prednisone|mesh-list
92263087|NCT04986072|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92263088|NCT04986072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263089|NCT04965935|Dapagliflozin|dapagliflozin|mesh-list
92263090|NCT04965935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92263091|NCT04965935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263092|NCT04965935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92263093|NCT04965935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263095|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92263096|NCT04964869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92263097|NCT04964869|Adrenergic Agents|adrenergic agents|mesh-ancestor
92263098|NCT04964869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263099|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263100|NCT04964869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263101|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92263102|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92263104|NCT04964869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263105|NCT04964869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92263106|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
92263108|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
92263109|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92263110|NCT04936841|Pembrolizumab|pembrolizumab|mesh-list
92263111|NCT04936841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263112|NCT04936841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263113|NCT04936841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263114|NCT04936841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263115|NCT04930536|Acalabrutinib|acalabrutinib|mesh-list
92263116|NCT04930536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263117|NCT04893291|Sirolimus|sirolimus|mesh-list
92263118|NCT04893291|Everolimus|everolimus|mesh-list
92263119|NCT04893291|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92263120|NCT04893291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92263121|NCT04893291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263122|NCT04893291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263123|NCT04893291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263124|NCT04893291|Immunologic Factors|immunologic factors|mesh-ancestor
92263125|NCT04893291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263126|NCT04893291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263127|NCT04893291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92263128|NCT04893291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263129|NCT04893291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92263130|NCT04893291|Antifungal Agents|antifungal agents|mesh-ancestor
92263131|NCT04864743|Factor VIII|factor viii|mesh-list
92263132|NCT04864743|Coagulants|coagulants|mesh-ancestor
92263133|NCT04847453|Dexamethasone|dexamethasone|mesh-list
92263134|NCT04847453|Dexamethasone acetate|dexamethasone acetate|mesh-list
92263135|NCT04847453|Venetoclax|venetoclax|mesh-list
92263136|NCT04847453|Ixazomib|ixazomib|mesh-list
92263137|NCT04847453|Ichthammol|ichthammol|mesh-list
92263138|NCT04847453|BB 1101|bb 1101|mesh-list
92263139|NCT04847453|Glycine|glycine|mesh-list
92263140|NCT04847453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92263141|NCT04847453|Antiemetics|antiemetics|mesh-ancestor
92263142|NCT04847453|Autonomic Agents|autonomic agents|mesh-ancestor
92263143|NCT04847453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263144|NCT04847453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263145|NCT04847453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92263146|NCT04847453|Glucocorticoids|glucocorticoids|mesh-ancestor
92263147|NCT04847453|Hormones|hormones|mesh-ancestor
92263148|NCT04847453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263149|NCT04847453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92263150|NCT04847453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263151|NCT04847453|Protease Inhibitors|protease inhibitors|mesh-ancestor
92263152|NCT04847453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263153|NCT04847453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263154|NCT04847453|Dermatologic Agents|dermatologic agents|mesh-ancestor
92263155|NCT04847453|Glycine Agents|glycine agents|mesh-ancestor
92263156|NCT04847453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263157|NCT04803422|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92263158|NCT04803422|Amoxicillin|amoxicillin|mesh-list
92263159|NCT04803422|Metronidazole|metronidazole|mesh-list
92263160|NCT04803422|Tazobactam|tazobactam|mesh-list
92263161|NCT04803422|Piperacillin|piperacillin|mesh-list
92263162|NCT04803422|Clavulanic Acids|clavulanic acids|mesh-list
92263163|NCT04803422|Clavulanic Acid|clavulanic acid|mesh-list
92263164|NCT04803422|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92263165|NCT04803422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263166|NCT04803422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92263167|NCT04803422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92263168|NCT04803422|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92263169|NCT04803422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263170|NCT04803422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263172|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
92263173|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263174|NCT04791943|Protective Agents|protective agents|mesh-ancestor
92263175|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263176|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263178|NCT04770532|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92263179|NCT04770532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92263180|NCT04770532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263182|NCT04731779|Anticonvulsants|anticonvulsants|mesh-ancestor
92263184|NCT04717765|alpha-Tocopherol|alpha-tocopherol|mesh-list
92263185|NCT04717765|Tocopherols|tocopherols|mesh-list
92263186|NCT04717765|Antioxidants|antioxidants|mesh-ancestor
92263187|NCT04717765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263188|NCT04717765|Protective Agents|protective agents|mesh-ancestor
92263189|NCT04717765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263190|NCT04717765|Vitamins|vitamins|mesh-ancestor
92263191|NCT04717765|Micronutrients|micronutrients|mesh-ancestor
92263192|NCT04715568|Losartan|losartan|mesh-list
92263193|NCT04715568|Antihypertensive Agents|antihypertensive agents|mesh-list
92263194|NCT04715568|Angiotensin II|angiotensin ii|mesh-list
92263195|NCT04715568|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92263196|NCT04715568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92263197|NCT04715568|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92263198|NCT04715568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263199|NCT04715568|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92263200|NCT04665947|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92263201|NCT04665947|Chelating Agents|chelating agents|mesh-ancestor
92263202|NCT04665947|Sequestering Agents|sequestering agents|mesh-ancestor
92263203|NCT04665947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263204|NCT04658849|Pioglitazone|pioglitazone|mesh-list
92263205|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92263206|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263207|NCT04616313|Xenon|xenon|mesh-list
92263208|NCT04616313|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92263209|NCT04616313|Anesthetics, General|anesthetics, general|mesh-ancestor
92263210|NCT04616313|Anesthetics|anesthetics|mesh-ancestor
92263211|NCT04616313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263212|NCT04616313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263213|NCT04577404|Edaravone|edaravone|mesh-list
92263214|NCT04577404|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263215|NCT04577404|Antioxidants|antioxidants|mesh-ancestor
92263216|NCT04577404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263217|NCT04577404|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92263218|NCT04577404|Protective Agents|protective agents|mesh-ancestor
92263219|NCT04577404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263220|NCT04569084|Edaravone|edaravone|mesh-list
92263221|NCT04569084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263222|NCT04569084|Antioxidants|antioxidants|mesh-ancestor
92263223|NCT04569084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263224|NCT04569084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92263225|NCT04569084|Protective Agents|protective agents|mesh-ancestor
92263226|NCT04569084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263227|NCT04566887|Acalabrutinib|acalabrutinib|mesh-list
92263228|NCT04566887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263229|NCT04564742|Dapagliflozin|dapagliflozin|mesh-list
92263230|NCT04564742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92263231|NCT04564742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263232|NCT04564742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92263233|NCT04564742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263234|NCT04452747|Dinoprostone|dinoprostone|mesh-list
92263235|NCT04452747|Oxytocics|oxytocics|mesh-ancestor
92263236|NCT04452747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92263237|NCT04452747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263238|NCT04421339|Melatonin|melatonin|mesh-list
92263239|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
92263240|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916108|NCT02129933|Bevacizumab|bevacizumab|mesh-list
92263241|NCT04421339|Protective Agents|protective agents|mesh-ancestor
92263242|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263243|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263244|NCT04418661|Pembrolizumab|pembrolizumab|mesh-list
92263245|NCT04418661|Adagrasib|adagrasib|mesh-list
92263246|NCT04418661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263247|NCT04418661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263248|NCT04418661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263249|NCT04418661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263250|NCT04391049|Paclitaxel|paclitaxel|mesh-list
92263251|NCT04391049|Carboplatin|carboplatin|mesh-list
92263252|NCT04391049|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92263253|NCT04391049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263254|NCT04391049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263255|NCT04391049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263256|NCT04391049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263257|NCT04391049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263258|NCT04391049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263259|NCT04342572|Melphalan|melphalan|mesh-list
92263260|NCT04342572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92263261|NCT04342572|Alkylating Agents|alkylating agents|mesh-ancestor
92263262|NCT04342572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263263|NCT04342572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263264|NCT04342572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92263265|NCT04342572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263266|NCT04342572|Immunologic Factors|immunologic factors|mesh-ancestor
92263267|NCT04342572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263268|NCT04294160|Tislelizumab|tislelizumab|mesh-list
92263269|NCT04294160|Spartalizumab|spartalizumab|mesh-list
92263270|NCT04294160|Trametinib|trametinib|mesh-list
92263271|NCT04294160|Dabrafenib|dabrafenib|mesh-list
92263272|NCT04294160|Naporafenib|naporafenib|mesh-list
92263273|NCT04294160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263274|NCT04294160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263275|NCT04294160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92263276|NCT04294160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263277|NCT04294160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263278|NCT04294160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263279|NCT04250051|Vidarabine|vidarabine|mesh-list
92263280|NCT04250051|Cytarabine|cytarabine|mesh-list
92263281|NCT04250051|Fludarabine|fludarabine|mesh-list
92263282|NCT04250051|Fludarabine phosphate|fludarabine phosphate|mesh-list
92263283|NCT04250051|Ivosidenib|ivosidenib|mesh-list
92263284|NCT04250051|Lenograstim|lenograstim|mesh-list
92263285|NCT04250051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263286|NCT04250051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263287|NCT04250051|Antimetabolites|antimetabolites|mesh-ancestor
92263288|NCT04250051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263289|NCT04250051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263290|NCT04250051|Immunologic Factors|immunologic factors|mesh-ancestor
92263291|NCT04250051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263292|NCT04250051|Antiviral Agents|antiviral agents|mesh-ancestor
92263293|NCT04250051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263294|NCT04250051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92263295|NCT04250051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263296|NCT04207060|Indomethacin|indomethacin|mesh-list
92263297|NCT04207060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92263298|NCT04207060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92263299|NCT04207060|Analgesics|analgesics|mesh-ancestor
92263300|NCT04207060|Sensory System Agents|sensory system agents|mesh-ancestor
92263301|NCT04207060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263302|NCT04207060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263303|NCT04207060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92263304|NCT04207060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263305|NCT04207060|Gout Suppressants|gout suppressants|mesh-ancestor
92263307|NCT04207060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92263308|NCT04207060|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92263309|NCT04207060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263310|NCT04207060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263311|NCT04204980|Daratumumab|daratumumab|mesh-list
92263312|NCT04204980|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92263313|NCT04204980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263314|NCT04204980|Immunologic Factors|immunologic factors|mesh-ancestor
92263315|NCT04204980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263316|NCT04165824|Edaravone|edaravone|mesh-list
92263317|NCT04165824|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263318|NCT04165824|Antioxidants|antioxidants|mesh-ancestor
92263319|NCT04165824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263320|NCT04165824|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92263321|NCT04165824|Protective Agents|protective agents|mesh-ancestor
92263322|NCT04165824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263323|NCT04158258|Bevacizumab|bevacizumab|mesh-list
92263324|NCT04158258|Trastuzumab|trastuzumab|mesh-list
92263325|NCT04158258|Atezolizumab|atezolizumab|mesh-list
92263327|NCT04158258|Capecitabine|capecitabine|mesh-list
92263328|NCT04158258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263329|NCT04158258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263330|NCT04158258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92263331|NCT04158258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92263332|NCT04158258|Growth Substances|growth substances|mesh-ancestor
92263333|NCT04158258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263334|NCT04158258|Growth Inhibitors|growth inhibitors|mesh-ancestor
92263335|NCT04158258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263336|NCT04158258|Antimetabolites|antimetabolites|mesh-ancestor
92263337|NCT04158258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263338|NCT04158258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263339|NCT04108039|Cetrorelix|cetrorelix|mesh-list
92263340|NCT04108039|Progesterone|progesterone|mesh-list
92263341|NCT04108039|Ganirelix|ganirelix|mesh-list
92263342|NCT04108039|Progestins|progestins|mesh-ancestor
92263343|NCT04108039|Hormones|hormones|mesh-ancestor
92263344|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263345|NCT04108039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263346|NCT04108039|Hormone Antagonists|hormone antagonists|mesh-ancestor
92263347|NCT04108039|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92263348|NCT04108039|Fertility Agents|fertility agents|mesh-ancestor
92263349|NCT04108039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92263350|NCT04069169|Lidocaine|lidocaine|mesh-list
92263351|NCT04069169|Anesthetics, Local|anesthetics, local|mesh-ancestor
92263352|NCT04069169|Anesthetics|anesthetics|mesh-ancestor
92263353|NCT04069169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263354|NCT04069169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263355|NCT04069169|Sensory System Agents|sensory system agents|mesh-ancestor
92263356|NCT04069169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263357|NCT04069169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92263358|NCT04069169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92263359|NCT04069169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92263360|NCT04069169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92263361|NCT04069169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263362|NCT03997097|Sildenafil Citrate|sildenafil citrate|mesh-list
92263363|NCT03997097|Vasodilator Agents|vasodilator agents|mesh-ancestor
92263364|NCT03997097|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92263365|NCT03997097|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92263366|NCT03997097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263367|NCT03997097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263368|NCT03997097|Urological Agents|urological agents|mesh-ancestor
92263369|NCT03988036|Pembrolizumab|pembrolizumab|mesh-list
92263370|NCT03988036|Trastuzumab|trastuzumab|mesh-list
92263371|NCT03988036|Pertuzumab|pertuzumab|mesh-list
92263372|NCT03988036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263373|NCT03988036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263374|NCT03988036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263375|NCT03988036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263377|NCT03899987|Interferons|interferons|mesh-list
92263378|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
92263379|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
92263380|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92263381|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263382|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
92263383|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263384|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92263385|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92263386|NCT03899987|Analgesics|analgesics|mesh-ancestor
92263387|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
92263388|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263389|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263390|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92263391|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916267|NCT02130869|Cytarabine|cytarabine|mesh-list
92263392|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92263393|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92263394|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263395|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92263396|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92263397|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263400|NCT03850028|Atezolizumab|atezolizumab|mesh-list
92263401|NCT03850028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263402|NCT03850028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263403|NCT03850028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263404|NCT03850028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263405|NCT03744468|Tislelizumab|tislelizumab|mesh-list
92263406|NCT03744468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263407|NCT03744468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263408|NCT03725436|Paclitaxel|paclitaxel|mesh-list
92263409|NCT03725436|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92263410|NCT03725436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263411|NCT03725436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263412|NCT03725436|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263413|NCT03725436|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263414|NCT03725436|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263415|NCT03725436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263416|NCT03678688|Bedaquiline|bedaquiline|mesh-list
92263417|NCT03678688|Diarylquinolines|diarylquinolines|mesh-list
92263418|NCT03678688|Antitubercular Agents|antitubercular agents|mesh-ancestor
92263419|NCT03678688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92263420|NCT03678688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263421|NCT03602612|Cyclophosphamide|cyclophosphamide|mesh-list
92263422|NCT03602612|Fludarabine|fludarabine|mesh-list
92263423|NCT03602612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263424|NCT03602612|Immunologic Factors|immunologic factors|mesh-ancestor
92263425|NCT03602612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263426|NCT03602612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263427|NCT03602612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92263428|NCT03602612|Alkylating Agents|alkylating agents|mesh-ancestor
92263429|NCT03602612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263430|NCT03602612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263431|NCT03602612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92263432|NCT03554044|Tamoxifen|tamoxifen|mesh-list
92263433|NCT03554044|Paclitaxel|paclitaxel|mesh-list
92263434|NCT03554044|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92263435|NCT03554044|Carboplatin|carboplatin|mesh-list
92263436|NCT03554044|Gemcitabine|gemcitabine|mesh-list
92263437|NCT03554044|Letrozole|letrozole|mesh-list
92263438|NCT03554044|Fulvestrant|fulvestrant|mesh-list
92263439|NCT03554044|Anastrozole|anastrozole|mesh-list
92263440|NCT03554044|Exemestane|exemestane|mesh-list
92263441|NCT03554044|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92263442|NCT03554044|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263443|NCT03554044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263444|NCT03554044|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263445|NCT03554044|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263446|NCT03554044|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263447|NCT03554044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263448|NCT03554044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263449|NCT03554044|Antimetabolites|antimetabolites|mesh-ancestor
92263450|NCT03554044|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92263451|NCT03554044|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92263452|NCT03554044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263453|NCT03554044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92263454|NCT03554044|Hormone Antagonists|hormone antagonists|mesh-ancestor
92263455|NCT03554044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263456|NCT03554044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263457|NCT03554044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92263458|NCT03554044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92263459|NCT03554044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92263460|NCT03554044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92263461|NCT03554044|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92263462|NCT03554044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263463|NCT03524937|Melatonin|melatonin|mesh-list
92263464|NCT03524937|Antioxidants|antioxidants|mesh-ancestor
92263465|NCT03524937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263466|NCT03524937|Protective Agents|protective agents|mesh-ancestor
92263467|NCT03524937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263468|NCT03524937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263469|NCT03505710|Trastuzumab|trastuzumab|mesh-list
92263470|NCT03505710|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92263471|NCT03505710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263472|NCT03505710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263473|NCT03505710|Immunoconjugates|immunoconjugates|mesh-ancestor
92263474|NCT03505710|Immunologic Factors|immunologic factors|mesh-ancestor
92263475|NCT03505710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263476|NCT03435458|Misoprostol|misoprostol|mesh-list
92263477|NCT03435458|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92263478|NCT03435458|Abortifacient Agents|abortifacient agents|mesh-ancestor
92263479|NCT03435458|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92263480|NCT03435458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263481|NCT03435458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92263482|NCT03435458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92263483|NCT03435458|Oxytocics|oxytocics|mesh-ancestor
92263484|NCT03323476|Mycophenolic Acid|mycophenolic acid|mesh-list
92263485|NCT03323476|Prednisone|prednisone|mesh-list
92263486|NCT03323476|Rituximab|rituximab|mesh-list
92263487|NCT03323476|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92263488|NCT03323476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263489|NCT03323476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263490|NCT03323476|Immunologic Factors|immunologic factors|mesh-ancestor
92263491|NCT03323476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263492|NCT03323476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263493|NCT03323476|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92263494|NCT03323476|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92263495|NCT03323476|Antitubercular Agents|antitubercular agents|mesh-ancestor
92263496|NCT03323476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92263497|NCT03323476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263498|NCT03323476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263499|NCT03323476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263500|NCT03323476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92263501|NCT03323476|Glucocorticoids|glucocorticoids|mesh-ancestor
92263502|NCT03323476|Hormones|hormones|mesh-ancestor
92263503|NCT03323476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263504|NCT03323476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92263505|NCT03260569|Nitric Oxide|nitric oxide|mesh-list
92263506|NCT03260569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92263507|NCT03260569|Autonomic Agents|autonomic agents|mesh-ancestor
92263508|NCT03260569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263509|NCT03260569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263510|NCT03260569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92263511|NCT03260569|Respiratory System Agents|respiratory system agents|mesh-ancestor
92263512|NCT03260569|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263513|NCT03260569|Antioxidants|antioxidants|mesh-ancestor
92263514|NCT03260569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263515|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263516|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92263517|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
92263518|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
92263519|NCT03260569|Protective Agents|protective agents|mesh-ancestor
92263520|NCT03188796|Vitamin D|vitamin d|mesh-list
92263521|NCT03188796|Cholecalciferol|cholecalciferol|mesh-list
92263522|NCT03188796|Vitamins|vitamins|mesh-ancestor
92263523|NCT03188796|Micronutrients|micronutrients|mesh-ancestor
92263524|NCT03188796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263525|NCT03188796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92263526|NCT03188796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92263527|NCT03184194|Cyclophosphamide|cyclophosphamide|mesh-list
92263528|NCT03184194|Nivolumab|nivolumab|mesh-list
92263529|NCT03184194|Daratumumab|daratumumab|mesh-list
92263530|NCT03184194|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92263531|NCT03184194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263532|NCT03184194|Immunologic Factors|immunologic factors|mesh-ancestor
92263533|NCT03184194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263534|NCT03184194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263535|NCT03184194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92263536|NCT03184194|Alkylating Agents|alkylating agents|mesh-ancestor
92263537|NCT03184194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263538|NCT03184194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263539|NCT03184194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92263540|NCT03184194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263541|NCT03184194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263542|NCT03096041|Analgesics|analgesics|mesh-list
92263543|NCT03096041|Sensory System Agents|sensory system agents|mesh-ancestor
92263544|NCT03096041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263545|NCT03096041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263546|NCT03018366|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92263547|NCT03018366|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92263548|NCT03018366|Estradiol|estradiol|mesh-list
92263549|NCT03018366|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92263550|NCT03018366|Progesterone|progesterone|mesh-list
92263551|NCT03018366|Estrogens|estrogens|mesh-ancestor
92263552|NCT03018366|Hormones|hormones|mesh-ancestor
92263553|NCT03018366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263554|NCT03018366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263555|NCT03018366|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92263556|NCT03018366|Contraceptive Agents|contraceptive agents|mesh-ancestor
92263557|NCT03018366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92263558|NCT03018366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92263559|NCT03018366|Progestins|progestins|mesh-ancestor
92263560|NCT02889159|Imiquimod|imiquimod|mesh-list
92263561|NCT02889159|Histamine|histamine|mesh-list
92263562|NCT02889159|Histamine phosphate|histamine phosphate|mesh-list
92263563|NCT02889159|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92263564|NCT02889159|Immunologic Factors|immunologic factors|mesh-ancestor
92263565|NCT02889159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263566|NCT02889159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263567|NCT02889159|Interferon Inducers|interferon inducers|mesh-ancestor
92263568|NCT02889159|Histamine Agonists|histamine agonists|mesh-ancestor
92263569|NCT02889159|Histamine Agents|histamine agents|mesh-ancestor
92263570|NCT02889159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263571|NCT02889159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263572|NCT02841280|Chlorthalidone|chlorthalidone|mesh-list
92263573|NCT02841280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92263574|NCT02841280|Diuretics|diuretics|mesh-ancestor
92263575|NCT02841280|Natriuretic Agents|natriuretic agents|mesh-ancestor
92263576|NCT02841280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263577|NCT02841280|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92263578|NCT02841280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92263579|NCT02841280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263580|NCT02813356|Naloxegol|naloxegol|mesh-list
92263581|NCT02813356|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92263582|NCT02813356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263583|NCT02813356|Sensory System Agents|sensory system agents|mesh-ancestor
92263584|NCT02813356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263585|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
92263586|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92263587|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
92263588|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263589|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263590|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92263591|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
92263592|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263593|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
92263594|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263595|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263596|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92263597|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
92263598|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
92263599|NCT02760329|Protective Agents|protective agents|mesh-ancestor
92263601|NCT02723500|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92263602|NCT02723500|Anesthetics, General|anesthetics, general|mesh-ancestor
92263603|NCT02723500|Anesthetics|anesthetics|mesh-ancestor
92263604|NCT02723500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263605|NCT02723500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263606|NCT02678182|Capecitabine|capecitabine|mesh-list
92263607|NCT02678182|Trastuzumab|trastuzumab|mesh-list
92263608|NCT02678182|Durvalumab|durvalumab|mesh-list
92263609|NCT02678182|Ramucirumab|ramucirumab|mesh-list
92263610|NCT02678182|Rucaparib|rucaparib|mesh-list
92263611|NCT02678182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263612|NCT02678182|Antimetabolites|antimetabolites|mesh-ancestor
92263613|NCT02678182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263614|NCT02678182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263615|NCT02678182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263616|NCT02678182|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92263617|NCT02678182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263618|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
92263619|NCT02620865|Leucovorin|leucovorin|mesh-list
92263620|NCT02620865|Folic Acid|folic acid|mesh-list
92263621|NCT02620865|Aldesleukin|aldesleukin|mesh-list
92263622|NCT02620865|Paclitaxel|paclitaxel|mesh-list
92263623|NCT02620865|Camptothecin|camptothecin|mesh-list
92263624|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92263625|NCT02620865|Gemcitabine|gemcitabine|mesh-list
92263626|NCT02620865|Fluorouracil|fluorouracil|mesh-list
92263627|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
92263628|NCT02620865|Irinotecan|irinotecan|mesh-list
92263629|NCT02620865|Interleukin-2|interleukin-2|mesh-list
92263630|NCT02620865|Antibodies|antibodies|mesh-list
92263631|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
92263632|NCT02620865|Sargramostim|sargramostim|mesh-list
92263633|NCT02620865|Calcium|calcium|mesh-list
92263634|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
92263635|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263636|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263637|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263638|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263639|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263640|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263641|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
92263642|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263643|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263644|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
92263645|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92263646|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92263647|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263648|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92263649|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92263650|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263651|NCT02620865|Antidotes|antidotes|mesh-ancestor
92263652|NCT02620865|Protective Agents|protective agents|mesh-ancestor
92263653|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
92263654|NCT02620865|Vitamins|vitamins|mesh-ancestor
92263655|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
92263656|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92263657|NCT02620865|Analgesics|analgesics|mesh-ancestor
92263658|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
92343550|NCT00005591|Cetuximab|cetuximab|mesh-list
92263659|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263660|NCT02620865|Hematinics|hematinics|mesh-ancestor
92263661|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92263662|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92263663|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
92263664|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263665|NCT02576574|Paclitaxel|paclitaxel|mesh-list
92263666|NCT02576574|Carboplatin|carboplatin|mesh-list
92263667|NCT02576574|Gemcitabine|gemcitabine|mesh-list
92263668|NCT02576574|Pemetrexed|pemetrexed|mesh-list
92263669|NCT02576574|Avelumab|avelumab|mesh-list
92263670|NCT02576574|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92263671|NCT02576574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263672|NCT02576574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263673|NCT02576574|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263674|NCT02576574|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263675|NCT02576574|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263676|NCT02576574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263677|NCT02576574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263678|NCT02576574|Antimetabolites|antimetabolites|mesh-ancestor
92263679|NCT02576574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263680|NCT02576574|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92263681|NCT02576574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92263682|NCT02576574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263683|NCT02576574|Immunologic Factors|immunologic factors|mesh-ancestor
92263684|NCT02576574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263685|NCT02550652|Mycophenolic Acid|mycophenolic acid|mesh-list
92263686|NCT02550652|Prednisone|prednisone|mesh-list
92263687|NCT02550652|Methylprednisolone|methylprednisolone|mesh-list
92263688|NCT02550652|Obinutuzumab|obinutuzumab|mesh-list
92263689|NCT02550652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92263690|NCT02550652|Glucocorticoids|glucocorticoids|mesh-ancestor
92263691|NCT02550652|Hormones|hormones|mesh-ancestor
92263692|NCT02550652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263693|NCT02550652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263694|NCT02550652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92263695|NCT02550652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263696|NCT02550652|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92263697|NCT02550652|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92263698|NCT02550652|Antitubercular Agents|antitubercular agents|mesh-ancestor
92263699|NCT02550652|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92263700|NCT02550652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263701|NCT02550652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263702|NCT02550652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263704|NCT02550652|Autonomic Agents|autonomic agents|mesh-ancestor
92263705|NCT02550652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263706|NCT02550652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92263707|NCT02550652|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92263708|NCT02550652|Protective Agents|protective agents|mesh-ancestor
92263709|NCT02550652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263710|NCT02505477|Acetylcysteine|acetylcysteine|mesh-list
92263711|NCT02505477|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92263712|NCT02505477|Antiviral Agents|antiviral agents|mesh-ancestor
92263713|NCT02505477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263714|NCT02505477|Expectorants|expectorants|mesh-ancestor
92263715|NCT02505477|Respiratory System Agents|respiratory system agents|mesh-ancestor
92263716|NCT02505477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92263717|NCT02505477|Antioxidants|antioxidants|mesh-ancestor
92263718|NCT02505477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263719|NCT02505477|Protective Agents|protective agents|mesh-ancestor
92263720|NCT02505477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263721|NCT02505477|Antidotes|antidotes|mesh-ancestor
92263722|NCT02484885|Xenon|xenon|mesh-list
92263723|NCT02484885|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92263724|NCT02484885|Anesthetics, General|anesthetics, general|mesh-ancestor
92263725|NCT02484885|Anesthetics|anesthetics|mesh-ancestor
92263726|NCT02484885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263727|NCT02484885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263728|NCT02418572|Testosterone|testosterone|mesh-list
92263729|NCT02418572|Androgens|androgens|mesh-ancestor
92263730|NCT02418572|Hormones|hormones|mesh-ancestor
92263731|NCT02418572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263732|NCT02418572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263733|NCT02345330|Interleukin-12|interleukin-12|mesh-list
92263734|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92263735|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
92263736|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263737|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92263738|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92263739|NCT02345330|Growth Substances|growth substances|mesh-ancestor
92263740|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92263741|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263742|NCT01665677|Atorvastatin|atorvastatin|mesh-list
92263743|NCT01665677|Calcium|calcium|mesh-list
92263744|NCT01665677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92263745|NCT01665677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263746|NCT01665677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92263747|NCT01665677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92263748|NCT01665677|Antimetabolites|antimetabolites|mesh-ancestor
92263749|NCT01665677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263750|NCT01665677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92263751|NCT01665677|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92263752|NCT01665677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263753|NCT01530373|Clonidine|clonidine|mesh-list
92263754|NCT01530373|Solifenacin Succinate|solifenacin succinate|mesh-list
92263755|NCT01530373|Analgesics|analgesics|mesh-ancestor
92263756|NCT01530373|Sensory System Agents|sensory system agents|mesh-ancestor
92263757|NCT01530373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263758|NCT01530373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263759|NCT01530373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92263760|NCT01530373|Sympatholytics|sympatholytics|mesh-ancestor
92263761|NCT01530373|Autonomic Agents|autonomic agents|mesh-ancestor
92263762|NCT01530373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92263763|NCT01530373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92263764|NCT01530373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92263765|NCT01530373|Adrenergic Agents|adrenergic agents|mesh-ancestor
92263766|NCT01530373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263767|NCT01530373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263768|NCT01530373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92263769|NCT01530373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92263770|NCT01530373|Cholinergic Agents|cholinergic agents|mesh-ancestor
92263771|NCT01530373|Urological Agents|urological agents|mesh-ancestor
91916631|NCT02139761|Tetrahydropalmatine|tetrahydropalmatine|mesh-list
92263772|NCT01499953|PENTA|penta|mesh-list
92263773|NCT01499953|Rivaroxaban|rivaroxaban|mesh-list
92263774|NCT01499953|Fondaparinux|fondaparinux|mesh-list
92263775|NCT01499953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92263776|NCT01499953|Antithrombins|antithrombins|mesh-ancestor
92263777|NCT01499953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92263778|NCT01499953|Protease Inhibitors|protease inhibitors|mesh-ancestor
92263779|NCT01499953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263780|NCT01499953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263781|NCT01499953|Anticoagulants|anticoagulants|mesh-ancestor
92263782|NCT01499953|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92263783|NCT01499953|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92263784|NCT01440816|Interleukin-12|interleukin-12|mesh-list
92263785|NCT01440816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92263786|NCT01440816|Immunologic Factors|immunologic factors|mesh-ancestor
92263787|NCT01440816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263788|NCT01440816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92263789|NCT01440816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92263790|NCT01440816|Growth Substances|growth substances|mesh-ancestor
92263791|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
92263792|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263793|NCT01348919|Dexamethasone|dexamethasone|mesh-list
92263794|NCT01348919|Lenalidomide|lenalidomide|mesh-list
92343552|NCT00005591|Antimetabolites|antimetabolites|mesh-ancestor
92263795|NCT01348919|Delanzomib|delanzomib|mesh-list
92263796|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343556|NCT01926444|Trimebutine|trimebutine|mesh-list
92263798|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
92263799|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263800|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263801|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92263802|NCT01348919|Glucocorticoids|glucocorticoids|mesh-ancestor
92263803|NCT01348919|Hormones|hormones|mesh-ancestor
92263804|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92263805|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92263806|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263807|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
92263808|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92263809|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92263810|NCT01348919|Growth Substances|growth substances|mesh-ancestor
92263811|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
92263812|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
92263813|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
92263814|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263815|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263816|NCT01333046|Azacitidine|azacitidine|mesh-list
92263817|NCT01333046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92263818|NCT01333046|Antimetabolites|antimetabolites|mesh-ancestor
92263819|NCT01333046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263820|NCT01333046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263821|NCT01333046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263822|NCT01280994|Xenon|xenon|mesh-list
92263823|NCT01280994|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92263824|NCT01280994|Anesthetics, General|anesthetics, general|mesh-ancestor
92263825|NCT01280994|Anesthetics|anesthetics|mesh-ancestor
92263826|NCT01280994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263827|NCT01280994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263828|NCT01217970|Ibudilast|ibudilast|mesh-list
92263829|NCT01217970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92263830|NCT01217970|Autonomic Agents|autonomic agents|mesh-ancestor
92263831|NCT01217970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263832|NCT01217970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263833|NCT01217970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92263834|NCT01217970|Respiratory System Agents|respiratory system agents|mesh-ancestor
92263835|NCT01217970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92263836|NCT01217970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263837|NCT01217970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263838|NCT01217970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92263839|NCT01217970|Vasodilator Agents|vasodilator agents|mesh-ancestor
92263840|NCT02431806|Milnacipran|milnacipran|mesh-list
92263841|NCT02431806|Fluoxetine|fluoxetine|mesh-list
92263842|NCT02431806|Levomilnacipran|levomilnacipran|mesh-list
92263843|NCT02431806|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92263844|NCT02431806|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92263845|NCT02431806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92263846|NCT02431806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263847|NCT02431806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263848|NCT02431806|Serotonin Agents|serotonin agents|mesh-ancestor
92263849|NCT02431806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263850|NCT02431806|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92263851|NCT02431806|Antidepressive Agents|antidepressive agents|mesh-ancestor
92263852|NCT02431806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92263853|NCT02431806|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92263854|NCT02431806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92263855|NCT02431806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263856|NCT02431806|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92263857|NCT02431806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92263858|NCT02431806|Analgesics|analgesics|mesh-ancestor
92263859|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
92263860|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263861|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
92263862|NCT05159193|Carboplatin|carboplatin|mesh-list
92263863|NCT05159193|Docetaxel|docetaxel|mesh-list
92263864|NCT05159193|Doxorubicin|doxorubicin|mesh-list
92263865|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92263866|NCT05159193|Trastuzumab|trastuzumab|mesh-list
92263867|NCT05159193|Pertuzumab|pertuzumab|mesh-list
92263868|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92263869|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
92263870|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263871|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263872|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92263873|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
92263874|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263875|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263876|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92263877|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263878|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263879|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263880|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92263881|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92263882|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92263883|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263884|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263885|NCT05220813|Lidocaine|lidocaine|mesh-list
92263886|NCT05220813|Bupivacaine|bupivacaine|mesh-list
92263887|NCT05220813|Anesthetics, Local|anesthetics, local|mesh-ancestor
92263888|NCT05220813|Anesthetics|anesthetics|mesh-ancestor
92263889|NCT05220813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263890|NCT05220813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263891|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
92263892|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263893|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92263894|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92263895|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92263896|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92263897|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263898|NCT01650246|Lesinurad|lesinurad|mesh-list
92263899|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
92263900|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263901|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
92263902|NCT01212302|Clopidogrel|clopidogrel|mesh-list
92263903|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263904|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263905|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92263906|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92263907|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92263908|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92263909|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
92263910|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263911|NCT01284296|Chrysarobin|chrysarobin|mesh-list
92263912|NCT01284296|Lidocaine|lidocaine|mesh-list
92263913|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92263914|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
92263915|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92263916|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263917|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
92263918|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263919|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92263920|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92263921|NCT01284296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91916784|NCT01359254|Fludarabine|fludarabine|mesh-list
92263922|NCT01284296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92263923|NCT01284296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263924|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92263926|NCT01284296|Analgesics|analgesics|mesh-ancestor
92263927|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92263928|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263929|NCT00364143|Irinotecan|irinotecan|mesh-list
92263930|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92263931|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92263932|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263933|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263934|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263935|NCT01652664|Timolol|timolol|mesh-list
92263936|NCT01652664|Travoprost|travoprost|mesh-list
92343568|NCT04172844|Venetoclax|venetoclax|mesh-list
92263937|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92263938|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92263939|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92263940|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92263941|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
92263942|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263943|NCT01652664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263944|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263945|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92263946|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92263947|NCT04055649|Paclitaxel|paclitaxel|mesh-list
92263948|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92263949|NCT04055649|TIC10 compound|tic10 compound|mesh-list
92117783|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92263950|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263951|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263952|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263953|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263954|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
92263955|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263956|NCT04899492|Nicotine|nicotine|mesh-list
92263957|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92263958|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
92263959|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92263960|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263961|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92263962|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92263963|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
92263964|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263965|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263966|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
92263967|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92263968|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263969|NCT01286402|Bupropion|bupropion|mesh-list
92263970|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92263971|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
92263972|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92263973|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92263974|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92263975|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92263976|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263977|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
92263978|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92263979|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92263980|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92263981|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92263982|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263983|NCT01222832|Bacitracin|bacitracin|mesh-list
92263984|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92263985|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92263986|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92263987|NCT04297605|Paclitaxel|paclitaxel|mesh-list
92263988|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
92263989|NCT04297605|Pemetrexed|pemetrexed|mesh-list
92263990|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92263991|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92263992|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
92263993|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
92263994|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
91916860|NCT05013632|Antiviral Agents|antiviral agents|mesh-list
92263995|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92263996|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92263997|NCT04297605|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92263998|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92263999|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92264000|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92264002|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
92264003|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264004|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
92264005|NCT02379390|Hormones|hormones|mesh-ancestor
92264006|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92264007|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264008|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92264009|NCT02379390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264010|NCT02379390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92264011|NCT02379390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264012|NCT02379390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264013|NCT02379390|Hormone Antagonists|hormone antagonists|mesh-ancestor
92264014|NCT02379390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92264015|NCT04932915|Niclosamide|niclosamide|mesh-list
92264016|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
92264017|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92264018|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
92264019|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92264020|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264021|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
92264022|NCT01223378|Latanoprost|latanoprost|mesh-list
92264023|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92264024|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92264025|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
92264026|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92264027|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264028|NCT01224626|Linezolid|linezolid|mesh-list
92264029|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264030|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264031|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92264032|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264033|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264034|NCT01289522|Cetuximab|cetuximab|mesh-list
92264035|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264036|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264037|NCT01226420|Alefacept|alefacept|mesh-list
92264038|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264039|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
92264040|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264041|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
92264042|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92264043|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264044|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92264045|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264046|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
92264047|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92264048|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
92264049|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92264050|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264051|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
92264052|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264053|NCT00365001|Methotrexate|methotrexate|mesh-list
92264054|NCT00365001|Simvastatin|simvastatin|mesh-list
92264055|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92264056|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
92264057|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92264058|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264059|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92264060|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
92264061|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264062|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264063|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264064|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264065|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92264066|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92264067|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
92264068|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264069|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92264071|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92264072|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92264073|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92264074|NCT01289912|Everolimus|everolimus|mesh-list
92264075|NCT01289912|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92264076|NCT01289912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92264077|NCT01289912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264078|NCT01289912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264079|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92264080|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
92264081|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264082|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264083|NCT03192345|Cemiplimab|cemiplimab|mesh-list
92264084|NCT03192345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264085|NCT03192345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264086|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
92264087|NCT03069963|Antacids|antacids|mesh-ancestor
92264088|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264089|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264090|NCT01227434|Palbociclib|palbociclib|mesh-list
92264091|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264092|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92264093|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264094|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264095|NCT01714739|Nivolumab|nivolumab|mesh-list
92264096|NCT01714739|Ipilimumab|ipilimumab|mesh-list
92264097|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
92264098|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264099|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264100|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92264101|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264102|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
92264103|NCT01714739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264104|NCT05440383|Leuprolide|leuprolide|mesh-list
92264105|NCT05440383|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92264106|NCT05440383|Fertility Agents|fertility agents|mesh-ancestor
92264107|NCT05440383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92264108|NCT05440383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264109|NCT05440383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92264110|NCT05440383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264111|NCT02377479|Letrozole|letrozole|mesh-list
92264112|NCT02377479|Clomiphene|clomiphene|mesh-list
92264113|NCT02377479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264114|NCT02377479|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92264115|NCT02377479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92264116|NCT02377479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264117|NCT02377479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264118|NCT02377479|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92264119|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
92264120|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92264121|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264122|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92264123|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
92264124|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92264125|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92264126|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92264127|NCT01291784|Antibodies|antibodies|mesh-list
92264128|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92264129|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
92264130|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264131|NCT00609791|Paclitaxel|paclitaxel|mesh-list
92264132|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92264133|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92264134|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264135|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92264136|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
92264137|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
92264138|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264139|NCT05457647|Riboflavin|riboflavin|mesh-list
92264140|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
92264142|NCT05457647|Micronutrients|micronutrients|mesh-ancestor
92264143|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264144|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92264145|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264146|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
92264147|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92264148|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92264149|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
92264150|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264151|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92264152|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92264153|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264154|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264155|NCT05439629|Ranibizumab|ranibizumab|mesh-list
92264156|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264157|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264158|NCT05439629|Growth Substances|growth substances|mesh-ancestor
92264159|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264160|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264161|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264162|NCT01229228|Naproxen|naproxen|mesh-list
92264163|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264164|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264165|NCT01229228|Analgesics|analgesics|mesh-ancestor
92264166|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
92264167|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264168|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264169|NCT01229228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264170|NCT01229228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264171|NCT01229228|Gout Suppressants|gout suppressants|mesh-ancestor
92264172|NCT01229228|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92264173|NCT01229228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264174|NCT01229228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264175|NCT01292252|Teriparatide|teriparatide|mesh-list
92264176|NCT01292252|Parathyroid Hormone|parathyroid hormone|mesh-list
92264177|NCT01292252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264178|NCT01292252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92264179|NCT01292252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92264180|NCT02192684|Pioglitazone|pioglitazone|mesh-list
92264181|NCT02192684|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92264182|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264183|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
92264184|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264185|NCT02243579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264186|NCT02243579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92264187|NCT02243579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264189|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
92264190|NCT00003407|Amifostine|amifostine|mesh-list
92264191|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92264192|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
92264193|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264194|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264195|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
92264196|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264197|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92264198|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
92264199|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264200|NCT00003407|Analgesics|analgesics|mesh-ancestor
92264201|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
92264202|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264203|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92264204|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264205|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264206|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92264207|NCT00003407|Protective Agents|protective agents|mesh-ancestor
92264209|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264210|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264211|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
92264212|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92264213|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92264214|NCT01710137|Varenicline|varenicline|mesh-list
92264215|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92264216|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92264217|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
92264218|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264219|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264220|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264221|NCT01710839|Ranibizumab|ranibizumab|mesh-list
92264222|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264223|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264224|NCT01710839|Growth Substances|growth substances|mesh-ancestor
92264225|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264226|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264227|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264228|NCT01215110|Bedaquiline|bedaquiline|mesh-list
92264229|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
92264230|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264231|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264232|NCT02980757|Gliclazide|gliclazide|mesh-list
92264233|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92264234|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264235|NCT01229462|Timolol|timolol|mesh-list
92264236|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92264237|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92264238|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92264239|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92264240|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92264241|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
92264242|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264243|NCT01229462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264244|NCT01229462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264245|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264246|NCT01229462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92264247|NCT01229462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92264248|NCT01229462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92264249|NCT01229462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92264250|NCT01292642|Nicotine|nicotine|mesh-list
92264251|NCT01292642|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92264252|NCT01292642|Autonomic Agents|autonomic agents|mesh-ancestor
92264253|NCT01292642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264254|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264255|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92264256|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92264257|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
92264258|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264259|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264260|NCT01231334|Clindamycin|clindamycin|mesh-list
92264261|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
92264262|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
92264263|NCT01231334|Dapsone|dapsone|mesh-list
92264264|NCT01231334|Adapalene|adapalene|mesh-list
92264265|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92264266|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264267|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264268|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92264269|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264270|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264271|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264272|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264273|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264274|NCT01231334|Analgesics|analgesics|mesh-ancestor
92264275|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
92264276|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264277|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264278|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264279|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264280|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
92264282|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92264283|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92264284|NCT01231334|Leprostatic Agents|leprostatic agents|mesh-ancestor
92264285|NCT04771481|Metoclopramide|metoclopramide|mesh-list
92264286|NCT04771481|Antiemetics|antiemetics|mesh-ancestor
92264287|NCT04771481|Autonomic Agents|autonomic agents|mesh-ancestor
92264288|NCT04771481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343597|NCT00005603|Antiemetics|antiemetics|mesh-ancestor
92264289|NCT04771481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264290|NCT04771481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264291|NCT04771481|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92264292|NCT04771481|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91917162|NCT00103285|Dexamethasone acetate|dexamethasone acetate|mesh-list
92264293|NCT04771481|Dopamine Agents|dopamine agents|mesh-ancestor
92264294|NCT04771481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264295|NCT04771481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264296|NCT01292798|Ranibizumab|ranibizumab|mesh-list
92264297|NCT01292798|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264298|NCT01292798|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264299|NCT01292798|Growth Substances|growth substances|mesh-ancestor
92264300|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264301|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264302|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264303|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
92264304|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92264305|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92264306|NCT03009500|Prednisolone|prednisolone|mesh-list
92264307|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
92264308|NCT03009500|Lidocaine|lidocaine|mesh-list
92264309|NCT03009500|Bupivacaine|bupivacaine|mesh-list
92264310|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92264311|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
92264312|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92264313|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
92264314|NCT03009500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264315|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264316|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
92264317|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264318|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264319|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92264320|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92264321|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92264322|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264323|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264324|NCT03009500|Antiemetics|antiemetics|mesh-ancestor
92264325|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
92264326|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264327|NCT03009500|Glucocorticoids|glucocorticoids|mesh-ancestor
92264328|NCT03009500|Hormones|hormones|mesh-ancestor
92264329|NCT03009500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92264330|NCT03009500|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92264331|NCT03009500|Protective Agents|protective agents|mesh-ancestor
92264332|NCT03009500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92264333|NCT03009500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264334|NCT01715207|Atenolol|atenolol|mesh-list
92264335|NCT01715207|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264336|NCT01715207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92264337|NCT01715207|Sympatholytics|sympatholytics|mesh-ancestor
92264338|NCT01715207|Autonomic Agents|autonomic agents|mesh-ancestor
92264339|NCT01715207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264340|NCT01715207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264341|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92264342|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92264343|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92264344|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
92264345|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264346|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264347|NCT01716221|Dexetimide|dexetimide|mesh-list
92264348|NCT01716221|Bupropion|bupropion|mesh-list
92264349|NCT01716221|Citalopram|citalopram|mesh-list
92264350|NCT01716221|Escitalopram|escitalopram|mesh-list
92264351|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92264352|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
92264353|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92264354|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92264355|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92264356|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92264357|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264358|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
92264359|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264360|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264361|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92264362|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92264363|NCT01716221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264364|NCT01716221|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92264365|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
91917243|NCT02158117|Naloxone|naloxone|mesh-list
92264366|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92264367|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92264368|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
92264369|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
92264370|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264371|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92264372|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92264373|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
92264374|NCT01215344|Diphosphonates|diphosphonates|mesh-list
92264375|NCT01215344|Dexamethasone|dexamethasone|mesh-list
92264376|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
92264377|NCT01215344|Doxorubicin|doxorubicin|mesh-list
92264378|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92264379|NCT01215344|Lenalidomide|lenalidomide|mesh-list
92264381|NCT01215344|BB 1101|bb 1101|mesh-list
92264382|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264383|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
92264384|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
92264385|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264386|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264387|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264388|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
92264389|NCT01215344|Hormones|hormones|mesh-ancestor
92264390|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92264391|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92264392|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264393|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
92264394|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264395|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264396|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92264397|NCT01215344|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92264398|NCT01215344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264399|NCT01215344|Immunologic Factors|immunologic factors|mesh-ancestor
92264400|NCT01215344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264401|NCT01215344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264402|NCT01215344|Growth Substances|growth substances|mesh-ancestor
92264403|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264404|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92264405|NCT01231412|Cyclosporine|cyclosporine|mesh-list
92264406|NCT01231412|Sirolimus|sirolimus|mesh-list
92264407|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
92264408|NCT01231412|Fludarabine|fludarabine|mesh-list
92264409|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
92264410|NCT01231412|Cyclosporins|cyclosporins|mesh-list
92264411|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264412|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92264413|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
92264414|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264415|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92264416|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
92264417|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264418|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264419|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
92264420|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264421|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264422|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264423|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92264424|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92264425|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92264426|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
92264427|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264428|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92264429|NCT01719653|Laxatives|laxatives|mesh-ancestor
92264430|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264431|NCT04580771|Cisplatin|cisplatin|mesh-list
92264432|NCT04580771|Vaccines|vaccines|mesh-list
92264433|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
92264434|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264435|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264437|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
92264438|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264439|NCT04514393|Methotrexate|methotrexate|mesh-list
92264440|NCT04514393|Temozolomide|temozolomide|mesh-list
92264441|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92264442|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
92264443|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92264444|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264445|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92264446|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
92264447|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264448|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264449|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264450|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264451|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92264452|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92264453|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
92264454|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264455|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92264456|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92264457|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
92264459|NCT01232504|Lenograstim|lenograstim|mesh-list
92264460|NCT01232504|Sargramostim|sargramostim|mesh-list
92264461|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92264462|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
92264463|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264464|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264465|NCT01737593|Acetaminophen|acetaminophen|mesh-list
92264466|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264467|NCT01737593|Analgesics|analgesics|mesh-ancestor
92264468|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
92264469|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264470|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264471|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
92264472|NCT01217840|Vitamin D|vitamin d|mesh-list
92264473|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
92264474|NCT01217840|Vitamins|vitamins|mesh-ancestor
92264475|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
92264476|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264477|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92264478|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92264479|NCT01721603|Trametinib|trametinib|mesh-list
92264480|NCT01721603|Dabrafenib|dabrafenib|mesh-list
92264481|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264482|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92264483|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264484|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264485|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
92264486|NCT01296542|Besifloxacin|besifloxacin|mesh-list
92264487|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264488|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264489|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92264490|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264491|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264492|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264493|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264494|NCT01234766|Rituximab|rituximab|mesh-list
92264495|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92264496|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264497|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264498|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
92264499|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264500|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264501|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92264502|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
92264503|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264504|NCT01234922|Losartan|losartan|mesh-list
92264505|NCT01234922|Ramipril|ramipril|mesh-list
92343604|NCT00005603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92264507|NCT01234922|Benazepril|benazepril|mesh-list
92264508|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264509|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92264510|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92264511|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92264512|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264513|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92264514|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
92264515|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264516|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92264517|NCT01234922|Protective Agents|protective agents|mesh-ancestor
92264518|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264519|NCT01337336|Fluticasone|fluticasone|mesh-list
92264521|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
92264522|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92264523|NCT01337336|Ipratropium|ipratropium|mesh-list
92264524|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92264525|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264526|NCT01337336|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92264527|NCT01337336|Autonomic Agents|autonomic agents|mesh-ancestor
92264528|NCT01337336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264529|NCT01337336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264530|NCT01337336|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92264531|NCT01337336|Respiratory System Agents|respiratory system agents|mesh-ancestor
92264532|NCT01337336|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264533|NCT01337336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92264534|NCT01337336|Parasympatholytics|parasympatholytics|mesh-ancestor
92264535|NCT01337336|Cholinergic Agents|cholinergic agents|mesh-ancestor
92264536|NCT01337336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264537|NCT01337336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264538|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92264539|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92264540|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92264541|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
92264542|NCT01239212|Levetiracetam|levetiracetam|mesh-list
92264543|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
92264544|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
92264545|NCT01242644|Ketorolac|ketorolac|mesh-list
92264546|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92264547|NCT01242644|Morphine|morphine|mesh-list
92264548|NCT01242644|Ropivacaine|ropivacaine|mesh-list
92264549|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92264550|NCT01242644|Narcotics|narcotics|mesh-ancestor
92264551|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264552|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264553|NCT01242644|Analgesics|analgesics|mesh-ancestor
92264554|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
92264555|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264556|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
92264557|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
92264558|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264559|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264560|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264561|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264562|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92264563|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264564|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264565|NCT01303406|Idebenone|idebenone|mesh-list
92264566|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
92264567|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264568|NCT01303406|Protective Agents|protective agents|mesh-ancestor
92264569|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264570|NCT02597907|Aprepitant|aprepitant|mesh-list
92264571|NCT02597907|Palonosetron|palonosetron|mesh-list
92264572|NCT02597907|Ramosetron|ramosetron|mesh-list
92264573|NCT02597907|Antiemetics|antiemetics|mesh-ancestor
92264574|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
92264575|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264576|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264577|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264578|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92264579|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264580|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264581|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92264582|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92264583|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
92264584|NCT02600325|Grazoprevir|grazoprevir|mesh-list
92264585|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92264586|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
92264587|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264588|NCT02600715|Morphine|morphine|mesh-list
92264589|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92264590|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92264591|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92264592|NCT02600715|Narcotics|narcotics|mesh-ancestor
92264593|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264594|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264595|NCT02600715|Analgesics|analgesics|mesh-ancestor
92264596|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
92264597|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264598|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92264599|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92264600|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92264601|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264602|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
92264603|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264604|NCT04743297|Dinoprostone|dinoprostone|mesh-list
92264605|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
92264606|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92264607|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264608|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
92264609|NCT04176783|Narcotics|narcotics|mesh-ancestor
92264610|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264611|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264612|NCT04176783|Analgesics|analgesics|mesh-ancestor
92264613|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
92264614|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264615|NCT00365313|Celecoxib|celecoxib|mesh-list
92264616|NCT00365313|Esomeprazole|esomeprazole|mesh-list
92264617|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264618|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264619|NCT00365313|Analgesics|analgesics|mesh-ancestor
92264620|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
92264621|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264622|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264623|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264624|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264625|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92264626|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92264627|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264628|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264629|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92264630|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264631|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92264632|NCT02605395|Rabeprazole|rabeprazole|mesh-list
92264633|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92264634|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92264635|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92264636|NCT02605395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264637|NCT02605395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264638|NCT04166721|Atezolizumab|atezolizumab|mesh-list
92264639|NCT04166721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92264640|NCT04166721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264641|NCT04166721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264642|NCT04166721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264643|NCT04343001|Aspirin|aspirin|mesh-list
92264644|NCT04343001|Losartan|losartan|mesh-list
92264645|NCT04343001|Simvastatin|simvastatin|mesh-list
92264646|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264647|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264648|NCT04343001|Analgesics|analgesics|mesh-ancestor
92264649|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
92264650|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264651|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264652|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264653|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264654|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92264655|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92264656|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264657|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92264658|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92264659|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264660|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
92264661|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92264662|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92264663|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
92264664|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92264665|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92264666|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264667|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92264668|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92264669|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91917541|NCT03107169|Vancomycin|vancomycin|mesh-list
92264671|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
92264672|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264673|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
92264674|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92264675|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92264676|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264677|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
92264678|NCT04742205|Coagulants|coagulants|mesh-ancestor
92264679|NCT04743063|Losartan|losartan|mesh-list
92264680|NCT04743063|Valsartan|valsartan|mesh-list
92264681|NCT04743063|Telmisartan|telmisartan|mesh-list
92264682|NCT04743063|Candesartan|candesartan|mesh-list
92264683|NCT04743063|Olmesartan|olmesartan|mesh-list
92264684|NCT04743063|Irbesartan|irbesartan|mesh-list
92264685|NCT04743063|Eprosartan|eprosartan|mesh-list
92264686|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
92264687|NCT04743063|Giapreza|giapreza|mesh-list
92264688|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92264689|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92264690|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
92264691|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92264692|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92264693|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264694|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264695|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92264696|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92264697|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92264698|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264699|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92264700|NCT01739699|Acetaminophen|acetaminophen|mesh-list
92264701|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264702|NCT01739699|Analgesics|analgesics|mesh-ancestor
92264703|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
92264704|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264705|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264706|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
92264707|NCT04154787|Rituximab|rituximab|mesh-list
92264708|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264709|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264710|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
92264711|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264712|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264713|NCT01740713|Deferiprone|deferiprone|mesh-list
92264714|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92264715|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
92264716|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
92264717|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264719|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
92264720|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
92264721|NCT02613117|Protective Agents|protective agents|mesh-ancestor
92264722|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264724|NCT01742117|Ticagrelor|ticagrelor|mesh-list
92264725|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92264726|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92264727|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92264728|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92264729|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
92264730|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264731|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264732|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264734|NCT02613897|Saxagliptin|saxagliptin|mesh-list
92264735|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92264736|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264737|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92264738|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264739|NCT02613897|Incretins|incretins|mesh-ancestor
92264740|NCT02613897|Hormones|hormones|mesh-ancestor
92264741|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92264742|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92264743|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
92264744|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264745|NCT02615535|Alprostadil|alprostadil|mesh-list
92264746|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92264747|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
92264748|NCT02615535|Urological Agents|urological agents|mesh-ancestor
92264750|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
92264751|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
92264752|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264753|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264754|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
92264755|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264756|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264757|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92264758|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92264759|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92264760|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264761|NCT01342172|Lenalidomide|lenalidomide|mesh-list
92264762|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
92264763|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264764|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264765|NCT01342172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264766|NCT01342172|Growth Substances|growth substances|mesh-ancestor
92264767|NCT01342172|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264768|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264769|NCT01243112|Lidocaine|lidocaine|mesh-list
92264770|NCT01243112|Epinephrine|epinephrine|mesh-list
92264771|NCT01243112|Racepinephrine|racepinephrine|mesh-list
92264772|NCT01243112|Bupivacaine|bupivacaine|mesh-list
92264773|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
92264774|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
92264775|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
92264776|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264777|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264778|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
92264779|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264780|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92264781|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92264782|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92264783|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925850|NCT02160275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92264784|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264785|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92264786|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92264787|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
92264788|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264789|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92264790|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92343623|NCT00005609|Rituximab|rituximab|mesh-list
92264791|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
92264792|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92264793|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
92264794|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
92264795|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
92264796|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92264797|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
92264798|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
92264799|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92264800|NCT01243580|Contraceptives, Oral|contraceptives, oral|mesh-list
92264801|NCT01243580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92264802|NCT01243580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264803|NCT01243580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92264804|NCT01243580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264805|NCT01243580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264806|NCT01243580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92264807|NCT01243580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264808|NCT01243580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264809|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264810|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264811|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92264812|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92264813|NCT01743521|Ribavirin|ribavirin|mesh-list
92264814|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
92264815|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264816|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
92264817|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264818|NCT00361803|Topotecan|topotecan|mesh-list
92264819|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92264820|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264822|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264823|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264824|NCT00361881|Acyclovir|acyclovir|mesh-list
92264825|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
92264826|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
92264827|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264828|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264829|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
92264830|NCT01743677|Tofacitinib|tofacitinib|mesh-list
92264831|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264832|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264833|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92264834|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264835|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264836|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264837|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264838|NCT01743677|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92264839|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92264840|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92264841|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92264842|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
92264843|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264844|NCT01246076|Lenalidomide|lenalidomide|mesh-list
92264845|NCT01246076|Immunologic Factors|immunologic factors|mesh-ancestor
92264846|NCT01246076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264847|NCT01246076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264848|NCT01246076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264849|NCT01246076|Growth Substances|growth substances|mesh-ancestor
92264850|NCT01246076|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264851|NCT01246076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264852|NCT00364455|Epoetin Alfa|epoetin alfa|mesh-list
92264853|NCT00364455|Hematinics|hematinics|mesh-ancestor
92264854|NCT01307462|Fluticasone|fluticasone|mesh-list
92264855|NCT01307462|Xhance|xhance|mesh-list
92264857|NCT01307462|Montelukast|montelukast|mesh-list
92264858|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264859|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92264860|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
91925930|NCT01373931|Moxifloxacin|moxifloxacin|mesh-list
92264861|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264862|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264863|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92264864|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
92264865|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
92264866|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92264867|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264868|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264869|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92264870|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
92264871|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92264872|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92264873|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92264874|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264875|NCT05731089|Aflibercept|aflibercept|mesh-list
92264876|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264877|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264878|NCT05731089|Growth Substances|growth substances|mesh-ancestor
92264879|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264881|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264882|NCT01307618|Interleukin-12|interleukin-12|mesh-list
92264883|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92264884|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
92264885|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264886|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92264887|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92264888|NCT01307618|Growth Substances|growth substances|mesh-ancestor
92264889|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
92264890|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264891|NCT01307930|Anidulafungin|anidulafungin|mesh-list
92264892|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
91917770|NCT02416869|Hormones|hormones|mesh-ancestor
92264893|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264894|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92264895|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264896|NCT05371197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264897|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264898|NCT01746095|Vancomycin|vancomycin|mesh-list
92264899|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92264900|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264901|NCT05730777|Paclitaxel|paclitaxel|mesh-list
92264902|NCT05730777|Carboplatin|carboplatin|mesh-list
92264903|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92264904|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264905|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
92264906|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
92264907|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
92264908|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264909|NCT04425239|Leucovorin|leucovorin|mesh-list
92264910|NCT04425239|Folic Acid|folic acid|mesh-list
92264911|NCT04425239|Fluorouracil|fluorouracil|mesh-list
92264912|NCT04425239|Irinotecan|irinotecan|mesh-list
92264913|NCT04425239|Panitumumab|panitumumab|mesh-list
92264914|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
92264915|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
92264916|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264917|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92264918|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92264919|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92264920|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
92264921|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264922|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92264923|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92264924|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264925|NCT04425239|Antidotes|antidotes|mesh-ancestor
92264926|NCT04425239|Protective Agents|protective agents|mesh-ancestor
92264927|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
92264928|NCT04425239|Vitamins|vitamins|mesh-ancestor
92264929|NCT04425239|Micronutrients|micronutrients|mesh-ancestor
92343642|NCT00005627|Mitosis Modulators|mitosis modulators|mesh-ancestor
92264930|NCT04425239|Hematinics|hematinics|mesh-ancestor
92264931|NCT04425239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92264932|NCT01309802|Botulinum Toxins|botulinum toxins|mesh-list
92264933|NCT01309802|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92264934|NCT01309802|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92264935|NCT01309802|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92264936|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92264937|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264938|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
92264939|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264940|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264941|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92264942|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264943|NCT00366093|Eszopiclone|eszopiclone|mesh-list
92264944|NCT00366093|Zopiclone|zopiclone|mesh-list
92264945|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92264946|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92264947|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264948|NCT04379999|Aspirin|aspirin|mesh-list
92264949|NCT04379999|Atorvastatin|atorvastatin|mesh-list
92264950|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264951|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264952|NCT04379999|Analgesics|analgesics|mesh-ancestor
92264953|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
91935084|NCT02309281|Aflibercept|aflibercept|mesh-list
92264954|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264955|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264956|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264958|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92264959|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92264960|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264961|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92264962|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92264963|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264964|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
92264965|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92264966|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92264967|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
92264968|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92264969|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92264970|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92264971|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92264972|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92264973|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92264974|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
92264975|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92264976|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
92264977|NCT05730621|Aspirin|aspirin|mesh-list
92264978|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
92264979|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92264980|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92264981|NCT05730621|Analgesics|analgesics|mesh-ancestor
92264982|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
92264983|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92264984|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92264985|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92264986|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92264987|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92264988|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92264989|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92264990|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92264991|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92264992|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92264993|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
92264994|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92264995|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
92264996|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92264997|NCT01346072|Tolvaptan|tolvaptan|mesh-list
92343644|NCT00005627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92264998|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92264999|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265000|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
92265001|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265002|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
92265003|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92265004|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
92265005|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265006|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265007|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92265008|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
92265009|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92265010|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
92265011|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265012|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265013|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92265014|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
92265015|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
92265016|NCT04292483|Protective Agents|protective agents|mesh-ancestor
92265017|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
92265018|NCT01347008|Citric Acid|citric acid|mesh-list
92265019|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
92265020|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
92265021|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92265022|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
92265023|NCT01347008|Sequestering Agents|sequestering agents|mesh-ancestor
92265024|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265025|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
92265026|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92265027|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92265028|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265029|NCT01347008|Urological Agents|urological agents|mesh-ancestor
92265030|NCT05343429|Aspirin|aspirin|mesh-list
92265031|NCT05343429|Benzydamine|benzydamine|mesh-list
92265032|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92265033|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92265034|NCT05343429|Analgesics|analgesics|mesh-ancestor
92265035|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
92265036|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265037|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265038|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92265039|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265040|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92265041|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92265042|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265043|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92265044|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92265045|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265047|NCT01310582|Sevoflurane|sevoflurane|mesh-list
92265048|NCT01310582|Desflurane|desflurane|mesh-list
92265049|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92265050|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92265051|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
92265052|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
92265053|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265054|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265055|NCT05193591|Autoantibodies|autoantibodies|mesh-list
92265056|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
92265057|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265058|NCT01311674|Vaccines|vaccines|mesh-list
92265059|NCT01311674|Immunologic Factors|immunologic factors|mesh-ancestor
92265060|NCT01311674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265061|NCT05561751|Propranolol|propranolol|mesh-list
92265062|NCT05561751|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92265063|NCT05561751|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92265064|NCT05561751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92265065|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343649|NCT00005639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92265066|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265067|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265069|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92265070|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
92265071|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
92265072|NCT05081193|Testosterone|testosterone|mesh-list
92265073|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
92265074|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
92265075|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92265076|NCT05081193|Androgens|androgens|mesh-ancestor
92265077|NCT05081193|Hormones|hormones|mesh-ancestor
92265078|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265079|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265080|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92265081|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265082|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
92265083|NCT01349972|Cytarabine|cytarabine|mesh-list
92265084|NCT01349972|Daunorubicin|daunorubicin|mesh-list
92265085|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
92265086|NCT01349972|Alvocidib|alvocidib|mesh-list
92265087|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92265088|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
92265089|NCT01349972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265090|NCT01349972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265091|NCT01349972|Antiviral Agents|antiviral agents|mesh-ancestor
92265092|NCT01349972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265093|NCT01349972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92265094|NCT01349972|Immunologic Factors|immunologic factors|mesh-ancestor
92265095|NCT01349972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265096|NCT01349972|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92265097|NCT01349972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92265098|NCT01349972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92265099|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265100|NCT01349972|Analgesics|analgesics|mesh-ancestor
92265101|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
92265102|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265103|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
92265104|NCT01349972|Growth Substances|growth substances|mesh-ancestor
92265105|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92265106|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
92265107|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
92265108|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92265109|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92265110|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265111|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
92265112|NCT01248104|Coagulants|coagulants|mesh-ancestor
92265113|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
92265114|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92265115|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
92265116|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265117|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265118|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92265119|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
92265120|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92265121|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
91917994|NCT02162485|Xhance|xhance|mesh-list
92265122|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265123|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265124|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92265125|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
92265126|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
92265127|NCT01748045|Protective Agents|protective agents|mesh-ancestor
92265128|NCT01312766|Menotropins|menotropins|mesh-list
92265129|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92265130|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
92265131|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92265132|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265134|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
92265135|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92265136|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265137|NCT04522167|Aflibercept|aflibercept|mesh-list
92265138|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92265139|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92265141|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265142|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92265143|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265144|NCT01248416|Letrozole|letrozole|mesh-list
92265145|NCT01248416|Anastrozole|anastrozole|mesh-list
92265146|NCT01248416|Hormones|hormones|mesh-list
92265147|NCT01248416|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92265148|NCT01248416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265149|NCT01248416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265150|NCT01248416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265151|NCT01248416|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92265152|NCT01248416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265153|NCT01248416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265154|NCT01248416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92265155|NCT01248416|Hormone Antagonists|hormone antagonists|mesh-ancestor
92265156|NCT01248416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92265157|NCT01749293|Cyclophosphamide|cyclophosphamide|mesh-list
92265158|NCT01749293|Busulfan|busulfan|mesh-list
92265159|NCT01749293|Fludarabine|fludarabine|mesh-list
92265160|NCT01749293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92265161|NCT01749293|Immunologic Factors|immunologic factors|mesh-ancestor
92265162|NCT01749293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265163|NCT01749293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265164|NCT01749293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92265165|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
92265166|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265167|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265168|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92265169|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
92265170|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92265171|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92265172|NCT01250210|Estradiol|estradiol|mesh-list
92265173|NCT01250210|Estrogens|estrogens|mesh-ancestor
92265174|NCT01250210|Hormones|hormones|mesh-ancestor
92265175|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265176|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265177|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92265178|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
92265179|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92265180|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92265181|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92265182|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92265183|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92265184|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92265185|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
92265186|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
92265187|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92265188|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265189|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92265190|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92265191|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265192|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265193|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265194|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91918066|NCT04320914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265195|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92265196|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92265197|NCT01312844|Scopolamine|scopolamine|mesh-list
92265198|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92265199|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92265200|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
92265201|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
92265202|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265203|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265204|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92265206|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92265207|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
92265208|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265209|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265210|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92265211|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
92265213|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92265214|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92265215|NCT01750931|Analgesics|analgesics|mesh-ancestor
92265216|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
92265217|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265218|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265219|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92265220|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265221|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92265222|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92265223|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265224|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265225|NCT01731041|Ticagrelor|ticagrelor|mesh-list
92265226|NCT01731041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92265227|NCT01731041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92265228|NCT01731041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92265229|NCT01731041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92265230|NCT01731041|Purinergic Agents|purinergic agents|mesh-ancestor
92265231|NCT01731041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265232|NCT01731041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265233|NCT01731041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265234|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92265235|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265236|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265237|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265238|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92265239|NCT01752413|Ferrous gluconate|ferrous gluconate|mesh-list
92265240|NCT01752413|Hematinics|hematinics|mesh-ancestor
92265241|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92265242|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92265243|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92265244|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265245|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265247|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92265248|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92265249|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92265250|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
92265251|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265252|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265253|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92265254|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92265255|NCT01731119|Serotonin Agents|serotonin agents|mesh-ancestor
92265256|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92265257|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92265258|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
92265259|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
92265260|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265261|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
92265262|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265263|NCT04750707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265264|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92265265|NCT01732445|Danazol|danazol|mesh-list
92265266|NCT01732445|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92265267|NCT01732445|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92265268|NCT01732445|Hormone Antagonists|hormone antagonists|mesh-ancestor
92265269|NCT01732445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265270|NCT01732445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265271|NCT01732445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92265272|NCT01732445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265273|NCT01732445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265274|NCT01250834|Dulaglutide|dulaglutide|mesh-list
92265276|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92265277|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92265278|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
92265279|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265280|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92265281|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92265282|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265283|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92265284|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265285|NCT04387695|Sorafenib|sorafenib|mesh-list
92265286|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265287|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92265288|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265289|NCT04387695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265290|NCT01354652|Lamivudine|lamivudine|mesh-list
92265291|NCT01354652|Entecavir|entecavir|mesh-list
92265292|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92265293|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92265294|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265295|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265296|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
92265297|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265298|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92265299|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92265300|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
92265301|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92265302|NCT01250990|Niacin|niacin|mesh-list
92265303|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92265304|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
92265305|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265306|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92265307|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
92265308|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
92265309|NCT01250990|Vitamins|vitamins|mesh-ancestor
92265310|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
92265311|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265312|NCT02990975|Ketamine|ketamine|mesh-list
92265313|NCT02990975|Analgesics|analgesics|mesh-ancestor
92265314|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
92265315|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265316|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265317|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92265319|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
92265320|NCT02990975|Anesthetics|anesthetics|mesh-ancestor
92265321|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265322|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92265323|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92265324|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265325|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265326|NCT01315574|Travoprost|travoprost|mesh-list
92265327|NCT01315574|Latanoprost|latanoprost|mesh-list
92265328|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92265329|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92265330|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92265331|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
92265332|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
92265333|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265334|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265335|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265336|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
92265337|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92265338|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265339|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265341|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92343670|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92265342|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265344|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92265345|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
92265346|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265347|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265348|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92265349|NCT04297995|Carboplatin|carboplatin|mesh-list
92265350|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265351|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
92265352|NCT04340349|Bromhexine|bromhexine|mesh-list
92265353|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
92265354|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92265355|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92265356|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265357|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265358|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265359|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265360|NCT04340349|Expectorants|expectorants|mesh-ancestor
92265361|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92265362|NCT04268771|Rituximab|rituximab|mesh-list
92265363|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92265364|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265365|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
92265366|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265367|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265368|NCT04267809|Vitamin D|vitamin d|mesh-list
92265369|NCT04267809|Metformin|metformin|mesh-list
92265370|NCT04267809|Calcium|calcium|mesh-list
92265371|NCT04267809|Vitamins|vitamins|mesh-ancestor
92265372|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
92265373|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265374|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92265375|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92265376|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92265377|NCT02242409|Paclitaxel|paclitaxel|mesh-list
92265378|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92265379|NCT02242409|Gemcitabine|gemcitabine|mesh-list
92265380|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92265381|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265382|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
92265383|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
92265384|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
92265385|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265386|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92265387|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
92265388|NCT00366873|Calcium|calcium|mesh-list
92265389|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92265390|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265391|NCT05317325|Vaccines|vaccines|mesh-list
92265392|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
92265393|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265394|NCT04182399|Zonisamide|zonisamide|mesh-list
92265395|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
92265396|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92265397|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265398|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265399|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92265400|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265401|NCT04246619|Pregabalin|pregabalin|mesh-list
92265402|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92265403|NCT04246619|Analgesics|analgesics|mesh-ancestor
92265404|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
92265405|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265406|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265407|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
92265408|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92265409|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343680|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265410|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265411|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92265412|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92265413|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92265414|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265415|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265416|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92265417|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92265418|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265419|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
92265422|NCT01757561|Sevoflurane|sevoflurane|mesh-list
92265423|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92265424|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265425|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265426|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92265427|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
92265428|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
92265429|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92265430|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92265431|NCT02618187|Vancomycin|vancomycin|mesh-list
92265432|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92265433|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265434|NCT05316857|Itraconazole|itraconazole|mesh-list
92265435|NCT05316857|Rifampin|rifampin|mesh-list
92265436|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
92265437|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265438|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92265439|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92265440|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265441|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265442|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92265443|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
92265444|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265445|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265446|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92265447|NCT05316857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92265448|NCT05316857|Antitubercular Agents|antitubercular agents|mesh-ancestor
92265449|NCT05316857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92265450|NCT05316857|Leprostatic Agents|leprostatic agents|mesh-ancestor
92265451|NCT05316857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92265452|NCT05316857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92265453|NCT05316857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92265454|NCT05316857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92265455|NCT05316857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92265456|NCT05316857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92265457|NCT05316857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92265458|NCT01759277|Anesthetics|anesthetics|mesh-list
92265459|NCT01759277|Anesthetics, Local|anesthetics, local|mesh-list
92265460|NCT01759277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265461|NCT01759277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265462|NCT01759277|Sensory System Agents|sensory system agents|mesh-ancestor
92265463|NCT01759277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265464|NCT02618343|Ondansetron|ondansetron|mesh-list
92265465|NCT02618343|Antiemetics|antiemetics|mesh-ancestor
92265466|NCT02618343|Autonomic Agents|autonomic agents|mesh-ancestor
92265467|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265468|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265469|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92265470|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
92265471|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
92265472|NCT02618343|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92265473|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92265474|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
92265475|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343687|NCT00385931|Valsartan|valsartan|mesh-list
92265476|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265477|NCT02991053|Ketamine|ketamine|mesh-list
92265478|NCT02991053|Analgesics|analgesics|mesh-ancestor
92265479|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
92265480|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265481|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265482|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92265483|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92265484|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
92265485|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
92265486|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265487|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92265488|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92265489|NCT02991053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918370|NCT05540600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265490|NCT02991053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265491|NCT01251536|Cetuximab|cetuximab|mesh-list
92265492|NCT01251536|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92265493|NCT01251536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265494|NCT02620683|Lidocaine|lidocaine|mesh-list
92265495|NCT02620683|Anesthetics, Local|anesthetics, local|mesh-ancestor
92265496|NCT02620683|Anesthetics|anesthetics|mesh-ancestor
92265497|NCT02620683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265498|NCT02620683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265499|NCT02620683|Sensory System Agents|sensory system agents|mesh-ancestor
92265500|NCT02620683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265501|NCT02620683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92265502|NCT02620683|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92265503|NCT02620683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92265504|NCT02620683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265505|NCT02620683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265506|NCT01355588|Ketorolac|ketorolac|mesh-list
92265507|NCT01355588|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92265508|NCT01355588|Lidocaine|lidocaine|mesh-list
92265509|NCT01355588|Anesthetics, Local|anesthetics, local|mesh-ancestor
92265510|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
92265511|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265512|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265513|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
92265514|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265515|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92265516|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92265517|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92265518|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265519|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265520|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92265521|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92265522|NCT01355588|Analgesics|analgesics|mesh-ancestor
92265523|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92265524|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265525|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92265526|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265527|NCT02621619|Acetaminophen|acetaminophen|mesh-list
92265528|NCT02621619|Hydromorphone|hydromorphone|mesh-list
92265529|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92265530|NCT02621619|Analgesics|analgesics|mesh-ancestor
92265531|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
92265532|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265533|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265534|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
92265535|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92265536|NCT02621619|Narcotics|narcotics|mesh-ancestor
92265537|NCT02621619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265538|NCT01253642|Docetaxel|docetaxel|mesh-list
92265539|NCT01253642|Phenelzine|phenelzine|mesh-list
92265540|NCT01253642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265541|NCT01253642|Tubulin Modulators|tubulin modulators|mesh-ancestor
92265542|NCT01253642|Antimitotic Agents|antimitotic agents|mesh-ancestor
92265543|NCT01253642|Mitosis Modulators|mitosis modulators|mesh-ancestor
92265544|NCT01253642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265545|NCT01253642|Antidepressive Agents|antidepressive agents|mesh-ancestor
92265546|NCT01253642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265547|NCT01253642|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92265548|NCT01253642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265549|NCT01357148|Metformin|metformin|mesh-list
92265550|NCT01357148|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92265551|NCT01357148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92265552|NCT01357148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265553|NCT01357148|Incretins|incretins|mesh-ancestor
92265554|NCT01357148|Hormones|hormones|mesh-ancestor
92265555|NCT01357148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265556|NCT01357148|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92265557|NCT01357148|Protease Inhibitors|protease inhibitors|mesh-ancestor
92265558|NCT01357148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265559|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265560|NCT02623803|Lidocaine|lidocaine|mesh-list
92265561|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
92265562|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
92265563|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265564|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265565|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
92265566|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265567|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92265568|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92265569|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92265570|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265571|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265572|NCT02322788|Terbutaline|terbutaline|mesh-list
92265573|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92265574|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
92265575|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265576|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265577|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92265578|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92265579|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
92265580|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
92265581|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92265582|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92265583|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92265584|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92265585|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
92265586|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265587|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265588|NCT02625207|Maraviroc|maraviroc|mesh-list
92265589|NCT02625207|Darunavir|darunavir|mesh-list
92265590|NCT02625207|Cobicistat|cobicistat|mesh-list
92265591|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92265592|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92265593|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92265594|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265595|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92265596|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92265597|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
92265598|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265599|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92265600|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92265601|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92265602|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
92265603|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265604|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92265605|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92265606|NCT05315999|Palonosetron|palonosetron|mesh-list
92265607|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
92265608|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
92265609|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265610|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265611|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92265612|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92265613|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92265614|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
92265615|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265616|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265618|NCT01763645|Bevacizumab|bevacizumab|mesh-list
92265619|NCT01763645|Carboplatin|carboplatin|mesh-list
92265620|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92265621|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265622|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
92265623|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
92265624|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
92265625|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265626|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92265627|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92265628|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92265629|NCT01763645|Growth Substances|growth substances|mesh-ancestor
92265630|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265631|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
92265632|NCT02253173|Estradiol|estradiol|mesh-list
92265633|NCT02253173|Estrogens|estrogens|mesh-ancestor
92265634|NCT02253173|Hormones|hormones|mesh-ancestor
92265635|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265636|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265637|NCT03924791|Dexamethasone|dexamethasone|mesh-list
92265638|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
92265639|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92265640|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92265641|NCT03924791|Prednisolone|prednisolone|mesh-list
92265642|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
92265643|NCT03924791|Lidocaine|lidocaine|mesh-list
92265644|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92265645|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
92265646|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92265647|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
92265648|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
92265649|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265650|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265651|NCT03924791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92265652|NCT03924791|Glucocorticoids|glucocorticoids|mesh-ancestor
92265653|NCT03924791|Hormones|hormones|mesh-ancestor
92265654|NCT03924791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265655|NCT03924791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92265656|NCT03924791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265657|NCT03924791|Anesthetics, Local|anesthetics, local|mesh-ancestor
92265658|NCT03924791|Anesthetics|anesthetics|mesh-ancestor
92265659|NCT03924791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265660|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
92265661|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92265662|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92265663|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92265664|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265665|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265666|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92265667|NCT03924791|Protective Agents|protective agents|mesh-ancestor
92265668|NCT01318694|Ribavirin|ribavirin|mesh-list
92265669|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92265670|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
92265671|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265672|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
92265673|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265674|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92265675|NCT03009578|Hematinics|hematinics|mesh-ancestor
92265676|NCT01361048|Metronidazole|metronidazole|mesh-list
92265677|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265678|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92265679|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92265680|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92265681|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
92265682|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
92265683|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265684|NCT01766219|Protective Agents|protective agents|mesh-ancestor
92265685|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265687|NCT01766219|Vitamins|vitamins|mesh-ancestor
92265688|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
92265689|NCT01767155|Doxorubicin|doxorubicin|mesh-list
92265690|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92265691|NCT01767155|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92265692|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265693|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92265694|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92265695|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265696|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265697|NCT01362686|Rivastigmine|rivastigmine|mesh-list
92265698|NCT01362686|Donepezil|donepezil|mesh-list
92265699|NCT01362686|Galantamine|galantamine|mesh-list
92265700|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92265701|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265702|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265703|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
92265704|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265705|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265706|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
92265707|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92265708|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
92265709|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265710|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92265711|NCT01362686|Protective Agents|protective agents|mesh-ancestor
92265712|NCT01322048|Propranolol|propranolol|mesh-list
92265713|NCT01322048|Clonidine|clonidine|mesh-list
92265714|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92265715|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92265716|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92265717|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265718|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265719|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265720|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92265721|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92265722|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
92265723|NCT01322048|Analgesics|analgesics|mesh-ancestor
92265724|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
92265725|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265726|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
92265727|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
92265728|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92265729|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92265730|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92265731|NCT01322360|Morphine|morphine|mesh-list
92265732|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92265733|NCT01322360|Narcotics|narcotics|mesh-ancestor
92265734|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265735|NCT01322360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265736|NCT01322360|Analgesics|analgesics|mesh-ancestor
92265737|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
92265738|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265739|NCT04351724|Ritonavir|ritonavir|mesh-list
92265740|NCT04351724|Lopinavir|lopinavir|mesh-list
92265741|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
92265742|NCT04351724|Chloroquine|chloroquine|mesh-list
92265743|NCT04351724|Remdesivir|remdesivir|mesh-list
92265744|NCT04351724|Candesartan|candesartan|mesh-list
92265745|NCT04351724|Candesartan cilexetil|candesartan cilexetil|mesh-list
92265746|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
92265747|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
92265748|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92265749|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92265750|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
92265751|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265752|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265753|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92265754|NCT04351724|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92265755|NCT04351724|Antiviral Agents|antiviral agents|mesh-ancestor
92265756|NCT04351724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265757|NCT04351724|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92265758|NCT04351724|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92265759|NCT04351724|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92265760|NCT04351724|Antithrombins|antithrombins|mesh-ancestor
92265761|NCT04351724|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92265762|NCT04351724|Anticoagulants|anticoagulants|mesh-ancestor
92265764|NCT04351724|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92265765|NCT04351724|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92265766|NCT04351724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265767|NCT04351724|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92265768|NCT04351724|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92265769|NCT04351724|Amebicides|amebicides|mesh-ancestor
92265770|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
92265771|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
92265772|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92265773|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92265774|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
92265775|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265776|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92265777|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92265778|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265779|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265781|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
92265782|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
92265783|NCT04351412|Protective Agents|protective agents|mesh-ancestor
92265784|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265785|NCT01364090|Interferons|interferons|mesh-list
92265786|NCT01364090|Ribavirin|ribavirin|mesh-list
92265787|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
92265788|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
92265789|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91918679|NCT03171831|Antimetabolites|antimetabolites|mesh-ancestor
92265790|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265791|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
92265792|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265793|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
92265794|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265795|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
92265796|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265797|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
92265798|NCT03684785|Cemiplimab|cemiplimab|mesh-list
92265799|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92265800|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265801|NCT03684785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92265802|NCT03684785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265803|NCT01364558|Diazepam|diazepam|mesh-list
92265804|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92265805|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
92265806|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
92265807|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
92265808|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265809|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265810|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92265811|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92265812|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265813|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92265814|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92265815|NCT01364558|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92265816|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92265817|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265818|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92265819|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
92265820|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
92265821|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
92265822|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
92265824|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265825|NCT01323140|Testosterone|testosterone|mesh-list
92265826|NCT01323140|Androgens|androgens|mesh-ancestor
92265827|NCT01323140|Hormones|hormones|mesh-ancestor
92265828|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265829|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265830|NCT03516305|Alprazolam|alprazolam|mesh-list
92265831|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92265832|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265833|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265834|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92265835|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92265836|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265837|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
92265838|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
91926006|NCT02547038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92265840|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265841|NCT03823287|Aflibercept|aflibercept|mesh-list
92265842|NCT03823287|Faricimab|faricimab|mesh-list
92265843|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92265844|NCT03823287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92265845|NCT03823287|Growth Substances|growth substances|mesh-ancestor
92265846|NCT03823287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265847|NCT03823287|Growth Inhibitors|growth inhibitors|mesh-ancestor
92265848|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265849|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
92265850|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92265851|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265852|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265853|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
92265854|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265855|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265856|NCT02626611|Omalizumab|omalizumab|mesh-list
92265857|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92265858|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92265859|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
92265860|NCT01260662|Ketamine|ketamine|mesh-list
92265861|NCT01260662|Propofol|propofol|mesh-list
92265862|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92265863|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265864|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265865|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92265866|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
92265867|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
92265868|NCT01260662|Analgesics|analgesics|mesh-ancestor
92265869|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
92265870|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265871|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92265872|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92265873|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92265874|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265875|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265876|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
92265877|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92265878|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92265879|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265880|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
92265881|NCT02327117|Coagulants|coagulants|mesh-ancestor
92265882|NCT01365650|Fluticasone|fluticasone|mesh-list
92265883|NCT01365650|Xhance|xhance|mesh-list
92265884|NCT01365650|Ketorolac|ketorolac|mesh-list
92265885|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92265886|NCT01365650|Phenylephrine|phenylephrine|mesh-list
92265887|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
92265888|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92265889|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92265890|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
92265891|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265892|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343732|NCT05895513|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92265893|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92265894|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
92265895|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
92265896|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92265897|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92265898|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92265900|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
92265901|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92265902|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92265903|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265904|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265905|NCT01365650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92265906|NCT01365650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92265907|NCT01365650|Adrenergic Agents|adrenergic agents|mesh-ancestor
92265908|NCT01365650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265909|NCT01365650|Sympathomimetics|sympathomimetics|mesh-ancestor
92265910|NCT01365650|Nasal Decongestants|nasal decongestants|mesh-ancestor
92265911|NCT01365650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92265912|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92265913|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
92265914|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92265915|NCT01365650|Protective Agents|protective agents|mesh-ancestor
92265916|NCT01324700|Dexetimide|dexetimide|mesh-list
92265917|NCT01324700|Citalopram|citalopram|mesh-list
92265918|NCT01324700|Escitalopram|escitalopram|mesh-list
92265919|NCT01324700|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92265920|NCT01324700|Serotonin|serotonin|mesh-list
92265921|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92265922|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265923|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265924|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265925|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
92265926|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265927|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92265928|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92265929|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
92265930|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
92265931|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265932|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92265933|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92265934|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
92265935|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92265936|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
92265937|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92265938|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92265939|NCT04769297|Ketamine|ketamine|mesh-list
92265940|NCT04769297|Analgesics|analgesics|mesh-ancestor
92265941|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
92265942|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265943|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265944|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91918825|NCT02405793|Analgesics|analgesics|mesh-ancestor
92265945|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92265946|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
92265947|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
92265948|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265949|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92265950|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92265951|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92265952|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265953|NCT02631057|Warfarin|warfarin|mesh-list
92265954|NCT02631057|Dabigatran|dabigatran|mesh-list
92265955|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
92265956|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
92265957|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92265958|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
92343735|NCT05895513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265959|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265960|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265962|NCT02631525|Desflurane|desflurane|mesh-list
92265963|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92265964|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92265965|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265966|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92265967|NCT02631525|Anesthetics, General|anesthetics, general|mesh-ancestor
92265968|NCT02631525|Anesthetics|anesthetics|mesh-ancestor
92265969|NCT02631525|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92265970|NCT03162497|Azithromycin|azithromycin|mesh-list
92265971|NCT03162497|Doxycycline|doxycycline|mesh-list
92265972|NCT03162497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92265973|NCT03162497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92265974|NCT03162497|Antimalarials|antimalarials|mesh-ancestor
92265975|NCT03162497|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92265976|NCT03162497|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92265977|NCT05167643|Anastrozole|anastrozole|mesh-list
92265978|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92265979|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92265980|NCT05167643|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92265981|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92265982|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92265983|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265984|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92265986|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92265987|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265988|NCT01366196|Pregabalin|pregabalin|mesh-list
92265989|NCT01366196|Analgesics|analgesics|mesh-ancestor
92265990|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
92265991|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92265992|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92265993|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
92265994|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92265995|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92265996|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92265997|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92265998|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92265999|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92266000|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266001|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92266002|NCT01366976|Acetaminophen|acetaminophen|mesh-list
92266003|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266004|NCT01366976|Analgesics|analgesics|mesh-ancestor
92266005|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
92266006|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266007|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266008|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
92266009|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
92266010|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92266011|NCT01777217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92266012|NCT01777217|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266013|NCT01777217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266014|NCT01777217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266015|NCT01777217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266016|NCT01777217|Urological Agents|urological agents|mesh-ancestor
92266017|NCT02251379|Fluticasone|fluticasone|mesh-list
92266019|NCT02251379|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92266020|NCT02251379|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92266021|NCT02251379|Autonomic Agents|autonomic agents|mesh-ancestor
92266022|NCT02251379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266023|NCT02251379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266024|NCT02251379|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92266025|NCT02251379|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266026|NCT02251379|Glucocorticoids|glucocorticoids|mesh-ancestor
92266027|NCT02251379|Hormones|hormones|mesh-ancestor
92266028|NCT02251379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266029|NCT02251379|Sympathomimetics|sympathomimetics|mesh-ancestor
92266030|NCT02251379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266031|NCT02251379|Dermatologic Agents|dermatologic agents|mesh-ancestor
92266032|NCT02251379|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92266033|NCT02255513|Methylphenidate|methylphenidate|mesh-list
92266034|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92266035|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266036|NCT02255513|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92266037|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92266038|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266039|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266040|NCT02255513|Dopamine Agents|dopamine agents|mesh-ancestor
92266041|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266042|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
92266043|NCT01778465|Salicylates|salicylates|mesh-list
92266044|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266045|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266046|NCT01778465|Analgesics|analgesics|mesh-ancestor
92266047|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
92266048|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266049|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266050|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266051|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266052|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92266053|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266054|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266055|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266056|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
92266057|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
92266058|NCT01778465|Dermatologic Agents|dermatologic agents|mesh-ancestor
92266059|NCT01779167|Thalidomide|thalidomide|mesh-list
92266060|NCT01779167|Rituximab|rituximab|mesh-list
92266061|NCT01779167|Lenalidomide|lenalidomide|mesh-list
92266062|NCT01779167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266063|NCT01779167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266064|NCT01779167|Immunologic Factors|immunologic factors|mesh-ancestor
92266065|NCT01779167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266066|NCT01779167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266067|NCT01779167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92266068|NCT01779167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92266069|NCT01779167|Growth Substances|growth substances|mesh-ancestor
92266070|NCT01779167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92266071|NCT01779167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266072|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
92266073|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92266074|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266075|NCT01780337|Oxytocin|oxytocin|mesh-list
92266076|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
92266077|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92266078|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266079|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92266080|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92266081|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92266082|NCT02251613|Epinastine|epinastine|mesh-list
92266083|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266084|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266085|NCT02251613|Analgesics|analgesics|mesh-ancestor
92266086|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
92266087|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266088|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266089|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266090|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266091|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92266092|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92266093|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91918976|NCT02401269|Aspirin|aspirin|mesh-list
92266095|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
92266096|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266097|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266098|NCT02865473|Pilocarpine|pilocarpine|mesh-list
92266099|NCT02865473|Miotics|miotics|mesh-ancestor
92266100|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
92266101|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266102|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266103|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92266104|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92266105|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266106|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343742|NCT05895448|Sofosbuvir|sofosbuvir|mesh-list
92266107|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266108|NCT02850419|Doxorubicin|doxorubicin|mesh-list
92266109|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92266110|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92266111|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266112|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92266113|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92266114|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266115|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266116|NCT02841371|Edetic Acid|edetic acid|mesh-list
92266117|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
92266118|NCT02841371|Antidotes|antidotes|mesh-ancestor
92266119|NCT02841371|Protective Agents|protective agents|mesh-ancestor
92266120|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266121|NCT02841371|Chelating Agents|chelating agents|mesh-ancestor
92266122|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
92266123|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266124|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92266125|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
92266126|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92266127|NCT01783847|Prednisolone|prednisolone|mesh-list
92266128|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92266129|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
92266130|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92266131|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
92266132|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
92266133|NCT01783847|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92266134|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
92266135|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266136|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
92266137|NCT01783847|Hormones|hormones|mesh-ancestor
92266138|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266139|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266140|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92266141|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266142|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
92266143|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
92266144|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266145|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266146|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92266147|NCT01783847|Protective Agents|protective agents|mesh-ancestor
92266148|NCT01783847|Hematinics|hematinics|mesh-ancestor
92266149|NCT02585375|Latanoprost|latanoprost|mesh-list
92266150|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92266151|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92266152|NCT02516813|Peposertib|peposertib|mesh-list
92266153|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92266154|NCT02516813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266155|NCT02516813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266156|NCT01785095|Hormones|hormones|mesh-list
92266157|NCT01785095|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92266158|NCT01785095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266159|NCT01785095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266160|NCT01786343|Decitabine|decitabine|mesh-list
92266161|NCT01786343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92266162|NCT01786343|Antimetabolites|antimetabolites|mesh-ancestor
92266163|NCT01786343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266164|NCT01786343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266165|NCT01786343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266166|NCT03362775|Propofol|propofol|mesh-list
92266167|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92266168|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266169|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266170|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92266172|NCT03362775|Anesthetics|anesthetics|mesh-ancestor
92266173|NCT01786967|Fesoterodine|fesoterodine|mesh-list
92266174|NCT01786967|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92266175|NCT01786967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92266176|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266177|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266178|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266179|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343749|NCT05895370|Analgesics|analgesics|mesh-ancestor
92266180|NCT01786967|Urological Agents|urological agents|mesh-ancestor
92266181|NCT02392871|Trametinib|trametinib|mesh-list
92266182|NCT02392871|Dabrafenib|dabrafenib|mesh-list
92266183|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266184|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92266185|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266186|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266188|NCT02382575|Tacrolimus|tacrolimus|mesh-list
92266189|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92266190|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266191|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266192|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
92266193|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266194|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266195|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266196|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266197|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266198|NCT01807871|Nicotine|nicotine|mesh-list
92266199|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92266200|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
92266201|NCT01807871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266202|NCT01807871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266203|NCT01807871|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92266204|NCT01807871|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92266205|NCT01807871|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266206|NCT01807871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266207|NCT01807871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266208|NCT01263938|Atorvastatin|atorvastatin|mesh-list
92266209|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92266210|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92266211|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
92266212|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266213|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92266214|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92266215|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266216|NCT02327741|Clopidogrel|clopidogrel|mesh-list
92266217|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92266218|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92266219|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92266220|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92266221|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
92266222|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266223|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266224|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266225|NCT00367185|Thalidomide|thalidomide|mesh-list
92266226|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266227|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
92266228|NCT00367185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266229|NCT00367185|Leprostatic Agents|leprostatic agents|mesh-ancestor
92266230|NCT00367185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92266231|NCT00367185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266232|NCT00367185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92266233|NCT00367185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92266234|NCT00367185|Growth Substances|growth substances|mesh-ancestor
92266235|NCT00367185|Growth Inhibitors|growth inhibitors|mesh-ancestor
92266236|NCT00367185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266237|NCT02635035|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92266238|NCT02635035|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92266239|NCT02635035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266240|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92266241|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92266242|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266243|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266244|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
92266245|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266246|NCT03283137|Pembrolizumab|pembrolizumab|mesh-list
92266247|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266248|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266249|NCT03283137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92266250|NCT03283137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266252|NCT01267136|Tramadol|tramadol|mesh-list
92266253|NCT01267136|Codeine|codeine|mesh-list
92266254|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266255|NCT01267136|Analgesics|analgesics|mesh-ancestor
92266256|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
92266257|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266258|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266259|NCT01267136|Antipyretics|antipyretics|mesh-ancestor
92266260|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92266261|NCT01267136|Narcotics|narcotics|mesh-ancestor
92266262|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266263|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
92266264|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266265|NCT01370564|Diuretics|diuretics|mesh-list
92266266|NCT01370564|Natriuretic Agents|natriuretic agents|mesh-ancestor
92266267|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266268|NCT00367263|Ciclesonide|ciclesonide|mesh-list
92266269|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
92266270|NCT00367263|Hormones|hormones|mesh-ancestor
92266271|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266272|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266273|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92266274|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92266275|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
92266276|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
92266277|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266278|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266279|NCT01371110|Midazolam|midazolam|mesh-list
92266280|NCT01371110|Ketamine|ketamine|mesh-list
92266281|NCT01371110|Analgesics|analgesics|mesh-ancestor
92266282|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
92266283|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266284|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266285|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92266286|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92266287|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
92266288|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
92266289|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266290|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92266291|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92266292|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266293|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266294|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92266295|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92266296|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92266297|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92266298|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92266299|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
92266300|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
92266301|NCT01791491|Abatacept|abatacept|mesh-list
92266302|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92266303|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266304|NCT01791491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266305|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266306|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266307|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
92266308|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266309|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266310|NCT00367419|Erythromycin|erythromycin|mesh-list
92266311|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
92266312|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92266313|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
92266314|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92266315|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266316|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266317|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92266318|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266319|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343754|NCT05895305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92266321|NCT01372202|Fluorouracil|fluorouracil|mesh-list
92266322|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
92266323|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92266324|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266325|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92266326|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92266327|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92266328|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266329|NCT01372202|Antimetabolites|antimetabolites|mesh-ancestor
92266330|NCT01372202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92266331|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266332|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
92266333|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266334|NCT01811147|Norepinephrine|norepinephrine|mesh-list
92266335|NCT01811147|Serotonin|serotonin|mesh-list
92266336|NCT01811147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92266337|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92266338|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92266339|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
92266340|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266341|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266342|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266343|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
92266344|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
92266345|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266346|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92266347|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92266348|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
92266349|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92266350|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266351|NCT01373450|Liraglutide|liraglutide|mesh-list
92266352|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92266353|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266354|NCT01373450|Incretins|incretins|mesh-ancestor
92266355|NCT01373450|Hormones|hormones|mesh-ancestor
92266356|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266357|NCT01793285|Etanercept|etanercept|mesh-list
92266358|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266359|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266360|NCT01793285|Analgesics|analgesics|mesh-ancestor
92266361|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
92266362|NCT01793285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266363|NCT01793285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266364|NCT01793285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266365|NCT01793285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266366|NCT01793285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266367|NCT01793285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266368|NCT01793285|Immunologic Factors|immunologic factors|mesh-ancestor
92266369|NCT05049525|Itraconazole|itraconazole|mesh-list
92266370|NCT05049525|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92266371|NCT05049525|Terbinafine|terbinafine|mesh-list
92266372|NCT05049525|Antifungal Agents|antifungal agents|mesh-ancestor
92266373|NCT05049525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266374|NCT05049525|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92266375|NCT05049525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92266376|NCT05049525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266377|NCT05049525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266378|NCT05049525|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92266379|NCT05049525|Hormone Antagonists|hormone antagonists|mesh-ancestor
92266380|NCT05049525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266381|NCT05049525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266382|NCT05049525|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92266383|NCT01811693|Nitroglycerin|nitroglycerin|mesh-list
92266384|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
92266385|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92266386|NCT02639637|Valsartan|valsartan|mesh-list
92266387|NCT02639637|Enalaprilat|enalaprilat|mesh-list
92266388|NCT02639637|Enalapril|enalapril|mesh-list
92266389|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92266390|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266391|NCT02639637|Incretins|incretins|mesh-ancestor
92266392|NCT02639637|Hormones|hormones|mesh-ancestor
92266393|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266394|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92266395|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
92266396|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266397|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266398|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92266399|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92266400|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92266401|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92266403|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92266404|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92266405|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92266406|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
92266407|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
92266408|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266409|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266410|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266412|NCT01794455|Candesartan cilexetil|candesartan cilexetil|mesh-list
92266413|NCT01794455|Sertraline|sertraline|mesh-list
92266414|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
92266415|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92266416|NCT01794455|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92266417|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92266418|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266419|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266420|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266421|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
92266422|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266423|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92266424|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92266425|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92266426|NCT01332500|Naproxen|naproxen|mesh-list
92266427|NCT01332500|Sumatriptan|sumatriptan|mesh-list
92266428|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266429|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266430|NCT01332500|Analgesics|analgesics|mesh-ancestor
92266431|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
92266432|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266433|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266434|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266435|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266436|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
92266437|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92266438|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266439|NCT01332500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266440|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92266441|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92266442|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92266443|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
92266444|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266445|NCT01812005|Rituximab|rituximab|mesh-list
92266446|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266447|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266448|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
92266449|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266450|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266451|NCT01332578|Acetaminophen|acetaminophen|mesh-list
92266452|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
92266453|NCT01332578|Phenylephrine|phenylephrine|mesh-list
92266454|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
92266455|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266456|NCT01332578|Analgesics|analgesics|mesh-ancestor
92266457|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
92266458|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266459|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266460|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
92266461|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
92266462|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266463|NCT01332578|Protective Agents|protective agents|mesh-ancestor
91919359|NCT05613842|Copper|copper|mesh-list
92266465|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
92266466|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92266467|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
92266468|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
92266470|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92266471|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
92266472|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266473|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92266474|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92266475|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92266476|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
92266477|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266478|NCT01333592|Mitiglinide|mitiglinide|mesh-list
92266479|NCT01333592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92266480|NCT01333592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266481|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
92266482|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92266483|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266484|NCT01267292|Buspirone|buspirone|mesh-list
92266485|NCT01267292|Methylphenidate|methylphenidate|mesh-list
92266486|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92266487|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266488|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92266489|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92266490|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266491|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266492|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
92266493|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266494|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92266495|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92266496|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266497|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92266498|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92266499|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
92266500|NCT01734161|Dexamethasone|dexamethasone|mesh-list
92266501|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266502|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
92266503|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
92266504|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266505|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266506|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266507|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
92266508|NCT01734161|Hormones|hormones|mesh-ancestor
92266509|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266510|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92266511|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266512|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92266513|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
92266514|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266515|NCT01797575|Aspirin|aspirin|mesh-list
92266516|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
92266517|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92266518|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266519|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266520|NCT01797575|Analgesics|analgesics|mesh-ancestor
92266521|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
92266522|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266523|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266524|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266525|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266526|NCT01797575|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92266527|NCT01797575|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92266528|NCT01797575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266529|NCT01797575|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92266530|NCT01797575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92266531|NCT01797575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266532|NCT01797575|Antipyretics|antipyretics|mesh-ancestor
92266533|NCT01797575|Antiviral Agents|antiviral agents|mesh-ancestor
92266534|NCT01797575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343766|NCT05895136|Enoxaparin|enoxaparin|mesh-list
92266535|NCT01797575|Expectorants|expectorants|mesh-ancestor
92266536|NCT01797575|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266537|NCT01797575|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92266538|NCT01797575|Antioxidants|antioxidants|mesh-ancestor
92266539|NCT01797575|Protective Agents|protective agents|mesh-ancestor
92266540|NCT01797575|Antidotes|antidotes|mesh-ancestor
92266541|NCT02641353|Thalidomide|thalidomide|mesh-list
92266542|NCT02641353|Apremilast|apremilast|mesh-list
92266543|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266544|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266545|NCT02641353|Analgesics|analgesics|mesh-ancestor
92266546|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
92266547|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266548|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266549|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266550|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266551|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92266552|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92266553|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266554|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266555|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266556|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
92266557|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
92266558|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92266559|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266560|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92266561|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92266562|NCT02641353|Growth Substances|growth substances|mesh-ancestor
92266563|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
92266564|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266565|NCT01378520|Ketoconazole|ketoconazole|mesh-list
92266566|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
92266567|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266568|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92266569|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92266570|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266571|NCT01378520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266572|NCT01378520|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92266574|NCT01378520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266575|NCT01378520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266576|NCT01378520|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92266577|NCT01378988|Dexmedetomidine|dexmedetomidine|mesh-list
92266578|NCT01378988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92266579|NCT01378988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266580|NCT01378988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266581|NCT01378988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266582|NCT01378988|Analgesics|analgesics|mesh-ancestor
92266583|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
92266584|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266585|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92266586|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92266587|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92266588|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
92266589|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266590|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266591|NCT01335620|Tenofovir|tenofovir|mesh-list
92266592|NCT01335620|Emtricitabine|emtricitabine|mesh-list
92266593|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
92266594|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
92266595|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266596|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92266597|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92266598|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266599|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266600|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92266601|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92266602|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92266603|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92266604|NCT01335932|Ganciclovir|ganciclovir|mesh-list
92266605|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92266606|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
92266607|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266608|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92266609|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266610|NCT01335932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266611|NCT01273766|Deferasirox|deferasirox|mesh-list
92266612|NCT01273766|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92266613|NCT01273766|Chelating Agents|chelating agents|mesh-ancestor
92266614|NCT01273766|Sequestering Agents|sequestering agents|mesh-ancestor
92266615|NCT01273766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266617|NCT01403246|Chlorambucil|chlorambucil|mesh-list
92266618|NCT01403246|Immunologic Factors|immunologic factors|mesh-ancestor
92266619|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266620|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92266621|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92266622|NCT01403246|Growth Substances|growth substances|mesh-ancestor
92266623|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92266624|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266625|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92266626|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
92266627|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266628|NCT01734551|Clonidine|clonidine|mesh-list
92266629|NCT01734551|Morphine|morphine|mesh-list
92266630|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92266631|NCT01734551|Narcotics|narcotics|mesh-ancestor
92266632|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266633|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266634|NCT01734551|Analgesics|analgesics|mesh-ancestor
92266635|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
92266636|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266637|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92266638|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
92266639|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
92266640|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92266641|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92266642|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92266643|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
92266644|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266645|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266646|NCT01404260|Carboplatin|carboplatin|mesh-list
92266647|NCT01404260|Gemcitabine|gemcitabine|mesh-list
92266648|NCT01404260|Gefitinib|gefitinib|mesh-list
92266649|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266650|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92266651|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
92266652|NCT01404260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266653|NCT01404260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92266654|NCT01404260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266655|NCT02235909|Losartan|losartan|mesh-list
92266656|NCT02235909|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92266657|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92266658|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92266659|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92266660|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92266661|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266662|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92266663|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92266664|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92266665|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
92266666|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266667|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266668|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92266669|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92266670|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
92266671|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266672|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
92266673|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92266674|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
92266675|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343771|NCT05895123|Atorvastatin|atorvastatin|mesh-list
92266676|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266677|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92266678|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266679|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
92266680|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92266681|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266682|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266683|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266684|NCT01799213|Meloxicam|meloxicam|mesh-list
92266685|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266686|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266688|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
92266689|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266690|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266691|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266692|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266693|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92266694|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92266695|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266696|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266697|NCT01383200|Lidocaine|lidocaine|mesh-list
92266698|NCT01383200|Tetracaine|tetracaine|mesh-list
92266699|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
92266700|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
92266701|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266702|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266703|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
92266704|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266705|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92266706|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92266707|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92266708|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266709|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266710|NCT05588037|Dexamethasone|dexamethasone|mesh-list
92266711|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
92266712|NCT05588037|BB 1101|bb 1101|mesh-list
92266713|NCT05588037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266714|NCT05588037|Antiemetics|antiemetics|mesh-ancestor
92266715|NCT05588037|Autonomic Agents|autonomic agents|mesh-ancestor
92266716|NCT05588037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266717|NCT05588037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266718|NCT05588037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266720|NCT05588037|Hormones|hormones|mesh-ancestor
92266721|NCT05588037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266722|NCT05588037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92266723|NCT05588037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266724|NCT05588037|Protease Inhibitors|protease inhibitors|mesh-ancestor
92266725|NCT05588037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266726|NCT05588037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266727|NCT02194088|Diclofenac|diclofenac|mesh-list
92266728|NCT02194088|Atropine|atropine|mesh-list
92266729|NCT02194088|Analgesics|analgesics|mesh-list
92266730|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266731|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266732|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
92266733|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266734|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266735|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266736|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266737|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92266738|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266739|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266740|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92266741|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92266742|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92266743|NCT02194088|Autonomic Agents|autonomic agents|mesh-ancestor
92266744|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92266745|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266747|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
92266748|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92266749|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92266750|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266751|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266752|NCT02023593|Leucovorin|leucovorin|mesh-list
92266753|NCT02023593|Fluorouracil|fluorouracil|mesh-list
92266754|NCT02023593|Irinotecan|irinotecan|mesh-list
92266755|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
92266756|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266757|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92266758|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266759|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266760|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
92266761|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266762|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92266763|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92266764|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266765|NCT02023593|Antidotes|antidotes|mesh-ancestor
92266766|NCT02023593|Protective Agents|protective agents|mesh-ancestor
92266767|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
92266768|NCT02023593|Vitamins|vitamins|mesh-ancestor
92266769|NCT02023593|Micronutrients|micronutrients|mesh-ancestor
92266770|NCT01978431|Cocaine|cocaine|mesh-list
92266771|NCT01978431|Methylphenidate|methylphenidate|mesh-list
92266772|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92266773|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266774|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92266775|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92266776|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266777|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266778|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
92266779|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266780|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
92266781|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
92266782|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266783|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
92266784|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266785|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92266786|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
92266787|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92266788|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266789|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266790|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92266791|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266792|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92266794|NCT02685267|Docetaxel|docetaxel|mesh-list
92266795|NCT02685267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266796|NCT02685267|Tubulin Modulators|tubulin modulators|mesh-ancestor
92266797|NCT02685267|Antimitotic Agents|antimitotic agents|mesh-ancestor
92266798|NCT02685267|Mitosis Modulators|mitosis modulators|mesh-ancestor
92266799|NCT02685267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266800|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266801|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
92266802|NCT02685267|Hormones|hormones|mesh-ancestor
92266803|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266804|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266805|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92266806|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
92266807|NCT02257541|Infigratinib|infigratinib|mesh-list
92266808|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266809|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92266811|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266812|NCT01817855|AZD7624|azd7624|mesh-list
92266813|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92266814|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266815|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266816|NCT00368121|Dexamethasone|dexamethasone|mesh-list
92266817|NCT00368121|Cetuximab|cetuximab|mesh-list
92266818|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266819|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
92266820|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
92266821|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266822|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266823|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266824|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
92266825|NCT00368121|Hormones|hormones|mesh-ancestor
92266826|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266827|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92266828|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266829|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266830|NCT00367497|Cytarabine|cytarabine|mesh-list
92266831|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
92266832|NCT00367497|Rituximab|rituximab|mesh-list
92266833|NCT00367497|Etoposide|etoposide|mesh-list
92266834|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92266835|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266836|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
92266837|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266838|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266839|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92266841|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92266842|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266843|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266844|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92266845|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
92266846|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
92266847|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266848|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266849|NCT00367497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266850|NCT00367497|Antiemetics|antiemetics|mesh-ancestor
92266851|NCT00367497|Autonomic Agents|autonomic agents|mesh-ancestor
92266852|NCT00367497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266853|NCT00367497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92266854|NCT00367497|Glucocorticoids|glucocorticoids|mesh-ancestor
92266855|NCT00367497|Hormones|hormones|mesh-ancestor
92266856|NCT00367497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266857|NCT00367497|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92266858|NCT00367497|Protective Agents|protective agents|mesh-ancestor
92266859|NCT01387178|Fluticasone|fluticasone|mesh-list
92266860|NCT01387178|Xhance|xhance|mesh-list
92266861|NCT01387178|Bromides|bromides|mesh-list
92266862|NCT01387178|Tiotropium Bromide|tiotropium bromide|mesh-list
92266863|NCT01387178|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92266864|NCT01387178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266865|NCT01387178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92266866|NCT01387178|Autonomic Agents|autonomic agents|mesh-ancestor
92266867|NCT01387178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266868|NCT01387178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266869|NCT01387178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92266870|NCT01387178|Respiratory System Agents|respiratory system agents|mesh-ancestor
92266871|NCT01387178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92266872|NCT01387178|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92266873|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
92266874|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92266875|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266876|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266877|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266878|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92266879|NCT01387178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92266880|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92266881|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
92266882|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
92266883|NCT01805297|Aflibercept|aflibercept|mesh-list
92266884|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92266885|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92266886|NCT01805297|Growth Substances|growth substances|mesh-ancestor
92266887|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266888|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
92266889|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266890|NCT01389284|Naproxen|naproxen|mesh-list
92266891|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92266892|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92266893|NCT01389284|Analgesics|analgesics|mesh-ancestor
92266894|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
92266895|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266896|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266897|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92266898|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266899|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
92266900|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92266901|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266902|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266903|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92266904|NCT01794143|Liraglutide|liraglutide|mesh-list
92266905|NCT01794143|Glimepiride|glimepiride|mesh-list
92266906|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92266907|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92266908|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266909|NCT01794143|Incretins|incretins|mesh-ancestor
92266910|NCT01794143|Hormones|hormones|mesh-ancestor
92266911|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92266912|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
92266913|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266914|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266915|NCT01794143|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92266916|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266917|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
92266918|NCT01547741|Paclitaxel|paclitaxel|mesh-list
92266919|NCT01547741|Docetaxel|docetaxel|mesh-list
92266920|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
92266921|NCT01547741|Doxorubicin|doxorubicin|mesh-list
92266922|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92266923|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92266924|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
92266925|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
92266926|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
92266927|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266928|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92266929|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
92266930|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266931|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92266932|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92266933|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
92266934|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92266935|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92266936|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92266937|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92266938|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266939|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92266940|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92266941|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
92266942|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266944|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
92266945|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
92266946|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92266947|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92266948|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92266949|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92266950|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92266951|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266952|NCT04351490|Cholecalciferol|cholecalciferol|mesh-list
92266953|NCT04351490|Vitamin D|vitamin d|mesh-list
92266954|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92266955|NCT04351490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266956|NCT04351490|Vitamins|vitamins|mesh-ancestor
92266957|NCT04351490|Micronutrients|micronutrients|mesh-ancestor
92266958|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92266959|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
92343791|NCT05894889|Pembrolizumab|pembrolizumab|mesh-list
92343792|NCT05894889|Pemetrexed|pemetrexed|mesh-list
92266960|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92266961|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92266962|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92266963|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92266964|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266965|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92266966|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266967|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266968|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92266969|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266970|NCT03008252|Caseins|caseins|mesh-list
92266971|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
92266972|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
92266973|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266974|NCT05328635|Candesartan|candesartan|mesh-list
92266975|NCT05328635|Candesartan cilexetil|candesartan cilexetil|mesh-list
92266976|NCT05328635|Gabapentin|gabapentin|mesh-list
92266977|NCT05328635|Analgesics|analgesics|mesh-ancestor
92266978|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
92266979|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266980|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266981|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
92266982|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92266983|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92266984|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92266985|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92266986|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92266987|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92266988|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92266989|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92266990|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
92266991|NCT05328635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92266992|NCT05328635|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92266993|NCT05328635|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92266994|NCT01391858|Pregabalin|pregabalin|mesh-list
92266995|NCT01391858|Analgesics|analgesics|mesh-ancestor
92266996|NCT01391858|Sensory System Agents|sensory system agents|mesh-ancestor
92266997|NCT01391858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92266998|NCT01391858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92266999|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
92267000|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92267001|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92267002|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267003|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92267004|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92267005|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92267006|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267007|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92267009|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92267010|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
92267011|NCT01825655|Cetirizine|cetirizine|mesh-list
92267012|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92267013|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92267014|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92267015|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
92267016|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
92267017|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267018|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267019|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267020|NCT02249663|Fluticasone|fluticasone|mesh-list
92267021|NCT02249663|Xhance|xhance|mesh-list
92267022|NCT02249663|Azelastine|azelastine|mesh-list
92267023|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267024|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92267025|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
92267026|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267027|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267028|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92267029|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267030|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267031|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92267032|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92267033|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267034|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267035|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92267036|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92267037|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
92267038|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
92267039|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267040|NCT04237623|Sargramostim|sargramostim|mesh-list
92267041|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
92267042|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267043|NCT01825889|Evacetrapib|evacetrapib|mesh-list
92267044|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92267045|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92267046|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
92267047|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267048|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92267049|NCT02692755|Letrozole|letrozole|mesh-list
92267050|NCT02692755|Fulvestrant|fulvestrant|mesh-list
92267051|NCT02692755|Palbociclib|palbociclib|mesh-list
92267052|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267053|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92267054|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92267055|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267056|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267057|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92267058|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
92267059|NCT02692755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267060|NCT02692755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267061|NCT02692755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267062|NCT02692755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92267063|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92267064|NCT01829399|Epinephrine|epinephrine|mesh-list
92267065|NCT01829399|Bupivacaine|bupivacaine|mesh-list
92267066|NCT01829399|Anesthetics, Local|anesthetics, local|mesh-ancestor
92267067|NCT01829399|Anesthetics|anesthetics|mesh-ancestor
92267068|NCT01829399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267069|NCT01829399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267070|NCT01829399|Sensory System Agents|sensory system agents|mesh-ancestor
92267071|NCT01829399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267072|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92267073|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92267074|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
92267075|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267076|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267077|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92267078|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92267079|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
92267080|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92267081|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267082|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
92267083|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
92267084|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92267085|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
92267086|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92267087|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
92267088|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267089|NCT01394510|Expectorants|expectorants|mesh-ancestor
92267090|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267091|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92267092|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
92267093|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267094|NCT01394510|Protective Agents|protective agents|mesh-ancestor
92267095|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267096|NCT01394510|Antidotes|antidotes|mesh-ancestor
92267097|NCT05580549|Ethanol|ethanol|mesh-list
92267098|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92267099|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267100|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267101|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267102|NCT05327621|Pamiparib|pamiparib|mesh-list
92343800|NCT05894889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92267103|NCT05327621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92267104|NCT05327621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267105|NCT05327621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267106|NCT05327621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267108|NCT05327309|Propranolol|propranolol|mesh-list
92267109|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92267110|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92267111|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
92267112|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267113|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267114|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267115|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92267116|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92267117|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
92267118|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92267119|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267120|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92267121|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
92267122|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267123|NCT05326841|Vitamin D|vitamin d|mesh-list
92267124|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
92267125|NCT05326841|Vitamins|vitamins|mesh-ancestor
92267126|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
92267127|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267128|NCT05326841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92267129|NCT05326841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92267130|NCT01412372|Mesalamine|mesalamine|mesh-list
92267131|NCT01412372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92267132|NCT01412372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92267133|NCT01412372|Analgesics|analgesics|mesh-ancestor
92267134|NCT01412372|Sensory System Agents|sensory system agents|mesh-ancestor
92267135|NCT01412372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920030|NCT02578316|Lenvatinib|lenvatinib|mesh-list
92267136|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267137|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267138|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267139|NCT01414010|Amoxicillin|amoxicillin|mesh-list
92267140|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92267141|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267142|NCT01415960|Leuprolide|leuprolide|mesh-list
92267143|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92267144|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
92267145|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92267146|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267147|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267148|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267149|NCT01833845|Ribavirin|ribavirin|mesh-list
92267150|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
92267151|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
92267152|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267153|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
92267154|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267155|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
92267156|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92267157|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92267158|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267159|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267160|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92267161|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
92267162|NCT01416194|Diphosphonates|diphosphonates|mesh-list
92267163|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92267164|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
92267165|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267166|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267167|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92267168|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92267169|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92267170|NCT01416584|Methadone|methadone|mesh-list
92267171|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267172|NCT01416584|Narcotics|narcotics|mesh-ancestor
92267173|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267174|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267175|NCT01416584|Analgesics|analgesics|mesh-ancestor
92267176|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
92267177|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267178|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
92267179|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267180|NCT02698215|Naltrexone|naltrexone|mesh-list
92267181|NCT02698215|Varenicline|varenicline|mesh-list
92267182|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92267183|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92267184|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267185|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
92267186|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267187|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92267188|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92267189|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
92267190|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267191|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267192|NCT04172961|Cyclosporine|cyclosporine|mesh-list
92267193|NCT04172961|Lifitegrast|lifitegrast|mesh-list
92267194|NCT04172961|Cyclosporins|cyclosporins|mesh-list
92267195|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926007|NCT02547038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92267196|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267197|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92267198|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
92267199|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267200|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
92267201|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267202|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267203|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267204|NCT04172961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92267205|NCT04172961|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92267206|NCT04172961|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92267207|NCT01480232|Nicotine|nicotine|mesh-list
92267208|NCT01480232|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92267209|NCT01480232|Autonomic Agents|autonomic agents|mesh-ancestor
92267210|NCT01480232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267211|NCT01480232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267212|NCT01480232|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91920100|NCT05532020|Diazoxide|diazoxide|mesh-list
92267213|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92267214|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
92267215|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267216|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267217|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
92267218|NCT04049799|Narcotics|narcotics|mesh-ancestor
92267219|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267220|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267221|NCT04049799|Analgesics|analgesics|mesh-ancestor
92267222|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
92267223|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267224|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
92267225|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267226|NCT03008876|Acetaminophen|acetaminophen|mesh-list
92267227|NCT03008876|Ibuprofen|ibuprofen|mesh-list
92267228|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92267229|NCT03008876|Analgesics|analgesics|mesh-ancestor
92267230|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
92267231|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267232|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267233|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
92267234|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92267235|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267236|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267237|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92267238|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267239|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267240|NCT05414487|Ofatumumab|ofatumumab|mesh-list
92267241|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267242|NCT02701257|Glucagon|glucagon|mesh-list
92267243|NCT02701257|Pancrelipase|pancrelipase|mesh-list
92267244|NCT02701257|Pancreatin|pancreatin|mesh-list
92267245|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92267247|NCT02701257|Hormones|hormones|mesh-ancestor
92267248|NCT02701257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267249|NCT02701257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267250|NCT02701257|Incretins|incretins|mesh-ancestor
92267251|NCT01836029|Carboplatin|carboplatin|mesh-list
92267252|NCT01836029|Fluorouracil|fluorouracil|mesh-list
92267253|NCT01836029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267254|NCT01836029|Antimetabolites|antimetabolites|mesh-ancestor
92267255|NCT01836029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267256|NCT01836029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92267257|NCT01836029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92267258|NCT01836029|Immunologic Factors|immunologic factors|mesh-ancestor
92267259|NCT01836029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267260|NCT02703909|Rocuronium|rocuronium|mesh-list
92267261|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92267262|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92267263|NCT02703909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92267264|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267265|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267266|NCT01836185|Evacetrapib|evacetrapib|mesh-list
92267267|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92267268|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92267269|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
92267270|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267271|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92267272|NCT02706249|Enoxaparin|enoxaparin|mesh-list
92267273|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
92267274|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92267275|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92267276|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267277|NCT04740021|Carboplatin|carboplatin|mesh-list
92267278|NCT04740021|Etoposide|etoposide|mesh-list
92267279|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267280|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92267281|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92267282|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92267283|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267284|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267285|NCT02708433|Lidocaine|lidocaine|mesh-list
92267286|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
92267287|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
92267288|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267289|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267290|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
92267291|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267292|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92267293|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92267294|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92267295|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92267296|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267297|NCT03575013|Docetaxel|docetaxel|mesh-list
92267298|NCT03575013|Avelumab|avelumab|mesh-list
92267299|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267300|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92267301|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92267302|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92267303|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267304|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92267305|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
92267306|NCT00559637|Hematinics|hematinics|mesh-ancestor
92267307|NCT03349281|Cytarabine|cytarabine|mesh-list
92267308|NCT03349281|Dexamethasone|dexamethasone|mesh-list
92267309|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
92267310|NCT03349281|Doxorubicin|doxorubicin|mesh-list
92267311|NCT03349281|Methotrexate|methotrexate|mesh-list
92343811|NCT05894447|Naptumomab estafenatox|naptumomab estafenatox|mesh-list
92267312|NCT03349281|Vincristine|vincristine|mesh-list
92267313|NCT03349281|Asparaginase|asparaginase|mesh-list
92267314|NCT03349281|Pegaspargase|pegaspargase|mesh-list
92267315|NCT03349281|Pevonedistat|pevonedistat|mesh-list
92267316|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267317|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
92267319|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267320|NCT03349281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267321|NCT03349281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92267322|NCT03349281|Glucocorticoids|glucocorticoids|mesh-ancestor
92267323|NCT03349281|Hormones|hormones|mesh-ancestor
92267324|NCT03349281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267325|NCT03349281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267326|NCT03349281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267327|NCT03349281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92267328|NCT03349281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92267329|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92267330|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267331|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267332|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92267333|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
92267334|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92267335|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92267336|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
92267337|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267338|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92267339|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92267340|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
92267341|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267342|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92267343|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
92267344|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267345|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92267346|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92267347|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92267348|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92267349|NCT03206151|Leucovorin|leucovorin|mesh-list
92267350|NCT03206151|Folic Acid|folic acid|mesh-list
92267351|NCT03206151|Fluorouracil|fluorouracil|mesh-list
92267352|NCT03206151|Irinotecan|irinotecan|mesh-list
92267353|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
92267354|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
92267355|NCT03206151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267356|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92267357|NCT03206151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267358|NCT03206151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92267359|NCT03206151|Immunologic Factors|immunologic factors|mesh-ancestor
92267360|NCT03206151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267361|NCT03206151|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92267362|NCT03206151|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92267363|NCT03206151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267364|NCT03206151|Antidotes|antidotes|mesh-ancestor
92267365|NCT03206151|Protective Agents|protective agents|mesh-ancestor
92267366|NCT03206151|Vitamin B Complex|vitamin b complex|mesh-ancestor
92267367|NCT03206151|Vitamins|vitamins|mesh-ancestor
92267368|NCT03206151|Micronutrients|micronutrients|mesh-ancestor
92267369|NCT03206151|Hematinics|hematinics|mesh-ancestor
92267370|NCT01841021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92267371|NCT01841021|Immunoconjugates|immunoconjugates|mesh-list
92267372|NCT01841021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92267373|NCT01841021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267374|NCT01841021|Immunotoxins|immunotoxins|mesh-ancestor
92267375|NCT01841021|Immunologic Factors|immunologic factors|mesh-ancestor
92267376|NCT01841021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267377|NCT02714283|Azithromycin|azithromycin|mesh-list
92267378|NCT02714283|Erythromycin|erythromycin|mesh-list
92267379|NCT02714283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92267380|NCT02714283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267381|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92267382|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92267383|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267384|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267385|NCT04814927|Copper|copper|mesh-list
92267386|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92343814|NCT05894447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92267387|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
92267388|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
92267389|NCT04814927|Etonogestrel|etonogestrel|mesh-list
92267390|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92267391|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
92267392|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92267393|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267394|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92267395|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92267396|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92267397|NCT04814927|Trace Elements|trace elements|mesh-ancestor
92267398|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
92267399|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92267400|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92267401|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267402|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267403|NCT04810949|Vitamin D|vitamin d|mesh-list
92267404|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
92267405|NCT04810949|Vitamins|vitamins|mesh-ancestor
92267406|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
92267407|NCT04810949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267408|NCT04810949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92267409|NCT04810949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92267410|NCT04795583|Prednisone|prednisone|mesh-list
92267411|NCT04795583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267412|NCT04795583|Glucocorticoids|glucocorticoids|mesh-ancestor
92267413|NCT04795583|Hormones|hormones|mesh-ancestor
92267414|NCT04795583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267415|NCT04795583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267416|NCT04795583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267417|NCT04795583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267418|NCT02722239|Metformin|metformin|mesh-list
92267419|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
92267420|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92267421|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267422|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92267423|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267424|NCT02578641|Carboplatin|carboplatin|mesh-list
92267425|NCT02578641|Gemcitabine|gemcitabine|mesh-list
92267426|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267427|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92267428|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
92267429|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267430|NCT05084859|Prednisone|prednisone|mesh-list
92267431|NCT05084859|Docetaxel|docetaxel|mesh-list
92267432|NCT05084859|Panitumumab|panitumumab|mesh-list
92267433|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267434|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
92267435|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
92267436|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
92267437|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267438|NCT05084859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267439|NCT05084859|Glucocorticoids|glucocorticoids|mesh-ancestor
92267440|NCT05084859|Hormones|hormones|mesh-ancestor
91920324|NCT02182531|Ephedrine|ephedrine|mesh-list
92267441|NCT05084859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267442|NCT05084859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267443|NCT05084859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267444|NCT05084859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92267445|NCT01846871|Tivozanib|tivozanib|mesh-list
92267446|NCT01846871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92267447|NCT01846871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267448|NCT01846871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267449|NCT02431260|INCB054329|incb054329|mesh-list
92267450|NCT02431260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267451|NCT02055963|Minocycline|minocycline|mesh-list
92267452|NCT02055963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92267453|NCT02055963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267454|NCT01848041|Phenylephrine|phenylephrine|mesh-list
92267455|NCT01848041|Oxymetazoline|oxymetazoline|mesh-list
92267456|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92267457|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92267458|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92267459|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92267460|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
92267461|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267462|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343815|NCT05894447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267463|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267464|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
92267465|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
92267466|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267467|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
92267468|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92267469|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267470|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92267471|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
92267472|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92267473|NCT01848041|Protective Agents|protective agents|mesh-ancestor
92267474|NCT02724033|Dexamethasone|dexamethasone|mesh-list
92267475|NCT02724033|Ondansetron|ondansetron|mesh-list
92267476|NCT02724033|Antiemetics|antiemetics|mesh-list
92267477|NCT02724033|Bupivacaine|bupivacaine|mesh-list
92267478|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267479|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
92267480|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267481|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267482|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92267483|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
92267484|NCT02724033|Hormones|hormones|mesh-ancestor
92267485|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267486|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267487|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267488|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267489|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
92267490|NCT02724033|Anesthetics|anesthetics|mesh-ancestor
92267491|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267492|NCT02724033|Sensory System Agents|sensory system agents|mesh-ancestor
92267493|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
92267494|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267495|NCT02724033|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92267496|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92267497|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
92267498|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267499|NCT02724423|Diazepam|diazepam|mesh-list
92267500|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92267501|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
92267502|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
92267503|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
92267504|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267505|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267506|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92267507|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92267508|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267509|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92267510|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92267511|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92267512|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92267513|NCT02724423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92267514|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92267515|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
92267516|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
91920393|NCT02179645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267517|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
92267518|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
92267519|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267520|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267521|NCT02989259|Apatinib|apatinib|mesh-list
92267522|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267523|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92267524|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267525|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267526|NCT04950621|Propofol|propofol|mesh-list
92267527|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92267528|NCT04950621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267529|NCT04950621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267530|NCT04950621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92267531|NCT04950621|Anesthetics, General|anesthetics, general|mesh-ancestor
92267532|NCT04950621|Anesthetics|anesthetics|mesh-ancestor
92267533|NCT01848899|Bivalirudin|bivalirudin|mesh-list
92267534|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
92267535|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92267536|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92267537|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267538|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267539|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
92267541|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
92267542|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
92267543|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
92267544|NCT02731833|Protective Agents|protective agents|mesh-ancestor
92267545|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267546|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92267547|NCT01852019|Cangrelor|cangrelor|mesh-list
92267548|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92267549|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92267550|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92267551|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92267552|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
92267553|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267554|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267555|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267556|NCT04457219|Hemostatics|hemostatics|mesh-list
92267557|NCT04457219|Coagulants|coagulants|mesh-ancestor
92267558|NCT01852175|Ticagrelor|ticagrelor|mesh-list
92267559|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92267560|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92267561|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92267562|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92267563|NCT01852175|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92267564|NCT01852175|Purinergic Agents|purinergic agents|mesh-ancestor
92267565|NCT01852175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267566|NCT01852175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267567|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267568|NCT02429934|Abatacept|abatacept|mesh-list
92267569|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92267570|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267571|NCT02429934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92267572|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267573|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92267574|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
92267575|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267576|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267577|NCT01852955|Acetaminophen|acetaminophen|mesh-list
92267578|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92267579|NCT01852955|Analgesics|analgesics|mesh-ancestor
92267580|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
92267581|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267582|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267583|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
92267584|NCT00558467|Pramipexole|pramipexole|mesh-list
92267585|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
92267586|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267587|NCT00558467|Protective Agents|protective agents|mesh-ancestor
92267588|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267589|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92267590|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92267591|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
92267592|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
91920466|NCT02177461|Telmisartan|telmisartan|mesh-list
92267593|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267595|NCT04226495|Dsuvia|dsuvia|mesh-list
92267596|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267597|NCT04226495|Narcotics|narcotics|mesh-ancestor
92267598|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267599|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267600|NCT04226495|Analgesics|analgesics|mesh-ancestor
92267601|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
92267602|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267603|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92267604|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92267605|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
92267606|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
92267607|NCT02401230|Tenofovir|tenofovir|mesh-list
92267608|NCT02401230|Emtricitabine|emtricitabine|mesh-list
92267609|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92267610|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
92267611|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267612|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92267613|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92267614|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267615|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267616|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92267617|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92267618|NCT01854359|Idebenone|idebenone|mesh-list
92267619|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
92267620|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267621|NCT01854359|Protective Agents|protective agents|mesh-ancestor
92267622|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267623|NCT01854593|Bevacizumab|bevacizumab|mesh-list
92267624|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92267625|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267626|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92267627|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92267628|NCT01854593|Growth Substances|growth substances|mesh-ancestor
92267629|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267630|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
92267631|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92267632|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
92267633|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
92267634|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267635|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267636|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
92267637|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92267638|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
92267639|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267640|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267641|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92267642|NCT02734953|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267643|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92267645|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267646|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267647|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92267648|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
92267649|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
92267650|NCT02734953|Protective Agents|protective agents|mesh-ancestor
92267651|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92267652|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92267653|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267654|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267655|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92267656|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92267657|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267658|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
92267659|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267660|NCT02735187|Vitamin D|vitamin d|mesh-list
92267661|NCT02735187|Vitamins|vitamins|mesh-ancestor
92267662|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
92267663|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267664|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92267665|NCT02428296|Sirolimus|sirolimus|mesh-list
92267666|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91920550|NCT04141904|Tofacitinib|tofacitinib|mesh-list
92267667|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267668|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92267669|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267670|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
92267671|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92267672|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
92267673|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267674|NCT02643615|Propofol|propofol|mesh-list
92267675|NCT02643615|Desflurane|desflurane|mesh-list
92343824|NCT05894057|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92267676|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92267677|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267678|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267679|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92267680|NCT02643615|Anesthetics, General|anesthetics, general|mesh-ancestor
92267681|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
92267682|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92267683|NCT02265341|Ponatinib|ponatinib|mesh-list
92267684|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267685|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92267686|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267687|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267689|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
92267690|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267691|NCT01421186|Dexamethasone|dexamethasone|mesh-list
92267692|NCT01421186|Lenalidomide|lenalidomide|mesh-list
92267693|NCT01421186|Pomalidomide|pomalidomide|mesh-list
92267694|NCT01421186|Felzartamab|felzartamab|mesh-list
92267695|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267696|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
92267697|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
92267698|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267699|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267700|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92267701|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
92267702|NCT01421186|Hormones|hormones|mesh-ancestor
92267703|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267704|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92267705|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267706|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
92267707|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92267708|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92267709|NCT01421186|Growth Substances|growth substances|mesh-ancestor
92267710|NCT01421186|Growth Inhibitors|growth inhibitors|mesh-ancestor
92267711|NCT01860287|Buprenorphine|buprenorphine|mesh-list
92267712|NCT01860287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267713|NCT01860287|Narcotics|narcotics|mesh-ancestor
92267714|NCT01860287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267715|NCT01860287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267716|NCT01860287|Analgesics|analgesics|mesh-ancestor
92267717|NCT01860287|Sensory System Agents|sensory system agents|mesh-ancestor
92267718|NCT01860287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267719|NCT01860287|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92267720|NCT01421498|Lifitegrast|lifitegrast|mesh-list
92267721|NCT01421498|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92267722|NCT01421498|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92267723|NCT01422200|Vaccines|vaccines|mesh-list
92267724|NCT01422200|Immunologic Factors|immunologic factors|mesh-ancestor
92267725|NCT01422200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267726|NCT01860521|Sufentanil|sufentanil|mesh-list
92267727|NCT01860521|Levobupivacaine|levobupivacaine|mesh-list
92267728|NCT01860521|Gemeprost|gemeprost|mesh-list
92267729|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267730|NCT01860521|Narcotics|narcotics|mesh-ancestor
92267731|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267732|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267733|NCT01860521|Analgesics|analgesics|mesh-ancestor
92267734|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
92267735|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267736|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92267737|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92267738|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
92267739|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
92267740|NCT01860521|Anesthetics, Local|anesthetics, local|mesh-ancestor
92267741|NCT01860521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92267742|NCT01860521|Abortifacient Agents|abortifacient agents|mesh-ancestor
92267743|NCT01860521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92267744|NCT01400906|Fluticasone|fluticasone|mesh-list
92267745|NCT01400906|Xhance|xhance|mesh-list
92267746|NCT01400906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267747|NCT01400906|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92267748|NCT01400906|Autonomic Agents|autonomic agents|mesh-ancestor
92267749|NCT01400906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267750|NCT01400906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267751|NCT01400906|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92267752|NCT01400906|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267753|NCT01400906|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267754|NCT01400906|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92267755|NCT00367653|Azithromycin|azithromycin|mesh-list
92267756|NCT00367653|Chloroquine|chloroquine|mesh-list
92267757|NCT00367653|Mefloquine|mefloquine|mesh-list
92267758|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92267759|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267760|NCT00367653|Amebicides|amebicides|mesh-ancestor
92267761|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92267762|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92267763|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
92267764|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267765|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
92267766|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92267767|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267768|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267769|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92267770|NCT01485380|Analgesics|analgesics|mesh-ancestor
92267771|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
92267772|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267773|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92267774|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92267775|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92267776|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
92267777|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267778|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267779|NCT05445297|Amiodarone|amiodarone|mesh-list
92267780|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92267781|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
92267782|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92267783|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92267784|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267786|NCT05445297|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92267787|NCT05445297|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92267788|NCT05445297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267789|NCT05445297|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92267790|NCT05445297|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92267791|NCT05445297|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92267792|NCT00556673|Fluticasone|fluticasone|mesh-list
92267793|NCT00556673|Mometasone Furoate|mometasone furoate|mesh-list
92267794|NCT00556673|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92267795|NCT00556673|Maleic acid|maleic acid|mesh-list
92267796|NCT00556673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267797|NCT00556673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92267798|NCT00556673|Autonomic Agents|autonomic agents|mesh-ancestor
92267799|NCT00556673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267800|NCT00556673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267801|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92267802|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267803|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267804|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92267805|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92267806|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92267807|NCT00556673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92267808|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
92267809|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267810|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267811|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267812|NCT05437029|Plant Lectins|plant lectins|mesh-list
92267813|NCT05437029|Agglutinins|agglutinins|mesh-ancestor
92267814|NCT05437029|Immunologic Factors|immunologic factors|mesh-ancestor
92267815|NCT05437029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267816|NCT05437029|Coagulants|coagulants|mesh-ancestor
92267817|NCT05437029|Hemagglutinins|hemagglutinins|mesh-ancestor
92267818|NCT01422434|Calcitriol|calcitriol|mesh-list
92343838|NCT05893888|Cisplatin|cisplatin|mesh-list
92343840|NCT05893810|Mupirocin|mupirocin|mesh-list
92267819|NCT01422434|Betamethasone|betamethasone|mesh-list
92267820|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
92267821|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92267822|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
92267823|NCT01422434|Calcipotriene|calcipotriene|mesh-list
92267824|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92267825|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267826|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
92267827|NCT01422434|Hormones|hormones|mesh-ancestor
92267828|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92267829|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267830|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92267831|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92267832|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
92267833|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92267834|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92267835|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92267836|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267837|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92267838|NCT01422434|Vitamins|vitamins|mesh-ancestor
92267839|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
92267840|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92267841|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92267842|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267843|NCT02270255|Lidocaine|lidocaine|mesh-list
92267844|NCT02270255|Ropivacaine|ropivacaine|mesh-list
92267845|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92267846|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
92267847|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267848|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267849|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
92267851|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92267852|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92267853|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92267854|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92267855|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267856|NCT02651259|Vitamins|vitamins|mesh-list
92267857|NCT02651259|Pyridoxine|pyridoxine|mesh-list
92267858|NCT02651259|Pyridoxal|pyridoxal|mesh-list
92267859|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
92267860|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
92267861|NCT02651259|Isoniazid|isoniazid|mesh-list
92267862|NCT02651259|Rifapentine|rifapentine|mesh-list
92267863|NCT02651259|Rifamycins|rifamycins|mesh-list
92267864|NCT02651259|Hydrazine|hydrazine|mesh-list
92267865|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
92267866|NCT02651259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267867|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
92267868|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92267869|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267870|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92267871|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92267872|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
92267873|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267874|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92267875|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92267876|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
92267877|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267878|NCT02271425|Evacetrapib|evacetrapib|mesh-list
92267879|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92267880|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92267881|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
92267882|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267883|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92267884|NCT05442411|Parecoxib|parecoxib|mesh-list
92267885|NCT05442411|Ropivacaine|ropivacaine|mesh-list
92267886|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
92267887|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
92267888|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343846|NCT05893654|Melphalan|melphalan|mesh-list
92267889|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267891|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267892|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92267893|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92267894|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267895|NCT05442411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920765|NCT02183467|Hormones|hormones|mesh-ancestor
92267896|NCT05442411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92267897|NCT05442411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92267899|NCT05442411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92267900|NCT05442411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92267901|NCT05654363|Morphine|morphine|mesh-list
92267902|NCT05654363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267903|NCT05654363|Narcotics|narcotics|mesh-ancestor
92267904|NCT05654363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267905|NCT05654363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267906|NCT05654363|Analgesics|analgesics|mesh-ancestor
92267907|NCT05654363|Sensory System Agents|sensory system agents|mesh-ancestor
92267908|NCT05654363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267909|NCT02651415|Perindopril|perindopril|mesh-list
92267910|NCT02651415|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92267911|NCT02651415|Protease Inhibitors|protease inhibitors|mesh-ancestor
92267912|NCT02651415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267913|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267914|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92267916|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92267917|NCT00555425|Naloxone|naloxone|mesh-list
92267918|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267919|NCT00555425|Narcotics|narcotics|mesh-ancestor
92267920|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267921|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267922|NCT00555425|Analgesics|analgesics|mesh-ancestor
92267923|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
92267924|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267925|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92267927|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
92267928|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267929|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267930|NCT05444673|Cisplatin|cisplatin|mesh-list
92267931|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267932|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
92267933|NCT04338633|Calcium|calcium|mesh-list
92267934|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92267935|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267936|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92267937|NCT01488188|Vaccines|vaccines|mesh-list
92267938|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
92267939|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267940|NCT01489670|Bimatoprost|bimatoprost|mesh-list
92267941|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92267942|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92267943|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92267944|NCT01427504|Etravirine|etravirine|mesh-list
92267945|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92267946|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92267947|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267948|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267949|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
92267950|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92267951|NCT03169361|Ixazomib|ixazomib|mesh-list
92267952|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267953|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
92267954|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92267955|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267956|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
92267957|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
92267958|NCT03021083|Fentanyl|fentanyl|mesh-list
92267959|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92267960|NCT03021083|Narcotics|narcotics|mesh-ancestor
92267961|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92267962|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267963|NCT03021083|Analgesics|analgesics|mesh-ancestor
92267964|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
92267965|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267966|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92267967|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92267968|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
92267969|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
92267970|NCT03000257|Venetoclax|venetoclax|mesh-list
92267971|NCT03000257|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92267972|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92267973|NCT03000257|Immunoconjugates|immunoconjugates|mesh-ancestor
92267974|NCT03000257|Immunologic Factors|immunologic factors|mesh-ancestor
92267975|NCT03000257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267976|NCT02945813|Metformin|metformin|mesh-list
92267977|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92267978|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267979|NCT05442801|Tropicamide|tropicamide|mesh-list
92267980|NCT05442801|Cyclopentolate|cyclopentolate|mesh-list
92267981|NCT05442801|Mydriatics|mydriatics|mesh-ancestor
92267982|NCT05442801|Autonomic Agents|autonomic agents|mesh-ancestor
92267983|NCT05442801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267984|NCT05442801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267985|NCT05442801|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92267986|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92267987|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
92267988|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92267989|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92267990|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
92267991|NCT05339373|Aceclofenac|aceclofenac|mesh-list
92267992|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92267993|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92267994|NCT05339373|Analgesics|analgesics|mesh-ancestor
92267995|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
92267996|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92267997|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92267998|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268000|NCT05439993|Paclitaxel|paclitaxel|mesh-list
92268001|NCT05439993|Tepotinib|tepotinib|mesh-list
92268002|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92268003|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268004|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92268005|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92268006|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92268007|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268008|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92268009|NCT00554099|Mesalamine|mesalamine|mesh-list
92268010|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268011|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92268012|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92268013|NCT00554099|Analgesics|analgesics|mesh-ancestor
92268014|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
92268015|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268016|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268017|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268018|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268019|NCT04048161|Mycophenolic Acid|mycophenolic acid|mesh-list
92268020|NCT04048161|Tacrolimus|tacrolimus|mesh-list
92268021|NCT04048161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92268022|NCT04048161|Immunologic Factors|immunologic factors|mesh-ancestor
92268023|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268024|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92268025|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268026|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268027|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92268028|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268029|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92268030|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
92268031|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268032|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268033|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
92268034|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92268035|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92268036|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268037|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
92268038|NCT02664909|Coagulants|coagulants|mesh-ancestor
92268039|NCT00368589|Atorvastatin|atorvastatin|mesh-list
92268040|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92268041|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92268042|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
92268043|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268044|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92268045|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92268046|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268047|NCT00553319|Amphetamine|amphetamine|mesh-list
92268048|NCT00553319|Adderall|adderall|mesh-list
91920917|NCT02185651|Miglustat|miglustat|mesh-list
92268049|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92268050|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268051|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
92268052|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
92268053|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268054|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
92268055|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268056|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268057|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
92268058|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92268059|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92268060|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268061|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92268062|NCT00369291|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92268063|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92268064|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
92268065|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268067|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268068|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
92268069|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
92268070|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268071|NCT01868633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268072|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268073|NCT01868633|Glucocorticoids|glucocorticoids|mesh-ancestor
92268074|NCT01868633|Hormones|hormones|mesh-ancestor
92268075|NCT01868633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268076|NCT01868633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92268077|NCT01868633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268078|NCT04738773|Naltrexone|naltrexone|mesh-list
92268079|NCT04738773|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92268080|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92268081|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268082|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
92268083|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268084|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
92268085|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92268086|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92268087|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92268088|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268089|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268090|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
92268091|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268092|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268093|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92268094|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268095|NCT02676375|Bupropion|bupropion|mesh-list
92268096|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92268097|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
92343863|NCT05892913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92268099|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92268100|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92268101|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268102|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268103|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
92268104|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268105|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268106|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92268107|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92268108|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268109|NCT01871441|Mycophenolic Acid|mycophenolic acid|mesh-list
92268110|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
92268111|NCT01871441|Tacrolimus|tacrolimus|mesh-list
92268112|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92268113|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
92268114|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268115|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268116|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92268117|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
92268118|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268119|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268120|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91920988|NCT05514080|Insulin|insulin|mesh-list
92268121|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92268122|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268123|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92268124|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92268125|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
92268126|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268127|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268129|NCT04338711|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92268130|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92268131|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268132|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268133|NCT01874951|Naltrexone|naltrexone|mesh-list
92268134|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92268136|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268137|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
92268138|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268139|NCT04739241|Insulin|insulin|mesh-list
92268140|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92268141|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268142|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268143|NCT03024437|Bevacizumab|bevacizumab|mesh-list
92268144|NCT03024437|Atezolizumab|atezolizumab|mesh-list
92268145|NCT03024437|Entinostat|entinostat|mesh-list
92268146|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268147|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268148|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268149|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268150|NCT03024437|Growth Substances|growth substances|mesh-ancestor
92268151|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268152|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
92268153|NCT03024437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92268154|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268155|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92268156|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268157|NCT01489826|HU 211|hu 211|mesh-list
92268158|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92268159|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
92268160|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
92268161|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268162|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268163|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268164|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92268165|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92268166|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268167|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268168|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92268169|NCT01489826|Protective Agents|protective agents|mesh-ancestor
92268170|NCT02677623|Mannitol|mannitol|mesh-list
92268171|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92268172|NCT02677623|Diuretics|diuretics|mesh-ancestor
92268173|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
92268174|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268175|NCT02677701|Azithromycin|azithromycin|mesh-list
92268176|NCT02677701|Tobramycin|tobramycin|mesh-list
92268177|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268178|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268179|NCT01543178|Rifaximin|rifaximin|mesh-list
92268180|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268181|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268182|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268183|NCT01649856|Rituximab|rituximab|mesh-list
92268184|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268185|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268186|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
92268187|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268188|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268189|NCT01543568|Aflibercept|aflibercept|mesh-list
92268190|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268191|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268192|NCT01543568|Growth Substances|growth substances|mesh-ancestor
92268193|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268194|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
92268195|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268196|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92268197|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268198|NCT02375724|Bromides|bromides|mesh-list
92268199|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
92268200|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92268201|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92268202|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
92268203|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268204|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268205|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92268206|NCT02398188|Respiratory System Agents|respiratory system agents|mesh-ancestor
92268207|NCT02398188|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91935126|NCT03509701|Antibodies|antibodies|mesh-list
92268208|NCT02398188|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92268209|NCT02398188|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92268210|NCT02398188|Adrenergic Agents|adrenergic agents|mesh-ancestor
92268211|NCT02398188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268212|NCT02398188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268213|NCT02425098|Vaccines|vaccines|mesh-list
92268214|NCT02425098|Immunologic Factors|immunologic factors|mesh-ancestor
92268215|NCT02425098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268216|NCT02424630|Ropivacaine|ropivacaine|mesh-list
92268217|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
92268218|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
92268219|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268220|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268221|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
92268222|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268223|NCT02397408|Choline|choline|mesh-list
92268224|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
92268225|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92268226|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
92268227|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268228|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268229|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92268230|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
92268231|NCT02397096|Ritonavir|ritonavir|mesh-list
92268232|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92268233|NCT02397096|Tenofovir|tenofovir|mesh-list
92268234|NCT02397096|Lamivudine|lamivudine|mesh-list
92268235|NCT02397096|Cobicistat|cobicistat|mesh-list
92268236|NCT02397096|Elvitegravir|elvitegravir|mesh-list
92268237|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92268238|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
92268239|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92268240|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268241|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268242|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92268243|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92268244|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
92268245|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268246|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92268247|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92268248|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92268249|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92268250|NCT02396316|Aflibercept|aflibercept|mesh-list
92268251|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268252|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268253|NCT02396316|Growth Substances|growth substances|mesh-ancestor
92268254|NCT02396316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268255|NCT02396316|Growth Inhibitors|growth inhibitors|mesh-ancestor
92268256|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268257|NCT02682381|Teduglutide|teduglutide|mesh-list
92268258|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268259|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92268260|NCT02682381|Protective Agents|protective agents|mesh-ancestor
92268261|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268262|NCT04915950|APD791|apd791|mesh-list
92268263|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92268264|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92268265|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
92268266|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268267|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268268|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268269|NCT04976595|Testosterone|testosterone|mesh-list
92268270|NCT04976595|Androgens|androgens|mesh-ancestor
92268271|NCT04976595|Hormones|hormones|mesh-ancestor
92268272|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268273|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268275|NCT00367965|Zopiclone|zopiclone|mesh-list
92268276|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92268277|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268278|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268279|NCT02683161|Varenicline|varenicline|mesh-list
92268280|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92268281|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92268282|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92268283|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268284|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268285|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268286|NCT02683707|Lidocaine|lidocaine|mesh-list
92268287|NCT02683707|Fentanyl|fentanyl|mesh-list
92268288|NCT02683707|Midazolam|midazolam|mesh-list
92268289|NCT02683707|Anesthetics, Local|anesthetics, local|mesh-ancestor
92268290|NCT02683707|Anesthetics|anesthetics|mesh-ancestor
92268291|NCT02683707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268292|NCT02683707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268293|NCT02683707|Sensory System Agents|sensory system agents|mesh-ancestor
92268294|NCT02683707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268295|NCT02683707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92268296|NCT02683707|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92268297|NCT02683707|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92268298|NCT02683707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268299|NCT02683707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268300|NCT02683707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92268301|NCT02683707|Narcotics|narcotics|mesh-ancestor
92268302|NCT02683707|Analgesics|analgesics|mesh-ancestor
92268303|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92268304|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92268305|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
92268306|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92268307|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92268308|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92268309|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92268310|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
92268311|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
92268312|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268313|NCT02371980|Vortioxetine|vortioxetine|mesh-list
92268314|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
92268315|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92268316|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92268317|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92268318|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268319|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268320|NCT02371980|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92268321|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92268322|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268323|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268324|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268325|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
92268326|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92268327|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92268328|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92268329|NCT02371980|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92268330|NCT02867865|Gemcitabine|gemcitabine|mesh-list
92268331|NCT02867865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268332|NCT02867865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92268333|NCT02867865|Antimetabolites|antimetabolites|mesh-ancestor
92268334|NCT02867865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268335|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
92268336|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
92268337|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
92268338|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268339|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268340|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
92268341|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268342|NCT05447871|Bupivacaine|bupivacaine|mesh-list
92268343|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
92268344|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
92268345|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921213|NCT04766996|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92268346|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268347|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
92268348|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268349|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
92268350|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268351|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268352|NCT04772235|Osimertinib|osimertinib|mesh-list
92268353|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268354|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92268355|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268356|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268358|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92268359|NCT04766463|Narcotics|narcotics|mesh-ancestor
92268360|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268361|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268362|NCT04766463|Analgesics|analgesics|mesh-ancestor
92268363|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
92268364|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268365|NCT00823563|Adenosine|adenosine|mesh-list
92268366|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
92268367|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
92268368|NCT00823563|Analgesics|analgesics|mesh-ancestor
92268369|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
92268370|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268371|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268372|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92268373|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92268374|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
92268375|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
92268376|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268377|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268378|NCT05447169|Antibodies|antibodies|mesh-list
92268379|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
92268380|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268381|NCT04652193|Anesthetics|anesthetics|mesh-list
92268382|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268383|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268384|NCT05451147|Metformin|metformin|mesh-list
92268385|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268386|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268387|NCT04553367|Meropenem|meropenem|mesh-list
92268388|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268389|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268390|NCT00369837|Clevidipine|clevidipine|mesh-list
92268391|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92268392|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268393|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268394|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92268395|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268396|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
92268397|NCT05449899|Busulfan|busulfan|mesh-list
92268398|NCT05449899|Fludarabine|fludarabine|mesh-list
92268399|NCT05449899|Decitabine|decitabine|mesh-list
92268400|NCT05449899|Lenograstim|lenograstim|mesh-list
92268401|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92268402|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
92268403|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268404|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268405|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92268406|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
92268407|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268408|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268409|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92268410|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92268411|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
92268412|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268413|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92268414|NCT05441631|Insulin|insulin|mesh-list
92268415|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92268416|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268417|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268418|NCT01546454|Leuprolide|leuprolide|mesh-list
92268419|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91921300|NCT05507606|Pemetrexed|pemetrexed|mesh-list
92268420|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92268421|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
92268422|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92268423|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92268425|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92268426|NCT01546454|Progesterone|progesterone|mesh-list
92268427|NCT01546454|Estrogens|estrogens|mesh-ancestor
92268429|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268431|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92268432|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
92268433|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92268434|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92268435|NCT01546454|Progestins|progestins|mesh-ancestor
92268436|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92268437|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
92268438|NCT01546454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92268439|NCT01546454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268440|NCT01546454|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92268441|NCT01546454|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92268442|NCT01546454|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92268443|NCT01546454|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92268444|NCT00368901|Darbepoetin alfa|darbepoetin alfa|mesh-list
92268445|NCT00368901|Hematinics|hematinics|mesh-ancestor
92268446|NCT05430867|Memantine|memantine|mesh-list
92268447|NCT05430867|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92268448|NCT05430867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92268449|NCT05430867|Dopamine Agents|dopamine agents|mesh-ancestor
92268450|NCT05430867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268451|NCT05430867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268452|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268453|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92268454|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92268455|NCT05448885|Cisplatin|cisplatin|mesh-list
92268456|NCT05448885|Gemcitabine|gemcitabine|mesh-list
92268457|NCT05448885|Tislelizumab|tislelizumab|mesh-list
92268458|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268459|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92268460|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
92268461|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268462|NCT05448885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268463|NCT01547000|Guanfacine|guanfacine|mesh-list
92268464|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92268465|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92268466|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92268467|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92268468|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92268469|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268470|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268471|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268472|NCT02980016|Isoniazid|isoniazid|mesh-list
92268473|NCT02980016|Rifapentine|rifapentine|mesh-list
92268474|NCT02980016|Rifampin|rifampin|mesh-list
92268475|NCT02980016|Antitubercular Agents|antitubercular agents|mesh-ancestor
92268476|NCT02980016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268477|NCT02980016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268478|NCT02980016|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92268479|NCT02980016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92268480|NCT02980016|Antimetabolites|antimetabolites|mesh-ancestor
92268481|NCT02980016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268482|NCT02980016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92268483|NCT02980016|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92268484|NCT02980016|Leprostatic Agents|leprostatic agents|mesh-ancestor
92268485|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92268486|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268487|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91926084|NCT03738683|Tazobactam|tazobactam|mesh-list
92268488|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92268489|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92268490|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92268491|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92268492|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92268493|NCT01493180|Rebamipide|rebamipide|mesh-list
92268494|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92268495|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
92268496|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92268497|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92268498|NCT01493180|Immunologic Factors|immunologic factors|mesh-ancestor
92268499|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268500|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
92268501|NCT01493180|Protective Agents|protective agents|mesh-ancestor
92268502|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92268503|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268504|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
92268505|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268506|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268507|NCT01431014|Dexamethasone|dexamethasone|mesh-list
92268508|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
92268509|NCT01431014|BB 1101|bb 1101|mesh-list
92268510|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268511|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
92268512|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
92268513|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268514|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268515|NCT01431014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268516|NCT01431014|Glucocorticoids|glucocorticoids|mesh-ancestor
92268517|NCT01431014|Hormones|hormones|mesh-ancestor
92268518|NCT01431014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268519|NCT01431014|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92268520|NCT01431014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268521|NCT01431014|Protease Inhibitors|protease inhibitors|mesh-ancestor
92268522|NCT01431014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268523|NCT01431014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268524|NCT01431170|Trimethoprim|trimethoprim|mesh-list
92268525|NCT01431170|Polymyxins|polymyxins|mesh-list
92268526|NCT01431170|Polymyxin B|polymyxin b|mesh-list
92268527|NCT01431170|Besifloxacin|besifloxacin|mesh-list
92268528|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
92268529|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92268530|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268531|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
92268532|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92268533|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92268534|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92268535|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268536|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268537|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92268538|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92268539|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92268540|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268541|NCT01431170|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92268542|NCT01431170|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92268543|NCT01431170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268544|NCT01431170|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92268545|NCT05448183|Gemcitabine|gemcitabine|mesh-list
92268546|NCT05448183|Oxaliplatin|oxaliplatin|mesh-list
92268547|NCT05448183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92268548|NCT05448183|Antimetabolites|antimetabolites|mesh-ancestor
92268549|NCT05448183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268550|NCT05448183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268551|NCT04732455|Lidocaine|lidocaine|mesh-list
92268552|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92268553|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
92268554|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
92268555|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268556|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268557|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
92268558|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268559|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92268560|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92268561|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92268562|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268563|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268564|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92268565|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92268566|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921446|NCT03535051|Tacrolimus|tacrolimus|mesh-list
92268567|NCT04732455|Analgesics|analgesics|mesh-ancestor
92268568|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
92268569|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92268570|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
92268572|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92268573|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92268574|NCT04306965|Analgesics|analgesics|mesh-ancestor
92268575|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
92268576|NCT04306965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268577|NCT04306965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268578|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268579|NCT04306965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268580|NCT04306965|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92268581|NCT04306965|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92268582|NCT04306965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268583|NCT04306965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268585|NCT02371746|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92268586|NCT01431794|Paclitaxel|paclitaxel|mesh-list
92268587|NCT01431794|Gemcitabine|gemcitabine|mesh-list
92268588|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92268589|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268590|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92268591|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92268592|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92268593|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268594|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92268595|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
92268596|NCT01497860|Vinorelbine|vinorelbine|mesh-list
92268597|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92268598|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268599|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343887|NCT05887830|Nivolumab|nivolumab|mesh-list
92268600|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
92268601|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
92268602|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268604|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
92268605|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
92268606|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
92268607|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268608|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268609|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268610|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92268611|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92268612|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268613|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92268614|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92268615|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
92268616|NCT02213900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268617|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268618|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92268619|NCT02370888|Lenalidomide|lenalidomide|mesh-list
92268620|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
92268621|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268622|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268623|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268624|NCT02370888|Growth Substances|growth substances|mesh-ancestor
92268626|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268627|NCT05358873|Antibodies|antibodies|mesh-list
92268628|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
92268629|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268630|NCT02214290|Caffeine|caffeine|mesh-list
92268631|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92268632|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268633|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92268634|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268635|NCT02214290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268636|NCT02214290|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92268637|NCT02214290|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92268638|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
92268639|NCT02214290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268640|NCT03160911|Hemostatics|hemostatics|mesh-list
92268641|NCT03160911|Coagulants|coagulants|mesh-ancestor
92268642|NCT04685499|Pembrolizumab|pembrolizumab|mesh-list
92268643|NCT04685499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921505|NCT03534895|Anesthetics|anesthetics|mesh-ancestor
92268645|NCT04685499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92268646|NCT04685499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268647|NCT04678869|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92268648|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
92268650|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92268651|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92268652|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268653|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268654|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268655|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92268656|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92268657|NCT00369603|Donepezil|donepezil|mesh-list
92268658|NCT00369603|Galantamine|galantamine|mesh-list
92268659|NCT00369603|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92268660|NCT00369603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268661|NCT00369603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268662|NCT00369603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92268663|NCT00369603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268664|NCT00369603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268665|NCT00369603|Nootropic Agents|nootropic agents|mesh-ancestor
92268666|NCT00369603|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92268667|NCT00369603|Autonomic Agents|autonomic agents|mesh-ancestor
92268668|NCT00369603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268669|NCT01551056|Cetirizine|cetirizine|mesh-list
92268670|NCT01551056|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92268671|NCT01551056|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92268672|NCT01551056|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92268673|NCT01551056|Histamine Antagonists|histamine antagonists|mesh-ancestor
92268674|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
92268675|NCT01551056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268676|NCT01551056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268677|NCT01551056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268678|NCT05227131|Capecitabine|capecitabine|mesh-list
92268679|NCT05227131|Tucatinib|tucatinib|mesh-list
92268680|NCT05227131|Margetuximab|margetuximab|mesh-list
92268681|NCT05227131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92268682|NCT05227131|Antimetabolites|antimetabolites|mesh-ancestor
92268683|NCT05227131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268684|NCT05227131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268685|NCT05227131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92268686|NCT05227131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268687|NCT01499498|Sildenafil Citrate|sildenafil citrate|mesh-list
92268688|NCT01499498|Vasodilator Agents|vasodilator agents|mesh-ancestor
92268689|NCT01499498|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92268690|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92268691|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268692|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268693|NCT01499498|Urological Agents|urological agents|mesh-ancestor
92268694|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92268695|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92268696|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268697|NCT02421588|Doxorubicin|doxorubicin|mesh-list
92268698|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92268699|NCT02421588|Topotecan|topotecan|mesh-list
92268700|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92268701|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268702|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92268703|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92268704|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268705|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268706|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92268707|NCT02768727|Xenon|xenon|mesh-list
92268708|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92268709|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
92268710|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
92268711|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268712|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268713|NCT02688309|Dexamethasone|dexamethasone|mesh-list
92268714|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268715|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
92268716|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
91921583|NCT02194309|Amlodipine|amlodipine|mesh-list
92268717|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268718|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268719|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268720|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
92268721|NCT02688309|Hormones|hormones|mesh-ancestor
92268722|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268723|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92268724|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268725|NCT00370851|Bevacizumab|bevacizumab|mesh-list
92268726|NCT00370851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268727|NCT00370851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268728|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268729|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268730|NCT00370851|Growth Substances|growth substances|mesh-ancestor
92268731|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268732|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
92268733|NCT05124171|Vaccines|vaccines|mesh-list
92268734|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
92268735|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268736|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
92268737|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268738|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268739|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92268740|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268741|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268742|NCT00371007|Incretins|incretins|mesh-ancestor
92268743|NCT00371007|Hormones|hormones|mesh-ancestor
92268744|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268745|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92268746|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92268747|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268748|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268749|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92268750|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92268751|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268752|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268753|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268754|NCT00552617|Rocuronium|rocuronium|mesh-list
92268755|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
92268756|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92268757|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92268758|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92268759|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268760|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268761|NCT00552617|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92268762|NCT00552617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92268763|NCT00552617|Cholinergic Agents|cholinergic agents|mesh-ancestor
92268764|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268765|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268766|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
92268767|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92268768|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92268769|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268770|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
92268771|NCT04387305|Coagulants|coagulants|mesh-ancestor
92268772|NCT02421120|Tazobactam|tazobactam|mesh-list
92268773|NCT02421120|Ceftolozane|ceftolozane|mesh-list
92268774|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92268775|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268776|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268777|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92268778|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268779|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268780|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92268781|NCT03022877|Simendan|simendan|mesh-list
92268782|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92268783|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
92268784|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92268785|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92268786|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268787|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268788|NCT03022877|Protective Agents|protective agents|mesh-ancestor
92268789|NCT03022877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268790|NCT02420262|Insulin|insulin|mesh-list
92268791|NCT02420262|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92268792|NCT02420262|Insulin Glargine|insulin glargine|mesh-list
92268793|NCT02420262|Insulin Aspart|insulin aspart|mesh-list
92268794|NCT02420262|Liraglutide|liraglutide|mesh-list
92268795|NCT02420262|Xultophy|xultophy|mesh-list
92268796|NCT02420262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92268797|NCT02420262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268798|NCT02420262|Incretins|incretins|mesh-ancestor
92268799|NCT02420262|Hormones|hormones|mesh-ancestor
92268800|NCT02420262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268801|NCT00369993|Fluticasone|fluticasone|mesh-list
92268802|NCT00369993|Xhance|xhance|mesh-list
92268803|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92268804|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268805|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92268806|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
92268807|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268808|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268809|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92268810|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
92268811|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
92268812|NCT00369993|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92268813|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92268814|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92268815|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92268816|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
92268817|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92268818|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268819|NCT00552305|Lacosamide|lacosamide|mesh-list
92268820|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
92268821|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92268822|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92268823|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268824|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268825|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
92268826|NCT02278887|Fludarabine|fludarabine|mesh-list
92268827|NCT02278887|Ipilimumab|ipilimumab|mesh-list
92268828|NCT02278887|Interleukin-2|interleukin-2|mesh-list
92268829|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92268830|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
92268831|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268832|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92268833|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92268834|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
92268835|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268836|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268837|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92268838|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268839|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92268840|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92268841|NCT02278887|Analgesics|analgesics|mesh-ancestor
92268842|NCT02278887|Sensory System Agents|sensory system agents|mesh-ancestor
92268843|NCT02278887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268844|NCT04168203|Apixaban|apixaban|mesh-list
92268845|NCT04168203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92268846|NCT04168203|Antithrombins|antithrombins|mesh-ancestor
92268847|NCT04168203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92268848|NCT04168203|Protease Inhibitors|protease inhibitors|mesh-ancestor
92268849|NCT04168203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268850|NCT04168203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268851|NCT04168203|Anticoagulants|anticoagulants|mesh-ancestor
92268852|NCT04135989|Everolimus|everolimus|mesh-list
92268853|NCT04135989|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92268854|NCT04135989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92268855|NCT04135989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268856|NCT04135989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268857|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92268858|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
92268859|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268860|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268861|NCT01854255|Cisplatin|cisplatin|mesh-list
92268862|NCT01854255|Doxorubicin|doxorubicin|mesh-list
92268863|NCT01854255|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92268864|NCT01854255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268865|NCT01854255|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92268866|NCT01854255|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92268867|NCT01854255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92268868|NCT01854255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268869|NCT01854255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268870|NCT01555281|Nelfinavir|nelfinavir|mesh-list
92268871|NCT01555281|Dexamethasone|dexamethasone|mesh-list
92268872|NCT01555281|Lenalidomide|lenalidomide|mesh-list
92268873|NCT01555281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268874|NCT01555281|Antiemetics|antiemetics|mesh-ancestor
92268875|NCT01555281|Autonomic Agents|autonomic agents|mesh-ancestor
92268876|NCT01555281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268877|NCT01555281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268878|NCT01555281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268879|NCT01555281|Glucocorticoids|glucocorticoids|mesh-ancestor
92268880|NCT01555281|Hormones|hormones|mesh-ancestor
92343905|NCT05877027|Diclofenac|diclofenac|mesh-list
92343908|NCT05877027|Analgesics|analgesics|mesh-ancestor
92268881|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268882|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92268883|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268884|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
92268885|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268886|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268887|NCT01555281|Growth Substances|growth substances|mesh-ancestor
92268888|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
92268889|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92268890|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92268891|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
92268892|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268893|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268894|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92268895|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92268896|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
92268897|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268898|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
92268899|NCT04938765|Analgesics|analgesics|mesh-ancestor
92268900|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
92268901|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268902|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268903|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
92268904|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92268905|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92268906|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
92268907|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92268908|NCT04938765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92268909|NCT04938765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268910|NCT04938765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92268911|NCT04938765|Tocolytic Agents|tocolytic agents|mesh-ancestor
92268912|NCT04938765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92268913|NCT00370539|Triamcinolone|triamcinolone|mesh-list
92268914|NCT00370539|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92268915|NCT00370539|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92268916|NCT00370539|Bevacizumab|bevacizumab|mesh-list
92268917|NCT00370539|Verteporfin|verteporfin|mesh-list
92268918|NCT00370539|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92268919|NCT00370539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268920|NCT00370539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268921|NCT00370539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92268922|NCT00370539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92268923|NCT00370539|Growth Substances|growth substances|mesh-ancestor
92268924|NCT00370539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268925|NCT00370539|Growth Inhibitors|growth inhibitors|mesh-ancestor
92268926|NCT00370539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92268927|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
92268929|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268930|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92268931|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
92268932|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268933|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268934|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92268935|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92268936|NCT03996057|Methenamine|methenamine|mesh-list
92268937|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
92268938|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
92268941|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268942|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268943|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92268944|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268945|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92268946|NCT03150875|Docetaxel|docetaxel|mesh-list
92268947|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268948|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92268949|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92268950|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92268951|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268952|NCT00552071|Octreotide|octreotide|mesh-list
92268953|NCT00552071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92268954|NCT00552071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92268955|NCT00552071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268956|NCT00673335|Letrozole|letrozole|mesh-list
92268957|NCT00673335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268958|NCT00673335|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92268959|NCT00673335|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92268960|NCT00673335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92268961|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268962|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92268963|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92268964|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92268965|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268966|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
92268967|NCT04880889|Thiamine|thiamine|mesh-list
92268968|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
92268969|NCT04880889|Vitamins|vitamins|mesh-ancestor
92268970|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
92268971|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268972|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
92268973|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92268974|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268975|NCT03833427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92268976|NCT03833427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92268977|NCT04849377|Cisplatin|cisplatin|mesh-list
92268978|NCT04849377|Carboplatin|carboplatin|mesh-list
92268979|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92268981|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
92268982|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92268983|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92268984|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92268985|NCT00551525|Analgesics|analgesics|mesh-ancestor
92268986|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
92268987|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92268988|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268989|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92268990|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
92268991|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92268992|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
92268993|NCT05454345|Rifampin|rifampin|mesh-list
92268994|NCT05454345|Isoniazid|isoniazid|mesh-list
92268995|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
92268996|NCT05454345|Ethambutol|ethambutol|mesh-list
92268997|NCT05454345|Rifapentine|rifapentine|mesh-list
92268998|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
92268999|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92269000|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269001|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92269002|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92269003|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269004|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269005|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269006|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92269007|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
92269008|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
92269009|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92269010|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92269011|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92269012|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92269013|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92269014|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92343921|NCT05807204|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92343924|NCT05807204|Expectorants|expectorants|mesh-ancestor
92269015|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92269016|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92269017|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92269018|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
92269019|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92269020|NCT04459611|Paclitaxel|paclitaxel|mesh-list
92269021|NCT04459611|Carboplatin|carboplatin|mesh-list
92269022|NCT04459611|Pemetrexed|pemetrexed|mesh-list
92269023|NCT04459611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92269024|NCT04459611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92269025|NCT04459611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269026|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
92269027|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
92269028|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269029|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269030|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269031|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92269032|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92269033|NCT00370617|Metformin|metformin|mesh-list
92269034|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269035|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269036|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
92269037|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92269038|NCT01553708|Mitogens|mitogens|mesh-list
92269039|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269040|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269041|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92269042|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269043|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92269044|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92269045|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
92269046|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92269047|NCT02370498|Paclitaxel|paclitaxel|mesh-list
92269048|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
92269049|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92269050|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269051|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
92269052|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
92269053|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269054|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269055|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92269056|NCT02370498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92269057|NCT01554488|Fluticasone|fluticasone|mesh-list
92269058|NCT01554488|Xhance|xhance|mesh-list
92269059|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269060|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92269061|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
92269062|NCT01554488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269063|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269064|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92269065|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
92269066|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
92269067|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92269068|NCT02347332|Methotrexate|methotrexate|mesh-list
92269069|NCT02347332|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92269070|NCT02347332|Abortifacient Agents|abortifacient agents|mesh-ancestor
92269071|NCT02347332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92269072|NCT02347332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269073|NCT02347332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92269074|NCT02347332|Antimetabolites|antimetabolites|mesh-ancestor
92343926|NCT05807204|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92343927|NCT05807204|Antioxidants|antioxidants|mesh-ancestor
92269075|NCT02347332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269076|NCT02347332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269078|NCT02347332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269079|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92269080|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92269081|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
92269082|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269083|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92269084|NCT01502306|Nicotine|nicotine|mesh-list
92269085|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92269086|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
92269087|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269088|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269089|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92269090|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92269091|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
92269092|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269093|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269094|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92269095|NCT03325959|Analgesics|analgesics|mesh-ancestor
92269096|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
92269097|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269098|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269099|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269100|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269101|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92269102|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92269103|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92269104|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269105|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
92269106|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
92269107|NCT02347176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92269108|NCT02347176|Immunologic Factors|immunologic factors|mesh-ancestor
92269109|NCT02347176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269110|NCT05451381|Dexmedetomidine|dexmedetomidine|mesh-list
92269111|NCT05451381|Propofol|propofol|mesh-list
92269112|NCT05451381|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92269113|NCT05451381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269114|NCT05451381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269115|NCT05451381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269116|NCT05451381|Analgesics|analgesics|mesh-ancestor
92269117|NCT05451381|Sensory System Agents|sensory system agents|mesh-ancestor
92269118|NCT05451381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269119|NCT05451381|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92269120|NCT05451381|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92269121|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92269122|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92269123|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269124|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269125|NCT05451381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92269126|NCT05451381|Anesthetics, General|anesthetics, general|mesh-ancestor
92269127|NCT05451381|Anesthetics|anesthetics|mesh-ancestor
92269128|NCT05450913|Lidocaine|lidocaine|mesh-list
92269129|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
92269130|NCT05450913|Anesthetics|anesthetics|mesh-list
92269131|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269132|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269133|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
92269134|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269135|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92269136|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92269137|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92269138|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269139|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269140|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
92269141|NCT05446779|Epinephrine|epinephrine|mesh-list
92269142|NCT05446779|Racepinephrine|racepinephrine|mesh-list
92269143|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
92269145|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92269146|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92269147|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92269148|NCT05446779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269149|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269150|NCT05446779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269151|NCT05446779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92269152|NCT05446779|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92269153|NCT05446779|Autonomic Agents|autonomic agents|mesh-ancestor
92269154|NCT05446779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269155|NCT05446779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92269156|NCT05446779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92269157|NCT05446779|Mydriatics|mydriatics|mesh-ancestor
91935145|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
92269159|NCT05446779|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92269160|NCT02215070|Pasireotide|pasireotide|mesh-list
92269161|NCT02215070|Hormones|hormones|mesh-ancestor
92269162|NCT02215070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269163|NCT02215070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269164|NCT04000737|Sorafenib|sorafenib|mesh-list
92269165|NCT04000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269166|NCT04000737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92269167|NCT04000737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269168|NCT04000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269169|NCT02347098|Atorvastatin|atorvastatin|mesh-list
92269170|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92269171|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92269172|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92269173|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
92269174|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269175|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92269176|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269177|NCT03708237|Gabapentin|gabapentin|mesh-list
92269178|NCT03708237|Ropinirole|ropinirole|mesh-list
92269179|NCT03708237|Analgesics|analgesics|mesh-ancestor
92269180|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
92269181|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269182|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269183|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
92269184|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92269185|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92269186|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269187|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92269188|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92269189|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92269190|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269191|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269192|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
92269193|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92269194|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92269195|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
92269196|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
92269197|NCT01556594|Glucagon|glucagon|mesh-list
92269198|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92269199|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269200|NCT01556594|Hormones|hormones|mesh-ancestor
92269201|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269202|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269203|NCT01556594|Incretins|incretins|mesh-ancestor
92269204|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
92269205|NCT00371319|Tacrolimus|tacrolimus|mesh-list
92269206|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92269207|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
92269208|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269209|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92269210|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269211|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269212|NCT00371319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92269213|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269214|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92269215|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
92269216|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92269217|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269218|NCT01439672|Insulin|insulin|mesh-list
92269219|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269220|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269221|NCT03465111|Hormones|hormones|mesh-list
92269222|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92269223|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92269224|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
92269225|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269226|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269227|NCT03465111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269228|NCT03465111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269229|NCT01440764|Furosemide|furosemide|mesh-list
92269230|NCT01440764|Diuretics|diuretics|mesh-ancestor
92269231|NCT01440764|Natriuretic Agents|natriuretic agents|mesh-ancestor
92269232|NCT01440764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926085|NCT03738683|Piperacillin|piperacillin|mesh-list
92269233|NCT01440764|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92269234|NCT01440764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269235|NCT01440764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269236|NCT01557452|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
91922111|NCT02209441|Sorafenib|sorafenib|mesh-list
92269238|NCT01557452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269239|NCT01557452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269240|NCT05283837|Pertuzumab|pertuzumab|mesh-list
92269241|NCT05283837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92269242|NCT05283837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269243|NCT02209610|Fentanyl|fentanyl|mesh-list
92269244|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92269245|NCT02209610|Narcotics|narcotics|mesh-ancestor
92269246|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269247|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269248|NCT02209610|Analgesics|analgesics|mesh-ancestor
92269249|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
92269250|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269251|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92269252|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92269253|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
92269254|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
92269255|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92269256|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269257|NCT05244993|Paclitaxel|paclitaxel|mesh-list
92269258|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92269259|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269260|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92269261|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92269262|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269263|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269264|NCT03289299|Dexamethasone|dexamethasone|mesh-list
92269265|NCT03289299|Lenalidomide|lenalidomide|mesh-list
92269266|NCT03289299|Daratumumab|daratumumab|mesh-list
92269267|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269268|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
92269269|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
92269270|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269271|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269272|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269273|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
92269274|NCT03289299|Hormones|hormones|mesh-ancestor
92269275|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269276|NCT03289299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92269277|NCT03289299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269278|NCT03289299|Immunologic Factors|immunologic factors|mesh-ancestor
92269279|NCT03289299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92269280|NCT03289299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92343951|NCT05779007|Analgesics|analgesics|mesh-ancestor
92269281|NCT03289299|Growth Substances|growth substances|mesh-ancestor
92269282|NCT03289299|Growth Inhibitors|growth inhibitors|mesh-ancestor
92269283|NCT01558700|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92269284|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92269285|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92269286|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269287|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269288|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269289|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269291|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
92269292|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269293|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
92269294|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92269295|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
92269296|NCT02757105|Ondansetron|ondansetron|mesh-list
92269297|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
92269298|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
92269299|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269300|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269301|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269302|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
92269303|NCT02757105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92269304|NCT02757105|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92269305|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92269306|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
92269307|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269308|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269309|NCT05083845|Anesthetics|anesthetics|mesh-list
92269310|NCT05083845|Anesthetics, Local|anesthetics, local|mesh-list
92269311|NCT05083845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269312|NCT05083845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269313|NCT05083845|Sensory System Agents|sensory system agents|mesh-ancestor
92269314|NCT05083845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269316|NCT00371553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269317|NCT00371553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92269318|NCT00371553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92269319|NCT00371553|Growth Substances|growth substances|mesh-ancestor
92269320|NCT00371553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269321|NCT00371553|Growth Inhibitors|growth inhibitors|mesh-ancestor
92269322|NCT00371553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92269323|NCT00371553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269324|NCT00371553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269325|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
92269326|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92269327|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269328|NCT02892201|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92269329|NCT02892201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269330|NCT01507220|Morphine|morphine|mesh-list
92269331|NCT01507220|Bupivacaine|bupivacaine|mesh-list
92269332|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
92269333|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
92269334|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269335|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269336|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
92269337|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269338|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92269339|NCT01507220|Narcotics|narcotics|mesh-ancestor
92269340|NCT01507220|Analgesics|analgesics|mesh-ancestor
92269341|NCT01509404|Valganciclovir|valganciclovir|mesh-list
92269342|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
92269343|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269344|NCT01562132|Fluconazole|fluconazole|mesh-list
92269345|NCT01562132|Flucytosine|flucytosine|mesh-list
92269346|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
92269347|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269348|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92343956|NCT05779007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269349|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92269350|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269351|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269352|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92269353|NCT01562132|Hormone Antagonists|hormone antagonists|mesh-ancestor
92269354|NCT01562132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269355|NCT01562132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269356|NCT01562132|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92269357|NCT01562132|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92269358|NCT01562132|Antimetabolites|antimetabolites|mesh-ancestor
92269359|NCT02762331|Ascorbic Acid|ascorbic acid|mesh-list
92269361|NCT02762331|Micronutrients|micronutrients|mesh-ancestor
92269362|NCT02762331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269363|NCT02762331|Antioxidants|antioxidants|mesh-ancestor
92269364|NCT02762331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269365|NCT02762331|Protective Agents|protective agents|mesh-ancestor
92269366|NCT02762799|Lenograstim|lenograstim|mesh-list
92269367|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92269368|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
92269369|NCT02762799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269370|NCT01447706|Paclitaxel|paclitaxel|mesh-list
92269371|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92269372|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269373|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
92269374|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
92269375|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269376|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269378|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
92269379|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
92269380|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269381|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269382|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
92269383|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269384|NCT04336917|Lidocaine|lidocaine|mesh-list
92269385|NCT04336917|Bupivacaine|bupivacaine|mesh-list
92269386|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
92269387|NCT04336917|Anesthetics|anesthetics|mesh-list
92269388|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269389|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269390|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
92269391|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269392|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92269393|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92269394|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92269395|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269396|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269397|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
92269398|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92269399|NCT01448486|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92269400|NCT01448486|Antiviral Agents|antiviral agents|mesh-ancestor
92269401|NCT01448486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269402|NCT01448486|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92269403|NCT01448486|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92269404|NCT01448486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269405|NCT01448486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269407|NCT01562678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269408|NCT01562678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269409|NCT01562678|Incretins|incretins|mesh-ancestor
92269410|NCT01562678|Hormones|hormones|mesh-ancestor
92269411|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269412|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
92269413|NCT02767869|Antacids|antacids|mesh-ancestor
92269414|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269415|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269416|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92269417|NCT01449266|Chelating Agents|chelating agents|mesh-ancestor
92269418|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
92269419|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269420|NCT02767947|Luliconazole|luliconazole|mesh-list
92269421|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
92269422|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269423|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92269424|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92269425|NCT02770365|Estradiol|estradiol|mesh-list
92269426|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92269427|NCT02770365|Estrogens|estrogens|mesh-ancestor
92269428|NCT02770365|Hormones|hormones|mesh-ancestor
92269429|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269430|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269431|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92269432|NCT02770365|Contraceptive Agents|contraceptive agents|mesh-ancestor
92269433|NCT02770365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92269434|NCT02770365|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92269435|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
92269436|NCT02770521|Treprostinil|treprostinil|mesh-list
92269437|NCT02770521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269438|NCT02770521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269439|NCT02770521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92269440|NCT02346240|Etanercept|etanercept|mesh-list
92269441|NCT02346240|Certolizumab Pegol|certolizumab pegol|mesh-list
92269442|NCT02346240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92269443|NCT02346240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269444|NCT02346240|Analgesics|analgesics|mesh-ancestor
92269445|NCT02346240|Sensory System Agents|sensory system agents|mesh-ancestor
92269446|NCT02346240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269447|NCT02346240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269448|NCT02346240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269449|NCT02346240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269450|NCT02346240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269452|NCT02346240|Immunologic Factors|immunologic factors|mesh-ancestor
92269453|NCT02346240|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92269454|NCT01511978|Amifampridine|amifampridine|mesh-list
92269455|NCT01511978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92269456|NCT01511978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942314|NCT05293041|Hemostatics|hemostatics|mesh-ancestor
92269457|NCT01511978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269458|NCT01511978|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92269459|NCT01511978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269460|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269461|NCT02772783|Insulin|insulin|mesh-list
92269462|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92269463|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269464|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269465|NCT02774343|Pioglitazone|pioglitazone|mesh-list
92269466|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269467|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269468|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92269469|NCT05349045|Antibodies|antibodies|mesh-list
92269470|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
92269471|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269472|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92269473|NCT05349045|Growth Substances|growth substances|mesh-ancestor
92269474|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
92269475|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269477|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
92269478|NCT04336605|Analgesics|analgesics|mesh-list
92269479|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
92269480|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269481|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269482|NCT01450826|Ondansetron|ondansetron|mesh-list
92269483|NCT01450826|Aprepitant|aprepitant|mesh-list
92269484|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
92269485|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
92269486|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269487|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269488|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269489|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
92269490|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
92343969|NCT05767047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269491|NCT01450826|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92269492|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92269493|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
92269494|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269495|NCT01450826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269496|NCT01450826|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92269497|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92269498|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
92269499|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269500|NCT05349903|Protective Agents|protective agents|mesh-ancestor
92269501|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269502|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92269503|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92269504|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269505|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92269506|NCT05349825|Losartan|losartan|mesh-list
92269507|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92269508|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92269509|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92269510|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92269511|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269512|NCT01451996|Loratadine|loratadine|mesh-list
92269513|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
92269514|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
92269515|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92269516|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92269517|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92269518|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
92269519|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
92269520|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269521|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269522|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269523|NCT01512446|Alendronate|alendronate|mesh-list
92269524|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92269525|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269527|NCT04334967|Hydroxychloroquine|hydroxychloroquine|mesh-list
92269528|NCT04334967|Vitamins|vitamins|mesh-ancestor
92269529|NCT04334967|Micronutrients|micronutrients|mesh-ancestor
92269530|NCT04334967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269531|NCT04334967|Antimalarials|antimalarials|mesh-ancestor
92269532|NCT04334967|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92269533|NCT04334967|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92269534|NCT04334967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922414|NCT02220049|Bortezomib|bortezomib|mesh-list
92269535|NCT04334967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269536|NCT04334967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269537|NCT04334967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269538|NCT04334967|Antioxidants|antioxidants|mesh-ancestor
92269539|NCT04334967|Protective Agents|protective agents|mesh-ancestor
92269540|NCT04335123|Losartan|losartan|mesh-list
92269541|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92269542|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92269543|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92269544|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92269545|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269546|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92269547|NCT02742987|Clopidogrel|clopidogrel|mesh-list
92269548|NCT02742987|Ticagrelor|ticagrelor|mesh-list
92269549|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92269550|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92269551|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92269552|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92269553|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
92269554|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269555|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269556|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269557|NCT05450055|Lidocaine|lidocaine|mesh-list
92269558|NCT05450055|Analgesics|analgesics|mesh-list
92269559|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
92269560|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
92269561|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269562|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269563|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
92269564|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269565|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92269566|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92269567|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92269568|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269569|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269570|NCT02743377|Rolipram|rolipram|mesh-list
92269571|NCT02743377|Antidepressive Agents|antidepressive agents|mesh-ancestor
92269572|NCT02743377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92269573|NCT02743377|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92269574|NCT02743377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92269575|NCT02743377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269576|NCT02743377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269577|NCT05437965|Glucocorticoids|glucocorticoids|mesh-list
92269578|NCT05437965|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92269579|NCT05437965|Hormones|hormones|mesh-ancestor
92269580|NCT05437965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269581|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269582|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
92269583|NCT00372099|Calcitonin|calcitonin|mesh-list
92269584|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
92269585|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92269586|NCT00372099|Katacalcin|katacalcin|mesh-list
92269587|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92269588|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269589|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92269590|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
92269591|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
92269592|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92269593|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269594|NCT01454414|Permethrin|permethrin|mesh-list
92269595|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935149|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269596|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269597|NCT04335513|Insulin|insulin|mesh-list
92269598|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269599|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269600|NCT01568528|Oxytocin|oxytocin|mesh-list
92269601|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
92269602|NCT01568528|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92269603|NCT01568528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269604|NCT05013255|Pioglitazone|pioglitazone|mesh-list
92269605|NCT05013255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269606|NCT05013255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269607|NCT01461668|Retapamulin|retapamulin|mesh-list
92269608|NCT01461668|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92269609|NCT01461668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269610|NCT00372177|Immunoglobulin Fab Fragments|immunoglobulin fab fragments|mesh-list
92269611|NCT00372177|Immunologic Factors|immunologic factors|mesh-ancestor
92269612|NCT00372177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269613|NCT05177991|Bupivacaine|bupivacaine|mesh-list
92269614|NCT05177991|Anesthetics, Local|anesthetics, local|mesh-ancestor
92269615|NCT05177991|Anesthetics|anesthetics|mesh-ancestor
92269616|NCT05177991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269617|NCT05177991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269618|NCT05177991|Sensory System Agents|sensory system agents|mesh-ancestor
92269619|NCT05177991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269620|NCT01461824|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92269621|NCT01461824|Medroxyprogesterone|medroxyprogesterone|mesh-list
92269622|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92269623|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92269624|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92269625|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
92269626|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92269627|NCT01461824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269628|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92269629|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92269630|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92269631|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343975|NCT05767047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269632|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269634|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
92269635|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92269636|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
92269637|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269638|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269639|NCT04737837|Lacosamide|lacosamide|mesh-list
92269640|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
92269641|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92269642|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92269643|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269644|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269645|NCT04826133|Calcitriol|calcitriol|mesh-list
92269646|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92269647|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92269648|NCT04826133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269649|NCT04826133|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92269650|NCT04826133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269651|NCT04826133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269652|NCT04826133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92269653|NCT04826133|Vitamins|vitamins|mesh-ancestor
92269654|NCT04826133|Micronutrients|micronutrients|mesh-ancestor
92269655|NCT04826133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92269656|NCT05456763|Butyric Acid|butyric acid|mesh-list
92269657|NCT05456763|Histamine Antagonists|histamine antagonists|mesh-ancestor
92269658|NCT05456763|Histamine Agents|histamine agents|mesh-ancestor
92269659|NCT05456763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269660|NCT05456763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269661|NCT05456763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269662|NCT05456061|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92269663|NCT05456061|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92269664|NCT02369874|Durvalumab|durvalumab|mesh-list
92269665|NCT02369874|Tremelimumab|tremelimumab|mesh-list
92269666|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92269667|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92269668|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269669|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
92269670|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269671|NCT00372645|Folic Acid|folic acid|mesh-list
92269672|NCT00372645|Hematinics|hematinics|mesh-ancestor
92269673|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
92269674|NCT00372645|Vitamins|vitamins|mesh-ancestor
92269675|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
92269676|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269677|NCT00372723|Infliximab|infliximab|mesh-list
92269678|NCT00372723|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91926320|NCT02535416|Cetirizine|cetirizine|mesh-list
92269679|NCT00372723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269680|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
92269681|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922563|NCT02399397|GABA Agents|gaba agents|mesh-ancestor
92269682|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269683|NCT00372801|Ibuprofen|ibuprofen|mesh-list
92269684|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92269685|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269686|NCT00372801|Analgesics|analgesics|mesh-ancestor
92269687|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
92269688|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269689|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269690|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269691|NCT00372801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269692|NCT00372801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92269693|NCT00372801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269694|NCT00372801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269695|NCT04797429|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92269696|NCT04797429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269697|NCT05455359|Famotidine|famotidine|mesh-list
92269698|NCT05455359|Prucalopride|prucalopride|mesh-list
92269699|NCT05455359|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92269700|NCT05455359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92269701|NCT05455359|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92269702|NCT05455359|Histamine Antagonists|histamine antagonists|mesh-ancestor
92269703|NCT05455359|Histamine Agents|histamine agents|mesh-ancestor
92269704|NCT05455359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269705|NCT05455359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269706|NCT05455359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269707|NCT05455359|Laxatives|laxatives|mesh-ancestor
92269708|NCT05455359|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92269709|NCT05455359|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92269710|NCT05455359|Serotonin Agents|serotonin agents|mesh-ancestor
92269711|NCT00373503|Lofexidine|lofexidine|mesh-list
92269712|NCT00373503|Dronabinol|dronabinol|mesh-list
92269713|NCT00373503|Hallucinogens|hallucinogens|mesh-ancestor
92269714|NCT00373503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269715|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92269716|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269717|NCT00373503|Analgesics|analgesics|mesh-ancestor
92269718|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
92269719|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269720|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92269721|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92269722|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269723|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269724|NCT00373503|Hormones|hormones|mesh-ancestor
92269725|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269726|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92269727|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92269728|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92269729|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92269730|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92269731|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92269732|NCT01515176|Ofatumumab|ofatumumab|mesh-list
92269733|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92269734|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269735|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
92269736|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269737|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92269738|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92269739|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
92269740|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269741|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92269742|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92269743|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
92269745|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269746|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269747|NCT01515566|Fentanyl|fentanyl|mesh-list
92269748|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92269750|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269751|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269752|NCT01515566|Analgesics|analgesics|mesh-ancestor
92269753|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
92269754|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269755|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92269756|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92269757|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
92269759|NCT02522715|Prednisone|prednisone|mesh-list
92269760|NCT02522715|Cortisone|cortisone|mesh-list
92269761|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269762|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
92269763|NCT02522715|Hormones|hormones|mesh-ancestor
92269764|NCT02522715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269765|NCT02522715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269766|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92269767|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269768|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
92269769|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
92269770|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269771|NCT00708045|Antiviral Agents|antiviral agents|mesh-ancestor
92343986|NCT05756569|Immunologic Factors|immunologic factors|mesh-ancestor
92269772|NCT00708045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269774|NCT01516268|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92269775|NCT01516268|Narcotics|narcotics|mesh-ancestor
92269776|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269777|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269778|NCT01516268|Analgesics|analgesics|mesh-ancestor
92269779|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
92269780|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269781|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92269782|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92269783|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
92269784|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
92269785|NCT05440968|Chrysarobin|chrysarobin|mesh-list
92269786|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92269787|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269788|NCT05440968|Analgesics|analgesics|mesh-ancestor
92269789|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
92269790|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269791|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269792|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269793|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269794|NCT01516424|Risperidone|risperidone|mesh-list
92269795|NCT01516424|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92269796|NCT01516424|Serotonin Agents|serotonin agents|mesh-ancestor
92269797|NCT01516424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269798|NCT01516424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269799|NCT01516424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269800|NCT01516424|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92269801|NCT01516424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92269802|NCT01516424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269803|NCT01516424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92269804|NCT01516424|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92269805|NCT01516424|Dopamine Agents|dopamine agents|mesh-ancestor
92269806|NCT02368314|Enoxaparin|enoxaparin|mesh-list
92269807|NCT02368314|Enoxaparin sodium|enoxaparin sodium|mesh-list
92269808|NCT02368314|Anticoagulants|anticoagulants|mesh-ancestor
92269809|NCT02368314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92269810|NCT02368314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92269811|NCT02368314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269812|NCT01463384|Minocycline|minocycline|mesh-list
92269813|NCT01463384|Tetracycline|tetracycline|mesh-list
92269814|NCT01463384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92269815|NCT01463384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269816|NCT01463384|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92269817|NCT01463384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269818|NCT01463384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269819|NCT02785185|Clobetasol|clobetasol|mesh-list
92269821|NCT02785185|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92269822|NCT02785185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269823|NCT02785185|Glucocorticoids|glucocorticoids|mesh-ancestor
92269824|NCT02785185|Hormones|hormones|mesh-ancestor
92269825|NCT02785185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269826|NCT02785185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269827|NCT02787057|Moxifloxacin|moxifloxacin|mesh-list
92269828|NCT02787057|Vancomycin|vancomycin|mesh-list
92269829|NCT02787057|Ceftazidime|ceftazidime|mesh-list
92269830|NCT02787057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92269831|NCT02787057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269832|NCT02787057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92269833|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92269834|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269835|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269836|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269837|NCT01972347|Trametinib|trametinib|mesh-list
92269838|NCT01972347|Dabrafenib|dabrafenib|mesh-list
92269839|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269840|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92269841|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269842|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269843|NCT01468532|Prednisone|prednisone|mesh-list
92269844|NCT01468532|Docetaxel|docetaxel|mesh-list
92269845|NCT01468532|Pasireotide|pasireotide|mesh-list
92343990|NCT05727098|Anesthetics, Local|anesthetics, local|mesh-list
92269846|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269847|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
92269848|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
92269849|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
92269850|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269851|NCT01468532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269852|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
92269853|NCT01468532|Hormones|hormones|mesh-ancestor
92269854|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269855|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269856|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92269857|NCT05062317|Leucovorin|leucovorin|mesh-list
92269858|NCT05062317|Bevacizumab|bevacizumab|mesh-list
92269859|NCT05062317|Fluorouracil|fluorouracil|mesh-list
92269860|NCT05062317|Capecitabine|capecitabine|mesh-list
92269861|NCT05062317|Oxaliplatin|oxaliplatin|mesh-list
92269862|NCT05062317|Irinotecan|irinotecan|mesh-list
92269863|NCT05062317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92269864|NCT05062317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269865|NCT05062317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92269866|NCT05062317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92269867|NCT05062317|Growth Substances|growth substances|mesh-ancestor
92269868|NCT05062317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269869|NCT05062317|Growth Inhibitors|growth inhibitors|mesh-ancestor
92269870|NCT05062317|Antimetabolites|antimetabolites|mesh-ancestor
92269871|NCT05062317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269872|NCT05062317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92269873|NCT05062317|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92269874|NCT05062317|Immunologic Factors|immunologic factors|mesh-ancestor
92269875|NCT05062317|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92269876|NCT05062317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92269877|NCT05062317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269878|NCT05062317|Antidotes|antidotes|mesh-ancestor
92269879|NCT05062317|Protective Agents|protective agents|mesh-ancestor
92269880|NCT05062317|Vitamin B Complex|vitamin b complex|mesh-ancestor
92269881|NCT05062317|Vitamins|vitamins|mesh-ancestor
92269882|NCT05062317|Micronutrients|micronutrients|mesh-ancestor
92269883|NCT01469234|Loratadine|loratadine|mesh-list
92269884|NCT01469234|Fexofenadine|fexofenadine|mesh-list
92269885|NCT01469234|Terfenadine|terfenadine|mesh-list
92269886|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
92269887|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
92269888|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92269889|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92269890|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92269891|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
92269892|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
92269893|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269894|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269895|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269896|NCT05045937|Vitamin D|vitamin d|mesh-list
92269897|NCT05045937|Vitamins|vitamins|mesh-list
92269898|NCT05045937|Ivermectin|ivermectin|mesh-list
92269899|NCT05045937|Remdesivir|remdesivir|mesh-list
92269900|NCT05045937|Ibuprofen|ibuprofen|mesh-list
92269901|NCT05045937|Budesonide|budesonide|mesh-list
92269902|NCT05045937|Melatonin|melatonin|mesh-list
92269903|NCT05045937|Albuterol|albuterol|mesh-list
92269904|NCT05045937|Quercetin|quercetin|mesh-list
92269905|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269906|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
92269907|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92269908|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92269909|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92269910|NCT05045937|Analgesics|analgesics|mesh-ancestor
92269911|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
91926473|NCT00961675|Plasma Substitutes|plasma substitutes|mesh-ancestor
92269912|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269913|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92269914|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269915|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269916|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92269917|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269918|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92269919|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
92269920|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92269921|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
92269922|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
92269923|NCT05045937|Hormones|hormones|mesh-ancestor
92269924|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92269925|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
92269926|NCT05045937|Protective Agents|protective agents|mesh-ancestor
92269927|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269928|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
92269929|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92269930|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92269931|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92269932|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92269933|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92269934|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269935|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92269936|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92269937|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
92269938|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
92269939|NCT00373581|Cocaine|cocaine|mesh-list
92269940|NCT00373581|Vigabatrin|vigabatrin|mesh-list
92269941|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
92269942|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
92269943|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269944|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269945|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
92269946|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269947|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92269948|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92269949|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92269950|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92269951|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269952|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
92269953|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92269954|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
92269955|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269956|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
92269957|NCT01470170|Alfentanil|alfentanil|mesh-list
92269958|NCT01470170|Propofol|propofol|mesh-list
92269959|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92269960|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92269961|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269962|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92269963|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
92269964|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
92269965|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92269966|NCT01470170|Narcotics|narcotics|mesh-ancestor
92269967|NCT01470170|Analgesics|analgesics|mesh-ancestor
92269968|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
92269969|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92269970|NCT04311567|Methotrexate|methotrexate|mesh-list
92269971|NCT04311567|Tofacitinib|tofacitinib|mesh-list
92269972|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92269973|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
92269974|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92269975|NCT04311567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269976|NCT04311567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92269977|NCT04311567|Antimetabolites|antimetabolites|mesh-ancestor
92269978|NCT04311567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269979|NCT04311567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269980|NCT04311567|Dermatologic Agents|dermatologic agents|mesh-ancestor
92269981|NCT04311567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92269982|NCT04311567|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92269983|NCT04311567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92269984|NCT04311567|Immunologic Factors|immunologic factors|mesh-ancestor
92269985|NCT04311567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92269986|NCT04311567|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92269987|NCT04311567|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92269988|NCT04311567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92269989|NCT04259775|Insulin|insulin|mesh-list
92269990|NCT04259775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92269991|NCT04259775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92269992|NCT05037825|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92269993|NCT05037825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92269994|NCT05037825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92269995|NCT05037825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92269996|NCT01573052|Chlordiazepoxide|chlordiazepoxide|mesh-list
92269997|NCT01573052|Gabapentin|gabapentin|mesh-list
92269998|NCT01573052|Analgesics|analgesics|mesh-ancestor
92269999|NCT01573052|Sensory System Agents|sensory system agents|mesh-ancestor
92270000|NCT01573052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270001|NCT01573052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270002|NCT01573052|Anticonvulsants|anticonvulsants|mesh-ancestor
92270003|NCT01573052|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92270004|NCT01573052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92270005|NCT01573052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270006|NCT01573052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92270007|NCT01573052|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92270008|NCT01573052|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92270009|NCT01573052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270010|NCT01573052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270011|NCT01573052|Antimanic Agents|antimanic agents|mesh-ancestor
92270012|NCT01573052|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92270013|NCT01573052|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92270014|NCT01573052|GABA Modulators|gaba modulators|mesh-ancestor
92270015|NCT01573052|GABA Agents|gaba agents|mesh-ancestor
92270016|NCT01521260|Chlorhexidine|chlorhexidine|mesh-list
92270017|NCT01521260|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92270018|NCT01521260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270019|NCT01521260|Disinfectants|disinfectants|mesh-ancestor
92270020|NCT01523834|Panobinostat|panobinostat|mesh-list
92270021|NCT01523834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270022|NCT01523834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92270023|NCT01523834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270024|NCT01523834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270025|NCT01472432|Vildagliptin|vildagliptin|mesh-list
92270026|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270027|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270028|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92270029|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
92270030|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270031|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270032|NCT01524302|Levofloxacin|levofloxacin|mesh-list
92270033|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92270034|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92270035|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270036|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92270037|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92270038|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92270039|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270040|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270041|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270042|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92270043|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92270044|NCT02802111|Albuterol|albuterol|mesh-list
92270045|NCT02802111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92270046|NCT02802111|Autonomic Agents|autonomic agents|mesh-ancestor
92270047|NCT02802111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270048|NCT02802111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270049|NCT02802111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92270050|NCT02802111|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270051|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
92270052|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92270053|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92270054|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92270055|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92270056|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92270057|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270058|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270059|NCT01576874|Oxytocin|oxytocin|mesh-list
92270060|NCT01576874|Oxytocics|oxytocics|mesh-ancestor
92270061|NCT01576874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92270062|NCT01576874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270063|NCT01576952|Bromfenac|bromfenac|mesh-list
92270064|NCT01576952|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270065|NCT01576952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270067|NCT01576952|Sensory System Agents|sensory system agents|mesh-ancestor
92270068|NCT01576952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270069|NCT01576952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270070|NCT01576952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270072|NCT01577966|Sulfasalazine|sulfasalazine|mesh-list
92270073|NCT01577966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270074|NCT01577966|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270075|NCT01577966|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270076|NCT01577966|Analgesics|analgesics|mesh-ancestor
92270077|NCT01577966|Sensory System Agents|sensory system agents|mesh-ancestor
92270078|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270079|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270080|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270081|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270082|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270083|NCT02345226|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92270084|NCT02345226|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92270085|NCT02345226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92270086|NCT02345226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270087|NCT02345226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270088|NCT02345226|Antiviral Agents|antiviral agents|mesh-ancestor
92270089|NCT02345226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270090|NCT02345226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92270091|NCT02345226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92270092|NCT02802501|Primaquine|primaquine|mesh-list
92270093|NCT02802501|Piperaquine|piperaquine|mesh-list
92270094|NCT02802501|Artenimol|artenimol|mesh-list
92270095|NCT02802501|Tafenoquine|tafenoquine|mesh-list
92270096|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
92270097|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92270098|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92270099|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270100|NCT01528592|Levodopa|levodopa|mesh-list
92270101|NCT01528592|Carbidopa|carbidopa|mesh-list
92270102|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92270103|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92270104|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92270105|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
92270106|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270107|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270108|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270109|NCT01528592|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92270110|NCT01528592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270111|NCT01528592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92270112|NCT01528592|Immunologic Factors|immunologic factors|mesh-ancestor
92270113|NCT01528592|Dopamine Agonists|dopamine agonists|mesh-ancestor
92270114|NCT01578278|Fluticasone|fluticasone|mesh-list
92270116|NCT01578278|Bepotastine besilate|bepotastine besilate|mesh-list
92270117|NCT01578278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270118|NCT01578278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92270119|NCT01578278|Autonomic Agents|autonomic agents|mesh-ancestor
92270120|NCT01578278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270121|NCT01578278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270123|NCT01578278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270124|NCT01578278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92270125|NCT01578278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92270126|NCT02803749|Buspirone|buspirone|mesh-list
92270127|NCT02803749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92270128|NCT02803749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92270129|NCT02803749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270130|NCT02803749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270132|NCT02803749|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92270133|NCT02803749|Serotonin Agents|serotonin agents|mesh-ancestor
92270134|NCT02803749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270135|NCT02803749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270136|NCT01578980|Pancrelipase|pancrelipase|mesh-list
92270137|NCT01578980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270138|NCT01529060|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92270139|NCT01529060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270141|NCT00372879|Vitamins|vitamins|mesh-ancestor
92270142|NCT00372879|Micronutrients|micronutrients|mesh-ancestor
92270143|NCT00372879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270144|NCT00372879|Antioxidants|antioxidants|mesh-ancestor
92270145|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270146|NCT00372879|Protective Agents|protective agents|mesh-ancestor
92270147|NCT02806869|Ibuprofen|ibuprofen|mesh-list
92270148|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270149|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270150|NCT02806869|Analgesics|analgesics|mesh-ancestor
92270151|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
92270152|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270153|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270154|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270155|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270156|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92270157|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270158|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270159|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
92270160|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92270161|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270162|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270163|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92270164|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270165|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270166|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92270167|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92270168|NCT05564858|Antibodies|antibodies|mesh-list
92270169|NCT05564858|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92270170|NCT05564858|Immunoconjugates|immunoconjugates|mesh-list
92270171|NCT05564858|Immunologic Factors|immunologic factors|mesh-ancestor
92270172|NCT05564858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270173|NCT02814279|Dipyrone|dipyrone|mesh-list
92270174|NCT02814279|Chlorhexidine|chlorhexidine|mesh-list
92270175|NCT02814279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92270176|NCT02814279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270177|NCT02814279|Disinfectants|disinfectants|mesh-ancestor
92270178|NCT02814279|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270179|NCT02814279|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270180|NCT02814279|Analgesics|analgesics|mesh-ancestor
92270181|NCT02814279|Sensory System Agents|sensory system agents|mesh-ancestor
92270182|NCT02814279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270183|NCT02814279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270184|NCT02814279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270185|NCT02814279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270186|NCT02814279|Antipyretics|antipyretics|mesh-ancestor
92270187|NCT00373659|Ranibizumab|ranibizumab|mesh-list
92270188|NCT00373659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92270189|NCT00373659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92270191|NCT00373659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270192|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
92270193|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270194|NCT02885025|Fluticasone|fluticasone|mesh-list
92270196|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92270197|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
92270198|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270199|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270200|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92270201|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270202|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
92270203|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92270204|NCT01580618|Tenecteplase|tenecteplase|mesh-list
92270205|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92270206|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92270207|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270208|NCT01581710|Montelukast|montelukast|mesh-list
92270209|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92270210|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270211|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92270212|NCT01581710|Hormone Antagonists|hormone antagonists|mesh-ancestor
92270213|NCT01581710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270214|NCT01581710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270215|NCT01581710|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92270216|NCT01581710|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92270217|NCT01581710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270218|NCT01582490|Bupivacaine|bupivacaine|mesh-list
92270219|NCT01582490|Anesthetics, Local|anesthetics, local|mesh-ancestor
92270220|NCT01582490|Anesthetics|anesthetics|mesh-ancestor
92270221|NCT01582490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270222|NCT01582490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270223|NCT01582490|Sensory System Agents|sensory system agents|mesh-ancestor
92270224|NCT01582490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270225|NCT01582880|Riboflavin|riboflavin|mesh-list
92270226|NCT01582880|Vitamins|vitamins|mesh-ancestor
92270227|NCT01582880|Micronutrients|micronutrients|mesh-ancestor
92270228|NCT01582880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270229|NCT01582880|Vitamin B Complex|vitamin b complex|mesh-ancestor
92270230|NCT01582880|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92270231|NCT01582880|Dermatologic Agents|dermatologic agents|mesh-ancestor
92270232|NCT02889393|Teduglutide|teduglutide|mesh-list
92270233|NCT02889393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270234|NCT02889393|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92270235|NCT02889393|Protective Agents|protective agents|mesh-ancestor
92270236|NCT02889393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270237|NCT02818569|Dexmedetomidine|dexmedetomidine|mesh-list
92270238|NCT02818569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92270239|NCT02818569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270240|NCT02818569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270241|NCT02818569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270242|NCT02818569|Analgesics|analgesics|mesh-ancestor
92270243|NCT02818569|Sensory System Agents|sensory system agents|mesh-ancestor
92270244|NCT02818569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270245|NCT02818569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92270246|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92270247|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92270248|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
92270249|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270250|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270251|NCT03581409|Aspirin|aspirin|mesh-list
92270252|NCT03581409|Cilostazol|cilostazol|mesh-list
92270253|NCT03581409|Clopidogrel|clopidogrel|mesh-list
92270254|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92270255|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270256|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270257|NCT03581409|Analgesics|analgesics|mesh-ancestor
92270258|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
92270259|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270260|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270262|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270263|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92270264|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92270265|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270266|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92270267|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92270268|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270269|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
92270270|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92270271|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92270272|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92344020|NCT05687058|Empagliflozin|empagliflozin|mesh-list
92270273|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
92270274|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270275|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92270276|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
92270277|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92270278|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270279|NCT03581409|Vasodilator Agents|vasodilator agents|mesh-ancestor
92270280|NCT03581409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92270281|NCT03581409|Protective Agents|protective agents|mesh-ancestor
92270282|NCT03581409|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92270283|NCT03581409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92270284|NCT03566667|Metoprolol|metoprolol|mesh-list
92270285|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91923161|NCT02394093|Aspirin|aspirin|mesh-list
92270286|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92270287|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
92270289|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270290|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270291|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92270292|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92270293|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92270294|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
92270295|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270296|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270297|NCT01533116|Levodopa|levodopa|mesh-list
92270298|NCT01533116|Carbidopa|carbidopa|mesh-list
92270299|NCT01533116|Opicapone|opicapone|mesh-list
92270300|NCT01533116|Benserazide|benserazide|mesh-list
92270301|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92270302|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92270303|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
92270304|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270305|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270306|NCT01533116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270307|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92270308|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270309|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92270310|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
92270311|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
92270312|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92270313|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
92270314|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270315|NCT03510741|Expectorants|expectorants|mesh-ancestor
92270316|NCT03510741|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270317|NCT03510741|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92270318|NCT03510741|Antioxidants|antioxidants|mesh-ancestor
92270319|NCT03510741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270320|NCT03510741|Protective Agents|protective agents|mesh-ancestor
92270321|NCT03510741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270322|NCT03510741|Antidotes|antidotes|mesh-ancestor
92270323|NCT03510741|Antifungal Agents|antifungal agents|mesh-ancestor
92270324|NCT05556044|Empagliflozin|empagliflozin|mesh-list
92270325|NCT05556044|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92270326|NCT05556044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270327|NCT05556044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270328|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270329|NCT01584518|Furosemide|furosemide|mesh-list
92270330|NCT01584518|Diuretics|diuretics|mesh-ancestor
92270331|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
92270332|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270333|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92270334|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270335|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270337|NCT02901249|Sertraline|sertraline|mesh-list
92270338|NCT02901249|Nortriptyline|nortriptyline|mesh-list
92270339|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
92270340|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92270341|NCT02901249|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92270342|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92344023|NCT05687058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270344|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270345|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270346|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
92270347|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270348|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270349|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
92270350|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92270351|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270352|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92270353|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92270354|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
92270355|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92270356|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92270357|NCT00373815|Everolimus|everolimus|mesh-list
92270358|NCT00373815|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92270359|NCT00373815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92270360|NCT00373815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270361|NCT00373815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270362|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92270363|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
92270364|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270365|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270366|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
92270367|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92270368|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
92270369|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270370|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
92270371|NCT01586312|Protective Agents|protective agents|mesh-ancestor
92270373|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
92270374|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
92270375|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270376|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270377|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
92270378|NCT00373893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270379|NCT00373893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92270380|NCT00373893|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92270381|NCT00373893|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92270382|NCT00373893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270383|NCT00373893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270384|NCT02977299|Aripiprazole|aripiprazole|mesh-list
92270385|NCT02977299|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92270386|NCT02977299|Antidepressive Agents|antidepressive agents|mesh-ancestor
92270387|NCT02977299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92270388|NCT02977299|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92270389|NCT02977299|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92270390|NCT02977299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270391|NCT02977299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270392|NCT02977299|Dopamine Agonists|dopamine agonists|mesh-ancestor
92270393|NCT02977299|Dopamine Agents|dopamine agents|mesh-ancestor
92270394|NCT02977299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270395|NCT02977299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270396|NCT02977299|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92270397|NCT02977299|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92270398|NCT02977299|Serotonin Agents|serotonin agents|mesh-ancestor
92270399|NCT02977299|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92270400|NCT02977299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92270401|NCT02977299|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92270402|NCT02977299|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92270403|NCT02977299|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92270404|NCT02977299|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92270405|NCT02977299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270406|NCT02977299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92270407|NCT02212106|Vaccines|vaccines|mesh-list
92270408|NCT02212106|Immunologic Factors|immunologic factors|mesh-ancestor
92270409|NCT02212106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270410|NCT02903121|Tamoxifen|tamoxifen|mesh-list
92270411|NCT02903121|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92270412|NCT02903121|Hormone Antagonists|hormone antagonists|mesh-ancestor
92344024|NCT05687058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322584|NCT00002156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270413|NCT02903121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270414|NCT02903121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270415|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92270416|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270417|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92270418|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92270419|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92270420|NCT02638701|Infliximab|infliximab|mesh-list
92270421|NCT02638701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92270422|NCT02638701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270423|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92270424|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270425|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270426|NCT02904915|Lidocaine|lidocaine|mesh-list
92270427|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
92270428|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
92270429|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270430|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270431|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
91923303|NCT04440267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270432|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270433|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92270434|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92270435|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92270436|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270437|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270438|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92270439|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92270440|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270441|NCT01535924|Gemcitabine|gemcitabine|mesh-list
92270442|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92270443|NCT01535924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92270444|NCT01535924|Antimetabolites|antimetabolites|mesh-ancestor
92270445|NCT01535924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270446|NCT01535924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270447|NCT01535924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92270448|NCT01535924|Alkylating Agents|alkylating agents|mesh-ancestor
92270449|NCT02909439|Neostigmine|neostigmine|mesh-list
92270450|NCT02909439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92270451|NCT02909439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270452|NCT02909439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270453|NCT02909439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92270454|NCT02909439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270455|NCT02909439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270456|NCT02909439|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92270457|NCT02909439|Autonomic Agents|autonomic agents|mesh-ancestor
92270458|NCT02909439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270459|NCT01536938|Calcitriol|calcitriol|mesh-list
92270460|NCT01536938|Betamethasone|betamethasone|mesh-list
92270461|NCT01536938|Betamethasone Valerate|betamethasone valerate|mesh-list
92270462|NCT01536938|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92270463|NCT01536938|Betamethasone benzoate|betamethasone benzoate|mesh-list
92270464|NCT01536938|Calcipotriene|calcipotriene|mesh-list
92270465|NCT01536938|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92270466|NCT01536938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270467|NCT01536938|Glucocorticoids|glucocorticoids|mesh-ancestor
92270468|NCT01536938|Hormones|hormones|mesh-ancestor
92270469|NCT01536938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270470|NCT01536938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270471|NCT01536938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92270472|NCT01536938|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270473|NCT01536938|Dermatologic Agents|dermatologic agents|mesh-ancestor
92270474|NCT01536938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92270475|NCT01536938|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92270476|NCT01536938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270477|NCT01536938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344030|NCT05681884|Growth Inhibitors|growth inhibitors|mesh-ancestor
92270479|NCT01536938|Vitamins|vitamins|mesh-ancestor
92270480|NCT01536938|Micronutrients|micronutrients|mesh-ancestor
92270481|NCT01536938|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92270482|NCT01588418|Exenatide|exenatide|mesh-list
92270483|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270484|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270485|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92270486|NCT01588418|Incretins|incretins|mesh-ancestor
92270487|NCT01588418|Hormones|hormones|mesh-ancestor
92270488|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270489|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
92270490|NCT03007160|Diuretics|diuretics|mesh-ancestor
92270491|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
92270492|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270493|NCT03007160|Expectorants|expectorants|mesh-ancestor
92270494|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270495|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92270496|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
92270497|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92270498|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92270499|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92270500|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270501|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270502|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
92270503|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270504|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923377|NCT02229175|Bevacizumab|bevacizumab|mesh-list
92270505|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92270506|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270507|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92270508|NCT02914119|Rocuronium|rocuronium|mesh-list
92270509|NCT02914119|Mivacurium|mivacurium|mesh-list
92270510|NCT02914119|Cisatracurium|cisatracurium|mesh-list
92270511|NCT02914119|Succinylcholine|succinylcholine|mesh-list
92270512|NCT02914119|Neostigmine|neostigmine|mesh-list
92270513|NCT02914119|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92270514|NCT02914119|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92270515|NCT02914119|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92270516|NCT02914119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270517|NCT02914119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270518|NCT02914119|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92270519|NCT02914119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270520|NCT02914119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270521|NCT02914119|Cholinergic Agents|cholinergic agents|mesh-ancestor
92270522|NCT02914119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270523|NCT02914119|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92270524|NCT02914119|Autonomic Agents|autonomic agents|mesh-ancestor
92270525|NCT02914119|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92270526|NCT01589510|Bimatoprost|bimatoprost|mesh-list
92270527|NCT01589510|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92270528|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92270529|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92270530|NCT02914509|Travoprost|travoprost|mesh-list
92270531|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92270532|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
92270533|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92270534|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92270535|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270536|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
92270537|NCT02840097|Coagulants|coagulants|mesh-ancestor
92270538|NCT02841033|Daratumumab|daratumumab|mesh-list
92270539|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270540|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92270541|NCT02988089|Amoxicillin|amoxicillin|mesh-list
92270542|NCT02988089|Metronidazole|metronidazole|mesh-list
92270543|NCT02988089|Clarithromycin|clarithromycin|mesh-list
92270544|NCT02988089|Levofloxacin|levofloxacin|mesh-list
92270545|NCT02988089|Ofloxacin|ofloxacin|mesh-list
92270546|NCT02988089|Tetracycline|tetracycline|mesh-list
92270547|NCT02988089|Tinidazole|tinidazole|mesh-list
92270548|NCT02988089|Furazolidone|furazolidone|mesh-list
92270549|NCT02988089|Bismuth|bismuth|mesh-list
92270550|NCT02988089|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92270551|NCT02988089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270552|NCT02988089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92270553|NCT02988089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92270554|NCT02988089|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92270555|NCT02988089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270556|NCT02988089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270557|NCT02988089|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92270558|NCT02988089|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92270559|NCT02988089|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92270560|NCT02988089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92270561|NCT02988089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92270562|NCT02988089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270563|NCT02988089|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92270565|NCT02988089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270566|NCT02988089|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92270567|NCT02988089|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92270568|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92270569|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
92270570|NCT02430233|Progesterone|progesterone|mesh-list
92270571|NCT02430233|Progestins|progestins|mesh-ancestor
92270572|NCT02430233|Hormones|hormones|mesh-ancestor
92270573|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270574|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270575|NCT01589978|Aspirin|aspirin|mesh-list
92270576|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
92270577|NCT01589978|Salicylates|salicylates|mesh-list
92270578|NCT01589978|Ticlopidine|ticlopidine|mesh-list
92270579|NCT01589978|Clopidogrel|clopidogrel|mesh-list
92270580|NCT01589978|Ticagrelor|ticagrelor|mesh-list
91923453|NCT05498012|Cannabidiol|cannabidiol|mesh-list
92270581|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92270582|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270583|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270584|NCT01589978|Analgesics|analgesics|mesh-ancestor
92270585|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
92270586|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270587|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270588|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270589|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270590|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92270591|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92270592|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270593|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92270594|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92270595|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270596|NCT01589978|Antipyretics|antipyretics|mesh-ancestor
92270597|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92270598|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92270599|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92270600|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
92270601|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270602|NCT01589978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270603|NCT01589978|Antifungal Agents|antifungal agents|mesh-ancestor
92270604|NCT01589978|Keratolytic Agents|keratolytic agents|mesh-ancestor
92270605|NCT01589978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92270606|NCT01589978|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92270607|NCT01589978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92270608|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
92270609|NCT02417285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92270610|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270611|NCT01592006|Ribavirin|ribavirin|mesh-list
92270612|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92270613|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
92270614|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270615|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
92270616|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270617|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
92270618|NCT00551291|Prednisone|prednisone|mesh-list
92270619|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
92270620|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270621|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
92270622|NCT00551291|Hormones|hormones|mesh-ancestor
92270623|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270624|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270625|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92270626|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270627|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92270628|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92270629|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
92270630|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92270631|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270632|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270633|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270635|NCT02981264|Lidocaine|lidocaine|mesh-list
92270636|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
92270637|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
92270638|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270639|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270640|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
92270641|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270642|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92270643|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92270644|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92270645|NCT02981264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270646|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270647|NCT05470985|Ozanimod|ozanimod|mesh-list
92270648|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92270649|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270650|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92270651|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
92270652|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270653|NCT01593722|Ivermectin|ivermectin|mesh-list
92270654|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
92270655|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92270656|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270657|NCT01593722|Filaricides|filaricides|mesh-ancestor
92270658|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
92270659|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
92270660|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92270661|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117784|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270662|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270663|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
92270664|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92270665|NCT01594424|Antibodies|antibodies|mesh-list
92270666|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
92270667|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92270668|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
92270669|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270670|NCT01595282|Ibuprofen|ibuprofen|mesh-list
92270671|NCT01595282|Ketorolac|ketorolac|mesh-list
92270672|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92270673|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270674|NCT01595282|Analgesics|analgesics|mesh-ancestor
92270675|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
92270676|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270677|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270678|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92270679|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270680|NCT01595282|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92270681|NCT01595282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270682|NCT01595282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270683|NCT01595516|Metoprolol|metoprolol|mesh-list
92270684|NCT01595516|Nebivolol|nebivolol|mesh-list
92344042|NCT05656352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270686|NCT01595516|Kininogens|kininogens|mesh-list
92270687|NCT01595516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270688|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270689|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92270690|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92270691|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
92270692|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
92270693|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270694|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92270695|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92270696|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92270697|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
92270698|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270699|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
92270700|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92270701|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92270702|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92270703|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92270704|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
92270705|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270706|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
92270707|NCT01596842|Vitamin D|vitamin d|mesh-list
92322585|NCT04092907|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92270708|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92270709|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270711|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
92270712|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92270713|NCT02217800|Octreotide|octreotide|mesh-list
92270714|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270715|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92270716|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270717|NCT02218190|Alvimopan|alvimopan|mesh-list
92270718|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270719|NCT03006614|Cisplatin|cisplatin|mesh-list
92270720|NCT03006614|Gemcitabine|gemcitabine|mesh-list
92270721|NCT03006614|Docetaxel|docetaxel|mesh-list
92270722|NCT03006614|Capecitabine|capecitabine|mesh-list
92270723|NCT03006614|Trastuzumab|trastuzumab|mesh-list
92270724|NCT03006614|Vinorelbine|vinorelbine|mesh-list
92270725|NCT03006614|Epirubicin|epirubicin|mesh-list
92270726|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270727|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92270728|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
92270729|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270730|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
92270731|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
92270732|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
92270733|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92270734|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92270735|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92270736|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92270737|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92270738|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270739|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92270740|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92270741|NCT03006380|Oxytocin|oxytocin|mesh-list
92270742|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
92270743|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92270744|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270745|NCT02981030|Misoprostol|misoprostol|mesh-list
92270746|NCT02981030|Mifepristone|mifepristone|mesh-list
92270747|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92270748|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
92270749|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92270750|NCT02981030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270751|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92270752|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270753|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
92270754|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92270755|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92270756|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92344054|NCT05632809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270757|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92270759|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92270760|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92270761|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
92270762|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270763|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
92270764|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92270765|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92270766|NCT03006146|Molgramostim|molgramostim|mesh-list
92270767|NCT03006146|Sargramostim|sargramostim|mesh-list
92270768|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
92270769|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270770|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270771|NCT00551213|Capecitabine|capecitabine|mesh-list
92270772|NCT00551213|Irinotecan|irinotecan|mesh-list
92270773|NCT00551213|Cetuximab|cetuximab|mesh-list
92270774|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92270775|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
92270776|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270777|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270778|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92270779|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92270780|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270781|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92270782|NCT01999361|Mycophenolic Acid|mycophenolic acid|mesh-list
92270783|NCT01999361|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92270784|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270785|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92270786|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
92270787|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92270788|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270789|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270790|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270791|NCT03006471|Dapagliflozin|dapagliflozin|mesh-list
92270792|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92270793|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270794|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270795|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270796|NCT01684397|Bevacizumab|bevacizumab|mesh-list
92270797|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92270798|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
92270800|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
92270801|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92270802|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
92270803|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270804|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92270805|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92270806|NCT01684397|Growth Substances|growth substances|mesh-ancestor
92270807|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270808|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
92270809|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
92270810|NCT03005678|Denosumab|denosumab|mesh-list
92270811|NCT03005678|Alendronate|alendronate|mesh-list
92270812|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92270813|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270814|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
92270815|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92270816|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
92270817|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270818|NCT03008889|Expectorants|expectorants|mesh-ancestor
92270819|NCT03008889|Respiratory System Agents|respiratory system agents|mesh-ancestor
92270820|NCT03008889|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92270821|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
92270822|NCT03008889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270823|NCT03008889|Protective Agents|protective agents|mesh-ancestor
92270824|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270825|NCT03008889|Antidotes|antidotes|mesh-ancestor
92270826|NCT04980482|Interferons|interferons|mesh-list
92270827|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
92270828|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
92270829|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92270830|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270831|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
92270832|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270833|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
92270834|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270835|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92270836|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
92270837|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92270839|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92270840|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270841|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270842|NCT03000218|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92270843|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270844|NCT03010683|Metformin|metformin|mesh-list
92270845|NCT03010683|Liraglutide|liraglutide|mesh-list
92270846|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270847|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270848|NCT03010683|Incretins|incretins|mesh-ancestor
92270849|NCT03010683|Hormones|hormones|mesh-ancestor
92270850|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92270851|NCT04877678|Bepotastine besilate|bepotastine besilate|mesh-list
92270852|NCT04877678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92270853|NCT02918097|Risperidone|risperidone|mesh-list
92270854|NCT02918097|Lithium Carbonate|lithium carbonate|mesh-list
92270855|NCT02918097|Sertraline|sertraline|mesh-list
92270856|NCT02918097|Nortriptyline|nortriptyline|mesh-list
92270857|NCT02918097|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92270858|NCT02918097|Serotonin Agents|serotonin agents|mesh-ancestor
92270859|NCT02918097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270860|NCT02918097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270861|NCT02918097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270862|NCT02918097|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92270863|NCT02918097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92270864|NCT02918097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270865|NCT02918097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92270866|NCT02918097|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92270867|NCT02918097|Dopamine Agents|dopamine agents|mesh-ancestor
92270868|NCT02918097|Antidepressive Agents|antidepressive agents|mesh-ancestor
92270869|NCT02918097|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92270870|NCT02918097|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92270871|NCT02918097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270872|NCT02918097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270873|NCT02918097|Antimanic Agents|antimanic agents|mesh-ancestor
92270874|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92270875|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92270876|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
92270877|NCT05408585|Anesthetics|anesthetics|mesh-list
92270878|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270879|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270880|NCT02999204|Vitamin D|vitamin d|mesh-list
92270881|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
92270882|NCT02999204|Vitamins|vitamins|mesh-ancestor
92270883|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
92270884|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270885|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92270886|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92270887|NCT03012477|Adavosertib|adavosertib|mesh-list
92270888|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92270889|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270890|NCT02919111|Edetic Acid|edetic acid|mesh-list
92270891|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92270892|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
92270893|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
92344063|NCT05608369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92270894|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270895|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
92344066|NCT05590468|Niacinamide|niacinamide|mesh-list
92270896|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92270897|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92270898|NCT02999126|Remifentanil|remifentanil|mesh-list
92270899|NCT02999126|Propofol|propofol|mesh-list
92270900|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92270901|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270902|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270903|NCT02999126|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92270904|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
92270905|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
92270906|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92270907|NCT02999126|Narcotics|narcotics|mesh-ancestor
92270908|NCT02999126|Analgesics|analgesics|mesh-ancestor
92270909|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
92270910|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270911|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
92270912|NCT03019887|Haloperidol|haloperidol|mesh-list
92270913|NCT03019887|Olanzapine|olanzapine|mesh-list
92270914|NCT03019887|Risperidone|risperidone|mesh-list
92270915|NCT03019887|Aripiprazole|aripiprazole|mesh-list
92270916|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92270917|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92270918|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
92270919|NCT03019887|Perphenazine|perphenazine|mesh-list
92270920|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92270921|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
92270922|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270923|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270924|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270925|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92270926|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92270927|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270928|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92270929|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92270930|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
92270931|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
92270932|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
92270933|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270934|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92270935|NCT03019887|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92270936|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92270937|NCT03019887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92270938|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
92270939|NCT03019887|Dopamine Agonists|dopamine agonists|mesh-ancestor
92270940|NCT03019887|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92270941|NCT03019887|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92270942|NCT03019887|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92270943|NCT03019887|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92270944|NCT03019887|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92270945|NCT03019887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270947|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
92270948|NCT02998970|Empagliflozin|empagliflozin|mesh-list
92270949|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92270950|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270951|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92270952|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270953|NCT05406752|Acetaminophen|acetaminophen|mesh-list
92270954|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92270955|NCT05406752|Analgesics|analgesics|mesh-ancestor
92270956|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
92270957|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92270958|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270959|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
92270960|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
92270961|NCT02247362|Vaccines|vaccines|mesh-list
92270962|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
92270963|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270964|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
92270965|NCT02247362|Coagulants|coagulants|mesh-ancestor
92270966|NCT02920749|Anesthetics|anesthetics|mesh-list
92270967|NCT02920749|Propofol|propofol|mesh-list
92270968|NCT02920749|Sevoflurane|sevoflurane|mesh-list
91926474|NCT00961675|Blood Substitutes|blood substitutes|mesh-ancestor
92270969|NCT02920749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92270970|NCT02920749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270971|NCT02920749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92270972|NCT02920749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92270973|NCT02920749|Anesthetics, General|anesthetics, general|mesh-ancestor
92270974|NCT02920749|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92270975|NCT02920749|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92270976|NCT02248142|Pramipexole|pramipexole|mesh-list
92270977|NCT02248142|Antioxidants|antioxidants|mesh-ancestor
92270978|NCT02248142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270979|NCT02248142|Protective Agents|protective agents|mesh-ancestor
92270980|NCT02248142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270981|NCT02248142|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92270982|NCT02248142|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92270983|NCT02248142|Dopamine Agonists|dopamine agonists|mesh-ancestor
92270984|NCT02248142|Dopamine Agents|dopamine agents|mesh-ancestor
92270985|NCT02248142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92270986|NCT04667780|Colchicine|colchicine|mesh-list
92270987|NCT04667780|Gout Suppressants|gout suppressants|mesh-ancestor
92270988|NCT04667780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92270989|NCT04667780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92270990|NCT04667780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92270991|NCT04667780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92270992|NCT04667780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270993|NCT04667780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92270994|NCT02248220|Pramipexole|pramipexole|mesh-list
92270995|NCT02248220|Antioxidants|antioxidants|mesh-ancestor
92270996|NCT02248220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92270997|NCT02248220|Protective Agents|protective agents|mesh-ancestor
92270998|NCT02248220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92270999|NCT02248220|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92271000|NCT02248220|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92271001|NCT02248220|Dopamine Agonists|dopamine agonists|mesh-ancestor
92271002|NCT02248220|Dopamine Agents|dopamine agents|mesh-ancestor
92271003|NCT02248220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271004|NCT02921061|Cytarabine|cytarabine|mesh-list
92271005|NCT02921061|Decitabine|decitabine|mesh-list
92271006|NCT02921061|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92271007|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
92271008|NCT02921061|Cladribine|cladribine|mesh-list
92271009|NCT02921061|Lenograstim|lenograstim|mesh-list
92271010|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92271011|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
92271012|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935158|NCT03916419|Carboplatin|carboplatin|mesh-list
92271013|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271014|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
92271015|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271016|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271017|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
92271018|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271019|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92271020|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271021|NCT02921061|Analgesics|analgesics|mesh-ancestor
92271022|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
92271023|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271024|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92271025|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92271026|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92271027|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92271028|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92271029|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92271030|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271031|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
92271032|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92271033|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271034|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
92271035|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
92271036|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271037|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
92271038|NCT04523480|Testosterone|testosterone|mesh-list
92271039|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
92271040|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
92271041|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92271042|NCT04523480|Androgens|androgens|mesh-ancestor
92271043|NCT04523480|Hormones|hormones|mesh-ancestor
92271044|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926554|NCT04474093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92271045|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271046|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271047|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271048|NCT04523480|Anabolic Agents|anabolic agents|mesh-ancestor
92271049|NCT05200442|Cetuximab|cetuximab|mesh-list
92271050|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271051|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271052|NCT02859441|Ranibizumab|ranibizumab|mesh-list
92271053|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92271054|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92271055|NCT02859441|Growth Substances|growth substances|mesh-ancestor
92271056|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271057|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
92271058|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271060|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92271061|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271062|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271063|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271064|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271065|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271066|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92271067|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
92271068|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271069|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
92271070|NCT05183204|Metformin|metformin|mesh-list
92271071|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92271072|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271073|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
92271074|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92271075|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
92271076|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
92271077|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271078|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271079|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92271080|NCT02860845|Clindamycin|clindamycin|mesh-list
92271081|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
92271082|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
92271083|NCT02860845|Clotrimazole|clotrimazole|mesh-list
92271084|NCT02860845|Miconazole|miconazole|mesh-list
92271085|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
92271086|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271087|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92271088|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271089|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271090|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92271091|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92271092|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92271093|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92271094|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
92271095|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271096|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271097|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92271098|NCT02860845|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92271099|NCT03003884|Propofol|propofol|mesh-list
92271100|NCT03003884|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92271101|NCT03003884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271102|NCT03003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271103|NCT03003884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92271104|NCT03003884|Anesthetics, General|anesthetics, general|mesh-ancestor
92271105|NCT03003884|Anesthetics|anesthetics|mesh-ancestor
92271106|NCT01880723|Albuterol|albuterol|mesh-list
92271107|NCT01880723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92271108|NCT01880723|Autonomic Agents|autonomic agents|mesh-ancestor
92271109|NCT01880723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271110|NCT01880723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271111|NCT01880723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92271112|NCT01880723|Respiratory System Agents|respiratory system agents|mesh-ancestor
92271113|NCT01880723|Tocolytic Agents|tocolytic agents|mesh-ancestor
92271114|NCT01880723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92271115|NCT01880723|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92271116|NCT01880723|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92271117|NCT01880723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92271119|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271120|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271121|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
92271122|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92271123|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271124|NCT04466618|Heparin|heparin|mesh-list
92271125|NCT04466618|Calcium heparin|calcium heparin|mesh-list
92271126|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92271128|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92271129|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92271130|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271131|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92271132|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92271133|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92271134|NCT01881113|Cetirizine|cetirizine|mesh-list
92271135|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92271136|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92271137|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92271138|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
92271139|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
92271140|NCT01881113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271141|NCT01881113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271142|NCT01881113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271143|NCT05140694|Empagliflozin|empagliflozin|mesh-list
92271144|NCT05140694|Dulaglutide|dulaglutide|mesh-list
92271145|NCT05140694|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92271146|NCT05140694|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92271147|NCT05140694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271148|NCT05140694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92271149|NCT05140694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271150|NCT05140694|Immunologic Factors|immunologic factors|mesh-ancestor
92271151|NCT02987699|Leucovorin|leucovorin|mesh-list
92271152|NCT02987699|Oxaliplatin|oxaliplatin|mesh-list
92271153|NCT02987699|Fluorouracil|fluorouracil|mesh-list
92271154|NCT02987699|Levoleucovorin|levoleucovorin|mesh-list
92271155|NCT02987699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271156|NCT02987699|Antidotes|antidotes|mesh-ancestor
92271157|NCT02987699|Protective Agents|protective agents|mesh-ancestor
92271158|NCT02987699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271159|NCT02987699|Vitamin B Complex|vitamin b complex|mesh-ancestor
92271160|NCT02987699|Vitamins|vitamins|mesh-ancestor
92271161|NCT02987699|Micronutrients|micronutrients|mesh-ancestor
92271162|NCT02987699|Antimetabolites|antimetabolites|mesh-ancestor
92271163|NCT02987699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271164|NCT02987699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92271165|NCT02987699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271166|NCT02987699|Immunologic Factors|immunologic factors|mesh-ancestor
92271167|NCT03003728|Melphalan|melphalan|mesh-list
92271168|NCT03003728|Elotuzumab|elotuzumab|mesh-list
92271169|NCT03003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92271170|NCT03003728|Alkylating Agents|alkylating agents|mesh-ancestor
92271171|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271172|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271173|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92271174|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271175|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
92271176|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271177|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
92271178|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92271179|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92271180|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271181|NCT05672810|Hemostatics|hemostatics|mesh-ancestor
92271182|NCT05672810|Coagulants|coagulants|mesh-ancestor
92271183|NCT00559247|Asunaprevir|asunaprevir|mesh-list
92271184|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
92271185|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271186|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271187|NCT03003416|Dexamethasone|dexamethasone|mesh-list
92271188|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271189|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
92271190|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
92271191|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271192|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344081|NCT05565560|Analgesics|analgesics|mesh-ancestor
92271193|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271195|NCT03003416|Hormones|hormones|mesh-ancestor
92271196|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271197|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271198|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271199|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
92271200|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
92271201|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92271202|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
92271203|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271204|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271205|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92271206|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
92271207|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92271208|NCT02988869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92271209|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92271210|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
92271211|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271212|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271213|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
92271214|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92271215|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271216|NCT03028467|Folic Acid|folic acid|mesh-list
92271217|NCT03028467|Methotrexate|methotrexate|mesh-list
92271218|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92271219|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
92271220|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92271221|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271222|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92271223|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
92271224|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271225|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271226|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271227|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271228|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92271229|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271230|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
92271231|NCT03028467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271232|NCT03028467|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92271233|NCT03028467|Hematinics|hematinics|mesh-ancestor
92271234|NCT03028467|Vitamin B Complex|vitamin b complex|mesh-ancestor
92271235|NCT03028467|Vitamins|vitamins|mesh-ancestor
92271236|NCT03028467|Micronutrients|micronutrients|mesh-ancestor
92271237|NCT04327310|Meplazumab|meplazumab|mesh-list
92271238|NCT04327310|Antiviral Agents|antiviral agents|mesh-ancestor
92271239|NCT04327310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271240|NCT02222870|Vaccines|vaccines|mesh-list
92271241|NCT02222870|Immunologic Factors|immunologic factors|mesh-ancestor
92271242|NCT02222870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271243|NCT02223260|Dabigatran|dabigatran|mesh-list
92271244|NCT02223260|Antithrombins|antithrombins|mesh-ancestor
92271245|NCT02223260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92271246|NCT02223260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92271247|NCT02223260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271248|NCT02223260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271249|NCT02223260|Anticoagulants|anticoagulants|mesh-ancestor
92271250|NCT02863263|Povidone-Iodine|povidone-iodine|mesh-list
92271251|NCT02863263|Povidone|povidone|mesh-list
92271252|NCT02863263|Plasma Substitutes|plasma substitutes|mesh-ancestor
92271253|NCT02863263|Blood Substitutes|blood substitutes|mesh-ancestor
92271254|NCT02863263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92271255|NCT02863263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271256|NCT02223338|Ciprofloxacin|ciprofloxacin|mesh-list
92271257|NCT02223338|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92271258|NCT02223338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271259|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92271260|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92271261|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344082|NCT05565560|Sensory System Agents|sensory system agents|mesh-ancestor
92271262|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271263|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271264|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92271265|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92271266|NCT01887587|Dexamethasone|dexamethasone|mesh-list
92271267|NCT01887587|Doxorubicin|doxorubicin|mesh-list
92271268|NCT01887587|Vincristine|vincristine|mesh-list
92271269|NCT01887587|Ixazomib|ixazomib|mesh-list
91924129|NCT02744833|Enoxaparin|enoxaparin|mesh-list
92271270|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271271|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
92271272|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
92271273|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271274|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271275|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271276|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
92271278|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271279|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271280|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271281|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92271282|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92271283|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92271284|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271285|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271286|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92271287|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92271288|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92271289|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92271290|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
92271291|NCT03029091|Losartan|losartan|mesh-list
92271292|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92271293|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92271294|NCT03029091|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92271295|NCT03029091|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92271296|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271297|NCT02997410|Salicylic Acid|salicylic acid|mesh-list
92271298|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271299|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
92271300|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
92271301|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271302|NCT00374205|Artesunate|artesunate|mesh-list
92271303|NCT00374205|Lumefantrine|lumefantrine|mesh-list
92271304|NCT00374205|Artemether|artemether|mesh-list
92271305|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92271306|NCT00374205|Amodiaquine|amodiaquine|mesh-list
92271307|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
92271308|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92271309|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92271310|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271311|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271312|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
92271313|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
92271314|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92271315|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
92271316|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
92271317|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92271318|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92271319|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92271320|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92271321|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271322|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271323|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271324|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271325|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92271326|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271327|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
92271328|NCT03029715|Remifentanil|remifentanil|mesh-list
92271329|NCT03029715|Propofol|propofol|mesh-list
92271330|NCT03029715|Desflurane|desflurane|mesh-list
92271331|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92271332|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271333|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271334|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92271335|NCT03029715|Analgesics|analgesics|mesh-ancestor
92271336|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
92271337|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271338|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92271339|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92271340|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92271341|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
92271342|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271343|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271344|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92271345|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
92271346|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
92271347|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92271348|NCT03029715|Narcotics|narcotics|mesh-ancestor
92271349|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92271350|NCT00555035|Dolutegravir|dolutegravir|mesh-list
92271351|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92271352|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92271353|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271354|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271355|NCT00555035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92271356|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92271357|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
92271358|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271359|NCT03035955|Azelaic acid|azelaic acid|mesh-list
92271360|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271361|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271362|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
92271363|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271364|NCT02927223|Atropine|atropine|mesh-list
92271365|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92271366|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92271367|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92271368|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
92271369|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271370|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271371|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92271372|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
92271373|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
92271374|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
92271375|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92271376|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92271377|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271378|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271379|NCT02927223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271380|NCT03002792|Anesthetics|anesthetics|mesh-list
92271381|NCT03002792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271382|NCT03002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271383|NCT02927457|GSK2646264|gsk2646264|mesh-list
92271384|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92271385|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271386|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271387|NCT01891331|Fluconazole|fluconazole|mesh-list
92271388|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
92271389|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271390|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92271391|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92271392|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271393|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271394|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92271395|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
92271396|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271397|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271398|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92271399|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92271400|NCT02247518|Tadalafil|tadalafil|mesh-list
92271401|NCT02247518|Tamsulosin|tamsulosin|mesh-list
92271402|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
92344096|NCT05564546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92271403|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92271404|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92271405|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271406|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271407|NCT02247518|Urological Agents|urological agents|mesh-ancestor
92271408|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92271409|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92271410|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92271411|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
92271412|NCT02247518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271413|NCT02247518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271414|NCT02867163|Tranexamic Acid|tranexamic acid|mesh-list
92271415|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92271416|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92271417|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271419|NCT02867163|Coagulants|coagulants|mesh-ancestor
92271420|NCT04067609|Dexamethasone|dexamethasone|mesh-list
92271421|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271422|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
92271423|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
92271424|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271425|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271426|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271427|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
92271428|NCT04067609|Hormones|hormones|mesh-ancestor
92271429|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271430|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271431|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271432|NCT03022097|Bromides|bromides|mesh-list
92271433|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
92271434|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92271435|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
92271436|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271437|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271438|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92271439|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
92271440|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92271441|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92271442|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92271443|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
92271444|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271445|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271446|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
92271447|NCT03002636|Anesthetics|anesthetics|mesh-list
92271448|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271449|NCT03002636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271450|NCT03039543|Rocuronium|rocuronium|mesh-list
92271451|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92271452|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92271453|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92271454|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271455|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271456|NCT04047875|Norethindrone|norethindrone|mesh-list
92271457|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
92271458|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92271459|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92271460|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92271461|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
92271462|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92271463|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271464|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92271465|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92271467|NCT03002090|Trace Elements|trace elements|mesh-ancestor
92271468|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
92271469|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271470|NCT02328755|Methotrexate|methotrexate|mesh-list
92271471|NCT02328755|Tacrolimus|tacrolimus|mesh-list
92271472|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92271473|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
92344099|NCT05564546|Antioxidants|antioxidants|mesh-ancestor
92271474|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92271475|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271476|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92271477|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
92271478|NCT02328755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271479|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271480|NCT02328755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271481|NCT02328755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271482|NCT02328755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92271483|NCT02328755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271484|NCT02328755|Immunologic Factors|immunologic factors|mesh-ancestor
92271485|NCT02328755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271486|NCT02328755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92271487|NCT02328755|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92271488|NCT02870283|Carbamazepine|carbamazepine|mesh-list
92271489|NCT02870283|Valproic Acid|valproic acid|mesh-list
92271490|NCT02870283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92271491|NCT02870283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924352|NCT02553343|Vaccines|vaccines|mesh-list
92271492|NCT02870283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271493|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
92271494|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92271495|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271496|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271497|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
92271498|NCT02870283|GABA Agents|gaba agents|mesh-ancestor
92271499|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271500|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92271501|NCT02870283|Analgesics|analgesics|mesh-ancestor
92271502|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
92271503|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271504|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92271505|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92271506|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92271507|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92271508|NCT02931045|Clopidogrel|clopidogrel|mesh-list
92271509|NCT02931045|Ticagrelor|ticagrelor|mesh-list
92271510|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92271511|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92271512|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92271513|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92271514|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
92271515|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271516|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271517|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271518|NCT03040011|Dexamethasone|dexamethasone|mesh-list
92271519|NCT03040011|Bupivacaine|bupivacaine|mesh-list
92271520|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271521|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
92271522|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
92271523|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271524|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271525|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271526|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
92271527|NCT03040011|Hormones|hormones|mesh-ancestor
92271528|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271529|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271530|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271531|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
92271532|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
92271533|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271534|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
92271535|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
92271536|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271537|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
92271538|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271539|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271540|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92271541|NCT03040479|Lasmiditan|lasmiditan|mesh-list
92271542|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92271543|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
92271544|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271545|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271546|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271547|NCT02872857|Galantamine|galantamine|mesh-list
92271548|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92271549|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271550|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271551|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271552|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271553|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271554|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92271555|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
92271556|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271557|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
92271558|NCT02996318|Sirolimus|sirolimus|mesh-list
92271559|NCT02996318|Paclitaxel|paclitaxel|mesh-list
92271560|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92271561|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271562|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92271563|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92271564|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92271565|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271567|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271568|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92271569|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
92271570|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271571|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
92271572|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271573|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92271574|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92271575|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
92271576|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271577|NCT05197751|Antacids|antacids|mesh-ancestor
92271578|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271579|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271580|NCT02994602|ST 1435|st 1435|mesh-list
92271581|NCT02994602|Testosterone|testosterone|mesh-list
92271582|NCT02994602|Androgens|androgens|mesh-ancestor
92271583|NCT02994602|Hormones|hormones|mesh-ancestor
92271584|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271585|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271586|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92271587|NCT02994602|Contraceptive Agents|contraceptive agents|mesh-ancestor
92271588|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92271589|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92271590|NCT03297710|Trifluridine|trifluridine|mesh-list
92271591|NCT03297710|Antimetabolites|antimetabolites|mesh-ancestor
92271592|NCT03297710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271593|NCT03297710|Antiviral Agents|antiviral agents|mesh-ancestor
92271594|NCT03297710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271595|NCT04350671|Interferons|interferons|mesh-list
92271596|NCT04350671|Ritonavir|ritonavir|mesh-list
92271597|NCT04350671|Lopinavir|lopinavir|mesh-list
92271598|NCT04350671|Interferon-beta|interferon-beta|mesh-list
92271599|NCT04350671|Interferon beta-1a|interferon beta-1a|mesh-list
92271600|NCT04350671|Hydroxychloroquine|hydroxychloroquine|mesh-list
92271601|NCT04350671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271602|NCT04350671|Antiviral Agents|antiviral agents|mesh-ancestor
92271603|NCT04350671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271604|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92271605|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92271606|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
92271607|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271608|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271609|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92271610|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92271611|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92271612|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92271613|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
92271614|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92271615|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92271616|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271617|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
92271618|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271619|NCT04350671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92271620|NCT04850846|Metformin|metformin|mesh-list
92271621|NCT04850846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92271622|NCT04850846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271623|NCT05166083|Testosterone|testosterone|mesh-list
92271624|NCT05166083|Androgens|androgens|mesh-ancestor
92271625|NCT05166083|Hormones|hormones|mesh-ancestor
92271626|NCT05166083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271627|NCT05166083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271628|NCT04826354|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92271629|NCT04826354|Ezetimibe|ezetimibe|mesh-list
92271630|NCT04826354|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92271631|NCT04826354|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92271632|NCT04826354|Antimetabolites|antimetabolites|mesh-ancestor
92271633|NCT04826354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271634|NCT04826354|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92271635|NCT04826354|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92271636|NCT04826354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271637|NCT04707794|Sevoflurane|sevoflurane|mesh-list
92271638|NCT04707794|Desflurane|desflurane|mesh-list
92271639|NCT04707794|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92271640|NCT04707794|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92271641|NCT04707794|Anesthetics, General|anesthetics, general|mesh-ancestor
92271642|NCT04707794|Anesthetics|anesthetics|mesh-ancestor
92271643|NCT04707794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271644|NCT04707794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271645|NCT04667312|Durvalumab|durvalumab|mesh-list
92271646|NCT04667312|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271647|NCT04667312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271648|NCT02759588|Bevacizumab|bevacizumab|mesh-list
92271649|NCT02759588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271650|NCT02759588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271651|NCT02759588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92271652|NCT02759588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92271653|NCT02759588|Growth Substances|growth substances|mesh-ancestor
92271654|NCT02759588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271655|NCT02759588|Growth Inhibitors|growth inhibitors|mesh-ancestor
92271656|NCT03045861|Cobicistat|cobicistat|mesh-list
92271657|NCT03045861|GSK-2838232|gsk-2838232|mesh-list
92271658|NCT03045861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92271659|NCT03045861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92271660|NCT03045861|Antiviral Agents|antiviral agents|mesh-ancestor
92271661|NCT03045861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271662|NCT03045861|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92271663|NCT03045861|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92271664|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271665|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271666|NCT02249078|Quetmolimab|quetmolimab|mesh-list
92271667|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271668|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
92271669|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92271670|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
92271671|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92271672|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92271673|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271674|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92271675|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271676|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92271677|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271678|NCT01907321|Capsaicin|capsaicin|mesh-list
92271679|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
92271680|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271681|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
92271682|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271683|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271685|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
92344111|NCT05548062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92271686|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271688|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271689|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
92271690|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
92271691|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271692|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271693|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271694|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
92271695|NCT04976777|Hormones|hormones|mesh-ancestor
92271696|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271697|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271698|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271699|NCT02247596|Resveratrol|resveratrol|mesh-list
92271700|NCT02247596|Antioxidants|antioxidants|mesh-ancestor
92271701|NCT02247596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271702|NCT02247596|Protective Agents|protective agents|mesh-ancestor
92271703|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271704|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271705|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92271706|NCT03686657|Metformin|metformin|mesh-list
92271707|NCT03686657|Celecoxib|celecoxib|mesh-list
92271708|NCT03686657|Valsartan|valsartan|mesh-list
92271709|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92271710|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271711|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92271712|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92271713|NCT03686657|Analgesics|analgesics|mesh-ancestor
92271714|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
92271715|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271716|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271717|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271718|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92271719|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92271720|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271721|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271722|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92271723|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91932461|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92271724|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92271725|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
92271726|NCT02476058|Promethazine|promethazine|mesh-list
92271727|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92271728|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92271729|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271730|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271731|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
92271732|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
92271733|NCT02476058|Sensory System Agents|sensory system agents|mesh-ancestor
92271734|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271735|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
92271736|NCT02476058|Autonomic Agents|autonomic agents|mesh-ancestor
92271737|NCT02476058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271738|NCT02476058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92271739|NCT02476058|Histamine Antagonists|histamine antagonists|mesh-ancestor
92271740|NCT02476058|Histamine Agents|histamine agents|mesh-ancestor
92271741|NCT02476058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271742|NCT02476058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271743|NCT02476058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92271744|NCT02476058|Antipruritics|antipruritics|mesh-ancestor
92271745|NCT02476058|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271746|NCT02143466|Durvalumab|durvalumab|mesh-list
92271747|NCT02143466|Osimertinib|osimertinib|mesh-list
92271748|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92271749|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271750|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271751|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
92271752|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271753|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92271754|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271755|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271756|NCT03050619|Empagliflozin|empagliflozin|mesh-list
92271757|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92344114|NCT05541341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271758|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271760|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271762|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92271763|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
92271764|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
92271765|NCT02071394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271766|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271767|NCT01911065|Vaccines|vaccines|mesh-list
92271768|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
92271769|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271770|NCT02995772|Tamoxifen|tamoxifen|mesh-list
92271771|NCT02995772|Fluorouracil|fluorouracil|mesh-list
92271772|NCT02995772|Letrozole|letrozole|mesh-list
92271773|NCT02995772|Anastrozole|anastrozole|mesh-list
92271774|NCT02995772|Exemestane|exemestane|mesh-list
92271775|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92271776|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
92271777|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271778|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92271779|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271780|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271781|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
92271782|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271783|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271784|NCT02995772|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92271785|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92271786|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
92271787|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271788|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271789|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92271790|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92271791|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92271793|NCT02987465|Acetylcholine|acetylcholine|mesh-list
92271794|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
92271795|NCT02987465|Hematinics|hematinics|mesh-ancestor
92271796|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92271797|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92271798|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
92271799|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271800|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271801|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271802|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
92271803|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
92271804|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271805|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92271806|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
92271807|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92271808|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271809|NCT04895579|Durvalumab|durvalumab|mesh-list
92271810|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271811|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271812|NCT02227316|Acetaminophen|acetaminophen|mesh-list
92271813|NCT02227316|Ibuprofen|ibuprofen|mesh-list
92271814|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92271815|NCT02227316|Analgesics|analgesics|mesh-ancestor
92271816|NCT02227316|Sensory System Agents|sensory system agents|mesh-ancestor
92271817|NCT02227316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271818|NCT02227316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271819|NCT02227316|Antipyretics|antipyretics|mesh-ancestor
92271820|NCT02227316|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92271821|NCT02227316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271822|NCT02227316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271823|NCT02227316|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92271824|NCT02227316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271825|NCT02227316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271826|NCT00555971|Omalizumab|omalizumab|mesh-list
92271827|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92271828|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92271829|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
92271830|NCT02943213|Chlorpromazine|chlorpromazine|mesh-list
92271831|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
92271832|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
92271833|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271834|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271835|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271836|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92271837|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92271838|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271839|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92271840|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92271841|NCT02943213|Dopamine Agents|dopamine agents|mesh-ancestor
92271842|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271843|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271844|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
92271846|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
92271847|NCT01850108|Fludarabine|fludarabine|mesh-list
92271848|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
92271849|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271850|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
92271851|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271852|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271853|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92271854|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
92271855|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271856|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271857|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92271858|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92271859|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92271860|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
92271861|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92271862|NCT01850108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271863|NCT01850108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271864|NCT01850108|Antifungal Agents|antifungal agents|mesh-ancestor
92271865|NCT01822652|Cyclophosphamide|cyclophosphamide|mesh-list
92271866|NCT01822652|Pembrolizumab|pembrolizumab|mesh-list
92271867|NCT01822652|Fludarabine|fludarabine|mesh-list
92271868|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
92271869|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92271870|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
92271871|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271872|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271873|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92271874|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
92271875|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271876|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271877|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92271878|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92271879|NCT01822652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92271880|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92271881|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
92271882|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92271883|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92271884|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271885|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271886|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92271887|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92271888|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271889|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
92271890|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271891|NCT01338740|Adalimumab|adalimumab|mesh-list
92271892|NCT01338740|Infliximab|infliximab|mesh-list
92271893|NCT01338740|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92271894|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271895|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271896|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
92271897|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92271898|NCT02944461|Dapsone|dapsone|mesh-list
92271899|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92271900|NCT02944461|Antimalarials|antimalarials|mesh-ancestor
92271901|NCT02944461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92271902|NCT02944461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92271903|NCT02944461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92271904|NCT02944461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271905|NCT02944461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271906|NCT02944461|Leprostatic Agents|leprostatic agents|mesh-ancestor
92271907|NCT02944461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92271908|NCT05376722|Prednisone|prednisone|mesh-list
92271910|NCT05376722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271911|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
92271912|NCT05376722|Hormones|hormones|mesh-ancestor
92271913|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92271914|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271915|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92271916|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271917|NCT05376722|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92271918|NCT05376722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271919|NCT05376722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271920|NCT04737057|Fluorides|fluorides|mesh-list
92271921|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
92271922|NCT04737057|Protective Agents|protective agents|mesh-ancestor
92271923|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271924|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92271925|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92271926|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92271927|NCT03111381|Analgesics|analgesics|mesh-ancestor
92271928|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
92271929|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271930|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271931|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92271932|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92271933|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92271934|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92271935|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271936|NCT02946489|Ketamine|ketamine|mesh-list
92271937|NCT02946489|Analgesics|analgesics|mesh-ancestor
92271938|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
92271939|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271940|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271941|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92271942|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92271943|NCT02946489|Anesthetics, General|anesthetics, general|mesh-ancestor
92271944|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
92271945|NCT02946489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271946|NCT02946489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92271947|NCT02946489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92271948|NCT02946489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271949|NCT02946489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271950|NCT02949921|Lidocaine|lidocaine|mesh-list
92271951|NCT02949921|Anesthetics, Local|anesthetics, local|mesh-ancestor
92271952|NCT02949921|Anesthetics|anesthetics|mesh-ancestor
92271953|NCT02949921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271954|NCT02949921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271955|NCT02949921|Sensory System Agents|sensory system agents|mesh-ancestor
92271956|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92271957|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92271958|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92271959|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92271960|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92271961|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271962|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92271963|NCT02227706|Hemostatics|hemostatics|mesh-ancestor
92271964|NCT02227706|Coagulants|coagulants|mesh-ancestor
92271965|NCT03112863|Vitamin A|vitamin a|mesh-list
92271966|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
92271967|NCT03112863|Vitamins|vitamins|mesh-ancestor
92271968|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
92271969|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271970|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
92271971|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271972|NCT03112863|Protective Agents|protective agents|mesh-ancestor
92271973|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92271974|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92271975|NCT02950467|Psilocybin|psilocybin|mesh-list
92271976|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92344124|NCT05496335|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92271977|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
92271978|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271979|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92271980|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92271981|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
92271982|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92271983|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271984|NCT02950467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92271985|NCT01930487|Antioxidants|antioxidants|mesh-list
92271986|NCT01930487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92271987|NCT01930487|Protective Agents|protective agents|mesh-ancestor
92271988|NCT01930487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271989|NCT03864068|Inositol|inositol|mesh-list
92271990|NCT03864068|Vitamin B Complex|vitamin b complex|mesh-ancestor
92271991|NCT03864068|Vitamins|vitamins|mesh-ancestor
92271992|NCT03864068|Micronutrients|micronutrients|mesh-ancestor
92271993|NCT03864068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271994|NCT03063255|Anesthetics|anesthetics|mesh-list
92271995|NCT03063255|Mepivacaine|mepivacaine|mesh-list
92271996|NCT03063255|Rocuronium|rocuronium|mesh-list
92271997|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92271998|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92271999|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92272000|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92272001|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92272002|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272003|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92272004|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
92272005|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92272006|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92272007|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272008|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92272009|NCT05245292|Antibodies|antibodies|mesh-list
92272010|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
92272011|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92272012|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
92272013|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
92272014|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272015|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272016|NCT03115827|Carbidopa|carbidopa|mesh-list
92272017|NCT03115827|Droxidopa|droxidopa|mesh-list
92272018|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92272019|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92272020|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
92272021|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272022|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272023|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272024|NCT03115827|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92272025|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272027|NCT01915823|Xhance|xhance|mesh-list
92272028|NCT01915823|Azelastine|azelastine|mesh-list
92272029|NCT01915823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272030|NCT01915823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92272031|NCT01915823|Autonomic Agents|autonomic agents|mesh-ancestor
92272032|NCT01915823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272033|NCT01915823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272034|NCT01915823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92272035|NCT01915823|Respiratory System Agents|respiratory system agents|mesh-ancestor
92272036|NCT01915823|Dermatologic Agents|dermatologic agents|mesh-ancestor
92272037|NCT01915823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92272038|NCT01915823|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92272039|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272040|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272041|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92272042|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92272043|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
92272044|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
92272045|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272046|NCT05199194|Tenecteplase|tenecteplase|mesh-list
92272047|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92272048|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92272049|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272050|NCT01916681|Misoprostol|misoprostol|mesh-list
92272051|NCT01916681|Oxytocin|oxytocin|mesh-list
92272052|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
92272053|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92272054|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272055|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92272056|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
92272057|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92272058|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272059|NCT05735951|Stiripentol|stiripentol|mesh-list
92272060|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
92272061|NCT01917773|Octreotide|octreotide|mesh-list
92272062|NCT01917773|Bisacodyl|bisacodyl|mesh-list
92272063|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272064|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92272065|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272066|NCT01917773|Cathartics|cathartics|mesh-ancestor
92272067|NCT01917773|Laxatives|laxatives|mesh-ancestor
92272068|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92272069|NCT02283749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272070|NCT01934231|Amoxicillin|amoxicillin|mesh-list
92272071|NCT01934231|Clavulanic Acid|clavulanic acid|mesh-list
92272072|NCT01934231|Clavulanic Acids|clavulanic acids|mesh-list
92272073|NCT01934231|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92272074|NCT01934231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272075|NCT01934231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272076|NCT01934231|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92272077|NCT01934231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272078|NCT01934231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272079|NCT01935791|Glucagon|glucagon|mesh-list
92272080|NCT01935791|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92272081|NCT01935791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272082|NCT01935791|Hormones|hormones|mesh-ancestor
92272083|NCT01935791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272084|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272085|NCT01935791|Incretins|incretins|mesh-ancestor
92272086|NCT03074409|Oxytocin|oxytocin|mesh-list
92272087|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
92272088|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92272089|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272090|NCT02955147|Prednisone|prednisone|mesh-list
92272091|NCT02955147|Ustekinumab|ustekinumab|mesh-list
92272092|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272093|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
92272094|NCT02955147|Hormones|hormones|mesh-ancestor
92272095|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272096|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272097|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92272098|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272099|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
92272100|NCT03119181|Lidocaine|lidocaine|mesh-list
92272101|NCT03119181|Epinephrine|epinephrine|mesh-list
92272102|NCT03119181|Racepinephrine|racepinephrine|mesh-list
92272103|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92272104|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
92272105|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
92272106|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
92272107|NCT03119181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272108|NCT03119181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272109|NCT03119181|Sensory System Agents|sensory system agents|mesh-ancestor
92272110|NCT03119181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272111|NCT03119181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92272112|NCT03119181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92272113|NCT03119181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92272114|NCT03119181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272115|NCT03119181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272116|NCT03119181|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92272117|NCT03119181|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92272118|NCT03119181|Adrenergic Agents|adrenergic agents|mesh-ancestor
92272119|NCT03119181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272120|NCT03119181|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92272121|NCT03119181|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92272122|NCT03119181|Autonomic Agents|autonomic agents|mesh-ancestor
92272123|NCT03119181|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92272124|NCT03119181|Respiratory System Agents|respiratory system agents|mesh-ancestor
92272125|NCT03119181|Mydriatics|mydriatics|mesh-ancestor
92272126|NCT03119181|Sympathomimetics|sympathomimetics|mesh-ancestor
92272127|NCT03119181|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92272128|NCT01691534|Pyrazinamide|pyrazinamide|mesh-list
92272129|NCT01691534|Clofazimine|clofazimine|mesh-list
92272130|NCT01691534|Antitubercular Agents|antitubercular agents|mesh-ancestor
92272131|NCT01691534|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272132|NCT01691534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272133|NCT01691534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272134|NCT01691534|Leprostatic Agents|leprostatic agents|mesh-ancestor
92272136|NCT01691690|Dexamethasone|dexamethasone|mesh-list
92272137|NCT01691690|Midazolam|midazolam|mesh-list
92272138|NCT01691690|Morphine|morphine|mesh-list
92272139|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
92272140|NCT01691690|Ondansetron|ondansetron|mesh-list
92272141|NCT01691690|Propofol|propofol|mesh-list
92272142|NCT01691690|Sevoflurane|sevoflurane|mesh-list
92272143|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272144|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
92272145|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
92272146|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272147|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272148|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272149|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
92272150|NCT01691690|Hormones|hormones|mesh-ancestor
92272151|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272152|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92272153|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272154|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92272155|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272156|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92272157|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
92272158|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
92272159|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92272160|NCT01691690|Narcotics|narcotics|mesh-ancestor
92272161|NCT01691690|Analgesics|analgesics|mesh-ancestor
92272162|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
92272163|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92272164|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92272165|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92272166|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92272167|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
92272168|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
92272169|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272170|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272171|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92272172|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
92272173|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92272174|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92272175|NCT01691690|Antipruritics|antipruritics|mesh-ancestor
92272176|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92272177|NCT01691690|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92272178|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92272179|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
92272180|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
92272181|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92272182|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
92272183|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272184|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92272185|NCT02283827|Phenytoin|phenytoin|mesh-list
92272186|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
92272187|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92272188|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92272189|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272190|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272191|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92272192|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92272193|NCT01626092|Cyclosporine|cyclosporine|mesh-list
92272194|NCT01626092|Mycophenolic Acid|mycophenolic acid|mesh-list
92272195|NCT01626092|Melphalan|melphalan|mesh-list
92272196|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
92272197|NCT01626092|Clofarabine|clofarabine|mesh-list
92272198|NCT01626092|Cyclosporins|cyclosporins|mesh-list
92272199|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272200|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272201|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92272202|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
92272203|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272204|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
92272205|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272206|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
92272207|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272208|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92272209|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92272210|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272211|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92272212|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
92272213|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272214|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92272215|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
92272216|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92272217|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92272218|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92272219|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
92272221|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272222|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272223|NCT01937975|Grazoprevir|grazoprevir|mesh-list
92272224|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
92272225|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272226|NCT01628588|Bimatoprost|bimatoprost|mesh-list
92272227|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92272228|NCT00374985|Docetaxel|docetaxel|mesh-list
92272229|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
92272230|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272231|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92272232|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92272233|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92272234|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272235|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92272236|NCT01695668|Cyclosporine|cyclosporine|mesh-list
92272237|NCT01695668|Cyclosporins|cyclosporins|mesh-list
92272238|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272239|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272240|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92272241|NCT01695668|Immunologic Factors|immunologic factors|mesh-ancestor
92272242|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272243|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
92272244|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272245|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92272246|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272247|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92272248|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92272249|NCT03270020|Denosumab|denosumab|mesh-list
92272250|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91925100|NCT01393639|Hormones|hormones|mesh-ancestor
92272251|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272252|NCT01921751|Paclitaxel|paclitaxel|mesh-list
92272253|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92272254|NCT01921751|Gemcitabine|gemcitabine|mesh-list
92272255|NCT01921751|Capecitabine|capecitabine|mesh-list
92272256|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92272257|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272258|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
92272259|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
92272260|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92272261|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272262|NCT01921751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92272263|NCT01921751|Antimetabolites|antimetabolites|mesh-ancestor
92272264|NCT02958345|Vaccines|vaccines|mesh-list
92272265|NCT02958345|Immunologic Factors|immunologic factors|mesh-ancestor
92272266|NCT02958345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272267|NCT01629134|Hyaluronic Acid|hyaluronic acid|mesh-list
92272268|NCT01629134|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92272269|NCT01629134|Immunologic Factors|immunologic factors|mesh-ancestor
92272270|NCT01629134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272271|NCT01629134|Viscosupplements|viscosupplements|mesh-ancestor
92272272|NCT01629134|Protective Agents|protective agents|mesh-ancestor
92272273|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92272274|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
92272275|NCT01629290|Protective Agents|protective agents|mesh-ancestor
92272276|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272277|NCT01696760|Aspirin|aspirin|mesh-list
92272278|NCT01696760|Enoxaparin|enoxaparin|mesh-list
92272279|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
92272280|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
92272281|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92272282|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92272283|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272284|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92272285|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92272286|NCT01696760|Analgesics|analgesics|mesh-ancestor
92272287|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
92272288|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272289|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272290|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272291|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272292|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92272293|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92272294|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272295|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
92272296|NCT01924169|Lenalidomide|lenalidomide|mesh-list
92272297|NCT01924169|Vaccines|vaccines|mesh-list
92272298|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
92272299|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272300|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92272301|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92272302|NCT01924169|Growth Substances|growth substances|mesh-ancestor
92272303|NCT01924169|Growth Inhibitors|growth inhibitors|mesh-ancestor
92272304|NCT01924169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272305|NCT02958969|Apixaban|apixaban|mesh-list
92272306|NCT02958969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92272307|NCT02958969|Antithrombins|antithrombins|mesh-ancestor
92272308|NCT02958969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92272309|NCT02958969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92272310|NCT02958969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272311|NCT02958969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272312|NCT02958969|Anticoagulants|anticoagulants|mesh-ancestor
92272313|NCT01924871|Remifentanil|remifentanil|mesh-list
92272314|NCT01924871|Desflurane|desflurane|mesh-list
92272315|NCT01924871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92272316|NCT01924871|Narcotics|narcotics|mesh-ancestor
92272317|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272318|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272319|NCT01924871|Analgesics|analgesics|mesh-ancestor
92272320|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
92272321|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272322|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92272323|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
92272324|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
92272325|NCT01698710|Paclitaxel|paclitaxel|mesh-list
92272326|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92272327|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92272328|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272329|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
92272330|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
92272331|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
92272332|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272333|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
92272334|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92272335|NCT01924949|Ledipasvir|ledipasvir|mesh-list
92272336|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
92272337|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272338|NCT01938989|Methamphetamine|methamphetamine|mesh-list
92272339|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
92272340|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92272341|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92272342|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92272343|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272344|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
92272345|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
92272346|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272347|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
92272348|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272349|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272350|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
92272351|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92272352|NCT01938989|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92272353|NCT01938989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272354|NCT01938989|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92272355|NCT01938989|Hormones|hormones|mesh-ancestor
92272356|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272357|NCT01939301|Nitric Oxide|nitric oxide|mesh-list
92272358|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92272359|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
92272360|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272361|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272362|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92272363|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
92272364|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92272365|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
92272366|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272367|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272368|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92272369|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92272370|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
92272371|NCT01939301|Protective Agents|protective agents|mesh-ancestor
92272372|NCT03078075|Naltrexone|naltrexone|mesh-list
92272373|NCT03078075|Bupropion|bupropion|mesh-list
92272374|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92272375|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92272376|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272377|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
92272378|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272379|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92272380|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
92272381|NCT03078075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92272382|NCT03078075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92272383|NCT03078075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92272384|NCT03078075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272385|NCT03078075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272386|NCT03078075|Dopamine Agents|dopamine agents|mesh-ancestor
92272387|NCT03078075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272388|NCT03078075|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92272389|NCT03078075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92272390|NCT03078075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272391|NCT01926977|Ranibizumab|ranibizumab|mesh-list
92272392|NCT01926977|Aflibercept|aflibercept|mesh-list
92272393|NCT01926977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92272394|NCT01926977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92272395|NCT01926977|Growth Substances|growth substances|mesh-ancestor
92272396|NCT01926977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272397|NCT01926977|Growth Inhibitors|growth inhibitors|mesh-ancestor
92272398|NCT01926977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272399|NCT01928693|Moxifloxacin|moxifloxacin|mesh-list
92272400|NCT01928693|Gatifloxacin|gatifloxacin|mesh-list
92272401|NCT01928693|Besifloxacin|besifloxacin|mesh-list
92272402|NCT01928693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92272403|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92272404|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92272405|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272406|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272407|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92272408|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92272409|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272410|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272411|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272412|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92272413|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
92272414|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92272415|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272416|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92272417|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92272418|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92272419|NCT01928849|Valproic Acid|valproic acid|mesh-list
92272420|NCT01928849|Anticonvulsants|anticonvulsants|mesh-ancestor
92272421|NCT01928849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272422|NCT01928849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272423|NCT01928849|GABA Agents|gaba agents|mesh-ancestor
92272425|NCT01928849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272426|NCT01928849|Antimanic Agents|antimanic agents|mesh-ancestor
92272427|NCT01928849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92272428|NCT01928849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272429|NCT01928849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92272430|NCT01631552|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92272431|NCT01631552|Immunoconjugates|immunoconjugates|mesh-ancestor
92272432|NCT01631552|Immunologic Factors|immunologic factors|mesh-ancestor
92272433|NCT01631552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272434|NCT03081117|Insulin|insulin|mesh-list
92272435|NCT03081117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92272436|NCT03081117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272437|NCT01944293|Midazolam|midazolam|mesh-list
92272438|NCT01944293|Ketamine|ketamine|mesh-list
92272439|NCT01944293|Analgesics|analgesics|mesh-ancestor
92272440|NCT01944293|Sensory System Agents|sensory system agents|mesh-ancestor
92272441|NCT01944293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272442|NCT01944293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272443|NCT01944293|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92272444|NCT01944293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92272445|NCT01944293|Anesthetics, General|anesthetics, general|mesh-ancestor
92272446|NCT01944293|Anesthetics|anesthetics|mesh-ancestor
92272447|NCT01944293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272448|NCT01944293|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92272449|NCT01944293|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92272450|NCT01944293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272451|NCT01944293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272452|NCT01944293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92272453|NCT01944293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92272454|NCT01944293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92272455|NCT01944293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92272456|NCT01944293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92272457|NCT01944293|GABA Modulators|gaba modulators|mesh-ancestor
92272458|NCT01944293|GABA Agents|gaba agents|mesh-ancestor
92272459|NCT01944371|Disulfiram|disulfiram|mesh-list
92272460|NCT01944371|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92272461|NCT01944371|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92272462|NCT01944371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272463|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272464|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
92272465|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272466|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92272467|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272468|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272469|NCT01631630|Pioglitazone|pioglitazone|mesh-list
92272470|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92272471|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272472|NCT03837860|Oxycodone|oxycodone|mesh-list
92272473|NCT03837860|Risperidone|risperidone|mesh-list
92272474|NCT03837860|Ziprasidone|ziprasidone|mesh-list
92272475|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92272476|NCT03837860|Narcotics|narcotics|mesh-ancestor
91925323|NCT01345045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92272477|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272478|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272479|NCT03837860|Analgesics|analgesics|mesh-ancestor
92272480|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
92272481|NCT03837860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272482|NCT03837860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92272483|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
92272484|NCT03837860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272485|NCT03837860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272486|NCT03837860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92272487|NCT03837860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92272488|NCT03837860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92272489|NCT03837860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92272490|NCT03837860|Dopamine Agents|dopamine agents|mesh-ancestor
92272491|NCT02289989|Hydrocortisone|hydrocortisone|mesh-list
92272492|NCT02289989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272493|NCT03076112|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92272494|NCT03076112|Ipragliflozin|ipragliflozin|mesh-list
92272495|NCT03076112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92272496|NCT03076112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272497|NCT03076112|Incretins|incretins|mesh-ancestor
92272498|NCT03076112|Hormones|hormones|mesh-ancestor
92272499|NCT03076112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272500|NCT03076112|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92272501|NCT03076112|Protease Inhibitors|protease inhibitors|mesh-ancestor
92272502|NCT03076112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272503|NCT03076112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272504|NCT03076112|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92272505|NCT03129945|Indomethacin|indomethacin|mesh-list
92272506|NCT03129945|Nifedipine|nifedipine|mesh-list
92272507|NCT03129945|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92272508|NCT03129945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272509|NCT03129945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272510|NCT03129945|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92272511|NCT03129945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272512|NCT03129945|Vasodilator Agents|vasodilator agents|mesh-ancestor
92272513|NCT03129945|Tocolytic Agents|tocolytic agents|mesh-ancestor
92272514|NCT03129945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92272515|NCT03129945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92272516|NCT03129945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92272517|NCT03129945|Analgesics|analgesics|mesh-ancestor
92272518|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
92272519|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272520|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272521|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272522|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
92272523|NCT03129945|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92272524|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272525|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92272526|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
92272527|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92272528|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92272529|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
92272530|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272531|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272532|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
92272533|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92272534|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272535|NCT02971748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92272536|NCT02971748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272537|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92272538|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272539|NCT03093207|Aspirin|aspirin|mesh-list
92272540|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92272541|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92272542|NCT03093207|Analgesics|analgesics|mesh-ancestor
92272543|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
92272544|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272545|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272546|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272547|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272548|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92272549|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92272550|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272551|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92272553|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272554|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
92272555|NCT05482451|Nivolumab|nivolumab|mesh-list
92272556|NCT05482451|Tretinoin|tretinoin|mesh-list
92272557|NCT05482451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92272558|NCT05482451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272559|NCT05482451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92272560|NCT05482451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272561|NCT05482451|Keratolytic Agents|keratolytic agents|mesh-ancestor
92272562|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
92272563|NCT02228408|Hydralazine|hydralazine|mesh-list
92272564|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92272565|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
92272566|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92272568|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92272569|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272570|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
92272571|NCT02342886|Rifampin|rifampin|mesh-list
92272572|NCT02342886|Isoniazid|isoniazid|mesh-list
92272573|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
92272574|NCT02342886|Ethambutol|ethambutol|mesh-list
92272575|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272576|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272577|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92272578|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92272579|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272580|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272581|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272582|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92272583|NCT02342886|Antitubercular Agents|antitubercular agents|mesh-ancestor
92272584|NCT02342886|Leprostatic Agents|leprostatic agents|mesh-ancestor
92272585|NCT02342886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92272586|NCT02342886|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92272587|NCT02342886|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92272588|NCT02342886|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92272589|NCT02342886|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92272590|NCT02342886|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92272591|NCT02342886|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92272592|NCT02342886|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92272593|NCT02342886|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92272594|NCT02342886|Antimetabolites|antimetabolites|mesh-ancestor
92272595|NCT02342886|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92272596|NCT04350281|Interferons|interferons|mesh-list
92272597|NCT04350281|Interferon-beta|interferon-beta|mesh-list
92272598|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
92272599|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
92272600|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272601|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
92272602|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272603|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
92272604|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92272605|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92272606|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272607|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272608|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272609|NCT04350281|Immunologic Factors|immunologic factors|mesh-ancestor
92272610|NCT04350281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272611|NCT04350281|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92272612|NCT02389998|Hyoscyamine|hyoscyamine|mesh-list
92272613|NCT02389998|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92272614|NCT02389998|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92272615|NCT02389998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92272616|NCT02389998|Autonomic Agents|autonomic agents|mesh-ancestor
92272617|NCT02389998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272618|NCT02389998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272619|NCT02389998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92272620|NCT02389998|Respiratory System Agents|respiratory system agents|mesh-ancestor
92272621|NCT02389998|Mydriatics|mydriatics|mesh-ancestor
92272622|NCT02389998|Parasympatholytics|parasympatholytics|mesh-ancestor
92272623|NCT02389998|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92272624|NCT02389998|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92272625|NCT02389998|Cholinergic Agents|cholinergic agents|mesh-ancestor
92272626|NCT02389998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272627|NCT02389998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272628|NCT02389764|Nintedanib|nintedanib|mesh-list
92272629|NCT02389764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272630|NCT02389764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92272631|NCT02389764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272632|NCT02389764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272633|NCT04903470|Bisacodyl|bisacodyl|mesh-list
92272634|NCT04903470|Cathartics|cathartics|mesh-ancestor
92272635|NCT04903470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272636|NCT04903470|Laxatives|laxatives|mesh-ancestor
92272637|NCT01647932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92272638|NCT01647932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92272639|NCT01647932|Diuretics|diuretics|mesh-ancestor
92272640|NCT01647932|Natriuretic Agents|natriuretic agents|mesh-ancestor
92272641|NCT01647932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272642|NCT01647932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92272643|NCT01647932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272644|NCT01647932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272645|NCT04903002|Oxytocin|oxytocin|mesh-list
92272646|NCT04903002|Oxytocics|oxytocics|mesh-ancestor
92272647|NCT04903002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92272648|NCT04903002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272649|NCT02366130|Denosumab|denosumab|mesh-list
92272650|NCT02366130|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92272651|NCT02366130|Hormones|hormones|mesh-list
92272652|NCT02366130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272653|NCT02366130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272654|NCT02366130|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92272655|NCT02366130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272656|NCT01635062|Calcitriol|calcitriol|mesh-list
92272657|NCT01635062|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92272658|NCT01635062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92272659|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272660|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92272661|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272662|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272663|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92272664|NCT01635062|Vitamins|vitamins|mesh-ancestor
92272665|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
92272666|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92272667|NCT01637090|Everolimus|everolimus|mesh-list
92272668|NCT01637090|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92272669|NCT01637090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92272670|NCT01637090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272671|NCT01637090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272672|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92272673|NCT01637090|Immunologic Factors|immunologic factors|mesh-ancestor
92272674|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272675|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272676|NCT02389452|Hylan|hylan|mesh-list
92272677|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
92272678|NCT02389452|Protective Agents|protective agents|mesh-ancestor
92272679|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272680|NCT02365584|Lanreotide|lanreotide|mesh-list
92272681|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272682|NCT02342418|Tedizolid|tedizolid|mesh-list
92272683|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
92272684|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272685|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272686|NCT05727449|Anesthetics|anesthetics|mesh-list
92344177|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92272687|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272688|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272689|NCT03102645|Imipramine|imipramine|mesh-list
92272690|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92272691|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
92272692|NCT03102645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92272693|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92272694|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92272695|NCT03102645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272696|NCT03102645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272697|NCT03102645|Adrenergic Agents|adrenergic agents|mesh-ancestor
92272698|NCT03102645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272699|NCT03102645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272700|NCT01639352|Pasireotide|pasireotide|mesh-list
92272701|NCT01639352|Hormones|hormones|mesh-ancestor
92272702|NCT01639352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272703|NCT01639352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272704|NCT01705496|Fialuridine|fialuridine|mesh-list
92272705|NCT01705496|Antiviral Agents|antiviral agents|mesh-ancestor
92272706|NCT01705496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272707|NCT01705496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92272708|NCT01705496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272709|NCT01705496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272710|NCT02287415|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92272711|NCT02287415|Warfarin|warfarin|mesh-list
92272712|NCT02287415|Anticoagulants|anticoagulants|mesh-ancestor
92272713|NCT02287415|Anticonvulsants|anticonvulsants|mesh-ancestor
92272714|NCT02287415|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92272715|NCT02287415|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92272716|NCT02287415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272717|NCT02287415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272718|NCT02312934|Nicotine|nicotine|mesh-list
92272719|NCT02312934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92272720|NCT02312934|Autonomic Agents|autonomic agents|mesh-ancestor
92272721|NCT02312934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272722|NCT02312934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272723|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92272724|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92272725|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
92272726|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272727|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272728|NCT04707027|Aflibercept|aflibercept|mesh-list
92272729|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92272730|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92272732|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272733|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
92272734|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272735|NCT01602068|Dexamethasone|dexamethasone|mesh-list
92272736|NCT01602068|Citric Acid|citric acid|mesh-list
92272737|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
92272738|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92272739|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272740|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
92272741|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
92272742|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272743|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272744|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272745|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
92272746|NCT01602068|Hormones|hormones|mesh-ancestor
92272747|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272748|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92272749|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272750|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
92272751|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92272752|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
92272753|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
92272754|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272755|NCT02978157|Amoxicillin|amoxicillin|mesh-list
92272756|NCT02978157|Levofloxacin|levofloxacin|mesh-list
92272757|NCT02978157|Ofloxacin|ofloxacin|mesh-list
92272758|NCT02978157|Tetracycline|tetracycline|mesh-list
92272759|NCT02978157|Esomeprazole|esomeprazole|mesh-list
92272760|NCT02978157|Bismuth|bismuth|mesh-list
92272761|NCT02978157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92272762|NCT02978157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272763|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92272764|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272765|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92272766|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272767|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272768|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92272769|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92272770|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92272771|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272772|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92272773|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92272774|NCT02978157|Antacids|antacids|mesh-ancestor
91925646|NCT01033123|Iniparib|iniparib|mesh-list
92272775|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92272776|NCT01705964|Epinephrine|epinephrine|mesh-list
92272777|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92272778|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92272779|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92272780|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272781|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272782|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272783|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91926555|NCT04474093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272784|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92272785|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
92272786|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272787|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92272788|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
92272789|NCT01705964|Mydriatics|mydriatics|mesh-ancestor
92272790|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
92272791|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92272792|NCT02341482|Itraconazole|itraconazole|mesh-list
92272793|NCT02341482|Antifungal Agents|antifungal agents|mesh-ancestor
92272794|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272795|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92272796|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92272797|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272798|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272799|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92272800|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
92272801|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272802|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272803|NCT02341482|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92272805|NCT03140631|Heparin Antagonists|heparin antagonists|mesh-ancestor
92272806|NCT03140631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272807|NCT03140631|Coagulants|coagulants|mesh-ancestor
92272808|NCT04420260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
92272809|NCT04420260|Immunologic Factors|immunologic factors|mesh-ancestor
92272810|NCT04420260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272811|NCT00422643|Hyaluronic Acid|hyaluronic acid|mesh-list
92272812|NCT00422643|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92272813|NCT00422643|Immunologic Factors|immunologic factors|mesh-ancestor
92272814|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272815|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
92272816|NCT00422643|Protective Agents|protective agents|mesh-ancestor
92272817|NCT05405907|Hemostatics|hemostatics|mesh-list
92272818|NCT05405907|Coagulants|coagulants|mesh-ancestor
92272819|NCT01706588|Diclofenac|diclofenac|mesh-list
92272820|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92272821|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92272822|NCT01706588|Analgesics|analgesics|mesh-ancestor
92272823|NCT01706588|Sensory System Agents|sensory system agents|mesh-ancestor
92272824|NCT01706588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344184|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272825|NCT01706588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272826|NCT01706588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272827|NCT01706588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272828|NCT01706588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92272829|NCT01706588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272830|NCT01706588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272831|NCT01602692|Lidocaine|lidocaine|mesh-list
92272832|NCT01602692|Epinephrine|epinephrine|mesh-list
92272833|NCT01602692|Racepinephrine|racepinephrine|mesh-list
92272834|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92272835|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
92272836|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
92272837|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
92272838|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272839|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272840|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
92272841|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272842|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92272843|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92272844|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92272845|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92272846|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272847|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92272848|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92272849|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
92272850|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272851|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92272852|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92272853|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
92272854|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92272855|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92272856|NCT01602692|Mydriatics|mydriatics|mesh-ancestor
92272857|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
92272858|NCT01602692|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92272859|NCT01603940|Losartan|losartan|mesh-list
92272860|NCT01603940|Benazepril|benazepril|mesh-list
92272861|NCT01603940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92272862|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92272863|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92272864|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92272865|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272866|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92272867|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
92272868|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272869|NCT01605032|Bortezomib|bortezomib|mesh-list
92272870|NCT01605032|Melphalan|melphalan|mesh-list
92272871|NCT01605032|Busulfan|busulfan|mesh-list
92272872|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272873|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92272874|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
92272875|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272876|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92272877|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92272878|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
92272879|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272880|NCT01706666|Dexamethasone|dexamethasone|mesh-list
92272881|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
92272882|NCT01706666|Lenalidomide|lenalidomide|mesh-list
92272883|NCT01706666|Bortezomib|bortezomib|mesh-list
92272884|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92272885|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
92272886|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272887|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272888|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92272889|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
92272890|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272891|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272892|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92272893|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92272894|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
92272895|NCT01706666|Autonomic Agents|autonomic agents|mesh-ancestor
92272896|NCT01706666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272897|NCT01706666|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272898|NCT01706666|Glucocorticoids|glucocorticoids|mesh-ancestor
92272899|NCT01706666|Hormones|hormones|mesh-ancestor
92272900|NCT01706666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272901|NCT01706666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92272902|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92272903|NCT01706666|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92272904|NCT01706666|Growth Substances|growth substances|mesh-ancestor
92272905|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
92272906|NCT03149991|Ketamine|ketamine|mesh-list
92272907|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
92272908|NCT03149991|Analgesics|analgesics|mesh-ancestor
92272909|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
92272910|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92272911|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272912|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92272913|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92272914|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
92272915|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
92272916|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92272917|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92272918|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92272919|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92272920|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272921|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
92272922|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
92272923|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
92272924|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
92272925|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
92272926|NCT05400993|Docetaxel|docetaxel|mesh-list
92272928|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92272929|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
92272930|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272931|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92272932|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92272933|NCT05400993|Alkylating Agents|alkylating agents|mesh-ancestor
91926708|NCT04681105|Promethazine|promethazine|mesh-list
92272934|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272935|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272936|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92272937|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92272938|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92272939|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92272940|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92272941|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92272942|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92272943|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272944|NCT01605890|Tenofovir|tenofovir|mesh-list
92272945|NCT01605890|Emtricitabine|emtricitabine|mesh-list
92272946|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
92272947|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92272948|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
92272949|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92272950|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92272951|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92272952|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92272953|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272955|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92272956|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92272957|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92272958|NCT02288273|Exenatide|exenatide|mesh-list
92272959|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92272960|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272961|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92272962|NCT02288273|Incretins|incretins|mesh-ancestor
92272963|NCT02288273|Hormones|hormones|mesh-ancestor
92272964|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272965|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92272966|NCT01606124|Antioxidants|antioxidants|mesh-ancestor
92272967|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92272968|NCT01606124|Protective Agents|protective agents|mesh-ancestor
92272969|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272970|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92272971|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92272972|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272973|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92272974|NCT01607450|Glucagon|glucagon|mesh-list
92272975|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92272976|NCT01607450|Incretins|incretins|mesh-ancestor
92272977|NCT01607450|Hormones|hormones|mesh-ancestor
92272978|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92272979|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272980|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92272981|NCT05738993|Pertuzumab|pertuzumab|mesh-list
92272982|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92272983|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92272984|NCT01709474|Vitamin D|vitamin d|mesh-list
92272985|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
92272986|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
92272987|NCT01709474|Vitamins|vitamins|mesh-list
92272988|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
92272989|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272990|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92272991|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92272992|NCT02992808|Menotropins|menotropins|mesh-list
92272993|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92272994|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
92272995|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92272996|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92272998|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92272999|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
91925849|NCT02160275|Pancrelipase|pancrelipase|mesh-list
92273000|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273001|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273002|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92273003|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273004|NCT02331095|Warfarin|warfarin|mesh-list
92273005|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
92273006|NCT02331095|Atorvastatin|atorvastatin|mesh-list
92273007|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92273008|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92273009|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
92117785|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273010|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273011|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92273012|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92273013|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273014|NCT02331095|Anticoagulants|anticoagulants|mesh-ancestor
92273015|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92273016|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
92273017|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92273018|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
92273019|NCT01640834|Glucagon|glucagon|mesh-list
92273020|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273021|NCT01640834|Hormones|hormones|mesh-ancestor
92273022|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273023|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273024|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
92273025|NCT03029273|Fludarabine|fludarabine|mesh-list
92273026|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273027|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
92273028|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273029|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273030|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92273031|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
92273032|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273033|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273034|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92273036|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92273037|NCT05316935|Cyproterone|cyproterone|mesh-list
92273038|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
92273039|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273040|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92273041|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92273042|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273043|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273044|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92273045|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
92273046|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273047|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273048|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92273049|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92273050|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92273051|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
92273052|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92273053|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92273054|NCT05316935|Estrogens|estrogens|mesh-ancestor
92273055|NCT05316935|Hormones|hormones|mesh-ancestor
92273056|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
92273057|NCT05738759|Anesthetics|anesthetics|mesh-list
92273058|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273059|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273060|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
92273061|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92273062|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
92273063|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273064|NCT05738681|Expectorants|expectorants|mesh-ancestor
92273065|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
92273066|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92273067|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
92273068|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273070|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273071|NCT05738681|Antidotes|antidotes|mesh-ancestor
92273072|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92273073|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
91925925|NCT02153879|Vasodilator Agents|vasodilator agents|mesh-ancestor
92273074|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273075|NCT02288819|Diuretics|diuretics|mesh-list
92273076|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92273077|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
92273078|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273079|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273080|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273081|NCT01642238|Aspirin|aspirin|mesh-list
92273082|NCT01642238|Hirudins|hirudins|mesh-list
92273083|NCT01642238|Bivalirudin|bivalirudin|mesh-list
92273084|NCT01642238|Clopidogrel|clopidogrel|mesh-list
92273085|NCT01642238|Ticagrelor|ticagrelor|mesh-list
92273086|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92273087|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92273088|NCT01642238|Analgesics|analgesics|mesh-ancestor
92273089|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
92273090|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273091|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273092|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273093|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273094|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92273095|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92273096|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273097|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92273098|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92273099|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273101|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92273102|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92273103|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92344211|NCT05239741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92273104|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
92273105|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273106|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
92273107|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92273108|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
92273109|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
92273110|NCT05710874|Fluorides|fluorides|mesh-list
92273111|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
92273112|NCT05710874|Protective Agents|protective agents|mesh-ancestor
92273113|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273114|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
92273115|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92273116|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92273117|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
92273118|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273119|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273120|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273121|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
92273122|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
92273123|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273124|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
92273125|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92273126|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92273127|NCT03028883|Buprenorphine|buprenorphine|mesh-list
92273128|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273129|NCT03028883|Narcotics|narcotics|mesh-ancestor
92273130|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273131|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273132|NCT03028883|Analgesics|analgesics|mesh-ancestor
92273133|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
92273134|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273135|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92273136|NCT05238467|Antibodies|antibodies|mesh-list
92273137|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
92273138|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273139|NCT02290613|Ambrisentan|ambrisentan|mesh-list
92273140|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92273141|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
92273142|NCT05736419|Dexamethasone|dexamethasone|mesh-list
92273143|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
92273144|NCT05736419|Rituximab|rituximab|mesh-list
92273145|NCT05736419|Fludarabine|fludarabine|mesh-list
92273146|NCT05736419|Bortezomib|bortezomib|mesh-list
92273147|NCT05736419|Tacrolimus|tacrolimus|mesh-list
92273148|NCT05736419|Thymoglobulin|thymoglobulin|mesh-list
92273149|NCT05736419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273150|NCT05736419|Immunologic Factors|immunologic factors|mesh-ancestor
92273151|NCT05736419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273152|NCT05736419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273153|NCT05736419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92273155|NCT05736419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273156|NCT05736419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273157|NCT05736419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92273158|NCT05736419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92273159|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273160|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
92273161|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
92117786|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
92273162|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273163|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273164|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
92273165|NCT05736419|Hormones|hormones|mesh-ancestor
92273166|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273167|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92273168|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92273169|NCT05736419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273170|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92273171|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92273172|NCT05736419|Antitubercular Agents|antitubercular agents|mesh-ancestor
92273173|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92273174|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273175|NCT02986685|Rabeprazole|rabeprazole|mesh-list
92273176|NCT02986685|Trimebutine|trimebutine|mesh-list
92273177|NCT02986685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273178|NCT02986685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273179|NCT02986685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92273180|NCT02986685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273181|NCT02986685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92273182|NCT02986685|Parasympatholytics|parasympatholytics|mesh-ancestor
92273183|NCT02986685|Autonomic Agents|autonomic agents|mesh-ancestor
92273184|NCT02986685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273185|NCT02986685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273186|NCT01610570|Plicamycin|plicamycin|mesh-list
92273187|NCT01610570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92273188|NCT01610570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273189|NCT01610570|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92273190|NCT01610570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273191|NCT01610570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92273192|NCT01610570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273193|NCT01610570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273194|NCT01610570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92273195|NCT01611662|Gemcitabine|gemcitabine|mesh-list
92273196|NCT01611662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273197|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273198|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
92273199|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273200|NCT05200481|Carboplatin|carboplatin|mesh-list
92273201|NCT05200481|Pemetrexed|pemetrexed|mesh-list
92273202|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273203|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273204|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273205|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92273206|NCT05200481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92273207|NCT01615484|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92273208|NCT05139563|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92273209|NCT05139563|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92273210|NCT05139563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92273211|NCT05139563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92273212|NCT01646762|Paclitaxel|paclitaxel|mesh-list
92273213|NCT01646762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92273214|NCT01646762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92273216|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92273217|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92273218|NCT01646762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92273219|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273220|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92273221|NCT04997525|Estradiol|estradiol|mesh-list
92273222|NCT04997525|Progesterone|progesterone|mesh-list
92273223|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92273224|NCT04997525|Estrogens|estrogens|mesh-ancestor
92273225|NCT04997525|Hormones|hormones|mesh-ancestor
92273226|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273227|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273228|NCT04997525|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92273229|NCT04997525|Progestins|progestins|mesh-ancestor
92273230|NCT01649180|Axitinib|axitinib|mesh-list
92273231|NCT01649180|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92273232|NCT01649180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273233|NCT01649180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273234|NCT01649180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273235|NCT01649180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273236|NCT04408313|Naltrexone|naltrexone|mesh-list
92273237|NCT04408313|Buprenorphine|buprenorphine|mesh-list
92273238|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273239|NCT04408313|Narcotics|narcotics|mesh-ancestor
92273240|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273241|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273242|NCT04408313|Analgesics|analgesics|mesh-ancestor
92273243|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
92273244|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273245|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92273246|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92273248|NCT01619774|Dabrafenib|dabrafenib|mesh-list
92273249|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273250|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273251|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273252|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273254|NCT01651442|Trazodone|trazodone|mesh-list
92273255|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92273256|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92273257|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273258|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273259|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92273260|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
92273261|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
92273262|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273263|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273264|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92273265|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92273266|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92273267|NCT01651442|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92273268|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92273269|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273270|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
92273271|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92273272|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
92273273|NCT04901975|Spironolactone|spironolactone|mesh-list
92273274|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92273275|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
92273276|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273277|NCT04901975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273278|NCT04901975|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92273279|NCT04901975|Diuretics|diuretics|mesh-ancestor
92273280|NCT04901975|Natriuretic Agents|natriuretic agents|mesh-ancestor
92273281|NCT05421416|Loratadine|loratadine|mesh-list
92273282|NCT05421416|Antipruritics|antipruritics|mesh-ancestor
92273283|NCT05421416|Dermatologic Agents|dermatologic agents|mesh-ancestor
92273284|NCT05421416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92273285|NCT05421416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92273286|NCT05421416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92273287|NCT05421416|Histamine Antagonists|histamine antagonists|mesh-ancestor
92273288|NCT05421416|Histamine Agents|histamine agents|mesh-ancestor
92273289|NCT05421416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273290|NCT05421416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273291|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273292|NCT04868045|Hormones|hormones|mesh-list
92273293|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
92273294|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273295|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273296|NCT04803539|Capecitabine|capecitabine|mesh-list
92273297|NCT04803539|Apatinib|apatinib|mesh-list
92273298|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926151|NCT02254967|Fidaxomicin|fidaxomicin|mesh-list
92273300|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273301|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273302|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273303|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273304|NCT04799015|Dexamethasone|dexamethasone|mesh-list
92273305|NCT04799015|Metoclopramide|metoclopramide|mesh-list
92273306|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273307|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
92273308|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
92273309|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273310|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273311|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273312|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
92273313|NCT04799015|Hormones|hormones|mesh-ancestor
92273314|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273315|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92344227|NCT05239741|Vitamins|vitamins|mesh-ancestor
92273316|NCT04799015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273317|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92273318|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92273319|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
92273320|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273321|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273322|NCT01658228|Donepezil|donepezil|mesh-list
92273323|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92273324|NCT01658228|Citalopram|citalopram|mesh-list
92273325|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92273326|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273327|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273328|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
92273329|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273330|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273331|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
92273332|NCT01658228|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92273333|NCT01658228|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92273334|NCT01658228|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273335|NCT01658228|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92273336|NCT01658228|Antidepressive Agents|antidepressive agents|mesh-ancestor
92273337|NCT01658228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92273338|NCT01658228|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92273339|NCT01658228|Serotonin Agents|serotonin agents|mesh-ancestor
92273340|NCT05709938|Insulin|insulin|mesh-list
92273341|NCT05709938|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92273342|NCT05709938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92273343|NCT05709938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273345|NCT01659866|Gentamicins|gentamicins|mesh-list
92273346|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
92273347|NCT01659866|Imipenem|imipenem|mesh-list
92273348|NCT01659866|Amikacin|amikacin|mesh-list
92273349|NCT01659866|Cefuroxime|cefuroxime|mesh-list
92273350|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92273351|NCT01659866|Aztreonam|aztreonam|mesh-list
92273352|NCT01659866|Trimethoprim|trimethoprim|mesh-list
92273353|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
92273354|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92273355|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273356|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92273357|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92273358|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273359|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273360|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273361|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92273362|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92273363|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92273364|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92273365|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
92273366|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92273367|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92273368|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92273369|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92273370|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92273371|NCT02249702|Gemcitabine|gemcitabine|mesh-list
92273372|NCT02249702|Docetaxel|docetaxel|mesh-list
92273373|NCT02249702|Trabectedin|trabectedin|mesh-list
92273375|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
92273376|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273377|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273378|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92273379|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92273380|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344236|NCT05180942|Calcium|calcium|mesh-list
92273381|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92273382|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
92273383|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
92273384|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92273385|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92273386|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273387|NCT02947529|Hemostatics|hemostatics|mesh-ancestor
92273388|NCT02947529|Coagulants|coagulants|mesh-ancestor
92273389|NCT01660802|Dexamethasone|dexamethasone|mesh-list
92273390|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273391|NCT01660802|Antiemetics|antiemetics|mesh-ancestor
92273392|NCT01660802|Autonomic Agents|autonomic agents|mesh-ancestor
92273393|NCT01660802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273394|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273395|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273396|NCT01660802|Glucocorticoids|glucocorticoids|mesh-ancestor
92273397|NCT01660802|Hormones|hormones|mesh-ancestor
92273398|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273399|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92273400|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273401|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92273402|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92273403|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273404|NCT01661114|Gemcitabine|gemcitabine|mesh-list
92273405|NCT01661114|Fluorouracil|fluorouracil|mesh-list
92273406|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273407|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273408|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
92273409|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273410|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273411|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
92273412|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273413|NCT02683265|Methylphenidate|methylphenidate|mesh-list
92273414|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92273415|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273416|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92273417|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92273418|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273419|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273421|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273422|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92273423|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
92273424|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
92273425|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273426|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273427|NCT02988843|Bevacizumab|bevacizumab|mesh-list
92273428|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92273429|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92273430|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273431|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92273432|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92273433|NCT02988843|Growth Substances|growth substances|mesh-ancestor
92273434|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273435|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
92273436|NCT02988843|Immunotoxins|immunotoxins|mesh-ancestor
92273437|NCT02988843|Immunoconjugates|immunoconjugates|mesh-ancestor
92273438|NCT02988843|Immunologic Factors|immunologic factors|mesh-ancestor
92273439|NCT01661270|Aflibercept|aflibercept|mesh-list
92273440|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92273441|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92273442|NCT01661270|Growth Substances|growth substances|mesh-ancestor
92273443|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273444|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
92273445|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273446|NCT03000309|Apremilast|apremilast|mesh-list
92273447|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92344246|NCT05171075|Dalteparin|dalteparin|mesh-list
92273448|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92273450|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
92273451|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273452|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273453|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273454|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273455|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92273456|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92273457|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273458|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273459|NCT02992028|Vitamins|vitamins|mesh-list
92273460|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
92273461|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273462|NCT03165981|Vaccines|vaccines|mesh-list
92273463|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92273464|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
92273465|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273466|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
92273467|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92273468|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273469|NCT03170661|Rocuronium|rocuronium|mesh-list
92273470|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92273471|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92273472|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92273473|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273474|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273475|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92273476|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273477|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273478|NCT01662908|Heparin|heparin|mesh-list
92273479|NCT01662908|Enoxaparin|enoxaparin|mesh-list
92273480|NCT01662908|Calcium heparin|calcium heparin|mesh-list
92273481|NCT01662908|Warfarin|warfarin|mesh-list
92273482|NCT01662908|Edoxaban|edoxaban|mesh-list
92273483|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
92273484|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92273485|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92273486|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273487|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92273488|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
92273489|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92273490|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
92273491|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273492|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
92273493|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
92273494|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92273495|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92273496|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273497|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273498|NCT00375297|Urological Agents|urological agents|mesh-ancestor
92273499|NCT02234570|Oxfendazole|oxfendazole|mesh-list
92273500|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
92273501|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92273502|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273503|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
92273504|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92273505|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
92273506|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273507|NCT02240030|Levodopa|levodopa|mesh-list
92273508|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92273509|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92273510|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
92273511|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273512|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273513|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273514|NCT03180489|Dapagliflozin|dapagliflozin|mesh-list
92273515|NCT03180489|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92273516|NCT03180489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273517|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92273518|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273520|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273521|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273522|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273523|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273524|NCT01664858|Calcium|calcium|mesh-list
92273525|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92273526|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273527|NCT04348695|Simvastatin|simvastatin|mesh-list
92273528|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92273529|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92273530|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
92273531|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273532|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92273533|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92273534|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273535|NCT04316871|Morphine|morphine|mesh-list
92273536|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273537|NCT04316871|Narcotics|narcotics|mesh-ancestor
92273538|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273539|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273540|NCT04316871|Analgesics|analgesics|mesh-ancestor
92273541|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
92273542|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273543|NCT05364567|Vitamin D|vitamin d|mesh-list
92273544|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
92273545|NCT05364567|Vitamins|vitamins|mesh-ancestor
92273546|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
92273547|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273548|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92273549|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92273550|NCT00375765|Dutasteride|dutasteride|mesh-list
92273551|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92273552|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92273553|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273554|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273555|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
92273556|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273557|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273558|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
92273559|NCT03325647|Testosterone|testosterone|mesh-list
92273560|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
92273561|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
92273562|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92273564|NCT03325647|Hormones|hormones|mesh-ancestor
92273565|NCT03325647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273566|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273567|NCT03325647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92273568|NCT03325647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273569|NCT03325647|Anabolic Agents|anabolic agents|mesh-ancestor
92273570|NCT01665950|Simvastatin|simvastatin|mesh-list
92273571|NCT01665950|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92273572|NCT01665950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92273573|NCT01665950|Antimetabolites|antimetabolites|mesh-ancestor
92273574|NCT01665950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273575|NCT01665950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92273576|NCT01665950|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92273577|NCT01665950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273578|NCT01667978|Ritonavir|ritonavir|mesh-list
92273579|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92273580|NCT01667978|Norethindrone|norethindrone|mesh-list
92273581|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
92273582|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
92273583|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92273584|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92273585|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273586|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273587|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92273588|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92273589|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
92344253|NCT05171049|Apixaban|apixaban|mesh-list
92273590|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273591|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92273592|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92273593|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92273594|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92273595|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92273596|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
92273597|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92273598|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273599|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92273600|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92273602|NCT03282669|Hydromorphone|hydromorphone|mesh-list
92273603|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273604|NCT03282669|Narcotics|narcotics|mesh-ancestor
92273605|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273606|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273607|NCT03282669|Analgesics|analgesics|mesh-ancestor
92273608|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
92273609|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273610|NCT00375843|Sertraline|sertraline|mesh-list
92273611|NCT00375843|Escitalopram|escitalopram|mesh-list
92273612|NCT00375843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92273613|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92273614|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273615|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273616|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273617|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
92273618|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273619|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
92273620|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92273621|NCT03247569|Edoxaban|edoxaban|mesh-list
92273622|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92273623|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
92273624|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92273625|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92273626|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273627|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273628|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
92273629|NCT01668836|Resveratrol|resveratrol|mesh-list
92273630|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
92273631|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273632|NCT01668836|Protective Agents|protective agents|mesh-ancestor
92273633|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273634|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273635|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92273636|NCT03744663|Buprenorphine|buprenorphine|mesh-list
92273637|NCT03744663|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92273638|NCT03744663|Naloxone|naloxone|mesh-list
92273639|NCT03744663|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273640|NCT03744663|Narcotics|narcotics|mesh-ancestor
92273641|NCT03744663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273642|NCT03744663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273643|NCT03744663|Analgesics|analgesics|mesh-ancestor
92273644|NCT03744663|Sensory System Agents|sensory system agents|mesh-ancestor
92273645|NCT03744663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273646|NCT03744663|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92273647|NCT01669538|Galantamine|galantamine|mesh-list
92273648|NCT01669538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92273649|NCT01669538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273650|NCT01669538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273651|NCT01669538|Cholinergic Agents|cholinergic agents|mesh-ancestor
92273652|NCT01669538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273653|NCT01669538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273654|NCT01669538|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92273655|NCT01669538|Autonomic Agents|autonomic agents|mesh-ancestor
92273656|NCT01669538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273657|NCT01669538|Nootropic Agents|nootropic agents|mesh-ancestor
92273658|NCT00375375|Lactulose|lactulose|mesh-list
92273659|NCT00375375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273660|NCT04333095|Bupivacaine|bupivacaine|mesh-list
92273661|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
92273662|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
92273663|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273664|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273665|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
92273666|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273667|NCT05045144|Vaccines|vaccines|mesh-list
92273668|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
91926532|NCT00813163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273669|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273670|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92273671|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
92273672|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92273673|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
92273674|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92273675|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273676|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92273677|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92273678|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273679|NCT01658241|Panobinostat|panobinostat|mesh-list
92273680|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273681|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92273682|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273683|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273684|NCT01455051|Ofatumumab|ofatumumab|mesh-list
92273685|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273686|NCT01673828|Pregnanolone|pregnanolone|mesh-list
92273687|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92273688|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
92273689|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273690|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273691|NCT05325099|Azacitidine|azacitidine|mesh-list
92273692|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273693|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
92273694|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273695|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273696|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273697|NCT05293509|Cyclosporine|cyclosporine|mesh-list
92273698|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
92273699|NCT05293509|Dexamethasone|dexamethasone|mesh-list
92273700|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
92273701|NCT05293509|Busulfan|busulfan|mesh-list
92273702|NCT05293509|Rituximab|rituximab|mesh-list
92273703|NCT05293509|Fludarabine|fludarabine|mesh-list
92273704|NCT05293509|Bortezomib|bortezomib|mesh-list
92273705|NCT05293509|Tacrolimus|tacrolimus|mesh-list
92273706|NCT05293509|Cyclosporins|cyclosporins|mesh-list
92273707|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
92273708|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273709|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
92273710|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273711|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273712|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92273713|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
92273714|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273715|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273716|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92273717|NCT05293509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92273718|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273719|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
92273720|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
92273721|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273722|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273723|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
92273724|NCT05293509|Hormones|hormones|mesh-ancestor
92273725|NCT05293509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92273726|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92273727|NCT05293509|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92273728|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273729|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
92344260|NCT05171049|Anticoagulants|anticoagulants|mesh-ancestor
92273730|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273731|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
92273732|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92344261|NCT05164653|Valsartan|valsartan|mesh-list
92273733|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92273734|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
92273735|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92273736|NCT04736433|Valsartan|valsartan|mesh-list
92273737|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92273738|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92273739|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92273740|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92273741|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92273742|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273743|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
92273744|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273745|NCT02296775|Rituximab|rituximab|mesh-list
92273746|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92273747|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273748|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
92273749|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273750|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273751|NCT01675778|Hydromorphone|hydromorphone|mesh-list
92273752|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273753|NCT01675778|Narcotics|narcotics|mesh-ancestor
92273754|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273755|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273756|NCT01675778|Analgesics|analgesics|mesh-ancestor
92273757|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
92273758|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273759|NCT04736589|Sirolimus|sirolimus|mesh-list
92273760|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92273761|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273762|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92273763|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273764|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
92273765|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273766|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
92273767|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273768|NCT05201859|Capecitabine|capecitabine|mesh-list
92273769|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273770|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
92273771|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273772|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273773|NCT02594111|Colchicine|colchicine|mesh-list
92273774|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
92273775|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273776|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
92273777|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
92273778|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
92273779|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273780|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273781|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
92273782|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92273783|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92273784|NCT03186261|Fluorides|fluorides|mesh-list
92273785|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
92273786|NCT03186261|Protective Agents|protective agents|mesh-ancestor
92273787|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273788|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92273789|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273790|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
92273791|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
92273792|NCT02589353|Acarbose|acarbose|mesh-list
92273793|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92273794|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273795|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273796|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92273797|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273798|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
92273799|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92273800|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273801|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92273803|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
92273804|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92273805|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92273806|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273807|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273808|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92273809|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92273810|NCT04645667|Tacrolimus|tacrolimus|mesh-list
92273811|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92273812|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
92273813|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273814|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92273815|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273816|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273817|NCT02249936|Omeprazole|omeprazole|mesh-list
92273818|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92273819|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92273820|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92273821|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273822|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273823|NCT03190005|Clopidogrel|clopidogrel|mesh-list
92273824|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92273825|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92273826|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92273827|NCT03190005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92273828|NCT03190005|Purinergic Agents|purinergic agents|mesh-ancestor
92273829|NCT03190005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273830|NCT03190005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273831|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273832|NCT04816214|Carboplatin|carboplatin|mesh-list
92273833|NCT04816214|Pemetrexed|pemetrexed|mesh-list
92273834|NCT04816214|Osimertinib|osimertinib|mesh-list
92273835|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273836|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273837|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273838|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92273839|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92273840|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273841|NCT01461915|Paclitaxel|paclitaxel|mesh-list
92273842|NCT01461915|Gemcitabine|gemcitabine|mesh-list
92273843|NCT01461915|Heparin|heparin|mesh-list
92273844|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92273845|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273846|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
92273847|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
92273848|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
92273849|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273850|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273851|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
92273852|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
92273853|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92273854|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92273855|NCT01682642|Goserelin|goserelin|mesh-list
92273856|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92273857|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273858|NCT01683422|Gemcitabine|gemcitabine|mesh-list
92273859|NCT01683422|Capecitabine|capecitabine|mesh-list
92273860|NCT01683422|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92273861|NCT01683422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92273862|NCT01683422|Antimetabolites|antimetabolites|mesh-ancestor
92273863|NCT01683422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273864|NCT01683422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273865|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273866|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273867|NCT03194373|Carboplatin|carboplatin|mesh-list
92273868|NCT03194373|Palbociclib|palbociclib|mesh-list
92273869|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273870|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92273871|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344266|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92273872|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273873|NCT05066061|Analgesics|analgesics|mesh-list
92273874|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
92273875|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
92273876|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273877|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273878|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92273879|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273880|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92273881|NCT04781673|Lidocaine|lidocaine|mesh-list
92273882|NCT04781673|Ketamine|ketamine|mesh-list
92273883|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
92273884|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
92273885|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273886|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273887|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
92273888|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273889|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92273890|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92273891|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92273892|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92273893|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273894|NCT04781673|Analgesics|analgesics|mesh-ancestor
92273895|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92273896|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92273897|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
92273898|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92273899|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92273900|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92273901|NCT03197025|Aldesleukin|aldesleukin|mesh-list
92273902|NCT03197025|Interleukin-2|interleukin-2|mesh-list
92273903|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273904|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92273905|NCT03197025|Analgesics|analgesics|mesh-ancestor
92273906|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
92273907|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273908|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273909|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92273910|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92273911|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
92273912|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273913|NCT02249546|Amoxicillin|amoxicillin|mesh-list
92273914|NCT02249546|Clarithromycin|clarithromycin|mesh-list
92273915|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
92273916|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92273917|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92273918|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273919|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92273920|NCT02249546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273921|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273922|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92273923|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92273924|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
92273925|NCT02249546|Expectorants|expectorants|mesh-ancestor
92273926|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92273927|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92273928|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
92273929|NCT02249546|Protective Agents|protective agents|mesh-ancestor
92273930|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273931|NCT02249546|Antidotes|antidotes|mesh-ancestor
92273932|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
92273933|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92273934|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92273935|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
92273936|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273937|NCT04960215|Ubiquinone|ubiquinone|mesh-list
92273938|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
92273939|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
92273940|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273941|NCT04960215|Vitamins|vitamins|mesh-ancestor
92344272|NCT05160896|Bevacizumab|bevacizumab|mesh-list
92273942|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92273943|NCT02333045|Maraviroc|maraviroc|mesh-list
92273944|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92273945|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92273946|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273947|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273948|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
92273949|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92273950|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92273951|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92273952|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92273953|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92273954|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92273955|NCT01684748|Olmesartan|olmesartan|mesh-list
92273956|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92273957|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92273958|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92273959|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92273960|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273961|NCT04028063|Doxorubicin|doxorubicin|mesh-list
92273962|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92273963|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92273964|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92273965|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92273966|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273967|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273968|NCT01685684|Oxycodone|oxycodone|mesh-list
91926841|NCT02162537|Pemetrexed|pemetrexed|mesh-list
92273969|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273971|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273972|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273974|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
92273975|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273976|NCT03978767|Acetaminophen|acetaminophen|mesh-list
92273977|NCT03978767|Ibuprofen|ibuprofen|mesh-list
92273978|NCT03978767|Ketorolac|ketorolac|mesh-list
92273979|NCT03978767|Oxycodone|oxycodone|mesh-list
92273980|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92273981|NCT03978767|Analgesics|analgesics|mesh-ancestor
92273982|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
92273983|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92273984|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273985|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
92273986|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92273987|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92273988|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92273989|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92273990|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92273991|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92273992|NCT03978767|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92273993|NCT03978767|Narcotics|narcotics|mesh-ancestor
92273994|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92273996|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
92273997|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92273998|NCT01685996|Zonisamide|zonisamide|mesh-list
92273999|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
92274000|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92274001|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92274002|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274003|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92274004|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274005|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92274006|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
92274007|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274008|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
92274009|NCT04633148|Fludarabine|fludarabine|mesh-list
92274010|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274011|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
92274012|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274013|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274014|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92274015|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
92274016|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274017|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274018|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92274019|NCT04543409|Benralizumab|benralizumab|mesh-list
92274020|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92274021|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92274022|NCT02196155|Cortisone|cortisone|mesh-list
92274023|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
92274024|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92274025|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92274026|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92274027|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92274028|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274029|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92274030|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274031|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274032|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274033|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92274034|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274035|NCT02175173|Rufinamide|rufinamide|mesh-list
92274036|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
92274037|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92274038|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92274039|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92274040|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274041|NCT04121403|Rituximab|rituximab|mesh-list
92274042|NCT04121403|Cladribine|cladribine|mesh-list
91926933|NCT02167061|Metformin|metformin|mesh-list
92274043|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274044|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274045|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
92274046|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274047|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274048|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274049|NCT02049515|Ofatumumab|ofatumumab|mesh-list
92274050|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274051|NCT03224403|Acetaminophen|acetaminophen|mesh-list
92274052|NCT03224403|Ibuprofen|ibuprofen|mesh-list
92274053|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92274054|NCT03224403|Analgesics|analgesics|mesh-ancestor
92274055|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
92274056|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932464|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274057|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274058|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
92274059|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92274060|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274061|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274062|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92274063|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274064|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274065|NCT02334059|Ketamine|ketamine|mesh-list
92274066|NCT02334059|Analgesics|analgesics|mesh-ancestor
92274067|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
92274068|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274069|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274070|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92274071|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92274072|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
92274073|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
92274074|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274075|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92274076|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92274077|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274078|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274079|NCT04501523|Capecitabine|capecitabine|mesh-list
92274080|NCT04501523|Tislelizumab|tislelizumab|mesh-list
92274081|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274082|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
92274083|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274084|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274085|NCT04501523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274086|NCT04499573|Cytarabine|cytarabine|mesh-list
92274087|NCT04499573|Dexamethasone|dexamethasone|mesh-list
92274088|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
92274089|NCT04499573|Fludarabine|fludarabine|mesh-list
92274090|NCT04499573|Etoposide|etoposide|mesh-list
92274091|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274092|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
92274093|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274094|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274095|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92274096|NCT04499573|Alkylating Agents|alkylating agents|mesh-ancestor
92274097|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274098|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274099|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92274100|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274101|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
92274102|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
92274103|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274104|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274105|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
92274106|NCT04499573|Hormones|hormones|mesh-ancestor
92274107|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274108|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274109|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274110|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274111|NCT04499573|Antimetabolites|antimetabolites|mesh-ancestor
92274112|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92274113|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92274114|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92274115|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
92274116|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926987|NCT02163707|Psilocybin|psilocybin|mesh-list
92274117|NCT03425097|Fexofenadine|fexofenadine|mesh-list
92274118|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92274119|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92274120|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92274121|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
92274122|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
92274123|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274124|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274125|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274126|NCT01926041|Varenicline|varenicline|mesh-list
92274127|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92274128|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92274129|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
92274130|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274131|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274132|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274133|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92274134|NCT01769027|Azithromycin|azithromycin|mesh-list
92274135|NCT01769027|Penicillins|penicillins|mesh-list
92274136|NCT01769027|Sertraline|sertraline|mesh-list
92274137|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92274138|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274139|NCT01769027|Antidepressive Agents|antidepressive agents|mesh-ancestor
92274140|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92274141|NCT01769027|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92274142|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92274143|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92274144|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274145|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274146|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
92274147|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274148|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
92274149|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
92274150|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92274151|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274152|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92274153|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274154|NCT04706949|Carboplatin|carboplatin|mesh-list
92274155|NCT04706949|Pemetrexed|pemetrexed|mesh-list
92274156|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274157|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274158|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274159|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92274160|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92274161|NCT02299349|Epinephrine|epinephrine|mesh-list
92274162|NCT02299349|Racepinephrine|racepinephrine|mesh-list
92274163|NCT02299349|Morphine|morphine|mesh-list
92274164|NCT02299349|Bupivacaine|bupivacaine|mesh-list
92274165|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
92274166|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
92274167|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
92274168|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274169|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274170|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
92274171|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274172|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92274173|NCT02299349|Narcotics|narcotics|mesh-ancestor
92274174|NCT02299349|Analgesics|analgesics|mesh-ancestor
92274175|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92274176|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92274177|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
92274178|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274179|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274180|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92274181|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92274182|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
92274183|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92274184|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
92274185|NCT02299349|Mydriatics|mydriatics|mesh-ancestor
92274186|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
92274187|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92274188|NCT03296163|Paclitaxel|paclitaxel|mesh-list
92274189|NCT03296163|Bevacizumab|bevacizumab|mesh-list
92274190|NCT03296163|Carboplatin|carboplatin|mesh-list
92274191|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92274192|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274193|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92274194|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92274195|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92274196|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274197|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274198|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92274199|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92274200|NCT03296163|Growth Substances|growth substances|mesh-ancestor
92274201|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274202|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
92274204|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
92274205|NCT00376155|Amodiaquine|amodiaquine|mesh-list
92274206|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
92274207|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92274208|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92274209|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274210|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92274212|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274213|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92274214|NCT01989221|Granisetron|granisetron|mesh-list
92274215|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
92274216|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
92274217|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274218|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274219|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274220|NCT01989221|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92274221|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92274222|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
92274223|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274224|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274226|NCT03226899|Allopurinol|allopurinol|mesh-list
92274227|NCT03226899|Febuxostat|febuxostat|mesh-list
92274228|NCT03226899|Lesinurad|lesinurad|mesh-list
92274229|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
92274230|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274231|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
92274232|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
92274233|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
92274234|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274235|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274236|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
92274237|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274238|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92274239|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
92274240|NCT03226899|Protective Agents|protective agents|mesh-ancestor
92274241|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274242|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
92274243|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
92274244|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92274245|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
92274246|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92274247|NCT01990703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274248|NCT01990703|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92274249|NCT01990703|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92274250|NCT01990703|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92274251|NCT03230175|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92274252|NCT03230175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274253|NCT01992185|Sunscreening Agents|sunscreening agents|mesh-list
92274254|NCT01992185|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92274255|NCT01992185|Protective Agents|protective agents|mesh-ancestor
92274256|NCT01992185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274257|NCT01992185|Dermatologic Agents|dermatologic agents|mesh-ancestor
92274258|NCT04332627|Neostigmine|neostigmine|mesh-list
92274259|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92274260|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274261|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274262|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
92274263|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274264|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274265|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92274266|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
92274267|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274268|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92274270|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274271|NCT01963091|Oxytocin|oxytocin|mesh-list
92274272|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
92274273|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92274274|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274275|NCT02306759|Ketamine|ketamine|mesh-list
92274276|NCT02306759|Analgesics|analgesics|mesh-ancestor
92274277|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
92274278|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274279|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274280|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92274281|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92274282|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
92274283|NCT02306759|Anesthetics|anesthetics|mesh-ancestor
92274284|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274285|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91926709|NCT04681105|Dexamethasone|dexamethasone|mesh-list
92274286|NCT02306759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92274287|NCT02306759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274288|NCT02306759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274289|NCT03298113|Protective Agents|protective agents|mesh-list
92274290|NCT03298113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274291|NCT03232749|Methylprednisolone|methylprednisolone|mesh-list
92274292|NCT03232749|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92274293|NCT03232749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274294|NCT03232749|Antiemetics|antiemetics|mesh-ancestor
92274295|NCT03232749|Autonomic Agents|autonomic agents|mesh-ancestor
92274296|NCT03232749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274297|NCT03232749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274298|NCT03232749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274299|NCT03232749|Glucocorticoids|glucocorticoids|mesh-ancestor
92274300|NCT03232749|Hormones|hormones|mesh-ancestor
92274301|NCT03232749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274302|NCT03232749|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92274303|NCT03232749|Protective Agents|protective agents|mesh-ancestor
92274304|NCT01687400|Decitabine|decitabine|mesh-list
92274305|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274306|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
92274307|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274308|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274309|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274310|NCT01688102|Vitamin D|vitamin d|mesh-list
92274311|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
92274312|NCT01688102|Vitamins|vitamins|mesh-ancestor
92274313|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
92274314|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274315|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92274316|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92274317|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92274318|NCT01994993|Metronidazole|metronidazole|mesh-list
92274319|NCT01994993|Clindamycin|clindamycin|mesh-list
92274320|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
92274321|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
92274322|NCT01994993|Gentamicins|gentamicins|mesh-list
92274323|NCT01994993|Tazobactam|tazobactam|mesh-list
92274324|NCT01994993|Piperacillin|piperacillin|mesh-list
92274325|NCT01994993|Ampicillin|ampicillin|mesh-list
92274326|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92274327|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274328|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92274329|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92274330|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92274331|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274332|NCT01994993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274333|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92274334|NCT01688336|Leucovorin|leucovorin|mesh-list
92274335|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
92274336|NCT01688336|Irinotecan|irinotecan|mesh-list
92274337|NCT01688336|Folfirinox|folfirinox|mesh-list
92274338|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274339|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92274340|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92274341|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274342|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274343|NCT01688336|Antidotes|antidotes|mesh-ancestor
92274345|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274346|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
92274347|NCT01688336|Vitamins|vitamins|mesh-ancestor
92274348|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
92274349|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
92274350|NCT01963481|Exemestane|exemestane|mesh-list
92274351|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274352|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
92274353|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274354|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274355|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92274356|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
92274357|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274358|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274359|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92274360|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92274361|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92274362|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344300|NCT05137054|Growth Substances|growth substances|mesh-ancestor
92274363|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92274364|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274365|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274366|NCT04436744|Palbociclib|palbociclib|mesh-list
92274367|NCT04436744|Anastrozole|anastrozole|mesh-list
92274368|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274369|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92274370|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274371|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274372|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274373|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92274374|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92274375|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92274376|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274377|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274378|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274379|NCT01963793|Aprepitant|aprepitant|mesh-list
92274380|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
92274381|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
92274382|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
92274383|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274384|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274385|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274386|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92274387|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274388|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274389|NCT03449433|Insulin|insulin|mesh-list
92274390|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92274391|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
92274392|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
92274393|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92274394|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
92274395|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92274396|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274397|NCT03241485|Morphine|morphine|mesh-list
92274398|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92274399|NCT03241485|Narcotics|narcotics|mesh-ancestor
92274400|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274401|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274402|NCT03241485|Analgesics|analgesics|mesh-ancestor
92274403|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
92274404|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274405|NCT04313504|Niraparib|niraparib|mesh-list
92274406|NCT04313504|Dostarlimab|dostarlimab|mesh-list
92274407|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92274408|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274409|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274410|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274411|NCT01996943|Ethanol|ethanol|mesh-list
92274412|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92274413|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274414|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274415|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274416|NCT04812626|Triamcinolone|triamcinolone|mesh-list
92274417|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92274418|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92274419|NCT04812626|Fluorouracil|fluorouracil|mesh-list
92274420|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92274421|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
92274422|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274423|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274424|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274425|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274426|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
92274427|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274428|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274429|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
92274431|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274432|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274433|NCT04197986|Infigratinib|infigratinib|mesh-list
92274434|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274435|NCT01997411|Glucagon|glucagon|mesh-list
92274436|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92344308|NCT05129670|Antacids|antacids|mesh-ancestor
92274437|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274438|NCT01997411|Hormones|hormones|mesh-ancestor
92274439|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274440|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274441|NCT01997411|Incretins|incretins|mesh-ancestor
92274442|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
92274443|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274444|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274445|NCT03534635|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92274446|NCT03534635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274447|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
92274448|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
92274449|NCT02657486|Infigratinib|infigratinib|mesh-list
92274450|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274451|NCT02385110|Dexamethasone|dexamethasone|mesh-list
92274452|NCT02385110|Methotrexate|methotrexate|mesh-list
92274453|NCT02385110|Etoposide|etoposide|mesh-list
92274454|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
92274455|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274456|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
92274457|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
92274458|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274459|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274460|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274461|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
92274462|NCT02385110|Hormones|hormones|mesh-ancestor
92274463|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274464|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274465|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274466|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92274467|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
92274468|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92274469|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274470|NCT02385110|Antimetabolites|antimetabolites|mesh-ancestor
92274471|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274472|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92274473|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274474|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92274475|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274476|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
92274477|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274478|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92274479|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92274480|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92274481|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92274482|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274483|NCT01999985|Dasatinib|dasatinib|mesh-list
92274484|NCT01999985|Afatinib|afatinib|mesh-list
92274485|NCT01999985|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92274486|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274487|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92274488|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274489|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274491|NCT01968317|Megestrol|megestrol|mesh-list
92274492|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
92274493|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92274494|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274495|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92274496|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92274497|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92274498|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
92274499|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92274500|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92274501|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92274502|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274503|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274504|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
92344309|NCT05129670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274505|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92274506|NCT01971593|Eplerenone|eplerenone|mesh-list
92274507|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92274508|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274509|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274510|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274511|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92274512|NCT01971593|Diuretics|diuretics|mesh-ancestor
92274513|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
92274514|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92274515|NCT02986451|Clarithromycin|clarithromycin|mesh-list
92274516|NCT02986451|Dexamethasone|dexamethasone|mesh-list
92274517|NCT02986451|Lenalidomide|lenalidomide|mesh-list
92274518|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274519|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
92274520|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
92274521|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274522|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274523|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274524|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
92274525|NCT02986451|Hormones|hormones|mesh-ancestor
92274526|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274527|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274528|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274529|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
92274530|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92274531|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92274532|NCT02986451|Growth Substances|growth substances|mesh-ancestor
92274533|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92274534|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92274535|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274536|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92274537|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274538|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274539|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92274540|NCT02986451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92274541|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
92274542|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92274543|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
92274544|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274545|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
92274546|NCT03245463|Protective Agents|protective agents|mesh-ancestor
92274547|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
92274548|NCT01974245|Vitamin D|vitamin d|mesh-list
92274549|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92274550|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274551|NCT01974245|Vitamins|vitamins|mesh-ancestor
92274552|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
92274553|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92274554|NCT03307005|Zolpidem|zolpidem|mesh-list
92274555|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92274556|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92274557|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274558|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274559|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92274560|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
92274561|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
92274562|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274563|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274565|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92274566|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92274567|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92274568|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274569|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274570|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274571|NCT02005601|Analgesics|analgesics|mesh-ancestor
92274572|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
92274573|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344317|NCT05128617|Antimitotic Agents|antimitotic agents|mesh-ancestor
92274574|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
92274575|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92274576|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
92274577|NCT02007863|Fludarabine|fludarabine|mesh-list
92274578|NCT02007863|Melphalan|melphalan|mesh-list
92274579|NCT02007863|Busulfan|busulfan|mesh-list
92274580|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274581|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274582|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274583|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
92274584|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926710|NCT04681105|Dexamethasone acetate|dexamethasone acetate|mesh-list
92274585|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92274586|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
92274587|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92274588|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92274589|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274590|NCT02305277|Opicapone|opicapone|mesh-list
92274591|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92274592|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274593|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274594|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92274595|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92274596|NCT03309657|Tazobactam|tazobactam|mesh-list
92274597|NCT03309657|Ceftolozane|ceftolozane|mesh-list
92274598|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92274599|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92274600|NCT03309657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274601|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92274602|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274603|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274604|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92274605|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
92274606|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274607|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274608|NCT03463161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92274609|NCT03463161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274610|NCT03467685|Anesthetics|anesthetics|mesh-list
92274611|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274612|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274613|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
92274614|NCT03468075|Gemcitabine|gemcitabine|mesh-list
92274615|NCT03468075|Vitamins|vitamins|mesh-ancestor
92274616|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
92274617|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274618|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274619|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
92274620|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274621|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274622|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
92274623|NCT03468075|Protective Agents|protective agents|mesh-ancestor
92274624|NCT03468933|Plasminogen|plasminogen|mesh-list
92274625|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92274626|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92274627|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92274628|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274629|NCT03472287|Diacerein|diacerein|mesh-list
92274630|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274631|NCT02219984|Anticoagulants|anticoagulants|mesh-list
92274632|NCT02067416|Paclitaxel|paclitaxel|mesh-list
92274633|NCT02067416|Docetaxel|docetaxel|mesh-list
92274634|NCT02067416|Epirubicin|epirubicin|mesh-list
92274635|NCT02067416|Taxane|taxane|mesh-list
92274636|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92274637|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274638|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
92274639|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344321|NCT05128617|Immunologic Factors|immunologic factors|mesh-ancestor
92274640|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
92274641|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274642|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92274643|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92274644|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92274645|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274647|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
92274648|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92274649|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
92274650|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274651|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274652|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
92274653|NCT03482583|Nicotine|nicotine|mesh-list
92274654|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92274655|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
92274656|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274657|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274658|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92274659|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92274660|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
92274661|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274662|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274663|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
92274664|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92274665|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
92274666|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274667|NCT03261999|Leuprolide|leuprolide|mesh-list
92274668|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92274669|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
92274670|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92274671|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274672|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274673|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274674|NCT03482973|Bupivacaine|bupivacaine|mesh-list
92274675|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
92274676|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
92274677|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92274678|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274679|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
92274680|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274681|NCT01602380|Fulvestrant|fulvestrant|mesh-list
92274682|NCT01602380|Anastrozole|anastrozole|mesh-list
92274683|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274684|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274685|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92274686|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92274687|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274688|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274689|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274690|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92274691|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92274692|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274693|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274694|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92274695|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
92274696|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274697|NCT03327051|Omeprazole|omeprazole|mesh-list
92274698|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92274699|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274700|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92274701|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274702|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274703|NCT02057939|Leuprolide|leuprolide|mesh-list
92274704|NCT02057939|Androgens|androgens|mesh-list
92274705|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92274706|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
92274707|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92344331|NCT05107375|Vaccines|vaccines|mesh-list
92274708|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274709|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274710|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274712|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274713|NCT03496467|Nepafenac|nepafenac|mesh-list
92274714|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92274715|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92274716|NCT03496467|Analgesics|analgesics|mesh-ancestor
92274717|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
92274718|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274719|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274720|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274721|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274723|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92274724|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
92274725|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274726|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274727|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92274728|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92274729|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
92274730|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274731|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274732|NCT02058251|Oxytocin|oxytocin|mesh-list
92274733|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
92274734|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91942563|NCT04959175|Sirolimus|sirolimus|mesh-list
92274735|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274736|NCT03329937|Niraparib|niraparib|mesh-list
92274737|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92274738|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274739|NCT03329937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274740|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274741|NCT01710254|Regadenoson|regadenoson|mesh-list
92274742|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92274743|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92274744|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
92274745|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
92274746|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274747|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274748|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274749|NCT03496545|Acetaminophen|acetaminophen|mesh-list
92274750|NCT03496545|Bromocriptine|bromocriptine|mesh-list
92274751|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92274752|NCT03496545|Analgesics|analgesics|mesh-ancestor
92274753|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
92274754|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274755|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274756|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
92274757|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92274758|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92274759|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274760|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274761|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
92274762|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
92274763|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274764|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274765|NCT01710332|Aflibercept|aflibercept|mesh-list
92274766|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92274767|NCT01710332|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92274768|NCT01710332|Growth Substances|growth substances|mesh-ancestor
92274769|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274770|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
92274771|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274772|NCT02311907|Paclitaxel|paclitaxel|mesh-list
92274773|NCT02311907|Carboplatin|carboplatin|mesh-list
92274774|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92274775|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92274776|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274777|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
92274778|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
92274779|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344339|NCT05094128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274780|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274782|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
92274783|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274784|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
92274785|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
92274786|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274787|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
92274788|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274789|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274791|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
92274792|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274793|NCT01982123|Edetic Acid|edetic acid|mesh-list
92274794|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
92274795|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
92274796|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
92274797|NCT01982123|Antidotes|antidotes|mesh-ancestor
92274798|NCT01982123|Protective Agents|protective agents|mesh-ancestor
92274799|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274800|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
92274801|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
92274802|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274803|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92274804|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
92274805|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92274806|NCT01982123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92274807|NCT02061683|Bimatoprost|bimatoprost|mesh-list
92274808|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92274809|NCT01711658|Lapatinib|lapatinib|mesh-list
92274810|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274811|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92274812|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274813|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274814|NCT01712360|Naftifine|naftifine|mesh-list
92274815|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
92274816|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274817|NCT02396147|Relugolix|relugolix|mesh-list
92274818|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
92274819|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274820|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274821|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274822|NCT01713608|Artefenomel|artefenomel|mesh-list
92274823|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
92274824|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92274825|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92274826|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274827|NCT02018627|Glucagon|glucagon|mesh-list
92274828|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92274829|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274830|NCT02018627|Hormones|hormones|mesh-ancestor
92274831|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274832|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274833|NCT02018627|Incretins|incretins|mesh-ancestor
92274834|NCT03476330|Quercetin|quercetin|mesh-list
92274835|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
92274836|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274837|NCT03476330|Protective Agents|protective agents|mesh-ancestor
92274838|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274839|NCT04413344|Bromocriptine|bromocriptine|mesh-list
92274840|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92274841|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92274842|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274843|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274844|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274845|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
92274846|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
92274847|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274848|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344345|NCT05031520|Metoprolol|metoprolol|mesh-list
92274849|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92274851|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92274852|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92274853|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274854|NCT01717898|Prednisone|prednisone|mesh-list
92274855|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
92274856|NCT01717898|Dactolisib|dactolisib|mesh-list
92274857|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274858|NCT01717898|Glucocorticoids|glucocorticoids|mesh-ancestor
92274859|NCT01717898|Hormones|hormones|mesh-ancestor
92274860|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274861|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274862|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274863|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274864|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92274865|NCT01717898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274866|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274867|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
92274868|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92274869|NCT01737944|Methotrexate|methotrexate|mesh-list
92274870|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92274871|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
92274872|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92274873|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274874|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92274875|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
92274876|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274877|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274878|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
92274879|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274880|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92274881|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92274882|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
92274883|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274884|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92274885|NCT01740206|Methylphenidate|methylphenidate|mesh-list
92274886|NCT01740206|Amphetamine|amphetamine|mesh-list
92274887|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92274888|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274889|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92274890|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92274891|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92274892|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274893|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
92274894|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274895|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
92274896|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
92274897|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274898|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
92274899|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92274900|NCT01740362|Tofacitinib|tofacitinib|mesh-list
92274901|NCT01740362|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92274902|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92274903|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274904|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274905|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92274906|NCT02068157|Trioxsalen|trioxsalen|mesh-list
92274907|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274908|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
92274909|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92274910|NCT01741454|Tamsulosin|tamsulosin|mesh-list
92274911|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92274912|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92274913|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92274914|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92274915|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
92274916|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274917|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274918|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274919|NCT01741454|Urological Agents|urological agents|mesh-ancestor
92274920|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92274921|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92274922|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
92274923|NCT01720316|Glycine|glycine|mesh-list
92274924|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
92274925|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92274926|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274927|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274929|NCT02399345|Ribavirin|ribavirin|mesh-list
92274930|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
92274931|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92274932|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92274933|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
92274934|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274935|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274936|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92274937|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92274938|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
92274939|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92274940|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92274941|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92274942|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
92274943|NCT02400437|Dexamethasone|dexamethasone|mesh-list
92274945|NCT02400437|Ixazomib|ixazomib|mesh-list
92274946|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92274947|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92274948|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
92274949|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274950|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92274951|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92274952|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
92274953|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
92274954|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92274955|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92274956|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
92274957|NCT02400437|Hormones|hormones|mesh-ancestor
92274958|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274959|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92274960|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
92274961|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274962|NCT02400437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274963|NCT02024477|Saxagliptin|saxagliptin|mesh-list
92274964|NCT02024477|Incretins|incretins|mesh-ancestor
92274965|NCT02024477|Hormones|hormones|mesh-ancestor
92274966|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274967|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274968|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92274969|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
92274970|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274971|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274972|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92274973|NCT02024711|Hyaluronic Acid|hyaluronic acid|mesh-list
92274974|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92274975|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
92274976|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274977|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
92274978|NCT02024711|Protective Agents|protective agents|mesh-ancestor
92274979|NCT02071823|Opicapone|opicapone|mesh-list
92274980|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92274981|NCT02071823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274982|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274983|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92274984|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92274986|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
92274987|NCT02029703|Protective Agents|protective agents|mesh-ancestor
92274988|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274989|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92274990|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92274991|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92274992|NCT02406443|Incretins|incretins|mesh-ancestor
92274993|NCT02406443|Hormones|hormones|mesh-ancestor
92274994|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92274995|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92274996|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92274997|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92274998|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92274999|NCT02032433|Naltrexone|naltrexone|mesh-list
92275000|NCT02032433|Buprenorphine|buprenorphine|mesh-list
92275001|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92275002|NCT02032433|Naloxone|naloxone|mesh-list
92275003|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92275004|NCT02032433|Narcotics|narcotics|mesh-ancestor
92275005|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275006|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275007|NCT02032433|Analgesics|analgesics|mesh-ancestor
92275008|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
92275009|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275010|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92275011|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92275012|NCT02342015|Atorvastatin|atorvastatin|mesh-list
92275013|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92275014|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92275015|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
92275016|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275017|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91927881|NCT02166359|Icodextrin|icodextrin|mesh-list
92275018|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92275019|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275020|NCT02342327|Menthol|menthol|mesh-list
92275021|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
92275022|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275023|NCT01721564|Bosentan|bosentan|mesh-list
92275024|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275025|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92275026|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275027|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
92275028|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92275029|NCT02343575|Valproic Acid|valproic acid|mesh-list
92275030|NCT02343575|Haloperidol|haloperidol|mesh-list
92275031|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
92275032|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
92275033|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
92275034|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275035|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275036|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92275037|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92275038|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92275039|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275040|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92275041|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92275042|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
92275043|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275044|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275045|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92275046|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
92275047|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275048|NCT02343575|GABA Agents|gaba agents|mesh-ancestor
92275049|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
92275050|NCT01744574|Progesterone|progesterone|mesh-list
92275051|NCT01744574|Progestins|progestins|mesh-ancestor
92275052|NCT01744574|Hormones|hormones|mesh-ancestor
92275053|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344359|NCT05031520|Vasodilator Agents|vasodilator agents|mesh-ancestor
92275054|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344361|NCT05018585|Vitamin D|vitamin d|mesh-list
92275055|NCT01744730|Clindamycin|clindamycin|mesh-list
92275056|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
92275057|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
92275058|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275059|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275060|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92275061|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275062|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275063|NCT02033993|Paclitaxel|paclitaxel|mesh-list
92275064|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92275065|NCT02033993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92275066|NCT02033993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275067|NCT02033993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92275068|NCT02033993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92275069|NCT02033993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92275070|NCT02033993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275071|NCT00354965|Amoxicillin|amoxicillin|mesh-list
92275072|NCT00354965|Clavulanic Acid|clavulanic acid|mesh-list
92275073|NCT00354965|Clavulanic Acids|clavulanic acids|mesh-list
92275074|NCT00354965|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92275075|NCT00354965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275076|NCT00354965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275077|NCT00354965|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92275079|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275080|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92275081|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92275082|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92275083|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275084|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275085|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92275086|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275087|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275088|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
92275089|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275090|NCT00355043|Zinc Sulfate|zinc sulfate|mesh-list
92275091|NCT00355043|Astringents|astringents|mesh-ancestor
92275092|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275093|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275096|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92275097|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
92275098|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
92275099|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275100|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275101|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
92275102|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275103|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92275104|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275105|NCT02037893|Analgesics|analgesics|mesh-ancestor
92275106|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275107|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275108|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92275109|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92275110|NCT02041325|Lenalidomide|lenalidomide|mesh-list
92275111|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
92275112|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275113|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92275114|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92275115|NCT02041325|Growth Substances|growth substances|mesh-ancestor
92275116|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
92275117|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275118|NCT01723514|Erenumab|erenumab|mesh-list
92275119|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92275120|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275121|NCT01723514|Analgesics|analgesics|mesh-ancestor
92275122|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
92275123|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275124|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275126|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
92275127|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92275128|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
92275129|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275130|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275131|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
92275132|NCT01745822|Tenofovir|tenofovir|mesh-list
92275133|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
92275134|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275135|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92275136|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92275137|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275138|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275140|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92275141|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
92275142|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
92275143|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
92275144|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275145|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275146|NCT05718869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92275147|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275148|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275149|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
92275150|NCT02354339|Antacids|antacids|mesh-ancestor
92275151|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275153|NCT01747850|Ethanol|ethanol|mesh-list
92275154|NCT01747850|Nabiximols|nabiximols|mesh-list
92275155|NCT01747850|Dronabinol|dronabinol|mesh-list
92275156|NCT01747850|Cannabidiol|cannabidiol|mesh-list
92275157|NCT01747850|Peppermint oil|peppermint oil|mesh-list
92275158|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
92275159|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92275160|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275161|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275162|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275163|NCT01747850|Analgesics|analgesics|mesh-ancestor
92275164|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
92275165|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275166|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
92275167|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92275168|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275169|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92275170|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92275172|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275173|NCT01747850|Hormones|hormones|mesh-ancestor
92275174|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275175|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
92275176|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
92275177|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92275178|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
92275179|NCT01727414|Methylphenidate|methylphenidate|mesh-list
92275180|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92275181|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275182|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92275183|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92275184|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275185|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275186|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
92275187|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275188|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92275189|NCT02048891|Progesterone|progesterone|mesh-list
92275190|NCT02048891|Progestins|progestins|mesh-ancestor
92275191|NCT02048891|Hormones|hormones|mesh-ancestor
92275192|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275193|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275194|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
92275195|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92275196|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
92275197|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92275198|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92275199|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92275200|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275201|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92275203|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
92275204|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92275205|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92275206|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92275207|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275208|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275209|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
92275210|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275211|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275212|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
92275213|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
92275215|NCT02355821|Moxonidine|moxonidine|mesh-list
92275216|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275217|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
92275218|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
92275219|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275220|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275221|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92275222|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92275223|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92275224|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
92275225|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275226|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275228|NCT01748240|Vorinostat|vorinostat|mesh-list
92275229|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92275230|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
92275231|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275232|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275233|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275234|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92275235|NCT01748942|Dexamethasone|dexamethasone|mesh-list
92275236|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
92275237|NCT01748942|Ichthammol|ichthammol|mesh-list
92275238|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92275239|NCT01748942|BB 1101|bb 1101|mesh-list
92275240|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275241|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
92275242|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
92275243|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275244|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275245|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92275246|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
92275247|NCT01748942|Hormones|hormones|mesh-ancestor
92275248|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275249|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92275250|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275251|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
92275252|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275253|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275254|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275255|NCT02355977|Minocycline|minocycline|mesh-list
92275256|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275257|NCT02355977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275258|NCT01749410|Botulinum Toxins|botulinum toxins|mesh-list
92275259|NCT01749410|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92275260|NCT01749410|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92275261|NCT01749410|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92275262|NCT01749410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275263|NCT01749410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275264|NCT01749410|Cholinergic Agents|cholinergic agents|mesh-ancestor
92275265|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275266|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275267|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92275268|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275269|NCT01729598|Valproic Acid|valproic acid|mesh-list
92275270|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
92275271|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275272|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275273|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
92275274|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275275|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275276|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
92275277|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92275278|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275279|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92275280|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
92275281|NCT05718011|Ketamine|ketamine|mesh-list
92275282|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92275283|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275284|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275285|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275286|NCT05718011|Analgesics|analgesics|mesh-ancestor
92275287|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
92275288|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275289|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92275290|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92275291|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92275292|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
92275293|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275294|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275295|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92275296|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92275297|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
92275298|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
92275299|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92275300|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92275301|NCT05717933|Hormones|hormones|mesh-list
92275302|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275303|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275304|NCT01730846|Doxazosin|doxazosin|mesh-list
92275305|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275306|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92275307|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92275308|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92275309|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
92275310|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275311|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275312|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275313|NCT02314403|Rituximab|rituximab|mesh-list
92275314|NCT02314403|Abatacept|abatacept|mesh-list
92275315|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275316|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275317|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
92275318|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275319|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275320|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92275321|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275322|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92275323|NCT02052557|Bupivacaine|bupivacaine|mesh-list
92275324|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
92275325|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
92275326|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275327|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275328|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
92275329|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275330|NCT02052635|Clopidogrel|clopidogrel|mesh-list
92275331|NCT02052635|Ticagrelor|ticagrelor|mesh-list
92275332|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92275333|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92275334|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92275335|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92275337|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275338|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275339|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275340|NCT01732718|Atorvastatin|atorvastatin|mesh-list
92275341|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92275342|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92275343|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
92275344|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275345|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92275346|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92275347|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275348|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
92275349|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92275350|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
92275351|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92275352|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275353|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92275354|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92275355|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92275356|NCT02363621|Ranibizumab|ranibizumab|mesh-list
92275357|NCT02363621|Aflibercept|aflibercept|mesh-list
92275358|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92275359|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92275360|NCT02363621|Growth Substances|growth substances|mesh-ancestor
92275361|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275362|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
92275363|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275364|NCT01749956|Leucovorin|leucovorin|mesh-list
92275365|NCT01749956|Fluorouracil|fluorouracil|mesh-list
92275366|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
92275367|NCT01749956|Aflibercept|aflibercept|mesh-list
92275368|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
92275369|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275370|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92275371|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275372|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92275373|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
92275374|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275375|NCT01749956|Antidotes|antidotes|mesh-ancestor
92275376|NCT01749956|Protective Agents|protective agents|mesh-ancestor
92275377|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
92275378|NCT01749956|Vitamins|vitamins|mesh-ancestor
92275379|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
92275380|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92275381|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92275382|NCT01749956|Growth Substances|growth substances|mesh-ancestor
92275383|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
92275384|NCT02365961|Clonidine|clonidine|mesh-list
92275385|NCT02365961|Epinephrine|epinephrine|mesh-list
92275386|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92275387|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92275388|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92275389|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275390|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275391|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275392|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92275393|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92275394|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
92275395|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275396|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92275397|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92275398|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
92275399|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
92275400|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92275401|NCT02365961|Analgesics|analgesics|mesh-ancestor
92275402|NCT02365961|Sensory System Agents|sensory system agents|mesh-ancestor
92275403|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275405|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92275406|NCT05532059|Cisplatin|cisplatin|mesh-list
92275407|NCT05532059|Gemcitabine|gemcitabine|mesh-list
92275408|NCT05532059|Lenvatinib|lenvatinib|mesh-list
92275409|NCT05532059|Tislelizumab|tislelizumab|mesh-list
92275410|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275411|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92275412|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
92275413|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275414|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92275415|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275416|NCT05532059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275417|NCT03809234|Ondansetron|ondansetron|mesh-list
92275418|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
92275419|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
92275420|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275421|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275422|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92275423|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
92275424|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275425|NCT03809234|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92275426|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92275427|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
92275428|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275429|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275430|NCT03711188|Nivolumab|nivolumab|mesh-list
92275431|NCT03711188|Ipilimumab|ipilimumab|mesh-list
92275432|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275433|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275434|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92275435|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275436|NCT02366663|Cytarabine|cytarabine|mesh-list
92275437|NCT02366663|Rituximab|rituximab|mesh-list
92275438|NCT02366663|Etoposide|etoposide|mesh-list
92275439|NCT02366663|Melphalan|melphalan|mesh-list
92275440|NCT02366663|Carmustine|carmustine|mesh-list
92275441|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275442|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275443|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
92275444|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275445|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275446|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92275447|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91935224|NCT02303899|Antimetabolites|antimetabolites|mesh-ancestor
92275448|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92275449|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275450|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275451|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92275452|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
92275453|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
92275454|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275455|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92275456|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92275457|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
92275458|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92275459|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92275460|NCT01754480|Hemostatics|hemostatics|mesh-ancestor
92275461|NCT01754480|Coagulants|coagulants|mesh-ancestor
92275462|NCT02367599|Vitamin D|vitamin d|mesh-list
92275463|NCT02367599|Vitamins|vitamins|mesh-ancestor
92275464|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
92275465|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275466|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92275467|NCT02368457|Tocopherols|tocopherols|mesh-list
92275468|NCT02368457|Vitamin E|vitamin e|mesh-list
92275469|NCT02368457|Tocotrienols|tocotrienols|mesh-list
92275470|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
92275471|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
92275472|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92275473|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275474|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275475|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92275476|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92275477|NCT02368457|Protective Agents|protective agents|mesh-ancestor
92275478|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275479|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
92275480|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92275481|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
92275482|NCT02368457|Vitamins|vitamins|mesh-ancestor
92275483|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
92275484|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
92275485|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92275486|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275487|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92275488|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275489|NCT02373137|Ofloxacin|ofloxacin|mesh-list
92275490|NCT02373137|Prednisolone|prednisolone|mesh-list
92275491|NCT02373137|Phenylephrine|phenylephrine|mesh-list
92275492|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
92275493|NCT02373137|Tropicamide|tropicamide|mesh-list
92275494|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942582|NCT04929808|Emollients|emollients|mesh-list
92275495|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
92275496|NCT02373137|Hormones|hormones|mesh-ancestor
92275497|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275498|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275499|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92275500|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275501|NCT02373137|Autonomic Agents|autonomic agents|mesh-ancestor
92275502|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275504|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92275506|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
92275507|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92275508|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
92275509|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
92275510|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92275511|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92275512|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92275513|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
92275514|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275515|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275516|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92275517|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275518|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275519|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92275521|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275522|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92275523|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92275524|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92275525|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92275526|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
92275527|NCT05488067|Atorvastatin|atorvastatin|mesh-list
92275528|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92275529|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92275530|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
92275531|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275532|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92275533|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92275534|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275535|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92275536|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92275537|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275538|NCT00354653|Lamivudine|lamivudine|mesh-list
92275539|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92275540|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92275541|NCT00354653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275542|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275543|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
92275544|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275545|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92275546|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92275548|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92275549|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275550|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275551|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92275552|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92275553|NCT00354731|Protective Agents|protective agents|mesh-ancestor
92275554|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275555|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
92275556|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92275557|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
92275558|NCT00354809|Casopitant|casopitant|mesh-list
92275559|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
92275560|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
92275561|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275562|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275563|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92275564|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92275565|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275566|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275567|NCT04769258|Vaccines|vaccines|mesh-list
92275568|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
92275569|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275570|NCT01762904|Ethanol|ethanol|mesh-list
92275571|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
92275572|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92275573|NCT01762904|Triclosan|triclosan|mesh-list
92275574|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92275575|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275576|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275577|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275579|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275580|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92275581|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92275582|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
92275583|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275584|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92275585|NCT02376257|Cycloserine|cycloserine|mesh-list
92275586|NCT02376257|Modafinil|modafinil|mesh-list
92275588|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275589|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92275590|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92275591|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92275592|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275593|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92275594|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275595|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92275596|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
92275597|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275598|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
92275599|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92275600|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92275601|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275602|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
92275603|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92275604|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92275605|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92275606|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275607|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
92275608|NCT03211286|Coagulants|coagulants|mesh-ancestor
92275609|NCT01763606|Aspirin|aspirin|mesh-list
92275610|NCT01763606|Enoxaparin|enoxaparin|mesh-list
92275611|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92275612|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275613|NCT01763606|Analgesics|analgesics|mesh-ancestor
92344413|NCT04850495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92275614|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
92275615|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275616|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275617|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275618|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275619|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92275620|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92275621|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275622|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92275623|NCT01763606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92275624|NCT01763606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275626|NCT01763606|Anticoagulants|anticoagulants|mesh-ancestor
92275627|NCT03161756|Denosumab|denosumab|mesh-list
92275628|NCT03161756|Nivolumab|nivolumab|mesh-list
92275629|NCT03161756|Ipilimumab|ipilimumab|mesh-list
92275630|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275631|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275632|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92275633|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275634|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92275635|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275636|NCT01766024|Interferons|interferons|mesh-list
92275637|NCT01766024|Interferon-beta|interferon-beta|mesh-list
92275638|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
92275639|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275640|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
92275641|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275642|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
92275643|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275644|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92275645|NCT01767506|Azithromycin|azithromycin|mesh-list
92275646|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275647|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275648|NCT02383043|Cocaine|cocaine|mesh-list
92275649|NCT02383043|Amphetamine|amphetamine|mesh-list
92275650|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
92275651|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92275652|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275653|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
92275654|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
92275655|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275656|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
92275657|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275658|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275659|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92275660|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92275661|NCT02383043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92275662|NCT02383043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275663|NCT02383043|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92275664|NCT02383043|Anesthetics, Local|anesthetics, local|mesh-ancestor
92275666|NCT02383043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275667|NCT02383043|Sensory System Agents|sensory system agents|mesh-ancestor
92275668|NCT02383043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92275669|NCT01768520|Celecoxib|celecoxib|mesh-list
92275670|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92275671|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275672|NCT01768520|Analgesics|analgesics|mesh-ancestor
92275673|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
92275674|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275675|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275676|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275677|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275678|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92275679|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92275680|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275681|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275682|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92275683|NCT00355589|Ramipril|ramipril|mesh-list
92275684|NCT00355589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275685|NCT00355589|Diuretics|diuretics|mesh-ancestor
92275686|NCT00355589|Natriuretic Agents|natriuretic agents|mesh-ancestor
92275687|NCT00355589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275688|NCT00355589|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92275689|NCT00355589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275690|NCT00355589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275691|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92275692|NCT00355589|Protease Inhibitors|protease inhibitors|mesh-ancestor
92275693|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275694|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92275695|NCT01769222|Ipilimumab|ipilimumab|mesh-list
92275696|NCT01769222|Antibodies|antibodies|mesh-list
92275697|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
92275698|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92275699|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
92275700|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275701|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275702|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92275703|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275704|NCT02386319|Melatonin|melatonin|mesh-list
92275705|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
92275706|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275707|NCT02386319|Protective Agents|protective agents|mesh-ancestor
92275708|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275709|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275710|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92275711|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
92275712|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275713|NCT02387801|Ixekizumab|ixekizumab|mesh-list
92275714|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92275715|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
92275716|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92275717|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
92275718|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275719|NCT05284097|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92275720|NCT05284097|Antiviral Agents|antiviral agents|mesh-ancestor
92275721|NCT05284097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275722|NCT02326844|Talazoparib|talazoparib|mesh-list
92275723|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92275724|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275725|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275726|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275727|NCT02239874|Vitamin D|vitamin d|mesh-list
92275728|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
92275729|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
92275730|NCT02239874|Vitamins|vitamins|mesh-list
92275731|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
92275732|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275733|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92275734|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92275735|NCT01771952|Hyaluronic Acid|hyaluronic acid|mesh-list
92275736|NCT01771952|Hylan|hylan|mesh-list
92275737|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92275738|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
92275739|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275740|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
92275741|NCT01771952|Protective Agents|protective agents|mesh-ancestor
92275742|NCT02389361|Acetaminophen|acetaminophen|mesh-list
92275743|NCT02389361|Tramadol|tramadol|mesh-list
92275744|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275745|NCT02389361|Analgesics|analgesics|mesh-ancestor
92275746|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
92275747|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275748|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275749|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
92275750|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92275751|NCT02389361|Narcotics|narcotics|mesh-ancestor
92275752|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275753|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92275754|NCT02252354|Relugolix|relugolix|mesh-list
92275755|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
92275756|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
92275757|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275758|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275759|NCT02393339|Acetaminophen|acetaminophen|mesh-list
92275760|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275761|NCT02393339|Analgesics|analgesics|mesh-ancestor
92275762|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
92275763|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928634|NCT02183441|Incretins|incretins|mesh-ancestor
92275764|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275765|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
92275766|NCT05235191|Methadone|methadone|mesh-list
92275767|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92275768|NCT05235191|Narcotics|narcotics|mesh-ancestor
92275769|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275770|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275771|NCT05235191|Analgesics|analgesics|mesh-ancestor
92275772|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
92275773|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275774|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
92275775|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
92275776|NCT01774604|Indomethacin|indomethacin|mesh-list
92275777|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92275778|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275779|NCT01774604|Analgesics|analgesics|mesh-ancestor
92275780|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
92275781|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275782|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275783|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275784|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275785|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
92275786|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
92275787|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92275788|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92275789|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275790|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275791|NCT01777412|Bevacizumab|bevacizumab|mesh-list
92275792|NCT01777412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275793|NCT01777412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275795|NCT01777412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92275796|NCT01777412|Growth Substances|growth substances|mesh-ancestor
92275797|NCT01777412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275798|NCT01777412|Growth Inhibitors|growth inhibitors|mesh-ancestor
92275799|NCT02236910|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92275800|NCT02236910|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92275801|NCT02236910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275802|NCT04873349|Oleuropein|oleuropein|mesh-list
92275803|NCT04873349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275804|NCT04873349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275806|NCT01780454|Rituximab|rituximab|mesh-list
92275807|NCT01780454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275808|NCT01780454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275809|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
92275810|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275811|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275812|NCT04869449|Ketoconazole|ketoconazole|mesh-list
92275813|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
92275814|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275815|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92275816|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92275817|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275818|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275819|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92275820|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
92275821|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275822|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275823|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92275824|NCT00355901|Visilizumab|visilizumab|mesh-list
92275825|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
92275826|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275827|NCT00355667|Furosemide|furosemide|mesh-list
92275828|NCT00355667|Azosemide|azosemide|mesh-list
92275829|NCT00355667|Diuretics|diuretics|mesh-ancestor
92275830|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
92275831|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275832|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92275833|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275834|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275835|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92275836|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
92275837|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275838|NCT04419948|Ibuprofen|ibuprofen|mesh-list
92275839|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92275840|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275841|NCT04419948|Analgesics|analgesics|mesh-ancestor
92275842|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
92275843|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275844|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275845|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275846|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275847|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92275848|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275849|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275850|NCT01312922|Dexetimide|dexetimide|mesh-list
92275851|NCT01312922|Pipamperone|pipamperone|mesh-list
92275852|NCT01312922|Citalopram|citalopram|mesh-list
92275853|NCT01312922|Escitalopram|escitalopram|mesh-list
92275854|NCT01312922|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92275855|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92275856|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275857|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275858|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275859|NCT01312922|Serotonin Agents|serotonin agents|mesh-ancestor
92275860|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275861|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92275862|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
92275863|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92275864|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92275865|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92275866|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
92275867|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
92275868|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275869|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92275870|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92275871|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
92275872|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92275873|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92275874|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92275875|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275876|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
92275878|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
92275879|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
92275880|NCT01783574|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92275881|NCT01783574|Androgens|androgens|mesh-ancestor
92275883|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92275884|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275885|NCT01783574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92275886|NCT01783574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275887|NCT01783574|Anabolic Agents|anabolic agents|mesh-ancestor
92275888|NCT03656783|Tenofovir|tenofovir|mesh-list
92275889|NCT03656783|Emtricitabine|emtricitabine|mesh-list
92275890|NCT03656783|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92275891|NCT03656783|Antiviral Agents|antiviral agents|mesh-ancestor
92275892|NCT03656783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275893|NCT03656783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92275894|NCT03656783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92275895|NCT03656783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275896|NCT03656783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275897|NCT03656783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92275898|NCT03656783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92275899|NCT01784666|Isradipine|isradipine|mesh-list
92275900|NCT01784666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92275901|NCT01784666|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92275902|NCT01784666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92275903|NCT01784666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275904|NCT01784666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92275905|NCT01784666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275906|NCT01784666|Vasodilator Agents|vasodilator agents|mesh-ancestor
92275907|NCT04362293|Sirolimus|sirolimus|mesh-list
92275908|NCT04362293|Plerixafor|plerixafor|mesh-list
92275909|NCT04362293|Cyclophosphamide|cyclophosphamide|mesh-list
92275910|NCT04362293|Thiotepa|thiotepa|mesh-list
92275911|NCT04362293|Temsirolimus|temsirolimus|mesh-list
92275912|NCT04362293|Alemtuzumab|alemtuzumab|mesh-list
92275913|NCT04362293|Hydroxyurea|hydroxyurea|mesh-list
92275914|NCT04362293|Azathioprine|azathioprine|mesh-list
92275915|NCT04362293|MTOR Inhibitors|mtor inhibitors|mesh-list
92275916|NCT04362293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92275917|NCT04362293|Immunologic Factors|immunologic factors|mesh-ancestor
92275919|NCT04362293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275920|NCT04362293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92275921|NCT04362293|Alkylating Agents|alkylating agents|mesh-ancestor
92275922|NCT04362293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275923|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275924|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92275925|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92275926|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275927|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92275928|NCT04362293|Antifungal Agents|antifungal agents|mesh-ancestor
92275929|NCT04362293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92275930|NCT04362293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275931|NCT04362293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275932|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
92275933|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92275934|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
92275935|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92275936|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92275937|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92275938|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
92275939|NCT04296695|Tenofovir|tenofovir|mesh-list
92275940|NCT04296695|Efavirenz|efavirenz|mesh-list
92275941|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
92275942|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92275943|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92275944|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92275945|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92275946|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275947|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92275948|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92275949|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91942593|NCT04903223|Antimetabolites|antimetabolites|mesh-ancestor
92275950|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92275951|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91935242|NCT02331771|Cholinergic Agents|cholinergic agents|mesh-ancestor
92275952|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92275953|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92275954|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92275956|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
92275957|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
92275958|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92275959|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275960|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
92275961|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275962|NCT01787006|Fluorouracil|fluorouracil|mesh-list
92275963|NCT01787006|Cetuximab|cetuximab|mesh-list
92275964|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92275965|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
92275966|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275967|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92275968|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92275969|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
92275970|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275971|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92275972|NCT02260622|Aspirin|aspirin|mesh-list
92275973|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
92275974|NCT02260622|Clopidogrel|clopidogrel|mesh-list
92275975|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92275976|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92275977|NCT02260622|Analgesics|analgesics|mesh-ancestor
92275978|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
92275979|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92275980|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92275981|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92275982|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92275983|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92275984|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92275985|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92275986|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92275987|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92275988|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928863|NCT05149365|Hormones|hormones|mesh-ancestor
92275989|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
92275990|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92275991|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92275992|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92275993|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
92275994|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92275995|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92275996|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
92275997|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92275998|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
92275999|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
92276000|NCT03186209|Benralizumab|benralizumab|mesh-list
92276001|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92276002|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
92276004|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92276005|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
92276006|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92276007|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92276008|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276009|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276010|NCT02261948|Protective Agents|protective agents|mesh-ancestor
92276011|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276013|NCT01787240|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92276014|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92276015|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92276016|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276017|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276018|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
92276019|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276020|NCT00357149|Cisplatin|cisplatin|mesh-list
92276021|NCT00357149|Docetaxel|docetaxel|mesh-list
92276022|NCT00357149|Fluorouracil|fluorouracil|mesh-list
92276023|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276024|NCT00357149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92276025|NCT00357149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92276026|NCT00357149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276027|NCT00357149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276028|NCT00357149|Antimetabolites|antimetabolites|mesh-ancestor
92276029|NCT00357149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92276030|NCT00357149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92276031|NCT00357149|Immunologic Factors|immunologic factors|mesh-ancestor
92276032|NCT00357149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276033|NCT04903652|Vinorelbine|vinorelbine|mesh-list
92276034|NCT04903652|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92276035|NCT04903652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276036|NCT04903652|Tubulin Modulators|tubulin modulators|mesh-ancestor
92276037|NCT04903652|Antimitotic Agents|antimitotic agents|mesh-ancestor
92276038|NCT04903652|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276039|NCT04903652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276040|NCT04071821|Cetirizine|cetirizine|mesh-list
92276041|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92276042|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92276043|NCT04071821|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92276044|NCT04071821|Histamine Antagonists|histamine antagonists|mesh-ancestor
92276045|NCT04071821|Histamine Agents|histamine agents|mesh-ancestor
92276046|NCT04071821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276047|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276048|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276049|NCT03064295|Adenosine|adenosine|mesh-list
92276050|NCT03064295|Regadenoson|regadenoson|mesh-list
92276051|NCT03064295|Analgesics|analgesics|mesh-ancestor
92276052|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
92276053|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276054|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276055|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92276056|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
92276057|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92276058|NCT03064295|Purinergic Agonists|purinergic agonists|mesh-ancestor
92276059|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
92276060|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276061|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276062|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92276063|NCT01789814|Clopidogrel|clopidogrel|mesh-list
92276064|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92276065|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92276066|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92276067|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92276068|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92276069|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
92276070|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276071|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276072|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276073|NCT00356447|Estradiol|estradiol|mesh-list
92276074|NCT00356447|Estrogens|estrogens|mesh-ancestor
92276075|NCT00356447|Hormones|hormones|mesh-ancestor
92276076|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276077|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276078|NCT01736852|Oxytocin|oxytocin|mesh-list
92276079|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
92276080|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92276081|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276082|NCT01810952|Insulin|insulin|mesh-list
92276083|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92276084|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
92276085|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
92276086|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
92276087|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
92276088|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
92276089|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92276090|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276091|NCT04059887|Atezolizumab|atezolizumab|mesh-list
92276092|NCT04059887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92276093|NCT04059887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276094|NCT04059887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276095|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276096|NCT01877642|Lorazepam|lorazepam|mesh-list
92276097|NCT01877642|Loxapine|loxapine|mesh-list
92276098|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
92276100|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
92276101|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276102|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276103|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276104|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276105|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276106|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92276107|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276108|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276109|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
92276111|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276112|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276113|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92276114|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92276115|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
92276116|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92276117|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276118|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276119|NCT01878656|Sevoflurane|sevoflurane|mesh-list
92276120|NCT01878656|Desflurane|desflurane|mesh-list
92276121|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92276122|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92276123|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
92276124|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
92276125|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276126|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276127|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
92276128|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92276129|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
92276130|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276131|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
92276132|NCT01811654|Protective Agents|protective agents|mesh-ancestor
92276133|NCT02266472|Metformin|metformin|mesh-list
92276134|NCT02266472|Empagliflozin|empagliflozin|mesh-list
92276135|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92276136|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276137|NCT02266472|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92276138|NCT02266472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276139|NCT03500289|Midazolam|midazolam|mesh-list
92276140|NCT03500289|Ketamine|ketamine|mesh-list
92276141|NCT03500289|Analgesics|analgesics|mesh-ancestor
92276142|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
92276143|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276144|NCT03500289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276145|NCT03500289|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92276146|NCT03500289|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92276147|NCT03500289|Anesthetics, General|anesthetics, general|mesh-ancestor
92276148|NCT03500289|Anesthetics|anesthetics|mesh-ancestor
92276149|NCT03500289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276150|NCT03500289|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92276151|NCT03500289|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92276152|NCT03500289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276153|NCT03500289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276154|NCT03500289|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92276155|NCT03500289|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276156|NCT03500289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92276157|NCT03500289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276158|NCT03500289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276159|NCT03500289|GABA Modulators|gaba modulators|mesh-ancestor
92276160|NCT03500289|GABA Agents|gaba agents|mesh-ancestor
92276161|NCT01812044|Lidocaine|lidocaine|mesh-list
92276162|NCT01812044|Bupivacaine|bupivacaine|mesh-list
92276163|NCT01812044|Anesthetics, Local|anesthetics, local|mesh-list
92276164|NCT01812044|Anesthetics|anesthetics|mesh-list
92276165|NCT01812044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276166|NCT01812044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276167|NCT01812044|Sensory System Agents|sensory system agents|mesh-ancestor
92276168|NCT01812044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276169|NCT01812044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92276170|NCT01812044|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92276171|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92276172|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92276173|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276174|NCT03974789|Dexamethasone|dexamethasone|mesh-list
92276175|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276177|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
92276178|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276179|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276180|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276181|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
92276183|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276184|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92276185|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276186|NCT01812668|Fluorides|fluorides|mesh-list
92276187|NCT01812668|Cariostatic Agents|cariostatic agents|mesh-ancestor
92276188|NCT01812668|Protective Agents|protective agents|mesh-ancestor
92276189|NCT01812668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276190|NCT02570477|Vancomycin|vancomycin|mesh-list
92276191|NCT02570477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92276192|NCT02570477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276193|NCT04344821|Calcium|calcium|mesh-list
92276194|NCT04344821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92276195|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276196|NCT04351100|Diacerein|diacerein|mesh-list
92276197|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276198|NCT05328674|Mitogens|mitogens|mesh-list
92276199|NCT05328674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276200|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276201|NCT01798316|Acetaminophen|acetaminophen|mesh-list
92276202|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92276203|NCT01798316|Analgesics|analgesics|mesh-ancestor
92276204|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
92276205|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276206|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276207|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
92276208|NCT03883763|Bupivacaine|bupivacaine|mesh-list
92276209|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
92276210|NCT03883763|Anesthetics|anesthetics|mesh-ancestor
92276211|NCT03883763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276212|NCT03883763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276213|NCT03883763|Sensory System Agents|sensory system agents|mesh-ancestor
92276214|NCT03883763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276215|NCT01798394|Progesterone|progesterone|mesh-list
92276216|NCT01798394|Progestins|progestins|mesh-ancestor
92276217|NCT01798394|Hormones|hormones|mesh-ancestor
92276218|NCT01798394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276219|NCT01798394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276220|NCT01798550|Enoxaparin|enoxaparin|mesh-list
92276221|NCT01798550|Anticoagulants|anticoagulants|mesh-ancestor
92276222|NCT01798550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92276223|NCT01798550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92276224|NCT01798550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276225|NCT00357305|Cytarabine|cytarabine|mesh-list
92276226|NCT00357305|Etoposide|etoposide|mesh-list
92276227|NCT00357305|Etoposide phosphate|etoposide phosphate|mesh-list
92276228|NCT00357305|Vorinostat|vorinostat|mesh-list
92276229|NCT00357305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92276230|NCT00357305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276231|NCT00357305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92276232|NCT00357305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92276233|NCT00357305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276234|NCT00357305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276235|NCT00357305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92276236|NCT00357305|Antimetabolites|antimetabolites|mesh-ancestor
92276237|NCT00357305|Antiviral Agents|antiviral agents|mesh-ancestor
92276238|NCT00357305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276239|NCT00357305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92276240|NCT00357305|Immunologic Factors|immunologic factors|mesh-ancestor
92276241|NCT00357305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276242|NCT00357305|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92276243|NCT02340000|Amoxicillin|amoxicillin|mesh-list
92276244|NCT02340000|Clavulanic Acid|clavulanic acid|mesh-list
92276245|NCT02340000|Clavulanic Acids|clavulanic acids|mesh-list
92276246|NCT02340000|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92276247|NCT02340000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92276248|NCT02340000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276249|NCT02340000|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92276250|NCT02340000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276251|NCT02340000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276252|NCT01813214|Vemurafenib|vemurafenib|mesh-list
92276253|NCT01813214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926711|NCT04681105|Ibuprofen|ibuprofen|mesh-list
92276254|NCT01813214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276255|NCT01813214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276256|NCT01813214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276258|NCT01815008|Clopidogrel|clopidogrel|mesh-list
92276259|NCT01815008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92276260|NCT01815008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92276261|NCT01815008|Analgesics|analgesics|mesh-ancestor
92276262|NCT01815008|Sensory System Agents|sensory system agents|mesh-ancestor
92276263|NCT01815008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276264|NCT01815008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276265|NCT01815008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276266|NCT01815008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92276267|NCT01815008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92276268|NCT01815008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92276269|NCT01815008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276270|NCT01815008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92276271|NCT01815008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92276272|NCT01815008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276273|NCT01815008|Antipyretics|antipyretics|mesh-ancestor
92276274|NCT01815008|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92276275|NCT01815008|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92276276|NCT01815008|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92276277|NCT01815008|Purinergic Agents|purinergic agents|mesh-ancestor
92276278|NCT01815008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276279|NCT01801124|Bupivacaine|bupivacaine|mesh-list
92276280|NCT01801124|Anesthetics, Local|anesthetics, local|mesh-ancestor
92276281|NCT01801124|Anesthetics|anesthetics|mesh-ancestor
92276282|NCT01801124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276283|NCT01801124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276284|NCT01801124|Sensory System Agents|sensory system agents|mesh-ancestor
92276285|NCT01801124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276286|NCT00357461|Ipilimumab|ipilimumab|mesh-list
92276287|NCT00357461|Vaccines|vaccines|mesh-list
92276288|NCT00357461|Freund's Adjuvant|freund's adjuvant|mesh-list
92276289|NCT00357461|Immunologic Factors|immunologic factors|mesh-ancestor
92276290|NCT00357461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276291|NCT00357461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276292|NCT00357461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276293|NCT00357461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92276294|NCT00357461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276295|NCT00357461|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92276296|NCT00357539|Azithromycin|azithromycin|mesh-list
92276297|NCT00357539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92276298|NCT00357539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276299|NCT03331965|Metoclopramide|metoclopramide|mesh-list
92276300|NCT03331965|Antiemetics|antiemetics|mesh-ancestor
92276301|NCT03331965|Autonomic Agents|autonomic agents|mesh-ancestor
92276302|NCT03331965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276303|NCT03331965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276304|NCT03331965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276305|NCT03331965|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92276306|NCT03331965|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92276307|NCT03331965|Dopamine Agents|dopamine agents|mesh-ancestor
92276308|NCT03331965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276309|NCT03331965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276310|NCT03278223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92276311|NCT03279237|Leucovorin|leucovorin|mesh-list
92276312|NCT03279237|Paclitaxel|paclitaxel|mesh-list
92276313|NCT03279237|Carboplatin|carboplatin|mesh-list
92276314|NCT03279237|Fluorouracil|fluorouracil|mesh-list
92276315|NCT03279237|Oxaliplatin|oxaliplatin|mesh-list
92276316|NCT03279237|Irinotecan|irinotecan|mesh-list
92276317|NCT03279237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92276318|NCT03279237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276319|NCT03279237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92276320|NCT03279237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92276321|NCT03279237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276322|NCT03279237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276323|NCT03279237|Antimetabolites|antimetabolites|mesh-ancestor
92276324|NCT03279237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92276325|NCT03279237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92276326|NCT03279237|Immunologic Factors|immunologic factors|mesh-ancestor
92276327|NCT03279237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276328|NCT03279237|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92276329|NCT03279237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92276330|NCT03279237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276331|NCT03279237|Antidotes|antidotes|mesh-ancestor
92276332|NCT03279237|Protective Agents|protective agents|mesh-ancestor
92276333|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
92276334|NCT03279237|Vitamins|vitamins|mesh-ancestor
92276335|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
92276336|NCT03282591|Serlopitant|serlopitant|mesh-list
92276337|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92276338|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276339|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276340|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276341|NCT03509883|Apixaban|apixaban|mesh-list
92276342|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92276343|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
92276344|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92276345|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92276346|NCT03509883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276347|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276348|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
92276349|NCT03336645|Midazolam|midazolam|mesh-list
92276350|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92276351|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276352|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276353|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276354|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92276355|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276356|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276357|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92276358|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
92276359|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
92276360|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
92276361|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
92276362|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276363|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276364|NCT00376311|Calcitonin|calcitonin|mesh-list
92276365|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
92276366|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92276367|NCT00376311|Katacalcin|katacalcin|mesh-list
92276368|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92276369|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276370|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92276371|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
92276372|NCT03511521|Insulin|insulin|mesh-list
92276373|NCT03511521|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92276374|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
92276375|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
92276376|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
92276377|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
92276378|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92276379|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276380|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
92276381|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92276382|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92276383|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
92344482|NCT04700072|Lenvatinib|lenvatinib|mesh-list
92276384|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92276385|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276387|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
92276388|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276389|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276390|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276391|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
92276392|NCT00376077|Hormones|hormones|mesh-ancestor
92276393|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276394|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92276395|NCT00376077|Protective Agents|protective agents|mesh-ancestor
92276396|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92276397|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276398|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
92276399|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
92276400|NCT03519243|Hematinics|hematinics|mesh-ancestor
92276401|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
92276402|NCT03577275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92276403|NCT03577275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276404|NCT03577275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92276405|NCT03577275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92276406|NCT03577275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926712|NCT04681105|Ranitidine|ranitidine|mesh-list
92276407|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276408|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276409|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
92276410|NCT03521505|Propofol|propofol|mesh-list
92276411|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276412|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276413|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276414|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92276415|NCT03521505|Analgesics|analgesics|mesh-ancestor
92276416|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
92276417|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276418|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92276419|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92276420|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92276421|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92276422|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276423|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276424|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92276425|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
92276426|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
92276427|NCT03522441|Clindamycin|clindamycin|mesh-list
92276428|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
92276429|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
92276431|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276432|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92276433|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276434|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276435|NCT03530631|Adderall|adderall|mesh-list
92276436|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92276437|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276438|NCT03350217|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92276439|NCT03350217|Plasma Substitutes|plasma substitutes|mesh-ancestor
92276440|NCT03350217|Blood Substitutes|blood substitutes|mesh-ancestor
92276441|NCT03351933|Immunoglobulins|immunoglobulins|mesh-list
92276442|NCT03351933|Antibodies|antibodies|mesh-list
92276443|NCT03351933|gamma-Globulins|gamma-globulins|mesh-list
92276444|NCT03351933|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92276445|NCT03351933|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92276446|NCT03351933|Immunologic Factors|immunologic factors|mesh-ancestor
92276447|NCT03351933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276449|NCT03594045|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92276450|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
92276451|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92276452|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
92276453|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276454|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276455|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
92276456|NCT03595449|Lidocaine|lidocaine|mesh-list
92276457|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
92276458|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
92276459|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276460|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276461|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
92276462|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276463|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92276464|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92276465|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92276466|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92276467|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276468|NCT03597009|Nivolumab|nivolumab|mesh-list
92276469|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92276470|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276471|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276472|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92276473|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276474|NCT03352323|Phenylephrine|phenylephrine|mesh-list
92276475|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
92276476|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92276477|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92276479|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276480|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276481|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276482|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
92276483|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
92276484|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276485|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
92276486|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92276487|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
92276488|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92276489|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
92276490|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92276491|NCT03352323|Protective Agents|protective agents|mesh-ancestor
92276492|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
92276493|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276494|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276495|NCT03357393|Midazolam|midazolam|mesh-list
92276496|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
92276497|NCT03357393|Scopolamine|scopolamine|mesh-list
92276498|NCT03357393|Morphine|morphine|mesh-list
92276499|NCT03357393|Propofol|propofol|mesh-list
92276500|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92276501|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276502|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276503|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276504|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92276505|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
92276506|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
92276507|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92276508|NCT03357393|Narcotics|narcotics|mesh-ancestor
92276509|NCT03357393|Analgesics|analgesics|mesh-ancestor
92276510|NCT03357393|Sensory System Agents|sensory system agents|mesh-ancestor
92276511|NCT03357393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276512|NCT03357393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92276513|NCT03357393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92276514|NCT03357393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276515|NCT03357393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276516|NCT03357393|GABA Modulators|gaba modulators|mesh-ancestor
92276517|NCT03357393|GABA Agents|gaba agents|mesh-ancestor
92276518|NCT03357393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929384|NCT02190695|Decitabine|decitabine|mesh-list
92276519|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276520|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92276521|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92276522|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
92276523|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
92276524|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
92276525|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276526|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
92276527|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
92276528|NCT03541941|Bupivacaine|bupivacaine|mesh-list
92276529|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
92276530|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
92344487|NCT04700072|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276531|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276532|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276533|NCT03541941|Sensory System Agents|sensory system agents|mesh-ancestor
92276534|NCT03541941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276535|NCT00376467|Imatinib Mesylate|imatinib mesylate|mesh-list
92276536|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276537|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276538|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276539|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276540|NCT03556761|Furosemide|furosemide|mesh-list
92276541|NCT03556761|Diuretics|diuretics|mesh-ancestor
92276542|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
92276543|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276544|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92276545|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92276546|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276547|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
92276548|NCT03559179|Narcotics|narcotics|mesh-ancestor
92276549|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276550|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276551|NCT03559179|Analgesics|analgesics|mesh-ancestor
92276552|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
92276553|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276554|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
92276555|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92276556|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276557|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92276558|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92276559|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276560|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276561|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276562|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92276563|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92276564|NCT03368235|Prednisolone|prednisolone|mesh-list
92276565|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276566|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
92276568|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276569|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276570|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92276571|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276572|NCT02310750|PF-06700841|pf-06700841|mesh-list
92276573|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276574|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276575|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276576|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92276577|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276578|NCT02310672|Macitentan|macitentan|mesh-list
92276579|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92276580|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92276581|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276582|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92276583|NCT03626415|Abrocitinib|abrocitinib|mesh-list
92276584|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276585|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276586|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276587|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
92276588|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92276589|NCT04373421|Benzydamine|benzydamine|mesh-list
92276590|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92276591|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276593|NCT04373421|Dermatologic Agents|dermatologic agents|mesh-ancestor
92276594|NCT04373421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276595|NCT03632109|Gentamicins|gentamicins|mesh-list
92276596|NCT03632109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92276597|NCT03632109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276598|NCT03632109|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92276599|NCT03632109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276600|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276601|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
92276602|NCT02363946|Promethazine|promethazine|mesh-list
92276603|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92276604|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276605|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276606|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276607|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
92276609|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
92276610|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276611|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
92276612|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
92276613|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276614|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92276615|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
92276616|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
92276617|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276618|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276619|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92276620|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
92276621|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92276622|NCT02363478|Buspirone|buspirone|mesh-list
92276623|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92276624|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276625|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276626|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276627|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276628|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92276629|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
92276630|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276631|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276632|NCT02338362|Fluticasone|fluticasone|mesh-list
92276633|NCT02338362|Xhance|xhance|mesh-list
92276634|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276635|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92276636|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
92276637|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276638|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276639|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92276640|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
92276641|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
92276642|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92276643|NCT01803074|Ritonavir|ritonavir|mesh-list
92276644|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92276645|NCT01803074|Tenofovir|tenofovir|mesh-list
92276646|NCT01803074|Emtricitabine|emtricitabine|mesh-list
92276648|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92276649|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92276650|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
92276651|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276652|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276653|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92276654|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92276655|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
92276656|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276657|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92276658|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92276659|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92276660|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92276662|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92276663|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276664|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
92276665|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276666|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
92276667|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
92276668|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276669|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
92276670|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276671|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276672|NCT01822886|Gemcitabine|gemcitabine|mesh-list
92276673|NCT01822886|Romidepsin|romidepsin|mesh-list
92344494|NCT04666272|Trametinib|trametinib|mesh-list
92276674|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92276675|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
92276676|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276677|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276678|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92276679|NCT01822886|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92276680|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276681|NCT01823510|Aspirin|aspirin|mesh-list
92276682|NCT01823510|Clopidogrel|clopidogrel|mesh-list
92276683|NCT01823510|Ticagrelor|ticagrelor|mesh-list
92276684|NCT01823510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92276685|NCT01823510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92276686|NCT01823510|Analgesics|analgesics|mesh-ancestor
92276687|NCT01823510|Sensory System Agents|sensory system agents|mesh-ancestor
92276688|NCT01823510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276689|NCT01823510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276690|NCT01823510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276691|NCT01823510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92276692|NCT01823510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92276693|NCT01823510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92276694|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276695|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92276696|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92276697|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276698|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
92276699|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92276700|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92276701|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92276702|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
92276703|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276704|NCT05327582|Paclitaxel|paclitaxel|mesh-list
92276705|NCT05327582|Durvalumab|durvalumab|mesh-list
92276706|NCT05327582|Lenvatinib|lenvatinib|mesh-list
92276707|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92276708|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276709|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92276710|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92276711|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276712|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276713|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276714|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276715|NCT05327582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276716|NCT02271698|Dexamethasone|dexamethasone|mesh-list
92276717|NCT02271698|Dexamethasone acetate|dexamethasone acetate|mesh-list
92276718|NCT02271698|BB 1101|bb 1101|mesh-list
92276719|NCT02271698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92276720|NCT02271698|Antiemetics|antiemetics|mesh-ancestor
92276721|NCT02271698|Autonomic Agents|autonomic agents|mesh-ancestor
92276722|NCT02271698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276723|NCT02271698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276724|NCT02271698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276725|NCT02271698|Glucocorticoids|glucocorticoids|mesh-ancestor
92276726|NCT02271698|Hormones|hormones|mesh-ancestor
92276727|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276728|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92276729|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276730|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
92276731|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276732|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276733|NCT02328404|Vitamin D|vitamin d|mesh-list
92276734|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
92276735|NCT02328404|Vitamins|vitamins|mesh-ancestor
92276736|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
92276737|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276738|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92276739|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92276740|NCT05748236|Lamotrigine|lamotrigine|mesh-list
92276741|NCT05748236|Carbamazepine|carbamazepine|mesh-list
92276742|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
92276743|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92276744|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92276745|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276746|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92276747|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276748|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92276749|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276750|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276751|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276752|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92276753|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
92276754|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92276756|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
92276757|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276758|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92276759|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92276760|NCT01829516|Oxytocin|oxytocin|mesh-list
92276761|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
92276762|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92276763|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276764|NCT01830140|Bimatoprost|bimatoprost|mesh-list
92276765|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92276766|NCT01830842|Nicotine|nicotine|mesh-list
92276767|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92276768|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
92276769|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276770|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276771|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92276772|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92276773|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
92276775|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276776|NCT01831232|Cytarabine|cytarabine|mesh-list
92276777|NCT01831232|Idarubicin|idarubicin|mesh-list
92276778|NCT01831232|Pravastatin|pravastatin|mesh-list
92276779|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92276780|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
92276781|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276782|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276783|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
92276784|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276785|NCT01831232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92276786|NCT01831232|Immunologic Factors|immunologic factors|mesh-ancestor
92276787|NCT01831232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276788|NCT01831232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92276789|NCT01831232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92276790|NCT01831232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92276791|NCT01831232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276792|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92276793|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92276794|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92276795|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92276796|NCT01831934|Vaccines|vaccines|mesh-list
92276797|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
92276798|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276799|NCT01833026|Albuterol|albuterol|mesh-list
92276800|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92276801|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
92276802|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276803|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276804|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92276805|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
92276806|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
92276807|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92276808|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92276809|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92276810|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92276811|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
92276812|NCT01833026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276813|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276815|NCT03383523|Emodepside|emodepside|mesh-list
92276816|NCT03383523|Toltrazuril|toltrazuril|mesh-list
92276817|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
92276818|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92276819|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276820|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
92276821|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92276822|NCT00377091|PENTA|penta|mesh-list
92276823|NCT00377091|Fondaparinux|fondaparinux|mesh-list
92276824|NCT00377091|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92276825|NCT00377091|Antithrombins|antithrombins|mesh-ancestor
92276826|NCT00377091|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92276827|NCT00377091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92276828|NCT00377091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276829|NCT00377091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276830|NCT00377091|Anticoagulants|anticoagulants|mesh-ancestor
92276831|NCT00377091|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92276832|NCT00377091|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92276833|NCT01835912|Citric Acid|citric acid|mesh-list
92276834|NCT01835912|Sodium Citrate|sodium citrate|mesh-list
92276835|NCT01835912|Anticoagulants|anticoagulants|mesh-ancestor
92276836|NCT01835912|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92276837|NCT01835912|Chelating Agents|chelating agents|mesh-ancestor
92276838|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
92276839|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276840|NCT05747768|Midazolam|midazolam|mesh-list
92276841|NCT05747768|Dabigatran|dabigatran|mesh-list
92276842|NCT05747768|Atorvastatin|atorvastatin|mesh-list
92276843|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92276844|NCT05747768|Pitavastatin|pitavastatin|mesh-list
92276845|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92276846|NCT05747768|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92276847|NCT05747768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92276848|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276849|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92276850|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92276851|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92276852|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92276853|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
92276854|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
92276855|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
92276856|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
92276857|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276858|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276859|NCT05747768|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92276860|NCT05747768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92276861|NCT05747768|Antimetabolites|antimetabolites|mesh-ancestor
92276862|NCT05747768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92276863|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92276864|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276865|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
92276866|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92276867|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
92276868|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
92276869|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
92276870|NCT04410159|Listerine|listerine|mesh-list
92276871|NCT04410159|Povidone|povidone|mesh-list
92276872|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
92276873|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
92276874|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92276875|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276876|NCT03398421|Itraconazole|itraconazole|mesh-list
92276877|NCT03398421|Nemiralisib|nemiralisib|mesh-list
92276878|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
92276879|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276880|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92276881|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92276882|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276883|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276884|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92276885|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
92276886|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92276887|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276888|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92276889|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92276891|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92276892|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929752|NCT00071461|Bosentan|bosentan|mesh-list
92276893|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276894|NCT00559754|Bevacizumab|bevacizumab|mesh-list
92276895|NCT00559754|Docetaxel|docetaxel|mesh-list
92276896|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276898|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92276899|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92276900|NCT00559754|Growth Substances|growth substances|mesh-ancestor
92276901|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276902|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
92276903|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
92276904|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
92276905|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276906|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276907|NCT03402243|Menthol|menthol|mesh-list
92276908|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
92276909|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
92276910|NCT01841606|Ondansetron|ondansetron|mesh-list
92276911|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
92276912|NCT01841606|Autonomic Agents|autonomic agents|mesh-ancestor
92276913|NCT01841606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92276914|NCT01841606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276915|NCT01841606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276916|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
92276917|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
92276918|NCT01841606|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92276919|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92276920|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
92276921|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92276922|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276923|NCT04392141|Colchicine|colchicine|mesh-list
92276924|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
92276925|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92276926|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92276927|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92276928|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92276929|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276930|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276931|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
92276932|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
92276933|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
92276934|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276935|NCT00559364|Omeprazole|omeprazole|mesh-list
92276936|NCT00559364|Pancrelipase|pancrelipase|mesh-list
92276937|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92276938|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92276939|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92276940|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276941|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276942|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
92276943|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276944|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92276945|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
92276946|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
92276947|NCT05746676|Protective Agents|protective agents|mesh-ancestor
92276948|NCT05746598|Cisplatin|cisplatin|mesh-list
92276949|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276950|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
92276951|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92276952|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92276953|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276954|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
92276955|NCT05745974|Coagulants|coagulants|mesh-ancestor
92276956|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
92276957|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276958|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276959|NCT02306850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92276960|NCT02306850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276961|NCT02306694|Factor VIII|factor viii|mesh-list
92276962|NCT02306694|Coagulants|coagulants|mesh-ancestor
92276963|NCT01648140|Interferons|interferons|mesh-list
92276964|NCT01648140|Ribavirin|ribavirin|mesh-list
92276965|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
92276966|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
92276967|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92276968|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276969|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
92276970|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92276971|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
91929823|NCT02192723|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92276972|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276973|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
92276974|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276975|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
92276976|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
92276977|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92276978|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92276979|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92276980|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92276981|NCT02335242|Urological Agents|urological agents|mesh-ancestor
92276982|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
92276983|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92276984|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
92276985|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276986|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
92276987|NCT04883892|Protective Agents|protective agents|mesh-ancestor
92276988|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
92276989|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92276990|NCT02305758|Bevacizumab|bevacizumab|mesh-list
92276991|NCT02305758|Fluorouracil|fluorouracil|mesh-list
92276992|NCT02305758|Veliparib|veliparib|mesh-list
92276993|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92276994|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92276995|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92276996|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92276997|NCT02305758|Growth Substances|growth substances|mesh-ancestor
92276998|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92276999|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
92277000|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
92277001|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277002|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92277003|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277004|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
92277005|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92277006|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277007|NCT04392219|Molnupiravir|molnupiravir|mesh-list
92277008|NCT04392219|Antiviral Agents|antiviral agents|mesh-ancestor
92277009|NCT04392219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277010|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92277011|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
92277012|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277013|NCT03654417|Lidocaine|lidocaine|mesh-list
92277014|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277015|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
92277016|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277017|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277018|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
92277019|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277020|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92277021|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92277022|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92277023|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277024|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277025|NCT00376701|Bevacizumab|bevacizumab|mesh-list
92277026|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277027|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277028|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92277029|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92277030|NCT00376701|Growth Substances|growth substances|mesh-ancestor
92277031|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277032|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
92277033|NCT04358991|Ceftazidime|ceftazidime|mesh-list
92277034|NCT04358991|Avibactam|avibactam|mesh-list
92277035|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92277036|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92277037|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277038|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92277039|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277040|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277041|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92277042|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
92277043|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277044|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277045|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92277046|NCT02354976|Fenofibrate|fenofibrate|mesh-list
92277047|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92277048|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
92277049|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277050|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92277051|NCT02303262|Gemcitabine|gemcitabine|mesh-list
92277052|NCT02303262|Mocetinostat|mocetinostat|mesh-list
92277053|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92277054|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
92277055|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277056|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277057|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92277058|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277059|NCT04889664|Ketamine|ketamine|mesh-list
91935268|NCT05012865|Avelumab|avelumab|mesh-list
92277060|NCT04889664|Analgesics|analgesics|mesh-ancestor
92277061|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
92277062|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277063|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277064|NCT04889664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92277065|NCT04889664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92277066|NCT04889664|Anesthetics, General|anesthetics, general|mesh-ancestor
92277067|NCT04889664|Anesthetics|anesthetics|mesh-ancestor
92277068|NCT04889664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277069|NCT04889664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92277070|NCT04889664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92277071|NCT04889664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277072|NCT04889664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277073|NCT00558896|Dexamethasone|dexamethasone|mesh-list
92277074|NCT00558896|Pomalidomide|pomalidomide|mesh-list
92277075|NCT00558896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277076|NCT00558896|Antiemetics|antiemetics|mesh-ancestor
92277077|NCT00558896|Autonomic Agents|autonomic agents|mesh-ancestor
92277078|NCT00558896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277079|NCT00558896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277080|NCT00558896|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277081|NCT00558896|Glucocorticoids|glucocorticoids|mesh-ancestor
92277082|NCT00558896|Hormones|hormones|mesh-ancestor
92277083|NCT00558896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277084|NCT00558896|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277085|NCT00558896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277086|NCT00558896|Immunologic Factors|immunologic factors|mesh-ancestor
92277087|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92277088|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92277089|NCT00558896|Growth Substances|growth substances|mesh-ancestor
92277090|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
92277091|NCT01857362|Nitisinone|nitisinone|mesh-list
92277092|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277093|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277094|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
92277095|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92277097|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277098|NCT02265224|Expectorants|expectorants|mesh-ancestor
92277099|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277100|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92277101|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
92277102|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277103|NCT02265224|Protective Agents|protective agents|mesh-ancestor
92277104|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277105|NCT02265224|Antidotes|antidotes|mesh-ancestor
92277106|NCT01859078|Digoxin|digoxin|mesh-list
92277107|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92277108|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92277109|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277110|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277111|NCT01859078|Protective Agents|protective agents|mesh-ancestor
92277112|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277113|NCT00558428|Amlodipine|amlodipine|mesh-list
92277114|NCT00558428|Telmisartan|telmisartan|mesh-list
92277115|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92277116|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92277117|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92277118|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277119|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277120|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92277121|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277122|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
92277123|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92277124|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92277125|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92277126|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277127|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92277128|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277129|NCT04310085|Lumefantrine|lumefantrine|mesh-list
92277130|NCT04310085|Artemether|artemether|mesh-list
92277131|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92277132|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
92277133|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92277134|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92277135|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277136|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
92277137|NCT00558272|Saracatinib|saracatinib|mesh-list
92277138|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92277139|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277140|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277141|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277142|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277143|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
92277144|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92277145|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277146|NCT03407625|Misoprostol|misoprostol|mesh-list
92277147|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92277148|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
92277149|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92277150|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277151|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92277152|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277153|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
92277154|NCT03666663|Lidocaine|lidocaine|mesh-list
92277155|NCT03666663|Bupivacaine|bupivacaine|mesh-list
92277156|NCT03666663|Ropivacaine|ropivacaine|mesh-list
92277157|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277158|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
92344528|NCT04608487|Alkylating Agents|alkylating agents|mesh-ancestor
92277159|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277160|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277161|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
92277162|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277163|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92277164|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92277165|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92277166|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277167|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277168|NCT05692154|Fexofenadine|fexofenadine|mesh-list
92277169|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92277170|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92277171|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92277172|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
92277173|NCT05692154|Histamine Agents|histamine agents|mesh-ancestor
92277174|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277175|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277176|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277177|NCT01863134|Eptifibatide|eptifibatide|mesh-list
92277178|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92277179|NCT03415581|Oxycodone|oxycodone|mesh-list
92277180|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92277181|NCT03415581|Narcotics|narcotics|mesh-ancestor
92277182|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277183|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277184|NCT03415581|Analgesics|analgesics|mesh-ancestor
92277185|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
92277186|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277187|NCT00557492|Bevacizumab|bevacizumab|mesh-list
92277188|NCT00557492|Gemcitabine|gemcitabine|mesh-list
92277189|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277190|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277191|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92277192|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92277193|NCT00557492|Growth Substances|growth substances|mesh-ancestor
92277194|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277195|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
92277196|NCT00557492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92277197|NCT00557492|Antimetabolites|antimetabolites|mesh-ancestor
92277198|NCT00557492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277199|NCT01865708|Ethanol|ethanol|mesh-list
92277200|NCT01865708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92277201|NCT01865708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277202|NCT01865708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277203|NCT01865708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277205|NCT04203225|Epinephrine|epinephrine|mesh-list
92277206|NCT04203225|Tetracaine|tetracaine|mesh-list
92277207|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277208|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
92277209|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277210|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277211|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
92277212|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277213|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92277214|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92277215|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92277216|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277217|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277218|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92277219|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92277220|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
92277221|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277222|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92277223|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92277224|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
92277225|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92277226|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277227|NCT04203225|Mydriatics|mydriatics|mesh-ancestor
92277229|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92277230|NCT05314257|Granisetron|granisetron|mesh-list
92277231|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
92277232|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
92277233|NCT05314257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277234|NCT05314257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277235|NCT05314257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277236|NCT05314257|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92277237|NCT05314257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92277238|NCT05314257|Serotonin Agents|serotonin agents|mesh-ancestor
92277239|NCT05314257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277240|NCT05314257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277241|NCT02354586|Niraparib|niraparib|mesh-list
92277242|NCT02354586|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92277243|NCT02354586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277244|NCT02354586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277245|NCT02354586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277246|NCT01866410|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92277247|NCT01866410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277248|NCT01866410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277249|NCT01866410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277250|NCT01866410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277251|NCT00377325|Cyclosporine|cyclosporine|mesh-list
92277252|NCT00377325|Cyclosporins|cyclosporins|mesh-list
92277253|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277254|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277255|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277256|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
92277257|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277258|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
92277259|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277260|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277261|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277262|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92277263|NCT02332824|Candesartan|candesartan|mesh-list
92277264|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
92277265|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
92277266|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92277267|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92277268|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92277269|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277270|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277271|NCT03701061|Vaccines|vaccines|mesh-list
92277272|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
92277273|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277274|NCT03420014|Doxorubicin|doxorubicin|mesh-list
92277275|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92277276|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92277277|NCT03420014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277278|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92277279|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92277280|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277281|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277282|NCT03705273|Dexamethasone|dexamethasone|mesh-list
92277283|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
92277285|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277286|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
92277287|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
92277288|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277289|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277290|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277291|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
92277293|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277294|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277295|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277296|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
92277297|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277298|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277299|NCT04184271|Fluorides|fluorides|mesh-list
92277300|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
92277301|NCT04184271|Protective Agents|protective agents|mesh-ancestor
92277302|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277303|NCT03936387|Ropivacaine|ropivacaine|mesh-list
92277304|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277305|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
92277306|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277307|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277308|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
92277309|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277310|NCT04173429|Nadroparin|nadroparin|mesh-list
92277311|NCT04173429|Warfarin|warfarin|mesh-list
92277312|NCT04173429|Calcium|calcium|mesh-list
92277313|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92277314|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277315|NCT04173429|Anticoagulants|anticoagulants|mesh-ancestor
92277316|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92277317|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92277318|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277319|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
92277320|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277321|NCT04167189|Lidocaine|lidocaine|mesh-list
92277322|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277323|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
92277324|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277325|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277326|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
92277327|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277328|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92277329|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92277330|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92277331|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277332|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277333|NCT03929367|Oxytocin|oxytocin|mesh-list
92277334|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
92277335|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92277336|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277337|NCT04149405|Diphosphonates|diphosphonates|mesh-list
92277338|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92277339|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277340|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92277341|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277342|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277343|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935273|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277344|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277346|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92277347|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
92277348|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277349|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277350|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92277351|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92277352|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
92277353|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277354|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277355|NCT04350320|Colchicine|colchicine|mesh-list
92277356|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
92277357|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277358|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92277359|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92277360|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277361|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277362|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277363|NCT03920865|Risdiplam|risdiplam|mesh-list
92277364|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92277365|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277366|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277367|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92277368|NCT00556322|Docetaxel|docetaxel|mesh-list
92277369|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277370|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277371|NCT00556322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277372|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277373|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
92277374|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
92277375|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277376|NCT04137627|Melatonin|melatonin|mesh-list
92277377|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
92277378|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277379|NCT04137627|Protective Agents|protective agents|mesh-ancestor
92277380|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277381|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277382|NCT04136145|Belimumab|belimumab|mesh-list
92277383|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277384|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
92277385|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277386|NCT01869686|Denosumab|denosumab|mesh-list
92277387|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92277388|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277389|NCT03360890|Docetaxel|docetaxel|mesh-list
92277390|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
92277391|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277392|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942632|NCT04827953|Paclitaxel|paclitaxel|mesh-list
92277393|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92277394|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277395|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277396|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277397|NCT03360890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92277398|NCT03862755|Heparin|heparin|mesh-list
92277399|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92277400|NCT03862755|Tinzaparin|tinzaparin|mesh-list
92277401|NCT03862755|Dalteparin|dalteparin|mesh-list
92277402|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
92277403|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92277404|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92277405|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277406|NCT02332590|Adalimumab|adalimumab|mesh-list
92277407|NCT02332590|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92277408|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277409|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277410|NCT04076787|Sunitinib|sunitinib|mesh-list
92277411|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277412|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92277413|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92277414|NCT04076787|Growth Substances|growth substances|mesh-ancestor
92277415|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277416|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
92277417|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277418|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277419|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277421|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92277422|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92277423|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
92277424|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277425|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277426|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277427|NCT04069221|Cobicistat|cobicistat|mesh-list
92277428|NCT04069221|Artefenomel|artefenomel|mesh-list
92277429|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92277430|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92277431|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
92277432|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277433|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92277434|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92277435|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344558|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92277436|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277437|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
92277438|NCT04069221|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92277439|NCT04069221|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92277440|NCT03054038|Afatinib|afatinib|mesh-list
92277441|NCT03054038|Necitumumab|necitumumab|mesh-list
92277442|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277443|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277444|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277445|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277446|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277447|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92277448|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277449|NCT03958071|Pirfenidone|pirfenidone|mesh-list
92277450|NCT03958071|Nintedanib|nintedanib|mesh-list
92277451|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277452|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277453|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277454|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277455|NCT03958071|Analgesics|analgesics|mesh-ancestor
92277456|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
92277457|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277458|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277459|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92277460|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92277461|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277462|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277463|NCT04066647|Dexamethasone|dexamethasone|mesh-list
92277464|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277465|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
92277466|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
92277467|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277468|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277469|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277470|NCT04066647|Glucocorticoids|glucocorticoids|mesh-ancestor
92277471|NCT04066647|Hormones|hormones|mesh-ancestor
92277472|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277473|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277474|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277475|NCT04041453|Ivermectin|ivermectin|mesh-list
92277476|NCT04041453|Albendazole|albendazole|mesh-list
92277477|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92277478|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277479|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
92277480|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
92277481|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92277482|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92277483|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
92277484|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
92277485|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277486|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277487|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277488|NCT02354508|Pasireotide|pasireotide|mesh-list
92277489|NCT02354508|Hormones|hormones|mesh-ancestor
92277490|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277491|NCT02354508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277492|NCT00554216|Topiramate|topiramate|mesh-list
92277493|NCT00554216|Phentermine|phentermine|mesh-list
92277494|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
92277495|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92277496|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277497|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92277498|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
92277499|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92277500|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
92277501|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
92277502|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277503|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
92277504|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277505|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277507|NCT02353572|Bortezomib|bortezomib|mesh-list
92277509|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277510|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
92277511|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
92277512|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277513|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277514|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277515|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
92277516|NCT02353572|Hormones|hormones|mesh-ancestor
92277517|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277518|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277519|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277520|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92277521|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
92277522|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277523|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92277524|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277525|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
92277526|NCT03886701|Isoniazid|isoniazid|mesh-list
92277527|NCT03886701|Rifapentine|rifapentine|mesh-list
92277528|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
92277529|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92277530|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277531|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92277532|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92277533|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
92277534|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277535|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92277536|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92277537|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
92277538|NCT00552578|Buprenorphine|buprenorphine|mesh-list
92277539|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92277540|NCT00552578|Naloxone|naloxone|mesh-list
92277541|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92277542|NCT00552578|Narcotics|narcotics|mesh-ancestor
92277543|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277544|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277545|NCT00552578|Analgesics|analgesics|mesh-ancestor
92277546|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
92277547|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277548|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92277549|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
92277550|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92277551|NCT02301936|Ledipasvir|ledipasvir|mesh-list
92277552|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
92277553|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277554|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
92277555|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92277556|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
92277557|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277558|NCT03881163|Expectorants|expectorants|mesh-ancestor
92277559|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277560|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92277561|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
92277562|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277563|NCT03881163|Protective Agents|protective agents|mesh-ancestor
92277564|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277565|NCT03881163|Antidotes|antidotes|mesh-ancestor
92277566|NCT03848871|Betamethasone|betamethasone|mesh-list
92277567|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
92277568|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92277569|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
92277570|NCT03848871|Calcipotriene|calcipotriene|mesh-list
92277571|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92277572|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277573|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
92277574|NCT03848871|Hormones|hormones|mesh-ancestor
92277575|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277576|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277577|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92277578|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277579|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277580|NCT04032327|Bupivacaine|bupivacaine|mesh-list
92277581|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277582|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
92277583|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277585|NCT04032327|Sensory System Agents|sensory system agents|mesh-ancestor
92277586|NCT04032327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277588|NCT04041219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277589|NCT04041219|Immunologic Factors|immunologic factors|mesh-ancestor
92277590|NCT04041219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277591|NCT04041219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92277592|NCT04041219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277593|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277594|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
92277595|NCT00552344|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92277596|NCT00552344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277597|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277598|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
92277599|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277600|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277601|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92277602|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92277603|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277604|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92277605|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92277606|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
92277607|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277608|NCT03879603|Antacids|antacids|mesh-ancestor
92277609|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277610|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277611|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92277612|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92277613|NCT00553514|Hormones|hormones|mesh-ancestor
92277614|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277615|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277616|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92277617|NCT02813642|Mitogens|mitogens|mesh-list
92277618|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277619|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277620|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
92277621|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92277622|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92277623|NCT03852537|Prednisolone|prednisolone|mesh-list
92277624|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
92277625|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92277626|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
92277627|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277628|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
92277629|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
92277630|NCT03852537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277631|NCT03852537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277632|NCT03852537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277633|NCT03852537|Glucocorticoids|glucocorticoids|mesh-ancestor
92277635|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277636|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92277637|NCT03852537|Protective Agents|protective agents|mesh-ancestor
92277638|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277639|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277640|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
92277641|NCT03875859|Antifungal Agents|antifungal agents|mesh-ancestor
92277642|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277643|NCT00553202|Cyclosporine|cyclosporine|mesh-list
92277644|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
92277645|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92277646|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92277647|NCT00553202|Prednisolone|prednisolone|mesh-list
92277648|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
92277649|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
92277650|NCT00553202|Busulfan|busulfan|mesh-list
92277651|NCT00553202|Methotrexate|methotrexate|mesh-list
92277652|NCT00553202|Tacrolimus|tacrolimus|mesh-list
92277653|NCT00553202|Cyclosporins|cyclosporins|mesh-list
92277654|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
92277655|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92277656|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92277657|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
92277658|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277659|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
92277660|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277661|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277662|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92277663|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
92277664|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277665|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277666|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92277667|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92277668|NCT00553202|Abortifacient Agents|abortifacient agents|mesh-ancestor
92277669|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92277670|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92277671|NCT00553202|Antimetabolites|antimetabolites|mesh-ancestor
92277672|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277673|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277674|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92277675|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92277676|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92277677|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
92277678|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277679|NCT00553202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277680|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
92277681|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
92277682|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277683|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277684|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
92277685|NCT00553202|Hormones|hormones|mesh-ancestor
92277686|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277687|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92277688|NCT00553202|Protective Agents|protective agents|mesh-ancestor
92277689|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277690|NCT00552188|Atreleuton|atreleuton|mesh-list
92277691|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92277692|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277693|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277694|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92277695|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
92277696|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92277697|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92277698|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277699|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277700|NCT00377793|Urological Agents|urological agents|mesh-ancestor
92277701|NCT04027803|Eculizumab|eculizumab|mesh-list
92277702|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92277703|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277704|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
92277705|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277706|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
92277707|NCT00552110|Phenylephrine|phenylephrine|mesh-list
92277708|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
92277709|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277710|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277711|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92277712|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92277713|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92277714|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
92277715|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277716|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277717|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277718|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
92277719|NCT00552110|Autonomic Agents|autonomic agents|mesh-ancestor
92277720|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277721|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
92277723|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277724|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92277725|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
92277726|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92277727|NCT00552110|Protective Agents|protective agents|mesh-ancestor
92277728|NCT02301624|Eculizumab|eculizumab|mesh-list
92277729|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92277731|NCT02301624|Immunologic Factors|immunologic factors|mesh-ancestor
92277732|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277733|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92277734|NCT02007122|Cephalosporins|cephalosporins|mesh-list
92277735|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92277736|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277737|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
92277738|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
92277739|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92277740|NCT03250520|Protective Agents|protective agents|mesh-ancestor
92277741|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277742|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277743|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92277744|NCT03847389|Clobetasol|clobetasol|mesh-list
92277745|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277746|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
92277747|NCT03847389|Hormones|hormones|mesh-ancestor
92277748|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277749|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277750|NCT02351934|Celecoxib|celecoxib|mesh-list
92277751|NCT02351934|Furosemide|furosemide|mesh-list
92277752|NCT02351934|Gabapentin|gabapentin|mesh-list
92277753|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92277754|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92277755|NCT02351934|Analgesics|analgesics|mesh-ancestor
92277756|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
92277757|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277758|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277759|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277760|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277761|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92277762|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92277763|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277764|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277765|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
92277766|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92277767|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92277768|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277769|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92277770|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92277771|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92277772|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277773|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
92277774|NCT02351934|Diuretics|diuretics|mesh-ancestor
92277775|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
92277776|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92277777|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277778|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
92277779|NCT00377481|Hematinics|hematinics|mesh-ancestor
92277780|NCT00377559|Docetaxel|docetaxel|mesh-list
92277781|NCT00377559|Doxorubicin|doxorubicin|mesh-list
92277782|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92277783|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277784|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
92277785|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
92277786|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
92277787|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277788|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92277789|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92277790|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92277791|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277792|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
92277793|NCT03026348|Vaccines|vaccines|mesh-list
92277794|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
92277795|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277796|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92277797|NCT03026348|Antacids|antacids|mesh-ancestor
92277798|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277799|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277800|NCT04763408|Sorafenib|sorafenib|mesh-list
92277801|NCT04763408|Lenvatinib|lenvatinib|mesh-list
92277802|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277803|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277804|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277805|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277806|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
92277807|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92277808|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92277809|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277810|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
92277811|NCT03825939|Coagulants|coagulants|mesh-ancestor
92277812|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
92277813|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277814|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277815|NCT03988647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92277816|NCT03988647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277817|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
92277818|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92277819|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
92277820|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277821|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277822|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92277823|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277824|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92277825|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
92277826|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277827|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277828|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92277829|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
92277830|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
92277831|NCT00551642|Protective Agents|protective agents|mesh-ancestor
92277832|NCT02799212|Somatostatin|somatostatin|mesh-list
92277833|NCT02799212|Hormones|hormones|mesh-ancestor
92277834|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277835|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277836|NCT04690322|Factor VIII|factor viii|mesh-list
92277837|NCT04690322|BAX 855|bax 855|mesh-list
92277838|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92277839|NCT04690322|Coagulants|coagulants|mesh-ancestor
92277840|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
92277841|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277842|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
92277843|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
92277844|NCT02648282|Vaccines|vaccines|mesh-list
92277845|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
92277846|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277847|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92277848|NCT02648282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277849|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92277850|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
92277851|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277852|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277853|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92277854|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277855|NCT02648282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92277856|NCT04004481|Morphine|morphine|mesh-list
92277857|NCT04004481|Tramadol|tramadol|mesh-list
92277858|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92277859|NCT04004481|Narcotics|narcotics|mesh-ancestor
92277860|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277861|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277862|NCT04004481|Analgesics|analgesics|mesh-ancestor
92277863|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
92277864|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277865|NCT03997851|Acetaminophen|acetaminophen|mesh-list
92277866|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92277867|NCT03997851|Analgesics|analgesics|mesh-ancestor
92277868|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
92277869|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277870|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277871|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
92277872|NCT03989427|Listerine|listerine|mesh-list
92277873|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
92277875|NCT03989427|Protective Agents|protective agents|mesh-ancestor
92277876|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277877|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92277878|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92277879|NCT03007719|Fluorides|fluorides|mesh-list
92277880|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
92277881|NCT03007719|Protective Agents|protective agents|mesh-ancestor
92277882|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277883|NCT02985801|Pancrelipase|pancrelipase|mesh-list
92277884|NCT02985801|Pancreatin|pancreatin|mesh-list
92277885|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277886|NCT02988362|Amlodipine|amlodipine|mesh-list
92277887|NCT02988362|Candesartan|candesartan|mesh-list
92277888|NCT02988362|Candesartan cilexetil|candesartan cilexetil|mesh-list
92277889|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92277890|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92277891|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277892|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277893|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92277894|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277895|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
92277896|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92277897|NCT02988362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92277898|NCT02988440|Sorafenib|sorafenib|mesh-list
92277899|NCT02988440|Spartalizumab|spartalizumab|mesh-list
92277900|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277901|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277902|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277903|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277904|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92277905|NCT02988440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92277906|NCT05405192|Dostarlimab|dostarlimab|mesh-list
92277907|NCT05405192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277908|NCT00550550|Fluticasone|fluticasone|mesh-list
92277909|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
92277910|NCT00550550|Loratadine|loratadine|mesh-list
92277911|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92277912|NCT00550550|Prednisone|prednisone|mesh-list
92277913|NCT00550550|Albuterol|albuterol|mesh-list
92277914|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92277915|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
92277916|NCT00550550|Hormones|hormones|mesh-ancestor
92277917|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92277918|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277919|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92277920|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277921|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92277922|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
92277923|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277924|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92277925|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
92277926|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277927|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92277928|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
92277929|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92277930|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92277931|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92277932|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92277933|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92277934|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92277935|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277936|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
92277937|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92277938|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92277939|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
92277940|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
92277941|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92277942|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92277943|NCT00550550|Analgesics|analgesics|mesh-ancestor
92277944|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
92277945|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277946|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92277947|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277948|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277949|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277951|NCT02971839|Ivacaftor|ivacaftor|mesh-list
92277952|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92277953|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277954|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277955|NCT02974803|Trametinib|trametinib|mesh-list
92277956|NCT02974803|Dabrafenib|dabrafenib|mesh-list
92277957|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277958|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92277959|NCT02974803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277960|NCT02974803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277961|NCT02281136|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92277962|NCT02281136|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92277963|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
92277964|NCT00558038|Lactulose|lactulose|mesh-list
92277965|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92277966|NCT01507233|Morphine|morphine|mesh-list
92277967|NCT01507233|Bupivacaine|bupivacaine|mesh-list
92277968|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
92277969|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
92277970|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92277971|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277972|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
92277973|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92277974|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92277975|NCT01507233|Narcotics|narcotics|mesh-ancestor
92277976|NCT01507233|Analgesics|analgesics|mesh-ancestor
92277977|NCT02301390|Amiodarone|amiodarone|mesh-list
92277978|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92277979|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
92277980|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92277981|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92277982|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92277983|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92277984|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92277985|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92277986|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92277987|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92277988|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92277989|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92277990|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92277991|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92277992|NCT00378417|Vaccines|vaccines|mesh-list
92277993|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
92277994|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92277995|NCT01487499|Cisplatin|cisplatin|mesh-list
92277996|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92277997|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
92277998|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92277999|NCT01483209|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92278000|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92278001|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278002|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278003|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
92278004|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278005|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278006|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92278007|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278008|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92278009|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
92278010|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
92278011|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92278012|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92278013|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278014|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
92278015|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92278016|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92278017|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278018|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278019|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92278021|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92278022|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278023|NCT00378495|Miltefosine|miltefosine|mesh-list
92278024|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
92278025|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278026|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278027|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92278028|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92278029|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92278030|NCT02281526|Anticonvulsants|anticonvulsants|mesh-ancestor
92278031|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92278032|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92278033|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278034|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278035|NCT03802227|Oxycodone|oxycodone|mesh-list
92278036|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92278037|NCT03802227|Narcotics|narcotics|mesh-ancestor
92278038|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278039|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278040|NCT03802227|Analgesics|analgesics|mesh-ancestor
92278041|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
92278042|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278043|NCT02749617|Apixaban|apixaban|mesh-list
92278044|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92278045|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
92278046|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92278047|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
92278048|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278049|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278050|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
92278051|NCT02749227|Pasireotide|pasireotide|mesh-list
92278052|NCT02749227|Hormones|hormones|mesh-ancestor
92278053|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278054|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278055|NCT02746263|Acetaminophen|acetaminophen|mesh-list
92278056|NCT02746263|Morphine|morphine|mesh-list
92278057|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92278058|NCT02746263|Narcotics|narcotics|mesh-ancestor
92278059|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278060|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278061|NCT02746263|Analgesics|analgesics|mesh-ancestor
92278062|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
92278063|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278064|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92278065|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
92278066|NCT01394211|Anastrozole|anastrozole|mesh-list
92278067|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92278068|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278069|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92278070|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92278071|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278072|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278073|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92278074|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
92278075|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278076|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278077|NCT02717949|Ribavirin|ribavirin|mesh-list
92278078|NCT02717949|Sofosbuvir|sofosbuvir|mesh-list
92278079|NCT02717949|Ledipasvir|ledipasvir|mesh-list
92278080|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
92344595|NCT04484259|Clopidogrel|clopidogrel|mesh-list
92278081|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278082|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
92278083|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278086|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278087|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278088|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
92278089|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278090|NCT01880840|Azelastine|azelastine|mesh-list
92278091|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92278092|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
92278093|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278094|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278095|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92278096|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278097|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92278098|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278099|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278100|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92278101|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92278102|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92278103|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
92278104|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
92278105|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278106|NCT01377441|Ibuprofen|ibuprofen|mesh-list
92278107|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92278108|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92278109|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92278110|NCT01377441|Analgesics|analgesics|mesh-ancestor
92278111|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
92278112|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278113|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278114|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278115|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92278116|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278117|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278118|NCT01882868|Leucovorin|leucovorin|mesh-list
92278119|NCT01882868|Irinotecan|irinotecan|mesh-list
92278120|NCT01882868|Aflibercept|aflibercept|mesh-list
92278121|NCT01882868|Levoleucovorin|levoleucovorin|mesh-list
92278122|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92278123|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92278124|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278125|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278126|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278127|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92278128|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92278129|NCT01882868|Growth Substances|growth substances|mesh-ancestor
92278130|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278131|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
92278132|NCT01882868|Antidotes|antidotes|mesh-ancestor
92278133|NCT01882868|Protective Agents|protective agents|mesh-ancestor
92278134|NCT01882868|Vitamin B Complex|vitamin b complex|mesh-ancestor
92278135|NCT01882868|Vitamins|vitamins|mesh-ancestor
92278136|NCT01882868|Micronutrients|micronutrients|mesh-ancestor
92278137|NCT01383447|Imatinib Mesylate|imatinib mesylate|mesh-list
92278138|NCT01383447|Entinostat|entinostat|mesh-list
92278139|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92278140|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278141|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92278142|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278143|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278144|NCT02300298|Docetaxel|docetaxel|mesh-list
92278145|NCT02300298|Nintedanib|nintedanib|mesh-list
92278146|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278147|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
92278148|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
92278149|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
92278150|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278151|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92278152|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278153|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
92278154|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278155|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278156|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92278157|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92278158|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278159|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278160|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278161|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92278162|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92278163|NCT01379469|Carbamazepine|carbamazepine|mesh-list
92278164|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
92278165|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
92278166|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92278167|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278168|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278169|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278170|NCT01379469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92278171|NCT01379469|Analgesics|analgesics|mesh-ancestor
92278172|NCT01379469|Sensory System Agents|sensory system agents|mesh-ancestor
92278173|NCT01379469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278174|NCT01379469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92278175|NCT01379469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278176|NCT01379469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278177|NCT01379469|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92278178|NCT01379469|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92278179|NCT01309581|Ketamine|ketamine|mesh-list
92278180|NCT01309581|Methohexital|methohexital|mesh-list
92278181|NCT01309581|Analgesics|analgesics|mesh-ancestor
92278182|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
92278183|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278184|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278185|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92278186|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92278187|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
92278188|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
92278189|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278190|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92278191|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92278192|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278193|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278194|NCT05289050|Ketamine|ketamine|mesh-list
92278195|NCT05289050|Esketamine|esketamine|mesh-list
92278196|NCT05289050|Analgesics|analgesics|mesh-ancestor
92278197|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
92278198|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278199|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278200|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92278201|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92278202|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
92278203|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
92278204|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278205|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92278206|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92278207|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278208|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278209|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
92278210|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278211|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
92278212|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92278213|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278214|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92278215|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278216|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
92278217|NCT01292265|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92278218|NCT01292265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278219|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278220|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
92278221|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278222|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278223|NCT01885910|Doxycycline|doxycycline|mesh-list
92278224|NCT01885910|Dapsone|dapsone|mesh-list
92278225|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278226|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278227|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
92278228|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92278229|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92278230|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92278231|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278232|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278233|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
92278234|NCT02658357|Risperidone|risperidone|mesh-list
92278235|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92278236|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
92278237|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278238|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278239|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278240|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92278241|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92278242|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278243|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278244|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92278245|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
92278246|NCT02988908|Donepezil|donepezil|mesh-list
92278247|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92278248|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278249|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278250|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
92278251|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278252|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278253|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
92278254|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
92278255|NCT02326272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92278256|NCT02326272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278257|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278258|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
92278259|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278260|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278261|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
92278262|NCT02325414|Diphosphonates|diphosphonates|mesh-list
92278263|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92278264|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278265|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
92278266|NCT02349048|Simeprevir|simeprevir|mesh-list
92278267|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
92278268|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278269|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
92278270|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278271|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278272|NCT01280643|Leucovorin|leucovorin|mesh-list
92278273|NCT01280643|Bevacizumab|bevacizumab|mesh-list
92278274|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92278275|NCT01280643|Cetuximab|cetuximab|mesh-list
92278276|NCT01280643|Fluorouracil|fluorouracil|mesh-list
92278277|NCT01280643|Capecitabine|capecitabine|mesh-list
92278278|NCT01280643|Oxaliplatin|oxaliplatin|mesh-list
92278279|NCT01280643|Irinotecan|irinotecan|mesh-list
92278280|NCT01280643|Antibodies|antibodies|mesh-list
92278281|NCT01280643|Immunoglobulins|immunoglobulins|mesh-list
92278282|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92278283|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
92278284|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278285|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92278286|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92278287|NCT01280643|Growth Substances|growth substances|mesh-ancestor
92278288|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278289|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92278290|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
92278291|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
92278292|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278293|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278294|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278295|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92278296|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92278297|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278298|NCT01280643|Antidotes|antidotes|mesh-ancestor
92278299|NCT01280643|Protective Agents|protective agents|mesh-ancestor
92278300|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
92278301|NCT01280643|Vitamins|vitamins|mesh-ancestor
92278302|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
92278303|NCT01888952|Prednisone|prednisone|mesh-list
92278304|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278305|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
92278306|NCT01888952|Hormones|hormones|mesh-ancestor
92278307|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278308|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278309|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92278310|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278312|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
92278313|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
92278314|NCT02299206|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92278315|NCT02299206|Protective Agents|protective agents|mesh-ancestor
92278316|NCT02299206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278317|NCT02640573|Hydroxyurea|hydroxyurea|mesh-list
92278318|NCT02640573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278319|NCT02640573|Antisickling Agents|antisickling agents|mesh-ancestor
92278320|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931192|NCT05518734|Midazolam|midazolam|mesh-list
92278321|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278322|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92278323|NCT02298192|Liraglutide|liraglutide|mesh-list
92278324|NCT02298192|Xultophy|xultophy|mesh-list
92278325|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92278326|NCT02298192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278327|NCT02298192|Incretins|incretins|mesh-ancestor
92278328|NCT02298192|Hormones|hormones|mesh-ancestor
92278329|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278330|NCT01893632|Gabapentin|gabapentin|mesh-list
92278331|NCT01893632|Analgesics|analgesics|mesh-ancestor
92278332|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
92278333|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278334|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278335|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
92278336|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92278337|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92278338|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278339|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278340|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92278341|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92278342|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278343|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278344|NCT01893632|Antimanic Agents|antimanic agents|mesh-ancestor
92278345|NCT01272141|Everolimus|everolimus|mesh-list
92278346|NCT01272141|Lapatinib|lapatinib|mesh-list
92278347|NCT01272141|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92278348|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92278349|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278350|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278351|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278352|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
92278353|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278354|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278355|NCT01895036|Naltrexone|naltrexone|mesh-list
92278356|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92278357|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92278358|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278359|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
92278360|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278361|NCT03781479|Amifampridine|amifampridine|mesh-list
92278362|NCT03781479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92278363|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278364|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278365|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92278366|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278367|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278368|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92278370|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92278371|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278372|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278373|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278374|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278375|NCT01223001|Analgesics|analgesics|mesh-ancestor
92278376|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
92278377|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278378|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
92278379|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278380|NCT01223001|Dopamine Agents|dopamine agents|mesh-ancestor
92278381|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
92278382|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92278383|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278384|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92278385|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278386|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
92278387|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278388|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278389|NCT03964532|Avelumab|avelumab|mesh-list
92278390|NCT03964532|Talazoparib|talazoparib|mesh-list
92278391|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278392|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278393|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92278394|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278395|NCT03964532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278396|NCT01189071|Darifenacin|darifenacin|mesh-list
92278397|NCT01189071|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92278398|NCT01189071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92278399|NCT01189071|Cholinergic Agents|cholinergic agents|mesh-ancestor
92278400|NCT01189071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278401|NCT01189071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278402|NCT01189071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278403|NCT01189071|Urological Agents|urological agents|mesh-ancestor
92278404|NCT02515851|Bupivacaine|bupivacaine|mesh-list
92278405|NCT02515851|Anesthetics, Local|anesthetics, local|mesh-ancestor
92278406|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
92278407|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278408|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278409|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
92278410|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278411|NCT02492295|Propofol|propofol|mesh-list
92278412|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92278413|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278414|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278415|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92278416|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
92278417|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
92278418|NCT02468583|Triamcinolone|triamcinolone|mesh-list
92278419|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92278420|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92278421|NCT02468583|FX006|fx006|mesh-list
92278422|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92278423|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278424|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
92278425|NCT02468583|Hormones|hormones|mesh-ancestor
92278426|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278427|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278428|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278429|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
92278430|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278431|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278432|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92278433|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
92278434|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278435|NCT03763929|Protective Agents|protective agents|mesh-ancestor
92278436|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278437|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92278438|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278439|NCT01118013|Mycophenolic Acid|mycophenolic acid|mesh-list
92278441|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
92278442|NCT01118013|Fludarabine|fludarabine|mesh-list
92278443|NCT01118013|Busulfan|busulfan|mesh-list
92278444|NCT01118013|Tacrolimus|tacrolimus|mesh-list
92278445|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92278446|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92278447|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
92278448|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92278449|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278450|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278451|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
92278452|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278453|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278454|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
92278455|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278456|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92278457|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278458|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
92278459|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278460|NCT01118013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92278461|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92278462|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92278463|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92278464|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
92278465|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278466|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278467|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
92278468|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92278469|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92278471|NCT00378027|Fondaparinux|fondaparinux|mesh-list
92278472|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92278473|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
92278474|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92278475|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
92278476|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278477|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278479|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92278480|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92278481|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
92278482|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278483|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
92278484|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92278485|NCT02429583|Vaccines|vaccines|mesh-list
92278486|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
92278487|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278488|NCT02413047|Methotrexate|methotrexate|mesh-list
92278489|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
92278490|NCT02413047|Azathioprine|azathioprine|mesh-list
92278491|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92278492|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
92278493|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92278494|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278495|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278496|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
92278497|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278498|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278499|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
92278500|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278501|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92278502|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278503|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
92278504|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278505|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92278506|NCT02277548|Pregabalin|pregabalin|mesh-list
92278507|NCT02277548|Analgesics|analgesics|mesh-ancestor
92278509|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278510|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278511|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
92278512|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92278513|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278514|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278515|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92278516|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92278517|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92278518|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278519|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278520|NCT02411643|Calcipotriene|calcipotriene|mesh-list
92278521|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
92278522|NCT01085643|Lubiprostone|lubiprostone|mesh-list
92278523|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92278524|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92278525|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278526|NCT03028766|Adavosertib|adavosertib|mesh-list
92278527|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278528|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278529|NCT01071993|Atorvastatin|atorvastatin|mesh-list
92278530|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92278531|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92278532|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
92278533|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278534|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92278535|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92278536|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278537|NCT02379585|Paclitaxel|paclitaxel|mesh-list
92278538|NCT02379585|Docetaxel|docetaxel|mesh-list
92278539|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
92278540|NCT02379585|Doxorubicin|doxorubicin|mesh-list
92278541|NCT02379585|Trastuzumab|trastuzumab|mesh-list
92278542|NCT02379585|Pertuzumab|pertuzumab|mesh-list
92278543|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92278544|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278545|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92278546|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92278547|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92278548|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278549|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278550|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
92278551|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278552|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278553|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92278554|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
92278555|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92278556|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92278557|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92278558|NCT02379585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92278559|NCT02379585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278560|NCT02379585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278561|NCT03756818|Paclitaxel|paclitaxel|mesh-list
92278562|NCT03756818|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92278563|NCT03756818|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92278564|NCT03756818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92278565|NCT03756818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278566|NCT03756818|Tubulin Modulators|tubulin modulators|mesh-ancestor
92278567|NCT03756818|Antimitotic Agents|antimitotic agents|mesh-ancestor
92278568|NCT03756818|Mitosis Modulators|mitosis modulators|mesh-ancestor
92278569|NCT03756818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278570|NCT03756818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92278571|NCT03756818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278572|NCT01065051|Riociguat|riociguat|mesh-list
92278573|NCT01065051|Enzyme Activators|enzyme activators|mesh-ancestor
92278574|NCT01065051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278575|NCT01048125|Nitroprusside|nitroprusside|mesh-list
92278576|NCT01048125|Phenylephrine|phenylephrine|mesh-list
92278577|NCT01048125|Oxymetazoline|oxymetazoline|mesh-list
92278579|NCT01048125|Mydriatics|mydriatics|mesh-ancestor
92278580|NCT01048125|Autonomic Agents|autonomic agents|mesh-ancestor
92278581|NCT01048125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278582|NCT01048125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278583|NCT01048125|Sympathomimetics|sympathomimetics|mesh-ancestor
92278584|NCT01048125|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92278585|NCT01048125|Nasal Decongestants|nasal decongestants|mesh-ancestor
92278586|NCT01048125|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278587|NCT01048125|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92278588|NCT01048125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92278589|NCT01048125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92278590|NCT01048125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92278591|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278592|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278593|NCT01048125|Protective Agents|protective agents|mesh-ancestor
92278594|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92278595|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
92278596|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92278597|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
92278598|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92278599|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278600|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278601|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92278602|NCT01901588|Analgesics|analgesics|mesh-ancestor
92278603|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
92278604|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278605|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92278606|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92278607|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92278608|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
92278609|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278610|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278611|NCT03673124|Letrozole|letrozole|mesh-list
92278612|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278613|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92278614|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92278615|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278616|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278617|NCT03673124|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92278618|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92278619|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278620|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278621|NCT01025271|Daptomycin|daptomycin|mesh-list
92278622|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278623|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278624|NCT01902758|Ambrisentan|ambrisentan|mesh-list
92278625|NCT01902758|Theophylline|theophylline|mesh-list
92278626|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92278627|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
92278628|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278629|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278630|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92278631|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278632|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92278633|NCT01902758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278634|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278635|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92278636|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92278637|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92278638|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
92278639|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278640|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92278641|NCT01020903|Aprepitant|aprepitant|mesh-list
92278642|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
92278643|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
92278644|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278645|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278646|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92278647|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92278648|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278649|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278650|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
92278651|NCT02318901|Trastuzumab|trastuzumab|mesh-list
92278652|NCT02318901|Cetuximab|cetuximab|mesh-list
92278653|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92278654|NCT02318901|Maytansine|maytansine|mesh-list
92278655|NCT02318901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278656|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278657|NCT02318901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92278658|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278659|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92278660|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92278661|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92278662|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92278663|NCT02318901|Immunotoxins|immunotoxins|mesh-ancestor
92278664|NCT02318901|Immunoconjugates|immunoconjugates|mesh-ancestor
92278665|NCT02318901|Immunologic Factors|immunologic factors|mesh-ancestor
92278666|NCT02318901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278667|NCT01904864|Iron|iron|mesh-list
92278668|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
92278669|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278670|NCT01904864|Trace Elements|trace elements|mesh-ancestor
92278671|NCT01016847|Montelukast|montelukast|mesh-list
92278672|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92278673|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278674|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92278675|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
92278676|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278677|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278678|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92278679|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92278680|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278681|NCT00989937|Oxytocin|oxytocin|mesh-list
92278682|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
92278683|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92278684|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278685|NCT00982995|Palonosetron|palonosetron|mesh-list
92278686|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
92278687|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
91926713|NCT04681105|Antibodies|antibodies|mesh-list
92278688|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278689|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278690|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92278691|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92278692|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92278693|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
92278694|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278695|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278696|NCT00965055|Atorvastatin|atorvastatin|mesh-list
92278697|NCT00965055|Ezetimibe|ezetimibe|mesh-list
92278698|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92278699|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92278700|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
92278701|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278702|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92278703|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92278704|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278705|NCT02266797|Dexamethasone|dexamethasone|mesh-list
92278706|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278707|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
92278708|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
92278709|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278710|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278711|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92278712|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
92278713|NCT02266797|Hormones|hormones|mesh-ancestor
92278714|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278715|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92278716|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278717|NCT00378183|Risperidone|risperidone|mesh-list
92278718|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92278719|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
92278720|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344632|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92278721|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278722|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278723|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92278724|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92278725|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278726|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278727|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92278728|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
92278729|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92278730|NCT01906658|Hormones|hormones|mesh-ancestor
92278731|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278732|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278733|NCT01908062|Naltrexone|naltrexone|mesh-list
92278734|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92278735|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92278736|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278737|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
92278738|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278740|NCT00924807|Leuprolide|leuprolide|mesh-list
92278741|NCT00924807|Bicalutamide|bicalutamide|mesh-list
92278742|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278743|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92278744|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278745|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278746|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92278747|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
92278748|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92278749|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278750|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92278751|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
92278752|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
92278753|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278754|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
92278755|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92278756|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
92278757|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278758|NCT00896025|Expectorants|expectorants|mesh-ancestor
92278759|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278760|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92278761|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
92278762|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278763|NCT00896025|Protective Agents|protective agents|mesh-ancestor
92278764|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278765|NCT00896025|Antidotes|antidotes|mesh-ancestor
92278766|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
92278767|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
92278768|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92278769|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92278770|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278771|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278772|NCT02162979|Urological Agents|urological agents|mesh-ancestor
92278773|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
92278774|NCT03734601|Tacrolimus|tacrolimus|mesh-list
92278775|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92278776|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278777|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
92278778|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278779|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92278780|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278781|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278782|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92278783|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278784|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92278785|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
92278786|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278787|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278788|NCT01908842|Buprenorphine|buprenorphine|mesh-list
92278789|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92278790|NCT01908842|Narcotics|narcotics|mesh-ancestor
92278791|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278792|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278793|NCT01908842|Analgesics|analgesics|mesh-ancestor
92278794|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
92278795|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278796|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92278797|NCT00833859|Gemcitabine|gemcitabine|mesh-list
92278798|NCT00833859|Capecitabine|capecitabine|mesh-list
92278799|NCT00833859|Docetaxel|docetaxel|mesh-list
92278800|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278801|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
92278802|NCT00833859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278803|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278804|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
92278805|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
92278806|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
92278807|NCT00832299|Leucovorin|leucovorin|mesh-list
92278808|NCT00832299|Fluorouracil|fluorouracil|mesh-list
92278809|NCT00832299|Oxaliplatin|oxaliplatin|mesh-list
92278810|NCT00832299|Antimetabolites|antimetabolites|mesh-ancestor
92278811|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278812|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278813|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278814|NCT00832299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278815|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
92278816|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278817|NCT00832299|Antidotes|antidotes|mesh-ancestor
92278818|NCT00832299|Protective Agents|protective agents|mesh-ancestor
92278819|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
92278820|NCT00832299|Vitamins|vitamins|mesh-ancestor
92278821|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
92278822|NCT03723447|Dexamethasone|dexamethasone|mesh-list
92278823|NCT03723447|Epinephrine|epinephrine|mesh-list
92278824|NCT03723447|Bupivacaine|bupivacaine|mesh-list
92278825|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278826|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
92278827|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
92278828|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278829|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278830|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92278831|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
92278832|NCT03723447|Hormones|hormones|mesh-ancestor
92278833|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92278834|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92278835|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278836|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
92278837|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
92278838|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278839|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
92278840|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92278841|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92278842|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
92278843|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278844|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278845|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92278846|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91931708|NCT03019588|Paclitaxel|paclitaxel|mesh-list
92278847|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92278848|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278849|NCT03723447|Mydriatics|mydriatics|mesh-ancestor
92278850|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
92278851|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92278852|NCT00836355|Minocycline|minocycline|mesh-list
92278853|NCT00836355|Enoxaparin|enoxaparin|mesh-list
92278854|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
92278855|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92278856|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92278857|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278858|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92278859|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278860|NCT00816777|Irinotecan|irinotecan|mesh-list
92278861|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92278862|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92278863|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278864|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278865|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278867|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92278868|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
92278869|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278870|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278871|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92278872|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
92278873|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92278874|NCT00823095|Antioxidants|antioxidants|mesh-ancestor
92278875|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278876|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278877|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92278878|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
92278879|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
92278880|NCT00823095|Protective Agents|protective agents|mesh-ancestor
92278881|NCT00803283|Morphine|morphine|mesh-list
92278882|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92278883|NCT00803283|Narcotics|narcotics|mesh-ancestor
92278884|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278885|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278886|NCT00803283|Analgesics|analgesics|mesh-ancestor
92278887|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
92278888|NCT00803283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278889|NCT03701295|Azacitidine|azacitidine|mesh-list
92278890|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278891|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
92278892|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278893|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278894|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278895|NCT00799773|Rituximab|rituximab|mesh-list
92278896|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278897|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278898|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
92278899|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278900|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278901|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
92278902|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
92278903|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92278904|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92278905|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92278906|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278907|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278908|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278909|NCT00760461|Domperidone|domperidone|mesh-list
92278910|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
92278911|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
92278912|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278913|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278914|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92278915|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92278916|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
92278917|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92278918|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278919|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92278920|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278921|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92278922|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278923|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278924|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92278925|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92278926|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92278927|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
92278928|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92278929|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278930|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92278931|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92278932|NCT01941615|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92278933|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92344646|NCT04370301|Mechlorethamine|mechlorethamine|mesh-list
92278934|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92278935|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92278936|NCT01941615|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92278937|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92278939|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92278940|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92278942|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
92278943|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92278944|NCT01901679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278945|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92278946|NCT01901679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92278947|NCT01901679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92278948|NCT01901679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92278949|NCT01901679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278950|NCT01901679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278951|NCT00688935|Melatonin|melatonin|mesh-list
92278952|NCT00688935|Antioxidants|antioxidants|mesh-ancestor
92278953|NCT00688935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278954|NCT00688935|Protective Agents|protective agents|mesh-ancestor
92278955|NCT00688935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278956|NCT00688935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278958|NCT00684255|Busulfan|busulfan|mesh-list
92278959|NCT00684255|Alemtuzumab|alemtuzumab|mesh-list
92278960|NCT00684255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278961|NCT00684255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278962|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92278963|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
92278964|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278965|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
92278966|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92278967|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92278968|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278969|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92278970|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
92278971|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92278972|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92278973|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92278974|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92278975|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278976|NCT01856361|Ramipril|ramipril|mesh-list
92278977|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92278978|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
92278979|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278980|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278981|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92278982|NCT00642603|Bevacizumab|bevacizumab|mesh-list
92278983|NCT00642603|Capecitabine|capecitabine|mesh-list
92278984|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
92278985|NCT00642603|Irinotecan|irinotecan|mesh-list
92278986|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92278987|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92278988|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92278989|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92278990|NCT00642603|Growth Substances|growth substances|mesh-ancestor
92278991|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92278992|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92278993|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92278994|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
92278995|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92278996|NCT00642603|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92278997|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92278998|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92278999|NCT01841931|Buprenorphine|buprenorphine|mesh-list
92279000|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92279001|NCT01841931|Naloxone|naloxone|mesh-list
92279002|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279003|NCT01841931|Narcotics|narcotics|mesh-ancestor
92279004|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279005|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279006|NCT01841931|Analgesics|analgesics|mesh-ancestor
92344649|NCT04370301|Tacrolimus|tacrolimus|mesh-list
92279008|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279009|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279010|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
92279011|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
92279012|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279013|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
92279014|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279015|NCT04713891|Atezolizumab|atezolizumab|mesh-list
92279016|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92279017|NCT04713891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92279018|NCT04713891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279019|NCT04713891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279020|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279021|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
92279022|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279023|NCT00379509|Lapatinib|lapatinib|mesh-list
92279024|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279025|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92279026|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322586|NCT04092907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92279027|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279028|NCT04706247|Anesthetics|anesthetics|mesh-list
92279029|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279030|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279031|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
92279032|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
92279033|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92279034|NCT00597909|Antimetabolites|antimetabolites|mesh-ancestor
92279035|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279036|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279037|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
92279038|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279039|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
92279040|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92279041|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279042|NCT00588471|Simvastatin|simvastatin|mesh-list
92279043|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92279044|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92279045|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
92279046|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279047|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92279048|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92279049|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279050|NCT05600673|Bimatoprost|bimatoprost|mesh-list
92279051|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92279052|NCT01784991|Morphine|morphine|mesh-list
92279053|NCT01784991|Hydromorphone|hydromorphone|mesh-list
92279054|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279055|NCT01784991|Narcotics|narcotics|mesh-ancestor
92279056|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279057|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279058|NCT01784991|Analgesics|analgesics|mesh-ancestor
92279059|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
92279060|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279061|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92279062|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92279063|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279064|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92279065|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92279066|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279067|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279068|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
92279069|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931937|NCT01371630|Immunotoxins|immunotoxins|mesh-ancestor
92279071|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
92279072|NCT05600517|Protective Agents|protective agents|mesh-ancestor
92279073|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279074|NCT01745913|Fludarabine|fludarabine|mesh-list
92279075|NCT01745913|Melphalan|melphalan|mesh-list
92279076|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
92279077|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279078|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279079|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279080|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
92279081|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279082|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279083|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
92279084|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92279085|NCT05600127|Avelumab|avelumab|mesh-list
92279086|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279087|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279088|NCT01691079|Bromides|bromides|mesh-list
92279089|NCT01691079|Ipratropium|ipratropium|mesh-list
92279090|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
92279091|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92279092|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
92279093|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279094|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279095|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92279096|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
92279097|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92279098|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
92279099|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279100|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279102|NCT01673061|Epinephrine|epinephrine|mesh-list
92279103|NCT01673061|Norflurane|norflurane|mesh-list
92279104|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
92279105|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
92279106|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279107|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279108|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
92279109|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279110|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92279111|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92279112|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92279113|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279114|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279115|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92279116|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92279117|NCT01673061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92279118|NCT01673061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279119|NCT01673061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92279120|NCT01673061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92279121|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
92279122|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92279123|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
92279124|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
92279125|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
92279126|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92279127|NCT05599347|Azithromycin|azithromycin|mesh-list
92279128|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279129|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279130|NCT01621737|Oxytocin|oxytocin|mesh-list
92279131|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
92279132|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92279133|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279134|NCT00379665|Cisplatin|cisplatin|mesh-list
92279135|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279136|NCT00357383|Azithromycin|azithromycin|mesh-list
92279137|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279138|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279139|NCT01598025|Fludarabine|fludarabine|mesh-list
92279140|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
92279141|NCT01598025|Melphalan|melphalan|mesh-list
92279142|NCT01598025|Thiotepa|thiotepa|mesh-list
92279143|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92279144|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279145|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92279146|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
92344657|NCT04370301|Alkylating Agents|alkylating agents|mesh-ancestor
92279147|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279148|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279149|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
92279150|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279151|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279152|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
92279153|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92279154|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
92279155|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
92279156|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279157|NCT01587963|Protective Agents|protective agents|mesh-ancestor
92279158|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279159|NCT01587963|Vitamins|vitamins|mesh-ancestor
92279160|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
92279161|NCT01648751|Estrogens|estrogens|mesh-list
92279162|NCT01648751|Hormones|hormones|mesh-ancestor
92279163|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279164|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279165|NCT05550519|Tenofovir|tenofovir|mesh-list
92279166|NCT05550519|Entecavir|entecavir|mesh-list
92279167|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
92279169|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92279170|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92279171|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279172|NCT05550519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279173|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92279174|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92279175|NCT01203371|Naftopidil|naftopidil|mesh-list
92279176|NCT01203371|Tamsulosin|tamsulosin|mesh-list
92279177|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92279178|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92279179|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92279180|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92279181|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279182|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279183|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279184|NCT01203371|Urological Agents|urological agents|mesh-ancestor
92279185|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92279186|NCT01203371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92279187|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279188|NCT01203371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92279189|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92279190|NCT01549977|Febuxostat|febuxostat|mesh-list
92279191|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
92279192|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279193|NCT00357617|Celecoxib|celecoxib|mesh-list
92279194|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92279195|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279196|NCT00357617|Analgesics|analgesics|mesh-ancestor
92279197|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
92279198|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279199|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279200|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279201|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279202|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92279203|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92279204|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279205|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279206|NCT01548651|Saxagliptin|saxagliptin|mesh-list
92279207|NCT01548651|Incretins|incretins|mesh-ancestor
92279208|NCT01548651|Hormones|hormones|mesh-ancestor
92279209|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279210|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942712|NCT04594551|Vaccines|vaccines|mesh-list
92279211|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92279212|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
92279213|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279214|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279215|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92279216|NCT01533753|Gabapentin|gabapentin|mesh-list
92279217|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92279218|NCT01533753|Analgesics|analgesics|mesh-ancestor
92279219|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
92279220|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279221|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279222|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
92279223|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92279224|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92279225|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279226|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279227|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92279228|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92279229|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279230|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279231|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
92279232|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92279233|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92279234|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279235|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92279236|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
92279237|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
92279238|NCT05722301|Testosterone|testosterone|mesh-list
92279239|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
92279240|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
92279241|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92279242|NCT05722301|Androgens|androgens|mesh-ancestor
92279244|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279245|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279246|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92279247|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279248|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
92279249|NCT01534143|Sirolimus|sirolimus|mesh-list
92279250|NCT01534143|Fludarabine|fludarabine|mesh-list
92279251|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
92279252|NCT01534143|Bortezomib|bortezomib|mesh-list
92279253|NCT01534143|Busulfan|busulfan|mesh-list
92279254|NCT01534143|Tacrolimus|tacrolimus|mesh-list
92279255|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
92279256|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92279257|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
92279258|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279259|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92279260|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
92279261|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279262|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279263|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
92279264|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279265|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92279266|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279267|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279268|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279269|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92279270|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
92279271|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
92279272|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279273|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92279274|NCT05722067|Calcium|calcium|mesh-list
92279275|NCT05722067|Ionophores|ionophores|mesh-list
92279276|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
92279277|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92279278|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279279|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279280|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279281|NCT01692171|Heparin|heparin|mesh-list
92279282|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92279283|NCT01692171|Tinzaparin|tinzaparin|mesh-list
92279284|NCT01692171|Dalteparin|dalteparin|mesh-list
92279285|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
92279286|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92279287|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92279288|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279289|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92279290|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
92279291|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279293|NCT00570531|Bevacizumab|bevacizumab|mesh-list
91932161|NCT03532841|Tramadol|tramadol|mesh-list
92279294|NCT00570531|Fluorouracil|fluorouracil|mesh-list
92279295|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92279296|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279297|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
92279298|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
92279299|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
92279300|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279301|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279302|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92279303|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92279304|NCT00570531|Growth Substances|growth substances|mesh-ancestor
92279305|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279306|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
92279307|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
92279308|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92279309|NCT00570531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279310|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
92279311|NCT05258565|Plasminogen|plasminogen|mesh-list
92279312|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92279313|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92279314|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92279315|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279316|NCT05715437|Ketamine|ketamine|mesh-list
92279317|NCT05715437|Bupivacaine|bupivacaine|mesh-list
92279318|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
92279319|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
92279320|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279321|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279322|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
92279323|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279324|NCT05715437|Analgesics|analgesics|mesh-ancestor
92279325|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92279326|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92279327|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
92279328|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92279329|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92279330|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279331|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279332|NCT05721443|Cetuximab|cetuximab|mesh-list
92279333|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279334|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279335|NCT00523809|Bevacizumab|bevacizumab|mesh-list
92279336|NCT00523809|Fludarabine|fludarabine|mesh-list
92279337|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
92279338|NCT00523809|Melphalan|melphalan|mesh-list
92279339|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
92279340|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92279341|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279342|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279343|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92279344|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92279345|NCT00523809|Growth Substances|growth substances|mesh-ancestor
92279346|NCT00523809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279347|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
92279348|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92279349|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
92279350|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279351|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279352|NCT00523809|Immunologic Factors|immunologic factors|mesh-ancestor
92279353|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279354|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
92279355|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92279356|NCT00501345|Aspirin|aspirin|mesh-list
92279357|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92279358|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279359|NCT00501345|Analgesics|analgesics|mesh-ancestor
92279360|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
92279361|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279362|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279363|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279364|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279365|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92279366|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92279367|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279368|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92279369|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92279371|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
92279372|NCT00357773|Azithromycin|azithromycin|mesh-list
92279373|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279374|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279376|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92279377|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92279378|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
92279379|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279380|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92279381|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92279382|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279383|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
92279384|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92279385|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
92279386|NCT04972383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279387|NCT04972383|Viscosupplements|viscosupplements|mesh-ancestor
92279388|NCT04972383|Protective Agents|protective agents|mesh-ancestor
92279389|NCT00356187|Propranolol|propranolol|mesh-list
92279390|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92279391|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92279392|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
92279393|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279394|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279395|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279396|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92279397|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92279398|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
92279399|NCT02224729|Dexamethasone|dexamethasone|mesh-list
92279400|NCT02224729|Bortezomib|bortezomib|mesh-list
92279401|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92279402|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279403|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
92279404|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
92279405|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279406|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279407|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92279408|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
92279409|NCT02224729|Hormones|hormones|mesh-ancestor
92279410|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279411|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92279412|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279413|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279414|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
92279415|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279416|NCT00305643|Celecoxib|celecoxib|mesh-list
92279417|NCT00305643|Capecitabine|capecitabine|mesh-list
92279418|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92279419|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
92279420|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279421|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279422|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92279423|NCT00305643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279424|NCT00305643|Analgesics|analgesics|mesh-ancestor
92279425|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
92279426|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279427|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279428|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279429|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279430|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92279431|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92279432|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279433|NCT03004105|Durvalumab|durvalumab|mesh-list
92279434|NCT03004105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279435|NCT03004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279436|NCT00271011|Irinotecan|irinotecan|mesh-list
92279437|NCT00271011|Cetuximab|cetuximab|mesh-list
92279438|NCT00271011|Mitomycins|mitomycins|mesh-list
92279439|NCT00271011|Mitomycin|mitomycin|mesh-list
92279440|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92279441|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92279442|NCT00271011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279443|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279444|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279446|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92279447|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
92279448|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92279449|NCT03312530|Atezolizumab|atezolizumab|mesh-list
92279450|NCT03312530|Venetoclax|venetoclax|mesh-list
92279451|NCT03312530|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92279452|NCT03312530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279453|NCT03312530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279454|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279455|NCT05697965|Vancomycin|vancomycin|mesh-list
92279456|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279457|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279458|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
92279459|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92279460|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279461|NCT05720273|Calcitriol|calcitriol|mesh-list
92279462|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92279463|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279464|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92279465|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279466|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279467|NCT05720273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92279469|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
92279470|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92279471|NCT00183963|Tamoxifen|tamoxifen|mesh-list
92279472|NCT00183963|Fulvestrant|fulvestrant|mesh-list
92279473|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92279474|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
92279475|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279476|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279477|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92279478|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279479|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92279480|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92279481|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92279482|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92279483|NCT00176631|Docetaxel|docetaxel|mesh-list
92279484|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279485|NCT00176631|Tubulin Modulators|tubulin modulators|mesh-ancestor
92279486|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
92279487|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
92279488|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279489|NCT05719961|Insulin|insulin|mesh-list
92279490|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92279491|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
92279492|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
92279493|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92279494|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92279495|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279496|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
92279497|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
92279498|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279499|NCT04317807|Levetiracetam|levetiracetam|mesh-list
92279500|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
92279501|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
92279502|NCT00118053|Carboplatin|carboplatin|mesh-list
92279503|NCT00118053|Docetaxel|docetaxel|mesh-list
92279504|NCT00118053|Trastuzumab|trastuzumab|mesh-list
92279506|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
92279507|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
92279508|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
92279509|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279510|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92279511|NCT04225611|Dexamethasone|dexamethasone|mesh-list
92279512|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279513|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
92279514|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
92279515|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942720|NCT04544449|Ocrelizumab|ocrelizumab|mesh-list
92279516|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279517|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92279518|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
92279519|NCT04225611|Hormones|hormones|mesh-ancestor
92279520|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279521|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92279524|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
92279525|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279526|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
92279527|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92279528|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92279529|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92279530|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279531|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279532|NCT05669885|Urological Agents|urological agents|mesh-ancestor
92279533|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
92279534|NCT00955929|Alprostadil|alprostadil|mesh-list
92279535|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
92279536|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92279537|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92279538|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279539|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279540|NCT00955929|Urological Agents|urological agents|mesh-ancestor
92279541|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92279542|NCT00357851|Aprotinin|aprotinin|mesh-list
92279543|NCT00357851|Hemostatics|hemostatics|mesh-ancestor
92279544|NCT00357851|Coagulants|coagulants|mesh-ancestor
92279545|NCT00357851|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92279546|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92279547|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
92279548|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279549|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279550|NCT00358319|Valproic Acid|valproic acid|mesh-list
92279551|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
92279552|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279553|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279554|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
92279555|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279556|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279557|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
92279558|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92279559|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279560|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279561|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
92279562|NCT05663801|Ketamine|ketamine|mesh-list
92279563|NCT05663801|Bupivacaine|bupivacaine|mesh-list
92279564|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
92279565|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
92279566|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279567|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279568|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
92279569|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279570|NCT05663801|Analgesics|analgesics|mesh-ancestor
92279571|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92279572|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92279573|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
92344679|NCT04299113|Tubulin Modulators|tubulin modulators|mesh-ancestor
92279574|NCT05663801|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92279575|NCT05663801|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92279576|NCT05663801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279577|NCT05663801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279578|NCT05663801|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92279579|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
92279580|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92279581|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279582|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92279583|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
92279584|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92279585|NCT03866499|Gefitinib|gefitinib|mesh-list
92279586|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279587|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92279588|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279589|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279590|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92279591|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
92279592|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92279593|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
92279594|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279596|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92279597|NCT00000117|Antibodies|antibodies|mesh-list
92279598|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
92279599|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279600|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92279601|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
92279602|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92279603|NCT00000123|Protective Agents|protective agents|mesh-ancestor
92279604|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279605|NCT00380133|Prednisolone|prednisolone|mesh-list
92279606|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279607|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
92279608|NCT00380133|Hormones|hormones|mesh-ancestor
92279609|NCT00380133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279610|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279611|NCT00380133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92279612|NCT00380133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279614|NCT02959229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279615|NCT02953665|Liraglutide|liraglutide|mesh-list
92279616|NCT02953665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92279617|NCT02953665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279618|NCT02953665|Incretins|incretins|mesh-ancestor
92279619|NCT02953665|Hormones|hormones|mesh-ancestor
92279620|NCT02953665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279621|NCT00000189|Gepirone|gepirone|mesh-list
92279622|NCT00000189|Antidepressive Agents|antidepressive agents|mesh-ancestor
92279623|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279624|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92279625|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92279626|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279627|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279628|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92279629|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
92279630|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279631|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279632|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
92279633|NCT02681211|Promethazine|promethazine|mesh-list
92279634|NCT02681211|Ketorolac|ketorolac|mesh-list
92279635|NCT02681211|Metoclopramide|metoclopramide|mesh-list
92279636|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92279637|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279638|NCT02681211|Analgesics|analgesics|mesh-ancestor
92279639|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
92279640|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279641|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279642|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279643|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279644|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92279645|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279646|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279647|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92279648|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92279649|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279651|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
92279652|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
92279653|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
92279654|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92279655|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92279656|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
92279657|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
92279658|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279659|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92279660|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
92279661|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
92279662|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92279663|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92279664|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
92279665|NCT00000195|Naltrexone|naltrexone|mesh-list
92279666|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92279667|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279668|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279669|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
92279670|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279672|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
92279673|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279674|NCT00000201|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92279675|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92279676|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92279677|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279678|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279679|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92279680|NCT00000201|Protective Agents|protective agents|mesh-ancestor
92279681|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279682|NCT00000207|Buprenorphine|buprenorphine|mesh-list
92279683|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279684|NCT00000207|Narcotics|narcotics|mesh-ancestor
92279685|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279686|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279687|NCT00000207|Analgesics|analgesics|mesh-ancestor
92279688|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
92279689|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279690|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279691|NCT02295774|Methylene Blue|methylene blue|mesh-list
92279692|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279693|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279694|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
92279695|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
92279696|NCT01807611|Melphalan|melphalan|mesh-list
92279697|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
92279698|NCT01807611|Thiotepa|thiotepa|mesh-list
92279699|NCT01807611|Fludarabine|fludarabine|mesh-list
92279700|NCT01807611|Lenograstim|lenograstim|mesh-list
92279701|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279702|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
92279703|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279704|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279705|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279706|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
92279707|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279708|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279709|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92279710|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92279711|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92279712|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
92279713|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279714|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279715|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279716|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92279717|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92279718|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92279719|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
92344691|NCT04291001|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92279720|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92279721|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279722|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92279723|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92279724|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92279725|NCT02294682|Gepotidacin|gepotidacin|mesh-list
92279726|NCT02294682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92279727|NCT02294682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279728|NCT02294682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279729|NCT02294682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279730|NCT01692717|Losartan|losartan|mesh-list
92279731|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92279732|NCT01692717|Atorvastatin|atorvastatin|mesh-list
92279733|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92279734|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92279735|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
92279736|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279737|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92279738|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92279739|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279740|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92279741|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92279742|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91932627|NCT02366247|Antiviral Agents|antiviral agents|mesh-ancestor
92279743|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92279744|NCT01692717|Diuretics|diuretics|mesh-ancestor
92279745|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
92279746|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279747|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92279748|NCT01692717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279749|NCT00355277|Amitriptyline|amitriptyline|mesh-list
92279750|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92279751|NCT00355277|Antidepressive Agents|antidepressive agents|mesh-ancestor
92279752|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279753|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279754|NCT00355277|Analgesics|analgesics|mesh-ancestor
92279755|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
92279756|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279757|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279758|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92279759|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92279760|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279761|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279762|NCT00355277|Adrenergic Agents|adrenergic agents|mesh-ancestor
92279763|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279764|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92279765|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
92279766|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279768|NCT00000213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92279769|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92279770|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279771|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279772|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279773|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
92279774|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279775|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92279776|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
92279777|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279778|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92279779|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92279780|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279781|NCT00000219|Buprenorphine|buprenorphine|mesh-list
92279782|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279783|NCT00000219|Narcotics|narcotics|mesh-ancestor
92279784|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279785|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279786|NCT00000219|Analgesics|analgesics|mesh-ancestor
92279787|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
92279788|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279789|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279790|NCT00000225|Buprenorphine|buprenorphine|mesh-list
92279791|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279792|NCT00000225|Narcotics|narcotics|mesh-ancestor
92279793|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279794|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279795|NCT00000225|Analgesics|analgesics|mesh-ancestor
92279796|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
92279797|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279798|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279799|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
92279800|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92279801|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
92279802|NCT02294604|Povidone|povidone|mesh-list
92279803|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92279804|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279805|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
92279806|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92279807|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
92279808|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
92279809|NCT01645176|Hydroxychloroquine|hydroxychloroquine|mesh-list
92279810|NCT01645176|Atorvastatin|atorvastatin|mesh-list
92279811|NCT01645176|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92279812|NCT01645176|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92279813|NCT01645176|Antimetabolites|antimetabolites|mesh-ancestor
92279814|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279815|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92279816|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92279817|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279818|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
92279819|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92279820|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92279821|NCT01645176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279822|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279824|NCT03465735|Enoxaparin|enoxaparin|mesh-list
92279825|NCT03465735|Dalteparin|dalteparin|mesh-list
92279826|NCT03465735|Warfarin|warfarin|mesh-list
92279827|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
92279828|NCT03465735|Dabigatran|dabigatran|mesh-list
92279829|NCT03465735|Apixaban|apixaban|mesh-list
92279830|NCT03465735|Edoxaban|edoxaban|mesh-list
92279831|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
92279832|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92279833|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92279834|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279835|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92279836|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
92279837|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92279838|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
92279839|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279840|NCT05637671|Paroxetine|paroxetine|mesh-list
92279841|NCT05637671|Oxybutynin|oxybutynin|mesh-list
92279842|NCT05637671|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92279843|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92279844|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92279845|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279846|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279847|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
92279848|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279849|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92279850|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
92279851|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92279852|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92279853|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92279854|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279855|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
92279856|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
92279857|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279858|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92279859|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92279860|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
92279861|NCT05637671|Urological Agents|urological agents|mesh-ancestor
92279862|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92279863|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92279864|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92279865|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92279866|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279867|NCT02322216|Analgesics|analgesics|mesh-ancestor
92279868|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
92279869|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279870|NCT02322216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279871|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279872|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279873|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92279874|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92279875|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92279876|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
92279877|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
92279878|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279879|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279880|NCT03447639|Povidone-Iodine|povidone-iodine|mesh-list
92279881|NCT03447639|Povidone|povidone|mesh-list
92279882|NCT03447639|Plasma Substitutes|plasma substitutes|mesh-ancestor
92279883|NCT03447639|Blood Substitutes|blood substitutes|mesh-ancestor
92279884|NCT03447639|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92279885|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279886|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
92279887|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92279888|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92279889|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279890|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
92279891|NCT03425799|Coagulants|coagulants|mesh-ancestor
92279892|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
92279893|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92279894|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92279895|NCT03360903|Caffeine|caffeine|mesh-list
92279896|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92279897|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279898|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92279899|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279900|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279901|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92279902|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92279903|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
92279904|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92279905|NCT00000231|Buprenorphine|buprenorphine|mesh-list
92279906|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279907|NCT00000231|Narcotics|narcotics|mesh-ancestor
92279908|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279909|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279910|NCT00000231|Analgesics|analgesics|mesh-ancestor
92279911|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
92279912|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279913|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279914|NCT00000237|Buprenorphine|buprenorphine|mesh-list
92279915|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279916|NCT00000237|Narcotics|narcotics|mesh-ancestor
92279917|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279918|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279919|NCT00000237|Analgesics|analgesics|mesh-ancestor
92279920|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
92279921|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279922|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279923|NCT00000765|Zidovudine|zidovudine|mesh-list
92279924|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
92279925|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279926|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92279927|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92279928|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279929|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
92279930|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279931|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92279932|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92279933|NCT00000243|Buprenorphine|buprenorphine|mesh-list
92279934|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92279935|NCT00000243|Narcotics|narcotics|mesh-ancestor
92279936|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279937|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279938|NCT00000243|Analgesics|analgesics|mesh-ancestor
92279939|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
92279940|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279941|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92279942|NCT00000771|Paromomycin|paromomycin|mesh-list
92279943|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92279944|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92279945|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92279946|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92279947|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
92279948|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92279949|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92279950|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279951|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92279952|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92279953|NCT05575505|Protective Agents|protective agents|mesh-ancestor
92279954|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279955|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
92279956|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92279957|NCT05575505|Antioxidants|antioxidants|mesh-ancestor
92279958|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
92279959|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92279960|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
92279961|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
92279962|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279963|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279964|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279965|NCT00000249|Analgesics|analgesics|mesh-ancestor
92279966|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
91932852|NCT02373033|Hematinics|hematinics|mesh-ancestor
92279967|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279968|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
92279969|NCT00000261|Sevoflurane|sevoflurane|mesh-list
92279970|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92279971|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92279972|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
92279973|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
92279974|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92279975|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279976|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92279977|NCT00000261|Analgesics|analgesics|mesh-ancestor
92279978|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
92279979|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279980|NCT00000801|Cytarabine|cytarabine|mesh-list
92279981|NCT00000801|Dexamethasone|dexamethasone|mesh-list
92279982|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
92279983|NCT00000801|Doxorubicin|doxorubicin|mesh-list
92279984|NCT00000801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92279985|NCT00000801|Vincristine|vincristine|mesh-list
92279986|NCT00000801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92279987|NCT00000801|Immunologic Factors|immunologic factors|mesh-ancestor
92279988|NCT00000801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92279989|NCT00000801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92279990|NCT00000801|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92279991|NCT00000801|Alkylating Agents|alkylating agents|mesh-ancestor
92279992|NCT00000801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92279993|NCT00000801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92279994|NCT00000801|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92279995|NCT00000801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92279996|NCT00000801|Antiemetics|antiemetics|mesh-ancestor
92279997|NCT00000801|Autonomic Agents|autonomic agents|mesh-ancestor
92279998|NCT00000801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92279999|NCT00000801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92280000|NCT00000801|Glucocorticoids|glucocorticoids|mesh-ancestor
92280001|NCT00000801|Hormones|hormones|mesh-ancestor
92280002|NCT00000801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280003|NCT00000801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92280004|NCT00000801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92280005|NCT00000801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92280006|NCT00000801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280007|NCT00000801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280008|NCT00000801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92280009|NCT00000801|Antimetabolites|antimetabolites|mesh-ancestor
92280010|NCT00000801|Antiviral Agents|antiviral agents|mesh-ancestor
92280011|NCT00000801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280012|NCT00000801|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280013|NCT00000801|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280014|NCT00000801|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280015|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280016|NCT00000267|Risperidone|risperidone|mesh-list
92280017|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92280018|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
92280019|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280020|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280021|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280022|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92280023|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92280024|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92280025|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92280026|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92280027|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
92280028|NCT00000807|Etoposide|etoposide|mesh-list
92280029|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280030|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280031|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92280032|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280033|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280034|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280035|NCT00001677|Methotrexate|methotrexate|mesh-list
92280036|NCT00001677|Fludarabine|fludarabine|mesh-list
92280037|NCT00001677|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92280038|NCT00001677|Abortifacient Agents|abortifacient agents|mesh-ancestor
92280039|NCT00001677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92280040|NCT00001677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932925|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
92280041|NCT00001677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92280042|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
92280043|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280044|NCT00001677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280045|NCT00001677|Dermatologic Agents|dermatologic agents|mesh-ancestor
92280046|NCT00001677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280047|NCT00001677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92280048|NCT00001677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280049|NCT00001677|Immunologic Factors|immunologic factors|mesh-ancestor
92280050|NCT00001677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280051|NCT00001677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280052|NCT00001689|Vincristine|vincristine|mesh-list
92280053|NCT00001689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280054|NCT00001689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280055|NCT00001689|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280056|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280057|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280058|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280059|NCT00001713|Heparin|heparin|mesh-list
92280060|NCT00001713|Plasminogen|plasminogen|mesh-list
92280061|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92280062|NCT00001713|Warfarin|warfarin|mesh-list
92280063|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
92280064|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92280065|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92280066|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280067|NCT00000273|Fentanyl|fentanyl|mesh-list
92280068|NCT00000273|Morphine|morphine|mesh-list
92280069|NCT00000273|Oxycodone|oxycodone|mesh-list
92280070|NCT00000273|Buprenorphine|buprenorphine|mesh-list
92280071|NCT00000273|Methadone|methadone|mesh-list
92280072|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92280073|NCT00000273|Narcotics|narcotics|mesh-ancestor
92280074|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92280075|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280076|NCT00000273|Analgesics|analgesics|mesh-ancestor
92280077|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
92280078|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280079|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92280080|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92280081|NCT00000273|Anesthetics, General|anesthetics, general|mesh-ancestor
92280082|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
92280083|NCT00000273|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92280084|NCT00000273|Antitussive Agents|antitussive agents|mesh-ancestor
92280085|NCT00000273|Respiratory System Agents|respiratory system agents|mesh-ancestor
92280086|NCT00000819|Prednisone|prednisone|mesh-list
92280087|NCT00000819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280088|NCT00000819|Glucocorticoids|glucocorticoids|mesh-ancestor
92280089|NCT00000819|Hormones|hormones|mesh-ancestor
92280090|NCT00000819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280091|NCT00000819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280092|NCT00000819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92280093|NCT00000819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280094|NCT00000279|Clonidine|clonidine|mesh-list
92280095|NCT00000279|Analgesics|analgesics|mesh-ancestor
92280096|NCT00000279|Sensory System Agents|sensory system agents|mesh-ancestor
92280097|NCT00000279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280098|NCT00000279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280099|NCT00000279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92280100|NCT00000279|Sympatholytics|sympatholytics|mesh-ancestor
92280101|NCT00000279|Autonomic Agents|autonomic agents|mesh-ancestor
92280102|NCT00000279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92280103|NCT00000279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92280104|NCT00000279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92280105|NCT00000279|Adrenergic Agents|adrenergic agents|mesh-ancestor
92280106|NCT00000279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280107|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280108|NCT00000825|Aldesleukin|aldesleukin|mesh-list
92280109|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280110|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280111|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280112|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
92280113|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280114|NCT00000285|Phenytoin|phenytoin|mesh-list
92280115|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
92280116|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92280117|NCT00000285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92280118|NCT00000285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92280119|NCT00000285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280120|NCT00000285|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92280121|NCT00000285|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92280123|NCT00001737|Cyclosporins|cyclosporins|mesh-list
92280124|NCT00001737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280125|NCT00001737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280126|NCT00001737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280127|NCT00001737|Immunologic Factors|immunologic factors|mesh-ancestor
92280128|NCT00001737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280129|NCT00001737|Antifungal Agents|antifungal agents|mesh-ancestor
92280130|NCT00001737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280131|NCT00001737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92280132|NCT00001737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280133|NCT00001737|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92280134|NCT00000843|Adefovir|adefovir|mesh-list
92280136|NCT00000843|Antiviral Agents|antiviral agents|mesh-ancestor
92280137|NCT00000843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280138|NCT00000843|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280139|NCT00000843|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280140|NCT00000843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280141|NCT00000843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280143|NCT05362487|Tiotropium Bromide|tiotropium bromide|mesh-list
92280144|NCT05362487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92280145|NCT05362487|Autonomic Agents|autonomic agents|mesh-ancestor
92280146|NCT05362487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280147|NCT05362487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280148|NCT05362487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92280149|NCT05362487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92280150|NCT05362487|Parasympatholytics|parasympatholytics|mesh-ancestor
92280151|NCT05362487|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92280152|NCT05362487|Cholinergic Agents|cholinergic agents|mesh-ancestor
92280153|NCT05362487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280154|NCT05362487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280155|NCT05362487|Anticonvulsants|anticonvulsants|mesh-ancestor
92280156|NCT00000291|Labetalol|labetalol|mesh-list
92280157|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92280158|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92280159|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
92280160|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280161|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280162|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280163|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92280164|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
92280165|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
92280166|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280167|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92280168|NCT00000291|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92280169|NCT00000861|Indinavir|indinavir|mesh-list
92280170|NCT00000861|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92280171|NCT00000861|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92280172|NCT00000861|Protease Inhibitors|protease inhibitors|mesh-ancestor
92280173|NCT00000861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280174|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280175|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280176|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280177|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
92280178|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280179|NCT00000297|Labetalol|labetalol|mesh-list
92280180|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92280181|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92280182|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92280183|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280184|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280185|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280186|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92280187|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
92280188|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
92280189|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280190|NCT00000297|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92280191|NCT00000297|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92280192|NCT00359879|Exenatide|exenatide|mesh-list
92280193|NCT00359879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92280194|NCT00359879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280195|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92280196|NCT00359879|Incretins|incretins|mesh-ancestor
92280197|NCT00359879|Hormones|hormones|mesh-ancestor
92280198|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280199|NCT00000303|Baclofen|baclofen|mesh-list
92280200|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92280201|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280202|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92280203|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280204|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92280205|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
92280206|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
92280207|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280208|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280209|NCT00001785|Interferons|interferons|mesh-list
92280210|NCT00001785|Interferon-beta|interferon-beta|mesh-list
92280212|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280213|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
92280214|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280215|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
92280216|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280217|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280218|NCT00001827|Aldesleukin|aldesleukin|mesh-list
92280219|NCT00001827|Sargramostim|sargramostim|mesh-list
92280220|NCT00001827|Freund's Adjuvant|freund's adjuvant|mesh-list
92280221|NCT00001827|Immunologic Factors|immunologic factors|mesh-ancestor
92280222|NCT00001827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280223|NCT00001827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280224|NCT00001827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280225|NCT00001827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280226|NCT00001827|Antiviral Agents|antiviral agents|mesh-ancestor
92280227|NCT00001827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280228|NCT00001827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280229|NCT01647516|Ozanimod|ozanimod|mesh-list
92280230|NCT01647516|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92280231|NCT01647516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280232|NCT01647516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280233|NCT01647516|Immunologic Factors|immunologic factors|mesh-ancestor
92280234|NCT01647516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280235|NCT00001839|Cyclosporine|cyclosporine|mesh-list
92280236|NCT00001839|Cyclosporins|cyclosporins|mesh-list
92280237|NCT00001839|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92280238|NCT00001839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280239|NCT00001839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280240|NCT00001839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280241|NCT00001839|Immunologic Factors|immunologic factors|mesh-ancestor
92280242|NCT00001839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280243|NCT00001839|Antifungal Agents|antifungal agents|mesh-ancestor
92280244|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280245|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
92280246|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280247|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92280248|NCT00000885|Lamivudine|lamivudine|mesh-list
92280249|NCT00000885|Zidovudine|zidovudine|mesh-list
92280250|NCT00000885|Efavirenz|efavirenz|mesh-list
92280251|NCT00000885|Abacavir|abacavir|mesh-list
92280252|NCT00000885|Didanosine|didanosine|mesh-list
92280253|NCT00000885|Stavudine|stavudine|mesh-list
92280254|NCT00000885|Adefovir|adefovir|mesh-list
92280255|NCT00000885|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92280256|NCT00000885|Nelfinavir|nelfinavir|mesh-list
92280257|NCT00000885|Indinavir|indinavir|mesh-list
92280258|NCT00000885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280259|NCT00000885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280260|NCT00000885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280261|NCT00000885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280262|NCT00000885|Antiviral Agents|antiviral agents|mesh-ancestor
92280263|NCT00000885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280264|NCT00000885|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280265|NCT00000885|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280266|NCT00000885|Antimetabolites|antimetabolites|mesh-ancestor
92280267|NCT00000885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92280268|NCT00000885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92280269|NCT00000885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92280270|NCT00000885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92280271|NCT00000885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92280272|NCT00000885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92280273|NCT00000885|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92280274|NCT00000885|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92280275|NCT00000885|Protease Inhibitors|protease inhibitors|mesh-ancestor
92280276|NCT01647282|Minocycline|minocycline|mesh-list
92280277|NCT01647282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280278|NCT01647282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280279|NCT00000897|Zidovudine|zidovudine|mesh-list
92280280|NCT00000897|Antimetabolites|antimetabolites|mesh-ancestor
92280281|NCT00000897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280282|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322588|NCT00002162|Zidovudine|zidovudine|mesh-list
92280283|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280284|NCT00000897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280285|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
92280286|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280287|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280288|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280289|NCT05347979|Dabigatran|dabigatran|mesh-list
92280290|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
92280291|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92280292|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
92280293|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280294|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280295|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
92280296|NCT00000909|Aldesleukin|aldesleukin|mesh-list
92280297|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280298|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280299|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280300|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
92280301|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280302|NCT05444699|Prednisolone|prednisolone|mesh-list
92280303|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92280304|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
92280305|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92280306|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
92280307|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92280308|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
92280309|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280310|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
92280311|NCT05444699|Hormones|hormones|mesh-ancestor
92280312|NCT05444699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280313|NCT05444699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280314|NCT05444699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92280315|NCT05444699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280316|NCT05444699|Antiemetics|antiemetics|mesh-ancestor
92280317|NCT05444699|Autonomic Agents|autonomic agents|mesh-ancestor
92280318|NCT05444699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280319|NCT05444699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92280320|NCT05444699|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92280321|NCT05444699|Protective Agents|protective agents|mesh-ancestor
92280322|NCT00001863|Leflunomide|leflunomide|mesh-list
92280323|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280324|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280325|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280326|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
92280327|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280328|NCT05530655|Lisinopril|lisinopril|mesh-list
92280329|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92280330|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
92280331|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280332|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280333|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92280334|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92280335|NCT05530655|Protective Agents|protective agents|mesh-ancestor
92280336|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280337|NCT00000921|Prednisone|prednisone|mesh-list
92280338|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280339|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
92280340|NCT00000921|Hormones|hormones|mesh-ancestor
92280341|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280342|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280343|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92344741|NCT03992131|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92280344|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280345|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
92280346|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92280347|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92280348|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92280349|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92280350|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280351|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
92280352|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280353|NCT02321436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280354|NCT02321436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92280355|NCT02321436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280356|NCT05325515|Alendronate|alendronate|mesh-list
92280357|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92280358|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280360|NCT00000939|Didanosine|didanosine|mesh-list
92280361|NCT00000939|Stavudine|stavudine|mesh-list
92280362|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
92280363|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280364|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280365|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280366|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280367|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
92280368|NCT00000939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280369|NCT00000939|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92280370|NCT00000939|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92280371|NCT00000939|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92280372|NCT00000939|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92280373|NCT00000939|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92280374|NCT00000939|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92280375|NCT00000939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280376|NCT00000939|Antisickling Agents|antisickling agents|mesh-ancestor
92280377|NCT00000939|Antimetabolites|antimetabolites|mesh-ancestor
92280378|NCT00000939|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280379|NCT00000939|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280380|NCT00000945|Cidofovir|cidofovir|mesh-list
92280381|NCT00000945|Probenecid|probenecid|mesh-list
92280382|NCT00000945|Uricosuric Agents|uricosuric agents|mesh-ancestor
92280383|NCT00000945|Gout Suppressants|gout suppressants|mesh-ancestor
92280384|NCT00000945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280385|NCT00000945|Antiviral Agents|antiviral agents|mesh-ancestor
92280386|NCT00000945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280387|NCT00000945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280388|NCT00000945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280389|NCT04344041|Cholecalciferol|cholecalciferol|mesh-list
92280390|NCT04344041|Vitamin D|vitamin d|mesh-list
92280391|NCT04344041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92280392|NCT04344041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280393|NCT04344041|Vitamins|vitamins|mesh-ancestor
92280394|NCT04344041|Micronutrients|micronutrients|mesh-ancestor
92280395|NCT04344041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92280396|NCT00000963|Didanosine|didanosine|mesh-list
92280397|NCT00000963|Antimetabolites|antimetabolites|mesh-ancestor
92280398|NCT00000963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280399|NCT00000963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280400|NCT00000963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280401|NCT00000963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280402|NCT00000963|Antiviral Agents|antiviral agents|mesh-ancestor
92280403|NCT00000963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280404|NCT00000963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280405|NCT00000963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280406|NCT05322707|Budesonide|budesonide|mesh-list
92280407|NCT05322707|Formoterol Fumarate|formoterol fumarate|mesh-list
92280408|NCT05322707|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92280409|NCT05322707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280410|NCT05322707|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92280411|NCT05322707|Autonomic Agents|autonomic agents|mesh-ancestor
92280412|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280413|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280414|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92280415|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
92280416|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
92280417|NCT05322707|Hormones|hormones|mesh-ancestor
92280418|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280419|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92280420|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92280421|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92280422|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
92280423|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280424|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280425|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
91926714|NCT04681105|Immunoglobulins|immunoglobulins|mesh-list
92280426|NCT02319642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92280427|NCT02319642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280428|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280429|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
92280430|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280431|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280432|NCT00001893|Etanercept|etanercept|mesh-list
92280433|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92280434|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92280435|NCT00001893|Analgesics|analgesics|mesh-ancestor
92280436|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
92280437|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280438|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280439|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280440|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280441|NCT00001893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92280442|NCT00001893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280443|NCT00001893|Immunologic Factors|immunologic factors|mesh-ancestor
92280444|NCT00000981|Fiacitabine|fiacitabine|mesh-list
92280445|NCT00000981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280446|NCT00000981|Antiviral Agents|antiviral agents|mesh-ancestor
92280447|NCT00000981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280448|NCT02280096|4-Aminopyridine|4-aminopyridine|mesh-list
92280449|NCT02280096|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92280450|NCT02280096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92280451|NCT02280096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280452|NCT00001905|Interferons|interferons|mesh-list
92280453|NCT00001905|Interferon-gamma|interferon-gamma|mesh-list
92280454|NCT00001905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280455|NCT00001905|Antiviral Agents|antiviral agents|mesh-ancestor
92280456|NCT00001905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280457|NCT00000987|Zidovudine|zidovudine|mesh-list
92280458|NCT00000987|Doxorubicin|doxorubicin|mesh-list
92280459|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92280460|NCT00000987|Bleomycin|bleomycin|mesh-list
92280461|NCT00000987|Vincristine|vincristine|mesh-list
92280462|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92280463|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280464|NCT00000987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92280465|NCT00000987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280466|NCT00000987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280467|NCT00000987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280468|NCT00000987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280469|NCT00000987|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280470|NCT00000987|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280471|NCT00000987|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280472|NCT00000987|Antimetabolites|antimetabolites|mesh-ancestor
92280473|NCT00000987|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280474|NCT00000987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280475|NCT00000987|Antiviral Agents|antiviral agents|mesh-ancestor
92280476|NCT00000987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280477|NCT00000987|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280478|NCT00000987|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280479|NCT00001911|Interleukin-12|interleukin-12|mesh-list
92280480|NCT00001911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280481|NCT00001911|Immunologic Factors|immunologic factors|mesh-ancestor
92280482|NCT00001911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280483|NCT00001911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92280484|NCT00001911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92280485|NCT00001911|Growth Substances|growth substances|mesh-ancestor
92280486|NCT00001911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92280487|NCT00001911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280488|NCT00001929|Eliprodil|eliprodil|mesh-list
92280489|NCT00001929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92280490|NCT00001929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92280491|NCT00001929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280492|NCT00001929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280493|NCT00001929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280494|NCT00001929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92280495|NCT00001929|Protective Agents|protective agents|mesh-ancestor
92280496|NCT00358553|Insulin|insulin|mesh-list
92280497|NCT00358553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92280498|NCT00358553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280499|NCT00000993|Zidovudine|zidovudine|mesh-list
92280500|NCT00000993|Antimetabolites|antimetabolites|mesh-ancestor
92280501|NCT00000993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280502|NCT00000993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280503|NCT00000993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280504|NCT00000993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280505|NCT00000993|Antiviral Agents|antiviral agents|mesh-ancestor
92280506|NCT00000993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280507|NCT00000993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280508|NCT00000993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280509|NCT00359177|Casopitant|casopitant|mesh-list
92280510|NCT00359177|Antiemetics|antiemetics|mesh-ancestor
92280511|NCT00359177|Autonomic Agents|autonomic agents|mesh-ancestor
92280512|NCT00359177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280513|NCT00359177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280514|NCT00359177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92280515|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92280516|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280517|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280518|NCT00001017|Fluconazole|fluconazole|mesh-list
92280519|NCT00001017|Amphotericin B|amphotericin b|mesh-list
92280520|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92280521|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
92280522|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280523|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92280524|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92280525|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280526|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280527|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92280528|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
92280529|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280530|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280531|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92280532|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92280533|NCT00001017|Amebicides|amebicides|mesh-ancestor
92280534|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280535|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280536|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280538|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92280539|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280540|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92280541|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280542|NCT00001965|Cyclosporine|cyclosporine|mesh-list
92280543|NCT00001965|Cyclosporins|cyclosporins|mesh-list
92280544|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280545|NCT00001965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280546|NCT00001965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280547|NCT00001965|Immunologic Factors|immunologic factors|mesh-ancestor
92280548|NCT00001965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280549|NCT00001965|Antifungal Agents|antifungal agents|mesh-ancestor
92280550|NCT00001965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280551|NCT00001965|Dermatologic Agents|dermatologic agents|mesh-ancestor
92280552|NCT00001965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280553|NCT00001965|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92280554|NCT00001023|Azithromycin|azithromycin|mesh-list
92280555|NCT00001023|Clarithromycin|clarithromycin|mesh-list
92280556|NCT00001023|Rifabutin|rifabutin|mesh-list
92280557|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280558|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280559|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92280560|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280561|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280562|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92280563|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92280564|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92280565|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
92280566|NCT00001035|Interferons|interferons|mesh-list
92280567|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
92280568|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
92280569|NCT00001035|Zidovudine|zidovudine|mesh-list
92280570|NCT00001035|Didanosine|didanosine|mesh-list
92280571|NCT00001035|Zalcitabine|zalcitabine|mesh-list
92280572|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280574|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280575|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
92280576|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280577|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
91926715|NCT04681105|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92280578|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280579|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280580|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280581|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280582|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280583|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280584|NCT05503901|Timolol|timolol|mesh-list
92280585|NCT05503901|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92280586|NCT05503901|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92280587|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92280588|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92280589|NCT05503901|Adrenergic Agents|adrenergic agents|mesh-ancestor
92280590|NCT05503901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92280591|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280592|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280593|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92280594|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92280595|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92280596|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280597|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
92280598|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280599|NCT00001053|Antacids|antacids|mesh-ancestor
92280600|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280601|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92280602|NCT00001989|Zidovudine|zidovudine|mesh-list
92280603|NCT00001989|Trichosanthin|trichosanthin|mesh-list
92280604|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
92280605|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280606|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280607|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280608|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280609|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
92280610|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280611|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280612|NCT00001989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280613|NCT00001989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92280614|NCT00001989|Abortifacient Agents|abortifacient agents|mesh-ancestor
92280615|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92280616|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280617|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280618|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280619|NCT00001059|Doxorubicin|doxorubicin|mesh-list
92280620|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92280621|NCT00001059|Bleomycin|bleomycin|mesh-list
92280622|NCT00001059|Vincristine|vincristine|mesh-list
92280623|NCT00001059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92280624|NCT00001059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280625|NCT00001059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92280626|NCT00001059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280627|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280628|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280629|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280630|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280631|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280632|NCT00001059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280633|NCT00001065|Amphotericin B|amphotericin b|mesh-list
92280634|NCT00001065|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92280635|NCT00001065|Amebicides|amebicides|mesh-ancestor
92280636|NCT00001065|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280637|NCT00001065|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280638|NCT00001065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280639|NCT00001065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280640|NCT00001065|Antifungal Agents|antifungal agents|mesh-ancestor
92280641|NCT02977637|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92280642|NCT02977637|Hematinics|hematinics|mesh-ancestor
92280643|NCT02977637|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92280644|NCT02977637|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92280645|NCT00001995|Rifabutin|rifabutin|mesh-list
92280646|NCT00001995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91933516|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92280647|NCT00001995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280648|NCT00001995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92280649|NCT00001995|Antitubercular Agents|antitubercular agents|mesh-ancestor
92280650|NCT05501483|Pioglitazone|pioglitazone|mesh-list
92280651|NCT05501483|Empagliflozin|empagliflozin|mesh-list
92280652|NCT05501483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92280653|NCT05501483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280654|NCT05501483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92280655|NCT05501483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280657|NCT00002001|Didanosine|didanosine|mesh-list
92280658|NCT00002001|Zalcitabine|zalcitabine|mesh-list
92280659|NCT00002001|Antimetabolites|antimetabolites|mesh-ancestor
92280660|NCT00002001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280661|NCT00002001|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280662|NCT00002001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280663|NCT00002001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280664|NCT00002001|Antiviral Agents|antiviral agents|mesh-ancestor
92280665|NCT00002001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280666|NCT00002001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280667|NCT00002001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280668|NCT00002007|Zidovudine|zidovudine|mesh-list
92280669|NCT00002007|Sargramostim|sargramostim|mesh-list
92280670|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
92280671|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280672|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280673|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280674|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280675|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
92280676|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280677|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280678|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280679|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
92280680|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280681|NCT00001095|Lamivudine|lamivudine|mesh-list
92280682|NCT00001095|Zidovudine|zidovudine|mesh-list
92280683|NCT00001095|Nevirapine|nevirapine|mesh-list
92280684|NCT00001095|Stavudine|stavudine|mesh-list
92280685|NCT00001095|Indinavir|indinavir|mesh-list
92280686|NCT00001095|Amprenavir|amprenavir|mesh-list
92280687|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280688|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280689|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280690|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280691|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
92280692|NCT00001095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280693|NCT00001095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280694|NCT00001095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280695|NCT00001095|Antimetabolites|antimetabolites|mesh-ancestor
92280696|NCT00001095|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92280697|NCT00001095|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92280698|NCT00001095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92280699|NCT00001095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92280700|NCT00001095|Protease Inhibitors|protease inhibitors|mesh-ancestor
92280701|NCT00001095|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92280702|NCT00001095|Antitubercular Agents|antitubercular agents|mesh-ancestor
92280703|NCT00001095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280704|NCT02294058|Interferons|interferons|mesh-list
92280705|NCT02294058|Interferon-beta|interferon-beta|mesh-list
92280706|NCT02294058|Interferon beta-1a|interferon beta-1a|mesh-list
92280707|NCT02294058|Ozanimod|ozanimod|mesh-list
92280708|NCT02294058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280709|NCT02294058|Antiviral Agents|antiviral agents|mesh-ancestor
92280710|NCT02294058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280711|NCT02294058|Immunologic Factors|immunologic factors|mesh-ancestor
92280712|NCT02294058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280713|NCT02294058|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280714|NCT02294058|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92280715|NCT02294058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280716|NCT02294058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280717|NCT00002013|Zidovudine|zidovudine|mesh-list
92280718|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
92280719|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280720|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280721|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280722|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280723|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
92280724|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280725|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280726|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280727|NCT00359333|Gemcitabine|gemcitabine|mesh-list
92280728|NCT00359333|Docetaxel|docetaxel|mesh-list
92280729|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92280730|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
92280731|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280732|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280733|NCT00359333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280734|NCT00359333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280735|NCT00359333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280736|NCT00001101|Doxycycline|doxycycline|mesh-list
92280737|NCT00001101|Ceftriaxone|ceftriaxone|mesh-list
92280738|NCT00001101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280739|NCT00001101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280740|NCT00001101|Antimalarials|antimalarials|mesh-ancestor
92280741|NCT00001101|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280742|NCT00001101|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280743|NCT00001107|Fluconazole|fluconazole|mesh-list
92280744|NCT00001107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92280745|NCT00001107|Antifungal Agents|antifungal agents|mesh-ancestor
92280746|NCT00001107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280747|NCT00001107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92280748|NCT00001107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92280749|NCT00001107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280750|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926716|NCT04681105|BB 1101|bb 1101|mesh-list
91926717|NCT04681105|Immunologic Factors|immunologic factors|mesh-ancestor
91926718|NCT04681105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926719|NCT04681105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926720|NCT04681105|Antiemetics|antiemetics|mesh-ancestor
91926721|NCT04681105|Autonomic Agents|autonomic agents|mesh-ancestor
91926722|NCT04681105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926723|NCT04681105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926724|NCT04681105|Glucocorticoids|glucocorticoids|mesh-ancestor
91926725|NCT04681105|Hormones|hormones|mesh-ancestor
91926726|NCT04681105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926727|NCT04681105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926728|NCT04681105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926729|NCT04681105|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926730|NCT04681105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926731|NCT04681105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926732|NCT04681105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926733|NCT04681105|Analgesics|analgesics|mesh-ancestor
92280751|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92280752|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
92280753|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280754|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280755|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92280756|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92280757|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280758|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280759|NCT00002019|Amphotericin B|amphotericin b|mesh-list
92280760|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91942786|NCT04414475|Growth Inhibitors|growth inhibitors|mesh-ancestor
92280761|NCT00002019|Amebicides|amebicides|mesh-ancestor
92280762|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280763|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280764|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280765|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280766|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
92280767|NCT00002025|Ganciclovir|ganciclovir|mesh-list
92280768|NCT00002025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92280769|NCT00002025|Antiviral Agents|antiviral agents|mesh-ancestor
92280770|NCT00002025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280771|NCT00002025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280772|NCT00002025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280773|NCT00002025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280774|NCT00001131|Aldesleukin|aldesleukin|mesh-list
91926886|NCT02163161|Abrocitinib|abrocitinib|mesh-list
91926887|NCT02163161|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91926888|NCT02163161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926889|NCT02163161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926890|NCT00917293|Pyridoxal|pyridoxal|mesh-list
91926891|NCT00917293|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
91926892|NCT00917293|Vitamin B Complex|vitamin b complex|mesh-ancestor
91926894|NCT00917293|Micronutrients|micronutrients|mesh-ancestor
91926895|NCT00917293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926896|NCT00845299|Benzalkonium Compounds|benzalkonium compounds|mesh-list
91926897|NCT00845299|Latanoprost|latanoprost|mesh-list
91926898|NCT00845299|Lubricant Eye Drops|lubricant eye drops|mesh-list
91926899|NCT00845299|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91926900|NCT00845299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91926901|NCT00845299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91926902|NCT00845299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926903|NCT02255591|Lidocaine|lidocaine|mesh-list
91926904|NCT02255591|Epinephrine|epinephrine|mesh-list
91926905|NCT02255591|Racepinephrine|racepinephrine|mesh-list
92280775|NCT00001131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280776|NCT00001131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280777|NCT00001131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280778|NCT00001131|Antiviral Agents|antiviral agents|mesh-ancestor
92280779|NCT00001131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280780|NCT00001155|Cyclophosphamide|cyclophosphamide|mesh-list
92280781|NCT00001155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280782|NCT00001155|Immunologic Factors|immunologic factors|mesh-ancestor
92280783|NCT00001155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280784|NCT00001155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280785|NCT00001155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92280786|NCT00001155|Alkylating Agents|alkylating agents|mesh-ancestor
92280787|NCT00001155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280788|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926906|NCT02255591|Epinephryl borate|epinephryl borate|mesh-list
91926907|NCT02255591|Anesthetics, Local|anesthetics, local|mesh-ancestor
91926908|NCT02255591|Anesthetics|anesthetics|mesh-ancestor
91926909|NCT02255591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926910|NCT02255591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926911|NCT02255591|Sensory System Agents|sensory system agents|mesh-ancestor
91926912|NCT02255591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926913|NCT02255591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91926914|NCT02255591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91926915|NCT02255591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92280789|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92280791|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
92280792|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280793|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
92280794|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280795|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
92280796|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280797|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
91933671|NCT03133195|Vitamin D|vitamin d|mesh-list
92280798|NCT00001197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280799|NCT00001197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280800|NCT00001197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280801|NCT05270057|Prednisone|prednisone|mesh-list
92280802|NCT05270057|Cyclophosphamide|cyclophosphamide|mesh-list
92280803|NCT05270057|Rituximab|rituximab|mesh-list
92280804|NCT05270057|Doxorubicin|doxorubicin|mesh-list
92280805|NCT05270057|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92280806|NCT05270057|Etoposide|etoposide|mesh-list
92280807|NCT05270057|Vincristine|vincristine|mesh-list
92280808|NCT05270057|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92280809|NCT05270057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280810|NCT05270057|Immunologic Factors|immunologic factors|mesh-ancestor
92280811|NCT05270057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280812|NCT05270057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280813|NCT05270057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92280814|NCT05270057|Alkylating Agents|alkylating agents|mesh-ancestor
92280815|NCT05270057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280816|NCT05270057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280817|NCT05270057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92280818|NCT05270057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92280819|NCT05270057|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92280820|NCT05270057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92280821|NCT05270057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280822|NCT05270057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280823|NCT05270057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280825|NCT05270057|Hormones|hormones|mesh-ancestor
91942819|NCT04357366|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91942821|NCT04335461|Anesthetics|anesthetics|mesh-list
91926992|NCT00769795|Bicalutamide|bicalutamide|mesh-list
91926993|NCT00769795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926994|NCT00769795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926995|NCT00769795|Androgen Antagonists|androgen antagonists|mesh-ancestor
91926996|NCT00769795|Hormone Antagonists|hormone antagonists|mesh-ancestor
91926997|NCT00769795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926998|NCT00769795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926999|NCT03134677|Bupivacaine|bupivacaine|mesh-list
91927000|NCT03134677|Sevoflurane|sevoflurane|mesh-list
91927001|NCT03134677|Anesthetics, Local|anesthetics, local|mesh-ancestor
91927002|NCT03134677|Anesthetics|anesthetics|mesh-ancestor
91927003|NCT03134677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927004|NCT03134677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927005|NCT03134677|Sensory System Agents|sensory system agents|mesh-ancestor
91927006|NCT03134677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927007|NCT03134677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92117787|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92117788|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117789|NCT02353780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92117790|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117791|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
92117792|NCT03176472|Ricolinostat|ricolinostat|mesh-list
92117793|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117794|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92117795|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117796|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117797|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92117798|NCT03246360|Cloxacillin|cloxacillin|mesh-list
92117799|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942827|NCT04332211|Pseudoephedrine|pseudoephedrine|mesh-list
92348211|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348212|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348213|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92348214|NCT01565148|Ranibizumab|ranibizumab|mesh-list
92348215|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348216|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92348217|NCT01565148|Growth Substances|growth substances|mesh-ancestor
91945284|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92348218|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348219|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
92348220|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348221|NCT04410354|Remdesivir|remdesivir|mesh-list
92348222|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
92348223|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348224|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
92348225|NCT04410354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348226|NCT01564758|Linezolid|linezolid|mesh-list
92348227|NCT01564758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92348228|NCT01564758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348229|NCT01564758|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92280826|NCT05270057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92280827|NCT05270057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92280828|NCT05270057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280829|NCT05270057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280830|NCT05270057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280831|NCT05270057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280832|NCT00002043|Dapsone|dapsone|mesh-list
92280833|NCT00002043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280834|NCT00002043|Antimalarials|antimalarials|mesh-ancestor
92280835|NCT00002043|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280836|NCT00002043|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280837|NCT00002043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92280838|NCT00002043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280839|NCT00002043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280840|NCT00002043|Leprostatic Agents|leprostatic agents|mesh-ancestor
92280841|NCT00002043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280842|NCT00001209|Cyclophosphamide|cyclophosphamide|mesh-list
92280843|NCT00001209|Ifosfamide|ifosfamide|mesh-list
92280844|NCT00001209|Vincristine|vincristine|mesh-list
92280845|NCT00001209|Doxorubicin|doxorubicin|mesh-list
92280846|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92280847|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92280848|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
92280849|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280850|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348230|NCT01564758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348231|NCT01564758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348232|NCT01589094|Gemcitabine|gemcitabine|mesh-list
92348233|NCT01589094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348234|NCT01589094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92348235|NCT01589094|Antimetabolites|antimetabolites|mesh-ancestor
92348236|NCT01589094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348237|NCT01563354|Everolimus|everolimus|mesh-list
92280851|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92280852|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
92280853|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280854|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280855|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92280856|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280857|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280858|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92280859|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92280860|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92280861|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92280862|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280863|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280865|NCT00002049|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280866|NCT00002049|Immunologic Factors|immunologic factors|mesh-ancestor
92280867|NCT00002049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280868|NCT05044637|Primaquine|primaquine|mesh-list
92280869|NCT05044637|Antimalarials|antimalarials|mesh-ancestor
92280870|NCT05044637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280871|NCT05044637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280872|NCT05044637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280873|NCT05043077|Phenylephrine|phenylephrine|mesh-list
92280874|NCT05043077|Oxymetazoline|oxymetazoline|mesh-list
92280875|NCT05043077|Tropicamide|tropicamide|mesh-list
92280876|NCT05043077|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92280877|NCT05043077|Mydriatics|mydriatics|mesh-ancestor
92280878|NCT05043077|Autonomic Agents|autonomic agents|mesh-ancestor
92280879|NCT05043077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280880|NCT05043077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280881|NCT05043077|Sympathomimetics|sympathomimetics|mesh-ancestor
92280882|NCT05043077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92280883|NCT05043077|Nasal Decongestants|nasal decongestants|mesh-ancestor
92280884|NCT05043077|Respiratory System Agents|respiratory system agents|mesh-ancestor
92280885|NCT05043077|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92280886|NCT05043077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92280887|NCT05043077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92280888|NCT05043077|Adrenergic Agents|adrenergic agents|mesh-ancestor
92280889|NCT05043077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348239|NCT01563354|Somatostatin|somatostatin|mesh-list
92280890|NCT05043077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280891|NCT05043077|Protective Agents|protective agents|mesh-ancestor
92280892|NCT05043077|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92280893|NCT05043077|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92280894|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
92280895|NCT00002055|Pentamidine|pentamidine|mesh-list
92280896|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
92280897|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280898|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92280899|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92280900|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92280901|NCT05031455|Aspirin|aspirin|mesh-list
92280902|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92280903|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92280904|NCT05031455|Analgesics|analgesics|mesh-ancestor
92280905|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
92280906|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92280907|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348240|NCT01563354|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92348241|NCT01563354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92348242|NCT01563354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348243|NCT01563354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348244|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348245|NCT01563354|Immunologic Factors|immunologic factors|mesh-ancestor
92348246|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280908|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92280909|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280910|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92280911|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92280912|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280913|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92280914|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92280915|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280916|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
92280917|NCT05029973|Bevacizumab|bevacizumab|mesh-list
92280918|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92280919|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280920|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92280921|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92280922|NCT05029973|Growth Substances|growth substances|mesh-ancestor
92280923|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280924|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
92280925|NCT00002061|Inosine Pranobex|inosine pranobex|mesh-list
92280926|NCT00002061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92280928|NCT00002061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280929|NCT00002061|Antiviral Agents|antiviral agents|mesh-ancestor
91942862|NCT04256421|Etoposide|etoposide|mesh-list
92280930|NCT00002061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280931|NCT00002067|Megestrol|megestrol|mesh-list
92280932|NCT00002067|Megestrol Acetate|megestrol acetate|mesh-list
92280933|NCT00002067|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92280934|NCT00002067|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92280935|NCT00002067|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92280936|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
92280937|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92280938|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280939|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92280940|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92280941|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92280942|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280943|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
92280944|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92280945|NCT05442983|Probenecid|probenecid|mesh-list
92280946|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
92280947|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
92280948|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92280949|NCT00380835|Amrubicin|amrubicin|mesh-list
92280950|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942868|NCT04256421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280951|NCT00001311|Heparin|heparin|mesh-list
92280952|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
92280953|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92280954|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92280955|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280956|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
92280957|NCT05016713|Fluorides|fluorides|mesh-list
92280958|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
92280959|NCT05016713|Protective Agents|protective agents|mesh-ancestor
92280960|NCT05016713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280961|NCT05016713|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92280962|NCT05016713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280963|NCT05016713|Disinfectants|disinfectants|mesh-ancestor
92280964|NCT00002073|Epoetin Alfa|epoetin alfa|mesh-list
92280965|NCT00002073|Hematinics|hematinics|mesh-ancestor
92280966|NCT00001317|Interferons|interferons|mesh-list
92280967|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
92280968|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280969|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
92280970|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280971|NCT00001335|Topotecan|topotecan|mesh-list
92280972|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92280973|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92280974|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280975|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280976|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280977|NCT00002079|Miglustat|miglustat|mesh-list
92280978|NCT00002079|Zidovudine|zidovudine|mesh-list
92280979|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
92280980|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92280981|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92280982|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92280983|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92280984|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
92280985|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280986|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92280987|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92280988|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92280989|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92280990|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92280991|NCT00002085|Azithromycin|azithromycin|mesh-list
92280992|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92280993|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92280994|NCT00001383|Paclitaxel|paclitaxel|mesh-list
92117800|NCT02354092|Anesthetics|anesthetics|mesh-list
92117801|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
92117802|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117803|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117804|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
92117805|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117806|NCT00907101|Adapalene|adapalene|mesh-list
92117807|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92117808|NCT00907101|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92117809|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92117810|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117811|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117812|NCT00907101|Analgesics|analgesics|mesh-ancestor
92117813|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
92117814|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117815|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408386|NCT01451489|Cyclophosphamide|cyclophosphamide|mesh-list
92408388|NCT01451489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408389|NCT01451489|Immunologic Factors|immunologic factors|mesh-ancestor
92408390|NCT01451489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408391|NCT01451489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408392|NCT01451489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92408393|NCT01451489|Alkylating Agents|alkylating agents|mesh-ancestor
92408394|NCT01451489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408395|NCT01451489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408396|NCT01451489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92408397|NCT01451489|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92408398|NCT01451489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408399|NCT01451853|Ebselen|ebselen|mesh-list
91942887|NCT04166773|Incretins|incretins|mesh-ancestor
91942890|NCT04141995|Leucovorin|leucovorin|mesh-list
92280995|NCT00001383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92280996|NCT00001383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92280997|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
92280999|NCT00001383|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281000|NCT00001383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281001|NCT00002091|Pentoxifylline|pentoxifylline|mesh-list
92281002|NCT00002091|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92281003|NCT00002091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281004|NCT00002091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281005|NCT00002091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92281006|NCT00002091|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92281007|NCT00002091|Protective Agents|protective agents|mesh-ancestor
92281008|NCT00002091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281009|NCT00002091|Vasodilator Agents|vasodilator agents|mesh-ancestor
92281010|NCT00002091|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92281011|NCT00002091|Antioxidants|antioxidants|mesh-ancestor
92281012|NCT00001407|Interferons|interferons|mesh-list
92281013|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
92281014|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281015|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
92281016|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281017|NCT00002097|Nystatin|nystatin|mesh-list
92281018|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281019|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281020|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
92281021|NCT00002097|Ionophores|ionophores|mesh-ancestor
92281022|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92281023|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942892|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
91911911|NCT02145091|Psilocybin|psilocybin|mesh-list
91911912|NCT02145091|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
91911913|NCT02145091|Hallucinogens|hallucinogens|mesh-ancestor
91911914|NCT02145091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91911915|NCT02145091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91911916|NCT02145091|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91911917|NCT02145091|Serotonin Agents|serotonin agents|mesh-ancestor
92281024|NCT00001431|Gemcitabine|gemcitabine|mesh-list
91911996|NCT04871750|Caseins|caseins|mesh-list
92281025|NCT00001431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91912148|NCT02153437|Sotalol|sotalol|mesh-list
92281026|NCT00001431|Antimetabolites|antimetabolites|mesh-ancestor
91912382|NCT02086019|Sympatholytics|sympatholytics|mesh-ancestor
92281027|NCT00001431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912691|NCT02339506|Hormones|hormones|mesh-ancestor
92408554|NCT05963347|Vincristine|vincristine|mesh-list
91912908|NCT02337946|Antidotes|antidotes|mesh-ancestor
91940156|NCT03496831|Abatacept|abatacept|mesh-list
92281028|NCT00001431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281029|NCT05428007|Nivolumab|nivolumab|mesh-list
92281030|NCT05428007|Ipilimumab|ipilimumab|mesh-list
92281031|NCT05428007|Relatlimab|relatlimab|mesh-list
91913514|NCT02103881|Ketamine|ketamine|mesh-list
92281032|NCT05428007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92281033|NCT05428007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940160|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
92281034|NCT05428007|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92281035|NCT05428007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281036|NCT00002103|Leucovorin|leucovorin|mesh-list
92281037|NCT00002103|Trimetrexate|trimetrexate|mesh-list
92281038|NCT00002103|Calcium|calcium|mesh-list
91914351|NCT03038516|Vitamin D|vitamin d|mesh-list
92281039|NCT00002103|Levoleucovorin|levoleucovorin|mesh-list
92348247|NCT01563354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281040|NCT00002103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92348248|NCT01563354|Hormones|hormones|mesh-ancestor
91915037|NCT02251223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91915109|NCT05618912|Petrolatum|petrolatum|mesh-list
91915493|NCT02121197|Hormones|hormones|mesh-ancestor
92281041|NCT00002103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281042|NCT00002103|Antidotes|antidotes|mesh-ancestor
92281043|NCT00002103|Protective Agents|protective agents|mesh-ancestor
91916001|NCT03550781|Hormones|hormones|mesh-ancestor
92281044|NCT00002103|Vitamin B Complex|vitamin b complex|mesh-ancestor
92281045|NCT00002103|Vitamins|vitamins|mesh-ancestor
91916257|NCT02133755|Bromocriptine|bromocriptine|mesh-list
91916322|NCT02138045|Incretins|incretins|mesh-ancestor
92281046|NCT00002103|Micronutrients|micronutrients|mesh-ancestor
92281047|NCT00002103|Antifungal Agents|antifungal agents|mesh-ancestor
92281048|NCT00002103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408800|NCT05961527|Adrenergic Agents|adrenergic agents|mesh-ancestor
92281049|NCT00002103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281050|NCT00002103|Antimetabolites|antimetabolites|mesh-ancestor
92281051|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281052|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409031|NCT05930197|Antidiarrheals|antidiarrheals|mesh-ancestor
92281053|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91917236|NCT03541837|Ropivacaine|ropivacaine|mesh-list
92281054|NCT00002103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281055|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
92281056|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92281057|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281058|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281059|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92281060|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92281061|NCT00001437|Protective Agents|protective agents|mesh-ancestor
91918308|NCT01664624|Exenatide|exenatide|mesh-list
92281062|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918476|NCT02162797|Zinc|zinc|mesh-list
92281063|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
92281064|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92281065|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
92281066|NCT00360191|Buspirone|buspirone|mesh-list
91918860|NCT02411955|Tazarotene|tazarotene|mesh-list
91918921|NCT03175653|Oxycodone|oxycodone|mesh-list
92281067|NCT00360191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91919073|NCT02411331|Ethanol|ethanol|mesh-list
92281068|NCT00360191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91919148|NCT04133480|Cannabidiol|cannabidiol|mesh-list
91919227|NCT02165449|Anesthetics|anesthetics|mesh-ancestor
92281069|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409032|NCT05928611|Dexamethasone|dexamethasone|mesh-list
92281070|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281071|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92281072|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92281073|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
91920143|NCT04152473|Proglumide|proglumide|mesh-list
91920222|NCT05312216|Durvalumab|durvalumab|mesh-list
92281074|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920363|NCT02182765|Nevirapine|nevirapine|mesh-list
92281075|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281076|NCT00001443|Indinavir|indinavir|mesh-list
91920740|NCT02180425|Tretinoin|tretinoin|mesh-list
91920830|NCT02183623|Hormones|hormones|mesh-ancestor
92281077|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281078|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281079|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281080|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921224|NCT02191423|Oxytocin|oxytocin|mesh-list
92116614|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92116615|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921576|NCT05509478|Lenvatinib|lenvatinib|mesh-list
92116616|NCT03287076|Exenatide|exenatide|mesh-list
92281081|NCT00001443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281082|NCT00001443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281083|NCT00001443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281084|NCT00001443|Antiviral Agents|antiviral agents|mesh-ancestor
92281085|NCT00001443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922645|NCT02231437|Autonomic Agents|autonomic agents|mesh-ancestor
92281086|NCT00001449|Leucovorin|leucovorin|mesh-list
92281087|NCT00001449|Gemcitabine|gemcitabine|mesh-list
92281088|NCT00001449|Floxuridine|floxuridine|mesh-list
92116617|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92281089|NCT00001449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281090|NCT00001449|Antimetabolites|antimetabolites|mesh-ancestor
92281091|NCT00001449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281092|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923544|NCT02230033|Itraconazole|itraconazole|mesh-list
92281093|NCT00001449|Antidotes|antidotes|mesh-ancestor
91923696|NCT02230735|Autonomic Agents|autonomic agents|mesh-ancestor
91923852|NCT03626545|Docetaxel|docetaxel|mesh-list
92281094|NCT00001449|Protective Agents|protective agents|mesh-ancestor
91923995|NCT05491460|Antithrombins|antithrombins|mesh-ancestor
92281095|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281096|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
92281097|NCT00001449|Vitamins|vitamins|mesh-ancestor
92281098|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
91924541|NCT02679573|Linezolid|linezolid|mesh-list
92281099|NCT00002109|Zidovudine|zidovudine|mesh-list
92281100|NCT00002109|Didanosine|didanosine|mesh-list
91924719|NCT05488106|Riboflavin|riboflavin|mesh-list
92281101|NCT00002109|Stavudine|stavudine|mesh-list
92281102|NCT00002109|Zalcitabine|zalcitabine|mesh-list
92281103|NCT00002109|Thymopentin|thymopentin|mesh-list
91924917|NCT01484119|Cetirizine|cetirizine|mesh-list
92281104|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
92116618|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925146|NCT01188187|Prednisone|prednisone|mesh-list
92281105|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281106|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91925671|NCT04506554|Nivolumab|nivolumab|mesh-list
92116619|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91925899|NCT01303783|Candesartan|candesartan|mesh-list
92281107|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281108|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281109|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
92281110|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281111|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91926817|NCT02155439|Triamcinolone|triamcinolone|mesh-list
91926893|NCT00917293|Vitamins|vitamins|mesh-ancestor
92281112|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91927045|NCT00758953|Danazol|danazol|mesh-list
92281113|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92281114|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
91927356|NCT00694135|BB 1101|bb 1101|mesh-list
92281115|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927654|NCT02669043|Ketamine|ketamine|mesh-list
91927736|NCT02281201|Thrombin|thrombin|mesh-list
92281116|NCT00359567|Palonosetron|palonosetron|mesh-list
92281117|NCT00359567|Granisetron|granisetron|mesh-list
92281118|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
92281119|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
92281120|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281121|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116620|NCT03287076|Incretins|incretins|mesh-ancestor
91928405|NCT03170115|Antipyretics|antipyretics|mesh-ancestor
91928479|NCT02403687|Anesthetics|anesthetics|mesh-ancestor
92281122|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92116621|NCT03287076|Hormones|hormones|mesh-ancestor
91928702|NCT00576667|Rimonabant|rimonabant|mesh-list
92281123|NCT00359567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92281124|NCT00359567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92281125|NCT00359567|Serotonin Agents|serotonin agents|mesh-ancestor
91929222|NCT02753075|Fluorides|fluorides|mesh-list
91929525|NCT02191007|Vitamins|vitamins|mesh-ancestor
92281126|NCT00359567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409033|NCT05928611|Dexamethasone acetate|dexamethasone acetate|mesh-list
91929824|NCT00319969|Topotecan|topotecan|mesh-list
91929968|NCT00028639|Bortezomib|bortezomib|mesh-list
91930277|NCT02376309|Androgens|androgens|mesh-ancestor
92281127|NCT00359567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281128|NCT00381147|Clarithromycin|clarithromycin|mesh-list
92281129|NCT00381147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281130|NCT00381147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931114|NCT05786599|Methadone|methadone|mesh-list
92281131|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91931279|NCT05237960|Metformin|metformin|mesh-list
91931426|NCT04796220|Gemcitabine|gemcitabine|mesh-list
92281132|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281133|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281134|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281135|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281136|NCT05210465|Dobutamine|dobutamine|mesh-list
92281137|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92281138|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
92281139|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
92281140|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281141|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281142|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92281143|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92281144|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92281145|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
92281146|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92281147|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281148|NCT05210465|Protective Agents|protective agents|mesh-ancestor
92281149|NCT00002115|Adefovir|adefovir|mesh-list
92281150|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
92281151|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281152|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281153|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281154|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281155|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281156|NCT04983407|Paclitaxel|paclitaxel|mesh-list
92281157|NCT04983407|Gemcitabine|gemcitabine|mesh-list
92281158|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281159|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281160|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
92281161|NCT04983407|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281162|NCT04983407|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281163|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281164|NCT04983407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281165|NCT04983407|Antimetabolites|antimetabolites|mesh-ancestor
92281166|NCT00001569|Paclitaxel|paclitaxel|mesh-list
92281167|NCT00001569|Cisplatin|cisplatin|mesh-list
92281168|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281169|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281170|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92281171|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281172|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281173|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281174|NCT00001587|Melphalan|melphalan|mesh-list
92281175|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92281176|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
92281177|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281178|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281179|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92281180|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281181|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
92281182|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281183|NCT00002127|Thalidomide|thalidomide|mesh-list
92281184|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281185|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
92281186|NCT00002127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281187|NCT00002127|Leprostatic Agents|leprostatic agents|mesh-ancestor
92281188|NCT00002127|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281189|NCT00002127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281190|NCT00002127|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92281191|NCT00002127|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92281192|NCT00002127|Growth Substances|growth substances|mesh-ancestor
92281193|NCT00002127|Growth Inhibitors|growth inhibitors|mesh-ancestor
92281194|NCT00002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281195|NCT00001599|Thalidomide|thalidomide|mesh-list
92281196|NCT00001599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281197|NCT00001599|Immunologic Factors|immunologic factors|mesh-ancestor
92281198|NCT00001599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281199|NCT00001599|Leprostatic Agents|leprostatic agents|mesh-ancestor
92281200|NCT00001599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281201|NCT00001599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281202|NCT00001599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92281203|NCT00001599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92281204|NCT00001599|Growth Substances|growth substances|mesh-ancestor
92281205|NCT00001599|Growth Inhibitors|growth inhibitors|mesh-ancestor
92281206|NCT00001599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281207|NCT00380913|Nabilone|nabilone|mesh-list
92281208|NCT00380913|Antiemetics|antiemetics|mesh-ancestor
92281209|NCT00380913|Autonomic Agents|autonomic agents|mesh-ancestor
92281210|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281211|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281212|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92281213|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92281214|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92281215|NCT00380913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92281216|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92281217|NCT00002133|Itraconazole|itraconazole|mesh-list
92281218|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
92281219|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281220|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92281221|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281222|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281223|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281224|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92281225|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
92281226|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92281227|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281228|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281229|NCT00001629|Angiotensin II|angiotensin ii|mesh-list
92281231|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
92281232|NCT00001629|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
92281233|NCT00001629|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92281234|NCT00001629|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92281235|NCT00001629|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281236|NCT00001629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281237|NCT00001629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281238|NCT00001629|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92281239|NCT00002139|Azithromycin|azithromycin|mesh-list
92281240|NCT00002139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281241|NCT00002139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281242|NCT00002295|Inosine Pranobex|inosine pranobex|mesh-list
92281243|NCT00002295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92281244|NCT00002295|Immunologic Factors|immunologic factors|mesh-ancestor
92281245|NCT00002295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281246|NCT00002295|Antiviral Agents|antiviral agents|mesh-ancestor
92281247|NCT00002295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281248|NCT00002145|Foscarnet|foscarnet|mesh-list
92281249|NCT00002145|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92281250|NCT00002145|Antiviral Agents|antiviral agents|mesh-ancestor
92281251|NCT00002145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281252|NCT00002145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281253|NCT00002145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281254|NCT00002145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281255|NCT00002145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281256|NCT00002301|Foscarnet|foscarnet|mesh-list
92281257|NCT00002301|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92281258|NCT00002301|Antiviral Agents|antiviral agents|mesh-ancestor
92281259|NCT00002301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281260|NCT00002301|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281261|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281262|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281263|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281264|NCT00002307|Zidovudine|zidovudine|mesh-list
92281265|NCT00002307|Stavudine|stavudine|mesh-list
92281266|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
92281267|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281268|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281269|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281270|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281271|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
92281272|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281273|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281274|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281275|NCT00002313|Didanosine|didanosine|mesh-list
92281276|NCT00002313|Nystatin|nystatin|mesh-list
92281277|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
92281278|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281279|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281280|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281281|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281282|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
92281283|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281284|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281285|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281286|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281287|NCT00002313|Antifungal Agents|antifungal agents|mesh-ancestor
92281288|NCT00002313|Ionophores|ionophores|mesh-ancestor
92281289|NCT00002313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92281290|NCT00002157|Thalidomide|thalidomide|mesh-list
92281291|NCT00002157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281292|NCT00002157|Immunologic Factors|immunologic factors|mesh-ancestor
92281293|NCT00002157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281294|NCT00002157|Leprostatic Agents|leprostatic agents|mesh-ancestor
92281295|NCT00002157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281296|NCT00002157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281297|NCT00002157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92281298|NCT00002157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92281299|NCT00002157|Growth Substances|growth substances|mesh-ancestor
92281300|NCT00002157|Growth Inhibitors|growth inhibitors|mesh-ancestor
92281301|NCT00002157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281302|NCT00002319|Doxorubicin|doxorubicin|mesh-list
92281303|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92281304|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92281305|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281306|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92281307|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92281308|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281309|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281310|NCT00002163|Abacavir|abacavir|mesh-list
92281311|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281312|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281313|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281314|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281315|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
92281316|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281317|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281318|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281319|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
92281320|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92281321|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
92281322|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281324|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
92281325|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281326|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92281327|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281328|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281329|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281330|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92281331|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
92281332|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92281333|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281334|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92281335|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92281338|NCT00002331|Clofazimine|clofazimine|mesh-list
92281339|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281340|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281341|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92281342|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281343|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281344|NCT00002331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281345|NCT00002331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281346|NCT00002331|Antitubercular Agents|antitubercular agents|mesh-ancestor
92281347|NCT00002331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92281348|NCT00002331|Leprostatic Agents|leprostatic agents|mesh-ancestor
92281349|NCT00002337|Vesnarinone|vesnarinone|mesh-list
92281350|NCT00002337|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92281351|NCT00002337|Immunologic Factors|immunologic factors|mesh-ancestor
92281352|NCT00002337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281353|NCT00002337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281354|NCT00002337|Antiviral Agents|antiviral agents|mesh-ancestor
92281355|NCT00002337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281356|NCT00002337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92281357|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92281358|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281359|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281360|NCT00002337|Protective Agents|protective agents|mesh-ancestor
92281361|NCT00002169|Nelfinavir|nelfinavir|mesh-list
92281362|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281363|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281364|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281365|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281366|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281367|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281368|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281369|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
92281370|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281371|NCT02293902|Folic Acid|folic acid|mesh-list
92281372|NCT02293902|Methotrexate|methotrexate|mesh-list
92281373|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92281374|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
92281375|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92281376|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281377|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281378|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
92281379|NCT02293902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281380|NCT02293902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281381|NCT02293902|Dermatologic Agents|dermatologic agents|mesh-ancestor
92281382|NCT02293902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281383|NCT02293902|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92281384|NCT02293902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281385|NCT02293902|Immunologic Factors|immunologic factors|mesh-ancestor
92281386|NCT02293902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92281387|NCT02293902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281388|NCT02293902|Hematinics|hematinics|mesh-ancestor
92281389|NCT02293902|Vitamin B Complex|vitamin b complex|mesh-ancestor
92281390|NCT02293902|Vitamins|vitamins|mesh-ancestor
92281391|NCT02293902|Micronutrients|micronutrients|mesh-ancestor
92281392|NCT00002343|Ethambutol|ethambutol|mesh-list
92281393|NCT00002343|Rifabutin|rifabutin|mesh-list
92281394|NCT00002343|Antitubercular Agents|antitubercular agents|mesh-ancestor
92281395|NCT00002343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281396|NCT00002343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281397|NCT00002343|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92281398|NCT05168735|Ketamine|ketamine|mesh-list
92281399|NCT05168735|Analgesics|analgesics|mesh-ancestor
92281400|NCT05168735|Sensory System Agents|sensory system agents|mesh-ancestor
92281401|NCT05168735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281402|NCT05168735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934271|NCT03949673|Gout Suppressants|gout suppressants|mesh-ancestor
92281403|NCT05168735|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92281404|NCT05168735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92281405|NCT05168735|Anesthetics, General|anesthetics, general|mesh-ancestor
92281407|NCT05168735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92281408|NCT05168735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92281409|NCT05168735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92281410|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92281411|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281413|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
92281414|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281415|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281416|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281417|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281418|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
92281419|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281420|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281421|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281422|NCT04706013|Pyridoxal|pyridoxal|mesh-list
92281423|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
92281424|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
92281425|NCT04706013|Vitamins|vitamins|mesh-ancestor
92281426|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
92281427|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281428|NCT00002355|Fomivirsen|fomivirsen|mesh-list
92281429|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
92281430|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281431|NCT02278614|Timolol|timolol|mesh-list
92281432|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92281433|NCT02278614|Latanoprost|latanoprost|mesh-list
92281434|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92281435|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92281436|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92281437|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92281438|NCT02278614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92281439|NCT02278614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281440|NCT02278614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281441|NCT02278614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92281442|NCT02278614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92281443|NCT00002361|Ritonavir|ritonavir|mesh-list
92281444|NCT00002361|Indinavir|indinavir|mesh-list
92281445|NCT00002361|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281446|NCT00002361|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281447|NCT00002361|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281448|NCT00002361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281449|NCT00002361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281450|NCT00002361|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281451|NCT00002361|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281452|NCT00002361|Antiviral Agents|antiviral agents|mesh-ancestor
92281453|NCT00002361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281454|NCT00002361|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281455|NCT00002361|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281456|NCT00002181|Cidofovir|cidofovir|mesh-list
92281457|NCT00002181|Antiviral Agents|antiviral agents|mesh-ancestor
92281458|NCT00002181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281459|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281460|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281461|NCT00002367|Lamivudine|lamivudine|mesh-list
92281462|NCT00002367|Zidovudine|zidovudine|mesh-list
92281463|NCT00002367|Saquinavir|saquinavir|mesh-list
92281464|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281465|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281466|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281467|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281468|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
92281469|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281470|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281471|NCT00002367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281472|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
92281473|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281474|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281475|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281476|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281477|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281478|NCT00002187|Fomivirsen|fomivirsen|mesh-list
92281479|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
92281480|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281482|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
92281483|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281484|NCT00002379|Lamivudine|lamivudine|mesh-list
92281485|NCT00002379|Zidovudine|zidovudine|mesh-list
92281486|NCT00002379|Stavudine|stavudine|mesh-list
92281487|NCT00002379|Adefovir|adefovir|mesh-list
92281488|NCT00002379|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92281489|NCT00002379|Indinavir|indinavir|mesh-list
92281490|NCT00002379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281491|NCT00002379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281492|NCT00002379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281493|NCT00002379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281494|NCT00002379|Antiviral Agents|antiviral agents|mesh-ancestor
92281495|NCT00002379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281496|NCT00002379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281497|NCT00002379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281498|NCT00002379|Antimetabolites|antimetabolites|mesh-ancestor
92281499|NCT00002379|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281500|NCT00002379|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281501|NCT00002379|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281502|NCT00359723|Methylphenidate|methylphenidate|mesh-list
92281503|NCT00359723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92281504|NCT00359723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281505|NCT00359723|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92281506|NCT00359723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92281507|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92281508|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281509|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
92281510|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92281511|NCT00002193|Amprenavir|amprenavir|mesh-list
92281512|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92281513|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
92281514|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281515|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281516|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281517|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281518|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281519|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281520|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281521|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281522|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281523|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
92281524|NCT00002391|Lamivudine|lamivudine|mesh-list
92281525|NCT00002391|Zidovudine|zidovudine|mesh-list
92281526|NCT00002391|Abacavir|abacavir|mesh-list
92281527|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281528|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281529|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281530|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281531|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
92281532|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281533|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281534|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281535|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
92281536|NCT00002199|Lamivudine|lamivudine|mesh-list
92281537|NCT00002199|Zidovudine|zidovudine|mesh-list
92281538|NCT00002199|Abacavir|abacavir|mesh-list
92281539|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92281540|NCT00002199|Indinavir|indinavir|mesh-list
92281541|NCT00002199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281542|NCT00002199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281543|NCT00002199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281544|NCT00002199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281545|NCT00002199|Antiviral Agents|antiviral agents|mesh-ancestor
92281546|NCT00002199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281547|NCT00002199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281548|NCT00002199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281549|NCT00002199|Antimetabolites|antimetabolites|mesh-ancestor
92281550|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281551|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281552|NCT00002199|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281553|NCT00002397|Lamivudine|lamivudine|mesh-list
92281554|NCT00002397|Stavudine|stavudine|mesh-list
92281555|NCT00002397|Nelfinavir|nelfinavir|mesh-list
92281556|NCT00002397|Saquinavir|saquinavir|mesh-list
92281557|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281558|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281559|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281560|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935357|NCT02311777|Pregabalin|pregabalin|mesh-list
92281561|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
92281562|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281563|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281564|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281565|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281566|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281567|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281568|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
92281569|NCT00002397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281570|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281572|NCT00002205|Amprenavir|amprenavir|mesh-list
92281573|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281574|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281575|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281576|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281577|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
92281578|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281579|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281580|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281581|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92281582|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
92281583|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92281584|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281585|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281586|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281587|NCT02977169|Cisplatin|cisplatin|mesh-list
92281588|NCT02977169|Carboplatin|carboplatin|mesh-list
92281589|NCT02977169|Pemetrexed|pemetrexed|mesh-list
92281590|NCT02977169|Vinorelbine|vinorelbine|mesh-list
92281591|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281592|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281593|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281594|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92281595|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281596|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281597|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
92281598|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281599|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281600|NCT00002409|Lamivudine|lamivudine|mesh-list
92281601|NCT00002409|Zidovudine|zidovudine|mesh-list
92281602|NCT00002409|Abacavir|abacavir|mesh-list
92281603|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92281604|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281605|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281606|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281607|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281608|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
92281609|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281610|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281611|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281612|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
92281613|NCT00002211|Nelfinavir|nelfinavir|mesh-list
92281614|NCT00002211|Didanosine|didanosine|mesh-list
92281615|NCT00002211|Stavudine|stavudine|mesh-list
92281616|NCT00002211|Delavirdine|delavirdine|mesh-list
92281617|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281618|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281619|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281620|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281621|NCT00002211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281622|NCT00002211|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281623|NCT00002211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281624|NCT00002211|Antiviral Agents|antiviral agents|mesh-ancestor
92281625|NCT00002211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281626|NCT00002211|Antimetabolites|antimetabolites|mesh-ancestor
92281627|NCT00002211|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281628|NCT00002211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91934495|NCT02342769|Abacavir|abacavir|mesh-list
92281630|NCT00002415|Antiviral Agents|antiviral agents|mesh-ancestor
92281631|NCT00002415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281632|NCT00002415|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281633|NCT00002415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281634|NCT00002415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281635|NCT00002415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281636|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281637|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281638|NCT00381537|Carbamazepine|carbamazepine|mesh-list
92281639|NCT00381537|Phenobarbital|phenobarbital|mesh-list
92281640|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
92281641|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
92281642|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92281643|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92281644|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281645|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92281646|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92281647|NCT00381537|Analgesics|analgesics|mesh-ancestor
92281648|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
92281649|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281650|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92281651|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92281652|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281653|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92281654|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92281655|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92281656|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92281657|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92281658|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92281659|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
92281660|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
92281661|NCT00381537|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92281662|NCT00002427|Didanosine|didanosine|mesh-list
92281663|NCT00002427|Stavudine|stavudine|mesh-list
92281664|NCT00002427|Hydroxyurea|hydroxyurea|mesh-list
92281665|NCT00002427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281666|NCT00002427|Antisickling Agents|antisickling agents|mesh-ancestor
92281667|NCT00002427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281668|NCT00002427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281669|NCT00002427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281670|NCT00002427|Antimetabolites|antimetabolites|mesh-ancestor
92281671|NCT00002427|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281672|NCT00002427|Antiviral Agents|antiviral agents|mesh-ancestor
92281673|NCT00002427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281674|NCT00002427|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281675|NCT00002427|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281676|NCT00002223|Ritonavir|ritonavir|mesh-list
92281677|NCT00002223|Indinavir|indinavir|mesh-list
92281678|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281679|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281680|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281681|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281682|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281683|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281684|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281685|NCT00002223|Antiviral Agents|antiviral agents|mesh-ancestor
92281686|NCT00002223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281687|NCT00002223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281688|NCT00002223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281689|NCT00002433|Interferons|interferons|mesh-list
92281690|NCT00002433|Interferon-gamma|interferon-gamma|mesh-list
92281691|NCT00002433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281692|NCT00002433|Antiviral Agents|antiviral agents|mesh-ancestor
92281693|NCT00002433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281694|NCT00002439|Alitretinoin|alitretinoin|mesh-list
92281695|NCT00002439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281696|NCT00002439|Dermatologic Agents|dermatologic agents|mesh-ancestor
92281697|NCT00002229|Saquinavir|saquinavir|mesh-list
92281698|NCT00002229|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281699|NCT00002229|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281700|NCT00002229|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281701|NCT00002229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281702|NCT00002229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281703|NCT00002229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281704|NCT00002229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281705|NCT00002229|Antiviral Agents|antiviral agents|mesh-ancestor
92281706|NCT00002229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281707|NCT00002229|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281708|NCT00002229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281709|NCT04963673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92281710|NCT04963673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322589|NCT00002162|Didanosine|didanosine|mesh-list
92344818|NCT03864042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92281711|NCT04963673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281714|NCT00002451|Lamivudine|lamivudine|mesh-list
92281715|NCT00002451|Stavudine|stavudine|mesh-list
92281716|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281717|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281718|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281719|NCT00002451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281720|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281721|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281722|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281723|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
92281724|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281725|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281726|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281727|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281728|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281729|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
92281730|NCT00002235|Efavirenz|efavirenz|mesh-list
92281731|NCT00002235|Nelfinavir|nelfinavir|mesh-list
92281732|NCT00002235|Indinavir|indinavir|mesh-list
92281733|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281734|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281735|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281736|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281737|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
92281738|NCT00002235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281739|NCT00002235|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92281740|NCT00002235|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281741|NCT00002235|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92281742|NCT00002235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92281743|NCT00002235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92281744|NCT00002235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92281745|NCT00002235|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281746|NCT00002235|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281747|NCT00002235|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281748|NCT00002235|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281749|NCT00002235|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281750|NCT00002241|Ritonavir|ritonavir|mesh-list
92281751|NCT00002241|Indinavir|indinavir|mesh-list
92281752|NCT00002241|Lamivudine|lamivudine|mesh-list
92281753|NCT00002241|Stavudine|stavudine|mesh-list
92281754|NCT00002241|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92281755|NCT00002241|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92281756|NCT00002241|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281757|NCT00002241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281758|NCT00002241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281759|NCT00002241|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92281760|NCT00002241|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92281761|NCT00002241|Antiviral Agents|antiviral agents|mesh-ancestor
92281762|NCT00002241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281763|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92281764|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281765|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92281766|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281767|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
92281768|NCT00002463|Leucovorin|leucovorin|mesh-list
92281769|NCT00002463|Prednisone|prednisone|mesh-list
92281770|NCT00002463|Methotrexate|methotrexate|mesh-list
92281771|NCT00002463|Vincristine|vincristine|mesh-list
92281772|NCT00002463|Procarbazine|procarbazine|mesh-list
92281773|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
92281774|NCT00002463|Calcium|calcium|mesh-list
92281775|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
92281776|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92281777|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281778|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92281779|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
92281780|NCT00002463|Hormones|hormones|mesh-ancestor
92281781|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92281782|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92281783|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281784|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92281785|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
92281786|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92281787|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281788|NCT00002463|Antimetabolites|antimetabolites|mesh-ancestor
92281789|NCT00002463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281790|NCT00002463|Dermatologic Agents|dermatologic agents|mesh-ancestor
92281791|NCT00002463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281792|NCT00002463|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92281793|NCT00002463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281794|NCT00002463|Immunologic Factors|immunologic factors|mesh-ancestor
92281795|NCT00002463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92281796|NCT00002463|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281797|NCT00002463|Antidotes|antidotes|mesh-ancestor
92281798|NCT00002463|Protective Agents|protective agents|mesh-ancestor
92281799|NCT00002463|Vitamin B Complex|vitamin b complex|mesh-ancestor
92281800|NCT00002463|Vitamins|vitamins|mesh-ancestor
92281801|NCT00002463|Micronutrients|micronutrients|mesh-ancestor
92281802|NCT00002463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281803|NCT00002463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92281804|NCT00002463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281805|NCT00002463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281806|NCT00002463|Alkylating Agents|alkylating agents|mesh-ancestor
92281807|NCT00002463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92281808|NCT00002247|Ganciclovir|ganciclovir|mesh-list
92281809|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92281810|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
92281811|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281812|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281813|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281814|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281815|NCT00002475|Interferons|interferons|mesh-list
92281816|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
92281817|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
92281818|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
92281819|NCT00002475|Vaccines|vaccines|mesh-list
92281820|NCT00002475|Sargramostim|sargramostim|mesh-list
92281821|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
92281822|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281823|NCT00002475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281824|NCT00002475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92281825|NCT00002475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92281826|NCT00002475|Alkylating Agents|alkylating agents|mesh-ancestor
92281827|NCT00002475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281828|NCT00002475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281829|NCT00002475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92281830|NCT00002475|Antiviral Agents|antiviral agents|mesh-ancestor
92281831|NCT00002475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281832|NCT00002481|Cytarabine|cytarabine|mesh-list
92281833|NCT00002481|Dexamethasone|dexamethasone|mesh-list
92281834|NCT00002481|Cyclophosphamide|cyclophosphamide|mesh-list
92281835|NCT00002481|Etoposide|etoposide|mesh-list
92281836|NCT00002481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281837|NCT00002481|Immunologic Factors|immunologic factors|mesh-ancestor
92281838|NCT00002481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281839|NCT00002481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92281840|NCT00002481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92281841|NCT00002481|Alkylating Agents|alkylating agents|mesh-ancestor
92281842|NCT00002481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281843|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281844|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92281845|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92281846|NCT00002481|Antiemetics|antiemetics|mesh-ancestor
92281847|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
92281848|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281849|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92281850|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
92281852|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92281853|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92281854|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281855|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92281856|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92281857|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281858|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281859|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
92281860|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
92281861|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281863|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92281864|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92281865|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281867|NCT04862585|Promethazine|promethazine|mesh-list
92281868|NCT04862585|Dexamethasone|dexamethasone|mesh-list
92281869|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
92281870|NCT04862585|Paclitaxel|paclitaxel|mesh-list
92281871|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92281872|NCT04862585|Famotidine|famotidine|mesh-list
92281873|NCT04862585|Ranitidine|ranitidine|mesh-list
92281874|NCT04862585|Cimetidine|cimetidine|mesh-list
92281875|NCT04862585|BB 1101|bb 1101|mesh-list
92281876|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281877|NCT04862585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281878|NCT04862585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92281879|NCT04862585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281880|NCT04862585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281881|NCT04862585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281882|NCT04862585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92281883|NCT04862585|Antiemetics|antiemetics|mesh-ancestor
92281884|NCT04862585|Autonomic Agents|autonomic agents|mesh-ancestor
92281885|NCT04862585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281886|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281887|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92281888|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
92281889|NCT04862585|Hormones|hormones|mesh-ancestor
92281890|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92281891|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92281892|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
92281893|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281894|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92281895|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92281896|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92281897|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
92281898|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
92281899|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
92281900|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92281901|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
92281902|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
92281903|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92281904|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92281905|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
92281906|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92281907|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92281908|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92281909|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92281910|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92281911|NCT00002487|Methotrexate|methotrexate|mesh-list
92281912|NCT00002487|Dipyridamole|dipyridamole|mesh-list
92281913|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92281914|NCT00002487|Abortifacient Agents|abortifacient agents|mesh-ancestor
92281915|NCT00002487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92281916|NCT00002487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281917|NCT00002487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281918|NCT00002487|Antimetabolites|antimetabolites|mesh-ancestor
92281919|NCT00002487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281920|NCT00002487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281921|NCT00002487|Dermatologic Agents|dermatologic agents|mesh-ancestor
92281922|NCT00002487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281923|NCT00002487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92281924|NCT00002487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281925|NCT00002487|Immunologic Factors|immunologic factors|mesh-ancestor
92281926|NCT00002487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92281927|NCT00002487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281928|NCT00002487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92281929|NCT00002487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92281930|NCT00002487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92281932|NCT00002493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92281933|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281934|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92281935|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92281936|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92281937|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281938|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281939|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
92281940|NCT00002259|Analgesics|analgesics|mesh-ancestor
92281941|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
92281942|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281943|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281944|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281945|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92281946|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92281947|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281948|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281949|NCT00002499|Cytarabine|cytarabine|mesh-list
92281950|NCT00002499|Dexamethasone|dexamethasone|mesh-list
92281951|NCT00002499|Prednisone|prednisone|mesh-list
92281952|NCT00002499|Methotrexate|methotrexate|mesh-list
92281953|NCT00002499|Vincristine|vincristine|mesh-list
92281954|NCT00002499|Daunorubicin|daunorubicin|mesh-list
92281955|NCT00002499|Asparaginase|asparaginase|mesh-list
92281956|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92281957|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
92281958|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
92281959|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92281960|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281961|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92281962|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
92281963|NCT00002499|Hormones|hormones|mesh-ancestor
92281964|NCT00002499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92281965|NCT00002499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92281966|NCT00002499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281967|NCT00002499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92281968|NCT00002499|Abortifacient Agents|abortifacient agents|mesh-ancestor
92281969|NCT00002499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92281970|NCT00002499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92281971|NCT00002499|Antimetabolites|antimetabolites|mesh-ancestor
92281972|NCT00002499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92281973|NCT00002499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92281974|NCT00002499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92281975|NCT00002499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92281976|NCT00002499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92281977|NCT00002499|Immunologic Factors|immunologic factors|mesh-ancestor
92281978|NCT00002499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92281979|NCT00002499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92281980|NCT00002499|Antiviral Agents|antiviral agents|mesh-ancestor
92281981|NCT00002499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281982|NCT00002499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92281983|NCT00002499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92281984|NCT00002499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92281985|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92281986|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92281987|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92281988|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92281989|NCT00002505|Interferons|interferons|mesh-list
92281990|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
92281991|NCT00002505|Vaccines|vaccines|mesh-list
92281992|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92281993|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
92281994|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92281995|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
92281996|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92281997|NCT00002265|Zalcitabine|zalcitabine|mesh-list
92281998|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
92281999|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282000|NCT00002265|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92282001|NCT00002265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92282002|NCT00002265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282003|NCT00002265|Antiviral Agents|antiviral agents|mesh-ancestor
92282004|NCT00002265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282005|NCT00002265|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282006|NCT00002265|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282008|NCT04933331|Fluorides|fluorides|mesh-list
92282009|NCT04933331|Fluorides, Topical|fluorides, topical|mesh-list
92282010|NCT04933331|Cariostatic Agents|cariostatic agents|mesh-ancestor
92282011|NCT04933331|Protective Agents|protective agents|mesh-ancestor
92282012|NCT04933331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282013|NCT04933331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92282014|NCT04933331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282015|NCT00002271|Alovudine|alovudine|mesh-list
92282016|NCT00002271|Antiviral Agents|antiviral agents|mesh-ancestor
92282017|NCT00002271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282018|NCT00002517|Cytarabine|cytarabine|mesh-list
92282019|NCT00002517|Dexamethasone|dexamethasone|mesh-list
92282020|NCT00002517|Etoposide|etoposide|mesh-list
92282021|NCT00002517|Daunorubicin|daunorubicin|mesh-list
92282022|NCT00002517|Mitoxantrone|mitoxantrone|mesh-list
92282023|NCT00002517|Idarubicin|idarubicin|mesh-list
92282024|NCT00002517|Thioguanine|thioguanine|mesh-list
92282025|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282026|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
92282027|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
92282028|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282029|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282030|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282031|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
92282032|NCT00002517|Hormones|hormones|mesh-ancestor
92282033|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282034|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282035|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282036|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282037|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92282038|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92282039|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282040|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282041|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282042|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
92282043|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
92282044|NCT00002517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282045|NCT00002517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282046|NCT00002517|Immunologic Factors|immunologic factors|mesh-ancestor
92282047|NCT00002517|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92282048|NCT00002517|Analgesics|analgesics|mesh-ancestor
92282049|NCT00002517|Sensory System Agents|sensory system agents|mesh-ancestor
92282050|NCT00002277|Fluconazole|fluconazole|mesh-list
92282051|NCT00002277|Amphotericin B|amphotericin b|mesh-list
92282052|NCT00002277|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92282053|NCT00002277|Antifungal Agents|antifungal agents|mesh-ancestor
92282054|NCT00002277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282055|NCT00002277|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92282056|NCT00002277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92282057|NCT00002277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282058|NCT00002277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282059|NCT00002277|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92282060|NCT00002277|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282061|NCT00002277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282062|NCT00002277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282063|NCT00002277|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92282064|NCT00002277|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92282065|NCT00002277|Amebicides|amebicides|mesh-ancestor
92282066|NCT00002277|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92282067|NCT00002277|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92282068|NCT00002277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92282069|NCT04469075|Clindamycin|clindamycin|mesh-list
92282070|NCT04469075|Clindamycin palmitate|clindamycin palmitate|mesh-list
92282071|NCT04469075|Clindamycin phosphate|clindamycin phosphate|mesh-list
92282072|NCT04469075|Triamcinolone|triamcinolone|mesh-list
92282073|NCT04469075|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92282074|NCT04469075|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92282075|NCT04469075|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92282076|NCT04469075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282077|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
92282078|NCT04469075|Hormones|hormones|mesh-ancestor
92282079|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282080|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282081|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282082|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
92282083|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282084|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282085|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92282086|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282087|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92282088|NCT00002523|Leucovorin|leucovorin|mesh-list
92282089|NCT00002523|Fluorouracil|fluorouracil|mesh-list
92282090|NCT00002523|Calcium|calcium|mesh-list
92282091|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
92282092|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92282093|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282094|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
92282095|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282096|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282097|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282098|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282099|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
92282100|NCT00002523|Antidotes|antidotes|mesh-ancestor
92282101|NCT00002523|Protective Agents|protective agents|mesh-ancestor
92282102|NCT00002523|Vitamin B Complex|vitamin b complex|mesh-ancestor
92282103|NCT00002523|Vitamins|vitamins|mesh-ancestor
92282104|NCT00002523|Micronutrients|micronutrients|mesh-ancestor
92282105|NCT00002529|Tamoxifen|tamoxifen|mesh-list
92282106|NCT00002529|Toremifene|toremifene|mesh-list
92282107|NCT00002529|Cyclophosphamide|cyclophosphamide|mesh-list
92282108|NCT00002529|Doxorubicin|doxorubicin|mesh-list
92282109|NCT00002529|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92282110|NCT00002529|Epirubicin|epirubicin|mesh-list
92282111|NCT00002529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282112|NCT00002529|Immunologic Factors|immunologic factors|mesh-ancestor
92282113|NCT00002529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282114|NCT00002529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282115|NCT00002529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282116|NCT00002529|Alkylating Agents|alkylating agents|mesh-ancestor
92282117|NCT00002529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282118|NCT00002529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282119|NCT00002529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282120|NCT00002529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92282121|NCT00002529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92282122|NCT00002529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92282123|NCT00002529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282124|NCT00002529|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92282125|NCT00002529|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282126|NCT00002529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282127|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282128|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92282129|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92282130|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92282131|NCT04832087|Teduglutide|teduglutide|mesh-list
92282132|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282133|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92282134|NCT04832087|Protective Agents|protective agents|mesh-ancestor
92282135|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282137|NCT00002217|Zidovudine|zidovudine|mesh-list
92282138|NCT00002217|Abacavir|abacavir|mesh-list
92282139|NCT00002217|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92282140|NCT00002217|Amprenavir|amprenavir|mesh-list
92282141|NCT00002217|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92282142|NCT00002217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92282143|NCT00002217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282144|NCT00002217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282145|NCT00002217|Antiviral Agents|antiviral agents|mesh-ancestor
92282146|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282147|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282148|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282150|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92282151|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
92282152|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92282153|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92282154|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92282155|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
92282156|NCT00002283|Trimethoprim|trimethoprim|mesh-list
92282157|NCT00002283|Dapsone|dapsone|mesh-list
92282158|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
92282159|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92282160|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282161|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
92282162|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92282163|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92282164|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92282165|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282166|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282167|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92282168|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92282169|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92282170|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
92282171|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92282172|NCT04826237|Dexamethasone|dexamethasone|mesh-list
92282173|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
92282174|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92282175|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92282176|NCT04826237|Prednisolone|prednisolone|mesh-list
92282177|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
92282178|NCT04826237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92282179|NCT04826237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92282180|NCT04826237|Prednisolone phosphate|prednisolone phosphate|mesh-list
92282181|NCT04826237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282182|NCT04826237|Antiemetics|antiemetics|mesh-ancestor
92282183|NCT04826237|Autonomic Agents|autonomic agents|mesh-ancestor
92282184|NCT04826237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282185|NCT04826237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282186|NCT04826237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282187|NCT04826237|Glucocorticoids|glucocorticoids|mesh-ancestor
92282188|NCT04826237|Hormones|hormones|mesh-ancestor
92282189|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282190|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282191|NCT04826237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282192|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92282193|NCT04826237|Protective Agents|protective agents|mesh-ancestor
92282194|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92282195|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92282196|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
92282197|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282198|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282199|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92282200|NCT00002535|Aldesleukin|aldesleukin|mesh-list
92282201|NCT00002535|Indomethacin|indomethacin|mesh-list
92282202|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
92282203|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282204|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
92409034|NCT05928611|BB 1101|bb 1101|mesh-list
92282205|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282206|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282207|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282208|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
92282209|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282210|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282211|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282212|NCT00002535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282213|NCT00002535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282214|NCT00002535|Antiviral Agents|antiviral agents|mesh-ancestor
92282215|NCT00002535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282216|NCT00002535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92282217|NCT00002535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92282218|NCT00002535|Analgesics|analgesics|mesh-ancestor
92282219|NCT00002535|Sensory System Agents|sensory system agents|mesh-ancestor
92282220|NCT00002535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282221|NCT00002535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282222|NCT00002535|Gout Suppressants|gout suppressants|mesh-ancestor
92282223|NCT00002535|Tocolytic Agents|tocolytic agents|mesh-ancestor
92282224|NCT00002535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92282225|NCT00002535|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92282226|NCT00002535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282227|NCT00002547|Cytarabine|cytarabine|mesh-list
92282228|NCT00002547|Cyclosporine|cyclosporine|mesh-list
92282229|NCT00002547|Cyclophosphamide|cyclophosphamide|mesh-list
92282230|NCT00002547|Busulfan|busulfan|mesh-list
92282231|NCT00002547|Methotrexate|methotrexate|mesh-list
92282232|NCT00002547|Cyclosporins|cyclosporins|mesh-list
92282233|NCT00002547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282234|NCT00002547|Immunologic Factors|immunologic factors|mesh-ancestor
92282235|NCT00002547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282236|NCT00002547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282237|NCT00002547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282238|NCT00002547|Alkylating Agents|alkylating agents|mesh-ancestor
92282239|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282240|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282241|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282242|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92282243|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
92282244|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92282245|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282246|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
92282247|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
92282248|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282249|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92282250|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92282251|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
92282252|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282253|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
92282254|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92282255|NCT00002289|Thymopentin|thymopentin|mesh-list
92282256|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92282257|NCT00002289|Immunologic Factors|immunologic factors|mesh-ancestor
92282258|NCT00002289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282260|NCT00002553|Cyclophosphamide|cyclophosphamide|mesh-list
92282261|NCT00002553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282262|NCT00002553|Immunologic Factors|immunologic factors|mesh-ancestor
92282263|NCT00002553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282264|NCT00002553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282265|NCT00002553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282266|NCT00002553|Alkylating Agents|alkylating agents|mesh-ancestor
92282267|NCT00002553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282268|NCT00002553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282269|NCT00002553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282270|NCT00002553|Trace Elements|trace elements|mesh-ancestor
92282271|NCT00002553|Micronutrients|micronutrients|mesh-ancestor
92282272|NCT00002559|Paclitaxel|paclitaxel|mesh-list
92282273|NCT00002559|Ifosfamide|ifosfamide|mesh-list
92282274|NCT00002559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282275|NCT00002559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282276|NCT00002559|Tubulin Modulators|tubulin modulators|mesh-ancestor
92282277|NCT00002559|Antimitotic Agents|antimitotic agents|mesh-ancestor
92282278|NCT00002559|Mitosis Modulators|mitosis modulators|mesh-ancestor
92282279|NCT00002559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282280|NCT00002559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282281|NCT00002559|Alkylating Agents|alkylating agents|mesh-ancestor
92282282|NCT00002565|Cytarabine|cytarabine|mesh-list
92282283|NCT00002565|Prednisone|prednisone|mesh-list
92282284|NCT00002565|Methylprednisolone|methylprednisolone|mesh-list
92282285|NCT00002565|Cyclophosphamide|cyclophosphamide|mesh-list
92282286|NCT00002565|Ifosfamide|ifosfamide|mesh-list
92282287|NCT00002565|Doxorubicin|doxorubicin|mesh-list
92282288|NCT00002565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92282289|NCT00002565|Etoposide|etoposide|mesh-list
92282290|NCT00002565|Vincristine|vincristine|mesh-list
92282291|NCT00002565|Mitoxantrone|mitoxantrone|mesh-list
92282293|NCT00002565|Bleomycin|bleomycin|mesh-list
92282294|NCT00002565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282295|NCT00002565|Immunologic Factors|immunologic factors|mesh-ancestor
92282296|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282297|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282298|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282299|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
92282300|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282301|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282302|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282303|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92282304|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92282305|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92282306|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282307|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282308|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
92282309|NCT00002565|Hormones|hormones|mesh-ancestor
92282310|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282311|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282312|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282313|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282314|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
92282315|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
92282316|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282317|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
92282318|NCT00002565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92282319|NCT00002565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92282320|NCT00002565|Antiemetics|antiemetics|mesh-ancestor
92282321|NCT00002565|Autonomic Agents|autonomic agents|mesh-ancestor
92282322|NCT00002565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282323|NCT00002565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282324|NCT00002565|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92282325|NCT00002565|Protective Agents|protective agents|mesh-ancestor
92282326|NCT00002565|Analgesics|analgesics|mesh-ancestor
92282327|NCT00002565|Sensory System Agents|sensory system agents|mesh-ancestor
92282328|NCT00002571|Leucovorin|leucovorin|mesh-list
92282329|NCT00002571|Cytarabine|cytarabine|mesh-list
92282330|NCT00002571|Trimethoprim|trimethoprim|mesh-list
92282331|NCT00002571|Sulfamethoxazole|sulfamethoxazole|mesh-list
92282332|NCT00002571|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92282333|NCT00002571|Prednisone|prednisone|mesh-list
92282334|NCT00002571|Cyclophosphamide|cyclophosphamide|mesh-list
92282335|NCT00002571|Doxorubicin|doxorubicin|mesh-list
92282336|NCT00002571|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92282337|NCT00002571|Methotrexate|methotrexate|mesh-list
92282338|NCT00002571|Etoposide|etoposide|mesh-list
92282339|NCT00002571|Vincristine|vincristine|mesh-list
92282340|NCT00002571|Bleomycin|bleomycin|mesh-list
92282341|NCT00002571|Levoleucovorin|levoleucovorin|mesh-list
92282342|NCT00002571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282343|NCT00002571|Immunologic Factors|immunologic factors|mesh-ancestor
92282344|NCT00002571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282345|NCT00002571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282346|NCT00002571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282347|NCT00002571|Alkylating Agents|alkylating agents|mesh-ancestor
92282348|NCT00002571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282349|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282350|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282351|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92282352|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92282353|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92282354|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282355|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282356|NCT00002571|Glucocorticoids|glucocorticoids|mesh-ancestor
92282357|NCT00002571|Hormones|hormones|mesh-ancestor
92282358|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282359|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282360|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92282361|NCT00002571|Abortifacient Agents|abortifacient agents|mesh-ancestor
92282362|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92282363|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282364|NCT00002571|Antimetabolites|antimetabolites|mesh-ancestor
92282365|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
92282366|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92282367|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92282368|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282369|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
92282370|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282371|NCT00002571|Antidotes|antidotes|mesh-ancestor
92282372|NCT00002571|Protective Agents|protective agents|mesh-ancestor
92282373|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
92282374|NCT00002571|Vitamins|vitamins|mesh-ancestor
92282375|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
92282376|NCT00002571|Tubulin Modulators|tubulin modulators|mesh-ancestor
92282377|NCT00002571|Antimitotic Agents|antimitotic agents|mesh-ancestor
92282378|NCT00002571|Mitosis Modulators|mitosis modulators|mesh-ancestor
92282379|NCT00002571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92282380|NCT00002571|Antimalarials|antimalarials|mesh-ancestor
92282381|NCT00002571|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92282382|NCT00002571|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92282383|NCT00002571|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92282384|NCT00002571|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92282385|NCT00002571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92282386|NCT00002571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92282387|NCT00360815|Insulin|insulin|mesh-list
92282388|NCT00360815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92282389|NCT00360815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282390|NCT00002583|Vinorelbine|vinorelbine|mesh-list
92282391|NCT00002583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282392|NCT00002583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282393|NCT00002583|Tubulin Modulators|tubulin modulators|mesh-ancestor
92282394|NCT00002583|Antimitotic Agents|antimitotic agents|mesh-ancestor
92282395|NCT00002583|Mitosis Modulators|mitosis modulators|mesh-ancestor
92282396|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282397|NCT00002589|Aldesleukin|aldesleukin|mesh-list
91935253|NCT02331927|Aflibercept|aflibercept|mesh-list
92282398|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
92282399|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282400|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282401|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282402|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
92282403|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282404|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
92282405|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282406|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282407|NCT02223871|Lumefantrine|lumefantrine|mesh-list
92282409|NCT02223871|Primaquine|primaquine|mesh-list
92282410|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
92282411|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92282412|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92282413|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282414|NCT00002595|Toremifene|toremifene|mesh-list
92282415|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282416|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282417|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92282418|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92282419|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282420|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282421|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282422|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92282423|NCT03004339|Betamethasone|betamethasone|mesh-list
92282424|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
92282425|NCT03004339|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92282426|NCT03004339|Betamethasone benzoate|betamethasone benzoate|mesh-list
92282427|NCT03004339|Calcipotriene|calcipotriene|mesh-list
92282428|NCT03004339|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92282429|NCT03004339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282430|NCT03004339|Glucocorticoids|glucocorticoids|mesh-ancestor
92282431|NCT03004339|Hormones|hormones|mesh-ancestor
92282432|NCT03004339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282433|NCT03004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282434|NCT03004339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92282435|NCT03004339|Respiratory System Agents|respiratory system agents|mesh-ancestor
92282436|NCT03004339|Dermatologic Agents|dermatologic agents|mesh-ancestor
92282437|NCT00002619|Carboplatin|carboplatin|mesh-list
92282438|NCT00002619|Thiotepa|thiotepa|mesh-list
92282439|NCT00002619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282440|NCT00002619|Immunologic Factors|immunologic factors|mesh-ancestor
92282441|NCT00002619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282442|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282443|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
92282444|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282445|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282446|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282447|NCT00002625|Topotecan|topotecan|mesh-list
92282448|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92282449|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92282450|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282451|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282452|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282453|NCT00360737|Antitoxins|antitoxins|mesh-list
92282454|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
92282455|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
92282456|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282457|NCT05752305|Dexamethasone|dexamethasone|mesh-list
92282458|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
92282459|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92282460|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92282461|NCT05752305|Prednisolone|prednisolone|mesh-list
92282462|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
92282463|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92282464|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
92282465|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282466|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
92282467|NCT05752305|Autonomic Agents|autonomic agents|mesh-ancestor
92282468|NCT05752305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282469|NCT05752305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282470|NCT05752305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282471|NCT05752305|Glucocorticoids|glucocorticoids|mesh-ancestor
92282472|NCT05752305|Hormones|hormones|mesh-ancestor
92282473|NCT05752305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282474|NCT05752305|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282476|NCT05752305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92282477|NCT05752305|Protective Agents|protective agents|mesh-ancestor
92282478|NCT04343729|Methylprednisolone|methylprednisolone|mesh-list
92282479|NCT04343729|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92282480|NCT04343729|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92282481|NCT04343729|Prednisolone|prednisolone|mesh-list
92282482|NCT04343729|Prednisolone acetate|prednisolone acetate|mesh-list
92282483|NCT04343729|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92282484|NCT04343729|Prednisolone phosphate|prednisolone phosphate|mesh-list
92282485|NCT04343729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282486|NCT04343729|Antiemetics|antiemetics|mesh-ancestor
92282487|NCT04343729|Autonomic Agents|autonomic agents|mesh-ancestor
92282488|NCT04343729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282489|NCT04343729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282490|NCT04343729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282491|NCT04343729|Glucocorticoids|glucocorticoids|mesh-ancestor
92282492|NCT04343729|Hormones|hormones|mesh-ancestor
92282493|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282494|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92282495|NCT04343729|Protective Agents|protective agents|mesh-ancestor
92282496|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282497|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282498|NCT00002631|Fluorouracil|fluorouracil|mesh-list
92282499|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282500|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
92282501|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282502|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282503|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282504|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
92282505|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282506|NCT00002637|Interferons|interferons|mesh-list
92282507|NCT00002637|Aldesleukin|aldesleukin|mesh-list
92282508|NCT00002637|Interferon-gamma|interferon-gamma|mesh-list
92282509|NCT00002637|Vaccines|vaccines|mesh-list
92282510|NCT00002637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282511|NCT00002637|Antiviral Agents|antiviral agents|mesh-ancestor
92282512|NCT00002637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282513|NCT00002637|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282514|NCT00002637|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282515|NCT00002637|Immunologic Factors|immunologic factors|mesh-ancestor
92282516|NCT00002637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282517|NCT02977013|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92282518|NCT02977013|Dalteparin|dalteparin|mesh-list
92282519|NCT02977013|Anticoagulants|anticoagulants|mesh-ancestor
92282520|NCT02977013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92282521|NCT02977013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92282522|NCT02977013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282523|NCT05806918|Interferons|interferons|mesh-list
92282524|NCT05806918|Interferon alpha-2|interferon alpha-2|mesh-list
92282525|NCT05806918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282526|NCT05806918|Antiviral Agents|antiviral agents|mesh-ancestor
92282527|NCT05806918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282528|NCT05806853|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92282529|NCT05806853|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92282530|NCT05806853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282531|NCT05806749|Belumosudil|belumosudil|mesh-list
92282532|NCT05806749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92282533|NCT05806749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282534|NCT05806749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282535|NCT05806723|Atorvastatin|atorvastatin|mesh-list
92282536|NCT05806723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92282537|NCT05806723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92282538|NCT05806723|Antimetabolites|antimetabolites|mesh-ancestor
92282539|NCT05806723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282540|NCT05806723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92282541|NCT05806723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92282542|NCT05806723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282543|NCT05806697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92282544|NCT05806697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92282545|NCT05806697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282547|NCT05806671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282548|NCT05806671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282549|NCT05806671|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92282550|NCT05806671|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92282551|NCT05806671|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282552|NCT05806671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282553|NCT05806671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282555|NCT05806515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282556|NCT05806476|Caffeine|caffeine|mesh-list
92282557|NCT05806476|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92282558|NCT05806476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282559|NCT05806476|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92282560|NCT05806476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282561|NCT05806476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282562|NCT05806476|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92282563|NCT05806476|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92282564|NCT05806476|Purinergic Agents|purinergic agents|mesh-ancestor
92282565|NCT05806476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92282566|NCT05806385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92282567|NCT05806385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282568|NCT05806385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92282569|NCT05806385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282570|NCT05806307|Vasopressins|vasopressins|mesh-list
92282571|NCT05806307|Arginine Vasopressin|arginine vasopressin|mesh-list
92282572|NCT05806307|Epinephrine|epinephrine|mesh-list
92282573|NCT05806307|Bupivacaine|bupivacaine|mesh-list
92282574|NCT05806307|Misoprostol|misoprostol|mesh-list
92282575|NCT05806307|Ethamsylate|ethamsylate|mesh-list
92282576|NCT05806307|Oxytocin|oxytocin|mesh-list
92282577|NCT05806307|Carbetocin|carbetocin|mesh-list
92282578|NCT05806307|Anesthetics, Local|anesthetics, local|mesh-ancestor
92282579|NCT05806307|Anesthetics|anesthetics|mesh-ancestor
92344876|NCT03726879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282580|NCT05806307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92282581|NCT05806307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282582|NCT05806307|Sensory System Agents|sensory system agents|mesh-ancestor
92282583|NCT05806307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282584|NCT05806307|Oxytocics|oxytocics|mesh-ancestor
92282585|NCT05806307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92282586|NCT05806307|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92282587|NCT05806307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92282588|NCT05806307|Adrenergic Agents|adrenergic agents|mesh-ancestor
92282589|NCT05806307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92282590|NCT05806307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282591|NCT05806307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92282592|NCT05806307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92282593|NCT05806307|Autonomic Agents|autonomic agents|mesh-ancestor
92282594|NCT05806307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92282595|NCT05806307|Respiratory System Agents|respiratory system agents|mesh-ancestor
92282596|NCT05806307|Mydriatics|mydriatics|mesh-ancestor
92282597|NCT05806307|Sympathomimetics|sympathomimetics|mesh-ancestor
92282598|NCT05806307|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92282599|NCT05806307|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92282600|NCT05806307|Abortifacient Agents|abortifacient agents|mesh-ancestor
92282601|NCT05806307|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92282602|NCT05806307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282603|NCT05806307|Hemostatics|hemostatics|mesh-ancestor
92282604|NCT05806307|Coagulants|coagulants|mesh-ancestor
92282605|NCT05806307|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92282606|NCT05806307|Natriuretic Agents|natriuretic agents|mesh-ancestor
92282607|NCT05806047|Fulvestrant|fulvestrant|mesh-list
92282608|NCT05806047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282609|NCT05806047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282610|NCT05806047|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92282611|NCT05806047|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92282612|NCT05806047|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282613|NCT05806047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282614|NCT05806047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282615|NCT05805930|Prednisone|prednisone|mesh-list
92282616|NCT05805930|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92282617|NCT05805930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282618|NCT05805930|Glucocorticoids|glucocorticoids|mesh-ancestor
92282619|NCT05805930|Hormones|hormones|mesh-ancestor
92282620|NCT05805930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282621|NCT05805930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282622|NCT05805930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282623|NCT05805930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282624|NCT05805930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282625|NCT05805891|Bortezomib|bortezomib|mesh-list
92282626|NCT05805891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282627|NCT05805800|Dexamethasone|dexamethasone|mesh-list
92282628|NCT05805800|Olanzapine|olanzapine|mesh-list
92282629|NCT05805800|Serotonin|serotonin|mesh-list
92282630|NCT05805800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282631|NCT05805800|Antiemetics|antiemetics|mesh-ancestor
92282632|NCT05805800|Autonomic Agents|autonomic agents|mesh-ancestor
92282633|NCT05805800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282634|NCT05805800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282635|NCT05805800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282636|NCT05805800|Glucocorticoids|glucocorticoids|mesh-ancestor
92282637|NCT05805800|Hormones|hormones|mesh-ancestor
92282638|NCT05805800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282639|NCT05805800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282640|NCT05805800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282641|NCT05805800|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92282642|NCT05805800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92282643|NCT05805800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92282644|NCT05805800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92282645|NCT05805800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92282646|NCT05805800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92282647|NCT05805800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92282648|NCT05805800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282649|NCT05805800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92282650|NCT05805800|Serotonin Agents|serotonin agents|mesh-ancestor
92282651|NCT05805800|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92282652|NCT05805761|Anti-Infective Agents|anti-infective agents|mesh-list
92282653|NCT05805761|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92282654|NCT05805631|Pemetrexed|pemetrexed|mesh-list
92282655|NCT05805631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282656|NCT05805631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282657|NCT05805631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282658|NCT05805631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92282659|NCT05805631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92282660|NCT05805553|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92282661|NCT05805553|Propranolol|propranolol|mesh-list
92282662|NCT05805553|Nandrolone|nandrolone|mesh-list
92282663|NCT05805553|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92282664|NCT05805553|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92282665|NCT05805553|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92282666|NCT05805553|Adrenergic Agents|adrenergic agents|mesh-ancestor
92282667|NCT05805553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92282668|NCT05805553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282669|NCT05805553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282670|NCT05805553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92282671|NCT05805553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92282672|NCT05805553|Vasodilator Agents|vasodilator agents|mesh-ancestor
92282673|NCT05805553|Androgens|androgens|mesh-ancestor
92282674|NCT05805553|Hormones|hormones|mesh-ancestor
92282675|NCT05805553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282676|NCT05805553|Anabolic Agents|anabolic agents|mesh-ancestor
92282677|NCT05805553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92282678|NCT05804747|Edoxaban|edoxaban|mesh-list
92282679|NCT05804747|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92282680|NCT05804747|Antithrombins|antithrombins|mesh-ancestor
92282681|NCT05804747|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92282682|NCT05804747|Protease Inhibitors|protease inhibitors|mesh-ancestor
92282683|NCT05804747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282684|NCT05804747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282685|NCT05804747|Anticoagulants|anticoagulants|mesh-ancestor
92282686|NCT05800938|Isosorbide|isosorbide|mesh-list
92282687|NCT05800938|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92282688|NCT05800938|Diuretics|diuretics|mesh-ancestor
92282689|NCT05800938|Natriuretic Agents|natriuretic agents|mesh-ancestor
92282690|NCT05800938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282691|NCT05797935|Dapagliflozin|dapagliflozin|mesh-list
92282692|NCT05797935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92322590|NCT00002162|Stavudine|stavudine|mesh-list
92282693|NCT05797935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282694|NCT05797935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92282695|NCT05797935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282696|NCT05775237|Vitamins|vitamins|mesh-list
92282697|NCT05775237|Ascorbic Acid|ascorbic acid|mesh-list
92282698|NCT05775237|Curcumin|curcumin|mesh-list
92282699|NCT05775237|Micronutrients|micronutrients|mesh-ancestor
92282700|NCT05775237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282701|NCT05775237|Antioxidants|antioxidants|mesh-ancestor
92282702|NCT05775237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282703|NCT05775237|Protective Agents|protective agents|mesh-ancestor
92282704|NCT05775237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92282705|NCT05775237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92282706|NCT05775237|Analgesics|analgesics|mesh-ancestor
92282707|NCT05775237|Sensory System Agents|sensory system agents|mesh-ancestor
92282708|NCT05775237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282709|NCT05775237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282710|NCT05775237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282711|NCT05775237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282712|NCT05775237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282713|NCT05773365|Anesthetics|anesthetics|mesh-list
92282714|NCT05773365|Anesthetics, Local|anesthetics, local|mesh-list
92282715|NCT05773365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92282716|NCT05773365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282717|NCT05773365|Sensory System Agents|sensory system agents|mesh-ancestor
92282718|NCT05773365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282720|NCT05751044|Dexamethasone|dexamethasone|mesh-list
92282721|NCT05751044|Cyclophosphamide|cyclophosphamide|mesh-list
92282722|NCT05751044|Venetoclax|venetoclax|mesh-list
92282723|NCT05751044|Dasatinib|dasatinib|mesh-list
92282724|NCT05751044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282725|NCT05751044|Immunologic Factors|immunologic factors|mesh-ancestor
92282726|NCT05751044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282727|NCT05751044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282728|NCT05751044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92282729|NCT05751044|Alkylating Agents|alkylating agents|mesh-ancestor
92282730|NCT05751044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282731|NCT05751044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282732|NCT05751044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92282733|NCT05751044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282734|NCT05751044|Antiemetics|antiemetics|mesh-ancestor
92282735|NCT05751044|Autonomic Agents|autonomic agents|mesh-ancestor
92282736|NCT05751044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282737|NCT05751044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282738|NCT05751044|Glucocorticoids|glucocorticoids|mesh-ancestor
92282739|NCT05751044|Hormones|hormones|mesh-ancestor
92282740|NCT05751044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282741|NCT05751044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282742|NCT05751044|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282743|NCT05751044|Antimetabolites|antimetabolites|mesh-ancestor
92282744|NCT05751044|Antiviral Agents|antiviral agents|mesh-ancestor
92282745|NCT05751044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282746|NCT05751044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92282747|NCT05751044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282748|NCT05709093|Azacitidine|azacitidine|mesh-list
92282749|NCT05709093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282750|NCT05709093|Antimetabolites|antimetabolites|mesh-ancestor
92282751|NCT05709093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282752|NCT05709093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282753|NCT05709093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282754|NCT05690646|Ritonavir|ritonavir|mesh-list
92282755|NCT05690646|Nirmatrelvir|nirmatrelvir|mesh-list
92282756|NCT05690646|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92282757|NCT05690646|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92282758|NCT05690646|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92282759|NCT05690646|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92282760|NCT05690646|Protease Inhibitors|protease inhibitors|mesh-ancestor
92282761|NCT05690646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282762|NCT05690646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282763|NCT05690646|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282764|NCT05690646|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282765|NCT05690646|Antiviral Agents|antiviral agents|mesh-ancestor
92282766|NCT05690646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282767|NCT05690646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92282768|NCT05690646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92282769|NCT05690646|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92282770|NCT05690646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282771|NCT05648201|Raltegravir Potassium|raltegravir potassium|mesh-list
92282772|NCT05648201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282773|NCT05648201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282774|NCT05648201|Antiviral Agents|antiviral agents|mesh-ancestor
92282775|NCT05648201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282776|NCT05648201|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92282777|NCT05648201|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92282778|NCT05648201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282779|NCT05648201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282780|NCT05627635|Calcium, Dietary|calcium, dietary|mesh-list
92282781|NCT05627635|Leucovorin|leucovorin|mesh-list
92282782|NCT05627635|Folic Acid|folic acid|mesh-list
92282783|NCT05627635|Bevacizumab|bevacizumab|mesh-list
92282784|NCT05627635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92282785|NCT05627635|Fluorouracil|fluorouracil|mesh-list
92282786|NCT05627635|Oxaliplatin|oxaliplatin|mesh-list
92282787|NCT05627635|Endothelial Growth Factors|endothelial growth factors|mesh-list
92282789|NCT05627635|Immunoglobulins|immunoglobulins|mesh-list
92282790|NCT05627635|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92282791|NCT05627635|Immunoglobulin G|immunoglobulin g|mesh-list
92282792|NCT05627635|Calcium|calcium|mesh-list
92282793|NCT05627635|Levoleucovorin|levoleucovorin|mesh-list
92282794|NCT05627635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282795|NCT05627635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92282796|NCT05627635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92282797|NCT05627635|Growth Substances|growth substances|mesh-ancestor
92282798|NCT05627635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282799|NCT05627635|Growth Inhibitors|growth inhibitors|mesh-ancestor
92282800|NCT05627635|Immunologic Factors|immunologic factors|mesh-ancestor
92282801|NCT05627635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92282802|NCT05627635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92282803|NCT05627635|Antimetabolites|antimetabolites|mesh-ancestor
92282804|NCT05627635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282805|NCT05627635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282806|NCT05627635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282807|NCT05627635|Antidotes|antidotes|mesh-ancestor
92282808|NCT05627635|Protective Agents|protective agents|mesh-ancestor
92282809|NCT05627635|Vitamin B Complex|vitamin b complex|mesh-ancestor
92282810|NCT05627635|Vitamins|vitamins|mesh-ancestor
92282811|NCT05627635|Micronutrients|micronutrients|mesh-ancestor
92282812|NCT05627635|Hematinics|hematinics|mesh-ancestor
92282813|NCT05607004|Exemestane|exemestane|mesh-list
92282814|NCT05607004|Goserelin|goserelin|mesh-list
92282815|NCT05607004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282816|NCT05607004|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92282817|NCT05607004|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92282818|NCT05607004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282819|NCT05607004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282820|NCT05607004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92282821|NCT05607004|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282822|NCT05607004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282823|NCT05607004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282824|NCT05607004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92282825|NCT05604300|Vitamin E|vitamin e|mesh-list
92282826|NCT05604300|Vitamins|vitamins|mesh-ancestor
92282827|NCT05604300|Micronutrients|micronutrients|mesh-ancestor
92282828|NCT05604300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282829|NCT05604300|Antioxidants|antioxidants|mesh-ancestor
92282830|NCT05604300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282831|NCT05604300|Protective Agents|protective agents|mesh-ancestor
92282832|NCT05593497|Abiraterone Acetate|abiraterone acetate|mesh-list
92282833|NCT05593497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282834|NCT05593497|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92282835|NCT05593497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282836|NCT05593497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282837|NCT05593497|Hormone Antagonists|hormone antagonists|mesh-ancestor
92282838|NCT05593497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92282839|NCT05593497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282840|NCT05593497|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92282841|NCT05511870|Etripamil|etripamil|mesh-list
92282842|NCT05511870|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92282843|NCT05511870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92282844|NCT05511870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282845|NCT05511870|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92282846|NCT05511870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282848|NCT05492851|Viscosupplements|viscosupplements|mesh-ancestor
92282849|NCT05492851|Protective Agents|protective agents|mesh-ancestor
92282850|NCT05492851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282852|NCT05486104|Dermatologic Agents|dermatologic agents|mesh-ancestor
92282853|NCT05486104|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92282854|NCT05486104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92282855|NCT05486104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282856|NCT05486104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282857|NCT05429762|Maytansine|maytansine|mesh-list
92282858|NCT05429762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282859|NCT05429762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282860|NCT05429762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92282861|NCT05429762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92282862|NCT05429762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92282863|NCT05429762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282864|NCT05423535|Fibrin Foam|fibrin foam|mesh-list
92282865|NCT05423535|Hemostatics|hemostatics|mesh-ancestor
92282866|NCT05423535|Coagulants|coagulants|mesh-ancestor
92282867|NCT05414409|Metformin|metformin|mesh-list
92282868|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92282869|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282870|NCT05411575|Plerixafor|plerixafor|mesh-list
92282871|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92282872|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92282873|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
92282874|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282875|NCT05367401|Azacitidine|azacitidine|mesh-list
92282876|NCT05367401|Magrolimab|magrolimab|mesh-list
92282877|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92282878|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
92282879|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282880|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282881|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282882|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92282883|NCT05297448|Rifaximin|rifaximin|mesh-list
92282884|NCT05297448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92282885|NCT05297448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92282886|NCT05297448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92282887|NCT05161156|Bromides|bromides|mesh-list
92282888|NCT05161156|Tiotropium Bromide|tiotropium bromide|mesh-list
92282889|NCT05161156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92282890|NCT05161156|Autonomic Agents|autonomic agents|mesh-ancestor
92282891|NCT05161156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282892|NCT05161156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282893|NCT05161156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92282894|NCT05161156|Respiratory System Agents|respiratory system agents|mesh-ancestor
92282895|NCT05161156|Parasympatholytics|parasympatholytics|mesh-ancestor
92282896|NCT05161156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92282897|NCT05161156|Cholinergic Agents|cholinergic agents|mesh-ancestor
92282898|NCT05161156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92282899|NCT05161156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282900|NCT05161156|Anticonvulsants|anticonvulsants|mesh-ancestor
92282901|NCT05132101|Palbociclib|palbociclib|mesh-list
92282902|NCT05132101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282903|NCT05132101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92282904|NCT05132101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282905|NCT05132101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282906|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
92282907|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92282908|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92282909|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282910|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
92282911|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
92282913|NCT05045950|Memantine|memantine|mesh-list
92282914|NCT05045950|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92282915|NCT05045950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92282916|NCT05045950|Dopamine Agents|dopamine agents|mesh-ancestor
92282917|NCT05045950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92282918|NCT05045950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282919|NCT05045950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282920|NCT05045950|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92282921|NCT05045950|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92282922|NCT04947514|Tranexamic Acid|tranexamic acid|mesh-list
92282923|NCT04947514|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92282924|NCT04947514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91935780|NCT02330757|Clomiphene|clomiphene|mesh-list
92282925|NCT04947514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282926|NCT04947514|Hemostatics|hemostatics|mesh-ancestor
92282927|NCT04947514|Coagulants|coagulants|mesh-ancestor
92282928|NCT04924101|Cisplatin|cisplatin|mesh-list
92282929|NCT04924101|Carboplatin|carboplatin|mesh-list
92282930|NCT04924101|Pembrolizumab|pembrolizumab|mesh-list
92282931|NCT04924101|Etoposide|etoposide|mesh-list
92282932|NCT04924101|Etoposide phosphate|etoposide phosphate|mesh-list
92282933|NCT04924101|Lenvatinib|lenvatinib|mesh-list
92282934|NCT04924101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282935|NCT04924101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92282936|NCT04924101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92282937|NCT04924101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282938|NCT04924101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92282939|NCT04924101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92282940|NCT04924101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92282941|NCT04924101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282942|NCT04924101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92282943|NCT04860011|Dapagliflozin|dapagliflozin|mesh-list
92282944|NCT04860011|Metolazone|metolazone|mesh-list
92282945|NCT04860011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92282946|NCT04860011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282948|NCT04860011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282949|NCT04860011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92282950|NCT04860011|Diuretics|diuretics|mesh-ancestor
92282951|NCT04860011|Natriuretic Agents|natriuretic agents|mesh-ancestor
92282952|NCT04860011|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92282953|NCT04860011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92282954|NCT04837014|Acetaminophen|acetaminophen|mesh-list
92282955|NCT04837014|Naproxen|naproxen|mesh-list
92282956|NCT04837014|Hydromorphone|hydromorphone|mesh-list
92282957|NCT04837014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92282958|NCT04837014|Analgesics|analgesics|mesh-ancestor
92282959|NCT04837014|Sensory System Agents|sensory system agents|mesh-ancestor
92282960|NCT04837014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92282961|NCT04837014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282962|NCT04837014|Antipyretics|antipyretics|mesh-ancestor
92282963|NCT04837014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92282964|NCT04837014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92282965|NCT04837014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92282966|NCT04837014|Gout Suppressants|gout suppressants|mesh-ancestor
92282967|NCT04837014|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92282968|NCT04837014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282969|NCT04837014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282970|NCT04837014|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92282971|NCT04837014|Narcotics|narcotics|mesh-ancestor
92282972|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92282973|NCT04827745|Blinatumomab|blinatumomab|mesh-list
92282974|NCT04827745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282975|NCT04735978|Nivolumab|nivolumab|mesh-list
92282976|NCT04735978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92282977|NCT04735978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282978|NCT04735978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92282979|NCT04735978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282980|NCT04704050|Dronedarone|dronedarone|mesh-list
92282981|NCT04704050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92282982|NCT04696146|Complement C1s|complement c1s|mesh-list
92282983|NCT04696146|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92282984|NCT04696146|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92282985|NCT04696146|Immunologic Factors|immunologic factors|mesh-ancestor
92282986|NCT04696146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282987|NCT04696146|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92282989|NCT04669210|Mycophenolic Acid|mycophenolic acid|mesh-list
92282990|NCT04669210|Tacrolimus|tacrolimus|mesh-list
92282991|NCT04669210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92282992|NCT04669210|Immunologic Factors|immunologic factors|mesh-ancestor
92282993|NCT04669210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92282994|NCT04669210|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92282995|NCT04669210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92282996|NCT04669210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92282997|NCT04669210|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92282998|NCT04669210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92282999|NCT04669210|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92283000|NCT04669210|Antitubercular Agents|antitubercular agents|mesh-ancestor
92283001|NCT04669210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283002|NCT04669210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283004|NCT04655157|Ipilimumab|ipilimumab|mesh-list
92283005|NCT04655157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283006|NCT04655157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409107|NCT05907746|Mycophenolic Acid|mycophenolic acid|mesh-list
92283007|NCT04655157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283008|NCT04655157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283009|NCT04650269|Emtricitabine|emtricitabine|mesh-list
92283010|NCT04650269|Antiviral Agents|antiviral agents|mesh-ancestor
92283011|NCT04650269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283012|NCT04650269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92283013|NCT04650269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92283014|NCT04650269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283015|NCT04650269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283016|NCT04650269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92283017|NCT04650269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92283018|NCT04629196|Ustekinumab|ustekinumab|mesh-list
92283019|NCT04629196|Dermatologic Agents|dermatologic agents|mesh-ancestor
92283020|NCT04628338|Interferons|interferons|mesh-list
92283021|NCT04628338|Interferon-gamma|interferon-gamma|mesh-list
92283022|NCT04628338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283023|NCT04628338|Antiviral Agents|antiviral agents|mesh-ancestor
92283024|NCT04628338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283025|NCT04617002|TIC10 compound|tic10 compound|mesh-list
92283026|NCT04617002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283027|NCT04591808|Perindopril|perindopril|mesh-list
92283028|NCT04591808|Atorvastatin|atorvastatin|mesh-list
92283029|NCT04591808|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92283030|NCT04591808|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92283031|NCT04591808|Antimetabolites|antimetabolites|mesh-ancestor
92283032|NCT04591808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283033|NCT04591808|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92283034|NCT04591808|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92283035|NCT04591808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283036|NCT04591808|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92283037|NCT04591808|Protease Inhibitors|protease inhibitors|mesh-ancestor
92283038|NCT04591808|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92283039|NCT04587687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92283040|NCT04587687|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92283041|NCT04587687|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92283042|NCT04587687|Antibodies|antibodies|mesh-list
92283043|NCT04587687|Immunoglobulins|immunoglobulins|mesh-list
92283044|NCT04587687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92283045|NCT04587687|Immunoconjugates|immunoconjugates|mesh-list
92283046|NCT04587687|Immunologic Factors|immunologic factors|mesh-ancestor
92283047|NCT04587687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283048|NCT04587687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283049|NCT04587687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283050|NCT04587687|Alkylating Agents|alkylating agents|mesh-ancestor
92283051|NCT04587687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283052|NCT04587687|Immunotoxins|immunotoxins|mesh-ancestor
92283053|NCT04585750|Pembrolizumab|pembrolizumab|mesh-list
92283054|NCT04585750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283055|NCT04585750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283056|NCT04585750|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283057|NCT04585750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283058|NCT04578600|Lenalidomide|lenalidomide|mesh-list
92283059|NCT04578600|Azacitidine|azacitidine|mesh-list
92283060|NCT04578600|Obinutuzumab|obinutuzumab|mesh-list
92283061|NCT04578600|Immunologic Factors|immunologic factors|mesh-ancestor
92283062|NCT04578600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283063|NCT04578600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283064|NCT04578600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283065|NCT04578600|Growth Substances|growth substances|mesh-ancestor
92283066|NCT04578600|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283067|NCT04578600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283068|NCT04578600|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283069|NCT04578600|Antimetabolites|antimetabolites|mesh-ancestor
92283070|NCT04578600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283071|NCT04578600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283072|NCT04578600|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283073|NCT04471987|Interleukin-12|interleukin-12|mesh-list
91935956|NCT02319187|Irinotecan|irinotecan|mesh-list
92283074|NCT04471987|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92283075|NCT04471987|Immunologic Factors|immunologic factors|mesh-ancestor
92283076|NCT04471987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283077|NCT04471987|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283078|NCT04471987|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283079|NCT04471987|Growth Substances|growth substances|mesh-ancestor
92283080|NCT04471987|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283081|NCT04471987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283082|NCT04447768|Venetoclax|venetoclax|mesh-list
92283083|NCT04447768|Obinutuzumab|obinutuzumab|mesh-list
92283084|NCT04447768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283085|NCT04447768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283086|NCT04405037|Alvimopan|alvimopan|mesh-list
92283087|NCT04405037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283088|NCT04389177|Paclitaxel|paclitaxel|mesh-list
92283089|NCT04389177|Cisplatin|cisplatin|mesh-list
92283090|NCT04389177|Pembrolizumab|pembrolizumab|mesh-list
92283091|NCT04389177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283092|NCT04389177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283093|NCT04389177|Tubulin Modulators|tubulin modulators|mesh-ancestor
92283094|NCT04389177|Antimitotic Agents|antimitotic agents|mesh-ancestor
92283095|NCT04389177|Mitosis Modulators|mitosis modulators|mesh-ancestor
92283096|NCT04389177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283097|NCT04389177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283098|NCT04389177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283099|NCT04368988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92283100|NCT04365257|Prazosin|prazosin|mesh-list
92283101|NCT04365257|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-list
92283102|NCT04365257|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92283103|NCT04365257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92283104|NCT04365257|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92283105|NCT04365257|Adrenergic Agents|adrenergic agents|mesh-ancestor
92283106|NCT04365257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283107|NCT04365257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283108|NCT04365257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283109|NCT04341545|Letrozole|letrozole|mesh-list
92283110|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283111|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92283112|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92283113|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283114|NCT04341545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283115|NCT04341545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92283116|NCT04341545|Hormone Antagonists|hormone antagonists|mesh-ancestor
92283117|NCT04341545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283118|NCT04341545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283119|NCT04220021|Metformin|metformin|mesh-list
92283120|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92283121|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283122|NCT04219722|Hyaluronic Acid|hyaluronic acid|mesh-list
92283123|NCT04219722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92283124|NCT04219722|Immunologic Factors|immunologic factors|mesh-ancestor
92283125|NCT04219722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283126|NCT04219722|Viscosupplements|viscosupplements|mesh-ancestor
92283127|NCT04219722|Protective Agents|protective agents|mesh-ancestor
92283128|NCT04191304|Benralizumab|benralizumab|mesh-list
92283129|NCT04191304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92283130|NCT04191304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92283131|NCT04186299|Clonidine|clonidine|mesh-list
92283132|NCT04186299|Epinephrine|epinephrine|mesh-list
92283134|NCT04186299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92283135|NCT04186299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92283136|NCT04186299|Adrenergic Agents|adrenergic agents|mesh-ancestor
92283137|NCT04186299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283138|NCT04186299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283139|NCT04186299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283140|NCT04186299|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92283141|NCT04186299|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92283142|NCT04186299|Autonomic Agents|autonomic agents|mesh-ancestor
92283143|NCT04186299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283144|NCT04186299|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92283145|NCT04186299|Respiratory System Agents|respiratory system agents|mesh-ancestor
92283147|NCT04186299|Sympathomimetics|sympathomimetics|mesh-ancestor
92283148|NCT04186299|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92283149|NCT04186299|Analgesics|analgesics|mesh-ancestor
92283150|NCT04186299|Sensory System Agents|sensory system agents|mesh-ancestor
92283151|NCT04186299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92283152|NCT04186299|Sympatholytics|sympatholytics|mesh-ancestor
92283153|NCT04186299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92283154|NCT04186299|Anesthetics, Local|anesthetics, local|mesh-ancestor
92283155|NCT04186299|Anesthetics|anesthetics|mesh-ancestor
92344903|NCT03695380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283156|NCT04186299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92283157|NCT04165096|Acetaminophen|acetaminophen|mesh-list
92283158|NCT04165096|Diphenhydramine|diphenhydramine|mesh-list
92283159|NCT04165096|Promethazine|promethazine|mesh-list
92283160|NCT04165096|Pembrolizumab|pembrolizumab|mesh-list
92283161|NCT04165096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283162|NCT04165096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283163|NCT04165096|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283164|NCT04165096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283165|NCT04165096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92283166|NCT04165096|Analgesics|analgesics|mesh-ancestor
92283167|NCT04165096|Sensory System Agents|sensory system agents|mesh-ancestor
92283168|NCT04165096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283169|NCT04165096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283170|NCT04165096|Antipyretics|antipyretics|mesh-ancestor
92283171|NCT04165096|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92283172|NCT04165096|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92283173|NCT04165096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92283174|NCT04165096|Anesthetics, Local|anesthetics, local|mesh-ancestor
92283175|NCT04165096|Anesthetics|anesthetics|mesh-ancestor
92283176|NCT04165096|Antiemetics|antiemetics|mesh-ancestor
92283177|NCT04165096|Autonomic Agents|autonomic agents|mesh-ancestor
92283178|NCT04165096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283179|NCT04165096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92283180|NCT04165096|Histamine Antagonists|histamine antagonists|mesh-ancestor
92283181|NCT04165096|Histamine Agents|histamine agents|mesh-ancestor
92283182|NCT04165096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283183|NCT04165096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92283184|NCT04165096|Antipruritics|antipruritics|mesh-ancestor
92283185|NCT04165096|Dermatologic Agents|dermatologic agents|mesh-ancestor
92283186|NCT04145700|Gemcitabine|gemcitabine|mesh-list
92283187|NCT04145700|Docetaxel|docetaxel|mesh-list
92283188|NCT04145700|Ramucirumab|ramucirumab|mesh-list
92283189|NCT04145700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283190|NCT04145700|Antimetabolites|antimetabolites|mesh-ancestor
92283191|NCT04145700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283192|NCT04145700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283193|NCT04145700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92283194|NCT04145700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92283195|NCT04145700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92283196|NCT04068753|Niraparib|niraparib|mesh-list
92283197|NCT04068753|Dostarlimab|dostarlimab|mesh-list
92283198|NCT04068753|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92283199|NCT04068753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283200|NCT04068753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283201|NCT04068753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283202|NCT04005690|Olaparib|olaparib|mesh-list
92283203|NCT04005690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92283204|NCT04005690|Onvansertib|onvansertib|mesh-list
92283205|NCT04005690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283206|NCT04005690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283207|NCT04005690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283208|NCT04005690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92283210|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92283211|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283212|NCT03973268|Immunologic Factors|immunologic factors|mesh-ancestor
92283213|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283214|NCT03927222|Temozolomide|temozolomide|mesh-list
92283215|NCT03927222|Molgramostim|molgramostim|mesh-list
92283216|NCT03927222|Sargramostim|sargramostim|mesh-list
92283217|NCT03927222|Immunologic Factors|immunologic factors|mesh-ancestor
92283218|NCT03927222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283219|NCT03927222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283220|NCT03927222|Alkylating Agents|alkylating agents|mesh-ancestor
92283221|NCT03927222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283222|NCT03927222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283223|NCT03869892|Trifluridine|trifluridine|mesh-list
92283224|NCT03869892|Bevacizumab|bevacizumab|mesh-list
92283225|NCT03869892|Capecitabine|capecitabine|mesh-list
92283226|NCT03869892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283227|NCT03869892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283228|NCT03869892|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283229|NCT03869892|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283230|NCT03869892|Growth Substances|growth substances|mesh-ancestor
92283231|NCT03869892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283232|NCT03869892|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283233|NCT03869892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283234|NCT03869892|Antimetabolites|antimetabolites|mesh-ancestor
92283235|NCT03869892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283236|NCT03869892|Antiviral Agents|antiviral agents|mesh-ancestor
92283237|NCT03869892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283238|NCT03822663|Caffeine|caffeine|mesh-list
92283239|NCT03822663|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92283240|NCT03822663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283241|NCT03822663|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92283242|NCT03822663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283243|NCT03822663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283244|NCT03822663|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92283245|NCT03822663|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92283246|NCT03822663|Purinergic Agents|purinergic agents|mesh-ancestor
92283247|NCT03822663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283248|NCT03801525|Venetoclax|venetoclax|mesh-list
92283249|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283250|NCT03778957|Bevacizumab|bevacizumab|mesh-list
92283251|NCT03778957|Durvalumab|durvalumab|mesh-list
92283252|NCT03778957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283253|NCT03778957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283254|NCT03778957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283255|NCT03778957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283256|NCT03778957|Growth Substances|growth substances|mesh-ancestor
92283257|NCT03778957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283258|NCT03778957|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283259|NCT03767933|Acetaminophen|acetaminophen|mesh-list
92283260|NCT03767933|Ibuprofen|ibuprofen|mesh-list
92283261|NCT03767933|Hydromorphone|hydromorphone|mesh-list
92283262|NCT03767933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92283263|NCT03767933|Analgesics|analgesics|mesh-ancestor
92283264|NCT03767933|Sensory System Agents|sensory system agents|mesh-ancestor
92283265|NCT03767933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283266|NCT03767933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283267|NCT03767933|Antipyretics|antipyretics|mesh-ancestor
92283268|NCT03767933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92283269|NCT03767933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92283270|NCT03767933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283271|NCT03767933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92283272|NCT03767933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283273|NCT03767933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283274|NCT03767933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92283275|NCT03767933|Narcotics|narcotics|mesh-ancestor
92283276|NCT03767933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92283277|NCT03701919|Botulinum Toxins|botulinum toxins|mesh-list
92283278|NCT03701919|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92283279|NCT03701919|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92283280|NCT03701919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92283281|NCT03701919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283282|NCT03701919|Cholinergic Agents|cholinergic agents|mesh-ancestor
92283283|NCT03701919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283284|NCT03701919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283285|NCT03701919|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92283286|NCT03701919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283287|NCT03636152|Hydroxychloroquine|hydroxychloroquine|mesh-list
92283288|NCT03636152|Chloroquine|chloroquine|mesh-list
92283289|NCT03636152|Antimalarials|antimalarials|mesh-ancestor
92283290|NCT03636152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92283291|NCT03636152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92283292|NCT03636152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283293|NCT03636152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283294|NCT03636152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283295|NCT03636152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283296|NCT03636152|Amebicides|amebicides|mesh-ancestor
92283297|NCT03633604|HBOC 201|hboc 201|mesh-list
92283298|NCT03633604|Blood Substitutes|blood substitutes|mesh-ancestor
92283299|NCT03555916|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92283300|NCT03555916|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92283301|NCT03555916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283302|NCT03555916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283303|NCT03555916|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92283304|NCT03555916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92283305|NCT03555916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283307|NCT03555916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283308|NCT03474497|Pembrolizumab|pembrolizumab|mesh-list
92283309|NCT03474497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283310|NCT03474497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283311|NCT03474497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283312|NCT03474497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283313|NCT03395223|Methylene Blue|methylene blue|mesh-list
92283314|NCT03395223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283315|NCT03395223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283316|NCT03289650|Tacrolimus|tacrolimus|mesh-list
92283317|NCT03289650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283318|NCT03289650|Immunologic Factors|immunologic factors|mesh-ancestor
92283319|NCT03289650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283320|NCT03289650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92283321|NCT03289650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283322|NCT03289650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283323|NCT03255070|Immunoconjugates|immunoconjugates|mesh-list
92283324|NCT03255070|Immunologic Factors|immunologic factors|mesh-ancestor
92283325|NCT03255070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283326|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
92283327|NCT03192397|Sirolimus|sirolimus|mesh-list
92283328|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
92283329|NCT03192397|Melphalan|melphalan|mesh-list
92283330|NCT03192397|Fludarabine|fludarabine|mesh-list
92283331|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
92283332|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283333|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
92283334|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283335|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283336|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283337|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
92283338|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283339|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283340|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283341|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283342|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
92283343|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283344|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92283345|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
92283346|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283347|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283348|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283349|NCT03192397|Antifungal Agents|antifungal agents|mesh-ancestor
92283350|NCT02975492|Vitamin D|vitamin d|mesh-list
92283351|NCT02975492|Ergocalciferols|ergocalciferols|mesh-list
92283352|NCT02975492|Cholecalciferol|cholecalciferol|mesh-list
92283353|NCT02975492|Vitamins|vitamins|mesh-list
92283354|NCT02975492|Micronutrients|micronutrients|mesh-ancestor
92283355|NCT02975492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283356|NCT02975492|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92283357|NCT02975492|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92283359|NCT02937818|Durvalumab|durvalumab|mesh-list
92283360|NCT02937818|Olaparib|olaparib|mesh-list
92283361|NCT02937818|Tremelimumab|tremelimumab|mesh-list
92283362|NCT02937818|Adavosertib|adavosertib|mesh-list
92283363|NCT02937818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283364|NCT02937818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283365|NCT02937818|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92283366|NCT02937818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283367|NCT02937818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283368|NCT02867267|Thymalfasin|thymalfasin|mesh-list
92283369|NCT02867267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92283370|NCT02867267|Immunologic Factors|immunologic factors|mesh-ancestor
92283371|NCT02867267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283372|NCT02821832|Rifampin|rifampin|mesh-list
92283373|NCT02821832|Isoniazid|isoniazid|mesh-list
92283374|NCT02821832|Pyrazinamide|pyrazinamide|mesh-list
92283375|NCT02821832|Ethambutol|ethambutol|mesh-list
92283376|NCT02821832|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91936228|NCT02321371|Rifaximin|rifaximin|mesh-list
92283377|NCT02821832|Antitubercular Agents|antitubercular agents|mesh-ancestor
92283378|NCT02821832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283379|NCT02821832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283380|NCT02821832|Leprostatic Agents|leprostatic agents|mesh-ancestor
92283381|NCT02821832|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92283382|NCT02821832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283383|NCT02821832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283384|NCT02821832|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92283385|NCT02821832|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92283386|NCT02821832|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92283387|NCT02821832|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92283388|NCT02821832|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92283389|NCT02821832|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92283390|NCT02821832|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92283391|NCT02821832|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92283392|NCT02821832|Antimetabolites|antimetabolites|mesh-ancestor
92283393|NCT02821832|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92283394|NCT02813148|Naloxegol|naloxegol|mesh-list
92283395|NCT02813148|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92283396|NCT02813148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283397|NCT02813148|Sensory System Agents|sensory system agents|mesh-ancestor
92283398|NCT02813148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283399|NCT02756611|Venetoclax|venetoclax|mesh-list
92283400|NCT02756611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283401|NCT02673359|Progesterone|progesterone|mesh-list
92283402|NCT02673359|Progestins|progestins|mesh-ancestor
92283403|NCT02673359|Hormones|hormones|mesh-ancestor
92283404|NCT02673359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283405|NCT02673359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283406|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
92283407|NCT02629809|Fludarabine|fludarabine|mesh-list
92283408|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
92283409|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
92283410|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283411|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
92283412|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283413|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283414|NCT02629809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283415|NCT02629809|Alkylating Agents|alkylating agents|mesh-ancestor
92283416|NCT02629809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283417|NCT02629809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283418|NCT02629809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283419|NCT02629809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283420|NCT02629809|Antimetabolites|antimetabolites|mesh-ancestor
92283421|NCT02629809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283422|NCT02624518|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
92283423|NCT02624518|Bombesin|bombesin|mesh-list
92283424|NCT02624518|Gastrins|gastrins|mesh-list
92283425|NCT02624518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283426|NCT02624518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283427|NCT02624518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283428|NCT02624518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283429|NCT02624518|Hormones|hormones|mesh-ancestor
92283430|NCT02624518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283432|NCT02542657|Dexamethasone|dexamethasone|mesh-list
92283433|NCT02542657|Pomalidomide|pomalidomide|mesh-list
92283434|NCT02542657|Ixazomib|ixazomib|mesh-list
92283435|NCT02542657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92283436|NCT02542657|Antiemetics|antiemetics|mesh-ancestor
92283437|NCT02542657|Autonomic Agents|autonomic agents|mesh-ancestor
92283438|NCT02542657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283439|NCT02542657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283440|NCT02542657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283441|NCT02542657|Glucocorticoids|glucocorticoids|mesh-ancestor
92283442|NCT02542657|Hormones|hormones|mesh-ancestor
92283443|NCT02542657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283444|NCT02542657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92283445|NCT02542657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283446|NCT02542657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283447|NCT02542657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283448|NCT02542657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283449|NCT02542657|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91936307|NCT04881955|Ecopipam|ecopipam|mesh-list
92283450|NCT02542657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283451|NCT02542657|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92283452|NCT02542657|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92283453|NCT02542657|Immunologic Factors|immunologic factors|mesh-ancestor
92283454|NCT02542657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283455|NCT02542657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283456|NCT02542657|Growth Substances|growth substances|mesh-ancestor
92283457|NCT02542657|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283458|NCT02542657|Protease Inhibitors|protease inhibitors|mesh-ancestor
92283459|NCT02303171|Enoxaparin|enoxaparin|mesh-list
92283460|NCT02303171|Warfarin|warfarin|mesh-list
92283461|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
92283462|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92283463|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92283464|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283465|NCT02287623|Bupivacaine|bupivacaine|mesh-list
92283466|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
92283467|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
92283468|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92283469|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283470|NCT02287623|Sensory System Agents|sensory system agents|mesh-ancestor
92283471|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283472|NCT02266329|Prazosin|prazosin|mesh-list
92283473|NCT02266329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92283474|NCT02266329|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92283475|NCT02266329|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92283476|NCT02266329|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92283477|NCT02266329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92283478|NCT02266329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283479|NCT02266329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283480|NCT02266329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283481|NCT01794520|Dexamethasone|dexamethasone|mesh-list
92283482|NCT01794520|Venetoclax|venetoclax|mesh-list
92283483|NCT01794520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92283484|NCT01794520|Antiemetics|antiemetics|mesh-ancestor
92283485|NCT01794520|Autonomic Agents|autonomic agents|mesh-ancestor
92283486|NCT01794520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283487|NCT01794520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283488|NCT01794520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283489|NCT01794520|Glucocorticoids|glucocorticoids|mesh-ancestor
92283490|NCT01794520|Hormones|hormones|mesh-ancestor
92283491|NCT01794520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283492|NCT01794520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92283493|NCT01794520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283494|NCT01653678|Vitamin D|vitamin d|mesh-list
92283495|NCT01653678|Ergocalciferols|ergocalciferols|mesh-list
92283496|NCT01653678|Cholecalciferol|cholecalciferol|mesh-list
92283497|NCT01653678|Vitamins|vitamins|mesh-list
92283498|NCT01653678|Micronutrients|micronutrients|mesh-ancestor
92283499|NCT01653678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283500|NCT01653678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92283501|NCT01653678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92283502|NCT01370811|Mandelic Acids|mandelic acids|mesh-list
92283503|NCT01370811|Clonidine|clonidine|mesh-list
92283504|NCT01370811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92283505|NCT01370811|Oxybutynin|oxybutynin|mesh-list
92283507|NCT01370811|Sensory System Agents|sensory system agents|mesh-ancestor
92283508|NCT01370811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283509|NCT01370811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283510|NCT01370811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92283511|NCT01370811|Sympatholytics|sympatholytics|mesh-ancestor
92283512|NCT01370811|Autonomic Agents|autonomic agents|mesh-ancestor
92283513|NCT01370811|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92283514|NCT01370811|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92283515|NCT01370811|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92283516|NCT01370811|Adrenergic Agents|adrenergic agents|mesh-ancestor
92283517|NCT01370811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283518|NCT01370811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283519|NCT01370811|Parasympatholytics|parasympatholytics|mesh-ancestor
92283520|NCT01370811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92283521|NCT01370811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92283522|NCT01370811|Cholinergic Agents|cholinergic agents|mesh-ancestor
92283523|NCT01370811|Urological Agents|urological agents|mesh-ancestor
92283524|NCT01370811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91936380|NCT02321839|Ranibizumab|ranibizumab|mesh-list
92283525|NCT01370811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283526|NCT01323569|Nabiximols|nabiximols|mesh-list
92283527|NCT01323569|Dronabinol|dronabinol|mesh-list
92283528|NCT01323569|Analgesics|analgesics|mesh-ancestor
92283529|NCT01323569|Sensory System Agents|sensory system agents|mesh-ancestor
92283530|NCT01323569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283531|NCT01323569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283532|NCT01323569|Hallucinogens|hallucinogens|mesh-ancestor
92283533|NCT01323569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92283534|NCT01323569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92283535|NCT01323569|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92283536|NCT01323569|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92283537|NCT01323569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283538|NCT01323569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283539|NCT01323569|Hormones|hormones|mesh-ancestor
92283540|NCT01323569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283541|NCT01323465|Rifampin|rifampin|mesh-list
92283542|NCT01323465|Ketoconazole|ketoconazole|mesh-list
92283543|NCT01323465|Nabiximols|nabiximols|mesh-list
92283544|NCT01323465|Omeprazole|omeprazole|mesh-list
92283545|NCT01323465|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92283546|NCT01323465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283547|NCT01323465|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92283548|NCT01323465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283549|NCT01323465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283550|NCT01323465|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92283551|NCT01323465|Antitubercular Agents|antitubercular agents|mesh-ancestor
92283552|NCT01323465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283553|NCT01323465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283554|NCT01323465|Leprostatic Agents|leprostatic agents|mesh-ancestor
92283555|NCT01323465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92283556|NCT01323465|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92283557|NCT01323465|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92283558|NCT01323465|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92283559|NCT01323465|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92283560|NCT01323465|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92283561|NCT01323465|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92283562|NCT01323465|Antifungal Agents|antifungal agents|mesh-ancestor
92283563|NCT01323465|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92283564|NCT01323465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92283565|NCT01323465|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92283566|NCT01323465|Hormone Antagonists|hormone antagonists|mesh-ancestor
92283567|NCT01323465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283568|NCT01323465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283569|NCT01323465|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92283570|NCT01323465|Analgesics|analgesics|mesh-ancestor
92283571|NCT01323465|Sensory System Agents|sensory system agents|mesh-ancestor
92283572|NCT01323465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283573|NCT01322464|Nabiximols|nabiximols|mesh-list
92283574|NCT01322464|Analgesics|analgesics|mesh-ancestor
92283575|NCT01322464|Sensory System Agents|sensory system agents|mesh-ancestor
92283576|NCT01322464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322591|NCT00002162|Zalcitabine|zalcitabine|mesh-list
92283578|NCT01322139|Moxifloxacin|moxifloxacin|mesh-list
92283579|NCT01322139|Nabiximols|nabiximols|mesh-list
92283580|NCT01322139|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92283581|NCT01322139|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283582|NCT01322139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283583|NCT01322139|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283584|NCT01322139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283585|NCT01322139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283586|NCT01322139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283587|NCT01322139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283588|NCT01322139|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92283589|NCT01322139|Contraceptive Agents|contraceptive agents|mesh-ancestor
92283590|NCT01322139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92283591|NCT01322139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283592|NCT01322139|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92283593|NCT01322139|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92283594|NCT01322139|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92283596|NCT01322139|Sensory System Agents|sensory system agents|mesh-ancestor
92283597|NCT01322139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283599|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
92283600|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
92283601|NCT01169259|Vitamins|vitamins|mesh-list
92283602|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
92283603|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283604|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92283605|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92283606|NCT01165632|Fluorides|fluorides|mesh-list
92283607|NCT01165632|Cariostatic Agents|cariostatic agents|mesh-ancestor
92283608|NCT01165632|Protective Agents|protective agents|mesh-ancestor
92283609|NCT01165632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283610|NCT01019850|Vorinostat|vorinostat|mesh-list
92283611|NCT01019850|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92283612|NCT01019850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283613|NCT01019850|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92283614|NCT01019850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283615|NCT01019850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283616|NCT01019850|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92283617|NCT00885326|Zoledronic Acid|zoledronic acid|mesh-list
92283618|NCT00885326|Cyclophosphamide|cyclophosphamide|mesh-list
92283619|NCT00885326|Bevacizumab|bevacizumab|mesh-list
92283620|NCT00885326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283621|NCT00885326|Immunologic Factors|immunologic factors|mesh-ancestor
92283622|NCT00885326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283623|NCT00885326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283624|NCT00885326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283625|NCT00885326|Alkylating Agents|alkylating agents|mesh-ancestor
92283626|NCT00885326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283627|NCT00885326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283628|NCT00885326|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283629|NCT00885326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283630|NCT00885326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283631|NCT00885326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283632|NCT00885326|Growth Substances|growth substances|mesh-ancestor
92283633|NCT00885326|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283634|NCT00885326|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92283635|NCT00606138|Ranibizumab|ranibizumab|mesh-list
92283636|NCT00606138|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92283637|NCT00606138|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92283638|NCT00606138|Growth Substances|growth substances|mesh-ancestor
92283639|NCT00606138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283640|NCT00606138|Growth Inhibitors|growth inhibitors|mesh-ancestor
92283641|NCT00606138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283642|NCT00005835|Melphalan|melphalan|mesh-list
92283643|NCT00005835|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
92283644|NCT00005835|Immunologic Factors|immunologic factors|mesh-ancestor
92283645|NCT00005835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283646|NCT00005835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283647|NCT00005835|Alkylating Agents|alkylating agents|mesh-ancestor
92283648|NCT00005835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283649|NCT00005835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283650|NCT00005835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283651|NCT00005835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283653|NCT00005835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283654|NCT00005835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283655|NCT00005835|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92283656|NCT00005835|Protective Agents|protective agents|mesh-ancestor
92283657|NCT04401995|Nivolumab|nivolumab|mesh-list
92283658|NCT04401995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283659|NCT04401995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283660|NCT04401995|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283661|NCT04401995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283662|NCT00002643|Cobalt|cobalt|mesh-list
92283663|NCT00002643|Cyclophosphamide|cyclophosphamide|mesh-list
92283664|NCT00002643|Ifosfamide|ifosfamide|mesh-list
92283665|NCT00002643|Doxorubicin|doxorubicin|mesh-list
92283666|NCT00002643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92283667|NCT00002643|Etoposide|etoposide|mesh-list
92283668|NCT00002643|Vincristine|vincristine|mesh-list
92283669|NCT00002643|Topotecan|topotecan|mesh-list
92283670|NCT00002643|Amifostine|amifostine|mesh-list
92283671|NCT00002643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283672|NCT00002643|Immunologic Factors|immunologic factors|mesh-ancestor
92283673|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283674|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283675|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283676|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
92283677|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283678|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283679|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283680|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283681|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283682|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283683|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283684|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283685|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92283686|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92283687|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92283688|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92283689|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92283690|NCT00002643|Protective Agents|protective agents|mesh-ancestor
92283691|NCT00002643|Trace Elements|trace elements|mesh-ancestor
92283692|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
92283693|NCT00002649|Aldesleukin|aldesleukin|mesh-list
92283694|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
92283695|NCT00002649|Etoposide|etoposide|mesh-list
92283696|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
92283697|NCT00002649|Interleukin-2|interleukin-2|mesh-list
92283698|NCT00002649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283699|NCT00002649|Immunologic Factors|immunologic factors|mesh-ancestor
92283700|NCT00002649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283701|NCT00002649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283702|NCT00002649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283703|NCT00002649|Alkylating Agents|alkylating agents|mesh-ancestor
92283704|NCT00002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283705|NCT00002649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283706|NCT00002649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283707|NCT00002649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283708|NCT00002649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283709|NCT00002649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283710|NCT00002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283711|NCT00002649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92283712|NCT00002649|Analgesics|analgesics|mesh-ancestor
92283713|NCT00002649|Sensory System Agents|sensory system agents|mesh-ancestor
92283714|NCT00002649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283715|NCT00002649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92283716|NCT00002649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92283717|NCT00002649|Antiviral Agents|antiviral agents|mesh-ancestor
92283718|NCT00002649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283719|NCT01151605|Insulin|insulin|mesh-list
92283720|NCT01151605|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92283721|NCT01151605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92283722|NCT01151605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283723|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
92283724|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92283725|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92283726|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283727|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
92283728|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
92283729|NCT00995059|Sirolimus|sirolimus|mesh-list
92283730|NCT00995059|Bortezomib|bortezomib|mesh-list
92283731|NCT00995059|Melphalan|melphalan|mesh-list
92283732|NCT00995059|Tacrolimus|tacrolimus|mesh-list
92283733|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
92283734|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92283735|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
92283736|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283737|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
92283738|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283739|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92283740|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283741|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283742|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283743|NCT00995059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283744|NCT00995059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283745|NCT00995059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936607|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283746|NCT00995059|Antifungal Agents|antifungal agents|mesh-ancestor
92283747|NCT00995059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283748|NCT00995059|Alkylating Agents|alkylating agents|mesh-ancestor
92283749|NCT00995059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283750|NCT02249299|Nabiximols|nabiximols|mesh-list
92283751|NCT02249299|Analgesics|analgesics|mesh-ancestor
92283752|NCT02249299|Sensory System Agents|sensory system agents|mesh-ancestor
92283753|NCT02249299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283754|NCT02249299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283755|NCT00002679|Tamoxifen|tamoxifen|mesh-list
92283756|NCT00002679|Paclitaxel|paclitaxel|mesh-list
92283757|NCT00002679|Cyclophosphamide|cyclophosphamide|mesh-list
92283758|NCT00002679|Doxorubicin|doxorubicin|mesh-list
92283759|NCT00002679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92283760|NCT00002679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283761|NCT00002679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283762|NCT00002679|Tubulin Modulators|tubulin modulators|mesh-ancestor
92283763|NCT00002679|Antimitotic Agents|antimitotic agents|mesh-ancestor
92283764|NCT00002679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92283765|NCT00002679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283766|NCT00002679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283767|NCT00002679|Immunologic Factors|immunologic factors|mesh-ancestor
92283768|NCT00002679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283769|NCT00002679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283770|NCT00002679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283771|NCT00002679|Alkylating Agents|alkylating agents|mesh-ancestor
92283772|NCT00002679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283773|NCT00002679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283774|NCT00002679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283775|NCT00002679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283776|NCT00002679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283777|NCT00002679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92283778|NCT00002679|Hormone Antagonists|hormone antagonists|mesh-ancestor
92283779|NCT00002679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283780|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92283781|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92283782|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92283783|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92283784|NCT00002691|Leucovorin|leucovorin|mesh-list
92283785|NCT00002691|Cytarabine|cytarabine|mesh-list
92283786|NCT00002691|Dexamethasone|dexamethasone|mesh-list
92283787|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
92283788|NCT00002691|Methotrexate|methotrexate|mesh-list
92283789|NCT00002691|Etoposide|etoposide|mesh-list
92283790|NCT00002691|Vincristine|vincristine|mesh-list
92283791|NCT00002691|Daunorubicin|daunorubicin|mesh-list
92283792|NCT00002691|Asparaginase|asparaginase|mesh-list
92283793|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
92283794|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283795|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
92283796|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283797|NCT00002691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92283798|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283799|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
92283800|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283801|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283802|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92283803|NCT00002691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92283806|NCT00002691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283809|NCT00002691|Hormones|hormones|mesh-ancestor
92283810|NCT00002691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283811|NCT00002691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92283812|NCT00002691|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92283813|NCT00002691|Abortifacient Agents|abortifacient agents|mesh-ancestor
92283814|NCT00002691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92283815|NCT00002691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92283816|NCT00002691|Antimetabolites|antimetabolites|mesh-ancestor
92283817|NCT00002691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92283818|NCT00002691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283819|NCT00002691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92283820|NCT00002691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92283821|NCT00002691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283822|NCT00002691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283823|NCT00002691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283824|NCT00002691|Antiviral Agents|antiviral agents|mesh-ancestor
92283825|NCT00002691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283826|NCT00002691|Antidotes|antidotes|mesh-ancestor
92283827|NCT00002691|Protective Agents|protective agents|mesh-ancestor
92283829|NCT00002691|Vitamins|vitamins|mesh-ancestor
92283830|NCT00002691|Micronutrients|micronutrients|mesh-ancestor
92283831|NCT00002691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92283832|NCT00002691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92283833|NCT00002691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92283834|NCT00002691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283835|NCT03003637|Nivolumab|nivolumab|mesh-list
92283836|NCT03003637|Ipilimumab|ipilimumab|mesh-list
92283837|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92283838|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283839|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92283840|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283841|NCT04054115|Alprostadil|alprostadil|mesh-list
92283842|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92283843|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
92283844|NCT04054115|Urological Agents|urological agents|mesh-ancestor
92283845|NCT00002697|Carboplatin|carboplatin|mesh-list
92283846|NCT00002697|Etoposide|etoposide|mesh-list
92283847|NCT00002697|Ifosfamide|ifosfamide|mesh-list
92283848|NCT00002697|Sargramostim|sargramostim|mesh-list
92283849|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283850|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283851|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283852|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283853|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283854|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283855|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
92283856|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283857|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283858|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
92283859|NCT04488601|Sirolimus|sirolimus|mesh-list
92283860|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283861|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283862|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283863|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283864|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
92283865|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92283866|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
92283867|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283868|NCT05032807|Cannabidiol|cannabidiol|mesh-list
92283869|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
92283870|NCT00002715|Prednisone|prednisone|mesh-list
92283871|NCT00002715|Doxorubicin|doxorubicin|mesh-list
92283872|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92283873|NCT00002715|Bleomycin|bleomycin|mesh-list
92283874|NCT00002715|Etoposide|etoposide|mesh-list
92283875|NCT00002715|Vincristine|vincristine|mesh-list
92283876|NCT00002715|Vinblastine|vinblastine|mesh-list
92283877|NCT00002715|Mechlorethamine|mechlorethamine|mesh-list
92283878|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283879|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283880|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91935386|NCT02304289|Artesunate|artesunate|mesh-list
92283881|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283882|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283883|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283884|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92283885|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
92283886|NCT00002715|Hormones|hormones|mesh-ancestor
92283887|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283888|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283889|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92283890|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92283891|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92283892|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92283893|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92283894|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
92283895|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283896|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
92283897|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92283898|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
92283899|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283900|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283901|NCT04972513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92283902|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
92283903|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92283904|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
92283905|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283906|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283907|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92283908|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
92283909|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
92283910|NCT04972513|Protective Agents|protective agents|mesh-ancestor
92283911|NCT02976467|Fulacimstat|fulacimstat|mesh-list
92283912|NCT02976467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283913|NCT02976467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283914|NCT02981095|Bupivacaine|bupivacaine|mesh-list
92283915|NCT02981095|Anesthetics, Local|anesthetics, local|mesh-ancestor
92283916|NCT02981095|Anesthetics|anesthetics|mesh-ancestor
92283917|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92283918|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283919|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
92283920|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283921|NCT00002721|Doxorubicin|doxorubicin|mesh-list
92283922|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92283923|NCT00002721|Estramustine|estramustine|mesh-list
92283924|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92283925|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283926|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92283927|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92283928|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283929|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283930|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92283931|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
92283932|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92283933|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
92283934|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92283935|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283936|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283937|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92283938|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92283939|NCT04739345|Protective Agents|protective agents|mesh-ancestor
92283940|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283941|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
92283942|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92283943|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
92283944|NCT01625455|Aprepitant|aprepitant|mesh-list
92283945|NCT01625455|Antiemetics|antiemetics|mesh-ancestor
92283946|NCT01625455|Autonomic Agents|autonomic agents|mesh-ancestor
92283947|NCT01625455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283948|NCT01625455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283949|NCT01625455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283950|NCT01625455|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92283951|NCT01625455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322592|NCT00002162|Saquinavir|saquinavir|mesh-list
92283952|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283953|NCT05751681|Cetrorelix|cetrorelix|mesh-list
92283954|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
92283955|NCT05751681|Progestins|progestins|mesh-list
92283956|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92283957|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
92283958|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92283959|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283960|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
92283961|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92283962|NCT05751681|Hormones|hormones|mesh-ancestor
92283963|NCT02976623|Metronidazole|metronidazole|mesh-list
92283964|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283965|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92283966|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92283967|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92283968|NCT00002733|Interferons|interferons|mesh-list
92283969|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
92283970|NCT00002733|Aldesleukin|aldesleukin|mesh-list
92283971|NCT00002733|Cimetidine|cimetidine|mesh-list
92283972|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92283973|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
92283974|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92283975|NCT00002733|Immunologic Factors|immunologic factors|mesh-ancestor
92283976|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283977|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91936824|NCT01480583|Alovudine|alovudine|mesh-list
92283978|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92283979|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92283980|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283981|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92283982|NCT00002733|Histamine Antagonists|histamine antagonists|mesh-ancestor
92283983|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
92283984|NCT00002733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92283985|NCT00002733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92283986|NCT00002733|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92283987|NCT00002733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92283988|NCT00002733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92283989|NCT01625923|Olanzapine|olanzapine|mesh-list
92283990|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
92283991|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
92283992|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92283993|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92283994|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92283995|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92283996|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92283997|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92283998|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92283999|NCT01625923|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92284000|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284001|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284002|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284003|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284004|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
92284005|NCT00002751|Antibodies|antibodies|mesh-list
92284006|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92284007|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
92284008|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284009|NCT00002757|Cytarabine|cytarabine|mesh-list
92284010|NCT00002757|Prednisone|prednisone|mesh-list
92284011|NCT00002757|Prednisolone|prednisolone|mesh-list
92284012|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
92284013|NCT00002757|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92284014|NCT00002757|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92284015|NCT00002757|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92284016|NCT00002757|Cyclophosphamide|cyclophosphamide|mesh-list
92284017|NCT00002757|Doxorubicin|doxorubicin|mesh-list
92284018|NCT00002757|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92284019|NCT00002757|Methotrexate|methotrexate|mesh-list
92284020|NCT00002757|Etoposide|etoposide|mesh-list
92284021|NCT00002757|Vincristine|vincristine|mesh-list
92284022|NCT00002757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92284023|NCT00002757|Immunologic Factors|immunologic factors|mesh-ancestor
92284024|NCT00002757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284025|NCT00002757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284026|NCT00002757|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92284027|NCT00002757|Alkylating Agents|alkylating agents|mesh-ancestor
92284028|NCT00002757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284029|NCT00002757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284030|NCT00002757|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92284031|NCT00002757|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92284032|NCT00002757|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92284033|NCT00002757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92284034|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284035|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284036|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
92284037|NCT00002757|Hormones|hormones|mesh-ancestor
92284038|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284039|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92284040|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92284041|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
92284042|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92284043|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284044|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
92284045|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
92284046|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92284047|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92284048|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92284049|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
92284050|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284051|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
92284052|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
92284053|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
92284054|NCT00002763|Interferons|interferons|mesh-list
92284056|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284057|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
92284058|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284059|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
92284060|NCT00002763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284061|NCT00002775|Docetaxel|docetaxel|mesh-list
92284062|NCT00002775|Estramustine|estramustine|mesh-list
92284063|NCT00002775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284064|NCT00002775|Tubulin Modulators|tubulin modulators|mesh-ancestor
92284065|NCT00002775|Antimitotic Agents|antimitotic agents|mesh-ancestor
92284066|NCT00002775|Mitosis Modulators|mitosis modulators|mesh-ancestor
92284067|NCT00002775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284068|NCT00002775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92284069|NCT00002775|Alkylating Agents|alkylating agents|mesh-ancestor
92284070|NCT00002775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92284071|NCT01631149|Rocuronium|rocuronium|mesh-list
92284072|NCT01631149|Atracurium|atracurium|mesh-list
92284073|NCT01631149|Mivacurium|mivacurium|mesh-list
92284074|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92284075|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92284076|NCT01631149|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92284077|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284078|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284079|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92284080|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92284081|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
92284082|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284083|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284084|NCT00002787|Aldesleukin|aldesleukin|mesh-list
92284085|NCT00002787|Interleukin-2|interleukin-2|mesh-list
92284086|NCT00002787|Vaccines|vaccines|mesh-list
92284087|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
92284088|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92284089|NCT00002787|Antibodies|antibodies|mesh-list
92284090|NCT00002787|Sargramostim|sargramostim|mesh-list
92284091|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92284092|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92284093|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
92284094|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284095|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284096|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92284097|NCT00002787|Analgesics|analgesics|mesh-ancestor
92284098|NCT00002787|Sensory System Agents|sensory system agents|mesh-ancestor
92284099|NCT00002787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284100|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92284101|NCT00002787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92284102|NCT00002787|Antiviral Agents|antiviral agents|mesh-ancestor
92284103|NCT00002787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284104|NCT00002787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92284105|NCT02975453|Rivaroxaban|rivaroxaban|mesh-list
92284106|NCT02975453|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92284107|NCT02975453|Antithrombins|antithrombins|mesh-ancestor
92284108|NCT02975453|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92284109|NCT02975453|Protease Inhibitors|protease inhibitors|mesh-ancestor
92284110|NCT02975453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284111|NCT02975453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284112|NCT02975453|Anticoagulants|anticoagulants|mesh-ancestor
92284114|NCT00002793|Fluorouracil|fluorouracil|mesh-list
92284115|NCT00002793|Calcium|calcium|mesh-list
92284116|NCT00002793|Levoleucovorin|levoleucovorin|mesh-list
92284117|NCT00002793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92284118|NCT00002793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284119|NCT00002793|Antimetabolites|antimetabolites|mesh-ancestor
92284120|NCT00002793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284121|NCT00002793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284122|NCT00002793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284123|NCT00002793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92284124|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
92284125|NCT00002793|Antidotes|antidotes|mesh-ancestor
92284126|NCT00002793|Protective Agents|protective agents|mesh-ancestor
92284127|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
92284128|NCT00002793|Vitamins|vitamins|mesh-ancestor
92284129|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
92284130|NCT01632709|Bupivacaine|bupivacaine|mesh-list
92284131|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284132|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
92284133|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284134|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284135|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
92284136|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284137|NCT05751291|Bupivacaine|bupivacaine|mesh-list
92284138|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284139|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
92284140|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409108|NCT05907746|Cyclophosphamide|cyclophosphamide|mesh-list
92284141|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284142|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
92284143|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284144|NCT01634191|Apremilast|apremilast|mesh-list
92284145|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92284146|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92284147|NCT01634191|Analgesics|analgesics|mesh-ancestor
92284148|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
92284149|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284150|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284151|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284152|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284153|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92284154|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92284155|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284156|NCT01634191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284157|NCT04005443|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92284158|NCT04005443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284159|NCT04003649|Nivolumab|nivolumab|mesh-list
92284160|NCT04003649|Ipilimumab|ipilimumab|mesh-list
92284161|NCT04003649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284162|NCT04003649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284163|NCT04003649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92284164|NCT04003649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284165|NCT05713851|Dapagliflozin|dapagliflozin|mesh-list
92284166|NCT05713851|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92284167|NCT05713851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284168|NCT05713851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284169|NCT05713851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284170|NCT00361907|Insulin|insulin|mesh-list
92284171|NCT00361907|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92284172|NCT00361907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284173|NCT00361907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284174|NCT05710185|Deucravacitinib|deucravacitinib|mesh-list
92284175|NCT05710185|Dermatologic Agents|dermatologic agents|mesh-ancestor
92284176|NCT05710185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92284177|NCT05710185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284178|NCT05710185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284180|NCT04276493|Capecitabine|capecitabine|mesh-list
92284181|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
92284182|NCT04276493|Tislelizumab|tislelizumab|mesh-list
92284183|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284184|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
92284185|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
92284186|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
92284187|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284188|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284189|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
92284190|NCT04276493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284191|NCT05670795|Clomiphene|clomiphene|mesh-list
92284192|NCT05670795|Enclomiphene|enclomiphene|mesh-list
92284193|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
92284194|NCT05670795|Hormones|hormones|mesh-list
92284195|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92284196|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284197|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284198|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92284199|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
92284200|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92284201|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
92284202|NCT05670795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92284203|NCT05670795|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92284204|NCT05670795|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92284205|NCT04266197|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92284206|NCT04266197|Vasodilator Agents|vasodilator agents|mesh-ancestor
92284207|NCT04266197|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92284208|NCT04266197|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92284209|NCT04266197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284210|NCT04266197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284211|NCT04266197|Urological Agents|urological agents|mesh-ancestor
92284212|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
92284213|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92284214|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
92409109|NCT05907746|Fludarabine|fludarabine|mesh-list
92284215|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92284216|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
92284217|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284218|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284219|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
92284220|NCT04343963|Bromides|bromides|mesh-list
92284221|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92284222|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
92284223|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92284224|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344974|NCT03509012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92284225|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284227|NCT04343963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284228|NCT04343963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284229|NCT05750199|Immunomodulating Agents|immunomodulating agents|mesh-list
92284230|NCT05750199|Immunologic Factors|immunologic factors|mesh-ancestor
92284231|NCT05750199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284232|NCT04248179|Sufentanil|sufentanil|mesh-list
92284233|NCT04248179|Ropivacaine|ropivacaine|mesh-list
92284234|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284235|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
92284236|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284237|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284238|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
92284239|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284240|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92284241|NCT04248179|Narcotics|narcotics|mesh-ancestor
92284242|NCT04248179|Analgesics|analgesics|mesh-ancestor
92284243|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92284244|NCT04248179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92284245|NCT04248179|Anesthetics, General|anesthetics, general|mesh-ancestor
92284246|NCT00361517|Amphotericin B|amphotericin b|mesh-list
92284247|NCT00361517|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92284248|NCT00361517|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92284249|NCT00361517|Deoxycholic Acid|deoxycholic acid|mesh-list
92284250|NCT00361517|Amebicides|amebicides|mesh-ancestor
92284251|NCT00361517|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92284252|NCT00361517|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92284253|NCT00361517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284254|NCT00361517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92284255|NCT00361517|Antifungal Agents|antifungal agents|mesh-ancestor
92284256|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92284257|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284258|NCT03920267|Deucravacitinib|deucravacitinib|mesh-list
92284259|NCT03920267|Dermatologic Agents|dermatologic agents|mesh-ancestor
92284260|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92284261|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284262|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284263|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
92284264|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92284265|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284266|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284267|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92284268|NCT05447507|Analgesics|analgesics|mesh-ancestor
92284269|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
92284270|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284271|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92284272|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92284273|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92284274|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284275|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284276|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284277|NCT01635439|Dinoprostone|dinoprostone|mesh-list
92284278|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
92284279|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92284280|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284281|NCT01636063|Misoprostol|misoprostol|mesh-list
92284282|NCT01636063|Mifepristone|mifepristone|mesh-list
92284283|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92284284|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
92284285|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92284286|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284287|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92284288|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284289|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
92284290|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92284291|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92284292|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92284293|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92284294|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
92284295|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92284296|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92284297|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92284298|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284299|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
92284300|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92284301|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92284302|NCT05635305|Zoliflodacin|zoliflodacin|mesh-list
92284303|NCT05635305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92284304|NCT05635305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92284305|NCT05635305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284306|NCT05635305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284307|NCT05635305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284309|NCT05749575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92284310|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284311|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92284312|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92284313|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92284314|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284315|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
92284316|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
92284317|NCT04387201|Dulaglutide|dulaglutide|mesh-list
92284318|NCT04387201|Vitamins|vitamins|mesh-ancestor
92284319|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
92284320|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284321|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
92284322|NCT04387201|Hematinics|hematinics|mesh-ancestor
92284323|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284324|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
92284325|NCT04370587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284326|NCT04370587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284327|NCT04370587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92284328|NCT04370587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284329|NCT04178005|Cladribine|cladribine|mesh-list
92284330|NCT04178005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284331|NCT04178005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92284332|NCT04178005|Immunologic Factors|immunologic factors|mesh-ancestor
92284333|NCT04178005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284334|NCT05623761|Fluorides|fluorides|mesh-list
92284335|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
92284336|NCT05623761|Protective Agents|protective agents|mesh-ancestor
92284337|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284338|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
92284339|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92284340|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284341|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284342|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284343|NCT00361985|Esomeprazole|esomeprazole|mesh-list
92284344|NCT00361985|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92284345|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284346|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92284347|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284348|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284349|NCT00362063|Hormones|hormones|mesh-list
92284350|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284351|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284352|NCT00382239|Exenatide|exenatide|mesh-list
92284353|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284354|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284355|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92284356|NCT00382239|Incretins|incretins|mesh-ancestor
92116774|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92284358|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284359|NCT04004845|Misoprostol|misoprostol|mesh-list
92284360|NCT04004845|Oxytocin|oxytocin|mesh-list
92284361|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
92284362|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92284363|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284364|NCT04004845|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92284365|NCT04004845|Abortifacient Agents|abortifacient agents|mesh-ancestor
92284366|NCT04004845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92284367|NCT04004845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284368|NCT01637935|Pioglitazone|pioglitazone|mesh-list
92284369|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284370|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284371|NCT00382083|Acetaminophen|acetaminophen|mesh-list
92284372|NCT00382083|Ibuprofen|ibuprofen|mesh-list
92284373|NCT00382083|Lidocaine|lidocaine|mesh-list
92284374|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284375|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
92284376|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284377|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284378|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
92284379|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284380|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92284381|NCT00382083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92284382|NCT00382083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92284383|NCT00382083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284384|NCT00382083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284385|NCT00382083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92284386|NCT00382083|Analgesics|analgesics|mesh-ancestor
92284387|NCT00382083|Antipyretics|antipyretics|mesh-ancestor
92284388|NCT00382083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92284389|NCT00382083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284390|NCT00382083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284391|NCT00382083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92284392|NCT00382083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284393|NCT01640197|Resveratrol|resveratrol|mesh-list
92284394|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
92284395|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284396|NCT01640197|Protective Agents|protective agents|mesh-ancestor
92284397|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284398|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284399|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92284400|NCT01641445|Topiramate|topiramate|mesh-list
92284401|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
92284402|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284403|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284404|NCT04185311|Nivolumab|nivolumab|mesh-list
92284405|NCT04185311|Ipilimumab|ipilimumab|mesh-list
92284406|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92284407|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284408|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284409|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92284410|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284411|NCT05513937|Amlodipine|amlodipine|mesh-list
92284412|NCT05513937|Nebivolol|nebivolol|mesh-list
92284413|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92284414|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92284415|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284416|NCT05513937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284417|NCT05513937|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92284418|NCT05513937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284419|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
92284420|NCT05513937|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92284421|NCT05513937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92284422|NCT05513937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92284423|NCT05513937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284424|NCT05513937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284425|NCT01642147|Anesthetics|anesthetics|mesh-list
92284426|NCT01642147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284427|NCT01642147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284428|NCT04584749|Lidocaine|lidocaine|mesh-list
92284429|NCT04584749|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284430|NCT04584749|Anesthetics|anesthetics|mesh-ancestor
92284431|NCT04584749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284432|NCT04584749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284433|NCT04584749|Sensory System Agents|sensory system agents|mesh-ancestor
92284434|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284435|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92284436|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92284437|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92284438|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284439|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284440|NCT01644331|Tolvaptan|tolvaptan|mesh-list
92284441|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92284442|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284443|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
92284444|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284445|NCT00362141|Levetiracetam|levetiracetam|mesh-list
92284446|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
92284447|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
92284448|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
92284449|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
92284450|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92284451|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92284452|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284453|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284454|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284455|NCT05733897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284456|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92284457|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92284458|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284459|NCT03561259|Vorinostat|vorinostat|mesh-list
92284460|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92284461|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284462|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92284463|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284464|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284465|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92284467|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
92284468|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284469|NCT03002935|Vitamins|vitamins|mesh-ancestor
92284470|NCT03788291|Rituximab|rituximab|mesh-list
92284471|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
92284472|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284473|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284474|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
92284475|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284476|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284477|NCT04593459|Metformin|metformin|mesh-list
92284478|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284479|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284480|NCT04120883|Hydroxychloroquine|hydroxychloroquine|mesh-list
92284481|NCT04120883|Antimalarials|antimalarials|mesh-ancestor
92284482|NCT04120883|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92284483|NCT04120883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92284484|NCT04120883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284485|NCT04120883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284486|NCT04120883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284487|NCT04120883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284488|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92284489|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
92284490|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284491|NCT03251924|Nivolumab|nivolumab|mesh-list
92284492|NCT03251924|Ipilimumab|ipilimumab|mesh-list
92284493|NCT03251924|Antibodies|antibodies|mesh-list
92284494|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
92284495|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
92284496|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
92284497|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284498|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284499|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284500|NCT03251924|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92284501|NCT03251924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284502|NCT01651351|Protease Inhibitors|protease inhibitors|mesh-list
92284503|NCT01651351|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92284504|NCT01651351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284505|NCT01651351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284506|NCT01651351|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92284507|NCT01651351|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92284508|NCT03762317|Clonidine|clonidine|mesh-list
92284509|NCT03762317|Analgesics|analgesics|mesh-ancestor
92284510|NCT03762317|Sensory System Agents|sensory system agents|mesh-ancestor
92284511|NCT03762317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284512|NCT03762317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284513|NCT03762317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92284514|NCT03762317|Sympatholytics|sympatholytics|mesh-ancestor
92284515|NCT03762317|Autonomic Agents|autonomic agents|mesh-ancestor
92284516|NCT03762317|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92284517|NCT03762317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92284518|NCT03762317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92284519|NCT03762317|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284520|NCT03762317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284521|NCT03762317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284522|NCT04383639|Locust bean gum|locust bean gum|mesh-list
92284523|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
92284524|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284525|NCT03083431|Propranolol|propranolol|mesh-list
92284526|NCT03083431|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92284527|NCT03083431|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92284528|NCT03083431|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284529|NCT03083431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284530|NCT03083431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284531|NCT03083431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284532|NCT03083431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92284533|NCT03083431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92284534|NCT03083431|Vasodilator Agents|vasodilator agents|mesh-ancestor
92284535|NCT02975921|Povidone-Iodine|povidone-iodine|mesh-list
92284536|NCT02975921|Povidone|povidone|mesh-list
92284537|NCT02975921|Plasma Substitutes|plasma substitutes|mesh-ancestor
92284538|NCT02975921|Blood Substitutes|blood substitutes|mesh-ancestor
92284539|NCT02975921|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92284540|NCT02975921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284541|NCT05452785|Minocycline|minocycline|mesh-list
92284542|NCT05452785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92284543|NCT05452785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284544|NCT03002545|Magnesium citrate|magnesium citrate|mesh-list
92284545|NCT03002545|Cathartics|cathartics|mesh-ancestor
92284546|NCT03002545|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284547|NCT04517747|Ramucirumab|ramucirumab|mesh-list
92284548|NCT04517747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284549|NCT02219581|Dexamethasone|dexamethasone|mesh-list
92284550|NCT02219581|Dexamethasone acetate|dexamethasone acetate|mesh-list
92284551|NCT02219581|BB 1101|bb 1101|mesh-list
92284552|NCT02219581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284553|NCT02219581|Antiemetics|antiemetics|mesh-ancestor
92284554|NCT02219581|Autonomic Agents|autonomic agents|mesh-ancestor
92284555|NCT02219581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284556|NCT02219581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284557|NCT02219581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284558|NCT02219581|Glucocorticoids|glucocorticoids|mesh-ancestor
92284559|NCT02219581|Hormones|hormones|mesh-ancestor
92284560|NCT02219581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284561|NCT02219581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92284562|NCT02219581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284563|NCT02219581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92284564|NCT02219581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284565|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284566|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92284567|NCT01437709|Ofatumumab|ofatumumab|mesh-list
92284568|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92284569|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92284570|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
92284571|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284572|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284573|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
92284574|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284575|NCT03740165|Paclitaxel|paclitaxel|mesh-list
92284576|NCT03740165|Docetaxel|docetaxel|mesh-list
92284577|NCT03740165|Bevacizumab|bevacizumab|mesh-list
92284578|NCT03740165|Carboplatin|carboplatin|mesh-list
92284579|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
91937373|NCT01009775|Docetaxel|docetaxel|mesh-list
92284580|NCT03740165|Olaparib|olaparib|mesh-list
92284581|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92284582|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284583|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
92284584|NCT03740165|Antimitotic Agents|antimitotic agents|mesh-ancestor
92284585|NCT03740165|Mitosis Modulators|mitosis modulators|mesh-ancestor
92284586|NCT03740165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284587|NCT03740165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284588|NCT03740165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92284589|NCT03740165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92284590|NCT03740165|Growth Substances|growth substances|mesh-ancestor
92284591|NCT03740165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284592|NCT03740165|Growth Inhibitors|growth inhibitors|mesh-ancestor
92284593|NCT03740165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92284594|NCT03740165|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92284595|NCT03740165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284596|NCT01912274|Azacitidine|azacitidine|mesh-list
92284597|NCT01912274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284598|NCT01912274|Antimetabolites|antimetabolites|mesh-ancestor
92284599|NCT01912274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284600|NCT01912274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284601|NCT01912274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284602|NCT01654861|Ascorbic Acid|ascorbic acid|mesh-list
92284603|NCT01654861|Gemcitabine|gemcitabine|mesh-list
92284604|NCT01654861|Vitamins|vitamins|mesh-ancestor
92284605|NCT01654861|Micronutrients|micronutrients|mesh-ancestor
92284606|NCT01654861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284607|NCT01654861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284608|NCT01654861|Antimetabolites|antimetabolites|mesh-ancestor
92284609|NCT01654861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284610|NCT01654861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284611|NCT01654861|Antioxidants|antioxidants|mesh-ancestor
92284612|NCT01654861|Protective Agents|protective agents|mesh-ancestor
92284613|NCT01934582|Treprostinil|treprostinil|mesh-list
92284614|NCT01934582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92284615|NCT05735834|Rituximab|rituximab|mesh-list
92284616|NCT05735834|Zanubrutinib|zanubrutinib|mesh-list
92284617|NCT05735834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92284618|NCT05735834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284619|NCT05735834|Immunologic Factors|immunologic factors|mesh-ancestor
92284620|NCT05735834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284621|NCT05735834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345029|NCT02990338|Hormones|hormones|mesh-ancestor
92284622|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92284623|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284624|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284625|NCT05184777|Estradiol|estradiol|mesh-list
92284626|NCT05184777|Progesterone|progesterone|mesh-list
92284627|NCT05184777|Estrogens|estrogens|mesh-ancestor
92284628|NCT05184777|Hormones|hormones|mesh-ancestor
92284629|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284630|NCT05184777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284631|NCT05184777|Progestins|progestins|mesh-ancestor
92284632|NCT01912352|Methylphenidate|methylphenidate|mesh-list
92284633|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92284634|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284635|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92284636|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284637|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284638|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284639|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
92284640|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284641|NCT02975843|Beclomethasone|beclomethasone|mesh-list
92284642|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
92284643|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
92284644|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92284645|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
92284646|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284647|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284648|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92284649|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92284650|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92284651|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92284652|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92284653|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284654|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284655|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284656|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92284657|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92284658|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92284659|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
92284660|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284661|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
92284662|NCT02975843|Hormones|hormones|mesh-ancestor
92284663|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284664|NCT01655563|Tacrolimus|tacrolimus|mesh-list
92284665|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92284666|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
92284667|NCT01655563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284668|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92284669|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284670|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284671|NCT01655719|Pioglitazone|pioglitazone|mesh-list
92284672|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92284673|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284674|NCT05735756|Citalopram|citalopram|mesh-list
92284675|NCT05735756|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92284676|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284677|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284678|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284680|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
92284681|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284682|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92284683|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
92284684|NCT05735756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92284685|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92284686|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284687|NCT02987348|Insulin|insulin|mesh-list
92284688|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92284689|NCT02987348|Exenatide|exenatide|mesh-list
92284690|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
92284691|NCT02987348|Glucagon|glucagon|mesh-list
92284692|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92284693|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92345037|NCT02990338|Growth Inhibitors|growth inhibitors|mesh-ancestor
92284694|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284695|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92284696|NCT02987348|Incretins|incretins|mesh-ancestor
92284698|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284699|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284700|NCT01656031|Cytarabine|cytarabine|mesh-list
92284701|NCT01656031|Clofarabine|clofarabine|mesh-list
92284702|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92284703|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
92284704|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284705|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284706|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
92284707|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284708|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92284709|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
92284710|NCT01656031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284711|NCT01656187|Memantine|memantine|mesh-list
92284712|NCT01656187|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92284713|NCT01656187|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92284714|NCT01656187|Dopamine Agents|dopamine agents|mesh-ancestor
92284715|NCT01656187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284716|NCT01656187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284717|NCT01656187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284718|NCT01656187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92284719|NCT01656187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92284720|NCT01658839|Travoprost|travoprost|mesh-list
92284721|NCT01658839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92284722|NCT01658839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92284723|NCT01658839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92284724|NCT01658995|Doxycycline|doxycycline|mesh-list
92284725|NCT01658995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92284726|NCT01658995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284727|NCT01658995|Antimalarials|antimalarials|mesh-ancestor
92284728|NCT01658995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92284729|NCT01658995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92284730|NCT01350141|Bococizumab|bococizumab|mesh-list
92284731|NCT01350141|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92284732|NCT01350141|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92284733|NCT01350141|Antimetabolites|antimetabolites|mesh-ancestor
92409110|NCT05907746|Tacrolimus|tacrolimus|mesh-list
92284734|NCT01350141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284735|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92284736|NCT01662115|Nicotine|nicotine|mesh-list
92284737|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92284738|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
92284739|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284740|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284741|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92284742|NCT01662115|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92284743|NCT01662115|Cholinergic Agents|cholinergic agents|mesh-ancestor
92284744|NCT01662115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284745|NCT01662115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284746|NCT01598545|Hydromorphone|hydromorphone|mesh-list
92284747|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92284748|NCT01598545|Narcotics|narcotics|mesh-ancestor
92284749|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284750|NCT01598545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284751|NCT01598545|Analgesics|analgesics|mesh-ancestor
92284752|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
92284753|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284754|NCT01598701|Acetaminophen|acetaminophen|mesh-list
92284755|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92284756|NCT01598701|Analgesics|analgesics|mesh-ancestor
92284757|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
92284758|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284759|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284760|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
92284761|NCT00000309|Risperidone|risperidone|mesh-list
92284762|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92284763|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
92284764|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284765|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345040|NCT02971956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284766|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284767|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92284768|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92284769|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284770|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92284771|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92284772|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
92284773|NCT00000315|Cocaine|cocaine|mesh-list
92284774|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284775|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
92284776|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284777|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284778|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
92284779|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284780|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92284781|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92284782|NCT00000315|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284783|NCT00000315|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284784|NCT00000315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284785|NCT00000315|Dopamine Agents|dopamine agents|mesh-ancestor
92284786|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284787|NCT00000321|Desipramine|desipramine|mesh-list
92284788|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92284789|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
92284790|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92284791|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284792|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284793|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92284794|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284795|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284796|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284797|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284798|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284799|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
92284800|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92284801|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284802|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284803|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
92284804|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284805|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284806|NCT01940276|Prednisone|prednisone|mesh-list
92284808|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284809|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
92284810|NCT01940276|Hormones|hormones|mesh-ancestor
92284811|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284812|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284813|NCT01940276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92284814|NCT01940276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284815|NCT01940276|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92284816|NCT01940276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284817|NCT01940276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284818|NCT01940276|Hormone Antagonists|hormone antagonists|mesh-ancestor
92284819|NCT01940276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92284820|NCT00000327|Heroin|heroin|mesh-list
92284821|NCT00000327|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92284822|NCT00000327|Narcotics|narcotics|mesh-ancestor
92284823|NCT00000327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284824|NCT00000327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284825|NCT00000327|Analgesics|analgesics|mesh-ancestor
92284826|NCT00000327|Sensory System Agents|sensory system agents|mesh-ancestor
92284827|NCT00000327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284828|NCT01919216|Citalopram|citalopram|mesh-list
92284829|NCT01919216|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92284830|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284831|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284832|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345043|NCT02787369|Idelalisib|idelalisib|mesh-list
92284833|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284834|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
92284835|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284836|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92284837|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
92284838|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92284839|NCT01940510|Rifampin|rifampin|mesh-list
92284840|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92284841|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
92284842|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92284843|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284844|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
92284845|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92284846|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284847|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284848|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92284849|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92284850|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92284851|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92284852|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92284853|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92284854|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92284855|NCT00380289|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92284856|NCT00380289|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284857|NCT00380289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284858|NCT00380289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284859|NCT00380289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284860|NCT05364645|Carboplatin|carboplatin|mesh-list
92284861|NCT05364645|Pemetrexed|pemetrexed|mesh-list
92284862|NCT05364645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284863|NCT05364645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284864|NCT05364645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284865|NCT05364645|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92284866|NCT05364645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92284867|NCT01919450|Regadenoson|regadenoson|mesh-list
92284868|NCT01919450|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92284869|NCT01919450|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92284870|NCT01919450|Purinergic Agonists|purinergic agonists|mesh-ancestor
92284871|NCT01919450|Purinergic Agents|purinergic agents|mesh-ancestor
92284872|NCT01919450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284873|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284874|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284875|NCT01602679|Progesterone|progesterone|mesh-list
92284876|NCT01602679|Progestins|progestins|mesh-ancestor
92284877|NCT01602679|Hormones|hormones|mesh-ancestor
92284878|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92284879|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284880|NCT01919606|Bupivacaine|bupivacaine|mesh-list
92284881|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284882|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
92284883|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284884|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284885|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
92284886|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284887|NCT01919996|Azithromycin|azithromycin|mesh-list
92284888|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92284889|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284890|NCT05735132|Lidocaine|lidocaine|mesh-list
92284891|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
92284892|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
92284893|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284894|NCT05735132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284895|NCT05735132|Sensory System Agents|sensory system agents|mesh-ancestor
92284896|NCT05735132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284897|NCT05735132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92284898|NCT05735132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92284899|NCT05735132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92284900|NCT05735132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284901|NCT05735132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284902|NCT01667029|Sulfasalazine|sulfasalazine|mesh-list
92284903|NCT01667029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92284904|NCT01667029|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92284905|NCT01667029|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92284906|NCT01667029|Analgesics|analgesics|mesh-ancestor
92284907|NCT01667029|Sensory System Agents|sensory system agents|mesh-ancestor
92284908|NCT01667029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284909|NCT01667029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284910|NCT01667029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284912|NCT01667029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284913|NCT01943864|Trametinib|trametinib|mesh-list
92284914|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284915|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92284916|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92284917|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284918|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92284919|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92284920|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
92284921|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92284922|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
92284923|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92284924|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284925|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92284926|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92284927|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92284928|NCT00000333|Benztropine|benztropine|mesh-list
92284929|NCT00000333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92284930|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92284931|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
92284932|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
92284933|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284934|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284935|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92284936|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92284937|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
92284938|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284939|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284940|NCT00000333|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92284941|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92284942|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92284943|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
92284944|NCT00000339|Risperidone|risperidone|mesh-list
92284945|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92284946|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
92284947|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284948|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284949|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284950|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92284951|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92284952|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92284953|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92284954|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92284955|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
92284956|NCT00000345|Lofexidine|lofexidine|mesh-list
92284957|NCT00000345|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92284958|NCT00000345|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92284959|NCT00000345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284960|NCT00000345|Sensory System Agents|sensory system agents|mesh-ancestor
92284961|NCT00000345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284962|NCT00000345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92284963|NCT00000345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92284964|NCT00000345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92284965|NCT00000345|Adrenergic Agents|adrenergic agents|mesh-ancestor
92284966|NCT00000345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284967|NCT00000345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284968|NCT00000357|Buprenorphine|buprenorphine|mesh-list
92284969|NCT00000357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92284970|NCT00000357|Narcotics|narcotics|mesh-ancestor
92284971|NCT00000357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345050|NCT02366728|Basiliximab|basiliximab|mesh-list
92284972|NCT00000357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284973|NCT00000357|Analgesics|analgesics|mesh-ancestor
92284974|NCT00000357|Sensory System Agents|sensory system agents|mesh-ancestor
92284975|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92284976|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92284977|NCT05095311|Cetirizine|cetirizine|mesh-list
92284978|NCT05095311|Nedocromil|nedocromil|mesh-list
92284979|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92284980|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92284981|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92284982|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
92284983|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
92284984|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92284985|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92284986|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92284987|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92284988|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
92284989|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284990|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92284991|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
92284992|NCT01922336|Infliximab|infliximab|mesh-list
92284993|NCT01922336|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92284994|NCT01922336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92284995|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
92284996|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92284997|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92284998|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
92284999|NCT04330755|Simendan|simendan|mesh-list
92285000|NCT04330755|Analgesics|analgesics|mesh-ancestor
92285001|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
92285002|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285003|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285004|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
92285005|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285006|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92285007|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
92285008|NCT04330755|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92285009|NCT04330755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285010|NCT04330755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285011|NCT04330755|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285012|NCT04330755|Tocolytic Agents|tocolytic agents|mesh-ancestor
92285013|NCT04330755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92285014|NCT04330755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92285015|NCT04330755|Vasodilator Agents|vasodilator agents|mesh-ancestor
92285016|NCT04330755|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92285017|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92285018|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285019|NCT04330755|Protective Agents|protective agents|mesh-ancestor
92285020|NCT01608295|Paroxetine|paroxetine|mesh-list
92285021|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
92285022|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92285023|NCT01608295|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92285024|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92285025|NCT01608295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285026|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285027|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285028|NCT01608295|Serotonin Agents|serotonin agents|mesh-ancestor
92285029|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285030|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92285031|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92285032|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92285033|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92285034|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285035|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92285036|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92285037|NCT04713189|Fentanyl|fentanyl|mesh-list
92285038|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92285039|NCT04713189|Narcotics|narcotics|mesh-ancestor
92285040|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285041|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285042|NCT04713189|Analgesics|analgesics|mesh-ancestor
92285043|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
92285044|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285045|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92285046|NCT04713189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92285047|NCT04713189|Anesthetics, General|anesthetics, general|mesh-ancestor
92285048|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
92285049|NCT01610011|Glycine|glycine|mesh-list
92285050|NCT01610011|Glycine Agents|glycine agents|mesh-ancestor
92285051|NCT01610011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285052|NCT01610011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285053|NCT01610011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285054|NCT00000399|Hormones|hormones|mesh-list
92322593|NCT00002162|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285055|NCT00000399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285056|NCT00000399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285057|NCT02237989|Acetaminophen|acetaminophen|mesh-list
92285058|NCT02237989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285059|NCT02237989|Analgesics|analgesics|mesh-ancestor
92285060|NCT02237989|Sensory System Agents|sensory system agents|mesh-ancestor
92285061|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285062|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285063|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
92285064|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
92285065|NCT00000429|Calcium|calcium|mesh-list
92285066|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285067|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285068|NCT00000429|Antacids|antacids|mesh-ancestor
92285069|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285070|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285071|NCT01673191|Dexamethasone|dexamethasone|mesh-list
92285072|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
92285073|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92285074|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285075|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
92285076|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
92285077|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285078|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285079|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285080|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
92285081|NCT01673191|Hormones|hormones|mesh-ancestor
92285082|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285083|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285084|NCT01673191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285085|NCT01673191|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92285086|NCT01925144|Omeprazole|omeprazole|mesh-list
92285087|NCT01925144|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92285088|NCT01925144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285089|NCT01925144|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92285090|NCT01925144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285091|NCT01925144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285092|NCT00000441|Carbamazepine|carbamazepine|mesh-list
92285093|NCT00000441|Lorazepam|lorazepam|mesh-list
92285094|NCT00000441|Anticonvulsants|anticonvulsants|mesh-ancestor
92285095|NCT00000441|Antiemetics|antiemetics|mesh-ancestor
92285096|NCT00000441|Autonomic Agents|autonomic agents|mesh-ancestor
92285097|NCT00000441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285098|NCT00000441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285099|NCT00000441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285100|NCT00000441|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92285101|NCT00000441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285102|NCT00000441|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92285103|NCT00000441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92285104|NCT00000441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92285105|NCT00000441|GABA Modulators|gaba modulators|mesh-ancestor
92285106|NCT00000441|GABA Agents|gaba agents|mesh-ancestor
92285107|NCT00000441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285108|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285109|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
92285110|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285111|NCT00000441|Analgesics|analgesics|mesh-ancestor
92285112|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
92285113|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92285114|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285115|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92285116|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92285118|NCT00000447|Nicotine|nicotine|mesh-list
92285119|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92285120|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
92285121|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285122|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285123|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92285124|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92285125|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
92285126|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285127|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285128|NCT00000447|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92285129|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92285130|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
92285131|NCT01927718|Thalidomide|thalidomide|mesh-list
92285132|NCT01927718|Lenalidomide|lenalidomide|mesh-list
92285133|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
92285134|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285135|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92285136|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92285137|NCT01927718|Growth Substances|growth substances|mesh-ancestor
92285138|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
92285139|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285140|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285141|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
92285142|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92285143|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285144|NCT05066607|Dexamethasone|dexamethasone|mesh-list
92285145|NCT05066607|Pomalidomide|pomalidomide|mesh-list
92285146|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285147|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
92285148|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
92285149|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285150|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285151|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285152|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
92285153|NCT05066607|Hormones|hormones|mesh-ancestor
92285154|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285155|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285156|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285157|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
92285158|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92285159|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92285160|NCT05066607|Growth Substances|growth substances|mesh-ancestor
92285161|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
92285162|NCT01948310|Ranolazine|ranolazine|mesh-list
92285163|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92285164|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285165|NCT01948310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285166|NCT01948388|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92285167|NCT01948388|Hormones|hormones|mesh-ancestor
92285168|NCT01948388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285169|NCT01948388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285170|NCT01675297|Cholecalciferol|cholecalciferol|mesh-list
92285171|NCT01675297|Vitamin D|vitamin d|mesh-list
92285172|NCT01675297|Risedronic Acid|risedronic acid|mesh-list
92285173|NCT01675297|Etidronic Acid|etidronic acid|mesh-list
92285174|NCT01675297|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285175|NCT01675297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285176|NCT01675297|Vitamins|vitamins|mesh-ancestor
92285178|NCT01675297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92285179|NCT01675297|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92285180|NCT01675297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285181|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285182|NCT05295537|Liver Extracts|liver extracts|mesh-list
92285183|NCT05295537|Hematinics|hematinics|mesh-ancestor
92285184|NCT02287376|Diclofenac|diclofenac|mesh-list
92285185|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92285186|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285187|NCT02287376|Analgesics|analgesics|mesh-ancestor
92285188|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
92285189|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285190|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285191|NCT02287376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285192|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285193|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92285194|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285195|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285196|NCT01928186|Alovudine|alovudine|mesh-list
92285197|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
92285198|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285199|NCT01611571|Teriparatide|teriparatide|mesh-list
92285200|NCT01611571|Risedronic Acid|risedronic acid|mesh-list
92285201|NCT01611571|Etidronic Acid|etidronic acid|mesh-list
92285202|NCT01611571|Parathyroid Hormone|parathyroid hormone|mesh-list
92285203|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285205|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92285206|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92285207|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285208|NCT01611571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285209|NCT00000477|Lovastatin|lovastatin|mesh-list
92285210|NCT00000477|L 647318|l 647318|mesh-list
92285211|NCT00000477|Dihydromevinolin|dihydromevinolin|mesh-list
92285212|NCT00000477|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92285213|NCT00000477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92285214|NCT00000477|Antimetabolites|antimetabolites|mesh-ancestor
92285215|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285216|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92285217|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92285218|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285219|NCT00000483|Niacin|niacin|mesh-list
92285220|NCT00000483|Clofibrate|clofibrate|mesh-list
92285221|NCT00000483|Estrogens|estrogens|mesh-list
92285222|NCT00000483|Hormones|hormones|mesh-ancestor
92285223|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285224|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285225|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92285226|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
92285227|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285228|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92285229|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
92285230|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
92285231|NCT00000483|Vitamins|vitamins|mesh-ancestor
92285232|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
92285233|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92285234|NCT00000507|Streptokinase|streptokinase|mesh-list
92285235|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92285236|NCT00000507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92285237|NCT00000507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285238|NCT00380445|Vildagliptin|vildagliptin|mesh-list
92285239|NCT00380445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92285240|NCT00380445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285241|NCT00380445|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92285242|NCT00380445|Protease Inhibitors|protease inhibitors|mesh-ancestor
92285243|NCT00380445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285244|NCT00380445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285245|NCT01950260|Hormones|hormones|mesh-list
92285246|NCT01950260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285247|NCT01950260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285248|NCT01676311|Huperzine A|huperzine a|mesh-list
92285249|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92285250|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285251|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285252|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
92285253|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285254|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285255|NCT01676311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92285256|NCT01676311|Protective Agents|protective agents|mesh-ancestor
92285257|NCT01951118|Donepezil|donepezil|mesh-list
92285258|NCT01951118|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92285259|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285260|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285261|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
92285262|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285263|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285264|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
92285265|NCT01951820|Lidocaine|lidocaine|mesh-list
92285266|NCT01951820|Tetracaine|tetracaine|mesh-list
92285267|NCT01951820|Carticaine|carticaine|mesh-list
92285268|NCT01951820|Benzocaine|benzocaine|mesh-list
92285269|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
92285270|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
92285271|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285272|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285273|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
92285274|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285275|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92285276|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92285277|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92285278|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285279|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285281|NCT01952444|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92285282|NCT01952444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285283|NCT01952444|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92285284|NCT01952444|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92285285|NCT01952444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285286|NCT01952444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285287|NCT01952444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285288|NCT01952444|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92285289|NCT01952444|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92285290|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
92285291|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92285292|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92285293|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
92285294|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
92285295|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285296|NCT00382629|Protective Agents|protective agents|mesh-ancestor
92285297|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285298|NCT00000513|Atenolol|atenolol|mesh-list
92285299|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
92285300|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92285301|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92285302|NCT00000513|Sympatholytics|sympatholytics|mesh-ancestor
92285303|NCT00000513|Autonomic Agents|autonomic agents|mesh-ancestor
92285304|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285305|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285306|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92285307|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92285308|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92285309|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
92285310|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285311|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285312|NCT00000513|Diuretics|diuretics|mesh-ancestor
92285313|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
92285314|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92285315|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285316|NCT00000543|Calcium|calcium|mesh-list
92285317|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285318|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285319|NCT00000549|Hormones|hormones|mesh-list
92285320|NCT00000549|Estrogens|estrogens|mesh-list
92285321|NCT00000549|Progestins|progestins|mesh-list
92285322|NCT00000549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285323|NCT00000549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285324|NCT01617577|Lenograstim|lenograstim|mesh-list
92285325|NCT01617577|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92285326|NCT01617577|Immunologic Factors|immunologic factors|mesh-ancestor
92285327|NCT01617577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285328|NCT01701037|Trametinib|trametinib|mesh-list
92285329|NCT01701037|Dabrafenib|dabrafenib|mesh-list
92285330|NCT01701037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285331|NCT01701037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92285332|NCT01701037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285333|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285334|NCT00000585|Penicillins|penicillins|mesh-list
92285335|NCT00000585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92285336|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285337|NCT01701115|Bupivacaine|bupivacaine|mesh-list
92285338|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
92285339|NCT01701115|Mepivacaine|mepivacaine|mesh-list
92285340|NCT01701115|Anesthetics|anesthetics|mesh-list
92285341|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285342|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285343|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
92285344|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285345|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92285346|NCT00000597|Nandrolone|nandrolone|mesh-list
92285347|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92285348|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92285349|NCT00000597|Androgens|androgens|mesh-ancestor
92285350|NCT00000597|Hormones|hormones|mesh-ancestor
92285351|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285352|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285354|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92285355|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
92285356|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285357|NCT01621009|Bupropion|bupropion|mesh-list
92285358|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92285359|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
92285360|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92285361|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92285362|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92285363|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285364|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285365|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
92285366|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285367|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285368|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92285369|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92285370|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285371|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
92285372|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92285373|NCT04830969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92285374|NCT04830969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285375|NCT04830969|Disinfectants|disinfectants|mesh-ancestor
92285376|NCT04830969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285377|NCT01683331|Insulin|insulin|mesh-list
92285378|NCT01683331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92285379|NCT01683331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285380|NCT02986880|Botulinum Toxins|botulinum toxins|mesh-list
92285381|NCT02986880|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92285382|NCT02986880|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92285383|NCT02986880|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92285384|NCT02986880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285385|NCT02986880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285386|NCT02986880|Cholinergic Agents|cholinergic agents|mesh-ancestor
92285387|NCT02986880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285388|NCT02986880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285389|NCT02986880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92285390|NCT02986880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285391|NCT02290106|Pitavastatin|pitavastatin|mesh-list
92285392|NCT02290106|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92285393|NCT02290106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92285394|NCT02290106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92285395|NCT02290106|Antimetabolites|antimetabolites|mesh-ancestor
92285396|NCT02290106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285397|NCT02290106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938202|NCT03561831|Propofol|propofol|mesh-list
92285398|NCT02290106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92285399|NCT00000621|Tretinoin|tretinoin|mesh-list
92285400|NCT00000621|Isotretinoin|isotretinoin|mesh-list
92285401|NCT00000621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285402|NCT00000621|Keratolytic Agents|keratolytic agents|mesh-ancestor
92285403|NCT00000621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285404|NCT04818957|Vitamin D|vitamin d|mesh-list
92285405|NCT04818957|Cholecalciferol|cholecalciferol|mesh-list
92285406|NCT04818957|Vitamins|vitamins|mesh-ancestor
92285407|NCT04818957|Micronutrients|micronutrients|mesh-ancestor
92285408|NCT04818957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285409|NCT04818957|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92285410|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285411|NCT01621477|Cytarabine|cytarabine|mesh-list
92285412|NCT01621477|Plerixafor|plerixafor|mesh-list
92285413|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
92285414|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
92285415|NCT01621477|Busulfan|busulfan|mesh-list
92285416|NCT01621477|Clofarabine|clofarabine|mesh-list
92285417|NCT01621477|Tacrolimus|tacrolimus|mesh-list
92285418|NCT01621477|Thymoglobulin|thymoglobulin|mesh-list
92285419|NCT01621477|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92285420|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285421|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
92285422|NCT01621477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285423|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285424|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92285425|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
92285426|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285427|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285428|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92285429|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92285430|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
92285431|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
92285432|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285433|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92285434|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285435|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92285436|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92285437|NCT01621477|Antitubercular Agents|antitubercular agents|mesh-ancestor
92285438|NCT01621477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92285439|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285440|NCT01621477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92285441|NCT00000627|Fluconazole|fluconazole|mesh-list
92285442|NCT00000627|Antifungal Agents|antifungal agents|mesh-ancestor
92285443|NCT00000627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285444|NCT00000627|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92285445|NCT00000627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92285446|NCT00000627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285447|NCT00000627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285448|NCT00000627|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92285449|NCT00000627|Hormone Antagonists|hormone antagonists|mesh-ancestor
92285450|NCT00000627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285451|NCT00000627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285452|NCT00000627|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92285453|NCT00000627|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92285454|NCT00000633|Vaccines|vaccines|mesh-list
92285455|NCT00000633|Immunologic Factors|immunologic factors|mesh-ancestor
92285456|NCT00000633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285457|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92285458|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92285459|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285460|NCT05479214|Metformin|metformin|mesh-list
92285461|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92285462|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285463|NCT00000657|Zidovudine|zidovudine|mesh-list
92285464|NCT00000657|Didanosine|didanosine|mesh-list
92285465|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
92285466|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285467|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285468|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92285469|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285470|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
92285471|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285472|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285473|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91938254|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285474|NCT01701505|Phenylephrine|phenylephrine|mesh-list
92285475|NCT01701505|Oxymetazoline|oxymetazoline|mesh-list
92285477|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
92285478|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
92285479|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285480|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285481|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
92285482|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285483|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92285484|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92285485|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92285486|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285487|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285488|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
92285489|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
92285490|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
92285491|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92285492|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
92285493|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92285494|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
92285495|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92285496|NCT01701505|Protective Agents|protective agents|mesh-ancestor
92285497|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92285498|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
92285499|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285501|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
92285502|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285503|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285504|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92285505|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285506|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
92285507|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285508|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285509|NCT00000669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92285510|NCT01622257|Metformin|metformin|mesh-list
92285511|NCT01622257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92285512|NCT01622257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285513|NCT04942899|Capecitabine|capecitabine|mesh-list
92285514|NCT04942899|Letrozole|letrozole|mesh-list
92285515|NCT04942899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92285516|NCT04942899|Antimetabolites|antimetabolites|mesh-ancestor
92285517|NCT04942899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285518|NCT04942899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285519|NCT04942899|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92285520|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92285521|NCT04942899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285522|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92285523|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
92285524|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285525|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285526|NCT00000693|Zidovudine|zidovudine|mesh-list
92285527|NCT00000693|Acyclovir|acyclovir|mesh-list
92285528|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
92285529|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285530|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285531|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92285532|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285533|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
92285534|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285535|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285536|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92285538|NCT04752033|Hydromorphone|hydromorphone|mesh-list
92285539|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92285540|NCT04752033|Narcotics|narcotics|mesh-ancestor
92285541|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285542|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285543|NCT04752033|Analgesics|analgesics|mesh-ancestor
92285544|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
92285545|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285546|NCT02987270|Piperaquine|piperaquine|mesh-list
92285547|NCT02987270|Artenimol|artenimol|mesh-list
92285548|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
92285549|NCT02987270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92285550|NCT02987270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92285551|NCT02987270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285552|NCT00000699|Ribavirin|ribavirin|mesh-list
92285553|NCT00000699|Inosine Pranobex|inosine pranobex|mesh-list
92285554|NCT00000699|Antimetabolites|antimetabolites|mesh-ancestor
92285555|NCT00000699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285556|NCT00000699|Antiviral Agents|antiviral agents|mesh-ancestor
92285557|NCT00000699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285558|NCT00000699|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92285559|NCT00000699|Immunologic Factors|immunologic factors|mesh-ancestor
92285560|NCT00000699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285561|NCT04931979|Pembrolizumab|pembrolizumab|mesh-list
92285562|NCT04931979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92285563|NCT04931979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285564|NCT04931979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92285565|NCT04931979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285566|NCT00000723|Leucovorin|leucovorin|mesh-list
92285567|NCT00000723|Zidovudine|zidovudine|mesh-list
92285568|NCT00000723|Dexamethasone|dexamethasone|mesh-list
92285569|NCT00000723|Methotrexate|methotrexate|mesh-list
92285570|NCT00000723|Calcium|calcium|mesh-list
92285571|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
92285572|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285573|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
92285574|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
91935414|NCT02320396|Desloratadine|desloratadine|mesh-list
92285575|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285576|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285577|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285578|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
92285579|NCT00000723|Hormones|hormones|mesh-ancestor
92285580|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285581|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285582|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285583|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285584|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92285585|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
92285586|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92285587|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92285588|NCT00000723|Antimetabolites|antimetabolites|mesh-ancestor
92285589|NCT00000723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285590|NCT00000723|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285591|NCT00000723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285592|NCT00000723|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92285593|NCT00000723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285594|NCT00000723|Immunologic Factors|immunologic factors|mesh-ancestor
92285595|NCT00000723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285596|NCT00000723|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92285597|NCT00000723|Antidotes|antidotes|mesh-ancestor
92285598|NCT00000723|Protective Agents|protective agents|mesh-ancestor
92285599|NCT00000723|Vitamin B Complex|vitamin b complex|mesh-ancestor
92285600|NCT00000723|Vitamins|vitamins|mesh-ancestor
92285601|NCT00000723|Micronutrients|micronutrients|mesh-ancestor
92285602|NCT00000723|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285603|NCT00000723|Antiviral Agents|antiviral agents|mesh-ancestor
92285604|NCT00000723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285605|NCT00000723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285606|NCT00000723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92285607|NCT02329964|Neostigmine|neostigmine|mesh-list
92285608|NCT02329964|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92285609|NCT02329964|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92285610|NCT02329964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345089|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
92285611|NCT02329964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285612|NCT02329964|Cholinergic Agents|cholinergic agents|mesh-ancestor
92285613|NCT02329964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285614|NCT02329964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285615|NCT02329964|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92285616|NCT02329964|Autonomic Agents|autonomic agents|mesh-ancestor
92285617|NCT02329964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285618|NCT04750395|Haloperidol|haloperidol|mesh-list
92285620|NCT04750395|Haloperidol decanoate|haloperidol decanoate|mesh-list
92285621|NCT04750395|Antiemetics|antiemetics|mesh-ancestor
92285622|NCT04750395|Autonomic Agents|autonomic agents|mesh-ancestor
92285623|NCT04750395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285624|NCT04750395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285625|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285626|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92285627|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92285628|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285629|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92285630|NCT04750395|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92285631|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92285632|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285633|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285634|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285635|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
92285636|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92285637|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
92285638|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92285639|NCT00000729|Foscarnet|foscarnet|mesh-list
92285640|NCT00000729|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92285641|NCT00000729|Antiviral Agents|antiviral agents|mesh-ancestor
92285642|NCT00000729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285643|NCT00000729|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285644|NCT00000729|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92285645|NCT00000729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285646|NCT00000729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285647|NCT03438773|Tacrolimus|tacrolimus|mesh-list
92285648|NCT03438773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285649|NCT03438773|Immunologic Factors|immunologic factors|mesh-ancestor
92285650|NCT03438773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285651|NCT03438773|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92285652|NCT03438773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285653|NCT03438773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285654|NCT02974985|Hyaluronic Acid|hyaluronic acid|mesh-list
92285655|NCT02974985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92285656|NCT02974985|Immunologic Factors|immunologic factors|mesh-ancestor
92285657|NCT02974985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285658|NCT02974985|Viscosupplements|viscosupplements|mesh-ancestor
92285659|NCT02974985|Protective Agents|protective agents|mesh-ancestor
92285660|NCT01704781|Lenalidomide|lenalidomide|mesh-list
92285661|NCT01704781|Immunologic Factors|immunologic factors|mesh-ancestor
92285662|NCT01704781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285663|NCT01704781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92285664|NCT01704781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92285665|NCT01704781|Growth Substances|growth substances|mesh-ancestor
92285666|NCT01704781|Growth Inhibitors|growth inhibitors|mesh-ancestor
92285667|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285668|NCT02288156|Capsaicin|capsaicin|mesh-list
92285669|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
92285670|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285671|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
92285672|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285673|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285674|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92285675|NCT04699383|Allopurinol|allopurinol|mesh-list
92285676|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
92285677|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285678|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285679|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
92285680|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285681|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92285682|NCT04699383|Antioxidants|antioxidants|mesh-ancestor
92285683|NCT04699383|Protective Agents|protective agents|mesh-ancestor
92285684|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285685|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92285686|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92285687|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285688|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
92285689|NCT04699383|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92285690|NCT04699383|Anthelmintics|anthelmintics|mesh-ancestor
92285692|NCT05700266|Rivaroxaban|rivaroxaban|mesh-list
92285693|NCT05700266|Clopidogrel|clopidogrel|mesh-list
92285694|NCT05700266|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92285695|NCT05700266|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285696|NCT05700266|Analgesics|analgesics|mesh-ancestor
92285697|NCT05700266|Sensory System Agents|sensory system agents|mesh-ancestor
92285698|NCT05700266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285699|NCT05700266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285700|NCT05700266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285701|NCT05700266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285702|NCT05700266|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92285703|NCT05700266|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92285704|NCT05700266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285705|NCT05700266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92285706|NCT05700266|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92285707|NCT05700266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285708|NCT05700266|Antipyretics|antipyretics|mesh-ancestor
92285709|NCT05700266|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92285710|NCT05700266|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92285711|NCT05700266|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92285712|NCT05700266|Purinergic Agents|purinergic agents|mesh-ancestor
92285713|NCT05700266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285714|NCT05700266|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92285715|NCT05700266|Antithrombins|antithrombins|mesh-ancestor
92285716|NCT05700266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92285717|NCT05700266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92285718|NCT05700266|Anticoagulants|anticoagulants|mesh-ancestor
92285719|NCT05423132|Ropivacaine|ropivacaine|mesh-list
92285720|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
92285721|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
92285722|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285723|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285724|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
92285725|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285726|NCT02975219|Bevacizumab|bevacizumab|mesh-list
92285727|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92285728|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285729|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92285730|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92285731|NCT02975219|Growth Substances|growth substances|mesh-ancestor
92285732|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285733|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
92285734|NCT01686451|Simvastatin|simvastatin|mesh-list
92285735|NCT01686451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92285736|NCT01686451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92285737|NCT01686451|Antimetabolites|antimetabolites|mesh-ancestor
92285738|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285739|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92285740|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92285741|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285742|NCT00361751|Fenofibrate|fenofibrate|mesh-list
92285743|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92285744|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
92285745|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285746|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92285747|NCT05681702|Aspirin|aspirin|mesh-list
92285748|NCT05681702|Clopidogrel|clopidogrel|mesh-list
92285749|NCT05681702|Ticagrelor|ticagrelor|mesh-list
92285750|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92285751|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92285752|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285754|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
92285755|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285756|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285757|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285758|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285759|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92285760|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92285761|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285762|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92285763|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92285764|NCT05681702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285765|NCT05681702|Antipyretics|antipyretics|mesh-ancestor
92285766|NCT05681702|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92285767|NCT05681702|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92285768|NCT05681702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92285769|NCT05681702|Purinergic Agents|purinergic agents|mesh-ancestor
92285770|NCT05681702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285771|NCT04675983|Fluorouracil|fluorouracil|mesh-list
92285772|NCT04675983|Capecitabine|capecitabine|mesh-list
92285773|NCT04675983|Oxaliplatin|oxaliplatin|mesh-list
92285774|NCT04675983|Ramucirumab|ramucirumab|mesh-list
92285775|NCT04675983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938559|NCT05249972|Hormones|hormones|mesh-ancestor
92285776|NCT04675983|Antimetabolites|antimetabolites|mesh-ancestor
92285777|NCT04675983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285778|NCT04675983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92285779|NCT04675983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285780|NCT04675983|Immunologic Factors|immunologic factors|mesh-ancestor
92285781|NCT04675983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285782|NCT03668951|Dexmedetomidine|dexmedetomidine|mesh-list
92285783|NCT03668951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92285784|NCT03668951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285785|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285786|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285787|NCT03668951|Analgesics|analgesics|mesh-ancestor
92285788|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
92285789|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285790|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92285791|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92285792|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92285793|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
92285794|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285795|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285796|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
92285797|NCT04889703|Salicylates|salicylates|mesh-list
92285798|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285799|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
92285800|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
92285801|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285802|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92285803|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285804|NCT04889703|Analgesics|analgesics|mesh-ancestor
92285805|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
92285806|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285807|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285808|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285809|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285810|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92285811|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285812|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285813|NCT00421811|Melphalan|melphalan|mesh-list
92285814|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92285815|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
92285816|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285817|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285818|NCT00421811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92285819|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285820|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
92285821|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285822|NCT03363893|Fulvestrant|fulvestrant|mesh-list
92285823|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285824|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285825|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92285826|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92285827|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
92285828|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285829|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285830|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92285831|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
92285832|NCT01706263|Salicylates|salicylates|mesh-list
92285833|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285834|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
92285835|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
92285836|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
92285837|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92285838|NCT01706263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285839|NCT01706263|Analgesics|analgesics|mesh-ancestor
92285840|NCT01706263|Sensory System Agents|sensory system agents|mesh-ancestor
92285841|NCT01706263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285842|NCT01706263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285843|NCT01706263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285844|NCT01706263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92285845|NCT01706263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92285846|NCT01706263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285847|NCT01706263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285848|NCT05738798|Immunomodulating Agents|immunomodulating agents|mesh-list
92285849|NCT05738798|Immunologic Factors|immunologic factors|mesh-ancestor
91938632|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
92285850|NCT05738798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285851|NCT04342247|Methyltestosterone|methyltestosterone|mesh-list
92285852|NCT04342247|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92285853|NCT04342247|Testosterone|testosterone|mesh-list
92285854|NCT04342247|Testosterone undecanoate|testosterone undecanoate|mesh-list
92285855|NCT04342247|Testosterone enanthate|testosterone enanthate|mesh-list
92285856|NCT04342247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285857|NCT04342247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285858|NCT04342247|Anabolic Agents|anabolic agents|mesh-ancestor
92285859|NCT04342247|Hormones|hormones|mesh-ancestor
92285860|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285861|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285862|NCT04342247|Androgens|androgens|mesh-ancestor
92285863|NCT05738642|Thrombin|thrombin|mesh-list
92285864|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
92285865|NCT05738642|Coagulants|coagulants|mesh-ancestor
92285866|NCT01690663|Dexamethasone|dexamethasone|mesh-list
92285867|NCT01690663|Bupivacaine|bupivacaine|mesh-list
92285868|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92285869|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
92285870|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
92285871|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285872|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285873|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92285874|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
92285876|NCT01690663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92285877|NCT01690663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92285878|NCT01690663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285879|NCT01690663|Anesthetics, Local|anesthetics, local|mesh-ancestor
92285880|NCT01690663|Anesthetics|anesthetics|mesh-ancestor
92285881|NCT01690663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285882|NCT01690663|Sensory System Agents|sensory system agents|mesh-ancestor
92285883|NCT05738564|Lidocaine|lidocaine|mesh-list
92285884|NCT05738564|Epinephrine|epinephrine|mesh-list
92285885|NCT05738564|Oxymetazoline|oxymetazoline|mesh-list
92285886|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
92285887|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
92285888|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285889|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285890|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
92345108|NCT01832402|Anesthetics, General|anesthetics, general|mesh-ancestor
92285891|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285892|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92285893|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92285894|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92285895|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285896|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285897|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92285898|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92285899|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
92285900|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285901|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92285902|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92285903|NCT05738564|Autonomic Agents|autonomic agents|mesh-ancestor
92285904|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92285905|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
92285906|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
92285907|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
92285908|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92285909|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
92285910|NCT05343572|Plerixafor|plerixafor|mesh-list
92285911|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285912|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92285913|NCT05343572|Antiviral Agents|antiviral agents|mesh-ancestor
92285914|NCT05343572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285915|NCT04350086|Dexmedetomidine|dexmedetomidine|mesh-list
92285916|NCT04350086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92285917|NCT04350086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92285918|NCT04350086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285919|NCT04350086|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92285920|NCT04350086|Analgesics|analgesics|mesh-ancestor
91938706|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285921|NCT04350086|Sensory System Agents|sensory system agents|mesh-ancestor
92285922|NCT04350086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285923|NCT04350086|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92285924|NCT04350086|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92285925|NCT04350086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92285926|NCT04350086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92285927|NCT04350086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285928|NCT04350086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285929|NCT05738408|Nicotine|nicotine|mesh-list
92285930|NCT05738408|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92285931|NCT05738408|Autonomic Agents|autonomic agents|mesh-ancestor
92285932|NCT05738408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92285933|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285934|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92285935|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92285936|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
92285937|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285938|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285939|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
92285940|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92285941|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285942|NCT03414229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92285943|NCT03414229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285944|NCT01352117|Tenofovir|tenofovir|mesh-list
92285945|NCT01352117|Emtricitabine|emtricitabine|mesh-list
92285946|NCT01352117|Efavirenz|efavirenz|mesh-list
92285947|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92285948|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92285949|NCT01352117|Etoposide|etoposide|mesh-list
92285950|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92285951|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92285952|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92285953|NCT01352117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92285954|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285955|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285956|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
92285957|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285958|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92285959|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92285960|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92285961|NCT01352117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92285962|NCT01352117|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92285963|NCT01352117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92285964|NCT01352117|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92285965|NCT01352117|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92285966|NCT01352117|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92285967|NCT01352117|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92285968|NCT03379207|Dimercaprol|dimercaprol|mesh-list
92285969|NCT03379207|Chelating Agents|chelating agents|mesh-ancestor
92285970|NCT03379207|Sequestering Agents|sequestering agents|mesh-ancestor
92285971|NCT03379207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285972|NCT02974439|Amlodipine|amlodipine|mesh-list
92285973|NCT02974439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92285974|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92285975|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92285976|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285977|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92285978|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285979|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
92285980|NCT03340727|Caffeine|caffeine|mesh-list
92285981|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
92285982|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92285983|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92285984|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92285985|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92285986|NCT03340727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92285987|NCT03340727|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92285988|NCT03340727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92285989|NCT03340727|Purinergic Agents|purinergic agents|mesh-ancestor
92285990|NCT03340727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92285991|NCT04612179|Sirolimus|sirolimus|mesh-list
92285992|NCT04612179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92285993|NCT04612179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92285994|NCT04612179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92285995|NCT04612179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938779|NCT00966953|Honokiol|honokiol|mesh-list
92285996|NCT04612179|Antifungal Agents|antifungal agents|mesh-ancestor
92285997|NCT04612179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92285998|NCT04612179|Immunologic Factors|immunologic factors|mesh-ancestor
92285999|NCT04612179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286001|NCT05578820|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92286002|NCT05578820|Antiviral Agents|antiviral agents|mesh-ancestor
92286003|NCT05578820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286004|NCT05578820|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92286005|NCT05578820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286006|NCT05578820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286007|NCT01707043|Calcitriol|calcitriol|mesh-list
92286008|NCT01707043|Betamethasone|betamethasone|mesh-list
92286009|NCT01707043|Betamethasone Valerate|betamethasone valerate|mesh-list
92286010|NCT01707043|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92286011|NCT01707043|Betamethasone benzoate|betamethasone benzoate|mesh-list
92286012|NCT01707043|Calcipotriene|calcipotriene|mesh-list
92286013|NCT01707043|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92286014|NCT01707043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286015|NCT01707043|Glucocorticoids|glucocorticoids|mesh-ancestor
92286016|NCT01707043|Hormones|hormones|mesh-ancestor
92286017|NCT01707043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286018|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286019|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92286020|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286021|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92286022|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92286023|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92286024|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286025|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286026|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92286027|NCT01707043|Vitamins|vitamins|mesh-ancestor
92286028|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
92286029|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92286030|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
92286031|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
92286032|NCT04258839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286033|NCT04258839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286034|NCT04258839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286035|NCT04258839|Dopamine Agonists|dopamine agonists|mesh-ancestor
92286036|NCT04258839|Dopamine Agents|dopamine agents|mesh-ancestor
92286037|NCT01708525|Deuterium Oxide|deuterium oxide|mesh-list
92286038|NCT01708525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286039|NCT01708525|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92286040|NCT01708525|Protective Agents|protective agents|mesh-ancestor
92286041|NCT01708525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286043|NCT03634917|Acamprosate|acamprosate|mesh-list
92286044|NCT03634917|Calcium Carbonate|calcium carbonate|mesh-list
92286045|NCT03634917|Calcium|calcium|mesh-list
92286046|NCT03634917|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92286047|NCT03634917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286048|NCT03634917|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92286049|NCT03634917|Antacids|antacids|mesh-ancestor
92286050|NCT03634917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286051|NCT03634917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286052|NCT03634917|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92286053|NCT05058872|Levonorgestrel|levonorgestrel|mesh-list
92286054|NCT05058872|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92286055|NCT05058872|Estradiol|estradiol|mesh-list
92286056|NCT05058872|Estrogens|estrogens|mesh-ancestor
92286057|NCT05058872|Hormones|hormones|mesh-ancestor
92286058|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286059|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286060|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92286061|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
92286062|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286063|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92286064|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92286065|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92286066|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92286067|NCT04595565|Carboplatin|carboplatin|mesh-list
92286068|NCT04595565|Capecitabine|capecitabine|mesh-list
92286069|NCT04595565|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92286070|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286071|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92286072|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
92286073|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286074|NCT04595565|Immunoconjugates|immunoconjugates|mesh-ancestor
92286075|NCT04595565|Immunologic Factors|immunologic factors|mesh-ancestor
92286076|NCT04595565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286077|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92286078|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
92286079|NCT02284880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92286080|NCT02284880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92286081|NCT02284880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286082|NCT02284880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286083|NCT03538899|Busulfan|busulfan|mesh-list
92286084|NCT03538899|Alkylating Agents|alkylating agents|mesh-ancestor
92286085|NCT03538899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286086|NCT03538899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286087|NCT03538899|Immunologic Factors|immunologic factors|mesh-ancestor
92345131|NCT01473628|Immunologic Factors|immunologic factors|mesh-ancestor
92286088|NCT03538899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286089|NCT03538899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92286090|NCT03538899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286091|NCT03538899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92286092|NCT04230681|Fentanyl|fentanyl|mesh-list
92286093|NCT04230681|Hydromorphone|hydromorphone|mesh-list
92286094|NCT04230681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92286095|NCT04230681|Narcotics|narcotics|mesh-ancestor
92286096|NCT04230681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286097|NCT04230681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286098|NCT04230681|Analgesics|analgesics|mesh-ancestor
92286099|NCT04230681|Sensory System Agents|sensory system agents|mesh-ancestor
92286100|NCT04230681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286101|NCT04230681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92286102|NCT04230681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92286103|NCT04230681|Anesthetics, General|anesthetics, general|mesh-ancestor
92286104|NCT04230681|Anesthetics|anesthetics|mesh-ancestor
92286105|NCT01708603|Ustekinumab|ustekinumab|mesh-list
92286106|NCT01708603|Brodalumab|brodalumab|mesh-list
92286107|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92286108|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92286109|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
92286110|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286111|NCT03523221|Dexamethasone|dexamethasone|mesh-list
92286112|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286113|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
92286114|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
92286115|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286116|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286117|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286118|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
92286119|NCT03523221|Hormones|hormones|mesh-ancestor
92286120|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286121|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92286122|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286123|NCT03590171|Bortezomib|bortezomib|mesh-list
92286124|NCT03590171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286125|NCT00362765|Metformin|metformin|mesh-list
92286126|NCT00362765|Fenofibrate|fenofibrate|mesh-list
92286127|NCT00362765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92286128|NCT00362765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286129|NCT00362765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92286130|NCT00362765|Antimetabolites|antimetabolites|mesh-ancestor
92286131|NCT00362765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286132|NCT00362765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92286133|NCT03430011|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92286134|NCT03430011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286135|NCT04174365|Brexpiprazole|brexpiprazole|mesh-list
92286136|NCT04174365|Serotonin Agents|serotonin agents|mesh-ancestor
92286137|NCT04174365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286138|NCT04174365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286139|NCT04174365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286140|NCT04174365|Dopamine Agonists|dopamine agonists|mesh-ancestor
92286141|NCT04174365|Dopamine Agents|dopamine agents|mesh-ancestor
92286142|NCT03300947|Lorazepam|lorazepam|mesh-list
92286143|NCT03300947|Psilocybin|psilocybin|mesh-list
92286144|NCT03300947|Hallucinogens|hallucinogens|mesh-ancestor
92286145|NCT03300947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286146|NCT03300947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92286148|NCT03300947|Antiemetics|antiemetics|mesh-ancestor
92286149|NCT03300947|Autonomic Agents|autonomic agents|mesh-ancestor
92286150|NCT03300947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286151|NCT03300947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286152|NCT03300947|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92286153|NCT03300947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286154|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92286155|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92286156|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
92286157|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
92286158|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286159|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286160|NCT03543839|Belimumab|belimumab|mesh-list
92286161|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286162|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
92286163|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286165|NCT04173507|Talazoparib|talazoparib|mesh-list
92286166|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92286167|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286168|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286169|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92286171|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286172|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
92286173|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286174|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
92286175|NCT05033756|Olaparib|olaparib|mesh-list
92286176|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286177|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286178|NCT05033756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92286179|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286180|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92286181|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286182|NCT03522077|Hemostatics|hemostatics|mesh-list
92286183|NCT03522077|Coagulants|coagulants|mesh-ancestor
92286184|NCT02980562|Bisacodyl|bisacodyl|mesh-list
92286185|NCT02980562|Cathartics|cathartics|mesh-ancestor
92286186|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286187|NCT02980562|Laxatives|laxatives|mesh-ancestor
92286188|NCT03266393|Tacrolimus|tacrolimus|mesh-list
92286189|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286190|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
92286191|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286192|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92286193|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286194|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286195|NCT00421967|Ketorolac|ketorolac|mesh-list
92286196|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92286197|NCT00421967|Epinephrine|epinephrine|mesh-list
92286198|NCT00421967|Racepinephrine|racepinephrine|mesh-list
92286199|NCT00421967|Ropivacaine|ropivacaine|mesh-list
92286200|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
92286201|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
92286202|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
92286203|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286204|NCT00421967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286205|NCT00421967|Sensory System Agents|sensory system agents|mesh-ancestor
92286206|NCT00421967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286207|NCT00421967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92286208|NCT00421967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92286209|NCT00421967|Analgesics|analgesics|mesh-ancestor
92286210|NCT00421967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286211|NCT00421967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286212|NCT00421967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92286213|NCT00421967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286214|NCT00421967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286215|NCT00421967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92286216|NCT00421967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92286217|NCT00421967|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286218|NCT00421967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286219|NCT00421967|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92286220|NCT00421967|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92286221|NCT00421967|Autonomic Agents|autonomic agents|mesh-ancestor
92286222|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92286223|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286224|NCT00421967|Mydriatics|mydriatics|mesh-ancestor
92286225|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
92286226|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92286227|NCT03209687|Menotropins|menotropins|mesh-list
92286228|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92286229|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
92286230|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286231|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286232|NCT04997798|Trastuzumab|trastuzumab|mesh-list
92286233|NCT04997798|Exemestane|exemestane|mesh-list
92286234|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286235|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286236|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92286237|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92286238|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322594|NCT00002162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92286239|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286240|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92286241|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
92286242|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286243|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286245|NCT00362531|Tacrolimus|tacrolimus|mesh-list
92286246|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286247|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
92286248|NCT00362531|Hormones|hormones|mesh-ancestor
92286249|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286250|NCT00362531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286251|NCT00362531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92286252|NCT00362531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286253|NCT00362531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286254|NCT00362531|Immunologic Factors|immunologic factors|mesh-ancestor
92286255|NCT00362531|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92286256|NCT00362531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286257|NCT00362531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286258|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92286259|NCT04330443|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286260|NCT04330677|Oxytocin|oxytocin|mesh-list
92286261|NCT04330677|Estrogens|estrogens|mesh-list
92286262|NCT04330677|Oxytocics|oxytocics|mesh-ancestor
92286263|NCT04330677|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286264|NCT04330677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286265|NCT04330677|Hormones|hormones|mesh-ancestor
92286266|NCT04330677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286267|NCT04965116|Contraceptive Agents|contraceptive agents|mesh-list
92286268|NCT04965116|Progestins|progestins|mesh-list
92286269|NCT04965116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286270|NCT04965116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286271|NCT04965116|Hormones|hormones|mesh-ancestor
92286272|NCT04965116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286273|NCT04964960|Paclitaxel|paclitaxel|mesh-list
92286274|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92286275|NCT04964960|Carboplatin|carboplatin|mesh-list
92286276|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
92286277|NCT04964960|Pemetrexed|pemetrexed|mesh-list
92286278|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286279|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286280|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286281|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286282|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286283|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286284|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286285|NCT04964960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92286286|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286287|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92286288|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92286289|NCT05114486|Pilocarpine|pilocarpine|mesh-list
92286290|NCT05114486|Miotics|miotics|mesh-ancestor
92286291|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
92286292|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286293|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286294|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92286295|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92286296|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
92286297|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939084|NCT02443831|Fludarabine|fludarabine|mesh-list
92286298|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286299|NCT03200847|Pembrolizumab|pembrolizumab|mesh-list
92286300|NCT03200847|Tretinoin|tretinoin|mesh-list
92286301|NCT03200847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286302|NCT03200847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286303|NCT03200847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92286304|NCT03200847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286305|NCT03200847|Keratolytic Agents|keratolytic agents|mesh-ancestor
92286306|NCT03200847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92286307|NCT02259517|Guanfacine|guanfacine|mesh-list
92286308|NCT02259517|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92286309|NCT02259517|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92286310|NCT02259517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286311|NCT02259517|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92286312|NCT02259517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92286313|NCT02259517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286314|NCT02259517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286315|NCT02259517|Dopamine Agents|dopamine agents|mesh-ancestor
92286316|NCT02259517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286317|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92286318|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92286319|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92286320|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92286321|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286322|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
92286323|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92286324|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
92286325|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286326|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286327|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92286328|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286329|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92286330|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
92286331|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286332|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286333|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92286334|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
92286335|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
92286336|NCT04358588|Protective Agents|protective agents|mesh-ancestor
92286337|NCT03166761|Dexamethasone|dexamethasone|mesh-list
92286338|NCT03166761|Triamcinolone|triamcinolone|mesh-list
92286339|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92286340|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92286341|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92286342|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286343|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
92286344|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
92286345|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286346|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286347|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286348|NCT03166761|Glucocorticoids|glucocorticoids|mesh-ancestor
92286349|NCT03166761|Hormones|hormones|mesh-ancestor
92286350|NCT03166761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286351|NCT03166761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92286352|NCT03166761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286353|NCT03166761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286354|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
92286355|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286356|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286357|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
92286358|NCT04042155|Apixaban|apixaban|mesh-list
92286359|NCT04042155|Edoxaban|edoxaban|mesh-list
92286360|NCT04042155|Dabigatran|dabigatran|mesh-list
92345167|NCT00003671|Leucovorin|leucovorin|mesh-list
92286361|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92286362|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
92286363|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92286364|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92286365|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286366|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286367|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
92286368|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
92286369|NCT04195256|Ketamine|ketamine|mesh-list
91935436|NCT02310997|Fludarabine|fludarabine|mesh-list
92286370|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92286371|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939162|NCT05082441|Bupivacaine|bupivacaine|mesh-list
92286372|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286373|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92286374|NCT04195256|Analgesics|analgesics|mesh-ancestor
92286375|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
92286376|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286377|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92286378|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92286379|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92286380|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286381|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286382|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286383|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92286384|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92286385|NCT04195256|Anesthetics, General|anesthetics, general|mesh-ancestor
92286386|NCT04195256|Anesthetics|anesthetics|mesh-ancestor
92286387|NCT04195256|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92286388|NCT04195256|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92286390|NCT00002901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286391|NCT00002901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286392|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286393|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286394|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286395|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
92286396|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92286397|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
92286398|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286399|NCT00002907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286400|NCT01710787|Phenylephrine|phenylephrine|mesh-list
92286401|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
92286402|NCT01710787|Tetracaine|tetracaine|mesh-list
92286403|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
92286404|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
92286405|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286406|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286407|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
92286408|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286409|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92286410|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92286411|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286412|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286413|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286414|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
92286415|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
92286416|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
92286417|NCT01710787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92286418|NCT01710787|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286419|NCT01710787|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92286420|NCT01710787|Mydriatics|mydriatics|mesh-ancestor
92286421|NCT01710787|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92286422|NCT01710787|Protective Agents|protective agents|mesh-ancestor
92286423|NCT01711177|Travoprost|travoprost|mesh-list
92286424|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92286425|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92286426|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286427|NCT01715233|Leucovorin|leucovorin|mesh-list
92286428|NCT01715233|Carboplatin|carboplatin|mesh-list
92286429|NCT01715233|Docetaxel|docetaxel|mesh-list
92286430|NCT01715233|Fluorouracil|fluorouracil|mesh-list
92286431|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286432|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286433|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286434|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286435|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286436|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
92286437|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92286438|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286439|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
92286440|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286441|NCT01715233|Antidotes|antidotes|mesh-ancestor
92286442|NCT01715233|Protective Agents|protective agents|mesh-ancestor
91939235|NCT00836069|Paroxetine|paroxetine|mesh-list
92286443|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
92286444|NCT01715233|Vitamins|vitamins|mesh-ancestor
92286445|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
92286446|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92286447|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92286448|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286449|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
92286450|NCT05145283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286451|NCT04826588|Methylprednisolone|methylprednisolone|mesh-list
92286452|NCT04826588|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92286453|NCT04826588|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92286454|NCT04826588|Prednisolone|prednisolone|mesh-list
92286455|NCT04826588|Prednisolone acetate|prednisolone acetate|mesh-list
92286456|NCT04826588|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92286457|NCT04826588|Prednisolone phosphate|prednisolone phosphate|mesh-list
92286458|NCT04826588|Immunoglobulins|immunoglobulins|mesh-list
92286459|NCT04826588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286460|NCT04826588|Antiemetics|antiemetics|mesh-ancestor
92286461|NCT04826588|Autonomic Agents|autonomic agents|mesh-ancestor
92286462|NCT04826588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286463|NCT04826588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286464|NCT04826588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286465|NCT04826588|Glucocorticoids|glucocorticoids|mesh-ancestor
92286466|NCT04826588|Hormones|hormones|mesh-ancestor
92286467|NCT04826588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286468|NCT04826588|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92286469|NCT04826588|Protective Agents|protective agents|mesh-ancestor
92286470|NCT04826588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92286471|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286472|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
92286473|NCT01719367|Atenolol|atenolol|mesh-list
92286474|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92286475|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92286476|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
92286477|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
92286478|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286479|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286480|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92286481|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92286482|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92286483|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286484|NCT01719367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286485|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286486|NCT02276040|Bupivacaine|bupivacaine|mesh-list
92286487|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
92286488|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
92286489|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286490|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286491|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
92286492|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286493|NCT02250703|Midazolam|midazolam|mesh-list
92286494|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
92286495|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92409264|NCT05867550|Mebeverine|mebeverine|mesh-list
92286496|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286497|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286498|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92286499|NCT02250703|Analgesics|analgesics|mesh-ancestor
92286500|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
92286501|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286502|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92286503|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92286504|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92286505|NCT02250703|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286506|NCT02250703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286507|NCT02250703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286508|NCT02250703|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92286509|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92286510|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92286511|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92286512|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92286513|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
92286514|NCT02250703|Anesthetics|anesthetics|mesh-ancestor
92286515|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
92286516|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
92286517|NCT02314728|Misoprostol|misoprostol|mesh-list
92286518|NCT02314728|Oxytocin|oxytocin|mesh-list
92286519|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
92286520|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286521|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286522|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92286523|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
92286524|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92286525|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286526|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
92286527|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92286528|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
92286529|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286530|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286531|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92286532|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286533|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92286534|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
92286535|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286536|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286537|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92286538|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
92286539|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
92286540|NCT03135860|Protective Agents|protective agents|mesh-ancestor
92286541|NCT02275338|Lanreotide|lanreotide|mesh-list
92286542|NCT02275338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286543|NCT01646268|Rotigotine|rotigotine|mesh-list
92286544|NCT01646268|Dopamine Agonists|dopamine agonists|mesh-ancestor
92286545|NCT01646268|Dopamine Agents|dopamine agents|mesh-ancestor
92286546|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286547|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286548|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286549|NCT03988634|Valsartan|valsartan|mesh-list
92286550|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92286551|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92286552|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92286553|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92286554|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286555|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92286556|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92286557|NCT01722487|Chlorambucil|chlorambucil|mesh-list
92286558|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92286559|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
92286560|NCT01722487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286561|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286562|NCT02795858|Octreotide|octreotide|mesh-list
92286563|NCT02795858|Ramucirumab|ramucirumab|mesh-list
92286565|NCT02795858|Somatostatin|somatostatin|mesh-list
92286566|NCT02795858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286567|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92286568|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286569|NCT02795858|Hormones|hormones|mesh-ancestor
92286570|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286571|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286572|NCT02730962|Vancomycin|vancomycin|mesh-list
92286573|NCT02730962|Clindamycin|clindamycin|mesh-list
92286574|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
92286575|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
92286576|NCT02730962|Neomycin|neomycin|mesh-list
92286577|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92286578|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286579|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92286580|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286581|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286582|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92286583|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92286584|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
92286586|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
92286587|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92286588|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
92286589|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286590|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
92286591|NCT02296346|Hormones|hormones|mesh-ancestor
92286592|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286593|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286594|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92286595|NCT02296346|Protective Agents|protective agents|mesh-ancestor
92286596|NCT02296346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92286597|NCT02296346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286598|NCT02296346|Antiemetics|antiemetics|mesh-ancestor
92286599|NCT02296346|Autonomic Agents|autonomic agents|mesh-ancestor
92286600|NCT02296346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286601|NCT02296346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92286602|NCT01726621|Insulin|insulin|mesh-list
92286603|NCT01726621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92286604|NCT01726621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286605|NCT02372630|Linagliptin|linagliptin|mesh-list
92286606|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92286607|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286608|NCT02372630|Incretins|incretins|mesh-ancestor
92286609|NCT02372630|Hormones|hormones|mesh-ancestor
92286610|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286611|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92286612|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
92286613|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286614|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286615|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92286616|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
92286617|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
92286618|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286619|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286620|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
92286621|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286622|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92286623|NCT04349930|Cannabidiol|cannabidiol|mesh-list
92286624|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
92286625|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
92286626|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286627|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286628|NCT02303990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92286629|NCT02303990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286630|NCT01727089|Bevacizumab|bevacizumab|mesh-list
92286631|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92286632|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
92286633|NCT01727089|Antibodies|antibodies|mesh-list
92286634|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
92286635|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92286636|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
92286637|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286638|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92286639|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92286640|NCT01727089|Growth Substances|growth substances|mesh-ancestor
92286641|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286642|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92286643|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
92286644|NCT01727791|Pregabalin|pregabalin|mesh-list
92286645|NCT01727791|Analgesics|analgesics|mesh-ancestor
92286646|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
92286647|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286648|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286649|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
92286650|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92286651|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286652|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286653|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92286654|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92286655|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92286656|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286657|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92286658|NCT01728337|Botulinum Toxins|botulinum toxins|mesh-list
92286659|NCT01728337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92286660|NCT01728337|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92286661|NCT01728337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92286662|NCT01728337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286663|NCT01728337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286664|NCT01728337|Cholinergic Agents|cholinergic agents|mesh-ancestor
92286665|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286666|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286667|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92286668|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286669|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
92286670|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91939454|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92286671|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92286672|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92286673|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286674|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286675|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
92286676|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286677|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286678|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92286679|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286681|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92286682|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92286683|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
92286684|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286685|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92286686|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92286687|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286688|NCT04726969|Ivermectin|ivermectin|mesh-list
92286689|NCT04726969|Albendazole|albendazole|mesh-list
92286690|NCT04726969|Moxidectin|moxidectin|mesh-list
92286691|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92286692|NCT04726969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286693|NCT04726969|Anthelmintics|anthelmintics|mesh-ancestor
92286694|NCT04726969|Anticestodal Agents|anticestodal agents|mesh-ancestor
92286695|NCT04726969|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92286696|NCT04726969|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92286697|NCT04726969|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286698|NCT04726969|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286699|NCT04726969|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286700|NCT04726969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286701|NCT04726969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286702|NCT04726969|Antinematodal Agents|antinematodal agents|mesh-ancestor
92286703|NCT03174275|Paclitaxel|paclitaxel|mesh-list
92286704|NCT03174275|Carboplatin|carboplatin|mesh-list
92286705|NCT03174275|Durvalumab|durvalumab|mesh-list
92286706|NCT03174275|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286707|NCT03174275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286708|NCT03174275|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286709|NCT03174275|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286710|NCT03174275|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286711|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286712|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92286713|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
92286714|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92286715|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286716|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286717|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92286718|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92286719|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92286720|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92286721|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286722|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
92286723|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286724|NCT02975141|Paclitaxel|paclitaxel|mesh-list
92286725|NCT02975141|Gemcitabine|gemcitabine|mesh-list
92286726|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92286727|NCT02975141|Afatinib|afatinib|mesh-list
92286728|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286729|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286730|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286731|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286732|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286733|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286734|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92286735|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
92286736|NCT02975141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92286737|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286738|NCT03452891|Simvastatin|simvastatin|mesh-list
92286739|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92286740|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92286741|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
92286742|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286743|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92286744|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92286745|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286746|NCT04341935|Linagliptin|linagliptin|mesh-list
92286747|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92286748|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286750|NCT04341935|Hormones|hormones|mesh-ancestor
92286751|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92286752|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92286753|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
92286754|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286755|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286756|NCT05317039|Calcium|calcium|mesh-list
92286757|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92286758|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286759|NCT05316883|Clozapine|clozapine|mesh-list
92286760|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92286761|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
92286763|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286764|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286765|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92286766|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92286767|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286768|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92286769|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
92286770|NCT05316883|GABA Agents|gaba agents|mesh-ancestor
92286771|NCT05316649|Chrysarobin|chrysarobin|mesh-list
92286772|NCT05316649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92286773|NCT05316649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92286774|NCT05316649|Analgesics|analgesics|mesh-ancestor
92286775|NCT05316649|Sensory System Agents|sensory system agents|mesh-ancestor
92286776|NCT05316649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92286777|NCT05316649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286778|NCT05316649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92286779|NCT05316649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286780|NCT03990363|Allopurinol|allopurinol|mesh-list
92286781|NCT03990363|Verinurad|verinurad|mesh-list
92286782|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
92286783|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286784|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286785|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
92286786|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286787|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92286788|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
92286789|NCT03990363|Protective Agents|protective agents|mesh-ancestor
92286790|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286792|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92286793|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
92286794|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286795|NCT00002913|Paclitaxel|paclitaxel|mesh-list
92286796|NCT00002913|Topotecan|topotecan|mesh-list
92286797|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286798|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286799|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286800|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286801|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286802|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286803|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92286804|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92286805|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286806|NCT00002919|Doxorubicin|doxorubicin|mesh-list
92286807|NCT00002919|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92286808|NCT00002919|Methotrexate|methotrexate|mesh-list
92286809|NCT00002919|Vinblastine|vinblastine|mesh-list
92286810|NCT00002919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286811|NCT00002919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92286812|NCT00002919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92286813|NCT00002919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92286814|NCT00002919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286815|NCT00002919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286816|NCT00002919|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92286817|NCT00002919|Abortifacient Agents|abortifacient agents|mesh-ancestor
92286818|NCT00002919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286819|NCT00002919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286820|NCT00002919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92286821|NCT00002919|Antimetabolites|antimetabolites|mesh-ancestor
92286822|NCT00002919|Dermatologic Agents|dermatologic agents|mesh-ancestor
92286823|NCT00002919|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92286824|NCT00002919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286825|NCT00002919|Immunologic Factors|immunologic factors|mesh-ancestor
92286826|NCT00002919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286827|NCT00002919|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92286828|NCT00002919|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286829|NCT00002919|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286830|NCT00002919|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286831|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286833|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92286834|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
92286835|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92286836|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92286837|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92286838|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92286839|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286840|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92286841|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286842|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286843|NCT00383799|Amiodarone|amiodarone|mesh-list
92286844|NCT00383799|Procainamide|procainamide|mesh-list
92286845|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92286846|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
92286847|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92286848|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92116775|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92286849|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286850|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92286851|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92286852|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92286853|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286854|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92286855|NCT00383799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92286856|NCT00383799|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92286857|NCT00383799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92286859|NCT04635241|Calcium heparin|calcium heparin|mesh-list
92286860|NCT04635241|Anticoagulants|anticoagulants|mesh-ancestor
92286861|NCT04635241|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92286862|NCT04635241|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92286863|NCT04635241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286864|NCT03954483|Triazolam|triazolam|mesh-list
92286865|NCT03954483|Buspirone|buspirone|mesh-list
92286866|NCT03954483|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92286867|NCT03954483|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92286868|NCT03954483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92286869|NCT03954483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286870|NCT03954483|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92286871|NCT03954483|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92286872|NCT03954483|Serotonin Agents|serotonin agents|mesh-ancestor
92286873|NCT03954483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92286874|NCT03954483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286875|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92286876|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
92286877|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
92286878|NCT04545541|Heparin|heparin|mesh-list
92286879|NCT04545541|Calcium heparin|calcium heparin|mesh-list
92286880|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
92286881|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92286882|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92286883|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286884|NCT00002925|Aldesleukin|aldesleukin|mesh-list
92286885|NCT00002925|Etoposide|etoposide|mesh-list
92286886|NCT00002925|Daunorubicin|daunorubicin|mesh-list
92286887|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286888|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286889|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92286890|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92286891|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286892|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286893|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92286894|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92286895|NCT00002925|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92286896|NCT00002925|Antiviral Agents|antiviral agents|mesh-ancestor
92286897|NCT00002925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286899|NCT00002937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286900|NCT00002937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286901|NCT00002937|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286902|NCT00002937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286903|NCT00002937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286904|NCT00002937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286905|NCT02922777|Docetaxel|docetaxel|mesh-list
92286906|NCT02922777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286907|NCT02922777|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286908|NCT02922777|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286909|NCT02922777|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286910|NCT02922777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286912|NCT02918955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286913|NCT00002943|Cyclophosphamide|cyclophosphamide|mesh-list
92286914|NCT00002943|Carboplatin|carboplatin|mesh-list
92286915|NCT00002943|Etoposide|etoposide|mesh-list
92286916|NCT00002943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286917|NCT00002943|Immunologic Factors|immunologic factors|mesh-ancestor
92286918|NCT00002943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286919|NCT00002943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286920|NCT00002943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92286921|NCT00002943|Alkylating Agents|alkylating agents|mesh-ancestor
92286922|NCT00002943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286923|NCT00002943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286924|NCT00002943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92286925|NCT00002943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286926|NCT00002943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92286927|NCT00002943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92286928|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286929|NCT00002949|Paclitaxel|paclitaxel|mesh-list
92286930|NCT00002949|Vinorelbine|vinorelbine|mesh-list
92286931|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286932|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286933|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92286934|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92286935|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92286936|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286937|NCT05315557|Terlipressin|terlipressin|mesh-list
92286938|NCT05315557|Vasopressins|vasopressins|mesh-list
92286939|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
92286940|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
92286941|NCT05315557|Coagulants|coagulants|mesh-ancestor
92286942|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92286943|NCT05315557|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92286944|NCT05315557|Natriuretic Agents|natriuretic agents|mesh-ancestor
92286945|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286946|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92286947|NCT00002955|Leucovorin|leucovorin|mesh-list
92286948|NCT00002955|Trimetrexate|trimetrexate|mesh-list
92286949|NCT00002955|Fluorouracil|fluorouracil|mesh-list
92286950|NCT00002955|Calcium|calcium|mesh-list
92286951|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
92286952|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92286953|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286954|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
92286955|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286956|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92286957|NCT00002955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286958|NCT00002955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286959|NCT00002955|Immunologic Factors|immunologic factors|mesh-ancestor
92286960|NCT00002955|Antidotes|antidotes|mesh-ancestor
92286961|NCT00002955|Protective Agents|protective agents|mesh-ancestor
92286962|NCT00002955|Vitamin B Complex|vitamin b complex|mesh-ancestor
92286963|NCT00002955|Vitamins|vitamins|mesh-ancestor
92286964|NCT00002955|Micronutrients|micronutrients|mesh-ancestor
92286965|NCT00002955|Antifungal Agents|antifungal agents|mesh-ancestor
92286966|NCT00002955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286967|NCT00002955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92286968|NCT00002955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286969|NCT00002961|Cyclosporine|cyclosporine|mesh-list
91939759|NCT05036798|Lenvatinib|lenvatinib|mesh-list
92286970|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
92286971|NCT00002961|Busulfan|busulfan|mesh-list
92286972|NCT00002961|Methotrexate|methotrexate|mesh-list
92286973|NCT00002961|Etoposide|etoposide|mesh-list
92286974|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
92286975|NCT00002961|Cyclosporins|cyclosporins|mesh-list
92286976|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92286977|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
92286978|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92286979|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92286980|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92286981|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
92286982|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92286983|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92286984|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92286985|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92286986|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
92286987|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92286988|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92286989|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
92286990|NCT00002961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92286991|NCT00002961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92286992|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92286993|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92286994|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92286995|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92286996|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92286997|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
92286998|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92286999|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92287000|NCT00002967|Tamoxifen|tamoxifen|mesh-list
92287001|NCT00002967|Cyclophosphamide|cyclophosphamide|mesh-list
92287002|NCT00002967|Doxorubicin|doxorubicin|mesh-list
92287003|NCT00002967|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92287004|NCT00002967|Octreotide|octreotide|mesh-list
92287005|NCT00002967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287006|NCT00002967|Immunologic Factors|immunologic factors|mesh-ancestor
92287007|NCT00002967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287008|NCT00002967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287009|NCT00002967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287010|NCT00002967|Alkylating Agents|alkylating agents|mesh-ancestor
92287011|NCT00002967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287012|NCT00002967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287013|NCT00002967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92287014|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287015|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287016|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287017|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287018|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92287019|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
92287020|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287021|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287022|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92287023|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92287024|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92287025|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287026|NCT04246177|Pembrolizumab|pembrolizumab|mesh-list
92287027|NCT04246177|Lenvatinib|lenvatinib|mesh-list
92287028|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287029|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287030|NCT04246177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287031|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287032|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92287033|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287034|NCT00002973|Melphalan|melphalan|mesh-list
92287035|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287036|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
92287037|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287038|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287039|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92287040|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287041|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
92287042|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287043|NCT00002985|Doxorubicin|doxorubicin|mesh-list
92287044|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92287045|NCT00002985|Daunorubicin|daunorubicin|mesh-list
92287046|NCT00002985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91939829|NCT02267746|Tazarotene|tazarotene|mesh-list
92287047|NCT00002985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287048|NCT00002985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287049|NCT00002985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287050|NCT00002985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287051|NCT00002985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287052|NCT02767557|Paclitaxel|paclitaxel|mesh-list
92287053|NCT02767557|Gemcitabine|gemcitabine|mesh-list
92287054|NCT02767557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287055|NCT02767557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287056|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287057|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287058|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287059|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287060|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287061|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
92287062|NCT00363389|Misoprostol|misoprostol|mesh-list
92287063|NCT00363389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92287064|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
92287065|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92287066|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287067|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92287068|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287069|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
92287070|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92287071|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92287072|NCT03057431|Diuretics|diuretics|mesh-ancestor
92287073|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
92287074|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287075|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92409265|NCT05867550|Psyllium|psyllium|mesh-list
92287076|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92287077|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287078|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
92287079|NCT00003003|Mitomycins|mitomycins|mesh-list
92287080|NCT00003003|Mitomycin|mitomycin|mesh-list
92287081|NCT00003003|Sargramostim|sargramostim|mesh-list
92287082|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
92287083|NCT00003003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287084|NCT00003003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287085|NCT00003003|Analgesics|analgesics|mesh-ancestor
92287086|NCT00003003|Sensory System Agents|sensory system agents|mesh-ancestor
92287087|NCT00003003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287088|NCT00003003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287089|NCT00003003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287090|NCT00003003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287091|NCT00003003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287092|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287093|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
92287094|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287095|NCT00003009|Aldesleukin|aldesleukin|mesh-list
92287096|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287097|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92287098|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92287099|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
92287100|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287101|NCT00003015|Carboplatin|carboplatin|mesh-list
92287102|NCT00003015|Vincristine|vincristine|mesh-list
92287103|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287104|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287105|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287106|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287107|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287108|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287109|NCT04204837|Nivolumab|nivolumab|mesh-list
92287110|NCT04204837|Relatlimab|relatlimab|mesh-list
92287111|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287112|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287113|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287114|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287115|NCT00003021|Bizelesin|bizelesin|mesh-list
92287116|NCT00003021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287117|NCT00003021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287118|NCT00003021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287119|NCT00003021|Alkylating Agents|alkylating agents|mesh-ancestor
92287120|NCT00003021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287121|NCT00003039|Alvocidib|alvocidib|mesh-list
92287122|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287123|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92287124|NCT00003039|Growth Substances|growth substances|mesh-ancestor
92287125|NCT00003039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287126|NCT00003039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92287127|NCT00003039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287128|NCT00003039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287129|NCT00383877|Insulin|insulin|mesh-list
92287130|NCT00383877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92287131|NCT00383877|Insulin Detemir|insulin detemir|mesh-list
92287132|NCT00383877|Isophane Insulin, Human|isophane insulin, human|mesh-list
92287133|NCT00383877|Insulin, Isophane|insulin, isophane|mesh-list
92287134|NCT00383877|Isophane insulin, beef|isophane insulin, beef|mesh-list
92287135|NCT00383877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92287136|NCT00383877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287137|NCT00003063|Leucovorin|leucovorin|mesh-list
92287138|NCT00003063|Interferons|interferons|mesh-list
92287139|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
92287140|NCT00003063|Levamisole|levamisole|mesh-list
92287141|NCT00003063|Fluorouracil|fluorouracil|mesh-list
92287143|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
92287144|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92287145|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287146|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
92287147|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287148|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287149|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287150|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287151|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
92287152|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
92287153|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287154|NCT00003063|Antidotes|antidotes|mesh-ancestor
92287155|NCT00003063|Protective Agents|protective agents|mesh-ancestor
92287156|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
92287157|NCT00003063|Vitamins|vitamins|mesh-ancestor
92287158|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
92287159|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92287160|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
92287161|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
92287162|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92287163|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287164|NCT00003075|Fenretinide|fenretinide|mesh-list
92287165|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287166|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92287167|NCT00003075|Protective Agents|protective agents|mesh-ancestor
92287168|NCT00003075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287169|NCT00003081|Melphalan|melphalan|mesh-list
92287170|NCT00003081|Busulfan|busulfan|mesh-list
92287171|NCT00003081|Thiotepa|thiotepa|mesh-list
92287172|NCT00003081|Immunologic Factors|immunologic factors|mesh-ancestor
92287173|NCT00003081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287174|NCT00003081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287175|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
92287176|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287177|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287178|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92287179|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287180|NCT02348385|Amphetamine|amphetamine|mesh-list
92287181|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
92287182|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92287183|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287184|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
92287185|NCT02348385|Autonomic Agents|autonomic agents|mesh-ancestor
92287186|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287187|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
92287188|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287189|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287190|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92287191|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92287192|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92287193|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92287194|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91939977|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
92287196|NCT00003087|Cisplatin|cisplatin|mesh-list
92287197|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287198|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287199|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287200|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287201|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287202|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287203|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
92287204|NCT00003093|Carboplatin|carboplatin|mesh-list
92287205|NCT00003093|Doxorubicin|doxorubicin|mesh-list
92287206|NCT00003093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92287207|NCT00003093|Etoposide|etoposide|mesh-list
92287208|NCT00003093|Molgramostim|molgramostim|mesh-list
92287209|NCT00003093|Lenograstim|lenograstim|mesh-list
92287210|NCT00003093|Sargramostim|sargramostim|mesh-list
92287211|NCT00003093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287212|NCT00003093|Immunologic Factors|immunologic factors|mesh-ancestor
92287213|NCT00003093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287214|NCT00003093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287215|NCT00003093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287216|NCT00003093|Alkylating Agents|alkylating agents|mesh-ancestor
92287217|NCT00003093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287218|NCT00003093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287219|NCT00003093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92287220|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287221|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287222|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287223|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287224|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287225|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92287227|NCT00003099|Fenretinide|fenretinide|mesh-list
92287228|NCT00003099|Retinamide|retinamide|mesh-list
92287229|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92287230|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
92409266|NCT05867550|Calcium polycarbophil|calcium polycarbophil|mesh-list
92287231|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287232|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287233|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287234|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287235|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92287236|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92287237|NCT00003099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92287238|NCT00003099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92287239|NCT00003099|Protective Agents|protective agents|mesh-ancestor
92287240|NCT00003105|Paclitaxel|paclitaxel|mesh-list
92287241|NCT00003105|Gemcitabine|gemcitabine|mesh-list
92287242|NCT00003105|Doxorubicin|doxorubicin|mesh-list
92287243|NCT00003105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92287244|NCT00003105|Ifosfamide|ifosfamide|mesh-list
92287245|NCT00003105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287246|NCT00003105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287247|NCT00003105|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287248|NCT00003105|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287249|NCT00003105|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287250|NCT00003105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287251|NCT00003105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287252|NCT00003105|Antimetabolites|antimetabolites|mesh-ancestor
92287253|NCT00003105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287254|NCT00003105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287255|NCT00003105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287256|NCT00003105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287257|NCT00003105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287258|NCT00003105|Alkylating Agents|alkylating agents|mesh-ancestor
92287259|NCT00003111|Paclitaxel|paclitaxel|mesh-list
92287260|NCT00003111|Carboplatin|carboplatin|mesh-list
92287261|NCT00003111|Irinotecan|irinotecan|mesh-list
92287262|NCT00003111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287263|NCT00003111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287264|NCT00003111|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287265|NCT00003111|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287266|NCT00003111|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287267|NCT00003111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287268|NCT00003111|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92287269|NCT00003111|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287270|NCT00003111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287271|NCT05709301|Donepezil|donepezil|mesh-list
92287272|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92287273|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287274|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287275|NCT05709301|Cholinergic Agents|cholinergic agents|mesh-ancestor
92287276|NCT05709301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287277|NCT05709301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287278|NCT05709301|Nootropic Agents|nootropic agents|mesh-ancestor
92287279|NCT00003117|Paclitaxel|paclitaxel|mesh-list
92287280|NCT00003117|Carboplatin|carboplatin|mesh-list
92287281|NCT00003117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287282|NCT00003117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287283|NCT00003117|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287284|NCT00003117|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287285|NCT00003117|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287286|NCT00003117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287287|NCT02240329|Capsaicin|capsaicin|mesh-list
92287288|NCT02240329|Antipruritics|antipruritics|mesh-ancestor
92287289|NCT02240329|Dermatologic Agents|dermatologic agents|mesh-ancestor
92287290|NCT02240329|Sensory System Agents|sensory system agents|mesh-ancestor
92287291|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287292|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287293|NCT00003123|Amifostine|amifostine|mesh-list
92287294|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92287295|NCT00003123|Protective Agents|protective agents|mesh-ancestor
92287296|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287297|NCT03981523|Benzonidazole|benzonidazole|mesh-list
92287298|NCT03981523|Nifurtimox|nifurtimox|mesh-list
92287299|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287300|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
92287301|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287302|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92287303|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92287304|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92287305|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287306|NCT03965923|Tenofovir|tenofovir|mesh-list
92287307|NCT03965923|Emtricitabine|emtricitabine|mesh-list
92287308|NCT03965923|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92287309|NCT03965923|Dapivirine|dapivirine|mesh-list
92287310|NCT03965923|Antiviral Agents|antiviral agents|mesh-ancestor
92287311|NCT03965923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287312|NCT03965923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92287313|NCT03965923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287314|NCT03965923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287315|NCT03965923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287316|NCT03965923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92287317|NCT03965923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92287318|NCT03962725|Dexmedetomidine|dexmedetomidine|mesh-list
92287319|NCT03962725|Ketamine|ketamine|mesh-list
92287320|NCT03962725|Propofol|propofol|mesh-list
92287321|NCT03962725|Anesthetics|anesthetics|mesh-list
92287322|NCT03962725|Rocuronium|rocuronium|mesh-list
92287323|NCT03962725|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92287324|NCT03962725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92287325|NCT03962725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92287326|NCT03962725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287327|NCT03962725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92287328|NCT03962725|Analgesics|analgesics|mesh-ancestor
92287329|NCT03962725|Sensory System Agents|sensory system agents|mesh-ancestor
92287330|NCT03962725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287331|NCT03962725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92287332|NCT03962725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92287333|NCT03962725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92287334|NCT03962725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92287335|NCT03962725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345256|NCT00003725|Valrubicin|valrubicin|mesh-list
92287336|NCT03962725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287338|NCT03962725|Anesthetics, General|anesthetics, general|mesh-ancestor
92287339|NCT03962725|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92287340|NCT03962725|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92287341|NCT03962725|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92287342|NCT03962725|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92287343|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92287344|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
92287345|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
92287346|NCT05699473|Calcium|calcium|mesh-list
92287347|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92287348|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287349|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92287350|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
92287351|NCT05699473|Vitamins|vitamins|mesh-ancestor
92287352|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
92287353|NCT02210559|Paclitaxel|paclitaxel|mesh-list
92287354|NCT02210559|Gemcitabine|gemcitabine|mesh-list
92287355|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287356|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287357|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287358|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287359|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287360|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287361|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287362|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
92287363|NCT00003135|Doxorubicin|doxorubicin|mesh-list
92287364|NCT00003135|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92287365|NCT00003135|Fluorouracil|fluorouracil|mesh-list
92287366|NCT00003135|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287367|NCT00003135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287368|NCT00003135|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287369|NCT00003135|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287370|NCT00003135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287371|NCT00003135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287372|NCT00003135|Antimetabolites|antimetabolites|mesh-ancestor
92287373|NCT00003135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287374|NCT00003135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287375|NCT00003135|Immunologic Factors|immunologic factors|mesh-ancestor
92287376|NCT00003135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287377|NCT03439891|Nivolumab|nivolumab|mesh-list
92287378|NCT03439891|Sorafenib|sorafenib|mesh-list
92287379|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287380|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287381|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409267|NCT05867550|Alverine|alverine|mesh-list
92287382|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287383|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92287384|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287385|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
92287386|NCT00003141|Thiotepa|thiotepa|mesh-list
92287387|NCT00003141|Cisplatin|cisplatin|mesh-list
92287388|NCT00003141|Carboplatin|carboplatin|mesh-list
92287389|NCT00003141|Etoposide|etoposide|mesh-list
92287390|NCT00003141|Vincristine|vincristine|mesh-list
92287391|NCT00003141|Lenograstim|lenograstim|mesh-list
92287392|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287393|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
92287394|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287395|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287396|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92287397|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
92287398|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287399|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287400|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92287401|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287402|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287403|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287404|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287405|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92287406|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287407|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287408|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287409|NCT04867135|Amikacin|amikacin|mesh-list
92287410|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287411|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287412|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92287413|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92287414|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92287415|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92287416|NCT04728217|Factor VIII|factor viii|mesh-list
92287417|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92287418|NCT04728217|Coagulants|coagulants|mesh-ancestor
92287419|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
92287420|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287421|NCT04581343|Paclitaxel|paclitaxel|mesh-list
92287422|NCT04581343|Gemcitabine|gemcitabine|mesh-list
92287423|NCT04581343|Spartalizumab|spartalizumab|mesh-list
92287424|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287425|NCT04581343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287426|NCT04581343|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287427|NCT04581343|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287428|NCT04581343|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287429|NCT04581343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287430|NCT04581343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287431|NCT04581343|Antimetabolites|antimetabolites|mesh-ancestor
92287432|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287433|NCT04581343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287434|NCT01743859|Lenalidomide|lenalidomide|mesh-list
92287435|NCT01743859|Azacitidine|azacitidine|mesh-list
92287436|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
92287437|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287438|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92287439|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92287440|NCT01743859|Growth Substances|growth substances|mesh-ancestor
92287441|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
92287442|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287443|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287444|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
92287445|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287446|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287447|NCT01746043|Minocycline|minocycline|mesh-list
92287448|NCT01746043|Modafinil|modafinil|mesh-list
92287449|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287450|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287451|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92287452|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287453|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92287454|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92287455|NCT01746043|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92287456|NCT01746043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287457|NCT05635903|Diazepam|diazepam|mesh-list
92287458|NCT05635903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92287459|NCT05635903|Anticonvulsants|anticonvulsants|mesh-ancestor
92287460|NCT05635903|Antiemetics|antiemetics|mesh-ancestor
92287461|NCT05635903|Autonomic Agents|autonomic agents|mesh-ancestor
92287462|NCT05635903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287463|NCT05635903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287464|NCT05635903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287465|NCT05635903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92287466|NCT05635903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92287467|NCT05635903|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92287468|NCT05635903|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92287469|NCT05635903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92287470|NCT05635903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92287471|NCT05635903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92287472|NCT05635903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92287473|NCT05635903|Anesthetics, General|anesthetics, general|mesh-ancestor
92287474|NCT05635903|Anesthetics|anesthetics|mesh-ancestor
92287475|NCT05635903|GABA Modulators|gaba modulators|mesh-ancestor
92287476|NCT05635903|GABA Agents|gaba agents|mesh-ancestor
92287477|NCT05635903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287478|NCT05635903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287479|NCT01746511|Glycerol|glycerol|mesh-list
92287480|NCT01746511|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92287481|NCT01746511|Protective Agents|protective agents|mesh-ancestor
92287482|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287483|NCT01746979|Gemcitabine|gemcitabine|mesh-list
92287484|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287485|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
92287486|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287487|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287488|NCT05614453|Tislelizumab|tislelizumab|mesh-list
92287489|NCT05614453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287490|NCT05614453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287491|NCT01754389|Sirolimus|sirolimus|mesh-list
92287492|NCT01754389|Methotrexate|methotrexate|mesh-list
92287493|NCT01754389|Bortezomib|bortezomib|mesh-list
92287494|NCT01754389|Tacrolimus|tacrolimus|mesh-list
92287495|NCT01754389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92287496|NCT01754389|Abortifacient Agents|abortifacient agents|mesh-ancestor
92287497|NCT01754389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92287498|NCT01754389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287499|NCT01754389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287500|NCT01754389|Antimetabolites|antimetabolites|mesh-ancestor
92287501|NCT01754389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287502|NCT01754389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287503|NCT01754389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92287504|NCT01754389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287505|NCT01754389|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92287506|NCT01754389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287507|NCT01754389|Immunologic Factors|immunologic factors|mesh-ancestor
92287508|NCT01754389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287509|NCT01754389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287510|NCT01754389|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92287511|NCT01754389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287512|NCT01754389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287513|NCT01754389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287514|NCT01754389|Antifungal Agents|antifungal agents|mesh-ancestor
92287515|NCT01754623|Gemcitabine|gemcitabine|mesh-list
92287516|NCT01754623|Fluorouracil|fluorouracil|mesh-list
92287517|NCT01754623|Capecitabine|capecitabine|mesh-list
92287518|NCT01754623|Docetaxel|docetaxel|mesh-list
92287519|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287520|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
92287521|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287522|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287523|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287524|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287525|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287526|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287527|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
92287528|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287529|NCT01755169|Ketamine|ketamine|mesh-list
92287530|NCT01755169|Analgesics|analgesics|mesh-ancestor
92287531|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
92287532|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287533|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287534|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92287535|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92287536|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
92287537|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
92287538|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92287539|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92345269|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92287540|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92287541|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287542|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287543|NCT01755949|Colchicine|colchicine|mesh-list
92287544|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
92287545|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287546|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287547|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287548|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287549|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287550|NCT01755949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287551|NCT01756885|Varenicline|varenicline|mesh-list
92287552|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92287553|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92287554|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
92287555|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287556|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287557|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287558|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
92287559|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92287560|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287561|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287562|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287563|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92287565|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
92287566|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287567|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287568|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
92287569|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287570|NCT01760785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287571|NCT01760785|Antimanic Agents|antimanic agents|mesh-ancestor
92287572|NCT01760785|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92287573|NCT01760785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92287574|NCT01760785|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92287575|NCT04062097|Vitamin K|vitamin k|mesh-list
92287576|NCT04062097|Dabigatran|dabigatran|mesh-list
92287577|NCT04062097|Vitamins|vitamins|mesh-ancestor
92287578|NCT04062097|Micronutrients|micronutrients|mesh-ancestor
92287579|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287581|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92287582|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
92287583|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287584|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287585|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
92287586|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92287587|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92287588|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
92287589|NCT04062097|Coagulants|coagulants|mesh-ancestor
92287590|NCT02241655|Anesthetics|anesthetics|mesh-list
92287591|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92287592|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287593|NCT04005079|Ofloxacin|ofloxacin|mesh-list
92287594|NCT04005079|Prednisolone|prednisolone|mesh-list
92287595|NCT04005079|Pilocarpine|pilocarpine|mesh-list
92287596|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92287597|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
92287598|NCT04005079|Hormones|hormones|mesh-ancestor
92287599|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287600|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287601|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287602|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287603|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
92287604|NCT04005079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287605|NCT04005079|Miotics|miotics|mesh-ancestor
92287606|NCT04005079|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92287607|NCT04005079|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92287608|NCT04005079|Cholinergic Agents|cholinergic agents|mesh-ancestor
92287609|NCT04005079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287610|NCT04005079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287611|NCT04005079|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92287612|NCT04005079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287613|NCT04005079|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287614|NCT04005079|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287615|NCT04005079|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287616|NCT04005079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287617|NCT04005079|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92287618|NCT04005079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92287619|NCT01762501|Amlodipine|amlodipine|mesh-list
92287620|NCT01762501|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92287621|NCT01762501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92287622|NCT01762501|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92287623|NCT01762501|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92287624|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287625|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92287626|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287627|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92287628|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92287629|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92287630|NCT01764607|Sirolimus|sirolimus|mesh-list
92287631|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287632|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287633|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287634|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287635|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
92287636|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287638|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287639|NCT01764685|Topiramate|topiramate|mesh-list
92287640|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
92287641|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92287642|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287643|NCT05115409|Rituximab|rituximab|mesh-list
92287644|NCT05115409|Antibodies|antibodies|mesh-list
92287645|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
92287646|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287647|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287648|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287649|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287650|NCT01766713|Ezetimibe|ezetimibe|mesh-list
92287651|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92287652|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92287653|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
91940423|NCT01352585|Anagrelide|anagrelide|mesh-list
92287654|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287655|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92287656|NCT01767103|Deferiprone|deferiprone|mesh-list
92287657|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92287658|NCT01767103|Chelating Agents|chelating agents|mesh-ancestor
92287659|NCT01767103|Sequestering Agents|sequestering agents|mesh-ancestor
92287660|NCT01767103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287662|NCT01769209|Dexamethasone|dexamethasone|mesh-list
92287663|NCT01769209|Doxorubicin|doxorubicin|mesh-list
92287664|NCT01769209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92287665|NCT01769209|Methotrexate|methotrexate|mesh-list
92287666|NCT01769209|Vincristine|vincristine|mesh-list
92287667|NCT01769209|Bortezomib|bortezomib|mesh-list
92287668|NCT01769209|Asparaginase|asparaginase|mesh-list
92287669|NCT01769209|Pegaspargase|pegaspargase|mesh-list
92287670|NCT01769209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92287671|NCT01769209|Antiemetics|antiemetics|mesh-ancestor
92287672|NCT01769209|Autonomic Agents|autonomic agents|mesh-ancestor
92287673|NCT01769209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287674|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287675|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287676|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
92287677|NCT01769209|Hormones|hormones|mesh-ancestor
92287678|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409345|NCT05841420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287679|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287680|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287681|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92287682|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92287683|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92287684|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287685|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287686|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92287687|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
92287688|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92287689|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287690|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
92287691|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
92287692|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92287693|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287694|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
92287695|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287696|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287697|NCT01769209|Antiviral Agents|antiviral agents|mesh-ancestor
92287698|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287699|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287700|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287701|NCT01769209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287702|NCT01769209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287703|NCT01769365|Amoxicillin|amoxicillin|mesh-list
92287704|NCT01769365|Metronidazole|metronidazole|mesh-list
92287705|NCT01769365|Clarithromycin|clarithromycin|mesh-list
92287706|NCT01769365|Pantoprazole|pantoprazole|mesh-list
92287707|NCT01769365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287708|NCT01769365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287709|NCT01769365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92287710|NCT01769365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92287711|NCT01769365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92287712|NCT01769365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287713|NCT01769365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287714|NCT01769365|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92287715|NCT01769365|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92287717|NCT01769365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287718|NCT01769365|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92287720|NCT01771627|Varenicline|varenicline|mesh-list
92287721|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92287722|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
92287723|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287724|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287725|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92287726|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92287727|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
92287728|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287729|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287731|NCT03682393|Hydrocortisone|hydrocortisone|mesh-list
92409422|NCT05796388|Linaclotide|linaclotide|mesh-list
92287732|NCT03682393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92287734|NCT03499483|Emtricitabine|emtricitabine|mesh-list
92287735|NCT03499483|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92287736|NCT03499483|Antiviral Agents|antiviral agents|mesh-ancestor
92287737|NCT03499483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287738|NCT03499483|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92287739|NCT03499483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287740|NCT03499483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287741|NCT03499483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287742|NCT03499483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92287743|NCT03499483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92287744|NCT04350931|BCG Vaccine|bcg vaccine|mesh-list
92287745|NCT04350931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92287746|NCT04350931|Immunologic Factors|immunologic factors|mesh-ancestor
92287747|NCT04350931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287748|NCT01673867|Docetaxel|docetaxel|mesh-list
92287749|NCT01673867|Nivolumab|nivolumab|mesh-list
92287750|NCT01673867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287751|NCT01673867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287752|NCT01673867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287753|NCT01673867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287754|NCT01673867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287755|NCT01673867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287756|NCT01673867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287757|NCT01777945|Docetaxel|docetaxel|mesh-list
92287758|NCT01777945|Capecitabine|capecitabine|mesh-list
92287759|NCT01777945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287760|NCT01777945|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287761|NCT01777945|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287762|NCT01777945|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287763|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287764|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287765|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
92287766|NCT03012581|Nivolumab|nivolumab|mesh-list
92287767|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287768|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287769|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287770|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287771|NCT05451043|Paclitaxel|paclitaxel|mesh-list
92287772|NCT05451043|Gemcitabine|gemcitabine|mesh-list
92287773|NCT05451043|Durvalumab|durvalumab|mesh-list
92287774|NCT05451043|Tremelimumab|tremelimumab|mesh-list
92287775|NCT05451043|Propranolol|propranolol|mesh-list
92287776|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287777|NCT05451043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287778|NCT05451043|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287779|NCT05451043|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287780|NCT05451043|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287781|NCT05451043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287782|NCT05451043|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287783|NCT05451043|Antimetabolites|antimetabolites|mesh-ancestor
92287784|NCT05451043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287785|NCT05451043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91932641|NCT03526315|Fluorides|fluorides|mesh-list
92287786|NCT05451043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92287787|NCT05451043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92287788|NCT05451043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322595|NCT00002162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287789|NCT05451043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287790|NCT05451043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92287791|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92287792|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
92287793|NCT02652169|Amikacin|amikacin|mesh-list
92287794|NCT02652169|Teicoplanin|teicoplanin|mesh-list
92287795|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92287796|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287797|NCT02478775|Cetrorelix|cetrorelix|mesh-list
92287798|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92287799|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
92287800|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92287801|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287802|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
92287803|NCT02478775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287804|NCT01783561|Caffeine|caffeine|mesh-list
92287805|NCT01783561|Caffeine citrate|caffeine citrate|mesh-list
92287806|NCT01783561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287807|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92287808|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287809|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92287810|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287811|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92287812|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92287813|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
92287814|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287815|NCT02452931|Leuprolide|leuprolide|mesh-list
92287816|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92287817|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
92287818|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92287819|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287820|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287821|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287823|NCT04744727|Meperidine|meperidine|mesh-list
92287824|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92287825|NCT04744727|Analgesics|analgesics|mesh-ancestor
92287826|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
92287827|NCT04744727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287828|NCT04744727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287829|NCT04744727|Antipyretics|antipyretics|mesh-ancestor
92287830|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92287831|NCT04744727|Narcotics|narcotics|mesh-ancestor
92287832|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92287833|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92287834|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
92287835|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
92287836|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287837|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287838|NCT02454179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287839|NCT02454179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287840|NCT02041533|Paclitaxel|paclitaxel|mesh-list
92287841|NCT02041533|Carboplatin|carboplatin|mesh-list
92287842|NCT02041533|Gemcitabine|gemcitabine|mesh-list
92287843|NCT02041533|Nivolumab|nivolumab|mesh-list
92287844|NCT02041533|Pemetrexed|pemetrexed|mesh-list
92287845|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92287846|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287847|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
92287848|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
92287849|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
92287850|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287851|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287852|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
92287853|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287854|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92287855|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287856|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92287857|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287858|NCT02260531|Trastuzumab|trastuzumab|mesh-list
92287859|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287860|NCT02260531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287861|NCT02458235|Azacitidine|azacitidine|mesh-list
92287862|NCT02458235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287863|NCT02458235|Antimetabolites|antimetabolites|mesh-ancestor
92287864|NCT02458235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287865|NCT02458235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287866|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287867|NCT02115997|Prednisone|prednisone|mesh-list
92287868|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
92287869|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92287870|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92287871|NCT02115997|Prednisolone|prednisolone|mesh-list
92287872|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
92287873|NCT02115997|Rituximab|rituximab|mesh-list
92287874|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92287875|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
92287876|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92287877|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287878|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
92287879|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287880|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287881|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92287882|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
92287884|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287885|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287886|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
92287887|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
92287888|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287889|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287890|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92287891|NCT02115997|Protective Agents|protective agents|mesh-ancestor
92287892|NCT01805323|Dexamethasone|dexamethasone|mesh-list
92287893|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92287894|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
92287895|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
92287896|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287897|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287898|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92287899|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
92287900|NCT01805323|Hormones|hormones|mesh-ancestor
92287901|NCT01805323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287902|NCT01805323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92287903|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287904|NCT01641055|Caseins|caseins|mesh-list
92287905|NCT01641055|Chelating Agents|chelating agents|mesh-ancestor
92287906|NCT01641055|Sequestering Agents|sequestering agents|mesh-ancestor
92287907|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287908|NCT01788631|Regadenoson|regadenoson|mesh-list
92287909|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92287910|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92287911|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
92287912|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
92287913|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92287914|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287915|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287916|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92287917|NCT00907283|Deferiprone|deferiprone|mesh-list
92287918|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92287919|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
92287920|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
92287921|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287922|NCT01789255|Cyclosporine|cyclosporine|mesh-list
92287923|NCT01789255|Methotrexate|methotrexate|mesh-list
92287924|NCT01789255|Vorinostat|vorinostat|mesh-list
92287925|NCT01789255|Tacrolimus|tacrolimus|mesh-list
92287926|NCT01789255|Cyclosporins|cyclosporins|mesh-list
92287927|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92287928|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
92287929|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92287930|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287931|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92287932|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
92287933|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287934|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92287935|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
92287936|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287937|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92287938|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287939|NCT01789255|Immunologic Factors|immunologic factors|mesh-ancestor
92287940|NCT01789255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287941|NCT01789255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287943|NCT01789255|Antifungal Agents|antifungal agents|mesh-ancestor
92287944|NCT01789255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287945|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92287946|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
92287947|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
92287948|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
92287949|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287950|NCT02464163|Coagulants|coagulants|mesh-ancestor
92287951|NCT01808755|Trimethoprim|trimethoprim|mesh-list
92287952|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
92287953|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92287954|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287955|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
92287956|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92287957|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92287958|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92287959|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287960|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287961|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92287962|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92287963|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92287964|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
92287965|NCT02694809|Estrogens|estrogens|mesh-list
92287966|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92287967|NCT02694809|Hormones|hormones|mesh-ancestor
92287968|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92287969|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287970|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92287972|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
92287973|NCT02694809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92287974|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
92287975|NCT00568997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92287976|NCT00568997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92287977|NCT00568997|Analgesics|analgesics|mesh-ancestor
92287978|NCT00568997|Sensory System Agents|sensory system agents|mesh-ancestor
92287979|NCT00568997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92287980|NCT00568997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92287981|NCT00568997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92287982|NCT00568997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92287983|NCT00568997|Dermatologic Agents|dermatologic agents|mesh-ancestor
92287984|NCT00568997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92287985|NCT00568997|Immunologic Factors|immunologic factors|mesh-ancestor
92287986|NCT00568997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92287987|NCT00568997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287988|NCT00568997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287989|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92287990|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92287991|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92287992|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92287993|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92287994|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
92287995|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92287996|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92287997|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92287998|NCT01790659|Gentamicins|gentamicins|mesh-list
92287999|NCT01790659|Paromomycin|paromomycin|mesh-list
92288000|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288001|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288002|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92288003|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288004|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288005|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92288006|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92288007|NCT02469701|Nivolumab|nivolumab|mesh-list
92288008|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288009|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288010|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92288011|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288013|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92288014|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92288016|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288017|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92288018|NCT01733953|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92288019|NCT01733953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288020|NCT00362921|Carmustine|carmustine|mesh-list
92288021|NCT00362921|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92288022|NCT00362921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92288023|NCT00362921|Alkylating Agents|alkylating agents|mesh-ancestor
92288024|NCT00362921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288025|NCT00362921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288026|NCT00362921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288027|NCT01734889|Nitisinone|nitisinone|mesh-list
92288028|NCT01734889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288029|NCT01734889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288030|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92288031|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92288032|NCT01796665|Clindamycin|clindamycin|mesh-list
92288033|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
92288034|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
92288035|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92288036|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288037|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288038|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92288039|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288040|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288041|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92288042|NCT01798225|Doxycycline|doxycycline|mesh-list
92288043|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92345356|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288044|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288045|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
92288046|NCT01798225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92288047|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92288048|NCT01800877|Phenylephrine|phenylephrine|mesh-list
92288049|NCT01800877|Dopamine|dopamine|mesh-list
92288050|NCT01800877|Vasopressins|vasopressins|mesh-list
92288051|NCT01800877|Epinephrine|epinephrine|mesh-list
92288052|NCT01800877|Norepinephrine|norepinephrine|mesh-list
92288053|NCT01800877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92288054|NCT01800877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92288055|NCT01800877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92288056|NCT01800877|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288057|NCT01800877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288058|NCT01800877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288059|NCT01800877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288060|NCT01800877|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92288061|NCT01800877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92288062|NCT01800877|Autonomic Agents|autonomic agents|mesh-ancestor
92288063|NCT01800877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288064|NCT01800877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92288065|NCT01800877|Respiratory System Agents|respiratory system agents|mesh-ancestor
92288066|NCT01800877|Mydriatics|mydriatics|mesh-ancestor
92288067|NCT01800877|Sympathomimetics|sympathomimetics|mesh-ancestor
92288068|NCT01800877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92288069|NCT01800877|Nasal Decongestants|nasal decongestants|mesh-ancestor
92288070|NCT01800877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92288071|NCT01800877|Protective Agents|protective agents|mesh-ancestor
92288072|NCT01800877|Hemostatics|hemostatics|mesh-ancestor
92288073|NCT01800877|Coagulants|coagulants|mesh-ancestor
92288074|NCT01800877|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92288075|NCT01800877|Natriuretic Agents|natriuretic agents|mesh-ancestor
92288076|NCT01800877|Dopamine Agents|dopamine agents|mesh-ancestor
92288077|NCT02471651|Dexamethasone|dexamethasone|mesh-list
92288078|NCT02471651|Ranibizumab|ranibizumab|mesh-list
92288079|NCT02471651|Aflibercept|aflibercept|mesh-list
92288080|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288081|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92288082|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92288083|NCT02471651|Growth Substances|growth substances|mesh-ancestor
92288084|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288085|NCT02471651|Growth Inhibitors|growth inhibitors|mesh-ancestor
92288086|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288087|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
92288088|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
92288089|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288090|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92288091|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
92288092|NCT02471651|Hormones|hormones|mesh-ancestor
92288093|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288094|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92288095|NCT02477423|Gentamicins|gentamicins|mesh-list
92288096|NCT02477423|Ampicillin|ampicillin|mesh-list
92288097|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288098|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288099|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92288100|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288101|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288102|NCT00363701|Esomeprazole|esomeprazole|mesh-list
92288103|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92288104|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92288105|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92288106|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288107|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288108|NCT04744571|Aspirin|aspirin|mesh-list
92288109|NCT04744571|Metoprolol|metoprolol|mesh-list
92288110|NCT04744571|Clopidogrel|clopidogrel|mesh-list
92288111|NCT04744571|Ticagrelor|ticagrelor|mesh-list
92288112|NCT04744571|Atorvastatin|atorvastatin|mesh-list
92288113|NCT04744571|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92288114|NCT04744571|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288115|NCT04744571|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288116|NCT04744571|Analgesics|analgesics|mesh-ancestor
92288117|NCT04744571|Sensory System Agents|sensory system agents|mesh-ancestor
92288118|NCT04744571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288119|NCT04744571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288120|NCT04744571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288121|NCT04744571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288122|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92288123|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92288124|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288125|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92288126|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288127|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288128|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
92288129|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92288130|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92288131|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
92288132|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92288133|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92288134|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92288135|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92288136|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92288137|NCT04744571|Purinergic Agents|purinergic agents|mesh-ancestor
92288138|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288139|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92288140|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92288141|NCT04744571|Sympatholytics|sympatholytics|mesh-ancestor
92288142|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
92288143|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92288144|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92288145|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92288146|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288147|NCT00363155|KRN 7000|krn 7000|mesh-list
92288148|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92288149|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
92288150|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288151|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288152|NCT02519387|Buprenorphine|buprenorphine|mesh-list
92288153|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92288154|NCT02519387|Narcotics|narcotics|mesh-ancestor
92288155|NCT02519387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288156|NCT02519387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288157|NCT02519387|Analgesics|analgesics|mesh-ancestor
92288158|NCT02519387|Sensory System Agents|sensory system agents|mesh-ancestor
92288159|NCT02519387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288160|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92288161|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92288162|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
92288163|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92288164|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92288165|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
92288166|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288167|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
92288168|NCT02257957|Protective Agents|protective agents|mesh-ancestor
92288169|NCT02524769|Estrogens|estrogens|mesh-list
92288170|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92288171|NCT02524769|Hormones|hormones|mesh-ancestor
92288172|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288173|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288174|NCT02525549|Adapalene|adapalene|mesh-list
92288175|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92288176|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
92288177|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288178|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288179|NCT02525549|Analgesics|analgesics|mesh-ancestor
92288180|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
92288181|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288182|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288183|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288184|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288185|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
92288186|NCT01878799|Ledipasvir|ledipasvir|mesh-list
92288187|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
92288188|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288189|NCT02527265|Insulin|insulin|mesh-list
92288190|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92288191|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288192|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92288193|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
92288194|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92288195|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92288196|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288197|NCT01879345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288198|NCT01804075|Morphine|morphine|mesh-list
92288199|NCT01804075|Methadone|methadone|mesh-list
92288200|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92288201|NCT01804075|Narcotics|narcotics|mesh-ancestor
92288202|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288203|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288204|NCT01804075|Analgesics|analgesics|mesh-ancestor
92288205|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
92288206|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288207|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
92288208|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
92288209|NCT02416193|Vitamin D|vitamin d|mesh-list
92288210|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
92288211|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
92288212|NCT02416193|Vitamins|vitamins|mesh-list
92288213|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
92288214|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288215|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92288216|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92288217|NCT02530151|Clonidine|clonidine|mesh-list
92288218|NCT02530151|Morphine|morphine|mesh-list
92288219|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92288220|NCT02530151|Narcotics|narcotics|mesh-ancestor
92288221|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288222|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288223|NCT02530151|Analgesics|analgesics|mesh-ancestor
92288224|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
92288225|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288226|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92288227|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
92288228|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
92288229|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92288230|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92288231|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92288232|NCT02530151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288233|NCT02530151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288234|NCT02530151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288235|NCT02530541|Chlorhexidine|chlorhexidine|mesh-list
92288236|NCT02530541|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92288238|NCT02530541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288239|NCT02530541|Disinfectants|disinfectants|mesh-ancestor
92288240|NCT02530541|Dermatologic Agents|dermatologic agents|mesh-ancestor
92288241|NCT01804465|Ipilimumab|ipilimumab|mesh-list
92288242|NCT01804465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288243|NCT01804465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288244|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92288245|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288246|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
92288247|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92288248|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92288249|NCT02531321|Estradiol|estradiol|mesh-list
92288250|NCT02531321|Estrogens|estrogens|mesh-ancestor
92288251|NCT02531321|Hormones|hormones|mesh-ancestor
92288252|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288253|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288254|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92288255|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
92288256|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92288257|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92288258|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92288259|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91941027|NCT03483415|Morphine|morphine|mesh-list
92288260|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92288261|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92288262|NCT01805089|Melatonin|melatonin|mesh-list
92288263|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
92288264|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288265|NCT01805089|Protective Agents|protective agents|mesh-ancestor
92288266|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288267|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288268|NCT02417129|Rituximab|rituximab|mesh-list
92288269|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288270|NCT02417129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288271|NCT02417129|Immunologic Factors|immunologic factors|mesh-ancestor
92288272|NCT02417129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288273|NCT02417129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288274|NCT01879735|Cholylsarcosine|cholylsarcosine|mesh-list
92288275|NCT01879735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92288276|NCT02417831|Tamsulosin|tamsulosin|mesh-list
92288277|NCT02417831|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92288278|NCT02417831|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92288279|NCT02417831|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92288280|NCT02417831|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288281|NCT02417831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288282|NCT02417831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288283|NCT02417831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288284|NCT02417831|Urological Agents|urological agents|mesh-ancestor
92288285|NCT02419547|Fentanyl|fentanyl|mesh-list
92288286|NCT02419547|Midazolam|midazolam|mesh-list
92288287|NCT02419547|Propofol|propofol|mesh-list
92288288|NCT02419547|Sevoflurane|sevoflurane|mesh-list
92288289|NCT02419547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92288290|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288291|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288292|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92288293|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
92288294|NCT02419547|Anesthetics|anesthetics|mesh-ancestor
92288295|NCT02419547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92288296|NCT02419547|Narcotics|narcotics|mesh-ancestor
92288297|NCT02419547|Analgesics|analgesics|mesh-ancestor
92288298|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
92288299|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288300|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92288301|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92288302|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92288303|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92288304|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
92288305|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
92288306|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288307|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288308|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92288309|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92288310|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92288311|NCT02533427|Norgestimate|norgestimate|mesh-list
92288312|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92288313|NCT02533427|Estradiol|estradiol|mesh-list
92288314|NCT02533427|Estrogens|estrogens|mesh-ancestor
92288315|NCT02533427|Hormones|hormones|mesh-ancestor
92288316|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288317|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288318|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92288319|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
92288320|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92288321|NCT02533427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92288322|NCT02533427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92288323|NCT02533427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92288324|NCT02533427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92288325|NCT02533427|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92288326|NCT05328817|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92288327|NCT05328817|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92288328|NCT05328817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288329|NCT05328817|Antitubercular Agents|antitubercular agents|mesh-ancestor
92288330|NCT05328427|Tin Fluorides|tin fluorides|mesh-list
92288331|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
92288332|NCT05328427|Protective Agents|protective agents|mesh-ancestor
92288333|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288334|NCT02533505|Budesonide|budesonide|mesh-list
92288335|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
92288336|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288337|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92288338|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
92288339|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288340|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288341|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92288342|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
92288343|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
92288344|NCT02533505|Hormones|hormones|mesh-ancestor
92288345|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288346|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92288347|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92288348|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92288349|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288350|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288351|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288352|NCT02420015|Bupropion|bupropion|mesh-list
92288353|NCT02420015|Nicotine|nicotine|mesh-list
92288354|NCT02420015|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92288355|NCT02420015|Autonomic Agents|autonomic agents|mesh-ancestor
92288356|NCT02420015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288357|NCT02420015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288358|NCT02420015|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92288359|NCT02420015|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92288360|NCT02420015|Cholinergic Agents|cholinergic agents|mesh-ancestor
92288361|NCT02420015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288362|NCT02420015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288363|NCT02420015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92288364|NCT02420015|Antidepressive Agents|antidepressive agents|mesh-ancestor
92288365|NCT02420015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92288366|NCT02420015|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92288367|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92288368|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288369|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
92288370|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92288371|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92288372|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288373|NCT05326867|Lidocaine|lidocaine|mesh-list
92288374|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288375|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
92288376|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288377|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288378|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
92288379|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288380|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92288381|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92288382|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92288383|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288384|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288385|NCT05324995|Celecoxib|celecoxib|mesh-list
92288386|NCT05324995|Epinephrine|epinephrine|mesh-list
92288387|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92288388|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92288389|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288390|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288391|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288392|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288393|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92288394|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92288395|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
92288396|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288397|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92288398|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92288399|NCT05324995|Mydriatics|mydriatics|mesh-ancestor
92288400|NCT05324995|Sympathomimetics|sympathomimetics|mesh-ancestor
92288401|NCT05324995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92288402|NCT05324995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288403|NCT05324995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288404|NCT05324995|Analgesics|analgesics|mesh-ancestor
92288405|NCT05324995|Sensory System Agents|sensory system agents|mesh-ancestor
92288406|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288407|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941178|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288408|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92288409|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288410|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288411|NCT05318521|Ibuprofen|ibuprofen|mesh-list
92288412|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288413|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288414|NCT05318521|Analgesics|analgesics|mesh-ancestor
92288415|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
92288416|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288417|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288418|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288419|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288420|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288421|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288422|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288423|NCT02420873|Maytansine|maytansine|mesh-list
92288424|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
92288425|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92288426|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288427|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
92288428|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92288429|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92288430|NCT02420873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288431|NCT02420873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288432|NCT02420873|Immunotoxins|immunotoxins|mesh-ancestor
92288433|NCT02420873|Immunoconjugates|immunoconjugates|mesh-ancestor
92288434|NCT02420873|Immunologic Factors|immunologic factors|mesh-ancestor
92288435|NCT02420873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288436|NCT02534129|Petrolatum|petrolatum|mesh-list
92288437|NCT02534129|Emollients|emollients|mesh-ancestor
92288438|NCT02534129|Dermatologic Agents|dermatologic agents|mesh-ancestor
92288439|NCT02420951|Bupivacaine|bupivacaine|mesh-list
92288440|NCT02420951|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288441|NCT02420951|Anesthetics|anesthetics|mesh-ancestor
92288442|NCT02420951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288443|NCT02420951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288445|NCT02420951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288446|NCT02267083|Doxorubicin|doxorubicin|mesh-list
92288447|NCT02267083|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92288448|NCT02267083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288449|NCT02267083|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92288450|NCT02267083|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92288451|NCT02267083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288452|NCT02267083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288453|NCT05748145|Metronidazole|metronidazole|mesh-list
92288454|NCT05748145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288455|NCT05748145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288456|NCT05748145|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92288457|NCT05748145|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92288458|NCT02535611|Memantine|memantine|mesh-list
92288459|NCT02535611|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92288460|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92288461|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
92288462|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288463|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288464|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288465|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92288466|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92288468|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92288469|NCT01823497|Narcotics|narcotics|mesh-ancestor
92288470|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288471|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288472|NCT01823497|Analgesics|analgesics|mesh-ancestor
92288473|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
92288474|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288475|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
92288476|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92288477|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288478|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288479|NCT00363935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288480|NCT00363935|Analgesics|analgesics|mesh-ancestor
92288481|NCT00363935|Sensory System Agents|sensory system agents|mesh-ancestor
92288482|NCT00363935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288483|NCT00363935|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92288484|NCT00363935|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92288485|NCT00363935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92288486|NCT00363935|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288487|NCT00363935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288488|NCT00363935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288490|NCT05747521|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92288491|NCT05747521|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92288492|NCT05747521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288493|NCT05747521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92288494|NCT05747521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92288495|NCT05747521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288496|NCT05747521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288498|NCT02537873|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288499|NCT02537873|Anesthetics|anesthetics|mesh-ancestor
92288500|NCT02537873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288501|NCT02537873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288502|NCT02537873|Sensory System Agents|sensory system agents|mesh-ancestor
92288503|NCT02537873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288504|NCT02537873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92288505|NCT02537873|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92288506|NCT02537873|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92288507|NCT02537873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288508|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288509|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
92288510|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288511|NCT02537951|Lidocaine|lidocaine|mesh-list
92288512|NCT02537951|Prilocaine|prilocaine|mesh-list
92288513|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92288514|NCT02537951|Capsaicin|capsaicin|mesh-list
92288515|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288516|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
92288517|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288518|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288519|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
92288520|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288521|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92288522|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92288523|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92288524|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288525|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288526|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
92288527|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
92288528|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92288529|NCT02487485|Sirolimus|sirolimus|mesh-list
92288530|NCT02487485|Ketamine|ketamine|mesh-list
92288531|NCT02487485|Analgesics|analgesics|mesh-ancestor
92288532|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
92288533|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288534|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409726|NCT05645913|Anticoagulants|anticoagulants|mesh-list
92288535|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92288536|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92288537|NCT02487485|Anesthetics, General|anesthetics, general|mesh-ancestor
92288538|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
92288539|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288540|NCT02487485|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92288541|NCT02487485|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92288542|NCT02487485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288543|NCT02487485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288544|NCT02487485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288545|NCT02487485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288546|NCT02487485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92288547|NCT02487485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288548|NCT02487485|Antifungal Agents|antifungal agents|mesh-ancestor
92288549|NCT02487485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288550|NCT02487485|Immunologic Factors|immunologic factors|mesh-ancestor
92288551|NCT02487563|Decitabine|decitabine|mesh-list
92288552|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92288553|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
92288554|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288555|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288556|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288557|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92288558|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288559|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288561|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288562|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288563|NCT02489357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92288564|NCT02489357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288565|NCT02490293|Cephalosporins|cephalosporins|mesh-list
92288566|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288567|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288568|NCT02539511|Ketamine|ketamine|mesh-list
92288569|NCT02539511|Analgesics|analgesics|mesh-ancestor
92288570|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
92288571|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288572|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288573|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92288574|NCT02539511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92288575|NCT02539511|Anesthetics, General|anesthetics, general|mesh-ancestor
92288576|NCT02539511|Anesthetics|anesthetics|mesh-ancestor
92288577|NCT02539511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288578|NCT02539511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92288579|NCT02539511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92288580|NCT02539511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288581|NCT02539511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288582|NCT02493257|Ethanol|ethanol|mesh-list
92288583|NCT02493257|Capsaicin|capsaicin|mesh-list
92288584|NCT02493257|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92288585|NCT02493257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288586|NCT02493257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288587|NCT02493257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288588|NCT02493257|Antipruritics|antipruritics|mesh-ancestor
92288589|NCT02493257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92288590|NCT02493257|Sensory System Agents|sensory system agents|mesh-ancestor
92288591|NCT02493257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288592|NCT02430389|Remifentanil|remifentanil|mesh-list
92288593|NCT02430389|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92288594|NCT02430389|Narcotics|narcotics|mesh-ancestor
92288595|NCT02430389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288596|NCT02430389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288597|NCT02430389|Analgesics|analgesics|mesh-ancestor
92288598|NCT02430389|Sensory System Agents|sensory system agents|mesh-ancestor
92288599|NCT02430389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288600|NCT02431637|Piperaquine|piperaquine|mesh-list
92288601|NCT02431637|Antimalarials|antimalarials|mesh-ancestor
92288602|NCT02431637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92288603|NCT02431637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92288604|NCT02431637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288605|NCT02545907|Thalidomide|thalidomide|mesh-list
92288606|NCT02545907|Dexamethasone|dexamethasone|mesh-list
92288607|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288608|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
92288609|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
92288610|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288611|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288612|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92288613|NCT02545907|Glucocorticoids|glucocorticoids|mesh-ancestor
92288614|NCT02545907|Hormones|hormones|mesh-ancestor
92288615|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288616|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92288617|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288618|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288619|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
92288620|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
92288621|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92288622|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288623|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92288624|NCT02545907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92288625|NCT02545907|Growth Substances|growth substances|mesh-ancestor
92288626|NCT02545907|Growth Inhibitors|growth inhibitors|mesh-ancestor
92288627|NCT02495831|Diclofenac|diclofenac|mesh-list
92345623|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92288628|NCT02495831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288629|NCT02495831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288630|NCT02495831|Analgesics|analgesics|mesh-ancestor
92288631|NCT02495831|Sensory System Agents|sensory system agents|mesh-ancestor
92288632|NCT02495831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288633|NCT02495831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288634|NCT02495831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288635|NCT02495831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288636|NCT02495831|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288637|NCT02495831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288638|NCT02495831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288639|NCT02498483|Acetaminophen|acetaminophen|mesh-list
92288640|NCT02498483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288641|NCT02498483|Analgesics|analgesics|mesh-ancestor
92288642|NCT02498483|Sensory System Agents|sensory system agents|mesh-ancestor
92288643|NCT02498483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288644|NCT02498483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288645|NCT02498483|Antipyretics|antipyretics|mesh-ancestor
92288646|NCT02547623|Dexamethasone|dexamethasone|mesh-list
92288647|NCT02547623|Prednisolone|prednisolone|mesh-list
92288648|NCT02547623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288649|NCT02547623|Antiemetics|antiemetics|mesh-ancestor
92288650|NCT02547623|Autonomic Agents|autonomic agents|mesh-ancestor
92288651|NCT02547623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288652|NCT02547623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288653|NCT02547623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92288654|NCT02547623|Glucocorticoids|glucocorticoids|mesh-ancestor
92288655|NCT02547623|Hormones|hormones|mesh-ancestor
92288656|NCT02547623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288657|NCT02547623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92288658|NCT02547623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288659|NCT02547779|Plasma-lyte 148|plasma-lyte 148|mesh-list
92288660|NCT02547779|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92288661|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92288662|NCT00559585|Abatacept|abatacept|mesh-list
92288663|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92288664|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288665|NCT00559585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288666|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288667|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288668|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
92288669|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288670|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288671|NCT01824901|Docetaxel|docetaxel|mesh-list
92288672|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288673|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92288674|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92288675|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92288676|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288677|NCT00559507|Saracatinib|saracatinib|mesh-list
92288678|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288679|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288680|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288681|NCT04969627|Metformin|metformin|mesh-list
92288682|NCT04969627|Exenatide|exenatide|mesh-list
92288683|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92288684|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288685|NCT04969627|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92288686|NCT04969627|Incretins|incretins|mesh-ancestor
92288687|NCT04969627|Hormones|hormones|mesh-ancestor
92288688|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288689|NCT04953325|Vaccines|vaccines|mesh-list
92288690|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92288691|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
92288692|NCT04953325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288693|NCT01826851|Bupivacaine|bupivacaine|mesh-list
92288694|NCT01826851|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288695|NCT01826851|Anesthetics|anesthetics|mesh-ancestor
92288696|NCT01826851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288697|NCT01826851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288699|NCT01826851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288700|NCT02499497|Androgens|androgens|mesh-list
92288701|NCT02499497|Hormones|hormones|mesh-ancestor
92288702|NCT02499497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92288703|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288704|NCT01827475|Acetaminophen|acetaminophen|mesh-list
92288705|NCT01827475|Ibuprofen|ibuprofen|mesh-list
92288706|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288708|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
92288709|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288710|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288711|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
92288712|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288713|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288714|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288715|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288716|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288717|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288718|NCT02434523|Amitriptyline|amitriptyline|mesh-list
92288719|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92288720|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
92288721|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92288722|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288723|NCT02434523|Analgesics|analgesics|mesh-ancestor
92288724|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
92288725|NCT02434523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288726|NCT02434523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288727|NCT02434523|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92288728|NCT02434523|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92288729|NCT02434523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288730|NCT02434523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288731|NCT02434523|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288732|NCT02434523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288733|NCT02501135|Bupivacaine|bupivacaine|mesh-list
92288734|NCT02501135|Ropivacaine|ropivacaine|mesh-list
92288735|NCT02501135|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288736|NCT02501135|Anesthetics|anesthetics|mesh-ancestor
92288737|NCT02501135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288738|NCT02501135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288739|NCT02501135|Sensory System Agents|sensory system agents|mesh-ancestor
92288740|NCT02501135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288741|NCT02550743|Capecitabine|capecitabine|mesh-list
92288742|NCT02550743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92288743|NCT02550743|Antimetabolites|antimetabolites|mesh-ancestor
92288744|NCT02550743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288745|NCT02550743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288746|NCT02437253|Adalimumab|adalimumab|mesh-list
92288747|NCT02437253|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92288748|NCT02437253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288749|NCT02437253|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288750|NCT01829503|Cytarabine|cytarabine|mesh-list
92288751|NCT01829503|Decitabine|decitabine|mesh-list
92288752|NCT01829503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92288753|NCT01829503|Antimetabolites|antimetabolites|mesh-ancestor
91935459|NCT02631447|Nivolumab|nivolumab|mesh-list
92288754|NCT01829503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288755|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288756|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
92288757|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288758|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288759|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
92288760|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288761|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288763|NCT05742763|Ibuprofen|ibuprofen|mesh-list
92288764|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288765|NCT05742763|Analgesics|analgesics|mesh-ancestor
92288766|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
92288767|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288768|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288769|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
92288770|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288771|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288772|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288773|NCT05742763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288774|NCT05742763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288775|NCT05742763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288777|NCT02504723|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92288778|NCT02504723|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92288779|NCT02504723|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288780|NCT02504723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288781|NCT02504723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288782|NCT02504723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288783|NCT02504723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92288784|NCT02504723|Antioxidants|antioxidants|mesh-ancestor
92288785|NCT02504723|Protective Agents|protective agents|mesh-ancestor
92288786|NCT02504723|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92288787|NCT02504723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92288788|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92288789|NCT02504723|Vasodilator Agents|vasodilator agents|mesh-ancestor
92288790|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92288791|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92288792|NCT02439281|Clonidine|clonidine|mesh-list
92288793|NCT02439281|Ropivacaine|ropivacaine|mesh-list
92288794|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
92288795|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
92288796|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288797|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288798|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
92288799|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288801|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92288802|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
92288803|NCT02439281|Autonomic Agents|autonomic agents|mesh-ancestor
92288804|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92288805|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92288806|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92288807|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
92288808|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288809|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288810|NCT02505269|Doxorubicin|doxorubicin|mesh-list
92288811|NCT02505269|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92288812|NCT02505269|Dacarbazine|dacarbazine|mesh-list
92288813|NCT02505269|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92288814|NCT02505269|Imidazole|imidazole|mesh-list
92288815|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92288816|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288817|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92288818|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92288819|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288820|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288821|NCT02505269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92288822|NCT02505269|Alkylating Agents|alkylating agents|mesh-ancestor
92288823|NCT02505269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92288824|NCT02505269|Immunotoxins|immunotoxins|mesh-ancestor
92288825|NCT02505269|Immunoconjugates|immunoconjugates|mesh-ancestor
92288826|NCT02505269|Immunologic Factors|immunologic factors|mesh-ancestor
92288827|NCT02505269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288828|NCT00422123|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92288829|NCT00422123|Antidepressive Agents|antidepressive agents|mesh-ancestor
92288830|NCT00422123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92288831|NCT00422123|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92288832|NCT00422123|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92288833|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288834|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288835|NCT00559273|Darbepoetin alfa|darbepoetin alfa|mesh-list
92288836|NCT00559273|Hematinics|hematinics|mesh-ancestor
92288837|NCT02506673|Midazolam|midazolam|mesh-list
92288838|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92288839|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92288840|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92288841|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288842|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92288843|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92288844|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92288845|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92288846|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
92288847|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
92288848|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
92288849|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
92288850|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288851|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288852|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
92288853|NCT02508077|Leucovorin|leucovorin|mesh-list
92288854|NCT02508077|Folic Acid|folic acid|mesh-list
92288855|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92288856|NCT02508077|Panitumumab|panitumumab|mesh-list
92288857|NCT02508077|Fluorouracil|fluorouracil|mesh-list
92288858|NCT02508077|Irinotecan|irinotecan|mesh-list
92288859|NCT02508077|Camptothecin|camptothecin|mesh-list
92288860|NCT02508077|Antibodies|antibodies|mesh-list
92288861|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
92288862|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92288863|NCT02508077|Calcium|calcium|mesh-list
92288864|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
92288865|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
92288866|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288867|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288868|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92288869|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92288870|NCT02508077|Antimetabolites|antimetabolites|mesh-ancestor
92288871|NCT02508077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288872|NCT02508077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92288873|NCT02508077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288874|NCT02508077|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92288875|NCT02508077|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92288876|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288878|NCT02508077|Protective Agents|protective agents|mesh-ancestor
92288879|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
92288880|NCT02508077|Vitamins|vitamins|mesh-ancestor
92288881|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
92288882|NCT02508077|Hematinics|hematinics|mesh-ancestor
92288883|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92288884|NCT00558259|Dabigatran|dabigatran|mesh-list
92288885|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
92288886|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92288887|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
92288888|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288889|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288890|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
92288891|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
92288892|NCT02508389|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92288893|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
92288894|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288895|NCT02508389|Protective Agents|protective agents|mesh-ancestor
92288896|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288897|NCT02509481|Ivermectin|ivermectin|mesh-list
92288898|NCT02509481|Albendazole|albendazole|mesh-list
92288899|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92288900|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288901|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
92288902|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
92288903|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92288904|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92288905|NCT02509481|Tubulin Modulators|tubulin modulators|mesh-ancestor
92288906|NCT02509481|Antimitotic Agents|antimitotic agents|mesh-ancestor
92288907|NCT02509481|Mitosis Modulators|mitosis modulators|mesh-ancestor
92288908|NCT02509481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288909|NCT02509481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288910|NCT04341077|Fluzoparib|fluzoparib|mesh-list
92288911|NCT04341077|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92288912|NCT04341077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288913|NCT04341077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288914|NCT04341077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288915|NCT02561897|Warfarin|warfarin|mesh-list
92288916|NCT02561897|Edoxaban|edoxaban|mesh-list
92288917|NCT02561897|Anticoagulants|anticoagulants|mesh-ancestor
92288918|NCT02561897|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92288920|NCT02561897|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92288921|NCT02561897|Protease Inhibitors|protease inhibitors|mesh-ancestor
92288922|NCT02561897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288923|NCT02561897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288924|NCT02512679|Cyclophosphamide|cyclophosphamide|mesh-list
92288925|NCT02512679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92288926|NCT02512679|Immunologic Factors|immunologic factors|mesh-ancestor
92288927|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288928|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288929|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92288930|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
92288931|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288932|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288933|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92288934|NCT02562521|Nicotine|nicotine|mesh-list
92288935|NCT02562521|Varenicline|varenicline|mesh-list
92288936|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92288937|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
92288938|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288939|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288940|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92288941|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92288942|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
92288943|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288944|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288945|NCT02562755|Sorafenib|sorafenib|mesh-list
92288946|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288947|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92288948|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288949|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288950|NCT05446883|Paclitaxel|paclitaxel|mesh-list
92288951|NCT05446883|Carboplatin|carboplatin|mesh-list
92288952|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92288953|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288954|NCT05446883|Tubulin Modulators|tubulin modulators|mesh-ancestor
92288955|NCT05446883|Antimitotic Agents|antimitotic agents|mesh-ancestor
92288956|NCT05446883|Mitosis Modulators|mitosis modulators|mesh-ancestor
92288957|NCT05446883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288959|NCT00363857|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92288960|NCT00363857|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92288961|NCT00363857|Dopamine Agonists|dopamine agonists|mesh-ancestor
92288962|NCT00363857|Dopamine Agents|dopamine agents|mesh-ancestor
92288963|NCT00363857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92288964|NCT00363857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288965|NCT00363857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288966|NCT04563923|Avdoralimab|avdoralimab|mesh-list
92288967|NCT04563923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288968|NCT04563923|Antiviral Agents|antiviral agents|mesh-ancestor
92288969|NCT04563923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288970|NCT00558103|Lapatinib|lapatinib|mesh-list
92288971|NCT00558103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92288972|NCT00558103|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92288973|NCT00558103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288974|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288975|NCT02974361|Ibuprofen|ibuprofen|mesh-list
92288976|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92288977|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92288978|NCT02974361|Analgesics|analgesics|mesh-ancestor
92288979|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
92288980|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92288981|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92288982|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92288983|NCT02974361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92288984|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92288985|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288986|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288987|NCT05690815|Tenofovir|tenofovir|mesh-list
92288988|NCT05690815|Emtricitabine|emtricitabine|mesh-list
92288989|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92288990|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
92288991|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92288992|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92288993|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92288994|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92288995|NCT05690815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92288996|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92288997|NCT05690815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92288998|NCT02569541|Fusidic Acid|fusidic acid|mesh-list
92288999|NCT02569541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92289000|NCT02569541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289001|NCT02569541|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92289002|NCT02569541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289003|NCT02569541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289004|NCT04477733|Butorphanol|butorphanol|mesh-list
92289005|NCT04477733|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92289006|NCT04477733|Narcotics|narcotics|mesh-ancestor
92289007|NCT04477733|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289008|NCT04477733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289010|NCT04477733|Sensory System Agents|sensory system agents|mesh-ancestor
92289011|NCT04477733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289012|NCT04477733|Antitussive Agents|antitussive agents|mesh-ancestor
92289013|NCT04477733|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289014|NCT04477733|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92289015|NCT00558025|Pramipexole|pramipexole|mesh-list
92289016|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
92289017|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289018|NCT00558025|Protective Agents|protective agents|mesh-ancestor
92289019|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289020|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92289021|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92289022|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
92289023|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
92289024|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289026|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92289027|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92289028|NCT02576249|Prednisolone|prednisolone|mesh-list
92289029|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
92289030|NCT02576249|Ropivacaine|ropivacaine|mesh-list
92289031|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92289032|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
92289033|NCT02576249|Anesthetics, Local|anesthetics, local|mesh-ancestor
92289034|NCT02576249|Anesthetics|anesthetics|mesh-ancestor
92289035|NCT02576249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289036|NCT02576249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289037|NCT02576249|Sensory System Agents|sensory system agents|mesh-ancestor
92289038|NCT02576249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289039|NCT02576249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289040|NCT02576249|Antiemetics|antiemetics|mesh-ancestor
92289041|NCT02576249|Autonomic Agents|autonomic agents|mesh-ancestor
92289042|NCT02576249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92289043|NCT02576249|Glucocorticoids|glucocorticoids|mesh-ancestor
92289044|NCT02576249|Hormones|hormones|mesh-ancestor
92289045|NCT02576249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289046|NCT02576249|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92289047|NCT02576249|Protective Agents|protective agents|mesh-ancestor
92289048|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92289049|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289050|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
92289051|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92289052|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289053|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92289054|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92289055|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289056|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289057|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289058|NCT01834261|Oxytocin|oxytocin|mesh-list
92289059|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
92289060|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92289061|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289062|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
92289063|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92289064|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92289065|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289066|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
92289067|NCT02578901|Coagulants|coagulants|mesh-ancestor
92289068|NCT02579057|Furosemide|furosemide|mesh-list
92289069|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92289070|NCT02579057|Diuretics|diuretics|mesh-ancestor
92289071|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
92289072|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289073|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92289074|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289075|NCT02579057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289076|NCT00557245|Tenofovir|tenofovir|mesh-list
92289077|NCT00557245|Emtricitabine|emtricitabine|mesh-list
92289078|NCT00557245|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92289079|NCT00557245|Antiviral Agents|antiviral agents|mesh-ancestor
92289080|NCT00557245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289081|NCT00557245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92289082|NCT00557245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92289083|NCT00557245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289084|NCT00557245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289085|NCT00557245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92289086|NCT00557245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92289087|NCT00364091|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92289088|NCT00364091|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92289090|NCT04743011|Calcium heparin|calcium heparin|mesh-list
92289091|NCT04743011|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92289092|NCT04743011|Anticoagulants|anticoagulants|mesh-ancestor
92289093|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92289094|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92289095|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289096|NCT03528941|Lamivudine|lamivudine|mesh-list
92289097|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92289098|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92289099|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289100|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289101|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
92289102|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289103|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92289104|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92289105|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92289106|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289107|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92289108|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289109|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289110|NCT00365183|Pemetrexed|pemetrexed|mesh-list
92289111|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
92289112|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289113|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289114|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289115|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92289116|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92289117|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92289118|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
92289119|NCT01837069|Metoprolol|metoprolol|mesh-list
92289120|NCT01837069|Lisinopril|lisinopril|mesh-list
92289121|NCT01837069|Atorvastatin|atorvastatin|mesh-list
92289122|NCT01837069|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92289123|NCT01837069|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92289124|NCT01837069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92289125|NCT01837069|Antimetabolites|antimetabolites|mesh-ancestor
92289126|NCT01837069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289127|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92289128|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92289129|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289130|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92289131|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92289132|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
92289133|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
92289134|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289135|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289136|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92289137|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92289138|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92289139|NCT01837069|Adrenergic Agents|adrenergic agents|mesh-ancestor
92289140|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289141|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
92289142|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92289143|NCT01837069|Protective Agents|protective agents|mesh-ancestor
92289144|NCT02289690|Carboplatin|carboplatin|mesh-list
92289145|NCT02289690|Etoposide|etoposide|mesh-list
92289146|NCT02289690|Veliparib|veliparib|mesh-list
92289147|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289148|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92289149|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92289150|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92289151|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289152|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289153|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92289154|NCT02268955|Ibuprofen|ibuprofen|mesh-list
92289155|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92289156|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92289157|NCT02268955|Analgesics|analgesics|mesh-ancestor
92289158|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
92289159|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289160|NCT02268955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289161|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289162|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289163|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92289164|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289165|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289167|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92289168|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
92289169|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289170|NCT02585843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289171|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92289172|NCT02585843|Diuretics|diuretics|mesh-ancestor
92289173|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
92289174|NCT01838317|Pioglitazone|pioglitazone|mesh-list
92289175|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92289176|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289177|NCT05249231|Fluorides|fluorides|mesh-list
92289178|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
92289179|NCT05249231|Protective Agents|protective agents|mesh-ancestor
92289180|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289181|NCT05249153|Sufentanil|sufentanil|mesh-list
92289182|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
92289183|NCT05249153|Dsuvia|dsuvia|mesh-list
92289184|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92289185|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289186|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289187|NCT05249153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92289188|NCT05249153|Analgesics|analgesics|mesh-ancestor
92289189|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
92289190|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289191|NCT05249153|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92289192|NCT05249153|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92289193|NCT05249153|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92289194|NCT05249153|Adrenergic Agents|adrenergic agents|mesh-ancestor
92289195|NCT05249153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289196|NCT05249153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289197|NCT05249153|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92289198|NCT05249153|Narcotics|narcotics|mesh-ancestor
92289199|NCT05249153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92289200|NCT05249153|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92289201|NCT05249153|Anesthetics, General|anesthetics, general|mesh-ancestor
92289202|NCT05249153|Anesthetics|anesthetics|mesh-ancestor
92289203|NCT02961257|Prednisone|prednisone|mesh-list
92289204|NCT02961257|Lenograstim|lenograstim|mesh-list
92289205|NCT02961257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289206|NCT02961257|Glucocorticoids|glucocorticoids|mesh-ancestor
92289207|NCT02961257|Hormones|hormones|mesh-ancestor
92289208|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289209|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289210|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92289211|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289212|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92289213|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
92289214|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
92289215|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92289216|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289217|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289218|NCT02989519|Progesterone|progesterone|mesh-list
92289219|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
92289220|NCT02989519|Progestins|progestins|mesh-ancestor
92289221|NCT02989519|Hormones|hormones|mesh-ancestor
92289222|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289223|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289224|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92289225|NCT02429375|Mocetinostat|mocetinostat|mesh-list
92289226|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289227|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289228|NCT02429375|Immunotoxins|immunotoxins|mesh-ancestor
92289229|NCT02429375|Immunoconjugates|immunoconjugates|mesh-ancestor
92289230|NCT02429375|Immunologic Factors|immunologic factors|mesh-ancestor
92289231|NCT02429375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942004|NCT05648006|Bevacizumab|bevacizumab|mesh-list
92289232|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92289233|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289234|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289235|NCT02289456|Paclitaxel|paclitaxel|mesh-list
92289236|NCT02289456|Carboplatin|carboplatin|mesh-list
92289237|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92289238|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289239|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
92289240|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
92289241|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
92289242|NCT02289456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289243|NCT02589977|Regadenoson|regadenoson|mesh-list
92289244|NCT02589977|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92289245|NCT02589977|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92289246|NCT02589977|Purinergic Agonists|purinergic agonists|mesh-ancestor
92289247|NCT02589977|Purinergic Agents|purinergic agents|mesh-ancestor
92289248|NCT02589977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289249|NCT02589977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289250|NCT02589977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289252|NCT02274948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92289253|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289254|NCT02274792|Etanercept|etanercept|mesh-list
92289255|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92289256|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92289257|NCT02274792|Analgesics|analgesics|mesh-ancestor
92289258|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
92289259|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289260|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289261|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289262|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289263|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92289264|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289265|NCT02274792|Immunologic Factors|immunologic factors|mesh-ancestor
92289266|NCT05432466|Celiprolol|celiprolol|mesh-list
92289267|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92289268|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92289269|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
92289270|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
92289271|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289272|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289273|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
92289274|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92289275|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92289276|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92289277|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
92289278|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289279|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289280|NCT02592629|Triamcinolone|triamcinolone|mesh-list
92289281|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92289282|NCT02592629|Lidocaine|lidocaine|mesh-list
92289283|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
92289284|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
92289285|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
92289286|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289287|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289288|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
92289289|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289290|NCT02592629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92289291|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92289292|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92289293|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289294|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289295|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289296|NCT02592629|Glucocorticoids|glucocorticoids|mesh-ancestor
92289297|NCT02592629|Hormones|hormones|mesh-ancestor
92289298|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289299|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289300|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
92289301|NCT02596451|Diclofenac|diclofenac|mesh-list
92289302|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92289303|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92289304|NCT02596451|Analgesics|analgesics|mesh-ancestor
92289305|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
92289306|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289307|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289308|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289310|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92289311|NCT02596451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289312|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289313|NCT01839799|Paclitaxel|paclitaxel|mesh-list
92289314|NCT01839799|Gemcitabine|gemcitabine|mesh-list
92289315|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92289316|NCT01839799|Folfirinox|folfirinox|mesh-list
92289317|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92289318|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289319|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
92289320|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
92289321|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
92289322|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289323|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92289324|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
92289325|NCT03062059|Gemcitabine|gemcitabine|mesh-list
92289326|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92289327|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
92289328|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289329|NCT03062059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289330|NCT02597543|Regadenoson|regadenoson|mesh-list
92289331|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92289332|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92289333|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
92289334|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
92289335|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289336|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289337|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289338|NCT00553501|Rituximab|rituximab|mesh-list
92289339|NCT00553501|Epratuzumab|epratuzumab|mesh-list
92289340|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289341|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289342|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
92289343|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289344|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289345|NCT02599649|Nivolumab|nivolumab|mesh-list
92289346|NCT02599649|Azacitidine|azacitidine|mesh-list
92289347|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289348|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289349|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92289350|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289351|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92289352|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
92289353|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289354|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
92289355|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92289356|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
92289357|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289358|NCT01840345|Expectorants|expectorants|mesh-ancestor
92289359|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289360|NCT01840345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92289361|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
92289362|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289363|NCT01840345|Protective Agents|protective agents|mesh-ancestor
92289364|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289365|NCT01840345|Antidotes|antidotes|mesh-ancestor
92289366|NCT00364481|Omeprazole|omeprazole|mesh-list
92289367|NCT00364481|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92289368|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92289369|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92289370|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289371|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289372|NCT02601833|Fluorides|fluorides|mesh-list
92289373|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
92289374|NCT02601833|Protective Agents|protective agents|mesh-ancestor
92289375|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289376|NCT00553267|Amlodipine|amlodipine|mesh-list
92289377|NCT00553267|Telmisartan|telmisartan|mesh-list
92289378|NCT00553267|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92289379|NCT00553267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92289380|NCT00553267|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92289381|NCT00553267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289382|NCT00553267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289383|NCT00553267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92289384|NCT00553267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289385|NCT00553267|Vasodilator Agents|vasodilator agents|mesh-ancestor
92289386|NCT00553267|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92289387|NCT00553267|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92289388|NCT00364559|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92289389|NCT00364559|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92289391|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
92289392|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289393|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92289394|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92289395|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289396|NCT02271984|Praziquantel|praziquantel|mesh-list
92289397|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
92289398|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92289399|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289400|NCT02604173|Budesonide|budesonide|mesh-list
92289401|NCT02604173|Acetazolamide|acetazolamide|mesh-list
92289402|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289403|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92289404|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
92289405|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289406|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289407|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92289408|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289409|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
92289410|NCT02604173|Hormones|hormones|mesh-ancestor
92289411|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289412|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
92289413|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92289414|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289415|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289416|NCT02604173|Diuretics|diuretics|mesh-ancestor
92289417|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
92289418|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92289419|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92289420|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92289421|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289422|NCT02287038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289423|NCT02287038|Adrenergic Agents|adrenergic agents|mesh-ancestor
92289424|NCT02287038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289425|NCT02287038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289426|NCT00365339|Ritonavir|ritonavir|mesh-list
92289427|NCT00365339|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92289428|NCT00365339|Tenofovir|tenofovir|mesh-list
92289429|NCT00365339|Aripiprazole|aripiprazole|mesh-list
92289430|NCT00365339|Famotidine|famotidine|mesh-list
92289431|NCT00365339|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92289432|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92289433|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
92289434|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289435|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289436|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92289437|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92289438|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
92289439|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289440|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92289441|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92289442|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92289443|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92289444|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
92289445|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289446|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92289447|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92289448|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289449|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289450|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
92289451|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
92289452|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289453|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92289454|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92289455|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
92289456|NCT00365339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92289457|NCT00365339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92289458|NCT00365339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92289459|NCT00365339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92289460|NCT00365339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92289461|NCT00365339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92289462|NCT00365339|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92289463|NCT00365339|Histamine Antagonists|histamine antagonists|mesh-ancestor
92289465|NCT02815033|Choline|choline|mesh-list
92289466|NCT02815033|Lipotropic Agents|lipotropic agents|mesh-ancestor
92289467|NCT02815033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92289468|NCT02815033|Antimetabolites|antimetabolites|mesh-ancestor
92289469|NCT02815033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289470|NCT02815033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92289471|NCT02815033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92289472|NCT02815033|Nootropic Agents|nootropic agents|mesh-ancestor
92289473|NCT00366119|Ramipril|ramipril|mesh-list
92289474|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92289475|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
92289476|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289477|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289478|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92289479|NCT05371301|Paclitaxel|paclitaxel|mesh-list
92289480|NCT05371301|Carboplatin|carboplatin|mesh-list
92289481|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92289482|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289483|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
92289484|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
92289485|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
92289486|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289487|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
92289489|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289490|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92289491|NCT02605187|Acetaminophen|acetaminophen|mesh-list
92289492|NCT02605187|Ibuprofen|ibuprofen|mesh-list
92289493|NCT02605187|Morphine|morphine|mesh-list
92289494|NCT02605187|Gabapentin|gabapentin|mesh-list
92289495|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92289496|NCT02605187|Narcotics|narcotics|mesh-ancestor
92289497|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289498|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289499|NCT02605187|Analgesics|analgesics|mesh-ancestor
92289500|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
92289501|NCT02605187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289502|NCT02605187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92289503|NCT02605187|Antipyretics|antipyretics|mesh-ancestor
92289504|NCT02605187|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92289505|NCT02605187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289506|NCT02605187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289507|NCT02605187|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92289508|NCT02605187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289509|NCT02605187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289510|NCT02605187|Anticonvulsants|anticonvulsants|mesh-ancestor
92289511|NCT02605187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92289512|NCT02605187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92289513|NCT02605187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289514|NCT02605187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92289515|NCT02605187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92289516|NCT02605187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289517|NCT02605187|Antimanic Agents|antimanic agents|mesh-ancestor
92289518|NCT05592197|Lenvatinib|lenvatinib|mesh-list
92289519|NCT05592197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289520|NCT05592197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92289521|NCT05592197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289522|NCT05592197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289523|NCT02989207|Mitomycins|mitomycins|mesh-list
92289524|NCT02989207|Mitomycin|mitomycin|mesh-list
92289525|NCT02989207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92289526|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289527|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
92289528|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289529|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92289530|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289531|NCT02647099|Aspirin|aspirin|mesh-list
92289532|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935500|NCT03505255|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92289533|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92289535|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
92289536|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289537|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289538|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289539|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289540|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92289541|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92289542|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289543|NCT02647099|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92289544|NCT02647099|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92289545|NCT02647099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289546|NCT02647099|Antipyretics|antipyretics|mesh-ancestor
92289547|NCT01843621|Vaccines|vaccines|mesh-list
92289548|NCT01843621|Immunologic Factors|immunologic factors|mesh-ancestor
92289549|NCT01843621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289550|NCT02608229|Paclitaxel|paclitaxel|mesh-list
92289551|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92289552|NCT02608229|Gemcitabine|gemcitabine|mesh-list
92289553|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92345686|NCT01921140|Olaparib|olaparib|mesh-list
92289554|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289555|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
92289556|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
92289557|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
92289558|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289559|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92289560|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
92289561|NCT00555061|Retapamulin|retapamulin|mesh-list
92289562|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92289563|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289564|NCT01642212|Budesonide|budesonide|mesh-list
92289565|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289566|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92289567|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
92289568|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289569|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289570|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92289571|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289572|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
92289573|NCT01642212|Hormones|hormones|mesh-ancestor
92289574|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289575|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
92289576|NCT05649618|Fludarabine|fludarabine|mesh-list
92289577|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289578|NCT05649618|Immunologic Factors|immunologic factors|mesh-ancestor
92289579|NCT05649618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289580|NCT05649618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289581|NCT05649618|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92289582|NCT05649618|Alkylating Agents|alkylating agents|mesh-ancestor
92289583|NCT05649618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289584|NCT05649618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289585|NCT05649618|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92289586|NCT00552175|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92289587|NCT00552175|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92289588|NCT00552175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92289589|NCT00552175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289590|NCT00552175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289591|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289592|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289593|NCT00552175|Analgesics|analgesics|mesh-ancestor
92289594|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
92289595|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935511|NCT02311231|Heparin|heparin|mesh-list
92289596|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
92289597|NCT00552175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289598|NCT00552175|Dopamine Agents|dopamine agents|mesh-ancestor
92289599|NCT01644474|Ezetimibe|ezetimibe|mesh-list
92289600|NCT01644474|Alirocumab|alirocumab|mesh-list
91942380|NCT05249426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289601|NCT01644474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92289602|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92289603|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92289605|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289606|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92289608|NCT01644474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92289609|NCT01644474|Protease Inhibitors|protease inhibitors|mesh-ancestor
92289610|NCT01644474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289611|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
92289612|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289613|NCT02989129|Quercetin|quercetin|mesh-list
92289614|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
92289615|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289616|NCT02989129|Protective Agents|protective agents|mesh-ancestor
92289617|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289618|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
92289619|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92289620|NCT04879524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289621|NCT04879524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289622|NCT04879524|Cholinergic Agents|cholinergic agents|mesh-ancestor
92289623|NCT04879524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289624|NCT04879524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289626|NCT01847131|Oxymetazoline|oxymetazoline|mesh-list
92289627|NCT01847131|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92289628|NCT01847131|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92289629|NCT01847131|Adrenergic Agents|adrenergic agents|mesh-ancestor
92289630|NCT01847131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289631|NCT01847131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289632|NCT01847131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289633|NCT01847131|Sympathomimetics|sympathomimetics|mesh-ancestor
92289634|NCT01847131|Autonomic Agents|autonomic agents|mesh-ancestor
92289635|NCT01847131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289636|NCT01847131|Nasal Decongestants|nasal decongestants|mesh-ancestor
92289637|NCT01847131|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92289638|NCT01847131|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289639|NCT01847131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92289640|NCT01847131|Mydriatics|mydriatics|mesh-ancestor
92289641|NCT01847131|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92289642|NCT01847131|Protective Agents|protective agents|mesh-ancestor
92289643|NCT02285010|Pregabalin|pregabalin|mesh-list
92289644|NCT02285010|Analgesics|analgesics|mesh-ancestor
92289645|NCT02285010|Sensory System Agents|sensory system agents|mesh-ancestor
92289646|NCT02285010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289647|NCT02285010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289648|NCT02285010|Anticonvulsants|anticonvulsants|mesh-ancestor
92289649|NCT02285010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92289650|NCT02285010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289651|NCT02285010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289652|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92289653|NCT02285010|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92289654|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92289655|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289656|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289657|NCT02617667|Cyclosporine|cyclosporine|mesh-list
92289658|NCT02617667|Cyclosporins|cyclosporins|mesh-list
92289659|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289660|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289661|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289662|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
92289663|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289664|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
92289665|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289666|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92289667|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289668|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92289669|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
92289670|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92289671|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
92289672|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289673|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289674|NCT03023449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92289675|NCT03023449|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289676|NCT03023449|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92289677|NCT03023449|Antioxidants|antioxidants|mesh-ancestor
92289678|NCT03023449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289679|NCT03023449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289680|NCT03023449|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92289681|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
92289683|NCT03023449|Protective Agents|protective agents|mesh-ancestor
92289684|NCT01848067|Prednisone|prednisone|mesh-list
92289685|NCT01848067|Abiraterone Acetate|abiraterone acetate|mesh-list
92289686|NCT01848067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289687|NCT01848067|Glucocorticoids|glucocorticoids|mesh-ancestor
92289688|NCT01848067|Hormones|hormones|mesh-ancestor
92289689|NCT01848067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289690|NCT01848067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289691|NCT01848067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92289692|NCT01848067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289693|NCT01848067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92289694|NCT01848067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289695|NCT01848067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289696|NCT01848067|Hormone Antagonists|hormone antagonists|mesh-ancestor
92289697|NCT01848067|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92289698|NCT05731973|Sufentanil|sufentanil|mesh-list
92289699|NCT05731973|Oxycodone|oxycodone|mesh-list
92289700|NCT05731973|Analgesics, Opioid|analgesics, opioid|mesh-list
92289701|NCT05731973|Bupivacaine|bupivacaine|mesh-list
92289702|NCT05731973|Anesthetics, Local|anesthetics, local|mesh-ancestor
92289703|NCT05731973|Anesthetics|anesthetics|mesh-ancestor
92289704|NCT05731973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289705|NCT05731973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289706|NCT05731973|Sensory System Agents|sensory system agents|mesh-ancestor
92289707|NCT05731973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289708|NCT05731973|Narcotics|narcotics|mesh-ancestor
92289709|NCT05731973|Analgesics|analgesics|mesh-ancestor
92289710|NCT05731973|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92289711|NCT05731973|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92289712|NCT05731973|Anesthetics, General|anesthetics, general|mesh-ancestor
92289713|NCT05068349|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92289714|NCT05068349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92289715|NCT05068349|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92289716|NCT05068349|Protective Agents|protective agents|mesh-ancestor
92289717|NCT05068349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289718|NCT05452577|Estazolam|estazolam|mesh-list
92289719|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
92289720|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92289721|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92289722|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289723|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289724|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289725|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
92289726|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
92289727|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289728|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289729|NCT05464615|Amoxicillin|amoxicillin|mesh-list
92289730|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92289731|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289732|NCT00364871|Naltrexone|naltrexone|mesh-list
92289733|NCT00364871|Bupropion|bupropion|mesh-list
92289734|NCT00364871|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92289735|NCT00364871|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92289736|NCT00364871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289737|NCT00364871|Sensory System Agents|sensory system agents|mesh-ancestor
92289738|NCT00364871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289739|NCT00364871|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92289740|NCT00364871|Antidepressive Agents|antidepressive agents|mesh-ancestor
92289741|NCT00364871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289742|NCT00364871|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92289743|NCT00364871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92289744|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289745|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289746|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
92289747|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289748|NCT00364871|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92289749|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92289750|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289751|NCT00551161|Memantine|memantine|mesh-list
91942530|NCT04975308|Exemestane|exemestane|mesh-list
92289752|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92289753|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92289754|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
92289755|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289756|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289757|NCT00551161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289758|NCT00551161|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92289759|NCT00551161|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92289760|NCT00550771|Paclitaxel|paclitaxel|mesh-list
92289761|NCT00550771|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92289763|NCT00550771|Doxorubicin|doxorubicin|mesh-list
92289764|NCT00550771|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92289765|NCT00550771|Trastuzumab|trastuzumab|mesh-list
92289766|NCT00550771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92289767|NCT00550771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289768|NCT00550771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92289769|NCT00550771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92289770|NCT00550771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92289771|NCT00550771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289772|NCT00550771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289773|NCT00550771|Immunologic Factors|immunologic factors|mesh-ancestor
91935549|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
92289774|NCT00550771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289775|NCT00550771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289776|NCT00550771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92289777|NCT00550771|Alkylating Agents|alkylating agents|mesh-ancestor
92289778|NCT00550771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92289779|NCT00550771|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92289780|NCT00550771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92289781|NCT00550771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92289782|NCT00550771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289783|NCT00550771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289785|NCT01852669|Diuretics|diuretics|mesh-ancestor
92289786|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
92289787|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289788|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92289789|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289790|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289791|NCT04741295|Heparin|heparin|mesh-list
92289792|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92289793|NCT04741295|Tinzaparin|tinzaparin|mesh-list
92289794|NCT04741295|Dalteparin|dalteparin|mesh-list
92289795|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
92289796|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92289797|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92289798|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289799|NCT00550537|Paclitaxel|paclitaxel|mesh-list
92289800|NCT00550537|Bevacizumab|bevacizumab|mesh-list
92289801|NCT00550537|Carboplatin|carboplatin|mesh-list
92289802|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92289803|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92289804|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289805|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
92289806|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
92289807|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
92289808|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289809|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289810|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92289811|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92289812|NCT00550537|Growth Substances|growth substances|mesh-ancestor
92289813|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289814|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
92289815|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92289816|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289817|NCT04801043|Imipenem|imipenem|mesh-list
92289818|NCT04801043|Cilastatin|cilastatin|mesh-list
92289819|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92289820|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289821|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
92289822|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289823|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289824|NCT05706701|Nicotine|nicotine|mesh-list
91942600|NCT04895748|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92289825|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92289826|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
92289827|NCT05706701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289828|NCT05706701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289829|NCT05706701|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92289830|NCT05706701|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92289831|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
92289832|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289833|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289834|NCT04734197|Cyclosporine|cyclosporine|mesh-list
92289835|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
92289836|NCT04734197|Betamethasone|betamethasone|mesh-list
92289837|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
92289838|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92289839|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
92289840|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92289841|NCT04734197|Lifitegrast|lifitegrast|mesh-list
92289842|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92289843|NCT04734197|Cyclosporins|cyclosporins|mesh-list
92289844|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92289845|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289846|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289847|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289848|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
92289849|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289850|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
92289851|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289852|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
92289853|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289854|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92289855|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92289856|NCT04734197|Glucocorticoids|glucocorticoids|mesh-ancestor
92289857|NCT04734197|Hormones|hormones|mesh-ancestor
92289858|NCT04734197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92289859|NCT04734197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92289860|NCT04734197|Respiratory System Agents|respiratory system agents|mesh-ancestor
92289861|NCT04734197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92289862|NCT04734197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289863|NCT04734197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92289864|NCT04734197|Antitubercular Agents|antitubercular agents|mesh-ancestor
92289865|NCT04734197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92289866|NCT00550147|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92289867|NCT00550147|Methylphenidate|methylphenidate|mesh-list
92289868|NCT00550147|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92289869|NCT00550147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289870|NCT00550147|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92289871|NCT00550147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92289872|NCT00550147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92289873|NCT00550147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289875|NCT00550147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289876|NCT00550147|Antidepressive Agents|antidepressive agents|mesh-ancestor
92289877|NCT00550147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92289878|NCT00550147|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92289879|NCT00550147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92289880|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289881|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
92289882|NCT05688215|Leucovorin|leucovorin|mesh-list
92289883|NCT05688215|Folic Acid|folic acid|mesh-list
92289884|NCT05688215|Fluorouracil|fluorouracil|mesh-list
92289885|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
92289886|NCT05688215|Irinotecan|irinotecan|mesh-list
92289887|NCT05688215|Quemliclustat|quemliclustat|mesh-list
92289888|NCT05688215|Calcium|calcium|mesh-list
92289889|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
92289890|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92289891|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289892|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92289893|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
92289894|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289895|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92289896|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289897|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92289898|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
92289899|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92289900|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92289901|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289903|NCT05688215|Protective Agents|protective agents|mesh-ancestor
92289904|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
92289905|NCT05688215|Vitamins|vitamins|mesh-ancestor
92289906|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
92289907|NCT05688215|Hematinics|hematinics|mesh-ancestor
92289908|NCT05688215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92289909|NCT05688215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289910|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
92289911|NCT00557401|Baclofen|baclofen|mesh-list
92289912|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92289913|NCT00557401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289914|NCT00557401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92289915|NCT00557401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289916|NCT00557401|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92289917|NCT00557401|GABA Agonists|gaba agonists|mesh-ancestor
92289918|NCT00557401|GABA Agents|gaba agents|mesh-ancestor
92289919|NCT00557401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289920|NCT00557401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289921|NCT02264353|Donepezil|donepezil|mesh-list
92289922|NCT02264353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92289923|NCT02264353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289924|NCT02264353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289925|NCT02264353|Cholinergic Agents|cholinergic agents|mesh-ancestor
92289926|NCT02264353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289927|NCT02264353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289928|NCT02264353|Nootropic Agents|nootropic agents|mesh-ancestor
92289929|NCT02265913|Acyclovir|acyclovir|mesh-list
92289930|NCT02265913|Antiviral Agents|antiviral agents|mesh-ancestor
92289931|NCT02265913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289932|NCT02624843|Ethanol|ethanol|mesh-list
92289933|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
92289934|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92289935|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92289936|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92289937|NCT02624843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289938|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
92289939|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
92289940|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
92289941|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92289942|NCT02279641|Allopurinol|allopurinol|mesh-list
92289943|NCT02279641|Verinurad|verinurad|mesh-list
92289944|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
92289945|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289946|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289947|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
92289948|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92289949|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92289950|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
92289951|NCT02279641|Protective Agents|protective agents|mesh-ancestor
92289952|NCT02279641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289953|NCT02629991|Oxytocin|oxytocin|mesh-list
92289954|NCT02629991|Oxytocics|oxytocics|mesh-ancestor
92289955|NCT02629991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92289956|NCT02629991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345728|NCT01919190|Bupivacaine|bupivacaine|mesh-list
92289957|NCT00553657|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92289958|NCT00553657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92289959|NCT00553657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92289960|NCT00553657|Cholinergic Agents|cholinergic agents|mesh-ancestor
92289961|NCT00553657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92289962|NCT00553657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289963|NCT00553657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289964|NCT00553657|Urological Agents|urological agents|mesh-ancestor
92289965|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92289966|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289967|NCT05142709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289968|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289969|NCT04992143|Sorafenib|sorafenib|mesh-list
92289970|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289971|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92289972|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92289973|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289974|NCT04485065|Azacitidine|azacitidine|mesh-list
92289975|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942752|NCT04482803|beta-Endorphin|beta-endorphin|mesh-list
92289976|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
92289977|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289978|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289980|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
92289981|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92289982|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92289983|NCT03769129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92289984|NCT03769129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289985|NCT00367445|Insulin|insulin|mesh-list
92289986|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92289987|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
92289988|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92289989|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92289990|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
92289991|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92289992|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92289993|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92289994|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
92289995|NCT01866943|Coagulants|coagulants|mesh-ancestor
92289996|NCT01868425|Acetaminophen|acetaminophen|mesh-list
92289997|NCT01868425|Ketamine|ketamine|mesh-list
92289998|NCT01868425|Gabapentin|gabapentin|mesh-list
92289999|NCT01868425|Bupivacaine|bupivacaine|mesh-list
92290000|NCT01868425|Anesthetics, Local|anesthetics, local|mesh-ancestor
92290001|NCT01868425|Anesthetics|anesthetics|mesh-ancestor
92290002|NCT01868425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290003|NCT01868425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290004|NCT01868425|Sensory System Agents|sensory system agents|mesh-ancestor
92290005|NCT01868425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290006|NCT01868425|Analgesics|analgesics|mesh-ancestor
92290007|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92290008|NCT01868425|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92290009|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
92290010|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92290011|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92290012|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290013|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290014|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290015|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
92290016|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
92290017|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92290018|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92290019|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92290020|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
92290021|NCT00550459|Tolvaptan|tolvaptan|mesh-list
92290022|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92116854|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92290023|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290024|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
92290025|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290026|NCT01871077|Ketorolac|ketorolac|mesh-list
92290027|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92290028|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290029|NCT01871077|Analgesics|analgesics|mesh-ancestor
92290030|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
92290031|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290032|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290033|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290034|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290035|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92290036|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290037|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290038|NCT01874119|Fosaprepitant|fosaprepitant|mesh-list
92290039|NCT01874119|Aprepitant|aprepitant|mesh-list
92290040|NCT01874119|Antiemetics|antiemetics|mesh-ancestor
92290041|NCT01874119|Autonomic Agents|autonomic agents|mesh-ancestor
92290042|NCT01874119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290043|NCT01874119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290044|NCT01874119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92290045|NCT01874119|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92290046|NCT01874119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290047|NCT01874119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290048|NCT02823145|Fenfluramine|fenfluramine|mesh-list
92290049|NCT02823145|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92290050|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92290051|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290052|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290053|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290054|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
92290055|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290056|NCT02280811|Aldesleukin|aldesleukin|mesh-list
92290057|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
92290058|NCT02280811|Fludarabine|fludarabine|mesh-list
92290059|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290060|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
92290061|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290062|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290063|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92290064|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
92290065|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290066|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290067|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92290068|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92290069|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92290070|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
92290071|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290072|NCT01930747|Remifentanil|remifentanil|mesh-list
92290073|NCT01930747|Sevoflurane|sevoflurane|mesh-list
92290074|NCT01930747|Rocuronium|rocuronium|mesh-list
92290075|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92290076|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92290077|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
92290078|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
92290079|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290080|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290081|NCT01930747|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92290082|NCT01930747|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92290083|NCT01930747|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92290084|NCT01930747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290085|NCT01930747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92290086|NCT01930747|Narcotics|narcotics|mesh-ancestor
92290087|NCT01930747|Analgesics|analgesics|mesh-ancestor
92290088|NCT01930747|Sensory System Agents|sensory system agents|mesh-ancestor
92290089|NCT01931527|Rasburicase|rasburicase|mesh-list
92290090|NCT01931527|Gout Suppressants|gout suppressants|mesh-ancestor
92290091|NCT01931527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290092|NCT02639429|Misoprostol|misoprostol|mesh-list
92290093|NCT02639429|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92290094|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
92290095|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92290096|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290097|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92290098|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92290099|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
92290100|NCT01936363|Niacinamide|niacinamide|mesh-list
92290101|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
92290102|NCT01936363|Vitamins|vitamins|mesh-ancestor
92290103|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
92290104|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290105|NCT04893629|Digoxin|digoxin|mesh-list
92290106|NCT04893629|Captopril|captopril|mesh-list
92290107|NCT04893629|Furosemide|furosemide|mesh-list
92290108|NCT04893629|Diuretics|diuretics|mesh-ancestor
92290109|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
92290110|NCT04893629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290111|NCT04893629|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92290112|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290113|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290114|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92290115|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92290116|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290117|NCT04893629|Protective Agents|protective agents|mesh-ancestor
92290118|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92290119|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
92290120|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92290121|NCT04891991|Infliximab|infliximab|mesh-list
92290122|NCT04891991|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92290123|NCT04891991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290124|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
92290125|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92290126|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290127|NCT01936519|Cyclosporine|cyclosporine|mesh-list
92290128|NCT01936519|Mycophenolic Acid|mycophenolic acid|mesh-list
92290129|NCT01936519|Everolimus|everolimus|mesh-list
92290130|NCT01936519|Tacrolimus|tacrolimus|mesh-list
92290131|NCT01936519|Cyclosporins|cyclosporins|mesh-list
92290132|NCT01936519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92290133|NCT01936519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290134|NCT01936519|Immunologic Factors|immunologic factors|mesh-ancestor
92290135|NCT01936519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290136|NCT01936519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290137|NCT01936519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290138|NCT01936519|Antifungal Agents|antifungal agents|mesh-ancestor
92290139|NCT01936519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290140|NCT01936519|Dermatologic Agents|dermatologic agents|mesh-ancestor
92290141|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290142|NCT01936519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92290143|NCT01936519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92290144|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290145|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92290146|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92290147|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
92290148|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92290149|NCT04507841|Niraparib|niraparib|mesh-list
92290150|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92290151|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935701|NCT02313103|Lofexidine|lofexidine|mesh-list
92290152|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290153|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290154|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92290155|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290156|NCT01938079|Ketamine|ketamine|mesh-list
92290157|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92290158|NCT01938079|Analgesics|analgesics|mesh-ancestor
92290159|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
92290160|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290161|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290162|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92290163|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92290164|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
92290165|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
92290166|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290167|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92290168|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92290169|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290170|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290172|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92290173|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
92290174|NCT02641691|Fluorouracil|fluorouracil|mesh-list
92290175|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
92290176|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
92290177|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
92290178|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290179|NCT02641691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92290180|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290181|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290182|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
92290183|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290184|NCT02641691|Antidotes|antidotes|mesh-ancestor
92290185|NCT02641691|Protective Agents|protective agents|mesh-ancestor
92290186|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
92290187|NCT02641691|Vitamins|vitamins|mesh-ancestor
92290188|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
92290189|NCT04047251|Topotecan|topotecan|mesh-list
92290190|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92290191|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92290192|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290193|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290194|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290195|NCT04045613|Atezolizumab|atezolizumab|mesh-list
92290196|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92290197|NCT04045613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92290198|NCT04045613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290199|NCT04045613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290200|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290201|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
91942978|NCT04029688|Venetoclax|venetoclax|mesh-list
92290202|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290204|NCT05588999|Salicylates|salicylates|mesh-list
92290205|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290206|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
92290207|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
92290208|NCT05588999|Dermatologic Agents|dermatologic agents|mesh-ancestor
92290209|NCT05588999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92290210|NCT05588999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290211|NCT05588999|Analgesics|analgesics|mesh-ancestor
92290212|NCT05588999|Sensory System Agents|sensory system agents|mesh-ancestor
92290213|NCT05588999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290214|NCT05588999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290215|NCT05588999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290216|NCT05588999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290217|NCT05588999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92290218|NCT05588999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290219|NCT05588999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290220|NCT01643928|Rituximab|rituximab|mesh-list
92290221|NCT01643928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290222|NCT01643928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290223|NCT01643928|Immunologic Factors|immunologic factors|mesh-ancestor
92290224|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290225|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290226|NCT04234997|Suvorexant|suvorexant|mesh-list
92290227|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92290228|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92290229|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290230|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290231|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92290232|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290233|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290234|NCT03750071|Avelumab|avelumab|mesh-list
92290235|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290236|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290237|NCT03635567|Paclitaxel|paclitaxel|mesh-list
92290238|NCT03635567|Bevacizumab|bevacizumab|mesh-list
92290240|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
92290241|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92290242|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290243|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290244|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290245|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290246|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290247|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290248|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92290249|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92290250|NCT03635567|Growth Substances|growth substances|mesh-ancestor
92290251|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290252|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
92290253|NCT03635567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92290254|NCT05588531|Cefepime|cefepime|mesh-list
92290255|NCT05588531|Avibactam|avibactam|mesh-list
92290256|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92290257|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290258|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92290259|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290260|NCT05588531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290261|NCT05588297|Bevacizumab|bevacizumab|mesh-list
92290262|NCT05588297|Nivolumab|nivolumab|mesh-list
92290263|NCT05588297|Capecitabine|capecitabine|mesh-list
92290264|NCT05588297|Oxaliplatin|oxaliplatin|mesh-list
92290265|NCT05588297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290266|NCT05588297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290267|NCT05588297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92290268|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92290269|NCT05588297|Growth Substances|growth substances|mesh-ancestor
92290270|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290271|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
92290272|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92290273|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
92290274|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290275|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92290276|NCT05588219|Cisplatin|cisplatin|mesh-list
92290277|NCT05588219|Tislelizumab|tislelizumab|mesh-list
92290278|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92290279|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290280|NCT05588219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290281|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290282|NCT02303405|Pioglitazone|pioglitazone|mesh-list
92290283|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
92290284|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92290285|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290286|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
92290287|NCT02303405|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92290288|NCT02303405|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92290289|NCT02303405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290290|NCT02303405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290291|NCT02303405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290292|NCT02303405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290293|NCT02164955|Pomalidomide|pomalidomide|mesh-list
92290294|NCT02164955|Immunologic Factors|immunologic factors|mesh-ancestor
92290295|NCT02164955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290296|NCT02164955|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92290297|NCT02164955|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92290298|NCT02164955|Growth Substances|growth substances|mesh-ancestor
92290299|NCT02164955|Growth Inhibitors|growth inhibitors|mesh-ancestor
92290300|NCT02164955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290301|NCT05587361|Propranolol|propranolol|mesh-list
92290302|NCT05587361|Nicotine|nicotine|mesh-list
92290303|NCT05587361|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92290304|NCT05587361|Autonomic Agents|autonomic agents|mesh-ancestor
92290305|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290306|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290307|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92290308|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92290309|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
92290310|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290311|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290312|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92290313|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92290314|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92290315|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92290316|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92290317|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
92290318|NCT01943461|Avelumab|avelumab|mesh-list
92290319|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92290320|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290321|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290322|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
92290323|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290324|NCT00422435|Paclitaxel|paclitaxel|mesh-list
92290325|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92290326|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290327|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290328|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290329|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290330|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290331|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
92290332|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290333|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290334|NCT03559049|Carboplatin|carboplatin|mesh-list
92290335|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
92290336|NCT03559049|Pemetrexed|pemetrexed|mesh-list
92290337|NCT03559049|Rucaparib|rucaparib|mesh-list
92290338|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290339|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290340|NCT03559049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92290341|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290342|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290343|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92290344|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92290345|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92290346|NCT05559437|Bupivacaine|bupivacaine|mesh-list
92290347|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
92290349|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
92290350|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290351|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290352|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
92290353|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290354|NCT00367211|Naproxen|naproxen|mesh-list
92290355|NCT00367211|Omeprazole|omeprazole|mesh-list
92290356|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92290357|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92290358|NCT00367211|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92290359|NCT00367211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290360|NCT00367211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290361|NCT00367211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92290362|NCT00367211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290363|NCT00367211|Analgesics|analgesics|mesh-ancestor
92290364|NCT00367211|Sensory System Agents|sensory system agents|mesh-ancestor
92290365|NCT00367211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290366|NCT00367211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290367|NCT00367211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290368|NCT00367211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290369|NCT00367211|Gout Suppressants|gout suppressants|mesh-ancestor
92290370|NCT00367211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92290371|NCT02646449|Mirtazapine|mirtazapine|mesh-list
92290372|NCT02646449|Antidepressive Agents|antidepressive agents|mesh-ancestor
92290373|NCT02646449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92290374|NCT02646449|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92290375|NCT02646449|Histamine Antagonists|histamine antagonists|mesh-ancestor
92290376|NCT02646449|Histamine Agents|histamine agents|mesh-ancestor
92290377|NCT02646449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290378|NCT02646449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935783|NCT02330757|Estradiol|estradiol|mesh-list
92290379|NCT02646449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290380|NCT02646449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92290381|NCT02646449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92290382|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290383|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92290384|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92290385|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92290386|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92290387|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92290388|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92290389|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
92290390|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92290391|NCT04339361|Lidocaine|lidocaine|mesh-list
92290392|NCT04339361|Dinoprostone|dinoprostone|mesh-list
92290393|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92290394|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
92290395|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290396|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290397|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
92290398|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290399|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92290400|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92290401|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92290402|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290403|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290404|NCT04339361|Oxytocics|oxytocics|mesh-ancestor
92290405|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92290406|NCT05369351|Mirabegron|mirabegron|mesh-list
92290407|NCT05369351|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92290408|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92290409|NCT05369351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92290410|NCT05369351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92290411|NCT05369351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290412|NCT05369351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290413|NCT05369351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290414|NCT05369351|Urological Agents|urological agents|mesh-ancestor
92290415|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92290416|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92290418|NCT05303987|Propofol|propofol|mesh-list
92290419|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92290420|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290421|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290422|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290423|NCT05303987|Analgesics|analgesics|mesh-ancestor
92290424|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
92290425|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943207|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
92290426|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92290427|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92290428|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92290429|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
92290430|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290431|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290432|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92290433|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
92290434|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
92290435|NCT02654483|Serlopitant|serlopitant|mesh-list
92290436|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92290437|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290438|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290439|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290440|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
92290441|NCT02655653|Aminocaproic Acid|aminocaproic acid|mesh-list
92290442|NCT02655653|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91935790|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
92290443|NCT02655653|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92290444|NCT02655653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290445|NCT02655653|Hemostatics|hemostatics|mesh-ancestor
92290446|NCT02655653|Coagulants|coagulants|mesh-ancestor
92290447|NCT03081143|Paclitaxel|paclitaxel|mesh-list
92290448|NCT03081143|Ramucirumab|ramucirumab|mesh-list
92290449|NCT03081143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92290450|NCT03081143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290451|NCT03081143|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290452|NCT03081143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290453|NCT03081143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290454|NCT03081143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290455|NCT02658461|Trastuzumab|trastuzumab|mesh-list
92290456|NCT02658461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290457|NCT02658461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290458|NCT00367913|Clarithromycin|clarithromycin|mesh-list
92290459|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
92290460|NCT00367913|Rifampin|rifampin|mesh-list
92290461|NCT00367913|Ethambutol|ethambutol|mesh-list
92290462|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92290463|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290464|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92290465|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290466|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290467|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92290468|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92290469|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92290470|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92290471|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290472|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92290473|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92290474|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
92290475|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
92290476|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92290477|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92290478|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92290479|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92290480|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92290481|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92290482|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92290483|NCT02659787|Buprenorphine|buprenorphine|mesh-list
92290484|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92290485|NCT02659787|Narcotics|narcotics|mesh-ancestor
92290486|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290487|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290488|NCT02659787|Analgesics|analgesics|mesh-ancestor
92290489|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
92290490|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290491|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92290492|NCT05044871|Paclitaxel|paclitaxel|mesh-list
92290493|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92290494|NCT05044871|Bevacizumab|bevacizumab|mesh-list
92290495|NCT05044871|Tislelizumab|tislelizumab|mesh-list
92290496|NCT05044871|Pamiparib|pamiparib|mesh-list
92290497|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92290498|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290499|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943297|NCT02838420|Crizotinib|crizotinib|mesh-list
92290500|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290501|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290502|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290503|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290504|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92290505|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92290506|NCT05044871|Growth Substances|growth substances|mesh-ancestor
92290507|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290508|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
92290509|NCT05044871|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92290510|NCT05044871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290511|NCT04931693|Acetaminophen|acetaminophen|mesh-list
92290512|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290513|NCT04931693|Analgesics|analgesics|mesh-ancestor
92290514|NCT04931693|Sensory System Agents|sensory system agents|mesh-ancestor
92290515|NCT04931693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290516|NCT04931693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290517|NCT04931693|Antipyretics|antipyretics|mesh-ancestor
92290518|NCT02271594|Insulin|insulin|mesh-list
92290519|NCT02271594|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92290520|NCT02271594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290521|NCT04817969|Cimetidine|cimetidine|mesh-list
92290522|NCT04817969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92290523|NCT04817969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92290524|NCT04817969|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92290525|NCT04817969|Histamine Antagonists|histamine antagonists|mesh-ancestor
92290526|NCT04817969|Histamine Agents|histamine agents|mesh-ancestor
92290527|NCT04817969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290528|NCT04817969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290529|NCT04817969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290530|NCT04817969|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92290531|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92290532|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290533|NCT05649228|Capsaicin|capsaicin|mesh-list
92290534|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
92290535|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
92290536|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
92290537|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290538|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290539|NCT02350517|Paclitaxel|paclitaxel|mesh-list
92290540|NCT02350517|Endostar protein|endostar protein|mesh-list
92290541|NCT02350517|Endostatins|endostatins|mesh-list
92290542|NCT02350517|Nedaplatin|nedaplatin|mesh-list
92290543|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91935806|NCT02305615|Growth Substances|growth substances|mesh-ancestor
92290544|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290545|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290546|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290547|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290548|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290549|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92290550|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92290551|NCT02350517|Growth Substances|growth substances|mesh-ancestor
92290552|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290553|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
92290554|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
92290555|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92290556|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92290557|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92290558|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92290559|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290560|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290561|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
92290562|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290563|NCT02270736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290564|NCT02270736|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92290565|NCT02270736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290566|NCT02205047|Fluorouracil|fluorouracil|mesh-list
92290567|NCT02205047|Capecitabine|capecitabine|mesh-list
92290568|NCT02205047|Trastuzumab|trastuzumab|mesh-list
92290569|NCT02205047|Pertuzumab|pertuzumab|mesh-list
92290570|NCT02205047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290571|NCT02205047|Antimetabolites|antimetabolites|mesh-ancestor
92290572|NCT02205047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290573|NCT02205047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92290574|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290575|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
92290576|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290577|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290578|NCT04878198|Melatonin|melatonin|mesh-list
92290579|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
92290580|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290581|NCT04878198|Protective Agents|protective agents|mesh-ancestor
92290582|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290583|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290584|NCT04651595|Morphine|morphine|mesh-list
92290585|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92290586|NCT04651595|Narcotics|narcotics|mesh-ancestor
92290587|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290588|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290589|NCT04651595|Analgesics|analgesics|mesh-ancestor
92290590|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
92290591|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290592|NCT02669615|Melphalan|melphalan|mesh-list
92290593|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92290594|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
92290595|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290596|NCT02669615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290597|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92290598|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290599|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
92290600|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290601|NCT02672111|Buprenorphine|buprenorphine|mesh-list
92290602|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92290603|NCT02672111|Narcotics|narcotics|mesh-ancestor
92290604|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290605|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290606|NCT02672111|Analgesics|analgesics|mesh-ancestor
92290607|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
92290608|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290609|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92290610|NCT00586391|Ipilimumab|ipilimumab|mesh-list
92290611|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290612|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290613|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92290614|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290615|NCT05432843|Pregabalin|pregabalin|mesh-list
92290616|NCT05432843|Analgesics|analgesics|mesh-ancestor
92290617|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
92290618|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290619|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290620|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
92290621|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92290622|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290623|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290624|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92290625|NCT05432843|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92290626|NCT05432843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92290627|NCT05432843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290628|NCT05432843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92290629|NCT05411471|Vaccines|vaccines|mesh-list
92290630|NCT05411471|Immunologic Factors|immunologic factors|mesh-ancestor
92290631|NCT05411471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290632|NCT02677493|Vaccines|vaccines|mesh-list
92290633|NCT02677493|Immunologic Factors|immunologic factors|mesh-ancestor
92290634|NCT02677493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290635|NCT02679911|Ciclopirox|ciclopirox|mesh-list
92290636|NCT02679911|Amorolfine|amorolfine|mesh-list
92290637|NCT02679911|Antifungal Agents|antifungal agents|mesh-ancestor
92290638|NCT02679911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290639|NCT02680301|Triamcinolone|triamcinolone|mesh-list
92290640|NCT02680301|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92290641|NCT02680301|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92290642|NCT02680301|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92290643|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290644|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
92290645|NCT02680301|Hormones|hormones|mesh-ancestor
92290646|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92290647|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290648|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290649|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
92290650|NCT02680301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290651|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290652|NCT02680457|Insulin|insulin|mesh-list
92290653|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92290654|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
92290655|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92290656|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290657|NCT02283762|Riociguat|riociguat|mesh-list
92290658|NCT02283762|Enzyme Activators|enzyme activators|mesh-ancestor
92290659|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290660|NCT02692391|Indomethacin|indomethacin|mesh-list
92290661|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92290662|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290663|NCT02692391|Analgesics|analgesics|mesh-ancestor
92116855|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290664|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
92290665|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290666|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290667|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290668|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290669|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
92290670|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
92290671|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92290672|NCT02692391|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92290673|NCT02692391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935859|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290674|NCT02692391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290675|NCT02696291|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92290677|NCT02682563|Gliclazide|gliclazide|mesh-list
92290678|NCT02682563|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92290679|NCT02682563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290680|NCT02682563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92290681|NCT02682563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290682|NCT02697071|Ketamine|ketamine|mesh-list
92290683|NCT02697071|Analgesics|analgesics|mesh-ancestor
92290684|NCT02697071|Sensory System Agents|sensory system agents|mesh-ancestor
92290685|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290686|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290687|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92290688|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92290689|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
92290690|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
92290691|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290692|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92290693|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92290694|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290695|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290696|NCT02283294|Warfarin|warfarin|mesh-list
92290697|NCT02283294|Apixaban|apixaban|mesh-list
92290698|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
92290699|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92290700|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
92290701|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92290702|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
92290703|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290704|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290705|NCT05648994|Paclitaxel|paclitaxel|mesh-list
92290706|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
92290707|NCT05648994|Fludarabine|fludarabine|mesh-list
92290708|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92290709|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92290710|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290711|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290712|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290713|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290714|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290715|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290716|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
92290717|NCT05648994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290718|NCT05648994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290719|NCT05648994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92290720|NCT05648994|Alkylating Agents|alkylating agents|mesh-ancestor
92290721|NCT05648994|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92290722|NCT04869306|Hyaluronic Acid|hyaluronic acid|mesh-list
92290723|NCT04869306|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92290724|NCT04869306|Immunologic Factors|immunologic factors|mesh-ancestor
92290725|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290727|NCT04869306|Protective Agents|protective agents|mesh-ancestor
92290728|NCT02268864|Simeprevir|simeprevir|mesh-list
92290729|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
92290730|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290731|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
92290732|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290733|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290734|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
92290735|NCT04859946|Busulfan|busulfan|mesh-list
92290736|NCT04859946|Thiotepa|thiotepa|mesh-list
92290737|NCT04859946|Fludarabine|fludarabine|mesh-list
92290738|NCT04859946|Tacrolimus|tacrolimus|mesh-list
92290739|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290740|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
92290741|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290742|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290743|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92290744|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
92290745|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290746|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290747|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92290748|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92290749|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290750|NCT02703779|Plerixafor|plerixafor|mesh-list
92290751|NCT02703779|Bortezomib|bortezomib|mesh-list
92290752|NCT02703779|Lenograstim|lenograstim|mesh-list
92290753|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92290754|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
92290755|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290756|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290757|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92290758|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92290759|NCT02703779|Antiviral Agents|antiviral agents|mesh-ancestor
92290760|NCT02703779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290761|NCT04738955|Micafungin|micafungin|mesh-list
92290762|NCT04738955|Antifungal Agents|antifungal agents|mesh-ancestor
92290763|NCT04738955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290764|NCT02268396|Glycopyrrolate|glycopyrrolate|mesh-list
92290765|NCT02268396|Formoterol Fumarate|formoterol fumarate|mesh-list
92290766|NCT02268396|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92290767|NCT02268396|Autonomic Agents|autonomic agents|mesh-ancestor
92290768|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290769|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290770|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92290771|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
92290772|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92290773|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92290774|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92290775|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
92290776|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290777|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290778|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92290779|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92290780|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92290781|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
92290782|NCT05648526|Ketamine|ketamine|mesh-list
92290783|NCT05648526|Analgesics|analgesics|mesh-ancestor
92290784|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
92290785|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290786|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290787|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92290788|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92290789|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
92290790|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
92290791|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290792|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92290793|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92290794|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290795|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290796|NCT02705807|Epoprostenol|epoprostenol|mesh-list
92290797|NCT02705807|Tezosentan|tezosentan|mesh-list
92290798|NCT02705807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92290799|NCT02705807|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92290800|NCT02705807|Vasodilator Agents|vasodilator agents|mesh-ancestor
92290801|NCT01643772|Oxycodone|oxycodone|mesh-list
92290802|NCT01643772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92290803|NCT01643772|Narcotics|narcotics|mesh-ancestor
92290804|NCT01643772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290805|NCT01643772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290806|NCT01643772|Analgesics|analgesics|mesh-ancestor
92290807|NCT01643772|Sensory System Agents|sensory system agents|mesh-ancestor
92290808|NCT01643772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290809|NCT02707523|Azithromycin|azithromycin|mesh-list
92290810|NCT02707523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92290811|NCT02707523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290812|NCT02712047|Fluticasone|fluticasone|mesh-list
92290813|NCT02712047|Xhance|xhance|mesh-list
92290814|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290815|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92290816|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
92290817|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290818|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290819|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92290820|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92290821|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
92290822|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92290823|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92290824|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92290825|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290826|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
92290827|NCT00369239|Risperidone|risperidone|mesh-list
92290828|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92290829|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
92290830|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290831|NCT00369239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290832|NCT00369239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290834|NCT00369239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92290835|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290836|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92290837|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92290838|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
92290839|NCT03833921|Prednisone|prednisone|mesh-list
92290840|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
92290841|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290842|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
92290843|NCT03833921|Hormones|hormones|mesh-ancestor
92290844|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92290845|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290846|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92290847|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290848|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92290849|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290850|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290851|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
92290852|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92290853|NCT05215925|Carboplatin|carboplatin|mesh-list
92290854|NCT05215925|Docetaxel|docetaxel|mesh-list
92290855|NCT05215925|Pemetrexed|pemetrexed|mesh-list
92290856|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290857|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290858|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290859|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290860|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290861|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290862|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92290863|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92290864|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92290865|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92290866|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92290867|NCT05159687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290868|NCT05159687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290869|NCT05159687|Adrenergic Agents|adrenergic agents|mesh-ancestor
92290870|NCT05159687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290871|NCT05159687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290872|NCT02721017|Fentanyl|fentanyl|mesh-list
92290873|NCT02721017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92290874|NCT02721017|Narcotics|narcotics|mesh-ancestor
92290875|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290876|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290877|NCT02721017|Analgesics|analgesics|mesh-ancestor
92290878|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
92290879|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935863|NCT02305927|Vitamins|vitamins|mesh-ancestor
92290880|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92290881|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92290882|NCT02721017|Anesthetics, General|anesthetics, general|mesh-ancestor
92290883|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
92290884|NCT02721641|Trastuzumab|trastuzumab|mesh-list
92290885|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290886|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290887|NCT03649061|Etanercept|etanercept|mesh-list
92290888|NCT03649061|Leflunomide|leflunomide|mesh-list
92290889|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92290890|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290891|NCT03649061|Analgesics|analgesics|mesh-ancestor
92290892|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
92290893|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290894|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290895|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290896|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290897|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92290898|NCT03649061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290899|NCT03649061|Immunologic Factors|immunologic factors|mesh-ancestor
92290900|NCT03649061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290901|NCT03649061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290902|NCT02265744|Antibodies|antibodies|mesh-list
92290903|NCT02265744|Immunologic Factors|immunologic factors|mesh-ancestor
92290904|NCT02265744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290905|NCT05109143|Indomethacin|indomethacin|mesh-list
92290906|NCT05109143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92290907|NCT05109143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92290908|NCT05109143|Analgesics|analgesics|mesh-ancestor
92290909|NCT05109143|Sensory System Agents|sensory system agents|mesh-ancestor
92290910|NCT05109143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290911|NCT05109143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290912|NCT05109143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92290913|NCT05109143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290914|NCT05109143|Gout Suppressants|gout suppressants|mesh-ancestor
92290915|NCT05109143|Tocolytic Agents|tocolytic agents|mesh-ancestor
92290916|NCT05109143|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92290917|NCT05109143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92290918|NCT05109143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290919|NCT05109143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290920|NCT03614663|Cannabidiol|cannabidiol|mesh-list
92290921|NCT03614663|Anticonvulsants|anticonvulsants|mesh-ancestor
92290922|NCT00085735|Cyclophosphamide|cyclophosphamide|mesh-list
92290923|NCT00085735|Lomustine|lomustine|mesh-list
92290924|NCT00085735|Cisplatin|cisplatin|mesh-list
92290925|NCT00085735|Vincristine|vincristine|mesh-list
92290926|NCT00085735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92290927|NCT00085735|Immunologic Factors|immunologic factors|mesh-ancestor
92290928|NCT00085735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290929|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92290930|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92290931|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
92290932|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290933|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290934|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92290935|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92290936|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
92290937|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
92290938|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
92290939|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92290940|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
92290941|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
92290942|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92290943|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290944|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
92290945|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92290946|NCT03578783|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92290947|NCT05544786|Ritonavir|ritonavir|mesh-list
92290948|NCT05544786|Nirmatrelvir|nirmatrelvir|mesh-list
92290949|NCT05544786|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
91931944|NCT01036087|Epirubicin|epirubicin|mesh-list
92290951|NCT05544786|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92290952|NCT05544786|Protease Inhibitors|protease inhibitors|mesh-ancestor
92290953|NCT05544786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92290954|NCT05544786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290955|NCT05544786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92290956|NCT05544786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92290957|NCT05544786|Antiviral Agents|antiviral agents|mesh-ancestor
92290958|NCT05544786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290959|NCT05544786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92290960|NCT05544786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92290961|NCT02726789|Interferons|interferons|mesh-list
92290962|NCT02726789|Interferon-alpha|interferon-alpha|mesh-list
92290963|NCT02726789|Interferon alpha-2|interferon alpha-2|mesh-list
92290964|NCT02726789|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92290965|NCT02726789|Entecavir|entecavir|mesh-list
92290966|NCT02726789|REP 2139|rep 2139|mesh-list
92290967|NCT02726789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290968|NCT02726789|Antiviral Agents|antiviral agents|mesh-ancestor
92290969|NCT02726789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290970|NCT02726789|Immunologic Factors|immunologic factors|mesh-ancestor
92290971|NCT02726789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290972|NCT02731313|Trastuzumab|trastuzumab|mesh-list
92290973|NCT02731313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92290974|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92290975|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92290976|NCT02281591|Anticonvulsants|anticonvulsants|mesh-ancestor
92290977|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92290978|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92290979|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290980|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290981|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
92290982|NCT02731469|Hematinics|hematinics|mesh-ancestor
92290983|NCT01944319|Meropenem|meropenem|mesh-list
92290984|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92290985|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92290986|NCT00368303|Paroxetine|paroxetine|mesh-list
92290987|NCT00368303|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92290988|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92290989|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92290990|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92290991|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92290992|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
92290993|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92290994|NCT00368303|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92290995|NCT00368303|Antidepressive Agents|antidepressive agents|mesh-ancestor
92290996|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92290997|NCT00368303|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92290998|NCT00368303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92290999|NCT00368303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291000|NCT00368381|Hydrocortisone|hydrocortisone|mesh-list
92291001|NCT00368381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291002|NCT05020145|Vaccines|vaccines|mesh-list
92291003|NCT05020145|Immunologic Factors|immunologic factors|mesh-ancestor
92291004|NCT05020145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291005|NCT02734355|Amlodipine|amlodipine|mesh-list
92291006|NCT02734355|Telmisartan|telmisartan|mesh-list
92291007|NCT02734355|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92291008|NCT02734355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291009|NCT02734355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92291010|NCT02734355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92291011|NCT02734355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291012|NCT02734355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92291013|NCT02734355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291014|NCT02734355|Vasodilator Agents|vasodilator agents|mesh-ancestor
92291015|NCT02734355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92291016|NCT02734355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92291017|NCT00369395|Volociximab|volociximab|mesh-list
92291018|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92291019|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92291020|NCT00369395|Growth Substances|growth substances|mesh-ancestor
92291021|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291022|NCT00369395|Growth Inhibitors|growth inhibitors|mesh-ancestor
92291023|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116932|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291025|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943818|NCT03336541|Ketamine|ketamine|mesh-list
92291027|NCT01948141|Nintedanib|nintedanib|mesh-list
92291028|NCT01948141|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92291029|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291030|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92291031|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291032|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291033|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
92291034|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92291035|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
92291036|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291037|NCT05446493|Tadalafil|tadalafil|mesh-list
92291038|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
92291039|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92291040|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92291041|NCT05446493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291042|NCT05446493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291043|NCT05446493|Urological Agents|urological agents|mesh-ancestor
92291044|NCT02863055|Nintedanib|nintedanib|mesh-list
92291045|NCT02863055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291046|NCT02863055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92291047|NCT02863055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291048|NCT02863055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291049|NCT05445479|Doxycycline|doxycycline|mesh-list
92291050|NCT05445479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92291051|NCT05445479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291052|NCT05445479|Antimalarials|antimalarials|mesh-ancestor
92291053|NCT05445479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92291054|NCT05445479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92291055|NCT02711735|Vaccines|vaccines|mesh-list
92291056|NCT02711735|Immunologic Factors|immunologic factors|mesh-ancestor
92291057|NCT02711735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291058|NCT05445011|Cyclophosphamide|cyclophosphamide|mesh-list
92291059|NCT05445011|Fludarabine|fludarabine|mesh-list
92291060|NCT05445011|Fludarabine phosphate|fludarabine phosphate|mesh-list
92291061|NCT05445011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92291062|NCT05445011|Immunologic Factors|immunologic factors|mesh-ancestor
92291063|NCT05445011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291064|NCT05445011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291065|NCT05445011|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92291066|NCT05445011|Alkylating Agents|alkylating agents|mesh-ancestor
92291067|NCT05445011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291068|NCT05445011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291069|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92291070|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92291071|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
92291072|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
92291073|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92291074|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291075|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291076|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291077|NCT04770155|Bosentan|bosentan|mesh-list
92291078|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
92291079|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
92291080|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92291081|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92291082|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291083|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291084|NCT04770155|Urological Agents|urological agents|mesh-ancestor
92291085|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291086|NCT04770155|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92291087|NCT04744181|Folic Acid|folic acid|mesh-list
92291088|NCT04744181|Vitamin B Complex|vitamin b complex|mesh-list
92291089|NCT04744181|Vitamins|vitamins|mesh-ancestor
92291090|NCT04744181|Micronutrients|micronutrients|mesh-ancestor
92291091|NCT04744181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291092|NCT04744181|Hematinics|hematinics|mesh-ancestor
92291093|NCT01970345|Mecasermin|mecasermin|mesh-list
92291094|NCT01970345|Growth Substances|growth substances|mesh-ancestor
92291095|NCT01970345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291097|NCT00619931|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92291098|NCT00619931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92291100|NCT00619931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291101|NCT00619931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291102|NCT00619931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291104|NCT04739111|Immunoglobulins|immunoglobulins|mesh-list
92291105|NCT04739111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92291106|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
92291107|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291108|NCT04768231|Rifampin|rifampin|mesh-list
92291109|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92291110|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
92291111|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92291112|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291113|NCT04768231|Leprostatic Agents|leprostatic agents|mesh-ancestor
92291114|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92291115|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291116|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291117|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92291118|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92291119|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92291120|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91935922|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
92291121|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92291122|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92291123|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92291124|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
92291125|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291126|NCT01889797|Rituximab|rituximab|mesh-list
92291127|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
92291128|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92291129|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291130|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
92291131|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291132|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291133|NCT00369551|Paclitaxel|paclitaxel|mesh-list
92291134|NCT00369551|Bevacizumab|bevacizumab|mesh-list
92291135|NCT00369551|Carboplatin|carboplatin|mesh-list
92291136|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92291137|NCT00369551|Antibodies|antibodies|mesh-list
92291138|NCT00369551|Immunoglobulins|immunoglobulins|mesh-list
92291139|NCT00369551|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92291140|NCT00369551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92291141|NCT00369551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291142|NCT00369551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92291143|NCT00369551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92291144|NCT00369551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92291145|NCT00369551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291146|NCT00369551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92291147|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92291148|NCT00369551|Growth Substances|growth substances|mesh-ancestor
92291149|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291150|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
92291151|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
92291152|NCT04537793|Ivacaftor|ivacaftor|mesh-list
92291153|NCT04537793|Elexacaftor|elexacaftor|mesh-list
92291154|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92291155|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92291156|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291157|NCT05451173|Durvalumab|durvalumab|mesh-list
92291158|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92291159|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291160|NCT05437601|Carotenoids|carotenoids|mesh-list
92291161|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
92291162|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291163|NCT05437601|Protective Agents|protective agents|mesh-ancestor
92291164|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291165|NCT05449145|Vitamin D|vitamin d|mesh-list
92291166|NCT05449145|Vitamins|vitamins|mesh-ancestor
92291167|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
92291168|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291169|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92291170|NCT05447039|Montelukast|montelukast|mesh-list
92291171|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92291172|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92291173|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91943952|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
92291174|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
92291175|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291176|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291177|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92291178|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92291179|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291181|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291182|NCT05446415|Glucagon|glucagon|mesh-list
92291183|NCT05446415|Incretins|incretins|mesh-list
92291184|NCT05446415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92291185|NCT05446415|Hormones|hormones|mesh-ancestor
92291186|NCT05446415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291187|NCT05446415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291188|NCT05448365|Vitamin D|vitamin d|mesh-list
92291189|NCT05448365|Vitamins|vitamins|mesh-list
92291190|NCT05448365|Inositol|inositol|mesh-list
92291191|NCT05448365|Vitamin B 6|vitamin b 6|mesh-list
92291192|NCT05448365|Pyridoxal|pyridoxal|mesh-list
92291193|NCT05448365|Pyridoxine|pyridoxine|mesh-list
92291194|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92291195|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
92291196|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291197|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92291198|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
92291199|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
92291200|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291201|NCT05448365|Protective Agents|protective agents|mesh-ancestor
92291202|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92291203|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92291204|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291205|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92291206|NCT00370799|Betamethasone|betamethasone|mesh-list
92291207|NCT00370799|Betamethasone Valerate|betamethasone valerate|mesh-list
92291208|NCT00370799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92291209|NCT00370799|Betamethasone benzoate|betamethasone benzoate|mesh-list
92291210|NCT00370799|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92291211|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92291212|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291213|NCT00370799|Glucocorticoids|glucocorticoids|mesh-ancestor
92291214|NCT00370799|Hormones|hormones|mesh-ancestor
92291215|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291216|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291217|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92291218|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92291219|NCT02661971|Leucovorin|leucovorin|mesh-list
92291220|NCT02661971|Docetaxel|docetaxel|mesh-list
92291221|NCT02661971|Fluorouracil|fluorouracil|mesh-list
92291222|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
92291223|NCT02661971|Ramucirumab|ramucirumab|mesh-list
92291224|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291225|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92291226|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92291227|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92291228|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291229|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
92291230|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92291231|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92291232|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
92291233|NCT02661971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291234|NCT02661971|Antidotes|antidotes|mesh-ancestor
92291235|NCT02661971|Protective Agents|protective agents|mesh-ancestor
92291236|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
92291237|NCT02661971|Vitamins|vitamins|mesh-ancestor
92291238|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
92291239|NCT05442905|Anesthetics|anesthetics|mesh-list
92291240|NCT05442905|Propofol|propofol|mesh-list
92291241|NCT05442905|Sevoflurane|sevoflurane|mesh-list
92291242|NCT05442905|Atracurium|atracurium|mesh-list
92409727|NCT05642195|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92291243|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291244|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291245|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92291246|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92291247|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
91944025|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
92291248|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92291249|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91935962|NCT02319265|Melatonin|melatonin|mesh-list
92291250|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92291251|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92291252|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92291253|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291254|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92291255|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92291256|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
92291257|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291258|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291259|NCT00369863|Triamcinolone|triamcinolone|mesh-list
92291260|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92291261|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92291262|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92291263|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291264|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
92291265|NCT00369863|Hormones|hormones|mesh-ancestor
92291266|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291267|NCT00369863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291268|NCT00369863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92291269|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
92291270|NCT00369863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291271|NCT00369863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291272|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92291273|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92291274|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291275|NCT02588027|Ibuprofen|ibuprofen|mesh-list
92291276|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92291277|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291278|NCT02588027|Analgesics|analgesics|mesh-ancestor
92291279|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
92291280|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291281|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291282|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291283|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291284|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92291285|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291286|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291287|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
92291288|NCT04449965|Povidone|povidone|mesh-list
92291289|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
92291290|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
92291291|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92291292|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291293|NCT05431673|Doxycycline|doxycycline|mesh-list
92291294|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
92291295|NCT05431673|Rifampin|rifampin|mesh-list
92291296|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92291297|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291298|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
92291299|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92291300|NCT05431673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92291301|NCT05431673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92291302|NCT05431673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92291303|NCT05431673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291304|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291305|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291306|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92291307|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92291308|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92291309|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
92291310|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
92291311|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92291312|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92291313|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92291314|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91935963|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
92291315|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92291316|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92291317|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92291318|NCT01951651|Exenatide|exenatide|mesh-list
92291319|NCT01951651|Glipizide|glipizide|mesh-list
92291320|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291321|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291322|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92291323|NCT01951651|Incretins|incretins|mesh-ancestor
92291324|NCT01951651|Hormones|hormones|mesh-ancestor
92291325|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291326|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
92291327|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
92291328|NCT02466581|Prednisolone|prednisolone|mesh-list
92291329|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92291330|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
92291331|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92291332|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
92291333|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
92291334|NCT02466581|Abatacept|abatacept|mesh-list
92291335|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92291336|NCT02466581|Prednisolone phosphate|prednisolone phosphate|mesh-list
92291337|NCT02466581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291338|NCT02466581|Glucocorticoids|glucocorticoids|mesh-ancestor
92291339|NCT02466581|Hormones|hormones|mesh-ancestor
92291340|NCT02466581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291341|NCT02466581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291342|NCT02466581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92291343|NCT02466581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291345|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
92291346|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291347|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92291348|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92291349|NCT02466581|Protective Agents|protective agents|mesh-ancestor
92291350|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
92291351|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92291352|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92291353|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291354|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291355|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291356|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291357|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92291358|NCT02466581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92291359|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92291360|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
92291361|NCT02466581|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92291362|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92291363|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291364|NCT02466581|Analgesics|analgesics|mesh-ancestor
92291365|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
92291366|NCT01951963|Ketamine|ketamine|mesh-list
92291367|NCT01951963|Morphine|morphine|mesh-list
92291368|NCT01951963|Analgesics|analgesics|mesh-ancestor
92291369|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
92291370|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346002|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
92291371|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291372|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92291373|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92291374|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
92291375|NCT01951963|Anesthetics|anesthetics|mesh-ancestor
92291376|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291377|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92291378|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91931966|NCT00783367|Dexamethasone|dexamethasone|mesh-list
92291379|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291380|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291381|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92291382|NCT01951963|Narcotics|narcotics|mesh-ancestor
92291384|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291385|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92291386|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291387|NCT01894555|Aspirin|aspirin|mesh-list
92291388|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92291389|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291390|NCT01894555|Analgesics|analgesics|mesh-ancestor
92291391|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
92291392|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291393|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291394|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291395|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291396|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92291397|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92291398|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291399|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92291400|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92291401|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291402|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
92291403|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
92291404|NCT01953211|Norinyl|norinyl|mesh-list
92291405|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
92291406|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92291407|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92291408|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291409|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92291410|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92291411|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92291412|NCT02028221|Metformin|metformin|mesh-list
92291413|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291414|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291415|NCT05735197|Dapagliflozin|dapagliflozin|mesh-list
92291416|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92291417|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291418|NCT05735197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346044|NCT01873950|Dofetilide|dofetilide|mesh-list
92291419|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291420|NCT00370097|Fluticasone|fluticasone|mesh-list
92291421|NCT00370097|Xhance|xhance|mesh-list
92291422|NCT00370097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291423|NCT00370097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92291424|NCT00370097|Autonomic Agents|autonomic agents|mesh-ancestor
92291425|NCT00370097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291426|NCT00370097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291427|NCT00370097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92291428|NCT00370097|Respiratory System Agents|respiratory system agents|mesh-ancestor
92291429|NCT00370097|Dermatologic Agents|dermatologic agents|mesh-ancestor
92291430|NCT00370097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92291431|NCT01897285|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92291432|NCT01897285|Laxatives|laxatives|mesh-ancestor
92291433|NCT01897285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92291434|NCT00370253|Terlipressin|terlipressin|mesh-list
92291435|NCT00370253|Norepinephrine|norepinephrine|mesh-list
92291436|NCT00370253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291437|NCT00370253|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92291438|NCT00370253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92291439|NCT00370253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92291440|NCT00370253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92291441|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291442|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346084|NCT01856790|Liraglutide|liraglutide|mesh-list
92291443|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291444|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
92291445|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
92291446|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291447|NCT01491815|Abatacept|abatacept|mesh-list
92291448|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92291449|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291450|NCT01491815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92291451|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291454|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291455|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291456|NCT04359953|Azithromycin|azithromycin|mesh-list
92291457|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
92291458|NCT04359953|Telmisartan|telmisartan|mesh-list
92291459|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92291460|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291461|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
92291462|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92291463|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92291464|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291465|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291466|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291467|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291468|NCT04359953|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92291469|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92291470|NCT05364515|Clobetasol|clobetasol|mesh-list
92291471|NCT05364515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291472|NCT05364515|Glucocorticoids|glucocorticoids|mesh-ancestor
92291473|NCT05364515|Hormones|hormones|mesh-ancestor
92291474|NCT05364515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291475|NCT05364515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944272|NCT00394199|Xhance|xhance|mesh-list
92291476|NCT01438073|Hormones|hormones|mesh-list
92291477|NCT01438073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291478|NCT01438073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291479|NCT04338191|Leucovorin|leucovorin|mesh-list
92291480|NCT04338191|Fluorouracil|fluorouracil|mesh-list
92291481|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
92291482|NCT04338191|Irinotecan|irinotecan|mesh-list
92291483|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
92291484|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
92291485|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291486|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92291487|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291488|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92291489|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
92291490|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291491|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92291492|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92291493|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291494|NCT04338191|Antidotes|antidotes|mesh-ancestor
92291495|NCT04338191|Protective Agents|protective agents|mesh-ancestor
92291496|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
92291497|NCT04338191|Vitamins|vitamins|mesh-ancestor
92291498|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
92291499|NCT00371033|Pregabalin|pregabalin|mesh-list
92291500|NCT00371033|Analgesics|analgesics|mesh-ancestor
92291501|NCT00371033|Sensory System Agents|sensory system agents|mesh-ancestor
92291502|NCT00371033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291503|NCT00371033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291504|NCT00371033|Anticonvulsants|anticonvulsants|mesh-ancestor
92291505|NCT00371033|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92291506|NCT00371033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92291507|NCT00371033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291508|NCT00371033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92291509|NCT00371033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92291510|NCT00371033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92291511|NCT00371033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291512|NCT00371033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92291513|NCT00371111|Triamcinolone|triamcinolone|mesh-list
92291514|NCT00371111|Bevacizumab|bevacizumab|mesh-list
92291515|NCT00371111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92291516|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291517|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92291518|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92291519|NCT00371111|Growth Substances|growth substances|mesh-ancestor
92291520|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291521|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
92291522|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291523|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
92291525|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291526|NCT05454683|Melatonin|melatonin|mesh-list
92291527|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
92291528|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291529|NCT05454683|Protective Agents|protective agents|mesh-ancestor
92291530|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291531|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291532|NCT05193071|Aspirin|aspirin|mesh-list
92291533|NCT05193071|Clopidogrel|clopidogrel|mesh-list
92291534|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92291535|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291536|NCT05193071|Analgesics|analgesics|mesh-ancestor
92291537|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
92291538|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291539|NCT05193071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291540|NCT05193071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291541|NCT05193071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291542|NCT05193071|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92291543|NCT05193071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92291544|NCT05193071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291545|NCT05193071|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92291546|NCT05193071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92291547|NCT05193071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291548|NCT05193071|Antipyretics|antipyretics|mesh-ancestor
92291549|NCT05193071|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92291550|NCT05193071|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92291551|NCT05193071|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92291552|NCT05193071|Purinergic Agents|purinergic agents|mesh-ancestor
92291553|NCT05193071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291554|NCT05180825|Trametinib|trametinib|mesh-list
92291555|NCT05180825|Vinblastine|vinblastine|mesh-list
92291556|NCT05180825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291557|NCT05180825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92291558|NCT05180825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936009|NCT03502135|Phenylephrine|phenylephrine|mesh-list
92291559|NCT05180825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291560|NCT05180825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92291561|NCT05180825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92291562|NCT05180825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92291563|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92291564|NCT05139095|Apatinib|apatinib|mesh-list
92291565|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291566|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92291567|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291568|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291569|NCT04108247|Fluzoparib|fluzoparib|mesh-list
92291570|NCT04108247|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92291571|NCT04108247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291572|NCT04108247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291573|NCT04108247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291574|NCT05453435|Entecavir|entecavir|mesh-list
92291575|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
92291576|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291577|NCT03029845|Propranolol|propranolol|mesh-list
92291578|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92291579|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92291580|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
92291581|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291582|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291583|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291584|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92291585|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291586|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
92291587|NCT05451719|Capecitabine|capecitabine|mesh-list
92291588|NCT05451719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92291589|NCT05451719|Antimetabolites|antimetabolites|mesh-ancestor
92291590|NCT05451719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291591|NCT05451719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291592|NCT01955629|Capecitabine|capecitabine|mesh-list
92291593|NCT01955629|Oxaliplatin|oxaliplatin|mesh-list
92291594|NCT01955629|Aflibercept|aflibercept|mesh-list
92291595|NCT01955629|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92291596|NCT01955629|Antimetabolites|antimetabolites|mesh-ancestor
92291597|NCT01955629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291598|NCT01955629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291599|NCT01955629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92291600|NCT01955629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92291601|NCT01955629|Growth Substances|growth substances|mesh-ancestor
92291602|NCT01955629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291603|NCT01955629|Growth Inhibitors|growth inhibitors|mesh-ancestor
92291604|NCT01898689|Ropivacaine|ropivacaine|mesh-list
92291605|NCT01898689|Anesthetics, Local|anesthetics, local|mesh-ancestor
92291606|NCT01898689|Anesthetics|anesthetics|mesh-ancestor
92291607|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291608|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291609|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
92291610|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291612|NCT04021121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92291613|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291614|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92291615|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291616|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291617|NCT05062577|Buprenorphine|buprenorphine|mesh-list
92291618|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92291619|NCT05062577|ASP8062|asp8062|mesh-list
92291621|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92291622|NCT05062577|Narcotics|narcotics|mesh-ancestor
92291623|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291624|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944399|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291625|NCT05062577|Analgesics|analgesics|mesh-ancestor
92291626|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
92291627|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291628|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92291629|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
92291630|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
92291631|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291632|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291633|NCT05448989|Atropine|atropine|mesh-list
92291634|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92291635|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92291636|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92291637|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
92291638|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291639|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291640|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92291641|NCT05448989|Respiratory System Agents|respiratory system agents|mesh-ancestor
92291642|NCT05448989|Mydriatics|mydriatics|mesh-ancestor
92291643|NCT05448989|Parasympatholytics|parasympatholytics|mesh-ancestor
92291644|NCT05448989|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92291645|NCT05448989|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92291646|NCT05448989|Cholinergic Agents|cholinergic agents|mesh-ancestor
92291647|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291648|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291649|NCT00370565|Insulin|insulin|mesh-list
92291650|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92291651|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291652|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291653|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92291654|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92291655|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291656|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291657|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92291658|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92291659|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291660|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
92291661|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291662|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92291663|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
92291666|NCT00370019|Hormones|hormones|mesh-ancestor
92291667|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291668|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291669|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92291670|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
92291671|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92291672|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92291673|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92291674|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92291675|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92291676|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92291677|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92291678|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291679|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92291680|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92291681|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
92291682|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92291683|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92291684|NCT04969211|Iloperidone|iloperidone|mesh-list
92291685|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92291686|NCT04969211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92291687|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291688|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291689|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92291690|NCT01901575|Remifentanil|remifentanil|mesh-list
92291691|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92291692|NCT01901575|Narcotics|narcotics|mesh-ancestor
92291693|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291694|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291695|NCT01901575|Analgesics|analgesics|mesh-ancestor
92291696|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
92291697|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291698|NCT03754049|Dexamethasone|dexamethasone|mesh-list
92291699|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
92291700|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92291701|NCT03754049|BB 1101|bb 1101|mesh-list
92291702|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291703|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
92291704|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
92291705|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291706|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291707|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92291708|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
92291709|NCT03754049|Hormones|hormones|mesh-ancestor
92291710|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291711|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92291712|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291713|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92291714|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291715|NCT03754049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291716|NCT01901809|Dopamine|dopamine|mesh-list
92291717|NCT01901809|Furosemide|furosemide|mesh-list
92291718|NCT01901809|Diuretics|diuretics|mesh-ancestor
92291719|NCT01901809|Natriuretic Agents|natriuretic agents|mesh-ancestor
92291720|NCT01901809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291721|NCT01901809|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92291722|NCT01901809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92291723|NCT01901809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291724|NCT01901809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92291725|NCT01901809|Sympathomimetics|sympathomimetics|mesh-ancestor
92291726|NCT01901809|Autonomic Agents|autonomic agents|mesh-ancestor
92291727|NCT01901809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291728|NCT01901809|Dopamine Agents|dopamine agents|mesh-ancestor
92291729|NCT01901809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291730|NCT01901809|Protective Agents|protective agents|mesh-ancestor
92291731|NCT03029533|Leuprolide|leuprolide|mesh-list
92291732|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92291733|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
92291734|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92291735|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291736|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92291737|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291738|NCT04921007|Bupivacaine|bupivacaine|mesh-list
92291739|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
92291740|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
92291741|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291742|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291743|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
92291744|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291745|NCT01904071|Morphine|morphine|mesh-list
92291746|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92291747|NCT01904071|Narcotics|narcotics|mesh-ancestor
92291748|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291749|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291750|NCT01904071|Analgesics|analgesics|mesh-ancestor
92291751|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
91936047|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
92291752|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291754|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92291755|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291756|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291757|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291758|NCT00370643|Insulin|insulin|mesh-list
92291759|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92291760|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291761|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291762|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
92291763|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291764|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
92291765|NCT01908127|Keratolytic Agents|keratolytic agents|mesh-ancestor
92291766|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
92291767|NCT04679831|Praziquantel|praziquantel|mesh-list
92291768|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
92291769|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92291770|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291771|NCT01908751|Vitamin D|vitamin d|mesh-list
91944549|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92291772|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
92291773|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
92291774|NCT01908751|Vitamins|vitamins|mesh-list
92291775|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
92291776|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291777|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92291778|NCT01908751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92291779|NCT00370721|Bevacizumab|bevacizumab|mesh-list
92291780|NCT00370721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92291781|NCT00370721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291782|NCT00370721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92291783|NCT00370721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92291784|NCT00370721|Growth Substances|growth substances|mesh-ancestor
92291785|NCT00370721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291786|NCT00370721|Growth Inhibitors|growth inhibitors|mesh-ancestor
92291787|NCT01909141|Metformin|metformin|mesh-list
92291788|NCT01909141|Pioglitazone|pioglitazone|mesh-list
92291789|NCT01909141|Carbamide Peroxide|carbamide peroxide|mesh-list
92291790|NCT01909141|Letrozole|letrozole|mesh-list
92291791|NCT01909141|Clomiphene|clomiphene|mesh-list
92291792|NCT01909141|Enclomiphene|enclomiphene|mesh-list
92291793|NCT01909141|Zuclomiphene|zuclomiphene|mesh-list
92291794|NCT01909141|Hormones|hormones|mesh-list
92291795|NCT01909141|Estradiol|estradiol|mesh-list
92291796|NCT01909141|Testosterone|testosterone|mesh-list
92291797|NCT01909141|Progesterone|progesterone|mesh-list
92291798|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92291799|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92291800|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291801|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291802|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291803|NCT01909141|Estrogens|estrogens|mesh-ancestor
92291804|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92291805|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291806|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92291807|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92291808|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291809|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92291810|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
92291811|NCT01909141|Androgens|androgens|mesh-ancestor
92291812|NCT01909141|Progestins|progestins|mesh-ancestor
92291813|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92291814|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291815|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92291816|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
92291817|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92291818|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92291819|NCT04486859|Rivaroxaban|rivaroxaban|mesh-list
92291820|NCT04486859|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92291821|NCT04486859|Antithrombins|antithrombins|mesh-ancestor
92291822|NCT04486859|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92291823|NCT04486859|Protease Inhibitors|protease inhibitors|mesh-ancestor
92291824|NCT04486859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291825|NCT04486859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291826|NCT04486859|Anticoagulants|anticoagulants|mesh-ancestor
92291827|NCT01910311|Rifampin|rifampin|mesh-list
92291828|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92291829|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
92291830|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92291831|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291832|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
92291833|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92291834|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291835|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291836|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92291837|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92291838|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92291839|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92291840|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92291841|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92291842|NCT04404959|Ropivacaine|ropivacaine|mesh-list
92291843|NCT04404959|Anesthetics|anesthetics|mesh-list
92291844|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
92291845|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291846|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291847|NCT04404959|Sensory System Agents|sensory system agents|mesh-ancestor
92291848|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291849|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
91944630|NCT03951025|Melatonin|melatonin|mesh-list
92291851|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
92291852|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92291853|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291854|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291855|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291856|NCT04403711|Analgesics|analgesics|mesh-ancestor
92291857|NCT04403711|Sensory System Agents|sensory system agents|mesh-ancestor
92291858|NCT04403711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346153|NCT01894152|Immunologic Factors|immunologic factors|mesh-ancestor
92291859|NCT04403711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92291860|NCT04403711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92291861|NCT04403711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92291862|NCT04403711|Adrenergic Agents|adrenergic agents|mesh-ancestor
92291863|NCT04403711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291864|NCT04403711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291866|NCT01911169|Cholecalciferol|cholecalciferol|mesh-list
92291867|NCT01911169|Vitamins|vitamins|mesh-list
92291868|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
92291869|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291870|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92291871|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92291872|NCT04403087|Trimebutine|trimebutine|mesh-list
92291873|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92291874|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
92291875|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
92291876|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291877|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291878|NCT04358393|Azacitidine|azacitidine|mesh-list
92291879|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92291880|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
92291881|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291882|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291883|NCT04358393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291884|NCT04748887|Superoxide Dismutase|superoxide dismutase|mesh-list
92291885|NCT04748887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92291886|NCT04748887|Antioxidants|antioxidants|mesh-ancestor
92291887|NCT04748887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291888|NCT04748887|Protective Agents|protective agents|mesh-ancestor
92291889|NCT04748887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291890|NCT01916629|Sunscreening Agents|sunscreening agents|mesh-list
92291891|NCT01916629|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92291892|NCT01916629|Protective Agents|protective agents|mesh-ancestor
92291893|NCT01916629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291894|NCT01916629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92291895|NCT01916941|Prazosin|prazosin|mesh-list
92291896|NCT01916941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92291897|NCT01916941|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92291898|NCT01916941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92291899|NCT01916941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92291900|NCT01916941|Adrenergic Agents|adrenergic agents|mesh-ancestor
92291901|NCT01916941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291902|NCT01916941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291903|NCT01916941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291904|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
92291905|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291906|NCT04210037|Paclitaxel|paclitaxel|mesh-list
92291907|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92291908|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291909|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92291910|NCT04210037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92291911|NCT04210037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92291912|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291913|NCT00371501|Aspirin|aspirin|mesh-list
92291914|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92291915|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92291916|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291917|NCT00371501|Analgesics|analgesics|mesh-ancestor
92291918|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
92291919|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291920|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291921|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291922|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92291923|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92291924|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92291925|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291926|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92291927|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92291928|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92291929|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
92291930|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92291931|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92291932|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
92291933|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92291934|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92291935|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
92291937|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92291938|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291939|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291940|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92291941|NCT03251651|Analgesics|analgesics|mesh-ancestor
92291942|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
92291943|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291944|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92291945|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92291946|NCT03251651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92291947|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92291948|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92291949|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92291950|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92291951|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
92291952|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
92291953|NCT05738707|Vaccines|vaccines|mesh-list
92291954|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
92291955|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291956|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92291957|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92291958|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
92291959|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92291960|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92291961|NCT05349071|Prednisolone|prednisolone|mesh-list
92291962|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
92291963|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92291964|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
92291965|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92291966|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
92291967|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
92291968|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92291969|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291971|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
92291972|NCT05349071|Hormones|hormones|mesh-ancestor
92291973|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92291974|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92291975|NCT05349071|Protective Agents|protective agents|mesh-ancestor
92291976|NCT05349071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92291977|NCT05349071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291978|NCT01929889|Iloperidone|iloperidone|mesh-list
92291979|NCT01929889|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92291980|NCT01929889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92291981|NCT01929889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291982|NCT01929889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291983|NCT01929889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92291984|NCT05738473|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92291985|NCT05738473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92291986|NCT05725135|Propofol|propofol|mesh-list
92291987|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92291988|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92291989|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92291990|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92291991|NCT05725135|Anesthetics, General|anesthetics, general|mesh-ancestor
92291992|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
92291993|NCT05738317|Paclitaxel|paclitaxel|mesh-list
92291994|NCT05738317|Bevacizumab|bevacizumab|mesh-list
92291995|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92291996|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92291997|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
92291998|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944775|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92291999|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
92292000|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292001|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292002|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92292003|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92292004|NCT05738317|Growth Substances|growth substances|mesh-ancestor
92292005|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292006|NCT05738317|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292008|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292009|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292010|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92292011|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292012|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292013|NCT03029689|Raltegravir Potassium|raltegravir potassium|mesh-list
92292014|NCT03029689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92292015|NCT03029689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92292016|NCT03029689|Antiviral Agents|antiviral agents|mesh-ancestor
92292017|NCT03029689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292018|NCT03029689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92292019|NCT03029689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92292020|NCT03029689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292021|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292022|NCT02287909|Clopidogrel|clopidogrel|mesh-list
92292024|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92292025|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92292026|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92292027|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92292028|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
92292029|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292030|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292031|NCT02287909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292032|NCT04335383|Antibodies|antibodies|mesh-list
92292033|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
92292034|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292035|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92292036|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92292037|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92292038|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
92292039|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292040|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92292041|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92292042|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292043|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
92292044|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
92292045|NCT02833805|Fludarabine|fludarabine|mesh-list
92292046|NCT02833805|Tacrolimus|tacrolimus|mesh-list
92292047|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
92292048|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92292049|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292050|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
92292051|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292052|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292053|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92292054|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
92292055|NCT02833805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292056|NCT02833805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292057|NCT02833805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92292058|NCT02833805|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92292059|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292060|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92292061|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92292063|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292064|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292065|NCT02327195|Methylphenidate|methylphenidate|mesh-list
92292066|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92292067|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292068|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92292069|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92292070|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944850|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
92292071|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292072|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
92292073|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292074|NCT04768465|Prednisone|prednisone|mesh-list
92292075|NCT04768465|Bromides|bromides|mesh-list
92292076|NCT04768465|Tacrolimus|tacrolimus|mesh-list
92292077|NCT04768465|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92292078|NCT04768465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292079|NCT04768465|Glucocorticoids|glucocorticoids|mesh-ancestor
92292080|NCT04768465|Hormones|hormones|mesh-ancestor
92292081|NCT04768465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292082|NCT04768465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292083|NCT04768465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92292084|NCT04768465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292085|NCT04768465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292086|NCT04768465|Immunologic Factors|immunologic factors|mesh-ancestor
92292087|NCT04768465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92292088|NCT04768465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292089|NCT04768465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292090|NCT04768465|Anticonvulsants|anticonvulsants|mesh-ancestor
92292091|NCT04768465|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92292092|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
92292093|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292094|NCT01614665|Tacrolimus|tacrolimus|mesh-list
92292095|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292096|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
92292097|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292098|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92292099|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292100|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292101|NCT05691829|Pembrolizumab|pembrolizumab|mesh-list
92292102|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292103|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292104|NCT05691829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92292105|NCT05691829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292106|NCT00371735|Artesunate|artesunate|mesh-list
92292107|NCT00371735|Dapsone|dapsone|mesh-list
92292108|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
92292109|NCT00371735|Proguanil|proguanil|mesh-list
92292110|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
92292111|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92292112|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92292113|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292114|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292115|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
92292117|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92292118|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
92292119|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92292120|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292121|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292122|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
92292123|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292124|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
92292125|NCT05052307|Vaccines|vaccines|mesh-list
92292126|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
92292127|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292128|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92292129|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92292130|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292131|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292132|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292133|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292134|NCT05417659|Niacin|niacin|mesh-list
92292135|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92292136|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
92292137|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292138|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92292139|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
92292140|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
92292141|NCT05417659|Vitamins|vitamins|mesh-ancestor
92292142|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
92292143|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292144|NCT02762513|Axitinib|axitinib|mesh-list
92292145|NCT02762513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292146|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292147|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292148|NCT02762513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292149|NCT02958761|Hyaluronic Acid|hyaluronic acid|mesh-list
92292150|NCT02958761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92292151|NCT02958761|Immunologic Factors|immunologic factors|mesh-ancestor
92292152|NCT02958761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292153|NCT02958761|Viscosupplements|viscosupplements|mesh-ancestor
92292154|NCT02958761|Protective Agents|protective agents|mesh-ancestor
92292155|NCT05215535|Liver Extracts|liver extracts|mesh-list
92292156|NCT05215535|Hematinics|hematinics|mesh-ancestor
92292157|NCT02767271|Luliconazole|luliconazole|mesh-list
92292158|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
92292159|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292160|NCT05647993|Azithromycin|azithromycin|mesh-list
92292161|NCT05647993|Cefazolin|cefazolin|mesh-list
92292162|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292163|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292164|NCT02741687|Insulin|insulin|mesh-list
92292165|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92292166|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
92292167|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92292168|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
92292169|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
92292170|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
92292171|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92292172|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292173|NCT02741687|Incretins|incretins|mesh-ancestor
92292174|NCT02741687|Hormones|hormones|mesh-ancestor
92292175|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292176|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92292177|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
92292178|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292179|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292180|NCT05361499|Amoxicillin|amoxicillin|mesh-list
92292181|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292182|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292184|NCT04337099|TEMPO|tempo|mesh-list
92292185|NCT04337099|TEMPOL-H|tempol-h|mesh-list
92292186|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
92292187|NCT04337099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292188|NCT04337099|Protective Agents|protective agents|mesh-ancestor
92292189|NCT04337099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292190|NCT04337099|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92292191|NCT04337099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292192|NCT04337099|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92292193|NCT04337099|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92292194|NCT05630677|Rabeprazole|rabeprazole|mesh-list
92292195|NCT05630677|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92292196|NCT05630677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92292197|NCT05630677|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92292198|NCT05630677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292199|NCT05630677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292200|NCT05627791|Oxytocin|oxytocin|mesh-list
92292201|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
92292202|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92292203|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292204|NCT02771093|Alogliptin|alogliptin|mesh-list
92292205|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92292206|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292207|NCT02771093|Incretins|incretins|mesh-ancestor
92292208|NCT02771093|Hormones|hormones|mesh-ancestor
92292209|NCT02771093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292210|NCT02771093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92292211|NCT02771093|Protease Inhibitors|protease inhibitors|mesh-ancestor
92292212|NCT02771093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292213|NCT02771093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292214|NCT05306587|Daratumumab|daratumumab|mesh-list
92292215|NCT05306587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292216|NCT04337879|Oxaliplatin|oxaliplatin|mesh-list
92292217|NCT04337879|Irinotecan|irinotecan|mesh-list
92292218|NCT04337879|Calcium|calcium|mesh-list
92292219|NCT04337879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92292220|NCT04337879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292221|NCT04337879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292222|NCT04337879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92292223|NCT04337879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92292224|NCT04337879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292225|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292226|NCT02745353|Naloxegol|naloxegol|mesh-list
92292227|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92292228|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292229|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
92292230|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292231|NCT04778839|Paclitaxel|paclitaxel|mesh-list
92292232|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92292233|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92292234|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292235|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
92292236|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
92292237|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
92292238|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292240|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292241|NCT05602207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292242|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292243|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
92292244|NCT05598619|Vitamins|vitamins|mesh-ancestor
92292245|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
92292246|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292247|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
92292248|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292249|NCT05598619|Protective Agents|protective agents|mesh-ancestor
92292250|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92292251|NCT02746991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292252|NCT02746991|Glucocorticoids|glucocorticoids|mesh-ancestor
92292253|NCT02746991|Hormones|hormones|mesh-ancestor
92292254|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292255|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292256|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
92292257|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92292258|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92292259|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292260|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
92292261|NCT02747615|Coagulants|coagulants|mesh-ancestor
92292262|NCT02775617|Azithromycin|azithromycin|mesh-list
92292263|NCT02775617|Ivermectin|ivermectin|mesh-list
92292264|NCT02775617|Permethrin|permethrin|mesh-list
92292265|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292266|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292267|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92292268|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292269|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292270|NCT00371813|Varenicline|varenicline|mesh-list
92292271|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92292272|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92292273|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
92292274|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292275|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292276|NCT00371813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292278|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92292279|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
92292280|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92292281|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292282|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92292283|NCT02748785|Antimetabolites|antimetabolites|mesh-ancestor
92292284|NCT02748785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292285|NCT02748785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292286|NCT02748785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92292287|NCT02748785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292288|NCT02748785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92292289|NCT02748785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292290|NCT02748785|Immunologic Factors|immunologic factors|mesh-ancestor
92292291|NCT02748785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292292|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92292293|NCT02295553|Ketamine|ketamine|mesh-list
92292294|NCT02295553|Propofol|propofol|mesh-list
92292295|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92292296|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292297|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292298|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92292299|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
92292300|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
92292301|NCT02295553|Analgesics|analgesics|mesh-ancestor
92292302|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
92292303|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292304|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92292305|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92292306|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92292307|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292308|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292309|NCT02296099|Bupivacaine|bupivacaine|mesh-list
92292310|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
92292311|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
92292312|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292313|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292314|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
92292315|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292316|NCT05455073|Folic Acid|folic acid|mesh-list
92292317|NCT05455073|Hematinics|hematinics|mesh-ancestor
92292318|NCT05455073|Vitamin B Complex|vitamin b complex|mesh-ancestor
92292319|NCT05455073|Vitamins|vitamins|mesh-ancestor
92292320|NCT05455073|Micronutrients|micronutrients|mesh-ancestor
92292321|NCT05455073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292322|NCT04334993|Blinatumomab|blinatumomab|mesh-list
92292323|NCT04334993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292324|NCT05349929|Ibuprofen|ibuprofen|mesh-list
92292325|NCT05349929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92292326|NCT05349929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292327|NCT05349929|Analgesics|analgesics|mesh-ancestor
92292328|NCT05349929|Sensory System Agents|sensory system agents|mesh-ancestor
92292329|NCT05349929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292330|NCT05349929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292331|NCT05349929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292332|NCT05349929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292333|NCT05349929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92292334|NCT05349929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292335|NCT05349929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292336|NCT04692103|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92292337|NCT04692103|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92292338|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292339|NCT04669171|Rituximab|rituximab|mesh-list
92292340|NCT04669171|Lenalidomide|lenalidomide|mesh-list
92292341|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292342|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292343|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
92292344|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292345|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292346|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92292347|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92292348|NCT04669171|Growth Substances|growth substances|mesh-ancestor
92292349|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292350|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
92292351|NCT04757675|Ketamine|ketamine|mesh-list
92292352|NCT04757675|Esketamine|esketamine|mesh-list
92292353|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92292354|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292355|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292356|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292357|NCT04757675|Analgesics|analgesics|mesh-ancestor
92292358|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
92292359|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292360|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92292361|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92292362|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92292363|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292364|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292365|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292366|NCT04757675|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92292367|NCT04757675|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92292368|NCT04757675|Anesthetics, General|anesthetics, general|mesh-ancestor
92292369|NCT04757675|Anesthetics|anesthetics|mesh-ancestor
92292370|NCT04757675|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92292371|NCT04757675|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92292372|NCT04757675|Antidepressive Agents|antidepressive agents|mesh-ancestor
92292373|NCT04757675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92292374|NCT04611529|Ibuprofen|ibuprofen|mesh-list
92292375|NCT04611529|Diclofenac|diclofenac|mesh-list
92292376|NCT04611529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92292377|NCT04611529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292378|NCT04611529|Analgesics|analgesics|mesh-ancestor
92292379|NCT04611529|Sensory System Agents|sensory system agents|mesh-ancestor
92292380|NCT04611529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292381|NCT04611529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292382|NCT04611529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292383|NCT04611529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292384|NCT04611529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92292385|NCT04611529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292386|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292387|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
92292388|NCT05323721|Piperaquine|piperaquine|mesh-list
92292389|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
92292390|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92292391|NCT05323721|Amodiaquine|amodiaquine|mesh-list
92292392|NCT05323721|Artenimol|artenimol|mesh-list
92292393|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
92292394|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92292395|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92292396|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292397|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92292398|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292399|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292400|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92292401|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
92292402|NCT05288075|Charcoal|charcoal|mesh-list
92292403|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92292404|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92292405|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92292406|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
92292407|NCT05288075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292408|NCT05288075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292409|NCT05288075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292410|NCT05288075|Antidotes|antidotes|mesh-ancestor
92292411|NCT05288075|Protective Agents|protective agents|mesh-ancestor
92292412|NCT05272787|Sunscreening Agents|sunscreening agents|mesh-list
92292413|NCT05272787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92292414|NCT05272787|Protective Agents|protective agents|mesh-ancestor
92292415|NCT05272787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292416|NCT05272787|Dermatologic Agents|dermatologic agents|mesh-ancestor
92292417|NCT05145569|Paclitaxel|paclitaxel|mesh-list
92292418|NCT05145569|Carboplatin|carboplatin|mesh-list
92292419|NCT05145569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92292420|NCT05145569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292421|NCT05145569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92292422|NCT05145569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92292423|NCT05145569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92292424|NCT05145569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292425|NCT04566991|Deferoxamine|deferoxamine|mesh-list
92292426|NCT04566991|Siderophores|siderophores|mesh-ancestor
92292427|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92292428|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
92292429|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
92292430|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292431|NCT04645823|Lidocaine|lidocaine|mesh-list
92292432|NCT04645823|Fentanyl|fentanyl|mesh-list
92292433|NCT04645823|Citric Acid|citric acid|mesh-list
92292434|NCT04645823|Sodium Citrate|sodium citrate|mesh-list
92292435|NCT04645823|Anesthetics, Local|anesthetics, local|mesh-ancestor
92292436|NCT04645823|Anesthetics|anesthetics|mesh-ancestor
92292437|NCT04645823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292438|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292439|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
92292440|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292441|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92292442|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92292443|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92292444|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92292445|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292446|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92292447|NCT04645823|Narcotics|narcotics|mesh-ancestor
92292448|NCT04645823|Analgesics|analgesics|mesh-ancestor
92292449|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92292450|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92292451|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
92292452|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
92292453|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92292454|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
92292455|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
92292457|NCT03763175|L 647318|l 647318|mesh-list
92292458|NCT03763175|Dihydromevinolin|dihydromevinolin|mesh-list
92292459|NCT03763175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92292460|NCT03763175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92292461|NCT03763175|Antimetabolites|antimetabolites|mesh-ancestor
92292462|NCT03763175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292463|NCT03763175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92292464|NCT03763175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92292465|NCT03763175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292466|NCT04365049|Paclitaxel|paclitaxel|mesh-list
92292467|NCT04365049|Gemcitabine|gemcitabine|mesh-list
92292468|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92292469|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292470|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92292471|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92292472|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92292473|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292474|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92292475|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
92292476|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
92292477|NCT04606901|Neostigmine|neostigmine|mesh-list
92292478|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92292479|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292480|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292481|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92292482|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292483|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292484|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92292485|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
92292486|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292487|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92292488|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92292489|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92292490|NCT03092011|Clonidine|clonidine|mesh-list
92292491|NCT03092011|Morphine|morphine|mesh-list
92292492|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92292493|NCT03092011|Narcotics|narcotics|mesh-ancestor
92292494|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292495|NCT03092011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292496|NCT03092011|Analgesics|analgesics|mesh-ancestor
92292497|NCT03092011|Sensory System Agents|sensory system agents|mesh-ancestor
92292498|NCT03092011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292499|NCT03092011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92292500|NCT03092011|Sympatholytics|sympatholytics|mesh-ancestor
92292501|NCT03092011|Autonomic Agents|autonomic agents|mesh-ancestor
92292502|NCT03092011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92292503|NCT03092011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92292504|NCT03092011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92292505|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292506|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292507|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292508|NCT00372515|Gefitinib|gefitinib|mesh-list
92292509|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292510|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292511|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292512|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292513|NCT04448119|Favipiravir|favipiravir|mesh-list
92292514|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
92292515|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292516|NCT03047473|Avelumab|avelumab|mesh-list
92292517|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292518|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292519|NCT03069131|Rifaximin|rifaximin|mesh-list
92292520|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292521|NCT03069131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292522|NCT03069131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92292523|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
92292525|NCT02990845|Exemestane|exemestane|mesh-list
92292526|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292527|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292528|NCT02990845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92292529|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292530|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92292531|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
92292532|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92292533|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292534|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92292535|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92292536|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92292537|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292538|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92292539|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
92292540|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292541|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
92292542|NCT04438213|Metolazone|metolazone|mesh-list
92292543|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92292544|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292545|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92292546|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292547|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92292548|NCT04438213|Diuretics|diuretics|mesh-ancestor
92292549|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
92292550|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92292551|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92292552|NCT01987219|Bromides|bromides|mesh-list
92292553|NCT01987219|Albuterol|albuterol|mesh-list
92292554|NCT01987219|Ipratropium|ipratropium|mesh-list
92292555|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
92292556|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92292557|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
92292558|NCT01987219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292559|NCT01987219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292560|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92292561|NCT01987219|Respiratory System Agents|respiratory system agents|mesh-ancestor
92292562|NCT01987219|Tocolytic Agents|tocolytic agents|mesh-ancestor
92292563|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92292564|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92292565|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92292566|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92292567|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292568|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292569|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292570|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92292571|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
92292573|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292574|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292575|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292576|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292577|NCT04405349|Atezolizumab|atezolizumab|mesh-list
92292578|NCT04405349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92292579|NCT04405349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292580|NCT04405349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292581|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292582|NCT04265053|Ketorolac|ketorolac|mesh-list
92292583|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92292584|NCT04265053|Estradiol|estradiol|mesh-list
92292585|NCT04265053|Testosterone|testosterone|mesh-list
92292586|NCT04265053|Ganirelix|ganirelix|mesh-list
92292587|NCT04265053|Estrogens|estrogens|mesh-ancestor
92292588|NCT04265053|Hormones|hormones|mesh-ancestor
92292589|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292590|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292591|NCT04265053|Androgens|androgens|mesh-ancestor
92292593|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292594|NCT04265053|Analgesics|analgesics|mesh-ancestor
92292595|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
92292596|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292597|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292598|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292599|NCT04265053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92292600|NCT04265053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292601|NCT04265053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292602|NCT04265053|Hormone Antagonists|hormone antagonists|mesh-ancestor
92292603|NCT04332497|Ibuprofen|ibuprofen|mesh-list
92292604|NCT04332497|Fentanyl|fentanyl|mesh-list
92292605|NCT04332497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91936072|NCT02447419|Gefitinib|gefitinib|mesh-list
92292607|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292608|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292609|NCT04332497|Analgesics|analgesics|mesh-ancestor
92292610|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
92292611|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292612|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92292613|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92292614|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
92292615|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
92292616|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92292617|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292618|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292619|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292620|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92292621|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292622|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292623|NCT02633137|Cytarabine|cytarabine|mesh-list
92292624|NCT02633137|Lenalidomide|lenalidomide|mesh-list
92292625|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92292626|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
92292627|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292628|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292629|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
92292630|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292631|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292632|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
92292633|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292634|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92292635|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92292636|NCT02633137|Growth Substances|growth substances|mesh-ancestor
92292637|NCT02633137|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292638|NCT04258397|Pirfenidone|pirfenidone|mesh-list
92292639|NCT04258397|Analgesics|analgesics|mesh-ancestor
92292640|NCT04258397|Sensory System Agents|sensory system agents|mesh-ancestor
92292641|NCT04258397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292642|NCT04258397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292643|NCT04258397|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92292644|NCT04258397|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292645|NCT04258397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292646|NCT04258397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409805|NCT05609578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292647|NCT04258397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292648|NCT04707209|Sirolimus|sirolimus|mesh-list
92292649|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292650|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292651|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92292652|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292653|NCT04707209|Antifungal Agents|antifungal agents|mesh-ancestor
92292654|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292655|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
92292656|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292657|NCT01989793|Losartan|losartan|mesh-list
92292658|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92292659|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92292660|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92292661|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92292662|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292663|NCT01992523|Ticagrelor|ticagrelor|mesh-list
92292664|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92292665|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92292666|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92292668|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
92292669|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292670|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292671|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292672|NCT04186247|Azithromycin|azithromycin|mesh-list
92292673|NCT04186247|Metronidazole|metronidazole|mesh-list
92292674|NCT04186247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292675|NCT04186247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292676|NCT04186247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92292677|NCT04186247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92292678|NCT04181255|Poractant alfa|poractant alfa|mesh-list
92292679|NCT04181255|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92292680|NCT04181255|Respiratory System Agents|respiratory system agents|mesh-ancestor
92292681|NCT00373373|Sorafenib|sorafenib|mesh-list
92292682|NCT00373373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292683|NCT00373373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292684|NCT00373373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292685|NCT00373373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292686|NCT00373451|Heparin|heparin|mesh-list
92292687|NCT00373451|Calcium heparin|calcium heparin|mesh-list
92292688|NCT00373451|Bivalirudin|bivalirudin|mesh-list
92292689|NCT00373451|Abciximab|abciximab|mesh-list
92292690|NCT00373451|Anticoagulants|anticoagulants|mesh-ancestor
92292691|NCT00373451|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92292692|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92292693|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292694|NCT00373451|Antithrombins|antithrombins|mesh-ancestor
92292695|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92292696|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
92292697|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292698|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92292699|NCT01387763|Interferons|interferons|mesh-list
92292700|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
92292701|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
92292702|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92292703|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92292704|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
92292705|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292706|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
92292707|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292708|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
92409882|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92292709|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292710|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
92292711|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292712|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292713|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92292714|NCT00373061|Omalizumab|omalizumab|mesh-list
92292715|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92292716|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92292717|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
92292718|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
92292719|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
92292720|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292721|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
92292722|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292723|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
92292724|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92292725|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
92292726|NCT01993849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292727|NCT01993849|Expectorants|expectorants|mesh-ancestor
92292728|NCT01993849|Respiratory System Agents|respiratory system agents|mesh-ancestor
92292729|NCT01993849|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92292730|NCT01993849|Antioxidants|antioxidants|mesh-ancestor
92292731|NCT01993849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292732|NCT01993849|Protective Agents|protective agents|mesh-ancestor
92292733|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292734|NCT01993849|Antidotes|antidotes|mesh-ancestor
92292735|NCT02778113|Glucagon|glucagon|mesh-list
92292736|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92292737|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92292738|NCT02778113|Hormones|hormones|mesh-ancestor
92292739|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292740|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292741|NCT02778113|Incretins|incretins|mesh-ancestor
92292742|NCT04982237|Paclitaxel|paclitaxel|mesh-list
92292743|NCT04982237|Bevacizumab|bevacizumab|mesh-list
92292744|NCT04982237|Carboplatin|carboplatin|mesh-list
92292745|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92292746|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292747|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92292748|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92292749|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92292750|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292751|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292752|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91936105|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92292753|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92292754|NCT04982237|Growth Substances|growth substances|mesh-ancestor
92292755|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292756|NCT04982237|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292757|NCT01996657|Warfarin|warfarin|mesh-list
92292758|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
92292759|NCT02316379|Xenon|xenon|mesh-list
92292760|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92292761|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
92292762|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
92292763|NCT02316379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292764|NCT02316379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292765|NCT02303977|Gemcitabine|gemcitabine|mesh-list
92292766|NCT02303977|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92292767|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92292768|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
92292769|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292770|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292771|NCT01997515|Ketamine|ketamine|mesh-list
92292772|NCT01997515|Analgesics|analgesics|mesh-ancestor
92292773|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
92292774|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292775|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292776|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92292777|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92292778|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
92292779|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
92292780|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292781|NCT01997515|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92292782|NCT01997515|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92292783|NCT01997515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292784|NCT01997515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292785|NCT04333823|Dapagliflozin|dapagliflozin|mesh-list
92292786|NCT04333823|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92292787|NCT04333823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292788|NCT04333823|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92292789|NCT04333823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292790|NCT01997905|Protein S|protein s|mesh-list
92292791|NCT01997905|Anticoagulants|anticoagulants|mesh-ancestor
92292792|NCT02788019|Ropivacaine|ropivacaine|mesh-list
92292793|NCT02788019|Anesthetics, Local|anesthetics, local|mesh-ancestor
92292794|NCT02788019|Anesthetics|anesthetics|mesh-ancestor
92292795|NCT02788019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292796|NCT02788019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292797|NCT02788019|Sensory System Agents|sensory system agents|mesh-ancestor
92292798|NCT02788019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292799|NCT02788097|Progesterone|progesterone|mesh-list
92292800|NCT02788097|Progestins|progestins|mesh-ancestor
92292801|NCT02788097|Hormones|hormones|mesh-ancestor
92292802|NCT02788097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92292803|NCT02788097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292804|NCT02789033|Isosorbide|isosorbide|mesh-list
92292805|NCT02789033|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92292806|NCT02789033|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92292808|NCT02789033|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92292809|NCT02789033|Diuretics|diuretics|mesh-ancestor
92292810|NCT02789033|Natriuretic Agents|natriuretic agents|mesh-ancestor
92292811|NCT02789033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292812|NCT02789033|Vasodilator Agents|vasodilator agents|mesh-ancestor
92292813|NCT02789033|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92292814|NCT02789033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292815|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92292816|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92292817|NCT02789033|Antimetabolites|antimetabolites|mesh-ancestor
92292818|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92292819|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
92292820|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
92292821|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
92292822|NCT02789033|Coagulants|coagulants|mesh-ancestor
92292823|NCT00372827|Travoprost|travoprost|mesh-list
92292824|NCT00372827|Brinzolamide|brinzolamide|mesh-list
92292825|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92292826|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92292827|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292828|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292829|NCT02278315|Dexamethasone|dexamethasone|mesh-list
92292830|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292831|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
92292832|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
92292833|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292834|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292835|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92292836|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
92292837|NCT02278315|Hormones|hormones|mesh-ancestor
92292838|NCT02278315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410038|NCT05519085|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292839|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92292840|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292841|NCT02795117|Ivermectin|ivermectin|mesh-list
92292842|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92292843|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292844|NCT02882633|Bupivacaine|bupivacaine|mesh-list
92292845|NCT02882633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92292846|NCT02882633|Anesthetics|anesthetics|mesh-ancestor
92292847|NCT02882633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292848|NCT02882633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292849|NCT02882633|Sensory System Agents|sensory system agents|mesh-ancestor
92346220|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
92292850|NCT02882633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292851|NCT00373607|Artesunate|artesunate|mesh-list
92292852|NCT00373607|Piperaquine|piperaquine|mesh-list
92292853|NCT00373607|Mefloquine|mefloquine|mesh-list
92292854|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
92292855|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92292856|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92292857|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292858|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292859|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
92292860|NCT00373607|Schistosomicides|schistosomicides|mesh-ancestor
92292861|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92292862|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
92292863|NCT02882711|Ketamine|ketamine|mesh-list
92292864|NCT02882711|Analgesics|analgesics|mesh-ancestor
92292865|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
92292866|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292867|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292868|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92292869|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92292870|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
92292871|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
92292872|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292873|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92292874|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92292875|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292876|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292877|NCT02794337|Sorafenib|sorafenib|mesh-list
92292878|NCT02794337|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92292879|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292880|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92292881|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292882|NCT02794337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292883|NCT02590523|Moxifloxacin|moxifloxacin|mesh-list
92292884|NCT02590523|Vancomycin|vancomycin|mesh-list
92292885|NCT02590523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292886|NCT02590523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292887|NCT02590523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92292888|NCT02590523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92292889|NCT02590523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292890|NCT02590523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292891|NCT02590523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292892|NCT02895035|Ketorolac|ketorolac|mesh-list
92292893|NCT02895035|Phenylephrine|phenylephrine|mesh-list
92292894|NCT02895035|Epinephrine|epinephrine|mesh-list
92292895|NCT02895035|Oxymetazoline|oxymetazoline|mesh-list
92292896|NCT02895035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92292897|NCT02895035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92292898|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292899|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292900|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292901|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292902|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92292903|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92292904|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
92292905|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292906|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92292907|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
92292908|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
92292909|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
92292910|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92292911|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92292912|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292913|NCT02895035|Analgesics|analgesics|mesh-ancestor
92292914|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
92292915|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92292916|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292917|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92292918|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92292919|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92292920|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
92292921|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92292922|NCT02895035|Protective Agents|protective agents|mesh-ancestor
92292923|NCT02802449|Vitamin D|vitamin d|mesh-list
92292924|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
92292925|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
92292926|NCT02802449|Calcifediol|calcifediol|mesh-list
92292927|NCT02802449|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92292928|NCT02802449|Vitamins|vitamins|mesh-list
92292929|NCT02802449|Micronutrients|micronutrients|mesh-ancestor
92292930|NCT02802449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292931|NCT02802449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92292932|NCT02802449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92292933|NCT02803229|Amphetamine|amphetamine|mesh-list
92292934|NCT02803229|Adderall|adderall|mesh-list
92292935|NCT02803229|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92292936|NCT02803229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292937|NCT02803229|Sympathomimetics|sympathomimetics|mesh-ancestor
92292938|NCT02803229|Autonomic Agents|autonomic agents|mesh-ancestor
92292939|NCT02803229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292940|NCT02803229|Dopamine Agents|dopamine agents|mesh-ancestor
92292941|NCT02803229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292942|NCT02803229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292943|NCT02803229|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292944|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92292945|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92292946|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92292947|NCT02803229|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92292948|NCT01938001|Rituximab|rituximab|mesh-list
92292949|NCT01938001|Lenalidomide|lenalidomide|mesh-list
92292950|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292951|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292952|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
92292953|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292954|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92292955|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92292956|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92292957|NCT01938001|Growth Substances|growth substances|mesh-ancestor
92292958|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292959|NCT02805179|Temozolomide|temozolomide|mesh-list
92292960|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92292961|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
92292962|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292963|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292964|NCT02896595|Anesthetics|anesthetics|mesh-list
92292965|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292966|NCT02896595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292967|NCT02003911|Azithromycin|azithromycin|mesh-list
92292968|NCT02003911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92292969|NCT02003911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92292970|NCT04147351|Bevacizumab|bevacizumab|mesh-list
92292971|NCT04147351|Atezolizumab|atezolizumab|mesh-list
92292972|NCT04147351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92292973|NCT04147351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92292974|NCT04147351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92292975|NCT04147351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92292976|NCT04147351|Growth Substances|growth substances|mesh-ancestor
92292977|NCT04147351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292978|NCT04147351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92292979|NCT04147351|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92292980|NCT04147351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292981|NCT02004613|Dexmedetomidine|dexmedetomidine|mesh-list
92292982|NCT02004613|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92292983|NCT02004613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92292984|NCT02004613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92292985|NCT02004613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92292986|NCT02004613|Analgesics|analgesics|mesh-ancestor
92292987|NCT02004613|Sensory System Agents|sensory system agents|mesh-ancestor
92292988|NCT02004613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92292989|NCT02004613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92292990|NCT02004613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92292991|NCT02004613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92292992|NCT02004613|Adrenergic Agents|adrenergic agents|mesh-ancestor
92292993|NCT02004613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92292994|NCT02004613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92292995|NCT01754779|Potassium Citrate|potassium citrate|mesh-list
92292996|NCT01754779|Citric Acid|citric acid|mesh-list
92292997|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
92292998|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
92292999|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92293000|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
92293001|NCT01754779|Sequestering Agents|sequestering agents|mesh-ancestor
92293002|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293003|NCT01754779|Diuretics|diuretics|mesh-ancestor
92293004|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
92293005|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293006|NCT01754779|Expectorants|expectorants|mesh-ancestor
92293007|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92293008|NCT02149277|Lenograstim|lenograstim|mesh-list
92293009|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92293010|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
92293011|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293012|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
92293013|NCT02896907|Vitamins|vitamins|mesh-list
92293014|NCT02896907|Leucovorin|leucovorin|mesh-list
92293015|NCT02896907|Ascorbic Acid|ascorbic acid|mesh-list
92293016|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92293017|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
92293018|NCT02896907|Fluorouracil|fluorouracil|mesh-list
92293019|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
92293020|NCT02896907|Irinotecan|irinotecan|mesh-list
92293021|NCT02896907|Camptothecin|camptothecin|mesh-list
92293022|NCT02896907|Calcium|calcium|mesh-list
92293023|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
92293024|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
92293025|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293026|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92293027|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92293028|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
92293029|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293030|NCT02896907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92293031|NCT02896907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293032|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92293033|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
92293034|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92293035|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92293036|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293037|NCT02896907|Antidotes|antidotes|mesh-ancestor
92293038|NCT02896907|Protective Agents|protective agents|mesh-ancestor
92293039|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
92293040|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
92293041|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92293042|NCT02005549|Bevacizumab|bevacizumab|mesh-list
92293043|NCT02005549|Docetaxel|docetaxel|mesh-list
92293044|NCT02005549|Capecitabine|capecitabine|mesh-list
92293045|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92293046|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293047|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92293048|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92293049|NCT02005549|Growth Substances|growth substances|mesh-ancestor
92293050|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293051|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
92293052|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92293053|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92293054|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92293055|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293056|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92293057|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
92293058|NCT04349696|Mitiglinide|mitiglinide|mesh-list
92293059|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293060|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293061|NCT02810873|Copper|copper|mesh-list
91945838|NCT04418908|Cetrorelix|cetrorelix|mesh-list
92293062|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
92293063|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92293064|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92293065|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293066|NCT02810873|Trace Elements|trace elements|mesh-ancestor
92293068|NCT02810873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293069|NCT02810873|Antimetabolites|antimetabolites|mesh-ancestor
92293070|NCT02810873|Antiviral Agents|antiviral agents|mesh-ancestor
92293071|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293072|NCT04492358|Prednisone|prednisone|mesh-list
92293073|NCT04492358|Colchicine|colchicine|mesh-list
92293074|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293075|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
92293076|NCT04492358|Hormones|hormones|mesh-ancestor
92293077|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293078|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293079|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92293080|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293081|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
92293082|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293083|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92293084|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92293085|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92293086|NCT04492358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293087|NCT03488420|Edoxaban|edoxaban|mesh-list
92293088|NCT03488420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92293089|NCT03488420|Antithrombins|antithrombins|mesh-ancestor
92293090|NCT03488420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92293091|NCT03488420|Protease Inhibitors|protease inhibitors|mesh-ancestor
92293092|NCT03488420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293093|NCT03488420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293094|NCT03488420|Anticoagulants|anticoagulants|mesh-ancestor
92293095|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
92293096|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
92293097|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92293098|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92293099|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293100|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92293101|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293102|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293103|NCT01959685|Enclomiphene|enclomiphene|mesh-list
92293104|NCT01959685|Clomiphene|clomiphene|mesh-list
92293105|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
92293106|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92293107|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
92293108|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293109|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293110|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92293111|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
92293112|NCT01959685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92293113|NCT01959685|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92293114|NCT01959685|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92293115|NCT02901899|Pembrolizumab|pembrolizumab|mesh-list
92293116|NCT02901899|Guadecitabine|guadecitabine|mesh-list
92293117|NCT02901899|Azacitidine|azacitidine|mesh-list
92293118|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92293119|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293120|NCT02901899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92293121|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293122|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92293123|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
92293124|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293125|NCT04333589|Favipiravir|favipiravir|mesh-list
92293126|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
92293127|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293128|NCT02902913|Ibuprofen|ibuprofen|mesh-list
92293129|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92293130|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293131|NCT02902913|Analgesics|analgesics|mesh-ancestor
92293132|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
92293133|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293134|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293135|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293136|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293137|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92293138|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945918|NCT03178864|Heparin|heparin|mesh-list
92293139|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293140|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
92293141|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
92293142|NCT03417986|Autonomic Agents|autonomic agents|mesh-ancestor
92293143|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293144|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293145|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293146|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92293147|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
92293148|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293149|NCT03417986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293150|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
92293151|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
92293152|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92293153|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92293154|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293155|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293156|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293157|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293158|NCT02301416|Topiramate|topiramate|mesh-list
92293159|NCT02301416|Phentermine|phentermine|mesh-list
92293160|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
92293161|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293162|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293163|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92293164|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
92293165|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92293166|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
92293167|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
92293168|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293169|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
92293170|NCT02301416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293171|NCT02301416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293172|NCT02815709|Morphine|morphine|mesh-list
92293173|NCT02815709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92293174|NCT02815709|Narcotics|narcotics|mesh-ancestor
92293175|NCT02815709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293176|NCT02815709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293177|NCT02815709|Analgesics|analgesics|mesh-ancestor
92293178|NCT02815709|Sensory System Agents|sensory system agents|mesh-ancestor
92293179|NCT02815709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293180|NCT02912195|Lidocaine|lidocaine|mesh-list
92293181|NCT02912195|Morphine|morphine|mesh-list
92293182|NCT02912195|Anesthetics, Local|anesthetics, local|mesh-ancestor
92293183|NCT02912195|Anesthetics|anesthetics|mesh-ancestor
92293184|NCT02912195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293185|NCT02912195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293186|NCT02912195|Sensory System Agents|sensory system agents|mesh-ancestor
92293187|NCT02912195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293188|NCT02912195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92293189|NCT02912195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92293190|NCT02912195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92293191|NCT02912195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293192|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293193|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92293194|NCT02912195|Narcotics|narcotics|mesh-ancestor
92293195|NCT02912195|Analgesics|analgesics|mesh-ancestor
92293196|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
92293197|NCT01960075|Levetiracetam|levetiracetam|mesh-list
92293198|NCT01960075|Valproic Acid|valproic acid|mesh-list
92293199|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
92293200|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
92293201|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293202|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293203|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
92346250|NCT01868022|Paclitaxel|paclitaxel|mesh-list
92293204|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293205|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293206|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
92293207|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92293208|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293209|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92293210|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92293211|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293212|NCT01988246|Aflibercept|aflibercept|mesh-list
92293213|NCT01988246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92293214|NCT01988246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92293215|NCT01988246|Growth Substances|growth substances|mesh-ancestor
92293216|NCT01988246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293217|NCT01988246|Growth Inhibitors|growth inhibitors|mesh-ancestor
92293218|NCT01988246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293219|NCT01990898|Cyclosporine|cyclosporine|mesh-list
92293220|NCT01990898|Cyclosporins|cyclosporins|mesh-list
92293221|NCT01990898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293222|NCT01990898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293223|NCT01990898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92293224|NCT01990898|Immunologic Factors|immunologic factors|mesh-ancestor
92293225|NCT01990898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293226|NCT01990898|Antifungal Agents|antifungal agents|mesh-ancestor
92293227|NCT01990898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293228|NCT01990898|Dermatologic Agents|dermatologic agents|mesh-ancestor
92293229|NCT01990898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293230|NCT01990898|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92293231|NCT01960387|Cytarabine|cytarabine|mesh-list
92293232|NCT01960387|Clofarabine|clofarabine|mesh-list
92293233|NCT01960387|Antimetabolites|antimetabolites|mesh-list
92293234|NCT01960387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92293235|NCT01960387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293236|NCT01960387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293237|NCT01960387|Antiviral Agents|antiviral agents|mesh-ancestor
92293238|NCT01960387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293239|NCT01960387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92293240|NCT01960387|Immunologic Factors|immunologic factors|mesh-ancestor
92293241|NCT01960387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293242|NCT02823431|Lidocaine|lidocaine|mesh-list
92293243|NCT02823431|Anesthetics, Local|anesthetics, local|mesh-ancestor
92293244|NCT02823431|Anesthetics|anesthetics|mesh-ancestor
92293245|NCT02823431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293246|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293247|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
92293248|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293249|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92293250|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92293251|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92293252|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293253|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293254|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92293255|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92293256|NCT03008213|Palonosetron|palonosetron|mesh-list
92293257|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
92293258|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
92293259|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293260|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293261|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293262|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92293263|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92293264|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
92293265|NCT03008213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293266|NCT03008213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293267|NCT02059070|Bupivacaine|bupivacaine|mesh-list
92293268|NCT02059070|Ropivacaine|ropivacaine|mesh-list
92293269|NCT02059070|Anesthetics, Local|anesthetics, local|mesh-ancestor
92293270|NCT02059070|Anesthetics|anesthetics|mesh-ancestor
92293271|NCT02059070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293272|NCT02059070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293273|NCT02059070|Sensory System Agents|sensory system agents|mesh-ancestor
92293274|NCT02059070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293275|NCT01962961|Acetylcysteine|acetylcysteine|mesh-list
92293276|NCT01962961|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92293277|NCT01962961|Antiviral Agents|antiviral agents|mesh-ancestor
92293278|NCT01962961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293279|NCT01962961|Expectorants|expectorants|mesh-ancestor
92293280|NCT01962961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92293281|NCT01962961|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92293282|NCT01962961|Antioxidants|antioxidants|mesh-ancestor
92293283|NCT01962961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293284|NCT01962961|Protective Agents|protective agents|mesh-ancestor
92293285|NCT01962961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293286|NCT01962961|Antidotes|antidotes|mesh-ancestor
92293287|NCT03010631|Lubiprostone|lubiprostone|mesh-list
91946064|NCT04193878|Budesonide|budesonide|mesh-list
92293288|NCT03010631|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92293289|NCT03010631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293290|NCT03010631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293292|NCT00374621|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92293293|NCT00374621|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92293294|NCT00374621|Misoprostol|misoprostol|mesh-list
92293295|NCT00374621|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92293296|NCT00374621|Abortifacient Agents|abortifacient agents|mesh-ancestor
92293297|NCT00374621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92293298|NCT00374621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293299|NCT00374621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92293300|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293301|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
92293302|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92293303|NCT00374621|Diuretics|diuretics|mesh-ancestor
92293304|NCT00374621|Natriuretic Agents|natriuretic agents|mesh-ancestor
92293305|NCT00374621|Vasodilator Agents|vasodilator agents|mesh-ancestor
92293306|NCT00374621|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92293307|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293308|NCT03012191|Gentamicins|gentamicins|mesh-list
92293309|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92293310|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293311|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92293312|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293313|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293314|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
92293315|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
92293316|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293317|NCT01967641|Buprenorphine|buprenorphine|mesh-list
92293318|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92293319|NCT01967641|Naloxone|naloxone|mesh-list
92293320|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92293321|NCT01967641|Narcotics|narcotics|mesh-ancestor
92293322|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293323|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293324|NCT01967641|Analgesics|analgesics|mesh-ancestor
92293325|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
92293326|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293327|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92293328|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
92293329|NCT01968421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92293330|NCT01968421|Immunologic Factors|immunologic factors|mesh-ancestor
92293331|NCT01968421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293332|NCT02913521|Diclofenac|diclofenac|mesh-list
92293333|NCT02913521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92293334|NCT02913521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293335|NCT02913521|Analgesics|analgesics|mesh-ancestor
92293336|NCT02913521|Sensory System Agents|sensory system agents|mesh-ancestor
92293337|NCT02913521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293338|NCT02913521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293339|NCT02913521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293340|NCT02913521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293341|NCT02913521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92293342|NCT02913521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293343|NCT02913521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293344|NCT01969201|Hormones|hormones|mesh-list
92346258|NCT01868022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92293345|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293346|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293347|NCT01962428|Ticagrelor|ticagrelor|mesh-list
92293348|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92293349|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92293350|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92293351|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92293352|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
92293353|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293354|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293355|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293357|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92293358|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293359|NCT01999400|Analgesics|analgesics|mesh-ancestor
92293360|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
92293361|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293362|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946140|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293363|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293364|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293365|NCT01969435|Cytarabine|cytarabine|mesh-list
92293366|NCT01969435|Etoposide|etoposide|mesh-list
92293367|NCT01969435|Melphalan|melphalan|mesh-list
92293368|NCT01969435|Carmustine|carmustine|mesh-list
92293369|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
92293370|NCT01969435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92293371|NCT01969435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293372|NCT01969435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92293373|NCT01969435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92293374|NCT01969435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293375|NCT01969435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293376|NCT01969435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92293377|NCT01969435|Antimetabolites|antimetabolites|mesh-ancestor
92293378|NCT01969435|Antiviral Agents|antiviral agents|mesh-ancestor
92293379|NCT01969435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293380|NCT01969435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92293381|NCT01969435|Immunologic Factors|immunologic factors|mesh-ancestor
92293382|NCT01969435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293383|NCT01969435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92293384|NCT01969435|Alkylating Agents|alkylating agents|mesh-ancestor
92293385|NCT01969435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92293386|NCT01965002|Aspirin|aspirin|mesh-list
92293387|NCT01965002|Enoxaparin|enoxaparin|mesh-list
92293388|NCT01965002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92293389|NCT01965002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293390|NCT01965002|Analgesics|analgesics|mesh-ancestor
92293391|NCT01965002|Sensory System Agents|sensory system agents|mesh-ancestor
92293392|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293393|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293394|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293395|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293396|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92293397|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92293398|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293399|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92293400|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92293401|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293402|NCT01965002|Antipyretics|antipyretics|mesh-ancestor
92293403|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
92293404|NCT02304757|Alendronate|alendronate|mesh-list
92293405|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
92293406|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92293407|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293408|NCT01969747|Empagliflozin|empagliflozin|mesh-list
92293409|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92293410|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293411|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346263|NCT01850004|Dasatinib|dasatinib|mesh-list
92293412|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293413|NCT02002832|Risperidone|risperidone|mesh-list
92293414|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92293415|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92293416|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
92293417|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293418|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293419|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293420|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92293421|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92293422|NCT02002832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293423|NCT02002832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92293424|NCT02002832|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92293425|NCT02002832|Dopamine Agents|dopamine agents|mesh-ancestor
92293426|NCT02002832|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92293427|NCT02002832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92293428|NCT02002832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92293429|NCT02002832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92293430|NCT02002832|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92293431|NCT02002832|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92293432|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92293433|NCT01966718|Hormones|hormones|mesh-ancestor
92293434|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293435|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293436|NCT02308501|Alcaftadine|alcaftadine|mesh-list
91946215|NCT02442284|Ritonavir|ritonavir|mesh-list
92293437|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92293438|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
92293439|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
92293440|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293441|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293442|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293443|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92293444|NCT02006108|Hematinics|hematinics|mesh-ancestor
92293445|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92293446|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92293447|NCT02006342|Insulin|insulin|mesh-list
92293448|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92293449|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
92293450|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293451|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293452|NCT01968356|Ethanol|ethanol|mesh-list
92293453|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
92293454|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92293455|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92293456|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293457|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293458|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293459|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
92293460|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
92293461|NCT02008682|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92293462|NCT02008682|Liraglutide|liraglutide|mesh-list
92293463|NCT02008682|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293464|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293465|NCT02008682|Incretins|incretins|mesh-ancestor
92293466|NCT02008682|Hormones|hormones|mesh-ancestor
92293467|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293468|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92293469|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
92293470|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293471|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293472|NCT01969916|Regadenoson|regadenoson|mesh-list
92293473|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92293474|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92293475|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
92293476|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
92293477|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293478|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293479|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293480|NCT00373919|Erythromycin|erythromycin|mesh-list
92293481|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
92293482|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92293483|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
92293484|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92293485|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293486|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293487|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92293488|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293489|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293490|NCT02916407|Sevoflurane|sevoflurane|mesh-list
92293491|NCT02916407|Desflurane|desflurane|mesh-list
92293492|NCT02916407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92293493|NCT02916407|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92293494|NCT02916407|Anesthetics, General|anesthetics, general|mesh-ancestor
92293495|NCT02916407|Anesthetics|anesthetics|mesh-ancestor
92293496|NCT02916407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293497|NCT02916407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293498|NCT02918357|Edetic Acid|edetic acid|mesh-list
92293499|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92293500|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
92293501|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
92293502|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293503|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
92293504|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92293505|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92293506|NCT02829983|Clarithromycin|clarithromycin|mesh-list
92293507|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92293508|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293509|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92293510|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293511|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293512|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92293513|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92293515|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92293516|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293517|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
92293518|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
92293519|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
92293520|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293521|NCT02066792|Cycloserine|cycloserine|mesh-list
92293522|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92293523|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293524|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92293525|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
92293526|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92293527|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
92293528|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293529|NCT02922959|Naloxone|naloxone|mesh-list
92293530|NCT02922959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293531|NCT02922959|Sensory System Agents|sensory system agents|mesh-ancestor
92293532|NCT02922959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293533|NCT02922959|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92293534|NCT02014363|Amitriptyline|amitriptyline|mesh-list
92293535|NCT02014363|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92293536|NCT02014363|Antidepressive Agents|antidepressive agents|mesh-ancestor
92293537|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92293538|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293539|NCT02014363|Analgesics|analgesics|mesh-ancestor
92293540|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
92293541|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293542|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293543|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92293544|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92293545|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293546|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293547|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
92293548|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293549|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
92293550|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
92293551|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
92293552|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293553|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293554|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
92293555|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293556|NCT02833415|Empagliflozin|empagliflozin|mesh-list
92293557|NCT02833415|Glycerol|glycerol|mesh-list
92293558|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92293559|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293560|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293561|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293562|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92293563|NCT02833415|Protective Agents|protective agents|mesh-ancestor
92293564|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92293565|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92293566|NCT02012348|Triclocarban|triclocarban|mesh-list
92293567|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293568|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92293569|NCT02834663|Ranibizumab|ranibizumab|mesh-list
92293570|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92293572|NCT02834663|Growth Substances|growth substances|mesh-ancestor
92293573|NCT02834663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293574|NCT02834663|Growth Inhibitors|growth inhibitors|mesh-ancestor
92293575|NCT02834663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293576|NCT01973036|Oxytocin|oxytocin|mesh-list
92293577|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
92293578|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92293579|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293580|NCT02017327|Bimatoprost|bimatoprost|mesh-list
92293581|NCT02017327|Latanoprost|latanoprost|mesh-list
92293582|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92293583|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92293584|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91946361|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
92293585|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92293586|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
92293587|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
92293588|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293589|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293590|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92293591|NCT02837237|Diuretics|diuretics|mesh-ancestor
92293592|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
92293593|NCT02837237|Hormones|hormones|mesh-ancestor
92293594|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92293595|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92293596|NCT02018107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293597|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
92293598|NCT02018653|Antidiarrheals|antidiarrheals|mesh-list
92293599|NCT02018653|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
92293600|NCT02018653|Calcium|calcium|mesh-list
92293601|NCT02018653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92293602|NCT02018653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293603|NCT02018653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92293604|NCT02018653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293605|NCT02923895|Fluorides|fluorides|mesh-list
92293606|NCT02923895|Tin Fluorides|tin fluorides|mesh-list
92293607|NCT02923895|Fluorophosphate|fluorophosphate|mesh-list
92293608|NCT02923895|Cariostatic Agents|cariostatic agents|mesh-ancestor
92293609|NCT02923895|Protective Agents|protective agents|mesh-ancestor
92293610|NCT02923895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293611|NCT01973348|Methamphetamine|methamphetamine|mesh-list
92293612|NCT01973348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92293613|NCT01973348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293614|NCT01973348|Sympathomimetics|sympathomimetics|mesh-ancestor
92293615|NCT01973348|Autonomic Agents|autonomic agents|mesh-ancestor
92293616|NCT01973348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293617|NCT01973348|Dopamine Agents|dopamine agents|mesh-ancestor
92293618|NCT01973348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346283|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293619|NCT01973348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293621|NCT01973348|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92293622|NCT01973348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92293623|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293624|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92293625|NCT02839889|Naloxegol|naloxegol|mesh-list
92293626|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92293627|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293628|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
92293629|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293630|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92293631|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
92293632|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92293633|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
92293634|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293635|NCT02925611|Desflurane|desflurane|mesh-list
92293636|NCT02925611|Isoflurane|isoflurane|mesh-list
92293637|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92293638|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
92293639|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
92293640|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293641|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293642|NCT01973335|Spironolactone|spironolactone|mesh-list
92293643|NCT01973335|Acetazolamide|acetazolamide|mesh-list
92293644|NCT01973335|Bumetanide|bumetanide|mesh-list
92293645|NCT01973335|Diuretics|diuretics|mesh-list
92293646|NCT01973335|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92293647|NCT01973335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92293648|NCT01973335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92293649|NCT01973335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293650|NCT01973335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293651|NCT01973335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92293652|NCT01973335|Natriuretic Agents|natriuretic agents|mesh-ancestor
92293653|NCT01973335|Anticonvulsants|anticonvulsants|mesh-ancestor
91946435|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293654|NCT01973335|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92293655|NCT01973335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293656|NCT01973335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293657|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293658|NCT01973413|Insulin|insulin|mesh-list
92293659|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92293660|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293661|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92293662|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
92293663|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92293664|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92293665|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293666|NCT02021461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293667|NCT02929667|Fluoxetine|fluoxetine|mesh-list
92293668|NCT02929667|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92293669|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92293670|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293671|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293672|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293673|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
92293674|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293675|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92293676|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
92293677|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92293678|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92293679|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92293680|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293681|NCT02021929|Sorafenib|sorafenib|mesh-list
92293682|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293683|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92293684|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293685|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293686|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92293687|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92293688|NCT02023411|Teriparatide|teriparatide|mesh-list
92293689|NCT02023411|Hormones|hormones|mesh-list
92293690|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
92293691|NCT02023411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293692|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293693|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92293694|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92293695|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
92293696|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
92293697|NCT02068820|Protective Agents|protective agents|mesh-ancestor
92293698|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293699|NCT01975519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92293700|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
92293701|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293702|NCT02934191|Acetaminophen|acetaminophen|mesh-list
92293703|NCT02934191|Celecoxib|celecoxib|mesh-list
92293704|NCT02934191|Oxycodone|oxycodone|mesh-list
92293705|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
92293706|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293707|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293708|NCT02934191|Analgesics|analgesics|mesh-ancestor
92293709|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
92293710|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293711|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
92293712|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92293713|NCT02934191|Narcotics|narcotics|mesh-ancestor
92293714|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293715|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92293716|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293717|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293718|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92293719|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92293720|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293721|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293722|NCT02934191|Antacids|antacids|mesh-ancestor
92293723|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293724|NCT02937623|Calcium|calcium|mesh-list
92293725|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92293726|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293727|NCT01977781|Methylprednisolone|methylprednisolone|mesh-list
92293728|NCT01977781|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92293729|NCT01977781|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92293730|NCT01977781|Prednisolone|prednisolone|mesh-list
92293731|NCT01977781|Prednisolone acetate|prednisolone acetate|mesh-list
92293732|NCT01977781|Tacrolimus|tacrolimus|mesh-list
92293733|NCT01977781|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92293734|NCT01977781|Prednisolone phosphate|prednisolone phosphate|mesh-list
92293735|NCT01977781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92293736|NCT01977781|Immunologic Factors|immunologic factors|mesh-ancestor
92293737|NCT01977781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293738|NCT01977781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92293739|NCT01977781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293740|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293741|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293742|NCT01977781|Antiemetics|antiemetics|mesh-ancestor
92293743|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
92293744|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293745|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293746|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
92293747|NCT01977781|Hormones|hormones|mesh-ancestor
92293748|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293749|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92293750|NCT01977781|Protective Agents|protective agents|mesh-ancestor
92293751|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92293752|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293753|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
92293754|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92293755|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92293756|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92293757|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293758|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293759|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
92293760|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293761|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293762|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92293763|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293765|NCT02938949|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92293766|NCT02938949|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92293767|NCT02938949|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92293768|NCT02938949|Antimetabolites|antimetabolites|mesh-ancestor
92293769|NCT02938949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293770|NCT02938949|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92293771|NCT02938949|Protease Inhibitors|protease inhibitors|mesh-ancestor
92293772|NCT02938949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293773|NCT02938949|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92293774|NCT02025439|Amantadine|amantadine|mesh-list
92293775|NCT02025439|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92293776|NCT02025439|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92293777|NCT02025439|Antiviral Agents|antiviral agents|mesh-ancestor
92293778|NCT02025439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293779|NCT02025439|Dopamine Agents|dopamine agents|mesh-ancestor
92293780|NCT02025439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293781|NCT02025439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293782|NCT02025439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293783|NCT02025439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293784|NCT02025439|Analgesics|analgesics|mesh-ancestor
92293785|NCT02025439|Sensory System Agents|sensory system agents|mesh-ancestor
92293786|NCT02025439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293787|NCT02939651|Pembrolizumab|pembrolizumab|mesh-list
92293788|NCT02939651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92293789|NCT02939651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293790|NCT02939651|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92293791|NCT02939651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293792|NCT02026297|Tranexamic Acid|tranexamic acid|mesh-list
92293793|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92293794|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92293795|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293796|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
92293797|NCT02026297|Coagulants|coagulants|mesh-ancestor
92293798|NCT02070692|Tamoxifen|tamoxifen|mesh-list
92293799|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92293800|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
92293801|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293802|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293803|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92293804|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293805|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92293806|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92293807|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92293808|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
92293809|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92293810|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
92293811|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92293812|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92293813|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293814|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92293815|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293816|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92293817|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293820|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92293821|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
92293822|NCT02869451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293823|NCT02869451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346287|NCT01832766|Dronabinol|dronabinol|mesh-list
92293824|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92293825|NCT02869451|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92293826|NCT02869451|Cholinergic Agents|cholinergic agents|mesh-ancestor
92293827|NCT02869451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293828|NCT02869451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293829|NCT02869451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92293830|NCT02869451|Antidepressive Agents|antidepressive agents|mesh-ancestor
92293831|NCT02869451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92293832|NCT02869451|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92293833|NCT02869451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92293834|NCT02869451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92293835|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
92293836|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92293837|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92293838|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293839|NCT02305316|Opicapone|opicapone|mesh-list
92293840|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92293841|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293842|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293843|NCT02305316|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92293844|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92293845|NCT02944565|Daratumumab|daratumumab|mesh-list
92293846|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293847|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92293848|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92293849|NCT02870309|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92293850|NCT02870309|Protease Inhibitors|protease inhibitors|mesh-ancestor
92293851|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293852|NCT02870309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293853|NCT01979276|Dexamethasone|dexamethasone|mesh-list
92293854|NCT01979276|Pomalidomide|pomalidomide|mesh-list
92293855|NCT01979276|Romidepsin|romidepsin|mesh-list
92293856|NCT01979276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293857|NCT01979276|Antiemetics|antiemetics|mesh-ancestor
92293858|NCT01979276|Autonomic Agents|autonomic agents|mesh-ancestor
92293859|NCT01979276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293860|NCT01979276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293861|NCT01979276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293863|NCT01979276|Hormones|hormones|mesh-ancestor
92293864|NCT01979276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293865|NCT01979276|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92293866|NCT01979276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293867|NCT01979276|Immunologic Factors|immunologic factors|mesh-ancestor
92293868|NCT01979276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92293869|NCT01979276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92293870|NCT01979276|Growth Substances|growth substances|mesh-ancestor
92293871|NCT01979276|Growth Inhibitors|growth inhibitors|mesh-ancestor
92293872|NCT01979276|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92293873|NCT01979276|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92293874|NCT01979276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293875|NCT01979276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293876|NCT02871011|Nitric Oxide|nitric oxide|mesh-list
92293877|NCT02871011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92293878|NCT02871011|Autonomic Agents|autonomic agents|mesh-ancestor
91946664|NCT03522935|Elafin|elafin|mesh-list
92293879|NCT02871011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293880|NCT02871011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293881|NCT02871011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92293882|NCT02871011|Respiratory System Agents|respiratory system agents|mesh-ancestor
92293883|NCT02871011|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92293885|NCT02871011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293886|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92293887|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92293888|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
92293889|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
92293890|NCT02871011|Protective Agents|protective agents|mesh-ancestor
92293891|NCT02344238|Riboflavin|riboflavin|mesh-list
92293892|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
92293893|NCT02344238|Vitamins|vitamins|mesh-ancestor
92293894|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
92293895|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293896|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92293897|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
92293898|NCT02344316|Melatonin|melatonin|mesh-list
92293899|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
92293900|NCT02344316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293901|NCT02344316|Protective Agents|protective agents|mesh-ancestor
92293902|NCT02344316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293903|NCT02344316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293904|NCT02344628|Azithromycin|azithromycin|mesh-list
92293905|NCT02344628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92293906|NCT02344628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293907|NCT02345486|Plasma-lyte 148|plasma-lyte 148|mesh-list
92293908|NCT02345486|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92293909|NCT02345486|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92293910|NCT02019758|Fluticasone|fluticasone|mesh-list
92293911|NCT02019758|Budesonide|budesonide|mesh-list
92293912|NCT02019758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293913|NCT02019758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92293914|NCT02019758|Autonomic Agents|autonomic agents|mesh-ancestor
92293915|NCT02019758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293916|NCT02019758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293917|NCT02019758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92293918|NCT02019758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92293919|NCT02019758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92293920|NCT02019758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92293921|NCT02019758|Glucocorticoids|glucocorticoids|mesh-ancestor
92293922|NCT02019758|Hormones|hormones|mesh-ancestor
92293923|NCT02019758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293924|NCT01980589|Dexamethasone|dexamethasone|mesh-list
92293925|NCT01980589|Cyclophosphamide|cyclophosphamide|mesh-list
92293926|NCT01980589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92293927|NCT01980589|Immunologic Factors|immunologic factors|mesh-ancestor
92293928|NCT01980589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293929|NCT01980589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293930|NCT01980589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92293931|NCT01980589|Alkylating Agents|alkylating agents|mesh-ancestor
92293932|NCT01980589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293933|NCT01980589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92293934|NCT01980589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92293935|NCT01980589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293936|NCT01980589|Antiemetics|antiemetics|mesh-ancestor
92293937|NCT01980589|Autonomic Agents|autonomic agents|mesh-ancestor
92293938|NCT01980589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293939|NCT01980589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92293940|NCT01980589|Glucocorticoids|glucocorticoids|mesh-ancestor
92293941|NCT01980589|Hormones|hormones|mesh-ancestor
92293942|NCT01980589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293943|NCT01980589|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92293944|NCT02021942|Pasireotide|pasireotide|mesh-list
92293945|NCT02021942|Hormones|hormones|mesh-ancestor
92293946|NCT02021942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92293947|NCT02021942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293948|NCT01981759|Cycloserine|cycloserine|mesh-list
92293949|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92293950|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92293951|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92293952|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
91946738|NCT03967288|Procaine|procaine|mesh-list
92293953|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92293954|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
92293955|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293956|NCT01980524|Acipimox|acipimox|mesh-list
92293957|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92293958|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
92293959|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293960|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92293961|NCT01982539|Diclofenac|diclofenac|mesh-list
92293962|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92293963|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92293964|NCT01982539|Analgesics|analgesics|mesh-ancestor
92293965|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
92293966|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293967|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293968|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92293969|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92293970|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92293971|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293972|NCT01982539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293973|NCT01982695|Losartan|losartan|mesh-list
92293974|NCT01982695|Lisinopril|lisinopril|mesh-list
92293975|NCT01982695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92293976|NCT01982695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92293977|NCT01982695|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92293978|NCT01982695|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92293979|NCT01982695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92293980|NCT01982695|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92293981|NCT01982695|Protease Inhibitors|protease inhibitors|mesh-ancestor
92293982|NCT01982695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92293983|NCT01982695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92293984|NCT01982695|Protective Agents|protective agents|mesh-ancestor
92293985|NCT01982695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293986|NCT01981772|Lidocaine|lidocaine|mesh-list
92293987|NCT01981772|Epinephrine|epinephrine|mesh-list
92293988|NCT01981772|Racepinephrine|racepinephrine|mesh-list
92293989|NCT01981772|Epinephryl borate|epinephryl borate|mesh-list
92293990|NCT01981772|Anesthetics, Local|anesthetics, local|mesh-ancestor
92293991|NCT01981772|Anesthetics|anesthetics|mesh-ancestor
92293992|NCT01981772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92293993|NCT01981772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92293994|NCT01981772|Sensory System Agents|sensory system agents|mesh-ancestor
92293995|NCT01981772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92293996|NCT01981772|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92293997|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92293998|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92293999|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294000|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294001|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92294002|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294003|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294004|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294005|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92294006|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92294007|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
92294008|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92294009|NCT01981772|Respiratory System Agents|respiratory system agents|mesh-ancestor
92294010|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
92294011|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
92294012|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92294013|NCT01982240|Bisacodyl|bisacodyl|mesh-list
92294014|NCT01982240|Plecanatide|plecanatide|mesh-list
92294015|NCT01982240|Cathartics|cathartics|mesh-ancestor
92294016|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294017|NCT01982240|Laxatives|laxatives|mesh-ancestor
92294018|NCT01982240|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92294019|NCT01982240|Enzyme Activators|enzyme activators|mesh-ancestor
92294020|NCT01982240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294021|NCT02029495|Brodalumab|brodalumab|mesh-list
92294022|NCT02029495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92294023|NCT02029495|Dermatologic Agents|dermatologic agents|mesh-ancestor
92294024|NCT02029495|Immunologic Factors|immunologic factors|mesh-ancestor
92294025|NCT02029495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294026|NCT01985425|Colchicine|colchicine|mesh-list
92294027|NCT01985425|Gout Suppressants|gout suppressants|mesh-ancestor
91946807|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
92294028|NCT01985425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294029|NCT01985425|Tubulin Modulators|tubulin modulators|mesh-ancestor
92294030|NCT01985425|Antimitotic Agents|antimitotic agents|mesh-ancestor
92294031|NCT01985425|Mitosis Modulators|mitosis modulators|mesh-ancestor
92294032|NCT01985425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294033|NCT01985425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294034|NCT02348918|Bevacizumab|bevacizumab|mesh-list
92294035|NCT02348918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92294036|NCT02348918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294037|NCT02348918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92294038|NCT02348918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92294039|NCT02348918|Growth Substances|growth substances|mesh-ancestor
92294040|NCT02348918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294041|NCT02348918|Growth Inhibitors|growth inhibitors|mesh-ancestor
92294042|NCT01985581|Guanfacine|guanfacine|mesh-list
92294043|NCT01985581|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92294044|NCT01985581|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92294046|NCT01985581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294047|NCT01985581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294048|NCT01985581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294049|NCT01985581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294050|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294051|NCT02024204|Fluticasone|fluticasone|mesh-list
92294053|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92294054|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92294055|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294056|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92294057|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
92294058|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294059|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294060|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92294061|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92294062|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
92294063|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92294064|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92294065|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92294066|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294067|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294068|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294069|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294070|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
92294071|NCT02024204|Hormones|hormones|mesh-ancestor
92294072|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294073|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
92294074|NCT03930745|TOL-463|tol-463|mesh-list
92294075|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294076|NCT02034019|Dexamethasone|dexamethasone|mesh-list
92294077|NCT02034019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294078|NCT02034019|Antiemetics|antiemetics|mesh-ancestor
92294079|NCT02034019|Autonomic Agents|autonomic agents|mesh-ancestor
92294080|NCT02034019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294081|NCT02034019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294082|NCT02034019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294083|NCT02034019|Glucocorticoids|glucocorticoids|mesh-ancestor
92294084|NCT02034019|Hormones|hormones|mesh-ancestor
92294085|NCT02034019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294086|NCT02034019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294087|NCT02034019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294088|NCT02349152|Fentanyl|fentanyl|mesh-list
92294089|NCT02349152|Remifentanil|remifentanil|mesh-list
92294090|NCT02349152|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92294091|NCT02349152|Narcotics|narcotics|mesh-ancestor
92294092|NCT02349152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294093|NCT02349152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294094|NCT02349152|Analgesics|analgesics|mesh-ancestor
92294095|NCT02349152|Sensory System Agents|sensory system agents|mesh-ancestor
92294096|NCT02349152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294097|NCT02349152|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92294098|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294099|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
92294100|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
92294101|NCT02035345|Carboplatin|carboplatin|mesh-list
92294102|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294103|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
92294104|NCT01986361|Analgesics|analgesics|mesh-ancestor
92294105|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
92294106|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294107|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294108|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294109|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294110|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294111|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294112|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92294113|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294114|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294115|NCT01983020|Lidocaine|lidocaine|mesh-list
92294116|NCT01983020|Ketamine|ketamine|mesh-list
92294117|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
92294118|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
92294119|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294120|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294121|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
92294122|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294123|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92294124|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92294125|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92294126|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294127|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294128|NCT01983020|Analgesics|analgesics|mesh-ancestor
92294129|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92294130|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294131|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
92294132|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92294133|NCT01983020|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92294134|NCT01983020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294135|NCT02058511|Anesthetics|anesthetics|mesh-list
92294136|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294137|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294138|NCT01983566|Omeprazole|omeprazole|mesh-list
92294139|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92294140|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294141|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92294142|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294143|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294144|NCT01983878|Ramucirumab|ramucirumab|mesh-list
92294145|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294146|NCT02396732|Aspirin|aspirin|mesh-list
92294147|NCT02396732|Enoxaparin|enoxaparin|mesh-list
92294148|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294149|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294150|NCT02396732|Analgesics|analgesics|mesh-ancestor
92294151|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
92294152|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294153|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294154|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294155|NCT02396732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294156|NCT02396732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92294157|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92294158|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294159|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92294160|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92294161|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294163|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
92294164|NCT02352974|Vitamin D|vitamin d|mesh-list
92294165|NCT02352974|Vitamins|vitamins|mesh-ancestor
92294166|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
92294167|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294168|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92294169|NCT02353754|Morphine|morphine|mesh-list
92294170|NCT02353754|Bupivacaine|bupivacaine|mesh-list
92294171|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
92294172|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
92294173|NCT02353754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294174|NCT02353754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294175|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
92294176|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346318|NCT01848990|Insulin|insulin|mesh-list
92294177|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91946961|NCT03138447|Insulin|insulin|mesh-list
92294178|NCT02353754|Narcotics|narcotics|mesh-ancestor
92294179|NCT02353754|Analgesics|analgesics|mesh-ancestor
92294180|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
92294181|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92294182|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294183|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294184|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294185|NCT02354378|Analgesics|analgesics|mesh-ancestor
92294186|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
92294187|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294188|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92294189|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92294190|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294191|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294192|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294193|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294195|NCT02059213|Leuprolide|leuprolide|mesh-list
92294196|NCT02059213|Goserelin|goserelin|mesh-list
92294197|NCT02059213|Bicalutamide|bicalutamide|mesh-list
92294198|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294199|NCT02059213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92294200|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294201|NCT02059213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294202|NCT02059213|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92294203|NCT02059213|Fertility Agents|fertility agents|mesh-ancestor
92294204|NCT02059213|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92294205|NCT02059213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294206|NCT02059213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294207|NCT02059213|Androgen Antagonists|androgen antagonists|mesh-ancestor
92294208|NCT02059213|Hormone Antagonists|hormone antagonists|mesh-ancestor
92294209|NCT02059213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294210|NCT02037061|Bupivacaine|bupivacaine|mesh-list
92294211|NCT02037061|Anesthetics, Local|anesthetics, local|mesh-ancestor
92294212|NCT02037061|Anesthetics|anesthetics|mesh-ancestor
92294213|NCT02037061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294214|NCT02037061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294215|NCT02037061|Sensory System Agents|sensory system agents|mesh-ancestor
92294216|NCT02037061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294217|NCT02354534|Artesunate|artesunate|mesh-list
92294218|NCT02354534|Antimalarials|antimalarials|mesh-ancestor
92294219|NCT02354534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92294220|NCT02354534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92294221|NCT02354534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294222|NCT02354534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294223|NCT02354534|Antiviral Agents|antiviral agents|mesh-ancestor
92294224|NCT02354534|Schistosomicides|schistosomicides|mesh-ancestor
92294225|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92294226|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
92294227|NCT02355158|Clonidine|clonidine|mesh-list
92294228|NCT02355158|Analgesics|analgesics|mesh-ancestor
92294229|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
92294230|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294231|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294233|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
92294234|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
92294235|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92294236|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92294237|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294238|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294239|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294240|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294241|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92294242|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92294243|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294244|NCT02061397|Sirolimus|sirolimus|mesh-list
92294245|NCT02061397|Everolimus|everolimus|mesh-list
92294246|NCT02061397|Simvastatin|simvastatin|mesh-list
92294247|NCT02061397|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92294248|NCT02061397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92294249|NCT02061397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294250|NCT02061397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294251|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294252|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
92294253|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294254|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294255|NCT02061397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92294256|NCT02061397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294257|NCT02061397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92294258|NCT02061397|Antifungal Agents|antifungal agents|mesh-ancestor
92294259|NCT02061397|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92294260|NCT02061397|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92294262|NCT02061397|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92294263|NCT02061397|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92294265|NCT02062177|Propofol|propofol|mesh-list
92294266|NCT02062177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92294267|NCT02062177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294268|NCT02062177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294269|NCT02062177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294270|NCT02062177|Anesthetics, General|anesthetics, general|mesh-ancestor
92294271|NCT02062177|Anesthetics|anesthetics|mesh-ancestor
92294272|NCT02062177|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92294273|NCT02062177|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92294274|NCT02062177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92294275|NCT02062177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294276|NCT02062177|GABA Modulators|gaba modulators|mesh-ancestor
92294277|NCT02062177|GABA Agents|gaba agents|mesh-ancestor
92294278|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294279|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294280|NCT02034578|Apixaban|apixaban|mesh-list
92294281|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92294282|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
92294283|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92294284|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
92294285|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294286|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294287|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
92294288|NCT02403830|Morphine|morphine|mesh-list
92294289|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
92294290|NCT02403830|Ticagrelor|ticagrelor|mesh-list
92294291|NCT02403830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92294292|NCT02403830|Narcotics|narcotics|mesh-ancestor
92294293|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294294|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294295|NCT02403830|Analgesics|analgesics|mesh-ancestor
92294296|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
92294297|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294298|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92294299|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92294300|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92294301|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92294302|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
92294303|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294304|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294305|NCT02403830|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92294306|NCT02036840|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92294307|NCT02036840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294308|NCT02951195|Ivacaftor|ivacaftor|mesh-list
92294309|NCT02951195|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92294310|NCT02951195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294311|NCT02951195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294312|NCT02037230|Gemcitabine|gemcitabine|mesh-list
92294313|NCT02037230|Adavosertib|adavosertib|mesh-list
92294314|NCT02037230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92294315|NCT02037230|Antimetabolites|antimetabolites|mesh-ancestor
92294316|NCT02037230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294317|NCT02037230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294318|NCT02037230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294319|NCT02312882|Tofacitinib|tofacitinib|mesh-list
92294320|NCT02312882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92294321|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92294322|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294323|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294324|NCT02877095|Furosemide|furosemide|mesh-list
92294325|NCT02877095|Diuretics|diuretics|mesh-ancestor
92294326|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
92294327|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294328|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92294329|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294330|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294332|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92294333|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92294334|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92294335|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294336|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
92294337|NCT02877485|Hormones|hormones|mesh-ancestor
92294338|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294339|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294340|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294341|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
92294342|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294343|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294344|NCT00374387|NuvaRing|nuvaring|mesh-list
92294345|NCT00374387|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92294346|NCT00374387|Contraceptive Agents|contraceptive agents|mesh-ancestor
92294347|NCT00374387|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92294348|NCT00374387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294349|NCT03023891|Prednisone|prednisone|mesh-list
92294350|NCT03023891|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294351|NCT03023891|Glucocorticoids|glucocorticoids|mesh-ancestor
92294352|NCT03023891|Hormones|hormones|mesh-ancestor
92294353|NCT03023891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294354|NCT03023891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294355|NCT03023891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294356|NCT03023891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294357|NCT03028025|Hemostatics|hemostatics|mesh-list
92294358|NCT03028025|Coagulants|coagulants|mesh-ancestor
92294359|NCT02955329|Nicotine|nicotine|mesh-list
92294360|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92294361|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
92294362|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294363|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294364|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92294365|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92294366|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
92294367|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294368|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294369|NCT02359058|Capecitabine|capecitabine|mesh-list
92294370|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
92294371|NCT02359058|Ramucirumab|ramucirumab|mesh-list
92294372|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294373|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92294374|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
92294375|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294376|NCT02404610|Propofol|propofol|mesh-list
92294377|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92294378|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294379|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294380|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294381|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
92294382|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
92294383|NCT03110003|Bupivacaine|bupivacaine|mesh-list
92294384|NCT03110003|Anesthetics, Local|anesthetics, local|mesh-ancestor
92294385|NCT03110003|Anesthetics|anesthetics|mesh-ancestor
92294386|NCT03110003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294387|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294388|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
92294389|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294390|NCT03114995|Tirofiban|tirofiban|mesh-list
92294391|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92294392|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92294393|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294394|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92294395|NCT02959853|Anastrozole|anastrozole|mesh-list
92294396|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294397|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294398|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92294399|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92294400|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294401|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947183|NCT02493764|Piperacillin|piperacillin|mesh-list
92294402|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92294403|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
92294404|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294405|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294406|NCT00374465|Verapamil|verapamil|mesh-list
92294407|NCT00374465|Carvedilol|carvedilol|mesh-list
92294408|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92294409|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92294411|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294412|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294413|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294414|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92294415|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
92294416|NCT00374465|Protective Agents|protective agents|mesh-ancestor
92294417|NCT00374465|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92294418|NCT00374465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294419|NCT00374465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92294420|NCT00374465|Vasodilator Agents|vasodilator agents|mesh-ancestor
92294421|NCT00374465|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92294422|NCT00374465|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92294423|NCT00374465|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92294424|NCT02040116|Rituximab|rituximab|mesh-list
92294425|NCT02040116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92294426|NCT02040116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294427|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
92294428|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294429|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294430|NCT02360774|Canagliflozin|canagliflozin|mesh-list
92294431|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92294432|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294433|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92294434|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294435|NCT02361476|Clonidine|clonidine|mesh-list
92294436|NCT02361476|Analgesics|analgesics|mesh-ancestor
92294437|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
92294438|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294439|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294440|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92294441|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
92294442|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
92294443|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92294444|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92294445|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294446|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294447|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294448|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294450|NCT02363270|Analgesics|analgesics|mesh-ancestor
92294451|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
92294452|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294453|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294454|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92294455|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294456|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
92294457|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
92294458|NCT02363270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294459|NCT02363270|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92294460|NCT02363270|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92294461|NCT02363270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294462|NCT02363270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294463|NCT02042534|Warfarin|warfarin|mesh-list
92294464|NCT02042534|Rivaroxaban|rivaroxaban|mesh-list
92294465|NCT02042534|Anticoagulants|anticoagulants|mesh-ancestor
92294466|NCT02042534|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92294467|NCT02042534|Antithrombins|antithrombins|mesh-ancestor
92294468|NCT02042534|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92294469|NCT02042534|Protease Inhibitors|protease inhibitors|mesh-ancestor
92294470|NCT02042534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294471|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294472|NCT02043704|Acetaminophen|acetaminophen|mesh-list
92294473|NCT02043704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294474|NCT02043704|Analgesics|analgesics|mesh-ancestor
92294475|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
92294476|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294477|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294479|NCT02410382|Dexamethasone|dexamethasone|mesh-list
92294480|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294481|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
92294482|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
92294483|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294484|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294485|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294486|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
92294487|NCT02410382|Hormones|hormones|mesh-ancestor
92294488|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294489|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294490|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294491|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92294492|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92294493|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92294494|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294495|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294496|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294497|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294498|NCT03038867|Analgesics|analgesics|mesh-ancestor
92294499|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
92294500|NCT03038867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294501|NCT03038867|Antidepressive Agents|antidepressive agents|mesh-ancestor
92294502|NCT03038867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294503|NCT03038867|Dopamine Agents|dopamine agents|mesh-ancestor
92294504|NCT03119831|Ethanol|ethanol|mesh-list
92294505|NCT03119831|Chlorhexidine|chlorhexidine|mesh-list
92294506|NCT03119831|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92294507|NCT03119831|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92294508|NCT03119831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294509|NCT03119831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294510|NCT03119831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294511|NCT03119831|Disinfectants|disinfectants|mesh-ancestor
92294512|NCT03119831|Dermatologic Agents|dermatologic agents|mesh-ancestor
92294513|NCT02965781|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
92294514|NCT02965781|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92294515|NCT02965781|Immunologic Factors|immunologic factors|mesh-ancestor
92294516|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294517|NCT03124121|Golimumab|golimumab|mesh-list
92294518|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92294519|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294520|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294521|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
92294523|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92294524|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92294525|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92294526|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294527|NCT00374699|Bortezomib|bortezomib|mesh-list
92294528|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294529|NCT00374777|Nitrazepam|nitrazepam|mesh-list
92294530|NCT00374777|Zolpidem|zolpidem|mesh-list
92294531|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92294532|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92294533|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294534|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294535|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92294536|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
92294537|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
92294538|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294539|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294540|NCT00374777|Anticonvulsants|anticonvulsants|mesh-ancestor
92294541|NCT00374777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92294542|NCT00374777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92294543|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294544|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
92294545|NCT02044796|Cytarabine|cytarabine|mesh-list
92294546|NCT02044796|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92294547|NCT02044796|Mitoxantrone|mitoxantrone|mesh-list
92294548|NCT02044796|Cladribine|cladribine|mesh-list
92294549|NCT02044796|Lenograstim|lenograstim|mesh-list
91947336|NCT02302547|Ritonavir|ritonavir|mesh-list
92294550|NCT02044796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92294551|NCT02044796|Antimetabolites|antimetabolites|mesh-ancestor
92294552|NCT02044796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294553|NCT02044796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294555|NCT02044796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294556|NCT02044796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294557|NCT02044796|Immunologic Factors|immunologic factors|mesh-ancestor
92294558|NCT02044796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294559|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92294560|NCT02044796|Analgesics|analgesics|mesh-ancestor
92294561|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
92294562|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294563|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92294564|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92294565|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294566|NCT02973503|Grazoprevir|grazoprevir|mesh-list
92294567|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92294568|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
92294569|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294570|NCT03127943|Lidocaine|lidocaine|mesh-list
92294571|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
92294572|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
92294573|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294574|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294575|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
92294576|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294577|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92294578|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92294579|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92294580|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294581|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294582|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92294583|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92294584|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92294585|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294586|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294587|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92294588|NCT03048383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294589|NCT03048383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294590|NCT03048383|Cholinergic Agents|cholinergic agents|mesh-ancestor
92294591|NCT03048383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294592|NCT02045264|Icatibant|icatibant|mesh-list
92294593|NCT02045264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294594|NCT02045264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294596|NCT02045264|Sensory System Agents|sensory system agents|mesh-ancestor
92294597|NCT02045264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294598|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294599|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294600|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294601|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92294602|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92294603|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294604|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92294606|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
92294607|NCT02975297|Exenatide|exenatide|mesh-list
92294608|NCT02975297|Nicotine|nicotine|mesh-list
92294609|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92294610|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
92294611|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294612|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294613|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92294614|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92294615|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
92294616|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294617|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294618|NCT02975297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92294619|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92294620|NCT02975297|Incretins|incretins|mesh-ancestor
92294621|NCT02975297|Hormones|hormones|mesh-ancestor
92294622|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294623|NCT02046200|Ethanol|ethanol|mesh-list
92294624|NCT02046200|Ivermectin|ivermectin|mesh-list
92294625|NCT02046200|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92294626|NCT02046200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294627|NCT02046200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294628|NCT02046200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294629|NCT02046200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92294630|NCT02978339|Curcumin|curcumin|mesh-list
92294631|NCT02978339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294632|NCT02978339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294633|NCT02978339|Analgesics|analgesics|mesh-ancestor
92294634|NCT02978339|Sensory System Agents|sensory system agents|mesh-ancestor
92294635|NCT02978339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294636|NCT02978339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294637|NCT02978339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294638|NCT02978339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294639|NCT02978339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294640|NCT02978339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294641|NCT02978339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294642|NCT02367872|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
92294643|NCT02367872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294644|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294645|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92294646|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92294647|NCT00374855|Diuretics|diuretics|mesh-ancestor
92294648|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
92294649|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294650|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92294651|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294652|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294653|NCT02412644|Apremilast|apremilast|mesh-list
92294654|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294655|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294656|NCT02412644|Analgesics|analgesics|mesh-ancestor
92294657|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
92294658|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294659|NCT02412644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294660|NCT02412644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294661|NCT02412644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294662|NCT02412644|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92294663|NCT02412644|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92294664|NCT02412644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294665|NCT02412644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294666|NCT02413034|Vancomycin|vancomycin|mesh-list
92294667|NCT02413034|Cefazolin|cefazolin|mesh-list
92294668|NCT02413034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346353|NCT04589754|Ifosfamide|ifosfamide|mesh-list
92294669|NCT02413034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294671|NCT04737473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294672|NCT04737473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294673|NCT02369900|Esmolol|esmolol|mesh-list
92294674|NCT02369900|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92294675|NCT02369900|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92294676|NCT02369900|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294677|NCT02369900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294678|NCT02369900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294679|NCT02369900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294680|NCT02369900|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92294681|NCT03054857|Dexmedetomidine|dexmedetomidine|mesh-list
92294682|NCT03054857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92294683|NCT03054857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294684|NCT03054857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294685|NCT03054857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294686|NCT03054857|Analgesics|analgesics|mesh-ancestor
92294687|NCT03054857|Sensory System Agents|sensory system agents|mesh-ancestor
92294688|NCT03054857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294689|NCT03054857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92294690|NCT03054857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92294691|NCT03054857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294692|NCT03054857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294693|NCT03054857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294694|NCT03054857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294695|NCT02414204|Sildenafil Citrate|sildenafil citrate|mesh-list
92294696|NCT02414204|Vasodilator Agents|vasodilator agents|mesh-ancestor
92294697|NCT02414204|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92294698|NCT02414204|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92294699|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294700|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294701|NCT02414204|Urological Agents|urological agents|mesh-ancestor
92294702|NCT02989493|Doxazosin|doxazosin|mesh-list
92294703|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92294704|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92294705|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92294706|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92294707|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294708|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294709|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294710|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294711|NCT02050334|Caffeic acid|caffeic acid|mesh-list
92294712|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
92294713|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294714|NCT02050334|Protective Agents|protective agents|mesh-ancestor
92294715|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294716|NCT02371850|Nicotine|nicotine|mesh-list
92294717|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92294718|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
92294719|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294720|NCT02371850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294721|NCT02371850|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92294722|NCT02371850|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92294723|NCT02371850|Cholinergic Agents|cholinergic agents|mesh-ancestor
92294724|NCT02371850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294725|NCT02371850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294726|NCT03144635|Grazoprevir|grazoprevir|mesh-list
92294727|NCT03144635|Antiviral Agents|antiviral agents|mesh-ancestor
92294728|NCT03144635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294729|NCT03145259|Diclofenac|diclofenac|mesh-list
92294730|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92294731|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92294732|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294733|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294734|NCT03145259|Analgesics|analgesics|mesh-ancestor
92294735|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
92294736|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294737|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294738|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294739|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294740|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92294741|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294742|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294743|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92294744|NCT00354692|Ferric gluconate|ferric gluconate|mesh-list
92294745|NCT00354692|Hematinics|hematinics|mesh-ancestor
92294746|NCT02989727|Lamotrigine|lamotrigine|mesh-list
92294747|NCT02989727|Anticonvulsants|anticonvulsants|mesh-ancestor
92294748|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92294749|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294750|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294751|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92294752|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294753|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92294754|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92294755|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294756|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294757|NCT02989727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92294758|NCT02039947|Trametinib|trametinib|mesh-list
92294759|NCT02039947|Dabrafenib|dabrafenib|mesh-list
92294760|NCT02039947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294761|NCT02039947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92294762|NCT02039947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294763|NCT02039947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294764|NCT02052752|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92294765|NCT02052752|Dermatologic Agents|dermatologic agents|mesh-ancestor
92294766|NCT02996591|Dexamethasone|dexamethasone|mesh-list
92294767|NCT02996591|Dexamethasone acetate|dexamethasone acetate|mesh-list
92294768|NCT02996591|Midazolam|midazolam|mesh-list
92294769|NCT02996591|Glycopyrrolate|glycopyrrolate|mesh-list
92294770|NCT02996591|Ketamine|ketamine|mesh-list
92294771|NCT02996591|Bupivacaine|bupivacaine|mesh-list
92294772|NCT02996591|Mepivacaine|mepivacaine|mesh-list
92294773|NCT02996591|Anesthetics|anesthetics|mesh-list
92294774|NCT02996591|Propofol|propofol|mesh-list
92294775|NCT02996591|Sevoflurane|sevoflurane|mesh-list
92294776|NCT02996591|BB 1101|bb 1101|mesh-list
92294777|NCT02996591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294778|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
92294779|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
92294780|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294781|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294782|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294783|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
92294784|NCT02996591|Hormones|hormones|mesh-ancestor
92294785|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294786|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294787|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294788|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92294789|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294790|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294791|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
92294792|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294793|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
92294794|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92294795|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294796|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
92294797|NCT02996591|Analgesics|analgesics|mesh-ancestor
92294798|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92294799|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92294800|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92294801|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294802|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92294803|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92294804|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92294805|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294806|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
92294807|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
92346361|NCT01803282|Leucovorin|leucovorin|mesh-list
92294808|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92294809|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92294810|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92294811|NCT02996591|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92294812|NCT02996591|Cholinergic Agents|cholinergic agents|mesh-ancestor
92294814|NCT03066947|Interferon-alpha|interferon-alpha|mesh-list
92294815|NCT03066947|Interferon alpha-2|interferon alpha-2|mesh-list
92294816|NCT03066947|Cyclophosphamide|cyclophosphamide|mesh-list
92294817|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294818|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
92294819|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294820|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294821|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92294822|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
92294823|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294824|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294825|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92294827|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294828|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
92294829|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92294830|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92294831|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92294832|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294833|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294834|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
92294835|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294836|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294837|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92294838|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294839|NCT02062801|Ephedrine|ephedrine|mesh-list
92294840|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92294841|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294842|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
92294843|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
92294844|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294845|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92294846|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294847|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294848|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294849|NCT03152591|Licogliflozin|licogliflozin|mesh-list
92294850|NCT03152591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92294851|NCT03152591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294852|NCT03152591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92294853|NCT03152591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294854|NCT02063035|Tranexamic Acid|tranexamic acid|mesh-list
92294855|NCT02063035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92294856|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92294857|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294858|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
92294859|NCT02063035|Coagulants|coagulants|mesh-ancestor
92294860|NCT00375245|Sirolimus|sirolimus|mesh-list
92294861|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92294862|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294863|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92294864|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294865|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
92294866|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294867|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
92294868|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294869|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92294870|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
92294871|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294872|NCT02054156|Azithromycin|azithromycin|mesh-list
92294873|NCT02054156|Tobramycin|tobramycin|mesh-list
92294874|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92294875|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294876|NCT03159143|Docetaxel|docetaxel|mesh-list
92294877|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
92294878|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294879|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
92294880|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92346368|NCT01803282|Irinotecan|irinotecan|mesh-list
92294881|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92294882|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294883|NCT03068897|Ibuprofen|ibuprofen|mesh-list
92294884|NCT03068897|Tizanidine|tizanidine|mesh-list
92294885|NCT03068897|Baclofen|baclofen|mesh-list
92294886|NCT03068897|Metaxalone|metaxalone|mesh-list
92294887|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92294888|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92294889|NCT03068897|Analgesics|analgesics|mesh-ancestor
92294890|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
92294891|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936128|NCT03132181|Empagliflozin|empagliflozin|mesh-list
92294892|NCT03068897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294893|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294894|NCT03068897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92294895|NCT03068897|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92294896|NCT03068897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294897|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294898|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92294900|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92294901|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
92294902|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
92294903|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294904|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
92294905|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
92294906|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
92294907|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92294908|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92294909|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92294910|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
92294911|NCT02049476|Dexamethasone|dexamethasone|mesh-list
92294912|NCT02049476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294913|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
92294914|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
92294915|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92294916|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294917|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294918|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
92294919|NCT02049476|Hormones|hormones|mesh-ancestor
92294920|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294921|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92294922|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92294923|NCT02299297|Tofacitinib|tofacitinib|mesh-list
92294924|NCT02299297|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92294925|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92294926|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294927|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294928|NCT03069677|Midazolam|midazolam|mesh-list
92294929|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92294930|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92294931|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294932|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294933|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92294934|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92294935|NCT03069677|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294936|NCT03069677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92294937|NCT03069677|Anesthetics, General|anesthetics, general|mesh-ancestor
92294938|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
92294939|NCT03069677|GABA Modulators|gaba modulators|mesh-ancestor
92294940|NCT03069677|GABA Agents|gaba agents|mesh-ancestor
92294941|NCT03069677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294942|NCT03069677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294943|NCT02044393|Itraconazole|itraconazole|mesh-list
92294944|NCT02044393|Antifungal Agents|antifungal agents|mesh-ancestor
92294945|NCT02044393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92294946|NCT02044393|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92294947|NCT02044393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92294948|NCT02044393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294949|NCT02044393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294951|NCT02044393|Hormone Antagonists|hormone antagonists|mesh-ancestor
92294952|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92294953|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294954|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92294955|NCT05405465|Golimumab|golimumab|mesh-list
92294956|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92294957|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92294958|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92294959|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
92294960|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294961|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
92294962|NCT02064907|Lansoprazole|lansoprazole|mesh-list
92294963|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92294964|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92294965|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92294966|NCT02064907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294967|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294968|NCT02064985|Ticagrelor|ticagrelor|mesh-list
92294969|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92294970|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92294971|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92294972|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92294973|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
92294974|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294975|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294976|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294977|NCT03170219|Furosemide|furosemide|mesh-list
92294978|NCT03170219|Diuretics|diuretics|mesh-ancestor
92294979|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
92294980|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294981|NCT03170219|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92294982|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92294983|NCT03170219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294984|NCT00375557|Valproic Acid|valproic acid|mesh-list
92294985|NCT00375557|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92294986|NCT00375557|Antidepressive Agents|antidepressive agents|mesh-ancestor
92294987|NCT00375557|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92294988|NCT00375557|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92294989|NCT00375557|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92294990|NCT00375557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92294991|NCT00375557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92294992|NCT00375557|Anticonvulsants|anticonvulsants|mesh-ancestor
92294993|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92294994|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92294995|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
92294996|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92294997|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
92294998|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
92294999|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92295000|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
92295001|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295002|NCT03177395|Expectorants|expectorants|mesh-ancestor
92295003|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
92295004|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92295005|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
92295006|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295007|NCT03177395|Protective Agents|protective agents|mesh-ancestor
92295008|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295009|NCT03177395|Antidotes|antidotes|mesh-ancestor
92295010|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
92295011|NCT05282069|DA-8010|da-8010|mesh-list
92295012|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92295013|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92295014|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
92295015|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295016|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295017|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295018|NCT05282069|Urological Agents|urological agents|mesh-ancestor
92295019|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
92295020|NCT03179345|Pregabalin|pregabalin|mesh-list
92295021|NCT03179345|Gabapentin|gabapentin|mesh-list
92295022|NCT03179345|Analgesics|analgesics|mesh-ancestor
92295023|NCT03179345|Sensory System Agents|sensory system agents|mesh-ancestor
92295024|NCT03179345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295025|NCT03179345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295026|NCT03179345|Anticonvulsants|anticonvulsants|mesh-ancestor
92295027|NCT03179345|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92295028|NCT03179345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92295029|NCT03179345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295030|NCT03179345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92295031|NCT03179345|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92295032|NCT03179345|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92295033|NCT03179345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295034|NCT03179345|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92295035|NCT03179345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92295036|NCT03179345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92295037|NCT03179345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295038|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
92295039|NCT03086213|Lidocaine|lidocaine|mesh-list
92295040|NCT03086213|Sufentanil|sufentanil|mesh-list
92295041|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
92295043|NCT03086213|Ropivacaine|ropivacaine|mesh-list
92295044|NCT03086213|Propofol|propofol|mesh-list
92295046|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
92295047|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295048|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295049|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
92295050|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295051|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92295052|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92295053|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92295054|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92295055|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295056|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92295057|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92295058|NCT03086213|Analgesics|analgesics|mesh-ancestor
92295059|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92295060|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92295061|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92295062|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295063|NCT03086213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295064|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92295065|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
92295066|NCT03086213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92295067|NCT03086213|Narcotics|narcotics|mesh-ancestor
92295068|NCT03086213|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92295069|NCT02378714|Varenicline|varenicline|mesh-list
91947852|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295070|NCT02378714|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92295071|NCT02378714|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92295072|NCT02378714|Cholinergic Agents|cholinergic agents|mesh-ancestor
92295073|NCT02378714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295074|NCT02378714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295075|NCT02378714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295076|NCT03091673|Glucagon|glucagon|mesh-list
92295077|NCT03091673|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92295078|NCT03091673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92295079|NCT03091673|Hormones|hormones|mesh-ancestor
92346390|NCT01803282|Vitamins|vitamins|mesh-ancestor
92295080|NCT03091673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295081|NCT03091673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295083|NCT02382848|Prazosin|prazosin|mesh-list
92295084|NCT02382848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92295085|NCT02382848|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92295086|NCT02382848|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92295087|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92295088|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295089|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295090|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295091|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295092|NCT02065687|Metformin|metformin|mesh-list
92295093|NCT02065687|Paclitaxel|paclitaxel|mesh-list
92295094|NCT02065687|Carboplatin|carboplatin|mesh-list
92295095|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92295096|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92295097|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295098|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92295099|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92295100|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92295101|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295102|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92295103|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295104|NCT03096353|Naloxone|naloxone|mesh-list
92295105|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92295106|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295107|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
92295108|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295109|NCT03098615|Efinaconazole|efinaconazole|mesh-list
92295110|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
92295111|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295112|NCT05363501|Naloxone|naloxone|mesh-list
92295114|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295115|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
92295116|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295117|NCT04736927|Midazolam|midazolam|mesh-list
92295118|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92295119|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92295120|NCT04736927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295121|NCT04736927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295122|NCT04736927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92295123|NCT04736927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92295124|NCT04736927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92295125|NCT04736927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92295126|NCT04736927|Anesthetics, General|anesthetics, general|mesh-ancestor
92295127|NCT04736927|Anesthetics|anesthetics|mesh-ancestor
92295128|NCT04736927|GABA Modulators|gaba modulators|mesh-ancestor
92295129|NCT04736927|GABA Agents|gaba agents|mesh-ancestor
92295130|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295131|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295132|NCT03810703|Amphetamine|amphetamine|mesh-list
92295133|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
92295134|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92295135|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295136|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
92295137|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
92295138|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295139|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
92295140|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295141|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295142|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295143|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92295144|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92295145|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92295146|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92295148|NCT02389088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295149|NCT02389088|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92295150|NCT02389088|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92295151|NCT02389088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295152|NCT02389088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295153|NCT02389088|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92295154|NCT02389088|Hormone Antagonists|hormone antagonists|mesh-ancestor
92295155|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295156|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295157|NCT02068027|Clonidine|clonidine|mesh-list
92295158|NCT02068027|Analgesics|analgesics|mesh-ancestor
92295159|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
92295160|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295161|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295162|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92295163|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
92295164|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
92295165|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92295166|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92295167|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92295168|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295169|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295170|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295171|NCT02392208|Telavancin|telavancin|mesh-list
92295172|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92295173|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295174|NCT05185583|Methylphenidate|methylphenidate|mesh-list
92295175|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92295176|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295177|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92295178|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92295179|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92295180|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295181|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
92295182|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295183|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
92295184|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
91936133|NCT02320045|Exenatide|exenatide|mesh-list
92295185|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295187|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295188|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295190|NCT04603937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92295191|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92295192|NCT04603937|Growth Substances|growth substances|mesh-ancestor
92295193|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295194|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
92295195|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295196|NCT02392286|Prednisone|prednisone|mesh-list
92295197|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
92295198|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295199|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
92295200|NCT02392286|Hormones|hormones|mesh-ancestor
92295201|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295202|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295203|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295204|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295205|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
92295206|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
92295207|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295208|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92295209|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92295210|NCT02392286|Protective Agents|protective agents|mesh-ancestor
92295211|NCT04586153|Meplazumab|meplazumab|mesh-list
92295212|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
92295213|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295214|NCT05717738|Bevacizumab|bevacizumab|mesh-list
92295215|NCT05717738|Atezolizumab|atezolizumab|mesh-list
92295216|NCT05717738|Sorafenib|sorafenib|mesh-list
92295217|NCT05717738|Apatinib|apatinib|mesh-list
92295218|NCT05717738|Lenvatinib|lenvatinib|mesh-list
92295219|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92295220|NCT05717738|Antibodies|antibodies|mesh-list
91948005|NCT02305901|Repaglinide|repaglinide|mesh-list
92295221|NCT05717738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92295222|NCT05717738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92295223|NCT05717738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295224|NCT05717738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92295225|NCT05717738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92295226|NCT05717738|Growth Substances|growth substances|mesh-ancestor
92295227|NCT05717738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295228|NCT05717738|Growth Inhibitors|growth inhibitors|mesh-ancestor
92295229|NCT05717738|Immunologic Factors|immunologic factors|mesh-ancestor
92295230|NCT05717738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92295231|NCT05717738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295232|NCT05717738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295233|NCT02393378|Folic Acid|folic acid|mesh-list
92295234|NCT02393378|Adalimumab|adalimumab|mesh-list
92295235|NCT02393378|Methotrexate|methotrexate|mesh-list
92295236|NCT02393378|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92295237|NCT02393378|Abortifacient Agents|abortifacient agents|mesh-ancestor
92295238|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92295239|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295240|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92295241|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
92295242|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295243|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295244|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
92295245|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295246|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92295247|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92295248|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
92295249|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295250|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92295251|NCT02393378|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92295252|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295253|NCT02393378|Hematinics|hematinics|mesh-ancestor
92295254|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
92295255|NCT02393378|Vitamins|vitamins|mesh-ancestor
92295256|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
92295257|NCT04949477|Acetaminophen|acetaminophen|mesh-list
92295258|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
92295259|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92295260|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295262|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92295263|NCT04949477|Analgesics|analgesics|mesh-ancestor
92295265|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295266|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92295267|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92295268|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92295269|NCT04949477|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295270|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295271|NCT04949477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295272|NCT04949477|Antipyretics|antipyretics|mesh-ancestor
92295273|NCT04873895|Hydroxychloroquine|hydroxychloroquine|mesh-list
92295274|NCT04873895|Axitinib|axitinib|mesh-list
92295275|NCT04873895|Antimalarials|antimalarials|mesh-ancestor
92295276|NCT04873895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92295277|NCT04873895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92295278|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295279|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295280|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295281|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295282|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295283|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92295284|NCT05717582|Androgens|androgens|mesh-list
92295285|NCT05717582|Hormones|hormones|mesh-ancestor
92295286|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295287|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295288|NCT03101033|Betamethasone|betamethasone|mesh-list
92295289|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
92295290|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92295291|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
92346410|NCT01611090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295292|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92295293|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295295|NCT03101033|Hormones|hormones|mesh-ancestor
92295296|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295297|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295298|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92295299|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
92295300|NCT02069041|Leucovorin|leucovorin|mesh-list
92295301|NCT02069041|Fluorouracil|fluorouracil|mesh-list
92295302|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
92295303|NCT02069041|Ramucirumab|ramucirumab|mesh-list
92295304|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
92295305|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295306|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92295307|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295308|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92295309|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
92295310|NCT02069041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295311|NCT02069041|Antidotes|antidotes|mesh-ancestor
92295312|NCT02069041|Protective Agents|protective agents|mesh-ancestor
92295313|NCT02069041|Vitamin B Complex|vitamin b complex|mesh-ancestor
92295314|NCT02069041|Vitamins|vitamins|mesh-ancestor
92295315|NCT02069041|Micronutrients|micronutrients|mesh-ancestor
92295316|NCT04920344|Cisplatin|cisplatin|mesh-list
92295317|NCT04920344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295318|NCT03101111|Vaccines|vaccines|mesh-list
92295319|NCT03101111|Immunologic Factors|immunologic factors|mesh-ancestor
92295320|NCT03101111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295321|NCT05423834|Tenofovir|tenofovir|mesh-list
92295322|NCT05423834|Entecavir|entecavir|mesh-list
92295323|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
92295324|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295325|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92295326|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92295327|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295328|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295329|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92295330|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92295331|NCT03103061|Regadenoson|regadenoson|mesh-list
92295332|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92410039|NCT05508100|Pembrolizumab|pembrolizumab|mesh-list
92295333|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92295334|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
92295335|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
92295336|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295337|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295339|NCT03105479|Vancomycin|vancomycin|mesh-list
92295340|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92295341|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295342|NCT00355862|Cyclosporine|cyclosporine|mesh-list
92295343|NCT00355862|Sirolimus|sirolimus|mesh-list
92295344|NCT00355862|Prednisolone|prednisolone|mesh-list
92295345|NCT00355862|Temsirolimus|temsirolimus|mesh-list
92295346|NCT00355862|Azathioprine|azathioprine|mesh-list
92295347|NCT00355862|MTOR Inhibitors|mtor inhibitors|mesh-list
92295348|NCT00355862|Tacrolimus|tacrolimus|mesh-list
92295349|NCT00355862|Cyclosporins|cyclosporins|mesh-list
92295350|NCT00355862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92295351|NCT00355862|Immunologic Factors|immunologic factors|mesh-ancestor
92295352|NCT00355862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295353|NCT00355862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92295354|NCT00355862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295355|NCT00355862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295356|NCT00355862|Antifungal Agents|antifungal agents|mesh-ancestor
92295357|NCT00355862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295358|NCT00355862|Dermatologic Agents|dermatologic agents|mesh-ancestor
92295359|NCT00355862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295360|NCT00355862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92295361|NCT00355862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92295362|NCT00355862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295363|NCT00355862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92295364|NCT00355862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295365|NCT00355862|Glucocorticoids|glucocorticoids|mesh-ancestor
92295366|NCT00355862|Hormones|hormones|mesh-ancestor
92295367|NCT00355862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295368|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295369|NCT00355862|Antimetabolites|antimetabolites|mesh-ancestor
92295370|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92295371|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
92295372|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92295373|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
92295374|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295375|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295376|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92295377|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
92295378|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295379|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295380|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92295382|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92295383|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92295384|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92295385|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92295386|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295387|NCT00355628|Fentanyl|fentanyl|mesh-list
92295388|NCT00355628|Citric Acid|citric acid|mesh-list
92295389|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
92295390|NCT00355628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92295391|NCT00355628|Narcotics|narcotics|mesh-ancestor
92295392|NCT00355628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295393|NCT00355628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295394|NCT00355628|Analgesics|analgesics|mesh-ancestor
92295395|NCT00355628|Sensory System Agents|sensory system agents|mesh-ancestor
92295396|NCT00355628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295397|NCT00355628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92295398|NCT00355628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92295399|NCT00355628|Anesthetics, General|anesthetics, general|mesh-ancestor
92295400|NCT00355628|Anesthetics|anesthetics|mesh-ancestor
92295401|NCT00355628|Anticoagulants|anticoagulants|mesh-ancestor
92295402|NCT00355628|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92295403|NCT00355628|Chelating Agents|chelating agents|mesh-ancestor
92295404|NCT00355628|Sequestering Agents|sequestering agents|mesh-ancestor
92295405|NCT00355628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295406|NCT02049385|Diazoxide|diazoxide|mesh-list
92295407|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92295408|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
92295409|NCT03717155|Carboplatin|carboplatin|mesh-list
92295410|NCT03717155|Gemcitabine|gemcitabine|mesh-list
92295411|NCT03717155|Cetuximab|cetuximab|mesh-list
92295412|NCT03717155|Avelumab|avelumab|mesh-list
92295413|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295414|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92295415|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
92295416|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295417|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92295418|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
92295419|NCT03789097|Poly ICLC|poly iclc|mesh-list
92295420|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92295421|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295422|NCT03789097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92295423|NCT03789097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295424|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
92295425|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
92295426|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295427|NCT03655613|Nivolumab|nivolumab|mesh-list
92295428|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92295429|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295430|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92295431|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295432|NCT04820036|Insulin|insulin|mesh-list
92295433|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92295434|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295435|NCT03286829|Metoprolol|metoprolol|mesh-list
92295436|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92295437|NCT03286829|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92295438|NCT03286829|Sympatholytics|sympatholytics|mesh-ancestor
92295439|NCT03286829|Autonomic Agents|autonomic agents|mesh-ancestor
92295440|NCT03286829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295441|NCT03286829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295442|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92295443|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92295444|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92295445|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
92295446|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295447|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295448|NCT02051335|Scopolamine|scopolamine|mesh-list
92295449|NCT02051335|Donepezil|donepezil|mesh-list
92295450|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92295451|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92295452|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295453|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295454|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
92295455|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295456|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295457|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
92295458|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92295459|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
92295460|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
92295461|NCT02051335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295462|NCT02051335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92295463|NCT02051335|Mydriatics|mydriatics|mesh-ancestor
92295464|NCT02051335|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92295465|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92295466|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
92295467|NCT03290027|Tazarotene|tazarotene|mesh-list
92295468|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
92295469|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
92295470|NCT02300077|Fentanyl|fentanyl|mesh-list
92295471|NCT02300077|Morphine|morphine|mesh-list
92295472|NCT02300077|Methadone|methadone|mesh-list
92295473|NCT02300077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92295474|NCT02300077|Narcotics|narcotics|mesh-ancestor
92295475|NCT02300077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295476|NCT02300077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295477|NCT02300077|Analgesics|analgesics|mesh-ancestor
92295478|NCT02300077|Sensory System Agents|sensory system agents|mesh-ancestor
92295479|NCT02300077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295480|NCT02300077|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92295481|NCT02300077|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92295482|NCT02300077|Anesthetics, General|anesthetics, general|mesh-ancestor
92295483|NCT02300077|Anesthetics|anesthetics|mesh-ancestor
92295484|NCT02300077|Antitussive Agents|antitussive agents|mesh-ancestor
92295485|NCT02300077|Respiratory System Agents|respiratory system agents|mesh-ancestor
92295486|NCT05272826|Dexamethasone|dexamethasone|mesh-list
92295487|NCT05272826|Bortezomib|bortezomib|mesh-list
92295488|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295489|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
92295490|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
92295491|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295492|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295493|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92295494|NCT05272826|Glucocorticoids|glucocorticoids|mesh-ancestor
92295495|NCT05272826|Hormones|hormones|mesh-ancestor
92295496|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295497|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295498|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295499|NCT03458429|Lenograstim|lenograstim|mesh-list
92295500|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92295501|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
92295502|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295503|NCT03291197|Bupivacaine|bupivacaine|mesh-list
92295504|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
92295505|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
92295506|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295507|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295508|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
92295509|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295510|NCT05638880|Empagliflozin|empagliflozin|mesh-list
92295511|NCT05638880|Valsartan|valsartan|mesh-list
92295512|NCT05638880|Levocetirizine|levocetirizine|mesh-list
92295513|NCT05638880|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92295514|NCT05638880|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92295515|NCT05638880|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92295516|NCT05638880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295517|NCT05638880|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92295518|NCT05638880|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92295519|NCT05638880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295520|NCT05638880|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92295521|NCT05638880|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92295522|NCT05638880|Histamine Antagonists|histamine antagonists|mesh-ancestor
92295523|NCT05638880|Histamine Agents|histamine agents|mesh-ancestor
92295524|NCT05638880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295525|NCT00356096|Pramipexole|pramipexole|mesh-list
92295526|NCT00356096|Antioxidants|antioxidants|mesh-ancestor
92295527|NCT00356096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295528|NCT00356096|Protective Agents|protective agents|mesh-ancestor
92295529|NCT00356096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295530|NCT00356096|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92295531|NCT00356096|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92295532|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
92295533|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
92295534|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295535|NCT05637086|Phenytoin|phenytoin|mesh-list
92295536|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
92295537|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92295538|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295539|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295540|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92295541|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92295542|NCT05637086|Protective Agents|protective agents|mesh-ancestor
92295543|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295544|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
92295545|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92295546|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
92295547|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
91936149|NCT03498235|Propofol|propofol|mesh-list
92295548|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92295549|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92295550|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92410040|NCT05508100|Tislelizumab|tislelizumab|mesh-list
92295551|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92295552|NCT05637086|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92295553|NCT03243461|Temozolomide|temozolomide|mesh-list
92295554|NCT03243461|Valproic Acid|valproic acid|mesh-list
92295555|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92295556|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
92295557|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295558|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295559|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
92295560|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295561|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
92295562|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295563|NCT03243461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295564|NCT03243461|Antimanic Agents|antimanic agents|mesh-ancestor
92295565|NCT03243461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92295566|NCT03243461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295567|NCT03243461|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92295568|NCT03296345|Ketamine|ketamine|mesh-list
92295569|NCT03296345|Analgesics|analgesics|mesh-ancestor
92295570|NCT03296345|Sensory System Agents|sensory system agents|mesh-ancestor
92295571|NCT03296345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295572|NCT03296345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295573|NCT03296345|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92295574|NCT03296345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92295575|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
92295576|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
92295577|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295578|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92295579|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92295580|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295581|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295582|NCT00421694|Bicalutamide|bicalutamide|mesh-list
92295583|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
92295584|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
92295585|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295586|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295587|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295588|NCT00376181|Pioglitazone|pioglitazone|mesh-list
92295589|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92295590|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92295591|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295592|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92295593|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92295594|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295595|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
92295596|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92295597|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92295598|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295599|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92295600|NCT04736693|Hormone Antagonists|hormone antagonists|mesh-ancestor
92295601|NCT04736693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295602|NCT04736693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92295603|NCT04736693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92295605|NCT04652414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295606|NCT04652414|Glucocorticoids|glucocorticoids|mesh-ancestor
92295608|NCT04652414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295609|NCT04652414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295610|NCT04652414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295611|NCT04652414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295613|NCT04630964|Psilocybin|psilocybin|mesh-list
92295614|NCT04630964|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92295615|NCT04630964|Antimetabolites|antimetabolites|mesh-ancestor
92295616|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295617|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92295618|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
92295619|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
92295620|NCT04630964|Vitamins|vitamins|mesh-ancestor
92295621|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
92295622|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295623|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
92295624|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92295625|NCT05595044|Vitamin D|vitamin d|mesh-list
92295626|NCT05595044|Vitamins|vitamins|mesh-ancestor
92295627|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
92295628|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295629|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92295630|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
92295631|NCT04736381|Abatacept|abatacept|mesh-list
92295632|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92295633|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295634|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92295635|NCT04736381|Antitubercular Agents|antitubercular agents|mesh-ancestor
92295636|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92295637|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295638|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295639|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295640|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92295641|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
92295642|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295643|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92295644|NCT04736381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92295645|NCT04736381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295646|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
92295647|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92295648|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92295649|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295650|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
92295651|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295652|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295653|NCT02792465|Fulvestrant|fulvestrant|mesh-list
92295654|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295655|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295656|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92295657|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92295658|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
92295659|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295660|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295661|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
92295662|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92295663|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295664|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
92295665|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295666|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295667|NCT04525820|Vitamin D|vitamin d|mesh-list
92295668|NCT04525820|Ergocalciferols|ergocalciferols|mesh-list
92295669|NCT04525820|Cholecalciferol|cholecalciferol|mesh-list
92295670|NCT04525820|Vitamins|vitamins|mesh-list
92295671|NCT04525820|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92295672|NCT04525820|Micronutrients|micronutrients|mesh-ancestor
92295673|NCT04525820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295674|NCT04525820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92295675|NCT04525820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92295677|NCT05570708|Hallucinogens|hallucinogens|mesh-ancestor
92295678|NCT05570708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295679|NCT05570708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92295680|NCT03305159|Chlorhexidine|chlorhexidine|mesh-list
92295681|NCT03305159|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92295682|NCT03305159|Povidone-Iodine|povidone-iodine|mesh-list
92295683|NCT03305159|Povidone|povidone|mesh-list
92295684|NCT03305159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92295685|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295686|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
92295687|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92295688|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
92295689|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
92295690|NCT05552144|Listerine|listerine|mesh-list
92295691|NCT05552144|Sodium Fluoride|sodium fluoride|mesh-list
92295692|NCT05552144|Cariostatic Agents|cariostatic agents|mesh-ancestor
92295693|NCT05552144|Protective Agents|protective agents|mesh-ancestor
92295694|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295695|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92295696|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295698|NCT03308669|Lasmiditan|lasmiditan|mesh-list
92295699|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
92295701|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295702|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92295703|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
92295704|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295705|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295706|NCT00356252|Carotenoids|carotenoids|mesh-list
92295707|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
92295708|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295709|NCT00356252|Protective Agents|protective agents|mesh-ancestor
92295710|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295711|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92295712|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
92295713|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92295714|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92295715|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92295716|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295717|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295718|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
92295719|NCT03312023|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92295720|NCT03312023|Ledipasvir|ledipasvir|mesh-list
92295721|NCT03312023|Antiviral Agents|antiviral agents|mesh-ancestor
92295722|NCT03312023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295723|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92295724|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
92295725|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92295726|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
92295727|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92295728|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295729|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92295730|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295731|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295732|NCT02344225|Ibuprofen|ibuprofen|mesh-list
92295733|NCT02344225|Ketorolac|ketorolac|mesh-list
92295734|NCT02344225|Caffeine|caffeine|mesh-list
92295735|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
92295736|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295737|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92295738|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92295739|NCT02344225|Analgesics|analgesics|mesh-ancestor
92295740|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
92295741|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295742|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295743|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295744|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295745|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92295746|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295747|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92295748|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92295749|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92295750|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92295751|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
92295752|NCT02344225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295753|NCT04319588|Anesthetics|anesthetics|mesh-list
92295754|NCT04319588|Anesthetics, Local|anesthetics, local|mesh-list
92295755|NCT04319588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295756|NCT04319588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295757|NCT04319588|Sensory System Agents|sensory system agents|mesh-ancestor
92295758|NCT04319588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295759|NCT04298606|Vaccines|vaccines|mesh-list
92295760|NCT04298606|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92295761|NCT04298606|Mitogens|mitogens|mesh-list
92295762|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
92295763|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295764|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
92295765|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295766|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92295767|NCT03769844|Molgramostim|molgramostim|mesh-list
92295768|NCT03769844|Sargramostim|sargramostim|mesh-list
92295769|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
92295770|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295771|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295772|NCT02347345|Sofosbuvir|sofosbuvir|mesh-list
92295773|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92295774|NCT02347345|Ledipasvir|ledipasvir|mesh-list
92295775|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
92295776|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295777|NCT03319277|Opiate Alkaloids|opiate alkaloids|mesh-list
92295778|NCT03319277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92295779|NCT03319277|Narcotics|narcotics|mesh-ancestor
92295780|NCT03319277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295781|NCT03319277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295782|NCT03319277|Analgesics|analgesics|mesh-ancestor
92295783|NCT03319277|Sensory System Agents|sensory system agents|mesh-ancestor
92295784|NCT03319277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295785|NCT03768440|Ropivacaine|ropivacaine|mesh-list
92295786|NCT03768440|Anesthetics, Local|anesthetics, local|mesh-ancestor
92295787|NCT03768440|Anesthetics|anesthetics|mesh-ancestor
92295788|NCT03768440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295789|NCT03768440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295790|NCT03768440|Sensory System Agents|sensory system agents|mesh-ancestor
92295791|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295792|NCT04624295|Aspirin|aspirin|mesh-list
92295793|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92295794|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92295795|NCT04624295|Analgesics|analgesics|mesh-ancestor
92295796|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
92295797|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295798|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295799|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295800|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92295801|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92295802|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92295803|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295804|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92295805|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92295806|NCT04624295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295807|NCT04624295|Antipyretics|antipyretics|mesh-ancestor
92295808|NCT03323801|Tretinoin|tretinoin|mesh-list
92295809|NCT03323801|Isotretinoin|isotretinoin|mesh-list
92295810|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295811|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
92295812|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92295813|NCT04450355|Nefopam|nefopam|mesh-list
92295814|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92295815|NCT04450355|Analgesics|analgesics|mesh-ancestor
92295816|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
92295817|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295818|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295819|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
92295820|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92295821|NCT02352259|Bleomycin|bleomycin|mesh-list
92295822|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92295823|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295824|NCT03326999|Bupivacaine|bupivacaine|mesh-list
92295825|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948604|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
92295826|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
92295827|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295828|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295829|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
92295830|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295832|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92295833|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295834|NCT00356720|Azithromycin|azithromycin|mesh-list
92295835|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92295836|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295837|NCT04121780|Hormones|hormones|mesh-list
92295838|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295839|NCT04121780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295840|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
92295841|NCT00375869|Hematinics|hematinics|mesh-ancestor
92295842|NCT03198221|Picosulfate sodium|picosulfate sodium|mesh-list
92295843|NCT03198221|Magnesium Oxide|magnesium oxide|mesh-list
92295844|NCT03198221|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92295845|NCT03198221|Citric Acid|citric acid|mesh-list
92295847|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92295848|NCT03198221|Anticoagulants|anticoagulants|mesh-ancestor
92295849|NCT03198221|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92295850|NCT03198221|Chelating Agents|chelating agents|mesh-ancestor
92295851|NCT03198221|Sequestering Agents|sequestering agents|mesh-ancestor
92295852|NCT03198221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295854|NCT03198221|Laxatives|laxatives|mesh-ancestor
92295855|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
92295856|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92295857|NCT03203681|Testosterone|testosterone|mesh-list
92295858|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
92295859|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
92295860|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295861|NCT03203681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295862|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
92295863|NCT03203681|Hormones|hormones|mesh-ancestor
92295864|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295865|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295866|NCT03203681|Androgens|androgens|mesh-ancestor
92295867|NCT02399917|Azacitidine|azacitidine|mesh-list
92295868|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92295869|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
92295870|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295871|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295872|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295873|NCT00356486|Ribavirin|ribavirin|mesh-list
92295874|NCT00356486|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92295875|NCT00356486|Interferon-alpha|interferon-alpha|mesh-list
92295876|NCT00356486|Antimetabolites|antimetabolites|mesh-ancestor
92295877|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295878|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
92295879|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92295880|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
92295881|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295882|NCT03331835|Brodalumab|brodalumab|mesh-list
92295883|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
92295884|NCT02403895|Paclitaxel|paclitaxel|mesh-list
92295885|NCT02403895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92295886|NCT02403895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295887|NCT02403895|Tubulin Modulators|tubulin modulators|mesh-ancestor
92295888|NCT02403895|Antimitotic Agents|antimitotic agents|mesh-ancestor
92295889|NCT02403895|Mitosis Modulators|mitosis modulators|mesh-ancestor
92295890|NCT02403895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295891|NCT03994874|Furosemide|furosemide|mesh-list
92295892|NCT03994874|Dialysis Solutions|dialysis solutions|mesh-list
92295893|NCT03994874|Diuretics|diuretics|mesh-list
92295894|NCT03994874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92295895|NCT03994874|Natriuretic Agents|natriuretic agents|mesh-ancestor
92295896|NCT03994874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295897|NCT03994874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92295898|NCT03994874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295899|NCT03994874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92295900|NCT03987776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92295901|NCT05722340|Anesthetics|anesthetics|mesh-list
92295902|NCT05722340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92295903|NCT05722340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295904|NCT02354833|Phenylephrine|phenylephrine|mesh-list
92295905|NCT02354833|Oxymetazoline|oxymetazoline|mesh-list
92295906|NCT02354833|Norepinephrine|norepinephrine|mesh-list
92295907|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92295908|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
92295909|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
92295910|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295911|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295912|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
92295913|NCT02354833|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92295914|NCT02354833|Nasal Decongestants|nasal decongestants|mesh-ancestor
92295915|NCT02354833|Respiratory System Agents|respiratory system agents|mesh-ancestor
92295916|NCT02354833|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92295917|NCT02354833|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92295918|NCT02354833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92295920|NCT02354833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295921|NCT02354833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295922|NCT02354833|Protective Agents|protective agents|mesh-ancestor
92295923|NCT03337724|Paclitaxel|paclitaxel|mesh-list
92295924|NCT03337724|Ipatasertib|ipatasertib|mesh-list
92295925|NCT03337724|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92295926|NCT03337724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295927|NCT03337724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92295928|NCT03337724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92295929|NCT03337724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92295930|NCT03337724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295931|NCT03337724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92295932|NCT03337724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295933|NCT03838484|Nicotine|nicotine|mesh-list
92295934|NCT03838484|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92295935|NCT03838484|Autonomic Agents|autonomic agents|mesh-ancestor
92295936|NCT03838484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92295937|NCT03838484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295938|NCT03838484|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92295939|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92295940|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
92295941|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92295942|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295943|NCT03307616|Nivolumab|nivolumab|mesh-list
92295944|NCT03307616|Ipilimumab|ipilimumab|mesh-list
92295945|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92295946|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295947|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92295948|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295949|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
92295950|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
92295951|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295952|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
92295953|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295954|NCT05721872|Protective Agents|protective agents|mesh-ancestor
92295955|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295956|NCT02408965|Methylergonovine|methylergonovine|mesh-list
92295957|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
92295958|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92295959|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295960|NCT03299426|Vaccines|vaccines|mesh-list
92295961|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
92295962|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295963|NCT03220022|Prednisone|prednisone|mesh-list
92295964|NCT03220022|Cortisone|cortisone|mesh-list
92295965|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
92295966|NCT03220022|Rituximab|rituximab|mesh-list
92295967|NCT03220022|Doxorubicin|doxorubicin|mesh-list
92295968|NCT03220022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92295969|NCT03220022|Etoposide|etoposide|mesh-list
92295970|NCT03220022|Vincristine|vincristine|mesh-list
92295971|NCT03220022|Etoposide phosphate|etoposide phosphate|mesh-list
92295972|NCT03220022|Podophyllotoxin|podophyllotoxin|mesh-list
92295973|NCT03220022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92295974|NCT03220022|Antibodies|antibodies|mesh-list
92295975|NCT03220022|Immunoglobulins|immunoglobulins|mesh-list
92295976|NCT03220022|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92295977|NCT03220022|Lenograstim|lenograstim|mesh-list
92295978|NCT03220022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92295979|NCT03220022|Immunologic Factors|immunologic factors|mesh-ancestor
92295980|NCT03220022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92295982|NCT03220022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92295983|NCT03220022|Alkylating Agents|alkylating agents|mesh-ancestor
92295984|NCT03220022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92295985|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92295986|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92295987|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92295988|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92295989|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92295990|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92295991|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92295992|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
92295993|NCT03220022|Hormones|hormones|mesh-ancestor
92295994|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92295995|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92295996|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92295997|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92295998|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92295999|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296000|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296001|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
92296002|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
92296003|NCT03216356|Cycloserine|cycloserine|mesh-list
92296004|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92296005|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932100|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
92296006|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92296007|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
92296008|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92296009|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
92296010|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296011|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
92296012|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92296013|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296014|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92296015|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296016|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92296018|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
92296019|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
92296020|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
92296021|NCT00356954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296022|NCT00356954|Protective Agents|protective agents|mesh-ancestor
92296023|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296024|NCT00356954|Vitamins|vitamins|mesh-ancestor
92296025|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
92296026|NCT02358889|Ranibizumab|ranibizumab|mesh-list
92296027|NCT02358889|hI-con1|hi-con1|mesh-list
92296028|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
92296029|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92296030|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92296031|NCT02358889|Growth Substances|growth substances|mesh-ancestor
92296032|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296033|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
92296034|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296035|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
92296036|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92296037|NCT05721170|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92296038|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296039|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296040|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296041|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296042|NCT00358124|Metformin|metformin|mesh-list
92296043|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
92296044|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
92296045|NCT00358124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92296046|NCT00358124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296047|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
92296048|NCT00358202|Cefepime|cefepime|mesh-list
92296049|NCT00358202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92296050|NCT00358202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296051|NCT02802566|Vitamins|vitamins|mesh-list
92296052|NCT02802566|Micronutrients|micronutrients|mesh-ancestor
92346495|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
92296054|NCT04736225|Insulin|insulin|mesh-list
92296055|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92296056|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296057|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92296058|NCT03344861|Trioxsalen|trioxsalen|mesh-list
92296059|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296060|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
92296061|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92296062|NCT03348683|Propranolol|propranolol|mesh-list
92296063|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92296064|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92296065|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296066|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296067|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296068|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296069|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92296070|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92296071|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
92296072|NCT04344782|Bevacizumab|bevacizumab|mesh-list
92296073|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92296074|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296075|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92296076|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92296077|NCT04344782|Growth Substances|growth substances|mesh-ancestor
92296078|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296079|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
92296080|NCT00357188|Ritonavir|ritonavir|mesh-list
92296081|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92296082|NCT00357188|Efavirenz|efavirenz|mesh-list
92296083|NCT00357188|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92296084|NCT00357188|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92296085|NCT00357188|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296086|NCT00357188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296087|NCT00357188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296088|NCT00357188|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92296089|NCT00357188|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92296090|NCT00357188|Antiviral Agents|antiviral agents|mesh-ancestor
92296091|NCT00357188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296092|NCT00357188|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92296093|NCT00357188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92296094|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92296095|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92296096|NCT00357188|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92296097|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92296098|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92296099|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92296100|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92296101|NCT02360215|Memantine|memantine|mesh-list
92296102|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92296103|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92296104|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
92296105|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296106|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296107|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296108|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92296109|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92296110|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
92296111|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92296112|NCT01349192|Minocycline|minocycline|mesh-list
92296113|NCT01349192|Rifampin|rifampin|mesh-list
92296114|NCT01349192|Trimethoprim|trimethoprim|mesh-list
92296115|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
92296116|NCT01349192|Mupirocin|mupirocin|mesh-list
92296117|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92296118|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296119|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
92296120|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92296121|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92296122|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92296123|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
92296124|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
92296125|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92296126|NCT01349192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296127|NCT01349192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296128|NCT01349192|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92296129|NCT01349192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92296130|NCT01349192|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92296131|NCT01349192|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92296132|NCT01349192|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92296133|NCT01349192|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92296134|NCT01349192|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92296136|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92296137|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92296138|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92296139|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92296140|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92296141|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92296142|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92296143|NCT02362321|Dexamethasone|dexamethasone|mesh-list
92296144|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296145|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
92296146|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
92296147|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296148|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296149|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296150|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
92296152|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296153|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92296154|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296156|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92296157|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92296158|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92296159|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92296160|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92296161|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296162|NCT00354991|Diuretics|diuretics|mesh-ancestor
92296163|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
92296164|NCT00354991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296165|NCT00354991|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92296166|NCT00354991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296167|NCT02112578|Meclizine|meclizine|mesh-list
92296168|NCT02112578|Dimenhydrinate|dimenhydrinate|mesh-list
92296169|NCT02112578|Antiemetics|antiemetics|mesh-ancestor
92296170|NCT02112578|Autonomic Agents|autonomic agents|mesh-ancestor
92296171|NCT02112578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296172|NCT02112578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296173|NCT02112578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296174|NCT02112578|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92296175|NCT02112578|Histamine Antagonists|histamine antagonists|mesh-ancestor
92296176|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
92296177|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296178|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296179|NCT02112578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92296180|NCT02112578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92296181|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92296182|NCT00358280|Bupivacaine|bupivacaine|mesh-list
92296183|NCT00358280|Ropivacaine|ropivacaine|mesh-list
92296184|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
92296185|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
92296186|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296187|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296188|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
92296189|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296190|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92296191|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92346505|NCT01798992|Antioxidants|antioxidants|mesh-ancestor
92296193|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
92296194|NCT02363803|Lidocaine|lidocaine|mesh-list
92296195|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
92296196|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
92296197|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296198|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296199|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
92296200|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296201|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92296202|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92296203|NCT02363803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91948986|NCT02738879|Metformin|metformin|mesh-list
92296204|NCT02363803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296205|NCT02363803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296206|NCT03417193|Analgesics, Opioid|analgesics, opioid|mesh-list
92296207|NCT03417193|Anesthetics|anesthetics|mesh-list
92296208|NCT03417193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296209|NCT03417193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296211|NCT03417193|Analgesics|analgesics|mesh-ancestor
92296212|NCT03417193|Sensory System Agents|sensory system agents|mesh-ancestor
92296213|NCT03417193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296214|NCT02367859|Trametinib|trametinib|mesh-list
92296215|NCT02367859|Dabrafenib|dabrafenib|mesh-list
92296216|NCT02367859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296217|NCT02367859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92296218|NCT02367859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116933|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92296219|NCT02367859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296220|NCT02368093|Dextromethorphan|dextromethorphan|mesh-list
92296221|NCT02368093|Antitussive Agents|antitussive agents|mesh-ancestor
92296222|NCT02368093|Respiratory System Agents|respiratory system agents|mesh-ancestor
92296223|NCT02368093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92296224|NCT02368093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92296225|NCT02368093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296226|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296227|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296228|NCT03342937|Pembrolizumab|pembrolizumab|mesh-list
92296229|NCT03342937|Capecitabine|capecitabine|mesh-list
92296230|NCT03342937|Oxaliplatin|oxaliplatin|mesh-list
92296231|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92296232|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296233|NCT03342937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92296234|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296235|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92296236|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
92296237|NCT05718661|Methamphetamine|methamphetamine|mesh-list
92296238|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92296239|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296240|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
92296241|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
92296242|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296243|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
92296244|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296245|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296246|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296247|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92296248|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92296249|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296250|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92296251|NCT00354757|Rabeprazole|rabeprazole|mesh-list
92296252|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92296253|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296254|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92296255|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296256|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296257|NCT02376283|Clopidogrel|clopidogrel|mesh-list
92296259|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92296260|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92296261|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92296262|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92296263|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92296264|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
92296265|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296266|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296267|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296268|NCT00425347|Elotuzumab|elotuzumab|mesh-list
92296269|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296270|NCT05718037|Vaccines|vaccines|mesh-list
92296271|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
92296272|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296273|NCT05717881|Propolis|propolis|mesh-list
92296274|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296275|NCT00355303|Misoprostol|misoprostol|mesh-list
92296276|NCT00355303|Dinoprostone|dinoprostone|mesh-list
91949056|NCT05350917|Tislelizumab|tislelizumab|mesh-list
92296277|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92296278|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
92296279|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92296280|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296281|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92296282|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296283|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
92296284|NCT05717569|Vitamin D|vitamin d|mesh-list
92296285|NCT05717569|Vitamins|vitamins|mesh-ancestor
92296286|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
92296287|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296288|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92296289|NCT02385097|Ropivacaine|ropivacaine|mesh-list
92296290|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
92296291|NCT02385097|Anesthetics, Local|anesthetics, local|mesh-ancestor
92296292|NCT02385097|Anesthetics|anesthetics|mesh-ancestor
92410118|NCT05459571|Antiemetics|antiemetics|mesh-ancestor
92296293|NCT02385097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296294|NCT02385097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296295|NCT02385097|Sensory System Agents|sensory system agents|mesh-ancestor
92296296|NCT02385097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296297|NCT02387359|Plecanatide|plecanatide|mesh-list
92296298|NCT02387359|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92296299|NCT02387359|Enzyme Activators|enzyme activators|mesh-ancestor
92296300|NCT02387359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296301|NCT02387359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296302|NCT00355459|Doxycycline|doxycycline|mesh-list
92296303|NCT00355459|Tetracycline|tetracycline|mesh-list
92296304|NCT00355459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92296305|NCT00355459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296306|NCT00355459|Antimalarials|antimalarials|mesh-ancestor
92296307|NCT00355459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92296308|NCT00355459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92296309|NCT00355459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92296310|NCT00355459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296311|NCT00355459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296312|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
92296313|NCT02393677|Ropivacaine|ropivacaine|mesh-list
92296314|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92296315|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296316|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296317|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92296318|NCT02393677|Analgesics|analgesics|mesh-ancestor
92296319|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
92296320|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296321|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92296322|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92296323|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92296324|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296325|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296326|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296327|NCT02393677|Anesthetics, Local|anesthetics, local|mesh-ancestor
92296328|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
92296329|NCT02394457|Cosyntropin|cosyntropin|mesh-list
92296330|NCT02394457|Hormones|hormones|mesh-ancestor
92296331|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296332|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296333|NCT00355771|Levocetirizine|levocetirizine|mesh-list
92296334|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92296335|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92296336|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
92296337|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
92296338|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296339|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296340|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296341|NCT05664139|Paclitaxel|paclitaxel|mesh-list
92296342|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92296343|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296344|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296345|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296346|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296347|NCT05664139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296348|NCT03224351|Ivacaftor|ivacaftor|mesh-list
92296350|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92296351|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296352|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296354|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92296355|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296356|NCT05642923|Thiamine|thiamine|mesh-list
92296357|NCT05642923|Vitamins|vitamins|mesh-ancestor
92296358|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
92296359|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296360|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
92296361|NCT03906071|Docetaxel|docetaxel|mesh-list
92296362|NCT03906071|Nivolumab|nivolumab|mesh-list
92296363|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296364|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296365|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296366|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
91936155|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
92296367|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296368|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92296369|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92296370|NCT01721876|Cytarabine|cytarabine|mesh-list
92296371|NCT01721876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92296372|NCT01721876|Antimetabolites|antimetabolites|mesh-ancestor
92296373|NCT01721876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296374|NCT01721876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296375|NCT01721876|Antiviral Agents|antiviral agents|mesh-ancestor
92296376|NCT01721876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296377|NCT01721876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92296378|NCT01721876|Immunologic Factors|immunologic factors|mesh-ancestor
92296379|NCT01721876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296380|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92296381|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92296382|NCT03423641|Antiviral Agents|antiviral agents|mesh-list
92296383|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296384|NCT01112072|Riboflavin|riboflavin|mesh-list
92296385|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
92296386|NCT01112072|Vitamins|vitamins|mesh-ancestor
92296387|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
92296388|NCT01112072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296389|NCT01112072|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92296390|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
92296391|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92296392|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296393|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296394|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296395|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92296396|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296397|NCT03226223|Methamphetamine|methamphetamine|mesh-list
92296398|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92296399|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296400|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
92296401|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
92296402|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296403|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
92296404|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296405|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296406|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296407|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92296408|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92296409|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296410|NCT03226223|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92296411|NCT05620771|Bevacizumab|bevacizumab|mesh-list
92296412|NCT05620771|Atezolizumab|atezolizumab|mesh-list
92296413|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92296414|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296415|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92296416|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92296417|NCT05620771|Growth Substances|growth substances|mesh-ancestor
92296418|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296419|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
92296420|NCT05620771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92296421|NCT05620771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296422|NCT05419297|Buprenorphine|buprenorphine|mesh-list
92296423|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92296424|NCT05419297|Narcotics|narcotics|mesh-ancestor
92296425|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296426|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296427|NCT05419297|Analgesics|analgesics|mesh-ancestor
92296428|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
92296429|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296430|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92296431|NCT03226457|Empagliflozin|empagliflozin|mesh-list
92296433|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92296434|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296435|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92296436|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296437|NCT03226457|Diuretics|diuretics|mesh-ancestor
92296438|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
92296439|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92296440|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296442|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92296443|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92296444|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
92296445|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296446|NCT00003159|Paclitaxel|paclitaxel|mesh-list
92296447|NCT00003159|Vinorelbine|vinorelbine|mesh-list
92296448|NCT00003159|Vinblastine|vinblastine|mesh-list
92296449|NCT00003159|Docetaxel|docetaxel|mesh-list
92296450|NCT00003159|Carboplatin|carboplatin|mesh-list
92296451|NCT00003159|Gemcitabine|gemcitabine|mesh-list
92296452|NCT00003159|Ifosfamide|ifosfamide|mesh-list
92296453|NCT00003159|Mitomycins|mitomycins|mesh-list
92296454|NCT00003159|Mitomycin|mitomycin|mesh-list
92296455|NCT00003159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92296456|NCT00003159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296457|NCT00003159|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296458|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296459|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296460|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296461|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92296462|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
92296463|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92296464|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
92296465|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92296466|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92296467|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296468|NCT03228017|Aspirin|aspirin|mesh-list
92296469|NCT03228017|Atorvastatin|atorvastatin|mesh-list
92296470|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92296471|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92296472|NCT03228017|Analgesics|analgesics|mesh-ancestor
92296473|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
92296474|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296475|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296476|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296477|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92296478|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92296479|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92296480|NCT03228017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296481|NCT03228017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92296482|NCT03228017|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92296483|NCT03228017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296485|NCT03228017|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92296486|NCT03228017|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92296487|NCT03228017|Antimetabolites|antimetabolites|mesh-ancestor
92296488|NCT03228017|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92296489|NCT03228017|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92296490|NCT00355927|Propofol|propofol|mesh-list
92296491|NCT00355927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92296492|NCT00355927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296493|NCT00355927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296494|NCT00355927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92296495|NCT00355927|Anesthetics, General|anesthetics, general|mesh-ancestor
92296496|NCT00355927|Anesthetics|anesthetics|mesh-ancestor
92296497|NCT00357422|Ethanol|ethanol|mesh-list
92296498|NCT00357422|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92296499|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296500|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296501|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296502|NCT00356005|Azithromycin|azithromycin|mesh-list
91949284|NCT02317601|Prednisolone|prednisolone|mesh-list
92296504|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932121|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
92296505|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296506|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
92296507|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92296508|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92296509|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296510|NCT00356005|Antiviral Agents|antiviral agents|mesh-ancestor
92296511|NCT00356005|Schistosomicides|schistosomicides|mesh-ancestor
92296512|NCT00356005|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92296513|NCT00356005|Anthelmintics|anthelmintics|mesh-ancestor
92296514|NCT00376337|Micafungin|micafungin|mesh-list
92296515|NCT00376337|Antifungal Agents|antifungal agents|mesh-list
92296517|NCT00376337|Miconazole|miconazole|mesh-list
92296518|NCT00376337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296519|NCT00376337|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92296520|NCT00376337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92296521|NCT00376337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92296522|NCT00376337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296523|NCT00376337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296524|NCT00376337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92296525|NCT00376337|Hormone Antagonists|hormone antagonists|mesh-ancestor
92296526|NCT00376337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296527|NCT00376337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296528|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92296529|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92296530|NCT00003165|Doxorubicin|doxorubicin|mesh-list
92296531|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92296532|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296533|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92296534|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92296535|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296536|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296537|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
92296538|NCT05723510|Apixaban|apixaban|mesh-list
92296539|NCT05723510|Edoxaban|edoxaban|mesh-list
92296540|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92296541|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
92296542|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92296543|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296544|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296545|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296546|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
92296547|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
92296548|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92296549|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
92296550|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296551|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296552|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
92296553|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296554|NCT00003183|Analgesics|analgesics|mesh-ancestor
92296555|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
92296556|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296557|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296558|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92296559|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92296560|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296561|NCT00003183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296562|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
92296563|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
92296564|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
92296565|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296566|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
92296567|NCT02979223|Protective Agents|protective agents|mesh-ancestor
92296568|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296569|NCT02979223|Vitamins|vitamins|mesh-ancestor
92296570|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
92296571|NCT02979223|Cathartics|cathartics|mesh-ancestor
92296572|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296573|NCT01805271|Everolimus|everolimus|mesh-list
92296574|NCT01805271|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92296575|NCT01805271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92296576|NCT01805271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296577|NCT01805271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296578|NCT01805271|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92296579|NCT01805271|Immunologic Factors|immunologic factors|mesh-ancestor
92296580|NCT01805271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296581|NCT01805271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296582|NCT05723276|Psilocybin|psilocybin|mesh-list
92296583|NCT05723276|Hallucinogens|hallucinogens|mesh-ancestor
92296584|NCT05723276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296585|NCT05723276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92296586|NCT01768767|Ketamine|ketamine|mesh-list
92296587|NCT01768767|Analgesics|analgesics|mesh-ancestor
92296588|NCT01768767|Sensory System Agents|sensory system agents|mesh-ancestor
92296589|NCT01768767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296590|NCT01768767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296591|NCT01768767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92296592|NCT01768767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92296593|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
92296594|NCT01768767|Anesthetics|anesthetics|mesh-ancestor
92296595|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296596|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92296597|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92296598|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296599|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296600|NCT00376493|Metronidazole|metronidazole|mesh-list
92296601|NCT00376493|Doxycycline|doxycycline|mesh-list
92296602|NCT00376493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296603|NCT00376493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92296604|NCT00376493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92296605|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92296606|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
92296607|NCT00003195|Interferons|interferons|mesh-list
92296608|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
92296609|NCT00003195|Busulfan|busulfan|mesh-list
92296610|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296611|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
92296612|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296613|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
92296614|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296615|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
92296616|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296617|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92296618|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92296620|NCT05716256|Urinastatin|urinastatin|mesh-list
92296621|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92296622|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92296623|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296624|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296625|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296626|NCT00356083|Methadone|methadone|mesh-list
92296627|NCT00356083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92296628|NCT00356083|Narcotics|narcotics|mesh-ancestor
92296629|NCT00356083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296630|NCT00356083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296631|NCT00356083|Analgesics|analgesics|mesh-ancestor
92296632|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
92296633|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296634|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
92296635|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
92296636|NCT02977832|Alfuzosin|alfuzosin|mesh-list
92296637|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92296638|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92296639|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92296640|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296641|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296642|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296643|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296644|NCT02977832|Urological Agents|urological agents|mesh-ancestor
92296645|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
92296646|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
92296647|NCT04344236|Povidone|povidone|mesh-list
92296648|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92296649|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296650|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
92296651|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
92296652|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
92296653|NCT00355537|Testosterone|testosterone|mesh-list
91949434|NCT04454281|Naloxone|naloxone|mesh-list
92296654|NCT00355537|Androgens|androgens|mesh-ancestor
92296655|NCT00355537|Hormones|hormones|mesh-ancestor
92296656|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296657|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296658|NCT00003207|Doxorubicin|doxorubicin|mesh-list
92296659|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92296660|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92296661|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296662|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92296663|NCT00003207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92296664|NCT00003207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296665|NCT00003207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296666|NCT00003387|Paclitaxel|paclitaxel|mesh-list
92296667|NCT00003387|Carboplatin|carboplatin|mesh-list
92296668|NCT00003387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92296669|NCT00003387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296670|NCT00003387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296671|NCT00003387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296672|NCT00003387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296673|NCT00003387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296674|NCT01542021|Androgens|androgens|mesh-list
92296675|NCT01542021|Hormones|hormones|mesh-ancestor
92296676|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296677|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296678|NCT04706897|Lidocaine|lidocaine|mesh-list
92296679|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
92296680|NCT04706897|Ketamine|ketamine|mesh-list
92296681|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
92296682|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
92296683|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296684|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296685|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
92296686|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296687|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92296688|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92296689|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92296690|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296691|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296692|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92296693|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92296694|NCT04706897|Analgesics|analgesics|mesh-ancestor
92296695|NCT04706897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92296696|NCT04706897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92296697|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92296698|NCT04706897|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296699|NCT04706897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296700|NCT04706897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92296701|NCT04706897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92296702|NCT04706897|Anesthetics, General|anesthetics, general|mesh-ancestor
92296703|NCT04706897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92296704|NCT04706897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92296705|NCT00003213|Dexamethasone|dexamethasone|mesh-list
92296706|NCT00003213|Dexamethasone acetate|dexamethasone acetate|mesh-list
92296707|NCT00003213|Metoclopramide|metoclopramide|mesh-list
92296708|NCT00003213|Granisetron|granisetron|mesh-list
92296709|NCT00003213|BB 1101|bb 1101|mesh-list
92296710|NCT00003213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296712|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
92296713|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296714|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296715|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296716|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
92296717|NCT00003213|Hormones|hormones|mesh-ancestor
92296718|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296719|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92296720|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296721|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296722|NCT00003213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296723|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296724|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92296725|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92296726|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
92296727|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296728|NCT00003213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92296729|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92296731|NCT01445067|Calcitonin|calcitonin|mesh-list
92296732|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92296733|NCT01445067|Katacalcin|katacalcin|mesh-list
92296734|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
92410119|NCT05459571|Autonomic Agents|autonomic agents|mesh-ancestor
92296735|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92296736|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296737|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92296738|NCT02978066|Anesthetics|anesthetics|mesh-list
92296739|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296740|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296741|NCT00003399|Dexamethasone|dexamethasone|mesh-list
92296742|NCT00003399|Paclitaxel|paclitaxel|mesh-list
92296743|NCT00003399|Etoposide|etoposide|mesh-list
92296744|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
92296745|NCT00003399|Melphalan|melphalan|mesh-list
92296746|NCT00003399|Carmustine|carmustine|mesh-list
92296747|NCT00003399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92296748|NCT00003399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296749|NCT00003399|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296750|NCT00003399|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296751|NCT00003399|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296752|NCT00003399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296753|NCT00003399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92296754|NCT00003399|Immunologic Factors|immunologic factors|mesh-ancestor
92296755|NCT00003399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296756|NCT00003399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92296757|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92296758|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
92296759|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92296760|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296761|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
92296762|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
92296763|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296764|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296765|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
92296767|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296768|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92296769|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92296770|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92296771|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296772|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
92296773|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92296774|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92296775|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296776|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
92296777|NCT03376061|Coagulants|coagulants|mesh-ancestor
92296778|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
92296780|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
92296781|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296782|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296783|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92296784|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
92296785|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
92296786|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92296787|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
92296788|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296789|NCT03376295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296790|NCT04735523|Warfarin|warfarin|mesh-list
92296791|NCT04735523|Dabigatran|dabigatran|mesh-list
92296792|NCT04735523|Anticoagulants|anticoagulants|mesh-ancestor
92296793|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
92296794|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92296795|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296796|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296797|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296798|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
92296799|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296800|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296801|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296802|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
92296803|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92296804|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
92296805|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296806|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296807|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92296808|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92296809|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92296810|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
92296811|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296812|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296813|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92296814|NCT05715788|Vasodilator Agents|vasodilator agents|mesh-ancestor
92296815|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
92296816|NCT05715788|Protective Agents|protective agents|mesh-ancestor
92296817|NCT00003225|Irinotecan|irinotecan|mesh-list
92296818|NCT00003225|Amifostine|amifostine|mesh-list
92296819|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92296820|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92296821|NCT00003225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296822|NCT00003225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296823|NCT00003225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296824|NCT00003225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92296825|NCT00003225|Protective Agents|protective agents|mesh-ancestor
92296826|NCT00003225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296827|NCT05372588|Vaccines|vaccines|mesh-list
92296828|NCT05372588|Immunologic Factors|immunologic factors|mesh-ancestor
92296829|NCT05372588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296830|NCT03838094|Calcium|calcium|mesh-list
92296831|NCT03838094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92296832|NCT03838094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296833|NCT03441269|Ibuprofen|ibuprofen|mesh-list
92296834|NCT03441269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92296835|NCT03441269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92296836|NCT03441269|Analgesics|analgesics|mesh-ancestor
92296837|NCT03441269|Sensory System Agents|sensory system agents|mesh-ancestor
92296838|NCT03441269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296839|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296840|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296841|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92296842|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92296843|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296844|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296845|NCT03252353|Octreotide|octreotide|mesh-list
92296846|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296847|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92296848|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296849|NCT05355272|Hormones|hormones|mesh-list
92296850|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296851|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296852|NCT00358358|Fluticasone|fluticasone|mesh-list
92296853|NCT00358358|Xhance|xhance|mesh-list
92296854|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92296855|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92296856|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296857|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92296858|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
92296859|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296860|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296861|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92296862|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
92296863|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
92296864|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92296865|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92296866|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92296867|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92296868|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
92296869|NCT00358358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296870|NCT00358358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296871|NCT00358358|Glucocorticoids|glucocorticoids|mesh-ancestor
92296873|NCT00358358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296874|NCT00358358|Sympathomimetics|sympathomimetics|mesh-ancestor
91949657|NCT02319941|Ticagrelor|ticagrelor|mesh-list
92296875|NCT03441581|Eluxadoline|eluxadoline|mesh-list
92296876|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296877|NCT02265510|Dexamethasone|dexamethasone|mesh-list
92296878|NCT02265510|Paclitaxel|paclitaxel|mesh-list
92296880|NCT02265510|Lenalidomide|lenalidomide|mesh-list
92296881|NCT02265510|Azacitidine|azacitidine|mesh-list
92296882|NCT02265510|Bortezomib|bortezomib|mesh-list
92296883|NCT02265510|Pomalidomide|pomalidomide|mesh-list
92296884|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92296885|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296886|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296887|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296888|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296889|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296890|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92296891|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
92296892|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
92296893|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296894|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296895|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92296896|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
92296897|NCT02265510|Hormones|hormones|mesh-ancestor
92296898|NCT02265510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92296899|NCT02265510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92296900|NCT02265510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92296901|NCT02265510|Antimetabolites|antimetabolites|mesh-ancestor
92296903|NCT02265510|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92296904|NCT02265510|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92296905|NCT02265510|Growth Substances|growth substances|mesh-ancestor
92296906|NCT02265510|Growth Inhibitors|growth inhibitors|mesh-ancestor
92296907|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296908|NCT03254147|Warfarin|warfarin|mesh-list
92296909|NCT03254147|Rivaroxaban|rivaroxaban|mesh-list
92296910|NCT03254147|Dabigatran|dabigatran|mesh-list
92296911|NCT03254147|Apixaban|apixaban|mesh-list
92296912|NCT03254147|Edoxaban|edoxaban|mesh-list
92296913|NCT03254147|Anticoagulants|anticoagulants|mesh-ancestor
92296914|NCT03254147|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92296915|NCT03254147|Antithrombins|antithrombins|mesh-ancestor
92296916|NCT03254147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92296917|NCT03254147|Protease Inhibitors|protease inhibitors|mesh-ancestor
92296918|NCT03254147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296919|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296920|NCT03384329|Resveratrol|resveratrol|mesh-list
92296921|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
92296922|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296923|NCT03384329|Protective Agents|protective agents|mesh-ancestor
92296924|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296925|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296926|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92296927|NCT03443063|Lemborexant|lemborexant|mesh-list
92296928|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92296929|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296930|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296931|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92296932|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92296933|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296934|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296935|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92296936|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92296937|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296938|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296939|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92296940|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296941|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296942|NCT05327972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92296943|NCT05327972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92296945|NCT03256253|Analgesics|analgesics|mesh-ancestor
92296946|NCT03256253|Sensory System Agents|sensory system agents|mesh-ancestor
92296947|NCT03256253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92296948|NCT03256253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296949|NCT03256253|Anticonvulsants|anticonvulsants|mesh-ancestor
92296950|NCT03256253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92296951|NCT03256253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296952|NCT03256253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949727|NCT03821545|Lidocaine|lidocaine|mesh-list
92296953|NCT03256253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92296954|NCT03256253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92296955|NCT03256253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92296956|NCT03256253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92296957|NCT03256253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92296958|NCT03256799|Ivacaftor|ivacaftor|mesh-list
92296959|NCT03256799|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92296960|NCT03256799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92296961|NCT03256799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296962|NCT01238211|Cytarabine|cytarabine|mesh-list
92296963|NCT01238211|Daunorubicin|daunorubicin|mesh-list
92296964|NCT01238211|Dasatinib|dasatinib|mesh-list
92296965|NCT01238211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92296966|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
92296967|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296968|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296969|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
92296970|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92296971|NCT01238211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92296972|NCT01238211|Immunologic Factors|immunologic factors|mesh-ancestor
92296973|NCT01238211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92296974|NCT01238211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92296975|NCT01238211|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92296976|NCT01238211|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92296977|NCT01238211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92296978|NCT01238211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92296979|NCT04735445|Liver Extracts|liver extracts|mesh-list
92296980|NCT04735445|Hematinics|hematinics|mesh-ancestor
92296981|NCT00003231|Docetaxel|docetaxel|mesh-list
92296982|NCT00003231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296983|NCT00003231|Tubulin Modulators|tubulin modulators|mesh-ancestor
92296984|NCT00003231|Antimitotic Agents|antimitotic agents|mesh-ancestor
92296985|NCT00003231|Mitosis Modulators|mitosis modulators|mesh-ancestor
92296986|NCT00003231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92296987|NCT00003405|Interferons|interferons|mesh-list
92296988|NCT00003405|Cytarabine|cytarabine|mesh-list
92296989|NCT00003405|Interferon-alpha|interferon-alpha|mesh-list
92296990|NCT00003405|Bromodeoxyuridine|bromodeoxyuridine|mesh-list
92296991|NCT00003405|5-bromouridine|5-bromouridine|mesh-list
92296992|NCT00003405|Idoxuridine|idoxuridine|mesh-list
92296993|NCT00003405|Mitoxantrone|mitoxantrone|mesh-list
92296994|NCT00003405|Idarubicin|idarubicin|mesh-list
92296995|NCT00003405|Isotretinoin|isotretinoin|mesh-list
92296996|NCT00003405|Amifostine|amifostine|mesh-list
92296997|NCT00003405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92296998|NCT00003405|Antiviral Agents|antiviral agents|mesh-ancestor
92296999|NCT00003405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297000|NCT00003405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92297001|NCT00003405|Antimetabolites|antimetabolites|mesh-ancestor
92297002|NCT00003405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297003|NCT00003405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297004|NCT00003405|Immunologic Factors|immunologic factors|mesh-ancestor
92297005|NCT00003405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297006|NCT00003405|Analgesics|analgesics|mesh-ancestor
92297007|NCT00003405|Sensory System Agents|sensory system agents|mesh-ancestor
92297008|NCT00003405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297009|NCT00003405|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92297010|NCT00003405|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297011|NCT00003405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297012|NCT00003405|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92297013|NCT00003405|Dermatologic Agents|dermatologic agents|mesh-ancestor
92297014|NCT00003405|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92297015|NCT00003405|Protective Agents|protective agents|mesh-ancestor
92297016|NCT00003405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92297017|NCT05131646|Axitinib|axitinib|mesh-list
92297018|NCT05131646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297019|NCT05131646|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297020|NCT05131646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297021|NCT05131646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297022|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
92297023|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297024|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92297025|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
92297026|NCT00003243|Aldesleukin|aldesleukin|mesh-list
92297027|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
92297028|NCT00003243|Doxorubicin|doxorubicin|mesh-list
92297029|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92297030|NCT00003243|Etoposide|etoposide|mesh-list
92297031|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297032|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
92297033|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297034|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297035|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297036|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
92297037|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297038|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297039|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92297040|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92410192|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92297041|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92297042|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297043|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297044|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92297045|NCT00003243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92297046|NCT00003243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92297047|NCT00003243|Antiviral Agents|antiviral agents|mesh-ancestor
92297048|NCT00003243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297049|NCT04344158|Sorafenib|sorafenib|mesh-list
92297050|NCT04344158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297051|NCT04344158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297052|NCT04344158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297053|NCT04344158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297054|NCT00003249|Ketoconazole|ketoconazole|mesh-list
92297055|NCT00003249|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92297056|NCT00003249|Antifungal Agents|antifungal agents|mesh-ancestor
92297057|NCT00003249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297058|NCT00003249|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92297059|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92297060|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297061|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297062|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92297063|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
92297064|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297065|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297066|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92297067|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297068|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92297069|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297070|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92297071|NCT00003255|Carboplatin|carboplatin|mesh-list
92297072|NCT00003255|Topotecan|topotecan|mesh-list
92297073|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297074|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92297075|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297076|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297077|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297078|NCT03269435|Metoclopramide|metoclopramide|mesh-list
92297079|NCT03269435|Bupivacaine|bupivacaine|mesh-list
92297080|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
92297081|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
92297082|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297083|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297084|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
92297085|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297087|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
92297088|NCT03269435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297089|NCT03269435|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92297090|NCT03269435|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92297091|NCT03269435|Dopamine Agents|dopamine agents|mesh-ancestor
92297092|NCT03269435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297093|NCT03269435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297094|NCT00003261|Zidovudine|zidovudine|mesh-list
92297095|NCT00003261|Methotrexate|methotrexate|mesh-list
92297096|NCT00003261|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92297097|NCT00003261|Abortifacient Agents|abortifacient agents|mesh-ancestor
92297098|NCT00003261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92297099|NCT00003261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297100|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92297101|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
92297102|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297103|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297104|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
92297105|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297106|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92297107|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297108|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
92297109|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297110|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92297111|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92297112|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
92297113|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297114|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92297115|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92297116|NCT03279731|Liraglutide|liraglutide|mesh-list
92297117|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92297118|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297119|NCT03279731|Incretins|incretins|mesh-ancestor
92297120|NCT03279731|Hormones|hormones|mesh-ancestor
92297121|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297122|NCT04530409|Dexamethasone|dexamethasone|mesh-list
92297123|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
92297124|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297125|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
92297126|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
92297127|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297128|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297129|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297130|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
92297131|NCT04530409|Hormones|hormones|mesh-ancestor
92297132|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297133|NCT04530409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92297134|NCT04530409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297135|NCT04530409|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92297136|NCT04530409|Protective Agents|protective agents|mesh-ancestor
92297137|NCT04477837|Rivaroxaban|rivaroxaban|mesh-list
92297138|NCT04477837|Apixaban|apixaban|mesh-list
92297139|NCT04477837|Edoxaban|edoxaban|mesh-list
92297140|NCT04477837|Dabigatran|dabigatran|mesh-list
92297141|NCT04477837|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92297142|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
92297143|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92297144|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
92297145|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297146|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297147|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
92297148|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92297149|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297150|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
92297151|NCT02264574|Chlorambucil|chlorambucil|mesh-list
92297152|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297153|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297154|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297155|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
92297156|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297158|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
92297159|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
92297160|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92297161|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297162|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
92297163|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297164|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
92297165|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297166|NCT03400475|Simvastatin|simvastatin|mesh-list
92297167|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92297168|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92297169|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
92297170|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297171|NCT03400475|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92297172|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92297173|NCT03400475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297174|NCT01641900|Eszopiclone|eszopiclone|mesh-list
92297175|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92297176|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297177|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297179|NCT03834571|Cisplatin|cisplatin|mesh-list
92297180|NCT03834571|Carboplatin|carboplatin|mesh-list
92297181|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92297182|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92297183|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297184|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
92297185|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
92297186|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
92297187|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297188|NCT05088980|Lidocaine|lidocaine|mesh-list
92297189|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
92297190|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
92297191|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297192|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297193|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
92297194|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297195|NCT05088980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92297196|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92297197|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92297198|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297199|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297200|NCT00376727|Cetuximab|cetuximab|mesh-list
92297201|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297202|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297203|NCT05468606|Imiquimod|imiquimod|mesh-list
92297204|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92297205|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
92297206|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297207|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297208|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
92297209|NCT04290871|Nitric Oxide|nitric oxide|mesh-list
92297210|NCT04290871|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92297211|NCT04290871|Autonomic Agents|autonomic agents|mesh-ancestor
92297212|NCT04290871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297213|NCT04290871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297214|NCT04290871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92297215|NCT04290871|Respiratory System Agents|respiratory system agents|mesh-ancestor
92297216|NCT04290871|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92297218|NCT04290871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297219|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297220|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92297221|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92297222|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
92297223|NCT04290871|Protective Agents|protective agents|mesh-ancestor
92297224|NCT03501979|Capecitabine|capecitabine|mesh-list
92297225|NCT03501979|Trastuzumab|trastuzumab|mesh-list
92297226|NCT03501979|Tucatinib|tucatinib|mesh-list
92297227|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92297228|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
92297229|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297230|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297231|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297232|NCT03501979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297233|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297234|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92297235|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92297236|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
92297237|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297238|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92297239|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92297240|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297241|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297242|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92297243|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92297244|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92297245|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92297246|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297247|NCT03465787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297248|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92297249|NCT03465787|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92297250|NCT03465787|Serotonin Agents|serotonin agents|mesh-ancestor
92297251|NCT03465787|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92297252|NCT03465787|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92297253|NCT03465787|Dopamine Agents|dopamine agents|mesh-ancestor
92297255|NCT05071352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92297256|NCT05071352|Analgesics|analgesics|mesh-ancestor
92297257|NCT05071352|Sensory System Agents|sensory system agents|mesh-ancestor
92346570|NCT01796964|Aflibercept|aflibercept|mesh-list
92297259|NCT05071352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297260|NCT00376025|Antioxidants|antioxidants|mesh-list
92297261|NCT00376025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297262|NCT00376025|Protective Agents|protective agents|mesh-ancestor
92297263|NCT00376025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297264|NCT00376103|Temozolomide|temozolomide|mesh-list
92297265|NCT00376103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297266|NCT00376103|Alkylating Agents|alkylating agents|mesh-ancestor
92297267|NCT00376103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297268|NCT00376103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297269|NCT03836287|Bromides|bromides|mesh-list
92297270|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
92297271|NCT03403517|Dexamethasone|dexamethasone|mesh-list
92297272|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
92297273|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92297274|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92297275|NCT03403517|Prednisolone|prednisolone|mesh-list
92297276|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
92297277|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92297278|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
92297279|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297280|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
92297281|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
92297282|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297283|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297284|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297285|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
92297286|NCT03403517|Hormones|hormones|mesh-ancestor
92297287|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297288|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92297289|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297290|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92297291|NCT03403517|Protective Agents|protective agents|mesh-ancestor
92297292|NCT05247788|Ethanol|ethanol|mesh-list
92297293|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92297294|NCT05247788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297295|NCT05247788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297296|NCT05247788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297297|NCT02263326|Lamivudine|lamivudine|mesh-list
92297298|NCT02263326|Dolutegravir|dolutegravir|mesh-list
92297299|NCT02263326|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92297300|NCT02263326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92297301|NCT02263326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92297302|NCT02263326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297303|NCT02263326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297304|NCT02263326|Antiviral Agents|antiviral agents|mesh-ancestor
92297305|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297306|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92297307|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92297308|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92297309|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
92297310|NCT05463848|Temozolomide|temozolomide|mesh-list
92297311|NCT05463848|Olaparib|olaparib|mesh-list
92297312|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297313|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297314|NCT05463848|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92297315|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297316|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297317|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
92297318|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92297319|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297320|NCT05647512|Dexamethasone|dexamethasone|mesh-list
92297321|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297322|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
92297323|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
92297324|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297325|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297326|NCT05647512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297327|NCT05647512|Glucocorticoids|glucocorticoids|mesh-ancestor
92297328|NCT05647512|Hormones|hormones|mesh-ancestor
92297329|NCT05647512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297330|NCT05647512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92297331|NCT05647512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297333|NCT00356395|Candesartan cilexetil|candesartan cilexetil|mesh-list
92297334|NCT00356395|Ramipril|ramipril|mesh-list
92297335|NCT00356395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92297336|NCT00356395|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92297337|NCT00356395|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92297338|NCT00356395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297339|NCT00356395|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92297340|NCT00356395|Protease Inhibitors|protease inhibitors|mesh-ancestor
92297341|NCT00356395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297342|NCT00356473|Atorvastatin|atorvastatin|mesh-list
92297343|NCT00356473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92297344|NCT00356473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92297345|NCT00356473|Antimetabolites|antimetabolites|mesh-ancestor
92297346|NCT00356473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297347|NCT00356473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92297348|NCT00356473|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92297349|NCT00356473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297350|NCT05461508|Amoxicillin|amoxicillin|mesh-list
92297351|NCT05461508|Fucoidan|fucoidan|mesh-list
92297352|NCT05461508|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92297353|NCT05461508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297354|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92297355|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297356|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
92297357|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297359|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
92297360|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297361|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
92297362|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
92297363|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
92297364|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297365|NCT03450083|Benralizumab|benralizumab|mesh-list
92297366|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92297367|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
92297368|NCT03580343|Tofacitinib|tofacitinib|mesh-list
92297369|NCT03580343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92297370|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297371|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297372|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297373|NCT05445440|Leucovorin|leucovorin|mesh-list
92297374|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
92297375|NCT05445440|Methotrexate|methotrexate|mesh-list
92297376|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92297377|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
92297378|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92297379|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297380|NCT05445440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92297381|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
92297382|NCT05445440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297383|NCT05445440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297384|NCT05445440|Dermatologic Agents|dermatologic agents|mesh-ancestor
92297385|NCT05445440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297386|NCT05445440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92297387|NCT05445440|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297388|NCT05445440|Immunologic Factors|immunologic factors|mesh-ancestor
92297389|NCT05445440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297390|NCT05445440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92297391|NCT05445440|Antidotes|antidotes|mesh-ancestor
92297392|NCT05445440|Protective Agents|protective agents|mesh-ancestor
92297393|NCT05445440|Vitamin B Complex|vitamin b complex|mesh-ancestor
92297394|NCT05445440|Vitamins|vitamins|mesh-ancestor
92297395|NCT05445440|Micronutrients|micronutrients|mesh-ancestor
92297396|NCT05445440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297397|NCT05445440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92297398|NCT05445440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92297399|NCT05445440|Analgesics|analgesics|mesh-ancestor
92297400|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
92346575|NCT01796964|Growth Inhibitors|growth inhibitors|mesh-ancestor
92297401|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297402|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297403|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297404|NCT05041322|Buspirone|buspirone|mesh-list
91950188|NCT02616055|XL647|xl647|mesh-list
92297405|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92297406|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92297407|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297408|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297409|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297410|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92297411|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
92297412|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297413|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297414|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
92297415|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297416|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297417|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297418|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297419|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
92297420|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297421|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297422|NCT05229614|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92297423|NCT05229614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297424|NCT05445128|Plerixafor|plerixafor|mesh-list
92297425|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92297426|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92297427|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
92297428|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297429|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92297430|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
92297431|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297433|NCT05483010|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92297434|NCT05483010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92297435|NCT05483010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92297436|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
92297437|NCT05483010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297438|NCT05483010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92297439|NCT05483010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92297440|NCT05483010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297441|NCT05210582|Afamelanotide|afamelanotide|mesh-list
92297442|NCT05210582|Dermatologic Agents|dermatologic agents|mesh-ancestor
92297443|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
92297444|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92297445|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
92297446|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297447|NCT05647356|Bicalutamide|bicalutamide|mesh-list
92297448|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
92297449|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
92297450|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297451|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297452|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297454|NCT05647278|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92297455|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297456|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92297457|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297458|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297459|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
92297460|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297461|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
92297462|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
92297463|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297464|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
92297465|NCT00359840|Hematinics|hematinics|mesh-ancestor
92297466|NCT02259582|Carboplatin|carboplatin|mesh-list
92297467|NCT02259582|Pemetrexed|pemetrexed|mesh-list
92297468|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297469|NCT02259582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297470|NCT02259582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297471|NCT02259582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92346583|NCT01794780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297472|NCT02259582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92297474|NCT00360386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92297475|NCT00360386|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92297476|NCT00360386|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92297477|NCT00360386|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92297478|NCT00360386|Purinergic Agents|purinergic agents|mesh-ancestor
92297479|NCT00360386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297480|NCT00360386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297481|NCT00360386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297482|NCT02977208|Gabapentin|gabapentin|mesh-list
92297483|NCT02977208|Analgesics|analgesics|mesh-ancestor
92297484|NCT02977208|Sensory System Agents|sensory system agents|mesh-ancestor
92297485|NCT02977208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297486|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297487|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
92297488|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92297489|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92297490|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297491|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297492|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92297493|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92297494|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297495|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297496|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
92297497|NCT04866108|Capecitabine|capecitabine|mesh-list
92297498|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92297499|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
92297500|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297501|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297502|NCT04343768|Interferons|interferons|mesh-list
92297503|NCT04343768|Ritonavir|ritonavir|mesh-list
92297504|NCT04343768|Lopinavir|lopinavir|mesh-list
92297505|NCT04343768|Interferon-beta|interferon-beta|mesh-list
92297506|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
92297507|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
92297508|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
92297509|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297510|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
92297511|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297512|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92297513|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92297514|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
92297515|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297516|NCT04343768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297517|NCT04343768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92297518|NCT04343768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92297519|NCT04343768|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92297520|NCT04343768|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92297521|NCT04343768|Antimalarials|antimalarials|mesh-ancestor
92297522|NCT04343768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92297523|NCT04343768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92297524|NCT04343768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081560|NCT01426269|Doxycycline|doxycycline|mesh-list
92297525|NCT04343768|Immunologic Factors|immunologic factors|mesh-ancestor
92297526|NCT04343768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297527|NCT04343768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92297528|NCT05925803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92297529|NCT05925803|Immunologic Factors|immunologic factors|mesh-ancestor
92297530|NCT05925803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297531|NCT05925790|Antibodies|antibodies|mesh-list
92297532|NCT05925790|Immunologic Factors|immunologic factors|mesh-ancestor
92297533|NCT05925790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297534|NCT05925686|Tramadol|tramadol|mesh-list
92297535|NCT05925686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92297536|NCT05925686|Narcotics|narcotics|mesh-ancestor
92297537|NCT05925686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297538|NCT05925686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297539|NCT05925686|Analgesics|analgesics|mesh-ancestor
92297540|NCT05925686|Sensory System Agents|sensory system agents|mesh-ancestor
92297541|NCT05925686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297542|NCT05925530|Durvalumab|durvalumab|mesh-list
92297543|NCT05925530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297544|NCT05925530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297545|NCT05925504|Luspatercept|luspatercept|mesh-list
92297546|NCT05925504|Hematinics|hematinics|mesh-ancestor
92297547|NCT05925491|Pembrolizumab|pembrolizumab|mesh-list
92297548|NCT05925491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297549|NCT05925491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297550|NCT05925491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92297551|NCT05925491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297552|NCT05925309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92297553|NCT05925309|Meropenem|meropenem|mesh-list
92297554|NCT05925309|Imipenem|imipenem|mesh-list
92297555|NCT05925309|Cefaclor|cefaclor|mesh-list
92297556|NCT05925309|Sulfamethoxazole|sulfamethoxazole|mesh-list
92297557|NCT05925309|Sulperazone|sulperazone|mesh-list
92297558|NCT05925309|Methylprednisolone|methylprednisolone|mesh-list
92297559|NCT05925309|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92297560|NCT05925309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92297561|NCT05925309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297562|NCT05925309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297563|NCT05925309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297564|NCT05925309|Antiemetics|antiemetics|mesh-ancestor
92297565|NCT05925309|Autonomic Agents|autonomic agents|mesh-ancestor
92297566|NCT05925309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297567|NCT05925309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297568|NCT05925309|Glucocorticoids|glucocorticoids|mesh-ancestor
92297569|NCT05925309|Hormones|hormones|mesh-ancestor
92297570|NCT05925309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297571|NCT05925309|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92297572|NCT05925309|Protective Agents|protective agents|mesh-ancestor
92297573|NCT05925309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92297574|NCT05925309|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92297576|NCT05925283|Esketamine|esketamine|mesh-list
92297577|NCT05925283|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92297578|NCT05925283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92297579|NCT05925283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297580|NCT05925283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297581|NCT05925283|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92297582|NCT05925283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92297583|NCT05925283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297584|NCT05925283|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92297585|NCT05925283|Anesthetics, General|anesthetics, general|mesh-ancestor
92297586|NCT05925283|Anesthetics|anesthetics|mesh-ancestor
92297587|NCT05925283|GABA Modulators|gaba modulators|mesh-ancestor
92297588|NCT05925283|GABA Agents|gaba agents|mesh-ancestor
92297589|NCT05925283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297590|NCT05925283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297591|NCT05925283|Antidepressive Agents|antidepressive agents|mesh-ancestor
92297592|NCT05925140|Ritonavir|ritonavir|mesh-list
92297593|NCT05925140|Lopinavir|lopinavir|mesh-list
92297594|NCT05925140|Remdesivir|remdesivir|mesh-list
92297595|NCT05925140|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92297596|NCT05925140|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92297597|NCT05925140|Protease Inhibitors|protease inhibitors|mesh-ancestor
92297598|NCT05925140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297599|NCT05925140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297600|NCT05925140|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92297601|NCT05925140|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92297602|NCT05925140|Antiviral Agents|antiviral agents|mesh-ancestor
92297604|NCT05925140|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92297605|NCT05925140|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92297606|NCT05925140|Antimetabolites|antimetabolites|mesh-ancestor
92297607|NCT05925023|Sirolimus|sirolimus|mesh-list
92297608|NCT05925023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92297609|NCT05925023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297610|NCT05925023|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92297611|NCT05925023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297612|NCT05925023|Antifungal Agents|antifungal agents|mesh-ancestor
92297613|NCT05925023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297614|NCT05925023|Immunologic Factors|immunologic factors|mesh-ancestor
92297615|NCT05925023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297616|NCT05924971|Aspirin|aspirin|mesh-list
92297617|NCT05924971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92297618|NCT05924971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92297619|NCT05924971|Analgesics|analgesics|mesh-ancestor
92297620|NCT05924971|Sensory System Agents|sensory system agents|mesh-ancestor
92297621|NCT05924971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297622|NCT05924971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297623|NCT05924971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297624|NCT05924971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297625|NCT05924971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92297626|NCT05924971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92297627|NCT05924971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297628|NCT05924971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92297629|NCT05924971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92297630|NCT05924971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297631|NCT05924971|Antipyretics|antipyretics|mesh-ancestor
92297632|NCT05924893|Naltrexone|naltrexone|mesh-list
92297633|NCT05924893|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92297634|NCT05924893|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92297635|NCT05924893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297636|NCT05924893|Sensory System Agents|sensory system agents|mesh-ancestor
92297637|NCT05924893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297638|NCT05924880|Durvalumab|durvalumab|mesh-list
92297639|NCT05924880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297640|NCT05924880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297641|NCT05924815|Moxifloxacin|moxifloxacin|mesh-list
92297642|NCT05924815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92297643|NCT05924815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297644|NCT05924815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92297645|NCT05924815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297646|NCT05924815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297647|NCT05924815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297648|NCT05924815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297649|NCT05924672|Diphosphonates|diphosphonates|mesh-list
92297650|NCT05924672|Methylene diphosphonate|methylene diphosphonate|mesh-list
92297651|NCT05924672|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92297652|NCT05924672|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92297653|NCT05924672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297654|NCT05924672|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92297655|NCT05924672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297656|NCT05924672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92297657|NCT05924672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297658|NCT05924594|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92297659|NCT05924594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92297660|NCT05924594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297661|NCT05924594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92297662|NCT05924594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92297663|NCT05924594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297664|NCT05924594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297665|NCT05924594|Dopamine Agents|dopamine agents|mesh-ancestor
92297666|NCT05924594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297667|NCT05924321|Moxifloxacin|moxifloxacin|mesh-list
92297669|NCT05924321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92297670|NCT05924321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297671|NCT05924321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92297672|NCT05924321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297673|NCT05924321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936195|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92297674|NCT05924321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297675|NCT05924321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297676|NCT05924321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92297677|NCT05924321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297678|NCT05924321|Oxytocics|oxytocics|mesh-ancestor
92297679|NCT05924256|Leuprolide|leuprolide|mesh-list
92297680|NCT05924256|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92297681|NCT05924256|Fertility Agents|fertility agents|mesh-ancestor
92297682|NCT05924256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92297683|NCT05924256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297684|NCT05924256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92297685|NCT05924256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297686|NCT05924165|Ketorolac|ketorolac|mesh-list
92297687|NCT05924165|Oxycodone|oxycodone|mesh-list
92297688|NCT05924165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92297689|NCT05924165|Narcotics|narcotics|mesh-ancestor
92297690|NCT05924165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297691|NCT05924165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297692|NCT05924165|Analgesics|analgesics|mesh-ancestor
92297693|NCT05924165|Sensory System Agents|sensory system agents|mesh-ancestor
92297694|NCT05924165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297695|NCT05924165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92297696|NCT05924165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92297697|NCT05924165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297698|NCT05924165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297699|NCT05924165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92297700|NCT05924165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297701|NCT05924165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297702|NCT05924126|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92297703|NCT05924126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297704|NCT05924100|Luspatercept|luspatercept|mesh-list
92297705|NCT05924100|Hematinics|hematinics|mesh-ancestor
92297706|NCT05923996|Botulinum Toxins|botulinum toxins|mesh-list
92297707|NCT05923996|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92297709|NCT05923996|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92297710|NCT05923996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297711|NCT05923996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297712|NCT05923996|Cholinergic Agents|cholinergic agents|mesh-ancestor
92297713|NCT05923996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297714|NCT05923996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297715|NCT05923996|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92297716|NCT05923996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297718|NCT05923970|Antibodies|antibodies|mesh-list
92297719|NCT05923970|Immunoglobulins|immunoglobulins|mesh-list
92297720|NCT05923970|Immunologic Factors|immunologic factors|mesh-ancestor
92297721|NCT05923970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297722|NCT05923879|Rituximab|rituximab|mesh-list
92297723|NCT05923879|Lenalidomide|lenalidomide|mesh-list
92297724|NCT05923879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297725|NCT05923879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297726|NCT05923879|Immunologic Factors|immunologic factors|mesh-ancestor
92297727|NCT05923879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297728|NCT05923879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297729|NCT05923879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92297730|NCT05923879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92297731|NCT05923879|Growth Substances|growth substances|mesh-ancestor
92297732|NCT05923879|Growth Inhibitors|growth inhibitors|mesh-ancestor
92297733|NCT05923476|Lithium Carbonate|lithium carbonate|mesh-list
92297734|NCT05923476|Antidepressive Agents|antidepressive agents|mesh-ancestor
92297735|NCT05923476|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297736|NCT05923476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297737|NCT05923476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297738|NCT05923476|Antimanic Agents|antimanic agents|mesh-ancestor
92297739|NCT05923476|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92297740|NCT05923476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297741|NCT05923476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297742|NCT05923021|Sertraline|sertraline|mesh-list
92297743|NCT05923021|Antidepressive Agents|antidepressive agents|mesh-ancestor
92297744|NCT05923021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297745|NCT05923021|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92297746|NCT05923021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92297747|NCT05923021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91936196|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92297748|NCT05923021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297749|NCT05923021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297750|NCT05923021|Serotonin Agents|serotonin agents|mesh-ancestor
92297751|NCT05923021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297752|NCT05922930|Cyclophosphamide|cyclophosphamide|mesh-list
92297753|NCT05922930|Fludarabine|fludarabine|mesh-list
92297754|NCT05922930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297755|NCT05922930|Immunologic Factors|immunologic factors|mesh-ancestor
92297756|NCT05922930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297757|NCT05922930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92297758|NCT05922930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297759|NCT05922930|Alkylating Agents|alkylating agents|mesh-ancestor
92297760|NCT05922930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297761|NCT05922930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297762|NCT05922930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92297763|NCT05922904|Doxorubicin|doxorubicin|mesh-list
92297764|NCT05922904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92297765|NCT05922904|Pembrolizumab|pembrolizumab|mesh-list
92297766|NCT05922904|Dacarbazine|dacarbazine|mesh-list
92297767|NCT05922904|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92297768|NCT05922904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92297769|NCT05922904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297770|NCT05922904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92297771|NCT05922904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297772|NCT05922904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297773|NCT05922904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297774|NCT05922904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297775|NCT05922904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92297776|NCT05922904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297777|NCT05922904|Alkylating Agents|alkylating agents|mesh-ancestor
92297778|NCT05922904|Immunotoxins|immunotoxins|mesh-ancestor
92297779|NCT05922904|Immunoconjugates|immunoconjugates|mesh-ancestor
92297780|NCT05922904|Immunologic Factors|immunologic factors|mesh-ancestor
92297781|NCT05922904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297783|NCT05922839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297784|NCT05922839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297785|NCT05922839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297786|NCT05922839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297787|NCT05922800|Gamma-oryzanol|gamma-oryzanol|mesh-list
92297788|NCT05922800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92297789|NCT05922800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297790|NCT05922800|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92297791|NCT05922800|Antimetabolites|antimetabolites|mesh-ancestor
92297792|NCT05922800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297793|NCT05922800|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92297794|NCT05922761|Fluticasone|fluticasone|mesh-list
92297795|NCT05922761|Xhance|xhance|mesh-list
92297796|NCT05922761|Azithromycin|azithromycin|mesh-list
92297797|NCT05922761|Prednisone|prednisone|mesh-list
92297798|NCT05922761|Montelukast|montelukast|mesh-list
92297799|NCT05922761|Belumosudil|belumosudil|mesh-list
92297800|NCT05922761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297801|NCT05922761|Glucocorticoids|glucocorticoids|mesh-ancestor
92297802|NCT05922761|Hormones|hormones|mesh-ancestor
92297803|NCT05922761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297804|NCT05922761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297805|NCT05922761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92297806|NCT05922761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297807|NCT05922761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92297808|NCT05922761|Autonomic Agents|autonomic agents|mesh-ancestor
92297809|NCT05922761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297810|NCT05922761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92297811|NCT05922761|Respiratory System Agents|respiratory system agents|mesh-ancestor
92297812|NCT05922761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92297813|NCT05922761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92297814|NCT05922761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92297815|NCT05922761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297816|NCT05922761|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92297817|NCT05922761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92297818|NCT05922761|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92297819|NCT05922761|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92297820|NCT05922761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297821|NCT05922761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297822|NCT05922761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297824|NCT05922696|Cholecalciferol|cholecalciferol|mesh-list
92297825|NCT05922696|Vitamins|vitamins|mesh-ancestor
92297826|NCT05922696|Micronutrients|micronutrients|mesh-ancestor
92297827|NCT05922696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297828|NCT05922696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92297829|NCT05922696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92297831|NCT05922605|Ropivacaine|ropivacaine|mesh-list
92297832|NCT05922605|Esketamine|esketamine|mesh-list
92297833|NCT05922605|Analgesics|analgesics|mesh-ancestor
92297834|NCT05922605|Sensory System Agents|sensory system agents|mesh-ancestor
92297835|NCT05922605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297836|NCT05922605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297837|NCT05922605|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92297838|NCT05922605|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92297839|NCT05922605|Anesthetics, General|anesthetics, general|mesh-ancestor
92297840|NCT05922605|Anesthetics|anesthetics|mesh-ancestor
92297841|NCT05922605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297842|NCT05922605|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92297843|NCT05922605|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92297844|NCT05922605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297845|NCT05922605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297846|NCT05922605|Anesthetics, Local|anesthetics, local|mesh-ancestor
92297847|NCT05922605|Antidepressive Agents|antidepressive agents|mesh-ancestor
92297848|NCT05922605|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297849|NCT05922501|Dexamethasone|dexamethasone|mesh-list
92297850|NCT05922501|Pomalidomide|pomalidomide|mesh-list
92297851|NCT05922501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92297852|NCT05922501|Antiemetics|antiemetics|mesh-ancestor
92297853|NCT05922501|Autonomic Agents|autonomic agents|mesh-ancestor
92297854|NCT05922501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297855|NCT05922501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297856|NCT05922501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92297857|NCT05922501|Glucocorticoids|glucocorticoids|mesh-ancestor
92297859|NCT05922501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92297860|NCT05922501|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92297861|NCT05922501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297862|NCT05922501|Immunologic Factors|immunologic factors|mesh-ancestor
92297863|NCT05922501|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92297864|NCT05922501|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92297865|NCT05922501|Growth Substances|growth substances|mesh-ancestor
92297866|NCT05922501|Growth Inhibitors|growth inhibitors|mesh-ancestor
92297867|NCT05922436|Clevidipine|clevidipine|mesh-list
92297868|NCT05922436|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92297869|NCT05922436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297870|NCT05922436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297871|NCT05922436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92297872|NCT05922436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297873|NCT05922384|Etoposide|etoposide|mesh-list
92297874|NCT05922384|Melphalan|melphalan|mesh-list
92297875|NCT05922384|Carmustine|carmustine|mesh-list
92297876|NCT05922384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92297877|NCT05922384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297878|NCT05922384|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92297879|NCT05922384|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92297880|NCT05922384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297881|NCT05922384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297882|NCT05922384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92297883|NCT05922384|Alkylating Agents|alkylating agents|mesh-ancestor
92297884|NCT05922384|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92297885|NCT05922384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92297886|NCT05922384|Immunologic Factors|immunologic factors|mesh-ancestor
92297887|NCT05922384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297888|NCT05922358|Anti-Allergic Agents|anti-allergic agents|mesh-list
92297889|NCT05922345|Docetaxel|docetaxel|mesh-list
92297890|NCT05922345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297891|NCT05922345|Tubulin Modulators|tubulin modulators|mesh-ancestor
92297892|NCT05922345|Antimitotic Agents|antimitotic agents|mesh-ancestor
92297893|NCT05922345|Mitosis Modulators|mitosis modulators|mesh-ancestor
92297894|NCT05922345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297895|NCT05922306|Interferons|interferons|mesh-list
92297896|NCT05922306|Interferon-alpha|interferon-alpha|mesh-list
92297897|NCT05922306|Interferon alpha-2|interferon alpha-2|mesh-list
92297900|NCT05922306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92297901|NCT05922306|Immunologic Factors|immunologic factors|mesh-ancestor
92297902|NCT05922306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297903|NCT05922033|Insulin|insulin|mesh-list
92297904|NCT05922033|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92297905|NCT05922033|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92297906|NCT05922033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297907|NCT05921942|Metformin|metformin|mesh-list
92297908|NCT05921942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92297909|NCT05921942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297910|NCT05921604|Gabapentin|gabapentin|mesh-list
92297911|NCT05921604|Baclofen|baclofen|mesh-list
92297912|NCT05921604|Analgesics|analgesics|mesh-ancestor
92297913|NCT05921604|Sensory System Agents|sensory system agents|mesh-ancestor
92297914|NCT05921604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297915|NCT05921604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297916|NCT05921604|Anticonvulsants|anticonvulsants|mesh-ancestor
92297917|NCT05921604|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92297918|NCT05921604|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92297919|NCT05921604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297920|NCT05921604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92297921|NCT05921604|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92297922|NCT05921604|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92297923|NCT05921604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297924|NCT05921604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297925|NCT05921604|Antimanic Agents|antimanic agents|mesh-ancestor
92297926|NCT05921604|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92297927|NCT05921604|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92297928|NCT05921604|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92297929|NCT05921604|GABA Agonists|gaba agonists|mesh-ancestor
92297930|NCT05921604|GABA Agents|gaba agents|mesh-ancestor
92297931|NCT05921370|Silodosin|silodosin|mesh-list
91950687|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
92297932|NCT05921370|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92297933|NCT05921370|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92297934|NCT05921370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92297935|NCT05921370|Adrenergic Agents|adrenergic agents|mesh-ancestor
92297936|NCT05921370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297937|NCT05921370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297938|NCT05921370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297939|NCT05921370|Urological Agents|urological agents|mesh-ancestor
92297940|NCT05921292|Lidocaine|lidocaine|mesh-list
92297941|NCT05921292|Anesthetics, Local|anesthetics, local|mesh-ancestor
92297942|NCT05921292|Anesthetics|anesthetics|mesh-ancestor
92297943|NCT05921292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297944|NCT05921292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297945|NCT05921292|Sensory System Agents|sensory system agents|mesh-ancestor
92297946|NCT05921292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297947|NCT05921292|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92297948|NCT05921292|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92297949|NCT05921292|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92297950|NCT05921292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297951|NCT05921292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297952|NCT05921149|Paclitaxel|paclitaxel|mesh-list
92297953|NCT05921149|Carboplatin|carboplatin|mesh-list
92297954|NCT05921149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92297955|NCT05921149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297956|NCT05921149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92297957|NCT05921149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92297958|NCT05921149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92297959|NCT05921149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297960|NCT05921097|Histamine|histamine|mesh-list
92297961|NCT05921097|Histamine Agonists|histamine agonists|mesh-ancestor
92297962|NCT05921097|Histamine Agents|histamine agents|mesh-ancestor
92297963|NCT05921097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92297964|NCT05921097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297965|NCT05921097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297966|NCT05921071|Tranexamic Acid|tranexamic acid|mesh-list
92297967|NCT05921071|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92297968|NCT05921071|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92297969|NCT05921071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297970|NCT05921071|Hemostatics|hemostatics|mesh-ancestor
92297972|NCT05920980|Lidocaine|lidocaine|mesh-list
92297973|NCT05920980|Anesthetics, Local|anesthetics, local|mesh-ancestor
92297974|NCT05920980|Anesthetics|anesthetics|mesh-ancestor
92297975|NCT05920980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92297976|NCT05920980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297977|NCT05920980|Sensory System Agents|sensory system agents|mesh-ancestor
92297978|NCT05920980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92297979|NCT05920980|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92297980|NCT05920980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92297981|NCT05920980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92297982|NCT05920980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92297983|NCT05920980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297984|NCT05920928|Capecitabine|capecitabine|mesh-list
92297985|NCT05920928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92297986|NCT05920928|Antimetabolites|antimetabolites|mesh-ancestor
92297987|NCT05920928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297988|NCT05920928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297989|NCT05920876|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92297990|NCT05920876|Immunologic Factors|immunologic factors|mesh-ancestor
92297991|NCT05920876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92297992|NCT05920863|Lenvatinib|lenvatinib|mesh-list
92297993|NCT05920863|Tislelizumab|tislelizumab|mesh-list
92297994|NCT05920863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92297995|NCT05920863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92297996|NCT05920863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92297997|NCT05920863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92297998|NCT05920863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92297999|NCT05920707|Vasopressins|vasopressins|mesh-list
92298000|NCT05920707|Arginine Vasopressin|arginine vasopressin|mesh-list
92298001|NCT05920707|Oxytocin|oxytocin|mesh-list
92298002|NCT05920707|Oxytocics|oxytocics|mesh-ancestor
92298003|NCT05920707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92298004|NCT05920707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298005|NCT05920707|Hemostatics|hemostatics|mesh-ancestor
92298006|NCT05920707|Coagulants|coagulants|mesh-ancestor
92298007|NCT05920707|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92298008|NCT05920707|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92298009|NCT05920707|Natriuretic Agents|natriuretic agents|mesh-ancestor
92298010|NCT05920538|Nicardipine|nicardipine|mesh-list
92298011|NCT05920538|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92298012|NCT05920538|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92298013|NCT05920538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298014|NCT05920538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298015|NCT05920538|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92298016|NCT05920538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298017|NCT05920538|Vasodilator Agents|vasodilator agents|mesh-ancestor
92298018|NCT05920512|Calcitriol|calcitriol|mesh-list
92298019|NCT05920512|Sirolimus|sirolimus|mesh-list
92298020|NCT05920512|Valproic Acid|valproic acid|mesh-list
92298021|NCT05920512|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92298022|NCT05920512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298023|NCT05920512|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92298024|NCT05920512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298025|NCT05920512|Antifungal Agents|antifungal agents|mesh-ancestor
92298026|NCT05920512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92298027|NCT05920512|Immunologic Factors|immunologic factors|mesh-ancestor
92298028|NCT05920512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298029|NCT05920512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298030|NCT05920512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298031|NCT05920512|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92298032|NCT05920512|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92298033|NCT05920512|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298034|NCT05920512|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92298035|NCT05920512|Vitamins|vitamins|mesh-ancestor
92298036|NCT05920512|Micronutrients|micronutrients|mesh-ancestor
92298037|NCT05920512|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92298038|NCT05920512|Anticonvulsants|anticonvulsants|mesh-ancestor
92298040|NCT05920512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298041|NCT05920512|Antimanic Agents|antimanic agents|mesh-ancestor
92298042|NCT05920512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92298043|NCT05920512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298044|NCT05920512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298045|NCT05920356|Pembrolizumab|pembrolizumab|mesh-list
92298047|NCT05920356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298048|NCT05920356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298049|NCT05920356|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298050|NCT05920356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298051|NCT05920343|Rivaroxaban|rivaroxaban|mesh-list
92298052|NCT05920343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92298053|NCT05920343|Antithrombins|antithrombins|mesh-ancestor
92298054|NCT05920343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92298055|NCT05920343|Protease Inhibitors|protease inhibitors|mesh-ancestor
92298056|NCT05920343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298057|NCT05920343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298058|NCT05920343|Anticoagulants|anticoagulants|mesh-ancestor
92298059|NCT05920187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92298060|NCT05920122|Chlorhexidine|chlorhexidine|mesh-list
92298061|NCT05920122|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92298062|NCT05920122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92298063|NCT05920122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298064|NCT05920122|Disinfectants|disinfectants|mesh-ancestor
92298065|NCT05920122|Dermatologic Agents|dermatologic agents|mesh-ancestor
92298066|NCT05920005|Amlodipine|amlodipine|mesh-list
92298067|NCT05920005|Valsartan|valsartan|mesh-list
92298068|NCT05920005|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92298069|NCT05920005|Candesartan|candesartan|mesh-list
92298070|NCT05920005|Candesartan cilexetil|candesartan cilexetil|mesh-list
92298071|NCT05920005|Chlorthalidone|chlorthalidone|mesh-list
92298072|NCT05920005|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92298073|NCT05920005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92298074|NCT05920005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92298075|NCT05920005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298076|NCT05920005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950831|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
92298077|NCT05920005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92298078|NCT05920005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298079|NCT05920005|Vasodilator Agents|vasodilator agents|mesh-ancestor
92298080|NCT05920005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92298081|NCT05920005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92298082|NCT05920005|Diuretics|diuretics|mesh-ancestor
92298083|NCT05920005|Natriuretic Agents|natriuretic agents|mesh-ancestor
92298084|NCT05920005|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92298085|NCT05919992|Hydrocortisone|hydrocortisone|mesh-list
92298087|NCT05919992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298088|NCT05919992|Antimetabolites|antimetabolites|mesh-ancestor
92116934|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298089|NCT05919992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298090|NCT05919992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298091|NCT05919966|Chlorhexidine|chlorhexidine|mesh-list
92298092|NCT05919966|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92298093|NCT05919966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298094|NCT05919966|Disinfectants|disinfectants|mesh-ancestor
92298095|NCT05919745|Acetaminophen|acetaminophen|mesh-list
92298096|NCT05919745|Ibuprofen|ibuprofen|mesh-list
92298097|NCT05919745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298098|NCT05919745|Analgesics|analgesics|mesh-ancestor
92298099|NCT05919745|Sensory System Agents|sensory system agents|mesh-ancestor
92298100|NCT05919745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298101|NCT05919745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298102|NCT05919745|Antipyretics|antipyretics|mesh-ancestor
92298103|NCT05919745|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92298104|NCT05919745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298105|NCT05919745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298106|NCT05919745|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92298107|NCT05919745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298108|NCT05919745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298110|NCT05919316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298111|NCT05919316|Dermatologic Agents|dermatologic agents|mesh-ancestor
92298112|NCT05919316|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92298113|NCT05918133|Paclitaxel|paclitaxel|mesh-list
92298114|NCT05918133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298115|NCT05918133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298116|NCT05918133|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298117|NCT05918133|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298118|NCT05918133|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298119|NCT05918133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298120|NCT05918107|Carboplatin|carboplatin|mesh-list
92298121|NCT05918107|Pemetrexed|pemetrexed|mesh-list
92298122|NCT05918107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298123|NCT05918107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298124|NCT05918107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298125|NCT05918107|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92298126|NCT05918107|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92298127|NCT05916950|Calcium|calcium|mesh-list
92298128|NCT05916950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92298129|NCT05916950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298130|NCT05900466|Metformin|metformin|mesh-list
92298131|NCT05900466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92298132|NCT05900466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298133|NCT05898646|Daratumumab|daratumumab|mesh-list
92298134|NCT05898646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298135|NCT05897268|Lenvatinib|lenvatinib|mesh-list
92298136|NCT05897268|Tislelizumab|tislelizumab|mesh-list
92298137|NCT05897268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298138|NCT05897268|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298139|NCT05897268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298140|NCT05897268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298141|NCT05897268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298142|NCT05895773|Povidone-Iodine|povidone-iodine|mesh-list
92298143|NCT05895773|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92298144|NCT05895773|Povidone|povidone|mesh-list
92298145|NCT05895773|Plasma Substitutes|plasma substitutes|mesh-ancestor
92298146|NCT05895773|Blood Substitutes|blood substitutes|mesh-ancestor
92298147|NCT05895773|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92298148|NCT05895773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298149|NCT05895773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298150|NCT05895266|Midazolam|midazolam|mesh-list
92298151|NCT05895266|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92298152|NCT05895266|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91950904|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
92298153|NCT05895266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298154|NCT05895266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298155|NCT05895266|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92298156|NCT05895266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92298157|NCT05895266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298158|NCT05895266|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92298159|NCT05895266|Anesthetics, General|anesthetics, general|mesh-ancestor
92298160|NCT05895266|Anesthetics|anesthetics|mesh-ancestor
92298161|NCT05895266|GABA Modulators|gaba modulators|mesh-ancestor
92298162|NCT05895266|GABA Agents|gaba agents|mesh-ancestor
92298163|NCT05895266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298164|NCT05895266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298165|NCT05895019|Propofol|propofol|mesh-list
92298166|NCT05895019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92298167|NCT05895019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298168|NCT05895019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298169|NCT05895019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92298170|NCT05895019|Anesthetics, General|anesthetics, general|mesh-ancestor
92298171|NCT05895019|Anesthetics|anesthetics|mesh-ancestor
92298172|NCT05893056|Lenvatinib|lenvatinib|mesh-list
92298173|NCT05893056|Tislelizumab|tislelizumab|mesh-list
92298174|NCT05893056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298175|NCT05893056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298176|NCT05893056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298177|NCT05893056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298178|NCT05893056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298179|NCT05891379|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92298180|NCT05891379|Immunologic Factors|immunologic factors|mesh-ancestor
92346633|NCT04580472|Clindamycin|clindamycin|mesh-list
92298181|NCT05891379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298183|NCT05888311|Antidotes|antidotes|mesh-ancestor
92298184|NCT05888311|Protective Agents|protective agents|mesh-ancestor
92298185|NCT05888311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298186|NCT05888207|Fluvoxamine|fluvoxamine|mesh-list
92298187|NCT05888207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92298188|NCT05888207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92298189|NCT05888207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298190|NCT05888207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298191|NCT05888207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298192|NCT05888207|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92298193|NCT05888207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92298194|NCT05888207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298195|NCT05888207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298196|NCT05888207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298197|NCT05888207|Serotonin Agents|serotonin agents|mesh-ancestor
92298198|NCT05888207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92298199|NCT05888207|Antidepressive Agents|antidepressive agents|mesh-ancestor
92298200|NCT05888207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92298201|NCT05888207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92298202|NCT05888207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298203|NCT05888207|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92298204|NCT05883852|Cyclophosphamide|cyclophosphamide|mesh-list
92298205|NCT05883852|Carboplatin|carboplatin|mesh-list
92298207|NCT05883852|Trastuzumab|trastuzumab|mesh-list
92298208|NCT05883852|Epirubicin|epirubicin|mesh-list
92298209|NCT05883852|Pertuzumab|pertuzumab|mesh-list
92298210|NCT05883852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92298211|NCT05883852|Immunologic Factors|immunologic factors|mesh-ancestor
92298212|NCT05883852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298213|NCT05883852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298214|NCT05883852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92298215|NCT05883852|Alkylating Agents|alkylating agents|mesh-ancestor
92298216|NCT05883852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298217|NCT05883852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298218|NCT05883852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92298219|NCT05883852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298220|NCT05883852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298221|NCT05883852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298222|NCT05883852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298223|NCT05883852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92298224|NCT05883852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92298225|NCT05883852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92298226|NCT05883852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298228|NCT05871606|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92298229|NCT05871606|Anesthetics, General|anesthetics, general|mesh-ancestor
92298230|NCT05871606|Anesthetics|anesthetics|mesh-ancestor
92298231|NCT05871606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298232|NCT05871606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298233|NCT05871606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298235|NCT05871606|Sensory System Agents|sensory system agents|mesh-ancestor
92298236|NCT05871606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298237|NCT05862545|Budesonide|budesonide|mesh-list
92298238|NCT05862545|Glycopyrrolate|glycopyrrolate|mesh-list
92298239|NCT05862545|Formoterol Fumarate|formoterol fumarate|mesh-list
92298240|NCT05862545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298241|NCT05862545|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92298242|NCT05862545|Autonomic Agents|autonomic agents|mesh-ancestor
92410193|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
92298243|NCT05862545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298244|NCT05862545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298245|NCT05862545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92298246|NCT05862545|Respiratory System Agents|respiratory system agents|mesh-ancestor
92298247|NCT05862545|Glucocorticoids|glucocorticoids|mesh-ancestor
92298248|NCT05862545|Hormones|hormones|mesh-ancestor
92298249|NCT05862545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92298250|NCT05862545|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92298251|NCT05862545|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92298252|NCT05862545|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92298253|NCT05862545|Adrenergic Agents|adrenergic agents|mesh-ancestor
92298254|NCT05862545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298255|NCT05862545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298256|NCT05862545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92298257|NCT05862545|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92298258|NCT05862545|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92298259|NCT05862545|Cholinergic Agents|cholinergic agents|mesh-ancestor
92298260|NCT05857514|Indomethacin|indomethacin|mesh-list
92298261|NCT05857514|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92298262|NCT05857514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298263|NCT05857514|Analgesics|analgesics|mesh-ancestor
92298264|NCT05857514|Sensory System Agents|sensory system agents|mesh-ancestor
92298265|NCT05857514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298266|NCT05857514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298267|NCT05857514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298268|NCT05857514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298269|NCT05857514|Gout Suppressants|gout suppressants|mesh-ancestor
92298270|NCT05857514|Tocolytic Agents|tocolytic agents|mesh-ancestor
92298271|NCT05857514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92298272|NCT05857514|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92298273|NCT05857514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298274|NCT05857514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298275|NCT05857007|Glucocorticoids|glucocorticoids|mesh-list
92298276|NCT05857007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298277|NCT05857007|Hormones|hormones|mesh-ancestor
92298278|NCT05857007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92298279|NCT05846789|Carboplatin|carboplatin|mesh-list
92298280|NCT05846789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298281|NCT05845645|Esomeprazole|esomeprazole|mesh-list
92298282|NCT05845645|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92298283|NCT05845645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92298284|NCT05845645|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92298285|NCT05845645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298286|NCT05845645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298287|NCT05839951|Trifluridine|trifluridine|mesh-list
92298288|NCT05839951|Bevacizumab|bevacizumab|mesh-list
92298289|NCT05839951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298290|NCT05839951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298291|NCT05839951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92298292|NCT05839951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92298293|NCT05839951|Growth Substances|growth substances|mesh-ancestor
92298294|NCT05839951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298295|NCT05839951|Growth Inhibitors|growth inhibitors|mesh-ancestor
92298296|NCT05839951|Antimetabolites|antimetabolites|mesh-ancestor
92298297|NCT05839951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298298|NCT05839951|Antiviral Agents|antiviral agents|mesh-ancestor
92298299|NCT05839951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298301|NCT05832892|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92298302|NCT05832892|Gemcitabine|gemcitabine|mesh-list
92298303|NCT05832892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298304|NCT05832892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298305|NCT05832892|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298306|NCT05832892|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298307|NCT05832892|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298308|NCT05832892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298309|NCT05832892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92298310|NCT05832892|Antimetabolites|antimetabolites|mesh-ancestor
92298311|NCT05832398|Leucovorin|leucovorin|mesh-list
92298312|NCT05832398|Fluorouracil|fluorouracil|mesh-list
92298313|NCT05832398|Oxaliplatin|oxaliplatin|mesh-list
92298314|NCT05832398|Irinotecan|irinotecan|mesh-list
92298315|NCT05832398|Antimetabolites|antimetabolites|mesh-ancestor
92298316|NCT05832398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298317|NCT05832398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92298318|NCT05832398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298319|NCT05832398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92298320|NCT05832398|Immunologic Factors|immunologic factors|mesh-ancestor
92298321|NCT05832398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298322|NCT05832398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92298323|NCT05832398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92298324|NCT05832398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298326|NCT05832398|Protective Agents|protective agents|mesh-ancestor
92298327|NCT05832398|Vitamin B Complex|vitamin b complex|mesh-ancestor
92298328|NCT05832398|Vitamins|vitamins|mesh-ancestor
92298329|NCT05832398|Micronutrients|micronutrients|mesh-ancestor
92298330|NCT05828147|Rituximab|rituximab|mesh-list
92298331|NCT05828147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298332|NCT05828147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298333|NCT05828147|Immunologic Factors|immunologic factors|mesh-ancestor
92298334|NCT05828147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298335|NCT05828147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298336|NCT05823987|Lenvatinib|lenvatinib|mesh-list
92298337|NCT05823987|Tislelizumab|tislelizumab|mesh-list
92298338|NCT05823987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298339|NCT05823987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298340|NCT05823987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936202|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92298341|NCT05823987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298342|NCT05823987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298344|NCT05823467|Sulfamethoxazole|sulfamethoxazole|mesh-list
92298345|NCT05823467|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92298346|NCT05823467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298347|NCT05823467|Antimalarials|antimalarials|mesh-ancestor
92298348|NCT05823467|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92298349|NCT05823467|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92298350|NCT05823467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92298351|NCT05823467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298352|NCT05823467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298353|NCT05823467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92298354|NCT05823467|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92298355|NCT05823467|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92298356|NCT05823337|Selenium|selenium|mesh-list
92298357|NCT05823337|Antioxidants|antioxidants|mesh-ancestor
92298358|NCT05823337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298359|NCT05823337|Protective Agents|protective agents|mesh-ancestor
92298360|NCT05823337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298361|NCT05823337|Trace Elements|trace elements|mesh-ancestor
92298362|NCT05823337|Micronutrients|micronutrients|mesh-ancestor
92298363|NCT05822752|Sorafenib|sorafenib|mesh-list
92298364|NCT05822752|Lenvatinib|lenvatinib|mesh-list
92298365|NCT05822752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298366|NCT05822752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298367|NCT05822752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298368|NCT05822752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298369|NCT05817591|Capsaicin|capsaicin|mesh-list
92298370|NCT05817591|Antipruritics|antipruritics|mesh-ancestor
92298371|NCT05817591|Dermatologic Agents|dermatologic agents|mesh-ancestor
92298372|NCT05817591|Sensory System Agents|sensory system agents|mesh-ancestor
92298373|NCT05817591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298374|NCT05817591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298375|NCT05815160|Carboplatin|carboplatin|mesh-list
92298376|NCT05815160|Etoposide|etoposide|mesh-list
92298377|NCT05815160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298378|NCT05815160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298379|NCT05815160|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92298380|NCT05815160|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92298381|NCT05815160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298382|NCT05815160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298383|NCT05803551|Ketamine|ketamine|mesh-list
92298384|NCT05803551|Analgesics|analgesics|mesh-ancestor
92298385|NCT05803551|Sensory System Agents|sensory system agents|mesh-ancestor
92298386|NCT05803551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298387|NCT05803551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298388|NCT05803551|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92298389|NCT05803551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92298390|NCT05803551|Anesthetics, General|anesthetics, general|mesh-ancestor
92298392|NCT05803551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298393|NCT05803551|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92298394|NCT05803551|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92298395|NCT05803551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298396|NCT05803551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298397|NCT05796791|Ketamine|ketamine|mesh-list
92298398|NCT05796791|Analgesics|analgesics|mesh-ancestor
92298399|NCT05796791|Sensory System Agents|sensory system agents|mesh-ancestor
92298400|NCT05796791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298401|NCT05796791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298402|NCT05796791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92298403|NCT05796791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92298404|NCT05796791|Anesthetics, General|anesthetics, general|mesh-ancestor
92298405|NCT05796791|Anesthetics|anesthetics|mesh-ancestor
92298406|NCT05796791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298407|NCT05796791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92298408|NCT05796791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92298409|NCT05796791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298410|NCT05796791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298411|NCT05784844|Meropenem|meropenem|mesh-list
92298412|NCT05784844|Micafungin|micafungin|mesh-list
92298413|NCT05784844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92298414|NCT05784844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298416|NCT05782244|Sildenafil Citrate|sildenafil citrate|mesh-list
92298417|NCT05782244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298418|NCT05782244|Vasodilator Agents|vasodilator agents|mesh-ancestor
92298419|NCT05782244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92298420|NCT05782244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92298421|NCT05782244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298422|NCT05782244|Urological Agents|urological agents|mesh-ancestor
92298423|NCT05770102|Atezolizumab|atezolizumab|mesh-list
92298424|NCT05770102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298425|NCT05770102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298426|NCT05770102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298427|NCT05770102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298429|NCT05768139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92298430|NCT05768139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298431|NCT05768139|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92298432|NCT05768139|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92298433|NCT05768139|Hormone Antagonists|hormone antagonists|mesh-ancestor
92298434|NCT05768139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92298435|NCT05768139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298436|NCT05765812|Temozolomide|temozolomide|mesh-list
92298437|NCT05765812|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92298438|NCT05765812|Alkylating Agents|alkylating agents|mesh-ancestor
92298439|NCT05765812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298440|NCT05765812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298441|NCT05764733|Diphosphonates|diphosphonates|mesh-list
92298442|NCT05764733|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92298443|NCT05764733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298444|NCT05759364|Papaverine|papaverine|mesh-list
92298445|NCT05759364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92298446|NCT05759364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298447|NCT05759364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298448|NCT05759364|Vasodilator Agents|vasodilator agents|mesh-ancestor
92298449|NCT05759364|Urological Agents|urological agents|mesh-ancestor
92298450|NCT05755035|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92298451|NCT05755035|Immunoglobulins|immunoglobulins|mesh-list
92298452|NCT05755035|Antibodies|antibodies|mesh-list
92298453|NCT05755035|gamma-Globulins|gamma-globulins|mesh-list
92298454|NCT05755035|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92298455|NCT05755035|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92298456|NCT05755035|Immunoglobulin G|immunoglobulin g|mesh-list
92298457|NCT05755035|Immunologic Factors|immunologic factors|mesh-ancestor
92298458|NCT05755035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298459|NCT05753735|Amoxicillin|amoxicillin|mesh-list
92298460|NCT05753735|Tazobactam|tazobactam|mesh-list
92298461|NCT05753735|Piperacillin|piperacillin|mesh-list
92298462|NCT05753735|Clavulanic Acids|clavulanic acids|mesh-list
92298463|NCT05753735|Clavulanic Acid|clavulanic acid|mesh-list
92298464|NCT05753735|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92298465|NCT05753735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92298466|NCT05753735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298467|NCT05753735|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92298468|NCT05753735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298469|NCT05753735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298470|NCT05749926|Vaccines|vaccines|mesh-list
92298471|NCT05749926|Immunologic Factors|immunologic factors|mesh-ancestor
92298472|NCT05749926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298473|NCT05739981|Paclitaxel|paclitaxel|mesh-list
92298474|NCT05739981|Bevacizumab|bevacizumab|mesh-list
92298475|NCT05739981|Carboplatin|carboplatin|mesh-list
92298476|NCT05739981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298477|NCT05739981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298478|NCT05739981|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298479|NCT05739981|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298480|NCT05739981|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298481|NCT05739981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298482|NCT05739981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298483|NCT05739981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92298484|NCT05739981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92298485|NCT05739981|Growth Substances|growth substances|mesh-ancestor
92298486|NCT05739981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298487|NCT05739981|Growth Inhibitors|growth inhibitors|mesh-ancestor
92298488|NCT05736562|Vitamins|vitamins|mesh-list
92298489|NCT05736562|Micronutrients|micronutrients|mesh-ancestor
92298490|NCT05736562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298491|NCT05730205|Etonogestrel|etonogestrel|mesh-list
92298492|NCT05730205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92298493|NCT05730205|Contraceptive Agents|contraceptive agents|mesh-ancestor
92298494|NCT05730205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92298495|NCT05730205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298496|NCT05730205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92298497|NCT05728736|Lemborexant|lemborexant|mesh-list
92298498|NCT05728736|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92298499|NCT05728736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298500|NCT05728736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298501|NCT05728736|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92298502|NCT05728736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92298503|NCT05728736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298504|NCT05728736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298506|NCT05725837|Paroxetine|paroxetine|mesh-list
92298507|NCT05725837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92298508|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92298509|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298510|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298511|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298512|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
92298513|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298514|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92298515|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
92298516|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298517|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92298518|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92298519|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298520|NCT05717140|Nivolumab|nivolumab|mesh-list
92298521|NCT05717140|Sargramostim|sargramostim|mesh-list
92298522|NCT05717140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298523|NCT05717140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298524|NCT05717140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298525|NCT05717140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298526|NCT05717140|Immunologic Factors|immunologic factors|mesh-ancestor
92298527|NCT05717140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298528|NCT05714865|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92298529|NCT05714865|Respiratory System Agents|respiratory system agents|mesh-ancestor
92298530|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
92298531|NCT05714345|Fludarabine|fludarabine|mesh-list
92298532|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92298533|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
92298534|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298535|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298536|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92298537|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
92298538|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298539|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298540|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92298541|NCT05711615|Doxorubicin|doxorubicin|mesh-list
92298542|NCT05711615|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92298543|NCT05711615|Peposertib|peposertib|mesh-list
92298544|NCT05711615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936212|NCT02321293|Curcumin|curcumin|mesh-list
92298545|NCT05711615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298546|NCT05711615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92298547|NCT05711615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92298548|NCT05711615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298549|NCT05711615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298550|NCT05711615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298552|NCT05707208|Anesthetics, Local|anesthetics, local|mesh-ancestor
92298553|NCT05707208|Anesthetics|anesthetics|mesh-ancestor
92298554|NCT05707208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298555|NCT05707208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298556|NCT05707208|Sensory System Agents|sensory system agents|mesh-ancestor
92298557|NCT05707208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298558|NCT05707208|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92298559|NCT05707208|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92298560|NCT05707208|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92298561|NCT05707208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298562|NCT05707208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298563|NCT05706233|Analgesics|analgesics|mesh-list
92298564|NCT05706233|Sensory System Agents|sensory system agents|mesh-ancestor
92298565|NCT05706233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298566|NCT05706233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298567|NCT05705050|Aminophylline|aminophylline|mesh-list
92298568|NCT05705050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92298569|NCT05705050|Autonomic Agents|autonomic agents|mesh-ancestor
92298570|NCT05705050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298571|NCT05705050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298572|NCT05705050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92298573|NCT05705050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92298574|NCT05705050|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92298575|NCT05705050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92298576|NCT05705050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298577|NCT05705050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298578|NCT05705050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92298579|NCT05705050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92298580|NCT05705050|Purinergic Agents|purinergic agents|mesh-ancestor
92298581|NCT05705050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298582|NCT05705050|Protective Agents|protective agents|mesh-ancestor
92298583|NCT05693454|Tramadol|tramadol|mesh-list
92298584|NCT05693454|Levobupivacaine|levobupivacaine|mesh-list
92298585|NCT05693454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92298586|NCT05693454|Narcotics|narcotics|mesh-ancestor
92298587|NCT05693454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298588|NCT05693454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298589|NCT05693454|Analgesics|analgesics|mesh-ancestor
92298590|NCT05693454|Sensory System Agents|sensory system agents|mesh-ancestor
92298591|NCT05693454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298592|NCT05693454|Anesthetics, Local|anesthetics, local|mesh-ancestor
92298593|NCT05693454|Anesthetics|anesthetics|mesh-ancestor
92298594|NCT05681650|Paclitaxel|paclitaxel|mesh-list
92298595|NCT05681650|Cyclophosphamide|cyclophosphamide|mesh-list
92298596|NCT05681650|Fludarabine|fludarabine|mesh-list
92298597|NCT05681650|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92298598|NCT05681650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298599|NCT05681650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298600|NCT05681650|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298601|NCT05681650|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298602|NCT05681650|Mitosis Modulators|mitosis modulators|mesh-ancestor
91951356|NCT03470363|Sufentanil|sufentanil|mesh-list
92298603|NCT05681650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298604|NCT05681650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92298605|NCT05681650|Immunologic Factors|immunologic factors|mesh-ancestor
92298606|NCT05681650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298607|NCT05681650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298608|NCT05681650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92298609|NCT05681650|Alkylating Agents|alkylating agents|mesh-ancestor
92298610|NCT05681650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92298612|NCT05672108|Mitomycin|mitomycin|mesh-list
92298613|NCT05672108|Ethiodized Oil|ethiodized oil|mesh-list
92298614|NCT05672108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92298615|NCT05672108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298616|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
92298617|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298618|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92298619|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298620|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
92298621|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
92298622|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92298623|NCT05655598|Palbociclib|palbociclib|mesh-list
92298624|NCT05655598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298625|NCT05655598|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298626|NCT05655598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298627|NCT05655598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298628|NCT05648591|Iloperidone|iloperidone|mesh-list
92298629|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92298630|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92298631|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298632|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298633|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298634|NCT05633654|Pembrolizumab|pembrolizumab|mesh-list
92298635|NCT05633654|Capecitabine|capecitabine|mesh-list
92298636|NCT05633654|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92298637|NCT05633654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298638|NCT05633654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298639|NCT05633654|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298640|NCT05633654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298641|NCT05633654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92298642|NCT05633654|Antimetabolites|antimetabolites|mesh-ancestor
92298643|NCT05633654|Immunoconjugates|immunoconjugates|mesh-ancestor
92298644|NCT05633654|Immunologic Factors|immunologic factors|mesh-ancestor
92298645|NCT05633654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298646|NCT05630781|Suvorexant|suvorexant|mesh-list
92298647|NCT05630781|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92298648|NCT05630781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92298649|NCT05630781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298650|NCT05630781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298651|NCT05630781|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92298652|NCT05630781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298653|NCT05630781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298654|NCT05624957|Lidocaine|lidocaine|mesh-list
92298655|NCT05624957|Epinephrine|epinephrine|mesh-list
92298656|NCT05624957|Racepinephrine|racepinephrine|mesh-list
92298657|NCT05624957|Epinephryl borate|epinephryl borate|mesh-list
92298658|NCT05624957|Anesthetics, Local|anesthetics, local|mesh-ancestor
92298659|NCT05624957|Anesthetics|anesthetics|mesh-ancestor
92298660|NCT05624957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298661|NCT05624957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298662|NCT05624957|Sensory System Agents|sensory system agents|mesh-ancestor
92298663|NCT05624957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298664|NCT05624957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92298665|NCT05624957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92298666|NCT05624957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92298667|NCT05624957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298668|NCT05624957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298669|NCT05624957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92298670|NCT05624957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92298671|NCT05624957|Adrenergic Agents|adrenergic agents|mesh-ancestor
92298672|NCT05624957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298673|NCT05624957|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92298674|NCT05624957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92298675|NCT05624957|Autonomic Agents|autonomic agents|mesh-ancestor
91951431|NCT02421341|Fentanyl|fentanyl|mesh-list
92298676|NCT05624957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92298677|NCT05624957|Respiratory System Agents|respiratory system agents|mesh-ancestor
92298678|NCT05624957|Mydriatics|mydriatics|mesh-ancestor
92298679|NCT05624957|Sympathomimetics|sympathomimetics|mesh-ancestor
92298680|NCT05624957|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92298681|NCT05613426|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92298682|NCT05613426|Evolocumab|evolocumab|mesh-list
92298683|NCT05613426|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92298684|NCT05613426|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92298685|NCT05613426|Antimetabolites|antimetabolites|mesh-ancestor
92298686|NCT05613426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298687|NCT05613426|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92298688|NCT05613426|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92298689|NCT05613426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298690|NCT05613426|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92298691|NCT05613426|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92298692|NCT05613426|Protease Inhibitors|protease inhibitors|mesh-ancestor
92298693|NCT05610657|Mitapivat|mitapivat|mesh-list
92298694|NCT05610657|Enzyme Activators|enzyme activators|mesh-ancestor
92298695|NCT05610657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298696|NCT05603065|Paclitaxel|paclitaxel|mesh-list
92298697|NCT05603065|Tislelizumab|tislelizumab|mesh-list
92298698|NCT05603065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298699|NCT05603065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298700|NCT05603065|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298701|NCT05603065|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298702|NCT05603065|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298703|NCT05603065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298704|NCT05603065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298705|NCT05601700|Paclitaxel|paclitaxel|mesh-list
92298706|NCT05601700|Carboplatin|carboplatin|mesh-list
92298707|NCT05601700|Letrozole|letrozole|mesh-list
92298708|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298709|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298710|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298711|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298712|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298713|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298714|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92298715|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92298716|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298717|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92298718|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
92298719|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92298720|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298721|NCT05585125|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92298722|NCT05585125|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92298723|NCT05585125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92298724|NCT05585125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298725|NCT05585125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298726|NCT05585125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298728|NCT05578872|Ipilimumab|ipilimumab|mesh-list
92298729|NCT05578872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298730|NCT05578872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298731|NCT05578872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298732|NCT05578872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298733|NCT05572684|Pembrolizumab|pembrolizumab|mesh-list
92298734|NCT05572684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298735|NCT05572684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298736|NCT05572684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298737|NCT05572684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298738|NCT05566756|Ofatumumab|ofatumumab|mesh-list
92298739|NCT05566756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298740|NCT05558150|Aceclofenac|aceclofenac|mesh-list
92298741|NCT05558150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92298742|NCT05558150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298743|NCT05558150|Analgesics|analgesics|mesh-ancestor
92298744|NCT05558150|Sensory System Agents|sensory system agents|mesh-ancestor
92298745|NCT05558150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298746|NCT05558150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298747|NCT05558150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298748|NCT05558150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298749|NCT05552859|Insulin|insulin|mesh-list
92298750|NCT05552859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92298751|NCT05552859|Insulin Glargine|insulin glargine|mesh-list
92298752|NCT05552859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92298753|NCT05552859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298754|NCT05537740|Pembrolizumab|pembrolizumab|mesh-list
92298755|NCT05537740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298756|NCT05537740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298757|NCT05537740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298758|NCT05537740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298759|NCT05521997|Cisplatin|cisplatin|mesh-list
92298760|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298761|NCT05514912|Paclitaxel|paclitaxel|mesh-list
92298762|NCT05514912|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92298763|NCT05514912|Cisplatin|cisplatin|mesh-list
92298764|NCT05514912|Gemcitabine|gemcitabine|mesh-list
92298765|NCT05514912|Infigratinib|infigratinib|mesh-list
92298766|NCT05514912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298767|NCT05514912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298768|NCT05514912|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298769|NCT05514912|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298770|NCT05514912|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298771|NCT05514912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298772|NCT05514912|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92298773|NCT05514912|Antimetabolites|antimetabolites|mesh-ancestor
92298774|NCT05502237|Paclitaxel|paclitaxel|mesh-list
92298775|NCT05502237|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92298776|NCT05502237|Carboplatin|carboplatin|mesh-list
92298777|NCT05502237|Pembrolizumab|pembrolizumab|mesh-list
92298778|NCT05502237|Pemetrexed|pemetrexed|mesh-list
92298779|NCT05502237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298780|NCT05502237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298781|NCT05502237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298782|NCT05502237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298783|NCT05502237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298784|NCT05502237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298785|NCT05502237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298786|NCT05502237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298787|NCT05502237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298788|NCT05502237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92298789|NCT05502237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92298791|NCT05467748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298792|NCT05467748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298793|NCT05467748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298794|NCT05467748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298795|NCT05460871|Pregabalin|pregabalin|mesh-list
92298796|NCT05460871|Analgesics|analgesics|mesh-ancestor
92298797|NCT05460871|Sensory System Agents|sensory system agents|mesh-ancestor
92298798|NCT05460871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298799|NCT05460871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298800|NCT05460871|Anticonvulsants|anticonvulsants|mesh-ancestor
92298801|NCT05460871|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92298802|NCT05460871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298803|NCT05460871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298804|NCT05460871|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92298805|NCT05460871|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92298806|NCT05460871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92298807|NCT05460871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298808|NCT05460871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298809|NCT05457998|Flutemetamol|flutemetamol|mesh-list
92298810|NCT05457998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92298811|NCT05457998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298812|NCT05438316|Ramipril|ramipril|mesh-list
92298813|NCT05438316|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92298814|NCT05438316|Protease Inhibitors|protease inhibitors|mesh-ancestor
92298815|NCT05438316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298816|NCT05438316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298817|NCT05438316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92298818|NCT05426525|Empagliflozin|empagliflozin|mesh-list
92298819|NCT05426525|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92298820|NCT05426525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298821|NCT05426525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92298822|NCT05426525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298823|NCT05403138|Daratumumab|daratumumab|mesh-list
92298824|NCT05403138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298825|NCT05375929|Abrocitinib|abrocitinib|mesh-list
92298826|NCT05375929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298827|NCT05375929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298828|NCT05375929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298829|NCT05371054|Prednisone|prednisone|mesh-list
92298830|NCT05371054|Venetoclax|venetoclax|mesh-list
92298831|NCT05371054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298832|NCT05371054|Glucocorticoids|glucocorticoids|mesh-ancestor
92298833|NCT05371054|Hormones|hormones|mesh-ancestor
92298834|NCT05371054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92298835|NCT05371054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298836|NCT05371054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92298837|NCT05371054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298838|NCT05367440|Abiraterone Acetate|abiraterone acetate|mesh-list
92298839|NCT05367440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298840|NCT05367440|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92298841|NCT05367440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116935|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92298842|NCT05367440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298843|NCT05367440|Hormone Antagonists|hormone antagonists|mesh-ancestor
92298844|NCT05367440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92298845|NCT05367440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298846|NCT05367440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92298848|NCT05364944|Lanreotide|lanreotide|mesh-list
92298849|NCT05364944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92298850|NCT05364944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92298851|NCT05364944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298852|NCT05353140|Aspirin|aspirin|mesh-list
92298853|NCT05353140|Rivaroxaban|rivaroxaban|mesh-list
92298854|NCT05353140|Clopidogrel|clopidogrel|mesh-list
92298855|NCT05353140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92298856|NCT05353140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298857|NCT05353140|Analgesics|analgesics|mesh-ancestor
92298858|NCT05353140|Sensory System Agents|sensory system agents|mesh-ancestor
92298859|NCT05353140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298860|NCT05353140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298861|NCT05353140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298862|NCT05353140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298863|NCT05353140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92298864|NCT05353140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92298865|NCT05353140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298866|NCT05353140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92298867|NCT05353140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92298868|NCT05353140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298869|NCT05353140|Antipyretics|antipyretics|mesh-ancestor
92298870|NCT05353140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92298871|NCT05353140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92298872|NCT05353140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92298873|NCT05353140|Purinergic Agents|purinergic agents|mesh-ancestor
92298874|NCT05353140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298875|NCT05353140|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92298876|NCT05353140|Antithrombins|antithrombins|mesh-ancestor
92298877|NCT05353140|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92298878|NCT05353140|Protease Inhibitors|protease inhibitors|mesh-ancestor
92298879|NCT05353140|Anticoagulants|anticoagulants|mesh-ancestor
92298880|NCT05351944|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92298881|NCT05351944|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92298882|NCT05351944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92298883|NCT05351944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298884|NCT05351944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298885|NCT05351944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92298886|NCT05351944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298887|NCT05351944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298888|NCT05346393|Terlipressin|terlipressin|mesh-list
92298889|NCT05346393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92298890|NCT05346393|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92298892|NCT05340465|Dextrans|dextrans|mesh-list
92298893|NCT05340465|Darbepoetin alfa|darbepoetin alfa|mesh-list
92298894|NCT05340465|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92298895|NCT05340465|Iron-Dextran Complex|iron-dextran complex|mesh-list
92298896|NCT05340465|Trace Elements|trace elements|mesh-ancestor
92298897|NCT05340465|Micronutrients|micronutrients|mesh-ancestor
91951650|NCT03460405|Vaccines|vaccines|mesh-list
92298898|NCT05340465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298899|NCT05340465|Hematinics|hematinics|mesh-ancestor
92298900|NCT05340465|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92298901|NCT05340465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92298902|NCT05340465|Anticoagulants|anticoagulants|mesh-ancestor
92298903|NCT05340465|Plasma Substitutes|plasma substitutes|mesh-ancestor
92298904|NCT05340465|Blood Substitutes|blood substitutes|mesh-ancestor
92298905|NCT05303090|Lenvatinib|lenvatinib|mesh-list
92298906|NCT05303090|Tislelizumab|tislelizumab|mesh-list
92298907|NCT05303090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298908|NCT05303090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92298909|NCT05303090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298910|NCT05303090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298911|NCT05303090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298912|NCT05303064|Olanzapine|olanzapine|mesh-list
92298913|NCT05303064|Antiemetics|antiemetics|mesh-ancestor
92298914|NCT05303064|Autonomic Agents|autonomic agents|mesh-ancestor
92298915|NCT05303064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298916|NCT05303064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298917|NCT05303064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92298918|NCT05303064|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92298919|NCT05303064|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92298920|NCT05303064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298921|NCT05303064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298922|NCT05303064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92298923|NCT05303064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92298924|NCT05303064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92298925|NCT05303064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298926|NCT05303064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92298927|NCT05303064|Serotonin Agents|serotonin agents|mesh-ancestor
92298928|NCT05296798|Paclitaxel|paclitaxel|mesh-list
92298929|NCT05296798|Docetaxel|docetaxel|mesh-list
92298930|NCT05296798|Trastuzumab|trastuzumab|mesh-list
92298931|NCT05296798|Pertuzumab|pertuzumab|mesh-list
92298932|NCT05296798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92298933|NCT05296798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298934|NCT05296798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92298935|NCT05296798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92298936|NCT05296798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92298937|NCT05296798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298938|NCT05296798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298939|NCT05283304|Buprenorphine|buprenorphine|mesh-list
92298940|NCT05283304|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92298941|NCT05283304|Narcotics|narcotics|mesh-ancestor
92298942|NCT05283304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92298943|NCT05283304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298944|NCT05283304|Analgesics|analgesics|mesh-ancestor
92298945|NCT05283304|Sensory System Agents|sensory system agents|mesh-ancestor
92298946|NCT05283304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298947|NCT05283304|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92298948|NCT05259943|Psilocybin|psilocybin|mesh-list
92298949|NCT05259943|Hallucinogens|hallucinogens|mesh-ancestor
92298950|NCT05259943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298951|NCT05259943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298952|NCT05255991|Treprostinil|treprostinil|mesh-list
92298953|NCT05255991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92298954|NCT05251948|Capecitabine|capecitabine|mesh-list
92298955|NCT05251948|Oxaliplatin|oxaliplatin|mesh-list
92298956|NCT05251948|Atezolizumab|atezolizumab|mesh-list
92298957|NCT05251948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92298958|NCT05251948|Antimetabolites|antimetabolites|mesh-ancestor
92298959|NCT05251948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298960|NCT05251948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298961|NCT05251948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92298962|NCT05251948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92298963|NCT05243329|Psilocybin|psilocybin|mesh-list
92298964|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
92298965|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298966|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92298967|NCT05237297|Celecoxib|celecoxib|mesh-list
92298968|NCT05237297|Naproxen|naproxen|mesh-list
92298969|NCT05237297|Aceclofenac|aceclofenac|mesh-list
92298970|NCT05237297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92298971|NCT05237297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92298972|NCT05237297|Analgesics|analgesics|mesh-ancestor
92298973|NCT05237297|Sensory System Agents|sensory system agents|mesh-ancestor
92298974|NCT05237297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92298975|NCT05237297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298976|NCT05237297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92298977|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92298978|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92298979|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92298980|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92298981|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92298982|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
92298983|NCT05224102|Faricimab|faricimab|mesh-list
92298984|NCT05224102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92298985|NCT05224102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92298986|NCT05224102|Growth Substances|growth substances|mesh-ancestor
92298987|NCT05224102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298988|NCT05224102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92298989|NCT05224102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298990|NCT05222555|Lenalidomide|lenalidomide|mesh-list
92298991|NCT05222555|Immunologic Factors|immunologic factors|mesh-ancestor
92298992|NCT05222555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92298993|NCT05222555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92298994|NCT05222555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92298995|NCT05222555|Growth Substances|growth substances|mesh-ancestor
92298996|NCT05222555|Growth Inhibitors|growth inhibitors|mesh-ancestor
92298997|NCT05222555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92298998|NCT05216952|Misoprostol|misoprostol|mesh-list
92298999|NCT05216952|Ulipristal acetate|ulipristal acetate|mesh-list
92299000|NCT05216952|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92299002|NCT05216952|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92299003|NCT05216952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299004|NCT05216952|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92299005|NCT05216952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92299006|NCT05216952|Oxytocics|oxytocics|mesh-ancestor
92299007|NCT05216952|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92299008|NCT05216952|Contraceptive Agents|contraceptive agents|mesh-ancestor
92299009|NCT05216952|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92299010|NCT05213676|Nitric Oxide|nitric oxide|mesh-list
92299011|NCT05213676|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92299012|NCT05213676|Autonomic Agents|autonomic agents|mesh-ancestor
92299013|NCT05213676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299014|NCT05213676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299015|NCT05213676|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92299016|NCT05213676|Respiratory System Agents|respiratory system agents|mesh-ancestor
92299017|NCT05213676|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92299018|NCT05213676|Antioxidants|antioxidants|mesh-ancestor
92299019|NCT05213676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299020|NCT05213676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299021|NCT05213676|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92299022|NCT05213676|Vasodilator Agents|vasodilator agents|mesh-ancestor
92299024|NCT05213676|Protective Agents|protective agents|mesh-ancestor
92299025|NCT05206110|Ketorolac|ketorolac|mesh-list
92299026|NCT05206110|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92299027|NCT05206110|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92299028|NCT05206110|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299029|NCT05206110|Analgesics|analgesics|mesh-ancestor
92299030|NCT05206110|Sensory System Agents|sensory system agents|mesh-ancestor
92299031|NCT05206110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299032|NCT05206110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299033|NCT05206110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299034|NCT05206110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299035|NCT05206110|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92299036|NCT05206110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299037|NCT05206110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299038|NCT05190770|Triamcinolone|triamcinolone|mesh-list
92299039|NCT05190770|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92299040|NCT05190770|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92299041|NCT05190770|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92299042|NCT05190770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299043|NCT05190770|Glucocorticoids|glucocorticoids|mesh-ancestor
92299044|NCT05190770|Hormones|hormones|mesh-ancestor
92299045|NCT05190770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299046|NCT05190770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299047|NCT05190770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92299048|NCT05190770|Immunologic Factors|immunologic factors|mesh-ancestor
91951798|NCT05322499|Paclitaxel|paclitaxel|mesh-list
92299049|NCT05190770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299050|NCT05190770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299051|NCT05183412|Methamphetamine|methamphetamine|mesh-list
92299052|NCT05183412|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92299053|NCT05183412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299054|NCT05183412|Sympathomimetics|sympathomimetics|mesh-ancestor
92299055|NCT05183412|Autonomic Agents|autonomic agents|mesh-ancestor
92299056|NCT05183412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299057|NCT05183412|Dopamine Agents|dopamine agents|mesh-ancestor
92299058|NCT05183412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299059|NCT05183412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299060|NCT05183412|Adrenergic Agents|adrenergic agents|mesh-ancestor
92299061|NCT05183412|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92299062|NCT05183412|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92299063|NCT05183412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92299064|NCT05183412|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92299065|NCT05176288|Palbociclib|palbociclib|mesh-list
92299066|NCT05176288|Avelumab|avelumab|mesh-list
92299067|NCT05176288|Axitinib|axitinib|mesh-list
92299068|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299069|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299070|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299071|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299072|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299073|NCT05172245|Cisplatin|cisplatin|mesh-list
92299074|NCT05172245|Ipatasertib|ipatasertib|mesh-list
92299075|NCT05172245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299076|NCT05172245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299077|NCT05172245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299078|NCT05172245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299079|NCT05170204|Durvalumab|durvalumab|mesh-list
92299080|NCT05170204|Pralsetinib|pralsetinib|mesh-list
92299081|NCT05170204|Entrectinib|entrectinib|mesh-list
92299082|NCT05170204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299083|NCT05170204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299084|NCT05170204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299085|NCT05170204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299086|NCT05170204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299087|NCT05155293|Aflibercept|aflibercept|mesh-list
92299088|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92299089|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92299091|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299092|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
92299093|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299094|NCT05154747|Rilpivirine|rilpivirine|mesh-list
92299095|NCT05154747|Cabotegravir|cabotegravir|mesh-list
92299096|NCT05154747|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
92299097|NCT05154747|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92299098|NCT05154747|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92299099|NCT05154747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299100|NCT05154747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299101|NCT05154747|Antiviral Agents|antiviral agents|mesh-ancestor
92299102|NCT05154747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299103|NCT05154747|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92299104|NCT05154747|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92299105|NCT05154747|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92299106|NCT05154747|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92299107|NCT05151640|Nintedanib|nintedanib|mesh-list
92299108|NCT05151640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299109|NCT05151640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299110|NCT05151640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299111|NCT05151640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299112|NCT05144243|Azacitidine|azacitidine|mesh-list
92299113|NCT05144243|Venetoclax|venetoclax|mesh-list
92299114|NCT05144243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92299115|NCT05144243|Antimetabolites|antimetabolites|mesh-ancestor
92299116|NCT05144243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299117|NCT05144243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299118|NCT05144243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299119|NCT05139238|Labetalol|labetalol|mesh-list
92299120|NCT05139238|Nifedipine|nifedipine|mesh-list
92299121|NCT05139238|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92299122|NCT05139238|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951886|NCT05579249|Topiramate|topiramate|mesh-list
92299123|NCT05139238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299124|NCT05139238|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92299125|NCT05139238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299126|NCT05139238|Vasodilator Agents|vasodilator agents|mesh-ancestor
92299127|NCT05139238|Tocolytic Agents|tocolytic agents|mesh-ancestor
92299128|NCT05139238|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92299129|NCT05139238|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92299130|NCT05139238|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92299131|NCT05139238|Adrenergic Agents|adrenergic agents|mesh-ancestor
92299132|NCT05139238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299133|NCT05139238|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299134|NCT05139238|Sympathomimetics|sympathomimetics|mesh-ancestor
92299135|NCT05139238|Autonomic Agents|autonomic agents|mesh-ancestor
92299136|NCT05139238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299137|NCT05139238|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92299138|NCT05139238|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92299139|NCT05138614|Analgesics, Opioid|analgesics, opioid|mesh-list
92299140|NCT05138614|Narcotics|narcotics|mesh-ancestor
92299141|NCT05138614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299142|NCT05138614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299143|NCT05138614|Analgesics|analgesics|mesh-ancestor
92299144|NCT05138614|Sensory System Agents|sensory system agents|mesh-ancestor
92299145|NCT05138614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299146|NCT05132439|Metformin|metformin|mesh-list
92299147|NCT05132439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92299148|NCT05132439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299149|NCT05120141|Listerine|listerine|mesh-list
92299150|NCT05120141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92299151|NCT05120141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299152|NCT05119907|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92299153|NCT05119907|Immunoconjugates|immunoconjugates|mesh-ancestor
92299154|NCT05119907|Immunologic Factors|immunologic factors|mesh-ancestor
92299155|NCT05119907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299156|NCT05103904|Lenvatinib|lenvatinib|mesh-list
92299157|NCT05103904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299158|NCT05103904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299159|NCT05103904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299160|NCT05103904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299161|NCT05093582|Cromakalim|cromakalim|mesh-list
92299162|NCT05093582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299163|NCT05093582|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92299164|NCT05093582|Autonomic Agents|autonomic agents|mesh-ancestor
92299165|NCT05093582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299166|NCT05093582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299167|NCT05093582|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92299168|NCT05093582|Respiratory System Agents|respiratory system agents|mesh-ancestor
92299169|NCT05093582|Parasympatholytics|parasympatholytics|mesh-ancestor
92299170|NCT05093582|Vasodilator Agents|vasodilator agents|mesh-ancestor
92299171|NCT05090384|Prednisone|prednisone|mesh-list
92299172|NCT05090384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299173|NCT05090384|Glucocorticoids|glucocorticoids|mesh-ancestor
92299174|NCT05090384|Hormones|hormones|mesh-ancestor
92299175|NCT05090384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299176|NCT05090384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299177|NCT05090384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92299178|NCT05090384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299179|NCT05089734|Docetaxel|docetaxel|mesh-list
92299180|NCT05089734|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92299181|NCT05089734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299182|NCT05089734|Tubulin Modulators|tubulin modulators|mesh-ancestor
92299183|NCT05089734|Antimitotic Agents|antimitotic agents|mesh-ancestor
92299184|NCT05089734|Mitosis Modulators|mitosis modulators|mesh-ancestor
92299185|NCT05089734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299186|NCT05089734|Immunoconjugates|immunoconjugates|mesh-ancestor
92299187|NCT05089734|Immunologic Factors|immunologic factors|mesh-ancestor
92299188|NCT05089734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299189|NCT05201183|Fludarabine|fludarabine|mesh-list
92299190|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299191|NCT05086692|Pembrolizumab|pembrolizumab|mesh-list
92299192|NCT05086692|Interleukin-2|interleukin-2|mesh-list
92299193|NCT05086692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299194|NCT05086692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299195|NCT05086692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299196|NCT05086692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299197|NCT05086692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299198|NCT05086692|Analgesics|analgesics|mesh-ancestor
92299199|NCT05086692|Sensory System Agents|sensory system agents|mesh-ancestor
92299200|NCT05086692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299201|NCT05086692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299202|NCT05062889|Leucovorin|leucovorin|mesh-list
92299203|NCT05062889|Trifluridine|trifluridine|mesh-list
92299204|NCT05062889|Fluorouracil|fluorouracil|mesh-list
92299205|NCT05062889|Capecitabine|capecitabine|mesh-list
92299206|NCT05062889|Oxaliplatin|oxaliplatin|mesh-list
92299207|NCT05062889|Irinotecan|irinotecan|mesh-list
92299209|NCT05062889|Antimetabolites|antimetabolites|mesh-ancestor
92299210|NCT05062889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299211|NCT05062889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92299212|NCT05062889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299213|NCT05062889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92299214|NCT05062889|Immunologic Factors|immunologic factors|mesh-ancestor
92299215|NCT05062889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299216|NCT05062889|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92299217|NCT05062889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92299218|NCT05062889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299220|NCT05062889|Protective Agents|protective agents|mesh-ancestor
92299221|NCT05062889|Vitamin B Complex|vitamin b complex|mesh-ancestor
92299222|NCT05062889|Vitamins|vitamins|mesh-ancestor
92299223|NCT05062889|Micronutrients|micronutrients|mesh-ancestor
92299224|NCT05062889|Antiviral Agents|antiviral agents|mesh-ancestor
92299225|NCT05062889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299226|NCT05045703|Vitamin A|vitamin a|mesh-list
92299227|NCT05045703|Retinol palmitate|retinol palmitate|mesh-list
92299228|NCT05045703|Vitamins|vitamins|mesh-ancestor
92299229|NCT05045703|Micronutrients|micronutrients|mesh-ancestor
92299230|NCT05045703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299231|NCT05045703|Antioxidants|antioxidants|mesh-ancestor
92299232|NCT05045703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299233|NCT05045703|Protective Agents|protective agents|mesh-ancestor
92299234|NCT05045703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92299235|NCT05045703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299236|NCT05027945|Mycophenolic Acid|mycophenolic acid|mesh-list
92299237|NCT05027945|Sirolimus|sirolimus|mesh-list
92299238|NCT05027945|Cyclophosphamide|cyclophosphamide|mesh-list
92299239|NCT05027945|Busulfan|busulfan|mesh-list
92299240|NCT05027945|Fludarabine|fludarabine|mesh-list
92299241|NCT05027945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92299242|NCT05027945|Immunologic Factors|immunologic factors|mesh-ancestor
92299243|NCT05027945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299244|NCT05027945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299245|NCT05027945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92299246|NCT05027945|Alkylating Agents|alkylating agents|mesh-ancestor
92299247|NCT05027945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299248|NCT05027945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299249|NCT05027945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92299250|NCT05027945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92299251|NCT05027945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92299252|NCT05027945|Antitubercular Agents|antitubercular agents|mesh-ancestor
92299253|NCT05027945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92299254|NCT05027945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299255|NCT05027945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299256|NCT05027945|Antifungal Agents|antifungal agents|mesh-ancestor
92299257|NCT05005728|Carboplatin|carboplatin|mesh-list
92299258|NCT05005728|Docetaxel|docetaxel|mesh-list
92299259|NCT05005728|Olaparib|olaparib|mesh-list
92299260|NCT05005728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299261|NCT05005728|Tubulin Modulators|tubulin modulators|mesh-ancestor
92299262|NCT05005728|Antimitotic Agents|antimitotic agents|mesh-ancestor
92299263|NCT05005728|Mitosis Modulators|mitosis modulators|mesh-ancestor
92299264|NCT05005728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299265|NCT05005728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92299266|NCT05005728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299267|NCT04992507|Anesthetics|anesthetics|mesh-list
92299268|NCT04992507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299269|NCT04992507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299270|NCT04990037|Folfirinox|folfirinox|mesh-list
92299271|NCT04990037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299272|NCT04987203|Nivolumab|nivolumab|mesh-list
92299273|NCT04987203|Tivozanib|tivozanib|mesh-list
92299274|NCT04987203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299275|NCT04987203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299276|NCT04987203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299277|NCT04987203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299278|NCT04987203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299279|NCT04987203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299280|NCT04973254|Rilpivirine|rilpivirine|mesh-list
92299281|NCT04973254|Cabotegravir|cabotegravir|mesh-list
92299282|NCT04973254|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92299283|NCT04973254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92299285|NCT04973254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299286|NCT04973254|Antiviral Agents|antiviral agents|mesh-ancestor
92299287|NCT04973254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299288|NCT04973254|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92299289|NCT04973254|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92299290|NCT04973254|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92299291|NCT04973254|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92299292|NCT04956640|Carboplatin|carboplatin|mesh-list
92299293|NCT04956640|Pembrolizumab|pembrolizumab|mesh-list
92299294|NCT04956640|Pemetrexed|pemetrexed|mesh-list
92299295|NCT04956640|Cetuximab|cetuximab|mesh-list
92299296|NCT04956640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299297|NCT04956640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299298|NCT04956640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299299|NCT04956640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299300|NCT04956640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299301|NCT04956640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92299302|NCT04956640|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92299303|NCT04949828|Pancrelipase|pancrelipase|mesh-list
92299304|NCT04949828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92299305|NCT04949191|Pembrolizumab|pembrolizumab|mesh-list
92299306|NCT04949191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299307|NCT04949191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299308|NCT04949191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299309|NCT04949191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299310|NCT04927884|Cyclophosphamide|cyclophosphamide|mesh-list
92299311|NCT04927884|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92299312|NCT04927884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92299313|NCT04927884|Immunologic Factors|immunologic factors|mesh-ancestor
92299314|NCT04927884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299315|NCT04927884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299316|NCT04927884|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92299317|NCT04927884|Alkylating Agents|alkylating agents|mesh-ancestor
92299318|NCT04927884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299319|NCT04927884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299320|NCT04927884|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92299321|NCT04927884|Immunoconjugates|immunoconjugates|mesh-ancestor
92299322|NCT04882072|Ustekinumab|ustekinumab|mesh-list
92299323|NCT04882072|Dermatologic Agents|dermatologic agents|mesh-ancestor
92299324|NCT04868773|Trifluridine|trifluridine|mesh-list
92299325|NCT04868773|Antimetabolites|antimetabolites|mesh-ancestor
92299326|NCT04868773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299327|NCT04868773|Antiviral Agents|antiviral agents|mesh-ancestor
92299328|NCT04868773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299329|NCT04865029|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92299330|NCT04865029|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92299331|NCT04865029|Estradiol|estradiol|mesh-list
92299332|NCT04865029|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92299333|NCT04865029|Progesterone|progesterone|mesh-list
92299334|NCT04865029|Estrogens|estrogens|mesh-ancestor
92299335|NCT04865029|Hormones|hormones|mesh-ancestor
92299336|NCT04865029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299337|NCT04865029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299338|NCT04865029|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92299339|NCT04865029|Contraceptive Agents|contraceptive agents|mesh-ancestor
92299340|NCT04865029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92299341|NCT04865029|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92299342|NCT04865029|Progestins|progestins|mesh-ancestor
92299343|NCT04859660|Tamsulosin|tamsulosin|mesh-list
92299344|NCT04859660|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92299345|NCT04859660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92299346|NCT04859660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92299347|NCT04859660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92299348|NCT04859660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299349|NCT04859660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299350|NCT04859660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299351|NCT04859660|Urological Agents|urological agents|mesh-ancestor
92299352|NCT04838769|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92299353|NCT04838769|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-list
92299354|NCT04838769|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92299355|NCT04838769|Adrenergic Agents|adrenergic agents|mesh-ancestor
92299356|NCT04838769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299357|NCT04838769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299358|NCT04838769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299359|NCT04838769|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92299360|NCT04838769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299361|NCT04838769|Hormone Antagonists|hormone antagonists|mesh-ancestor
92299362|NCT04838769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299364|NCT04828486|Futibatinib|futibatinib|mesh-list
92299365|NCT04828486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299366|NCT04828486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299367|NCT04828486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299368|NCT04828486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299370|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92299371|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92299372|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299373|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299374|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92299375|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92299376|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
92299377|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299378|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299379|NCT04806919|Progesterone|progesterone|mesh-list
92299380|NCT04806919|Progestins|progestins|mesh-ancestor
92299381|NCT04806919|Hormones|hormones|mesh-ancestor
92299382|NCT04806919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299383|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299384|NCT04805957|Sulforaphane|sulforaphane|mesh-list
92299385|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92299386|NCT04805957|Protective Agents|protective agents|mesh-ancestor
92299387|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299388|NCT04805957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299389|NCT04797780|Azacitidine|azacitidine|mesh-list
92299390|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92299391|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
92299392|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299393|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299394|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299395|NCT04796779|Ferrous fumarate|ferrous fumarate|mesh-list
92299396|NCT04796779|Trace Elements|trace elements|mesh-ancestor
92299397|NCT04796779|Micronutrients|micronutrients|mesh-ancestor
92299398|NCT04796779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299399|NCT04793815|Pembrolizumab|pembrolizumab|mesh-list
92299400|NCT04793815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299401|NCT04793815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299402|NCT04793815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299403|NCT04793815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299404|NCT04775082|Liraglutide|liraglutide|mesh-list
92299405|NCT04775082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92299406|NCT04775082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299407|NCT04775082|Incretins|incretins|mesh-ancestor
92299408|NCT04775082|Hormones|hormones|mesh-ancestor
92299409|NCT04775082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299410|NCT04762888|Edetic Acid|edetic acid|mesh-list
92299411|NCT04762888|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92299412|NCT04762888|Chelating Agents|chelating agents|mesh-ancestor
92299413|NCT04762888|Sequestering Agents|sequestering agents|mesh-ancestor
92299414|NCT04762888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299415|NCT04762888|Anticoagulants|anticoagulants|mesh-ancestor
92299416|NCT04762888|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92299417|NCT04762888|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92299418|NCT04762134|Doxycycline|doxycycline|mesh-list
92299419|NCT04762134|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92299420|NCT04762134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299421|NCT04762134|Antimalarials|antimalarials|mesh-ancestor
92299422|NCT04762134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92299423|NCT04762134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92299424|NCT04743934|Androgens|androgens|mesh-list
92299425|NCT04743934|Hormones|hormones|mesh-ancestor
92299426|NCT04743934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299427|NCT04743934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299428|NCT04736329|Telmisartan|telmisartan|mesh-list
92299429|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299430|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92299431|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92299432|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299433|NCT04735068|Hydroxychloroquine|hydroxychloroquine|mesh-list
92299434|NCT04735068|Antimalarials|antimalarials|mesh-ancestor
92299435|NCT04735068|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92299436|NCT04735068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92299437|NCT04735068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299438|NCT04735068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299439|NCT04735068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299440|NCT04735068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299442|NCT04730544|Ipilimumab|ipilimumab|mesh-list
92299443|NCT04730544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299444|NCT04730544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299445|NCT04730544|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299446|NCT04730544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299447|NCT04721548|Minoxidil|minoxidil|mesh-list
92299448|NCT04721548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299449|NCT04721548|Vasodilator Agents|vasodilator agents|mesh-ancestor
92299450|NCT04717089|Anesthetics|anesthetics|mesh-list
92299451|NCT04717089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299452|NCT04717089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299453|NCT04712799|Xylometazoline|xylometazoline|mesh-list
92299454|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
92299455|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92299456|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92299457|NCT04712734|Iloperidone|iloperidone|mesh-list
92299458|NCT04712734|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92299459|NCT04712734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92299460|NCT04712734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299461|NCT04712734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299462|NCT04712734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92299463|NCT04704154|Nivolumab|nivolumab|mesh-list
92299464|NCT04704154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299465|NCT04704154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299466|NCT04704154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299467|NCT04704154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299468|NCT04687098|Idarubicin|idarubicin|mesh-list
92299469|NCT04687098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92299470|NCT04687098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299471|NCT04687098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92299472|NCT04687098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92299473|NCT04687098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299474|NCT04687098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299475|NCT04685135|Docetaxel|docetaxel|mesh-list
92299476|NCT04685135|Adagrasib|adagrasib|mesh-list
92299477|NCT04685135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299478|NCT04685135|Tubulin Modulators|tubulin modulators|mesh-ancestor
92299479|NCT04685135|Antimitotic Agents|antimitotic agents|mesh-ancestor
92299480|NCT04685135|Mitosis Modulators|mitosis modulators|mesh-ancestor
92299481|NCT04685135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299482|NCT04683406|Oseltamivir|oseltamivir|mesh-list
92299483|NCT04683406|Antiviral Agents|antiviral agents|mesh-ancestor
92299484|NCT04683406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299485|NCT04683406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299486|NCT04683406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299487|NCT04680052|Rituximab|rituximab|mesh-list
92299488|NCT04680052|Lenalidomide|lenalidomide|mesh-list
92299489|NCT04680052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299490|NCT04680052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299491|NCT04680052|Immunologic Factors|immunologic factors|mesh-ancestor
92299492|NCT04680052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299493|NCT04680052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299494|NCT04680052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92299495|NCT04680052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92299496|NCT04680052|Growth Substances|growth substances|mesh-ancestor
92299497|NCT04680052|Growth Inhibitors|growth inhibitors|mesh-ancestor
92299498|NCT04678401|Cyclophosphamide|cyclophosphamide|mesh-list
92299499|NCT04678401|Thiotepa|thiotepa|mesh-list
92299500|NCT04678401|Fludarabine|fludarabine|mesh-list
92299501|NCT04678401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92299502|NCT04678401|Immunologic Factors|immunologic factors|mesh-ancestor
92299503|NCT04678401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299504|NCT04678401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299505|NCT04678401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92299506|NCT04678401|Alkylating Agents|alkylating agents|mesh-ancestor
92299507|NCT04678401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299508|NCT04678401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299509|NCT04678401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92299511|NCT04677504|Atezolizumab|atezolizumab|mesh-list
92299512|NCT04677504|Gemcitabine|gemcitabine|mesh-list
92299513|NCT04677504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299514|NCT04677504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299515|NCT04677504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92299516|NCT04677504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92299517|NCT04677504|Growth Substances|growth substances|mesh-ancestor
92299518|NCT04677504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299519|NCT04677504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92299520|NCT04677504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92299521|NCT04677504|Antimetabolites|antimetabolites|mesh-ancestor
92299522|NCT04677504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299523|NCT04677504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299524|NCT04676087|Mogamulizumab|mogamulizumab|mesh-list
92299525|NCT04676087|Immunoglobulins|immunoglobulins|mesh-list
92299526|NCT04676087|Immunoglobulin G|immunoglobulin g|mesh-list
92299527|NCT04676087|Immunologic Factors|immunologic factors|mesh-ancestor
92299528|NCT04676087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299529|NCT04676087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299530|NCT04662086|Camostat|camostat|mesh-list
92299531|NCT04662086|Protease Inhibitors|protease inhibitors|mesh-ancestor
92299532|NCT04662086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299533|NCT04662086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299534|NCT04662086|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92299535|NCT04662086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92299536|NCT04662073|Camostat|camostat|mesh-list
92299537|NCT04662073|Protease Inhibitors|protease inhibitors|mesh-ancestor
92299538|NCT04662073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299539|NCT04662073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299540|NCT04662073|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92299541|NCT04662073|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92299542|NCT04647877|Phenytoin|phenytoin|mesh-list
92299543|NCT04647877|Anticonvulsants|anticonvulsants|mesh-ancestor
92299544|NCT04647877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92299545|NCT04647877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92299546|NCT04647877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92299547|NCT04647877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299548|NCT04647877|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92299549|NCT04647877|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92299550|NCT04632992|Maytansine|maytansine|mesh-list
92299551|NCT04632992|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92299552|NCT04632992|Trastuzumab|trastuzumab|mesh-list
92299553|NCT04632992|Atezolizumab|atezolizumab|mesh-list
92299554|NCT04632992|Pertuzumab|pertuzumab|mesh-list
92299555|NCT04632992|Ipatasertib|ipatasertib|mesh-list
92299556|NCT04632992|Tucatinib|tucatinib|mesh-list
92299557|NCT04632992|Pralsetinib|pralsetinib|mesh-list
92299558|NCT04632992|Entrectinib|entrectinib|mesh-list
92299559|NCT04632992|Inavolisib|inavolisib|mesh-list
92299560|NCT04632992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92299561|NCT04632992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299562|NCT04632992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92299563|NCT04632992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92299564|NCT04632992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92299565|NCT04632992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299566|NCT04632992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299567|NCT04632992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299568|NCT04632992|Immunotoxins|immunotoxins|mesh-ancestor
92299569|NCT04632992|Immunoconjugates|immunoconjugates|mesh-ancestor
92346754|NCT01790568|Methotrexate|methotrexate|mesh-list
92299570|NCT04632992|Immunologic Factors|immunologic factors|mesh-ancestor
92299571|NCT04632992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299572|NCT04632992|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299573|NCT04632992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299574|NCT04632992|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92299575|NCT04629547|Suvorexant|suvorexant|mesh-list
92299576|NCT04629547|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92299577|NCT04629547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92299578|NCT04629547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299579|NCT04629547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299580|NCT04629547|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92299581|NCT04629547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299582|NCT04629547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299583|NCT04617938|Analgesics, Opioid|analgesics, opioid|mesh-list
92299585|NCT04617938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299586|NCT04617938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299587|NCT04617938|Analgesics|analgesics|mesh-ancestor
92299588|NCT04617938|Sensory System Agents|sensory system agents|mesh-ancestor
92299589|NCT04617938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299590|NCT04615403|Travoprost|travoprost|mesh-list
92299591|NCT04615403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299592|NCT04609020|Lidocaine|lidocaine|mesh-list
92299593|NCT04609020|Anesthetics, Local|anesthetics, local|mesh-ancestor
92299594|NCT04609020|Anesthetics|anesthetics|mesh-ancestor
92299595|NCT04609020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299596|NCT04609020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299597|NCT04609020|Sensory System Agents|sensory system agents|mesh-ancestor
92299598|NCT04609020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299599|NCT04609020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92299600|NCT04609020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92299601|NCT04609020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92299602|NCT04609020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92299603|NCT04609020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299604|NCT04608539|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92299605|NCT04608539|Hematinics|hematinics|mesh-ancestor
92299606|NCT04597437|Zanamivir|zanamivir|mesh-list
92299607|NCT04597437|Antiviral Agents|antiviral agents|mesh-ancestor
92299608|NCT04597437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299609|NCT04597437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299610|NCT04597437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299611|NCT04586660|Denosumab|denosumab|mesh-list
92299612|NCT04586660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92299613|NCT04586660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299614|NCT04586166|Imidacloprid|imidacloprid|mesh-list
92299615|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
92299616|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299617|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299618|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299619|NCT04578756|Cariprazine|cariprazine|mesh-list
92299620|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92299621|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92299622|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299623|NCT04578756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299624|NCT04578756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92299625|NCT04575597|Molnupiravir|molnupiravir|mesh-list
92299626|NCT04575597|Antiviral Agents|antiviral agents|mesh-ancestor
92299627|NCT04575597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299628|NCT04564755|Abrocitinib|abrocitinib|mesh-list
92299629|NCT04564755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299630|NCT04564755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299631|NCT04564755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299632|NCT04562792|Daunorubicin|daunorubicin|mesh-list
92299633|NCT04562792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92299634|NCT04562792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299635|NCT04562792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92299636|NCT04562792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92299637|NCT04562792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299638|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299639|NCT04550377|Cannabidiol|cannabidiol|mesh-list
92299640|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
92299641|NCT04544813|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92299642|NCT04544813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299643|NCT04524871|Bevacizumab|bevacizumab|mesh-list
92299644|NCT04524871|Atezolizumab|atezolizumab|mesh-list
92299645|NCT04524871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299646|NCT04524871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299647|NCT04524871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92299648|NCT04524871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92299649|NCT04524871|Growth Substances|growth substances|mesh-ancestor
92299650|NCT04524871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299651|NCT04524871|Growth Inhibitors|growth inhibitors|mesh-ancestor
92299652|NCT04524871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299653|NCT04524871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299654|NCT04519619|Aflibercept|aflibercept|mesh-list
92299655|NCT04519619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92299656|NCT04519619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92299657|NCT04519619|Growth Substances|growth substances|mesh-ancestor
92299658|NCT04519619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299659|NCT04519619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92299660|NCT04519619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299661|NCT04501367|Dexamethasone|dexamethasone|mesh-list
92299662|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
92299664|NCT04501367|BB 1101|bb 1101|mesh-list
92299665|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299666|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
92299667|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
92299668|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299669|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299670|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92299671|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
92299672|NCT04501367|Hormones|hormones|mesh-ancestor
91932185|NCT03532763|Vitamin E|vitamin e|mesh-list
92299673|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299674|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92299675|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299676|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
92299677|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299678|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299679|NCT04496960|Tofacitinib|tofacitinib|mesh-list
92299680|NCT04496960|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92299681|NCT04496960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299682|NCT04496960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299683|NCT04496960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299684|NCT04491617|Analgesics, Opioid|analgesics, opioid|mesh-list
92299685|NCT04491617|Narcotics|narcotics|mesh-ancestor
92299686|NCT04491617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299687|NCT04491617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299688|NCT04491617|Analgesics|analgesics|mesh-ancestor
92299689|NCT04491617|Sensory System Agents|sensory system agents|mesh-ancestor
92299690|NCT04491617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299691|NCT04490057|Bupropion|bupropion|mesh-list
92299692|NCT04490057|Nicotine|nicotine|mesh-list
92299693|NCT04490057|Varenicline|varenicline|mesh-list
92299694|NCT04490057|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92299695|NCT04490057|Autonomic Agents|autonomic agents|mesh-ancestor
92299696|NCT04490057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299697|NCT04490057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299698|NCT04490057|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92299699|NCT04490057|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92299700|NCT04490057|Cholinergic Agents|cholinergic agents|mesh-ancestor
92299701|NCT04490057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299702|NCT04490057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299703|NCT04490057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92299704|NCT04490057|Antidepressive Agents|antidepressive agents|mesh-ancestor
92299705|NCT04490057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92299706|NCT04490057|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92299707|NCT04490057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92299708|NCT04490057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92299709|NCT04490057|Dopamine Agents|dopamine agents|mesh-ancestor
92299710|NCT04490057|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92299711|NCT04490057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92299712|NCT04490057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299713|NCT04487392|Estrogens|estrogens|mesh-list
92299714|NCT04487392|Hormones|hormones|mesh-ancestor
92299715|NCT04487392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299716|NCT04487392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299717|NCT04485546|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92299718|NCT04485546|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92299719|NCT04476446|Esketamine|esketamine|mesh-list
92299720|NCT04476446|Antidepressive Agents|antidepressive agents|mesh-ancestor
92299721|NCT04476446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92299722|NCT04472416|Analgesics|analgesics|mesh-list
92299723|NCT04472416|Sensory System Agents|sensory system agents|mesh-ancestor
92299724|NCT04472416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299725|NCT04472416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299726|NCT04466150|Ocrelizumab|ocrelizumab|mesh-list
92299727|NCT04466150|Immunologic Factors|immunologic factors|mesh-ancestor
92299728|NCT04466150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299730|NCT04439136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299731|NCT04439136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299732|NCT04439136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299733|NCT04439136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299734|NCT04439110|Trastuzumab|trastuzumab|mesh-list
92299735|NCT04439110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92299736|NCT04439110|Maytansine|maytansine|mesh-list
92299737|NCT04439110|Immunoconjugates|immunoconjugates|mesh-list
92299738|NCT04439110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299739|NCT04439110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299740|NCT04439110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92299741|NCT04439110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92299742|NCT04439110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92299743|NCT04439110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92299744|NCT04439110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299745|NCT04439110|Immunotoxins|immunotoxins|mesh-ancestor
92299746|NCT04439110|Immunologic Factors|immunologic factors|mesh-ancestor
92299747|NCT04439110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299748|NCT04435782|Selexipag|selexipag|mesh-list
92299749|NCT04435782|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299750|NCT04432831|Faricimab|faricimab|mesh-list
92299751|NCT04432831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92299752|NCT04432831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92299753|NCT04432831|Growth Substances|growth substances|mesh-ancestor
92299754|NCT04432831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299755|NCT04432831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92299756|NCT04432831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299757|NCT04427293|Pembrolizumab|pembrolizumab|mesh-list
92299758|NCT04427293|Lenvatinib|lenvatinib|mesh-list
92299759|NCT04427293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299760|NCT04427293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299761|NCT04427293|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299762|NCT04427293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299763|NCT04427293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92299764|NCT04427293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299765|NCT04391842|Diclofenac|diclofenac|mesh-list
92299766|NCT04391842|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92299767|NCT04391842|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299768|NCT04391842|Analgesics|analgesics|mesh-ancestor
92299769|NCT04391842|Sensory System Agents|sensory system agents|mesh-ancestor
92299770|NCT04391842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299771|NCT04391842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299772|NCT04391842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299773|NCT04391842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299774|NCT04391842|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92299775|NCT04391842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299776|NCT04391842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299777|NCT04383262|Fosamprenavir|fosamprenavir|mesh-list
92299778|NCT04383262|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92299779|NCT04383262|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92299780|NCT04383262|Protease Inhibitors|protease inhibitors|mesh-ancestor
92299781|NCT04383262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299782|NCT04383262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299783|NCT04383262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92299784|NCT04383262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92299785|NCT04383262|Antiviral Agents|antiviral agents|mesh-ancestor
92299786|NCT04383262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299787|NCT04360681|Lofexidine|lofexidine|mesh-list
92299788|NCT04360681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92299789|NCT04360681|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92299790|NCT04360681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299791|NCT04360681|Sensory System Agents|sensory system agents|mesh-ancestor
91936236|NCT04002037|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92299792|NCT04360681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299793|NCT04360681|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92299794|NCT04360681|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92299796|NCT04360681|Adrenergic Agents|adrenergic agents|mesh-ancestor
92299797|NCT04360681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299798|NCT04360681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299799|NCT04344795|Pembrolizumab|pembrolizumab|mesh-list
92299800|NCT04344795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299801|NCT04344795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299802|NCT04344795|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299803|NCT04344795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299805|NCT04334759|Carboplatin|carboplatin|mesh-list
92299806|NCT04334759|Nivolumab|nivolumab|mesh-list
92299807|NCT04334759|Pemetrexed|pemetrexed|mesh-list
92299808|NCT04334759|Ipilimumab|ipilimumab|mesh-list
92299809|NCT04334759|Durvalumab|durvalumab|mesh-list
92299810|NCT04334759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299811|NCT04334759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299812|NCT04334759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92299813|NCT04334759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299814|NCT04334759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299815|NCT04334759|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92299816|NCT04334759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92299817|NCT04330248|Carbamazepine|carbamazepine|mesh-list
92299818|NCT04330248|Anticonvulsants|anticonvulsants|mesh-ancestor
92299819|NCT04330248|Antimanic Agents|antimanic agents|mesh-ancestor
92299820|NCT04330248|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92299821|NCT04330248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299822|NCT04330248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299823|NCT04330248|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92299824|NCT04330248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299825|NCT04330248|Analgesics|analgesics|mesh-ancestor
92299826|NCT04330248|Sensory System Agents|sensory system agents|mesh-ancestor
92299827|NCT04330248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299828|NCT04330248|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92299829|NCT04330248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92299830|NCT04330248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299831|NCT04330248|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92299832|NCT04330248|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92299833|NCT04328844|Pemetrexed|pemetrexed|mesh-list
92299834|NCT04328844|Avelumab|avelumab|mesh-list
92299835|NCT04328844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299836|NCT04328844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299837|NCT04328844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299838|NCT04328844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92299839|NCT04328844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92299840|NCT04328844|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299841|NCT04327024|Allopurinol|allopurinol|mesh-list
92299842|NCT04327024|Verinurad|verinurad|mesh-list
92299843|NCT04327024|Antimetabolites|antimetabolites|mesh-ancestor
92299844|NCT04327024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299845|NCT04327024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299846|NCT04327024|Gout Suppressants|gout suppressants|mesh-ancestor
92299847|NCT04327024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299848|NCT04327024|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92299849|NCT04327024|Antioxidants|antioxidants|mesh-ancestor
92299850|NCT04327024|Protective Agents|protective agents|mesh-ancestor
92299851|NCT04327024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299852|NCT04315272|Azithromycin|azithromycin|mesh-list
92299853|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92299854|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299855|NCT04304352|Cyclophosphamide|cyclophosphamide|mesh-list
92299856|NCT04304352|Capecitabine|capecitabine|mesh-list
92299857|NCT04304352|Vinorelbine|vinorelbine|mesh-list
92299858|NCT04304352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92299859|NCT04304352|Immunologic Factors|immunologic factors|mesh-ancestor
92299860|NCT04304352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299861|NCT04304352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299862|NCT04304352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92299863|NCT04304352|Alkylating Agents|alkylating agents|mesh-ancestor
92299864|NCT04304352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299865|NCT04304352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299866|NCT04304352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92299867|NCT04304352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92299868|NCT04304352|Antimetabolites|antimetabolites|mesh-ancestor
92299869|NCT04304352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92299870|NCT04304352|Tubulin Modulators|tubulin modulators|mesh-ancestor
92299871|NCT04304352|Antimitotic Agents|antimitotic agents|mesh-ancestor
92299872|NCT04304352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92299873|NCT04298567|Aspirin|aspirin|mesh-list
92299874|NCT04298567|Rivaroxaban|rivaroxaban|mesh-list
92299875|NCT04298567|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92299876|NCT04298567|Antithrombins|antithrombins|mesh-ancestor
92299877|NCT04298567|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92299878|NCT04298567|Protease Inhibitors|protease inhibitors|mesh-ancestor
92299879|NCT04298567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299880|NCT04298567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299881|NCT04298567|Anticoagulants|anticoagulants|mesh-ancestor
92299882|NCT04298567|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92299883|NCT04298567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299884|NCT04298567|Analgesics|analgesics|mesh-ancestor
92299885|NCT04298567|Sensory System Agents|sensory system agents|mesh-ancestor
92299886|NCT04298567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299887|NCT04298567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299888|NCT04298567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299889|NCT04298567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92299890|NCT04298567|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92299891|NCT04298567|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92299892|NCT04298567|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92299893|NCT04298567|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92299894|NCT04298567|Antipyretics|antipyretics|mesh-ancestor
92299895|NCT04297592|Doxycycline|doxycycline|mesh-list
92299896|NCT04297592|Cephalexin|cephalexin|mesh-list
92299897|NCT04297592|Cefadroxil|cefadroxil|mesh-list
92299898|NCT04297592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92299899|NCT04297592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299900|NCT04297592|Antimalarials|antimalarials|mesh-ancestor
92299901|NCT04297592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92299902|NCT04297592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92299903|NCT04294459|Acetaminophen|acetaminophen|mesh-list
92299904|NCT04294459|Diphenhydramine|diphenhydramine|mesh-list
92299905|NCT04294459|Promethazine|promethazine|mesh-list
92299906|NCT04294459|Methylprednisolone|methylprednisolone|mesh-list
92299907|NCT04294459|Ranitidine|ranitidine|mesh-list
92299908|NCT04294459|Montelukast|montelukast|mesh-list
92299909|NCT04294459|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299910|NCT04294459|Analgesics|analgesics|mesh-ancestor
92299911|NCT04294459|Sensory System Agents|sensory system agents|mesh-ancestor
92299912|NCT04294459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299913|NCT04294459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299914|NCT04294459|Antipyretics|antipyretics|mesh-ancestor
92299915|NCT04294459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299916|NCT04294459|Antiemetics|antiemetics|mesh-ancestor
92299917|NCT04294459|Autonomic Agents|autonomic agents|mesh-ancestor
92299918|NCT04294459|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92299919|NCT04294459|Glucocorticoids|glucocorticoids|mesh-ancestor
92299920|NCT04294459|Hormones|hormones|mesh-ancestor
92346777|NCT01836198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92299921|NCT04294459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299922|NCT04294459|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92299923|NCT04294459|Protective Agents|protective agents|mesh-ancestor
92299924|NCT04294459|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92299925|NCT04294459|Respiratory System Agents|respiratory system agents|mesh-ancestor
92299926|NCT04294459|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92299927|NCT04294459|Hormone Antagonists|hormone antagonists|mesh-ancestor
92299928|NCT04294459|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92299929|NCT04294459|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92299930|NCT04294459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299931|NCT04294459|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92299932|NCT04294459|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92299933|NCT04294459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299934|NCT04294459|Anesthetics, Local|anesthetics, local|mesh-ancestor
92299935|NCT04294459|Anesthetics|anesthetics|mesh-ancestor
92299936|NCT04294459|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92299937|NCT04294459|Histamine Antagonists|histamine antagonists|mesh-ancestor
92299938|NCT04294459|Histamine Agents|histamine agents|mesh-ancestor
92299939|NCT04294459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299940|NCT04294459|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92299941|NCT04294459|Antipruritics|antipruritics|mesh-ancestor
92299942|NCT04294459|Dermatologic Agents|dermatologic agents|mesh-ancestor
92299944|NCT04294459|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92299945|NCT04291105|Cemiplimab|cemiplimab|mesh-list
92299946|NCT04291105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299947|NCT04291105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299948|NCT04268121|Cisplatin|cisplatin|mesh-list
91952685|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92299949|NCT04268121|Etoposide|etoposide|mesh-list
92299950|NCT04268121|Etoposide phosphate|etoposide phosphate|mesh-list
92299951|NCT04268121|Carboplatin|carboplatin|mesh-list
92299952|NCT04268121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299953|NCT04268121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92299954|NCT04268121|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92299955|NCT04268121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92299956|NCT04268121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92299957|NCT04268121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299959|NCT04252612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92299960|NCT04252612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299961|NCT04225715|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92299962|NCT04225715|Antiviral Agents|antiviral agents|mesh-ancestor
92299963|NCT04225715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92299964|NCT04221477|Acetaminophen|acetaminophen|mesh-list
92299965|NCT04221477|Diphenhydramine|diphenhydramine|mesh-list
92299966|NCT04221477|Promethazine|promethazine|mesh-list
92299967|NCT04221477|Prednisone|prednisone|mesh-list
92299968|NCT04221477|Methylprednisolone|methylprednisolone|mesh-list
92299969|NCT04221477|Obinutuzumab|obinutuzumab|mesh-list
92299970|NCT04221477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92299971|NCT04221477|Glucocorticoids|glucocorticoids|mesh-ancestor
92299972|NCT04221477|Hormones|hormones|mesh-ancestor
92299973|NCT04221477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92299974|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92299975|NCT04221477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92299976|NCT04221477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92299977|NCT04221477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92299978|NCT04221477|Analgesics|analgesics|mesh-ancestor
92299979|NCT04221477|Sensory System Agents|sensory system agents|mesh-ancestor
92299980|NCT04221477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92299981|NCT04221477|Antipyretics|antipyretics|mesh-ancestor
92299982|NCT04221477|Antiemetics|antiemetics|mesh-ancestor
92299983|NCT04221477|Autonomic Agents|autonomic agents|mesh-ancestor
92299984|NCT04221477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92299985|NCT04221477|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92299986|NCT04221477|Protective Agents|protective agents|mesh-ancestor
92299987|NCT04221477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92299988|NCT04221477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92299989|NCT04221477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92299990|NCT04221477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92299991|NCT04221477|Anesthetics, Local|anesthetics, local|mesh-ancestor
92299992|NCT04221477|Anesthetics|anesthetics|mesh-ancestor
92299993|NCT04221477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92299994|NCT04221477|Histamine Antagonists|histamine antagonists|mesh-ancestor
92299995|NCT04221477|Histamine Agents|histamine agents|mesh-ancestor
92299996|NCT04221477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92299997|NCT04221477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92299998|NCT04221477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92299999|NCT04221477|Antipruritics|antipruritics|mesh-ancestor
92300000|NCT04221477|Dermatologic Agents|dermatologic agents|mesh-ancestor
92300001|NCT04214288|Fulvestrant|fulvestrant|mesh-list
92300002|NCT04214288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300003|NCT04214288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300004|NCT04214288|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92300005|NCT04214288|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92300006|NCT04214288|Hormone Antagonists|hormone antagonists|mesh-ancestor
91936243|NCT04002037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300007|NCT04214288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300009|NCT04210505|Povidone-Iodine|povidone-iodine|mesh-list
92300010|NCT04210505|Povidone|povidone|mesh-list
92300011|NCT04210505|Plasma Substitutes|plasma substitutes|mesh-ancestor
92300012|NCT04210505|Blood Substitutes|blood substitutes|mesh-ancestor
92300013|NCT04210505|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92300014|NCT04210505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300015|NCT04195698|Upadacitinib|upadacitinib|mesh-list
92300016|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92300017|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92300018|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300019|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300020|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300021|NCT04194528|Acetaminophen|acetaminophen|mesh-list
92300022|NCT04194528|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92300023|NCT04194528|Oxycodone|oxycodone|mesh-list
92300024|NCT04194528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92300025|NCT04194528|Analgesics|analgesics|mesh-ancestor
92300026|NCT04194528|Sensory System Agents|sensory system agents|mesh-ancestor
92300027|NCT04194528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300028|NCT04194528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300029|NCT04194528|Antipyretics|antipyretics|mesh-ancestor
92300030|NCT04194528|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92300031|NCT04194528|Narcotics|narcotics|mesh-ancestor
92300032|NCT04194528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92300033|NCT04194528|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92300034|NCT04194528|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300035|NCT04194528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300036|NCT04189614|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
92300037|NCT04189614|Immunoconjugates|immunoconjugates|mesh-ancestor
92300038|NCT04189614|Immunologic Factors|immunologic factors|mesh-ancestor
92300039|NCT04189614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300040|NCT04182204|Rituximab|rituximab|mesh-list
92300041|NCT04182204|Gemcitabine|gemcitabine|mesh-list
92300042|NCT04182204|Oxaliplatin|oxaliplatin|mesh-list
92300043|NCT04182204|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92300044|NCT04182204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300045|NCT04182204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300046|NCT04182204|Immunologic Factors|immunologic factors|mesh-ancestor
92300047|NCT04182204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300048|NCT04182204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300049|NCT04182204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300050|NCT04182204|Antimetabolites|antimetabolites|mesh-ancestor
92300051|NCT04182204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300052|NCT04182204|Immunoconjugates|immunoconjugates|mesh-ancestor
92300053|NCT04179396|Rucaparib|rucaparib|mesh-list
92300054|NCT04179396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92300055|NCT04179396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300056|NCT04179396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300057|NCT04179396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300058|NCT04172675|Gemcitabine|gemcitabine|mesh-list
92300059|NCT04172675|Mitomycins|mitomycins|mesh-list
92300060|NCT04172675|Mitomycin|mitomycin|mesh-list
92300061|NCT04172675|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300062|NCT04172675|Antimetabolites|antimetabolites|mesh-ancestor
92300063|NCT04172675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300065|NCT04172675|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92300066|NCT04172675|Alkylating Agents|alkylating agents|mesh-ancestor
92300067|NCT04172675|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300068|NCT04172675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300069|NCT04170348|Vitamin D|vitamin d|mesh-list
92300070|NCT04170348|Ergocalciferols|ergocalciferols|mesh-list
92300071|NCT04170348|Cholecalciferol|cholecalciferol|mesh-list
92300072|NCT04170348|Vitamins|vitamins|mesh-list
92300073|NCT04170348|Trientine|trientine|mesh-list
92300074|NCT04170348|Micronutrients|micronutrients|mesh-ancestor
92300075|NCT04170348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300076|NCT04170348|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92300077|NCT04170348|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92300078|NCT04170348|Chelating Agents|chelating agents|mesh-ancestor
92300079|NCT04170348|Sequestering Agents|sequestering agents|mesh-ancestor
92300080|NCT04170348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300081|NCT04166487|Paclitaxel|paclitaxel|mesh-list
92300082|NCT04166487|Carboplatin|carboplatin|mesh-list
92300083|NCT04166487|Pembrolizumab|pembrolizumab|mesh-list
92300084|NCT04166487|Pemetrexed|pemetrexed|mesh-list
92300085|NCT04166487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300086|NCT04166487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300087|NCT04166487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300088|NCT04166487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300089|NCT04166487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300090|NCT04166487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300091|NCT04166487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300092|NCT04166487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300093|NCT04166487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300094|NCT04166487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92300095|NCT04166487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300096|NCT04158440|Paclitaxel|paclitaxel|mesh-list
92300097|NCT04158440|Docetaxel|docetaxel|mesh-list
92300098|NCT04158440|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92300099|NCT04158440|Cisplatin|cisplatin|mesh-list
92300100|NCT04158440|Carboplatin|carboplatin|mesh-list
92300101|NCT04158440|Pemetrexed|pemetrexed|mesh-list
92300102|NCT04158440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300103|NCT04158440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952831|NCT04358003|Coal Tar|coal tar|mesh-list
92300104|NCT04158440|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300105|NCT04158440|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300106|NCT04158440|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300107|NCT04158440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300108|NCT04158440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300109|NCT04158440|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92300110|NCT04158440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300111|NCT04150887|Azacitidine|azacitidine|mesh-list
92300112|NCT04150887|Venetoclax|venetoclax|mesh-list
92300113|NCT04150887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300114|NCT04150887|Antimetabolites|antimetabolites|mesh-ancestor
92300115|NCT04150887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300116|NCT04150887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300117|NCT04150887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300118|NCT04140162|Dexamethasone|dexamethasone|mesh-list
92300119|NCT04140162|Lenalidomide|lenalidomide|mesh-list
92300120|NCT04140162|Bortezomib|bortezomib|mesh-list
92300121|NCT04140162|Daratumumab|daratumumab|mesh-list
92300122|NCT04140162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300123|NCT04140162|Antiemetics|antiemetics|mesh-ancestor
92300124|NCT04140162|Autonomic Agents|autonomic agents|mesh-ancestor
92300125|NCT04140162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300126|NCT04140162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300127|NCT04140162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300128|NCT04140162|Glucocorticoids|glucocorticoids|mesh-ancestor
92300129|NCT04140162|Hormones|hormones|mesh-ancestor
92300130|NCT04140162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410269|NCT05330429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300131|NCT04140162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300132|NCT04140162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300133|NCT04140162|Immunologic Factors|immunologic factors|mesh-ancestor
92300134|NCT04140162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92346790|NCT01836198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92300135|NCT04140162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300136|NCT04140162|Growth Substances|growth substances|mesh-ancestor
92300137|NCT04140162|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300138|NCT04129515|Pembrolizumab|pembrolizumab|mesh-list
92300139|NCT04129515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300140|NCT04129515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300141|NCT04129515|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300142|NCT04129515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300143|NCT04124939|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92300144|NCT04124939|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92300145|NCT04124939|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92300146|NCT04124939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300147|NCT04124939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300148|NCT04124939|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92300149|NCT04124939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92300150|NCT04124939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300151|NCT04124939|Cholinergic Agents|cholinergic agents|mesh-ancestor
92300152|NCT04124939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300153|NCT04111978|Letrozole|letrozole|mesh-list
92300154|NCT04111978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300155|NCT04111978|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92300156|NCT04111978|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92300157|NCT04111978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300158|NCT04111978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300159|NCT04111978|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92300160|NCT04111978|Hormone Antagonists|hormone antagonists|mesh-ancestor
92300161|NCT04111978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300162|NCT04111978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300163|NCT04085458|Factor VIII|factor viii|mesh-list
92300164|NCT04085458|Coagulants|coagulants|mesh-ancestor
92300165|NCT04077580|Methenamine|methenamine|mesh-list
92300166|NCT04077580|Methenamine hippurate|methenamine hippurate|mesh-list
92300167|NCT04077580|Methenamine mandelate|methenamine mandelate|mesh-list
92300168|NCT04077580|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92300169|NCT04077580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300170|NCT04077580|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300171|NCT04056910|Nivolumab|nivolumab|mesh-list
92300172|NCT04056910|Ivosidenib|ivosidenib|mesh-list
92300173|NCT04056910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300174|NCT04056910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300175|NCT04056910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300176|NCT04056910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300177|NCT04056910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300178|NCT04054752|Vaccines|vaccines|mesh-list
92300179|NCT04054752|Immunologic Factors|immunologic factors|mesh-ancestor
92300180|NCT04054752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300181|NCT04037527|Gemcitabine|gemcitabine|mesh-list
92300183|NCT04037527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300184|NCT04037527|Antimetabolites|antimetabolites|mesh-ancestor
92300185|NCT04037527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300186|NCT04037527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300187|NCT04037527|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300188|NCT04037527|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300189|NCT04037527|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300190|NCT04023526|Azacitidine|azacitidine|mesh-list
92300191|NCT04023526|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300192|NCT04023526|Antimetabolites|antimetabolites|mesh-ancestor
92300193|NCT04023526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300194|NCT04023526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300195|NCT04023526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300196|NCT04008030|Leucovorin|leucovorin|mesh-list
92300197|NCT04008030|Bevacizumab|bevacizumab|mesh-list
92300198|NCT04008030|Nivolumab|nivolumab|mesh-list
92300199|NCT04008030|Cetuximab|cetuximab|mesh-list
92300200|NCT04008030|Ipilimumab|ipilimumab|mesh-list
92300201|NCT04008030|Fluorouracil|fluorouracil|mesh-list
92300202|NCT04008030|Oxaliplatin|oxaliplatin|mesh-list
92300203|NCT04008030|Irinotecan|irinotecan|mesh-list
92300204|NCT04008030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300205|NCT04008030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300206|NCT04008030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300207|NCT04008030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300208|NCT04008030|Growth Substances|growth substances|mesh-ancestor
92300209|NCT04008030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300210|NCT04008030|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300211|NCT04008030|Antimetabolites|antimetabolites|mesh-ancestor
92300212|NCT04008030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300213|NCT04008030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300214|NCT04008030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300215|NCT04008030|Immunologic Factors|immunologic factors|mesh-ancestor
92300216|NCT04008030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300217|NCT04008030|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92300218|NCT04008030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92300219|NCT04008030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300220|NCT04008030|Antidotes|antidotes|mesh-ancestor
92300221|NCT04008030|Protective Agents|protective agents|mesh-ancestor
92300222|NCT04008030|Vitamin B Complex|vitamin b complex|mesh-ancestor
92300223|NCT04008030|Vitamins|vitamins|mesh-ancestor
92300224|NCT04008030|Micronutrients|micronutrients|mesh-ancestor
92300225|NCT03989414|Dexamethasone|dexamethasone|mesh-list
92300226|NCT03989414|Bortezomib|bortezomib|mesh-list
92300227|NCT03989414|Daratumumab|daratumumab|mesh-list
92300228|NCT03989414|Elotuzumab|elotuzumab|mesh-list
92300229|NCT03989414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300230|NCT03989414|Antiemetics|antiemetics|mesh-ancestor
92300231|NCT03989414|Autonomic Agents|autonomic agents|mesh-ancestor
92300232|NCT03989414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300233|NCT03989414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300234|NCT03989414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300235|NCT03989414|Glucocorticoids|glucocorticoids|mesh-ancestor
92300236|NCT03989414|Hormones|hormones|mesh-ancestor
92300237|NCT03989414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300238|NCT03989414|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300239|NCT03989414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300240|NCT03978624|Pembrolizumab|pembrolizumab|mesh-list
92300241|NCT03978624|Entinostat|entinostat|mesh-list
92300242|NCT03978624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300243|NCT03978624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300244|NCT03978624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300245|NCT03978624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300246|NCT03978624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92300247|NCT03978624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300248|NCT03974217|Decitabine|decitabine|mesh-list
92300249|NCT03974217|Talazoparib|talazoparib|mesh-list
92300250|NCT03974217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300251|NCT03974217|Antimetabolites|antimetabolites|mesh-ancestor
92300252|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300253|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300254|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300255|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92300256|NCT03971045|Cyclophosphamide|cyclophosphamide|mesh-list
92300257|NCT03971045|Pembrolizumab|pembrolizumab|mesh-list
91952980|NCT03866525|Irinotecan|irinotecan|mesh-list
92300258|NCT03971045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300259|NCT03971045|Immunologic Factors|immunologic factors|mesh-ancestor
92300260|NCT03971045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300261|NCT03971045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300262|NCT03971045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300263|NCT03971045|Alkylating Agents|alkylating agents|mesh-ancestor
92300264|NCT03971045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300265|NCT03971045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300266|NCT03971045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92300267|NCT03971045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300268|NCT03971045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300269|NCT03968653|Carboplatin|carboplatin|mesh-list
92300270|NCT03968653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300271|NCT03946800|Durvalumab|durvalumab|mesh-list
92300272|NCT03946800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300273|NCT03946800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300274|NCT03940235|Androgens|androgens|mesh-list
92300275|NCT03940235|Hormones|hormones|mesh-ancestor
92300276|NCT03940235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300277|NCT03940235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300278|NCT03935893|Cyclophosphamide|cyclophosphamide|mesh-list
92300279|NCT03935893|Fludarabine|fludarabine|mesh-list
92300280|NCT03935893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300281|NCT03935893|Immunologic Factors|immunologic factors|mesh-ancestor
92300282|NCT03935893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300283|NCT03935893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300284|NCT03935893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300285|NCT03935893|Alkylating Agents|alkylating agents|mesh-ancestor
92300286|NCT03935893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300287|NCT03935893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300288|NCT03935893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92300289|NCT03932201|Factor VIII|factor viii|mesh-list
92300290|NCT03932201|Coagulants|coagulants|mesh-ancestor
92300291|NCT03916510|Capecitabine|capecitabine|mesh-list
92300292|NCT03916510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300293|NCT03916510|Antimetabolites|antimetabolites|mesh-ancestor
92300294|NCT03916510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300295|NCT03916510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300296|NCT03905798|Lorazepam|lorazepam|mesh-list
92300297|NCT03905798|Anticonvulsants|anticonvulsants|mesh-ancestor
92300298|NCT03905798|Antiemetics|antiemetics|mesh-ancestor
92300299|NCT03905798|Autonomic Agents|autonomic agents|mesh-ancestor
92300300|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300301|NCT03905798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300302|NCT03905798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300303|NCT03905798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92300304|NCT03905798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92300305|NCT03905798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92300306|NCT03905798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92300307|NCT03905798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92300308|NCT03905798|GABA Modulators|gaba modulators|mesh-ancestor
92300309|NCT03905798|GABA Agents|gaba agents|mesh-ancestor
92300310|NCT03905798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300311|NCT03905798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300312|NCT03901482|Dihydroergotamine|dihydroergotamine|mesh-list
92300313|NCT03901482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92300314|NCT03901482|Dopamine Agonists|dopamine agonists|mesh-ancestor
92300315|NCT03901482|Dopamine Agents|dopamine agents|mesh-ancestor
92300316|NCT03901482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300317|NCT03901482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300318|NCT03901482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300319|NCT03901482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92300320|NCT03901482|Analgesics|analgesics|mesh-ancestor
92300321|NCT03901482|Sensory System Agents|sensory system agents|mesh-ancestor
92300322|NCT03901482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300323|NCT03900377|Rituximab|rituximab|mesh-list
92300324|NCT03900377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300325|NCT03900377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300326|NCT03900377|Immunologic Factors|immunologic factors|mesh-ancestor
92300327|NCT03900377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300328|NCT03900377|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300329|NCT03868124|Travoprost|travoprost|mesh-list
92300330|NCT03868124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92300331|NCT03868124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92300332|NCT03868124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92300333|NCT03860844|Cytarabine|cytarabine|mesh-list
92300334|NCT03860844|Dexamethasone|dexamethasone|mesh-list
92300335|NCT03860844|Cyclophosphamide|cyclophosphamide|mesh-list
92300336|NCT03860844|Doxorubicin|doxorubicin|mesh-list
92300337|NCT03860844|Methotrexate|methotrexate|mesh-list
92300338|NCT03860844|Fludarabine|fludarabine|mesh-list
92300339|NCT03860844|Etoposide|etoposide|mesh-list
92300340|NCT03860844|Vincristine|vincristine|mesh-list
92300341|NCT03860844|Daunorubicin|daunorubicin|mesh-list
92300342|NCT03860844|Asparaginase|asparaginase|mesh-list
92300343|NCT03860844|Mitoxantrone|mitoxantrone|mesh-list
92300344|NCT03860844|Idarubicin|idarubicin|mesh-list
92300345|NCT03860844|Hydroxyurea|hydroxyurea|mesh-list
92300346|NCT03860844|Pegaspargase|pegaspargase|mesh-list
92300347|NCT03860844|Montelukast|montelukast|mesh-list
92300348|NCT03860844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300349|NCT03860844|Immunologic Factors|immunologic factors|mesh-ancestor
91932764|NCT05262413|Lenvatinib|lenvatinib|mesh-list
92300350|NCT03860844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300351|NCT03860844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300352|NCT03860844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300353|NCT03860844|Alkylating Agents|alkylating agents|mesh-ancestor
92300354|NCT03860844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300355|NCT03860844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300356|NCT03860844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92300357|NCT03860844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300358|NCT03860844|Antiemetics|antiemetics|mesh-ancestor
92300359|NCT03860844|Autonomic Agents|autonomic agents|mesh-ancestor
92300360|NCT03860844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300361|NCT03860844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300362|NCT03860844|Glucocorticoids|glucocorticoids|mesh-ancestor
92300363|NCT03860844|Hormones|hormones|mesh-ancestor
92300364|NCT03860844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300365|NCT03860844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300366|NCT03860844|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92300367|NCT03860844|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92300368|NCT03860844|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92300369|NCT03860844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300370|NCT03860844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92300371|NCT03860844|Abortifacient Agents|abortifacient agents|mesh-ancestor
92300372|NCT03860844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92300373|NCT03860844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300374|NCT03860844|Antimetabolites|antimetabolites|mesh-ancestor
92300375|NCT03860844|Dermatologic Agents|dermatologic agents|mesh-ancestor
92300376|NCT03860844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92300377|NCT03860844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300378|NCT03860844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300379|NCT03860844|Antiviral Agents|antiviral agents|mesh-ancestor
92300380|NCT03860844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300381|NCT03860844|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300382|NCT03860844|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300383|NCT03860844|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300384|NCT03860844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92300385|NCT03860844|Respiratory System Agents|respiratory system agents|mesh-ancestor
92300386|NCT03860844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92300387|NCT03860844|Hormone Antagonists|hormone antagonists|mesh-ancestor
92300388|NCT03860844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92300389|NCT03860844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92300390|NCT03860844|Analgesics|analgesics|mesh-ancestor
92300391|NCT03860844|Sensory System Agents|sensory system agents|mesh-ancestor
92300392|NCT03860844|Antisickling Agents|antisickling agents|mesh-ancestor
92300393|NCT03853317|Avelumab|avelumab|mesh-list
92300394|NCT03853317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300395|NCT03853317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300396|NCT03848676|Immunomodulating Agents|immunomodulating agents|mesh-list
92300397|NCT03848676|Immunologic Factors|immunologic factors|mesh-ancestor
92300398|NCT03848676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300399|NCT03845010|Verapamil|verapamil|mesh-list
92300400|NCT03845010|Sotalol|sotalol|mesh-list
92300401|NCT03845010|Flecainide|flecainide|mesh-list
92300402|NCT03845010|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92300403|NCT03845010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92300404|NCT03845010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92300405|NCT03845010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300406|NCT03845010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92300407|NCT03845010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300408|NCT03845010|Vasodilator Agents|vasodilator agents|mesh-ancestor
92300409|NCT03845010|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92300410|NCT03845010|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92300411|NCT03845010|Adrenergic Agents|adrenergic agents|mesh-ancestor
92300412|NCT03845010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300413|NCT03845010|Sympatholytics|sympatholytics|mesh-ancestor
92300414|NCT03845010|Autonomic Agents|autonomic agents|mesh-ancestor
92300415|NCT03845010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300416|NCT03845010|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92300417|NCT03845010|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92300419|NCT03841617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300420|NCT03841617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300421|NCT03829371|Dexamethasone|dexamethasone|mesh-list
92300422|NCT03829371|Prednisone|prednisone|mesh-list
92300423|NCT03829371|Lenalidomide|lenalidomide|mesh-list
92300424|NCT03829371|Melphalan|melphalan|mesh-list
92300425|NCT03829371|Bortezomib|bortezomib|mesh-list
92300426|NCT03829371|Daratumumab|daratumumab|mesh-list
92300427|NCT03829371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300428|NCT03829371|Antiemetics|antiemetics|mesh-ancestor
92300429|NCT03829371|Autonomic Agents|autonomic agents|mesh-ancestor
92300430|NCT03829371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300431|NCT03829371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300432|NCT03829371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300433|NCT03829371|Glucocorticoids|glucocorticoids|mesh-ancestor
92300434|NCT03829371|Hormones|hormones|mesh-ancestor
92300435|NCT03829371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300436|NCT03829371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300437|NCT03829371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300438|NCT03829371|Immunologic Factors|immunologic factors|mesh-ancestor
92300439|NCT03829371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300440|NCT03829371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300441|NCT03829371|Growth Substances|growth substances|mesh-ancestor
92300442|NCT03829371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300443|NCT03829371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300444|NCT03829371|Alkylating Agents|alkylating agents|mesh-ancestor
92300445|NCT03829371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300446|NCT03829371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92300447|NCT03829371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300448|NCT03828227|Bevacizumab|bevacizumab|mesh-list
92300449|NCT03828227|Fluorouracil|fluorouracil|mesh-list
92300450|NCT03828227|Capecitabine|capecitabine|mesh-list
92300451|NCT03828227|Oxaliplatin|oxaliplatin|mesh-list
92300452|NCT03828227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300453|NCT03828227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300454|NCT03828227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300455|NCT03828227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300456|NCT03828227|Growth Substances|growth substances|mesh-ancestor
92300457|NCT03828227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300458|NCT03828227|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300459|NCT03828227|Antimetabolites|antimetabolites|mesh-ancestor
92300460|NCT03828227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300461|NCT03828227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300462|NCT03828227|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300463|NCT03828227|Immunologic Factors|immunologic factors|mesh-ancestor
92300464|NCT03816358|Gemcitabine|gemcitabine|mesh-list
92300465|NCT03816358|Nivolumab|nivolumab|mesh-list
92300466|NCT03816358|Ipilimumab|ipilimumab|mesh-list
92300467|NCT03816358|Maytansine|maytansine|mesh-list
92300468|NCT03816358|Anetumab ravtansine|anetumab ravtansine|mesh-list
92300469|NCT03816358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300470|NCT03816358|Antimetabolites|antimetabolites|mesh-ancestor
92300471|NCT03816358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300472|NCT03816358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300473|NCT03816358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300474|NCT03816358|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300475|NCT03816358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300476|NCT03816358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300477|NCT03816358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300478|NCT03816358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300479|NCT03816358|Immunoconjugates|immunoconjugates|mesh-ancestor
92300480|NCT03816358|Immunologic Factors|immunologic factors|mesh-ancestor
92300481|NCT03816358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300482|NCT03785964|Nirogacestat|nirogacestat|mesh-list
92300483|NCT03785964|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92300484|NCT03785964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300485|NCT03785964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300486|NCT03743428|Bevacizumab|bevacizumab|mesh-list
92300487|NCT03743428|Apatinib|apatinib|mesh-list
92300488|NCT03743428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300489|NCT03743428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300490|NCT03743428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300491|NCT03743428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300492|NCT03743428|Growth Substances|growth substances|mesh-ancestor
92300493|NCT03743428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300494|NCT03743428|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300495|NCT03743428|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92300496|NCT03743428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300497|NCT03743428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300498|NCT03739710|Docetaxel|docetaxel|mesh-list
92300499|NCT03739710|Ipilimumab|ipilimumab|mesh-list
92300500|NCT03739710|Dostarlimab|dostarlimab|mesh-list
92300501|NCT03739710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300502|NCT03739710|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300503|NCT03739710|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300504|NCT03739710|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300505|NCT03739710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300506|NCT03739710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300507|NCT03739710|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300508|NCT03723551|Afabicin|afabicin|mesh-list
92300509|NCT03723551|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300510|NCT03723551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300511|NCT03715933|Carboplatin|carboplatin|mesh-list
92300512|NCT03715933|Fluorouracil|fluorouracil|mesh-list
92300513|NCT03715933|Irinotecan|irinotecan|mesh-list
92300514|NCT03715933|Pemetrexed|pemetrexed|mesh-list
92300515|NCT03715933|Temozolomide|temozolomide|mesh-list
92300516|NCT03715933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300517|NCT03715933|Antimetabolites|antimetabolites|mesh-ancestor
92300518|NCT03715933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300519|NCT03715933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300520|NCT03715933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300521|NCT03715933|Immunologic Factors|immunologic factors|mesh-ancestor
92300522|NCT03715933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300523|NCT03715933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92300524|NCT03715933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92300525|NCT03715933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300526|NCT03715933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92300527|NCT03715933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300528|NCT03715933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300529|NCT03715933|Alkylating Agents|alkylating agents|mesh-ancestor
92300530|NCT03691064|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92300531|NCT03691064|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92300532|NCT03691064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300533|NCT03690921|Cisplatin|cisplatin|mesh-list
92300534|NCT03690921|Fluorouracil|fluorouracil|mesh-list
92300535|NCT03690921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300536|NCT03690921|Antimetabolites|antimetabolites|mesh-ancestor
92300537|NCT03690921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300538|NCT03690921|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300539|NCT03690921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300540|NCT03690921|Immunologic Factors|immunologic factors|mesh-ancestor
92300541|NCT03690921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300542|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
92300543|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300544|NCT03666273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300545|NCT03666273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300546|NCT03666273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300547|NCT03637660|Penicillins|penicillins|mesh-list
92300548|NCT03637660|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92300549|NCT03637660|Penicillin G|penicillin g|mesh-list
92300550|NCT03637660|Penicillin G Procaine|penicillin g procaine|mesh-list
92300551|NCT03637660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300552|NCT03637660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300553|NCT03635489|Paclitaxel|paclitaxel|mesh-list
92300554|NCT03635489|Bevacizumab|bevacizumab|mesh-list
92300555|NCT03635489|Carboplatin|carboplatin|mesh-list
92300556|NCT03635489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300557|NCT03635489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300558|NCT03635489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300559|NCT03635489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300560|NCT03635489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300561|NCT03635489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300562|NCT03635489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300564|NCT03635489|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300565|NCT03635489|Growth Substances|growth substances|mesh-ancestor
92300566|NCT03635489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300567|NCT03635489|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300568|NCT03631784|Paclitaxel|paclitaxel|mesh-list
92300569|NCT03631784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92300570|NCT03631784|Carboplatin|carboplatin|mesh-list
92300571|NCT03631784|Pembrolizumab|pembrolizumab|mesh-list
92300573|NCT03631784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300574|NCT03631784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300575|NCT03631784|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300576|NCT03631784|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300577|NCT03631784|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410270|NCT05330429|Antidotes|antidotes|mesh-ancestor
92300578|NCT03631784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300579|NCT03631784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300580|NCT03631784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300581|NCT03631784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300582|NCT03631784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92300583|NCT03631784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300584|NCT03617705|Ethanol|ethanol|mesh-list
92300585|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92300586|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300587|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92300588|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300589|NCT03607422|Upadacitinib|upadacitinib|mesh-list
92300590|NCT03607422|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92300591|NCT03607422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92300592|NCT03607422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300593|NCT03607422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300594|NCT03607422|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300595|NCT03604978|Nivolumab|nivolumab|mesh-list
92300596|NCT03604978|Ipilimumab|ipilimumab|mesh-list
92300597|NCT03604978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300598|NCT03604978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300599|NCT03604978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300600|NCT03604978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300601|NCT03576885|Nitric Oxide|nitric oxide|mesh-list
92300602|NCT03576885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92300603|NCT03576885|Autonomic Agents|autonomic agents|mesh-ancestor
92300604|NCT03576885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300605|NCT03576885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300606|NCT03576885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92300607|NCT03576885|Respiratory System Agents|respiratory system agents|mesh-ancestor
92300609|NCT03576885|Antioxidants|antioxidants|mesh-ancestor
92300610|NCT03576885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300611|NCT03576885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300612|NCT03576885|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92300613|NCT03576885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92300614|NCT03576885|Gasotransmitters|gasotransmitters|mesh-ancestor
92300615|NCT03576885|Protective Agents|protective agents|mesh-ancestor
92300616|NCT03576612|Valacyclovir|valacyclovir|mesh-list
92300617|NCT03576612|Acyclovir|acyclovir|mesh-list
92300618|NCT03576612|Nivolumab|nivolumab|mesh-list
92300619|NCT03576612|Temozolomide|temozolomide|mesh-list
92300620|NCT03576612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300621|NCT03576612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300622|NCT03576612|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300623|NCT03576612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300624|NCT03576612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300625|NCT03576612|Alkylating Agents|alkylating agents|mesh-ancestor
92300626|NCT03576612|Antiviral Agents|antiviral agents|mesh-ancestor
92300627|NCT03576612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300628|NCT03576105|Photosensitizing Agents|photosensitizing agents|mesh-list
92300629|NCT03576105|Methylene Blue|methylene blue|mesh-list
92300630|NCT03576105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300631|NCT03576105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300632|NCT03576105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92300633|NCT03568318|Upadacitinib|upadacitinib|mesh-list
92300634|NCT03568318|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92300635|NCT03568318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92300636|NCT03568318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300637|NCT03568318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300638|NCT03568318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300640|NCT03550794|Vitamins|vitamins|mesh-ancestor
92300641|NCT03550794|Micronutrients|micronutrients|mesh-ancestor
92300642|NCT03550794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300643|NCT03550794|Vitamin B Complex|vitamin b complex|mesh-ancestor
92300644|NCT03539614|Prazosin|prazosin|mesh-list
92300645|NCT03539614|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92300646|NCT03539614|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92300647|NCT03539614|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92300648|NCT03539614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92300649|NCT03539614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92300650|NCT03539614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300651|NCT03539614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300652|NCT03539614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300653|NCT03523858|Ocrelizumab|ocrelizumab|mesh-list
92300654|NCT03523858|Immunologic Factors|immunologic factors|mesh-ancestor
92300655|NCT03523858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300656|NCT03519386|Travoprost|travoprost|mesh-list
92300657|NCT03519386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92300658|NCT03519386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92300659|NCT03519386|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92300660|NCT03495713|Nivolumab|nivolumab|mesh-list
92300661|NCT03495713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300662|NCT03495713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300663|NCT03495713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300664|NCT03495713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300665|NCT03491059|Nicotine|nicotine|mesh-list
92300666|NCT03491059|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92300667|NCT03491059|Autonomic Agents|autonomic agents|mesh-ancestor
92300668|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300669|NCT03491059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300670|NCT03491059|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92300671|NCT03491059|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92300672|NCT03491059|Cholinergic Agents|cholinergic agents|mesh-ancestor
92300673|NCT03491059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300674|NCT03491059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300675|NCT03459846|Durvalumab|durvalumab|mesh-list
92300676|NCT03459846|Olaparib|olaparib|mesh-list
92346857|NCT01814046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300677|NCT03459846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300678|NCT03459846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300679|NCT03459846|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92300680|NCT03459846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300681|NCT03459846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300682|NCT03456102|Pravastatin|pravastatin|mesh-list
92300684|NCT03456102|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92300685|NCT03456102|Antimetabolites|antimetabolites|mesh-ancestor
92300686|NCT03456102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300687|NCT03456102|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92300688|NCT03456102|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92300689|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300690|NCT03448666|Pembrolizumab|pembrolizumab|mesh-list
92300691|NCT03448666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300692|NCT03448666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300693|NCT03448666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300694|NCT03448666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300696|NCT03439865|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92300697|NCT03439865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92300698|NCT03439865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300699|NCT03436654|Prednisone|prednisone|mesh-list
92300700|NCT03436654|Abiraterone Acetate|abiraterone acetate|mesh-list
92300701|NCT03436654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300702|NCT03436654|Glucocorticoids|glucocorticoids|mesh-ancestor
92300703|NCT03436654|Hormones|hormones|mesh-ancestor
92300704|NCT03436654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300705|NCT03436654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300706|NCT03436654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300707|NCT03436654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300708|NCT03436654|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92300709|NCT03436654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300710|NCT03436654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300711|NCT03436654|Hormone Antagonists|hormone antagonists|mesh-ancestor
92300712|NCT03436654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92300713|NCT03427125|Sevelamer|sevelamer|mesh-list
92300714|NCT03427125|Chelating Agents|chelating agents|mesh-ancestor
92300715|NCT03427125|Sequestering Agents|sequestering agents|mesh-ancestor
92300716|NCT03427125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300717|NCT03393884|Paclitaxel|paclitaxel|mesh-list
92300718|NCT03393884|Carboplatin|carboplatin|mesh-list
92300719|NCT03393884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300720|NCT03393884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300721|NCT03393884|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300722|NCT03393884|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300723|NCT03393884|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300724|NCT03393884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300725|NCT03359863|Pirfenidone|pirfenidone|mesh-list
92300726|NCT03359863|Analgesics|analgesics|mesh-ancestor
92300727|NCT03359863|Sensory System Agents|sensory system agents|mesh-ancestor
92300728|NCT03359863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300729|NCT03359863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300730|NCT03359863|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92300731|NCT03359863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92300732|NCT03359863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300733|NCT03359863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300734|NCT03359863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300735|NCT03341273|Azithromycin|azithromycin|mesh-list
92300736|NCT03341273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300737|NCT03341273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300738|NCT03334617|Trastuzumab|trastuzumab|mesh-list
92300739|NCT03334617|Durvalumab|durvalumab|mesh-list
92300740|NCT03334617|Olaparib|olaparib|mesh-list
92300741|NCT03334617|Cediranib|cediranib|mesh-list
92300742|NCT03334617|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92300743|NCT03334617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300744|NCT03334617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300745|NCT03334617|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92300746|NCT03334617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300747|NCT03334617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300748|NCT03334617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92300749|NCT03334617|Immunoconjugates|immunoconjugates|mesh-ancestor
92300750|NCT03334617|Immunologic Factors|immunologic factors|mesh-ancestor
92300751|NCT03334617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300752|NCT03332797|Palbociclib|palbociclib|mesh-list
92300753|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300754|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92300755|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300756|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300758|NCT03319901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300759|NCT03307785|Paclitaxel|paclitaxel|mesh-list
92300760|NCT03307785|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92300761|NCT03307785|Bevacizumab|bevacizumab|mesh-list
92300762|NCT03307785|Carboplatin|carboplatin|mesh-list
92300763|NCT03307785|Pemetrexed|pemetrexed|mesh-list
92300764|NCT03307785|Niraparib|niraparib|mesh-list
92300765|NCT03307785|Dostarlimab|dostarlimab|mesh-list
92300766|NCT03307785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300767|NCT03307785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300768|NCT03307785|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300769|NCT03307785|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300770|NCT03307785|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300771|NCT03307785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300772|NCT03307785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300773|NCT03307785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300774|NCT03307785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300775|NCT03307785|Growth Substances|growth substances|mesh-ancestor
92300776|NCT03307785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300777|NCT03307785|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300778|NCT03307785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300779|NCT03307785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92300780|NCT03307785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300781|NCT03307785|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92300782|NCT03301766|Lidocaine|lidocaine|mesh-list
92300783|NCT03301766|Anesthetics, Local|anesthetics, local|mesh-ancestor
92300784|NCT03301766|Anesthetics|anesthetics|mesh-ancestor
92300785|NCT03301766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92300786|NCT03301766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300787|NCT03301766|Sensory System Agents|sensory system agents|mesh-ancestor
92300788|NCT03301766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300789|NCT03301766|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92300790|NCT03301766|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92300791|NCT03301766|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92300792|NCT03301766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92300793|NCT03301766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300795|NCT03248167|Anticonvulsants|anticonvulsants|mesh-ancestor
92300796|NCT03243552|Levodopa|levodopa|mesh-list
92300797|NCT03243552|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92300798|NCT03243552|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92300799|NCT03243552|Dopamine Agents|dopamine agents|mesh-ancestor
92300800|NCT03243552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300801|NCT03243552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300802|NCT03243552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300803|NCT03242278|Rivaroxaban|rivaroxaban|mesh-list
92300804|NCT03242278|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92300805|NCT03242278|Antithrombins|antithrombins|mesh-ancestor
92300806|NCT03242278|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92300807|NCT03242278|Protease Inhibitors|protease inhibitors|mesh-ancestor
92300808|NCT03242278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300809|NCT03242278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300810|NCT03242278|Anticoagulants|anticoagulants|mesh-ancestor
92300811|NCT03198728|Testosterone|testosterone|mesh-list
92300812|NCT03198728|Androgens|androgens|mesh-ancestor
92300813|NCT03198728|Hormones|hormones|mesh-ancestor
92300814|NCT03198728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300815|NCT03198728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300816|NCT03151811|Dexamethasone|dexamethasone|mesh-list
92300817|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
92300818|NCT03151811|Melphalan|melphalan|mesh-list
92300819|NCT03151811|Pomalidomide|pomalidomide|mesh-list
92300820|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300821|NCT03151811|Antiemetics|antiemetics|mesh-ancestor
92300822|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
92300823|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300824|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300825|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300826|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
92300827|NCT03151811|Hormones|hormones|mesh-ancestor
92300828|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300829|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300831|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300832|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
92300833|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300834|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92300835|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300836|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
92300837|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300838|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300839|NCT03151811|Growth Substances|growth substances|mesh-ancestor
92300840|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300841|NCT03148418|Atezolizumab|atezolizumab|mesh-list
92300842|NCT03148418|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300843|NCT03148418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300844|NCT03148418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300845|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300846|NCT03144804|Lamivudine|lamivudine|mesh-list
92300847|NCT03144804|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92300848|NCT03144804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92300849|NCT03144804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300850|NCT03144804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300851|NCT03144804|Antiviral Agents|antiviral agents|mesh-ancestor
92300852|NCT03144804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300853|NCT03144804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92300854|NCT03144804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92300855|NCT03142334|Pembrolizumab|pembrolizumab|mesh-list
92300856|NCT03142334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300857|NCT03142334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300858|NCT03142334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953629|NCT03433001|Ixazomib|ixazomib|mesh-list
92300859|NCT03142334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300860|NCT03141034|Irinotecan|irinotecan|mesh-list
92300861|NCT03141034|Ramucirumab|ramucirumab|mesh-list
92300862|NCT03141034|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92300863|NCT03141034|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92300864|NCT03141034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300865|NCT03141034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300866|NCT03141034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300867|NCT03126539|Sulforaphane|sulforaphane|mesh-list
92300868|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92300869|NCT03126539|Protective Agents|protective agents|mesh-ancestor
92300870|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300871|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300872|NCT03107923|Dobutamine|dobutamine|mesh-list
92300873|NCT03107923|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92300874|NCT03107923|Sympathomimetics|sympathomimetics|mesh-ancestor
92300875|NCT03107923|Autonomic Agents|autonomic agents|mesh-ancestor
92300876|NCT03107923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300877|NCT03107923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300878|NCT03107923|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92300879|NCT03107923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92300880|NCT03107923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92300881|NCT03107923|Adrenergic Agents|adrenergic agents|mesh-ancestor
92300882|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92300883|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300884|NCT03107923|Protective Agents|protective agents|mesh-ancestor
92300885|NCT03096782|Mycophenolic Acid|mycophenolic acid|mesh-list
92300886|NCT03096782|Cyclophosphamide|cyclophosphamide|mesh-list
92300887|NCT03096782|Melphalan|melphalan|mesh-list
92300888|NCT03096782|Busulfan|busulfan|mesh-list
92300889|NCT03096782|Mechlorethamine|mechlorethamine|mesh-list
92300890|NCT03096782|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92300891|NCT03096782|Rituximab|rituximab|mesh-list
92300892|NCT03096782|Fludarabine|fludarabine|mesh-list
92300893|NCT03096782|Clofarabine|clofarabine|mesh-list
92300894|NCT03096782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92300895|NCT03096782|Tacrolimus|tacrolimus|mesh-list
92300896|NCT03096782|Thymoglobulin|thymoglobulin|mesh-list
92300897|NCT03096782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92300898|NCT03096782|Antibodies|antibodies|mesh-list
92300899|NCT03096782|Immunoglobulins|immunoglobulins|mesh-list
92300900|NCT03096782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92300901|NCT03096782|Lenograstim|lenograstim|mesh-list
92300902|NCT03096782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92300903|NCT03096782|Immunologic Factors|immunologic factors|mesh-ancestor
92300904|NCT03096782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300905|NCT03096782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92300906|NCT03096782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92300907|NCT03096782|Alkylating Agents|alkylating agents|mesh-ancestor
92300908|NCT03096782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300909|NCT03096782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300910|NCT03096782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92300911|NCT03096782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92300912|NCT03096782|Antimetabolites|antimetabolites|mesh-ancestor
92300913|NCT03096782|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92300914|NCT03096782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92300915|NCT03096782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300916|NCT03096782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92300917|NCT03096782|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92300918|NCT03096782|Antitubercular Agents|antitubercular agents|mesh-ancestor
92300919|NCT03096782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300920|NCT03096782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300921|NCT03092817|Dexamethasone|dexamethasone|mesh-list
92300922|NCT03092817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92300923|NCT03092817|Antiemetics|antiemetics|mesh-ancestor
92300924|NCT03092817|Autonomic Agents|autonomic agents|mesh-ancestor
92300925|NCT03092817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92300926|NCT03092817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300927|NCT03092817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92300928|NCT03092817|Glucocorticoids|glucocorticoids|mesh-ancestor
92300929|NCT03092817|Hormones|hormones|mesh-ancestor
92300930|NCT03092817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92300931|NCT03092817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92300932|NCT03092817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300933|NCT03078010|Tazobactam|tazobactam|mesh-list
92300934|NCT03078010|Piperacillin|piperacillin|mesh-list
92300935|NCT03078010|Cefepime|cefepime|mesh-list
92300936|NCT03078010|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92300937|NCT03078010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300938|NCT03078010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300939|NCT03078010|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92300940|NCT03078010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300941|NCT03078010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300942|NCT03064126|Paclitaxel|paclitaxel|mesh-list
92300943|NCT03064126|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92300944|NCT03064126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92300945|NCT03064126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300946|NCT03064126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92300947|NCT03064126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92300948|NCT03064126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92300949|NCT03064126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300950|NCT03043664|Pembrolizumab|pembrolizumab|mesh-list
92300951|NCT03043664|Lanreotide|lanreotide|mesh-list
92300952|NCT03043664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300953|NCT03043664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300954|NCT03043664|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92300955|NCT03043664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300956|NCT02992522|Lenalidomide|lenalidomide|mesh-list
92300957|NCT02992522|Venetoclax|venetoclax|mesh-list
92300958|NCT02992522|Obinutuzumab|obinutuzumab|mesh-list
92300959|NCT02992522|Immunologic Factors|immunologic factors|mesh-ancestor
92300960|NCT02992522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300961|NCT02992522|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92300962|NCT02992522|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92300963|NCT02992522|Growth Substances|growth substances|mesh-ancestor
92300964|NCT02992522|Growth Inhibitors|growth inhibitors|mesh-ancestor
92300965|NCT02992522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92300966|NCT02992522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92300967|NCT02969681|Ascorbic Acid|ascorbic acid|mesh-list
92300968|NCT02969681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300969|NCT02969681|Vitamins|vitamins|mesh-ancestor
92300970|NCT02969681|Micronutrients|micronutrients|mesh-ancestor
92300971|NCT02969681|Antioxidants|antioxidants|mesh-ancestor
92300972|NCT02969681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300973|NCT02969681|Protective Agents|protective agents|mesh-ancestor
92300974|NCT02956590|Pitavastatin|pitavastatin|mesh-list
92300975|NCT02956590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92300976|NCT02956590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92300977|NCT02956590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92300978|NCT02956590|Antimetabolites|antimetabolites|mesh-ancestor
92300979|NCT02956590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300980|NCT02956590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300981|NCT02956590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92300982|NCT02949700|Metformin|metformin|mesh-list
92300983|NCT02949700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92300984|NCT02949700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92300985|NCT02947087|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92300986|NCT02947087|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92300987|NCT02947087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92300988|NCT02947087|Protease Inhibitors|protease inhibitors|mesh-ancestor
92300989|NCT02947087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92300990|NCT02947087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92300991|NCT02941783|Factor VIII|factor viii|mesh-list
92300992|NCT02941783|Coagulants|coagulants|mesh-ancestor
92300993|NCT02864550|Doxycycline|doxycycline|mesh-list
92300994|NCT02864550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92300995|NCT02864550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92300996|NCT02864550|Antimalarials|antimalarials|mesh-ancestor
92300997|NCT02864550|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92300998|NCT02864550|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92300999|NCT02841995|Belumosudil|belumosudil|mesh-list
92301000|NCT02841995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301001|NCT02841995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301002|NCT02841995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301003|NCT02754596|Timolol|timolol|mesh-list
92301004|NCT02754596|Travoprost|travoprost|mesh-list
92301005|NCT02754596|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92301006|NCT02754596|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92301007|NCT02754596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301008|NCT02754596|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91953735|NCT03432689|Cycloserine|cycloserine|mesh-list
92301009|NCT02754596|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92301010|NCT02754596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92301011|NCT02754596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92301012|NCT02754596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301013|NCT02754596|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92301014|NCT02754596|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92301015|NCT02702414|Pembrolizumab|pembrolizumab|mesh-list
92301016|NCT02702414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301017|NCT02702414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301018|NCT02702414|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92301019|NCT02702414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301021|NCT02667587|Temozolomide|temozolomide|mesh-list
92301022|NCT02667587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301023|NCT02667587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410271|NCT05330429|Protective Agents|protective agents|mesh-ancestor
92301024|NCT02667587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92301025|NCT02667587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301026|NCT02667587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301027|NCT02667587|Alkylating Agents|alkylating agents|mesh-ancestor
92301028|NCT02640534|Metformin|metformin|mesh-list
92301029|NCT02640534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92301030|NCT02640534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301031|NCT02632409|Nivolumab|nivolumab|mesh-list
92301032|NCT02632409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301033|NCT02632409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301034|NCT02632409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92301035|NCT02632409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301036|NCT02628366|Dialysis Solutions|dialysis solutions|mesh-list
92301037|NCT02628366|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92301038|NCT02626455|Prednisone|prednisone|mesh-list
92301039|NCT02626455|Cyclophosphamide|cyclophosphamide|mesh-list
92301040|NCT02626455|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92301041|NCT02626455|Rituximab|rituximab|mesh-list
92301042|NCT02626455|Doxorubicin|doxorubicin|mesh-list
92301043|NCT02626455|Vincristine|vincristine|mesh-list
92301044|NCT02626455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301045|NCT02626455|Immunologic Factors|immunologic factors|mesh-ancestor
92301046|NCT02626455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301047|NCT02626455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301048|NCT02626455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301049|NCT02626455|Alkylating Agents|alkylating agents|mesh-ancestor
92301050|NCT02626455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301051|NCT02626455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301052|NCT02626455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301053|NCT02626455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301054|NCT02626455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301055|NCT02626455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92301056|NCT02626455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301057|NCT02626455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301058|NCT02626455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301059|NCT02626455|Glucocorticoids|glucocorticoids|mesh-ancestor
92301061|NCT02626455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301062|NCT02626455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301063|NCT02626455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301064|NCT02626455|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301065|NCT02626455|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301066|NCT02626455|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301067|NCT02625480|Cyclophosphamide|cyclophosphamide|mesh-list
92301068|NCT02625480|Fludarabine|fludarabine|mesh-list
92301069|NCT02625480|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92301070|NCT02625480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301071|NCT02625480|Immunologic Factors|immunologic factors|mesh-ancestor
92301072|NCT02625480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301073|NCT02625480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301074|NCT02625480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301075|NCT02625480|Alkylating Agents|alkylating agents|mesh-ancestor
92301076|NCT02625480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301078|NCT02625480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301079|NCT02625480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301080|NCT02598726|Curcumin|curcumin|mesh-list
92301081|NCT02598726|Piperine|piperine|mesh-list
92301082|NCT02598726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92301083|NCT02598726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92301084|NCT02598726|Analgesics|analgesics|mesh-ancestor
92301085|NCT02598726|Sensory System Agents|sensory system agents|mesh-ancestor
92301086|NCT02598726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301087|NCT02598726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301088|NCT02598726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301089|NCT02598726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301090|NCT02598726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301091|NCT02598726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301092|NCT02598726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301093|NCT02598726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92301094|NCT02586038|Thalidomide|thalidomide|mesh-list
92301095|NCT02586038|Dexamethasone|dexamethasone|mesh-list
92301096|NCT02586038|Cyclophosphamide|cyclophosphamide|mesh-list
92301097|NCT02586038|Ixazomib|ixazomib|mesh-list
92301098|NCT02586038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301099|NCT02586038|Immunologic Factors|immunologic factors|mesh-ancestor
92301100|NCT02586038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301101|NCT02586038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301102|NCT02586038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301103|NCT02586038|Alkylating Agents|alkylating agents|mesh-ancestor
92301104|NCT02586038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301105|NCT02586038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301106|NCT02586038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301107|NCT02586038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301108|NCT02586038|Antiemetics|antiemetics|mesh-ancestor
92301109|NCT02586038|Autonomic Agents|autonomic agents|mesh-ancestor
92301110|NCT02586038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301111|NCT02586038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92301112|NCT02586038|Glucocorticoids|glucocorticoids|mesh-ancestor
92301113|NCT02586038|Hormones|hormones|mesh-ancestor
92301114|NCT02586038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301115|NCT02586038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301116|NCT02586038|Leprostatic Agents|leprostatic agents|mesh-ancestor
92301117|NCT02586038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301118|NCT02586038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301119|NCT02586038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301120|NCT02586038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301121|NCT02586038|Growth Substances|growth substances|mesh-ancestor
92301122|NCT02586038|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301123|NCT02586038|Protease Inhibitors|protease inhibitors|mesh-ancestor
92301124|NCT02586038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301126|NCT02579811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301127|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301128|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301129|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301130|NCT02554383|Amoxicillin|amoxicillin|mesh-list
92301131|NCT02554383|Clavulanic Acid|clavulanic acid|mesh-list
92301132|NCT02554383|Clavulanic Acids|clavulanic acids|mesh-list
92301133|NCT02554383|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92301134|NCT02554383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301135|NCT02554383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301136|NCT02554383|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92301137|NCT02554383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301138|NCT02554383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301139|NCT02519439|Ganaxolone|ganaxolone|mesh-list
92301140|NCT02519439|Neurosteroids|neurosteroids|mesh-ancestor
92301141|NCT02519439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92301142|NCT02519439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301143|NCT02519439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301144|NCT02519439|GABA Modulators|gaba modulators|mesh-ancestor
92301145|NCT02519439|GABA Agents|gaba agents|mesh-ancestor
92301146|NCT02500797|Nivolumab|nivolumab|mesh-list
92301147|NCT02500797|Ipilimumab|ipilimumab|mesh-list
92301148|NCT02500797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301149|NCT02500797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301150|NCT02500797|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92301151|NCT02500797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301152|NCT02404870|Canagliflozin|canagliflozin|mesh-list
92301153|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92346909|NCT01770912|Hormones|hormones|mesh-ancestor
92301154|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301155|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92301156|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953878|NCT03431597|Micronutrients|micronutrients|mesh-list
92301158|NCT02359175|Fentanyl|fentanyl|mesh-list
92301159|NCT02359175|Analgesics, Opioid|analgesics, opioid|mesh-list
92301160|NCT02359175|Bupivacaine|bupivacaine|mesh-list
92301161|NCT02359175|Anesthetics, Local|anesthetics, local|mesh-ancestor
92301162|NCT02359175|Anesthetics|anesthetics|mesh-ancestor
92301163|NCT02359175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92301164|NCT02359175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301165|NCT02359175|Sensory System Agents|sensory system agents|mesh-ancestor
92301166|NCT02359175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301167|NCT02359175|Narcotics|narcotics|mesh-ancestor
92301168|NCT02359175|Analgesics|analgesics|mesh-ancestor
92301169|NCT02359175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92301170|NCT02359175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92301171|NCT02359175|Anesthetics, General|anesthetics, general|mesh-ancestor
92301172|NCT02359175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92301173|NCT02359175|Antipyretics|antipyretics|mesh-ancestor
92301174|NCT02215980|Dexamethasone|dexamethasone|mesh-list
92301175|NCT02215980|Lenalidomide|lenalidomide|mesh-list
92301176|NCT02215980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301177|NCT02215980|Antiemetics|antiemetics|mesh-ancestor
92301178|NCT02215980|Autonomic Agents|autonomic agents|mesh-ancestor
92301179|NCT02215980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301180|NCT02215980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301181|NCT02215980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92301182|NCT02215980|Glucocorticoids|glucocorticoids|mesh-ancestor
92301183|NCT02215980|Hormones|hormones|mesh-ancestor
92301184|NCT02215980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301185|NCT02215980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301186|NCT02215980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301187|NCT02215980|Immunologic Factors|immunologic factors|mesh-ancestor
92301188|NCT02215980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301189|NCT02215980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301190|NCT02215980|Growth Substances|growth substances|mesh-ancestor
92301191|NCT02215980|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301192|NCT02185560|Sorafenib|sorafenib|mesh-list
92301193|NCT02185560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301194|NCT02185560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301195|NCT02185560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301196|NCT02185560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301198|NCT02101021|Gemcitabine|gemcitabine|mesh-list
92301199|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92301200|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301201|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301202|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301203|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301204|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301205|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301206|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301207|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
92301208|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301209|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301210|NCT02088632|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92301211|NCT02088632|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92301212|NCT02088632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301213|NCT02088632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301214|NCT02088632|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92301215|NCT02088632|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92301216|NCT02088632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301217|NCT02088632|Cholinergic Agents|cholinergic agents|mesh-ancestor
92301218|NCT02088632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92301219|NCT02031536|Everolimus|everolimus|mesh-list
92301220|NCT02031536|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92301221|NCT02031536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301222|NCT02031536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301223|NCT02031536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301224|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301225|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
92301226|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301227|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301228|NCT02023996|Trastuzumab|trastuzumab|mesh-list
92301229|NCT02023996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301230|NCT02023996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301231|NCT02020720|Fluorides|fluorides|mesh-list
92301232|NCT02020720|Cariostatic Agents|cariostatic agents|mesh-ancestor
92301233|NCT02020720|Protective Agents|protective agents|mesh-ancestor
92301234|NCT02020720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301236|NCT02020707|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92301237|NCT02020707|Bevacizumab|bevacizumab|mesh-list
92301238|NCT02020707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92301239|NCT02020707|Endothelial Growth Factors|endothelial growth factors|mesh-list
92301240|NCT02020707|Antibodies|antibodies|mesh-list
92301241|NCT02020707|Immunoglobulins|immunoglobulins|mesh-list
92301242|NCT02020707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92301243|NCT02020707|Immunoglobulin G|immunoglobulin g|mesh-list
92301244|NCT02020707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301245|NCT02020707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301246|NCT02020707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301247|NCT02020707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301248|NCT02020707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301249|NCT02020707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301250|NCT02020707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301251|NCT02020707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301252|NCT02020707|Growth Substances|growth substances|mesh-ancestor
92301253|NCT02020707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301254|NCT02020707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301255|NCT02020707|Immunologic Factors|immunologic factors|mesh-ancestor
92301256|NCT01968200|Enalapril|enalapril|mesh-list
92301257|NCT01968200|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92301258|NCT01968200|Protease Inhibitors|protease inhibitors|mesh-ancestor
92301259|NCT01968200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301260|NCT01968200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301261|NCT01968200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92301262|NCT01964430|Paclitaxel|paclitaxel|mesh-list
92301263|NCT01964430|Gemcitabine|gemcitabine|mesh-list
92301264|NCT01964430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301265|NCT01964430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301266|NCT01964430|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301267|NCT01964430|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301268|NCT01964430|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301269|NCT01964430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301271|NCT01964430|Antimetabolites|antimetabolites|mesh-ancestor
92301272|NCT01934868|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92301273|NCT01928394|Nivolumab|nivolumab|mesh-list
92301274|NCT01928394|Ipilimumab|ipilimumab|mesh-list
92301275|NCT01928394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301276|NCT01928394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301277|NCT01928394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92301278|NCT01928394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301279|NCT01898494|Cisplatin|cisplatin|mesh-list
92301280|NCT01898494|Carboplatin|carboplatin|mesh-list
92301281|NCT01898494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301282|NCT01841359|Pramlintide|pramlintide|mesh-list
92301283|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92301284|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301285|NCT01824875|Capecitabine|capecitabine|mesh-list
92301286|NCT01824875|Temozolomide|temozolomide|mesh-list
92301287|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301288|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
92301289|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301290|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301291|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301292|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
92301293|NCT01724346|Chlorambucil|chlorambucil|mesh-list
92301294|NCT01724346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301295|NCT01724346|Alkylating Agents|alkylating agents|mesh-ancestor
92301296|NCT01724346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301297|NCT01724346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301298|NCT01579734|Tamoxifen|tamoxifen|mesh-list
92301299|NCT01579734|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92301300|NCT01579734|Hormone Antagonists|hormone antagonists|mesh-ancestor
92301301|NCT01579734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301302|NCT01579734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301303|NCT01579734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301304|NCT01579734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301305|NCT01579734|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92301306|NCT01579734|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91954083|NCT03428633|Morphine|morphine|mesh-list
92301307|NCT01579734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92301309|NCT01566240|Carboplatin|carboplatin|mesh-list
92301310|NCT01566240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301311|NCT01566240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301312|NCT01566240|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301313|NCT01566240|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301314|NCT01566240|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301315|NCT01566240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301316|NCT01390584|Prednisone|prednisone|mesh-list
92301317|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
92301318|NCT01390584|Dacarbazine|dacarbazine|mesh-list
92301319|NCT01390584|Doxorubicin|doxorubicin|mesh-list
92301320|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92301321|NCT01390584|Etoposide|etoposide|mesh-list
92301322|NCT01390584|Vincristine|vincristine|mesh-list
92301323|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
92301324|NCT01390584|Bleomycin|bleomycin|mesh-list
92301325|NCT01390584|Vinblastine|vinblastine|mesh-list
92301326|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
92301327|NCT01390584|Procarbazine|procarbazine|mesh-list
92301328|NCT01390584|Imidazole|imidazole|mesh-list
92301329|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301330|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
92301331|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301332|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301333|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301334|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
92301335|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301336|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301337|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301338|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301339|NCT01390584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92301340|NCT01390584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301341|NCT01390584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301342|NCT01390584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301343|NCT01390584|Glucocorticoids|glucocorticoids|mesh-ancestor
92301344|NCT01390584|Hormones|hormones|mesh-ancestor
91936267|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
92301345|NCT01390584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301346|NCT01390584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301347|NCT01390584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301348|NCT01390584|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301349|NCT01390584|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301350|NCT01390584|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301351|NCT01390584|Keratolytic Agents|keratolytic agents|mesh-ancestor
92301352|NCT01390584|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301353|NCT01374841|Cyclophosphamide|cyclophosphamide|mesh-list
92301354|NCT01374841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301355|NCT01374841|Immunologic Factors|immunologic factors|mesh-ancestor
92301356|NCT01374841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301357|NCT01374841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301358|NCT01374841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301359|NCT01374841|Alkylating Agents|alkylating agents|mesh-ancestor
92301360|NCT01374841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301361|NCT01374841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301362|NCT01374841|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301364|NCT01216683|Lenalidomide|lenalidomide|mesh-list
92301365|NCT01216683|Bortezomib|bortezomib|mesh-list
92301366|NCT01216683|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92301367|NCT01216683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301368|NCT01216683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301369|NCT01216683|Immunologic Factors|immunologic factors|mesh-ancestor
92301370|NCT01216683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301371|NCT01216683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301372|NCT01216683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301373|NCT01216683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301374|NCT01216683|Growth Substances|growth substances|mesh-ancestor
92301375|NCT01216683|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301376|NCT01216683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301377|NCT01216683|Alkylating Agents|alkylating agents|mesh-ancestor
92301378|NCT01216683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301379|NCT01166113|Prednisone|prednisone|mesh-list
92301380|NCT01166113|Cyclophosphamide|cyclophosphamide|mesh-list
92301381|NCT01166113|Pomalidomide|pomalidomide|mesh-list
92301382|NCT01166113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301383|NCT01166113|Immunologic Factors|immunologic factors|mesh-ancestor
92301384|NCT01166113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301385|NCT01166113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301386|NCT01166113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301387|NCT01166113|Alkylating Agents|alkylating agents|mesh-ancestor
92301388|NCT01166113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301389|NCT01166113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301390|NCT01166113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301391|NCT01166113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301392|NCT01166113|Glucocorticoids|glucocorticoids|mesh-ancestor
92301393|NCT01166113|Hormones|hormones|mesh-ancestor
92301394|NCT01166113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301395|NCT01166113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301396|NCT01166113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301397|NCT01166113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301398|NCT01166113|Growth Substances|growth substances|mesh-ancestor
92301399|NCT01166113|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301400|NCT01160107|Prednisone|prednisone|mesh-list
92301401|NCT01160107|Melphalan|melphalan|mesh-list
92301402|NCT01160107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301403|NCT01160107|Glucocorticoids|glucocorticoids|mesh-ancestor
92301404|NCT01160107|Hormones|hormones|mesh-ancestor
92301405|NCT01160107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301406|NCT01160107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301407|NCT01160107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301408|NCT01160107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301409|NCT01160107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301410|NCT01160107|Alkylating Agents|alkylating agents|mesh-ancestor
92301411|NCT01160107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301412|NCT01160107|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301413|NCT01160107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301414|NCT01160107|Immunologic Factors|immunologic factors|mesh-ancestor
92301415|NCT01145495|Rituximab|rituximab|mesh-list
92301416|NCT01145495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92301418|NCT01145495|Antibodies|antibodies|mesh-list
92301419|NCT01145495|Immunoglobulins|immunoglobulins|mesh-list
92301420|NCT01145495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92301421|NCT01145495|Immunologic Factors|immunologic factors|mesh-ancestor
92301422|NCT01145495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301424|NCT01145495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301425|NCT01145495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301426|NCT01145495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301427|NCT01145495|Growth Substances|growth substances|mesh-ancestor
92301428|NCT01145495|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301429|NCT01124695|Tamoxifen|tamoxifen|mesh-list
92301430|NCT01124695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92301431|NCT01124695|Hormone Antagonists|hormone antagonists|mesh-ancestor
92301432|NCT01124695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301433|NCT01124695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301434|NCT01124695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301435|NCT01124695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301436|NCT01124695|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92301437|NCT01124695|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92301438|NCT01124695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92301439|NCT01084083|Paclitaxel|paclitaxel|mesh-list
92301440|NCT01084083|Cetuximab|cetuximab|mesh-list
92301441|NCT01084083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301442|NCT01084083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301443|NCT01084083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301444|NCT01084083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301445|NCT01084083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301446|NCT01084083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301447|NCT01084083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301448|NCT01079780|Irinotecan|irinotecan|mesh-list
92301449|NCT01079780|Cetuximab|cetuximab|mesh-list
92301450|NCT01079780|Ramucirumab|ramucirumab|mesh-list
92301451|NCT01079780|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92301452|NCT01079780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301453|NCT01079780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301454|NCT01079780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301455|NCT01079780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301456|NCT01079780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301457|NCT01063179|Thalidomide|thalidomide|mesh-list
92301459|NCT01063179|Bortezomib|bortezomib|mesh-list
92301460|NCT01063179|Melphalan|melphalan|mesh-list
92301461|NCT01063179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301462|NCT01063179|Glucocorticoids|glucocorticoids|mesh-ancestor
92301463|NCT01063179|Hormones|hormones|mesh-ancestor
92301464|NCT01063179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301465|NCT01063179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301466|NCT01063179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301467|NCT01063179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301468|NCT01063179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301469|NCT01063179|Alkylating Agents|alkylating agents|mesh-ancestor
92301470|NCT01063179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301471|NCT01063179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301472|NCT01063179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301473|NCT01063179|Immunologic Factors|immunologic factors|mesh-ancestor
92301474|NCT01063179|Leprostatic Agents|leprostatic agents|mesh-ancestor
92301475|NCT01063179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301476|NCT01063179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301477|NCT01063179|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301478|NCT01063179|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301479|NCT01063179|Growth Substances|growth substances|mesh-ancestor
92301480|NCT01063179|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301481|NCT01013961|Rituximab|rituximab|mesh-list
92301482|NCT01013961|Alemtuzumab|alemtuzumab|mesh-list
92301483|NCT01013961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301484|NCT01013961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301485|NCT01013961|Immunologic Factors|immunologic factors|mesh-ancestor
92301486|NCT01013961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301487|NCT01013961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301488|NCT00834093|Immunomodulating Agents|immunomodulating agents|mesh-list
92301489|NCT00834093|Immunologic Factors|immunologic factors|mesh-ancestor
92301490|NCT00834093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301491|NCT00783510|Adalimumab|adalimumab|mesh-list
92301492|NCT00783510|Methotrexate|methotrexate|mesh-list
92301493|NCT00783510|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92301495|NCT00783510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92301496|NCT00783510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301497|NCT00783510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301498|NCT00783510|Antimetabolites|antimetabolites|mesh-ancestor
92301499|NCT00783510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301500|NCT00783510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301501|NCT00783510|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301502|NCT00783510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301503|NCT00783510|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92301504|NCT00783510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301505|NCT00783510|Immunologic Factors|immunologic factors|mesh-ancestor
92301506|NCT00783510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301507|NCT00783510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92301508|NCT00783510|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92301509|NCT00783510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301510|NCT00779194|Sirolimus|sirolimus|mesh-list
92301511|NCT00779194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301512|NCT00779194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301513|NCT00779194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301514|NCT00779194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301515|NCT00779194|Antifungal Agents|antifungal agents|mesh-ancestor
92301516|NCT00779194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301517|NCT00779194|Immunologic Factors|immunologic factors|mesh-ancestor
92301518|NCT00779194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301519|NCT00665600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92301520|NCT00665600|Albuterol|albuterol|mesh-list
92301521|NCT00665600|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92301522|NCT00665600|Autonomic Agents|autonomic agents|mesh-ancestor
92301523|NCT00665600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301524|NCT00665600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301525|NCT00665600|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92301526|NCT00665600|Respiratory System Agents|respiratory system agents|mesh-ancestor
92301527|NCT00665600|Tocolytic Agents|tocolytic agents|mesh-ancestor
92301528|NCT00665600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92301529|NCT00665600|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92301530|NCT00665600|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92301531|NCT00665600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92301532|NCT00665600|Adrenergic Agents|adrenergic agents|mesh-ancestor
92301534|NCT00665600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301535|NCT00606294|Misonidazole|misonidazole|mesh-list
92301536|NCT00606294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301537|NCT00606294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92301538|NCT00606294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92301539|NCT00606294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301540|NCT00551928|Prednisone|prednisone|mesh-list
92301541|NCT00551928|Lenalidomide|lenalidomide|mesh-list
92301542|NCT00551928|Melphalan|melphalan|mesh-list
92301543|NCT00551928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301544|NCT00551928|Glucocorticoids|glucocorticoids|mesh-ancestor
92301545|NCT00551928|Hormones|hormones|mesh-ancestor
92301546|NCT00551928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301547|NCT00551928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301548|NCT00551928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301549|NCT00551928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301550|NCT00551928|Immunologic Factors|immunologic factors|mesh-ancestor
92301551|NCT00551928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301552|NCT00551928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301553|NCT00551928|Growth Substances|growth substances|mesh-ancestor
92301554|NCT00551928|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301555|NCT00551928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301556|NCT00551928|Alkylating Agents|alkylating agents|mesh-ancestor
92410272|NCT05330429|Vitamin B Complex|vitamin b complex|mesh-ancestor
92301557|NCT00551928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301558|NCT00551928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301559|NCT00551928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301560|NCT00330564|Sunitinib|sunitinib|mesh-list
92301561|NCT00330564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301562|NCT00330564|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92301563|NCT00330564|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92301564|NCT00330564|Growth Substances|growth substances|mesh-ancestor
92301565|NCT00330564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301566|NCT00330564|Growth Inhibitors|growth inhibitors|mesh-ancestor
92301567|NCT00330564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301568|NCT00330564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301569|NCT00330564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301571|NCT00316888|Fluorouracil|fluorouracil|mesh-list
92301572|NCT00316888|Cetuximab|cetuximab|mesh-list
92301573|NCT00316888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301574|NCT00316888|Antimetabolites|antimetabolites|mesh-ancestor
92301575|NCT00316888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301576|NCT00316888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301577|NCT00316888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301578|NCT00316888|Immunologic Factors|immunologic factors|mesh-ancestor
92301579|NCT00316888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301580|NCT00316888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301581|NCT00309478|Tamoxifen|tamoxifen|mesh-list
92301582|NCT00309478|Cyclophosphamide|cyclophosphamide|mesh-list
92301583|NCT00309478|Fluorouracil|fluorouracil|mesh-list
92301584|NCT00309478|Methotrexate|methotrexate|mesh-list
92301585|NCT00309478|Goserelin|goserelin|mesh-list
92301586|NCT00309478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301587|NCT00309478|Immunologic Factors|immunologic factors|mesh-ancestor
92301588|NCT00309478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301589|NCT00309478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301590|NCT00309478|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301591|NCT00309478|Alkylating Agents|alkylating agents|mesh-ancestor
92301592|NCT00309478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301593|NCT00309478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301594|NCT00309478|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301595|NCT00309478|Antimetabolites|antimetabolites|mesh-ancestor
92301596|NCT00309478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301597|NCT00309478|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92301598|NCT00309478|Abortifacient Agents|abortifacient agents|mesh-ancestor
92301599|NCT00309478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92301600|NCT00309478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301601|NCT00309478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301602|NCT00309478|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92301603|NCT00309478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92301604|NCT00309478|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92301605|NCT00309478|Hormone Antagonists|hormone antagonists|mesh-ancestor
92301606|NCT00309478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301607|NCT00309478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301608|NCT00309478|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92346954|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
92301609|NCT00309478|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92301610|NCT00309478|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92301611|NCT00295646|Tamoxifen|tamoxifen|mesh-list
92301612|NCT00295646|Zoledronic Acid|zoledronic acid|mesh-list
92301613|NCT00295646|Anastrozole|anastrozole|mesh-list
92301614|NCT00295646|Goserelin|goserelin|mesh-list
92301615|NCT00295646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92301616|NCT00295646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92301617|NCT00295646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301618|NCT00295646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301619|NCT00295646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301620|NCT00295646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301621|NCT00295646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92301622|NCT00295646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92301623|NCT00295646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92301624|NCT00295646|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92301625|NCT00295646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92301626|NCT00295646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301627|NCT00295646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301628|NCT00274924|Prednisone|prednisone|mesh-list
92301629|NCT00274924|Cyclophosphamide|cyclophosphamide|mesh-list
92301630|NCT00274924|Ifosfamide|ifosfamide|mesh-list
92301631|NCT00274924|Rituximab|rituximab|mesh-list
92301632|NCT00274924|Carboplatin|carboplatin|mesh-list
92301633|NCT00274924|Doxorubicin|doxorubicin|mesh-list
92301634|NCT00274924|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92301635|NCT00274924|Etoposide|etoposide|mesh-list
92301636|NCT00274924|Vincristine|vincristine|mesh-list
92301637|NCT00274924|Podophyllotoxin|podophyllotoxin|mesh-list
92301638|NCT00274924|Lenograstim|lenograstim|mesh-list
92301639|NCT00274924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301640|NCT00274924|Immunologic Factors|immunologic factors|mesh-ancestor
92301641|NCT00274924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301642|NCT00274924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301643|NCT00274924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301644|NCT00274924|Alkylating Agents|alkylating agents|mesh-ancestor
92301645|NCT00274924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301646|NCT00274924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301647|NCT00274924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301648|NCT00274924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301649|NCT00274924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301650|NCT00274924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92301651|NCT00274924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301652|NCT00274924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301653|NCT00274924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301654|NCT00274924|Glucocorticoids|glucocorticoids|mesh-ancestor
92301655|NCT00274924|Hormones|hormones|mesh-ancestor
92301656|NCT00274924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301657|NCT00274924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301658|NCT00274924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301659|NCT00274924|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92301660|NCT00274924|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301661|NCT00274924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301662|NCT00274924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301663|NCT00274924|Keratolytic Agents|keratolytic agents|mesh-ancestor
92301664|NCT00274924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301665|NCT00104884|Romidepsin|romidepsin|mesh-list
92347002|NCT01783548|Hormones|hormones|mesh-ancestor
92301666|NCT00104884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301667|NCT00104884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301668|NCT00104884|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92301669|NCT00104884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301670|NCT00104884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301671|NCT00096174|Cisplatin|cisplatin|mesh-list
92301672|NCT00096174|Cetuximab|cetuximab|mesh-list
92301673|NCT00096174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301674|NCT00096174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301675|NCT00080938|Temozolomide|temozolomide|mesh-list
92301676|NCT00080938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301677|NCT00080938|Alkylating Agents|alkylating agents|mesh-ancestor
92301678|NCT00080938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932779|NCT02361567|Acetaminophen|acetaminophen|mesh-list
92301679|NCT00080938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301680|NCT00078949|Cytarabine|cytarabine|mesh-list
92301681|NCT00078949|Dexamethasone|dexamethasone|mesh-list
92301682|NCT00078949|Rituximab|rituximab|mesh-list
92301684|NCT00078949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301685|NCT00078949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301686|NCT00078949|Immunologic Factors|immunologic factors|mesh-ancestor
92301687|NCT00078949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301688|NCT00078949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301689|NCT00078949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301690|NCT00078949|Antiemetics|antiemetics|mesh-ancestor
92301691|NCT00078949|Autonomic Agents|autonomic agents|mesh-ancestor
92301692|NCT00078949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301694|NCT00078949|Glucocorticoids|glucocorticoids|mesh-ancestor
92301695|NCT00078949|Hormones|hormones|mesh-ancestor
92301696|NCT00078949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301697|NCT00078949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301698|NCT00078949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301699|NCT00078949|Antimetabolites|antimetabolites|mesh-ancestor
92301700|NCT00078949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301701|NCT00078949|Antiviral Agents|antiviral agents|mesh-ancestor
92301702|NCT00078949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301703|NCT00078949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301704|NCT00074282|Cyclophosphamide|cyclophosphamide|mesh-list
92301705|NCT00074282|Rituximab|rituximab|mesh-list
92301706|NCT00074282|Alemtuzumab|alemtuzumab|mesh-list
92301707|NCT00074282|Pentostatin|pentostatin|mesh-list
92301708|NCT00074282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301709|NCT00074282|Immunologic Factors|immunologic factors|mesh-ancestor
92301710|NCT00074282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301711|NCT00074282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301712|NCT00074282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301713|NCT00074282|Alkylating Agents|alkylating agents|mesh-ancestor
92301714|NCT00074282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301715|NCT00074282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301716|NCT00074282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301717|NCT00074282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301718|NCT00074282|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92301719|NCT00074282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301720|NCT00071981|Molgramostim|molgramostim|mesh-list
92301721|NCT00071981|Vaccines|vaccines|mesh-list
92301722|NCT00071981|Sargramostim|sargramostim|mesh-list
92301723|NCT00071981|Freund's Adjuvant|freund's adjuvant|mesh-list
92301724|NCT00071981|Immunologic Factors|immunologic factors|mesh-ancestor
92301725|NCT00071981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301726|NCT00071981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301727|NCT00071981|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92301728|NCT00070291|Cyclosporine|cyclosporine|mesh-list
92301729|NCT00070291|Cyclosporins|cyclosporins|mesh-list
92301730|NCT00070291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301731|NCT00070291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301732|NCT00070291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301733|NCT00070291|Immunologic Factors|immunologic factors|mesh-ancestor
92301734|NCT00070291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301735|NCT00070291|Antifungal Agents|antifungal agents|mesh-ancestor
92301737|NCT00070291|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301738|NCT00070291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301739|NCT00070291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92301740|NCT00064350|Sorafenib|sorafenib|mesh-list
92301741|NCT00064350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301742|NCT00064350|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92301743|NCT00064350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301744|NCT00064350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301745|NCT00060346|Prednisone|prednisone|mesh-list
92301746|NCT00060346|Cyclophosphamide|cyclophosphamide|mesh-list
92301747|NCT00060346|Rituximab|rituximab|mesh-list
92301748|NCT00060346|Doxorubicin|doxorubicin|mesh-list
92301749|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92301750|NCT00060346|Vincristine|vincristine|mesh-list
92301751|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301752|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
92301753|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301754|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301755|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301756|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
92301757|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301758|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301759|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301760|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301761|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301762|NCT00060346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92301763|NCT00060346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301764|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301765|NCT00060346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301766|NCT00060346|Glucocorticoids|glucocorticoids|mesh-ancestor
92301767|NCT00060346|Hormones|hormones|mesh-ancestor
92301768|NCT00060346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301769|NCT00060346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301770|NCT00060346|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301771|NCT00060346|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301772|NCT00060346|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301773|NCT00060346|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301774|NCT00057954|Cyclosporine|cyclosporine|mesh-list
92301775|NCT00057954|Mycophenolic Acid|mycophenolic acid|mesh-list
92301776|NCT00057954|Methotrexate|methotrexate|mesh-list
92301777|NCT00057954|Pentostatin|pentostatin|mesh-list
92301778|NCT00057954|Cyclosporins|cyclosporins|mesh-list
92301779|NCT00057954|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92301780|NCT00057954|Abortifacient Agents|abortifacient agents|mesh-ancestor
92301781|NCT00057954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92301782|NCT00057954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301783|NCT00057954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301784|NCT00057954|Antimetabolites|antimetabolites|mesh-ancestor
92301785|NCT00057954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301786|NCT00057954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301787|NCT00057954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301788|NCT00057954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301789|NCT00057954|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92301790|NCT00057954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301791|NCT00057954|Immunologic Factors|immunologic factors|mesh-ancestor
92301792|NCT00057954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301793|NCT00057954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92301794|NCT00057954|Antifungal Agents|antifungal agents|mesh-ancestor
92301795|NCT00057954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301796|NCT00057954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92301797|NCT00057954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301798|NCT00057954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92301799|NCT00057954|Antitubercular Agents|antitubercular agents|mesh-ancestor
92301800|NCT00057954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301801|NCT00057954|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92301802|NCT00049530|Interferons|interferons|mesh-list
92301803|NCT00049530|Interferon-alpha|interferon-alpha|mesh-list
92301804|NCT00049530|Interferon alpha-2|interferon alpha-2|mesh-list
92301805|NCT00049530|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92301806|NCT00049530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301807|NCT00049530|Antiviral Agents|antiviral agents|mesh-ancestor
92301808|NCT00049530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301809|NCT00049530|Immunologic Factors|immunologic factors|mesh-ancestor
92301810|NCT00049530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301811|NCT00045305|Cyclosporine|cyclosporine|mesh-list
92301812|NCT00045305|Mycophenolic Acid|mycophenolic acid|mesh-list
92301813|NCT00045305|Methotrexate|methotrexate|mesh-list
92301814|NCT00045305|Pentostatin|pentostatin|mesh-list
92301815|NCT00045305|Methoxsalen|methoxsalen|mesh-list
92301816|NCT00045305|Cyclosporins|cyclosporins|mesh-list
92301817|NCT00045305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92301818|NCT00045305|Abortifacient Agents|abortifacient agents|mesh-ancestor
92301819|NCT00045305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92301820|NCT00045305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301821|NCT00045305|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301822|NCT00045305|Antimetabolites|antimetabolites|mesh-ancestor
92301823|NCT00045305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301824|NCT00045305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301825|NCT00045305|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301826|NCT00045305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301827|NCT00045305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92301828|NCT00045305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301829|NCT00045305|Immunologic Factors|immunologic factors|mesh-ancestor
92301830|NCT00045305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301831|NCT00045305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92301832|NCT00045305|Antifungal Agents|antifungal agents|mesh-ancestor
92301833|NCT00045305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301834|NCT00045305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92301835|NCT00045305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301836|NCT00045305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92301837|NCT00045305|Antitubercular Agents|antitubercular agents|mesh-ancestor
92301838|NCT00045305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301839|NCT00045305|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92301840|NCT00045305|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92301841|NCT00033657|Paclitaxel|paclitaxel|mesh-list
92301842|NCT00033657|Camptothecin|camptothecin|mesh-list
92301843|NCT00033657|Cisplatin|cisplatin|mesh-list
92301844|NCT00033657|Irinotecan|irinotecan|mesh-list
92301845|NCT00033657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301846|NCT00033657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301847|NCT00033657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301848|NCT00033657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301849|NCT00033657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301850|NCT00033657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301851|NCT00033657|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92301852|NCT00033657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301853|NCT00033657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301854|NCT00003389|Prednisone|prednisone|mesh-list
92301855|NCT00003389|Cyclophosphamide|cyclophosphamide|mesh-list
92301856|NCT00003389|Dacarbazine|dacarbazine|mesh-list
92301857|NCT00003389|Mechlorethamine|mechlorethamine|mesh-list
92301858|NCT00003389|Doxorubicin|doxorubicin|mesh-list
92301859|NCT00003389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92301860|NCT00003389|Etoposide|etoposide|mesh-list
92301861|NCT00003389|Vincristine|vincristine|mesh-list
92301863|NCT00003389|Bleomycin|bleomycin|mesh-list
92301864|NCT00003389|Vinblastine|vinblastine|mesh-list
92301865|NCT00003389|Podophyllotoxin|podophyllotoxin|mesh-list
92301866|NCT00003389|Imidazole|imidazole|mesh-list
92301867|NCT00003389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301868|NCT00003389|Immunologic Factors|immunologic factors|mesh-ancestor
92301869|NCT00003389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301870|NCT00003389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301871|NCT00003389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301872|NCT00003389|Alkylating Agents|alkylating agents|mesh-ancestor
92301873|NCT00003389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301874|NCT00003389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301875|NCT00003389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301876|NCT00003389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92301877|NCT00003389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92301878|NCT00003389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92301879|NCT00003389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301880|NCT00003389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92301881|NCT00003389|Glucocorticoids|glucocorticoids|mesh-ancestor
92301882|NCT00003389|Hormones|hormones|mesh-ancestor
92301883|NCT00003389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92301884|NCT00003389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92301885|NCT00003389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92301886|NCT00003389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92301887|NCT00003389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92301888|NCT00003389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92301889|NCT00003389|Keratolytic Agents|keratolytic agents|mesh-ancestor
92301890|NCT00003389|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301891|NCT00003138|Epoetin Alfa|epoetin alfa|mesh-list
92301892|NCT00003138|Lenograstim|lenograstim|mesh-list
92301893|NCT00003138|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92301894|NCT00003138|Immunologic Factors|immunologic factors|mesh-ancestor
92301895|NCT00003138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301896|NCT00003138|Hematinics|hematinics|mesh-ancestor
92301897|NCT00002525|Leucovorin|leucovorin|mesh-list
92301898|NCT00002525|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92301899|NCT00002525|Tetrahydrofolates|tetrahydrofolates|mesh-list
92301900|NCT00002525|Fluorouracil|fluorouracil|mesh-list
92301901|NCT00002525|Calcium|calcium|mesh-list
92301902|NCT00002525|Levoleucovorin|levoleucovorin|mesh-list
92301903|NCT00002525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92301904|NCT00002525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301905|NCT00002525|Antimetabolites|antimetabolites|mesh-ancestor
92301906|NCT00002525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301907|NCT00002525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301908|NCT00002525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301909|NCT00002525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301910|NCT00002525|Immunologic Factors|immunologic factors|mesh-ancestor
92301911|NCT00002525|Antidotes|antidotes|mesh-ancestor
92301912|NCT00002525|Protective Agents|protective agents|mesh-ancestor
92301913|NCT00002525|Vitamin B Complex|vitamin b complex|mesh-ancestor
92301915|NCT00002525|Micronutrients|micronutrients|mesh-ancestor
92301916|NCT05475522|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92301917|NCT05475522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92301918|NCT05475522|Dermatologic Agents|dermatologic agents|mesh-ancestor
92301919|NCT02259348|Aldesleukin|aldesleukin|mesh-list
92301920|NCT02259348|Cyclophosphamide|cyclophosphamide|mesh-list
92301921|NCT02259348|Melphalan|melphalan|mesh-list
92301922|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
92301923|NCT02259348|Thiotepa|thiotepa|mesh-list
92301924|NCT02259348|Rituximab|rituximab|mesh-list
92301925|NCT02259348|Fludarabine|fludarabine|mesh-list
92301926|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
92301927|NCT02259348|Interleukin-2|interleukin-2|mesh-list
92301928|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301929|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
92301930|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301931|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347040|NCT01809132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301932|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301933|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
92301934|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301935|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301936|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301937|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92301938|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92301939|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
92301940|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
92301941|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301942|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92301943|NCT02259348|Analgesics|analgesics|mesh-ancestor
92410273|NCT05330429|Vitamins|vitamins|mesh-ancestor
92301944|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
92301945|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301946|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92301947|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92301948|NCT00357019|Isospaglumic acid|isospaglumic acid|mesh-list
92301949|NCT00357019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92301950|NCT00357019|Autonomic Agents|autonomic agents|mesh-ancestor
92301951|NCT00357019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301952|NCT00357019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301953|NCT00357019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92301954|NCT00357019|Respiratory System Agents|respiratory system agents|mesh-ancestor
92301955|NCT00357019|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92301956|NCT00357019|Histamine Antagonists|histamine antagonists|mesh-ancestor
92301957|NCT00357019|Histamine Agents|histamine agents|mesh-ancestor
92301958|NCT00357019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92301959|NCT00357019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301960|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92301961|NCT00357019|Protective Agents|protective agents|mesh-ancestor
92301962|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92301963|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
92301964|NCT03994705|Fludarabine|fludarabine|mesh-list
92301965|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92301966|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
92301967|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301968|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92301969|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92301970|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
92301971|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301972|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92301973|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92301974|NCT03587207|Vaccines|vaccines|mesh-list
92301975|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
92301976|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301977|NCT03592121|Phenylephrine|phenylephrine|mesh-list
92301978|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92301979|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
92301980|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
92301981|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92301982|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92301983|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
92301984|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92301985|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
92301986|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
92301987|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92301988|NCT03592121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92301989|NCT03592121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92301990|NCT03592121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92301991|NCT03592121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92301992|NCT03592121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92301993|NCT03592121|Protective Agents|protective agents|mesh-ancestor
92301994|NCT04332809|Gentamicins|gentamicins|mesh-list
92301995|NCT04332809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92301996|NCT04332809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92301997|NCT04332809|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92301998|NCT04332809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92301999|NCT04332809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302000|NCT03596723|Prednisolone|prednisolone|mesh-list
92302001|NCT03596723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92302002|NCT03596723|Methylprednisolone|methylprednisolone|mesh-list
92302003|NCT03596723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92302004|NCT03596723|Prednisolone acetate|prednisolone acetate|mesh-list
92302005|NCT03596723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92302006|NCT03596723|Prednisolone phosphate|prednisolone phosphate|mesh-list
92302007|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302008|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
92302009|NCT03596723|Hormones|hormones|mesh-ancestor
92302010|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302011|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302012|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92302013|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302014|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
92302015|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
92302016|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302017|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92302018|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92302019|NCT03596723|Protective Agents|protective agents|mesh-ancestor
92302020|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92302021|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92302022|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302023|NCT03472469|Acetaminophen|acetaminophen|mesh-list
92302024|NCT03472469|Ketorolac|ketorolac|mesh-list
92302025|NCT03472469|Naproxen|naproxen|mesh-list
92302026|NCT03472469|Celecoxib|celecoxib|mesh-list
92302027|NCT03472469|Lidocaine|lidocaine|mesh-list
92302028|NCT03472469|Pregabalin|pregabalin|mesh-list
92302029|NCT03472469|Gabapentin|gabapentin|mesh-list
92302030|NCT03472469|Tramadol|tramadol|mesh-list
92302031|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
92302032|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
92302033|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302034|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302035|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
92302036|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302037|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92302038|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92302039|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92302040|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302041|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302042|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92302043|NCT03472469|Analgesics|analgesics|mesh-ancestor
92302044|NCT03472469|Antipyretics|antipyretics|mesh-ancestor
92302045|NCT03472469|Anticonvulsants|anticonvulsants|mesh-ancestor
92302046|NCT03472469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92302047|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92302048|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92302049|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92302050|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92302051|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92302052|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92302053|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302054|NCT03472469|Antimanic Agents|antimanic agents|mesh-ancestor
92302055|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92302056|NCT03472469|Narcotics|narcotics|mesh-ancestor
92302057|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92302058|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302059|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302060|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92302061|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302062|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
92302063|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92302064|NCT04926233|Bromides|bromides|mesh-list
92302065|NCT04926233|Tiotropium Bromide|tiotropium bromide|mesh-list
92302066|NCT04926233|Olodaterol|olodaterol|mesh-list
92302067|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92302068|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
92302069|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302070|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302071|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92302072|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
92302073|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
92302074|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92302075|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302076|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302077|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302078|NCT04926233|Anticonvulsants|anticonvulsants|mesh-ancestor
92302079|NCT04943159|Afamelanotide|afamelanotide|mesh-list
92302080|NCT04943159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92302081|NCT04525157|Afamelanotide|afamelanotide|mesh-list
92302082|NCT04525157|Dermatologic Agents|dermatologic agents|mesh-ancestor
92302083|NCT04734665|Bevacizumab|bevacizumab|mesh-list
92302084|NCT04734665|Niraparib|niraparib|mesh-list
92302085|NCT04734665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302086|NCT04734665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302087|NCT04734665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92302088|NCT04734665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92302089|NCT04734665|Growth Substances|growth substances|mesh-ancestor
92302090|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302091|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
92302092|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92302093|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302094|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302095|NCT02258334|Vaccines|vaccines|mesh-list
92302096|NCT02258334|Immunologic Factors|immunologic factors|mesh-ancestor
92302097|NCT02258334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302098|NCT03478163|Clindamycin|clindamycin|mesh-list
92302099|NCT03478163|Clindamycin palmitate|clindamycin palmitate|mesh-list
92302100|NCT03478163|Clindamycin phosphate|clindamycin phosphate|mesh-list
92302101|NCT03478163|Cefazolin|cefazolin|mesh-list
92302102|NCT03478163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92302103|NCT03478163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302104|NCT03478163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92302105|NCT03478163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302106|NCT03478163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302107|NCT05646810|Lidocaine|lidocaine|mesh-list
92302108|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
92302109|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
92302110|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302111|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302112|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
92302113|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302114|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92302115|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92302116|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92302117|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302118|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302119|NCT04960202|Ritonavir|ritonavir|mesh-list
92302120|NCT04960202|Nirmatrelvir|nirmatrelvir|mesh-list
92302121|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92302122|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92302123|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
92302124|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302125|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302126|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92302127|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92302128|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
92302129|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347063|NCT01808196|Angiotensin II|angiotensin ii|mesh-list
92302130|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92302131|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92302133|NCT02959112|Epinephrine|epinephrine|mesh-list
92302134|NCT02959112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92302135|NCT02959112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92302136|NCT02959112|Adrenergic Agents|adrenergic agents|mesh-ancestor
92302137|NCT02959112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302138|NCT02959112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302139|NCT02959112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302140|NCT02959112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92302141|NCT02959112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92302142|NCT02959112|Autonomic Agents|autonomic agents|mesh-ancestor
92302143|NCT02959112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302144|NCT02959112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92302145|NCT02959112|Respiratory System Agents|respiratory system agents|mesh-ancestor
92302146|NCT02959112|Mydriatics|mydriatics|mesh-ancestor
92302147|NCT02959112|Sympathomimetics|sympathomimetics|mesh-ancestor
92302148|NCT02959112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92302149|NCT02959112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92302150|NCT02959112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92302151|NCT02959112|Analgesics|analgesics|mesh-ancestor
92302152|NCT02959112|Sensory System Agents|sensory system agents|mesh-ancestor
92302153|NCT02959112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302154|NCT02959112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302155|NCT02959112|Gout Suppressants|gout suppressants|mesh-ancestor
92302156|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
92302157|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92302158|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92302159|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302160|NCT05377034|Bevacizumab|bevacizumab|mesh-list
92302161|NCT05377034|Atezolizumab|atezolizumab|mesh-list
92302162|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302163|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302164|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92302165|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92302166|NCT05377034|Growth Substances|growth substances|mesh-ancestor
92302167|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302168|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
92302169|NCT05377034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92116936|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92302170|NCT05377034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302172|NCT03622619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92302173|NCT03622619|Lubricant Eye Drops|lubricant eye drops|mesh-list
92302174|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92302175|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302176|NCT04428359|Vitamin D|vitamin d|mesh-list
92302177|NCT04428359|Vitamins|vitamins|mesh-ancestor
92302178|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
92302179|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302180|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92302181|NCT02257632|Ranibizumab|ranibizumab|mesh-list
92302182|NCT02257632|Aflibercept|aflibercept|mesh-list
92302183|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92302184|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92302185|NCT02257632|Growth Substances|growth substances|mesh-ancestor
92302186|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302187|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
92302188|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302189|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
92302190|NCT05436054|Cathartics|cathartics|mesh-ancestor
92302191|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92302192|NCT04932434|Psilocybin|psilocybin|mesh-list
92302193|NCT04932434|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92302194|NCT04932434|Hallucinogens|hallucinogens|mesh-ancestor
92302195|NCT04932434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302196|NCT04932434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92302197|NCT04932434|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92302198|NCT04932434|Serotonin Agents|serotonin agents|mesh-ancestor
92302199|NCT04932434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302200|NCT04932434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302201|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92302202|NCT01642914|Linaclotide|linaclotide|mesh-list
92302203|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92302204|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
92302205|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302206|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92302207|NCT04497116|Gemcitabine|gemcitabine|mesh-list
92302208|NCT04497116|Talazoparib|talazoparib|mesh-list
92302209|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92302210|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
92302211|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302212|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302213|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92302214|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302215|NCT04486352|Bevacizumab|bevacizumab|mesh-list
92302216|NCT04486352|Trastuzumab|trastuzumab|mesh-list
92302217|NCT04486352|Atezolizumab|atezolizumab|mesh-list
92302218|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92302221|NCT04486352|Talazoparib|talazoparib|mesh-list
92302222|NCT04486352|Ipatasertib|ipatasertib|mesh-list
92302223|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92302224|NCT04486352|Inavolisib|inavolisib|mesh-list
92302225|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302226|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302227|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92302228|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92302229|NCT04486352|Growth Substances|growth substances|mesh-ancestor
92302230|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302231|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
92302232|NCT04486352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92302233|NCT04486352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302234|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
92302235|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92302236|NCT04486352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92302237|NCT04486352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302238|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92302239|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92302240|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302241|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92302242|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
92302243|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
92302244|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92302245|NCT04486352|Immunotoxins|immunotoxins|mesh-ancestor
92302246|NCT04486352|Immunoconjugates|immunoconjugates|mesh-ancestor
92302247|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92302249|NCT04486352|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92302250|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
92302251|NCT01642602|Lansoprazole|lansoprazole|mesh-list
92302252|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92302253|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92302254|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92302255|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302256|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302257|NCT02256540|Resveratrol|resveratrol|mesh-list
92302258|NCT02256540|Estradiol|estradiol|mesh-list
92302259|NCT02256540|Estrogens|estrogens|mesh-ancestor
92302260|NCT02256540|Hormones|hormones|mesh-ancestor
92302261|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302262|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302263|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
92302264|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302265|NCT02256540|Protective Agents|protective agents|mesh-ancestor
92302266|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302267|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92302268|NCT05646264|Agomelatine|agomelatine|mesh-list
92302269|NCT05646264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92302270|NCT05646264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302271|NCT05646264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302272|NCT01640184|Vitamin D|vitamin d|mesh-list
92302273|NCT01640184|Vitamins|vitamins|mesh-ancestor
92302274|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
92302275|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302276|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92302277|NCT04904978|Listerine|listerine|mesh-list
92302278|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
92302279|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
92302280|NCT04904978|Protective Agents|protective agents|mesh-ancestor
92302281|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302282|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92302283|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302284|NCT03631433|Acetaminophen|acetaminophen|mesh-list
92302285|NCT03631433|Ibuprofen|ibuprofen|mesh-list
92302286|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92302287|NCT03631433|Analgesics|analgesics|mesh-ancestor
92302288|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
92302289|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302290|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302291|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
92302292|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92302293|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302294|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954991|NCT03420703|Analgesics|analgesics|mesh-ancestor
92302295|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92302296|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302297|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302298|NCT02973659|Oxybutynin|oxybutynin|mesh-list
92302299|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
92302300|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
92302301|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302302|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302303|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92302304|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92302305|NCT02973659|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302306|NCT02973659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302307|NCT02973659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302308|NCT02973659|Urological Agents|urological agents|mesh-ancestor
92302309|NCT04439396|Ketorolac|ketorolac|mesh-list
92302310|NCT04439396|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92302311|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92302312|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92302313|NCT04439396|Analgesics|analgesics|mesh-ancestor
92302314|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
92302315|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302316|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302317|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302318|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302319|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92302320|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302321|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302322|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92302323|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
92302324|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302325|NCT00360464|Azithromycin|azithromycin|mesh-list
92302326|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92302327|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302328|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
92302329|NCT04825496|Fludarabine|fludarabine|mesh-list
92302330|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92302331|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
92302332|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302333|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302334|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92302335|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
92302336|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302337|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302339|NCT05651256|Botulinum Toxins|botulinum toxins|mesh-list
92302340|NCT05651256|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92302341|NCT05651256|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92302342|NCT05651256|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92302343|NCT05651256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302344|NCT05651256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302345|NCT05651256|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302346|NCT05651256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302347|NCT05651256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302348|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92302349|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302350|NCT04297631|Tobramycin|tobramycin|mesh-list
92302351|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92302352|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302353|NCT04812470|Melphalan|melphalan|mesh-list
92302354|NCT04812470|Interleukin-2|interleukin-2|mesh-list
92302355|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92302356|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
92302357|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302358|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302359|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92302360|NCT04812470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92302361|NCT04812470|Immunologic Factors|immunologic factors|mesh-ancestor
92302362|NCT04812470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302363|NCT04812470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92302364|NCT04812470|Analgesics|analgesics|mesh-ancestor
92302365|NCT04812470|Sensory System Agents|sensory system agents|mesh-ancestor
92302366|NCT04812470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302367|NCT02976194|Ranibizumab|ranibizumab|mesh-list
92302368|NCT02976194|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92302369|NCT02976194|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92302370|NCT02976194|Growth Substances|growth substances|mesh-ancestor
92302371|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302372|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
92302373|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302374|NCT00360776|Tipifarnib|tipifarnib|mesh-list
92302375|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302376|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
92302377|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302378|NCT04342910|Paclitaxel|paclitaxel|mesh-list
92302379|NCT04342910|Irinotecan|irinotecan|mesh-list
92302380|NCT04342910|Apatinib|apatinib|mesh-list
92302381|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92302382|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302383|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92302384|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92302385|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92302386|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302387|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92302388|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92302389|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302390|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92302391|NCT04714073|Itraconazole|itraconazole|mesh-list
92302392|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
92302393|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302394|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92302395|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92302396|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302397|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302398|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92302399|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
92302400|NCT04714073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302401|NCT04714073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302402|NCT04714073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92302403|NCT04342676|Panitumumab|panitumumab|mesh-list
92302404|NCT04342676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302405|NCT04342676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302406|NCT01641822|Tobramycin|tobramycin|mesh-list
92302407|NCT01641822|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92302408|NCT01641822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302409|NCT04398368|Gemcitabine|gemcitabine|mesh-list
92302410|NCT04398368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92302411|NCT04398368|Antimetabolites|antimetabolites|mesh-ancestor
92302412|NCT04398368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302413|NCT04398368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302414|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
92302415|NCT05364762|Tacrolimus|tacrolimus|mesh-list
92302416|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92302417|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
92302418|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302419|NCT05364762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302420|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92302421|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
92302422|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302423|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302424|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92302425|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92302426|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302427|NCT04871958|Insulin|insulin|mesh-list
92302428|NCT04871958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302429|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302430|NCT04342598|Vitamin D|vitamin d|mesh-list
92302431|NCT04342598|Vitamins|vitamins|mesh-ancestor
92302432|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
92302433|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302434|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92302435|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92302436|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302437|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92302438|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302439|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302440|NCT05641818|Vitamin D|vitamin d|mesh-list
92302441|NCT05641818|Vitamins|vitamins|mesh-ancestor
92302442|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
92302443|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302444|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92302445|NCT04762082|Tadalafil|tadalafil|mesh-list
92302446|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
92302447|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92302448|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92302449|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116937|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302450|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302451|NCT04762082|Urological Agents|urological agents|mesh-ancestor
92302452|NCT03514277|Bupivacaine|bupivacaine|mesh-list
92302453|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
92302454|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
92302455|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302456|NCT03514277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302457|NCT03514277|Sensory System Agents|sensory system agents|mesh-ancestor
92302458|NCT03514277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302459|NCT05334108|Ecopipam|ecopipam|mesh-list
92302460|NCT05334108|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92302461|NCT05334108|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92302462|NCT05334108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302463|NCT05334108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302464|NCT05334108|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92302465|NCT05334108|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92302466|NCT05334108|Dopamine Agents|dopamine agents|mesh-ancestor
92302467|NCT05334108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302468|NCT05334108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302469|NCT03984656|Lidocaine|lidocaine|mesh-list
92302470|NCT03984656|Anesthetics, Local|anesthetics, local|mesh-ancestor
92302471|NCT03984656|Anesthetics|anesthetics|mesh-ancestor
92302472|NCT03984656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302473|NCT03984656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302474|NCT03984656|Sensory System Agents|sensory system agents|mesh-ancestor
92302475|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302476|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92302477|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92302478|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92302479|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302480|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302481|NCT05299944|Cannabidiol|cannabidiol|mesh-list
92302482|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
92302483|NCT04329494|Leucovorin|leucovorin|mesh-list
92302484|NCT04329494|Cisplatin|cisplatin|mesh-list
92302485|NCT04329494|Doxorubicin|doxorubicin|mesh-list
92302486|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92302487|NCT04329494|Fluorouracil|fluorouracil|mesh-list
92302488|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
92302489|NCT04329494|Irinotecan|irinotecan|mesh-list
92302490|NCT04329494|Daunorubicin|daunorubicin|mesh-list
92302491|NCT04329494|Mitomycins|mitomycins|mesh-list
92302492|NCT04329494|Mitomycin|mitomycin|mesh-list
92302493|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302494|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92302495|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92302496|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92302497|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302498|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302499|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
92302500|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92302501|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92302502|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
92302503|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302504|NCT04329494|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92302505|NCT04329494|Antidotes|antidotes|mesh-ancestor
92302506|NCT04329494|Protective Agents|protective agents|mesh-ancestor
92302507|NCT04329494|Vitamin B Complex|vitamin b complex|mesh-ancestor
92302508|NCT04329494|Vitamins|vitamins|mesh-ancestor
92302509|NCT04329494|Micronutrients|micronutrients|mesh-ancestor
92302510|NCT04329494|Alkylating Agents|alkylating agents|mesh-ancestor
92302511|NCT04329494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92302512|NCT03655301|Metformin|metformin|mesh-list
92302513|NCT03655301|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302514|NCT03655301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302515|NCT04870866|Niacinamide|niacinamide|mesh-list
92302516|NCT04870866|Niacin|niacin|mesh-list
92302517|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
92302518|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
92302519|NCT04870866|Vitamins|vitamins|mesh-ancestor
92302520|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
92302521|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302522|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92302523|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
92302524|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302525|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92302526|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
92302527|NCT03657407|Glycerol|glycerol|mesh-list
92302528|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92302529|NCT03657407|Protective Agents|protective agents|mesh-ancestor
92302530|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302531|NCT01639560|Varenicline|varenicline|mesh-list
92302532|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92302533|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92302534|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302535|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302536|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302537|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302538|NCT04243616|Paclitaxel|paclitaxel|mesh-list
92302539|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
92302540|NCT04243616|Carboplatin|carboplatin|mesh-list
92302541|NCT04243616|Doxorubicin|doxorubicin|mesh-list
92302542|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92302543|NCT04243616|Cemiplimab|cemiplimab|mesh-list
92302544|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92302545|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302546|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92302547|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92302548|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92302549|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302550|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92302551|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
92302552|NCT04243616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302553|NCT04243616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302554|NCT04243616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92302555|NCT04243616|Alkylating Agents|alkylating agents|mesh-ancestor
92302556|NCT04243616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92302557|NCT04243616|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92302558|NCT04243616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92302559|NCT04243616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92302560|NCT04243616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302561|NCT04243616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302563|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92302564|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92302565|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302567|NCT03954314|Coagulants|coagulants|mesh-ancestor
92302568|NCT03952130|Insulin|insulin|mesh-list
92302569|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92302570|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
92302571|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
92302572|NCT03952130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302573|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302574|NCT03661541|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
92302575|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92302576|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
92302577|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302578|NCT03925532|Denosumab|denosumab|mesh-list
92302579|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92302580|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302581|NCT05430828|Evolocumab|evolocumab|mesh-list
92302582|NCT05430828|Alirocumab|alirocumab|mesh-list
92302583|NCT05430828|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92302584|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92302585|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92302586|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
92302587|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302588|NCT05430828|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92302589|NCT05430828|Protease Inhibitors|protease inhibitors|mesh-ancestor
92302590|NCT05430828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302591|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92302592|NCT01640964|Terlipressin|terlipressin|mesh-list
92302593|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92302594|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92302595|NCT03663101|Lidocaine|lidocaine|mesh-list
92302596|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
92302597|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92302598|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92302599|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
92302600|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
92302601|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302602|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302603|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
92302604|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302605|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92302606|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92302607|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92302608|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302609|NCT03663101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302610|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92302611|NCT03663101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302612|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302613|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92302614|NCT05430048|Bisoprolol|bisoprolol|mesh-list
92302615|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92302616|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92302617|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
92302618|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
92302619|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302620|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302621|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92302622|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92302623|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92302624|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92302625|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302626|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302627|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
92302628|NCT05430048|Coagulants|coagulants|mesh-ancestor
92302629|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92302630|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
92302631|NCT02975570|Levofloxacin|levofloxacin|mesh-list
92302632|NCT02975570|Linezolid|linezolid|mesh-list
92302633|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
92302634|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92302635|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302636|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92302637|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92302638|NCT02975570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92302639|NCT02975570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302640|NCT02975570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302641|NCT02975570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302642|NCT02975570|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92302643|NCT02975570|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92302644|NCT02975570|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92302645|NCT02975570|Antitubercular Agents|antitubercular agents|mesh-ancestor
92302646|NCT04184999|Dexamethasone|dexamethasone|mesh-list
92302647|NCT04184999|Prednisolone|prednisolone|mesh-list
92302648|NCT04184999|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92302649|NCT04184999|Methylprednisolone|methylprednisolone|mesh-list
92302650|NCT04184999|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92302651|NCT04184999|Prednisolone acetate|prednisolone acetate|mesh-list
92302652|NCT04184999|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92302653|NCT04184999|Prednisolone phosphate|prednisolone phosphate|mesh-list
92302654|NCT04184999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302655|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
92302656|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
92302657|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302658|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302659|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92302660|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
92302661|NCT04184999|Hormones|hormones|mesh-ancestor
92302662|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302663|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92302664|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302665|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92302666|NCT04184999|Protective Agents|protective agents|mesh-ancestor
92302667|NCT03524339|Tamsulosin|tamsulosin|mesh-list
92302668|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92302669|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92302670|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92302671|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
92302672|NCT03524339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302673|NCT03524339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302674|NCT03524339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302675|NCT03524339|Urological Agents|urological agents|mesh-ancestor
92302676|NCT03667547|Raltegravir Potassium|raltegravir potassium|mesh-list
92302677|NCT03667547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92302678|NCT03667547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92302679|NCT03667547|Antiviral Agents|antiviral agents|mesh-ancestor
92302680|NCT03667547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302681|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92302682|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92302683|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302684|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302685|NCT00361010|Levetiracetam|levetiracetam|mesh-list
92302686|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
92302687|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
92302688|NCT00361088|Bortezomib|bortezomib|mesh-list
92302689|NCT00361088|Tipifarnib|tipifarnib|mesh-list
92302690|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302691|NCT04172402|Gemcitabine|gemcitabine|mesh-list
92302692|NCT04172402|Nivolumab|nivolumab|mesh-list
92302693|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92302694|NCT04172402|Antimetabolites|antimetabolites|mesh-ancestor
92302695|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302696|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302697|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302698|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92302699|NCT04662242|Selenium|selenium|mesh-list
92302700|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
92302701|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302702|NCT04662242|Protective Agents|protective agents|mesh-ancestor
92302703|NCT04662242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302704|NCT04662242|Trace Elements|trace elements|mesh-ancestor
92302705|NCT04662242|Micronutrients|micronutrients|mesh-ancestor
92302706|NCT04160546|Aspirin|aspirin|mesh-list
92302707|NCT04160546|Ponatinib|ponatinib|mesh-list
92302708|NCT04160546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92302709|NCT04160546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92302710|NCT04160546|Analgesics|analgesics|mesh-ancestor
92302711|NCT04160546|Sensory System Agents|sensory system agents|mesh-ancestor
92302712|NCT04160546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302713|NCT04160546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302714|NCT04160546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302715|NCT04160546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302716|NCT04160546|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92302717|NCT04160546|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92302718|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302719|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92302720|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92302721|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302722|NCT04160546|Antipyretics|antipyretics|mesh-ancestor
92302723|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302724|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92302725|NCT03675581|Nintedanib|nintedanib|mesh-list
92302726|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92302727|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92302728|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302729|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92302730|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302731|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302732|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92302733|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
92302734|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92302735|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302736|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92302737|NCT03675581|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92302738|NCT03675581|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92302739|NCT03675581|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92302740|NCT03675581|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92302741|NCT03675581|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92302742|NCT03675581|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92302743|NCT03675581|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92302744|NCT05142228|Erenumab|erenumab|mesh-list
92302745|NCT05142228|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92302746|NCT05142228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302747|NCT05142228|Analgesics|analgesics|mesh-ancestor
92302748|NCT05142228|Sensory System Agents|sensory system agents|mesh-ancestor
92302749|NCT05142228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302750|NCT05142228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302751|NCT00362102|Cetuximab|cetuximab|mesh-list
92302752|NCT00362102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302753|NCT00362102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302754|NCT05122026|Isoniazid|isoniazid|mesh-list
92302755|NCT05122026|Rifapentine|rifapentine|mesh-list
92302756|NCT05122026|Antitubercular Agents|antitubercular agents|mesh-ancestor
92302757|NCT05122026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92302758|NCT05122026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92302759|NCT05122026|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92302760|NCT05122026|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92302762|NCT05122026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302763|NCT05122026|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92302764|NCT05122026|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92302765|NCT05122026|Leprostatic Agents|leprostatic agents|mesh-ancestor
92302766|NCT02958878|Tamsulosin|tamsulosin|mesh-list
92302767|NCT02958878|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92302768|NCT02958878|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92302769|NCT02958878|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92302770|NCT02958878|Adrenergic Agents|adrenergic agents|mesh-ancestor
92302771|NCT02958878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302772|NCT02958878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302773|NCT02958878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302774|NCT02958878|Urological Agents|urological agents|mesh-ancestor
92302775|NCT02976116|Gefitinib|gefitinib|mesh-list
92302776|NCT02976116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302777|NCT02976116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92302778|NCT02976116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302779|NCT02976116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302780|NCT01600716|Botulinum Toxins|botulinum toxins|mesh-list
92302781|NCT01600716|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92302782|NCT01600716|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92302783|NCT01600716|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92302784|NCT01600716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302785|NCT01600716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302786|NCT01600716|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302787|NCT01600716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302788|NCT01600716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302789|NCT01600716|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92302790|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302791|NCT02975258|Nitric Oxide|nitric oxide|mesh-list
92302792|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
92302793|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92302794|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
92302795|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302796|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302797|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92302798|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
92302799|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92302800|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
92302801|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302802|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302803|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92302804|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
92302805|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
92302806|NCT02975258|Protective Agents|protective agents|mesh-ancestor
92302807|NCT02975258|Miotics|miotics|mesh-ancestor
92302808|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91932300|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
92302809|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92302810|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92302811|NCT02975258|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92302812|NCT02975258|Cholinergic Agents|cholinergic agents|mesh-ancestor
92302813|NCT05114460|Naloxone|naloxone|mesh-list
92302814|NCT05114460|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92302815|NCT05114460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302816|NCT05114460|Sensory System Agents|sensory system agents|mesh-ancestor
92302817|NCT05114460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302818|NCT04844814|Prednisone|prednisone|mesh-list
92302819|NCT04844814|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92302820|NCT04844814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92302821|NCT04844814|Glucocorticoids|glucocorticoids|mesh-ancestor
92302822|NCT04844814|Hormones|hormones|mesh-ancestor
92302823|NCT04844814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302824|NCT04844814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302825|NCT04844814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92302826|NCT04844814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302827|NCT04844814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302828|NCT02975102|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92302829|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92302830|NCT04833114|Carboplatin|carboplatin|mesh-list
92302831|NCT04833114|Etoposide|etoposide|mesh-list
92302832|NCT04833114|Rituximab|rituximab|mesh-list
92302833|NCT04833114|Ifosfamide|ifosfamide|mesh-list
92302834|NCT04833114|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92302835|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302836|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92302837|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92302838|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92302839|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302840|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302841|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302842|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
92302843|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302844|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302845|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92302846|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
92302847|NCT04833114|Immunoconjugates|immunoconjugates|mesh-ancestor
92302848|NCT00376883|Pamidronate|pamidronate|mesh-list
92302849|NCT00376883|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92302850|NCT00376883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302851|NCT05314673|Bevacizumab|bevacizumab|mesh-list
92302852|NCT05314673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302853|NCT05314673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302854|NCT05314673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92302855|NCT05314673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92302856|NCT05314673|Growth Substances|growth substances|mesh-ancestor
92302857|NCT05314673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302858|NCT05314673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92302859|NCT04112069|Insulin Lispro|insulin lispro|mesh-list
92302860|NCT04112069|Insulin Aspart|insulin aspart|mesh-list
92302861|NCT04112069|Pancrelipase|pancrelipase|mesh-list
92302862|NCT04112069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302863|NCT04112069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302864|NCT04112069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92302865|NCT04098575|Empagliflozin|empagliflozin|mesh-list
92302866|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92302867|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302868|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302869|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302870|NCT03776240|Trastuzumab|trastuzumab|mesh-list
92302871|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302872|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302874|NCT04832100|Imipramine|imipramine|mesh-list
92302875|NCT04832100|Analgesics|analgesics|mesh-ancestor
92302876|NCT04832100|Sensory System Agents|sensory system agents|mesh-ancestor
92302877|NCT04832100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92302878|NCT04832100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302879|NCT04832100|Anticonvulsants|anticonvulsants|mesh-ancestor
92302880|NCT04832100|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92302881|NCT04832100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302882|NCT04832100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302883|NCT04832100|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92302884|NCT04832100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92302885|NCT04832100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92302886|NCT04832100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302887|NCT04832100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92302888|NCT04832100|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92302889|NCT04832100|Antidepressive Agents|antidepressive agents|mesh-ancestor
92302890|NCT04832100|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92302891|NCT04832100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92302892|NCT04832100|Adrenergic Agents|adrenergic agents|mesh-ancestor
92302893|NCT04832100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302894|NCT02976272|Bortezomib|bortezomib|mesh-list
92302895|NCT02976272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302896|NCT00361790|Aripiprazole|aripiprazole|mesh-list
92302897|NCT00361790|Escitalopram|escitalopram|mesh-list
92302898|NCT00361790|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92302899|NCT00361790|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92302900|NCT00361790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92302901|NCT00361790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302902|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302903|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
92302904|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302905|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
92302906|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92302907|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92302908|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92302909|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302910|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
92302911|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
92302912|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92302913|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92302914|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92302915|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92302916|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92302917|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92302918|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
92302919|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302920|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302921|NCT04570332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92302922|NCT04570332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302924|NCT00361868|Rosiglitazone|rosiglitazone|mesh-list
92302925|NCT00361868|Fenofibrate|fenofibrate|mesh-list
92302926|NCT00361868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302927|NCT00361868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302928|NCT00361868|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92302929|NCT00361868|Antimetabolites|antimetabolites|mesh-ancestor
92302930|NCT00361868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302931|NCT00361868|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92302932|NCT04564872|Linagliptin|linagliptin|mesh-list
92302933|NCT04564872|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92302934|NCT04564872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302935|NCT04564872|Incretins|incretins|mesh-ancestor
92302936|NCT04564872|Hormones|hormones|mesh-ancestor
92302937|NCT04564872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302938|NCT04564872|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92302939|NCT04564872|Protease Inhibitors|protease inhibitors|mesh-ancestor
92302940|NCT04564872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92302941|NCT04564872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302942|NCT04343144|Nivolumab|nivolumab|mesh-list
92302943|NCT04343144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92302944|NCT04343144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302945|NCT04343144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410274|NCT05330429|Micronutrients|micronutrients|mesh-ancestor
92302946|NCT04343144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302947|NCT04075409|Padsevonil|padsevonil|mesh-list
92302948|NCT04075409|Anticonvulsants|anticonvulsants|mesh-ancestor
92302949|NCT03743246|Cyclophosphamide|cyclophosphamide|mesh-list
92302950|NCT03743246|Fludarabine|fludarabine|mesh-list
92302951|NCT03743246|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92302952|NCT03743246|Immunologic Factors|immunologic factors|mesh-ancestor
92302953|NCT03743246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302954|NCT03743246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92302955|NCT03743246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92302956|NCT03743246|Alkylating Agents|alkylating agents|mesh-ancestor
92302957|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302958|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302959|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92302960|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
92302961|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
92302962|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92302963|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92302964|NCT03703778|Androgens|androgens|mesh-list
92302965|NCT03703778|Hormones|hormones|mesh-ancestor
92302966|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92302967|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302968|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
92302969|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955670|NCT03424759|Osimertinib|osimertinib|mesh-list
92302970|NCT03703778|Protective Agents|protective agents|mesh-ancestor
92302971|NCT03703778|Vitamins|vitamins|mesh-ancestor
92302972|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
92302973|NCT03703778|Estrogens|estrogens|mesh-ancestor
92302974|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92302975|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92302976|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
92302977|NCT05346666|Midazolam|midazolam|mesh-list
92302978|NCT05346666|Phenobarbital|phenobarbital|mesh-list
92302979|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92302980|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92302981|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92302982|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92302983|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92302984|NCT05346666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92302985|NCT05346666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91936280|NCT03493087|Coagulants|coagulants|mesh-ancestor
92302986|NCT05346666|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92302987|NCT05346666|Anesthetics, General|anesthetics, general|mesh-ancestor
92302989|NCT05346666|GABA Modulators|gaba modulators|mesh-ancestor
92302990|NCT05346666|GABA Agents|gaba agents|mesh-ancestor
92302991|NCT05346666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92302992|NCT05346666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92302994|NCT05346666|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92302995|NCT05346666|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92302996|NCT05346666|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92302997|NCT05346666|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92302998|NCT05346666|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92302999|NCT00361166|Pimavanserin|pimavanserin|mesh-list
92303000|NCT00361166|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92303001|NCT00361166|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92303002|NCT00361166|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92303003|NCT00361166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92303004|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303005|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303006|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92303007|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92303008|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92303009|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
92303010|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303011|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303012|NCT03674294|Dexamethasone|dexamethasone|mesh-list
92303013|NCT03674294|Aprepitant|aprepitant|mesh-list
92303014|NCT03674294|Palonosetron|palonosetron|mesh-list
92303015|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303016|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
92303017|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
92303018|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303019|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303020|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303021|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
92303022|NCT03674294|Hormones|hormones|mesh-ancestor
92303023|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303024|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303025|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303026|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92303027|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347150|NCT01762800|Bromides|bromides|mesh-list
92303028|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303029|NCT03674294|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92303030|NCT03674294|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92303031|NCT03674294|Serotonin Agents|serotonin agents|mesh-ancestor
92303032|NCT00377273|Fluorouracil|fluorouracil|mesh-list
92303033|NCT00377273|Antimetabolites|antimetabolites|mesh-ancestor
92303034|NCT00377273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303035|NCT00377273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92303036|NCT00377273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303037|NCT00377273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92303038|NCT00377273|Immunologic Factors|immunologic factors|mesh-ancestor
92303039|NCT00377273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303040|NCT03706313|Bupivacaine|bupivacaine|mesh-list
92303041|NCT03706313|Anesthetics, Local|anesthetics, local|mesh-ancestor
92303042|NCT03706313|Anesthetics|anesthetics|mesh-ancestor
92303043|NCT03706313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303044|NCT03706313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303045|NCT03706313|Sensory System Agents|sensory system agents|mesh-ancestor
92303046|NCT03706313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303047|NCT05369364|Dexamethasone|dexamethasone|mesh-list
92303048|NCT05369364|Zanubrutinib|zanubrutinib|mesh-list
92303049|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303050|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
92303051|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
92303052|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303053|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303054|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303055|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
92303056|NCT05369364|Hormones|hormones|mesh-ancestor
92303057|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303058|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303059|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303060|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92303061|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303062|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303065|NCT00361244|Sunitinib|sunitinib|mesh-list
92303066|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92303067|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92303068|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303069|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303070|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303071|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303072|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92303073|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92303074|NCT00361244|Growth Substances|growth substances|mesh-ancestor
92303075|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303076|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
92303077|NCT00361244|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92303078|NCT03381482|Anesthetics|anesthetics|mesh-list
92303079|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303080|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303081|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92303082|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
92303083|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92303084|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303085|NCT04968522|Methylphenidate|methylphenidate|mesh-list
92303086|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
92303087|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92303088|NCT04968522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303089|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92303090|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92303091|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303092|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303093|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
92303094|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303095|NCT00361322|Clindamycin|clindamycin|mesh-list
92303096|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
92303097|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
92303098|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
92303099|NCT00361322|Salicylates|salicylates|mesh-list
92303100|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303101|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303102|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92303103|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303104|NCT00361322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303105|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
92303106|NCT00361322|Keratolytic Agents|keratolytic agents|mesh-ancestor
92303107|NCT00361322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92303108|NCT00361322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92303109|NCT00361322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92303110|NCT00361322|Analgesics|analgesics|mesh-ancestor
92303111|NCT00361322|Sensory System Agents|sensory system agents|mesh-ancestor
92303112|NCT00361322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303113|NCT00361322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303114|NCT00361322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303115|NCT00361322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303116|NCT00361322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91955819|NCT02410772|Rifampin|rifampin|mesh-list
92303118|NCT02974712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92303120|NCT02974712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303121|NCT02974712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303122|NCT02974712|Analgesics|analgesics|mesh-ancestor
92303123|NCT02974712|Sensory System Agents|sensory system agents|mesh-ancestor
92303124|NCT02974712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303125|NCT02974712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92303126|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92303127|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
92303128|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
92303129|NCT02974556|Capecitabine|capecitabine|mesh-list
92303130|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
92303131|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92303132|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
91936281|NCT03136627|Nivolumab|nivolumab|mesh-list
92303133|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303134|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303135|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92303136|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92303138|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92303139|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
92303140|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
92303141|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303142|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303143|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303144|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92303146|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
92303147|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303148|NCT04957368|Midazolam|midazolam|mesh-list
92303149|NCT04957368|Nitrous Oxide|nitrous oxide|mesh-list
92303150|NCT04957368|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92303151|NCT04957368|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92303152|NCT04957368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303153|NCT04957368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303154|NCT04957368|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92303155|NCT04957368|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92303156|NCT04957368|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92303157|NCT04957368|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92303158|NCT04957368|Anesthetics, General|anesthetics, general|mesh-ancestor
92303159|NCT04957368|Anesthetics|anesthetics|mesh-ancestor
92303160|NCT04957368|GABA Modulators|gaba modulators|mesh-ancestor
92303161|NCT04957368|GABA Agents|gaba agents|mesh-ancestor
92303162|NCT04957368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303163|NCT04957368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303164|NCT04957368|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92303165|NCT04957368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92303166|NCT04957368|Analgesics|analgesics|mesh-ancestor
92303167|NCT04957368|Sensory System Agents|sensory system agents|mesh-ancestor
92303168|NCT04957368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303169|NCT04818450|Gabapentin|gabapentin|mesh-list
92303170|NCT04818450|Analgesics|analgesics|mesh-ancestor
92303171|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
92303172|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410275|NCT05328908|Trifluridine|trifluridine|mesh-list
92303173|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303174|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
92303175|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92303176|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92303177|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303178|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92303179|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92303180|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92303181|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303182|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303183|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
92303184|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
92303185|NCT04841148|Palbociclib|palbociclib|mesh-list
92303187|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
92303188|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92303189|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92303190|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303191|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303192|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303193|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955893|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92303194|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303195|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92303196|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303197|NCT04829760|Psyllium|psyllium|mesh-list
92303198|NCT04829760|Cathartics|cathartics|mesh-ancestor
92303199|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303200|NCT05289804|Lidocaine|lidocaine|mesh-list
92303201|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
92303202|NCT05289804|Prilocaine|prilocaine|mesh-list
92303203|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92303204|NCT05289804|Anesthetics|anesthetics|mesh-list
92303205|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303206|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303207|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
92303208|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303209|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92303210|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92303211|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92303212|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303213|NCT05289804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303214|NCT05289804|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92303216|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92303217|NCT05448872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92303218|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92303219|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92303220|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303221|NCT04817826|Durvalumab|durvalumab|mesh-list
92303222|NCT04817826|Tremelimumab|tremelimumab|mesh-list
92303223|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303224|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303225|NCT00362258|Irbesartan|irbesartan|mesh-list
92303226|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92303227|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92303228|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92303229|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303230|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
92303231|NCT00362726|Ritonavir|ritonavir|mesh-list
92303232|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92303233|NCT00362726|Maleic acid|maleic acid|mesh-list
92303234|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92303235|NCT00362726|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92303236|NCT00362726|Protease Inhibitors|protease inhibitors|mesh-ancestor
92303237|NCT00362726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303238|NCT00362726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303239|NCT00362726|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92303240|NCT00362726|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92303241|NCT00362726|Antiviral Agents|antiviral agents|mesh-ancestor
92303242|NCT00362726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303243|NCT00362726|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92347165|NCT01762800|Cholinergic Agents|cholinergic agents|mesh-ancestor
92303244|NCT00362726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92303245|NCT00362726|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92303246|NCT00362726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303247|NCT04474470|Cetuximab|cetuximab|mesh-list
92303248|NCT04474470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303249|NCT04474470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303250|NCT05330754|Caffeine|caffeine|mesh-list
92303251|NCT05330754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92303252|NCT05330754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303253|NCT05330754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92303254|NCT05330754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303255|NCT05330754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303256|NCT05330754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92303257|NCT05330754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92303258|NCT05330754|Purinergic Agents|purinergic agents|mesh-ancestor
92303259|NCT05330754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303260|NCT02271932|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92303261|NCT02271932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303262|NCT04448184|Tranexamic Acid|tranexamic acid|mesh-list
92303263|NCT04448184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92303264|NCT04448184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92303265|NCT04448184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303266|NCT04448184|Hemostatics|hemostatics|mesh-ancestor
92303267|NCT04448184|Coagulants|coagulants|mesh-ancestor
92303268|NCT04426968|Interferons|interferons|mesh-list
92303269|NCT04426968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303270|NCT04426968|Antiviral Agents|antiviral agents|mesh-ancestor
92303271|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303272|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92303273|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
92303274|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303275|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
92303276|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92303277|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92303278|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
92303279|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92303280|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303281|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92303282|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92303283|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
92303284|NCT04184297|Olodaterol|olodaterol|mesh-list
92303285|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92303286|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
92303287|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303288|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303289|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92303290|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
92303291|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
92303292|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92303293|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
92303294|NCT04184297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303295|NCT04184297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303296|NCT04031885|Paclitaxel|paclitaxel|mesh-list
92303297|NCT04031885|Docetaxel|docetaxel|mesh-list
92303298|NCT04031885|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92303299|NCT04031885|Capecitabine|capecitabine|mesh-list
92303300|NCT04031885|Fulvestrant|fulvestrant|mesh-list
92303301|NCT04031885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92303302|NCT04031885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303303|NCT04031885|Tubulin Modulators|tubulin modulators|mesh-ancestor
92303304|NCT04031885|Antimitotic Agents|antimitotic agents|mesh-ancestor
92303305|NCT04031885|Mitosis Modulators|mitosis modulators|mesh-ancestor
92303306|NCT04031885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303307|NCT04031885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92303308|NCT04031885|Antimetabolites|antimetabolites|mesh-ancestor
92303309|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303310|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92303311|NCT04031885|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92303312|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
92303313|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303314|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303315|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
92303316|NCT01638000|Mirabegron|mirabegron|mesh-list
92303317|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92303318|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92303319|NCT01638000|Cholinergic Agents|cholinergic agents|mesh-ancestor
92303320|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303321|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303322|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303323|NCT01638000|Urological Agents|urological agents|mesh-ancestor
92303324|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92303325|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92303326|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92303327|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92303328|NCT04023695|Lidocaine|lidocaine|mesh-list
92303329|NCT04023695|Epinephrine|epinephrine|mesh-list
92303330|NCT04023695|Anesthetics, Local|anesthetics, local|mesh-ancestor
92303331|NCT04023695|Anesthetics|anesthetics|mesh-ancestor
92303332|NCT04023695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303333|NCT04023695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303334|NCT04023695|Sensory System Agents|sensory system agents|mesh-ancestor
92303335|NCT04023695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303336|NCT04023695|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92303337|NCT04023695|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92303338|NCT04023695|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92303339|NCT04023695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91956043|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
92303340|NCT04023695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303341|NCT04023695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92303342|NCT04023695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92303343|NCT04023695|Adrenergic Agents|adrenergic agents|mesh-ancestor
92303344|NCT04023695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303345|NCT04023695|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92303346|NCT04023695|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92303348|NCT04023695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92303349|NCT04023695|Respiratory System Agents|respiratory system agents|mesh-ancestor
92303350|NCT04023695|Mydriatics|mydriatics|mesh-ancestor
92303351|NCT04023695|Sympathomimetics|sympathomimetics|mesh-ancestor
92303352|NCT04023695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92303353|NCT04211909|Sofosbuvir|sofosbuvir|mesh-list
92303354|NCT04211909|Velpatasvir|velpatasvir|mesh-list
92303355|NCT04211909|Antiviral Agents|antiviral agents|mesh-ancestor
92303356|NCT04211909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303357|NCT04223843|Tiotropium Bromide|tiotropium bromide|mesh-list
92303358|NCT04223843|Olodaterol|olodaterol|mesh-list
92303359|NCT04223843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92303360|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
92303361|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303362|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303363|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92303364|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92303365|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
92303366|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92303367|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
92303368|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303369|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303370|NCT05722951|Metformin|metformin|mesh-list
92303371|NCT05722951|Levetiracetam|levetiracetam|mesh-list
92303372|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92303373|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303374|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
92303375|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
92303376|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
92303377|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303378|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303379|NCT04838652|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92303380|NCT04838652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303381|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
92303382|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303383|NCT05722795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92303384|NCT05722795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347169|NCT01762800|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92303385|NCT05722795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303386|NCT03778554|Metoprolol|metoprolol|mesh-list
92303387|NCT03778554|Carvedilol|carvedilol|mesh-list
92303388|NCT03778554|Nebivolol|nebivolol|mesh-list
92303389|NCT03778554|Bisoprolol|bisoprolol|mesh-list
92303390|NCT03778554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92303391|NCT03778554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92303392|NCT03778554|Sympatholytics|sympatholytics|mesh-ancestor
92303393|NCT03778554|Autonomic Agents|autonomic agents|mesh-ancestor
92303394|NCT03778554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303395|NCT03778554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303396|NCT03778554|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92303397|NCT03778554|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92303398|NCT03778554|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92303399|NCT03778554|Adrenergic Agents|adrenergic agents|mesh-ancestor
92303400|NCT03778554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303401|NCT03778554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303402|NCT03778554|Antioxidants|antioxidants|mesh-ancestor
92303403|NCT03778554|Protective Agents|protective agents|mesh-ancestor
92303404|NCT03778554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92303405|NCT03778554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303406|NCT03778554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92303407|NCT03778554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92303408|NCT03778554|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92303409|NCT03778554|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92303410|NCT03778554|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92303411|NCT03778554|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92303412|NCT03778554|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92303413|NCT04810494|Lidocaine|lidocaine|mesh-list
92303414|NCT04810494|Anesthetics, Local|anesthetics, local|mesh-ancestor
92303415|NCT04810494|Anesthetics|anesthetics|mesh-ancestor
92303416|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303417|NCT04810494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303418|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
92303419|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303420|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92303421|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92303422|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92303423|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303424|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303425|NCT05722405|Lenalidomide|lenalidomide|mesh-list
92303426|NCT05722405|Ixazomib|ixazomib|mesh-list
92303427|NCT05722405|Glycine|glycine|mesh-list
92303428|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
92303429|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303430|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92303431|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92303432|NCT05722405|Growth Substances|growth substances|mesh-ancestor
92303433|NCT05722405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92303434|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303435|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92303436|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303437|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303438|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
92303439|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303440|NCT04259658|Calcium|calcium|mesh-list
92303441|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92303442|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303443|NCT02767531|Orlistat|orlistat|mesh-list
92303444|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347176|NCT01762800|Sympathomimetics|sympathomimetics|mesh-ancestor
92303445|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303446|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92303447|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92303448|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
92303449|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92303450|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92303451|NCT04419246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303452|NCT04419246|Hemostatics|hemostatics|mesh-ancestor
92303453|NCT04419246|Coagulants|coagulants|mesh-ancestor
92303455|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92303456|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303457|NCT04229303|Voriconazole|voriconazole|mesh-list
92303458|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
92303459|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303460|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92303461|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92303462|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303463|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303464|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92303465|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
92303466|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303467|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410276|NCT05328908|Nivolumab|nivolumab|mesh-list
92303468|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92303469|NCT05263986|Adagrasib|adagrasib|mesh-list
92303470|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303471|NCT00357643|Vitamin D|vitamin d|mesh-list
92303472|NCT00357643|Calcium|calcium|mesh-list
92303473|NCT00357643|Vitamins|vitamins|mesh-ancestor
92303474|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
92303475|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303476|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92303477|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92303478|NCT04232358|Anesthetics|anesthetics|mesh-list
92303479|NCT04232358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303480|NCT04232358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303481|NCT05395494|Cycloserine|cycloserine|mesh-list
92303482|NCT05395494|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92303483|NCT05395494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303484|NCT05395494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92303485|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
92303486|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303487|NCT05395494|Antimetabolites|antimetabolites|mesh-ancestor
92303488|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303489|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92303490|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92303491|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92303492|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
92303493|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303494|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303495|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92303496|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92303497|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
92303498|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303499|NCT03504410|Cytarabine|cytarabine|mesh-list
92303500|NCT03504410|Fludarabine|fludarabine|mesh-list
92303501|NCT03504410|Etoposide|etoposide|mesh-list
92303502|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
92303503|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303504|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92303505|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
92303506|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303507|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92303508|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
92303509|NCT03504410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303510|NCT03504410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92303511|NCT03504410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92303512|NCT03504410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92303513|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303514|NCT03504410|Antiviral Agents|antiviral agents|mesh-ancestor
92303515|NCT03504410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303516|NCT03504410|Analgesics|analgesics|mesh-ancestor
92303517|NCT03504410|Sensory System Agents|sensory system agents|mesh-ancestor
92303518|NCT03504410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303519|NCT02464969|Apixaban|apixaban|mesh-list
92303520|NCT02464969|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92303521|NCT02464969|Antithrombins|antithrombins|mesh-ancestor
92303522|NCT02464969|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92303523|NCT02464969|Protease Inhibitors|protease inhibitors|mesh-ancestor
92303524|NCT02464969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303525|NCT02464969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303526|NCT02464969|Anticoagulants|anticoagulants|mesh-ancestor
92303527|NCT05392530|Macitentan|macitentan|mesh-list
92303528|NCT05392530|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92303529|NCT05392530|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92303530|NCT05392530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303531|NCT05392530|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92303532|NCT03498014|Analgesics, Opioid|analgesics, opioid|mesh-list
92303533|NCT03498014|Narcotics|narcotics|mesh-ancestor
92303534|NCT03498014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303535|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303536|NCT03498014|Analgesics|analgesics|mesh-ancestor
92303537|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
92303538|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303539|NCT02460133|Ritonavir|ritonavir|mesh-list
92303540|NCT02460133|Ribavirin|ribavirin|mesh-list
92303541|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92303542|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92303543|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
92303544|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303545|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303546|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92303547|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92303548|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
92303549|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303550|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92303551|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92303552|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
92303553|NCT02220452|Anesthetics|anesthetics|mesh-list
92303554|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303555|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303556|NCT04256603|Gabapentin|gabapentin|mesh-list
92303557|NCT04256603|Analgesics|analgesics|mesh-ancestor
92303558|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
92303559|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303560|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303561|NCT04256603|Anticonvulsants|anticonvulsants|mesh-ancestor
92303562|NCT04256603|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92303563|NCT04256603|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92303564|NCT04256603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956269|NCT01602224|Glucocorticoids|glucocorticoids|mesh-ancestor
92303565|NCT04256603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92303566|NCT04256603|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92303567|NCT04256603|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92303568|NCT04256603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303569|NCT04256603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303570|NCT04256603|Antimanic Agents|antimanic agents|mesh-ancestor
92303571|NCT05721079|Methoxsalen|methoxsalen|mesh-list
92303572|NCT05721079|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92303573|NCT05721079|Dermatologic Agents|dermatologic agents|mesh-ancestor
92303574|NCT00362570|Temozolomide|temozolomide|mesh-list
92303575|NCT00362570|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92303576|NCT00362570|Alkylating Agents|alkylating agents|mesh-ancestor
92303577|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303578|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303579|NCT00357253|Capecitabine|capecitabine|mesh-list
92303580|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92303581|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
92303582|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303583|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303584|NCT02386735|Prednisone|prednisone|mesh-list
92303585|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303586|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
92303587|NCT02386735|Hormones|hormones|mesh-ancestor
92303588|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303589|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303590|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303591|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303592|NCT02068430|Riboflavin|riboflavin|mesh-list
92303593|NCT02068430|Vitamin B Complex|vitamin b complex|mesh-ancestor
92303594|NCT02068430|Vitamins|vitamins|mesh-ancestor
92303595|NCT02068430|Micronutrients|micronutrients|mesh-ancestor
92303596|NCT02068430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303597|NCT02068430|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92303598|NCT02068430|Dermatologic Agents|dermatologic agents|mesh-ancestor
92303599|NCT03138512|Nivolumab|nivolumab|mesh-list
92303600|NCT03138512|Ipilimumab|ipilimumab|mesh-list
92303601|NCT03138512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303602|NCT03138512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303603|NCT03138512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92303604|NCT03138512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303605|NCT03127592|Etodolac|etodolac|mesh-list
92303606|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
92303607|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92303608|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
92303609|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92303610|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92303611|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303612|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92303613|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303614|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92303615|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303616|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92303617|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92303618|NCT03127592|Analgesics|analgesics|mesh-ancestor
92303619|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
92303620|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303621|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303622|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92303623|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92303624|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303625|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303626|NCT02444234|Tedizolid|tedizolid|mesh-list
92303627|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
92303628|NCT02444234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303629|NCT02444234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303630|NCT02444234|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92303631|NCT02444234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303632|NCT02444234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303633|NCT02444936|Vaccines|vaccines|mesh-list
92303634|NCT02444936|Immunologic Factors|immunologic factors|mesh-ancestor
92303635|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303636|NCT02445326|Dexamethasone|dexamethasone|mesh-list
92303637|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303638|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
92303639|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
92303640|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303641|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303642|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303643|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
92303644|NCT02445326|Hormones|hormones|mesh-ancestor
92303645|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303646|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303647|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303648|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
92303649|NCT04344457|Azithromycin|azithromycin|mesh-list
92303650|NCT04344457|Indomethacin|indomethacin|mesh-list
92303651|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
92303652|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92303653|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92303654|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303655|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303656|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303658|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92303659|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92303660|NCT04344457|Analgesics|analgesics|mesh-ancestor
92303661|NCT04344457|Sensory System Agents|sensory system agents|mesh-ancestor
92303662|NCT04344457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303663|NCT04344457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303664|NCT04344457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303665|NCT04344457|Gout Suppressants|gout suppressants|mesh-ancestor
92303666|NCT04344457|Tocolytic Agents|tocolytic agents|mesh-ancestor
92303667|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92303668|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92303669|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303671|NCT01920932|Prednisolone|prednisolone|mesh-list
92303672|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
92303673|NCT01920932|Dacarbazine|dacarbazine|mesh-list
92303674|NCT01920932|Doxorubicin|doxorubicin|mesh-list
92303675|NCT01920932|Etoposide|etoposide|mesh-list
92303676|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92303677|NCT01920932|Imidazole|imidazole|mesh-list
92303678|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92303679|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
92303680|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303681|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303682|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92303683|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
92303684|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303685|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303686|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92303687|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92303688|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92303689|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92303690|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303691|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303692|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
92303693|NCT01920932|Hormones|hormones|mesh-ancestor
92303694|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303695|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303696|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92303697|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303698|NCT01920932|Immunotoxins|immunotoxins|mesh-ancestor
92303699|NCT01920932|Immunoconjugates|immunoconjugates|mesh-ancestor
92303700|NCT05720533|Disitamab vedotin|disitamab vedotin|mesh-list
92303701|NCT05720533|Immunoconjugates|immunoconjugates|mesh-ancestor
92303702|NCT05720533|Immunologic Factors|immunologic factors|mesh-ancestor
92303703|NCT05720533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303704|NCT02446496|Cefadroxil|cefadroxil|mesh-list
92303705|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303706|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303707|NCT00355693|Propofol|propofol|mesh-list
92303708|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92303709|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303710|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303711|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92303712|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
92303713|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
92303714|NCT02448368|Verinurad|verinurad|mesh-list
92303715|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
92303716|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303717|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92303718|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92303719|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
92303720|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303721|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92303722|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92303723|NCT02448914|Dopamine Agonists|dopamine agonists|mesh-ancestor
92303724|NCT02448914|Dopamine Agents|dopamine agents|mesh-ancestor
92303725|NCT02448914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303726|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303727|NCT03496662|Paclitaxel|paclitaxel|mesh-list
92303728|NCT03496662|Gemcitabine|gemcitabine|mesh-list
92303729|NCT03496662|Nivolumab|nivolumab|mesh-list
92303730|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92303731|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303732|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
92303733|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
92303734|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
92303735|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303736|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92303737|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
92303738|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303739|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92303740|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
92303741|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92303742|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
92303743|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92303744|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92303745|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92303746|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303747|NCT05720065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303748|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
92303749|NCT05720065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303750|NCT05720065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303751|NCT05720065|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92303752|NCT05720065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303753|NCT05719831|Amoxicillin|amoxicillin|mesh-list
92303754|NCT05719831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303755|NCT05719831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303756|NCT01152541|Riboflavin|riboflavin|mesh-list
92303757|NCT01152541|Dextrans|dextrans|mesh-list
92303758|NCT01152541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92303759|NCT01152541|Vitamin B Complex|vitamin b complex|mesh-ancestor
92303760|NCT01152541|Vitamins|vitamins|mesh-ancestor
92303761|NCT01152541|Micronutrients|micronutrients|mesh-ancestor
92303762|NCT01152541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303763|NCT01152541|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92303764|NCT01152541|Dermatologic Agents|dermatologic agents|mesh-ancestor
92303765|NCT01152541|Anticoagulants|anticoagulants|mesh-ancestor
92303766|NCT01152541|Plasma Substitutes|plasma substitutes|mesh-ancestor
92303767|NCT01152541|Blood Substitutes|blood substitutes|mesh-ancestor
92303768|NCT01638546|Temozolomide|temozolomide|mesh-list
92303769|NCT01638546|Veliparib|veliparib|mesh-list
92303770|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92303771|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
92303772|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303773|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303774|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92303775|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303776|NCT04948489|Norethindrone|norethindrone|mesh-list
92303777|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
92303778|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92303779|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92303780|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92303781|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
92303782|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92303783|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303784|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92303785|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92303786|NCT05723341|Morphine|morphine|mesh-list
92303787|NCT05723341|Bupivacaine|bupivacaine|mesh-list
92303788|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
92303789|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
92303790|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303791|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303792|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
92303793|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303795|NCT05723341|Narcotics|narcotics|mesh-ancestor
92303796|NCT05723341|Analgesics|analgesics|mesh-ancestor
92303797|NCT05718583|Butyric Acid|butyric acid|mesh-list
92303798|NCT05718583|Histamine Antagonists|histamine antagonists|mesh-ancestor
92303799|NCT05718583|Histamine Agents|histamine agents|mesh-ancestor
92303800|NCT05718583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347207|NCT01777854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303801|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303802|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303803|NCT00363350|Rituximab|rituximab|mesh-list
92303804|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303805|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303806|NCT00363350|Immunologic Factors|immunologic factors|mesh-ancestor
92303807|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303808|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303809|NCT05717335|Thrombin|thrombin|mesh-list
92303810|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
92303811|NCT05717335|Coagulants|coagulants|mesh-ancestor
92303812|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
92303813|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92303814|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303815|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92303816|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303817|NCT04341818|Vitamin D|vitamin d|mesh-list
92303818|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
92303819|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
92303820|NCT04341818|Vitamins|vitamins|mesh-list
92303821|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
92303822|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303823|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92303824|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92303825|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
92303826|NCT00362804|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92303827|NCT00362804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92303828|NCT00362804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303829|NCT00362804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303830|NCT00362804|Adrenergic Agents|adrenergic agents|mesh-ancestor
92303831|NCT00362804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303832|NCT00362804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303833|NCT02451488|Sargramostim|sargramostim|mesh-list
92303834|NCT02451488|Immunologic Factors|immunologic factors|mesh-ancestor
92303835|NCT02451488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303836|NCT03172494|Insulin|insulin|mesh-list
92303837|NCT03172494|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92303838|NCT03172494|Liraglutide|liraglutide|mesh-list
92303839|NCT03172494|Insulin, Long-Acting|insulin, long-acting|mesh-list
92303840|NCT03172494|Xultophy|xultophy|mesh-list
92303841|NCT03172494|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92303842|NCT03172494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303843|NCT03172494|Incretins|incretins|mesh-ancestor
92303844|NCT03172494|Hormones|hormones|mesh-ancestor
92303845|NCT03172494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303846|NCT02452346|Tosedostat|tosedostat|mesh-list
92303847|NCT02452346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303848|NCT02452346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303849|NCT02959255|Esomeprazole|esomeprazole|mesh-list
92303850|NCT02959255|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92303851|NCT02959255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303852|NCT02959255|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92303853|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303854|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303855|NCT05716945|Fluorometholone|fluorometholone|mesh-list
92303856|NCT05716945|Dexamethasone|dexamethasone|mesh-list
92303857|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92303858|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
92303859|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
92303860|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303861|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303862|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303863|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
92303864|NCT05716945|Hormones|hormones|mesh-ancestor
92303865|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92303866|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92303868|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92303869|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
92303870|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303871|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347211|NCT01777620|Botulinum Toxins|botulinum toxins|mesh-list
92303872|NCT03012620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92303873|NCT03012620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303875|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
92303876|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92303877|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
92303878|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303879|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303880|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92303881|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303882|NCT01345136|Everolimus|everolimus|mesh-list
92303883|NCT01345136|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92303884|NCT01345136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92303885|NCT01345136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303886|NCT01345136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303887|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92303888|NCT01345136|Immunologic Factors|immunologic factors|mesh-ancestor
92303889|NCT01345136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303890|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303891|NCT04341428|Lansoprazole|lansoprazole|mesh-list
92303892|NCT04341428|Dexlansoprazole|dexlansoprazole|mesh-list
92303893|NCT04341428|Fexuprazan|fexuprazan|mesh-list
92303894|NCT04341428|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92303895|NCT04341428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92303896|NCT04341428|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92303897|NCT04341428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303898|NCT04341428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303900|NCT02453360|Anesthetics, Local|anesthetics, local|mesh-ancestor
92303901|NCT02453360|Anesthetics|anesthetics|mesh-ancestor
92303902|NCT02453360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303903|NCT02453360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303904|NCT02453360|Sensory System Agents|sensory system agents|mesh-ancestor
92303905|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303906|NCT03140670|Rucaparib|rucaparib|mesh-list
92303907|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92303908|NCT03140670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303909|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303910|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303911|NCT02453672|Bevacizumab|bevacizumab|mesh-list
92303912|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92303913|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303914|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92303915|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92303916|NCT02453672|Growth Substances|growth substances|mesh-ancestor
92303917|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303918|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92303919|NCT03119064|Irinotecan|irinotecan|mesh-list
92303920|NCT03119064|Temozolomide|temozolomide|mesh-list
92303921|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92303922|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92303923|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303924|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303925|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303926|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92303927|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
92303928|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
92303929|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
92303930|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303931|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303932|NCT02453750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92303933|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
92303934|NCT03831295|Antibodies|antibodies|mesh-list
92303935|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
92303936|NCT03831295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303937|NCT02454296|Lidocaine|lidocaine|mesh-list
92303938|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92303939|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
92303940|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92303941|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303942|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
92303943|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92303944|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92303945|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92303946|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92303947|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92303948|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303949|NCT03836833|Lamivudine|lamivudine|mesh-list
92303950|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92303951|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92303952|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303953|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303954|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
92303955|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303956|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92303957|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92303958|NCT05710471|Aflibercept|aflibercept|mesh-list
92303959|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92303960|NCT05710471|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92303961|NCT05710471|Growth Substances|growth substances|mesh-ancestor
92303962|NCT05710471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303963|NCT05710471|Growth Inhibitors|growth inhibitors|mesh-ancestor
92303964|NCT05710471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303965|NCT00358969|Guanfacine|guanfacine|mesh-list
92303966|NCT00358969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92303967|NCT00358969|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92303969|NCT00358969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92303970|NCT00358969|Adrenergic Agents|adrenergic agents|mesh-ancestor
92303971|NCT00358969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92303972|NCT00358969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303973|NCT00358969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303974|NCT02896712|Modafinil|modafinil|mesh-list
92303975|NCT02896712|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92303976|NCT02896712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92303977|NCT02896712|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92303978|NCT02896712|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92303979|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92303980|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303981|NCT05346601|Chiauranib|chiauranib|mesh-list
92303982|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92303983|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92303984|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303985|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303986|NCT04344379|Azithromycin|azithromycin|mesh-list
92303987|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
92303988|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92303989|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92303990|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
92303991|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92303992|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92303993|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92303994|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92303995|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92303996|NCT00359125|Mifepristone|mifepristone|mesh-list
92303997|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92303998|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
92303999|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92304000|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304001|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92304002|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92304003|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92304004|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
92304005|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92304006|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92304007|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
92304008|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304009|NCT00359125|Luteolytic Agents|luteolytic agents|mesh-ancestor
92304010|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92304011|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92304012|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92304014|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92304015|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304017|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
92304018|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304019|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
92304020|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304021|NCT05679193|Propranolol|propranolol|mesh-list
92304022|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92304023|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92304024|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
92304025|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304026|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304027|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304028|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92304029|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92304030|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
92304031|NCT04795752|Cyclosporine|cyclosporine|mesh-list
92304032|NCT04795752|Cyclosporins|cyclosporins|mesh-list
92304033|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304034|NCT04795752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304035|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304036|NCT04795752|Immunologic Factors|immunologic factors|mesh-ancestor
92304037|NCT04795752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304038|NCT04795752|Antifungal Agents|antifungal agents|mesh-ancestor
92304039|NCT04795752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304040|NCT04795752|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304041|NCT04795752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304042|NCT04795752|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92304043|NCT02977741|Olanzapine|olanzapine|mesh-list
92304044|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
92304045|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
92304046|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304047|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304048|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304049|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92304050|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92304051|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304052|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92304053|NCT02977741|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92304054|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92304055|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92304056|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304057|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304058|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
92304059|NCT04334070|Clofazimine|clofazimine|mesh-list
92304060|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304061|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
92304062|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304063|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304064|NCT05292001|Dextrans|dextrans|mesh-list
92304065|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
92304066|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
92304067|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
92304068|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
92304069|NCT05292001|Hematinics|hematinics|mesh-ancestor
92304070|NCT01634178|Apremilast|apremilast|mesh-list
92304071|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92304072|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304073|NCT01634178|Analgesics|analgesics|mesh-ancestor
92304074|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
92304075|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304076|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304077|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304078|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304079|NCT01634178|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92304080|NCT01634178|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92304081|NCT01634178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304082|NCT01634178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304084|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304085|NCT04782804|Capecitabine|capecitabine|mesh-list
92304086|NCT04782804|Tislelizumab|tislelizumab|mesh-list
91956794|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304087|NCT04782804|Antibodies|antibodies|mesh-list
92304088|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
92304089|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304090|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92304091|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
92304092|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304093|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304094|NCT04782804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304095|NCT04227288|Betamethasone|betamethasone|mesh-list
92304096|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
92304097|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92304098|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
92304099|NCT04227288|Calcipotriene|calcipotriene|mesh-list
92304100|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92304101|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304102|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
92304103|NCT04227288|Hormones|hormones|mesh-ancestor
92304104|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304105|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304106|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92304107|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92304108|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304109|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
92304110|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
92304111|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304112|NCT02978443|Nivolumab|nivolumab|mesh-list
92304113|NCT02978443|Ipilimumab|ipilimumab|mesh-list
92304114|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304115|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304116|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304117|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304118|NCT02465450|Lenabasum|lenabasum|mesh-list
92304119|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92304120|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92304121|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304122|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304123|NCT02465450|Hormones|hormones|mesh-ancestor
92304124|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304125|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304126|NCT00608972|Bevacizumab|bevacizumab|mesh-list
92304127|NCT00608972|Carboplatin|carboplatin|mesh-list
92304128|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304129|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304130|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92304131|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92304132|NCT00608972|Growth Substances|growth substances|mesh-ancestor
92304133|NCT00608972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304134|NCT00608972|Growth Inhibitors|growth inhibitors|mesh-ancestor
92304135|NCT02729714|Suvorexant|suvorexant|mesh-list
92304136|NCT02729714|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92304137|NCT02729714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92304138|NCT02729714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304139|NCT02729714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304140|NCT02729714|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92304141|NCT02729714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304142|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304143|NCT04802382|Fibrin fragment D|fibrin fragment d|mesh-list
92304144|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92304145|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92116938|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92304146|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304147|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
92304148|NCT04802382|Coagulants|coagulants|mesh-ancestor
92304149|NCT05648916|Celecoxib|celecoxib|mesh-list
92304150|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92304151|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304152|NCT05648916|Analgesics|analgesics|mesh-ancestor
92304153|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
92304154|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304155|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304156|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304157|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304158|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92304160|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304161|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304162|NCT05458609|Naltrexone|naltrexone|mesh-list
92304163|NCT05458609|Lemborexant|lemborexant|mesh-list
92304164|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92304165|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92304166|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304167|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
92304168|NCT05458609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304169|NCT05458609|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92304170|NCT05458609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304171|NCT05458609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304172|NCT05458609|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92304173|NCT05458609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92304174|NCT05458609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304175|NCT05648058|Diphenhydramine|diphenhydramine|mesh-list
92304176|NCT05648058|Promethazine|promethazine|mesh-list
92304177|NCT05648058|Nefopam|nefopam|mesh-list
92304178|NCT05648058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92304179|NCT05648058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92304180|NCT05648058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304181|NCT05648058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304182|NCT05648058|Anesthetics, Local|anesthetics, local|mesh-ancestor
92304183|NCT05648058|Anesthetics|anesthetics|mesh-ancestor
92304184|NCT05648058|Sensory System Agents|sensory system agents|mesh-ancestor
92304185|NCT05648058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304186|NCT05648058|Antiemetics|antiemetics|mesh-ancestor
92304187|NCT05648058|Autonomic Agents|autonomic agents|mesh-ancestor
92304188|NCT05648058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304189|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92304190|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
92304191|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
92304192|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304193|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304194|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92304195|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
92304196|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304197|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304198|NCT05648058|Analgesics|analgesics|mesh-ancestor
92304199|NCT05649085|Cobalt|cobalt|mesh-list
92304200|NCT05649085|Chromium|chromium|mesh-list
92304201|NCT05649085|Trace Elements|trace elements|mesh-ancestor
92304202|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
92304203|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304204|NCT05639712|Fentanyl|fentanyl|mesh-list
92304205|NCT05639712|Morphine|morphine|mesh-list
92304206|NCT05639712|Oxycodone|oxycodone|mesh-list
92304207|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92304208|NCT05639712|Narcotics|narcotics|mesh-ancestor
92304209|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304210|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304211|NCT05639712|Analgesics|analgesics|mesh-ancestor
92304212|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
92304213|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304214|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92304215|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92304216|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
92304217|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
92304218|NCT05210101|Sotrovimab|sotrovimab|mesh-list
92304219|NCT05210101|Antiviral Agents|antiviral agents|mesh-ancestor
92304220|NCT05210101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304221|NCT02959411|Tolvaptan|tolvaptan|mesh-list
92304222|NCT02959411|Diuretics|diuretics|mesh-list
92304223|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
92304224|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304225|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92304226|NCT02959411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304227|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
92304228|NCT05426161|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92304229|NCT05426161|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92304230|NCT05426161|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92304231|NCT05426161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92304232|NCT05426161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304233|NCT05426161|Cholinergic Agents|cholinergic agents|mesh-ancestor
92304234|NCT05426161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304235|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304237|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304238|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
92304239|NCT05630833|Gepotidacin|gepotidacin|mesh-list
92304240|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92304241|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304242|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304243|NCT05630833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92304244|NCT05630833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304245|NCT05630833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304246|NCT05630833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304247|NCT00359671|Docetaxel|docetaxel|mesh-list
92304248|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304249|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92304250|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92304251|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92304252|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304253|NCT02977897|Octreotide|octreotide|mesh-list
92304254|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304255|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304256|NCT02977897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304257|NCT05114941|Immunoglobulins|immunoglobulins|mesh-list
92304258|NCT05114941|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92304259|NCT05114941|Antibodies|antibodies|mesh-list
92304260|NCT05114941|gamma-Globulins|gamma-globulins|mesh-list
92304261|NCT05114941|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92304262|NCT05114941|Immunologic Factors|immunologic factors|mesh-ancestor
92304263|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304264|NCT00359905|Tamsulosin|tamsulosin|mesh-list
92304265|NCT00359905|Silodosin|silodosin|mesh-list
92304266|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92304267|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92304268|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92304269|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
92304270|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304271|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304272|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304273|NCT00359905|Urological Agents|urological agents|mesh-ancestor
92304274|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
92304275|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92304276|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
92304277|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304278|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
92304279|NCT05086939|Protective Agents|protective agents|mesh-ancestor
92304280|NCT00358813|Casopitant|casopitant|mesh-list
92304281|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
92304282|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
92304283|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304284|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304285|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304286|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92304287|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304288|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304289|NCT04871191|Rituximab|rituximab|mesh-list
92304290|NCT04871191|Abatacept|abatacept|mesh-list
92304291|NCT04871191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304292|NCT04871191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304293|NCT04871191|Immunologic Factors|immunologic factors|mesh-ancestor
92304294|NCT04871191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304295|NCT04871191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304296|NCT04871191|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304297|NCT04871191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304298|NCT04871191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304300|NCT02976805|Cathartics|cathartics|mesh-ancestor
92304301|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304302|NCT02976805|Laxatives|laxatives|mesh-ancestor
92304303|NCT04835623|Cyclosporine|cyclosporine|mesh-list
92304304|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92304305|NCT04835623|Cyclosporins|cyclosporins|mesh-list
92304306|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304307|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304308|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304309|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
92304310|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304311|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
92304312|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304313|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304314|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304315|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92304316|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92304317|NCT04500613|Dexamethasone|dexamethasone|mesh-list
92304318|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
92304319|NCT04500613|Bupivacaine|bupivacaine|mesh-list
92304321|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304322|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
92304323|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
92304324|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304325|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304326|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304327|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
92304328|NCT04500613|Hormones|hormones|mesh-ancestor
92304329|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304330|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304331|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304332|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
92304333|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304334|NCT04500613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304335|NCT04500613|Anesthetics, Local|anesthetics, local|mesh-ancestor
92304336|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
92304337|NCT04500613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304338|NCT04500613|Sensory System Agents|sensory system agents|mesh-ancestor
92304339|NCT04833907|Prednisone|prednisone|mesh-list
92304340|NCT04833907|Levetiracetam|levetiracetam|mesh-list
92304341|NCT04833907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304342|NCT04833907|Glucocorticoids|glucocorticoids|mesh-ancestor
92304343|NCT04833907|Hormones|hormones|mesh-ancestor
92304344|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304345|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304346|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304347|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304348|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
92304349|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
92304350|NCT02976259|Dolutegravir|dolutegravir|mesh-list
92304351|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92304352|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92304353|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304354|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304355|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92304356|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92304357|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
92304358|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304359|NCT00360295|Azithromycin|azithromycin|mesh-list
92304360|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304361|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304362|NCT02976727|Vitamin D|vitamin d|mesh-list
92304363|NCT02976727|Lidocaine|lidocaine|mesh-list
92304364|NCT02976727|Prilocaine|prilocaine|mesh-list
92304365|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92304366|NCT02976727|Calcipotriene|calcipotriene|mesh-list
92304367|NCT02976727|Vitamins|vitamins|mesh-ancestor
92304368|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
92304369|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304370|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
92304371|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
92304372|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304373|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
92304374|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304375|NCT02976727|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92304376|NCT02976727|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92304377|NCT02976727|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92304378|NCT02976727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92304379|NCT02976727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304380|NCT02976727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92304381|NCT02976727|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304382|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92304383|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
92304384|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92304385|NCT00360607|Metronidazole|metronidazole|mesh-list
92304386|NCT00360607|Amikacin|amikacin|mesh-list
92304387|NCT00360607|Ceftazidime|ceftazidime|mesh-list
92304388|NCT00360607|Sulbactam|sulbactam|mesh-list
92304389|NCT00360607|Cefoperazone|cefoperazone|mesh-list
92304390|NCT00360607|Sulperazone|sulperazone|mesh-list
92304391|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304392|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304393|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91957092|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304394|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92304395|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92304396|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304397|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304398|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92304399|NCT00360763|Candesartan|candesartan|mesh-list
92304400|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
92304401|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92304402|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92304403|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92304404|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304405|NCT04032301|Ketamine|ketamine|mesh-list
92304406|NCT04032301|Analgesics|analgesics|mesh-ancestor
92304407|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
92304408|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304409|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304410|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92304411|NCT04032301|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92304412|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
92304413|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
92304414|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304415|NCT04032301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92304416|NCT04032301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92304417|NCT04032301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304418|NCT04032301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304419|NCT04010305|Dexmedetomidine|dexmedetomidine|mesh-list
92304420|NCT04010305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92304421|NCT04010305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304422|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304423|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304424|NCT04010305|Analgesics|analgesics|mesh-ancestor
92304425|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
92304426|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304427|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92304428|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92304429|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92304430|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
92304431|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304432|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304433|NCT00361933|Valganciclovir|valganciclovir|mesh-list
92304434|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
92304435|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304436|NCT04786093|Durvalumab|durvalumab|mesh-list
92304437|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304438|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304439|NCT02976571|Bupivacaine|bupivacaine|mesh-list
92304440|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
92304441|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
92304442|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304443|NCT02976571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304444|NCT02976571|Sensory System Agents|sensory system agents|mesh-ancestor
92304445|NCT02976571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304446|NCT04731025|Vancomycin|vancomycin|mesh-list
92304447|NCT04731025|Gentamicins|gentamicins|mesh-list
92304448|NCT04731025|Cefazolin|cefazolin|mesh-list
92304449|NCT04731025|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304450|NCT04731025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304451|NCT04731025|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92304452|NCT04731025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304453|NCT04731025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304455|NCT04730635|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92304456|NCT04730635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304457|NCT04730635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304458|NCT04730635|Cholinergic Agents|cholinergic agents|mesh-ancestor
92304459|NCT04730635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304460|NCT04730635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304461|NCT04730635|Nootropic Agents|nootropic agents|mesh-ancestor
92304462|NCT04686799|Doxycycline|doxycycline|mesh-list
92304463|NCT04686799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304464|NCT04686799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304465|NCT04686799|Antimalarials|antimalarials|mesh-ancestor
92304466|NCT04686799|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92304467|NCT04686799|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92304468|NCT04676035|Vitamin K 1|vitamin k 1|mesh-list
92304469|NCT04676035|Vitamin K|vitamin k|mesh-list
92304470|NCT04676035|Midazolam|midazolam|mesh-list
92304471|NCT04676035|Omeprazole|omeprazole|mesh-list
92304472|NCT04676035|Warfarin|warfarin|mesh-list
92304473|NCT04676035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92304474|NCT04676035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92304475|NCT04676035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304476|NCT04676035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304477|NCT04676035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92304478|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92304479|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92304480|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92304481|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
92304482|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
92304483|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
92304484|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
92304485|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304486|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304487|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
92304488|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92304489|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304490|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92304491|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304492|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92304493|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92304494|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
92304495|NCT04676035|Coagulants|coagulants|mesh-ancestor
92304496|NCT04676035|Vitamins|vitamins|mesh-ancestor
92304497|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
92304498|NCT03926299|Clobetasol|clobetasol|mesh-list
92304499|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304500|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
92304501|NCT03926299|Hormones|hormones|mesh-ancestor
92304502|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304503|NCT03926299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304504|NCT04359199|Cisplatin|cisplatin|mesh-list
92304505|NCT04359199|Pembrolizumab|pembrolizumab|mesh-list
92304506|NCT04359199|Nivolumab|nivolumab|mesh-list
92304507|NCT04359199|Cetuximab|cetuximab|mesh-list
92304508|NCT04359199|Durvalumab|durvalumab|mesh-list
92304509|NCT04359199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304510|NCT04359199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304511|NCT04359199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304512|NCT04359199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304514|NCT03875911|Mitomycin|mitomycin|mesh-list
92304515|NCT03875911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92304516|NCT03875911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304517|NCT03875911|Alkylating Agents|alkylating agents|mesh-ancestor
92304518|NCT03875911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304519|NCT03875911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92304520|NCT03875911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304522|NCT00361075|Estrogens|estrogens|mesh-list
92304523|NCT00361075|Progesterone|progesterone|mesh-list
92304524|NCT00361075|Hormones|hormones|mesh-ancestor
92304525|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304526|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304527|NCT00361075|Progestins|progestins|mesh-ancestor
92304528|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92304529|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
92304530|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92304531|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
92304532|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92304533|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304534|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92304535|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92304536|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304537|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304538|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92304539|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92304540|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92304541|NCT00362089|Dronabinol|dronabinol|mesh-list
92304542|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
91957243|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92304543|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304544|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92304545|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304546|NCT00362089|Analgesics|analgesics|mesh-ancestor
92304547|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
92304548|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304549|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92304550|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92304551|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304552|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304553|NCT00362089|Hormones|hormones|mesh-ancestor
92304554|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304555|NCT04666987|Liraglutide|liraglutide|mesh-list
92304556|NCT04666987|Xultophy|xultophy|mesh-list
92304557|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92304558|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304559|NCT04666987|Incretins|incretins|mesh-ancestor
92304560|NCT04666987|Hormones|hormones|mesh-ancestor
92304561|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304562|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
92304563|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304564|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304565|NCT04318717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304566|NCT04318717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304567|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
92304568|NCT03822637|Albuterol|albuterol|mesh-list
92304569|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92304570|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92304571|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
92304572|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304573|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304574|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92304575|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92304576|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
92304577|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92304578|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92304579|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92304580|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92304581|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
92304582|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304583|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304584|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
92304585|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304586|NCT03822637|Expectorants|expectorants|mesh-ancestor
92304587|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92304588|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
92304589|NCT03822637|Protective Agents|protective agents|mesh-ancestor
92304590|NCT03822637|Antidotes|antidotes|mesh-ancestor
92304591|NCT05444101|Nicotine|nicotine|mesh-list
92304592|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92304593|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
92304594|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304595|NCT05444101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304596|NCT05444101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92304597|NCT05444101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92304598|NCT05444101|Cholinergic Agents|cholinergic agents|mesh-ancestor
92304599|NCT05444101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304600|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304601|NCT04342819|Empagliflozin|empagliflozin|mesh-list
92304602|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92304603|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304604|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92304605|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304606|NCT02412306|Blinatumomab|blinatumomab|mesh-list
92304607|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304608|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
92304609|NCT05616468|Fludarabine|fludarabine|mesh-list
92304610|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304611|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
92304612|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304613|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304614|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304615|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
92304616|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304617|NCT05616468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304618|NCT05616468|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92304619|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
92304620|NCT03654768|Dasatinib|dasatinib|mesh-list
92304621|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92304622|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304623|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92304624|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304625|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304626|NCT01352221|Ferric maltol|ferric maltol|mesh-list
92304627|NCT01352221|Hematinics|hematinics|mesh-ancestor
92304628|NCT03583710|Cisplatin|cisplatin|mesh-list
92304629|NCT03583710|Etoposide|etoposide|mesh-list
92304630|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
92304631|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
92304632|NCT03583710|Mitotane|mitotane|mesh-list
92304633|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304634|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92304635|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92304636|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92304637|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304638|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304639|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
92304640|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304641|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
92304642|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
92304643|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
92304644|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304645|NCT05195034|Dexmedetomidine|dexmedetomidine|mesh-list
92304646|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92304647|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304648|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304649|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304651|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
92304652|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304653|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92304654|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92304655|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92304656|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
92304657|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304658|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304659|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
92304660|NCT05496894|Analgesics|analgesics|mesh-ancestor
92304661|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
92304662|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304663|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304664|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304665|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92304666|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92304667|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304668|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304669|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
92304670|NCT02065362|Fludarabine|fludarabine|mesh-list
92304671|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304672|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
92304673|NCT02065362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304674|NCT02065362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304675|NCT02065362|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304677|NCT02065362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304678|NCT02065362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304679|NCT02065362|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92304680|NCT02021604|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92304681|NCT02021604|Dopamine Agents|dopamine agents|mesh-ancestor
92304682|NCT02021604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304683|NCT02021604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304684|NCT02021604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304685|NCT03518034|Testosterone|testosterone|mesh-list
92304686|NCT03518034|Androgens|androgens|mesh-ancestor
92304687|NCT03518034|Hormones|hormones|mesh-ancestor
92304688|NCT03518034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304689|NCT03518034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304690|NCT04789668|Atezolizumab|atezolizumab|mesh-list
92304691|NCT04789668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304692|NCT04789668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304693|NCT04789668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957394|NCT03383315|Tramadol|tramadol|mesh-list
92304694|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304695|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
92304696|NCT04448886|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92304697|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304698|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304699|NCT04448886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304700|NCT04448886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304701|NCT04448886|Immunoconjugates|immunoconjugates|mesh-ancestor
92304702|NCT04448886|Immunologic Factors|immunologic factors|mesh-ancestor
92304703|NCT04448886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304704|NCT02389218|Sotalol|sotalol|mesh-list
92304705|NCT02389218|Flecainide|flecainide|mesh-list
92304706|NCT02389218|Propafenone|propafenone|mesh-list
92304707|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92304708|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92304709|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
92304710|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304711|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304712|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304713|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92304714|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
92304715|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
92304716|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304717|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92304718|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92304719|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92304720|NCT01953120|Abatacept|abatacept|mesh-list
92304721|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304722|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304723|NCT01953120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304724|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304725|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304726|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
92304727|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304728|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304729|NCT01634100|Empagliflozin|empagliflozin|mesh-list
92304730|NCT01634100|Rifampin|rifampin|mesh-list
92304731|NCT01634100|Probenecid|probenecid|mesh-list
92304732|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92304733|NCT01634100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304734|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92304735|NCT01634100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304736|NCT01634100|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92304737|NCT01634100|Antitubercular Agents|antitubercular agents|mesh-ancestor
92304738|NCT01634100|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304739|NCT01634100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304740|NCT01634100|Leprostatic Agents|leprostatic agents|mesh-ancestor
92304741|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92304742|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304743|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92304744|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92304745|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91936312|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92304746|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92304747|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92304748|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92304749|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
92304750|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
92304751|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304752|NCT03662659|Nivolumab|nivolumab|mesh-list
92304753|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304754|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304755|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92304756|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304757|NCT03661645|Dexamethasone|dexamethasone|mesh-list
92304758|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
92304759|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
92304760|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92304761|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92304762|NCT03661645|BB 1101|bb 1101|mesh-list
92304763|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304764|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
92304765|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
92304766|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304767|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304768|NCT03661645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304769|NCT03661645|Glucocorticoids|glucocorticoids|mesh-ancestor
92304770|NCT03661645|Hormones|hormones|mesh-ancestor
92304771|NCT03661645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304772|NCT03661645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304773|NCT03661645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304774|NCT03661645|Protease Inhibitors|protease inhibitors|mesh-ancestor
92304775|NCT03661645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304776|NCT03661645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304777|NCT03661645|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92304778|NCT03661645|Protective Agents|protective agents|mesh-ancestor
92304779|NCT01633944|Buprenorphine|buprenorphine|mesh-list
92304780|NCT01633944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92304781|NCT01633944|Narcotics|narcotics|mesh-ancestor
92304782|NCT01633944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92304783|NCT01633944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304784|NCT01633944|Analgesics|analgesics|mesh-ancestor
92304785|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
92304786|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304787|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92304788|NCT04592419|Aflibercept|aflibercept|mesh-list
92304789|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92304790|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92304791|NCT04592419|Growth Substances|growth substances|mesh-ancestor
92304792|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304793|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
92304794|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304795|NCT00589316|Iodine|iodine|mesh-list
92304796|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
92304797|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
92304798|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
92304799|NCT00589316|Fludarabine|fludarabine|mesh-list
92304800|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
92304801|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92304802|NCT00589316|Tacrolimus|tacrolimus|mesh-list
92304803|NCT00589316|Antibodies|antibodies|mesh-list
92304804|NCT00589316|Immunoglobulins|immunoglobulins|mesh-list
92304805|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92304806|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304807|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
92116939|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
92304808|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304809|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304810|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304811|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
92304812|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304813|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304814|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92304815|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92304816|NCT00589316|Antimetabolites|antimetabolites|mesh-ancestor
92304817|NCT00589316|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92304818|NCT00589316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304819|NCT00589316|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92304820|NCT00589316|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92304821|NCT00589316|Antitubercular Agents|antitubercular agents|mesh-ancestor
92304822|NCT00589316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304823|NCT00589316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304824|NCT00589316|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92304825|NCT00589316|Trace Elements|trace elements|mesh-ancestor
92304826|NCT00589316|Micronutrients|micronutrients|mesh-ancestor
92304827|NCT00362245|Amikacin|amikacin|mesh-list
92304828|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92304829|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304830|NCT04786548|Celecoxib|celecoxib|mesh-list
92304831|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92304832|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304833|NCT04786548|Analgesics|analgesics|mesh-ancestor
92304834|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
92304835|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304836|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304837|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304838|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304839|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92304840|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92304841|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304842|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304843|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92304844|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92304845|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
92304846|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304847|NCT00361543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304848|NCT00361543|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92304849|NCT00361543|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92304850|NCT00361543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92304852|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304853|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
92304854|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304855|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304857|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92304858|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304859|NCT00003423|Cytarabine|cytarabine|mesh-list
92304860|NCT00003423|Dexamethasone|dexamethasone|mesh-list
92304861|NCT00003423|Prednisolone|prednisolone|mesh-list
92304862|NCT00003423|Cyclophosphamide|cyclophosphamide|mesh-list
92304863|NCT00003423|Methotrexate|methotrexate|mesh-list
92304864|NCT00003423|Etoposide|etoposide|mesh-list
92304865|NCT00003423|Vincristine|vincristine|mesh-list
92304866|NCT00003423|Daunorubicin|daunorubicin|mesh-list
92304867|NCT00003423|Asparaginase|asparaginase|mesh-list
92304868|NCT00003423|Mercaptopurine|mercaptopurine|mesh-list
92304869|NCT00003423|Thioguanine|thioguanine|mesh-list
92304870|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304872|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304873|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304874|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304875|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
92304876|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304877|NCT00003423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304878|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92304879|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304880|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
92304881|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
92304882|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304883|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92304884|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
92304885|NCT00003423|Hormones|hormones|mesh-ancestor
92304886|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92304887|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92304888|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92304889|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
92304890|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92304891|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92304892|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
92304893|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304894|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304895|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92304896|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92304897|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92304898|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92304899|NCT00003423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92304900|NCT00003423|Antiviral Agents|antiviral agents|mesh-ancestor
92304901|NCT00003423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304902|NCT00003423|Tubulin Modulators|tubulin modulators|mesh-ancestor
92304903|NCT00003423|Antimitotic Agents|antimitotic agents|mesh-ancestor
92304904|NCT00003423|Mitosis Modulators|mitosis modulators|mesh-ancestor
92304905|NCT00003423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92304906|NCT00003273|Leucovorin|leucovorin|mesh-list
92304907|NCT00003273|Cyclophosphamide|cyclophosphamide|mesh-list
92304908|NCT00003273|Temozolomide|temozolomide|mesh-list
92304909|NCT00003273|Thiotepa|thiotepa|mesh-list
92304910|NCT00003273|Carboplatin|carboplatin|mesh-list
92304911|NCT00003273|Methotrexate|methotrexate|mesh-list
92304913|NCT00003273|Vincristine|vincristine|mesh-list
92304914|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
92304915|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304916|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
92304917|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304918|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304919|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304920|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
92304921|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304922|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304923|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92304924|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92304926|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92304927|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92304928|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
92304929|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
92304930|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304931|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92304932|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92304933|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92304934|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92304935|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92304936|NCT00003273|Antidotes|antidotes|mesh-ancestor
92304937|NCT00003273|Protective Agents|protective agents|mesh-ancestor
92304938|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
92304939|NCT00003273|Vitamins|vitamins|mesh-ancestor
92304940|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
92304941|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
92304942|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
92304943|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
92304944|NCT04329585|Flumazenil|flumazenil|mesh-list
92304945|NCT04329585|Antidotes|antidotes|mesh-ancestor
92304946|NCT04329585|Protective Agents|protective agents|mesh-ancestor
92304947|NCT04329585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304948|NCT04329585|GABA Modulators|gaba modulators|mesh-ancestor
92304949|NCT04329585|GABA Agents|gaba agents|mesh-ancestor
92304950|NCT04329585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92304951|NCT04329585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304952|NCT00003279|Antibodies|antibodies|mesh-list
92304953|NCT00003279|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92304954|NCT00003279|BCG Vaccine|bcg vaccine|mesh-list
92304955|NCT00003279|Immunologic Factors|immunologic factors|mesh-ancestor
92304956|NCT00003279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304957|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92304958|NCT00383487|Calcitriol|calcitriol|mesh-list
92304959|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92304960|NCT00383487|Naproxen|naproxen|mesh-list
92304961|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92304962|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92304963|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92304964|NCT00383487|Analgesics|analgesics|mesh-ancestor
92304965|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
92304966|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92304967|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304968|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92304969|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92304970|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
92304971|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92304972|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92304973|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304974|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92304975|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92304976|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92304977|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92304978|NCT00383487|Vitamins|vitamins|mesh-ancestor
92304979|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
92304980|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92304981|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92304982|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92304983|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92304984|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304986|NCT00003435|Melphalan|melphalan|mesh-list
92304987|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92304988|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304989|NCT00003435|Alkylating Agents|alkylating agents|mesh-ancestor
92304990|NCT00003435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92304991|NCT00003435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92304992|NCT00003435|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92304993|NCT00003435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92304994|NCT00003435|Immunologic Factors|immunologic factors|mesh-ancestor
92304995|NCT00003435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92304996|NCT00003435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92304997|NCT00003441|Irofulven|irofulven|mesh-list
92304998|NCT00003441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92304999|NCT00003441|Alkylating Agents|alkylating agents|mesh-ancestor
92305000|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305001|NCT00003441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305002|NCT00002805|Cobalt|cobalt|mesh-list
92305003|NCT00002805|Cytarabine|cytarabine|mesh-list
92305004|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
92305005|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92305006|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92305007|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92305008|NCT00002805|Methotrexate|methotrexate|mesh-list
92305009|NCT00002805|Etoposide|etoposide|mesh-list
92305010|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
92305011|NCT00002805|Cladribine|cladribine|mesh-list
92305012|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92305013|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
92305014|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92305015|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305016|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305017|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
92305018|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305019|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305020|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
92305021|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305022|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92305023|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305024|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
92305025|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305026|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92305027|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305028|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305029|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305030|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
92305031|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305032|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305033|NCT00002805|Analgesics|analgesics|mesh-ancestor
92305034|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
92305035|NCT00002805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305036|NCT00002805|Trace Elements|trace elements|mesh-ancestor
92305037|NCT00002805|Micronutrients|micronutrients|mesh-ancestor
92305038|NCT00003297|Topotecan|topotecan|mesh-list
92305039|NCT00003297|Mitoxantrone|mitoxantrone|mesh-list
92305040|NCT00003297|Thiotepa|thiotepa|mesh-list
92116940|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92305041|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305042|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305043|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305044|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305045|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305046|NCT00003297|Analgesics|analgesics|mesh-ancestor
92305047|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
92305048|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305049|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305050|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305051|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305052|NCT00003297|Alkylating Agents|alkylating agents|mesh-ancestor
92305053|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305054|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305055|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
92305056|NCT00003447|Gemcitabine|gemcitabine|mesh-list
92305057|NCT00003447|Vinorelbine|vinorelbine|mesh-list
92305058|NCT00003447|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305059|NCT00003447|Antimetabolites|antimetabolites|mesh-ancestor
92305060|NCT00003447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305061|NCT00003447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305062|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305063|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305064|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305065|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305066|NCT00003315|Amphotericin B|amphotericin b|mesh-list
92305067|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92305068|NCT00003315|Sargramostim|sargramostim|mesh-list
92305069|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
92305070|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305071|NCT00003315|Amebicides|amebicides|mesh-ancestor
92305072|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92305073|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92305074|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305075|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92305076|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
92305077|NCT00002817|Sargramostim|sargramostim|mesh-list
92305078|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
92305079|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305080|NCT00003465|Temozolomide|temozolomide|mesh-list
92305081|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305082|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
92305083|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305084|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305085|NCT00002823|Etoposide|etoposide|mesh-list
92305086|NCT00002823|Vinorelbine|vinorelbine|mesh-list
92305087|NCT00002823|Vinblastine|vinblastine|mesh-list
92305088|NCT00002823|Vindesine|vindesine|mesh-list
92305089|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305090|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305091|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305092|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305093|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305094|NCT00002823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305095|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305096|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305097|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305098|NCT00361621|Prednisone|prednisone|mesh-list
92305099|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
92305100|NCT00361621|Rituximab|rituximab|mesh-list
92305101|NCT00361621|Doxorubicin|doxorubicin|mesh-list
92305102|NCT00361621|Vincristine|vincristine|mesh-list
92305103|NCT00361621|Bortezomib|bortezomib|mesh-list
92305104|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305105|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
92305106|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305107|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305108|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305109|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
92305110|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305111|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305112|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305113|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305114|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305115|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305116|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305117|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305118|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305120|NCT00361621|Hormones|hormones|mesh-ancestor
92305121|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305122|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305123|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305124|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305125|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305126|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305127|NCT00003327|Paclitaxel|paclitaxel|mesh-list
92305128|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305129|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305130|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305131|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305132|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305133|NCT00003327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305134|NCT00003339|Interleukin-12|interleukin-12|mesh-list
92305135|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
92305136|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92305137|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
92305138|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305139|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92305140|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92305141|NCT00003339|Growth Substances|growth substances|mesh-ancestor
92305142|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92305143|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305144|NCT00002829|Interferons|interferons|mesh-list
92305145|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
92305146|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
92305147|NCT00002829|Etoposide|etoposide|mesh-list
92305148|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305149|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
92305150|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305151|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305152|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305153|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
92305154|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305155|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305156|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305157|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305158|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305159|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305160|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305161|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
92305162|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305163|NCT03614221|Tacrolimus|tacrolimus|mesh-list
92305164|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305165|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
92305166|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305167|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92305168|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305169|NCT03614221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305170|NCT00003345|Irinotecan|irinotecan|mesh-list
92305171|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305172|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305173|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305174|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305175|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305176|NCT03596905|Plecanatide|plecanatide|mesh-list
92305177|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92305178|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
92305179|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305180|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92305181|NCT00002835|Leucovorin|leucovorin|mesh-list
92305182|NCT00002835|Interferons|interferons|mesh-list
92305183|NCT00002835|Cytarabine|cytarabine|mesh-list
92305184|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
92305185|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
92305186|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92305187|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92305188|NCT00002835|Prednisolone|prednisolone|mesh-list
92305189|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
92305190|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
92305191|NCT00002835|Melphalan|melphalan|mesh-list
92305192|NCT00002835|Ifosfamide|ifosfamide|mesh-list
92305193|NCT00002835|Carmustine|carmustine|mesh-list
92305194|NCT00002835|Cisplatin|cisplatin|mesh-list
92305195|NCT00002835|Methotrexate|methotrexate|mesh-list
92305196|NCT00002835|Etoposide|etoposide|mesh-list
92305197|NCT00002835|Vincristine|vincristine|mesh-list
92305198|NCT00002835|Mitoxantrone|mitoxantrone|mesh-list
92305199|NCT00002835|Idarubicin|idarubicin|mesh-list
92305200|NCT00002835|Bleomycin|bleomycin|mesh-list
92305201|NCT00002835|Levoleucovorin|levoleucovorin|mesh-list
92305202|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92305203|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
92305204|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305205|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
92305206|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305207|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305208|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305209|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
92305210|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305211|NCT00002835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305212|NCT00002835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305213|NCT00002835|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92305214|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
92305215|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92305216|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305217|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
92305218|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
92305219|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305220|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92305221|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92305222|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305223|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91957934|NCT05172115|Heparin|heparin|mesh-list
92305224|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305225|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
92305226|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305227|NCT00002835|Antidotes|antidotes|mesh-ancestor
92305228|NCT00002835|Protective Agents|protective agents|mesh-ancestor
92305229|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
92305230|NCT00002835|Vitamins|vitamins|mesh-ancestor
92305231|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
92305232|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305233|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305234|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305235|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305236|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
92305237|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
92305238|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305239|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92305240|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
92305241|NCT00002835|Hormones|hormones|mesh-ancestor
92305242|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305243|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92305244|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305245|NCT00002835|Analgesics|analgesics|mesh-ancestor
92305246|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
92305247|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305248|NCT04560673|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92305249|NCT04560673|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92305250|NCT04560673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92305251|NCT04560673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92305252|NCT04560673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305253|NCT04560673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92305254|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305255|NCT04560673|Analgesics|analgesics|mesh-ancestor
92305256|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
92305257|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305258|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
92305259|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92305260|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
92305261|NCT00003351|Irinotecan|irinotecan|mesh-list
92305262|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305263|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305264|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305265|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305266|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305267|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92305268|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92305269|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92305270|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
92305271|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305272|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92305274|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
92305275|NCT00002847|Aldesleukin|aldesleukin|mesh-list
92305276|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305277|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
92305278|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305279|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
92305280|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305281|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92305282|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92305283|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
92305284|NCT03576001|Testosterone|testosterone|mesh-list
92305285|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
92305286|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
92305287|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92305288|NCT03576001|Androgens|androgens|mesh-ancestor
92305289|NCT03576001|Hormones|hormones|mesh-ancestor
92305290|NCT03576001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305291|NCT03576001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305292|NCT03576001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305293|NCT03576001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305294|NCT03576001|Anabolic Agents|anabolic agents|mesh-ancestor
92305295|NCT04220827|Paclitaxel|paclitaxel|mesh-list
92305296|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92305297|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305298|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305299|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305300|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305301|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305302|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305303|NCT00002865|Leucovorin|leucovorin|mesh-list
92305304|NCT00002865|Cobalt|cobalt|mesh-list
92305305|NCT00002865|Cytarabine|cytarabine|mesh-list
92305306|NCT00002865|Dexamethasone|dexamethasone|mesh-list
92305307|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
92305308|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92305309|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92305310|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92305311|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
92305312|NCT00002865|Ifosfamide|ifosfamide|mesh-list
92305313|NCT00002865|Doxorubicin|doxorubicin|mesh-list
92305314|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92305315|NCT00002865|Methotrexate|methotrexate|mesh-list
92305316|NCT00002865|Etoposide|etoposide|mesh-list
92305317|NCT00002865|Vincristine|vincristine|mesh-list
92305318|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
92305319|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305320|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
92305321|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305322|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305323|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305324|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
92305325|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305326|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305327|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305328|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305329|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
92305330|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
92305331|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305332|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92305333|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
92305334|NCT00002865|Hormones|hormones|mesh-ancestor
92305335|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305336|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305337|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305338|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305339|NCT00002865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305340|NCT00002865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305341|NCT00002865|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92305342|NCT00002865|Abortifacient Agents|abortifacient agents|mesh-ancestor
92305343|NCT00002865|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92305344|NCT00002865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305345|NCT00002865|Antimetabolites|antimetabolites|mesh-ancestor
92305346|NCT00002865|Dermatologic Agents|dermatologic agents|mesh-ancestor
92305347|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92305348|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92305349|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305351|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305352|NCT00002865|Antidotes|antidotes|mesh-ancestor
92305353|NCT00002865|Protective Agents|protective agents|mesh-ancestor
92305354|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
92305355|NCT00002865|Vitamins|vitamins|mesh-ancestor
92305356|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
92305357|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305358|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305359|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305360|NCT00002865|Trace Elements|trace elements|mesh-ancestor
92305361|NCT00361309|Sunitinib|sunitinib|mesh-list
92305362|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305363|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92305364|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92305365|NCT00361309|Growth Substances|growth substances|mesh-ancestor
92305366|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305367|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
92305368|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92305369|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305370|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305371|NCT04154943|Cemiplimab|cemiplimab|mesh-list
92305372|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305373|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305374|NCT00361387|Methylphenidate|methylphenidate|mesh-list
92305375|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92305376|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305377|NCT00361387|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92305378|NCT00361387|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92305379|NCT00361387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92305380|NCT00361387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305382|NCT00361387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92305383|NCT04530487|Cyclosporine|cyclosporine|mesh-list
92305384|NCT04530487|Mycophenolic Acid|mycophenolic acid|mesh-list
92305385|NCT04530487|Fludarabine|fludarabine|mesh-list
92305386|NCT04530487|Fludarabine phosphate|fludarabine phosphate|mesh-list
92305388|NCT04530487|Etoposide phosphate|etoposide phosphate|mesh-list
92305389|NCT04530487|Melphalan|melphalan|mesh-list
92305390|NCT04530487|Mechlorethamine|mechlorethamine|mesh-list
92305391|NCT04530487|Thiotepa|thiotepa|mesh-list
92305392|NCT04530487|Podophyllotoxin|podophyllotoxin|mesh-list
92305393|NCT04530487|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92305394|NCT04530487|Tacrolimus|tacrolimus|mesh-list
92305395|NCT04530487|Cyclosporins|cyclosporins|mesh-list
92305396|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
92305397|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92305398|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
92305399|NCT04530487|Antibodies|antibodies|mesh-list
92305400|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
92305401|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92305402|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92305403|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305404|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305405|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
92305406|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305407|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305408|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
92305409|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305410|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305411|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305412|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305413|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305414|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92305415|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
92305416|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305417|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
92305418|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305419|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305420|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92305421|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
92305422|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92305423|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305424|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
92305425|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305426|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
92305427|NCT04530487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305428|NCT04530487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305429|NCT04530487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305431|NCT00003369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305432|NCT04342351|Valsartan|valsartan|mesh-list
92305433|NCT04342351|Perindopril|perindopril|mesh-list
92305434|NCT04342351|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92305435|NCT04342351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92305436|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92305437|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92305438|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305439|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92305440|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
92305441|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305442|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
92305443|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92305444|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305445|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305446|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305447|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305448|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305449|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305450|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
92305451|NCT03504241|Sirolimus|sirolimus|mesh-list
92305452|NCT03504241|Prednisone|prednisone|mesh-list
92305453|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
92305454|NCT03504241|Abatacept|abatacept|mesh-list
92305455|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305456|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
92305457|NCT03504241|Hormones|hormones|mesh-ancestor
92305458|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305459|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305460|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305462|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305463|NCT03504241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92305464|NCT03504241|Antitubercular Agents|antitubercular agents|mesh-ancestor
92305465|NCT03504241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92305466|NCT03504241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305467|NCT03504241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305468|NCT03504241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305469|NCT03504241|Antifungal Agents|antifungal agents|mesh-ancestor
92305470|NCT03504241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305471|NCT03504241|Immunologic Factors|immunologic factors|mesh-ancestor
92305472|NCT03504241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305473|NCT03504241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92305474|NCT03504241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305475|NCT00003375|Vincristine|vincristine|mesh-list
92305476|NCT00003375|Lomustine|lomustine|mesh-list
92305477|NCT00003375|Procarbazine|procarbazine|mesh-list
92305478|NCT00003375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305479|NCT00003375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305480|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305481|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305482|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305483|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305484|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305485|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
92305486|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
92305487|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92305488|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
92305489|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305490|NCT03499249|Expectorants|expectorants|mesh-ancestor
92305491|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
92305493|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
92305494|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305495|NCT03499249|Protective Agents|protective agents|mesh-ancestor
92305496|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305497|NCT03499249|Antidotes|antidotes|mesh-ancestor
92305498|NCT03498391|Ketamine|ketamine|mesh-list
92305499|NCT03498391|Propofol|propofol|mesh-list
92305500|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92305501|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92305502|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305503|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92305504|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
92305505|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
92305506|NCT03498391|Analgesics|analgesics|mesh-ancestor
92305507|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
92305508|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305509|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92305510|NCT03498391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92305511|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92305512|NCT03498391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92305513|NCT03498391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305514|NCT00003939|Trabectedin|trabectedin|mesh-list
92305515|NCT00003939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305516|NCT00003939|Alkylating Agents|alkylating agents|mesh-ancestor
92305517|NCT00003939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305518|NCT00003939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305519|NCT00003543|Fluorouracil|fluorouracil|mesh-list
92305520|NCT00003543|Vincristine|vincristine|mesh-list
92305521|NCT00003543|Carmustine|carmustine|mesh-list
92305522|NCT00003543|Streptozocin|streptozocin|mesh-list
92305523|NCT00003543|Antibodies|antibodies|mesh-list
92305524|NCT00003543|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92305525|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
92305526|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305527|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
92305528|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305529|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305530|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305531|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305532|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305533|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305534|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305535|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305536|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305537|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
92305538|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305539|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
92305540|NCT00003549|Fluorouracil|fluorouracil|mesh-list
92305541|NCT00003549|Methotrexate|methotrexate|mesh-list
92305542|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305543|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
92305544|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305545|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305546|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305547|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
92305548|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305549|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305550|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305551|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
92305552|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305553|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92305554|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
92305555|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92305556|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
92305557|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305558|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92305559|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92305560|NCT00002883|Fluorouracil|fluorouracil|mesh-list
92305561|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305562|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
92305563|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305564|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305565|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305566|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
92305567|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305568|NCT00002889|Leuprolide|leuprolide|mesh-list
92305569|NCT00002889|Goserelin|goserelin|mesh-list
92305570|NCT00002889|Flutamide|flutamide|mesh-list
92305571|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92305572|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
92305573|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92305574|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305575|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305576|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305577|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
92305578|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
92305579|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305580|NCT03492463|Nicotine|nicotine|mesh-list
92305581|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92305582|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
92305583|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305584|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305585|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92305586|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92305587|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
92305588|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92305589|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305590|NCT00003945|Topotecan|topotecan|mesh-list
92305591|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305592|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305593|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305594|NCT00003945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305595|NCT00003945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305596|NCT00003951|Exatecan|exatecan|mesh-list
92305597|NCT00003951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305598|NCT00003951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305599|NCT00003951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305600|NCT00003951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305601|NCT00003951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305603|NCT00003957|Paclitaxel|paclitaxel|mesh-list
92305604|NCT00003957|Etoposide|etoposide|mesh-list
92305605|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
92305606|NCT00003957|Melphalan|melphalan|mesh-list
91958294|NCT03370159|Thioctic Acid|thioctic acid|mesh-list
92305607|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
92305608|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305609|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305610|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305611|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305612|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305613|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305614|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305615|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
92305616|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305617|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305618|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305619|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
92305620|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305621|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305622|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305623|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305624|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305625|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
92305626|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
92305627|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305628|NCT00003957|Analgesics|analgesics|mesh-ancestor
92305629|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
92305630|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305631|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
92305633|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
92305634|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92305635|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92305636|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
92305637|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305639|NCT00003555|Amifostine|amifostine|mesh-list
92305640|NCT00003555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305641|NCT00003555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305642|NCT00003555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305643|NCT00003555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305644|NCT00003555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305645|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305646|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92305647|NCT00003555|Protective Agents|protective agents|mesh-ancestor
92305648|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305649|NCT00003963|Rituximab|rituximab|mesh-list
92305650|NCT00003963|Vinorelbine|vinorelbine|mesh-list
92305651|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305652|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305653|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
92305654|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305655|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305656|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305657|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305658|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305659|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305660|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305661|NCT00004845|Naproxen|naproxen|mesh-list
92305662|NCT00004845|Rofecoxib|rofecoxib|mesh-list
92305663|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92305664|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92305665|NCT00004845|Analgesics|analgesics|mesh-ancestor
92305666|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
92305667|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305668|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305669|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305670|NCT00004845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305671|NCT00004845|Gout Suppressants|gout suppressants|mesh-ancestor
92305672|NCT00004845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92305673|NCT00004845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305674|NCT00004845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305675|NCT00004845|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92305676|NCT00003981|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|mesh-list
92305677|NCT00003981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305678|NCT00003981|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92305679|NCT00003981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305680|NCT00003981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305681|NCT00003993|Aldesleukin|aldesleukin|mesh-list
92305682|NCT00003993|Bryostatin 1|bryostatin 1|mesh-list
92305683|NCT00003993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305684|NCT00003993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92305685|NCT00003993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92305686|NCT00003993|Antiviral Agents|antiviral agents|mesh-ancestor
92305687|NCT00003993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305688|NCT00003993|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92305689|NCT00003993|Immunologic Factors|immunologic factors|mesh-ancestor
92305690|NCT00003993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305691|NCT00004857|Fludarabine|fludarabine|mesh-list
92305692|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
92305693|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
92305694|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305695|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305696|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
92305697|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305698|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305699|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
92305700|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305701|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305703|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305704|NCT00004863|Paclitaxel|paclitaxel|mesh-list
92305705|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305706|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305707|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305708|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305709|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305710|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305711|NCT00004875|Heparin|heparin|mesh-list
92305712|NCT00004875|Enoxaparin|enoxaparin|mesh-list
92305713|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
92305714|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92305715|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92305716|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305717|NCT00003561|Interferons|interferons|mesh-list
92305718|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
92305719|NCT00003561|Sargramostim|sargramostim|mesh-list
92305720|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305721|NCT00003561|Antiviral Agents|antiviral agents|mesh-ancestor
92305722|NCT00003561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305723|NCT00003561|Immunologic Factors|immunologic factors|mesh-ancestor
92305724|NCT00003561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305725|NCT00003567|Temozolomide|temozolomide|mesh-list
92305726|NCT00003567|Carmustine|carmustine|mesh-list
92305727|NCT00003567|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92305728|NCT00003567|Sargramostim|sargramostim|mesh-list
92305729|NCT00003567|Immunologic Factors|immunologic factors|mesh-ancestor
92305730|NCT00003567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305731|NCT00003567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305732|NCT00003567|Alkylating Agents|alkylating agents|mesh-ancestor
92305733|NCT00003567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305734|NCT00003567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305735|NCT00003567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305736|NCT00003573|Cyclophosphamide|cyclophosphamide|mesh-list
92305737|NCT00003573|Cisplatin|cisplatin|mesh-list
92305738|NCT00003573|Etoposide|etoposide|mesh-list
92305739|NCT00003573|Vincristine|vincristine|mesh-list
92305740|NCT00003573|Lenograstim|lenograstim|mesh-list
92305741|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305742|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
92305743|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305744|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305745|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305746|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
92305747|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305748|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305749|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305750|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305751|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305752|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305753|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305754|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92305755|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305756|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305757|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305760|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305761|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305762|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92305763|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305764|NCT00003585|Interferons|interferons|mesh-list
92305765|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
92305766|NCT00003585|Aldesleukin|aldesleukin|mesh-list
92305767|NCT00003585|Fluorouracil|fluorouracil|mesh-list
92305768|NCT00003585|Isotretinoin|isotretinoin|mesh-list
92305769|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
92305770|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305771|NCT00003585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305772|NCT00003585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305773|NCT00003585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305774|NCT00003585|Immunologic Factors|immunologic factors|mesh-ancestor
92305775|NCT00003585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305776|NCT00003585|Antiviral Agents|antiviral agents|mesh-ancestor
92305777|NCT00003585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305778|NCT00003585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92305779|NCT00003585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92305780|NCT00003585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92305781|NCT00003591|Paclitaxel|paclitaxel|mesh-list
92305782|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305783|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305784|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305785|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305786|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305787|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305788|NCT02975323|Carvedilol|carvedilol|mesh-list
92305789|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92305790|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92305791|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
92305792|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92305793|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305794|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305795|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92305796|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
92305797|NCT02975323|Protective Agents|protective agents|mesh-ancestor
92305798|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92305799|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92305800|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92305801|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
92305802|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92305803|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92305804|NCT00003597|Carboplatin|carboplatin|mesh-list
92305805|NCT00003597|Etoposide|etoposide|mesh-list
92305806|NCT00003597|Ifosfamide|ifosfamide|mesh-list
92305807|NCT00003597|Lenograstim|lenograstim|mesh-list
92305808|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305809|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305810|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305811|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305812|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305813|NCT00003597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305814|NCT00003597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305815|NCT00003597|Alkylating Agents|alkylating agents|mesh-ancestor
92305816|NCT00003597|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92305817|NCT00003597|Immunologic Factors|immunologic factors|mesh-ancestor
92305818|NCT00003597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305819|NCT00004005|Leucovorin|leucovorin|mesh-list
92305820|NCT00004005|Fluorouracil|fluorouracil|mesh-list
92305821|NCT00004005|Irinotecan|irinotecan|mesh-list
92305822|NCT00004005|Calcium|calcium|mesh-list
92305823|NCT00004005|Levoleucovorin|levoleucovorin|mesh-list
92305824|NCT00004005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92305825|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305826|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
92305827|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305828|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305829|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305830|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305831|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
92305832|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305833|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305834|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305835|NCT00004005|Antidotes|antidotes|mesh-ancestor
92305836|NCT00004005|Protective Agents|protective agents|mesh-ancestor
92305837|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
92305838|NCT00004005|Vitamins|vitamins|mesh-ancestor
92305839|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
92305840|NCT00003603|Dexamethasone|dexamethasone|mesh-list
92305841|NCT00003603|Prednisolone|prednisolone|mesh-list
92305842|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
92305843|NCT00003603|Melphalan|melphalan|mesh-list
92305844|NCT00003603|Lomustine|lomustine|mesh-list
92305845|NCT00003603|Idarubicin|idarubicin|mesh-list
92305846|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347365|NCT01755234|Propofol|propofol|mesh-list
92305847|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
92305848|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305849|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305850|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305851|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
92305852|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305853|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305854|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305855|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305856|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
92305857|NCT00003603|Autonomic Agents|autonomic agents|mesh-ancestor
92305858|NCT00003603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305859|NCT00003603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92305860|NCT00003603|Glucocorticoids|glucocorticoids|mesh-ancestor
92305861|NCT00003603|Hormones|hormones|mesh-ancestor
92305862|NCT00003603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92305863|NCT00003603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92305864|NCT00003603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305865|NCT00003603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305866|NCT00003603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305867|NCT00003603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305869|NCT00004887|Vinblastine|vinblastine|mesh-list
92305870|NCT00004887|Carboplatin|carboplatin|mesh-list
92305871|NCT00004887|Ifosfamide|ifosfamide|mesh-list
92305872|NCT00004887|Mitomycins|mitomycins|mesh-list
92305873|NCT00004887|Mitomycin|mitomycin|mesh-list
92305874|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305875|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305876|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305877|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305878|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305879|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305880|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305881|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
92305882|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305883|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92305884|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305885|NCT00004893|Interleukin-12|interleukin-12|mesh-list
92305886|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92305887|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
92305888|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305889|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92305890|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92305891|NCT00004893|Growth Substances|growth substances|mesh-ancestor
92305892|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92305893|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305894|NCT04513951|Leucovorin|leucovorin|mesh-list
92305895|NCT04513951|Fluorouracil|fluorouracil|mesh-list
92305896|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
92305897|NCT04513951|Irinotecan|irinotecan|mesh-list
92305898|NCT04513951|Cetuximab|cetuximab|mesh-list
92305899|NCT04513951|Avelumab|avelumab|mesh-list
92305900|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
92305901|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
92305902|NCT04513951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305903|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305904|NCT04513951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305905|NCT04513951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305906|NCT04513951|Immunologic Factors|immunologic factors|mesh-ancestor
92305907|NCT04513951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958595|NCT04520503|Propofol|propofol|mesh-list
92305908|NCT04513951|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305909|NCT04513951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305910|NCT04513951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305911|NCT04513951|Antidotes|antidotes|mesh-ancestor
92305912|NCT04513951|Protective Agents|protective agents|mesh-ancestor
92305913|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
92305914|NCT04513951|Vitamins|vitamins|mesh-ancestor
92305915|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
92305916|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305917|NCT00004011|Paclitaxel|paclitaxel|mesh-list
92305918|NCT00004011|Carboplatin|carboplatin|mesh-list
92305919|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305920|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305921|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
92305922|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
92305923|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
92305924|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305925|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
92305926|NCT03448393|Fludarabine|fludarabine|mesh-list
92305927|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305928|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
92305929|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305930|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305931|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305932|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
92305933|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305934|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305935|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305936|NCT00004017|Antibodies|antibodies|mesh-list
92305937|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92305938|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
92305939|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305940|NCT00004905|Interferons|interferons|mesh-list
92305941|NCT00004905|Cytarabine|cytarabine|mesh-list
92305942|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
92305943|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
92305944|NCT00004905|Etoposide|etoposide|mesh-list
92305945|NCT00004905|Idarubicin|idarubicin|mesh-list
92305946|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305947|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
92305948|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305949|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305950|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92305951|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
92305952|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305953|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305954|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92305955|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92305956|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92305957|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305958|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305959|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
92305960|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92305961|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92305962|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
92305963|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92305965|NCT00004029|Vaccines|vaccines|mesh-list
92305966|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
92305967|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305968|NCT00362323|Metformin|metformin|mesh-list
92305969|NCT00362323|Fenofibrate|fenofibrate|mesh-list
92305970|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92305971|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305972|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92305973|NCT00362323|Antimetabolites|antimetabolites|mesh-ancestor
92305974|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305975|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92305976|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
92305977|NCT00004917|Hematinics|hematinics|mesh-ancestor
92305978|NCT00421915|Etanercept|etanercept|mesh-list
92305979|NCT00421915|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92305980|NCT00421915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92305981|NCT00421915|Analgesics|analgesics|mesh-ancestor
92305982|NCT00421915|Sensory System Agents|sensory system agents|mesh-ancestor
92305983|NCT00421915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92305984|NCT00421915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92305985|NCT00421915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92305986|NCT00421915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92305987|NCT00421915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92305988|NCT00421915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92305989|NCT00421915|Immunologic Factors|immunologic factors|mesh-ancestor
92305990|NCT00362713|Ipilimumab|ipilimumab|mesh-list
92305991|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92305992|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92305993|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92305994|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92305995|NCT00004047|Exatecan|exatecan|mesh-list
92305996|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92305997|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92305998|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92305999|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306000|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306001|NCT00003627|Fluorouracil|fluorouracil|mesh-list
92306002|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306003|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
92306004|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306005|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306006|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306007|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
92306008|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306009|NCT00004059|Fluorouracil|fluorouracil|mesh-list
92306010|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92306011|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
92306012|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306013|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306014|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306015|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306016|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
92306017|NCT00004059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306018|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92306019|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306020|NCT00003633|Prednisone|prednisone|mesh-list
92306021|NCT00003633|Docetaxel|docetaxel|mesh-list
92306022|NCT00003633|Mitoxantrone|mitoxantrone|mesh-list
92306023|NCT00003633|Estramustine|estramustine|mesh-list
92306024|NCT00003633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306025|NCT00003633|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306026|NCT00003633|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306027|NCT00003633|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306028|NCT00003633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306029|NCT00003633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306030|NCT00003633|Glucocorticoids|glucocorticoids|mesh-ancestor
92306031|NCT00003633|Hormones|hormones|mesh-ancestor
92306032|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306033|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306034|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306035|NCT00003633|Analgesics|analgesics|mesh-ancestor
92306036|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
92306037|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306038|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306039|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306040|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306041|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306042|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
92306043|NCT00003639|Interferons|interferons|mesh-list
92306044|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
92306045|NCT00003639|Dexamethasone|dexamethasone|mesh-list
92306046|NCT00003639|Idarubicin|idarubicin|mesh-list
92306047|NCT00003639|Chlorambucil|chlorambucil|mesh-list
92306048|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306049|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
92306050|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
92306051|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306052|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306053|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306054|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
92306055|NCT00003639|Hormones|hormones|mesh-ancestor
92306056|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306057|NCT00003639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306058|NCT00003639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306059|NCT00003639|Antiviral Agents|antiviral agents|mesh-ancestor
92306060|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306061|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
92306062|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306063|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306064|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306065|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306066|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306067|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306068|NCT00003639|Alkylating Agents|alkylating agents|mesh-ancestor
92306069|NCT00004923|Docetaxel|docetaxel|mesh-list
92306070|NCT00004923|Irinotecan|irinotecan|mesh-list
92306071|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306072|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306073|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306074|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306075|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306076|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306077|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306078|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306079|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
92306080|NCT02317783|Flutemetamol|flutemetamol|mesh-list
92306081|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
92306082|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306083|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
92306084|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306085|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92306086|NCT00004071|Prednisone|prednisone|mesh-list
92306087|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
92306088|NCT00004071|Leflunomide|leflunomide|mesh-list
92306089|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306090|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
92306091|NCT00004071|Hormones|hormones|mesh-ancestor
92306092|NCT00004071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306093|NCT00004071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306094|NCT00004071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306095|NCT00004071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306097|NCT00004071|Sensory System Agents|sensory system agents|mesh-ancestor
92306098|NCT00004071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306099|NCT00004071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306100|NCT00004071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306101|NCT00004071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306102|NCT00004071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306103|NCT00004071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306104|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
92306105|NCT00004077|Paclitaxel|paclitaxel|mesh-list
92306106|NCT00004077|Ifosfamide|ifosfamide|mesh-list
92306107|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306108|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306109|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306110|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306111|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306112|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306113|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306114|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
92306115|NCT00004083|Cisplatin|cisplatin|mesh-list
92306116|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306117|NCT00004941|Infliximab|infliximab|mesh-list
92306118|NCT00004941|Antibodies|antibodies|mesh-list
92306119|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92306120|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
92306121|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306122|NCT00004941|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92306123|NCT00004941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306124|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
92306125|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306126|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306127|NCT00003657|Carboplatin|carboplatin|mesh-list
92306128|NCT00003657|Etoposide|etoposide|mesh-list
92306129|NCT00003657|Ifosfamide|ifosfamide|mesh-list
92306130|NCT00003657|Amifostine|amifostine|mesh-list
92306131|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306132|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306133|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306134|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306135|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306136|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306137|NCT00003657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306138|NCT00003657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306139|NCT00003657|Alkylating Agents|alkylating agents|mesh-ancestor
92306140|NCT00003657|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92306141|NCT00003657|Protective Agents|protective agents|mesh-ancestor
92306142|NCT00004089|Paclitaxel|paclitaxel|mesh-list
92306143|NCT00004089|Fluorouracil|fluorouracil|mesh-list
92306144|NCT00004089|Hydroxyurea|hydroxyurea|mesh-list
92306145|NCT00004089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306146|NCT00004089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306147|NCT00004089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306148|NCT00004089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306149|NCT00004089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306150|NCT00004089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306151|NCT00004089|Antimetabolites|antimetabolites|mesh-ancestor
92306152|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306153|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306154|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
92306155|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306156|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
92306157|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306158|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306159|NCT00004095|Gemcitabine|gemcitabine|mesh-list
92306160|NCT00004095|Irinotecan|irinotecan|mesh-list
92306161|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306162|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
92306163|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306164|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306165|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306166|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306167|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306168|NCT00003663|Dexamethasone|dexamethasone|mesh-list
92306169|NCT00003663|Rituximab|rituximab|mesh-list
92306170|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306171|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306172|NCT00003663|Immunologic Factors|immunologic factors|mesh-ancestor
92306173|NCT00003663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306174|NCT00003663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306175|NCT00003663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306176|NCT00003663|Antiemetics|antiemetics|mesh-ancestor
92306177|NCT00003663|Autonomic Agents|autonomic agents|mesh-ancestor
92306178|NCT00003663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306179|NCT00003663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306180|NCT00003663|Glucocorticoids|glucocorticoids|mesh-ancestor
92306181|NCT00003663|Hormones|hormones|mesh-ancestor
92306182|NCT00003663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306183|NCT00003663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306184|NCT00004107|Epratuzumab|epratuzumab|mesh-list
92306185|NCT00004107|Antibodies|antibodies|mesh-list
92306186|NCT00004107|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92306187|NCT00004107|Immunologic Factors|immunologic factors|mesh-ancestor
92306188|NCT00004107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306189|NCT00004107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306190|NCT00004107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306191|NCT00004113|Temozolomide|temozolomide|mesh-list
92306192|NCT00004113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306193|NCT00004113|Alkylating Agents|alkylating agents|mesh-ancestor
92306194|NCT00004113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306195|NCT00004113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306196|NCT00003675|Topotecan|topotecan|mesh-list
92306197|NCT00003675|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306198|NCT00003675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306199|NCT00003675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306200|NCT00003675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306201|NCT00003675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306202|NCT00004137|Paclitaxel|paclitaxel|mesh-list
92306203|NCT00004137|Carboplatin|carboplatin|mesh-list
92306204|NCT00004137|Topotecan|topotecan|mesh-list
92306205|NCT00004137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306206|NCT00004137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306207|NCT00004137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306208|NCT00004137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306209|NCT00004137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306210|NCT00004137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306211|NCT00004137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306212|NCT00004137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306213|NCT00004137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306214|NCT00003681|Epoetin Alfa|epoetin alfa|mesh-list
92306215|NCT00003681|Amifostine|amifostine|mesh-list
92306216|NCT00003681|Hematinics|hematinics|mesh-ancestor
92306217|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92306218|NCT00003681|Protective Agents|protective agents|mesh-ancestor
92306219|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306220|NCT00005007|Etanercept|etanercept|mesh-list
92306221|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92306222|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92306223|NCT00005007|Analgesics|analgesics|mesh-ancestor
92306224|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
92306225|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306226|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306227|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306228|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306229|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306230|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306231|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
92306232|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
92306233|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92306234|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92306235|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306236|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
92306237|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306238|NCT00384579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306239|NCT00004149|Arsenic Trioxide|arsenic trioxide|mesh-list
92306240|NCT00004149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306241|NCT00384657|Iron|iron|mesh-list
92306242|NCT00384657|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92306244|NCT00384657|Micronutrients|micronutrients|mesh-ancestor
92306245|NCT00384657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306246|NCT00384657|Hematinics|hematinics|mesh-ancestor
92306247|NCT00005013|Sertraline|sertraline|mesh-list
92306248|NCT00005013|Antidepressive Agents|antidepressive agents|mesh-ancestor
92306249|NCT00005013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92306250|NCT00005013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92306251|NCT00005013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92306252|NCT00005013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92306253|NCT00005013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306254|NCT00005013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306255|NCT00005013|Serotonin Agents|serotonin agents|mesh-ancestor
92306256|NCT00005013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306257|NCT00004161|Fenretinide|fenretinide|mesh-list
92306258|NCT00004161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306259|NCT00004161|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92306260|NCT00004161|Protective Agents|protective agents|mesh-ancestor
92306261|NCT00004161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306262|NCT00004173|Paclitaxel|paclitaxel|mesh-list
92306263|NCT00004173|Oxaliplatin|oxaliplatin|mesh-list
92306264|NCT00004173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306265|NCT00004173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306266|NCT00004173|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306267|NCT00004173|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306268|NCT00004173|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306269|NCT00004173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306270|NCT00005025|Ganciclovir|ganciclovir|mesh-list
92306271|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92306272|NCT00005025|Antiviral Agents|antiviral agents|mesh-ancestor
92306273|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306274|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306275|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306276|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306277|NCT00004179|Prednisone|prednisone|mesh-list
92306278|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
92306279|NCT00004179|Rituximab|rituximab|mesh-list
92306280|NCT00004179|Doxorubicin|doxorubicin|mesh-list
92306281|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92306282|NCT00004179|Vincristine|vincristine|mesh-list
92306283|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306284|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
92306285|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306286|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306287|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306288|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
92306289|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306290|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306291|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306292|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306293|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306294|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306295|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306297|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306298|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
92306299|NCT00004179|Hormones|hormones|mesh-ancestor
92306300|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306301|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306302|NCT00004179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306303|NCT00004179|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306304|NCT00004179|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306305|NCT00004179|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306306|NCT00003687|Morphine|morphine|mesh-list
92306307|NCT00003687|Dextromethorphan|dextromethorphan|mesh-list
92306308|NCT00003687|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92306309|NCT00003687|Narcotics|narcotics|mesh-ancestor
92306310|NCT00003687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92306311|NCT00003687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306312|NCT00003687|Analgesics|analgesics|mesh-ancestor
92306313|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
92306314|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306315|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
92306316|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
92306317|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92306318|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92306319|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306320|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306321|NCT00004197|Prednisone|prednisone|mesh-list
92306322|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
92306323|NCT00004197|Doxorubicin|doxorubicin|mesh-list
92306324|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92306325|NCT00004197|Vincristine|vincristine|mesh-list
92306326|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
92306327|NCT00004197|Sargramostim|sargramostim|mesh-list
92306328|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92306330|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306331|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
92306332|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306333|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306334|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306335|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
92347409|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92306336|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306337|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306338|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306339|NCT00004197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306340|NCT00004197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306341|NCT00004197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306342|NCT00004197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306343|NCT00004197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306344|NCT00004197|Glucocorticoids|glucocorticoids|mesh-ancestor
92306346|NCT00004197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306347|NCT00004197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306348|NCT00004197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306349|NCT00004197|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306350|NCT00004197|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306351|NCT00004197|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306352|NCT00004197|Analgesics|analgesics|mesh-ancestor
92306353|NCT00004197|Sensory System Agents|sensory system agents|mesh-ancestor
92306354|NCT00004197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306355|NCT00004197|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92306356|NCT00003693|Dolastatin 10|dolastatin 10|mesh-list
92306357|NCT00003693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306358|NCT00003693|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306359|NCT00003693|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306360|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306361|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306362|NCT00005031|Irofulven|irofulven|mesh-list
92306363|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306364|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
92306365|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306366|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306367|NCT00005037|Temozolomide|temozolomide|mesh-list
91959045|NCT03349177|Docetaxel|docetaxel|mesh-list
92306368|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306369|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
92306370|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306371|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306372|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
92306373|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306374|NCT00004209|Mitomycins|mitomycins|mesh-list
92306375|NCT00004209|Mitomycin|mitomycin|mesh-list
92306376|NCT00004209|Vinblastine|vinblastine|mesh-list
92306377|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306378|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306379|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
92306380|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306381|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306382|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306383|NCT00004209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306384|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306385|NCT00004209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306386|NCT00004209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306387|NCT00005049|Carboplatin|carboplatin|mesh-list
92306388|NCT00005049|Floxuridine|floxuridine|mesh-list
92306389|NCT00005049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306390|NCT00005049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306391|NCT00005049|Antimetabolites|antimetabolites|mesh-ancestor
92306392|NCT00005049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306393|NCT00004215|Cytarabine|cytarabine|mesh-list
92306394|NCT00004215|Daunorubicin|daunorubicin|mesh-list
92306395|NCT00004215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306396|NCT00004215|Antimetabolites|antimetabolites|mesh-ancestor
92306397|NCT00004215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306398|NCT00004215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306399|NCT00004215|Antiviral Agents|antiviral agents|mesh-ancestor
92306400|NCT00004215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306401|NCT00004215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306402|NCT00004215|Immunologic Factors|immunologic factors|mesh-ancestor
92306403|NCT00004215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306404|NCT00004215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306405|NCT00004215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306407|NCT00004215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306408|NCT00004221|Paclitaxel|paclitaxel|mesh-list
92306409|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
92306410|NCT00004221|Carboplatin|carboplatin|mesh-list
92306411|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92306412|NCT00004221|Topotecan|topotecan|mesh-list
92306413|NCT00004221|Lenograstim|lenograstim|mesh-list
92306414|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306415|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306416|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306417|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306418|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306419|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306420|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306421|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
92306422|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306423|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306424|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306425|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
92306426|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306427|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92306428|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306429|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306430|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306431|NCT00003711|Irinotecan|irinotecan|mesh-list
92306432|NCT00003711|Pemetrexed|pemetrexed|mesh-list
92306433|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306434|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306435|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306436|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306437|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306438|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92306439|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306440|NCT00004227|Cetuximab|cetuximab|mesh-list
92306441|NCT00004227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306442|NCT00004227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306443|NCT00003621|Etoposide|etoposide|mesh-list
92306444|NCT00003621|Carmustine|carmustine|mesh-list
92306445|NCT00003621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306446|NCT00003621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306447|NCT00003621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306448|NCT00003621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306449|NCT00003621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306450|NCT00003621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306451|NCT00003621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306452|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
92306453|NCT00385359|Albuterol|albuterol|mesh-list
92306454|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92306455|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
92306456|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306457|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306458|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92306459|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
92306460|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
92306461|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92306462|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92306463|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92306464|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92306465|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
92306466|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306467|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306470|NCT00004233|Calcium|calcium|mesh-list
92306471|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
92306472|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92306473|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306474|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
92306475|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347418|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306476|NCT00004233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306477|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306478|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306479|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
92306480|NCT00004233|Antidotes|antidotes|mesh-ancestor
92306481|NCT00004233|Protective Agents|protective agents|mesh-ancestor
92306482|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
92306483|NCT00004233|Vitamins|vitamins|mesh-ancestor
92306484|NCT00004233|Micronutrients|micronutrients|mesh-ancestor
92306485|NCT00003717|Paclitaxel|paclitaxel|mesh-list
92306486|NCT00003717|Estramustine|estramustine|mesh-list
92306487|NCT00003717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306488|NCT00003717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306489|NCT00003717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306490|NCT00003717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306491|NCT00003717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306492|NCT00003717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306493|NCT00003717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306494|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
92306495|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306496|NCT00003723|Gemcitabine|gemcitabine|mesh-list
92306497|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306498|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
92306499|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306500|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306501|NCT00005061|Bevacizumab|bevacizumab|mesh-list
92306502|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306503|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306504|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92306505|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92306506|NCT00005061|Growth Substances|growth substances|mesh-ancestor
92306507|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306508|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
92306509|NCT00004245|Salicylates|salicylates|mesh-list
92306510|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
92306511|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92306512|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92306513|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92306514|NCT00004245|Analgesics|analgesics|mesh-ancestor
92306515|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
92306516|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306517|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959196|NCT04373733|Favipiravir|favipiravir|mesh-list
92306518|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306519|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306520|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92306521|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306522|NCT00004245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306523|NCT00004251|Letrozole|letrozole|mesh-list
92306524|NCT00004251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306525|NCT00004251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92306526|NCT00004251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92306527|NCT00004251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306528|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306529|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92306530|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
92306531|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936345|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306532|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306533|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
92306534|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92306535|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92306536|NCT00003729|Cytarabine|cytarabine|mesh-list
92306537|NCT00003729|Fludarabine|fludarabine|mesh-list
92306538|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
92306539|NCT00003729|Idarubicin|idarubicin|mesh-list
92306540|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306541|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306542|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
92306543|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306544|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306545|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
92306546|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306547|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
92306548|NCT00003729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306549|NCT00003729|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306550|NCT00003729|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306551|NCT00003729|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306552|NCT00003729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306553|NCT00004263|Cytarabine|cytarabine|mesh-list
92306554|NCT00004263|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92306555|NCT00004263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306556|NCT00004263|Antimetabolites|antimetabolites|mesh-ancestor
92306557|NCT00004263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306558|NCT00004263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306559|NCT00004263|Antiviral Agents|antiviral agents|mesh-ancestor
92306560|NCT00004263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306561|NCT00004263|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306562|NCT00004263|Immunologic Factors|immunologic factors|mesh-ancestor
92306563|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306564|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92306565|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306566|NCT00003735|Topotecan|topotecan|mesh-list
92306567|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
92306568|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306569|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306570|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306571|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306572|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306573|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306574|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
92306575|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92306576|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306577|NCT00004275|Hormones|hormones|mesh-list
92306578|NCT00004275|Oxandrolone|oxandrolone|mesh-list
92306579|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306580|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306581|NCT00004275|Androgens|androgens|mesh-ancestor
92306582|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
92306583|NCT00003741|Antibodies|antibodies|mesh-list
92306584|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92306585|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
92306586|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306587|NCT00003747|Carboplatin|carboplatin|mesh-list
92306588|NCT00003747|Temozolomide|temozolomide|mesh-list
92306589|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306590|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306591|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
92306592|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306593|NCT00004311|Leuprolide|leuprolide|mesh-list
92306594|NCT00004311|Spironolactone|spironolactone|mesh-list
92306595|NCT00004311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92306596|NCT00004311|Fertility Agents|fertility agents|mesh-ancestor
92306597|NCT00004311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92306598|NCT00004311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306599|NCT00004311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306600|NCT00004311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306601|NCT00004311|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92306602|NCT00004311|Hormone Antagonists|hormone antagonists|mesh-ancestor
92306603|NCT00004311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306604|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92306605|NCT00004311|Diuretics|diuretics|mesh-ancestor
92306606|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
92306607|NCT00004317|Leucovorin|leucovorin|mesh-list
92306608|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
92306609|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
92306610|NCT00004317|Spiramycin|spiramycin|mesh-list
92306611|NCT00004317|Calcium|calcium|mesh-list
92306612|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
92306613|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92306614|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306615|NCT00004317|Antidotes|antidotes|mesh-ancestor
92306616|NCT00004317|Protective Agents|protective agents|mesh-ancestor
92306617|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
92306619|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
92306620|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
92306621|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92306622|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92306623|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306624|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92306625|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306626|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306627|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92306628|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
92306629|NCT00005091|Exatecan|exatecan|mesh-list
92306630|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306631|NCT00005091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306632|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306633|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306634|NCT00005091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306635|NCT00004323|Cyclosporine|cyclosporine|mesh-list
92306636|NCT00004323|Methylprednisolone|methylprednisolone|mesh-list
92306637|NCT00004323|Cyclophosphamide|cyclophosphamide|mesh-list
92306638|NCT00004323|Methotrexate|methotrexate|mesh-list
92306639|NCT00004323|Cyclosporins|cyclosporins|mesh-list
92306640|NCT00004323|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92306641|NCT00004323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306642|NCT00004323|Immunologic Factors|immunologic factors|mesh-ancestor
92306643|NCT00004323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306644|NCT00004323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306645|NCT00004323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306646|NCT00004323|Alkylating Agents|alkylating agents|mesh-ancestor
92306647|NCT00004323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306648|NCT00004323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306649|NCT00004323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306650|NCT00004323|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92306651|NCT00004323|Abortifacient Agents|abortifacient agents|mesh-ancestor
92306652|NCT00004323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92306653|NCT00004323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306654|NCT00004323|Antimetabolites|antimetabolites|mesh-ancestor
92306655|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
92306656|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306657|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92306658|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306659|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
92306660|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306661|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92306662|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306663|NCT00004323|Antiemetics|antiemetics|mesh-ancestor
92306664|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
92306665|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306666|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306667|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
92306668|NCT00004323|Hormones|hormones|mesh-ancestor
92306669|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306670|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92306671|NCT00004323|Protective Agents|protective agents|mesh-ancestor
92306672|NCT00003753|Dexamethasone|dexamethasone|mesh-list
92306673|NCT00003753|Irinotecan|irinotecan|mesh-list
92306674|NCT00003753|Floxuridine|floxuridine|mesh-list
92306675|NCT00003753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306676|NCT00003753|Antiemetics|antiemetics|mesh-ancestor
92306677|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
92306678|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306679|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306680|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306681|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
92306682|NCT00003753|Hormones|hormones|mesh-ancestor
92306683|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306684|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306685|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306686|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306687|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92347434|NCT01706328|Fluticasone|fluticasone|mesh-list
92306688|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306689|NCT00003753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306690|NCT00003753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306691|NCT00003753|Antimetabolites|antimetabolites|mesh-ancestor
92306693|NCT00003759|BCG Vaccine|bcg vaccine|mesh-list
92306694|NCT00003759|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92306695|NCT00003759|Immunologic Factors|immunologic factors|mesh-ancestor
92306696|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306697|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306698|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306699|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306700|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306701|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306702|NCT00003765|Carmustine|carmustine|mesh-list
92306703|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92306704|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306705|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
92410277|NCT05328908|Relatlimab|relatlimab|mesh-list
92306706|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306707|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306708|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306709|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92306710|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92306711|NCT00003771|Norethindrone|norethindrone|mesh-list
92306712|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
92306713|NCT00003771|Estradiol|estradiol|mesh-list
92306714|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92306715|NCT00003771|Estrogens|estrogens|mesh-ancestor
92306716|NCT00003771|Hormones|hormones|mesh-ancestor
92306717|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306718|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306719|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92306720|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
92306721|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92306722|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92306723|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92306724|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92306725|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92306726|NCT00004359|Methoxsalen|methoxsalen|mesh-list
92306727|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92306728|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92306729|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
92306730|NCT00004401|Antibodies|antibodies|mesh-list
92306731|NCT00004401|gamma-Globulins|gamma-globulins|mesh-list
92306732|NCT00004401|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92306733|NCT00004401|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92306734|NCT00004401|Immunologic Factors|immunologic factors|mesh-ancestor
92306735|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306736|NCT00003783|Leucovorin|leucovorin|mesh-list
92306737|NCT00003783|Cytarabine|cytarabine|mesh-list
92306738|NCT00003783|Dexamethasone|dexamethasone|mesh-list
92306739|NCT00003783|Prednisone|prednisone|mesh-list
92306740|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
92306741|NCT00003783|Methotrexate|methotrexate|mesh-list
92306742|NCT00003783|Etoposide|etoposide|mesh-list
92306743|NCT00003783|Vincristine|vincristine|mesh-list
92306744|NCT00003783|Daunorubicin|daunorubicin|mesh-list
92306745|NCT00003783|Asparaginase|asparaginase|mesh-list
92306746|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
92306747|NCT00003783|Idarubicin|idarubicin|mesh-list
92306748|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
92306749|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306750|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
92306751|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306752|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306753|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306754|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
92306755|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306756|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306757|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306758|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92306761|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306762|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92306763|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
92306764|NCT00003783|Hormones|hormones|mesh-ancestor
92306765|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306766|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92306767|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92306768|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
92306769|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92306770|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306771|NCT00003783|Antimetabolites|antimetabolites|mesh-ancestor
92306772|NCT00003783|Dermatologic Agents|dermatologic agents|mesh-ancestor
92306773|NCT00003783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306774|NCT00003783|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92306775|NCT00003783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306776|NCT00003783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92306777|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92306778|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306779|NCT00003783|Antiviral Agents|antiviral agents|mesh-ancestor
92306780|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306781|NCT00003783|Antidotes|antidotes|mesh-ancestor
92306782|NCT00003783|Protective Agents|protective agents|mesh-ancestor
92306783|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
92306784|NCT00003783|Vitamins|vitamins|mesh-ancestor
92306785|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
92306786|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306787|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306788|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306789|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306790|NCT00003789|Melphalan|melphalan|mesh-list
92306791|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306792|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
92306793|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306794|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306795|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92306796|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306797|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
92306798|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306799|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
92306800|NCT00004407|Antibodies|antibodies|mesh-list
92306801|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
92306802|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92306803|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92306804|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
92306805|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306806|NCT00004419|Mitogens|mitogens|mesh-list
92306807|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
92306808|NCT00004419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306809|NCT00004431|Baclofen|baclofen|mesh-list
92306810|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92306811|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306812|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92306813|NCT00004431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306814|NCT00004431|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92306815|NCT00004431|GABA Agonists|gaba agonists|mesh-ancestor
92306816|NCT00004431|GABA Agents|gaba agents|mesh-ancestor
92306817|NCT00004431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306818|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306819|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
92306820|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92306821|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
92306822|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306823|NCT00384969|Sorafenib|sorafenib|mesh-list
92306824|NCT00384969|Everolimus|everolimus|mesh-list
92306825|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306826|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92306827|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306828|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306830|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306831|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
92306832|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306834|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
92306835|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92306836|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92306837|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
92306838|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
92306839|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306840|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306841|NCT00385437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306842|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92306843|NCT00385437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92306844|NCT00385437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92306845|NCT00385437|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92306846|NCT00385437|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92306847|NCT00385437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92306848|NCT00385437|Adrenergic Agents|adrenergic agents|mesh-ancestor
92306849|NCT00385437|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92306850|NCT00385437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92306851|NCT00385437|Serotonin Agents|serotonin agents|mesh-ancestor
92306852|NCT00385437|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92306853|NCT00004467|Acetylcysteine|acetylcysteine|mesh-list
92306854|NCT00004467|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92306855|NCT00004467|Antiviral Agents|antiviral agents|mesh-ancestor
92306856|NCT00004467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306857|NCT00004467|Expectorants|expectorants|mesh-ancestor
92306858|NCT00004467|Respiratory System Agents|respiratory system agents|mesh-ancestor
92306859|NCT00004467|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92306860|NCT00004467|Antioxidants|antioxidants|mesh-ancestor
92306861|NCT00004467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306862|NCT00004467|Protective Agents|protective agents|mesh-ancestor
92306863|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306864|NCT00004467|Antidotes|antidotes|mesh-ancestor
92306865|NCT00004479|Midodrine|midodrine|mesh-list
92306866|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
92306867|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
92306868|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306869|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306870|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92306871|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92306872|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92306873|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92306874|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
92306875|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306876|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306877|NCT00004485|Cyclosporine|cyclosporine|mesh-list
92306878|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
92306879|NCT00004485|Fludarabine|fludarabine|mesh-list
92306880|NCT00004485|Cyclosporins|cyclosporins|mesh-list
92306881|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306882|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306883|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92306884|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
92306885|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306886|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306887|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
92306888|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306889|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
92306890|NCT00004485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306891|NCT00004485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92306892|NCT00004485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92306893|NCT00004485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92306894|NCT00004485|Antitubercular Agents|antitubercular agents|mesh-ancestor
92306895|NCT00004485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92306896|NCT00385125|Rituximab|rituximab|mesh-list
92306898|NCT00385125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306899|NCT00385125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306900|NCT00385125|Immunologic Factors|immunologic factors|mesh-ancestor
92306901|NCT00385125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306902|NCT00385125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306903|NCT00385125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92306904|NCT00385125|Alkylating Agents|alkylating agents|mesh-ancestor
92306905|NCT00385125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306906|NCT00003819|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92306907|NCT00003819|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92306908|NCT00003819|Immunologic Factors|immunologic factors|mesh-ancestor
92306909|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306910|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
92306911|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
92306913|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92306914|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
92306915|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92306916|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306917|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92306918|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92306919|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
92306920|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306921|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306922|NCT02678312|Enalapril|enalapril|mesh-list
92306923|NCT02678312|Enalaprilat|enalaprilat|mesh-list
91932846|NCT03522181|Insulin|insulin|mesh-list
92306924|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92306925|NCT02678312|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92306926|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
92306927|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306928|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306929|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92306930|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92306931|NCT00003843|Irinotecan|irinotecan|mesh-list
92306932|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92306933|NCT00003843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92306934|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306935|NCT00003843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306936|NCT00003843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306937|NCT00003849|Rituximab|rituximab|mesh-list
92306938|NCT00003849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92306939|NCT00003849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306940|NCT00003849|Immunologic Factors|immunologic factors|mesh-ancestor
92306941|NCT00003849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306942|NCT00003849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92306943|NCT00004575|Miconazole|miconazole|mesh-list
92306944|NCT00004575|Bradykinin|bradykinin|mesh-list
92306945|NCT00004575|Kininogens|kininogens|mesh-list
92306946|NCT00004575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306947|NCT00004575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306948|NCT00004575|Antifungal Agents|antifungal agents|mesh-ancestor
92306949|NCT00004575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306950|NCT00004575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92306951|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92306952|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92306953|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
92306954|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92306955|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306956|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92306957|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92306958|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
92306959|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92306960|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
92306961|NCT00004581|Ritonavir|ritonavir|mesh-list
92306962|NCT00004581|Lopinavir|lopinavir|mesh-list
92306963|NCT00004581|Nevirapine|nevirapine|mesh-list
92306964|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92306965|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92306966|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92306967|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92306968|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306969|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92306970|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92306971|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
91959644|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92306972|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92306973|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92306974|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92306975|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92306976|NCT00004581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92306977|NCT00004581|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92306978|NCT00004581|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92306980|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
92306981|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
92306982|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306983|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92306984|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306985|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932854|NCT02373033|Micronutrients|micronutrients|mesh-ancestor
92306986|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
92306987|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92306988|NCT00004647|Mexiletine|mexiletine|mesh-list
92306989|NCT00004647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92306990|NCT00004647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92306991|NCT00004647|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92306992|NCT00004647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92306993|NCT00004647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92306994|NCT02469116|Carboplatin|carboplatin|mesh-list
92306995|NCT02469116|Docetaxel|docetaxel|mesh-list
92306996|NCT02469116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92306997|NCT02469116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92306998|NCT02469116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92306999|NCT02469116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92307000|NCT02469116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307001|NCT00362960|Losartan|losartan|mesh-list
92307002|NCT00362960|Olmesartan|olmesartan|mesh-list
92307003|NCT00362960|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92307004|NCT00362960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92307005|NCT00362960|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92307006|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92307007|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92307008|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307009|NCT00003867|Capecitabine|capecitabine|mesh-list
92307010|NCT00003867|Irinotecan|irinotecan|mesh-list
92307011|NCT00003867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307012|NCT00003867|Antimetabolites|antimetabolites|mesh-ancestor
92307013|NCT00003867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307014|NCT00003867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307015|NCT00003867|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92307016|NCT00003867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307017|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307018|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92307019|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92307020|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
92307021|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307022|NCT00363584|Capecitabine|capecitabine|mesh-list
92307023|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307024|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
92307025|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307026|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307027|NCT00003873|Fluorouracil|fluorouracil|mesh-list
92307028|NCT00003873|Eniluracil|eniluracil|mesh-list
92307029|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
92307030|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307031|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307032|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307033|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307034|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
92307035|NCT00003873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307036|NCT00003873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307037|NCT00363116|Daclizumab|daclizumab|mesh-list
92307038|NCT00363116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307039|NCT00363116|Immunologic Factors|immunologic factors|mesh-ancestor
92307040|NCT00363116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307041|NCT00004689|Clarithromycin|clarithromycin|mesh-list
92307042|NCT00004689|Rifampin|rifampin|mesh-list
92307043|NCT00004689|Ethambutol|ethambutol|mesh-list
92307044|NCT00004689|Streptomycin|streptomycin|mesh-list
92307045|NCT00004689|Thioacetazone|thioacetazone|mesh-list
92307046|NCT00004689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92307047|NCT00004689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307048|NCT00004689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92307049|NCT00004689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307050|NCT00004689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307051|NCT00004689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92307052|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92307053|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92307054|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
92307055|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
92307056|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92307057|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92307058|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92307059|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92307060|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92307061|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92307062|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92307063|NCT00004695|Interleukin-2|interleukin-2|mesh-list
92307064|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307065|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92307066|NCT00004695|Analgesics|analgesics|mesh-ancestor
92307067|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
92307068|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307069|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307070|NCT02570984|Omalizumab|omalizumab|mesh-list
92307071|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92307072|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92307073|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
92307074|NCT00004731|Ubiquinone|ubiquinone|mesh-list
92307075|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
92307076|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
92307077|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307078|NCT00004731|Vitamins|vitamins|mesh-ancestor
92307079|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
92307080|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307081|NCT00003891|Lurtotecan|lurtotecan|mesh-list
92307082|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307083|NCT02472314|Bupivacaine|bupivacaine|mesh-list
92307084|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
92307085|NCT02472314|Anesthetics|anesthetics|mesh-ancestor
92307086|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307087|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307088|NCT02472314|Sensory System Agents|sensory system agents|mesh-ancestor
92307089|NCT02472314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307090|NCT00004755|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92307091|NCT00004755|Allopurinol|allopurinol|mesh-list
92307092|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
92307093|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307094|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307095|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
92307096|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307097|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92307098|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
92307099|NCT00004755|Protective Agents|protective agents|mesh-ancestor
92307100|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307101|NCT00004755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92307102|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92307103|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307104|NCT00003897|Sargramostim|sargramostim|mesh-list
92307105|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
92307106|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307107|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
92307108|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307109|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92307110|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307111|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
92307112|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92307113|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
92307114|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307115|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307116|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
92307117|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307118|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
92307119|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307120|NCT00004785|Dexamethasone|dexamethasone|mesh-list
92307122|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92307123|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92307125|NCT00004785|Prednisolone acetate|prednisolone acetate|mesh-list
92307126|NCT00004785|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92307127|NCT00004785|Prednisolone phosphate|prednisolone phosphate|mesh-list
92307128|NCT00004785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307129|NCT00004785|Antiemetics|antiemetics|mesh-ancestor
92307130|NCT00004785|Autonomic Agents|autonomic agents|mesh-ancestor
92307131|NCT00004785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307132|NCT00004785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307133|NCT00004785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307134|NCT00004785|Glucocorticoids|glucocorticoids|mesh-ancestor
92307136|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307137|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92307138|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307139|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92307140|NCT00004785|Protective Agents|protective agents|mesh-ancestor
92307141|NCT00004815|Hormones|hormones|mesh-list
92307142|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307143|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307144|NCT02279823|Minoxidil|minoxidil|mesh-list
92307145|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92307146|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92307147|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
92307148|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
92307149|NCT04040361|Ramucirumab|ramucirumab|mesh-list
92307150|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307151|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307152|NCT04040361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92307153|NCT04040361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307154|NCT00386061|Rimonabant|rimonabant|mesh-list
92307155|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92307156|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92307157|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92307158|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307159|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307160|NCT00386061|Hormones|hormones|mesh-ancestor
92307161|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307162|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307163|NCT00005571|Eculizumab|eculizumab|mesh-list
92307164|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92307165|NCT00005571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307166|NCT00005571|Immunologic Factors|immunologic factors|mesh-ancestor
92307167|NCT00005571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307168|NCT00005577|Gemcitabine|gemcitabine|mesh-list
92307169|NCT00005577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307170|NCT00005577|Antimetabolites|antimetabolites|mesh-ancestor
92307171|NCT00005577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307172|NCT00005577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307173|NCT00005583|Doxorubicin|doxorubicin|mesh-list
92307174|NCT00005583|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92307176|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307177|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92307178|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307179|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307180|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307181|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307182|NCT00005589|Cytarabine|cytarabine|mesh-list
92307183|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
92307184|NCT00005589|Melphalan|melphalan|mesh-list
92307185|NCT00005589|Carmustine|carmustine|mesh-list
92307186|NCT00005589|Rituximab|rituximab|mesh-list
92307187|NCT00005589|Etoposide|etoposide|mesh-list
92307188|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307189|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
92307190|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307191|NCT00005589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307192|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307193|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
92307194|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307195|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307196|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92307197|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307198|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92307199|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307200|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307201|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307202|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307203|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
92307204|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
92307205|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307206|NCT00005601|Cytarabine|cytarabine|mesh-list
92307207|NCT00005601|Dexamethasone|dexamethasone|mesh-list
92307208|NCT00005601|Rituximab|rituximab|mesh-list
92307209|NCT00005601|Sargramostim|sargramostim|mesh-list
92307210|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307211|NCT00005601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307212|NCT00005601|Immunologic Factors|immunologic factors|mesh-ancestor
92307213|NCT00005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307214|NCT00005601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307215|NCT00005601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307216|NCT00005601|Antiemetics|antiemetics|mesh-ancestor
92307217|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
92307218|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307219|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307220|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
92307221|NCT00005601|Hormones|hormones|mesh-ancestor
92307222|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307223|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92307224|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307225|NCT00005601|Antimetabolites|antimetabolites|mesh-ancestor
92307226|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307227|NCT00005601|Antiviral Agents|antiviral agents|mesh-ancestor
92307228|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307229|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307230|NCT00005607|Leucovorin|leucovorin|mesh-list
92307231|NCT00005607|Fluorouracil|fluorouracil|mesh-list
92307232|NCT00005607|Irinotecan|irinotecan|mesh-list
92307233|NCT00005607|Calcium|calcium|mesh-list
92307234|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
92307235|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92307236|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307237|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
92307238|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307239|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307240|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307241|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307242|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
92307243|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92307244|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307245|NCT00005607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307246|NCT00005607|Antidotes|antidotes|mesh-ancestor
92307247|NCT00005607|Protective Agents|protective agents|mesh-ancestor
92307249|NCT00005607|Vitamins|vitamins|mesh-ancestor
92307250|NCT00005607|Micronutrients|micronutrients|mesh-ancestor
92307251|NCT00005613|Cyclophosphamide|cyclophosphamide|mesh-list
92307252|NCT00005613|Carmustine|carmustine|mesh-list
92307253|NCT00005613|Etoposide|etoposide|mesh-list
92307254|NCT00005613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307255|NCT00005613|Immunologic Factors|immunologic factors|mesh-ancestor
92307256|NCT00005613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307257|NCT00005613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307258|NCT00005613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307259|NCT00005613|Alkylating Agents|alkylating agents|mesh-ancestor
92307260|NCT00005613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307261|NCT00005613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307262|NCT00005613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92307263|NCT00005613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92307265|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307266|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307268|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307269|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
92307270|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307271|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307272|NCT00005631|Rituximab|rituximab|mesh-list
91959942|NCT04065009|Anesthetics|anesthetics|mesh-ancestor
92307273|NCT00005631|Carboplatin|carboplatin|mesh-list
92307274|NCT00005631|Etoposide|etoposide|mesh-list
92307275|NCT00005631|Ifosfamide|ifosfamide|mesh-list
92307276|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307277|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307278|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
92307279|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307280|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307281|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92307282|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307283|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307284|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307285|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307286|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307287|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
92307288|NCT00005637|Temozolomide|temozolomide|mesh-list
92307289|NCT00005637|Carmustine|carmustine|mesh-list
92307290|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307291|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
92307292|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307293|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307294|NCT00005643|Doxorubicin|doxorubicin|mesh-list
92307295|NCT00005643|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92307296|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92307297|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307298|NCT00005643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307299|NCT00005643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307300|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307301|NCT00005643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307302|NCT00005649|Paclitaxel|paclitaxel|mesh-list
92307303|NCT00005649|Capecitabine|capecitabine|mesh-list
92307304|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92307305|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307306|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
92307307|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
92307308|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
92307309|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307310|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307311|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
92307312|NCT00005673|Capravirine|capravirine|mesh-list
92307313|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92307314|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92307315|NCT00005673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347484|NCT01729728|Adrenergic Agents|adrenergic agents|mesh-ancestor
92307316|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307317|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
92307318|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307319|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92307320|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92307322|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307323|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307324|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92307325|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307326|NCT03390673|Bevacizumab|bevacizumab|mesh-list
92307327|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307328|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307329|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92307330|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92307331|NCT03390673|Growth Substances|growth substances|mesh-ancestor
92307332|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307333|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
92307334|NCT02974933|Pemetrexed|pemetrexed|mesh-list
92307335|NCT02974933|Apatinib|apatinib|mesh-list
92307336|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307338|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307339|NCT02974933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92307340|NCT02974933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92307341|NCT02974933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92307342|NCT00005769|Hormones|hormones|mesh-list
92307343|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307344|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307345|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
92307346|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92307347|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92307348|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
92307349|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
92307350|NCT00005787|Sargramostim|sargramostim|mesh-list
92307351|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92307352|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
92307353|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307354|NCT00005787|Hematinics|hematinics|mesh-ancestor
92307355|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92307356|NCT00005787|Protective Agents|protective agents|mesh-ancestor
92307357|NCT00005793|Cytarabine|cytarabine|mesh-list
92307358|NCT00005793|Etoposide|etoposide|mesh-list
92307359|NCT00005793|Daunorubicin|daunorubicin|mesh-list
92307360|NCT00005793|Topotecan|topotecan|mesh-list
92307361|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92307362|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307363|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307364|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307365|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307366|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307367|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307368|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
92307369|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
92307370|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307371|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307372|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
92307373|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307374|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92307375|NCT00005793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92307376|NCT00005799|Cyclosporine|cyclosporine|mesh-list
92307377|NCT00005799|Mycophenolic Acid|mycophenolic acid|mesh-list
92307378|NCT00005799|Fludarabine|fludarabine|mesh-list
92307379|NCT00005799|Fludarabine phosphate|fludarabine phosphate|mesh-list
92307380|NCT00005799|Cyclosporins|cyclosporins|mesh-list
92307381|NCT00005799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307382|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307383|NCT00005799|Antimetabolites|antimetabolites|mesh-ancestor
92307384|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307385|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307386|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
92347492|NCT01728246|Tramadol|tramadol|mesh-list
92307387|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307388|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307389|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
92307390|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307391|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307392|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307393|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92307394|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92307395|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92307396|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
92307397|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92307398|NCT00386373|Imatinib Mesylate|imatinib mesylate|mesh-list
92307399|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307400|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92307401|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307402|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307403|NCT00005811|Topotecan|topotecan|mesh-list
92307404|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92307405|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307406|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307407|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307408|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307410|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92307411|NCT02520518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307413|NCT02520518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307414|NCT01689987|Sirolimus|sirolimus|mesh-list
92307415|NCT01689987|Hydroxychloroquine|hydroxychloroquine|mesh-list
92307416|NCT01689987|Dexamethasone|dexamethasone|mesh-list
92307417|NCT01689987|Dexamethasone acetate|dexamethasone acetate|mesh-list
91960092|NCT02512471|Ropivacaine|ropivacaine|mesh-list
92307418|NCT01689987|Cyclophosphamide|cyclophosphamide|mesh-list
92307419|NCT01689987|Ichthammol|ichthammol|mesh-list
92307420|NCT01689987|BB 1101|bb 1101|mesh-list
92307421|NCT01689987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307422|NCT01689987|Immunologic Factors|immunologic factors|mesh-ancestor
92307423|NCT01689987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307424|NCT01689987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307425|NCT01689987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307426|NCT01689987|Alkylating Agents|alkylating agents|mesh-ancestor
92307427|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307428|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307429|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92307430|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307431|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
92307432|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
92307433|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307434|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307435|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
92307436|NCT01689987|Hormones|hormones|mesh-ancestor
92307437|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307438|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92307439|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92307440|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307441|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92307442|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
92307443|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307444|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
92307445|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92307446|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92307447|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
92307448|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307449|NCT01680939|Ibuprofen|ibuprofen|mesh-list
92307450|NCT01680939|Morphine|morphine|mesh-list
92307451|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92307452|NCT01680939|Narcotics|narcotics|mesh-ancestor
92307453|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307454|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307455|NCT01680939|Analgesics|analgesics|mesh-ancestor
92307456|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
92307457|NCT01680939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307458|NCT01680939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92307459|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92307460|NCT01680939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307461|NCT01680939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307462|NCT01680939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92307463|NCT01680939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307464|NCT01680939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307465|NCT01689597|Morphine|morphine|mesh-list
92307466|NCT01689597|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92307467|NCT01689597|Narcotics|narcotics|mesh-ancestor
92307468|NCT01689597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307469|NCT01689597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307470|NCT01689597|Analgesics|analgesics|mesh-ancestor
92307471|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
92307472|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307473|NCT02163733|Osimertinib|osimertinib|mesh-list
92307474|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307475|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92307476|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307477|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307478|NCT02483000|Biotin|biotin|mesh-list
92307479|NCT02483000|Cytarabine|cytarabine|mesh-list
92307480|NCT02483000|Etoposide|etoposide|mesh-list
92307481|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
92307482|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
92307483|NCT02483000|Melphalan|melphalan|mesh-list
92307484|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
92307485|NCT02483000|Carmustine|carmustine|mesh-list
92307486|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92307487|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92307488|NCT02483000|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92307489|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307490|NCT02483000|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307491|NCT02483000|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307492|NCT02483000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307493|NCT02483000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307494|NCT02483000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92307495|NCT02483000|Antimetabolites|antimetabolites|mesh-ancestor
92307496|NCT02483000|Antiviral Agents|antiviral agents|mesh-ancestor
92307497|NCT02483000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307498|NCT02483000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307499|NCT02483000|Immunologic Factors|immunologic factors|mesh-ancestor
92307500|NCT02483000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307501|NCT02483000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307502|NCT02483000|Alkylating Agents|alkylating agents|mesh-ancestor
92307503|NCT02483000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92307504|NCT02483000|Chelating Agents|chelating agents|mesh-ancestor
92307505|NCT02483000|Sequestering Agents|sequestering agents|mesh-ancestor
92307506|NCT02483000|Keratolytic Agents|keratolytic agents|mesh-ancestor
92307507|NCT02483000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307508|NCT02483000|Tubulin Modulators|tubulin modulators|mesh-ancestor
92307509|NCT02483000|Antimitotic Agents|antimitotic agents|mesh-ancestor
92307510|NCT02483000|Mitosis Modulators|mitosis modulators|mesh-ancestor
92307511|NCT02483000|Vitamin B Complex|vitamin b complex|mesh-ancestor
92307512|NCT02483000|Vitamins|vitamins|mesh-ancestor
92307513|NCT02483000|Micronutrients|micronutrients|mesh-ancestor
92307514|NCT02420210|Dexamethasone|dexamethasone|mesh-list
92307515|NCT02420210|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92307516|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
92307517|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307518|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
92347513|NCT01751802|Ecopipam|ecopipam|mesh-list
92307519|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
92307520|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307521|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307522|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307523|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
92307524|NCT02420210|Hormones|hormones|mesh-ancestor
92307525|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307526|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92307527|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307528|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307529|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
92307530|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307531|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307532|NCT04829799|Ketorolac|ketorolac|mesh-list
92307533|NCT04829799|Lidocaine|lidocaine|mesh-list
92307534|NCT04829799|Phenylephrine|phenylephrine|mesh-list
92307535|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
92307536|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
92307537|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
92307538|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307539|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307540|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
92307541|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307542|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92307543|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92307544|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92307545|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307546|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307547|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92307548|NCT04829799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92307549|NCT04829799|Analgesics|analgesics|mesh-ancestor
92307550|NCT04829799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307551|NCT04829799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307552|NCT04829799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92307553|NCT04829799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307554|NCT04829799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92307555|NCT04829799|Mydriatics|mydriatics|mesh-ancestor
92307556|NCT04829799|Autonomic Agents|autonomic agents|mesh-ancestor
92307557|NCT04829799|Sympathomimetics|sympathomimetics|mesh-ancestor
92307558|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92307559|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
92307560|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92307561|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92307562|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92307564|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
92307565|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307566|NCT04829799|Protective Agents|protective agents|mesh-ancestor
92307567|NCT01789333|Riboflavin|riboflavin|mesh-list
92307568|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92307569|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92307570|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
92307571|NCT01789333|Vitamins|vitamins|mesh-ancestor
92307572|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
92307573|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960242|NCT02516527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307574|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92307575|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307576|NCT02524106|Bococizumab|bococizumab|mesh-list
92307577|NCT02524106|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92307578|NCT02524106|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92307579|NCT02524106|Antimetabolites|antimetabolites|mesh-ancestor
92307580|NCT02524106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307581|NCT02524106|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92307582|NCT01761877|Sulindac|sulindac|mesh-list
92307583|NCT01761877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92307584|NCT01761877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92307585|NCT01761877|Analgesics|analgesics|mesh-ancestor
92307586|NCT01761877|Sensory System Agents|sensory system agents|mesh-ancestor
92307587|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307588|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307589|NCT01761877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307590|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307591|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307592|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92307593|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307594|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307595|NCT02488070|Edetic Acid|edetic acid|mesh-list
92307596|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92307597|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
92307598|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
92307599|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307600|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
92307601|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92307602|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92307603|NCT04116541|Trametinib|trametinib|mesh-list
92307604|NCT04116541|Dabrafenib|dabrafenib|mesh-list
92307605|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307606|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92307607|NCT04116541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307608|NCT04116541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307609|NCT03306979|Acetylcysteine|acetylcysteine|mesh-list
92307610|NCT03306979|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92307611|NCT03306979|Antiviral Agents|antiviral agents|mesh-ancestor
92307612|NCT03306979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307613|NCT03306979|Expectorants|expectorants|mesh-ancestor
92307614|NCT03306979|Respiratory System Agents|respiratory system agents|mesh-ancestor
92307615|NCT03306979|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92307616|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
92307617|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307618|NCT03306979|Protective Agents|protective agents|mesh-ancestor
92307619|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307620|NCT03306979|Antidotes|antidotes|mesh-ancestor
92307621|NCT00362869|Levofloxacin|levofloxacin|mesh-list
92307622|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92307623|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307624|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92307625|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307627|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307628|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307629|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307630|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92307631|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92307632|NCT03257215|Vitamin D|vitamin d|mesh-list
92307633|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
92307634|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
92307635|NCT03257215|Vitamins|vitamins|mesh-list
92307636|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
92307637|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307638|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92307639|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92307640|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
92307641|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92307642|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307643|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307644|NCT00588523|Temozolomide|temozolomide|mesh-list
92307646|NCT00588523|Thiotepa|thiotepa|mesh-list
92307647|NCT00588523|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92307648|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
91960334|NCT04499989|Isoniazid|isoniazid|mesh-list
92307649|NCT00588523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307650|NCT00588523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307651|NCT00588523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307652|NCT00588523|Immunologic Factors|immunologic factors|mesh-ancestor
92307653|NCT00588523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307654|NCT00588523|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92307655|NCT02974387|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92307656|NCT02974387|Fluorometholone|fluorometholone|mesh-list
92307657|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92307658|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307659|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
92307660|NCT02974387|Hormones|hormones|mesh-ancestor
92307661|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307662|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307663|NCT00493831|Nicotine|nicotine|mesh-list
92307664|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92307665|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
92307666|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307667|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307668|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92307669|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92307670|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
92307671|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307672|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307673|NCT00430183|Docetaxel|docetaxel|mesh-list
92307674|NCT00430183|Leuprolide|leuprolide|mesh-list
92307675|NCT00430183|Goserelin|goserelin|mesh-list
92307676|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307677|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92307678|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92307679|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92307680|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307681|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92307682|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
92307683|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92307684|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307685|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92307686|NCT00362947|Parnaparin|parnaparin|mesh-list
92307687|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
92307688|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92307689|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92307690|NCT00362947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307691|NCT00363025|Daunorubicin|daunorubicin|mesh-list
92307692|NCT00363025|Idarubicin|idarubicin|mesh-list
92307693|NCT00363025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92307694|NCT00363025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307695|NCT00363025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92307696|NCT00363025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92307697|NCT00363025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307698|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307699|NCT02444143|Tacrolimus|tacrolimus|mesh-list
92307700|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307701|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
92307702|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307703|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92307704|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307705|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307706|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
92307707|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92307708|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307709|NCT03161431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92307710|NCT03161431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307711|NCT02445859|Cefuroxime|cefuroxime|mesh-list
92307712|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
92307713|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92307714|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307715|NCT02446483|Rabeprazole|rabeprazole|mesh-list
92307716|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92307717|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307718|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92307719|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307720|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307721|NCT00362635|Clevudine|clevudine|mesh-list
92307722|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
92307723|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307724|NCT04744753|Calcium|calcium|mesh-list
92307725|NCT04744753|Ionophores|ionophores|mesh-list
92307726|NCT04744753|Calcium Ionophores|calcium ionophores|mesh-list
92307727|NCT04744753|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92307728|NCT04744753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347530|NCT01703286|Incretins|incretins|mesh-ancestor
92307729|NCT04744753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307730|NCT04744753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307731|NCT02420041|Triamcinolone|triamcinolone|mesh-list
92307732|NCT02420041|Lidocaine|lidocaine|mesh-list
92307733|NCT02420041|Anesthetics, Local|anesthetics, local|mesh-ancestor
92307734|NCT02420041|Anesthetics|anesthetics|mesh-ancestor
92307735|NCT02420041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307736|NCT02420041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307737|NCT02420041|Sensory System Agents|sensory system agents|mesh-ancestor
92307738|NCT02420041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307739|NCT02420041|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92307740|NCT02420041|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92307741|NCT02420041|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92307742|NCT02420041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307743|NCT02420041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307744|NCT02420041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307745|NCT02420041|Glucocorticoids|glucocorticoids|mesh-ancestor
92307746|NCT02420041|Hormones|hormones|mesh-ancestor
92410354|NCT05289323|Autonomic Agents|autonomic agents|mesh-ancestor
92307747|NCT02420041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307748|NCT02421211|Sofosbuvir|sofosbuvir|mesh-list
92307749|NCT02421211|Ledipasvir|ledipasvir|mesh-list
92307750|NCT02421211|Simeprevir|simeprevir|mesh-list
92307751|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
92307752|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307753|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
92307754|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307755|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307756|NCT00363259|Ribavirin|ribavirin|mesh-list
92307757|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92307758|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
92307759|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307760|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
92307761|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307762|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
92307763|NCT03089905|Remifentanil|remifentanil|mesh-list
92307764|NCT03089905|Sevoflurane|sevoflurane|mesh-list
92307765|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92307766|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307767|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307768|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92307769|NCT03089905|Analgesics|analgesics|mesh-ancestor
92307770|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
92307771|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307772|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92307773|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92307774|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92307775|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
92307776|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307777|NCT03089905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307778|NCT03089905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92307779|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92307780|NCT03089905|Anesthetics, General|anesthetics, general|mesh-ancestor
92307781|NCT03089905|Anesthetics|anesthetics|mesh-ancestor
92307782|NCT03089905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92307783|NCT03089905|Narcotics|narcotics|mesh-ancestor
92307784|NCT02424968|Cyclosporine|cyclosporine|mesh-list
92307785|NCT02424968|Mycophenolic Acid|mycophenolic acid|mesh-list
92307786|NCT02424968|Cyclosporins|cyclosporins|mesh-list
92307787|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
92307788|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92307789|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307790|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307791|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307792|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
92307793|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307794|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
92307795|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307796|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307797|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307798|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92307799|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91960470|NCT02504359|Methotrexate|methotrexate|mesh-list
92307800|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307801|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92307802|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
92307803|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92307805|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92307806|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307807|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307809|NCT02492750|Dexamethasone acetate|dexamethasone acetate|mesh-list
92307810|NCT02492750|Lenalidomide|lenalidomide|mesh-list
92307811|NCT02492750|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92307812|NCT02492750|Ichthammol|ichthammol|mesh-list
92307813|NCT02492750|BB 1101|bb 1101|mesh-list
92307814|NCT02492750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307815|NCT02492750|Antiemetics|antiemetics|mesh-ancestor
92307816|NCT02492750|Autonomic Agents|autonomic agents|mesh-ancestor
92307817|NCT02492750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307818|NCT02492750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307819|NCT02492750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307820|NCT02492750|Glucocorticoids|glucocorticoids|mesh-ancestor
92307821|NCT02492750|Hormones|hormones|mesh-ancestor
92307822|NCT02492750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307823|NCT02492750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92307824|NCT02492750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307825|NCT02492750|Immunologic Factors|immunologic factors|mesh-ancestor
92307826|NCT02492750|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92307827|NCT02492750|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92307828|NCT02492750|Growth Substances|growth substances|mesh-ancestor
92307829|NCT02492750|Growth Inhibitors|growth inhibitors|mesh-ancestor
92307830|NCT02492750|Protease Inhibitors|protease inhibitors|mesh-ancestor
92307831|NCT02492750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307832|NCT02492750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307833|NCT02492750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307834|NCT02492750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92307835|NCT00363337|Aripiprazole|aripiprazole|mesh-list
92307836|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
92307837|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92307838|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92307839|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92307840|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307841|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307842|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
92307843|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
92307844|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307845|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307846|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92307847|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92307849|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92307850|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92307851|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92307852|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92307853|NCT02493452|Plecanatide|plecanatide|mesh-list
92307854|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92307855|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
92307856|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307857|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92307858|NCT02429869|Everolimus|everolimus|mesh-list
92307859|NCT02429869|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92307860|NCT02429869|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92307861|NCT02429869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307862|NCT02429869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307863|NCT02429869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92307864|NCT02429869|Immunologic Factors|immunologic factors|mesh-ancestor
92307865|NCT02429869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307866|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92307867|NCT02428478|Desipramine|desipramine|mesh-list
92307868|NCT02428478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92307869|NCT02428478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92307870|NCT02428478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92307871|NCT02428478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307872|NCT02428478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307873|NCT02428478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92307874|NCT02428478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92307875|NCT02428478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307877|NCT02428478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307878|NCT02428478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307879|NCT04341493|Hydroxychloroquine|hydroxychloroquine|mesh-list
92307880|NCT04341493|Nitazoxanide|nitazoxanide|mesh-list
92307881|NCT04341493|Antimalarials|antimalarials|mesh-ancestor
92307882|NCT04341493|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92307883|NCT04341493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92307884|NCT04341493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307885|NCT04341493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307886|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307887|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307888|NCT02432287|Metformin|metformin|mesh-list
92307889|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92307890|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307891|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
92307892|NCT02532998|Eplerenone|eplerenone|mesh-list
92307893|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92307894|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
92307895|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307896|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307897|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92307898|NCT02532998|Diuretics|diuretics|mesh-ancestor
92307899|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
92307900|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92307901|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307902|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
92307903|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
92307904|NCT02453581|Artefenomel|artefenomel|mesh-list
92307905|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
92307906|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92307907|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92307908|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307909|NCT02533466|Listerine|listerine|mesh-list
92307910|NCT02533466|Fluorides|fluorides|mesh-list
92307911|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
92307912|NCT02533466|Cariostatic Agents|cariostatic agents|mesh-ancestor
92307913|NCT02533466|Protective Agents|protective agents|mesh-ancestor
92307914|NCT02533466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307915|NCT02533466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92307916|NCT02533466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307917|NCT02974244|Exenatide|exenatide|mesh-list
92307918|NCT02974244|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92307919|NCT02974244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307920|NCT02974244|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92307921|NCT02974244|Incretins|incretins|mesh-ancestor
92307922|NCT02974244|Hormones|hormones|mesh-ancestor
92307923|NCT02974244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307924|NCT02436031|Desipramine|desipramine|mesh-list
92307925|NCT02436031|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92307926|NCT02436031|Antidepressive Agents|antidepressive agents|mesh-ancestor
92307927|NCT02436031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92307928|NCT02436031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307929|NCT02436031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307930|NCT02436031|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92307931|NCT02436031|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92307932|NCT02436031|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307933|NCT02436031|Adrenergic Agents|adrenergic agents|mesh-ancestor
92307934|NCT02436031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307935|NCT02436031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307936|NCT02454283|Vanoxerine|vanoxerine|mesh-list
92307937|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92307938|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92307939|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92307940|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307941|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
92307942|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307943|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307944|NCT02437669|Hydromorphone|hydromorphone|mesh-list
92307945|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92307946|NCT02437669|Narcotics|narcotics|mesh-ancestor
91960622|NCT02509351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307947|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307948|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307950|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
92307951|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307952|NCT02430818|Ketamine|ketamine|mesh-list
92307953|NCT02430818|Morphine|morphine|mesh-list
92307954|NCT02430818|Analgesics|analgesics|mesh-ancestor
92307955|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
92307956|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307957|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307958|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92307959|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92307960|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
92307961|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
92307962|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307963|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92307964|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92307965|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92307966|NCT02430818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307967|NCT02430818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92307968|NCT02430818|Narcotics|narcotics|mesh-ancestor
92307969|NCT02455453|Estradiol|estradiol|mesh-list
92307970|NCT02455453|Estrogens|estrogens|mesh-ancestor
92307971|NCT02455453|Hormones|hormones|mesh-ancestor
92307972|NCT02455453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92307973|NCT02455453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307974|NCT02533934|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92307975|NCT02533934|Antiviral Agents|antiviral agents|mesh-ancestor
92307976|NCT02533934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92307977|NCT02519023|Acetaminophen|acetaminophen|mesh-list
92307978|NCT02519023|Ibuprofen|ibuprofen|mesh-list
92307979|NCT02519023|Epinephrine|epinephrine|mesh-list
92307980|NCT02519023|Oxycodone|oxycodone|mesh-list
92307981|NCT02519023|Bupivacaine|bupivacaine|mesh-list
92307982|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
92307983|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
92307984|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92307985|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92307986|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
92307987|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92307988|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92307989|NCT02519023|Analgesics|analgesics|mesh-ancestor
92307990|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
92307991|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92307992|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92307993|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92307994|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92307995|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92307996|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92307997|NCT02519023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92307998|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92307999|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
92308000|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308001|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92308002|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92308003|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
92308004|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92308007|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
92308008|NCT02519023|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92308009|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92308010|NCT02519023|Narcotics|narcotics|mesh-ancestor
92308011|NCT02497040|Bupivacaine|bupivacaine|mesh-list
92308012|NCT02497040|Levobupivacaine|levobupivacaine|mesh-list
92308013|NCT02497040|Anesthetics, Local|anesthetics, local|mesh-ancestor
92308014|NCT02497040|Anesthetics|anesthetics|mesh-ancestor
92308015|NCT02497040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308016|NCT02497040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308017|NCT02497040|Sensory System Agents|sensory system agents|mesh-ancestor
92308018|NCT02497040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308019|NCT02523235|Ropivacaine|ropivacaine|mesh-list
92308020|NCT02523235|Anesthetics, Local|anesthetics, local|mesh-ancestor
92308021|NCT02523235|Anesthetics|anesthetics|mesh-ancestor
92308022|NCT02523235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960709|NCT02502877|Midazolam|midazolam|mesh-list
92308023|NCT02523235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308025|NCT02523235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308026|NCT02498522|Metformin|metformin|mesh-list
92308027|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92308028|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308029|NCT02919787|Irinotecan|irinotecan|mesh-list
92308030|NCT02919787|Fluorouracil|fluorouracil|mesh-list
92308031|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
92308032|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92308033|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92308034|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308035|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308036|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308037|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
92308038|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308039|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308040|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
92308041|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308042|NCT02459275|Metoclopramide|metoclopramide|mesh-list
92308043|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
92308044|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
92308045|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308046|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308047|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308048|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92308049|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92308050|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
92308051|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308052|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308053|NCT02524561|Estradiol|estradiol|mesh-list
92308054|NCT02524561|Progesterone|progesterone|mesh-list
92308055|NCT02524561|Estrogens|estrogens|mesh-ancestor
92308056|NCT02524561|Hormones|hormones|mesh-ancestor
92308057|NCT02524561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308058|NCT02524561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308059|NCT02524561|Progestins|progestins|mesh-ancestor
92308060|NCT02431598|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92308061|NCT02431598|Chelating Agents|chelating agents|mesh-ancestor
92308062|NCT02431598|Sequestering Agents|sequestering agents|mesh-ancestor
92308063|NCT02431598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308064|NCT04743739|Cyclosporine|cyclosporine|mesh-list
92308065|NCT04743739|Rituximab|rituximab|mesh-list
92308066|NCT04743739|Cyclosporins|cyclosporins|mesh-list
92308067|NCT04743739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308068|NCT04743739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308069|NCT04743739|Immunologic Factors|immunologic factors|mesh-ancestor
92308070|NCT04743739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308071|NCT04743739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308072|NCT04743739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308073|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308074|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308075|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
92308076|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308077|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308078|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92308079|NCT02461693|Caffeine|caffeine|mesh-list
91936383|NCT02321839|Growth Substances|growth substances|mesh-ancestor
92308080|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92308081|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308082|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92308083|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308084|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308085|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92308086|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92308087|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
92308088|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308089|NCT02525653|Paclitaxel|paclitaxel|mesh-list
92308090|NCT02525653|Gemcitabine|gemcitabine|mesh-list
92308091|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92308092|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92308093|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308094|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
92308095|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308096|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308097|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308098|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308099|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
92308100|NCT02431754|Tadalafil|tadalafil|mesh-list
92308101|NCT02431754|Vasodilator Agents|vasodilator agents|mesh-ancestor
92308102|NCT02431754|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92308103|NCT02431754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92308104|NCT02431754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308105|NCT02431754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308106|NCT02431754|Urological Agents|urological agents|mesh-ancestor
92308107|NCT02500628|Metformin|metformin|mesh-list
92308108|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92308109|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308110|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
92308111|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92308112|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92308113|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308114|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
92308115|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308116|NCT02535806|Cytarabine|cytarabine|mesh-list
92308117|NCT02535806|Dexamethasone|dexamethasone|mesh-list
92308118|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
92308119|NCT02535806|Methotrexate|methotrexate|mesh-list
92308120|NCT02535806|Vincristine|vincristine|mesh-list
92308121|NCT02535806|Bortezomib|bortezomib|mesh-list
92308122|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
92308124|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308125|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
92308126|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
92308127|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308128|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308129|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308130|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
92308131|NCT02535806|Hormones|hormones|mesh-ancestor
92308132|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308133|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308134|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308135|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92308136|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
92308137|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92308138|NCT02535806|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308139|NCT02535806|Antimetabolites|antimetabolites|mesh-ancestor
92308140|NCT02535806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308141|NCT02535806|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308142|NCT02535806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308143|NCT02535806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92308144|NCT02535806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308145|NCT02535806|Immunologic Factors|immunologic factors|mesh-ancestor
92308146|NCT02535806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347567|NCT01725126|Hormones|hormones|mesh-ancestor
92308147|NCT02535806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92308148|NCT02535806|Antiviral Agents|antiviral agents|mesh-ancestor
92308149|NCT02535806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308150|NCT02535806|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92308151|NCT02535806|Tubulin Modulators|tubulin modulators|mesh-ancestor
92308152|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308153|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308154|NCT02535806|Analgesics|analgesics|mesh-ancestor
92308155|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
92308156|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92308157|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92308158|NCT02536040|Fluorides|fluorides|mesh-list
92308159|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
92308160|NCT02536040|Protective Agents|protective agents|mesh-ancestor
92308161|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308162|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
92308163|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
92308164|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308165|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308166|NCT02537444|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92308167|NCT02537444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308168|NCT02464033|Vitamin D|vitamin d|mesh-list
92308169|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
92308170|NCT02464033|Etanercept|etanercept|mesh-list
92308171|NCT02464033|Vitamins|vitamins|mesh-ancestor
92308172|NCT02464033|Micronutrients|micronutrients|mesh-ancestor
92308173|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308174|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92308175|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92308176|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92308177|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92308179|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
92308180|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308181|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308182|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308183|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308184|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308185|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
92308186|NCT02432456|Acetaminophen|acetaminophen|mesh-list
92308187|NCT02432456|Ibuprofen|ibuprofen|mesh-list
92308188|NCT02432456|Ketamine|ketamine|mesh-list
92308189|NCT02432456|Narcotics|narcotics|mesh-list
92308190|NCT02432456|Methocarbamol|methocarbamol|mesh-list
92308191|NCT02432456|Pantoprazole|pantoprazole|mesh-list
92308192|NCT02432456|Analgesics|analgesics|mesh-ancestor
92308193|NCT02432456|Sensory System Agents|sensory system agents|mesh-ancestor
92308194|NCT02432456|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308195|NCT02432456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308196|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92308197|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92308198|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
92308199|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
92308200|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308201|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92308202|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92308203|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308204|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308205|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92308206|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
92410509|NCT05179512|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92308207|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92308208|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308209|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308210|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92308211|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308212|NCT02432456|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92308213|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308214|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92308215|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92308216|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92308217|NCT02531971|Fentanyl|fentanyl|mesh-list
92308218|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92308219|NCT02531971|Narcotics|narcotics|mesh-ancestor
92308220|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308221|NCT02531971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308222|NCT02531971|Analgesics|analgesics|mesh-ancestor
92308223|NCT02531971|Sensory System Agents|sensory system agents|mesh-ancestor
92308224|NCT02531971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308225|NCT02531971|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92308226|NCT02531971|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92308227|NCT02531971|Anesthetics, General|anesthetics, general|mesh-ancestor
92308228|NCT02531971|Anesthetics|anesthetics|mesh-ancestor
92308229|NCT02464657|Cytarabine|cytarabine|mesh-list
92308230|NCT02464657|Dexamethasone|dexamethasone|mesh-list
92308231|NCT02464657|Methylprednisolone|methylprednisolone|mesh-list
92308232|NCT02464657|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92308233|NCT02464657|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92308234|NCT02464657|Prednisolone|prednisolone|mesh-list
92308235|NCT02464657|Prednisolone acetate|prednisolone acetate|mesh-list
92308237|NCT02464657|Idarubicin|idarubicin|mesh-list
92308238|NCT02464657|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92308239|NCT02464657|Prednisolone phosphate|prednisolone phosphate|mesh-list
92308240|NCT02464657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308241|NCT02464657|Antiemetics|antiemetics|mesh-ancestor
92308242|NCT02464657|Autonomic Agents|autonomic agents|mesh-ancestor
92308243|NCT02464657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308244|NCT02464657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308245|NCT02464657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308246|NCT02464657|Glucocorticoids|glucocorticoids|mesh-ancestor
92308247|NCT02464657|Hormones|hormones|mesh-ancestor
92308248|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308249|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308250|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308251|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308252|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92308253|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308254|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308255|NCT02464657|Antimetabolites|antimetabolites|mesh-ancestor
92308256|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
92308257|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308258|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308259|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
92308260|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92308261|NCT02464657|Protective Agents|protective agents|mesh-ancestor
92308262|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92308263|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92308264|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92308265|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308266|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
92308267|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92308268|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92308269|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308270|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
92308271|NCT02535949|Coagulants|coagulants|mesh-ancestor
92308272|NCT02536105|Methylphenidate|methylphenidate|mesh-list
92308273|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92308274|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308275|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92308276|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92308277|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92308278|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308279|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
92308280|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308281|NCT02758951|Bevacizumab|bevacizumab|mesh-list
92308282|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308283|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308284|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92308285|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92308286|NCT02758951|Growth Substances|growth substances|mesh-ancestor
92308287|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308288|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
92308289|NCT02436668|Paclitaxel|paclitaxel|mesh-list
92308290|NCT02436668|Gemcitabine|gemcitabine|mesh-list
92308291|NCT02436668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92308292|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308293|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92308294|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308295|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308296|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308297|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308298|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
92308299|NCT02503982|Valganciclovir|valganciclovir|mesh-list
92308300|NCT02503982|Antiviral Agents|antiviral agents|mesh-ancestor
92308301|NCT02503982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308302|NCT02438540|Metformin|metformin|mesh-list
92308303|NCT02438540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92308304|NCT02438540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308305|NCT02506634|Esomeprazole|esomeprazole|mesh-list
92308306|NCT02506634|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92308308|NCT02506634|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92308309|NCT02506634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308310|NCT02506634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308311|NCT02506868|Darbepoetin alfa|darbepoetin alfa|mesh-list
92308312|NCT02506868|Hematinics|hematinics|mesh-ancestor
92308313|NCT02541422|Acetylcysteine|acetylcysteine|mesh-list
92308314|NCT02541422|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92308315|NCT02541422|Antiviral Agents|antiviral agents|mesh-ancestor
92308316|NCT02541422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308317|NCT02541422|Expectorants|expectorants|mesh-ancestor
92308318|NCT02541422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92308319|NCT02541422|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92308320|NCT02541422|Antioxidants|antioxidants|mesh-ancestor
92308321|NCT02541422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308322|NCT02541422|Protective Agents|protective agents|mesh-ancestor
92308323|NCT02541422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308324|NCT02541422|Antidotes|antidotes|mesh-ancestor
92308325|NCT02439164|Midazolam|midazolam|mesh-list
92308326|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92308327|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92308328|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308329|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308331|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92308332|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92308333|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92308334|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
92308335|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
92308336|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
92308337|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
92308338|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308339|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308340|NCT02440178|Micafungin|micafungin|mesh-list
92308341|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
92308342|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308343|NCT05078606|Anesthetics|anesthetics|mesh-list
92308344|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308345|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308346|NCT02546570|Oxytocin|oxytocin|mesh-list
92308347|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
92308348|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92308349|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308350|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
92308351|NCT02548910|Citric Acid|citric acid|mesh-list
92308352|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
92308353|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92308354|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
92308355|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
92308356|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308357|NCT02510144|Chlorhexidine|chlorhexidine|mesh-list
92308358|NCT02510144|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92308359|NCT02510144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92308360|NCT02510144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308361|NCT02510144|Disinfectants|disinfectants|mesh-ancestor
92308362|NCT02510144|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308363|NCT02538679|Epinephrine|epinephrine|mesh-list
92308364|NCT02538679|Racepinephrine|racepinephrine|mesh-list
92308365|NCT02538679|Bupivacaine|bupivacaine|mesh-list
92308366|NCT02538679|Epinephryl borate|epinephryl borate|mesh-list
92308367|NCT02538679|Anesthetics, Local|anesthetics, local|mesh-ancestor
92308368|NCT02538679|Anesthetics|anesthetics|mesh-ancestor
92308369|NCT02538679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308370|NCT02538679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308371|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
92308372|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308373|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92308374|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92308375|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
92308376|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308377|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308378|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92308379|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92308380|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
92308381|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92308382|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
92308383|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
92308384|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
92308385|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92308386|NCT02511236|Nicotine|nicotine|mesh-list
92308387|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92308388|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
92308389|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308390|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308391|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92308392|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92308393|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
92308394|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308395|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308396|NCT02551094|Colchicine|colchicine|mesh-list
92308397|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
92308398|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308399|NCT02551094|Tubulin Modulators|tubulin modulators|mesh-ancestor
92308400|NCT02551094|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308401|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308402|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308403|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308404|NCT02513498|Ixazomib|ixazomib|mesh-list
91961112|NCT02496715|Xhance|xhance|mesh-list
92308405|NCT02513498|Glycine|glycine|mesh-list
92308406|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308407|NCT02513498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308408|NCT02513498|Protease Inhibitors|protease inhibitors|mesh-ancestor
92308409|NCT02513498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308410|NCT02513498|Glycine Agents|glycine agents|mesh-ancestor
92308411|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308412|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308413|NCT04787354|Capecitabine|capecitabine|mesh-list
92308414|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
92308415|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308416|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
92308417|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308418|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308419|NCT02514044|Adderall|adderall|mesh-list
92308420|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
92308421|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92308422|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308423|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92308424|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92308425|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92308426|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308427|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
92308428|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308429|NCT02555228|Simethicone|simethicone|mesh-list
92308430|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
92308431|NCT02555228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308432|NCT02555228|Emollients|emollients|mesh-ancestor
92308434|NCT02556788|Trifarotene|trifarotene|mesh-list
92308435|NCT02556788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308436|NCT02516150|Ethanol|ethanol|mesh-list
92308437|NCT02516150|Glucagon|glucagon|mesh-list
92308438|NCT02516150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92308439|NCT02516150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308440|NCT02516150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308441|NCT02516150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308442|NCT02516150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308443|NCT02516150|Hormones|hormones|mesh-ancestor
92308444|NCT02516150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308445|NCT04025060|Caffeine|caffeine|mesh-list
92308446|NCT04025060|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92308447|NCT04025060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308448|NCT04025060|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92308449|NCT04025060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308450|NCT04025060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308451|NCT04025060|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92308452|NCT04025060|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92308453|NCT04025060|Purinergic Agents|purinergic agents|mesh-ancestor
92308454|NCT04025060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308455|NCT04542434|Niclosamide|niclosamide|mesh-list
92308456|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
92308457|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92308458|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
92308459|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92308460|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308461|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
92308462|NCT04186286|Propranolol|propranolol|mesh-list
92308463|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92308464|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92308465|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
92308466|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308467|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308468|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308469|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92308470|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92308471|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
92308472|NCT04341038|Methylprednisolone|methylprednisolone|mesh-list
92308473|NCT04341038|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92308474|NCT04341038|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92308475|NCT04341038|Prednisolone|prednisolone|mesh-list
92308476|NCT04341038|Prednisolone acetate|prednisolone acetate|mesh-list
92308477|NCT04341038|Tacrolimus|tacrolimus|mesh-list
92308478|NCT04341038|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92308479|NCT04341038|Prednisolone phosphate|prednisolone phosphate|mesh-list
92308480|NCT04341038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308481|NCT04341038|Immunologic Factors|immunologic factors|mesh-ancestor
92308482|NCT04341038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308483|NCT04341038|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92308484|NCT04341038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308485|NCT04341038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308486|NCT04341038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308487|NCT04341038|Antiemetics|antiemetics|mesh-ancestor
92308488|NCT04341038|Autonomic Agents|autonomic agents|mesh-ancestor
92308489|NCT04341038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308490|NCT04341038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308491|NCT04341038|Glucocorticoids|glucocorticoids|mesh-ancestor
92308492|NCT04341038|Hormones|hormones|mesh-ancestor
92308493|NCT04341038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308494|NCT04341038|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92308496|NCT04341038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308497|NCT04341038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308498|NCT02561702|Mexiletine|mexiletine|mesh-list
92308499|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92308500|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92308501|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92308502|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92308503|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308504|NCT02563496|Chloroquine|chloroquine|mesh-list
92308505|NCT02563496|Tafenoquine|tafenoquine|mesh-list
92308506|NCT02563496|Amebicides|amebicides|mesh-ancestor
92308507|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92308508|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92308509|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308510|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
92308511|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308512|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92308513|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
92308514|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308515|NCT02568644|Ketoprofen|ketoprofen|mesh-list
92308516|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92308517|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92308518|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92308519|NCT02568644|Analgesics|analgesics|mesh-ancestor
92308520|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
92308521|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308522|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308523|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308524|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92308525|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308526|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308527|NCT02541409|Interferons|interferons|mesh-list
92308528|NCT02541409|Ribavirin|ribavirin|mesh-list
92308529|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
92308530|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
92308531|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92308532|NCT02541409|Sofosbuvir|sofosbuvir|mesh-list
92308533|NCT02541409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308534|NCT02541409|Antiviral Agents|antiviral agents|mesh-ancestor
92308535|NCT02541409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308536|NCT02541409|Antimetabolites|antimetabolites|mesh-ancestor
92308537|NCT02541409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308538|NCT02541409|Immunologic Factors|immunologic factors|mesh-ancestor
92308539|NCT02541409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308540|NCT02569658|Tranexamic Acid|tranexamic acid|mesh-list
92308541|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92308542|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92308543|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308544|NCT02569658|Hemostatics|hemostatics|mesh-ancestor
92308545|NCT02569658|Coagulants|coagulants|mesh-ancestor
92308546|NCT02541565|Prednisone|prednisone|mesh-list
92308547|NCT02541565|Cortisone|cortisone|mesh-list
92308548|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
92308549|NCT02541565|Rituximab|rituximab|mesh-list
92308550|NCT02541565|Doxorubicin|doxorubicin|mesh-list
92308551|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92308552|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
92308553|NCT02541565|Vincristine|vincristine|mesh-list
92308554|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92308555|NCT02541565|Antibodies|antibodies|mesh-list
91961224|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308556|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
92308557|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92308558|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308559|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
92308560|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308561|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308562|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92308563|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
92308564|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308565|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308566|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92308567|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92308568|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92308569|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92308570|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308571|NCT02541565|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92308572|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308573|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
92308574|NCT02541565|Hormones|hormones|mesh-ancestor
92308575|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308576|NCT02541565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308577|NCT02541565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92308579|NCT02541565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308580|NCT02541565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308581|NCT04707950|Tranexamic Acid|tranexamic acid|mesh-list
92308582|NCT04707950|Oxytocin|oxytocin|mesh-list
92308583|NCT04707950|Oxytocics|oxytocics|mesh-ancestor
92308584|NCT04707950|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92308585|NCT04707950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308586|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92308587|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92308588|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308589|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
92308590|NCT04707950|Coagulants|coagulants|mesh-ancestor
92308591|NCT04044560|Blinatumomab|blinatumomab|mesh-list
92308592|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308593|NCT03807440|Empagliflozin|empagliflozin|mesh-list
92308594|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92308595|NCT03807440|Linagliptin|linagliptin|mesh-list
92308596|NCT03807440|Metformin|metformin|mesh-list
92308597|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92308598|NCT03807440|Glucagon|glucagon|mesh-list
92308599|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92308600|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308601|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92308602|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308603|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92308604|NCT03807440|Hormones|hormones|mesh-ancestor
92308605|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308606|NCT03807440|Incretins|incretins|mesh-ancestor
92308607|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
92308608|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308609|NCT03256916|Nelfinavir|nelfinavir|mesh-list
92308610|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92308611|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92308612|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
92308613|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308614|NCT03256916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308615|NCT03256916|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92308616|NCT03256916|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92308617|NCT03256916|Antiviral Agents|antiviral agents|mesh-ancestor
92308618|NCT03256916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308619|NCT02579876|Immunomodulating Agents|immunomodulating agents|mesh-list
92308620|NCT02579876|Immunologic Factors|immunologic factors|mesh-list
92308621|NCT02579876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308622|NCT00364052|Valganciclovir|valganciclovir|mesh-list
92308623|NCT00364052|Ganciclovir|ganciclovir|mesh-list
92308624|NCT00364052|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92308625|NCT00364052|Antiviral Agents|antiviral agents|mesh-ancestor
92308626|NCT00364052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308627|NCT00364052|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92308628|NCT00364052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308629|NCT00364052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308630|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
92308631|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92308632|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308633|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92308634|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308635|NCT00364988|Pioglitazone|pioglitazone|mesh-list
92308636|NCT00364988|Losartan|losartan|mesh-list
92308637|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92308638|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308639|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92308640|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92308641|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92308642|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92308643|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308644|NCT00365222|Temozolomide|temozolomide|mesh-list
92308645|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92308646|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
92347597|NCT01751178|Ethanol|ethanol|mesh-list
92308647|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308649|NCT03119012|Aspirin|aspirin|mesh-list
92308650|NCT03119012|Clopidogrel|clopidogrel|mesh-list
92308651|NCT03119012|Ticagrelor|ticagrelor|mesh-list
92308652|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92308653|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92308654|NCT03119012|Analgesics|analgesics|mesh-ancestor
92308655|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
92308656|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308657|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308658|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308659|NCT03119012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308660|NCT03119012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92308661|NCT03119012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92308662|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308663|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92308664|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92308665|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308666|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
92410510|NCT05179512|Parasympatholytics|parasympatholytics|mesh-ancestor
92308667|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92308668|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92308669|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92308670|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
92308671|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308672|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92308673|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
92308674|NCT02584868|Blood Substitutes|blood substitutes|mesh-ancestor
92308675|NCT02791568|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92308676|NCT02791568|Hematinics|hematinics|mesh-ancestor
92308677|NCT02791568|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92308678|NCT02791568|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92308679|NCT05248022|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92308680|NCT05248022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308681|NCT05248022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308682|NCT05248022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308683|NCT05247554|Hydroxychloroquine|hydroxychloroquine|mesh-list
92308684|NCT05247554|Prednisone|prednisone|mesh-list
92308685|NCT05247554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308686|NCT05247554|Glucocorticoids|glucocorticoids|mesh-ancestor
92308687|NCT05247554|Hormones|hormones|mesh-ancestor
92308688|NCT05247554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308689|NCT05247554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308690|NCT05247554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308691|NCT05247554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308692|NCT05247554|Antimalarials|antimalarials|mesh-ancestor
92308693|NCT05247554|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92308694|NCT05247554|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92308695|NCT05247554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308696|NCT05247554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308697|NCT05247554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308698|NCT05247554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308699|NCT02596022|Ketamine|ketamine|mesh-list
92308700|NCT02596022|Analgesics|analgesics|mesh-ancestor
92308701|NCT02596022|Sensory System Agents|sensory system agents|mesh-ancestor
92308702|NCT02596022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308703|NCT02596022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308704|NCT02596022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92308705|NCT02596022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92308706|NCT02596022|Anesthetics, General|anesthetics, general|mesh-ancestor
92308707|NCT02596022|Anesthetics|anesthetics|mesh-ancestor
92308708|NCT02596022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308709|NCT02596022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92308710|NCT02596022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92308711|NCT02596022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308712|NCT02596022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308713|NCT00364442|Fluticasone|fluticasone|mesh-list
92308715|NCT00364442|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92308716|NCT00364442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308717|NCT00364442|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92308718|NCT00364442|Autonomic Agents|autonomic agents|mesh-ancestor
92308719|NCT00364442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308720|NCT00364442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308721|NCT00364442|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92308722|NCT00364442|Respiratory System Agents|respiratory system agents|mesh-ancestor
92308723|NCT00364442|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308724|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92308725|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92308726|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92308727|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92308728|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92308729|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308730|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308731|NCT05371574|Clonidine|clonidine|mesh-list
92308732|NCT05371574|Analgesics|analgesics|mesh-ancestor
92308733|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
92308734|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308735|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308736|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92308737|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
92308738|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
92308739|NCT05371574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92308740|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92308741|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92308742|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
92308743|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308744|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308745|NCT05371340|Quercetin|quercetin|mesh-list
92308746|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
92308747|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308748|NCT05371340|Protective Agents|protective agents|mesh-ancestor
92308749|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308750|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
92308751|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92308752|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
92308753|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308754|NCT02601170|Viscosupplements|viscosupplements|mesh-ancestor
92308755|NCT02601170|Protective Agents|protective agents|mesh-ancestor
92308756|NCT00366002|Darifenacin|darifenacin|mesh-list
92308757|NCT00366002|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92308758|NCT00366002|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92308759|NCT00366002|Cholinergic Agents|cholinergic agents|mesh-ancestor
92308760|NCT00366002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308761|NCT00366002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308762|NCT00366002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308763|NCT00366002|Urological Agents|urological agents|mesh-ancestor
92308764|NCT00422240|Adapalene|adapalene|mesh-list
92308765|NCT00422240|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92308766|NCT00422240|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92308767|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
92308768|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92308769|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92308770|NCT00422240|Analgesics|analgesics|mesh-ancestor
92308771|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
92308772|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308773|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308774|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308775|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308776|NCT02605304|Ribavirin|ribavirin|mesh-list
92308777|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
92308778|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92308779|NCT02605304|Ledipasvir|ledipasvir|mesh-list
92308781|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308782|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
92308783|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308784|NCT05365880|Lidocaine|lidocaine|mesh-list
92308785|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
92308786|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
92308787|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308788|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308789|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
92308790|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308791|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92308792|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92308793|NCT05365880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92308794|NCT05365880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92308795|NCT05365880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308796|NCT05362994|Sirolimus|sirolimus|mesh-list
92308797|NCT05362994|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92308798|NCT05362994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308799|NCT05362994|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92308800|NCT05362994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308801|NCT05362994|Antifungal Agents|antifungal agents|mesh-ancestor
92308802|NCT05362994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92308803|NCT05362994|Immunologic Factors|immunologic factors|mesh-ancestor
92308804|NCT05362994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308805|NCT02607254|Pregabalin|pregabalin|mesh-list
92308806|NCT02607254|Analgesics|analgesics|mesh-ancestor
92308807|NCT02607254|Sensory System Agents|sensory system agents|mesh-ancestor
92308808|NCT02607254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308809|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308810|NCT02607254|Anticonvulsants|anticonvulsants|mesh-ancestor
92308811|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92308812|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92308813|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308814|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92308815|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92308816|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92308817|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308818|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92308819|NCT02611154|Testosterone|testosterone|mesh-list
92308820|NCT02611154|Androgens|androgens|mesh-ancestor
92308821|NCT02611154|Hormones|hormones|mesh-ancestor
92308822|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308823|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308824|NCT02617784|Oseltamivir|oseltamivir|mesh-list
92308825|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
92308826|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308827|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308828|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308829|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92308830|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92308831|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308832|NCT00365612|Tenofovir|tenofovir|mesh-list
92308833|NCT00365612|Emtricitabine|emtricitabine|mesh-list
92308834|NCT00365612|Efavirenz|efavirenz|mesh-list
92308835|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
92308836|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308837|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92308838|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92308839|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308840|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308841|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92308842|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92308843|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92308844|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92308845|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92308846|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92308847|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92308848|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92308849|NCT02974166|Ibuprofen|ibuprofen|mesh-list
92308850|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92308851|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
92308852|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92308853|NCT02974166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92308854|NCT02974166|Analgesics|analgesics|mesh-ancestor
92308855|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
92308856|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308857|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308858|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308859|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92308860|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308861|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308862|NCT02974166|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92308863|NCT02974166|Antidepressive Agents|antidepressive agents|mesh-ancestor
92308864|NCT02974166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92308865|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92308866|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92308867|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92308868|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308870|NCT05731778|Fluorides|fluorides|mesh-list
92308871|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
92308872|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
92308873|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
92308874|NCT05731778|Protective Agents|protective agents|mesh-ancestor
92308875|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308876|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92308877|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308878|NCT05477264|Tislelizumab|tislelizumab|mesh-list
92308879|NCT05477264|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308880|NCT05477264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308881|NCT00422318|Benzbromarone|benzbromarone|mesh-list
92308882|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
92308883|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
92308884|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92308885|NCT00364754|Tesmilifene|tesmilifene|mesh-list
92308886|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
92308887|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
92308888|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308889|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308890|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308891|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92308892|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
92308893|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92308894|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92308895|NCT04741880|Lidocaine|lidocaine|mesh-list
92308896|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
92308897|NCT04741880|Anesthetics|anesthetics|mesh-ancestor
92308898|NCT04741880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308899|NCT04741880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308900|NCT04741880|Sensory System Agents|sensory system agents|mesh-ancestor
92308901|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308902|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92308903|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92308904|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92308905|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92308906|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308907|NCT04742504|Benralizumab|benralizumab|mesh-list
92308908|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92308909|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
92308910|NCT00365924|Teriparatide|teriparatide|mesh-list
92308911|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92308912|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308913|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92308914|NCT05360030|Ketamine|ketamine|mesh-list
92308915|NCT05360030|Naloxone|naloxone|mesh-list
92308916|NCT05360030|Analgesics|analgesics|mesh-ancestor
92308917|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
92308918|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92308919|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308920|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92308921|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92308922|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
92308924|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308925|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92308926|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92308927|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92308928|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308929|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92308930|NCT04158362|Paclitaxel|paclitaxel|mesh-list
92308931|NCT04158362|Capecitabine|capecitabine|mesh-list
92308932|NCT04158362|Letrozole|letrozole|mesh-list
92308933|NCT04158362|Fulvestrant|fulvestrant|mesh-list
92308934|NCT04158362|Anastrozole|anastrozole|mesh-list
92308935|NCT04158362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92308936|NCT04158362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308937|NCT04158362|Tubulin Modulators|tubulin modulators|mesh-ancestor
92308938|NCT04158362|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308939|NCT04158362|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308940|NCT04158362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308941|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92308942|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
92308943|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92308944|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92308945|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308946|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92308947|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
92308948|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308949|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308950|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308951|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92308952|NCT05272202|Propofol|propofol|mesh-list
92308953|NCT05272202|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92308954|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92308955|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308956|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92308957|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
92308959|NCT01575834|Denosumab|denosumab|mesh-list
92308960|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92308961|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308962|NCT05707442|Acetazolamide|acetazolamide|mesh-list
92308963|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
92308964|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92308965|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92308966|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308967|NCT05707442|Diuretics|diuretics|mesh-ancestor
92308968|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
92308969|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308970|NCT04604132|Paclitaxel|paclitaxel|mesh-list
92308971|NCT04604132|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92308972|NCT04604132|Atezolizumab|atezolizumab|mesh-list
92308973|NCT04604132|Ramucirumab|ramucirumab|mesh-list
92308974|NCT04604132|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92308975|NCT04604132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92308976|NCT04604132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308977|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92308978|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92308979|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92308980|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308981|NCT04604132|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92308982|NCT04604132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308983|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
92308984|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308985|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92308986|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92308987|NCT05193188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92308988|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308989|NCT04799262|Prednisone|prednisone|mesh-list
92308990|NCT04799262|Tofacitinib|tofacitinib|mesh-list
92308991|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92308992|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
92308993|NCT04799262|Hormones|hormones|mesh-ancestor
92308994|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92308995|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92308996|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92308997|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92308998|NCT04799262|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92308999|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92309000|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309001|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309002|NCT00851136|Bevacizumab|bevacizumab|mesh-list
92309003|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309004|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309005|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92309006|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92309007|NCT00851136|Growth Substances|growth substances|mesh-ancestor
92309008|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309009|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
92309010|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
92309011|NCT00366470|Vitamin D|vitamin d|mesh-list
92309012|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92309013|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309014|NCT00366470|Vitamins|vitamins|mesh-ancestor
92309015|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
92309016|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92309017|NCT04537286|Paclitaxel|paclitaxel|mesh-list
92309018|NCT04537286|Cisplatin|cisplatin|mesh-list
92309019|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92309020|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309021|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
92309022|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
92309023|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
92309024|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309025|NCT02620904|Mifepristone|mifepristone|mesh-list
92309026|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92309027|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
92309028|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92309029|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309030|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92309031|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92309032|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92309033|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
92309034|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92309035|NCT02620904|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92309036|NCT02620904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92309037|NCT02620904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309038|NCT02620904|Luteolytic Agents|luteolytic agents|mesh-ancestor
92309039|NCT02620904|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92309040|NCT02620904|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92309042|NCT00300768|Moxidectin|moxidectin|mesh-list
92309043|NCT00300768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92309044|NCT00300768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309045|NCT00300768|Anthelmintics|anthelmintics|mesh-ancestor
92309046|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
92309047|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
92309048|NCT02621060|Antacids|antacids|mesh-ancestor
92309049|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309050|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92309051|NCT04740554|Prednisone|prednisone|mesh-list
92309052|NCT04740554|Deflazacort|deflazacort|mesh-list
92309053|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309055|NCT04740554|Hormones|hormones|mesh-ancestor
92309056|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309057|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309058|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92309059|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309060|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309061|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
92309062|NCT04506086|Blinatumomab|blinatumomab|mesh-list
92309063|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309064|NCT02624180|Colchicine|colchicine|mesh-list
92309065|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
92309066|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309067|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
92309068|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
92309069|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
92309070|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309071|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309072|NCT05068232|Carboplatin|carboplatin|mesh-list
92309073|NCT05068232|Etoposide|etoposide|mesh-list
92309074|NCT05068232|Durvalumab|durvalumab|mesh-list
92309075|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309076|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92309077|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309078|NCT05068232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309079|NCT05068232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309080|NCT05068232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309081|NCT05068232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309082|NCT04326764|Panobinostat|panobinostat|mesh-list
92309083|NCT04326764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309084|NCT04326764|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92309085|NCT04326764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309086|NCT04326764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309087|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92309088|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92309089|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92309090|NCT02629094|Eplerenone|eplerenone|mesh-list
92309091|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92309092|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
92309093|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309094|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309095|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92309096|NCT02629094|Diuretics|diuretics|mesh-ancestor
92309097|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
92309098|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309099|NCT02630030|Ixazomib|ixazomib|mesh-list
92309100|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309102|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309103|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309104|NCT04289792|Paclitaxel|paclitaxel|mesh-list
92309105|NCT04289792|Gemcitabine|gemcitabine|mesh-list
92309106|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92309107|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309108|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
92309109|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
92309110|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
92309111|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309112|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92309113|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
92309114|NCT02631590|Gemcitabine|gemcitabine|mesh-list
92309115|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309116|NCT02631590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92309117|NCT02631590|Antimetabolites|antimetabolites|mesh-ancestor
92309118|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309119|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
92309120|NCT02253654|Hematinics|hematinics|mesh-ancestor
92309121|NCT02252406|Ranolazine|ranolazine|mesh-list
92309122|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92309123|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309124|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309125|NCT02252016|Grazoprevir|grazoprevir|mesh-list
92309126|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
92309127|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309128|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92309129|NCT04784442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92309130|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
92309131|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309132|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92309133|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309134|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92309135|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309136|NCT02706847|Upadacitinib|upadacitinib|mesh-list
92309137|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92309138|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92309139|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309140|NCT02706847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309141|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309142|NCT02470741|Letrozole|letrozole|mesh-list
92309143|NCT02470741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309144|NCT02470741|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92309145|NCT02470741|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92309146|NCT02470741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309147|NCT02470741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309148|NCT02470741|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92309149|NCT02470741|Hormone Antagonists|hormone antagonists|mesh-ancestor
92309150|NCT02470741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309151|NCT02470741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309152|NCT02544607|Ketamine|ketamine|mesh-list
92309153|NCT02544607|Analgesics|analgesics|mesh-ancestor
91961827|NCT02483221|Morphine|morphine|mesh-list
92309154|NCT02544607|Sensory System Agents|sensory system agents|mesh-ancestor
92309155|NCT02544607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309156|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309157|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92309158|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92309159|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
92309160|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
92309161|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309162|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92309163|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92309164|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309165|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309166|NCT00363571|Acetazolamide|acetazolamide|mesh-list
92309167|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
92309168|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92309169|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309170|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309171|NCT00363571|Diuretics|diuretics|mesh-ancestor
92309172|NCT00363571|Natriuretic Agents|natriuretic agents|mesh-ancestor
92309173|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309174|NCT04744675|Triamcinolone|triamcinolone|mesh-list
92309175|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92309176|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92309177|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92309178|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309179|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
92309180|NCT04744675|Hormones|hormones|mesh-ancestor
92309181|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309182|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309183|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309184|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
92309185|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309186|NCT04744675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309187|NCT02471521|Rocuronium|rocuronium|mesh-list
92309188|NCT02471521|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92309189|NCT02471521|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92309190|NCT02471521|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92309191|NCT02471521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309192|NCT02471521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309193|NCT02624479|Sodium thiosulfate|sodium thiosulfate|mesh-list
92309194|NCT02624479|Antidotes|antidotes|mesh-ancestor
92309195|NCT02624479|Protective Agents|protective agents|mesh-ancestor
92309196|NCT02624479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309197|NCT02624479|Antioxidants|antioxidants|mesh-ancestor
92309198|NCT02624479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309199|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
92309200|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309201|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309202|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
92309203|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
92309204|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
92309205|NCT02472223|Povidone|povidone|mesh-list
92309206|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
92309207|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
92309208|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
92309209|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92309210|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309211|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92309212|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92309213|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
92309214|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309215|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309216|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309217|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309218|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309219|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309220|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309221|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92309222|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92309223|NCT02473783|Sertraline|sertraline|mesh-list
92309224|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
92309225|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92309226|NCT02473783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92309227|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92309228|NCT02473783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309229|NCT02473783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309231|NCT02473783|Serotonin Agents|serotonin agents|mesh-ancestor
92309232|NCT02473783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309233|NCT02247804|Timolol|timolol|mesh-list
92309234|NCT02247804|Bimatoprost|bimatoprost|mesh-list
92309235|NCT02247804|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92309236|NCT02247804|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92309237|NCT02247804|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309238|NCT02247804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309239|NCT02247804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309240|NCT02247804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309241|NCT02247804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92309242|NCT02247804|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309243|NCT00366938|Lumiracoxib|lumiracoxib|mesh-list
92309244|NCT00366938|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92309245|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92309246|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309247|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309248|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92309249|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92309250|NCT00366938|Analgesics|analgesics|mesh-ancestor
92309251|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
92309252|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309253|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309254|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309255|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309257|NCT05026320|Naproxen|naproxen|mesh-list
92309258|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92309259|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92309260|NCT05026320|Analgesics|analgesics|mesh-ancestor
92309261|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
92309262|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309263|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309264|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309265|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309266|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92309267|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309268|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309269|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
92309270|NCT04068272|Bosentan|bosentan|mesh-list
92309271|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309272|NCT04068272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92309273|NCT04068272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309274|NCT04058756|Spartalizumab|spartalizumab|mesh-list
92309275|NCT04058756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92347636|NCT01722162|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92309276|NCT04058756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309277|NCT04058756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309278|NCT04058756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309280|NCT02243202|Phentermine|phentermine|mesh-list
92309281|NCT02243202|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92309282|NCT02243202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309283|NCT02243202|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92309284|NCT02243202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309285|NCT02243202|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92309286|NCT02243202|Appetite Depressants|appetite depressants|mesh-ancestor
92309287|NCT02243202|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92309288|NCT02243202|Sympathomimetics|sympathomimetics|mesh-ancestor
92309289|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
92309290|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309291|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309292|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309293|NCT04050410|Moxonidine|moxonidine|mesh-list
92309294|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309295|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
92309296|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92309297|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92309298|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92309299|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91961989|NCT02476825|Xhance|xhance|mesh-list
92309300|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309301|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309302|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
92309303|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309304|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309305|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92309306|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309308|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309309|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309310|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
92309311|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309312|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309313|NCT02560051|Ketoconazole|ketoconazole|mesh-list
92309314|NCT02560051|Docetaxel|docetaxel|mesh-list
92309315|NCT02560051|Doxorubicin|doxorubicin|mesh-list
92309316|NCT02560051|Estramustine|estramustine|mesh-list
92309317|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309318|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
92309319|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
92309320|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
92309321|NCT02560051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309322|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92309323|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309324|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309325|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309326|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
92309327|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309328|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92309329|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92309330|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92309331|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
92309332|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309333|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309334|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92309335|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92309336|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
92309337|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92309338|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92309339|NCT03786770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92309340|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92309341|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309342|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309343|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92309344|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309345|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309347|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309348|NCT00367718|Bortezomib|bortezomib|mesh-list
92309349|NCT00367718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309350|NCT02474407|Diazepam|diazepam|mesh-list
92309351|NCT02474407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92309352|NCT02474407|Anticonvulsants|anticonvulsants|mesh-ancestor
92309353|NCT02474407|Antiemetics|antiemetics|mesh-ancestor
92309354|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
92309355|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309356|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309357|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92309358|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92309359|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309360|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92309361|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92309362|NCT02474407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92309363|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92309364|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92309365|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92309366|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
92309367|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
92309368|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
92309369|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
92309370|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309371|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309372|NCT05588492|Rifamycins|rifamycins|mesh-list
92309373|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
92309374|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309375|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309377|NCT03777956|Lacosamide|lacosamide|mesh-list
92309378|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
92309379|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92309380|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92309381|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309382|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309383|NCT02481505|Chloroprocaine|chloroprocaine|mesh-list
92309384|NCT02481505|Anesthetics, Local|anesthetics, local|mesh-ancestor
92309385|NCT02481505|Anesthetics|anesthetics|mesh-ancestor
92309386|NCT02481505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309387|NCT02481505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309388|NCT02481505|Sensory System Agents|sensory system agents|mesh-ancestor
92309389|NCT02481505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309390|NCT02563093|Vaccines|vaccines|mesh-list
92309391|NCT02563093|Immunologic Factors|immunologic factors|mesh-ancestor
92309392|NCT02563093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309394|NCT02564029|PF-06372865|pf-06372865|mesh-list
92309395|NCT02564029|Anticonvulsants|anticonvulsants|mesh-ancestor
92309396|NCT02564029|Antiemetics|antiemetics|mesh-ancestor
92309397|NCT02564029|Autonomic Agents|autonomic agents|mesh-ancestor
92309398|NCT02564029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309399|NCT02564029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309400|NCT02564029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92309401|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92309402|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309403|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92309404|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92309405|NCT02564029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92309406|NCT02564029|GABA Modulators|gaba modulators|mesh-ancestor
92309407|NCT02564029|GABA Agents|gaba agents|mesh-ancestor
92309408|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309409|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309410|NCT05588336|Morphine|morphine|mesh-list
92309411|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92309412|NCT05588336|Narcotics|narcotics|mesh-ancestor
92309413|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309414|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309415|NCT05588336|Analgesics|analgesics|mesh-ancestor
92309416|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
92309417|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309418|NCT02564497|Abatacept|abatacept|mesh-list
92309419|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92309420|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309421|NCT02564497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309422|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309423|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309424|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
92309425|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309426|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309427|NCT02565901|Sirolimus|sirolimus|mesh-list
92309428|NCT02565901|Carboplatin|carboplatin|mesh-list
92309429|NCT02565901|Docetaxel|docetaxel|mesh-list
92309430|NCT02565901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309431|NCT02565901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92309432|NCT02565901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92309433|NCT02565901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92309434|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309435|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309436|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309437|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92309438|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
92309439|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309440|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
92309441|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309442|NCT03926624|Cytarabine|cytarabine|mesh-list
92309443|NCT03926624|Fludarabine|fludarabine|mesh-list
92309444|NCT03926624|Etoposide|etoposide|mesh-list
92309445|NCT03926624|Azacitidine|azacitidine|mesh-list
92309446|NCT03926624|Decitabine|decitabine|mesh-list
92309447|NCT03926624|Venetoclax|venetoclax|mesh-list
92309448|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
92309449|NCT03926624|Idarubicin|idarubicin|mesh-list
92309450|NCT03926624|Cladribine|cladribine|mesh-list
92309451|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309452|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92309453|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
92309454|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309455|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309456|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
92309457|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309458|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92309459|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309460|NCT03926624|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309461|NCT03926624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309462|NCT03926624|Antiviral Agents|antiviral agents|mesh-ancestor
92309463|NCT03926624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309464|NCT03926624|Analgesics|analgesics|mesh-ancestor
92309465|NCT03926624|Sensory System Agents|sensory system agents|mesh-ancestor
92309466|NCT03926624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309467|NCT03926624|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92309468|NCT05588102|Fluvoxamine|fluvoxamine|mesh-list
92309469|NCT05588102|Citalopram|citalopram|mesh-list
92309470|NCT05588102|Fluoxetine|fluoxetine|mesh-list
92309471|NCT05588102|Paroxetine|paroxetine|mesh-list
92309472|NCT05588102|Sertraline|sertraline|mesh-list
92309473|NCT05588102|Escitalopram|escitalopram|mesh-list
92309474|NCT05588102|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92309475|NCT05588102|Serotonin|serotonin|mesh-list
92309476|NCT05588102|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92309477|NCT05588102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309478|NCT05588102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309479|NCT05588102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309480|NCT05588102|Serotonin Agents|serotonin agents|mesh-ancestor
92309481|NCT05588102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309482|NCT05588102|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92309483|NCT05588102|Antidepressive Agents|antidepressive agents|mesh-ancestor
92309484|NCT05588102|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92309485|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92309486|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92309487|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309489|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92309490|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309491|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92309492|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92411115|NCT04745299|Riluzole|riluzole|mesh-list
92309493|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92309494|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92309495|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309496|NCT03551210|Levofloxacin|levofloxacin|mesh-list
92309497|NCT03551210|Ofloxacin|ofloxacin|mesh-list
92309498|NCT03551210|Nemonoxacin|nemonoxacin|mesh-list
92309499|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92309500|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309501|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309502|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309503|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309504|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309505|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309506|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309507|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92309508|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92309509|NCT02482675|Caseins|caseins|mesh-list
92309510|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
92309511|NCT02482675|Sequestering Agents|sequestering agents|mesh-ancestor
92309512|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309513|NCT00364195|Tesmilifene|tesmilifene|mesh-list
92309514|NCT00364195|Histamine Antagonists|histamine antagonists|mesh-ancestor
92309515|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
92309516|NCT00364195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309517|NCT00364195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309518|NCT00364195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309519|NCT00364195|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92309520|NCT02566369|Trifarotene|trifarotene|mesh-list
92309521|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
92309522|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
92309523|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309524|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92309525|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92309526|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
92309527|NCT02571439|Ropivacaine|ropivacaine|mesh-list
92309528|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
92309529|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
92309530|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309531|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309532|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
92309533|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309534|NCT02573857|Artefenomel|artefenomel|mesh-list
92309535|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
92309536|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92309537|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92309538|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309539|NCT03678428|Leucovorin|leucovorin|mesh-list
92309540|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
92309541|NCT03678428|Irinotecan|irinotecan|mesh-list
92309542|NCT03678428|Floxuridine|floxuridine|mesh-list
92309543|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309544|NCT03678428|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92309545|NCT03678428|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309546|NCT03678428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309547|NCT03678428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309549|NCT03678428|Protective Agents|protective agents|mesh-ancestor
92309550|NCT03678428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309551|NCT03678428|Vitamin B Complex|vitamin b complex|mesh-ancestor
92309552|NCT03678428|Vitamins|vitamins|mesh-ancestor
92309553|NCT03678428|Micronutrients|micronutrients|mesh-ancestor
92309554|NCT03678428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92309555|NCT03678428|Antimetabolites|antimetabolites|mesh-ancestor
92309557|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92309558|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
92309559|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
92309560|NCT02577601|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92309561|NCT02577601|Estradiol|estradiol|mesh-list
92309562|NCT02577601|Estrogens|estrogens|mesh-ancestor
92309563|NCT02577601|Hormones|hormones|mesh-ancestor
92309564|NCT02577601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309565|NCT02577601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309566|NCT02577601|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92309567|NCT02577601|Contraceptive Agents|contraceptive agents|mesh-ancestor
92309568|NCT02577601|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92309569|NCT02577601|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92411116|NCT04745299|Anticonvulsants|anticonvulsants|mesh-ancestor
92309570|NCT02577601|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92309571|NCT02577601|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92309572|NCT02577991|Triamcinolone|triamcinolone|mesh-list
92309573|NCT02577991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309574|NCT02577991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309575|NCT02577991|Glucocorticoids|glucocorticoids|mesh-ancestor
92309576|NCT02577991|Hormones|hormones|mesh-ancestor
92309577|NCT02577991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309578|NCT02207634|Evolocumab|evolocumab|mesh-list
92309579|NCT02207634|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92309580|NCT02207634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92309581|NCT02207634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92309582|NCT02207634|Antimetabolites|antimetabolites|mesh-ancestor
92309583|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309584|NCT02207634|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92309585|NCT02207634|Protease Inhibitors|protease inhibitors|mesh-ancestor
92309586|NCT02207634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309587|NCT02207634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92309588|NCT02484859|Metoprolol|metoprolol|mesh-list
92309589|NCT02484859|Remifentanil|remifentanil|mesh-list
92309590|NCT02484859|Tramadol|tramadol|mesh-list
92309591|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92309592|NCT02484859|Narcotics|narcotics|mesh-ancestor
92309593|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309594|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309595|NCT02484859|Analgesics|analgesics|mesh-ancestor
92309596|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
92309597|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309598|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92309599|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309600|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
92309601|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
92309602|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92309603|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92309604|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92309605|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309606|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309607|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309608|NCT04341727|Azithromycin|azithromycin|mesh-list
92309609|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
92309610|NCT04341727|Chloroquine|chloroquine|mesh-list
92309611|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92309612|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309613|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309614|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
92309615|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92309616|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92309617|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309618|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309619|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309620|NCT04341727|Amebicides|amebicides|mesh-ancestor
92309621|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92309622|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92309623|NCT04341727|Analgesics|analgesics|mesh-ancestor
92309624|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
92309625|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309626|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309627|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309628|NCT04341727|Filaricides|filaricides|mesh-ancestor
92309629|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
92309630|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
92309631|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92309633|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309634|NCT00367094|Diuretics|diuretics|mesh-ancestor
92309635|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
92309636|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309637|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92309638|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309639|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309640|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92309641|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92309642|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309643|NCT02581111|Naloxone|naloxone|mesh-list
92309644|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92309645|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309646|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
92309647|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309648|NCT05587400|Dobutamine|dobutamine|mesh-list
92309649|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
92309650|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92309651|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
92309652|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309653|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309654|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92309655|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
92309656|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92309657|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
92309658|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309659|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309660|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92309661|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
92309662|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
92309663|NCT05587400|Protective Agents|protective agents|mesh-ancestor
92309664|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92309665|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
92309666|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92309667|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92309668|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92309669|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309670|NCT04339868|Terlipressin|terlipressin|mesh-list
92309671|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309672|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92309673|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92309674|NCT00367172|Antiviral Agents|antiviral agents|mesh-ancestor
92309675|NCT00367172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309676|NCT00367250|Trastuzumab|trastuzumab|mesh-list
92309677|NCT00367250|Cetuximab|cetuximab|mesh-list
92309678|NCT00367250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309679|NCT00367250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309680|NCT02489227|Adalimumab|adalimumab|mesh-list
92309681|NCT02489227|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92309682|NCT02489227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309684|NCT02490631|Chlorhexidine|chlorhexidine|mesh-list
92309685|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92309686|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92309687|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309688|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
92309689|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92309690|NCT02207556|Doxycycline|doxycycline|mesh-list
92309691|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309692|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309693|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
92309694|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92309695|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92309696|NCT02572609|Ambroxol|ambroxol|mesh-list
92309697|NCT02572609|Expectorants|expectorants|mesh-ancestor
92309698|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
92309699|NCT02587117|Prednisolone|prednisolone|mesh-list
92309700|NCT02587117|Lycopene|lycopene|mesh-list
92309701|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92309702|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
92309703|NCT02587117|Hormones|hormones|mesh-ancestor
92309704|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309705|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309706|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92309707|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309708|NCT02587117|Protective Agents|protective agents|mesh-ancestor
92309709|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
92309710|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309711|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92309712|NCT02587117|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92309713|NCT02587351|Metoprolol|metoprolol|mesh-list
92309714|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92309715|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309716|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
92309717|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
92309718|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309719|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309720|NCT02587351|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92309721|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92309722|NCT02587351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92309723|NCT02587351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309724|NCT02587351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309725|NCT02587351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309726|NCT05553314|Carvedilol|carvedilol|mesh-list
92309727|NCT05553314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92309728|NCT05553314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92309729|NCT05553314|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309730|NCT05553314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309731|NCT05553314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309732|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309733|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309734|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
92309735|NCT05553314|Protective Agents|protective agents|mesh-ancestor
92309736|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92309737|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309738|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92309739|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
92309740|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92309741|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92309742|NCT03260504|Aldesleukin|aldesleukin|mesh-list
92309743|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
92309744|NCT03260504|Interleukin-2|interleukin-2|mesh-list
92309745|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
92309746|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
92309747|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92309748|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309749|NCT03260504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92309750|NCT03260504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309751|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
92309752|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309753|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92309754|NCT03260504|Analgesics|analgesics|mesh-ancestor
92309755|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
92309756|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309757|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92309758|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92309759|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
92309760|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309761|NCT00422396|Fenofibrate|fenofibrate|mesh-list
92309762|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92309763|NCT00422396|Antimetabolites|antimetabolites|mesh-ancestor
92309764|NCT00422396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309765|NCT00422396|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92309766|NCT00364273|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92309767|NCT00364273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92309768|NCT00364273|Autonomic Agents|autonomic agents|mesh-ancestor
92309769|NCT00364273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309770|NCT00364273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309771|NCT00364273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92309772|NCT00364273|Respiratory System Agents|respiratory system agents|mesh-ancestor
92309773|NCT00364273|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92309774|NCT00364273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92309775|NCT00364273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92309776|NCT00364273|Adrenergic Agents|adrenergic agents|mesh-ancestor
92309777|NCT00364273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309778|NCT00364273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309779|NCT02495467|Nitroglycerin|nitroglycerin|mesh-list
92309780|NCT02495467|Vasodilator Agents|vasodilator agents|mesh-ancestor
92309781|NCT05249023|Butyric Acid|butyric acid|mesh-list
92309782|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
92309783|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
92309784|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309785|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309786|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309788|NCT02495779|Emtricitabine|emtricitabine|mesh-list
92309789|NCT02495779|Antiviral Agents|antiviral agents|mesh-ancestor
92309790|NCT02495779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309791|NCT02495779|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92309792|NCT02495779|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92309793|NCT02495779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309794|NCT02495779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309795|NCT02495779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92309796|NCT02495779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92309797|NCT03241771|Naloxone|naloxone|mesh-list
92309798|NCT03241771|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92309799|NCT03241771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309800|NCT03241771|Sensory System Agents|sensory system agents|mesh-ancestor
92309801|NCT03241771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309802|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
92309803|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
92309804|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309805|NCT02502487|Ropivacaine|ropivacaine|mesh-list
92309806|NCT02502487|Tetracaine|tetracaine|mesh-list
92309807|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
92309808|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
92309809|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309810|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309811|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
92309812|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309813|NCT03238196|Fulvestrant|fulvestrant|mesh-list
92309814|NCT03238196|Palbociclib|palbociclib|mesh-list
92309815|NCT03238196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92309816|NCT03238196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309817|NCT03238196|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92309818|NCT03238196|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92309819|NCT03238196|Hormone Antagonists|hormone antagonists|mesh-ancestor
92309820|NCT03238196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309821|NCT03238196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309822|NCT03238196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92309823|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309824|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309825|NCT02632045|Fulvestrant|fulvestrant|mesh-list
92309826|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92309827|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309828|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92309829|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92309830|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
92309831|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92309832|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309833|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
92309834|NCT02503735|Ledipasvir|ledipasvir|mesh-list
92309835|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
92309836|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309837|NCT04001881|Anesthetics|anesthetics|mesh-list
92309838|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309839|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309840|NCT03019640|Cytarabine|cytarabine|mesh-list
92309841|NCT03019640|Rituximab|rituximab|mesh-list
92309842|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92309843|NCT03019640|Etoposide|etoposide|mesh-list
92309844|NCT03019640|Lenalidomide|lenalidomide|mesh-list
92309845|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
92309846|NCT03019640|Melphalan|melphalan|mesh-list
92309847|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
92309848|NCT03019640|Carmustine|carmustine|mesh-list
92309849|NCT03019640|Podophyllotoxin|podophyllotoxin|mesh-list
92309850|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92309851|NCT03019640|Antibodies|antibodies|mesh-list
92309852|NCT03019640|Immunoglobulins|immunoglobulins|mesh-list
92309853|NCT03019640|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92309854|NCT03019640|Lenograstim|lenograstim|mesh-list
92309855|NCT03019640|Immunologic Factors|immunologic factors|mesh-ancestor
92309856|NCT03019640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309857|NCT03019640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309858|NCT03019640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92309859|NCT03019640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92309860|NCT03019640|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309861|NCT03019640|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309862|NCT03019640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309863|NCT03019640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309864|NCT03019640|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92309865|NCT03019640|Antimetabolites|antimetabolites|mesh-ancestor
92309866|NCT03019640|Antiviral Agents|antiviral agents|mesh-ancestor
92309867|NCT03019640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309868|NCT03019640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309869|NCT03019640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92309870|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92309871|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92309872|NCT03019640|Growth Substances|growth substances|mesh-ancestor
92309873|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
92309874|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92309875|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
92309876|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92309877|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
92309878|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
92309879|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92309880|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92309881|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92309882|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
92309883|NCT02136901|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92309884|NCT02136901|Immunologic Factors|immunologic factors|mesh-ancestor
92309885|NCT02136901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309886|NCT02136901|Viscosupplements|viscosupplements|mesh-ancestor
92309887|NCT02136901|Protective Agents|protective agents|mesh-ancestor
92309888|NCT02507011|Carvedilol|carvedilol|mesh-list
92309889|NCT02507011|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92309890|NCT02507011|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92309892|NCT02507011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92309893|NCT02507011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309894|NCT02507011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309895|NCT02507011|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92309896|NCT02507011|Antioxidants|antioxidants|mesh-ancestor
92309897|NCT02507011|Protective Agents|protective agents|mesh-ancestor
92309898|NCT02507011|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92309899|NCT02507011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92309900|NCT02507011|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92309901|NCT02507011|Vasodilator Agents|vasodilator agents|mesh-ancestor
92309902|NCT02507011|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92309903|NCT02507011|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92309904|NCT02977286|Methylnaltrexone|methylnaltrexone|mesh-list
92309905|NCT02977286|Naloxegol|naloxegol|mesh-list
92309906|NCT02977286|Bisacodyl|bisacodyl|mesh-list
91962590|NCT05058105|Meropenem|meropenem|mesh-list
92309907|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
92309908|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92309909|NCT02977286|Cathartics|cathartics|mesh-ancestor
92309910|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92309911|NCT02977286|Laxatives|laxatives|mesh-ancestor
92309912|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92309913|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309914|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
92309915|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309916|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
92309917|NCT05345210|Amoxicillin|amoxicillin|mesh-list
92309918|NCT05345210|Clarithromycin|clarithromycin|mesh-list
92309919|NCT05345210|Tetracycline|tetracycline|mesh-list
92309920|NCT05345210|Furazolidone|furazolidone|mesh-list
92309921|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309922|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309923|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92309924|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309925|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309926|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92309927|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92309928|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92309929|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92309930|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92309931|NCT05345210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92309932|NCT05345210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92309933|NCT05345210|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92309934|NCT02976896|Apatinib|apatinib|mesh-list
92309935|NCT02976896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309936|NCT02976896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92309937|NCT02976896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309938|NCT02976896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309939|NCT01810705|Asparaginase|asparaginase|mesh-list
92309940|NCT01810705|Eryaspase|eryaspase|mesh-list
92309941|NCT01810705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309942|NCT02508103|Oxytocin|oxytocin|mesh-list
92309943|NCT02508103|Oxytocics|oxytocics|mesh-ancestor
92309944|NCT02508103|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92309945|NCT02508103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309946|NCT02508259|Suramin|suramin|mesh-list
92309947|NCT02508259|Antinematodal Agents|antinematodal agents|mesh-ancestor
92309948|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
92309949|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92309950|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309951|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309952|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92309953|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92309954|NCT02848820|Amoxicillin|amoxicillin|mesh-list
92309955|NCT02848820|Gentamicins|gentamicins|mesh-list
92309956|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92309957|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
92309958|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
92309959|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92309960|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309961|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92309962|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309963|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309964|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92309965|NCT00534469|Cytarabine|cytarabine|mesh-list
92309966|NCT00534469|Aldesleukin|aldesleukin|mesh-list
92309967|NCT00534469|Etoposide|etoposide|mesh-list
92309968|NCT00534469|Idarubicin|idarubicin|mesh-list
92309969|NCT00534469|Busulfan|busulfan|mesh-list
92309970|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92309971|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92309972|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92309973|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92309974|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92309975|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92309976|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92309977|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
92309978|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
92309979|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92309980|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92309981|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
92309982|NCT00534469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309983|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
92309984|NCT00534469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92309985|NCT00534469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92309986|NCT00534469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92309987|NCT00534469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92309988|NCT00534469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92309989|NCT02240628|Lidocaine|lidocaine|mesh-list
92309990|NCT02240628|Tetracaine|tetracaine|mesh-list
92309991|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
92309992|NCT02240628|Anesthetics|anesthetics|mesh-ancestor
92309993|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92309994|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92309995|NCT02240628|Sensory System Agents|sensory system agents|mesh-ancestor
92309996|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92309997|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92309998|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92309999|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92310000|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310001|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310002|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
92310003|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92310004|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92310005|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310006|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
92310007|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310008|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92310009|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92310010|NCT02207400|Listerine|listerine|mesh-list
92310011|NCT02207400|Fluorides|fluorides|mesh-list
92310012|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
92310013|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
92310014|NCT02207400|Protective Agents|protective agents|mesh-ancestor
92310015|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310016|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92310017|NCT02207400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310018|NCT02511535|Vaccines|vaccines|mesh-list
92310019|NCT02511535|Immunologic Factors|immunologic factors|mesh-ancestor
92310020|NCT02511535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310021|NCT03545035|Rituximab|rituximab|mesh-list
92310022|NCT03545035|Idelalisib|idelalisib|mesh-list
92310023|NCT03545035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310024|NCT03545035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310025|NCT03545035|Immunologic Factors|immunologic factors|mesh-ancestor
92310026|NCT03545035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310027|NCT03545035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310028|NCT03545035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310029|NCT03545035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310030|NCT02589847|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92310031|NCT02589847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92310032|NCT02589847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310033|NCT02589847|Antitubercular Agents|antitubercular agents|mesh-ancestor
92310034|NCT02592421|Dapagliflozin|dapagliflozin|mesh-list
92310035|NCT02592421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92310036|NCT02592421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310037|NCT02592421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92310038|NCT02592421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310039|NCT02512783|Lidocaine|lidocaine|mesh-list
92310040|NCT02512783|Propofol|propofol|mesh-list
92310041|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310042|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
92310043|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310044|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310045|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
92310046|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310047|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92310048|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92310049|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92310050|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310051|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310052|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310053|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92310054|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
92310055|NCT02513095|Dantrolene|dantrolene|mesh-list
92310056|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92310057|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310058|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92310059|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310060|NCT02513719|Everolimus|everolimus|mesh-list
92310061|NCT02513719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92310062|NCT02513719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92310063|NCT02513719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310064|NCT02513719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310065|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92310066|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
92310067|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310068|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310069|NCT00363727|Ropinirole|ropinirole|mesh-list
92310070|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92310071|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92310072|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
92310073|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
92310074|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310075|NCT00363727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310076|NCT00363727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310077|NCT04340869|Theobromine|theobromine|mesh-list
92310078|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92310079|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
92310080|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310081|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310082|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92310083|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
92310084|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
92310085|NCT00366067|Phenytoin|phenytoin|mesh-list
92310086|NCT00366067|Anticonvulsants|anticonvulsants|mesh-ancestor
92310087|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92310088|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92310089|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310090|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310091|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92310092|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92310093|NCT00364429|Lorazepam|lorazepam|mesh-list
92310094|NCT00364429|Risperidone|risperidone|mesh-list
92310095|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92310096|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
92310097|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310098|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310099|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310101|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92310102|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310103|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92310104|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92310105|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
92310106|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
92310107|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
92310108|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
92310109|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310110|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92310111|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310112|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92310113|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
92310114|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
92310115|NCT02593903|Trimethoprim|trimethoprim|mesh-list
92310116|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92310117|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
92310118|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92310119|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310120|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
92310121|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92310122|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92310123|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92310124|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310125|NCT02593903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310126|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92310127|NCT02593903|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92310128|NCT02593903|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92310129|NCT02593903|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310130|NCT02596867|Propranolol|propranolol|mesh-list
92310131|NCT02596867|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92310132|NCT02596867|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92310133|NCT02596867|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310134|NCT02596867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310135|NCT02596867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310136|NCT02596867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310137|NCT02596867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92310138|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92310139|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
92310140|NCT02597101|Metformin|metformin|mesh-list
92310141|NCT02597101|Saxagliptin|saxagliptin|mesh-list
92310143|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310144|NCT02597101|Incretins|incretins|mesh-ancestor
92310145|NCT02597101|Hormones|hormones|mesh-ancestor
92310146|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310147|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92310148|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
92310149|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310150|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310151|NCT02600611|Vancomycin|vancomycin|mesh-list
92310152|NCT02600611|Iclaprim|iclaprim|mesh-list
92310153|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310154|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310155|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92310156|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310157|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310158|NCT02600767|Lumefantrine|lumefantrine|mesh-list
92310159|NCT02600767|Artemether|artemether|mesh-list
92310160|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92310161|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
92310162|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92310163|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92310164|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310165|NCT00365287|Cyclosporine|cyclosporine|mesh-list
92310166|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
92310167|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
92310168|NCT00365287|Fludarabine|fludarabine|mesh-list
92310169|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
92310170|NCT00365287|Cyclosporins|cyclosporins|mesh-list
92310171|NCT00365287|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92310172|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92310173|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
92310174|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310175|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310176|NCT00365287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92310177|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
92310178|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310179|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310180|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92310181|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92310182|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
92310183|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310184|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
92310185|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310186|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310187|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92310188|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92310189|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92310190|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
92310191|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310192|NCT04743193|Sevoflurane|sevoflurane|mesh-list
92310193|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
92310194|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310195|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310196|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92310197|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92310198|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
92310199|NCT05572645|Trastuzumab|trastuzumab|mesh-list
92310201|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310202|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310203|NCT02608177|Linagliptin|linagliptin|mesh-list
92310204|NCT02608177|Glipizide|glipizide|mesh-list
92310205|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92310206|NCT02608177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310207|NCT02608177|Incretins|incretins|mesh-ancestor
92310208|NCT02608177|Hormones|hormones|mesh-ancestor
92310209|NCT02608177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310210|NCT02608177|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91962915|NCT02299999|Taxane|taxane|mesh-list
92310211|NCT02608177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92310212|NCT02608177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310213|NCT02608177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310214|NCT02608489|Hyaluronic Acid|hyaluronic acid|mesh-list
92310215|NCT02608489|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92310216|NCT02608489|Immunologic Factors|immunologic factors|mesh-ancestor
92310217|NCT02608489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310218|NCT02608489|Viscosupplements|viscosupplements|mesh-ancestor
92310219|NCT02608489|Protective Agents|protective agents|mesh-ancestor
92310220|NCT02611765|Penicillins|penicillins|mesh-list
92310221|NCT02611765|Penicillin G|penicillin g|mesh-list
92310222|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92310223|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
92310224|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310225|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310226|NCT05552287|Infliximab|infliximab|mesh-list
92310227|NCT05552287|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92310228|NCT05552287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310229|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310230|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92310231|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310232|NCT02616523|Lidocaine|lidocaine|mesh-list
92310233|NCT02616523|Fentanyl|fentanyl|mesh-list
92310234|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
92310235|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310236|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
92310237|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310238|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310239|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
92310240|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310241|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92310242|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92310244|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310245|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310246|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310247|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310248|NCT02616523|Analgesics|analgesics|mesh-ancestor
92310249|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92310250|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92310251|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92310252|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310253|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310254|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92310255|NCT02616523|Narcotics|narcotics|mesh-ancestor
92310256|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92310257|NCT02616523|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92310258|NCT02616523|Anesthetics, General|anesthetics, general|mesh-ancestor
92310259|NCT05732155|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92310260|NCT05732155|Hallucinogens|hallucinogens|mesh-ancestor
92310261|NCT05732155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310262|NCT05732155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92310263|NCT05732155|Serotonin Agents|serotonin agents|mesh-ancestor
92310264|NCT05732155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310265|NCT05732155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310266|NCT05732155|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92310267|NCT05732155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92310268|NCT05732155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310269|NCT05732155|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310270|NCT05528419|Valsartan|valsartan|mesh-list
92310271|NCT05528419|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92310272|NCT05528419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92310273|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92310274|NCT05528419|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92310275|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310276|NCT05485831|Cannabidiol|cannabidiol|mesh-list
92310277|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
92310278|NCT05480293|Ranibizumab|ranibizumab|mesh-list
92310279|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92310280|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92310281|NCT05480293|Growth Substances|growth substances|mesh-ancestor
92310282|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310283|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
92310284|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310285|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
92310286|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92310288|NCT05449327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92310289|NCT05449327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92310290|NCT05449327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936425|NCT01388491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310291|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310292|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
92310293|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
92310294|NCT00365755|Melphalan|melphalan|mesh-list
92310295|NCT00365755|Carboplatin|carboplatin|mesh-list
92310296|NCT00365755|Etoposide|etoposide|mesh-list
92310297|NCT00365755|Vincristine|vincristine|mesh-list
92310298|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92310299|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
92310300|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310301|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310302|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92310303|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
92310304|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310305|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310306|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92310307|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92347752|NCT01748292|Ranibizumab|ranibizumab|mesh-list
92310308|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92310309|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92310310|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310311|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
92310312|NCT00365755|Antimitotic Agents|antimitotic agents|mesh-ancestor
92310313|NCT00365755|Mitosis Modulators|mitosis modulators|mesh-ancestor
92310314|NCT05730907|Simendan|simendan|mesh-list
92310315|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92310316|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
92310317|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92310318|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92310319|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310320|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310321|NCT05730907|Protective Agents|protective agents|mesh-ancestor
92310322|NCT05730907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310323|NCT05355337|Pramipexole|pramipexole|mesh-list
92310324|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
92310325|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310326|NCT05355337|Protective Agents|protective agents|mesh-ancestor
92310327|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310328|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92310329|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92310330|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
92310331|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
92310332|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310333|NCT04340401|Capecitabine|capecitabine|mesh-list
92310334|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
92310335|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92310336|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
92310337|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310338|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310339|NCT04143607|Gefitinib|gefitinib|mesh-list
92310340|NCT04143607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310341|NCT04143607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92310342|NCT04143607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310343|NCT04143607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310344|NCT04802863|Imipenem|imipenem|mesh-list
92310345|NCT04802863|Cilastatin|cilastatin|mesh-list
92310346|NCT04802863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310347|NCT04802863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310348|NCT04802863|Protease Inhibitors|protease inhibitors|mesh-ancestor
92310349|NCT04802863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310350|NCT04802863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310351|NCT04622839|Acetaminophen|acetaminophen|mesh-list
92310352|NCT04622839|Ibuprofen|ibuprofen|mesh-list
92310353|NCT04622839|Diclofenac|diclofenac|mesh-list
92310354|NCT04622839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92310355|NCT04622839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310356|NCT04622839|Analgesics|analgesics|mesh-ancestor
92310357|NCT04622839|Sensory System Agents|sensory system agents|mesh-ancestor
92310358|NCT04622839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310359|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310360|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310361|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310362|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92310363|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310364|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310365|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
92310366|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
92310367|NCT02619799|Midazolam|midazolam|mesh-list
92310368|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92310369|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310370|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310371|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310372|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92310373|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92310374|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92310375|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92310376|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
92310377|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
92310378|NCT02619799|GABA Modulators|gaba modulators|mesh-ancestor
92310379|NCT02619799|GABA Agents|gaba agents|mesh-ancestor
92310380|NCT02619799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310381|NCT02619799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310382|NCT02619799|Analgesics|analgesics|mesh-ancestor
92310383|NCT02619799|Sensory System Agents|sensory system agents|mesh-ancestor
92310384|NCT02619799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310385|NCT02619799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92310386|NCT02619799|Anticonvulsants|anticonvulsants|mesh-ancestor
92310387|NCT02619799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92310388|NCT02619799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310389|NCT02619799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92310390|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
92310391|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92310392|NCT04592809|Midazolam|midazolam|mesh-list
92310393|NCT04592809|Ketamine|ketamine|mesh-list
92310394|NCT04592809|Analgesics|analgesics|mesh-ancestor
92310395|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
92310396|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310397|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310398|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92310399|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92310400|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
92310401|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
92310402|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310403|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92310404|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92310405|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310406|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310407|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92310408|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310409|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92310410|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92310411|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92310412|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
92310413|NCT04592809|GABA Agents|gaba agents|mesh-ancestor
92310414|NCT04741165|Bevacizumab|bevacizumab|mesh-list
92310415|NCT04741165|Lenvatinib|lenvatinib|mesh-list
92310416|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310417|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310418|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92310419|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92310420|NCT04741165|Growth Substances|growth substances|mesh-ancestor
92310421|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310422|NCT04741165|Growth Inhibitors|growth inhibitors|mesh-ancestor
92310423|NCT04741165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92310424|NCT04741165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310425|NCT04741165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310426|NCT02625181|Promethazine|promethazine|mesh-list
92310427|NCT02625181|Diphenhydramine|diphenhydramine|mesh-list
92310428|NCT02625181|Meclizine|meclizine|mesh-list
92310429|NCT02625181|Dexamethasone|dexamethasone|mesh-list
92310430|NCT02625181|Fentanyl|fentanyl|mesh-list
92310431|NCT02625181|Sufentanil|sufentanil|mesh-list
92310432|NCT02625181|Scopolamine|scopolamine|mesh-list
92310433|NCT02625181|Oxymorphone|oxymorphone|mesh-list
92310434|NCT02625181|Meperidine|meperidine|mesh-list
92310435|NCT02625181|Droperidol|droperidol|mesh-list
92310436|NCT02625181|Ketamine|ketamine|mesh-list
91963129|NCT03302299|Antimetabolites|antimetabolites|mesh-ancestor
92310437|NCT02625181|Morphine|morphine|mesh-list
92310438|NCT02625181|Remifentanil|remifentanil|mesh-list
92310439|NCT02625181|Oxycodone|oxycodone|mesh-list
92310440|NCT02625181|Methadone|methadone|mesh-list
92310441|NCT02625181|Hydromorphone|hydromorphone|mesh-list
92310443|NCT02625181|Alfentanil|alfentanil|mesh-list
92310444|NCT02625181|Haloperidol|haloperidol|mesh-list
92310445|NCT02625181|Ondansetron|ondansetron|mesh-list
92310446|NCT02625181|Aprepitant|aprepitant|mesh-list
92310447|NCT02625181|Palonosetron|palonosetron|mesh-list
92310448|NCT02625181|Metoclopramide|metoclopramide|mesh-list
92310449|NCT02625181|Granisetron|granisetron|mesh-list
92310450|NCT02625181|Ramosetron|ramosetron|mesh-list
92310451|NCT02625181|Tropisetron|tropisetron|mesh-list
92310452|NCT02625181|Dolasetron|dolasetron|mesh-list
92310453|NCT02625181|Anesthetics|anesthetics|mesh-list
92310454|NCT02625181|Propofol|propofol|mesh-list
92310455|NCT02625181|Sevoflurane|sevoflurane|mesh-list
92310456|NCT02625181|Desflurane|desflurane|mesh-list
92310457|NCT02625181|Isoflurane|isoflurane|mesh-list
92310458|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92310459|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310460|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
92310461|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
92310462|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310463|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310464|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92310465|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
92310467|NCT02625181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310468|NCT02625181|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92310469|NCT02625181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310470|NCT02625181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310471|NCT02625181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310472|NCT02625181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92310473|NCT02625181|Anesthetics, General|anesthetics, general|mesh-ancestor
92310475|NCT02625181|Sensory System Agents|sensory system agents|mesh-ancestor
92310476|NCT02625181|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92310477|NCT02625181|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92310478|NCT02625181|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92310479|NCT02625181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310480|NCT02625181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310481|NCT02625181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92310482|NCT02625181|Narcotics|narcotics|mesh-ancestor
92310483|NCT02625181|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92310484|NCT02625181|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92310485|NCT02625181|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92310486|NCT02625181|Antipruritics|antipruritics|mesh-ancestor
92310487|NCT02625181|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310488|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92310489|NCT02625181|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92310490|NCT02625181|Serotonin Agents|serotonin agents|mesh-ancestor
92310491|NCT02625181|Antitussive Agents|antitussive agents|mesh-ancestor
92310492|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
92310493|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92310494|NCT02625181|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92310495|NCT02625181|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92310496|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92310497|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92310498|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
92310499|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92310500|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92310501|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
92310502|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92310503|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
92310504|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92310505|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
92310506|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92310507|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
92310508|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
92310509|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92310510|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92310511|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310512|NCT02630017|Methylphenidate|methylphenidate|mesh-list
91963198|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310513|NCT02630017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92310514|NCT02630017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310515|NCT02630017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92310516|NCT02630017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92310517|NCT02630017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310518|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310519|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
92310520|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310521|NCT02630719|Timolol|timolol|mesh-list
92310522|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92310523|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
92310524|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92310525|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92310526|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92310527|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310528|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310529|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310530|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310531|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92310532|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92310534|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92310535|NCT04979377|Hormones|hormones|mesh-list
92310536|NCT04979377|Testosterone|testosterone|mesh-list
92310537|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92310538|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92310539|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310540|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310541|NCT04979377|Androgens|androgens|mesh-ancestor
92310542|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92310543|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
92310544|NCT02633371|Oxybutynin|oxybutynin|mesh-list
92310545|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
92310546|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
92310547|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310548|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310549|NCT02633371|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92310550|NCT02633371|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92310551|NCT02633371|Cholinergic Agents|cholinergic agents|mesh-ancestor
92310552|NCT02633371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310553|NCT02633371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310554|NCT02633371|Urological Agents|urological agents|mesh-ancestor
92310555|NCT04159519|Budesonide|budesonide|mesh-list
92310556|NCT04159519|Albuterol|albuterol|mesh-list
92310557|NCT04159519|Formoterol Fumarate|formoterol fumarate|mesh-list
92310558|NCT04159519|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92310559|NCT04159519|Benralizumab|benralizumab|mesh-list
92310560|NCT04159519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310561|NCT04159519|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92310562|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
92310563|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310564|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310565|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92310566|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
92310567|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
92310568|NCT04159519|Hormones|hormones|mesh-ancestor
92310569|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310570|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92310571|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92310572|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92310573|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310574|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310575|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310576|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
92310577|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92310578|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92310579|NCT04913311|Dimercaprol|dimercaprol|mesh-list
92310580|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
92310581|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
92310582|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310583|NCT04913311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310584|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310585|NCT04054375|Prednisone|prednisone|mesh-list
92310586|NCT04054375|Prednisolone|prednisolone|mesh-list
92310587|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310588|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
92310589|NCT04054375|Hormones|hormones|mesh-ancestor
92310590|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310591|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310592|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92310593|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310594|NCT02634073|Lamivudine|lamivudine|mesh-list
92310595|NCT02634073|Sorbitol|sorbitol|mesh-list
92310596|NCT02634073|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92310597|NCT02634073|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92310598|NCT02634073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310599|NCT02634073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310600|NCT02634073|Antiviral Agents|antiviral agents|mesh-ancestor
92310601|NCT02634073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310602|NCT02634073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92310603|NCT02634073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92310604|NCT02634073|Cathartics|cathartics|mesh-ancestor
92310605|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92310606|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92310607|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92310608|NCT00367393|Pimecrolimus|pimecrolimus|mesh-list
92310609|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92310610|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310611|NCT00367393|Analgesics|analgesics|mesh-ancestor
92310612|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
92310613|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310614|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310615|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310616|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310617|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310618|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92310619|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
92310620|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92310621|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310622|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310624|NCT00367471|Carboplatin|carboplatin|mesh-list
92310625|NCT00367471|Trastuzumab|trastuzumab|mesh-list
92310626|NCT00367471|Lapatinib|lapatinib|mesh-list
92310627|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92310628|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310629|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
92310630|NCT00367471|Antimitotic Agents|antimitotic agents|mesh-ancestor
92310631|NCT00367471|Mitosis Modulators|mitosis modulators|mesh-ancestor
92310632|NCT00367471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310633|NCT00367471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310634|NCT00367471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92310635|NCT00367471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310636|NCT02207244|Adalimumab|adalimumab|mesh-list
92310637|NCT02207244|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92310638|NCT02207244|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92310639|NCT02207244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310640|NCT02207244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310641|NCT02207244|Immunologic Factors|immunologic factors|mesh-ancestor
92310642|NCT02207244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310643|NCT02207088|Ritonavir|ritonavir|mesh-list
92310644|NCT02207088|Ribavirin|ribavirin|mesh-list
92310645|NCT02207088|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92310646|NCT02207088|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92310647|NCT02207088|Protease Inhibitors|protease inhibitors|mesh-ancestor
92310648|NCT02207088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310649|NCT02207088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310650|NCT02207088|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92310651|NCT02207088|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92310652|NCT02207088|Antiviral Agents|antiviral agents|mesh-ancestor
92310653|NCT02207088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310654|NCT02207088|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92310655|NCT02207088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92310656|NCT02207088|Antimetabolites|antimetabolites|mesh-ancestor
92310657|NCT02638597|Gemfibrozil|gemfibrozil|mesh-list
92310658|NCT02638597|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92310659|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
92310660|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310661|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92310662|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92310663|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92310664|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347777|NCT01746732|Evacetrapib|evacetrapib|mesh-list
92310666|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92310667|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310668|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310669|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
92310670|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310671|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310672|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
92310673|NCT02239926|Ranolazine|ranolazine|mesh-list
92310674|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92310675|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310676|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310677|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
92310678|NCT02239692|Cathartics|cathartics|mesh-ancestor
92310679|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92310680|NCT02641561|Indomethacin|indomethacin|mesh-list
92310681|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92310682|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310683|NCT02641561|Analgesics|analgesics|mesh-ancestor
92310684|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
92310685|NCT02641561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310686|NCT02641561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310687|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310688|NCT02641561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310689|NCT02641561|Gout Suppressants|gout suppressants|mesh-ancestor
92310690|NCT02641561|Tocolytic Agents|tocolytic agents|mesh-ancestor
92310691|NCT02641561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92310692|NCT02641561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92310693|NCT02641561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310694|NCT02641561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310695|NCT02206152|Acetylcysteine|acetylcysteine|mesh-list
92310696|NCT02206152|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92310697|NCT02206152|Antiviral Agents|antiviral agents|mesh-ancestor
92310698|NCT02206152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310699|NCT02206152|Expectorants|expectorants|mesh-ancestor
92310700|NCT02206152|Respiratory System Agents|respiratory system agents|mesh-ancestor
92310701|NCT02206152|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92310702|NCT02206152|Antioxidants|antioxidants|mesh-ancestor
92310703|NCT02206152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310704|NCT02206152|Protective Agents|protective agents|mesh-ancestor
92310705|NCT02206152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310706|NCT02206152|Antidotes|antidotes|mesh-ancestor
92310707|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
92310708|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92310709|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
92310710|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
92310711|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92310712|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92310713|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310714|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92310715|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310716|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310717|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92310718|NCT00367081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310719|NCT00367081|Coccidiostats|coccidiostats|mesh-ancestor
92310721|NCT04146571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310722|NCT04146571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92310723|NCT04146571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310724|NCT04146571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310725|NCT02204982|Rituximab|rituximab|mesh-list
92310726|NCT02204982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310727|NCT02204982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310728|NCT02204982|Immunologic Factors|immunologic factors|mesh-ancestor
92310729|NCT02204982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310730|NCT02204982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310731|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
92310732|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310733|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310734|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310735|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310736|NCT05342376|Analgesics|analgesics|mesh-ancestor
92310737|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
92310738|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310739|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92310740|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92310741|NCT05342376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92310742|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310743|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310744|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310746|NCT02237196|Immunologic Factors|immunologic factors|mesh-list
92310747|NCT02237196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310748|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92310749|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
92310750|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92310751|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310752|NCT04776096|Analgesics|analgesics|mesh-ancestor
92310753|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
92310754|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310755|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310756|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92310757|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310758|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92310759|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92310760|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92310761|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
92310762|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
92310763|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310764|NCT04776096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310765|NCT03260491|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92310766|NCT03260491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310767|NCT03260491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310768|NCT03250273|Nivolumab|nivolumab|mesh-list
92310769|NCT03250273|Entinostat|entinostat|mesh-list
92310770|NCT03250273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92310771|NCT03250273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310772|NCT03250273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92310773|NCT03250273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310774|NCT03250273|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92310775|NCT03250273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310776|NCT02203032|Ustekinumab|ustekinumab|mesh-list
92310777|NCT02203032|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92310778|NCT02203032|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310779|NCT02203032|Immunologic Factors|immunologic factors|mesh-ancestor
92310780|NCT02203032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310781|NCT03587701|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92310782|NCT03587701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310783|NCT02169414|Levodopa|levodopa|mesh-list
92310784|NCT02169414|Carbidopa|carbidopa|mesh-list
92310785|NCT02169414|Opicapone|opicapone|mesh-list
92310786|NCT02169414|Benserazide|benserazide|mesh-list
92310787|NCT02169414|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92310788|NCT02169414|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92310789|NCT02169414|Dopamine Agents|dopamine agents|mesh-ancestor
92310790|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310791|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310792|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310793|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92310794|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310795|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92310796|NCT03213457|Norethindrone|norethindrone|mesh-list
92310797|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
92310798|NCT03213457|Estradiol|estradiol|mesh-list
92310799|NCT03213457|Estrogens|estrogens|mesh-ancestor
92310800|NCT03213457|Hormones|hormones|mesh-ancestor
92310801|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310802|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310803|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92310804|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
92310805|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92310806|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92310807|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92310808|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92310809|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92310811|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92310812|NCT02201940|Velpatasvir|velpatasvir|mesh-list
92310813|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
92310814|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310815|NCT05588869|Cyclosporine|cyclosporine|mesh-list
92310816|NCT05588869|Cyclosporins|cyclosporins|mesh-list
92310817|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310818|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310819|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92310820|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
92310821|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310822|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
92310823|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310824|NCT05588869|Dermatologic Agents|dermatologic agents|mesh-ancestor
92310825|NCT05588869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92310826|NCT05588869|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92310827|NCT02169336|Dexmedetomidine|dexmedetomidine|mesh-list
92310828|NCT02169336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92310829|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310830|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310831|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92310832|NCT02169336|Analgesics|analgesics|mesh-ancestor
92310833|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
92310834|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310835|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92310836|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92310837|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92310838|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
92310839|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310840|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310841|NCT03043807|Docetaxel|docetaxel|mesh-list
92310842|NCT03043807|Leuprolide|leuprolide|mesh-list
92310843|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
92310844|NCT03043807|Bicalutamide|bicalutamide|mesh-list
92310845|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310846|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92310847|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92310848|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92310849|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310850|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92310851|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
92310852|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92310853|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310854|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92310855|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92310856|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310857|NCT03043807|Hormone Antagonists|hormone antagonists|mesh-ancestor
92310858|NCT03043807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310859|NCT03043807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92310861|NCT02609828|Tanezumab|tanezumab|mesh-list
92310862|NCT02609828|Analgesics|analgesics|mesh-ancestor
92310863|NCT02609828|Sensory System Agents|sensory system agents|mesh-ancestor
92310864|NCT02609828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310865|NCT02609828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310866|NCT05588557|Bupivacaine|bupivacaine|mesh-list
92310867|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310868|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
92411270|NCT04593043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310869|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310870|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310871|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
92347791|NCT01746732|Contraceptive Agents|contraceptive agents|mesh-ancestor
92310872|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310873|NCT01632306|Leucovorin|leucovorin|mesh-list
92310874|NCT01632306|Paclitaxel|paclitaxel|mesh-list
92310875|NCT01632306|Gemcitabine|gemcitabine|mesh-list
92310876|NCT01632306|Fluorouracil|fluorouracil|mesh-list
92310877|NCT01632306|Oxaliplatin|oxaliplatin|mesh-list
92310878|NCT01632306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92310879|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92310880|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
92310881|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
92310882|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
92310883|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310884|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92310885|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
92310886|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92310887|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
92310888|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310889|NCT01632306|Antidotes|antidotes|mesh-ancestor
92310890|NCT01632306|Protective Agents|protective agents|mesh-ancestor
92310891|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
92310892|NCT01632306|Vitamins|vitamins|mesh-ancestor
92310893|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
92310894|NCT02201784|Ropivacaine|ropivacaine|mesh-list
92310895|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
92310896|NCT02201784|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310897|NCT02201784|Anesthetics|anesthetics|mesh-ancestor
92310898|NCT02201784|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310899|NCT02201784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310900|NCT02201784|Sensory System Agents|sensory system agents|mesh-ancestor
92310901|NCT02201784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310902|NCT05587933|Parasympatholytics|parasympatholytics|mesh-list
92310903|NCT05587933|Autonomic Agents|autonomic agents|mesh-ancestor
92310904|NCT05587933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310905|NCT05587933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310906|NCT02018263|Cocaine|cocaine|mesh-list
92310907|NCT02018263|Nicotine|nicotine|mesh-list
92310908|NCT02018263|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92310909|NCT02018263|Autonomic Agents|autonomic agents|mesh-ancestor
92310910|NCT02018263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310911|NCT02018263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310912|NCT02018263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92310913|NCT02018263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92310914|NCT02018263|Cholinergic Agents|cholinergic agents|mesh-ancestor
92310915|NCT02018263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310916|NCT02018263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310917|NCT02018263|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310918|NCT02018263|Anesthetics|anesthetics|mesh-ancestor
92310919|NCT02018263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310920|NCT02018263|Sensory System Agents|sensory system agents|mesh-ancestor
92310921|NCT02018263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92310922|NCT02018263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92310923|NCT02018263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92310924|NCT02018263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310925|NCT02018263|Dopamine Agents|dopamine agents|mesh-ancestor
92310926|NCT02168946|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92310927|NCT02168946|Meropenem|meropenem|mesh-list
92310928|NCT02168946|Vaborbactam|vaborbactam|mesh-list
92310929|NCT02168946|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92310930|NCT02168946|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92310931|NCT02168946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310932|NCT02168946|Antitubercular Agents|antitubercular agents|mesh-ancestor
92310933|NCT02168946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310934|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310935|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
92310936|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92310937|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92310938|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310939|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
92310940|NCT02650856|Coagulants|coagulants|mesh-ancestor
92310941|NCT02168478|Neomycin|neomycin|mesh-list
92310942|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92310943|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92310944|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92310945|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310946|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310947|NCT00367874|Buprenorphine|buprenorphine|mesh-list
92310948|NCT00367874|Valproic Acid|valproic acid|mesh-list
92310949|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92310950|NCT00367874|Narcotics|narcotics|mesh-ancestor
92310951|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310952|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310953|NCT00367874|Analgesics|analgesics|mesh-ancestor
92310954|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
92310955|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310956|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92310957|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
92310958|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310959|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310960|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
92310961|NCT00367874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310962|NCT00367874|Antimanic Agents|antimanic agents|mesh-ancestor
92310963|NCT00367874|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92310964|NCT00367874|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92310965|NCT00367562|Valsartan|valsartan|mesh-list
92310966|NCT00367562|Enalapril|enalapril|mesh-list
92310967|NCT00367562|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92310968|NCT00367562|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92310969|NCT00367562|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91963650|NCT02462707|Nirogacestat|nirogacestat|mesh-list
92310970|NCT00367562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310971|NCT00367562|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92310973|NCT00367562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92310974|NCT02302976|Exenatide|exenatide|mesh-list
92310975|NCT02302976|Cocaine|cocaine|mesh-list
92310976|NCT02302976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92310977|NCT02302976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92310978|NCT02302976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92310979|NCT02302976|Incretins|incretins|mesh-ancestor
92310980|NCT02302976|Hormones|hormones|mesh-ancestor
92310981|NCT02302976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92310982|NCT02302976|Anesthetics, Local|anesthetics, local|mesh-ancestor
92310983|NCT02302976|Anesthetics|anesthetics|mesh-ancestor
92310984|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92310985|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
92310986|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92310987|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92310988|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92310989|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92310990|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92310991|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92310992|NCT02302976|Dopamine Agents|dopamine agents|mesh-ancestor
92310993|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92310994|NCT05073692|Liraglutide|liraglutide|mesh-list
92310995|NCT05073692|Empagliflozin|empagliflozin|mesh-list
92310996|NCT05073692|Exenatide|exenatide|mesh-list
92310997|NCT05073692|Glimepiride|glimepiride|mesh-list
92310998|NCT05073692|Linagliptin|linagliptin|mesh-list
92310999|NCT05073692|Saxagliptin|saxagliptin|mesh-list
92311000|NCT05073692|Alogliptin|alogliptin|mesh-list
92311001|NCT05073692|Glipizide|glipizide|mesh-list
92311002|NCT05073692|Glucagon|glucagon|mesh-list
92311003|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92311004|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311005|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311006|NCT05073692|Incretins|incretins|mesh-ancestor
92311007|NCT05073692|Hormones|hormones|mesh-ancestor
92311008|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311009|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91936462|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92311010|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311012|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92311013|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311014|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
92311015|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92311016|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
92311017|NCT05073692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311018|NCT05073692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311019|NCT02244164|Liraglutide|liraglutide|mesh-list
92311021|NCT02244164|Lixisenatide|lixisenatide|mesh-list
92311022|NCT02244164|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92311023|NCT02244164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311024|NCT02244164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311025|NCT02244164|Incretins|incretins|mesh-ancestor
92311026|NCT02244164|Hormones|hormones|mesh-ancestor
92311027|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311028|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92311029|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
92311030|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311031|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311032|NCT02152670|Raclopride|raclopride|mesh-list
92311033|NCT02152670|Methylphenidate|methylphenidate|mesh-list
92311034|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
92311035|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92311036|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311037|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92311038|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92311039|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311040|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311041|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
92311042|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311043|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92311044|NCT02152670|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92311045|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311047|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92311048|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311049|NCT02028806|Leucovorin|leucovorin|mesh-list
92311050|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
92311051|NCT02028806|Irinotecan|irinotecan|mesh-list
92311052|NCT02028806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311053|NCT02028806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92311054|NCT02028806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92311055|NCT02028806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311056|NCT02028806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311057|NCT02028806|Antidotes|antidotes|mesh-ancestor
92311058|NCT02028806|Protective Agents|protective agents|mesh-ancestor
92311059|NCT02028806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311060|NCT02028806|Vitamin B Complex|vitamin b complex|mesh-ancestor
92311061|NCT02028806|Vitamins|vitamins|mesh-ancestor
92311062|NCT02028806|Micronutrients|micronutrients|mesh-ancestor
92311063|NCT01756118|Dactolisib|dactolisib|mesh-list
92311064|NCT01756118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311065|NCT04339712|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92311066|NCT04339712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311067|NCT02656160|4-Aminopyridine|4-aminopyridine|mesh-list
92311068|NCT02656160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92311069|NCT02656160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311070|NCT02656160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311071|NCT02657252|Polidocanol|polidocanol|mesh-list
92311072|NCT02657252|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92311073|NCT02657252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92311074|NCT04740086|Calcium|calcium|mesh-list
92311075|NCT04740086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92311076|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311077|NCT04739618|Pembrolizumab|pembrolizumab|mesh-list
92311078|NCT04739618|Ipilimumab|ipilimumab|mesh-list
92311079|NCT04739618|Sargramostim|sargramostim|mesh-list
92311080|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311081|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311082|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311083|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311084|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
92311085|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311087|NCT02684942|Meperidine|meperidine|mesh-list
92311088|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92311089|NCT02684942|Narcotics|narcotics|mesh-ancestor
92311090|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311091|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311092|NCT02684942|Analgesics|analgesics|mesh-ancestor
92311093|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
92311094|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311095|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92311096|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311097|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
92311098|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
92311099|NCT04739774|Itraconazole|itraconazole|mesh-list
92311100|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
92311101|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311102|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92311103|NCT04739774|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92311104|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311105|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311106|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92311107|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
92311108|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311109|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311110|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92311111|NCT02660918|Bupivacaine|bupivacaine|mesh-list
92311112|NCT02660918|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311113|NCT02660918|Anesthetics|anesthetics|mesh-ancestor
92311114|NCT02660918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311115|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311116|NCT02660918|Sensory System Agents|sensory system agents|mesh-ancestor
91963803|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
92311117|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311118|NCT00367315|Lumiracoxib|lumiracoxib|mesh-list
92311119|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92311120|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92311121|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311122|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311123|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92311124|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92311126|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
92311127|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311128|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311129|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311130|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311131|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
92311132|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311133|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
92311134|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311135|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311136|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92311137|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
92311138|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311139|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311140|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92311141|NCT05441761|Dexamethasone|dexamethasone|mesh-list
92311142|NCT05441761|Gemcitabine|gemcitabine|mesh-list
92311143|NCT05441761|Mitoxantrone|mitoxantrone|mesh-list
92311144|NCT05441761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311145|NCT05441761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311146|NCT05441761|Antiemetics|antiemetics|mesh-ancestor
92311147|NCT05441761|Autonomic Agents|autonomic agents|mesh-ancestor
92311148|NCT05441761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311149|NCT05441761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311150|NCT05441761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311151|NCT05441761|Glucocorticoids|glucocorticoids|mesh-ancestor
92311152|NCT05441761|Hormones|hormones|mesh-ancestor
92311153|NCT05441761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311154|NCT05441761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311155|NCT05441761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92311157|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311158|NCT05441761|Analgesics|analgesics|mesh-ancestor
92311159|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
92311160|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92311161|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92311162|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311163|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92311164|NCT05587621|Ezetimibe|ezetimibe|mesh-list
92311165|NCT05587621|Evolocumab|evolocumab|mesh-list
92311166|NCT05587621|Alirocumab|alirocumab|mesh-list
92311167|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92311168|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92311169|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
92311170|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311171|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92311172|NCT05587621|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92311173|NCT05587621|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92311174|NCT05587621|Protease Inhibitors|protease inhibitors|mesh-ancestor
92311175|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311176|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311177|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311178|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
92311179|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92311180|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311181|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311182|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311183|NCT02688829|Sirolimus|sirolimus|mesh-list
92311184|NCT02688829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92311185|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311186|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92311187|NCT02688829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311188|NCT02688829|Antifungal Agents|antifungal agents|mesh-ancestor
92311189|NCT02688829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311190|NCT02688829|Immunologic Factors|immunologic factors|mesh-ancestor
92311191|NCT02688829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311192|NCT02688842|Sirolimus|sirolimus|mesh-list
92311193|NCT02688842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92311194|NCT02688842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311195|NCT02688842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92311196|NCT02688842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311197|NCT02688842|Antifungal Agents|antifungal agents|mesh-ancestor
92311198|NCT02688842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311199|NCT02688842|Immunologic Factors|immunologic factors|mesh-ancestor
92311200|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311201|NCT02689063|Acetaminophen|acetaminophen|mesh-list
92311202|NCT02689063|Ibuprofen|ibuprofen|mesh-list
92311203|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92311204|NCT02689063|Analgesics|analgesics|mesh-ancestor
92311205|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
92311206|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311207|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311208|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
92311209|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92311210|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311211|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311212|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92311213|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311214|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311215|NCT02690935|Immunomodulating Agents|immunomodulating agents|mesh-list
92311216|NCT02690935|Immunologic Factors|immunologic factors|mesh-ancestor
92311217|NCT02690935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311218|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
92311219|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311220|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92311221|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311222|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311223|NCT02666846|Ibuprofen|ibuprofen|mesh-list
92311224|NCT02666846|Diclofenac|diclofenac|mesh-list
92311225|NCT02666846|Salicylates|salicylates|mesh-list
92311226|NCT02666846|Methyl salicylate|methyl salicylate|mesh-list
92311227|NCT02666846|Menthol|menthol|mesh-list
92311228|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92311229|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92311230|NCT02666846|Analgesics|analgesics|mesh-ancestor
92311231|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
92311232|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311233|NCT02666846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311234|NCT02666846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311235|NCT02666846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311236|NCT02666846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92311237|NCT02666846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311238|NCT02666846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311239|NCT02666846|Antipruritics|antipruritics|mesh-ancestor
92311240|NCT02666846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92311241|NCT02643979|Ketamine|ketamine|mesh-list
92311242|NCT02643979|Propofol|propofol|mesh-list
92311243|NCT02643979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92311244|NCT02643979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311245|NCT02643979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311246|NCT02643979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311247|NCT02643979|Anesthetics, General|anesthetics, general|mesh-ancestor
92311248|NCT02643979|Anesthetics|anesthetics|mesh-ancestor
92311249|NCT02643979|Analgesics|analgesics|mesh-ancestor
92311251|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311252|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92311253|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92311254|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92311255|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311256|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311257|NCT05587231|Fluorometholone|fluorometholone|mesh-list
92311258|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311259|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311260|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
92311261|NCT05587231|Hormones|hormones|mesh-ancestor
92311262|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311263|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92311264|NCT02667704|Nintedanib|nintedanib|mesh-list
92311265|NCT02667704|Bosentan|bosentan|mesh-list
92311266|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311267|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92311268|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311269|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311271|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92311272|NCT02645617|Imidacloprid|imidacloprid|mesh-list
92311273|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
92311274|NCT02645617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311275|NCT02645617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311276|NCT02645617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311277|NCT02694601|Caffeine|caffeine|mesh-list
92311278|NCT02694601|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92311279|NCT02694601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311280|NCT02694601|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92311281|NCT02694601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311282|NCT02694601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311283|NCT02694601|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92311284|NCT02694601|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92311285|NCT02694601|Purinergic Agents|purinergic agents|mesh-ancestor
92311286|NCT02694601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311287|NCT02690948|Pembrolizumab|pembrolizumab|mesh-list
92311288|NCT02690948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311289|NCT02690948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311290|NCT02690948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311291|NCT02690948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311292|NCT02698735|Gentamicins|gentamicins|mesh-list
92311293|NCT02698735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92311294|NCT02698735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311295|NCT02698735|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92311296|NCT02698735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311297|NCT02698735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311299|NCT02691416|Sevoflurane|sevoflurane|mesh-list
92311300|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92311301|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311302|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311303|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311304|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
92311305|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
92311306|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92311307|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92311308|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
92311309|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311310|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311311|NCT02650999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311312|NCT02650999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311313|NCT05502211|Lidocaine|lidocaine|mesh-list
92311314|NCT05502211|Fentanyl|fentanyl|mesh-list
92311315|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311316|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
92311317|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311318|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311319|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
92311320|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311321|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92311322|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92311323|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92311324|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311325|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311326|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92311327|NCT05502211|Narcotics|narcotics|mesh-ancestor
92311328|NCT05502211|Analgesics|analgesics|mesh-ancestor
92311329|NCT05502211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92311330|NCT05502211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311331|NCT05502211|Anesthetics, General|anesthetics, general|mesh-ancestor
92311332|NCT02674412|Buspirone|buspirone|mesh-list
92311333|NCT02674412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92311334|NCT02674412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92311335|NCT02674412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311336|NCT02674412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311337|NCT02674412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92311338|NCT02674412|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92311339|NCT02674412|Serotonin Agents|serotonin agents|mesh-ancestor
92311340|NCT02674412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311341|NCT02674412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311343|NCT04708106|Antipruritics|antipruritics|mesh-ancestor
92311344|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
92311345|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
92311346|NCT02697188|Testosterone|testosterone|mesh-list
92311347|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
92311348|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
92311349|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92311350|NCT02697188|Androgens|androgens|mesh-ancestor
92311351|NCT02697188|Hormones|hormones|mesh-ancestor
92311352|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311353|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311354|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311355|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311356|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
92311357|NCT04707560|Heparin|heparin|mesh-list
92311358|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
92311359|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92311360|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92311361|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311362|NCT02653183|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92311364|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311365|NCT02701400|Durvalumab|durvalumab|mesh-list
92311366|NCT02701400|Ipilimumab|ipilimumab|mesh-list
92311367|NCT02701400|Tremelimumab|tremelimumab|mesh-list
92311368|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311369|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311370|NCT02701400|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311371|NCT02701400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311372|NCT05403710|Botulinum Toxins|botulinum toxins|mesh-list
92311373|NCT05403710|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92311374|NCT05403710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311375|NCT05403710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311376|NCT05403710|Cholinergic Agents|cholinergic agents|mesh-ancestor
92311377|NCT05403710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311378|NCT05403710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311379|NCT02703350|Insulin Lispro|insulin lispro|mesh-list
92311380|NCT02703350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311381|NCT02703350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311382|NCT05470465|Oxycodone|oxycodone|mesh-list
92311383|NCT05470465|Paroxetine|paroxetine|mesh-list
92311384|NCT05470465|Escitalopram|escitalopram|mesh-list
92311385|NCT05470465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92311386|NCT05470465|Narcotics|narcotics|mesh-ancestor
92311387|NCT05470465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311388|NCT05470465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311389|NCT05470465|Analgesics|analgesics|mesh-ancestor
92311390|NCT05470465|Sensory System Agents|sensory system agents|mesh-ancestor
92311391|NCT05470465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311392|NCT05470465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92311394|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311395|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311396|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311397|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
92311398|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92311399|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
92311400|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92411346|NCT04468061|Immunoconjugates|immunoconjugates|mesh-ancestor
92311401|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92311402|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92311403|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311404|NCT00368030|Eszopiclone|eszopiclone|mesh-list
92311405|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92311406|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311407|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311408|NCT02656069|Glucagon|glucagon|mesh-list
92311409|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92311410|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311411|NCT02656069|Hormones|hormones|mesh-ancestor
92311412|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311413|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964097|NCT03293641|Proguanil|proguanil|mesh-list
92311414|NCT02656069|Incretins|incretins|mesh-ancestor
92311415|NCT05351762|Paclitaxel|paclitaxel|mesh-list
92311416|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
92311417|NCT05351762|Nedaplatin|nedaplatin|mesh-list
92311418|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92311419|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311420|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92311421|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92311422|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92311423|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311424|NCT05351762|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311425|NCT02708641|Pembrolizumab|pembrolizumab|mesh-list
92311426|NCT02708641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311427|NCT02708641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311428|NCT02708641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311429|NCT02708641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311430|NCT02710981|Sildenafil Citrate|sildenafil citrate|mesh-list
92311431|NCT02710981|Clomiphene|clomiphene|mesh-list
92311432|NCT02710981|Enclomiphene|enclomiphene|mesh-list
92311433|NCT02710981|Zuclomiphene|zuclomiphene|mesh-list
92311434|NCT02710981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311435|NCT02710981|Vasodilator Agents|vasodilator agents|mesh-ancestor
92311436|NCT02710981|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92311437|NCT02710981|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92311438|NCT02710981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311439|NCT02710981|Urological Agents|urological agents|mesh-ancestor
92311440|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92311441|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
92311442|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311443|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311444|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92311445|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
92311446|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92311447|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92311448|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92311449|NCT04193228|Carbon Fiber|carbon fiber|mesh-list
92311450|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92311451|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311452|NCT04738838|Oxytocin|oxytocin|mesh-list
92311453|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
92311454|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92311455|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311456|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92311457|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92311458|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
92311459|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311460|NCT02659501|Acetaminophen|acetaminophen|mesh-list
92311461|NCT02659501|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92311462|NCT02659501|Epinephrine|epinephrine|mesh-list
92311463|NCT02659501|Diazepam|diazepam|mesh-list
92311464|NCT02659501|Morphine|morphine|mesh-list
92311465|NCT02659501|Hydrocodone|hydrocodone|mesh-list
92311466|NCT02659501|Bupivacaine|bupivacaine|mesh-list
92311467|NCT02659501|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311468|NCT02659501|Anesthetics|anesthetics|mesh-ancestor
92311469|NCT02659501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311470|NCT02659501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311471|NCT02659501|Sensory System Agents|sensory system agents|mesh-ancestor
92311472|NCT02659501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311473|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92311474|NCT02659501|Narcotics|narcotics|mesh-ancestor
92311475|NCT02659501|Analgesics|analgesics|mesh-ancestor
92311476|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92311477|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
92311478|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92311479|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92311480|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
92311481|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311482|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311483|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92311484|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92311485|NCT02659501|Autonomic Agents|autonomic agents|mesh-ancestor
92311486|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92311487|NCT02659501|Respiratory System Agents|respiratory system agents|mesh-ancestor
92311489|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
92311490|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92311492|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92311493|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
92311494|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
92311495|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311496|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92311497|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92311498|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92311499|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92311500|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92311501|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92311502|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311503|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
92311504|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
92311505|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
92311506|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92311507|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311508|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311509|NCT00367939|Amlodipine|amlodipine|mesh-list
92311510|NCT00367939|Valsartan|valsartan|mesh-list
92311511|NCT00367939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92311512|NCT00367939|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92311513|NCT00367939|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311514|NCT00367939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311515|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92311516|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311517|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
92311518|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92311519|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92311520|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92311521|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92311522|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311523|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311524|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
92311525|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311526|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
92311527|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92311528|NCT02722837|Velpatasvir|velpatasvir|mesh-list
92311529|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
92311530|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311531|NCT02710526|Buprenorphine|buprenorphine|mesh-list
92311532|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92311533|NCT02710526|Narcotics|narcotics|mesh-ancestor
92311534|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311535|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311536|NCT02710526|Analgesics|analgesics|mesh-ancestor
92311537|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
92311538|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311539|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92311540|NCT02664961|Bevacizumab|bevacizumab|mesh-list
92311541|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311542|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311543|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92311544|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92311545|NCT02664961|Growth Substances|growth substances|mesh-ancestor
92311546|NCT02664961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311547|NCT02664961|Growth Inhibitors|growth inhibitors|mesh-ancestor
92311548|NCT02665273|Bupivacaine|bupivacaine|mesh-list
92311549|NCT02665273|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311550|NCT02665273|Anesthetics|anesthetics|mesh-ancestor
92311551|NCT02665273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311552|NCT02665273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311553|NCT02665273|Sensory System Agents|sensory system agents|mesh-ancestor
92311554|NCT02665273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311555|NCT02713178|Bupivacaine|bupivacaine|mesh-list
92311556|NCT02713178|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311557|NCT02713178|Anesthetics|anesthetics|mesh-ancestor
92311558|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311559|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311560|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
92311561|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311562|NCT04130438|Nebivolol|nebivolol|mesh-list
92311563|NCT04130438|Diltiazem|diltiazem|mesh-list
92311564|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92311565|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
92311566|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92311567|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92311568|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92311569|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
92311570|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311571|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311572|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311573|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92311574|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311575|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92311576|NCT04048850|Grazoprevir|grazoprevir|mesh-list
92311577|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92311578|NCT04048850|Antiviral Agents|antiviral agents|mesh-ancestor
92311579|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311581|NCT05261672|Bupivacaine|bupivacaine|mesh-list
92311582|NCT05261672|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311583|NCT05261672|Anesthetics|anesthetics|mesh-ancestor
92311584|NCT05261672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311585|NCT05261672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311586|NCT05261672|Sensory System Agents|sensory system agents|mesh-ancestor
92311587|NCT05261672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311588|NCT05261672|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92311589|NCT05261672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92311590|NCT05261672|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92311591|NCT05261672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92311592|NCT05261672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92311593|NCT05261672|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311594|NCT05261672|Anesthetics, General|anesthetics, general|mesh-ancestor
92311595|NCT05261672|GABA Modulators|gaba modulators|mesh-ancestor
92311596|NCT05261672|GABA Agents|gaba agents|mesh-ancestor
92311597|NCT05261672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311598|NCT05261672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311599|NCT02714504|Voriconazole|voriconazole|mesh-list
92311600|NCT02714504|Posaconazole|posaconazole|mesh-list
92311601|NCT02714504|Antifungal Agents|antifungal agents|mesh-ancestor
92311602|NCT02714504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311603|NCT02714504|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92311604|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92311605|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311606|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311607|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92311608|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
92311609|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311610|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311611|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92311612|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92311613|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92311614|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92311615|NCT05221502|Bedaquiline|bedaquiline|mesh-list
92311616|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
92311617|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
92311618|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92311619|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311620|NCT00368576|Darapladib|darapladib|mesh-list
92311621|NCT00368576|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92311622|NCT00368576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311623|NCT00368576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311624|NCT02730247|Paclitaxel|paclitaxel|mesh-list
92311625|NCT02730247|Ramucirumab|ramucirumab|mesh-list
92311626|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92311627|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311628|NCT02730247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92311629|NCT02730247|Antimitotic Agents|antimitotic agents|mesh-ancestor
92311630|NCT02730247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92311631|NCT02730247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311632|NCT03889106|Ribavirin|ribavirin|mesh-list
92311633|NCT03889106|Antimetabolites|antimetabolites|mesh-ancestor
92311634|NCT03889106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311635|NCT03889106|Antiviral Agents|antiviral agents|mesh-ancestor
92311636|NCT03889106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311637|NCT00368329|Carboplatin|carboplatin|mesh-list
92311638|NCT00368329|Fluorouracil|fluorouracil|mesh-list
92311639|NCT00368329|Capecitabine|capecitabine|mesh-list
92311640|NCT00368329|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92311641|NCT00368329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311642|NCT00368329|Antimetabolites|antimetabolites|mesh-ancestor
92311643|NCT00368329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347852|NCT01716156|Grazoprevir|grazoprevir|mesh-list
92311644|NCT00368329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92311645|NCT00368329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311646|NCT00368329|Immunologic Factors|immunologic factors|mesh-ancestor
92311647|NCT00368329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311648|NCT00368329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92311649|NCT02670343|Methyltestosterone|methyltestosterone|mesh-list
92311650|NCT02670343|Testosterone|testosterone|mesh-list
92311651|NCT02670343|Testosterone undecanoate|testosterone undecanoate|mesh-list
92311652|NCT02670343|Testosterone enanthate|testosterone enanthate|mesh-list
92311653|NCT02670343|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92311654|NCT02670343|Androgens|androgens|mesh-ancestor
92311655|NCT02670343|Hormones|hormones|mesh-ancestor
92311656|NCT02670343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311657|NCT02670343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311658|NCT02670343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311659|NCT02670343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311660|NCT02670343|Anabolic Agents|anabolic agents|mesh-ancestor
92311661|NCT03697850|Atezolizumab|atezolizumab|mesh-list
92311662|NCT03697850|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311663|NCT03697850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311664|NCT03697850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311665|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311666|NCT02730884|ON 01910|on 01910|mesh-list
92311667|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311668|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92311669|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311670|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311671|NCT02732587|Saracatinib|saracatinib|mesh-list
92311672|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311673|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936473|NCT03736265|Carvedilol|carvedilol|mesh-list
92311674|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311675|NCT02731820|Vitamin D|vitamin d|mesh-list
92311676|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
92311677|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
92311678|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
92311679|NCT02731820|Calcium|calcium|mesh-list
92311680|NCT02731820|Vitamins|vitamins|mesh-ancestor
92311681|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
92311682|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311683|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92311684|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92311685|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311686|NCT02731820|Antacids|antacids|mesh-ancestor
92311687|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311688|NCT02731820|Diuretics|diuretics|mesh-ancestor
92311689|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
92311690|NCT02731820|Expectorants|expectorants|mesh-ancestor
92311691|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
92311692|NCT02732899|Sirolimus|sirolimus|mesh-list
92311693|NCT02732899|Aflibercept|aflibercept|mesh-list
92311694|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92311695|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311696|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92311697|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311698|NCT02732899|Antifungal Agents|antifungal agents|mesh-ancestor
92311699|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311700|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
92311701|NCT02732899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311702|NCT02732899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92311703|NCT02732899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92311704|NCT02732899|Growth Substances|growth substances|mesh-ancestor
92311705|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
92311706|NCT02733757|Clonidine|clonidine|mesh-list
92311707|NCT02733757|Analgesics|analgesics|mesh-ancestor
92311708|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
92311709|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311710|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311711|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92311712|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
92311713|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
92311714|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92311715|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91964402|NCT04527055|Metronidazole|metronidazole|mesh-list
92311717|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92311718|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311719|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311720|NCT00368264|Infliximab|infliximab|mesh-list
92311721|NCT00368264|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92311722|NCT00368264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311723|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
92311724|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311725|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92311726|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
92311727|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
92311728|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311729|NCT02734147|Protective Agents|protective agents|mesh-ancestor
92311730|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311731|NCT02734147|Vitamins|vitamins|mesh-ancestor
92311732|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
92311733|NCT00368342|Azithromycin|azithromycin|mesh-list
92311734|NCT00368342|Clarithromycin|clarithromycin|mesh-list
92311735|NCT00368342|Erythromycin|erythromycin|mesh-list
92311736|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
92311737|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92311738|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
92311739|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92311740|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311741|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92311742|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311743|NCT00368342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311744|NCT00368342|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92311745|NCT00368342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92311746|NCT00368342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311747|NCT03609008|Cromakalim|cromakalim|mesh-list
92311748|NCT03609008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92311749|NCT03609008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92311750|NCT03609008|Autonomic Agents|autonomic agents|mesh-ancestor
92311751|NCT03609008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311752|NCT03609008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311753|NCT03609008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92311754|NCT03609008|Respiratory System Agents|respiratory system agents|mesh-ancestor
92311755|NCT03609008|Parasympatholytics|parasympatholytics|mesh-ancestor
92311756|NCT03609008|Vasodilator Agents|vasodilator agents|mesh-ancestor
92311757|NCT02734238|Methyltestosterone|methyltestosterone|mesh-list
92311758|NCT02734238|Testosterone|testosterone|mesh-list
92311759|NCT02734238|Testosterone undecanoate|testosterone undecanoate|mesh-list
92311760|NCT02734238|Testosterone enanthate|testosterone enanthate|mesh-list
92311761|NCT02734238|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92311762|NCT02734238|Androgens|androgens|mesh-ancestor
92311763|NCT02734238|Hormones|hormones|mesh-ancestor
92311764|NCT02734238|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311765|NCT02734238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311766|NCT02734238|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311767|NCT02734238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311768|NCT02734238|Anabolic Agents|anabolic agents|mesh-ancestor
92311769|NCT04707547|Nivolumab|nivolumab|mesh-list
92311770|NCT04707547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311771|NCT04707547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311772|NCT04707547|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311773|NCT04707547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311774|NCT02736175|Dexamethasone|dexamethasone|mesh-list
92311775|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311776|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
92311777|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
92311778|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311779|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311780|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92311781|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
92311782|NCT02736175|Hormones|hormones|mesh-ancestor
92311783|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311784|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311785|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311786|NCT00369356|Prednisone|prednisone|mesh-list
92311787|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92311788|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
92311789|NCT00369356|Hormones|hormones|mesh-ancestor
92311790|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311791|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311792|NCT00369356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311793|NCT00369356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311795|NCT04947085|Analgesics|analgesics|mesh-ancestor
92311796|NCT04947085|Sensory System Agents|sensory system agents|mesh-ancestor
92311797|NCT04947085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311798|NCT04947085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311799|NCT04947085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92311800|NCT04947085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311801|NCT04947085|Anesthetics, General|anesthetics, general|mesh-ancestor
92311802|NCT04947085|Anesthetics|anesthetics|mesh-ancestor
92311803|NCT04947085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311804|NCT04947085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92311805|NCT04947085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92311806|NCT04947085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311807|NCT04947085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311808|NCT03357224|Atezolizumab|atezolizumab|mesh-list
92311809|NCT03357224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92311810|NCT03357224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311811|NCT03357224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311812|NCT03357224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311813|NCT04947020|Metformin|metformin|mesh-list
92311814|NCT04947020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311815|NCT04947020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311816|NCT02679469|Nalmefene|nalmefene|mesh-list
92311817|NCT02679469|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92311818|NCT02679469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311819|NCT02679469|Sensory System Agents|sensory system agents|mesh-ancestor
92311820|NCT02679469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311821|NCT02681809|Fibrinolysin|fibrinolysin|mesh-list
92311822|NCT02681809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92311823|NCT02681809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92311824|NCT02681809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311825|NCT05445661|Mannitol|mannitol|mesh-list
92311826|NCT05445661|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92311827|NCT05445661|Diuretics|diuretics|mesh-ancestor
92311828|NCT05445661|Natriuretic Agents|natriuretic agents|mesh-ancestor
92311829|NCT05445661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311830|NCT04805125|Vaccines|vaccines|mesh-list
92311831|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
92311832|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311833|NCT00368017|Pioglitazone|pioglitazone|mesh-list
92311834|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92311835|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311836|NCT00367627|Albendazole|albendazole|mesh-list
92311837|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
92311838|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92311839|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92311840|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
92311841|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92311842|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92311843|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
92311844|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
92311845|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
92311846|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311847|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311848|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92311849|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311850|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311852|NCT05424523|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92311853|NCT05424523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92311854|NCT05424523|Respiratory System Agents|respiratory system agents|mesh-ancestor
92311855|NCT05442931|Magnesium Sulfate|magnesium sulfate|mesh-list
92311856|NCT05442931|Pregabalin|pregabalin|mesh-list
92311857|NCT05442931|Nitroglycerin|nitroglycerin|mesh-list
92311858|NCT05442931|Analgesics|analgesics|mesh-ancestor
92311859|NCT05442931|Sensory System Agents|sensory system agents|mesh-ancestor
92311860|NCT05442931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311861|NCT05442931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311862|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
92311863|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92311864|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311865|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311866|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92311868|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92311869|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311870|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92311871|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
92311872|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92311873|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
92311874|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92311875|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
92311876|NCT05439499|Letrozole|letrozole|mesh-list
92311877|NCT05439499|Anastrozole|anastrozole|mesh-list
92311878|NCT05439499|Goserelin|goserelin|mesh-list
92311879|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311880|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92311881|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92311882|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311883|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311884|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92311885|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
92311886|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311887|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311888|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92311889|NCT04003987|Bupivacaine|bupivacaine|mesh-list
92311890|NCT04003987|Anesthetics, Local|anesthetics, local|mesh-ancestor
92311891|NCT04003987|Anesthetics|anesthetics|mesh-ancestor
92311892|NCT04003987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311893|NCT04003987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311894|NCT04003987|Sensory System Agents|sensory system agents|mesh-ancestor
92311895|NCT04003987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311896|NCT05448001|Lansoprazole|lansoprazole|mesh-list
92311897|NCT05448001|Dexlansoprazole|dexlansoprazole|mesh-list
92311898|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92311900|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92311901|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311902|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311903|NCT05447455|Anesthetics|anesthetics|mesh-list
92311904|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
92311905|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311906|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311907|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
92311908|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311909|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
92311910|NCT00369733|Hematinics|hematinics|mesh-ancestor
92311911|NCT00368719|Tacrolimus|tacrolimus|mesh-list
92311912|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92311913|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
92311914|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311915|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92311916|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92311917|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311918|NCT00369811|Fentanyl|fentanyl|mesh-list
92311919|NCT00369811|Oxycodone|oxycodone|mesh-list
92311920|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92311921|NCT00369811|Narcotics|narcotics|mesh-ancestor
92311922|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92311924|NCT00369811|Analgesics|analgesics|mesh-ancestor
92311925|NCT00369811|Sensory System Agents|sensory system agents|mesh-ancestor
92311926|NCT00369811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311927|NCT00369811|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92311928|NCT00369811|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92311929|NCT00369811|Anesthetics, General|anesthetics, general|mesh-ancestor
92311930|NCT00369811|Anesthetics|anesthetics|mesh-ancestor
92311931|NCT03615547|Clomiphene|clomiphene|mesh-list
92311932|NCT03615547|Enclomiphene|enclomiphene|mesh-list
92311933|NCT03615547|Zuclomiphene|zuclomiphene|mesh-list
92311934|NCT03615547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92311935|NCT03615547|Hormone Antagonists|hormone antagonists|mesh-ancestor
92311936|NCT03615547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311937|NCT03615547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311938|NCT03615547|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92311939|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
92311940|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92311941|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92311943|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92311944|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
92311945|NCT03105128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311946|NCT03122509|Durvalumab|durvalumab|mesh-list
92311947|NCT03122509|Tremelimumab|tremelimumab|mesh-list
92311948|NCT03122509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311949|NCT03122509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311950|NCT03113695|Lenalidomide|lenalidomide|mesh-list
92311951|NCT03113695|Obinutuzumab|obinutuzumab|mesh-list
92311952|NCT03113695|Immunologic Factors|immunologic factors|mesh-ancestor
92311953|NCT03113695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311954|NCT03113695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92311955|NCT03113695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92311956|NCT03113695|Growth Substances|growth substances|mesh-ancestor
92311957|NCT03113695|Growth Inhibitors|growth inhibitors|mesh-ancestor
92311958|NCT03113695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92311959|NCT03113695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92311960|NCT05315947|Brivaracetam|brivaracetam|mesh-list
92311961|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
92311962|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92311963|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92311964|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92311965|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92311966|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311967|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311968|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311969|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
92311970|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92311972|NCT05444738|Oxytocics|oxytocics|mesh-ancestor
92311973|NCT05444738|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91936475|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92311974|NCT05444738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311976|NCT05243953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92311977|NCT05243953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92311978|NCT05243953|Autonomic Agents|autonomic agents|mesh-ancestor
92311979|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311980|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311981|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92311982|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
92311983|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
92311984|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
92311985|NCT02757313|Dronabinol|dronabinol|mesh-list
92311986|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
92311987|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92311988|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92311989|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92311990|NCT02757313|Analgesics|analgesics|mesh-ancestor
92311991|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
92311992|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92311993|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92311994|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92311995|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92311996|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92311997|NCT02757313|Hormones|hormones|mesh-ancestor
92311998|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92311999|NCT02514278|Capecitabine|capecitabine|mesh-list
92312000|NCT02514278|Folfirinox|folfirinox|mesh-list
92312001|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92312002|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
92312003|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312004|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312005|NCT02379806|Enoxaparin|enoxaparin|mesh-list
92312006|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
92312007|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92312008|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92312009|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312010|NCT02358356|Capecitabine|capecitabine|mesh-list
92312011|NCT02358356|Temozolomide|temozolomide|mesh-list
92312012|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92312013|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
92312014|NCT02358356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312015|NCT02358356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312016|NCT02358356|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92312017|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
92312019|NCT04700761|Anesthetics|anesthetics|mesh-list
92312020|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312021|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312022|NCT04700761|Narcotics|narcotics|mesh-ancestor
92312023|NCT04700761|Analgesics|analgesics|mesh-ancestor
92312024|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
92312025|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312026|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
92312027|NCT04651088|Diuretics|diuretics|mesh-ancestor
92312028|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
92312029|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312030|NCT04651088|Expectorants|expectorants|mesh-ancestor
92312031|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312032|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
92312033|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312034|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312035|NCT04595617|Antibodies|antibodies|mesh-list
92312036|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
92312037|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312038|NCT02162810|Prednisolone|prednisolone|mesh-list
92312039|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312040|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
92312041|NCT02162810|Hormones|hormones|mesh-ancestor
92312042|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312043|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312044|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92312045|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312046|NCT00368498|Teicoplanin|teicoplanin|mesh-list
92312047|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92312048|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312050|NCT05172817|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92312051|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312053|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
92312054|NCT05145907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312055|NCT05145907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312056|NCT05145907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312057|NCT05145907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312058|NCT04563325|Ceftriaxone|ceftriaxone|mesh-list
92312059|NCT04563325|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92312060|NCT04563325|Dicloxacillin|dicloxacillin|mesh-list
92312061|NCT04563325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92312062|NCT04563325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312063|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92312064|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312065|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312066|NCT04545151|Verapamil|verapamil|mesh-list
92312067|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92312068|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92312069|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312070|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312071|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92312072|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312073|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
92312074|NCT00961142|Fludarabine|fludarabine|mesh-list
92312075|NCT00961142|Melphalan|melphalan|mesh-list
92312076|NCT00961142|Thiotepa|thiotepa|mesh-list
92312077|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
92312078|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312079|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312080|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92312081|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
92312082|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312083|NCT00961142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92312084|NCT00961142|Alkylating Agents|alkylating agents|mesh-ancestor
92312085|NCT00961142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92312086|NCT04523701|SMOFlipid|smoflipid|mesh-list
92312087|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92312088|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92312089|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92312090|NCT04338373|Atropine|atropine|mesh-list
92312091|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92312092|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92312093|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312094|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
92312095|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312096|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312097|NCT04338373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312098|NCT04338373|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312099|NCT04338373|Mydriatics|mydriatics|mesh-ancestor
92312100|NCT04338373|Parasympatholytics|parasympatholytics|mesh-ancestor
92312101|NCT04338373|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92312102|NCT04338373|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92312103|NCT04338373|Cholinergic Agents|cholinergic agents|mesh-ancestor
92312104|NCT04338373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312105|NCT04338373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312106|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
92312107|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92312108|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
92312109|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312110|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92312111|NCT00369031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312112|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
92312113|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312114|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
92312115|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92312116|NCT00369031|Protective Agents|protective agents|mesh-ancestor
92312117|NCT05443178|Isoniazid|isoniazid|mesh-list
92312118|NCT05443178|Ethambutol|ethambutol|mesh-list
92312119|NCT05443178|Chloroquine|chloroquine|mesh-list
92312120|NCT05443178|Antitubercular Agents|antitubercular agents|mesh-ancestor
92312121|NCT05443178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92312122|NCT05443178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312123|NCT05443178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312124|NCT05443178|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92312125|NCT05443178|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92312126|NCT05443178|Antimetabolites|antimetabolites|mesh-ancestor
92312127|NCT05443178|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92312128|NCT05443178|Amebicides|amebicides|mesh-ancestor
92312129|NCT05443178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92312130|NCT05443178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92312131|NCT05443178|Antimalarials|antimalarials|mesh-ancestor
92312132|NCT05443178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312134|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92312135|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
92312136|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347886|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92312137|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312139|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92312140|NCT05061901|Protective Agents|protective agents|mesh-ancestor
92312141|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312142|NCT04338919|Aspirin|aspirin|mesh-list
92312143|NCT04338919|Ticagrelor|ticagrelor|mesh-list
92312144|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92312145|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92312146|NCT04338919|Analgesics|analgesics|mesh-ancestor
92312147|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
92312148|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312149|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312150|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312151|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312152|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92312153|NCT04338919|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92312154|NCT04338919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312155|NCT04338919|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92312156|NCT04338919|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92312157|NCT04338919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312158|NCT04338919|Antipyretics|antipyretics|mesh-ancestor
92312159|NCT04338919|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92312160|NCT04338919|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92312161|NCT04338919|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92312162|NCT04338919|Purinergic Agents|purinergic agents|mesh-ancestor
92312163|NCT04338919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312164|NCT05451290|Gemcitabine|gemcitabine|mesh-list
92312165|NCT05451290|Tegafur|tegafur|mesh-list
92312166|NCT05451290|Oxaliplatin|oxaliplatin|mesh-list
92312167|NCT05451290|Apatinib|apatinib|mesh-list
92312168|NCT05451290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92312169|NCT05451290|Antimetabolites|antimetabolites|mesh-ancestor
92312170|NCT05451290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312171|NCT05451290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312172|NCT05451290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92312173|NCT05451290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312174|NCT00369889|Bevacizumab|bevacizumab|mesh-list
92312175|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92312176|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312177|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312178|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92312179|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92312180|NCT00369889|Growth Substances|growth substances|mesh-ancestor
92312181|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312182|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
92312183|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92312184|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312185|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312187|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312188|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
92312189|NCT00369044|Hormones|hormones|mesh-ancestor
92312190|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312191|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312192|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92312193|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312194|NCT00370045|Bivalirudin|bivalirudin|mesh-list
92312195|NCT00370045|Eptifibatide|eptifibatide|mesh-list
92312196|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
92312197|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92312198|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
92312199|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312200|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312201|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
92312202|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92312204|NCT05451056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312205|NCT05451056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312206|NCT05451056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312207|NCT05451056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312208|NCT05441150|Ketamine|ketamine|mesh-list
92312209|NCT05441150|Analgesics|analgesics|mesh-ancestor
92312210|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
92312211|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312212|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312213|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92312214|NCT05441150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92312215|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
92312216|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
92312217|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312218|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92312219|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92312220|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312221|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312222|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92312223|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92312224|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312225|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312226|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
92312227|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312228|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312230|NCT05438810|Goserelin|goserelin|mesh-list
92312231|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92312232|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312233|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92312234|NCT05438810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92312235|NCT05438810|Hormone Antagonists|hormone antagonists|mesh-ancestor
92312236|NCT05438810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312237|NCT05438810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312238|NCT05451121|Dexmedetomidine|dexmedetomidine|mesh-list
92312239|NCT05451121|Propofol|propofol|mesh-list
92312240|NCT05451121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92312241|NCT05451121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312242|NCT05451121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312243|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92312245|NCT05451121|Sensory System Agents|sensory system agents|mesh-ancestor
92312246|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312247|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92312248|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92312249|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92312250|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92312251|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312252|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312253|NCT05451121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92312254|NCT05451121|Anesthetics, General|anesthetics, general|mesh-ancestor
92312255|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
92312256|NCT04967443|Prazosin|prazosin|mesh-list
92312257|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92312258|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92312259|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92312260|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92347914|NCT01695954|Antimetabolites|antimetabolites|mesh-ancestor
92312261|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
92312262|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312263|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312264|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312265|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
92312266|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312267|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
92312268|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
92312269|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312270|NCT02230956|Botulinum Toxins|botulinum toxins|mesh-list
92312271|NCT02230956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92312272|NCT02230956|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92312273|NCT02230956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92312274|NCT02230956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312275|NCT02230956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312276|NCT02230956|Cholinergic Agents|cholinergic agents|mesh-ancestor
92312277|NCT02230956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312278|NCT02230956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312279|NCT02230956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92312280|NCT02230956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312281|NCT05450042|Paclitaxel|paclitaxel|mesh-list
92312282|NCT05450042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92312283|NCT05450042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312284|NCT05450042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92312285|NCT05450042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92312286|NCT05450042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312287|NCT05450042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312288|NCT05447936|Vitamin D|vitamin d|mesh-list
92312289|NCT05447936|Vitamins|vitamins|mesh-ancestor
92312290|NCT05447936|Micronutrients|micronutrients|mesh-ancestor
92312291|NCT05447936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312292|NCT05447936|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92312293|NCT04739384|Ticagrelor|ticagrelor|mesh-list
92312294|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92312295|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92312296|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92312297|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92312298|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
92312299|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312300|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312301|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312302|NCT04704596|Anesthetics|anesthetics|mesh-list
92312303|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312304|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312305|NCT05450497|Dexmedetomidine|dexmedetomidine|mesh-list
92312306|NCT05450497|Propofol|propofol|mesh-list
92312307|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92312308|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312309|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312310|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92312311|NCT05450497|Analgesics|analgesics|mesh-ancestor
91965003|NCT03263299|Analgesics|analgesics|mesh-ancestor
92312312|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
92411347|NCT04468061|Immunologic Factors|immunologic factors|mesh-ancestor
92312313|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312314|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92312315|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92312316|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92312317|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
92312318|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312319|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312320|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92312321|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
92312322|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
92312323|NCT02230332|Alendronate|alendronate|mesh-list
92312324|NCT02230332|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92312325|NCT02230332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312326|NCT05449028|Bismuth|bismuth|mesh-list
92312327|NCT05449028|Antacids|antacids|mesh-ancestor
92312328|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312329|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312330|NCT04845139|Nivolumab|nivolumab|mesh-list
92312331|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312332|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312333|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312334|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312335|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
92312336|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
92312337|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92312338|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936479|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312339|NCT04738526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312340|NCT04738526|Antimanic Agents|antimanic agents|mesh-ancestor
92312341|NCT04738526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92312342|NCT04738526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312343|NCT04738526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312344|NCT05449483|Paclitaxel|paclitaxel|mesh-list
92312345|NCT05449483|Tislelizumab|tislelizumab|mesh-list
92312346|NCT05449483|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92312347|NCT05449483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312348|NCT05449483|Tubulin Modulators|tubulin modulators|mesh-ancestor
92312349|NCT05449483|Antimitotic Agents|antimitotic agents|mesh-ancestor
92312350|NCT05449483|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312351|NCT05449483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312352|NCT05449483|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312353|NCT05448404|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92312354|NCT05448404|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92312355|NCT05448404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312357|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
92312358|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92312359|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312360|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312361|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92312362|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312363|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
92312364|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92312365|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312366|NCT05448937|Eugenol|eugenol|mesh-list
92312367|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
92312368|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312369|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
92312370|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92312371|NCT05448937|Protective Agents|protective agents|mesh-ancestor
92312372|NCT05448937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312373|NCT05448937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312374|NCT00370201|Colchicine|colchicine|mesh-list
92312375|NCT00370201|Gout Suppressants|gout suppressants|mesh-ancestor
92312376|NCT00370201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312377|NCT00370201|Tubulin Modulators|tubulin modulators|mesh-ancestor
92312378|NCT00370201|Antimitotic Agents|antimitotic agents|mesh-ancestor
92312379|NCT00370201|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312380|NCT00370201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312381|NCT00370201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312382|NCT05448781|Paclitaxel|paclitaxel|mesh-list
92312383|NCT05448781|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91965076|NCT03984955|Immunologic Factors|immunologic factors|mesh-ancestor
92312384|NCT05448781|Carboplatin|carboplatin|mesh-list
92312386|NCT05448781|Endostatins|endostatins|mesh-list
92312387|NCT05448781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92312388|NCT05448781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312389|NCT05448781|Tubulin Modulators|tubulin modulators|mesh-ancestor
92312390|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
92312391|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312392|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312393|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312394|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92312395|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92312396|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92312397|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92312398|NCT05448781|Growth Substances|growth substances|mesh-ancestor
92312399|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312400|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
92312402|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312403|NCT03134755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312404|NCT03134755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92312405|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92312406|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92312407|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92312408|NCT00370825|Miltefosine|miltefosine|mesh-list
92312409|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
92312410|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312411|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92312412|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92312413|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312414|NCT04450316|Naltrexone|naltrexone|mesh-list
92312415|NCT04450316|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92312416|NCT04450316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92312417|NCT04450316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312418|NCT04450316|Sensory System Agents|sensory system agents|mesh-ancestor
92312419|NCT04450316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312420|NCT05398094|Sotorasib|sotorasib|mesh-list
92312421|NCT05398094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312422|NCT05398094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312423|NCT05398094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312424|NCT05398094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312425|NCT02535247|Pembrolizumab|pembrolizumab|mesh-list
92312426|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312427|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312428|NCT02535247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312429|NCT02535247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312430|NCT04417920|Mitomycins|mitomycins|mesh-list
92312431|NCT04417920|Mitomycin|mitomycin|mesh-list
92312432|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92312433|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312434|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
92312435|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312436|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92312437|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312438|NCT02626130|Tremelimumab|tremelimumab|mesh-list
92312439|NCT02626130|Ipilimumab|ipilimumab|mesh-list
92312440|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312441|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312442|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312443|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312444|NCT02618720|Ornidazole|ornidazole|mesh-list
92312445|NCT02618720|Amebicides|amebicides|mesh-ancestor
92312446|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92312447|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92312448|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312449|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92312450|NCT03758989|Prednisone|prednisone|mesh-list
92312451|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
92312452|NCT03758989|Rituximab|rituximab|mesh-list
92312453|NCT03758989|Doxorubicin|doxorubicin|mesh-list
92312454|NCT03758989|Vincristine|vincristine|mesh-list
92312455|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92312456|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
92312457|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312458|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312459|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92312460|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
92312461|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312462|NCT03758989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312463|NCT03758989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92312464|NCT03758989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312465|NCT03758989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92312466|NCT03758989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92312467|NCT03758989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92312468|NCT03758989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312469|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312470|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
92312471|NCT03758989|Hormones|hormones|mesh-ancestor
92312472|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312473|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92312474|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92312475|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
92312476|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
92312477|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312478|NCT02042989|Vorinostat|vorinostat|mesh-list
92312479|NCT02042989|Ixazomib|ixazomib|mesh-list
92312480|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312481|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92312482|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312483|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312484|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
92312485|NCT04093531|Ustekinumab|ustekinumab|mesh-list
92312486|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312487|NCT05208944|Cemiplimab|cemiplimab|mesh-list
91936480|NCT03736265|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92312488|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312489|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312490|NCT01809379|Cisplatin|cisplatin|mesh-list
92312491|NCT01809379|Doxorubicin|doxorubicin|mesh-list
92312492|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312493|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92312494|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92312495|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92312496|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312497|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312498|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
92312499|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92312500|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312501|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92312502|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312503|NCT05202158|Gentamicins|gentamicins|mesh-list
92312504|NCT05202158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92312505|NCT05202158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312506|NCT05202158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92312507|NCT05202158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312508|NCT05202158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312509|NCT00370370|Triamcinolone|triamcinolone|mesh-list
92312510|NCT00370370|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92312511|NCT00370370|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92312512|NCT00370370|Bevacizumab|bevacizumab|mesh-list
92312513|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92312514|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312515|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312516|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92312517|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92312518|NCT00370370|Growth Substances|growth substances|mesh-ancestor
92312519|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312520|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92312521|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312522|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
92312523|NCT00370370|Hormones|hormones|mesh-ancestor
92312524|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312525|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92312526|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
92312527|NCT00370370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312528|NCT00370370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312529|NCT02197416|Dabigatran|dabigatran|mesh-list
92312530|NCT02197416|Antithrombins|antithrombins|mesh-ancestor
92312531|NCT02197416|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92312532|NCT02197416|Protease Inhibitors|protease inhibitors|mesh-ancestor
92312533|NCT02197416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312534|NCT02197416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312536|NCT00370591|Fluticasone|fluticasone|mesh-list
92312537|NCT00370591|Xhance|xhance|mesh-list
92312538|NCT00370591|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92312539|NCT00370591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312540|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312541|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
92312542|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312543|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312544|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312545|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312546|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312547|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92312548|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92312549|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92312550|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92312551|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
92312552|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312553|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312554|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92312555|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312556|NCT00371527|Ipratropium|ipratropium|mesh-list
92312557|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312558|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
92312559|NCT00371527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312560|NCT00371527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312561|NCT00371527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312562|NCT00371527|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312563|NCT00371527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92312564|NCT00371527|Cholinergic Agents|cholinergic agents|mesh-ancestor
92312565|NCT00371527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312566|NCT00371527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312567|NCT00392756|Hormones|hormones|mesh-list
92312568|NCT00392756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312569|NCT00392756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312570|NCT03908593|Pantoprazole|pantoprazole|mesh-list
92312571|NCT03908593|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92312572|NCT03908593|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312573|NCT03908593|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92312574|NCT03908593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312575|NCT03908593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312576|NCT04027322|Dexamethasone|dexamethasone|mesh-list
92312577|NCT04027322|Budesonide|budesonide|mesh-list
92312578|NCT04027322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312579|NCT04027322|Antiemetics|antiemetics|mesh-ancestor
92312580|NCT04027322|Autonomic Agents|autonomic agents|mesh-ancestor
92312581|NCT04027322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312582|NCT04027322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312583|NCT04027322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312584|NCT04027322|Glucocorticoids|glucocorticoids|mesh-ancestor
92312585|NCT04027322|Hormones|hormones|mesh-ancestor
92312586|NCT04027322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312587|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92312588|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312589|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312590|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312591|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312592|NCT03845257|Dimercaprol|dimercaprol|mesh-list
92312593|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
92312594|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
92312595|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312596|NCT00371072|Mitomycins|mitomycins|mesh-list
92312597|NCT00371072|Mitomycin|mitomycin|mesh-list
92312598|NCT00371072|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92312599|NCT00371072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312600|NCT00371072|Alkylating Agents|alkylating agents|mesh-ancestor
92312601|NCT00371072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312602|NCT00371072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92312603|NCT00371072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312604|NCT05454332|Caffeine|caffeine|mesh-list
92312605|NCT05454332|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92312606|NCT05454332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312607|NCT05454332|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92312608|NCT05454332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312609|NCT05454332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312610|NCT05454332|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92312611|NCT05454332|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92312612|NCT05454332|Purinergic Agents|purinergic agents|mesh-ancestor
92312613|NCT05454332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312614|NCT03924518|Granisetron|granisetron|mesh-list
92312615|NCT03924518|Serotonin|serotonin|mesh-list
92312616|NCT03924518|Antiemetics|antiemetics|mesh-ancestor
92312617|NCT03924518|Autonomic Agents|autonomic agents|mesh-ancestor
92312618|NCT03924518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312619|NCT03924518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312620|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312621|NCT03924518|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92312622|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92312623|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
92312624|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312625|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312626|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92312627|NCT05454085|Bisphenol A|bisphenol a|mesh-list
92312628|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92312629|NCT05454085|Estrogens|estrogens|mesh-ancestor
92312630|NCT05454085|Hormones|hormones|mesh-ancestor
92312631|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312632|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312633|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92312634|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
92312635|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312636|NCT05454085|Protective Agents|protective agents|mesh-ancestor
92312637|NCT03886922|Cromakalim|cromakalim|mesh-list
92312638|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92312639|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312640|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
92312641|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312642|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312643|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312644|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312645|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
92312646|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
92312647|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
92312648|NCT05453552|Busulfan|busulfan|mesh-list
92312649|NCT05453552|Fludarabine|fludarabine|mesh-list
92312650|NCT05453552|Decitabine|decitabine|mesh-list
92312651|NCT05453552|Lenograstim|lenograstim|mesh-list
92312652|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92312653|NCT05453552|Immunologic Factors|immunologic factors|mesh-ancestor
92312654|NCT05453552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312655|NCT05453552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312656|NCT05453552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92312657|NCT05453552|Alkylating Agents|alkylating agents|mesh-ancestor
92312658|NCT05453552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312659|NCT05453552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312660|NCT05453552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92312661|NCT05453552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92312662|NCT05453552|Antimetabolites|antimetabolites|mesh-ancestor
92312663|NCT05453552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312664|NCT05453552|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92312665|NCT03787082|Chlorhexidine|chlorhexidine|mesh-list
92312666|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92312667|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92312668|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312669|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
92312670|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312671|NCT02165202|Rilpivirine|rilpivirine|mesh-list
92312672|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92312673|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92312674|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312675|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312676|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
92312677|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312678|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92312679|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92312680|NCT01628874|Lidocaine|lidocaine|mesh-list
92312681|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92312682|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
92312683|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
92312684|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312685|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312686|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
92312687|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312688|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92312689|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92312690|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92312691|NCT01628874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312692|NCT01628874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312693|NCT01628874|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92312694|NCT04891718|Nivolumab|nivolumab|mesh-list
92312695|NCT04891718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312696|NCT04891718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312697|NCT04891718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92312698|NCT04891718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312699|NCT03770689|Capecitabine|capecitabine|mesh-list
92312700|NCT03770689|Peposertib|peposertib|mesh-list
92312701|NCT03770689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92312702|NCT03770689|Antimetabolites|antimetabolites|mesh-ancestor
92312703|NCT03770689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312704|NCT03770689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312705|NCT03770689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92312706|NCT03770689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312707|NCT00371306|Metformin|metformin|mesh-list
92312709|NCT00371306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92312710|NCT00371306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312711|NCT02196714|Glycopyrrolate|glycopyrrolate|mesh-list
92312712|NCT02196714|Formoterol Fumarate|formoterol fumarate|mesh-list
92312713|NCT02196714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312714|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
92312715|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312716|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312717|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312718|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312719|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92312720|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92312721|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92312722|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
92312723|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312724|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312725|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92312726|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92312727|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92312728|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
92312729|NCT05453929|Rocuronium|rocuronium|mesh-list
92312730|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92312731|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92312732|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92312733|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312734|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312735|NCT00370760|Dexamethasone|dexamethasone|mesh-list
92312736|NCT00370760|Colchicine|colchicine|mesh-list
92312737|NCT00370760|Heparin|heparin|mesh-list
92312738|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92312739|NCT00370760|Tinzaparin|tinzaparin|mesh-list
92312740|NCT00370760|Dalteparin|dalteparin|mesh-list
92312741|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312742|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
92312743|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
92312744|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312745|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312746|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312747|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
92312748|NCT00370760|Hormones|hormones|mesh-ancestor
92312749|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347939|NCT01693068|Dacarbazine|dacarbazine|mesh-list
92312750|NCT00370760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92312751|NCT00370760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312753|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92312754|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92312755|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312756|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
92312757|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312758|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
92312759|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
92312760|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
92312762|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
92312763|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
92312764|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312765|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312766|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
92312767|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312768|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92312769|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92312770|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92312771|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312772|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312773|NCT05203562|Letrozole|letrozole|mesh-list
92312774|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312775|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92312776|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92312777|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312778|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312779|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92312780|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
92312781|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312782|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312783|NCT04766762|Flunarizine|flunarizine|mesh-list
92312784|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
92312785|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92312786|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312787|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312788|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92312789|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312790|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92312791|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
92312792|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
92312793|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312794|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
92312795|NCT04330040|Olaparib|olaparib|mesh-list
92312796|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92312797|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312798|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312799|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312800|NCT02737891|Metoprolol|metoprolol|mesh-list
92312801|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92312802|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92312803|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
92312804|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
92312805|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312806|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312807|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92312808|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92312809|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92312810|NCT02737891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92312811|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312812|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312813|NCT05055050|Imiquimod|imiquimod|mesh-list
92312814|NCT05055050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92312815|NCT05055050|Immunologic Factors|immunologic factors|mesh-ancestor
92312816|NCT05055050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312817|NCT05055050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312818|NCT05055050|Interferon Inducers|interferon inducers|mesh-ancestor
92312819|NCT02196558|Quetmolimab|quetmolimab|mesh-list
92312820|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312822|NCT04809662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92312823|NCT04809662|Immunologic Factors|immunologic factors|mesh-ancestor
92312824|NCT04809662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312825|NCT04809662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312826|NCT04809662|Interferon Inducers|interferon inducers|mesh-ancestor
92312827|NCT02196324|Serlopitant|serlopitant|mesh-list
92312828|NCT02196324|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92312829|NCT02196324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312830|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312831|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312832|NCT05450419|Vitamin D|vitamin d|mesh-list
92312833|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
92312834|NCT05450419|Vitamins|vitamins|mesh-ancestor
92312835|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
92312836|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312837|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92312838|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92312839|NCT05443009|Lidocaine|lidocaine|mesh-list
92312840|NCT05443009|Carticaine|carticaine|mesh-list
92312841|NCT05443009|Anesthetics, Local|anesthetics, local|mesh-ancestor
92312842|NCT05443009|Anesthetics|anesthetics|mesh-ancestor
92312843|NCT05443009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92312844|NCT05443009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312845|NCT05443009|Sensory System Agents|sensory system agents|mesh-ancestor
92312846|NCT05443009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312847|NCT05443009|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92312848|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92312849|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92312850|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312851|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312852|NCT00370669|Triamcinolone|triamcinolone|mesh-list
92312853|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92312854|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92312855|NCT00370669|Bevacizumab|bevacizumab|mesh-list
92312856|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92312857|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92312859|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92312860|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92312861|NCT00370669|Growth Substances|growth substances|mesh-ancestor
92312862|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312863|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92312864|NCT00370669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312865|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
92312866|NCT00370669|Hormones|hormones|mesh-ancestor
92312867|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92312868|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92312869|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
92312870|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312871|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312872|NCT05378971|Pomalidomide|pomalidomide|mesh-list
92312873|NCT05378971|Immunologic Factors|immunologic factors|mesh-ancestor
92312874|NCT05378971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312875|NCT05378971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92312876|NCT05378971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92312877|NCT05378971|Growth Substances|growth substances|mesh-ancestor
92312878|NCT05378971|Growth Inhibitors|growth inhibitors|mesh-ancestor
92312879|NCT05378971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312880|NCT04337450|Lamivudine|lamivudine|mesh-list
92312881|NCT04337450|Dolutegravir|dolutegravir|mesh-list
92312882|NCT04337450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92312883|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92312884|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312885|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312886|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
92312887|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312888|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347953|NCT01691898|Immunoconjugates|immunoconjugates|mesh-ancestor
92312889|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92312890|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92312891|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92312892|NCT02740543|Fluticasone|fluticasone|mesh-list
92312893|NCT02740543|Xhance|xhance|mesh-list
92312894|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312895|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92312896|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
92312897|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312898|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312899|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92312900|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
92312901|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
92312902|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92312903|NCT00370747|Ecabet|ecabet|mesh-list
92312904|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312905|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92312906|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312907|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
92312908|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411726|NCT03975231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312909|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312911|NCT00370747|Protective Agents|protective agents|mesh-ancestor
92312912|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312913|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312914|NCT02752256|Plasminogen|plasminogen|mesh-list
92312915|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92312916|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92312917|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92312918|NCT02752256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312919|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92312920|NCT02227446|Vancomycin|vancomycin|mesh-list
92312921|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312922|NCT04738058|Lactoferrin|lactoferrin|mesh-list
92312923|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92312924|NCT02227368|Ticagrelor|ticagrelor|mesh-list
92312925|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312926|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312927|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91936486|NCT03736265|Vasodilator Agents|vasodilator agents|mesh-ancestor
92312928|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92312929|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92312930|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92312931|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
92312932|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312933|NCT02162862|Bupropion|bupropion|mesh-list
92312934|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92312935|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
92312936|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92312937|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92312938|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92312939|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92312940|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312941|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
92312942|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92312943|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312944|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92312945|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92312946|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312947|NCT05277727|Fucoidan|fucoidan|mesh-list
92312948|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92312949|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92312950|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
92312951|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312952|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92312953|NCT02226198|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92312954|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92312955|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
92312956|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312957|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92312958|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92312959|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312960|NCT02754518|Valsartan|valsartan|mesh-list
92312961|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92312962|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92312963|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92312964|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92312965|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312966|NCT02751385|Nintedanib|nintedanib|mesh-list
92312967|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92312968|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92312969|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312970|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92312971|NCT02751385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312972|NCT02751385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312973|NCT02751385|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92312974|NCT02751385|Contraceptive Agents|contraceptive agents|mesh-ancestor
92312975|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92312976|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312977|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92312978|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92312979|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92312980|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92312981|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92312982|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92312983|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92312984|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92312985|NCT05349032|Curcumin|curcumin|mesh-list
92312986|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92312987|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92312988|NCT05349032|Analgesics|analgesics|mesh-ancestor
92312989|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
92312990|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92312991|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92312992|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92312993|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92312994|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92312995|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92312996|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92312998|NCT05057689|Midazolam|midazolam|mesh-list
92312999|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
92313000|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92313001|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313002|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313003|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313004|NCT05057689|Analgesics|analgesics|mesh-ancestor
92313005|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
92313006|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313007|NCT05057689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92313008|NCT05057689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92313009|NCT05057689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92313010|NCT05057689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92313011|NCT05057689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313012|NCT05057689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313013|NCT05057689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92313014|NCT05057689|Narcotics|narcotics|mesh-ancestor
92313015|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92313016|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92313017|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
92313018|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
92313019|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92313020|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92313021|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92313022|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
92313023|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
92313024|NCT05032183|Leucovorin|leucovorin|mesh-list
92313025|NCT05032183|Cytarabine|cytarabine|mesh-list
92313026|NCT05032183|Dexamethasone|dexamethasone|mesh-list
92313027|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
92313028|NCT05032183|Prednisone|prednisone|mesh-list
92313029|NCT05032183|Cortisone|cortisone|mesh-list
92313030|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
92313031|NCT05032183|Rituximab|rituximab|mesh-list
92313032|NCT05032183|Methotrexate|methotrexate|mesh-list
92313033|NCT05032183|Vincristine|vincristine|mesh-list
92313034|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
92313035|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92313036|NCT05032183|Antibodies|antibodies|mesh-list
92313037|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
92313038|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92313039|NCT05032183|Lenograstim|lenograstim|mesh-list
92313040|NCT05032183|BB 1101|bb 1101|mesh-list
92313041|NCT05032183|Mesna|mesna|mesh-list
92313042|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92313043|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
92313044|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313045|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313046|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92313047|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
92313048|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313049|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965763|NCT04502771|Clotrimazole|clotrimazole|mesh-list
92313050|NCT05032183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92313051|NCT05032183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313052|NCT05032183|Antiemetics|antiemetics|mesh-ancestor
92313053|NCT05032183|Autonomic Agents|autonomic agents|mesh-ancestor
92313054|NCT05032183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313055|NCT05032183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92313056|NCT05032183|Glucocorticoids|glucocorticoids|mesh-ancestor
92313057|NCT05032183|Hormones|hormones|mesh-ancestor
92411802|NCT03936049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92313058|NCT05032183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313059|NCT05032183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313060|NCT05032183|Protease Inhibitors|protease inhibitors|mesh-ancestor
92313061|NCT05032183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313062|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92313063|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
92313064|NCT05032183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92313065|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92313066|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
92313067|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
92313068|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92313069|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92313070|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
92313071|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313072|NCT05032183|Antidotes|antidotes|mesh-ancestor
92313073|NCT05032183|Protective Agents|protective agents|mesh-ancestor
92313074|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
92313075|NCT05032183|Vitamins|vitamins|mesh-ancestor
92313076|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
92313077|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92313078|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92313079|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92313080|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92313081|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92313082|NCT04737980|Dexamethasone|dexamethasone|mesh-list
92313083|NCT04737980|Bupivacaine|bupivacaine|mesh-list
92313084|NCT04737980|Ropivacaine|ropivacaine|mesh-list
92313085|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313086|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
92313087|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
92313088|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313089|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313090|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92313091|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
92313092|NCT04737980|Hormones|hormones|mesh-ancestor
92313093|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313094|NCT04737980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313095|NCT04737980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313096|NCT04737980|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313097|NCT04737980|Anesthetics|anesthetics|mesh-ancestor
92313098|NCT04737980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313099|NCT04737980|Sensory System Agents|sensory system agents|mesh-ancestor
92313100|NCT00371696|Acetaminophen|acetaminophen|mesh-list
92313101|NCT00371696|Diclofenac|diclofenac|mesh-list
92313102|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313103|NCT00371696|Analgesics|analgesics|mesh-ancestor
92313104|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
92313105|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313106|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313107|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
92313108|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92313109|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313110|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313111|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92313112|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313113|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313114|NCT02756624|Cetirizine|cetirizine|mesh-list
92313115|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92313116|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92313117|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92313118|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
92313119|NCT02756624|Histamine Agents|histamine agents|mesh-ancestor
92313120|NCT02756624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313121|NCT02756624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313122|NCT02756624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313123|NCT02958800|Olanzapine|olanzapine|mesh-list
92313124|NCT02958800|Risperidone|risperidone|mesh-list
92313125|NCT02958800|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92313126|NCT02958800|Antipsychotic Agents|antipsychotic agents|mesh-list
92313127|NCT02958800|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92313128|NCT02958800|Serotonin Agents|serotonin agents|mesh-ancestor
92313129|NCT02958800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313130|NCT02958800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313131|NCT02958800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313132|NCT02958800|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92411803|NCT03936049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313133|NCT02958800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313134|NCT02958800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92313135|NCT02958800|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92313136|NCT02958800|Dopamine Agents|dopamine agents|mesh-ancestor
92313137|NCT02958800|Antiemetics|antiemetics|mesh-ancestor
92313138|NCT02958800|Autonomic Agents|autonomic agents|mesh-ancestor
92313139|NCT02958800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313140|NCT02958800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92313141|NCT02958800|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92313142|NCT02958800|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92313143|NCT02958800|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92313144|NCT02958800|Antidepressive Agents|antidepressive agents|mesh-ancestor
92313145|NCT00372086|Rosiglitazone|rosiglitazone|mesh-list
92313146|NCT00372086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92313147|NCT00372086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313148|NCT04738045|Ritonavir|ritonavir|mesh-list
92313149|NCT04738045|Lopinavir|lopinavir|mesh-list
92313150|NCT04738045|Remdesivir|remdesivir|mesh-list
92313151|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92313152|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92313153|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
92313154|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313155|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313156|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92313157|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92313158|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
92313159|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313160|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92313161|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92313162|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
92313163|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92313164|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92313165|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313166|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
92313167|NCT04587973|Ropivacaine|ropivacaine|mesh-list
92313168|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92313169|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313170|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313171|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313172|NCT04587973|Analgesics|analgesics|mesh-ancestor
92313173|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
92313174|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313175|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92313176|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92313177|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92313178|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
92313179|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313180|NCT04587973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313181|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313182|NCT04587973|Anesthetics|anesthetics|mesh-ancestor
92313183|NCT04516915|Oseltamivir|oseltamivir|mesh-list
92313184|NCT04516915|Antiviral Agents|antiviral agents|mesh-ancestor
92313185|NCT04516915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313186|NCT04516915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313187|NCT04516915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313188|NCT02753881|Doxorubicin|doxorubicin|mesh-list
92313189|NCT02753881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92313190|NCT02753881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92313191|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313192|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92313193|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92313194|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313195|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313196|NCT00425360|Gemcitabine|gemcitabine|mesh-list
92313197|NCT00425360|Capecitabine|capecitabine|mesh-list
92313198|NCT00425360|Sargramostim|sargramostim|mesh-list
92313199|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92313200|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
92313201|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313202|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313203|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
92313204|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313206|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92313207|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
92313208|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313209|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313210|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313212|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
92313213|NCT01190306|Vitamins|vitamins|mesh-ancestor
92313214|NCT01190306|Micronutrients|micronutrients|mesh-ancestor
92313215|NCT01190306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313216|NCT01190306|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92313217|NCT01190306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92313218|NCT02759575|Pembrolizumab|pembrolizumab|mesh-list
92313219|NCT02759575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313220|NCT02759575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313221|NCT02759575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313222|NCT02759575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313223|NCT05320718|Ropivacaine|ropivacaine|mesh-list
92313224|NCT05320718|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313225|NCT05320718|Anesthetics|anesthetics|mesh-ancestor
92313226|NCT05320718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313227|NCT05320718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313228|NCT05320718|Sensory System Agents|sensory system agents|mesh-ancestor
92313229|NCT05320718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313230|NCT02739698|Paclitaxel|paclitaxel|mesh-list
92313231|NCT02739698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92313232|NCT02739698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313233|NCT02739698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92313234|NCT02739698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92313235|NCT02739698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92313236|NCT02739698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313237|NCT04336904|Favipiravir|favipiravir|mesh-list
92313238|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
92313239|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313240|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
92313241|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313242|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313244|NCT02767934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313245|NCT02194998|Ritonavir|ritonavir|mesh-list
92313246|NCT02194998|Ribavirin|ribavirin|mesh-list
92313247|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92313248|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92313249|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92313250|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313251|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313252|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92313253|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92313254|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
92313255|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313256|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92313257|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92313258|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
92313259|NCT02194062|Fluticasone|fluticasone|mesh-list
92313260|NCT02194062|Xhance|xhance|mesh-list
92313261|NCT02194062|Budesonide|budesonide|mesh-list
92313262|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313263|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92313264|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
92313265|NCT02194062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313266|NCT02194062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313267|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92313268|NCT02194062|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313269|NCT02194062|Dermatologic Agents|dermatologic agents|mesh-ancestor
92313270|NCT02194062|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92313271|NCT02194062|Glucocorticoids|glucocorticoids|mesh-ancestor
92313272|NCT02194062|Hormones|hormones|mesh-ancestor
92313273|NCT02194062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313274|NCT02768558|Nivolumab|nivolumab|mesh-list
92313275|NCT02768558|Etoposide|etoposide|mesh-list
92313276|NCT02768558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313277|NCT02768558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313278|NCT02768558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313279|NCT02768558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313280|NCT02768558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92313281|NCT02768558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92313282|NCT02768558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92313283|NCT02768558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313285|NCT02192970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313286|NCT02192970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313287|NCT02192970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92313288|NCT02192970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92313289|NCT02192970|Growth Substances|growth substances|mesh-ancestor
92313290|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313291|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
92313292|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
92313293|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313294|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
92313295|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92313296|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313297|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92313298|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313299|NCT02762071|Bupivacaine|bupivacaine|mesh-list
92313300|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313302|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313303|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313304|NCT02762071|Sensory System Agents|sensory system agents|mesh-ancestor
92313305|NCT02762071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313306|NCT04336891|Methyltestosterone|methyltestosterone|mesh-list
92313307|NCT04336891|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92313308|NCT04336891|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92313309|NCT04336891|Estradiol|estradiol|mesh-list
92313310|NCT04336891|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92313311|NCT04336891|Testosterone|testosterone|mesh-list
92313312|NCT04336891|Testosterone undecanoate|testosterone undecanoate|mesh-list
92313313|NCT04336891|Testosterone enanthate|testosterone enanthate|mesh-list
92313314|NCT04336891|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92313316|NCT04336891|Hormones|hormones|mesh-ancestor
92313317|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313318|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313319|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92313320|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
92313321|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92313322|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92313323|NCT04336891|Androgens|androgens|mesh-ancestor
92313324|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313325|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313326|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
92313327|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
92313328|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92313329|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92313330|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
92313331|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313332|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313333|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92313334|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313335|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92313336|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
92313337|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313338|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313339|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92313340|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
92313341|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
92313342|NCT04337918|Protective Agents|protective agents|mesh-ancestor
92313343|NCT02747186|Lidocaine|lidocaine|mesh-list
92313344|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313345|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
92313346|NCT02747186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313347|NCT02747186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313348|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
92313349|NCT02747186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313350|NCT02747186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92313351|NCT02747186|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92313352|NCT02747186|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92313353|NCT02747186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92313354|NCT02747186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313355|NCT02766517|Capsaicin|capsaicin|mesh-list
91966048|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
92313356|NCT02766517|Antipruritics|antipruritics|mesh-ancestor
92313357|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
92313358|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
92313359|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313360|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313361|NCT04336046|Bupivacaine|bupivacaine|mesh-list
92313362|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313363|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
92313364|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313365|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313366|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
92313367|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313368|NCT05348239|Copper|copper|mesh-list
92313369|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
92313370|NCT05348239|Trace Elements|trace elements|mesh-ancestor
92313371|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
92313372|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313373|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92313374|NCT05348239|Protective Agents|protective agents|mesh-ancestor
92313376|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92313377|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
92313378|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313379|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313380|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92313381|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313383|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92313384|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92313385|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92313386|NCT02766673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92313387|NCT02766673|Adrenergic Agents|adrenergic agents|mesh-ancestor
92313388|NCT02766673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313389|NCT02766673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313390|NCT00372008|Testosterone|testosterone|mesh-list
92313391|NCT00372008|Androgens|androgens|mesh-ancestor
92313392|NCT00372008|Hormones|hormones|mesh-ancestor
92313393|NCT00372008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313394|NCT00372008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313395|NCT02973763|Aflutinib|aflutinib|mesh-list
92313396|NCT02973763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92313397|NCT02973763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313398|NCT02973763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313399|NCT04337593|Pegaspargase|pegaspargase|mesh-list
92313400|NCT04337593|Basiliximab|basiliximab|mesh-list
92313401|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313402|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92313403|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
92313404|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313405|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
92313406|NCT05339581|Tislelizumab|tislelizumab|mesh-list
92313407|NCT05339581|Lenvatinib|lenvatinib|mesh-list
92313408|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313409|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313410|NCT05339581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313411|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313412|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92313413|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313414|NCT04064684|Budesonide|budesonide|mesh-list
92313415|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313416|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92313417|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
92313418|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313419|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313420|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92313421|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313422|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
92313423|NCT04064684|Hormones|hormones|mesh-ancestor
92313424|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313425|NCT02192190|Celecoxib|celecoxib|mesh-list
92313426|NCT02192190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92313427|NCT02192190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313428|NCT02192190|Analgesics|analgesics|mesh-ancestor
92313429|NCT02192190|Sensory System Agents|sensory system agents|mesh-ancestor
92313430|NCT02192190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966154|NCT03664895|Goserelin|goserelin|mesh-list
92313431|NCT02192190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313432|NCT02192190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313433|NCT02192190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313434|NCT02192190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92313435|NCT02192190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92313436|NCT02192190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412335|NCT03193190|Fluorouracil|fluorouracil|mesh-list
92313437|NCT02192190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313439|NCT02748889|Etoposide|etoposide|mesh-list
92313440|NCT02748889|Atezolizumab|atezolizumab|mesh-list
92313441|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313442|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92313443|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92313444|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92313445|NCT02748889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313446|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313447|NCT02748889|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313448|NCT02748889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313449|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92313450|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
92313451|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313452|NCT04654988|Prednisone|prednisone|mesh-list
92313453|NCT04654988|Azathioprine|azathioprine|mesh-list
92313454|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313455|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
92313456|NCT04654988|Hormones|hormones|mesh-ancestor
92313457|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313458|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313459|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313460|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313461|NCT04654988|Antimetabolites|antimetabolites|mesh-ancestor
92313462|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313463|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92313464|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92313465|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
92313466|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313467|NCT02224560|Cannabidiol|cannabidiol|mesh-list
92313468|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
92313469|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
92313470|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92313471|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313472|NCT02973776|Clobetasol|clobetasol|mesh-list
92313473|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92313474|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313475|NCT02973776|Glucocorticoids|glucocorticoids|mesh-ancestor
92313476|NCT02973776|Hormones|hormones|mesh-ancestor
92313477|NCT02973776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313478|NCT02973776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313479|NCT02161458|Dexetimide|dexetimide|mesh-list
92313480|NCT02161458|Citalopram|citalopram|mesh-list
92313481|NCT02161458|Escitalopram|escitalopram|mesh-list
92313482|NCT02161458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92313483|NCT02161458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92313484|NCT02161458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92313485|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313486|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313487|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
92313488|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313489|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92313490|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92313491|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
92313492|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
92313493|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313494|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92313495|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92313496|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
92313497|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92313498|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
92313499|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92313500|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92313501|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92313502|NCT04507022|Estradiol|estradiol|mesh-list
92313503|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92313504|NCT04507022|Progesterone|progesterone|mesh-list
92313505|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92313507|NCT04507022|Hormones|hormones|mesh-ancestor
92313508|NCT04507022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313509|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313510|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92313511|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
92313512|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92313513|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92313514|NCT04507022|Progestins|progestins|mesh-ancestor
92313515|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92313516|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313517|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313518|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92313519|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
92313520|NCT00372788|Pemetrexed|pemetrexed|mesh-list
92313521|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313522|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313523|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313524|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92313525|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92313526|NCT00372476|Imatinib Mesylate|imatinib mesylate|mesh-list
92313527|NCT00372476|Vinorelbine|vinorelbine|mesh-list
92313528|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313529|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92313530|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313531|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313532|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92313533|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
92313534|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
92313535|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
92313536|NCT04737967|Memantine|memantine|mesh-list
92313537|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92313538|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92313539|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92313540|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
92313541|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313542|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313543|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313544|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92313545|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92313546|NCT04737967|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92313547|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92313548|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92313549|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92313550|NCT04737967|Antidepressive Agents|antidepressive agents|mesh-ancestor
92313551|NCT04737967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92313552|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
92313553|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92313554|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
92313555|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313556|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
92313557|NCT04766918|Protective Agents|protective agents|mesh-ancestor
92313558|NCT03365414|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92313559|NCT04367090|Docetaxel|docetaxel|mesh-list
92313560|NCT04367090|Trastuzumab|trastuzumab|mesh-list
92313561|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313562|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92313563|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92313564|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
92313565|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313566|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313567|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
92313568|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313569|NCT00371995|Amphotericin B|amphotericin b|mesh-list
92313570|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92313571|NCT00371995|Miltefosine|miltefosine|mesh-list
92313572|NCT00371995|Amebicides|amebicides|mesh-ancestor
92313573|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92313574|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92313575|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313576|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92313577|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
91966289|NCT05600075|Insulin|insulin|mesh-list
92313578|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313579|NCT04193306|Alirocumab|alirocumab|mesh-list
92313580|NCT04193306|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92313581|NCT04193306|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92313582|NCT04193306|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92313583|NCT04193306|Antimetabolites|antimetabolites|mesh-ancestor
92313584|NCT04193306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313585|NCT04193306|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92313586|NCT04193306|Protease Inhibitors|protease inhibitors|mesh-ancestor
92313587|NCT04193306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313588|NCT04193306|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92313589|NCT02303678|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
92313590|NCT02303678|Immunoconjugates|immunoconjugates|mesh-ancestor
92313591|NCT02303678|Immunologic Factors|immunologic factors|mesh-ancestor
92313592|NCT02303678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348001|NCT01682148|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92313594|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92313595|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313596|NCT00372307|Analgesics|analgesics|mesh-ancestor
92313597|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
92313598|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313599|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313600|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313601|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313602|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92313603|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92313604|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
92313605|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92313606|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313607|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313608|NCT04647110|Crizotinib|crizotinib|mesh-list
92313609|NCT04647110|Ceritinib|ceritinib|mesh-list
92313610|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313611|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92313612|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313613|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313614|NCT04061330|Ketamine|ketamine|mesh-list
92313615|NCT04061330|Morphine|morphine|mesh-list
92313616|NCT04061330|Analgesics|analgesics|mesh-ancestor
92313617|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
92313618|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313619|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313620|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92313621|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92313622|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
92313623|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
92313624|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313625|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92313626|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92313627|NCT04061330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313628|NCT04061330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313629|NCT04061330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92313630|NCT04061330|Narcotics|narcotics|mesh-ancestor
92313631|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
92313632|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
92313633|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92313634|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
92313635|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92313636|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92313637|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313638|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92313639|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313640|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313641|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92313642|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
92313643|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92313644|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
92313645|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313646|NCT04792021|Expectorants|expectorants|mesh-ancestor
92313647|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313648|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92313649|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
92313650|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313651|NCT04792021|Protective Agents|protective agents|mesh-ancestor
92313652|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313653|NCT04792021|Antidotes|antidotes|mesh-ancestor
92313654|NCT04333927|Immunomodulating Agents|immunomodulating agents|mesh-list
92313655|NCT04333927|Immunologic Factors|immunologic factors|mesh-ancestor
92313656|NCT04333927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313657|NCT04334005|Vitamin D|vitamin d|mesh-list
92313658|NCT04334005|Vitamins|vitamins|mesh-ancestor
92313659|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
92313660|NCT04334005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313661|NCT04334005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92313662|NCT00966914|Paclitaxel|paclitaxel|mesh-list
92313663|NCT00966914|Docetaxel|docetaxel|mesh-list
92313664|NCT00966914|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92313665|NCT00966914|Cisplatin|cisplatin|mesh-list
92313666|NCT00966914|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
92313667|NCT00966914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92313668|NCT00966914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313669|NCT00966914|Tubulin Modulators|tubulin modulators|mesh-ancestor
92313670|NCT00966914|Antimitotic Agents|antimitotic agents|mesh-ancestor
92313671|NCT00966914|Mitosis Modulators|mitosis modulators|mesh-ancestor
92313672|NCT00966914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313673|NCT00966914|Protective Agents|protective agents|mesh-ancestor
92313674|NCT00966914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313675|NCT04432285|Botulinum Toxins|botulinum toxins|mesh-list
92313676|NCT04432285|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92313677|NCT04432285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92313678|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313679|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
92313680|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313681|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313682|NCT04430959|Candesartan|candesartan|mesh-list
92313683|NCT04430959|Candesartan cilexetil|candesartan cilexetil|mesh-list
92313684|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92313685|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92313686|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92313687|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313688|NCT04737655|Beclomethasone|beclomethasone|mesh-list
92313689|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
92313690|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
92313691|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92313692|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
92313693|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313694|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313695|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92313696|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313697|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92313698|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92313699|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92313700|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
92313701|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313702|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313703|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92313704|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92313705|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92313706|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
92313707|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313708|NCT04737655|Glucocorticoids|glucocorticoids|mesh-ancestor
92313710|NCT04737655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313711|NCT05063396|Analgesics, Opioid|analgesics, opioid|mesh-list
92313712|NCT05063396|Anesthetics|anesthetics|mesh-list
92313713|NCT05063396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313714|NCT05063396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313715|NCT05063396|Narcotics|narcotics|mesh-ancestor
92313716|NCT05063396|Analgesics|analgesics|mesh-ancestor
92313717|NCT05063396|Sensory System Agents|sensory system agents|mesh-ancestor
92313718|NCT05063396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313719|NCT05055752|Aspirin|aspirin|mesh-list
92313720|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92313721|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313722|NCT05055752|Analgesics|analgesics|mesh-ancestor
92313723|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
92313724|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313725|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313726|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313727|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313728|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92313729|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92313730|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313731|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92313732|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92313734|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
92313735|NCT04209140|Lithium Carbonate|lithium carbonate|mesh-list
92313736|NCT04209140|Antidepressive Agents|antidepressive agents|mesh-ancestor
92313737|NCT04209140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92313738|NCT04209140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313739|NCT04209140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313741|NCT04209140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92313742|NCT04209140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313743|NCT04209140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313744|NCT00372541|Ceftriaxone|ceftriaxone|mesh-list
92313745|NCT00372541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92313746|NCT00372541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313747|NCT04762381|Dexamethasone|dexamethasone|mesh-list
92313748|NCT04762381|Glucocorticoids|glucocorticoids|mesh-list
92313749|NCT04762381|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92313750|NCT04762381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313751|NCT04762381|Antiemetics|antiemetics|mesh-ancestor
92313752|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
92313753|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313754|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313755|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92313756|NCT04762381|Hormones|hormones|mesh-ancestor
92313757|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313758|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313759|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313760|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
92313761|NCT01547468|Narcotics|narcotics|mesh-ancestor
92313762|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313763|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313764|NCT01547468|Analgesics|analgesics|mesh-ancestor
92313765|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
92313766|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313767|NCT04333628|Chloroquine|chloroquine|mesh-list
92313768|NCT04333628|Amebicides|amebicides|mesh-ancestor
92313769|NCT04333628|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92313770|NCT04333628|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92313771|NCT04333628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313772|NCT04333628|Antimalarials|antimalarials|mesh-ancestor
92313773|NCT04333628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313774|NCT00373412|Vaccines|vaccines|mesh-list
92313775|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
92313776|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313777|NCT00373178|Metformin|metformin|mesh-list
92313778|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
92313779|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92313780|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313781|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
92313782|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313783|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313784|NCT03254732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313785|NCT03254732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313786|NCT02923466|Interferon-beta|interferon-beta|mesh-list
92313787|NCT02923466|Avelumab|avelumab|mesh-list
92313788|NCT02923466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313789|NCT02923466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313790|NCT02923466|Antiviral Agents|antiviral agents|mesh-ancestor
92313791|NCT02923466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313792|NCT02923466|Immunologic Factors|immunologic factors|mesh-ancestor
92313793|NCT02923466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313794|NCT00813566|Deoxyglucose|deoxyglucose|mesh-list
92313795|NCT00813566|Antimetabolites|antimetabolites|mesh-ancestor
92313796|NCT00813566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313797|NCT00813566|Antiviral Agents|antiviral agents|mesh-ancestor
92313798|NCT00813566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313799|NCT02885012|Ambrisentan|ambrisentan|mesh-list
92313800|NCT02885012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92313801|NCT00372853|Tremelimumab|tremelimumab|mesh-list
91966517|NCT03236623|Menthol|menthol|mesh-list
92313803|NCT00372853|Sunitinib|sunitinib|mesh-list
92313804|NCT00372853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313805|NCT00372853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313806|NCT00372853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313807|NCT00372853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313808|NCT00372853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348012|NCT01687998|Evacetrapib|evacetrapib|mesh-list
92313809|NCT00372853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92313810|NCT00372853|Growth Substances|growth substances|mesh-ancestor
92313811|NCT00372853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313812|NCT00372853|Growth Inhibitors|growth inhibitors|mesh-ancestor
92313813|NCT00372853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92313814|NCT00372853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313817|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
92313818|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313819|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313820|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92313821|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
92313822|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
92313823|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92313824|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92313825|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92313826|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92313827|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
92313828|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313829|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313830|NCT00373087|Entacapone|entacapone|mesh-list
92313831|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92313832|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92313833|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313834|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92313835|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313836|NCT02892110|Varenicline|varenicline|mesh-list
92313837|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92313838|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92313839|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
92313840|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313841|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313842|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313843|NCT02779166|Celecoxib|celecoxib|mesh-list
92313844|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92313845|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92313846|NCT02779166|Analgesics|analgesics|mesh-ancestor
92313847|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
92313848|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313849|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313850|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313851|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313852|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92313853|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92313854|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313855|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313856|NCT00373165|Ganciclovir|ganciclovir|mesh-list
92313857|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92313858|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
92313859|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313860|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92313861|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313862|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313863|NCT04333550|Deferoxamine|deferoxamine|mesh-list
92313864|NCT04333550|Siderophores|siderophores|mesh-ancestor
92313865|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92313866|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
92313867|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
92313868|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313869|NCT02827838|Durvalumab|durvalumab|mesh-list
92313870|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
92313871|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92313872|NCT02827838|Immunoglobulin G|immunoglobulin g|mesh-list
92313873|NCT02827838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313874|NCT02827838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313875|NCT02827838|Immunologic Factors|immunologic factors|mesh-ancestor
92313876|NCT02827838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313877|NCT02902172|Acetaminophen|acetaminophen|mesh-list
92313878|NCT02902172|Ibuprofen|ibuprofen|mesh-list
92313880|NCT02902172|Analgesics|analgesics|mesh-ancestor
92313881|NCT02902172|Sensory System Agents|sensory system agents|mesh-ancestor
92313882|NCT02902172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313883|NCT02902172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313884|NCT02902172|Antipyretics|antipyretics|mesh-ancestor
92313885|NCT02902172|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92313886|NCT02902172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313887|NCT02902172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92313888|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92313889|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412336|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
92313890|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313892|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92313893|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313894|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
92313895|NCT04208347|Apatinib|apatinib|mesh-list
92313896|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313897|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92313898|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313899|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313900|NCT02777749|Bupivacaine|bupivacaine|mesh-list
92313901|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
92313902|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
92313903|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313904|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313905|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
92313906|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313907|NCT02785172|Clobetasol|clobetasol|mesh-list
92313908|NCT02785172|Halobetasol|halobetasol|mesh-list
92313909|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92313910|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313911|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
92313912|NCT02785172|Hormones|hormones|mesh-ancestor
92313913|NCT02785172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313914|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313915|NCT02582125|Nivolumab|nivolumab|mesh-list
92313916|NCT02582125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313917|NCT02582125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313918|NCT02582125|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313919|NCT02582125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313920|NCT02785406|Suvorexant|suvorexant|mesh-list
92313921|NCT02785406|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92313922|NCT02785406|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92313923|NCT02785406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92313924|NCT02785406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313925|NCT02785406|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92313926|NCT02785406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92313927|NCT02785406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313928|NCT02062489|Tamoxifen|tamoxifen|mesh-list
92313929|NCT02062489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92313930|NCT02062489|Hormone Antagonists|hormone antagonists|mesh-ancestor
92313931|NCT02062489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313932|NCT02062489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313933|NCT02062489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313934|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313935|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92313936|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92313937|NCT02062489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92313938|NCT02780869|Thrombin|thrombin|mesh-list
92313939|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92313940|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
92313941|NCT02780869|Coagulants|coagulants|mesh-ancestor
92313942|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
92313943|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
92313944|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92313945|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92313946|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313947|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313948|NCT02908490|Urological Agents|urological agents|mesh-ancestor
92313950|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313951|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313952|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92313953|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92313954|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
92313955|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313956|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313957|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
92313958|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92313959|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92313960|NCT02790788|Prednisolone|prednisolone|mesh-list
91936501|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
92313961|NCT02790788|Prednisolone acetate|prednisolone acetate|mesh-list
92313962|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
92313963|NCT02790788|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92313964|NCT02790788|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92313965|NCT02790788|Prednisolone phosphate|prednisolone phosphate|mesh-list
92313966|NCT02790788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92313967|NCT02790788|Antiemetics|antiemetics|mesh-ancestor
92313968|NCT02790788|Autonomic Agents|autonomic agents|mesh-ancestor
92313969|NCT02790788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313970|NCT02790788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92313971|NCT02790788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92313972|NCT02790788|Glucocorticoids|glucocorticoids|mesh-ancestor
92313973|NCT02790788|Hormones|hormones|mesh-ancestor
92313974|NCT02790788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92313975|NCT02790788|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92313976|NCT02790788|Protective Agents|protective agents|mesh-ancestor
92313977|NCT02790788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92313978|NCT02790788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313979|NCT02888665|Doxorubicin|doxorubicin|mesh-list
92313980|NCT02888665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92313981|NCT02888665|Pembrolizumab|pembrolizumab|mesh-list
92313982|NCT02888665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92313983|NCT02888665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92313984|NCT02888665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92313985|NCT02888665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92313986|NCT02888665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92313987|NCT02888665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92313988|NCT02888665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92313989|NCT02888665|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92313990|NCT02781571|Sofosbuvir|sofosbuvir|mesh-list
92313991|NCT02781571|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92313992|NCT02781571|Velpatasvir|velpatasvir|mesh-list
92313993|NCT02781571|Antiviral Agents|antiviral agents|mesh-ancestor
92313994|NCT02781571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92313995|NCT02918630|Nicotine|nicotine|mesh-list
92313996|NCT02918630|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92313997|NCT02918630|Autonomic Agents|autonomic agents|mesh-ancestor
92313998|NCT02918630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92313999|NCT02918630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314000|NCT02918630|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92314001|NCT02918630|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92314002|NCT02918630|Cholinergic Agents|cholinergic agents|mesh-ancestor
92314003|NCT02918630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314004|NCT02918630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314005|NCT02781649|Ribavirin|ribavirin|mesh-list
92314006|NCT02781649|Sofosbuvir|sofosbuvir|mesh-list
92314007|NCT02781649|Grazoprevir|grazoprevir|mesh-list
92314008|NCT02781649|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92314009|NCT02781649|Antimetabolites|antimetabolites|mesh-ancestor
92314010|NCT02781649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314011|NCT02781649|Antiviral Agents|antiviral agents|mesh-ancestor
92314012|NCT02781649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314013|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92314014|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314015|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314016|NCT02783443|Anesthetics|anesthetics|mesh-list
92314017|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314018|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314019|NCT00373568|Miltefosine|miltefosine|mesh-list
92314020|NCT00373568|Antifungal Agents|antifungal agents|mesh-ancestor
92314021|NCT00373568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314022|NCT00373568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314023|NCT00373568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92314024|NCT00373568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92314025|NCT03002012|Fluconazole|fluconazole|mesh-list
92314026|NCT03002012|Sertraline|sertraline|mesh-list
92314027|NCT03002012|Antidepressive Agents|antidepressive agents|mesh-ancestor
92314028|NCT03002012|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314029|NCT03002012|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92314030|NCT03002012|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92314031|NCT03002012|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92314032|NCT03002012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314033|NCT03002012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314034|NCT03002012|Serotonin Agents|serotonin agents|mesh-ancestor
92314036|NCT03002012|Antifungal Agents|antifungal agents|mesh-ancestor
92314037|NCT03002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314038|NCT03002012|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92314039|NCT03002012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92314040|NCT03002012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314041|NCT03002012|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92314042|NCT03002012|Hormone Antagonists|hormone antagonists|mesh-ancestor
92314043|NCT03002012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314044|NCT03002012|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92314045|NCT03002012|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92314046|NCT00373646|Thalidomide|thalidomide|mesh-list
92314047|NCT00373646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314048|NCT00373646|Immunologic Factors|immunologic factors|mesh-ancestor
92314049|NCT00373646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314050|NCT00373646|Leprostatic Agents|leprostatic agents|mesh-ancestor
92314051|NCT00373646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92314052|NCT00373646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314053|NCT00373646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92314054|NCT00373646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92314055|NCT00373646|Growth Substances|growth substances|mesh-ancestor
92314056|NCT00373646|Growth Inhibitors|growth inhibitors|mesh-ancestor
92314057|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314058|NCT03001453|Epinephrine|epinephrine|mesh-list
92314059|NCT03001453|Bupivacaine|bupivacaine|mesh-list
92314060|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
92314061|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
92314062|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314063|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314064|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
92314065|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314066|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92314067|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314068|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314069|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314070|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314071|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92314072|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92314073|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
92314074|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92314075|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
92314077|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
92314078|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92314079|NCT03001843|Ketamine|ketamine|mesh-list
92314080|NCT03001843|Narcotics|narcotics|mesh-list
92314081|NCT03001843|Analgesics|analgesics|mesh-ancestor
92314082|NCT03001843|Sensory System Agents|sensory system agents|mesh-ancestor
92314083|NCT03001843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314084|NCT03001843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314085|NCT03001843|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92314086|NCT03001843|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92314087|NCT03001843|Anesthetics, General|anesthetics, general|mesh-ancestor
92314089|NCT03001843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314090|NCT03001843|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92314091|NCT03001843|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92314092|NCT03001843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314093|NCT03001843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314094|NCT02785159|Tazarotene|tazarotene|mesh-list
92314095|NCT02785159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92314096|NCT02785159|Keratolytic Agents|keratolytic agents|mesh-ancestor
92314097|NCT02786719|Cyclophosphamide|cyclophosphamide|mesh-list
92314098|NCT02786719|Doxorubicin|doxorubicin|mesh-list
92314099|NCT02786719|Etoposide|etoposide|mesh-list
92314100|NCT02786719|Vincristine|vincristine|mesh-list
92314101|NCT02786719|Topotecan|topotecan|mesh-list
92314102|NCT02786719|Sargramostim|sargramostim|mesh-list
92314103|NCT02786719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314104|NCT02786719|Immunologic Factors|immunologic factors|mesh-ancestor
92314105|NCT02786719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314106|NCT02786719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314107|NCT02786719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92314108|NCT02786719|Alkylating Agents|alkylating agents|mesh-ancestor
91936503|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314109|NCT02786719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314110|NCT02786719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314111|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92314112|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92314113|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92314115|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314116|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92314117|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
92314118|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
92314119|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
92314120|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92314121|NCT03003949|Estradiol|estradiol|mesh-list
92314122|NCT03003949|Progesterone|progesterone|mesh-list
92314123|NCT03003949|Estrogens|estrogens|mesh-ancestor
92314124|NCT03003949|Hormones|hormones|mesh-ancestor
92314125|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314126|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314127|NCT03003949|Progestins|progestins|mesh-ancestor
92314128|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
92314129|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92314130|NCT03007225|Estrogens|estrogens|mesh-ancestor
92314131|NCT03007225|Hormones|hormones|mesh-ancestor
92314132|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314133|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314134|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314135|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314136|NCT02800148|Azelaic acid|azelaic acid|mesh-list
92314137|NCT02800148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314138|NCT02800148|Dermatologic Agents|dermatologic agents|mesh-ancestor
92314139|NCT02902081|Cannabidiol|cannabidiol|mesh-list
92314140|NCT02902081|Anticonvulsants|anticonvulsants|mesh-ancestor
92314141|NCT02791945|Acetylcysteine|acetylcysteine|mesh-list
92314142|NCT02791945|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92314143|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
92314144|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314145|NCT02791945|Expectorants|expectorants|mesh-ancestor
92314146|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
92314147|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92314148|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
92314149|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314150|NCT02791945|Protective Agents|protective agents|mesh-ancestor
92314151|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314152|NCT02791945|Antidotes|antidotes|mesh-ancestor
92314153|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92314154|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92314155|NCT00374192|Eszopiclone|eszopiclone|mesh-list
92314156|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92314157|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314158|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314160|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92314161|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
92314162|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314163|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314164|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314165|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314166|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92314167|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92314168|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92314169|NCT00374348|Aripiprazole|aripiprazole|mesh-list
92314170|NCT00374348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92314171|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314172|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92314173|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92314174|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314175|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314176|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
91966877|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
92314177|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
92314178|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314179|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314180|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92314181|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92314182|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
92314183|NCT00374348|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92314184|NCT00374348|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92314185|NCT00374348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92314186|NCT00374348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92314187|NCT02933372|Varenicline|varenicline|mesh-list
92314188|NCT02933372|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92314189|NCT02933372|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92314190|NCT02933372|Cholinergic Agents|cholinergic agents|mesh-ancestor
92314191|NCT02933372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92412337|NCT03193190|Atezolizumab|atezolizumab|mesh-list
92314192|NCT02933372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314193|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314194|NCT02902237|Thromboplastin|thromboplastin|mesh-list
92314195|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
92314196|NCT02902237|Coagulants|coagulants|mesh-ancestor
92314198|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
92314199|NCT02903407|Propofol|propofol|mesh-list
92314200|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92314201|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314202|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314203|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314204|NCT02903407|Analgesics|analgesics|mesh-ancestor
92314206|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314207|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92314208|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92314209|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314210|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314211|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314212|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314213|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92314214|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
92314215|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
92314216|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92314217|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92314218|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92314219|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314220|NCT02903407|GABA Modulators|gaba modulators|mesh-ancestor
92314221|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
92314222|NCT02905981|Citric Acid|citric acid|mesh-list
92314223|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
92314224|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
92314225|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92314226|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
92314227|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
92314228|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314229|NCT00374023|Vitamin A|vitamin a|mesh-list
92314230|NCT00374023|Vitamins|vitamins|mesh-ancestor
92314231|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
92314232|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314233|NCT02812238|Niacinamide|niacinamide|mesh-list
92314235|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
92314236|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
92314237|NCT02812238|Vitamins|vitamins|mesh-ancestor
92314238|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
92314239|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314240|NCT02812238|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92314241|NCT02812238|Antimetabolites|antimetabolites|mesh-ancestor
92314242|NCT02812238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314243|NCT02812238|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92314244|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
92314245|NCT03015961|Bupivacaine|bupivacaine|mesh-list
92314246|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
92314247|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
92314248|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314249|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314250|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
92314251|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314252|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
92314253|NCT03018223|Sirolimus|sirolimus|mesh-list
92314254|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
92314255|NCT03018223|Busulfan|busulfan|mesh-list
92314256|NCT03018223|Fludarabine|fludarabine|mesh-list
92314257|NCT03018223|Lenograstim|lenograstim|mesh-list
92314258|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314259|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
92314260|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314261|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314262|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92314263|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
92314264|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314265|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314266|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92314267|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92314268|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92314269|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
92314270|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92314271|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314272|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314273|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
92314274|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92314275|NCT03018925|Golimumab|golimumab|mesh-list
92314276|NCT03018925|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92314277|NCT03018925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314278|NCT03018925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314279|NCT03018925|Immunologic Factors|immunologic factors|mesh-ancestor
92314280|NCT03018925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314281|NCT03019783|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92314282|NCT03019783|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92314283|NCT03019783|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92314284|NCT03019783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92314285|NCT03019783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314286|NCT03019783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314287|NCT03019783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92314288|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92314289|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
92314290|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314291|NCT03019939|Isavuconazole|isavuconazole|mesh-list
92314292|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
92314293|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314294|NCT03020095|Ritonavir|ritonavir|mesh-list
92314295|NCT03020095|Ribavirin|ribavirin|mesh-list
92314296|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92314297|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92314298|NCT03020095|Protease Inhibitors|protease inhibitors|mesh-ancestor
92314299|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314300|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314301|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92314302|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92314303|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
92314304|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314305|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92314306|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92314307|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
92314308|NCT02934698|Ivacaftor|ivacaftor|mesh-list
92314309|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92314310|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92314311|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314312|NCT03021343|Colchicine|colchicine|mesh-list
92314313|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
92314314|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314315|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
92314316|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
92314317|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
92314318|NCT03021343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314319|NCT03021343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314320|NCT03025945|Nepafenac|nepafenac|mesh-list
92314321|NCT03025945|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92314322|NCT03025945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314323|NCT03025945|Analgesics|analgesics|mesh-ancestor
92314324|NCT03025945|Sensory System Agents|sensory system agents|mesh-ancestor
92314325|NCT03025945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314326|NCT03025945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314327|NCT03025945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314328|NCT03025945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314329|NCT02937506|Fentanyl|fentanyl|mesh-list
92314330|NCT02937506|Midazolam|midazolam|mesh-list
92314331|NCT02937506|Propofol|propofol|mesh-list
92314332|NCT02937506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92314333|NCT02937506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314334|NCT02937506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314336|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
92314337|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
92314338|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92314339|NCT02937506|Narcotics|narcotics|mesh-ancestor
92314340|NCT02937506|Analgesics|analgesics|mesh-ancestor
92314341|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
92314342|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314343|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92314344|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92314345|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92314346|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314347|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
92314348|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
92314349|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314350|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314351|NCT03026803|Capecitabine|capecitabine|mesh-list
92314352|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
92314353|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92314354|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
92314355|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314356|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314357|NCT03027661|Bupivacaine|bupivacaine|mesh-list
92314358|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
92314359|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
92314360|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314361|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314362|NCT03027661|Sensory System Agents|sensory system agents|mesh-ancestor
92314363|NCT03027661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314364|NCT03022526|Fentanyl|fentanyl|mesh-list
92314365|NCT03022526|Bupivacaine|bupivacaine|mesh-list
92314366|NCT03022526|Anesthetics, Local|anesthetics, local|mesh-ancestor
92314367|NCT03022526|Anesthetics|anesthetics|mesh-ancestor
92314368|NCT03022526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314369|NCT03022526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314370|NCT03022526|Sensory System Agents|sensory system agents|mesh-ancestor
92314371|NCT03022526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314372|NCT03022526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92314373|NCT03022526|Narcotics|narcotics|mesh-ancestor
92314374|NCT03022526|Analgesics|analgesics|mesh-ancestor
92314375|NCT03022526|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92314376|NCT03022526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92314377|NCT03022526|Anesthetics, General|anesthetics, general|mesh-ancestor
92314378|NCT02794441|Dexamethasone|dexamethasone|mesh-list
92314379|NCT02794441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314380|NCT02794441|Antiemetics|antiemetics|mesh-ancestor
92314381|NCT02794441|Autonomic Agents|autonomic agents|mesh-ancestor
92314382|NCT02794441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314383|NCT02794441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314384|NCT02794441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314385|NCT02794441|Glucocorticoids|glucocorticoids|mesh-ancestor
92314386|NCT02794441|Hormones|hormones|mesh-ancestor
92314387|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314388|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314389|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314390|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92314391|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92314392|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
92314393|NCT02941640|Hormones|hormones|mesh-ancestor
92314394|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314395|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314396|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314397|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314399|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92314400|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
92314401|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314402|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314403|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92314404|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314405|NCT03022916|Efinaconazole|efinaconazole|mesh-list
92314406|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92314407|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
92314409|NCT03031795|Ketorolac|ketorolac|mesh-list
92314410|NCT03031795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92314411|NCT03031795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314412|NCT03031795|Analgesics|analgesics|mesh-ancestor
92314413|NCT03031795|Sensory System Agents|sensory system agents|mesh-ancestor
92314414|NCT03031795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314415|NCT03031795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314416|NCT03031795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314417|NCT03031795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314418|NCT03031795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92314419|NCT03031795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314420|NCT03031795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314421|NCT02942654|Insulin Lispro|insulin lispro|mesh-list
92314422|NCT02942654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92314423|NCT02942654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314424|NCT02909959|Sulforaphane|sulforaphane|mesh-list
92314425|NCT02909959|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92314426|NCT02909959|Protective Agents|protective agents|mesh-ancestor
92314427|NCT02909959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314428|NCT02909959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314429|NCT00373802|Phenylephrine|phenylephrine|mesh-list
92314430|NCT00373802|Oxymetazoline|oxymetazoline|mesh-list
92314431|NCT00373802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92314432|NCT00373802|Mydriatics|mydriatics|mesh-ancestor
92314433|NCT00373802|Autonomic Agents|autonomic agents|mesh-ancestor
92314434|NCT00373802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314435|NCT00373802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314436|NCT00373802|Sympathomimetics|sympathomimetics|mesh-ancestor
92314437|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92314438|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
92314439|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
92314440|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92314441|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92314442|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314443|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314444|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314445|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314446|NCT00373802|Protective Agents|protective agents|mesh-ancestor
92314448|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
92314449|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314450|NCT03032965|Adenosine|adenosine|mesh-list
92314451|NCT03032965|Isoproterenol|isoproterenol|mesh-list
92314452|NCT03032965|Analgesics|analgesics|mesh-ancestor
92314453|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
92314454|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314455|NCT03032965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314456|NCT03032965|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92314457|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
92314458|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92314459|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
92314460|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
92314461|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314462|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314463|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92314464|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314465|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314466|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92314467|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
92314468|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92314469|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
92314470|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92314471|NCT03032965|Sympathomimetics|sympathomimetics|mesh-ancestor
92314472|NCT03032965|Protective Agents|protective agents|mesh-ancestor
92314473|NCT02948426|Interferon-gamma|interferon-gamma|mesh-list
92314474|NCT02948426|Antiviral Agents|antiviral agents|mesh-ancestor
92314475|NCT02948426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314476|NCT03030638|Olodaterol|olodaterol|mesh-list
92314477|NCT03030638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92314478|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
92314479|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314480|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314481|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92314482|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
92314483|NCT02949674|Bupivacaine|bupivacaine|mesh-list
92314484|NCT02949674|Ropivacaine|ropivacaine|mesh-list
92314485|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
92314486|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
92314487|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314488|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314489|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
92314490|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314491|NCT03033511|Dexamethasone|dexamethasone|mesh-list
92314492|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
92314493|NCT03033511|BB 1101|bb 1101|mesh-list
92314494|NCT03033511|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92314495|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
92314496|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314497|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
92314498|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
92314499|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314500|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314501|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314502|NCT03033511|Glucocorticoids|glucocorticoids|mesh-ancestor
92314503|NCT03033511|Hormones|hormones|mesh-ancestor
92314504|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348076|NCT01568112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92314505|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314507|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
92314508|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314509|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314510|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
92314511|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
92314512|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92314513|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92314514|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92314515|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92314516|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92314517|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314518|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314519|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314520|NCT03035929|Dexamethasone|dexamethasone|mesh-list
92314521|NCT03035929|Dexamethasone acetate|dexamethasone acetate|mesh-list
92314523|NCT03035929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314524|NCT03035929|Antiemetics|antiemetics|mesh-ancestor
92314525|NCT03035929|Autonomic Agents|autonomic agents|mesh-ancestor
92314526|NCT03035929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314527|NCT03035929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314528|NCT03035929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314529|NCT03035929|Glucocorticoids|glucocorticoids|mesh-ancestor
92314530|NCT03035929|Hormones|hormones|mesh-ancestor
92314531|NCT03035929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314532|NCT03035929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314533|NCT03035929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314534|NCT03035929|Protease Inhibitors|protease inhibitors|mesh-ancestor
92314535|NCT03035929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314536|NCT03035929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314537|NCT02951702|Vancomycin|vancomycin|mesh-list
92314538|NCT02951702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92314539|NCT02951702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314540|NCT02831816|Ethanol|ethanol|mesh-list
92314541|NCT02831816|Chlorhexidine|chlorhexidine|mesh-list
92314542|NCT02831816|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92314543|NCT02831816|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92314544|NCT02831816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314545|NCT02831816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314546|NCT02831816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314547|NCT02831816|Disinfectants|disinfectants|mesh-ancestor
92314548|NCT02831816|Dermatologic Agents|dermatologic agents|mesh-ancestor
92314549|NCT03036163|Macozinone|macozinone|mesh-list
92314550|NCT03036163|Antitubercular Agents|antitubercular agents|mesh-ancestor
92314551|NCT03036163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92314552|NCT03036163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314553|NCT02953886|Fluorides|fluorides|mesh-list
92314554|NCT02953886|Cariostatic Agents|cariostatic agents|mesh-ancestor
92314555|NCT02953886|Protective Agents|protective agents|mesh-ancestor
92314556|NCT02953886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314557|NCT02802241|Peppermint oil|peppermint oil|mesh-list
92314559|NCT02802241|Autonomic Agents|autonomic agents|mesh-ancestor
92314560|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314561|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314562|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314563|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
92314564|NCT03035708|Varenicline|varenicline|mesh-list
92314565|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92314566|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92314567|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
92314568|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314569|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314570|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314571|NCT00374426|Sertraline|sertraline|mesh-list
92314572|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
92314573|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314574|NCT00374426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92314575|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92314576|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348082|NCT01568034|Levodopa|levodopa|mesh-list
92314577|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314579|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
92314580|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314581|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92314582|NCT02916745|Trioxsalen|trioxsalen|mesh-list
92314583|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314584|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
92314585|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92314586|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
92314587|NCT02954198|Prednisone|prednisone|mesh-list
92314588|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
92314589|NCT02954198|Everolimus|everolimus|mesh-list
92314590|NCT02954198|Tacrolimus|tacrolimus|mesh-list
92314591|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314592|NCT02954198|Glucocorticoids|glucocorticoids|mesh-ancestor
92314593|NCT02954198|Hormones|hormones|mesh-ancestor
92314594|NCT02954198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314595|NCT02954198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314596|NCT02954198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314597|NCT02954198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314598|NCT02954198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314599|NCT02954198|Immunologic Factors|immunologic factors|mesh-ancestor
92314600|NCT02954198|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92314601|NCT02954198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314602|NCT02954198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314603|NCT02954198|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92314604|NCT02954198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92314605|NCT02954198|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92314606|NCT02954198|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92314607|NCT02954198|Antitubercular Agents|antitubercular agents|mesh-ancestor
92314608|NCT02954198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92314609|NCT02954198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314610|NCT02954198|Antiemetics|antiemetics|mesh-ancestor
92314611|NCT02954198|Autonomic Agents|autonomic agents|mesh-ancestor
92314612|NCT02954198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314613|NCT02954198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314614|NCT02954198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92314615|NCT02954198|Protective Agents|protective agents|mesh-ancestor
92314616|NCT02956070|Dexamethasone|dexamethasone|mesh-list
92314617|NCT02956070|Dexamethasone acetate|dexamethasone acetate|mesh-list
92314618|NCT02956070|BB 1101|bb 1101|mesh-list
92314619|NCT02956070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314620|NCT02956070|Antiemetics|antiemetics|mesh-ancestor
92314621|NCT02956070|Autonomic Agents|autonomic agents|mesh-ancestor
92314622|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314623|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314624|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314625|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
92314626|NCT02956070|Hormones|hormones|mesh-ancestor
92314627|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314628|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314629|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314630|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92314631|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314632|NCT02956070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314633|NCT02956616|Ketorolac|ketorolac|mesh-list
92314634|NCT02956616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92314635|NCT02956616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314636|NCT02956616|Analgesics|analgesics|mesh-ancestor
92314637|NCT02956616|Sensory System Agents|sensory system agents|mesh-ancestor
92314638|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314639|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314640|NCT02956616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314641|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314642|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92314643|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314644|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314645|NCT02958956|Pioglitazone|pioglitazone|mesh-list
92314646|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92314647|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314649|NCT05829603|Hallucinogens|hallucinogens|mesh-ancestor
92314650|NCT05829603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314651|NCT05829603|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314652|NCT05829603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92314653|NCT05829603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314654|NCT05829603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314655|NCT05829551|Ritonavir|ritonavir|mesh-list
92314656|NCT05829551|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92314657|NCT05829551|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92314658|NCT05829551|Protease Inhibitors|protease inhibitors|mesh-ancestor
92314659|NCT05829551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314660|NCT05829551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314662|NCT05829551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92314663|NCT05829551|Antiviral Agents|antiviral agents|mesh-ancestor
92314664|NCT05829551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314665|NCT05829551|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92314666|NCT05829551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92314667|NCT05829460|Progestins|progestins|mesh-list
92314668|NCT05829460|Hormones|hormones|mesh-ancestor
92314669|NCT05829460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314670|NCT05829460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314671|NCT05829434|Cytarabine|cytarabine|mesh-list
92314672|NCT05829434|Magrolimab|magrolimab|mesh-list
92314673|NCT05829434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92314674|NCT05829434|Antimetabolites|antimetabolites|mesh-ancestor
92314675|NCT05829434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314676|NCT05829434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314677|NCT05829434|Antiviral Agents|antiviral agents|mesh-ancestor
92314678|NCT05829434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314679|NCT05829434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314680|NCT05829434|Immunologic Factors|immunologic factors|mesh-ancestor
92314681|NCT05829434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314682|NCT05829434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92314683|NCT05829317|Magnesium Sulfate|magnesium sulfate|mesh-list
92314684|NCT05829317|Analgesics|analgesics|mesh-ancestor
92314685|NCT05829317|Sensory System Agents|sensory system agents|mesh-ancestor
92314686|NCT05829317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314687|NCT05829317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314688|NCT05829317|Anesthetics|anesthetics|mesh-ancestor
92314689|NCT05829317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314690|NCT05829317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92314691|NCT05829317|Anticonvulsants|anticonvulsants|mesh-ancestor
92314692|NCT05829317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92314693|NCT05829317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92314694|NCT05829317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314695|NCT05829317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92314696|NCT05829317|Tocolytic Agents|tocolytic agents|mesh-ancestor
92314697|NCT05829317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314698|NCT05829148|Pregabalin|pregabalin|mesh-list
92314699|NCT05829148|Dexmedetomidine|dexmedetomidine|mesh-list
92314700|NCT05829148|Melatonin|melatonin|mesh-list
92314701|NCT05829148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92314702|NCT05829148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314703|NCT05829148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314704|NCT05829148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314705|NCT05829148|Analgesics|analgesics|mesh-ancestor
92314706|NCT05829148|Sensory System Agents|sensory system agents|mesh-ancestor
92314707|NCT05829148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314708|NCT05829148|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92314709|NCT05829148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91967400|NCT05051163|Gentamicins|gentamicins|mesh-list
92314710|NCT05829148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314711|NCT05829148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314712|NCT05829148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314713|NCT05829148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314714|NCT05829148|Anticonvulsants|anticonvulsants|mesh-ancestor
92314715|NCT05829148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92314716|NCT05829148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92314717|NCT05829148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92314718|NCT05829148|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92314719|NCT05829148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92314720|NCT05829148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314721|NCT05829148|Antioxidants|antioxidants|mesh-ancestor
92314722|NCT05829148|Protective Agents|protective agents|mesh-ancestor
92314723|NCT05829057|Interleukin-2|interleukin-2|mesh-list
92314724|NCT05829057|Antibodies|antibodies|mesh-list
92314725|NCT05829057|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92314726|NCT05829057|Immunologic Factors|immunologic factors|mesh-ancestor
92314727|NCT05829057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314728|NCT05829057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314729|NCT05829057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314730|NCT05829057|Analgesics|analgesics|mesh-ancestor
92314731|NCT05829057|Sensory System Agents|sensory system agents|mesh-ancestor
92314732|NCT05829057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314733|NCT05829044|Melatonin|melatonin|mesh-list
92314734|NCT05829044|Antioxidants|antioxidants|mesh-ancestor
92314735|NCT05829044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314736|NCT05829044|Protective Agents|protective agents|mesh-ancestor
92314737|NCT05829044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314738|NCT05829044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314739|NCT05828966|Magnesium Sulfate|magnesium sulfate|mesh-list
92314740|NCT05828966|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92314741|NCT05828966|Analgesics|analgesics|mesh-ancestor
92314742|NCT05828966|Sensory System Agents|sensory system agents|mesh-ancestor
92314743|NCT05828966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314744|NCT05828966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314745|NCT05828966|Anesthetics|anesthetics|mesh-ancestor
92314746|NCT05828966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314747|NCT05828966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92314748|NCT05828966|Anticonvulsants|anticonvulsants|mesh-ancestor
92314749|NCT05828966|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92314750|NCT05828966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92314751|NCT05828966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314752|NCT05828966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92314753|NCT05828966|Tocolytic Agents|tocolytic agents|mesh-ancestor
92314754|NCT05828966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314755|NCT05828836|Allopurinol|allopurinol|mesh-list
92314756|NCT05828836|Antimetabolites|antimetabolites|mesh-ancestor
92314757|NCT05828836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314758|NCT05828836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314759|NCT05828836|Gout Suppressants|gout suppressants|mesh-ancestor
92314760|NCT05828836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314761|NCT05828836|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92314762|NCT05828836|Antioxidants|antioxidants|mesh-ancestor
92314763|NCT05828836|Protective Agents|protective agents|mesh-ancestor
92314764|NCT05828836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314765|NCT05828810|Chlorhexidine|chlorhexidine|mesh-list
92314766|NCT05828810|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92314767|NCT05828810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314768|NCT05828810|Disinfectants|disinfectants|mesh-ancestor
92314769|NCT05828550|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92314770|NCT05828550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314771|NCT05828381|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92314772|NCT05828381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314773|NCT05828199|Dexmedetomidine|dexmedetomidine|mesh-list
92314774|NCT05828199|Ketamine|ketamine|mesh-list
92314775|NCT05828199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92314776|NCT05828199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314779|NCT05828199|Analgesics|analgesics|mesh-ancestor
92314780|NCT05828199|Sensory System Agents|sensory system agents|mesh-ancestor
92314781|NCT05828199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314782|NCT05828199|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92314783|NCT05828199|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92314784|NCT05828199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314785|NCT05828199|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314786|NCT05828199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314787|NCT05828199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314788|NCT05828199|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92314789|NCT05828199|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92314790|NCT05828199|Anesthetics, General|anesthetics, general|mesh-ancestor
92314791|NCT05828199|Anesthetics|anesthetics|mesh-ancestor
92314792|NCT05828199|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92314793|NCT05828199|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92314794|NCT05827991|Minoxidil|minoxidil|mesh-list
92314795|NCT05827991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92314797|NCT05827796|Paclitaxel|paclitaxel|mesh-list
92314798|NCT05827796|Gemcitabine|gemcitabine|mesh-list
92314799|NCT05827796|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92314800|NCT05827796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92314801|NCT05827796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314802|NCT05827796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92314803|NCT05827796|Antimitotic Agents|antimitotic agents|mesh-ancestor
92314804|NCT05827796|Mitosis Modulators|mitosis modulators|mesh-ancestor
92314805|NCT05827796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314806|NCT05827796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92314807|NCT05827796|Antimetabolites|antimetabolites|mesh-ancestor
92314808|NCT05827770|Temozolomide|temozolomide|mesh-list
92314809|NCT05827770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92314810|NCT05827770|Alkylating Agents|alkylating agents|mesh-ancestor
92314811|NCT05827770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314812|NCT05827770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314813|NCT05827497|Methotrexate|methotrexate|mesh-list
92314814|NCT05827497|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92314815|NCT05827497|Abortifacient Agents|abortifacient agents|mesh-ancestor
92314816|NCT05827497|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314817|NCT05827497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314818|NCT05827497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92314819|NCT05827497|Antimetabolites|antimetabolites|mesh-ancestor
92314820|NCT05827497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314821|NCT05827497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314822|NCT05827497|Dermatologic Agents|dermatologic agents|mesh-ancestor
92314823|NCT05827497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314824|NCT05827497|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92314825|NCT05827497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92314826|NCT05827497|Immunologic Factors|immunologic factors|mesh-ancestor
92314827|NCT05827497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92314828|NCT05827497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92314829|NCT05827263|Salicylic Acid|salicylic acid|mesh-list
92314830|NCT05827263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314831|NCT05827263|Antifungal Agents|antifungal agents|mesh-ancestor
92314832|NCT05827263|Keratolytic Agents|keratolytic agents|mesh-ancestor
92314833|NCT05827263|Dermatologic Agents|dermatologic agents|mesh-ancestor
92314834|NCT05826119|Magnesium Sulfate|magnesium sulfate|mesh-list
92314835|NCT05826119|Analgesics|analgesics|mesh-ancestor
92314836|NCT05826119|Sensory System Agents|sensory system agents|mesh-ancestor
92314837|NCT05826119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314838|NCT05826119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314839|NCT05826119|Anesthetics|anesthetics|mesh-ancestor
92314840|NCT05826119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314841|NCT05826119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92314842|NCT05826119|Anticonvulsants|anticonvulsants|mesh-ancestor
92314843|NCT05826119|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92314844|NCT05826119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92314845|NCT05826119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314846|NCT05826119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92314847|NCT05826119|Tocolytic Agents|tocolytic agents|mesh-ancestor
92314848|NCT05826119|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314850|NCT05825443|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92314851|NCT05825443|Cisplatin|cisplatin|mesh-list
92314852|NCT05825443|Carboplatin|carboplatin|mesh-list
92314853|NCT05825443|Pemetrexed|pemetrexed|mesh-list
92314854|NCT05825443|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92314855|NCT05825443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314856|NCT05825443|Tubulin Modulators|tubulin modulators|mesh-ancestor
92314857|NCT05825443|Antimitotic Agents|antimitotic agents|mesh-ancestor
92314858|NCT05825443|Mitosis Modulators|mitosis modulators|mesh-ancestor
92314859|NCT05825443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314860|NCT05825443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92314861|NCT05825443|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92314862|NCT05825443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92314863|NCT05824299|Anesthetics|anesthetics|mesh-list
92314864|NCT05824299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314865|NCT05824299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314866|NCT05822934|Carboplatin|carboplatin|mesh-list
92314867|NCT05822934|Gemcitabine|gemcitabine|mesh-list
92314868|NCT05822934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314869|NCT05822934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92314870|NCT05822934|Antimetabolites|antimetabolites|mesh-ancestor
92314871|NCT05822934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314872|NCT05821972|Dexmedetomidine|dexmedetomidine|mesh-list
92314873|NCT05821972|Ketamine|ketamine|mesh-list
92314874|NCT05821972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92314875|NCT05821972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314876|NCT05821972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314877|NCT05821972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314878|NCT05821972|Analgesics|analgesics|mesh-ancestor
92314879|NCT05821972|Sensory System Agents|sensory system agents|mesh-ancestor
92314880|NCT05821972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314881|NCT05821972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92314882|NCT05821972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92314883|NCT05821972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92314884|NCT05821972|Adrenergic Agents|adrenergic agents|mesh-ancestor
92314885|NCT05821972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314886|NCT05821972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314887|NCT05821972|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92314888|NCT05821972|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92314889|NCT05821972|Anesthetics, General|anesthetics, general|mesh-ancestor
92314890|NCT05821972|Anesthetics|anesthetics|mesh-ancestor
92314891|NCT05821972|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92314892|NCT05821972|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92314894|NCT05790213|Hormones|hormones|mesh-ancestor
92314895|NCT05790213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314896|NCT05790213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314897|NCT05786066|Ketamine|ketamine|mesh-list
92314898|NCT05786066|Analgesics|analgesics|mesh-ancestor
92314899|NCT05786066|Sensory System Agents|sensory system agents|mesh-ancestor
92314900|NCT05786066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314901|NCT05786066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314902|NCT05786066|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92314903|NCT05786066|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92314904|NCT05786066|Anesthetics, General|anesthetics, general|mesh-ancestor
92314905|NCT05786066|Anesthetics|anesthetics|mesh-ancestor
92314906|NCT05786066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92314907|NCT05786066|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92314908|NCT05786066|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92314909|NCT05786066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314910|NCT05786066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314911|NCT05774236|Dinoprostone|dinoprostone|mesh-list
92314912|NCT05774236|Oxytocics|oxytocics|mesh-ancestor
92314913|NCT05774236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314914|NCT05774236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314915|NCT05748587|Iron|iron|mesh-list
92314916|NCT05748587|Deferoxamine|deferoxamine|mesh-list
92314917|NCT05748587|Trace Elements|trace elements|mesh-ancestor
92314918|NCT05748587|Micronutrients|micronutrients|mesh-ancestor
92314919|NCT05748587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314920|NCT05748587|Siderophores|siderophores|mesh-ancestor
92314921|NCT05748587|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92314922|NCT05748587|Chelating Agents|chelating agents|mesh-ancestor
92314923|NCT05748587|Sequestering Agents|sequestering agents|mesh-ancestor
92314924|NCT05748587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314925|NCT05728814|Dostarlimab|dostarlimab|mesh-list
92314926|NCT05728814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314927|NCT05707468|Hormones|hormones|mesh-list
92314928|NCT05707468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314929|NCT05707468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314930|NCT05700903|Leuprolide|leuprolide|mesh-list
92314931|NCT05700903|Goserelin|goserelin|mesh-list
92314932|NCT05700903|Flutamide|flutamide|mesh-list
92314933|NCT05700903|Bicalutamide|bicalutamide|mesh-list
92314934|NCT05700903|Hormones|hormones|mesh-list
92314935|NCT05700903|Androgens|androgens|mesh-list
92314936|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92314937|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314938|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314939|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92314941|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92314942|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314943|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314944|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
92314945|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
92314946|NCT05698381|Acetic Acid|acetic acid|mesh-list
92314947|NCT05698381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92314948|NCT05698381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92314949|NCT05683535|Atropine|atropine|mesh-list
92314950|NCT05683535|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92314951|NCT05683535|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92314952|NCT05683535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92314953|NCT05683535|Autonomic Agents|autonomic agents|mesh-ancestor
92314954|NCT05683535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314955|NCT05683535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314956|NCT05683535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92314957|NCT05683535|Respiratory System Agents|respiratory system agents|mesh-ancestor
92314958|NCT05683535|Mydriatics|mydriatics|mesh-ancestor
92314959|NCT05683535|Parasympatholytics|parasympatholytics|mesh-ancestor
92314960|NCT05683535|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92314961|NCT05683535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92314962|NCT05683535|Cholinergic Agents|cholinergic agents|mesh-ancestor
92314963|NCT05683535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92314964|NCT05683535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92314965|NCT05678244|Acetaminophen|acetaminophen|mesh-list
92314966|NCT05678244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92314967|NCT05678244|Analgesics|analgesics|mesh-ancestor
92314968|NCT05678244|Sensory System Agents|sensory system agents|mesh-ancestor
92314969|NCT05678244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314970|NCT05678244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314971|NCT05678244|Antipyretics|antipyretics|mesh-ancestor
92314972|NCT05676034|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92314973|NCT05676034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314974|NCT05675800|Psilocybin|psilocybin|mesh-list
92314975|NCT05675800|Hallucinogens|hallucinogens|mesh-ancestor
92314976|NCT05675800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314977|NCT05675800|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92314978|NCT05675319|Dexamethasone|dexamethasone|mesh-list
92314979|NCT05675319|Dexamethasone acetate|dexamethasone acetate|mesh-list
92314980|NCT05675319|Lenalidomide|lenalidomide|mesh-list
92314981|NCT05675319|Bortezomib|bortezomib|mesh-list
92314982|NCT05675319|Daratumumab|daratumumab|mesh-list
92314983|NCT05675319|Pomalidomide|pomalidomide|mesh-list
92314984|NCT05675319|Ixazomib|ixazomib|mesh-list
92314985|NCT05675319|Elotuzumab|elotuzumab|mesh-list
92314986|NCT05675319|BB 1101|bb 1101|mesh-list
92314987|NCT05675319|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92314988|NCT05675319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92314989|NCT05675319|Antiemetics|antiemetics|mesh-ancestor
92314990|NCT05675319|Autonomic Agents|autonomic agents|mesh-ancestor
92314991|NCT05675319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92314992|NCT05675319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92314993|NCT05675319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92314994|NCT05675319|Glucocorticoids|glucocorticoids|mesh-ancestor
92314995|NCT05675319|Hormones|hormones|mesh-ancestor
92314996|NCT05675319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92314997|NCT05675319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92314998|NCT05675319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92314999|NCT05675319|Protease Inhibitors|protease inhibitors|mesh-ancestor
92315000|NCT05675319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315001|NCT05675319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315002|NCT05675319|Immunologic Factors|immunologic factors|mesh-ancestor
92315003|NCT05675319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92315004|NCT05675319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92315005|NCT05675319|Growth Substances|growth substances|mesh-ancestor
92315006|NCT05675319|Growth Inhibitors|growth inhibitors|mesh-ancestor
92315008|NCT05674487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92315009|NCT05674487|Abortifacient Agents|abortifacient agents|mesh-ancestor
92315010|NCT05674487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315011|NCT05674487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967705|NCT03327389|Analgesics|analgesics|mesh-ancestor
92315012|NCT05674487|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92315013|NCT05674487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315014|NCT05674487|Oxytocics|oxytocics|mesh-ancestor
92315015|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
92315016|NCT05644873|Analgesics|analgesics|mesh-ancestor
92315017|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
92315018|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315019|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315020|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
92315021|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315022|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92315023|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
92315024|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92315025|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92315026|NCT05644873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315027|NCT05644873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92315028|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
92315029|NCT05644873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315030|NCT05641376|Dexmedetomidine|dexmedetomidine|mesh-list
92315031|NCT05641376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92315032|NCT05641376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315033|NCT05641376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315034|NCT05641376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92315035|NCT05641376|Analgesics|analgesics|mesh-ancestor
92315036|NCT05641376|Sensory System Agents|sensory system agents|mesh-ancestor
92315037|NCT05641376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315038|NCT05641376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92315039|NCT05641376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92315040|NCT05641376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92315041|NCT05641376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92315042|NCT05641376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315043|NCT05641376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315044|NCT05615311|Vitamin D|vitamin d|mesh-list
92315045|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
92315046|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
92315047|NCT05615311|Vitamins|vitamins|mesh-list
92315048|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
92315049|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315050|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92315051|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92315052|NCT05607615|Betadex|betadex|mesh-list
92315053|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
92315054|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315055|NCT05593939|Niacinamide|niacinamide|mesh-list
92315056|NCT05593939|Niacin|niacin|mesh-list
92315057|NCT05593939|Nicotinic Acids|nicotinic acids|mesh-list
92315058|NCT05593939|Vitamin B Complex|vitamin b complex|mesh-ancestor
92315059|NCT05593939|Vitamins|vitamins|mesh-ancestor
92315060|NCT05593939|Micronutrients|micronutrients|mesh-ancestor
92315062|NCT05593939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92315063|NCT05593939|Antimetabolites|antimetabolites|mesh-ancestor
92315064|NCT05593939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315065|NCT05593939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92315066|NCT05593939|Vasodilator Agents|vasodilator agents|mesh-ancestor
92315067|NCT05577845|Ramosetron|ramosetron|mesh-list
92315068|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
92315069|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
92315070|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315071|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315072|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315073|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92315074|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
92315075|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315076|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315077|NCT05527912|Rituximab|rituximab|mesh-list
92315078|NCT05527912|Zanubrutinib|zanubrutinib|mesh-list
92315079|NCT05527912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315080|NCT05527912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315081|NCT05527912|Immunologic Factors|immunologic factors|mesh-ancestor
92315082|NCT05527912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315083|NCT05527912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92315084|NCT05527912|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315085|NCT05527912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315086|NCT05527912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315087|NCT05504083|Benzbromarone|benzbromarone|mesh-list
92315088|NCT05504083|Uricosuric Agents|uricosuric agents|mesh-ancestor
92315089|NCT05504083|Gout Suppressants|gout suppressants|mesh-ancestor
92315090|NCT05504083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92315092|NCT05491187|Bupivacaine|bupivacaine|mesh-list
92315093|NCT05491187|Anesthetics, Local|anesthetics, local|mesh-ancestor
92315094|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
92315095|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315096|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315097|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
92315098|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315099|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92315100|NCT05491187|Narcotics|narcotics|mesh-ancestor
92315101|NCT05491187|Analgesics|analgesics|mesh-ancestor
92315102|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92315103|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92315104|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
92315105|NCT05480878|Nitazoxanide|nitazoxanide|mesh-list
92315106|NCT05480878|Escitalopram|escitalopram|mesh-list
92315107|NCT05480878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92315108|NCT05480878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92315109|NCT05480878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92315110|NCT05480878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315111|NCT05480878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315112|NCT05480878|Serotonin Agents|serotonin agents|mesh-ancestor
92315113|NCT05480878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315114|NCT05480878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92315115|NCT05480878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315116|NCT05462730|Methylprednisolone|methylprednisolone|mesh-list
92315117|NCT05462730|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92315118|NCT05462730|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92315119|NCT05462730|Prednisolone|prednisolone|mesh-list
92315120|NCT05462730|Prednisolone acetate|prednisolone acetate|mesh-list
92315121|NCT05462730|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92315122|NCT05462730|Prednisolone phosphate|prednisolone phosphate|mesh-list
92315123|NCT05462730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92315124|NCT05462730|Antiemetics|antiemetics|mesh-ancestor
92315125|NCT05462730|Autonomic Agents|autonomic agents|mesh-ancestor
92315126|NCT05462730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315127|NCT05462730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315128|NCT05462730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315129|NCT05462730|Glucocorticoids|glucocorticoids|mesh-ancestor
92315130|NCT05462730|Hormones|hormones|mesh-ancestor
92315131|NCT05462730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315132|NCT05462730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92315133|NCT05462730|Protective Agents|protective agents|mesh-ancestor
92315134|NCT05462730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92315135|NCT05462730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315136|NCT05462236|Pembrolizumab|pembrolizumab|mesh-list
92315137|NCT05462236|Irinotecan|irinotecan|mesh-list
92315138|NCT05462236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315139|NCT05462236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315140|NCT05462236|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315141|NCT05462236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315142|NCT05462236|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92315143|NCT05462236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92315144|NCT05462236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315145|NCT05417594|Temozolomide|temozolomide|mesh-list
92315146|NCT05417594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92315147|NCT05417594|Alkylating Agents|alkylating agents|mesh-ancestor
92315148|NCT05417594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315149|NCT05417594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315150|NCT05414331|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92315151|NCT05414331|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92315152|NCT05414331|Adrenergic Agents|adrenergic agents|mesh-ancestor
92315153|NCT05414331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315154|NCT05414331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315155|NCT05414331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315156|NCT05398367|Galactogogues|galactogogues|mesh-list
92315157|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315158|NCT05383716|Pembrolizumab|pembrolizumab|mesh-list
92315159|NCT05383716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315160|NCT05383716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315161|NCT05383716|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315162|NCT05383716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315163|NCT05378945|Varenicline|varenicline|mesh-list
92315164|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92315165|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92315166|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
92315167|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315168|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315169|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315171|NCT05376319|Obinutuzumab|obinutuzumab|mesh-list
92315172|NCT05376319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315173|NCT05376319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315174|NCT05376319|Immunologic Factors|immunologic factors|mesh-ancestor
92315175|NCT05376319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315176|NCT05376319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92315177|NCT05362877|Salicylic Acid|salicylic acid|mesh-list
92315178|NCT05362877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315179|NCT05362877|Antifungal Agents|antifungal agents|mesh-ancestor
92315180|NCT05362877|Keratolytic Agents|keratolytic agents|mesh-ancestor
92315181|NCT05362877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92315182|NCT05358587|Anesthetics|anesthetics|mesh-list
92315183|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
92315184|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92315185|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315186|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315187|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
92315188|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315189|NCT05330377|Cytarabine|cytarabine|mesh-list
92315190|NCT05330377|Mitoxantrone|mitoxantrone|mesh-list
92315191|NCT05330377|Cladribine|cladribine|mesh-list
92315192|NCT05330377|Lenograstim|lenograstim|mesh-list
92315193|NCT05330377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315194|NCT05330377|Antimetabolites|antimetabolites|mesh-ancestor
92412414|NCT02899052|Dexamethasone|dexamethasone|mesh-list
92315195|NCT05330377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315196|NCT05330377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315197|NCT05330377|Antiviral Agents|antiviral agents|mesh-ancestor
92315198|NCT05330377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315199|NCT05330377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92315200|NCT05330377|Immunologic Factors|immunologic factors|mesh-ancestor
92315201|NCT05330377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315202|NCT05330377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92315203|NCT05330377|Analgesics|analgesics|mesh-ancestor
92315204|NCT05330377|Sensory System Agents|sensory system agents|mesh-ancestor
92315205|NCT05330377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315206|NCT05330377|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92315207|NCT05330377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92315208|NCT05330377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315210|NCT05326087|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92315211|NCT05326087|Fertility Agents|fertility agents|mesh-ancestor
92315212|NCT05326087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315213|NCT05326087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315214|NCT05326087|Hormone Antagonists|hormone antagonists|mesh-ancestor
92315215|NCT05326087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315216|NCT05323435|Vaccines|vaccines|mesh-list
92315217|NCT05323435|Immunologic Factors|immunologic factors|mesh-ancestor
92315218|NCT05323435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315219|NCT05322252|Misoprostol|misoprostol|mesh-list
92315220|NCT05322252|Mifepristone|mifepristone|mesh-list
92315221|NCT05322252|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92315222|NCT05322252|Abortifacient Agents|abortifacient agents|mesh-ancestor
92315223|NCT05322252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315224|NCT05322252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315225|NCT05322252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92348121|NCT01686828|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92315226|NCT05322252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315227|NCT05322252|Oxytocics|oxytocics|mesh-ancestor
92315228|NCT05322252|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92315229|NCT05322252|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92315230|NCT05322252|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92315231|NCT05322252|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92315232|NCT05322252|Contraceptive Agents|contraceptive agents|mesh-ancestor
92315233|NCT05322252|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92315234|NCT05322252|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92315235|NCT05322252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92315236|NCT05322252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967935|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
92315237|NCT05322252|Luteolytic Agents|luteolytic agents|mesh-ancestor
92315238|NCT05322252|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92315239|NCT05322252|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92315240|NCT05293912|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92315241|NCT05293912|Immunologic Factors|immunologic factors|mesh-ancestor
92315242|NCT05293912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315243|NCT05288062|Dexamethasone|dexamethasone|mesh-list
92315244|NCT05288062|Dexamethasone acetate|dexamethasone acetate|mesh-list
92315245|NCT05288062|Lenalidomide|lenalidomide|mesh-list
92315246|NCT05288062|Pomalidomide|pomalidomide|mesh-list
92315247|NCT05288062|Ichthammol|ichthammol|mesh-list
92315248|NCT05288062|BB 1101|bb 1101|mesh-list
92315249|NCT05288062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92315250|NCT05288062|Antiemetics|antiemetics|mesh-ancestor
92315251|NCT05288062|Autonomic Agents|autonomic agents|mesh-ancestor
92315252|NCT05288062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315253|NCT05288062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315254|NCT05288062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315255|NCT05288062|Glucocorticoids|glucocorticoids|mesh-ancestor
92315256|NCT05288062|Hormones|hormones|mesh-ancestor
92315257|NCT05288062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315258|NCT05288062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92315259|NCT05288062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315260|NCT05288062|Protease Inhibitors|protease inhibitors|mesh-ancestor
92315261|NCT05288062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315262|NCT05288062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315263|NCT05288062|Immunologic Factors|immunologic factors|mesh-ancestor
92315264|NCT05288062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92315265|NCT05288062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92315266|NCT05288062|Growth Substances|growth substances|mesh-ancestor
92315267|NCT05288062|Growth Inhibitors|growth inhibitors|mesh-ancestor
92315268|NCT05288062|Dermatologic Agents|dermatologic agents|mesh-ancestor
92315269|NCT05246943|Fibrin fragment D|fibrin fragment d|mesh-list
92315270|NCT05246943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92315271|NCT05246943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92315272|NCT05246943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315273|NCT05246943|Hemostatics|hemostatics|mesh-ancestor
92315274|NCT05246943|Coagulants|coagulants|mesh-ancestor
92315275|NCT05239468|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92315276|NCT05239468|Bezafibrate|bezafibrate|mesh-list
92315277|NCT05239468|Cathartics|cathartics|mesh-ancestor
92315278|NCT05239468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315279|NCT05239468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92315280|NCT05239468|Antimetabolites|antimetabolites|mesh-ancestor
92315281|NCT05239468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315282|NCT05239468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92315283|NCT05212454|Capecitabine|capecitabine|mesh-list
92315284|NCT05212454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315285|NCT05212454|Antimetabolites|antimetabolites|mesh-ancestor
92315286|NCT05212454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315287|NCT05212454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315288|NCT05157581|Methoxsalen|methoxsalen|mesh-list
92315289|NCT05157581|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92315290|NCT05157581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92315291|NCT05096845|Vaccines|vaccines|mesh-list
92315292|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
92315293|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315294|NCT05091866|Progesterone|progesterone|mesh-list
92315295|NCT05091866|Progestins|progestins|mesh-list
92315296|NCT05091866|Hormones|hormones|mesh-ancestor
92315297|NCT05091866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315298|NCT05091866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315299|NCT05084989|Vaccines|vaccines|mesh-list
92315300|NCT05084989|Immunologic Factors|immunologic factors|mesh-ancestor
92315301|NCT05084989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315302|NCT05079828|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92315303|NCT05079828|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92315304|NCT05079828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315305|NCT05042700|Melatonin|melatonin|mesh-list
92315306|NCT05042700|Antioxidants|antioxidants|mesh-ancestor
92315307|NCT05042700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315308|NCT05042700|Protective Agents|protective agents|mesh-ancestor
92315309|NCT05042700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315310|NCT05042700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315311|NCT05010954|Lansoprazole|lansoprazole|mesh-list
92315312|NCT05010954|Dexlansoprazole|dexlansoprazole|mesh-list
92315313|NCT05010954|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92315314|NCT05010954|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315315|NCT05010954|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92315316|NCT05010954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315317|NCT05010954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315319|NCT05001724|Lenvatinib|lenvatinib|mesh-list
92315320|NCT05001724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315321|NCT05001724|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315322|NCT05001724|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315323|NCT05001724|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315324|NCT05001724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315325|NCT05001724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315326|NCT05001724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315327|NCT04996368|Tranexamic Acid|tranexamic acid|mesh-list
92315328|NCT04996368|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92315329|NCT04996368|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92315330|NCT04996368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315331|NCT04996368|Hemostatics|hemostatics|mesh-ancestor
92315332|NCT04996368|Coagulants|coagulants|mesh-ancestor
92315333|NCT04994444|Nicotine|nicotine|mesh-list
92315334|NCT04994444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92315335|NCT04994444|Autonomic Agents|autonomic agents|mesh-ancestor
92315336|NCT04994444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315338|NCT04994444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92315339|NCT04994444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92315340|NCT04994444|Cholinergic Agents|cholinergic agents|mesh-ancestor
92315341|NCT04994444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315342|NCT04994444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315343|NCT04987892|Tamsulosin|tamsulosin|mesh-list
92315344|NCT04987892|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92315345|NCT04987892|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92315346|NCT04987892|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92315347|NCT04987892|Adrenergic Agents|adrenergic agents|mesh-ancestor
92315348|NCT04987892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315349|NCT04987892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315350|NCT04987892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315351|NCT04987892|Urological Agents|urological agents|mesh-ancestor
92315352|NCT05019222|Anesthetics|anesthetics|mesh-list
92315353|NCT05019222|Sevoflurane|sevoflurane|mesh-list
92315354|NCT05019222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315355|NCT05019222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315356|NCT05019222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92315357|NCT05019222|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92315358|NCT05019222|Anesthetics, General|anesthetics, general|mesh-ancestor
92315359|NCT04966702|Ivermectin|ivermectin|mesh-list
92315360|NCT04966702|Albendazole|albendazole|mesh-list
92315361|NCT04966702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92315362|NCT04966702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315363|NCT04966702|Anthelmintics|anthelmintics|mesh-ancestor
92315364|NCT04966702|Anticestodal Agents|anticestodal agents|mesh-ancestor
92315366|NCT04966702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92315367|NCT04966702|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315368|NCT04966702|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315369|NCT04966702|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315370|NCT04966702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315371|NCT04966702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315372|NCT04966663|Carboplatin|carboplatin|mesh-list
92315373|NCT04966663|Gemcitabine|gemcitabine|mesh-list
92315374|NCT04966663|Nivolumab|nivolumab|mesh-list
92315375|NCT04966663|Pemetrexed|pemetrexed|mesh-list
92315376|NCT04966663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315377|NCT04966663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315378|NCT04966663|Antimetabolites|antimetabolites|mesh-ancestor
92315379|NCT04966663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315380|NCT04966663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315381|NCT04966663|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315382|NCT04966663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315383|NCT04966663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92315384|NCT04966663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92315385|NCT04922593|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92315386|NCT04922593|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92315387|NCT04922593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92315388|NCT04922593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315389|NCT04922593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315390|NCT04922593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92315391|NCT04922593|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92315392|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92315393|NCT04922593|Serotonin Agents|serotonin agents|mesh-ancestor
92315394|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315395|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315396|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92315397|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92315398|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
92315399|NCT04902950|Tranexamic Acid|tranexamic acid|mesh-list
92315400|NCT04902950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92315401|NCT04902950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92315402|NCT04902950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315403|NCT04902950|Hemostatics|hemostatics|mesh-ancestor
92315404|NCT04902950|Coagulants|coagulants|mesh-ancestor
92315405|NCT04889118|Pembrolizumab|pembrolizumab|mesh-list
92315406|NCT04889118|Lenvatinib|lenvatinib|mesh-list
92315407|NCT04889118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315408|NCT04889118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315409|NCT04889118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315410|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315411|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315412|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315413|NCT04838301|Pregnanolone|pregnanolone|mesh-list
92315414|NCT04838301|Anesthetics|anesthetics|mesh-ancestor
92315415|NCT04838301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315416|NCT04838301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315417|NCT04819971|Docetaxel|docetaxel|mesh-list
92315418|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
92315419|NCT04819971|Trastuzumab|trastuzumab|mesh-list
92315420|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315421|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315422|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315423|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315424|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315425|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315426|NCT04724148|Fentanyl|fentanyl|mesh-list
92315427|NCT04724148|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92315429|NCT04724148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315430|NCT04724148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315432|NCT04724148|Sensory System Agents|sensory system agents|mesh-ancestor
92315433|NCT04724148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315434|NCT04724148|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92315435|NCT04724148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92315436|NCT04724148|Anesthetics, General|anesthetics, general|mesh-ancestor
92315438|NCT04703803|Lidocaine|lidocaine|mesh-list
92315439|NCT04703803|Anesthetics, Local|anesthetics, local|mesh-ancestor
92315440|NCT04703803|Anesthetics|anesthetics|mesh-ancestor
92315441|NCT04703803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315442|NCT04703803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315443|NCT04703803|Sensory System Agents|sensory system agents|mesh-ancestor
92315444|NCT04703803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315445|NCT04703803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92315446|NCT04703803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92315447|NCT04703803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92315448|NCT04703803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92315449|NCT04703803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315450|NCT04681417|Carboplatin|carboplatin|mesh-list
92315451|NCT04681417|Etoposide|etoposide|mesh-list
92315452|NCT04681417|Etoposide phosphate|etoposide phosphate|mesh-list
92315453|NCT04681417|Vincristine|vincristine|mesh-list
92315454|NCT04681417|Melphalan|melphalan|mesh-list
92315455|NCT04681417|Topotecan|topotecan|mesh-list
92315456|NCT04681417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315457|NCT04681417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92315458|NCT04681417|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92315459|NCT04681417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92315460|NCT04681417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315461|NCT04681417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315462|NCT04681417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315463|NCT04681417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315464|NCT04681417|Mitosis Modulators|mitosis modulators|mesh-ancestor
91968154|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92315465|NCT04681417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92315466|NCT04681417|Alkylating Agents|alkylating agents|mesh-ancestor
92315467|NCT04681417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92315468|NCT04681417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92315469|NCT04681417|Immunologic Factors|immunologic factors|mesh-ancestor
92315470|NCT04681417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315471|NCT04681417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92315472|NCT04670978|Bevacizumab|bevacizumab|mesh-list
92315473|NCT04670978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315474|NCT04670978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315475|NCT04670978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92315476|NCT04670978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92315477|NCT04670978|Growth Substances|growth substances|mesh-ancestor
92315478|NCT04670978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315479|NCT04670978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92315481|NCT04639180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315482|NCT04639180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315483|NCT04639180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315484|NCT04639180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315485|NCT04594694|Bezafibrate|bezafibrate|mesh-list
92315486|NCT04594694|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92315487|NCT04594694|Antimetabolites|antimetabolites|mesh-ancestor
92315488|NCT04594694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315489|NCT04594694|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92315490|NCT04531943|Progesterone|progesterone|mesh-list
92315491|NCT04531943|Estrogens|estrogens|mesh-list
92315492|NCT04531943|Progestins|progestins|mesh-ancestor
92315493|NCT04531943|Hormones|hormones|mesh-ancestor
92315494|NCT04531943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315495|NCT04531943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315496|NCT04522973|Ethanol|ethanol|mesh-list
92315497|NCT04522973|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92315498|NCT04522973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315499|NCT04522973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936547|NCT02638805|Hormones|hormones|mesh-ancestor
92315500|NCT04522973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315501|NCT04520048|Acetylcholine|acetylcholine|mesh-list
92315502|NCT04520048|Vasodilator Agents|vasodilator agents|mesh-ancestor
92315503|NCT04520048|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92315504|NCT04520048|Cholinergic Agents|cholinergic agents|mesh-ancestor
92315505|NCT04520048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315506|NCT04520048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315507|NCT04520048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315508|NCT04516850|Steroid delta-isomerase|steroid delta-isomerase|mesh-list
92315509|NCT04516850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315510|NCT04516850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315511|NCT04503460|Fluticasone|fluticasone|mesh-list
92315512|NCT04503460|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92315513|NCT04503460|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92315514|NCT04503460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92315515|NCT04503460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92315516|NCT04503460|Autonomic Agents|autonomic agents|mesh-ancestor
92315517|NCT04503460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315518|NCT04503460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315519|NCT04503460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92315520|NCT04503460|Respiratory System Agents|respiratory system agents|mesh-ancestor
92315521|NCT04503460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92315522|NCT04503460|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92315523|NCT04503460|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92315524|NCT04503460|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92315525|NCT04503460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92315526|NCT04503460|Adrenergic Agents|adrenergic agents|mesh-ancestor
92315527|NCT04503460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92315528|NCT04503460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315529|NCT04503460|Glucocorticoids|glucocorticoids|mesh-ancestor
92315530|NCT04503460|Hormones|hormones|mesh-ancestor
92315531|NCT04503460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315532|NCT04503460|Sympathomimetics|sympathomimetics|mesh-ancestor
92315533|NCT04460326|Insulin|insulin|mesh-list
92315534|NCT04460326|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92315535|NCT04460326|Insulin Glargine|insulin glargine|mesh-list
92315537|NCT04460326|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92315538|NCT04460326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315539|NCT04414761|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92315540|NCT04414761|Medroxyprogesterone|medroxyprogesterone|mesh-list
92315541|NCT04414761|Cetrorelix|cetrorelix|mesh-list
92315542|NCT04414761|Progesterone|progesterone|mesh-list
92315543|NCT04414761|Dydrogesterone|dydrogesterone|mesh-list
92315544|NCT04414761|Ganirelix|ganirelix|mesh-list
92315545|NCT04414761|Progestins|progestins|mesh-ancestor
92315546|NCT04414761|Hormones|hormones|mesh-ancestor
92315547|NCT04414761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315548|NCT04414761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315549|NCT04414761|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92315550|NCT04414761|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92315551|NCT04414761|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92315552|NCT04414761|Contraceptive Agents|contraceptive agents|mesh-ancestor
92315553|NCT04414761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315554|NCT04414761|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92315555|NCT04414761|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92315556|NCT04414761|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92315557|NCT04414761|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92315558|NCT04414761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315559|NCT04414761|Hormone Antagonists|hormone antagonists|mesh-ancestor
92315560|NCT04414761|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92315561|NCT04414761|Fertility Agents|fertility agents|mesh-ancestor
92315562|NCT04414748|Cetrorelix|cetrorelix|mesh-list
92315563|NCT04414748|Dydrogesterone|dydrogesterone|mesh-list
92315564|NCT04414748|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92315565|NCT04414748|Fertility Agents|fertility agents|mesh-ancestor
92315566|NCT04414748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315567|NCT04414748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315568|NCT04414748|Hormone Antagonists|hormone antagonists|mesh-ancestor
92315569|NCT04414748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315570|NCT04414748|Progestins|progestins|mesh-ancestor
92315571|NCT04414748|Hormones|hormones|mesh-ancestor
92315572|NCT04395196|Choline|choline|mesh-list
92315573|NCT04395196|Lipotropic Agents|lipotropic agents|mesh-ancestor
92315574|NCT04395196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92315575|NCT04395196|Antimetabolites|antimetabolites|mesh-ancestor
92315576|NCT04395196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315577|NCT04395196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315578|NCT04395196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92315579|NCT04395196|Nootropic Agents|nootropic agents|mesh-ancestor
92315580|NCT04234113|Pembrolizumab|pembrolizumab|mesh-list
92315581|NCT04234113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315582|NCT04234113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315583|NCT04234113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315584|NCT04234113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315585|NCT04233515|Anticoagulants|anticoagulants|mesh-list
92315586|NCT04169373|Upadacitinib|upadacitinib|mesh-list
92315587|NCT04169373|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92315588|NCT04169373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315589|NCT04169373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315590|NCT04169373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315591|NCT04169373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92315592|NCT04167514|Protease Inhibitors|protease inhibitors|mesh-list
92315593|NCT04167514|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92315594|NCT04167514|Protein C Inhibitor|protein c inhibitor|mesh-list
92315595|NCT04167514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315596|NCT04167514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315597|NCT04167514|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92315598|NCT04167514|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92315600|NCT04150042|Ascorbic Acid|ascorbic acid|mesh-list
92315601|NCT04150042|Vitamin B 12|vitamin b 12|mesh-list
92315602|NCT04150042|Hydroxocobalamin|hydroxocobalamin|mesh-list
92315603|NCT04150042|Ethanol|ethanol|mesh-list
92315604|NCT04150042|Melphalan|melphalan|mesh-list
92315605|NCT04150042|Carmustine|carmustine|mesh-list
92315606|NCT04150042|Micronutrients|micronutrients|mesh-ancestor
92315607|NCT04150042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315608|NCT04150042|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92315609|NCT04150042|Alkylating Agents|alkylating agents|mesh-ancestor
92315610|NCT04150042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315611|NCT04150042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315612|NCT04150042|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92315613|NCT04150042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92315614|NCT04150042|Immunologic Factors|immunologic factors|mesh-ancestor
92315615|NCT04150042|Antioxidants|antioxidants|mesh-ancestor
92315616|NCT04150042|Protective Agents|protective agents|mesh-ancestor
92315617|NCT04150042|Vitamin B Complex|vitamin b complex|mesh-ancestor
92315618|NCT04150042|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92315619|NCT04150042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315620|NCT04150042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315621|NCT04150042|Hematinics|hematinics|mesh-ancestor
92315622|NCT04141644|Ipilimumab|ipilimumab|mesh-list
92315623|NCT04141644|Osimertinib|osimertinib|mesh-list
92315624|NCT04141644|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315625|NCT04141644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315626|NCT04141644|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315627|NCT04141644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315628|NCT04141644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315629|NCT04141644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315630|NCT04125927|Cysteamine|cysteamine|mesh-list
92315631|NCT04125927|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92315632|NCT04125927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315633|NCT04093024|Nintedanib|nintedanib|mesh-list
92315634|NCT04093024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315635|NCT04093024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315636|NCT04093024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315637|NCT04093024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315638|NCT04091503|Temozolomide|temozolomide|mesh-list
92315639|NCT04091503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92315640|NCT04091503|Alkylating Agents|alkylating agents|mesh-ancestor
92315641|NCT04091503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315642|NCT04091503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315643|NCT04067752|Dialysis Solutions|dialysis solutions|mesh-list
92315644|NCT04067752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92315646|NCT04044534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92315647|NCT04044534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315648|NCT04020913|Hormones|hormones|mesh-list
92315649|NCT04020913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412496|NCT02586831|Analgesics|analgesics|mesh-ancestor
92315650|NCT04020913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315651|NCT04014790|KRN 7000|krn 7000|mesh-list
92315652|NCT04014790|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92315653|NCT04014790|Immunologic Factors|immunologic factors|mesh-ancestor
92315654|NCT04014790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315655|NCT04014790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315656|NCT03971474|Gemcitabine|gemcitabine|mesh-list
92315657|NCT03971474|Docetaxel|docetaxel|mesh-list
92315658|NCT03971474|Pembrolizumab|pembrolizumab|mesh-list
92315659|NCT03971474|Pemetrexed|pemetrexed|mesh-list
92315660|NCT03971474|Ramucirumab|ramucirumab|mesh-list
92315661|NCT03971474|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92315662|NCT03971474|Antibodies|antibodies|mesh-list
92315663|NCT03971474|Immunoglobulins|immunoglobulins|mesh-list
92315664|NCT03971474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92315665|NCT03971474|Lexatumumab|lexatumumab|mesh-list
92315666|NCT03971474|Immunologic Factors|immunologic factors|mesh-ancestor
92315667|NCT03971474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315668|NCT03971474|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315669|NCT03971474|Antimetabolites|antimetabolites|mesh-ancestor
92315670|NCT03971474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315671|NCT03971474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315672|NCT03971474|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315673|NCT03971474|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315674|NCT03971474|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315675|NCT03971474|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315676|NCT03971474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315677|NCT03971474|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92315678|NCT03971474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92315679|NCT03965234|Cisplatin|cisplatin|mesh-list
92315680|NCT03965234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315681|NCT03921060|Denosumab|denosumab|mesh-list
92315682|NCT03921060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92315683|NCT03921060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315684|NCT03859973|BI 425809|bi 425809|mesh-list
92315685|NCT03859973|Nootropic Agents|nootropic agents|mesh-ancestor
92315686|NCT03827070|Afatinib|afatinib|mesh-list
92315687|NCT03827070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315688|NCT03827070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315689|NCT03827070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315690|NCT03827070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315691|NCT03820986|Pembrolizumab|pembrolizumab|mesh-list
92315692|NCT03820986|Lenvatinib|lenvatinib|mesh-list
92315693|NCT03820986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315694|NCT03820986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315695|NCT03820986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315696|NCT03820986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315697|NCT03820986|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315698|NCT03820986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315699|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
92315700|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92315701|NCT03805789|Protein C Inhibitor|protein c inhibitor|mesh-list
92315702|NCT03805789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315703|NCT03805789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315704|NCT03805789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92315705|NCT03805789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92315706|NCT03748303|Pregnanolone|pregnanolone|mesh-list
92315707|NCT03748303|Anesthetics|anesthetics|mesh-ancestor
92315708|NCT03748303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315709|NCT03748303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315711|NCT03680053|Dydrogesterone|dydrogesterone|mesh-list
92315712|NCT03680053|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92315713|NCT03680053|Fertility Agents|fertility agents|mesh-ancestor
92315714|NCT03680053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315715|NCT03680053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315716|NCT03680053|Hormone Antagonists|hormone antagonists|mesh-ancestor
92315717|NCT03680053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315718|NCT03680053|Progestins|progestins|mesh-ancestor
92315719|NCT03680053|Hormones|hormones|mesh-ancestor
92315720|NCT03673007|Contraceptive Agents|contraceptive agents|mesh-list
92315721|NCT03673007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315722|NCT03673007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315723|NCT03672630|Azithromycin|azithromycin|mesh-list
92315724|NCT03672630|Rifampin|rifampin|mesh-list
92315725|NCT03672630|Ethambutol|ethambutol|mesh-list
92315726|NCT03672630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92315727|NCT03672630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315728|NCT03672630|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92315729|NCT03672630|Antitubercular Agents|antitubercular agents|mesh-ancestor
92315730|NCT03672630|Leprostatic Agents|leprostatic agents|mesh-ancestor
92315731|NCT03672630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92315732|NCT03672630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315733|NCT03672630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315734|NCT03672630|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92315735|NCT03672630|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92315736|NCT03672630|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92315737|NCT03672630|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92315738|NCT03672630|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92315739|NCT03672630|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92315740|NCT03657602|Levonorgestrel|levonorgestrel|mesh-list
92315741|NCT03657602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92315742|NCT03657602|Contraceptive Agents|contraceptive agents|mesh-ancestor
92315743|NCT03657602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315744|NCT03657602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315745|NCT03657602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92315746|NCT03657602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92315747|NCT03657602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92315748|NCT03656718|Nivolumab|nivolumab|mesh-list
92315749|NCT03656718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315750|NCT03656718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315751|NCT03656718|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315752|NCT03656718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315754|NCT03646175|Lipotropic Agents|lipotropic agents|mesh-ancestor
92315755|NCT03646175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92315756|NCT03646175|Antimetabolites|antimetabolites|mesh-ancestor
92315757|NCT03646175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315758|NCT03646175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92315759|NCT03646175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92315760|NCT03646175|Nootropic Agents|nootropic agents|mesh-ancestor
92315761|NCT03632369|Xenon|xenon|mesh-list
92315762|NCT03632369|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92315763|NCT03632369|Anesthetics, General|anesthetics, general|mesh-ancestor
92315764|NCT03632369|Anesthetics|anesthetics|mesh-ancestor
92315765|NCT03632369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315766|NCT03632369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315767|NCT03625687|Antiviral Agents|antiviral agents|mesh-list
92315768|NCT03625687|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92315769|NCT03625687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315770|NCT03605342|Buprenorphine|buprenorphine|mesh-list
92315771|NCT03605342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92315772|NCT03605342|Narcotics|narcotics|mesh-ancestor
92315773|NCT03605342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315774|NCT03605342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315775|NCT03605342|Analgesics|analgesics|mesh-ancestor
92315776|NCT03605342|Sensory System Agents|sensory system agents|mesh-ancestor
92315777|NCT03605342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315778|NCT03605342|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92315779|NCT03598842|Metronidazole|metronidazole|mesh-list
92315780|NCT03598842|Ivermectin|ivermectin|mesh-list
92315781|NCT03598842|Albendazole|albendazole|mesh-list
92315782|NCT03598842|Antiparasitic Agents|antiparasitic agents|mesh-list
92315783|NCT03598842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315784|NCT03598842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92315785|NCT03598842|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92315786|NCT03598842|Anthelmintics|anthelmintics|mesh-ancestor
92315787|NCT03598842|Anticestodal Agents|anticestodal agents|mesh-ancestor
92315788|NCT03598842|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92315789|NCT03598842|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315790|NCT03598842|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315791|NCT03598842|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315792|NCT03598842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315793|NCT03598842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315794|NCT03471364|Ketoconazole|ketoconazole|mesh-list
92315795|NCT03471364|Antifungal Agents|antifungal agents|mesh-ancestor
92315796|NCT03471364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315797|NCT03471364|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92315798|NCT03471364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92315799|NCT03471364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315800|NCT03471364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315801|NCT03471364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92315802|NCT03471364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92116941|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315803|NCT03471364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315804|NCT03471364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315805|NCT03471364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92315806|NCT03469284|Methylene Blue|methylene blue|mesh-list
92315807|NCT03469284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315808|NCT03469284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315809|NCT03456076|Carboplatin|carboplatin|mesh-list
92315810|NCT03456076|Gemcitabine|gemcitabine|mesh-list
92315811|NCT03456076|Pemetrexed|pemetrexed|mesh-list
92315812|NCT03456076|Vinorelbine|vinorelbine|mesh-list
92315813|NCT03456076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315814|NCT03456076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315815|NCT03456076|Antimetabolites|antimetabolites|mesh-ancestor
92315816|NCT03456076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315817|NCT03456076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315818|NCT03456076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92315819|NCT03456076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92315820|NCT03456076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92315821|NCT03456076|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315822|NCT03456076|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315823|NCT03456076|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315824|NCT03425331|Nivolumab|nivolumab|mesh-list
92315825|NCT03425331|Ipilimumab|ipilimumab|mesh-list
92315826|NCT03425331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315827|NCT03425331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315828|NCT03425331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315829|NCT03425331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315830|NCT03276832|Pembrolizumab|pembrolizumab|mesh-list
92315831|NCT03276832|Imiquimod|imiquimod|mesh-list
92348191|NCT01565850|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92315832|NCT03276832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315833|NCT03276832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315834|NCT03276832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315835|NCT03276832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315836|NCT03276832|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92315837|NCT03276832|Immunologic Factors|immunologic factors|mesh-ancestor
91968529|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
92315838|NCT03276832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315839|NCT03276832|Interferon Inducers|interferon inducers|mesh-ancestor
92315840|NCT03149211|UB-421|ub-421|mesh-list
92315841|NCT03149211|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92315842|NCT03149211|Antiviral Agents|antiviral agents|mesh-ancestor
92315843|NCT03149211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315844|NCT03141671|Prednisone|prednisone|mesh-list
92315845|NCT03141671|Bicalutamide|bicalutamide|mesh-list
92315846|NCT03141671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92315847|NCT03141671|Glucocorticoids|glucocorticoids|mesh-ancestor
92315848|NCT03141671|Hormones|hormones|mesh-ancestor
92315849|NCT03141671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92315850|NCT03141671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315851|NCT03141671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92315852|NCT03141671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315853|NCT03141671|Androgen Antagonists|androgen antagonists|mesh-ancestor
92315854|NCT03141671|Hormone Antagonists|hormone antagonists|mesh-ancestor
92315855|NCT03043430|Midazolam|midazolam|mesh-list
92315856|NCT03043430|Ketamine|ketamine|mesh-list
92315857|NCT03043430|Analgesics|analgesics|mesh-ancestor
92315858|NCT03043430|Sensory System Agents|sensory system agents|mesh-ancestor
92315859|NCT03043430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315860|NCT03043430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315861|NCT03043430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92315862|NCT03043430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92315863|NCT03043430|Anesthetics, General|anesthetics, general|mesh-ancestor
92315864|NCT03043430|Anesthetics|anesthetics|mesh-ancestor
92315865|NCT03043430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92315866|NCT03043430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92315867|NCT03043430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92315869|NCT03043430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315870|NCT03043430|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92315871|NCT03043430|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92315872|NCT03043430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92315873|NCT03043430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92315874|NCT03043430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92315875|NCT03043430|GABA Modulators|gaba modulators|mesh-ancestor
92315876|NCT03043430|GABA Agents|gaba agents|mesh-ancestor
92315877|NCT03035890|Immunomodulating Agents|immunomodulating agents|mesh-list
92315878|NCT03035890|Immunologic Factors|immunologic factors|mesh-ancestor
92315879|NCT03035890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315880|NCT03004261|Ganciclovir|ganciclovir|mesh-list
92315881|NCT03004261|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92315882|NCT03004261|Foscarnet|foscarnet|mesh-list
92315883|NCT03004261|Antiviral Agents|antiviral agents|mesh-ancestor
92315884|NCT03004261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315885|NCT03004261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92315886|NCT03004261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315887|NCT03004261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315888|NCT03004261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92315889|NCT02856425|Pembrolizumab|pembrolizumab|mesh-list
92315890|NCT02856425|Nintedanib|nintedanib|mesh-list
92315891|NCT02856425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315892|NCT02856425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315893|NCT02856425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315894|NCT02856425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315895|NCT02856425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315896|NCT02856425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315897|NCT02785952|Nivolumab|nivolumab|mesh-list
92315898|NCT02785952|Ipilimumab|ipilimumab|mesh-list
92315899|NCT02785952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92315900|NCT02785952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315901|NCT02785952|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92315902|NCT02785952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315904|NCT02652195|Oxytocics|oxytocics|mesh-ancestor
92315905|NCT02652195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315906|NCT02652195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315907|NCT02567409|Cisplatin|cisplatin|mesh-list
92315908|NCT02567409|Gemcitabine|gemcitabine|mesh-list
92315909|NCT02567409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315910|NCT02567409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315911|NCT02567409|Antimetabolites|antimetabolites|mesh-ancestor
92315912|NCT02567409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315913|NCT02443727|Oxytocin|oxytocin|mesh-list
92315914|NCT02443727|Oxytocics|oxytocics|mesh-ancestor
92315915|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92315916|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315917|NCT02429700|Paclitaxel|paclitaxel|mesh-list
92315918|NCT02429700|Etoposide|etoposide|mesh-list
92315919|NCT02429700|Carboplatin|carboplatin|mesh-list
92315920|NCT02429700|Bleomycin|bleomycin|mesh-list
92315921|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92315922|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315923|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315924|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315925|NCT02429700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315926|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315927|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92315928|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92315929|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315930|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92315931|NCT02429687|Paclitaxel|paclitaxel|mesh-list
92315932|NCT02429687|Etoposide|etoposide|mesh-list
92315933|NCT02429687|Carboplatin|carboplatin|mesh-list
92315934|NCT02429687|Bleomycin|bleomycin|mesh-list
92315935|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92315936|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315937|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315938|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315939|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315940|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315941|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92315942|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92315944|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92315945|NCT02194829|Paclitaxel|paclitaxel|mesh-list
92315946|NCT02194829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92315947|NCT02194829|Gemcitabine|gemcitabine|mesh-list
92315948|NCT02194829|Adavosertib|adavosertib|mesh-list
92315949|NCT02194829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92315950|NCT02194829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315951|NCT02194829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92315952|NCT02194829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92315953|NCT02194829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92315954|NCT02194829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315955|NCT02194829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315956|NCT02194829|Antimetabolites|antimetabolites|mesh-ancestor
92315957|NCT02194829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315959|NCT01740557|Cyclophosphamide|cyclophosphamide|mesh-list
92315960|NCT01740557|Fludarabine|fludarabine|mesh-list
92315961|NCT01740557|Fludarabine phosphate|fludarabine phosphate|mesh-list
92315962|NCT01740557|Interleukin-2|interleukin-2|mesh-list
92315963|NCT01740557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92315964|NCT01740557|Immunologic Factors|immunologic factors|mesh-ancestor
92315965|NCT01740557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92315966|NCT01740557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92315967|NCT01740557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92315968|NCT01740557|Alkylating Agents|alkylating agents|mesh-ancestor
92315969|NCT01740557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315970|NCT01740557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315971|NCT01740557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92315972|NCT01740557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92315973|NCT01740557|Antimetabolites|antimetabolites|mesh-ancestor
92315974|NCT01740557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92315975|NCT01740557|Analgesics|analgesics|mesh-ancestor
92315976|NCT01740557|Sensory System Agents|sensory system agents|mesh-ancestor
92315977|NCT01740557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92315978|NCT01740557|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92315979|NCT01740557|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92315980|NCT01740557|Antiviral Agents|antiviral agents|mesh-ancestor
92315981|NCT01740557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315982|NCT01370460|Tranexamic Acid|tranexamic acid|mesh-list
92315983|NCT01370460|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92315984|NCT01370460|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92315985|NCT01370460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315986|NCT01370460|Hemostatics|hemostatics|mesh-ancestor
92315987|NCT01370460|Coagulants|coagulants|mesh-ancestor
92315988|NCT00621192|Meropenem|meropenem|mesh-list
92315989|NCT00621192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92315990|NCT00621192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92315991|NCT00364286|Dasatinib|dasatinib|mesh-list
92315992|NCT00364286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315993|NCT00364286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315994|NCT00364286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92315995|NCT00364286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92315996|NCT00255346|Dasatinib|dasatinib|mesh-list
92315997|NCT00255346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92315998|NCT00255346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92315999|NCT00255346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316000|NCT00255346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316002|NCT02834624|Calfactant|calfactant|mesh-list
92316003|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92316004|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92316005|NCT02837744|Hemostatics|hemostatics|mesh-list
92316006|NCT02837744|Coagulants|coagulants|mesh-ancestor
92316007|NCT02918617|Fluorides|fluorides|mesh-list
92316008|NCT02918617|Cariostatic Agents|cariostatic agents|mesh-ancestor
92316009|NCT02918617|Protective Agents|protective agents|mesh-ancestor
92316010|NCT02918617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316011|NCT02839772|Glycerol|glycerol|mesh-list
92316012|NCT02839772|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92316013|NCT02839772|Protective Agents|protective agents|mesh-ancestor
92316014|NCT02839772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316015|NCT03041636|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92316016|NCT03041636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92316017|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316018|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316019|NCT03043105|Thalidomide|thalidomide|mesh-list
92316020|NCT03043105|Prednisone|prednisone|mesh-list
92316021|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
92316022|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92316023|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
92316024|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316025|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92316026|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92316027|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
92316028|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316029|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316030|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92316031|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316032|NCT03043105|Glucocorticoids|glucocorticoids|mesh-ancestor
92316033|NCT03043105|Hormones|hormones|mesh-ancestor
92316034|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316035|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316036|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
92316037|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92316038|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316039|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92316040|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92316041|NCT03043105|Growth Substances|growth substances|mesh-ancestor
92316042|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
92316043|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
92316044|NCT00374647|Sirolimus|sirolimus|mesh-list
92316045|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92316046|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316047|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92316048|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
92316049|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92316050|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316051|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316052|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316053|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
92316054|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92316055|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
92316056|NCT00374647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316058|NCT02964416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316059|NCT02964416|Narcotics|narcotics|mesh-ancestor
92316060|NCT02964416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316061|NCT02964416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316062|NCT02964416|Analgesics|analgesics|mesh-ancestor
92316063|NCT02964416|Sensory System Agents|sensory system agents|mesh-ancestor
92316064|NCT02964416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316065|NCT02812771|Efinaconazole|efinaconazole|mesh-list
92316066|NCT02812771|Antifungal Agents|antifungal agents|mesh-ancestor
92316067|NCT02812771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316068|NCT02969876|Vortioxetine|vortioxetine|mesh-list
92316069|NCT02969876|Antidepressive Agents|antidepressive agents|mesh-ancestor
92316070|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92316071|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92316072|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92316073|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316074|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316075|NCT02969876|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92316076|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92316077|NCT02969876|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316078|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316079|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316080|NCT02969876|Serotonin Agents|serotonin agents|mesh-ancestor
92316081|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92316082|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92316083|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92316084|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92316086|NCT02970032|Calcium heparin|calcium heparin|mesh-list
92316087|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
92316088|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92316089|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92316090|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316091|NCT02813551|Torsemide|torsemide|mesh-list
92316092|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92316093|NCT02813551|Diuretics|diuretics|mesh-ancestor
92316095|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316096|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92316097|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316098|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316099|NCT02817763|Dipyrone|dipyrone|mesh-list
92316100|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92316101|NCT02817763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92316102|NCT02817763|Analgesics|analgesics|mesh-ancestor
92316103|NCT02817763|Sensory System Agents|sensory system agents|mesh-ancestor
92316104|NCT02817763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316105|NCT02817763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316106|NCT02817763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316107|NCT02817763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92316108|NCT02817763|Antipyretics|antipyretics|mesh-ancestor
92316110|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92316111|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316112|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92316113|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316114|NCT03053401|Anesthetics|anesthetics|mesh-list
92316115|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
92316116|NCT03053401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316117|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316118|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
92316119|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316120|NCT03054103|Midazolam|midazolam|mesh-list
92316121|NCT03054103|Ketamine|ketamine|mesh-list
92316122|NCT03054103|Analgesics|analgesics|mesh-ancestor
92316123|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
92316124|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316125|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316126|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92316127|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92316128|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
92316129|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
92316130|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316131|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92316132|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92316133|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316134|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316135|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92316136|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92316137|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92316138|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92316139|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92316140|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
92316141|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
92316142|NCT03043274|Cangrelor|cangrelor|mesh-list
92316143|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92316144|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92316145|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92316146|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92316147|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
92316148|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316149|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316150|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316151|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
92316152|NCT03054805|Antacids|antacids|mesh-ancestor
92316153|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316154|NCT03054805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316155|NCT00374101|Omeprazole|omeprazole|mesh-list
92316156|NCT00374101|Pantoprazole|pantoprazole|mesh-list
92316157|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92316158|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316159|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92316160|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316161|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316162|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
92316163|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92316164|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92316165|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91936560|NCT02261675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92316166|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316167|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316169|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316170|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316171|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92316172|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316173|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
92316174|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92316175|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316176|NCT03050294|Desoximetasone|desoximetasone|mesh-list
92316177|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316178|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
92316180|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316181|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316182|NCT02831569|Loxoprofen|loxoprofen|mesh-list
92316183|NCT02831569|Methocarbamol|methocarbamol|mesh-list
92116942|NCT05075460|Azacitidine|azacitidine|mesh-list
92316184|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92316185|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92316186|NCT02831569|Analgesics|analgesics|mesh-ancestor
92316187|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
92316188|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316189|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316190|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316191|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92316192|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92316193|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92316194|NCT03065179|Nivolumab|nivolumab|mesh-list
92316195|NCT03065179|Ipilimumab|ipilimumab|mesh-list
92316196|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92316197|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316198|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92316199|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316200|NCT02988050|Lidocaine|lidocaine|mesh-list
92316201|NCT02988050|Epinephrine|epinephrine|mesh-list
92316202|NCT02988050|Dexmedetomidine|dexmedetomidine|mesh-list
92316203|NCT02988050|Remifentanil|remifentanil|mesh-list
92316204|NCT02988050|Bupivacaine|bupivacaine|mesh-list
92316205|NCT02988050|Propofol|propofol|mesh-list
92316206|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
92316207|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
92316208|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316209|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316210|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
92316211|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316212|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92316213|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92316214|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92316215|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316216|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316217|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92316218|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92316219|NCT02988050|Analgesics|analgesics|mesh-ancestor
92316220|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92316221|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92316222|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92316223|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316224|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316225|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92316226|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
92316227|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316228|NCT02988050|Narcotics|narcotics|mesh-ancestor
92316229|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92316230|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92316231|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
92316232|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92316233|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92316234|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
92316235|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
92316236|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92316237|NCT02988986|Tamoxifen|tamoxifen|mesh-list
92316238|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92316239|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
92316240|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316241|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316242|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316243|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316244|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92316245|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92316246|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92316247|NCT02832115|Lidocaine|lidocaine|mesh-list
92316248|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
92316249|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
92316250|NCT02832115|Anesthetics|anesthetics|mesh-list
92316251|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316252|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316253|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
92316254|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316255|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92316256|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92316257|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92316258|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316259|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316260|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
92316261|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92316262|NCT03054506|Laxatives|laxatives|mesh-ancestor
92316263|NCT03054506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316264|NCT02935699|Diphenhydramine|diphenhydramine|mesh-list
92316265|NCT02935699|Promethazine|promethazine|mesh-list
92316266|NCT02935699|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92316267|NCT02935699|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92316268|NCT02935699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316269|NCT02935699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316270|NCT02935699|Anesthetics, Local|anesthetics, local|mesh-ancestor
92316271|NCT02935699|Anesthetics|anesthetics|mesh-ancestor
92316272|NCT02935699|Sensory System Agents|sensory system agents|mesh-ancestor
92316273|NCT02935699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316274|NCT02935699|Antiemetics|antiemetics|mesh-ancestor
92316275|NCT02935699|Autonomic Agents|autonomic agents|mesh-ancestor
92316276|NCT02935699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316277|NCT02935699|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92316278|NCT02935699|Histamine Antagonists|histamine antagonists|mesh-ancestor
92316279|NCT02935699|Histamine Agents|histamine agents|mesh-ancestor
92316280|NCT02935699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316281|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316282|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92316283|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
92316284|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316285|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92316286|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92316287|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92316288|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92316289|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
92316290|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316291|NCT02841241|Esmolol|esmolol|mesh-list
92316292|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92316293|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92316294|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92316295|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316296|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316297|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316298|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316299|NCT00374881|Phenylephrine|phenylephrine|mesh-list
92316300|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
92316301|NCT00374881|Morphine|morphine|mesh-list
92316302|NCT00374881|Sorbitol|sorbitol|mesh-list
92316303|NCT00374881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316304|NCT00374881|Narcotics|narcotics|mesh-ancestor
92316305|NCT00374881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316306|NCT00374881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316307|NCT00374881|Analgesics|analgesics|mesh-ancestor
92316308|NCT00374881|Sensory System Agents|sensory system agents|mesh-ancestor
92316309|NCT00374881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316310|NCT00374881|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92316311|NCT00374881|Mydriatics|mydriatics|mesh-ancestor
92316313|NCT00374881|Sympathomimetics|sympathomimetics|mesh-ancestor
92316314|NCT00374881|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92316315|NCT00374881|Nasal Decongestants|nasal decongestants|mesh-ancestor
92316316|NCT00374881|Respiratory System Agents|respiratory system agents|mesh-ancestor
92316317|NCT00374881|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92316318|NCT00374881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92316319|NCT00374881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92316320|NCT00374881|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316321|NCT00374881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316322|NCT00374881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316323|NCT00374881|Protective Agents|protective agents|mesh-ancestor
92316324|NCT00374881|Cathartics|cathartics|mesh-ancestor
92316325|NCT00374881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316326|NCT00374959|Ceftriaxone|ceftriaxone|mesh-list
92316327|NCT00374959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92316328|NCT00374959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316329|NCT02846233|Metformin|metformin|mesh-list
92316330|NCT02846233|Empagliflozin|empagliflozin|mesh-list
92316331|NCT02846233|Dulaglutide|dulaglutide|mesh-list
92316332|NCT02846233|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92316333|NCT02846233|rGLP-1 protein|rglp-1 protein|mesh-list
92316334|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92316335|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316336|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316337|NCT02846233|Incretins|incretins|mesh-ancestor
92316338|NCT02846233|Hormones|hormones|mesh-ancestor
92316339|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316340|NCT02865590|Cimetidine|cimetidine|mesh-list
92316341|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92316342|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316343|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92316344|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
92316345|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
92316346|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316347|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316348|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316349|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92316350|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92316351|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316353|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92316354|NCT02868242|Ledipasvir|ledipasvir|mesh-list
92316355|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
92316356|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316357|NCT03075553|Nivolumab|nivolumab|mesh-list
92316358|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92316359|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316360|NCT03075553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92316361|NCT03075553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316362|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
92316363|NCT03054740|Anesthetics, Local|anesthetics, local|mesh-ancestor
92316364|NCT03054740|Anesthetics|anesthetics|mesh-ancestor
92316365|NCT03054740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316366|NCT03054740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316367|NCT03054740|Sensory System Agents|sensory system agents|mesh-ancestor
92316368|NCT03054740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316370|NCT02997722|Analgesics|analgesics|mesh-ancestor
92316371|NCT02997722|Sensory System Agents|sensory system agents|mesh-ancestor
92316372|NCT02997722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316373|NCT02997722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316374|NCT02997722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92316375|NCT02997722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92316376|NCT02997722|Anesthetics, General|anesthetics, general|mesh-ancestor
92316377|NCT02997722|Anesthetics|anesthetics|mesh-ancestor
92316378|NCT02997722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316379|NCT02997722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92316380|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92316381|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316382|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316383|NCT03108482|Celecoxib|celecoxib|mesh-list
92316384|NCT03108482|Tramadol|tramadol|mesh-list
92316385|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92316386|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92316387|NCT03108482|Analgesics|analgesics|mesh-ancestor
92316388|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
92316389|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316390|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348238|NCT01563354|Pasireotide|pasireotide|mesh-list
92316391|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316392|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92316393|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92316394|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92316395|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316396|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316397|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316398|NCT03108482|Narcotics|narcotics|mesh-ancestor
92316399|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316400|NCT02850601|Dexamethasone|dexamethasone|mesh-list
92316401|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316402|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
92316403|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
92316404|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316405|NCT02850601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316406|NCT02850601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316407|NCT02850601|Glucocorticoids|glucocorticoids|mesh-ancestor
92316408|NCT02850601|Hormones|hormones|mesh-ancestor
92316409|NCT02850601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316410|NCT02850601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316411|NCT02850601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316412|NCT03056456|Insulin Lispro|insulin lispro|mesh-list
92316413|NCT03056456|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92316414|NCT03056456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316415|NCT03057704|Lidocaine|lidocaine|mesh-list
92316416|NCT03057704|Anesthetics, Local|anesthetics, local|mesh-ancestor
92316417|NCT03057704|Anesthetics|anesthetics|mesh-ancestor
92316418|NCT03057704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316419|NCT03057704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316420|NCT03057704|Sensory System Agents|sensory system agents|mesh-ancestor
92316421|NCT03057704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316422|NCT03057704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92316423|NCT03057704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92316424|NCT03057704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92316425|NCT03057704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316426|NCT03057704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316427|NCT02874092|Ticagrelor|ticagrelor|mesh-list
92316428|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92316429|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92316430|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92316431|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92316432|NCT02874092|Purinergic Agents|purinergic agents|mesh-ancestor
92316433|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316434|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316435|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316436|NCT02876900|Asenapine|asenapine|mesh-list
92316437|NCT02876900|Maleic acid|maleic acid|mesh-list
92316438|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316439|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316440|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92316441|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92316442|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316443|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316444|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92316445|NCT02878382|Calcipotriene|calcipotriene|mesh-list
92316446|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316447|NCT03117140|Dexamethasone|dexamethasone|mesh-list
92316449|NCT03117140|Buprenorphine|buprenorphine|mesh-list
92316450|NCT03117140|Ropivacaine|ropivacaine|mesh-list
92316451|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316452|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
92316453|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
92316454|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316455|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316456|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316457|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
92316458|NCT03117140|Hormones|hormones|mesh-ancestor
92316459|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316460|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316461|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316462|NCT03117140|Anesthetics, Local|anesthetics, local|mesh-ancestor
92316463|NCT03117140|Anesthetics|anesthetics|mesh-ancestor
92316464|NCT03117140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316465|NCT03117140|Sensory System Agents|sensory system agents|mesh-ancestor
92316467|NCT03117140|Narcotics|narcotics|mesh-ancestor
92316468|NCT03117140|Analgesics|analgesics|mesh-ancestor
92316469|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92316470|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92316471|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
92316472|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92316473|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92316474|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92316475|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316476|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316477|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316478|NCT03118466|Cytarabine|cytarabine|mesh-list
92316479|NCT03118466|Etoposide|etoposide|mesh-list
92316480|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
92316481|NCT03118466|Lenalidomide|lenalidomide|mesh-list
92316482|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92316483|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316484|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92316485|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92316486|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316487|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316488|NCT03118466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92316489|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
92316490|NCT03118466|Antiviral Agents|antiviral agents|mesh-ancestor
92316491|NCT03118466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316492|NCT03118466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92316493|NCT03118466|Immunologic Factors|immunologic factors|mesh-ancestor
92316494|NCT03118466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316495|NCT03118466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92316496|NCT03118466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92316497|NCT03118466|Growth Substances|growth substances|mesh-ancestor
92316498|NCT03118466|Growth Inhibitors|growth inhibitors|mesh-ancestor
92316499|NCT03118466|Analgesics|analgesics|mesh-ancestor
92316500|NCT03118466|Sensory System Agents|sensory system agents|mesh-ancestor
92316501|NCT03118466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316502|NCT03068312|Ivacaftor|ivacaftor|mesh-list
92316503|NCT03068312|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92316504|NCT03068312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316505|NCT03068312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316506|NCT03119168|Simethicone|simethicone|mesh-list
92316507|NCT03119168|Antifoaming Agents|antifoaming agents|mesh-ancestor
92316508|NCT03119168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316509|NCT03119168|Emollients|emollients|mesh-ancestor
92316510|NCT03119168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316511|NCT03070730|Atenolol|atenolol|mesh-list
92316513|NCT03070730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92316514|NCT03070730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92316515|NCT03070730|Sympatholytics|sympatholytics|mesh-ancestor
92316516|NCT03070730|Autonomic Agents|autonomic agents|mesh-ancestor
91969209|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92316517|NCT03070730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316518|NCT03070730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316519|NCT03070730|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92316520|NCT03070730|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92316521|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92316522|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316523|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316524|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316525|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92316526|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92316528|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92316529|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
92316530|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316531|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316532|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
92316533|NCT03121820|Memantine|memantine|mesh-list
92316534|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92316535|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92316536|NCT03121820|Dopamine Agents|dopamine agents|mesh-ancestor
92316537|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316538|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316539|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316540|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92316541|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92316542|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92316543|NCT03123614|Prednisolone|prednisolone|mesh-list
92316544|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92316545|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
92316546|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92316547|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
92316548|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92316549|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
92316550|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316551|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
92316552|NCT03123614|Hormones|hormones|mesh-ancestor
92316553|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316554|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316555|NCT03123614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316556|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316557|NCT03123614|Antiemetics|antiemetics|mesh-ancestor
92316558|NCT03123614|Autonomic Agents|autonomic agents|mesh-ancestor
92316559|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316560|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316561|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92316562|NCT03123614|Protective Agents|protective agents|mesh-ancestor
92316563|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92316564|NCT03123848|Darunavir|darunavir|mesh-list
92316565|NCT03123848|Cobicistat|cobicistat|mesh-list
92316566|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92316567|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92316568|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92316569|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
92316570|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316571|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316572|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92316573|NCT03123848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92316574|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
92316575|NCT03123848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316576|NCT03123848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92316577|NCT03123848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92316578|NCT02946073|Buprenorphine|buprenorphine|mesh-list
92316579|NCT02946073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316580|NCT02946073|Narcotics|narcotics|mesh-ancestor
92316581|NCT02946073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316582|NCT02946073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316583|NCT02946073|Analgesics|analgesics|mesh-ancestor
92316584|NCT02946073|Sensory System Agents|sensory system agents|mesh-ancestor
92316585|NCT02946073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316586|NCT02946073|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92316587|NCT03071744|Fentanyl|fentanyl|mesh-list
92316588|NCT03071744|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316589|NCT03071744|Narcotics|narcotics|mesh-ancestor
92316590|NCT03071744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316591|NCT03071744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316592|NCT03071744|Analgesics|analgesics|mesh-ancestor
92316593|NCT03071744|Sensory System Agents|sensory system agents|mesh-ancestor
92316594|NCT03071744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316595|NCT03071744|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92316596|NCT03071744|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92316597|NCT03071744|Anesthetics, General|anesthetics, general|mesh-ancestor
92316598|NCT03071744|Anesthetics|anesthetics|mesh-ancestor
92316599|NCT03074630|Dapagliflozin|dapagliflozin|mesh-list
92316600|NCT03074630|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92316601|NCT03074630|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92316602|NCT03074630|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92316603|NCT03074630|Antimetabolites|antimetabolites|mesh-ancestor
92316604|NCT03074630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316605|NCT03074630|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92316606|NCT03074630|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92316607|NCT03074630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316608|NCT03074630|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92316609|NCT03074630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92316610|NCT03074630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316611|NCT05404334|Androgens|androgens|mesh-list
92316612|NCT05404334|Hormones|hormones|mesh-ancestor
92316613|NCT05404334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316614|NCT05404334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316615|NCT00374894|Succimer|succimer|mesh-list
92316616|NCT00374894|Antidotes|antidotes|mesh-ancestor
92316617|NCT00374894|Protective Agents|protective agents|mesh-ancestor
92316618|NCT00374894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316619|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
92316620|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
92316621|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316622|NCT03088267|Amphetamine|amphetamine|mesh-list
92316623|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92316624|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316625|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
92316626|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
92316627|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316628|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
92316629|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316630|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316631|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316632|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92316633|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92316634|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92316635|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92316636|NCT03088345|Vasopressins|vasopressins|mesh-list
92316637|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
92316638|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
92316639|NCT03088345|Coagulants|coagulants|mesh-ancestor
92316640|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92316641|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92316642|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
92316643|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316644|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92316645|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316647|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
92316648|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92316649|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
92316650|NCT02858713|Calcipotriene|calcipotriene|mesh-list
92316651|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92316652|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316653|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
92316654|NCT02858713|Hormones|hormones|mesh-ancestor
92316655|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316656|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316657|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92316658|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
92316659|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316660|NCT00375050|Riluzole|riluzole|mesh-list
92316661|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
92316662|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92316663|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92316664|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316665|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316666|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969375|NCT05713721|Dopamine|dopamine|mesh-list
92316667|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92316668|NCT00375050|Protective Agents|protective agents|mesh-ancestor
92316669|NCT02860507|Glycopyrrolate|glycopyrrolate|mesh-list
92316670|NCT02860507|Neostigmine|neostigmine|mesh-list
92316671|NCT02860507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92316672|NCT02860507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316673|NCT02860507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316674|NCT02860507|Cholinergic Agents|cholinergic agents|mesh-ancestor
92316675|NCT02860507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316676|NCT02860507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316677|NCT02860507|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92316678|NCT02860507|Autonomic Agents|autonomic agents|mesh-ancestor
92316679|NCT02860507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316680|NCT02860507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92316681|NCT02860507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92316682|NCT02860507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92316683|NCT03082196|Fluorides|fluorides|mesh-list
92316684|NCT03082196|Sodium Fluoride|sodium fluoride|mesh-list
92316685|NCT03082196|Fluorides, Topical|fluorides, topical|mesh-list
92316687|NCT03082196|Protective Agents|protective agents|mesh-ancestor
92316688|NCT03082196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316689|NCT02861131|Neostigmine|neostigmine|mesh-list
92316690|NCT02861131|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92316691|NCT02861131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316692|NCT02861131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316693|NCT02861131|Cholinergic Agents|cholinergic agents|mesh-ancestor
92316694|NCT02861131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316695|NCT02861131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316696|NCT02861131|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92316697|NCT02861131|Autonomic Agents|autonomic agents|mesh-ancestor
92316698|NCT02861131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316699|NCT05057858|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92316700|NCT05057858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92316701|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92316702|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316703|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316704|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
92316705|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316706|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92316707|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92316708|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92316709|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932887|NCT05172167|Antibodies|antibodies|mesh-list
92316710|NCT02953561|Azacitidine|azacitidine|mesh-list
92316711|NCT02953561|Avelumab|avelumab|mesh-list
92316712|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92316713|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92316714|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
92316715|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316716|NCT02953561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316717|NCT02953561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316718|NCT02953561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92316719|NCT02953561|Immunologic Factors|immunologic factors|mesh-ancestor
92316720|NCT02953561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316721|NCT03090620|Lorazepam|lorazepam|mesh-list
92316722|NCT03090620|Physostigmine|physostigmine|mesh-list
92316723|NCT03090620|Anticonvulsants|anticonvulsants|mesh-ancestor
92316724|NCT03090620|Antiemetics|antiemetics|mesh-ancestor
92316725|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
92316726|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316727|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316728|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316729|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92316730|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316732|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92316733|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92316734|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
92316735|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
92316736|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316737|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316738|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92316739|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316740|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
91969437|NCT02483195|Minoxidil|minoxidil|mesh-list
92316742|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
92316743|NCT02953873|Prednisone|prednisone|mesh-list
92316744|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
92316745|NCT02953873|Tacrolimus|tacrolimus|mesh-list
92316746|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316747|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
92316748|NCT02953873|Hormones|hormones|mesh-ancestor
92316749|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316750|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316751|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316752|NCT02953873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316753|NCT02953873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92316754|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
92316755|NCT02953873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92316756|NCT02953873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316757|NCT02953873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316758|NCT02953873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92316759|NCT02953873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92316760|NCT02953873|Antitubercular Agents|antitubercular agents|mesh-ancestor
92316761|NCT02953873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92316762|NCT02953873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316763|NCT02953873|Antiemetics|antiemetics|mesh-ancestor
92316764|NCT02953873|Autonomic Agents|autonomic agents|mesh-ancestor
92316765|NCT02953873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316766|NCT02953873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316767|NCT02953873|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92316768|NCT02953873|Protective Agents|protective agents|mesh-ancestor
92316769|NCT03091478|Pembrolizumab|pembrolizumab|mesh-list
92316770|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92316771|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316772|NCT03091478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92316773|NCT03091478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316774|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
92316775|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92316776|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
92316777|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316778|NCT02867605|Viscosupplements|viscosupplements|mesh-ancestor
92316779|NCT02867605|Protective Agents|protective agents|mesh-ancestor
92316780|NCT00375596|Ketotifen|ketotifen|mesh-list
92316781|NCT00375596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92316782|NCT00375596|Antipruritics|antipruritics|mesh-ancestor
92316783|NCT00375596|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316784|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92316785|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
92316786|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
92316787|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316788|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316789|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316790|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92316791|NCT03093272|Prednisone|prednisone|mesh-list
92316792|NCT03093272|Docetaxel|docetaxel|mesh-list
92316793|NCT03093272|Leuprolide|leuprolide|mesh-list
92316794|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316795|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
92316796|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
92316797|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
92316798|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316799|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316800|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
92316801|NCT03093272|Hormones|hormones|mesh-ancestor
92316802|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316803|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316804|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316805|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92316806|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
92316807|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92316809|NCT03100123|Heparin|heparin|mesh-list
92316810|NCT03100123|Enoxaparin|enoxaparin|mesh-list
92316811|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92316812|NCT03100123|Tinzaparin|tinzaparin|mesh-list
92316813|NCT03100123|Dalteparin|dalteparin|mesh-list
92316814|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92316815|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92316816|NCT03100123|Analgesics|analgesics|mesh-ancestor
92316817|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
92316818|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316819|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316820|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316821|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92316822|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92316823|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92316824|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316825|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92316826|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92316827|NCT03100123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316828|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
92316829|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
92316830|NCT02957305|Misoprostol|misoprostol|mesh-list
92316831|NCT02957305|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92316832|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
92316833|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92316834|NCT02957305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316835|NCT02957305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92316836|NCT02957305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316837|NCT02957305|Oxytocics|oxytocics|mesh-ancestor
92316838|NCT04611152|Aflibercept|aflibercept|mesh-list
92316839|NCT04611152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92316840|NCT04611152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92316841|NCT04611152|Growth Substances|growth substances|mesh-ancestor
92316842|NCT04611152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316843|NCT04611152|Growth Inhibitors|growth inhibitors|mesh-ancestor
92316844|NCT04611152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316845|NCT03104725|Acetylcysteine|acetylcysteine|mesh-list
92316846|NCT03104725|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92316847|NCT03104725|Antiviral Agents|antiviral agents|mesh-ancestor
92316848|NCT03104725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316849|NCT03104725|Expectorants|expectorants|mesh-ancestor
92316850|NCT03104725|Respiratory System Agents|respiratory system agents|mesh-ancestor
92316851|NCT03104725|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92316852|NCT03104725|Antioxidants|antioxidants|mesh-ancestor
92316853|NCT03104725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316854|NCT03104725|Protective Agents|protective agents|mesh-ancestor
92316855|NCT03104725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316856|NCT03104725|Antidotes|antidotes|mesh-ancestor
92316857|NCT03154658|Ropivacaine|ropivacaine|mesh-list
92316858|NCT03154658|Anesthetics, Local|anesthetics, local|mesh-ancestor
92316859|NCT03154658|Anesthetics|anesthetics|mesh-ancestor
92316860|NCT03154658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316861|NCT03154658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316862|NCT03154658|Sensory System Agents|sensory system agents|mesh-ancestor
92316863|NCT03154658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316864|NCT03098420|Dexamethasone|dexamethasone|mesh-list
92316865|NCT03098420|Dexamethasone acetate|dexamethasone acetate|mesh-list
92316866|NCT03098420|Morphine|morphine|mesh-list
92316867|NCT03098420|Bupivacaine|bupivacaine|mesh-list
92316868|NCT03098420|Ropivacaine|ropivacaine|mesh-list
92316869|NCT03098420|BB 1101|bb 1101|mesh-list
92316870|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92316871|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
92316872|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
92316873|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316874|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316875|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92316876|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
92316878|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316879|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92316880|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316881|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
92316882|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316883|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316885|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
92316886|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316887|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
92316888|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92316889|NCT03098420|Narcotics|narcotics|mesh-ancestor
92316890|NCT03098420|Analgesics|analgesics|mesh-ancestor
92316891|NCT02878057|Apatinib|apatinib|mesh-list
92316892|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316893|NCT02878057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92316894|NCT02878057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316895|NCT02878057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316896|NCT00422617|Alefacept|alefacept|mesh-list
92316897|NCT00422617|Dermatologic Agents|dermatologic agents|mesh-ancestor
92316898|NCT00422617|Immunologic Factors|immunologic factors|mesh-ancestor
92316899|NCT00422617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316900|NCT03104738|Insulin|insulin|mesh-list
92316901|NCT03104738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92316902|NCT03104738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316903|NCT03163472|Anesthetics|anesthetics|mesh-list
92316904|NCT03163472|Anesthetics, Local|anesthetics, local|mesh-list
92316905|NCT03163472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316906|NCT03163472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316907|NCT03163472|Sensory System Agents|sensory system agents|mesh-ancestor
92316908|NCT03163472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316909|NCT04468568|Terbutaline|terbutaline|mesh-list
92316910|NCT04468568|Atosiban|atosiban|mesh-list
92316911|NCT04468568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92316912|NCT04468568|Autonomic Agents|autonomic agents|mesh-ancestor
92316913|NCT04468568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316914|NCT04468568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316915|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92316916|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
92316917|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
92316918|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
92316919|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92316920|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92316921|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92316922|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92316923|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
92316924|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316925|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316926|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
92316927|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92316928|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
92316929|NCT03168308|Neostigmine|neostigmine|mesh-list
92316930|NCT03168308|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92316931|NCT03168308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316932|NCT03168308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316933|NCT03168308|Cholinergic Agents|cholinergic agents|mesh-ancestor
92316934|NCT03168308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316935|NCT03168308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316936|NCT03168308|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92316937|NCT03168308|Autonomic Agents|autonomic agents|mesh-ancestor
92316938|NCT03168308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316939|NCT03168308|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92316940|NCT03168308|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92316941|NCT03168308|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92316942|NCT03109015|Sunitinib|sunitinib|mesh-list
92316943|NCT03109015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316944|NCT03109015|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92316945|NCT03109015|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92316946|NCT03109015|Growth Substances|growth substances|mesh-ancestor
92316947|NCT03109015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316948|NCT03109015|Growth Inhibitors|growth inhibitors|mesh-ancestor
92316949|NCT03109015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92316950|NCT03109015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92316951|NCT03109015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316952|NCT03115177|Doxycycline|doxycycline|mesh-list
92316953|NCT03115177|Cefazolin|cefazolin|mesh-list
92316954|NCT03115177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92316955|NCT03115177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92316956|NCT03115177|Antimalarials|antimalarials|mesh-ancestor
92316957|NCT03115177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92316958|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92316959|NCT03174158|Nicotine|nicotine|mesh-list
92316960|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92316961|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
92316962|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92316963|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316964|NCT03174158|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92316965|NCT03174158|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92316966|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
92316967|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316968|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316969|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
92316970|NCT03115801|Nivolumab|nivolumab|mesh-list
92316971|NCT03115801|Atezolizumab|atezolizumab|mesh-list
92316973|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
92316974|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92316975|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92316976|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92316977|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316978|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316979|NCT00422708|Anesthetics|anesthetics|mesh-list
92316980|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92316981|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316982|NCT03117517|Metformin|metformin|mesh-list
92316983|NCT03117517|Pioglitazone|pioglitazone|mesh-list
92316984|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92316985|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316986|NCT00375284|Pramipexole|pramipexole|mesh-list
92316987|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
92316988|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92316989|NCT00375284|Protective Agents|protective agents|mesh-ancestor
92316990|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92316991|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92316992|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92316993|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
92316994|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
92316995|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92316996|NCT02966275|Glucagon|glucagon|mesh-list
92316997|NCT02966275|Pancrelipase|pancrelipase|mesh-list
92316998|NCT02966275|Pancreatin|pancreatin|mesh-list
92316999|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92317000|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317001|NCT02966275|Hormones|hormones|mesh-ancestor
92317002|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317003|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317004|NCT02966275|Incretins|incretins|mesh-ancestor
92317005|NCT03795350|Beclomethasone|beclomethasone|mesh-list
92317006|NCT03795350|Glycopyrrolate|glycopyrrolate|mesh-list
92317007|NCT03795350|Bromides|bromides|mesh-list
92317008|NCT03795350|Formoterol Fumarate|formoterol fumarate|mesh-list
92317009|NCT03795350|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92317010|NCT03795350|Autonomic Agents|autonomic agents|mesh-ancestor
92317011|NCT03795350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317012|NCT03795350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317013|NCT03795350|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92317014|NCT03795350|Respiratory System Agents|respiratory system agents|mesh-ancestor
92317015|NCT03795350|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92317016|NCT03795350|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92317017|NCT03795350|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92317018|NCT03795350|Adrenergic Agents|adrenergic agents|mesh-ancestor
92317019|NCT03795350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317020|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317021|NCT03795350|Anticonvulsants|anticonvulsants|mesh-ancestor
92317022|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92317023|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92317024|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92317025|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317026|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317027|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
92317028|NCT03795350|Hormones|hormones|mesh-ancestor
91936597|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
92317029|NCT03795350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317030|NCT03118843|Velpatasvir|velpatasvir|mesh-list
92317031|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
92317032|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317033|NCT02222922|Fluconazole|fluconazole|mesh-list
92317035|NCT02222922|Cofetuzumab pelidotin|cofetuzumab pelidotin|mesh-list
92317036|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317037|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317038|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
92317039|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317040|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92317041|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92317042|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317043|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317044|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92317045|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
91969738|NCT02447809|Analgesics|analgesics|mesh-ancestor
92317046|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317047|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317048|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92317049|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92317050|NCT02222922|Immunoconjugates|immunoconjugates|mesh-ancestor
92317051|NCT02222922|Immunologic Factors|immunologic factors|mesh-ancestor
92317052|NCT03503942|Metformin|metformin|mesh-list
92317053|NCT03503942|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92317054|NCT03503942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317055|NCT03122587|Dihydrotachysterol|dihydrotachysterol|mesh-list
92317056|NCT03122587|Vitamins|vitamins|mesh-ancestor
92317057|NCT03122587|Micronutrients|micronutrients|mesh-ancestor
92317058|NCT03122587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317059|NCT03122587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92317060|NCT04736966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92317061|NCT04736966|Immunologic Factors|immunologic factors|mesh-ancestor
92317062|NCT04736966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317063|NCT02161146|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92317064|NCT02161146|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92317065|NCT02161146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92317066|NCT02161146|Analgesics|analgesics|mesh-ancestor
92317067|NCT02161146|Sensory System Agents|sensory system agents|mesh-ancestor
92317068|NCT02161146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317069|NCT02161146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317070|NCT02161146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317071|NCT02161146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317072|NCT02161146|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92317073|NCT02161146|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92317074|NCT02161146|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92317075|NCT02161146|Histamine Antagonists|histamine antagonists|mesh-ancestor
92317076|NCT02161146|Histamine Agents|histamine agents|mesh-ancestor
92317077|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317078|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317079|NCT03447782|Naltrexone|naltrexone|mesh-list
92317080|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92317081|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92348304|NCT01585584|Protease Inhibitors|protease inhibitors|mesh-list
92317082|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317083|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
92317084|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317086|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317087|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317088|NCT03123055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317089|NCT03123055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317090|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
92317091|NCT02969317|Olodaterol|olodaterol|mesh-list
92317092|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92317093|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
92317094|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317095|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317096|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92317097|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
92317098|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
92317099|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92317100|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317101|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317102|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317103|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
92317104|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
92317105|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
92317106|NCT05347082|Vitamin D|vitamin d|mesh-list
92317107|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92317108|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317109|NCT05347082|Vitamins|vitamins|mesh-ancestor
92317110|NCT05347082|Micronutrients|micronutrients|mesh-ancestor
92317111|NCT05347082|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92317112|NCT04736420|Warfarin|warfarin|mesh-list
92317113|NCT04736420|Rivaroxaban|rivaroxaban|mesh-list
92317114|NCT04736420|Anticoagulants|anticoagulants|mesh-ancestor
92317115|NCT04736420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92317116|NCT04736420|Antithrombins|antithrombins|mesh-ancestor
92317117|NCT04736420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92317118|NCT04736420|Protease Inhibitors|protease inhibitors|mesh-ancestor
92317119|NCT04736420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317120|NCT04736420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317122|NCT03087578|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92317123|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92317124|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92317125|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
92317126|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317127|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317128|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317129|NCT03087578|Urological Agents|urological agents|mesh-ancestor
92317130|NCT02807558|Azacitidine|azacitidine|mesh-list
92317131|NCT02807558|Daratumumab|daratumumab|mesh-list
92317132|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92317133|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
92317134|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317135|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317136|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317137|NCT05324384|Sirolimus|sirolimus|mesh-list
92317138|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92317139|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317140|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92317141|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317142|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
92317143|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92317144|NCT05324384|Immunologic Factors|immunologic factors|mesh-ancestor
92317145|NCT05324384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317146|NCT02975557|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92317147|NCT02975557|Lubricant Eye Drops|lubricant eye drops|mesh-list
92317148|NCT02975557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92317149|NCT02975557|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92317150|NCT02975557|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92317151|NCT02975557|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92317152|NCT02975557|Adrenergic Agents|adrenergic agents|mesh-ancestor
92317153|NCT02975557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317154|NCT02975557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317155|NCT02975557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317156|NCT02975557|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92317157|NCT02975557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92317158|NCT04736810|Gemcitabine|gemcitabine|mesh-list
92317159|NCT04736810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317160|NCT04736810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92317161|NCT04736810|Antimetabolites|antimetabolites|mesh-ancestor
92317162|NCT04736810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317164|NCT03132571|Bupropion|bupropion|mesh-list
92317165|NCT03132571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92317166|NCT03132571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92317168|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
92317169|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317170|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92317171|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92317172|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317173|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92317174|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92317175|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317176|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317177|NCT03132571|Dopamine Agents|dopamine agents|mesh-ancestor
92317178|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317179|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92317180|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92317181|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317182|NCT05267054|Rituximab|rituximab|mesh-list
92317183|NCT05267054|Tislelizumab|tislelizumab|mesh-list
92317184|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317185|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317186|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
92317187|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317188|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317189|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
92317190|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317191|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317192|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
92317193|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
92317194|NCT02002130|Butyric Acid|butyric acid|mesh-list
92317195|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92317196|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
92317197|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317198|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
92317199|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317200|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317201|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
92317202|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
92317203|NCT01306994|Adenosine|adenosine|mesh-list
92317204|NCT01306994|Analgesics|analgesics|mesh-ancestor
92317205|NCT01306994|Sensory System Agents|sensory system agents|mesh-ancestor
92317206|NCT01306994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317207|NCT01306994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317208|NCT01306994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92317209|NCT01306994|Vasodilator Agents|vasodilator agents|mesh-ancestor
92317210|NCT01306994|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92317211|NCT01306994|Purinergic Agonists|purinergic agonists|mesh-ancestor
92317212|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
92317213|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317214|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317215|NCT02979301|Tamoxifen|tamoxifen|mesh-list
92317216|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92317217|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
92317218|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317219|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317220|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92317221|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317222|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92317223|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92317224|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92317225|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
92317226|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92317227|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92317228|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317229|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
92317230|NCT00375440|Coagulants|coagulants|mesh-ancestor
92317231|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
92317232|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
92317233|NCT05113004|Leflunomide|leflunomide|mesh-list
92317234|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92317235|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317236|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92317237|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
92317238|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92317239|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317240|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317241|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317242|NCT05113004|Antimalarials|antimalarials|mesh-ancestor
92317243|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92317244|NCT05113004|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92317245|NCT05113004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317246|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92317247|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
92317248|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317249|NCT02983981|Desoximetasone|desoximetasone|mesh-list
92317250|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317251|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
92317252|NCT02983981|Hormones|hormones|mesh-ancestor
92317253|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317254|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317255|NCT00375583|Albendazole|albendazole|mesh-list
92317256|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
92317257|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92317258|NCT00375583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317259|NCT00375583|Anticestodal Agents|anticestodal agents|mesh-ancestor
92317260|NCT00375583|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92317261|NCT00375583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92317262|NCT00375583|Tubulin Modulators|tubulin modulators|mesh-ancestor
92317263|NCT00375583|Antimitotic Agents|antimitotic agents|mesh-ancestor
92317264|NCT00375583|Mitosis Modulators|mitosis modulators|mesh-ancestor
92317265|NCT00375583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317266|NCT00375583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317267|NCT03143569|Heparin|heparin|mesh-list
92317268|NCT03143569|Calcium heparin|calcium heparin|mesh-list
92317269|NCT03143569|Anticoagulants|anticoagulants|mesh-ancestor
92317270|NCT03143569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92317271|NCT03143569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92317272|NCT03143569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317273|NCT03149887|Bupivacaine|bupivacaine|mesh-list
92317274|NCT03149887|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317275|NCT03149887|Anesthetics|anesthetics|mesh-ancestor
92317276|NCT03149887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317277|NCT03149887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317278|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
92317279|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317280|NCT02988349|Listerine|listerine|mesh-list
92317281|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
92317282|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
92317283|NCT02988349|Protective Agents|protective agents|mesh-ancestor
92317284|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317285|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92317286|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317287|NCT02159352|Ritonavir|ritonavir|mesh-list
92317288|NCT02159352|Lopinavir|lopinavir|mesh-list
92317289|NCT02159352|Darunavir|darunavir|mesh-list
92317290|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92317291|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92317292|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
92317293|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317294|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317295|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92317296|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92317297|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
92317298|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317299|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92317300|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92317301|NCT02187744|Carboplatin|carboplatin|mesh-list
92317302|NCT02187744|Docetaxel|docetaxel|mesh-list
92317303|NCT02187744|Trastuzumab|trastuzumab|mesh-list
92317304|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317305|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
92317306|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
92317307|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
92317308|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317309|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317310|NCT03154333|Diacerein|diacerein|mesh-list
92317311|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317312|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
92317313|NCT04393441|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92317314|NCT04393441|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92317315|NCT02995915|Bupropion|bupropion|mesh-list
92317316|NCT02995915|Nicotine|nicotine|mesh-list
92317317|NCT02995915|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92317318|NCT02995915|Autonomic Agents|autonomic agents|mesh-ancestor
92317319|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317320|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317321|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92317322|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92317323|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317324|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317325|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317326|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92317327|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
92317328|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317329|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92317330|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92317331|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317332|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
92317333|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92317334|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92317335|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317336|NCT03163303|Nicotine|nicotine|mesh-list
92317337|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92317338|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
92317339|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317340|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317341|NCT03163303|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92317342|NCT03163303|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92317343|NCT03163303|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317344|NCT03163303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317345|NCT03163303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317346|NCT03000283|Conivaptan|conivaptan|mesh-list
92317347|NCT03000283|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92317348|NCT03000283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317349|NCT03000283|Natriuretic Agents|natriuretic agents|mesh-ancestor
92317350|NCT03000283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317351|NCT03168295|Dapagliflozin|dapagliflozin|mesh-list
92317352|NCT03168295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92317353|NCT03168295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317354|NCT03168295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92317355|NCT03168295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317356|NCT03168841|Efinaconazole|efinaconazole|mesh-list
92317357|NCT03168841|Antifungal Agents|antifungal agents|mesh-ancestor
92317358|NCT03168841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317359|NCT03865615|Oxytocin|oxytocin|mesh-list
92317360|NCT03865615|Oxytocics|oxytocics|mesh-ancestor
92317362|NCT03865615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317363|NCT03185546|Nicotine|nicotine|mesh-list
92317364|NCT03185546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92317365|NCT03185546|Autonomic Agents|autonomic agents|mesh-ancestor
92317366|NCT03185546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317367|NCT03185546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317368|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92317369|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92317370|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317371|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936629|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92317372|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317373|NCT02186652|Pantoprazole|pantoprazole|mesh-list
92317374|NCT02186652|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92317375|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317376|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92317377|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317378|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317379|NCT03606889|Bupivacaine|bupivacaine|mesh-list
92317380|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317381|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
92317382|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317383|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317384|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
92317385|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317386|NCT05363917|Folic Acid|folic acid|mesh-list
92317387|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
92317388|NCT05363917|Hematinics|hematinics|mesh-ancestor
92317389|NCT05363917|Vitamins|vitamins|mesh-ancestor
92317390|NCT05363917|Micronutrients|micronutrients|mesh-ancestor
92317391|NCT05363917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317392|NCT03187730|Nicotine|nicotine|mesh-list
92317393|NCT03187730|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92317394|NCT03187730|Autonomic Agents|autonomic agents|mesh-ancestor
92317395|NCT03187730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317396|NCT03187730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317397|NCT03187730|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92317398|NCT03187730|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92317399|NCT03187730|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317400|NCT03187730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317401|NCT03187730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317402|NCT03261193|Bupivacaine|bupivacaine|mesh-list
92317403|NCT03261193|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317404|NCT03261193|Anesthetics|anesthetics|mesh-ancestor
92317405|NCT03261193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317406|NCT03261193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317407|NCT03261193|Sensory System Agents|sensory system agents|mesh-ancestor
92317408|NCT03261193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317409|NCT00375661|Interferons|interferons|mesh-list
92317410|NCT00375661|Ribavirin|ribavirin|mesh-list
92317411|NCT00375661|Interferon-alpha|interferon-alpha|mesh-list
92317412|NCT00375661|Interferon alpha-2|interferon alpha-2|mesh-list
92317413|NCT00375661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317414|NCT00375661|Antiviral Agents|antiviral agents|mesh-ancestor
92317415|NCT00375661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317416|NCT00375661|Antimetabolites|antimetabolites|mesh-ancestor
92317417|NCT00375661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317418|NCT00375661|Immunologic Factors|immunologic factors|mesh-ancestor
91970114|NCT03192943|Nivolumab|nivolumab|mesh-list
92317419|NCT00375661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317420|NCT04736186|Loperamide|loperamide|mesh-list
92317421|NCT04736186|Antidiarrheals|antidiarrheals|mesh-list
92317422|NCT04736186|Bentonite|bentonite|mesh-list
92317423|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317424|NCT04736186|Antidotes|antidotes|mesh-ancestor
92317425|NCT04736186|Protective Agents|protective agents|mesh-ancestor
92317426|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317427|NCT04941170|Bupivacaine|bupivacaine|mesh-list
92317428|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317429|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
92348334|NCT01585272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317430|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317431|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317432|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
92317433|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317435|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92317436|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92317437|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317438|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317439|NCT05357911|Protective Agents|protective agents|mesh-ancestor
92317440|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317441|NCT03374839|Nivolumab|nivolumab|mesh-list
92317442|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317443|NCT03374839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317444|NCT03374839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91936631|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317445|NCT03374839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317446|NCT03347929|Naproxen|naproxen|mesh-list
92317447|NCT03347929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92317448|NCT03347929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92317449|NCT03347929|Analgesics|analgesics|mesh-ancestor
92317450|NCT03347929|Sensory System Agents|sensory system agents|mesh-ancestor
92317451|NCT03347929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317452|NCT03347929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317453|NCT03347929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317454|NCT03347929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317455|NCT03347929|Gout Suppressants|gout suppressants|mesh-ancestor
92317456|NCT03347929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92317457|NCT03347929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317458|NCT03347929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317459|NCT02221674|Tapentadol|tapentadol|mesh-list
92317460|NCT02221674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92317461|NCT02221674|Narcotics|narcotics|mesh-ancestor
92317462|NCT02221674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317463|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317464|NCT02221674|Analgesics|analgesics|mesh-ancestor
92317465|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
92317466|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317467|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92317468|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92317469|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317470|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317471|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
92317472|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317473|NCT04736719|Warfarin|warfarin|mesh-list
92317474|NCT04736719|Apixaban|apixaban|mesh-list
92317475|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
92317476|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92317477|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
92317478|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92317479|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92317480|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317481|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317482|NCT02221284|Alogliptin|alogliptin|mesh-list
92317483|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92317484|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317485|NCT02221284|Incretins|incretins|mesh-ancestor
92317486|NCT02221284|Hormones|hormones|mesh-ancestor
92317487|NCT02221284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317488|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92317489|NCT02221284|Protease Inhibitors|protease inhibitors|mesh-ancestor
92317490|NCT02221284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317491|NCT02221284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317492|NCT04736108|Prednisolone|prednisolone|mesh-list
92317493|NCT04736108|Goserelin|goserelin|mesh-list
92317494|NCT04736108|Abiraterone Acetate|abiraterone acetate|mesh-list
92317495|NCT04736108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317496|NCT04736108|Glucocorticoids|glucocorticoids|mesh-ancestor
92317498|NCT04736108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317499|NCT04736108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317500|NCT04736108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92317501|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317502|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92317503|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317504|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317505|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
92317506|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92317507|NCT02971033|Ezetimibe|ezetimibe|mesh-list
92317508|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92317509|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92317510|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
92317511|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317512|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92317513|NCT05406674|Cisplatin|cisplatin|mesh-list
92317514|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317515|NCT05341375|Anesthetics|anesthetics|mesh-list
92317516|NCT05341375|Esketamine|esketamine|mesh-list
92317517|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317518|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317519|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
92317520|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317521|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
92317522|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317523|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317524|NCT03196232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317525|NCT03196232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317526|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
92317527|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
92317528|NCT04356716|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92317529|NCT04356716|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92317530|NCT04356716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317531|NCT04356716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317532|NCT04356716|Urological Agents|urological agents|mesh-ancestor
92317533|NCT03200587|Avelumab|avelumab|mesh-list
92317534|NCT03200587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317535|NCT03200587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317536|NCT03198884|Dolutegravir|dolutegravir|mesh-list
92317537|NCT03198884|Darunavir|darunavir|mesh-list
92317538|NCT03198884|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92317539|NCT03198884|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92317540|NCT03198884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317541|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317542|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92317543|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92317544|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
92317545|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317546|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92317547|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92317548|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
92317549|NCT01801189|Pregabalin|pregabalin|mesh-list
92317550|NCT01801189|Analgesics|analgesics|mesh-ancestor
92317551|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
92317552|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317553|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317554|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
92317555|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92317556|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317557|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317558|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92317559|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92317560|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92317561|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317562|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317563|NCT04275362|Cimetidine|cimetidine|mesh-list
92317564|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92317565|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317566|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92317567|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
92317568|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
92317569|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317570|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317571|NCT04275362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317572|NCT04275362|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92317573|NCT04275362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92317574|NCT04275362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317575|NCT05178043|Nivolumab|nivolumab|mesh-list
92317576|NCT05178043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317577|NCT05178043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317578|NCT05178043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317579|NCT05178043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317580|NCT00716755|Olanzapine|olanzapine|mesh-list
92317581|NCT00716755|Risperidone|risperidone|mesh-list
92317582|NCT00716755|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92317583|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
92317584|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317585|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317586|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317587|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92317588|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92317589|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317590|NCT00716755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317591|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92317592|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
92317593|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
92317594|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
92317595|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317596|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317597|NCT00716755|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92317598|NCT00716755|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92317599|NCT00716755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317600|NCT05406050|Eldecalcitol|eldecalcitol|mesh-list
92317601|NCT05406050|Vitamin D|vitamin d|mesh-list
92317602|NCT05406050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92317603|NCT05406050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317604|NCT05406050|Vitamins|vitamins|mesh-ancestor
92317605|NCT05406050|Micronutrients|micronutrients|mesh-ancestor
92317606|NCT03202550|Oxycodone|oxycodone|mesh-list
92317607|NCT03202550|Lorazepam|lorazepam|mesh-list
92317608|NCT03202550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92317609|NCT03202550|Narcotics|narcotics|mesh-ancestor
92317610|NCT03202550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317611|NCT03202550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317612|NCT03202550|Analgesics|analgesics|mesh-ancestor
92317613|NCT03202550|Sensory System Agents|sensory system agents|mesh-ancestor
92317614|NCT03202550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317615|NCT03202550|Anticonvulsants|anticonvulsants|mesh-ancestor
92317616|NCT03202550|Antiemetics|antiemetics|mesh-ancestor
92317617|NCT03202550|Autonomic Agents|autonomic agents|mesh-ancestor
92317618|NCT03202550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317619|NCT03202550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92317620|NCT03202550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92317621|NCT03202550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92317622|NCT03202550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317623|NCT03202550|GABA Modulators|gaba modulators|mesh-ancestor
92317624|NCT03202550|GABA Agents|gaba agents|mesh-ancestor
92317625|NCT03202550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317626|NCT03202550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317627|NCT04088786|Irinotecan|irinotecan|mesh-list
92317628|NCT04088786|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92317629|NCT04088786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92317630|NCT04088786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317631|NCT04088786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317632|NCT04088786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317633|NCT00392821|Everolimus|everolimus|mesh-list
92317634|NCT00392821|Sorafenib|sorafenib|mesh-list
92317635|NCT00392821|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92317636|NCT00392821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92317637|NCT00392821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317638|NCT00392821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317640|NCT00392821|Immunologic Factors|immunologic factors|mesh-ancestor
92317641|NCT00392821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970331|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92317642|NCT00392821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317643|NCT04708171|Anesthetics|anesthetics|mesh-list
92317644|NCT04708171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317645|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317646|NCT03290378|Tramadol|tramadol|mesh-list
92317647|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92317648|NCT03290378|Narcotics|narcotics|mesh-ancestor
92317649|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317650|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317651|NCT03290378|Analgesics|analgesics|mesh-ancestor
92317652|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
92317653|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317654|NCT02076217|Copper|copper|mesh-list
92317655|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92317656|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
92317657|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
92317658|NCT02076217|Etonogestrel|etonogestrel|mesh-list
92317659|NCT02076217|Desogestrel|desogestrel|mesh-list
92317660|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92317661|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317662|NCT02076217|Trace Elements|trace elements|mesh-ancestor
92317663|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
92317664|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92317665|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92317666|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92317667|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92317668|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92317669|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92317670|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92317671|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317672|NCT02076217|Progestins|progestins|mesh-ancestor
92317673|NCT02076217|Hormones|hormones|mesh-ancestor
92317674|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317675|NCT03291080|Tretinoin|tretinoin|mesh-list
92317676|NCT03291080|Isotretinoin|isotretinoin|mesh-list
92317677|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317678|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
92317679|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
92317680|NCT04874545|Propofol|propofol|mesh-list
92317681|NCT04874545|Sevoflurane|sevoflurane|mesh-list
92317682|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92317683|NCT04874545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317684|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317685|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92317686|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
92317687|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
92317688|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92317689|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92317690|NCT03181009|Omalizumab|omalizumab|mesh-list
92317691|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92317692|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92317693|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
92317694|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92317695|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92317696|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92317697|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317698|NCT03296072|Listerine|listerine|mesh-list
92317699|NCT03296072|Fluorides|fluorides|mesh-list
92317700|NCT03296072|Sodium Fluoride|sodium fluoride|mesh-list
92317701|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
92317702|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
92317703|NCT03296072|Protective Agents|protective agents|mesh-ancestor
92317704|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317705|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92317706|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317707|NCT03185065|Amantadine|amantadine|mesh-list
92317708|NCT03185065|Methylphenidate|methylphenidate|mesh-list
92317709|NCT03185065|Modafinil|modafinil|mesh-list
92317710|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92317711|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317712|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92317713|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92317714|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317715|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317716|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
92317717|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317718|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92317719|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92317720|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92317721|NCT03185065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92317722|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92317723|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
92317724|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317725|NCT03185065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92317726|NCT03185065|Analgesics|analgesics|mesh-ancestor
92317727|NCT03185065|Sensory System Agents|sensory system agents|mesh-ancestor
92317728|NCT03185065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317729|NCT02220894|Paclitaxel|paclitaxel|mesh-list
92317730|NCT02220894|Carboplatin|carboplatin|mesh-list
92317731|NCT02220894|Pembrolizumab|pembrolizumab|mesh-list
92317732|NCT02220894|Pemetrexed|pemetrexed|mesh-list
92317733|NCT02220894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92317734|NCT02220894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317735|NCT02220894|Tubulin Modulators|tubulin modulators|mesh-ancestor
92317736|NCT02220894|Antimitotic Agents|antimitotic agents|mesh-ancestor
92317737|NCT02220894|Mitosis Modulators|mitosis modulators|mesh-ancestor
92317738|NCT02220894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317739|NCT02220894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317740|NCT02220894|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317741|NCT02220894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317742|NCT02220894|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92317743|NCT02220894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92317744|NCT02159040|Azacitidine|azacitidine|mesh-list
92317745|NCT02159040|Deferasirox|deferasirox|mesh-list
92317746|NCT02159040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92317747|NCT02159040|Antimetabolites|antimetabolites|mesh-ancestor
92317748|NCT02159040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317749|NCT02159040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317750|NCT02159040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317751|NCT02159040|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92317752|NCT02159040|Chelating Agents|chelating agents|mesh-ancestor
92317753|NCT02159040|Sequestering Agents|sequestering agents|mesh-ancestor
92317754|NCT03189589|Nemiralisib|nemiralisib|mesh-list
92317755|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92317756|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317757|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317758|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92317759|NCT03216902|Latanoprost|latanoprost|mesh-list
92317760|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92317761|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
92317762|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317763|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317764|NCT03190213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317765|NCT03190213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317766|NCT01632150|Thalidomide|thalidomide|mesh-list
92317767|NCT01632150|Dexamethasone|dexamethasone|mesh-list
92317768|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
92317769|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
92317770|NCT01632150|Elotuzumab|elotuzumab|mesh-list
92317771|NCT01632150|BB 1101|bb 1101|mesh-list
92317772|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92317773|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
92317774|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317775|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317776|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92317777|NCT01632150|Alkylating Agents|alkylating agents|mesh-ancestor
92317778|NCT01632150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317779|NCT01632150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317780|NCT01632150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92317781|NCT01632150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317782|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
92317783|NCT01632150|Autonomic Agents|autonomic agents|mesh-ancestor
92317784|NCT01632150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317785|NCT01632150|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317786|NCT01632150|Glucocorticoids|glucocorticoids|mesh-ancestor
92317787|NCT01632150|Hormones|hormones|mesh-ancestor
92317788|NCT01632150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317789|NCT01632150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92317790|NCT01632150|Protease Inhibitors|protease inhibitors|mesh-ancestor
92317791|NCT01632150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317792|NCT01632150|Leprostatic Agents|leprostatic agents|mesh-ancestor
92317793|NCT01632150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92317794|NCT01632150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92317795|NCT01632150|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92317796|NCT01632150|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92317797|NCT01632150|Growth Substances|growth substances|mesh-ancestor
92317798|NCT01632150|Growth Inhibitors|growth inhibitors|mesh-ancestor
92317799|NCT02185014|Adalimumab|adalimumab|mesh-list
92317800|NCT02185014|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92317801|NCT02185014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317802|NCT02185014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317803|NCT03297944|Zolpidem|zolpidem|mesh-list
92317804|NCT03297944|Alprazolam|alprazolam|mesh-list
92317805|NCT03297944|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92317806|NCT03297944|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92317807|NCT03297944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317808|NCT03297944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317809|NCT03297944|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92317810|NCT03297944|GABA Agonists|gaba agonists|mesh-ancestor
92317811|NCT03297944|GABA Agents|gaba agents|mesh-ancestor
92317812|NCT03297944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317813|NCT03297944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317814|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92317815|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92317816|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317817|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
92317818|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
92317819|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317820|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317821|NCT04333004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317822|NCT04333004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317823|NCT03219866|Budesonide|budesonide|mesh-list
92317824|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
92317825|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92317826|NCT03219866|Ipratropium|ipratropium|mesh-list
92317827|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317828|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92317829|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
92317830|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317831|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317832|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92317833|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92317834|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
92317835|NCT03219866|Hormones|hormones|mesh-ancestor
92317836|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92317837|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
92317838|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92317839|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
92317840|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348369|NCT01559844|Antiviral Agents|antiviral agents|mesh-ancestor
92317841|NCT03219866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317842|NCT03219866|Sympathomimetics|sympathomimetics|mesh-ancestor
92317843|NCT03300674|Lidocaine|lidocaine|mesh-list
92317844|NCT03300674|Hydromorphone|hydromorphone|mesh-list
92317845|NCT03300674|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317846|NCT03300674|Anesthetics|anesthetics|mesh-ancestor
92317847|NCT03300674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317848|NCT03300674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317849|NCT03300674|Sensory System Agents|sensory system agents|mesh-ancestor
92317850|NCT03300674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317851|NCT03300674|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92317852|NCT03300674|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92317853|NCT03300674|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92317854|NCT03300674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317855|NCT03300674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317856|NCT03300674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92317857|NCT03300674|Narcotics|narcotics|mesh-ancestor
92317858|NCT03300674|Analgesics|analgesics|mesh-ancestor
92317859|NCT02158806|Aspirin|aspirin|mesh-list
92317860|NCT02158806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92317861|NCT02158806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92317862|NCT02158806|Analgesics|analgesics|mesh-ancestor
92317863|NCT02158806|Sensory System Agents|sensory system agents|mesh-ancestor
92317864|NCT02158806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317865|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317866|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92317867|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92317868|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92317869|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92317870|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317871|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92317872|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91970555|NCT03313661|Gliclazide|gliclazide|mesh-list
92317873|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92317874|NCT02158806|Antipyretics|antipyretics|mesh-ancestor
92317875|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
92317876|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92317877|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92317878|NCT03197389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92317879|NCT03197389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317880|NCT03198871|Acetaminophen|acetaminophen|mesh-list
92317881|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92317882|NCT03198871|Analgesics|analgesics|mesh-ancestor
92317883|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
92317884|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317885|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317886|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
92317888|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92317889|NCT02157948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317890|NCT03220958|Diphenhydramine|diphenhydramine|mesh-list
92317891|NCT03220958|Promethazine|promethazine|mesh-list
92317892|NCT03220958|Metoclopramide|metoclopramide|mesh-list
92317893|NCT03220958|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92317894|NCT03220958|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92317895|NCT03220958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317896|NCT03220958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317897|NCT03220958|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317898|NCT03220958|Anesthetics|anesthetics|mesh-ancestor
92317899|NCT03220958|Sensory System Agents|sensory system agents|mesh-ancestor
92317900|NCT03220958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317901|NCT03220958|Antiemetics|antiemetics|mesh-ancestor
92317902|NCT03220958|Autonomic Agents|autonomic agents|mesh-ancestor
92317903|NCT03220958|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317904|NCT03220958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92317905|NCT03220958|Histamine Antagonists|histamine antagonists|mesh-ancestor
92317906|NCT03220958|Histamine Agents|histamine agents|mesh-ancestor
92317907|NCT03220958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317908|NCT03220958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317909|NCT03220958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92317910|NCT03220958|Antipruritics|antipruritics|mesh-ancestor
92317911|NCT03220958|Dermatologic Agents|dermatologic agents|mesh-ancestor
92317912|NCT03220958|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92317913|NCT03220958|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92317914|NCT03220958|Dopamine Agents|dopamine agents|mesh-ancestor
92317916|NCT02182830|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92317917|NCT02182830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317918|NCT02182830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92317919|NCT02182830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317921|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92317922|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317923|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92317924|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92412578|NCT02419495|Antimitotic Agents|antimitotic agents|mesh-ancestor
92317925|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92317926|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317927|NCT03303794|Bupivacaine|bupivacaine|mesh-list
92317928|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
92317929|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
92317930|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317931|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317932|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
92317933|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317934|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
92317935|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92317936|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317937|NCT03435614|Analgesics|analgesics|mesh-list
92317938|NCT03435614|Narcotics|narcotics|mesh-list
92317939|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92317940|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317941|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
92317942|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317943|NCT03437564|Vortioxetine|vortioxetine|mesh-list
92317944|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
92317945|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92317946|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92317947|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92317949|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317950|NCT03437564|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92317951|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92317952|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92317953|NCT03437564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317954|NCT03437564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317955|NCT03437564|Serotonin Agents|serotonin agents|mesh-ancestor
92317956|NCT03437564|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92317957|NCT03437564|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92317958|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92317959|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92317960|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
92317961|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92317962|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
92317963|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317964|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
92317965|NCT03438266|Protective Agents|protective agents|mesh-ancestor
92317966|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
92317967|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92317968|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
92317969|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92317970|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
92317971|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317972|NCT03228914|Phenylephrine|phenylephrine|mesh-list
92317973|NCT03228914|Epinephrine|epinephrine|mesh-list
92317974|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
92317975|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92317976|NCT03228914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92317977|NCT03228914|Adrenergic Agents|adrenergic agents|mesh-ancestor
92317978|NCT03228914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92317979|NCT03228914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92317980|NCT03228914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92317981|NCT03228914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92317982|NCT03228914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92317983|NCT03228914|Autonomic Agents|autonomic agents|mesh-ancestor
92317984|NCT03228914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92317985|NCT03228914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92317986|NCT03228914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92317987|NCT03228914|Mydriatics|mydriatics|mesh-ancestor
92317988|NCT03228914|Sympathomimetics|sympathomimetics|mesh-ancestor
92317989|NCT03228914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92317990|NCT03228914|Nasal Decongestants|nasal decongestants|mesh-ancestor
92317991|NCT03228914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92317992|NCT03228914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92317993|NCT03228914|Protective Agents|protective agents|mesh-ancestor
92317994|NCT03316976|Dexlansoprazole|dexlansoprazole|mesh-list
92317995|NCT03316976|Lansoprazole|lansoprazole|mesh-list
92317996|NCT03316976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92317997|NCT03316976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92317998|NCT03316976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92317999|NCT03316976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318000|NCT03316976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391778|NCT01726920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391779|NCT01726920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391780|NCT01726920|Analgesics|analgesics|mesh-ancestor
92391781|NCT01726920|Sensory System Agents|sensory system agents|mesh-ancestor
92391782|NCT01726920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391783|NCT01726920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391784|NCT01726920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391785|NCT01726920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391786|NCT01726920|Gout Suppressants|gout suppressants|mesh-ancestor
92391787|NCT01726920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92391788|NCT01726920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391789|NCT01726920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391790|NCT01726920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92391791|NCT01726920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92391792|NCT01726920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92391793|NCT01726920|Serotonin Agents|serotonin agents|mesh-ancestor
92391794|NCT01726920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391795|NCT01727622|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92391796|NCT01727622|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91970703|NCT02468999|Insulin|insulin|mesh-list
92318001|NCT03234374|Bupivacaine|bupivacaine|mesh-list
92318002|NCT03234374|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318003|NCT03234374|Anesthetics|anesthetics|mesh-ancestor
92318004|NCT03234374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318005|NCT03234374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318006|NCT03234374|Sensory System Agents|sensory system agents|mesh-ancestor
92318007|NCT03234374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318008|NCT04332536|Codeine|codeine|mesh-list
92318009|NCT04332536|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318010|NCT04332536|Narcotics|narcotics|mesh-ancestor
92318011|NCT04332536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318012|NCT04332536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318013|NCT04332536|Analgesics|analgesics|mesh-ancestor
92318014|NCT04332536|Sensory System Agents|sensory system agents|mesh-ancestor
92318015|NCT04332536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318016|NCT04332536|Antitussive Agents|antitussive agents|mesh-ancestor
92318017|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318018|NCT03236168|Ivermectin|ivermectin|mesh-list
92318019|NCT03236168|Permethrin|permethrin|mesh-list
92318020|NCT03236168|Malathion|malathion|mesh-list
92318021|NCT03236168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92318022|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318023|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318024|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318025|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92318026|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
92318027|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318028|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318030|NCT03306589|Sargramostim|sargramostim|mesh-list
92318031|NCT03306589|Cantharidin|cantharidin|mesh-list
92318032|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
92318033|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318034|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318035|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318036|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318037|NCT03312517|Suvorexant|suvorexant|mesh-list
92318038|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92318039|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92318040|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318041|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318042|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92318043|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318044|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318045|NCT03315559|Nemiralisib|nemiralisib|mesh-list
92318046|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92318047|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318048|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318050|NCT03239522|Glycine|glycine|mesh-list
92318051|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
92318052|NCT03239522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318053|NCT03239522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318054|NCT03239522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318055|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92318056|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
92318057|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92318058|NCT03242408|Testosterone|testosterone|mesh-list
92318059|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
92318060|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
92318061|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92318062|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318063|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
92318064|NCT03242408|Hormones|hormones|mesh-ancestor
92318065|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318066|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318067|NCT03242408|Androgens|androgens|mesh-ancestor
92318068|NCT03459794|Ivermectin|ivermectin|mesh-list
92318069|NCT03459794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92318070|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318071|NCT03211117|Docetaxel|docetaxel|mesh-list
92318072|NCT03211117|Doxorubicin|doxorubicin|mesh-list
92318073|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92318074|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
92318075|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318076|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
92318077|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
92318078|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
92318079|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318080|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92318081|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92318082|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92318083|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318084|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92318085|NCT03211117|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92318086|NCT00376285|Fenofibrate|fenofibrate|mesh-list
92318087|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92318089|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318090|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92318091|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
92318092|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92318093|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318094|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
92318095|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92318096|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348397|NCT01583166|Sensory System Agents|sensory system agents|mesh-ancestor
92318097|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318099|NCT03321097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318100|NCT03321097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318101|NCT03245762|Oxytocin|oxytocin|mesh-list
92318102|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
92318103|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92318104|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318105|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
92318106|NCT03322657|Neostigmine|neostigmine|mesh-list
92318107|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92318108|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318109|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318110|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
92318111|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318112|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318113|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92318114|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
92318115|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318116|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92318117|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92318118|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92318119|NCT03324451|Insulin|insulin|mesh-list
92318120|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92318121|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318122|NCT03247790|Lasmiditan|lasmiditan|mesh-list
92318123|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92318124|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
92318125|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318126|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318127|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318128|NCT03249272|Adenosine|adenosine|mesh-list
92318129|NCT03249272|Regadenoson|regadenoson|mesh-list
92318130|NCT03249272|Analgesics|analgesics|mesh-ancestor
92318131|NCT03249272|Sensory System Agents|sensory system agents|mesh-ancestor
92318132|NCT03249272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318133|NCT03249272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318134|NCT03249272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92318135|NCT03249272|Vasodilator Agents|vasodilator agents|mesh-ancestor
92318136|NCT03249272|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92318137|NCT03249272|Purinergic Agonists|purinergic agonists|mesh-ancestor
92318138|NCT03249272|Purinergic Agents|purinergic agents|mesh-ancestor
92318139|NCT03249272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318140|NCT03249272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318141|NCT03249272|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92318142|NCT03468920|Acetaminophen|acetaminophen|mesh-list
92318143|NCT03468920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92318144|NCT03468920|Analgesics|analgesics|mesh-ancestor
92318145|NCT03468920|Sensory System Agents|sensory system agents|mesh-ancestor
92318146|NCT03468920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318147|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318148|NCT03468920|Antipyretics|antipyretics|mesh-ancestor
92318149|NCT02181816|Amlodipine|amlodipine|mesh-list
92318150|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92318151|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92318152|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92318153|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92318154|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318155|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92318156|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318157|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
92318158|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92318159|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92318160|NCT03256136|Carboplatin|carboplatin|mesh-list
92318161|NCT03256136|Nivolumab|nivolumab|mesh-list
92318162|NCT03256136|Pemetrexed|pemetrexed|mesh-list
92318163|NCT03256136|Ipilimumab|ipilimumab|mesh-list
92318164|NCT03256136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318165|NCT03256136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92318166|NCT03256136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92318167|NCT03256136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318168|NCT03256136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318169|NCT03256136|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92318170|NCT03256136|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92318171|NCT03344510|Anesthetics|anesthetics|mesh-list
92318172|NCT03344510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318173|NCT03344510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318174|NCT03478982|Alprazolam|alprazolam|mesh-list
92318175|NCT03478982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92318176|NCT03478982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318177|NCT03478982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318178|NCT03478982|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92318179|NCT03478982|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92318180|NCT03478982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92318181|NCT03478982|GABA Modulators|gaba modulators|mesh-ancestor
92318182|NCT03478982|GABA Agents|gaba agents|mesh-ancestor
92318183|NCT03478982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318184|NCT03478982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318185|NCT03270332|Albuterol|albuterol|mesh-list
92318186|NCT03270332|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92318187|NCT03270332|Autonomic Agents|autonomic agents|mesh-ancestor
92318188|NCT03270332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318189|NCT03270332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318190|NCT03270332|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92318191|NCT03270332|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318192|NCT03270332|Tocolytic Agents|tocolytic agents|mesh-ancestor
92318193|NCT03270332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92318194|NCT03270332|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92318195|NCT03270332|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92318196|NCT03270332|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92318197|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
92318198|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318199|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318200|NCT03355820|Antibodies|antibodies|mesh-list
92318201|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
92318202|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318203|NCT03357614|Amoxicillin|amoxicillin|mesh-list
92318204|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
92318205|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
92318206|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
92318207|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92318208|NCT03357614|Ertapenem|ertapenem|mesh-list
92318209|NCT03357614|Lactams|lactams|mesh-list
92318210|NCT03357614|Probenecid|probenecid|mesh-list
92318211|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318212|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318213|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92318214|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92318215|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318216|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318217|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318218|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92318219|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92318220|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92318221|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
92318222|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
92318223|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318224|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
92318225|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
92318226|NCT03275870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92318227|NCT03275870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92318228|NCT03275870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318229|NCT03275870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318230|NCT03275870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318231|NCT03275870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318232|NCT02216214|Mirabegron|mirabegron|mesh-list
92318233|NCT02216214|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92318234|NCT02216214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92318235|NCT02216214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92318237|NCT02216214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318238|NCT02216214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318239|NCT02216214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318240|NCT02216214|Urological Agents|urological agents|mesh-ancestor
92318241|NCT00376376|Levofloxacin|levofloxacin|mesh-list
92318242|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92318243|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318244|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318245|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92318246|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92318247|NCT00376376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318248|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318249|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318250|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92318251|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92318252|NCT02181504|Ranibizumab|ranibizumab|mesh-list
92318253|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92318254|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92318255|NCT02181504|Growth Substances|growth substances|mesh-ancestor
92318256|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318257|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92318258|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318259|NCT02213094|Vitamins|vitamins|mesh-list
92318260|NCT02213094|Niacinamide|niacinamide|mesh-list
92318262|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
92318263|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
92318264|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
92318265|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318266|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92318267|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
92318268|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318269|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92318270|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
92318271|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92318272|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
92318273|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92318274|NCT01629966|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92318275|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92318276|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92318277|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318278|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318279|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
92318280|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318281|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92318282|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92318283|NCT02177838|Cetuximab|cetuximab|mesh-list
92318284|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92318285|NCT02177838|Antibodies|antibodies|mesh-list
92318286|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
92318287|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92318288|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
92318289|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318290|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318291|NCT03283436|Bupivacaine|bupivacaine|mesh-list
92318292|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318293|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
92318294|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318295|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318296|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
92318297|NCT03283436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318299|NCT00376064|Cabergoline|cabergoline|mesh-list
92318300|NCT00376064|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971016|NCT02467595|Fentanyl|fentanyl|mesh-list
92318301|NCT00376064|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92318302|NCT00376064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318303|NCT00376064|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92318304|NCT00376064|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92318305|NCT00376064|Dopamine Agonists|dopamine agonists|mesh-ancestor
92318306|NCT00376064|Dopamine Agents|dopamine agents|mesh-ancestor
92318307|NCT00376064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936648|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92318308|NCT00376064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318309|NCT00376064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318312|NCT03581084|Antiviral Agents|antiviral agents|mesh-ancestor
92318313|NCT03581084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318314|NCT03581084|Expectorants|expectorants|mesh-ancestor
92318315|NCT03581084|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318316|NCT03581084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92318317|NCT03581084|Antioxidants|antioxidants|mesh-ancestor
92318318|NCT03581084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318319|NCT03581084|Protective Agents|protective agents|mesh-ancestor
92318320|NCT03581084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318321|NCT03581084|Antidotes|antidotes|mesh-ancestor
92318322|NCT03383588|Epinephrine|epinephrine|mesh-list
92318323|NCT03383588|Fentanyl|fentanyl|mesh-list
92318324|NCT03383588|Morphine|morphine|mesh-list
92318325|NCT03383588|Bupivacaine|bupivacaine|mesh-list
92318326|NCT03383588|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318327|NCT03383588|Anesthetics|anesthetics|mesh-ancestor
92318328|NCT03383588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318329|NCT03383588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318330|NCT03383588|Sensory System Agents|sensory system agents|mesh-ancestor
92318331|NCT03383588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318332|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318333|NCT03383588|Narcotics|narcotics|mesh-ancestor
92318334|NCT03383588|Analgesics|analgesics|mesh-ancestor
92318335|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92318336|NCT03383588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92318337|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
92318338|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92318339|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92318340|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
92318341|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318342|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318343|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92318344|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92318346|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92318347|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318348|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
92318349|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
92318350|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92318351|NCT03388268|Vancomycin|vancomycin|mesh-list
92318352|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318353|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318354|NCT03393494|Adapalene|adapalene|mesh-list
92318355|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92318356|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92318357|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92318358|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92318359|NCT03393494|Analgesics|analgesics|mesh-ancestor
92412579|NCT02419495|Mitosis Modulators|mitosis modulators|mesh-ancestor
92318360|NCT03393494|Sensory System Agents|sensory system agents|mesh-ancestor
92318361|NCT03393494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318362|NCT03393494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318363|NCT03393494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318364|NCT03393494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318365|NCT03588806|Oxycodone|oxycodone|mesh-list
92318366|NCT03588806|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318367|NCT03588806|Narcotics|narcotics|mesh-ancestor
92318368|NCT03588806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318369|NCT03588806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318370|NCT03588806|Analgesics|analgesics|mesh-ancestor
92318371|NCT03588806|Sensory System Agents|sensory system agents|mesh-ancestor
92318372|NCT03588806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318373|NCT02176356|Bimatoprost|bimatoprost|mesh-list
92318374|NCT02176356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91971074|NCT02467673|Progestins|progestins|mesh-ancestor
92318375|NCT02176356|Botulinum Toxins|botulinum toxins|mesh-list
92318376|NCT02176356|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92318377|NCT02176356|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92318378|NCT02176356|Hyaluronic Acid|hyaluronic acid|mesh-list
92318379|NCT02176356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92318380|NCT02176356|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92318381|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92318382|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318383|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
92318384|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318385|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318386|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92318387|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318388|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92318389|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92318390|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
92318391|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
92318392|NCT02176356|Protective Agents|protective agents|mesh-ancestor
92318393|NCT03591068|Fluticasone|fluticasone|mesh-list
92318395|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318396|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92318397|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
92318398|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318399|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318400|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92318401|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318402|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
92318403|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92318404|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
92318405|NCT03395990|Procaine|procaine|mesh-list
92318406|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318407|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
92318408|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318409|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318410|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
92318411|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318413|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
92318414|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
92318415|NCT02175966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318416|NCT02175966|Antiviral Agents|antiviral agents|mesh-ancestor
92318417|NCT02175966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318418|NCT02136576|Listerine|listerine|mesh-list
92318419|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
92318420|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
92318421|NCT02136576|Protective Agents|protective agents|mesh-ancestor
92318422|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318423|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92318424|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318425|NCT03398330|Oxycodone|oxycodone|mesh-list
92318426|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318427|NCT03398330|Narcotics|narcotics|mesh-ancestor
92318428|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318429|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318430|NCT03398330|Analgesics|analgesics|mesh-ancestor
92318431|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
92318432|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318433|NCT00376766|Levetiracetam|levetiracetam|mesh-list
92318434|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
92318435|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
92318436|NCT03403712|Dexamethasone|dexamethasone|mesh-list
92318437|NCT03403712|Palonosetron|palonosetron|mesh-list
92318438|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318439|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
92318440|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
92318441|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318442|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318443|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92318444|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
92318445|NCT03403712|Hormones|hormones|mesh-ancestor
92318446|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318447|NCT03403712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92318448|NCT03403712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318449|NCT03403712|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92318451|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
92318452|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318453|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318454|NCT03404648|Choline|choline|mesh-list
92318455|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
92318456|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92318457|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
92318458|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318459|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92318460|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92318461|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
92318462|NCT03383198|Bupivacaine|bupivacaine|mesh-list
92318463|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318464|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
92318465|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318466|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318467|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
92318468|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318469|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
92318470|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92318471|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
92318472|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92318473|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
92318474|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318475|NCT03413618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318476|NCT03413618|Anticoagulants|anticoagulants|mesh-ancestor
92318478|NCT03523988|Ibuprofen|ibuprofen|mesh-list
92318479|NCT03523988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92318480|NCT03523988|Analgesics|analgesics|mesh-ancestor
92318481|NCT03523988|Sensory System Agents|sensory system agents|mesh-ancestor
92318482|NCT03523988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318483|NCT03523988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318484|NCT03523988|Antipyretics|antipyretics|mesh-ancestor
92318485|NCT03523988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92318486|NCT03523988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318487|NCT03523988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318488|NCT03523988|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92318489|NCT03523988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318490|NCT03523988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318491|NCT03525548|Ivacaftor|ivacaftor|mesh-list
92318492|NCT03525548|Elexacaftor|elexacaftor|mesh-list
92318493|NCT03525548|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92318494|NCT03525548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92318495|NCT03525548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318496|NCT03528512|Fentanyl|fentanyl|mesh-list
92318497|NCT03528512|Midazolam|midazolam|mesh-list
92318498|NCT03528512|Ketamine|ketamine|mesh-list
92318499|NCT03528512|Analgesics|analgesics|mesh-ancestor
92318500|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
92318501|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318502|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318503|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92318504|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92318505|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
92318506|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
92318507|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318508|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92318509|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92318510|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318511|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318512|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318513|NCT03528512|Narcotics|narcotics|mesh-ancestor
92318514|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92318515|NCT03528512|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92318516|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92318517|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92318518|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92318519|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
92318520|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
92318521|NCT02133924|Prednisone|prednisone|mesh-list
92318523|NCT02133924|Natalizumab|natalizumab|mesh-list
92318524|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318525|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
92318526|NCT02133924|Hormones|hormones|mesh-ancestor
92318527|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318528|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318529|NCT02133924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92318530|NCT02133924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318532|NCT02133924|Autonomic Agents|autonomic agents|mesh-ancestor
92318533|NCT02133924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318534|NCT02133924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92318535|NCT02133924|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92318536|NCT02133924|Protective Agents|protective agents|mesh-ancestor
92318537|NCT02133924|Immunologic Factors|immunologic factors|mesh-ancestor
92318538|NCT03537404|Ritonavir|ritonavir|mesh-list
92318539|NCT03537404|Tenofovir|tenofovir|mesh-list
92318540|NCT03537404|Raltegravir Potassium|raltegravir potassium|mesh-list
92318541|NCT03537404|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92318542|NCT03537404|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92318543|NCT03537404|Protease Inhibitors|protease inhibitors|mesh-ancestor
92318544|NCT03537404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318545|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318546|NCT03537404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92318547|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92318548|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
92318549|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318550|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92318551|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92318552|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92318553|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92318554|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92318555|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92318556|NCT03626714|Tacrolimus|tacrolimus|mesh-list
92318557|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92318558|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
92318559|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318560|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92318561|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318562|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318563|NCT03538808|Varenicline|varenicline|mesh-list
92318564|NCT03538808|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92318565|NCT03538808|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92318566|NCT03538808|Cholinergic Agents|cholinergic agents|mesh-ancestor
92318567|NCT03538808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318568|NCT03538808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318569|NCT03538808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318570|NCT00377000|Clindamycin|clindamycin|mesh-list
92318571|NCT00377000|Clindamycin palmitate|clindamycin palmitate|mesh-list
92318572|NCT00377000|Clindamycin phosphate|clindamycin phosphate|mesh-list
92318573|NCT00377000|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92318574|NCT00377000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318575|NCT00377000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318576|NCT00377000|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92318577|NCT00377000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318578|NCT00377000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318579|NCT00377000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92318580|NCT02173548|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92318581|NCT02173548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318583|NCT04501640|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92318584|NCT04501640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92318585|NCT04501640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92318586|NCT04501640|Adrenergic Agents|adrenergic agents|mesh-ancestor
92318587|NCT04501640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318588|NCT04501640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318589|NCT04501640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318590|NCT04501640|Urological Agents|urological agents|mesh-ancestor
92318591|NCT04757610|Ranibizumab|ranibizumab|mesh-list
92318592|NCT04757610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92318593|NCT04757610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92318594|NCT04757610|Growth Substances|growth substances|mesh-ancestor
92318595|NCT04757610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318596|NCT04757610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92318597|NCT04757610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318598|NCT03633344|Silicon|silicon|mesh-list
92318599|NCT03633344|Trace Elements|trace elements|mesh-ancestor
92318600|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
92318601|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318602|NCT02171130|Glucagon|glucagon|mesh-list
92318603|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92318604|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92318605|NCT02171130|Hormones|hormones|mesh-ancestor
92318606|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318607|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318608|NCT02171130|Incretins|incretins|mesh-ancestor
92318609|NCT04749810|Eculizumab|eculizumab|mesh-list
92318610|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92318611|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92318612|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
92318613|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318614|NCT00377078|Lactoferrin|lactoferrin|mesh-list
92318615|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318616|NCT04495712|Spironolactone|spironolactone|mesh-list
92318617|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92318618|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
92318619|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318620|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318621|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92318622|NCT04495712|Diuretics|diuretics|mesh-ancestor
92318623|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
92318624|NCT03553940|Vaccines|vaccines|mesh-list
92318625|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
92318626|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318627|NCT04456634|Lumefantrine|lumefantrine|mesh-list
92318628|NCT04456634|Artemether|artemether|mesh-list
92318629|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92318630|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
92318631|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92318632|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92318633|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318634|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
92318635|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92318636|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
92318637|NCT00377624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318638|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
92318639|NCT00377624|Protective Agents|protective agents|mesh-ancestor
92318640|NCT03562988|Vitamins|vitamins|mesh-list
92318641|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
92318642|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
92318643|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318644|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
92318645|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318646|NCT03562988|Protective Agents|protective agents|mesh-ancestor
92318647|NCT03644108|Guaifenesin|guaifenesin|mesh-list
92318648|NCT03644108|Expectorants|expectorants|mesh-ancestor
92318649|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318650|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
92318651|NCT04713956|Busulfan|busulfan|mesh-list
92318652|NCT04713956|Fludarabine|fludarabine|mesh-list
92318653|NCT04713956|Decitabine|decitabine|mesh-list
92318654|NCT04713956|Lenograstim|lenograstim|mesh-list
92318655|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92318656|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
92318657|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318658|NCT04713956|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318659|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92318660|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
92318661|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318662|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318663|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92318664|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92318665|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
92318666|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318667|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92318668|NCT04425746|Afamelanotide|afamelanotide|mesh-list
92318669|NCT04425746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92318670|NCT04392362|Adenosine|adenosine|mesh-list
92318671|NCT04392362|Analgesics|analgesics|mesh-ancestor
92318672|NCT04392362|Sensory System Agents|sensory system agents|mesh-ancestor
92318673|NCT04392362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318674|NCT04392362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318675|NCT04392362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92318676|NCT04392362|Vasodilator Agents|vasodilator agents|mesh-ancestor
92318677|NCT04392362|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92318678|NCT04392362|Purinergic Agonists|purinergic agonists|mesh-ancestor
92318679|NCT04392362|Purinergic Agents|purinergic agents|mesh-ancestor
92318680|NCT04392362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318681|NCT04392362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318682|NCT04734782|Antibodies|antibodies|mesh-list
92318683|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
92318684|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318686|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92318687|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318688|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
92318689|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
92318690|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
92318691|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318692|NCT03570476|Olaparib|olaparib|mesh-list
92318693|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92318694|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318695|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318696|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318697|NCT03571724|Menthol|menthol|mesh-list
92318698|NCT03571724|Nicotine|nicotine|mesh-list
92318699|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92318700|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
92318701|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318702|NCT03571724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318703|NCT03571724|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92318704|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92318705|NCT03571724|Cholinergic Agents|cholinergic agents|mesh-ancestor
92318706|NCT03571724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318707|NCT03571724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318708|NCT03571724|Antipruritics|antipruritics|mesh-ancestor
92318709|NCT03571724|Dermatologic Agents|dermatologic agents|mesh-ancestor
92318710|NCT03572972|Warfarin|warfarin|mesh-list
92318711|NCT03572972|Rivaroxaban|rivaroxaban|mesh-list
92318712|NCT03572972|Dabigatran|dabigatran|mesh-list
92318713|NCT03572972|Apixaban|apixaban|mesh-list
92318714|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
92318715|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92318716|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
92318717|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92318718|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
92318719|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318720|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318721|NCT04352660|Mitomycins|mitomycins|mesh-list
92318722|NCT04352660|Mitomycin|mitomycin|mesh-list
92318723|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92318724|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318725|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
92318726|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318727|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92318728|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318729|NCT04342130|Morphine|morphine|mesh-list
92318730|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318731|NCT04342130|Narcotics|narcotics|mesh-ancestor
92318732|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318733|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318734|NCT04342130|Analgesics|analgesics|mesh-ancestor
92318735|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
92318736|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318737|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
92318738|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92318739|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92318740|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318742|NCT04338074|Coagulants|coagulants|mesh-ancestor
92318743|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
92318744|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92318745|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
92318746|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318747|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318748|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92318749|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
92318750|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
92318751|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92318752|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
92318753|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318754|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318755|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
92318756|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92318757|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318758|NCT04337138|Immunotoxins|immunotoxins|mesh-ancestor
92318759|NCT04337138|Immunoconjugates|immunoconjugates|mesh-ancestor
92318760|NCT04337138|Immunologic Factors|immunologic factors|mesh-ancestor
92318761|NCT04337138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318762|NCT00422773|Cetuximab|cetuximab|mesh-list
92318763|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92318764|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318765|NCT03329209|Vedolizumab|vedolizumab|mesh-list
92318766|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92318767|NCT03661346|Labetalol|labetalol|mesh-list
92318768|NCT03661346|Esmolol|esmolol|mesh-list
92318769|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92318770|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92318771|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92318772|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
92318773|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318774|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318775|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318776|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92318777|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
92318778|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
92318779|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318780|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92318781|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92318782|NCT03329911|Paclitaxel|paclitaxel|mesh-list
92318783|NCT03329911|Carboplatin|carboplatin|mesh-list
92318784|NCT03329911|Bevacizumab|bevacizumab|mesh-list
92318785|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92318786|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318787|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92318788|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92318789|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92318790|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318791|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92318792|NCT03329911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92318793|NCT03329911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92318794|NCT03329911|Growth Substances|growth substances|mesh-ancestor
92318795|NCT03329911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318796|NCT03329911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92318797|NCT04322396|Azithromycin|azithromycin|mesh-list
92318798|NCT04322396|Hydroxychloroquine|hydroxychloroquine|mesh-list
92318799|NCT04322396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318800|NCT04322396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318801|NCT04322396|Antimalarials|antimalarials|mesh-ancestor
92318802|NCT04322396|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92318803|NCT04322396|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92318804|NCT04322396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318805|NCT04322396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318806|NCT04322396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318807|NCT03330457|Betrixaban|betrixaban|mesh-list
92318808|NCT03330457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92318809|NCT03330457|Antithrombins|antithrombins|mesh-ancestor
92318810|NCT03330457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92318811|NCT03330457|Protease Inhibitors|protease inhibitors|mesh-ancestor
92318812|NCT03330457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318813|NCT03330457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318814|NCT03330457|Anticoagulants|anticoagulants|mesh-ancestor
92318815|NCT03961100|Entrectinib|entrectinib|mesh-list
92318816|NCT03961100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92318817|NCT03961100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318818|NCT03961100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318820|NCT03336853|Dental Disinfectants|dental disinfectants|mesh-ancestor
92318821|NCT03336853|Disinfectants|disinfectants|mesh-ancestor
92318822|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318823|NCT03225313|Bupivacaine|bupivacaine|mesh-list
92318824|NCT03225313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92318825|NCT03225313|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318826|NCT03225313|Anesthetics|anesthetics|mesh-ancestor
92318827|NCT03225313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318828|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318829|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
92318830|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318832|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92318833|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92318834|NCT03948386|Bupivacaine|bupivacaine|mesh-list
92318835|NCT03948386|Mepivacaine|mepivacaine|mesh-list
92318836|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318837|NCT03948386|Anesthetics|anesthetics|mesh-ancestor
91971529|NCT04424225|Niacin|niacin|mesh-list
92318838|NCT03948386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318839|NCT03948386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318840|NCT03948386|Sensory System Agents|sensory system agents|mesh-ancestor
92318841|NCT03948386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318842|NCT03445195|Imipenem|imipenem|mesh-list
92318843|NCT03445195|Sulbactam|sulbactam|mesh-list
92318844|NCT03445195|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92318845|NCT03445195|Durlobactam|durlobactam|mesh-list
92318846|NCT03445195|Cilastatin|cilastatin|mesh-list
92318847|NCT03445195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318848|NCT03445195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318849|NCT03445195|Protease Inhibitors|protease inhibitors|mesh-ancestor
92318850|NCT03445195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318851|NCT03445195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318852|NCT03445195|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92318853|NCT04277936|Levetiracetam|levetiracetam|mesh-list
92318854|NCT04277936|Anticonvulsants|anticonvulsants|mesh-ancestor
92318855|NCT04277936|Nootropic Agents|nootropic agents|mesh-ancestor
92318856|NCT03670160|Clonidine|clonidine|mesh-list
92318857|NCT03670160|Phenobarbital|phenobarbital|mesh-list
92318858|NCT03670160|Analgesics|analgesics|mesh-ancestor
92318859|NCT03670160|Sensory System Agents|sensory system agents|mesh-ancestor
92318860|NCT03670160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318861|NCT03670160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318862|NCT03670160|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92318863|NCT03670160|Sympatholytics|sympatholytics|mesh-ancestor
92318864|NCT03670160|Autonomic Agents|autonomic agents|mesh-ancestor
92318865|NCT03670160|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92318866|NCT03670160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92318867|NCT03670160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92318868|NCT03670160|Adrenergic Agents|adrenergic agents|mesh-ancestor
92318869|NCT03670160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318870|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318871|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
92318872|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92318873|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318874|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92318875|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92318876|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
92318878|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92318879|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92318880|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92318881|NCT00375895|Cyclosporine|cyclosporine|mesh-list
92318882|NCT00375895|Cyclosporins|cyclosporins|mesh-list
92318883|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318884|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318885|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92318886|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
92318887|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318888|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
92318889|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318890|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
92318891|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318892|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92318893|NCT03338803|Linagliptin|linagliptin|mesh-list
92318894|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92318895|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318896|NCT03338803|Incretins|incretins|mesh-ancestor
92318897|NCT03338803|Hormones|hormones|mesh-ancestor
92318898|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318899|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92318900|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
92318901|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318902|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318903|NCT00377936|Gemcitabine|gemcitabine|mesh-list
92318904|NCT00377936|Paclitaxel|paclitaxel|mesh-list
92318905|NCT00377936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92318906|NCT00377936|Antimetabolites|antimetabolites|mesh-ancestor
91936656|NCT02262767|Trimethobenzamide|trimethobenzamide|mesh-list
92318907|NCT00377936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318908|NCT00377936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318909|NCT00377936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92318910|NCT00377936|Tubulin Modulators|tubulin modulators|mesh-ancestor
92318911|NCT00377936|Antimitotic Agents|antimitotic agents|mesh-ancestor
92318912|NCT00377936|Mitosis Modulators|mitosis modulators|mesh-ancestor
92318913|NCT03696758|Metoprolol|metoprolol|mesh-list
92318914|NCT03696758|Sildenafil Citrate|sildenafil citrate|mesh-list
92318915|NCT03696758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92318916|NCT03696758|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92318917|NCT03696758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92318918|NCT03696758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318919|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318920|NCT03696758|Urological Agents|urological agents|mesh-ancestor
92318921|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92318922|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92318923|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
92318924|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
92318925|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318926|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318927|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92318928|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92318929|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92348474|NCT01580670|Infliximab|infliximab|mesh-list
92318931|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92318932|NCT03233737|Anesthetics|anesthetics|mesh-list
92318933|NCT03233737|Tetracaine|tetracaine|mesh-list
92318934|NCT03233737|Benzocaine|benzocaine|mesh-list
92318935|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318936|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318937|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
92318938|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
92318939|NCT03233737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318940|NCT03711578|Tenalisib|tenalisib|mesh-list
92318941|NCT03711578|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92318942|NCT03711578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318943|NCT03711578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318944|NCT03463915|Triamcinolone|triamcinolone|mesh-list
92318945|NCT03463915|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92318946|NCT03463915|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92318947|NCT03463915|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92318948|NCT03463915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318949|NCT03463915|Glucocorticoids|glucocorticoids|mesh-ancestor
92318950|NCT03463915|Hormones|hormones|mesh-ancestor
92318951|NCT03463915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92318952|NCT03463915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318953|NCT03463915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92318954|NCT03463915|Immunologic Factors|immunologic factors|mesh-ancestor
92318955|NCT03463915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318956|NCT03463915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318957|NCT03473665|Celecoxib|celecoxib|mesh-list
92318958|NCT03473665|Diclofenac|diclofenac|mesh-list
92318959|NCT03473665|Indomethacin|indomethacin|mesh-list
92318960|NCT03473665|Meloxicam|meloxicam|mesh-list
92318961|NCT03473665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92318962|NCT03473665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92318963|NCT03473665|Analgesics|analgesics|mesh-ancestor
92318964|NCT03473665|Sensory System Agents|sensory system agents|mesh-ancestor
92318965|NCT03473665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318966|NCT03473665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318967|NCT03473665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92318968|NCT03473665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92318969|NCT03473665|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92318970|NCT03473665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92318971|NCT03473665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318972|NCT03473665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318973|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
92318974|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
92318975|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92318976|NCT03717506|Clindamycin|clindamycin|mesh-list
92318977|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
92318978|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
92318979|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92318980|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92318981|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92318982|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92318983|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92318984|NCT03861338|Buprenorphine|buprenorphine|mesh-list
92318985|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92318986|NCT03861338|Narcotics|narcotics|mesh-ancestor
92318987|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92318988|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92318989|NCT03861338|Analgesics|analgesics|mesh-ancestor
92318990|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
92318991|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92318992|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92318993|NCT00377780|Docetaxel|docetaxel|mesh-list
92318994|NCT00377780|Doxorubicin|doxorubicin|mesh-list
92318995|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92318996|NCT00377780|Trastuzumab|trastuzumab|mesh-list
92318997|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92318998|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92318999|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92319000|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92319001|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319002|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92319003|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92319004|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92319005|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319006|NCT00377780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92319007|NCT00376519|Cyclosporine|cyclosporine|mesh-list
92319008|NCT00376519|Mycophenolic Acid|mycophenolic acid|mesh-list
92319009|NCT00376519|Cyclophosphamide|cyclophosphamide|mesh-list
92319010|NCT00376519|Fludarabine|fludarabine|mesh-list
92319011|NCT00376519|Fludarabine phosphate|fludarabine phosphate|mesh-list
92319012|NCT00376519|Cyclosporins|cyclosporins|mesh-list
92319013|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92319014|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
92319015|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319016|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92319017|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92319018|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
92319019|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319020|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319021|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92319022|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319023|NCT00376519|Antimetabolites|antimetabolites|mesh-ancestor
92319024|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319025|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
92319026|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319027|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
92319028|NCT00376519|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92319029|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92319030|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92319031|NCT00376519|Antitubercular Agents|antitubercular agents|mesh-ancestor
92319032|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92319033|NCT00422864|Leucovorin|leucovorin|mesh-list
92319034|NCT00422864|Fluorouracil|fluorouracil|mesh-list
92319035|NCT00422864|Oxaliplatin|oxaliplatin|mesh-list
92319036|NCT00422864|Antimetabolites|antimetabolites|mesh-ancestor
92319037|NCT00422864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319038|NCT00422864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319039|NCT00422864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319040|NCT00422864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92319041|NCT00422864|Immunologic Factors|immunologic factors|mesh-ancestor
92319042|NCT00422864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319043|NCT00422864|Antidotes|antidotes|mesh-ancestor
92319044|NCT00422864|Protective Agents|protective agents|mesh-ancestor
92319045|NCT00422864|Vitamin B Complex|vitamin b complex|mesh-ancestor
92319046|NCT00422864|Vitamins|vitamins|mesh-ancestor
92319047|NCT00422864|Micronutrients|micronutrients|mesh-ancestor
92319048|NCT03373591|Bupivacaine|bupivacaine|mesh-list
92319049|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319050|NCT03373591|Anesthetics|anesthetics|mesh-ancestor
92319051|NCT03373591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319052|NCT03373591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319053|NCT03373591|Sensory System Agents|sensory system agents|mesh-ancestor
91941940|NCT05737693|Ketamine|ketamine|mesh-list
92319054|NCT03373591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319055|NCT03378973|Dexmedetomidine|dexmedetomidine|mesh-list
92319056|NCT03378973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319057|NCT03378973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319058|NCT03378973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319059|NCT03378973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319060|NCT03378973|Analgesics|analgesics|mesh-ancestor
92319061|NCT03378973|Sensory System Agents|sensory system agents|mesh-ancestor
91971775|NCT02462369|Hormones|hormones|mesh-ancestor
92319062|NCT03378973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319063|NCT03378973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92319064|NCT03378973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92319065|NCT03378973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319067|NCT03378973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348491|NCT01534182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92319068|NCT03378973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319070|NCT04121078|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92319071|NCT04121078|Antitubercular Agents|antitubercular agents|mesh-ancestor
92319072|NCT04121078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92319073|NCT04121078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319074|NCT04121078|Leprostatic Agents|leprostatic agents|mesh-ancestor
92319075|NCT04121078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92319076|NCT04121078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319077|NCT04121078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319078|NCT04121078|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92319079|NCT04121078|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92319080|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92319081|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92319082|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92319083|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92319084|NCT03248947|Buprenorphine|buprenorphine|mesh-list
92319085|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92319086|NCT03248947|Naloxone|naloxone|mesh-list
92319087|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92319088|NCT03248947|Narcotics|narcotics|mesh-ancestor
92319089|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319090|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319091|NCT03248947|Analgesics|analgesics|mesh-ancestor
92319092|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
92319093|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319094|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92319095|NCT04114058|Bupivacaine|bupivacaine|mesh-list
92319096|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319097|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
92319098|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319099|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319100|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
92319101|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319102|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92319103|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319104|NCT00376831|Fentanyl|fentanyl|mesh-list
92319105|NCT00376831|Midazolam|midazolam|mesh-list
92319106|NCT00376831|Ketamine|ketamine|mesh-list
92319107|NCT00376831|Analgesics|analgesics|mesh-ancestor
92319108|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
92319109|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319110|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319111|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92319112|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319113|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
92319114|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
92319115|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319116|NCT00376831|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92319117|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92319118|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319119|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319120|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92319121|NCT00376831|Narcotics|narcotics|mesh-ancestor
92319122|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92319123|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319124|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92319125|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319126|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319127|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
92319128|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
92319129|NCT03857750|Rocuronium|rocuronium|mesh-list
92319130|NCT03857750|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92319131|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92319132|NCT03857750|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92348503|NCT01579812|Metformin|metformin|mesh-list
92319133|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319134|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319135|NCT03828422|Calcium|calcium|mesh-list
92319136|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92319137|NCT03828422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319138|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
92319139|NCT03852524|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92319140|NCT03852524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319141|NCT03852524|Sensory System Agents|sensory system agents|mesh-ancestor
92319142|NCT03852524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319144|NCT04081610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92319145|NCT04081610|Immunologic Factors|immunologic factors|mesh-ancestor
92319146|NCT04081610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319147|NCT04081610|Viscosupplements|viscosupplements|mesh-ancestor
92319148|NCT04081610|Protective Agents|protective agents|mesh-ancestor
92319149|NCT03840278|Pancrelipase|pancrelipase|mesh-list
92319151|NCT03840278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319152|NCT03838874|Bupivacaine|bupivacaine|mesh-list
92319153|NCT03838874|Mepivacaine|mepivacaine|mesh-list
92319154|NCT03838874|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319155|NCT03838874|Anesthetics|anesthetics|mesh-ancestor
92319156|NCT03838874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319157|NCT03838874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319158|NCT03838874|Sensory System Agents|sensory system agents|mesh-ancestor
92319159|NCT03838874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319160|NCT04045964|Nicotine|nicotine|mesh-list
92319161|NCT04045964|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92319162|NCT04045964|Autonomic Agents|autonomic agents|mesh-ancestor
92319163|NCT04045964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319164|NCT04045964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319165|NCT04045964|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92319166|NCT04045964|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92319167|NCT04045964|Cholinergic Agents|cholinergic agents|mesh-ancestor
92319168|NCT04045964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319169|NCT04045964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319170|NCT05314400|Liver Extracts|liver extracts|mesh-list
92319171|NCT05314400|Hematinics|hematinics|mesh-ancestor
92319172|NCT04039412|Levofloxacin|levofloxacin|mesh-list
92319173|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92319174|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319175|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92319176|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92319177|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92319178|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319179|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319180|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319181|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92319182|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92319183|NCT03831854|Lamotrigine|lamotrigine|mesh-list
92319184|NCT03831854|Ketamine|ketamine|mesh-list
92319185|NCT03831854|Analgesics|analgesics|mesh-ancestor
92319186|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
92319187|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319188|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319189|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92319190|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319191|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
92319192|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
92319193|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319194|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92319195|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92319196|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319197|NCT03831854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319198|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
92319199|NCT03831854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92319200|NCT03831854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319201|NCT03831854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92319202|NCT03831854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92319203|NCT03831854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319204|NCT03831854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319205|NCT03831854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92319206|NCT03806270|Midazolam|midazolam|mesh-list
92319207|NCT03806270|Hydroxyzine|hydroxyzine|mesh-list
92319208|NCT03806270|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92319209|NCT03806270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319210|NCT03806270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319211|NCT03806270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319212|NCT03806270|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92319213|NCT03806270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91971900|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319214|NCT03806270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319215|NCT03806270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319216|NCT03806270|Anesthetics, General|anesthetics, general|mesh-ancestor
92319217|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
92319218|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
92319219|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
92319220|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319221|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319222|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
92319223|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
92319224|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92319225|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
92319226|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
92319227|NCT03497845|Vaccines|vaccines|mesh-list
92319228|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
92319229|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319230|NCT04036292|Varenicline|varenicline|mesh-list
92319231|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92319232|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92319233|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
92319234|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319235|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319236|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319237|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92319238|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92319239|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319240|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319241|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
92319242|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319243|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319244|NCT00377390|Omalizumab|omalizumab|mesh-list
92319245|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92319246|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92319247|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
92319248|NCT03820388|Propofol|propofol|mesh-list
92319249|NCT03820388|Etomidate|etomidate|mesh-list
92319250|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319251|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319252|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319253|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319254|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
92319255|NCT03820388|Anesthetics|anesthetics|mesh-ancestor
92319256|NCT03264157|Vaccines|vaccines|mesh-list
92319257|NCT03264157|Immunologic Factors|immunologic factors|mesh-ancestor
92319258|NCT03264157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319259|NCT04029584|Rifampin|rifampin|mesh-list
92319260|NCT04029584|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92319261|NCT04029584|Antitubercular Agents|antitubercular agents|mesh-ancestor
92319262|NCT04029584|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92319263|NCT04029584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319264|NCT04029584|Leprostatic Agents|leprostatic agents|mesh-ancestor
92319265|NCT04029584|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92319266|NCT04029584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319267|NCT04029584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319268|NCT04029584|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92319269|NCT04029584|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92319270|NCT04029584|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92319271|NCT04029584|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92319272|NCT04029584|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92319273|NCT04029584|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92319274|NCT04028960|Insulin|insulin|mesh-list
92319275|NCT04028960|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92319276|NCT04028960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92319277|NCT04028960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319278|NCT03502915|Nitrous Oxide|nitrous oxide|mesh-list
92319279|NCT03502915|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92319280|NCT03502915|Anesthetics, General|anesthetics, general|mesh-ancestor
92319281|NCT03502915|Anesthetics|anesthetics|mesh-ancestor
92319282|NCT03502915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319283|NCT03502915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319284|NCT03502915|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319285|NCT03502915|Analgesics|analgesics|mesh-ancestor
92319286|NCT03502915|Sensory System Agents|sensory system agents|mesh-ancestor
92319287|NCT03502915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319288|NCT03506347|Vancomycin|vancomycin|mesh-list
91971979|NCT03305445|Nivolumab|nivolumab|mesh-list
92319290|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319291|NCT03266419|Rocuronium|rocuronium|mesh-list
92319292|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92319293|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92319294|NCT03266419|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92319295|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319296|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319297|NCT00377468|Dronabinol|dronabinol|mesh-list
92319298|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
92319299|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319300|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319301|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319302|NCT00377468|Analgesics|analgesics|mesh-ancestor
92319303|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
92319304|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319305|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92319306|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92319307|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319308|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319309|NCT00377468|Hormones|hormones|mesh-ancestor
92319310|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92319311|NCT03799484|Lidocaine|lidocaine|mesh-list
92319312|NCT03799484|Prilocaine|prilocaine|mesh-list
92319313|NCT03799484|Petrolatum|petrolatum|mesh-list
92319314|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
92319315|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92319316|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92319317|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319318|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
92319319|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319320|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319321|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
92319322|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319323|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92319324|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92348522|NCT01555164|Metformin|metformin|mesh-list
92319325|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92319326|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319327|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319328|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92319329|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
92319330|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319331|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92319332|NCT03799484|Emollients|emollients|mesh-ancestor
92319333|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92319334|NCT00377546|Ketorolac|ketorolac|mesh-list
92319335|NCT00377546|Nepafenac|nepafenac|mesh-list
92319336|NCT00377546|Bromfenac|bromfenac|mesh-list
92319337|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92319338|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319339|NCT00377546|Analgesics|analgesics|mesh-ancestor
92319340|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
92319341|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319342|NCT00377546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319343|NCT00377546|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92319344|NCT00377546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92319345|NCT00377546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92319346|NCT00377546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319347|NCT00377546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319348|NCT04290494|Plasminogen|plasminogen|mesh-list
92319349|NCT04290494|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92319350|NCT04290494|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92319351|NCT04290494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319352|NCT04005404|Ropivacaine|ropivacaine|mesh-list
92319353|NCT04005404|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319354|NCT04005404|Anesthetics|anesthetics|mesh-ancestor
92319355|NCT04005404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319356|NCT04005404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319357|NCT04005404|Sensory System Agents|sensory system agents|mesh-ancestor
92319358|NCT04005404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319359|NCT03232892|Trametinib|trametinib|mesh-list
92319360|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319361|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92319362|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319363|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319364|NCT03510481|Lumefantrine|lumefantrine|mesh-list
92319365|NCT03510481|Artemether|artemether|mesh-list
92319366|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
92319367|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92319368|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92319369|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319370|NCT03109418|Ketamine|ketamine|mesh-list
92319371|NCT03109418|Analgesics|analgesics|mesh-ancestor
92319372|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
92319373|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319374|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319375|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92319376|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319377|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
92319378|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
92319379|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319380|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92319381|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92319382|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319383|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319384|NCT03404167|Zoliflodacin|zoliflodacin|mesh-list
92319385|NCT03404167|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92319386|NCT03404167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92319387|NCT03404167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319388|NCT03404167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319389|NCT03404167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319390|NCT03771560|Leucovorin|leucovorin|mesh-list
92319391|NCT03771560|Folic Acid|folic acid|mesh-list
92319392|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
92319393|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319394|NCT03771560|Antidotes|antidotes|mesh-ancestor
92319395|NCT03771560|Protective Agents|protective agents|mesh-ancestor
92319396|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
92319397|NCT03771560|Vitamins|vitamins|mesh-ancestor
92319398|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
92319399|NCT03771560|Hematinics|hematinics|mesh-ancestor
92319400|NCT03767738|Aflibercept|aflibercept|mesh-list
92319401|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92319402|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92319403|NCT03767738|Growth Substances|growth substances|mesh-ancestor
92319404|NCT03767738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319405|NCT03767738|Growth Inhibitors|growth inhibitors|mesh-ancestor
92319406|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319407|NCT02973620|Simendan|simendan|mesh-list
92319408|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92319409|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
92319410|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92319411|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92319412|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319413|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319414|NCT02973620|Protective Agents|protective agents|mesh-ancestor
92319415|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319416|NCT05313386|Dexmedetomidine|dexmedetomidine|mesh-list
92319417|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319418|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319419|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319420|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319421|NCT05313386|Analgesics|analgesics|mesh-ancestor
92319422|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
92319423|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319424|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92319425|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92319426|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319427|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
92319428|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936665|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319429|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319430|NCT04018664|Nalbuphine|nalbuphine|mesh-list
92319431|NCT04018664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92319432|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92319433|NCT04018664|Narcotics|narcotics|mesh-ancestor
92319434|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319435|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319436|NCT04018664|Analgesics|analgesics|mesh-ancestor
92319437|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
92319438|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319440|NCT03031340|Analgesics|analgesics|mesh-ancestor
92319441|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
92319442|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319443|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319444|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
92319445|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92319446|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319447|NCT03031340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319448|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92319449|NCT03031340|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92319450|NCT03031340|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319451|NCT03031340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319452|NCT03031340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319453|NCT03405259|Fluorides|fluorides|mesh-list
92319454|NCT03405259|Fluorides, Topical|fluorides, topical|mesh-list
92319455|NCT03405259|Cariostatic Agents|cariostatic agents|mesh-ancestor
92319456|NCT03405259|Protective Agents|protective agents|mesh-ancestor
92319457|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319458|NCT03513757|Lidocaine|lidocaine|mesh-list
92319459|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
92319460|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
92319461|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
92319463|NCT03513757|Sevoflurane|sevoflurane|mesh-list
92319464|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319465|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
92319466|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319467|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319468|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
92319469|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319470|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92319471|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92319472|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92319473|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319474|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319475|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319476|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319477|NCT03513757|Analgesics|analgesics|mesh-ancestor
92319478|NCT03513757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92319479|NCT03513757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92319480|NCT03513757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319481|NCT03513757|Adrenergic Agents|adrenergic agents|mesh-ancestor
92319482|NCT03513757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319483|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319484|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
92319485|NCT03513757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92319486|NCT03513757|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92319487|NCT03513757|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92319488|NCT03513757|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92319489|NCT03513757|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92319490|NCT03513757|Cholinergic Agents|cholinergic agents|mesh-ancestor
92319491|NCT03760640|Insulin Lispro|insulin lispro|mesh-list
92319492|NCT03760640|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92319493|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319494|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92319495|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319497|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
92319498|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
92319499|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
92319500|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319501|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319502|NCT03756038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319503|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319504|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319506|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319507|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319508|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
92319509|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
92319510|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319511|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319512|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
92319513|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92319514|NCT03754556|Contraceptive Agents|contraceptive agents|mesh-ancestor
92319515|NCT03754556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92319516|NCT03754556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319517|NCT03754556|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92319518|NCT03754556|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92319519|NCT03754556|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92319520|NCT03521479|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
92319521|NCT03521479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92319522|NCT03521479|Immunologic Factors|immunologic factors|mesh-ancestor
92319523|NCT03521479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319524|NCT01495988|Bevacizumab|bevacizumab|mesh-list
92319525|NCT01495988|Vemurafenib|vemurafenib|mesh-list
92348555|NCT01554618|Exenatide|exenatide|mesh-list
92319526|NCT01495988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92319527|NCT01495988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319528|NCT01495988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92319529|NCT01495988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92319530|NCT01495988|Growth Substances|growth substances|mesh-ancestor
92319531|NCT01495988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319532|NCT01495988|Growth Inhibitors|growth inhibitors|mesh-ancestor
92319533|NCT01495988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92319534|NCT01495988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319535|NCT01495988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319536|NCT02934932|Brexpiprazole|brexpiprazole|mesh-list
92319537|NCT02934932|Serotonin Agents|serotonin agents|mesh-ancestor
92319538|NCT02934932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319539|NCT02934932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319540|NCT02934932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319541|NCT02934932|Dopamine Agonists|dopamine agonists|mesh-ancestor
92319542|NCT02934932|Dopamine Agents|dopamine agents|mesh-ancestor
92319543|NCT03415243|Acetaminophen|acetaminophen|mesh-list
92319544|NCT03415243|Phenylephrine|phenylephrine|mesh-list
92319545|NCT03415243|Oxymetazoline|oxymetazoline|mesh-list
92319546|NCT03415243|Dextromethorphan|dextromethorphan|mesh-list
92319547|NCT03415243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319548|NCT03415243|Analgesics|analgesics|mesh-ancestor
92319549|NCT03415243|Sensory System Agents|sensory system agents|mesh-ancestor
92319550|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319551|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319552|NCT03415243|Antipyretics|antipyretics|mesh-ancestor
92319553|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92319554|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
92319555|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
92319556|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
92319557|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92319558|NCT03415243|Nasal Decongestants|nasal decongestants|mesh-ancestor
92319559|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
92319560|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92319561|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92319562|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319564|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319565|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319566|NCT03415243|Protective Agents|protective agents|mesh-ancestor
92319567|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
92319568|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92319569|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92319570|NCT02892500|Betamethasone|betamethasone|mesh-list
92319571|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
92319572|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92319573|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
92319574|NCT02892500|Bupivacaine|bupivacaine|mesh-list
92319575|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92319576|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319577|NCT02892500|Anesthetics|anesthetics|mesh-ancestor
92319578|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319579|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319580|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
92319581|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319582|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92319583|NCT02892500|Glucocorticoids|glucocorticoids|mesh-ancestor
92319585|NCT02892500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92319586|NCT02892500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92319587|NCT02892500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92319588|NCT00378872|Tranexamic Acid|tranexamic acid|mesh-list
92319589|NCT00378872|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92319591|NCT00378872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319592|NCT00378872|Hemostatics|hemostatics|mesh-ancestor
92319594|NCT00378404|Docetaxel|docetaxel|mesh-list
92319595|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319596|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
92319597|NCT00378404|Antimitotic Agents|antimitotic agents|mesh-ancestor
92319598|NCT00378404|Mitosis Modulators|mitosis modulators|mesh-ancestor
92319599|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319600|NCT03742154|Varenicline|varenicline|mesh-list
92319601|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92319602|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92319603|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
92319604|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319605|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319606|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319607|NCT02734940|Lidocaine|lidocaine|mesh-list
92319608|NCT02734940|Fentanyl|fentanyl|mesh-list
92319609|NCT02734940|Ketamine|ketamine|mesh-list
92319610|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
92319611|NCT02734940|Morphine|morphine|mesh-list
92319612|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319613|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
92319614|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319615|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319616|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
92319617|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319618|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92319619|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92319620|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92319621|NCT02734940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319622|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319623|NCT02734940|Analgesics|analgesics|mesh-ancestor
92319624|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92319625|NCT02734940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319626|NCT02734940|Anesthetics, General|anesthetics, general|mesh-ancestor
92319627|NCT02734940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92319628|NCT02734940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92319629|NCT02734940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319630|NCT02734940|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92319631|NCT02734940|Narcotics|narcotics|mesh-ancestor
92319632|NCT02734940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92319633|NCT02734940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319634|NCT02734940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319635|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92319636|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92319637|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319638|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
92319639|NCT00378092|Risperidone|risperidone|mesh-list
92319640|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92319641|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
92319642|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319643|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319644|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319645|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92319646|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319647|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319648|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319649|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92319650|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
92319652|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319653|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92319654|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92319655|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92319656|NCT02679560|Bupivacaine|bupivacaine|mesh-list
92319657|NCT02679560|Ropivacaine|ropivacaine|mesh-list
92319658|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
92319659|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
92319660|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91911957|NCT03154580|Acetylcysteine|acetylcysteine|mesh-list
92319661|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319662|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
92319663|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319665|NCT03723980|Calcium|calcium|mesh-list
92319666|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92319667|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319668|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319670|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319671|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
92319672|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319673|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319674|NCT02614586|Ondansetron|ondansetron|mesh-list
92319675|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
92319676|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
92319677|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319678|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319679|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319680|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
92319681|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
92319682|NCT02614586|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92319683|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92319684|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
92319685|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319686|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319687|NCT01211756|Oxytocin|oxytocin|mesh-list
92319688|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
92319689|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92319690|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319691|NCT03591458|Amitriptyline|amitriptyline|mesh-list
92319692|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92319693|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
92319694|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319695|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319696|NCT03591458|Analgesics|analgesics|mesh-ancestor
92319697|NCT03591458|Sensory System Agents|sensory system agents|mesh-ancestor
92319698|NCT03591458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319699|NCT03591458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319700|NCT03591458|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92319701|NCT03591458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92319702|NCT03591458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319703|NCT03591458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319704|NCT03591458|Adrenergic Agents|adrenergic agents|mesh-ancestor
92319705|NCT03591458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319706|NCT03565328|Niacinamide|niacinamide|mesh-list
92319708|NCT03565328|Nicotinic Acids|nicotinic acids|mesh-list
92319709|NCT03565328|Vitamin B Complex|vitamin b complex|mesh-ancestor
92319710|NCT03565328|Vitamins|vitamins|mesh-ancestor
92319711|NCT03565328|Micronutrients|micronutrients|mesh-ancestor
92319712|NCT03565328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319713|NCT03565328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92319714|NCT03565328|Antimetabolites|antimetabolites|mesh-ancestor
92319715|NCT03565328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319716|NCT03565328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92319717|NCT03565328|Vasodilator Agents|vasodilator agents|mesh-ancestor
92319718|NCT01206296|Gemcitabine|gemcitabine|mesh-list
92319719|NCT01206296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319720|NCT01206296|Antimetabolites|antimetabolites|mesh-ancestor
92319721|NCT01206296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319722|NCT01206296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319723|NCT02593682|Suvorexant|suvorexant|mesh-list
92319724|NCT02593682|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92348582|NCT01553916|Lithium Carbonate|lithium carbonate|mesh-list
92319726|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319727|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319728|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92319729|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319730|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319732|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
92319733|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92319734|NCT01200602|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92319735|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92319736|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
92319737|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972435|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319738|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319739|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92319740|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92319741|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92319742|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319743|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
92319744|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92319745|NCT01194908|Tamoxifen|tamoxifen|mesh-list
92319746|NCT01194908|Decitabine|decitabine|mesh-list
92319747|NCT01194908|Panobinostat|panobinostat|mesh-list
92319748|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319749|NCT01194908|Antimetabolites|antimetabolites|mesh-ancestor
92319750|NCT01194908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319751|NCT01194908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319752|NCT01194908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319753|NCT01194908|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92319754|NCT01194908|Hormone Antagonists|hormone antagonists|mesh-ancestor
92319755|NCT01194908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92319756|NCT01194908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319757|NCT01194908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92319758|NCT01194908|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92319759|NCT01194908|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92319760|NCT01194908|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92319761|NCT01194908|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92319762|NCT01163084|Leuprolide|leuprolide|mesh-list
92319763|NCT01163084|Goserelin|goserelin|mesh-list
92319764|NCT01163084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92319765|NCT01163084|Fertility Agents|fertility agents|mesh-ancestor
92319766|NCT01163084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92319767|NCT01163084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319768|NCT01163084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92319769|NCT01163084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319770|NCT01155518|Clomiphene|clomiphene|mesh-list
92319771|NCT01155518|Testosterone|testosterone|mesh-list
92319772|NCT01155518|Androgens|androgens|mesh-ancestor
92319773|NCT01155518|Hormones|hormones|mesh-ancestor
92319774|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92319775|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319776|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92319777|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
92319778|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92319779|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
92319780|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92319781|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92319782|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92319783|NCT03490916|Acetazolamide|acetazolamide|mesh-list
92319784|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
92319785|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92319786|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319787|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319789|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
92319790|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319791|NCT03333746|Nivolumab|nivolumab|mesh-list
92319792|NCT03333746|Lenalidomide|lenalidomide|mesh-list
92319793|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92319794|NCT03333746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319795|NCT03333746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92319796|NCT03333746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319797|NCT03333746|Immunologic Factors|immunologic factors|mesh-ancestor
92319798|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319799|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92319800|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92319801|NCT03333746|Growth Substances|growth substances|mesh-ancestor
92319802|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
92319803|NCT01139996|Clonidine|clonidine|mesh-list
92319804|NCT01139996|Analgesics|analgesics|mesh-ancestor
92319805|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
92319806|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319807|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319808|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92319809|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
92319810|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
92319811|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92319812|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92319813|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92319814|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92319815|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319816|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319817|NCT02417870|Aldesleukin|aldesleukin|mesh-list
92319818|NCT02417870|Interleukin-2|interleukin-2|mesh-list
92319819|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319820|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92319821|NCT02417870|Analgesics|analgesics|mesh-ancestor
92319822|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
92319823|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319824|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319825|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92319826|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92319827|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
92319828|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319829|NCT01131884|Alendronate|alendronate|mesh-list
92319830|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92319831|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319832|NCT02389712|Lamotrigine|lamotrigine|mesh-list
92319833|NCT02389712|Fluoxetine|fluoxetine|mesh-list
92319834|NCT02389712|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92319835|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92319836|NCT02389712|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348602|NCT01552902|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92319837|NCT02389712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319838|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319839|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
92319840|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319841|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92319842|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
92319843|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319844|NCT02389712|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92319845|NCT02389712|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92319846|NCT02389712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319847|NCT02389712|Anticonvulsants|anticonvulsants|mesh-ancestor
92319848|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92319849|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92319850|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92319851|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319852|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319853|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92319854|NCT02369744|Tamsulosin|tamsulosin|mesh-list
92319855|NCT02369744|Silodosin|silodosin|mesh-list
92319856|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92319857|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92319858|NCT02369744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92319859|NCT02369744|Adrenergic Agents|adrenergic agents|mesh-ancestor
92319860|NCT02369744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319861|NCT02369744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319862|NCT02369744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319863|NCT02369744|Urological Agents|urological agents|mesh-ancestor
92319864|NCT03577171|Entecavir|entecavir|mesh-list
92319865|NCT03577171|Antiviral Agents|antiviral agents|mesh-ancestor
92319866|NCT03577171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319867|NCT02367170|Midazolam|midazolam|mesh-list
92319868|NCT02367170|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92319869|NCT02367170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92319870|NCT02367170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319871|NCT02367170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319872|NCT02367170|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92319873|NCT02367170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319874|NCT02367170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319875|NCT02367170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92319876|NCT02367170|Anesthetics, General|anesthetics, general|mesh-ancestor
92319877|NCT02367170|Anesthetics|anesthetics|mesh-ancestor
92319878|NCT02367170|GABA Modulators|gaba modulators|mesh-ancestor
92319879|NCT02367170|GABA Agents|gaba agents|mesh-ancestor
92319880|NCT02367170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319881|NCT02367170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319882|NCT01078844|Memantine|memantine|mesh-list
92319883|NCT01078844|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92319884|NCT01078844|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92319885|NCT01078844|Dopamine Agents|dopamine agents|mesh-ancestor
92319886|NCT01078844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319887|NCT01078844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319888|NCT01078844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319889|NCT01078844|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92319890|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92319891|NCT00376051|Citalopram|citalopram|mesh-list
92319892|NCT00376051|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92319893|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92319894|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319895|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319896|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319897|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
92319898|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319899|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92348631|NCT01529268|Cysteamine|cysteamine|mesh-list
92319900|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
92319901|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319902|NCT01072526|Cyclosporine|cyclosporine|mesh-list
92319903|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
92319904|NCT01072526|Cyclosporins|cyclosporins|mesh-list
92319905|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319906|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319907|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92319908|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
92319909|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319910|NCT01072526|Antifungal Agents|antifungal agents|mesh-ancestor
92319911|NCT01072526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319912|NCT01072526|Dermatologic Agents|dermatologic agents|mesh-ancestor
92319913|NCT01072526|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92319914|NCT01072526|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92319915|NCT01072526|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92319916|NCT01072526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92319917|NCT05312840|Carboplatin|carboplatin|mesh-list
92319918|NCT05312840|Gemcitabine|gemcitabine|mesh-list
92319919|NCT05312840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319920|NCT05312840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92319921|NCT05312840|Antimetabolites|antimetabolites|mesh-ancestor
92319922|NCT05312840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319923|NCT00376129|Alefacept|alefacept|mesh-list
92319924|NCT00376129|Dermatologic Agents|dermatologic agents|mesh-ancestor
92319925|NCT00376129|Immunologic Factors|immunologic factors|mesh-ancestor
92319926|NCT00376129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319927|NCT01035944|Chitosan|chitosan|mesh-list
92319928|NCT01035944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92319929|NCT01035944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92319930|NCT01035944|Antimetabolites|antimetabolites|mesh-ancestor
92319931|NCT01035944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319932|NCT01035944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92319933|NCT01035944|Chelating Agents|chelating agents|mesh-ancestor
92319934|NCT01035944|Sequestering Agents|sequestering agents|mesh-ancestor
92319936|NCT01035944|Coagulants|coagulants|mesh-ancestor
92319937|NCT00378638|Bevacizumab|bevacizumab|mesh-list
92319938|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92319939|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92319940|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92319941|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92319942|NCT00378638|Growth Substances|growth substances|mesh-ancestor
92319943|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319944|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92319945|NCT03582553|Naringenin|naringenin|mesh-list
92319946|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92319947|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319948|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92319949|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
92319950|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92319951|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319952|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
92319953|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92319954|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92319955|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
92319956|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319957|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92319958|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
92319959|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
91972656|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
92319960|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92319961|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92319962|NCT04331834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319963|NCT04331834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319964|NCT04331834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319965|NCT04331834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92319966|NCT01023620|Pioglitazone|pioglitazone|mesh-list
92319967|NCT01023620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92319968|NCT01023620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319969|NCT03595579|Bupropion|bupropion|mesh-list
92319970|NCT03595579|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92319971|NCT03595579|Antidepressive Agents|antidepressive agents|mesh-ancestor
92319972|NCT03595579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319973|NCT03595579|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92319974|NCT03595579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92319975|NCT03595579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92319976|NCT03595579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92319977|NCT03595579|Dopamine Agents|dopamine agents|mesh-ancestor
92319978|NCT03595579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92319979|NCT03595579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319980|NCT03595579|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92319981|NCT03595579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92319982|NCT03595579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92319983|NCT02200328|Metronidazole|metronidazole|mesh-list
92319984|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92319985|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92319986|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92319987|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92319988|NCT04327843|Haloperidol|haloperidol|mesh-list
92319989|NCT04327843|Haloperidol decanoate|haloperidol decanoate|mesh-list
92319990|NCT04327843|Antiemetics|antiemetics|mesh-ancestor
92319991|NCT04327843|Autonomic Agents|autonomic agents|mesh-ancestor
92319992|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92319993|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92319994|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92319995|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92319996|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92319997|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92319998|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92319999|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92320000|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
92320001|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320002|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320003|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92320004|NCT02147834|Ranolazine|ranolazine|mesh-list
92320005|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92320006|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320007|NCT02147834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320008|NCT00979550|Imiquimod|imiquimod|mesh-list
92320009|NCT00979550|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92320010|NCT00979550|Immunologic Factors|immunologic factors|mesh-ancestor
92320011|NCT00979550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320012|NCT00979550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320013|NCT00979550|Interferon Inducers|interferon inducers|mesh-ancestor
92320014|NCT00966992|Zoledronic Acid|zoledronic acid|mesh-list
92320015|NCT00966992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92320016|NCT00966992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320018|NCT00379730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320019|NCT00379730|Glucocorticoids|glucocorticoids|mesh-ancestor
92320020|NCT00379730|Hormones|hormones|mesh-ancestor
91936669|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320021|NCT00379730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320022|NCT00379730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320023|NCT00379730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92320024|NCT00379730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320025|NCT02074904|Topiramate|topiramate|mesh-list
92320026|NCT02074904|Anticonvulsants|anticonvulsants|mesh-ancestor
92320027|NCT02074904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92320028|NCT02074904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320030|NCT02043860|Immunologic Factors|immunologic factors|mesh-ancestor
92320031|NCT02043860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320032|NCT02043860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92320033|NCT02043860|Alkylating Agents|alkylating agents|mesh-ancestor
92320034|NCT02043860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320035|NCT02043860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320036|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92320037|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320039|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92320040|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320041|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320042|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320043|NCT00869414|Insulin|insulin|mesh-list
92320044|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92320045|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
92320046|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92320047|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320048|NCT00843986|Conivaptan|conivaptan|mesh-list
92320049|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92320050|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320051|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
92320052|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320053|NCT03608839|Dexamethasone|dexamethasone|mesh-list
92320054|NCT03608839|Dexamethasone acetate|dexamethasone acetate|mesh-list
92320055|NCT03608839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92320056|NCT03608839|BB 1101|bb 1101|mesh-list
92320057|NCT03608839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320058|NCT03608839|Antiemetics|antiemetics|mesh-ancestor
92320059|NCT03608839|Autonomic Agents|autonomic agents|mesh-ancestor
92320060|NCT03608839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320061|NCT03608839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320062|NCT03608839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92320063|NCT03608839|Glucocorticoids|glucocorticoids|mesh-ancestor
92320064|NCT03608839|Hormones|hormones|mesh-ancestor
92320065|NCT03608839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320066|NCT03608839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92320067|NCT03608839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320068|NCT03608839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92320069|NCT03608839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320070|NCT03608839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320071|NCT00845702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92320072|NCT00845702|Chelating Agents|chelating agents|mesh-ancestor
92320073|NCT00845702|Sequestering Agents|sequestering agents|mesh-ancestor
92320074|NCT00845702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320075|NCT03610399|Primaquine|primaquine|mesh-list
92320076|NCT03610399|Antimalarials|antimalarials|mesh-ancestor
92320077|NCT03610399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92320078|NCT03610399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92320079|NCT03610399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320080|NCT03610633|Oxytocin|oxytocin|mesh-list
92320081|NCT03610633|Oxytocics|oxytocics|mesh-ancestor
92320082|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320083|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320084|NCT00832520|Mirtazapine|mirtazapine|mesh-list
92320085|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
92320086|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92320087|NCT00832520|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92320088|NCT00832520|Histamine Antagonists|histamine antagonists|mesh-ancestor
92320089|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
92320090|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320091|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320092|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320093|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92320095|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320096|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92320097|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92320098|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92320099|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
92320100|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92320101|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92320102|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
92320103|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92320104|NCT03545893|Ibuprofen|ibuprofen|mesh-list
92320105|NCT03545893|Oxycodone|oxycodone|mesh-list
92320106|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92320107|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92320108|NCT03545893|Analgesics|analgesics|mesh-ancestor
92320109|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
92320110|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320111|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320112|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320113|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320114|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92320115|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320116|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320117|NCT03545893|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92320118|NCT03545893|Narcotics|narcotics|mesh-ancestor
92320119|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320120|NCT01877564|Metformin|metformin|mesh-list
92320121|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92320122|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320123|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
92320124|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320125|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
92320126|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92320127|NCT00376987|Protective Agents|protective agents|mesh-ancestor
92320128|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320129|NCT01889420|Everolimus|everolimus|mesh-list
92320130|NCT01889420|Pomalidomide|pomalidomide|mesh-list
92320131|NCT01889420|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92320132|NCT01889420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92320133|NCT01889420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320134|NCT01889420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320135|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320136|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
92320137|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320138|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320139|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92320140|NCT01889420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92320141|NCT01889420|Growth Substances|growth substances|mesh-ancestor
92320142|NCT01889420|Growth Inhibitors|growth inhibitors|mesh-ancestor
92320143|NCT00379028|Fluticasone|fluticasone|mesh-list
92320144|NCT00379028|Budesonide|budesonide|mesh-list
92320145|NCT00379028|Formoterol Fumarate|formoterol fumarate|mesh-list
92320146|NCT00379028|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92320147|NCT00379028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320148|NCT00379028|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92320149|NCT00379028|Autonomic Agents|autonomic agents|mesh-ancestor
92320150|NCT00379028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320151|NCT00379028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320152|NCT00379028|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92320154|NCT00379028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320155|NCT00379028|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92320156|NCT00379028|Glucocorticoids|glucocorticoids|mesh-ancestor
92320157|NCT00379028|Hormones|hormones|mesh-ancestor
92320158|NCT00379028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320159|NCT00379028|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92320160|NCT00379028|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92320161|NCT00379028|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92320162|NCT00379028|Adrenergic Agents|adrenergic agents|mesh-ancestor
92320163|NCT00379028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320164|NCT00379028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320165|NCT05286554|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92320166|NCT05286554|Hormones|hormones|mesh-list
92320167|NCT05286554|Progesterone|progesterone|mesh-list
92320168|NCT05286554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320169|NCT05286554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320171|NCT05286554|Luteolytic Agents|luteolytic agents|mesh-ancestor
92320172|NCT05286554|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92320173|NCT05286554|Contraceptive Agents|contraceptive agents|mesh-ancestor
92320174|NCT05286554|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320175|NCT05286554|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92320176|NCT05286554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92320177|NCT05286554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320178|NCT00379262|Fluorouracil|fluorouracil|mesh-list
92320179|NCT00379262|Capecitabine|capecitabine|mesh-list
92320180|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
92320181|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320182|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320183|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320184|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320186|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320187|NCT00793520|Milnacipran|milnacipran|mesh-list
92320188|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
92320189|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92320190|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92320191|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320192|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320193|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320194|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320195|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92320196|NCT00793520|Analgesics|analgesics|mesh-ancestor
92320197|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
92320198|NCT00793520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320199|NCT00793520|Antidepressive Agents|antidepressive agents|mesh-ancestor
92320200|NCT00793520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92320201|NCT03621085|Ketamine|ketamine|mesh-list
92320202|NCT03621085|Analgesics|analgesics|mesh-ancestor
92320203|NCT03621085|Sensory System Agents|sensory system agents|mesh-ancestor
92320204|NCT03621085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320205|NCT03621085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320206|NCT03621085|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92320207|NCT03621085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92320208|NCT03621085|Anesthetics, General|anesthetics, general|mesh-ancestor
92320209|NCT03621085|Anesthetics|anesthetics|mesh-ancestor
92320210|NCT03621085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320211|NCT03621085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92320212|NCT03621085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92320213|NCT03621085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320214|NCT03621085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320215|NCT00795236|Melatonin|melatonin|mesh-list
92320216|NCT00795236|Antioxidants|antioxidants|mesh-ancestor
92320217|NCT00795236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320218|NCT00795236|Protective Agents|protective agents|mesh-ancestor
92320219|NCT00795236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320220|NCT00795236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320221|NCT00790478|Melatonin|melatonin|mesh-list
92320222|NCT00790478|Antioxidants|antioxidants|mesh-ancestor
92320223|NCT00790478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320224|NCT00790478|Protective Agents|protective agents|mesh-ancestor
92320225|NCT00790478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320226|NCT00790478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320227|NCT04490239|Heparin|heparin|mesh-list
92320228|NCT04490239|Calcium heparin|calcium heparin|mesh-list
92320229|NCT04490239|Anticoagulants|anticoagulants|mesh-ancestor
92320230|NCT04490239|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92320231|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92348676|NCT01549002|Fentanyl|fentanyl|mesh-list
92320232|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320233|NCT00791336|Nelfinavir|nelfinavir|mesh-list
92320234|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92320235|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92320236|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
92320237|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320238|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320239|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92320240|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92320241|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
92320242|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320243|NCT00771602|Rituximab|rituximab|mesh-list
92320244|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
92320245|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92320246|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320247|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
92320248|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320249|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320250|NCT01804166|Infliximab|infliximab|mesh-list
92320251|NCT01804166|Golimumab|golimumab|mesh-list
92320252|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92320253|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320254|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320255|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92320256|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320257|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320258|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
92320259|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320260|NCT04459585|Dabigatran|dabigatran|mesh-list
92320261|NCT04459585|Antithrombins|antithrombins|mesh-ancestor
92320262|NCT04459585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92320263|NCT04459585|Protease Inhibitors|protease inhibitors|mesh-ancestor
92320264|NCT04459585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320265|NCT04459585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320266|NCT04459585|Anticoagulants|anticoagulants|mesh-ancestor
92320267|NCT05080556|Carboplatin|carboplatin|mesh-list
92320268|NCT05080556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320269|NCT01797380|Escitalopram|escitalopram|mesh-list
92320270|NCT01797380|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92320271|NCT01797380|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92320272|NCT01797380|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320273|NCT01797380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320274|NCT01797380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320275|NCT01797380|Serotonin Agents|serotonin agents|mesh-ancestor
92320276|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320277|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
92320278|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92320279|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92320280|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92320281|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320282|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320283|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
92320284|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320285|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320286|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92320287|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320288|NCT00726830|Morphine|morphine|mesh-list
92320289|NCT00726830|Oxycodone|oxycodone|mesh-list
92320290|NCT00726830|Methadone|methadone|mesh-list
92320291|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92320292|NCT00726830|Narcotics|narcotics|mesh-ancestor
92320293|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320294|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320295|NCT00726830|Analgesics|analgesics|mesh-ancestor
92320296|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
92320297|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320298|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
92320299|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
92320300|NCT00691652|Rituximab|rituximab|mesh-list
92320301|NCT00691652|Clofarabine|clofarabine|mesh-list
92320302|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92320303|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320304|NCT00691652|Immunologic Factors|immunologic factors|mesh-ancestor
92320305|NCT00691652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320306|NCT00691652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320307|NCT00691652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320308|NCT00691652|Antimetabolites|antimetabolites|mesh-ancestor
92320309|NCT00691652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320310|NCT00691574|Melatonin|melatonin|mesh-list
92320311|NCT00691574|Antioxidants|antioxidants|mesh-ancestor
92320312|NCT00691574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320313|NCT00691574|Protective Agents|protective agents|mesh-ancestor
92320314|NCT00691574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320315|NCT00691574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320316|NCT00685880|Betamethasone|betamethasone|mesh-list
92320317|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
92320318|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320319|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
92320320|NCT00685880|Hormones|hormones|mesh-ancestor
92320321|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320322|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320323|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92320324|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
92320325|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92320326|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
92320327|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320328|NCT00681044|Melphalan|melphalan|mesh-list
92320329|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
92320330|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973038|NCT03277001|Enoxaparin|enoxaparin|mesh-list
92320331|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92320332|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
92320333|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320334|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320335|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92320336|NCT00681044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320337|NCT03632083|Contact Lens Solutions|contact lens solutions|mesh-list
92320338|NCT03632083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92320339|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
92320340|NCT03632083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320341|NCT03633487|Guaifenesin|guaifenesin|mesh-list
92320342|NCT03633487|Expectorants|expectorants|mesh-ancestor
92320343|NCT03633487|Respiratory System Agents|respiratory system agents|mesh-ancestor
92320344|NCT00423020|Epoetin Alfa|epoetin alfa|mesh-list
92320345|NCT00423020|Hematinics|hematinics|mesh-ancestor
92320346|NCT01756586|Dexamethasone|dexamethasone|mesh-list
92320347|NCT01756586|Bupivacaine|bupivacaine|mesh-list
92320348|NCT01756586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320349|NCT01756586|Antiemetics|antiemetics|mesh-ancestor
92320350|NCT01756586|Autonomic Agents|autonomic agents|mesh-ancestor
92320351|NCT01756586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320352|NCT01756586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320353|NCT01756586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92320354|NCT01756586|Glucocorticoids|glucocorticoids|mesh-ancestor
92320355|NCT01756586|Hormones|hormones|mesh-ancestor
92320356|NCT01756586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320357|NCT01756586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92320358|NCT01756586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320359|NCT01756586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92320360|NCT01756586|Anesthetics|anesthetics|mesh-ancestor
92320361|NCT01756586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320362|NCT01756586|Sensory System Agents|sensory system agents|mesh-ancestor
92320363|NCT03636061|Varenicline|varenicline|mesh-list
92320364|NCT03636061|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92320365|NCT03636061|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92320366|NCT03636061|Cholinergic Agents|cholinergic agents|mesh-ancestor
92320367|NCT03636061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320368|NCT03636061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320369|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320370|NCT00661466|Bupivacaine|bupivacaine|mesh-list
92320372|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
92320373|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320374|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320375|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
92320376|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320377|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
92320378|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92320379|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320380|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92320381|NCT01718444|Clomiphene|clomiphene|mesh-list
92320382|NCT01718444|Enclomiphene|enclomiphene|mesh-list
92320383|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
92320384|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
92320385|NCT01718444|Progestins|progestins|mesh-list
92320386|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92320387|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
92320388|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320389|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320390|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92320391|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
92320392|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320393|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92320394|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92320395|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92320396|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92320397|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92320398|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
92320399|NCT01718444|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92320400|NCT01718444|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92320401|NCT01718444|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92320402|NCT01718444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92320403|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320404|NCT01718444|Hormones|hormones|mesh-ancestor
92320405|NCT00638222|Carvedilol|carvedilol|mesh-list
92320406|NCT00638222|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92320407|NCT00638222|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92320408|NCT00638222|Adrenergic Agents|adrenergic agents|mesh-ancestor
92320409|NCT00638222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320410|NCT00638222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320411|NCT00638222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320412|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92320413|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
92320414|NCT00638222|Protective Agents|protective agents|mesh-ancestor
92320415|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92320416|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320417|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92320418|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
92320419|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92320420|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92320423|NCT00634322|Protective Agents|protective agents|mesh-ancestor
92320424|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320425|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
92320426|NCT00634322|Vitamins|vitamins|mesh-ancestor
92320427|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
92320428|NCT00379886|Thiopental|thiopental|mesh-list
92320429|NCT00379886|Propofol|propofol|mesh-list
92320430|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92320431|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320432|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320433|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92320434|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
92320435|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
92320436|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
92320437|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
92320438|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
92320439|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320440|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320441|NCT01705106|Celecoxib|celecoxib|mesh-list
92320442|NCT01705106|Capecitabine|capecitabine|mesh-list
92320443|NCT01705106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320444|NCT01705106|Antimetabolites|antimetabolites|mesh-ancestor
92320445|NCT01705106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320446|NCT01705106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320447|NCT01705106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92320448|NCT01705106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92320449|NCT01705106|Analgesics|analgesics|mesh-ancestor
92320450|NCT01705106|Sensory System Agents|sensory system agents|mesh-ancestor
92320451|NCT01705106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320452|NCT01705106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320453|NCT01705106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320454|NCT01705106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320455|NCT01705106|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92320456|NCT01705106|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92320457|NCT01705106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320458|NCT00624650|Phenylephrine|phenylephrine|mesh-list
92320459|NCT00624650|Dobutamine|dobutamine|mesh-list
92320460|NCT00624650|Furosemide|furosemide|mesh-list
92320461|NCT00624650|Vasopressins|vasopressins|mesh-list
92320462|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
92320463|NCT00624650|Epinephrine|epinephrine|mesh-list
92320464|NCT00624650|Racepinephrine|racepinephrine|mesh-list
92320465|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
92320466|NCT00624650|Norepinephrine|norepinephrine|mesh-list
92320467|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92320468|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
92320469|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92320470|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92320471|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
92320472|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320473|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320474|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320475|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92320476|NCT00624650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92320477|NCT00624650|Autonomic Agents|autonomic agents|mesh-ancestor
92320478|NCT00624650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320479|NCT00624650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92320480|NCT00624650|Respiratory System Agents|respiratory system agents|mesh-ancestor
92320482|NCT00624650|Sympathomimetics|sympathomimetics|mesh-ancestor
92320483|NCT00624650|Diuretics|diuretics|mesh-ancestor
92320484|NCT00624650|Natriuretic Agents|natriuretic agents|mesh-ancestor
92320485|NCT00624650|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92320486|NCT00624650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320487|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92320488|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
92320489|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92320490|NCT00624650|Protective Agents|protective agents|mesh-ancestor
92320491|NCT00624650|Hemostatics|hemostatics|mesh-ancestor
92320492|NCT00624650|Coagulants|coagulants|mesh-ancestor
92320493|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92320494|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92320495|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
92320496|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92320497|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92320498|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
92320499|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320500|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92320501|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92320502|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320503|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320505|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
92320506|NCT00610532|Probenecid|probenecid|mesh-list
92320507|NCT00610532|Phenytoin|phenytoin|mesh-list
92320508|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
92320509|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92320510|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92320511|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320512|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320513|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92320514|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92320515|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
92320516|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
92320517|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320518|NCT03642457|Bupivacaine|bupivacaine|mesh-list
92320519|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
92320520|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
92320521|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320522|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320523|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
92320524|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320525|NCT00379418|Abciximab|abciximab|mesh-list
92320526|NCT00379418|Anticoagulants|anticoagulants|mesh-ancestor
92320527|NCT00379418|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92320528|NCT00379496|Antidepressive Agents|antidepressive agents|mesh-list
92320529|NCT00379496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92320530|NCT00378716|Leucovorin|leucovorin|mesh-list
92320531|NCT00378716|Fluorouracil|fluorouracil|mesh-list
92320532|NCT00378716|Tegafur|tegafur|mesh-list
92320533|NCT00378716|Calcium|calcium|mesh-list
92320534|NCT00378716|Levoleucovorin|levoleucovorin|mesh-list
92320535|NCT00378716|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92320536|NCT00378716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320537|NCT00378716|Antimetabolites|antimetabolites|mesh-ancestor
92320538|NCT00378716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320539|NCT00378716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320540|NCT00378716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320541|NCT00378716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320542|NCT00378716|Immunologic Factors|immunologic factors|mesh-ancestor
92320543|NCT00378716|Antidotes|antidotes|mesh-ancestor
92320544|NCT00378716|Protective Agents|protective agents|mesh-ancestor
92320546|NCT00378716|Vitamins|vitamins|mesh-ancestor
92320547|NCT00378716|Micronutrients|micronutrients|mesh-ancestor
92320548|NCT03644095|Phenylpropanolamine|phenylpropanolamine|mesh-list
92320549|NCT03644095|Guaifenesin|guaifenesin|mesh-list
92320550|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92320551|NCT03644095|Expectorants|expectorants|mesh-ancestor
92320552|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
92320553|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92320554|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92320555|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
92320556|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320557|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320558|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320559|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
92320560|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92320561|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
92320562|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
92320563|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320564|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
92320565|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92320567|NCT01633814|Estrogens|estrogens|mesh-ancestor
92320568|NCT01633814|Hormones|hormones|mesh-ancestor
92320569|NCT01633814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91911958|NCT03154580|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92320570|NCT01633814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320571|NCT04585490|Paclitaxel|paclitaxel|mesh-list
92320572|NCT04585490|Cisplatin|cisplatin|mesh-list
92320573|NCT04585490|Carboplatin|carboplatin|mesh-list
92320574|NCT04585490|Pemetrexed|pemetrexed|mesh-list
92320575|NCT04585490|Durvalumab|durvalumab|mesh-list
92320576|NCT04585490|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92320577|NCT04585490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92320578|NCT04585490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320579|NCT04585490|Tubulin Modulators|tubulin modulators|mesh-ancestor
92320580|NCT04585490|Antimitotic Agents|antimitotic agents|mesh-ancestor
92320581|NCT04585490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92320582|NCT04585490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320583|NCT04585490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320584|NCT04585490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92320585|NCT04585490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320586|NCT04585490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92320587|NCT04585490|Immunologic Factors|immunologic factors|mesh-ancestor
92320588|NCT04585490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320589|NCT04714099|Cyclosporine|cyclosporine|mesh-list
92320590|NCT04714099|Cyclosporins|cyclosporins|mesh-list
92320591|NCT04714099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320592|NCT04714099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320593|NCT04714099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320594|NCT04714099|Immunologic Factors|immunologic factors|mesh-ancestor
92320595|NCT04714099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320596|NCT04714099|Antifungal Agents|antifungal agents|mesh-ancestor
92320597|NCT04714099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320598|NCT04714099|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320599|NCT04714099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320600|NCT04714099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92320601|NCT04566770|Vaccines|vaccines|mesh-list
92320602|NCT04566770|Immunologic Factors|immunologic factors|mesh-ancestor
92320603|NCT04566770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320604|NCT04342663|Fluvoxamine|fluvoxamine|mesh-list
92320605|NCT04342663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92320606|NCT04342663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92320607|NCT04342663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320608|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320609|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92320610|NCT04342663|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92320611|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92320612|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320613|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320614|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320615|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
92320616|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92320617|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
92320618|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92320619|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92320620|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320621|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92320623|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
92320624|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
92320625|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92320626|NCT00589550|Sorafenib|sorafenib|mesh-list
92320627|NCT00589550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320628|NCT00589550|Antiviral Agents|antiviral agents|mesh-ancestor
92320629|NCT00589550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320630|NCT00589550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92320631|NCT00589550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320632|NCT00589550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320633|NCT00589550|Immunologic Factors|immunologic factors|mesh-ancestor
91973325|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92320634|NCT00589550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320635|NCT01636466|Everolimus|everolimus|mesh-list
92320636|NCT01636466|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92320637|NCT01636466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92320638|NCT01636466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320639|NCT01636466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320640|NCT01636466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320641|NCT01636466|Immunologic Factors|immunologic factors|mesh-ancestor
92320642|NCT01636466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320643|NCT01636466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320644|NCT00568802|Hydroxyurea|hydroxyurea|mesh-list
92320645|NCT00568802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320646|NCT00568802|Antisickling Agents|antisickling agents|mesh-ancestor
92320647|NCT00568802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320648|NCT00568802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320649|NCT00568802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320650|NCT04499924|Paclitaxel|paclitaxel|mesh-list
92320651|NCT04499924|Trastuzumab|trastuzumab|mesh-list
92320652|NCT04499924|Ramucirumab|ramucirumab|mesh-list
92320653|NCT04499924|Tucatinib|tucatinib|mesh-list
92320654|NCT04499924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92320655|NCT04499924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320656|NCT04499924|Tubulin Modulators|tubulin modulators|mesh-ancestor
92320657|NCT04499924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92320658|NCT04499924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92320659|NCT04499924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320660|NCT04499924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92320661|NCT04499924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92320662|NCT04499924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320663|NCT03949621|Vedolizumab|vedolizumab|mesh-list
92320664|NCT03949621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92320665|NCT04429880|Oxytocin|oxytocin|mesh-list
92320666|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
92320667|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320668|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320669|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
92320670|NCT04311632|Tacrolimus|tacrolimus|mesh-list
92320671|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320672|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
92320673|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320674|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92320675|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320676|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320677|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92320678|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320679|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92320680|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
92320681|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92320682|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320683|NCT01692158|Heparin|heparin|mesh-list
92320684|NCT01692158|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92320685|NCT01692158|Tinzaparin|tinzaparin|mesh-list
92320686|NCT01692158|Dalteparin|dalteparin|mesh-list
92320687|NCT01692158|Anticoagulants|anticoagulants|mesh-ancestor
92320688|NCT01692158|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92320689|NCT01692158|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92320690|NCT01692158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320691|NCT01570634|Antidiarrheals|antidiarrheals|mesh-list
92320692|NCT01570634|Loperamide|loperamide|mesh-list
92320693|NCT01570634|Calcium Aluminosilicate|calcium aluminosilicate|mesh-list
92320694|NCT01570634|Calcium|calcium|mesh-list
92320695|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92320696|NCT01570634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320698|NCT03928327|Itraconazole|itraconazole|mesh-list
92320699|NCT03928327|Rifampin|rifampin|mesh-list
92320700|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
92320701|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320702|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92320703|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92320704|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320705|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320706|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92320708|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320709|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320710|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91973399|NCT03261635|Indomethacin|indomethacin|mesh-list
92320711|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92320712|NCT03928327|Antitubercular Agents|antitubercular agents|mesh-ancestor
92320713|NCT03928327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92320714|NCT03928327|Leprostatic Agents|leprostatic agents|mesh-ancestor
92320715|NCT03928327|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320716|NCT03928327|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92320717|NCT03928327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92320718|NCT03928327|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92320719|NCT03928327|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91911959|NCT03154580|Antiviral Agents|antiviral agents|mesh-ancestor
92320720|NCT03928327|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92320721|NCT03928327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92320723|NCT01055756|Pseudoephedrine|pseudoephedrine|mesh-list
92320724|NCT01055756|Ephedrine|ephedrine|mesh-list
92320725|NCT01055756|Antipruritics|antipruritics|mesh-ancestor
92320726|NCT01055756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320727|NCT01055756|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92320728|NCT01055756|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92320729|NCT01055756|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92320730|NCT01055756|Histamine Antagonists|histamine antagonists|mesh-ancestor
92320731|NCT01055756|Histamine Agents|histamine agents|mesh-ancestor
92320732|NCT01055756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92320733|NCT01055756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320734|NCT01055756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320735|NCT01055756|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92320736|NCT01055756|Autonomic Agents|autonomic agents|mesh-ancestor
92320737|NCT01055756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320738|NCT01055756|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92320739|NCT01055756|Respiratory System Agents|respiratory system agents|mesh-ancestor
92320740|NCT01055756|Nasal Decongestants|nasal decongestants|mesh-ancestor
92320741|NCT01055756|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92320742|NCT01055756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92320743|NCT01055756|Sympathomimetics|sympathomimetics|mesh-ancestor
92320744|NCT01055756|Adrenergic Agents|adrenergic agents|mesh-ancestor
92320745|NCT00652574|Dasatinib|dasatinib|mesh-list
92320746|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320747|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92320748|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320749|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320750|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
92320751|NCT01550510|Irinotecan|irinotecan|mesh-list
92320752|NCT01550510|Camptothecin|camptothecin|mesh-list
92320753|NCT01550510|Vitamins|vitamins|mesh-ancestor
92320754|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
92320755|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320756|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92320757|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92320758|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320759|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320760|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320761|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
92320762|NCT01550510|Protective Agents|protective agents|mesh-ancestor
92320763|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92320764|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
92320765|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
92320766|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92320767|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92320769|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320770|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320771|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320772|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
92320773|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
92348743|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
92320774|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92320775|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320776|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320777|NCT00556400|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92320779|NCT00521924|Chloroquine|chloroquine|mesh-list
92320780|NCT00521924|Sulfasalazine|sulfasalazine|mesh-list
92320781|NCT00521924|Infliximab|infliximab|mesh-list
92320782|NCT00521924|Methotrexate|methotrexate|mesh-list
92320783|NCT00521924|Antirheumatic Agents|antirheumatic agents|mesh-list
92320784|NCT00521924|Cyclosporins|cyclosporins|mesh-list
92320785|NCT00521924|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91973473|NCT03261791|Apatinib|apatinib|mesh-list
92320786|NCT00521924|Abortifacient Agents|abortifacient agents|mesh-ancestor
92320787|NCT00521924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320788|NCT00521924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320789|NCT00521924|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320790|NCT00521924|Antimetabolites|antimetabolites|mesh-ancestor
92320791|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320792|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320793|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320794|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320795|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92320796|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320797|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
92320798|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320799|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
92320800|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320801|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92320802|NCT00521924|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92320803|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320804|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92320805|NCT00521924|Amebicides|amebicides|mesh-ancestor
92320806|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92320807|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92320808|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
92320809|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92320810|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92320811|NCT00521924|Analgesics|analgesics|mesh-ancestor
92320812|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
92320813|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320814|NCT03927781|Pregabalin|pregabalin|mesh-list
92320815|NCT03927781|Analgesics|analgesics|mesh-ancestor
92320816|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
92320817|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320818|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320819|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
92320820|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92320821|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92320822|NCT03927781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320823|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92320824|NCT03927781|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92320825|NCT03927781|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92320826|NCT03927781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320827|NCT03927781|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92320828|NCT00379964|Caspofungin|caspofungin|mesh-list
92320829|NCT00379964|Antifungal Agents|antifungal agents|mesh-ancestor
92320830|NCT00379964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320831|NCT00379964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320832|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320833|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92320834|NCT01545518|Immunologic Factors|immunologic factors|mesh-ancestor
92320835|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320836|NCT01526408|Famciclovir|famciclovir|mesh-list
92320837|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
92320838|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320839|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320840|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348749|NCT01524198|Hormones|hormones|mesh-ancestor
92320841|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320843|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92320844|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320845|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320846|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92320847|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
92320848|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
92320849|NCT00000734|Zidovudine|zidovudine|mesh-list
92320850|NCT00000734|Trimethoprim|trimethoprim|mesh-list
92320851|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
92320852|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92320853|NCT00000734|Antimetabolites|antimetabolites|mesh-ancestor
92320854|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320855|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92320856|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320857|NCT00000734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320858|NCT00000734|Antiviral Agents|antiviral agents|mesh-ancestor
92320859|NCT00000734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320860|NCT00000734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92320861|NCT00000734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92320862|NCT00000734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92320863|NCT00000734|Antimalarials|antimalarials|mesh-ancestor
92320864|NCT00000734|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92320865|NCT00000734|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92320866|NCT00000734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92320867|NCT00000734|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92320868|NCT00000734|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92320869|NCT00000734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92320870|NCT00000734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92320871|NCT03663283|Bupivacaine|bupivacaine|mesh-list
92320872|NCT03663283|Anesthetics, Local|anesthetics, local|mesh-ancestor
92320873|NCT03663283|Anesthetics|anesthetics|mesh-ancestor
92320874|NCT03663283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320875|NCT03663283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320876|NCT03663283|Sensory System Agents|sensory system agents|mesh-ancestor
92320877|NCT03663283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320878|NCT00000764|Interferons|interferons|mesh-list
92320879|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
92320880|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
92320881|NCT00000764|Isotretinoin|isotretinoin|mesh-list
92320882|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320883|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
92320884|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320885|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
92320886|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320887|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320888|NCT03909763|Danazol|danazol|mesh-list
92320889|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92320890|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
92320891|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320892|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320893|NCT00484718|Celecoxib|celecoxib|mesh-list
92320894|NCT00484718|Oxycodone|oxycodone|mesh-list
92320895|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92320896|NCT00484718|Narcotics|narcotics|mesh-ancestor
92320897|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92320898|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320899|NCT00484718|Analgesics|analgesics|mesh-ancestor
92320900|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
92320901|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320902|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92320903|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92320904|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320905|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320906|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92320907|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92320908|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320909|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320910|NCT03665155|Daratumumab|daratumumab|mesh-list
92320911|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320912|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92320913|NCT00448682|Leucovorin|leucovorin|mesh-list
92320914|NCT00448682|Docetaxel|docetaxel|mesh-list
92320915|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
92320916|NCT00448682|Floxuridine|floxuridine|mesh-list
92320917|NCT00448682|Levoleucovorin|levoleucovorin|mesh-list
92320918|NCT00448682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320919|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
92320920|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
92320921|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
92320922|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320923|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320924|NCT00448682|Antidotes|antidotes|mesh-ancestor
92320925|NCT00448682|Protective Agents|protective agents|mesh-ancestor
92320926|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
92320927|NCT00448682|Vitamins|vitamins|mesh-ancestor
92320928|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
92320929|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320930|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
92320931|NCT04713488|Vaccines|vaccines|mesh-list
92320932|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
92320933|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320934|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92320935|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92320936|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320937|NCT00380120|Warfarin|warfarin|mesh-list
92320938|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
92320939|NCT00000770|Zidovudine|zidovudine|mesh-list
92320940|NCT00000770|Nevirapine|nevirapine|mesh-list
92320941|NCT00000770|Didanosine|didanosine|mesh-list
92320942|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
92320943|NCT00000770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320944|NCT00000770|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92320945|NCT00000770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320946|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320947|NCT00000770|Antiviral Agents|antiviral agents|mesh-ancestor
91912576|NCT02083055|Analgesics|analgesics|mesh-ancestor
92320948|NCT00000770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320949|NCT00000770|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92320950|NCT00000770|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92320951|NCT00000770|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92320952|NCT00000770|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92320953|NCT00368654|Methotrexate|methotrexate|mesh-list
92320954|NCT00368654|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92320955|NCT00368654|Abortifacient Agents|abortifacient agents|mesh-ancestor
92320956|NCT00368654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92320957|NCT00368654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320958|NCT00368654|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92320959|NCT00368654|Antimetabolites|antimetabolites|mesh-ancestor
92320960|NCT00368654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320961|NCT00368654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320962|NCT00368654|Dermatologic Agents|dermatologic agents|mesh-ancestor
92320963|NCT00368654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320964|NCT00368654|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92320965|NCT00368654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92320966|NCT00368654|Immunologic Factors|immunologic factors|mesh-ancestor
92320967|NCT00368654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92320968|NCT00368654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92320969|NCT00000776|Fluconazole|fluconazole|mesh-list
92320970|NCT00000776|Amphotericin B|amphotericin b|mesh-list
92320971|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92320972|NCT00000776|Flucytosine|flucytosine|mesh-list
92320973|NCT00000776|Dexamethasone|dexamethasone|mesh-list
92320974|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92320975|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
92320976|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
92320977|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92320978|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92320982|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92320983|NCT00000776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92320984|NCT00000776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92320985|NCT00000776|Antifungal Agents|antifungal agents|mesh-ancestor
92320986|NCT00000776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92320987|NCT00000776|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92320988|NCT00000776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92320989|NCT00000776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92320990|NCT00000776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92320991|NCT00000776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92320992|NCT00000776|Hormone Antagonists|hormone antagonists|mesh-ancestor
92320993|NCT00000776|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92320994|NCT00000776|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92320995|NCT00000776|Amebicides|amebicides|mesh-ancestor
92320996|NCT00000776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92320997|NCT00000776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92320998|NCT00000776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92320999|NCT00000776|Antimetabolites|antimetabolites|mesh-ancestor
92321000|NCT04283773|Antibodies|antibodies|mesh-list
92321001|NCT04283773|Immunoglobulins|immunoglobulins|mesh-list
92321002|NCT04283773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92321003|NCT04283773|Immunologic Factors|immunologic factors|mesh-ancestor
92321004|NCT04283773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321005|NCT00329732|Lidocaine|lidocaine|mesh-list
92321006|NCT00329732|Bupivacaine|bupivacaine|mesh-list
92321007|NCT00329732|Anesthetics, Local|anesthetics, local|mesh-ancestor
92321008|NCT00329732|Anesthetics|anesthetics|mesh-ancestor
92321009|NCT00329732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321010|NCT00329732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321011|NCT00329732|Sensory System Agents|sensory system agents|mesh-ancestor
92321012|NCT00329732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321013|NCT00329732|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92321014|NCT00329732|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92321015|NCT00329732|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92321016|NCT00329732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92321017|NCT00329732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321019|NCT00000782|Immunologic Factors|immunologic factors|mesh-ancestor
92321020|NCT00000782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321021|NCT00000800|Zidovudine|zidovudine|mesh-list
92321022|NCT00000800|Methadone|methadone|mesh-list
92321023|NCT00000800|Antimetabolites|antimetabolites|mesh-ancestor
92321024|NCT00000800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321025|NCT00000800|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321026|NCT00000800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321027|NCT00000800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321028|NCT00000800|Antiviral Agents|antiviral agents|mesh-ancestor
92321029|NCT00000800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321030|NCT00000800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321031|NCT00000800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321032|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321033|NCT00000800|Narcotics|narcotics|mesh-ancestor
92321034|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321035|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321036|NCT00000800|Analgesics|analgesics|mesh-ancestor
92321037|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
92321038|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321039|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
92321040|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
92321041|NCT03679975|Riluzole|riluzole|mesh-list
92321042|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
92321043|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92321044|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92321045|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321046|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321047|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321048|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92321049|NCT03679975|Protective Agents|protective agents|mesh-ancestor
92321051|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321052|NCT03684265|Meloxicam|meloxicam|mesh-list
92321053|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92321054|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321055|NCT03684265|Analgesics|analgesics|mesh-ancestor
92321056|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
92321057|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321058|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321059|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92321060|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321061|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92321062|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92321063|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321064|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321065|NCT00218036|Dexetimide|dexetimide|mesh-list
92321066|NCT00218036|Modafinil|modafinil|mesh-list
92321067|NCT00218036|Citalopram|citalopram|mesh-list
92321068|NCT00218036|Escitalopram|escitalopram|mesh-list
92321069|NCT00218036|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92321070|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92321071|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92321072|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321073|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321074|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
92321075|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321076|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92321077|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
92321078|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92321079|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92321080|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92321081|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
92321082|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
92321083|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321084|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92321085|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92321086|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
92321087|NCT00218036|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92321088|NCT00218036|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92321089|NCT00218036|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321090|NCT00218036|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321091|NCT00233090|Modafinil|modafinil|mesh-list
92321092|NCT00233090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92321093|NCT00233090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321094|NCT00233090|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92321095|NCT00233090|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321096|NCT00233090|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321097|NCT00233090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321098|NCT02921906|Acetaminophen|acetaminophen|mesh-list
92321099|NCT02921906|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321100|NCT02921906|Analgesics|analgesics|mesh-ancestor
92321101|NCT02921906|Sensory System Agents|sensory system agents|mesh-ancestor
92321102|NCT02921906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321103|NCT02921906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321104|NCT02921906|Antipyretics|antipyretics|mesh-ancestor
92321105|NCT00000812|Thalidomide|thalidomide|mesh-list
92321106|NCT00000812|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92321107|NCT00000812|Immunologic Factors|immunologic factors|mesh-ancestor
92321108|NCT00000812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321109|NCT00000812|Leprostatic Agents|leprostatic agents|mesh-ancestor
92348779|NCT01571232|Growth Substances|growth substances|mesh-ancestor
92321110|NCT00000812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321111|NCT00000812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321112|NCT00000812|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92321113|NCT00000812|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92321114|NCT00000812|Growth Substances|growth substances|mesh-ancestor
92321115|NCT00000812|Growth Inhibitors|growth inhibitors|mesh-ancestor
92321116|NCT00000812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321117|NCT00000818|Zidovudine|zidovudine|mesh-list
92321118|NCT00000818|Antimetabolites|antimetabolites|mesh-ancestor
92321119|NCT00000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321120|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321121|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321122|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321123|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
92321124|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321125|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321126|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321127|NCT00177866|Celecoxib|celecoxib|mesh-list
92321128|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92321129|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321130|NCT00177866|Analgesics|analgesics|mesh-ancestor
92321131|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
92321132|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321133|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321134|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92321135|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321136|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92321137|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92321138|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321139|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321140|NCT00089414|Drospirenone|drospirenone|mesh-list
92321141|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92321142|NCT00089414|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92321143|NCT00089414|Estradiol|estradiol|mesh-list
92321144|NCT00089414|Progesterone|progesterone|mesh-list
92321145|NCT00089414|Estrogens|estrogens|mesh-ancestor
92321146|NCT00089414|Hormones|hormones|mesh-ancestor
92321147|NCT00089414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92321148|NCT00089414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321149|NCT00089414|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92321150|NCT00089414|Contraceptive Agents|contraceptive agents|mesh-ancestor
92321151|NCT00089414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92321152|NCT00089414|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92321153|NCT00089414|Progestins|progestins|mesh-ancestor
92321154|NCT00089414|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92321155|NCT00089414|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92321156|NCT00089414|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92321157|NCT00089414|Hormone Antagonists|hormone antagonists|mesh-ancestor
92321158|NCT00089414|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92321159|NCT00089414|Diuretics|diuretics|mesh-ancestor
92321160|NCT00089414|Natriuretic Agents|natriuretic agents|mesh-ancestor
92321161|NCT00075608|Melphalan|melphalan|mesh-list
92321162|NCT00075608|Immunologic Factors|immunologic factors|mesh-ancestor
92321163|NCT00075608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321164|NCT00075608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92321165|NCT00075608|Alkylating Agents|alkylating agents|mesh-ancestor
92321166|NCT00075608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321167|NCT00075608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321168|NCT00075608|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92321169|NCT00075608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92321170|NCT03704467|Carboplatin|carboplatin|mesh-list
92321171|NCT03704467|Avelumab|avelumab|mesh-list
92321172|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912882|NCT00358163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92321173|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92321174|NCT00000842|Mitogens|mitogens|mesh-list
92321175|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
92321176|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321177|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
92321178|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92321179|NCT00000848|Indinavir|indinavir|mesh-list
92321180|NCT00000848|Saquinavir|saquinavir|mesh-list
92321181|NCT00000848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321182|NCT00000848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321183|NCT00000848|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321184|NCT00000848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321185|NCT00000848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321186|NCT00000848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321187|NCT00000848|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321188|NCT00000848|Antiviral Agents|antiviral agents|mesh-ancestor
92321189|NCT00000848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321190|NCT00000848|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321191|NCT00000848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321192|NCT01795586|Carboplatin|carboplatin|mesh-list
92321193|NCT01795586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321194|NCT02212574|Cyclophosphamide|cyclophosphamide|mesh-list
92321195|NCT02212574|Lomustine|lomustine|mesh-list
92321196|NCT02212574|Vincristine|vincristine|mesh-list
92321197|NCT02212574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92321198|NCT02212574|Immunologic Factors|immunologic factors|mesh-ancestor
92321199|NCT02212574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321200|NCT02212574|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321201|NCT02212574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92321202|NCT02212574|Alkylating Agents|alkylating agents|mesh-ancestor
92321203|NCT02212574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321204|NCT02212574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321205|NCT02212574|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92321206|NCT02212574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92321207|NCT02212574|Tubulin Modulators|tubulin modulators|mesh-ancestor
92321208|NCT02212574|Antimitotic Agents|antimitotic agents|mesh-ancestor
92321209|NCT02212574|Mitosis Modulators|mitosis modulators|mesh-ancestor
92321210|NCT00000854|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92321211|NCT00000854|Nandrolone|nandrolone|mesh-list
92321212|NCT00000854|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92321213|NCT00000854|Androgens|androgens|mesh-ancestor
92321214|NCT00000854|Hormones|hormones|mesh-ancestor
92321215|NCT00000854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92321216|NCT00000854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321217|NCT00000854|Anabolic Agents|anabolic agents|mesh-ancestor
92321218|NCT00000854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92321219|NCT04298918|Trastuzumab|trastuzumab|mesh-list
92321220|NCT04298918|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92321221|NCT04298918|Venetoclax|venetoclax|mesh-list
92321222|NCT04298918|Maytansine|maytansine|mesh-list
92321223|NCT04298918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92321224|NCT04298918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321225|NCT04298918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92321226|NCT04298918|Tubulin Modulators|tubulin modulators|mesh-ancestor
92321227|NCT04298918|Antimitotic Agents|antimitotic agents|mesh-ancestor
92321228|NCT04298918|Mitosis Modulators|mitosis modulators|mesh-ancestor
92321229|NCT04298918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321230|NCT04298918|Immunotoxins|immunotoxins|mesh-ancestor
92321231|NCT04298918|Immunoconjugates|immunoconjugates|mesh-ancestor
92321232|NCT04298918|Immunologic Factors|immunologic factors|mesh-ancestor
92321233|NCT04298918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321234|NCT00001676|Fludarabine|fludarabine|mesh-list
92321235|NCT00001676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321236|NCT03714919|Acetaminophen|acetaminophen|mesh-list
92321237|NCT03714919|Dexmedetomidine|dexmedetomidine|mesh-list
92321238|NCT03714919|Ketamine|ketamine|mesh-list
92321239|NCT03714919|Dextromethorphan|dextromethorphan|mesh-list
92321240|NCT03714919|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92321241|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321242|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321243|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321244|NCT03714919|Analgesics|analgesics|mesh-ancestor
92321245|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
92321246|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321247|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92321248|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92321249|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92321250|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92321251|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321252|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321253|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92321254|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92321255|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
92321256|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
92321257|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92321258|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92321259|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
92321260|NCT03714919|Antitussive Agents|antitussive agents|mesh-ancestor
92321261|NCT03714919|Respiratory System Agents|respiratory system agents|mesh-ancestor
92321262|NCT00000872|Lamivudine|lamivudine|mesh-list
92321263|NCT00000872|Zidovudine|zidovudine|mesh-list
92321264|NCT00000872|Nevirapine|nevirapine|mesh-list
92321265|NCT00000872|Abacavir|abacavir|mesh-list
92321266|NCT00000872|Stavudine|stavudine|mesh-list
92321267|NCT00000872|Nelfinavir|nelfinavir|mesh-list
92321268|NCT00000872|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321269|NCT00000872|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321270|NCT00000872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321271|NCT00000872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321272|NCT00000872|Antiviral Agents|antiviral agents|mesh-ancestor
92321273|NCT00000872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321274|NCT00000872|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321275|NCT00000872|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321276|NCT00000872|Antimetabolites|antimetabolites|mesh-ancestor
92321277|NCT00000872|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321278|NCT00000872|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321279|NCT00000872|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321280|NCT00000872|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321281|NCT00000872|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321282|NCT00000878|Lamivudine|lamivudine|mesh-list
92321283|NCT00000878|Zidovudine|zidovudine|mesh-list
92321284|NCT00000878|Stavudine|stavudine|mesh-list
92321285|NCT00000878|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321286|NCT00000878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321287|NCT00000878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321288|NCT00000878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321289|NCT00000878|Antiviral Agents|antiviral agents|mesh-ancestor
92321290|NCT00000878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321291|NCT00000878|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321292|NCT00000878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321293|NCT00000878|Antimetabolites|antimetabolites|mesh-ancestor
92321294|NCT04204057|Tenalisib|tenalisib|mesh-list
92321295|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92321296|NCT04204057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321297|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321298|NCT00001736|Cysteamine|cysteamine|mesh-list
92321299|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92321300|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321301|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
92321302|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92321303|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
92321304|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321305|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92321306|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321307|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
92321308|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321309|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
92321310|NCT00000884|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92321311|NCT00000884|Protective Agents|protective agents|mesh-ancestor
92321312|NCT00000896|Lamivudine|lamivudine|mesh-list
92321313|NCT00000896|Zidovudine|zidovudine|mesh-list
92321314|NCT00000896|Nevirapine|nevirapine|mesh-list
92321315|NCT00000896|Stavudine|stavudine|mesh-list
92321316|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92321317|NCT00000896|Indinavir|indinavir|mesh-list
92321318|NCT00000896|Interleukin-12|interleukin-12|mesh-list
92321319|NCT00000896|Sargramostim|sargramostim|mesh-list
92321320|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321321|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321322|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321323|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321324|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
92321325|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321326|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321327|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321328|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
92321329|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
92321330|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321331|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321332|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321333|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321334|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321335|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321336|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321337|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92321338|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92321339|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92321340|NCT00000896|Growth Substances|growth substances|mesh-ancestor
92321341|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
92321343|NCT00001790|Antifungal Agents|antifungal agents|mesh-ancestor
92321344|NCT00001790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321345|NCT00000902|Ritonavir|ritonavir|mesh-list
92321346|NCT00000902|Nelfinavir|nelfinavir|mesh-list
92321347|NCT00000902|Lamivudine|lamivudine|mesh-list
92321348|NCT00000902|Zidovudine|zidovudine|mesh-list
92321349|NCT00000902|Nevirapine|nevirapine|mesh-list
92321350|NCT00000902|Didanosine|didanosine|mesh-list
92321351|NCT00000902|Stavudine|stavudine|mesh-list
92321352|NCT00000902|Zalcitabine|zalcitabine|mesh-list
92321353|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321354|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321355|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321356|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321357|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321358|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321359|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321360|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
92321361|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321362|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321363|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321364|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321365|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321366|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
92321367|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321368|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321370|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92321371|NCT04331600|Amebicides|amebicides|mesh-ancestor
92321372|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321373|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321374|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321375|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
92321376|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321377|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92321378|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321379|NCT04331600|Analgesics|analgesics|mesh-ancestor
92321380|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
92321381|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321382|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321383|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92321385|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
92321386|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
92321387|NCT00000188|Selegiline|selegiline|mesh-list
92321388|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
92321389|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92321390|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92321391|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92321392|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92321393|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321394|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321395|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92321396|NCT00000188|Protective Agents|protective agents|mesh-ancestor
92321397|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321399|NCT00000914|Nelfinavir|nelfinavir|mesh-list
92321400|NCT00000914|Indinavir|indinavir|mesh-list
92321401|NCT00000914|Efavirenz|efavirenz|mesh-list
92321402|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321403|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321404|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321405|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321406|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321407|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321408|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321409|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
92321410|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321411|NCT00000914|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321412|NCT00000914|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321413|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321414|NCT00000914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321415|NCT00000914|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92321416|NCT00000914|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92321417|NCT00000914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92321418|NCT00000914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321419|NCT00000914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321421|NCT00000920|Saquinavir|saquinavir|mesh-list
92321422|NCT00000920|Lamivudine|lamivudine|mesh-list
92321423|NCT00000920|Zidovudine|zidovudine|mesh-list
92321424|NCT00000920|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321425|NCT00000920|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321426|NCT00000920|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321427|NCT00000920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321428|NCT00000920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321429|NCT00000920|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321430|NCT00000920|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321431|NCT00000920|Antiviral Agents|antiviral agents|mesh-ancestor
92321432|NCT00000920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321433|NCT00000920|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321434|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321435|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321436|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321437|NCT00000920|Antimetabolites|antimetabolites|mesh-ancestor
92321438|NCT00000938|Doxycycline|doxycycline|mesh-list
92321439|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
92321440|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321441|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321442|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
92321443|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321444|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321445|NCT00001862|Etanercept|etanercept|mesh-list
92321446|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92321447|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321448|NCT00001862|Analgesics|analgesics|mesh-ancestor
92321449|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
92321450|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321451|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321452|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92321453|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321454|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92321455|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92321456|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
92321457|NCT00000194|Cycloserine|cycloserine|mesh-list
92321458|NCT00000194|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92321459|NCT00000194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321460|NCT00000194|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92321461|NCT00000194|Antitubercular Agents|antitubercular agents|mesh-ancestor
92321462|NCT00000194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321463|NCT00000194|Antimetabolites|antimetabolites|mesh-ancestor
92321464|NCT00000194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321465|NCT00000200|Methadone|methadone|mesh-list
92321466|NCT00000200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321467|NCT00000200|Narcotics|narcotics|mesh-ancestor
92321468|NCT00000200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321469|NCT00000200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321470|NCT00000200|Analgesics|analgesics|mesh-ancestor
92321471|NCT00000200|Sensory System Agents|sensory system agents|mesh-ancestor
92321472|NCT00000200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321473|NCT00000200|Antitussive Agents|antitussive agents|mesh-ancestor
92321474|NCT00000200|Respiratory System Agents|respiratory system agents|mesh-ancestor
92321475|NCT00000206|Buprenorphine|buprenorphine|mesh-list
92321476|NCT00000206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321477|NCT00000206|Narcotics|narcotics|mesh-ancestor
92321478|NCT00000206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321479|NCT00000206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321480|NCT00000206|Analgesics|analgesics|mesh-ancestor
92321481|NCT00000206|Sensory System Agents|sensory system agents|mesh-ancestor
92321482|NCT00000206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321483|NCT00000206|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92321485|NCT00000944|Zidovudine|zidovudine|mesh-list
92321486|NCT00000944|Indinavir|indinavir|mesh-list
92321487|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321488|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321489|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321490|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321491|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
92321492|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321493|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321494|NCT00000944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321495|NCT00000944|Antimetabolites|antimetabolites|mesh-ancestor
92321496|NCT00000944|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321497|NCT00000944|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321498|NCT00000944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321499|NCT00000950|Pyridoxine|pyridoxine|mesh-list
92321500|NCT00000950|Vitamin B 6|vitamin b 6|mesh-list
92321501|NCT00000950|Rifampin|rifampin|mesh-list
92321502|NCT00000950|Isoniazid|isoniazid|mesh-list
92321503|NCT00000950|Pyrazinamide|pyrazinamide|mesh-list
92321505|NCT00000950|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92321506|NCT00000950|Antitubercular Agents|antitubercular agents|mesh-ancestor
92321507|NCT00000950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321508|NCT00000950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321509|NCT00000950|Leprostatic Agents|leprostatic agents|mesh-ancestor
92321510|NCT00000950|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321511|NCT00000950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321512|NCT00000950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321513|NCT00000950|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92321514|NCT00000950|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321515|NCT00000950|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92321516|NCT00000950|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92321517|NCT00000950|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92321518|NCT00000950|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321519|NCT00000950|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92321520|NCT00000950|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92321521|NCT00000950|Antimetabolites|antimetabolites|mesh-ancestor
92321522|NCT00000950|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92321523|NCT00000950|Vitamin B Complex|vitamin b complex|mesh-ancestor
92321524|NCT00000950|Vitamins|vitamins|mesh-ancestor
92321525|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
92321526|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321527|NCT00000218|Carbamazepine|carbamazepine|mesh-list
92321528|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
92321529|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
92321530|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92321531|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321532|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321533|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92321534|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321535|NCT00000218|Analgesics|analgesics|mesh-ancestor
92321536|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
92321537|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321538|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92321539|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92321540|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321541|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321542|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321543|NCT00000224|Buprenorphine|buprenorphine|mesh-list
92321544|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321545|NCT00000224|Narcotics|narcotics|mesh-ancestor
92321546|NCT00000224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321547|NCT00000224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321548|NCT00000224|Analgesics|analgesics|mesh-ancestor
92321549|NCT00000224|Sensory System Agents|sensory system agents|mesh-ancestor
92321550|NCT00000224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321551|NCT00000224|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92321552|NCT04332991|Hydroxychloroquine|hydroxychloroquine|mesh-list
92321553|NCT04332991|Antimalarials|antimalarials|mesh-ancestor
92321554|NCT04332991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321555|NCT04332991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321556|NCT04332991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321557|NCT04332991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321558|NCT04332991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321559|NCT04332991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321560|NCT00000230|Buprenorphine|buprenorphine|mesh-list
92321561|NCT00000230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321562|NCT00000230|Narcotics|narcotics|mesh-ancestor
92321563|NCT00000230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321564|NCT00000230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321565|NCT00000230|Analgesics|analgesics|mesh-ancestor
92321566|NCT00000230|Sensory System Agents|sensory system agents|mesh-ancestor
92321567|NCT00000230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321568|NCT00000230|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92321569|NCT00000236|Buprenorphine|buprenorphine|mesh-list
92321570|NCT00000236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92321571|NCT00000236|Naloxone|naloxone|mesh-list
92321572|NCT00000236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321573|NCT00000236|Narcotics|narcotics|mesh-ancestor
92321574|NCT00000236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321575|NCT00000236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321576|NCT00000236|Analgesics|analgesics|mesh-ancestor
92321577|NCT00000236|Sensory System Agents|sensory system agents|mesh-ancestor
92321578|NCT00000236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321579|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92321580|NCT00000974|Pentamidine|pentamidine|mesh-list
92321581|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
92321582|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321583|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321584|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321585|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92321586|NCT00000242|Carbamazepine|carbamazepine|mesh-list
92321587|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
92321588|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
92321589|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92321590|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321591|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321592|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92348837|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
92321594|NCT00000242|Analgesics|analgesics|mesh-ancestor
92321595|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
92321596|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321597|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92321598|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92321599|NCT00000242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321600|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92321601|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92321602|NCT00000980|Spiramycin|spiramycin|mesh-list
92321603|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321604|NCT00000980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321605|NCT00000980|Coccidiostats|coccidiostats|mesh-ancestor
92321606|NCT00000980|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321607|NCT00000980|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321608|NCT00000992|Itraconazole|itraconazole|mesh-list
92321609|NCT00000992|Antifungal Agents|antifungal agents|mesh-ancestor
92321610|NCT00000992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321611|NCT00000992|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92321612|NCT00000992|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321613|NCT00000992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321614|NCT00000992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321615|NCT00000992|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92321616|NCT00000992|Hormone Antagonists|hormone antagonists|mesh-ancestor
92321617|NCT00000992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92321618|NCT00000992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321619|NCT00000992|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321621|NCT00000254|Isoflurane|isoflurane|mesh-list
92321622|NCT00000254|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92321623|NCT00000254|Anesthetics, General|anesthetics, general|mesh-ancestor
92321624|NCT00000254|Anesthetics|anesthetics|mesh-ancestor
92321625|NCT00000254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321626|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321627|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321628|NCT00000254|Analgesics|analgesics|mesh-ancestor
92321629|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
92321630|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321631|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
92321632|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92321633|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
92321634|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
92321635|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321636|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321637|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321638|NCT00000260|Analgesics|analgesics|mesh-ancestor
92321639|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
91936704|NCT01590719|Fluorouracil|fluorouracil|mesh-list
92321640|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321641|NCT00000266|Flupenthixol|flupenthixol|mesh-list
92321642|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92321643|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92321644|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92321645|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321646|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321647|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92321648|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92321649|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
92321650|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321651|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321653|NCT00001016|Trimetrexate|trimetrexate|mesh-list
92321654|NCT00001016|Calcium|calcium|mesh-list
92321655|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
92321656|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92321657|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321658|NCT00001016|Antidotes|antidotes|mesh-ancestor
92321659|NCT00001016|Protective Agents|protective agents|mesh-ancestor
92321660|NCT00001016|Vitamin B Complex|vitamin b complex|mesh-ancestor
92321661|NCT00001016|Vitamins|vitamins|mesh-ancestor
92321662|NCT00001016|Micronutrients|micronutrients|mesh-ancestor
92321663|NCT00001016|Antifungal Agents|antifungal agents|mesh-ancestor
92321664|NCT00001016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321665|NCT00001016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92321667|NCT00001016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321668|NCT00001016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321669|NCT00001016|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92321670|NCT00001016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321672|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92321673|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321674|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
92321675|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321676|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92321677|NCT04332289|Protective Agents|protective agents|mesh-ancestor
92321678|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321679|NCT00001022|Zidovudine|zidovudine|mesh-list
92321680|NCT00001022|Didanosine|didanosine|mesh-list
92321681|NCT00001022|Zalcitabine|zalcitabine|mesh-list
92321682|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
92321683|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321684|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321685|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321686|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321687|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
92321688|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321689|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321690|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321691|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
92321692|NCT05218148|Trastuzumab|trastuzumab|mesh-list
92321693|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321694|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92321695|NCT00001934|Daclizumab|daclizumab|mesh-list
92321696|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974376|NCT03235973|Fludarabine|fludarabine|mesh-list
92321697|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
92321698|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321699|NCT00000278|Disulfiram|disulfiram|mesh-list
92321700|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92321701|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92321702|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321703|NCT00000278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321704|NCT00001028|Dapsone|dapsone|mesh-list
92321705|NCT00001028|Pentamidine|pentamidine|mesh-list
92321706|NCT00001028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321707|NCT00001028|Antimalarials|antimalarials|mesh-ancestor
92321708|NCT00001028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321709|NCT00001028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321710|NCT00001028|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92321711|NCT00001028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321712|NCT00001028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321713|NCT00001028|Leprostatic Agents|leprostatic agents|mesh-ancestor
92321714|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321715|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
92321716|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92321717|NCT00001940|Voriconazole|voriconazole|mesh-list
92321718|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
92321719|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321720|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92321721|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321722|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321723|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321724|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92321725|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
92321726|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92321727|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321728|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321729|NCT03907033|Bupivacaine|bupivacaine|mesh-list
92321730|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
92321731|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
92321732|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321733|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321734|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
92321735|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321736|NCT00001034|Ganciclovir|ganciclovir|mesh-list
92321737|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92321738|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
92321739|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321740|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321741|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321742|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321743|NCT03818815|Amoxicillin|amoxicillin|mesh-list
92321744|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
92321745|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
92321746|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92321747|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321748|NCT03818815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321749|NCT03818815|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92321750|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321751|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321752|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
92321753|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321754|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
92321755|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321756|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321757|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321758|NCT00001964|Cyclosporine|cyclosporine|mesh-list
92321760|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321761|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321762|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92321763|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
92321764|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321765|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
92321766|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321767|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
92321768|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92321769|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92321770|NCT03801265|Ropivacaine|ropivacaine|mesh-list
92321771|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
92321772|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
92321773|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321774|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321775|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
92321776|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321777|NCT00000290|Cocaine|cocaine|mesh-list
92321778|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92321779|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
92321780|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321781|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321782|NCT00000290|Sensory System Agents|sensory system agents|mesh-ancestor
92321783|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321784|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92321785|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92321786|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92321787|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91912883|NCT00358163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92321788|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321790|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321791|NCT00000212|Desipramine|desipramine|mesh-list
92321792|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92321793|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
92321794|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92321795|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348857|NCT01520922|Ofatumumab|ofatumumab|mesh-list
92321796|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321797|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92321798|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92321799|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92321800|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92321801|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321802|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321803|NCT00000302|Buprenorphine|buprenorphine|mesh-list
92321804|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321805|NCT00000302|Narcotics|narcotics|mesh-ancestor
92321806|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321807|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321808|NCT00000302|Analgesics|analgesics|mesh-ancestor
92321809|NCT00000302|Sensory System Agents|sensory system agents|mesh-ancestor
92321810|NCT00000302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321811|NCT00000302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92321812|NCT00001052|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92321813|NCT00001052|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92321814|NCT00001052|Immunologic Factors|immunologic factors|mesh-ancestor
92321815|NCT00001052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321817|NCT00001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321818|NCT00001052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92321819|NCT00001058|Ritonavir|ritonavir|mesh-list
92321820|NCT00001058|Indinavir|indinavir|mesh-list
92321821|NCT00001058|Clarithromycin|clarithromycin|mesh-list
92321822|NCT00001058|Ethambutol|ethambutol|mesh-list
92321823|NCT00001058|Rifabutin|rifabutin|mesh-list
92321824|NCT00001058|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321825|NCT00001058|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321826|NCT00001058|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321827|NCT00001058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321828|NCT00001058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321829|NCT00001058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321830|NCT00001058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321831|NCT00001058|Antiviral Agents|antiviral agents|mesh-ancestor
92321832|NCT00001058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321833|NCT00001058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321834|NCT00001058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321835|NCT00001058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92321836|NCT00001058|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92321837|NCT00001058|Antitubercular Agents|antitubercular agents|mesh-ancestor
92321838|NCT00001058|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92321840|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
92321841|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92321842|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321843|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
92321844|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
92321845|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321846|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
92321847|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321848|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321849|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
92321850|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92321851|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92321852|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92321853|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92321854|NCT00001994|Atovaquone|atovaquone|mesh-list
92321855|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321856|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
92321857|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92321858|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92321859|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321860|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321861|NCT00000320|Buprenorphine|buprenorphine|mesh-list
92321863|NCT00000320|Narcotics|narcotics|mesh-ancestor
92321864|NCT00000320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912884|NCT00358163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92321865|NCT00000320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321866|NCT00000320|Analgesics|analgesics|mesh-ancestor
92321867|NCT00000320|Sensory System Agents|sensory system agents|mesh-ancestor
92321868|NCT00000320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321869|NCT00000320|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92321870|NCT00000326|Heroin|heroin|mesh-list
92321871|NCT00000326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321872|NCT00000326|Narcotics|narcotics|mesh-ancestor
92321873|NCT00000326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321874|NCT00000326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321875|NCT00000326|Analgesics|analgesics|mesh-ancestor
92321876|NCT00000326|Sensory System Agents|sensory system agents|mesh-ancestor
92321877|NCT00000326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321878|NCT03978403|Zolmitriptan|zolmitriptan|mesh-list
92321879|NCT03978403|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92321880|NCT03978403|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92321881|NCT03978403|Serotonin Agents|serotonin agents|mesh-ancestor
92321882|NCT03978403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321883|NCT03978403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321884|NCT03978403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321885|NCT00002000|Valacyclovir|valacyclovir|mesh-list
92321887|NCT00002000|Antiviral Agents|antiviral agents|mesh-ancestor
92321888|NCT00002000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321889|NCT03979807|Bromides|bromides|mesh-list
92321890|NCT03979807|Tiotropium Bromide|tiotropium bromide|mesh-list
92321891|NCT03979807|Olodaterol|olodaterol|mesh-list
92321892|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92321893|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
92321894|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321895|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321896|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92321897|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
92321898|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
92321899|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92321900|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
92321901|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321902|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321903|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
92321904|NCT00001082|Adefovir|adefovir|mesh-list
92321905|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92321906|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
92321907|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321908|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321909|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321911|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321912|NCT00002006|Zidovudine|zidovudine|mesh-list
92321913|NCT00002006|Sargramostim|sargramostim|mesh-list
92321914|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
92321915|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321916|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321917|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321918|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321919|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
92321920|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321921|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321922|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321923|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
92321924|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321925|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
92321926|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92321927|NCT04169113|Narcotics|narcotics|mesh-ancestor
92321928|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321929|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321930|NCT04169113|Analgesics|analgesics|mesh-ancestor
92321931|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
92321932|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321933|NCT00002012|Interferons|interferons|mesh-list
92321934|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
92321935|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92321936|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
92321937|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321938|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
92321939|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321940|NCT00380276|Tarenflurbil|tarenflurbil|mesh-list
92321941|NCT00380276|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92321942|NCT00380276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321943|NCT00380276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321944|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
92321945|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92321946|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92321947|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321948|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321949|NCT03799783|Dexmedetomidine|dexmedetomidine|mesh-list
92321950|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92321951|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321952|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321953|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92321954|NCT03799783|Analgesics|analgesics|mesh-ancestor
92321955|NCT03799783|Sensory System Agents|sensory system agents|mesh-ancestor
92321956|NCT03799783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321957|NCT03799783|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92321958|NCT03799783|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92321959|NCT03799783|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92321960|NCT03799783|Adrenergic Agents|adrenergic agents|mesh-ancestor
92321961|NCT03799783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92321962|NCT03799783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321963|NCT00001088|Bupivacaine|bupivacaine|mesh-list
92321964|NCT00001088|Anesthetics, Local|anesthetics, local|mesh-ancestor
92321965|NCT00001088|Anesthetics|anesthetics|mesh-ancestor
92321966|NCT00001088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92321967|NCT00001088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92321968|NCT00001088|Sensory System Agents|sensory system agents|mesh-ancestor
92321969|NCT00001088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92321971|NCT00001094|Zidovudine|zidovudine|mesh-list
92321972|NCT00001094|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92321973|NCT00001094|Delavirdine|delavirdine|mesh-list
92321974|NCT00001094|Nelfinavir|nelfinavir|mesh-list
92321975|NCT00001094|Saquinavir|saquinavir|mesh-list
92321976|NCT00001094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92321977|NCT00001094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321978|NCT00001094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321979|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321980|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
92321981|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92321982|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92321983|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92321984|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
92321985|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92321986|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92321987|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92321988|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92321989|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92321990|NCT00001100|Ganciclovir|ganciclovir|mesh-list
92321991|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92321992|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
92321993|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974683|NCT03054207|Clopidogrel|clopidogrel|mesh-list
92321994|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92321995|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92321996|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92321998|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92321999|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92322000|NCT00000332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322001|NCT00000332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322002|NCT00000332|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92322003|NCT00000332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322004|NCT00000332|Vasodilator Agents|vasodilator agents|mesh-ancestor
92322005|NCT00000338|Lisuride|lisuride|mesh-list
92322006|NCT00000338|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92322008|NCT00000338|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92322009|NCT00000338|Serotonin Agents|serotonin agents|mesh-ancestor
92322010|NCT00000338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322011|NCT00000338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322012|NCT00000338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322013|NCT00000338|Dopamine Agonists|dopamine agonists|mesh-ancestor
92322014|NCT00000338|Dopamine Agents|dopamine agents|mesh-ancestor
92322015|NCT04085341|Sunitinib|sunitinib|mesh-list
92322016|NCT04085341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322017|NCT04085341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92322018|NCT04085341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92322019|NCT04085341|Growth Substances|growth substances|mesh-ancestor
92322020|NCT04085341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322021|NCT04085341|Growth Inhibitors|growth inhibitors|mesh-ancestor
92322022|NCT04085341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92322023|NCT04085341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322024|NCT04085341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322025|NCT00002018|Interferons|interferons|mesh-list
92322026|NCT00002018|Interferon-alpha|interferon-alpha|mesh-list
92322027|NCT00002018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322028|NCT00002018|Antiviral Agents|antiviral agents|mesh-ancestor
92322029|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322030|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
92322031|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322032|NCT00002024|Ganciclovir|ganciclovir|mesh-list
92322033|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92322035|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322036|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322037|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322038|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322039|NCT00001106|Zidovudine|zidovudine|mesh-list
92322040|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
92322041|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322042|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322043|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322044|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322045|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
92322046|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322047|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322048|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322049|NCT00000344|Buprenorphine|buprenorphine|mesh-list
92322050|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92322051|NCT00000344|Naloxone|naloxone|mesh-list
92322052|NCT00000344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92322053|NCT00000344|Narcotics|narcotics|mesh-ancestor
92322054|NCT00000344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92322055|NCT00000344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322056|NCT00000344|Analgesics|analgesics|mesh-ancestor
92322057|NCT00000344|Sensory System Agents|sensory system agents|mesh-ancestor
92322058|NCT00000344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322059|NCT00000344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92322060|NCT04103515|Cimetidine|cimetidine|mesh-list
92322061|NCT04103515|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92322062|NCT04103515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92322063|NCT04103515|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92322064|NCT04103515|Histamine Antagonists|histamine antagonists|mesh-ancestor
92322065|NCT04103515|Histamine Agents|histamine agents|mesh-ancestor
92322066|NCT04103515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322067|NCT04103515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322068|NCT04103515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322069|NCT04103515|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92322070|NCT04103515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322071|NCT04103515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322073|NCT00002030|Antifungal Agents|antifungal agents|mesh-ancestor
92322074|NCT00002030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322075|NCT00002030|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92322076|NCT00002030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92322077|NCT00002030|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92322079|NCT00001112|Zidovudine|zidovudine|mesh-list
92322080|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
92322081|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322082|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
92322083|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322084|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
92322085|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322086|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322087|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322088|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322089|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322090|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322091|NCT00002036|Immune Sera|immune sera|mesh-list
92322092|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
91913266|NCT02106767|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92322093|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322094|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92322095|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92322096|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92322097|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92322098|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92322099|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92322100|NCT03782701|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92322101|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
92322102|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322103|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322104|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322105|NCT00000374|Olanzapine|olanzapine|mesh-list
92322106|NCT00000374|Risperidone|risperidone|mesh-list
92322107|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92322108|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
92322109|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322110|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322111|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322112|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92322113|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92322114|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92322115|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92322116|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92322117|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
92322118|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
92322119|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
92322120|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322121|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92322122|NCT00000374|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92322123|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92322124|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322125|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
92322126|NCT00002042|Hematinics|hematinics|mesh-ancestor
92322127|NCT03789175|Niacinamide|niacinamide|mesh-list
92322128|NCT03789175|Niacin|niacin|mesh-list
92322129|NCT03789175|Nicotinic Acids|nicotinic acids|mesh-list
92322130|NCT03789175|Vitamin B Complex|vitamin b complex|mesh-ancestor
92322131|NCT03789175|Vitamins|vitamins|mesh-ancestor
92322132|NCT03789175|Micronutrients|micronutrients|mesh-ancestor
92322133|NCT03789175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322134|NCT03789175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92322135|NCT03789175|Antimetabolites|antimetabolites|mesh-ancestor
92322136|NCT03789175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322137|NCT03789175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92322138|NCT03789175|Vasodilator Agents|vasodilator agents|mesh-ancestor
92322139|NCT00002048|Zidovudine|zidovudine|mesh-list
92322140|NCT00002048|Antimetabolites|antimetabolites|mesh-ancestor
92322141|NCT00002048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322142|NCT00002048|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91974826|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
92322143|NCT00002048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322144|NCT00002048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322145|NCT00002048|Antiviral Agents|antiviral agents|mesh-ancestor
92322146|NCT00002048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322147|NCT00002048|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322148|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322149|NCT00002054|Pentamidine|pentamidine|mesh-list
92322150|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
92322151|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322152|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92322153|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92322154|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92322155|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
92322156|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92322157|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
92322158|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322159|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
92322160|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322162|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92322163|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
92322164|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322165|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
92322166|NCT00002072|Hematinics|hematinics|mesh-ancestor
92322167|NCT00002078|Interferons|interferons|mesh-list
92322168|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
92322169|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322170|NCT00002078|Antiviral Agents|antiviral agents|mesh-ancestor
92322171|NCT00002078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322172|NCT00002078|Immunologic Factors|immunologic factors|mesh-ancestor
92322173|NCT00002078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322174|NCT00000440|Naltrexone|naltrexone|mesh-list
92322175|NCT00000440|Sertraline|sertraline|mesh-list
92322176|NCT00000440|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92322177|NCT00000440|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92322178|NCT00000440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322179|NCT00000440|Sensory System Agents|sensory system agents|mesh-ancestor
92322180|NCT00000440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322181|NCT00000440|Antidepressive Agents|antidepressive agents|mesh-ancestor
92322182|NCT00000440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92322183|NCT00000440|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92322184|NCT00000440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92322185|NCT00000440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322186|NCT00000440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322187|NCT00000440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322188|NCT00000440|Serotonin Agents|serotonin agents|mesh-ancestor
92322189|NCT00002084|Valacyclovir|valacyclovir|mesh-list
92322190|NCT00002084|Acyclovir|acyclovir|mesh-list
92322191|NCT00002084|Antiviral Agents|antiviral agents|mesh-ancestor
92322192|NCT00002084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322193|NCT00000446|Sertraline|sertraline|mesh-list
92322194|NCT00000446|Antidepressive Agents|antidepressive agents|mesh-ancestor
92322195|NCT00000446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92322196|NCT00000446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92322197|NCT00000446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92322198|NCT00000446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322199|NCT00000446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322200|NCT00000446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322201|NCT00000446|Serotonin Agents|serotonin agents|mesh-ancestor
92322202|NCT00000446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322203|NCT04131517|Padsevonil|padsevonil|mesh-list
92322204|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92322205|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92322206|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92322207|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
92322208|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92322209|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322210|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92322211|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92322212|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92322213|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92322214|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92322215|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92322216|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92322217|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92322218|NCT04131517|Anticonvulsants|anticonvulsants|mesh-ancestor
92322219|NCT00001256|Prednisone|prednisone|mesh-list
92322220|NCT00001256|Methotrexate|methotrexate|mesh-list
92322221|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92322222|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
92322223|NCT00001256|Hormones|hormones|mesh-ancestor
92322224|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322225|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322226|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92322227|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322228|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92322229|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
92322230|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92322231|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92322232|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
92322233|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322234|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92322235|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322236|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92322237|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92322238|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
92322239|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92322240|NCT00001256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322241|NCT00000452|Naltrexone|naltrexone|mesh-list
92322242|NCT00000452|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92322243|NCT00000452|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92322244|NCT00000452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322245|NCT00000452|Sensory System Agents|sensory system agents|mesh-ancestor
92322246|NCT00000452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322247|NCT00000458|Sertraline|sertraline|mesh-list
92322248|NCT00000458|Antidepressive Agents|antidepressive agents|mesh-ancestor
92322249|NCT00000458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92322250|NCT00000458|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92322251|NCT00000458|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92322252|NCT00000458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92322253|NCT00000458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322254|NCT00000458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322255|NCT00000458|Serotonin Agents|serotonin agents|mesh-ancestor
92322256|NCT00000458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322257|NCT03782233|Bromides|bromides|mesh-list
92322258|NCT03782233|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92322259|NCT03782233|Rocuronium|rocuronium|mesh-list
92322260|NCT03782233|Anticonvulsants|anticonvulsants|mesh-ancestor
92322261|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92322262|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92322263|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92322264|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322265|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322266|NCT00002090|Azithromycin|azithromycin|mesh-list
92322267|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92322268|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322269|NCT00002096|Zidovudine|zidovudine|mesh-list
92322270|NCT00002096|Didanosine|didanosine|mesh-list
92322271|NCT00002096|Ganciclovir|ganciclovir|mesh-list
92322272|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92322273|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
92322274|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322275|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322276|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322277|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322278|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
92322279|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322280|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322281|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322282|NCT00002102|Leucovorin|leucovorin|mesh-list
92322283|NCT00002102|Trimetrexate|trimetrexate|mesh-list
92322284|NCT00002102|Calcium|calcium|mesh-list
92322285|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
92322286|NCT00002102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92322287|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322288|NCT00002102|Antidotes|antidotes|mesh-ancestor
92322289|NCT00002102|Protective Agents|protective agents|mesh-ancestor
92322290|NCT00002102|Vitamin B Complex|vitamin b complex|mesh-ancestor
92322291|NCT00002102|Vitamins|vitamins|mesh-ancestor
92322292|NCT00002102|Micronutrients|micronutrients|mesh-ancestor
92322293|NCT00002102|Antifungal Agents|antifungal agents|mesh-ancestor
92322294|NCT00002102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322295|NCT00002102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92322296|NCT00002102|Antimetabolites|antimetabolites|mesh-ancestor
92322297|NCT00002102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322298|NCT00002102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322299|NCT00002102|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92322300|NCT00002102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322301|NCT00002108|Lamivudine|lamivudine|mesh-list
92322302|NCT00002108|Zidovudine|zidovudine|mesh-list
92322303|NCT00002108|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91936715|NCT01590719|Protective Agents|protective agents|mesh-ancestor
92322596|NCT00002162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322598|NCT00002162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322599|NCT00002162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322600|NCT00002162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322601|NCT00002162|Antimetabolites|antimetabolites|mesh-ancestor
92322602|NCT00002162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92322603|NCT00002162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92322604|NCT00002162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92322605|NCT00002162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92322606|NCT00002162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322607|NCT00000638|Pyridoxine|pyridoxine|mesh-list
92322608|NCT00000638|Vitamin B 6|vitamin b 6|mesh-list
92322609|NCT00000638|Rifampin|rifampin|mesh-list
92322610|NCT00000638|Isoniazid|isoniazid|mesh-list
92322611|NCT00000638|Pyrazinamide|pyrazinamide|mesh-list
92322612|NCT00000638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92322613|NCT00000638|Antitubercular Agents|antitubercular agents|mesh-ancestor
92322614|NCT00000638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92322615|NCT00000638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322616|NCT00000638|Leprostatic Agents|leprostatic agents|mesh-ancestor
92322617|NCT00000638|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322618|NCT00000638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322619|NCT00000638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322620|NCT00000638|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92322621|NCT00000638|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92322622|NCT00000638|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92322623|NCT00000638|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92322624|NCT00000638|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92322625|NCT00000638|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92322626|NCT00000638|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92322627|NCT00000638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92322628|NCT00000638|Antimetabolites|antimetabolites|mesh-ancestor
92322629|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92322630|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
92322631|NCT00000638|Vitamins|vitamins|mesh-ancestor
92322632|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
92322633|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322634|NCT00000650|Ditiocarb|ditiocarb|mesh-list
92322635|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92322636|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
92322637|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322639|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322640|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
92322641|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
92348906|NCT01514370|Interferons|interferons|mesh-list
92322642|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322643|NCT00000656|Zidovudine|zidovudine|mesh-list
92322644|NCT00000656|Didanosine|didanosine|mesh-list
92322645|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
92322646|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322647|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322648|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322649|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322650|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
92322651|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322652|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322653|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322654|NCT00000662|Zidovudine|zidovudine|mesh-list
92322655|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
92322656|NCT00000662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322657|NCT00000662|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322658|NCT00000662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322659|NCT00000662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322660|NCT00000662|Antiviral Agents|antiviral agents|mesh-ancestor
92322661|NCT00000662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322662|NCT00000662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322663|NCT00000662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322664|NCT00002168|Lamivudine|lamivudine|mesh-list
92322665|NCT00002168|Zidovudine|zidovudine|mesh-list
92322666|NCT00002168|Didanosine|didanosine|mesh-list
92322667|NCT00002168|Stavudine|stavudine|mesh-list
92322668|NCT00002168|Indinavir|indinavir|mesh-list
92322669|NCT00002168|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91975361|NCT05257395|Letrozole|letrozole|mesh-list
92322670|NCT00002168|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322672|NCT00002168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322673|NCT00002168|Antiviral Agents|antiviral agents|mesh-ancestor
92322674|NCT00002168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322675|NCT00002168|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322676|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322677|NCT00002168|Antimetabolites|antimetabolites|mesh-ancestor
92322678|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92322679|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92322680|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
92322681|NCT00001442|Paclitaxel|paclitaxel|mesh-list
92322682|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92322683|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322684|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
92322685|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
92322687|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322688|NCT00002174|Thalidomide|thalidomide|mesh-list
92322689|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92322690|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
92322691|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322692|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
92322693|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92322694|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322695|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92322696|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92322697|NCT00002174|Growth Substances|growth substances|mesh-ancestor
92322698|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
92322699|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322700|NCT00000668|Ganciclovir|ganciclovir|mesh-list
92322701|NCT00000668|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92322702|NCT00000668|Antiviral Agents|antiviral agents|mesh-ancestor
92322703|NCT00000668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322704|NCT00000668|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322705|NCT00000668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322706|NCT00000668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322707|NCT00000680|Zidovudine|zidovudine|mesh-list
92322708|NCT00000680|Aldesleukin|aldesleukin|mesh-list
92322709|NCT00000680|Antimetabolites|antimetabolites|mesh-ancestor
92322710|NCT00000680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322711|NCT00000680|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322712|NCT00000680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322713|NCT00000680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322714|NCT00000680|Antiviral Agents|antiviral agents|mesh-ancestor
92322715|NCT00000680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322716|NCT00000680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322717|NCT00000680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322718|NCT00000680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322719|NCT00000692|Miglustat|miglustat|mesh-list
92322720|NCT00000692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322721|NCT00000692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322722|NCT00000692|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322723|NCT00000692|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322724|NCT00000692|Antiviral Agents|antiviral agents|mesh-ancestor
92322725|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322726|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92322727|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92322728|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322729|NCT00000698|Ganciclovir|ganciclovir|mesh-list
92322730|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92322731|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
92322732|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322733|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322734|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322735|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322736|NCT03764449|Balovaptan|balovaptan|mesh-list
92322737|NCT03764449|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92322738|NCT03764449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322739|NCT03764449|Natriuretic Agents|natriuretic agents|mesh-ancestor
92322740|NCT03764449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322741|NCT00002180|Tenofovir|tenofovir|mesh-list
92322742|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
92322743|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322744|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322745|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322746|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322747|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322749|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322751|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
92322752|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322753|NCT00001502|Carboplatin|carboplatin|mesh-list
92322754|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322755|NCT00002192|Azithromycin|azithromycin|mesh-list
92322756|NCT00002192|Clarithromycin|clarithromycin|mesh-list
92322757|NCT00002192|Ethambutol|ethambutol|mesh-list
92322758|NCT00002192|Rifapentine|rifapentine|mesh-list
92322759|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92322760|NCT00002192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322761|NCT00002192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92322762|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322763|NCT00002192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322764|NCT00002192|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92322765|NCT00002192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322766|NCT00002192|Antitubercular Agents|antitubercular agents|mesh-ancestor
92322767|NCT00002192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92322768|NCT00002192|Leprostatic Agents|leprostatic agents|mesh-ancestor
92322769|NCT00002198|Abacavir|abacavir|mesh-list
92322770|NCT00002198|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322771|NCT00002198|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322772|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322773|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322774|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
92322775|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322776|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322777|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322778|NCT00000704|Zalcitabine|zalcitabine|mesh-list
92322779|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
92322780|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322781|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322782|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322783|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322784|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
92322785|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322786|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322787|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322788|NCT00000728|Zidovudine|zidovudine|mesh-list
92322789|NCT00000728|Aldesleukin|aldesleukin|mesh-list
92322790|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
92322791|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322792|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322793|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322794|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322795|NCT00000728|Antiviral Agents|antiviral agents|mesh-ancestor
92322796|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322797|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322798|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322799|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322800|NCT00001520|Neostigmine|neostigmine|mesh-list
92322801|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92322802|NCT00001520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322803|NCT00001520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322804|NCT00001520|Cholinergic Agents|cholinergic agents|mesh-ancestor
92322805|NCT00001520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92322806|NCT00001520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322807|NCT00001520|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92322808|NCT00001520|Autonomic Agents|autonomic agents|mesh-ancestor
92322809|NCT00001520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92322810|NCT00001526|Daclizumab|daclizumab|mesh-list
92322811|NCT00001526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92322812|NCT00001526|Immunologic Factors|immunologic factors|mesh-ancestor
92322813|NCT00001526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322814|NCT00002294|Fluconazole|fluconazole|mesh-list
92322815|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
92322816|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081577|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92322817|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92322818|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322819|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322820|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322821|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92322822|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
92322823|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322824|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322825|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92322826|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92322827|NCT03758365|Triamcinolone|triamcinolone|mesh-list
92322828|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92322829|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92322831|NCT03758365|Betamethasone|betamethasone|mesh-list
92322832|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
92322833|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92322834|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
92322835|NCT03758365|Clobetasol|clobetasol|mesh-list
92322836|NCT03758365|Desonide|desonide|mesh-list
92322837|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
92322838|NCT03758365|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92322839|NCT03758365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92322840|NCT03758365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92322841|NCT03758365|Glucocorticoids|glucocorticoids|mesh-ancestor
92322842|NCT03758365|Hormones|hormones|mesh-ancestor
92322843|NCT03758365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322844|NCT03758365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322845|NCT03758365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92322846|NCT03758365|Immunologic Factors|immunologic factors|mesh-ancestor
92322847|NCT03758365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322848|NCT03758365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001441|NCT04630886|Sympathomimetics|sympathomimetics|mesh-ancestor
92322849|NCT03758365|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92322850|NCT03758365|Respiratory System Agents|respiratory system agents|mesh-ancestor
92322851|NCT03758365|Dermatologic Agents|dermatologic agents|mesh-ancestor
92322853|NCT00002300|Megestrol Acetate|megestrol acetate|mesh-list
92322854|NCT00002300|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92322855|NCT00002300|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92322856|NCT00002300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92322857|NCT00002300|Contraceptive Agents|contraceptive agents|mesh-ancestor
92322858|NCT00002300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92322859|NCT00002300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322860|NCT00002300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92322861|NCT00002300|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92322862|NCT00002300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92322863|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322864|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
92322865|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92322866|NCT00002306|Fluconazole|fluconazole|mesh-list
92322867|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
92322868|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322869|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92322870|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322871|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322872|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322873|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92322874|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
92322875|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92322876|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322877|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92322878|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92322879|NCT00002210|Delavirdine|delavirdine|mesh-list
92322880|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322881|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322882|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322883|NCT00002210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322884|NCT00002210|Antiviral Agents|antiviral agents|mesh-ancestor
92322885|NCT00002210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322886|NCT00002210|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322887|NCT00002210|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322888|NCT00002216|Lamivudine|lamivudine|mesh-list
92322889|NCT00002216|Zidovudine|zidovudine|mesh-list
92322890|NCT00002216|Abacavir|abacavir|mesh-list
92322891|NCT00002216|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92322892|NCT00002216|Nelfinavir|nelfinavir|mesh-list
92322893|NCT00002216|Amprenavir|amprenavir|mesh-list
92322894|NCT00002216|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322895|NCT00002216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322896|NCT00002216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322897|NCT00002216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322898|NCT00002216|Antiviral Agents|antiviral agents|mesh-ancestor
92322899|NCT00002216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322900|NCT00002216|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322901|NCT00002216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322902|NCT00002216|Antimetabolites|antimetabolites|mesh-ancestor
92322903|NCT00002216|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92322904|NCT00002216|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92322905|NCT00002216|Protease Inhibitors|protease inhibitors|mesh-ancestor
92322906|NCT00002216|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92322907|NCT00002216|Antitubercular Agents|antitubercular agents|mesh-ancestor
92322908|NCT00002216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92322909|NCT00002222|Valganciclovir|valganciclovir|mesh-list
92322910|NCT00002222|Antiviral Agents|antiviral agents|mesh-ancestor
92322911|NCT00002222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322912|NCT00002312|Zidovudine|zidovudine|mesh-list
92322913|NCT00002312|Delavirdine|delavirdine|mesh-list
92322914|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
92322915|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322916|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322917|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322918|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322919|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
92322920|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322921|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322922|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322923|NCT00002318|Doxorubicin|doxorubicin|mesh-list
92322924|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92322925|NCT00002318|Bleomycin|bleomycin|mesh-list
92322926|NCT00002318|Vincristine|vincristine|mesh-list
92322927|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92322928|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92322929|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92322930|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92322931|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322932|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322933|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92322934|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92322935|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92322936|NCT00002318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92322937|NCT00002228|Enfuvirtide|enfuvirtide|mesh-list
92322938|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92322939|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92322940|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322941|NCT00002228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322942|NCT00002228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322943|NCT00002228|Antiviral Agents|antiviral agents|mesh-ancestor
92322944|NCT00002228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322945|NCT04714177|Edaravone|edaravone|mesh-list
92322946|NCT04714177|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92322947|NCT04714177|Antioxidants|antioxidants|mesh-ancestor
92322948|NCT04714177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322949|NCT04714177|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92322950|NCT04714177|Protective Agents|protective agents|mesh-ancestor
92322951|NCT04714177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322952|NCT00001628|Angiotensin II|angiotensin ii|mesh-list
92322953|NCT00001628|Giapreza|giapreza|mesh-list
92322954|NCT00001628|Angiotensinogen|angiotensinogen|mesh-list
92322955|NCT00001628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-list
92322956|NCT00001628|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92322957|NCT00001628|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92322958|NCT00001628|Protease Inhibitors|protease inhibitors|mesh-ancestor
92322959|NCT00001628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322960|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322961|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92322962|NCT00002234|Lamivudine|lamivudine|mesh-list
92322964|NCT00002234|Didanosine|didanosine|mesh-list
92322965|NCT00002234|Adefovir|adefovir|mesh-list
92322966|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92322967|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322968|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322969|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322970|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322971|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
92322972|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322973|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322974|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322975|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92322976|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92322977|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92322978|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92322979|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92322980|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92322981|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
92322983|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
92322984|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
92322985|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92322986|NCT00002324|Zidovudine|zidovudine|mesh-list
92322987|NCT00002324|Nevirapine|nevirapine|mesh-list
92322988|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
92322989|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92322990|NCT00002324|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92322991|NCT00002324|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92322992|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92322993|NCT00002324|Antiviral Agents|antiviral agents|mesh-ancestor
92322994|NCT00002324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92322995|NCT00002324|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92322996|NCT00002324|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92322997|NCT00002324|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92322998|NCT00002324|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92322999|NCT00002330|Ganciclovir|ganciclovir|mesh-list
92323000|NCT00002330|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92323001|NCT00002330|Antiviral Agents|antiviral agents|mesh-ancestor
92323002|NCT00002330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323003|NCT00002330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323004|NCT00002330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323005|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323006|NCT03740659|Levofloxacin|levofloxacin|mesh-list
92323007|NCT03740659|Ofloxacin|ofloxacin|mesh-list
92323008|NCT03740659|Dexamethasone|dexamethasone|mesh-list
92323009|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
92323010|NCT03740659|BB 1101|bb 1101|mesh-list
92323011|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323012|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
92323013|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
92323014|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323015|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323016|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323017|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
92323018|NCT03740659|Hormones|hormones|mesh-ancestor
92323019|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323020|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323021|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323022|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
92323023|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323024|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323025|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92323026|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323027|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323028|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323029|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323030|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92323031|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323032|NCT00002336|Clarithromycin|clarithromycin|mesh-list
92323033|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323034|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323035|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92323036|NCT00002336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323037|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323038|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323039|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323040|NCT00001646|Voriconazole|voriconazole|mesh-list
92323041|NCT00001646|Amphotericin B|amphotericin b|mesh-list
92323042|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92323043|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
92323044|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323045|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91975731|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
92323046|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323047|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323048|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323049|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92323050|NCT00001646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92323051|NCT00001646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323052|NCT00001646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323053|NCT00001646|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323055|NCT00001646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92323056|NCT00001646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92323057|NCT00001646|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323058|NCT00001658|Amoxicillin|amoxicillin|mesh-list
92323059|NCT00001658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323060|NCT00001658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323061|NCT00002252|Octreotide|octreotide|mesh-list
92323062|NCT00002252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323063|NCT00002252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323064|NCT00002252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323065|NCT00002348|Mitoguazone|mitoguazone|mesh-list
92323066|NCT00002348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323067|NCT00002348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323068|NCT00002348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323070|NCT02721277|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92323071|NCT02721277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92323072|NCT02721277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92323073|NCT00378235|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92323074|NCT00378235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323075|NCT00002270|Interferons|interferons|mesh-list
92323076|NCT00002270|Interferon-alpha|interferon-alpha|mesh-list
92323077|NCT00002270|Interferon alpha-2|interferon alpha-2|mesh-list
92323078|NCT00002270|Zidovudine|zidovudine|mesh-list
92323079|NCT00002270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323080|NCT00002270|Antiviral Agents|antiviral agents|mesh-ancestor
92323081|NCT00002270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323082|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
92323083|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323084|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
92323085|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323086|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323087|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323088|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323089|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323090|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323091|NCT00002354|Stavudine|stavudine|mesh-list
92323092|NCT00002354|Indinavir|indinavir|mesh-list
92323093|NCT00002354|Antimetabolites|antimetabolites|mesh-ancestor
92323094|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323095|NCT00002354|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323096|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323097|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323098|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
92323099|NCT00002354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323100|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323101|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323102|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92323103|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92323104|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
92323107|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323108|NCT00002360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323109|NCT00002360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323110|NCT00002360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323111|NCT00002360|Antiviral Agents|antiviral agents|mesh-ancestor
92323112|NCT00002360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323113|NCT00002360|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323114|NCT00002360|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323116|NCT00002276|Ibuprofen|ibuprofen|mesh-list
92323117|NCT00002276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92323118|NCT00002276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92323119|NCT00002276|Analgesics|analgesics|mesh-ancestor
92323120|NCT00002276|Sensory System Agents|sensory system agents|mesh-ancestor
92323121|NCT00002276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323122|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323123|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323124|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323125|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92323126|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323127|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323128|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
92323129|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323130|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323131|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
92323132|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323133|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323134|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323135|NCT00378547|Acetaminophen|acetaminophen|mesh-list
92323136|NCT00378547|Dexamethasone|dexamethasone|mesh-list
92323137|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
92323138|NCT00378547|Pregabalin|pregabalin|mesh-list
92323139|NCT00378547|BB 1101|bb 1101|mesh-list
92323140|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323141|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
92323142|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
92323143|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323144|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323145|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323146|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
92323147|NCT00378547|Hormones|hormones|mesh-ancestor
92323148|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323149|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323151|NCT00378547|Protease Inhibitors|protease inhibitors|mesh-ancestor
92323152|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323153|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323154|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92323155|NCT00378547|Analgesics|analgesics|mesh-ancestor
92323156|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
92323157|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
92323158|NCT00378547|Anticonvulsants|anticonvulsants|mesh-ancestor
92323159|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92323160|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92323161|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92323162|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92323163|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92323164|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92323165|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92323166|NCT00002282|Fluconazole|fluconazole|mesh-list
92323167|NCT00002282|Clotrimazole|clotrimazole|mesh-list
92323168|NCT00002282|Miconazole|miconazole|mesh-list
92323169|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
92323170|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323171|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92323172|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323173|NCT00002282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323174|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323175|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92323176|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92323177|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323178|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323179|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92323180|NCT00002282|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92323181|NCT00002282|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92323182|NCT00002282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323183|NCT02658877|Omalizumab|omalizumab|mesh-list
92323184|NCT02658877|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92323185|NCT02658877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92323186|NCT02658877|Respiratory System Agents|respiratory system agents|mesh-ancestor
92323187|NCT00002288|Zidovudine|zidovudine|mesh-list
92323188|NCT00002288|Antimetabolites|antimetabolites|mesh-ancestor
92323189|NCT00002288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323190|NCT00002288|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323191|NCT00002288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323192|NCT00002288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323193|NCT00002288|Antiviral Agents|antiviral agents|mesh-ancestor
92323194|NCT00002288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323196|NCT00002288|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323197|NCT00002366|Ritonavir|ritonavir|mesh-list
92323198|NCT00002366|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92323199|NCT00002366|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92323200|NCT00002366|Protease Inhibitors|protease inhibitors|mesh-ancestor
92323201|NCT00002366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323202|NCT00002366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323203|NCT00002366|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323204|NCT00002366|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323205|NCT00002366|Antiviral Agents|antiviral agents|mesh-ancestor
92323206|NCT00002366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323207|NCT00002366|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323208|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323209|NCT00378313|Paclitaxel|paclitaxel|mesh-list
92323210|NCT00378313|Gemcitabine|gemcitabine|mesh-list
92323211|NCT00378313|Epirubicin|epirubicin|mesh-list
92323212|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323213|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323214|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
92323215|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
92323216|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
92116943|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323217|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323218|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323219|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
92323220|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92323221|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323222|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323223|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323224|NCT00002372|Nelfinavir|nelfinavir|mesh-list
92323225|NCT00002372|Indinavir|indinavir|mesh-list
92323226|NCT00002372|Saquinavir|saquinavir|mesh-list
92323227|NCT00002372|Amprenavir|amprenavir|mesh-list
92323228|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92323229|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92323230|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
92323231|NCT00002372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323232|NCT00002372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323233|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323234|NCT00002372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323235|NCT00002372|Antiviral Agents|antiviral agents|mesh-ancestor
92323236|NCT00002372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323237|NCT00002372|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323238|NCT00002372|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323239|NCT00002372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92323240|NCT00002372|Antitubercular Agents|antitubercular agents|mesh-ancestor
92323241|NCT00002372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323242|NCT00002378|Ritonavir|ritonavir|mesh-list
92323243|NCT00002378|Nelfinavir|nelfinavir|mesh-list
92323244|NCT00002378|Saquinavir|saquinavir|mesh-list
92323245|NCT00002378|Lamivudine|lamivudine|mesh-list
92323246|NCT00002378|Zidovudine|zidovudine|mesh-list
92323247|NCT00002378|Stavudine|stavudine|mesh-list
92323248|NCT00002378|Delavirdine|delavirdine|mesh-list
92323249|NCT00002378|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92323250|NCT00002378|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92323251|NCT00002378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92323252|NCT00002378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323253|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323255|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323256|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
92323257|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323258|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323259|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323260|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323261|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323262|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
92323263|NCT02589145|Pyridoxine|pyridoxine|mesh-list
92323264|NCT02589145|Dexamethasone|dexamethasone|mesh-list
92323265|NCT02589145|Rituximab|rituximab|mesh-list
92323266|NCT02589145|Gemcitabine|gemcitabine|mesh-list
92323267|NCT02589145|Lenalidomide|lenalidomide|mesh-list
92323268|NCT02589145|Melphalan|melphalan|mesh-list
92323269|NCT02589145|Busulfan|busulfan|mesh-list
92323270|NCT02589145|Vorinostat|vorinostat|mesh-list
92323271|NCT02589145|Enoxaparin|enoxaparin|mesh-list
92323272|NCT02589145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975957|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92323273|NCT02589145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323274|NCT02589145|Immunologic Factors|immunologic factors|mesh-ancestor
92323275|NCT02589145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323276|NCT02589145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323277|NCT02589145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323278|NCT02589145|Antiemetics|antiemetics|mesh-ancestor
92323279|NCT02589145|Autonomic Agents|autonomic agents|mesh-ancestor
92323280|NCT02589145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323281|NCT02589145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323282|NCT02589145|Glucocorticoids|glucocorticoids|mesh-ancestor
92323283|NCT02589145|Hormones|hormones|mesh-ancestor
92323284|NCT02589145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323285|NCT02589145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323286|NCT02589145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323287|NCT02589145|Antimetabolites|antimetabolites|mesh-ancestor
92323288|NCT02589145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323289|NCT02589145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92323290|NCT02589145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92323291|NCT02589145|Growth Substances|growth substances|mesh-ancestor
92323292|NCT02589145|Growth Inhibitors|growth inhibitors|mesh-ancestor
92323293|NCT02589145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323294|NCT02589145|Alkylating Agents|alkylating agents|mesh-ancestor
92323295|NCT02589145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323296|NCT02589145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323297|NCT02589145|Anticoagulants|anticoagulants|mesh-ancestor
92323298|NCT02589145|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92323299|NCT02589145|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92323300|NCT02589145|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92323301|NCT02589145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323302|NCT02589145|Vitamin B Complex|vitamin b complex|mesh-ancestor
92323303|NCT02589145|Vitamins|vitamins|mesh-ancestor
92323304|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
92323305|NCT00002384|Cidofovir|cidofovir|mesh-list
92323306|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
92323307|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323308|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323309|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323310|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
92323311|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
92323312|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
92323313|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323314|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92323315|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
92323316|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
92323317|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92323318|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323319|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323320|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92323321|NCT02568007|Serotonin Agents|serotonin agents|mesh-ancestor
92323322|NCT02568007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92323323|NCT00002390|Abacavir|abacavir|mesh-list
92323324|NCT00002390|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323325|NCT00002390|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323326|NCT00002390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323327|NCT00002390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323328|NCT00002390|Antiviral Agents|antiviral agents|mesh-ancestor
92323329|NCT00002390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323330|NCT00002390|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323331|NCT00002390|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323332|NCT00002396|Tenofovir|tenofovir|mesh-list
92323333|NCT00002396|Antiviral Agents|antiviral agents|mesh-ancestor
92323334|NCT00002396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323335|NCT00002396|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323336|NCT00002396|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323337|NCT00002396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323338|NCT00002396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323339|NCT00002396|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323340|NCT00002396|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323341|NCT00002402|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92323342|NCT00002402|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92323343|NCT00002402|Immunologic Factors|immunologic factors|mesh-ancestor
92323344|NCT00002402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323345|NCT00002402|Antacids|antacids|mesh-ancestor
92323346|NCT00002402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323347|NCT00002402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323349|NCT00002420|Stavudine|stavudine|mesh-list
92323350|NCT00002420|Delavirdine|delavirdine|mesh-list
92323351|NCT00002420|Emivirine|emivirine|mesh-list
92323352|NCT00002420|Hydroxyurea|hydroxyurea|mesh-list
92323353|NCT00002420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323354|NCT00002420|Antisickling Agents|antisickling agents|mesh-ancestor
92323355|NCT00002420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323356|NCT00002420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323357|NCT00002420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323358|NCT00002420|Antimetabolites|antimetabolites|mesh-ancestor
92323359|NCT00002420|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323360|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
92323361|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323362|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323363|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323364|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
92323365|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92323366|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323367|NCT04024501|Verinurad|verinurad|mesh-list
92323368|NCT04024501|Gout Suppressants|gout suppressants|mesh-ancestor
92323369|NCT04024501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323370|NCT05709626|Aspirin|aspirin|mesh-list
92323371|NCT05709626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92323372|NCT05709626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92323373|NCT05709626|Analgesics|analgesics|mesh-ancestor
92323374|NCT05709626|Sensory System Agents|sensory system agents|mesh-ancestor
92323375|NCT05709626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323376|NCT05709626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323377|NCT05709626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323378|NCT05709626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323379|NCT05709626|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92323380|NCT05709626|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92323381|NCT05709626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323382|NCT05709626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92323383|NCT05709626|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92323384|NCT05709626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323385|NCT05709626|Antipyretics|antipyretics|mesh-ancestor
92323386|NCT03538015|Carvedilol|carvedilol|mesh-list
92323387|NCT03538015|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92323388|NCT03538015|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92323389|NCT03538015|Adrenergic Agents|adrenergic agents|mesh-ancestor
92323390|NCT03538015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348998|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323391|NCT03538015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323392|NCT03538015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323393|NCT03538015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92323394|NCT03538015|Antioxidants|antioxidants|mesh-ancestor
92323395|NCT03538015|Protective Agents|protective agents|mesh-ancestor
92323396|NCT03538015|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92323397|NCT03538015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92323398|NCT03538015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92323399|NCT03538015|Vasodilator Agents|vasodilator agents|mesh-ancestor
92323400|NCT03538015|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92323401|NCT03538015|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92323402|NCT03342157|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92323404|NCT03342157|Antidiarrheals|antidiarrheals|mesh-ancestor
92323405|NCT03342157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323406|NCT03342157|Laxatives|laxatives|mesh-ancestor
92323407|NCT04331210|Diclofenac|diclofenac|mesh-list
92323408|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92323409|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92323410|NCT04331210|Analgesics|analgesics|mesh-ancestor
92323411|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
92323412|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323413|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323414|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323415|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323416|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92323417|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323418|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323419|NCT00002426|Adefovir|adefovir|mesh-list
92323420|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92323421|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
92323422|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323423|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323424|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323425|NCT00002426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323426|NCT00002426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323428|NCT00002432|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92323429|NCT00002432|Antiviral Agents|antiviral agents|mesh-ancestor
92323430|NCT00002432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323431|NCT00002432|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323432|NCT00002432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323433|NCT00002432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323434|NCT00002432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323435|NCT05701436|Leucovorin|leucovorin|mesh-list
92323437|NCT05701436|Fluorouracil|fluorouracil|mesh-list
92323438|NCT05701436|Oxaliplatin|oxaliplatin|mesh-list
92323439|NCT05701436|Raltitrexed|raltitrexed|mesh-list
92323440|NCT05701436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323441|NCT05701436|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92323442|NCT05701436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323443|NCT05701436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323444|NCT05701436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323445|NCT05701436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323446|NCT05701436|Antimetabolites|antimetabolites|mesh-ancestor
92323447|NCT05701436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323448|NCT05701436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323449|NCT05701436|Immunologic Factors|immunologic factors|mesh-ancestor
92323450|NCT05701436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323451|NCT05701436|Antidotes|antidotes|mesh-ancestor
92323452|NCT05701436|Protective Agents|protective agents|mesh-ancestor
92323453|NCT05701436|Vitamin B Complex|vitamin b complex|mesh-ancestor
92323454|NCT05701436|Vitamins|vitamins|mesh-ancestor
92323455|NCT05701436|Micronutrients|micronutrients|mesh-ancestor
92323456|NCT05701436|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323457|NCT02487277|Paclitaxel|paclitaxel|mesh-list
92323458|NCT02487277|Gemcitabine|gemcitabine|mesh-list
92323459|NCT02487277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323460|NCT02487277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323461|NCT02487277|Tubulin Modulators|tubulin modulators|mesh-ancestor
92323462|NCT02487277|Antimitotic Agents|antimitotic agents|mesh-ancestor
92323463|NCT02487277|Mitosis Modulators|mitosis modulators|mesh-ancestor
92323464|NCT02487277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323465|NCT02487277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323466|NCT02487277|Antimetabolites|antimetabolites|mesh-ancestor
92323467|NCT00002438|Itraconazole|itraconazole|mesh-list
92323468|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
92323469|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323470|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92323471|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92323472|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323473|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323474|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92323475|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
92323476|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323477|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081596|NCT01405911|Hormones|hormones|mesh-ancestor
92323478|NCT00002438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92323479|NCT00002444|Nitazoxanide|nitazoxanide|mesh-list
92323480|NCT00002444|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92323481|NCT00002444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323482|NCT02436265|Dexamethasone|dexamethasone|mesh-list
92323483|NCT02436265|Ropivacaine|ropivacaine|mesh-list
92323484|NCT02436265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323485|NCT02436265|Antiemetics|antiemetics|mesh-ancestor
92323486|NCT02436265|Autonomic Agents|autonomic agents|mesh-ancestor
92323487|NCT02436265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323488|NCT02436265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323489|NCT02436265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323490|NCT02436265|Glucocorticoids|glucocorticoids|mesh-ancestor
92323491|NCT02436265|Hormones|hormones|mesh-ancestor
92323492|NCT02436265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323493|NCT02436265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323494|NCT02436265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323495|NCT02436265|Anesthetics, Local|anesthetics, local|mesh-ancestor
92323496|NCT02436265|Anesthetics|anesthetics|mesh-ancestor
92323497|NCT02436265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976184|NCT02503943|Metformin|metformin|mesh-list
92323498|NCT02436265|Sensory System Agents|sensory system agents|mesh-ancestor
92323499|NCT05751746|Magnesium Sulfate|magnesium sulfate|mesh-list
92323500|NCT05751746|Analgesics|analgesics|mesh-ancestor
92323501|NCT05751746|Sensory System Agents|sensory system agents|mesh-ancestor
92323502|NCT05751746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323503|NCT05751746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323504|NCT05751746|Anesthetics|anesthetics|mesh-ancestor
92323505|NCT05751746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92323506|NCT05751746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92323507|NCT05751746|Anticonvulsants|anticonvulsants|mesh-ancestor
92323508|NCT05751746|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92323509|NCT05751746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92323510|NCT05751746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323511|NCT05751746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92323512|NCT05751746|Tocolytic Agents|tocolytic agents|mesh-ancestor
92323513|NCT05751746|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323514|NCT00002450|Tenofovir|tenofovir|mesh-list
92323515|NCT00002450|Antiviral Agents|antiviral agents|mesh-ancestor
92323516|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323517|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92323518|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323519|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323520|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323521|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92323522|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323523|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
92323524|NCT03277183|Hematinics|hematinics|mesh-ancestor
92323525|NCT00002456|Cyclosporine|cyclosporine|mesh-list
92323526|NCT00002456|Methotrexate|methotrexate|mesh-list
92323527|NCT00002456|Cyclosporins|cyclosporins|mesh-list
92323528|NCT00002456|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92323529|NCT00002456|Abortifacient Agents|abortifacient agents|mesh-ancestor
92323530|NCT00002456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323531|NCT00002456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323532|NCT00002456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323533|NCT00002456|Antimetabolites|antimetabolites|mesh-ancestor
92323534|NCT00002456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323535|NCT00002456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323536|NCT00002456|Dermatologic Agents|dermatologic agents|mesh-ancestor
92323537|NCT00002456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323538|NCT00002456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323539|NCT00002456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323540|NCT00002456|Immunologic Factors|immunologic factors|mesh-ancestor
92323541|NCT00002456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323542|NCT00002456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323543|NCT00002456|Antifungal Agents|antifungal agents|mesh-ancestor
92323544|NCT00002456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323545|NCT00002456|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92323546|NCT01525927|Cisplatin|cisplatin|mesh-list
92323547|NCT01525927|Carboplatin|carboplatin|mesh-list
92323548|NCT01525927|Etoposide|etoposide|mesh-list
92323549|NCT01525927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323550|NCT01525927|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323551|NCT01525927|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323552|NCT01525927|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323553|NCT01525927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323554|NCT01525927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323555|NCT00002474|Cyclophosphamide|cyclophosphamide|mesh-list
92323556|NCT00002474|Carboplatin|carboplatin|mesh-list
92323557|NCT00002474|Mitoxantrone|mitoxantrone|mesh-list
92323558|NCT00002474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323559|NCT00002474|Immunologic Factors|immunologic factors|mesh-ancestor
92323560|NCT00002474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323561|NCT00002474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323562|NCT00002474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323563|NCT00002474|Alkylating Agents|alkylating agents|mesh-ancestor
92323564|NCT00002474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323565|NCT00002474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349020|NCT01509846|Vaccines|vaccines|mesh-list
92323566|NCT00002474|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323567|NCT00002474|Analgesics|analgesics|mesh-ancestor
92323568|NCT00002474|Sensory System Agents|sensory system agents|mesh-ancestor
92323569|NCT00002474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323570|NCT00002474|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323571|NCT00002474|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323573|NCT00002492|Doxorubicin|doxorubicin|mesh-list
92323574|NCT00002492|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92323575|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323576|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92323577|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323578|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323579|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323580|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323581|NCT05751512|Methotrexate|methotrexate|mesh-list
92323582|NCT05751512|Cetuximab|cetuximab|mesh-list
92323583|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92323584|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
92323585|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323586|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323587|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323588|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
92323589|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323590|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323591|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92323592|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323593|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323594|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323595|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
92323596|NCT05751512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323597|NCT05751512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323598|NCT05751512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92323599|NCT02373865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92323600|NCT02373865|Glimepiride|glimepiride|mesh-list
92323601|NCT02373865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92323602|NCT02373865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323603|NCT02373865|Incretins|incretins|mesh-ancestor
92323604|NCT02373865|Hormones|hormones|mesh-ancestor
92323605|NCT02373865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323606|NCT02373865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92323608|NCT02373865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323609|NCT02373865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323610|NCT02373865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92323611|NCT02373865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323612|NCT02373865|Immunologic Factors|immunologic factors|mesh-ancestor
92323613|NCT00002498|Cyclophosphamide|cyclophosphamide|mesh-list
92323614|NCT00002498|Fluorouracil|fluorouracil|mesh-list
92323615|NCT00002498|Methotrexate|methotrexate|mesh-list
92323616|NCT00002498|Mitoxantrone|mitoxantrone|mesh-list
92323617|NCT00002498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323618|NCT00002498|Immunologic Factors|immunologic factors|mesh-ancestor
92323619|NCT00002498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323620|NCT00002498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323621|NCT00002498|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323622|NCT00002498|Alkylating Agents|alkylating agents|mesh-ancestor
92323623|NCT00002498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323624|NCT00002498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323625|NCT00002498|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323626|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
92323627|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323628|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92323629|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
92323630|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323631|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
92323632|NCT00002498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323633|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323634|NCT00002498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323635|NCT00002498|Analgesics|analgesics|mesh-ancestor
92323636|NCT00002498|Sensory System Agents|sensory system agents|mesh-ancestor
92323637|NCT00002498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323638|NCT00002498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323639|NCT00002498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323640|NCT00002504|Interferons|interferons|mesh-list
92323641|NCT00002504|Interferon-alpha|interferon-alpha|mesh-list
92323642|NCT00002504|Aldesleukin|aldesleukin|mesh-list
92323643|NCT00002504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323644|NCT00002504|Antiviral Agents|antiviral agents|mesh-ancestor
92323645|NCT00002504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323646|NCT00002504|Immunologic Factors|immunologic factors|mesh-ancestor
92323647|NCT00002504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323649|NCT00002504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92323650|NCT02360059|Metformin|metformin|mesh-list
92323651|NCT02360059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92323652|NCT02360059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323653|NCT00002510|Cyclophosphamide|cyclophosphamide|mesh-list
92323654|NCT00002510|Etoposide|etoposide|mesh-list
92323655|NCT00002510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323656|NCT00002510|Immunologic Factors|immunologic factors|mesh-ancestor
92323657|NCT00002510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323658|NCT00002510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323659|NCT00002510|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323660|NCT00002510|Alkylating Agents|alkylating agents|mesh-ancestor
92323661|NCT00002510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323662|NCT00002510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323663|NCT00002510|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323664|NCT00002510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323665|NCT00002510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323666|NCT00002510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323667|NCT00002510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323668|NCT01500109|Acetaminophen|acetaminophen|mesh-list
92323669|NCT01500109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92323670|NCT01500109|Analgesics|analgesics|mesh-ancestor
92323671|NCT01500109|Sensory System Agents|sensory system agents|mesh-ancestor
92323672|NCT01500109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323673|NCT01500109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323674|NCT01500109|Antipyretics|antipyretics|mesh-ancestor
92323676|NCT00002516|Dactinomycin|dactinomycin|mesh-list
92323677|NCT00002516|Cyclophosphamide|cyclophosphamide|mesh-list
92323678|NCT00002516|Ifosfamide|ifosfamide|mesh-list
92323679|NCT00002516|Doxorubicin|doxorubicin|mesh-list
92323680|NCT00002516|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92323681|NCT00002516|Etoposide|etoposide|mesh-list
92323682|NCT00002516|Vincristine|vincristine|mesh-list
92323683|NCT00002516|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323684|NCT00002516|Immunologic Factors|immunologic factors|mesh-ancestor
92323685|NCT00002516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323686|NCT00002516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323687|NCT00002516|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323688|NCT00002516|Alkylating Agents|alkylating agents|mesh-ancestor
92323689|NCT00002516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323690|NCT00002516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323691|NCT00002516|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323692|NCT00002516|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92323693|NCT00002516|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323694|NCT00002516|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323695|NCT00002516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323696|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323697|NCT00002516|Tubulin Modulators|tubulin modulators|mesh-ancestor
92323698|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
92323699|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
92323700|NCT00002516|Trace Elements|trace elements|mesh-ancestor
92323701|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
92323702|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323703|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323704|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92323705|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323706|NCT00002522|Cyclophosphamide|cyclophosphamide|mesh-list
92323707|NCT00002522|Etoposide|etoposide|mesh-list
92323708|NCT00002522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323709|NCT00002522|Immunologic Factors|immunologic factors|mesh-ancestor
92323710|NCT00002522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323711|NCT00002522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323712|NCT00002522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323713|NCT00002522|Alkylating Agents|alkylating agents|mesh-ancestor
92323714|NCT00002522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323715|NCT00002522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323716|NCT00002522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323717|NCT00002522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323718|NCT00002522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323719|NCT00002522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323720|NCT00002522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323721|NCT00002528|Tamoxifen|tamoxifen|mesh-list
92323722|NCT00002528|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92323723|NCT00002528|Hormone Antagonists|hormone antagonists|mesh-ancestor
92323724|NCT00002528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323725|NCT00002528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323726|NCT00002528|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323727|NCT00002528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323728|NCT00002528|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92323729|NCT00002528|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92323730|NCT00002528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92323731|NCT02341495|Vitamin D|vitamin d|mesh-list
92323732|NCT02341495|Cholecalciferol|cholecalciferol|mesh-list
92323733|NCT02341495|Azacitidine|azacitidine|mesh-list
92323734|NCT02341495|Deferasirox|deferasirox|mesh-list
92323735|NCT02341495|Vitamins|vitamins|mesh-ancestor
92323736|NCT02341495|Micronutrients|micronutrients|mesh-ancestor
92323737|NCT02341495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323738|NCT02341495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92323739|NCT02341495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323740|NCT02341495|Antimetabolites|antimetabolites|mesh-ancestor
92323741|NCT02341495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323742|NCT02341495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323743|NCT02341495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323744|NCT02341495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92323745|NCT02341495|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92323746|NCT02341495|Chelating Agents|chelating agents|mesh-ancestor
92323747|NCT02341495|Sequestering Agents|sequestering agents|mesh-ancestor
92323748|NCT00002534|Cytarabine|cytarabine|mesh-list
92323749|NCT00002534|Methylprednisolone|methylprednisolone|mesh-list
92323750|NCT00002534|Cyclophosphamide|cyclophosphamide|mesh-list
92323751|NCT00002534|Thiotepa|thiotepa|mesh-list
92323752|NCT00002534|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92323753|NCT00002534|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323754|NCT00002534|Immunologic Factors|immunologic factors|mesh-ancestor
92323755|NCT00002534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323756|NCT00002534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323757|NCT00002534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323758|NCT00002534|Alkylating Agents|alkylating agents|mesh-ancestor
92323759|NCT00002534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323760|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323761|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323762|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323763|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
92323764|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
92323765|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323766|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323767|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
92323768|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
92323769|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323770|NCT00002534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92323771|NCT00002534|Glucocorticoids|glucocorticoids|mesh-ancestor
92323772|NCT00002534|Hormones|hormones|mesh-ancestor
92323773|NCT00002534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323774|NCT00002534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92323775|NCT00002534|Protective Agents|protective agents|mesh-ancestor
92323776|NCT00002546|Ifosfamide|ifosfamide|mesh-list
92323777|NCT00002546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323778|NCT00002546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323780|NCT00002546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323781|NCT00378625|Artesunate|artesunate|mesh-list
92323782|NCT00378625|Antimalarials|antimalarials|mesh-ancestor
92323783|NCT00378625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92323784|NCT00378625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92323785|NCT00378625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323786|NCT00378625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323787|NCT00378625|Antiviral Agents|antiviral agents|mesh-ancestor
92323788|NCT00378625|Schistosomicides|schistosomicides|mesh-ancestor
92323789|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92323790|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
92323791|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92323792|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
92323793|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
92323794|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
92323795|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92323796|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323797|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323798|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91976485|NCT02117050|Interferons|interferons|mesh-list
92323799|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92323800|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92323801|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92323802|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92323803|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323804|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323805|NCT00002552|Leucovorin|leucovorin|mesh-list
92323806|NCT00002552|Cytarabine|cytarabine|mesh-list
92323807|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
92323808|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92323809|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92323810|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92323811|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
92323812|NCT00002552|Carmustine|carmustine|mesh-list
92323813|NCT00002552|Methotrexate|methotrexate|mesh-list
92323814|NCT00002552|Etoposide|etoposide|mesh-list
92323815|NCT00002552|Sargramostim|sargramostim|mesh-list
92323816|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
92323817|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323818|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
92323819|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323820|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323821|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323822|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
92323823|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323824|NCT00002552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323825|NCT00002552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323826|NCT00002552|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92323827|NCT00002552|Abortifacient Agents|abortifacient agents|mesh-ancestor
92323828|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323829|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323830|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
92323831|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
92323832|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323833|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323834|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323835|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323836|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323837|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323838|NCT00002552|Antiviral Agents|antiviral agents|mesh-ancestor
92323839|NCT00002552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323840|NCT00002552|Antidotes|antidotes|mesh-ancestor
92323841|NCT00002552|Protective Agents|protective agents|mesh-ancestor
92323842|NCT00002552|Vitamin B Complex|vitamin b complex|mesh-ancestor
92323843|NCT00002552|Vitamins|vitamins|mesh-ancestor
92323844|NCT00002552|Micronutrients|micronutrients|mesh-ancestor
92323845|NCT00002552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323846|NCT00378781|Minocycline|minocycline|mesh-list
92323847|NCT00378781|Heparin|heparin|mesh-list
92323848|NCT00378781|Anticoagulants|anticoagulants|mesh-ancestor
92323849|NCT00378781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92323850|NCT00378781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92323851|NCT00378781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323852|NCT00378781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92323853|NCT00378781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323855|NCT00377923|Progestins|progestins|mesh-ancestor
92323856|NCT00377923|Hormones|hormones|mesh-ancestor
92323857|NCT00377923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323858|NCT00377923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323859|NCT00002570|Leucovorin|leucovorin|mesh-list
92323860|NCT00002570|Fluorouracil|fluorouracil|mesh-list
92323861|NCT00002570|Calcium|calcium|mesh-list
92323862|NCT00002570|Levoleucovorin|levoleucovorin|mesh-list
92323863|NCT00002570|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92323864|NCT00002570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323865|NCT00002570|Antimetabolites|antimetabolites|mesh-ancestor
92323866|NCT00002570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323867|NCT00002570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323868|NCT00002570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323869|NCT00002570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323870|NCT00002570|Immunologic Factors|immunologic factors|mesh-ancestor
92323871|NCT00002570|Antidotes|antidotes|mesh-ancestor
92323872|NCT00002570|Protective Agents|protective agents|mesh-ancestor
92323873|NCT00002570|Vitamin B Complex|vitamin b complex|mesh-ancestor
91976562|NCT02606877|Analgesics|analgesics|mesh-ancestor
92323874|NCT00002570|Vitamins|vitamins|mesh-ancestor
92323875|NCT00002570|Micronutrients|micronutrients|mesh-ancestor
92323876|NCT00002576|Prednisolone|prednisolone|mesh-list
92323877|NCT00002576|Cyclophosphamide|cyclophosphamide|mesh-list
92323878|NCT00002576|Doxorubicin|doxorubicin|mesh-list
92323879|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92323880|NCT00002576|Vincristine|vincristine|mesh-list
92323881|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
92323882|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323883|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
92323884|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323885|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323886|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323887|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
92323888|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323890|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323891|NCT00002576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92323892|NCT00002576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323893|NCT00002576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323894|NCT00002576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323895|NCT00002576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323896|NCT00002576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92323897|NCT00002576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92323898|NCT00002576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92323899|NCT00002576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92323900|NCT00002576|Glucocorticoids|glucocorticoids|mesh-ancestor
92323901|NCT00002576|Hormones|hormones|mesh-ancestor
92323902|NCT00002576|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323903|NCT00002576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323904|NCT00002576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323905|NCT00002576|Analgesics|analgesics|mesh-ancestor
92323906|NCT00002576|Sensory System Agents|sensory system agents|mesh-ancestor
92323907|NCT00002582|Tamoxifen|tamoxifen|mesh-list
92323908|NCT00002582|Cyclophosphamide|cyclophosphamide|mesh-list
92323909|NCT00002582|Doxorubicin|doxorubicin|mesh-list
92323910|NCT00002582|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92323911|NCT00002582|Fluorouracil|fluorouracil|mesh-list
92323912|NCT00002582|Methotrexate|methotrexate|mesh-list
92323913|NCT00002582|Leuprolide|leuprolide|mesh-list
92323914|NCT00002582|Goserelin|goserelin|mesh-list
92323915|NCT00002582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323916|NCT00002582|Immunologic Factors|immunologic factors|mesh-ancestor
92323917|NCT00002582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323918|NCT00002582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323919|NCT00002582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323920|NCT00002582|Alkylating Agents|alkylating agents|mesh-ancestor
92323921|NCT00002582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323922|NCT00002582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323923|NCT00002582|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323924|NCT00002582|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92323925|NCT00002582|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323926|NCT00002582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92323927|NCT00002582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323929|NCT00002582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92323930|NCT00002582|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92323931|NCT00002582|Abortifacient Agents|abortifacient agents|mesh-ancestor
92323932|NCT00002582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92323933|NCT00002582|Dermatologic Agents|dermatologic agents|mesh-ancestor
92323934|NCT00002582|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92323935|NCT00002582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92323936|NCT00002582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92323937|NCT00002582|Hormone Antagonists|hormone antagonists|mesh-ancestor
92323938|NCT00002582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92323939|NCT00002582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92323940|NCT00002582|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92323941|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92323942|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92323943|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92323944|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
92323945|NCT00002588|Etoposide|etoposide|mesh-list
92323946|NCT00002588|Topotecan|topotecan|mesh-list
92323947|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92323948|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323949|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92323950|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91976635|NCT03038607|Aspirin|aspirin|mesh-list
92323951|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92323952|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323953|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92323954|NCT02239627|Clonidine|clonidine|mesh-list
92323955|NCT02239627|Analgesics|analgesics|mesh-ancestor
92323956|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
92323957|NCT02239627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323958|NCT02239627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323959|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92323960|NCT02239627|Sympatholytics|sympatholytics|mesh-ancestor
92323961|NCT02239627|Autonomic Agents|autonomic agents|mesh-ancestor
92323962|NCT02239627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92323963|NCT02239627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92323964|NCT02239627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92323965|NCT02239627|Adrenergic Agents|adrenergic agents|mesh-ancestor
92323966|NCT02239627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92323967|NCT02239627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323968|NCT05750576|Chlorhexidine|chlorhexidine|mesh-list
92323969|NCT05750576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92323970|NCT05750576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92323971|NCT05750576|Disinfectants|disinfectants|mesh-ancestor
92323972|NCT00002594|Cyclophosphamide|cyclophosphamide|mesh-list
92323973|NCT00002594|Melphalan|melphalan|mesh-list
92323974|NCT00002594|Molgramostim|molgramostim|mesh-list
92323975|NCT00002594|Sargramostim|sargramostim|mesh-list
92323976|NCT00002594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92323977|NCT00002594|Immunologic Factors|immunologic factors|mesh-ancestor
92323978|NCT00002594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323979|NCT00002594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92323980|NCT00002594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92323981|NCT00002594|Alkylating Agents|alkylating agents|mesh-ancestor
92323982|NCT00002594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323983|NCT00002594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92323984|NCT00002594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92323985|NCT02234011|Ketamine|ketamine|mesh-list
92323986|NCT02234011|Analgesics|analgesics|mesh-ancestor
92323987|NCT02234011|Sensory System Agents|sensory system agents|mesh-ancestor
92323988|NCT02234011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92323989|NCT02234011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92323990|NCT02234011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92323991|NCT02234011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92323992|NCT02234011|Anesthetics, General|anesthetics, general|mesh-ancestor
92323993|NCT02234011|Anesthetics|anesthetics|mesh-ancestor
92323994|NCT02234011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92323995|NCT02234011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92323996|NCT02234011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92323997|NCT02234011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92323998|NCT02234011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92323999|NCT00002600|Cyclophosphamide|cyclophosphamide|mesh-list
92324000|NCT00002600|Carboplatin|carboplatin|mesh-list
92324001|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324002|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
92324003|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324004|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324005|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324006|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
92324007|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324008|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324009|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324010|NCT02177773|Octreotide|octreotide|mesh-list
92324011|NCT02177773|Edotreotide|edotreotide|mesh-list
92324012|NCT02177773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324013|NCT02177773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324014|NCT02177773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324015|NCT02177773|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92324016|NCT02177773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324017|NCT02144155|Oxytocin|oxytocin|mesh-list
92324018|NCT02144155|Oxytocics|oxytocics|mesh-ancestor
92324019|NCT02144155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324020|NCT02144155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324021|NCT00002618|Leucovorin|leucovorin|mesh-list
92324023|NCT00002618|Cytarabine|cytarabine|mesh-list
92324024|NCT00002618|Prednisone|prednisone|mesh-list
92324025|NCT00002618|Doxorubicin|doxorubicin|mesh-list
92324026|NCT00002618|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92324027|NCT00002618|Methotrexate|methotrexate|mesh-list
92324029|NCT00002618|Mercaptopurine|mercaptopurine|mesh-list
92324030|NCT00002618|Levoleucovorin|levoleucovorin|mesh-list
92324031|NCT00002618|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324032|NCT00002618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324033|NCT00002618|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324034|NCT00002618|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324035|NCT00002618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324036|NCT00002618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324037|NCT00002618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324038|NCT00002618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324039|NCT00002618|Glucocorticoids|glucocorticoids|mesh-ancestor
92324040|NCT00002618|Hormones|hormones|mesh-ancestor
92324041|NCT00002618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324042|NCT00002618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324043|NCT00002618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92324044|NCT00002618|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324045|NCT00002618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324046|NCT00002618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324047|NCT00002618|Antimetabolites|antimetabolites|mesh-ancestor
92324048|NCT00002618|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324049|NCT00002618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324050|NCT00002618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324051|NCT00002618|Immunologic Factors|immunologic factors|mesh-ancestor
92324052|NCT00002618|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324053|NCT00002618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92324054|NCT00002618|Antiviral Agents|antiviral agents|mesh-ancestor
92324055|NCT00002618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324056|NCT00002618|Antidotes|antidotes|mesh-ancestor
92324057|NCT00002618|Protective Agents|protective agents|mesh-ancestor
92324058|NCT00002618|Vitamin B Complex|vitamin b complex|mesh-ancestor
92324059|NCT00002618|Vitamins|vitamins|mesh-ancestor
92324060|NCT00002618|Micronutrients|micronutrients|mesh-ancestor
92324061|NCT00002618|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324062|NCT00002618|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324063|NCT00002618|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324064|NCT00002618|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324065|NCT00002618|Trace Elements|trace elements|mesh-ancestor
92324067|NCT02145169|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92324068|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
92324069|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
92324070|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324071|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324072|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92324073|NCT02145169|Analgesics|analgesics|mesh-ancestor
92324074|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
92324075|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324076|NCT02110069|Sirolimus|sirolimus|mesh-list
92324077|NCT02110069|Vincristine|vincristine|mesh-list
92324078|NCT02110069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324079|NCT02110069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324080|NCT02110069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324081|NCT02110069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324082|NCT02110069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324083|NCT02110069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324084|NCT02110069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92324085|NCT02110069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324086|NCT02110069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324087|NCT02110069|Antifungal Agents|antifungal agents|mesh-ancestor
92324088|NCT02110069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324089|NCT02110069|Immunologic Factors|immunologic factors|mesh-ancestor
92324090|NCT02110069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324091|NCT00002630|Cobalt|cobalt|mesh-list
92324092|NCT00002630|Cyclophosphamide|cyclophosphamide|mesh-list
92324093|NCT00002630|Melphalan|melphalan|mesh-list
92324094|NCT00002630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324095|NCT00002630|Immunologic Factors|immunologic factors|mesh-ancestor
92324096|NCT00002630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324097|NCT00002630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324098|NCT00002630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324099|NCT00002630|Alkylating Agents|alkylating agents|mesh-ancestor
92324100|NCT00002630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324101|NCT00002630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324102|NCT00002630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324103|NCT00002630|Trace Elements|trace elements|mesh-ancestor
92324104|NCT00002630|Micronutrients|micronutrients|mesh-ancestor
92324105|NCT00002642|Cobalt|cobalt|mesh-list
92324106|NCT00002642|Etoposide|etoposide|mesh-list
92324107|NCT00002642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324108|NCT00002642|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324109|NCT00002642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324110|NCT00002642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324111|NCT00002642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324112|NCT00002642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324113|NCT00002642|Trace Elements|trace elements|mesh-ancestor
92324114|NCT00002642|Micronutrients|micronutrients|mesh-ancestor
92324115|NCT00002642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324116|NCT03983941|Ropivacaine|ropivacaine|mesh-list
92324117|NCT03983941|Anesthetics, Local|anesthetics, local|mesh-ancestor
92324118|NCT03983941|Anesthetics|anesthetics|mesh-ancestor
92324119|NCT03983941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324120|NCT03983941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324121|NCT03983941|Sensory System Agents|sensory system agents|mesh-ancestor
92324122|NCT03983941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324123|NCT05750030|Bevacizumab|bevacizumab|mesh-list
92324124|NCT05750030|Atezolizumab|atezolizumab|mesh-list
92324125|NCT05750030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324126|NCT05750030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324127|NCT05750030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92324128|NCT05750030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92324129|NCT05750030|Growth Substances|growth substances|mesh-ancestor
92324130|NCT05750030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324131|NCT05750030|Growth Inhibitors|growth inhibitors|mesh-ancestor
92324132|NCT05750030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92324133|NCT05750030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324134|NCT04331054|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92324135|NCT04331054|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92324136|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
92324138|NCT00002654|Trace Elements|trace elements|mesh-ancestor
92324139|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
92324140|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324141|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
92324142|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92324143|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324144|NCT01434745|Simvastatin|simvastatin|mesh-list
92324145|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92324146|NCT01434745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92324147|NCT01434745|Antimetabolites|antimetabolites|mesh-ancestor
92324148|NCT01434745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324149|NCT01434745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92324150|NCT01434745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92324152|NCT01401049|Lidocaine|lidocaine|mesh-list
92324153|NCT01401049|Propofol|propofol|mesh-list
92324154|NCT01401049|Fospropofol|fospropofol|mesh-list
92324155|NCT01401049|Anesthetics, Local|anesthetics, local|mesh-ancestor
92324156|NCT01401049|Anesthetics|anesthetics|mesh-ancestor
92324157|NCT01401049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324158|NCT01401049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324159|NCT01401049|Sensory System Agents|sensory system agents|mesh-ancestor
92324160|NCT01401049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324161|NCT01401049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92324162|NCT01401049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92324163|NCT01401049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92324164|NCT01401049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92324165|NCT01401049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324166|NCT01401049|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92324167|NCT01401049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92324168|NCT01401049|Anesthetics, General|anesthetics, general|mesh-ancestor
92324169|NCT00381758|Methylphenidate|methylphenidate|mesh-list
92324170|NCT00381758|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92324171|NCT00381758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324172|NCT00381758|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92324173|NCT00381758|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92324174|NCT00381758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92324175|NCT00381758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324176|NCT00381758|Dopamine Agents|dopamine agents|mesh-ancestor
91976857|NCT03040791|Nivolumab|nivolumab|mesh-list
92324177|NCT00381758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92324178|NCT01402531|Bevacizumab|bevacizumab|mesh-list
92324179|NCT01402531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324180|NCT01402531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324181|NCT01402531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92324182|NCT01402531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92324183|NCT01402531|Growth Substances|growth substances|mesh-ancestor
92324184|NCT01402531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324185|NCT01402531|Growth Inhibitors|growth inhibitors|mesh-ancestor
92324186|NCT00381836|Darbepoetin alfa|darbepoetin alfa|mesh-list
92324187|NCT00381836|Hematinics|hematinics|mesh-ancestor
92324188|NCT01971853|Analgesics|analgesics|mesh-list
92324189|NCT01971853|Sensory System Agents|sensory system agents|mesh-ancestor
92324190|NCT01971853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324191|NCT01971853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324192|NCT00002678|Dexamethasone|dexamethasone|mesh-list
92324193|NCT00002678|Prednisone|prednisone|mesh-list
92324194|NCT00002678|Melphalan|melphalan|mesh-list
92324195|NCT00002678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324196|NCT00002678|Antiemetics|antiemetics|mesh-ancestor
92324197|NCT00002678|Autonomic Agents|autonomic agents|mesh-ancestor
92324198|NCT00002678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324199|NCT00002678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324200|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324201|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
92324202|NCT00002678|Hormones|hormones|mesh-ancestor
92324203|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324204|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324205|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324206|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324207|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
92324208|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324209|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324210|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324211|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
92324212|NCT01397695|Bevacizumab|bevacizumab|mesh-list
92324213|NCT01397695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324214|NCT01397695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324215|NCT01397695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92324216|NCT01397695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92324217|NCT01397695|Growth Substances|growth substances|mesh-ancestor
92324218|NCT01397695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324219|NCT01397695|Growth Inhibitors|growth inhibitors|mesh-ancestor
92324220|NCT00002684|Paclitaxel|paclitaxel|mesh-list
92324221|NCT00002684|Ifosfamide|ifosfamide|mesh-list
92324222|NCT00002684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324223|NCT00002684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324224|NCT00002684|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324225|NCT00002684|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324226|NCT00002684|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324227|NCT00002684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324228|NCT00002684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324229|NCT00002684|Alkylating Agents|alkylating agents|mesh-ancestor
92324230|NCT02972918|Simendan|simendan|mesh-list
92324231|NCT02972918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92324232|NCT02972918|Vasodilator Agents|vasodilator agents|mesh-ancestor
92324233|NCT02972918|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92324234|NCT02972918|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92324235|NCT02972918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324236|NCT02972918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324237|NCT02972918|Protective Agents|protective agents|mesh-ancestor
92324238|NCT02972918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324239|NCT05600491|Temozolomide|temozolomide|mesh-list
92324240|NCT05600491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324241|NCT05600491|Alkylating Agents|alkylating agents|mesh-ancestor
92324242|NCT05600491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324243|NCT05600491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324244|NCT00002696|Cyclophosphamide|cyclophosphamide|mesh-list
92324245|NCT00002696|Doxorubicin|doxorubicin|mesh-list
92324246|NCT00002696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92324247|NCT00002696|Fluorouracil|fluorouracil|mesh-list
92324249|NCT00002696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324250|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
92324251|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324252|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324253|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324254|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
92324255|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324256|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324257|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324258|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324259|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324260|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324261|NCT00002696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324262|NCT00002696|Antimetabolites|antimetabolites|mesh-ancestor
92324263|NCT00002696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324264|NCT00002696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92324265|NCT00002696|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324266|NCT00002696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324267|NCT00002696|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324268|NCT00002696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324269|NCT00002696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92324270|NCT00002702|Aldesleukin|aldesleukin|mesh-list
92324271|NCT00002702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324272|NCT00002702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92324273|NCT00002702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92324274|NCT00002702|Antiviral Agents|antiviral agents|mesh-ancestor
92324275|NCT00002702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324276|NCT01890577|Darbepoetin alfa|darbepoetin alfa|mesh-list
92324277|NCT01890577|Hematinics|hematinics|mesh-ancestor
92324279|NCT01315873|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92324280|NCT01315873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324281|NCT01315873|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324282|NCT01315873|Alkylating Agents|alkylating agents|mesh-ancestor
92324283|NCT01315873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324284|NCT01895959|Hyaluronic Acid|hyaluronic acid|mesh-list
92324285|NCT01895959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92324286|NCT01895959|Immunologic Factors|immunologic factors|mesh-ancestor
92324287|NCT01895959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324288|NCT01895959|Viscosupplements|viscosupplements|mesh-ancestor
92324289|NCT01895959|Protective Agents|protective agents|mesh-ancestor
92324290|NCT01303003|Dexamethasone|dexamethasone|mesh-list
92324291|NCT01303003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324292|NCT01303003|Antiemetics|antiemetics|mesh-ancestor
92324293|NCT01303003|Autonomic Agents|autonomic agents|mesh-ancestor
92324294|NCT01303003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324295|NCT01303003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324296|NCT01303003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324297|NCT01303003|Glucocorticoids|glucocorticoids|mesh-ancestor
92324299|NCT01303003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324300|NCT01303003|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324301|NCT01303003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324302|NCT00002714|Prednisone|prednisone|mesh-list
92324303|NCT00002714|Doxorubicin|doxorubicin|mesh-list
92324304|NCT00002714|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92324305|NCT00002714|Bleomycin|bleomycin|mesh-list
92324306|NCT00002714|Etoposide|etoposide|mesh-list
92324307|NCT00002714|Vincristine|vincristine|mesh-list
92324308|NCT00002714|Vinblastine|vinblastine|mesh-list
92324309|NCT00002714|Mechlorethamine|mechlorethamine|mesh-list
92324310|NCT00002714|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324311|NCT00002714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324312|NCT00002714|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324313|NCT00002714|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324314|NCT00002714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324315|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324316|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324317|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
92324318|NCT00002714|Hormones|hormones|mesh-ancestor
92324319|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324320|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324321|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324322|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324323|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324324|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324325|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977007|NCT04365933|Interferons|interferons|mesh-list
92324326|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
92324327|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324328|NCT00002720|Tamoxifen|tamoxifen|mesh-list
92324329|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92324330|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
92324331|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324332|NCT00002720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324333|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324334|NCT00002720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324335|NCT00002720|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92324336|NCT00002720|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92324337|NCT00002720|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92324338|NCT01821859|Bevacizumab|bevacizumab|mesh-list
92324339|NCT01821859|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92324340|NCT01821859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324341|NCT01821859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324342|NCT01821859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92324343|NCT01821859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92324344|NCT01821859|Growth Substances|growth substances|mesh-ancestor
92324345|NCT01821859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324346|NCT01821859|Growth Inhibitors|growth inhibitors|mesh-ancestor
92324347|NCT05600023|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92324348|NCT05600023|Nitrofurantoin|nitrofurantoin|mesh-list
92324349|NCT05600023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324350|NCT05600023|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92324351|NCT01194427|Tamoxifen|tamoxifen|mesh-list
92324352|NCT01194427|Vorinostat|vorinostat|mesh-list
92324353|NCT01194427|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92324354|NCT01194427|Hormone Antagonists|hormone antagonists|mesh-ancestor
92324355|NCT01194427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324356|NCT01194427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324357|NCT01194427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324358|NCT01194427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324359|NCT01194427|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92324360|NCT01194427|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92324361|NCT01194427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92324362|NCT01194427|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92324363|NCT01194427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324364|NCT01194427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324365|NCT05599555|Vaccines|vaccines|mesh-list
92324366|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
92324367|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324368|NCT00002738|Leucovorin|leucovorin|mesh-list
92324369|NCT00002738|Trimetrexate|trimetrexate|mesh-list
92324370|NCT00002738|Calcium|calcium|mesh-list
92324371|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
92324372|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92324373|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324374|NCT00002738|Antidotes|antidotes|mesh-ancestor
92324375|NCT00002738|Protective Agents|protective agents|mesh-ancestor
92324376|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
92324377|NCT00002738|Vitamins|vitamins|mesh-ancestor
92324378|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
92324379|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
92324380|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324381|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324382|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
92324383|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324384|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324385|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324386|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324387|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
92324388|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92324389|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
92324390|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324391|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
92324392|NCT04706455|Protective Agents|protective agents|mesh-ancestor
92324394|NCT00002744|Cytarabine|cytarabine|mesh-list
92324395|NCT00002744|Dexamethasone|dexamethasone|mesh-list
92324396|NCT00002744|Prednisone|prednisone|mesh-list
92324397|NCT00002744|Hydrocortisone|hydrocortisone|mesh-list
92324398|NCT00002744|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92324399|NCT00002744|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92324400|NCT00002744|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92324401|NCT00002744|Cyclophosphamide|cyclophosphamide|mesh-list
92324402|NCT00002744|Doxorubicin|doxorubicin|mesh-list
92324403|NCT00002744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92324404|NCT00002744|Methotrexate|methotrexate|mesh-list
92324405|NCT00002744|Vincristine|vincristine|mesh-list
92324406|NCT00002744|Daunorubicin|daunorubicin|mesh-list
92324407|NCT00002744|Asparaginase|asparaginase|mesh-list
92324408|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
92324409|NCT00002744|Pegaspargase|pegaspargase|mesh-list
92324410|NCT00002744|Thioguanine|thioguanine|mesh-list
92324411|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324412|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
92324413|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324414|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324415|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324416|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
92324417|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324418|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324419|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324420|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324421|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
92324422|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
92324423|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324424|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324425|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
92324426|NCT00002744|Hormones|hormones|mesh-ancestor
92324427|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324428|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324429|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324430|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324431|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324432|NCT00002744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324433|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92324434|NCT00002744|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324435|NCT00002744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324436|NCT00002744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324437|NCT00002744|Antimetabolites|antimetabolites|mesh-ancestor
92324438|NCT00002744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324439|NCT00002744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324440|NCT00002744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92324441|NCT00002744|Antiviral Agents|antiviral agents|mesh-ancestor
92324442|NCT00002744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324443|NCT00002744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324444|NCT00002744|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324445|NCT00002744|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324446|NCT00002744|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324447|NCT00002744|Trace Elements|trace elements|mesh-ancestor
92324448|NCT00002744|Micronutrients|micronutrients|mesh-ancestor
92324449|NCT01788475|Dexamethasone|dexamethasone|mesh-list
92324450|NCT01788475|Dexamethasone acetate|dexamethasone acetate|mesh-list
92324451|NCT01788475|BB 1101|bb 1101|mesh-list
92324452|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324453|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
92324454|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
92324455|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324456|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324457|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324458|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
92324459|NCT01788475|Hormones|hormones|mesh-ancestor
92324460|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324461|NCT01788475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324462|NCT01788475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324463|NCT01788475|Protease Inhibitors|protease inhibitors|mesh-ancestor
92324464|NCT01788475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324465|NCT01788475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349140|NCT01505634|Cilastatin|cilastatin|mesh-list
92324466|NCT01183897|Immunomodulating Agents|immunomodulating agents|mesh-list
92324467|NCT01183897|Immunologic Factors|immunologic factors|mesh-ancestor
92324468|NCT01183897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324469|NCT00381914|Vitamin D|vitamin d|mesh-list
92324470|NCT00381914|Ergocalciferols|ergocalciferols|mesh-list
92324471|NCT00381914|Cholecalciferol|cholecalciferol|mesh-list
92324472|NCT00381914|Vitamins|vitamins|mesh-list
92324473|NCT00381914|Micronutrients|micronutrients|mesh-ancestor
92324474|NCT00381914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324475|NCT00381914|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92324476|NCT00381914|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92324477|NCT00423007|Bromfenac|bromfenac|mesh-list
92324478|NCT00423007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92324479|NCT00423007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92324480|NCT00423007|Analgesics|analgesics|mesh-ancestor
92324481|NCT00423007|Sensory System Agents|sensory system agents|mesh-ancestor
92324482|NCT00423007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324483|NCT00423007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324484|NCT00423007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324485|NCT00423007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324487|NCT04713787|Oxfendazole|oxfendazole|mesh-list
92324488|NCT04713787|Anthelmintics|anthelmintics|mesh-ancestor
92324489|NCT04713787|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92324490|NCT04713787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324491|NCT04713787|Anticestodal Agents|anticestodal agents|mesh-ancestor
92324492|NCT04713787|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92324493|NCT04713787|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92324494|NCT04713787|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324495|NCT04713787|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324496|NCT04713787|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324497|NCT04713787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324498|NCT04713787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324499|NCT04713787|Antinematodal Agents|antinematodal agents|mesh-ancestor
92324501|NCT00002750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324502|NCT00002750|Alkylating Agents|alkylating agents|mesh-ancestor
92324503|NCT00002750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324504|NCT00002750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324505|NCT00002750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324506|NCT00002750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324507|NCT00002750|Immunologic Factors|immunologic factors|mesh-ancestor
92324508|NCT00002750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324509|NCT00002756|Leucovorin|leucovorin|mesh-list
92324510|NCT00002756|Cytarabine|cytarabine|mesh-list
92324511|NCT00002756|Prednisone|prednisone|mesh-list
92324512|NCT00002756|Hydrocortisone|hydrocortisone|mesh-list
92324513|NCT00002756|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92324514|NCT00002756|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92324515|NCT00002756|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92324516|NCT00002756|Cyclophosphamide|cyclophosphamide|mesh-list
92324517|NCT00002756|Methotrexate|methotrexate|mesh-list
92324518|NCT00002756|Etoposide|etoposide|mesh-list
92324519|NCT00002756|Vincristine|vincristine|mesh-list
92324520|NCT00002756|Daunorubicin|daunorubicin|mesh-list
92324521|NCT00002756|Asparaginase|asparaginase|mesh-list
92324522|NCT00002756|Mercaptopurine|mercaptopurine|mesh-list
92324523|NCT00002756|Levoleucovorin|levoleucovorin|mesh-list
92324524|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324525|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
92324526|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324527|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324528|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324529|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
92324530|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324531|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324532|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324533|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324534|NCT00002756|Glucocorticoids|glucocorticoids|mesh-ancestor
92324535|NCT00002756|Hormones|hormones|mesh-ancestor
92324536|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324537|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324538|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92324539|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324540|NCT00002756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324541|NCT00002756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324543|NCT00002756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324544|NCT00002756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324545|NCT00002756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324546|NCT00002756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92324547|NCT00002756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324548|NCT00002756|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324549|NCT00002756|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324550|NCT00002756|Antiviral Agents|antiviral agents|mesh-ancestor
92324551|NCT00002756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324552|NCT00002756|Antidotes|antidotes|mesh-ancestor
92324553|NCT00002756|Protective Agents|protective agents|mesh-ancestor
92324554|NCT00002756|Vitamin B Complex|vitamin b complex|mesh-ancestor
92324555|NCT00002756|Vitamins|vitamins|mesh-ancestor
92324556|NCT00002756|Micronutrients|micronutrients|mesh-ancestor
92324557|NCT00002756|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324558|NCT00002756|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324559|NCT00002756|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324560|NCT00002756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324562|NCT01183429|Isotretinoin|isotretinoin|mesh-list
92324563|NCT01183429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324564|NCT01183429|Keratolytic Agents|keratolytic agents|mesh-ancestor
92324565|NCT01183429|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324566|NCT01157533|Vancomycin|vancomycin|mesh-list
92324567|NCT01157533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92324568|NCT01157533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324569|NCT05749016|Paclitaxel|paclitaxel|mesh-list
92324570|NCT05749016|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92324571|NCT05749016|Carboplatin|carboplatin|mesh-list
92324572|NCT05749016|Pertuzumab|pertuzumab|mesh-list
92324573|NCT05749016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324574|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324575|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324576|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324577|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324578|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324579|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324580|NCT01756573|Bupivacaine|bupivacaine|mesh-list
92324581|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
92324582|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
92324583|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324584|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324585|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
92324586|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324587|NCT01126801|Estradiol|estradiol|mesh-list
92324588|NCT01126801|Estrogens|estrogens|mesh-ancestor
92324589|NCT01126801|Hormones|hormones|mesh-ancestor
92324590|NCT01126801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324591|NCT01126801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324592|NCT01702909|Interleukin-2|interleukin-2|mesh-list
92324593|NCT01702909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324594|NCT01702909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92324595|NCT01702909|Analgesics|analgesics|mesh-ancestor
92324596|NCT01702909|Sensory System Agents|sensory system agents|mesh-ancestor
92324597|NCT01702909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324598|NCT01702909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324599|NCT00002768|Cytarabine|cytarabine|mesh-list
92324600|NCT00002768|Methotrexate|methotrexate|mesh-list
92324601|NCT00002768|Etoposide|etoposide|mesh-list
92324603|NCT00002768|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92324604|NCT00002768|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324605|NCT00002768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324606|NCT00002768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324607|NCT00002768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324608|NCT00002768|Antimetabolites|antimetabolites|mesh-ancestor
92324609|NCT00002768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324610|NCT00002768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324611|NCT00002768|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324612|NCT00002768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324613|NCT00002768|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324614|NCT00002768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324615|NCT00002768|Immunologic Factors|immunologic factors|mesh-ancestor
92324616|NCT00002768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324617|NCT00002768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92324618|NCT00002768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92324619|NCT00002768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324620|NCT00002768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324621|NCT00002768|Antiviral Agents|antiviral agents|mesh-ancestor
92324622|NCT00002768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324623|NCT00002768|Alkylating Agents|alkylating agents|mesh-ancestor
92324624|NCT00002768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324625|NCT00002768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324626|NCT00002774|Cisplatin|cisplatin|mesh-list
92324627|NCT00002774|Fluorouracil|fluorouracil|mesh-list
92324628|NCT00002774|Tirapazamine|tirapazamine|mesh-list
92324629|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977309|NCT04411875|Amlodipine|amlodipine|mesh-list
92324630|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
92324631|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324632|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324633|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324634|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
92324635|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324637|NCT00002780|Cyclophosphamide|cyclophosphamide|mesh-list
92324638|NCT00002780|Thiotepa|thiotepa|mesh-list
92324639|NCT00002780|Carboplatin|carboplatin|mesh-list
92324640|NCT00002780|Sargramostim|sargramostim|mesh-list
92324641|NCT00002780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324643|NCT00002780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324644|NCT00002780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324645|NCT00002780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324646|NCT00002780|Alkylating Agents|alkylating agents|mesh-ancestor
92324647|NCT00002780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324648|NCT00002780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324649|NCT00002780|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324650|NCT00002780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92324651|NCT00002780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92324652|NCT00002780|Antiviral Agents|antiviral agents|mesh-ancestor
92324653|NCT00002780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324654|NCT01692691|Dacarbazine|dacarbazine|mesh-list
92324655|NCT01692691|Carmustine|carmustine|mesh-list
92324656|NCT01692691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324657|NCT01692691|Alkylating Agents|alkylating agents|mesh-ancestor
92324658|NCT01692691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324659|NCT01692691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324660|NCT01127503|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
92324661|NCT01127503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324662|NCT01127503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324663|NCT01122511|Dexamethasone|dexamethasone|mesh-list
92324664|NCT01122511|Ranibizumab|ranibizumab|mesh-list
92324665|NCT01122511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324666|NCT01122511|Antiemetics|antiemetics|mesh-ancestor
92324667|NCT01122511|Autonomic Agents|autonomic agents|mesh-ancestor
92324668|NCT01122511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324669|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324670|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324671|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
92324672|NCT01122511|Hormones|hormones|mesh-ancestor
92324673|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324674|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324675|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324676|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92324677|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92324678|NCT01122511|Growth Substances|growth substances|mesh-ancestor
92324679|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
92324680|NCT05535218|Pembrolizumab|pembrolizumab|mesh-list
92324681|NCT05535218|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92324682|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324683|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324684|NCT05535218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92324685|NCT05535218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324686|NCT05535218|Immunoconjugates|immunoconjugates|mesh-ancestor
92324687|NCT05535218|Immunologic Factors|immunologic factors|mesh-ancestor
92324688|NCT05535218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324689|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
92324690|NCT05531708|Fludarabine|fludarabine|mesh-list
92324691|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324692|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
92324693|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324694|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324695|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324696|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
92324697|NCT05531708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324698|NCT05531708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324699|NCT05531708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324700|NCT01663285|Gemcitabine|gemcitabine|mesh-list
92324701|NCT01663285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324702|NCT01663285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324703|NCT01663285|Antimetabolites|antimetabolites|mesh-ancestor
92324704|NCT01663285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324705|NCT00002786|Aldesleukin|aldesleukin|mesh-list
92324706|NCT00002786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324707|NCT00002786|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92324708|NCT00002786|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92324709|NCT00002786|Antiviral Agents|antiviral agents|mesh-ancestor
92324710|NCT00002786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324711|NCT00378937|Acetaminophen|acetaminophen|mesh-list
92324712|NCT00378937|Morphine|morphine|mesh-list
92324713|NCT00378937|Oxycodone|oxycodone|mesh-list
92324714|NCT00378937|Codeine|codeine|mesh-list
92324715|NCT00378937|Dextropropoxyphene|dextropropoxyphene|mesh-list
92324716|NCT00378937|Levopropoxyphene|levopropoxyphene|mesh-list
92324717|NCT00378937|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92324718|NCT00378937|Narcotics|narcotics|mesh-ancestor
92324719|NCT00378937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324720|NCT00378937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324721|NCT00378937|Analgesics|analgesics|mesh-ancestor
92324722|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
92324723|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324724|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92324725|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
92324726|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
92324727|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
92324728|NCT00002792|Cyclosporine|cyclosporine|mesh-list
92324729|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
92324730|NCT00002792|Busulfan|busulfan|mesh-list
92324731|NCT00002792|Methotrexate|methotrexate|mesh-list
92324732|NCT00002792|Tacrolimus|tacrolimus|mesh-list
92324733|NCT00002792|Cyclosporins|cyclosporins|mesh-list
92324734|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324735|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
92324736|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324737|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324738|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324739|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
92324740|NCT00002792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324741|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324742|NCT00002792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324743|NCT00002792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92324744|NCT00002792|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324745|NCT00002792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324746|NCT00002792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324747|NCT00002792|Antimetabolites|antimetabolites|mesh-ancestor
92324748|NCT00002792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92324749|NCT00002792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324750|NCT00002792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92324751|NCT00002792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92324752|NCT00002792|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92324753|NCT00002792|Antifungal Agents|antifungal agents|mesh-ancestor
92324754|NCT00002792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324755|NCT01090141|Micafungin|micafungin|mesh-list
92324756|NCT01090141|Antifungal Agents|antifungal agents|mesh-ancestor
92324757|NCT01090141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324758|NCT01048723|Everolimus|everolimus|mesh-list
92324759|NCT01048723|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92324760|NCT01048723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92324761|NCT01048723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324762|NCT01048723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324763|NCT01048723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324764|NCT01048723|Immunologic Factors|immunologic factors|mesh-ancestor
92324765|NCT01048723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324766|NCT01048723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324767|NCT05513612|Cyclophosphamide|cyclophosphamide|mesh-list
92324768|NCT05513612|Fludarabine|fludarabine|mesh-list
92324769|NCT05513612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324770|NCT05513612|Immunologic Factors|immunologic factors|mesh-ancestor
92324771|NCT05513612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324772|NCT05513612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324773|NCT05513612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324774|NCT05513612|Alkylating Agents|alkylating agents|mesh-ancestor
92324775|NCT05513612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324776|NCT05513612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324777|NCT05513612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324778|NCT05594407|Lidocaine|lidocaine|mesh-list
92324779|NCT05594407|Dexmedetomidine|dexmedetomidine|mesh-list
92324780|NCT05594407|Ketamine|ketamine|mesh-list
92324781|NCT05594407|Remifentanil|remifentanil|mesh-list
92324782|NCT05594407|Anesthetics, Local|anesthetics, local|mesh-ancestor
91977452|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
92324783|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
92324784|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324785|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324787|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324788|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92324789|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92324790|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92324791|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92324792|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324793|NCT05594407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92324794|NCT05594407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92324795|NCT05594407|Analgesics|analgesics|mesh-ancestor
92324796|NCT05594407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92324797|NCT05594407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92324798|NCT05594407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92324799|NCT05594407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92324800|NCT05594407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92324801|NCT05594407|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92324802|NCT05594407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92324803|NCT05594407|Anesthetics, General|anesthetics, general|mesh-ancestor
92324804|NCT05594407|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92324805|NCT05594407|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92324806|NCT05594407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92324807|NCT05594407|Narcotics|narcotics|mesh-ancestor
92324808|NCT00379717|Docetaxel|docetaxel|mesh-list
92324809|NCT00379717|Cisplatin|cisplatin|mesh-list
92324810|NCT00379717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324811|NCT00379717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92324812|NCT00379717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92324813|NCT00379717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92324814|NCT00379717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324815|NCT04706377|Vitamin B 12|vitamin b 12|mesh-list
92324816|NCT04706377|Vitamins|vitamins|mesh-ancestor
92324817|NCT04706377|Micronutrients|micronutrients|mesh-ancestor
92324818|NCT04706377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324819|NCT04706377|Vitamin B Complex|vitamin b complex|mesh-ancestor
92324821|NCT01583647|Niacinamide|niacinamide|mesh-list
92324822|NCT01583647|Nicotinic Acids|nicotinic acids|mesh-list
92324823|NCT01583647|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92324824|NCT01583647|Antimetabolites|antimetabolites|mesh-ancestor
92324825|NCT01583647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324826|NCT01583647|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92324827|NCT01583647|Vasodilator Agents|vasodilator agents|mesh-ancestor
92324828|NCT01583647|Vitamin B Complex|vitamin b complex|mesh-ancestor
92324830|NCT01583647|Micronutrients|micronutrients|mesh-ancestor
92324831|NCT01583647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324832|NCT04403516|Dexamethasone|dexamethasone|mesh-list
92324833|NCT04403516|Prednisolone|prednisolone|mesh-list
92324834|NCT04403516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92324835|NCT04403516|Methylprednisolone|methylprednisolone|mesh-list
92324836|NCT04403516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92324837|NCT04403516|Prednisolone acetate|prednisolone acetate|mesh-list
92324838|NCT04403516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92324839|NCT04403516|Prednisolone phosphate|prednisolone phosphate|mesh-list
92324840|NCT04403516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92324841|NCT04403516|Antiemetics|antiemetics|mesh-ancestor
92324842|NCT04403516|Autonomic Agents|autonomic agents|mesh-ancestor
92324843|NCT04403516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324844|NCT04403516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324845|NCT04403516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92324846|NCT04403516|Glucocorticoids|glucocorticoids|mesh-ancestor
92324847|NCT04403516|Hormones|hormones|mesh-ancestor
92324848|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324849|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92324850|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324851|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92324852|NCT04403516|Protective Agents|protective agents|mesh-ancestor
92324853|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
92324854|NCT01555489|Vitamins|vitamins|mesh-ancestor
92324855|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
92324856|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324857|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
92324858|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324859|NCT01555489|Protective Agents|protective agents|mesh-ancestor
92324860|NCT05243654|Metformin|metformin|mesh-list
92324861|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92324862|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324863|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92324864|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92324865|NCT01035073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92324866|NCT01035073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92324867|NCT01035073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324868|NCT01035073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92324869|NCT01035073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324870|NCT01035073|Analgesics|analgesics|mesh-ancestor
92324871|NCT01035073|Sensory System Agents|sensory system agents|mesh-ancestor
92324872|NCT01035073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324873|NCT01035073|Antidepressive Agents|antidepressive agents|mesh-ancestor
92324874|NCT01035073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92324875|NCT01035073|Dopamine Agents|dopamine agents|mesh-ancestor
92324876|NCT04331743|Mitoxantrone|mitoxantrone|mesh-list
92324877|NCT04331743|Analgesics|analgesics|mesh-ancestor
92324878|NCT04331743|Sensory System Agents|sensory system agents|mesh-ancestor
92324879|NCT04331743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324880|NCT04331743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324881|NCT04331743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324882|NCT04331743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92324883|NCT04331743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92324884|NCT04331743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324885|NCT04331743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324886|NCT05296759|Gabapentin|gabapentin|mesh-list
92324887|NCT05296759|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92324888|NCT05296759|Botulinum Toxins|botulinum toxins|mesh-list
92324889|NCT05296759|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92324890|NCT05296759|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92324891|NCT05296759|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92324892|NCT05296759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92324893|NCT05296759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324894|NCT05296759|Cholinergic Agents|cholinergic agents|mesh-ancestor
92324895|NCT05296759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92324896|NCT05296759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324897|NCT05296759|Analgesics|analgesics|mesh-ancestor
92324898|NCT05296759|Sensory System Agents|sensory system agents|mesh-ancestor
92324899|NCT05296759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92324900|NCT05296759|Anticonvulsants|anticonvulsants|mesh-ancestor
92324901|NCT05296759|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92324902|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92324903|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92324904|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92324905|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92324906|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92324908|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92324909|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92324910|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
92324911|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
92324912|NCT05296759|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92324913|NCT05546047|Tacrolimus|tacrolimus|mesh-list
92324914|NCT05546047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324915|NCT05546047|Immunologic Factors|immunologic factors|mesh-ancestor
92324916|NCT05546047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324917|NCT05546047|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92324918|NCT05546047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324919|NCT05546047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324920|NCT01532635|Mycophenolic Acid|mycophenolic acid|mesh-list
92324921|NCT01532635|Cyclophosphamide|cyclophosphamide|mesh-list
92324922|NCT01532635|Tacrolimus|tacrolimus|mesh-list
92324923|NCT01532635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324924|NCT01532635|Immunologic Factors|immunologic factors|mesh-ancestor
92324925|NCT01532635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324926|NCT01532635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324927|NCT01532635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92324928|NCT01532635|Alkylating Agents|alkylating agents|mesh-ancestor
92324929|NCT01532635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324930|NCT01532635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324931|NCT01532635|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92324932|NCT01532635|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92324933|NCT01532635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324934|NCT01532635|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92324935|NCT01532635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91977600|NCT03200093|Vancomycin|vancomycin|mesh-list
92324936|NCT01532635|Antitubercular Agents|antitubercular agents|mesh-ancestor
92324937|NCT01532635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92324938|NCT01532635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324939|NCT00986947|Rituximab|rituximab|mesh-list
92324940|NCT00986947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92324941|NCT00986947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324942|NCT00986947|Immunologic Factors|immunologic factors|mesh-ancestor
92324943|NCT00986947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324944|NCT00986947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92324945|NCT00539617|Leucovorin|leucovorin|mesh-list
92324946|NCT00539617|Fluorouracil|fluorouracil|mesh-list
92324947|NCT00539617|Oxaliplatin|oxaliplatin|mesh-list
92324948|NCT00539617|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92324949|NCT00539617|Antimetabolites|antimetabolites|mesh-ancestor
92324950|NCT00539617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324951|NCT00539617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324952|NCT00539617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324953|NCT00539617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324954|NCT00539617|Immunologic Factors|immunologic factors|mesh-ancestor
92324955|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324956|NCT00539617|Antidotes|antidotes|mesh-ancestor
92324957|NCT00539617|Protective Agents|protective agents|mesh-ancestor
92324958|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
92324959|NCT00539617|Vitamins|vitamins|mesh-ancestor
92324960|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
92324961|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92324962|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92324963|NCT05467514|Liraglutide|liraglutide|mesh-list
92324964|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92324965|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324966|NCT05467514|Incretins|incretins|mesh-ancestor
92324967|NCT05467514|Hormones|hormones|mesh-ancestor
92324968|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92324969|NCT00976339|Vitamin D|vitamin d|mesh-list
92324970|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
92324971|NCT00976339|Vitamins|vitamins|mesh-ancestor
92324972|NCT00976339|Micronutrients|micronutrients|mesh-ancestor
92324973|NCT00976339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324974|NCT00976339|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92324975|NCT00976339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92324977|NCT04579640|Vitamins|vitamins|mesh-ancestor
92324978|NCT04579640|Micronutrients|micronutrients|mesh-ancestor
92324979|NCT04579640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324980|NCT04579640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92324981|NCT00523939|Cytarabine|cytarabine|mesh-list
92324982|NCT00523939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92324983|NCT00523939|Antimetabolites|antimetabolites|mesh-ancestor
92324984|NCT00523939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92324985|NCT00523939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92324986|NCT00523939|Antiviral Agents|antiviral agents|mesh-ancestor
92324987|NCT00523939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92324988|NCT00523939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92324989|NCT00523939|Immunologic Factors|immunologic factors|mesh-ancestor
92324990|NCT00523939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324991|NCT00382538|Mifepristone|mifepristone|mesh-list
92324992|NCT00382538|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92324993|NCT00382538|Abortifacient Agents|abortifacient agents|mesh-ancestor
92324994|NCT00382538|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92324995|NCT00382538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92324996|NCT00382538|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92324997|NCT00382538|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92324998|NCT00382538|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92324999|NCT00382538|Contraceptive Agents|contraceptive agents|mesh-ancestor
92325000|NCT00382538|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92325001|NCT00382538|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92325002|NCT00382538|Hormone Antagonists|hormone antagonists|mesh-ancestor
92325003|NCT00382538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325004|NCT00382538|Luteolytic Agents|luteolytic agents|mesh-ancestor
92325005|NCT00382538|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92325006|NCT00382538|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92325007|NCT00954187|Pregabalin|pregabalin|mesh-list
92325008|NCT00954187|Gabapentin|gabapentin|mesh-list
92325009|NCT00954187|Analgesics|analgesics|mesh-ancestor
91977673|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92325010|NCT00954187|Sensory System Agents|sensory system agents|mesh-ancestor
92325011|NCT00954187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325012|NCT00954187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325013|NCT00954187|Anticonvulsants|anticonvulsants|mesh-ancestor
92325014|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92325015|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325016|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325017|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92325018|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92325019|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325020|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325021|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325022|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92325023|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92325024|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325025|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
92325026|NCT04796012|Irinotecan|irinotecan|mesh-list
92325027|NCT04796012|Vincristine|vincristine|mesh-list
92325028|NCT04796012|Temozolomide|temozolomide|mesh-list
92325029|NCT04796012|Atezolizumab|atezolizumab|mesh-list
92325030|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92325031|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92325032|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325033|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325034|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325035|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92325036|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325037|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325038|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325039|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92325040|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
92325041|NCT04796012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92325042|NCT04796012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325043|NCT00947791|Midazolam|midazolam|mesh-list
92325044|NCT00947791|Ketamine|ketamine|mesh-list
92325045|NCT00947791|Analgesics|analgesics|mesh-ancestor
92325046|NCT00947791|Sensory System Agents|sensory system agents|mesh-ancestor
92325047|NCT00947791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325048|NCT00947791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325049|NCT00947791|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92325050|NCT00947791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92325051|NCT00947791|Anesthetics, General|anesthetics, general|mesh-ancestor
92325052|NCT00947791|Anesthetics|anesthetics|mesh-ancestor
92325053|NCT00947791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325054|NCT00947791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92325055|NCT00947791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92325056|NCT00947791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325057|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325058|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92325059|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92325061|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325062|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325063|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
92325064|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
92325065|NCT05136326|Capecitabine|capecitabine|mesh-list
92325066|NCT05136326|Temozolomide|temozolomide|mesh-list
92325067|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325068|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
92325069|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325070|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325071|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92325072|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
92325073|NCT05387941|Dexamethasone|dexamethasone|mesh-list
92325074|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92325075|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
92325076|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
92325077|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325078|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325079|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92325080|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
92325081|NCT05387941|Hormones|hormones|mesh-ancestor
92325082|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325083|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92325084|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325085|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
92325086|NCT00379015|Docetaxel|docetaxel|mesh-list
92325087|NCT00379015|Trastuzumab|trastuzumab|mesh-list
92325088|NCT00379015|Epirubicin|epirubicin|mesh-list
92325089|NCT00379015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92325090|NCT00379015|Immunologic Factors|immunologic factors|mesh-ancestor
92325091|NCT00379015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325092|NCT00379015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325093|NCT00379015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92325094|NCT00379015|Alkylating Agents|alkylating agents|mesh-ancestor
92325095|NCT00379015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325096|NCT00379015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325097|NCT00379015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92325098|NCT00379015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325099|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325100|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325101|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325102|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92325103|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92325104|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92325105|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325106|NCT00911053|Melatonin|melatonin|mesh-list
92325107|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
92325108|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325109|NCT00911053|Protective Agents|protective agents|mesh-ancestor
92325110|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325111|NCT00911053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325112|NCT04713176|Remdesivir|remdesivir|mesh-list
92325113|NCT04713176|Antimetabolites|antimetabolites|mesh-ancestor
92325114|NCT04713176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325115|NCT04713176|Antiviral Agents|antiviral agents|mesh-ancestor
92325116|NCT04713176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325117|NCT04713410|Prednisolone|prednisolone|mesh-list
92325118|NCT04713410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92325119|NCT04713410|Glucocorticoids|glucocorticoids|mesh-ancestor
92325120|NCT04713410|Hormones|hormones|mesh-ancestor
92325121|NCT04713410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325122|NCT04713410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325123|NCT04713410|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92325124|NCT04713410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325125|NCT04713332|Vitamin E|vitamin e|mesh-list
92325126|NCT04713332|Tocopherols|tocopherols|mesh-list
92325127|NCT04713332|alpha-Tocopherol|alpha-tocopherol|mesh-list
92325128|NCT04713332|Vitamins|vitamins|mesh-ancestor
92325129|NCT04713332|Micronutrients|micronutrients|mesh-ancestor
92325130|NCT04713332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325131|NCT04713332|Antioxidants|antioxidants|mesh-ancestor
92325132|NCT04713332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325134|NCT00476827|Paclitaxel|paclitaxel|mesh-list
92325135|NCT00476827|Vinorelbine|vinorelbine|mesh-list
92325136|NCT00476827|Docetaxel|docetaxel|mesh-list
92325137|NCT00476827|Bevacizumab|bevacizumab|mesh-list
92325138|NCT00476827|Gemcitabine|gemcitabine|mesh-list
92325139|NCT00476827|Irinotecan|irinotecan|mesh-list
92325140|NCT00476827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92325141|NCT00476827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325142|NCT00476827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325143|NCT00476827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325144|NCT00476827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325145|NCT00476827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325146|NCT00476827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325147|NCT00476827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325148|NCT00476827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325149|NCT00476827|Growth Substances|growth substances|mesh-ancestor
92325150|NCT00476827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325151|NCT00476827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325152|NCT00476827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325153|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
92325154|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92325155|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92325156|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325157|NCT00459121|Paclitaxel|paclitaxel|mesh-list
92325158|NCT00459121|Carboplatin|carboplatin|mesh-list
92325159|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92325160|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325161|NCT00459121|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325162|NCT00459121|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325163|NCT00459121|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325164|NCT00459121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325165|NCT00904423|Vitamin D|vitamin d|mesh-list
92325166|NCT00904423|Vitamins|vitamins|mesh-ancestor
92325167|NCT00904423|Micronutrients|micronutrients|mesh-ancestor
92325168|NCT00904423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325169|NCT00904423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92325170|NCT05328895|Betahistine|betahistine|mesh-list
92325171|NCT05328895|Vasodilator Agents|vasodilator agents|mesh-ancestor
92325172|NCT05328895|Histamine Agonists|histamine agonists|mesh-ancestor
92325173|NCT05328895|Histamine Agents|histamine agents|mesh-ancestor
92325174|NCT05328895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325175|NCT05328895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325176|NCT05328895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325177|NCT00879619|Prednisone|prednisone|mesh-list
92325178|NCT00879619|Cortisone|cortisone|mesh-list
92325179|NCT00879619|Docetaxel|docetaxel|mesh-list
92325180|NCT00879619|Sunitinib|sunitinib|mesh-list
92325181|NCT00879619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325182|NCT00879619|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325183|NCT00879619|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325184|NCT00879619|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325185|NCT00879619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325186|NCT00879619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92325187|NCT00879619|Glucocorticoids|glucocorticoids|mesh-ancestor
92325188|NCT00879619|Hormones|hormones|mesh-ancestor
92325189|NCT00879619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325190|NCT00879619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325191|NCT00879619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92325192|NCT00879619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325193|NCT00879619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325194|NCT00879619|Growth Substances|growth substances|mesh-ancestor
92325195|NCT00879619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325196|NCT00879619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92325197|NCT00879619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325198|NCT00822679|Eszopiclone|eszopiclone|mesh-list
92325199|NCT00822679|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92325200|NCT00822679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325201|NCT00822679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325202|NCT00323635|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92325203|NCT00323635|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92325204|NCT00323635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92325205|NCT00323635|Cholinergic Agents|cholinergic agents|mesh-ancestor
92325206|NCT00323635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325207|NCT00323635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325208|NCT00323635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325209|NCT00323635|Urological Agents|urological agents|mesh-ancestor
92325210|NCT00314353|Bevacizumab|bevacizumab|mesh-list
92325211|NCT00314353|Capecitabine|capecitabine|mesh-list
92325212|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
92325214|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325215|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325216|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325217|NCT00314353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325218|NCT00314353|Growth Substances|growth substances|mesh-ancestor
92325219|NCT00314353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325220|NCT00314353|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325221|NCT00314353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325222|NCT00314353|Antimetabolites|antimetabolites|mesh-ancestor
92325223|NCT00314353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325224|NCT00314353|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92325225|NCT00314353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92325226|NCT00314353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325227|NCT00279409|Aripiprazole|aripiprazole|mesh-list
92325228|NCT00279409|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325229|NCT00279409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325230|NCT00279409|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92325231|NCT00279409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325232|NCT00279409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325233|NCT00279409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325234|NCT00279409|Dopamine Agonists|dopamine agonists|mesh-ancestor
92325235|NCT00279409|Dopamine Agents|dopamine agents|mesh-ancestor
92325236|NCT00279409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325237|NCT00279409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325238|NCT00279409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92325239|NCT00279409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92325240|NCT00279409|Serotonin Agents|serotonin agents|mesh-ancestor
92325241|NCT00279409|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92325242|NCT00279409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92325243|NCT00279409|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92325244|NCT00279409|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92325245|NCT05007392|Febuxostat|febuxostat|mesh-list
92325246|NCT05007392|Dotinurad|dotinurad|mesh-list
92325247|NCT05007392|Gout Suppressants|gout suppressants|mesh-ancestor
92325248|NCT05007392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325249|NCT05007392|Uricosuric Agents|uricosuric agents|mesh-ancestor
92325250|NCT00379249|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92325251|NCT00379249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92325252|NCT00379249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92325253|NCT00379249|Antimetabolites|antimetabolites|mesh-ancestor
92325254|NCT00379249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325255|NCT00379249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92325256|NCT00379249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92325257|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325258|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
92325260|NCT00801931|Busulfan|busulfan|mesh-list
92325261|NCT00801931|Thiotepa|thiotepa|mesh-list
92325262|NCT00801931|Fludarabine|fludarabine|mesh-list
92325263|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
92325264|NCT00801931|Phenytoin|phenytoin|mesh-list
92325265|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
92325266|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
92325267|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92325268|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92325269|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
92325270|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325271|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325272|NCT00801931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92325273|NCT00801931|Alkylating Agents|alkylating agents|mesh-ancestor
92325274|NCT00801931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325275|NCT00801931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325276|NCT00801931|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92325277|NCT00801931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325278|NCT00801931|Anticonvulsants|anticonvulsants|mesh-ancestor
92325279|NCT00801931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92325280|NCT00801931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92325281|NCT00801931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325282|NCT00801931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92325283|NCT00801931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92325284|NCT00780481|Bradykinin|bradykinin|mesh-list
92325285|NCT00780481|Kininogens|kininogens|mesh-list
92325286|NCT00780481|Vasodilator Agents|vasodilator agents|mesh-ancestor
92325287|NCT00780481|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92325288|NCT00780481|Protease Inhibitors|protease inhibitors|mesh-ancestor
92325289|NCT00780481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325290|NCT00780481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325291|NCT05345990|Immunoglobulins|immunoglobulins|mesh-list
92325292|NCT05345990|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92325293|NCT05345990|Antibodies|antibodies|mesh-list
92325294|NCT05345990|Immunologic Factors|immunologic factors|mesh-ancestor
92325295|NCT05345990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325296|NCT00019747|Thalidomide|thalidomide|mesh-list
92325297|NCT00019747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92325298|NCT00019747|Immunologic Factors|immunologic factors|mesh-ancestor
92325299|NCT00019747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325300|NCT00019747|Leprostatic Agents|leprostatic agents|mesh-ancestor
92325301|NCT00019747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92325302|NCT00019747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325303|NCT00019747|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325304|NCT00019747|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325305|NCT00019747|Growth Substances|growth substances|mesh-ancestor
92325306|NCT00019747|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325307|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325308|NCT05048719|Dulaglutide|dulaglutide|mesh-list
92325309|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92325310|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325311|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
92325312|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92325313|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92325314|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
92325315|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325316|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325317|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325319|NCT00746239|Dexetimide|dexetimide|mesh-list
92325320|NCT00746239|Citalopram|citalopram|mesh-list
92325321|NCT00746239|Escitalopram|escitalopram|mesh-list
92325322|NCT00746239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92325323|NCT00746239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325324|NCT00746239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325325|NCT00746239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325327|NCT00746239|Serotonin Agents|serotonin agents|mesh-ancestor
92325328|NCT00746239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325329|NCT00746239|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92325330|NCT00746239|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92325331|NCT00746239|Parasympatholytics|parasympatholytics|mesh-ancestor
92325332|NCT00746239|Autonomic Agents|autonomic agents|mesh-ancestor
92325333|NCT00746239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325334|NCT00746239|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92325335|NCT00746239|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92325336|NCT00746239|Cholinergic Agents|cholinergic agents|mesh-ancestor
92325337|NCT00746239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92325339|NCT00746239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325340|NCT04977674|Naltrexone|naltrexone|mesh-list
92325341|NCT04977674|Ketamine|ketamine|mesh-list
92325342|NCT04977674|Analgesics|analgesics|mesh-ancestor
92325343|NCT04977674|Sensory System Agents|sensory system agents|mesh-ancestor
92325344|NCT04977674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325345|NCT04977674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325346|NCT04977674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92325347|NCT04977674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92325348|NCT04977674|Anesthetics, General|anesthetics, general|mesh-ancestor
92325349|NCT04977674|Anesthetics|anesthetics|mesh-ancestor
92325350|NCT04977674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325351|NCT04977674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92325352|NCT04977674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92325353|NCT04977674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325354|NCT04977674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325355|NCT04977674|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92325356|NCT04977674|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325357|NCT04965038|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92325358|NCT04965038|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92325359|NCT04965038|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92325360|NCT04965038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325361|NCT00402883|Folic Acid|folic acid|mesh-list
92325362|NCT00402883|Vitamin B 12|vitamin b 12|mesh-list
92325363|NCT00402883|Bevacizumab|bevacizumab|mesh-list
92325364|NCT00402883|Carboplatin|carboplatin|mesh-list
92325365|NCT00402883|Pemetrexed|pemetrexed|mesh-list
92325366|NCT00402883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325367|NCT00402883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325368|NCT00402883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325369|NCT00402883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325370|NCT00402883|Growth Substances|growth substances|mesh-ancestor
92325371|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325372|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325373|NCT00402883|Vitamins|vitamins|mesh-ancestor
92325374|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
92325375|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325376|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325377|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92325378|NCT00402883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92325379|NCT00402883|Hematinics|hematinics|mesh-ancestor
92325380|NCT00402883|Vitamin B Complex|vitamin b complex|mesh-ancestor
92325381|NCT04939844|Lenalidomide|lenalidomide|mesh-list
92325382|NCT04939844|Bortezomib|bortezomib|mesh-list
92325383|NCT04939844|Immunologic Factors|immunologic factors|mesh-ancestor
92325384|NCT04939844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325385|NCT04939844|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325386|NCT04939844|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325387|NCT04939844|Growth Substances|growth substances|mesh-ancestor
92325388|NCT04939844|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325389|NCT04939844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325390|NCT05295212|Atezolizumab|atezolizumab|mesh-list
92325391|NCT05295212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92325392|NCT05295212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325393|NCT05295212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325395|NCT05286320|Pembrolizumab|pembrolizumab|mesh-list
92325396|NCT05286320|Lenvatinib|lenvatinib|mesh-list
92325397|NCT05286320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325398|NCT05286320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325399|NCT05286320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92325400|NCT05286320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325401|NCT05286320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92325402|NCT05286320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325403|NCT00728845|Hydroxychloroquine|hydroxychloroquine|mesh-list
92325405|NCT00728845|Bevacizumab|bevacizumab|mesh-list
92325406|NCT00728845|Carboplatin|carboplatin|mesh-list
92325407|NCT00728845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92325408|NCT00728845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325409|NCT00728845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325410|NCT00728845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325411|NCT00728845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325412|NCT00728845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325413|NCT00728845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325415|NCT00728845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325417|NCT00728845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325418|NCT00728845|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325419|NCT00728845|Antimalarials|antimalarials|mesh-ancestor
92325420|NCT00728845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92325421|NCT00728845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92325422|NCT00728845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325423|NCT00728845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325424|NCT00728845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325425|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
92325426|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325427|NCT05278676|Dotinurad|dotinurad|mesh-list
92325428|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
92325429|NCT05278676|Gout Suppressants|gout suppressants|mesh-ancestor
92325430|NCT05278676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325431|NCT00703885|Alprazolam|alprazolam|mesh-list
92325432|NCT00703885|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92325433|NCT00703885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325434|NCT00703885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325435|NCT00703885|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92325436|NCT00703885|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325437|NCT00703885|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325438|NCT00703885|GABA Modulators|gaba modulators|mesh-ancestor
92325439|NCT00703885|GABA Agents|gaba agents|mesh-ancestor
92325440|NCT00703885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325441|NCT00703885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325442|NCT00703339|Treprostinil|treprostinil|mesh-list
92325443|NCT00703339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92325444|NCT04330586|Ciclesonide|ciclesonide|mesh-list
92325445|NCT04330586|Glucocorticoids|glucocorticoids|mesh-ancestor
92325446|NCT04330586|Hormones|hormones|mesh-ancestor
92325447|NCT04330586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325448|NCT04330586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325449|NCT04330586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92325450|NCT00382694|Fludarabine|fludarabine|mesh-list
92325451|NCT00382694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325452|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
92325453|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92325454|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92325455|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325456|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
92325457|NCT04508036|Coagulants|coagulants|mesh-ancestor
92325458|NCT04828057|Timolol|timolol|mesh-list
92325459|NCT04828057|Bimatoprost|bimatoprost|mesh-list
92325460|NCT04828057|Travoprost|travoprost|mesh-list
92325461|NCT04828057|Latanoprost|latanoprost|mesh-list
92325462|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325463|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92325464|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92325465|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92325466|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325467|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325468|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92325469|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92325470|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92325471|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92325472|NCT02973451|Bupivacaine|bupivacaine|mesh-list
92325473|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
92325474|NCT02973451|Anesthetics|anesthetics|mesh-ancestor
92325475|NCT02973451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325476|NCT02973451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325477|NCT02973451|Sensory System Agents|sensory system agents|mesh-ancestor
92325478|NCT02973451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325479|NCT00000199|Piracetam|piracetam|mesh-list
92325480|NCT00000199|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92325481|NCT00000199|Protective Agents|protective agents|mesh-ancestor
92325482|NCT00000199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325483|NCT00000199|Nootropic Agents|nootropic agents|mesh-ancestor
92325484|NCT00668785|Ranibizumab|ranibizumab|mesh-list
92325485|NCT00668785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325486|NCT00668785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325487|NCT00668785|Growth Substances|growth substances|mesh-ancestor
92325488|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325489|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325490|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325491|NCT00655057|Citalopram|citalopram|mesh-list
92325492|NCT00655057|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92325493|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325494|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325495|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325496|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325497|NCT00655057|Serotonin Agents|serotonin agents|mesh-ancestor
92325498|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325499|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92325500|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325501|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325502|NCT00000211|Buprenorphine|buprenorphine|mesh-list
92325503|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325504|NCT00000211|Narcotics|narcotics|mesh-ancestor
92325505|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325506|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325507|NCT00000211|Analgesics|analgesics|mesh-ancestor
92325508|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
92325509|NCT00000211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325510|NCT00000211|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325511|NCT04358432|Ezetimibe|ezetimibe|mesh-list
92325512|NCT04358432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92325513|NCT04358432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92325514|NCT04358432|Antimetabolites|antimetabolites|mesh-ancestor
92325515|NCT04358432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325516|NCT04358432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92325517|NCT00000217|Carbamazepine|carbamazepine|mesh-list
92325518|NCT00000217|Anticonvulsants|anticonvulsants|mesh-ancestor
92325519|NCT00000217|Antimanic Agents|antimanic agents|mesh-ancestor
92325520|NCT00000217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325521|NCT00000217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325522|NCT00000217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325523|NCT00000217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325524|NCT00000217|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325525|NCT00000217|Analgesics|analgesics|mesh-ancestor
92325526|NCT00000217|Sensory System Agents|sensory system agents|mesh-ancestor
92325527|NCT00000217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325528|NCT00000217|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92325529|NCT00000217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325530|NCT00000217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325531|NCT00000217|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92325532|NCT00000217|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92325533|NCT00000223|Buprenorphine|buprenorphine|mesh-list
92325534|NCT00000223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325535|NCT00000223|Narcotics|narcotics|mesh-ancestor
92325536|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325537|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325538|NCT00000223|Analgesics|analgesics|mesh-ancestor
92325539|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
92325540|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325541|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325543|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325544|NCT00000229|Narcotics|narcotics|mesh-ancestor
92325545|NCT00000229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325546|NCT00000229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325547|NCT00000229|Analgesics|analgesics|mesh-ancestor
92325548|NCT00000229|Sensory System Agents|sensory system agents|mesh-ancestor
92325549|NCT00000229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325550|NCT00000229|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325551|NCT00000235|Buprenorphine|buprenorphine|mesh-list
92325552|NCT00000235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325553|NCT00000235|Narcotics|narcotics|mesh-ancestor
92325554|NCT00000235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325555|NCT00000235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325556|NCT00000235|Analgesics|analgesics|mesh-ancestor
92325557|NCT00000235|Sensory System Agents|sensory system agents|mesh-ancestor
92325558|NCT00000235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325559|NCT00000235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325560|NCT00000241|Flupenthixol|flupenthixol|mesh-list
92325561|NCT00000241|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92325562|NCT00000241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92325563|NCT00000241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325564|NCT00000241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325565|NCT00000241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325566|NCT00000241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325567|NCT00000241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92325568|NCT00000241|Dopamine Agents|dopamine agents|mesh-ancestor
92325569|NCT00000241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325570|NCT00000241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325571|NCT00000253|Nitrous Oxide|nitrous oxide|mesh-list
92325572|NCT00000253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92325573|NCT00000253|Anesthetics, General|anesthetics, general|mesh-ancestor
92325574|NCT00000253|Anesthetics|anesthetics|mesh-ancestor
92325575|NCT00000253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325576|NCT00000253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325577|NCT00000253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325578|NCT00000253|Analgesics|analgesics|mesh-ancestor
92325579|NCT00000253|Sensory System Agents|sensory system agents|mesh-ancestor
92325580|NCT00000253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325581|NCT00000259|Nitrous Oxide|nitrous oxide|mesh-list
92325582|NCT00000259|Sevoflurane|sevoflurane|mesh-list
92325583|NCT00000259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92325584|NCT00000259|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92325585|NCT00000259|Anesthetics, General|anesthetics, general|mesh-ancestor
92325586|NCT00000259|Anesthetics|anesthetics|mesh-ancestor
92325587|NCT00000259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325588|NCT00000259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325589|NCT00000259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325590|NCT00000259|Analgesics|analgesics|mesh-ancestor
92325591|NCT00000259|Sensory System Agents|sensory system agents|mesh-ancestor
92325592|NCT00000259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325593|NCT04330664|Adagrasib|adagrasib|mesh-list
92325594|NCT04330664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325595|NCT00379405|Ritonavir|ritonavir|mesh-list
92325596|NCT00379405|Saquinavir|saquinavir|mesh-list
92325597|NCT00379405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92325598|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92325599|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92325600|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325601|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325602|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92325603|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92325604|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
92325605|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325606|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92325607|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92325608|NCT00379483|Deferasirox|deferasirox|mesh-list
92325609|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92325610|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
92325611|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
92325612|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325613|NCT00607477|Minoxidil|minoxidil|mesh-list
92325614|NCT00607477|Hydralazine|hydralazine|mesh-list
92325615|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92325616|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
92325617|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
92325618|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92325619|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325621|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92325622|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325623|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325624|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325625|NCT00000271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325626|NCT00000271|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92325627|NCT00000271|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325628|NCT00000271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325629|NCT00000271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92325630|NCT00000271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325631|NCT00000271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325633|NCT00000277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92325634|NCT00000277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325635|NCT00000277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92325636|NCT00000277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325637|NCT00000277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325638|NCT00000277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325639|NCT00000277|Adrenergic Agents|adrenergic agents|mesh-ancestor
92325640|NCT00000277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325641|NCT00000277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92325642|NCT00000277|Dopamine Agents|dopamine agents|mesh-ancestor
92325643|NCT00599131|Docetaxel|docetaxel|mesh-list
92325644|NCT00599131|Fluorouracil|fluorouracil|mesh-list
92325645|NCT00599131|Cetuximab|cetuximab|mesh-list
92325646|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325647|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325648|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325649|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325650|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325651|NCT00599131|Antimetabolites|antimetabolites|mesh-ancestor
92325652|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325653|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92325654|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
92325655|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325656|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325657|NCT04302350|Nitrous Oxide|nitrous oxide|mesh-list
92325658|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92325659|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
92325660|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
92325661|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325662|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325663|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325664|NCT04302350|Analgesics|analgesics|mesh-ancestor
92325665|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
92325666|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325667|NCT00584935|Rituximab|rituximab|mesh-list
92325668|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325669|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325670|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
92325671|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325672|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325673|NCT04295486|Aspirin|aspirin|mesh-list
92325674|NCT04295486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92325675|NCT04295486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325676|NCT04295486|Analgesics|analgesics|mesh-ancestor
92325677|NCT04295486|Sensory System Agents|sensory system agents|mesh-ancestor
92325678|NCT04295486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325679|NCT04295486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325680|NCT04295486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92325681|NCT04295486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325682|NCT04295486|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92325683|NCT04295486|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92325684|NCT04295486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325685|NCT04295486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92325686|NCT04295486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92325687|NCT04295486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325688|NCT04295486|Antipyretics|antipyretics|mesh-ancestor
92325689|NCT00000289|Ondansetron|ondansetron|mesh-list
92325690|NCT00000289|Antiemetics|antiemetics|mesh-ancestor
92325691|NCT00000289|Autonomic Agents|autonomic agents|mesh-ancestor
92325692|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325693|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325694|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92325695|NCT00000289|Antipruritics|antipruritics|mesh-ancestor
92325696|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
92325697|NCT00000289|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92325698|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92325699|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
92325700|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325701|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325702|NCT00000295|Progesterone|progesterone|mesh-list
92325703|NCT00000295|Progestins|progestins|mesh-ancestor
92325704|NCT00000295|Hormones|hormones|mesh-ancestor
92325705|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325706|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325707|NCT00000733|Ribavirin|ribavirin|mesh-list
92325708|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
92325709|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325710|NCT00000733|Antiviral Agents|antiviral agents|mesh-ancestor
92325711|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325712|NCT04246723|Ritonavir|ritonavir|mesh-list
92325713|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
91936833|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
92325714|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92325715|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92325716|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92325717|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325718|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325719|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92325720|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92325721|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
92325722|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325723|NCT04246723|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92325724|NCT04246723|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92325726|NCT00000301|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92325727|NCT00000301|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92325728|NCT00000301|Antiviral Agents|antiviral agents|mesh-ancestor
92325729|NCT00000301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325730|NCT00000301|Dopamine Agents|dopamine agents|mesh-ancestor
92325731|NCT00000301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325732|NCT00000301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325733|NCT00000301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325734|NCT00000301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325735|NCT00000301|Analgesics|analgesics|mesh-ancestor
92325736|NCT00000301|Sensory System Agents|sensory system agents|mesh-ancestor
92325737|NCT00000301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325738|NCT00000307|Naltrexone|naltrexone|mesh-list
92325739|NCT00000307|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92325740|NCT00000307|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325741|NCT00000307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325742|NCT00000307|Sensory System Agents|sensory system agents|mesh-ancestor
92325743|NCT00000307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325744|NCT00000313|Fenfluramine|fenfluramine|mesh-list
92325745|NCT00000313|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92325746|NCT00000313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325747|NCT00000313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325748|NCT00000313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325749|NCT00000313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325750|NCT00000313|Serotonin Agents|serotonin agents|mesh-ancestor
92325751|NCT00000313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325752|NCT00000319|Buprenorphine|buprenorphine|mesh-list
92325753|NCT00000319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325755|NCT00000319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325756|NCT00000319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325757|NCT00000319|Analgesics|analgesics|mesh-ancestor
92325758|NCT00000319|Sensory System Agents|sensory system agents|mesh-ancestor
92325759|NCT00000319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325760|NCT00000319|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325761|NCT00000325|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92325762|NCT00000325|Hormones|hormones|mesh-ancestor
92325763|NCT00000325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325764|NCT00000325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325765|NCT04181203|Leuprolide|leuprolide|mesh-list
92325766|NCT04181203|Goserelin|goserelin|mesh-list
92325767|NCT04181203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92325768|NCT04181203|Hormones|hormones|mesh-list
92325769|NCT04181203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92325770|NCT04181203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325771|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92325772|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
92325773|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92325774|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92325775|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325776|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
92325777|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92325778|NCT04181203|Contraceptive Agents|contraceptive agents|mesh-ancestor
92325779|NCT04181203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92325780|NCT03521102|Acetaminophen|acetaminophen|mesh-list
92325781|NCT03521102|Hydromorphone|hydromorphone|mesh-list
92325782|NCT03521102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92325783|NCT03521102|Analgesics|analgesics|mesh-ancestor
92325784|NCT03521102|Sensory System Agents|sensory system agents|mesh-ancestor
92325785|NCT03521102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325786|NCT03521102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325788|NCT03521102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325789|NCT03521102|Narcotics|narcotics|mesh-ancestor
92325790|NCT03521102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325791|NCT00000763|O-(Chloroacetylcarbamoyl)fumagillol|o-(chloroacetylcarbamoyl)fumagillol|mesh-list
92325792|NCT00000763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92325793|NCT00000763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325794|NCT00000763|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92325795|NCT00000763|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92325796|NCT00000763|Growth Substances|growth substances|mesh-ancestor
92325797|NCT00000763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325798|NCT00000763|Growth Inhibitors|growth inhibitors|mesh-ancestor
92325799|NCT00380263|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
92325800|NCT00380263|Growth Substances|growth substances|mesh-ancestor
92325801|NCT00380263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325802|NCT00380263|Vasodilator Agents|vasodilator agents|mesh-ancestor
92325803|NCT00380263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325804|NCT00380263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325805|NCT00000769|Interleukin-4|interleukin-4|mesh-list
92325806|NCT00000769|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92325807|NCT00000769|Immunologic Factors|immunologic factors|mesh-ancestor
92325808|NCT00000769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325809|NCT00000769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325810|NCT00000769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325811|NCT05440591|Metformin|metformin|mesh-list
92325812|NCT05440591|Dapagliflozin|dapagliflozin|mesh-list
92325813|NCT05440591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92325814|NCT05440591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325815|NCT05440591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92325816|NCT05440591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325817|NCT04099303|Vaccines|vaccines|mesh-list
92325818|NCT04099303|Immunologic Factors|immunologic factors|mesh-ancestor
92325819|NCT04099303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325820|NCT00379951|Ertapenem|ertapenem|mesh-list
92325821|NCT00379951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92325822|NCT00379951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325823|NCT00000337|Selegiline|selegiline|mesh-list
92325824|NCT00000337|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325825|NCT00000337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325826|NCT00000337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92325827|NCT00000337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92325828|NCT00000337|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92325829|NCT00000337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325830|NCT00000337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325831|NCT00000337|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92325832|NCT00000337|Protective Agents|protective agents|mesh-ancestor
92325833|NCT00000337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325834|NCT00000781|Zidovudine|zidovudine|mesh-list
92325835|NCT00000781|Nevirapine|nevirapine|mesh-list
92325836|NCT00000781|Didanosine|didanosine|mesh-list
92325837|NCT00000781|Zalcitabine|zalcitabine|mesh-list
92325838|NCT00000781|Antimetabolites|antimetabolites|mesh-ancestor
92325839|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325840|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92325841|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92325842|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325843|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
92325844|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325845|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92325846|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92325847|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92325848|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92325849|NCT00000349|Flupenthixol|flupenthixol|mesh-list
92325850|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92325851|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92325852|NCT00000349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325853|NCT00000349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325854|NCT00000349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325855|NCT00000349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325856|NCT00000349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92325857|NCT00000349|Dopamine Agents|dopamine agents|mesh-ancestor
92325858|NCT00000349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325859|NCT00000349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325860|NCT00000805|Ganciclovir|ganciclovir|mesh-list
92325862|NCT00000805|Antiviral Agents|antiviral agents|mesh-ancestor
92325863|NCT00000805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325864|NCT00000805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92325865|NCT00000805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325866|NCT00000805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325867|NCT04270682|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92325868|NCT04270682|Cathartics|cathartics|mesh-ancestor
92325869|NCT04270682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92325870|NCT00000355|Buprenorphine|buprenorphine|mesh-list
92325871|NCT00000355|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92325872|NCT00000355|Narcotics|narcotics|mesh-ancestor
92325873|NCT00000355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325874|NCT00000355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325875|NCT00000355|Analgesics|analgesics|mesh-ancestor
92325876|NCT00000355|Sensory System Agents|sensory system agents|mesh-ancestor
92325877|NCT00000355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325878|NCT00000355|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92325879|NCT04022785|Azacitidine|azacitidine|mesh-list
92325880|NCT04022785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325881|NCT04022785|Antimetabolites|antimetabolites|mesh-ancestor
92325882|NCT04022785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325883|NCT04022785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325884|NCT04022785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325885|NCT00000361|Methotrexate|methotrexate|mesh-list
92325886|NCT00000361|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92325887|NCT00000361|Abortifacient Agents|abortifacient agents|mesh-ancestor
92325888|NCT00000361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92325889|NCT00000361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325890|NCT00000361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92325891|NCT00000361|Antimetabolites|antimetabolites|mesh-ancestor
92325892|NCT00000361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325893|NCT00000361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325894|NCT00000361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92325895|NCT00000361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325896|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92325897|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92325898|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
92325899|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92325900|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92325901|NCT00000811|Azithromycin|azithromycin|mesh-list
92325902|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92325903|NCT00000811|Trimethoprim|trimethoprim|mesh-list
92325904|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
92325905|NCT00000811|Atovaquone|atovaquone|mesh-list
92325906|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92325907|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325908|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92325909|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
92325910|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92325911|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92325912|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92325913|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325914|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325915|NCT00000811|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92325916|NCT00000811|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92325917|NCT00000811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92325918|NCT00000373|Olanzapine|olanzapine|mesh-list
92325919|NCT00000373|Fluoxetine|fluoxetine|mesh-list
92325920|NCT00000373|Antiemetics|antiemetics|mesh-ancestor
92325921|NCT00000373|Autonomic Agents|autonomic agents|mesh-ancestor
92325922|NCT00000373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92325923|NCT00000373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325924|NCT00000373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92325925|NCT00000373|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92325926|NCT00000373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325927|NCT00000373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325928|NCT00000373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325929|NCT00000373|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92325930|NCT00000373|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325931|NCT00000373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325932|NCT00000373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325933|NCT00000373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325934|NCT00000373|Serotonin Agents|serotonin agents|mesh-ancestor
92325935|NCT00000373|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92325936|NCT00000373|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325937|NCT00000373|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92325938|NCT00000373|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92325939|NCT00000373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325940|NCT00000823|Zidovudine|zidovudine|mesh-list
92325941|NCT00000823|Didanosine|didanosine|mesh-list
92325942|NCT00000823|Antimetabolites|antimetabolites|mesh-ancestor
92325943|NCT00000823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325944|NCT00000823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92325945|NCT00000823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92325946|NCT00000823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325947|NCT00000823|Antiviral Agents|antiviral agents|mesh-ancestor
92325948|NCT00000823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325949|NCT00000823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92325950|NCT00000823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92325951|NCT00000379|Fluoxetine|fluoxetine|mesh-list
92325952|NCT00000379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92325953|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92325954|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92325955|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325956|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92325957|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
92325958|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325959|NCT00000379|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92325960|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325961|NCT00000379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325962|NCT00000379|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92325963|NCT00000379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92325964|NCT00000379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325965|NCT00000385|Lithium Carbonate|lithium carbonate|mesh-list
92325966|NCT00000385|Antidepressive Agents|antidepressive agents|mesh-ancestor
92325967|NCT00000385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92325968|NCT00000385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92325969|NCT00000385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325970|NCT00000385|Antimanic Agents|antimanic agents|mesh-ancestor
92325971|NCT00000385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92325972|NCT00000385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92325973|NCT00000385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325974|NCT00002894|Paclitaxel|paclitaxel|mesh-list
92325975|NCT00002894|Carboplatin|carboplatin|mesh-list
92325976|NCT00002894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92325977|NCT00002894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325978|NCT00002894|Tubulin Modulators|tubulin modulators|mesh-ancestor
92325979|NCT00002894|Antimitotic Agents|antimitotic agents|mesh-ancestor
92325980|NCT00002894|Mitosis Modulators|mitosis modulators|mesh-ancestor
92325981|NCT00002894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325982|NCT00000829|Vaccines|vaccines|mesh-list
92325983|NCT00000829|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92325984|NCT00000829|Immunologic Factors|immunologic factors|mesh-ancestor
92325985|NCT00000829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92325986|NCT03282344|Nivolumab|nivolumab|mesh-list
92325987|NCT03282344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92325988|NCT03282344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92325989|NCT03282344|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91978654|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
92325990|NCT03282344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92325991|NCT00000403|Doxycycline|doxycycline|mesh-list
92325992|NCT00000403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92325993|NCT00000403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92325994|NCT00000403|Antimalarials|antimalarials|mesh-ancestor
92325995|NCT00000403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92325996|NCT00000403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92325997|NCT00000841|Lamivudine|lamivudine|mesh-list
92325998|NCT00000841|Zidovudine|zidovudine|mesh-list
92325999|NCT00000841|Stavudine|stavudine|mesh-list
92326000|NCT00000841|Indinavir|indinavir|mesh-list
92326001|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326002|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326003|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326004|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326005|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
92326006|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326007|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326008|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326009|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
92326010|NCT00000841|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92326011|NCT00000841|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92326012|NCT00000841|Protease Inhibitors|protease inhibitors|mesh-ancestor
92326013|NCT04226456|Acetylcysteine|acetylcysteine|mesh-list
92326014|NCT04226456|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92326015|NCT04226456|Antiviral Agents|antiviral agents|mesh-ancestor
92326016|NCT04226456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326017|NCT04226456|Expectorants|expectorants|mesh-ancestor
92326018|NCT04226456|Respiratory System Agents|respiratory system agents|mesh-ancestor
92326019|NCT04226456|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92326020|NCT04226456|Antioxidants|antioxidants|mesh-ancestor
92326021|NCT04226456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326022|NCT04226456|Protective Agents|protective agents|mesh-ancestor
92326023|NCT04226456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326024|NCT04226456|Antidotes|antidotes|mesh-ancestor
92326026|NCT00000415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92326027|NCT00000415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326029|NCT00000847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92326030|NCT00000847|Immunologic Factors|immunologic factors|mesh-ancestor
92326031|NCT00000847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326032|NCT00000847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92326033|NCT00000847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326034|NCT00000847|Antiviral Agents|antiviral agents|mesh-ancestor
92326035|NCT00000847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326036|NCT00000847|Interferon Inducers|interferon inducers|mesh-ancestor
92326037|NCT00000847|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92326038|NCT00000847|Protective Agents|protective agents|mesh-ancestor
92326039|NCT04195568|Calcium Carbonate|calcium carbonate|mesh-list
92326040|NCT04195568|Antacids|antacids|mesh-ancestor
92326041|NCT04195568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326042|NCT04195568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92326043|NCT00000439|Valproic Acid|valproic acid|mesh-list
92326044|NCT00000439|Anticonvulsants|anticonvulsants|mesh-ancestor
92326045|NCT00000439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326046|NCT00000439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326047|NCT00000439|GABA Agents|gaba agents|mesh-ancestor
92326048|NCT00000439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326049|NCT00000439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326050|NCT00000439|Antimanic Agents|antimanic agents|mesh-ancestor
92326051|NCT00000439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92326052|NCT00000439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92326053|NCT00000439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92326054|NCT00002912|Etoposide|etoposide|mesh-list
92326055|NCT00002912|Mitoxantrone|mitoxantrone|mesh-list
92326056|NCT00002912|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92326057|NCT00002912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326058|NCT00002912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92326059|NCT00002912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326060|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326061|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326062|NCT00002912|Analgesics|analgesics|mesh-ancestor
92326063|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
92326064|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326065|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978733|NCT02367105|Testosterone|testosterone|mesh-list
92326066|NCT04183790|Ivacaftor|ivacaftor|mesh-list
92326067|NCT04183790|Elexacaftor|elexacaftor|mesh-list
92326068|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92326069|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92326070|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326071|NCT00000445|Naltrexone|naltrexone|mesh-list
92326072|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92326073|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92326074|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326075|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
92326076|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326077|NCT00000451|Naltrexone|naltrexone|mesh-list
92326078|NCT00000451|Sertraline|sertraline|mesh-list
92326079|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92326080|NCT00000451|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92326081|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326082|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
92326083|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326084|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
92326085|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92326086|NCT00000451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92326087|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92326088|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92326089|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326090|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326091|NCT00000451|Serotonin Agents|serotonin agents|mesh-ancestor
92326092|NCT00000865|Lamivudine|lamivudine|mesh-list
92326093|NCT00000865|Zidovudine|zidovudine|mesh-list
92326094|NCT00000865|Abacavir|abacavir|mesh-list
92326095|NCT00000865|Didanosine|didanosine|mesh-list
92326096|NCT00000865|Stavudine|stavudine|mesh-list
92326097|NCT00000865|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326098|NCT00000865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326099|NCT00000865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326100|NCT00000865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326101|NCT00000865|Antiviral Agents|antiviral agents|mesh-ancestor
92326102|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326103|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326104|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326105|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
92326106|NCT00000469|Aspirin|aspirin|mesh-list
92326107|NCT00000469|Lovastatin|lovastatin|mesh-list
92326108|NCT00000469|L 647318|l 647318|mesh-list
92326109|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
92326110|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92326111|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92326112|NCT00000469|Analgesics|analgesics|mesh-ancestor
92326113|NCT00000469|Sensory System Agents|sensory system agents|mesh-ancestor
92326114|NCT00000469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326115|NCT00000469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326116|NCT00000469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92326117|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92326118|NCT00000469|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92326119|NCT00000469|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92326120|NCT00000469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326121|NCT00000469|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92326122|NCT00000469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92326123|NCT00000469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326124|NCT00000469|Antipyretics|antipyretics|mesh-ancestor
92326125|NCT00000469|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92326126|NCT00000469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92326127|NCT00000469|Antimetabolites|antimetabolites|mesh-ancestor
92326128|NCT00000469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92326129|NCT00000469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92326130|NCT00000889|Aldesleukin|aldesleukin|mesh-list
92326131|NCT00000889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326132|NCT00000889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326133|NCT00000889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326134|NCT00000889|Antiviral Agents|antiviral agents|mesh-ancestor
92326135|NCT00000889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326136|NCT00000505|Plasminogen|plasminogen|mesh-list
92326137|NCT00000505|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92326139|NCT00000505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92326140|NCT00000505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326141|NCT00000901|Lamivudine|lamivudine|mesh-list
92326142|NCT00000901|Stavudine|stavudine|mesh-list
92326143|NCT00000901|Indinavir|indinavir|mesh-list
92326144|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326145|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326146|NCT00000901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326147|NCT00000901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326148|NCT00000901|Antiviral Agents|antiviral agents|mesh-ancestor
92326149|NCT00000901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326150|NCT00000901|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326151|NCT00000901|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326152|NCT00000901|Antimetabolites|antimetabolites|mesh-ancestor
92326153|NCT00000901|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92326154|NCT00000901|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92326155|NCT00000901|Protease Inhibitors|protease inhibitors|mesh-ancestor
92326156|NCT00000541|Vitamins|vitamins|mesh-list
92326157|NCT00000541|Folic Acid|folic acid|mesh-list
92326158|NCT00000541|Vitamin E|vitamin e|mesh-list
92326159|NCT00000541|Vitamin B 12|vitamin b 12|mesh-list
92326160|NCT00000541|Vitamin B 6|vitamin b 6|mesh-list
92326161|NCT00000541|Pyridoxal|pyridoxal|mesh-list
92326162|NCT00000541|Pyridoxine|pyridoxine|mesh-list
92326163|NCT00000541|Beta Carotene|beta carotene|mesh-list
92326164|NCT00000541|Vitamin B Complex|vitamin b complex|mesh-list
92326165|NCT00000541|Carotenoids|carotenoids|mesh-list
92326166|NCT00000541|Micronutrients|micronutrients|mesh-ancestor
92326167|NCT00000541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326168|NCT00000541|Antioxidants|antioxidants|mesh-ancestor
92326169|NCT00000541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326170|NCT00000541|Protective Agents|protective agents|mesh-ancestor
92326171|NCT00000541|Hematinics|hematinics|mesh-ancestor
92326172|NCT00000541|Provitamins|provitamins|mesh-ancestor
92326173|NCT00000913|Ritonavir|ritonavir|mesh-list
92326174|NCT00000913|Nelfinavir|nelfinavir|mesh-list
92326175|NCT00000913|Saquinavir|saquinavir|mesh-list
92326176|NCT00000913|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92326177|NCT00000913|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92326178|NCT00000913|Protease Inhibitors|protease inhibitors|mesh-ancestor
92326179|NCT00000913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326180|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326181|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326182|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326183|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
92326184|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326185|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92326186|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326188|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92326189|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
92326190|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326191|NCT00000547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326192|NCT00000547|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92326193|NCT00002930|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92326194|NCT00002930|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92326195|NCT00002930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326196|NCT00000577|Colchicine|colchicine|mesh-list
92326197|NCT00000577|Albuterol|albuterol|mesh-list
92326198|NCT00000577|Hormones|hormones|mesh-list
92326199|NCT00000577|Adrenergic Agents|adrenergic agents|mesh-list
92326200|NCT00000577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-list
92326201|NCT00000577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92326202|NCT00000577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326203|NCT00000577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92326204|NCT00000577|Autonomic Agents|autonomic agents|mesh-ancestor
92326205|NCT00000577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326206|NCT00000577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92326207|NCT00000577|Respiratory System Agents|respiratory system agents|mesh-ancestor
92326208|NCT00000577|Tocolytic Agents|tocolytic agents|mesh-ancestor
92326209|NCT00000577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92326210|NCT00000577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92326211|NCT00000577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92326212|NCT00000577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326213|NCT00000577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326215|NCT00000577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92326216|NCT00000577|Tubulin Modulators|tubulin modulators|mesh-ancestor
92326217|NCT00000577|Antimitotic Agents|antimitotic agents|mesh-ancestor
92326218|NCT00000577|Mitosis Modulators|mitosis modulators|mesh-ancestor
92326219|NCT00000577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326221|NCT03321799|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92326223|NCT03015896|Lenalidomide|lenalidomide|mesh-list
92326224|NCT03015896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92326225|NCT03015896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326226|NCT03015896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92326227|NCT03015896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326228|NCT03015896|Immunologic Factors|immunologic factors|mesh-ancestor
92326229|NCT03015896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326230|NCT03015896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92326231|NCT03015896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92326232|NCT03015896|Growth Substances|growth substances|mesh-ancestor
92326233|NCT03015896|Growth Inhibitors|growth inhibitors|mesh-ancestor
92326234|NCT02994836|Adalimumab|adalimumab|mesh-list
92326235|NCT02994836|Infliximab|infliximab|mesh-list
92326236|NCT02994836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92326237|NCT02994836|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92326238|NCT02994836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92326239|NCT02994836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92326240|NCT02994836|Dermatologic Agents|dermatologic agents|mesh-ancestor
92326241|NCT02994836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92326242|NCT00000937|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92326243|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326244|NCT00000613|Genistein|genistein|mesh-list
92326245|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92326246|NCT00000613|Protective Agents|protective agents|mesh-ancestor
92326247|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326248|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326249|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92326250|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326251|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326252|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
92326253|NCT00000613|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92326254|NCT00000613|Estrogens|estrogens|mesh-ancestor
92326255|NCT00000613|Hormones|hormones|mesh-ancestor
92326256|NCT00000613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92326257|NCT02909348|Pembrolizumab|pembrolizumab|mesh-list
92326258|NCT02909348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92326259|NCT02909348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326260|NCT02909348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92326261|NCT02909348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326262|NCT00000949|Aldesleukin|aldesleukin|mesh-list
92326263|NCT00000949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326264|NCT00000949|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326265|NCT00000949|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326266|NCT00000949|Antiviral Agents|antiviral agents|mesh-ancestor
92326267|NCT00000949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326268|NCT00002936|Etoposide|etoposide|mesh-list
92326269|NCT00002936|Altretamine|altretamine|mesh-list
92326270|NCT00002936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92326271|NCT00002936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326272|NCT00002936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92326273|NCT00002936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326274|NCT00002936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326275|NCT00002936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326276|NCT00002936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92326277|NCT00002936|Alkylating Agents|alkylating agents|mesh-ancestor
92326278|NCT00000649|Zidovudine|zidovudine|mesh-list
92326279|NCT00000649|Nevirapine|nevirapine|mesh-list
92326280|NCT00000649|Antimetabolites|antimetabolites|mesh-ancestor
92326281|NCT00000649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326282|NCT00000649|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326283|NCT00000649|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326284|NCT00000649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326285|NCT00000649|Antiviral Agents|antiviral agents|mesh-ancestor
92326286|NCT00000649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326287|NCT00000649|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326288|NCT00000649|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326289|NCT00000649|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92326290|NCT00000649|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92326291|NCT00000961|Zidovudine|zidovudine|mesh-list
92326292|NCT00000961|Immune Sera|immune sera|mesh-list
92326293|NCT00000961|Antimetabolites|antimetabolites|mesh-ancestor
92326294|NCT00000961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326295|NCT00000961|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326296|NCT00000961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326297|NCT00000961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326298|NCT00000961|Antiviral Agents|antiviral agents|mesh-ancestor
92326299|NCT00000961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326300|NCT00000961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326301|NCT00000961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326302|NCT00000961|Immunologic Factors|immunologic factors|mesh-ancestor
92326303|NCT00000961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326304|NCT04048304|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92326305|NCT04048304|Vancomycin|vancomycin|mesh-list
92326306|NCT04048304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326307|NCT00000655|Trimethoprim|trimethoprim|mesh-list
92326308|NCT00000655|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92326309|NCT00000655|Atovaquone|atovaquone|mesh-list
92326310|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
92326311|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92326312|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326313|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
92326314|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326315|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326316|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92326317|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326318|NCT00000655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326319|NCT00000655|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92326320|NCT00000655|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92326321|NCT00000655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326322|NCT00000655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326323|NCT00002948|Topotecan|topotecan|mesh-list
92326324|NCT00002948|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92326325|NCT00002948|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326326|NCT00002948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326327|NCT00002948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326328|NCT00002948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326329|NCT02594293|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92326330|NCT02594293|Antiviral Agents|antiviral agents|mesh-ancestor
92326331|NCT02594293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326332|NCT00000967|Interferons|interferons|mesh-list
92326333|NCT00000967|Interferon-alpha|interferon-alpha|mesh-list
92326334|NCT00000967|Interferon alpha-2|interferon alpha-2|mesh-list
92326335|NCT00000967|Zidovudine|zidovudine|mesh-list
92326336|NCT00000967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326337|NCT00000967|Antiviral Agents|antiviral agents|mesh-ancestor
92326338|NCT00000967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326339|NCT00000967|Immunologic Factors|immunologic factors|mesh-ancestor
92326340|NCT00000967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326341|NCT00000967|Antimetabolites|antimetabolites|mesh-ancestor
92326342|NCT00000967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326343|NCT00000967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326344|NCT00000967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326345|NCT00000967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326346|NCT00000967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326347|NCT00000967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326348|NCT00000661|Zidovudine|zidovudine|mesh-list
92326349|NCT00000661|Oxazepam|oxazepam|mesh-list
92326350|NCT00000661|Antimetabolites|antimetabolites|mesh-ancestor
92326351|NCT00000661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326352|NCT00000661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326353|NCT00000661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326354|NCT00000661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326355|NCT00000661|Antiviral Agents|antiviral agents|mesh-ancestor
92326356|NCT00000661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326357|NCT00000661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326358|NCT00000661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326359|NCT00000661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92326360|NCT00000661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92326361|NCT00000661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326362|NCT00000661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92326363|NCT00000661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92326364|NCT00000661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92326365|NCT00000661|GABA Modulators|gaba modulators|mesh-ancestor
92326366|NCT00000661|GABA Agents|gaba agents|mesh-ancestor
92326367|NCT00000661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979061|NCT05552391|Ketamine|ketamine|mesh-list
92326369|NCT00000979|Didanosine|didanosine|mesh-list
92326370|NCT00000979|Antimetabolites|antimetabolites|mesh-ancestor
92326371|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326372|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326373|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326374|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326375|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
92326376|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326377|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326378|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326380|NCT00000991|Trimethoprim|trimethoprim|mesh-list
92326381|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
92326382|NCT00000991|Dapsone|dapsone|mesh-list
92326383|NCT00000991|Pentamidine|pentamidine|mesh-list
92326384|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92326385|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
92326386|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326387|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326388|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326389|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326390|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
92326391|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326392|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326393|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326394|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92326395|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
92326396|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326397|NCT00000991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326398|NCT00000991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92326399|NCT00000991|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92326400|NCT00000991|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92326401|NCT00000991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326402|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
92326403|NCT00000991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326404|NCT00000991|Antifungal Agents|antifungal agents|mesh-ancestor
92326405|NCT00000991|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92326406|NCT00000673|Ganciclovir|ganciclovir|mesh-list
92326407|NCT00000673|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92326408|NCT00000673|Antiviral Agents|antiviral agents|mesh-ancestor
92326409|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326410|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326411|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326412|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326413|NCT00000685|Zidovudine|zidovudine|mesh-list
92326414|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
92326415|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326416|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326417|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326418|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326419|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
92326420|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326421|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326422|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326424|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92326425|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326426|NCT00002972|Tubulin Modulators|tubulin modulators|mesh-ancestor
92326427|NCT00002972|Antimitotic Agents|antimitotic agents|mesh-ancestor
92326428|NCT00002972|Mitosis Modulators|mitosis modulators|mesh-ancestor
92326429|NCT00002972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326430|NCT00000691|Foscarnet|foscarnet|mesh-list
92326431|NCT00000691|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92326432|NCT00000691|Antiviral Agents|antiviral agents|mesh-ancestor
92326433|NCT00000691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326434|NCT00000691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92116944|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
92326435|NCT00000691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326436|NCT00000691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326437|NCT00000691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326438|NCT00002984|Paclitaxel|paclitaxel|mesh-list
92326439|NCT00002984|Fluorouracil|fluorouracil|mesh-list
92326440|NCT00002984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92326441|NCT00002984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326442|NCT00002984|Tubulin Modulators|tubulin modulators|mesh-ancestor
92326443|NCT00002984|Antimitotic Agents|antimitotic agents|mesh-ancestor
92326444|NCT00002984|Mitosis Modulators|mitosis modulators|mesh-ancestor
92326445|NCT00002984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326446|NCT00002984|Antimetabolites|antimetabolites|mesh-ancestor
92326447|NCT00002984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92326448|NCT00002984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92326449|NCT00002984|Immunologic Factors|immunologic factors|mesh-ancestor
92326450|NCT00002984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326451|NCT00002990|BCG Vaccine|bcg vaccine|mesh-list
92326452|NCT00002990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92326453|NCT00002990|Immunologic Factors|immunologic factors|mesh-ancestor
92326454|NCT00002990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326455|NCT00000997|Zalcitabine|zalcitabine|mesh-list
92326456|NCT00000997|Antimetabolites|antimetabolites|mesh-ancestor
92326457|NCT00000997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326458|NCT00000997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326459|NCT00000997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326461|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
92326462|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326463|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326464|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326465|NCT00000697|Foscarnet|foscarnet|mesh-list
92326466|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92326467|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
92326468|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326469|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326470|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326471|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326472|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326473|NCT00001009|Dextrans|dextrans|mesh-list
92326474|NCT00001009|Anticoagulants|anticoagulants|mesh-ancestor
92326475|NCT00001009|Plasma Substitutes|plasma substitutes|mesh-ancestor
92326476|NCT00001009|Blood Substitutes|blood substitutes|mesh-ancestor
92326477|NCT00000703|Leucovorin|leucovorin|mesh-list
92326478|NCT00000703|Cytarabine|cytarabine|mesh-list
92326479|NCT00000703|Zidovudine|zidovudine|mesh-list
92326480|NCT00000703|Dexamethasone|dexamethasone|mesh-list
92326481|NCT00000703|Cyclophosphamide|cyclophosphamide|mesh-list
92326482|NCT00000703|Doxorubicin|doxorubicin|mesh-list
92326483|NCT00000703|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92326484|NCT00000703|Methotrexate|methotrexate|mesh-list
92326485|NCT00000703|Vincristine|vincristine|mesh-list
92326486|NCT00000703|Bleomycin|bleomycin|mesh-list
92326487|NCT00000703|Allopurinol|allopurinol|mesh-list
92326488|NCT00000703|Levoleucovorin|levoleucovorin|mesh-list
92326489|NCT00000703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92326490|NCT00000703|Immunologic Factors|immunologic factors|mesh-ancestor
92326491|NCT00000703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326492|NCT00000703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92326493|NCT00000703|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92326494|NCT00000703|Alkylating Agents|alkylating agents|mesh-ancestor
92326495|NCT00000703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326496|NCT00000703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326497|NCT00000703|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92326498|NCT00000703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92326499|NCT00000703|Antiemetics|antiemetics|mesh-ancestor
92326500|NCT00000703|Autonomic Agents|autonomic agents|mesh-ancestor
92326501|NCT00000703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326502|NCT00000703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92326503|NCT00000703|Glucocorticoids|glucocorticoids|mesh-ancestor
92326504|NCT00000703|Hormones|hormones|mesh-ancestor
92326505|NCT00000703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92326506|NCT00000703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92326507|NCT00000703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92326508|NCT00000703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92326509|NCT00000703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326510|NCT00000703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326511|NCT00000703|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92326512|NCT00000703|Abortifacient Agents|abortifacient agents|mesh-ancestor
92326513|NCT00000703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92326514|NCT00000703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92326515|NCT00000703|Antimetabolites|antimetabolites|mesh-ancestor
92326516|NCT00000703|Dermatologic Agents|dermatologic agents|mesh-ancestor
92326517|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92326518|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326519|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
92326520|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326521|NCT00000703|Antidotes|antidotes|mesh-ancestor
92326522|NCT00000703|Protective Agents|protective agents|mesh-ancestor
92326523|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
92326524|NCT00000703|Vitamins|vitamins|mesh-ancestor
92326525|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
92326526|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92326527|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
92326528|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
92326529|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
92326530|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326531|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326532|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326533|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
92326534|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92326535|NCT00000703|Antioxidants|antioxidants|mesh-ancestor
92326536|NCT00001015|Ribavirin|ribavirin|mesh-list
92326537|NCT00001015|Antimetabolites|antimetabolites|mesh-ancestor
92326538|NCT00001015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326539|NCT00001015|Antiviral Agents|antiviral agents|mesh-ancestor
92326540|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326541|NCT00000709|Zidovudine|zidovudine|mesh-list
92326542|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
92326543|NCT00000709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326544|NCT00000709|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326545|NCT00000709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326546|NCT00000709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326547|NCT00000709|Antiviral Agents|antiviral agents|mesh-ancestor
92326548|NCT00000709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326549|NCT00000709|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326550|NCT00000709|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326551|NCT00001027|Pentamidine|pentamidine|mesh-list
92326552|NCT00001027|Antifungal Agents|antifungal agents|mesh-ancestor
92326553|NCT00001027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326554|NCT00001027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326555|NCT00001027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326556|NCT00001027|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92326557|NCT00000727|Zidovudine|zidovudine|mesh-list
92326558|NCT00000727|Pyrimethamine|pyrimethamine|mesh-list
92326559|NCT00000727|Sulfadoxine|sulfadoxine|mesh-list
92326560|NCT00000727|Trimethoprim|trimethoprim|mesh-list
92326561|NCT00000727|Sulfamethoxazole|sulfamethoxazole|mesh-list
92326562|NCT00000727|Pentamidine|pentamidine|mesh-list
92326563|NCT00000727|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92326564|NCT00000727|Antimetabolites|antimetabolites|mesh-ancestor
92326565|NCT00000727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326566|NCT00000727|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326567|NCT00000727|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326568|NCT00000727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326569|NCT00000727|Antiviral Agents|antiviral agents|mesh-ancestor
92326570|NCT00000727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326571|NCT00000727|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326572|NCT00000727|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326573|NCT00000727|Antimalarials|antimalarials|mesh-ancestor
92326574|NCT00000727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326575|NCT00000727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326576|NCT00000727|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92326577|NCT00000727|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92326578|NCT00000727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92326579|NCT00000727|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92326580|NCT00000727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326581|NCT00000727|Antifungal Agents|antifungal agents|mesh-ancestor
92326582|NCT00000727|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92326583|NCT00000727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326584|NCT00001039|Clarithromycin|clarithromycin|mesh-list
92326585|NCT00001039|Ethambutol|ethambutol|mesh-list
92326586|NCT00001039|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326587|NCT00001039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326588|NCT00001039|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92326589|NCT00001039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117020|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326590|NCT00001039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326591|NCT00001039|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92326592|NCT00001039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326593|NCT00001039|Antitubercular Agents|antitubercular agents|mesh-ancestor
92326594|NCT00001057|Zidovudine|zidovudine|mesh-list
92326595|NCT00001057|Didanosine|didanosine|mesh-list
92326596|NCT00001057|Antimetabolites|antimetabolites|mesh-ancestor
91979256|NCT05591235|Metformin|metformin|mesh-list
92326597|NCT00001057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326598|NCT00001057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326599|NCT00001057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326600|NCT00001057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326601|NCT00001057|Antiviral Agents|antiviral agents|mesh-ancestor
92326602|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326603|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92349294|NCT01454076|Glycine Agents|glycine agents|mesh-ancestor
92326604|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326605|NCT00002293|Nystatin|nystatin|mesh-list
92326606|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326607|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326608|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
92326609|NCT00002293|Ionophores|ionophores|mesh-ancestor
92326610|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92326611|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326612|NCT00002299|Interferons|interferons|mesh-list
92326613|NCT00002299|Interferon-beta|interferon-beta|mesh-list
92326614|NCT00002299|Ganciclovir|ganciclovir|mesh-list
92326615|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92326616|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
92326617|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326618|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
92326619|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326620|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
92326621|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326622|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326623|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326624|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326625|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92326626|NCT00001063|Zidovudine|zidovudine|mesh-list
92326627|NCT00001063|Didanosine|didanosine|mesh-list
92326628|NCT00001063|Stavudine|stavudine|mesh-list
92326629|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
92326630|NCT00001063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326631|NCT00001063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326632|NCT00001063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326633|NCT00001063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326634|NCT00001063|Antiviral Agents|antiviral agents|mesh-ancestor
92326635|NCT00001063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326636|NCT00001063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326637|NCT00001063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326638|NCT00002305|Fluconazole|fluconazole|mesh-list
92326639|NCT00002305|Amphotericin B|amphotericin b|mesh-list
92326640|NCT00002305|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92326641|NCT00002305|Flucytosine|flucytosine|mesh-list
92326642|NCT00002305|Antifungal Agents|antifungal agents|mesh-ancestor
92326643|NCT00002305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326644|NCT00002305|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92326645|NCT00002305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326646|NCT00002305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326647|NCT00002305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326648|NCT00002305|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92326649|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
92326650|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92326651|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326652|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92326653|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92326656|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326657|NCT00002305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326658|NCT00002305|Antimetabolites|antimetabolites|mesh-ancestor
92326659|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
92326660|NCT00001081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326661|NCT00001081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326662|NCT00002311|Wobenzym|wobenzym|mesh-list
92326663|NCT00002311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92326664|NCT00002311|Immunologic Factors|immunologic factors|mesh-ancestor
91913267|NCT02106767|Antimetabolites|antimetabolites|mesh-ancestor
92326665|NCT00002311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326666|NCT00002317|Leucovorin|leucovorin|mesh-list
92326667|NCT00002317|Trimetrexate|trimetrexate|mesh-list
92326668|NCT00002317|Calcium|calcium|mesh-list
92326669|NCT00002317|Levoleucovorin|levoleucovorin|mesh-list
92326670|NCT00002317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92326671|NCT00002317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326672|NCT00002317|Antidotes|antidotes|mesh-ancestor
91979327|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92326673|NCT00002317|Protective Agents|protective agents|mesh-ancestor
92326674|NCT00002317|Vitamin B Complex|vitamin b complex|mesh-ancestor
92326675|NCT00002317|Vitamins|vitamins|mesh-ancestor
92326676|NCT00002317|Micronutrients|micronutrients|mesh-ancestor
92326677|NCT00002317|Antifungal Agents|antifungal agents|mesh-ancestor
92326678|NCT00002317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326679|NCT00002317|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92326680|NCT00002317|Antimetabolites|antimetabolites|mesh-ancestor
92326681|NCT00002317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326682|NCT00002317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326683|NCT00002317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92326684|NCT00002317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326685|NCT00001123|Ribavirin|ribavirin|mesh-list
92326686|NCT00001123|Antimetabolites|antimetabolites|mesh-ancestor
92326687|NCT00001123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326688|NCT00001123|Antiviral Agents|antiviral agents|mesh-ancestor
92326689|NCT00001123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326690|NCT00002323|Zidovudine|zidovudine|mesh-list
92326691|NCT00002323|Nevirapine|nevirapine|mesh-list
92326692|NCT00002323|Antimetabolites|antimetabolites|mesh-ancestor
92326693|NCT00002323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326694|NCT00002323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326695|NCT00002323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326696|NCT00002323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326697|NCT00002323|Antiviral Agents|antiviral agents|mesh-ancestor
92326698|NCT00002323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326699|NCT00002323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326700|NCT00002323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326701|NCT00002323|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92326702|NCT00002323|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92326703|NCT00380965|Nabilone|nabilone|mesh-list
92326704|NCT00380965|Antiemetics|antiemetics|mesh-ancestor
92326705|NCT00380965|Autonomic Agents|autonomic agents|mesh-ancestor
92326706|NCT00380965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326707|NCT00380965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326708|NCT00380965|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92326709|NCT00380965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92326710|NCT00380965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92326711|NCT00380965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92326712|NCT00380965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92326713|NCT00001135|Nevirapine|nevirapine|mesh-list
92326714|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326715|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326716|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326717|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326718|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
92326719|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326720|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326721|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326722|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92326723|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92326724|NCT00003002|Sargramostim|sargramostim|mesh-list
92326726|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326727|NCT00001891|Dobutamine|dobutamine|mesh-list
92326728|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92326729|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
92326730|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
92326731|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326732|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326733|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92326734|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92326735|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92326736|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92326737|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326738|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326739|NCT00001891|Protective Agents|protective agents|mesh-ancestor
92326740|NCT00383864|Interferons|interferons|mesh-list
92326741|NCT00383864|Ribavirin|ribavirin|mesh-list
92326742|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326743|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
92326744|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326745|NCT00383864|Antimetabolites|antimetabolites|mesh-ancestor
92326746|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326747|NCT00001903|Immunoglobulins|immunoglobulins|mesh-list
92326748|NCT00001903|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92326749|NCT00001903|Antibodies|antibodies|mesh-list
92326750|NCT00001903|Immunologic Factors|immunologic factors|mesh-ancestor
92326751|NCT00001903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326752|NCT00002335|Emtricitabine|emtricitabine|mesh-list
92326753|NCT00002335|Antiviral Agents|antiviral agents|mesh-ancestor
92326754|NCT00002335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326755|NCT00002335|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326756|NCT00002335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326757|NCT00002335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326758|NCT00002335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326759|NCT00002335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326760|NCT00002335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326761|NCT00002341|Itraconazole|itraconazole|mesh-list
92326762|NCT00002341|Antifungal Agents|antifungal agents|mesh-ancestor
92326763|NCT00002341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326764|NCT00002341|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92326765|NCT00002341|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326766|NCT00002341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326767|NCT00002341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326768|NCT00002341|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92326769|NCT00002341|Hormone Antagonists|hormone antagonists|mesh-ancestor
92326770|NCT00002341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92326771|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326772|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92326774|NCT00002347|Nevirapine|nevirapine|mesh-list
92326775|NCT00002347|Zalcitabine|zalcitabine|mesh-list
92326776|NCT00002347|Saquinavir|saquinavir|mesh-list
92326777|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
92326778|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326779|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326780|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326781|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326782|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
92326783|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326784|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326785|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326786|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92326787|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92326788|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92326789|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92326790|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
92326791|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92326792|NCT00002347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326793|NCT00001237|Molgramostim|molgramostim|mesh-list
92326794|NCT00001237|Sargramostim|sargramostim|mesh-list
92326795|NCT00001237|Immunologic Factors|immunologic factors|mesh-ancestor
92326796|NCT00001237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326797|NCT00001237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326798|NCT00001933|Nefiracetam|nefiracetam|mesh-list
92326799|NCT00001933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92326800|NCT00001933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92326801|NCT00001933|Protective Agents|protective agents|mesh-ancestor
92326802|NCT00001933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326803|NCT00001933|Nootropic Agents|nootropic agents|mesh-ancestor
92326804|NCT00001249|Antibodies|antibodies|mesh-list
92326805|NCT00001249|Immunologic Factors|immunologic factors|mesh-ancestor
92326806|NCT00001249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326807|NCT00380575|Conivaptan|conivaptan|mesh-list
92326808|NCT00380575|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92326809|NCT00380575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326810|NCT00380575|Natriuretic Agents|natriuretic agents|mesh-ancestor
92326811|NCT00380575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326812|NCT00001963|Chrysarobin|chrysarobin|mesh-list
92326813|NCT00001963|Nitric Oxide|nitric oxide|mesh-list
92326814|NCT00001963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92326815|NCT00001963|Autonomic Agents|autonomic agents|mesh-ancestor
92326816|NCT00001963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001826|NCT04417062|Olaparib|olaparib|mesh-list
92326817|NCT00001963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326818|NCT00001963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92326819|NCT00001963|Respiratory System Agents|respiratory system agents|mesh-ancestor
92326820|NCT00001963|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92326821|NCT00001963|Antioxidants|antioxidants|mesh-ancestor
92326822|NCT00001963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326823|NCT00001963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92326824|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92326825|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
92326826|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
92326827|NCT00001963|Protective Agents|protective agents|mesh-ancestor
92326828|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92326829|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92326830|NCT00001963|Analgesics|analgesics|mesh-ancestor
92326831|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
92326832|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92326833|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92326834|NCT00002377|Valganciclovir|valganciclovir|mesh-list
92326835|NCT00002377|Ganciclovir|ganciclovir|mesh-list
92326836|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92326837|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
92326838|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326839|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326840|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326841|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326842|NCT00001339|Doxorubicin|doxorubicin|mesh-list
92326843|NCT00001339|Etoposide|etoposide|mesh-list
92326844|NCT00001339|Vincristine|vincristine|mesh-list
92326845|NCT00001339|Mitotane|mitotane|mesh-list
92326846|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92326847|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326848|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92326849|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326850|NCT00001339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326851|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326852|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92326853|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
92326854|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
92326855|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
92326856|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92326857|NCT00001993|Miglustat|miglustat|mesh-list
92326858|NCT00001993|Zidovudine|zidovudine|mesh-list
92326859|NCT00001993|Antimetabolites|antimetabolites|mesh-ancestor
92326860|NCT00001993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326861|NCT00001993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326862|NCT00001993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326863|NCT00001993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326864|NCT00001993|Antiviral Agents|antiviral agents|mesh-ancestor
92326865|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326866|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326867|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326868|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92326869|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92326870|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326871|NCT00001999|Ganciclovir|ganciclovir|mesh-list
92326872|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92326874|NCT00001999|Antibodies|antibodies|mesh-list
92326875|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
92326876|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326877|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326878|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326879|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326880|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
92326881|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326882|NCT00002383|Saquinavir|saquinavir|mesh-list
92326883|NCT00002383|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92326884|NCT00002383|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92326885|NCT00002383|Protease Inhibitors|protease inhibitors|mesh-ancestor
92326886|NCT00002383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326887|NCT00002383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326888|NCT00002383|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326889|NCT00002383|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326890|NCT00002383|Antiviral Agents|antiviral agents|mesh-ancestor
92326891|NCT00002383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326892|NCT00002383|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92326893|NCT00002383|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92326894|NCT00002389|Lamivudine|lamivudine|mesh-list
92326895|NCT00002389|Zidovudine|zidovudine|mesh-list
92326896|NCT00002389|Abacavir|abacavir|mesh-list
92326897|NCT00002389|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326898|NCT00002389|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326899|NCT00002389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326900|NCT00002389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326901|NCT00002389|Antiviral Agents|antiviral agents|mesh-ancestor
92326902|NCT00002389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326903|NCT00002389|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326904|NCT00002389|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326905|NCT00002389|Antimetabolites|antimetabolites|mesh-ancestor
92326906|NCT00001357|Interleukin-2|interleukin-2|mesh-list
92326907|NCT00001357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326908|NCT00001357|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92326909|NCT00001357|Analgesics|analgesics|mesh-ancestor
92326910|NCT00001357|Sensory System Agents|sensory system agents|mesh-ancestor
92326911|NCT00001357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326912|NCT00001357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326914|NCT00001381|Antinematodal Agents|antinematodal agents|mesh-ancestor
92326915|NCT00001381|Anthelmintics|anthelmintics|mesh-ancestor
92326916|NCT00001381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326917|NCT00001381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326918|NCT00001381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326919|NCT00001381|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92326920|NCT00001381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326921|NCT00002011|Methoxsalen|methoxsalen|mesh-list
92326922|NCT00002011|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92326923|NCT00002011|Dermatologic Agents|dermatologic agents|mesh-ancestor
92326924|NCT00002017|Interleukin-2|interleukin-2|mesh-list
92326925|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326926|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92326927|NCT00002017|Analgesics|analgesics|mesh-ancestor
92326928|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
92326929|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92326930|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326931|NCT00002023|Zidovudine|zidovudine|mesh-list
92326932|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
92326933|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326934|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326935|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326936|NCT00002023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326937|NCT00002023|Antiviral Agents|antiviral agents|mesh-ancestor
92326938|NCT00002023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326939|NCT00002023|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326940|NCT00002023|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326941|NCT00002029|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92326942|NCT00002029|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92326943|NCT00002029|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92326944|NCT00002029|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92326945|NCT00002035|Zidovudine|zidovudine|mesh-list
92326946|NCT00002035|Didanosine|didanosine|mesh-list
92326947|NCT00002035|Antimetabolites|antimetabolites|mesh-ancestor
92326948|NCT00002035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326949|NCT00002035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326950|NCT00002035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326951|NCT00002035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326952|NCT00002035|Antiviral Agents|antiviral agents|mesh-ancestor
92326953|NCT00002035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326954|NCT00002035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326955|NCT00002035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326957|NCT00002041|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92326958|NCT00002041|Amebicides|amebicides|mesh-ancestor
92326959|NCT00002041|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326960|NCT00002041|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326961|NCT00002041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326962|NCT00002041|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92326963|NCT00002041|Antifungal Agents|antifungal agents|mesh-ancestor
92326964|NCT00002047|Zidovudine|zidovudine|mesh-list
92326965|NCT00002047|Antimetabolites|antimetabolites|mesh-ancestor
92326966|NCT00002047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326967|NCT00002047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92326968|NCT00002047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92326969|NCT00002047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326970|NCT00002047|Antiviral Agents|antiviral agents|mesh-ancestor
92326971|NCT00002047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326972|NCT00002047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92326973|NCT00002047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92326974|NCT00002053|Pentamidine|pentamidine|mesh-list
92326975|NCT00002053|Antifungal Agents|antifungal agents|mesh-ancestor
92326976|NCT00002053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326977|NCT00002053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92326978|NCT00002053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92326979|NCT00002053|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92326980|NCT00002059|Inosine Pranobex|inosine pranobex|mesh-list
92326982|NCT00002059|Immunologic Factors|immunologic factors|mesh-ancestor
92326983|NCT00002059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92326984|NCT00002059|Antiviral Agents|antiviral agents|mesh-ancestor
92326985|NCT00002059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92326986|NCT00002065|Disulfiram|disulfiram|mesh-list
92326987|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92326988|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92326989|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326990|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326991|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
92326992|NCT00002071|Hematinics|hematinics|mesh-ancestor
92326993|NCT00002395|Topotecan|topotecan|mesh-list
92326994|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92326995|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92326996|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92326997|NCT00002395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92326998|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92326999|NCT00002401|Lamivudine|lamivudine|mesh-list
92327000|NCT00002401|Zidovudine|zidovudine|mesh-list
92327001|NCT00002401|Delavirdine|delavirdine|mesh-list
92327002|NCT00002401|Indinavir|indinavir|mesh-list
92327003|NCT00002401|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327004|NCT00002401|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327005|NCT00002401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327006|NCT00002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327007|NCT00002401|Antiviral Agents|antiviral agents|mesh-ancestor
92327008|NCT00002401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327009|NCT00002401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327010|NCT00002401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327011|NCT00002401|Antimetabolites|antimetabolites|mesh-ancestor
92327012|NCT00002401|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327013|NCT00002401|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327014|NCT00002401|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327015|NCT00002407|Lamivudine|lamivudine|mesh-list
92327016|NCT00002407|Nevirapine|nevirapine|mesh-list
92327017|NCT00002407|Didanosine|didanosine|mesh-list
92327018|NCT00002407|Stavudine|stavudine|mesh-list
92327019|NCT00002407|Indinavir|indinavir|mesh-list
92327020|NCT00002407|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327021|NCT00002407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327022|NCT00002407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327023|NCT00002407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327024|NCT00002407|Antiviral Agents|antiviral agents|mesh-ancestor
92327025|NCT00002407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327026|NCT00002407|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327028|NCT00002407|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92327029|NCT00002407|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92327030|NCT00002407|Antimetabolites|antimetabolites|mesh-ancestor
92327031|NCT00002407|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327032|NCT00002407|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327033|NCT00002407|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327034|NCT00002413|Emivirine|emivirine|mesh-list
92327035|NCT00002413|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327036|NCT00002413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327037|NCT00002413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327038|NCT00002413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327039|NCT00002413|Antiviral Agents|antiviral agents|mesh-ancestor
92327040|NCT00002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327041|NCT00002419|Efavirenz|efavirenz|mesh-list
92327042|NCT00002419|Abacavir|abacavir|mesh-list
92327043|NCT00002419|Adefovir|adefovir|mesh-list
92327044|NCT00002419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92327045|NCT00002419|Amprenavir|amprenavir|mesh-list
92327046|NCT00002419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327047|NCT00002419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327048|NCT00002419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327049|NCT00002419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327050|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
92327051|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327052|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92327053|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327054|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91979698|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
92327055|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92327056|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92327057|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92327058|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327059|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327060|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92327061|NCT00002419|Antitubercular Agents|antitubercular agents|mesh-ancestor
92327062|NCT00002419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327063|NCT00002419|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327064|NCT00002419|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327065|NCT00002419|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327066|NCT00381511|Heparin|heparin|mesh-list
92327067|NCT00381511|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92327068|NCT00381511|Tinzaparin|tinzaparin|mesh-list
92327069|NCT00381511|Dalteparin|dalteparin|mesh-list
92327070|NCT00381511|Anticoagulants|anticoagulants|mesh-ancestor
92327071|NCT00381511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92327072|NCT00381511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92327073|NCT00381511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327074|NCT00002425|Saquinavir|saquinavir|mesh-list
92327075|NCT00002425|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327076|NCT00002425|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327077|NCT00002425|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327078|NCT00002425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327079|NCT00002425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327080|NCT00002425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327081|NCT00002425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327082|NCT00002425|Antiviral Agents|antiviral agents|mesh-ancestor
92327083|NCT00002425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327084|NCT00002425|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92327085|NCT00002425|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327086|NCT00002431|Chlorhexidine|chlorhexidine|mesh-list
92327087|NCT00002431|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92327088|NCT00002431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92327089|NCT00002431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327090|NCT00002431|Disinfectants|disinfectants|mesh-ancestor
92327091|NCT00002431|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327092|NCT00002077|Fluconazole|fluconazole|mesh-list
92327093|NCT00002077|Antifungal Agents|antifungal agents|mesh-ancestor
92327094|NCT00002077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327095|NCT00002077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92327096|NCT00002077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327097|NCT00002077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327098|NCT00002077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327099|NCT00002077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92327100|NCT00002077|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327101|NCT00002077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327102|NCT00002077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327103|NCT00002077|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92327104|NCT00002077|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92327106|NCT00002089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327107|NCT00002089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327108|NCT00002095|Ganciclovir|ganciclovir|mesh-list
92327109|NCT00002095|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92327110|NCT00002095|Antiviral Agents|antiviral agents|mesh-ancestor
92327111|NCT00002095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327112|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327113|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327114|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327115|NCT00002101|Clarithromycin|clarithromycin|mesh-list
92327117|NCT00002101|Rifabutin|rifabutin|mesh-list
92327118|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327119|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327120|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92327121|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327122|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327123|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92327124|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327125|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
92327126|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92327127|NCT02335424|Pembrolizumab|pembrolizumab|mesh-list
92327128|NCT02335424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92327129|NCT02335424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327130|NCT02335424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92327131|NCT02335424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327132|NCT00002107|Aldesleukin|aldesleukin|mesh-list
92327133|NCT00002107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327134|NCT00002107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327135|NCT00002107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327136|NCT00002107|Antiviral Agents|antiviral agents|mesh-ancestor
92327137|NCT00002107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327138|NCT00002113|Fluconazole|fluconazole|mesh-list
92327139|NCT00002113|Flucytosine|flucytosine|mesh-list
92327140|NCT00002113|Antifungal Agents|antifungal agents|mesh-ancestor
92327141|NCT00002113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327142|NCT00002113|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92327143|NCT00002113|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327144|NCT00002113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327145|NCT00002113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327146|NCT00002113|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92327147|NCT00002113|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327148|NCT00002113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327149|NCT00002113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327150|NCT00002113|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92327151|NCT00002113|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92327152|NCT00002113|Antimetabolites|antimetabolites|mesh-ancestor
92327153|NCT00002437|Cidofovir|cidofovir|mesh-list
92327154|NCT00002437|Probenecid|probenecid|mesh-list
92327155|NCT00002437|Uricosuric Agents|uricosuric agents|mesh-ancestor
92327156|NCT00002437|Gout Suppressants|gout suppressants|mesh-ancestor
92327157|NCT00002437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327159|NCT00002437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327160|NCT00002437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349339|NCT01499160|Everolimus|everolimus|mesh-list
92327161|NCT00002437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327163|NCT04329650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92327164|NCT04329650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92327165|NCT04329650|Prednisolone|prednisolone|mesh-list
92327166|NCT04329650|Prednisolone acetate|prednisolone acetate|mesh-list
92327167|NCT04329650|Siltuximab|siltuximab|mesh-list
92327168|NCT04329650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92327169|NCT04329650|Prednisolone phosphate|prednisolone phosphate|mesh-list
92327170|NCT04329650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92327171|NCT04329650|Antiemetics|antiemetics|mesh-ancestor
92327172|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
92327173|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327174|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327175|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92327176|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
92327177|NCT04329650|Hormones|hormones|mesh-ancestor
92327178|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327179|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92327180|NCT04329650|Protective Agents|protective agents|mesh-ancestor
92327181|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92327182|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327183|NCT00002443|Zidovudine|zidovudine|mesh-list
92327184|NCT00002443|Indinavir|indinavir|mesh-list
92327185|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
92327186|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327187|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327188|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327189|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327190|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
92327191|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327192|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327193|NCT00002443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327194|NCT00002443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327195|NCT00002443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327196|NCT00002443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327197|NCT00001561|Immunoglobulins|immunoglobulins|mesh-list
92327198|NCT00001561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92327199|NCT00001561|Antibodies|antibodies|mesh-list
92327200|NCT00001561|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
92327201|NCT00001561|Immunologic Factors|immunologic factors|mesh-ancestor
92327202|NCT00001561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327203|NCT00002449|Aldesleukin|aldesleukin|mesh-list
92327204|NCT00002449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327205|NCT00002449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327206|NCT00002449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327207|NCT00002449|Antiviral Agents|antiviral agents|mesh-ancestor
92327208|NCT00002449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327209|NCT00003014|Carboplatin|carboplatin|mesh-list
92327210|NCT00003014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327211|NCT00002125|Foscarnet|foscarnet|mesh-list
92327212|NCT00002125|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92327213|NCT00002125|Antiviral Agents|antiviral agents|mesh-ancestor
92327214|NCT00002125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327215|NCT00002125|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327216|NCT00002125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327217|NCT00002125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327218|NCT00002125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327219|NCT00001579|Leucovorin|leucovorin|mesh-list
92327220|NCT00001579|Fluorouracil|fluorouracil|mesh-list
92327221|NCT00001579|Eniluracil|eniluracil|mesh-list
92327222|NCT00001579|Antimetabolites|antimetabolites|mesh-ancestor
92327223|NCT00001579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327224|NCT00001579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92327225|NCT00001579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327226|NCT00001579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327227|NCT00001579|Immunologic Factors|immunologic factors|mesh-ancestor
92327228|NCT00001579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327229|NCT00001579|Antidotes|antidotes|mesh-ancestor
92327230|NCT00001579|Protective Agents|protective agents|mesh-ancestor
92327231|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
92327232|NCT00001579|Vitamins|vitamins|mesh-ancestor
92327233|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
92327234|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327235|NCT00003020|Immunotoxins|immunotoxins|mesh-list
92327236|NCT00003020|Immunoconjugates|immunoconjugates|mesh-ancestor
92327237|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
92327238|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327239|NCT00002131|Vesnarinone|vesnarinone|mesh-list
92327240|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92327241|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
92327242|NCT00002131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327243|NCT00002131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327244|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
92327245|NCT00002131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327246|NCT00002131|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92327247|NCT00002131|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92327248|NCT00002131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936880|NCT02264873|Decitabine|decitabine|mesh-list
92327249|NCT00002131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327250|NCT00002131|Protective Agents|protective agents|mesh-ancestor
92327251|NCT00380887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92327252|NCT00380887|Estrogens|estrogens|mesh-ancestor
92327253|NCT00380887|Hormones|hormones|mesh-ancestor
92327254|NCT00380887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327255|NCT00380887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327256|NCT00002461|Cyclophosphamide|cyclophosphamide|mesh-list
92327257|NCT00002461|Carmustine|carmustine|mesh-list
92327258|NCT00002461|Etoposide|etoposide|mesh-list
92327259|NCT00002461|Sargramostim|sargramostim|mesh-list
92327260|NCT00002461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327261|NCT00002461|Immunologic Factors|immunologic factors|mesh-ancestor
92327262|NCT00002461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327263|NCT00002461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327264|NCT00002461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327265|NCT00002461|Alkylating Agents|alkylating agents|mesh-ancestor
92327266|NCT00002461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327267|NCT00002461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327268|NCT00002461|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327269|NCT00002461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327270|NCT00002461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327271|NCT00002461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327272|NCT00002461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327273|NCT00003026|Bicalutamide|bicalutamide|mesh-list
92327274|NCT00003026|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92327275|NCT00003026|Flutamide|flutamide|mesh-list
92327276|NCT00003026|Androgen Antagonists|androgen antagonists|mesh-ancestor
92327277|NCT00003026|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327278|NCT00003026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913731|NCT03191721|Protective Agents|protective agents|mesh-ancestor
92327279|NCT00003026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327280|NCT00003026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327281|NCT00003026|Luteolytic Agents|luteolytic agents|mesh-ancestor
92327282|NCT00003026|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92327283|NCT00003026|Contraceptive Agents|contraceptive agents|mesh-ancestor
92327284|NCT00003026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92327285|NCT00003026|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92327286|NCT00003026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92327287|NCT00002143|Acitretin|acitretin|mesh-list
92327288|NCT00002143|Keratolytic Agents|keratolytic agents|mesh-ancestor
92327289|NCT00002143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327290|NCT00002149|Amoxicillin|amoxicillin|mesh-list
92327291|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
92327292|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
92327293|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
92327294|NCT00002149|Ephedrine|ephedrine|mesh-list
92327295|NCT00002149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327296|NCT00002149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327297|NCT00002149|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92327298|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349355|NCT01498068|Interferons|interferons|mesh-list
92327299|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327300|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92327301|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
92327302|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327303|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327304|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92327305|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
92327306|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
92327307|NCT00002149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92327308|NCT00002149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92327309|NCT00002149|Sympathomimetics|sympathomimetics|mesh-ancestor
92327310|NCT00002149|Adrenergic Agents|adrenergic agents|mesh-ancestor
92327311|NCT00002149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327312|NCT03868046|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92327313|NCT03868046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327314|NCT03868046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92327315|NCT03868046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327316|NCT02973295|Silymarin|silymarin|mesh-list
92327317|NCT02973295|Antioxidants|antioxidants|mesh-ancestor
92327318|NCT02973295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327319|NCT02973295|Protective Agents|protective agents|mesh-ancestor
92327320|NCT02973295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327321|NCT00003032|Tamoxifen|tamoxifen|mesh-list
92327322|NCT00003032|Cyclophosphamide|cyclophosphamide|mesh-list
92327323|NCT00003032|Mitoxantrone|mitoxantrone|mesh-list
92327324|NCT00003032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327325|NCT00003032|Immunologic Factors|immunologic factors|mesh-ancestor
92327326|NCT00003032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327327|NCT00003032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327328|NCT00003032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327329|NCT00003032|Alkylating Agents|alkylating agents|mesh-ancestor
92327330|NCT00003032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327331|NCT00003032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327332|NCT00003032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327333|NCT00003032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92327334|NCT00003032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327335|NCT00003032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327336|NCT00003032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92327337|NCT00003032|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92327338|NCT00003032|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92327339|NCT00003032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92327340|NCT00003032|Analgesics|analgesics|mesh-ancestor
92327341|NCT00003032|Sensory System Agents|sensory system agents|mesh-ancestor
92327342|NCT00003032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327343|NCT00003032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327344|NCT00003032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327345|NCT00003032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327346|NCT00002155|Lamivudine|lamivudine|mesh-list
92327347|NCT00002155|Zidovudine|zidovudine|mesh-list
92327348|NCT00002155|Indinavir|indinavir|mesh-list
92327349|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327350|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327351|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914036|NCT04851548|Viscosupplements|viscosupplements|mesh-ancestor
92327352|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327353|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
92327354|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327355|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327356|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91980001|NCT05530395|Testosterone|testosterone|mesh-list
92327357|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
92327358|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327359|NCT00002155|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327360|NCT00002155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327362|NCT00003038|Doxorubicin|doxorubicin|mesh-list
92327363|NCT00003038|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92327364|NCT00003038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327365|NCT00003038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327366|NCT00003038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327367|NCT00003038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327368|NCT00003038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327369|NCT00003038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327370|NCT00003038|Antinematodal Agents|antinematodal agents|mesh-ancestor
92327371|NCT00003038|Anthelmintics|anthelmintics|mesh-ancestor
92327372|NCT00003038|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92327373|NCT00003038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327374|NCT00003038|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92327375|NCT00003038|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92327376|NCT00003044|Cisplatin|cisplatin|mesh-list
92327377|NCT00003044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327378|NCT00002161|Adefovir|adefovir|mesh-list
92327379|NCT00002161|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92327380|NCT00002161|Antiviral Agents|antiviral agents|mesh-ancestor
92327381|NCT00002161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327382|NCT00002161|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327383|NCT00002161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327384|NCT00002161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327385|NCT00002161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327386|NCT00002167|Tin etiopurpurin|tin etiopurpurin|mesh-list
92327387|NCT00002167|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92327388|NCT00002167|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327389|NCT03805022|Doxorubicin|doxorubicin|mesh-list
92327390|NCT03805022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92327391|NCT03805022|Ifosfamide|ifosfamide|mesh-list
92327392|NCT03805022|Isophosphamide mustard|isophosphamide mustard|mesh-list
92327393|NCT03805022|Dacarbazine|dacarbazine|mesh-list
92327394|NCT03805022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327395|NCT03805022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327396|NCT03805022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327397|NCT03805022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327398|NCT03805022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327399|NCT03805022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327400|NCT03805022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327401|NCT03805022|Alkylating Agents|alkylating agents|mesh-ancestor
92327403|NCT05752435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327404|NCT05752435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327405|NCT00003050|Tamoxifen|tamoxifen|mesh-list
92327406|NCT00003050|Paclitaxel|paclitaxel|mesh-list
92327407|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
92327408|NCT00003050|Doxorubicin|doxorubicin|mesh-list
92327409|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92327410|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327411|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327412|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92327413|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92327414|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92327415|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327416|NCT00003050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327417|NCT00003050|Immunologic Factors|immunologic factors|mesh-ancestor
92327418|NCT00003050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327419|NCT00003050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327420|NCT00003050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327421|NCT00003050|Alkylating Agents|alkylating agents|mesh-ancestor
92327422|NCT00003050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327423|NCT00003050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327424|NCT00003050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327425|NCT00003050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327426|NCT00003050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327427|NCT00003050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92327428|NCT00003050|Hormone Antagonists|hormone antagonists|mesh-ancestor
91914037|NCT04851548|Protective Agents|protective agents|mesh-ancestor
92327429|NCT00003050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327430|NCT00003050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92327431|NCT00003050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92327432|NCT00003050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92327433|NCT00003050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92327434|NCT00002179|Lamivudine|lamivudine|mesh-list
92327435|NCT00002179|Zidovudine|zidovudine|mesh-list
92327436|NCT00002179|Indinavir|indinavir|mesh-list
92327437|NCT00002179|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327438|NCT00002179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327439|NCT00002179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327440|NCT00002179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327441|NCT00002179|Antiviral Agents|antiviral agents|mesh-ancestor
92327442|NCT00002179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327443|NCT00002179|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327444|NCT00002179|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327445|NCT00002179|Antimetabolites|antimetabolites|mesh-ancestor
92327446|NCT00002179|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327447|NCT00002179|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327448|NCT00002179|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327449|NCT00003056|Cyclosporine|cyclosporine|mesh-list
92327450|NCT00003056|Methotrexate|methotrexate|mesh-list
92327451|NCT00003056|Cyclosporins|cyclosporins|mesh-list
92327452|NCT00003056|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92327453|NCT00003056|Abortifacient Agents|abortifacient agents|mesh-ancestor
92327454|NCT00003056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92327455|NCT00003056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327456|NCT00003056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92327457|NCT00003056|Antimetabolites|antimetabolites|mesh-ancestor
92327458|NCT00003056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327459|NCT00003056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327460|NCT00003056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327461|NCT00003056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327462|NCT00003056|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92327463|NCT00003056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327464|NCT00003056|Immunologic Factors|immunologic factors|mesh-ancestor
92327465|NCT00003056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327466|NCT00003056|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327467|NCT00003056|Antifungal Agents|antifungal agents|mesh-ancestor
92327468|NCT00003056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327469|NCT00003056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92327471|NCT00002185|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327472|NCT00002185|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327473|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327474|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327475|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327476|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327477|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327478|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
92327479|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327480|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
92327481|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92327482|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92327483|NCT00003062|Temozolomide|temozolomide|mesh-list
92327484|NCT00003062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327485|NCT00003062|Alkylating Agents|alkylating agents|mesh-ancestor
92327486|NCT00003062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327487|NCT00003062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327488|NCT00002191|Albendazole|albendazole|mesh-list
92327489|NCT00002191|Anthelmintics|anthelmintics|mesh-ancestor
92327490|NCT00002191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92327491|NCT00002191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327492|NCT00002191|Anticestodal Agents|anticestodal agents|mesh-ancestor
92327493|NCT00002191|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92327494|NCT00002191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92327495|NCT00002191|Tubulin Modulators|tubulin modulators|mesh-ancestor
92327496|NCT00002191|Antimitotic Agents|antimitotic agents|mesh-ancestor
92327497|NCT00002191|Mitosis Modulators|mitosis modulators|mesh-ancestor
92327498|NCT00002191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327499|NCT00002191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327500|NCT00383396|Cyclosporine|cyclosporine|mesh-list
92327501|NCT00383396|Cyclosporins|cyclosporins|mesh-list
92327502|NCT00383396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327503|NCT00383396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327504|NCT00383396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980152|NCT02576145|Daclizumab|daclizumab|mesh-list
92327505|NCT00383396|Immunologic Factors|immunologic factors|mesh-ancestor
92327506|NCT00383396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327507|NCT00383396|Antifungal Agents|antifungal agents|mesh-ancestor
92327508|NCT00383396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327509|NCT00383396|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327510|NCT00383396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327511|NCT00383396|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92327513|NCT00002197|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327514|NCT00002197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327515|NCT00002197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327516|NCT00002197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327517|NCT00002197|Antiviral Agents|antiviral agents|mesh-ancestor
92327518|NCT00002197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327519|NCT00002197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327520|NCT00002197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327521|NCT00003068|Cyclophosphamide|cyclophosphamide|mesh-list
92327522|NCT00003068|Thiotepa|thiotepa|mesh-list
92327523|NCT00003068|Mitoxantrone|mitoxantrone|mesh-list
92327524|NCT00003068|Amifostine|amifostine|mesh-list
92327525|NCT00003068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327526|NCT00003068|Immunologic Factors|immunologic factors|mesh-ancestor
92327527|NCT00003068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327528|NCT00003068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327529|NCT00003068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327530|NCT00003068|Alkylating Agents|alkylating agents|mesh-ancestor
92327531|NCT00003068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327532|NCT00003068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327533|NCT00003068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327534|NCT00003068|Analgesics|analgesics|mesh-ancestor
92327535|NCT00003068|Sensory System Agents|sensory system agents|mesh-ancestor
92327536|NCT00003068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327537|NCT00003068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327538|NCT00003068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327539|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327540|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92327541|NCT00003068|Protective Agents|protective agents|mesh-ancestor
92327542|NCT00003080|Tamoxifen|tamoxifen|mesh-list
92327543|NCT00003080|Melphalan|melphalan|mesh-list
92327544|NCT00003080|Thiotepa|thiotepa|mesh-list
92327545|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
92327546|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327547|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327548|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
92327549|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327550|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327551|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327552|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
92327553|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327554|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92327555|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327556|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327557|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92327558|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92327559|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92327560|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92327561|NCT00003080|Analgesics|analgesics|mesh-ancestor
92327562|NCT00003080|Sensory System Agents|sensory system agents|mesh-ancestor
92327563|NCT00003080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327564|NCT00003080|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327565|NCT00003080|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327566|NCT00003080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327567|NCT00002203|Lamivudine|lamivudine|mesh-list
92327568|NCT00002203|Zidovudine|zidovudine|mesh-list
92327569|NCT00002203|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92327570|NCT00002203|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327571|NCT00002203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327572|NCT00002203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327573|NCT00002203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327574|NCT00002203|Antiviral Agents|antiviral agents|mesh-ancestor
92327575|NCT00002203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327576|NCT00002203|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327577|NCT00002203|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327578|NCT00002203|Antimetabolites|antimetabolites|mesh-ancestor
92327579|NCT01568918|Tamsulosin|tamsulosin|mesh-list
92327580|NCT01568918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92327581|NCT01568918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92327583|NCT01568918|Adrenergic Agents|adrenergic agents|mesh-ancestor
92327584|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327585|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327636|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327637|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
92327638|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327639|NCT00381199|Antiemetics|antiemetics|mesh-ancestor
92327640|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
92327641|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92327642|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92327643|NCT00381199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92327644|NCT00381199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92327645|NCT00002509|Cyclophosphamide|cyclophosphamide|mesh-list
92327646|NCT00002509|Carboplatin|carboplatin|mesh-list
92327647|NCT00002509|Etoposide|etoposide|mesh-list
92327648|NCT00002509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327649|NCT00002509|Immunologic Factors|immunologic factors|mesh-ancestor
92327650|NCT00002509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327651|NCT00002509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327652|NCT00002509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327653|NCT00002509|Alkylating Agents|alkylating agents|mesh-ancestor
92327654|NCT00002509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327655|NCT00002509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327656|NCT00002509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327657|NCT00002509|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327658|NCT00002509|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327659|NCT00002509|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327660|NCT00002509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327661|NCT00002515|Carboplatin|carboplatin|mesh-list
92327662|NCT00002515|Topotecan|topotecan|mesh-list
92327663|NCT00002515|Thiotepa|thiotepa|mesh-list
92327664|NCT00002515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327665|NCT00002515|Immunologic Factors|immunologic factors|mesh-ancestor
92327666|NCT00002515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327667|NCT00002515|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92327668|NCT00002515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327669|NCT00002515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327670|NCT00002515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327671|NCT00002515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327672|NCT00002515|Alkylating Agents|alkylating agents|mesh-ancestor
92327673|NCT00002515|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327674|NCT00002515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327675|NCT00002521|Cyclophosphamide|cyclophosphamide|mesh-list
92327676|NCT00002521|Etoposide|etoposide|mesh-list
92327677|NCT00002521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327678|NCT00002521|Immunologic Factors|immunologic factors|mesh-ancestor
92327679|NCT00002521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327680|NCT00002521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327681|NCT00002521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92349399|NCT01474746|Sertraline|sertraline|mesh-list
92327682|NCT00002521|Alkylating Agents|alkylating agents|mesh-ancestor
92327683|NCT00002521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327684|NCT00002521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327685|NCT00002521|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327686|NCT00002521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327687|NCT00002521|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327688|NCT00002521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327689|NCT00002521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327690|NCT00003110|Bleomycin|bleomycin|mesh-list
92327691|NCT00003110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327692|NCT00003110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327694|NCT00002215|Emivirine|emivirine|mesh-list
92327695|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327696|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327697|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327698|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327699|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327700|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327701|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327702|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
92327703|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327704|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91914038|NCT02706951|Methotrexate|methotrexate|mesh-list
92327705|NCT00002215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327706|NCT00003116|Cyclosporine|cyclosporine|mesh-list
92327707|NCT00003116|Cyclophosphamide|cyclophosphamide|mesh-list
92327708|NCT00003116|Busulfan|busulfan|mesh-list
92327709|NCT00003116|Cyclosporins|cyclosporins|mesh-list
92327710|NCT00003116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327711|NCT00003116|Immunologic Factors|immunologic factors|mesh-ancestor
92327712|NCT00003116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327713|NCT00003116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327714|NCT00003116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327715|NCT00003116|Alkylating Agents|alkylating agents|mesh-ancestor
92327716|NCT00003116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327717|NCT00003116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327718|NCT00003116|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327719|NCT00003116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327720|NCT00003116|Antifungal Agents|antifungal agents|mesh-ancestor
92327721|NCT00003116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327722|NCT00003116|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327723|NCT00003116|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92327724|NCT00002227|Lamivudine|lamivudine|mesh-list
92327725|NCT00002227|Efavirenz|efavirenz|mesh-list
92327726|NCT00002227|Stavudine|stavudine|mesh-list
92327727|NCT00002227|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327728|NCT00002227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327729|NCT00002227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327730|NCT00002227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327731|NCT00002227|Antiviral Agents|antiviral agents|mesh-ancestor
91980374|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327732|NCT00002227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327733|NCT00002227|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327734|NCT00002227|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327735|NCT00002227|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92327736|NCT00002227|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327737|NCT00002227|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92327738|NCT00002227|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92327739|NCT00002227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92327740|NCT00002227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92327741|NCT00002227|Antimetabolites|antimetabolites|mesh-ancestor
92327742|NCT03689972|Natalizumab|natalizumab|mesh-list
92327743|NCT03689972|Immunologic Factors|immunologic factors|mesh-ancestor
92327744|NCT03689972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327745|NCT00002233|Lamivudine|lamivudine|mesh-list
92327746|NCT00002233|Abacavir|abacavir|mesh-list
92327747|NCT00002233|Indinavir|indinavir|mesh-list
92327748|NCT00002233|Amprenavir|amprenavir|mesh-list
92349406|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327749|NCT00002233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327750|NCT00002233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327751|NCT00002233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327752|NCT00002233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327753|NCT00002233|Antiviral Agents|antiviral agents|mesh-ancestor
92327754|NCT00002233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327755|NCT00002233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327756|NCT00002233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327757|NCT00002233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327758|NCT00002233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327759|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327760|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92327761|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
92327762|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327763|NCT00002527|Aspirin|aspirin|mesh-list
92327764|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92327765|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92327766|NCT00002527|Analgesics|analgesics|mesh-ancestor
92327767|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
92327768|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327769|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327770|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92327772|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92327773|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92327774|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327775|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92327776|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92327777|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327778|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
92327779|NCT00002533|Fluconazole|fluconazole|mesh-list
92327780|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
92327781|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327782|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92327783|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327784|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327785|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327786|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92327787|NCT00002533|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327788|NCT00002533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327789|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327790|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92327791|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92327792|NCT00002539|Doxorubicin|doxorubicin|mesh-list
92327793|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92327794|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327795|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327796|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327797|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327798|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327799|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327800|NCT00381589|Bromides|bromides|mesh-list
92327801|NCT00381589|Ipratropium|ipratropium|mesh-list
92327802|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
92327803|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92327804|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
91980458|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
92327805|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327806|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327807|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92327808|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
92327809|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92327810|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
92327811|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92327812|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327813|NCT00002239|Ritonavir|ritonavir|mesh-list
92327814|NCT00002239|Amprenavir|amprenavir|mesh-list
92327815|NCT00002239|Abacavir|abacavir|mesh-list
92327816|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
92327818|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327819|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327820|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327821|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327822|NCT00002239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327823|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327824|NCT00002239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327825|NCT00002239|Antiviral Agents|antiviral agents|mesh-ancestor
92327826|NCT00002239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327827|NCT00002239|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92327828|NCT00002239|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92327829|NCT00002239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327830|NCT00002239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327831|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92327832|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92327833|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92327834|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92327835|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92327836|NCT00002239|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92327837|NCT00002239|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92327838|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92327839|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
92327840|NCT00002239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327842|NCT00383474|Tipifarnib|tipifarnib|mesh-list
92327843|NCT00383474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327844|NCT00002245|Lamivudine|lamivudine|mesh-list
92327845|NCT00002245|Abacavir|abacavir|mesh-list
92327846|NCT00002245|Amprenavir|amprenavir|mesh-list
92327847|NCT00002245|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92327848|NCT00002245|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327849|NCT00002245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327850|NCT00002245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327851|NCT00002245|Antiviral Agents|antiviral agents|mesh-ancestor
92327852|NCT00002245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327853|NCT00002245|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327854|NCT00002245|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327855|NCT00002245|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92327856|NCT00002245|Antitubercular Agents|antitubercular agents|mesh-ancestor
92327857|NCT00002245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92327858|NCT00002245|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92327859|NCT00002245|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92327860|NCT00002245|Protease Inhibitors|protease inhibitors|mesh-ancestor
92327861|NCT00003128|Paclitaxel|paclitaxel|mesh-list
92327862|NCT00003128|Ifosfamide|ifosfamide|mesh-list
92327863|NCT00003128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327864|NCT00003128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327865|NCT00003128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92327866|NCT00003128|Antimitotic Agents|antimitotic agents|mesh-ancestor
92327867|NCT00003128|Mitosis Modulators|mitosis modulators|mesh-ancestor
92327868|NCT00003128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327869|NCT00003128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327870|NCT00003128|Alkylating Agents|alkylating agents|mesh-ancestor
92327871|NCT04331197|Letrozole|letrozole|mesh-list
92327872|NCT04331197|Clomiphene|clomiphene|mesh-list
92327873|NCT04331197|Enclomiphene|enclomiphene|mesh-list
92327874|NCT04331197|Zuclomiphene|zuclomiphene|mesh-list
92327875|NCT04331197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327876|NCT04331197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327877|NCT04331197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92327878|NCT04331197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91980523|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
92327879|NCT04331197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327880|NCT04331197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92327881|NCT04331197|Hormone Antagonists|hormone antagonists|mesh-ancestor
92327882|NCT04331197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327883|NCT04331197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327884|NCT04331197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92327885|NCT04331197|Fertility Agents|fertility agents|mesh-ancestor
92327886|NCT04331197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92327887|NCT04331197|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92327888|NCT04331197|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92327889|NCT05751733|Sunitinib|sunitinib|mesh-list
92327890|NCT05751733|Imatinib Mesylate|imatinib mesylate|mesh-list
92327891|NCT05751733|Apatinib|apatinib|mesh-list
92327892|NCT05751733|Dasatinib|dasatinib|mesh-list
92327893|NCT05751733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327894|NCT05751733|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92327895|NCT05751733|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92327896|NCT05751733|Growth Substances|growth substances|mesh-ancestor
92327897|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327898|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
92327899|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92327900|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327901|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327902|NCT00002798|Cytarabine|cytarabine|mesh-list
92327903|NCT00002798|Aldesleukin|aldesleukin|mesh-list
92327904|NCT00002798|Dexamethasone|dexamethasone|mesh-list
92327905|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
92327906|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92327907|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92327908|NCT00002798|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92327909|NCT00002798|Cyclophosphamide|cyclophosphamide|mesh-list
92327910|NCT00002798|Busulfan|busulfan|mesh-list
92327911|NCT00002798|Methotrexate|methotrexate|mesh-list
92327912|NCT00002798|Fludarabine|fludarabine|mesh-list
92327913|NCT00002798|Fludarabine phosphate|fludarabine phosphate|mesh-list
92327914|NCT00002798|Etoposide|etoposide|mesh-list
92327915|NCT00002798|Etoposide phosphate|etoposide phosphate|mesh-list
92327917|NCT00002798|Interleukin-2|interleukin-2|mesh-list
92327918|NCT00002798|Asparaginase|asparaginase|mesh-list
92327919|NCT00002798|Idarubicin|idarubicin|mesh-list
92327920|NCT00002798|Thioguanine|thioguanine|mesh-list
92327921|NCT00002798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92327922|NCT00002798|Immunologic Factors|immunologic factors|mesh-ancestor
92327923|NCT00002798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92327924|NCT00002798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92327925|NCT00002798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327926|NCT00002798|Alkylating Agents|alkylating agents|mesh-ancestor
92327927|NCT00002798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327928|NCT00002798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327929|NCT00002798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92327930|NCT00002798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92327932|NCT00002798|Autonomic Agents|autonomic agents|mesh-ancestor
92327933|NCT00002798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92327934|NCT00002798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92327935|NCT00002798|Glucocorticoids|glucocorticoids|mesh-ancestor
92327936|NCT00002798|Hormones|hormones|mesh-ancestor
92327937|NCT00002798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92327938|NCT00002798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92327939|NCT00002798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92327940|NCT00002798|Abortifacient Agents|abortifacient agents|mesh-ancestor
92327941|NCT00002798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92327942|NCT00002798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92327943|NCT00002798|Antimetabolites|antimetabolites|mesh-ancestor
92327944|NCT00002798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92327945|NCT00002798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327946|NCT00002798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92327947|NCT00002798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327948|NCT00002798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92327949|NCT00002798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327950|NCT00002798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327951|NCT00002798|Antiviral Agents|antiviral agents|mesh-ancestor
92327952|NCT00002798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327953|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92327954|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92327955|NCT00002798|Analgesics|analgesics|mesh-ancestor
91980605|NCT02428751|Hormones|hormones|mesh-ancestor
92327956|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
92327957|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92327958|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92327959|NCT00002251|Ganciclovir|ganciclovir|mesh-list
92327960|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92327961|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
92327962|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349422|NCT02985606|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92327963|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327964|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327965|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327966|NCT00002257|Ganciclovir|ganciclovir|mesh-list
92327967|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92327968|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
92327969|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92327970|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92327971|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327972|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327973|NCT00003134|Irinotecan|irinotecan|mesh-list
92327974|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92327975|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327976|NCT00003134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327977|NCT00003134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327978|NCT00003134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327979|NCT00002545|Carmustine|carmustine|mesh-list
92327980|NCT00002545|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92327981|NCT00002545|Alkylating Agents|alkylating agents|mesh-ancestor
92327982|NCT00002545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327983|NCT00002545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327984|NCT00002804|Cobalt|cobalt|mesh-list
92327985|NCT00002804|Doxorubicin|doxorubicin|mesh-list
92327986|NCT00002804|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92327987|NCT00002804|Vincristine|vincristine|mesh-list
92327988|NCT00002804|Ifosfamide|ifosfamide|mesh-list
92327989|NCT00002804|Lenograstim|lenograstim|mesh-list
92327992|NCT00002804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92327993|NCT00002804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92327994|NCT00002804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92327995|NCT00002804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92327996|NCT00002804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92327997|NCT00002804|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92327998|NCT00002804|Immunologic Factors|immunologic factors|mesh-ancestor
92327999|NCT00002804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328000|NCT00002804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328001|NCT00002804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328002|NCT00002804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328003|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328004|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328005|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
92328006|NCT00002804|Protective Agents|protective agents|mesh-ancestor
92328007|NCT00002804|Trace Elements|trace elements|mesh-ancestor
92328008|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
92328009|NCT00002810|Melphalan|melphalan|mesh-list
92328010|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
92328011|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328012|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328013|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
92328014|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328015|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328016|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328017|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328018|NCT00003140|Letrozole|letrozole|mesh-list
92328019|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328020|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92328021|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92328022|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328023|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328024|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92328025|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
92328026|NCT00003140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328027|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328028|NCT00003392|Paclitaxel|paclitaxel|mesh-list
92328029|NCT00003392|Cyclophosphamide|cyclophosphamide|mesh-list
92328030|NCT00003392|Carboplatin|carboplatin|mesh-list
92328031|NCT00003392|Melphalan|melphalan|mesh-list
92328032|NCT00003392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328033|NCT00003392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328034|NCT00003392|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328035|NCT00003392|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328036|NCT00003392|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328037|NCT00003392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328038|NCT00003392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328039|NCT00003392|Immunologic Factors|immunologic factors|mesh-ancestor
92328040|NCT00003392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328041|NCT00003392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328042|NCT00003392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328043|NCT00003392|Alkylating Agents|alkylating agents|mesh-ancestor
92328044|NCT00003392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328045|NCT00002551|Leucovorin|leucovorin|mesh-list
92328046|NCT00002551|Levamisole|levamisole|mesh-list
92328047|NCT00002551|Fluorouracil|fluorouracil|mesh-list
92328048|NCT00002551|Calcium|calcium|mesh-list
92328049|NCT00002551|Levoleucovorin|levoleucovorin|mesh-list
92328050|NCT00002551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92328051|NCT00002551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328052|NCT00002551|Antimetabolites|antimetabolites|mesh-ancestor
92328053|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328054|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328056|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328057|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
92328058|NCT00002551|Antidotes|antidotes|mesh-ancestor
92328059|NCT00002551|Protective Agents|protective agents|mesh-ancestor
92328060|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328061|NCT00002551|Vitamins|vitamins|mesh-ancestor
92328062|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
92328063|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92328064|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
92328065|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
92328066|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92328067|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328068|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328070|NCT00003146|Busulfan|busulfan|mesh-list
92328071|NCT00003146|Thiotepa|thiotepa|mesh-list
92328072|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328073|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
92328074|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328075|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328076|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328077|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328078|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
92328079|NCT00003146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328080|NCT00003398|Cyclophosphamide|cyclophosphamide|mesh-list
92328081|NCT00003398|Thiotepa|thiotepa|mesh-list
92328082|NCT00003398|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92328083|NCT00003398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328084|NCT00003398|Immunologic Factors|immunologic factors|mesh-ancestor
92328085|NCT00003398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328086|NCT00003398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328087|NCT00003398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328088|NCT00003398|Alkylating Agents|alkylating agents|mesh-ancestor
92328089|NCT00003398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328090|NCT00003398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328091|NCT00003398|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328092|NCT00002263|Zidovudine|zidovudine|mesh-list
92328093|NCT00002263|Sargramostim|sargramostim|mesh-list
92328094|NCT00002263|Antimetabolites|antimetabolites|mesh-ancestor
92328095|NCT00002263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328096|NCT00002263|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92328097|NCT00002263|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328098|NCT00002263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328099|NCT00002263|Antiviral Agents|antiviral agents|mesh-ancestor
92328100|NCT00002263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328101|NCT00002263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328102|NCT00002263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328103|NCT00002263|Immunologic Factors|immunologic factors|mesh-ancestor
92328104|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328105|NCT00002816|Leucovorin|leucovorin|mesh-list
92328106|NCT00002816|Cobalt|cobalt|mesh-list
91980745|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92328107|NCT00002816|Cytarabine|cytarabine|mesh-list
92328108|NCT00002816|Dexamethasone|dexamethasone|mesh-list
92328109|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
92328110|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92328111|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92328112|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92328113|NCT00002816|Methotrexate|methotrexate|mesh-list
92328114|NCT00002816|Etoposide|etoposide|mesh-list
92328115|NCT00002816|Vincristine|vincristine|mesh-list
92328116|NCT00002816|Asparaginase|asparaginase|mesh-list
92328117|NCT00002816|Ifosfamide|ifosfamide|mesh-list
92328118|NCT00002816|Idarubicin|idarubicin|mesh-list
92328119|NCT00002816|Pegaspargase|pegaspargase|mesh-list
92328120|NCT00002816|Thioguanine|thioguanine|mesh-list
92328121|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
92328122|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328123|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
92328124|NCT00002816|Autonomic Agents|autonomic agents|mesh-ancestor
92328125|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92328126|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328127|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92328128|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
92328129|NCT00002816|Hormones|hormones|mesh-ancestor
92328130|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328132|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328133|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92328134|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
92328135|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92328136|NCT00002816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328137|NCT00002816|Antimetabolites|antimetabolites|mesh-ancestor
92328138|NCT00002816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328139|NCT00002816|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328140|NCT00002816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328141|NCT00002816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92328142|NCT00002816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328143|NCT00002816|Immunologic Factors|immunologic factors|mesh-ancestor
92328144|NCT00002816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328145|NCT00002816|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328146|NCT00002816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328147|NCT00002816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328148|NCT00002816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328150|NCT00002816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328151|NCT00002816|Antidotes|antidotes|mesh-ancestor
92328152|NCT00002816|Protective Agents|protective agents|mesh-ancestor
92328153|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328154|NCT00002816|Vitamins|vitamins|mesh-ancestor
92328155|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
92328156|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328157|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328158|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328159|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328160|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
92328161|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328162|NCT00002816|Trace Elements|trace elements|mesh-ancestor
92328163|NCT00002269|Zidovudine|zidovudine|mesh-list
92328164|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92328165|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
91914039|NCT02706951|Upadacitinib|upadacitinib|mesh-list
92328166|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328167|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92328168|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328169|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328170|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
92328171|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328172|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328173|NCT00002269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328174|NCT00002275|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92328175|NCT00002275|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92328176|NCT00002275|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92328177|NCT00002275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92328178|NCT00003152|Interferons|interferons|mesh-list
92328179|NCT00003152|Interferon-alpha|interferon-alpha|mesh-list
92328180|NCT00003152|Prednisone|prednisone|mesh-list
92328181|NCT00003152|Cyclophosphamide|cyclophosphamide|mesh-list
91980824|NCT03184493|Analgesics|analgesics|mesh-ancestor
92328182|NCT00003152|Vincristine|vincristine|mesh-list
92328183|NCT00003152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328184|NCT00003152|Immunologic Factors|immunologic factors|mesh-ancestor
92328185|NCT00003152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328186|NCT00003152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328187|NCT00003152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328188|NCT00003152|Alkylating Agents|alkylating agents|mesh-ancestor
92328189|NCT00003152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328190|NCT00003152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328191|NCT00003152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328192|NCT00003152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328195|NCT00003152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328196|NCT00003152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328197|NCT00003152|Antiviral Agents|antiviral agents|mesh-ancestor
92328198|NCT00003152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328199|NCT00003152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328200|NCT00003152|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328201|NCT00003152|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328202|NCT00003152|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328203|NCT05751421|Meloxicam|meloxicam|mesh-list
92328204|NCT05751421|Bupivacaine|bupivacaine|mesh-list
92328205|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92328206|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
92328207|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
92328208|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92328209|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328210|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
92328211|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92328212|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92328213|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92328214|NCT05751421|Analgesics|analgesics|mesh-ancestor
92328215|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328216|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328217|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92328218|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92328219|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328220|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328222|NCT00002822|Ifosfamide|ifosfamide|mesh-list
92328223|NCT00002822|Carboplatin|carboplatin|mesh-list
92328224|NCT00002822|Doxorubicin|doxorubicin|mesh-list
92328225|NCT00002822|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328226|NCT00002822|Etoposide|etoposide|mesh-list
92328227|NCT00002822|Vincristine|vincristine|mesh-list
92328228|NCT00002822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328229|NCT00002822|Immunologic Factors|immunologic factors|mesh-ancestor
92328230|NCT00002822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328231|NCT00002822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328232|NCT00002822|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328233|NCT00002822|Alkylating Agents|alkylating agents|mesh-ancestor
92328234|NCT00002822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328235|NCT00002822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328236|NCT00002822|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328237|NCT00002822|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328238|NCT00002822|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328239|NCT00002822|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328240|NCT00002822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328241|NCT00002822|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328242|NCT00002822|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328243|NCT00002822|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328244|NCT00002822|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328246|NCT00002281|Epoetin Alfa|epoetin alfa|mesh-list
92328247|NCT00002281|Antimetabolites|antimetabolites|mesh-ancestor
92328248|NCT00002281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328249|NCT00002281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92328250|NCT00002281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328251|NCT00002281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328252|NCT00002281|Antiviral Agents|antiviral agents|mesh-ancestor
92328253|NCT00002281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328254|NCT00002281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328255|NCT00002281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328256|NCT00002281|Hematinics|hematinics|mesh-ancestor
92328257|NCT00002287|Zidovudine|zidovudine|mesh-list
92328258|NCT00002287|Antimetabolites|antimetabolites|mesh-ancestor
92328259|NCT00002287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328260|NCT00002287|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92328261|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328262|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328263|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
92328264|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328265|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328266|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328267|NCT00002828|Fluorouracil|fluorouracil|mesh-list
92328268|NCT00002828|Raltitrexed|raltitrexed|mesh-list
92328269|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
92328270|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328271|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328272|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328273|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328274|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
92328275|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328276|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92328277|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328278|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
92328279|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328280|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92328281|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328282|NCT00384020|Paroxetine|paroxetine|mesh-list
92328283|NCT00384020|Escitalopram|escitalopram|mesh-list
92328284|NCT00384020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92328285|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92328286|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92328287|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328288|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92328289|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
92328290|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328291|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92328292|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
92328293|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92328294|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92328295|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92328296|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328297|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92328298|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92328299|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92328300|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328302|NCT00002557|Doxorubicin|doxorubicin|mesh-list
92328303|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328304|NCT00002557|Etoposide|etoposide|mesh-list
92328305|NCT00002557|Methotrexate|methotrexate|mesh-list
92328306|NCT00002557|Calcium|calcium|mesh-list
92328307|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
92328308|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328309|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328310|NCT00002557|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328311|NCT00002557|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328312|NCT00002557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328313|NCT00002557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328314|NCT00002557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92328315|NCT00002557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328316|NCT00002557|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92328317|NCT00002557|Abortifacient Agents|abortifacient agents|mesh-ancestor
92328318|NCT00002557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92328319|NCT00002557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328321|NCT00002557|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328322|NCT00002557|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92328323|NCT00002557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328324|NCT00002557|Immunologic Factors|immunologic factors|mesh-ancestor
92328325|NCT00002557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328326|NCT00002557|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328327|NCT00002557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328328|NCT00002557|Antidotes|antidotes|mesh-ancestor
92328329|NCT00002557|Protective Agents|protective agents|mesh-ancestor
92328330|NCT00002557|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328331|NCT00002557|Vitamins|vitamins|mesh-ancestor
92328332|NCT00002557|Micronutrients|micronutrients|mesh-ancestor
92328333|NCT00003158|Paclitaxel|paclitaxel|mesh-list
92328334|NCT00003158|Etoposide|etoposide|mesh-list
92328336|NCT00003158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328337|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328338|NCT00003158|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328339|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328340|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328341|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328342|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328343|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328344|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328345|NCT00003416|Interferons|interferons|mesh-list
92328346|NCT00003416|Interferon-alpha|interferon-alpha|mesh-list
92328347|NCT00003416|Dexamethasone|dexamethasone|mesh-list
92328348|NCT00003416|Melphalan|melphalan|mesh-list
92328349|NCT00003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328350|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
92328351|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
92328352|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92328353|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328354|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92328355|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
92328356|NCT00003416|Hormones|hormones|mesh-ancestor
92328357|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328358|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328359|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328360|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
92328361|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328362|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
92328363|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328364|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
92328365|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328366|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328367|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328368|NCT00002569|Vincristine|vincristine|mesh-list
92328369|NCT00002569|Lomustine|lomustine|mesh-list
92328370|NCT00002569|Procarbazine|procarbazine|mesh-list
92328371|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328372|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328373|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328374|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328375|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328376|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328377|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328378|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
92328379|NCT00002840|Vincristine|vincristine|mesh-list
92328380|NCT00002840|Lomustine|lomustine|mesh-list
92328381|NCT00002840|Procarbazine|procarbazine|mesh-list
92328382|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328383|NCT00002840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328384|NCT00002840|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328385|NCT00002840|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328386|NCT00002840|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328387|NCT00002840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328388|NCT00002840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328389|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
92328390|NCT00002846|Aldesleukin|aldesleukin|mesh-list
92328391|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328392|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328393|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328394|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
92328395|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328396|NCT05720767|Itraconazole|itraconazole|mesh-list
92328397|NCT05720767|Rifampin|rifampin|mesh-list
92328398|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
92328399|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328400|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92328401|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92328402|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328403|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328404|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92328405|NCT05720767|Hormone Antagonists|hormone antagonists|mesh-ancestor
92328406|NCT05720767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328407|NCT05720767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328408|NCT05720767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92328409|NCT05720767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92328410|NCT05720767|Antitubercular Agents|antitubercular agents|mesh-ancestor
92328411|NCT05720767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92328412|NCT05720767|Leprostatic Agents|leprostatic agents|mesh-ancestor
92328413|NCT05720767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328414|NCT05720767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92328415|NCT05720767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92328416|NCT05720767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92328417|NCT05720767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92328418|NCT05720767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92328419|NCT05720767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92328420|NCT05751031|Raltegravir Potassium|raltegravir potassium|mesh-list
92328421|NCT05751031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328422|NCT05751031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328423|NCT05751031|Antiviral Agents|antiviral agents|mesh-ancestor
92328424|NCT05751031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328425|NCT05751031|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92328426|NCT05751031|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92328427|NCT05751031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328428|NCT05751031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328429|NCT00002852|Paclitaxel|paclitaxel|mesh-list
92328430|NCT00002852|Carboplatin|carboplatin|mesh-list
92328431|NCT00002852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328432|NCT00002852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328433|NCT00002852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328434|NCT00002852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328435|NCT00002852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328436|NCT00002852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328437|NCT00003422|Leucovorin|leucovorin|mesh-list
92328438|NCT00003422|Fluorouracil|fluorouracil|mesh-list
92328439|NCT00003422|Calcium|calcium|mesh-list
92328440|NCT00003422|Levoleucovorin|levoleucovorin|mesh-list
92328441|NCT00003422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92328442|NCT00003422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328443|NCT00003422|Antimetabolites|antimetabolites|mesh-ancestor
92328444|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328445|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328446|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328447|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328448|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
92328449|NCT00003422|Antidotes|antidotes|mesh-ancestor
92328450|NCT00003422|Protective Agents|protective agents|mesh-ancestor
92328451|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328452|NCT00003422|Vitamins|vitamins|mesh-ancestor
92328453|NCT00003422|Micronutrients|micronutrients|mesh-ancestor
92328454|NCT00003176|Temozolomide|temozolomide|mesh-list
92328455|NCT00003176|Carmustine|carmustine|mesh-list
92328456|NCT00003176|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328457|NCT00003176|Alkylating Agents|alkylating agents|mesh-ancestor
92328458|NCT00003176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328459|NCT00003176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328460|NCT00002858|Cyclophosphamide|cyclophosphamide|mesh-list
92328461|NCT00002858|Doxorubicin|doxorubicin|mesh-list
92328462|NCT00002858|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328463|NCT00002858|Etoposide|etoposide|mesh-list
92328464|NCT00002858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328465|NCT00002858|Immunologic Factors|immunologic factors|mesh-ancestor
92328466|NCT00002858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328467|NCT00002858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328468|NCT00002858|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328469|NCT00002858|Alkylating Agents|alkylating agents|mesh-ancestor
92328470|NCT00002858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328471|NCT00002858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328472|NCT00002858|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91914113|NCT02429505|Antifungal Agents|antifungal agents|mesh-ancestor
92328473|NCT00002858|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328474|NCT00002858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328475|NCT00002858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328476|NCT00002858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328477|NCT00002858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328478|NCT00002864|Tamoxifen|tamoxifen|mesh-list
92328479|NCT00002864|Octreotide|octreotide|mesh-list
92328480|NCT00002864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92328481|NCT00002864|Hormone Antagonists|hormone antagonists|mesh-ancestor
92328482|NCT00002864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328483|NCT00002864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328484|NCT00002864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328485|NCT00002864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328486|NCT00002864|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92328487|NCT00002864|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92328488|NCT00002864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92328489|NCT00002864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92328490|NCT00002870|Cyclophosphamide|cyclophosphamide|mesh-list
92328491|NCT00002870|Thiotepa|thiotepa|mesh-list
92328492|NCT00002870|Fluorouracil|fluorouracil|mesh-list
92328493|NCT00002870|Epirubicin|epirubicin|mesh-list
92328494|NCT00002870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328495|NCT00002870|Immunologic Factors|immunologic factors|mesh-ancestor
92328496|NCT00002870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328497|NCT00002870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328498|NCT00002870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328499|NCT00002870|Alkylating Agents|alkylating agents|mesh-ancestor
92328500|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328501|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328502|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328503|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
92328504|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328505|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328506|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328507|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328508|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328509|NCT00002581|Tamoxifen|tamoxifen|mesh-list
92328510|NCT00002581|Cyclophosphamide|cyclophosphamide|mesh-list
92328511|NCT00002581|Fluorouracil|fluorouracil|mesh-list
92328512|NCT00002581|Methotrexate|methotrexate|mesh-list
92328513|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328514|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
92328515|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328516|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328517|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328518|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
92328519|NCT00002581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328520|NCT00002581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328521|NCT00002581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328522|NCT00002581|Antimetabolites|antimetabolites|mesh-ancestor
92328523|NCT00002581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328524|NCT00002581|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92328525|NCT00002581|Abortifacient Agents|abortifacient agents|mesh-ancestor
92328526|NCT00002581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92328527|NCT00002581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328528|NCT00002581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328529|NCT00002581|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92328530|NCT00002581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328531|NCT00002581|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92328532|NCT00002581|Hormone Antagonists|hormone antagonists|mesh-ancestor
92328533|NCT00002581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328534|NCT00002581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328535|NCT00002581|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92328536|NCT00002581|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92328537|NCT00002581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92328538|NCT00003182|Gemcitabine|gemcitabine|mesh-list
92328539|NCT00003182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328540|NCT00003182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328541|NCT00003182|Antimetabolites|antimetabolites|mesh-ancestor
92328542|NCT00003182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328544|NCT00002587|Topotecan|topotecan|mesh-list
92328545|NCT00002587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328546|NCT00002587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328547|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328548|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328549|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328550|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328551|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92328552|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328553|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328554|NCT00002876|Etoposide|etoposide|mesh-list
92328555|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328556|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328557|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328558|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328559|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328560|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328561|NCT00002593|Leucovorin|leucovorin|mesh-list
92328562|NCT00002593|Levamisole|levamisole|mesh-list
92328563|NCT00002593|Fluorouracil|fluorouracil|mesh-list
92328564|NCT00002593|Calcium|calcium|mesh-list
92328565|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
92328566|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92328567|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328568|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
92328569|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328570|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328571|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328572|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328573|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
92328574|NCT00002593|Antidotes|antidotes|mesh-ancestor
92328575|NCT00002593|Protective Agents|protective agents|mesh-ancestor
92328576|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328577|NCT00002593|Vitamins|vitamins|mesh-ancestor
92328578|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
92328579|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92328580|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
92328581|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
92328582|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92328583|NCT00002593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328584|NCT00002593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328585|NCT00003194|Cyclophosphamide|cyclophosphamide|mesh-list
92328587|NCT00003194|Carboplatin|carboplatin|mesh-list
92328589|NCT00003194|Topotecan|topotecan|mesh-list
92328590|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328591|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
92328592|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328593|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328594|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328595|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
92328596|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328597|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328598|NCT00003194|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328599|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328600|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328601|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328602|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328603|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92328604|NCT00002882|Interferons|interferons|mesh-list
92328605|NCT00002882|Interferon-alpha|interferon-alpha|mesh-list
92328606|NCT00002882|Interferon alpha-2|interferon alpha-2|mesh-list
92328607|NCT00002882|Aldesleukin|aldesleukin|mesh-list
92328608|NCT00002882|Cisplatin|cisplatin|mesh-list
92328609|NCT00002882|Interleukin-2|interleukin-2|mesh-list
92328610|NCT00002882|Dacarbazine|dacarbazine|mesh-list
92328611|NCT00002882|Vinblastine|vinblastine|mesh-list
92328612|NCT00002882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328613|NCT00002882|Antiviral Agents|antiviral agents|mesh-ancestor
92328614|NCT00002882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328615|NCT00002882|Immunologic Factors|immunologic factors|mesh-ancestor
92328616|NCT00002882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328617|NCT00002882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92328618|NCT00002882|Analgesics|analgesics|mesh-ancestor
92328619|NCT00002882|Sensory System Agents|sensory system agents|mesh-ancestor
92328620|NCT00002882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92328621|NCT00002882|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328622|NCT00002882|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328623|NCT00002882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328624|NCT00002882|Alkylating Agents|alkylating agents|mesh-ancestor
92328625|NCT00002882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914423|NCT03039842|Memantine|memantine|mesh-list
92328626|NCT00002882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328627|NCT00002882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328628|NCT00002882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328629|NCT00002882|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328630|NCT00002888|Paclitaxel|paclitaxel|mesh-list
92328631|NCT00002888|Fluorouracil|fluorouracil|mesh-list
92328632|NCT00002888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328633|NCT00002888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328634|NCT00002888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328635|NCT00002888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328636|NCT00002888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328637|NCT00002888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328638|NCT00002888|Antimetabolites|antimetabolites|mesh-ancestor
92328639|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328640|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328641|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
92328642|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328643|NCT00002599|Cobalt|cobalt|mesh-list
92349503|NCT01447446|Ribavirin|ribavirin|mesh-list
92328644|NCT00002599|Interferons|interferons|mesh-list
92328645|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
92328646|NCT00002599|Prednisone|prednisone|mesh-list
92328647|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
92328648|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
92328649|NCT00002599|Melphalan|melphalan|mesh-list
92328650|NCT00002599|Carmustine|carmustine|mesh-list
92328651|NCT00002599|Doxorubicin|doxorubicin|mesh-list
92328652|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328653|NCT00002599|Vincristine|vincristine|mesh-list
92328654|NCT00002599|Sargramostim|sargramostim|mesh-list
92328655|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328656|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
92328657|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328658|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328659|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328660|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
92328661|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328662|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328663|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328664|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936893|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
92328665|NCT00002599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328666|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328667|NCT00002599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328668|NCT00002599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328669|NCT00002599|Glucocorticoids|glucocorticoids|mesh-ancestor
92328670|NCT00002599|Hormones|hormones|mesh-ancestor
92328671|NCT00002599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328672|NCT00002599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328673|NCT00002599|Antiviral Agents|antiviral agents|mesh-ancestor
92328674|NCT00002599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328675|NCT00002599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328676|NCT00002599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328677|NCT00002599|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328678|NCT00002599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328679|NCT00002599|Antiemetics|antiemetics|mesh-ancestor
92328680|NCT00002599|Autonomic Agents|autonomic agents|mesh-ancestor
92328681|NCT00002599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92328682|NCT00002599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92328683|NCT00002599|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92328684|NCT00002599|Protective Agents|protective agents|mesh-ancestor
92328685|NCT00002599|Trace Elements|trace elements|mesh-ancestor
92328686|NCT00002599|Micronutrients|micronutrients|mesh-ancestor
92328687|NCT00003440|Paclitaxel|paclitaxel|mesh-list
92328688|NCT00003440|Trastuzumab|trastuzumab|mesh-list
92328689|NCT00003440|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328690|NCT00003440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328691|NCT00003440|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328692|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328693|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328694|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328695|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92328696|NCT00003200|Docetaxel|docetaxel|mesh-list
92328697|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328698|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328699|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328700|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328701|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328702|NCT00003446|Leucovorin|leucovorin|mesh-list
92328703|NCT00003446|Trimetrexate|trimetrexate|mesh-list
92328704|NCT00003446|Fluorouracil|fluorouracil|mesh-list
92328705|NCT00003446|Calcium|calcium|mesh-list
92328706|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
92328707|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92328708|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328709|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
92349512|NCT01447446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328710|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328711|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328712|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328713|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328714|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
92328715|NCT00003446|Antidotes|antidotes|mesh-ancestor
92328716|NCT00003446|Protective Agents|protective agents|mesh-ancestor
92328717|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328720|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
92328721|NCT00003446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328722|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92328723|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328724|NCT00003938|Amphotericin B|amphotericin b|mesh-list
92328725|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92328726|NCT00003938|Amebicides|amebicides|mesh-ancestor
92328727|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92328728|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92328729|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328730|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92328731|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
92328732|NCT00003212|Doxorubicin|doxorubicin|mesh-list
92328733|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328735|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328736|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328737|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328738|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328739|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328740|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328741|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328742|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
92328743|NCT00002611|Dactinomycin|dactinomycin|mesh-list
92328744|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
92328745|NCT00002611|Doxorubicin|doxorubicin|mesh-list
92328746|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328747|NCT00002611|Etoposide|etoposide|mesh-list
92328748|NCT00002611|Vincristine|vincristine|mesh-list
92328749|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328750|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
92328751|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328752|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328753|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328754|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
92328755|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328756|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328757|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328758|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328759|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328760|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328761|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328762|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328763|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328764|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328765|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328766|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92328767|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328768|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92328769|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92328770|NCT00003944|Paclitaxel|paclitaxel|mesh-list
92328771|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
92328772|NCT00003944|Carboplatin|carboplatin|mesh-list
92328773|NCT00003944|Topotecan|topotecan|mesh-list
92328774|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328775|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328776|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328777|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328778|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328779|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328780|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328781|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
92328782|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328783|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328784|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328785|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
92328786|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328787|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92328788|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328789|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328790|NCT00003950|Cyclosporine|cyclosporine|mesh-list
92328791|NCT00003950|Irinotecan|irinotecan|mesh-list
92328792|NCT00003950|Cyclosporins|cyclosporins|mesh-list
92328793|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92328794|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328796|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328797|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328798|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328799|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
92328800|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328801|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
92328802|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328803|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328804|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328805|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92328806|NCT00003464|Temozolomide|temozolomide|mesh-list
92328807|NCT00003464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328808|NCT00003464|Alkylating Agents|alkylating agents|mesh-ancestor
92328809|NCT00003464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328810|NCT00003464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328811|NCT00003230|Paclitaxel|paclitaxel|mesh-list
92328812|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328813|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328814|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328815|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328816|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328817|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328818|NCT00003956|Leucovorin|leucovorin|mesh-list
92328819|NCT00003956|Fluorouracil|fluorouracil|mesh-list
92328820|NCT00003956|Calcium|calcium|mesh-list
92328821|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
92328822|NCT00003956|Lonafarnib|lonafarnib|mesh-list
92328823|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92328824|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328825|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
92328826|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328827|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328828|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328829|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328830|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
92328831|NCT00003956|Antidotes|antidotes|mesh-ancestor
92328832|NCT00003956|Protective Agents|protective agents|mesh-ancestor
92328833|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
92328834|NCT00003956|Vitamins|vitamins|mesh-ancestor
92328835|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
92328836|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328837|NCT00002623|Carboplatin|carboplatin|mesh-list
92328838|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328839|NCT00003962|Aldesleukin|aldesleukin|mesh-list
92328840|NCT00003962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328841|NCT00003962|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92328842|NCT00003962|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92328843|NCT00003962|Antiviral Agents|antiviral agents|mesh-ancestor
92328844|NCT00003962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92328845|NCT00003968|Bryostatin 1|bryostatin 1|mesh-list
92328846|NCT00003968|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92328847|NCT00003968|Immunologic Factors|immunologic factors|mesh-ancestor
92328848|NCT00003968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328849|NCT00003968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328850|NCT00003974|Cyclophosphamide|cyclophosphamide|mesh-list
92328851|NCT00003974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328852|NCT00003974|Immunologic Factors|immunologic factors|mesh-ancestor
92328853|NCT00003974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328854|NCT00003974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328855|NCT00003974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328856|NCT00003974|Alkylating Agents|alkylating agents|mesh-ancestor
92328857|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328858|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328859|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328860|NCT00002635|Lenograstim|lenograstim|mesh-list
92328862|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
92328863|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328864|NCT00003242|Paclitaxel|paclitaxel|mesh-list
92328865|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
92328866|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328867|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328868|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981495|NCT05511831|Ketotifen|ketotifen|mesh-list
92328869|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328870|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328871|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328872|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92328873|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
92328874|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328875|NCT05664061|Fluticasone|fluticasone|mesh-list
92328876|NCT05664061|Xhance|xhance|mesh-list
92328877|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92328878|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92328879|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328880|NCT05664061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92328881|NCT05664061|Autonomic Agents|autonomic agents|mesh-ancestor
92328882|NCT05664061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92328883|NCT05664061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328884|NCT05664061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92328885|NCT05664061|Respiratory System Agents|respiratory system agents|mesh-ancestor
92328886|NCT05664061|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328887|NCT05664061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92328888|NCT05664061|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92328889|NCT05664061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92328890|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92328891|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92328892|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92328893|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328894|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
92328895|NCT05664061|Hormones|hormones|mesh-ancestor
92328896|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328897|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
92328898|NCT00003248|Rituximab|rituximab|mesh-list
92328899|NCT00003248|Fludarabine|fludarabine|mesh-list
92328900|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
92328901|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92328902|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328903|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
92328904|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328905|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328906|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328907|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
92349552|NCT01490190|NuvaRing|nuvaring|mesh-list
92328908|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328909|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328910|NCT05663905|Ambroxol|ambroxol|mesh-list
92328911|NCT05663905|Expectorants|expectorants|mesh-ancestor
92328912|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
92328913|NCT00002641|Doxorubicin|doxorubicin|mesh-list
92328914|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328915|NCT00002641|Ifosfamide|ifosfamide|mesh-list
92328916|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328917|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328918|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328919|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328920|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328921|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328922|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328923|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
92328924|NCT00003992|Tamoxifen|tamoxifen|mesh-list
92328925|NCT00003992|Paclitaxel|paclitaxel|mesh-list
92328926|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
92328928|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328929|NCT00003992|Trastuzumab|trastuzumab|mesh-list
92328930|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328931|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328932|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92328933|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92328934|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92328935|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328936|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328937|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
92328938|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328939|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328940|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328941|NCT00003992|Alkylating Agents|alkylating agents|mesh-ancestor
92328942|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328943|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92349556|NCT01490190|Contraceptive Agents|contraceptive agents|mesh-ancestor
92328944|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328945|NCT00003992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328946|NCT00003992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328947|NCT00003992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92328948|NCT00003992|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92328949|NCT00003992|Hormone Antagonists|hormone antagonists|mesh-ancestor
92328950|NCT00003992|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328951|NCT00003992|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328952|NCT00003992|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92328953|NCT00003992|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92328954|NCT00003992|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92328955|NCT00002647|Verteporfin|verteporfin|mesh-list
92328956|NCT00002647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92328957|NCT00002647|Dermatologic Agents|dermatologic agents|mesh-ancestor
92328958|NCT00002653|Prednisone|prednisone|mesh-list
92328959|NCT00002653|Cyclophosphamide|cyclophosphamide|mesh-list
92328960|NCT00002653|Melphalan|melphalan|mesh-list
92328961|NCT00002653|Carmustine|carmustine|mesh-list
92328962|NCT00002653|Doxorubicin|doxorubicin|mesh-list
92328963|NCT00002653|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92328964|NCT00002653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328965|NCT00002653|Immunologic Factors|immunologic factors|mesh-ancestor
92328966|NCT00002653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349611|NCT03026244|Vitamin D|vitamin d|mesh-list
92328967|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92328968|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92328969|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
92328970|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328971|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328972|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92328973|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92328974|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92328975|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92328976|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328977|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92328979|NCT00002653|Hormones|hormones|mesh-ancestor
92328980|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92328981|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92328982|NCT00003254|Fluorouracil|fluorouracil|mesh-list
92328983|NCT00003254|Eniluracil|eniluracil|mesh-list
92328984|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
92328985|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92328986|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92328987|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328988|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92328989|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
92328990|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92328991|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92328992|NCT00002659|Cisplatin|cisplatin|mesh-list
92328993|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328994|NCT00003998|Paclitaxel|paclitaxel|mesh-list
92328995|NCT00003998|Docetaxel|docetaxel|mesh-list
92328996|NCT00003998|Carboplatin|carboplatin|mesh-list
92328997|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92328998|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92328999|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329000|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329001|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329002|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329003|NCT00004004|Procarbazine|procarbazine|mesh-list
92329004|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329005|NCT00003260|Leucovorin|leucovorin|mesh-list
92329006|NCT00003260|Fluorouracil|fluorouracil|mesh-list
92329007|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
92329008|NCT00003260|Irinotecan|irinotecan|mesh-list
92329009|NCT00003260|Calcium|calcium|mesh-list
92329010|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
92329011|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92329012|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329013|NCT00003260|Antimetabolites|antimetabolites|mesh-ancestor
92329014|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329015|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329016|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329017|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329018|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
92329019|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92329020|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329021|NCT00003260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329022|NCT00003260|Antidotes|antidotes|mesh-ancestor
92329023|NCT00003260|Protective Agents|protective agents|mesh-ancestor
91981702|NCT02416739|Niacin|niacin|mesh-list
92329024|NCT00003260|Vitamin B Complex|vitamin b complex|mesh-ancestor
92329025|NCT00003260|Vitamins|vitamins|mesh-ancestor
92329026|NCT00003260|Micronutrients|micronutrients|mesh-ancestor
92329028|NCT00002665|Cytarabine|cytarabine|mesh-list
92329029|NCT00002665|Dexamethasone|dexamethasone|mesh-list
92329030|NCT00002665|Prednisone|prednisone|mesh-list
92329031|NCT00002665|Cyclophosphamide|cyclophosphamide|mesh-list
92329032|NCT00002665|Doxorubicin|doxorubicin|mesh-list
92329033|NCT00002665|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329034|NCT00002665|Methotrexate|methotrexate|mesh-list
92329035|NCT00002665|Etoposide|etoposide|mesh-list
92329036|NCT00002665|Vincristine|vincristine|mesh-list
92329037|NCT00002665|Daunorubicin|daunorubicin|mesh-list
92329038|NCT00002665|Asparaginase|asparaginase|mesh-list
92329039|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
92329040|NCT00002665|Thioguanine|thioguanine|mesh-list
92329041|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
92350033|NCT01428258|Coal Tar|coal tar|mesh-list
92329042|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329043|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
92329044|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329045|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329046|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329047|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
92329048|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329049|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329050|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329051|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329052|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
92329053|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
92329054|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329055|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329056|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
92329057|NCT00002665|Hormones|hormones|mesh-ancestor
92329058|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329059|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329060|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329061|NCT00002665|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329062|NCT00002665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329063|NCT00002665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329064|NCT00002665|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329065|NCT00002665|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329066|NCT00002665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329067|NCT00002665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329068|NCT00002665|Antimetabolites|antimetabolites|mesh-ancestor
92329069|NCT00002665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329070|NCT00002665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329071|NCT00002665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329072|NCT00002665|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329073|NCT00002665|Antiviral Agents|antiviral agents|mesh-ancestor
92329074|NCT00002665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329075|NCT00002665|Antidotes|antidotes|mesh-ancestor
92329076|NCT00002665|Protective Agents|protective agents|mesh-ancestor
92329077|NCT00002665|Vitamin B Complex|vitamin b complex|mesh-ancestor
92329078|NCT00002665|Vitamins|vitamins|mesh-ancestor
92329079|NCT00002665|Micronutrients|micronutrients|mesh-ancestor
92329080|NCT00002665|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329081|NCT00002665|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329082|NCT00002665|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329083|NCT00003536|Methotrexate|methotrexate|mesh-list
92329084|NCT00003536|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329085|NCT00003536|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329086|NCT00003536|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329087|NCT00003536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914424|NCT03039842|Dextromethorphan|dextromethorphan|mesh-list
92329088|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329089|NCT00003536|Antimetabolites|antimetabolites|mesh-ancestor
92329090|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329091|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329092|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329093|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329094|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329095|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329096|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
92329097|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329098|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91981713|NCT02416583|Oxytocin|oxytocin|mesh-list
92329100|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
92329101|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329102|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
92329103|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329104|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
92329105|NCT00003542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329106|NCT00004010|Prednisone|prednisone|mesh-list
92329107|NCT00004010|Cyclophosphamide|cyclophosphamide|mesh-list
92329108|NCT00004010|Dacarbazine|dacarbazine|mesh-list
92329109|NCT00004010|Doxorubicin|doxorubicin|mesh-list
92329110|NCT00004010|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329111|NCT00004010|Etoposide|etoposide|mesh-list
92329112|NCT00004010|Vincristine|vincristine|mesh-list
92329113|NCT00004010|Bleomycin|bleomycin|mesh-list
92329115|NCT00004010|Procarbazine|procarbazine|mesh-list
92329116|NCT00004010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329117|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
92329118|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329119|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329120|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329121|NCT00004010|Alkylating Agents|alkylating agents|mesh-ancestor
92329122|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329123|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329124|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329125|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329126|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329127|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329128|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329129|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350629|NCT04326738|Anesthetics|anesthetics|mesh-ancestor
92329130|NCT00004010|Glucocorticoids|glucocorticoids|mesh-ancestor
92329131|NCT00004010|Hormones|hormones|mesh-ancestor
92329132|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329133|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329134|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329135|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329136|NCT00004010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329137|NCT00004010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329138|NCT00004016|Interferons|interferons|mesh-list
92329139|NCT00004016|Interferon-gamma|interferon-gamma|mesh-list
92350713|NCT03599778|Apatinib|apatinib|mesh-list
92329140|NCT00004016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329141|NCT00004016|Antiviral Agents|antiviral agents|mesh-ancestor
92329142|NCT00004016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329143|NCT00004022|Aldesleukin|aldesleukin|mesh-list
92329144|NCT00004022|Muromonab-CD3|muromonab-cd3|mesh-list
92329145|NCT00004022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329146|NCT00004022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92329147|NCT00004022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92329148|NCT00004022|Antiviral Agents|antiviral agents|mesh-ancestor
92329149|NCT00004022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329150|NCT00004022|Immunologic Factors|immunologic factors|mesh-ancestor
92329151|NCT00004022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350762|NCT03594396|Durvalumab|durvalumab|mesh-list
92329152|NCT00004022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329154|NCT00381901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329155|NCT00381901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329156|NCT00003278|Dexamethasone|dexamethasone|mesh-list
92329157|NCT00003278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329158|NCT00003278|Antiemetics|antiemetics|mesh-ancestor
92329159|NCT00003278|Autonomic Agents|autonomic agents|mesh-ancestor
92329160|NCT00003278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329161|NCT00003278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329162|NCT00003278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329163|NCT00003278|Glucocorticoids|glucocorticoids|mesh-ancestor
92329164|NCT00003278|Hormones|hormones|mesh-ancestor
92117021|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92329165|NCT00003278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329166|NCT00003278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329167|NCT00003278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329168|NCT00004028|Carmustine|carmustine|mesh-list
92329169|NCT00004028|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329170|NCT00004028|Alkylating Agents|alkylating agents|mesh-ancestor
92329171|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329172|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329174|NCT00003554|Rituximab|rituximab|mesh-list
92329175|NCT00003554|Melphalan|melphalan|mesh-list
92329176|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329177|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329178|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
92329179|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329181|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329182|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
92329183|NCT00003554|Hormones|hormones|mesh-ancestor
92329184|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329185|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329186|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329187|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
92329188|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329189|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329190|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329192|NCT00003284|Etoposide|etoposide|mesh-list
92329193|NCT00003284|Carboplatin|carboplatin|mesh-list
92329194|NCT00003284|Ifosfamide|ifosfamide|mesh-list
92329195|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329196|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329197|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329198|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329199|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329200|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329201|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329202|NCT00003284|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329203|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329204|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329205|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
92329206|NCT00384410|Nabilone|nabilone|mesh-list
92329207|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
92329208|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
92329209|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329210|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329211|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329212|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92329213|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92329214|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92329215|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92329216|NCT00004040|Interferons|interferons|mesh-list
92329217|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
92329218|NCT00004040|Rituximab|rituximab|mesh-list
92329219|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329220|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329221|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
92329222|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329223|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329224|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
92329225|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329226|NCT00004046|Exatecan|exatecan|mesh-list
92329227|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92329228|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329229|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329230|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329231|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329232|NCT00003560|Carboplatin|carboplatin|mesh-list
92329233|NCT00003560|Docetaxel|docetaxel|mesh-list
92329234|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351081|NCT04028466|Omeprazole|omeprazole|mesh-list
92329235|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329236|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329237|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329238|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329239|NCT00003290|Hormones|hormones|mesh-list
92329240|NCT00003290|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329241|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329242|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
92329243|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92329244|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329245|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92329246|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329247|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
92329248|NCT00003572|Tacrolimus|tacrolimus|mesh-list
92329249|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329250|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
92329251|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329252|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92329253|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981867|NCT02414945|Analgesics|analgesics|mesh-ancestor
92329254|NCT00003572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329255|NCT00003572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329256|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329257|NCT00003572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92329258|NCT00003572|Antitubercular Agents|antitubercular agents|mesh-ancestor
92329259|NCT00003572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92329260|NCT00003572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329262|NCT00002689|Fluorouracil|fluorouracil|mesh-list
92329263|NCT00002689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329264|NCT00002689|Antiemetics|antiemetics|mesh-ancestor
92329265|NCT00002689|Autonomic Agents|autonomic agents|mesh-ancestor
92329266|NCT00002689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329267|NCT00002689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329268|NCT00002689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329269|NCT00002689|Glucocorticoids|glucocorticoids|mesh-ancestor
92329270|NCT00002689|Hormones|hormones|mesh-ancestor
92329271|NCT00002689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329272|NCT00002689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329273|NCT00002689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329274|NCT00002689|Antimetabolites|antimetabolites|mesh-ancestor
92329275|NCT00002689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329276|NCT00002689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329277|NCT00002689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329278|NCT00002689|Immunologic Factors|immunologic factors|mesh-ancestor
92329279|NCT00003296|Doxorubicin|doxorubicin|mesh-list
92329280|NCT00003296|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329281|NCT00003296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329282|NCT00003296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329283|NCT00003296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329284|NCT00003296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329285|NCT00003296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329286|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329287|NCT00004064|Oregovomab|oregovomab|mesh-list
92351341|NCT04145856|Alverine|alverine|mesh-list
92329288|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329289|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329290|NCT00382057|Anastrozole|anastrozole|mesh-list
92329291|NCT00382057|Goserelin|goserelin|mesh-list
92329292|NCT00382057|Testosterone|testosterone|mesh-list
92329293|NCT00382057|Androgens|androgens|mesh-ancestor
92329294|NCT00382057|Hormones|hormones|mesh-ancestor
92349498|NCT01491672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329295|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329296|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329297|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329298|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329299|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92329300|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92329301|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329302|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329303|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92329304|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
92329306|NCT00003578|Prednisone|prednisone|mesh-list
92329307|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
92329308|NCT00003578|Melphalan|melphalan|mesh-list
92329309|NCT00003578|Carmustine|carmustine|mesh-list
92329310|NCT00003578|Doxorubicin|doxorubicin|mesh-list
92329311|NCT00003578|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329312|NCT00003578|Etoposide|etoposide|mesh-list
92329313|NCT00003578|Vincristine|vincristine|mesh-list
92329314|NCT00003578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329315|NCT00003578|Immunologic Factors|immunologic factors|mesh-ancestor
92329316|NCT00003578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329317|NCT00003578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329318|NCT00003578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329319|NCT00003578|Alkylating Agents|alkylating agents|mesh-ancestor
92329320|NCT00003578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329321|NCT00003578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329322|NCT00003578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329323|NCT00003578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329324|NCT00003578|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329325|NCT00003578|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329326|NCT00003578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329327|NCT00003578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329328|NCT00003578|Glucocorticoids|glucocorticoids|mesh-ancestor
92329329|NCT00003578|Hormones|hormones|mesh-ancestor
92329330|NCT00003578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351567|NCT04149132|Protective Agents|protective agents|mesh-ancestor
92329331|NCT00003578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329332|NCT00003578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329333|NCT00003578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329334|NCT00003578|Antimetabolites|antimetabolites|mesh-ancestor
92329335|NCT00003578|Antiviral Agents|antiviral agents|mesh-ancestor
92329336|NCT00003578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329337|NCT00003578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329338|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329339|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329340|NCT00003584|Prednisone|prednisone|mesh-list
92329341|NCT00003584|Estramustine|estramustine|mesh-list
92329342|NCT00003584|Vinorelbine|vinorelbine|mesh-list
92351625|NCT04148820|Aspirin|aspirin|mesh-list
92329343|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329344|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
92329345|NCT00003584|Hormones|hormones|mesh-ancestor
92329346|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329347|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329348|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329349|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329350|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329351|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329352|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329353|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351690|NCT03587220|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92329354|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329355|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329356|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
92329357|NCT00002701|Cytarabine|cytarabine|mesh-list
92329358|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
92329359|NCT00002701|Busulfan|busulfan|mesh-list
92329360|NCT00002701|Methotrexate|methotrexate|mesh-list
92329361|NCT00002701|Etoposide|etoposide|mesh-list
92329362|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
92329363|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
92329364|NCT00002701|Idarubicin|idarubicin|mesh-list
92329365|NCT00002701|Tretinoin|tretinoin|mesh-list
92329366|NCT00002701|Thioguanine|thioguanine|mesh-list
92329367|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329368|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
92329369|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329370|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329371|NCT00002701|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329372|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
92329373|NCT00002701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329374|NCT00002701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329375|NCT00002701|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329376|NCT00002701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329377|NCT00002701|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329379|NCT00002701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329380|NCT00002701|Antimetabolites|antimetabolites|mesh-ancestor
92329381|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329382|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329383|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329384|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329385|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329386|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329387|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329388|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
92329389|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329390|NCT00002701|Analgesics|analgesics|mesh-ancestor
92329391|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
92329392|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329393|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329394|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
92329395|NCT00004070|Interleukin-12|interleukin-12|mesh-list
92329396|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92329397|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
92329398|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329399|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92329400|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92329401|NCT00004070|Growth Substances|growth substances|mesh-ancestor
92329402|NCT00004070|Growth Inhibitors|growth inhibitors|mesh-ancestor
92329403|NCT00004070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329404|NCT00004082|Carboplatin|carboplatin|mesh-list
92329405|NCT00004082|Gemcitabine|gemcitabine|mesh-list
92329406|NCT00004082|Docetaxel|docetaxel|mesh-list
92329407|NCT00004082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329408|NCT00004082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329409|NCT00004082|Antimetabolites|antimetabolites|mesh-ancestor
92329410|NCT00004082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329411|NCT00004082|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329412|NCT00004082|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329413|NCT00004082|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329415|NCT00002707|Cyclophosphamide|cyclophosphamide|mesh-list
92329416|NCT00002707|Docetaxel|docetaxel|mesh-list
92329417|NCT00002707|Doxorubicin|doxorubicin|mesh-list
92329418|NCT00002707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329419|NCT00002707|Immunologic Factors|immunologic factors|mesh-ancestor
92329420|NCT00002707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329421|NCT00002707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329422|NCT00002707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329423|NCT00002707|Alkylating Agents|alkylating agents|mesh-ancestor
92329424|NCT00002707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329425|NCT00002707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329426|NCT00002707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329427|NCT00002707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329428|NCT00002707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329429|NCT00002707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329430|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329431|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329432|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329433|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329434|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92329435|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
92349499|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329436|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329437|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329438|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92329439|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92329440|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92329441|NCT00003596|Fluorouracil|fluorouracil|mesh-list
92329442|NCT00003596|Mitomycins|mitomycins|mesh-list
92329443|NCT00003596|Mitomycin|mitomycin|mesh-list
92329444|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329445|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
92329446|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329447|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329448|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329449|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
92329450|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329451|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329452|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
92352268|NCT04747080|BB 1101|bb 1101|mesh-list
92329453|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329454|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329457|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
92329458|NCT00002719|Idarubicin|idarubicin|mesh-list
92329459|NCT00002719|Carmustine|carmustine|mesh-list
92329460|NCT00002719|Amsacrine|amsacrine|mesh-list
92329461|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329462|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329463|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329464|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329465|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349500|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
92329466|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329467|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329468|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
92329469|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
92329470|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329471|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329472|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
92329473|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329475|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
92329476|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329477|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329478|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329479|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
92329480|NCT00003326|Paclitaxel|paclitaxel|mesh-list
92352404|NCT03865212|Interferons|interferons|mesh-list
92329481|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329482|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329483|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329484|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329485|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329486|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329487|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
92329488|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92329489|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
92329490|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329491|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329493|NCT00003602|Etoposide|etoposide|mesh-list
92329494|NCT00003602|Mitoxantrone|mitoxantrone|mesh-list
92329495|NCT00003602|Idarubicin|idarubicin|mesh-list
92329496|NCT00003602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329497|NCT00003602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329498|NCT00003602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329499|NCT00003602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329500|NCT00003602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329501|NCT00003602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329502|NCT00003602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329503|NCT00003602|Antimetabolites|antimetabolites|mesh-ancestor
92329504|NCT00003602|Antiviral Agents|antiviral agents|mesh-ancestor
92329505|NCT00003602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329506|NCT00003602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329507|NCT00003602|Immunologic Factors|immunologic factors|mesh-ancestor
92329508|NCT00003602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329509|NCT00003602|Analgesics|analgesics|mesh-ancestor
92329510|NCT00003602|Sensory System Agents|sensory system agents|mesh-ancestor
92329511|NCT00003602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329512|NCT00003602|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329514|NCT04609423|Cod Liver Oil|cod liver oil|mesh-list
92329515|NCT04609423|Vitamins|vitamins|mesh-ancestor
92329516|NCT04609423|Micronutrients|micronutrients|mesh-ancestor
92329517|NCT04609423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329518|NCT04609423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92329519|NCT00003332|Gemcitabine|gemcitabine|mesh-list
92329520|NCT00003332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329521|NCT00003332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329522|NCT00003332|Antimetabolites|antimetabolites|mesh-ancestor
92329523|NCT00003332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329524|NCT00004094|Paclitaxel|paclitaxel|mesh-list
92329525|NCT00004094|Carboplatin|carboplatin|mesh-list
92329526|NCT00004094|Fluorouracil|fluorouracil|mesh-list
92329527|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
92329528|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329529|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329530|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329531|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329532|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329533|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329534|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
92329535|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329536|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329537|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
92329538|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329539|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
92329540|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329541|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329542|NCT00004100|Gemcitabine|gemcitabine|mesh-list
92329543|NCT00004100|Vinorelbine|vinorelbine|mesh-list
92329544|NCT00004100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329545|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329546|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
92329547|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329548|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329549|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329550|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329551|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329552|NCT00002737|Interferons|interferons|mesh-list
92329553|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
92329554|NCT00002737|Isotretinoin|isotretinoin|mesh-list
92329555|NCT00002737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329556|NCT00002737|Antiviral Agents|antiviral agents|mesh-ancestor
92329557|NCT00002737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329558|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
92329559|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329560|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329561|NCT00003338|Epratuzumab|epratuzumab|mesh-list
92329562|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329563|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329564|NCT00003620|Alvocidib|alvocidib|mesh-list
92329565|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329566|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
92329567|NCT00003620|Growth Substances|growth substances|mesh-ancestor
92329568|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329569|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92329570|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329571|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329573|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92329574|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329575|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329576|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329577|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329578|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
92329579|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329580|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329581|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329582|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329583|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329584|NCT00003632|Cytarabine|cytarabine|mesh-list
92329585|NCT00003632|Methotrexate|methotrexate|mesh-list
92329586|NCT00003632|Etoposide|etoposide|mesh-list
92329587|NCT00003632|Melphalan|melphalan|mesh-list
92329588|NCT00003632|Carmustine|carmustine|mesh-list
92329589|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329590|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329591|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92352833|NCT04403568|Analgesics|analgesics|mesh-ancestor
92329592|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329593|NCT00003632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329594|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
92329595|NCT00003632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329596|NCT00003632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329597|NCT00003632|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329598|NCT00003632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329599|NCT00003632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329600|NCT00003632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329601|NCT00003632|Immunologic Factors|immunologic factors|mesh-ancestor
92329602|NCT00003632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329603|NCT00003632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329604|NCT00003632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329605|NCT00003632|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329606|NCT00003632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329607|NCT00003632|Antiviral Agents|antiviral agents|mesh-ancestor
92329608|NCT00003632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329609|NCT00003632|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329610|NCT00003632|Alkylating Agents|alkylating agents|mesh-ancestor
92329611|NCT00003632|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329612|NCT00004112|Prednisone|prednisone|mesh-list
92329613|NCT00004112|Cyclophosphamide|cyclophosphamide|mesh-list
92329614|NCT00004112|Rituximab|rituximab|mesh-list
92329615|NCT00004112|Doxorubicin|doxorubicin|mesh-list
92329616|NCT00004112|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329617|NCT00004112|Vincristine|vincristine|mesh-list
92329618|NCT00004112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329619|NCT00004112|Immunologic Factors|immunologic factors|mesh-ancestor
92329620|NCT00004112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329621|NCT00004112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329622|NCT00004112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329623|NCT00004112|Alkylating Agents|alkylating agents|mesh-ancestor
92352942|NCT04403334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329624|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329625|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329626|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329627|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329628|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329629|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329630|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329631|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329632|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329633|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
92329634|NCT00004112|Hormones|hormones|mesh-ancestor
92329635|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329636|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329637|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329638|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329639|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329640|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329642|NCT00003350|Doxorubicin|doxorubicin|mesh-list
92329643|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329644|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329645|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329646|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329647|NCT00003350|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329648|NCT00003350|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329649|NCT00003350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329650|NCT00003350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329651|NCT00003350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329652|NCT00003350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329653|NCT00003350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329654|NCT05584267|Immunomodulating Agents|immunomodulating agents|mesh-list
92329655|NCT05584267|Immunologic Factors|immunologic factors|mesh-ancestor
92329656|NCT05584267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329657|NCT00003356|Aldesleukin|aldesleukin|mesh-list
92329658|NCT00003356|Rituximab|rituximab|mesh-list
92329659|NCT00003356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92329660|NCT00003356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353143|NCT00084864|Vitamins|vitamins|mesh-ancestor
92329661|NCT00003356|Immunologic Factors|immunologic factors|mesh-ancestor
92329662|NCT00003356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329663|NCT00003356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329664|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92329665|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92329666|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
92329667|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329668|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
92329669|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92329671|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329672|NCT00003638|Immunologic Factors|immunologic factors|mesh-ancestor
92329673|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329674|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329675|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329676|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
92329677|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329678|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329679|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329680|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92329681|NCT00004142|Fluorouracil|fluorouracil|mesh-list
92329682|NCT00004142|Floxuridine|floxuridine|mesh-list
92329683|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
92329684|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329685|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329686|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329687|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329688|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
92329689|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329690|NCT00002749|Carboplatin|carboplatin|mesh-list
92353343|NCT01679652|Nebivolol|nebivolol|mesh-list
92329691|NCT00002749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329692|NCT00003362|Sargramostim|sargramostim|mesh-list
92329693|NCT00003362|Freund's Adjuvant|freund's adjuvant|mesh-list
92329694|NCT00003362|Immunologic Factors|immunologic factors|mesh-ancestor
92329695|NCT00003362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329696|NCT00003362|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92329697|NCT00003650|Cytarabine|cytarabine|mesh-list
92329698|NCT00003650|Dexamethasone|dexamethasone|mesh-list
92329699|NCT00003650|Prednisone|prednisone|mesh-list
92329700|NCT00003650|Methylprednisolone|methylprednisolone|mesh-list
92329701|NCT00003650|Cyclophosphamide|cyclophosphamide|mesh-list
92329702|NCT00003650|Methotrexate|methotrexate|mesh-list
92329703|NCT00003650|Etoposide|etoposide|mesh-list
92329704|NCT00003650|Vincristine|vincristine|mesh-list
92329705|NCT00003650|Daunorubicin|daunorubicin|mesh-list
92329706|NCT00003650|Asparaginase|asparaginase|mesh-list
92329707|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
92329708|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
92329709|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329710|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
92329711|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329712|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329714|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
92329715|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329716|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329717|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329718|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329720|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
92329721|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329722|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329723|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
92329724|NCT00003650|Hormones|hormones|mesh-ancestor
92329725|NCT00003650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329726|NCT00003650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329727|NCT00003650|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329728|NCT00003650|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329729|NCT00003650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329730|NCT00003650|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329731|NCT00003650|Antimetabolites|antimetabolites|mesh-ancestor
92329732|NCT00003650|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329733|NCT00003650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329734|NCT00003650|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329735|NCT00003650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329736|NCT00003650|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329737|NCT00003650|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329738|NCT00003650|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329739|NCT00003650|Antiviral Agents|antiviral agents|mesh-ancestor
92329740|NCT00003650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329741|NCT00003650|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329742|NCT00003650|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329743|NCT00003650|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329744|NCT00003650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92329745|NCT00003650|Protective Agents|protective agents|mesh-ancestor
92329746|NCT00003650|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329747|NCT00003650|Analgesics|analgesics|mesh-ancestor
92329748|NCT00003650|Sensory System Agents|sensory system agents|mesh-ancestor
92329749|NCT00002755|Tamoxifen|tamoxifen|mesh-list
92329750|NCT00002755|Cobalt|cobalt|mesh-list
92329751|NCT00002755|Cyclophosphamide|cyclophosphamide|mesh-list
92329752|NCT00002755|Thiotepa|thiotepa|mesh-list
92329753|NCT00002755|Doxorubicin|doxorubicin|mesh-list
92329754|NCT00002755|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329755|NCT00002755|Fluorouracil|fluorouracil|mesh-list
92329756|NCT00002755|Methotrexate|methotrexate|mesh-list
92329757|NCT00002755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329758|NCT00002755|Immunologic Factors|immunologic factors|mesh-ancestor
92329759|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329760|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329761|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329762|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
92329763|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329764|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329765|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329766|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329767|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329768|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329769|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329770|NCT00002755|Antimetabolites|antimetabolites|mesh-ancestor
92329771|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329772|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329773|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329774|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329775|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92353774|NCT03292926|Hormones|hormones|mesh-ancestor
92329776|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329777|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329778|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92329779|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
92329780|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329781|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329782|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92329783|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92329784|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92329785|NCT00002755|Trace Elements|trace elements|mesh-ancestor
92329786|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
92329787|NCT00002761|Interferons|interferons|mesh-list
92329789|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
92329790|NCT00002761|Cyclosporine|cyclosporine|mesh-list
92329791|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
92329792|NCT00002761|Busulfan|busulfan|mesh-list
92329793|NCT00002761|Idarubicin|idarubicin|mesh-list
92329794|NCT00002761|Cyclosporins|cyclosporins|mesh-list
92329795|NCT00002761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329796|NCT00002761|Immunologic Factors|immunologic factors|mesh-ancestor
92329797|NCT00002761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329798|NCT00002761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329799|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329800|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
92329801|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329802|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329803|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329804|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
92329806|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329807|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
92329808|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329809|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
92329810|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329811|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92329812|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92329813|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329814|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329816|NCT00382135|Vasodilator Agents|vasodilator agents|mesh-ancestor
92329817|NCT00382135|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92329818|NCT00382135|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92329819|NCT00382135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329820|NCT00382135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329821|NCT00382135|Urological Agents|urological agents|mesh-ancestor
92329822|NCT00003662|Cyclosporine|cyclosporine|mesh-list
92329823|NCT00003662|Methylprednisolone|methylprednisolone|mesh-list
92329824|NCT00003662|Cyclophosphamide|cyclophosphamide|mesh-list
92329825|NCT00003662|Melphalan|melphalan|mesh-list
92329826|NCT00003662|Busulfan|busulfan|mesh-list
92329827|NCT00003662|Cyclosporins|cyclosporins|mesh-list
92329828|NCT00003662|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92329829|NCT00003662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329830|NCT00003662|Immunologic Factors|immunologic factors|mesh-ancestor
92329831|NCT00003662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329832|NCT00003662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329833|NCT00003662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329834|NCT00003662|Alkylating Agents|alkylating agents|mesh-ancestor
92329835|NCT00003662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329836|NCT00003662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329837|NCT00003662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329838|NCT00003662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329839|NCT00003662|Antifungal Agents|antifungal agents|mesh-ancestor
92329840|NCT00003662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329841|NCT00003662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329842|NCT00003662|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92329843|NCT00003662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329844|NCT00003662|Antiemetics|antiemetics|mesh-ancestor
92329845|NCT00003662|Autonomic Agents|autonomic agents|mesh-ancestor
92329846|NCT00003662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329847|NCT00003662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329848|NCT00003662|Glucocorticoids|glucocorticoids|mesh-ancestor
92329849|NCT00003662|Hormones|hormones|mesh-ancestor
92329850|NCT00003662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329851|NCT00003662|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92354228|NCT05240274|Metformin|metformin|mesh-list
92329852|NCT00003662|Protective Agents|protective agents|mesh-ancestor
92329853|NCT00004154|Fenretinide|fenretinide|mesh-list
92329854|NCT00004154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329855|NCT00004154|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92329856|NCT00004154|Protective Agents|protective agents|mesh-ancestor
92329857|NCT00004154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329859|NCT00002767|Interferon-alpha|interferon-alpha|mesh-list
92329860|NCT00002767|Detox adjuvant|detox adjuvant|mesh-list
92329861|NCT00002767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329862|NCT00002767|Antiviral Agents|antiviral agents|mesh-ancestor
92354296|NCT02914158|Tamoxifen|tamoxifen|mesh-list
92329863|NCT00002767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329864|NCT00002767|Immunologic Factors|immunologic factors|mesh-ancestor
92329865|NCT00002767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329866|NCT00002767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92329867|NCT00002773|Interferons|interferons|mesh-list
92329868|NCT00002773|Interferon-alpha|interferon-alpha|mesh-list
92329869|NCT00002773|Cyclophosphamide|cyclophosphamide|mesh-list
92329870|NCT00002773|Sargramostim|sargramostim|mesh-list
92329871|NCT00002773|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329872|NCT00002773|Immunologic Factors|immunologic factors|mesh-ancestor
92329873|NCT00002773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329874|NCT00002773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329875|NCT00002773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329876|NCT00002773|Alkylating Agents|alkylating agents|mesh-ancestor
92329877|NCT00002773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329878|NCT00002773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329879|NCT00002773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329880|NCT00002773|Antiviral Agents|antiviral agents|mesh-ancestor
92329881|NCT00002773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92329882|NCT00004160|Paclitaxel|paclitaxel|mesh-list
92329883|NCT00004160|Gemcitabine|gemcitabine|mesh-list
92329884|NCT00004160|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329885|NCT00004160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329886|NCT00004160|Tubulin Modulators|tubulin modulators|mesh-ancestor
92329887|NCT00004160|Antimitotic Agents|antimitotic agents|mesh-ancestor
92329888|NCT00004160|Mitosis Modulators|mitosis modulators|mesh-ancestor
92329889|NCT00004160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329890|NCT00004160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329891|NCT00004160|Antimetabolites|antimetabolites|mesh-ancestor
92329893|NCT00003368|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92329894|NCT00003368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329895|NCT00003368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329896|NCT00003368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329897|NCT00003368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329898|NCT00003674|Dalteparin|dalteparin|mesh-list
92329899|NCT00003674|Tinzaparin|tinzaparin|mesh-list
92329900|NCT00003674|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92329901|NCT00003674|Anticoagulants|anticoagulants|mesh-ancestor
92329902|NCT00003674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92329903|NCT00003674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92329904|NCT00003674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329905|NCT00003380|Doxorubicin|doxorubicin|mesh-list
92329906|NCT00003380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92329907|NCT00003380|Etoposide|etoposide|mesh-list
92329909|NCT00003380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329910|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92329911|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92329912|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329913|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329914|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92329915|NCT00002779|Fludarabine|fludarabine|mesh-list
92329916|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
92329917|NCT00002779|Octreotide|octreotide|mesh-list
92329918|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329919|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329920|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
92329921|NCT00002779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329922|NCT00002779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329923|NCT00002779|Immunologic Factors|immunologic factors|mesh-ancestor
92329924|NCT00002779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329925|NCT00002779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329926|NCT00002779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329927|NCT00003680|Tamoxifen|tamoxifen|mesh-list
92329928|NCT00003680|Cyclophosphamide|cyclophosphamide|mesh-list
92329929|NCT00003680|Thiotepa|thiotepa|mesh-list
92329930|NCT00003680|Fluorouracil|fluorouracil|mesh-list
92329931|NCT00003680|Methotrexate|methotrexate|mesh-list
92329932|NCT00003680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329934|NCT00003680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329935|NCT00003680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329936|NCT00003680|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329937|NCT00003680|Alkylating Agents|alkylating agents|mesh-ancestor
92329938|NCT00003680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329939|NCT00003680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329940|NCT00003680|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329941|NCT00003680|Antimetabolites|antimetabolites|mesh-ancestor
92354737|NCT01923948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92329942|NCT00003680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92329943|NCT00003680|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329944|NCT00003680|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329945|NCT00003680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329946|NCT00003680|Dermatologic Agents|dermatologic agents|mesh-ancestor
92329947|NCT00003680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92329948|NCT00003680|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92329949|NCT00003680|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92329950|NCT00003680|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92329951|NCT00003680|Hormone Antagonists|hormone antagonists|mesh-ancestor
92329952|NCT00003680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329953|NCT00003680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329954|NCT00003680|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92329955|NCT00003680|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92329956|NCT00003680|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92329957|NCT00002785|Leucovorin|leucovorin|mesh-list
92329958|NCT00002785|Cobalt|cobalt|mesh-list
92329959|NCT00002785|Cytarabine|cytarabine|mesh-list
92329960|NCT00002785|Cyclosporine|cyclosporine|mesh-list
92329961|NCT00002785|Dexamethasone|dexamethasone|mesh-list
92329962|NCT00002785|Prednisone|prednisone|mesh-list
92329963|NCT00002785|Methylprednisolone|methylprednisolone|mesh-list
92329964|NCT00002785|Hydrocortisone|hydrocortisone|mesh-list
92329965|NCT00002785|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92329966|NCT00002785|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92329967|NCT00002785|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92329968|NCT00002785|Cyclophosphamide|cyclophosphamide|mesh-list
92329969|NCT00002785|Methotrexate|methotrexate|mesh-list
92329970|NCT00002785|Etoposide|etoposide|mesh-list
92329971|NCT00002785|Vincristine|vincristine|mesh-list
92329972|NCT00002785|Daunorubicin|daunorubicin|mesh-list
92329973|NCT00002785|Asparaginase|asparaginase|mesh-list
92329974|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
92329975|NCT00002785|Pegaspargase|pegaspargase|mesh-list
92329976|NCT00002785|Cyclosporins|cyclosporins|mesh-list
92329977|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
92329978|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92329979|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
92329980|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92329981|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92329982|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92329983|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
92329984|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92329985|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92329986|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92329987|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92329988|NCT00002785|Antiemetics|antiemetics|mesh-ancestor
92329989|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
92329990|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92329991|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92329992|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
92329993|NCT00002785|Hormones|hormones|mesh-ancestor
92329994|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92329995|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92329996|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92329997|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
92329998|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92329999|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330000|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
92330001|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330002|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330003|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92330004|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330005|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330006|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330007|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330009|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330010|NCT00002785|Antidotes|antidotes|mesh-ancestor
92330011|NCT00002785|Protective Agents|protective agents|mesh-ancestor
92330012|NCT00002785|Vitamin B Complex|vitamin b complex|mesh-ancestor
92330013|NCT00002785|Vitamins|vitamins|mesh-ancestor
92330014|NCT00002785|Micronutrients|micronutrients|mesh-ancestor
92330015|NCT00002785|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330016|NCT00002785|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330017|NCT00002785|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330018|NCT00002785|Antifungal Agents|antifungal agents|mesh-ancestor
92330019|NCT00002785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92355196|NCT04760262|Sevoflurane|sevoflurane|mesh-list
92330020|NCT00002785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92330021|NCT00002785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330022|NCT00002785|Trace Elements|trace elements|mesh-ancestor
92330023|NCT00004184|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92330024|NCT00004184|Antibodies|antibodies|mesh-list
92330025|NCT00004184|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92330026|NCT00004184|Sargramostim|sargramostim|mesh-list
92330027|NCT00004184|Aluminum sulfate|aluminum sulfate|mesh-list
92330028|NCT00004184|Immunologic Factors|immunologic factors|mesh-ancestor
92330029|NCT00004184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330030|NCT00004184|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92330031|NCT00004184|Antacids|antacids|mesh-ancestor
92330032|NCT00004184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330033|NCT00004184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330034|NCT00003386|Paclitaxel|paclitaxel|mesh-list
92330035|NCT00003386|Cyclophosphamide|cyclophosphamide|mesh-list
92330037|NCT00003386|Vaccines|vaccines|mesh-list
92330038|NCT00003386|BCG Vaccine|bcg vaccine|mesh-list
92330039|NCT00003386|Immunologic Factors|immunologic factors|mesh-ancestor
92330040|NCT00003386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330041|NCT00003386|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330042|NCT00003386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330043|NCT00003386|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330044|NCT00003386|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330045|NCT00003386|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330046|NCT00003386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330047|NCT00003386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330048|NCT00003386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330049|NCT00003386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330050|NCT00003386|Alkylating Agents|alkylating agents|mesh-ancestor
92330051|NCT00003386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92330052|NCT00003386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92330053|NCT00384566|Metoprolol|metoprolol|mesh-list
92330054|NCT00384566|Carvedilol|carvedilol|mesh-list
92330055|NCT00384566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92330056|NCT00384566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92330057|NCT00384566|Sympatholytics|sympatholytics|mesh-ancestor
92330058|NCT00384566|Autonomic Agents|autonomic agents|mesh-ancestor
92330059|NCT00384566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330060|NCT00384566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330061|NCT00384566|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92330062|NCT00384566|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92330063|NCT00384566|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92330064|NCT00384566|Adrenergic Agents|adrenergic agents|mesh-ancestor
92330065|NCT00384566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330066|NCT00384566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330069|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92330070|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92330071|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330072|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
92330073|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92330074|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92330075|NCT00004832|Amifampridine|amifampridine|mesh-list
92330076|NCT00004832|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92330077|NCT00004832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330078|NCT00004832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330079|NCT00004832|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92330080|NCT00004832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349501|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330081|NCT00004832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330082|NCT00002791|Doxorubicin|doxorubicin|mesh-list
92330083|NCT00002791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92330084|NCT00002791|Ifosfamide|ifosfamide|mesh-list
92330085|NCT00002791|Dacarbazine|dacarbazine|mesh-list
92330086|NCT00002791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330087|NCT00002791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330088|NCT00002791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330089|NCT00002791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330090|NCT00002791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349502|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330091|NCT00002791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330092|NCT00002791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330093|NCT00002791|Alkylating Agents|alkylating agents|mesh-ancestor
92330094|NCT00004190|Gemcitabine|gemcitabine|mesh-list
92330095|NCT00004190|Oxaliplatin|oxaliplatin|mesh-list
92330096|NCT00004190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330098|NCT00004190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330099|NCT00004190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330100|NCT00004196|Interferons|interferons|mesh-list
92330101|NCT00004196|Interferon-alpha|interferon-alpha|mesh-list
92330102|NCT00004196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330103|NCT00004196|Antiviral Agents|antiviral agents|mesh-ancestor
92330104|NCT00004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330105|NCT00004196|Immunologic Factors|immunologic factors|mesh-ancestor
92330106|NCT00004196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330107|NCT00004838|Succimer|succimer|mesh-list
92330108|NCT00004838|Antidotes|antidotes|mesh-ancestor
92330109|NCT00004838|Protective Agents|protective agents|mesh-ancestor
92330110|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330111|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
92330112|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
92330113|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330114|NCT00004202|Paclitaxel|paclitaxel|mesh-list
92330115|NCT00004202|Carboplatin|carboplatin|mesh-list
92330116|NCT00004202|Efaproxiral|efaproxiral|mesh-list
92330117|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330118|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330119|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330120|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330121|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330122|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330123|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
92330124|NCT00003686|Pilocarpine|pilocarpine|mesh-list
92330125|NCT00003686|Miotics|miotics|mesh-ancestor
92330126|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
92330127|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330128|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330129|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92330130|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92330131|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
92330132|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330133|NCT00003686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330135|NCT05495035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330136|NCT05495035|Antiemetics|antiemetics|mesh-ancestor
92330137|NCT05495035|Autonomic Agents|autonomic agents|mesh-ancestor
92330138|NCT05495035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330139|NCT05495035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330140|NCT05495035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330141|NCT05495035|Glucocorticoids|glucocorticoids|mesh-ancestor
92330142|NCT05495035|Hormones|hormones|mesh-ancestor
92330143|NCT05495035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330144|NCT05495035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330145|NCT05495035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330146|NCT00004856|Trastuzumab|trastuzumab|mesh-list
92330147|NCT00004856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92330148|NCT00004856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330149|NCT00003698|Fosbretabulin|fosbretabulin|mesh-list
92330150|NCT00003698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330151|NCT00003698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330152|NCT00004862|Cytarabine|cytarabine|mesh-list
92330153|NCT00004862|Fludarabine|fludarabine|mesh-list
92330154|NCT00004862|Fludarabine phosphate|fludarabine phosphate|mesh-list
92330155|NCT00004862|Oblimersen|oblimersen|mesh-list
92330156|NCT00004862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330157|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330158|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
92330159|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330160|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330161|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
92330162|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330163|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
92330164|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330165|NCT00004220|Gemcitabine|gemcitabine|mesh-list
92330166|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
92330167|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330168|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
92330169|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330170|NCT00004220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330171|NCT00003704|Capecitabine|capecitabine|mesh-list
92330172|NCT00003704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330173|NCT00003704|Antimetabolites|antimetabolites|mesh-ancestor
92330174|NCT00003704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330175|NCT00003704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330177|NCT00004868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92330178|NCT00004868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92330179|NCT00004868|Growth Substances|growth substances|mesh-ancestor
92330180|NCT00004868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330181|NCT00004868|Growth Inhibitors|growth inhibitors|mesh-ancestor
92330182|NCT00004868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330183|NCT00004868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92330184|NCT00004868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330185|NCT00004868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330186|NCT00003710|Irinotecan|irinotecan|mesh-list
92330187|NCT00003710|Mitomycins|mitomycins|mesh-list
92330188|NCT00003710|Mitomycin|mitomycin|mesh-list
92330189|NCT00003710|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92330190|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330191|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330192|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330193|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330194|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330195|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
92330196|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330197|NCT00004232|Cyclosporine|cyclosporine|mesh-list
92330199|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
92330200|NCT00004232|Cyclosporins|cyclosporins|mesh-list
92330201|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330202|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
92330204|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330205|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330206|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330207|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330208|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
92330209|NCT00004232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330210|NCT00004232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330211|NCT00004232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330212|NCT00004232|Antifungal Agents|antifungal agents|mesh-ancestor
92330213|NCT00004232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330214|NCT00004232|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330215|NCT00004232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330216|NCT00004232|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92330217|NCT00004232|Antiemetics|antiemetics|mesh-ancestor
92330218|NCT00004232|Autonomic Agents|autonomic agents|mesh-ancestor
92330219|NCT00004232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330220|NCT00004232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330221|NCT00004232|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92330222|NCT00004232|Protective Agents|protective agents|mesh-ancestor
92330223|NCT00004874|Iodine|iodine|mesh-list
92330224|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
92330225|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92330226|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330227|NCT00004874|Trace Elements|trace elements|mesh-ancestor
92330228|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
92330229|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330230|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330231|NCT00004244|Interferons|interferons|mesh-list
92330232|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
92330233|NCT00004244|Interleukin-12|interleukin-12|mesh-list
92330234|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330235|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
92330236|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330237|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
92330238|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330239|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92330240|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92330241|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92330242|NCT00004244|Growth Substances|growth substances|mesh-ancestor
92330243|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
92330244|NCT00004880|Vaccines|vaccines|mesh-list
92330245|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
92330246|NCT00004880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330247|NCT00004250|Dactinomycin|dactinomycin|mesh-list
92330248|NCT00004250|Melphalan|melphalan|mesh-list
92330249|NCT00004250|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330250|NCT00004250|Alkylating Agents|alkylating agents|mesh-ancestor
92330251|NCT00004250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330252|NCT00004250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330253|NCT00004250|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92330254|NCT00004250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330255|NCT00004250|Immunologic Factors|immunologic factors|mesh-ancestor
92330256|NCT00004250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330257|NCT00004250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92330258|NCT00004250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330259|NCT00004250|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330260|NCT00004250|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92330261|NCT00004250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330262|NCT00004250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330264|NCT00003728|Cytarabine|cytarabine|mesh-list
92330265|NCT00003728|Dexamethasone|dexamethasone|mesh-list
92330266|NCT00003728|Methylprednisolone|methylprednisolone|mesh-list
92330267|NCT00003728|Prednisolone|prednisolone|mesh-list
92330268|NCT00003728|Hydrocortisone|hydrocortisone|mesh-list
92330269|NCT00003728|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92330270|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92330271|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92330272|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
92330273|NCT00003728|Doxorubicin|doxorubicin|mesh-list
92330274|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92330275|NCT00003728|Methotrexate|methotrexate|mesh-list
92330276|NCT00003728|Etoposide|etoposide|mesh-list
92330278|NCT00003728|Daunorubicin|daunorubicin|mesh-list
92330279|NCT00003728|Asparaginase|asparaginase|mesh-list
92330280|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
92330281|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
92330282|NCT00003728|Thioguanine|thioguanine|mesh-list
92330283|NCT00003728|Vindesine|vindesine|mesh-list
92330284|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
92330285|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330286|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
92330287|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330288|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330289|NCT00003728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330290|NCT00003728|Alkylating Agents|alkylating agents|mesh-ancestor
92330291|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330292|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330293|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92330294|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330295|NCT00003728|Antiemetics|antiemetics|mesh-ancestor
92330296|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
92330297|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330298|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330299|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
92330300|NCT00003728|Hormones|hormones|mesh-ancestor
92330301|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330302|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330303|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330304|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330305|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330306|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330307|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92330308|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
92330309|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92330310|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330311|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
92330312|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330313|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92330314|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330315|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330316|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
92330317|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330318|NCT00003728|Antidotes|antidotes|mesh-ancestor
92330319|NCT00003728|Protective Agents|protective agents|mesh-ancestor
92330320|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
92330321|NCT00003728|Vitamins|vitamins|mesh-ancestor
92330322|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
92330323|NCT00003728|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330324|NCT00003728|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330325|NCT00003728|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330326|NCT00003728|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92330327|NCT00003728|Analgesics|analgesics|mesh-ancestor
92330328|NCT00003728|Sensory System Agents|sensory system agents|mesh-ancestor
92330330|NCT00004886|Dofequidar|dofequidar|mesh-list
92330331|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330332|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330333|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330334|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330335|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330336|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92330337|NCT00003734|Flutamide|flutamide|mesh-list
92330338|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
92330339|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92355842|NCT03823638|Mannitol|mannitol|mesh-list
92330340|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
92330341|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92330342|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330343|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92330344|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330345|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330346|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
92330347|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
92330348|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330349|NCT00003740|Trastuzumab|trastuzumab|mesh-list
92330350|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92330351|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330352|NCT05477875|Acetaminophen|acetaminophen|mesh-list
92330353|NCT05477875|Dronabinol|dronabinol|mesh-list
92330354|NCT05477875|Codeine|codeine|mesh-list
92330355|NCT05477875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92330356|NCT05477875|Analgesics|analgesics|mesh-ancestor
92330357|NCT05477875|Sensory System Agents|sensory system agents|mesh-ancestor
92330358|NCT05477875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330359|NCT05477875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330360|NCT05477875|Antipyretics|antipyretics|mesh-ancestor
92330361|NCT05477875|Hallucinogens|hallucinogens|mesh-ancestor
92330362|NCT05477875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92330363|NCT05477875|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92330364|NCT05477875|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92330365|NCT05477875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330366|NCT05477875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330367|NCT05477875|Hormones|hormones|mesh-ancestor
92330368|NCT05477875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330369|NCT05477875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92330370|NCT05477875|Narcotics|narcotics|mesh-ancestor
92330371|NCT05477875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92330372|NCT05477875|Antitussive Agents|antitussive agents|mesh-ancestor
92330373|NCT05477875|Respiratory System Agents|respiratory system agents|mesh-ancestor
92330374|NCT00004256|Sargramostim|sargramostim|mesh-list
92330375|NCT00004256|Immunologic Factors|immunologic factors|mesh-ancestor
92330376|NCT00004256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330377|NCT00004262|Motexafin gadolinium|motexafin gadolinium|mesh-list
92330378|NCT00004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330379|NCT00004262|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92330380|NCT00004262|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330381|NCT00004892|Carmustine|carmustine|mesh-list
92330382|NCT00004892|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92330383|NCT00004892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330384|NCT00004892|Alkylating Agents|alkylating agents|mesh-ancestor
92330385|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330386|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330387|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330388|NCT00004268|Midodrine|midodrine|mesh-list
92330389|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
92330390|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
92330391|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330392|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330393|NCT00004268|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92330394|NCT00004268|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92330395|NCT00004268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92330396|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92330397|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
92330398|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330399|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330400|NCT00004274|Estrogens|estrogens|mesh-list
92330401|NCT00004274|Hormones|hormones|mesh-ancestor
91983015|NCT04417348|Tretinoin|tretinoin|mesh-list
92330402|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330403|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330405|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
92330406|NCT00004904|Etoposide|etoposide|mesh-list
92330407|NCT00004904|Cladribine|cladribine|mesh-list
92330408|NCT00004904|Tacrolimus|tacrolimus|mesh-list
92330409|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92330410|NCT00004904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330411|NCT00004904|Immunologic Factors|immunologic factors|mesh-ancestor
92330412|NCT00004904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330413|NCT00004904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330414|NCT00004904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330415|NCT00004904|Alkylating Agents|alkylating agents|mesh-ancestor
92330416|NCT00004904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330417|NCT00004904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330418|NCT00004904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92330419|NCT00004904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330420|NCT00004904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330421|NCT00004904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330422|NCT00004904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330423|NCT00004904|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92330424|NCT00004904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330425|NCT00004904|Antiemetics|antiemetics|mesh-ancestor
92330426|NCT00004904|Autonomic Agents|autonomic agents|mesh-ancestor
92330427|NCT00004904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330428|NCT00004904|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330429|NCT00004904|Glucocorticoids|glucocorticoids|mesh-ancestor
92330430|NCT00004904|Hormones|hormones|mesh-ancestor
92330431|NCT00004904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330432|NCT00004904|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92330433|NCT00004904|Protective Agents|protective agents|mesh-ancestor
92330434|NCT00004286|Immunoglobulins|immunoglobulins|mesh-list
92330435|NCT00004286|Antibodies|antibodies|mesh-list
92330436|NCT00004286|gamma-Globulins|gamma-globulins|mesh-list
92330437|NCT00004286|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92330438|NCT00004286|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92330439|NCT00004286|Immunologic Factors|immunologic factors|mesh-ancestor
92330440|NCT00004286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330441|NCT00003746|Cladribine|cladribine|mesh-list
92330442|NCT00003746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330443|NCT00003746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330444|NCT00003746|Immunologic Factors|immunologic factors|mesh-ancestor
92330445|NCT00003746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330446|NCT00003752|Bexarotene|bexarotene|mesh-list
92330447|NCT00003752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330448|NCT00003758|Cytarabine|cytarabine|mesh-list
92330449|NCT00003758|Idarubicin|idarubicin|mesh-list
92330450|NCT00003758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330451|NCT00003758|Antimetabolites|antimetabolites|mesh-ancestor
92330452|NCT00003758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330453|NCT00003758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330454|NCT00003758|Antiviral Agents|antiviral agents|mesh-ancestor
92330455|NCT00003758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330456|NCT00003758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330457|NCT00003758|Immunologic Factors|immunologic factors|mesh-ancestor
92330458|NCT00003758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330459|NCT00003758|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330460|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330461|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330462|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330463|NCT00004310|Clomipramine|clomipramine|mesh-list
92330464|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92330465|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
92330466|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92330467|NCT00004310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92330468|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92330469|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92330470|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330471|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330473|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330474|NCT00004922|Irinotecan|irinotecan|mesh-list
92330475|NCT00004922|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92330476|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330478|NCT00004922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330479|NCT00004922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330481|NCT00004316|Antipruritics|antipruritics|mesh-ancestor
92330482|NCT00004316|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330483|NCT00004316|Sensory System Agents|sensory system agents|mesh-ancestor
92330484|NCT00004316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330485|NCT00004316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330486|NCT00004928|Zoledronic Acid|zoledronic acid|mesh-list
92330487|NCT00004928|Calcitriol|calcitriol|mesh-list
92330488|NCT00004928|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92330489|NCT00004928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330490|NCT00004928|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330491|NCT00004928|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92330492|NCT00004928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92330493|NCT00004928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330494|NCT00004928|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92330495|NCT00004928|Vitamins|vitamins|mesh-ancestor
92330496|NCT00004928|Micronutrients|micronutrients|mesh-ancestor
92330497|NCT00004328|Enalapril|enalapril|mesh-list
92330498|NCT00004328|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
92330499|NCT00004328|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92330500|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
92330501|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330502|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330503|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92330504|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
92330505|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
92330506|NCT00004934|Paclitaxel|paclitaxel|mesh-list
92330507|NCT00004934|Carboplatin|carboplatin|mesh-list
92330508|NCT00004934|Epirubicin|epirubicin|mesh-list
92330509|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330510|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330511|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330512|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330513|NCT00004934|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330514|NCT00004934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330515|NCT00004934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330516|NCT00004934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330517|NCT00004934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330518|NCT00004934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330519|NCT00003776|Leucovorin|leucovorin|mesh-list
92330520|NCT00003776|Trimetrexate|trimetrexate|mesh-list
92330521|NCT00003776|Doxorubicin|doxorubicin|mesh-list
92330522|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92330523|NCT00003776|Methotrexate|methotrexate|mesh-list
92330524|NCT00003776|Ifosfamide|ifosfamide|mesh-list
92330525|NCT00003776|Calcium|calcium|mesh-list
92330526|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
92330527|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330528|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330529|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330530|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330531|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330532|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330533|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330534|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330535|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92330536|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
92330537|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92330538|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330539|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
92330540|NCT00003776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330541|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92330542|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330543|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
92330544|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330545|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330546|NCT00003776|Antidotes|antidotes|mesh-ancestor
92330547|NCT00003776|Protective Agents|protective agents|mesh-ancestor
92330548|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
92330549|NCT00003776|Vitamins|vitamins|mesh-ancestor
92330550|NCT00003776|Micronutrients|micronutrients|mesh-ancestor
92330551|NCT00003776|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330552|NCT00003776|Alkylating Agents|alkylating agents|mesh-ancestor
92330554|NCT00003776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330555|NCT00003788|Carmustine|carmustine|mesh-list
92330556|NCT00003788|Lomustine|lomustine|mesh-list
92330557|NCT00003788|Procarbazine|procarbazine|mesh-list
92330558|NCT00003788|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92330559|NCT00003788|Trioxsalen|trioxsalen|mesh-list
92330560|NCT00003788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330561|NCT00003788|Alkylating Agents|alkylating agents|mesh-ancestor
92330562|NCT00003788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330563|NCT00003788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330564|NCT00003788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92330565|NCT00003788|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92330566|NCT00004340|Calcitriol|calcitriol|mesh-list
92330567|NCT00004340|Hormones|hormones|mesh-list
92330568|NCT00004340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330569|NCT00004340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330570|NCT00004340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330571|NCT00004340|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92330572|NCT00004340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92330573|NCT00004340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330574|NCT00004340|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92330575|NCT00004340|Vitamins|vitamins|mesh-ancestor
92330576|NCT00004340|Micronutrients|micronutrients|mesh-ancestor
92330577|NCT00004340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92330578|NCT00004346|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92330579|NCT00004346|Lovastatin|lovastatin|mesh-list
92330580|NCT00004346|L 647318|l 647318|mesh-list
92330581|NCT00004346|Dihydromevinolin|dihydromevinolin|mesh-list
92330582|NCT00004346|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92330583|NCT00004346|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92330584|NCT00004346|Antimetabolites|antimetabolites|mesh-ancestor
92330585|NCT00004346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330586|NCT00004346|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92330587|NCT00004346|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92330588|NCT00004346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330589|NCT00004346|Cathartics|cathartics|mesh-ancestor
92330590|NCT00004346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330591|NCT00384800|Thalidomide|thalidomide|mesh-list
92330592|NCT00384800|Tegafur|tegafur|mesh-list
92330593|NCT00384800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330594|NCT00384800|Immunologic Factors|immunologic factors|mesh-ancestor
92330595|NCT00384800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330596|NCT00384800|Leprostatic Agents|leprostatic agents|mesh-ancestor
92330597|NCT00384800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92330598|NCT00384800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330599|NCT00384800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92330600|NCT00384800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92330601|NCT00384800|Growth Substances|growth substances|mesh-ancestor
92330602|NCT00384800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92330603|NCT00384800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330604|NCT00384800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330605|NCT00384800|Antimetabolites|antimetabolites|mesh-ancestor
92330606|NCT00384800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330607|NCT00384878|Leucovorin|leucovorin|mesh-list
92330608|NCT00384878|Fluorouracil|fluorouracil|mesh-list
92330609|NCT00384878|Cetuximab|cetuximab|mesh-list
92355874|NCT02861898|Cetuximab|cetuximab|mesh-list
92330610|NCT00384878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330611|NCT00384878|Antimetabolites|antimetabolites|mesh-ancestor
92330612|NCT00384878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330613|NCT00384878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330614|NCT00384878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330615|NCT00384878|Immunologic Factors|immunologic factors|mesh-ancestor
92330616|NCT00384878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330617|NCT00384878|Antidotes|antidotes|mesh-ancestor
92330618|NCT00384878|Protective Agents|protective agents|mesh-ancestor
92330619|NCT00384878|Vitamin B Complex|vitamin b complex|mesh-ancestor
92330620|NCT00384878|Vitamins|vitamins|mesh-ancestor
92330621|NCT00384878|Micronutrients|micronutrients|mesh-ancestor
92330622|NCT00384878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92330623|NCT02972762|Propofol|propofol|mesh-list
92330624|NCT02972762|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92330625|NCT02972762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92330626|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330627|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92330628|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
92330629|NCT02972762|Anesthetics|anesthetics|mesh-ancestor
92330630|NCT00004358|Calcitonin|calcitonin|mesh-list
92330631|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
92330632|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92330633|NCT00004358|Katacalcin|katacalcin|mesh-list
92330634|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330635|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330636|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92330637|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
92330638|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92330639|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
92330640|NCT00004364|Coagulants|coagulants|mesh-ancestor
92330641|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92330642|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
92330643|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330644|NCT00005000|Lamivudine|lamivudine|mesh-list
92330645|NCT00005000|Zidovudine|zidovudine|mesh-list
92330646|NCT00005000|Efavirenz|efavirenz|mesh-list
92330647|NCT00005000|Didanosine|didanosine|mesh-list
92330648|NCT00005000|Stavudine|stavudine|mesh-list
92330649|NCT00005000|Nelfinavir|nelfinavir|mesh-list
92330650|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92330651|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92330652|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330653|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330654|NCT00005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330655|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
92330656|NCT00005000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330657|NCT00005000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92330658|NCT00005000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92330659|NCT00005000|Antimetabolites|antimetabolites|mesh-ancestor
92330660|NCT00005000|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92330661|NCT00005000|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92330662|NCT00005000|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92330663|NCT00005000|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92330664|NCT00005000|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92330665|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92330666|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92330667|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92330668|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
92330669|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92330670|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
92330671|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330672|NCT00004376|Guanfacine|guanfacine|mesh-list
92330673|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92330674|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92330675|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92330676|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92330677|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92330678|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330679|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330680|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330681|NCT00005006|Alendronate|alendronate|mesh-list
92330682|NCT00005006|Teriparatide|teriparatide|mesh-list
92330683|NCT00005006|Hormones|hormones|mesh-list
92330684|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
92330685|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330686|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330687|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92330688|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330689|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92330690|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330691|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330692|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92330693|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
92330694|NCT00005012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330695|NCT00004400|Testosterone|testosterone|mesh-list
92330696|NCT00004400|Androgens|androgens|mesh-ancestor
92330697|NCT00004400|Hormones|hormones|mesh-ancestor
92330698|NCT00004400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330699|NCT00004400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330700|NCT00003812|Paclitaxel|paclitaxel|mesh-list
92330701|NCT00003812|Etoposide|etoposide|mesh-list
92330702|NCT00003812|Carboplatin|carboplatin|mesh-list
92330703|NCT00003812|Topotecan|topotecan|mesh-list
92330704|NCT00003812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330705|NCT00003812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330706|NCT00003812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330707|NCT00003812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330708|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330709|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330710|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330711|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330712|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330713|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92330714|NCT00005018|Efavirenz|efavirenz|mesh-list
92330715|NCT00005018|Abacavir|abacavir|mesh-list
92330716|NCT00005018|Didanosine|didanosine|mesh-list
92330717|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
92330718|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92330719|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92330720|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330721|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330722|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
92330723|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330724|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92330725|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92330726|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92330727|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92330728|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92330729|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92330730|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330731|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
92330732|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92330733|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92330734|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
92330735|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92330736|NCT00003824|Ciprofloxacin|ciprofloxacin|mesh-list
92330737|NCT00003824|Cephalexin|cephalexin|mesh-list
92330738|NCT00003824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92330739|NCT00003824|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330740|NCT00003824|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330741|NCT00003824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330742|NCT00003824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330743|NCT00003824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330744|NCT00003824|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92330745|NCT00003824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92330746|NCT00004406|Hormones|hormones|mesh-list
92330747|NCT00004406|Parathyroid Hormone|parathyroid hormone|mesh-list
92330748|NCT00004406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330749|NCT00004406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355882|NCT02851056|Lenograstim|lenograstim|mesh-list
92330750|NCT00004406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330751|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
92330752|NCT00005024|Carboplatin|carboplatin|mesh-list
92330753|NCT00005024|Doxorubicin|doxorubicin|mesh-list
92330754|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92330755|NCT00005024|Granisetron|granisetron|mesh-list
92330756|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330757|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
92330758|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330759|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330760|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330761|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
92330762|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330763|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330764|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92330765|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92330766|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330767|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330768|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330769|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
92330770|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
92330771|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330772|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330773|NCT00005024|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92330774|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92330775|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
92330776|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330777|NCT00005030|Lonafarnib|lonafarnib|mesh-list
92330778|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330779|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983372|NCT02055976|Antimetabolites|antimetabolites|mesh-ancestor
92330781|NCT00004424|Midazolam|midazolam|mesh-list
92330782|NCT00004424|Propofol|propofol|mesh-list
92330783|NCT00004424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92330784|NCT00004424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92330785|NCT00004424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330786|NCT00004424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92330787|NCT00004424|Anesthetics, General|anesthetics, general|mesh-ancestor
92330788|NCT00004424|Anesthetics|anesthetics|mesh-ancestor
92330789|NCT00004424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92330790|NCT00004424|Narcotics|narcotics|mesh-ancestor
92330791|NCT00004424|Analgesics|analgesics|mesh-ancestor
92330792|NCT00004424|Sensory System Agents|sensory system agents|mesh-ancestor
92330793|NCT00004424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330794|NCT00004424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92330795|NCT00004424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92330796|NCT00004424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92330797|NCT00004424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92330798|NCT00004424|GABA Modulators|gaba modulators|mesh-ancestor
92330799|NCT00004424|GABA Agents|gaba agents|mesh-ancestor
92330800|NCT00004424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330801|NCT00004424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330802|NCT00004430|Prednisolone|prednisolone|mesh-list
92330803|NCT00004430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330804|NCT00004430|Glucocorticoids|glucocorticoids|mesh-ancestor
92330805|NCT00004430|Hormones|hormones|mesh-ancestor
92330806|NCT00004430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330807|NCT00004430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330808|NCT00004430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330809|NCT00004430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330810|NCT00003842|Interleukin-4|interleukin-4|mesh-list
92330811|NCT00003842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92330812|NCT00003842|Immunologic Factors|immunologic factors|mesh-ancestor
92330813|NCT00003842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330814|NCT00003842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330815|NCT00003842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92330816|NCT00005036|Leucovorin|leucovorin|mesh-list
92330817|NCT00005036|Fluorouracil|fluorouracil|mesh-list
92330818|NCT00005036|Oxaliplatin|oxaliplatin|mesh-list
92330819|NCT00005036|Irinotecan|irinotecan|mesh-list
92330820|NCT00005036|Calcium|calcium|mesh-list
92330821|NCT00005036|Levoleucovorin|levoleucovorin|mesh-list
92330822|NCT00005036|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92330823|NCT00005036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330824|NCT00005036|Antimetabolites|antimetabolites|mesh-ancestor
92330825|NCT00005036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330826|NCT00005036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330827|NCT00005036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330828|NCT00005036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92330829|NCT00005036|Immunologic Factors|immunologic factors|mesh-ancestor
92330830|NCT00005036|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92330831|NCT00005036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330832|NCT00005036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330833|NCT00005036|Antidotes|antidotes|mesh-ancestor
92330834|NCT00005036|Protective Agents|protective agents|mesh-ancestor
92330835|NCT00005036|Vitamin B Complex|vitamin b complex|mesh-ancestor
92330836|NCT00005036|Vitamins|vitamins|mesh-ancestor
92330837|NCT00005036|Micronutrients|micronutrients|mesh-ancestor
92330838|NCT00004436|Prednisone|prednisone|mesh-list
92330839|NCT00004436|Leuprolide|leuprolide|mesh-list
92330840|NCT00004436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330841|NCT00004436|Glucocorticoids|glucocorticoids|mesh-ancestor
92330842|NCT00004436|Hormones|hormones|mesh-ancestor
92330843|NCT00004436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330844|NCT00004436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330845|NCT00004436|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330846|NCT00004436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330847|NCT00004436|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92330848|NCT00004436|Fertility Agents|fertility agents|mesh-ancestor
92330849|NCT00004436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92330850|NCT00005042|Semaxinib|semaxinib|mesh-list
92330851|NCT00005042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92330852|NCT00005042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92330853|NCT00005042|Growth Substances|growth substances|mesh-ancestor
92330854|NCT00005042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330855|NCT00005042|Growth Inhibitors|growth inhibitors|mesh-ancestor
92330856|NCT00005042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330857|NCT00005042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92330858|NCT00005042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330859|NCT00005042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330860|NCT00004442|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92330861|NCT00004442|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92330863|NCT00004442|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92330864|NCT00004442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92330865|NCT00004442|Cathartics|cathartics|mesh-ancestor
92330866|NCT05444569|Liraglutide|liraglutide|mesh-list
92330867|NCT05444569|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92330868|NCT05444569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330869|NCT05444569|Incretins|incretins|mesh-ancestor
92330870|NCT05444569|Hormones|hormones|mesh-ancestor
92330871|NCT05444569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330872|NCT00004448|Prednisone|prednisone|mesh-list
92330873|NCT00004448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92330874|NCT00004448|Glucocorticoids|glucocorticoids|mesh-ancestor
92330875|NCT00004448|Hormones|hormones|mesh-ancestor
92330876|NCT00004448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330877|NCT00004448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330878|NCT00004448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330879|NCT00004448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330880|NCT00003860|Carboplatin|carboplatin|mesh-list
92330881|NCT00003860|Etoposide|etoposide|mesh-list
92330882|NCT00003860|Ifosfamide|ifosfamide|mesh-list
92330883|NCT00003860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330884|NCT00003860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330885|NCT00003860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92330886|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92330887|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330888|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330889|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330890|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
92330891|NCT00005048|Paclitaxel|paclitaxel|mesh-list
92330892|NCT00005048|Estramustine|estramustine|mesh-list
92330893|NCT00005048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330894|NCT00005048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330895|NCT00005048|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330896|NCT00005048|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330897|NCT00005048|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330898|NCT00005048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330899|NCT00005048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330900|NCT00005048|Alkylating Agents|alkylating agents|mesh-ancestor
92330901|NCT00005048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92330902|NCT04756765|Talazoparib|talazoparib|mesh-list
92330903|NCT04756765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92330904|NCT04756765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330905|NCT04756765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330906|NCT04756765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330907|NCT00004466|Atorvastatin|atorvastatin|mesh-list
92330908|NCT00004466|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92330909|NCT00004466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92330910|NCT00004466|Antimetabolites|antimetabolites|mesh-ancestor
92330911|NCT00004466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330912|NCT00004466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92330913|NCT00004466|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92330914|NCT00004466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330915|NCT00005054|Temozolomide|temozolomide|mesh-list
92330916|NCT00005054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330917|NCT00005054|Alkylating Agents|alkylating agents|mesh-ancestor
92330918|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330919|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330920|NCT00004478|Droxidopa|droxidopa|mesh-list
92330921|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92330922|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92330923|NCT00003878|Carmustine|carmustine|mesh-list
92330924|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92330925|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
92330926|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330927|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330928|NCT00005060|Docetaxel|docetaxel|mesh-list
92330929|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330930|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330931|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330932|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330933|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330934|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
92330935|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92330936|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330937|NCT00005066|Carmustine|carmustine|mesh-list
92330938|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92330939|NCT00005066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355902|NCT01452828|Tedizolid|tedizolid|mesh-list
92330941|NCT00005066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330942|NCT00005066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330943|NCT00005066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92330944|NCT04711915|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92330945|NCT04711915|Hallucinogens|hallucinogens|mesh-ancestor
92330946|NCT04711915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330947|NCT04711915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92330948|NCT04711915|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92330949|NCT04711915|Serotonin Agents|serotonin agents|mesh-ancestor
92330950|NCT04711915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349504|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
92330951|NCT04711915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330952|NCT04711915|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92330953|NCT00005072|Interleukin-2|interleukin-2|mesh-list
92330954|NCT00005072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330955|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92330956|NCT00005072|Analgesics|analgesics|mesh-ancestor
92330957|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
92330958|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92330959|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330960|NCT00004496|Hormones|hormones|mesh-list
92330961|NCT00004496|alpha-MSH|alpha-msh|mesh-list
92330962|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92355987|NCT04849650|Amisulpride|amisulpride|mesh-list
92330963|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92330964|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
92330965|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92330966|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92330967|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92330968|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330969|NCT00003902|Capecitabine|capecitabine|mesh-list
92330970|NCT00003902|Vinorelbine|vinorelbine|mesh-list
92330971|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92330972|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
92330973|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330974|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330975|NCT00003902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330976|NCT00003902|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330977|NCT00003902|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330978|NCT00003902|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330980|NCT00003908|Docetaxel|docetaxel|mesh-list
92330981|NCT00003908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330982|NCT00003908|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330983|NCT00003908|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330984|NCT00003908|Mitosis Modulators|mitosis modulators|mesh-ancestor
92330985|NCT00003908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330986|NCT00382837|Epratuzumab|epratuzumab|mesh-list
92330987|NCT00382837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92330988|NCT00382837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330989|NCT00003914|Dolastatin 10|dolastatin 10|mesh-list
92330990|NCT00003914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92330991|NCT00003914|Tubulin Modulators|tubulin modulators|mesh-ancestor
92330992|NCT00003914|Antimitotic Agents|antimitotic agents|mesh-ancestor
92330993|NCT00003914|Mitosis Modulators|mitosis modulators|mesh-ancestor
92349505|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
92330994|NCT00003914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92330995|NCT00005078|Paclitaxel|paclitaxel|mesh-list
92330996|NCT00005078|Carboplatin|carboplatin|mesh-list
92330997|NCT00005078|Tirapazamine|tirapazamine|mesh-list
92330998|NCT00005078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92330999|NCT00005078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331000|NCT00005078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331001|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331002|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331003|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331005|NCT04698031|Clopidogrel|clopidogrel|mesh-list
92331006|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92331008|NCT04698031|Analgesics|analgesics|mesh-ancestor
92331009|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
92331010|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331011|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331012|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331013|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331014|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92331015|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92349506|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92331016|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331017|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92331018|NCT04698031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92331019|NCT04698031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331020|NCT04698031|Antipyretics|antipyretics|mesh-ancestor
92331021|NCT04698031|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92331022|NCT04698031|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92331023|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92331024|NCT04698031|Purinergic Agents|purinergic agents|mesh-ancestor
92331025|NCT04698031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331026|NCT00003920|Cyclosporine|cyclosporine|mesh-list
92331027|NCT00003920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92331028|NCT00003920|Antibodies|antibodies|mesh-list
92331029|NCT00003920|Immunoglobulins|immunoglobulins|mesh-list
92331030|NCT00003920|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92331031|NCT00003920|Cyclosporins|cyclosporins|mesh-list
92331032|NCT00003920|Immunologic Factors|immunologic factors|mesh-ancestor
92331033|NCT00003920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331034|NCT00003920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331035|NCT00003920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331036|NCT00003920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331037|NCT00003920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331038|NCT00003920|Antifungal Agents|antifungal agents|mesh-ancestor
92331039|NCT00003920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331040|NCT00003920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331041|NCT00003920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331042|NCT00003920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92331043|NCT00003926|Melphalan|melphalan|mesh-list
92331044|NCT00003926|Busulfan|busulfan|mesh-list
92331045|NCT00003926|Thiotepa|thiotepa|mesh-list
92331046|NCT00003926|Lenograstim|lenograstim|mesh-list
92331047|NCT00003926|Amifostine|amifostine|mesh-list
92331048|NCT00003926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92331049|NCT00003926|Immunologic Factors|immunologic factors|mesh-ancestor
92331050|NCT00003926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331051|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331052|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
92331053|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331054|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331055|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92331056|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331057|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92331058|NCT00003926|Protective Agents|protective agents|mesh-ancestor
92331059|NCT05122819|Anesthetics|anesthetics|mesh-list
92349507|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92331060|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331061|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331062|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
92331063|NCT00005090|Dacarbazine|dacarbazine|mesh-list
92331064|NCT00005090|Carmustine|carmustine|mesh-list
92331065|NCT00005090|Doxorubicin|doxorubicin|mesh-list
92331066|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92331067|NCT00005090|Etoposide|etoposide|mesh-list
92331068|NCT00005090|Bleomycin|bleomycin|mesh-list
92331069|NCT00005090|Vinblastine|vinblastine|mesh-list
92331070|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331071|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
92331072|NCT00005090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331073|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331074|NCT00005090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331075|NCT00005090|Alkylating Agents|alkylating agents|mesh-ancestor
92331076|NCT00005090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331077|NCT00005090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331078|NCT00005090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92331079|NCT00005090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92331080|NCT00005090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92331081|NCT00005090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92331082|NCT00005090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331083|NCT00005090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92331084|NCT00005090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331085|NCT00005090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331086|NCT00005090|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331088|NCT00004580|Lopinavir|lopinavir|mesh-list
92331089|NCT00004580|Nevirapine|nevirapine|mesh-list
92331090|NCT00004580|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92331091|NCT00004580|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92331092|NCT00004580|Protease Inhibitors|protease inhibitors|mesh-ancestor
92331093|NCT00004580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331094|NCT00004580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331095|NCT00004580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331096|NCT00004580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92331097|NCT00004580|Antiviral Agents|antiviral agents|mesh-ancestor
92331098|NCT00004580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331099|NCT00004580|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92331100|NCT00004580|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92331101|NCT00004580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92331102|NCT00004580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331103|NCT00004580|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92331104|NCT00004580|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92331105|NCT00005096|Docetaxel|docetaxel|mesh-list
92331106|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331107|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331108|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331109|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331110|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331111|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
92331112|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92331113|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331114|NCT00004640|Disinfectants|disinfectants|mesh-ancestor
92331115|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92331116|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92331117|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331118|NCT00004646|Prednisone|prednisone|mesh-list
92331119|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331120|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
92331121|NCT00004646|Hormones|hormones|mesh-ancestor
92331122|NCT00004646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331123|NCT00004646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331124|NCT00004646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331125|NCT00004646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331126|NCT00005108|Estradiol|estradiol|mesh-list
92331127|NCT00005108|Progesterone|progesterone|mesh-list
92331128|NCT00005108|Estrogens|estrogens|mesh-ancestor
92331129|NCT00005108|Hormones|hormones|mesh-ancestor
92331130|NCT00005108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331131|NCT00005108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331132|NCT00005108|Progestins|progestins|mesh-ancestor
92331133|NCT00004652|Pimozide|pimozide|mesh-list
92331134|NCT00004652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92331135|NCT00004652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92331136|NCT00004652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331137|NCT00004652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331138|NCT00004652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92331139|NCT00004652|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92331140|NCT00004652|Dopamine Agents|dopamine agents|mesh-ancestor
92331141|NCT00004652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331142|NCT00004652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331143|NCT00004652|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92331144|NCT00005120|Calanolide A|calanolide a|mesh-list
92331145|NCT00005120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331146|NCT00005120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92331147|NCT00005120|Antiviral Agents|antiviral agents|mesh-ancestor
92331148|NCT00005120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331149|NCT00004664|Megestrol|megestrol|mesh-list
92331150|NCT00004664|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92331151|NCT00004664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92331152|NCT00004664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92331153|NCT00004664|Contraceptive Agents|contraceptive agents|mesh-ancestor
92331154|NCT00004664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331155|NCT00004664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331156|NCT00004664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92331157|NCT00004664|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92117022|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
92331158|NCT00004664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331159|NCT00004664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331160|NCT00004682|Immunoglobulins|immunoglobulins|mesh-list
92331162|NCT00004682|gamma-Globulins|gamma-globulins|mesh-list
92331163|NCT00004682|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92331164|NCT00004682|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92331165|NCT00004682|Immunologic Factors|immunologic factors|mesh-ancestor
92331166|NCT00004682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331167|NCT00004688|Mercaptopurine|mercaptopurine|mesh-list
92331168|NCT00004688|Carmustine|carmustine|mesh-list
92331169|NCT00004688|Streptozocin|streptozocin|mesh-list
92331170|NCT00004688|Antimetabolites|antimetabolites|mesh-ancestor
92331171|NCT00004688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331172|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331173|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331174|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331175|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
92331176|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331177|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331178|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331179|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331180|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
92331181|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92331182|NCT00004694|Heparin|heparin|mesh-list
92331183|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
92331184|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92331185|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92331186|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331187|NCT04608409|Paclitaxel|paclitaxel|mesh-list
92331188|NCT04608409|Lapatinib|lapatinib|mesh-list
92331189|NCT04608409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92331190|NCT04608409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331191|NCT04608409|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331192|NCT04608409|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331193|NCT04608409|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331194|NCT04608409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331195|NCT04608409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92331196|NCT04608409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331197|NCT00004700|Mitogens|mitogens|mesh-list
92331198|NCT00004700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331199|NCT00004700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331200|NCT00004730|Magnesium Sulfate|magnesium sulfate|mesh-list
92331201|NCT00004730|Analgesics|analgesics|mesh-ancestor
92331202|NCT00004730|Sensory System Agents|sensory system agents|mesh-ancestor
92331203|NCT00004730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331204|NCT00004730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331205|NCT00004730|Anesthetics|anesthetics|mesh-ancestor
92331206|NCT00004730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331207|NCT00004730|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92331208|NCT00004730|Anticonvulsants|anticonvulsants|mesh-ancestor
92331209|NCT00004730|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92331210|NCT00004730|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92331211|NCT00004730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331212|NCT00004730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92331213|NCT00004730|Tocolytic Agents|tocolytic agents|mesh-ancestor
92331214|NCT00004730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331215|NCT00004736|Lamivudine|lamivudine|mesh-list
92331216|NCT00004736|Zidovudine|zidovudine|mesh-list
92331217|NCT00004736|Stavudine|stavudine|mesh-list
92331218|NCT00004736|Nelfinavir|nelfinavir|mesh-list
92331219|NCT00004736|Isoniazid|isoniazid|mesh-list
92331220|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
92331221|NCT00004736|Ethambutol|ethambutol|mesh-list
92331222|NCT00004736|Rifabutin|rifabutin|mesh-list
92331223|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92331224|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331225|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331226|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331227|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
92331228|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331229|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331230|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92331231|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
92331232|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
92331233|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92331234|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92331235|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92331236|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92331237|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92331238|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92331239|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
92331240|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92331242|NCT00004748|Colchicine|colchicine|mesh-list
92331243|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92331244|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92331245|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
92331246|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331247|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331248|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331249|NCT00004748|Antimetabolites|antimetabolites|mesh-ancestor
92331250|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331251|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331252|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331253|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331254|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92331255|NCT00004748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331256|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
92331257|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331258|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331259|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
92331260|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331261|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331262|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331263|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92331264|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331265|NCT04585477|Durvalumab|durvalumab|mesh-list
92331266|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92331267|NCT04585477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331268|NCT00004754|Epoprostenol|epoprostenol|mesh-list
92331269|NCT00004754|Tezosentan|tezosentan|mesh-list
92331270|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92331271|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92331272|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
92331273|NCT00005576|Aldesleukin|aldesleukin|mesh-list
92331274|NCT00005576|Interleukin-2|interleukin-2|mesh-list
92331275|NCT00005576|Dinutuximab|dinutuximab|mesh-list
92331276|NCT00005576|Isotretinoin|isotretinoin|mesh-list
92331277|NCT00005576|Antibodies|antibodies|mesh-list
92331278|NCT00005576|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92331279|NCT00005576|Sargramostim|sargramostim|mesh-list
92331280|NCT00005576|Immunologic Factors|immunologic factors|mesh-ancestor
92331281|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331282|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331283|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92331284|NCT00005576|Analgesics|analgesics|mesh-ancestor
92331285|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
92331286|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331287|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331288|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92331289|NCT00005576|Antiviral Agents|antiviral agents|mesh-ancestor
92331290|NCT00005576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331291|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331292|NCT04713163|Vaccines|vaccines|mesh-list
92331293|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
92331294|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331295|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
92331296|NCT00004772|Antibodies|antibodies|mesh-list
92331297|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
92331298|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92331299|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92331300|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
92331301|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331302|NCT04712929|Fluconazole|fluconazole|mesh-list
92331303|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
92331304|NCT04712929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331305|NCT04712929|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92331306|NCT04712929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92331307|NCT04712929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331308|NCT04712929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331309|NCT04712929|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92331310|NCT04712929|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331311|NCT04712929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331312|NCT04712929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331313|NCT04712929|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92331314|NCT04712929|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92331316|NCT00004784|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92331317|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92331318|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
92331319|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331320|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331321|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331322|NCT00004784|Antimetabolites|antimetabolites|mesh-ancestor
92331323|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331324|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331325|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331326|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331327|NCT00004784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92331328|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331329|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
92331330|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331331|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331332|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92331333|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331334|NCT00004796|Lactulose|lactulose|mesh-list
92331335|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331336|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
92331337|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92331338|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331339|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331340|NCT00004808|Fluconazole|fluconazole|mesh-list
92331341|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
92331342|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331343|NCT00004808|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92331344|NCT00004808|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92331345|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331346|NCT00004808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331347|NCT00004808|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92331348|NCT00004808|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331349|NCT00004808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331350|NCT00004808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331351|NCT00004808|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92331352|NCT00004808|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92331353|NCT00004814|Glatiramer Acetate|glatiramer acetate|mesh-list
92331355|NCT00004814|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92331356|NCT00004814|Immunologic Factors|immunologic factors|mesh-ancestor
92331357|NCT00004814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331358|NCT00004814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331359|NCT00004814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331360|NCT00004826|Clozapine|clozapine|mesh-list
92331361|NCT00004826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92331362|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
92331363|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331364|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331365|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331366|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92331367|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92331368|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331369|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92331370|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
92331371|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
92331372|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
92331373|NCT04555603|Avelumab|avelumab|mesh-list
92331374|NCT04555603|Axitinib|axitinib|mesh-list
92331375|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92331376|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331377|NCT04555603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91914425|NCT03039842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92331378|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356578|NCT05585736|Mydriatics|mydriatics|mesh-list
92331379|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92331380|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331381|NCT04552327|Diclofenac|diclofenac|mesh-list
92331382|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92331383|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92331384|NCT04552327|Analgesics|analgesics|mesh-ancestor
92331385|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
92331386|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331387|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331388|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331389|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331390|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92331391|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331392|NCT04552327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331393|NCT00004778|Dexamethasone|dexamethasone|mesh-list
92331394|NCT00004778|Betamethasone|betamethasone|mesh-list
92331395|NCT00004778|Hormones|hormones|mesh-list
92331396|NCT00004778|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
92331397|NCT00004778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331398|NCT00004778|Antiemetics|antiemetics|mesh-ancestor
92331399|NCT00004778|Autonomic Agents|autonomic agents|mesh-ancestor
92331400|NCT00004778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331401|NCT00004778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331402|NCT00004778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331403|NCT00004778|Glucocorticoids|glucocorticoids|mesh-ancestor
92331404|NCT00004778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331405|NCT00004778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331407|NCT00004778|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92331408|NCT00004778|Respiratory System Agents|respiratory system agents|mesh-ancestor
92331410|NCT00005612|Etoposide|etoposide|mesh-list
92331411|NCT00005612|Cyclophosphamide|cyclophosphamide|mesh-list
92331412|NCT00005612|Carboplatin|carboplatin|mesh-list
92331413|NCT00005612|Topotecan|topotecan|mesh-list
92331414|NCT00005612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92331415|NCT00005612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331416|NCT00005612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331417|NCT00005612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331418|NCT00005612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331419|NCT00005612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331420|NCT00005612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331421|NCT00005612|Immunologic Factors|immunologic factors|mesh-ancestor
92331422|NCT00005612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331423|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331424|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331425|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
92331426|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92331427|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92331428|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92331429|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331430|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92331431|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
92331432|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331433|NCT04534153|Fexofenadine|fexofenadine|mesh-list
92331434|NCT04534153|Terfenadine|terfenadine|mesh-list
92331435|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92331436|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92331437|NCT04534153|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92331438|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
92331439|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
92331440|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331441|NCT04534153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331442|NCT04534153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331443|NCT00005624|Tacedinaline|tacedinaline|mesh-list
92331444|NCT00005624|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92331445|NCT00005624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357025|NCT01331148|Vitamin D|vitamin d|mesh-list
92331446|NCT00005624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331447|NCT00005624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331448|NCT00385502|Econazole|econazole|mesh-list
92331449|NCT00385502|Antifungal Agents|antifungal agents|mesh-ancestor
92331450|NCT00385502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331451|NCT00385502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92331452|NCT00385502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92331453|NCT00385502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331454|NCT00385502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331455|NCT00385502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92331456|NCT00385502|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331457|NCT00385502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984046|NCT02394821|Metronidazole|metronidazole|mesh-list
92331458|NCT00385502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331459|NCT00005630|Sargramostim|sargramostim|mesh-list
92331460|NCT00005630|Immunologic Factors|immunologic factors|mesh-ancestor
92331461|NCT00005630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331462|NCT00005636|Pemetrexed|pemetrexed|mesh-list
92331463|NCT00005636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331464|NCT00005636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331465|NCT00005636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331466|NCT00005636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92331467|NCT00005636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331469|NCT00005642|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92331470|NCT00005642|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92331471|NCT00005642|Growth Substances|growth substances|mesh-ancestor
92357368|NCT04777968|Fluorides|fluorides|mesh-list
92331472|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331473|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
92331474|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331475|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92331476|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331477|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331479|NCT00005648|Tipifarnib|tipifarnib|mesh-list
92331480|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331481|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
92349508|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92331482|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331483|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331484|NCT00005654|Metformin|metformin|mesh-list
92331485|NCT00005654|Clomiphene|clomiphene|mesh-list
92331486|NCT00005654|Enclomiphene|enclomiphene|mesh-list
92331487|NCT00005654|Zuclomiphene|zuclomiphene|mesh-list
92331488|NCT00005654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92331489|NCT00005654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331490|NCT00005654|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92331491|NCT00005654|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331492|NCT00005654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331493|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92331494|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
92331495|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331496|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92331497|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92331498|NCT00005684|Heparin|heparin|mesh-list
92331499|NCT00005684|Warfarin|warfarin|mesh-list
92331500|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
92331501|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92331502|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92331503|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331504|NCT00386282|Misoprostol|misoprostol|mesh-list
92331505|NCT00386282|Mifepristone|mifepristone|mesh-list
92331506|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92331507|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
92331508|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331509|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331510|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92331511|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331512|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
92331513|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92331514|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92331515|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92331516|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92357779|NCT00038610|Cytarabine|cytarabine|mesh-list
92331517|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
92331518|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92331519|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92331520|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331521|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331522|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
92331523|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92331524|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92331525|NCT04456699|Leucovorin|leucovorin|mesh-list
92331526|NCT04456699|Bevacizumab|bevacizumab|mesh-list
92331527|NCT04456699|Fluorouracil|fluorouracil|mesh-list
92331528|NCT04456699|Capecitabine|capecitabine|mesh-list
92331529|NCT04456699|Olaparib|olaparib|mesh-list
92331530|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
92331531|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92331532|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331533|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92331534|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92331535|NCT04456699|Growth Substances|growth substances|mesh-ancestor
92331536|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331537|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
92331538|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
92331539|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357968|NCT00255684|Fludarabine|fludarabine|mesh-list
92331540|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331541|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331542|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
92331543|NCT04456699|Antidotes|antidotes|mesh-ancestor
92331544|NCT04456699|Protective Agents|protective agents|mesh-ancestor
92331545|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
92331546|NCT04456699|Vitamins|vitamins|mesh-ancestor
92331547|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
92331548|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92331549|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331550|NCT00385658|Simvastatin|simvastatin|mesh-list
92331551|NCT00385658|Ezetimibe|ezetimibe|mesh-list
92331552|NCT00385658|Fenofibrate|fenofibrate|mesh-list
92331553|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92331554|NCT00385658|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92331555|NCT00385658|Antimetabolites|antimetabolites|mesh-ancestor
92331556|NCT00385658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331557|NCT00385658|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92331558|NCT00385658|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92331559|NCT00385658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331560|NCT00005762|Ritonavir|ritonavir|mesh-list
92331561|NCT00005762|Nelfinavir|nelfinavir|mesh-list
92331562|NCT00005762|Indinavir|indinavir|mesh-list
92331563|NCT00005762|Saquinavir|saquinavir|mesh-list
92331564|NCT00005762|Amprenavir|amprenavir|mesh-list
92331565|NCT00005762|Efavirenz|efavirenz|mesh-list
92331566|NCT00005762|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92331567|NCT00005762|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92331568|NCT00005762|Protease Inhibitors|protease inhibitors|mesh-ancestor
92331569|NCT00005762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331570|NCT00005762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331571|NCT00005762|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331572|NCT00005762|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92331573|NCT00005762|Antiviral Agents|antiviral agents|mesh-ancestor
92331574|NCT00005762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331575|NCT00005762|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92331576|NCT00005762|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92331577|NCT00005762|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92331578|NCT00005762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331579|NCT00005762|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92331580|NCT00005762|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92331581|NCT00005762|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92331582|NCT00005762|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92331583|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92331584|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92331585|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
92331586|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92331588|NCT00005768|Hormones|hormones|mesh-ancestor
92331589|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331590|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331591|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92331592|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
92331593|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
92331594|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331595|NCT00005792|Etoposide|etoposide|mesh-list
92331596|NCT00005792|Melphalan|melphalan|mesh-list
92331597|NCT00005792|Topotecan|topotecan|mesh-list
92331598|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
91937379|NCT02319148|Itraconazole|itraconazole|mesh-list
92331599|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92331600|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914580|NCT03180723|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331601|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92331602|NCT00005792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92331603|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331604|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331605|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331606|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
92331607|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92331608|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984274|NCT05471661|PENTA|penta|mesh-list
92331609|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
92331610|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331611|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92331612|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
92331613|NCT00005798|Thiotepa|thiotepa|mesh-list
92331614|NCT00005798|Carboplatin|carboplatin|mesh-list
92331615|NCT00005798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331616|NCT00005798|Immunologic Factors|immunologic factors|mesh-ancestor
92331617|NCT00005798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331618|NCT00005798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331619|NCT00005798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331621|NCT00005798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331622|NCT00005798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331623|NCT00005798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92331624|NCT00005810|Carboplatin|carboplatin|mesh-list
92331625|NCT00005810|Docetaxel|docetaxel|mesh-list
92331626|NCT00005810|Estramustine|estramustine|mesh-list
92331627|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331628|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331629|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331630|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331631|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331632|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331634|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331635|NCT00385970|Leucovorin|leucovorin|mesh-list
92331636|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
92331637|NCT00385970|Tegafur|tegafur|mesh-list
92331638|NCT00385970|Calcium|calcium|mesh-list
92331639|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
92331640|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92331641|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331642|NCT00385970|Antidotes|antidotes|mesh-ancestor
92331643|NCT00385970|Protective Agents|protective agents|mesh-ancestor
92331644|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
92331645|NCT00385970|Vitamins|vitamins|mesh-ancestor
92331646|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
92331647|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331648|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
92331649|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331650|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331651|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92331652|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
92331653|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92331654|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
92331655|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331656|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
92358759|NCT00300456|Simvastatin|simvastatin|mesh-list
92331657|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92331658|NCT05006677|Vitamin K|vitamin k|mesh-list
92331659|NCT05006677|Anticoagulants|anticoagulants|mesh-list
92331660|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92331661|NCT05006677|Vitamins|vitamins|mesh-ancestor
92331662|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
92331663|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331664|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92358831|NCT04389060|Grape Seed Extract|grape seed extract|mesh-list
92331665|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92331666|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331667|NCT05006677|Hemostatics|hemostatics|mesh-ancestor
92331668|NCT05006677|Coagulants|coagulants|mesh-ancestor
92331669|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92331670|NCT00386126|Hematinics|hematinics|mesh-ancestor
92331671|NCT05296603|Lenvatinib|lenvatinib|mesh-list
92331672|NCT05296603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331673|NCT05296603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92331674|NCT05296603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331675|NCT05296603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331676|NCT04569890|Hydroxychloroquine|hydroxychloroquine|mesh-list
92331678|NCT04569890|Certolizumab Pegol|certolizumab pegol|mesh-list
92331679|NCT04569890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331680|NCT04569890|Glucocorticoids|glucocorticoids|mesh-ancestor
92331681|NCT04569890|Hormones|hormones|mesh-ancestor
92331682|NCT04569890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331683|NCT04569890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331684|NCT04569890|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331685|NCT04569890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331686|NCT04569890|Antimalarials|antimalarials|mesh-ancestor
92331687|NCT04569890|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92331688|NCT04569890|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92331689|NCT04569890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331690|NCT04569890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331691|NCT04569890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331692|NCT04569890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331693|NCT04569890|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92331694|NCT04569890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331695|NCT04569890|Immunologic Factors|immunologic factors|mesh-ancestor
92331696|NCT00423163|Voriconazole|voriconazole|mesh-list
92331697|NCT00423163|Micafungin|micafungin|mesh-list
92331698|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
92331699|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331700|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92331701|NCT00423163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92331702|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331703|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331704|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92331705|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331706|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331707|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331708|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92331709|NCT04379635|Paclitaxel|paclitaxel|mesh-list
92331710|NCT04379635|Carboplatin|carboplatin|mesh-list
92331711|NCT04379635|Pemetrexed|pemetrexed|mesh-list
92331712|NCT04379635|Tislelizumab|tislelizumab|mesh-list
92331713|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92331714|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331715|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92331716|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92331717|NCT04379635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331718|NCT04379635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331719|NCT04379635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331720|NCT04379635|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92331721|NCT04379635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331722|NCT04379635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92331724|NCT04568876|Analgesics|analgesics|mesh-ancestor
92331725|NCT04568876|Sensory System Agents|sensory system agents|mesh-ancestor
92331726|NCT04568876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331727|NCT04568876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331728|NCT04568876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92331729|NCT04568876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92331730|NCT04568876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331731|NCT04568876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331732|NCT04568876|Antiviral Agents|antiviral agents|mesh-ancestor
92331733|NCT04568876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331734|NCT04568876|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92331735|NCT04568876|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92331736|NCT04568876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331737|NCT04568876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331738|NCT04568876|Hormones|hormones|mesh-ancestor
92331739|NCT04568876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331740|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92331741|NCT02210702|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92331742|NCT02210702|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92331743|NCT02210702|Norethindrone|norethindrone|mesh-list
92331744|NCT02210702|Norethindrone Acetate|norethindrone acetate|mesh-list
92331745|NCT02210702|Estradiol|estradiol|mesh-list
92331746|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92331747|NCT02210702|Estrogens|estrogens|mesh-ancestor
92331748|NCT02210702|Hormones|hormones|mesh-ancestor
92331749|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331750|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331751|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92331752|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
92331753|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331754|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92331755|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92331756|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92331757|NCT02210702|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92331758|NCT04568096|Tamoxifen|tamoxifen|mesh-list
91984353|NCT02541903|Afatinib|afatinib|mesh-list
92331759|NCT04568096|Tretinoin|tretinoin|mesh-list
92331760|NCT04568096|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92331761|NCT04568096|Hormone Antagonists|hormone antagonists|mesh-ancestor
92331762|NCT04568096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331763|NCT04568096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331764|NCT04568096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331765|NCT04568096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331766|NCT04568096|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92331767|NCT04568096|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92331768|NCT04568096|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92331769|NCT04568096|Keratolytic Agents|keratolytic agents|mesh-ancestor
92331770|NCT04568096|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331771|NCT04568018|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92331772|NCT04568018|Respiratory System Agents|respiratory system agents|mesh-ancestor
92331773|NCT02278172|Vitamin D|vitamin d|mesh-list
92331774|NCT02278172|Ergocalciferols|ergocalciferols|mesh-list
92331775|NCT02278172|Cholecalciferol|cholecalciferol|mesh-list
92331776|NCT02278172|Vitamins|vitamins|mesh-list
92331777|NCT02278172|Micronutrients|micronutrients|mesh-ancestor
92331778|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331779|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92331780|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92331781|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92331782|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92331783|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
92331784|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
92331785|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331786|NCT02210858|Tipifarnib|tipifarnib|mesh-list
92331787|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331788|NCT04565678|Mitapivat|mitapivat|mesh-list
92331789|NCT04565678|Enzyme Activators|enzyme activators|mesh-ancestor
92331790|NCT04565678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331791|NCT04564430|Clonidine|clonidine|mesh-list
92331792|NCT04564430|Analgesics|analgesics|mesh-ancestor
92331793|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
92331794|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331795|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331796|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92331797|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
92331798|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
92331799|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92331800|NCT04564430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92331801|NCT04564430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92331802|NCT04564430|Adrenergic Agents|adrenergic agents|mesh-ancestor
92331803|NCT04564430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331804|NCT04564430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331805|NCT04564040|Acalabrutinib|acalabrutinib|mesh-list
92331806|NCT04564040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331807|NCT00005804|Cyclophosphamide|cyclophosphamide|mesh-list
92331808|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331809|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
92331810|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331811|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331812|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92331813|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
92331814|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331815|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331816|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92331817|NCT04563962|Methamphetamine|methamphetamine|mesh-list
92331818|NCT04563962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92331819|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331820|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
92331821|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
92331822|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331823|NCT04563962|Dopamine Agents|dopamine agents|mesh-ancestor
92331824|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331825|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331826|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
92331827|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92331828|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92331829|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92331830|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91984436|NCT02540265|Meloxicam|meloxicam|mesh-list
92331832|NCT02211482|Dolutegravir|dolutegravir|mesh-list
92331833|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92331834|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92331835|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331836|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331837|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
92331838|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331839|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331840|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92331841|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92331842|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92331843|NCT04929847|Emollients|emollients|mesh-list
92331844|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92331845|NCT04561934|Fluorides|fluorides|mesh-list
92331846|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
92331847|NCT04561934|Protective Agents|protective agents|mesh-ancestor
92331848|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331849|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
92331850|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
92331851|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92331852|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92331853|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92331854|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331855|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331856|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331857|NCT04563260|Palonosetron|palonosetron|mesh-list
92331858|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
92331859|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
92331860|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331861|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331862|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331863|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92331864|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92331865|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
92331866|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331867|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331868|NCT04173793|Ezetimibe|ezetimibe|mesh-list
92331869|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92331870|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92331871|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
92331872|NCT04173793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331873|NCT04173793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92331874|NCT04561466|Bezafibrate|bezafibrate|mesh-list
92331875|NCT04561466|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92331876|NCT04561466|Antimetabolites|antimetabolites|mesh-ancestor
92331877|NCT04561466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331878|NCT04561466|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92331879|NCT04561856|Dexamethasone|dexamethasone|mesh-list
92331880|NCT04561856|Dexamethasone acetate|dexamethasone acetate|mesh-list
92331881|NCT04561856|BB 1101|bb 1101|mesh-list
92331882|NCT04561856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331883|NCT04561856|Antiemetics|antiemetics|mesh-ancestor
92331884|NCT04561856|Autonomic Agents|autonomic agents|mesh-ancestor
92331885|NCT04561856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331886|NCT04561856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331887|NCT04561856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331888|NCT04561856|Glucocorticoids|glucocorticoids|mesh-ancestor
92331889|NCT04561856|Hormones|hormones|mesh-ancestor
92331890|NCT04561856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92331891|NCT04561856|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92331892|NCT04561856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331893|NCT04561856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92331894|NCT04561856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331895|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331896|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92331898|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92331899|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92331900|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
92331901|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331902|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92331903|NCT03539887|Ketamine|ketamine|mesh-list
92331904|NCT03539887|Analgesics|analgesics|mesh-ancestor
92331905|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
92331906|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331907|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331908|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91984501|NCT03190941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92331909|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92331910|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
92331911|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
92331912|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331913|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92331914|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92331915|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92331916|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331917|NCT04123717|Acetaminophen|acetaminophen|mesh-list
92331919|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92331920|NCT04123717|Analgesics|analgesics|mesh-ancestor
92331921|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
92331922|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331923|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331924|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
92331925|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92331926|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92331927|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92331928|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92331929|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331930|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331931|NCT03472495|Diltiazem|diltiazem|mesh-list
92331932|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92331933|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92331934|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92331935|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331936|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92331937|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331938|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
92331939|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
92331940|NCT04094701|Narcotics|narcotics|mesh-ancestor
92331941|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331942|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331943|NCT04094701|Analgesics|analgesics|mesh-ancestor
92331944|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
92331945|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92331946|NCT03351361|Nivolumab|nivolumab|mesh-list
92331947|NCT03351361|Ipilimumab|ipilimumab|mesh-list
92331948|NCT03351361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92331949|NCT03351361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331950|NCT03351361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92331951|NCT03351361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331952|NCT03234907|Vedolizumab|vedolizumab|mesh-list
92331953|NCT03234907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92331954|NCT03228667|Pembrolizumab|pembrolizumab|mesh-list
92331955|NCT03228667|Nivolumab|nivolumab|mesh-list
92331956|NCT03228667|Atezolizumab|atezolizumab|mesh-list
92331957|NCT03228667|Durvalumab|durvalumab|mesh-list
92331958|NCT03228667|Avelumab|avelumab|mesh-list
92331959|NCT03228667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92331960|NCT03228667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92331961|NCT03228667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331962|NCT03228667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92331963|NCT03228667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331964|NCT03228667|Immunologic Factors|immunologic factors|mesh-ancestor
92331965|NCT03228667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331967|NCT04330027|Mitosis Modulators|mitosis modulators|mesh-ancestor
92331968|NCT04330027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331969|NCT00002893|Leucovorin|leucovorin|mesh-list
92331970|NCT00002893|Fluorouracil|fluorouracil|mesh-list
92331971|NCT00002893|Raltitrexed|raltitrexed|mesh-list
92331972|NCT00002893|Calcium|calcium|mesh-list
92331973|NCT00002893|Levoleucovorin|levoleucovorin|mesh-list
92331974|NCT00002893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92331975|NCT00002893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331976|NCT00002893|Antimetabolites|antimetabolites|mesh-ancestor
92331977|NCT00002893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92331978|NCT00002893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92331979|NCT00002893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92331980|NCT00002893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92331981|NCT00002893|Immunologic Factors|immunologic factors|mesh-ancestor
92331982|NCT00002893|Antidotes|antidotes|mesh-ancestor
92331983|NCT00002893|Protective Agents|protective agents|mesh-ancestor
92331984|NCT00002893|Vitamin B Complex|vitamin b complex|mesh-ancestor
92331985|NCT00002893|Vitamins|vitamins|mesh-ancestor
92331986|NCT00002893|Micronutrients|micronutrients|mesh-ancestor
92331987|NCT00002893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92331988|NCT00002893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92331989|NCT03905941|Metformin|metformin|mesh-list
92331990|NCT03905941|Contraceptive Agents|contraceptive agents|mesh-list
92331991|NCT03905941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92331992|NCT03905941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331993|NCT03905941|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92331994|NCT03818581|Suvorexant|suvorexant|mesh-list
92331995|NCT03818581|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92331996|NCT03818581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92331997|NCT03818581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92331998|NCT03818581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92331999|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92332000|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92332001|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332002|NCT00002905|Zidovudine|zidovudine|mesh-list
92332003|NCT00002905|Didanosine|didanosine|mesh-list
92332004|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
92332005|NCT00002905|Prednimustine|prednimustine|mesh-list
92332006|NCT00002905|Doxorubicin|doxorubicin|mesh-list
92332007|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332008|NCT00002905|Etoposide|etoposide|mesh-list
92332009|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
92332010|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332011|NCT00002905|Immunologic Factors|immunologic factors|mesh-ancestor
92332012|NCT00002905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332013|NCT00002905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332014|NCT00002905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332015|NCT00002905|Alkylating Agents|alkylating agents|mesh-ancestor
92332016|NCT00002905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332017|NCT00002905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332018|NCT00002905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332019|NCT00002905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332020|NCT00002905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332021|NCT00002905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332022|NCT00002905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332023|NCT00002905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332024|NCT00002905|Antimetabolites|antimetabolites|mesh-ancestor
92332025|NCT00002905|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92332026|NCT00002905|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332027|NCT00002905|Antiviral Agents|antiviral agents|mesh-ancestor
92332028|NCT00002905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332029|NCT00002905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92332030|NCT00002905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92332031|NCT00002905|Analgesics|analgesics|mesh-ancestor
92332032|NCT00002905|Sensory System Agents|sensory system agents|mesh-ancestor
92332033|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332034|NCT00002911|Marimastat|marimastat|mesh-list
92332035|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332036|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332037|NCT00002917|Paclitaxel|paclitaxel|mesh-list
92332038|NCT00002917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332039|NCT00002917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332040|NCT00002917|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332041|NCT00002917|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332042|NCT00002917|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332043|NCT00002917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332045|NCT00383695|Oxaliplatin|oxaliplatin|mesh-list
92332046|NCT00383695|Cetuximab|cetuximab|mesh-list
92332047|NCT00383695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332048|NCT00383695|Antimetabolites|antimetabolites|mesh-ancestor
92332049|NCT00383695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332050|NCT00383695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332051|NCT00383695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92332052|NCT00383851|Temozolomide|temozolomide|mesh-list
92332053|NCT00383851|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92332054|NCT00383851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332055|NCT00383851|Alkylating Agents|alkylating agents|mesh-ancestor
92332056|NCT00383851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332057|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332058|NCT00383851|Chelating Agents|chelating agents|mesh-ancestor
92332059|NCT00383851|Sequestering Agents|sequestering agents|mesh-ancestor
92332060|NCT00383851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332061|NCT00383851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92332062|NCT00383851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92332063|NCT00383851|Growth Substances|growth substances|mesh-ancestor
92332064|NCT00383851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332065|NCT00383851|Growth Inhibitors|growth inhibitors|mesh-ancestor
92332067|NCT00002923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332068|NCT00002923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92332069|NCT00002923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332070|NCT00002923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332071|NCT02636569|Diclofenac|diclofenac|mesh-list
92332072|NCT02636569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92332073|NCT02636569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92332074|NCT02636569|Analgesics|analgesics|mesh-ancestor
92332076|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332077|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332078|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332079|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332080|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92332081|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332082|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332083|NCT02461927|Midazolam|midazolam|mesh-list
92332084|NCT02461927|Naltrexone|naltrexone|mesh-list
92332085|NCT02461927|Ketamine|ketamine|mesh-list
92332086|NCT02461927|Analgesics|analgesics|mesh-ancestor
92332087|NCT02461927|Sensory System Agents|sensory system agents|mesh-ancestor
92332088|NCT02461927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332089|NCT02461927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332090|NCT02461927|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92332091|NCT02461927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92332092|NCT02461927|Anesthetics, General|anesthetics, general|mesh-ancestor
92332093|NCT02461927|Anesthetics|anesthetics|mesh-ancestor
92332094|NCT02461927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92332095|NCT02461927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92332096|NCT02461927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92332097|NCT02461927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92332098|NCT02461927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332099|NCT02461927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92332100|NCT02461927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92332101|NCT02461927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92332102|NCT02461927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92332103|NCT02461927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92332104|NCT02461927|GABA Modulators|gaba modulators|mesh-ancestor
92332105|NCT02461927|GABA Agents|gaba agents|mesh-ancestor
92332106|NCT02461927|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92332107|NCT02461927|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92332108|NCT00002935|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92332109|NCT00002935|Trioxsalen|trioxsalen|mesh-list
92332110|NCT00002935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332111|NCT00002935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332112|NCT00002935|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92332113|NCT00002941|Cyclophosphamide|cyclophosphamide|mesh-list
92332114|NCT00002941|Carmustine|carmustine|mesh-list
92332115|NCT00002941|Etoposide|etoposide|mesh-list
92332116|NCT00002941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332117|NCT00002941|Immunologic Factors|immunologic factors|mesh-ancestor
92332118|NCT00002941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332119|NCT00002941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332120|NCT00002941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332121|NCT00002941|Alkylating Agents|alkylating agents|mesh-ancestor
92332122|NCT00002941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332123|NCT00002941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332124|NCT00002941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332125|NCT00002941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332126|NCT00002941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332127|NCT00002941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332128|NCT00002941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332130|NCT00002953|Cyclophosphamide|cyclophosphamide|mesh-list
92332131|NCT00002953|Epirubicin|epirubicin|mesh-list
92332132|NCT00002953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332133|NCT00002953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332134|NCT00002953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332135|NCT00002953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332136|NCT00002953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332137|NCT00002953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332138|NCT00002953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332139|NCT00002953|Immunologic Factors|immunologic factors|mesh-ancestor
92332140|NCT00002953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332141|NCT00002953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332142|NCT00002953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332143|NCT00002953|Alkylating Agents|alkylating agents|mesh-ancestor
92332144|NCT00002953|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332145|NCT00002953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332146|NCT00002953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332147|NCT00002953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332148|NCT00002953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332149|NCT03693781|Colchicine|colchicine|mesh-list
92332150|NCT03693781|Gout Suppressants|gout suppressants|mesh-ancestor
92332151|NCT03693781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332152|NCT03693781|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332153|NCT03693781|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332154|NCT03693781|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332155|NCT03693781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332156|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332158|NCT02283853|Interferon-beta|interferon-beta|mesh-list
92332159|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
92332160|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92332161|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332162|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
92332163|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332164|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332165|NCT02283853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332166|NCT02283853|Immunologic Factors|immunologic factors|mesh-ancestor
92332167|NCT02283853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332168|NCT02283853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92332169|NCT03668041|Gabapentin|gabapentin|mesh-list
92332170|NCT03668041|Trazodone|trazodone|mesh-list
92332171|NCT03668041|Eszopiclone|eszopiclone|mesh-list
92332172|NCT03668041|Analgesics|analgesics|mesh-ancestor
92332173|NCT03668041|Sensory System Agents|sensory system agents|mesh-ancestor
92332174|NCT03668041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332175|NCT03668041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332176|NCT03668041|Anticonvulsants|anticonvulsants|mesh-ancestor
92332177|NCT03668041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92332178|NCT03668041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92332179|NCT03668041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92332180|NCT03668041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92332181|NCT03668041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92332182|NCT03668041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92332183|NCT03668041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92332184|NCT03668041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332185|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
92332186|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92332187|NCT03668041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92332188|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92332189|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92332190|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
92332191|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92332192|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
92332193|NCT00002965|Interferons|interferons|mesh-list
92332194|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
92332195|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
92332196|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92332197|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332198|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
92332199|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332200|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
92332201|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332202|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92332203|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332204|NCT00002971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332205|NCT00002971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332206|NCT00002977|Melphalan|melphalan|mesh-list
92332207|NCT00002977|Thiotepa|thiotepa|mesh-list
92332208|NCT00002977|Immunologic Factors|immunologic factors|mesh-ancestor
92332209|NCT00002977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332210|NCT00002977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984791|NCT05421819|Calcium|calcium|mesh-list
92332211|NCT00002977|Alkylating Agents|alkylating agents|mesh-ancestor
92332212|NCT00002977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332213|NCT00002977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332214|NCT00002977|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332215|NCT00002977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332217|NCT00003391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92332218|NCT00003391|Immunologic Factors|immunologic factors|mesh-ancestor
92332219|NCT00003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332220|NCT00003397|Dexamethasone|dexamethasone|mesh-list
92332221|NCT00003397|Paclitaxel|paclitaxel|mesh-list
92332222|NCT00003397|Etoposide|etoposide|mesh-list
92332223|NCT00003397|Cyclophosphamide|cyclophosphamide|mesh-list
92332224|NCT00003397|Rituximab|rituximab|mesh-list
92332225|NCT00003397|Gemcitabine|gemcitabine|mesh-list
92332226|NCT00003397|Melphalan|melphalan|mesh-list
92332227|NCT00003397|Carmustine|carmustine|mesh-list
92332228|NCT00003397|Sargramostim|sargramostim|mesh-list
92332229|NCT00003397|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332230|NCT00003397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332231|NCT00003397|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332232|NCT00003397|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332233|NCT00003397|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332234|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332235|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332236|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
92332237|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332238|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332239|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332240|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
92332241|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332242|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92332243|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332244|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
92332245|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
92332246|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332247|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92332248|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
92332249|NCT00003397|Hormones|hormones|mesh-ancestor
92332250|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332251|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332252|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332253|NCT00003397|Antimetabolites|antimetabolites|mesh-ancestor
92332254|NCT00003397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332255|NCT00003397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332256|NCT00003397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332257|NCT00003409|Motexafin gadolinium|motexafin gadolinium|mesh-list
92332258|NCT00003409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332259|NCT00003409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92332260|NCT00003409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332261|NCT00003415|Topotecan|topotecan|mesh-list
92332262|NCT00003415|Amifostine|amifostine|mesh-list
92332263|NCT00003415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92332264|NCT00003415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332265|NCT00003415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332266|NCT00003415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332267|NCT00003415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332268|NCT00003415|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92332269|NCT00003415|Protective Agents|protective agents|mesh-ancestor
92332270|NCT00003415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332271|NCT00002989|Cyclophosphamide|cyclophosphamide|mesh-list
92332272|NCT00002989|Melphalan|melphalan|mesh-list
92332273|NCT00002989|Busulfan|busulfan|mesh-list
92332274|NCT00002989|Idarubicin|idarubicin|mesh-list
92332275|NCT00002989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332276|NCT00002989|Immunologic Factors|immunologic factors|mesh-ancestor
92332277|NCT00002989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332278|NCT00002989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332279|NCT00002989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332280|NCT00002989|Alkylating Agents|alkylating agents|mesh-ancestor
92332281|NCT00002989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332282|NCT00002989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332283|NCT00002989|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332284|NCT00002989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332285|NCT00002989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332286|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332287|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332288|NCT00002995|Dactinomycin|dactinomycin|mesh-list
92332289|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
92332290|NCT00002995|Vincristine|vincristine|mesh-list
92332291|NCT00002995|Sargramostim|sargramostim|mesh-list
92332292|NCT00002995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332293|NCT00002995|Immunologic Factors|immunologic factors|mesh-ancestor
92332294|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332295|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332296|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332297|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
92332298|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332299|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332300|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332301|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332302|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332303|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332304|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332305|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92332306|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332307|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332308|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92332309|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332310|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332311|NCT00003001|Leucovorin|leucovorin|mesh-list
92332312|NCT00003001|Gemcitabine|gemcitabine|mesh-list
92332313|NCT00003001|Fluorouracil|fluorouracil|mesh-list
92332314|NCT00003001|Calcium|calcium|mesh-list
92332315|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
92332316|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332317|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
92332318|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332319|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332320|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92332321|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332322|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332323|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
92332324|NCT00003001|Antidotes|antidotes|mesh-ancestor
92332325|NCT00003001|Protective Agents|protective agents|mesh-ancestor
92332326|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
92332327|NCT00003001|Vitamins|vitamins|mesh-ancestor
92332328|NCT00003001|Micronutrients|micronutrients|mesh-ancestor
92332329|NCT00003421|Prednisolone|prednisolone|mesh-list
92332330|NCT00003421|Doxorubicin|doxorubicin|mesh-list
92332331|NCT00003421|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332332|NCT00003421|Bleomycin|bleomycin|mesh-list
92332333|NCT00003421|Etoposide|etoposide|mesh-list
92332334|NCT00003421|Vincristine|vincristine|mesh-list
92332335|NCT00003421|Dacarbazine|dacarbazine|mesh-list
92332336|NCT00003421|Vinblastine|vinblastine|mesh-list
92332337|NCT00003421|Procarbazine|procarbazine|mesh-list
92332338|NCT00003421|Chlorambucil|chlorambucil|mesh-list
92332339|NCT00003421|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332340|NCT00003421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332341|NCT00003421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332342|NCT00003421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332343|NCT00003421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332344|NCT00003421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332345|NCT00003421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332346|NCT00003421|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332347|NCT00003421|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332348|NCT00003421|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332349|NCT00003421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332350|NCT00003421|Glucocorticoids|glucocorticoids|mesh-ancestor
92332351|NCT00003421|Hormones|hormones|mesh-ancestor
92332352|NCT00003421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332353|NCT00003421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332354|NCT00003421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332355|NCT00003421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332356|NCT00003421|Alkylating Agents|alkylating agents|mesh-ancestor
92332357|NCT00003427|Oxaliplatin|oxaliplatin|mesh-list
92332358|NCT00003427|Irinotecan|irinotecan|mesh-list
92332359|NCT00003427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332360|NCT00003427|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92332361|NCT00003427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332362|NCT00003427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332363|NCT00003427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332364|NCT00003439|Interleukin-12|interleukin-12|mesh-list
92332365|NCT00003439|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92332367|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332368|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92332369|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92332370|NCT00003439|Growth Substances|growth substances|mesh-ancestor
92332371|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
92332372|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332373|NCT00003007|Interferons|interferons|mesh-list
92332374|NCT00003007|Interferon-alpha|interferon-alpha|mesh-list
92332375|NCT00003007|Dexamethasone|dexamethasone|mesh-list
92332376|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
92332377|NCT00003007|Melphalan|melphalan|mesh-list
92332378|NCT00003007|Sargramostim|sargramostim|mesh-list
92332379|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332380|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
92332381|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332382|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332383|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332384|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
92332385|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332386|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332387|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332388|NCT00003007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332389|NCT00003007|Antiemetics|antiemetics|mesh-ancestor
92332390|NCT00003007|Autonomic Agents|autonomic agents|mesh-ancestor
92332391|NCT00003007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332392|NCT00003007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92332393|NCT00003007|Glucocorticoids|glucocorticoids|mesh-ancestor
92332394|NCT00003007|Hormones|hormones|mesh-ancestor
92332395|NCT00003007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332396|NCT00003007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332397|NCT00003007|Antiviral Agents|antiviral agents|mesh-ancestor
92332398|NCT00003007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332399|NCT01478035|Phenytoin|phenytoin|mesh-list
92332400|NCT01478035|Anticonvulsants|anticonvulsants|mesh-ancestor
92332401|NCT01478035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92332402|NCT01478035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92332403|NCT01478035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92332404|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332405|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92332406|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92332407|NCT00003013|Tamoxifen|tamoxifen|mesh-list
92332408|NCT00003013|Paclitaxel|paclitaxel|mesh-list
92332409|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
92332410|NCT00003013|Doxorubicin|doxorubicin|mesh-list
92332411|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332412|NCT00003013|Fluorouracil|fluorouracil|mesh-list
92332414|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332415|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332416|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332417|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332418|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
91936942|NCT01372475|Protective Agents|protective agents|mesh-ancestor
92332419|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332420|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332421|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
92332422|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332423|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332424|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332425|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
92332426|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332427|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332428|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332429|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332430|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332431|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
92332432|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332433|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92332434|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
92332435|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332436|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332437|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92332438|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332439|NCT00003013|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92332440|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
91914660|NCT03183375|Antisickling Agents|antisickling agents|mesh-ancestor
92332441|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332443|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92332444|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92332445|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92332447|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332448|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332449|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332450|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332451|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332452|NCT00003451|Interferons|interferons|mesh-list
92332453|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
92332454|NCT00003451|Interleukin-12|interleukin-12|mesh-list
92332455|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332456|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
92332457|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332458|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
92332459|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332460|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92332461|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92332462|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92332463|NCT00003451|Growth Substances|growth substances|mesh-ancestor
92332464|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
92332465|NCT00003463|Irinotecan|irinotecan|mesh-list
92332466|NCT00003463|Carmustine|carmustine|mesh-list
92332467|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92332468|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332469|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332470|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332471|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332472|NCT00003463|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332473|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
92332474|NCT00003019|Methotrexate|methotrexate|mesh-list
92332475|NCT00003019|Vinblastine|vinblastine|mesh-list
92332476|NCT00003019|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92332477|NCT00003019|Abortifacient Agents|abortifacient agents|mesh-ancestor
92332478|NCT00003019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332479|NCT00003019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332480|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332481|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
92332482|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332483|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332484|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332485|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332486|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92332487|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332488|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
92332489|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332490|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332491|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332492|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332493|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332494|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332495|NCT00003493|Dexamethasone|dexamethasone|mesh-list
92332496|NCT00003493|Doxorubicin|doxorubicin|mesh-list
92332497|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332498|NCT00003493|Vincristine|vincristine|mesh-list
92332499|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332500|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
92332501|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
92332502|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332503|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332504|NCT00003493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92332506|NCT00003493|Hormones|hormones|mesh-ancestor
92332507|NCT00003493|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332508|NCT00003493|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332509|NCT00003493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332510|NCT00003493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332511|NCT00003493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332512|NCT00003493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332513|NCT00003493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985094|NCT01515527|Cytarabine|cytarabine|mesh-list
92332514|NCT00003493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332515|NCT00003493|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332516|NCT00003493|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332517|NCT00003493|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332518|NCT00003493|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332519|NCT00003031|Voriconazole|voriconazole|mesh-list
92332520|NCT00003031|Amphotericin B|amphotericin b|mesh-list
92332521|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92332522|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92332523|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
92332524|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
92332525|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332526|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92332527|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92332528|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349509|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
92332529|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332530|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92332531|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
92332532|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332533|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332534|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92332535|NCT00003031|Amebicides|amebicides|mesh-ancestor
92332536|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92332537|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92332538|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92332539|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92332540|NCT00003031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92332541|NCT00003517|Leuprolide|leuprolide|mesh-list
92332542|NCT00003517|Flutamide|flutamide|mesh-list
92332543|NCT00003517|Bicalutamide|bicalutamide|mesh-list
92332544|NCT00003517|Hormones|hormones|mesh-list
92332545|NCT00003517|Androgen Antagonists|androgen antagonists|mesh-list
92332546|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332547|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332548|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92332549|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
92332550|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332551|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332552|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332553|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
92332554|NCT00003037|Gemcitabine|gemcitabine|mesh-list
92332555|NCT00003037|Docetaxel|docetaxel|mesh-list
92332556|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332557|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332558|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
92332559|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332560|NCT00003037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332561|NCT00003037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332562|NCT00003037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332563|NCT00002803|Cyclophosphamide|cyclophosphamide|mesh-list
92332564|NCT00002803|Doxorubicin|doxorubicin|mesh-list
92332565|NCT00002803|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332566|NCT00002803|Vincristine|vincristine|mesh-list
92332567|NCT00002803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332568|NCT00002803|Immunologic Factors|immunologic factors|mesh-ancestor
92332569|NCT00002803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332570|NCT00002803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332571|NCT00002803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332572|NCT00002803|Alkylating Agents|alkylating agents|mesh-ancestor
92332573|NCT00002803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332574|NCT00002803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332575|NCT00002803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332576|NCT00002803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359092|NCT00324870|Bevacizumab|bevacizumab|mesh-list
92332577|NCT00002803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332578|NCT00002803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332579|NCT00002803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332580|NCT00002803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332581|NCT00002803|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332582|NCT00002803|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332583|NCT00002803|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332584|NCT00383929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92332586|NCT00383929|Candesartan cilexetil|candesartan cilexetil|mesh-list
92332587|NCT00383929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92332588|NCT00383929|Diuretics|diuretics|mesh-ancestor
92332589|NCT00383929|Natriuretic Agents|natriuretic agents|mesh-ancestor
92332590|NCT00383929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914661|NCT03183375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332591|NCT00383929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92332592|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92332593|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332594|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92332595|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92332597|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
92332598|NCT00003541|Ifosfamide|ifosfamide|mesh-list
92332599|NCT00003541|Carboplatin|carboplatin|mesh-list
92332600|NCT00003541|Doxorubicin|doxorubicin|mesh-list
92332601|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332602|NCT00003541|Etoposide|etoposide|mesh-list
92332603|NCT00003541|Vincristine|vincristine|mesh-list
92332604|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332605|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
92332606|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332607|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332608|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332609|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
92332610|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332611|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332612|NCT00003541|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332613|NCT00003541|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332614|NCT00003541|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332615|NCT00003541|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332616|NCT00003541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332617|NCT00003541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332618|NCT00003541|Glucocorticoids|glucocorticoids|mesh-ancestor
92332619|NCT00003541|Hormones|hormones|mesh-ancestor
92332620|NCT00003541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332621|NCT00003541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332622|NCT00003541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332624|NCT00003541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332625|NCT00003541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332626|NCT00002809|Cyclophosphamide|cyclophosphamide|mesh-list
92332627|NCT00002809|Methotrexate|methotrexate|mesh-list
92332628|NCT00002809|Tacrolimus|tacrolimus|mesh-list
92332629|NCT00002809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92332630|NCT00002809|Sargramostim|sargramostim|mesh-list
92332631|NCT00002809|Immunoglobulins|immunoglobulins|mesh-list
92332632|NCT00002809|Antibodies|antibodies|mesh-list
92332633|NCT00002809|gamma-Globulins|gamma-globulins|mesh-list
92332634|NCT00002809|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92332635|NCT00002809|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92332636|NCT00002809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332637|NCT00002809|Immunologic Factors|immunologic factors|mesh-ancestor
92332638|NCT00002809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332639|NCT00002809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332640|NCT00002809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332641|NCT00002809|Alkylating Agents|alkylating agents|mesh-ancestor
91936945|NCT00156065|Asenapine|asenapine|mesh-list
92332642|NCT00002809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332643|NCT00002809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332644|NCT00002809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332645|NCT00002809|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92332646|NCT00002809|Abortifacient Agents|abortifacient agents|mesh-ancestor
92332647|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332648|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332649|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
92332650|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332651|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332652|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92332653|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332654|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92332656|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
92332657|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332658|NCT00002827|Cobalt|cobalt|mesh-list
92332659|NCT00002827|Doxorubicin|doxorubicin|mesh-list
92332660|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332661|NCT00002827|Bleomycin|bleomycin|mesh-list
92332662|NCT00002827|Etoposide|etoposide|mesh-list
92332663|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
92332664|NCT00002827|Vincristine|vincristine|mesh-list
92332665|NCT00002827|Razoxane|razoxane|mesh-list
92332666|NCT00002827|Lenograstim|lenograstim|mesh-list
92332667|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332668|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332669|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332670|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332671|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332672|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332673|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332674|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92332675|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
92332676|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332677|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332678|NCT00002827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332679|NCT00002827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332680|NCT00002827|Trace Elements|trace elements|mesh-ancestor
92332681|NCT00002827|Micronutrients|micronutrients|mesh-ancestor
92332682|NCT00002827|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92332683|NCT00002827|Protective Agents|protective agents|mesh-ancestor
92332684|NCT00384475|Ciclesonide|ciclesonide|mesh-list
92332685|NCT00384475|Glucocorticoids|glucocorticoids|mesh-ancestor
92332686|NCT00384475|Hormones|hormones|mesh-ancestor
92332687|NCT00384475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332688|NCT00384475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332689|NCT00384475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92332690|NCT00003565|Docetaxel|docetaxel|mesh-list
92332691|NCT00003565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332692|NCT00003565|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332693|NCT00003565|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332694|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332695|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332696|NCT00003049|Leucovorin|leucovorin|mesh-list
92332697|NCT00003049|Fluorouracil|fluorouracil|mesh-list
92332698|NCT00003049|Calcium|calcium|mesh-list
92332699|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
92332700|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92332701|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332702|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
92332703|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332704|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332705|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332706|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332707|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
92332708|NCT00003049|Antidotes|antidotes|mesh-ancestor
92332709|NCT00003049|Protective Agents|protective agents|mesh-ancestor
92332710|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
92332711|NCT00003049|Vitamins|vitamins|mesh-ancestor
92332712|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
92332713|NCT00003055|Irinotecan|irinotecan|mesh-list
92332714|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332715|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92332716|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332717|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936946|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
92332718|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332719|NCT00002833|Cytarabine|cytarabine|mesh-list
92332720|NCT00002833|Cyclosporine|cyclosporine|mesh-list
92332721|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
92332722|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92332723|NCT00002833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92332724|NCT00002833|Prednisolone|prednisolone|mesh-list
92332725|NCT00002833|Prednisolone acetate|prednisolone acetate|mesh-list
92332726|NCT00002833|Fludarabine|fludarabine|mesh-list
92332727|NCT00002833|Fludarabine phosphate|fludarabine phosphate|mesh-list
92332728|NCT00002833|Idarubicin|idarubicin|mesh-list
92332729|NCT00002833|Cladribine|cladribine|mesh-list
92332730|NCT00002833|Cyclosporins|cyclosporins|mesh-list
92332731|NCT00002833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92332732|NCT00002833|Prednisolone phosphate|prednisolone phosphate|mesh-list
92332733|NCT00002833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332734|NCT00002833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332735|NCT00002833|Antimetabolites|antimetabolites|mesh-ancestor
92332736|NCT00002833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332737|NCT00002833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332738|NCT00002833|Immunologic Factors|immunologic factors|mesh-ancestor
92332739|NCT00002833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332740|NCT00002833|Antiviral Agents|antiviral agents|mesh-ancestor
92332741|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332742|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332743|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
92332744|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332745|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332746|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92332747|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332748|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
92332749|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
92332750|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92332751|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92332752|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
92332753|NCT00002833|Hormones|hormones|mesh-ancestor
92332754|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332755|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92332756|NCT00002833|Protective Agents|protective agents|mesh-ancestor
92332757|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332758|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332759|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332760|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332761|NCT00003061|Cytarabine|cytarabine|mesh-list
92332762|NCT00003061|Methotrexate|methotrexate|mesh-list
92332763|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92332764|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
92332765|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332766|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332767|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332768|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
92332769|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332770|NCT00003061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332771|NCT00003061|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332772|NCT00003061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332773|NCT00003061|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92332774|NCT00003061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332775|NCT00003061|Immunologic Factors|immunologic factors|mesh-ancestor
92332776|NCT00003061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332777|NCT00003061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332778|NCT00003061|Antiviral Agents|antiviral agents|mesh-ancestor
92332779|NCT00003061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332780|NCT00003577|Cyclophosphamide|cyclophosphamide|mesh-list
92332781|NCT00003577|Fluorouracil|fluorouracil|mesh-list
92332782|NCT00003577|Methotrexate|methotrexate|mesh-list
92332783|NCT00003577|Epirubicin|epirubicin|mesh-list
92332784|NCT00003577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359199|NCT00343044|Topotecan|topotecan|mesh-list
92332785|NCT00003577|Immunologic Factors|immunologic factors|mesh-ancestor
92332786|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332787|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332788|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332789|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
92332790|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332791|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332792|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332793|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
92332794|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332795|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92332797|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332798|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
92332799|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332800|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92332801|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332802|NCT00003577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332803|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332804|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332805|NCT00002839|Fluorouracil|fluorouracil|mesh-list
92332806|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332807|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
92332808|NCT00002839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332809|NCT00002839|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332810|NCT00002839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332811|NCT00002839|Immunologic Factors|immunologic factors|mesh-ancestor
92332812|NCT00002839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332813|NCT00003583|Etoposide|etoposide|mesh-list
92332814|NCT00003583|Amifostine|amifostine|mesh-list
92332815|NCT00003583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332816|NCT00003583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332817|NCT00003583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332818|NCT00003583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332819|NCT00003583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332820|NCT00003583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332821|NCT00003583|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92332822|NCT00003583|Protective Agents|protective agents|mesh-ancestor
92332823|NCT00003583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332824|NCT00002845|Aldesleukin|aldesleukin|mesh-list
92332825|NCT00002845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332826|NCT00002845|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92332827|NCT00002845|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92332828|NCT00002845|Antiviral Agents|antiviral agents|mesh-ancestor
92332829|NCT00002845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332830|NCT00003067|Aldesleukin|aldesleukin|mesh-list
92332831|NCT00003067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332832|NCT00003067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92332833|NCT00003067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92332834|NCT00003067|Antiviral Agents|antiviral agents|mesh-ancestor
92332835|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332836|NCT00003589|Paclitaxel|paclitaxel|mesh-list
92332837|NCT00003589|Gemcitabine|gemcitabine|mesh-list
92332838|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332839|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332840|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332841|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332842|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332843|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332844|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332845|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
92332846|NCT00003595|Prednisone|prednisone|mesh-list
92332847|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
92332848|NCT00003595|Rituximab|rituximab|mesh-list
92332849|NCT00003595|Doxorubicin|doxorubicin|mesh-list
92332850|NCT00003595|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92332851|NCT00003595|Vincristine|vincristine|mesh-list
92332852|NCT00003595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332853|NCT00003595|Immunologic Factors|immunologic factors|mesh-ancestor
92332854|NCT00003595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332855|NCT00003595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332856|NCT00003595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332857|NCT00003595|Alkylating Agents|alkylating agents|mesh-ancestor
92332858|NCT00003595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332859|NCT00003595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332860|NCT00003595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332861|NCT00003595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92332862|NCT00003595|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92332863|NCT00003595|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332864|NCT00003595|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332865|NCT00003595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332866|NCT00003595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332867|NCT00003595|Glucocorticoids|glucocorticoids|mesh-ancestor
92332868|NCT00003595|Hormones|hormones|mesh-ancestor
92332869|NCT00003595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332870|NCT00003595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332871|NCT00003595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332872|NCT00003595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332873|NCT00003595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332874|NCT00003595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332875|NCT00003073|Cytarabine|cytarabine|mesh-list
92332876|NCT00003073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332877|NCT00003073|Antimetabolites|antimetabolites|mesh-ancestor
92332878|NCT00003073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332879|NCT00003073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332880|NCT00003073|Antiviral Agents|antiviral agents|mesh-ancestor
92332881|NCT00003073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332882|NCT00003073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332883|NCT00003073|Immunologic Factors|immunologic factors|mesh-ancestor
92332884|NCT00003073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332885|NCT00003079|Cytarabine|cytarabine|mesh-list
92332886|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
92332887|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332888|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
92332889|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332890|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332891|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
92332892|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332893|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332894|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
91985467|NCT02381717|Morphine|morphine|mesh-list
92332895|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332896|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92332897|NCT00002869|Interferons|interferons|mesh-list
92332898|NCT00002869|Cytarabine|cytarabine|mesh-list
92332899|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
92332900|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
92332901|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332902|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
92332903|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332904|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332905|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
92332906|NCT00002869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332907|NCT00002869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332908|NCT00002869|Immunologic Factors|immunologic factors|mesh-ancestor
92332909|NCT00002869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332910|NCT00002869|Antisickling Agents|antisickling agents|mesh-ancestor
92332911|NCT00002869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332912|NCT00002869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92332913|NCT00002875|Cyclophosphamide|cyclophosphamide|mesh-list
92332914|NCT00002875|Lomustine|lomustine|mesh-list
92332915|NCT00002875|Cisplatin|cisplatin|mesh-list
92332916|NCT00002875|Vincristine|vincristine|mesh-list
92332917|NCT00002875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332918|NCT00002875|Immunologic Factors|immunologic factors|mesh-ancestor
92332919|NCT00002875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332920|NCT00002875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92332921|NCT00002875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332922|NCT00002875|Alkylating Agents|alkylating agents|mesh-ancestor
92332923|NCT00002875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332924|NCT00002875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332925|NCT00002875|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332926|NCT00002875|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332927|NCT00002875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92332928|NCT00002875|Antimitotic Agents|antimitotic agents|mesh-ancestor
92332929|NCT00002875|Mitosis Modulators|mitosis modulators|mesh-ancestor
92332930|NCT00003613|Carmustine|carmustine|mesh-list
92332931|NCT00003613|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92332932|NCT00003613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332933|NCT00003613|Alkylating Agents|alkylating agents|mesh-ancestor
92332934|NCT00003613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332935|NCT00003613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332936|NCT00003613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332937|NCT00002881|Suramin|suramin|mesh-list
92332938|NCT00002881|Hydrocortisone|hydrocortisone|mesh-list
92332939|NCT00002881|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92332940|NCT00002881|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92332941|NCT00002881|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92332944|NCT00002881|Flutamide|flutamide|mesh-list
92332945|NCT00002881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92332946|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92332947|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
92332948|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92332949|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332950|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92332951|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332952|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
92332953|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
92332954|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92332955|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
92332956|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
92332957|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92332958|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332959|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92332960|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92332961|NCT00003091|Interferons|interferons|mesh-list
92332962|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
92332963|NCT00003091|Aldesleukin|aldesleukin|mesh-list
92332964|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332965|NCT00003091|Antiviral Agents|antiviral agents|mesh-ancestor
92332966|NCT00003091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332967|NCT00003091|Immunologic Factors|immunologic factors|mesh-ancestor
92332968|NCT00003091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332969|NCT00003091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92332970|NCT00003091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92332971|NCT00003619|Vitamin E|vitamin e|mesh-list
92332972|NCT00003619|Cytarabine|cytarabine|mesh-list
92332973|NCT00003619|Fludarabine|fludarabine|mesh-list
92332974|NCT00003619|Fludarabine phosphate|fludarabine phosphate|mesh-list
92332975|NCT00003619|Etoposide|etoposide|mesh-list
92332976|NCT00003619|Busulfan|busulfan|mesh-list
92332977|NCT00003619|Topotecan|topotecan|mesh-list
92332978|NCT00003619|Isotretinoin|isotretinoin|mesh-list
92332979|NCT00003619|Vitamins|vitamins|mesh-ancestor
92332980|NCT00003619|Micronutrients|micronutrients|mesh-ancestor
92332981|NCT00003619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92332982|NCT00003619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92332983|NCT00003619|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92332984|NCT00003619|Antimetabolites|antimetabolites|mesh-ancestor
92332985|NCT00003619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92332986|NCT00003619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92332987|NCT00003619|Immunologic Factors|immunologic factors|mesh-ancestor
92332988|NCT00003619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92332989|NCT00003619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92332990|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92332991|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92332992|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
92332993|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92332994|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
92332995|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92332996|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92332997|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92332998|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
92332999|NCT00003619|Protective Agents|protective agents|mesh-ancestor
92333000|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333001|NCT00002887|Etoposide|etoposide|mesh-list
92333002|NCT00002887|Vinorelbine|vinorelbine|mesh-list
92333003|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
92333004|NCT00002887|Vinblastine|vinblastine|mesh-list
92333005|NCT00002887|Vindesine|vindesine|mesh-list
92333006|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333007|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333008|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333009|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333010|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333011|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333012|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333013|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333014|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333015|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
92333016|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92333017|NCT00003937|Cisplatin|cisplatin|mesh-list
92333018|NCT00003937|Doxorubicin|doxorubicin|mesh-list
92333019|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333020|NCT00003937|Methotrexate|methotrexate|mesh-list
92333021|NCT00003937|Etoposide|etoposide|mesh-list
92333022|NCT00003937|Ifosfamide|ifosfamide|mesh-list
92333023|NCT00003937|Dexrazoxane|dexrazoxane|mesh-list
92333024|NCT00003937|Razoxane|razoxane|mesh-list
92333025|NCT00003937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333026|NCT00003937|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333027|NCT00003937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333028|NCT00003937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333029|NCT00003937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333030|NCT00003937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333031|NCT00003937|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92333032|NCT00003937|Abortifacient Agents|abortifacient agents|mesh-ancestor
92333033|NCT00003937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92333034|NCT00003937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333035|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333036|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
92333037|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333038|NCT00003937|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92333039|NCT00003937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333040|NCT00003937|Immunologic Factors|immunologic factors|mesh-ancestor
92333041|NCT00003937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333042|NCT00003937|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92333043|NCT00003937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333044|NCT00003937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333045|NCT00003937|Alkylating Agents|alkylating agents|mesh-ancestor
92333046|NCT00003937|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92333047|NCT00003937|Protective Agents|protective agents|mesh-ancestor
92333048|NCT00003937|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333049|NCT00003937|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333050|NCT00003625|Cyclosporine|cyclosporine|mesh-list
92333051|NCT00003625|Etoposide|etoposide|mesh-list
92333052|NCT00003625|Vincristine|vincristine|mesh-list
92333053|NCT00003625|Cyclosporins|cyclosporins|mesh-list
92333054|NCT00003625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333055|NCT00003625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333056|NCT00003625|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333057|NCT00003625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333058|NCT00003625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333059|NCT00003625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333060|NCT00003625|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333061|NCT00003625|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333062|NCT00003625|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359290|NCT00351936|Aripiprazole|aripiprazole|mesh-list
92333063|NCT00003625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333064|NCT00003625|Immunologic Factors|immunologic factors|mesh-ancestor
92333065|NCT00003625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333066|NCT00003625|Antifungal Agents|antifungal agents|mesh-ancestor
92333067|NCT00003625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333068|NCT00003625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333069|NCT00003625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333070|NCT00003625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92333071|NCT00003637|Fluorouracil|fluorouracil|mesh-list
92333072|NCT00003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333073|NCT00003637|Antimetabolites|antimetabolites|mesh-ancestor
92333074|NCT00003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333075|NCT00003637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333076|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333077|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
92333078|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333079|NCT00003943|Paclitaxel|paclitaxel|mesh-list
92333080|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
92333081|NCT00003943|Carboplatin|carboplatin|mesh-list
92333082|NCT00003943|Topotecan|topotecan|mesh-list
92333083|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333084|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333085|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333086|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333087|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333088|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333089|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333090|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
92333091|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333092|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333093|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333094|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
92333095|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333096|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333097|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333098|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333099|NCT00003955|Dactinomycin|dactinomycin|mesh-list
92333100|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
92333102|NCT00003955|Vincristine|vincristine|mesh-list
92333103|NCT00003955|Sargramostim|sargramostim|mesh-list
92333104|NCT00003955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333105|NCT00003955|Immunologic Factors|immunologic factors|mesh-ancestor
92333106|NCT00003955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333107|NCT00003955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333108|NCT00003955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333109|NCT00003955|Alkylating Agents|alkylating agents|mesh-ancestor
92333110|NCT00003955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333111|NCT00003955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333112|NCT00003955|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333113|NCT00003955|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333114|NCT00003955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333115|NCT00003955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333116|NCT00003955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333117|NCT00003955|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333118|NCT00003955|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333119|NCT00003955|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333120|NCT00003955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92333121|NCT00003955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333122|NCT00003955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333123|NCT00003955|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92333124|NCT00003955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92333126|NCT00003103|Oblimersen|oblimersen|mesh-list
92333127|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333128|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333129|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333130|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333131|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333132|NCT00003109|Irinotecan|irinotecan|mesh-list
92333133|NCT00003109|Raltitrexed|raltitrexed|mesh-list
92333134|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333135|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333136|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333137|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333138|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333139|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333140|NCT00003109|Antimetabolites|antimetabolites|mesh-ancestor
92333141|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92333142|NCT00003643|Paclitaxel|paclitaxel|mesh-list
92333143|NCT00003643|Etoposide|etoposide|mesh-list
92333144|NCT00003643|Bleomycin|bleomycin|mesh-list
92333145|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333146|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333147|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333148|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333149|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333150|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333151|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333152|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333153|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333154|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333155|NCT00003961|Sargramostim|sargramostim|mesh-list
92333156|NCT00003961|Immunologic Factors|immunologic factors|mesh-ancestor
92333157|NCT00003961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333158|NCT00003661|Cyclosporine|cyclosporine|mesh-list
92333159|NCT00003661|Methylprednisolone|methylprednisolone|mesh-list
92333160|NCT00003661|Melphalan|melphalan|mesh-list
92333161|NCT00003661|Busulfan|busulfan|mesh-list
92333162|NCT00003661|Cyclosporins|cyclosporins|mesh-list
92333163|NCT00003661|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92333164|NCT00003661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333165|NCT00003661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333166|NCT00003661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333167|NCT00003661|Immunologic Factors|immunologic factors|mesh-ancestor
92333168|NCT00003661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333169|NCT00003661|Antifungal Agents|antifungal agents|mesh-ancestor
92333170|NCT00003661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333171|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333172|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333173|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92333174|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92333176|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
92333177|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92333178|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92333179|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
92333180|NCT00003661|Hormones|hormones|mesh-ancestor
92359342|NCT02982798|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92333181|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92333182|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92333183|NCT00003661|Protective Agents|protective agents|mesh-ancestor
92333184|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333185|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333186|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
92333187|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333188|NCT00003967|Etoposide|etoposide|mesh-list
92333189|NCT00003967|Topotecan|topotecan|mesh-list
92333190|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333191|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333192|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333193|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333194|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333195|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333196|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333197|NCT00003115|Hydromorphone|hydromorphone|mesh-list
92333198|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92333199|NCT00003115|Narcotics|narcotics|mesh-ancestor
92333200|NCT00003115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92333201|NCT00003115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333202|NCT00003115|Analgesics|analgesics|mesh-ancestor
92333203|NCT00003115|Sensory System Agents|sensory system agents|mesh-ancestor
92333204|NCT00003115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92333205|NCT00003667|Cyclophosphamide|cyclophosphamide|mesh-list
92333206|NCT00003667|Doxorubicin|doxorubicin|mesh-list
92333207|NCT00003667|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333208|NCT00003667|Vincristine|vincristine|mesh-list
92333209|NCT00003667|Dexrazoxane|dexrazoxane|mesh-list
92333210|NCT00003667|Razoxane|razoxane|mesh-list
92333211|NCT00003667|Glycerol|glycerol|mesh-list
92333212|NCT00003667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333213|NCT00003667|Immunologic Factors|immunologic factors|mesh-ancestor
92333214|NCT00003667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333215|NCT00003667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333216|NCT00003667|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333217|NCT00003667|Alkylating Agents|alkylating agents|mesh-ancestor
92333218|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333219|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333220|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333221|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333222|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333223|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333224|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333225|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333226|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333227|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333228|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333229|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92333230|NCT00003667|Protective Agents|protective agents|mesh-ancestor
92333232|NCT00003673|Gemtuzumab|gemtuzumab|mesh-list
92333233|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92333234|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333235|NCT00003673|Immunotoxins|immunotoxins|mesh-ancestor
92333236|NCT00003673|Immunoconjugates|immunoconjugates|mesh-ancestor
92333237|NCT00003673|Immunologic Factors|immunologic factors|mesh-ancestor
92333238|NCT00003673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333239|NCT00003679|Tamoxifen|tamoxifen|mesh-list
92333240|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
92333241|NCT00003679|Docetaxel|docetaxel|mesh-list
92333242|NCT00003679|Doxorubicin|doxorubicin|mesh-list
92333243|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333244|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333245|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
92333246|NCT00003679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333247|NCT00003679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333248|NCT00003679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333250|NCT00003679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333251|NCT00003679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333252|NCT00003679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333253|NCT00003679|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333254|NCT00003679|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333255|NCT00003679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333256|NCT00003679|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333257|NCT00003679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333258|NCT00003679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333259|NCT00003679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333260|NCT00003679|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92333261|NCT00003679|Hormone Antagonists|hormone antagonists|mesh-ancestor
92333262|NCT00003679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92333263|NCT00003679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92333264|NCT00003679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92333265|NCT00003679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92333266|NCT00003679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92333267|NCT00003985|KRN 7000|krn 7000|mesh-list
92333268|NCT00003985|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92333269|NCT00003985|Immunologic Factors|immunologic factors|mesh-ancestor
92333270|NCT00003985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333271|NCT00003985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333273|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92333274|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333275|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
92333276|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333277|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333279|NCT00003991|Histamine|histamine|mesh-list
92333280|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
92333281|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333282|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92333283|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92333284|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
92333285|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333286|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
92333287|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
92333288|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92333289|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333290|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333291|NCT00003997|Irofulven|irofulven|mesh-list
92333292|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333293|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
92333294|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333295|NCT00003997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333296|NCT00384631|Bevacizumab|bevacizumab|mesh-list
92333297|NCT00384631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92333298|NCT00384631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333299|NCT00384631|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92333300|NCT00384631|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92333301|NCT00384631|Growth Substances|growth substances|mesh-ancestor
92333302|NCT00384631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333303|NCT00384631|Growth Inhibitors|growth inhibitors|mesh-ancestor
92333304|NCT00003127|Paclitaxel|paclitaxel|mesh-list
92333305|NCT00003127|Carboplatin|carboplatin|mesh-list
92333306|NCT00003127|Amifostine|amifostine|mesh-list
92333307|NCT00003127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333308|NCT00003127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333309|NCT00003127|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333310|NCT00003127|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333311|NCT00003127|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333312|NCT00003127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333313|NCT00003127|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92333314|NCT00003127|Protective Agents|protective agents|mesh-ancestor
92333315|NCT00003127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333316|NCT00004003|Gemcitabine|gemcitabine|mesh-list
92333317|NCT00004003|Fluorouracil|fluorouracil|mesh-list
92333318|NCT00004003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333319|NCT00004003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333320|NCT00004003|Antimetabolites|antimetabolites|mesh-ancestor
92333321|NCT00004003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936954|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92333323|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
92333324|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333325|NCT00004009|Tipifarnib|tipifarnib|mesh-list
92333326|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333327|NCT00003133|Paclitaxel|paclitaxel|mesh-list
92333328|NCT00003133|Gemcitabine|gemcitabine|mesh-list
92333329|NCT00003133|Doxorubicin|doxorubicin|mesh-list
92333330|NCT00003133|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333331|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333332|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333333|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333334|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333335|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333336|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333337|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333338|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
92333339|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333340|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92359407|NCT03549000|Spartalizumab|spartalizumab|mesh-list
92333341|NCT00003133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333343|NCT00003691|Paclitaxel|paclitaxel|mesh-list
92333344|NCT00003691|Doxorubicin|doxorubicin|mesh-list
92333345|NCT00003691|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333346|NCT00003691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333347|NCT00003691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333348|NCT00003691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333349|NCT00003691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333350|NCT00003691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333351|NCT00003691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333352|NCT00003691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333353|NCT00003691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333354|NCT00003691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333355|NCT00003691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333356|NCT00003139|Pilocarpine|pilocarpine|mesh-list
92333357|NCT00003139|Miotics|miotics|mesh-ancestor
92333358|NCT00003139|Autonomic Agents|autonomic agents|mesh-ancestor
92333359|NCT00003139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92333360|NCT00003139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333361|NCT00003139|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92333362|NCT00003139|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92333363|NCT00003139|Cholinergic Agents|cholinergic agents|mesh-ancestor
92333364|NCT00003139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92333365|NCT00003139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333366|NCT00003697|Vadimezan|vadimezan|mesh-list
92333367|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333368|NCT02972983|Daptomycin|daptomycin|mesh-list
92333369|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359433|NCT03984240|Anesthetics|anesthetics|mesh-ancestor
92333370|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333371|NCT00003709|Carbendazim|carbendazim|mesh-list
92333372|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
92333373|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
92333374|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92333375|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333376|NCT00003145|Cyclosporine|cyclosporine|mesh-list
92333377|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
92333378|NCT00003145|Fludarabine|fludarabine|mesh-list
92333379|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
92333380|NCT00003145|Cyclosporins|cyclosporins|mesh-list
92333381|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333382|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333383|NCT00003145|Antimetabolites|antimetabolites|mesh-ancestor
92333384|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333385|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333386|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
92333387|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333388|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333389|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
92333390|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333391|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333392|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333393|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92333394|NCT00003145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333395|NCT00003145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92333396|NCT00003145|Antitubercular Agents|antitubercular agents|mesh-ancestor
92333397|NCT00003145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92333398|NCT00004039|Interferons|interferons|mesh-list
92333400|NCT00004039|Prednisone|prednisone|mesh-list
92333401|NCT00004039|Cyclophosphamide|cyclophosphamide|mesh-list
92333402|NCT00004039|Rituximab|rituximab|mesh-list
92333403|NCT00004039|Doxorubicin|doxorubicin|mesh-list
92333404|NCT00004039|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333405|NCT00004039|Vincristine|vincristine|mesh-list
92333406|NCT00004039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333407|NCT00004039|Immunologic Factors|immunologic factors|mesh-ancestor
92333408|NCT00004039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333409|NCT00004039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333410|NCT00004039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333411|NCT00004039|Alkylating Agents|alkylating agents|mesh-ancestor
92333412|NCT00004039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333413|NCT00004039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333414|NCT00004039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333415|NCT00004039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92333416|NCT00004039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333417|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333418|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333419|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333420|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92333421|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
92333422|NCT00004039|Hormones|hormones|mesh-ancestor
92333423|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92333424|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92333425|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
92333426|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333427|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333428|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333429|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333430|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333432|NCT00003151|Metronidazole|metronidazole|mesh-list
92333433|NCT00003151|Clarithromycin|clarithromycin|mesh-list
91985999|NCT02369939|Mitomycins|mitomycins|mesh-list
92333435|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92333436|NCT00003151|Omeprazole|omeprazole|mesh-list
92333437|NCT00003151|Bismuth|bismuth|mesh-list
92333438|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92333439|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333440|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92333441|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92333442|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92333443|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92333444|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92333445|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333446|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333447|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92333448|NCT00003151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92333449|NCT00003151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92333450|NCT00003151|Antacids|antacids|mesh-ancestor
92333451|NCT00004045|Exatecan|exatecan|mesh-list
92333452|NCT00004045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333453|NCT00004045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333454|NCT00004045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333455|NCT00004045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333456|NCT00004045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333457|NCT00003715|Interferons|interferons|mesh-list
92333458|NCT00003715|Interferon-alpha|interferon-alpha|mesh-list
92333459|NCT00003715|Cyclophosphamide|cyclophosphamide|mesh-list
92333461|NCT00003715|BCG Vaccine|bcg vaccine|mesh-list
92333462|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
92333463|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333464|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333465|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333466|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333467|NCT00003715|Alkylating Agents|alkylating agents|mesh-ancestor
92333468|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333469|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333470|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333472|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333473|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92333474|NCT00004051|Irinotecan|irinotecan|mesh-list
92333475|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333476|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333478|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333479|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333480|NCT00003727|Interferons|interferons|mesh-list
92333481|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
92333482|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
92333484|NCT00003727|Carmustine|carmustine|mesh-list
92333485|NCT00003727|Gemcitabine|gemcitabine|mesh-list
92333486|NCT00003727|Etoposide|etoposide|mesh-list
92333487|NCT00003727|Sargramostim|sargramostim|mesh-list
92333488|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333489|NCT00003727|Immunologic Factors|immunologic factors|mesh-ancestor
92333490|NCT00003727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333491|NCT00003727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333492|NCT00003727|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333493|NCT00003727|Alkylating Agents|alkylating agents|mesh-ancestor
92333494|NCT00003727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333495|NCT00003727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333496|NCT00003727|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333497|NCT00003727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333498|NCT00003727|Antimetabolites|antimetabolites|mesh-ancestor
92333499|NCT00003727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333500|NCT00003727|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333501|NCT00003727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333502|NCT00003727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333503|NCT00003727|Antiviral Agents|antiviral agents|mesh-ancestor
92333504|NCT00003727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333505|NCT00003157|Gemcitabine|gemcitabine|mesh-list
92333506|NCT00003157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333507|NCT00003157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333508|NCT00003157|Antimetabolites|antimetabolites|mesh-ancestor
92333509|NCT00003157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333510|NCT00004057|Paclitaxel|paclitaxel|mesh-list
91986070|NCT05653895|Resveratrol|resveratrol|mesh-list
92333511|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92359515|NCT00360672|Lenalidomide|lenalidomide|mesh-list
92333512|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333513|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333514|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333515|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333516|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333517|NCT00004063|Interferons|interferons|mesh-list
92333518|NCT00004063|Interferon-alpha|interferon-alpha|mesh-list
92333519|NCT00004063|Gemcitabine|gemcitabine|mesh-list
92333520|NCT00004063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333521|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333522|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
92333523|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333524|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
92333525|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333526|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
92333527|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333529|NCT00003733|Carboplatin|carboplatin|mesh-list
92333530|NCT00003733|Topotecan|topotecan|mesh-list
92333531|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333532|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333533|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333534|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333535|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333536|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333537|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333538|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333539|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333540|NCT00003739|Lenograstim|lenograstim|mesh-list
92333541|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92333542|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
92333543|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333544|NCT00003745|Topotecan|topotecan|mesh-list
92333545|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333546|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333547|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333548|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333549|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333550|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
92333551|NCT00003163|Melphalan|melphalan|mesh-list
92333552|NCT00003163|Sargramostim|sargramostim|mesh-list
92333553|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333554|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
92333555|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333557|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333558|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
92333559|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333560|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333561|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333562|NCT00004081|Docetaxel|docetaxel|mesh-list
92333563|NCT00004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333564|NCT00004081|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333565|NCT00004081|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333566|NCT00004081|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333567|NCT00004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333568|NCT00003751|Penicillamine|penicillamine|mesh-list
92333569|NCT00003751|Antidotes|antidotes|mesh-ancestor
92333570|NCT00003751|Protective Agents|protective agents|mesh-ancestor
92333571|NCT00003751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333572|NCT00003751|Chelating Agents|chelating agents|mesh-ancestor
92333573|NCT00003751|Sequestering Agents|sequestering agents|mesh-ancestor
92333574|NCT00003751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333575|NCT00003751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333576|NCT00004087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92333578|NCT00004087|Immunoglobulins|immunoglobulins|mesh-list
92333579|NCT00004087|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92333580|NCT00004087|Immunologic Factors|immunologic factors|mesh-ancestor
92333581|NCT00004087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333582|NCT00004087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333583|NCT00003757|Rituximab|rituximab|mesh-list
91986150|NCT03344159|Spironolactone|spironolactone|mesh-list
92333584|NCT00003757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92333585|NCT00003757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333586|NCT00003757|Immunologic Factors|immunologic factors|mesh-ancestor
92333587|NCT00003757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333588|NCT00003757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333589|NCT00003175|Fluorouracil|fluorouracil|mesh-list
92333590|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
92333591|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333592|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333593|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333594|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333595|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
92333596|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333597|NCT00004099|Leucovorin|leucovorin|mesh-list
92333598|NCT00004099|Fluorouracil|fluorouracil|mesh-list
92333599|NCT00004099|Calcium|calcium|mesh-list
92333600|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
92333601|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333602|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92333603|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333604|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
92333605|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333606|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333607|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333608|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
92359866|NCT05220462|Midazolam|midazolam|mesh-list
92333609|NCT00004099|Antidotes|antidotes|mesh-ancestor
92333610|NCT00004099|Protective Agents|protective agents|mesh-ancestor
92333611|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
92333612|NCT00004099|Vitamins|vitamins|mesh-ancestor
92333613|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
92333614|NCT00003763|Folic Acid|folic acid|mesh-list
92333615|NCT00003763|Hematinics|hematinics|mesh-ancestor
92333616|NCT00003763|Vitamin B Complex|vitamin b complex|mesh-ancestor
92333617|NCT00003763|Vitamins|vitamins|mesh-ancestor
92333618|NCT00003763|Micronutrients|micronutrients|mesh-ancestor
92333619|NCT00003763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333620|NCT00003181|Aldesleukin|aldesleukin|mesh-list
92333621|NCT00003181|Vinblastine|vinblastine|mesh-list
92333622|NCT00003181|Sargramostim|sargramostim|mesh-list
92333623|NCT00003181|Immunologic Factors|immunologic factors|mesh-ancestor
92333624|NCT00003181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333625|NCT00003181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333626|NCT00003181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92333627|NCT00003181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92333628|NCT00003181|Antiviral Agents|antiviral agents|mesh-ancestor
92333629|NCT00003181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333630|NCT00003181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333631|NCT00003181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333632|NCT00003181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333633|NCT00003181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333634|NCT00003181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333635|NCT00004105|Paclitaxel|paclitaxel|mesh-list
92333636|NCT00004105|Vinorelbine|vinorelbine|mesh-list
92333637|NCT00004105|Estramustine|estramustine|mesh-list
92333638|NCT00004105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333639|NCT00004105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333640|NCT00004105|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333641|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333642|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333643|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333644|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333645|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
92333646|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92333647|NCT00003187|Cytarabine|cytarabine|mesh-list
92333648|NCT00003187|Cyclosporine|cyclosporine|mesh-list
92333649|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
92333650|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
92333651|NCT00003187|Methotrexate|methotrexate|mesh-list
92333652|NCT00003187|Cyclosporins|cyclosporins|mesh-list
92333653|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333654|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
92333655|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333656|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333657|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333658|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
92333659|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333660|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333661|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333662|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92333663|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
92333664|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92333665|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333666|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
92333667|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333668|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333669|NCT00003187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92333670|NCT00003187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92333671|NCT00003187|Antiviral Agents|antiviral agents|mesh-ancestor
92333672|NCT00003187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333673|NCT00003187|Antifungal Agents|antifungal agents|mesh-ancestor
92333674|NCT00003187|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92333675|NCT00003187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92333676|NCT00003187|Antiemetics|antiemetics|mesh-ancestor
92333677|NCT00003187|Autonomic Agents|autonomic agents|mesh-ancestor
92333678|NCT00003187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92333679|NCT00003187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92333680|NCT00003187|Glucocorticoids|glucocorticoids|mesh-ancestor
92333681|NCT00003187|Hormones|hormones|mesh-ancestor
92333682|NCT00003187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92333683|NCT00003187|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92333684|NCT00003187|Protective Agents|protective agents|mesh-ancestor
92333685|NCT00003769|Perillyl alcohol|perillyl alcohol|mesh-list
92333686|NCT00003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333687|NCT00003769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333688|NCT00003769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333689|NCT00003775|Leflunomide|leflunomide|mesh-list
92333690|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333691|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333692|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333693|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
92360103|NCT00384774|Lasmiditan|lasmiditan|mesh-list
92333694|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333695|NCT00004123|Doxorubicin|doxorubicin|mesh-list
92333696|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333697|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333698|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333699|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333700|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333701|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333702|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333703|NCT00003781|Docetaxel|docetaxel|mesh-list
92333704|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333705|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333706|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333707|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333708|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333709|NCT00003193|Paclitaxel|paclitaxel|mesh-list
92333710|NCT00003193|Amifostine|amifostine|mesh-list
92333711|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333712|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333713|NCT00003193|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333714|NCT00003193|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333715|NCT00003193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333716|NCT00003193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333717|NCT00003193|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92333718|NCT00003193|Protective Agents|protective agents|mesh-ancestor
92333719|NCT00003193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333720|NCT00004135|Cyclophosphamide|cyclophosphamide|mesh-list
92333721|NCT00004135|Fludarabine|fludarabine|mesh-list
92333722|NCT00004135|Fludarabine phosphate|fludarabine phosphate|mesh-list
92333723|NCT00004135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333724|NCT00004135|Immunologic Factors|immunologic factors|mesh-ancestor
92333725|NCT00004135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333726|NCT00004135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333727|NCT00004135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333728|NCT00004135|Alkylating Agents|alkylating agents|mesh-ancestor
92333729|NCT00004135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333730|NCT00004135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333731|NCT00004135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333732|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333733|NCT00004135|Antimetabolites|antimetabolites|mesh-ancestor
92333734|NCT00004141|Dacarbazine|dacarbazine|mesh-list
92333735|NCT00004141|Molgramostim|molgramostim|mesh-list
92333736|NCT00004141|Sargramostim|sargramostim|mesh-list
92333737|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333738|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333739|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
92333740|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333741|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
92333742|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333743|NCT02972905|Nemiralisib|nemiralisib|mesh-list
92333744|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92333745|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333746|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333747|NCT00003799|Leucovorin|leucovorin|mesh-list
92333748|NCT00003799|Fluorouracil|fluorouracil|mesh-list
92333749|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
92333750|NCT00003799|Calcium|calcium|mesh-list
92333751|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
92333752|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92333753|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333754|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
92333755|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333756|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333757|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333758|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333759|NCT00003799|Immunologic Factors|immunologic factors|mesh-ancestor
92333760|NCT00003799|Antidotes|antidotes|mesh-ancestor
92333761|NCT00003799|Protective Agents|protective agents|mesh-ancestor
92333762|NCT00003799|Vitamin B Complex|vitamin b complex|mesh-ancestor
92333763|NCT00003799|Vitamins|vitamins|mesh-ancestor
92333764|NCT00003799|Micronutrients|micronutrients|mesh-ancestor
92333766|NCT00003205|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92333767|NCT00003205|Immunologic Factors|immunologic factors|mesh-ancestor
92333768|NCT00003205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333769|NCT00003205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333770|NCT00003211|Cyclophosphamide|cyclophosphamide|mesh-list
92333771|NCT00003211|Vincristine|vincristine|mesh-list
92333772|NCT00003211|Amifostine|amifostine|mesh-list
92333773|NCT00003211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333774|NCT00003211|Immunologic Factors|immunologic factors|mesh-ancestor
92333775|NCT00003211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333776|NCT00003211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333777|NCT00003211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333778|NCT00003211|Alkylating Agents|alkylating agents|mesh-ancestor
92333779|NCT00003211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333780|NCT00003211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333781|NCT00003211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333782|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333783|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333784|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333785|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333786|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92333787|NCT00003211|Protective Agents|protective agents|mesh-ancestor
92333789|NCT00003805|Tazobactam|tazobactam|mesh-list
92333790|NCT00003805|Piperacillin|piperacillin|mesh-list
92333791|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92333792|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92333793|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360503|NCT00530634|Gemcitabine|gemcitabine|mesh-list
92333794|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92333795|NCT00003805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333796|NCT00003805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333797|NCT00004159|Paclitaxel|paclitaxel|mesh-list
92333798|NCT00004159|Gemcitabine|gemcitabine|mesh-list
92333799|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333800|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333801|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333802|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333803|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333804|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333805|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333806|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
92333807|NCT00003811|Etoposide|etoposide|mesh-list
92333808|NCT00003811|Bleomycin|bleomycin|mesh-list
92333809|NCT00003811|Amifostine|amifostine|mesh-list
92333810|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333811|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333812|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333813|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333814|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333815|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333816|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333817|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92333818|NCT00003811|Protective Agents|protective agents|mesh-ancestor
92333819|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333820|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92333822|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
92333823|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92333824|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
92333825|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333826|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333827|NCT00003817|Ondansetron|ondansetron|mesh-list
92333828|NCT00003817|Granisetron|granisetron|mesh-list
92333829|NCT00003817|Tropisetron|tropisetron|mesh-list
92333830|NCT00003817|Dolasetron|dolasetron|mesh-list
92333831|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
92333832|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
92333833|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92333834|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333835|NCT00003817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92333836|NCT00003817|Antipruritics|antipruritics|mesh-ancestor
92333837|NCT00003817|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333838|NCT00003817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92333839|NCT00003817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92360692|NCT01795794|Omeprazole|omeprazole|mesh-list
92333840|NCT00003817|Serotonin Agents|serotonin agents|mesh-ancestor
92333841|NCT00003817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92333842|NCT00003817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333843|NCT00003829|Cyclophosphamide|cyclophosphamide|mesh-list
92333844|NCT00003829|Fludarabine|fludarabine|mesh-list
92333845|NCT00003829|Fludarabine phosphate|fludarabine phosphate|mesh-list
92333846|NCT00003829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333847|NCT00003829|Immunologic Factors|immunologic factors|mesh-ancestor
92333848|NCT00003829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333849|NCT00003829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333850|NCT00003829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333851|NCT00003829|Alkylating Agents|alkylating agents|mesh-ancestor
92333852|NCT00003829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333853|NCT00003829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333854|NCT00003829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333855|NCT00003829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333856|NCT00003829|Antimetabolites|antimetabolites|mesh-ancestor
92360752|NCT00539526|Bimatoprost|bimatoprost|mesh-list
92333858|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92333859|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92333860|NCT04329403|Analgesics|analgesics|mesh-ancestor
92333861|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
92333862|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92333863|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333864|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92333865|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333866|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333867|NCT00003217|Cytarabine|cytarabine|mesh-list
92333868|NCT00003217|Dexamethasone|dexamethasone|mesh-list
92333869|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
92333870|NCT00003217|Doxorubicin|doxorubicin|mesh-list
92333871|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333872|NCT00003217|Methotrexate|methotrexate|mesh-list
92333874|NCT00003217|Lenograstim|lenograstim|mesh-list
92333875|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333876|NCT00003217|Immunologic Factors|immunologic factors|mesh-ancestor
92333877|NCT00003217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333878|NCT00003217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92333879|NCT00003217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92333880|NCT00003217|Alkylating Agents|alkylating agents|mesh-ancestor
92333881|NCT00003217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333882|NCT00003217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333883|NCT00003217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92333884|NCT00003217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92333885|NCT00003217|Antiemetics|antiemetics|mesh-ancestor
92333886|NCT00003217|Autonomic Agents|autonomic agents|mesh-ancestor
92333887|NCT00003217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986445|NCT02358707|Analgesics|analgesics|mesh-ancestor
92333888|NCT00003217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92333889|NCT00003217|Glucocorticoids|glucocorticoids|mesh-ancestor
92333890|NCT00003217|Hormones|hormones|mesh-ancestor
92360977|NCT00449046|Xhance|xhance|mesh-list
92333891|NCT00003217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92333892|NCT00003217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92333893|NCT00003217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333894|NCT00003217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333895|NCT00003217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333896|NCT00003217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333897|NCT00003217|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92333898|NCT00003217|Abortifacient Agents|abortifacient agents|mesh-ancestor
92333899|NCT00003217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92361002|NCT00449748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333900|NCT00003217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333901|NCT00003217|Antimetabolites|antimetabolites|mesh-ancestor
92333902|NCT00003217|Dermatologic Agents|dermatologic agents|mesh-ancestor
92333903|NCT00003217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92333904|NCT00003217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92333905|NCT00003217|Antiviral Agents|antiviral agents|mesh-ancestor
92333906|NCT00003217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333907|NCT00003217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92361067|NCT00452868|Nootropic Agents|nootropic agents|mesh-ancestor
92333908|NCT00003217|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333909|NCT00003217|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333910|NCT00003217|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333911|NCT00003217|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333913|NCT00004183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333914|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
92333915|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333916|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333917|NCT00003223|Fenretinide|fenretinide|mesh-list
92333918|NCT00003223|Retinamide|retinamide|mesh-list
92333919|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333920|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92333921|NCT00003223|Protective Agents|protective agents|mesh-ancestor
92333922|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333923|NCT00004189|Cisplatin|cisplatin|mesh-list
92333924|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333925|NCT00003229|Aldesleukin|aldesleukin|mesh-list
92333926|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333927|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92333928|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92333929|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
92333930|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92333931|NCT00003835|Leucovorin|leucovorin|mesh-list
92333932|NCT00003835|Fluorouracil|fluorouracil|mesh-list
92333933|NCT00003835|Irinotecan|irinotecan|mesh-list
92333934|NCT00003835|Calcium|calcium|mesh-list
92333935|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
92333936|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92333937|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333938|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
92333939|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333940|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333941|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333942|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333943|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
92333944|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92333945|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333946|NCT00003835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333947|NCT00003835|Antidotes|antidotes|mesh-ancestor
92333948|NCT00003835|Protective Agents|protective agents|mesh-ancestor
92333949|NCT00003835|Vitamin B Complex|vitamin b complex|mesh-ancestor
92333951|NCT00003835|Micronutrients|micronutrients|mesh-ancestor
92333952|NCT00003847|Doxorubicin|doxorubicin|mesh-list
92333953|NCT00003847|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92333954|NCT00003847|Vincristine|vincristine|mesh-list
92333955|NCT00003847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333956|NCT00003847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333957|NCT00003847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92333958|NCT00003847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92333959|NCT00003847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333960|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333961|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92333962|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92333963|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92333964|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92333965|NCT00004195|Eniluracil|eniluracil|mesh-list
91986518|NCT02357615|Nifedipine|nifedipine|mesh-list
92333966|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333967|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92333968|NCT00003853|Esorubicin|esorubicin|mesh-list
92333969|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92333970|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333971|NCT00385021|Leucovorin|leucovorin|mesh-list
92333972|NCT00385021|Fluorouracil|fluorouracil|mesh-list
92333973|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
92333974|NCT00385021|Bevacizumab|bevacizumab|mesh-list
92333975|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
91914738|NCT02108639|Protease Inhibitors|protease inhibitors|mesh-ancestor
92333976|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333977|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333978|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333979|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92333980|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
92333981|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92333982|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92333983|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92333984|NCT00385021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92333985|NCT00385021|Growth Substances|growth substances|mesh-ancestor
92333986|NCT00385021|Growth Inhibitors|growth inhibitors|mesh-ancestor
92333987|NCT00385021|Antidotes|antidotes|mesh-ancestor
92333988|NCT00385021|Protective Agents|protective agents|mesh-ancestor
92333989|NCT00385021|Vitamin B Complex|vitamin b complex|mesh-ancestor
92333990|NCT00385021|Vitamins|vitamins|mesh-ancestor
92333991|NCT00385021|Micronutrients|micronutrients|mesh-ancestor
92333992|NCT00004201|Carboplatin|carboplatin|mesh-list
92333993|NCT00004201|Gemcitabine|gemcitabine|mesh-list
92333994|NCT00004201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92333995|NCT00004201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92333996|NCT00004201|Antimetabolites|antimetabolites|mesh-ancestor
92333997|NCT00004201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92333999|NCT00003241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334000|NCT00003241|Antimetabolites|antimetabolites|mesh-ancestor
92361735|NCT00605904|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92334001|NCT00003241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334002|NCT00003241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334003|NCT00003859|Cyclophosphamide|cyclophosphamide|mesh-list
92334004|NCT00003859|Carboplatin|carboplatin|mesh-list
92334006|NCT00003859|Vincristine|vincristine|mesh-list
92334007|NCT00003859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334008|NCT00003859|Immunologic Factors|immunologic factors|mesh-ancestor
92334009|NCT00003859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334010|NCT00003859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334011|NCT00003859|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334012|NCT00003859|Alkylating Agents|alkylating agents|mesh-ancestor
92334013|NCT00003859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334014|NCT00003859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334015|NCT00003859|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334016|NCT00003859|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361809|NCT02897700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334017|NCT00003859|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334018|NCT00003859|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334019|NCT00003859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334020|NCT00003859|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334021|NCT00003859|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334022|NCT00003859|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334023|NCT00003865|Toremifene|toremifene|mesh-list
92334024|NCT00003865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92334025|NCT00003865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334026|NCT00003865|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92334027|NCT00003865|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92334028|NCT00003865|Hormone Antagonists|hormone antagonists|mesh-ancestor
92334029|NCT00003865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334030|NCT00003865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334031|NCT00003865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92334032|NCT00004207|Daunorubicin|daunorubicin|mesh-list
92334033|NCT00004207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334034|NCT00004207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334035|NCT00004207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334036|NCT00004207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334037|NCT00004207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334038|NCT00004207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334039|NCT00004219|Granisetron|granisetron|mesh-list
92334040|NCT00004219|Antiemetics|antiemetics|mesh-ancestor
92334041|NCT00004219|Autonomic Agents|autonomic agents|mesh-ancestor
92334042|NCT00004219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334043|NCT00004219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334044|NCT00004219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334045|NCT00004219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92334046|NCT00004219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92334047|NCT00004219|Serotonin Agents|serotonin agents|mesh-ancestor
92334048|NCT00004219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914739|NCT02108639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334049|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334050|NCT00003877|Paclitaxel|paclitaxel|mesh-list
92334051|NCT00003877|Cyclophosphamide|cyclophosphamide|mesh-list
92334052|NCT00003877|Carboplatin|carboplatin|mesh-list
92334053|NCT00003877|Thiotepa|thiotepa|mesh-list
92334054|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334055|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334056|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334057|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334058|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361915|NCT00612222|Analgesics|analgesics|mesh-ancestor
92334059|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334060|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334062|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334063|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334064|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334065|NCT00003877|Alkylating Agents|alkylating agents|mesh-ancestor
92334066|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334067|NCT00003883|Itraconazole|itraconazole|mesh-list
92334068|NCT00003883|Fluconazole|fluconazole|mesh-list
92334069|NCT00003883|Antifungal Agents|antifungal agents|mesh-ancestor
92334071|NCT00003883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92334072|NCT00003883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92334073|NCT00003883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334074|NCT00003883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334075|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92334076|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
92334077|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334078|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334079|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92334080|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92334081|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92334083|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
92334085|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
92334087|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92362040|NCT00617058|Metformin|metformin|mesh-list
92334088|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334089|NCT00003253|Paclitaxel|paclitaxel|mesh-list
92334090|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
92334091|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334092|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334093|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334094|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334095|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334097|NCT00004237|Doxorubicin|doxorubicin|mesh-list
92334098|NCT00004237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92334099|NCT00004237|Vinorelbine|vinorelbine|mesh-list
92334100|NCT00004237|Epirubicin|epirubicin|mesh-list
92334101|NCT00004237|Mitoxantrone|mitoxantrone|mesh-list
92334102|NCT00004237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334103|NCT00004237|Immunologic Factors|immunologic factors|mesh-ancestor
92362090|NCT01168219|Methotrexate|methotrexate|mesh-list
92334104|NCT00004237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334105|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334106|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334107|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
92334108|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334109|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334110|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334111|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334112|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334113|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334114|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334115|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334116|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334117|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334118|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334120|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
92334121|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334123|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334124|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334125|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92362298|NCT05765617|Calcitriol|calcitriol|mesh-list
92334126|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334127|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334128|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334129|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
92334130|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
92334131|NCT00003913|Busulfan|busulfan|mesh-list
92334132|NCT00003913|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92334133|NCT00003913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334134|NCT00003913|Immunologic Factors|immunologic factors|mesh-ancestor
92334135|NCT00003913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334137|NCT00003913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334138|NCT00003913|Alkylating Agents|alkylating agents|mesh-ancestor
92334139|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334140|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334141|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334142|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334145|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334146|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334147|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
92334148|NCT00003913|Hormones|hormones|mesh-ancestor
92334149|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334150|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92334152|NCT00004243|Docetaxel|docetaxel|mesh-list
92334153|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
92334154|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334155|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334156|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334157|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
92362426|NCT05715931|Leucovorin|leucovorin|mesh-list
92334158|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334160|NCT00004249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92334161|NCT00004249|Immunologic Factors|immunologic factors|mesh-ancestor
92334162|NCT00004249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334164|NCT00003925|Gemcitabine|gemcitabine|mesh-list
92334166|NCT00003925|Calcium|calcium|mesh-list
92334167|NCT00003925|Levoleucovorin|levoleucovorin|mesh-list
92334168|NCT00003925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334169|NCT00003925|Antimetabolites|antimetabolites|mesh-ancestor
92334170|NCT00003925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334171|NCT00003925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334172|NCT00003925|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334173|NCT00003925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334174|NCT00003925|Antidotes|antidotes|mesh-ancestor
92334175|NCT00003925|Protective Agents|protective agents|mesh-ancestor
92334176|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
92334178|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
92334179|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
92334180|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
92334181|NCT00004255|Fludarabine|fludarabine|mesh-list
92334182|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
92334184|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92334185|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334186|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
92334187|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334188|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334189|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334190|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
92334191|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334192|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334193|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334194|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334195|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
92334196|NCT00004255|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92334197|NCT00004255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334198|NCT00004255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334199|NCT00004255|Antiemetics|antiemetics|mesh-ancestor
92334200|NCT00004255|Autonomic Agents|autonomic agents|mesh-ancestor
92334201|NCT00004255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334202|NCT00004255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334203|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
92334204|NCT00004255|Hormones|hormones|mesh-ancestor
92334205|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334206|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92334208|NCT00004261|Antibodies|antibodies|mesh-list
92334209|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
92334210|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334211|NCT00004297|Diazepam|diazepam|mesh-list
92334212|NCT00004297|Lorazepam|lorazepam|mesh-list
92334213|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
92334214|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
92334215|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
92362739|NCT04893109|Trastuzumab|trastuzumab|mesh-list
92334216|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334217|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334218|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334219|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936966|NCT04476173|Analgesics|analgesics|mesh-ancestor
92334220|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92334221|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92334222|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92334223|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92334224|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
92334225|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
92334226|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92334227|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334228|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92334229|NCT00004297|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92334230|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92334231|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92334232|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
92334233|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
92334234|NCT00004855|Ritonavir|ritonavir|mesh-list
92334235|NCT00004855|Lopinavir|lopinavir|mesh-list
92334236|NCT00004855|Lamivudine|lamivudine|mesh-list
92334237|NCT00004855|Nevirapine|nevirapine|mesh-list
92334238|NCT00004855|Abacavir|abacavir|mesh-list
92334239|NCT00004855|Stavudine|stavudine|mesh-list
92334240|NCT00004855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92334241|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92334242|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92334243|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334244|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334245|NCT00004855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92334246|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92334247|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
92334248|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334249|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92334250|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92334251|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92334252|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334253|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92334254|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92334255|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
92363080|NCT03831711|Bombesin|bombesin|mesh-list
92334256|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92334257|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334258|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92334259|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334260|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334262|NCT00004861|Tacedinaline|tacedinaline|mesh-list
92334263|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334264|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
92334265|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363146|NCT03538691|Serotonin Agents|serotonin agents|mesh-ancestor
92334266|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334267|NCT00004861|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92334268|NCT00004861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334269|NCT00004315|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92334270|NCT00004315|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92334271|NCT00004315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334273|NCT04074343|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92334274|NCT04074343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334275|NCT04074343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334276|NCT04074343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334277|NCT04074343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334279|NCT00003301|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92334280|NCT00003301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334281|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334282|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334283|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334284|NCT00003307|Amifostine|amifostine|mesh-list
92334285|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92334286|NCT00003307|Protective Agents|protective agents|mesh-ancestor
92334287|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334288|NCT00004327|Octreotide|octreotide|mesh-list
92334289|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334290|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92334291|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334293|NCT00003313|Carboplatin|carboplatin|mesh-list
92334294|NCT00003313|Amifostine|amifostine|mesh-list
92334295|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334296|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334297|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334298|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334299|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334300|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363413|NCT01285817|Immunologic Factors|immunologic factors|mesh-ancestor
92334301|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334302|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92334303|NCT00003313|Protective Agents|protective agents|mesh-ancestor
92334304|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92334305|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92334306|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334307|NCT00004873|Docetaxel|docetaxel|mesh-list
92334308|NCT00004873|Fluorouracil|fluorouracil|mesh-list
92334309|NCT00004873|Epirubicin|epirubicin|mesh-list
92334310|NCT00004873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363475|NCT00651456|Bevacizumab|bevacizumab|mesh-list
92334311|NCT00004873|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334312|NCT00004873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334313|NCT00004873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334314|NCT00004873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334315|NCT00004873|Antimetabolites|antimetabolites|mesh-ancestor
92334316|NCT00004873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334317|NCT00004873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334318|NCT00004873|Immunologic Factors|immunologic factors|mesh-ancestor
92334319|NCT00004873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334320|NCT00004873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334321|NCT00004873|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334322|NCT00004873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334323|NCT00004873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334325|NCT00004879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92334326|NCT00004879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334327|NCT00004339|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92334328|NCT00004339|Trientine|trientine|mesh-list
92334329|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
92334330|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
92363607|NCT04376970|Antifungal Agents|antifungal agents|mesh-ancestor
92334331|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334333|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92334334|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92334335|NCT00004339|Growth Substances|growth substances|mesh-ancestor
92334336|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334337|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92334338|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334339|NCT00003331|Leucovorin|leucovorin|mesh-list
92334340|NCT00003331|Fluorouracil|fluorouracil|mesh-list
92334341|NCT00003331|Topotecan|topotecan|mesh-list
92334342|NCT00003331|Calcium|calcium|mesh-list
92334343|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
92334344|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334345|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334346|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
92334347|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334348|NCT00003331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334349|NCT00003331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334350|NCT00003331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334351|NCT00003331|Immunologic Factors|immunologic factors|mesh-ancestor
92334352|NCT00003331|Antidotes|antidotes|mesh-ancestor
92334353|NCT00003331|Protective Agents|protective agents|mesh-ancestor
92334354|NCT00003331|Vitamin B Complex|vitamin b complex|mesh-ancestor
92334355|NCT00003331|Vitamins|vitamins|mesh-ancestor
92334356|NCT00003331|Micronutrients|micronutrients|mesh-ancestor
92334357|NCT00003331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92334358|NCT00003331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334359|NCT00003331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334360|NCT00004885|Leucovorin|leucovorin|mesh-list
92334363|NCT00004885|Calcium|calcium|mesh-list
92334364|NCT00004885|Levoleucovorin|levoleucovorin|mesh-list
92334365|NCT00004885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334366|NCT00004885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334367|NCT00004885|Antimetabolites|antimetabolites|mesh-ancestor
92334368|NCT00004885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334369|NCT00004885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334370|NCT00004885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334371|NCT00004885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334372|NCT00004885|Immunologic Factors|immunologic factors|mesh-ancestor
92334373|NCT00004885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92334374|NCT00004885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334375|NCT00004885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334377|NCT00004885|Protective Agents|protective agents|mesh-ancestor
92334378|NCT00004885|Vitamin B Complex|vitamin b complex|mesh-ancestor
92334379|NCT00004885|Vitamins|vitamins|mesh-ancestor
92334380|NCT00004885|Micronutrients|micronutrients|mesh-ancestor
92334381|NCT00004891|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92334382|NCT00004891|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92334383|NCT00004891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334384|NCT00003337|Epratuzumab|epratuzumab|mesh-list
92334385|NCT00003337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92334386|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334387|NCT00003343|Prednisone|prednisone|mesh-list
92334388|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
92334389|NCT00003343|Prinomastat|prinomastat|mesh-list
92334390|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334391|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
92334392|NCT00003343|Hormones|hormones|mesh-ancestor
92334393|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334394|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334395|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92334396|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334397|NCT00003343|Analgesics|analgesics|mesh-ancestor
92334398|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
92334399|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334400|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334401|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334402|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334403|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334404|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
92334405|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
92334406|NCT00004903|Interferons|interferons|mesh-list
92334407|NCT00004903|Cytarabine|cytarabine|mesh-list
92334408|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
92334409|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
92334410|NCT00004903|Melphalan|melphalan|mesh-list
92334411|NCT00004903|Etoposide|etoposide|mesh-list
92334412|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334413|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
92334414|NCT00004903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334415|NCT00004903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334416|NCT00004903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334417|NCT00004903|Alkylating Agents|alkylating agents|mesh-ancestor
92364057|NCT04353180|Keratolytic Agents|keratolytic agents|mesh-ancestor
92334418|NCT00004903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334419|NCT00004903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334420|NCT00004903|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334421|NCT00004903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334422|NCT00004903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334423|NCT00004903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334424|NCT00004903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334425|NCT00004903|Antiviral Agents|antiviral agents|mesh-ancestor
92334426|NCT00004903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334427|NCT00004903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334428|NCT00004903|Antimetabolites|antimetabolites|mesh-ancestor
92334429|NCT00004357|Methylprednisolone|methylprednisolone|mesh-list
92334430|NCT00004357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92364123|NCT04350684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334431|NCT00004357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92334432|NCT00004357|Prednisolone|prednisolone|mesh-list
92334433|NCT00004357|Prednisolone acetate|prednisolone acetate|mesh-list
92334434|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92334435|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
92334436|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334437|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
92334438|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
92334439|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334440|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334441|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334442|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
92334444|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334445|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92334446|NCT00004357|Protective Agents|protective agents|mesh-ancestor
92334447|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92334448|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334450|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92334451|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
92334452|NCT00004363|Coagulants|coagulants|mesh-ancestor
92334454|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
92334455|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334456|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92334457|NCT04069117|Letrozole|letrozole|mesh-list
92334458|NCT04069117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334459|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92334460|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92334461|NCT04069117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334462|NCT04069117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334463|NCT04069117|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92334464|NCT04069117|Hormone Antagonists|hormone antagonists|mesh-ancestor
92334465|NCT04069117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334466|NCT04069117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334467|NCT00004921|Paclitaxel|paclitaxel|mesh-list
92334468|NCT00004921|Cyclophosphamide|cyclophosphamide|mesh-list
92334469|NCT00004921|Carboplatin|carboplatin|mesh-list
92334470|NCT00004921|Melphalan|melphalan|mesh-list
92334471|NCT00004921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334472|NCT00004921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334473|NCT00004921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334474|NCT00004921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334475|NCT00004921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334476|NCT00004921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334477|NCT00004921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334478|NCT00004921|Immunologic Factors|immunologic factors|mesh-ancestor
92334479|NCT00004921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334481|NCT00004921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334482|NCT00004921|Alkylating Agents|alkylating agents|mesh-ancestor
92334483|NCT00004921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334484|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
92334485|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
92334486|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334487|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
92334488|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334489|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334490|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334491|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334492|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92334494|NCT00004981|Zidovudine|zidovudine|mesh-list
92334495|NCT00004981|Abacavir|abacavir|mesh-list
92334496|NCT00004981|Dideoxynucleosides|dideoxynucleosides|mesh-list
92334497|NCT00004981|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92334498|NCT00004981|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92334499|NCT00004981|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334501|NCT00004981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334503|NCT00004981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334504|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92334505|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92334506|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
92334507|NCT00004993|Hormones|hormones|mesh-list
92334509|NCT00004993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334510|NCT00004993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334511|NCT00004993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334512|NCT00004999|Lamivudine|lamivudine|mesh-list
92334513|NCT00004999|Zidovudine|zidovudine|mesh-list
92334514|NCT00004999|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92334515|NCT00004999|Capravirine|capravirine|mesh-list
92334516|NCT00004999|Nelfinavir|nelfinavir|mesh-list
92334517|NCT00004999|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92334518|NCT00004999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334520|NCT00004999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334521|NCT00004999|Antiviral Agents|antiviral agents|mesh-ancestor
92334522|NCT00004999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334523|NCT00004999|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92334524|NCT00004999|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92334525|NCT00004999|Antimetabolites|antimetabolites|mesh-ancestor
92334526|NCT00004999|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92334527|NCT00004999|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92334528|NCT00004999|Protease Inhibitors|protease inhibitors|mesh-ancestor
92334530|NCT00003361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334531|NCT00003361|Antimetabolites|antimetabolites|mesh-ancestor
92334532|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334533|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334534|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334535|NCT00003367|Vitamin E|vitamin e|mesh-list
92334536|NCT00003367|Vitamins|vitamins|mesh-ancestor
92334537|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
92334538|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334539|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
92334540|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334541|NCT00003367|Protective Agents|protective agents|mesh-ancestor
92334542|NCT00003379|Paclitaxel|paclitaxel|mesh-list
92334543|NCT00003379|Cisplatin|cisplatin|mesh-list
92334544|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334545|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334546|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334547|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334548|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334549|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334550|NCT00003385|Paclitaxel|paclitaxel|mesh-list
92334551|NCT00003385|Carboplatin|carboplatin|mesh-list
92334552|NCT00003385|Doxorubicin|doxorubicin|mesh-list
92334553|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92334554|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92364686|NCT03019848|Analgesics|analgesics|mesh-ancestor
92334555|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334556|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334557|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334558|NCT00003385|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334559|NCT00003385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334560|NCT00003385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334561|NCT00003385|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334562|NCT00003385|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334563|NCT00003385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334564|NCT00004381|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92334565|NCT00004381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364750|NCT03017430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334566|NCT00004381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334567|NCT00005005|Alendronate|alendronate|mesh-list
92334568|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92334569|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334570|NCT00004393|Risperidone|risperidone|mesh-list
92334571|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92334572|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
92334573|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92334574|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334575|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334577|NCT00004393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92364816|NCT03016260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334578|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92334579|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92334580|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92334581|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
92334582|NCT00004399|Magnesium Sulfate|magnesium sulfate|mesh-list
92334584|NCT00004399|Analgesics|analgesics|mesh-ancestor
92334585|NCT00004399|Sensory System Agents|sensory system agents|mesh-ancestor
92334586|NCT00004399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334587|NCT00004399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334588|NCT00004399|Anesthetics|anesthetics|mesh-ancestor
92334589|NCT00004399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92334590|NCT00004399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92334591|NCT00004399|Anticonvulsants|anticonvulsants|mesh-ancestor
92334592|NCT00004399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92334593|NCT00004399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92334594|NCT00004399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334595|NCT00004399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334596|NCT00004399|Tocolytic Agents|tocolytic agents|mesh-ancestor
92334597|NCT00004399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92365018|NCT03004014|Propofol|propofol|mesh-list
92334598|NCT00004399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92334599|NCT00004399|Vasodilator Agents|vasodilator agents|mesh-ancestor
92334600|NCT00004423|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92334601|NCT00004423|Antitubercular Agents|antitubercular agents|mesh-ancestor
92334602|NCT00004423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92334603|NCT00004423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334604|NCT00005017|Ritonavir|ritonavir|mesh-list
92334605|NCT00005017|Amprenavir|amprenavir|mesh-list
92334606|NCT00005017|Lamivudine|lamivudine|mesh-list
92334607|NCT00005017|Abacavir|abacavir|mesh-list
92334608|NCT00005017|Stavudine|stavudine|mesh-list
92334609|NCT00005017|Efavirenz|efavirenz|mesh-list
92334610|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92334611|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92334612|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
92334613|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334614|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334615|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92334616|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92334617|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
92334618|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334619|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92334620|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92334621|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92334622|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334623|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92334624|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92334625|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92334626|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92334627|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92334628|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
92334629|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92334630|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
92334631|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92334633|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
92334634|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334635|NCT00005029|Topotecan|topotecan|mesh-list
92334636|NCT00005029|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92334637|NCT00005029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334638|NCT00005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334639|NCT00005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334640|NCT00005029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334641|NCT00005035|Oxaliplatin|oxaliplatin|mesh-list
92334642|NCT00005035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334643|NCT00004429|Hormones|hormones|mesh-list
92334644|NCT00004429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334645|NCT00004429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334646|NCT00005041|Tipifarnib|tipifarnib|mesh-list
92334647|NCT00005041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334648|NCT00004441|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92334649|NCT00004441|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92365196|NCT02978040|Tirofiban|tirofiban|mesh-list
92334650|NCT00004441|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92334651|NCT00004441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334652|NCT00004441|Antiviral Agents|antiviral agents|mesh-ancestor
92334653|NCT00004441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334654|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
92334655|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92334656|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334657|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334658|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92334659|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
92334660|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
92334661|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334662|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334663|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92334665|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92365330|NCT02641314|Celecoxib|celecoxib|mesh-list
92334666|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
92334667|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334668|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92334670|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92334671|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
92334672|NCT00005575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92334673|NCT00005575|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92334674|NCT00005575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92334675|NCT00005575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92334676|NCT00005575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334677|NCT00005575|Adrenergic Agents|adrenergic agents|mesh-ancestor
92334678|NCT00005575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92334679|NCT00005575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334680|NCT00005059|Paclitaxel|paclitaxel|mesh-list
92334681|NCT00005059|Carboplatin|carboplatin|mesh-list
92334682|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334683|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334684|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334685|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334686|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334687|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334688|NCT00005065|Paclitaxel|paclitaxel|mesh-list
92334689|NCT00005065|Carboplatin|carboplatin|mesh-list
92334690|NCT00005065|Motexafin gadolinium|motexafin gadolinium|mesh-list
92334691|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334692|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334693|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334694|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334695|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334696|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334697|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92334698|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
92334699|NCT00386191|Clopidogrel|clopidogrel|mesh-list
92334700|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92334701|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92334702|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92334703|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92334704|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
92334705|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92334706|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334707|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334708|NCT00386269|Codeine|codeine|mesh-list
92334709|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92334710|NCT00386269|Narcotics|narcotics|mesh-ancestor
92334711|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365592|NCT03708354|Vitamins|vitamins|mesh-ancestor
92334712|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334713|NCT00386269|Analgesics|analgesics|mesh-ancestor
92334714|NCT00386269|Sensory System Agents|sensory system agents|mesh-ancestor
92334715|NCT00386269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334716|NCT00386269|Antitussive Agents|antitussive agents|mesh-ancestor
92334717|NCT00386269|Respiratory System Agents|respiratory system agents|mesh-ancestor
92334718|NCT00005581|Paclitaxel|paclitaxel|mesh-list
92334719|NCT00005581|Cyclophosphamide|cyclophosphamide|mesh-list
92334720|NCT00005581|Fluorouracil|fluorouracil|mesh-list
92334721|NCT00005581|Epirubicin|epirubicin|mesh-list
92334722|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334723|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334724|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334725|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334726|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334727|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334728|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334729|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
92334730|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334731|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334732|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334733|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
92334734|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334736|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334737|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334738|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365647|NCT00393354|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334739|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334740|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334741|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
92334742|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334743|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
92334744|NCT00004489|Vitamin D|vitamin d|mesh-list
92334745|NCT00004489|Alendronate|alendronate|mesh-list
92334746|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
92334747|NCT00004489|Calcium|calcium|mesh-list
92334748|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334749|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334750|NCT00004489|Vitamins|vitamins|mesh-ancestor
92334751|NCT00004489|Micronutrients|micronutrients|mesh-ancestor
92334752|NCT00004489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92334753|NCT00004489|Antacids|antacids|mesh-ancestor
92334754|NCT00004489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334755|NCT00004489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334757|NCT00005593|Fludarabine|fludarabine|mesh-list
92334758|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
92334759|NCT00005593|Topotecan|topotecan|mesh-list
92334760|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365759|NCT00598806|Apaziquone|apaziquone|mesh-list
92334761|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334763|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334764|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334765|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
92334766|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334767|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92334768|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334771|NCT00004495|Pyridoxine|pyridoxine|mesh-list
92334772|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
92334773|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
92334774|NCT00004495|Hematinics|hematinics|mesh-ancestor
92365889|NCT00638820|Busulfan|busulfan|mesh-list
92334775|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
92334776|NCT00004495|Vitamins|vitamins|mesh-ancestor
92334777|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
92334778|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334779|NCT00005089|Prednisone|prednisone|mesh-list
92334780|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
92334781|NCT00005089|Rituximab|rituximab|mesh-list
92334782|NCT00005089|Doxorubicin|doxorubicin|mesh-list
92334784|NCT00005089|Vincristine|vincristine|mesh-list
92334785|NCT00005089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334786|NCT00005089|Immunologic Factors|immunologic factors|mesh-ancestor
92334787|NCT00005089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334788|NCT00005089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334789|NCT00005089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334790|NCT00005089|Alkylating Agents|alkylating agents|mesh-ancestor
92334791|NCT00005089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334792|NCT00005089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334793|NCT00005089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334794|NCT00005089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92334795|NCT00005089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334796|NCT00005089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92334797|NCT00005089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92334798|NCT00005089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334799|NCT00005089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334800|NCT00005089|Glucocorticoids|glucocorticoids|mesh-ancestor
92334801|NCT00005089|Hormones|hormones|mesh-ancestor
92334802|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334803|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92334804|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334805|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334806|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92366162|NCT00683046|Melphalan|melphalan|mesh-list
92334807|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334808|NCT00005599|Paclitaxel|paclitaxel|mesh-list
92334809|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
92334810|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334811|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334812|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334813|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334814|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334815|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334816|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92334817|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
92334818|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334819|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
92334820|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334821|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334822|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92334823|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
92334824|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92366231|NCT00701376|Liver Extracts|liver extracts|mesh-list
92334825|NCT00004567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334826|NCT00004567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334827|NCT00004567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334829|NCT00005113|Sirolimus|sirolimus|mesh-list
92334830|NCT00005113|Tacrolimus|tacrolimus|mesh-list
92334831|NCT00005113|Cyclosporins|cyclosporins|mesh-list
92334832|NCT00005113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334833|NCT00005113|Immunologic Factors|immunologic factors|mesh-ancestor
92334834|NCT00005113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334835|NCT00005113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92334836|NCT00005113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334837|NCT00005113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334838|NCT00005113|Antifungal Agents|antifungal agents|mesh-ancestor
92334839|NCT00005113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334840|NCT00005113|Dermatologic Agents|dermatologic agents|mesh-ancestor
92334841|NCT00005113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334842|NCT00005113|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92334843|NCT00005113|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92334844|NCT00005113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334845|NCT00004573|Ganciclovir|ganciclovir|mesh-list
92334846|NCT00004573|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92334847|NCT00004573|Antiviral Agents|antiviral agents|mesh-ancestor
92334848|NCT00004573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334849|NCT00004573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334850|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334851|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334852|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
92334853|NCT00005623|Cyproterone|cyproterone|mesh-list
92334854|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
92366435|NCT00726414|Analgesics|analgesics|mesh-ancestor
92334855|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92334856|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334857|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334858|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334859|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92334860|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
92334861|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92334863|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92334864|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334865|NCT00004585|Lamivudine|lamivudine|mesh-list
92334866|NCT00004585|Zidovudine|zidovudine|mesh-list
92334867|NCT00004585|Efavirenz|efavirenz|mesh-list
92334868|NCT00004585|Abacavir|abacavir|mesh-list
92334869|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
92334870|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92334871|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92334872|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334873|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334874|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334875|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
91936976|NCT01360853|Gemcitabine|gemcitabine|mesh-list
92334876|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334877|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92334878|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92334879|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
92334880|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92334881|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92334882|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92334883|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92334884|NCT00004585|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92366686|NCT00756678|Lubricant Eye Drops|lubricant eye drops|mesh-list
92334885|NCT00004585|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92334887|NCT00005635|Trastuzumab|trastuzumab|mesh-list
92334888|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334889|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334890|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334891|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334892|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334893|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334894|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92334895|NCT00005641|Leucovorin|leucovorin|mesh-list
92334896|NCT00005641|Cyclosporine|cyclosporine|mesh-list
92334897|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
92334898|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
92334900|NCT00005641|Methotrexate|methotrexate|mesh-list
92334901|NCT00005641|Cyclosporins|cyclosporins|mesh-list
92334902|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92334903|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
92334904|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92334905|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
92366823|NCT00769392|Anesthetics|anesthetics|mesh-ancestor
92334906|NCT00005641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334907|NCT00005641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92334908|NCT00005641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92334909|NCT00005641|Alkylating Agents|alkylating agents|mesh-ancestor
92334910|NCT00005641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334911|NCT00005641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334912|NCT00005641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92334913|NCT00005641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92334915|NCT00005641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92334916|NCT00005641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92334917|NCT00005641|Antimetabolites|antimetabolites|mesh-ancestor
92334918|NCT00005641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92334919|NCT00005641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334920|NCT00005641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92334921|NCT00005641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92334922|NCT00005641|Antidotes|antidotes|mesh-ancestor
92334923|NCT00005641|Protective Agents|protective agents|mesh-ancestor
92334924|NCT00005641|Vitamin B Complex|vitamin b complex|mesh-ancestor
92334925|NCT00005641|Vitamins|vitamins|mesh-ancestor
92334926|NCT00005641|Micronutrients|micronutrients|mesh-ancestor
92334927|NCT00005641|Antifungal Agents|antifungal agents|mesh-ancestor
92334928|NCT00005641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334929|NCT00005641|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92334930|NCT00005641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334931|NCT00005641|Antiemetics|antiemetics|mesh-ancestor
92334932|NCT00005641|Autonomic Agents|autonomic agents|mesh-ancestor
92334933|NCT00005641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92334934|NCT00005641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92334935|NCT00005641|Glucocorticoids|glucocorticoids|mesh-ancestor
92334936|NCT00005641|Hormones|hormones|mesh-ancestor
92334937|NCT00005641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92334938|NCT00005641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92334939|NCT00005647|Paclitaxel|paclitaxel|mesh-list
92334940|NCT00005647|Semaxinib|semaxinib|mesh-list
92334941|NCT00005647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92334942|NCT00005647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92334943|NCT00005647|Tubulin Modulators|tubulin modulators|mesh-ancestor
92334944|NCT00005647|Antimitotic Agents|antimitotic agents|mesh-ancestor
92334945|NCT00005647|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334946|NCT00005647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334947|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92334948|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92334950|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334952|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92334954|NCT00005665|Interferons|interferons|mesh-list
92334955|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
92367004|NCT00795210|Hormones|hormones|mesh-list
92334957|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
92334958|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92334959|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
92334960|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334961|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
92334962|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92334963|NCT00385411|Valproic Acid|valproic acid|mesh-list
92334964|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
92334965|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92334966|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334967|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
92334968|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92334969|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334970|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
92334971|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92334972|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92334973|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92334974|NCT00004699|Mitogens|mitogens|mesh-list
92334975|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
92334976|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334977|NCT00004705|Amiloride|amiloride|mesh-list
92334978|NCT00004705|Diuretics|diuretics|mesh-ancestor
92334979|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
92334980|NCT00004705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334981|NCT00004705|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92334982|NCT00004705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92334983|NCT00004705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92334984|NCT00004705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92334985|NCT00004705|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92334986|NCT00004705|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92334988|NCT00004747|Antibodies|antibodies|mesh-list
92334989|NCT00004747|gamma-Globulins|gamma-globulins|mesh-list
92334990|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92334991|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92334992|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
92334993|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92334994|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
92334995|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92334996|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92334997|NCT00004759|Prednisolone|prednisolone|mesh-list
92334998|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
92334999|NCT00004759|Tirilazad|tirilazad|mesh-list
92335000|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92335001|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
92335002|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335003|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
92335004|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
92335005|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335006|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335007|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92335008|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
92335010|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335011|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92335012|NCT00004759|Protective Agents|protective agents|mesh-ancestor
92335013|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335014|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335015|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
92335016|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335017|NCT00004771|Leuprolide|leuprolide|mesh-list
92335018|NCT00004771|Testosterone|testosterone|mesh-list
92335019|NCT00004771|Androgens|androgens|mesh-ancestor
92335020|NCT00004771|Hormones|hormones|mesh-ancestor
92335021|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335022|NCT00004771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335023|NCT00004771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335024|NCT00004771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335025|NCT00004771|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91987558|NCT02435797|Vitamins|vitamins|mesh-ancestor
92335027|NCT00004771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92335028|NCT00004789|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92335029|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367308|NCT02682888|Oxytocin|oxytocin|mesh-list
92335030|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335031|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92335032|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92335033|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
92335034|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335036|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
92335038|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92335039|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335040|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335041|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335042|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335043|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335044|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
92335045|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
92335046|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335048|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335049|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92335050|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92335051|NCT00004825|Insulin|insulin|mesh-list
92335052|NCT00004825|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92335053|NCT00004825|Mitogens|mitogens|mesh-list
92335055|NCT00004825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335056|NCT00004825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335057|NCT00004825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92335058|NCT00004825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335059|NCT00004825|Growth Substances|growth substances|mesh-ancestor
92335060|NCT00385645|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92335061|NCT00385645|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92335063|NCT00385645|Lamivudine|lamivudine|mesh-list
92335064|NCT00385645|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92335065|NCT00385645|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92335066|NCT00385645|Protease Inhibitors|protease inhibitors|mesh-ancestor
92335067|NCT00385645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335068|NCT00385645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335069|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92335070|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92335072|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335073|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92335074|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92335075|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
92335076|NCT00385957|Lamivudine|lamivudine|mesh-list
92335077|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92335078|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92335079|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335080|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367656|NCT00875550|Fentanyl|fentanyl|mesh-list
92335081|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
92335082|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335083|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92335084|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92335085|NCT00005107|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
92335086|NCT00005107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335087|NCT00005107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335088|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
92335089|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92335090|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
92335091|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335092|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335093|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335094|NCT00005773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335095|NCT00005773|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92335096|NCT00005773|Antioxidants|antioxidants|mesh-ancestor
92335097|NCT00005773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335098|NCT00005773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335099|NCT00005773|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92335100|NCT00005773|Vasodilator Agents|vasodilator agents|mesh-ancestor
91987637|NCT02334605|Capsaicin|capsaicin|mesh-list
92335101|NCT00005773|Gasotransmitters|gasotransmitters|mesh-ancestor
92335102|NCT00005773|Protective Agents|protective agents|mesh-ancestor
92335103|NCT00005779|Interleukin-12|interleukin-12|mesh-list
92335104|NCT00005779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92335105|NCT00005779|Immunologic Factors|immunologic factors|mesh-ancestor
92335106|NCT00005779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335107|NCT00005779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92335108|NCT00005779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92335109|NCT00005779|Growth Substances|growth substances|mesh-ancestor
92335110|NCT00005779|Growth Inhibitors|growth inhibitors|mesh-ancestor
92335111|NCT00005779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335113|NCT00005791|Irinotecan|irinotecan|mesh-list
92367790|NCT00892710|Pemetrexed|pemetrexed|mesh-list
92335114|NCT00005791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335115|NCT00005791|Antimetabolites|antimetabolites|mesh-ancestor
92335116|NCT00005791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335117|NCT00005791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335118|NCT00005791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335119|NCT00005791|Immunologic Factors|immunologic factors|mesh-ancestor
92335120|NCT00005791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335121|NCT00005791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92335122|NCT00005791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92335123|NCT00005791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335124|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
92335125|NCT00005797|Busulfan|busulfan|mesh-list
92335126|NCT00005797|Etoposide|etoposide|mesh-list
92335127|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335128|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
92335129|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335130|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335131|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92335132|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
92335133|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335134|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335135|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92335136|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92335137|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92335138|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92335139|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335140|NCT00005815|Thalidomide|thalidomide|mesh-list
92335142|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92335143|NCT00005815|Alkylating Agents|alkylating agents|mesh-ancestor
92335144|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335145|NCT00005815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335146|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335147|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
92335148|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335149|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
92335150|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335151|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335152|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92335153|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92335154|NCT00005815|Growth Substances|growth substances|mesh-ancestor
92335155|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
92335157|NCT02132754|MK-4166|mk-4166|mesh-list
92335158|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92335159|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335160|NCT02132754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92335161|NCT02132754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335162|NCT02151786|Lansoprazole|lansoprazole|mesh-list
92335163|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
92335164|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92335165|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92335166|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92335167|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335168|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335169|NCT02106156|Interferons|interferons|mesh-list
92335170|NCT02106156|Ribavirin|ribavirin|mesh-list
92335171|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
92335172|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
92335173|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92335174|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335176|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335177|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
92335178|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335179|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
92335180|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335182|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92335183|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
92335184|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
92335185|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
92335186|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
92335187|NCT02131272|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335188|NCT02131272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335189|NCT02130882|Benralizumab|benralizumab|mesh-list
92335190|NCT02130882|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335191|NCT02130882|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335192|NCT02149836|Ezogabine|ezogabine|mesh-list
92335193|NCT02149836|Anticonvulsants|anticonvulsants|mesh-ancestor
92335194|NCT02149836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92335195|NCT02149836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335196|NCT02130024|Ranibizumab|ranibizumab|mesh-list
92335197|NCT02130024|Aflibercept|aflibercept|mesh-list
92335198|NCT02130024|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92367969|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
92335199|NCT02130024|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92335200|NCT02130024|Growth Substances|growth substances|mesh-ancestor
92335201|NCT02130024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335202|NCT02130024|Growth Inhibitors|growth inhibitors|mesh-ancestor
92335203|NCT02130024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335204|NCT02105688|Grazoprevir|grazoprevir|mesh-list
92335205|NCT02105688|Antiviral Agents|antiviral agents|mesh-ancestor
92335206|NCT02105688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335207|NCT02105454|Ribavirin|ribavirin|mesh-list
92335208|NCT02105454|Grazoprevir|grazoprevir|mesh-list
92335209|NCT02105454|Antimetabolites|antimetabolites|mesh-ancestor
92335210|NCT02105454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335211|NCT02105454|Antiviral Agents|antiviral agents|mesh-ancestor
92368118|NCT00939120|Dutasteride|dutasteride|mesh-list
92335212|NCT02105454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335213|NCT02104752|Curcumin|curcumin|mesh-list
92117023|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92335214|NCT02104752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92335215|NCT02104752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92335216|NCT02104752|Analgesics|analgesics|mesh-ancestor
92335217|NCT02104752|Sensory System Agents|sensory system agents|mesh-ancestor
92335218|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335219|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335220|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335221|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335222|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335223|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335224|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335225|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
92335226|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335227|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335228|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
92335229|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
92335231|NCT02127372|Cisplatin|cisplatin|mesh-list
92335232|NCT02127372|Docetaxel|docetaxel|mesh-list
92335233|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
92335234|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335235|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92335236|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92335237|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92335238|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335239|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92335240|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335241|NCT02125734|Bromides|bromides|mesh-list
92335242|NCT02125734|Tiotropium Bromide|tiotropium bromide|mesh-list
92335243|NCT02125734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92335244|NCT02125734|Autonomic Agents|autonomic agents|mesh-ancestor
92335245|NCT02125734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368447|NCT00998010|Bortezomib|bortezomib|mesh-list
92335246|NCT02125734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335247|NCT02125734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335248|NCT02125734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335249|NCT02125734|Parasympatholytics|parasympatholytics|mesh-ancestor
92335250|NCT02125734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92335251|NCT02125734|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335252|NCT02125734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335253|NCT02125734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335254|NCT02125734|Anticonvulsants|anticonvulsants|mesh-ancestor
92335255|NCT02124798|Belimumab|belimumab|mesh-list
92335256|NCT02124798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335257|NCT02124798|Immunologic Factors|immunologic factors|mesh-ancestor
92335258|NCT02124798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335259|NCT04735770|Levobupivacaine|levobupivacaine|mesh-list
92335261|NCT04735770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335262|NCT04735770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335263|NCT04735770|Anesthetics, Local|anesthetics, local|mesh-ancestor
92335264|NCT04735770|Sensory System Agents|sensory system agents|mesh-ancestor
92335265|NCT04735770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335266|NCT02146248|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92335267|NCT02146248|Contraceptive Agents|contraceptive agents|mesh-list
92335268|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
92335269|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
92335270|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92335271|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92335272|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335273|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92335274|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92335275|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92335276|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92335277|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92335278|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335279|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335280|NCT02124564|Lacosamide|lacosamide|mesh-list
92335281|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
92335282|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92335283|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92335284|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92335285|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335286|NCT02100696|Etrolizumab|etrolizumab|mesh-list
92335287|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92335288|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
92335289|NCT02100696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335290|NCT02123472|Cephalexin|cephalexin|mesh-list
92335291|NCT02123472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335292|NCT02123472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335293|NCT02145078|Gemcitabine|gemcitabine|mesh-list
92335294|NCT02145078|Docetaxel|docetaxel|mesh-list
92335295|NCT02145078|Pemetrexed|pemetrexed|mesh-list
92335296|NCT02145078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335297|NCT02145078|Antimetabolites|antimetabolites|mesh-ancestor
92335298|NCT02145078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335299|NCT02145078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335300|NCT02145078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92335301|NCT02145078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92335302|NCT02145078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92335303|NCT02145078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335304|NCT02145078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92335305|NCT02145078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92335306|NCT02100228|Vitamin K|vitamin k|mesh-list
92335307|NCT02100228|Heparin|heparin|mesh-list
92335308|NCT02100228|Apixaban|apixaban|mesh-list
92335309|NCT02100228|Vitamins|vitamins|mesh-ancestor
92335310|NCT02100228|Micronutrients|micronutrients|mesh-ancestor
92335311|NCT02100228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335312|NCT02100228|Anticoagulants|anticoagulants|mesh-ancestor
92368754|NCT01024686|Vaccines|vaccines|mesh-list
92335313|NCT02100228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92335314|NCT02100228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92335315|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335316|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92368826|NCT04780932|Macitentan|macitentan|mesh-list
92335318|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92335319|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92335320|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335321|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92335322|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
92335323|NCT02100228|Coagulants|coagulants|mesh-ancestor
92335324|NCT02099838|Metformin|metformin|mesh-list
92335325|NCT02099838|Pioglitazone|pioglitazone|mesh-list
92335326|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335327|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335328|NCT02099682|Lansoprazole|lansoprazole|mesh-list
92335329|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
92335330|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92335331|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92335332|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92335333|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335334|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335335|NCT02098746|Pioglitazone|pioglitazone|mesh-list
92335336|NCT02098746|Glimepiride|glimepiride|mesh-list
92335337|NCT02098746|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335338|NCT02098746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335339|NCT02098746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92335340|NCT02098746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335341|NCT02098746|Immunologic Factors|immunologic factors|mesh-ancestor
92335342|NCT02122770|Itraconazole|itraconazole|mesh-list
92335343|NCT02122770|Fluconazole|fluconazole|mesh-list
92335345|NCT02122770|Docetaxel|docetaxel|mesh-list
92335346|NCT02122770|Carboplatin|carboplatin|mesh-list
92335347|NCT02122770|Pevonedistat|pevonedistat|mesh-list
92335348|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92368905|NCT01044966|Temozolomide|temozolomide|mesh-list
92335349|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335350|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
92335351|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
92335352|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
92335353|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335354|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
92335355|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335356|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92335357|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92335359|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92335360|NCT02122770|Hormone Antagonists|hormone antagonists|mesh-ancestor
92335361|NCT02122770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335362|NCT02122770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335363|NCT02122770|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92335364|NCT02122770|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92335365|NCT02122770|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92335366|NCT02122380|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92335367|NCT02122380|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335368|NCT02122380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335370|NCT02122380|Hormones|hormones|mesh-ancestor
92369069|NCT05821361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335371|NCT02122380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335372|NCT02122380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92335373|NCT02122380|Protease Inhibitors|protease inhibitors|mesh-ancestor
92335374|NCT02122380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335375|NCT02122380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335377|NCT02121756|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92335378|NCT02121756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335379|NCT02121756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335380|NCT02121756|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92335381|NCT02121756|Vasodilator Agents|vasodilator agents|mesh-ancestor
92335382|NCT02141490|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92335383|NCT02141490|Hematinics|hematinics|mesh-ancestor
92335384|NCT02141490|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92335385|NCT02141490|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92335386|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
92335387|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92335388|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92335389|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
92335390|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335391|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92335392|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92335393|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335394|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335395|NCT02096952|Methylphenidate|methylphenidate|mesh-list
92335396|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92335397|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335398|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92335399|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92335400|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92335401|NCT02096952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335402|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
92335403|NCT02096952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987926|NCT02333123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335404|NCT02120898|Imiquimod|imiquimod|mesh-list
92369195|NCT05668286|Anesthetics|anesthetics|mesh-ancestor
92335405|NCT02120898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92335406|NCT02120898|Immunologic Factors|immunologic factors|mesh-ancestor
92335407|NCT02120898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335408|NCT02120898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335409|NCT02120898|Interferon Inducers|interferon inducers|mesh-ancestor
92369297|NCT05398484|Niacin|niacin|mesh-list
92335410|NCT02120664|Corticosterone|corticosterone|mesh-list
92335411|NCT02120664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335412|NCT01627860|Topiramate|topiramate|mesh-list
92335413|NCT01627860|Anticonvulsants|anticonvulsants|mesh-ancestor
92335414|NCT01627860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335415|NCT01627860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335416|NCT04732494|Tislelizumab|tislelizumab|mesh-list
92335417|NCT04732494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92335418|NCT04732494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335420|NCT01627782|Analgesics|analgesics|mesh-ancestor
92335421|NCT01627782|Sensory System Agents|sensory system agents|mesh-ancestor
92335422|NCT01627782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335423|NCT01627782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335424|NCT01627782|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92335425|NCT01627782|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92335426|NCT01627782|Anesthetics, General|anesthetics, general|mesh-ancestor
92335428|NCT01627782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335429|NCT01627782|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92335430|NCT01627782|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92335431|NCT01627782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335432|NCT01627782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335434|NCT02119650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335435|NCT02119650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369390|NCT05137262|Cisplatin|cisplatin|mesh-list
92335436|NCT02119650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335438|NCT02119650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92335440|NCT02119416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92335441|NCT02119416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335442|NCT02119416|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92335443|NCT02119416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335444|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369448|NCT05014087|Digoxin|digoxin|mesh-list
92335445|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92335446|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92335447|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
92335448|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335449|NCT02140164|Minocycline|minocycline|mesh-list
92335450|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335451|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335452|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92335453|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92335454|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
92335455|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335456|NCT02119026|Bevacizumab|bevacizumab|mesh-list
92335457|NCT02119026|Capecitabine|capecitabine|mesh-list
92335458|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
92335459|NCT02119026|Irinotecan|irinotecan|mesh-list
92335460|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92335461|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335462|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92335463|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92335464|NCT02119026|Growth Substances|growth substances|mesh-ancestor
92335465|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335466|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
92335467|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335468|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
92335469|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335470|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92335471|NCT02119026|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92335472|NCT02119026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335473|NCT02095158|Phenylephrine|phenylephrine|mesh-list
92335474|NCT02095158|Oxymetazoline|oxymetazoline|mesh-list
92335475|NCT02095158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92335476|NCT02095158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92369566|NCT04800107|Curcumin|curcumin|mesh-list
92335477|NCT02095158|Adrenergic Agents|adrenergic agents|mesh-ancestor
92335478|NCT02095158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335479|NCT02095158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335480|NCT02095158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335481|NCT02095158|Sympathomimetics|sympathomimetics|mesh-ancestor
92335482|NCT02095158|Autonomic Agents|autonomic agents|mesh-ancestor
92335483|NCT02095158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335484|NCT02095158|Nasal Decongestants|nasal decongestants|mesh-ancestor
92335485|NCT02095158|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92335486|NCT02095158|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335487|NCT02095158|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92335489|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92335490|NCT02095158|Protective Agents|protective agents|mesh-ancestor
92335491|NCT02118714|Atrasentan|atrasentan|mesh-list
92335492|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335493|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92335494|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92335495|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335496|NCT02138916|Benralizumab|benralizumab|mesh-list
92335497|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335498|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335499|NCT02118012|Ribavirin|ribavirin|mesh-list
92335500|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
92335501|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335502|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
92335503|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335504|NCT02138838|Cinacalcet|cinacalcet|mesh-list
92335505|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92335506|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335507|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92335508|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
92335509|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335510|NCT02092350|Grazoprevir|grazoprevir|mesh-list
92335511|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
92335512|NCT02092350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335513|NCT02138136|Lubiprostone|lubiprostone|mesh-list
92335514|NCT02138136|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92335515|NCT02138136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117024|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335516|NCT02138136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335517|NCT02116608|Povidone-Iodine|povidone-iodine|mesh-list
92335518|NCT02116608|Silver Nitrate|silver nitrate|mesh-list
92335519|NCT02116608|Hydrocortisone|hydrocortisone|mesh-list
92335520|NCT02116608|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
92335521|NCT02116608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335522|NCT02116608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92335523|NCT02116608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335524|NCT02116608|Dermatologic Agents|dermatologic agents|mesh-ancestor
92335525|NCT02092116|Romidepsin|romidepsin|mesh-list
92335526|NCT02092116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92335527|NCT02092116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335528|NCT02092116|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92335529|NCT02092116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335530|NCT02092116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335532|NCT02091414|Mycophenolic Acid|mycophenolic acid|mesh-list
92335533|NCT02091414|Cyclosporins|cyclosporins|mesh-list
92335534|NCT02091414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335535|NCT02091414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335536|NCT02091414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335537|NCT02091414|Immunologic Factors|immunologic factors|mesh-ancestor
92335538|NCT02091414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335539|NCT02091414|Antifungal Agents|antifungal agents|mesh-ancestor
92335540|NCT02091414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335541|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
92369815|NCT04033419|Memantine|memantine|mesh-list
92335542|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335543|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92335544|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92335545|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335546|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92335547|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
92369866|NCT03834519|Prednisone|prednisone|mesh-list
92335548|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335550|NCT04731558|Dalteparin|dalteparin|mesh-list
92335551|NCT04731558|Tinzaparin|tinzaparin|mesh-list
92335552|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92335553|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
92335554|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92335555|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92369928|NCT03636451|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92335556|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335558|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
92335560|NCT02116530|Ondansetron|ondansetron|mesh-list
92335561|NCT02116530|Olanzapine|olanzapine|mesh-list
92335562|NCT02116530|Aprepitant|aprepitant|mesh-list
92335563|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
92335564|NCT02116530|Palonosetron|palonosetron|mesh-list
92335565|NCT02116530|Granisetron|granisetron|mesh-list
92335566|NCT02116530|Antiemetics|antiemetics|mesh-list
92335567|NCT02116530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335568|NCT02116530|Immunologic Factors|immunologic factors|mesh-ancestor
92335569|NCT02116530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335570|NCT02116530|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335571|NCT02116530|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92335572|NCT02116530|Alkylating Agents|alkylating agents|mesh-ancestor
92335573|NCT02116530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335574|NCT02116530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335575|NCT02116530|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92335576|NCT02116530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335577|NCT02116530|Autonomic Agents|autonomic agents|mesh-ancestor
92335578|NCT02116530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335579|NCT02116530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92335580|NCT02116530|Glucocorticoids|glucocorticoids|mesh-ancestor
92335581|NCT02116530|Hormones|hormones|mesh-ancestor
92335582|NCT02116530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370063|NCT01154920|Paclitaxel|paclitaxel|mesh-list
92335583|NCT02116530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335584|NCT02116530|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92335585|NCT02116530|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92335586|NCT02116530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92335587|NCT02116530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335588|NCT02116530|Antipruritics|antipruritics|mesh-ancestor
92335589|NCT02116530|Dermatologic Agents|dermatologic agents|mesh-ancestor
92335590|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92335591|NCT02116530|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92335592|NCT02116530|Serotonin Agents|serotonin agents|mesh-ancestor
92335593|NCT02116530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335594|NCT02116530|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92335595|NCT02116530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92370121|NCT01060020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335596|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335597|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92335598|NCT02116530|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92335599|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92335600|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92335601|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92335602|NCT02072226|Aspirin|aspirin|mesh-list
92335603|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92335604|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92335605|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92335606|NCT02072226|Analgesics|analgesics|mesh-ancestor
92335607|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
92335608|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370257|NCT01096680|Modafinil|modafinil|mesh-list
92335609|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335610|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335611|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335612|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92335613|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92335614|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335615|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92335616|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92335617|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335619|NCT04730856|Tinzaparin|tinzaparin|mesh-list
92335620|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92335623|NCT04730856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92335624|NCT04730856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92335625|NCT04730856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335626|NCT02114892|Resveratrol|resveratrol|mesh-list
92335627|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
92335628|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335629|NCT02114892|Protective Agents|protective agents|mesh-ancestor
92335630|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335631|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335632|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92335634|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92335635|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92335636|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335637|NCT04741698|Propranolol|propranolol|mesh-list
92335638|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92335639|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92335640|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
92335641|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335642|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335643|NCT04741698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335644|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92370380|NCT01105650|Antiemetics|antiemetics|mesh-ancestor
92335645|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92335646|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
92335647|NCT02111850|Aldesleukin|aldesleukin|mesh-list
92335648|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
92335649|NCT02111850|Fludarabine|fludarabine|mesh-list
92335650|NCT02111850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92335651|NCT02111850|Immunologic Factors|immunologic factors|mesh-ancestor
92335652|NCT02111850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335653|NCT02111850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335654|NCT02111850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92335656|NCT02111850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335657|NCT02111850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335658|NCT02111850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92335659|NCT02111850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92335660|NCT02111850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92335661|NCT02111850|Antiviral Agents|antiviral agents|mesh-ancestor
92335662|NCT02111850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335663|NCT02085252|Bicalutamide|bicalutamide|mesh-list
92335664|NCT02085252|Leuprolide|leuprolide|mesh-list
92335665|NCT02085252|Androgen Antagonists|androgen antagonists|mesh-ancestor
92335666|NCT02085252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92335667|NCT02085252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335668|NCT02085252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335669|NCT02085252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335670|NCT02085252|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92335671|NCT02085252|Fertility Agents|fertility agents|mesh-ancestor
92335672|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92335673|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335675|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335676|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92335677|NCT02084238|Analgesics|analgesics|mesh-ancestor
92335678|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
92335679|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335680|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335682|NCT02084082|Linagliptin|linagliptin|mesh-list
92335683|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92335684|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335685|NCT02084082|Incretins|incretins|mesh-ancestor
92335686|NCT02084082|Hormones|hormones|mesh-ancestor
92335687|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370553|NCT03697356|Immunologic Factors|immunologic factors|mesh-ancestor
92335688|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92335689|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
92335690|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335691|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335692|NCT02083926|Ketamine|ketamine|mesh-list
92335693|NCT02083926|Analgesics|analgesics|mesh-ancestor
92335694|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
92335695|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335696|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335697|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92335698|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92335699|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
92335701|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335702|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92335703|NCT02083926|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92335705|NCT02083926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335707|NCT02083380|Artefenomel|artefenomel|mesh-list
92335708|NCT02083380|Antimalarials|antimalarials|mesh-ancestor
92335709|NCT02083380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92335710|NCT02083380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92335711|NCT02083380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335712|NCT02109744|Decitabine|decitabine|mesh-list
92335713|NCT02109744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335714|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
92335715|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335716|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335717|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335718|NCT04185402|Azithromycin|azithromycin|mesh-list
92335719|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335720|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335722|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
92335723|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92335724|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
92335725|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335726|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370751|NCT01149876|Tretinoin|tretinoin|mesh-list
92335727|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335728|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335729|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
92335730|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92335731|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335732|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335733|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335734|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335735|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
92335736|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92335737|NCT02082912|Cycloserine|cycloserine|mesh-list
92335738|NCT02082912|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92335739|NCT02082912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335740|NCT02082912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92335741|NCT02082912|Antitubercular Agents|antitubercular agents|mesh-ancestor
92335742|NCT02082912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335743|NCT02082912|Antimetabolites|antimetabolites|mesh-ancestor
92335744|NCT02082912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335745|NCT02082522|Cisplatin|cisplatin|mesh-list
92335746|NCT02082522|Gemcitabine|gemcitabine|mesh-list
92335747|NCT02082522|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92335748|NCT02082522|Hematoporphyrin Derivative|hematoporphyrin derivative|mesh-list
92335749|NCT02082522|Trioxsalen|trioxsalen|mesh-list
92335750|NCT02082522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335751|NCT02082522|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335752|NCT02082522|Antimetabolites|antimetabolites|mesh-ancestor
92335753|NCT02082522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335755|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92335756|NCT04723446|Chlorhexidine|chlorhexidine|mesh-list
92335757|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92335758|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92335759|NCT04723446|Cetylpyridinium|cetylpyridinium|mesh-list
92335760|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92335761|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335762|NCT04723446|Disinfectants|disinfectants|mesh-ancestor
92335763|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92335764|NCT02082210|Ramucirumab|ramucirumab|mesh-list
92335765|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335766|NCT02107014|Naltrexone|naltrexone|mesh-list
92335767|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92335768|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91937002|NCT02266511|Urological Agents|urological agents|mesh-ancestor
92335769|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335770|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
92335771|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335772|NCT01624974|Montelukast|montelukast|mesh-list
92335773|NCT01624974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335774|NCT01624974|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335775|NCT01624974|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91988327|NCT02428777|Diclofenac|diclofenac|mesh-list
92335776|NCT01624974|Hormone Antagonists|hormone antagonists|mesh-ancestor
92335777|NCT01624974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335778|NCT01624974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335779|NCT01624974|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92335780|NCT01624974|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92335781|NCT01624974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335782|NCT01624662|Fluticasone|fluticasone|mesh-list
92335783|NCT01624662|Xhance|xhance|mesh-list
92335784|NCT01624662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335785|NCT01624662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92335786|NCT01624662|Autonomic Agents|autonomic agents|mesh-ancestor
92335787|NCT01624662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335788|NCT01624662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335789|NCT01624662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335790|NCT01624662|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335791|NCT01624662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92335792|NCT01624662|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92335794|NCT02106390|Immunologic Factors|immunologic factors|mesh-ancestor
92335795|NCT02106390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335796|NCT02064894|Ibuprofen|ibuprofen|mesh-list
92335797|NCT02064894|Morphine|morphine|mesh-list
92335798|NCT02064894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92335799|NCT02064894|Narcotics|narcotics|mesh-ancestor
92335800|NCT02064894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335801|NCT02064894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335802|NCT02064894|Analgesics|analgesics|mesh-ancestor
92335803|NCT02064894|Sensory System Agents|sensory system agents|mesh-ancestor
92335804|NCT02064894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335805|NCT02064894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92335806|NCT02064894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92335807|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335808|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335809|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92335810|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335811|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335812|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
92335813|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92335814|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
92335815|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335816|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335817|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
92335818|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335819|NCT01624194|Oxytocin|oxytocin|mesh-list
92335820|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
92335821|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92335822|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335823|NCT02079636|Gemcitabine|gemcitabine|mesh-list
92335824|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
92335826|NCT02079636|Ramucirumab|ramucirumab|mesh-list
92335827|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335828|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
92335829|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335830|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335831|NCT02079636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92335832|NCT02079636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92335833|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335834|NCT02079636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92335835|NCT02079636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92335836|NCT02079246|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92371045|NCT01215318|Silicon|silicon|mesh-list
92335837|NCT02079246|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92335839|NCT02079246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335840|NCT02079246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335841|NCT02079246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335842|NCT02047110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92335843|NCT02047110|Immunologic Factors|immunologic factors|mesh-ancestor
92335844|NCT02047110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335845|NCT02045862|Solifenacin Succinate|solifenacin succinate|mesh-list
92335846|NCT02045862|Mirabegron|mirabegron|mesh-list
92335847|NCT02045862|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92335848|NCT02045862|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92335849|NCT02045862|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335850|NCT02045862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335851|NCT02045862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335852|NCT02045862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335853|NCT02045862|Urological Agents|urological agents|mesh-ancestor
92335854|NCT02045862|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92335855|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92335856|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92335857|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
92335858|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
92335859|NCT04182984|Prednisone|prednisone|mesh-list
92335860|NCT04182984|Azathioprine|azathioprine|mesh-list
92335861|NCT04182984|Bromides|bromides|mesh-list
92335862|NCT04182984|Tacrolimus|tacrolimus|mesh-list
92335863|NCT04182984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92335864|NCT04182984|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92335865|NCT04182984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335866|NCT04182984|Glucocorticoids|glucocorticoids|mesh-ancestor
92335867|NCT04182984|Hormones|hormones|mesh-ancestor
92335868|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92335869|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335870|NCT04182984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92335871|NCT04182984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335872|NCT04182984|Immunologic Factors|immunologic factors|mesh-ancestor
92335873|NCT04182984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92335874|NCT04182984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335875|NCT04182984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335876|NCT04182984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92335877|NCT04182984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92335878|NCT04182984|Antitubercular Agents|antitubercular agents|mesh-ancestor
92335879|NCT04182984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92371251|NCT01249872|Analgesics|analgesics|mesh-ancestor
92335880|NCT04182984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335881|NCT04182984|Anticonvulsants|anticonvulsants|mesh-ancestor
92335882|NCT04182984|Antimetabolites|antimetabolites|mesh-ancestor
92335883|NCT04182984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92335884|NCT04182984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335885|NCT04182984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92335886|NCT04182984|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335887|NCT04182984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335888|NCT02044302|Morphine|morphine|mesh-list
92335889|NCT02044302|Narcotics|narcotics|mesh-list
92335890|NCT02044302|Analgesics|analgesics|mesh-list
92335891|NCT02044302|Bupivacaine|bupivacaine|mesh-list
92335892|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
92335893|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
92335894|NCT02044302|Anesthetics|anesthetics|mesh-ancestor
92335895|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335896|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335897|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
91914816|NCT02426463|Anesthetics, General|anesthetics, general|mesh-ancestor
92335898|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335899|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92335900|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92335901|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92335902|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335903|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335904|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335905|NCT02062944|Sirolimus|sirolimus|mesh-list
92335906|NCT02062944|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92335907|NCT02062944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92335908|NCT02062944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92335909|NCT02062944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92335910|NCT02062944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335911|NCT02062944|Antifungal Agents|antifungal agents|mesh-ancestor
92335912|NCT02062944|Immunologic Factors|immunologic factors|mesh-ancestor
92335913|NCT02062944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335914|NCT02062632|Doxepin|doxepin|mesh-list
92335915|NCT02062632|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92335916|NCT02062632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91937005|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92335917|NCT02062632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335919|NCT02062632|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92335920|NCT02062632|Antidepressive Agents|antidepressive agents|mesh-ancestor
92335921|NCT02062632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92335922|NCT02062632|Histamine Antagonists|histamine antagonists|mesh-ancestor
92335923|NCT02062632|Histamine Agents|histamine agents|mesh-ancestor
92335924|NCT02062632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335925|NCT02062632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335927|NCT02043366|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92335928|NCT02043366|Sufentanil|sufentanil|mesh-list
92335929|NCT02043366|Remifentanil|remifentanil|mesh-list
92335930|NCT02043366|Butorphanol|butorphanol|mesh-list
92335931|NCT02043366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92335932|NCT02043366|Narcotics|narcotics|mesh-ancestor
92335933|NCT02043366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92335934|NCT02043366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335935|NCT02043366|Analgesics|analgesics|mesh-ancestor
92335936|NCT02043366|Sensory System Agents|sensory system agents|mesh-ancestor
92371366|NCT01271244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335937|NCT02043366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335938|NCT02043366|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92335939|NCT02043366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92335940|NCT02043366|Anesthetics, General|anesthetics, general|mesh-ancestor
92335942|NCT02043366|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92335943|NCT02043366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92335944|NCT02043366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92335945|NCT02043366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92335946|NCT02043366|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92335947|NCT02043366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335948|NCT02043366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335950|NCT02043366|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335951|NCT02043366|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92335952|NCT02060370|Sunitinib|sunitinib|mesh-list
92335953|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335954|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92335955|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92335956|NCT02060370|Growth Substances|growth substances|mesh-ancestor
92335958|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92335959|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92335960|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92335961|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335962|NCT01622088|Pramipexole|pramipexole|mesh-list
92335963|NCT01622088|Antioxidants|antioxidants|mesh-ancestor
92335964|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335965|NCT01622088|Protective Agents|protective agents|mesh-ancestor
92335966|NCT01622088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371549|NCT01304238|PENTA|penta|mesh-list
92335967|NCT01622088|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92335968|NCT01622088|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92335969|NCT01622088|Dopamine Agonists|dopamine agonists|mesh-ancestor
92335971|NCT01622088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335972|NCT02021292|Macitentan|macitentan|mesh-list
92335973|NCT02021292|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92335974|NCT02021292|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92117025|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92335975|NCT02021292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335976|NCT02021292|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92335977|NCT02043132|Tranexamic Acid|tranexamic acid|mesh-list
92335978|NCT02043132|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
92335979|NCT02043132|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92335980|NCT02043132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335981|NCT02043132|Hemostatics|hemostatics|mesh-ancestor
92335982|NCT02043132|Coagulants|coagulants|mesh-ancestor
92335983|NCT02059434|Tiotropium Bromide|tiotropium bromide|mesh-list
92335985|NCT02059434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92335986|NCT02059434|Autonomic Agents|autonomic agents|mesh-ancestor
92335987|NCT02059434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92335988|NCT02059434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92335989|NCT02059434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92335990|NCT02059434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92335991|NCT02059434|Parasympatholytics|parasympatholytics|mesh-ancestor
92335992|NCT02059434|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92335993|NCT02059434|Cholinergic Agents|cholinergic agents|mesh-ancestor
92335994|NCT02059434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92335995|NCT02059434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92335996|NCT02059434|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92335997|NCT02059434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92335998|NCT02059434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92335999|NCT02059434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92336000|NCT02059434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92336001|NCT02059278|Latanoprost|latanoprost|mesh-list
92336002|NCT02059278|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92336003|NCT02059278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92336004|NCT02020512|Bimatoprost|bimatoprost|mesh-list
92336006|NCT02019420|Linezolid|linezolid|mesh-list
92336007|NCT02019420|Tedizolid|tedizolid|mesh-list
92336008|NCT02019420|Tedizolid phosphate|tedizolid phosphate|mesh-list
92336009|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336010|NCT02019420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336011|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92336012|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336013|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336015|NCT02058966|Methamphetamine|methamphetamine|mesh-list
92336016|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92336017|NCT02058966|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92336018|NCT02058966|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92336019|NCT02058966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336020|NCT02058966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336021|NCT02058966|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92336022|NCT02058966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336023|NCT02058966|Sympathomimetics|sympathomimetics|mesh-ancestor
92336024|NCT02058966|Autonomic Agents|autonomic agents|mesh-ancestor
92336025|NCT02058966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336026|NCT02058966|Dopamine Agents|dopamine agents|mesh-ancestor
92336027|NCT02058966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336028|NCT02058966|Adrenergic Agents|adrenergic agents|mesh-ancestor
92336029|NCT02058966|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92336030|NCT02058966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92336031|NCT02058966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336032|NCT02058966|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92336034|NCT02017860|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92336035|NCT02017860|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336036|NCT02017860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336037|NCT02017860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336038|NCT02017860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336039|NCT02017860|Immunologic Factors|immunologic factors|mesh-ancestor
92336040|NCT02017860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336041|NCT02017860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336042|NCT02040870|Ceritinib|ceritinib|mesh-list
92336043|NCT02040870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336044|NCT02040870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336045|NCT02040870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336046|NCT02040870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336047|NCT04720716|Sorafenib|sorafenib|mesh-list
92336049|NCT04720716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336050|NCT04720716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336051|NCT04720716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336052|NCT02039778|Temozolomide|temozolomide|mesh-list
92117026|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
92336053|NCT02039778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92336054|NCT02039778|Alkylating Agents|alkylating agents|mesh-ancestor
92336055|NCT02039778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336056|NCT02039778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336057|NCT02015676|Paclitaxel|paclitaxel|mesh-list
92336058|NCT02015676|Trastuzumab|trastuzumab|mesh-list
92336059|NCT02015676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92336060|NCT02015676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336061|NCT02015676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92336062|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92336063|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92336064|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336065|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336067|NCT02058108|Antiviral Agents|antiviral agents|mesh-ancestor
92336068|NCT02058108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372205|NCT01404936|Alkylating Agents|alkylating agents|mesh-ancestor
92336069|NCT02058108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92336070|NCT02058108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336071|NCT02058108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336073|NCT04678362|Talazoparib|talazoparib|mesh-list
92336074|NCT04678362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92372271|NCT01429272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336075|NCT04678362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336076|NCT04678362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92336077|NCT04678362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336078|NCT04678362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336079|NCT04678050|Dexmedetomidine|dexmedetomidine|mesh-list
92336080|NCT04678050|Ketamine|ketamine|mesh-list
92336081|NCT04678050|Propofol|propofol|mesh-list
92336082|NCT04678050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92336083|NCT04678050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336084|NCT04678050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336086|NCT04678050|Analgesics|analgesics|mesh-ancestor
92336087|NCT04678050|Sensory System Agents|sensory system agents|mesh-ancestor
92336088|NCT04678050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336089|NCT04678050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92336090|NCT04678050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92336091|NCT04678050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92336092|NCT04678050|Adrenergic Agents|adrenergic agents|mesh-ancestor
92336093|NCT04678050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336094|NCT04678050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336095|NCT04678050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92336096|NCT04678050|Anesthetics, General|anesthetics, general|mesh-ancestor
92336097|NCT04678050|Anesthetics|anesthetics|mesh-ancestor
92336098|NCT04678050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92336099|NCT04678050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92336100|NCT04678050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92336101|NCT02038920|Vedolizumab|vedolizumab|mesh-list
92336102|NCT02038920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336104|NCT01622868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336105|NCT01622868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336106|NCT01622868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336107|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336108|NCT02014740|Metformin|metformin|mesh-list
92336109|NCT02014740|Liraglutide|liraglutide|mesh-list
92336110|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92336111|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336112|NCT02014740|Incretins|incretins|mesh-ancestor
92336113|NCT02014740|Hormones|hormones|mesh-ancestor
92336114|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336115|NCT02014584|Dutasteride|dutasteride|mesh-list
92336116|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92336117|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92336118|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336119|NCT02014584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336120|NCT02014584|Hormone Antagonists|hormone antagonists|mesh-ancestor
92336121|NCT02014584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336122|NCT02014584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336123|NCT02037984|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92336125|NCT02037984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336126|NCT02036580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92336127|NCT02036580|Immunologic Factors|immunologic factors|mesh-ancestor
92336128|NCT02036580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336129|NCT02057250|Hydroxychloroquine|hydroxychloroquine|mesh-list
92336130|NCT02057250|Sulfasalazine|sulfasalazine|mesh-list
92336131|NCT02057250|Methotrexate|methotrexate|mesh-list
92336132|NCT02057250|Leflunomide|leflunomide|mesh-list
92336133|NCT02057250|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92336134|NCT02057250|Abortifacient Agents|abortifacient agents|mesh-ancestor
92336135|NCT02057250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92336136|NCT02057250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336137|NCT02057250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92336138|NCT02057250|Antimetabolites|antimetabolites|mesh-ancestor
92372654|NCT01521546|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92336139|NCT02057250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336140|NCT02057250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336141|NCT02057250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92336142|NCT02057250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336143|NCT02057250|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92336144|NCT02057250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336145|NCT02057250|Immunologic Factors|immunologic factors|mesh-ancestor
92336146|NCT02057250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336147|NCT02057250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92336148|NCT02057250|Antimalarials|antimalarials|mesh-ancestor
92372728|NCT01537926|Acetylcysteine|acetylcysteine|mesh-list
92336149|NCT02057250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92336150|NCT02057250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92336151|NCT02057250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336152|NCT02057250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92336153|NCT02057250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92336155|NCT02057250|Sensory System Agents|sensory system agents|mesh-ancestor
92336156|NCT02057250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336157|NCT02057250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336158|NCT02057250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336160|NCT02036502|Pembrolizumab|pembrolizumab|mesh-list
92336161|NCT02036502|Lenalidomide|lenalidomide|mesh-list
92336162|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336163|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
92336164|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
92336165|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336166|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336167|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336168|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
92336170|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336171|NCT02036502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92336172|NCT02036502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336173|NCT02036502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336174|NCT02036502|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92336175|NCT02036502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336176|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
92336177|NCT02036502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92336178|NCT02036502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336179|NCT02036502|Growth Substances|growth substances|mesh-ancestor
92336180|NCT02036502|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336181|NCT02056626|Carvedilol|carvedilol|mesh-list
92336182|NCT02056626|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92336183|NCT02056626|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92336184|NCT02056626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92336185|NCT02056626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336186|NCT02056626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336187|NCT02056626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336188|NCT02056626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92336189|NCT02056626|Antioxidants|antioxidants|mesh-ancestor
92336190|NCT02056626|Protective Agents|protective agents|mesh-ancestor
92336192|NCT02056626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336193|NCT02056626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92336194|NCT02056626|Vasodilator Agents|vasodilator agents|mesh-ancestor
92336195|NCT02056626|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92336196|NCT02056626|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92336197|NCT02056392|Moxifloxacin|moxifloxacin|mesh-list
92336198|NCT02056392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336199|NCT02056392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336200|NCT02056392|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92336201|NCT02056392|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92336202|NCT02056392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117027|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
92336203|NCT02056392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336204|NCT02056392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336205|NCT02034552|Prednisone|prednisone|mesh-list
92373110|NCT03729258|Antiviral Agents|antiviral agents|mesh-ancestor
92336207|NCT02034552|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92336208|NCT02034552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336209|NCT02034552|Glucocorticoids|glucocorticoids|mesh-ancestor
92336210|NCT02034552|Hormones|hormones|mesh-ancestor
92336211|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373175|NCT04873596|Analgesics|analgesics|mesh-ancestor
92336212|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336213|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92336214|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336215|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92336216|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336217|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336218|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
92336219|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92336220|NCT02011386|Golimumab|golimumab|mesh-list
92336221|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92336222|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336223|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336224|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
92336225|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336226|NCT02034162|Mebendazole|mebendazole|mesh-list
92336227|NCT02034162|Piperazine|piperazine|mesh-list
92336228|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
92336229|NCT02034162|DMP 777|dmp 777|mesh-list
92336230|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
92336231|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
92336232|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92336233|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373308|NCT01611948|Aprepitant|aprepitant|mesh-list
92336235|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
92336236|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
92336237|NCT02034162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336238|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336239|NCT02034162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336241|NCT02034006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92336242|NCT02034006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336244|NCT02034006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336245|NCT02034006|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336246|NCT02034006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336247|NCT02052960|Cisplatin|cisplatin|mesh-list
92336248|NCT02052960|Fluorouracil|fluorouracil|mesh-list
92336249|NCT02052960|Cetuximab|cetuximab|mesh-list
92336250|NCT02052960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336251|NCT02052960|Antimetabolites|antimetabolites|mesh-ancestor
92336252|NCT02052960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336253|NCT02052960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92336254|NCT02052960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336255|NCT02052960|Immunologic Factors|immunologic factors|mesh-ancestor
92336256|NCT02052960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373436|NCT01639872|Serotonin Agents|serotonin agents|mesh-ancestor
92336257|NCT02052960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336258|NCT02008890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92336259|NCT02008890|Immunologic Factors|immunologic factors|mesh-ancestor
92336260|NCT02008890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336261|NCT02052414|Gabapentin|gabapentin|mesh-list
92336262|NCT02052414|Analgesics|analgesics|mesh-ancestor
92336263|NCT02052414|Sensory System Agents|sensory system agents|mesh-ancestor
92336264|NCT02052414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336265|NCT02052414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336266|NCT02052414|Anticonvulsants|anticonvulsants|mesh-ancestor
92336267|NCT02052414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92336268|NCT02052414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92336269|NCT02052414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336270|NCT02052414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92336271|NCT02052414|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92336272|NCT02052414|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92336273|NCT02052414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336274|NCT02052414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336275|NCT02052414|Antimanic Agents|antimanic agents|mesh-ancestor
92336276|NCT02031276|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92336277|NCT02031276|Immunologic Factors|immunologic factors|mesh-ancestor
92336278|NCT02031276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336279|NCT01363440|Aflibercept|aflibercept|mesh-list
92336280|NCT01363440|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92373562|NCT01652976|Vitamins|vitamins|mesh-ancestor
92336281|NCT01363440|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336282|NCT01363440|Growth Substances|growth substances|mesh-ancestor
92336283|NCT01363440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336284|NCT01363440|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336286|NCT02007096|Bupivacaine|bupivacaine|mesh-list
92336287|NCT02007096|Anesthetics, Local|anesthetics, local|mesh-ancestor
92336288|NCT02007096|Anesthetics|anesthetics|mesh-ancestor
92336289|NCT02007096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336290|NCT02007096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336291|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
92336292|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336293|NCT02006706|Methylprednisolone|methylprednisolone|mesh-list
92336294|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92336295|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92336296|NCT02006706|Prednisolone|prednisolone|mesh-list
92336297|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
92336298|NCT02006706|Rituximab|rituximab|mesh-list
92336299|NCT02006706|Methotrexate|methotrexate|mesh-list
92336300|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92336301|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
92336302|NCT02006706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336303|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336304|NCT02006706|Immunologic Factors|immunologic factors|mesh-ancestor
92336305|NCT02006706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336306|NCT02006706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336307|NCT02006706|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92336309|NCT02006706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92336310|NCT02006706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92336312|NCT02006706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336313|NCT02006706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92336314|NCT02006706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336315|NCT02006706|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92336317|NCT02006706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92336318|NCT02006706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336321|NCT02006706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336322|NCT02006706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336323|NCT02006706|Glucocorticoids|glucocorticoids|mesh-ancestor
92336324|NCT02006706|Hormones|hormones|mesh-ancestor
92336325|NCT02006706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336326|NCT02006706|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92336327|NCT02006706|Protective Agents|protective agents|mesh-ancestor
92336328|NCT02006706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92336329|NCT02049138|Upadacitinib|upadacitinib|mesh-list
92336330|NCT02049138|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92336331|NCT02049138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336332|NCT02049138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336333|NCT02049138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336334|NCT02049138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336335|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92336336|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92336337|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336338|NCT02048904|Incretins|incretins|mesh-ancestor
92336339|NCT02048904|Hormones|hormones|mesh-ancestor
92336340|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336341|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92336342|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
92336343|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336344|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336346|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
92336347|NCT02029638|Acetaminophen|acetaminophen|mesh-list
92336348|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
92336349|NCT02029638|Promethazine|promethazine|mesh-list
92336350|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
92336351|NCT02029638|Prednisone|prednisone|mesh-list
92336352|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
92336353|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
92336354|NCT02029638|Fludarabine|fludarabine|mesh-list
92336356|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92336357|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336358|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
92336359|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336360|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336361|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92336362|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
92336363|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336364|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336365|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92336366|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336368|NCT02029638|Hormones|hormones|mesh-ancestor
92336369|NCT02029638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336370|NCT02029638|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92336371|NCT02029638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92336372|NCT02029638|Analgesics|analgesics|mesh-ancestor
92336373|NCT02029638|Sensory System Agents|sensory system agents|mesh-ancestor
92336374|NCT02029638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336375|NCT02029638|Antipyretics|antipyretics|mesh-ancestor
91988898|NCT04065113|Ethanol|ethanol|mesh-list
92336376|NCT02029638|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92336377|NCT02029638|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92336378|NCT02029638|Antitubercular Agents|antitubercular agents|mesh-ancestor
92336379|NCT02029638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336380|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336381|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336382|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
92336383|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
92336384|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336385|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92336386|NCT02029638|Protective Agents|protective agents|mesh-ancestor
92336387|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92336388|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92336389|NCT02029638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336390|NCT02029638|Anesthetics, Local|anesthetics, local|mesh-ancestor
92336391|NCT02029638|Anesthetics|anesthetics|mesh-ancestor
92336392|NCT02029638|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92336393|NCT02029638|Histamine Antagonists|histamine antagonists|mesh-ancestor
92336394|NCT02029638|Histamine Agents|histamine agents|mesh-ancestor
92336395|NCT02029638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336396|NCT02029638|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92336397|NCT02029638|Antipruritics|antipruritics|mesh-ancestor
92336398|NCT02029638|Dermatologic Agents|dermatologic agents|mesh-ancestor
92336399|NCT02047734|Interferons|interferons|mesh-list
92336401|NCT02047734|Interferon beta-1a|interferon beta-1a|mesh-list
92336403|NCT02047734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336404|NCT02047734|Antiviral Agents|antiviral agents|mesh-ancestor
92336405|NCT02047734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336406|NCT02047734|Immunologic Factors|immunologic factors|mesh-ancestor
92336407|NCT02047734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336408|NCT02047734|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92336409|NCT02047734|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92336410|NCT02047734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336411|NCT02047734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336412|NCT01994850|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92336413|NCT01994850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336415|NCT01994850|Immunotoxins|immunotoxins|mesh-ancestor
92336416|NCT01994850|Immunoconjugates|immunoconjugates|mesh-ancestor
92336417|NCT01994850|Immunologic Factors|immunologic factors|mesh-ancestor
92336418|NCT01994850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336419|NCT01994382|Rituximab|rituximab|mesh-list
92336420|NCT01994382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374008|NCT05316168|Hormones|hormones|mesh-ancestor
92336422|NCT01994382|Immunologic Factors|immunologic factors|mesh-ancestor
92336423|NCT01994382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336424|NCT01994382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336426|NCT02003898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92336427|NCT02003898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336428|NCT01994226|Naproxen|naproxen|mesh-list
92336429|NCT01994226|Colchicine|colchicine|mesh-list
92336430|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92336431|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92336433|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
92336434|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336435|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336437|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336438|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
92336439|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92336440|NCT01994226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336441|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336442|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
92336443|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
92336444|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
92336445|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336447|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92336448|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92336449|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
91988976|NCT03138785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336450|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92336451|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336452|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336453|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336454|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336455|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336456|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92336457|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336459|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92336460|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336461|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92349510|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336462|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92336463|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92336464|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92336466|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336467|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336468|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92336469|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92336470|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
92336471|NCT01967940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336472|NCT01990560|Mifepristone|mifepristone|mesh-list
92336473|NCT01990560|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92336474|NCT01990560|Abortifacient Agents|abortifacient agents|mesh-ancestor
92336475|NCT01990560|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92336476|NCT01990560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336477|NCT01990560|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92336478|NCT01990560|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92336479|NCT01990560|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92336480|NCT01990560|Contraceptive Agents|contraceptive agents|mesh-ancestor
92336481|NCT01990560|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92336482|NCT01990560|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92336483|NCT01990560|Hormone Antagonists|hormone antagonists|mesh-ancestor
92336484|NCT01990560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336485|NCT01990560|Luteolytic Agents|luteolytic agents|mesh-ancestor
92336486|NCT01990560|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92336487|NCT01990560|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92336488|NCT01967628|Vitamin D|vitamin d|mesh-list
92336489|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
92336490|NCT01967628|Vitamins|vitamins|mesh-ancestor
92336491|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
92336492|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336493|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92336494|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92336495|NCT01998906|Paclitaxel|paclitaxel|mesh-list
92336496|NCT01998906|Doxorubicin|doxorubicin|mesh-list
92336497|NCT01998906|Trastuzumab|trastuzumab|mesh-list
92336498|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92336499|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336500|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92336501|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92336502|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92336503|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336504|NCT01998906|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92336505|NCT01998906|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92336507|NCT01998906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336508|NCT01998906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336510|NCT01967550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92336511|NCT01967550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92336512|NCT01967550|Analgesics|analgesics|mesh-ancestor
92336513|NCT01967550|Sensory System Agents|sensory system agents|mesh-ancestor
92336514|NCT01967550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336515|NCT01967550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336516|NCT01967550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336517|NCT01967550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336518|NCT01967550|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92336519|NCT01967550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336520|NCT01967550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336521|NCT01989546|Talazoparib|talazoparib|mesh-list
92336522|NCT01989546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92336523|NCT01989546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336524|NCT01989546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336526|NCT01989468|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92336527|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
92336528|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336530|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
92336531|NCT01989156|Dermatologic Agents|dermatologic agents|mesh-ancestor
92336532|NCT01965834|Fenofibrate|fenofibrate|mesh-list
92336533|NCT01965834|Fenofibric acid|fenofibric acid|mesh-list
92336534|NCT01965834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92336535|NCT01965834|Antimetabolites|antimetabolites|mesh-ancestor
92336536|NCT01965834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336537|NCT01965834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92336538|NCT01965834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92336539|NCT01996332|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92336540|NCT01996332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336541|NCT01996332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336542|NCT01996332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336543|NCT01996332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336545|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92336546|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
92336547|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336548|NCT01964898|Nicotine|nicotine|mesh-list
92336549|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92336551|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336552|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336553|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92336554|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92336555|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336556|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336557|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336558|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
92336559|NCT01964352|Olodaterol|olodaterol|mesh-list
92336560|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92336561|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
92336562|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336563|NCT01964352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336564|NCT01964352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92336565|NCT01964352|Respiratory System Agents|respiratory system agents|mesh-ancestor
92336566|NCT01964352|Parasympatholytics|parasympatholytics|mesh-ancestor
92336567|NCT01964352|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92336568|NCT01964352|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336569|NCT01964352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336570|NCT01964352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336572|NCT01946412|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92336573|NCT01946412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336574|NCT01946412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336575|NCT01945866|Dexamethasone|dexamethasone|mesh-list
92336576|NCT01945866|Ranibizumab|ranibizumab|mesh-list
92336577|NCT01945866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92336578|NCT01945866|Antiemetics|antiemetics|mesh-ancestor
92336579|NCT01945866|Autonomic Agents|autonomic agents|mesh-ancestor
92336580|NCT01945866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336581|NCT01945866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336582|NCT01945866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336583|NCT01945866|Glucocorticoids|glucocorticoids|mesh-ancestor
92336585|NCT01945866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336586|NCT01945866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92336587|NCT01945866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336588|NCT01945866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92336589|NCT01945866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336590|NCT01945866|Growth Substances|growth substances|mesh-ancestor
92336591|NCT01945866|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336593|NCT01986114|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92336594|NCT01986114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92336595|NCT01986114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117028|NCT03268278|Lidocaine|lidocaine|mesh-list
92336596|NCT01986114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336597|NCT01986114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92336598|NCT01986114|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92336599|NCT01986114|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92336600|NCT01986114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92336601|NCT01986114|Adrenergic Agents|adrenergic agents|mesh-ancestor
92336602|NCT01986114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336603|NCT01986114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336604|NCT01986114|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92336605|NCT01986114|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92336606|NCT01986114|Serotonin Agents|serotonin agents|mesh-ancestor
92336607|NCT01986114|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92336608|NCT01986114|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92336609|NCT01986114|Dopamine Agents|dopamine agents|mesh-ancestor
92336611|NCT01945242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92336612|NCT01945242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336613|NCT01945242|Incretins|incretins|mesh-ancestor
92336615|NCT01945242|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336616|NCT01945242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92336617|NCT01945242|Protease Inhibitors|protease inhibitors|mesh-ancestor
92336619|NCT01945242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336620|NCT01945086|Ustekinumab|ustekinumab|mesh-list
92336621|NCT01945086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92336622|NCT04658160|Imidacloprid|imidacloprid|mesh-list
92336623|NCT04658160|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336624|NCT04658160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336625|NCT04658160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336626|NCT04658160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336627|NCT01963728|Insulin|insulin|mesh-list
92336628|NCT01963728|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92336629|NCT01963728|Insulin Glargine|insulin glargine|mesh-list
92336630|NCT01963728|Insulin, Isophane|insulin, isophane|mesh-list
92336631|NCT01963728|Isophane Insulin, Human|isophane insulin, human|mesh-list
92336632|NCT01963728|Isophane insulin, beef|isophane insulin, beef|mesh-list
92336633|NCT01963728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92336634|NCT01963728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336635|NCT01962948|Paclitaxel|paclitaxel|mesh-list
92336636|NCT01962948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92336638|NCT01962948|Tubulin Modulators|tubulin modulators|mesh-ancestor
92336639|NCT01962948|Antimitotic Agents|antimitotic agents|mesh-ancestor
92336640|NCT01962948|Mitosis Modulators|mitosis modulators|mesh-ancestor
92336641|NCT01962948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336642|NCT01985334|Glycopyrrolate|glycopyrrolate|mesh-list
92336643|NCT01985334|Bromides|bromides|mesh-list
92336644|NCT01985334|Anticonvulsants|anticonvulsants|mesh-ancestor
92336645|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336646|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92336648|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92336649|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336650|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336651|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336652|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
92336653|NCT01944774|Nemonoxacin|nemonoxacin|mesh-list
92336654|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336655|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336656|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92336657|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92336658|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336659|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336660|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336662|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92336663|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92336664|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
92336665|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
92336666|NCT04665648|Vitamins|vitamins|mesh-ancestor
92336667|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
92336668|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336669|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92336670|NCT01944462|Immunologic Factors|immunologic factors|mesh-ancestor
92336671|NCT01944462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336672|NCT01942590|Clenbuterol|clenbuterol|mesh-list
92336673|NCT01942590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92336674|NCT01942590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92336675|NCT01942590|Adrenergic Agents|adrenergic agents|mesh-ancestor
92336676|NCT01942590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336677|NCT01942590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336678|NCT01942590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336680|NCT01942590|Autonomic Agents|autonomic agents|mesh-ancestor
92336681|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336682|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92336683|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
92336684|NCT01942590|Sympathomimetics|sympathomimetics|mesh-ancestor
92336685|NCT01984242|Bevacizumab|bevacizumab|mesh-list
92336686|NCT01984242|Atezolizumab|atezolizumab|mesh-list
92336687|NCT01984242|Sunitinib|sunitinib|mesh-list
92336688|NCT01984242|Antibodies|antibodies|mesh-list
92336689|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92336690|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336691|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336692|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92336693|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336694|NCT01984242|Growth Substances|growth substances|mesh-ancestor
92336695|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336696|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336697|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
92336698|NCT01984242|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92336699|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336700|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336701|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336702|NCT01960842|Levodopa|levodopa|mesh-list
92336703|NCT01960842|Carbidopa|carbidopa|mesh-list
92349511|NCT01447446|Antiviral Agents|antiviral agents|mesh-ancestor
92336704|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92336705|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92336706|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92336707|NCT01960842|Dopamine Agents|dopamine agents|mesh-ancestor
92374579|NCT01822548|Metformin|metformin|mesh-list
92336708|NCT01960842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336709|NCT01960842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336710|NCT01960842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336711|NCT01960842|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92027124|NCT02481635|Paclitaxel|paclitaxel|mesh-list
92336712|NCT01960842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336713|NCT01960842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92336714|NCT01960842|Immunologic Factors|immunologic factors|mesh-ancestor
92336715|NCT01960842|Dopamine Agonists|dopamine agonists|mesh-ancestor
92336716|NCT01984164|Candesartan|candesartan|mesh-list
92336717|NCT01984164|Candesartan cilexetil|candesartan cilexetil|mesh-list
92336718|NCT01984164|Lisinopril|lisinopril|mesh-list
92336719|NCT01984164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92336720|NCT01984164|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92336721|NCT01984164|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92336722|NCT01984164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336723|NCT01984164|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92336725|NCT01984164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336726|NCT01984164|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92336727|NCT01984164|Protective Agents|protective agents|mesh-ancestor
92336728|NCT01984164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336730|NCT01983774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92336731|NCT01983774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92336732|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92336733|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336734|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336735|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
92336736|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
92336737|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336738|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
92336739|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336740|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336741|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92336742|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
92336743|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336744|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336745|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92336746|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92336747|NCT01982682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92336748|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
92336749|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92336750|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336751|NCT01982682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374849|NCT01875510|SMOFlipid|smoflipid|mesh-list
92336752|NCT01940484|Epoetin Alfa|epoetin alfa|mesh-list
92336753|NCT01940484|Hematinics|hematinics|mesh-ancestor
92336754|NCT01960296|Clopidogrel|clopidogrel|mesh-list
92336755|NCT01960296|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92336756|NCT01960296|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92336757|NCT01960296|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92336758|NCT01960296|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92336759|NCT01960296|Purinergic Agents|purinergic agents|mesh-ancestor
92336760|NCT01960296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336761|NCT01960296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336762|NCT01960296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336764|NCT01939314|Anesthetics, Local|anesthetics, local|mesh-ancestor
92336765|NCT01939314|Anesthetics|anesthetics|mesh-ancestor
92336766|NCT01939314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336767|NCT01939314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336768|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
92336769|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336770|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92336771|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
92336772|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336773|NCT01939002|Interferons|interferons|mesh-list
92336774|NCT01939002|Interferon-beta|interferon-beta|mesh-list
92336775|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
92336776|NCT01939002|Naproxen|naproxen|mesh-list
92336777|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92336778|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92336779|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336780|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
92336781|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336782|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92336783|NCT01939002|Analgesics|analgesics|mesh-ancestor
92336784|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
92336785|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336786|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336787|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336788|NCT01939002|Gout Suppressants|gout suppressants|mesh-ancestor
92336789|NCT01939002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92336790|NCT01939002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336791|NCT01939002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336792|NCT01939002|Immunologic Factors|immunologic factors|mesh-ancestor
92336793|NCT01939002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92336795|NCT01938846|Exemestane|exemestane|mesh-list
92336796|NCT01938846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92336797|NCT01938846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336798|NCT01938846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92336799|NCT01938846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92336800|NCT01938846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92336801|NCT01938846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336802|NCT01938846|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92336803|NCT01938846|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92336804|NCT01938846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336805|NCT01938846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92336806|NCT01938846|Hormone Antagonists|hormone antagonists|mesh-ancestor
92336807|NCT01938846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92336808|NCT01938846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336809|NCT01960140|Simvastatin|simvastatin|mesh-list
92336810|NCT01960140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92336811|NCT01960140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92336812|NCT01960140|Antimetabolites|antimetabolites|mesh-ancestor
92336813|NCT01960140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336814|NCT01960140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92336815|NCT01960140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92336816|NCT01960140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336817|NCT01959672|Calcium, Dietary|calcium, dietary|mesh-list
92336818|NCT01959672|Leucovorin|leucovorin|mesh-list
92336819|NCT01959672|Folic Acid|folic acid|mesh-list
92336820|NCT01959672|Nelfinavir|nelfinavir|mesh-list
92336821|NCT01959672|Gemcitabine|gemcitabine|mesh-list
91989363|NCT05085587|Xhance|xhance|mesh-list
92336822|NCT01959672|Fluorouracil|fluorouracil|mesh-list
92336823|NCT01959672|Oregovomab|oregovomab|mesh-list
92336824|NCT01959672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92336825|NCT01959672|Antibodies|antibodies|mesh-list
92336826|NCT01959672|Immunoglobulins|immunoglobulins|mesh-list
92336827|NCT01959672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92336828|NCT01959672|Calcium|calcium|mesh-list
92336829|NCT01959672|Levoleucovorin|levoleucovorin|mesh-list
92336830|NCT01959672|Immunologic Factors|immunologic factors|mesh-ancestor
92336831|NCT01959672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336832|NCT01959672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92336833|NCT01959672|Antimetabolites|antimetabolites|mesh-ancestor
92336834|NCT01959672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336835|NCT01959672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375146|NCT01472562|Rituximab|rituximab|mesh-list
92336836|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92336837|NCT01959672|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92336838|NCT01959672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336840|NCT01959672|Protective Agents|protective agents|mesh-ancestor
92336841|NCT01959672|Vitamin B Complex|vitamin b complex|mesh-ancestor
92336843|NCT01959672|Micronutrients|micronutrients|mesh-ancestor
92336844|NCT01959672|Hematinics|hematinics|mesh-ancestor
92336845|NCT01959672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92336846|NCT01959672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92336847|NCT01959672|Protease Inhibitors|protease inhibitors|mesh-ancestor
92336848|NCT01959672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336849|NCT01959672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92336850|NCT01959672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92336851|NCT01959672|Antiviral Agents|antiviral agents|mesh-ancestor
92336852|NCT01959672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336853|NCT01980888|Rituximab|rituximab|mesh-list
92336854|NCT01980888|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92336855|NCT01980888|Idelalisib|idelalisib|mesh-list
92336856|NCT01980888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336857|NCT01980888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336858|NCT01980888|Immunologic Factors|immunologic factors|mesh-ancestor
92336859|NCT01980888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336860|NCT01980888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92336861|NCT01980888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92336862|NCT01980888|Alkylating Agents|alkylating agents|mesh-ancestor
92336863|NCT01980888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336864|NCT01980888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336866|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
92336867|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
92336868|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92336870|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
92336871|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336872|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91937016|NCT02267057|Buprenorphine|buprenorphine|mesh-list
92336873|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92336874|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92336875|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92336876|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336878|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92336879|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336880|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92349513|NCT01447446|Immunologic Factors|immunologic factors|mesh-ancestor
92336881|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336882|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92336883|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
92336885|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336886|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336887|NCT01979952|Nintedanib|nintedanib|mesh-list
92336888|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336889|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375453|NCT01957410|Ketamine|ketamine|mesh-list
92336890|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336891|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336892|NCT01999218|Metformin|metformin|mesh-list
92336893|NCT01999218|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92336894|NCT01999218|Glimepiride|glimepiride|mesh-list
92336895|NCT01999218|Ertugliflozin|ertugliflozin|mesh-list
92336896|NCT01999218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92336897|NCT01999218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336898|NCT01999218|Incretins|incretins|mesh-ancestor
92336899|NCT01999218|Hormones|hormones|mesh-ancestor
92336900|NCT01999218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375518|NCT05739006|Pembrolizumab|pembrolizumab|mesh-list
91932375|NCT02220647|Metformin|metformin|mesh-list
92336901|NCT01999218|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92336902|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
92336903|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336904|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336905|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92336906|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92336907|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
92336908|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92336909|NCT01936974|Bevacizumab|bevacizumab|mesh-list
92336910|NCT01936974|Carboplatin|carboplatin|mesh-list
92336911|NCT01936974|Gemcitabine|gemcitabine|mesh-list
92336912|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
92336913|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92336914|NCT01936974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336915|NCT01936974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92336916|NCT01936974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336917|NCT01936974|Growth Substances|growth substances|mesh-ancestor
92336918|NCT01936974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336919|NCT01936974|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336920|NCT01936974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92336921|NCT01936974|Antimetabolites|antimetabolites|mesh-ancestor
92336922|NCT01936974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336923|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
92336924|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
92336925|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92336926|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
92336927|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336928|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336929|NCT01959516|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92336930|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
92336931|NCT01959516|Parasympatholytics|parasympatholytics|mesh-ancestor
92336932|NCT01959516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92336933|NCT01959516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336934|NCT01959516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336935|NCT01959516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336936|NCT01959516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92336937|NCT01959516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92336939|NCT01979016|Dermatologic Agents|dermatologic agents|mesh-ancestor
92336940|NCT01935336|Ponatinib|ponatinib|mesh-list
92336941|NCT01935336|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92336942|NCT01935336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336943|NCT01935336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336944|NCT01935336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336945|NCT01935336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336946|NCT01978236|Trametinib|trametinib|mesh-list
92336947|NCT01978236|Dabrafenib|dabrafenib|mesh-list
92336948|NCT01978236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336949|NCT01978236|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92336950|NCT01978236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92336951|NCT01978236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336952|NCT01934790|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92336953|NCT01934790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336954|NCT01934556|Ranibizumab|ranibizumab|mesh-list
92336956|NCT01934556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92336957|NCT01934556|Growth Substances|growth substances|mesh-ancestor
92336958|NCT01934556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336959|NCT01934556|Growth Inhibitors|growth inhibitors|mesh-ancestor
92336960|NCT01934556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336961|NCT04411212|Lenograstim|lenograstim|mesh-list
92336962|NCT04411212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92336963|NCT04411212|Immunologic Factors|immunologic factors|mesh-ancestor
92336964|NCT04411212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336965|NCT01620138|Cabergoline|cabergoline|mesh-list
92336966|NCT01620138|Pasireotide|pasireotide|mesh-list
92336967|NCT01620138|Hormones|hormones|mesh-ancestor
92336968|NCT01620138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989497|NCT04643249|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92336969|NCT01620138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336970|NCT01620138|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92336971|NCT01620138|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92336972|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
92336973|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
92336974|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336975|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336976|NCT01932996|Nicotine|nicotine|mesh-list
92336977|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92336978|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
92336979|NCT01932996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92336980|NCT01932996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92336981|NCT01932996|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92336982|NCT01932996|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92336983|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
92336984|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92336985|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336986|NCT01932762|Ribavirin|ribavirin|mesh-list
92336987|NCT01932762|Grazoprevir|grazoprevir|mesh-list
92336988|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
92336989|NCT01932762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336990|NCT01932762|Antiviral Agents|antiviral agents|mesh-ancestor
92336991|NCT01932762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92336992|NCT01977456|Eptifibatide|eptifibatide|mesh-list
92336993|NCT01977456|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92336995|NCT01957644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92336996|NCT01957644|Antimetabolites|antimetabolites|mesh-ancestor
92336997|NCT01957644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92336998|NCT01957644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92336999|NCT01957644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337000|NCT01931202|Escitalopram|escitalopram|mesh-list
92337001|NCT01931202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92337002|NCT01931202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92375862|NCT01858740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337003|NCT01931202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337004|NCT01931202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337005|NCT01931202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337006|NCT01931202|Serotonin Agents|serotonin agents|mesh-ancestor
92337007|NCT01931202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337009|NCT01930890|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337010|NCT01930890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337011|NCT01930890|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92337012|NCT01930890|Antitubercular Agents|antitubercular agents|mesh-ancestor
92337013|NCT01930890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337014|NCT01930890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337016|NCT01930890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337017|NCT01930188|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92337018|NCT01930188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92337019|NCT01930188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337022|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337023|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92337024|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337025|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337026|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337027|NCT01976364|Methotrexate|methotrexate|mesh-list
92337028|NCT01976364|Tofacitinib|tofacitinib|mesh-list
92337029|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92337030|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
92337031|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92337032|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337033|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92337034|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
92337035|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337036|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337037|NCT01976364|Dermatologic Agents|dermatologic agents|mesh-ancestor
92337038|NCT01976364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337039|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92337040|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92337041|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
92337042|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337043|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92337044|NCT01976364|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92337045|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92337046|NCT01929876|Itraconazole|itraconazole|mesh-list
92337047|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
92337048|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337049|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92337050|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92337051|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337052|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337054|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
92337055|NCT01929876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337056|NCT01929876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337057|NCT01929876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92337060|NCT01928940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337061|NCT01928940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375972|NCT01984398|Clomiphene|clomiphene|mesh-list
92337062|NCT01928940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337063|NCT01928940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337064|NCT01954056|Hydrocortisone|hydrocortisone|mesh-list
92337065|NCT01954056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337067|NCT01975272|Ferrous fumarate|ferrous fumarate|mesh-list
92337068|NCT01975272|Ferric Compounds|ferric compounds|mesh-list
92337069|NCT01975272|Trace Elements|trace elements|mesh-ancestor
92337070|NCT01975272|Micronutrients|micronutrients|mesh-ancestor
92337071|NCT01975272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337072|NCT01975272|Hematinics|hematinics|mesh-ancestor
92337073|NCT03965039|Fluorides|fluorides|mesh-list
92337074|NCT03965039|Tin Fluorides|tin fluorides|mesh-list
92337075|NCT03965039|Fluorophosphate|fluorophosphate|mesh-list
92337076|NCT03965039|Cariostatic Agents|cariostatic agents|mesh-ancestor
92337077|NCT03965039|Protective Agents|protective agents|mesh-ancestor
92337078|NCT03965039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337079|NCT03961295|Vedolizumab|vedolizumab|mesh-list
92337080|NCT03961295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337081|NCT03935399|Oxytocin|oxytocin|mesh-list
92337082|NCT03935399|Oxytocics|oxytocics|mesh-ancestor
92337083|NCT03935399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92337084|NCT03935399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337085|NCT03571607|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92337086|NCT03571607|Immunologic Factors|immunologic factors|mesh-ancestor
92337087|NCT03571607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337088|NCT03993119|Anticoagulants|anticoagulants|mesh-list
92337089|NCT03910439|Avelumab|avelumab|mesh-list
92337090|NCT03910439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92337091|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337092|NCT03895307|Anesthetics|anesthetics|mesh-list
92337093|NCT03895307|Anesthetics, Local|anesthetics, local|mesh-list
92337094|NCT03895307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337095|NCT03895307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337096|NCT03895307|Sensory System Agents|sensory system agents|mesh-ancestor
92337097|NCT03895307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337098|NCT03888755|Icatibant|icatibant|mesh-list
92337099|NCT03888755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92337100|NCT03888755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92337102|NCT03888755|Sensory System Agents|sensory system agents|mesh-ancestor
92337103|NCT03888755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337104|NCT03888755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028546|NCT02501629|Reslizumab|reslizumab|mesh-list
92337105|NCT03888755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337106|NCT03888755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337107|NCT03888755|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92337108|NCT03888755|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92337109|NCT03888755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337110|NCT03888755|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92337111|NCT03888755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92337112|NCT03888755|Immunologic Factors|immunologic factors|mesh-ancestor
92337113|NCT00378755|Bortezomib|bortezomib|mesh-list
92337114|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337115|NCT00378833|Niacin|niacin|mesh-list
92337116|NCT00378833|Niacinamide|niacinamide|mesh-list
92337117|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
92337118|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92337119|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
92337120|NCT00378833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989656|NCT05737511|Anesthetics|anesthetics|mesh-ancestor
92337121|NCT00378833|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92337123|NCT00378833|Vitamin B Complex|vitamin b complex|mesh-ancestor
92337125|NCT00378833|Micronutrients|micronutrients|mesh-ancestor
92337126|NCT00378833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337127|NCT02995967|Botulinum Toxins|botulinum toxins|mesh-list
92337128|NCT02995967|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92337129|NCT02995967|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92337130|NCT02995967|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92337131|NCT02995967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337132|NCT02995967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337133|NCT02995967|Cholinergic Agents|cholinergic agents|mesh-ancestor
92337134|NCT02995967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337135|NCT02995967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337136|NCT02995967|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92337137|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337138|NCT03888365|Treprostinil|treprostinil|mesh-list
92337139|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92337140|NCT00377975|Pioglitazone|pioglitazone|mesh-list
92337143|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92337144|NCT00377975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337145|NCT00377975|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92337146|NCT00377975|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92337147|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337148|NCT00377975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337149|NCT00377975|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92337150|NCT00377975|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92337151|NCT00377975|Purinergic Agents|purinergic agents|mesh-ancestor
92337152|NCT00377975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337153|NCT00377975|Sympathomimetics|sympathomimetics|mesh-ancestor
92337154|NCT00377975|Autonomic Agents|autonomic agents|mesh-ancestor
92337155|NCT00377975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337156|NCT00377975|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92337157|NCT00377975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92337158|NCT02994251|Gemcitabine|gemcitabine|mesh-list
92337159|NCT02994251|Doxorubicin|doxorubicin|mesh-list
92337160|NCT02994251|Mitomycins|mitomycins|mesh-list
92337162|NCT02994251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337163|NCT02994251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92337164|NCT02994251|Antimetabolites|antimetabolites|mesh-ancestor
92337165|NCT02994251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337166|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337168|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92337169|NCT02994251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337170|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
92337171|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92337172|NCT02936999|Vitamin D|vitamin d|mesh-list
92337173|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
92337174|NCT02936999|Vitamins|vitamins|mesh-ancestor
92337175|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
92337176|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337177|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92337178|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92337179|NCT02826551|Bupivacaine|bupivacaine|mesh-list
92337180|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
92337181|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
92337182|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337183|NCT02826551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337184|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
92337185|NCT02826551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337186|NCT00378443|Prednisone|prednisone|mesh-list
92337187|NCT00378443|Losartan|losartan|mesh-list
92337188|NCT00378443|Cilazapril|cilazapril|mesh-list
92337189|NCT00378443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337190|NCT00378443|Glucocorticoids|glucocorticoids|mesh-ancestor
92337191|NCT00378443|Hormones|hormones|mesh-ancestor
92337192|NCT00378443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337193|NCT00378443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337194|NCT00378443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337195|NCT00378443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337196|NCT00378443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376580|NCT02201394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337197|NCT00378443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92337198|NCT00378443|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92337199|NCT00378443|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92337200|NCT00378443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337201|NCT00378443|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92337202|NCT00378443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337203|NCT00378443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337204|NCT01340573|Interferons|interferons|mesh-list
92337205|NCT01340573|Ribavirin|ribavirin|mesh-list
92376688|NCT02233296|Lasmiditan|lasmiditan|mesh-list
92337206|NCT01340573|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92337207|NCT01340573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337208|NCT01340573|Antiviral Agents|antiviral agents|mesh-ancestor
92337209|NCT01340573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337210|NCT01340573|Antimetabolites|antimetabolites|mesh-ancestor
92337211|NCT01340573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337213|NCT01340885|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92337214|NCT01340885|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92337215|NCT01340885|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92337216|NCT01340885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337217|NCT01340885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337218|NCT01340885|Adrenergic Agents|adrenergic agents|mesh-ancestor
92337219|NCT01340885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337220|NCT01340885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337221|NCT01340885|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92337223|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
92337224|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92337225|NCT01340885|Protective Agents|protective agents|mesh-ancestor
92337227|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92337228|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337229|NCT03855059|Dexamethasone|dexamethasone|mesh-list
92376764|NCT02251236|Tenofovir|tenofovir|mesh-list
92337230|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
92337231|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92337233|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337234|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
92337236|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337237|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337238|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337239|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
92337241|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337242|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337244|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337245|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337246|NCT03855059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337247|NCT01301963|Plerixafor|plerixafor|mesh-list
92337248|NCT01301963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92337249|NCT01301963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92337250|NCT01301963|Antiviral Agents|antiviral agents|mesh-ancestor
92337251|NCT01301963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337252|NCT01262339|Botulinum Toxins|botulinum toxins|mesh-list
92337253|NCT01262339|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92337254|NCT01262339|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92337255|NCT01262339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337256|NCT01262339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337257|NCT01262339|Cholinergic Agents|cholinergic agents|mesh-ancestor
92337258|NCT01262339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337259|NCT01262339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337260|NCT01262339|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92337261|NCT01262339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337262|NCT02708849|Lamotrigine|lamotrigine|mesh-list
92337263|NCT02708849|Ketamine|ketamine|mesh-list
92337264|NCT02708849|Analgesics|analgesics|mesh-ancestor
92337265|NCT02708849|Sensory System Agents|sensory system agents|mesh-ancestor
92337266|NCT02708849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337267|NCT02708849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337268|NCT02708849|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92337270|NCT02708849|Anesthetics, General|anesthetics, general|mesh-ancestor
92337271|NCT02708849|Anesthetics|anesthetics|mesh-ancestor
92337272|NCT02708849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337273|NCT02708849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92337274|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92337275|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376958|NCT02285634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92337276|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337277|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
92337278|NCT02708849|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92337279|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337280|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92337281|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92337282|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92337283|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92337284|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92337285|NCT01222871|Triamcinolone|triamcinolone|mesh-list
92337286|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337287|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
92337289|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117029|NCT03268278|Epinephrine|epinephrine|mesh-list
92337290|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029537|NCT01641939|Taxane|taxane|mesh-list
92337291|NCT01219673|Minocycline|minocycline|mesh-list
92337292|NCT01219673|Modafinil|modafinil|mesh-list
92337293|NCT01219673|Bupropion|bupropion|mesh-list
92337294|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92337295|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
92337296|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92337297|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92337298|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92337299|NCT01219673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337300|NCT01219673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337301|NCT01219673|Dopamine Agents|dopamine agents|mesh-ancestor
92337302|NCT01219673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337303|NCT01219673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337304|NCT01219673|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92337305|NCT01219673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92337306|NCT01219673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337307|NCT01219673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337308|NCT01219673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337309|NCT01219673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92337310|NCT01219673|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92337311|NCT01219673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92337312|NCT01219673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92337313|NCT01216631|Methylprednisolone|methylprednisolone|mesh-list
92337315|NCT01216631|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92337316|NCT01216631|Prednisolone|prednisolone|mesh-list
92337317|NCT01216631|Prednisolone acetate|prednisolone acetate|mesh-list
92337318|NCT01216631|Infliximab|infliximab|mesh-list
92337319|NCT01216631|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92337320|NCT01216631|Prednisolone phosphate|prednisolone phosphate|mesh-list
92337321|NCT01216631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337322|NCT01216631|Antiemetics|antiemetics|mesh-ancestor
92337323|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
92337324|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337325|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377065|NCT02303184|Growth Inhibitors|growth inhibitors|mesh-ancestor
92337326|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337327|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
92337329|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337330|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92337331|NCT01216631|Protective Agents|protective agents|mesh-ancestor
92337332|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337333|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337334|NCT01216631|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92337335|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92337336|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337337|NCT02693717|Pemetrexed|pemetrexed|mesh-list
92377104|NCT02330094|Gabapentin|gabapentin|mesh-list
92337338|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337339|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337340|NCT02693717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337341|NCT02693717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92337342|NCT02693717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92337343|NCT03860753|Pioglitazone|pioglitazone|mesh-list
91989876|NCT02412475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337344|NCT03860753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92337345|NCT03860753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337346|NCT02687165|Cycloserine|cycloserine|mesh-list
92337347|NCT02687165|Milnacipran|milnacipran|mesh-list
92337348|NCT02687165|Levomilnacipran|levomilnacipran|mesh-list
92337349|NCT02687165|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92337350|NCT02687165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337351|NCT02687165|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92337352|NCT02687165|Antitubercular Agents|antitubercular agents|mesh-ancestor
92337353|NCT02687165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337354|NCT02687165|Antimetabolites|antimetabolites|mesh-ancestor
92337355|NCT02687165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337356|NCT02687165|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92337357|NCT02687165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92337358|NCT02687165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337359|NCT02687165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337360|NCT02687165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337361|NCT02687165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92337362|NCT02687165|Analgesics|analgesics|mesh-ancestor
92337363|NCT02687165|Sensory System Agents|sensory system agents|mesh-ancestor
92337364|NCT02687165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337365|NCT02687165|Antidepressive Agents|antidepressive agents|mesh-ancestor
92337366|NCT02687165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92337367|NCT01169753|Modafinil|modafinil|mesh-list
92337368|NCT01169753|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92337369|NCT01169753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337370|NCT01169753|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92337371|NCT01169753|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92337372|NCT01169753|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92337373|NCT01169753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337374|NCT02654639|Bevacizumab|bevacizumab|mesh-list
92337375|NCT02654639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92337376|NCT02654639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337377|NCT02654639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92337378|NCT02654639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92337379|NCT02654639|Growth Substances|growth substances|mesh-ancestor
92337380|NCT02654639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337381|NCT02654639|Growth Inhibitors|growth inhibitors|mesh-ancestor
92337382|NCT02634827|Decitabine|decitabine|mesh-list
92337383|NCT02634827|Midostaurin|midostaurin|mesh-list
92337385|NCT02634827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92337386|NCT02634827|Antimetabolites|antimetabolites|mesh-ancestor
92337387|NCT02634827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337388|NCT02634827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337389|NCT02634827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337390|NCT02634827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92337391|NCT02506985|Warfarin|warfarin|mesh-list
92337392|NCT02506985|Rivaroxaban|rivaroxaban|mesh-list
92337393|NCT02506985|Anticoagulants|anticoagulants|mesh-ancestor
92337394|NCT02506985|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92337395|NCT02506985|Antithrombins|antithrombins|mesh-ancestor
92337396|NCT02506985|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92337397|NCT02506985|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337398|NCT02506985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337399|NCT02506985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337400|NCT01150409|Hydrocortisone|hydrocortisone|mesh-list
92337401|NCT01150409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337402|NCT01133639|Ketorolac|ketorolac|mesh-list
92337403|NCT01133639|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92337404|NCT01133639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92337405|NCT01133639|Analgesics|analgesics|mesh-ancestor
92337406|NCT01133639|Sensory System Agents|sensory system agents|mesh-ancestor
92337407|NCT01133639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337408|NCT01133639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337409|NCT01133639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337410|NCT01133639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337411|NCT01133639|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92337412|NCT01133639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337413|NCT01133639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337415|NCT00378911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337416|NCT00378911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92337417|NCT00378911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92337418|NCT00378911|Growth Substances|growth substances|mesh-ancestor
92337419|NCT00378911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337420|NCT00378911|Growth Inhibitors|growth inhibitors|mesh-ancestor
92337421|NCT00378911|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92337422|NCT00378911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337423|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337424|NCT03822377|Ticagrelor|ticagrelor|mesh-list
92337425|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92337426|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92337427|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92337428|NCT03822377|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92337429|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
92337430|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337431|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337432|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337433|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
92337434|NCT02501759|Antidotes|antidotes|mesh-ancestor
92337435|NCT02501759|Protective Agents|protective agents|mesh-ancestor
92337436|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337437|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
92337438|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
92337439|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337440|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92337442|NCT02499887|Albuterol|albuterol|mesh-list
92337443|NCT02499887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337444|NCT02499887|Glucocorticoids|glucocorticoids|mesh-ancestor
92337445|NCT02499887|Hormones|hormones|mesh-ancestor
92337446|NCT02499887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337447|NCT02499887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337448|NCT02499887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337449|NCT02499887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337450|NCT02499887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92337451|NCT02499887|Autonomic Agents|autonomic agents|mesh-ancestor
92337452|NCT02499887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337453|NCT02499887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92337454|NCT02499887|Respiratory System Agents|respiratory system agents|mesh-ancestor
92337456|NCT02499887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92337457|NCT02499887|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92337459|NCT02499887|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92337460|NCT02499887|Adrenergic Agents|adrenergic agents|mesh-ancestor
92337461|NCT02499887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337462|NCT02499887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337464|NCT02504099|Ribavirin|ribavirin|mesh-list
92337465|NCT02504099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92337466|NCT02504099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92337467|NCT02504099|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337468|NCT02504099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337469|NCT02504099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337470|NCT02504099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92337471|NCT02504099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92337472|NCT02504099|Antiviral Agents|antiviral agents|mesh-ancestor
92337473|NCT02504099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337474|NCT02504099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92337475|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92337476|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
92337477|NCT02450591|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92337478|NCT02450591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337479|NCT02450591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92337480|NCT02450591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337481|NCT02450591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337483|NCT01094561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337484|NCT01094561|Hormones|hormones|mesh-ancestor
92337485|NCT01094561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337486|NCT01094561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377588|NCT02519322|Nivolumab|nivolumab|mesh-list
92337489|NCT01074437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337490|NCT01074437|Glucocorticoids|glucocorticoids|mesh-ancestor
92337491|NCT01074437|Hormones|hormones|mesh-ancestor
92337492|NCT01074437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337494|NCT01074437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337495|NCT01074437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337496|NCT01074437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92337497|NCT01074437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92337498|NCT01074437|Adrenergic Agents|adrenergic agents|mesh-ancestor
92337499|NCT01074437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337500|NCT01074437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337501|NCT01074437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92377628|NCT05722002|Acetaminophen|acetaminophen|mesh-list
92337502|NCT01074437|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92337503|NCT01074437|Vasodilator Agents|vasodilator agents|mesh-ancestor
92337504|NCT03807245|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92337505|NCT03807245|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92337506|NCT03807245|Immunologic Factors|immunologic factors|mesh-ancestor
92337507|NCT03807245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337508|NCT03807245|Antacids|antacids|mesh-ancestor
92337509|NCT03807245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337510|NCT03807245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337511|NCT03796013|Entrectinib|entrectinib|mesh-list
92337512|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92337513|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337514|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337515|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
92337516|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92337517|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337518|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337519|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92337520|NCT03793751|Analgesics|analgesics|mesh-ancestor
92337521|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
92337522|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337523|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92337524|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92337525|NCT03793751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92337526|NCT03793751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92337527|NCT03793751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337528|NCT03793751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337530|NCT02351063|Diuretics|diuretics|mesh-list
92337531|NCT02351063|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92337532|NCT02351063|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92337533|NCT02351063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92337534|NCT02351063|Natriuretic Agents|natriuretic agents|mesh-ancestor
92337535|NCT02351063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337536|NCT02351063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337537|NCT02351063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337538|NCT02351063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337539|NCT02351063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92337540|NCT02351063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92337541|NCT02351063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337542|NCT02351063|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92337543|NCT01016561|Cisplatin|cisplatin|mesh-list
92337544|NCT01016561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337545|NCT01009931|Dexamethasone|dexamethasone|mesh-list
92337546|NCT01009931|Dexamethasone acetate|dexamethasone acetate|mesh-list
92337549|NCT01009931|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92337550|NCT01009931|BB 1101|bb 1101|mesh-list
92337551|NCT01009931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337552|NCT01009931|Antiemetics|antiemetics|mesh-ancestor
92337553|NCT01009931|Autonomic Agents|autonomic agents|mesh-ancestor
92337554|NCT01009931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337555|NCT01009931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337556|NCT01009931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337557|NCT01009931|Glucocorticoids|glucocorticoids|mesh-ancestor
92337559|NCT01009931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337560|NCT01009931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337561|NCT01009931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337562|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337563|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337564|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337565|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
92337566|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92337567|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
92337568|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92337569|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
92337570|NCT01009931|Analgesics|analgesics|mesh-ancestor
92337571|NCT01009931|Sensory System Agents|sensory system agents|mesh-ancestor
92337572|NCT01009931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92337573|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92337574|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337575|NCT03792191|Fentanyl|fentanyl|mesh-list
92337576|NCT03792191|Bupivacaine|bupivacaine|mesh-list
92337577|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
92337578|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
92337579|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337580|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337581|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
92337582|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337583|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92337585|NCT03792191|Analgesics|analgesics|mesh-ancestor
92337586|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92337587|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92337588|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
92337589|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92337590|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92337591|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92337592|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
92337593|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337594|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92337595|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92337596|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337597|NCT00983645|Cyclosporine|cyclosporine|mesh-list
92337599|NCT00983645|Cyclosporins|cyclosporins|mesh-list
92337600|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92337601|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
92337602|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337603|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92337604|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337605|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337606|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
92337607|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337608|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
92337609|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337610|NCT00978419|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92337611|NCT00978419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92337612|NCT00978419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92337613|NCT00978419|Antimetabolites|antimetabolites|mesh-ancestor
92337614|NCT00978419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337615|NCT00978419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92337616|NCT00978419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92337617|NCT00978419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337619|NCT00957827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337620|NCT00957827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337621|NCT00962429|Thioctic Acid|thioctic acid|mesh-list
92337622|NCT00962429|Antioxidants|antioxidants|mesh-ancestor
92337623|NCT00962429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337624|NCT00962429|Protective Agents|protective agents|mesh-ancestor
92337625|NCT00962429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337626|NCT00962429|Vitamin B Complex|vitamin b complex|mesh-ancestor
92337627|NCT00962429|Vitamins|vitamins|mesh-ancestor
92337628|NCT00962429|Micronutrients|micronutrients|mesh-ancestor
92337629|NCT00949403|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92337630|NCT00949403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337631|NCT00920309|Sirolimus|sirolimus|mesh-list
92337632|NCT00920309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337633|NCT00920309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337634|NCT00920309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337635|NCT00920309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337637|NCT00920309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92337638|NCT00920309|Immunologic Factors|immunologic factors|mesh-ancestor
92337639|NCT00920309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337640|NCT02075411|Bupivacaine|bupivacaine|mesh-list
92337641|NCT02075411|Anesthetics, Local|anesthetics, local|mesh-ancestor
92337642|NCT02075411|Anesthetics|anesthetics|mesh-ancestor
92337643|NCT02075411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337644|NCT02075411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337645|NCT02075411|Sensory System Agents|sensory system agents|mesh-ancestor
92337646|NCT02075411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337647|NCT03753113|Minoxidil|minoxidil|mesh-list
92337648|NCT03753113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92337649|NCT03753113|Vasodilator Agents|vasodilator agents|mesh-ancestor
92337651|NCT02075021|Lenalidomide|lenalidomide|mesh-list
92337652|NCT02075021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92337653|NCT02075021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337654|NCT02075021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92337655|NCT02075021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92337656|NCT02075021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92337657|NCT02075021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337658|NCT02075021|Immunologic Factors|immunologic factors|mesh-ancestor
92337659|NCT02075021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337660|NCT02075021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92337661|NCT02075021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92337662|NCT02075021|Growth Substances|growth substances|mesh-ancestor
92337663|NCT02075021|Growth Inhibitors|growth inhibitors|mesh-ancestor
92337665|NCT02057237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92337666|NCT02057237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337667|NCT00378677|Cyclosporine|cyclosporine|mesh-list
92337668|NCT00378677|Cyclosporins|cyclosporins|mesh-list
92337669|NCT00378677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337670|NCT00378677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337671|NCT00378677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92337672|NCT00378677|Immunologic Factors|immunologic factors|mesh-ancestor
92337673|NCT00378677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337674|NCT00378677|Antifungal Agents|antifungal agents|mesh-ancestor
92337675|NCT00378677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337676|NCT00378677|Dermatologic Agents|dermatologic agents|mesh-ancestor
92337677|NCT00378677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337678|NCT00378677|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92337679|NCT00850421|Botulinum Toxins|botulinum toxins|mesh-list
92337680|NCT00850421|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92337681|NCT00850421|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92337682|NCT00850421|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92337683|NCT00850421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337684|NCT00850421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337685|NCT00850421|Cholinergic Agents|cholinergic agents|mesh-ancestor
92337686|NCT00850421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378422|NCT02418312|Histamine Antagonists|histamine antagonists|mesh-ancestor
92337687|NCT00850421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337688|NCT00850421|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92337689|NCT00850421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337690|NCT02017379|Erythromycin|erythromycin|mesh-list
92337691|NCT02017379|Erythromycin Estolate|erythromycin estolate|mesh-list
92337692|NCT02017379|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92337694|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337695|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337696|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337697|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92337698|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337699|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337700|NCT01997567|Ropivacaine|ropivacaine|mesh-list
92337701|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
92337702|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
92337703|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337704|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337705|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
92337706|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337707|NCT00825227|Modafinil|modafinil|mesh-list
92337708|NCT00825227|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92337709|NCT00825227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337710|NCT00825227|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92337711|NCT00825227|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92337712|NCT00825227|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92337713|NCT00825227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337715|NCT01978535|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92337716|NCT01978535|Trace Elements|trace elements|mesh-ancestor
92337717|NCT01978535|Micronutrients|micronutrients|mesh-ancestor
92337718|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337719|NCT01978535|Hematinics|hematinics|mesh-ancestor
92337720|NCT00808769|Omeprazole|omeprazole|mesh-list
92337721|NCT00808769|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92337722|NCT00808769|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92378686|NCT02500602|Doxazosin|doxazosin|mesh-list
92337723|NCT00808769|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337724|NCT00808769|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92337725|NCT00808769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337726|NCT00808769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337728|NCT00379067|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92337729|NCT00379067|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92337730|NCT00379067|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92337731|NCT00379067|Adrenergic Agents|adrenergic agents|mesh-ancestor
92337732|NCT00379067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337733|NCT00379067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337734|NCT00379067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337735|NCT00379067|Urological Agents|urological agents|mesh-ancestor
92337736|NCT00378287|Rabeprazole|rabeprazole|mesh-list
92337737|NCT00378287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92337738|NCT00378287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92337739|NCT00378287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92337740|NCT00378287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337741|NCT00378287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337743|NCT01938833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92337744|NCT01938833|Romidepsin|romidepsin|mesh-list
92378810|NCT02530476|Sorafenib|sorafenib|mesh-list
92337745|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92337746|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337747|NCT01938833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92337748|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92337749|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92337750|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337751|NCT01938833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337752|NCT01938833|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92337754|NCT01893359|Riboflavin|riboflavin|mesh-list
92337755|NCT01893359|Dextrans|dextrans|mesh-list
92337756|NCT01893359|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92337757|NCT01893359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92337758|NCT01893359|Vitamin B Complex|vitamin b complex|mesh-ancestor
92337759|NCT01893359|Vitamins|vitamins|mesh-ancestor
92337761|NCT01893359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337762|NCT01893359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92337763|NCT01893359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92337764|NCT01893359|Anticoagulants|anticoagulants|mesh-ancestor
92337765|NCT01893359|Plasma Substitutes|plasma substitutes|mesh-ancestor
92337766|NCT01893359|Blood Substitutes|blood substitutes|mesh-ancestor
92337767|NCT00795665|Bevacizumab|bevacizumab|mesh-list
92337768|NCT00795665|Carmustine|carmustine|mesh-list
92337769|NCT00795665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92337770|NCT00795665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337771|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92337772|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92337773|NCT00795665|Growth Substances|growth substances|mesh-ancestor
92379018|NCT02582970|Antimetabolites|antimetabolites|mesh-ancestor
92337774|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337775|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
92337776|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92337777|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
92337778|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337780|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92337781|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337782|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337783|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92337784|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
92337785|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337786|NCT00780455|Interferons|interferons|mesh-list
92337787|NCT00780455|Interferon-beta|interferon-beta|mesh-list
92337788|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
91990328|NCT05091359|Calcium|calcium|mesh-list
92337789|NCT00780455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337791|NCT00780455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337792|NCT00780455|Immunologic Factors|immunologic factors|mesh-ancestor
92337793|NCT00780455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337794|NCT00780455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92337795|NCT00755261|Bevacizumab|bevacizumab|mesh-list
92337796|NCT00755261|Doxorubicin|doxorubicin|mesh-list
92337797|NCT00755261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92337798|NCT00755261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337799|NCT00755261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92337800|NCT00755261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92337801|NCT00755261|Growth Substances|growth substances|mesh-ancestor
92337802|NCT00755261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337803|NCT00755261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92337804|NCT00755261|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337805|NCT00755261|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92337806|NCT00755261|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92337807|NCT00755261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379279|NCT05730660|Antioxidants|antioxidants|mesh-ancestor
92337808|NCT00755261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337809|NCT03724877|Cholinergic Agents|cholinergic agents|mesh-list
92337810|NCT03724877|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92337811|NCT03724877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337812|NCT03724877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337813|NCT03724877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337814|NCT03724877|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92337815|NCT00746603|Simvastatin|simvastatin|mesh-list
92337816|NCT00746603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92337817|NCT00746603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92379356|NCT04107168|Nivolumab|nivolumab|mesh-list
92337818|NCT00746603|Antimetabolites|antimetabolites|mesh-ancestor
92337819|NCT00746603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337820|NCT00746603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92337821|NCT00746603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92337822|NCT00746603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337823|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92337824|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337825|NCT00716807|Nalbuphine|nalbuphine|mesh-list
92337826|NCT00716807|Naloxone|naloxone|mesh-list
92337827|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92337828|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337829|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
92337830|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337831|NCT00716807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92337832|NCT00716807|Narcotics|narcotics|mesh-ancestor
92337833|NCT00716807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337835|NCT03426137|Ketorolac|ketorolac|mesh-list
92337836|NCT03426137|Oxycodone|oxycodone|mesh-list
92337837|NCT03426137|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92337838|NCT03426137|Narcotics|narcotics|mesh-ancestor
92337839|NCT03426137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337840|NCT03426137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337841|NCT03426137|Analgesics|analgesics|mesh-ancestor
92337842|NCT03426137|Sensory System Agents|sensory system agents|mesh-ancestor
92337843|NCT03426137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337844|NCT03426137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92337845|NCT03426137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92337846|NCT03426137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337847|NCT03426137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92337848|NCT03426137|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92337849|NCT03426137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337850|NCT03426137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337851|NCT01760993|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92337852|NCT01760993|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92337853|NCT01760993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337854|NCT01760993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92337855|NCT01760993|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92337856|NCT01760993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337857|NCT01760993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337858|NCT01760993|Dopamine Agents|dopamine agents|mesh-ancestor
92337859|NCT01760993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337861|NCT00669461|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92337862|NCT00669461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337863|NCT00669461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337865|NCT00673595|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92337866|NCT00673595|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92337867|NCT00673595|Cholinergic Agents|cholinergic agents|mesh-ancestor
92337868|NCT00673595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337869|NCT00673595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337870|NCT00673595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337872|NCT03248141|Coagulants|coagulants|mesh-ancestor
92337873|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
92337874|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337875|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92337876|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92337877|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
92337878|NCT01754987|Sorafenib|sorafenib|mesh-list
92337879|NCT01754987|Vitamins|vitamins|mesh-ancestor
92337880|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
92337881|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337882|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337883|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92337884|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337885|NCT01754987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337886|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
92337887|NCT01754987|Protective Agents|protective agents|mesh-ancestor
92337888|NCT00652457|Memantine|memantine|mesh-list
92337889|NCT00652457|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92337890|NCT00652457|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92337891|NCT00652457|Dopamine Agents|dopamine agents|mesh-ancestor
92337892|NCT00652457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337893|NCT00652457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337894|NCT00652457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337895|NCT00652457|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92337896|NCT00652457|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92337897|NCT00625703|Linezolid|linezolid|mesh-list
92337898|NCT00625703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337899|NCT00625703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337900|NCT00625703|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92337901|NCT00625703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337902|NCT00625703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337903|NCT00616577|Ropivacaine|ropivacaine|mesh-list
92337904|NCT00616577|Anesthetics, Local|anesthetics, local|mesh-ancestor
92337905|NCT00616577|Anesthetics|anesthetics|mesh-ancestor
92379799|NCT02658240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92337906|NCT00616577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92337907|NCT00616577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337908|NCT00616577|Sensory System Agents|sensory system agents|mesh-ancestor
92337909|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337910|NCT00616343|Zonisamide|zonisamide|mesh-list
92337911|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
92337912|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92337913|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337914|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379863|NCT02695290|Afatinib|afatinib|mesh-list
92337915|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92337916|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337917|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
92337918|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92337919|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
92337920|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92337921|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337922|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92337923|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
92337924|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92337926|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337927|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92337928|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92337929|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
92337930|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
92379990|NCT05444088|Bevacizumab|bevacizumab|mesh-list
92337931|NCT05599919|Protective Agents|protective agents|mesh-ancestor
92337932|NCT05599841|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92337934|NCT01645709|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92337935|NCT01645709|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92337936|NCT01645709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92337937|NCT01645709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349514|NCT01447446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337938|NCT01645709|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92337939|NCT01645709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337940|NCT01645709|Vasodilator Agents|vasodilator agents|mesh-ancestor
92337942|NCT00608465|Eplerenone|eplerenone|mesh-list
92337943|NCT00608465|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92337944|NCT00608465|Protease Inhibitors|protease inhibitors|mesh-ancestor
92337945|NCT00608465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380117|NCT04238754|Cannabidiol|cannabidiol|mesh-list
92337946|NCT00608465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337948|NCT00608465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92337949|NCT00608465|Hormone Antagonists|hormone antagonists|mesh-ancestor
92337950|NCT00608465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337951|NCT00608465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337952|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92337954|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
92337955|NCT00608777|Betamethasone|betamethasone|mesh-list
92337956|NCT00608777|Calcipotriene|calcipotriene|mesh-list
92337957|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92337958|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
92380245|NCT04569942|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92337960|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92337961|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337962|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92337963|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
92337964|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
92337965|NCT00379457|Dactinomycin|dactinomycin|mesh-list
92337966|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
92337967|NCT00379457|Ifosfamide|ifosfamide|mesh-list
92337969|NCT00379457|Doxorubicin|doxorubicin|mesh-list
92337970|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92337971|NCT00379457|Etoposide|etoposide|mesh-list
92337972|NCT00379457|Vincristine|vincristine|mesh-list
92337973|NCT00379457|Topotecan|topotecan|mesh-list
92337974|NCT00379457|Vinorelbine|vinorelbine|mesh-list
91932379|NCT02220647|Incretins|incretins|mesh-ancestor
92337975|NCT00379457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92337976|NCT00379457|Immunologic Factors|immunologic factors|mesh-ancestor
92337977|NCT00379457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92337978|NCT00379457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92380380|NCT05453448|Tenofovir|tenofovir|mesh-list
92337979|NCT00379457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92337980|NCT00379457|Alkylating Agents|alkylating agents|mesh-ancestor
92337981|NCT00379457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92337982|NCT00379457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92337983|NCT00379457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92337984|NCT00379457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92337985|NCT00379457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92337986|NCT00379457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92337987|NCT00379457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92337988|NCT00379457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92337989|NCT00379457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92337990|NCT00379457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92337991|NCT00379457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92337992|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92337993|NCT00379457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92337994|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92337995|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92337996|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92337997|NCT01629329|Aspirin|aspirin|mesh-list
92337998|NCT01629329|Acetaminophen|acetaminophen|mesh-list
92337999|NCT01629329|Prochlorperazine|prochlorperazine|mesh-list
92338000|NCT01629329|Caffeine|caffeine|mesh-list
92338001|NCT01629329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92338003|NCT01629329|Analgesics|analgesics|mesh-ancestor
92338004|NCT01629329|Sensory System Agents|sensory system agents|mesh-ancestor
92380654|NCT05348148|Mydriatics|mydriatics|mesh-ancestor
92338005|NCT01629329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338006|NCT01629329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338007|NCT01629329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92338008|NCT01629329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338009|NCT01629329|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92338010|NCT01629329|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92380724|NCT04549428|Atezolizumab|atezolizumab|mesh-list
92338011|NCT01629329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338012|NCT01629329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92338013|NCT01629329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92338014|NCT01629329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338015|NCT01629329|Antipyretics|antipyretics|mesh-ancestor
92338016|NCT01629329|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92338018|NCT01629329|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92338019|NCT01629329|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92338020|NCT01629329|Purinergic Agents|purinergic agents|mesh-ancestor
92338021|NCT01629329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338023|NCT01629329|Autonomic Agents|autonomic agents|mesh-ancestor
92338024|NCT01629329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92338026|NCT01629329|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92338027|NCT01629329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338028|NCT01629329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338029|NCT01629329|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92338030|NCT01629329|Dopamine Agents|dopamine agents|mesh-ancestor
92338031|NCT01606709|Leuprolide|leuprolide|mesh-list
92338032|NCT01606709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92338033|NCT01606709|Fertility Agents|fertility agents|mesh-ancestor
92338034|NCT01606709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338035|NCT01606709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338036|NCT01606709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92338037|NCT01606709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338039|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92338040|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338041|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92338042|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92338043|NCT00423059|Growth Substances|growth substances|mesh-ancestor
92338044|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338045|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
92338046|NCT00585611|Atorvastatin|atorvastatin|mesh-list
92338048|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92338049|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
92338050|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338051|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92338052|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92381128|NCT02937558|Glucagon|glucagon|mesh-list
92338054|NCT00379691|Phenylephrine|phenylephrine|mesh-list
92338055|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
92338056|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92338057|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
92338058|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
92338059|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338060|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338061|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
92338062|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92338063|NCT00379691|Nasal Decongestants|nasal decongestants|mesh-ancestor
92338064|NCT00379691|Respiratory System Agents|respiratory system agents|mesh-ancestor
92338065|NCT00379691|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92338066|NCT00379691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92338067|NCT00379691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92338068|NCT00379691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92338069|NCT00379691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338070|NCT00379691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338071|NCT00379691|Protective Agents|protective agents|mesh-ancestor
92338072|NCT01685333|Epoetin Alfa|epoetin alfa|mesh-list
92338073|NCT01685333|Hematinics|hematinics|mesh-ancestor
92338074|NCT01556009|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92338075|NCT01556009|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92338076|NCT01556009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92338077|NCT00546455|Fenretinide|fenretinide|mesh-list
92338078|NCT00546455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338079|NCT00546455|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92338080|NCT00546455|Protective Agents|protective agents|mesh-ancestor
92338081|NCT00546455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338082|NCT00000737|Megestrol|megestrol|mesh-list
92338083|NCT00000737|Megestrol Acetate|megestrol acetate|mesh-list
92338084|NCT00000737|Dronabinol|dronabinol|mesh-list
92338085|NCT00000737|Hallucinogens|hallucinogens|mesh-ancestor
92338086|NCT00000737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338087|NCT00000737|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338088|NCT00000737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92338089|NCT00000737|Analgesics|analgesics|mesh-ancestor
92338090|NCT00000737|Sensory System Agents|sensory system agents|mesh-ancestor
92338091|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338092|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92338093|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92338094|NCT00000737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338095|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338096|NCT00000737|Hormones|hormones|mesh-ancestor
92338097|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92338098|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92338099|NCT00000737|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92338100|NCT00000737|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92338101|NCT00000737|Contraceptive Agents|contraceptive agents|mesh-ancestor
92338102|NCT00000737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338103|NCT00000737|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92338104|NCT00000737|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92338105|NCT00000737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92338106|NCT00000737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338107|NCT00000737|Appetite Stimulants|appetite stimulants|mesh-ancestor
92338108|NCT00000737|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92338109|NCT00528437|Carboplatin|carboplatin|mesh-list
92338110|NCT00528437|Temozolomide|temozolomide|mesh-list
92338112|NCT00528437|Tretinoin|tretinoin|mesh-list
92338113|NCT00528437|Isotretinoin|isotretinoin|mesh-list
92338114|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338115|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92338116|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
92338117|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338118|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92338119|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92381369|NCT03051672|Pembrolizumab|pembrolizumab|mesh-list
92338120|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
92338121|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338122|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
92338123|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92338125|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
92338126|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117030|NCT03268278|Buprenorphine|buprenorphine|mesh-list
92338127|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338128|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338129|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338130|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
92338131|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338132|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338133|NCT00000743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338134|NCT00506909|Oxytocin|oxytocin|mesh-list
92338135|NCT00506909|Oxytocics|oxytocics|mesh-ancestor
92338136|NCT00506909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338137|NCT00506909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338138|NCT00500045|Niacin|niacin|mesh-list
92338139|NCT00500045|Nicotinic Acids|nicotinic acids|mesh-list
92338140|NCT00500045|Niacinamide|niacinamide|mesh-list
92338141|NCT00500045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92338142|NCT00500045|Antimetabolites|antimetabolites|mesh-ancestor
92338143|NCT00500045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338144|NCT00500045|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92338145|NCT00500045|Vasodilator Agents|vasodilator agents|mesh-ancestor
92338146|NCT00500045|Vitamin B Complex|vitamin b complex|mesh-ancestor
92338147|NCT00500045|Vitamins|vitamins|mesh-ancestor
92338148|NCT00500045|Micronutrients|micronutrients|mesh-ancestor
92338149|NCT00500045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338150|NCT00000767|Vaccines|vaccines|mesh-list
92338151|NCT00000767|Immunologic Factors|immunologic factors|mesh-ancestor
92338152|NCT00000767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338153|NCT05383547|Bortezomib|bortezomib|mesh-list
92338154|NCT05383547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338155|NCT00456989|Docetaxel|docetaxel|mesh-list
92338156|NCT00456989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338158|NCT00456989|Antimitotic Agents|antimitotic agents|mesh-ancestor
92338159|NCT00456989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92338160|NCT00456989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338162|NCT00000773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338163|NCT00000773|Antimalarials|antimalarials|mesh-ancestor
92338164|NCT00000773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92338165|NCT00000773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92338166|NCT00000773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338167|NCT00000773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338169|NCT00428207|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92338170|NCT00428207|Insulin Aspart|insulin aspart|mesh-list
92338171|NCT00428207|Insulin, Long-Acting|insulin, long-acting|mesh-list
92338172|NCT00428207|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92338173|NCT00428207|Insulin Lispro|insulin lispro|mesh-list
92338174|NCT00428207|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92338175|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338176|NCT00000791|Zidovudine|zidovudine|mesh-list
92338177|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
92338178|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338179|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338180|NCT00000791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338181|NCT00000791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338182|NCT00000791|Antiviral Agents|antiviral agents|mesh-ancestor
92338183|NCT00000791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338184|NCT00000791|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338185|NCT00000791|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338186|NCT00379847|Conivaptan|conivaptan|mesh-list
92338187|NCT00379847|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92338188|NCT00379847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338189|NCT00379847|Natriuretic Agents|natriuretic agents|mesh-ancestor
92338190|NCT00379847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338191|NCT00374543|Ziprasidone|ziprasidone|mesh-list
92338192|NCT00374543|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92338193|NCT00374543|Serotonin Agents|serotonin agents|mesh-ancestor
92338194|NCT00374543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338195|NCT00374543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338196|NCT00374543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338197|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92338198|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92338199|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338200|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338201|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92338202|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
92338204|NCT00000803|Didanosine|didanosine|mesh-list
92338205|NCT00000803|Delavirdine|delavirdine|mesh-list
92338206|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
92338207|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338208|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338209|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338210|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338211|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
92338212|NCT00000803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338213|NCT00000803|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338214|NCT00000803|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338215|NCT00299195|Sulindac|sulindac|mesh-list
92338216|NCT00299195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92338217|NCT00299195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92338218|NCT00299195|Analgesics|analgesics|mesh-ancestor
92338219|NCT00299195|Sensory System Agents|sensory system agents|mesh-ancestor
92338220|NCT00299195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338221|NCT00299195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338222|NCT00299195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92338223|NCT00299195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338224|NCT00299195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381957|NCT03453060|Hemostatics|hemostatics|mesh-ancestor
92338225|NCT00299195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92338226|NCT00299195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338227|NCT00299195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338228|NCT01351415|Bevacizumab|bevacizumab|mesh-list
92338230|NCT01351415|Pemetrexed|pemetrexed|mesh-list
92338231|NCT01351415|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92338232|NCT01351415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92338233|NCT01351415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338234|NCT01351415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92338235|NCT01351415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92338236|NCT01351415|Growth Substances|growth substances|mesh-ancestor
92338237|NCT01351415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338238|NCT01351415|Growth Inhibitors|growth inhibitors|mesh-ancestor
92338239|NCT01351415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92338240|NCT01351415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92338241|NCT01351415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92338242|NCT01351415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338243|NCT01351415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338244|NCT01351415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92338245|NCT01351415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338246|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92338248|NCT00281879|Cyclosporine|cyclosporine|mesh-list
92338249|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
92338250|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
92338251|NCT00281879|Cyclophosphamide|cyclophosphamide|mesh-list
92338252|NCT00281879|Melphalan|melphalan|mesh-list
92338253|NCT00281879|Busulfan|busulfan|mesh-list
92338254|NCT00281879|Carmustine|carmustine|mesh-list
92338256|NCT00281879|Fludarabine|fludarabine|mesh-list
92338257|NCT00281879|Fludarabine phosphate|fludarabine phosphate|mesh-list
92338258|NCT00281879|Etoposide|etoposide|mesh-list
92338259|NCT00281879|Tacrolimus|tacrolimus|mesh-list
92338260|NCT00281879|Cyclosporins|cyclosporins|mesh-list
92338261|NCT00281879|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92338262|NCT00281879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92338263|NCT00281879|Immunologic Factors|immunologic factors|mesh-ancestor
92338264|NCT00281879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338265|NCT00281879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382062|NCT03557658|Bexagliflozin|bexagliflozin|mesh-list
92338266|NCT00281879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92338267|NCT00281879|Alkylating Agents|alkylating agents|mesh-ancestor
92338268|NCT00281879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338269|NCT00281879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338270|NCT00281879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92338271|NCT00281879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92338272|NCT00281879|Abortifacient Agents|abortifacient agents|mesh-ancestor
92338273|NCT00281879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338274|NCT00281879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92338275|NCT00281879|Antimetabolites|antimetabolites|mesh-ancestor
92338276|NCT00281879|Dermatologic Agents|dermatologic agents|mesh-ancestor
92338277|NCT00281879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338278|NCT00281879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92338279|NCT00281879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338280|NCT00281879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92338281|NCT00281879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92338282|NCT00281879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92338283|NCT00281879|Antiviral Agents|antiviral agents|mesh-ancestor
92382189|NCT04138758|Anticonvulsants|anticonvulsants|mesh-ancestor
92338284|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338285|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92338286|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
92338288|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92338289|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
92338290|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92338291|NCT00281879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92338292|NCT00281879|Antiemetics|antiemetics|mesh-ancestor
92338293|NCT00281879|Autonomic Agents|autonomic agents|mesh-ancestor
92338294|NCT00281879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338295|NCT00281879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92338296|NCT00281879|Glucocorticoids|glucocorticoids|mesh-ancestor
92338297|NCT00281879|Hormones|hormones|mesh-ancestor
92338298|NCT00281879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92338299|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92338300|NCT00281879|Protective Agents|protective agents|mesh-ancestor
92338302|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92338303|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
92338304|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338305|NCT00000809|Antacids|antacids|mesh-ancestor
92338306|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338307|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92338309|NCT05091203|Vitamins|vitamins|mesh-ancestor
92338310|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
92338311|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338312|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92338313|NCT00240227|Prazosin|prazosin|mesh-list
92338314|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92338315|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92338316|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92338317|NCT00240227|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92338319|NCT00240227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338320|NCT00240227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338321|NCT00240227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338322|NCT00205049|Pentoxifylline|pentoxifylline|mesh-list
92338323|NCT00205049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92338324|NCT00205049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338325|NCT00205049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338326|NCT00205049|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92338327|NCT00205049|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92338328|NCT00205049|Protective Agents|protective agents|mesh-ancestor
92338329|NCT00205049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338330|NCT00205049|Vasodilator Agents|vasodilator agents|mesh-ancestor
92338331|NCT00205049|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92338332|NCT00205049|Antioxidants|antioxidants|mesh-ancestor
92338333|NCT00000833|Ribavirin|ribavirin|mesh-list
92338334|NCT00000833|Didanosine|didanosine|mesh-list
92338335|NCT00000833|Antimetabolites|antimetabolites|mesh-ancestor
92338336|NCT00000833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338337|NCT00000833|Antiviral Agents|antiviral agents|mesh-ancestor
92338338|NCT00000833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338339|NCT00000833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338340|NCT00000833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338341|NCT00000833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338342|NCT00000833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338343|NCT00000833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338344|NCT00000839|Didanosine|didanosine|mesh-list
91937039|NCT01262261|Analgesics|analgesics|mesh-ancestor
92382731|NCT01545648|Denosumab|denosumab|mesh-list
92338346|NCT00000839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338347|NCT00000839|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338348|NCT00000839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338349|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338351|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338352|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338353|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338354|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
92338355|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
92338356|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92382798|NCT01302444|Urological Agents|urological agents|mesh-ancestor
92338357|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92338359|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338360|NCT00133679|Urological Agents|urological agents|mesh-ancestor
92338361|NCT00000875|Acetaminophen|acetaminophen|mesh-list
92338362|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
92338363|NCT00000875|Promethazine|promethazine|mesh-list
92338364|NCT00000875|Lamivudine|lamivudine|mesh-list
92338365|NCT00000875|Zidovudine|zidovudine|mesh-list
92338366|NCT00000875|Aldesleukin|aldesleukin|mesh-list
92338367|NCT00000875|Indinavir|indinavir|mesh-list
92338368|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92338369|NCT00000875|Analgesics|analgesics|mesh-ancestor
92338370|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
92338371|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338372|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338373|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
92338374|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338375|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338376|NCT00000875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338377|NCT00000875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338378|NCT00000875|Antiviral Agents|antiviral agents|mesh-ancestor
92338379|NCT00000875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338380|NCT00000875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338381|NCT00000875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338382|NCT00000875|Antimetabolites|antimetabolites|mesh-ancestor
92338383|NCT00000875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338384|NCT00000875|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92338385|NCT00000875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92338386|NCT00000875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338387|NCT00000875|Anesthetics, Local|anesthetics, local|mesh-ancestor
92338388|NCT00000875|Anesthetics|anesthetics|mesh-ancestor
92383073|NCT00577356|Docetaxel|docetaxel|mesh-list
92338389|NCT00000875|Antiemetics|antiemetics|mesh-ancestor
92338390|NCT00000875|Autonomic Agents|autonomic agents|mesh-ancestor
92338391|NCT00000875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92338392|NCT00000875|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91990928|NCT02400619|Botulinum Toxins|botulinum toxins|mesh-list
92338393|NCT00000875|Histamine Antagonists|histamine antagonists|mesh-ancestor
92338394|NCT00000875|Histamine Agents|histamine agents|mesh-ancestor
92338395|NCT00000875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338396|NCT00000875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92338397|NCT00000875|Antipruritics|antipruritics|mesh-ancestor
92338398|NCT00000875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92338399|NCT00000875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92338400|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92338401|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338402|NCT04941833|Desogestrel|desogestrel|mesh-list
92338403|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92338404|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92338405|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92338406|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
92338407|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338408|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338409|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92338410|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92338412|NCT04941833|Hormones|hormones|mesh-ancestor
92338413|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92338414|NCT04841369|Vaccines|vaccines|mesh-list
92338415|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
92338416|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338417|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92338418|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92338419|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
92338421|NCT00521885|Fondaparinux|fondaparinux|mesh-list
92338422|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
92338423|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92338424|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92383263|NCT00108342|Nicotine|nicotine|mesh-list
92338425|NCT00521885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338426|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92338428|NCT00521885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92338429|NCT00521885|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338430|NCT00521885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338431|NCT05239013|Nitroglycerin|nitroglycerin|mesh-list
92338432|NCT05239013|Vasodilator Agents|vasodilator agents|mesh-ancestor
92338433|NCT00000881|Cidofovir|cidofovir|mesh-list
92338434|NCT00000881|Probenecid|probenecid|mesh-list
92338435|NCT00000881|Uricosuric Agents|uricosuric agents|mesh-ancestor
92338436|NCT00000881|Gout Suppressants|gout suppressants|mesh-ancestor
92338437|NCT00000881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338439|NCT00000881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338440|NCT00000881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338441|NCT00000881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338442|NCT00000887|Lamivudine|lamivudine|mesh-list
92338443|NCT00000887|Zidovudine|zidovudine|mesh-list
92338444|NCT00000887|Nelfinavir|nelfinavir|mesh-list
92338445|NCT00000887|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338446|NCT00000887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338447|NCT00000887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338448|NCT00000887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338449|NCT00000887|Antiviral Agents|antiviral agents|mesh-ancestor
92338450|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338451|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338452|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338453|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
92338454|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92338455|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92338456|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338457|NCT00000119|Heparin|heparin|mesh-list
92338458|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
92338459|NCT00000119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92338460|NCT00000119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92338461|NCT00000119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338462|NCT00000923|Lamivudine|lamivudine|mesh-list
92338463|NCT00000923|Zidovudine|zidovudine|mesh-list
92338464|NCT00000923|Didanosine|didanosine|mesh-list
92338465|NCT00000923|Stavudine|stavudine|mesh-list
92338466|NCT00000923|Aldesleukin|aldesleukin|mesh-list
92338468|NCT00000923|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338469|NCT00000923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338470|NCT00000923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338471|NCT00000923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338473|NCT00000923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338474|NCT00000923|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338475|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338476|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
92338477|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338478|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92338479|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92338480|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338481|NCT00000161|Aspirin|aspirin|mesh-list
92338482|NCT00000161|Vitamins|vitamins|mesh-list
92338484|NCT00000161|Beta Carotene|beta carotene|mesh-list
92338485|NCT00000161|Carotenoids|carotenoids|mesh-list
92338486|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
92338487|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338488|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92338490|NCT00000161|Analgesics|analgesics|mesh-ancestor
92338491|NCT00000161|Sensory System Agents|sensory system agents|mesh-ancestor
92338492|NCT00000161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338493|NCT00000161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92338494|NCT00000161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338495|NCT00000161|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92338496|NCT00000161|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92338497|NCT00000161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338498|NCT00000161|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92338499|NCT00000161|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92338500|NCT00000161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338502|NCT00000161|Antioxidants|antioxidants|mesh-ancestor
92338503|NCT00000161|Protective Agents|protective agents|mesh-ancestor
92338504|NCT00000161|Provitamins|provitamins|mesh-ancestor
92338506|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92338507|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92338508|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338509|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92338510|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
92383785|NCT00000738|Zidovudine|zidovudine|mesh-list
92338511|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338512|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92338513|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
92338515|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
92338516|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92338517|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92338518|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
92338519|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338520|NCT00000197|Propranolol|propranolol|mesh-list
92338521|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92338522|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92338523|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
92338524|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338525|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338526|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338527|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92338528|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92338529|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
92338530|NCT00000947|Azithromycin|azithromycin|mesh-list
92338531|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92338532|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338533|NCT00000203|Buprenorphine|buprenorphine|mesh-list
92338534|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338535|NCT00000203|Narcotics|narcotics|mesh-ancestor
92338536|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338537|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338538|NCT00000203|Analgesics|analgesics|mesh-ancestor
92338539|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
92338540|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338541|NCT00000203|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338542|NCT00000209|Buprenorphine|buprenorphine|mesh-list
92338543|NCT00000209|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338544|NCT00000209|Narcotics|narcotics|mesh-ancestor
92338545|NCT00000209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338546|NCT00000209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338547|NCT00000209|Analgesics|analgesics|mesh-ancestor
91991100|NCT04481815|Rituximab|rituximab|mesh-list
92338548|NCT00000209|Sensory System Agents|sensory system agents|mesh-ancestor
92338549|NCT00000209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338550|NCT00000209|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338551|NCT00000215|Pergolide|pergolide|mesh-list
92338552|NCT00000215|Dopamine Agonists|dopamine agonists|mesh-ancestor
92338553|NCT00000215|Dopamine Agents|dopamine agents|mesh-ancestor
92338554|NCT00000215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338555|NCT00000215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338556|NCT00000215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338557|NCT00000953|Acyclovir|acyclovir|mesh-list
92338558|NCT00000953|Sorivudine|sorivudine|mesh-list
92338559|NCT00000953|Antiviral Agents|antiviral agents|mesh-ancestor
92338560|NCT00000953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338561|NCT00000953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338562|NCT00000953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338563|NCT00000983|Zidovudine|zidovudine|mesh-list
92338564|NCT00000983|Antimetabolites|antimetabolites|mesh-ancestor
92338565|NCT00000983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338566|NCT00000983|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338567|NCT00000983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338568|NCT00000983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338569|NCT00000983|Antiviral Agents|antiviral agents|mesh-ancestor
92338570|NCT00000983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338571|NCT00000983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338572|NCT00000983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338573|NCT00000227|Buprenorphine|buprenorphine|mesh-list
92338574|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338575|NCT00000227|Narcotics|narcotics|mesh-ancestor
92338576|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338577|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338578|NCT00000227|Analgesics|analgesics|mesh-ancestor
92338580|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338581|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338582|NCT00000233|Buprenorphine|buprenorphine|mesh-list
92338583|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338584|NCT00000233|Narcotics|narcotics|mesh-ancestor
92338585|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338586|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338587|NCT00000233|Analgesics|analgesics|mesh-ancestor
92338588|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
92338589|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338590|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338591|NCT00000239|Buprenorphine|buprenorphine|mesh-list
92338592|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338593|NCT00000239|Narcotics|narcotics|mesh-ancestor
92338594|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338595|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338596|NCT00000239|Analgesics|analgesics|mesh-ancestor
92338597|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
92338598|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338599|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338600|NCT00000245|Desipramine|desipramine|mesh-list
92338601|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92384297|NCT00001968|Antiviral Agents|antiviral agents|mesh-ancestor
92338602|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
92338603|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338604|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338605|NCT00000245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338606|NCT00000245|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92338607|NCT00000245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92338608|NCT00000245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92338609|NCT00000245|Adrenergic Agents|adrenergic agents|mesh-ancestor
92338610|NCT00000245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338611|NCT00000245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338612|NCT00000263|Ethanol|ethanol|mesh-list
92338613|NCT00000263|Nitrous Oxide|nitrous oxide|mesh-list
92338614|NCT00000263|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92338615|NCT00000263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384434|NCT00002100|Antiviral Agents|antiviral agents|mesh-ancestor
92338616|NCT00000263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338617|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338618|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92338619|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
92338620|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
92338621|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92338622|NCT00000263|Analgesics|analgesics|mesh-ancestor
92338623|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
92338624|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338625|NCT00000269|Pergolide|pergolide|mesh-list
92338626|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
92338627|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
92338628|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338629|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338630|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338631|NCT04030559|Niraparib|niraparib|mesh-list
92338632|NCT04030559|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92338633|NCT04030559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338634|NCT04030559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338635|NCT04030559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338636|NCT03967223|Cyclophosphamide|cyclophosphamide|mesh-list
92338637|NCT03967223|Fludarabine|fludarabine|mesh-list
92338638|NCT03967223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92338639|NCT03967223|Immunologic Factors|immunologic factors|mesh-ancestor
92338640|NCT03967223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338641|NCT03967223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338642|NCT03967223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92338643|NCT03967223|Alkylating Agents|alkylating agents|mesh-ancestor
92338644|NCT03967223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338645|NCT03967223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338646|NCT03967223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92338647|NCT00000989|Zidovudine|zidovudine|mesh-list
92338648|NCT00000989|Ganciclovir|ganciclovir|mesh-list
92338649|NCT00000989|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92338650|NCT00000989|Sargramostim|sargramostim|mesh-list
92338651|NCT00000989|Antimetabolites|antimetabolites|mesh-ancestor
92338652|NCT00000989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338653|NCT00000989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338654|NCT00000989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338655|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338656|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
92384761|NCT00002316|Amphotericin B|amphotericin b|mesh-list
92338658|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338659|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338660|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
92338661|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338662|NCT00000995|Zidovudine|zidovudine|mesh-list
92338663|NCT00000995|Ganciclovir|ganciclovir|mesh-list
92338664|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92338665|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
92338666|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338667|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384831|NCT00002364|Abacavir|abacavir|mesh-list
92338668|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338669|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338670|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
92338671|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338672|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384895|NCT00002400|Lamivudine|lamivudine|mesh-list
92338673|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338676|NCT00001025|Antimetabolites|antimetabolites|mesh-ancestor
92338677|NCT00001025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338678|NCT00001025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338679|NCT00001025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338680|NCT00001025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338681|NCT00001025|Antiviral Agents|antiviral agents|mesh-ancestor
92338682|NCT00001025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338683|NCT00001025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338684|NCT00001025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338685|NCT03121001|Mycophenolic Acid|mycophenolic acid|mesh-list
92338687|NCT03121001|Cyclophosphamide|cyclophosphamide|mesh-list
92338688|NCT03121001|Fludarabine|fludarabine|mesh-list
92338689|NCT03121001|Thymoglobulin|thymoglobulin|mesh-list
92338690|NCT03121001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92338691|NCT03121001|Immunologic Factors|immunologic factors|mesh-ancestor
92338692|NCT03121001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338693|NCT03121001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338694|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92338695|NCT03121001|Alkylating Agents|alkylating agents|mesh-ancestor
92338696|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338697|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338698|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92338699|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92338700|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92338701|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
92338702|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92338703|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338704|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338705|NCT03121001|Antifungal Agents|antifungal agents|mesh-ancestor
92338707|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92338708|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92338710|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
92338711|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338712|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338713|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92338714|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92338715|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92338716|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338717|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338719|NCT00001049|Didanosine|didanosine|mesh-list
92338720|NCT00001049|Antimetabolites|antimetabolites|mesh-ancestor
92338721|NCT00001049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338722|NCT00001049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338723|NCT00001049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338725|NCT00001049|Antiviral Agents|antiviral agents|mesh-ancestor
92338726|NCT00001049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338727|NCT00001049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338728|NCT00001049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338729|NCT00001055|polysaccharide-K|polysaccharide-k|mesh-list
92338730|NCT00001055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92338731|NCT00001055|Immunologic Factors|immunologic factors|mesh-ancestor
92338732|NCT00001055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338733|NCT00001055|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92338734|NCT00001055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338735|NCT00001055|Antiviral Agents|antiviral agents|mesh-ancestor
92338736|NCT00001055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338737|NCT00001055|Interferon Inducers|interferon inducers|mesh-ancestor
92338738|NCT00001055|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92338739|NCT00001055|Protective Agents|protective agents|mesh-ancestor
92338740|NCT00000275|Flupenthixol|flupenthixol|mesh-list
92338741|NCT00000275|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92338742|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92338743|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92338744|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338745|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338746|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338747|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92338748|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
92338749|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338750|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338752|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92338753|NCT00001061|Foscarnet|foscarnet|mesh-list
92338754|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92338755|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
92338756|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338757|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338758|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338759|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338760|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338762|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92338763|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92338764|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
92338765|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338766|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
92338767|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349515|NCT01447446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338768|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338769|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338770|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92338771|NCT00000281|Analgesics|analgesics|mesh-ancestor
92338772|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
92338773|NCT00000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338774|NCT00001067|Lamivudine|lamivudine|mesh-list
92338775|NCT00001067|Zidovudine|zidovudine|mesh-list
92338777|NCT00001067|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338778|NCT00001067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338779|NCT00001067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338780|NCT00001067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338781|NCT00001067|Antiviral Agents|antiviral agents|mesh-ancestor
92338782|NCT00001067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338783|NCT00001067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338784|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338785|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
92338786|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
92338787|NCT00001079|Megestrol|megestrol|mesh-list
92338788|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
92338789|NCT00001079|Testosterone|testosterone|mesh-list
92338790|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
92338791|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
92338792|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92338794|NCT00001079|Hormones|hormones|mesh-ancestor
92338795|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92338796|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338797|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92338798|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338799|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
92338800|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92338801|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92338802|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92338803|NCT00001079|Contraceptive Agents|contraceptive agents|mesh-ancestor
92338804|NCT00001079|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92338805|NCT00001079|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92338806|NCT00001079|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92338807|NCT00001079|Appetite Stimulants|appetite stimulants|mesh-ancestor
92338808|NCT00001079|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92338810|NCT00000293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92338811|NCT00000293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92338812|NCT00000293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92338813|NCT00000293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338814|NCT00000293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338815|NCT00000293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338816|NCT00000293|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92338817|NCT00000293|Antidepressive Agents|antidepressive agents|mesh-ancestor
92338818|NCT00000293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338819|NCT00000293|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92338820|NCT00000293|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92338821|NCT00000293|Serotonin Agents|serotonin agents|mesh-ancestor
92338822|NCT00001091|Ritonavir|ritonavir|mesh-list
92338823|NCT00001091|Nelfinavir|nelfinavir|mesh-list
92338824|NCT00001091|Lamivudine|lamivudine|mesh-list
92338826|NCT00001091|Stavudine|stavudine|mesh-list
92338827|NCT00001091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92338828|NCT00001091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92338829|NCT00001091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338830|NCT00001091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92338831|NCT00001091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338832|NCT00001091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338833|NCT00001091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338834|NCT00001091|Antiviral Agents|antiviral agents|mesh-ancestor
92338835|NCT00001091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338836|NCT00001091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92349516|NCT01471782|Blinatumomab|blinatumomab|mesh-list
92338837|NCT00001091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92338838|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92338839|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92338840|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92338841|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92338842|NCT00001091|Antimetabolites|antimetabolites|mesh-ancestor
92338843|NCT00000299|Buprenorphine|buprenorphine|mesh-list
92338844|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338845|NCT00000299|Narcotics|narcotics|mesh-ancestor
92338846|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338847|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338848|NCT00000299|Analgesics|analgesics|mesh-ancestor
92338849|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
92338850|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338852|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
92338853|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92338854|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338855|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92338856|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92338857|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92338858|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338859|NCT00000305|Dopamine Agents|dopamine agents|mesh-ancestor
92338860|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338861|NCT00000311|Buprenorphine|buprenorphine|mesh-list
92338863|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338864|NCT00000311|Narcotics|narcotics|mesh-ancestor
92338865|NCT00000311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338866|NCT00000311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338867|NCT00000311|Analgesics|analgesics|mesh-ancestor
92338868|NCT00000311|Sensory System Agents|sensory system agents|mesh-ancestor
91937051|NCT02267681|Anesthetics|anesthetics|mesh-ancestor
92338869|NCT00000311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338870|NCT00000311|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338871|NCT00000311|Antitussive Agents|antitussive agents|mesh-ancestor
92338872|NCT00000311|Respiratory System Agents|respiratory system agents|mesh-ancestor
92338874|NCT00000317|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92338876|NCT00000317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338877|NCT00000317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338878|NCT00000317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338879|NCT00000317|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92338880|NCT00000317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92386067|NCT04360824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92338881|NCT00000317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338882|NCT00000317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338883|NCT00000317|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92338884|NCT00000317|Dopamine Agents|dopamine agents|mesh-ancestor
92338885|NCT00001115|Acyclovir|acyclovir|mesh-list
92338886|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
92338887|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338888|NCT00001757|Voriconazole|voriconazole|mesh-list
92338889|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
92338890|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338891|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92338892|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92338893|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386202|NCT02972034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92338894|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338895|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92338896|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
92338897|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92338898|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338899|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92338900|NCT00001133|Ritonavir|ritonavir|mesh-list
92338901|NCT00001133|Indinavir|indinavir|mesh-list
92338902|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92338903|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92338904|NCT00001133|Protease Inhibitors|protease inhibitors|mesh-ancestor
92338905|NCT00001133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386356|NCT00002814|Paclitaxel|paclitaxel|mesh-list
92338906|NCT00001133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338907|NCT00001133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92338908|NCT00001133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92338909|NCT00001133|Antiviral Agents|antiviral agents|mesh-ancestor
92338910|NCT00001133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92338911|NCT00001133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92338912|NCT00001133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92338913|NCT00000329|Analgesics, Opioid|analgesics, opioid|mesh-list
92338914|NCT00000329|Narcotics|narcotics|mesh-ancestor
92338915|NCT00000329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338916|NCT00000329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338917|NCT00000329|Analgesics|analgesics|mesh-ancestor
92338918|NCT00000329|Sensory System Agents|sensory system agents|mesh-ancestor
92338919|NCT00000329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338920|NCT00000335|Morphine|morphine|mesh-list
92338921|NCT00000335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338923|NCT00000335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338924|NCT00000335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338926|NCT00000335|Sensory System Agents|sensory system agents|mesh-ancestor
92338927|NCT00000335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338929|NCT00000341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338930|NCT00000341|Narcotics|narcotics|mesh-ancestor
92338931|NCT00000341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338932|NCT00000341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338933|NCT00000341|Analgesics|analgesics|mesh-ancestor
92338934|NCT00000341|Sensory System Agents|sensory system agents|mesh-ancestor
92338935|NCT00000341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338936|NCT00000341|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338937|NCT00000347|Risperidone|risperidone|mesh-list
92338938|NCT00000347|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92338939|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
92338940|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92386484|NCT00002964|Trioxsalen|trioxsalen|mesh-list
92338941|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338942|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338944|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92338945|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338946|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338947|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92338948|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
92338949|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
92338950|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338951|NCT00001193|Melphalan|melphalan|mesh-list
92338952|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92338953|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
92338954|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338955|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92338956|NCT00001193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92338957|NCT00001193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92338958|NCT00001193|Immunologic Factors|immunologic factors|mesh-ancestor
92338959|NCT00001193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338960|NCT00000353|Buprenorphine|buprenorphine|mesh-list
92338961|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92338963|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92338965|NCT00000353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338966|NCT00000353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338967|NCT00000353|Analgesics|analgesics|mesh-ancestor
92338968|NCT00000353|Sensory System Agents|sensory system agents|mesh-ancestor
92338969|NCT00000353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92338970|NCT00000353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92338971|NCT00000377|Nortriptyline|nortriptyline|mesh-list
92338972|NCT00000377|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92338973|NCT00000377|Antidepressive Agents|antidepressive agents|mesh-ancestor
92338974|NCT00000377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338975|NCT00000377|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92338976|NCT00000377|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92338977|NCT00000377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92338978|NCT00000377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338979|NCT00000377|Adrenergic Agents|adrenergic agents|mesh-ancestor
92338980|NCT00000377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338981|NCT00000377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338983|NCT00001865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92338984|NCT00001865|Immunologic Factors|immunologic factors|mesh-ancestor
92338985|NCT00001865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338986|NCT00000389|Fluvoxamine|fluvoxamine|mesh-list
92338987|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92338988|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92338989|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92338990|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92338991|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92338992|NCT00000389|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92338993|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92338994|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92338995|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92338996|NCT00000389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92338997|NCT00000389|Serotonin Agents|serotonin agents|mesh-ancestor
92338998|NCT00000389|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92338999|NCT00000389|Antidepressive Agents|antidepressive agents|mesh-ancestor
92339000|NCT00000389|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92339001|NCT00000389|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339002|NCT00000389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339003|NCT00000389|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339004|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
92339005|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92339006|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339007|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339008|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92339009|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92339010|NCT00001877|Protective Agents|protective agents|mesh-ancestor
92339011|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339012|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
92339013|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92339014|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
92339015|NCT00380939|Atorvastatin|atorvastatin|mesh-list
92339016|NCT00380939|Pravastatin|pravastatin|mesh-list
92339017|NCT00380939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92339018|NCT00380939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92339019|NCT00380939|Antimetabolites|antimetabolites|mesh-ancestor
92339020|NCT00380939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339021|NCT00380939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92339022|NCT00380939|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92339023|NCT00380939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339024|NCT00001889|Dobutamine|dobutamine|mesh-list
92339025|NCT00001889|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92339026|NCT00001889|Sympathomimetics|sympathomimetics|mesh-ancestor
92339027|NCT00001889|Autonomic Agents|autonomic agents|mesh-ancestor
92339028|NCT00001889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339029|NCT00001889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339030|NCT00001889|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92339031|NCT00001889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92339032|NCT00001889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92339033|NCT00001889|Adrenergic Agents|adrenergic agents|mesh-ancestor
92339034|NCT00001889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92339035|NCT00001889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339036|NCT00001889|Protective Agents|protective agents|mesh-ancestor
92339037|NCT00001901|Etanercept|etanercept|mesh-list
92339038|NCT00001901|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92339039|NCT00001901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339040|NCT00001901|Analgesics|analgesics|mesh-ancestor
92339041|NCT00001901|Sensory System Agents|sensory system agents|mesh-ancestor
92339042|NCT00001901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339043|NCT00001901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339044|NCT00001901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92339045|NCT00001901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92339046|NCT00001901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92339047|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92339048|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
92339049|NCT00000437|Naltrexone|naltrexone|mesh-list
92339050|NCT00000437|Nicotine|nicotine|mesh-list
92339051|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92339052|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
92339053|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339054|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339055|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92339056|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92339057|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
92339058|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92339059|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339060|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92339061|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92339062|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
92339063|NCT00000443|Ondansetron|ondansetron|mesh-list
92339064|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
92339065|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
92339066|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339067|NCT00000443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339068|NCT00000443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92339069|NCT00000443|Antipruritics|antipruritics|mesh-ancestor
92339070|NCT00000443|Dermatologic Agents|dermatologic agents|mesh-ancestor
92339071|NCT00000443|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92339072|NCT00000443|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92339073|NCT00000443|Serotonin Agents|serotonin agents|mesh-ancestor
92339074|NCT00000443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92339075|NCT00000443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339076|NCT00000449|Naltrexone|naltrexone|mesh-list
92339077|NCT00000449|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92339078|NCT00000449|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92339079|NCT00000449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339080|NCT00000449|Sensory System Agents|sensory system agents|mesh-ancestor
92386880|NCT00003240|Vinorelbine|vinorelbine|mesh-list
92339081|NCT00000449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339082|NCT00000455|Naltrexone|naltrexone|mesh-list
92339083|NCT00000455|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92339084|NCT00000455|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92339085|NCT00000455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339086|NCT00000455|Sensory System Agents|sensory system agents|mesh-ancestor
92339087|NCT00000455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339088|NCT00001307|Capsaicin|capsaicin|mesh-list
92339089|NCT00001307|Antipruritics|antipruritics|mesh-ancestor
92339090|NCT00001307|Dermatologic Agents|dermatologic agents|mesh-ancestor
92339091|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
92339092|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339093|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339095|NCT04713761|Pemetrexed|pemetrexed|mesh-list
92339096|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339097|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339098|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339099|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92339100|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339101|NCT00001937|Fluconazole|fluconazole|mesh-list
92339102|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
92339103|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339104|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92339105|NCT00001937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339106|NCT00001937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339107|NCT00001937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339108|NCT00001937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92339109|NCT00001937|Hormone Antagonists|hormone antagonists|mesh-ancestor
92339110|NCT00001937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92339111|NCT00001937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339112|NCT00001937|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339113|NCT00001937|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339114|NCT00001325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92339115|NCT00001325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92339116|NCT00001325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387055|NCT00003402|Hormones|hormones|mesh-ancestor
92339118|NCT04331327|Mitosis Modulators|mitosis modulators|mesh-ancestor
92339119|NCT04331327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339121|NCT00001955|Etanercept|etanercept|mesh-list
92339122|NCT00001955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92339123|NCT00001955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339124|NCT00001955|Analgesics|analgesics|mesh-ancestor
92339125|NCT00001955|Sensory System Agents|sensory system agents|mesh-ancestor
92339126|NCT00001955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339127|NCT00001955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339128|NCT00001955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92339129|NCT00001955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92339130|NCT00001955|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92339131|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92339132|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339133|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339134|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92339135|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92339136|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
92339137|NCT04943783|Atorvastatin|atorvastatin|mesh-list
92339138|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92339139|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92339140|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
92339141|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339142|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92339143|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92339144|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339145|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92339146|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
92339147|NCT00000605|Hormones|hormones|mesh-list
92339148|NCT00000605|Estrogens|estrogens|mesh-list
92339149|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92339150|NCT00000605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339151|NCT00000605|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92339152|NCT00000605|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92339153|NCT00000605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92339154|NCT00000605|Contraceptive Agents|contraceptive agents|mesh-ancestor
92339155|NCT00000605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92339156|NCT00000605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92339157|NCT00000605|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92339158|NCT00000605|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92339159|NCT00000605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92339160|NCT00000605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339162|NCT00000617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339163|NCT00000617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339164|NCT00000623|Decitabine|decitabine|mesh-list
92339165|NCT00000623|Sildenafil Citrate|sildenafil citrate|mesh-list
92339166|NCT00000623|Deferiprone|deferiprone|mesh-list
92339167|NCT00000623|Deferoxamine|deferoxamine|mesh-list
92339168|NCT00000623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92339169|NCT00000623|Antimetabolites|antimetabolites|mesh-ancestor
92339170|NCT00000623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339171|NCT00000623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339172|NCT00000623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339173|NCT00000623|Vasodilator Agents|vasodilator agents|mesh-ancestor
92339174|NCT00000623|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92339175|NCT00000623|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92339176|NCT00000623|Urological Agents|urological agents|mesh-ancestor
92339177|NCT00000623|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92339178|NCT00000623|Chelating Agents|chelating agents|mesh-ancestor
92339179|NCT00000623|Sequestering Agents|sequestering agents|mesh-ancestor
92339181|NCT00001991|Atovaquone|atovaquone|mesh-list
92339182|NCT00001991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339183|NCT00001991|Antimalarials|antimalarials|mesh-ancestor
92339184|NCT00001991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92339185|NCT00001991|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92339186|NCT00001991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339187|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339188|NCT00001997|Zidovudine|zidovudine|mesh-list
92339189|NCT00001997|Didanosine|didanosine|mesh-list
92339190|NCT00001997|Interleukin-2|interleukin-2|mesh-list
92339192|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339193|NCT00001997|Analgesics|analgesics|mesh-ancestor
92339194|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
92339195|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339196|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339197|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
92339198|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339199|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339200|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339201|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339202|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
92339203|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339204|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339205|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339206|NCT00002003|Etoposide|etoposide|mesh-list
92339207|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
92339208|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92339209|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339210|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92339211|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92339212|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387262|NCT00003642|Antimetabolites|antimetabolites|mesh-ancestor
92339213|NCT00002003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339214|NCT00002003|Analgesics|analgesics|mesh-ancestor
92339215|NCT00002003|Sensory System Agents|sensory system agents|mesh-ancestor
92339216|NCT00002003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339217|NCT00002003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339218|NCT00002009|Sargramostim|sargramostim|mesh-list
92339219|NCT00002009|Immunologic Factors|immunologic factors|mesh-ancestor
92339220|NCT00002009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339221|NCT00000629|Zidovudine|zidovudine|mesh-list
91991753|NCT01986010|Antacids|antacids|mesh-ancestor
92339223|NCT00000629|Antimetabolites|antimetabolites|mesh-ancestor
92339224|NCT00000629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339225|NCT00000629|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339226|NCT00000629|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339227|NCT00000629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339228|NCT00000629|Antiviral Agents|antiviral agents|mesh-ancestor
92339229|NCT00000629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339230|NCT00000629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339231|NCT00000629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339232|NCT00000629|Anticonvulsants|anticonvulsants|mesh-ancestor
92339234|NCT00000629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92339235|NCT00000629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339236|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
92339237|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92339238|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92339239|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92339241|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
92339242|NCT00000647|Zidovudine|zidovudine|mesh-list
92339243|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92339244|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339245|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
92339246|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339247|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
92339248|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339249|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
92339250|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339251|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339252|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339253|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339254|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92387437|NCT00003846|Thiotepa|thiotepa|mesh-list
92339255|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339256|NCT00000653|Zalcitabine|zalcitabine|mesh-list
92339257|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
92339258|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339259|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339260|NCT00000653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339261|NCT00000653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339262|NCT00000653|Antiviral Agents|antiviral agents|mesh-ancestor
92339263|NCT00000653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339264|NCT00000653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339265|NCT00000653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339266|NCT00001409|Interleukin-2|interleukin-2|mesh-list
92339267|NCT00001409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339268|NCT00001409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339269|NCT00001409|Analgesics|analgesics|mesh-ancestor
92339270|NCT00001409|Sensory System Agents|sensory system agents|mesh-ancestor
92339271|NCT00001409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339272|NCT00001409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339273|NCT00000659|Zidovudine|zidovudine|mesh-list
92387575|NCT00003930|Paclitaxel|paclitaxel|mesh-list
92339274|NCT00000659|Antimetabolites|antimetabolites|mesh-ancestor
92339275|NCT00000659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339276|NCT00000659|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339277|NCT00000659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339278|NCT00000659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339279|NCT00000659|Antiviral Agents|antiviral agents|mesh-ancestor
92339280|NCT00000659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339281|NCT00000659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339282|NCT00000659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339283|NCT00381017|Interferons|interferons|mesh-list
92339284|NCT00381017|Interferon-alpha|interferon-alpha|mesh-list
92339285|NCT00381017|Interferon alpha-2|interferon alpha-2|mesh-list
92339286|NCT00381017|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92339287|NCT00381017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339288|NCT00381017|Antiviral Agents|antiviral agents|mesh-ancestor
92339289|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339290|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
92339291|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339292|NCT00002015|Ganciclovir|ganciclovir|mesh-list
92339293|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92339294|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
92339295|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339296|NCT00002015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339297|NCT00002015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339298|NCT00002015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339300|NCT00002021|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92339301|NCT00002021|Antiviral Agents|antiviral agents|mesh-ancestor
92339302|NCT00002021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339303|NCT00002021|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339304|NCT00002021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339305|NCT00002021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339306|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339307|NCT00002027|Diclazuril|diclazuril|mesh-list
92339309|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92339310|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92339311|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339312|NCT00000695|Interferons|interferons|mesh-list
92339313|NCT00000695|Zidovudine|zidovudine|mesh-list
92339314|NCT00000695|Interferon-beta|interferon-beta|mesh-list
92339315|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
92339316|NCT00000695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339317|NCT00000695|Antiviral Agents|antiviral agents|mesh-ancestor
92339318|NCT00000695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339319|NCT00000695|Antimetabolites|antimetabolites|mesh-ancestor
92339320|NCT00000695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339321|NCT00000695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339322|NCT00000695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339324|NCT00000695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339325|NCT00000695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339326|NCT00000695|Immunologic Factors|immunologic factors|mesh-ancestor
92339327|NCT00000695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339328|NCT00000695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92339329|NCT00000701|Zidovudine|zidovudine|mesh-list
92339330|NCT00000701|Antimetabolites|antimetabolites|mesh-ancestor
92339331|NCT00000701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339332|NCT00000701|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339333|NCT00000701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339334|NCT00000701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339335|NCT00000701|Antiviral Agents|antiviral agents|mesh-ancestor
92339336|NCT00000701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339337|NCT00000701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339338|NCT00000701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339339|NCT00000713|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92339341|NCT00000713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339342|NCT00000725|Interferons|interferons|mesh-list
92339343|NCT00000725|Interferon-alpha|interferon-alpha|mesh-list
92339344|NCT00000725|Interferon alpha-2|interferon alpha-2|mesh-list
92339345|NCT00000725|Zidovudine|zidovudine|mesh-list
92339346|NCT00000725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339347|NCT00000725|Antiviral Agents|antiviral agents|mesh-ancestor
92339348|NCT00000725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339349|NCT00000725|Immunologic Factors|immunologic factors|mesh-ancestor
92339350|NCT00000725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339351|NCT00000725|Antimetabolites|antimetabolites|mesh-ancestor
92339352|NCT00000725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339353|NCT00000725|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339354|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339355|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339356|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339357|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339359|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
92339360|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339361|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339362|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92387955|NCT00004206|Vitamins|vitamins|mesh-ancestor
92339363|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339364|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
92339365|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339366|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339367|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339368|NCT00002039|Foscarnet|foscarnet|mesh-list
92339369|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
92339370|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
92339371|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991905|NCT02403349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92339372|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339373|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339374|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339375|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339377|NCT00000731|Zidovudine|zidovudine|mesh-list
92339378|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339379|NCT00000731|Analgesics|analgesics|mesh-ancestor
92339380|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
92339381|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339382|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339383|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
92339384|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
92388012|NCT00004224|Antimitotic Agents|antimitotic agents|mesh-ancestor
92339385|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339386|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339387|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339388|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339389|NCT00000731|Antiviral Agents|antiviral agents|mesh-ancestor
92339390|NCT00000731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339391|NCT00000731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339392|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339394|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
92339395|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339396|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339397|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339398|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339399|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
92339400|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339401|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339402|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339403|NCT00002051|Thymopentin|thymopentin|mesh-list
92339404|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92339405|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
92339407|NCT00001499|Paclitaxel|paclitaxel|mesh-list
92339408|NCT00001499|Cisplatin|cisplatin|mesh-list
92388138|NCT00004404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339409|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92339410|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339411|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92339412|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92339413|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92339414|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339415|NCT00002057|Nystatin|nystatin|mesh-list
92339416|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339417|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339418|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
92339419|NCT00002057|Ionophores|ionophores|mesh-ancestor
92339420|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92339421|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339422|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
92339423|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92339424|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
92339425|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339426|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
92339427|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339428|NCT00001535|Interleukin-2|interleukin-2|mesh-list
92339429|NCT00001535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339430|NCT00001535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339431|NCT00001535|Analgesics|analgesics|mesh-ancestor
92339432|NCT00001535|Sensory System Agents|sensory system agents|mesh-ancestor
92339433|NCT00001535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339434|NCT00001535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339435|NCT00002303|Epoetin Alfa|epoetin alfa|mesh-list
92339436|NCT00002303|Hematinics|hematinics|mesh-ancestor
92339437|NCT00002063|Zidovudine|zidovudine|mesh-list
92339438|NCT00002063|Antimetabolites|antimetabolites|mesh-ancestor
92339439|NCT00002063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339440|NCT00002063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339441|NCT00002063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339442|NCT00002063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339443|NCT00002063|Antiviral Agents|antiviral agents|mesh-ancestor
92339444|NCT00002063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339445|NCT00002063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388326|NCT00004728|Aspirin|aspirin|mesh-list
92339447|NCT00002069|Ditiocarb|ditiocarb|mesh-list
92339448|NCT00002069|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92339449|NCT00002069|Immunologic Factors|immunologic factors|mesh-ancestor
92339450|NCT00002069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339451|NCT00002069|Antiviral Agents|antiviral agents|mesh-ancestor
92339452|NCT00002069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339453|NCT00002069|Chelating Agents|chelating agents|mesh-ancestor
92339454|NCT00002069|Sequestering Agents|sequestering agents|mesh-ancestor
92339455|NCT00002069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339456|NCT00001565|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92339457|NCT00001565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339458|NCT00002309|Azithromycin|azithromycin|mesh-list
92339459|NCT00002309|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339460|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339461|NCT00002315|Acyclovir|acyclovir|mesh-list
92339462|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
92339463|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
92339464|NCT00002315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339465|NCT00002075|Fluconazole|fluconazole|mesh-list
92339466|NCT00002075|Amphotericin B|amphotericin b|mesh-list
92339467|NCT00002075|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92339468|NCT00002075|Flucytosine|flucytosine|mesh-list
92339469|NCT00002075|Antifungal Agents|antifungal agents|mesh-ancestor
92339470|NCT00002075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339471|NCT00002075|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92388386|NCT00004758|Vitamins|vitamins|mesh-ancestor
92339472|NCT00002075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339473|NCT00002075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339474|NCT00002075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339475|NCT00002075|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92339476|NCT00002075|Hormone Antagonists|hormone antagonists|mesh-ancestor
92339477|NCT00002075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92339478|NCT00002075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339479|NCT00002075|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339480|NCT00002075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339481|NCT00002075|Amebicides|amebicides|mesh-ancestor
92339482|NCT00002075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92339483|NCT00002075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92339484|NCT00002075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339485|NCT00002075|Antimetabolites|antimetabolites|mesh-ancestor
92339486|NCT00001577|Melphalan|melphalan|mesh-list
92339487|NCT00001577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92339488|NCT00001577|Alkylating Agents|alkylating agents|mesh-ancestor
92339489|NCT00001577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339490|NCT00001577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339491|NCT00001577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92339492|NCT00001577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92339493|NCT00001577|Immunologic Factors|immunologic factors|mesh-ancestor
92339494|NCT00001577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339495|NCT00002081|Zidovudine|zidovudine|mesh-list
92339496|NCT00002081|Zalcitabine|zalcitabine|mesh-list
92339497|NCT00002081|Antimetabolites|antimetabolites|mesh-ancestor
92339498|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339499|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339500|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339501|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339502|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
92339503|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339504|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339505|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339506|NCT00002093|Doxorubicin|doxorubicin|mesh-list
92339507|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92339508|NCT00002093|Daunorubicin|daunorubicin|mesh-list
92339510|NCT00002093|Vincristine|vincristine|mesh-list
92339511|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92339512|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339513|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92339514|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92339515|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339516|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339517|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92339518|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
92339519|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
92339520|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
92339521|NCT00002099|Didanosine|didanosine|mesh-list
92339522|NCT00002099|Lentinan|lentinan|mesh-list
92339523|NCT00002099|Antimetabolites|antimetabolites|mesh-ancestor
92339524|NCT00002099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339525|NCT00002099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339526|NCT00002099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339527|NCT00002099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339528|NCT00002099|Antiviral Agents|antiviral agents|mesh-ancestor
92339529|NCT00002099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339530|NCT00002099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339531|NCT00002099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339532|NCT00002099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92339533|NCT00002099|Immunologic Factors|immunologic factors|mesh-ancestor
91937063|NCT05177939|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92339534|NCT00002099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339535|NCT00002099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339536|NCT00002321|Aldesleukin|aldesleukin|mesh-list
92339537|NCT00002321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339538|NCT00002321|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339539|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339540|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
92339541|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339542|NCT00002327|Cidofovir|cidofovir|mesh-list
92339543|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
92339544|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339546|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339548|NCT00002333|Zalcitabine|zalcitabine|mesh-list
92339549|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339550|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339551|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339552|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339553|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339554|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339555|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339556|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
92339557|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339558|NCT00002333|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92339559|NCT00002333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339560|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
92339561|NCT00002333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339562|NCT00002333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339563|NCT00002339|Fluconazole|fluconazole|mesh-list
92339564|NCT00002339|Antifungal Agents|antifungal agents|mesh-ancestor
92339565|NCT00002339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339566|NCT00002339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92339567|NCT00002339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339568|NCT00002339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339569|NCT00002339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339570|NCT00002339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92339571|NCT00002339|Hormone Antagonists|hormone antagonists|mesh-ancestor
92339572|NCT00002339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92339573|NCT00002339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339574|NCT00002339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339575|NCT00002339|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339577|NCT00002105|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92339578|NCT00002105|Bleomycin|bleomycin|mesh-list
92339579|NCT00002105|Vincristine|vincristine|mesh-list
92339580|NCT00002105|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92339581|NCT00002105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339582|NCT00002105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92339583|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92339584|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339585|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339586|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92339587|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
92339588|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
92339589|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
92339590|NCT00002345|Megestrol|megestrol|mesh-list
92339591|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
92339592|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92339593|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92339594|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92339595|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
92339596|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92339597|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339598|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92339599|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92339600|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92339601|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339603|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92339605|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339606|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339607|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339608|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339609|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339610|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339611|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339612|NCT00002111|Antiviral Agents|antiviral agents|mesh-ancestor
92339613|NCT00002111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339614|NCT00002111|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92339615|NCT00002111|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339616|NCT00002351|Indinavir|indinavir|mesh-list
92339617|NCT00002351|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339618|NCT00002351|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339619|NCT00002351|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339620|NCT00002351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339621|NCT00002351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339622|NCT00002351|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339623|NCT00002351|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388896|NCT00356226|Clonidine|clonidine|mesh-list
92339624|NCT00002351|Antiviral Agents|antiviral agents|mesh-ancestor
92339625|NCT00002351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339626|NCT00002357|Zidovudine|zidovudine|mesh-list
92339627|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
92339628|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339629|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339630|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388957|NCT00357084|Hormones|hormones|mesh-ancestor
92339632|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
92339633|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339634|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339635|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339636|NCT00002117|Zidovudine|zidovudine|mesh-list
92339637|NCT00002117|Zalcitabine|zalcitabine|mesh-list
92339638|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
92339639|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339640|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339641|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339642|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339643|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
92339644|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339645|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339646|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339647|NCT00002123|Didanosine|didanosine|mesh-list
92339648|NCT00002123|Delavirdine|delavirdine|mesh-list
92339649|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
92339650|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339651|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339652|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339653|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339654|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
92339655|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389024|NCT00357708|Decitabine|decitabine|mesh-list
92339656|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339657|NCT00002123|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339658|NCT00381173|Cyclophosphamide|cyclophosphamide|mesh-list
92339659|NCT00381173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92339660|NCT00381173|Immunologic Factors|immunologic factors|mesh-ancestor
92339661|NCT00381173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339662|NCT00381173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389075|NCT00358410|Casopitant|casopitant|mesh-list
92339663|NCT00381173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92339664|NCT00381173|Alkylating Agents|alkylating agents|mesh-ancestor
92339665|NCT00381173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339666|NCT00381173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339667|NCT00381173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92339669|NCT05752409|Propofol|propofol|mesh-list
92339670|NCT05752409|Esketamine|esketamine|mesh-list
92339671|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92339672|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92339673|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339674|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92339675|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
92339676|NCT05752409|Anesthetics|anesthetics|mesh-ancestor
92339677|NCT05752409|Analgesics|analgesics|mesh-ancestor
92339678|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
92339679|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339680|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92339681|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92339682|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92339683|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92339684|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339685|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
92339686|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92339687|NCT00002129|Vesnarinone|vesnarinone|mesh-list
92339688|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92339689|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
92339690|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339691|NCT00002129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339692|NCT00002129|Antiviral Agents|antiviral agents|mesh-ancestor
92339693|NCT00002129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339694|NCT00002129|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92339695|NCT00002129|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92339696|NCT00002129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339697|NCT00002129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339698|NCT00002129|Protective Agents|protective agents|mesh-ancestor
92339699|NCT00002135|Ganciclovir|ganciclovir|mesh-list
92339700|NCT00002135|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92339701|NCT00002135|Antiviral Agents|antiviral agents|mesh-ancestor
92339702|NCT00002135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339703|NCT00002135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339704|NCT00002135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339705|NCT00002135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339706|NCT00002141|Abacavir|abacavir|mesh-list
92339707|NCT00002141|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339708|NCT00002141|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339709|NCT00002141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339710|NCT00002141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339711|NCT00002141|Antiviral Agents|antiviral agents|mesh-ancestor
92339712|NCT00002141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339713|NCT00002141|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339714|NCT00002141|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339715|NCT00002369|Lamivudine|lamivudine|mesh-list
92339716|NCT00002369|Zidovudine|zidovudine|mesh-list
92339717|NCT00002369|Stavudine|stavudine|mesh-list
92339718|NCT00002369|Indinavir|indinavir|mesh-list
92339719|NCT00002369|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339720|NCT00002369|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339721|NCT00002369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339722|NCT00002369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339723|NCT00002369|Antiviral Agents|antiviral agents|mesh-ancestor
92339724|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339725|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339726|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339727|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
92339728|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339729|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339730|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339731|NCT00002375|Nelfinavir|nelfinavir|mesh-list
92339732|NCT00002375|Indinavir|indinavir|mesh-list
92339733|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339734|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339735|NCT00002375|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339736|NCT00002375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349517|NCT01471782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339737|NCT00002375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339739|NCT00002375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339740|NCT00002375|Antiviral Agents|antiviral agents|mesh-ancestor
92339741|NCT00002375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339742|NCT00002381|Nevirapine|nevirapine|mesh-list
92339743|NCT00002381|Stavudine|stavudine|mesh-list
92339744|NCT00002381|Nelfinavir|nelfinavir|mesh-list
92339745|NCT00002381|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339746|NCT00002381|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339747|NCT00002381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339748|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389300|NCT00364026|Darusentan|darusentan|mesh-list
92339749|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
92339750|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339751|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339752|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339753|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92339755|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339756|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339757|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339758|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
92339760|NCT00002387|Indinavir|indinavir|mesh-list
92339761|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339762|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339763|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339764|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339765|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
92339766|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339767|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339768|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339769|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339770|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92339771|NCT00002387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92389362|NCT00365820|Tegaserod|tegaserod|mesh-list
92339772|NCT00002387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92339773|NCT00002387|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339774|NCT00002387|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339775|NCT00002387|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339776|NCT00002387|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339777|NCT00002387|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339778|NCT00002393|Efavirenz|efavirenz|mesh-list
92339779|NCT00002393|Indinavir|indinavir|mesh-list
92339780|NCT00002393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339781|NCT00002393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339782|NCT00002393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339783|NCT00002393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339784|NCT00002393|Antiviral Agents|antiviral agents|mesh-ancestor
92339785|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339786|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339787|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339788|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339789|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92339790|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92339791|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92339792|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339793|NCT00002393|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339794|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339795|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339796|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339798|NCT00002399|Posaconazole|posaconazole|mesh-list
92339799|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
92339800|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339801|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92339802|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339803|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339804|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339805|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92339806|NCT00002399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92339807|NCT00002399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92339808|NCT00002399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339809|NCT00002399|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339810|NCT00002399|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339811|NCT00002399|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92339812|NCT00002399|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92339813|NCT00002399|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92339814|NCT00002405|Amprenavir|amprenavir|mesh-list
92339815|NCT00002405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92339816|NCT00002405|Antitubercular Agents|antitubercular agents|mesh-ancestor
92339817|NCT00002405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339818|NCT00002405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339819|NCT00002405|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92389481|NCT00368862|Memantine|memantine|mesh-list
92117031|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
92339820|NCT00002405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339821|NCT00002405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339822|NCT00002405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339823|NCT00002405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339824|NCT00002405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339825|NCT00002405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339828|NCT00002417|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92339829|NCT00002417|Antitubercular Agents|antitubercular agents|mesh-ancestor
92339830|NCT00002417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339831|NCT00002417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339832|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339833|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339834|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339835|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339836|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339837|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339838|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339839|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
92339840|NCT00002423|Lamivudine|lamivudine|mesh-list
92339841|NCT00002423|Abacavir|abacavir|mesh-list
92339842|NCT00002423|Nelfinavir|nelfinavir|mesh-list
92339843|NCT00002423|Indinavir|indinavir|mesh-list
92339844|NCT00002423|Amprenavir|amprenavir|mesh-list
92339845|NCT00002423|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92349518|NCT01490580|Atropine|atropine|mesh-list
92339846|NCT00002423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339847|NCT00002423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339848|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339849|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
92339850|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339851|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339852|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339853|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339854|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339855|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339856|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92339857|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
92339858|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92339859|NCT02973581|Acetaminophen|acetaminophen|mesh-list
92339860|NCT02973581|Dipyrone|dipyrone|mesh-list
92339861|NCT02973581|Lidocaine|lidocaine|mesh-list
92339862|NCT02973581|Bupivacaine|bupivacaine|mesh-list
92339863|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
92339864|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
92339865|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
92339866|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92339867|NCT02973581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339868|NCT02973581|Sensory System Agents|sensory system agents|mesh-ancestor
92339869|NCT02973581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339870|NCT02973581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92339871|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92339872|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92339873|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92339874|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339875|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92339876|NCT02973581|Analgesics|analgesics|mesh-ancestor
92339877|NCT02973581|Antipyretics|antipyretics|mesh-ancestor
92339878|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92339879|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92339880|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92339881|NCT00002435|Zidovudine|zidovudine|mesh-list
92339882|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
92339883|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339884|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339885|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339886|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339887|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
92339888|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339889|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339890|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339891|NCT00002447|Ritonavir|ritonavir|mesh-list
92339892|NCT00002447|Saquinavir|saquinavir|mesh-list
92339893|NCT00002447|Efavirenz|efavirenz|mesh-list
92339894|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92339895|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92339896|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
92339897|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339898|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339899|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339900|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339901|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
92339902|NCT00002447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339903|NCT00002447|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92339904|NCT00002447|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92339905|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339906|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339907|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92339908|NCT00002447|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92339909|NCT00002447|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92339910|NCT00002447|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92339911|NCT00002447|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92339913|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
92339914|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339915|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92339916|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339917|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339918|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339919|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92339920|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92339922|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
92339923|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92339924|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92339925|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92339926|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
92339927|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92339928|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339929|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92339930|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92339931|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92339932|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339933|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
92339934|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92339935|NCT00002471|Leucovorin|leucovorin|mesh-list
92339936|NCT00002471|Cytarabine|cytarabine|mesh-list
92339937|NCT00002471|Dexamethasone|dexamethasone|mesh-list
92339938|NCT00002471|Methylprednisolone|methylprednisolone|mesh-list
92339939|NCT00002471|Hydrocortisone|hydrocortisone|mesh-list
92339940|NCT00002471|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92339941|NCT00002471|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92339942|NCT00002471|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92339943|NCT00002471|Cyclophosphamide|cyclophosphamide|mesh-list
92339944|NCT00002471|Thiotepa|thiotepa|mesh-list
92339945|NCT00002471|Methotrexate|methotrexate|mesh-list
92339946|NCT00002471|Etoposide|etoposide|mesh-list
92339947|NCT00002471|Vincristine|vincristine|mesh-list
92339948|NCT00002471|Daunorubicin|daunorubicin|mesh-list
92339949|NCT00002471|Asparaginase|asparaginase|mesh-list
92339950|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
92339951|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92339952|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
92339953|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92339954|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92339955|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92390092|NCT00385398|Temozolomide|temozolomide|mesh-list
92339956|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
92339957|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92339958|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92339959|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92339960|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92339961|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
92339962|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
92339963|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92339964|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92339965|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
92339966|NCT00002471|Hormones|hormones|mesh-ancestor
92339967|NCT00002471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92339968|NCT00002471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92339969|NCT00002471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92339970|NCT00002471|Abortifacient Agents|abortifacient agents|mesh-ancestor
92339971|NCT00002471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92339972|NCT00002471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92339973|NCT00002471|Antimetabolites|antimetabolites|mesh-ancestor
92339975|NCT00002471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92339976|NCT00002471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92339977|NCT00002471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92339978|NCT00002471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92339979|NCT00002471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92339980|NCT00002471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92339981|NCT00002471|Antiviral Agents|antiviral agents|mesh-ancestor
92339982|NCT00002471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92339983|NCT00002471|Antidotes|antidotes|mesh-ancestor
92339984|NCT00002471|Protective Agents|protective agents|mesh-ancestor
92339985|NCT00002471|Vitamin B Complex|vitamin b complex|mesh-ancestor
92339986|NCT00002471|Vitamins|vitamins|mesh-ancestor
92339987|NCT00002471|Micronutrients|micronutrients|mesh-ancestor
92339988|NCT00002471|Tubulin Modulators|tubulin modulators|mesh-ancestor
92339989|NCT00002471|Antimitotic Agents|antimitotic agents|mesh-ancestor
92339990|NCT00002471|Mitosis Modulators|mitosis modulators|mesh-ancestor
92339991|NCT00002471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92390196|NCT00422994|Ropinirole|ropinirole|mesh-list
92339992|NCT00002471|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92339993|NCT00002477|Cyclophosphamide|cyclophosphamide|mesh-list
92339994|NCT00002477|Carboplatin|carboplatin|mesh-list
92339995|NCT00002477|Doxorubicin|doxorubicin|mesh-list
92339996|NCT00002477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92339997|NCT00002477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92339998|NCT00002477|Immunologic Factors|immunologic factors|mesh-ancestor
92339999|NCT00002477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340000|NCT00002477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340001|NCT00002477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340002|NCT00002477|Alkylating Agents|alkylating agents|mesh-ancestor
92340003|NCT00002477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340004|NCT00002477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340005|NCT00002477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340006|NCT00002477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340007|NCT00002477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340008|NCT00002477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340009|NCT00002477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340010|NCT00002489|Leucovorin|leucovorin|mesh-list
92340011|NCT00002489|Dactinomycin|dactinomycin|mesh-list
92340012|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
92340013|NCT00002489|Carboplatin|carboplatin|mesh-list
92340014|NCT00002489|Doxorubicin|doxorubicin|mesh-list
92340015|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92340016|NCT00002489|Methotrexate|methotrexate|mesh-list
92340017|NCT00002489|Etoposide|etoposide|mesh-list
92340018|NCT00002489|Vincristine|vincristine|mesh-list
92340019|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
92340020|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340021|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
92340022|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340023|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340024|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340025|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
92340026|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340027|NCT00002489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340028|NCT00002489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340029|NCT00002489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340030|NCT00002489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92390387|NCT02992392|Dextrans|dextrans|mesh-list
92340031|NCT00002489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340032|NCT00002489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340033|NCT00002489|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92340034|NCT00002489|Abortifacient Agents|abortifacient agents|mesh-ancestor
92340035|NCT00002489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92340036|NCT00002489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340038|NCT00002489|Dermatologic Agents|dermatologic agents|mesh-ancestor
92340039|NCT00002489|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92340040|NCT00002489|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340041|NCT00002489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340042|NCT00002489|Antidotes|antidotes|mesh-ancestor
92340043|NCT00002489|Protective Agents|protective agents|mesh-ancestor
92340044|NCT00002489|Vitamin B Complex|vitamin b complex|mesh-ancestor
92340046|NCT00002489|Micronutrients|micronutrients|mesh-ancestor
92340047|NCT00002489|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340048|NCT00002489|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340049|NCT00002489|Mitosis Modulators|mitosis modulators|mesh-ancestor
92117032|NCT03268278|Anesthetics|anesthetics|mesh-list
92340050|NCT00002489|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340051|NCT00002489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340052|NCT00002489|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92340054|NCT00002495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92340056|NCT00002495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340057|NCT00002495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340058|NCT00002495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340059|NCT00002495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340060|NCT00002495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340061|NCT00002495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340062|NCT00002495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340063|NCT00002495|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340064|NCT00002495|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340065|NCT00002495|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340066|NCT00002501|Cyclophosphamide|cyclophosphamide|mesh-list
92340067|NCT00002501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340068|NCT00002501|Immunologic Factors|immunologic factors|mesh-ancestor
92340069|NCT00002501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340070|NCT00002501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340071|NCT00002501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340072|NCT00002501|Alkylating Agents|alkylating agents|mesh-ancestor
92340073|NCT00002501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340074|NCT00002501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340075|NCT00002501|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340076|NCT00002147|Doxorubicin|doxorubicin|mesh-list
92340077|NCT00002147|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92340078|NCT00002147|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340079|NCT00002147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340080|NCT00002147|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340081|NCT00002147|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340082|NCT00002147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340083|NCT00002147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340084|NCT00002159|Itraconazole|itraconazole|mesh-list
92340085|NCT00002159|Amphotericin B|amphotericin b|mesh-list
92340086|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92340087|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
92340088|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340089|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92340090|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340091|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340092|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340093|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92340094|NCT00002159|Hormone Antagonists|hormone antagonists|mesh-ancestor
92340095|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340096|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340097|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92340098|NCT00002159|Amebicides|amebicides|mesh-ancestor
92340099|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92340100|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92340101|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340104|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92390756|NCT01270464|Reslizumab|reslizumab|mesh-list
92340106|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340107|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340108|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340109|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340110|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
92340111|NCT00002165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340112|NCT00002171|Nelfinavir|nelfinavir|mesh-list
91937927|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
92340113|NCT00002171|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340114|NCT00002171|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340115|NCT00002171|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340116|NCT00002171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340117|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340118|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92390885|NCT00242580|Triamcinolone|triamcinolone|mesh-list
92340119|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340120|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
92340121|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340122|NCT00002177|Nelfinavir|nelfinavir|mesh-list
92340123|NCT00002177|Didanosine|didanosine|mesh-list
92340124|NCT00002177|Stavudine|stavudine|mesh-list
92340125|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
92340126|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340128|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340129|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390961|NCT03801252|Cefazolin|cefazolin|mesh-list
92340130|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340131|NCT00002177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340132|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340133|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340135|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340136|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
92340137|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340138|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
92340139|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340140|NCT00002183|Lamivudine|lamivudine|mesh-list
92340141|NCT00002183|Zidovudine|zidovudine|mesh-list
92340142|NCT00002183|Abacavir|abacavir|mesh-list
92340143|NCT00002183|Amprenavir|amprenavir|mesh-list
92340144|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340145|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340146|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340147|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340148|NCT00002183|Antiviral Agents|antiviral agents|mesh-ancestor
92340149|NCT00002183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340150|NCT00002183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340151|NCT00002183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340152|NCT00002183|Antimetabolites|antimetabolites|mesh-ancestor
92391148|NCT03218514|Anticoagulants|anticoagulants|mesh-ancestor
92340153|NCT00002183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92340154|NCT00002183|Antitubercular Agents|antitubercular agents|mesh-ancestor
92340155|NCT00002183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340156|NCT00002183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340157|NCT00002183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340158|NCT00002183|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340159|NCT00002189|Paclitaxel|paclitaxel|mesh-list
92340160|NCT00002189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340161|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340162|NCT00002189|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340163|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340164|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
92391231|NCT03214770|Calcium|calcium|mesh-list
92340165|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340166|NCT00002195|Lamivudine|lamivudine|mesh-list
92340167|NCT00002195|Zidovudine|zidovudine|mesh-list
92340168|NCT00002195|Amprenavir|amprenavir|mesh-list
92340169|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340170|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340171|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340172|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340173|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
92340174|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340175|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340176|NCT00002195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340177|NCT00002195|Antimetabolites|antimetabolites|mesh-ancestor
92340178|NCT00002195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92340179|NCT00002195|Antitubercular Agents|antitubercular agents|mesh-ancestor
92340180|NCT00002195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340181|NCT00002195|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340182|NCT00002195|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340184|NCT00002201|Ritonavir|ritonavir|mesh-list
92340185|NCT00002201|Nelfinavir|nelfinavir|mesh-list
92340186|NCT00002201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340187|NCT00002201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340188|NCT00002201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340189|NCT00002201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340190|NCT00002201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340191|NCT00002201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340192|NCT00002201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91937076|NCT05177939|Hormones|hormones|mesh-ancestor
92340193|NCT00002201|Antiviral Agents|antiviral agents|mesh-ancestor
92340194|NCT00002201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340195|NCT00002201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92340196|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340197|NCT00002213|Efavirenz|efavirenz|mesh-list
92340198|NCT00002213|Abacavir|abacavir|mesh-list
92340199|NCT00002213|Amprenavir|amprenavir|mesh-list
92340200|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340201|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340202|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340203|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391394|NCT01834170|Gemcitabine|gemcitabine|mesh-list
92340205|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340206|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92340207|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340208|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92340209|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92340210|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92340211|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92340212|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340213|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340214|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92340215|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
92340216|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340217|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340218|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340219|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340220|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92340221|NCT00381251|Estrogens|estrogens|mesh-ancestor
92340222|NCT00381251|Hormones|hormones|mesh-ancestor
92349519|NCT01490580|Sufentanil|sufentanil|mesh-list
92340223|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340224|NCT00381251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340225|NCT00002219|Nelfinavir|nelfinavir|mesh-list
92340226|NCT00002219|Adefovir|adefovir|mesh-list
92340227|NCT00002219|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92340228|NCT00002219|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340229|NCT00002219|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340230|NCT00002219|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340231|NCT00002219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340232|NCT00002219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340233|NCT00002219|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340234|NCT00002219|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340235|NCT00002219|Antiviral Agents|antiviral agents|mesh-ancestor
92340236|NCT00002219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340237|NCT00002219|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340238|NCT00002219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340239|NCT00002225|Efavirenz|efavirenz|mesh-list
92340240|NCT00002225|Didanosine|didanosine|mesh-list
92340241|NCT00002225|Stavudine|stavudine|mesh-list
92340242|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340243|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340245|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340246|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
92340247|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340248|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92340249|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340250|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92340251|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92340252|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92340253|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92340254|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
92340255|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340256|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340257|NCT00002243|Calanolide A|calanolide a|mesh-list
92340258|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340259|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340260|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
92340261|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340262|NCT00002249|Levofloxacin|levofloxacin|mesh-list
92340263|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92340264|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340265|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340266|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340267|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340268|NCT00002249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340269|NCT00002249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340270|NCT00002249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349520|NCT01490580|Propofol|propofol|mesh-list
92340271|NCT00002249|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92340272|NCT00002249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340274|NCT00002255|Epoetin Alfa|epoetin alfa|mesh-list
92340275|NCT00002255|Antimetabolites|antimetabolites|mesh-ancestor
92340276|NCT00002255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340277|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340278|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340279|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340281|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340282|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340283|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340284|NCT00002255|Hematinics|hematinics|mesh-ancestor
92340285|NCT00002261|Vaccines|vaccines|mesh-list
92340286|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
92340287|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340288|NCT00002507|Mitomycins|mitomycins|mesh-list
92340289|NCT00002507|Mitomycin|mitomycin|mesh-list
92340290|NCT00002507|Porfiromycin|porfiromycin|mesh-list
92340291|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340292|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340293|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
92340294|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340295|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340296|NCT00002507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340297|NCT00002519|Paclitaxel|paclitaxel|mesh-list
92340298|NCT00002519|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340299|NCT00002519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044416|NCT05345678|Durvalumab|durvalumab|mesh-list
92340300|NCT00002519|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340301|NCT00002519|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340302|NCT00002519|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340303|NCT00002519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340304|NCT00002267|Rifabutin|rifabutin|mesh-list
92340305|NCT00002267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340306|NCT00002267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340307|NCT00002267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92340308|NCT00002267|Antitubercular Agents|antitubercular agents|mesh-ancestor
92340309|NCT00002273|Ganciclovir|ganciclovir|mesh-list
92340310|NCT00002273|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92340311|NCT00002273|Antiviral Agents|antiviral agents|mesh-ancestor
92340312|NCT00002273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392140|NCT02241174|Eusol|eusol|mesh-list
92340313|NCT00002273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340314|NCT00002273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340315|NCT00002273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340317|NCT00002279|Antimetabolites|antimetabolites|mesh-ancestor
92340318|NCT00002279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340319|NCT00002279|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340320|NCT00002279|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340321|NCT00002279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340322|NCT00002279|Antiviral Agents|antiviral agents|mesh-ancestor
92340323|NCT00002279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340324|NCT00002279|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340325|NCT00002279|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340326|NCT00002285|Zidovudine|zidovudine|mesh-list
92340327|NCT00002285|Antimetabolites|antimetabolites|mesh-ancestor
92340328|NCT00002285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340329|NCT00002285|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92340330|NCT00002285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340331|NCT00002285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340332|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
92340333|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340334|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340335|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340336|NCT00002531|Leucovorin|leucovorin|mesh-list
92340337|NCT00002531|Cytarabine|cytarabine|mesh-list
92340338|NCT00002531|Dexamethasone|dexamethasone|mesh-list
92340339|NCT00002531|Prednisolone|prednisolone|mesh-list
92340340|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
92340341|NCT00002531|Ifosfamide|ifosfamide|mesh-list
92340343|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92340344|NCT00002531|Methotrexate|methotrexate|mesh-list
92340345|NCT00002531|Etoposide|etoposide|mesh-list
92340346|NCT00002531|Vincristine|vincristine|mesh-list
92340347|NCT00002531|Daunorubicin|daunorubicin|mesh-list
92340348|NCT00002531|Asparaginase|asparaginase|mesh-list
92340349|NCT00002531|Mitoxantrone|mitoxantrone|mesh-list
92340350|NCT00002531|Mercaptopurine|mercaptopurine|mesh-list
92340351|NCT00002531|Thioguanine|thioguanine|mesh-list
92340352|NCT00002531|Vindesine|vindesine|mesh-list
92340353|NCT00002531|Teniposide|teniposide|mesh-list
92340354|NCT00002531|Levoleucovorin|levoleucovorin|mesh-list
92340355|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340357|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340358|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340359|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340360|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
92340361|NCT00002531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340362|NCT00002531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340364|NCT00002531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92340365|NCT00002531|Antiemetics|antiemetics|mesh-ancestor
92340367|NCT00002531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92340368|NCT00002531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92340369|NCT00002531|Glucocorticoids|glucocorticoids|mesh-ancestor
92340370|NCT00002531|Hormones|hormones|mesh-ancestor
92340371|NCT00002531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340372|NCT00002531|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340373|NCT00002531|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340374|NCT00002531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340375|NCT00002531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340376|NCT00002531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340377|NCT00002531|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92340378|NCT00002531|Abortifacient Agents|abortifacient agents|mesh-ancestor
92340379|NCT00002531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92340380|NCT00002531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340381|NCT00002531|Antimetabolites|antimetabolites|mesh-ancestor
92340382|NCT00002531|Dermatologic Agents|dermatologic agents|mesh-ancestor
92340383|NCT00002531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92340384|NCT00002531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92349521|NCT01490580|Atracurium|atracurium|mesh-list
92340385|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340386|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
92340387|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340388|NCT00002531|Antidotes|antidotes|mesh-ancestor
92340389|NCT00002531|Protective Agents|protective agents|mesh-ancestor
92340390|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
92340391|NCT00002531|Vitamins|vitamins|mesh-ancestor
92340392|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
92340393|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340394|NCT00002531|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340395|NCT00002531|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340396|NCT00002531|Analgesics|analgesics|mesh-ancestor
92340397|NCT00002531|Sensory System Agents|sensory system agents|mesh-ancestor
92340398|NCT00002537|Topotecan|topotecan|mesh-list
92340399|NCT00002537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92340400|NCT00002537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340401|NCT00002537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340402|NCT00002537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340403|NCT00002537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340404|NCT00002543|Gallium nitrate|gallium nitrate|mesh-list
92340405|NCT00002543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92340406|NCT00002543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340407|NCT00002543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340409|NCT00002291|Antifungal Agents|antifungal agents|mesh-ancestor
92340410|NCT00002291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340411|NCT00002291|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92392995|NCT05767684|Lenvatinib|lenvatinib|mesh-list
92340413|NCT00002291|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92340414|NCT00002549|Cytarabine|cytarabine|mesh-list
92340415|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
92340416|NCT00002549|Busulfan|busulfan|mesh-list
92340417|NCT00002549|Etoposide|etoposide|mesh-list
92340418|NCT00002549|Daunorubicin|daunorubicin|mesh-list
92340419|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
92340422|NCT00002549|Immunologic Factors|immunologic factors|mesh-ancestor
92340423|NCT00002549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340424|NCT00002549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393210|NCT05379686|Glucagon|glucagon|mesh-list
92340425|NCT00002549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340426|NCT00002549|Alkylating Agents|alkylating agents|mesh-ancestor
92340427|NCT00002549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340428|NCT00002549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340429|NCT00002549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340430|NCT00002549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340431|NCT00002549|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340432|NCT00002549|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340434|NCT00002549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340435|NCT00002549|Antimetabolites|antimetabolites|mesh-ancestor
92340436|NCT00002549|Antiviral Agents|antiviral agents|mesh-ancestor
92340437|NCT00002549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340438|NCT00002549|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340439|NCT00002549|Analgesics|analgesics|mesh-ancestor
92340440|NCT00002549|Sensory System Agents|sensory system agents|mesh-ancestor
92340441|NCT00002549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92340442|NCT00002555|Cobalt|cobalt|mesh-list
92340443|NCT00002555|Trace Elements|trace elements|mesh-ancestor
92340444|NCT00002555|Micronutrients|micronutrients|mesh-ancestor
92340445|NCT00002555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340446|NCT00002561|Doxorubicin|doxorubicin|mesh-list
92340447|NCT00002561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92340448|NCT00002561|Bleomycin|bleomycin|mesh-list
92340449|NCT00002561|Dacarbazine|dacarbazine|mesh-list
92340450|NCT00002561|Vinblastine|vinblastine|mesh-list
92340451|NCT00002561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340452|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340453|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340454|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340455|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340456|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340457|NCT00002561|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340458|NCT00002561|Alkylating Agents|alkylating agents|mesh-ancestor
92393479|NCT04677959|Xhance|xhance|mesh-list
92340460|NCT00002561|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340461|NCT00002561|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340462|NCT00002561|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340464|NCT00002567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340465|NCT00002567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340466|NCT00002567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340467|NCT00002567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340468|NCT00002567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340469|NCT00002567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340470|NCT00002579|Tamoxifen|tamoxifen|mesh-list
92340471|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
92340472|NCT00002579|Fluorouracil|fluorouracil|mesh-list
92340473|NCT00002579|Methotrexate|methotrexate|mesh-list
92340474|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340475|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
92340476|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340477|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340478|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340479|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
92340480|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340481|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340482|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340483|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
92393682|NCT04263064|Clonidine|clonidine|mesh-list
92340484|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340485|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92340486|NCT00002579|Abortifacient Agents|abortifacient agents|mesh-ancestor
92340487|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92340488|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
92340489|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340490|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92340491|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340492|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92340493|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
92340494|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340495|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340496|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92340497|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92340498|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92340499|NCT00002585|NSC 366140|nsc 366140|mesh-list
92340500|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340501|NCT00002609|Cytarabine|cytarabine|mesh-list
92340502|NCT00002609|Idarubicin|idarubicin|mesh-list
92340503|NCT00002609|Lintuzumab|lintuzumab|mesh-list
92340504|NCT00002609|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340505|NCT00002609|Antimetabolites|antimetabolites|mesh-ancestor
92340506|NCT00002609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340507|NCT00002609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340509|NCT00002609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340510|NCT00002609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340511|NCT00002609|Immunologic Factors|immunologic factors|mesh-ancestor
92340512|NCT00002609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340513|NCT00002609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340514|NCT00002609|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340515|NCT00002609|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340516|NCT00002609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340517|NCT00002609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92340518|NCT00002615|Fluorouracil|fluorouracil|mesh-list
92340519|NCT00002615|Epirubicin|epirubicin|mesh-list
92394030|NCT02817360|Lisinopril|lisinopril|mesh-list
92340520|NCT00002615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340521|NCT00002615|Antimetabolites|antimetabolites|mesh-ancestor
92340522|NCT00002615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340523|NCT00002615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340524|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340525|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
92340526|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340527|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340528|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340529|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340530|NCT00002615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340531|NCT00002621|Interferons|interferons|mesh-list
92340533|NCT00002621|Interferon alpha-2|interferon alpha-2|mesh-list
92340534|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340535|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
92340536|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340537|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
92394162|NCT02537613|Obinutuzumab|obinutuzumab|mesh-list
92340538|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340539|NCT00002627|Paclitaxel|paclitaxel|mesh-list
92340540|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
92340541|NCT00002627|Carboplatin|carboplatin|mesh-list
92340542|NCT00002627|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340543|NCT00002627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340544|NCT00002627|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340545|NCT00002627|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340546|NCT00002627|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340547|NCT00002627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340548|NCT00002627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340549|NCT00002627|Immunologic Factors|immunologic factors|mesh-ancestor
92340550|NCT00002627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340551|NCT00002627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340552|NCT00002627|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340554|NCT00002627|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340555|NCT00002633|Leuprolide|leuprolide|mesh-list
92340556|NCT00002633|Goserelin|goserelin|mesh-list
92340557|NCT00002633|Flutamide|flutamide|mesh-list
92340558|NCT00002633|Bicalutamide|bicalutamide|mesh-list
92340559|NCT00002633|Nilutamide|nilutamide|mesh-list
92340560|NCT00002633|Buserelin|buserelin|mesh-list
92340561|NCT00002633|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92340562|NCT00002633|Fertility Agents|fertility agents|mesh-ancestor
92340563|NCT00002633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92340564|NCT00002633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340565|NCT00002633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340566|NCT00002633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340567|NCT00002633|Androgen Antagonists|androgen antagonists|mesh-ancestor
92340568|NCT00002633|Hormone Antagonists|hormone antagonists|mesh-ancestor
92340569|NCT00002633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340570|NCT00002639|Suramin|suramin|mesh-list
92394509|NCT01385683|Dabigatran|dabigatran|mesh-list
92340571|NCT00002639|Antinematodal Agents|antinematodal agents|mesh-ancestor
92340572|NCT00002639|Anthelmintics|anthelmintics|mesh-ancestor
92340573|NCT00002639|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92340574|NCT00002639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340575|NCT00002639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340576|NCT00002639|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92340577|NCT00002639|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92340578|NCT00002657|Interferons|interferons|mesh-list
91993117|NCT04184453|Deferiprone|deferiprone|mesh-list
92340579|NCT00002657|Cytarabine|cytarabine|mesh-list
92340580|NCT00002657|Interferon-alpha|interferon-alpha|mesh-list
92340581|NCT00002657|Prednisone|prednisone|mesh-list
92340582|NCT00002657|Cyclophosphamide|cyclophosphamide|mesh-list
92340583|NCT00002657|Doxorubicin|doxorubicin|mesh-list
92340584|NCT00002657|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92340585|NCT00002657|Methotrexate|methotrexate|mesh-list
92340586|NCT00002657|Etoposide|etoposide|mesh-list
92340587|NCT00002657|Vincristine|vincristine|mesh-list
92340588|NCT00002657|Bleomycin|bleomycin|mesh-list
92340589|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340590|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
91914817|NCT02426463|Anesthetics|anesthetics|mesh-ancestor
92340591|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340592|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340593|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340594|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
92340595|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340596|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340597|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340598|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340599|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340600|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340601|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340602|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92340603|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
92340604|NCT00002657|Hormones|hormones|mesh-ancestor
92394621|NCT01386268|Factor VIII|factor viii|mesh-list
92340605|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340606|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340607|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92340608|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
92340609|NCT00002657|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92340610|NCT00002657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340611|NCT00002657|Antimetabolites|antimetabolites|mesh-ancestor
92340612|NCT00002657|Dermatologic Agents|dermatologic agents|mesh-ancestor
92340613|NCT00002657|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92340614|NCT00002657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340615|NCT00002657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340616|NCT00002657|Antiviral Agents|antiviral agents|mesh-ancestor
92340617|NCT00002657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340618|NCT00002657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340619|NCT00002657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340620|NCT00002657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340621|NCT05673785|Prednisone|prednisone|mesh-list
92340622|NCT05673785|Cyclophosphamide|cyclophosphamide|mesh-list
92340623|NCT05673785|Doxorubicin|doxorubicin|mesh-list
92340624|NCT05673785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92340625|NCT05673785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340626|NCT05673785|Immunologic Factors|immunologic factors|mesh-ancestor
92340627|NCT05673785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340628|NCT05673785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340629|NCT05673785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340630|NCT05673785|Alkylating Agents|alkylating agents|mesh-ancestor
92340631|NCT05673785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340632|NCT05673785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340633|NCT05673785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340634|NCT05673785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92340635|NCT05673785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340636|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340637|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340638|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92340639|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
92340640|NCT05673785|Hormones|hormones|mesh-ancestor
92340641|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340642|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340643|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92340644|NCT05673785|Immunotoxins|immunotoxins|mesh-ancestor
92340645|NCT05673785|Immunoconjugates|immunoconjugates|mesh-ancestor
92340646|NCT00381875|Sargramostim|sargramostim|mesh-list
92340647|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
92340648|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
92340649|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340650|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92340651|NCT00002669|Interferons|interferons|mesh-list
92340652|NCT00002669|Interferon-alpha|interferon-alpha|mesh-list
92340653|NCT00002669|Aldesleukin|aldesleukin|mesh-list
92340654|NCT00002669|Dacarbazine|dacarbazine|mesh-list
92340655|NCT00002669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340656|NCT00002669|Antiviral Agents|antiviral agents|mesh-ancestor
92340657|NCT00002669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340658|NCT00002669|Immunologic Factors|immunologic factors|mesh-ancestor
92340659|NCT00002669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340660|NCT00002669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340661|NCT00002669|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340662|NCT00002669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340663|NCT00002669|Alkylating Agents|alkylating agents|mesh-ancestor
92340664|NCT00002669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340666|NCT00002675|Carboplatin|carboplatin|mesh-list
92340667|NCT00002675|Etoposide|etoposide|mesh-list
92340668|NCT00002675|Vincristine|vincristine|mesh-list
92340669|NCT00002675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340670|NCT00002675|Immunologic Factors|immunologic factors|mesh-ancestor
92340671|NCT00002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340672|NCT00002675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340673|NCT00002675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340675|NCT00002675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340676|NCT00002675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340677|NCT00002675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340678|NCT00002675|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340679|NCT00002675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340680|NCT00002675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340681|NCT00002675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395140|NCT01389427|Sirolimus|sirolimus|mesh-list
92340682|NCT00002675|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340683|NCT00002675|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340684|NCT00002675|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340685|NCT00002681|Aldesleukin|aldesleukin|mesh-list
92340686|NCT00002681|Daclizumab|daclizumab|mesh-list
92340687|NCT00002681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340688|NCT00002681|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340689|NCT00002681|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340690|NCT00002681|Antiviral Agents|antiviral agents|mesh-ancestor
92340691|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340692|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340693|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
92340694|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340695|NCT02973113|Nivolumab|nivolumab|mesh-list
92340696|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92340697|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340698|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92340699|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340700|NCT00002687|Aldesleukin|aldesleukin|mesh-list
92340701|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340702|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340703|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340704|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
92340705|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340706|NCT00002693|Carboplatin|carboplatin|mesh-list
92340707|NCT00002693|Topotecan|topotecan|mesh-list
92340708|NCT00002693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340709|NCT00002693|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92340710|NCT00002693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340711|NCT00002693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340712|NCT00002693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340713|NCT00002705|Topotecan|topotecan|mesh-list
92340714|NCT00002705|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92340715|NCT00002705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340716|NCT00002705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340717|NCT00002705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340718|NCT00002705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340719|NCT00002711|Paclitaxel|paclitaxel|mesh-list
92340720|NCT00002711|Cisplatin|cisplatin|mesh-list
92340721|NCT00002711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340722|NCT00002711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340723|NCT00002711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340724|NCT00002711|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340725|NCT00002711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340726|NCT00002711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340727|NCT00002717|Paclitaxel|paclitaxel|mesh-list
92340728|NCT00002717|Cisplatin|cisplatin|mesh-list
92340729|NCT00002717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92340730|NCT00002717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340731|NCT00002717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92340732|NCT00002717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92340733|NCT00002717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92340734|NCT00002717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340735|NCT00002723|Suramin|suramin|mesh-list
92340736|NCT00002723|Antinematodal Agents|antinematodal agents|mesh-ancestor
92395622|NCT01392287|Memantine|memantine|mesh-list
92340737|NCT00002723|Anthelmintics|anthelmintics|mesh-ancestor
92340738|NCT00002723|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92340739|NCT00002723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340740|NCT00002723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340741|NCT00002723|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92340742|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92340744|NCT00002735|Cisplatin|cisplatin|mesh-list
92340745|NCT00002735|Fluorouracil|fluorouracil|mesh-list
92340746|NCT00002735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340747|NCT00002735|Antimetabolites|antimetabolites|mesh-ancestor
92395750|NCT01392833|Immunologic Factors|immunologic factors|mesh-ancestor
92340748|NCT00002735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340749|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340750|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340751|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
92340752|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340753|NCT00002735|Trace Elements|trace elements|mesh-ancestor
92340755|NCT00002747|Cobalt|cobalt|mesh-list
92340756|NCT00002747|Fluorouracil|fluorouracil|mesh-list
92340757|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340758|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
92340759|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340760|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340761|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340762|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
92340763|NCT00002747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340764|NCT00002747|Trace Elements|trace elements|mesh-ancestor
92340765|NCT00002747|Micronutrients|micronutrients|mesh-ancestor
92340766|NCT02973035|Amlodipine|amlodipine|mesh-list
92340767|NCT02973035|Valsartan|valsartan|mesh-list
92340768|NCT02973035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92340769|NCT02973035|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92340770|NCT02973035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92340771|NCT02973035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340772|NCT02973035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92340773|NCT02973035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340774|NCT02973035|Vasodilator Agents|vasodilator agents|mesh-ancestor
92340775|NCT02973035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92340776|NCT02973035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92340777|NCT00002753|Antibodies|antibodies|mesh-list
92340778|NCT00002753|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92340779|NCT00002753|Immunologic Factors|immunologic factors|mesh-ancestor
92340780|NCT00002753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340782|NCT00002759|Irinotecan|irinotecan|mesh-list
92340783|NCT00002759|Phenobarbital|phenobarbital|mesh-list
92340784|NCT00002759|Cyclosporins|cyclosporins|mesh-list
92340785|NCT00002759|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92340786|NCT00002759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340787|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340788|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396458|NCT01396681|Gemcitabine|gemcitabine|mesh-list
92340790|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340791|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
92340792|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396531|NCT01397175|Everolimus|everolimus|mesh-list
92340793|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
92340794|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340795|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
92340796|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340797|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92396677|NCT04453449|Anesthetics|anesthetics|mesh-ancestor
92340798|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
92340799|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92340800|NCT00002759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396740|NCT03129321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340801|NCT00002759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92340802|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92340803|NCT00002759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92340805|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
92340806|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92340807|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92340808|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92340810|NCT00002765|Immunoconjugates|immunoconjugates|mesh-ancestor
92340811|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
92340812|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340813|NCT00002771|Interferons|interferons|mesh-list
92340815|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
92340816|NCT00002771|Busulfan|busulfan|mesh-list
92340817|NCT00002771|Idarubicin|idarubicin|mesh-list
92340818|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
92340819|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340820|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
92340821|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340823|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
92340824|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340825|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340826|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
92340827|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340829|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340830|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92397468|NCT04399746|Vitamin D|vitamin d|mesh-list
92340832|NCT00002771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92340833|NCT00002771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340834|NCT00002771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397545|NCT04108026|Durvalumab|durvalumab|mesh-list
92340835|NCT00002771|Antisickling Agents|antisickling agents|mesh-ancestor
92340836|NCT00002771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340838|NCT00002777|Exemestane|exemestane|mesh-list
92340839|NCT00002777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340840|NCT00002777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92340841|NCT00002777|Hormone Antagonists|hormone antagonists|mesh-ancestor
92397764|NCT03289325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92340842|NCT00002777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340843|NCT00002777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340844|NCT00002777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340845|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340846|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92340847|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92340848|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92340849|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92340850|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92340851|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340853|NCT00002783|Fluorouracil|fluorouracil|mesh-list
92340854|NCT00002783|Floxuridine|floxuridine|mesh-list
92340855|NCT00002783|Calcium|calcium|mesh-list
92340856|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
92340857|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349522|NCT01490580|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92340858|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92340859|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340861|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340862|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340863|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340864|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
92340865|NCT00002783|Antidotes|antidotes|mesh-ancestor
92340866|NCT00002783|Protective Agents|protective agents|mesh-ancestor
92340867|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
92340869|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
92340870|NCT00002789|Cyclosporine|cyclosporine|mesh-list
92340871|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
92340872|NCT00002789|Busulfan|busulfan|mesh-list
92340873|NCT00002789|Methotrexate|methotrexate|mesh-list
92340875|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92340876|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
92340877|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398338|NCT01622998|Nicotine|nicotine|mesh-list
92340878|NCT00002789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92340879|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92340880|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
92340881|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340882|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398479|NCT00600015|Sorafenib|sorafenib|mesh-list
92340883|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92340884|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92340886|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92340887|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92340888|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
92340889|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
92340890|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340891|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92340892|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92340893|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
92340894|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340895|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92340896|NCT00381953|Interferons|interferons|mesh-list
92340897|NCT00381953|Ribavirin|ribavirin|mesh-list
92340898|NCT00381953|Interferon-alpha|interferon-alpha|mesh-list
92340899|NCT00381953|Interferon alpha-2|interferon alpha-2|mesh-list
92340900|NCT00381953|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92340901|NCT00381953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340902|NCT00381953|Antiviral Agents|antiviral agents|mesh-ancestor
92340903|NCT00381953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340904|NCT00381953|Antimetabolites|antimetabolites|mesh-ancestor
92340905|NCT00381953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340906|NCT00381953|Immunologic Factors|immunologic factors|mesh-ancestor
92340907|NCT00381953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340908|NCT00382343|Trimethoprim|trimethoprim|mesh-list
92340909|NCT00382343|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92399059|NCT01401075|Immunologic Factors|immunologic factors|mesh-ancestor
92340911|NCT00382343|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92340912|NCT00382343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340913|NCT00382343|Antimalarials|antimalarials|mesh-ancestor
92340914|NCT00382343|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92340915|NCT00382343|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92399135|NCT01402024|Aprepitant|aprepitant|mesh-list
92340917|NCT00382343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340918|NCT00382343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340919|NCT00382343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92340920|NCT00382343|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92340921|NCT00382343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340922|NCT00382343|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340923|NCT05749445|Ritonavir|ritonavir|mesh-list
92399353|NCT01403389|Eculizumab|eculizumab|mesh-list
92340924|NCT05749445|Nirmatrelvir|nirmatrelvir|mesh-list
92340925|NCT05749445|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92340926|NCT05749445|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340927|NCT05749445|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340928|NCT05749445|Protease Inhibitors|protease inhibitors|mesh-ancestor
92340929|NCT05749445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340930|NCT05749445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340932|NCT05749445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340933|NCT05749445|Antiviral Agents|antiviral agents|mesh-ancestor
92340934|NCT05749445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340935|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92340936|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340937|NCT05749367|Ropivacaine|ropivacaine|mesh-list
92399488|NCT01404104|Sirolimus|sirolimus|mesh-list
92340938|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92340939|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
92340940|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
92340941|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399573|NCT01404338|Halobetasol|halobetasol|mesh-list
92340942|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340943|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
92340944|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92340945|NCT05749289|Octreotide|octreotide|mesh-list
92340946|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92340947|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340948|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340949|NCT02972957|Azithromycin|azithromycin|mesh-list
92340950|NCT02972957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92340951|NCT02972957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340952|NCT05545319|Ritonavir|ritonavir|mesh-list
92340953|NCT05545319|Nirmatrelvir|nirmatrelvir|mesh-list
92340954|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92340955|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92340956|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
92399635|NCT01404507|Abciximab|abciximab|mesh-list
92340957|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340958|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340959|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92340960|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92340961|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
92340962|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92340963|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92340964|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92340965|NCT05523869|Topotecan|topotecan|mesh-list
92340966|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92340967|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92340968|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92340969|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92340970|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340971|NCT05522465|Dexamethasone|dexamethasone|mesh-list
92340973|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92340974|NCT05522465|Antiemetics|antiemetics|mesh-ancestor
92340975|NCT05522465|Autonomic Agents|autonomic agents|mesh-ancestor
92340976|NCT05522465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92340977|NCT05522465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340978|NCT05522465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92340979|NCT05522465|Glucocorticoids|glucocorticoids|mesh-ancestor
92340980|NCT05522465|Hormones|hormones|mesh-ancestor
92399825|NCT01405157|Hormones|hormones|mesh-ancestor
92340981|NCT05522465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92340982|NCT05522465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92340983|NCT05522465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92340984|NCT05215691|Morphine|morphine|mesh-list
92340985|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92340986|NCT05215691|Narcotics|narcotics|mesh-ancestor
92340987|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92340988|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340990|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
92340991|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92340992|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92340994|NCT05204147|Immunoglobulins|immunoglobulins|mesh-list
92340995|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92349523|NCT01490580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92340996|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92340997|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
92340998|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92340999|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341001|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
92341002|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341003|NCT04824053|Selenium|selenium|mesh-list
92341004|NCT04824053|Caseins|caseins|mesh-list
92341005|NCT04824053|Antioxidants|antioxidants|mesh-ancestor
92341006|NCT04824053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341007|NCT04824053|Protective Agents|protective agents|mesh-ancestor
92341008|NCT04824053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341010|NCT04824053|Micronutrients|micronutrients|mesh-ancestor
92341011|NCT04824053|Chelating Agents|chelating agents|mesh-ancestor
92341012|NCT04824053|Sequestering Agents|sequestering agents|mesh-ancestor
92341013|NCT04811339|Bismuth|bismuth|mesh-list
92341014|NCT04811339|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92341015|NCT04811339|Antacids|antacids|mesh-ancestor
92341016|NCT04811339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341017|NCT04811339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92341019|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
92341020|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937089|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341021|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341022|NCT05406713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341023|NCT05406713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341025|NCT04783415|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92341026|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400121|NCT01406704|Thioctic Acid|thioctic acid|mesh-list
92341027|NCT04783415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92341028|NCT04783415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341029|NCT04783415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341030|NCT04331093|Apatinib|apatinib|mesh-list
92341031|NCT04331093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341032|NCT04331093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92341033|NCT04331093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341034|NCT04331093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341035|NCT05124977|Anti-Infective Agents|anti-infective agents|mesh-list
92341036|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92341037|NCT00382421|Aspirin|aspirin|mesh-list
92341038|NCT00382421|Amlodipine|amlodipine|mesh-list
92341039|NCT00382421|Bisoprolol|bisoprolol|mesh-list
91993552|NCT05676463|Methyltestosterone|methyltestosterone|mesh-list
92341040|NCT00382421|Molsidomine|molsidomine|mesh-list
92341041|NCT00382421|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92341042|NCT00382421|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92341043|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92341044|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341045|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92341046|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341047|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
92341048|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92341049|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92341050|NCT00382421|Analgesics|analgesics|mesh-ancestor
92341051|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
92341052|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341053|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341054|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341055|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92341056|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92341057|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92341058|NCT00382421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92341059|NCT00382421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341060|NCT00382421|Antipyretics|antipyretics|mesh-ancestor
92341062|NCT00382421|Autonomic Agents|autonomic agents|mesh-ancestor
92341063|NCT00382421|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92341064|NCT00382421|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92341065|NCT00382421|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92341066|NCT00382421|Adrenergic Agents|adrenergic agents|mesh-ancestor
92341067|NCT00382421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341068|NCT00382421|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92341069|NCT05343455|Doxycycline|doxycycline|mesh-list
92341070|NCT05343455|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92341071|NCT05343455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341072|NCT05343455|Antimalarials|antimalarials|mesh-ancestor
92341073|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92341074|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92341075|NCT05069831|Abrocitinib|abrocitinib|mesh-list
92341076|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92341077|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341078|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341079|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
92341080|NCT05049863|Irinotecan|irinotecan|mesh-list
92341081|NCT05049863|Allopurinol|allopurinol|mesh-list
92341082|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92341083|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341084|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341085|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341086|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341087|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341088|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92341089|NCT05049863|Antitubercular Agents|antitubercular agents|mesh-ancestor
92341090|NCT05049863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92341091|NCT05049863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341092|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
92341093|NCT05049863|Gout Suppressants|gout suppressants|mesh-ancestor
91937091|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
92341094|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341095|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92341097|NCT05049863|Protective Agents|protective agents|mesh-ancestor
92341098|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341099|NCT05312255|Propranolol|propranolol|mesh-list
92341100|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92341101|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
92341102|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92341103|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341104|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341105|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341106|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92341107|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92341108|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
92341110|NCT05015621|Fluorouracil|fluorouracil|mesh-list
92341112|NCT05015621|Calcium|calcium|mesh-list
92341113|NCT05015621|Levoleucovorin|levoleucovorin|mesh-list
92341114|NCT05015621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92341115|NCT05015621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341116|NCT05015621|Antimetabolites|antimetabolites|mesh-ancestor
92341117|NCT05015621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400519|NCT01409408|Vasodilator Agents|vasodilator agents|mesh-ancestor
92341118|NCT05015621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341119|NCT05015621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341120|NCT05015621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341121|NCT05015621|Immunologic Factors|immunologic factors|mesh-ancestor
92341122|NCT05015621|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92341123|NCT05015621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341124|NCT05015621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341125|NCT05015621|Antidotes|antidotes|mesh-ancestor
92341126|NCT05015621|Protective Agents|protective agents|mesh-ancestor
92341127|NCT05015621|Vitamin B Complex|vitamin b complex|mesh-ancestor
92341128|NCT05015621|Vitamins|vitamins|mesh-ancestor
92341129|NCT05015621|Micronutrients|micronutrients|mesh-ancestor
92341130|NCT05007509|Vaccines|vaccines|mesh-list
92341131|NCT05007509|Immunologic Factors|immunologic factors|mesh-ancestor
92341132|NCT05007509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341133|NCT05289167|Cyclophosphamide|cyclophosphamide|mesh-list
92341134|NCT05289167|Bortezomib|bortezomib|mesh-list
92341137|NCT05289167|Immunologic Factors|immunologic factors|mesh-ancestor
92341138|NCT05289167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341139|NCT05289167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341140|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341141|NCT05289167|Alkylating Agents|alkylating agents|mesh-ancestor
92341142|NCT05289167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341143|NCT05289167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341144|NCT05289167|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92400722|NCT01411124|Antimanic Agents|antimanic agents|mesh-ancestor
92341145|NCT05289167|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341146|NCT05289167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341148|NCT00382499|Anesthetics, Local|anesthetics, local|mesh-ancestor
92341149|NCT00382499|Anesthetics|anesthetics|mesh-ancestor
92341150|NCT00382499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341151|NCT00382499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341152|NCT00382499|Sensory System Agents|sensory system agents|mesh-ancestor
92341154|NCT00382499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92341155|NCT00382499|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92341156|NCT00382499|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92341157|NCT00382499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400788|NCT01411514|Glucocorticoids|glucocorticoids|mesh-ancestor
92341158|NCT00382499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341159|NCT04330547|Analgesics|analgesics|mesh-list
92341160|NCT04330547|Sensory System Agents|sensory system agents|mesh-ancestor
92341161|NCT04330547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341162|NCT04330547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341163|NCT00382889|Beclomethasone|beclomethasone|mesh-list
92341164|NCT00382889|Albuterol|albuterol|mesh-list
92341165|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92341166|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
92341167|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937092|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92341168|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341169|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92341170|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
92341171|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
92341172|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92341173|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92341174|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92341175|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92341176|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
92341177|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341178|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341179|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341180|NCT00382889|Glucocorticoids|glucocorticoids|mesh-ancestor
92341182|NCT00382889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341183|NCT04977167|Antibodies|antibodies|mesh-list
92341184|NCT04977167|Immunologic Factors|immunologic factors|mesh-ancestor
92341185|NCT04977167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341186|NCT04482959|Carbetocin|carbetocin|mesh-list
92341187|NCT04482959|Oxytocics|oxytocics|mesh-ancestor
92341188|NCT04482959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92341189|NCT04482959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341190|NCT04571879|Lidocaine|lidocaine|mesh-list
92341191|NCT04571879|Midazolam|midazolam|mesh-list
91993704|NCT03113773|Aldesleukin|aldesleukin|mesh-list
92341192|NCT04571879|Anesthetics, Local|anesthetics, local|mesh-ancestor
92341193|NCT04571879|Anesthetics|anesthetics|mesh-ancestor
92341194|NCT04571879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341195|NCT04571879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341196|NCT04571879|Sensory System Agents|sensory system agents|mesh-ancestor
92341197|NCT04571879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341198|NCT04571879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92341199|NCT04571879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92341200|NCT04571879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92341201|NCT04571879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117033|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341202|NCT04571879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341203|NCT04571879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92341204|NCT04571879|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92400903|NCT01412515|Everolimus|everolimus|mesh-list
92341205|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92341206|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92341207|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92341208|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92341209|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
92341210|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
92341211|NCT04571879|GABA Agents|gaba agents|mesh-ancestor
92341212|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341214|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
92341215|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341216|NCT04332107|Azithromycin|azithromycin|mesh-list
92341217|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92341218|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341219|NCT04328285|Ritonavir|ritonavir|mesh-list
92341220|NCT04328285|Lopinavir|lopinavir|mesh-list
92341221|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
92341222|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92341223|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92341224|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
92341225|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341226|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341228|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92341229|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
92341230|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341231|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92400952|NCT01412840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92341232|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92341233|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
92341234|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92341235|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92341236|NCT04328285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341237|NCT04928261|Trastuzumab|trastuzumab|mesh-list
92341238|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341239|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341240|NCT04920539|Dronabinol|dronabinol|mesh-list
92341241|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
92341242|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341243|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92341244|NCT04920539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92341245|NCT04920539|Analgesics|analgesics|mesh-ancestor
92341246|NCT04920539|Sensory System Agents|sensory system agents|mesh-ancestor
92341247|NCT04920539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341248|NCT04920539|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92341249|NCT04920539|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92341250|NCT04920539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341251|NCT04920539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341252|NCT04920539|Hormones|hormones|mesh-ancestor
92341253|NCT04920539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341254|NCT04882241|Leucovorin|leucovorin|mesh-list
92341255|NCT04882241|Docetaxel|docetaxel|mesh-list
92341256|NCT04882241|Pembrolizumab|pembrolizumab|mesh-list
92341257|NCT04882241|Fluorouracil|fluorouracil|mesh-list
92341258|NCT04882241|Capecitabine|capecitabine|mesh-list
92341259|NCT04882241|Oxaliplatin|oxaliplatin|mesh-list
92341260|NCT04882241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341261|NCT04882241|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341262|NCT04882241|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341263|NCT04882241|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341264|NCT04882241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341265|NCT04882241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341266|NCT04882241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341267|NCT04882241|Antimetabolites|antimetabolites|mesh-ancestor
92341268|NCT04882241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341269|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341270|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
92341271|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341272|NCT04882241|Antidotes|antidotes|mesh-ancestor
92341273|NCT04882241|Protective Agents|protective agents|mesh-ancestor
92341274|NCT04882241|Vitamin B Complex|vitamin b complex|mesh-ancestor
92341275|NCT04882241|Vitamins|vitamins|mesh-ancestor
92341276|NCT04882241|Micronutrients|micronutrients|mesh-ancestor
92341277|NCT04481243|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92341278|NCT04481243|Immunologic Factors|immunologic factors|mesh-ancestor
92341279|NCT04481243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341280|NCT03575195|Rifaximin|rifaximin|mesh-list
92341281|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92341282|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341283|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92341284|NCT00002897|Fluorouracil|fluorouracil|mesh-list
92341285|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341286|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
92341287|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341288|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341289|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401010|NCT01413230|Vitamins|vitamins|mesh-ancestor
92341290|NCT00002897|Immunologic Factors|immunologic factors|mesh-ancestor
92341291|NCT00002897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341292|NCT00002903|Docetaxel|docetaxel|mesh-list
92341293|NCT00002903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341294|NCT00002903|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341295|NCT00002903|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341296|NCT00002903|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341297|NCT00002903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341298|NCT03375203|Zolpidem|zolpidem|mesh-list
92341299|NCT03375203|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92341300|NCT03375203|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92341301|NCT03375203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341302|NCT03375203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341303|NCT03375203|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92341304|NCT03375203|GABA Agonists|gaba agonists|mesh-ancestor
92341305|NCT03375203|GABA Agents|gaba agents|mesh-ancestor
92341306|NCT03375203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341307|NCT03375203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341308|NCT00002909|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92401021|NCT01413477|Glucocorticoids|glucocorticoids|mesh-ancestor
92341309|NCT00002909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341310|NCT00002915|Penclomedine|penclomedine|mesh-list
92341311|NCT00002915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341312|NCT00002921|Suramin|suramin|mesh-list
92341313|NCT00002921|Hydrocortisone|hydrocortisone|mesh-list
92341314|NCT00002921|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92341315|NCT00002921|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92341316|NCT00002921|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92341317|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341318|NCT00002921|Antinematodal Agents|antinematodal agents|mesh-ancestor
92341319|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
92341320|NCT00002921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92341321|NCT00002921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341322|NCT00002921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341323|NCT00002921|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92341324|NCT00002921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92341326|NCT00383045|Buprenorphine|buprenorphine|mesh-list
92401160|NCT01414881|Mipomersen|mipomersen|mesh-list
92341327|NCT00383045|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92341328|NCT00383045|Narcotics|narcotics|mesh-ancestor
92341329|NCT00383045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341330|NCT00383045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341331|NCT00383045|Analgesics|analgesics|mesh-ancestor
92401238|NCT01415505|Nebivolol|nebivolol|mesh-list
92341332|NCT00383045|Sensory System Agents|sensory system agents|mesh-ancestor
92341333|NCT00383045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341334|NCT00383045|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92341335|NCT00383045|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92341336|NCT00383591|Vaccines|vaccines|mesh-list
92341337|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
92341338|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341339|NCT00002933|Irinotecan|irinotecan|mesh-list
92341340|NCT00002933|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92341341|NCT00002933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341342|NCT00002933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341343|NCT00002933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341344|NCT00002933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341345|NCT00002939|Paclitaxel|paclitaxel|mesh-list
92341346|NCT00002939|Irinotecan|irinotecan|mesh-list
92341347|NCT00002939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341348|NCT00002939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341349|NCT00002939|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341350|NCT00002939|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341351|NCT00002939|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341352|NCT00002939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914818|NCT02426463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92341353|NCT00002939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92341354|NCT00002939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341355|NCT00002939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341357|NCT04009967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341358|NCT04009967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401412|NCT01416246|Anti-Infective Agents|anti-infective agents|mesh-list
92341359|NCT04009967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341360|NCT04009967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341361|NCT03085823|Sirolimus|sirolimus|mesh-list
92341362|NCT03085823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92341363|NCT03085823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341364|NCT03085823|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341365|NCT03085823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341366|NCT03085823|Antifungal Agents|antifungal agents|mesh-ancestor
92341367|NCT03085823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341368|NCT03085823|Immunologic Factors|immunologic factors|mesh-ancestor
92341369|NCT03085823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341370|NCT00002945|Cytarabine|cytarabine|mesh-list
92341371|NCT00002945|Aldesleukin|aldesleukin|mesh-list
92341372|NCT00002945|Cyclophosphamide|cyclophosphamide|mesh-list
92341373|NCT00002945|Melphalan|melphalan|mesh-list
92341374|NCT00002945|Etoposide|etoposide|mesh-list
92341375|NCT00002945|Idarubicin|idarubicin|mesh-list
92341376|NCT00002945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341377|NCT00002945|Immunologic Factors|immunologic factors|mesh-ancestor
92341378|NCT00002945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341379|NCT00002945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341380|NCT00002945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341381|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
92341382|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341383|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401616|NCT01417689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92341384|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341385|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341386|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341387|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92401682|NCT01418118|Mydriatics|mydriatics|mesh-ancestor
92341388|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341389|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341390|NCT00002945|Antimetabolites|antimetabolites|mesh-ancestor
92341391|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
92341392|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341393|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92341394|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92401750|NCT01418430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341395|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341396|NCT00002951|Fluorouracil|fluorouracil|mesh-list
92341397|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
92341398|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
92341399|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341400|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341401|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341402|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341403|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
92341404|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341405|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
92341406|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341407|NCT00002951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92341409|NCT03058289|Ipilimumab|ipilimumab|mesh-list
92341410|NCT03058289|Antibodies|antibodies|mesh-list
92341411|NCT03058289|Immunoglobulins|immunoglobulins|mesh-list
92341412|NCT03058289|Immunologic Factors|immunologic factors|mesh-ancestor
92341413|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341414|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341415|NCT03058289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341416|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341417|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341418|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92341419|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91993933|NCT05899621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341420|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
92341421|NCT00002969|Paclitaxel|paclitaxel|mesh-list
92341422|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341423|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341424|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341425|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341426|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341427|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341428|NCT00002987|Prednisolone|prednisolone|mesh-list
92341429|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
92341430|NCT00002987|Doxorubicin|doxorubicin|mesh-list
92341431|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92341432|NCT00002987|Etoposide|etoposide|mesh-list
92341433|NCT00002987|Vincristine|vincristine|mesh-list
92341434|NCT00002987|Bleomycin|bleomycin|mesh-list
92341435|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341436|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
92341437|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341438|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341439|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341440|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
92341441|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341442|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341443|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341444|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341445|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341446|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341447|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341448|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341449|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341450|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341451|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341452|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341453|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
92341454|NCT00002987|Hormones|hormones|mesh-ancestor
92341455|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341456|NCT00002987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92341457|NCT02919683|Nivolumab|nivolumab|mesh-list
92341458|NCT02919683|Ipilimumab|ipilimumab|mesh-list
92341459|NCT02919683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341460|NCT02919683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341461|NCT02919683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92402066|NCT01420575|Olanzapine|olanzapine|mesh-list
92341462|NCT02919683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341463|NCT03933293|Ezetimibe|ezetimibe|mesh-list
92341464|NCT03933293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92341465|NCT03933293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92341466|NCT03933293|Antimetabolites|antimetabolites|mesh-ancestor
92341467|NCT03933293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341468|NCT03933293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92341470|NCT00002993|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92341471|NCT00002993|Mitomycins|mitomycins|mesh-list
92341472|NCT00002993|Mitomycin|mitomycin|mesh-list
92341473|NCT00002993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341474|NCT00002993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341475|NCT00002993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341476|NCT00002993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341477|NCT00002993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341478|NCT00002993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341479|NCT00002993|Alkylating Agents|alkylating agents|mesh-ancestor
92341480|NCT00002993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92341481|NCT01928082|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92341482|NCT01928082|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92341483|NCT01928082|Estradiol|estradiol|mesh-list
92341484|NCT01928082|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92341485|NCT01928082|Estrogens|estrogens|mesh-ancestor
92341486|NCT01928082|Hormones|hormones|mesh-ancestor
92341487|NCT01928082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341488|NCT01928082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341489|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92341490|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
92341491|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92341492|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92341493|NCT00002999|Fluorouracil|fluorouracil|mesh-list
92341494|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341495|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
92341496|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341497|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341498|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341499|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
91914819|NCT02426463|Narcotics|narcotics|mesh-ancestor
92341500|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341501|NCT00003005|Cordycepin|cordycepin|mesh-list
92341502|NCT00003005|Pentostatin|pentostatin|mesh-list
92341503|NCT00003005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341504|NCT00003005|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92341505|NCT00003005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341506|NCT00003005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341507|NCT00003005|Antifungal Agents|antifungal agents|mesh-ancestor
92341508|NCT00003005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341509|NCT03905603|Cosyntropin|cosyntropin|mesh-list
92341510|NCT03905603|Hormones|hormones|mesh-ancestor
92341511|NCT03905603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341512|NCT03905603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341513|NCT00003011|Marimastat|marimastat|mesh-list
92341514|NCT00003011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402302|NCT01422096|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92341515|NCT00003011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341516|NCT00003017|Interleukin-12|interleukin-12|mesh-list
92341517|NCT00003017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341518|NCT00003017|Immunologic Factors|immunologic factors|mesh-ancestor
92341519|NCT00003017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341520|NCT00003017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92341521|NCT00003017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92341522|NCT00003017|Growth Substances|growth substances|mesh-ancestor
92341523|NCT00003017|Growth Inhibitors|growth inhibitors|mesh-ancestor
92341524|NCT00003017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341525|NCT00003023|Vaccines|vaccines|mesh-list
92341526|NCT00003023|Antibodies|antibodies|mesh-list
92341527|NCT00003023|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92341528|NCT00003023|BCG Vaccine|bcg vaccine|mesh-list
92341529|NCT00003023|Immunologic Factors|immunologic factors|mesh-ancestor
92341530|NCT00003023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341531|NCT00003023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341532|NCT03850067|Carboplatin|carboplatin|mesh-list
92402511|NCT01423175|Antimetabolites|antimetabolites|mesh-ancestor
92341534|NCT03850067|Etoposide|etoposide|mesh-list
92341535|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
92341536|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341537|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341538|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92341539|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402583|NCT01423500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341540|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341541|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341542|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92402662|NCT01423864|Hormones|hormones|mesh-ancestor
92341543|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341544|NCT00003029|Fluorouracil|fluorouracil|mesh-list
92341545|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341546|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
92341547|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341548|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341549|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341550|NCT00003029|Immunologic Factors|immunologic factors|mesh-ancestor
92341551|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341552|NCT00003035|Tamoxifen|tamoxifen|mesh-list
92341553|NCT00003035|Paclitaxel|paclitaxel|mesh-list
92341554|NCT00003035|Doxorubicin|doxorubicin|mesh-list
92341555|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92341556|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341557|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341558|NCT00003035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341559|NCT00003035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341560|NCT00003035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341561|NCT00003035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341562|NCT00003035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341563|NCT00003035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341564|NCT00003035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341565|NCT00003035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341566|NCT00003035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341567|NCT00003035|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92341568|NCT00003035|Hormone Antagonists|hormone antagonists|mesh-ancestor
92341569|NCT00003035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994080|NCT05898087|Anesthetics|anesthetics|mesh-ancestor
92341570|NCT00003035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402852|NCT01424891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92341571|NCT00003035|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92341572|NCT00003035|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92341573|NCT00003035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92341574|NCT00003041|NSC 366140|nsc 366140|mesh-list
92341575|NCT00003041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341576|NCT00003053|Etoposide|etoposide|mesh-list
92341577|NCT00003053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341578|NCT00003053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341579|NCT00003053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341580|NCT00003053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341581|NCT00003053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341582|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341583|NCT00003065|Paclitaxel|paclitaxel|mesh-list
92341584|NCT00003065|Topotecan|topotecan|mesh-list
92341585|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341586|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341587|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341588|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341589|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341590|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341591|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92341592|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341593|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341594|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
92341595|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
92341596|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92341597|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92341598|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341599|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341600|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341601|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341603|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92341604|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92341605|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341606|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341607|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92341608|NCT00383357|GABA Agonists|gaba agonists|mesh-ancestor
92341609|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
92341610|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341611|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341613|NCT00003089|Carboplatin|carboplatin|mesh-list
92341614|NCT00003089|Amifostine|amifostine|mesh-list
92341615|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341616|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341617|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341618|NCT00003089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341619|NCT00003089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341620|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341622|NCT00003089|Protective Agents|protective agents|mesh-ancestor
92341623|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341624|NCT03713801|Metformin|metformin|mesh-list
92341625|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92341626|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341627|NCT00003101|Vincristine|vincristine|mesh-list
92341628|NCT00003101|Busulfan|busulfan|mesh-list
92341629|NCT00003101|Thiotepa|thiotepa|mesh-list
92341630|NCT00003101|Lomustine|lomustine|mesh-list
92341631|NCT00003101|Procarbazine|procarbazine|mesh-list
92341632|NCT00003101|Immunologic Factors|immunologic factors|mesh-ancestor
92341633|NCT00003101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341635|NCT00003101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341636|NCT00003101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341637|NCT00003101|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341638|NCT00003101|Mitosis Modulators|mitosis modulators|mesh-ancestor
92403228|NCT04850378|Dalteparin|dalteparin|mesh-list
92341639|NCT00003101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341640|NCT00003101|Alkylating Agents|alkylating agents|mesh-ancestor
92341641|NCT00003101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341642|NCT00003101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341643|NCT00003101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341644|NCT00003107|Interleukin-12|interleukin-12|mesh-list
92341645|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341646|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
92341647|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341648|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92341649|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92341650|NCT00003107|Growth Substances|growth substances|mesh-ancestor
92341651|NCT00003107|Growth Inhibitors|growth inhibitors|mesh-ancestor
92341652|NCT00003107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341653|NCT00003113|Cyclophosphamide|cyclophosphamide|mesh-list
92341654|NCT00003113|Lomustine|lomustine|mesh-list
92341655|NCT00003113|Etoposide|etoposide|mesh-list
92341656|NCT00003113|Procarbazine|procarbazine|mesh-list
92341657|NCT00003113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341658|NCT00003113|Immunologic Factors|immunologic factors|mesh-ancestor
92341659|NCT00003113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341660|NCT00003113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341661|NCT00003113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341663|NCT00003113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341664|NCT00003113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341665|NCT00003113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341666|NCT00003113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341668|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341669|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341670|NCT01545557|Lidocaine|lidocaine|mesh-list
92341671|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
92341672|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
92341673|NCT01545557|Anesthetics|anesthetics|mesh-ancestor
92341674|NCT01545557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341675|NCT01545557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341676|NCT01545557|Sensory System Agents|sensory system agents|mesh-ancestor
92341677|NCT01545557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341678|NCT01545557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92341679|NCT01545557|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92341680|NCT01545557|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92341681|NCT01545557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92341682|NCT01545557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341683|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341684|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
92341686|NCT01545557|Protective Agents|protective agents|mesh-ancestor
92341687|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
92341688|NCT00003119|Carboplatin|carboplatin|mesh-list
92341689|NCT00003119|Doxorubicin|doxorubicin|mesh-list
92341690|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92341691|NCT00003119|Etoposide|etoposide|mesh-list
92341692|NCT00003119|Sargramostim|sargramostim|mesh-list
92341693|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341694|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
92341695|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341696|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341697|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341698|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
92341699|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341700|NCT00003119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341701|NCT00003119|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341702|NCT00003119|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341703|NCT00003119|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341704|NCT00003119|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341705|NCT00003119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341706|NCT00003119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341707|NCT00003395|Arsenic Trioxide|arsenic trioxide|mesh-list
92341708|NCT00003395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341710|NCT00003401|Paclitaxel|paclitaxel|mesh-list
92341711|NCT00003401|Etoposide|etoposide|mesh-list
92341712|NCT00003401|Cyclophosphamide|cyclophosphamide|mesh-list
92341713|NCT00003401|Gemcitabine|gemcitabine|mesh-list
92341714|NCT00003401|Melphalan|melphalan|mesh-list
92341715|NCT00003401|Carmustine|carmustine|mesh-list
92341716|NCT00003401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341717|NCT00003401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341718|NCT00003401|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341719|NCT00003401|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341720|NCT00003401|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341721|NCT00003401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341722|NCT00003401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341723|NCT00003401|Immunologic Factors|immunologic factors|mesh-ancestor
92341724|NCT00003401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403897|NCT01427686|Dobutamine|dobutamine|mesh-list
92341725|NCT00003401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341726|NCT00003401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341727|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
92341728|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341729|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341731|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
92341732|NCT00003401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341733|NCT00003401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92341734|NCT00003401|Glucocorticoids|glucocorticoids|mesh-ancestor
92341735|NCT00003401|Hormones|hormones|mesh-ancestor
92341736|NCT00003401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341737|NCT00003401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92341738|NCT00003401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341739|NCT00003401|Antimetabolites|antimetabolites|mesh-ancestor
92341740|NCT00003401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341741|NCT00003401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341742|NCT00003401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341743|NCT00003125|Aldesleukin|aldesleukin|mesh-list
92341745|NCT00003125|Sargramostim|sargramostim|mesh-list
92341746|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
92404026|NCT01428427|Gemcitabine|gemcitabine|mesh-list
92341747|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341748|NCT00003125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341749|NCT00003125|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92341750|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92341751|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
92341752|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341754|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92341755|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341756|NCT00003131|Immunotoxins|immunotoxins|mesh-ancestor
92341757|NCT00003131|Immunoconjugates|immunoconjugates|mesh-ancestor
92341758|NCT00003131|Immunologic Factors|immunologic factors|mesh-ancestor
92341759|NCT00003131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341760|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
92341761|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92341762|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92341763|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92341764|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92341765|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341766|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
92341767|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341769|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92341770|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341771|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
92341772|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92341773|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341774|NCT00003413|Paclitaxel|paclitaxel|mesh-list
92341775|NCT00003413|Melphalan|melphalan|mesh-list
92341776|NCT00003413|Carmustine|carmustine|mesh-list
92341777|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341778|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341779|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341780|NCT00003413|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341781|NCT00003413|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341782|NCT00003413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341783|NCT00003413|Immunologic Factors|immunologic factors|mesh-ancestor
92341784|NCT00003413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341785|NCT00003413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341786|NCT00003413|Alkylating Agents|alkylating agents|mesh-ancestor
92341787|NCT00003413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341788|NCT00003413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341789|NCT00003137|Irinotecan|irinotecan|mesh-list
92341790|NCT00003137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92341791|NCT00003137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341792|NCT00003137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341793|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341794|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341795|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
92341796|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341797|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
92341799|NCT00003425|Amifostine|amifostine|mesh-list
92341800|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341801|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
92341802|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341803|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341804|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341805|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
92341806|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341807|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341808|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341809|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92341810|NCT00003425|Protective Agents|protective agents|mesh-ancestor
92341812|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92341813|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
92404412|NCT01431053|Antipyretics|antipyretics|mesh-ancestor
92341814|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92341815|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341816|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341818|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92341819|NCT00330551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92341820|NCT00330551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92341821|NCT00330551|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92341822|NCT00330551|Dopamine Agents|dopamine agents|mesh-ancestor
92341823|NCT00001259|Leuprolide|leuprolide|mesh-list
92341824|NCT00001259|Estradiol|estradiol|mesh-list
92341825|NCT00001259|Progesterone|progesterone|mesh-list
92341826|NCT00001259|Estrogens|estrogens|mesh-ancestor
92341827|NCT00001259|Hormones|hormones|mesh-ancestor
92341828|NCT00001259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341829|NCT00001259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341830|NCT00001259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404567|NCT01431404|Etanercept|etanercept|mesh-list
92341831|NCT00001259|Progestins|progestins|mesh-ancestor
92341832|NCT00001259|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92341833|NCT00001259|Fertility Agents|fertility agents|mesh-ancestor
92404618|NCT01431612|Phenylephrine|phenylephrine|mesh-list
92341834|NCT00001259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92341835|NCT00001259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341837|NCT00003143|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92341838|NCT00003143|Protective Agents|protective agents|mesh-ancestor
92341839|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341840|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
92341841|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341842|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
92341843|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341845|NCT00003431|Protective Agents|protective agents|mesh-ancestor
92341846|NCT00003149|Interleukin-12|interleukin-12|mesh-list
92341847|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341848|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
92341850|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92341851|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92341852|NCT00003149|Growth Substances|growth substances|mesh-ancestor
92341853|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
92341854|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341855|NCT00003437|Cytarabine|cytarabine|mesh-list
92341856|NCT00003437|Dexamethasone|dexamethasone|mesh-list
92341857|NCT00003437|Prednisolone|prednisolone|mesh-list
92341858|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
92341859|NCT00003437|Doxorubicin|doxorubicin|mesh-list
92341860|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92341861|NCT00003437|Methotrexate|methotrexate|mesh-list
92341862|NCT00003437|Vincristine|vincristine|mesh-list
92341863|NCT00003437|Daunorubicin|daunorubicin|mesh-list
92341864|NCT00003437|Asparaginase|asparaginase|mesh-list
92341865|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
92341866|NCT00003437|Pegaspargase|pegaspargase|mesh-list
92341867|NCT00003437|Thioguanine|thioguanine|mesh-list
92341868|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341869|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
92341870|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341871|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404899|NCT01433614|Antimetabolites|antimetabolites|mesh-ancestor
92341872|NCT00003437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341873|NCT00003437|Alkylating Agents|alkylating agents|mesh-ancestor
92341874|NCT00003437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341875|NCT00003437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341876|NCT00003437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341877|NCT00003437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341878|NCT00003437|Antiemetics|antiemetics|mesh-ancestor
92341879|NCT00003437|Autonomic Agents|autonomic agents|mesh-ancestor
92341880|NCT00003437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341881|NCT00003437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92341882|NCT00003437|Glucocorticoids|glucocorticoids|mesh-ancestor
92341884|NCT00003437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341885|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92341886|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92341887|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341888|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341890|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92341891|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
92341892|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92341893|NCT00003437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341895|NCT00003437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92341896|NCT00003437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92341897|NCT00003437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92341898|NCT00003437|Antiviral Agents|antiviral agents|mesh-ancestor
92405095|NCT01434303|Trastuzumab|trastuzumab|mesh-list
92341899|NCT00003437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92341900|NCT00003437|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341901|NCT00003437|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341902|NCT00003437|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341903|NCT00003437|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341904|NCT00003443|Bryostatin 1|bryostatin 1|mesh-list
92341905|NCT00003443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92341906|NCT00003443|Immunologic Factors|immunologic factors|mesh-ancestor
92341907|NCT00003443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341908|NCT00003443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341909|NCT00003449|Dexamethasone|dexamethasone|mesh-list
92341910|NCT00003449|Paclitaxel|paclitaxel|mesh-list
92341911|NCT00003449|Gemcitabine|gemcitabine|mesh-list
92341912|NCT00003449|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341913|NCT00003449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341915|NCT00003449|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341916|NCT00003449|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341917|NCT00003449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341918|NCT00003449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92341919|NCT00003449|Antiemetics|antiemetics|mesh-ancestor
92341920|NCT00003449|Autonomic Agents|autonomic agents|mesh-ancestor
92341921|NCT00003449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341922|NCT00003449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341923|NCT00003449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92341924|NCT00003449|Glucocorticoids|glucocorticoids|mesh-ancestor
92341926|NCT00003449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92341927|NCT00003449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92341928|NCT00003449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341929|NCT00003449|Antimetabolites|antimetabolites|mesh-ancestor
92341930|NCT00002801|Leucovorin|leucovorin|mesh-list
92341931|NCT00002801|Tegafur|tegafur|mesh-list
92341932|NCT00002801|Calcium|calcium|mesh-list
92341933|NCT00002801|Levoleucovorin|levoleucovorin|mesh-list
92099580|NCT00632229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92341934|NCT00002801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92341935|NCT00002801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341936|NCT00002801|Antidotes|antidotes|mesh-ancestor
92341937|NCT00002801|Protective Agents|protective agents|mesh-ancestor
92341938|NCT00002801|Vitamin B Complex|vitamin b complex|mesh-ancestor
92341939|NCT00002801|Vitamins|vitamins|mesh-ancestor
92341940|NCT00002801|Micronutrients|micronutrients|mesh-ancestor
92341941|NCT00002801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92341942|NCT00002801|Antimetabolites|antimetabolites|mesh-ancestor
92341943|NCT00002801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341944|NCT00002801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341946|NCT00002813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341947|NCT00002813|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341949|NCT00002813|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341950|NCT00002813|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341951|NCT00002813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341952|NCT00002819|Paclitaxel|paclitaxel|mesh-list
92341953|NCT00002819|Cyclophosphamide|cyclophosphamide|mesh-list
92341954|NCT00002819|Carboplatin|carboplatin|mesh-list
92341955|NCT00002819|Mitoxantrone|mitoxantrone|mesh-list
92341956|NCT00002819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92341957|NCT00002819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341958|NCT00002819|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341959|NCT00002819|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341960|NCT00002819|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341961|NCT00002819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341962|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341963|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
92341964|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341965|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341966|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92341967|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
92341968|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92341969|NCT00002819|Analgesics|analgesics|mesh-ancestor
92341970|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
92341971|NCT00002819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92341972|NCT00002819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92341973|NCT00002819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92341974|NCT00002819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92341976|NCT00002825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92341977|NCT00002825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92341978|NCT00002825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92341979|NCT00002825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92341980|NCT00002825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92341981|NCT00002831|Cyclosporine|cyclosporine|mesh-list
92341982|NCT00002831|Methylprednisolone|methylprednisolone|mesh-list
92341983|NCT00002831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92341984|NCT00002831|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92341986|NCT00002831|Prednisolone acetate|prednisolone acetate|mesh-list
92341987|NCT00002831|Cyclophosphamide|cyclophosphamide|mesh-list
92341988|NCT00002831|Busulfan|busulfan|mesh-list
92341989|NCT00002831|Methotrexate|methotrexate|mesh-list
92341990|NCT00002831|Decitabine|decitabine|mesh-list
92341992|NCT00002831|Cyclosporins|cyclosporins|mesh-list
92341993|NCT00002831|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92341994|NCT00002831|Prednisolone phosphate|prednisolone phosphate|mesh-list
92341995|NCT00002831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92341996|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
92341997|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92341998|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92341999|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342001|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342002|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342003|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342004|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92342005|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
92342006|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342007|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342008|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
92342009|NCT00002831|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342010|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342011|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342012|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92342013|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92342014|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
92342015|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342016|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342018|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
92342019|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342020|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92342021|NCT00002831|Glucocorticoids|glucocorticoids|mesh-ancestor
92342022|NCT00002831|Hormones|hormones|mesh-ancestor
92342023|NCT00002831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342024|NCT00002831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92342025|NCT00002831|Protective Agents|protective agents|mesh-ancestor
92342026|NCT00002831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342027|NCT00002837|Paclitaxel|paclitaxel|mesh-list
92342028|NCT00002837|Cyclophosphamide|cyclophosphamide|mesh-list
92342029|NCT00002837|Doxorubicin|doxorubicin|mesh-list
92342030|NCT00002837|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342031|NCT00002837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342032|NCT00002837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342033|NCT00002837|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342034|NCT00002837|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342035|NCT00002837|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342036|NCT00002837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342037|NCT00002837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342038|NCT00002837|Immunologic Factors|immunologic factors|mesh-ancestor
92342039|NCT00002837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342040|NCT00002837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342041|NCT00002837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342042|NCT00002837|Alkylating Agents|alkylating agents|mesh-ancestor
92342043|NCT00002837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342044|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342045|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342046|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342047|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342048|NCT00003461|Antibodies|antibodies|mesh-list
92342049|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92342050|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
92342051|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342052|NCT00003467|Carmustine|carmustine|mesh-list
92342053|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342054|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
92342055|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342056|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342057|NCT00002849|Interferons|interferons|mesh-list
92342058|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
92342059|NCT00002849|Dexamethasone|dexamethasone|mesh-list
92342060|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342061|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
92342062|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
92342063|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342064|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342065|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92342066|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
92342067|NCT00002849|Hormones|hormones|mesh-ancestor
92342068|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342069|NCT00002849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342070|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342071|NCT00002849|Antiviral Agents|antiviral agents|mesh-ancestor
92342072|NCT00002849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342073|NCT00002849|Immunologic Factors|immunologic factors|mesh-ancestor
92342074|NCT00002855|Ketoconazole|ketoconazole|mesh-list
92342075|NCT00002855|Hydrocortisone|hydrocortisone|mesh-list
92342076|NCT00002855|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92342077|NCT00002855|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92342078|NCT00002855|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92342079|NCT00002855|Doxorubicin|doxorubicin|mesh-list
92342080|NCT00002855|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342081|NCT00002855|Bicalutamide|bicalutamide|mesh-list
92342082|NCT00002855|Vinblastine|vinblastine|mesh-list
92342083|NCT00002855|Flutamide|flutamide|mesh-list
92342084|NCT00002855|Estramustine|estramustine|mesh-list
92342085|NCT00002855|Nilutamide|nilutamide|mesh-list
92342086|NCT00002855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342087|NCT00002855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342088|NCT00002855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342089|NCT00002855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342090|NCT00002855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342091|NCT00002855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342092|NCT00002855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342093|NCT00002855|Antifungal Agents|antifungal agents|mesh-ancestor
92342094|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342095|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92342096|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92342097|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92342098|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
92342099|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342100|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100177|NCT02977494|Hormones|hormones|mesh-ancestor
92342101|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92342102|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
92342103|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342104|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342105|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342106|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342107|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342108|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342109|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
92342111|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
92342112|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342113|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342114|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
92342115|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342116|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342117|NCT00003173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342118|NCT00003173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342119|NCT00003179|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92342120|NCT00003179|Medroxyprogesterone|medroxyprogesterone|mesh-list
92342121|NCT00003179|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92342122|NCT00003179|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92342123|NCT00003179|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92342124|NCT00003179|Contraceptive Agents|contraceptive agents|mesh-ancestor
92342125|NCT00003179|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342126|NCT00003179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342127|NCT00003179|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92342128|NCT00003179|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92342129|NCT00003179|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92342130|NCT00003179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342131|NCT00003179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342132|NCT00002879|Cladribine|cladribine|mesh-list
92342133|NCT00002879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342134|NCT00002879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342135|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
92342136|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342137|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
92342138|NCT00003185|Sargramostim|sargramostim|mesh-list
91937105|NCT02268149|Prednisone|prednisone|mesh-list
92342139|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342140|NCT00003185|Immunologic Factors|immunologic factors|mesh-ancestor
92342141|NCT00003185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342142|NCT00003185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342143|NCT00003185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342144|NCT00003185|Alkylating Agents|alkylating agents|mesh-ancestor
92342145|NCT00003185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342146|NCT00003185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342147|NCT00003185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342148|NCT00003557|Dolastatin 10|dolastatin 10|mesh-list
92342149|NCT00003557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342150|NCT00003557|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342151|NCT00003557|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342152|NCT00003557|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342153|NCT00003557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342154|NCT00003935|Etoposide|etoposide|mesh-list
92342155|NCT00003935|Vincristine|vincristine|mesh-list
92342156|NCT00003935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342157|NCT00003935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342158|NCT00003935|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342159|NCT00003935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342160|NCT00003935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100233|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342161|NCT00003935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342162|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342163|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342164|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342165|NCT00003191|Fenretinide|fenretinide|mesh-list
92342166|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342167|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92342168|NCT00003191|Protective Agents|protective agents|mesh-ancestor
92342169|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342170|NCT00003941|Etoposide|etoposide|mesh-list
92342171|NCT00003941|Ifosfamide|ifosfamide|mesh-list
92342172|NCT00003941|Bleomycin|bleomycin|mesh-list
92342173|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342174|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342175|NCT00003941|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342176|NCT00003941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342178|NCT00003941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994690|NCT04281108|Fluticasone|fluticasone|mesh-list
92342179|NCT00003941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342180|NCT00003941|Alkylating Agents|alkylating agents|mesh-ancestor
92342182|NCT00384527|Vancomycin|vancomycin|mesh-list
92342183|NCT00384527|Nitazoxanide|nitazoxanide|mesh-list
92342184|NCT00384527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92342185|NCT00384527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342186|NCT00384527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92342187|NCT00003569|Paclitaxel|paclitaxel|mesh-list
92342188|NCT00003569|Cisplatin|cisplatin|mesh-list
92342189|NCT00003569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342190|NCT00003569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342192|NCT00003569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342193|NCT00003569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342194|NCT00003569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342195|NCT00003953|Tamoxifen|tamoxifen|mesh-list
92342196|NCT00003953|Cyclophosphamide|cyclophosphamide|mesh-list
92342197|NCT00003953|Docetaxel|docetaxel|mesh-list
92342198|NCT00003953|Doxorubicin|doxorubicin|mesh-list
92342199|NCT00003953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342200|NCT00003953|Fluorouracil|fluorouracil|mesh-list
92342201|NCT00003953|Methotrexate|methotrexate|mesh-list
92342202|NCT00003953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342203|NCT00003953|Immunologic Factors|immunologic factors|mesh-ancestor
92342204|NCT00003953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342205|NCT00003953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342206|NCT00003953|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342207|NCT00003953|Alkylating Agents|alkylating agents|mesh-ancestor
92342208|NCT00003953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342209|NCT00003953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342211|NCT00003953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342212|NCT00003953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342213|NCT00003953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342214|NCT00003953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342215|NCT00003953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342216|NCT00003953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342217|NCT00003953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342218|NCT00003953|Antimetabolites|antimetabolites|mesh-ancestor
92342219|NCT00003953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342220|NCT00003953|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92342222|NCT00003953|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342224|NCT00003953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342225|NCT00003953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92342226|NCT00003953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92342227|NCT00003953|Hormone Antagonists|hormone antagonists|mesh-ancestor
92342228|NCT00003953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342229|NCT00003953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342230|NCT00003953|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92342231|NCT00003953|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92342232|NCT00003953|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92342234|NCT00003959|Immunologic Factors|immunologic factors|mesh-ancestor
92342235|NCT00003959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342237|NCT02972723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92342238|NCT02972723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342239|NCT00003203|Cyclophosphamide|cyclophosphamide|mesh-list
92342240|NCT00003203|Cisplatin|cisplatin|mesh-list
92342241|NCT00003203|Carboplatin|carboplatin|mesh-list
92342242|NCT00003203|Vincristine|vincristine|mesh-list
92342243|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342244|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
92342245|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342246|NCT00003203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342247|NCT00003203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342248|NCT00003203|Alkylating Agents|alkylating agents|mesh-ancestor
92342249|NCT00003203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342250|NCT00003203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342251|NCT00003203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342252|NCT00003203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342253|NCT00003203|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342254|NCT00003203|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342255|NCT00003203|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342256|NCT00003575|Etoposide|etoposide|mesh-list
92342257|NCT00003575|Ifosfamide|ifosfamide|mesh-list
92342258|NCT00003575|Interleukin-12|interleukin-12|mesh-list
92342259|NCT00003575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342260|NCT00003575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342261|NCT00003575|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342262|NCT00003575|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342263|NCT00003575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342264|NCT00003575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342266|NCT00003575|Immunologic Factors|immunologic factors|mesh-ancestor
92342267|NCT00003575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342268|NCT00003575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342269|NCT00003575|Alkylating Agents|alkylating agents|mesh-ancestor
92342270|NCT00003575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92342271|NCT00003575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92342272|NCT00003575|Growth Substances|growth substances|mesh-ancestor
92342273|NCT00003575|Growth Inhibitors|growth inhibitors|mesh-ancestor
92342274|NCT00003539|Paclitaxel|paclitaxel|mesh-list
92342275|NCT00003539|Trastuzumab|trastuzumab|mesh-list
92342276|NCT00003539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342277|NCT00003539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342278|NCT00003539|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342279|NCT00003539|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342280|NCT00003539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342281|NCT00003539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342282|NCT00003539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92342284|NCT00003209|Methotrexate|methotrexate|mesh-list
92342285|NCT00003209|Ifosfamide|ifosfamide|mesh-list
92342286|NCT00003209|Mitomycins|mitomycins|mesh-list
92342288|NCT00003209|Bleomycin|bleomycin|mesh-list
92342289|NCT00003209|Vinblastine|vinblastine|mesh-list
92342290|NCT00003209|Vindesine|vindesine|mesh-list
92342291|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342292|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
92342293|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342294|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342295|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342296|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
92342297|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342298|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92342299|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
92342300|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342301|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342302|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342303|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342304|NCT00003209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342305|NCT00003209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92342306|NCT00003209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342307|NCT00003209|Alkylating Agents|alkylating agents|mesh-ancestor
92342308|NCT00003209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342309|NCT00003209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342310|NCT00003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342311|NCT00003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342312|NCT00003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342313|NCT00003587|Paclitaxel|paclitaxel|mesh-list
92342314|NCT00003587|Vinorelbine|vinorelbine|mesh-list
92342315|NCT00003587|Docetaxel|docetaxel|mesh-list
92342316|NCT00003587|Carboplatin|carboplatin|mesh-list
92342317|NCT00003587|Gemcitabine|gemcitabine|mesh-list
92342318|NCT00003587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342319|NCT00003587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342320|NCT00003587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342321|NCT00003587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342322|NCT00003587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342323|NCT00003587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342324|NCT00003587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342325|NCT00003587|Antimetabolites|antimetabolites|mesh-ancestor
92342326|NCT00003215|Leucovorin|leucovorin|mesh-list
92342327|NCT00003215|Cytarabine|cytarabine|mesh-list
92342328|NCT00003215|Prednisone|prednisone|mesh-list
92342329|NCT00003215|Methylprednisolone|methylprednisolone|mesh-list
92342330|NCT00003215|Hydrocortisone|hydrocortisone|mesh-list
92342331|NCT00003215|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92342332|NCT00003215|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92342334|NCT00003215|Cyclophosphamide|cyclophosphamide|mesh-list
92342336|NCT00003215|Doxorubicin|doxorubicin|mesh-list
92342337|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342338|NCT00003215|Methotrexate|methotrexate|mesh-list
92342339|NCT00003215|Etoposide|etoposide|mesh-list
92342340|NCT00003215|Vincristine|vincristine|mesh-list
92342341|NCT00003215|Mitoxantrone|mitoxantrone|mesh-list
92342342|NCT00003215|Levoleucovorin|levoleucovorin|mesh-list
92342343|NCT00003215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342344|NCT00003215|Immunologic Factors|immunologic factors|mesh-ancestor
92342345|NCT00003215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342346|NCT00003215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342347|NCT00003215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342349|NCT00003215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342350|NCT00003215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342351|NCT00003215|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342352|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342353|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342354|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342356|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342358|NCT00003215|Hormones|hormones|mesh-ancestor
92342359|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342360|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342361|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92342362|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
92342363|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342364|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342365|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
92342366|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342367|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342368|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92342369|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342371|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342372|NCT00003215|Antidotes|antidotes|mesh-ancestor
92342373|NCT00003215|Protective Agents|protective agents|mesh-ancestor
92342374|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
92342375|NCT00003215|Vitamins|vitamins|mesh-ancestor
92342376|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
92342377|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342378|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342379|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342380|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
92342381|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
92342382|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342383|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92342384|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92342386|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
92342387|NCT00003995|Trastuzumab|trastuzumab|mesh-list
92342389|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92342390|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342391|NCT00003995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342392|NCT00003995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342393|NCT00003995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342394|NCT00003995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342395|NCT00003593|Cytarabine|cytarabine|mesh-list
92342396|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
92342397|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92342398|NCT00003593|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92342399|NCT00003593|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92342400|NCT00003593|Methotrexate|methotrexate|mesh-list
92342401|NCT00003593|Thioguanine|thioguanine|mesh-list
92342402|NCT00003593|Daunorubicin|daunorubicin|mesh-list
92342403|NCT00003593|Asparaginase|asparaginase|mesh-list
92342404|NCT00003593|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92342405|NCT00003593|Abortifacient Agents|abortifacient agents|mesh-ancestor
92342406|NCT00003593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342407|NCT00003593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100316|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
92342408|NCT00003593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342409|NCT00003593|Antimetabolites|antimetabolites|mesh-ancestor
92342410|NCT00003593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342411|NCT00003593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342412|NCT00003593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342413|NCT00003593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342414|NCT00003593|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342415|NCT00003593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342417|NCT00003593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342418|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92342419|NCT00003593|Antiviral Agents|antiviral agents|mesh-ancestor
92342420|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342421|NCT00003593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342422|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342423|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342424|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342425|NCT00003599|Vitamin E|vitamin e|mesh-list
92342426|NCT00003599|Tocopherols|tocopherols|mesh-list
92342427|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
92342428|NCT00003599|Isotretinoin|isotretinoin|mesh-list
92342429|NCT00003599|Vitamins|vitamins|mesh-ancestor
92342430|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
92342431|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342433|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342434|NCT00003599|Protective Agents|protective agents|mesh-ancestor
92342435|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342436|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
92342437|NCT00003605|Rituximab|rituximab|mesh-list
92342438|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342439|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
92342440|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342441|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914820|NCT02426463|Analgesics|analgesics|mesh-ancestor
92342442|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342443|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
92342444|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342445|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342446|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342447|NCT00003605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92342448|NCT00003611|Acitretin|acitretin|mesh-list
92342449|NCT00003611|Keratolytic Agents|keratolytic agents|mesh-ancestor
92342450|NCT00003611|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342451|NCT00003617|Clarithromycin|clarithromycin|mesh-list
92342452|NCT00003617|Tinidazole|tinidazole|mesh-list
92342453|NCT00003617|Chlorambucil|chlorambucil|mesh-list
92342454|NCT00003617|Omeprazole|omeprazole|mesh-list
92342455|NCT00003617|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92342456|NCT00003617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92342457|NCT00003617|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92342458|NCT00003617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342459|NCT00003617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342460|NCT00003617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92342461|NCT00003617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342462|NCT00003617|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92342463|NCT00003617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92342464|NCT00003617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92342465|NCT00003617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342467|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342468|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92342469|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92342471|NCT00004001|Prednisone|prednisone|mesh-list
92342472|NCT00004001|Docetaxel|docetaxel|mesh-list
92342473|NCT00004001|Mitoxantrone|mitoxantrone|mesh-list
92342474|NCT00004001|Estramustine|estramustine|mesh-list
92342475|NCT00004001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342477|NCT00004001|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342478|NCT00004001|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342479|NCT00004001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342480|NCT00004001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342481|NCT00004001|Glucocorticoids|glucocorticoids|mesh-ancestor
92342482|NCT00004001|Hormones|hormones|mesh-ancestor
92342483|NCT00004001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342484|NCT00004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342485|NCT00004001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342486|NCT00004001|Analgesics|analgesics|mesh-ancestor
92342487|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
92342488|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342489|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342490|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342491|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342492|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342493|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
92342495|NCT00004013|Trastuzumab|trastuzumab|mesh-list
92342496|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342497|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342498|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342499|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342500|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342501|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342502|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92342503|NCT00004025|Aldesleukin|aldesleukin|mesh-list
92342504|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342505|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92342506|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92342507|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
92342508|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342509|NCT00004037|Docetaxel|docetaxel|mesh-list
92342510|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342511|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342512|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342513|NCT00004037|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342514|NCT00004037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342516|NCT00004043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92342517|NCT00004043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342518|NCT00004043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92342519|NCT00004043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92342520|NCT00004043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342521|NCT00004043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92342523|NCT00004043|Micronutrients|micronutrients|mesh-ancestor
92342524|NCT00004043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92342525|NCT00004055|Paclitaxel|paclitaxel|mesh-list
92342526|NCT00004055|Topotecan|topotecan|mesh-list
92342527|NCT00004055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342528|NCT00004055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342529|NCT00004055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342530|NCT00004055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342531|NCT00004055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342532|NCT00004055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342533|NCT00004055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342534|NCT00004055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342535|NCT00004055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342536|NCT00004061|Cyclophosphamide|cyclophosphamide|mesh-list
92342537|NCT00004061|Ifosfamide|ifosfamide|mesh-list
92342538|NCT00004061|Etoposide|etoposide|mesh-list
92342539|NCT00004061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342540|NCT00004061|Immunologic Factors|immunologic factors|mesh-ancestor
92342541|NCT00004061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342542|NCT00004061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342543|NCT00004061|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342545|NCT00004061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342546|NCT00004061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342547|NCT00004061|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342548|NCT00004061|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342549|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342550|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342551|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342552|NCT00004067|Paclitaxel|paclitaxel|mesh-list
92342553|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
92342554|NCT00004067|Doxorubicin|doxorubicin|mesh-list
92342555|NCT00004067|Trastuzumab|trastuzumab|mesh-list
92342556|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342557|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342558|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342560|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995061|NCT02953509|Rituximab|rituximab|mesh-list
92342561|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342562|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342563|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342564|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
92342565|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342566|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342567|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342568|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
92342569|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342570|NCT00004067|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342571|NCT00004067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342572|NCT00004067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342573|NCT00004067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342574|NCT00004067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92342575|NCT00004073|Suramin|suramin|mesh-list
92342576|NCT00004073|Antinematodal Agents|antinematodal agents|mesh-ancestor
92342577|NCT00004073|Anthelmintics|anthelmintics|mesh-ancestor
92342578|NCT00004073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92342579|NCT00004073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342580|NCT00004073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342581|NCT00004073|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92342582|NCT00004073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92342583|NCT00004085|Antibodies|antibodies|mesh-list
92342584|NCT00004085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92342585|NCT00004085|Immunologic Factors|immunologic factors|mesh-ancestor
92342586|NCT00004085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342587|NCT00004091|Antibodies|antibodies|mesh-list
92342589|NCT00004091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342591|NCT00004097|Gemcitabine|gemcitabine|mesh-list
92342592|NCT00004097|Fluorouracil|fluorouracil|mesh-list
92342593|NCT00004097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945279|NCT03529331|Acetaminophen|acetaminophen|mesh-list
92342594|NCT00004097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342596|NCT00004097|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342597|NCT00004097|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342598|NCT00004097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342599|NCT00004097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342600|NCT00004097|Antimetabolites|antimetabolites|mesh-ancestor
92342601|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342602|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
92342603|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342604|NCT00004103|Irinotecan|irinotecan|mesh-list
92342605|NCT00004103|Floxuridine|floxuridine|mesh-list
92342606|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342607|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342608|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342609|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342610|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342611|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342612|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
92342613|NCT00004109|Doxorubicin|doxorubicin|mesh-list
92342614|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342615|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342616|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342617|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342618|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342619|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342620|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342621|NCT00003239|Interferons|interferons|mesh-list
92342623|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
92342624|NCT00003239|Interferon alpha-2|interferon alpha-2|mesh-list
92342625|NCT00003239|Homoharringtonine|homoharringtonine|mesh-list
92342626|NCT00003239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342627|NCT00003239|Antiviral Agents|antiviral agents|mesh-ancestor
92342628|NCT00003239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342629|NCT00003239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342630|NCT00003239|Antimetabolites|antimetabolites|mesh-ancestor
92349524|NCT01490580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342631|NCT00003239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342632|NCT00003239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342633|NCT00003239|Immunologic Factors|immunologic factors|mesh-ancestor
92342634|NCT00003239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342635|NCT00003239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342636|NCT00003239|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92342637|NCT00003239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342639|NCT00004115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92342640|NCT00004115|Immunologic Factors|immunologic factors|mesh-ancestor
92342641|NCT00004115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342642|NCT00003245|Irinotecan|irinotecan|mesh-list
92342643|NCT00003245|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342644|NCT00003245|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342645|NCT00003245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342646|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342647|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342648|NCT00004127|Leucovorin|leucovorin|mesh-list
92342649|NCT00004127|Fluorouracil|fluorouracil|mesh-list
92342650|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
92342651|NCT00004127|Calcium|calcium|mesh-list
92342652|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
92342653|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92342654|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342655|NCT00004127|Antimetabolites|antimetabolites|mesh-ancestor
92342656|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342657|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342658|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342659|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342660|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
92342662|NCT00004127|Protective Agents|protective agents|mesh-ancestor
92342663|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
92342664|NCT00004127|Vitamins|vitamins|mesh-ancestor
92342665|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
92342666|NCT00003251|Paclitaxel|paclitaxel|mesh-list
92342668|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342669|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342670|NCT00003251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342672|NCT00003251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342673|NCT00003251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342674|NCT00003251|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92342675|NCT00003251|Protective Agents|protective agents|mesh-ancestor
92342676|NCT00003251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342677|NCT00004139|Gemcitabine|gemcitabine|mesh-list
92342679|NCT00004139|Irinotecan|irinotecan|mesh-list
92342680|NCT00004139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342681|NCT00004139|Antimetabolites|antimetabolites|mesh-ancestor
92117034|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342682|NCT00004139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342683|NCT00004139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342685|NCT00004139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342686|NCT00004139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342687|NCT00004139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342688|NCT00004139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342689|NCT00004139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342690|NCT00004145|Cyclophosphamide|cyclophosphamide|mesh-list
92342691|NCT00004145|Fludarabine|fludarabine|mesh-list
92342692|NCT00004145|Fludarabine phosphate|fludarabine phosphate|mesh-list
92342693|NCT00004145|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92342694|NCT00004145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342695|NCT00004145|Immunologic Factors|immunologic factors|mesh-ancestor
92342696|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342697|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342698|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342699|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
92342700|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342701|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342703|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342704|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
92342705|NCT00003263|Interferons|interferons|mesh-list
92342706|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
92342707|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342708|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
92342709|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342710|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
92342711|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342712|NCT00004157|Oprelvekin|oprelvekin|mesh-list
92342713|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342714|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
92342715|NCT00003269|Etoposide|etoposide|mesh-list
92342718|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342719|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
92342720|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342721|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342722|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342724|NCT00003269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342725|NCT00003269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342726|NCT00003269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342727|NCT00003269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342728|NCT00003269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342729|NCT00003269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342730|NCT00003269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342731|NCT00003269|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92342732|NCT00003269|Protective Agents|protective agents|mesh-ancestor
92342733|NCT00004163|Trastuzumab|trastuzumab|mesh-list
92342734|NCT00004163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92342735|NCT00004163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342736|NCT00003281|Paclitaxel|paclitaxel|mesh-list
92342737|NCT00003281|Topotecan|topotecan|mesh-list
92342738|NCT00003281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342739|NCT00003281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342740|NCT00003281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342741|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342742|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342743|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342744|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342745|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342747|NCT00003287|Leucovorin|leucovorin|mesh-list
92342748|NCT00003287|Fluorouracil|fluorouracil|mesh-list
92342749|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
92342750|NCT00003287|Calcium|calcium|mesh-list
92342751|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
92342752|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92342753|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342755|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342756|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342758|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342760|NCT00003287|Antidotes|antidotes|mesh-ancestor
92342761|NCT00003287|Protective Agents|protective agents|mesh-ancestor
92342762|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
92342763|NCT00003287|Vitamins|vitamins|mesh-ancestor
92342765|NCT00004187|Capecitabine|capecitabine|mesh-list
92342766|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
92342767|NCT00004187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342768|NCT00004187|Antimetabolites|antimetabolites|mesh-ancestor
92342769|NCT00004187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342770|NCT00004187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342772|NCT00384137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342773|NCT00384137|Immunologic Factors|immunologic factors|mesh-ancestor
92342774|NCT00384137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342775|NCT00384137|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92342776|NCT00384137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342777|NCT00384137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342778|NCT00384215|Insulin Glargine|insulin glargine|mesh-list
92100344|NCT03079011|Palbociclib|palbociclib|mesh-list
92342779|NCT00384215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92342780|NCT00384215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342782|NCT00003293|Leflunomide|leflunomide|mesh-list
92342783|NCT00003293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342784|NCT00003293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342785|NCT00003293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342786|NCT00003293|Immunologic Factors|immunologic factors|mesh-ancestor
92342787|NCT00003293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342788|NCT00003293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342789|NCT00004199|Gemcitabine|gemcitabine|mesh-list
92342790|NCT00004199|Prinomastat|prinomastat|mesh-list
92342791|NCT00004199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342792|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342794|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342795|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
92342796|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
92342797|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342798|NCT00003299|Paclitaxel|paclitaxel|mesh-list
92342799|NCT00003299|Etoposide|etoposide|mesh-list
92342800|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342801|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342802|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342803|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342804|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342805|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342806|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342807|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342808|NCT00003299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342809|NCT00004205|Tamoxifen|tamoxifen|mesh-list
92342811|NCT00004205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937113|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92342812|NCT00004205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342813|NCT00004205|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92342814|NCT00004205|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92342816|NCT00004205|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92342817|NCT00004205|Hormone Antagonists|hormone antagonists|mesh-ancestor
92342818|NCT00004205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342819|NCT00004205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342820|NCT00004205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342821|NCT00004205|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92342822|NCT00004205|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92342823|NCT00004205|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92342824|NCT00003305|Leucovorin|leucovorin|mesh-list
92342825|NCT00003305|Calcium|calcium|mesh-list
92342826|NCT00003305|Levoleucovorin|levoleucovorin|mesh-list
92342827|NCT00003305|Aminopterin|aminopterin|mesh-list
92342828|NCT00003305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92342829|NCT00003305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342830|NCT00003305|Antidotes|antidotes|mesh-ancestor
92342831|NCT00003305|Protective Agents|protective agents|mesh-ancestor
92342832|NCT00003305|Vitamin B Complex|vitamin b complex|mesh-ancestor
92342833|NCT00003305|Vitamins|vitamins|mesh-ancestor
92342834|NCT00003305|Micronutrients|micronutrients|mesh-ancestor
92342835|NCT00003305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342836|NCT00003305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342837|NCT00003305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342838|NCT00003311|Cytarabine|cytarabine|mesh-list
92342839|NCT00003311|Dexamethasone|dexamethasone|mesh-list
92342840|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
92342841|NCT00003311|Doxorubicin|doxorubicin|mesh-list
92342842|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92342843|NCT00003311|Methotrexate|methotrexate|mesh-list
92342844|NCT00003311|Vincristine|vincristine|mesh-list
92342845|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915126|NCT03036800|Incretins|incretins|mesh-ancestor
92342847|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342848|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342849|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342850|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
92342851|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342852|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342853|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342854|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342855|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
92342856|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
92342857|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342858|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92342859|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
92342860|NCT00003311|Hormones|hormones|mesh-ancestor
92342861|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342862|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342863|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342864|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342865|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342866|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342867|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92342869|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92342870|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342871|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
92342872|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342873|NCT00003311|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92342874|NCT00003311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92342875|NCT00003311|Antiviral Agents|antiviral agents|mesh-ancestor
92342876|NCT00003311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342878|NCT00003311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342879|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342880|NCT00003311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342882|NCT00003317|Carboplatin|carboplatin|mesh-list
92342883|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342884|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342885|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342886|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342888|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342889|NCT00004217|Cytarabine|cytarabine|mesh-list
92342890|NCT00004217|Daunorubicin|daunorubicin|mesh-list
92342891|NCT00004217|Sargramostim|sargramostim|mesh-list
92342892|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92342893|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
92342894|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342895|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342896|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
92342897|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342898|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342899|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
92342900|NCT00004217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342901|NCT00004217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92342902|NCT00004217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92342904|NCT00004217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342905|NCT00003323|Flutamide|flutamide|mesh-list
92342906|NCT00003323|Finasteride|finasteride|mesh-list
92342907|NCT00003323|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92342908|NCT00003323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92342909|NCT00003323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342910|NCT00003323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342911|NCT00003323|Hormone Antagonists|hormone antagonists|mesh-ancestor
92342912|NCT00003323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342913|NCT00003323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342914|NCT00003323|Urological Agents|urological agents|mesh-ancestor
92342915|NCT00003323|Androgen Antagonists|androgen antagonists|mesh-ancestor
92342916|NCT00003323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92342917|NCT00003323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342918|NCT00004229|Endostatins|endostatins|mesh-list
92342919|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342920|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92342921|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92342922|NCT00004229|Growth Substances|growth substances|mesh-ancestor
92342923|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342924|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
92342927|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342928|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342929|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342930|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342931|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342932|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92342933|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92342934|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342935|NCT00003335|Cyclosporine|cyclosporine|mesh-list
92342936|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
92342937|NCT00003335|Melphalan|melphalan|mesh-list
92342938|NCT00003335|Busulfan|busulfan|mesh-list
92342939|NCT00003335|Cyclosporins|cyclosporins|mesh-list
91995429|NCT01228331|Hormones|hormones|mesh-ancestor
92342940|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92342941|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342943|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92342944|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
92342945|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342946|NCT00003335|Antifungal Agents|antifungal agents|mesh-ancestor
92342947|NCT00003335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92342948|NCT00003335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92342949|NCT00003335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342950|NCT00003335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92342951|NCT00003335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342952|NCT00003335|Antiemetics|antiemetics|mesh-ancestor
92342953|NCT00003335|Autonomic Agents|autonomic agents|mesh-ancestor
92342954|NCT00003335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342955|NCT00003335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92342956|NCT00003335|Glucocorticoids|glucocorticoids|mesh-ancestor
92342957|NCT00003335|Hormones|hormones|mesh-ancestor
92342958|NCT00003335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92342959|NCT00003335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92342960|NCT00003335|Protective Agents|protective agents|mesh-ancestor
92342961|NCT00003335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342962|NCT00003335|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92342964|NCT00003335|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92342965|NCT00003341|Epoetin Alfa|epoetin alfa|mesh-list
92342966|NCT00003341|Hematinics|hematinics|mesh-ancestor
92342968|NCT00004253|Carboplatin|carboplatin|mesh-list
92342969|NCT00004253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342970|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342971|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342972|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342973|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
92342974|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342975|NCT00004265|Paclitaxel|paclitaxel|mesh-list
92342976|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92342978|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
92342979|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
92342981|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342982|NCT00003365|Curcumin|curcumin|mesh-list
92342983|NCT00003365|Sulindac|sulindac|mesh-list
92342984|NCT00003365|Quercetin|quercetin|mesh-list
92342985|NCT00003365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92342986|NCT00003365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92342987|NCT00003365|Analgesics|analgesics|mesh-ancestor
92342988|NCT00003365|Sensory System Agents|sensory system agents|mesh-ancestor
92342989|NCT00003365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92342990|NCT00003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92342991|NCT00003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92342992|NCT00003365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92342993|NCT00003365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92342994|NCT00003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92342995|NCT00003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92342996|NCT00003365|Antioxidants|antioxidants|mesh-ancestor
92342997|NCT00003365|Protective Agents|protective agents|mesh-ancestor
92342999|NCT00004829|Tobramycin|tobramycin|mesh-list
92343000|NCT00004829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92343001|NCT00004829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343002|NCT00004313|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92343003|NCT00004313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92343004|NCT00004313|Immunologic Factors|immunologic factors|mesh-ancestor
92343005|NCT00004313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343006|NCT00004853|Lenograstim|lenograstim|mesh-list
92343007|NCT00004853|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92343008|NCT00004853|Immunologic Factors|immunologic factors|mesh-ancestor
92343009|NCT00004853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343010|NCT00004865|Paclitaxel|paclitaxel|mesh-list
92343011|NCT00004865|Fluorouracil|fluorouracil|mesh-list
92343012|NCT00004865|Cetuximab|cetuximab|mesh-list
92343013|NCT00004865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343014|NCT00004865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343016|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995507|NCT00416351|Clofarabine|clofarabine|mesh-list
92343017|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343018|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343019|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
92343021|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343022|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
92343023|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343024|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343025|NCT00004361|Citric Acid|citric acid|mesh-list
92343026|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
92343028|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92343029|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343030|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
92343031|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92343033|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
92343034|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343035|NCT00004373|Alprazolam|alprazolam|mesh-list
92343036|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92343037|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343038|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343039|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92343040|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92343041|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92343042|NCT00004373|GABA Modulators|gaba modulators|mesh-ancestor
92343043|NCT00004373|GABA Agents|gaba agents|mesh-ancestor
92343044|NCT00004373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343045|NCT00004373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343046|NCT00004871|Azacitidine|azacitidine|mesh-list
92343047|NCT00004871|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92343048|NCT00004871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343049|NCT00004871|Antimetabolites|antimetabolites|mesh-ancestor
92343050|NCT00004871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343051|NCT00004871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343052|NCT00004871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343055|NCT00004397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343056|NCT00004883|Trastuzumab|trastuzumab|mesh-list
92343057|NCT00004883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343059|NCT00004403|Albendazole|albendazole|mesh-list
92343060|NCT00004403|Dexamethasone|dexamethasone|mesh-list
92343061|NCT00004403|Phenytoin|phenytoin|mesh-list
92343062|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343063|NCT00004403|Antiemetics|antiemetics|mesh-ancestor
92343064|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
92343065|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343066|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343067|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92343068|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
92343069|NCT00004403|Hormones|hormones|mesh-ancestor
92343070|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343071|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343072|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343073|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
92343074|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92343075|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343076|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
92343077|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92343078|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92343079|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343080|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100368|NCT01349920|Infliximab|infliximab|mesh-list
92343081|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343082|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343083|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
92343084|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92343085|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92343086|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343087|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92343088|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92343089|NCT00004889|Rituximab|rituximab|mesh-list
91915127|NCT03036800|Hormones|hormones|mesh-ancestor
92343090|NCT00004889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995585|NCT03748433|Insulin|insulin|mesh-list
92343091|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343093|NCT00004889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343094|NCT00004889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343095|NCT00385307|Amibegron|amibegron|mesh-list
92343096|NCT00385307|Amibegron hydrochloride|amibegron hydrochloride|mesh-list
92343097|NCT00385307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92343098|NCT00385307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92343100|NCT00385307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343101|NCT00385307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343102|NCT00385307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343103|NCT00385307|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92343104|NCT00004901|Fluorouracil|fluorouracil|mesh-list
92343105|NCT00004901|Hydroxyurea|hydroxyurea|mesh-list
92343106|NCT00004901|Eniluracil|eniluracil|mesh-list
92343108|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343109|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343111|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343112|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
92343113|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343114|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
92343115|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343116|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343118|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
92343119|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
92343120|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343121|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343122|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343123|NCT00004913|Leucovorin|leucovorin|mesh-list
92343124|NCT00004913|Docetaxel|docetaxel|mesh-list
92343125|NCT00004913|Fluorouracil|fluorouracil|mesh-list
92343126|NCT00004913|Calcium|calcium|mesh-list
92343127|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
92343128|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343129|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343130|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343131|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343132|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343133|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92343134|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343136|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343137|NCT00004913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343138|NCT00004913|Immunologic Factors|immunologic factors|mesh-ancestor
92343139|NCT00004913|Antidotes|antidotes|mesh-ancestor
92343140|NCT00004913|Protective Agents|protective agents|mesh-ancestor
92343141|NCT00004913|Vitamin B Complex|vitamin b complex|mesh-ancestor
92343142|NCT00004913|Vitamins|vitamins|mesh-ancestor
92343143|NCT00004913|Micronutrients|micronutrients|mesh-ancestor
92343144|NCT00004919|Irinotecan|irinotecan|mesh-list
92343145|NCT00004919|Amifostine|amifostine|mesh-list
92343146|NCT00004919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343147|NCT00004919|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92343148|NCT00004919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343149|NCT00004919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343150|NCT00004919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100374|NCT03128346|Aspirin|aspirin|mesh-list
92343151|NCT00004919|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92343152|NCT00004919|Protective Agents|protective agents|mesh-ancestor
92343153|NCT00004919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343154|NCT00004925|Doxorubicin|doxorubicin|mesh-list
92343155|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92343157|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92343158|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343159|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92343160|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343161|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343162|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343163|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343164|NCT00004931|Leucovorin|leucovorin|mesh-list
92343165|NCT00004931|Fluorouracil|fluorouracil|mesh-list
92343166|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
92343167|NCT00004931|Calcium|calcium|mesh-list
92343168|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
92343169|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92343170|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343172|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343173|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343174|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343175|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343176|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
92343177|NCT00004931|Antidotes|antidotes|mesh-ancestor
92343178|NCT00004931|Protective Agents|protective agents|mesh-ancestor
92343179|NCT00004931|Vitamin B Complex|vitamin b complex|mesh-ancestor
92343180|NCT00004931|Vitamins|vitamins|mesh-ancestor
92343181|NCT00004931|Micronutrients|micronutrients|mesh-ancestor
92343182|NCT00004979|Paclitaxel|paclitaxel|mesh-list
92343183|NCT00004979|Topotecan|topotecan|mesh-list
92343184|NCT00004979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343185|NCT00004979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343186|NCT00004979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343187|NCT00004979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343188|NCT00004979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343189|NCT00004979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343190|NCT00004979|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92343191|NCT00004979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343192|NCT00004979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343194|NCT00004985|Capravirine|capravirine|mesh-list
92343195|NCT00004985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92343196|NCT00004985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92343197|NCT00004985|Protease Inhibitors|protease inhibitors|mesh-ancestor
92343198|NCT00004985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343199|NCT00004985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343200|NCT00004985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92343201|NCT00004985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92343202|NCT00004985|Antiviral Agents|antiviral agents|mesh-ancestor
92343203|NCT00004985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343204|NCT00004985|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92343205|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343206|NCT00004997|Leucovorin|leucovorin|mesh-list
92343207|NCT00004997|Antidotes|antidotes|mesh-ancestor
92343208|NCT00004997|Protective Agents|protective agents|mesh-ancestor
92343209|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343210|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
92343211|NCT00004997|Vitamins|vitamins|mesh-ancestor
92343212|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
92343213|NCT00005009|Vaccines|vaccines|mesh-list
92343214|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
92343215|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343216|NCT00004583|Ritonavir|ritonavir|mesh-list
92343218|NCT00004583|Nelfinavir|nelfinavir|mesh-list
92343219|NCT00004583|Lamivudine|lamivudine|mesh-list
92343220|NCT00004583|Stavudine|stavudine|mesh-list
92343221|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92343222|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92343223|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92343225|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343226|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92343227|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92343228|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
92343229|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100381|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
92343231|NCT00004583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92343233|NCT00004583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343234|NCT00004583|Antimetabolites|antimetabolites|mesh-ancestor
92343235|NCT00005015|Fluoxetine|fluoxetine|mesh-list
92343236|NCT00005015|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92343237|NCT00005015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92343238|NCT00005015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343239|NCT00005015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343240|NCT00005015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343241|NCT00005015|Serotonin Agents|serotonin agents|mesh-ancestor
92343242|NCT00005015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343243|NCT00005015|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92343244|NCT00005015|Antidepressive Agents|antidepressive agents|mesh-ancestor
92343245|NCT00005015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92343246|NCT00005015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92343247|NCT00005015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92343248|NCT00005015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343249|NCT00004637|Vitamin E|vitamin e|mesh-list
92343250|NCT00004637|Vitamins|vitamins|mesh-ancestor
92343252|NCT00004637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343253|NCT00004637|Antioxidants|antioxidants|mesh-ancestor
92343254|NCT00004637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343256|NCT00005021|Paclitaxel|paclitaxel|mesh-list
92343257|NCT00005021|Carboplatin|carboplatin|mesh-list
92343258|NCT00005021|Topotecan|topotecan|mesh-list
92343259|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343260|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343261|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343262|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343263|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343264|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343265|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92343266|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343268|NCT00004643|Cytarabine|cytarabine|mesh-list
92343269|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343271|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343272|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343273|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
92343274|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100508|NCT01253902|Bimatoprost|bimatoprost|mesh-list
92343275|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343276|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
92343277|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343278|NCT00005033|Trastuzumab|trastuzumab|mesh-list
92343279|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343280|NCT00005033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343282|NCT00005039|Immunologic Factors|immunologic factors|mesh-ancestor
92343283|NCT00005039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343284|NCT00004685|Albuterol|albuterol|mesh-list
92343285|NCT00004685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92343286|NCT00004685|Autonomic Agents|autonomic agents|mesh-ancestor
92343287|NCT00004685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343288|NCT00004685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343289|NCT00004685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92343290|NCT00004685|Respiratory System Agents|respiratory system agents|mesh-ancestor
92343292|NCT00004685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92343293|NCT00004685|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92343294|NCT00004685|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92343295|NCT00004685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92343296|NCT00004685|Adrenergic Agents|adrenergic agents|mesh-ancestor
92343297|NCT00004685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349525|NCT01490580|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92343298|NCT00004685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343299|NCT00005045|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92343300|NCT00005045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343301|NCT00005045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92343302|NCT00005045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343303|NCT00005045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343304|NCT00005045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92343305|NCT00005045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343306|NCT00005051|Paclitaxel|paclitaxel|mesh-list
92343307|NCT00005051|Carboplatin|carboplatin|mesh-list
92343308|NCT00005051|Topotecan|topotecan|mesh-list
92343309|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343310|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343311|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343312|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343313|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343314|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343315|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92343316|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343317|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343318|NCT00004697|Choline|choline|mesh-list
92343319|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
92343320|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92343321|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
92343322|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343323|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92343324|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92343325|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
92343326|NCT00004727|Aspirin|aspirin|mesh-list
92343327|NCT00004727|Ticlopidine|ticlopidine|mesh-list
92343328|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92343329|NCT00004727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92343330|NCT00004727|Analgesics|analgesics|mesh-ancestor
92343331|NCT00004727|Sensory System Agents|sensory system agents|mesh-ancestor
92343332|NCT00004727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343333|NCT00004727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343334|NCT00004727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343335|NCT00004727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343336|NCT00004727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92100823|NCT00983853|Ribavirin|ribavirin|mesh-list
92343337|NCT00004727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92343338|NCT00004727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343339|NCT00004727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92343340|NCT00004727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92343341|NCT00004727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343342|NCT00004727|Antipyretics|antipyretics|mesh-ancestor
92343343|NCT00004727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92343344|NCT00004727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92343345|NCT00004727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92343346|NCT00004727|Purinergic Agents|purinergic agents|mesh-ancestor
92343347|NCT00004727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343348|NCT00004727|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92343349|NCT00004727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92343351|NCT00004733|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92343352|NCT00004733|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92343353|NCT00004733|Dopamine Agents|dopamine agents|mesh-ancestor
92343354|NCT00004733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349526|NCT01490580|Anesthetics, General|anesthetics, general|mesh-ancestor
92343355|NCT00004733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343356|NCT00004733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343357|NCT00004739|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92343358|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
92343359|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343360|NCT00005057|Ganciclovir|ganciclovir|mesh-list
92343361|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92343363|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343364|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343365|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343366|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343367|NCT00004757|Acyclovir|acyclovir|mesh-list
92343368|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
92343369|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343370|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
92343371|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343372|NCT00004763|Leuprolide|leuprolide|mesh-list
92343373|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92343374|NCT00004763|Norethindrone|norethindrone|mesh-list
92343375|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
92343376|NCT00004763|Norinyl|norinyl|mesh-list
92343377|NCT00004763|Estradiol|estradiol|mesh-list
92343378|NCT00004763|Estrogens|estrogens|mesh-ancestor
92343379|NCT00004763|Hormones|hormones|mesh-ancestor
92343380|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343381|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343382|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92343384|NCT00004763|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92343385|NCT00004763|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92343386|NCT00004763|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92343387|NCT00004763|Fertility Agents|fertility agents|mesh-ancestor
92343388|NCT00004763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343389|NCT00004763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343390|NCT00004763|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92343391|NCT00004763|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92343392|NCT00004763|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92343393|NCT00004763|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92343396|NCT00004787|Immunologic Factors|immunologic factors|mesh-ancestor
92343397|NCT00004787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343398|NCT00005081|Carmustine|carmustine|mesh-list
92343399|NCT00005081|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92343400|NCT00005081|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343401|NCT00005081|Alkylating Agents|alkylating agents|mesh-ancestor
92343402|NCT00005081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343403|NCT00005081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343404|NCT00005081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343405|NCT00005087|Paclitaxel|paclitaxel|mesh-list
92343406|NCT00005087|Cisplatin|cisplatin|mesh-list
92343407|NCT00005087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91915663|NCT02122055|GABA Modulators|gaba modulators|mesh-ancestor
92343408|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343409|NCT00005087|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343410|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343411|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343412|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343413|NCT00004799|Vaccines|vaccines|mesh-list
92343414|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
92343415|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343416|NCT00005093|Gemcitabine|gemcitabine|mesh-list
92343417|NCT00005093|Tacedinaline|tacedinaline|mesh-list
92343418|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343419|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
92343420|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343421|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343422|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92343423|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343424|NCT00004811|Itraconazole|itraconazole|mesh-list
92343425|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
92343426|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343427|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92343428|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92343430|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343431|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92343432|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
92343433|NCT00004811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343436|NCT00004817|Phenytoin|phenytoin|mesh-list
92343437|NCT00004817|Valproic Acid|valproic acid|mesh-list
92343438|NCT00004817|Anticonvulsants|anticonvulsants|mesh-ancestor
92343439|NCT00004817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343440|NCT00004817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343441|NCT00004817|GABA Agents|gaba agents|mesh-ancestor
92343442|NCT00004817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343443|NCT00004817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343444|NCT00004817|Antimanic Agents|antimanic agents|mesh-ancestor
92343445|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92343446|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101394|NCT01869725|Hormones|hormones|mesh-ancestor
92343447|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92343448|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92343449|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92343450|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343451|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92343452|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92343453|NCT00005117|Pravastatin|pravastatin|mesh-list
92343454|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92343455|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92343456|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
92343457|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343458|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92343459|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92343460|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343462|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92343463|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
92343464|NCT00385385|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92343465|NCT00385385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343466|NCT00385385|Leprostatic Agents|leprostatic agents|mesh-ancestor
92343467|NCT00385463|Montelukast|montelukast|mesh-list
92343468|NCT00385463|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92343469|NCT00385463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92343470|NCT00385463|Respiratory System Agents|respiratory system agents|mesh-ancestor
92343471|NCT00385463|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92343472|NCT00385463|Hormone Antagonists|hormone antagonists|mesh-ancestor
92101595|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
92343473|NCT00385463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343474|NCT00385463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343475|NCT00385463|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92343476|NCT00385463|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92343477|NCT00385463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343478|NCT00385463|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92343479|NCT00385463|Autonomic Agents|autonomic agents|mesh-ancestor
92343480|NCT00385463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343481|NCT00385463|Glucocorticoids|glucocorticoids|mesh-ancestor
92343482|NCT00385463|Hormones|hormones|mesh-ancestor
92343483|NCT00385463|Sympathomimetics|sympathomimetics|mesh-ancestor
92343484|NCT00423371|Hyaluronic Acid|hyaluronic acid|mesh-list
92343485|NCT00423371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92343486|NCT00423371|Immunologic Factors|immunologic factors|mesh-ancestor
92343487|NCT00423371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343488|NCT00423371|Viscosupplements|viscosupplements|mesh-ancestor
92343489|NCT00423371|Protective Agents|protective agents|mesh-ancestor
92343490|NCT00005579|Dolastatin 10|dolastatin 10|mesh-list
92343491|NCT00005579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343492|NCT00005579|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343493|NCT00005579|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343494|NCT00005579|Mitosis Modulators|mitosis modulators|mesh-ancestor
92349527|NCT01490580|Anesthetics|anesthetics|mesh-ancestor
92343495|NCT00005579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343497|NCT00005585|Cytarabine|cytarabine|mesh-list
92343498|NCT00005585|Dexamethasone|dexamethasone|mesh-list
92343499|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
92343500|NCT00005585|Methotrexate|methotrexate|mesh-list
92343501|NCT00005585|Vincristine|vincristine|mesh-list
92343502|NCT00005585|Daunorubicin|daunorubicin|mesh-list
92343503|NCT00005585|Asparaginase|asparaginase|mesh-list
92343504|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
92343505|NCT00005585|Pegaspargase|pegaspargase|mesh-list
92343506|NCT00005585|Thioguanine|thioguanine|mesh-list
92343507|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
92343508|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343509|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
92343510|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343511|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343512|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343513|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
92343514|NCT00005585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343515|NCT00005585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343516|NCT00005585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92343517|NCT00005585|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343518|NCT00005585|Antiemetics|antiemetics|mesh-ancestor
92343519|NCT00005585|Autonomic Agents|autonomic agents|mesh-ancestor
92343520|NCT00005585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343521|NCT00005585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92343522|NCT00005585|Glucocorticoids|glucocorticoids|mesh-ancestor
92343523|NCT00005585|Hormones|hormones|mesh-ancestor
92343524|NCT00005585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343525|NCT00005585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343526|NCT00005585|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92343527|NCT00005585|Abortifacient Agents|abortifacient agents|mesh-ancestor
92343528|NCT00005585|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92343529|NCT00005585|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343530|NCT00005585|Antimetabolites|antimetabolites|mesh-ancestor
92343531|NCT00005585|Dermatologic Agents|dermatologic agents|mesh-ancestor
92343532|NCT00005585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343533|NCT00005585|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92343534|NCT00005585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343535|NCT00005585|Antiviral Agents|antiviral agents|mesh-ancestor
92343536|NCT00005585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343538|NCT00005585|Protective Agents|protective agents|mesh-ancestor
92343539|NCT00005585|Vitamin B Complex|vitamin b complex|mesh-ancestor
92343540|NCT00005585|Vitamins|vitamins|mesh-ancestor
92343541|NCT00005585|Micronutrients|micronutrients|mesh-ancestor
92349528|NCT01490580|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92343542|NCT00005585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343543|NCT00005585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343544|NCT00005585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343545|NCT00005585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343546|NCT00005585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92343547|NCT00005585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92343548|NCT00005585|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343549|NCT00005591|Gemcitabine|gemcitabine|mesh-list
92343551|NCT00005591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343553|NCT00005591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343554|NCT00005591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343555|NCT00005591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343557|NCT01926444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92343558|NCT01926444|Parasympatholytics|parasympatholytics|mesh-ancestor
92343559|NCT01926444|Autonomic Agents|autonomic agents|mesh-ancestor
92343560|NCT01926444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343561|NCT01926444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343562|NCT00005597|Temozolomide|temozolomide|mesh-list
91915664|NCT02122055|GABA Agents|gaba agents|mesh-ancestor
92343563|NCT00005597|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343564|NCT00005597|Alkylating Agents|alkylating agents|mesh-ancestor
92343565|NCT00005597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343566|NCT00005597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343567|NCT04172844|Azacitidine|azacitidine|mesh-list
92343569|NCT04172844|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92343570|NCT04172844|Pevonedistat|pevonedistat|mesh-list
92343571|NCT04172844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343572|NCT04172844|Antimetabolites|antimetabolites|mesh-ancestor
92343573|NCT04172844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343574|NCT04172844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343575|NCT00005603|Cytarabine|cytarabine|mesh-list
92343576|NCT00005603|Dexamethasone|dexamethasone|mesh-list
92343577|NCT00005603|Prednisone|prednisone|mesh-list
92343578|NCT00005603|Cyclophosphamide|cyclophosphamide|mesh-list
92343579|NCT00005603|Doxorubicin|doxorubicin|mesh-list
92343580|NCT00005603|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92343581|NCT00005603|Methotrexate|methotrexate|mesh-list
92343582|NCT00005603|Vincristine|vincristine|mesh-list
92343583|NCT00005603|Daunorubicin|daunorubicin|mesh-list
92343584|NCT00005603|Asparaginase|asparaginase|mesh-list
92343585|NCT00005603|Mercaptopurine|mercaptopurine|mesh-list
92343586|NCT00005603|Thioguanine|thioguanine|mesh-list
92343587|NCT00005603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343588|NCT00005603|Immunologic Factors|immunologic factors|mesh-ancestor
92343589|NCT00005603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343590|NCT00005603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343591|NCT00005603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343592|NCT00005603|Alkylating Agents|alkylating agents|mesh-ancestor
92343593|NCT00005603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102178|NCT01423162|Vitamins|vitamins|mesh-ancestor
92343594|NCT00005603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343595|NCT00005603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92343596|NCT00005603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343598|NCT00005603|Autonomic Agents|autonomic agents|mesh-ancestor
92060346|NCT05892770|Zinc|zinc|mesh-list
92343599|NCT00005603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343600|NCT00005603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92343601|NCT00005603|Glucocorticoids|glucocorticoids|mesh-ancestor
92343602|NCT00005603|Hormones|hormones|mesh-ancestor
92343603|NCT00005603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343605|NCT00005603|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92343606|NCT00005603|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92343607|NCT00005603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92343608|NCT00005603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343609|NCT00005603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92343610|NCT00005603|Abortifacient Agents|abortifacient agents|mesh-ancestor
92343611|NCT00005603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92343612|NCT00005603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92343613|NCT00005603|Antimetabolites|antimetabolites|mesh-ancestor
92343614|NCT00005603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92343615|NCT00005603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92343616|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343618|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343619|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343620|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343621|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343622|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343624|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343625|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343626|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
92343627|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343628|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343629|NCT00005615|Interferons|interferons|mesh-list
92343630|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
92343631|NCT00005615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102570|NCT04982172|Infliximab|infliximab|mesh-list
92343632|NCT00005615|Antiviral Agents|antiviral agents|mesh-ancestor
92343633|NCT00005615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343634|NCT00005615|Immunologic Factors|immunologic factors|mesh-ancestor
92343635|NCT00005615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343636|NCT00005627|Carboplatin|carboplatin|mesh-list
92343637|NCT00005627|Docetaxel|docetaxel|mesh-list
92343638|NCT00005627|Estramustine|estramustine|mesh-list
92343639|NCT00005627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343640|NCT00005627|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343641|NCT00005627|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343643|NCT00005627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343645|NCT00005627|Alkylating Agents|alkylating agents|mesh-ancestor
92343646|NCT00005627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343647|NCT00005639|Azacitidine|azacitidine|mesh-list
92343648|NCT00005639|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92343650|NCT00005639|Antimetabolites|antimetabolites|mesh-ancestor
92343651|NCT00005639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343652|NCT00005639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343653|NCT00005639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343654|NCT00005663|Valacyclovir|valacyclovir|mesh-list
92343655|NCT00005663|Antiviral Agents|antiviral agents|mesh-ancestor
92343656|NCT00005663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343657|NCT00385853|Temozolomide|temozolomide|mesh-list
92343658|NCT00385853|Vatalanib|vatalanib|mesh-list
92343659|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343660|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
92343661|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343662|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343663|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92343664|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343665|NCT00005765|Nicotine|nicotine|mesh-list
92343666|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92343667|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
92343668|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343669|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343671|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92343672|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
92343673|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343674|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343676|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343677|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
92343678|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
92343679|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343681|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92343682|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
92343683|NCT00005777|Hormones|hormones|mesh-ancestor
92343684|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343685|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92343686|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343688|NCT00385931|Simvastatin|simvastatin|mesh-list
92343689|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92102756|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
92343690|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92343691|NCT00385931|Antimetabolites|antimetabolites|mesh-ancestor
92343692|NCT00385931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343693|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92343694|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92343695|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343696|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92343697|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92343698|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92343699|NCT00386399|Mitomycins|mitomycins|mesh-list
92343700|NCT00386399|Mitomycin|mitomycin|mesh-list
92343701|NCT00386399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92343702|NCT00386399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343703|NCT00386399|Alkylating Agents|alkylating agents|mesh-ancestor
92343704|NCT00386399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349529|NCT01490580|Narcotics|narcotics|mesh-ancestor
92343705|NCT00386399|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343706|NCT00386399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343707|NCT00005807|Epothilones|epothilones|mesh-list
92343708|NCT00005807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343709|NCT00005807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343710|NCT00005807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343711|NCT00005807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343712|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343713|NCT00005813|Antibodies|antibodies|mesh-list
92343715|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
92343716|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343717|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
92343718|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343719|NCT00003647|Dacarbazine|dacarbazine|mesh-list
92343720|NCT00003647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343721|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
92349530|NCT01490580|Analgesics|analgesics|mesh-ancestor
92343722|NCT00003647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343723|NCT00003647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343724|NCT05895526|Fluorides|fluorides|mesh-list
92343725|NCT05895526|Fluorides, Topical|fluorides, topical|mesh-list
92343726|NCT05895526|Cariostatic Agents|cariostatic agents|mesh-ancestor
92343727|NCT05895526|Protective Agents|protective agents|mesh-ancestor
92343728|NCT05895526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343729|NCT05895513|Pimavanserin|pimavanserin|mesh-list
92343730|NCT05895513|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92343731|NCT05895513|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92343733|NCT05895513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92343734|NCT05895513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343736|NCT05895513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92343737|NCT05895513|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92343738|NCT05895513|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92343739|NCT05895513|Serotonin Agents|serotonin agents|mesh-ancestor
92343740|NCT05895513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343741|NCT05895513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343743|NCT05895448|Velpatasvir|velpatasvir|mesh-list
92343744|NCT05895448|Antiviral Agents|antiviral agents|mesh-ancestor
92343745|NCT05895448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343746|NCT05895370|Interleukin-2|interleukin-2|mesh-list
92343747|NCT05895370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103066|NCT03391050|Dabrafenib|dabrafenib|mesh-list
92343748|NCT05895370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92343750|NCT05895370|Sensory System Agents|sensory system agents|mesh-ancestor
92343751|NCT05895370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343752|NCT05895370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343753|NCT05895305|Paclitaxel|paclitaxel|mesh-list
92343755|NCT05895305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343756|NCT05895305|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343757|NCT05895305|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343758|NCT05895305|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343759|NCT05895305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343761|NCT05895240|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92343762|NCT05895240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92343763|NCT05895240|Protease Inhibitors|protease inhibitors|mesh-ancestor
92343764|NCT05895240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343765|NCT05895240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343767|NCT05895136|Anticoagulants|anticoagulants|mesh-ancestor
92343768|NCT05895136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92343769|NCT05895136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92343770|NCT05895136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996252|NCT01957150|Dermatologic Agents|dermatologic agents|mesh-ancestor
92343773|NCT05895123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92343774|NCT05895123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92343775|NCT05895123|Antimetabolites|antimetabolites|mesh-ancestor
92343776|NCT05895123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343777|NCT05895123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92343778|NCT05895123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92343779|NCT05895123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343780|NCT05894954|Hormones|hormones|mesh-list
92343781|NCT05894954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92343782|NCT05894954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343783|NCT05894928|Cholestyramine Resin|cholestyramine resin|mesh-list
92343784|NCT05894928|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92343785|NCT05894928|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92343786|NCT05894928|Antimetabolites|antimetabolites|mesh-ancestor
92349531|NCT01490580|Sensory System Agents|sensory system agents|mesh-ancestor
92343787|NCT05894928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343788|NCT05894928|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92343789|NCT05894889|Paclitaxel|paclitaxel|mesh-list
92343790|NCT05894889|Carboplatin|carboplatin|mesh-list
92343793|NCT05894889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92343794|NCT05894889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343795|NCT05894889|Tubulin Modulators|tubulin modulators|mesh-ancestor
92343796|NCT05894889|Antimitotic Agents|antimitotic agents|mesh-ancestor
92343797|NCT05894889|Mitosis Modulators|mitosis modulators|mesh-ancestor
92343798|NCT05894889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343799|NCT05894889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343801|NCT05894889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343802|NCT05894889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92343803|NCT05894889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92343804|NCT05894824|Ramucirumab|ramucirumab|mesh-list
92343805|NCT05894824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343806|NCT05894486|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92343807|NCT05894486|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92343808|NCT05894486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343809|NCT05894447|Pembrolizumab|pembrolizumab|mesh-list
92343810|NCT05894447|Obinutuzumab|obinutuzumab|mesh-list
92343812|NCT05894447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343813|NCT05894447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343816|NCT05894447|Immunoconjugates|immunoconjugates|mesh-ancestor
92343817|NCT05894447|Immunologic Factors|immunologic factors|mesh-ancestor
92343818|NCT05894447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343820|NCT05894200|Cariostatic Agents|cariostatic agents|mesh-ancestor
92343821|NCT05894200|Protective Agents|protective agents|mesh-ancestor
92343822|NCT05894200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343823|NCT05894057|Midazolam|midazolam|mesh-list
92343825|NCT05894057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92343826|NCT05894057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343827|NCT05894057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343828|NCT05894057|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92343829|NCT05894057|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92343830|NCT05894057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92103581|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
92343831|NCT05894057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92343832|NCT05894057|Anesthetics, General|anesthetics, general|mesh-ancestor
92343833|NCT05894057|Anesthetics|anesthetics|mesh-ancestor
92343834|NCT05894057|GABA Modulators|gaba modulators|mesh-ancestor
92343835|NCT05894057|GABA Agents|gaba agents|mesh-ancestor
92343836|NCT05894057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343837|NCT05894057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343839|NCT05893888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343841|NCT05893810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92343842|NCT05893810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343843|NCT05893810|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92343844|NCT05893810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343845|NCT05893810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343847|NCT05893654|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92343848|NCT05893654|Alkylating Agents|alkylating agents|mesh-ancestor
92343849|NCT05893654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343850|NCT05893654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343851|NCT05893654|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92343852|NCT05893654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92343853|NCT05893654|Immunologic Factors|immunologic factors|mesh-ancestor
92343854|NCT05893654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343855|NCT05893511|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92343856|NCT05893511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343858|NCT05893472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343859|NCT05892913|Atropine|atropine|mesh-list
92343860|NCT05892913|Ephedrine|ephedrine|mesh-list
92343861|NCT05892913|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92343862|NCT05892913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92343864|NCT05892913|Autonomic Agents|autonomic agents|mesh-ancestor
92343865|NCT05892913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343866|NCT05892913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343867|NCT05892913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92343868|NCT05892913|Respiratory System Agents|respiratory system agents|mesh-ancestor
92343869|NCT05892913|Mydriatics|mydriatics|mesh-ancestor
92343870|NCT05892913|Parasympatholytics|parasympatholytics|mesh-ancestor
92343871|NCT05892913|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92343872|NCT05892913|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92343874|NCT05892913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92343875|NCT05892913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343876|NCT05892913|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92343877|NCT05892913|Sympathomimetics|sympathomimetics|mesh-ancestor
92343878|NCT05892913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92343879|NCT05892913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92343880|NCT05889741|Ropivacaine|ropivacaine|mesh-list
92343881|NCT05889741|Anesthetics, Local|anesthetics, local|mesh-ancestor
92343882|NCT05889741|Anesthetics|anesthetics|mesh-ancestor
92343883|NCT05889741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343884|NCT05889741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343885|NCT05889741|Sensory System Agents|sensory system agents|mesh-ancestor
92343886|NCT05889741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343888|NCT05887830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343889|NCT05887830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343890|NCT05887830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91915665|NCT02125409|Aspirin|aspirin|mesh-list
92343891|NCT05887830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343892|NCT05885230|Lidocaine|lidocaine|mesh-list
92343893|NCT05885230|Bupivacaine|bupivacaine|mesh-list
92343894|NCT05885230|Anesthetics, Local|anesthetics, local|mesh-ancestor
92343895|NCT05885230|Anesthetics|anesthetics|mesh-ancestor
92343896|NCT05885230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343897|NCT05885230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343898|NCT05885230|Sensory System Agents|sensory system agents|mesh-ancestor
92343899|NCT05885230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343900|NCT05885230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92343901|NCT05885230|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92343902|NCT05885230|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92343903|NCT05885230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343904|NCT05885230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343906|NCT05877027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92343907|NCT05877027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92343909|NCT05877027|Sensory System Agents|sensory system agents|mesh-ancestor
92343910|NCT05877027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343911|NCT05877027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343912|NCT05877027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343913|NCT05877027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343914|NCT05877027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92343915|NCT05877027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343916|NCT05877027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343917|NCT05861258|Minocycline|minocycline|mesh-list
92343918|NCT05861258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92343919|NCT05861258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92343920|NCT05807204|Acetylcysteine|acetylcysteine|mesh-list
91996402|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
92343922|NCT05807204|Antiviral Agents|antiviral agents|mesh-ancestor
92343923|NCT05807204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104106|NCT04942158|Eugenol|eugenol|mesh-list
92343925|NCT05807204|Respiratory System Agents|respiratory system agents|mesh-ancestor
92343928|NCT05807204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343929|NCT05807204|Protective Agents|protective agents|mesh-ancestor
92343930|NCT05807204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343931|NCT05807204|Antidotes|antidotes|mesh-ancestor
92343932|NCT05784571|Insulin|insulin|mesh-list
92343933|NCT05784571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104161|NCT03377400|Tremelimumab|tremelimumab|mesh-list
92343934|NCT05784571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343935|NCT05779943|Furosemide|furosemide|mesh-list
92343936|NCT05779943|Fluorides|fluorides|mesh-list
92343937|NCT05779943|Diuretics|diuretics|mesh-ancestor
92343938|NCT05779943|Natriuretic Agents|natriuretic agents|mesh-ancestor
92343939|NCT05779943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343940|NCT05779943|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92343941|NCT05779943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92343942|NCT05779943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343943|NCT05779943|Cariostatic Agents|cariostatic agents|mesh-ancestor
92104234|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
92343944|NCT05779943|Protective Agents|protective agents|mesh-ancestor
92343945|NCT05779007|Pirfenidone|pirfenidone|mesh-list
92343946|NCT05779007|Nintedanib|nintedanib|mesh-list
92343947|NCT05779007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343948|NCT05779007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92343949|NCT05779007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343950|NCT05779007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343952|NCT05779007|Sensory System Agents|sensory system agents|mesh-ancestor
92343953|NCT05779007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343954|NCT05779007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343955|NCT05779007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92343957|NCT05779007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343958|NCT05779007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92343959|NCT05775471|Pembrolizumab|pembrolizumab|mesh-list
92343960|NCT05775471|Immunoconjugates|immunoconjugates|mesh-list
92343961|NCT05775471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343962|NCT05775471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343963|NCT05775471|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92343964|NCT05775471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343965|NCT05775471|Immunologic Factors|immunologic factors|mesh-ancestor
92343966|NCT05775471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343967|NCT05767047|Apremilast|apremilast|mesh-list
91915738|NCT02122601|Protective Agents|protective agents|mesh-ancestor
92343968|NCT05767047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92343970|NCT05767047|Analgesics|analgesics|mesh-ancestor
92343971|NCT05767047|Sensory System Agents|sensory system agents|mesh-ancestor
92343972|NCT05767047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343973|NCT05767047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343974|NCT05767047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92343976|NCT05767047|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92343977|NCT05767047|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92343978|NCT05767047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92343979|NCT05767047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343980|NCT05756569|Pembrolizumab|pembrolizumab|mesh-list
92343981|NCT05756569|Immunoconjugates|immunoconjugates|mesh-list
92343982|NCT05756569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92343983|NCT05756569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92343984|NCT05756569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92343985|NCT05756569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92343987|NCT05756569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343989|NCT05727098|Bupivacaine|bupivacaine|mesh-list
92343991|NCT05727098|Anesthetics|anesthetics|mesh-list
92343992|NCT05727098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92343993|NCT05727098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92343994|NCT05727098|Sensory System Agents|sensory system agents|mesh-ancestor
91996478|NCT02375191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92343995|NCT05727098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92343996|NCT05727098|Analgesics|analgesics|mesh-ancestor
92343997|NCT05727098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92343998|NCT05727098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92343999|NCT05727098|Anesthetics, General|anesthetics, general|mesh-ancestor
92344000|NCT05727098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92344001|NCT05727098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92344002|NCT05727098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344003|NCT05727098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344004|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
92344005|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
92344007|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344008|NCT05691699|Itraconazole|itraconazole|mesh-list
92344009|NCT05691699|Antifungal Agents|antifungal agents|mesh-ancestor
92344010|NCT05691699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92344011|NCT05691699|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92344012|NCT05691699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92344013|NCT05691699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344014|NCT05691699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344015|NCT05691699|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92344016|NCT05691699|Hormone Antagonists|hormone antagonists|mesh-ancestor
92344017|NCT05691699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344018|NCT05691699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344019|NCT05691699|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92344021|NCT05687058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92104829|NCT03005002|Durvalumab|durvalumab|mesh-list
92344022|NCT05687058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344025|NCT05681884|Faricimab|faricimab|mesh-list
92344026|NCT05681884|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92344027|NCT05681884|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92344028|NCT05681884|Growth Substances|growth substances|mesh-ancestor
92344029|NCT05681884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344031|NCT05681884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104893|NCT03004612|Hormones|hormones|mesh-ancestor
92344032|NCT05677451|Remibrutinib|remibrutinib|mesh-list
92344033|NCT05677451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344034|NCT05677451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344035|NCT05677451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344036|NCT05656352|Chrysarobin|chrysarobin|mesh-list
92344037|NCT05656352|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92344038|NCT05656352|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92344039|NCT05656352|Analgesics|analgesics|mesh-ancestor
92104963|NCT03000634|Dexamethasone|dexamethasone|mesh-list
92344040|NCT05656352|Sensory System Agents|sensory system agents|mesh-ancestor
92344041|NCT05656352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344043|NCT05656352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92344044|NCT05656352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344045|NCT05638620|Bupivacaine|bupivacaine|mesh-list
92344046|NCT05638620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105033|NCT03362268|Omeprazole|omeprazole|mesh-list
92344047|NCT05638620|Anesthetics|anesthetics|mesh-ancestor
92344048|NCT05638620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344049|NCT05638620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344050|NCT05638620|Sensory System Agents|sensory system agents|mesh-ancestor
92344051|NCT05638620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344052|NCT05632809|Durvalumab|durvalumab|mesh-list
92344053|NCT05632809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344055|NCT05610527|Etonogestrel|etonogestrel|mesh-list
92344056|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92344057|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
92344058|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92344059|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344060|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92344061|NCT05608369|Vorinostat|vorinostat|mesh-list
92344062|NCT05608369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344064|NCT05608369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344065|NCT05608369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344068|NCT05590468|Nicotinic Acids|nicotinic acids|mesh-list
92344069|NCT05590468|Vitamin B Complex|vitamin b complex|mesh-ancestor
92344070|NCT05590468|Vitamins|vitamins|mesh-ancestor
92344071|NCT05590468|Micronutrients|micronutrients|mesh-ancestor
92344072|NCT05590468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344073|NCT05590468|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92344074|NCT05590468|Antimetabolites|antimetabolites|mesh-ancestor
92105161|NCT03370848|Aspirin|aspirin|mesh-list
92344075|NCT05590468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344076|NCT05590468|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92344077|NCT05590468|Vasodilator Agents|vasodilator agents|mesh-ancestor
92344078|NCT05565560|Apremilast|apremilast|mesh-list
92344079|NCT05565560|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92344083|NCT05565560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344084|NCT05565560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344085|NCT05565560|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92344086|NCT05565560|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344087|NCT05565560|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92344088|NCT05565560|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92344089|NCT05565560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344090|NCT05565560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344091|NCT05564546|Nitric Oxide|nitric oxide|mesh-list
92344092|NCT05564546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92344093|NCT05564546|Autonomic Agents|autonomic agents|mesh-ancestor
92344094|NCT05564546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344095|NCT05564546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344097|NCT05564546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92344098|NCT05564546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92105287|NCT03367182|Growth Substances|growth substances|mesh-ancestor
92344100|NCT05564546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344101|NCT05564546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344102|NCT05564546|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92344103|NCT05564546|Vasodilator Agents|vasodilator agents|mesh-ancestor
92344104|NCT05564546|Gasotransmitters|gasotransmitters|mesh-ancestor
92344105|NCT05564546|Protective Agents|protective agents|mesh-ancestor
92344106|NCT05548062|Hydroxyurea|hydroxyurea|mesh-list
92344107|NCT05548062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344108|NCT05548062|Antisickling Agents|antisickling agents|mesh-ancestor
92344109|NCT05548062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344110|NCT05548062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344112|NCT05541341|Tisagenlecleucel|tisagenlecleucel|mesh-list
92344113|NCT05541341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344115|NCT05527808|Carboplatin|carboplatin|mesh-list
92344116|NCT05527808|Pemetrexed|pemetrexed|mesh-list
92344117|NCT05527808|Tislelizumab|tislelizumab|mesh-list
92344118|NCT05527808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344119|NCT05527808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105416|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
92344120|NCT05527808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344121|NCT05527808|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92344122|NCT05527808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92344123|NCT05527808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344125|NCT05496335|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92344126|NCT05496335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344127|NCT05496335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344128|NCT05496335|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92344129|NCT05496335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92344130|NCT05496335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344131|NCT05496335|Cholinergic Agents|cholinergic agents|mesh-ancestor
92344132|NCT05496335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344133|NCT05480098|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92344134|NCT05480098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92344135|NCT05480098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92344136|NCT05480098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92344137|NCT05480098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92344138|NCT05480098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92344139|NCT05480098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344140|NCT05480098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344142|NCT05426031|Protamines|protamines|mesh-list
92344143|NCT05426031|Heparin Antagonists|heparin antagonists|mesh-ancestor
92344144|NCT05426031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344145|NCT05426031|Coagulants|coagulants|mesh-ancestor
92344146|NCT05423106|Tenofovir|tenofovir|mesh-list
92344147|NCT05423106|Entecavir|entecavir|mesh-list
92344148|NCT05423106|Antiviral Agents|antiviral agents|mesh-ancestor
92344149|NCT05423106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92344150|NCT05423106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92344151|NCT05423106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92344152|NCT05423106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344153|NCT05423106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344154|NCT05423106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92344155|NCT05423106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92344156|NCT05399277|Rivaroxaban|rivaroxaban|mesh-list
92344157|NCT05399277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92344158|NCT05399277|Antithrombins|antithrombins|mesh-ancestor
92344159|NCT05399277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92344160|NCT05399277|Protease Inhibitors|protease inhibitors|mesh-ancestor
92344161|NCT05399277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344162|NCT05399277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344163|NCT05399277|Anticoagulants|anticoagulants|mesh-ancestor
92344164|NCT05362409|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92344165|NCT05362409|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92344166|NCT05362409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92344167|NCT05319873|Carboplatin|carboplatin|mesh-list
92344168|NCT05319873|Docetaxel|docetaxel|mesh-list
92344169|NCT05319873|Trastuzumab|trastuzumab|mesh-list
92344170|NCT05319873|Fulvestrant|fulvestrant|mesh-list
92344171|NCT05319873|Pertuzumab|pertuzumab|mesh-list
92344172|NCT05319873|Tucatinib|tucatinib|mesh-list
92344173|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92105599|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
92344174|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92344175|NCT05319873|Antibodies|antibodies|mesh-list
92344176|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
92105671|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
92344178|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
92344179|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344180|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344181|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
92344182|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344183|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344185|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92344186|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92344187|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92344188|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
92344189|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344190|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344191|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105800|NCT03355248|Oxycodone|oxycodone|mesh-list
92344192|NCT05296070|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92344193|NCT05296070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344194|NCT05296070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344195|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
92344196|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105872|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
92344197|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
92344198|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344199|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344200|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92344201|NCT05239741|Leucovorin|leucovorin|mesh-list
92344202|NCT05239741|Bevacizumab|bevacizumab|mesh-list
92344203|NCT05239741|Pembrolizumab|pembrolizumab|mesh-list
92344204|NCT05239741|Cetuximab|cetuximab|mesh-list
92344205|NCT05239741|Fluorouracil|fluorouracil|mesh-list
92344206|NCT05239741|Oxaliplatin|oxaliplatin|mesh-list
92344207|NCT05239741|Irinotecan|irinotecan|mesh-list
92344208|NCT05239741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344209|NCT05239741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344210|NCT05239741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92344212|NCT05239741|Growth Substances|growth substances|mesh-ancestor
92344213|NCT05239741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344214|NCT05239741|Growth Inhibitors|growth inhibitors|mesh-ancestor
92344215|NCT05239741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92349532|NCT01490580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344216|NCT05239741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344217|NCT05239741|Antimetabolites|antimetabolites|mesh-ancestor
92344218|NCT05239741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92344219|NCT05239741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344220|NCT05239741|Immunologic Factors|immunologic factors|mesh-ancestor
92344221|NCT05239741|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92344222|NCT05239741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92344223|NCT05239741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344224|NCT05239741|Antidotes|antidotes|mesh-ancestor
92344225|NCT05239741|Protective Agents|protective agents|mesh-ancestor
92344226|NCT05239741|Vitamin B Complex|vitamin b complex|mesh-ancestor
92344228|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
92344229|NCT05188326|Azacitidine|azacitidine|mesh-list
92344230|NCT05188326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92344231|NCT05188326|Antimetabolites|antimetabolites|mesh-ancestor
92344232|NCT05188326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344233|NCT05188326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106079|NCT05585346|Prednisolone|prednisolone|mesh-list
92344234|NCT05188326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344235|NCT05180942|Atorvastatin|atorvastatin|mesh-list
92344237|NCT05180942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92344238|NCT05180942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344239|NCT05180942|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92344240|NCT05180942|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92344241|NCT05180942|Antimetabolites|antimetabolites|mesh-ancestor
92344242|NCT05180942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106151|NCT03347916|Gabapentin|gabapentin|mesh-list
92344243|NCT05180942|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92344244|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92344245|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344247|NCT05171075|Tinzaparin|tinzaparin|mesh-list
92344248|NCT05171075|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92344249|NCT05171075|Anticoagulants|anticoagulants|mesh-ancestor
92344250|NCT05171075|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92344251|NCT05171075|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92344252|NCT05171075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344254|NCT05171049|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92344255|NCT05171049|Antithrombins|antithrombins|mesh-ancestor
92344256|NCT05171049|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92344257|NCT05171049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92344258|NCT05171049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344259|NCT05171049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344262|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
92344263|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92344264|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92344265|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92344267|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92106269|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
92344268|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344269|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92344270|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
92344271|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344274|NCT05160896|Irinotecan|irinotecan|mesh-list
92344275|NCT05160896|Raltitrexed|raltitrexed|mesh-list
92344276|NCT05160896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344277|NCT05160896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344278|NCT05160896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92344279|NCT05160896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92344280|NCT05160896|Growth Substances|growth substances|mesh-ancestor
92344281|NCT05160896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344282|NCT05160896|Growth Inhibitors|growth inhibitors|mesh-ancestor
92344283|NCT05160896|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92344284|NCT05160896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92344285|NCT05160896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344286|NCT05160896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344287|NCT05160896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92344288|NCT05160896|Antimetabolites|antimetabolites|mesh-ancestor
92344289|NCT05160896|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92344290|NCT05137054|Lenalidomide|lenalidomide|mesh-list
92344291|NCT05137054|Pomalidomide|pomalidomide|mesh-list
92344292|NCT05137054|Bortezomib|bortezomib|mesh-list
92344293|NCT05137054|Daratumumab|daratumumab|mesh-list
92344294|NCT05137054|Cemiplimab|cemiplimab|mesh-list
92344295|NCT05137054|Nirogacestat|nirogacestat|mesh-list
92106335|NCT03346200|Tamoxifen|tamoxifen|mesh-list
92344296|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
92344297|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344298|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92344299|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92344301|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
92344302|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106375|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
92344303|NCT05137054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344304|NCT05137054|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92344305|NCT05137054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344306|NCT05137054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344307|NCT05129670|Calcium Carbonate|calcium carbonate|mesh-list
92344310|NCT05129670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92344312|NCT05128617|Cyclophosphamide|cyclophosphamide|mesh-list
92344313|NCT05128617|Epirubicin|epirubicin|mesh-list
92106443|NCT03923556|Neostigmine|neostigmine|mesh-list
92344314|NCT05128617|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344315|NCT05128617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344316|NCT05128617|Tubulin Modulators|tubulin modulators|mesh-ancestor
92344318|NCT05128617|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344319|NCT05128617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344320|NCT05128617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344322|NCT05128617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344323|NCT05128617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344324|NCT05128617|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344325|NCT05128617|Alkylating Agents|alkylating agents|mesh-ancestor
92344326|NCT05128617|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344327|NCT05128617|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92344328|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92344329|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92344330|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344332|NCT05107375|Immunologic Factors|immunologic factors|mesh-ancestor
92344333|NCT05107375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344334|NCT05094128|Upadacitinib|upadacitinib|mesh-list
92344335|NCT05094128|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92344336|NCT05094128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344337|NCT05094128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344338|NCT05094128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344340|NCT05065957|Capecitabine|capecitabine|mesh-list
92344341|NCT05065957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92344342|NCT05065957|Antimetabolites|antimetabolites|mesh-ancestor
92344343|NCT05065957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344344|NCT05065957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344346|NCT05031520|Nitroglycerin|nitroglycerin|mesh-list
92344347|NCT05031520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92344348|NCT05031520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92344349|NCT05031520|Sympatholytics|sympatholytics|mesh-ancestor
92344350|NCT05031520|Autonomic Agents|autonomic agents|mesh-ancestor
92344351|NCT05031520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344352|NCT05031520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344353|NCT05031520|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92344354|NCT05031520|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92344355|NCT05031520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92344356|NCT05031520|Adrenergic Agents|adrenergic agents|mesh-ancestor
92344357|NCT05031520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344358|NCT05031520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344362|NCT05018585|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92344363|NCT05018585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92344364|NCT05018585|Immunologic Factors|immunologic factors|mesh-ancestor
92344365|NCT05018585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344366|NCT05018585|Antacids|antacids|mesh-ancestor
92344367|NCT05018585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344368|NCT05018585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92344369|NCT05018585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92344370|NCT05018585|Vitamins|vitamins|mesh-ancestor
92344371|NCT05018585|Micronutrients|micronutrients|mesh-ancestor
92106705|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
92344372|NCT05018585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92344374|NCT04989829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92344375|NCT04989829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92344376|NCT04989829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92344377|NCT04989829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344378|NCT04989829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344380|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
92344381|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344382|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
92344383|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92344384|NCT04939792|Vitamin D|vitamin d|mesh-list
92344385|NCT04939792|Ergocalciferols|ergocalciferols|mesh-list
92106845|NCT04499118|Paclitaxel|paclitaxel|mesh-list
92344386|NCT04939792|Cholecalciferol|cholecalciferol|mesh-list
92344387|NCT04939792|Vitamins|vitamins|mesh-list
92344388|NCT04939792|Micronutrients|micronutrients|mesh-ancestor
92344389|NCT04939792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344390|NCT04939792|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92344391|NCT04939792|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92344392|NCT04850495|Prednisone|prednisone|mesh-list
92344393|NCT04850495|Cortisone|cortisone|mesh-list
92344394|NCT04850495|Cyclophosphamide|cyclophosphamide|mesh-list
92344395|NCT04850495|Rituximab|rituximab|mesh-list
92106899|NCT04499586|Irinotecan|irinotecan|mesh-list
92344397|NCT04850495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92344398|NCT04850495|Vincristine|vincristine|mesh-list
92344399|NCT04850495|Zanubrutinib|zanubrutinib|mesh-list
92344400|NCT04850495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92344401|NCT04850495|Antibodies|antibodies|mesh-list
92344402|NCT04850495|Immunoglobulins|immunoglobulins|mesh-list
92344403|NCT04850495|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92344404|NCT04850495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344405|NCT04850495|Immunologic Factors|immunologic factors|mesh-ancestor
92344406|NCT04850495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344407|NCT04850495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344408|NCT04850495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344409|NCT04850495|Alkylating Agents|alkylating agents|mesh-ancestor
92344410|NCT04850495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344411|NCT04850495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344412|NCT04850495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344414|NCT04850495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92344415|NCT04850495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92344416|NCT04850495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344417|NCT04850495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92344418|NCT04850495|Glucocorticoids|glucocorticoids|mesh-ancestor
92344419|NCT04850495|Hormones|hormones|mesh-ancestor
92344420|NCT04850495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344421|NCT04850495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92344422|NCT04850495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344423|NCT04850495|Tubulin Modulators|tubulin modulators|mesh-ancestor
92344424|NCT04850495|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344425|NCT04850495|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344426|NCT04850495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344428|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344429|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344430|NCT04763135|Mirtazapine|mirtazapine|mesh-list
92344431|NCT04763135|Escitalopram|escitalopram|mesh-list
92344432|NCT04763135|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92107014|NCT02509728|Choline|choline|mesh-list
92344433|NCT04763135|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92344434|NCT04763135|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92344435|NCT04763135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344436|NCT04763135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344437|NCT04763135|Serotonin Agents|serotonin agents|mesh-ancestor
92344438|NCT04763135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344439|NCT04763135|Antidepressive Agents|antidepressive agents|mesh-ancestor
92344440|NCT04763135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92344441|NCT04763135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92344442|NCT04763135|Histamine Antagonists|histamine antagonists|mesh-ancestor
92344443|NCT04763135|Histamine Agents|histamine agents|mesh-ancestor
92344444|NCT04763135|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92344445|NCT04763135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92344446|NCT04763135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344447|NCT04763135|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92344448|NCT04763135|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92344449|NCT04763135|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92344450|NCT04763135|Adrenergic Agents|adrenergic agents|mesh-ancestor
92344451|NCT04763135|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92344452|NCT04763135|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92344453|NCT04763135|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92344455|NCT04762979|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92344456|NCT04762979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92344457|NCT04762979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344458|NCT04762979|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92344459|NCT04762979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92344460|NCT04762979|Hormone Antagonists|hormone antagonists|mesh-ancestor
92344461|NCT04762979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344462|NCT04762979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344463|NCT04762979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92344464|NCT04762979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344465|NCT04762979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344467|NCT04723134|Folic Acid|folic acid|mesh-list
92344468|NCT04723134|Calcium|calcium|mesh-list
92344469|NCT04723134|Levoleucovorin|levoleucovorin|mesh-list
92344470|NCT04723134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92344471|NCT04723134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344472|NCT04723134|Antidotes|antidotes|mesh-ancestor
92344473|NCT04723134|Protective Agents|protective agents|mesh-ancestor
92344474|NCT04723134|Vitamin B Complex|vitamin b complex|mesh-ancestor
92344475|NCT04723134|Vitamins|vitamins|mesh-ancestor
92344476|NCT04723134|Micronutrients|micronutrients|mesh-ancestor
92344477|NCT04723134|Hematinics|hematinics|mesh-ancestor
92344478|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92344479|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92107415|NCT02501850|Incretins|incretins|mesh-ancestor
92344480|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344481|NCT04700072|Pembrolizumab|pembrolizumab|mesh-list
92344483|NCT04700072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344484|NCT04700072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344485|NCT04700072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344486|NCT04700072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344488|NCT04700072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344489|NCT04676334|Rucaparib|rucaparib|mesh-list
92344490|NCT04676334|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92344491|NCT04676334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344492|NCT04676334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344493|NCT04676334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344496|NCT04666272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344497|NCT04666272|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344498|NCT04666272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344499|NCT04666272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344500|NCT04649060|Dexamethasone|dexamethasone|mesh-list
92344501|NCT04649060|Melphalan|melphalan|mesh-list
92344502|NCT04649060|Daratumumab|daratumumab|mesh-list
92344503|NCT04649060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92344504|NCT04649060|Antiemetics|antiemetics|mesh-ancestor
92344505|NCT04649060|Autonomic Agents|autonomic agents|mesh-ancestor
92344506|NCT04649060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344507|NCT04649060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344508|NCT04649060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92344509|NCT04649060|Glucocorticoids|glucocorticoids|mesh-ancestor
92344510|NCT04649060|Hormones|hormones|mesh-ancestor
92349533|NCT01490580|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92344511|NCT04649060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92344512|NCT04649060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92344513|NCT04649060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344514|NCT04649060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344515|NCT04649060|Alkylating Agents|alkylating agents|mesh-ancestor
92107752|NCT02493192|Haloperidol decanoate|haloperidol decanoate|mesh-list
92344516|NCT04649060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344517|NCT04649060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344518|NCT04649060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344519|NCT04649060|Immunologic Factors|immunologic factors|mesh-ancestor
92344520|NCT04608487|Cyclophosphamide|cyclophosphamide|mesh-list
92344522|NCT04608487|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92344523|NCT04608487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344524|NCT04608487|Immunologic Factors|immunologic factors|mesh-ancestor
92107829|NCT03340740|Cetirizine|cetirizine|mesh-list
92344525|NCT04608487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344526|NCT04608487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344527|NCT04608487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344529|NCT04608487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344530|NCT04608487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344531|NCT04608487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344532|NCT04608487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344533|NCT04602767|Phenylephrine|phenylephrine|mesh-list
92344534|NCT04602767|Vasopressins|vasopressins|mesh-list
92344535|NCT04602767|Arginine Vasopressin|arginine vasopressin|mesh-list
92344536|NCT04602767|Oxymetazoline|oxymetazoline|mesh-list
92344537|NCT04602767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92344538|NCT04602767|Mydriatics|mydriatics|mesh-ancestor
92344539|NCT04602767|Autonomic Agents|autonomic agents|mesh-ancestor
92344540|NCT04602767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344541|NCT04602767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344542|NCT04602767|Sympathomimetics|sympathomimetics|mesh-ancestor
92344543|NCT04602767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92344544|NCT04602767|Nasal Decongestants|nasal decongestants|mesh-ancestor
92344545|NCT04602767|Respiratory System Agents|respiratory system agents|mesh-ancestor
92344546|NCT04602767|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92344547|NCT04602767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92344548|NCT04602767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92344549|NCT04602767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92344550|NCT04602767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344551|NCT04602767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344552|NCT04602767|Protective Agents|protective agents|mesh-ancestor
92344553|NCT04602767|Hemostatics|hemostatics|mesh-ancestor
92344554|NCT04602767|Coagulants|coagulants|mesh-ancestor
92344555|NCT04602767|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92344556|NCT04602767|Natriuretic Agents|natriuretic agents|mesh-ancestor
92344557|NCT04581447|Metformin|metformin|mesh-list
92344559|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344560|NCT04524689|Carboplatin|carboplatin|mesh-list
92344561|NCT04524689|Pembrolizumab|pembrolizumab|mesh-list
92344562|NCT04524689|Pemetrexed|pemetrexed|mesh-list
92344563|NCT04524689|Maytansine|maytansine|mesh-list
92344564|NCT04524689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344565|NCT04524689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92108009|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
92344566|NCT04524689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344567|NCT04524689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344568|NCT04524689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344569|NCT04524689|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92344570|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92344571|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344572|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
92344573|NCT04524689|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344574|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344575|NCT04520685|Cannabidiol|cannabidiol|mesh-list
92344576|NCT04520685|Anticonvulsants|anticonvulsants|mesh-ancestor
92344577|NCT04519151|Pembrolizumab|pembrolizumab|mesh-list
92344578|NCT04519151|Lenvatinib|lenvatinib|mesh-list
92344579|NCT04519151|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344580|NCT04519151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344581|NCT04519151|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92349534|NCT01490580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92344582|NCT04519151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344583|NCT04519151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344584|NCT04519151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344585|NCT04511650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92344586|NCT04506372|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92108135|NCT03875638|Levetiracetam|levetiracetam|mesh-list
92344587|NCT04506372|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92344588|NCT04506372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997097|NCT05059145|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92344589|NCT04506372|Protease Inhibitors|protease inhibitors|mesh-ancestor
92344590|NCT04497012|Iron|iron|mesh-list
92344591|NCT04497012|Trace Elements|trace elements|mesh-ancestor
92344592|NCT04497012|Micronutrients|micronutrients|mesh-ancestor
92344593|NCT04497012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344594|NCT04484259|Aspirin|aspirin|mesh-list
92344596|NCT04484259|Ticagrelor|ticagrelor|mesh-list
92344597|NCT04484259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92344598|NCT04484259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92344599|NCT04484259|Analgesics|analgesics|mesh-ancestor
92344600|NCT04484259|Sensory System Agents|sensory system agents|mesh-ancestor
92344601|NCT04484259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344602|NCT04484259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344603|NCT04484259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92344604|NCT04484259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344605|NCT04484259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92344606|NCT04484259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92344607|NCT04484259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344608|NCT04484259|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92344609|NCT04484259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92344610|NCT04484259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344611|NCT04484259|Antipyretics|antipyretics|mesh-ancestor
92344612|NCT04484259|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92344613|NCT04484259|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92344614|NCT04484259|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92344615|NCT04484259|Purinergic Agents|purinergic agents|mesh-ancestor
92344616|NCT04484259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344617|NCT04463693|Etonogestrel|etonogestrel|mesh-list
92344618|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92344619|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
92344620|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92344621|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344622|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92344623|NCT04392011|Midazolam|midazolam|mesh-list
92344624|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
92344625|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92344626|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92344627|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344628|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344629|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92344630|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92344631|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92344633|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
92344634|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
92344635|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
92344636|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
92344637|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344638|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344639|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
92344640|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
92344641|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92344642|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92344643|NCT04370301|Mycophenolic Acid|mycophenolic acid|mesh-list
92344644|NCT04370301|Cyclophosphamide|cyclophosphamide|mesh-list
92344645|NCT04370301|Melphalan|melphalan|mesh-list
92344647|NCT04370301|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92344648|NCT04370301|Fludarabine|fludarabine|mesh-list
92344650|NCT04370301|Lenograstim|lenograstim|mesh-list
92344651|NCT04370301|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92344652|NCT04370301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344653|NCT04370301|Immunologic Factors|immunologic factors|mesh-ancestor
92344654|NCT04370301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344655|NCT04370301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344656|NCT04370301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344658|NCT04370301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344659|NCT04370301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344660|NCT04370301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344661|NCT04370301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92344662|NCT04370301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344663|NCT04370301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92344664|NCT04370301|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92344665|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
92344666|NCT04370301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92344667|NCT04370301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92344669|NCT04370301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344670|NCT04348916|Pembrolizumab|pembrolizumab|mesh-list
92344671|NCT04348916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344672|NCT04348916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344673|NCT04348916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91937128|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344674|NCT04348916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344675|NCT04299113|Vinorelbine|vinorelbine|mesh-list
92344676|NCT04299113|Mocetinostat|mocetinostat|mesh-list
92344677|NCT04299113|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344678|NCT04299113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344680|NCT04299113|Antimitotic Agents|antimitotic agents|mesh-ancestor
92108486|NCT02488590|Autonomic Agents|autonomic agents|mesh-ancestor
92344682|NCT04299113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344683|NCT04299113|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92344684|NCT04299113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344685|NCT04291001|Ulipristal acetate|ulipristal acetate|mesh-list
92344686|NCT04291001|Etonogestrel|etonogestrel|mesh-list
92344687|NCT04291001|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92344688|NCT04291001|Contraceptive Agents|contraceptive agents|mesh-ancestor
92344689|NCT04291001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92344690|NCT04291001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344692|NCT04285580|Bimatoprost|bimatoprost|mesh-list
92344693|NCT04285580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92344694|NCT04272606|Tranexamic Acid|tranexamic acid|mesh-list
92344695|NCT04272606|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92344696|NCT04272606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92344697|NCT04272606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344698|NCT04272606|Hemostatics|hemostatics|mesh-ancestor
92344699|NCT04272606|Coagulants|coagulants|mesh-ancestor
92344700|NCT04245371|Lidocaine|lidocaine|mesh-list
92344701|NCT04245371|Anesthetics, Local|anesthetics, local|mesh-ancestor
92344702|NCT04245371|Anesthetics|anesthetics|mesh-ancestor
92344703|NCT04245371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344704|NCT04245371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344705|NCT04245371|Sensory System Agents|sensory system agents|mesh-ancestor
92344706|NCT04245371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344707|NCT04245371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92344708|NCT04245371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92344709|NCT04245371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92344710|NCT04245371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92344711|NCT04245371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344712|NCT04231539|Nicotine|nicotine|mesh-list
92344713|NCT04231539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92344714|NCT04231539|Autonomic Agents|autonomic agents|mesh-ancestor
92344715|NCT04231539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108555|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
92344716|NCT04231539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344717|NCT04231539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92344718|NCT04231539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92344719|NCT04231539|Cholinergic Agents|cholinergic agents|mesh-ancestor
92344720|NCT04231539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344721|NCT04231539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344722|NCT04200313|Pancrelipase|pancrelipase|mesh-list
92344723|NCT04200313|Pancreatin|pancreatin|mesh-list
92344724|NCT04200313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92344725|NCT04200248|Aflibercept|aflibercept|mesh-list
92344726|NCT04200248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92344727|NCT04200248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92344728|NCT04200248|Growth Substances|growth substances|mesh-ancestor
92344729|NCT04200248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344730|NCT04200248|Growth Inhibitors|growth inhibitors|mesh-ancestor
92344731|NCT04200248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344732|NCT04137887|Vaccines|vaccines|mesh-list
92344733|NCT04137887|Immunologic Factors|immunologic factors|mesh-ancestor
92344734|NCT04137887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937140|NCT01253603|Xhance|xhance|mesh-list
92344735|NCT04095273|Pembrolizumab|pembrolizumab|mesh-list
92344736|NCT04095273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344737|NCT04095273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344738|NCT04095273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344739|NCT04095273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344740|NCT03992131|Rucaparib|rucaparib|mesh-list
92344742|NCT03992131|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92344743|NCT03992131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344744|NCT03992131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344745|NCT03992131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344746|NCT03992131|Immunoconjugates|immunoconjugates|mesh-ancestor
92344747|NCT03992131|Immunologic Factors|immunologic factors|mesh-ancestor
92344748|NCT03992131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344749|NCT03954366|Rucaparib|rucaparib|mesh-list
92344750|NCT03954366|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92344751|NCT03954366|Contraceptive Agents|contraceptive agents|mesh-list
92344752|NCT03954366|Contraceptives, Oral|contraceptives, oral|mesh-list
92344753|NCT03954366|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92344754|NCT03954366|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92344755|NCT03954366|Antimetabolites|antimetabolites|mesh-ancestor
92344756|NCT03954366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344757|NCT03954366|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92344758|NCT03954366|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92344759|NCT03954366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344760|NCT03954366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92344761|NCT03954366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344762|NCT03954366|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92344763|NCT03954366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92344764|NCT03954366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344765|NCT03940703|Osimertinib|osimertinib|mesh-list
92344766|NCT03940703|Tepotinib|tepotinib|mesh-list
92344767|NCT03940703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344768|NCT03940703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92344769|NCT03940703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344770|NCT03940703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344771|NCT03923270|Durvalumab|durvalumab|mesh-list
92344772|NCT03923270|Olaparib|olaparib|mesh-list
92344773|NCT03923270|Tremelimumab|tremelimumab|mesh-list
92344774|NCT03923270|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92344775|NCT03923270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344776|NCT03923270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344777|NCT03923270|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92344778|NCT03923270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344779|NCT03923270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344780|NCT03923270|Immunologic Factors|immunologic factors|mesh-ancestor
92344781|NCT03923270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344782|NCT03912220|Niacinamide|niacinamide|mesh-list
92344783|NCT03912220|Niacin|niacin|mesh-list
92344784|NCT03912220|Nicotinic Acids|nicotinic acids|mesh-list
92344785|NCT03912220|Vitamin B Complex|vitamin b complex|mesh-ancestor
92344786|NCT03912220|Vitamins|vitamins|mesh-ancestor
92344787|NCT03912220|Micronutrients|micronutrients|mesh-ancestor
92344788|NCT03912220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344789|NCT03912220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92344790|NCT03912220|Antimetabolites|antimetabolites|mesh-ancestor
92344791|NCT03912220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344792|NCT03912220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92344793|NCT03912220|Vasodilator Agents|vasodilator agents|mesh-ancestor
92344794|NCT03889912|Cemiplimab|cemiplimab|mesh-list
92344795|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344796|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344797|NCT03872791|Paclitaxel|paclitaxel|mesh-list
92344798|NCT03872791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344799|NCT03872791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344800|NCT03872791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92344801|NCT03872791|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344802|NCT03872791|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344803|NCT03872791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344804|NCT03864042|Losartan|losartan|mesh-list
92344805|NCT03864042|Midazolam|midazolam|mesh-list
92344806|NCT03864042|Dextromethorphan|dextromethorphan|mesh-list
92344807|NCT03864042|Caffeine|caffeine|mesh-list
92344808|NCT03864042|Modafinil|modafinil|mesh-list
92344809|NCT03864042|Bupropion|bupropion|mesh-list
92344810|NCT03864042|Omeprazole|omeprazole|mesh-list
92344811|NCT03864042|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92344812|NCT03864042|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92344813|NCT03864042|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92344814|NCT03864042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344815|NCT03864042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344816|NCT03864042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92344817|NCT03864042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92344819|NCT03864042|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92344820|NCT03864042|Anesthetics, General|anesthetics, general|mesh-ancestor
92344822|NCT03864042|GABA Modulators|gaba modulators|mesh-ancestor
92344823|NCT03864042|GABA Agents|gaba agents|mesh-ancestor
92344824|NCT03864042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92344825|NCT03864042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344826|NCT03864042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92344827|NCT03864042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92344828|NCT03864042|Antimetabolites|antimetabolites|mesh-ancestor
92344829|NCT03864042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92344830|NCT03864042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92344831|NCT03864042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344832|NCT03864042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92344833|NCT03864042|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92344834|NCT03864042|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92344835|NCT03864042|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92344836|NCT03864042|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92344837|NCT03864042|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92344838|NCT03864042|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92344839|NCT03864042|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92344840|NCT03864042|Purinergic Agents|purinergic agents|mesh-ancestor
92344841|NCT03864042|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92344842|NCT03864042|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92344843|NCT03864042|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92344844|NCT03864042|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92344845|NCT03864042|Antidepressive Agents|antidepressive agents|mesh-ancestor
92344846|NCT03864042|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92344847|NCT03864042|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92344848|NCT03864042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92344849|NCT03864042|Dopamine Agents|dopamine agents|mesh-ancestor
92344850|NCT03864042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92344851|NCT03864042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92344852|NCT03864042|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92344853|NCT03864042|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92108852|NCT03318744|Aspirin|aspirin|mesh-list
92344854|NCT03864042|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92344855|NCT03864042|Antitussive Agents|antitussive agents|mesh-ancestor
92344856|NCT03864042|Respiratory System Agents|respiratory system agents|mesh-ancestor
92344857|NCT03864042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92344858|NCT03864042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92344859|NCT03737604|Bupivacaine|bupivacaine|mesh-list
92344860|NCT03737604|Ropivacaine|ropivacaine|mesh-list
92344861|NCT03737604|Anesthetics, Local|anesthetics, local|mesh-ancestor
92344862|NCT03737604|Anesthetics|anesthetics|mesh-ancestor
92344863|NCT03737604|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92344864|NCT03737604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344865|NCT03737604|Sensory System Agents|sensory system agents|mesh-ancestor
92344866|NCT03737604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344867|NCT03726879|Paclitaxel|paclitaxel|mesh-list
92344868|NCT03726879|Maytansine|maytansine|mesh-list
92344869|NCT03726879|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92344870|NCT03726879|Cyclophosphamide|cyclophosphamide|mesh-list
92344871|NCT03726879|Doxorubicin|doxorubicin|mesh-list
92344872|NCT03726879|Trastuzumab|trastuzumab|mesh-list
92344873|NCT03726879|Atezolizumab|atezolizumab|mesh-list
92344874|NCT03726879|Pertuzumab|pertuzumab|mesh-list
92344875|NCT03726879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344877|NCT03726879|Tubulin Modulators|tubulin modulators|mesh-ancestor
92344878|NCT03726879|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344879|NCT03726879|Mitosis Modulators|mitosis modulators|mesh-ancestor
92344880|NCT03726879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344881|NCT03726879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344882|NCT03726879|Immunologic Factors|immunologic factors|mesh-ancestor
92344883|NCT03726879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344884|NCT03726879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344885|NCT03726879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344886|NCT03726879|Alkylating Agents|alkylating agents|mesh-ancestor
92344887|NCT03726879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344888|NCT03726879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92344889|NCT03726879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92344890|NCT03726879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92344891|NCT03726879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344892|NCT03726879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344893|NCT03726879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344895|NCT03726879|Immunoconjugates|immunoconjugates|mesh-ancestor
92344897|NCT03695380|Niraparib|niraparib|mesh-list
92344898|NCT03695380|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344899|NCT03695380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344900|NCT03695380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344901|NCT03695380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344902|NCT03695380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92344904|NCT03676504|Cyclophosphamide|cyclophosphamide|mesh-list
92344905|NCT03676504|Fludarabine|fludarabine|mesh-list
92344906|NCT03676504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344907|NCT03676504|Immunologic Factors|immunologic factors|mesh-ancestor
92344908|NCT03676504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344909|NCT03676504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344910|NCT03676504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344911|NCT03676504|Alkylating Agents|alkylating agents|mesh-ancestor
92344912|NCT03676504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344913|NCT03676504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344914|NCT03676504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344915|NCT03600155|Nivolumab|nivolumab|mesh-list
92344916|NCT03600155|Ipilimumab|ipilimumab|mesh-list
92344917|NCT03600155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344918|NCT03600155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344919|NCT03600155|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344920|NCT03600155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344922|NCT03597594|Busulfan|busulfan|mesh-list
92344923|NCT03597594|Thiotepa|thiotepa|mesh-list
92344924|NCT03597594|Thymoglobulin|thymoglobulin|mesh-list
92344925|NCT03597594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92344926|NCT03597594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344927|NCT03597594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344928|NCT03597594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92344929|NCT03597594|Immunologic Factors|immunologic factors|mesh-ancestor
92344930|NCT03597594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344931|NCT03597594|Alkylating Agents|alkylating agents|mesh-ancestor
92344932|NCT03597594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92344933|NCT03597594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92344934|NCT03563690|Celecoxib|celecoxib|mesh-list
92344935|NCT03563690|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92344936|NCT03563690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92344937|NCT03563690|Analgesics|analgesics|mesh-ancestor
92344938|NCT03563690|Sensory System Agents|sensory system agents|mesh-ancestor
92344939|NCT03563690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92344940|NCT03563690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92344941|NCT03563690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92344942|NCT03563690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92344943|NCT03563690|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92344944|NCT03563690|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92344946|NCT03563690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344947|NCT03557008|Metronidazole|metronidazole|mesh-list
92344948|NCT03557008|Vancomycin|vancomycin|mesh-list
92344949|NCT03557008|Neomycin|neomycin|mesh-list
92344950|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92344951|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92344952|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92344953|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92344954|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92344955|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344956|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344957|NCT03509012|Paclitaxel|paclitaxel|mesh-list
92344958|NCT03509012|Etoposide|etoposide|mesh-list
92344959|NCT03509012|Cisplatin|cisplatin|mesh-list
92344960|NCT03509012|Carboplatin|carboplatin|mesh-list
92344961|NCT03509012|Etoposide phosphate|etoposide phosphate|mesh-list
92344963|NCT03509012|Durvalumab|durvalumab|mesh-list
92344964|NCT03509012|Tremelimumab|tremelimumab|mesh-list
92344965|NCT03509012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92344966|NCT03509012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344967|NCT03509012|Tubulin Modulators|tubulin modulators|mesh-ancestor
91997474|NCT04410887|Olaparib|olaparib|mesh-list
92344968|NCT03509012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92344970|NCT03509012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344971|NCT03509012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92344972|NCT03509012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92344973|NCT03509012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344975|NCT03509012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92344976|NCT03509012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344977|NCT03404193|Decitabine|decitabine|mesh-list
92344978|NCT03404193|Venetoclax|venetoclax|mesh-list
92344979|NCT03404193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92344980|NCT03404193|Antimetabolites|antimetabolites|mesh-ancestor
92344981|NCT03404193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344982|NCT03404193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344983|NCT03404193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92344984|NCT03395847|Pembrolizumab|pembrolizumab|mesh-list
92109166|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92344985|NCT03395847|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344986|NCT03395847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344987|NCT03395847|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344988|NCT03395847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344989|NCT03347617|Pembrolizumab|pembrolizumab|mesh-list
92344990|NCT03347617|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92344991|NCT03347617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92344992|NCT03347617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92344993|NCT03347617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92344994|NCT03347617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92344995|NCT03347617|Hematinics|hematinics|mesh-ancestor
92344996|NCT03347617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92344997|NCT03347617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92344998|NCT03328273|Acalabrutinib|acalabrutinib|mesh-list
92344999|NCT03328273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345000|NCT03258593|Durvalumab|durvalumab|mesh-list
92345001|NCT03258593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345002|NCT03258593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345003|NCT03178149|Tacrolimus|tacrolimus|mesh-list
92345004|NCT03178149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345005|NCT03178149|Immunologic Factors|immunologic factors|mesh-ancestor
92345006|NCT03178149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345007|NCT03178149|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92345008|NCT03178149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349535|NCT01490580|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92345009|NCT03178149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345010|NCT03136029|Antioxidants|antioxidants|mesh-list
92345011|NCT03136029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345012|NCT03136029|Protective Agents|protective agents|mesh-ancestor
92345013|NCT03136029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345014|NCT03040999|Cisplatin|cisplatin|mesh-list
92345015|NCT03040999|Pembrolizumab|pembrolizumab|mesh-list
92345016|NCT03040999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345017|NCT03040999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345018|NCT03040999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92345019|NCT03040999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345020|NCT02990338|Dexamethasone|dexamethasone|mesh-list
92345021|NCT02990338|Pomalidomide|pomalidomide|mesh-list
92345022|NCT02990338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345023|NCT02990338|Antiemetics|antiemetics|mesh-ancestor
92345024|NCT02990338|Autonomic Agents|autonomic agents|mesh-ancestor
92345025|NCT02990338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345026|NCT02990338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345027|NCT02990338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345028|NCT02990338|Glucocorticoids|glucocorticoids|mesh-ancestor
92345030|NCT02990338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345031|NCT02990338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345032|NCT02990338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345033|NCT02990338|Immunologic Factors|immunologic factors|mesh-ancestor
92345034|NCT02990338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92345035|NCT02990338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92345036|NCT02990338|Growth Substances|growth substances|mesh-ancestor
92345039|NCT02971956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345041|NCT02971956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92345042|NCT02971956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345044|NCT02787369|Ricolinostat|ricolinostat|mesh-list
92345045|NCT02787369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345046|NCT02787369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345047|NCT02787369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345048|NCT02787369|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92345049|NCT02366728|Temozolomide|temozolomide|mesh-list
92345051|NCT02366728|Immunologic Factors|immunologic factors|mesh-ancestor
92345052|NCT02366728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345053|NCT02366728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345054|NCT02366728|Alkylating Agents|alkylating agents|mesh-ancestor
92349536|NCT01490580|Autonomic Agents|autonomic agents|mesh-ancestor
92345055|NCT02366728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345056|NCT02366728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345057|NCT02366728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345058|NCT02333370|Tamoxifen|tamoxifen|mesh-list
92345059|NCT02333370|Letrozole|letrozole|mesh-list
92345060|NCT02333370|Fulvestrant|fulvestrant|mesh-list
92345061|NCT02333370|Goserelin|goserelin|mesh-list
92345062|NCT02333370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345063|NCT02333370|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92345064|NCT02333370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92345065|NCT02333370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345066|NCT02333370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345067|NCT02333370|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92345068|NCT02333370|Hormone Antagonists|hormone antagonists|mesh-ancestor
92345069|NCT02333370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109375|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345070|NCT02333370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345071|NCT02333370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345072|NCT02333370|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92345073|NCT02333370|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92345074|NCT02333370|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92345075|NCT02333370|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92345076|NCT02303444|Sorafenib|sorafenib|mesh-list
92345077|NCT02303444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345078|NCT02303444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92345079|NCT02303444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109440|NCT02256358|Midazolam|midazolam|mesh-list
92345080|NCT02303444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345082|NCT02246920|Xhance|xhance|mesh-list
92345083|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345084|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92345085|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
92345086|NCT02246920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345087|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345088|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92345090|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92345091|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92345092|NCT01972919|Gemcitabine|gemcitabine|mesh-list
92345093|NCT01972919|Capecitabine|capecitabine|mesh-list
92345094|NCT01972919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345095|NCT01972919|Antimetabolites|antimetabolites|mesh-ancestor
92345096|NCT01972919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345097|NCT01972919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345098|NCT01832402|Fentanyl|fentanyl|mesh-list
92345099|NCT01832402|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92345100|NCT01832402|Narcotics|narcotics|mesh-ancestor
92345101|NCT01832402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345102|NCT01832402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345103|NCT01832402|Analgesics|analgesics|mesh-ancestor
92345104|NCT01832402|Sensory System Agents|sensory system agents|mesh-ancestor
92345105|NCT01832402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345106|NCT01832402|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92345107|NCT01832402|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92345109|NCT01832402|Anesthetics|anesthetics|mesh-ancestor
92345110|NCT01661881|Cytarabine|cytarabine|mesh-list
92345111|NCT01661881|Rituximab|rituximab|mesh-list
92345112|NCT01661881|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92345113|NCT01661881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345114|NCT01661881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345115|NCT01661881|Immunologic Factors|immunologic factors|mesh-ancestor
92345116|NCT01661881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345117|NCT01661881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345118|NCT01661881|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345119|NCT01661881|Antimetabolites|antimetabolites|mesh-ancestor
92345120|NCT01661881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345121|NCT01661881|Antiviral Agents|antiviral agents|mesh-ancestor
92345122|NCT01661881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345123|NCT01661881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345124|NCT01661881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345125|NCT01661881|Alkylating Agents|alkylating agents|mesh-ancestor
92345127|NCT01473628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92345128|NCT01473628|Antibodies|antibodies|mesh-list
92345129|NCT01473628|Immunoglobulins|immunoglobulins|mesh-list
92345130|NCT01473628|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92345132|NCT01473628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345133|NCT01473628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345134|NCT01473628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345135|NCT01210625|Psyllium|psyllium|mesh-list
92345136|NCT01210625|Cathartics|cathartics|mesh-ancestor
92345137|NCT01210625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345138|NCT01009190|Carboplatin|carboplatin|mesh-list
92345139|NCT01009190|Rucaparib|rucaparib|mesh-list
92345140|NCT01009190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345141|NCT01009190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92345142|NCT01009190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345143|NCT01009190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345144|NCT00321555|Immunotoxins|immunotoxins|mesh-list
92345145|NCT00321555|Immunoconjugates|immunoconjugates|mesh-ancestor
92345146|NCT00321555|Immunologic Factors|immunologic factors|mesh-ancestor
92345147|NCT00321555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345149|NCT00003653|Goserelin|goserelin|mesh-list
92345150|NCT00003653|Flutamide|flutamide|mesh-list
92345151|NCT00003653|Bicalutamide|bicalutamide|mesh-list
92345152|NCT00003653|Cyproterone Acetate|cyproterone acetate|mesh-list
92345153|NCT00003653|Nilutamide|nilutamide|mesh-list
92345154|NCT00003653|Buserelin|buserelin|mesh-list
92345155|NCT00003653|Cyproterone|cyproterone|mesh-list
92345156|NCT00003653|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92345157|NCT00003653|Fertility Agents|fertility agents|mesh-ancestor
92345158|NCT00003653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92345159|NCT00003653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345160|NCT00003653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345161|NCT00003653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345162|NCT00003653|Androgen Antagonists|androgen antagonists|mesh-ancestor
92345163|NCT00003653|Hormone Antagonists|hormone antagonists|mesh-ancestor
92345164|NCT00003653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345165|NCT00003653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92345166|NCT00003653|Contraceptive Agents|contraceptive agents|mesh-ancestor
92345168|NCT00003671|Cytarabine|cytarabine|mesh-list
92345169|NCT00003671|Dexamethasone|dexamethasone|mesh-list
92345170|NCT00003671|Cyclophosphamide|cyclophosphamide|mesh-list
92345171|NCT00003671|Methotrexate|methotrexate|mesh-list
92345172|NCT00003671|Vincristine|vincristine|mesh-list
92345173|NCT00003671|Daunorubicin|daunorubicin|mesh-list
92345174|NCT00003671|Asparaginase|asparaginase|mesh-list
92345175|NCT00003671|Mercaptopurine|mercaptopurine|mesh-list
92345176|NCT00003671|Thioguanine|thioguanine|mesh-list
92345177|NCT00003671|Levoleucovorin|levoleucovorin|mesh-list
92345178|NCT00003671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345179|NCT00003671|Immunologic Factors|immunologic factors|mesh-ancestor
92345180|NCT00003671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345181|NCT00003671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345182|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345183|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
92345184|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345185|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345186|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92345187|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345188|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
92345189|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
92345190|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345191|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345192|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
92345193|NCT00003671|Hormones|hormones|mesh-ancestor
92345194|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345195|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109717|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
92345196|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92345197|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
92345198|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92345199|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345200|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
92345201|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
92345202|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345203|NCT00003671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92345204|NCT00003671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345205|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
92345206|NCT00003671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345207|NCT00003671|Antidotes|antidotes|mesh-ancestor
92345208|NCT00003671|Protective Agents|protective agents|mesh-ancestor
92345209|NCT00003671|Vitamin B Complex|vitamin b complex|mesh-ancestor
92345210|NCT00003671|Vitamins|vitamins|mesh-ancestor
92345211|NCT00003671|Micronutrients|micronutrients|mesh-ancestor
92345212|NCT00003671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92345213|NCT00003671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92345214|NCT00003671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345215|NCT00003671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345216|NCT00003671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92345217|NCT00003671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92345218|NCT00003671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345219|NCT00003677|Dolastatin 10|dolastatin 10|mesh-list
92345220|NCT00003677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345221|NCT00003677|Tubulin Modulators|tubulin modulators|mesh-ancestor
92345222|NCT00003677|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345223|NCT00003677|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345224|NCT00003677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345225|NCT00384605|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|n-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|mesh-list
92345226|NCT00384605|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92345227|NCT00384605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92345228|NCT00384605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345229|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345230|NCT00384605|Hormones|hormones|mesh-ancestor
92345231|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345232|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345233|NCT00003683|Doxorubicin|doxorubicin|mesh-list
92345234|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92345235|NCT00003683|Ifosfamide|ifosfamide|mesh-list
92345236|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92345237|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345238|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92345239|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345240|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345241|NCT00003683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345242|NCT00003683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345243|NCT00003683|Alkylating Agents|alkylating agents|mesh-ancestor
92345244|NCT00003707|Gemcitabine|gemcitabine|mesh-list
92345245|NCT00003707|Tipifarnib|tipifarnib|mesh-list
92345246|NCT00003707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345247|NCT00003707|Antimetabolites|antimetabolites|mesh-ancestor
92345248|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345249|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345250|NCT00003719|Irinotecan|irinotecan|mesh-list
92345251|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92345252|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345253|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345254|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345255|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345257|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345258|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92109873|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
92345259|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345260|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345261|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345262|NCT00003731|Temozolomide|temozolomide|mesh-list
92345263|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345264|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
92345265|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345266|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997775|NCT05047991|Antidotes|antidotes|mesh-ancestor
92345267|NCT00003743|Aldesleukin|aldesleukin|mesh-list
92345268|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345270|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92345271|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
92345272|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345273|NCT00384917|Ketoconazole|ketoconazole|mesh-list
92345274|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
92345275|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345276|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92345277|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92345278|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345279|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109921|NCT02474628|Antacids|antacids|mesh-ancestor
92345280|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92345281|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
92345282|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345283|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345284|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92345285|NCT05444153|Empagliflozin|empagliflozin|mesh-list
92345286|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92345287|NCT05444153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345288|NCT05444153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92345289|NCT05444153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345290|NCT00003797|Gemcitabine|gemcitabine|mesh-list
92345291|NCT00003797|Trastuzumab|trastuzumab|mesh-list
92345292|NCT00003797|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345293|NCT00003797|Antimetabolites|antimetabolites|mesh-ancestor
92345294|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345295|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345296|NCT00003797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345297|NCT00003803|Gemcitabine|gemcitabine|mesh-list
92345298|NCT00003803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345299|NCT00003803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345300|NCT00003803|Antimetabolites|antimetabolites|mesh-ancestor
92345301|NCT00003803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345302|NCT00003815|Cytarabine|cytarabine|mesh-list
92345303|NCT00003815|Prednisolone|prednisolone|mesh-list
92345304|NCT00003815|Cyclophosphamide|cyclophosphamide|mesh-list
92345305|NCT00003815|Melphalan|melphalan|mesh-list
92345306|NCT00003815|Carmustine|carmustine|mesh-list
92345307|NCT00003815|Doxorubicin|doxorubicin|mesh-list
92345308|NCT00003815|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92345309|NCT00003815|Etoposide|etoposide|mesh-list
92345310|NCT00003815|Vincristine|vincristine|mesh-list
92345311|NCT00003815|Bleomycin|bleomycin|mesh-list
92345312|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345313|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
92345314|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345315|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345316|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345317|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
92345318|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345319|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345320|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92345321|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92345322|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92345323|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345324|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345325|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92345326|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345327|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
92345328|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
92345329|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345330|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
92345331|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345332|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345333|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345335|NCT00003815|Hormones|hormones|mesh-ancestor
92345336|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345337|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345338|NCT00003821|Aminopterin|aminopterin|mesh-list
92345339|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92345340|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997844|NCT05034965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345341|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345342|NCT00003827|Cytarabine|cytarabine|mesh-list
92345343|NCT00003827|Topotecan|topotecan|mesh-list
92345344|NCT00003827|Amifostine|amifostine|mesh-list
92345345|NCT00003827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345346|NCT00003827|Antimetabolites|antimetabolites|mesh-ancestor
92345347|NCT00003827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345348|NCT00003827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345349|NCT00003827|Antiviral Agents|antiviral agents|mesh-ancestor
92345350|NCT00003827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345351|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345352|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
92345353|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345354|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92345355|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345357|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92345358|NCT00003827|Protective Agents|protective agents|mesh-ancestor
92345359|NCT00003851|Gemcitabine|gemcitabine|mesh-list
92345360|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345361|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
92345362|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345363|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345364|NCT00003881|Paclitaxel|paclitaxel|mesh-list
92345365|NCT00003881|Carboplatin|carboplatin|mesh-list
92345366|NCT00003881|Trastuzumab|trastuzumab|mesh-list
92345367|NCT00003881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92345368|NCT00003881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345370|NCT00003881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345371|NCT00003881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345372|NCT00003881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345373|NCT00003881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345374|NCT00003893|Cyclophosphamide|cyclophosphamide|mesh-list
92345375|NCT00003893|Doxorubicin|doxorubicin|mesh-list
92345376|NCT00003893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92345377|NCT00003893|Fluorouracil|fluorouracil|mesh-list
92345378|NCT00003893|Methotrexate|methotrexate|mesh-list
92345379|NCT00003893|Epirubicin|epirubicin|mesh-list
92345380|NCT00003893|Mitoxantrone|mitoxantrone|mesh-list
92345381|NCT00003893|Mitomycins|mitomycins|mesh-list
92345382|NCT00003893|Mitomycin|mitomycin|mesh-list
92345383|NCT00003893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345384|NCT00003893|Immunologic Factors|immunologic factors|mesh-ancestor
92345385|NCT00003893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345386|NCT00003893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345387|NCT00003893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345388|NCT00003893|Alkylating Agents|alkylating agents|mesh-ancestor
92345389|NCT00003893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345390|NCT00003893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345391|NCT00003893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92345392|NCT00003893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92345393|NCT00003893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92345394|NCT00003893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110104|NCT02859558|Cobicistat|cobicistat|mesh-list
92345395|NCT00003893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345396|NCT00003893|Antimetabolites|antimetabolites|mesh-ancestor
92345397|NCT00003893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345398|NCT00003893|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92345399|NCT00003893|Abortifacient Agents|abortifacient agents|mesh-ancestor
92345400|NCT00003893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92345401|NCT00003893|Dermatologic Agents|dermatologic agents|mesh-ancestor
92345402|NCT00003893|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92345403|NCT00003893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345404|NCT00003893|Analgesics|analgesics|mesh-ancestor
92345405|NCT00003893|Sensory System Agents|sensory system agents|mesh-ancestor
92345406|NCT00003893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345407|NCT00003899|Paclitaxel|paclitaxel|mesh-list
92345408|NCT00003899|Cyclophosphamide|cyclophosphamide|mesh-list
92345410|NCT00003899|Thiotepa|thiotepa|mesh-list
92345411|NCT00003899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92345412|NCT00003899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345413|NCT00003899|Tubulin Modulators|tubulin modulators|mesh-ancestor
92345414|NCT00003899|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345415|NCT00003899|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345416|NCT00003899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345417|NCT00003899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345418|NCT00003899|Immunologic Factors|immunologic factors|mesh-ancestor
92345419|NCT00003899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345420|NCT00003899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110151|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
92345421|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345422|NCT00003899|Alkylating Agents|alkylating agents|mesh-ancestor
92345423|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92345424|NCT00003917|Topotecan|topotecan|mesh-list
92345425|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92345426|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345427|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345428|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345429|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345430|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92345431|NCT00003923|Trioxsalen|trioxsalen|mesh-list
92345432|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345433|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
92345434|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92345435|NCT00003929|Lomustine|lomustine|mesh-list
92345436|NCT00003929|Procarbazine|procarbazine|mesh-list
92345437|NCT00003929|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92345438|NCT00003929|Alkylating Agents|alkylating agents|mesh-ancestor
92345439|NCT00003929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345440|NCT00003929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345441|NCT02210663|Veliparib|veliparib|mesh-list
92345442|NCT02210663|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92345443|NCT02210663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110205|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
92345444|NCT02210663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345445|NCT02210663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345446|NCT04568837|Dexamethasone|dexamethasone|mesh-list
92345447|NCT04568837|Dexamethasone acetate|dexamethasone acetate|mesh-list
92345448|NCT04568837|Prednisone|prednisone|mesh-list
92345449|NCT04568837|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92345450|NCT04568837|BB 1101|bb 1101|mesh-list
92345451|NCT04568837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345452|NCT04568837|Antiemetics|antiemetics|mesh-ancestor
92345453|NCT04568837|Autonomic Agents|autonomic agents|mesh-ancestor
92345454|NCT04568837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345455|NCT04568837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345456|NCT04568837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345457|NCT04568837|Glucocorticoids|glucocorticoids|mesh-ancestor
92345458|NCT04568837|Hormones|hormones|mesh-ancestor
92345459|NCT04568837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345460|NCT04568837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345461|NCT04568837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345462|NCT04568837|Protease Inhibitors|protease inhibitors|mesh-ancestor
92345463|NCT04568837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345464|NCT04568837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345465|NCT02210819|Rivaroxaban|rivaroxaban|mesh-list
92345466|NCT02210819|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92345467|NCT02210819|Antithrombins|antithrombins|mesh-ancestor
92345468|NCT02210819|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92345469|NCT02210819|Protease Inhibitors|protease inhibitors|mesh-ancestor
92345470|NCT02210819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345471|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345472|NCT02210819|Anticoagulants|anticoagulants|mesh-ancestor
92345473|NCT04564469|Furosemide|furosemide|mesh-list
92345474|NCT04564469|Diuretics|diuretics|mesh-ancestor
92345475|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
92345476|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345477|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92345478|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92345479|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345480|NCT04564001|Infliximab|infliximab|mesh-list
92110264|NCT02047578|Busulfan|busulfan|mesh-list
92345481|NCT04564001|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92345482|NCT04564001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345483|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
92345484|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345485|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345487|NCT04568603|Methadone|methadone|mesh-list
92345488|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92345489|NCT04568603|Narcotics|narcotics|mesh-ancestor
92345490|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345491|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345492|NCT04568603|Analgesics|analgesics|mesh-ancestor
92345493|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
92345494|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345495|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
92345496|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
92345497|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
92345498|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345499|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345500|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345501|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92345502|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345503|NCT04568603|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92345504|NCT04563299|Prednisolone|prednisolone|mesh-list
92345505|NCT04563299|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92345506|NCT04563299|Methylprednisolone|methylprednisolone|mesh-list
92345507|NCT04563299|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92345508|NCT04563299|Prednisolone acetate|prednisolone acetate|mesh-list
92345510|NCT04563299|Prednisolone phosphate|prednisolone phosphate|mesh-list
92345511|NCT04563299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345512|NCT04563299|Glucocorticoids|glucocorticoids|mesh-ancestor
92345514|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345515|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345516|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91915739|NCT02127593|Moxifloxacin|moxifloxacin|mesh-list
92345517|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345518|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
92345519|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
92345520|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345521|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345522|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92345523|NCT04563299|Protective Agents|protective agents|mesh-ancestor
92345524|NCT04561817|Paclitaxel|paclitaxel|mesh-list
92345525|NCT04561817|Ipatasertib|ipatasertib|mesh-list
92345526|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92345527|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345528|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
92345529|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345530|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345531|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345532|NCT04561817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92345533|NCT04561817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345534|NCT02211833|Pemetrexed|pemetrexed|mesh-list
92345535|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345536|NCT02211833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345537|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345538|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92345539|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345540|NCT02211443|Antibodies|antibodies|mesh-list
92345541|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92345542|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
92345543|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345544|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
92345545|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92345546|NCT02211521|Immunologic Factors|immunologic factors|mesh-ancestor
92345547|NCT02211521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345548|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
92345549|NCT02211521|Protective Agents|protective agents|mesh-ancestor
92345550|NCT01597908|Trametinib|trametinib|mesh-list
92345551|NCT01597908|Vemurafenib|vemurafenib|mesh-list
92345552|NCT01597908|Dabrafenib|dabrafenib|mesh-list
92345553|NCT01597908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345554|NCT01597908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92345555|NCT01597908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345556|NCT01597908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345557|NCT01948908|Midazolam|midazolam|mesh-list
92345558|NCT01948908|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92345560|NCT01948908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345561|NCT01948908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345562|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92345563|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92345564|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92345565|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92345566|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
91998070|NCT01939366|Pregabalin|pregabalin|mesh-list
92345567|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
92345568|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
92345569|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
92345570|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345571|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345572|NCT01925274|Irinotecan|irinotecan|mesh-list
92345573|NCT01925274|Cetuximab|cetuximab|mesh-list
92345574|NCT01925274|Gedatolisib|gedatolisib|mesh-list
92345575|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92345576|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345577|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345578|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345579|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345580|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92345581|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92345582|NCT01948830|Ranibizumab|ranibizumab|mesh-list
92345583|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92345584|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92345585|NCT01948830|Growth Substances|growth substances|mesh-ancestor
92345586|NCT01948830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345587|NCT01948830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92345588|NCT01948830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345589|NCT01972464|Progesterone|progesterone|mesh-list
92345590|NCT01972464|Progestins|progestins|mesh-ancestor
92345591|NCT01972464|Hormones|hormones|mesh-ancestor
92345592|NCT01972464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345593|NCT01972464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345594|NCT01924182|Morphine|morphine|mesh-list
92345595|NCT01924182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92345596|NCT01924182|Narcotics|narcotics|mesh-ancestor
92345597|NCT01924182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345598|NCT01924182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345599|NCT01924182|Analgesics|analgesics|mesh-ancestor
92345600|NCT01924182|Sensory System Agents|sensory system agents|mesh-ancestor
92110435|NCT00557128|Lisinopril|lisinopril|mesh-list
92345601|NCT01924182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345602|NCT01946880|Mycophenolic Acid|mycophenolic acid|mesh-list
92345603|NCT01946880|Hydroxychloroquine|hydroxychloroquine|mesh-list
92345604|NCT01946880|Chloroquine|chloroquine|mesh-list
92345605|NCT01946880|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92345606|NCT01946880|Prednisone|prednisone|mesh-list
92345607|NCT01946880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345608|NCT01946880|Glucocorticoids|glucocorticoids|mesh-ancestor
92345609|NCT01946880|Hormones|hormones|mesh-ancestor
92345610|NCT01946880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345611|NCT01946880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345612|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345613|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345614|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92345615|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92345616|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
92345617|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92345618|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345619|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345620|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345621|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
92345622|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92345624|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92345625|NCT01946880|Amebicides|amebicides|mesh-ancestor
92345626|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92110472|NCT03303924|Sulbactam|sulbactam|mesh-list
92345627|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92345629|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
92345630|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345631|NCT01946880|Filaricides|filaricides|mesh-ancestor
92345632|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
92345633|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
92345634|NCT01972152|Glucagon|glucagon|mesh-list
92345635|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345636|NCT01972152|Hormones|hormones|mesh-ancestor
92345637|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345638|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345639|NCT01972074|Memantine|memantine|mesh-list
92345640|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92345641|NCT01972074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92345642|NCT01972074|Dopamine Agents|dopamine agents|mesh-ancestor
92345643|NCT01972074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345644|NCT01972074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345645|NCT01972074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345646|NCT01972074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92345647|NCT01972074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92345649|NCT01618266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345650|NCT01618266|Antiemetics|antiemetics|mesh-ancestor
92345651|NCT01618266|Autonomic Agents|autonomic agents|mesh-ancestor
92345652|NCT01618266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345653|NCT01618266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345654|NCT01618266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345655|NCT01618266|Glucocorticoids|glucocorticoids|mesh-ancestor
92345656|NCT01618266|Hormones|hormones|mesh-ancestor
92345657|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345658|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92345659|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345660|NCT01918332|Valsartan|valsartan|mesh-list
92345661|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92345662|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92345663|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92345664|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
92345665|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345666|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92345667|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92345668|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345669|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91916201|NCT02133287|Immunologic Factors|immunologic factors|mesh-ancestor
92345670|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92345671|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92345672|NCT01922934|Topiramate|topiramate|mesh-list
92345673|NCT01922934|Phentermine|phentermine|mesh-list
92345674|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
92345675|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92345676|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345677|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92345678|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
92345679|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92345680|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
92345681|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
92345682|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345683|NCT01922934|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345684|NCT01922934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345685|NCT01922934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345687|NCT01921140|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92345688|NCT01921140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345689|NCT01921140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345690|NCT01921140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345691|NCT01917006|Botulinum Toxins|botulinum toxins|mesh-list
92345692|NCT01917006|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92345693|NCT01917006|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92345694|NCT01917006|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92345695|NCT01917006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92345696|NCT01917006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345698|NCT01917006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345699|NCT01917006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345700|NCT01917006|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92345701|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345702|NCT01916226|Cetirizine|cetirizine|mesh-list
92110678|NCT03307590|Analgesics|analgesics|mesh-ancestor
92345704|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92345705|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92345706|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
92345708|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345709|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345710|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345711|NCT01915914|Fluticasone|fluticasone|mesh-list
92345712|NCT01915914|Xhance|xhance|mesh-list
92345713|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345714|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92345715|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
92345716|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345717|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345718|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92345719|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92345720|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
92345721|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92345722|NCT01968954|Bococizumab|bococizumab|mesh-list
92345723|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92345724|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92345725|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
92349537|NCT01490580|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92345726|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345727|NCT01968954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92345729|NCT01919190|Anesthetics, Local|anesthetics, local|mesh-ancestor
92345730|NCT01919190|Anesthetics|anesthetics|mesh-ancestor
92345731|NCT01919190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345732|NCT01919190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345733|NCT01919190|Sensory System Agents|sensory system agents|mesh-ancestor
92345734|NCT01919190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345735|NCT01620060|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92345736|NCT01620060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92345737|NCT01620060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92345738|NCT01620060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345739|NCT01620060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345740|NCT01620060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92345741|NCT01620060|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92345742|NCT01620060|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92345743|NCT01620060|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92345744|NCT01620060|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345745|NCT01620060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345746|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345747|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92345748|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92345749|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
92345750|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92345751|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92345752|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
92345753|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92345754|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92110799|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
92345755|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92345756|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92345757|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345758|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345759|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345760|NCT01914666|Analgesics|analgesics|mesh-ancestor
92345761|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
92345762|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345763|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
92345764|NCT01914666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92345765|NCT01914666|Dopamine Agents|dopamine agents|mesh-ancestor
92345766|NCT01913340|Epoetin Alfa|epoetin alfa|mesh-list
92345767|NCT01913340|Hematinics|hematinics|mesh-ancestor
92345768|NCT01912872|Omalizumab|omalizumab|mesh-list
92345769|NCT01912872|Budesonide|budesonide|mesh-list
92345770|NCT01912872|Formoterol Fumarate|formoterol fumarate|mesh-list
92345771|NCT01912872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92345772|NCT01912872|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92345773|NCT01912872|Autonomic Agents|autonomic agents|mesh-ancestor
92345774|NCT01912872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345775|NCT01912872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345776|NCT01912872|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92345777|NCT01912872|Respiratory System Agents|respiratory system agents|mesh-ancestor
92345778|NCT01912872|Glucocorticoids|glucocorticoids|mesh-ancestor
92345779|NCT01912872|Hormones|hormones|mesh-ancestor
92345780|NCT01912872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345781|NCT01912872|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92345782|NCT01912872|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92345783|NCT01912872|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92345784|NCT01912872|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345785|NCT01912872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345786|NCT01912872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345787|NCT01912872|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92345789|NCT01911780|Telmisartan|telmisartan|mesh-list
92345790|NCT01911780|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92345791|NCT01911780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92345792|NCT01911780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92345793|NCT01911780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92345794|NCT01911780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345795|NCT01911780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92345796|NCT01911780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345797|NCT01911780|Vasodilator Agents|vasodilator agents|mesh-ancestor
92345798|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92345799|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92345800|NCT01911780|Diuretics|diuretics|mesh-ancestor
92345802|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92345803|NCT01911546|Everolimus|everolimus|mesh-list
92345804|NCT01911546|Tacrolimus|tacrolimus|mesh-list
92345805|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92345806|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
92345807|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345808|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92345809|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349538|NCT01490580|Respiratory System Agents|respiratory system agents|mesh-ancestor
92345810|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345811|NCT01911546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92345812|NCT01911546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92345813|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345814|NCT01908816|Ranibizumab|ranibizumab|mesh-list
92345815|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92345816|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92345817|NCT01908816|Growth Substances|growth substances|mesh-ancestor
92345818|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345819|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
92345820|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345821|NCT01908582|Rifampin|rifampin|mesh-list
92345822|NCT01908582|Evacetrapib|evacetrapib|mesh-list
92345823|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92345824|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
92345825|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92345826|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345827|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
92345828|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345829|NCT01908582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345830|NCT01908582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345831|NCT01908582|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92345832|NCT01908582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92345833|NCT01908582|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92345834|NCT01908582|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92345835|NCT01908582|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92345836|NCT01908582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92345837|NCT01908582|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92345838|NCT01908582|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92345839|NCT01908582|Antimetabolites|antimetabolites|mesh-ancestor
92345840|NCT01908582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92345841|NCT01907100|Cisplatin|cisplatin|mesh-list
92345842|NCT01907100|Pemetrexed|pemetrexed|mesh-list
92345843|NCT01907100|Nintedanib|nintedanib|mesh-list
92345844|NCT01907100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345845|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345846|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345847|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92345848|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92345849|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92345850|NCT01889862|Dextrans|dextrans|mesh-list
92345851|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
92345852|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
92345853|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
92345854|NCT01887288|Capecitabine|capecitabine|mesh-list
92345855|NCT01887288|Digoxin|digoxin|mesh-list
92345856|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345857|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
92345858|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345859|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345860|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92345861|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92345862|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345863|NCT01887288|Protective Agents|protective agents|mesh-ancestor
92345864|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345865|NCT03405714|Brivaracetam|brivaracetam|mesh-list
92345866|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
92345867|NCT01885182|Oxycodone|oxycodone|mesh-list
92345868|NCT01885182|Naloxone|naloxone|mesh-list
92345869|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92345870|NCT01885182|Narcotics|narcotics|mesh-ancestor
92345871|NCT01885182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345872|NCT01885182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345873|NCT01885182|Analgesics|analgesics|mesh-ancestor
92345874|NCT01885182|Sensory System Agents|sensory system agents|mesh-ancestor
92345875|NCT01885182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345876|NCT01885182|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92345877|NCT01885104|Bisacodyl|bisacodyl|mesh-list
92345878|NCT01885104|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92345879|NCT01885104|Laxatives|laxatives|mesh-list
92345880|NCT01885104|Cathartics|cathartics|mesh-ancestor
92345881|NCT01885104|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345882|NCT01906008|Minocycline|minocycline|mesh-list
92345883|NCT01906008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92345884|NCT01906008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92345885|NCT01904760|Dexmedetomidine|dexmedetomidine|mesh-list
92345886|NCT01904760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92345887|NCT01904760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92345888|NCT01904760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345889|NCT01904760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92345890|NCT01904760|Analgesics|analgesics|mesh-ancestor
92345891|NCT01904760|Sensory System Agents|sensory system agents|mesh-ancestor
92345892|NCT01904760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345893|NCT01904760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92345894|NCT01904760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92345895|NCT01904760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92111266|NCT01768559|Insulin|insulin|mesh-list
92345896|NCT01904760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345897|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345898|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345899|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92345900|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92345901|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345902|NCT01881126|Timolol|timolol|mesh-list
92345903|NCT01881126|Bimatoprost|bimatoprost|mesh-list
92345904|NCT01881126|Travoprost|travoprost|mesh-list
92345905|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345906|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92345907|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92345908|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345909|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345910|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345911|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92345912|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92345913|NCT01880736|Insulin|insulin|mesh-list
92345914|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92345915|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
92345916|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92345917|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345918|NCT01880424|Linaclotide|linaclotide|mesh-list
92345919|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92345920|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
92345921|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345922|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92345923|NCT01862874|Vaccines|vaccines|mesh-list
92345924|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
92345925|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345926|NCT01903434|Evacetrapib|evacetrapib|mesh-list
92345927|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92345928|NCT01903434|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92345930|NCT01903434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345931|NCT01903434|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92345932|NCT01903356|Linagliptin|linagliptin|mesh-list
92345933|NCT01903356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92345934|NCT01903356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345935|NCT01903356|Incretins|incretins|mesh-ancestor
92345936|NCT01903356|Hormones|hormones|mesh-ancestor
92345937|NCT01903356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92345938|NCT01903356|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92345939|NCT01903356|Protease Inhibitors|protease inhibitors|mesh-ancestor
92345940|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345941|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345942|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
92345943|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
92345944|NCT01862640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345945|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345946|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345947|NCT01862640|Dopamine Agonists|dopamine agonists|mesh-ancestor
92345948|NCT01862640|Dopamine Agents|dopamine agents|mesh-ancestor
92345949|NCT01902966|Propranolol|propranolol|mesh-list
92345950|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92345951|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92345952|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345953|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345954|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345955|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345956|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92345957|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92345958|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
92345959|NCT01862328|Paclitaxel|paclitaxel|mesh-list
92345960|NCT01862328|Docetaxel|docetaxel|mesh-list
92345961|NCT01862328|Carboplatin|carboplatin|mesh-list
92345962|NCT01862328|Gemcitabine|gemcitabine|mesh-list
92345963|NCT01862328|Pevonedistat|pevonedistat|mesh-list
92345964|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92111426|NCT03832816|Analgesics|analgesics|mesh-ancestor
92345965|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345966|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
92345967|NCT01862328|Antimitotic Agents|antimitotic agents|mesh-ancestor
92345968|NCT01862328|Mitosis Modulators|mitosis modulators|mesh-ancestor
92345969|NCT01862328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345970|NCT01862328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92345971|NCT01862328|Antimetabolites|antimetabolites|mesh-ancestor
92345972|NCT01862328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345973|NCT01862250|Clonidine|clonidine|mesh-list
92345974|NCT01862250|Analgesics|analgesics|mesh-ancestor
92345975|NCT01862250|Sensory System Agents|sensory system agents|mesh-ancestor
92345976|NCT01862250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345977|NCT01862250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345978|NCT01862250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92345979|NCT01862250|Sympatholytics|sympatholytics|mesh-ancestor
92345980|NCT01862250|Autonomic Agents|autonomic agents|mesh-ancestor
92345981|NCT01862250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92345982|NCT01862250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92345983|NCT01862250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92345984|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
92345985|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92345986|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345987|NCT01876446|Irinotecan|irinotecan|mesh-list
92345988|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92345989|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92345990|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92345991|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92345992|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92345993|NCT04414800|Fentanyl|fentanyl|mesh-list
92345994|NCT04414800|Ketamine|ketamine|mesh-list
92345995|NCT04414800|Analgesics|analgesics|mesh-ancestor
92345996|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
92345997|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92345998|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92345999|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92346000|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92346003|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346004|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92346005|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92346006|NCT04414800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346007|NCT04414800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346008|NCT04414800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92346009|NCT04414800|Narcotics|narcotics|mesh-ancestor
92346010|NCT04414800|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92346011|NCT01898442|Ticagrelor|ticagrelor|mesh-list
92346012|NCT01898442|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92346013|NCT01898442|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92346014|NCT01898442|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92346015|NCT01898442|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92346016|NCT01898442|Purinergic Agents|purinergic agents|mesh-ancestor
92346017|NCT01898442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346018|NCT01898442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346020|NCT01898208|Anti-Infective Agents|anti-infective agents|mesh-list
92346021|NCT01898208|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92346022|NCT01898130|Bevacizumab|bevacizumab|mesh-list
92346023|NCT01898130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92346025|NCT01898130|Immunoglobulins|immunoglobulins|mesh-list
92346026|NCT01898130|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92346027|NCT01898130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346028|NCT01898130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92346029|NCT01898130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92346030|NCT01898130|Growth Substances|growth substances|mesh-ancestor
92346031|NCT01898130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346032|NCT01898130|Growth Inhibitors|growth inhibitors|mesh-ancestor
92346033|NCT01898130|Immunologic Factors|immunologic factors|mesh-ancestor
92346034|NCT01876368|Olmesartan|olmesartan|mesh-list
92346035|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92346036|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92346037|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92346038|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92346039|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92346040|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346041|NCT01873950|Quinidine|quinidine|mesh-list
92346042|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
92346043|NCT01873950|Verapamil|verapamil|mesh-list
92346045|NCT01873950|Ranolazine|ranolazine|mesh-list
92346046|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92346047|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92346048|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346049|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111719|NCT01938040|Ibuprofen|ibuprofen|mesh-list
92346050|NCT01873950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92346051|NCT01873950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346052|NCT01873950|Vasodilator Agents|vasodilator agents|mesh-ancestor
92346053|NCT01873950|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92346054|NCT01873950|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92346055|NCT01873950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92346056|NCT01873950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92346057|NCT01873950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346058|NCT01873950|Antimalarials|antimalarials|mesh-ancestor
92346059|NCT01873950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92346060|NCT01873950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92346061|NCT01873950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346062|NCT01873950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111764|NCT02284126|Vancomycin|vancomycin|mesh-list
92346063|NCT01873950|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92346064|NCT01873950|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92346065|NCT01873950|Cholinergic Agents|cholinergic agents|mesh-ancestor
92346066|NCT01873950|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92346067|NCT01873950|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92346068|NCT01873950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92346069|NCT01873950|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92346070|NCT01896726|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92346071|NCT01896726|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92346072|NCT01896726|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92346073|NCT01896726|Contraceptive Agents|contraceptive agents|mesh-ancestor
92346074|NCT01896726|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92346075|NCT01896726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111847|NCT02974257|Thiamine|thiamine|mesh-list
92346076|NCT01896726|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92346077|NCT01896726|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92346078|NCT01896726|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92346079|NCT01896726|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92346080|NCT01896726|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92346081|NCT01896726|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92346082|NCT01896726|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92346083|NCT01896726|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92346085|NCT01856790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346086|NCT01856790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346087|NCT01856790|Incretins|incretins|mesh-ancestor
92346089|NCT01856790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346090|NCT01856322|Sulindac|sulindac|mesh-list
92346091|NCT01856322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92346093|NCT01856322|Analgesics|analgesics|mesh-ancestor
92346094|NCT01856322|Sensory System Agents|sensory system agents|mesh-ancestor
92346095|NCT01856322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346096|NCT01856322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346097|NCT01856322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346098|NCT01856322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92346099|NCT01856322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346100|NCT01856322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92346101|NCT01856322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346102|NCT01856322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346103|NCT01871532|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92346104|NCT01871532|Hormones|hormones|mesh-ancestor
92346105|NCT01871532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346106|NCT01871532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346107|NCT01855074|Risperidone|risperidone|mesh-list
92346108|NCT01855074|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92346109|NCT01855074|Serotonin Agents|serotonin agents|mesh-ancestor
92346110|NCT01855074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346111|NCT01855074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346112|NCT01855074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346113|NCT01855074|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92346114|NCT01855074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92346115|NCT01855074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346116|NCT01855074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92346117|NCT01855074|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92346118|NCT01855074|Dopamine Agents|dopamine agents|mesh-ancestor
92346119|NCT01895322|Tolvaptan|tolvaptan|mesh-list
92346120|NCT01895322|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92346121|NCT01895322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346122|NCT01895322|Natriuretic Agents|natriuretic agents|mesh-ancestor
92346123|NCT01895322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346124|NCT01894776|Maraviroc|maraviroc|mesh-list
92346125|NCT01894776|Rifabutin|rifabutin|mesh-list
92346126|NCT01894776|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92346127|NCT01894776|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92346128|NCT01894776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346129|NCT01894776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92346130|NCT01894776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92346131|NCT01894776|Antiviral Agents|antiviral agents|mesh-ancestor
92346132|NCT01894776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346133|NCT01894776|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92346134|NCT01894776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346135|NCT01894776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92346136|NCT01894776|Antitubercular Agents|antitubercular agents|mesh-ancestor
92346137|NCT01854918|Evolocumab|evolocumab|mesh-list
92346138|NCT01854918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92346139|NCT01854918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92346140|NCT01854918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92346141|NCT01854918|Antimetabolites|antimetabolites|mesh-ancestor
92346142|NCT01854918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346143|NCT01854918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92346144|NCT01854918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346145|NCT01854918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346146|NCT01854918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92346147|NCT01894152|Everolimus|everolimus|mesh-list
92346148|NCT01894152|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92346149|NCT01894152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92346150|NCT01894152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346151|NCT01894152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346152|NCT01894152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346154|NCT01894152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346155|NCT01894152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346156|NCT01854528|Interferons|interferons|mesh-list
92346157|NCT01854528|Ribavirin|ribavirin|mesh-list
92346158|NCT01854528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346159|NCT01854528|Antiviral Agents|antiviral agents|mesh-ancestor
92346160|NCT01854528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346161|NCT01854528|Antimetabolites|antimetabolites|mesh-ancestor
92346162|NCT01854528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346163|NCT01853982|Tazobactam|tazobactam|mesh-list
92346164|NCT01853982|Piperacillin|piperacillin|mesh-list
92346165|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92346166|NCT01853982|Ceftolozane|ceftolozane|mesh-list
92346167|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92346168|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346169|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346170|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92346171|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346172|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346173|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92346174|NCT01853280|Methylphenidate|methylphenidate|mesh-list
92346175|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92346176|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346177|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92349539|NCT01490580|Mydriatics|mydriatics|mesh-ancestor
92346178|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92346179|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346180|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346181|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
92346182|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346183|NCT01891890|Lamotrigine|lamotrigine|mesh-list
92346184|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
92346185|NCT01891890|Levetiracetam|levetiracetam|mesh-list
92346186|NCT01891890|Anticonvulsants|anticonvulsants|mesh-ancestor
92346187|NCT01891890|Nootropic Agents|nootropic agents|mesh-ancestor
92346188|NCT01891890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92346189|NCT01891890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346190|NCT01891890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346191|NCT01891890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92346192|NCT01891890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346193|NCT01891890|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92346194|NCT01891890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92346195|NCT01891890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346196|NCT01891890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92346197|NCT01891890|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92346198|NCT01891890|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92346199|NCT01891890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92346200|NCT01891890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92346201|NCT01852812|Montelukast|montelukast|mesh-list
92346202|NCT01852812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92346203|NCT01852812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92346204|NCT01852812|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92346205|NCT01852812|Hormone Antagonists|hormone antagonists|mesh-ancestor
92346206|NCT01852812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346207|NCT01852812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112237|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
92346208|NCT01852812|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92346209|NCT01852812|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92346210|NCT01852812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346211|NCT01869192|Cyclophosphamide|cyclophosphamide|mesh-list
92346212|NCT01869192|Docetaxel|docetaxel|mesh-list
92346213|NCT01869192|Capecitabine|capecitabine|mesh-list
92346214|NCT01869192|Epirubicin|epirubicin|mesh-list
92346215|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346216|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
92346217|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346218|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92346219|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92346221|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346222|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346223|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92346224|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
92346225|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
92346226|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
92346227|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346228|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
92346229|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92346230|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92346231|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92346232|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346234|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92346235|NCT01851720|Narcotics|narcotics|mesh-ancestor
92346236|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937191|NCT01207115|Analgesics|analgesics|mesh-ancestor
92346237|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346238|NCT01851720|Analgesics|analgesics|mesh-ancestor
92346239|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
92346240|NCT01851720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346241|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92346242|NCT01851720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92346243|NCT01851720|Anesthetics, General|anesthetics, general|mesh-ancestor
92346244|NCT01851720|Anesthetics|anesthetics|mesh-ancestor
92346246|NCT01851330|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92346247|NCT01851330|Ledipasvir|ledipasvir|mesh-list
92346248|NCT01851330|Antiviral Agents|antiviral agents|mesh-ancestor
92346249|NCT01851330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346251|NCT01868022|Docetaxel|docetaxel|mesh-list
92346252|NCT01868022|Carboplatin|carboplatin|mesh-list
92346253|NCT01868022|Pemetrexed|pemetrexed|mesh-list
92346254|NCT01868022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92346255|NCT01868022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346256|NCT01868022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92346257|NCT01868022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92349540|NCT01490580|Parasympatholytics|parasympatholytics|mesh-ancestor
92346259|NCT01868022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346260|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346261|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92346262|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92346264|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346265|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92346266|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346267|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346268|NCT01867710|Dexamethasone|dexamethasone|mesh-list
92346269|NCT01867710|Prednisone|prednisone|mesh-list
92346270|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
92346271|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346272|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
92346273|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
92346274|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346275|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346276|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92346277|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
92346279|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346280|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92346281|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346282|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92346284|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346285|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
92112543|NCT04273035|Midazolam|midazolam|mesh-list
92346286|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92346288|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
92346289|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346290|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92346291|NCT01832766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92346292|NCT01832766|Analgesics|analgesics|mesh-ancestor
92346293|NCT01832766|Sensory System Agents|sensory system agents|mesh-ancestor
92346294|NCT01832766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346295|NCT01832766|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92346296|NCT01832766|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92346297|NCT01832766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346298|NCT01832766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346299|NCT01832766|Hormones|hormones|mesh-ancestor
92346300|NCT01832766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346301|NCT01832532|Liraglutide|liraglutide|mesh-list
92346302|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346303|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346304|NCT01832532|Incretins|incretins|mesh-ancestor
92346305|NCT01832532|Hormones|hormones|mesh-ancestor
92346306|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346307|NCT04414956|Vitamin K|vitamin k|mesh-list
92346308|NCT04414956|Agglutinins|agglutinins|mesh-list
92346309|NCT04414956|Vitamins|vitamins|mesh-ancestor
92346310|NCT04414956|Micronutrients|micronutrients|mesh-ancestor
92346311|NCT04414956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346312|NCT04414956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92346313|NCT04414956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92346314|NCT04414956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346315|NCT04414956|Hemostatics|hemostatics|mesh-ancestor
92346316|NCT04414956|Coagulants|coagulants|mesh-ancestor
92346317|NCT04414956|Immunologic Factors|immunologic factors|mesh-ancestor
92346319|NCT01848990|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92346320|NCT01848990|Insulin Aspart|insulin aspart|mesh-list
92346321|NCT01848990|Insulin Lispro|insulin lispro|mesh-list
92346322|NCT01848990|Insulin glulisine|insulin glulisine|mesh-list
92346323|NCT01848990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346324|NCT01848990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346325|NCT01867086|Carboplatin|carboplatin|mesh-list
92346326|NCT01867086|Vaccines|vaccines|mesh-list
92346327|NCT01867086|Immunologic Factors|immunologic factors|mesh-ancestor
92346328|NCT01867086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346329|NCT01867086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346330|NCT01848834|Pembrolizumab|pembrolizumab|mesh-list
92346331|NCT01848834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92346332|NCT01848834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346333|NCT01848834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92346334|NCT01848834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346335|NCT04600362|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92346336|NCT04600362|Immunologic Factors|immunologic factors|mesh-ancestor
92346337|NCT04600362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346338|NCT01848210|Troxerutin|troxerutin|mesh-list
92346339|NCT01848210|Anticoagulants|anticoagulants|mesh-ancestor
92346340|NCT01830816|Ixazomib|ixazomib|mesh-list
92346341|NCT01830816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346342|NCT01830816|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346343|NCT01830816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346344|NCT01830816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346345|NCT01846416|Atezolizumab|atezolizumab|mesh-list
92346346|NCT01846416|Antibodies|antibodies|mesh-list
92346347|NCT01846416|Immunologic Factors|immunologic factors|mesh-ancestor
92346348|NCT01846416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346349|NCT01846416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91916353|NCT04091126|Growth Inhibitors|growth inhibitors|mesh-ancestor
92346350|NCT01846416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346351|NCT01846416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92346352|NCT01846416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346354|NCT04589754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346355|NCT04589754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346356|NCT04589754|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92346357|NCT04589754|Alkylating Agents|alkylating agents|mesh-ancestor
92346358|NCT01846104|Vaccines|vaccines|mesh-list
92346359|NCT01846104|Immunologic Factors|immunologic factors|mesh-ancestor
92346360|NCT01846104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346362|NCT01803282|Paclitaxel|paclitaxel|mesh-list
92346363|NCT01803282|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92346364|NCT01803282|Bevacizumab|bevacizumab|mesh-list
92346365|NCT01803282|Carboplatin|carboplatin|mesh-list
92346366|NCT01803282|Gemcitabine|gemcitabine|mesh-list
92346367|NCT01803282|Oxaliplatin|oxaliplatin|mesh-list
92346369|NCT01803282|Pemetrexed|pemetrexed|mesh-list
92346370|NCT01803282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92346371|NCT01803282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346372|NCT01803282|Tubulin Modulators|tubulin modulators|mesh-ancestor
92346373|NCT01803282|Antimitotic Agents|antimitotic agents|mesh-ancestor
92346374|NCT01803282|Mitosis Modulators|mitosis modulators|mesh-ancestor
92346375|NCT01803282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346376|NCT01803282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92346377|NCT01803282|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92346378|NCT01803282|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92346379|NCT01803282|Growth Substances|growth substances|mesh-ancestor
92346380|NCT01803282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346381|NCT01803282|Growth Inhibitors|growth inhibitors|mesh-ancestor
92346382|NCT01803282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346383|NCT01803282|Antimetabolites|antimetabolites|mesh-ancestor
92346384|NCT01803282|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92346385|NCT01803282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92346386|NCT01803282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346387|NCT01803282|Antidotes|antidotes|mesh-ancestor
92346388|NCT01803282|Protective Agents|protective agents|mesh-ancestor
92346389|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
92346392|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92346393|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92346394|NCT01844778|Tobramycin|tobramycin|mesh-list
92346395|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346396|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346397|NCT01802580|Fluocinonide|fluocinonide|mesh-list
92346398|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346399|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
92346400|NCT01802580|Hormones|hormones|mesh-ancestor
92349541|NCT01490580|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92346401|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346402|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346403|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92346404|NCT01611090|Rituximab|rituximab|mesh-list
92346405|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92346406|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92346407|NCT01611090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346408|NCT01611090|Immunologic Factors|immunologic factors|mesh-ancestor
92346409|NCT01611090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346411|NCT01611090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92346412|NCT01611090|Alkylating Agents|alkylating agents|mesh-ancestor
92346413|NCT01611090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346414|NCT01844700|Risperidone|risperidone|mesh-list
92346415|NCT01844700|Aripiprazole|aripiprazole|mesh-list
92346416|NCT01844700|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92346417|NCT01844700|Ziprasidone|ziprasidone|mesh-list
92346418|NCT01844700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92346419|NCT01844700|Serotonin Agents|serotonin agents|mesh-ancestor
92346420|NCT01844700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346421|NCT01844700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346422|NCT01844700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346423|NCT01844700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92346424|NCT01844700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92346425|NCT01844700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346426|NCT01844700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92346427|NCT01844700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92346428|NCT01844700|Dopamine Agents|dopamine agents|mesh-ancestor
92346429|NCT01844700|Antidepressive Agents|antidepressive agents|mesh-ancestor
92346430|NCT01844700|Dopamine Agonists|dopamine agonists|mesh-ancestor
92346431|NCT01844700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92346432|NCT01844700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92346433|NCT01844700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92346434|NCT01844700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92346435|NCT01827384|Carboplatin|carboplatin|mesh-list
92346436|NCT01827384|Everolimus|everolimus|mesh-list
92346437|NCT01827384|Temozolomide|temozolomide|mesh-list
92346438|NCT01827384|Trametinib|trametinib|mesh-list
92346439|NCT01827384|Veliparib|veliparib|mesh-list
92346440|NCT01827384|Adavosertib|adavosertib|mesh-list
92346441|NCT01827384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346442|NCT01827384|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92346443|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92346444|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346445|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346446|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346447|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
92346448|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346449|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92346450|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
92346451|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92346453|NCT01844076|Capecitabine|capecitabine|mesh-list
92346454|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346455|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
92346456|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346457|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346458|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
92346459|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92346460|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
92346461|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92346462|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346463|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
92346464|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92346465|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
92346467|NCT01826448|Vemurafenib|vemurafenib|mesh-list
92346468|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346469|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92346470|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346471|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346472|NCT01826370|Linagliptin|linagliptin|mesh-list
92346473|NCT01826370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346474|NCT01826370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346475|NCT01826370|Incretins|incretins|mesh-ancestor
92346477|NCT01826370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346478|NCT01826370|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92346479|NCT01826370|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346480|NCT01826370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346481|NCT01826370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346482|NCT01799226|Triclosan|triclosan|mesh-list
92346483|NCT01799226|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92346484|NCT01799226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346485|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92346486|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92346487|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
92346488|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346489|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92346490|NCT01798992|Metoprolol|metoprolol|mesh-list
92346491|NCT01798992|Carvedilol|carvedilol|mesh-list
92346492|NCT01798992|Doxazosin|doxazosin|mesh-list
92346493|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92346494|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92346496|NCT01798992|Autonomic Agents|autonomic agents|mesh-ancestor
92346497|NCT01798992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346498|NCT01798992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346499|NCT01798992|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92346500|NCT01798992|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92346501|NCT01798992|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92346502|NCT01798992|Adrenergic Agents|adrenergic agents|mesh-ancestor
92346504|NCT01798992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346506|NCT01798992|Protective Agents|protective agents|mesh-ancestor
92346507|NCT01798992|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92346508|NCT01798992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346509|NCT01798992|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92346510|NCT01798992|Vasodilator Agents|vasodilator agents|mesh-ancestor
92346511|NCT01798992|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92346512|NCT01798992|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92346513|NCT01798056|Vaccines|vaccines|mesh-list
92346514|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
92346515|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346516|NCT01824342|Denosumab|denosumab|mesh-list
92346517|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92346518|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346519|NCT01823328|Ketamine|ketamine|mesh-list
92346520|NCT01823328|Etomidate|etomidate|mesh-list
92346521|NCT01823328|Analgesics|analgesics|mesh-ancestor
92346522|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
92346523|NCT01823328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346524|NCT01823328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346525|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92346526|NCT01823328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92346527|NCT01823328|Anesthetics, General|anesthetics, general|mesh-ancestor
92346528|NCT01823328|Anesthetics|anesthetics|mesh-ancestor
92346529|NCT01823328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346530|NCT01823328|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92346531|NCT01823328|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92346532|NCT01823328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346533|NCT01823328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346534|NCT01823328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92346535|NCT01840410|Ranibizumab|ranibizumab|mesh-list
92346536|NCT01840410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92346537|NCT01840410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92346538|NCT01840410|Growth Substances|growth substances|mesh-ancestor
91999045|NCT05915104|Budesonide|budesonide|mesh-list
92346539|NCT01840410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346540|NCT01840410|Growth Inhibitors|growth inhibitors|mesh-ancestor
92346541|NCT01840410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346542|NCT01797432|Triamcinolone|triamcinolone|mesh-list
92346543|NCT01797432|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92346544|NCT01797432|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92346545|NCT01797432|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92346546|NCT01797432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346547|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
92346548|NCT01797432|Hormones|hormones|mesh-ancestor
92346549|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346550|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346551|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346552|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
92346553|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346554|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346556|NCT01797120|MTOR Inhibitors|mtor inhibitors|mesh-list
92346557|NCT01797120|Fulvestrant|fulvestrant|mesh-list
92346558|NCT01797120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92346559|NCT01797120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346560|NCT01797120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346561|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346562|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
92346563|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346564|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346565|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92346566|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92346567|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92346568|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
92346569|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346571|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92346572|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92346573|NCT01796964|Growth Substances|growth substances|mesh-ancestor
92346574|NCT01796964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346576|NCT01796964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346577|NCT01794780|Fluticasone|fluticasone|mesh-list
92346578|NCT01794780|Budesonide|budesonide|mesh-list
92346579|NCT01794780|Theophylline|theophylline|mesh-list
92346580|NCT01794780|Formoterol Fumarate|formoterol fumarate|mesh-list
92346581|NCT01794780|Tiotropium Bromide|tiotropium bromide|mesh-list
92346582|NCT01794780|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92346584|NCT01794780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92346585|NCT01794780|Autonomic Agents|autonomic agents|mesh-ancestor
92346586|NCT01794780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346587|NCT01794780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346588|NCT01794780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92346589|NCT01794780|Respiratory System Agents|respiratory system agents|mesh-ancestor
92346590|NCT01794780|Dermatologic Agents|dermatologic agents|mesh-ancestor
92346591|NCT01794780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92346593|NCT01794780|Hormones|hormones|mesh-ancestor
92346594|NCT01794780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346595|NCT01794780|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92346596|NCT01794780|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92346597|NCT01794780|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92346598|NCT01794780|Adrenergic Agents|adrenergic agents|mesh-ancestor
92346599|NCT01794780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346600|NCT01794780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346601|NCT01794780|Parasympatholytics|parasympatholytics|mesh-ancestor
92346602|NCT01794780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92346603|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
92346604|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92113224|NCT05325632|Paclitaxel|paclitaxel|mesh-list
92346606|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
92346607|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92346608|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92346609|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
92346610|NCT01838616|Oxycodone|oxycodone|mesh-list
92346611|NCT01838616|Tapentadol|tapentadol|mesh-list
92346612|NCT01838616|Naloxone|naloxone|mesh-list
92346613|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92346614|NCT01838616|Narcotics|narcotics|mesh-ancestor
92346615|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346616|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346618|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
92346619|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346620|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92346621|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92346622|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92346623|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349542|NCT01490580|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92346624|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346625|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92346626|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346627|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92346628|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92346629|NCT01609218|Charcoal|charcoal|mesh-list
92346630|NCT01609218|Antidotes|antidotes|mesh-ancestor
92346631|NCT01609218|Protective Agents|protective agents|mesh-ancestor
92346632|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346634|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
92346635|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
92346636|NCT04580472|Cephalexin|cephalexin|mesh-list
92346637|NCT04580472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346638|NCT04580472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346639|NCT04580472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92346640|NCT04580472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346641|NCT04580472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346642|NCT01611558|Ipilimumab|ipilimumab|mesh-list
92346643|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92346644|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346645|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92346646|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346647|NCT01818726|Deferasirox|deferasirox|mesh-list
92346648|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92346649|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
92346650|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
92346651|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346652|NCT01818336|Amoxicillin|amoxicillin|mesh-list
92346653|NCT01818336|Penicillins|penicillins|mesh-list
92346654|NCT01818336|Penicillin G|penicillin g|mesh-list
92346655|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346656|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346657|NCT01818258|Ritonavir|ritonavir|mesh-list
92346658|NCT01818258|Lopinavir|lopinavir|mesh-list
92346659|NCT01818258|Lamivudine|lamivudine|mesh-list
92346660|NCT01818258|Zidovudine|zidovudine|mesh-list
92346661|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91937166|NCT01235039|Insulin Lispro|insulin lispro|mesh-list
92346662|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92346663|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346664|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346665|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346666|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92346667|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92346668|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
92346669|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346670|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92346671|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92346672|NCT01818258|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92346673|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92346674|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
92346675|NCT01817790|Fluticasone|fluticasone|mesh-list
92346677|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346678|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92346679|NCT01817790|Autonomic Agents|autonomic agents|mesh-ancestor
92346680|NCT01817790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346681|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346682|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92346683|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92346684|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
92346685|NCT01817790|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92346686|NCT01793688|Ampicillin|ampicillin|mesh-list
92346687|NCT01793688|Sulbactam|sulbactam|mesh-list
92346688|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346689|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346690|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92346691|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346692|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346693|NCT01792830|Metformin|metformin|mesh-list
92346694|NCT01792830|Insulin Glargine|insulin glargine|mesh-list
92346695|NCT01792830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346696|NCT01792830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346697|NCT01792518|Linagliptin|linagliptin|mesh-list
92346698|NCT01792518|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346699|NCT01792518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346700|NCT01792518|Incretins|incretins|mesh-ancestor
92346701|NCT01792518|Hormones|hormones|mesh-ancestor
92346702|NCT01792518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346703|NCT01792518|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92346704|NCT01792518|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346705|NCT01792518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346706|NCT01792518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346707|NCT01792284|Insulin|insulin|mesh-list
92346708|NCT01792284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92346709|NCT01792284|Insulin Lispro|insulin lispro|mesh-list
92346710|NCT01792284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346711|NCT01792284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346712|NCT04414566|Cisplatin|cisplatin|mesh-list
92346713|NCT04414566|Gemcitabine|gemcitabine|mesh-list
92346714|NCT04414566|Docetaxel|docetaxel|mesh-list
92346715|NCT04414566|Fluorouracil|fluorouracil|mesh-list
92349543|NCT01490580|Cholinergic Agents|cholinergic agents|mesh-ancestor
92346716|NCT04414566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346717|NCT04414566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346718|NCT04414566|Antimetabolites|antimetabolites|mesh-ancestor
92346719|NCT04414566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346720|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
92346721|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
92346722|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
92346723|NCT04414566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346724|NCT04414566|Immunologic Factors|immunologic factors|mesh-ancestor
92346725|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346726|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
92346727|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346728|NCT04592016|Diclofenac|diclofenac|mesh-list
92346729|NCT04592016|Coal Tar|coal tar|mesh-list
92346730|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92346731|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92346732|NCT04592016|Analgesics|analgesics|mesh-ancestor
92346733|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
92113527|NCT04650074|Analgesics|analgesics|mesh-ancestor
92346734|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346735|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346736|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346738|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92346739|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346740|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346741|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
92346742|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
92346743|NCT01837680|Insulin|insulin|mesh-list
92346744|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92346745|NCT01837680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346746|NCT01837680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346747|NCT01836276|Varenicline|varenicline|mesh-list
92346748|NCT01836276|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92346749|NCT01836276|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92346750|NCT01836276|Cholinergic Agents|cholinergic agents|mesh-ancestor
92113582|NCT04449549|Paclitaxel|paclitaxel|mesh-list
92346752|NCT01836276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346753|NCT01836276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346755|NCT01790568|Vorinostat|vorinostat|mesh-list
92346756|NCT01790568|Tacrolimus|tacrolimus|mesh-list
92346757|NCT01790568|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92346758|NCT01790568|Abortifacient Agents|abortifacient agents|mesh-ancestor
92346759|NCT01790568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92346760|NCT01790568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346761|NCT01790568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346762|NCT01790568|Antimetabolites|antimetabolites|mesh-ancestor
92346763|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346764|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346765|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
92346766|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999269|NCT05913414|Iron|iron|mesh-list
92346767|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92346768|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346769|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
92346770|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92346771|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92346772|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92346773|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92346774|NCT01836198|Clarithromycin|clarithromycin|mesh-list
92346775|NCT01836198|Ketoconazole|ketoconazole|mesh-list
92346776|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
92346778|NCT01836198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346779|NCT01836198|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92346780|NCT01836198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346781|NCT01836198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113807|NCT03864406|Antiviral Agents|antiviral agents|mesh-ancestor
92346782|NCT01836198|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92346783|NCT01836198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92346784|NCT01836198|Antifungal Agents|antifungal agents|mesh-ancestor
92346785|NCT01836198|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92346786|NCT01836198|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92346787|NCT01836198|Hormone Antagonists|hormone antagonists|mesh-ancestor
92346788|NCT01836198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346789|NCT01836198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346791|NCT01836198|Antimetabolites|antimetabolites|mesh-ancestor
92346792|NCT01836198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92346793|NCT01836198|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92346794|NCT01816074|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92346795|NCT01816074|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92346796|NCT01816074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346797|NCT01816074|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92346798|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92346799|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346800|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346801|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
92346802|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346804|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346805|NCT01789320|Triamcinolone|triamcinolone|mesh-list
92346806|NCT01789320|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92346808|NCT01789320|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92346809|NCT01789320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346810|NCT01789320|Glucocorticoids|glucocorticoids|mesh-ancestor
92346812|NCT01789320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346813|NCT01789320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346814|NCT01789320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346815|NCT01789320|Immunologic Factors|immunologic factors|mesh-ancestor
92346816|NCT01789320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346817|NCT01789320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346818|NCT01788228|Vaccines|vaccines|mesh-list
92346819|NCT01788228|Immunologic Factors|immunologic factors|mesh-ancestor
92346820|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346821|NCT01607346|Ezogabine|ezogabine|mesh-list
92346822|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
92346823|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346824|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346825|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92346826|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92346827|NCT01815138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346829|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
92346830|NCT01606800|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92346831|NCT01606800|Antimetabolites|antimetabolites|mesh-ancestor
92346832|NCT01606800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346833|NCT01606800|Antiviral Agents|antiviral agents|mesh-ancestor
92346834|NCT01606800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346835|NCT01606800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346836|NCT01814748|Metformin|metformin|mesh-list
92346837|NCT01814748|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92346838|NCT01814748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346839|NCT01814670|Botulinum Toxins|botulinum toxins|mesh-list
92346840|NCT01814670|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92346841|NCT01814670|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92346842|NCT01814670|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92346843|NCT01814670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346844|NCT01814670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346845|NCT01814670|Cholinergic Agents|cholinergic agents|mesh-ancestor
92346846|NCT01814670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346847|NCT01814670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346848|NCT01814670|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92346849|NCT01814670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346850|NCT01814046|Aldesleukin|aldesleukin|mesh-list
92346851|NCT01814046|Cyclophosphamide|cyclophosphamide|mesh-list
92346852|NCT01814046|Fludarabine|fludarabine|mesh-list
92346853|NCT01814046|Interleukin-2|interleukin-2|mesh-list
92346854|NCT01814046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346855|NCT01814046|Immunologic Factors|immunologic factors|mesh-ancestor
92346856|NCT01814046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346858|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92346859|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
92346860|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346861|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346862|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92346863|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92346864|NCT01814046|Analgesics|analgesics|mesh-ancestor
92346865|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
92346866|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346867|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92346868|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92346869|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
92346870|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346871|NCT01813890|Tapentadol|tapentadol|mesh-list
92346872|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92346873|NCT01813890|Narcotics|narcotics|mesh-ancestor
92346874|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346875|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346876|NCT01813890|Analgesics|analgesics|mesh-ancestor
92346877|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
92346878|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346879|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92346880|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92346881|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346882|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346883|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92346884|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346885|NCT01813422|Evolocumab|evolocumab|mesh-list
92346886|NCT01813422|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92346887|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92346888|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92346889|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
92346890|NCT01813422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346891|NCT01813422|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92346892|NCT01813422|Protease Inhibitors|protease inhibitors|mesh-ancestor
92346893|NCT01813422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346894|NCT01813422|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92346895|NCT01786668|Tofacitinib|tofacitinib|mesh-list
92346896|NCT01786668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92346897|NCT01786668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114757|NCT02185209|Amoxicillin|amoxicillin|mesh-list
92346899|NCT01786668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346900|NCT04414254|Cefprozil|cefprozil|mesh-list
92346901|NCT04414254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92346902|NCT04414254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346903|NCT01770912|Triamcinolone|triamcinolone|mesh-list
92346904|NCT01770912|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92346905|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92346906|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92346907|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346908|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
92346910|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92346911|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346912|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346913|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
92346914|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346915|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346916|NCT01811706|4-Aminopyridine|4-aminopyridine|mesh-list
92346917|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92346918|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346919|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346921|NCT01811238|Naloxone|naloxone|mesh-list
92346922|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92346923|NCT01811238|Narcotics|narcotics|mesh-ancestor
92115027|NCT05586711|Estradiol|estradiol|mesh-list
92346924|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346925|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346926|NCT01811238|Analgesics|analgesics|mesh-ancestor
92346927|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
92346928|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346929|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92346930|NCT01769508|Fluorouracil|fluorouracil|mesh-list
92346931|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
92346932|NCT01769508|Lapatinib|lapatinib|mesh-list
92346933|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
92349544|NCT01490580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346934|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346935|NCT01769508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346936|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346937|NCT01769508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346938|NCT01769508|Immunologic Factors|immunologic factors|mesh-ancestor
92346939|NCT01769508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346940|NCT01769508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92346941|NCT01769508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346942|NCT01810380|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92346943|NCT01810380|Brexpiprazole|brexpiprazole|mesh-list
92346944|NCT01810380|Antidepressive Agents|antidepressive agents|mesh-ancestor
92346945|NCT01810380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92346946|NCT01810380|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92346947|NCT01810380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92346948|NCT01810380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92346949|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346950|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
92346951|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92346952|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346953|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
92346955|NCT01810302|Nicardipine|nicardipine|mesh-list
92346956|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92346957|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92115385|NCT03195478|Nivolumab|nivolumab|mesh-list
92346958|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92346959|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346960|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92346961|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346962|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
92346963|NCT01783938|Nivolumab|nivolumab|mesh-list
92346964|NCT01783938|Ipilimumab|ipilimumab|mesh-list
92346965|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932408|NCT02220803|Acetazolamide|acetazolamide|mesh-list
92346966|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346967|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92346968|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346969|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
92346970|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
92346971|NCT01768572|Methotrexate|methotrexate|mesh-list
92346972|NCT01768572|Leflunomide|leflunomide|mesh-list
92346973|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92346974|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
92346975|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92115505|NCT02461836|Gemcitabine|gemcitabine|mesh-list
92346976|NCT01768572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92346977|NCT01768572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92346979|NCT01768572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92346980|NCT01768572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92346981|NCT01768572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92346982|NCT01768572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92346983|NCT01768572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92346984|NCT01768572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92346985|NCT01768572|Immunologic Factors|immunologic factors|mesh-ancestor
92346986|NCT01768572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92346987|NCT01768572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92346988|NCT01768572|Antimalarials|antimalarials|mesh-ancestor
92346989|NCT01768572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92346990|NCT01768572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92346991|NCT01768572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92346992|NCT01768572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92346993|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92346995|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
92346996|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92346997|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92346998|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115629|NCT01989910|Efavirenz|efavirenz|mesh-list
92346999|NCT01783548|Beclomethasone|beclomethasone|mesh-list
92347000|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347001|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
92347003|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347004|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347005|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92347006|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
92347007|NCT01809210|Carboplatin|carboplatin|mesh-list
92347008|NCT01809210|Gemcitabine|gemcitabine|mesh-list
92347009|NCT01809210|Pemetrexed|pemetrexed|mesh-list
92115769|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
92347010|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347011|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92347012|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
92347013|NCT01809210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347014|NCT01809210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347015|NCT01809210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92115912|NCT00469755|Analgesics|analgesics|mesh-ancestor
92347017|NCT01809132|Zinc|zinc|mesh-list
92347018|NCT01809132|Methylprednisolone|methylprednisolone|mesh-list
92347019|NCT01809132|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92347020|NCT01809132|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92347022|NCT01809132|Prednisolone acetate|prednisolone acetate|mesh-list
92347023|NCT01809132|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92347024|NCT01809132|Pentoxifylline|pentoxifylline|mesh-list
92347025|NCT01809132|Zinc Sulfate|zinc sulfate|mesh-list
92347026|NCT01809132|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92347027|NCT01809132|Prednisolone phosphate|prednisolone phosphate|mesh-list
92347029|NCT01809132|Antiemetics|antiemetics|mesh-ancestor
92347030|NCT01809132|Autonomic Agents|autonomic agents|mesh-ancestor
92116125|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347031|NCT01809132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347032|NCT01809132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347034|NCT01809132|Glucocorticoids|glucocorticoids|mesh-ancestor
92347035|NCT01809132|Hormones|hormones|mesh-ancestor
92347036|NCT01809132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116278|NCT02006836|Insulin|insulin|mesh-list
92347037|NCT01809132|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92347038|NCT01809132|Protective Agents|protective agents|mesh-ancestor
92347039|NCT01809132|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92347041|NCT01809132|Trace Elements|trace elements|mesh-ancestor
92347042|NCT01809132|Micronutrients|micronutrients|mesh-ancestor
92347043|NCT01809132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347044|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92347045|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116423|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92347046|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347047|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92347048|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92347049|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92347050|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92347052|NCT01809132|Astringents|astringents|mesh-ancestor
92347053|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347054|NCT01766778|Metformin|metformin|mesh-list
92347055|NCT01766778|Vildagliptin|vildagliptin|mesh-list
92347056|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347057|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347058|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92347059|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
92347060|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347061|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347062|NCT01808196|Losartan|losartan|mesh-list
92347064|NCT01808196|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92347065|NCT01808196|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92347066|NCT01808196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92347067|NCT01808196|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92347068|NCT01808196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347069|NCT01808196|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92347070|NCT01808118|Adalimumab|adalimumab|mesh-list
92347071|NCT01808118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92347072|NCT01808118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116699|NCT04755387|Ticagrelor|ticagrelor|mesh-list
92347073|NCT01808118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347074|NCT01782690|Gemcitabine|gemcitabine|mesh-list
92347075|NCT01782690|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92347076|NCT01782690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92347077|NCT01782690|Antimetabolites|antimetabolites|mesh-ancestor
92347078|NCT01782690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347079|NCT01782690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116767|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
92347080|NCT01782690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92347081|NCT01782690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347083|NCT01766310|Hematinics|hematinics|mesh-ancestor
92347084|NCT01766310|Vitamin B Complex|vitamin b complex|mesh-ancestor
92347085|NCT01766310|Vitamins|vitamins|mesh-ancestor
92347086|NCT01766310|Micronutrients|micronutrients|mesh-ancestor
92347087|NCT01766310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347088|NCT01782222|Rotigotine|rotigotine|mesh-list
92347089|NCT01782222|Dopamine Agonists|dopamine agonists|mesh-ancestor
92347090|NCT01782222|Dopamine Agents|dopamine agents|mesh-ancestor
92347091|NCT01782222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116987|NCT02457312|Letrozole|letrozole|mesh-list
92347092|NCT01782222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347093|NCT01782222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347094|NCT01807182|Aldesleukin|aldesleukin|mesh-list
92347095|NCT01807182|Cyclophosphamide|cyclophosphamide|mesh-list
92347096|NCT01807182|Fludarabine|fludarabine|mesh-list
92347097|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
92347098|NCT01807182|Interleukin-2|interleukin-2|mesh-list
92347099|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347100|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
92347101|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347102|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347103|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92347104|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
92117265|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
92347105|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347106|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347107|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92347108|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92347110|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347111|NCT01807182|Analgesics|analgesics|mesh-ancestor
92347112|NCT01807182|Sensory System Agents|sensory system agents|mesh-ancestor
92347113|NCT01807182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347114|NCT01807182|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347115|NCT01807182|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92347116|NCT01807182|Antiviral Agents|antiviral agents|mesh-ancestor
92347117|NCT01807182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347118|NCT01765764|Bimatoprost|bimatoprost|mesh-list
92347119|NCT01765764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92347120|NCT01765764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92347121|NCT01780974|Thioctic Acid|thioctic acid|mesh-list
92347122|NCT01780974|Antioxidants|antioxidants|mesh-ancestor
92347123|NCT01780974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347124|NCT01780974|Protective Agents|protective agents|mesh-ancestor
92347125|NCT01780974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347126|NCT01780974|Vitamin B Complex|vitamin b complex|mesh-ancestor
92347128|NCT01780974|Micronutrients|micronutrients|mesh-ancestor
92347129|NCT01780662|Gemcitabine|gemcitabine|mesh-list
92347130|NCT01780662|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92347131|NCT01780662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92347132|NCT01780662|Antibodies|antibodies|mesh-list
92347133|NCT01780662|Immunoglobulins|immunoglobulins|mesh-list
92347134|NCT01780662|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92347135|NCT01780662|Immunoconjugates|immunoconjugates|mesh-list
92347136|NCT01780662|Immunologic Factors|immunologic factors|mesh-ancestor
92347137|NCT01780662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347138|NCT01780662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92347139|NCT01780662|Antimetabolites|antimetabolites|mesh-ancestor
92347140|NCT01780662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347141|NCT01780662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347142|NCT01780662|Immunotoxins|immunotoxins|mesh-ancestor
92347143|NCT01780506|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92347144|NCT01780506|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347145|NCT01780506|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92347146|NCT01780506|Antiviral Agents|antiviral agents|mesh-ancestor
92347147|NCT01780506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347148|NCT01762800|Fluticasone|fluticasone|mesh-list
92347151|NCT01762800|Tiotropium Bromide|tiotropium bromide|mesh-list
92347152|NCT01762800|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92347153|NCT01762800|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92347154|NCT01762800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347155|NCT01762800|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92347156|NCT01762800|Autonomic Agents|autonomic agents|mesh-ancestor
92347157|NCT01762800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347158|NCT01762800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117974|NCT03250494|Hormones|hormones|mesh-ancestor
92347160|NCT01762800|Respiratory System Agents|respiratory system agents|mesh-ancestor
92347161|NCT01762800|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347162|NCT01762800|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92347163|NCT01762800|Parasympatholytics|parasympatholytics|mesh-ancestor
92347164|NCT01762800|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92347166|NCT01762800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347167|NCT01762800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347168|NCT01762800|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92347170|NCT01762800|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92347171|NCT01762800|Adrenergic Agents|adrenergic agents|mesh-ancestor
92347172|NCT01762800|Anticonvulsants|anticonvulsants|mesh-ancestor
92347173|NCT01762800|Glucocorticoids|glucocorticoids|mesh-ancestor
92347174|NCT01762800|Hormones|hormones|mesh-ancestor
92347175|NCT01762800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347177|NCT04562532|Sirolimus|sirolimus|mesh-list
92347178|NCT04562532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92347179|NCT04562532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347180|NCT04562532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92347181|NCT04562532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347182|NCT04562532|Antifungal Agents|antifungal agents|mesh-ancestor
92347183|NCT04562532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347184|NCT04562532|Immunologic Factors|immunologic factors|mesh-ancestor
92347185|NCT04562532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347186|NCT01778010|Cocaine|cocaine|mesh-list
92347187|NCT01778010|Modafinil|modafinil|mesh-list
92347188|NCT01778010|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92347190|NCT01778010|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92347191|NCT01778010|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92347192|NCT01778010|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92347193|NCT01778010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347194|NCT01778010|Anesthetics, Local|anesthetics, local|mesh-ancestor
92347195|NCT01778010|Anesthetics|anesthetics|mesh-ancestor
92347196|NCT01778010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347197|NCT01778010|Sensory System Agents|sensory system agents|mesh-ancestor
92347198|NCT01778010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347199|NCT01778010|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92347200|NCT01778010|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92347201|NCT01778010|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92347202|NCT01778010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92347203|NCT01778010|Dopamine Agents|dopamine agents|mesh-ancestor
92347204|NCT01778010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347205|NCT01777854|Omeprazole|omeprazole|mesh-list
92347206|NCT01777854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92347208|NCT01777854|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92347209|NCT01777854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347210|NCT01777854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347212|NCT01777620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92347213|NCT01777620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92347214|NCT01777620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92347215|NCT01777620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92347216|NCT01777620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347217|NCT01777620|Cholinergic Agents|cholinergic agents|mesh-ancestor
92347218|NCT01777620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347219|NCT01777620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347220|NCT01777620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92347221|NCT01777620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118585|NCT03241914|Megestrol|megestrol|mesh-list
92347223|NCT01777542|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92347224|NCT01777542|Mitogens|mitogens|mesh-list
92347225|NCT01777542|Mecasermin|mecasermin|mesh-list
92347226|NCT01777542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347227|NCT01777542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118726|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
92118801|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
92347229|NCT01777542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347230|NCT01777542|Growth Substances|growth substances|mesh-ancestor
92347231|NCT01777152|Prednisone|prednisone|mesh-list
92347232|NCT01777152|Cyclophosphamide|cyclophosphamide|mesh-list
92347233|NCT01777152|Doxorubicin|doxorubicin|mesh-list
92347234|NCT01777152|Vincristine|vincristine|mesh-list
92347235|NCT01777152|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92347236|NCT01777152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347237|NCT01777152|Immunologic Factors|immunologic factors|mesh-ancestor
92347238|NCT01777152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347239|NCT01777152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347240|NCT01777152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92347241|NCT01777152|Alkylating Agents|alkylating agents|mesh-ancestor
92119092|NCT03228498|Choline|choline|mesh-list
92347242|NCT01777152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347243|NCT01777152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119159|NCT00078897|Selenium|selenium|mesh-list
92347244|NCT01777152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92347245|NCT01777152|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92347246|NCT01777152|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92347247|NCT01777152|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92347248|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347249|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347250|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
92347251|NCT01777152|Hormones|hormones|mesh-ancestor
92347252|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347253|NCT01777152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92347254|NCT01777152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92119386|NCT00081939|Bortezomib|bortezomib|mesh-list
92347255|NCT01777152|Tubulin Modulators|tubulin modulators|mesh-ancestor
92347256|NCT01777152|Antimitotic Agents|antimitotic agents|mesh-ancestor
92347257|NCT01777152|Mitosis Modulators|mitosis modulators|mesh-ancestor
92119445|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
92347258|NCT01777152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92347259|NCT01777152|Immunotoxins|immunotoxins|mesh-ancestor
92347260|NCT01777152|Immunoconjugates|immunoconjugates|mesh-ancestor
92347261|NCT01775124|Ranibizumab|ranibizumab|mesh-list
92347262|NCT01775124|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92347263|NCT01775124|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92347264|NCT01775124|Growth Substances|growth substances|mesh-ancestor
92347265|NCT01775124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347266|NCT01775124|Growth Inhibitors|growth inhibitors|mesh-ancestor
92347267|NCT01775124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347269|NCT01733316|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92347270|NCT01733316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347271|NCT01732926|Rituximab|rituximab|mesh-list
92347272|NCT01732926|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92347273|NCT01732926|Idelalisib|idelalisib|mesh-list
92347274|NCT01732926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92347275|NCT01732926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347276|NCT01732926|Immunologic Factors|immunologic factors|mesh-ancestor
92347277|NCT01732926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347278|NCT01732926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119727|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92347279|NCT01732926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92347280|NCT01732926|Alkylating Agents|alkylating agents|mesh-ancestor
92347281|NCT01732926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347282|NCT01732926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347283|NCT01732770|Zoledronic Acid|zoledronic acid|mesh-list
92347284|NCT01732770|Denosumab|denosumab|mesh-list
92347285|NCT01732770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92347286|NCT01732770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347287|NCT01774968|Insulin|insulin|mesh-list
92347288|NCT01774968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347289|NCT01774968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999790|NCT05784012|Niraparib|niraparib|mesh-list
92347290|NCT01732536|Mometasone Furoate|mometasone furoate|mesh-list
92347291|NCT01732536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347292|NCT01732536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347293|NCT01732536|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92347294|NCT01755702|Acetaminophen|acetaminophen|mesh-list
92347295|NCT01755702|Ibuprofen|ibuprofen|mesh-list
92347296|NCT01755702|Caffeine|caffeine|mesh-list
92347297|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92347298|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347299|NCT01755702|Analgesics|analgesics|mesh-ancestor
92347300|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
92347301|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347302|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347303|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347304|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347305|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92347306|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347307|NCT01755702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347308|NCT01755702|Antipyretics|antipyretics|mesh-ancestor
92347309|NCT01755702|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92347310|NCT01755702|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92347311|NCT01755702|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92347312|NCT01755702|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92120215|NCT01712009|Loratadine|loratadine|mesh-list
92347313|NCT01755702|Purinergic Agents|purinergic agents|mesh-ancestor
92347314|NCT01755702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347315|NCT01732458|Ondansetron|ondansetron|mesh-list
92347316|NCT01732458|Aprepitant|aprepitant|mesh-list
92347317|NCT01732458|Fosaprepitant|fosaprepitant|mesh-list
92347318|NCT01732458|Antiemetics|antiemetics|mesh-ancestor
92347319|NCT01732458|Autonomic Agents|autonomic agents|mesh-ancestor
92347320|NCT01732458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347321|NCT01732458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347322|NCT01732458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92347323|NCT01732458|Antipruritics|antipruritics|mesh-ancestor
92347324|NCT01732458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347325|NCT01732458|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92347326|NCT01732458|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92347327|NCT01732458|Serotonin Agents|serotonin agents|mesh-ancestor
92347328|NCT01732458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347329|NCT01732458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347330|NCT01732458|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92347332|NCT01708902|Linagliptin|linagliptin|mesh-list
92347333|NCT01708902|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347334|NCT01708902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347335|NCT01708902|Incretins|incretins|mesh-ancestor
92347336|NCT01708902|Hormones|hormones|mesh-ancestor
92347337|NCT01708902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347338|NCT01708902|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92347339|NCT01708902|Protease Inhibitors|protease inhibitors|mesh-ancestor
92347340|NCT01708902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347341|NCT01708902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347342|NCT01755546|Buprenorphine|buprenorphine|mesh-list
92347343|NCT01755546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92347344|NCT01755546|Narcotics|narcotics|mesh-ancestor
92347345|NCT01755546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347346|NCT01755546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347347|NCT01755546|Analgesics|analgesics|mesh-ancestor
92347348|NCT01755546|Sensory System Agents|sensory system agents|mesh-ancestor
92347349|NCT01755546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347350|NCT01755546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92347351|NCT04413864|Dexmedetomidine|dexmedetomidine|mesh-list
92347352|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92347353|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347354|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347355|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347357|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
92347358|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347359|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92347360|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92347361|NCT04413864|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92347362|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
92347363|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121062|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347364|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347366|NCT01755234|Sevoflurane|sevoflurane|mesh-list
92347367|NCT01755234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92347368|NCT01755234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347369|NCT01755234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121145|NCT02446002|Analgesics|analgesics|mesh-ancestor
92347370|NCT01755234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92347371|NCT01755234|Anesthetics, General|anesthetics, general|mesh-ancestor
92347372|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
92347373|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92347374|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92347376|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92347377|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92347378|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347379|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
92347380|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
92347381|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
92347382|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347383|NCT01755156|Metformin|metformin|mesh-list
92347384|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
92347385|NCT01755156|Glimepiride|glimepiride|mesh-list
92347386|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347387|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347388|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92347389|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347390|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
92347391|NCT01754376|Aldesleukin|aldesleukin|mesh-list
92347392|NCT01754376|Interleukin-2|interleukin-2|mesh-list
92347393|NCT01754376|Vemurafenib|vemurafenib|mesh-list
92347394|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347395|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347396|NCT01754376|Analgesics|analgesics|mesh-ancestor
92347397|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
92121561|NCT01336530|Anesthetics, Local|anesthetics, local|mesh-ancestor
92347398|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347399|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347400|NCT01754376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347401|NCT01754376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92347402|NCT01754376|Antiviral Agents|antiviral agents|mesh-ancestor
92121701|NCT02831998|Ethanol|ethanol|mesh-list
92347403|NCT01754376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347404|NCT01754376|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92347406|NCT01754376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347408|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347410|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92347411|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347412|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347413|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92347414|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
92121913|NCT00215787|Lansoprazole|lansoprazole|mesh-list
92347415|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347416|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347417|NCT01730118|Mitogens|mitogens|mesh-list
92122072|NCT00109473|Prednisone|prednisone|mesh-list
92347419|NCT01730118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347420|NCT01730040|Atorvastatin|atorvastatin|mesh-list
92347421|NCT01730040|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92347422|NCT01730040|Ezetimibe|ezetimibe|mesh-list
92347423|NCT01730040|Alirocumab|alirocumab|mesh-list
92347424|NCT01730040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92347425|NCT01730040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92347426|NCT01730040|Antimetabolites|antimetabolites|mesh-ancestor
92122205|NCT05292586|Beclomethasone|beclomethasone|mesh-list
92347427|NCT01730040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347428|NCT01730040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92347429|NCT01730040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92347430|NCT01730040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122352|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
92347431|NCT01730040|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92347432|NCT01730040|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92347433|NCT01730040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92347435|NCT01706328|Xhance|xhance|mesh-list
92347436|NCT01706328|Albuterol|albuterol|mesh-list
92347437|NCT01706328|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92347438|NCT01706328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347439|NCT01706328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92347440|NCT01706328|Autonomic Agents|autonomic agents|mesh-ancestor
92347441|NCT01706328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347442|NCT01706328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347443|NCT01706328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92347444|NCT01706328|Respiratory System Agents|respiratory system agents|mesh-ancestor
92347445|NCT01706328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347446|NCT01706328|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92347447|NCT01706328|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92347448|NCT01706328|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92347449|NCT01706328|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92347450|NCT01706328|Adrenergic Agents|adrenergic agents|mesh-ancestor
92347451|NCT01706328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122485|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92347452|NCT01706328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347454|NCT01706328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92347455|NCT01706250|Salicylic Acid|salicylic acid|mesh-list
92347456|NCT01706250|Salicylates|salicylates|mesh-list
92347457|NCT01706250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347458|NCT01706250|Antifungal Agents|antifungal agents|mesh-ancestor
92347459|NCT01706250|Keratolytic Agents|keratolytic agents|mesh-ancestor
92347460|NCT01706250|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347461|NCT01706250|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92347462|NCT01706250|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347463|NCT01706250|Analgesics|analgesics|mesh-ancestor
92347464|NCT01706250|Sensory System Agents|sensory system agents|mesh-ancestor
92122702|NCT00053703|Molindone|molindone|mesh-list
92347465|NCT01706250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347466|NCT01706250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347467|NCT01706250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347468|NCT01706250|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347469|NCT01706250|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92347470|NCT01706250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347471|NCT01706250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347472|NCT01729728|Tapentadol|tapentadol|mesh-list
92347474|NCT01729728|Narcotics|narcotics|mesh-ancestor
92347475|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122989|NCT02428062|Phenylephrine|phenylephrine|mesh-list
92347476|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347477|NCT01729728|Analgesics|analgesics|mesh-ancestor
92347478|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
92347479|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347480|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92347481|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92123358|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
92347482|NCT01729728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92347483|NCT01729728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347485|NCT01729728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347486|NCT01728324|Ribavirin|ribavirin|mesh-list
92347487|NCT01728324|Antimetabolites|antimetabolites|mesh-ancestor
92347488|NCT01728324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347489|NCT01728324|Antiviral Agents|antiviral agents|mesh-ancestor
92347490|NCT01728324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347491|NCT01728246|Acetaminophen|acetaminophen|mesh-list
92347493|NCT01728246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347494|NCT01728246|Analgesics|analgesics|mesh-ancestor
92347495|NCT01728246|Sensory System Agents|sensory system agents|mesh-ancestor
92347496|NCT01728246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347497|NCT01728246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347498|NCT01728246|Antipyretics|antipyretics|mesh-ancestor
92347499|NCT01728246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92347500|NCT01728246|Narcotics|narcotics|mesh-ancestor
92347501|NCT01728246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347502|NCT04414020|Progesterone|progesterone|mesh-list
92347503|NCT04414020|Progestins|progestins|mesh-ancestor
92347504|NCT04414020|Hormones|hormones|mesh-ancestor
92347505|NCT04414020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347506|NCT04414020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347507|NCT01705236|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92347508|NCT01705236|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92123486|NCT01702025|Diuretics|diuretics|mesh-ancestor
92347509|NCT01705236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347510|NCT01705236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347511|NCT01705236|Immunologic Factors|immunologic factors|mesh-ancestor
92347512|NCT01705236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123560|NCT02416128|Hormones|hormones|mesh-ancestor
92347515|NCT01751802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92347516|NCT01751802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347517|NCT01751802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347518|NCT01751802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92347519|NCT01751802|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92347520|NCT01751802|Dopamine Agents|dopamine agents|mesh-ancestor
92347521|NCT01751802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347522|NCT01751802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347523|NCT01703286|Glimepiride|glimepiride|mesh-list
92347524|NCT01703286|Linagliptin|linagliptin|mesh-list
92347525|NCT01703286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92347526|NCT01703286|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347527|NCT01703286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347528|NCT01703286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347529|NCT01703286|Immunologic Factors|immunologic factors|mesh-ancestor
92347531|NCT01703286|Hormones|hormones|mesh-ancestor
92347532|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347533|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92347534|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
92347535|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347536|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347537|NCT01727700|Aripiprazole|aripiprazole|mesh-list
92347538|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
92347539|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92347540|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92347541|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92347542|NCT01727700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347543|NCT01727700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347544|NCT01727700|Dopamine Agonists|dopamine agonists|mesh-ancestor
92347545|NCT01727700|Dopamine Agents|dopamine agents|mesh-ancestor
92347546|NCT01727700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347547|NCT01727700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347548|NCT01727700|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92347549|NCT01727700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92347550|NCT01727700|Serotonin Agents|serotonin agents|mesh-ancestor
92347551|NCT01727700|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92123739|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
92347552|NCT01727700|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92347553|NCT01727700|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92347554|NCT01727700|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92347555|NCT01725282|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92347556|NCT01725282|Antidepressive Agents|antidepressive agents|mesh-ancestor
92347557|NCT01725282|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92347558|NCT01725282|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92347559|NCT01725282|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92347560|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347561|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347562|NCT01725126|Metformin|metformin|mesh-list
92347563|NCT01725126|Liraglutide|liraglutide|mesh-list
92347564|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347565|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347566|NCT01725126|Incretins|incretins|mesh-ancestor
92347568|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347569|NCT01751724|Caffeine|caffeine|mesh-list
92347570|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
92347571|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347572|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92347573|NCT01751724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347574|NCT01751724|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92347575|NCT01751724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347576|NCT01751724|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92347577|NCT01751724|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92347578|NCT01751724|Purinergic Agents|purinergic agents|mesh-ancestor
92347579|NCT01751724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347580|NCT01751646|Vitamin D|vitamin d|mesh-list
92347581|NCT01751646|Ergocalciferols|ergocalciferols|mesh-list
92347582|NCT01751646|Cholecalciferol|cholecalciferol|mesh-list
92347583|NCT01751646|Vitamins|vitamins|mesh-list
92347584|NCT01751646|Micronutrients|micronutrients|mesh-ancestor
92347585|NCT01751646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347586|NCT01751646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92347587|NCT01751646|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92347588|NCT01751568|Raltegravir Potassium|raltegravir potassium|mesh-list
92347589|NCT01751568|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347590|NCT01751568|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92347591|NCT01751568|Antiviral Agents|antiviral agents|mesh-ancestor
92347592|NCT01751568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347593|NCT01751568|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92347594|NCT01751568|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92347595|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347596|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347598|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
92347599|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92347600|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92347601|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347602|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347603|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347604|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
92347605|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347606|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92123918|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
92347608|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92347609|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347610|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347611|NCT01606254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92347612|NCT01606254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92347613|NCT01606254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92347614|NCT01606254|Serotonin Agents|serotonin agents|mesh-ancestor
92347615|NCT01606254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347616|NCT01606254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347617|NCT01606254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92347618|NCT01606254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92347619|NCT01606254|Dopamine Agents|dopamine agents|mesh-ancestor
92347620|NCT01723254|Immunoglobulin E|immunoglobulin e|mesh-list
92347621|NCT01723254|Immunologic Factors|immunologic factors|mesh-ancestor
92347622|NCT01723254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347623|NCT01722162|Bevacizumab|bevacizumab|mesh-list
92347624|NCT01722162|Capecitabine|capecitabine|mesh-list
92347625|NCT01722162|Levocetirizine|levocetirizine|mesh-list
92347626|NCT01722162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92347627|NCT01722162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347628|NCT01722162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92347629|NCT01722162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92347630|NCT01722162|Growth Substances|growth substances|mesh-ancestor
92347631|NCT01722162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347632|NCT01722162|Growth Inhibitors|growth inhibitors|mesh-ancestor
92347633|NCT01722162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92123985|NCT02451202|Rocuronium|rocuronium|mesh-list
92347634|NCT01722162|Antimetabolites|antimetabolites|mesh-ancestor
92347635|NCT01722162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347637|NCT01722162|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92347638|NCT01722162|Histamine Antagonists|histamine antagonists|mesh-ancestor
92347639|NCT01722162|Histamine Agents|histamine agents|mesh-ancestor
92347640|NCT01722162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347641|NCT01721772|Nivolumab|nivolumab|mesh-list
92347642|NCT01721772|Dacarbazine|dacarbazine|mesh-list
92347643|NCT01721772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92347644|NCT01721772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347645|NCT01721772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92347646|NCT01721772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347647|NCT01721772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92347648|NCT01721772|Alkylating Agents|alkylating agents|mesh-ancestor
92347649|NCT01702428|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92347650|NCT01702428|Immunologic Factors|immunologic factors|mesh-ancestor
92347651|NCT01702428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347652|NCT01701258|Amisulpride|amisulpride|mesh-list
92347653|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92347654|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92347655|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347656|NCT01701258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347657|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92347658|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92347659|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
92347660|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347661|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347662|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92347663|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
92347664|NCT01700946|Cytarabine|cytarabine|mesh-list
92347665|NCT01700946|Aldesleukin|aldesleukin|mesh-list
92347666|NCT01700946|Dexamethasone|dexamethasone|mesh-list
92347667|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
92347668|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92347669|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92347670|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92347671|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
92347672|NCT01700946|Rituximab|rituximab|mesh-list
92347673|NCT01700946|Methotrexate|methotrexate|mesh-list
92347674|NCT01700946|Etoposide|etoposide|mesh-list
92347675|NCT01700946|Vincristine|vincristine|mesh-list
92347676|NCT01700946|Interleukin-2|interleukin-2|mesh-list
92347677|NCT01700946|Asparaginase|asparaginase|mesh-list
92347678|NCT01700946|Mitoxantrone|mitoxantrone|mesh-list
92347679|NCT01700946|Mercaptopurine|mercaptopurine|mesh-list
92347680|NCT01700946|Clofarabine|clofarabine|mesh-list
92347681|NCT01700946|Vinblastine|vinblastine|mesh-list
92347682|NCT01700946|Pegaspargase|pegaspargase|mesh-list
92347683|NCT01700946|Teniposide|teniposide|mesh-list
92347684|NCT01700946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92347685|NCT01700946|Immunologic Factors|immunologic factors|mesh-ancestor
92347686|NCT01700946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347687|NCT01700946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347688|NCT01700946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92347689|NCT01700946|Alkylating Agents|alkylating agents|mesh-ancestor
92347690|NCT01700946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347691|NCT01700946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347692|NCT01700946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92347693|NCT01700946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92347694|NCT01700946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347695|NCT01700946|Antiemetics|antiemetics|mesh-ancestor
92347696|NCT01700946|Autonomic Agents|autonomic agents|mesh-ancestor
92347697|NCT01700946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347698|NCT01700946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92347699|NCT01700946|Glucocorticoids|glucocorticoids|mesh-ancestor
92347700|NCT01700946|Hormones|hormones|mesh-ancestor
92347701|NCT01700946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347702|NCT01700946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92347703|NCT01700946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92347704|NCT01700946|Abortifacient Agents|abortifacient agents|mesh-ancestor
92347705|NCT01700946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92347706|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92347707|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
92347708|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92347709|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347710|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92347711|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92347712|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92347713|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92347714|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92347715|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
92347716|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347717|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
92347718|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
92347719|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
92347720|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92347722|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
92347723|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347724|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92347725|NCT01748994|Pioglitazone|pioglitazone|mesh-list
92347726|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92347727|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347728|NCT01721070|Ketoconazole|ketoconazole|mesh-list
92347729|NCT01721070|Sufentanil|sufentanil|mesh-list
92347730|NCT01721070|Dsuvia|dsuvia|mesh-list
92347731|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92347732|NCT01721070|Narcotics|narcotics|mesh-ancestor
92347733|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92347734|NCT01721070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347735|NCT01721070|Analgesics|analgesics|mesh-ancestor
92347736|NCT01721070|Sensory System Agents|sensory system agents|mesh-ancestor
92347737|NCT01721070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92347738|NCT01721070|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92347739|NCT01721070|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92347740|NCT01721070|Anesthetics, General|anesthetics, general|mesh-ancestor
92347741|NCT01721070|Anesthetics|anesthetics|mesh-ancestor
92347742|NCT01721070|Antifungal Agents|antifungal agents|mesh-ancestor
92347743|NCT01721070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347744|NCT01721070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92347745|NCT01721070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92347746|NCT01721070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347747|NCT01721070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347748|NCT01721070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92347749|NCT01721070|Hormone Antagonists|hormone antagonists|mesh-ancestor
92347750|NCT01721070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347751|NCT01721070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92347753|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92347754|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92347755|NCT01748292|Growth Substances|growth substances|mesh-ancestor
92347756|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347757|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
92347758|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347759|NCT01720602|Letrozole|letrozole|mesh-list
92347760|NCT01720602|Anastrozole|anastrozole|mesh-list
92347761|NCT01720602|Vorinostat|vorinostat|mesh-list
92347762|NCT01720602|Exemestane|exemestane|mesh-list
92347763|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92347764|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347765|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92347766|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92347767|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347768|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347769|NCT01720602|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92347770|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
92347771|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124288|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347772|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347773|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92347774|NCT01720602|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92347775|NCT01720602|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92347778|NCT01746732|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92347779|NCT01746732|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92347780|NCT01746732|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92347781|NCT01746732|Antimetabolites|antimetabolites|mesh-ancestor
92347782|NCT01746732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347783|NCT01746732|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92347784|NCT01746732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92347785|NCT01746732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347786|NCT01746732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92347787|NCT01746732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92347788|NCT01746732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347789|NCT01746732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347790|NCT01746732|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92347792|NCT01746732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92347793|NCT01746732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347794|NCT01746732|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92347795|NCT01746732|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92347796|NCT01746732|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92347797|NCT01720524|Sildenafil Citrate|sildenafil citrate|mesh-list
92347798|NCT01720524|Vasodilator Agents|vasodilator agents|mesh-ancestor
92347799|NCT01720524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92347800|NCT01720524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92347801|NCT01720524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347802|NCT01720524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347804|NCT01717638|Vaccines|vaccines|mesh-list
92347805|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
92347806|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347807|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
92347808|NCT01745094|Mirabegron|mirabegron|mesh-list
92347809|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92347810|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92347811|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
92347812|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347813|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347814|NCT01745094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347815|NCT01745094|Urological Agents|urological agents|mesh-ancestor
92347816|NCT01745094|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92347817|NCT01745094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92347818|NCT01745094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92347820|NCT01717326|Ribavirin|ribavirin|mesh-list
92347821|NCT01717326|Grazoprevir|grazoprevir|mesh-list
92347822|NCT01717326|Antimetabolites|antimetabolites|mesh-ancestor
92124671|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92347823|NCT01717326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347825|NCT01717326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347826|NCT01744782|Cysteamine|cysteamine|mesh-list
92347827|NCT01744782|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92347828|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347829|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
92347830|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
92347831|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347832|NCT01742286|Ceritinib|ceritinib|mesh-list
92347833|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347834|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92347835|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347836|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347837|NCT01716234|Posaconazole|posaconazole|mesh-list
92347838|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
92347839|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347840|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92347841|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92347842|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92347843|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92347844|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92347845|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124890|NCT04481802|Acemannan|acemannan|mesh-list
92347846|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347847|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92347848|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
92347849|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347850|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347851|NCT01716156|Ribavirin|ribavirin|mesh-list
92347853|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
92347854|NCT01716156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347855|NCT01716156|Antiviral Agents|antiviral agents|mesh-ancestor
92347856|NCT01716156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347858|NCT01739790|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92347859|NCT01739790|Antiviral Agents|antiviral agents|mesh-ancestor
92347860|NCT01739790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347861|NCT01739790|Expectorants|expectorants|mesh-ancestor
92347862|NCT01739790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92347863|NCT01739790|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92347864|NCT01739790|Antioxidants|antioxidants|mesh-ancestor
92347865|NCT01739790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347866|NCT01739790|Protective Agents|protective agents|mesh-ancestor
92347867|NCT01739790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347868|NCT01739790|Antidotes|antidotes|mesh-ancestor
92347869|NCT01696032|Paclitaxel|paclitaxel|mesh-list
92347870|NCT01696032|Carboplatin|carboplatin|mesh-list
92347871|NCT01696032|Gemcitabine|gemcitabine|mesh-list
92347873|NCT01696032|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92347874|NCT01696032|Topotecan|topotecan|mesh-list
92347876|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125302|NCT02402868|Anesthetics|anesthetics|mesh-ancestor
92347877|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347878|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
92347879|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
92347880|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
92347881|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347882|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92347883|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
92347884|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92347885|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92347887|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347888|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92347889|NCT01695954|Ritonavir|ritonavir|mesh-list
92347890|NCT01695954|Darunavir|darunavir|mesh-list
92347891|NCT01695954|Efavirenz|efavirenz|mesh-list
92000390|NCT05418582|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92347892|NCT01695954|Pitavastatin|pitavastatin|mesh-list
92347893|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92347894|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92347895|NCT01695954|Protease Inhibitors|protease inhibitors|mesh-ancestor
92347896|NCT01695954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347897|NCT01695954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347898|NCT01695954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92347899|NCT01695954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92347900|NCT01695954|Antiviral Agents|antiviral agents|mesh-ancestor
92347901|NCT01695954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92347902|NCT01695954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92347903|NCT01695954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92347904|NCT01695954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92347905|NCT01695954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92347906|NCT01695954|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92347907|NCT01695954|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92347908|NCT01695954|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92347909|NCT01695954|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92347910|NCT01695954|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92347911|NCT01695954|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92347912|NCT01695954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92347913|NCT01695954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92347915|NCT01695954|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92347917|NCT01694706|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92347918|NCT01694706|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92347919|NCT01694706|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92347920|NCT01694706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347921|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347922|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
92347923|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92347924|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92347925|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92347926|NCT01715298|Cholinergic Agents|cholinergic agents|mesh-ancestor
92347927|NCT01715298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347928|NCT01715298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347929|NCT01715298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347930|NCT01739400|Macitentan|macitentan|mesh-list
92347931|NCT01739400|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92347932|NCT01739400|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92347933|NCT01739400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347934|NCT01739400|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92347935|NCT01712178|Adalimumab|adalimumab|mesh-list
92125680|NCT02876302|Paclitaxel|paclitaxel|mesh-list
92347936|NCT01712178|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92347937|NCT01712178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347938|NCT01712178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347940|NCT01693068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92347941|NCT01693068|Alkylating Agents|alkylating agents|mesh-ancestor
92347942|NCT01693068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347943|NCT01693068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347944|NCT01691898|Rituximab|rituximab|mesh-list
92347945|NCT01691898|Obinutuzumab|obinutuzumab|mesh-list
92347946|NCT01691898|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92347947|NCT01691898|Pinatuzumab vedotin|pinatuzumab vedotin|mesh-list
92347948|NCT01691898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92347949|NCT01691898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347950|NCT01691898|Immunologic Factors|immunologic factors|mesh-ancestor
92347951|NCT01691898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347952|NCT01691898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92347955|NCT01737840|Ranitidine|ranitidine|mesh-list
92347956|NCT01737840|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92347957|NCT01737840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92347958|NCT01737840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92347959|NCT01737840|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92347960|NCT01737840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92347961|NCT01737840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347962|NCT01737840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92347963|NCT01737840|Histamine Antagonists|histamine antagonists|mesh-ancestor
92347964|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
92347965|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347966|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347967|NCT01711866|Rotigotine|rotigotine|mesh-list
92347968|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
92347969|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
92347970|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92347971|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347972|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347974|NCT01691508|Prednisolone|prednisolone|mesh-list
92347975|NCT01691508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92347976|NCT01691508|Glucocorticoids|glucocorticoids|mesh-ancestor
92347977|NCT01691508|Hormones|hormones|mesh-ancestor
92126293|NCT01687283|Xhance|xhance|mesh-list
92347978|NCT01691508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92347979|NCT01691508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347980|NCT01691508|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92347981|NCT01691508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347982|NCT01682460|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92347983|NCT01682460|Lubricant Eye Drops|lubricant eye drops|mesh-list
92347984|NCT01682460|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92347985|NCT01709838|Deferasirox|deferasirox|mesh-list
92347986|NCT01709838|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92347987|NCT01709838|Chelating Agents|chelating agents|mesh-ancestor
92347988|NCT01709838|Sequestering Agents|sequestering agents|mesh-ancestor
92347989|NCT01709838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92347990|NCT01688466|Pomalidomide|pomalidomide|mesh-list
92347991|NCT01688466|Immunologic Factors|immunologic factors|mesh-ancestor
92347992|NCT01688466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92347993|NCT01688466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084789|NCT00687076|Niacin|niacin|mesh-list
92347994|NCT01688466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92347995|NCT01688466|Growth Substances|growth substances|mesh-ancestor
92347996|NCT01688466|Growth Inhibitors|growth inhibitors|mesh-ancestor
92347997|NCT01688466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92347998|NCT01682148|Botulinum Toxins|botulinum toxins|mesh-list
92347999|NCT01682148|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92348000|NCT01682148|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92348002|NCT01682148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348003|NCT01682148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348004|NCT01682148|Cholinergic Agents|cholinergic agents|mesh-ancestor
92348005|NCT01682148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348006|NCT01682148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348007|NCT01682148|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92126699|NCT01374906|Hormones|hormones|mesh-ancestor
92348008|NCT01682148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348010|NCT01681992|Immunologic Factors|immunologic factors|mesh-ancestor
92348011|NCT01681992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348013|NCT01687998|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92348015|NCT01687998|Antimetabolites|antimetabolites|mesh-ancestor
92348016|NCT01687998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348017|NCT01687998|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92348018|NCT01681212|Ipilimumab|ipilimumab|mesh-list
92348019|NCT01681212|Dacarbazine|dacarbazine|mesh-list
92348020|NCT01681212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348021|NCT01681212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348022|NCT01681212|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92348023|NCT01681212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348024|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92348025|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
92348028|NCT01687296|Prednisone|prednisone|mesh-list
92348029|NCT01687296|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92348030|NCT01687296|Albuterol|albuterol|mesh-list
92348031|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348032|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
92348033|NCT01687296|Hormones|hormones|mesh-ancestor
92127167|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92348034|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348035|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348036|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92348037|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348038|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92348039|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
92348040|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348041|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92348042|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
92348043|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
92348044|NCT01687296|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92348045|NCT01687296|Tocolytic Agents|tocolytic agents|mesh-ancestor
92348046|NCT01687296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92348047|NCT01687296|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92348048|NCT01687296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92348049|NCT01687296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92348051|NCT01687296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348052|NCT01687296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348053|NCT01568892|Dolutegravir|dolutegravir|mesh-list
92348054|NCT01568892|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92348055|NCT01568892|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92348056|NCT01568892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348057|NCT01568892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348058|NCT01568892|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92348059|NCT01568892|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92348060|NCT01568892|Antiviral Agents|antiviral agents|mesh-ancestor
92348061|NCT01568892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348062|NCT01568112|Aspirin|aspirin|mesh-list
92348063|NCT01568112|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92348064|NCT01568112|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92348065|NCT01568112|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92348066|NCT01568112|Analgesics|analgesics|mesh-ancestor
92348067|NCT01568112|Sensory System Agents|sensory system agents|mesh-ancestor
92348068|NCT01568112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348069|NCT01568112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348070|NCT01568112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348071|NCT01568112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348073|NCT01568112|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92348074|NCT01568112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348075|NCT01568112|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92348077|NCT01568112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348079|NCT01568112|Dermatologic Agents|dermatologic agents|mesh-ancestor
92348080|NCT01568112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348081|NCT01568112|Immunologic Factors|immunologic factors|mesh-ancestor
92348083|NCT01568034|Carbidopa|carbidopa|mesh-list
92348085|NCT01568034|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92127796|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348086|NCT01568034|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92348087|NCT01568034|Dopamine Agents|dopamine agents|mesh-ancestor
92348088|NCT01568034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348089|NCT01568034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348090|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348091|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92348092|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348093|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92348094|NCT01687218|Tenofovir|tenofovir|mesh-list
92348095|NCT01687218|Emtricitabine|emtricitabine|mesh-list
92348096|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92348097|NCT01687218|Glycerol|glycerol|mesh-list
92348098|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
92348099|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128078|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92348100|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92348101|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92348102|NCT01687218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348103|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348104|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92348105|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92348106|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92348107|NCT01687218|Protective Agents|protective agents|mesh-ancestor
92348108|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348109|NCT01686828|Letrozole|letrozole|mesh-list
92348110|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
92348111|NCT01686828|Acyline|acyline|mesh-list
92348112|NCT01686828|Testosterone|testosterone|mesh-list
92348113|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
92348114|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
92348115|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92348116|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000637|NCT05272384|Nivolumab|nivolumab|mesh-list
92348117|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92348118|NCT01686828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92348119|NCT01686828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348120|NCT01686828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348122|NCT01686828|Hormone Antagonists|hormone antagonists|mesh-ancestor
92348123|NCT01686828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348124|NCT01686828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348125|NCT01686828|Androgens|androgens|mesh-ancestor
92348126|NCT01686828|Hormones|hormones|mesh-ancestor
92348127|NCT01686828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92348128|NCT01686828|Anabolic Agents|anabolic agents|mesh-ancestor
92348129|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
92348130|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92348131|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92128294|NCT02662764|Dsuvia|dsuvia|mesh-list
92348132|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92348133|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348134|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348135|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
92348136|NCT01603602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348137|NCT01603602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128488|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
92348139|NCT01603602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348140|NCT01684878|Paclitaxel|paclitaxel|mesh-list
92348141|NCT01684878|Gemcitabine|gemcitabine|mesh-list
92348142|NCT01684878|Topotecan|topotecan|mesh-list
92348143|NCT01684878|Pertuzumab|pertuzumab|mesh-list
92128564|NCT03027167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92348144|NCT01684878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92348145|NCT01684878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348146|NCT01684878|Tubulin Modulators|tubulin modulators|mesh-ancestor
92348147|NCT01684878|Antimitotic Agents|antimitotic agents|mesh-ancestor
92128654|NCT02390700|Golimumab|golimumab|mesh-list
92348148|NCT01684878|Mitosis Modulators|mitosis modulators|mesh-ancestor
92348149|NCT01684878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348150|NCT01684878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92348151|NCT01684878|Antimetabolites|antimetabolites|mesh-ancestor
92348152|NCT01684878|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92348153|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92348154|NCT01684878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348155|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92128781|NCT02385396|Folic Acid|folic acid|mesh-list
92348158|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
92348159|NCT01684722|Vitamins|vitamins|mesh-list
92348160|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
92348161|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348162|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92348164|NCT01592292|Adalimumab|adalimumab|mesh-list
92348165|NCT01592292|Infliximab|infliximab|mesh-list
92348166|NCT01592292|Etanercept|etanercept|mesh-list
92348167|NCT01592292|Rituximab|rituximab|mesh-list
92348168|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348169|NCT01592292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348170|NCT01592292|Immunologic Factors|immunologic factors|mesh-ancestor
92348171|NCT01592292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348172|NCT01592292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348173|NCT01592292|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92348174|NCT01592292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348175|NCT01592292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92348176|NCT01592292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92348177|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92348178|NCT01592292|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92348180|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
92348181|NCT01592292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348182|NCT01592292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348184|NCT01565850|Cobicistat|cobicistat|mesh-list
92348185|NCT01565850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348186|NCT01565850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348188|NCT01565850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348189|NCT01565850|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92348190|NCT01565850|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92000686|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348192|NCT01565850|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92348193|NCT01565850|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348194|NCT01565850|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92348195|NCT01565850|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92348196|NCT01565694|Solifenacin Succinate|solifenacin succinate|mesh-list
92348249|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348250|NCT03027960|Empagliflozin|empagliflozin|mesh-list
92348251|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92130129|NCT04733118|Pertuzumab|pertuzumab|mesh-list
92348252|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348253|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348254|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348255|NCT01539642|Sufentanil|sufentanil|mesh-list
92348256|NCT01539642|Dsuvia|dsuvia|mesh-list
92348257|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92348258|NCT01539642|Narcotics|narcotics|mesh-ancestor
92348259|NCT01539642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348260|NCT01539642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348261|NCT01539642|Analgesics|analgesics|mesh-ancestor
92348262|NCT01539642|Sensory System Agents|sensory system agents|mesh-ancestor
92348263|NCT01539642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348264|NCT01539642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92348265|NCT01539642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92348266|NCT01539642|Anesthetics, General|anesthetics, general|mesh-ancestor
92348267|NCT01539642|Anesthetics|anesthetics|mesh-ancestor
92348268|NCT01538472|Cytarabine|cytarabine|mesh-list
92348269|NCT01538472|Rituximab|rituximab|mesh-list
92348270|NCT01538472|Melphalan|melphalan|mesh-list
92348271|NCT01538472|Carmustine|carmustine|mesh-list
92348272|NCT01538472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92348273|NCT01538472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348274|NCT01538472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348275|NCT01538472|Immunologic Factors|immunologic factors|mesh-ancestor
92348276|NCT01538472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348277|NCT01538472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348278|NCT01538472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92348279|NCT01538472|Antimetabolites|antimetabolites|mesh-ancestor
92130647|NCT01505569|Mesna|mesna|mesh-list
92348280|NCT01538472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348281|NCT01538472|Antiviral Agents|antiviral agents|mesh-ancestor
92348282|NCT01538472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348283|NCT01538472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130704|NCT01497899|Antiviral Agents|antiviral agents|mesh-ancestor
92348284|NCT01538472|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92348285|NCT01538472|Alkylating Agents|alkylating agents|mesh-ancestor
92348286|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92348287|NCT01562028|Bevacizumab|bevacizumab|mesh-list
92130785|NCT01496183|Olanzapine|olanzapine|mesh-list
92348288|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92348289|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348290|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348291|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348292|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92348294|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348295|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
92130922|NCT03922542|Vitamins|vitamins|mesh-ancestor
92348296|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92348297|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348298|NCT01562028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348300|NCT04767828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92348301|NCT04767828|Antimetabolites|antimetabolites|mesh-ancestor
92348302|NCT04767828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348303|NCT04767828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348305|NCT01585584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348306|NCT01585584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348307|NCT01537068|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92348308|NCT01537068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92131136|NCT02372916|Ranibizumab|ranibizumab|mesh-list
92348309|NCT01537068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92348310|NCT01537068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348311|NCT01537068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348313|NCT01537068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348314|NCT01537068|Antidepressive Agents|antidepressive agents|mesh-ancestor
92348315|NCT01537068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92348316|NCT01585428|Aldesleukin|aldesleukin|mesh-list
92348317|NCT01585428|Cyclophosphamide|cyclophosphamide|mesh-list
92348318|NCT01585428|Fludarabine|fludarabine|mesh-list
92348319|NCT01585428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348320|NCT01585428|Immunologic Factors|immunologic factors|mesh-ancestor
92348321|NCT01585428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348322|NCT01585428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348323|NCT01585428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92348324|NCT01585428|Alkylating Agents|alkylating agents|mesh-ancestor
92348325|NCT01585428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348326|NCT01585428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348327|NCT01585428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92348328|NCT01585428|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92348329|NCT01585428|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92348330|NCT01585428|Antiviral Agents|antiviral agents|mesh-ancestor
92348331|NCT01585428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348332|NCT01585272|Rivastigmine|rivastigmine|mesh-list
92131712|NCT02355678|Antiemetics|antiemetics|mesh-ancestor
92348333|NCT01585272|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92348335|NCT01585272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348336|NCT01585272|Cholinergic Agents|cholinergic agents|mesh-ancestor
92348337|NCT01585272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348338|NCT01585272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348339|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92000845|NCT05152628|Tacrolimus|tacrolimus|mesh-list
92348340|NCT01585272|Protective Agents|protective agents|mesh-ancestor
92348342|NCT01585194|Ipilimumab|ipilimumab|mesh-list
92348343|NCT01585194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131855|NCT02353494|Artenimol|artenimol|mesh-list
92348344|NCT01585194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348345|NCT01585194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92348346|NCT01585194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348347|NCT01560780|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92348348|NCT01560780|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92348350|NCT01585038|Rilpivirine|rilpivirine|mesh-list
92348351|NCT01585038|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92348352|NCT01585038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92348353|NCT01585038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348354|NCT01585038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348355|NCT01585038|Antiviral Agents|antiviral agents|mesh-ancestor
92348356|NCT01585038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348357|NCT01585038|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92348358|NCT01585038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92348359|NCT01585038|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92348361|NCT01585038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92348362|NCT01585038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92348363|NCT01585038|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92348364|NCT01585038|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92348365|NCT01559844|Ribavirin|ribavirin|mesh-list
92348366|NCT01559844|Sofosbuvir|sofosbuvir|mesh-list
92348367|NCT01559844|Antimetabolites|antimetabolites|mesh-ancestor
92348368|NCT01559844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348370|NCT01559844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348371|NCT01584648|Trametinib|trametinib|mesh-list
92348372|NCT01584648|Dabrafenib|dabrafenib|mesh-list
92348373|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348374|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92348375|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348376|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348377|NCT01559454|Buprenorphine|buprenorphine|mesh-list
92348378|NCT01559454|Methadone|methadone|mesh-list
92348379|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92348380|NCT01559454|Naloxone|naloxone|mesh-list
92348381|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92348382|NCT01559454|Narcotics|narcotics|mesh-ancestor
92348383|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348384|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348385|NCT01559454|Analgesics|analgesics|mesh-ancestor
92348386|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
92348387|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132414|NCT04681443|Phenol|phenol|mesh-list
92348389|NCT01559454|Antitussive Agents|antitussive agents|mesh-ancestor
92348390|NCT01559454|Respiratory System Agents|respiratory system agents|mesh-ancestor
92348391|NCT01583166|Epinephrine|epinephrine|mesh-list
92348392|NCT01583166|Bupivacaine|bupivacaine|mesh-list
92348393|NCT01583166|Anesthetics, Local|anesthetics, local|mesh-ancestor
92348394|NCT01583166|Anesthetics|anesthetics|mesh-ancestor
92348395|NCT01583166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348396|NCT01583166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348398|NCT01583166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348399|NCT01583166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91941202|NCT05151679|Iron|iron|mesh-list
92132484|NCT02338518|Oxaliplatin|oxaliplatin|mesh-list
92348400|NCT01583166|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92348401|NCT01583166|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348402|NCT01583166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348403|NCT01583166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132542|NCT00401817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348404|NCT01583166|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92348405|NCT01583166|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92348406|NCT01583166|Autonomic Agents|autonomic agents|mesh-ancestor
92348407|NCT01583166|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92348408|NCT01583166|Respiratory System Agents|respiratory system agents|mesh-ancestor
92348409|NCT01583166|Mydriatics|mydriatics|mesh-ancestor
92348410|NCT01583166|Sympathomimetics|sympathomimetics|mesh-ancestor
92348411|NCT01583166|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92348412|NCT01582854|Actovegin|actovegin|mesh-list
92348413|NCT01582854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92348414|NCT01582854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348415|NCT01582854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92348416|NCT01582854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92348417|NCT01582854|Antioxidants|antioxidants|mesh-ancestor
92348418|NCT01582854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348419|NCT01582854|Protective Agents|protective agents|mesh-ancestor
92348420|NCT01582854|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92132820|NCT02326194|Vaccines|vaccines|mesh-list
92348421|NCT01582308|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92348422|NCT01582308|Vildagliptin|vildagliptin|mesh-list
92348423|NCT01582308|Saxagliptin|saxagliptin|mesh-list
92348424|NCT01582308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348425|NCT01582308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348427|NCT01582308|Hormones|hormones|mesh-ancestor
92348428|NCT01582308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348429|NCT01582308|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92348430|NCT01582308|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348431|NCT01582308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348432|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348433|NCT01558674|Torsemide|torsemide|mesh-list
92348434|NCT01558674|Furosemide|furosemide|mesh-list
92348435|NCT01558674|Diuretics|diuretics|mesh-ancestor
92348436|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
92348437|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133109|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92348438|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92348439|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348440|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348442|NCT01535040|Memantine|memantine|mesh-list
92348443|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92348444|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92348445|NCT01535040|Dopamine Agents|dopamine agents|mesh-ancestor
92348446|NCT01535040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348447|NCT01535040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348448|NCT01535040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348449|NCT01535040|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92348450|NCT01535040|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92348452|NCT01534962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92348453|NCT01534962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348454|NCT01534962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348456|NCT01582152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348457|NCT01582152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133543|NCT00435591|Conivaptan|conivaptan|mesh-list
92348458|NCT01582152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348459|NCT01582152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92348460|NCT01582152|Growth Substances|growth substances|mesh-ancestor
92348461|NCT01582152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348462|NCT01582152|Growth Inhibitors|growth inhibitors|mesh-ancestor
92348464|NCT01557504|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92348465|NCT01557504|Hormones|hormones|mesh-list
92348467|NCT01557504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348468|NCT01557504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348469|NCT01557504|Incretins|incretins|mesh-ancestor
92348470|NCT01557504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92348471|NCT01557504|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348472|NCT01557504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133673|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92348473|NCT01557504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348475|NCT01580670|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92348476|NCT01580670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348477|NCT01580670|Dermatologic Agents|dermatologic agents|mesh-ancestor
92348478|NCT01580670|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92348479|NCT01580670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348480|NCT01534260|Bortezomib|bortezomib|mesh-list
92348481|NCT01534260|Sorafenib|sorafenib|mesh-list
92348482|NCT01534260|Vorinostat|vorinostat|mesh-list
92348483|NCT01534260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348484|NCT01534260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92348485|NCT01534260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348486|NCT01534260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348487|NCT01534260|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92000988|NCT05050162|Cisplatin|cisplatin|mesh-list
92348488|NCT01534182|Interferons|interferons|mesh-list
92348489|NCT01534182|Interferon-beta|interferon-beta|mesh-list
92348490|NCT01534182|Glatiramer Acetate|glatiramer acetate|mesh-list
92348492|NCT01534182|(T,G)-A-L|(t,g)-a-l|mesh-list
92348493|NCT01534182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348494|NCT01534182|Antiviral Agents|antiviral agents|mesh-ancestor
92348495|NCT01534182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348496|NCT01534182|Immunologic Factors|immunologic factors|mesh-ancestor
92348497|NCT01534182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348498|NCT01534182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92348499|NCT01534182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348500|NCT01534182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134167|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92348501|NCT01534182|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92348502|NCT01534182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348505|NCT01579812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348506|NCT01579578|Paclitaxel|paclitaxel|mesh-list
92348507|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92348508|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348509|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92348510|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92348511|NCT01579578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92134480|NCT00462735|Cetuximab|cetuximab|mesh-list
92348512|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348513|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92134538|NCT01465997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348514|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92348515|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92348517|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
92348518|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348519|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348520|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348521|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348523|NCT01555164|Ranolazine|ranolazine|mesh-list
92348524|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348525|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348526|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92348527|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135060|NCT00481845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92348528|NCT01555164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348529|NCT03028428|Hyaluronic Acid|hyaluronic acid|mesh-list
92348530|NCT03028428|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92348532|NCT03028428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348533|NCT03028428|Viscosupplements|viscosupplements|mesh-ancestor
92348534|NCT03028428|Protective Agents|protective agents|mesh-ancestor
92348535|NCT01578330|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92348536|NCT01578330|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92348537|NCT01578330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348538|NCT01578330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348539|NCT01578330|Immunologic Factors|immunologic factors|mesh-ancestor
92348540|NCT01578330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348541|NCT01577160|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92348542|NCT01577160|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92348543|NCT01577160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92348544|NCT01577160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348545|NCT01577160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348546|NCT01577160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92348547|NCT01577160|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92348548|NCT01577160|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92348549|NCT01577160|Serotonin Agents|serotonin agents|mesh-ancestor
92348550|NCT01577160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348551|NCT01577160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135636|NCT01493557|Dabigatran|dabigatran|mesh-list
92348552|NCT01577160|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92348553|NCT01577160|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92348556|NCT01554618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135783|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
92348557|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348558|NCT01554618|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92348560|NCT01554618|Hormones|hormones|mesh-ancestor
92348561|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348562|NCT01531998|Dexamethasone|dexamethasone|mesh-list
92348563|NCT01531998|Lenalidomide|lenalidomide|mesh-list
92348564|NCT01531998|Bortezomib|bortezomib|mesh-list
92348565|NCT01531998|Siltuximab|siltuximab|mesh-list
92348566|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348567|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
92348568|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
92348569|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348570|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348571|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92348572|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
92348573|NCT01531998|Hormones|hormones|mesh-ancestor
92348574|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348575|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135987|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
92348576|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348577|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
92348578|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348579|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92348580|NCT01531998|Growth Substances|growth substances|mesh-ancestor
92348581|NCT01531998|Growth Inhibitors|growth inhibitors|mesh-ancestor
92348583|NCT01553916|Antidepressive Agents|antidepressive agents|mesh-ancestor
92348584|NCT01553916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92348585|NCT01553916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348586|NCT01553916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348587|NCT01553916|Antimanic Agents|antimanic agents|mesh-ancestor
92348588|NCT01553916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92348589|NCT01553916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348590|NCT01553916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348592|NCT01553136|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92348593|NCT01553136|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92348594|NCT01553136|Cholinergic Agents|cholinergic agents|mesh-ancestor
92348595|NCT01553136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348596|NCT01553136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348597|NCT01553136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348598|NCT01552902|Methylphenidate|methylphenidate|mesh-list
92348599|NCT01552902|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92348600|NCT01552902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92136717|NCT01446809|Alkylating Agents|alkylating agents|mesh-ancestor
92348601|NCT01552902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136786|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348603|NCT01552902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92348604|NCT01552902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348605|NCT01552902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348606|NCT01552902|Dopamine Agents|dopamine agents|mesh-ancestor
92348607|NCT01552902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348608|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
92348609|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92348610|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92137228|NCT01517984|Glucocorticoids|glucocorticoids|mesh-ancestor
92348611|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92348612|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348613|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348614|NCT02072928|Cholinergic Agents|cholinergic agents|mesh-ancestor
92348615|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348616|NCT02072928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348617|NCT02072928|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92348618|NCT02072928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137528|NCT00668811|Sunitinib|sunitinib|mesh-list
92348620|NCT01529346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92348621|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92348622|NCT01529346|Analgesics|analgesics|mesh-ancestor
92348623|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
92348624|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348625|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348626|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348627|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348628|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92348629|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348630|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348632|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92348633|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348634|NCT01529112|Lenvatinib|lenvatinib|mesh-list
92348635|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137647|NCT00672243|Sirolimus|sirolimus|mesh-list
92348636|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92348637|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348638|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137756|NCT01077843|Etoricoxib|etoricoxib|mesh-list
92348639|NCT01575054|Botulinum Toxins|botulinum toxins|mesh-list
92348640|NCT01575054|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92348641|NCT01575054|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92348642|NCT01575054|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92348643|NCT01575054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137863|NCT00638937|Saracatinib|saracatinib|mesh-list
92348644|NCT01575054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348645|NCT01575054|Cholinergic Agents|cholinergic agents|mesh-ancestor
92348646|NCT01575054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348647|NCT01575054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348648|NCT01575054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92138002|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92348649|NCT01575054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348650|NCT01528254|Metformin|metformin|mesh-list
92138150|NCT00589563|Melphalan|melphalan|mesh-list
92348652|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348653|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348654|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92348655|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348656|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348657|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348658|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92348659|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
92348660|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
92348661|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92348662|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92348663|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92348664|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348665|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348666|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138513|NCT01514240|Analgesics|analgesics|mesh-ancestor
92348667|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348669|NCT01525602|Paclitaxel|paclitaxel|mesh-list
92348670|NCT01525602|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138583|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
92348671|NCT01525602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348672|NCT01525602|Tubulin Modulators|tubulin modulators|mesh-ancestor
92348673|NCT01525602|Antimitotic Agents|antimitotic agents|mesh-ancestor
92348674|NCT01525602|Mitosis Modulators|mitosis modulators|mesh-ancestor
92348675|NCT01525602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348677|NCT01549002|Morphine|morphine|mesh-list
92348678|NCT01549002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92348680|NCT01549002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92348681|NCT01549002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348683|NCT01549002|Sensory System Agents|sensory system agents|mesh-ancestor
92138793|NCT02427126|Analgesics|analgesics|mesh-ancestor
92348684|NCT01549002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348685|NCT01549002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92348686|NCT01549002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92348687|NCT01549002|Anesthetics, General|anesthetics, general|mesh-ancestor
92348689|NCT01548768|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92348690|NCT01548768|Antirheumatic Agents|antirheumatic agents|mesh-list
92348691|NCT01548768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348692|NCT01572792|Bromides|bromides|mesh-list
92348693|NCT01572792|Formoterol Fumarate|formoterol fumarate|mesh-list
92348694|NCT01572792|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92348695|NCT01572792|Autonomic Agents|autonomic agents|mesh-ancestor
92348696|NCT01572792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348697|NCT01572792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348698|NCT01572792|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92348699|NCT01572792|Respiratory System Agents|respiratory system agents|mesh-ancestor
92348700|NCT01572792|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92348701|NCT01572792|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92348702|NCT01572792|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92348703|NCT01572792|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348704|NCT01572792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348705|NCT01572792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348706|NCT01572792|Anticonvulsants|anticonvulsants|mesh-ancestor
92348707|NCT01547598|Timolol|timolol|mesh-list
92348708|NCT01547598|Bimatoprost|bimatoprost|mesh-list
92348709|NCT01547598|Travoprost|travoprost|mesh-list
92348710|NCT01547598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92348711|NCT01547598|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92348712|NCT01547598|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92348713|NCT01547598|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92348714|NCT01547598|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348715|NCT01547598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348716|NCT01547598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348717|NCT01547598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348718|NCT01547598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92348719|NCT01547598|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92348720|NCT01547286|Methacholine Chloride|methacholine chloride|mesh-list
92348721|NCT01547286|Miotics|miotics|mesh-ancestor
92348722|NCT01547286|Autonomic Agents|autonomic agents|mesh-ancestor
92348723|NCT01547286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348724|NCT01547286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348725|NCT01547286|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92348726|NCT01547286|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92348727|NCT01547286|Respiratory System Agents|respiratory system agents|mesh-ancestor
92348728|NCT01547286|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92348730|NCT01547286|Cholinergic Agents|cholinergic agents|mesh-ancestor
92139131|NCT00596271|Vaccines|vaccines|mesh-list
92348731|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348732|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348733|NCT01524978|Cetuximab|cetuximab|mesh-list
92348734|NCT01524978|Vemurafenib|vemurafenib|mesh-list
92348735|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348736|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139279|NCT00684723|Lovastatin|lovastatin|mesh-list
92348737|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92348738|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139345|NCT01525628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348739|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348740|NCT01524198|Budesonide|budesonide|mesh-list
92348741|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92139489|NCT01404325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348742|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92348744|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139643|NCT00691665|Xhance|xhance|mesh-list
92348745|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348746|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92348747|NCT01524198|Respiratory System Agents|respiratory system agents|mesh-ancestor
92139804|NCT03469050|Rifaximin|rifaximin|mesh-list
92348748|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
92348750|NCT01524198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348751|NCT01523886|Rocuronium|rocuronium|mesh-list
92348752|NCT01523886|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92348753|NCT01523886|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92348754|NCT01523886|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92348755|NCT01523886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139934|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348756|NCT01523886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348757|NCT01546038|Cytarabine|cytarabine|mesh-list
92348758|NCT01546038|Decitabine|decitabine|mesh-list
92348759|NCT01546038|Daunorubicin|daunorubicin|mesh-list
92348760|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92348761|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
92348762|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348763|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348764|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
92348765|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140166|NCT05088720|Oxytocics|oxytocics|mesh-ancestor
92348767|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
92348768|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348769|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92348770|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92348771|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92348772|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348773|NCT01571232|Dexamethasone|dexamethasone|mesh-list
92348774|NCT01571232|Bevacizumab|bevacizumab|mesh-list
92348775|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92348776|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348777|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92348778|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92348780|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348781|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92348782|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348783|NCT01571232|Antiemetics|antiemetics|mesh-ancestor
92348784|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
92348785|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348786|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140672|NCT01380691|Disinfectants|disinfectants|mesh-ancestor
92348789|NCT01571232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348790|NCT01571232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92348792|NCT01522950|Nebivolol|nebivolol|mesh-list
92348793|NCT01522950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92348794|NCT01522950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92348795|NCT01522950|Sympatholytics|sympatholytics|mesh-ancestor
92348796|NCT01522950|Autonomic Agents|autonomic agents|mesh-ancestor
92348797|NCT01522950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348798|NCT01522950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348799|NCT01522950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92348800|NCT01522950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92348801|NCT01522950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92348802|NCT01522950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348803|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348804|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141187|NCT03595189|Cilastatin|cilastatin|mesh-list
92348805|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
92348806|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92348807|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92348808|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92348809|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92348810|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92348811|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92348812|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92348813|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348814|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348815|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348816|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348817|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
92348818|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348819|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92348820|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348821|NCT01543776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348822|NCT01543776|Hormone Antagonists|hormone antagonists|mesh-ancestor
92348823|NCT01543776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348824|NCT01543776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348825|NCT01543776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92348826|NCT01518192|Doxycycline|doxycycline|mesh-list
92348827|NCT01518192|Cefuroxime|cefuroxime|mesh-list
92348828|NCT01518192|Cefuroxime axetil|cefuroxime axetil|mesh-list
92348829|NCT01518192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92348830|NCT01518192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348831|NCT01518192|Antimalarials|antimalarials|mesh-ancestor
92348832|NCT01518192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92348833|NCT01518192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92348834|NCT01517802|Prednisone|prednisone|mesh-list
92348835|NCT01517802|Abiraterone Acetate|abiraterone acetate|mesh-list
92348836|NCT01517802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348838|NCT01517802|Hormones|hormones|mesh-ancestor
92348839|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348840|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348841|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92348842|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348843|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92348844|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348845|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348846|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
92348847|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92348848|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
92348849|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92348850|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
92348851|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348852|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348853|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92348854|NCT04714710|Diuretics|diuretics|mesh-ancestor
92348855|NCT04714710|Natriuretic Agents|natriuretic agents|mesh-ancestor
92348856|NCT01520922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92348858|NCT01520922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92348859|NCT01520922|Alkylating Agents|alkylating agents|mesh-ancestor
92348860|NCT01520922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348861|NCT01520922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348862|NCT01517412|Metformin|metformin|mesh-list
92348863|NCT01517412|Lixisenatide|lixisenatide|mesh-list
92348864|NCT01517412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348865|NCT01517412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142257|NCT04025593|Glucocorticoids|glucocorticoids|mesh-ancestor
92142326|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
92348866|NCT01489956|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92348867|NCT01489956|Freund's Adjuvant|freund's adjuvant|mesh-list
92348868|NCT01489956|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92348869|NCT01489956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92348870|NCT01489956|Immunologic Factors|immunologic factors|mesh-ancestor
92142472|NCT04150770|Infliximab|infliximab|mesh-list
92348871|NCT01489956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348872|NCT01516008|Tapentadol|tapentadol|mesh-list
92348873|NCT01516008|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92348874|NCT01516008|Narcotics|narcotics|mesh-ancestor
92142624|NCT04149067|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348875|NCT01516008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142699|NCT05101356|Vaccines|vaccines|mesh-list
92348876|NCT01516008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348878|NCT01516008|Sensory System Agents|sensory system agents|mesh-ancestor
92348879|NCT01516008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92348880|NCT01516008|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92348881|NCT01516008|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92348882|NCT01516008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142996|NCT04525638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348883|NCT01516008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348884|NCT01516008|Adrenergic Agents|adrenergic agents|mesh-ancestor
92348885|NCT01516008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348886|NCT01489254|Glatiramer Acetate|glatiramer acetate|mesh-list
92348887|NCT01489254|(T,G)-A-L|(t,g)-a-l|mesh-list
92348888|NCT01489254|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92348889|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
92348890|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348891|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348892|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92348893|NCT01489020|Immunomodulating Agents|immunomodulating agents|mesh-list
92348894|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
92348895|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143503|NCT03158935|Cyclophosphamide|cyclophosphamide|mesh-list
92348896|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92348897|NCT01514448|Everolimus|everolimus|mesh-list
92348898|NCT01514448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92143652|NCT05002530|Vitamin D|vitamin d|mesh-list
92348899|NCT01514448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143806|NCT03076164|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92348901|NCT01514448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348902|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92348903|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
92348904|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348905|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348907|NCT01514370|Interferon-beta|interferon-beta|mesh-list
92348909|NCT01514370|Curcumin|curcumin|mesh-list
92348910|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92348911|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
92348912|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348913|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92144244|NCT01674205|Vaccines|vaccines|mesh-list
92348915|NCT01514370|Analgesics|analgesics|mesh-ancestor
92348916|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
92348918|NCT01514370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348919|NCT01514370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348920|NCT01514370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144539|NCT01677403|Tobramycin|tobramycin|mesh-list
92348921|NCT01514370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348922|NCT01514370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348923|NCT01514370|Immunologic Factors|immunologic factors|mesh-ancestor
92348924|NCT01514370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92348925|NCT01519674|Insulin|insulin|mesh-list
92144696|NCT02652624|Antiviral Agents|antiviral agents|mesh-ancestor
92348926|NCT01519674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92348927|NCT01519674|Metformin|metformin|mesh-list
92348928|NCT01519674|Insulin Aspart|insulin aspart|mesh-list
92348929|NCT01519674|Insulin, Long-Acting|insulin, long-acting|mesh-list
92348930|NCT01519674|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92348931|NCT01519674|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92348932|NCT01519674|Biphasic Insulins|biphasic insulins|mesh-list
92348933|NCT01519674|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92348934|NCT01519674|Insulin, Isophane|insulin, isophane|mesh-list
92348935|NCT01519674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348936|NCT01519674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348937|NCT01519674|Incretins|incretins|mesh-ancestor
92348938|NCT01519674|Hormones|hormones|mesh-ancestor
92348939|NCT01519674|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348940|NCT01519674|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92348941|NCT01519674|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348942|NCT01519674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348943|NCT01519674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348945|NCT01519518|Calcium heparin|calcium heparin|mesh-list
92348946|NCT01519518|Bivalirudin|bivalirudin|mesh-list
92348947|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
92348948|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92348949|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92348950|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348951|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
92145492|NCT00762645|Miotics|miotics|mesh-ancestor
92348952|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92348953|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
92348954|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92348956|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92348957|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92348958|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92348959|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92348960|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
92145713|NCT03291990|Temozolomide|temozolomide|mesh-list
92348961|NCT01518972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92348962|NCT01518972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348963|NCT01518972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348964|NCT01513590|Insulin|insulin|mesh-list
92348965|NCT01513590|Insulin Aspart|insulin aspart|mesh-list
92348966|NCT01513590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92348967|NCT01513590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348968|NCT04672512|Prednisone|prednisone|mesh-list
92348969|NCT04672512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92348970|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
92348971|NCT04672512|Hormones|hormones|mesh-ancestor
92348972|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92348973|NCT04672512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146365|NCT00786825|Somatostatin|somatostatin|mesh-list
92348974|NCT04672512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92348975|NCT04672512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146512|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
92348976|NCT01512108|Liraglutide|liraglutide|mesh-list
92348977|NCT01512108|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92348978|NCT01512108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92348979|NCT01512108|Incretins|incretins|mesh-ancestor
92348980|NCT01512108|Hormones|hormones|mesh-ancestor
92348981|NCT01512108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146685|NCT01402817|Sunitinib|sunitinib|mesh-list
92348982|NCT01486758|Azithromycin|azithromycin|mesh-list
92146738|NCT01424813|Albuterol|albuterol|mesh-list
92348983|NCT01486758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92348984|NCT01486758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92348985|NCT01463982|Capecitabine|capecitabine|mesh-list
92348986|NCT01463982|Irinotecan|irinotecan|mesh-list
92348987|NCT01463982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92348988|NCT01463982|Antimetabolites|antimetabolites|mesh-ancestor
92146959|NCT01678651|Hormones|hormones|mesh-ancestor
92348989|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348991|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92348992|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92348994|NCT01510158|Allopurinol|allopurinol|mesh-list
92348995|NCT01510158|Lesinurad|lesinurad|mesh-list
92348996|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
92147175|NCT05287308|Epirubicin|epirubicin|mesh-list
92348997|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92348999|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
92349000|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349001|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92349002|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
92349003|NCT01510158|Protective Agents|protective agents|mesh-ancestor
92349004|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349005|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
92349006|NCT04080882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92349007|NCT04080882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92001524|NCT04589208|Ketamine|ketamine|mesh-list
92349008|NCT04080882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92349009|NCT04080882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349010|NCT04080882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147390|NCT04608266|Camostat|camostat|mesh-list
92349011|NCT04080882|Cholinergic Agents|cholinergic agents|mesh-ancestor
92349012|NCT04080882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349013|NCT04080882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349014|NCT04080882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92349015|NCT04080882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349016|NCT01484496|Belimumab|belimumab|mesh-list
92349017|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349018|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
92147615|NCT00804609|Lidocaine|lidocaine|mesh-list
92349019|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349021|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
92349022|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349024|NCT01462344|Xhance|xhance|mesh-list
92147929|NCT04951986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92349025|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92349027|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
92349028|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349029|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349030|NCT01462344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92349031|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
92349032|NCT01462344|Glucocorticoids|glucocorticoids|mesh-ancestor
92349034|NCT01462344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92349035|NCT01462344|Sympathomimetics|sympathomimetics|mesh-ancestor
92349036|NCT01462344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92349037|NCT01462344|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349038|NCT01462344|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92349039|NCT01462266|Metformin|metformin|mesh-list
92349040|NCT01462266|Insulin Glargine|insulin glargine|mesh-list
92349041|NCT01462266|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92349042|NCT01462266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92349043|NCT01462266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349044|NCT01462266|Incretins|incretins|mesh-ancestor
92349045|NCT01462266|Hormones|hormones|mesh-ancestor
92147997|NCT04520217|Imipramine|imipramine|mesh-list
92349046|NCT01462266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148061|NCT00845481|Calcitriol|calcitriol|mesh-list
92349048|NCT01462266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92349049|NCT01462266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148123|NCT00814671|Leprostatic Agents|leprostatic agents|mesh-ancestor
92349050|NCT01462266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349051|NCT04087590|Glycopyrrolate|glycopyrrolate|mesh-list
92349052|NCT04087590|Formoterol Fumarate|formoterol fumarate|mesh-list
92148267|NCT01399697|Methotrexate|methotrexate|mesh-list
92349053|NCT04087590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92349054|NCT04087590|Autonomic Agents|autonomic agents|mesh-ancestor
92349055|NCT04087590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349056|NCT04087590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349057|NCT04087590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92349058|NCT04087590|Respiratory System Agents|respiratory system agents|mesh-ancestor
92349059|NCT04087590|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92349060|NCT04087590|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92349061|NCT04087590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92349062|NCT04087590|Adrenergic Agents|adrenergic agents|mesh-ancestor
92349063|NCT04087590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148555|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92349064|NCT04087590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349065|NCT04087590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92349066|NCT04087590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92349067|NCT04087590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92148773|NCT01397825|Vincristine|vincristine|mesh-list
92349068|NCT04087590|Cholinergic Agents|cholinergic agents|mesh-ancestor
92349069|NCT01508676|Diclofenac|diclofenac|mesh-list
92148849|NCT00835185|Oxaliplatin|oxaliplatin|mesh-list
92349070|NCT01508676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92349071|NCT01508676|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92349072|NCT01508676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92349073|NCT01508676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92349074|NCT01508676|Analgesics|analgesics|mesh-ancestor
92349075|NCT01508676|Sensory System Agents|sensory system agents|mesh-ancestor
92349076|NCT01508676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349077|NCT01508676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148984|NCT04760431|Taxane|taxane|mesh-list
92349079|NCT01508676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92349080|NCT01508676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349081|NCT01508676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349083|NCT02985372|Decitabine|decitabine|mesh-list
92349084|NCT02985372|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92349085|NCT02985372|Antimetabolites|antimetabolites|mesh-ancestor
92349086|NCT02985372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349087|NCT02985372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349088|NCT02985372|Antiviral Agents|antiviral agents|mesh-ancestor
92349089|NCT02985372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349090|NCT02985372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349091|NCT02985372|Immunologic Factors|immunologic factors|mesh-ancestor
92349092|NCT02985372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349093|NCT02985372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349095|NCT02985216|Analgesics|analgesics|mesh-ancestor
92149431|NCT04424862|Mycophenolic Acid|mycophenolic acid|mesh-list
92349096|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
92349097|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349098|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349100|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92349101|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349102|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149642|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
92349104|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92349105|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92149745|NCT05070468|Hormones|hormones|mesh-ancestor
92349106|NCT02985216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92349107|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92349108|NCT01461096|Vaccines|vaccines|mesh-list
92349109|NCT01461096|Immunologic Factors|immunologic factors|mesh-ancestor
92349110|NCT01461096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349111|NCT01480674|Trastuzumab|trastuzumab|mesh-list
92349112|NCT01480674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92349113|NCT01480674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349114|NCT01506882|Levetiracetam|levetiracetam|mesh-list
92349115|NCT01506882|Anticonvulsants|anticonvulsants|mesh-ancestor
92349116|NCT01506882|Nootropic Agents|nootropic agents|mesh-ancestor
92349117|NCT01506726|Salicylic Acid|salicylic acid|mesh-list
92349119|NCT01506726|Salicylates|salicylates|mesh-list
92349120|NCT01506726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92349121|NCT01506726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92349122|NCT01506726|Analgesics|analgesics|mesh-ancestor
92349123|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
92349124|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349125|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349126|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92349127|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349128|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92349129|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349130|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349132|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
92349133|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
92349134|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349135|NCT01505868|Carboplatin|carboplatin|mesh-list
92349136|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150904|NCT05248633|Bortezomib|bortezomib|mesh-list
92349137|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
92349138|NCT01505634|Imipenem|imipenem|mesh-list
92349139|NCT01505634|Relebactam|relebactam|mesh-list
92349141|NCT01505634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349142|NCT01505634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349143|NCT01505634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92349144|NCT01505634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92349145|NCT01505634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349146|NCT01505634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349147|NCT01505634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349148|NCT01505634|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92349149|NCT01505634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92349150|NCT01505634|Protease Inhibitors|protease inhibitors|mesh-ancestor
92349151|NCT01505634|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92349152|NCT01460628|Modafinil|modafinil|mesh-list
92349153|NCT01460628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92349154|NCT01460628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151566|NCT00988117|Rivastigmine|rivastigmine|mesh-list
92349155|NCT01460628|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92349156|NCT01460628|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92349157|NCT01460628|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92349158|NCT01460628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349160|NCT01480596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349161|NCT01480596|Immunologic Factors|immunologic factors|mesh-ancestor
92151863|NCT01360866|Paroxetine|paroxetine|mesh-list
92152010|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92349162|NCT01480596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152102|NCT00633217|Hormones|hormones|mesh-ancestor
92349164|NCT01459614|Docetaxel|docetaxel|mesh-list
92349165|NCT01459614|Capecitabine|capecitabine|mesh-list
92349166|NCT01459614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349167|NCT01459614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92349168|NCT01459614|Antimetabolites|antimetabolites|mesh-ancestor
92349169|NCT01459614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349171|NCT01459614|Antimitotic Agents|antimitotic agents|mesh-ancestor
92349172|NCT01459614|Mitosis Modulators|mitosis modulators|mesh-ancestor
92349173|NCT01458522|Lacosamide|lacosamide|mesh-list
92349174|NCT01458522|Fosphenytoin|fosphenytoin|mesh-list
92349175|NCT01458522|Anticonvulsants|anticonvulsants|mesh-ancestor
92349176|NCT01458522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92349177|NCT01458522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92349178|NCT01458522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349179|NCT01458522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349180|NCT03026946|Cyclosporine|cyclosporine|mesh-list
92349181|NCT03026946|Alitretinoin|alitretinoin|mesh-list
92349182|NCT03026946|Cyclosporins|cyclosporins|mesh-list
92349183|NCT03026946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349184|NCT03026946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349185|NCT03026946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349186|NCT03026946|Immunologic Factors|immunologic factors|mesh-ancestor
92349187|NCT03026946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349188|NCT03026946|Antifungal Agents|antifungal agents|mesh-ancestor
92349189|NCT03026946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349190|NCT03026946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349191|NCT03026946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349192|NCT03026946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92349193|NCT03026946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349194|NCT01458366|Carboplatin|carboplatin|mesh-list
92349195|NCT01458366|Etoposide|etoposide|mesh-list
92349196|NCT01458366|Etoposide phosphate|etoposide phosphate|mesh-list
92349197|NCT01458366|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92349199|NCT01458366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152878|NCT04194827|Adalimumab|adalimumab|mesh-list
92349200|NCT01458366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92152953|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
92153029|NCT03962465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349201|NCT01458366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92349202|NCT01458366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92349203|NCT01458366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349204|NCT01458366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349205|NCT01458366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92349206|NCT01458366|Alkylating Agents|alkylating agents|mesh-ancestor
92349207|NCT01458210|Dulaglutide|dulaglutide|mesh-list
92349208|NCT01458210|Moxifloxacin|moxifloxacin|mesh-list
92153494|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92349209|NCT01458210|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92349211|NCT01458210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349212|NCT01458210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153716|NCT02243553|Vitamin K|vitamin k|mesh-list
92349213|NCT01458210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153802|NCT05006664|Hormones|hormones|mesh-ancestor
92349215|NCT01458210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92349216|NCT01458210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349217|NCT01458210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153931|NCT04363203|Antimalarials|antimalarials|mesh-ancestor
92349218|NCT01458210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154005|NCT04025177|Analgesics|analgesics|mesh-ancestor
92349219|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92349220|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
92349221|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92349222|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92349223|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92349224|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92349225|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
92349226|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349227|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92349228|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92154145|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92349230|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349231|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
92349232|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92349233|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
92349234|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349235|NCT01501110|Expectorants|expectorants|mesh-ancestor
92349236|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92349237|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92349238|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
92349239|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349240|NCT01501110|Protective Agents|protective agents|mesh-ancestor
92349241|NCT01501110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349242|NCT01501110|Antidotes|antidotes|mesh-ancestor
92349243|NCT01500720|Topotecan|topotecan|mesh-list
92349244|NCT01500720|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92349245|NCT01500720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92349246|NCT01500720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349247|NCT01500720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349248|NCT01500720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349249|NCT01476696|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92349250|NCT01476696|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92349251|NCT01455012|Rotigotine|rotigotine|mesh-list
92349252|NCT01455012|Dopamine Agonists|dopamine agonists|mesh-ancestor
92349253|NCT01455012|Dopamine Agents|dopamine agents|mesh-ancestor
92349254|NCT01455012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349255|NCT01455012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349256|NCT01455012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349257|NCT01454778|Paclitaxel|paclitaxel|mesh-list
92349258|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92349259|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349260|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92405986|NCT04597372|Tamsulosin|tamsulosin|mesh-list
92349261|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92349262|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92349263|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349264|NCT01454076|Clarithromycin|clarithromycin|mesh-list
92349265|NCT01454076|Rifampin|rifampin|mesh-list
92349266|NCT01454076|Ketoconazole|ketoconazole|mesh-list
92349267|NCT01454076|Ixazomib|ixazomib|mesh-list
92349268|NCT01454076|Glycine|glycine|mesh-list
92349269|NCT01454076|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349270|NCT01454076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406348|NCT00113763|Panitumumab|panitumumab|mesh-list
92349271|NCT01454076|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92349272|NCT01454076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349273|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349274|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92349275|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92349276|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92349277|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
92349278|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
92349279|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92349280|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92406566|NCT01439750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349281|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92349282|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92349283|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92349284|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92349285|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92349287|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92406707|NCT01440751|Mitomycin|mitomycin|mesh-list
92349288|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92349289|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
92406850|NCT01441505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349290|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92407077|NCT01442818|Analgesics|analgesics|mesh-ancestor
92349291|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349292|NCT01454076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349293|NCT01454076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407156|NCT01443065|Vitamins|vitamins|mesh-ancestor
92407230|NCT01443338|Acitretin|acitretin|mesh-list
92349295|NCT01454076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349296|NCT01453998|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92349299|NCT01453374|Naltrexone|naltrexone|mesh-list
92349300|NCT01453374|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92349301|NCT01453374|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92349303|NCT01453374|Sensory System Agents|sensory system agents|mesh-ancestor
92349304|NCT01453374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349305|NCT01453140|Sirolimus|sirolimus|mesh-list
92349306|NCT01453140|Cyclophosphamide|cyclophosphamide|mesh-list
92349307|NCT01453140|Temsirolimus|temsirolimus|mesh-list
92349308|NCT01453140|Interleukin-2|interleukin-2|mesh-list
92349309|NCT01453140|Azacitidine|azacitidine|mesh-list
92407600|NCT01445743|Vaccines|vaccines|mesh-list
92349310|NCT01453140|MTOR Inhibitors|mtor inhibitors|mesh-list
92349311|NCT01453140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349312|NCT01453140|Immunologic Factors|immunologic factors|mesh-ancestor
92407733|NCT01446458|Folfirinox|folfirinox|mesh-list
92349313|NCT01453140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349314|NCT01453140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407807|NCT01446952|Vitamin E|vitamin e|mesh-list
92349315|NCT01453140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92349316|NCT01453140|Alkylating Agents|alkylating agents|mesh-ancestor
92407882|NCT01447394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349317|NCT01453140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349318|NCT01453140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349319|NCT01453140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92349320|NCT01453140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349321|NCT01453140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349322|NCT01453140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92349323|NCT01453140|Antifungal Agents|antifungal agents|mesh-ancestor
92349324|NCT01453140|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349325|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408097|NCT01448720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92349326|NCT01453140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92349327|NCT01453140|Analgesics|analgesics|mesh-ancestor
92349328|NCT01453140|Sensory System Agents|sensory system agents|mesh-ancestor
92349329|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349330|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92408317|NCT01449799|Xhance|xhance|mesh-list
92349332|NCT01499940|Vitamin D|vitamin d|mesh-list
92349333|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
92349334|NCT01499940|Vitamins|vitamins|mesh-ancestor
92349335|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
92349336|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349337|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92349338|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92349340|NCT01499160|Letrozole|letrozole|mesh-list
92349341|NCT01499160|Lapatinib|lapatinib|mesh-list
92408464|NCT01454869|Heparin|heparin|mesh-list
92349342|NCT01499160|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92349343|NCT01499160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349344|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349345|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349346|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349347|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
92349348|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349349|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349350|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92349351|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92349352|NCT01499160|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92349353|NCT01499160|Hormone Antagonists|hormone antagonists|mesh-ancestor
92115097|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
92349354|NCT01499160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92349356|NCT01498068|Ribavirin|ribavirin|mesh-list
92349357|NCT01498068|Interferon-alpha|interferon-alpha|mesh-list
92349358|NCT01498068|Interferon alpha-2|interferon alpha-2|mesh-list
92349359|NCT01498068|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92349360|NCT01498068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349361|NCT01498068|Antiviral Agents|antiviral agents|mesh-ancestor
92349362|NCT01498068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349363|NCT01498068|Antimetabolites|antimetabolites|mesh-ancestor
92349364|NCT01498068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349365|NCT01498068|Immunologic Factors|immunologic factors|mesh-ancestor
92349366|NCT01498068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349367|NCT01497366|Sofosbuvir|sofosbuvir|mesh-list
92349368|NCT01497366|Antiviral Agents|antiviral agents|mesh-ancestor
92349369|NCT01497366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349370|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92349371|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
92349372|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349373|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92349374|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92349375|NCT01451814|Nicotine|nicotine|mesh-list
92349376|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92349377|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
92349378|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349379|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349380|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92349381|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92349382|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
92349383|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349384|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349385|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92349386|NCT01496430|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92349387|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92349388|NCT01496430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349389|NCT04408326|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92349390|NCT04408326|Angiotensin II|angiotensin ii|mesh-list
92349391|NCT04408326|Giapreza|giapreza|mesh-list
92349393|NCT04408326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349395|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92349396|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
92349397|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349398|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349400|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
92349401|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92349402|NCT01474746|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92349403|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92349404|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349405|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349407|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
92349408|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349409|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
92349410|NCT01450800|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92349411|NCT01450800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349412|NCT01450800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349413|NCT01474512|Ixekizumab|ixekizumab|mesh-list
92349414|NCT01474512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349415|NCT02985606|Caffeine|caffeine|mesh-list
92349416|NCT02985606|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92349417|NCT02985606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349418|NCT02985606|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92349419|NCT02985606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349420|NCT02985606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349421|NCT02985606|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92349423|NCT02985606|Purinergic Agents|purinergic agents|mesh-ancestor
92349424|NCT02985606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349425|NCT01473732|Mycophenolic Acid|mycophenolic acid|mesh-list
92349426|NCT01473732|Everolimus|everolimus|mesh-list
92349428|NCT01473732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349429|NCT01473732|Immunologic Factors|immunologic factors|mesh-ancestor
92349430|NCT01473732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349431|NCT01473732|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92349432|NCT01473732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115098|NCT02074839|Ivosidenib|ivosidenib|mesh-list
92349433|NCT01473732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349434|NCT01473732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92349435|NCT01473732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349436|NCT01473732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349437|NCT01473732|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92349438|NCT01473732|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92349439|NCT01473732|Antitubercular Agents|antitubercular agents|mesh-ancestor
92349440|NCT01473732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349441|NCT01473732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349442|NCT01450098|Evacetrapib|evacetrapib|mesh-list
92349443|NCT01450098|Propyl Gallate|propyl gallate|mesh-list
92349444|NCT01450098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92349445|NCT01450098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92349446|NCT01450098|Antimetabolites|antimetabolites|mesh-ancestor
92349447|NCT01450098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349448|NCT01450098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92349449|NCT01450098|Antioxidants|antioxidants|mesh-ancestor
92349450|NCT01450098|Protective Agents|protective agents|mesh-ancestor
92349451|NCT01450098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349452|NCT01449630|Celecoxib|celecoxib|mesh-list
92349453|NCT01449630|LY3031207|ly3031207|mesh-list
92349454|NCT01449630|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92349455|NCT01449630|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92349456|NCT01449630|Analgesics|analgesics|mesh-ancestor
92349457|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
92349458|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349459|NCT01449630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349460|NCT01449630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92349461|NCT01449630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349462|NCT01449630|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92349463|NCT01449630|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92349464|NCT01449630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349465|NCT01449630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349466|NCT01449630|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
92349468|NCT01449630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92349469|NCT01473420|Epoetin Alfa|epoetin alfa|mesh-list
92349470|NCT01473420|Hematinics|hematinics|mesh-ancestor
92349471|NCT04674774|Lansoprazole|lansoprazole|mesh-list
92349472|NCT04674774|Dexlansoprazole|dexlansoprazole|mesh-list
92349473|NCT04674774|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92349474|NCT04674774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92349475|NCT04674774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92349476|NCT04674774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349477|NCT04674774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349478|NCT01492686|Edaravone|edaravone|mesh-list
92349479|NCT01492686|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92349480|NCT01492686|Antioxidants|antioxidants|mesh-ancestor
92349481|NCT01492686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349482|NCT01492686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92349483|NCT01492686|Protective Agents|protective agents|mesh-ancestor
92349484|NCT01492686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349485|NCT01449006|Maraviroc|maraviroc|mesh-list
92349486|NCT01449006|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92349487|NCT01449006|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92349488|NCT01449006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349489|NCT01449006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92349490|NCT01449006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92349491|NCT01449006|Antiviral Agents|antiviral agents|mesh-ancestor
92349492|NCT01449006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349493|NCT01449006|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92349494|NCT01491672|Everolimus|everolimus|mesh-list
92349495|NCT01491672|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92349496|NCT01491672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349545|NCT01490580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349546|NCT01490580|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92349547|NCT01490580|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92349548|NCT01490580|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92349549|NCT01490580|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92349550|NCT01490190|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92349551|NCT01490190|Etonogestrel|etonogestrel|mesh-list
92349553|NCT01490190|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92349554|NCT01490190|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92349555|NCT01490190|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92349557|NCT01490190|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92349558|NCT01490190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349559|NCT01490190|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92349560|NCT01490190|Estrogens|estrogens|mesh-ancestor
92349561|NCT01490190|Hormones|hormones|mesh-ancestor
92399295|NCT01402882|Tranexamic Acid|tranexamic acid|mesh-list
92349562|NCT01490190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92349564|NCT01446042|Testosterone|testosterone|mesh-list
92349565|NCT01446042|Testosterone undecanoate|testosterone undecanoate|mesh-list
92349566|NCT01446042|Testosterone enanthate|testosterone enanthate|mesh-list
92349567|NCT01446042|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92349568|NCT01446042|Androgens|androgens|mesh-ancestor
92349569|NCT01446042|Hormones|hormones|mesh-ancestor
92349570|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92349571|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349572|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92349573|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349574|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
92349575|NCT01445886|Calcitriol|calcitriol|mesh-list
92349576|NCT01445886|Calcipotriene|calcipotriene|mesh-list
92349577|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349578|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92349579|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349580|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92349581|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349582|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349583|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92349584|NCT01445886|Vitamins|vitamins|mesh-ancestor
92349585|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
92349586|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92349587|NCT01470612|Tofacitinib|tofacitinib|mesh-list
92349588|NCT01470612|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92349589|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349590|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349591|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349592|NCT04073316|Warfarin|warfarin|mesh-list
92349593|NCT04073316|Rivaroxaban|rivaroxaban|mesh-list
92349594|NCT04073316|Anticoagulants|anticoagulants|mesh-ancestor
92349595|NCT04073316|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92349596|NCT04073316|Antithrombins|antithrombins|mesh-ancestor
92349597|NCT04073316|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92349598|NCT04073316|Protease Inhibitors|protease inhibitors|mesh-ancestor
92349600|NCT04073316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349601|NCT04089852|Nitrous Oxide|nitrous oxide|mesh-list
92349602|NCT04089852|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92349603|NCT04089852|Anesthetics, General|anesthetics, general|mesh-ancestor
92349604|NCT04089852|Anesthetics|anesthetics|mesh-ancestor
92349605|NCT04089852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92349606|NCT04089852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349608|NCT04089852|Analgesics|analgesics|mesh-ancestor
92349609|NCT04089852|Sensory System Agents|sensory system agents|mesh-ancestor
92349610|NCT04089852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349612|NCT03026244|Caseins|caseins|mesh-list
92349613|NCT03026244|Vitamins|vitamins|mesh-ancestor
92349614|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
92349615|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349616|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92349617|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
92349618|NCT03026244|Sequestering Agents|sequestering agents|mesh-ancestor
92349619|NCT03026244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349620|NCT01470144|Epoprostenol|epoprostenol|mesh-list
92349621|NCT01470144|Tezosentan|tezosentan|mesh-list
92349622|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92349623|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92349624|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92349625|NCT01443858|Meclizine|meclizine|mesh-list
92349626|NCT01443858|Nicotine|nicotine|mesh-list
92349627|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92349628|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
92349629|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349630|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349631|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92349632|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92349633|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
92349634|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349635|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349636|NCT01443858|Antiemetics|antiemetics|mesh-ancestor
92349637|NCT01443858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92349638|NCT01443858|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92349639|NCT01443858|Histamine Antagonists|histamine antagonists|mesh-ancestor
92349640|NCT01443858|Histamine Agents|histamine agents|mesh-ancestor
92349641|NCT01443858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92349642|NCT01443858|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92349644|NCT01443078|Gemcitabine|gemcitabine|mesh-list
92349645|NCT01443078|Docetaxel|docetaxel|mesh-list
92349646|NCT01443078|Pemetrexed|pemetrexed|mesh-list
92349647|NCT01443078|Vinorelbine|vinorelbine|mesh-list
92349648|NCT01443078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349649|NCT01443078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92349650|NCT01443078|Antimetabolites|antimetabolites|mesh-ancestor
92349651|NCT01443078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349652|NCT01443078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92349653|NCT01443078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92349654|NCT01443078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92349655|NCT01443078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349656|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92349657|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92349658|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92349659|NCT01439880|Evolocumab|evolocumab|mesh-list
92349660|NCT01439880|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92349661|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92349662|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92349663|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
92349664|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349665|NCT01439880|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92349666|NCT01439880|Protease Inhibitors|protease inhibitors|mesh-ancestor
92349667|NCT01439880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349668|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92349670|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349671|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349672|NCT01439568|Carboplatin|carboplatin|mesh-list
92349673|NCT01439568|Etoposide|etoposide|mesh-list
92349674|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349675|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92349676|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92349677|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92349678|NCT01439568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399296|NCT01402882|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92349679|NCT01439568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349680|NCT01469052|Axitinib|axitinib|mesh-list
92349681|NCT01469052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349682|NCT01469052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349683|NCT01469052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349684|NCT01469052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349685|NCT01468818|Cyclophosphamide|cyclophosphamide|mesh-list
92349686|NCT01468818|Fludarabine|fludarabine|mesh-list
92349687|NCT01468818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349688|NCT01468818|Immunologic Factors|immunologic factors|mesh-ancestor
92349689|NCT01468818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349690|NCT01468818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349691|NCT01468818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92349692|NCT01468818|Alkylating Agents|alkylating agents|mesh-ancestor
92349693|NCT01468818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349694|NCT01468818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349695|NCT01468818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92349697|NCT01442376|Palonosetron|palonosetron|mesh-list
92349698|NCT01442376|Antiemetics|antiemetics|mesh-ancestor
92349699|NCT01442376|Autonomic Agents|autonomic agents|mesh-ancestor
92349700|NCT01442376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349701|NCT01442376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349702|NCT01442376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92349703|NCT01442376|Antipruritics|antipruritics|mesh-ancestor
92349704|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349705|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92349706|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92349707|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
92349708|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349709|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349711|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92349712|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92349714|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349715|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
92349716|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349717|NCT01441596|Vinorelbine|vinorelbine|mesh-list
92349718|NCT01441596|Afatinib|afatinib|mesh-list
92349719|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92349720|NCT01441596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349721|NCT01441596|Tubulin Modulators|tubulin modulators|mesh-ancestor
92349722|NCT01441596|Antimitotic Agents|antimitotic agents|mesh-ancestor
92349723|NCT01441596|Mitosis Modulators|mitosis modulators|mesh-ancestor
92349724|NCT01441596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349725|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349726|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349727|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92399297|NCT01402882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92349728|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92349729|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92349730|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349731|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349732|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349733|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349734|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92349735|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
92349736|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92349737|NCT03026478|Betamethasone|betamethasone|mesh-list
92349738|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
92349739|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92349740|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
92349742|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92349743|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92349744|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
92349745|NCT03026478|Hormones|hormones|mesh-ancestor
92349746|NCT03026478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92349747|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349748|NCT03026478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92349749|NCT03026478|Respiratory System Agents|respiratory system agents|mesh-ancestor
92349750|NCT04066764|Nadroparin|nadroparin|mesh-list
92349751|NCT04066764|Warfarin|warfarin|mesh-list
92349752|NCT04066764|Rivaroxaban|rivaroxaban|mesh-list
92349755|NCT04066764|Antithrombins|antithrombins|mesh-ancestor
92349756|NCT04066764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92349758|NCT04066764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349759|NCT04066764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349760|NCT04066764|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92349761|NCT04066764|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92349763|NCT01437540|Formoterol Fumarate|formoterol fumarate|mesh-list
92349764|NCT01437540|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92349765|NCT01437540|Autonomic Agents|autonomic agents|mesh-ancestor
92349766|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349767|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349768|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92349769|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
92349770|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92349771|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92349772|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92349773|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92349774|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349775|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349776|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
92349777|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
92349778|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349779|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
92349780|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
92349781|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349783|NCT01467492|Ribavirin|ribavirin|mesh-list
92349784|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
92349785|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
92349786|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92349787|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349788|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
92349789|NCT01467492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349790|NCT01467492|Antimetabolites|antimetabolites|mesh-ancestor
92349791|NCT01467492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349792|NCT01467492|Immunologic Factors|immunologic factors|mesh-ancestor
92349793|NCT01467492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349795|NCT01466790|Sofosbuvir|sofosbuvir|mesh-list
92349796|NCT01466790|Simeprevir|simeprevir|mesh-list
92349797|NCT01466790|Antimetabolites|antimetabolites|mesh-ancestor
92349798|NCT01466790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349799|NCT01466790|Antiviral Agents|antiviral agents|mesh-ancestor
92349800|NCT01466790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349801|NCT01466790|Protease Inhibitors|protease inhibitors|mesh-ancestor
92349802|NCT01466790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349803|NCT01418352|Aripiprazole|aripiprazole|mesh-list
92349805|NCT01418352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92349806|NCT01418352|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92349807|NCT01418352|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92349808|NCT01418352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92349809|NCT01418352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349810|NCT01418352|Dopamine Agonists|dopamine agonists|mesh-ancestor
92349811|NCT01418352|Dopamine Agents|dopamine agents|mesh-ancestor
92349812|NCT01418352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349813|NCT01418352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349814|NCT01418352|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92349815|NCT01418352|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92349816|NCT01418352|Serotonin Agents|serotonin agents|mesh-ancestor
92349817|NCT01418352|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92349818|NCT01418352|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92349819|NCT01418352|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92349820|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92349821|NCT01436370|Vaccines|vaccines|mesh-list
92349822|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
92349823|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349824|NCT01465464|Orantinib|orantinib|mesh-list
92349825|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349826|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349827|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349828|NCT01465386|Bortezomib|bortezomib|mesh-list
92349829|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349831|NCT04082364|Margetuximab|margetuximab|mesh-list
92349832|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92349833|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349834|NCT01465230|Lenalidomide|lenalidomide|mesh-list
92349835|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
92349836|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349837|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92349838|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92349839|NCT01465230|Growth Substances|growth substances|mesh-ancestor
92349840|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
92349841|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349842|NCT03820830|Palbociclib|palbociclib|mesh-list
92349843|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349844|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349845|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349846|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349847|NCT01435122|Axitinib|axitinib|mesh-list
92349848|NCT01435122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349849|NCT01435122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349850|NCT01435122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349851|NCT01435122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349852|NCT01393626|Tofacitinib|tofacitinib|mesh-list
92349853|NCT01393626|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92349854|NCT01393626|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349855|NCT01393626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349856|NCT01393626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349857|NCT01393158|Apremilast|apremilast|mesh-list
92349858|NCT01393158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92349859|NCT01393158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92349860|NCT01393158|Analgesics|analgesics|mesh-ancestor
92349861|NCT01393158|Sensory System Agents|sensory system agents|mesh-ancestor
92349862|NCT01393158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349863|NCT01393158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349864|NCT01393158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92349865|NCT01393158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349866|NCT01393158|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92349867|NCT01393158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92349868|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349869|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349871|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
92349872|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
92349873|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349874|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
92349875|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349876|NCT01413360|Protective Agents|protective agents|mesh-ancestor
92349877|NCT03815448|Methotrexate|methotrexate|mesh-list
92349878|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92349879|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
92349880|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92349881|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349882|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92349883|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
92349884|NCT03815448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349885|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349886|NCT03815448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92349887|NCT03815448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349888|NCT03815448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92349889|NCT03815448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92349890|NCT03815448|Immunologic Factors|immunologic factors|mesh-ancestor
92349891|NCT03815448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349892|NCT03815448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92349893|NCT01392378|Acetaminophen|acetaminophen|mesh-list
92349894|NCT01392378|Ibuprofen|ibuprofen|mesh-list
92349895|NCT01392378|Vaccines|vaccines|mesh-list
92349896|NCT01392378|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92349897|NCT01392378|Immunologic Factors|immunologic factors|mesh-ancestor
92349898|NCT01392378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349899|NCT01392378|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92349900|NCT01392378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92349901|NCT01392378|Analgesics|analgesics|mesh-ancestor
92349902|NCT01392378|Sensory System Agents|sensory system agents|mesh-ancestor
92349903|NCT01392378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349904|NCT01392378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92349905|NCT01392378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92349906|NCT01392378|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92349907|NCT01392378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349908|NCT01392378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349909|NCT01392378|Antipyretics|antipyretics|mesh-ancestor
92349910|NCT01412424|Octreotide|octreotide|mesh-list
92349911|NCT01412424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92349912|NCT01412424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92349913|NCT01412424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349914|NCT01433250|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92349915|NCT01433250|Immunologic Factors|immunologic factors|mesh-ancestor
92349916|NCT01433250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349917|NCT01432938|Dulaglutide|dulaglutide|mesh-list
92349918|NCT01432938|Warfarin|warfarin|mesh-list
92349919|NCT01432938|Anticoagulants|anticoagulants|mesh-ancestor
92349920|NCT01432938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92349921|NCT01432938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349922|NCT01392300|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92349923|NCT01392300|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92349924|NCT01392300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349925|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349926|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92349927|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92349928|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349929|NCT01392300|Cholinergic Agents|cholinergic agents|mesh-ancestor
92349930|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92349931|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92349932|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349933|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349934|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349935|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92349936|NCT01391130|Sunitinib|sunitinib|mesh-list
92349937|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349938|NCT01391130|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92349939|NCT01391130|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92349940|NCT01391130|Growth Substances|growth substances|mesh-ancestor
92349941|NCT01391130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349942|NCT01391130|Growth Inhibitors|growth inhibitors|mesh-ancestor
92349943|NCT01391130|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92349944|NCT01391130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349945|NCT01391130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349946|NCT04046094|Ascorbic Acid|ascorbic acid|mesh-list
92349947|NCT04046094|Vitamins|vitamins|mesh-ancestor
92349948|NCT04046094|Micronutrients|micronutrients|mesh-ancestor
92349949|NCT04046094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349950|NCT04046094|Antioxidants|antioxidants|mesh-ancestor
92349951|NCT04046094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349952|NCT04046094|Protective Agents|protective agents|mesh-ancestor
92349953|NCT01410240|Hemostatics|hemostatics|mesh-list
92349954|NCT01410240|Coagulants|coagulants|mesh-ancestor
92349955|NCT01408914|Rifampin|rifampin|mesh-list
92349956|NCT01408914|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92349957|NCT01408914|Antitubercular Agents|antitubercular agents|mesh-ancestor
92349958|NCT01408914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92349959|NCT01408914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349960|NCT01408914|Leprostatic Agents|leprostatic agents|mesh-ancestor
92349961|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92349962|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349963|NCT01408914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349964|NCT01408914|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92349965|NCT01408914|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92349966|NCT01408914|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92349967|NCT01408914|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92349968|NCT01408914|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92349969|NCT01408914|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92349970|NCT04044222|Carboplatin|carboplatin|mesh-list
92349971|NCT04044222|Etoposide|etoposide|mesh-list
92349972|NCT04044222|Etoposide phosphate|etoposide phosphate|mesh-list
92349973|NCT04044222|Ifosfamide|ifosfamide|mesh-list
92349974|NCT04044222|Isophosphamide mustard|isophosphamide mustard|mesh-list
92349975|NCT04044222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92349976|NCT04044222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92349977|NCT04044222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92349978|NCT04044222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92349979|NCT04044222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92349980|NCT04044222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92349981|NCT04044222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92349982|NCT04044222|Alkylating Agents|alkylating agents|mesh-ancestor
92349983|NCT01390428|Grazoprevir|grazoprevir|mesh-list
92349984|NCT01390428|Antiviral Agents|antiviral agents|mesh-ancestor
92349985|NCT01390428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92349986|NCT01429584|Bupivacaine|bupivacaine|mesh-list
92349987|NCT01429584|Anesthetics, Local|anesthetics, local|mesh-ancestor
92002504|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
92349988|NCT01429584|Anesthetics|anesthetics|mesh-ancestor
92349989|NCT01429584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92349990|NCT01429584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349991|NCT01429584|Sensory System Agents|sensory system agents|mesh-ancestor
92349992|NCT01429584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349993|NCT01405950|Clonidine|clonidine|mesh-list
92349994|NCT01405950|Tizanidine|tizanidine|mesh-list
92349995|NCT01405950|Analgesics|analgesics|mesh-ancestor
92349996|NCT01405950|Sensory System Agents|sensory system agents|mesh-ancestor
92349997|NCT01405950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92349998|NCT01405950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92349999|NCT01405950|Anticonvulsants|anticonvulsants|mesh-ancestor
92350000|NCT01405950|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92350001|NCT01405950|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92350002|NCT01405950|Parasympatholytics|parasympatholytics|mesh-ancestor
92350003|NCT01405950|Autonomic Agents|autonomic agents|mesh-ancestor
92350004|NCT01405950|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92350005|NCT01405950|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92350006|NCT01405950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92350007|NCT01405950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92350008|NCT01405950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350009|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350010|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92350011|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
92350012|NCT01405560|Ribavirin|ribavirin|mesh-list
92350013|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
92350014|NCT01405560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350015|NCT01405560|Antiviral Agents|antiviral agents|mesh-ancestor
92350016|NCT01405560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350017|NCT01428882|Midazolam|midazolam|mesh-list
92350018|NCT01428882|Propofol|propofol|mesh-list
92350019|NCT01428882|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92350020|NCT01428882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350021|NCT01428882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350022|NCT01428882|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92350023|NCT01428882|Anesthetics, General|anesthetics, general|mesh-ancestor
92350024|NCT01428882|Anesthetics|anesthetics|mesh-ancestor
92350025|NCT01428882|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92350026|NCT01428882|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92350027|NCT01428882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92350028|NCT01428882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92350029|NCT01428882|GABA Modulators|gaba modulators|mesh-ancestor
92350030|NCT01428882|GABA Agents|gaba agents|mesh-ancestor
92350031|NCT01428882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350032|NCT01428882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350034|NCT01428258|Keratolytic Agents|keratolytic agents|mesh-ancestor
92350035|NCT01428258|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350036|NCT01442688|Amoxicillin|amoxicillin|mesh-list
92350037|NCT01442688|Mesalamine|mesalamine|mesh-list
92350038|NCT01442688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92350039|NCT01442688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350040|NCT01442688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92350041|NCT01442688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350042|NCT01442688|Analgesics|analgesics|mesh-ancestor
92350043|NCT01442688|Sensory System Agents|sensory system agents|mesh-ancestor
92350044|NCT01442688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350045|NCT01442688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350046|NCT01442688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350047|NCT01442688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350048|NCT03814200|Rifampin|rifampin|mesh-list
92350049|NCT03814200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92350050|NCT03814200|Antitubercular Agents|antitubercular agents|mesh-ancestor
92350051|NCT03814200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92350052|NCT03814200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350053|NCT03814200|Leprostatic Agents|leprostatic agents|mesh-ancestor
92350054|NCT03814200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350055|NCT03814200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350056|NCT03814200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350057|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92350058|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92350059|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91937197|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
92350060|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92350061|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92350062|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92350063|NCT01426854|Nepafenac|nepafenac|mesh-list
92350064|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92350065|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92350066|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92350067|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350069|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
92350070|NCT01426854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350071|NCT01426854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350072|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350073|NCT01426854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350074|NCT04051320|Leuprolide|leuprolide|mesh-list
92350075|NCT04051320|Estradiol|estradiol|mesh-list
92350076|NCT04051320|Progesterone|progesterone|mesh-list
92350077|NCT04051320|Estrogens|estrogens|mesh-ancestor
92350078|NCT04051320|Hormones|hormones|mesh-ancestor
92350079|NCT04051320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350080|NCT04051320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350081|NCT04051320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92350082|NCT04051320|Progestins|progestins|mesh-ancestor
92350083|NCT04051320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92350084|NCT04051320|Fertility Agents|fertility agents|mesh-ancestor
92350085|NCT04051320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92350086|NCT04051320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350087|NCT01403610|Bevacizumab|bevacizumab|mesh-list
92350088|NCT01403610|Phosphoramide Mustards|phosphoramide mustards|mesh-list
92350089|NCT01403610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350090|NCT01403610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350091|NCT01403610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92350092|NCT01403610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92350093|NCT01403610|Growth Substances|growth substances|mesh-ancestor
92350094|NCT01403610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350095|NCT01403610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92350096|NCT01403610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92350097|NCT01403610|Alkylating Agents|alkylating agents|mesh-ancestor
92350098|NCT01403610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350099|NCT01402986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92350100|NCT01402986|Immunologic Factors|immunologic factors|mesh-ancestor
92350101|NCT01402986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350102|NCT01389102|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92350103|NCT01389102|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92350104|NCT01389102|Estradiol|estradiol|mesh-list
92350105|NCT01389102|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92350106|NCT01389102|Estrogens|estrogens|mesh-ancestor
92350107|NCT01389102|Hormones|hormones|mesh-ancestor
92350108|NCT01389102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350109|NCT01389102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350110|NCT01389102|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92350111|NCT01389102|Contraceptive Agents|contraceptive agents|mesh-ancestor
92350112|NCT01389102|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92350113|NCT01389102|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92350114|NCT01402284|Dexamethasone|dexamethasone|mesh-list
92350115|NCT01402284|Lenalidomide|lenalidomide|mesh-list
92350116|NCT01402284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350117|NCT01402284|Antiemetics|antiemetics|mesh-ancestor
92350118|NCT01402284|Autonomic Agents|autonomic agents|mesh-ancestor
92350119|NCT01402284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350120|NCT01402284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350121|NCT01402284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350122|NCT01402284|Glucocorticoids|glucocorticoids|mesh-ancestor
92350123|NCT01402284|Hormones|hormones|mesh-ancestor
92350124|NCT01402284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350125|NCT01402284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92350126|NCT01402284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350127|NCT01402284|Immunologic Factors|immunologic factors|mesh-ancestor
92350128|NCT01402284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92350129|NCT01402284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92350130|NCT01402284|Growth Substances|growth substances|mesh-ancestor
92350131|NCT01402284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92350132|NCT01388790|Cetuximab|cetuximab|mesh-list
92350133|NCT01388790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350134|NCT01388790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350135|NCT01388478|Pramipexole|pramipexole|mesh-list
92350136|NCT01388478|Antioxidants|antioxidants|mesh-ancestor
92350137|NCT01388478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350138|NCT01388478|Protective Agents|protective agents|mesh-ancestor
92350139|NCT01388478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350140|NCT01388478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92350141|NCT01388478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92350142|NCT01388478|Dopamine Agonists|dopamine agonists|mesh-ancestor
92350143|NCT01388478|Dopamine Agents|dopamine agents|mesh-ancestor
92350144|NCT01388478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350145|NCT01400958|Modafinil|modafinil|mesh-list
92350146|NCT01400958|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92350147|NCT01400958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350148|NCT01400958|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92350149|NCT01400958|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92350150|NCT01400958|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92350151|NCT01400958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350152|NCT01400412|Ritonavir|ritonavir|mesh-list
92350153|NCT01400412|Darunavir|darunavir|mesh-list
92350154|NCT01400412|Tenofovir|tenofovir|mesh-list
92350155|NCT01400412|Emtricitabine|emtricitabine|mesh-list
92350156|NCT01400412|Maraviroc|maraviroc|mesh-list
92350157|NCT01400412|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92350158|NCT01400412|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92350159|NCT01400412|Protease Inhibitors|protease inhibitors|mesh-ancestor
92350160|NCT01400412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350161|NCT01400412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350162|NCT01400412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92350163|NCT01400412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92350164|NCT01400412|Antiviral Agents|antiviral agents|mesh-ancestor
92350165|NCT01400412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350166|NCT01400412|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92350167|NCT01400412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92350168|NCT01400412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92350169|NCT01400412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350170|NCT01400412|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92350171|NCT01400412|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92350172|NCT01400412|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92350173|NCT01422876|Linagliptin|linagliptin|mesh-list
92350174|NCT01422876|Empagliflozin|empagliflozin|mesh-list
92350175|NCT01422876|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350176|NCT01422876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350177|NCT01422876|Incretins|incretins|mesh-ancestor
92350178|NCT01422876|Hormones|hormones|mesh-ancestor
92350179|NCT01422876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350180|NCT01422876|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92350181|NCT01422876|Protease Inhibitors|protease inhibitors|mesh-ancestor
92350182|NCT01422876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350183|NCT01422876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350184|NCT01422876|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92350185|NCT01422720|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92350186|NCT01422720|Anticonvulsants|anticonvulsants|mesh-ancestor
92350187|NCT01422720|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92350188|NCT01422720|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92350189|NCT01422720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92350190|NCT01422720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350191|NCT01387932|Doxorubicin|doxorubicin|mesh-list
92350192|NCT01387932|Ethiodized Oil|ethiodized oil|mesh-list
92350193|NCT01387932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92350194|NCT01387932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350195|NCT01387932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92350196|NCT01387932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92350197|NCT01387932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350198|NCT01387932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350199|NCT04413786|Oxytocin|oxytocin|mesh-list
92350200|NCT04413786|Oxytocics|oxytocics|mesh-ancestor
92350201|NCT04413786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92350202|NCT04413786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350203|NCT01422408|Fluocinonide|fluocinonide|mesh-list
92350204|NCT01422408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350205|NCT01422408|Glucocorticoids|glucocorticoids|mesh-ancestor
92350206|NCT01422408|Hormones|hormones|mesh-ancestor
92350207|NCT01422408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350208|NCT01422408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350209|NCT01422408|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92350210|NCT01387542|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92350211|NCT01387542|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92350212|NCT01387542|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92350213|NCT01387542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350214|NCT01387542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350215|NCT01387542|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92350216|NCT01387542|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92350217|NCT01387542|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92350218|NCT01387542|Serotonin Agents|serotonin agents|mesh-ancestor
92350219|NCT01387542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350220|NCT01387542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350221|NCT01387542|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92350222|NCT01387542|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92350223|NCT01387542|Dopamine Agents|dopamine agents|mesh-ancestor
92350224|NCT01387074|Botulinum Toxins|botulinum toxins|mesh-list
92350225|NCT01387074|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92350226|NCT01387074|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92350227|NCT01387074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92350228|NCT01387074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92350229|NCT01387074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350230|NCT01387074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92350231|NCT01387074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350232|NCT01387074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350233|NCT01387074|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92350234|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350235|NCT01386606|Methyltestosterone|methyltestosterone|mesh-list
92350236|NCT01386606|Enclomiphene|enclomiphene|mesh-list
92350238|NCT01386606|Zuclomiphene|zuclomiphene|mesh-list
92350239|NCT01386606|Testosterone|testosterone|mesh-list
92350240|NCT01386606|Testosterone undecanoate|testosterone undecanoate|mesh-list
92350241|NCT01386606|Testosterone enanthate|testosterone enanthate|mesh-list
92350242|NCT01386606|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92350243|NCT01386606|Androgens|androgens|mesh-ancestor
92350244|NCT01386606|Hormones|hormones|mesh-ancestor
92350245|NCT01386606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350246|NCT01386606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350247|NCT01386606|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92350248|NCT01386606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350249|NCT01386606|Anabolic Agents|anabolic agents|mesh-ancestor
92350250|NCT01386606|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92350251|NCT01386606|Hormone Antagonists|hormone antagonists|mesh-ancestor
92350252|NCT01386606|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92350253|NCT01386606|Fertility Agents|fertility agents|mesh-ancestor
92350254|NCT01386606|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92350255|NCT01386606|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92350256|NCT01386606|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92350257|NCT01385748|Clonidine|clonidine|mesh-list
92350258|NCT01385748|Analgesics|analgesics|mesh-ancestor
92350259|NCT01385748|Sensory System Agents|sensory system agents|mesh-ancestor
92350260|NCT01385748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350261|NCT01385748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350262|NCT01385748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92350263|NCT01385748|Sympatholytics|sympatholytics|mesh-ancestor
92350264|NCT01385748|Autonomic Agents|autonomic agents|mesh-ancestor
92350265|NCT01385748|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92350266|NCT01385748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92350267|NCT01385748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92350268|NCT01385748|Adrenergic Agents|adrenergic agents|mesh-ancestor
92350269|NCT01385748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350270|NCT01385748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350271|NCT01397448|Rabeprazole|rabeprazole|mesh-list
92350272|NCT01397448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92350273|NCT01397448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350274|NCT01397448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92350275|NCT01397448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350276|NCT01397448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350277|NCT01384734|Ritonavir|ritonavir|mesh-list
92350278|NCT01384734|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92350279|NCT01384734|Tenofovir|tenofovir|mesh-list
92350280|NCT01384734|Raltegravir Potassium|raltegravir potassium|mesh-list
92350281|NCT01384734|Fostemsavir|fostemsavir|mesh-list
92350282|NCT01384734|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92350283|NCT01384734|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92350284|NCT01384734|Protease Inhibitors|protease inhibitors|mesh-ancestor
92350285|NCT01384734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350286|NCT01384734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350287|NCT01384734|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92350288|NCT01384734|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92350289|NCT01384734|Antiviral Agents|antiviral agents|mesh-ancestor
92350290|NCT01384734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350291|NCT01384734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92350292|NCT01384734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92350293|NCT01384734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92350294|NCT01384734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350295|NCT01384734|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92350296|NCT01384734|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92350297|NCT01384734|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92350298|NCT01384734|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92350299|NCT01396512|Vaccines|vaccines|mesh-list
92350300|NCT01396512|Immunologic Factors|immunologic factors|mesh-ancestor
92350301|NCT01396512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350302|NCT01396434|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92350303|NCT01396434|Immunologic Factors|immunologic factors|mesh-ancestor
92350304|NCT01396434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350305|NCT01383954|Diclofenac|diclofenac|mesh-list
92350306|NCT01383954|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92350307|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350308|NCT01383954|Analgesics|analgesics|mesh-ancestor
92350309|NCT01383954|Sensory System Agents|sensory system agents|mesh-ancestor
92350310|NCT01383954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350311|NCT01383954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350312|NCT01383954|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350313|NCT01383954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350314|NCT01383954|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92350315|NCT01383954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350316|NCT01383954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350317|NCT05365464|Progesterone|progesterone|mesh-list
92350318|NCT05365464|Progestins|progestins|mesh-ancestor
92350319|NCT05365464|Hormones|hormones|mesh-ancestor
92350320|NCT05365464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350321|NCT05365464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350322|NCT01383486|Naproxen|naproxen|mesh-list
92115099|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350323|NCT01383486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92350324|NCT01383486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350325|NCT01383486|Analgesics|analgesics|mesh-ancestor
92350326|NCT01383486|Sensory System Agents|sensory system agents|mesh-ancestor
92350327|NCT01383486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350328|NCT01383486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350329|NCT01383486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350330|NCT01383486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350331|NCT01383486|Gout Suppressants|gout suppressants|mesh-ancestor
92350332|NCT01383486|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92350333|NCT01383486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350334|NCT01383486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350335|NCT04766736|Antibodies|antibodies|mesh-list
92350336|NCT04766736|Immunologic Factors|immunologic factors|mesh-ancestor
92350337|NCT04766736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350338|NCT01396278|Fluticasone|fluticasone|mesh-list
92350340|NCT01396278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350341|NCT01396278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92350342|NCT01396278|Autonomic Agents|autonomic agents|mesh-ancestor
92350343|NCT01396278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350344|NCT01396278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350345|NCT01396278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92350346|NCT01396278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92350347|NCT01396278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350348|NCT01396278|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92350349|NCT05365074|Chloroprocaine|chloroprocaine|mesh-list
92350350|NCT05365074|Anesthetics, Local|anesthetics, local|mesh-ancestor
92350351|NCT05365074|Anesthetics|anesthetics|mesh-ancestor
92350352|NCT05365074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350354|NCT05365074|Sensory System Agents|sensory system agents|mesh-ancestor
92350355|NCT05365074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350356|NCT01383096|Artefenomel|artefenomel|mesh-list
92350357|NCT01383096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92350358|NCT01383096|Antimalarials|antimalarials|mesh-ancestor
92350359|NCT01383096|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92350360|NCT01383096|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92350361|NCT01383096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002878|NCT03648437|Ibuprofen|ibuprofen|mesh-list
92350362|NCT01382940|Acetaminophen|acetaminophen|mesh-list
92350363|NCT01382940|Methylprednisolone|methylprednisolone|mesh-list
92350364|NCT01382940|Rituximab|rituximab|mesh-list
92350365|NCT01382940|Methotrexate|methotrexate|mesh-list
92350366|NCT01382940|Histamine Antagonists|histamine antagonists|mesh-list
92350367|NCT01382940|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92350368|NCT01382940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350369|NCT01382940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350370|NCT01382940|Immunologic Factors|immunologic factors|mesh-ancestor
92350371|NCT01382940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350372|NCT01382940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350373|NCT01382940|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92350374|NCT01382940|Abortifacient Agents|abortifacient agents|mesh-ancestor
92350375|NCT01382940|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92350376|NCT01382940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92350377|NCT01382940|Antimetabolites|antimetabolites|mesh-ancestor
92350378|NCT01382940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350379|NCT01382940|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350380|NCT01382940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350381|NCT01382940|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92350382|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350383|NCT01382940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350384|NCT01382940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350385|NCT01382940|Analgesics|analgesics|mesh-ancestor
92350386|NCT01382940|Sensory System Agents|sensory system agents|mesh-ancestor
92350387|NCT01382940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350388|NCT01382940|Antipyretics|antipyretics|mesh-ancestor
92350389|NCT01382940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350390|NCT01382940|Antiemetics|antiemetics|mesh-ancestor
92350391|NCT01382940|Autonomic Agents|autonomic agents|mesh-ancestor
92350392|NCT01382940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350393|NCT01382940|Glucocorticoids|glucocorticoids|mesh-ancestor
92350394|NCT01382940|Hormones|hormones|mesh-ancestor
92350395|NCT01382940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350396|NCT01382940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92350397|NCT01382940|Protective Agents|protective agents|mesh-ancestor
92350398|NCT01382940|Histamine Agents|histamine agents|mesh-ancestor
92350399|NCT01382940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350400|NCT01381926|Exenatide|exenatide|mesh-list
92350401|NCT01381926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350402|NCT01381926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350403|NCT01381926|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92350404|NCT01381926|Incretins|incretins|mesh-ancestor
92350405|NCT01381926|Hormones|hormones|mesh-ancestor
92350406|NCT01381926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350407|NCT01395888|Fluticasone|fluticasone|mesh-list
92350408|NCT01395888|Xhance|xhance|mesh-list
92350409|NCT01395888|Tiotropium Bromide|tiotropium bromide|mesh-list
92350410|NCT01395888|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350411|NCT01395888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92350412|NCT01395888|Autonomic Agents|autonomic agents|mesh-ancestor
92350413|NCT01395888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350414|NCT01395888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350415|NCT01395888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92350416|NCT01395888|Respiratory System Agents|respiratory system agents|mesh-ancestor
92350417|NCT01395888|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350418|NCT01395888|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92350419|NCT01395888|Parasympatholytics|parasympatholytics|mesh-ancestor
92350420|NCT01395888|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92350421|NCT01395888|Cholinergic Agents|cholinergic agents|mesh-ancestor
92350422|NCT01395888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350423|NCT01395888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350424|NCT01381692|Sirolimus|sirolimus|mesh-list
92350425|NCT01381692|Dexamethasone|dexamethasone|mesh-list
92350426|NCT01381692|Dexamethasone acetate|dexamethasone acetate|mesh-list
92350427|NCT01381692|Rituximab|rituximab|mesh-list
92350428|NCT01381692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92350429|NCT01381692|Bortezomib|bortezomib|mesh-list
92350430|NCT01381692|Temsirolimus|temsirolimus|mesh-list
92350431|NCT01381692|MTOR Inhibitors|mtor inhibitors|mesh-list
92350432|NCT01381692|Antibodies|antibodies|mesh-list
92350433|NCT01381692|Immunoglobulins|immunoglobulins|mesh-list
92350434|NCT01381692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92350435|NCT01381692|BB 1101|bb 1101|mesh-list
92350436|NCT01381692|Immunologic Factors|immunologic factors|mesh-ancestor
92350437|NCT01381692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350438|NCT01381692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350439|NCT01381692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350440|NCT01381692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350442|NCT01381692|Autonomic Agents|autonomic agents|mesh-ancestor
92350443|NCT01381692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350444|NCT01381692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350445|NCT01381692|Glucocorticoids|glucocorticoids|mesh-ancestor
92350446|NCT01381692|Hormones|hormones|mesh-ancestor
92350447|NCT01381692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350448|NCT01381692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92350449|NCT01381692|Protease Inhibitors|protease inhibitors|mesh-ancestor
92350450|NCT01381692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350451|NCT01381692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350452|NCT01381692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92350453|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350454|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92350455|NCT01381692|Antifungal Agents|antifungal agents|mesh-ancestor
92350456|NCT01381692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350457|NCT01381692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92350458|NCT01395030|Choline|choline|mesh-list
92350459|NCT01395030|Lipotropic Agents|lipotropic agents|mesh-ancestor
92350460|NCT01395030|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92350461|NCT01395030|Antimetabolites|antimetabolites|mesh-ancestor
92350462|NCT01395030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350463|NCT01395030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350464|NCT01395030|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92350465|NCT01395030|Nootropic Agents|nootropic agents|mesh-ancestor
92350466|NCT01394952|Dulaglutide|dulaglutide|mesh-list
92350467|NCT01394952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350468|NCT01394952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350469|NCT01394718|Acetaminophen|acetaminophen|mesh-list
92350470|NCT01394718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350471|NCT01394718|Analgesics|analgesics|mesh-ancestor
92350472|NCT01394718|Sensory System Agents|sensory system agents|mesh-ancestor
92350473|NCT01394718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350474|NCT01394718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350475|NCT01394718|Antipyretics|antipyretics|mesh-ancestor
92350476|NCT01394250|Lidocaine|lidocaine|mesh-list
92350477|NCT01394250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92350478|NCT01394250|Anesthetics|anesthetics|mesh-ancestor
92350479|NCT01394250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350480|NCT01394250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350481|NCT01394250|Sensory System Agents|sensory system agents|mesh-ancestor
92350482|NCT01394250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350483|NCT01394250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92350484|NCT01394250|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92350485|NCT01394250|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92350486|NCT01394250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92350487|NCT01394250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350488|NCT01380990|Busulfan|busulfan|mesh-list
92350489|NCT01380990|Alkylating Agents|alkylating agents|mesh-ancestor
92350490|NCT01380990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350491|NCT01380990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350492|NCT01380990|Immunologic Factors|immunologic factors|mesh-ancestor
92350493|NCT01380990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350494|NCT01380990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92350495|NCT01380990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350496|NCT01380990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92350497|NCT05361330|Fluoxetine|fluoxetine|mesh-list
92350498|NCT05361330|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92350499|NCT05361330|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91937205|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350500|NCT05361330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92350501|NCT05361330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350502|NCT05361330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350503|NCT05361330|Serotonin Agents|serotonin agents|mesh-ancestor
92350504|NCT05361330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350505|NCT05361330|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92350506|NCT05361330|Antidepressive Agents|antidepressive agents|mesh-ancestor
92350507|NCT05361330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92350508|NCT05361330|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92350509|NCT05361330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92350510|NCT05361330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350511|NCT00214968|Modafinil|modafinil|mesh-list
92350512|NCT00214968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92350513|NCT00214968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350514|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92350515|NCT00214968|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92350516|NCT00214968|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92350517|NCT00214968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350519|NCT03592212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92350520|NCT03592212|Autonomic Agents|autonomic agents|mesh-ancestor
92350521|NCT03592212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350522|NCT03592212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350523|NCT03592212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92350524|NCT03592212|Respiratory System Agents|respiratory system agents|mesh-ancestor
92350525|NCT03592212|Tocolytic Agents|tocolytic agents|mesh-ancestor
92350526|NCT03592212|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92350527|NCT03592212|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92350528|NCT03592212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92350529|NCT03592212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92350530|NCT03592212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92350531|NCT03592212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350532|NCT03592212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350533|NCT03024450|Trastuzumab|trastuzumab|mesh-list
92350534|NCT03024450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350535|NCT03024450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350536|NCT04263090|Nivolumab|nivolumab|mesh-list
92350537|NCT04263090|ON 01910|on 01910|mesh-list
92350538|NCT04263090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350539|NCT04263090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350540|NCT04263090|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92350541|NCT04263090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350542|NCT04263090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92350543|NCT04263090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350544|NCT03596424|Dexmedetomidine|dexmedetomidine|mesh-list
92350545|NCT03596424|Ketamine|ketamine|mesh-list
92350546|NCT03596424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92350547|NCT03596424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350548|NCT03596424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350549|NCT03596424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350550|NCT03596424|Analgesics|analgesics|mesh-ancestor
92350551|NCT03596424|Sensory System Agents|sensory system agents|mesh-ancestor
92350552|NCT03596424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350553|NCT03596424|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92350554|NCT03596424|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92350555|NCT03596424|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92350556|NCT03596424|Adrenergic Agents|adrenergic agents|mesh-ancestor
92350557|NCT03596424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350558|NCT03596424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350559|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92350560|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92350561|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
92350562|NCT03596424|Anesthetics|anesthetics|mesh-ancestor
92350563|NCT03596424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92350564|NCT03596424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92350565|NCT05630274|Moxifloxacin|moxifloxacin|mesh-list
92350566|NCT05630274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92350567|NCT05630274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350568|NCT05630274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92350569|NCT05630274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92350570|NCT05630274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350571|NCT05630274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350572|NCT05630274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350575|NCT05632692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350576|NCT03594162|Cyclophosphamide|cyclophosphamide|mesh-list
92350577|NCT03594162|Fludarabine|fludarabine|mesh-list
92350578|NCT03594162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350579|NCT03594162|Immunologic Factors|immunologic factors|mesh-ancestor
92350580|NCT03594162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350581|NCT03594162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350582|NCT03594162|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92350583|NCT03594162|Alkylating Agents|alkylating agents|mesh-ancestor
92350584|NCT03594162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350585|NCT03594162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350586|NCT03594162|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92350587|NCT04407312|Aspirin|aspirin|mesh-list
92350588|NCT04407312|Cilostazol|cilostazol|mesh-list
92350589|NCT04407312|Clopidogrel|clopidogrel|mesh-list
92350590|NCT04407312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92350591|NCT04407312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350592|NCT04407312|Analgesics|analgesics|mesh-ancestor
92350593|NCT04407312|Sensory System Agents|sensory system agents|mesh-ancestor
92350594|NCT04407312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350595|NCT04407312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350596|NCT04407312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350598|NCT04407312|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92350599|NCT04407312|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92350600|NCT04407312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350601|NCT04407312|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92350602|NCT04407312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92350603|NCT04407312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350604|NCT04407312|Antipyretics|antipyretics|mesh-ancestor
92350605|NCT04407312|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92350606|NCT04407312|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92350607|NCT04407312|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92350608|NCT04407312|Purinergic Agents|purinergic agents|mesh-ancestor
92350609|NCT04407312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350610|NCT04407312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92350611|NCT04407312|Autonomic Agents|autonomic agents|mesh-ancestor
92350612|NCT04407312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92350613|NCT04407312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92350614|NCT04407312|Vasodilator Agents|vasodilator agents|mesh-ancestor
92350615|NCT04407312|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92350616|NCT04407312|Protective Agents|protective agents|mesh-ancestor
92350617|NCT04407312|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92350618|NCT04407312|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92350619|NCT04326738|Midazolam|midazolam|mesh-list
92350620|NCT04326738|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92350621|NCT04326738|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92350622|NCT04326738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350623|NCT04326738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350624|NCT04326738|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92350625|NCT04326738|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92350626|NCT04326738|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92350627|NCT04326738|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92350628|NCT04326738|Anesthetics, General|anesthetics, general|mesh-ancestor
92350630|NCT04326738|GABA Modulators|gaba modulators|mesh-ancestor
92350631|NCT04326738|GABA Agents|gaba agents|mesh-ancestor
92350632|NCT04326738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350633|NCT04326738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350634|NCT04347486|Atropine|atropine|mesh-list
92350635|NCT04347486|Neostigmine|neostigmine|mesh-list
92350636|NCT04347486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92350637|NCT04347486|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92350638|NCT04347486|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92350639|NCT04347486|Autonomic Agents|autonomic agents|mesh-ancestor
92350640|NCT04347486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350641|NCT04347486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350642|NCT04347486|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92350643|NCT04347486|Respiratory System Agents|respiratory system agents|mesh-ancestor
92350644|NCT04347486|Mydriatics|mydriatics|mesh-ancestor
92350645|NCT04347486|Parasympatholytics|parasympatholytics|mesh-ancestor
92350646|NCT04347486|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92350647|NCT04347486|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92350648|NCT04347486|Cholinergic Agents|cholinergic agents|mesh-ancestor
92350649|NCT04347486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350650|NCT04347486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350651|NCT04347486|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92350652|NCT04347486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350653|NCT04347486|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92350654|NCT04407234|Acetaminophen|acetaminophen|mesh-list
92350655|NCT04407234|Tirzepatide|tirzepatide|mesh-list
92350656|NCT04407234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92350657|NCT04407234|Analgesics|analgesics|mesh-ancestor
92350658|NCT04407234|Sensory System Agents|sensory system agents|mesh-ancestor
92350659|NCT04407234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350660|NCT04407234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350661|NCT04407234|Antipyretics|antipyretics|mesh-ancestor
92350662|NCT04407234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350663|NCT04407234|Incretins|incretins|mesh-ancestor
92350665|NCT04407234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350667|NCT05632224|Granisetron|granisetron|mesh-list
92350668|NCT05632224|Antiemetics|antiemetics|mesh-ancestor
92350669|NCT05632224|Autonomic Agents|autonomic agents|mesh-ancestor
92350670|NCT05632224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350671|NCT05632224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350672|NCT05632224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350673|NCT05632224|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92350674|NCT05632224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350675|NCT05632224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350676|NCT05632224|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92350677|NCT05632224|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92350678|NCT05632224|Serotonin Agents|serotonin agents|mesh-ancestor
92350679|NCT03024840|Propofol|propofol|mesh-list
92350680|NCT03024840|Sevoflurane|sevoflurane|mesh-list
92350681|NCT03024840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92350682|NCT03024840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350683|NCT03024840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350684|NCT03024840|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92350685|NCT03024840|Anesthetics, General|anesthetics, general|mesh-ancestor
92350686|NCT03024840|Anesthetics|anesthetics|mesh-ancestor
92350687|NCT03024840|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92350688|NCT03024840|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92350689|NCT05631678|Itraconazole|itraconazole|mesh-list
92350690|NCT05631678|Rifampin|rifampin|mesh-list
92350691|NCT05631678|Antifungal Agents|antifungal agents|mesh-ancestor
92350692|NCT05631678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350693|NCT05631678|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92350694|NCT05631678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92350695|NCT05631678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350696|NCT05631678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350697|NCT05631678|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92350698|NCT05631678|Hormone Antagonists|hormone antagonists|mesh-ancestor
92350699|NCT05631678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350700|NCT05631678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350701|NCT05631678|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92350702|NCT05631678|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92350703|NCT05631678|Antitubercular Agents|antitubercular agents|mesh-ancestor
92350704|NCT05631678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92350705|NCT05631678|Leprostatic Agents|leprostatic agents|mesh-ancestor
92350706|NCT05631678|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350707|NCT05631678|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92350708|NCT05631678|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92350709|NCT05631678|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92350710|NCT05631678|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92350711|NCT05631678|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92350712|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92350714|NCT03599778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350715|NCT03599778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92350716|NCT03599778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350717|NCT03599778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350718|NCT04008264|Scopolamine|scopolamine|mesh-list
91937207|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92350719|NCT04008264|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92350720|NCT04008264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92350721|NCT04008264|Antiemetics|antiemetics|mesh-ancestor
92350722|NCT04008264|Autonomic Agents|autonomic agents|mesh-ancestor
92350723|NCT04008264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350724|NCT04008264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350725|NCT04008264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350726|NCT04008264|Mydriatics|mydriatics|mesh-ancestor
92350727|NCT04008264|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92350728|NCT04008264|Cholinergic Agents|cholinergic agents|mesh-ancestor
92350729|NCT04008264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350730|NCT04008264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350731|NCT04008264|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92350732|NCT04008264|Parasympatholytics|parasympatholytics|mesh-ancestor
92350733|NCT03595254|Nicotine|nicotine|mesh-list
92350734|NCT03595254|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92350735|NCT03595254|Autonomic Agents|autonomic agents|mesh-ancestor
92350736|NCT03595254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350737|NCT03595254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350738|NCT03595254|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92350739|NCT03595254|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92350740|NCT03595254|Cholinergic Agents|cholinergic agents|mesh-ancestor
92350741|NCT03595254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350742|NCT03595254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350744|NCT03599466|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92350745|NCT03599466|Protease Inhibitors|protease inhibitors|mesh-ancestor
92350746|NCT03599466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350747|NCT03599466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350748|NCT03599466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92350749|NCT03599466|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92350750|NCT03599466|Protective Agents|protective agents|mesh-ancestor
92350751|NCT03599466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350752|NCT03986970|Tenofovir|tenofovir|mesh-list
92350753|NCT03986970|Emtricitabine|emtricitabine|mesh-list
92350754|NCT03986970|Antiviral Agents|antiviral agents|mesh-ancestor
92350755|NCT03986970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350756|NCT03986970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92350757|NCT03986970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350758|NCT03986970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350759|NCT03986970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350761|NCT03986970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92350763|NCT03594396|Olaparib|olaparib|mesh-list
92350764|NCT03594396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350765|NCT03594396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350766|NCT03594396|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92350767|NCT03594396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350768|NCT03594396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350769|NCT03594240|Folic Acid|folic acid|mesh-list
92350770|NCT03594240|Vitamin B Complex|vitamin b complex|mesh-list
92350771|NCT03594240|Vitamins|vitamins|mesh-ancestor
92350772|NCT03594240|Micronutrients|micronutrients|mesh-ancestor
92350773|NCT03594240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350774|NCT03594240|Hematinics|hematinics|mesh-ancestor
92350775|NCT03976362|Paclitaxel|paclitaxel|mesh-list
92350776|NCT03976362|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92350777|NCT03976362|Carboplatin|carboplatin|mesh-list
92350778|NCT03976362|Pembrolizumab|pembrolizumab|mesh-list
92350779|NCT03976362|Olaparib|olaparib|mesh-list
92350780|NCT03976362|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92350781|NCT03976362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350782|NCT03976362|Tubulin Modulators|tubulin modulators|mesh-ancestor
92350783|NCT03976362|Antimitotic Agents|antimitotic agents|mesh-ancestor
92350784|NCT03976362|Mitosis Modulators|mitosis modulators|mesh-ancestor
92350785|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350786|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350787|NCT03976362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92350788|NCT03976362|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92350789|NCT03976362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350790|NCT03598374|Folic Acid|folic acid|mesh-list
92350791|NCT03598374|Vitamin B Complex|vitamin b complex|mesh-list
92350793|NCT03598374|Hematinics|hematinics|mesh-ancestor
92350795|NCT03598374|Micronutrients|micronutrients|mesh-ancestor
92350796|NCT03598374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350797|NCT04407078|Neostigmine|neostigmine|mesh-list
92350798|NCT04407078|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92350799|NCT04407078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350800|NCT04407078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350801|NCT04407078|Cholinergic Agents|cholinergic agents|mesh-ancestor
92350802|NCT04407078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92350803|NCT04407078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350804|NCT04407078|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92350805|NCT04407078|Autonomic Agents|autonomic agents|mesh-ancestor
92350806|NCT04407078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350808|NCT00217620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350809|NCT00217620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92350810|NCT00217620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350811|NCT00217620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350812|NCT00217464|Fulvestrant|fulvestrant|mesh-list
92350813|NCT00217464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92350814|NCT00217464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350815|NCT00217464|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92350817|NCT00217464|Hormone Antagonists|hormone antagonists|mesh-ancestor
92350818|NCT00217464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350819|NCT00217464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350820|NCT03597282|Nivolumab|nivolumab|mesh-list
92350821|NCT03597282|Ipilimumab|ipilimumab|mesh-list
92350822|NCT03597282|Poly ICLC|poly iclc|mesh-list
92350823|NCT03597282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350824|NCT03597282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350825|NCT03597282|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92350826|NCT03597282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350827|NCT03597282|Interferon Inducers|interferon inducers|mesh-ancestor
92350828|NCT03597282|Immunologic Factors|immunologic factors|mesh-ancestor
92350829|NCT03597282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350830|NCT03593304|Vitamins|vitamins|mesh-list
92350831|NCT03593304|Vitamin B 12|vitamin b 12|mesh-list
92350832|NCT03593304|Pyridoxine|pyridoxine|mesh-list
92350833|NCT03593304|Pyridoxal|pyridoxal|mesh-list
92350834|NCT03593304|Vitamin B 6|vitamin b 6|mesh-list
92350835|NCT03593304|Vitamin B Complex|vitamin b complex|mesh-list
92350836|NCT03593304|Micronutrients|micronutrients|mesh-ancestor
92350837|NCT03593304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350838|NCT00211536|Insulin|insulin|mesh-list
92350839|NCT00211536|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92350840|NCT00211536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350841|NCT00211536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350842|NCT03596970|Everolimus|everolimus|mesh-list
92350843|NCT03596970|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92350844|NCT03596970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92350845|NCT03596970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350846|NCT03596970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350847|NCT03596970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350848|NCT03596970|Immunologic Factors|immunologic factors|mesh-ancestor
92350849|NCT03596970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350850|NCT03596970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350851|NCT03596892|Cyclophosphamide|cyclophosphamide|mesh-list
92350852|NCT03596892|Busulfan|busulfan|mesh-list
92350853|NCT03596892|Decitabine|decitabine|mesh-list
92350854|NCT03596892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350855|NCT03596892|Immunologic Factors|immunologic factors|mesh-ancestor
92350856|NCT03596892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350857|NCT03596892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92350858|NCT03596892|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92350859|NCT03596892|Alkylating Agents|alkylating agents|mesh-ancestor
92350860|NCT03596892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350861|NCT03596892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350862|NCT03596892|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92350863|NCT03596892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92350864|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
92350865|NCT03596892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350867|NCT03592836|Diuretics|diuretics|mesh-list
92350868|NCT03592836|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92350869|NCT03592836|Natriuretic Agents|natriuretic agents|mesh-ancestor
92350870|NCT03592836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350871|NCT03592836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92350872|NCT03592836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350873|NCT03596502|Warfarin|warfarin|mesh-list
92350874|NCT03596502|Anticoagulants|anticoagulants|mesh-list
92350875|NCT04197570|Analgesics, Opioid|analgesics, opioid|mesh-list
92350876|NCT04197570|Analgesics|analgesics|mesh-list
92350877|NCT04197570|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92350878|NCT04197570|Anesthetics|anesthetics|mesh-list
92350879|NCT04197570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350880|NCT04197570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350881|NCT04197570|Narcotics|narcotics|mesh-ancestor
92350882|NCT04197570|Sensory System Agents|sensory system agents|mesh-ancestor
92350883|NCT04197570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350884|NCT04197882|Molgramostim|molgramostim|mesh-list
92350885|NCT04197882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350886|NCT03024060|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92350887|NCT03024060|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92350888|NCT03024060|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350889|NCT03024216|Atezolizumab|atezolizumab|mesh-list
92350890|NCT03024216|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92350891|NCT03024216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350892|NCT03024216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350893|NCT03024216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350894|NCT03981744|Ustekinumab|ustekinumab|mesh-list
92350895|NCT03981744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350896|NCT03591900|Insulin|insulin|mesh-list
92350897|NCT03591900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350898|NCT03591900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350899|NCT03591744|Dexamethasone|dexamethasone|mesh-list
92350900|NCT03591744|Dexamethasone acetate|dexamethasone acetate|mesh-list
92350901|NCT03591744|Doxorubicin|doxorubicin|mesh-list
92350902|NCT03591744|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92350903|NCT03591744|Lenalidomide|lenalidomide|mesh-list
92350904|NCT03591744|Bortezomib|bortezomib|mesh-list
92350905|NCT03591744|Daratumumab|daratumumab|mesh-list
92350906|NCT03591744|Ichthammol|ichthammol|mesh-list
92350907|NCT03591744|BB 1101|bb 1101|mesh-list
92350908|NCT03591744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350909|NCT03591744|Antiemetics|antiemetics|mesh-ancestor
92350910|NCT03591744|Autonomic Agents|autonomic agents|mesh-ancestor
92350911|NCT03591744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350912|NCT03591744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350913|NCT03591744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92350914|NCT03591744|Glucocorticoids|glucocorticoids|mesh-ancestor
92350915|NCT03591744|Hormones|hormones|mesh-ancestor
92350916|NCT03591744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350917|NCT03591744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92350918|NCT03591744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350919|NCT03591744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92350920|NCT03591744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92350921|NCT03591744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92350922|NCT03591744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350923|NCT03591744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350924|NCT03591744|Immunologic Factors|immunologic factors|mesh-ancestor
92350925|NCT03591744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92350926|NCT03591744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92350927|NCT03591744|Growth Substances|growth substances|mesh-ancestor
92350928|NCT03591744|Growth Inhibitors|growth inhibitors|mesh-ancestor
92350929|NCT03591744|Protease Inhibitors|protease inhibitors|mesh-ancestor
92350930|NCT03591744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92350931|NCT04196946|Fentanyl|fentanyl|mesh-list
92350932|NCT04196946|Alfentanil|alfentanil|mesh-list
92350933|NCT04196946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92350934|NCT04196946|Narcotics|narcotics|mesh-ancestor
92350935|NCT04196946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92350936|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350937|NCT04196946|Analgesics|analgesics|mesh-ancestor
92350938|NCT04196946|Sensory System Agents|sensory system agents|mesh-ancestor
92350939|NCT04196946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350940|NCT04196946|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92350941|NCT04196946|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92350942|NCT04196946|Anesthetics, General|anesthetics, general|mesh-ancestor
92350943|NCT04196946|Anesthetics|anesthetics|mesh-ancestor
92350944|NCT03023904|Nivolumab|nivolumab|mesh-list
92350945|NCT03023904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92350946|NCT03023904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350947|NCT03023904|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92350948|NCT03023904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350950|NCT04196010|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92350951|NCT04196010|Mitoxantrone|mitoxantrone|mesh-list
92350952|NCT04196010|Cladribine|cladribine|mesh-list
92350953|NCT04196010|Lenograstim|lenograstim|mesh-list
92350954|NCT04196010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92350955|NCT04196010|Antimetabolites|antimetabolites|mesh-ancestor
92350956|NCT04196010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350957|NCT04196010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350958|NCT04196010|Antiviral Agents|antiviral agents|mesh-ancestor
92350959|NCT04196010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350960|NCT04196010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350961|NCT04196010|Immunologic Factors|immunologic factors|mesh-ancestor
92350962|NCT04196010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350963|NCT04196010|Analgesics|analgesics|mesh-ancestor
92003494|NCT02924727|Valsartan|valsartan|mesh-list
92350964|NCT04196010|Sensory System Agents|sensory system agents|mesh-ancestor
92350965|NCT04196010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92350966|NCT04196010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92350967|NCT04196010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92350968|NCT04196010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350969|NCT04196010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92350970|NCT04196400|Betamethasone|betamethasone|mesh-list
92350971|NCT04196400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92350972|NCT04196400|Glucocorticoids|glucocorticoids|mesh-ancestor
92350973|NCT04196400|Hormones|hormones|mesh-ancestor
92350974|NCT04196400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92350975|NCT04196400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350976|NCT04196400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92350977|NCT04196400|Respiratory System Agents|respiratory system agents|mesh-ancestor
92350978|NCT03023436|Fluorouracil|fluorouracil|mesh-list
92350979|NCT03023436|Capecitabine|capecitabine|mesh-list
92350980|NCT03023436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92350981|NCT03023436|Antimetabolites|antimetabolites|mesh-ancestor
92350982|NCT03023436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350983|NCT03023436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92350984|NCT03023436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92350985|NCT03023436|Immunologic Factors|immunologic factors|mesh-ancestor
92350986|NCT03023436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92350987|NCT04195074|Tenofovir|tenofovir|mesh-list
92350988|NCT04195074|Entecavir|entecavir|mesh-list
92350989|NCT04195074|Antiviral Agents|antiviral agents|mesh-ancestor
92350990|NCT04195074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92350991|NCT04195074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92350992|NCT04195074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92350993|NCT04195074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92350994|NCT04195074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92350995|NCT04195074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92350996|NCT04195074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92350997|NCT03590262|Metformin|metformin|mesh-list
92350998|NCT03590262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92350999|NCT03590262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351000|NCT04029636|Xenon|xenon|mesh-list
92351001|NCT04029636|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92351002|NCT04029636|Anesthetics, General|anesthetics, general|mesh-ancestor
92351003|NCT04029636|Anesthetics|anesthetics|mesh-ancestor
92351004|NCT04029636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351005|NCT04029636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351007|NCT04194684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351008|NCT04194684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351009|NCT04194684|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351010|NCT04194684|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351011|NCT04194684|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351012|NCT04194684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351013|NCT04194294|Lidocaine|lidocaine|mesh-list
92351014|NCT04194294|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351015|NCT04194294|Anesthetics|anesthetics|mesh-ancestor
92351016|NCT04194294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351017|NCT04194294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351019|NCT04194294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351020|NCT04194294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92351021|NCT04194294|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92351022|NCT04194294|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92351024|NCT04194294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351025|NCT04029090|Edaravone|edaravone|mesh-list
92351026|NCT04029090|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92351027|NCT04029090|Antioxidants|antioxidants|mesh-ancestor
92351028|NCT04029090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351029|NCT04029090|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92351030|NCT04029090|Protective Agents|protective agents|mesh-ancestor
92351031|NCT04029090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351032|NCT04194216|Clindamycin|clindamycin|mesh-list
92351033|NCT04194216|Clindamycin palmitate|clindamycin palmitate|mesh-list
92351034|NCT04194216|Clindamycin phosphate|clindamycin phosphate|mesh-list
92351035|NCT04194216|Cephalexin|cephalexin|mesh-list
92351036|NCT04194216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351037|NCT04194216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351038|NCT04194216|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92351039|NCT04194216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351040|NCT04194216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351041|NCT04193982|Vitamin E|vitamin e|mesh-list
92351042|NCT04193982|Vitamins|vitamins|mesh-ancestor
92351043|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
92351044|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351045|NCT04193982|Antioxidants|antioxidants|mesh-ancestor
92351046|NCT04193982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351047|NCT04193982|Protective Agents|protective agents|mesh-ancestor
92351048|NCT04028778|Gefitinib|gefitinib|mesh-list
92351049|NCT04028778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351050|NCT04028778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92351051|NCT04028778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351052|NCT04028778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351053|NCT04028856|Interferons|interferons|mesh-list
92351054|NCT04028856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351055|NCT04028856|Antiviral Agents|antiviral agents|mesh-ancestor
92351056|NCT04028856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351057|NCT03594474|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92351058|NCT03594474|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92351059|NCT03594474|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92351060|NCT03594474|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92351061|NCT04193592|Pirfenidone|pirfenidone|mesh-list
92351062|NCT04193592|Analgesics|analgesics|mesh-ancestor
92351063|NCT04193592|Sensory System Agents|sensory system agents|mesh-ancestor
92351064|NCT04193592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351065|NCT04193592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351066|NCT04193592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92351067|NCT04193592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351068|NCT04193592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351069|NCT04193592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351070|NCT04193592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351071|NCT03933384|Tenofovir|tenofovir|mesh-list
92351072|NCT03933384|Entecavir|entecavir|mesh-list
92351073|NCT03933384|Antiviral Agents|antiviral agents|mesh-ancestor
92351074|NCT03933384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351075|NCT03933384|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92351076|NCT03933384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92351077|NCT03933384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351078|NCT03933384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351079|NCT03933384|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92351080|NCT03933384|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92351082|NCT04028466|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92351083|NCT04028466|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351084|NCT04028466|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92351085|NCT04028466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351086|NCT04028466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351087|NCT04027764|Paclitaxel|paclitaxel|mesh-list
92351088|NCT04027764|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351089|NCT04027764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351090|NCT04027764|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351091|NCT04027764|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351092|NCT04027764|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351093|NCT04027764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351094|NCT04027530|Ertugliflozin|ertugliflozin|mesh-list
92351095|NCT04027530|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91937211|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92351096|NCT04027530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351098|NCT04027530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351099|NCT03023358|Prednisone|prednisone|mesh-list
92351100|NCT03023358|Cyclophosphamide|cyclophosphamide|mesh-list
92351101|NCT03023358|Doxorubicin|doxorubicin|mesh-list
92351102|NCT03023358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92351104|NCT03023358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92351105|NCT03023358|Immunologic Factors|immunologic factors|mesh-ancestor
92351106|NCT03023358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351107|NCT03023358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351108|NCT03023358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92351109|NCT03023358|Alkylating Agents|alkylating agents|mesh-ancestor
92351110|NCT03023358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351111|NCT03023358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351112|NCT03023358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92351113|NCT03023358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92351114|NCT03023358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92351115|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92351116|NCT03023358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351117|NCT03023358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351118|NCT03023358|Glucocorticoids|glucocorticoids|mesh-ancestor
92351119|NCT03023358|Hormones|hormones|mesh-ancestor
92351120|NCT03023358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351121|NCT03023358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92351122|NCT03023358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351123|NCT03023358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351124|NCT03023358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351125|NCT03023358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351126|NCT04192812|Leuprolide|leuprolide|mesh-list
92351127|NCT04192812|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92351128|NCT04192812|Fertility Agents|fertility agents|mesh-ancestor
92351129|NCT04192812|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351130|NCT04192812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351131|NCT04192812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92351132|NCT04192812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351133|NCT04407000|Favipiravir|favipiravir|mesh-list
92351134|NCT04407000|Antiviral Agents|antiviral agents|mesh-ancestor
92351135|NCT04407000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351136|NCT04192656|Methylprednisolone|methylprednisolone|mesh-list
92351137|NCT04192656|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92351138|NCT04192656|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92351139|NCT04192656|Prednisolone|prednisolone|mesh-list
92351140|NCT04192656|Prednisolone acetate|prednisolone acetate|mesh-list
92351141|NCT04192656|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92351142|NCT04192656|Prednisolone phosphate|prednisolone phosphate|mesh-list
92351143|NCT04192656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351144|NCT04192656|Antiemetics|antiemetics|mesh-ancestor
92351145|NCT04192656|Autonomic Agents|autonomic agents|mesh-ancestor
92351146|NCT04192656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351147|NCT04192656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351148|NCT04192656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351149|NCT04192656|Glucocorticoids|glucocorticoids|mesh-ancestor
92351150|NCT04192656|Hormones|hormones|mesh-ancestor
92351151|NCT04192656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351152|NCT04192656|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92351153|NCT04192656|Protective Agents|protective agents|mesh-ancestor
92351154|NCT04192656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92351155|NCT04192656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351156|NCT04191954|Fasudil|fasudil|mesh-list
92351157|NCT04191954|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92351158|NCT04191954|Lubricant Eye Drops|lubricant eye drops|mesh-list
92351159|NCT04191954|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92351160|NCT04191954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92351161|NCT04191954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92351162|NCT04191954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351163|NCT04191954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92351164|NCT04191954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351165|NCT04191954|Vasodilator Agents|vasodilator agents|mesh-ancestor
92351166|NCT04191954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92351167|NCT04191954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351168|NCT04192032|Nicotine|nicotine|mesh-list
92351169|NCT04192032|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92351171|NCT04192032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351172|NCT04192032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351173|NCT04192032|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92351174|NCT04192032|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92351175|NCT04192032|Cholinergic Agents|cholinergic agents|mesh-ancestor
92351176|NCT04192032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351177|NCT04192032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351178|NCT03023982|Morphine|morphine|mesh-list
92351179|NCT03023982|Bupivacaine|bupivacaine|mesh-list
92351180|NCT03023982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351181|NCT03023982|Anesthetics|anesthetics|mesh-ancestor
92351182|NCT03023982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351183|NCT03023982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351184|NCT03023982|Sensory System Agents|sensory system agents|mesh-ancestor
92351185|NCT03023982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351186|NCT03023982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92351187|NCT03023982|Narcotics|narcotics|mesh-ancestor
92351188|NCT03023982|Analgesics|analgesics|mesh-ancestor
92351189|NCT04192110|Diuretics|diuretics|mesh-list
92351190|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
92351191|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351192|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
92351193|NCT04025736|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92351194|NCT04025736|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92351195|NCT04025736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351196|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
92351197|NCT04025736|Coagulants|coagulants|mesh-ancestor
92351198|NCT04190160|Xultophy|xultophy|mesh-list
92351199|NCT04190160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92351200|NCT04190160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351201|NCT04190160|Incretins|incretins|mesh-ancestor
92351202|NCT04190160|Hormones|hormones|mesh-ancestor
92351203|NCT04190160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351204|NCT04190004|Vasopressins|vasopressins|mesh-list
92351205|NCT04190004|Arginine Vasopressin|arginine vasopressin|mesh-list
92351206|NCT04190004|Hemostatics|hemostatics|mesh-ancestor
92351207|NCT04190004|Coagulants|coagulants|mesh-ancestor
92351208|NCT04190004|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92351209|NCT04190004|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92351210|NCT04190004|Natriuretic Agents|natriuretic agents|mesh-ancestor
92351211|NCT04190004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351212|NCT04406376|Prednisone|prednisone|mesh-list
92351213|NCT04406376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351214|NCT04406376|Glucocorticoids|glucocorticoids|mesh-ancestor
92351215|NCT04406376|Hormones|hormones|mesh-ancestor
92351216|NCT04406376|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351217|NCT04406376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351218|NCT04406376|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92351219|NCT04406376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351220|NCT04024800|Pembrolizumab|pembrolizumab|mesh-list
92351221|NCT04024800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351222|NCT04024800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351223|NCT04024800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92351224|NCT04024800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351225|NCT04198662|Epinephrine|epinephrine|mesh-list
92351226|NCT04198662|Ropivacaine|ropivacaine|mesh-list
92351227|NCT04198662|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351228|NCT04198662|Anesthetics|anesthetics|mesh-ancestor
92351229|NCT04198662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351230|NCT04198662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351231|NCT04198662|Sensory System Agents|sensory system agents|mesh-ancestor
92351232|NCT04198662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351233|NCT04198662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92351235|NCT04198662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92351236|NCT04198662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351237|NCT04198662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351238|NCT04198662|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92351239|NCT04198662|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92351240|NCT04198662|Autonomic Agents|autonomic agents|mesh-ancestor
92351241|NCT04198662|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92351242|NCT04198662|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351243|NCT04198662|Mydriatics|mydriatics|mesh-ancestor
92351244|NCT04198662|Sympathomimetics|sympathomimetics|mesh-ancestor
92351245|NCT04198662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92351246|NCT04406610|Immunomodulating Agents|immunomodulating agents|mesh-list
92351247|NCT04406610|Immunologic Factors|immunologic factors|mesh-ancestor
92351248|NCT04406610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351249|NCT04023630|Rivaroxaban|rivaroxaban|mesh-list
92351250|NCT04023630|Clopidogrel|clopidogrel|mesh-list
92351251|NCT04023630|Ticagrelor|ticagrelor|mesh-list
92351252|NCT04023630|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92351253|NCT04023630|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92351254|NCT04023630|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92351256|NCT04023630|Purinergic Agents|purinergic agents|mesh-ancestor
92351257|NCT04023630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351258|NCT04023630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351259|NCT04023630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351260|NCT04023630|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92351261|NCT04023630|Antithrombins|antithrombins|mesh-ancestor
92351262|NCT04023630|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92351263|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
92351264|NCT04023630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351266|NCT04199754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92351267|NCT04022304|Isophane Insulin, Human|isophane insulin, human|mesh-list
92351268|NCT04022304|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92351269|NCT04022304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351270|NCT04020666|Kallikreins|kallikreins|mesh-list
92351271|NCT04020666|Coagulants|coagulants|mesh-ancestor
92351272|NCT04020666|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92351273|NCT04020666|Fertility Agents|fertility agents|mesh-ancestor
92351274|NCT04020666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351275|NCT04020666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351276|NCT03929640|Acetaminophen|acetaminophen|mesh-list
92351277|NCT03929640|Ibuprofen|ibuprofen|mesh-list
92351278|NCT03929640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351279|NCT03929640|Analgesics|analgesics|mesh-ancestor
92351280|NCT03929640|Sensory System Agents|sensory system agents|mesh-ancestor
92351281|NCT03929640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351282|NCT03929640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351283|NCT03929640|Antipyretics|antipyretics|mesh-ancestor
92351284|NCT03929640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92351285|NCT03929640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351286|NCT03929640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351287|NCT03929640|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92351288|NCT03929640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351289|NCT03929640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351291|NCT04021992|Gemcitabine|gemcitabine|mesh-list
92351292|NCT04021992|Doxorubicin|doxorubicin|mesh-list
92351293|NCT04021992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92351294|NCT04021992|Vinorelbine|vinorelbine|mesh-list
92351295|NCT04021992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351296|NCT04021992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351297|NCT04021992|Immunologic Factors|immunologic factors|mesh-ancestor
92351298|NCT04021992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351299|NCT04021992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351300|NCT04021992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351301|NCT04021992|Antimetabolites|antimetabolites|mesh-ancestor
92351302|NCT04021992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351303|NCT04021992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92351304|NCT04021992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92351305|NCT04021992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92351306|NCT04021992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351307|NCT04021992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351308|NCT04021992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351309|NCT04021992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351310|NCT04021992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351311|NCT03926130|Mirikizumab|mirikizumab|mesh-list
92351312|NCT03926130|Ustekinumab|ustekinumab|mesh-list
92351313|NCT03926130|Dermatologic Agents|dermatologic agents|mesh-ancestor
92351314|NCT03926130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92351315|NCT03926130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351316|NCT03926130|Analgesics|analgesics|mesh-ancestor
92351317|NCT03926130|Sensory System Agents|sensory system agents|mesh-ancestor
92351318|NCT03926130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351319|NCT03926130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351320|NCT03926130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351321|NCT03926130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351322|NCT03926130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92351323|NCT03926130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351326|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92351327|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351328|NCT04020588|Analgesics|analgesics|mesh-ancestor
92351329|NCT04020588|Sensory System Agents|sensory system agents|mesh-ancestor
92351330|NCT04020588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351331|NCT04020588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351332|NCT04020588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351333|NCT04020588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351334|NCT04020588|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92351335|NCT04020588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92351336|NCT04020588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351337|NCT04020588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351338|NCT04020588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351339|NCT04020588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351340|NCT04145856|Simethicone|simethicone|mesh-list
92351342|NCT04145856|Antifoaming Agents|antifoaming agents|mesh-ancestor
92351343|NCT04145856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351344|NCT04145856|Emollients|emollients|mesh-ancestor
92351345|NCT04145856|Dermatologic Agents|dermatologic agents|mesh-ancestor
92351346|NCT04145856|Parasympatholytics|parasympatholytics|mesh-ancestor
92351347|NCT04145856|Autonomic Agents|autonomic agents|mesh-ancestor
92351348|NCT04145856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351349|NCT04145856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351351|NCT04140786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351352|NCT04140786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351353|NCT04140786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92351354|NCT04140786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351355|NCT04140786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351356|NCT04147650|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92351357|NCT04147650|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92351358|NCT04022226|Ketamine|ketamine|mesh-list
92351359|NCT04022226|Methohexital|methohexital|mesh-list
92351361|NCT04022226|Sensory System Agents|sensory system agents|mesh-ancestor
92351362|NCT04022226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351363|NCT04022226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351364|NCT04022226|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92351365|NCT04022226|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92351366|NCT04022226|Anesthetics, General|anesthetics, general|mesh-ancestor
92351367|NCT04022226|Anesthetics|anesthetics|mesh-ancestor
92351368|NCT04022226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351369|NCT04022226|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92351370|NCT04022226|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92351371|NCT04022226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351372|NCT04022226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351373|NCT04029012|Methoxyflurane|methoxyflurane|mesh-list
92351374|NCT04029012|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92351375|NCT04029012|Anesthetics, General|anesthetics, general|mesh-ancestor
92351376|NCT04029012|Anesthetics|anesthetics|mesh-ancestor
92351377|NCT04029012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351378|NCT04029012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351379|NCT04025658|Oxytocin|oxytocin|mesh-list
92351380|NCT04025658|Oxytocics|oxytocics|mesh-ancestor
92351381|NCT04025658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351382|NCT04025658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351383|NCT05586438|Colistin|colistin|mesh-list
92351384|NCT05586438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351385|NCT05586438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351386|NCT04145232|Nivolumab|nivolumab|mesh-list
92351387|NCT04145232|Ipilimumab|ipilimumab|mesh-list
92351388|NCT04145232|Atezolizumab|atezolizumab|mesh-list
92351389|NCT04145232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351390|NCT04145232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351391|NCT04145232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92351392|NCT04145232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351393|NCT04144920|Oxymetazoline|oxymetazoline|mesh-list
92351394|NCT04144920|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92351395|NCT04144920|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92351396|NCT04144920|Adrenergic Agents|adrenergic agents|mesh-ancestor
92351397|NCT04144920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351398|NCT04144920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351399|NCT04144920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351400|NCT04144920|Sympathomimetics|sympathomimetics|mesh-ancestor
92351401|NCT04144920|Autonomic Agents|autonomic agents|mesh-ancestor
92351402|NCT04144920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351403|NCT04144920|Nasal Decongestants|nasal decongestants|mesh-ancestor
92351404|NCT04144920|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92115100|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351405|NCT04144920|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351406|NCT04026282|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92351407|NCT04026282|Hormones|hormones|mesh-ancestor
92351408|NCT04026282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351409|NCT04026282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351410|NCT04144218|Lacosamide|lacosamide|mesh-list
92351411|NCT04144218|Anticonvulsants|anticonvulsants|mesh-ancestor
92351412|NCT04144218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92351413|NCT04144218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92351414|NCT04144218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92351415|NCT04144218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351416|NCT05580822|Tenecteplase|tenecteplase|mesh-list
92351417|NCT05580822|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92351418|NCT05580822|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92351419|NCT05580822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351420|NCT05580354|Tislelizumab|tislelizumab|mesh-list
92351421|NCT05580354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351422|NCT05580354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351423|NCT04143906|Carboplatin|carboplatin|mesh-list
92351424|NCT04143906|Gemcitabine|gemcitabine|mesh-list
92351425|NCT04143906|Vinorelbine|vinorelbine|mesh-list
92351426|NCT04143906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351427|NCT04143906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351428|NCT04143906|Antimetabolites|antimetabolites|mesh-ancestor
92351429|NCT04143906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351430|NCT04143906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351431|NCT04143906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351432|NCT04143906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351433|NCT04143906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351434|NCT02708706|Hyaluronic Acid|hyaluronic acid|mesh-list
92351435|NCT02708706|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92351436|NCT02708706|Immunologic Factors|immunologic factors|mesh-ancestor
92351437|NCT02708706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351438|NCT02708706|Viscosupplements|viscosupplements|mesh-ancestor
92351439|NCT02708706|Protective Agents|protective agents|mesh-ancestor
92351440|NCT05587608|Anesthetics|anesthetics|mesh-list
92351441|NCT05587608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351442|NCT05587608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351443|NCT02703714|Pembrolizumab|pembrolizumab|mesh-list
92351444|NCT02703714|Sargramostim|sargramostim|mesh-list
92351445|NCT02703714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351446|NCT02703714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351447|NCT02703714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92351448|NCT02703714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351449|NCT02703714|Immunologic Factors|immunologic factors|mesh-ancestor
92351450|NCT02703714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351451|NCT03945864|Anti-Infective Agents|anti-infective agents|mesh-list
92351452|NCT03945864|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92351453|NCT03904446|Methylergonovine|methylergonovine|mesh-list
92351454|NCT03904446|Oxytocics|oxytocics|mesh-ancestor
92351455|NCT03904446|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351456|NCT03904446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351457|NCT03916068|Vitamin E|vitamin e|mesh-list
92351458|NCT03916068|Pentoxifylline|pentoxifylline|mesh-list
92351460|NCT03916068|Micronutrients|micronutrients|mesh-ancestor
92351461|NCT03916068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351463|NCT03916068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351464|NCT03916068|Protective Agents|protective agents|mesh-ancestor
92351465|NCT03916068|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92351466|NCT03916068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351467|NCT03916068|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92351468|NCT03916068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92351469|NCT03916068|Vasodilator Agents|vasodilator agents|mesh-ancestor
92351470|NCT03916068|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92351472|NCT04143282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92351473|NCT04143282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351474|NCT04149678|Cyclosporine|cyclosporine|mesh-list
92351475|NCT04149678|Cyclosporins|cyclosporins|mesh-list
92351476|NCT04149678|Ozanimod|ozanimod|mesh-list
92351477|NCT04149678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351478|NCT04149678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351479|NCT04149678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92351480|NCT04149678|Immunologic Factors|immunologic factors|mesh-ancestor
92351481|NCT04149678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351482|NCT04149678|Antifungal Agents|antifungal agents|mesh-ancestor
92351483|NCT04149678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351484|NCT04149678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92351485|NCT04149678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351486|NCT04149678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92351487|NCT04149678|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92351488|NCT05581992|Sotorasib|sotorasib|mesh-list
92351489|NCT05581992|Omeprazole|omeprazole|mesh-list
92351490|NCT05581992|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92351491|NCT05581992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351492|NCT05581992|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92351493|NCT05581992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351494|NCT05581992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351495|NCT05581992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92351496|NCT05581992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351497|NCT05581992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351499|NCT03020940|Cefuroxime axetil|cefuroxime axetil|mesh-list
92351500|NCT03020940|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351501|NCT03020940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351502|NCT03645408|Exenatide|exenatide|mesh-list
92351503|NCT03645408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92351504|NCT03645408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351506|NCT03645408|Incretins|incretins|mesh-ancestor
92351507|NCT03645408|Hormones|hormones|mesh-ancestor
92351508|NCT03645408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351509|NCT04141410|Simendan|simendan|mesh-list
92351510|NCT04141410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92351511|NCT04141410|Vasodilator Agents|vasodilator agents|mesh-ancestor
92351512|NCT04141410|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92351513|NCT04141410|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92351515|NCT04141410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351516|NCT04141410|Protective Agents|protective agents|mesh-ancestor
92351517|NCT04141410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351518|NCT05586204|Vaccines|vaccines|mesh-list
92351519|NCT05586204|Immunologic Factors|immunologic factors|mesh-ancestor
92351520|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351521|NCT04149444|Trifluridine|trifluridine|mesh-list
92351522|NCT04149444|Antimetabolites|antimetabolites|mesh-ancestor
92351523|NCT04149444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351524|NCT04149444|Antiviral Agents|antiviral agents|mesh-ancestor
92351525|NCT04149444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351526|NCT03020706|Magnesium Sulfate|magnesium sulfate|mesh-list
92351527|NCT03020706|Analgesics|analgesics|mesh-ancestor
92351528|NCT03020706|Sensory System Agents|sensory system agents|mesh-ancestor
92351529|NCT03020706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351530|NCT03020706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351531|NCT03020706|Anesthetics|anesthetics|mesh-ancestor
92351532|NCT03020706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351533|NCT03020706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92351534|NCT03020706|Anticonvulsants|anticonvulsants|mesh-ancestor
92351535|NCT03020706|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92351536|NCT03020706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92351537|NCT03020706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351538|NCT03020706|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92351539|NCT03020706|Tocolytic Agents|tocolytic agents|mesh-ancestor
92351540|NCT03020706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351541|NCT03900624|Dexamethasone|dexamethasone|mesh-list
92351542|NCT03900624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351543|NCT03900624|Antiemetics|antiemetics|mesh-ancestor
92351544|NCT03900624|Autonomic Agents|autonomic agents|mesh-ancestor
92351545|NCT03900624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351546|NCT03900624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351547|NCT03900624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351548|NCT03900624|Glucocorticoids|glucocorticoids|mesh-ancestor
92351549|NCT03900624|Hormones|hormones|mesh-ancestor
92351550|NCT03900624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351551|NCT03900624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92351552|NCT03900624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351553|NCT04149132|Nitric Oxide|nitric oxide|mesh-list
92351554|NCT04149132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92351555|NCT04149132|Autonomic Agents|autonomic agents|mesh-ancestor
92351556|NCT04149132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351557|NCT04149132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351558|NCT04149132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92351559|NCT04149132|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351560|NCT04149132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92351561|NCT04149132|Antioxidants|antioxidants|mesh-ancestor
92351562|NCT04149132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351563|NCT04149132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351564|NCT04149132|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92351565|NCT04149132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92351566|NCT04149132|Gasotransmitters|gasotransmitters|mesh-ancestor
92351568|NCT03908892|Tetracycline|tetracycline|mesh-list
92351569|NCT03908892|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351570|NCT03908892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351571|NCT03908892|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92351572|NCT03908892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351573|NCT03908892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351574|NCT04140318|Paclitaxel|paclitaxel|mesh-list
92351575|NCT04140318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351576|NCT04140318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351577|NCT04140318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351578|NCT04140318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351579|NCT04140318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351580|NCT04140318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351581|NCT03021330|Cytarabine|cytarabine|mesh-list
92351582|NCT03021330|Daunorubicin|daunorubicin|mesh-list
92351583|NCT03021330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351584|NCT03021330|Antimetabolites|antimetabolites|mesh-ancestor
92351585|NCT03021330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351586|NCT03021330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351587|NCT03021330|Antiviral Agents|antiviral agents|mesh-ancestor
92351588|NCT03021330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351589|NCT03021330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92351590|NCT03021330|Immunologic Factors|immunologic factors|mesh-ancestor
92351591|NCT03021330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351592|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92351593|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92351594|NCT03021330|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92351595|NCT03021330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351596|NCT04140006|Alendronate|alendronate|mesh-list
92351597|NCT04140006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92351598|NCT04140006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351599|NCT04146324|Nivolumab|nivolumab|mesh-list
92351600|NCT04146324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351601|NCT04146324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351602|NCT04146324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92351603|NCT04146324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351604|NCT03588936|Nivolumab|nivolumab|mesh-list
92351605|NCT03588936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351606|NCT03588936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351607|NCT03588936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92351608|NCT03588936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351609|NCT03022500|Durvalumab|durvalumab|mesh-list
92351610|NCT03022500|Tremelimumab|tremelimumab|mesh-list
92351611|NCT03022500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351612|NCT03022500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351613|NCT04148898|Bevacizumab|bevacizumab|mesh-list
92351614|NCT04148898|Osimertinib|osimertinib|mesh-list
92351615|NCT04148898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92351616|NCT04148898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351617|NCT04148898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92351618|NCT04148898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92351619|NCT04148898|Growth Substances|growth substances|mesh-ancestor
92351620|NCT04148898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351621|NCT04148898|Growth Inhibitors|growth inhibitors|mesh-ancestor
92351622|NCT04148898|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92351623|NCT04148898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351624|NCT04148898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351626|NCT04148820|Perindopril|perindopril|mesh-list
92351627|NCT04148820|Atorvastatin|atorvastatin|mesh-list
92351628|NCT04148820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92351629|NCT04148820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351630|NCT04148820|Analgesics|analgesics|mesh-ancestor
92351631|NCT04148820|Sensory System Agents|sensory system agents|mesh-ancestor
92351632|NCT04148820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351633|NCT04148820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351634|NCT04148820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351635|NCT04148820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351636|NCT04148820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92351637|NCT04148820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92351638|NCT04148820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351639|NCT04148820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92351640|NCT04148820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92351641|NCT04148820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351642|NCT04148820|Antipyretics|antipyretics|mesh-ancestor
92351643|NCT04148820|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92351644|NCT04148820|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92351645|NCT04148820|Antimetabolites|antimetabolites|mesh-ancestor
92351646|NCT04148820|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92351647|NCT04148820|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92351648|NCT04148820|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92351650|NCT04148820|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92351651|NCT03941496|Azacitidine|azacitidine|mesh-list
92351652|NCT03941496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351653|NCT03941496|Antimetabolites|antimetabolites|mesh-ancestor
92351654|NCT03941496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351655|NCT03941496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351656|NCT03941496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351657|NCT03580980|Acetaminophen|acetaminophen|mesh-list
92351658|NCT03580980|Ketamine|ketamine|mesh-list
92351659|NCT03580980|Morphine|morphine|mesh-list
92351660|NCT03580980|Levobupivacaine|levobupivacaine|mesh-list
92351661|NCT03580980|Analgesics|analgesics|mesh-ancestor
92351662|NCT03580980|Sensory System Agents|sensory system agents|mesh-ancestor
92351663|NCT03580980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351664|NCT03580980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351665|NCT03580980|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92351666|NCT03580980|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92351667|NCT03580980|Anesthetics, General|anesthetics, general|mesh-ancestor
92351668|NCT03580980|Anesthetics|anesthetics|mesh-ancestor
92351669|NCT03580980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351670|NCT03580980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92351671|NCT03580980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92351672|NCT03580980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351673|NCT03580980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351674|NCT03580980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92351675|NCT03580980|Narcotics|narcotics|mesh-ancestor
92351676|NCT03580980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351677|NCT03580980|Antipyretics|antipyretics|mesh-ancestor
92351678|NCT03580980|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351679|NCT03587220|Lidocaine|lidocaine|mesh-list
92351680|NCT03587220|Capsaicin|capsaicin|mesh-list
92351681|NCT03587220|Histamine|histamine|mesh-list
92351682|NCT03587220|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351683|NCT03587220|Anesthetics|anesthetics|mesh-ancestor
92351684|NCT03587220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351685|NCT03587220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351686|NCT03587220|Sensory System Agents|sensory system agents|mesh-ancestor
92351687|NCT03587220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351689|NCT03587220|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92351691|NCT03587220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92351692|NCT03587220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351693|NCT03587220|Antipruritics|antipruritics|mesh-ancestor
92351694|NCT03587220|Dermatologic Agents|dermatologic agents|mesh-ancestor
92351695|NCT03587220|Histamine Agonists|histamine agonists|mesh-ancestor
92351696|NCT03587220|Histamine Agents|histamine agents|mesh-ancestor
92351697|NCT03587220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351698|NCT03586908|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92351699|NCT03586908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92351700|NCT04147572|Tiotropium Bromide|tiotropium bromide|mesh-list
92351701|NCT04147572|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92351702|NCT04147572|Autonomic Agents|autonomic agents|mesh-ancestor
92351703|NCT04147572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351704|NCT04147572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351705|NCT04147572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92351706|NCT04147572|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351707|NCT04147572|Parasympatholytics|parasympatholytics|mesh-ancestor
92351708|NCT04147572|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92351709|NCT04147572|Cholinergic Agents|cholinergic agents|mesh-ancestor
92351710|NCT04147572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351711|NCT04147572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351712|NCT03580590|Diltiazem|diltiazem|mesh-list
92351713|NCT03580590|Tranexamic Acid|tranexamic acid|mesh-list
92351714|NCT03580590|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92351715|NCT03580590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92351716|NCT03580590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351717|NCT03580590|Hemostatics|hemostatics|mesh-ancestor
92351719|NCT03580590|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92351720|NCT03580590|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92351721|NCT03580590|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92351722|NCT03580590|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92351723|NCT03580590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351724|NCT03580590|Vasodilator Agents|vasodilator agents|mesh-ancestor
92351725|NCT03891576|Niraparib|niraparib|mesh-list
92351726|NCT03891576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92351727|NCT03891576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351728|NCT03891576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351729|NCT03891576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351730|NCT03586674|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92351732|NCT03586674|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92351733|NCT03586674|Antimetabolites|antimetabolites|mesh-ancestor
92351734|NCT03586674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351735|NCT03586674|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92351736|NCT03586674|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92351737|NCT03586674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351738|NCT03346668|Gabapentin|gabapentin|mesh-list
92351739|NCT03346668|Analgesics|analgesics|mesh-ancestor
92351740|NCT03346668|Sensory System Agents|sensory system agents|mesh-ancestor
92351741|NCT03346668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351742|NCT03346668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351743|NCT03346668|Anticonvulsants|anticonvulsants|mesh-ancestor
92351744|NCT03346668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92351745|NCT03346668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92351746|NCT03346668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351747|NCT03346668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92351748|NCT03346668|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92351749|NCT03346668|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92351750|NCT03346668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351751|NCT03346668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351752|NCT03346668|Antimanic Agents|antimanic agents|mesh-ancestor
92351754|NCT03585738|Vitamin B Complex|vitamin b complex|mesh-list
92351755|NCT03585738|Inositol|inositol|mesh-list
92351756|NCT03585738|Hematinics|hematinics|mesh-ancestor
92351757|NCT03585738|Vitamins|vitamins|mesh-ancestor
92351758|NCT03585738|Micronutrients|micronutrients|mesh-ancestor
92351759|NCT03585738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351760|NCT03583164|Olorofim|olorofim|mesh-list
92351761|NCT03583164|Antifungal Agents|antifungal agents|mesh-ancestor
92351763|NCT03589326|Cytarabine|cytarabine|mesh-list
92351764|NCT03589326|Dexamethasone|dexamethasone|mesh-list
92351765|NCT03589326|Prednisone|prednisone|mesh-list
92351766|NCT03589326|Methotrexate|methotrexate|mesh-list
92351767|NCT03589326|Vincristine|vincristine|mesh-list
92351768|NCT03589326|Imatinib Mesylate|imatinib mesylate|mesh-list
92351769|NCT03589326|Ponatinib|ponatinib|mesh-list
92351770|NCT03589326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351771|NCT03589326|Antiemetics|antiemetics|mesh-ancestor
92351772|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
92351773|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351774|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351775|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92351776|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
92351777|NCT03589326|Hormones|hormones|mesh-ancestor
92351778|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351779|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92351780|NCT03589326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351781|NCT03589326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92351782|NCT03589326|Abortifacient Agents|abortifacient agents|mesh-ancestor
92351783|NCT03589326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92351784|NCT03589326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351785|NCT03589326|Antimetabolites|antimetabolites|mesh-ancestor
92351786|NCT03589326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351787|NCT03589326|Dermatologic Agents|dermatologic agents|mesh-ancestor
92351788|NCT03589326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351789|NCT03589326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92351790|NCT03589326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92351791|NCT03589326|Immunologic Factors|immunologic factors|mesh-ancestor
92351792|NCT03589326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351793|NCT03589326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92351794|NCT03589326|Antiviral Agents|antiviral agents|mesh-ancestor
92351795|NCT03589326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351796|NCT03589326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92351799|NCT03589326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351800|NCT03589326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92351801|NCT03156036|Capecitabine|capecitabine|mesh-list
92351802|NCT03156036|Temozolomide|temozolomide|mesh-list
92351803|NCT03156036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351804|NCT03156036|Antimetabolites|antimetabolites|mesh-ancestor
92351805|NCT03156036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351806|NCT03156036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351807|NCT03156036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92351808|NCT03156036|Alkylating Agents|alkylating agents|mesh-ancestor
92351809|NCT03583866|Candesartan|candesartan|mesh-list
92351810|NCT03583866|Candesartan cilexetil|candesartan cilexetil|mesh-list
92351811|NCT03583866|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92351812|NCT03583866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92351813|NCT03583866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92351814|NCT03583866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351816|NCT03585426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351817|NCT03585426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351818|NCT03585036|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92351819|NCT03585036|Tramadol|tramadol|mesh-list
92351820|NCT03585036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92351821|NCT03585036|Narcotics|narcotics|mesh-ancestor
92351822|NCT03585036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351823|NCT03585036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351824|NCT03585036|Analgesics|analgesics|mesh-ancestor
92351825|NCT03585036|Sensory System Agents|sensory system agents|mesh-ancestor
92351826|NCT03585036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351827|NCT03585036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92351828|NCT03585036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351829|NCT03585036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351830|NCT03585036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351831|NCT03155568|Bupivacaine|bupivacaine|mesh-list
92351832|NCT03155568|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351833|NCT03155568|Anesthetics|anesthetics|mesh-ancestor
92351834|NCT03155568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351835|NCT03155568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351836|NCT03155568|Sensory System Agents|sensory system agents|mesh-ancestor
92351837|NCT03155568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351839|NCT03159702|Melphalan|melphalan|mesh-list
92351840|NCT03159702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351841|NCT03159702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351842|NCT03159702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92351843|NCT03159702|Immunologic Factors|immunologic factors|mesh-ancestor
92351844|NCT03159702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351845|NCT03159702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92351846|NCT03159702|Alkylating Agents|alkylating agents|mesh-ancestor
92351847|NCT03159702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92351848|NCT03155646|Clonidine|clonidine|mesh-list
92351849|NCT03155646|Dexmedetomidine|dexmedetomidine|mesh-list
92351850|NCT03155646|Levobupivacaine|levobupivacaine|mesh-list
92351851|NCT03155646|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92351852|NCT03155646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351853|NCT03155646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351854|NCT03155646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351855|NCT03155646|Analgesics|analgesics|mesh-ancestor
92351856|NCT03155646|Sensory System Agents|sensory system agents|mesh-ancestor
92351857|NCT03155646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351858|NCT03155646|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92351859|NCT03155646|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92351860|NCT03155646|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92351861|NCT03155646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92351862|NCT03155646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351863|NCT03155646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351864|NCT03155646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92351865|NCT03155646|Sympatholytics|sympatholytics|mesh-ancestor
92351866|NCT03155646|Autonomic Agents|autonomic agents|mesh-ancestor
92351867|NCT03155646|Anesthetics, Local|anesthetics, local|mesh-ancestor
92351868|NCT03155646|Anesthetics|anesthetics|mesh-ancestor
92351869|NCT03584178|Budesonide|budesonide|mesh-list
92351870|NCT03584178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92351871|NCT03584178|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92351872|NCT03584178|Autonomic Agents|autonomic agents|mesh-ancestor
92351873|NCT03584178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351874|NCT03584178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351875|NCT03584178|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92351876|NCT03584178|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351877|NCT03584178|Glucocorticoids|glucocorticoids|mesh-ancestor
92351879|NCT03584178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92351880|NCT04405206|Capecitabine|capecitabine|mesh-list
92351881|NCT04405206|Oxaliplatin|oxaliplatin|mesh-list
92351882|NCT04405206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351883|NCT04405206|Antimetabolites|antimetabolites|mesh-ancestor
92351884|NCT04405206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351885|NCT04405206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351886|NCT03101046|Docetaxel|docetaxel|mesh-list
92351887|NCT03101046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351888|NCT03101046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351889|NCT03101046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351890|NCT03101046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351891|NCT03101046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351892|NCT03159936|Tofacitinib|tofacitinib|mesh-list
92351893|NCT03159936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351894|NCT03159936|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92351895|NCT03159936|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92351896|NCT03159936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351897|NCT03156816|Colchicine|colchicine|mesh-list
92351898|NCT03156816|Gout Suppressants|gout suppressants|mesh-ancestor
92351899|NCT03156816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351900|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
92351901|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
92351902|NCT03156816|Mitosis Modulators|mitosis modulators|mesh-ancestor
92351903|NCT03156816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351904|NCT03156816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351905|NCT03583476|Amoxicillin|amoxicillin|mesh-list
92351906|NCT03583476|Metronidazole|metronidazole|mesh-list
92351907|NCT03583476|Clarithromycin|clarithromycin|mesh-list
92351908|NCT03583476|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92351909|NCT03583476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92351910|NCT03583476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92351911|NCT03583476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92351912|NCT03583476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92351913|NCT03583476|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92351914|NCT03583476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351915|NCT03583476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351916|NCT03583476|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92351917|NCT03583476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92351918|NCT03583242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92351919|NCT03583242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92351920|NCT03583242|Growth Substances|growth substances|mesh-ancestor
92351921|NCT03583242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351922|NCT03583242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92351923|NCT03583242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351924|NCT05703126|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
92351925|NCT05703126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92351926|NCT05703126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351927|NCT03159390|Phenylacetic acid|phenylacetic acid|mesh-list
92351928|NCT03159390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351929|NCT03159390|Antimetabolites|antimetabolites|mesh-ancestor
92351930|NCT03159390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351931|NCT03159390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351932|NCT03582306|Chlorophyllin|chlorophyllin|mesh-list
92351933|NCT03582306|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92351934|NCT03582306|Protective Agents|protective agents|mesh-ancestor
92351935|NCT03582306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351936|NCT03159234|Epinephrine|epinephrine|mesh-list
92351937|NCT03159234|Racepinephrine|racepinephrine|mesh-list
92351938|NCT03159234|Epinephryl borate|epinephryl borate|mesh-list
92351939|NCT03159234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92351940|NCT03159234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92351941|NCT03159234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92351942|NCT03159234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351943|NCT03159234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351944|NCT03159234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351945|NCT03159234|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92351946|NCT03159234|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92351948|NCT03159234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351949|NCT03159234|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92351950|NCT03159234|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351951|NCT03159234|Mydriatics|mydriatics|mesh-ancestor
92351952|NCT03159234|Sympathomimetics|sympathomimetics|mesh-ancestor
92351953|NCT03159234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92351954|NCT05701332|Gemcitabine|gemcitabine|mesh-list
92351955|NCT05701332|BCG Vaccine|bcg vaccine|mesh-list
92351956|NCT05701332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92351957|NCT05701332|Antimetabolites|antimetabolites|mesh-ancestor
92351958|NCT05701332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351959|NCT05701332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92351960|NCT05701332|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92351961|NCT05701332|Immunologic Factors|immunologic factors|mesh-ancestor
92351962|NCT05701332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351963|NCT03581916|JNJ-64326067|jnj-64326067|mesh-list
92351964|NCT03581916|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92351965|NCT03581916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351966|NCT05703048|Dexmedetomidine|dexmedetomidine|mesh-list
92351967|NCT05703048|Esmolol|esmolol|mesh-list
92351968|NCT05703048|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92351969|NCT05703048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92351970|NCT05703048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351971|NCT05703048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92351972|NCT05703048|Analgesics|analgesics|mesh-ancestor
92351973|NCT05703048|Sensory System Agents|sensory system agents|mesh-ancestor
92351974|NCT05703048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351975|NCT05703048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92351976|NCT05703048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92351977|NCT05703048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92351978|NCT05703048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92351979|NCT05703048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351980|NCT05703048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92351981|NCT05703048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92351982|NCT05703048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92351983|NCT05703048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92351984|NCT03158142|Atropine|atropine|mesh-list
91937227|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92351985|NCT03158142|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92351986|NCT03158142|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92351987|NCT03158142|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92351988|NCT03158142|Autonomic Agents|autonomic agents|mesh-ancestor
92351989|NCT03158142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92351990|NCT03158142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92351991|NCT03158142|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92351992|NCT03158142|Respiratory System Agents|respiratory system agents|mesh-ancestor
92351993|NCT03158142|Mydriatics|mydriatics|mesh-ancestor
92351994|NCT03158142|Parasympatholytics|parasympatholytics|mesh-ancestor
92351995|NCT03158142|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92351996|NCT03158142|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92351997|NCT03158142|Cholinergic Agents|cholinergic agents|mesh-ancestor
92351998|NCT03158142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92351999|NCT03158142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352000|NCT03028740|Cenicriviroc|cenicriviroc|mesh-list
92352001|NCT03028740|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92352002|NCT03028740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352003|NCT03028740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92352004|NCT03028740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92352005|NCT03028740|Antiviral Agents|antiviral agents|mesh-ancestor
92352006|NCT03028740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352007|NCT03027648|Levonorgestrel|levonorgestrel|mesh-list
92352008|NCT03027648|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92352009|NCT03027648|Contraceptive Agents|contraceptive agents|mesh-ancestor
92352010|NCT03027648|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92352011|NCT03027648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352012|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92352013|NCT03027648|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92352014|NCT03027648|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92352015|NCT01671384|Valproic Acid|valproic acid|mesh-list
92352016|NCT01671384|Anticonvulsants|anticonvulsants|mesh-ancestor
92352017|NCT01671384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352018|NCT01671384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352019|NCT01671384|GABA Agents|gaba agents|mesh-ancestor
92352020|NCT01671384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352021|NCT01671384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352022|NCT01671384|Antimanic Agents|antimanic agents|mesh-ancestor
92352023|NCT01671384|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92352024|NCT01671384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352025|NCT01671384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352026|NCT01671774|Zoledronic Acid|zoledronic acid|mesh-list
92352027|NCT01671774|Interleukin-2|interleukin-2|mesh-list
92352028|NCT01671774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352029|NCT01671774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92352030|NCT01671774|Analgesics|analgesics|mesh-ancestor
92352031|NCT01671774|Sensory System Agents|sensory system agents|mesh-ancestor
92352032|NCT01671774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352033|NCT01671774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352034|NCT01671774|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92352035|NCT01671852|Mometasone Furoate|mometasone furoate|mesh-list
92352036|NCT01671852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352037|NCT01671852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92352038|NCT01671852|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92352039|NCT01672086|Calcium Carbonate|calcium carbonate|mesh-list
92352040|NCT01672086|Antacids|antacids|mesh-ancestor
92352041|NCT01672086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352042|NCT01672086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352043|NCT05547750|Vitamin K|vitamin k|mesh-list
92352044|NCT05547750|Vitamin K 2|vitamin k 2|mesh-list
92352045|NCT05547750|Vitamins|vitamins|mesh-ancestor
92352046|NCT05547750|Micronutrients|micronutrients|mesh-ancestor
92352047|NCT05547750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352048|NCT05547750|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92352049|NCT05547750|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92352050|NCT05547750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352051|NCT05547750|Hemostatics|hemostatics|mesh-ancestor
92352052|NCT05547750|Coagulants|coagulants|mesh-ancestor
92352053|NCT04296006|Amphetamine|amphetamine|mesh-list
92352054|NCT04296006|Dextroamphetamine|dextroamphetamine|mesh-list
92352055|NCT04296006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92352056|NCT04296006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352057|NCT04296006|Sympathomimetics|sympathomimetics|mesh-ancestor
92352058|NCT04296006|Autonomic Agents|autonomic agents|mesh-ancestor
92352059|NCT04296006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352060|NCT04296006|Dopamine Agents|dopamine agents|mesh-ancestor
92352061|NCT04296006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352062|NCT04296006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352063|NCT04296006|Adrenergic Agents|adrenergic agents|mesh-ancestor
92352064|NCT04296006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92352065|NCT04296006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92352066|NCT04296006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92352067|NCT04296006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92352068|NCT01672476|Valsartan|valsartan|mesh-list
92352069|NCT01672476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92352070|NCT01672476|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92352071|NCT01672476|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92352072|NCT01672476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352073|NCT01672554|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92352074|NCT01672554|Antidepressive Agents|antidepressive agents|mesh-ancestor
92352075|NCT01672554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352076|NCT01672554|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92352077|NCT01672554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92352078|NCT01672554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352079|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352080|NCT05067582|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
92352081|NCT05067582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352082|NCT05067582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352084|NCT05033808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92352085|NCT05033808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352086|NCT05033808|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352087|NCT05033808|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352088|NCT05033808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352089|NCT05033808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352090|NCT04026984|Rifamycins|rifamycins|mesh-list
92352091|NCT04026984|Rifamycin SV|rifamycin sv|mesh-list
92352092|NCT04026984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92117361|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
92352093|NCT04026984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352094|NCT04026984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352095|NCT04903314|Cenobamate|cenobamate|mesh-list
92352096|NCT04903314|Anticonvulsants|anticonvulsants|mesh-ancestor
92352097|NCT03153072|Amiodarone|amiodarone|mesh-list
92352098|NCT03153072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92352099|NCT03153072|Vasodilator Agents|vasodilator agents|mesh-ancestor
92352100|NCT03153072|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92352101|NCT03153072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92352102|NCT03153072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352103|NCT03153072|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92352104|NCT03153072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92352105|NCT03153072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92352106|NCT03153072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352107|NCT03153072|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92352108|NCT03153072|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92352109|NCT03153072|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92352110|NCT01673724|Pramipexole|pramipexole|mesh-list
92352111|NCT01673724|Bromocriptine|bromocriptine|mesh-list
92352112|NCT01673724|Antioxidants|antioxidants|mesh-ancestor
92352113|NCT01673724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352114|NCT01673724|Protective Agents|protective agents|mesh-ancestor
92352115|NCT01673724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352116|NCT01673724|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92352117|NCT01673724|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92352118|NCT01673724|Dopamine Agonists|dopamine agonists|mesh-ancestor
92352119|NCT01673724|Dopamine Agents|dopamine agents|mesh-ancestor
92352121|NCT01673724|Hormone Antagonists|hormone antagonists|mesh-ancestor
92352122|NCT01673724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352123|NCT04765098|Tamoxifen|tamoxifen|mesh-list
92352124|NCT04765098|Etoposide|etoposide|mesh-list
92352125|NCT04765098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352126|NCT04765098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352127|NCT04765098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352128|NCT04765098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352129|NCT04765098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352130|NCT04765098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352131|NCT04765098|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92352132|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
92352133|NCT04765098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352134|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352135|NCT04765098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92352136|NCT04765098|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92352137|NCT04765098|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92352138|NCT04765098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92352140|NCT01674036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352141|NCT01674036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352142|NCT03378102|Interferon-gamma|interferon-gamma|mesh-list
92352143|NCT03378102|Antiviral Agents|antiviral agents|mesh-ancestor
92352144|NCT03378102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352146|NCT03032328|Vitamins|vitamins|mesh-ancestor
92352147|NCT03032328|Micronutrients|micronutrients|mesh-ancestor
92352148|NCT03032328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352149|NCT03032328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92352150|NCT04747392|Teriparatide|teriparatide|mesh-list
92352151|NCT04747392|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92352152|NCT04747392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352153|NCT04747392|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92352154|NCT01674192|Prucalopride|prucalopride|mesh-list
92352155|NCT01674192|Laxatives|laxatives|mesh-ancestor
92352156|NCT01674192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352157|NCT01674192|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92352158|NCT01674192|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92352159|NCT01674192|Serotonin Agents|serotonin agents|mesh-ancestor
92352160|NCT01674192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352161|NCT01674192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352162|NCT01674192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352163|NCT01674270|Bicalutamide|bicalutamide|mesh-list
92352164|NCT01674270|Androgen Antagonists|androgen antagonists|mesh-ancestor
92352165|NCT01674270|Hormone Antagonists|hormone antagonists|mesh-ancestor
92352166|NCT01674270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352167|NCT01674270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004692|NCT02341027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92352168|NCT01674270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352170|NCT01674504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92352171|NCT01674504|Respiratory System Agents|respiratory system agents|mesh-ancestor
92352172|NCT01674504|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92352173|NCT01674504|Hormone Antagonists|hormone antagonists|mesh-ancestor
92352174|NCT01674504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352175|NCT01674504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352176|NCT01674504|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92352177|NCT01674504|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92352178|NCT01674504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352179|NCT05353062|Epinephrine|epinephrine|mesh-list
92352180|NCT05353062|Hemostatics|hemostatics|mesh-list
92352181|NCT05353062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92352182|NCT05353062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92352183|NCT05353062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92352184|NCT05353062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352185|NCT05353062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352186|NCT05353062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352187|NCT05353062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92352188|NCT05353062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92352189|NCT05353062|Autonomic Agents|autonomic agents|mesh-ancestor
92352190|NCT05353062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352191|NCT05353062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92352192|NCT05353062|Respiratory System Agents|respiratory system agents|mesh-ancestor
92352193|NCT05353062|Mydriatics|mydriatics|mesh-ancestor
92352194|NCT05353062|Sympathomimetics|sympathomimetics|mesh-ancestor
92352195|NCT05353062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92352196|NCT05353062|Coagulants|coagulants|mesh-ancestor
92352197|NCT03152370|Leucovorin|leucovorin|mesh-list
92352198|NCT03152370|Folic Acid|folic acid|mesh-list
92352199|NCT03152370|Capecitabine|capecitabine|mesh-list
92352200|NCT03152370|Oxaliplatin|oxaliplatin|mesh-list
92352201|NCT03152370|Levoleucovorin|levoleucovorin|mesh-list
92352202|NCT03152370|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352203|NCT03152370|Antimetabolites|antimetabolites|mesh-ancestor
92352204|NCT03152370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352205|NCT03152370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352206|NCT03152370|Antidotes|antidotes|mesh-ancestor
92352207|NCT03152370|Protective Agents|protective agents|mesh-ancestor
92352208|NCT03152370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352209|NCT03152370|Vitamin B Complex|vitamin b complex|mesh-ancestor
92352210|NCT03152370|Vitamins|vitamins|mesh-ancestor
92352211|NCT03152370|Micronutrients|micronutrients|mesh-ancestor
92352212|NCT03152370|Hematinics|hematinics|mesh-ancestor
92352213|NCT02187120|Tranexamic Acid|tranexamic acid|mesh-list
92352214|NCT02187120|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92352215|NCT02187120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92352216|NCT02187120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352217|NCT02187120|Hemostatics|hemostatics|mesh-ancestor
92352218|NCT02187120|Coagulants|coagulants|mesh-ancestor
92352219|NCT01674738|Bevacizumab|bevacizumab|mesh-list
92352220|NCT01674738|Pemetrexed|pemetrexed|mesh-list
92352221|NCT01674738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352222|NCT01674738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352223|NCT01674738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92352224|NCT01674738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92352225|NCT01674738|Growth Substances|growth substances|mesh-ancestor
92352226|NCT01674738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352227|NCT01674738|Growth Inhibitors|growth inhibitors|mesh-ancestor
92352228|NCT01674738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352229|NCT01674738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352230|NCT01674738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92352231|NCT01674738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92352232|NCT01675206|Vitamin K|vitamin k|mesh-list
92352233|NCT01675206|Vitamin K 2|vitamin k 2|mesh-list
92352234|NCT01675206|Vitamins|vitamins|mesh-ancestor
92352235|NCT01675206|Micronutrients|micronutrients|mesh-ancestor
92352236|NCT01675206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352237|NCT01675206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92352238|NCT01675206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92352239|NCT01675206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352240|NCT01675206|Hemostatics|hemostatics|mesh-ancestor
92352241|NCT01675206|Coagulants|coagulants|mesh-ancestor
92352242|NCT03150576|Paclitaxel|paclitaxel|mesh-list
92352243|NCT03150576|Carboplatin|carboplatin|mesh-list
92352245|NCT03150576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352247|NCT03150576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352248|NCT03150576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352249|NCT03150576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352250|NCT03150576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352251|NCT03150576|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92352252|NCT03150576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352253|NCT01059786|Rituximab|rituximab|mesh-list
92352254|NCT01059786|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92352255|NCT01059786|Pentostatin|pentostatin|mesh-list
92352256|NCT01059786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352257|NCT01059786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352258|NCT01059786|Immunologic Factors|immunologic factors|mesh-ancestor
92352259|NCT01059786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352260|NCT01059786|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352261|NCT01059786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92352262|NCT01059786|Alkylating Agents|alkylating agents|mesh-ancestor
92352263|NCT01059786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352264|NCT01059786|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92352265|NCT01059786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352266|NCT04747080|Dexamethasone|dexamethasone|mesh-list
92352267|NCT04747080|Dexamethasone acetate|dexamethasone acetate|mesh-list
92352269|NCT04747080|Tacrolimus|tacrolimus|mesh-list
92352270|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352271|NCT04747080|Antiemetics|antiemetics|mesh-ancestor
92352272|NCT04747080|Autonomic Agents|autonomic agents|mesh-ancestor
92352273|NCT04747080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352274|NCT04747080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352275|NCT04747080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352276|NCT04747080|Glucocorticoids|glucocorticoids|mesh-ancestor
92352277|NCT04747080|Hormones|hormones|mesh-ancestor
92352278|NCT04747080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352279|NCT04747080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92352281|NCT04747080|Protease Inhibitors|protease inhibitors|mesh-ancestor
92352282|NCT04747080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352283|NCT04747080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352284|NCT04747080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352285|NCT04747080|Immunologic Factors|immunologic factors|mesh-ancestor
92352286|NCT04747080|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92352287|NCT01675362|Selenium|selenium|mesh-list
92352288|NCT01675362|Losartan|losartan|mesh-list
92352289|NCT01675362|Verapamil|verapamil|mesh-list
92352290|NCT01675362|Calcium Channel Blockers|calcium channel blockers|mesh-list
92352291|NCT01675362|Calcium|calcium|mesh-list
92352292|NCT01675362|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92352293|NCT01675362|Antioxidants|antioxidants|mesh-list
92352294|NCT01675362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92352295|NCT01675362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352296|NCT01675362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92352297|NCT01675362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92352298|NCT01675362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92352299|NCT01675362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352300|NCT01675362|Protective Agents|protective agents|mesh-ancestor
92352301|NCT01675362|Trace Elements|trace elements|mesh-ancestor
92352302|NCT01675362|Micronutrients|micronutrients|mesh-ancestor
92352303|NCT01675362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92352304|NCT01675362|Vasodilator Agents|vasodilator agents|mesh-ancestor
92352305|NCT01675518|ASP7991|asp7991|mesh-list
92352306|NCT01675518|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92352307|NCT01675518|Hormone Antagonists|hormone antagonists|mesh-ancestor
92352308|NCT01675518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352309|NCT01675518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352310|NCT03158532|Nitroglycerin|nitroglycerin|mesh-list
92352311|NCT03158532|Vasodilator Agents|vasodilator agents|mesh-ancestor
92352312|NCT01675986|Pregabalin|pregabalin|mesh-list
92352313|NCT01675986|Hydroxyzine|hydroxyzine|mesh-list
92352314|NCT01675986|Analgesics|analgesics|mesh-ancestor
92352315|NCT01675986|Sensory System Agents|sensory system agents|mesh-ancestor
92352316|NCT01675986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352317|NCT01675986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352318|NCT01675986|Anticonvulsants|anticonvulsants|mesh-ancestor
92352319|NCT01675986|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92352320|NCT01675986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92352321|NCT01675986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352322|NCT01675986|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92352323|NCT01675986|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92352324|NCT01675986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92352325|NCT01675986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352326|NCT01675986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352327|NCT01675986|Antipruritics|antipruritics|mesh-ancestor
92352328|NCT01675986|Dermatologic Agents|dermatologic agents|mesh-ancestor
92352329|NCT01675986|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92352330|NCT01675986|Histamine Antagonists|histamine antagonists|mesh-ancestor
92352331|NCT01675986|Histamine Agents|histamine agents|mesh-ancestor
92352332|NCT01675986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352334|NCT03875664|Anesthetics, Local|anesthetics, local|mesh-ancestor
92352335|NCT03875664|Anesthetics|anesthetics|mesh-ancestor
92352336|NCT03875664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352337|NCT03875664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352338|NCT03875664|Sensory System Agents|sensory system agents|mesh-ancestor
92352339|NCT03875664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352340|NCT01670136|Sildenafil Citrate|sildenafil citrate|mesh-list
92352341|NCT01670136|Vasodilator Agents|vasodilator agents|mesh-ancestor
92352342|NCT01670136|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92352343|NCT01670136|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92352344|NCT01670136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352345|NCT01670136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352346|NCT01670136|Urological Agents|urological agents|mesh-ancestor
92352347|NCT03873480|Epinephrine|epinephrine|mesh-list
92352348|NCT03873480|Bupivacaine|bupivacaine|mesh-list
92352349|NCT03873480|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92352350|NCT03873480|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92352351|NCT03873480|Adrenergic Agents|adrenergic agents|mesh-ancestor
92352352|NCT03873480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352353|NCT03873480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352354|NCT03873480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352355|NCT03873480|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92352356|NCT03873480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92352357|NCT03873480|Autonomic Agents|autonomic agents|mesh-ancestor
92352358|NCT03873480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352359|NCT03873480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92352360|NCT03873480|Respiratory System Agents|respiratory system agents|mesh-ancestor
92352361|NCT03873480|Mydriatics|mydriatics|mesh-ancestor
92352362|NCT03873480|Sympathomimetics|sympathomimetics|mesh-ancestor
92352363|NCT03873480|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92352364|NCT03873480|Anesthetics, Local|anesthetics, local|mesh-ancestor
92352365|NCT03873480|Anesthetics|anesthetics|mesh-ancestor
92352366|NCT03873480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352367|NCT03873480|Sensory System Agents|sensory system agents|mesh-ancestor
92352368|NCT04764084|Niraparib|niraparib|mesh-list
92352369|NCT04764084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92352370|NCT04764084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352371|NCT04764084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352372|NCT04764084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352373|NCT03866772|Misoprostol|misoprostol|mesh-list
92352374|NCT03866772|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92352375|NCT03866772|Abortifacient Agents|abortifacient agents|mesh-ancestor
92352376|NCT03866772|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92352377|NCT03866772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352378|NCT03866772|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92352379|NCT03866772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352381|NCT03866538|Budesonide|budesonide|mesh-list
92352382|NCT03866538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352383|NCT03866538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92352384|NCT03866538|Autonomic Agents|autonomic agents|mesh-ancestor
92352385|NCT03866538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352386|NCT03866538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352387|NCT03866538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92352388|NCT03866538|Respiratory System Agents|respiratory system agents|mesh-ancestor
92352389|NCT03866538|Glucocorticoids|glucocorticoids|mesh-ancestor
92352390|NCT03866538|Hormones|hormones|mesh-ancestor
92352391|NCT03866538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352392|NCT03865992|Curcumin|curcumin|mesh-list
92352393|NCT03865992|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92352394|NCT03865992|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92352395|NCT03865992|Analgesics|analgesics|mesh-ancestor
92352396|NCT03865992|Sensory System Agents|sensory system agents|mesh-ancestor
92352397|NCT03865992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352398|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352399|NCT03865992|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352400|NCT03865992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352401|NCT03865992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352402|NCT03865992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352403|NCT03865992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352405|NCT03865212|Interferon-beta|interferon-beta|mesh-list
92352406|NCT03865212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352407|NCT03865212|Antiviral Agents|antiviral agents|mesh-ancestor
92352408|NCT03865212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352409|NCT03865212|Immunologic Factors|immunologic factors|mesh-ancestor
92352410|NCT03865212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352411|NCT01677390|Everolimus|everolimus|mesh-list
92352412|NCT01677390|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92352413|NCT01677390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92352414|NCT01677390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352415|NCT01677390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352416|NCT01677390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352417|NCT01677390|Immunologic Factors|immunologic factors|mesh-ancestor
92352418|NCT01677390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352419|NCT01677390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352421|NCT03749070|Antioxidants|antioxidants|mesh-ancestor
92352422|NCT03749070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352423|NCT03749070|Protective Agents|protective agents|mesh-ancestor
92352424|NCT03749070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352425|NCT03748134|Paclitaxel|paclitaxel|mesh-list
92352426|NCT03748134|Fluorouracil|fluorouracil|mesh-list
92352427|NCT03748134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352428|NCT03748134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352429|NCT03748134|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352430|NCT03748134|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352431|NCT03748134|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352432|NCT03748134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352434|NCT03748134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352435|NCT03748134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352436|NCT03748134|Immunologic Factors|immunologic factors|mesh-ancestor
92352437|NCT03748134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352438|NCT01345656|Spironolactone|spironolactone|mesh-list
92352439|NCT01345656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92352440|NCT01345656|Hormone Antagonists|hormone antagonists|mesh-ancestor
92352441|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352442|NCT01345656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352443|NCT01345656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92352444|NCT01345656|Diuretics|diuretics|mesh-ancestor
92352445|NCT01345656|Natriuretic Agents|natriuretic agents|mesh-ancestor
92352446|NCT03747120|Paclitaxel|paclitaxel|mesh-list
92352447|NCT03747120|Pembrolizumab|pembrolizumab|mesh-list
92352448|NCT03747120|Trastuzumab|trastuzumab|mesh-list
92352449|NCT03747120|Pertuzumab|pertuzumab|mesh-list
92352450|NCT03747120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352451|NCT03747120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352452|NCT03747120|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352453|NCT03747120|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352454|NCT03747120|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352455|NCT03747120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352456|NCT03747120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352457|NCT03747120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352458|NCT04763616|Cemiplimab|cemiplimab|mesh-list
92352459|NCT04763616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352460|NCT04763616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352461|NCT03652974|Valproic Acid|valproic acid|mesh-list
92352462|NCT03652974|Clozapine|clozapine|mesh-list
92352463|NCT03652974|Amisulpride|amisulpride|mesh-list
92352464|NCT03652974|Anticonvulsants|anticonvulsants|mesh-ancestor
92352465|NCT03652974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352466|NCT03652974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352467|NCT03652974|GABA Agents|gaba agents|mesh-ancestor
92352468|NCT03652974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352469|NCT03652974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352470|NCT03652974|Antimanic Agents|antimanic agents|mesh-ancestor
92352471|NCT03652974|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92352472|NCT03652974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352473|NCT03652974|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352474|NCT03652974|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92352475|NCT03652974|Serotonin Agents|serotonin agents|mesh-ancestor
92352476|NCT03652974|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92352477|NCT03652974|GABA Antagonists|gaba antagonists|mesh-ancestor
92352478|NCT03652974|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92352479|NCT03652974|Dopamine Agents|dopamine agents|mesh-ancestor
92352480|NCT03652974|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92352481|NCT03652974|Antidepressive Agents|antidepressive agents|mesh-ancestor
92352482|NCT03649152|Propagermanium|propagermanium|mesh-list
92352483|NCT03649152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352484|NCT03649152|Interferon Inducers|interferon inducers|mesh-ancestor
92352485|NCT03649152|Immunologic Factors|immunologic factors|mesh-ancestor
92352486|NCT03649152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352487|NCT03646188|Doxorubicin|doxorubicin|mesh-list
92352488|NCT03646188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92352489|NCT03646188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92352490|NCT03646188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352491|NCT03646188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352492|NCT03646188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352493|NCT03646188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352494|NCT03646188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352495|NCT03642210|Levonorgestrel|levonorgestrel|mesh-list
92352496|NCT03642210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92352497|NCT03642210|Contraceptive Agents|contraceptive agents|mesh-ancestor
92352498|NCT03642210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92352499|NCT03642210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352500|NCT03642210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92352501|NCT03642210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92352502|NCT03642210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92352503|NCT02082678|Ondansetron|ondansetron|mesh-list
92352504|NCT02082678|Antiemetics|antiemetics|mesh-ancestor
92352505|NCT02082678|Autonomic Agents|autonomic agents|mesh-ancestor
92352506|NCT02082678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352507|NCT02082678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352509|NCT02082678|Antipruritics|antipruritics|mesh-ancestor
92352510|NCT02082678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92352511|NCT02082678|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92352512|NCT02082678|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92352513|NCT02082678|Serotonin Agents|serotonin agents|mesh-ancestor
92352514|NCT02082678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352515|NCT02082678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352516|NCT03843294|Nivolumab|nivolumab|mesh-list
92352517|NCT03843294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352518|NCT03843294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352519|NCT03843294|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352520|NCT03843294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352521|NCT03834948|Paclitaxel|paclitaxel|mesh-list
92352523|NCT03834948|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352524|NCT03834948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352525|NCT03834948|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352526|NCT03834948|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352527|NCT03834948|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352528|NCT03834948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352529|NCT03834948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352530|NCT03834948|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352532|NCT01677468|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92352533|NCT01677468|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92352534|NCT01677468|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92352535|NCT01677468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352536|NCT01677468|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352537|NCT01677468|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352538|NCT01677468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352539|NCT01677468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352540|NCT01677468|Hemostatics|hemostatics|mesh-ancestor
92352541|NCT01677468|Coagulants|coagulants|mesh-ancestor
92352542|NCT00003816|Cyclophosphamide|cyclophosphamide|mesh-list
92352543|NCT00003816|Melphalan|melphalan|mesh-list
92352544|NCT00003816|Busulfan|busulfan|mesh-list
92005065|NCT02326441|KX2-361|kx2-361|mesh-list
92352545|NCT00003816|Thiotepa|thiotepa|mesh-list
92352546|NCT00003816|Carboplatin|carboplatin|mesh-list
92352547|NCT00003816|Fludarabine|fludarabine|mesh-list
92352548|NCT00003816|Fludarabine phosphate|fludarabine phosphate|mesh-list
92352549|NCT00003816|Etoposide|etoposide|mesh-list
92352550|NCT00003816|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92352551|NCT00003816|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352552|NCT00003816|Immunologic Factors|immunologic factors|mesh-ancestor
92352553|NCT00003816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352554|NCT00003816|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352555|NCT00003816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92352556|NCT00003816|Alkylating Agents|alkylating agents|mesh-ancestor
92115286|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352557|NCT00003816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352558|NCT00003816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352559|NCT00003816|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92352560|NCT00003816|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352561|NCT00003816|Antimetabolites|antimetabolites|mesh-ancestor
92352562|NCT00003816|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352563|NCT00003816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352564|NCT00003816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352565|NCT00003816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352566|NCT03618654|Metformin|metformin|mesh-list
92352567|NCT03618654|Durvalumab|durvalumab|mesh-list
92352568|NCT03618654|Immunoglobulins|immunoglobulins|mesh-list
92352569|NCT03618654|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92352570|NCT03618654|Immunoglobulin G|immunoglobulin g|mesh-list
92352571|NCT03618654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92352572|NCT03618654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352573|NCT03618654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352574|NCT03618654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352575|NCT03618654|Immunologic Factors|immunologic factors|mesh-ancestor
92352576|NCT04763070|Ciprofloxacin|ciprofloxacin|mesh-list
92352577|NCT04763070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92352578|NCT04763070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352579|NCT04763070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352580|NCT04763070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352581|NCT04763070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352582|NCT04763070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352584|NCT04763070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92352585|NCT04763070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92352586|NCT03611556|Leucovorin|leucovorin|mesh-list
92352587|NCT03611556|Paclitaxel|paclitaxel|mesh-list
92352588|NCT03611556|Gemcitabine|gemcitabine|mesh-list
92352589|NCT03611556|Oxaliplatin|oxaliplatin|mesh-list
92352590|NCT03611556|Fluorouracil|fluorouracil|mesh-list
92352591|NCT03611556|Durvalumab|durvalumab|mesh-list
92352592|NCT03611556|Levoleucovorin|levoleucovorin|mesh-list
92352593|NCT03611556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352594|NCT03611556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352595|NCT03611556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352596|NCT03611556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352597|NCT03611556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352598|NCT03611556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352599|NCT03611556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352600|NCT03611556|Antimetabolites|antimetabolites|mesh-ancestor
92352601|NCT03611556|Antidotes|antidotes|mesh-ancestor
92352602|NCT03611556|Protective Agents|protective agents|mesh-ancestor
92352603|NCT03611556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352604|NCT03611556|Vitamin B Complex|vitamin b complex|mesh-ancestor
92352605|NCT03611556|Vitamins|vitamins|mesh-ancestor
92352606|NCT03611556|Micronutrients|micronutrients|mesh-ancestor
92352607|NCT03611556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352608|NCT03611556|Immunologic Factors|immunologic factors|mesh-ancestor
92352609|NCT03611556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352610|NCT03609060|Dexamethasone|dexamethasone|mesh-list
92352611|NCT03609060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352612|NCT03609060|Antiemetics|antiemetics|mesh-ancestor
92352613|NCT03609060|Autonomic Agents|autonomic agents|mesh-ancestor
92352614|NCT03609060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352615|NCT03609060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352616|NCT03609060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352617|NCT03609060|Glucocorticoids|glucocorticoids|mesh-ancestor
92352618|NCT03609060|Hormones|hormones|mesh-ancestor
92352619|NCT03609060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352620|NCT03609060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92005149|NCT02332603|Prednisolone|prednisolone|mesh-list
92352621|NCT03609060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352622|NCT03704766|alpha-Defensins|alpha-defensins|mesh-list
92352623|NCT03704766|Defensins|defensins|mesh-list
92352624|NCT03704766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352627|NCT03826992|Venetoclax|venetoclax|mesh-list
92352628|NCT03826992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352629|NCT03826992|Antimetabolites|antimetabolites|mesh-ancestor
92352630|NCT03826992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352631|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352632|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
92352633|NCT03826992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352634|NCT03826992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352635|NCT03826992|Immunologic Factors|immunologic factors|mesh-ancestor
92352636|NCT03826992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352637|NCT03826992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92352638|NCT03826992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352639|NCT03826992|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352640|NCT03826992|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352641|NCT00004092|Paclitaxel|paclitaxel|mesh-list
92352642|NCT00004092|Cyclophosphamide|cyclophosphamide|mesh-list
92352643|NCT00004092|Carboplatin|carboplatin|mesh-list
92352644|NCT00004092|Doxorubicin|doxorubicin|mesh-list
92352645|NCT00004092|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92352646|NCT00004092|Thiotepa|thiotepa|mesh-list
92352647|NCT00004092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352648|NCT00004092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352649|NCT00004092|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352650|NCT00004092|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352651|NCT00004092|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352652|NCT00004092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352653|NCT00004092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352654|NCT00004092|Immunologic Factors|immunologic factors|mesh-ancestor
92352655|NCT00004092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352656|NCT00004092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352657|NCT00004092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92352658|NCT00004092|Alkylating Agents|alkylating agents|mesh-ancestor
92352659|NCT00004092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92352660|NCT00004092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92352661|NCT00004092|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352662|NCT00004092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352663|NCT00004092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352664|NCT00004146|Carboxyamido-triazole|carboxyamido-triazole|mesh-list
92352665|NCT00004146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352666|NCT00004146|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92352667|NCT00004146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92352668|NCT00004146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352669|NCT00004146|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92352670|NCT00004146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352671|NCT00004500|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92352672|NCT00004500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92352674|NCT03825198|Ketorolac|ketorolac|mesh-list
92352675|NCT03825198|Sufentanil|sufentanil|mesh-list
92352676|NCT03825198|Morphine|morphine|mesh-list
92352677|NCT03825198|Bromides|bromides|mesh-list
92352678|NCT03825198|Propofol|propofol|mesh-list
92352679|NCT03825198|Sevoflurane|sevoflurane|mesh-list
92352680|NCT03825198|Levobupivacaine|levobupivacaine|mesh-list
92352681|NCT03825198|Rocuronium|rocuronium|mesh-list
92352682|NCT03825198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352683|NCT03825198|Antiemetics|antiemetics|mesh-ancestor
92352684|NCT03825198|Autonomic Agents|autonomic agents|mesh-ancestor
92352685|NCT03825198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352686|NCT03825198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352687|NCT03825198|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352688|NCT03825198|Glucocorticoids|glucocorticoids|mesh-ancestor
92352689|NCT03825198|Hormones|hormones|mesh-ancestor
92352690|NCT03825198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352691|NCT03825198|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92352692|NCT03825198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352693|NCT03825198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92352694|NCT03825198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352695|NCT03825198|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92352696|NCT03825198|Anesthetics, General|anesthetics, general|mesh-ancestor
92352697|NCT03825198|Anesthetics|anesthetics|mesh-ancestor
92352698|NCT03825198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92352699|NCT03825198|Narcotics|narcotics|mesh-ancestor
92352700|NCT03825198|Analgesics|analgesics|mesh-ancestor
92352701|NCT03825198|Sensory System Agents|sensory system agents|mesh-ancestor
92352702|NCT03825198|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92352703|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92352704|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92352705|NCT03825198|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92352706|NCT03825198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352707|NCT03825198|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92352708|NCT03825198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352709|NCT03825198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352710|NCT03825198|Anticonvulsants|anticonvulsants|mesh-ancestor
92352711|NCT03825198|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92352712|NCT03825198|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92352713|NCT03825198|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92352714|NCT03825198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92352715|NCT03825198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92352716|NCT03824106|Vitamin D|vitamin d|mesh-list
92352717|NCT03824106|Vitamins|vitamins|mesh-ancestor
92352718|NCT03824106|Micronutrients|micronutrients|mesh-ancestor
92352719|NCT03824106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352720|NCT03824106|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92352721|NCT03598998|Pembrolizumab|pembrolizumab|mesh-list
92352722|NCT03598998|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92352723|NCT03598998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352724|NCT03598998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352725|NCT03598998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352726|NCT03598998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352727|NCT03598998|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92352729|NCT03817320|Leucovorin|leucovorin|mesh-list
92352730|NCT03817320|Cytarabine|cytarabine|mesh-list
92352731|NCT03817320|Dexamethasone|dexamethasone|mesh-list
92352732|NCT03817320|Hydrocortisone|hydrocortisone|mesh-list
92352733|NCT03817320|Doxorubicin|doxorubicin|mesh-list
92352734|NCT03817320|Methotrexate|methotrexate|mesh-list
92352735|NCT03817320|Vincristine|vincristine|mesh-list
92352736|NCT03817320|Asparaginase|asparaginase|mesh-list
92352737|NCT03817320|Ixazomib|ixazomib|mesh-list
92352738|NCT03817320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352739|NCT03817320|Antiemetics|antiemetics|mesh-ancestor
92352740|NCT03817320|Autonomic Agents|autonomic agents|mesh-ancestor
92352741|NCT03817320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352742|NCT03817320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352743|NCT03817320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352744|NCT03817320|Glucocorticoids|glucocorticoids|mesh-ancestor
92352745|NCT03817320|Hormones|hormones|mesh-ancestor
92352746|NCT03817320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92352747|NCT03817320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92352748|NCT03817320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352749|NCT03817320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92352750|NCT03817320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352751|NCT03817320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352752|NCT03817320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352753|NCT03817320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352754|NCT03817320|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92352755|NCT03817320|Abortifacient Agents|abortifacient agents|mesh-ancestor
92352756|NCT03817320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92352757|NCT03817320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352758|NCT03817320|Antimetabolites|antimetabolites|mesh-ancestor
92352759|NCT03817320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92352760|NCT03817320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92352761|NCT03817320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352762|NCT03817320|Immunologic Factors|immunologic factors|mesh-ancestor
92352763|NCT03817320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352764|NCT03817320|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92352765|NCT03817320|Antiviral Agents|antiviral agents|mesh-ancestor
92352766|NCT03817320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352767|NCT03817320|Antidotes|antidotes|mesh-ancestor
92352768|NCT03817320|Protective Agents|protective agents|mesh-ancestor
92352769|NCT03817320|Vitamin B Complex|vitamin b complex|mesh-ancestor
92352770|NCT03817320|Vitamins|vitamins|mesh-ancestor
92352771|NCT03817320|Micronutrients|micronutrients|mesh-ancestor
92352772|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352773|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352774|NCT03817320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352775|NCT03817320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352776|NCT03817320|Protease Inhibitors|protease inhibitors|mesh-ancestor
92352777|NCT03684018|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92352778|NCT03684018|Immunologic Factors|immunologic factors|mesh-ancestor
92352779|NCT03684018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352780|NCT03583086|Nivolumab|nivolumab|mesh-list
92352781|NCT03583086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352782|NCT03583086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352783|NCT03583086|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352784|NCT03583086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352785|NCT03580824|Adjuvants, Vaccine|adjuvants, vaccine|mesh-list
92352786|NCT03580824|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92352787|NCT03580824|Immunologic Factors|immunologic factors|mesh-ancestor
92352788|NCT03580824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352790|NCT03580356|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92352791|NCT03580356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92352792|NCT03580356|Respiratory System Agents|respiratory system agents|mesh-ancestor
92352793|NCT03575052|Pimavanserin|pimavanserin|mesh-list
92352794|NCT03575052|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92352795|NCT03575052|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92352796|NCT03575052|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92352797|NCT03575052|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92352798|NCT03575052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352799|NCT03575052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352800|NCT03575052|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352801|NCT03575052|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92352802|NCT03575052|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92352803|NCT03575052|Serotonin Agents|serotonin agents|mesh-ancestor
92352804|NCT03575052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352805|NCT03575052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352806|NCT03556020|VIP-ELP fusion molecule PB1046|vip-elp fusion molecule pb1046|mesh-list
92352807|NCT03556020|Vasodilator Agents|vasodilator agents|mesh-ancestor
92352808|NCT01677546|Insulin|insulin|mesh-list
92352809|NCT01677546|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92352811|NCT01677546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352812|NCT04403724|Fentanyl|fentanyl|mesh-list
92352813|NCT04403724|Morphine|morphine|mesh-list
92352814|NCT04403724|Bupivacaine|bupivacaine|mesh-list
92352815|NCT04403724|Anesthetics, Local|anesthetics, local|mesh-ancestor
92352816|NCT04403724|Anesthetics|anesthetics|mesh-ancestor
92352817|NCT04403724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352818|NCT04403724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352819|NCT04403724|Sensory System Agents|sensory system agents|mesh-ancestor
92352820|NCT04403724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352821|NCT04403724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92352822|NCT04403724|Narcotics|narcotics|mesh-ancestor
92352823|NCT04403724|Analgesics|analgesics|mesh-ancestor
92352824|NCT04403724|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92352825|NCT04403724|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92352826|NCT04403724|Anesthetics, General|anesthetics, general|mesh-ancestor
92352827|NCT03567876|Venetoclax|venetoclax|mesh-list
92352828|NCT03567876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352829|NCT04403568|Ursolic acid|ursolic acid|mesh-list
92352830|NCT04403568|Curcumin|curcumin|mesh-list
92352831|NCT04403568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92352832|NCT04403568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92352834|NCT04403568|Sensory System Agents|sensory system agents|mesh-ancestor
92352835|NCT04403568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352836|NCT04403568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352837|NCT04403568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92352838|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92352839|NCT04403568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352840|NCT04403568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352841|NCT04403568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352842|NCT04403568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352843|NCT04403568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352844|NCT04403568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92352845|NCT03564756|Ascorbic Acid|ascorbic acid|mesh-list
92352846|NCT03564756|Vitamins|vitamins|mesh-ancestor
92352847|NCT03564756|Micronutrients|micronutrients|mesh-ancestor
92352848|NCT03564756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352849|NCT03564756|Antioxidants|antioxidants|mesh-ancestor
92352850|NCT03564756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352851|NCT03564756|Protective Agents|protective agents|mesh-ancestor
92352852|NCT03462966|Rifaximin|rifaximin|mesh-list
92352853|NCT03462966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92352854|NCT03462966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352855|NCT03462966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352856|NCT03531762|Tepotinib|tepotinib|mesh-list
92352857|NCT03531762|Omeprazole|omeprazole|mesh-list
92352858|NCT03531762|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92352859|NCT03531762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352860|NCT03531762|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92352861|NCT03531762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352862|NCT03531762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352863|NCT03531762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352864|NCT03458598|Analgesics, Opioid|analgesics, opioid|mesh-list
92352865|NCT03458598|Narcotics|narcotics|mesh-ancestor
92352866|NCT03458598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352867|NCT03458598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352868|NCT03458598|Analgesics|analgesics|mesh-ancestor
92352869|NCT03458598|Sensory System Agents|sensory system agents|mesh-ancestor
92352870|NCT03458598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352871|NCT03791736|Octreotide|octreotide|mesh-list
92352872|NCT03791736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92352873|NCT03791736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92352874|NCT03791736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352875|NCT01679964|Raltegravir Potassium|raltegravir potassium|mesh-list
92352876|NCT01679964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92352877|NCT01679964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92352878|NCT01679964|Antiviral Agents|antiviral agents|mesh-ancestor
92352879|NCT01679964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352880|NCT01679964|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92352881|NCT01679964|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92352882|NCT01679964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352883|NCT01679964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352884|NCT03524898|Paclitaxel|paclitaxel|mesh-list
92352885|NCT03524898|Gemcitabine|gemcitabine|mesh-list
92352886|NCT03524898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352887|NCT03524898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352888|NCT03524898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352889|NCT03524898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352890|NCT03524898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352891|NCT03524898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352892|NCT03524898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352893|NCT03524898|Antimetabolites|antimetabolites|mesh-ancestor
92352894|NCT03524820|Cetuximab|cetuximab|mesh-list
92352895|NCT03524820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352896|NCT03524820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352897|NCT03524508|Fluorouracil|fluorouracil|mesh-list
92352898|NCT03524508|Irinotecan|irinotecan|mesh-list
92352899|NCT03524508|Antimetabolites|antimetabolites|mesh-ancestor
92352900|NCT03524508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352901|NCT03524508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352902|NCT03524508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352903|NCT03524508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92352904|NCT03524508|Immunologic Factors|immunologic factors|mesh-ancestor
92352905|NCT03524508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352906|NCT03524508|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92352907|NCT03524508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352908|NCT03524508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352909|NCT03522168|Risperidone|risperidone|mesh-list
92352910|NCT03522168|Aripiprazole|aripiprazole|mesh-list
92352911|NCT03522168|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92352912|NCT03522168|Serotonin Agents|serotonin agents|mesh-ancestor
92352913|NCT03522168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352914|NCT03522168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352915|NCT03522168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352916|NCT03522168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92352918|NCT03522168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92352919|NCT03522168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92352920|NCT03522168|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92352921|NCT03522168|Dopamine Agents|dopamine agents|mesh-ancestor
92352922|NCT03522168|Antidepressive Agents|antidepressive agents|mesh-ancestor
92352923|NCT03522168|Dopamine Agonists|dopamine agonists|mesh-ancestor
92352924|NCT03522168|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92352925|NCT03522168|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92352926|NCT03522168|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92352927|NCT03522168|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92352928|NCT03457818|Denosumab|denosumab|mesh-list
92005443|NCT03073343|Betaine|betaine|mesh-list
92352929|NCT03457818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92352930|NCT03457818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352931|NCT01676844|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92352932|NCT01676844|Potassium phosphate|potassium phosphate|mesh-list
92352933|NCT01676844|Cariostatic Agents|cariostatic agents|mesh-ancestor
92352934|NCT01676844|Protective Agents|protective agents|mesh-ancestor
92352935|NCT01676844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352936|NCT04403334|Moxifloxacin|moxifloxacin|mesh-list
92352937|NCT04403334|Levofloxacin|levofloxacin|mesh-list
92352938|NCT04403334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92352939|NCT04403334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92352940|NCT04403334|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92352941|NCT04403334|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92352943|NCT04403334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352944|NCT04403334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352945|NCT04403334|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92352946|NCT04403334|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92352947|NCT04403334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92352948|NCT03779646|Bisoprolol|bisoprolol|mesh-list
92352949|NCT03779646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92352950|NCT03779646|Sympatholytics|sympatholytics|mesh-ancestor
92352951|NCT03779646|Autonomic Agents|autonomic agents|mesh-ancestor
92352952|NCT03779646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352953|NCT03779646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352954|NCT03779646|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92352955|NCT03779646|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92352956|NCT03779646|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92352957|NCT03779646|Adrenergic Agents|adrenergic agents|mesh-ancestor
92352958|NCT03779646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92352959|NCT03779646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352960|NCT03774732|Paclitaxel|paclitaxel|mesh-list
92352961|NCT03774732|Cisplatin|cisplatin|mesh-list
92352962|NCT03774732|Carboplatin|carboplatin|mesh-list
92352963|NCT03774732|Pembrolizumab|pembrolizumab|mesh-list
92352964|NCT03774732|Pemetrexed|pemetrexed|mesh-list
92352965|NCT03774732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352966|NCT03774732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352967|NCT03774732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352968|NCT03774732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352969|NCT03774732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352970|NCT03774732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352971|NCT03774732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92352972|NCT03774732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92352973|NCT03774732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92352974|NCT03774732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92352975|NCT03774732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92352976|NCT05347134|Gemcitabine|gemcitabine|mesh-list
92352977|NCT05347134|Capecitabine|capecitabine|mesh-list
92352978|NCT05347134|Vinorelbine|vinorelbine|mesh-list
92352979|NCT05347134|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92352980|NCT05347134|Antimetabolites|antimetabolites|mesh-ancestor
92352981|NCT05347134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352982|NCT05347134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352983|NCT05347134|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92352984|NCT05347134|Tubulin Modulators|tubulin modulators|mesh-ancestor
92352985|NCT05347134|Antimitotic Agents|antimitotic agents|mesh-ancestor
92352986|NCT05347134|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352987|NCT00089778|Aldesleukin|aldesleukin|mesh-list
92352988|NCT00089778|Interleukin-2|interleukin-2|mesh-list
92352989|NCT00089778|Mitogens|mitogens|mesh-list
92352990|NCT00089778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92352991|NCT00089778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92352992|NCT00089778|Analgesics|analgesics|mesh-ancestor
92352993|NCT00089778|Sensory System Agents|sensory system agents|mesh-ancestor
92352994|NCT00089778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92352995|NCT00089778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92352996|NCT00089778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92352997|NCT00089778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92352998|NCT00089778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92352999|NCT00089778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92353000|NCT00089778|Antiviral Agents|antiviral agents|mesh-ancestor
92353001|NCT00089778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353002|NCT00089544|Thalidomide|thalidomide|mesh-list
92353003|NCT00089544|Doxorubicin|doxorubicin|mesh-list
92005515|NCT02328079|Autonomic Agents|autonomic agents|mesh-ancestor
92353004|NCT00089544|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92353005|NCT00089544|Ifosfamide|ifosfamide|mesh-list
92353006|NCT00089544|Isophosphamide mustard|isophosphamide mustard|mesh-list
92353007|NCT00089544|Dacarbazine|dacarbazine|mesh-list
92353008|NCT00089544|Imidazole|imidazole|mesh-list
92353009|NCT00089544|Lenograstim|lenograstim|mesh-list
92353010|NCT00089544|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92353011|NCT00089544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353012|NCT00089544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92353013|NCT00089544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92353015|NCT00089544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353016|NCT00089544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92353017|NCT00089544|Immunologic Factors|immunologic factors|mesh-ancestor
92353018|NCT00089544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353019|NCT00089544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92353020|NCT00089544|Alkylating Agents|alkylating agents|mesh-ancestor
92353021|NCT00089544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353022|NCT00089544|Leprostatic Agents|leprostatic agents|mesh-ancestor
92353023|NCT00089544|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353024|NCT00089544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353025|NCT00089544|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92353026|NCT00089544|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92353027|NCT00089544|Growth Substances|growth substances|mesh-ancestor
92353028|NCT00089544|Growth Inhibitors|growth inhibitors|mesh-ancestor
92353029|NCT00089076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92353031|NCT00089076|Antibodies|antibodies|mesh-list
92353032|NCT00089076|Immunoglobulins|immunoglobulins|mesh-list
92353033|NCT00089076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92353034|NCT00089076|Immunologic Factors|immunologic factors|mesh-ancestor
92353035|NCT00089076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353036|NCT00089076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353037|NCT00089076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353038|NCT00089076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353039|NCT03773562|Erenumab|erenumab|mesh-list
92353040|NCT03773562|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92353041|NCT03773562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353042|NCT03773562|Analgesics|analgesics|mesh-ancestor
92353043|NCT03773562|Sensory System Agents|sensory system agents|mesh-ancestor
92353044|NCT03773562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353045|NCT03773562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353046|NCT00088374|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92353047|NCT00088374|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92353048|NCT00088374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353049|NCT00087594|Ribavirin|ribavirin|mesh-list
92353050|NCT00087594|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92353051|NCT00087594|Antimetabolites|antimetabolites|mesh-ancestor
92353052|NCT00087594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353053|NCT00087594|Antiviral Agents|antiviral agents|mesh-ancestor
92353054|NCT00087594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353055|NCT03770286|Fluorides|fluorides|mesh-list
92353056|NCT03770286|Fluorides, Topical|fluorides, topical|mesh-list
92353057|NCT03770286|Cariostatic Agents|cariostatic agents|mesh-ancestor
92353058|NCT03770286|Protective Agents|protective agents|mesh-ancestor
92353059|NCT03770286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353060|NCT00087516|Metformin|metformin|mesh-list
92353061|NCT00087516|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92353062|NCT00087516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92353063|NCT00087516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353064|NCT00087516|Incretins|incretins|mesh-ancestor
92353065|NCT00087516|Hormones|hormones|mesh-ancestor
92353066|NCT00087516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353067|NCT00087516|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92353068|NCT00087516|Protease Inhibitors|protease inhibitors|mesh-ancestor
92353069|NCT00087516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353070|NCT00087516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353071|NCT03768960|Daratumumab|daratumumab|mesh-list
92353072|NCT03768960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353073|NCT00087126|Topotecan|topotecan|mesh-list
92353074|NCT00087126|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92353075|NCT00087126|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92353076|NCT00087126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353077|NCT00087126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353078|NCT00087126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353080|NCT00086346|Sirolimus|sirolimus|mesh-list
92353081|NCT00086346|Tacrolimus|tacrolimus|mesh-list
92353082|NCT00086346|Cyclosporins|cyclosporins|mesh-list
92353083|NCT00086346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353084|NCT00086346|Immunologic Factors|immunologic factors|mesh-ancestor
92353085|NCT00086346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353086|NCT00086346|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92353087|NCT00086346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353088|NCT00086346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353089|NCT00086346|Antifungal Agents|antifungal agents|mesh-ancestor
92353090|NCT00086346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353091|NCT00086346|Dermatologic Agents|dermatologic agents|mesh-ancestor
92353092|NCT00086346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353093|NCT00086346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353094|NCT00086346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92353095|NCT00086346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353096|NCT00085566|Everolimus|everolimus|mesh-list
92353097|NCT00085566|Gefitinib|gefitinib|mesh-list
92353098|NCT00085566|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92353099|NCT00085566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353100|NCT00085566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353101|NCT00085566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353102|NCT00085566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353103|NCT00085566|Immunologic Factors|immunologic factors|mesh-ancestor
92353104|NCT00085566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353105|NCT00085566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353106|NCT00085098|Cyclophosphamide|cyclophosphamide|mesh-list
92353107|NCT00085098|Cisplatin|cisplatin|mesh-list
92353108|NCT00085098|Carboplatin|carboplatin|mesh-list
92353109|NCT00085098|Etoposide|etoposide|mesh-list
91937237|NCT01183949|Bortezomib|bortezomib|mesh-list
92353111|NCT00085098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353112|NCT00085098|Immunologic Factors|immunologic factors|mesh-ancestor
92353113|NCT00085098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353114|NCT00085098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353115|NCT00085098|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92353116|NCT00085098|Alkylating Agents|alkylating agents|mesh-ancestor
92353117|NCT00085098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353118|NCT00085098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353119|NCT00085098|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92353120|NCT00085098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92353121|NCT00085098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92353122|NCT00085098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92353124|NCT00085098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92353125|NCT00084864|Calcitriol|calcitriol|mesh-list
92353126|NCT00084864|Dexamethasone|dexamethasone|mesh-list
92353127|NCT00084864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353128|NCT00084864|Antiemetics|antiemetics|mesh-ancestor
92353129|NCT00084864|Autonomic Agents|autonomic agents|mesh-ancestor
92353130|NCT00084864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353131|NCT00084864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353132|NCT00084864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92353133|NCT00084864|Glucocorticoids|glucocorticoids|mesh-ancestor
92353134|NCT00084864|Hormones|hormones|mesh-ancestor
92353135|NCT00084864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353136|NCT00084864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92353137|NCT00084864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353138|NCT00084864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92353139|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92353140|NCT00084864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353141|NCT00084864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353142|NCT00084864|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92353144|NCT00084864|Micronutrients|micronutrients|mesh-ancestor
92353145|NCT00084864|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92353146|NCT01677702|Lactoferrin|lactoferrin|mesh-list
92353147|NCT01677702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353148|NCT01473108|Eplerenone|eplerenone|mesh-list
92353149|NCT01473108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92353150|NCT01473108|Hormone Antagonists|hormone antagonists|mesh-ancestor
92353151|NCT01473108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353152|NCT01473108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005672|NCT02327923|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92353153|NCT01473108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92353154|NCT01473108|Diuretics|diuretics|mesh-ancestor
92353155|NCT01473108|Natriuretic Agents|natriuretic agents|mesh-ancestor
92353156|NCT01473108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92353157|NCT00084318|Docetaxel|docetaxel|mesh-list
92353158|NCT00084318|Cetuximab|cetuximab|mesh-list
92353159|NCT00084318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353160|NCT00084318|Tubulin Modulators|tubulin modulators|mesh-ancestor
92353161|NCT00084318|Antimitotic Agents|antimitotic agents|mesh-ancestor
92353162|NCT00084318|Mitosis Modulators|mitosis modulators|mesh-ancestor
92353163|NCT00084318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353164|NCT00084318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353165|NCT00083616|Panitumumab|panitumumab|mesh-list
92353166|NCT00083616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353167|NCT00083616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353169|NCT00083226|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92353170|NCT00083226|Bortezomib|bortezomib|mesh-list
92353171|NCT00083226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92353172|NCT00083226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353173|NCT00083226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92353174|NCT00083226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92353175|NCT00083226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353176|NCT00083226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353177|NCT00082758|Interleukin-2|interleukin-2|mesh-list
92353178|NCT00082758|Denileukin diftitox|denileukin diftitox|mesh-list
92353179|NCT00082758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353180|NCT00082758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92353181|NCT00082758|Analgesics|analgesics|mesh-ancestor
92353183|NCT00082758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353184|NCT00082758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353185|NCT03438318|Atezolizumab|atezolizumab|mesh-list
92353186|NCT03438318|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353187|NCT03438318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353188|NCT03438318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353189|NCT03438318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353190|NCT03087942|Indoleacetic Acids|indoleacetic acids|mesh-list
92353191|NCT03087942|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92353192|NCT03087942|Growth Substances|growth substances|mesh-ancestor
92353193|NCT03087942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353194|NCT01678092|Omalizumab|omalizumab|mesh-list
92353195|NCT01678092|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92353196|NCT01678092|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92353197|NCT01678092|Respiratory System Agents|respiratory system agents|mesh-ancestor
92353198|NCT04402320|Midazolam|midazolam|mesh-list
92353199|NCT04402320|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92353200|NCT04402320|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92353201|NCT04402320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353202|NCT04402320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353203|NCT04402320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92353204|NCT04402320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92353206|NCT04402320|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92353207|NCT04402320|Anesthetics, General|anesthetics, general|mesh-ancestor
92353208|NCT04402320|Anesthetics|anesthetics|mesh-ancestor
92353209|NCT04402320|GABA Modulators|gaba modulators|mesh-ancestor
92353210|NCT04402320|GABA Agents|gaba agents|mesh-ancestor
92353211|NCT04402320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353212|NCT04402320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353213|NCT03436056|Pembrolizumab|pembrolizumab|mesh-list
92353214|NCT03436056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353215|NCT03436056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353216|NCT03436056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353217|NCT03436056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353218|NCT03088176|Trametinib|trametinib|mesh-list
92353219|NCT03088176|Dabrafenib|dabrafenib|mesh-list
92353220|NCT03088176|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92353221|NCT03088176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353222|NCT03088176|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353223|NCT03088176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353224|NCT03088176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353225|NCT03088176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353226|NCT01678404|Rituximab|rituximab|mesh-list
92353227|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353228|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353229|NCT01678404|Immunologic Factors|immunologic factors|mesh-ancestor
92353230|NCT01678404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353231|NCT01678404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353233|NCT03087864|Carboplatin|carboplatin|mesh-list
92353234|NCT03087864|Atezolizumab|atezolizumab|mesh-list
92353235|NCT03087864|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92353236|NCT03087864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353237|NCT03087864|Tubulin Modulators|tubulin modulators|mesh-ancestor
92353238|NCT03087864|Antimitotic Agents|antimitotic agents|mesh-ancestor
92353239|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
92353240|NCT03087864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353241|NCT03087864|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353242|NCT03087864|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353244|NCT01678716|Trace Elements|trace elements|mesh-list
92353245|NCT01678716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353246|NCT00081510|Anastrozole|anastrozole|mesh-list
92353247|NCT00081510|Lonafarnib|lonafarnib|mesh-list
92353248|NCT00081510|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92353249|NCT00081510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353250|NCT00081510|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92353251|NCT00081510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92353252|NCT00081510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353253|NCT00081510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353254|NCT00081510|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92353255|NCT00081510|Hormone Antagonists|hormone antagonists|mesh-ancestor
91937240|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92353256|NCT00081510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353258|NCT00088452|Lamotrigine|lamotrigine|mesh-list
92353259|NCT00088452|Valproic Acid|valproic acid|mesh-list
92353260|NCT00088452|Ethosuximide|ethosuximide|mesh-list
92353261|NCT00088452|Anticonvulsants|anticonvulsants|mesh-ancestor
92353262|NCT00088452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92353263|NCT00088452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353264|NCT00088452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353265|NCT00088452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92353266|NCT00088452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353267|NCT00088452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92353268|NCT00088452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92353269|NCT00088452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353270|NCT00088452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92353271|NCT00088452|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92353272|NCT00088452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353273|NCT00088452|GABA Agents|gaba agents|mesh-ancestor
92353274|NCT00088452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353275|NCT00088452|Antimanic Agents|antimanic agents|mesh-ancestor
92353276|NCT01679106|Fentanyl|fentanyl|mesh-list
92408935|NCT05960578|Golimumab|golimumab|mesh-list
92353277|NCT01679106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92353278|NCT01679106|Narcotics|narcotics|mesh-ancestor
92353279|NCT01679106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353280|NCT01679106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353281|NCT01679106|Analgesics|analgesics|mesh-ancestor
92353282|NCT01679106|Sensory System Agents|sensory system agents|mesh-ancestor
92353283|NCT01679106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353284|NCT01679106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92353285|NCT01679106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92353286|NCT01679106|Anesthetics, General|anesthetics, general|mesh-ancestor
92353287|NCT01679106|Anesthetics|anesthetics|mesh-ancestor
92353288|NCT04403100|Ritonavir|ritonavir|mesh-list
92353289|NCT04403100|Lopinavir|lopinavir|mesh-list
92353290|NCT04403100|Hydroxychloroquine|hydroxychloroquine|mesh-list
92353291|NCT04403100|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92353292|NCT04403100|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92353293|NCT04403100|Protease Inhibitors|protease inhibitors|mesh-ancestor
92353294|NCT04403100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353295|NCT04403100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353296|NCT04403100|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92353297|NCT04403100|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92353298|NCT04403100|Antiviral Agents|antiviral agents|mesh-ancestor
92353299|NCT04403100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353300|NCT04403100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92005820|NCT03139591|Autonomic Agents|autonomic agents|mesh-ancestor
92353301|NCT04403100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92353302|NCT04403100|Antimalarials|antimalarials|mesh-ancestor
92353303|NCT04403100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92353304|NCT04403100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92353305|NCT04403100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353306|NCT03086538|Pemetrexed|pemetrexed|mesh-list
92353307|NCT03086538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92409191|NCT05894239|Inavolisib|inavolisib|mesh-list
92353308|NCT03086538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353309|NCT03086538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353310|NCT03086538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353311|NCT03086538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92353312|NCT03086538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92353313|NCT03086538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353315|NCT03473730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353316|NCT03081858|Paclitaxel|paclitaxel|mesh-list
92353317|NCT03081858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92353318|NCT03081858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353319|NCT03081858|Tubulin Modulators|tubulin modulators|mesh-ancestor
92353320|NCT03081858|Antimitotic Agents|antimitotic agents|mesh-ancestor
92353321|NCT03081858|Mitosis Modulators|mitosis modulators|mesh-ancestor
92353322|NCT03081858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353323|NCT01679340|Oxaliplatin|oxaliplatin|mesh-list
92353324|NCT01679340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353325|NCT01679574|Metformin|metformin|mesh-list
92353326|NCT01679574|Letrozole|letrozole|mesh-list
92353327|NCT01679574|Clomiphene|clomiphene|mesh-list
92353328|NCT01679574|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92353329|NCT01679574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353330|NCT01679574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353331|NCT01679574|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92353332|NCT01679574|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92353333|NCT01679574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409329|NCT05842044|Antipyretics|antipyretics|mesh-ancestor
92353334|NCT01679574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353335|NCT01679574|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92353336|NCT01679574|Hormone Antagonists|hormone antagonists|mesh-ancestor
92353337|NCT01679574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353338|NCT01679574|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92353340|NCT01679574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92353341|NCT01679574|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92353342|NCT01679574|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92353344|NCT01679652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92353345|NCT01679652|Vasodilator Agents|vasodilator agents|mesh-ancestor
92409385|NCT05800275|Capecitabine|capecitabine|mesh-list
92353346|NCT01679652|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92353347|NCT01679652|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92353348|NCT01679652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92353349|NCT01679652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92353350|NCT01679652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353351|NCT01679652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353352|NCT01679652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353353|NCT04761744|Nivolumab|nivolumab|mesh-list
92353354|NCT04761744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353355|NCT04761744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353356|NCT04761744|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353357|NCT04761744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353358|NCT03089658|Avelumab|avelumab|mesh-list
92353359|NCT03089658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353360|NCT03089658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353361|NCT03417492|Sildenafil Citrate|sildenafil citrate|mesh-list
92353362|NCT03417492|Citric Acid|citric acid|mesh-list
92353363|NCT03417492|Sodium Citrate|sodium citrate|mesh-list
92353364|NCT03417492|Anticoagulants|anticoagulants|mesh-ancestor
92353365|NCT03417492|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92353366|NCT03417492|Chelating Agents|chelating agents|mesh-ancestor
92353367|NCT03417492|Sequestering Agents|sequestering agents|mesh-ancestor
92353368|NCT03417492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353369|NCT03417492|Vasodilator Agents|vasodilator agents|mesh-ancestor
92353370|NCT03417492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92353371|NCT03417492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92353372|NCT03417492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353373|NCT03417492|Urological Agents|urological agents|mesh-ancestor
92353375|NCT03395184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353376|NCT03395184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353377|NCT03395184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353378|NCT03080766|Decitabine|decitabine|mesh-list
92005894|NCT04989257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92353379|NCT03080766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92353380|NCT03080766|Antimetabolites|antimetabolites|mesh-ancestor
92353381|NCT03080766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353382|NCT03080766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353383|NCT03080766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353384|NCT03088722|Contraceptive Agents|contraceptive agents|mesh-list
92409499|NCT05734625|Antiemetics|antiemetics|mesh-ancestor
92353385|NCT03088722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92353386|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353387|NCT03088644|(18)F-JNJ-64413739|(18)f-jnj-64413739|mesh-list
92353388|NCT03088644|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92353389|NCT03088644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353390|NCT03088254|Amlodipine|amlodipine|mesh-list
92353391|NCT03088254|Telmisartan|telmisartan|mesh-list
92353392|NCT03088254|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92353393|NCT03088254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92353394|NCT03088254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92353395|NCT03088254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353396|NCT03088254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353397|NCT03088254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92353398|NCT03088254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115365|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
92353400|NCT03088254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92353402|NCT03088254|Antimetabolites|antimetabolites|mesh-ancestor
92353403|NCT03088254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92353404|NCT03088254|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92409693|NCT05653401|Tocolytic Agents|tocolytic agents|mesh-ancestor
92353405|NCT03088254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353406|NCT03088254|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92353407|NCT03088254|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92353408|NCT05685342|Acetaminophen|acetaminophen|mesh-list
92353409|NCT05685342|Ibuprofen|ibuprofen|mesh-list
92353410|NCT05685342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92353411|NCT05685342|Analgesics|analgesics|mesh-ancestor
92353412|NCT05685342|Sensory System Agents|sensory system agents|mesh-ancestor
92353413|NCT05685342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353414|NCT05685342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353415|NCT05685342|Antipyretics|antipyretics|mesh-ancestor
92353416|NCT05685342|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92353417|NCT05685342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353418|NCT05685342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353419|NCT05685342|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92353420|NCT05685342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353421|NCT05685342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353422|NCT05684718|Itraconazole|itraconazole|mesh-list
92353423|NCT05684718|Rifabutin|rifabutin|mesh-list
92353424|NCT05684718|Antifungal Agents|antifungal agents|mesh-ancestor
92353425|NCT05684718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353426|NCT05684718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92353427|NCT05684718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92353428|NCT05684718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353429|NCT05684718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353430|NCT05684718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92353431|NCT05684718|Hormone Antagonists|hormone antagonists|mesh-ancestor
92353432|NCT05684718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353433|NCT05684718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353434|NCT05684718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92353435|NCT05684718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353436|NCT05684718|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92353437|NCT05684718|Antitubercular Agents|antitubercular agents|mesh-ancestor
92353438|NCT05684484|Salicylic Acid|salicylic acid|mesh-list
92353439|NCT05684484|Salicylates|salicylates|mesh-list
92353440|NCT05684484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409883|NCT05582694|UB-421|ub-421|mesh-list
92353441|NCT05684484|Antifungal Agents|antifungal agents|mesh-ancestor
92353442|NCT05684484|Keratolytic Agents|keratolytic agents|mesh-ancestor
92353443|NCT05684484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92409952|NCT05547542|Carfentanil|carfentanil|mesh-list
92353444|NCT05684484|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92353445|NCT05684484|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92353446|NCT05684484|Analgesics|analgesics|mesh-ancestor
92353447|NCT05684484|Sensory System Agents|sensory system agents|mesh-ancestor
92353448|NCT05684484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353449|NCT05684484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353450|NCT05684484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353451|NCT05684484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353453|NCT05684484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353454|NCT05684484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353455|NCT03086382|Lacosamide|lacosamide|mesh-list
92353456|NCT03086382|Anticonvulsants|anticonvulsants|mesh-ancestor
92353457|NCT03086382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92353458|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92353459|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353460|NCT03086382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353461|NCT03086226|Itraconazole|itraconazole|mesh-list
92353462|NCT03086226|Antifungal Agents|antifungal agents|mesh-ancestor
92353463|NCT03086226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410022|NCT05519085|Pomalidomide|pomalidomide|mesh-list
92353464|NCT03086226|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92353465|NCT03086226|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92410149|NCT05428215|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92353467|NCT03086226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353469|NCT03086226|Hormone Antagonists|hormone antagonists|mesh-ancestor
92353470|NCT03086226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353471|NCT03086226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353472|NCT03086226|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92353473|NCT03085992|Bevacizumab|bevacizumab|mesh-list
92353474|NCT03085992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353475|NCT03085992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353476|NCT03085992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92353477|NCT03085992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92353478|NCT03085992|Growth Substances|growth substances|mesh-ancestor
92353479|NCT03085992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353480|NCT03085992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92353481|NCT03086070|Omeprazole|omeprazole|mesh-list
92353482|NCT03086070|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92353483|NCT03086070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92353484|NCT03086070|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92353485|NCT03086070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353486|NCT03086070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353487|NCT05688306|Oprelvekin|oprelvekin|mesh-list
92353488|NCT05688306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353489|NCT03086148|Ketamine|ketamine|mesh-list
92353490|NCT03086148|Analgesics|analgesics|mesh-ancestor
92353491|NCT03086148|Sensory System Agents|sensory system agents|mesh-ancestor
92353492|NCT03086148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353493|NCT03086148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353494|NCT03086148|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92353495|NCT03086148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92353496|NCT03086148|Anesthetics, General|anesthetics, general|mesh-ancestor
92353497|NCT03086148|Anesthetics|anesthetics|mesh-ancestor
92353498|NCT03086148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353499|NCT03086148|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92353500|NCT03086148|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92353501|NCT03086148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353502|NCT03086148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353503|NCT03359538|Sirolimus|sirolimus|mesh-list
92353504|NCT03359538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353505|NCT03359538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353506|NCT03359538|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92353507|NCT03359538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353508|NCT03359538|Antifungal Agents|antifungal agents|mesh-ancestor
92353509|NCT03359538|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353510|NCT03359538|Immunologic Factors|immunologic factors|mesh-ancestor
92353511|NCT03359538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353512|NCT05345808|Triamcinolone|triamcinolone|mesh-list
92353513|NCT05345808|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92353514|NCT05345808|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92353515|NCT05345808|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92353516|NCT05345808|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353517|NCT05345808|Glucocorticoids|glucocorticoids|mesh-ancestor
92353518|NCT05345808|Hormones|hormones|mesh-ancestor
92353519|NCT05345808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353520|NCT05345808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353521|NCT05345808|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353522|NCT05345808|Immunologic Factors|immunologic factors|mesh-ancestor
92353523|NCT05345808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353524|NCT05345808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353525|NCT02336958|Ropivacaine|ropivacaine|mesh-list
92353526|NCT02336958|Prilocaine|prilocaine|mesh-list
92353527|NCT02336958|Anesthetics, Local|anesthetics, local|mesh-ancestor
92353528|NCT02336958|Anesthetics|anesthetics|mesh-ancestor
92353529|NCT02336958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353530|NCT02336958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353531|NCT02336958|Sensory System Agents|sensory system agents|mesh-ancestor
92353532|NCT02336958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353533|NCT03085368|Trastuzumab|trastuzumab|mesh-list
92353534|NCT03085368|Lapatinib|lapatinib|mesh-list
92353535|NCT03085368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353536|NCT03085368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353537|NCT03085368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353538|NCT03085368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353539|NCT03085368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353540|NCT05638932|Tofacitinib|tofacitinib|mesh-list
92353541|NCT05638932|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92353542|NCT05638932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937246|NCT05626829|Tranilast|tranilast|mesh-list
92353543|NCT05638932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353544|NCT05638932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353545|NCT03085290|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92353546|NCT03085290|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92353547|NCT05687760|Calcium|calcium|mesh-list
92353548|NCT05687760|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92353549|NCT05687760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353550|NCT03084978|Anesthetics|anesthetics|mesh-list
92353551|NCT03084978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353552|NCT03084978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353553|NCT03084588|Methadone|methadone|mesh-list
92353554|NCT03084588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92353555|NCT03084588|Narcotics|narcotics|mesh-ancestor
92353556|NCT03084588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353557|NCT03084588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353558|NCT03084588|Analgesics|analgesics|mesh-ancestor
92353559|NCT03084588|Sensory System Agents|sensory system agents|mesh-ancestor
92353560|NCT03084588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353561|NCT03084588|Antitussive Agents|antitussive agents|mesh-ancestor
92353562|NCT03084588|Respiratory System Agents|respiratory system agents|mesh-ancestor
92353563|NCT05345574|Dexmedetomidine|dexmedetomidine|mesh-list
92353564|NCT05345574|Remifentanil|remifentanil|mesh-list
92353565|NCT05345574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92353566|NCT05345574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353567|NCT05345574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353568|NCT05345574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92353569|NCT05345574|Analgesics|analgesics|mesh-ancestor
92353570|NCT05345574|Sensory System Agents|sensory system agents|mesh-ancestor
92353571|NCT05345574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353572|NCT05345574|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92353573|NCT05345574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92353574|NCT05345574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92353575|NCT05345574|Adrenergic Agents|adrenergic agents|mesh-ancestor
92353576|NCT05345574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353577|NCT05345574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353578|NCT05345574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92353579|NCT05345574|Narcotics|narcotics|mesh-ancestor
92353580|NCT05598606|Zoledronic Acid|zoledronic acid|mesh-list
92353581|NCT05598606|Denosumab|denosumab|mesh-list
92353582|NCT05598606|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92353583|NCT05598606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353584|NCT04400916|Tranexamic Acid|tranexamic acid|mesh-list
92353585|NCT04400916|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92353586|NCT04400916|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92353587|NCT04400916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353588|NCT04400916|Hemostatics|hemostatics|mesh-ancestor
92353589|NCT04400916|Coagulants|coagulants|mesh-ancestor
92353590|NCT05582538|Paclitaxel|paclitaxel|mesh-list
92353591|NCT05582538|Durvalumab|durvalumab|mesh-list
92353592|NCT05582538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92353593|NCT05582538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353594|NCT05582538|Tubulin Modulators|tubulin modulators|mesh-ancestor
92353595|NCT05582538|Antimitotic Agents|antimitotic agents|mesh-ancestor
92353596|NCT05582538|Mitosis Modulators|mitosis modulators|mesh-ancestor
92353597|NCT05582538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006117|NCT04452461|Protective Agents|protective agents|mesh-ancestor
92353598|NCT05582538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353599|NCT03406650|Durvalumab|durvalumab|mesh-list
92353600|NCT03406650|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353601|NCT03406650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353602|NCT05571072|Analgesics, Opioid|analgesics, opioid|mesh-list
92353603|NCT05571072|Narcotics|narcotics|mesh-ancestor
92353604|NCT05571072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353605|NCT05571072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353606|NCT05571072|Analgesics|analgesics|mesh-ancestor
92353607|NCT05571072|Sensory System Agents|sensory system agents|mesh-ancestor
92353608|NCT05571072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353610|NCT03832452|1-Deoxynojirimycin|1-deoxynojirimycin|mesh-list
92353611|NCT03832452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353612|NCT03832452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353613|NCT03832452|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92353614|NCT03832452|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92353615|NCT03832452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353616|NCT03832452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353617|NCT03832452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353618|NCT03832452|Antiviral Agents|antiviral agents|mesh-ancestor
92353619|NCT04279938|Rituximab|rituximab|mesh-list
92353620|NCT04279938|Pembrolizumab|pembrolizumab|mesh-list
92353621|NCT04279938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353622|NCT04279938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353623|NCT04279938|Immunologic Factors|immunologic factors|mesh-ancestor
92353624|NCT04279938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353625|NCT04279938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353626|NCT04279938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353627|NCT04279938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353628|NCT05686434|Osimertinib|osimertinib|mesh-list
92353629|NCT05686434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353630|NCT05686434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353631|NCT05686434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411114|NCT04749641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353632|NCT05686434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353634|NCT05686356|Bedaquiline|bedaquiline|mesh-list
92353635|NCT05686356|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92353636|NCT05686356|Antiviral Agents|antiviral agents|mesh-ancestor
92353637|NCT05686356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411248|NCT04608474|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92353639|NCT05686356|Respiratory System Agents|respiratory system agents|mesh-ancestor
92353640|NCT05686356|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92353641|NCT05686356|Antioxidants|antioxidants|mesh-ancestor
92411615|NCT04135937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353642|NCT05686356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353643|NCT05686356|Protective Agents|protective agents|mesh-ancestor
92353644|NCT05686356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353645|NCT05686356|Antidotes|antidotes|mesh-ancestor
92353646|NCT05686356|Antitubercular Agents|antitubercular agents|mesh-ancestor
92353647|NCT05686356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353648|NCT03083184|Ethanol|ethanol|mesh-list
92353649|NCT03083184|Enoxaparin|enoxaparin|mesh-list
92353650|NCT03083184|Anticoagulants|anticoagulants|mesh-ancestor
92353651|NCT03083184|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92353652|NCT03083184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92353653|NCT03083184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353654|NCT03083184|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92353655|NCT03083184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353656|NCT03083184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353657|NCT03083184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353658|NCT03338244|Azithromycin|azithromycin|mesh-list
92353659|NCT03338244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353660|NCT03338244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353661|NCT05512962|Triamcinolone|triamcinolone|mesh-list
92412204|NCT03369223|Nivolumab|nivolumab|mesh-list
92353662|NCT05512962|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92353663|NCT05512962|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92353664|NCT05512962|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92353665|NCT05512962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353667|NCT05512962|Hormones|hormones|mesh-ancestor
92353668|NCT05512962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353669|NCT05512962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412415|NCT02899052|Venetoclax|venetoclax|mesh-list
92353670|NCT05512962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92006200|NCT00157963|Losartan|losartan|mesh-list
92353671|NCT05512962|Immunologic Factors|immunologic factors|mesh-ancestor
92353672|NCT05512962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353673|NCT05512962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412647|NCT02123121|Resveratrol|resveratrol|mesh-list
92353674|NCT03082092|Methylprednisolone|methylprednisolone|mesh-list
92353675|NCT03082092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92353676|NCT03082092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92353677|NCT03082092|Prednisolone|prednisolone|mesh-list
92353678|NCT03082092|Prednisolone acetate|prednisolone acetate|mesh-list
92353679|NCT03082092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92353680|NCT03082092|Prednisolone phosphate|prednisolone phosphate|mesh-list
92353681|NCT03082092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353682|NCT03082092|Antiemetics|antiemetics|mesh-ancestor
92353683|NCT03082092|Autonomic Agents|autonomic agents|mesh-ancestor
92353684|NCT03082092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353685|NCT03082092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353686|NCT03082092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92353687|NCT03082092|Glucocorticoids|glucocorticoids|mesh-ancestor
92353689|NCT03082092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353690|NCT03082092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92353691|NCT03082092|Protective Agents|protective agents|mesh-ancestor
92353692|NCT03082092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92353693|NCT03082092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353694|NCT04401852|Magnesium Sulfate|magnesium sulfate|mesh-list
92353695|NCT04401852|Analgesics|analgesics|mesh-ancestor
92353696|NCT04401852|Sensory System Agents|sensory system agents|mesh-ancestor
92353697|NCT04401852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353698|NCT04401852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353699|NCT04401852|Anesthetics|anesthetics|mesh-ancestor
92353700|NCT04401852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353701|NCT04401852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92353702|NCT04401852|Anticonvulsants|anticonvulsants|mesh-ancestor
92353703|NCT04401852|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92353704|NCT04401852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353705|NCT04401852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353706|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92353707|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
92353708|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92353709|NCT03082482|Nicotine|nicotine|mesh-list
92353710|NCT03082482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92353711|NCT03082482|Autonomic Agents|autonomic agents|mesh-ancestor
92353712|NCT03082482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353713|NCT03082482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353714|NCT03082482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92353715|NCT03082482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92353716|NCT03082482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92353717|NCT03082482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353718|NCT03082482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353719|NCT03308916|Liver Extracts|liver extracts|mesh-list
92353720|NCT03308916|Hematinics|hematinics|mesh-ancestor
92353721|NCT03081702|Hydroxychloroquine|hydroxychloroquine|mesh-list
92353722|NCT03081702|Itraconazole|itraconazole|mesh-list
92353723|NCT03081702|Antimalarials|antimalarials|mesh-ancestor
92353724|NCT03081702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92353725|NCT03081702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92353726|NCT03081702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353727|NCT03081702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353728|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353729|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353730|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
92353731|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92353732|NCT03081702|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92353733|NCT03081702|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92353734|NCT03081702|Hormone Antagonists|hormone antagonists|mesh-ancestor
92353735|NCT03081702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353736|NCT03081702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353737|NCT03081702|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92353738|NCT04399434|Insulin|insulin|mesh-list
92353739|NCT04399434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92353740|NCT04399434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353741|NCT04760574|Testosterone|testosterone|mesh-list
92353742|NCT04760574|Androgens|androgens|mesh-ancestor
92353743|NCT04760574|Hormones|hormones|mesh-ancestor
92353744|NCT04760574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353745|NCT04760574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353746|NCT03237390|Gemcitabine|gemcitabine|mesh-list
92353747|NCT03237390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92353748|NCT03237390|Antimetabolites|antimetabolites|mesh-ancestor
92353749|NCT03237390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353750|NCT03237390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353752|NCT03302910|Furosemide|furosemide|mesh-list
92353753|NCT03302910|Bumetanide|bumetanide|mesh-list
92353754|NCT03302910|Nitroglycerin|nitroglycerin|mesh-list
92353755|NCT03302910|Diuretics|diuretics|mesh-list
92353756|NCT03302910|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92353757|NCT03302910|Natriuretic Agents|natriuretic agents|mesh-ancestor
92353758|NCT03302910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353759|NCT03302910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353760|NCT03302910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353761|NCT03302910|Vasodilator Agents|vasodilator agents|mesh-ancestor
92353762|NCT03302910|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92353763|NCT03292926|Dexamethasone|dexamethasone|mesh-list
92353764|NCT03292926|Dexamethasone acetate|dexamethasone acetate|mesh-list
92353765|NCT03292926|Bupivacaine|bupivacaine|mesh-list
92353766|NCT03292926|BB 1101|bb 1101|mesh-list
92353767|NCT03292926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353768|NCT03292926|Antiemetics|antiemetics|mesh-ancestor
92353769|NCT03292926|Autonomic Agents|autonomic agents|mesh-ancestor
92353770|NCT03292926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353771|NCT03292926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353772|NCT03292926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92353773|NCT03292926|Glucocorticoids|glucocorticoids|mesh-ancestor
92353775|NCT03292926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353776|NCT03292926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92353777|NCT03292926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353778|NCT03292926|Protease Inhibitors|protease inhibitors|mesh-ancestor
92353779|NCT03292926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353780|NCT03292926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353781|NCT03292926|Anesthetics, Local|anesthetics, local|mesh-ancestor
92353782|NCT03292926|Anesthetics|anesthetics|mesh-ancestor
92353783|NCT03292926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353784|NCT03292926|Sensory System Agents|sensory system agents|mesh-ancestor
92353785|NCT04400136|Lansoprazole|lansoprazole|mesh-list
92353786|NCT04400136|Dexlansoprazole|dexlansoprazole|mesh-list
92353787|NCT04400136|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92353788|NCT04400136|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92353789|NCT04400136|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92353790|NCT04400136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353791|NCT04400136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353792|NCT04962126|Atezolizumab|atezolizumab|mesh-list
92353793|NCT04962126|Obinutuzumab|obinutuzumab|mesh-list
92353794|NCT04962126|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92353795|NCT04962126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92353796|NCT04962126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353797|NCT04962126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92353798|NCT04962126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353799|NCT05338086|Vitamin D|vitamin d|mesh-list
92353800|NCT05338086|Denosumab|denosumab|mesh-list
92353801|NCT05338086|Calcium|calcium|mesh-list
92353802|NCT05338086|Vitamins|vitamins|mesh-ancestor
92353803|NCT05338086|Micronutrients|micronutrients|mesh-ancestor
92353804|NCT05338086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353805|NCT05338086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92353806|NCT05338086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92353807|NCT04857840|Firibastat|firibastat|mesh-list
92353808|NCT04857840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92353809|NCT04582968|Capecitabine|capecitabine|mesh-list
92353810|NCT04582968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92353811|NCT04582968|Antimetabolites|antimetabolites|mesh-ancestor
92353812|NCT04582968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353813|NCT04582968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353814|NCT03261570|Digoxin|digoxin|mesh-list
92353815|NCT03261570|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92353816|NCT03261570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92353817|NCT03261570|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92353818|NCT03261570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353819|NCT03261570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353820|NCT03261570|Protective Agents|protective agents|mesh-ancestor
92353821|NCT03261570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353822|NCT03261570|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92353823|NCT03261570|Cholinergic Agents|cholinergic agents|mesh-ancestor
92353824|NCT03261570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353825|NCT03227562|Risperidone|risperidone|mesh-list
92353826|NCT03227562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92353827|NCT03227562|Serotonin Agents|serotonin agents|mesh-ancestor
92353828|NCT03227562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353829|NCT03227562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353830|NCT03227562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353831|NCT03227562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92353832|NCT03227562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92353833|NCT03227562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353834|NCT03227562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92353835|NCT03227562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92353836|NCT03227562|Dopamine Agents|dopamine agents|mesh-ancestor
92353837|NCT04278378|Folic Acid|folic acid|mesh-list
92353838|NCT04278378|Riboflavin|riboflavin|mesh-list
92353839|NCT04278378|Hematinics|hematinics|mesh-ancestor
92353840|NCT04278378|Vitamin B Complex|vitamin b complex|mesh-ancestor
92353841|NCT04278378|Vitamins|vitamins|mesh-ancestor
92353842|NCT04278378|Micronutrients|micronutrients|mesh-ancestor
92353843|NCT04278378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353844|NCT04278378|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92353845|NCT04278378|Dermatologic Agents|dermatologic agents|mesh-ancestor
92353846|NCT04551144|Methyltestosterone|methyltestosterone|mesh-list
92353847|NCT04551144|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92353848|NCT04551144|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92353849|NCT04551144|Estradiol|estradiol|mesh-list
92353850|NCT04551144|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92353851|NCT04551144|Testosterone|testosterone|mesh-list
92353852|NCT04551144|Testosterone undecanoate|testosterone undecanoate|mesh-list
92353853|NCT04551144|Testosterone enanthate|testosterone enanthate|mesh-list
92353854|NCT04551144|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92353855|NCT04551144|Estrogens|estrogens|mesh-ancestor
92353856|NCT04551144|Hormones|hormones|mesh-ancestor
92353857|NCT04551144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353858|NCT04551144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353859|NCT04551144|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92353860|NCT04551144|Contraceptive Agents|contraceptive agents|mesh-ancestor
92353861|NCT04551144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92353862|NCT04551144|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92353863|NCT04551144|Androgens|androgens|mesh-ancestor
92353864|NCT04551144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92353865|NCT04551144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353866|NCT04551144|Anabolic Agents|anabolic agents|mesh-ancestor
92353867|NCT04785924|Imipenem|imipenem|mesh-list
92353868|NCT04785924|Relebactam|relebactam|mesh-list
92353869|NCT04785924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92353870|NCT04785924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353871|NCT04785924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92353872|NCT04785924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353873|NCT04785924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353874|NCT04451772|Upadacitinib|upadacitinib|mesh-list
92353875|NCT04451772|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92353876|NCT04451772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92353878|NCT04451772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353879|NCT04451772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353880|NCT03831984|Bromfenac|bromfenac|mesh-list
92353881|NCT03831984|Hyaluronic Acid|hyaluronic acid|mesh-list
92353883|NCT03831984|Immunologic Factors|immunologic factors|mesh-ancestor
92353884|NCT03831984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353885|NCT03831984|Viscosupplements|viscosupplements|mesh-ancestor
92353886|NCT03831984|Protective Agents|protective agents|mesh-ancestor
92353887|NCT03831984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92353888|NCT03831984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92353889|NCT03831984|Analgesics|analgesics|mesh-ancestor
92353890|NCT03831984|Sensory System Agents|sensory system agents|mesh-ancestor
92353891|NCT03831984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353892|NCT03831984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353893|NCT03831984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92353894|NCT02084706|Triamcinolone|triamcinolone|mesh-list
92353895|NCT02084706|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92353896|NCT02084706|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92353897|NCT02084706|Lidocaine|lidocaine|mesh-list
92353898|NCT02084706|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92353899|NCT02084706|Anesthetics, Local|anesthetics, local|mesh-ancestor
92353900|NCT02084706|Anesthetics|anesthetics|mesh-ancestor
92353901|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353902|NCT02084706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353903|NCT02084706|Sensory System Agents|sensory system agents|mesh-ancestor
92353904|NCT02084706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353905|NCT02084706|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92353906|NCT02084706|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92353907|NCT02084706|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92353908|NCT02084706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353909|NCT02084706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353910|NCT02084706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92353911|NCT02084706|Glucocorticoids|glucocorticoids|mesh-ancestor
92353913|NCT02084706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92353914|NCT02084706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353915|NCT02084706|Immunologic Factors|immunologic factors|mesh-ancestor
92353916|NCT02084706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353918|NCT04704024|Lamivudine|lamivudine|mesh-list
92353919|NCT04704024|Antiviral Agents|antiviral agents|mesh-ancestor
92353920|NCT04704024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353921|NCT04704024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92353922|NCT04704024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92353923|NCT04704024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353924|NCT04704024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353925|NCT04704024|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92353926|NCT04704024|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92353927|NCT04433988|Pentoxifylline|pentoxifylline|mesh-list
92353928|NCT04433988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92353929|NCT04433988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353930|NCT04433988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353931|NCT04433988|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92353932|NCT04433988|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92353933|NCT04433988|Protective Agents|protective agents|mesh-ancestor
92353934|NCT04433988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353935|NCT04433988|Vasodilator Agents|vasodilator agents|mesh-ancestor
92353936|NCT04433988|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92353937|NCT04433988|Antioxidants|antioxidants|mesh-ancestor
92353938|NCT04685538|Tetracaine|tetracaine|mesh-list
92353939|NCT04685538|Chloroprocaine|chloroprocaine|mesh-list
92353940|NCT04685538|Anesthetics, Local|anesthetics, local|mesh-ancestor
92353941|NCT04685538|Anesthetics|anesthetics|mesh-ancestor
92353942|NCT04685538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353943|NCT04685538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353944|NCT04685538|Sensory System Agents|sensory system agents|mesh-ancestor
92353945|NCT04685538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353947|NCT05121246|Antiviral Agents|antiviral agents|mesh-ancestor
92353948|NCT05121246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92353950|NCT04344678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353951|NCT04344678|Vasodilator Agents|vasodilator agents|mesh-ancestor
92353952|NCT04344678|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92353953|NCT04344678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92353954|NCT04344678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92353955|NCT04344678|Urological Agents|urological agents|mesh-ancestor
92353956|NCT03249558|Morphine|morphine|mesh-list
92353957|NCT03249558|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92353958|NCT03249558|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92353959|NCT03249558|Narcotics|narcotics|mesh-ancestor
92353960|NCT03249558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92353961|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353963|NCT03249558|Sensory System Agents|sensory system agents|mesh-ancestor
92353964|NCT03249558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92353965|NCT03249558|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92353966|NCT03249558|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92353967|NCT03249558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92353968|NCT03249558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353969|NCT03249558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92353970|NCT03249558|Antidepressive Agents|antidepressive agents|mesh-ancestor
92353971|NCT03249558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92006491|NCT05492123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353972|NCT03249558|Dopamine Agents|dopamine agents|mesh-ancestor
92353973|NCT03246828|Gliclazide|gliclazide|mesh-list
92353974|NCT03246828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92353975|NCT03246828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353976|NCT04316442|Immunoconjugates|immunoconjugates|mesh-list
92353977|NCT04316442|Immunologic Factors|immunologic factors|mesh-ancestor
92353978|NCT04316442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353979|NCT03204786|Vasopressins|vasopressins|mesh-list
92353980|NCT03204786|Arginine Vasopressin|arginine vasopressin|mesh-list
92353981|NCT03204786|Hemostatics|hemostatics|mesh-ancestor
92353982|NCT03204786|Coagulants|coagulants|mesh-ancestor
92353983|NCT03204786|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92353984|NCT03204786|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92353985|NCT03204786|Natriuretic Agents|natriuretic agents|mesh-ancestor
92353986|NCT03204786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353987|NCT03204396|Dulaglutide|dulaglutide|mesh-list
92353988|NCT03204396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92353989|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92353990|NCT02008656|Leucovorin|leucovorin|mesh-list
92353991|NCT02008656|Fluorouracil|fluorouracil|mesh-list
92353992|NCT02008656|Capecitabine|capecitabine|mesh-list
92353993|NCT02008656|Oxaliplatin|oxaliplatin|mesh-list
92353994|NCT02008656|Antimetabolites|antimetabolites|mesh-ancestor
92353995|NCT02008656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92353996|NCT02008656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92353997|NCT02008656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92353998|NCT02008656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92353999|NCT02008656|Immunologic Factors|immunologic factors|mesh-ancestor
92354000|NCT02008656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354001|NCT02008656|Antidotes|antidotes|mesh-ancestor
92354002|NCT02008656|Protective Agents|protective agents|mesh-ancestor
92354003|NCT02008656|Vitamin B Complex|vitamin b complex|mesh-ancestor
92354005|NCT02008656|Micronutrients|micronutrients|mesh-ancestor
92354006|NCT04300140|Nivolumab|nivolumab|mesh-list
92354007|NCT04300140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354008|NCT04300140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354009|NCT04300140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92354010|NCT04300140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354011|NCT03174132|Lidocaine|lidocaine|mesh-list
92354012|NCT03174132|Hyaluronic Acid|hyaluronic acid|mesh-list
92354013|NCT03174132|Anesthetics, Local|anesthetics, local|mesh-ancestor
92354015|NCT03174132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354016|NCT03174132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354017|NCT03174132|Sensory System Agents|sensory system agents|mesh-ancestor
92354018|NCT03174132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354019|NCT03174132|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92354020|NCT03174132|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92354021|NCT03174132|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92354022|NCT03174132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92354023|NCT03174132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354025|NCT03174132|Immunologic Factors|immunologic factors|mesh-ancestor
92354026|NCT03174132|Viscosupplements|viscosupplements|mesh-ancestor
92354027|NCT03174132|Protective Agents|protective agents|mesh-ancestor
92354028|NCT03173976|Zoledronic Acid|zoledronic acid|mesh-list
92354029|NCT03173976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92354030|NCT03173976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354031|NCT01812252|Azacitidine|azacitidine|mesh-list
92354033|NCT01812252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92354034|NCT01812252|Antimetabolites|antimetabolites|mesh-ancestor
92354035|NCT01812252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354036|NCT01812252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354037|NCT01812252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354039|NCT03818802|Niacin|niacin|mesh-list
92354040|NCT03818802|Nicotinic Acids|nicotinic acids|mesh-list
92354041|NCT03818802|Vitamin B Complex|vitamin b complex|mesh-ancestor
92354042|NCT03818802|Vitamins|vitamins|mesh-ancestor
92354043|NCT03818802|Micronutrients|micronutrients|mesh-ancestor
92354044|NCT03818802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354045|NCT03818802|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92354046|NCT03818802|Antimetabolites|antimetabolites|mesh-ancestor
92354047|NCT03818802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354048|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92354049|NCT03818802|Vasodilator Agents|vasodilator agents|mesh-ancestor
92354050|NCT04398108|Margetuximab|margetuximab|mesh-list
92354051|NCT04398108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354052|NCT01625286|Paclitaxel|paclitaxel|mesh-list
92354053|NCT01625286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92354054|NCT01625286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92354055|NCT01625286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354056|NCT01625286|Tubulin Modulators|tubulin modulators|mesh-ancestor
92354057|NCT01625286|Antimitotic Agents|antimitotic agents|mesh-ancestor
92354058|NCT01625286|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354059|NCT01625286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354060|NCT01583322|Nintedanib|nintedanib|mesh-list
92354061|NCT01583322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354062|NCT01583322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92354063|NCT01583322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354064|NCT01583322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354065|NCT04204122|Moxifloxacin|moxifloxacin|mesh-list
92354066|NCT04204122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354067|NCT04204122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354068|NCT04204122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92354069|NCT04204122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92354070|NCT04204122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354071|NCT04204122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354072|NCT04204122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354073|NCT05158062|Paclitaxel|paclitaxel|mesh-list
92354074|NCT05158062|Docetaxel|docetaxel|mesh-list
92354075|NCT05158062|Bevacizumab|bevacizumab|mesh-list
92354076|NCT05158062|Carboplatin|carboplatin|mesh-list
92354077|NCT05158062|Pembrolizumab|pembrolizumab|mesh-list
92354078|NCT05158062|Olaparib|olaparib|mesh-list
92354079|NCT05158062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92354080|NCT05158062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354081|NCT05158062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92354082|NCT05158062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92354083|NCT05158062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354084|NCT05158062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354085|NCT05158062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354086|NCT05158062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92354087|NCT05158062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92354088|NCT05158062|Growth Substances|growth substances|mesh-ancestor
92354089|NCT05158062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354091|NCT05158062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92354092|NCT05158062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92354094|NCT01076868|Primaquine|primaquine|mesh-list
92354095|NCT01076868|Antimalarials|antimalarials|mesh-ancestor
92354096|NCT01076868|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92354097|NCT01076868|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92354098|NCT01076868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354099|NCT03193866|Interferons|interferons|mesh-list
92354100|NCT03193866|Interferon-beta|interferon-beta|mesh-list
92354102|NCT03193866|Alemtuzumab|alemtuzumab|mesh-list
92354103|NCT03193866|Glatiramer Acetate|glatiramer acetate|mesh-list
92354104|NCT03193866|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92354105|NCT03193866|Natalizumab|natalizumab|mesh-list
92354106|NCT03193866|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92354107|NCT03193866|(T,G)-A-L|(t,g)-a-l|mesh-list
92354108|NCT03193866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354109|NCT03193866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354110|NCT03193866|Immunologic Factors|immunologic factors|mesh-ancestor
92354111|NCT03193866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354112|NCT03193866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354113|NCT03193866|Antiviral Agents|antiviral agents|mesh-ancestor
92354114|NCT03193866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354115|NCT03193866|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92354116|NCT03193866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354117|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92354118|NCT03193866|Dermatologic Agents|dermatologic agents|mesh-ancestor
92354119|NCT03193866|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92354121|NCT04195776|Antiviral Agents|antiviral agents|mesh-ancestor
92354122|NCT04195776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354123|NCT04195776|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92354124|NCT04195776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92354125|NCT04195776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354126|NCT04195776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006639|NCT04206059|Analgesics|analgesics|mesh-ancestor
92354127|NCT04195776|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92354128|NCT04195776|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92354129|NCT03708588|Ticagrelor|ticagrelor|mesh-list
92354130|NCT03708588|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92354131|NCT03708588|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92354132|NCT03708588|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92354133|NCT03708588|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92354134|NCT03708588|Purinergic Agents|purinergic agents|mesh-ancestor
92354135|NCT03708588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354136|NCT03708588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354137|NCT03708588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354139|NCT04130802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354141|NCT04130802|Autonomic Agents|autonomic agents|mesh-ancestor
92354142|NCT04130802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354143|NCT04130802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354144|NCT04130802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354145|NCT04130802|Glucocorticoids|glucocorticoids|mesh-ancestor
92354146|NCT04130802|Hormones|hormones|mesh-ancestor
92354147|NCT04130802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354148|NCT04130802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354149|NCT04130802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354150|NCT03087162|Dexlansoprazole|dexlansoprazole|mesh-list
92354151|NCT03087162|Lansoprazole|lansoprazole|mesh-list
92354152|NCT03087162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92354153|NCT03087162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354155|NCT03087162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354156|NCT03087162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354157|NCT03165942|Ethanol|ethanol|mesh-list
92354158|NCT03165942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92354159|NCT03165942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354160|NCT03165942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354161|NCT03165942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354162|NCT03163992|Pembrolizumab|pembrolizumab|mesh-list
92354163|NCT03163992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354164|NCT03163992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354165|NCT03163992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92354166|NCT03163992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354167|NCT04397328|Hydroxychloroquine|hydroxychloroquine|mesh-list
92354168|NCT04397328|Antimalarials|antimalarials|mesh-ancestor
92354169|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92354170|NCT04397328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92354171|NCT04397328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354172|NCT04397328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354173|NCT04397328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354174|NCT04397328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354175|NCT03162432|Vitamin D|vitamin d|mesh-list
92354176|NCT03162432|Cholecalciferol|cholecalciferol|mesh-list
92354177|NCT03162432|Vitamins|vitamins|mesh-ancestor
92354178|NCT03162432|Micronutrients|micronutrients|mesh-ancestor
92354179|NCT03162432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354180|NCT03162432|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92354181|NCT03162432|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92354182|NCT03392376|Haloperidol|haloperidol|mesh-list
92354183|NCT03392376|Haloperidol decanoate|haloperidol decanoate|mesh-list
92354184|NCT03392376|Antiemetics|antiemetics|mesh-ancestor
92354185|NCT03392376|Autonomic Agents|autonomic agents|mesh-ancestor
92354186|NCT03392376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354187|NCT03392376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354188|NCT03392376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354189|NCT03392376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92354190|NCT03392376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92354191|NCT03392376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354193|NCT03392376|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92354194|NCT03392376|Dopamine Agents|dopamine agents|mesh-ancestor
92354195|NCT03392376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354196|NCT03392376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354197|NCT03392376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92354198|NCT05243628|Insulin|insulin|mesh-list
92354199|NCT05243628|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92354200|NCT05243628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92354201|NCT05243628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354202|NCT05249478|Fentanyl|fentanyl|mesh-list
92354204|NCT05249478|Anesthetics, Local|anesthetics, local|mesh-ancestor
92354205|NCT05249478|Anesthetics|anesthetics|mesh-ancestor
92354206|NCT05249478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354207|NCT05249478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354208|NCT05249478|Sensory System Agents|sensory system agents|mesh-ancestor
92354209|NCT05249478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354212|NCT05249478|Analgesics|analgesics|mesh-ancestor
92354213|NCT05249478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92354214|NCT05249478|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92354215|NCT05249478|Anesthetics, General|anesthetics, general|mesh-ancestor
92354216|NCT05244252|Bupivacaine|bupivacaine|mesh-list
92354217|NCT05244252|Anesthetics, Local|anesthetics, local|mesh-ancestor
92354218|NCT05244252|Anesthetics|anesthetics|mesh-ancestor
92354219|NCT05244252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354220|NCT05244252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354221|NCT05244252|Sensory System Agents|sensory system agents|mesh-ancestor
92354222|NCT05244252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354223|NCT03286842|Olaparib|olaparib|mesh-list
92354224|NCT03286842|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92354225|NCT03286842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354226|NCT03286842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354227|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354229|NCT05240274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92354230|NCT05240274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354232|NCT05244018|Ergocalciferols|ergocalciferols|mesh-list
92354233|NCT05244018|Cholecalciferol|cholecalciferol|mesh-list
92354235|NCT05244018|Micronutrients|micronutrients|mesh-ancestor
92354236|NCT05244018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354237|NCT05244018|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92354238|NCT05244018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92354239|NCT02398500|Ranibizumab|ranibizumab|mesh-list
92354240|NCT02398500|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92354241|NCT02398500|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92354242|NCT02398500|Growth Substances|growth substances|mesh-ancestor
92354243|NCT02398500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354244|NCT02398500|Growth Inhibitors|growth inhibitors|mesh-ancestor
92354245|NCT02398500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354247|NCT02984514|Antimetabolites|antimetabolites|mesh-ancestor
92354248|NCT02984514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354249|NCT02984514|Antiviral Agents|antiviral agents|mesh-ancestor
92354250|NCT02984514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354251|NCT04276428|Insulin|insulin|mesh-list
92354252|NCT04276428|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92354253|NCT04276428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354254|NCT05248932|Norepinephrine|norepinephrine|mesh-list
92354255|NCT05248932|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92354256|NCT05248932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92354257|NCT05248932|Adrenergic Agents|adrenergic agents|mesh-ancestor
92354258|NCT05248932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354259|NCT05248932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354260|NCT05248932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354261|NCT05248932|Sympathomimetics|sympathomimetics|mesh-ancestor
92354262|NCT05248932|Autonomic Agents|autonomic agents|mesh-ancestor
92354263|NCT05248932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354264|NCT05248932|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92354265|NCT02392026|Metronidazole|metronidazole|mesh-list
92354266|NCT02392026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354267|NCT02392026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354268|NCT02392026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92354269|NCT02392026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92354270|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92354271|NCT02395614|Gentamicins|gentamicins|mesh-list
92354272|NCT02395614|Cefazolin|cefazolin|mesh-list
92354273|NCT02395614|Bacitracin|bacitracin|mesh-list
92354274|NCT02395614|Chlorhexidine|chlorhexidine|mesh-list
92354275|NCT02395614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354276|NCT02395614|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92354278|NCT02395614|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92354279|NCT02395614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354280|NCT02395614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354281|NCT04396938|Lamotrigine|lamotrigine|mesh-list
92354282|NCT04396938|Anticonvulsants|anticonvulsants|mesh-ancestor
92354283|NCT04396938|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92354284|NCT04396938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92354285|NCT04396938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354286|NCT04396938|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92354287|NCT04396938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354288|NCT04396938|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92354289|NCT04396938|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92354290|NCT04396938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354291|NCT04396938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92354292|NCT04396938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92354293|NCT00639678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92354294|NCT00639678|Immunologic Factors|immunologic factors|mesh-ancestor
92354295|NCT00639678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354297|NCT02914158|Leuprolide|leuprolide|mesh-list
92354298|NCT02914158|Goserelin|goserelin|mesh-list
92354299|NCT02914158|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92354300|NCT02914158|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92354301|NCT02914158|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354302|NCT02914158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354303|NCT02914158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354304|NCT02914158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354305|NCT02914158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354306|NCT02914158|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92354307|NCT02914158|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92354308|NCT02914158|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92354309|NCT02914158|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92354310|NCT02914158|Fertility Agents|fertility agents|mesh-ancestor
92354311|NCT02914158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92354312|NCT02914158|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92354314|NCT02914158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354315|NCT03136146|Dexamethasone|dexamethasone|mesh-list
92354316|NCT03136146|Dexamethasone acetate|dexamethasone acetate|mesh-list
92354317|NCT03136146|Cyclophosphamide|cyclophosphamide|mesh-list
92354318|NCT03136146|Rituximab|rituximab|mesh-list
92354319|NCT03136146|Etoposide|etoposide|mesh-list
92354320|NCT03136146|Vincristine|vincristine|mesh-list
92354321|NCT03136146|Etoposide phosphate|etoposide phosphate|mesh-list
92354322|NCT03136146|Bortezomib|bortezomib|mesh-list
92354323|NCT03136146|Clofarabine|clofarabine|mesh-list
92354325|NCT03136146|Podophyllotoxin|podophyllotoxin|mesh-list
92354326|NCT03136146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92354327|NCT03136146|Antibodies|antibodies|mesh-list
92354328|NCT03136146|Immunoglobulins|immunoglobulins|mesh-list
92354329|NCT03136146|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92354331|NCT03136146|BB 1101|bb 1101|mesh-list
92354332|NCT03136146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92354333|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
92354334|NCT03136146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354335|NCT03136146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354336|NCT03136146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92354337|NCT03136146|Alkylating Agents|alkylating agents|mesh-ancestor
92354338|NCT03136146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354339|NCT03136146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354340|NCT03136146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92354341|NCT03136146|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354342|NCT03136146|Antiemetics|antiemetics|mesh-ancestor
92354343|NCT03136146|Autonomic Agents|autonomic agents|mesh-ancestor
92354344|NCT03136146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354345|NCT03136146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354346|NCT03136146|Glucocorticoids|glucocorticoids|mesh-ancestor
92354347|NCT03136146|Hormones|hormones|mesh-ancestor
92354348|NCT03136146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354349|NCT03136146|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354350|NCT03136146|Protease Inhibitors|protease inhibitors|mesh-ancestor
92354351|NCT03136146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354352|NCT03136146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92354353|NCT03136146|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92354354|NCT03136146|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92354355|NCT03136146|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92354356|NCT03136146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92354357|NCT03136146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92354358|NCT03136146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354359|NCT03136146|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92354360|NCT03136146|Antimetabolites|antimetabolites|mesh-ancestor
92354361|NCT03136146|Keratolytic Agents|keratolytic agents|mesh-ancestor
92354362|NCT03136146|Dermatologic Agents|dermatologic agents|mesh-ancestor
92354364|NCT05241132|Cisplatin|cisplatin|mesh-list
92354365|NCT05241132|Tislelizumab|tislelizumab|mesh-list
92354366|NCT05241132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92354367|NCT05241132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354368|NCT05241132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92354369|NCT05241132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92354370|NCT05241132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354371|NCT05241132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354372|NCT05241132|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354373|NCT05241054|Acetaminophen|acetaminophen|mesh-list
92354374|NCT05241054|Nitroglycerin|nitroglycerin|mesh-list
92354375|NCT05241054|Fentanyl|fentanyl|mesh-list
92354376|NCT05241054|Bupivacaine|bupivacaine|mesh-list
92354377|NCT05241054|Propofol|propofol|mesh-list
92354378|NCT05241054|Sevoflurane|sevoflurane|mesh-list
92354379|NCT05241054|Atracurium|atracurium|mesh-list
92354380|NCT05241054|Anesthetics, Local|anesthetics, local|mesh-ancestor
92354381|NCT05241054|Anesthetics|anesthetics|mesh-ancestor
92354382|NCT05241054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354383|NCT05241054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354384|NCT05241054|Sensory System Agents|sensory system agents|mesh-ancestor
92354385|NCT05241054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354386|NCT05241054|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92354387|NCT05241054|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92354388|NCT05241054|Anesthetics, General|anesthetics, general|mesh-ancestor
92354389|NCT05241054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92354390|NCT05241054|Narcotics|narcotics|mesh-ancestor
92354391|NCT05241054|Analgesics|analgesics|mesh-ancestor
92354392|NCT05241054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92354393|NCT05241054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92354394|NCT05241054|Antipyretics|antipyretics|mesh-ancestor
92354395|NCT05241054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92354396|NCT05241054|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92354397|NCT05241054|Vasodilator Agents|vasodilator agents|mesh-ancestor
92354398|NCT05241054|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92354399|NCT05241054|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92354400|NCT05241054|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92354401|NCT05241054|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92354402|NCT05241054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92354403|NCT05241054|Cholinergic Agents|cholinergic agents|mesh-ancestor
92354404|NCT05241054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354405|NCT05241054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354406|NCT00638508|Ketorolac|ketorolac|mesh-list
92354407|NCT00638508|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92354408|NCT00638508|Ropivacaine|ropivacaine|mesh-list
92354409|NCT00638508|Anesthetics, Local|anesthetics, local|mesh-ancestor
92354410|NCT00638508|Anesthetics|anesthetics|mesh-ancestor
92354411|NCT00638508|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354412|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354413|NCT00638508|Sensory System Agents|sensory system agents|mesh-ancestor
92354414|NCT00638508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354415|NCT00638508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92354416|NCT00638508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92354417|NCT00638508|Analgesics|analgesics|mesh-ancestor
92354418|NCT00638508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354419|NCT00638508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354420|NCT00638508|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92354421|NCT00638508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354422|NCT00638508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354423|NCT00637806|Megestrol|megestrol|mesh-list
92354424|NCT00637806|Megestrol Acetate|megestrol acetate|mesh-list
92354425|NCT00637806|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92354426|NCT00637806|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92354427|NCT00637806|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92354428|NCT00637806|Contraceptive Agents|contraceptive agents|mesh-ancestor
92354429|NCT00637806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92354430|NCT00637806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354431|NCT00637806|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92354432|NCT00637806|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92354433|NCT00637806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354434|NCT00637806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354435|NCT00637806|Appetite Stimulants|appetite stimulants|mesh-ancestor
92354436|NCT00637806|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92354438|NCT00637728|Megestrol Acetate|megestrol acetate|mesh-list
92354439|NCT00637728|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92354440|NCT00637728|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92354441|NCT00637728|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92354442|NCT00637728|Contraceptive Agents|contraceptive agents|mesh-ancestor
92354443|NCT00637728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92354444|NCT00637728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354445|NCT00637728|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92354446|NCT00637728|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92354447|NCT00637728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354448|NCT00637728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354449|NCT00637728|Appetite Stimulants|appetite stimulants|mesh-ancestor
92354450|NCT00637728|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92354452|NCT01922466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92354453|NCT01922466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92354454|NCT01922466|Analgesics|analgesics|mesh-ancestor
92354455|NCT01922466|Sensory System Agents|sensory system agents|mesh-ancestor
92354456|NCT01922466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354457|NCT01922466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354458|NCT01922466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354459|NCT01922466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354460|NCT00637572|Megestrol|megestrol|mesh-list
92354461|NCT00637572|Megestrol Acetate|megestrol acetate|mesh-list
92354462|NCT00637572|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92354463|NCT00637572|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92354464|NCT00637572|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92354465|NCT00637572|Contraceptive Agents|contraceptive agents|mesh-ancestor
92354466|NCT00637572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91937301|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
92354467|NCT00637572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354468|NCT00637572|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92354469|NCT00637572|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92354470|NCT00637572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354471|NCT00637572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354472|NCT00637572|Appetite Stimulants|appetite stimulants|mesh-ancestor
92354473|NCT00637572|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92354474|NCT00637416|Lansoprazole|lansoprazole|mesh-list
92354475|NCT00637416|Dexlansoprazole|dexlansoprazole|mesh-list
92354476|NCT00637416|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92354477|NCT00637416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354478|NCT00637416|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92354479|NCT00637416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115366|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354480|NCT00637416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354481|NCT00636792|Rituximab|rituximab|mesh-list
92354482|NCT00636792|Bortezomib|bortezomib|mesh-list
92354483|NCT00636792|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92354484|NCT00636792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354485|NCT00636792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354486|NCT00636792|Immunologic Factors|immunologic factors|mesh-ancestor
92354487|NCT00636792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354488|NCT00636792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354489|NCT00636792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92354490|NCT00636792|Alkylating Agents|alkylating agents|mesh-ancestor
92354491|NCT00636792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354492|NCT03153462|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92354493|NCT03153462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354494|NCT03153462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354495|NCT00636636|Gabapentin|gabapentin|mesh-list
92354496|NCT00636636|Analgesics|analgesics|mesh-ancestor
92354497|NCT00636636|Sensory System Agents|sensory system agents|mesh-ancestor
92354498|NCT00636636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354499|NCT00636636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354501|NCT00636636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92354502|NCT00636636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92354503|NCT00636636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354504|NCT00636636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92354505|NCT00636636|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92354506|NCT00636636|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92354507|NCT00636636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354508|NCT00636636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354509|NCT00636636|Antimanic Agents|antimanic agents|mesh-ancestor
92354511|NCT05244954|Piperaquine|piperaquine|mesh-list
92354512|NCT05244954|Artenimol|artenimol|mesh-list
92354513|NCT05244954|Amebicides|amebicides|mesh-ancestor
92354514|NCT05244954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92354515|NCT05244954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92354516|NCT05244954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354517|NCT05244954|Antimalarials|antimalarials|mesh-ancestor
92354518|NCT05244954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354519|NCT01929252|Dexmedetomidine|dexmedetomidine|mesh-list
92354520|NCT01929252|Levobupivacaine|levobupivacaine|mesh-list
92354521|NCT01929252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92354522|NCT01929252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354523|NCT01929252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354524|NCT01929252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92354525|NCT01929252|Analgesics|analgesics|mesh-ancestor
92354526|NCT01929252|Sensory System Agents|sensory system agents|mesh-ancestor
92354527|NCT01929252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354528|NCT01929252|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92354529|NCT01929252|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92354530|NCT01929252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92354531|NCT01929252|Adrenergic Agents|adrenergic agents|mesh-ancestor
92354532|NCT01929252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354533|NCT01929252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354534|NCT01929252|Anesthetics, Local|anesthetics, local|mesh-ancestor
92354535|NCT01929252|Anesthetics|anesthetics|mesh-ancestor
92354536|NCT04275960|Selitrectinib|selitrectinib|mesh-list
92354537|NCT04275960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354538|NCT04275960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354539|NCT00634920|Cyclosporine|cyclosporine|mesh-list
92354540|NCT00634920|Mycophenolic Acid|mycophenolic acid|mesh-list
92354541|NCT00634920|Prednisolone|prednisolone|mesh-list
92354542|NCT00634920|Everolimus|everolimus|mesh-list
92354543|NCT00634920|Cyclosporins|cyclosporins|mesh-list
92354544|NCT00634920|Basiliximab|basiliximab|mesh-list
92354545|NCT00634920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354546|NCT00634920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354547|NCT00634920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92354548|NCT00634920|Immunologic Factors|immunologic factors|mesh-ancestor
92354549|NCT00634920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354550|NCT00634920|Antifungal Agents|antifungal agents|mesh-ancestor
92354551|NCT00634920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354552|NCT00634920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92354553|NCT00634920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354554|NCT00634920|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92354555|NCT00634920|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92354556|NCT00634920|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92354557|NCT00634920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354558|NCT00634920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92354559|NCT00634920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92354560|NCT00634920|Antitubercular Agents|antitubercular agents|mesh-ancestor
92354561|NCT00634920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354562|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354563|NCT00634920|Glucocorticoids|glucocorticoids|mesh-ancestor
92354564|NCT00634920|Hormones|hormones|mesh-ancestor
92354565|NCT00634920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354566|NCT00634920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354567|NCT01923012|Vitamin K|vitamin k|mesh-list
92354568|NCT01923012|Vitamin K 2|vitamin k 2|mesh-list
92354569|NCT01923012|Vitamins|vitamins|mesh-ancestor
92354570|NCT01923012|Micronutrients|micronutrients|mesh-ancestor
92354571|NCT01923012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354573|NCT01923012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92354574|NCT01923012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354575|NCT01923012|Hemostatics|hemostatics|mesh-ancestor
92354576|NCT01923012|Coagulants|coagulants|mesh-ancestor
92354577|NCT01923090|Finasteride|finasteride|mesh-list
92354578|NCT01923090|Dutasteride|dutasteride|mesh-list
92354579|NCT01923090|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92354580|NCT01923090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92354581|NCT01923090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354582|NCT01923090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354583|NCT01923090|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354584|NCT01923090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354585|NCT01923090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354586|NCT01923090|Urological Agents|urological agents|mesh-ancestor
92354587|NCT01929330|Dutasteride|dutasteride|mesh-list
92354588|NCT01929330|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92354589|NCT01929330|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92354590|NCT01929330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354591|NCT01929330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354592|NCT01929330|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354593|NCT01929330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354594|NCT01929330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354596|NCT00634842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92354597|NCT00634842|Insulin Detemir|insulin detemir|mesh-list
92354598|NCT00634842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92354599|NCT00634842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354600|NCT04396548|Midodrine|midodrine|mesh-list
92354601|NCT04396548|Anesthetics|anesthetics|mesh-list
92354602|NCT04396548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354603|NCT04396548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354604|NCT04396548|Sympathomimetics|sympathomimetics|mesh-ancestor
92354605|NCT04396548|Autonomic Agents|autonomic agents|mesh-ancestor
92354606|NCT04396548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354607|NCT04396548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92354608|NCT04396548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92354609|NCT04396548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92354610|NCT04396548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92354611|NCT04396548|Adrenergic Agents|adrenergic agents|mesh-ancestor
92354612|NCT04396548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354613|NCT04396548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354614|NCT01929798|Pancrelipase|pancrelipase|mesh-list
92354615|NCT01929798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354616|NCT00633984|Cycloserine|cycloserine|mesh-list
92354617|NCT00633984|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92354618|NCT00633984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354619|NCT00633984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92354620|NCT00633984|Antitubercular Agents|antitubercular agents|mesh-ancestor
92354621|NCT00633984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354622|NCT00633984|Antimetabolites|antimetabolites|mesh-ancestor
92354623|NCT00633984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354624|NCT04395612|Niraparib|niraparib|mesh-list
92354625|NCT04395612|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92354626|NCT04395612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354627|NCT04395612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354628|NCT04395612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354629|NCT01923558|Donepezil|donepezil|mesh-list
92354630|NCT01923558|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92354631|NCT01923558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354632|NCT01923558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354633|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
92354634|NCT01923558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354635|NCT01923558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354636|NCT01923558|Nootropic Agents|nootropic agents|mesh-ancestor
92354637|NCT01921218|Cyclosporine|cyclosporine|mesh-list
92354638|NCT01921218|Mycophenolic Acid|mycophenolic acid|mesh-list
92354639|NCT01921218|Prednisone|prednisone|mesh-list
92354640|NCT01921218|Abatacept|abatacept|mesh-list
92354641|NCT01921218|Tacrolimus|tacrolimus|mesh-list
92354642|NCT01921218|Cyclosporins|cyclosporins|mesh-list
92354643|NCT01921218|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92354644|NCT01921218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354645|NCT01921218|Glucocorticoids|glucocorticoids|mesh-ancestor
92354646|NCT01921218|Hormones|hormones|mesh-ancestor
92354647|NCT01921218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354648|NCT01921218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354649|NCT01921218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92354650|NCT01921218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354651|NCT01921218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92354652|NCT01921218|Immunologic Factors|immunologic factors|mesh-ancestor
92354653|NCT01921218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354654|NCT01921218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354655|NCT01921218|Antifungal Agents|antifungal agents|mesh-ancestor
92354656|NCT01921218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007173|NCT04262869|Paclitaxel|paclitaxel|mesh-list
92354658|NCT01921218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354659|NCT01921218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92354660|NCT01921218|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92354661|NCT01921218|Antitubercular Agents|antitubercular agents|mesh-ancestor
92354662|NCT01921218|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354663|NCT01921218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92354664|NCT01921218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354665|NCT03129828|Bortezomib|bortezomib|mesh-list
92354666|NCT03129828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354668|NCT01922076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354669|NCT01922076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354670|NCT00633750|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92354672|NCT00633750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92354673|NCT00633750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354674|NCT00633750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354675|NCT00633360|Drospirenone|drospirenone|mesh-list
92354676|NCT00633360|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92354677|NCT00633360|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92354678|NCT00633360|Estradiol|estradiol|mesh-list
92354679|NCT00633360|Estrogens|estrogens|mesh-ancestor
92354680|NCT00633360|Hormones|hormones|mesh-ancestor
92354681|NCT00633360|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354682|NCT00633360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354683|NCT00633360|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92354684|NCT00633360|Contraceptive Agents|contraceptive agents|mesh-ancestor
92354685|NCT00633360|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92354686|NCT00633360|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92354687|NCT00633360|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92354688|NCT00633360|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92354689|NCT00633360|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92354690|NCT00633360|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354691|NCT00633360|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92354692|NCT00633360|Diuretics|diuretics|mesh-ancestor
92354693|NCT00633360|Natriuretic Agents|natriuretic agents|mesh-ancestor
92354694|NCT00988260|Ganirelix|ganirelix|mesh-list
92354695|NCT00988260|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354696|NCT00988260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354697|NCT00988260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354698|NCT00633126|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92354699|NCT00633126|Cephalosporins|cephalosporins|mesh-list
92354700|NCT00633126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354701|NCT00633126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354702|NCT00989664|Tositumomab I-131|tositumomab i-131|mesh-list
92354703|NCT00989664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354705|NCT01923870|Clomiphene|clomiphene|mesh-list
92354706|NCT01923870|Zuclomiphene|zuclomiphene|mesh-list
92354707|NCT01923870|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92354708|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354709|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354710|NCT01923870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354711|NCT01923870|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92354712|NCT01923870|Fertility Agents|fertility agents|mesh-ancestor
92354713|NCT01923870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92354714|NCT01923870|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92354715|NCT01923870|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92354716|NCT00632736|Ropinirole|ropinirole|mesh-list
92354717|NCT00632736|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92354718|NCT00632736|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92354719|NCT00632736|Dopamine Agonists|dopamine agonists|mesh-ancestor
92354720|NCT00632736|Dopamine Agents|dopamine agents|mesh-ancestor
92354721|NCT00632736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354722|NCT00632736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354723|NCT00632736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354725|NCT01923948|Analgesics|analgesics|mesh-ancestor
92354726|NCT01923948|Sensory System Agents|sensory system agents|mesh-ancestor
92354727|NCT01923948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354728|NCT01923948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354729|NCT01923948|Anticonvulsants|anticonvulsants|mesh-ancestor
92354730|NCT01923948|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92354731|NCT01923948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92354732|NCT01923948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354733|NCT01923948|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92354734|NCT01923948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92354735|NCT01923948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92354736|NCT01923948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354740|NCT00631488|Metformin|metformin|mesh-list
92354741|NCT00631488|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92354742|NCT00631488|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92354743|NCT00631488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354744|NCT00631488|Incretins|incretins|mesh-ancestor
92354745|NCT00631488|Hormones|hormones|mesh-ancestor
92354746|NCT00631488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354747|NCT00631488|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92354748|NCT00631488|Protease Inhibitors|protease inhibitors|mesh-ancestor
92354749|NCT00631488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354750|NCT00631488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354752|NCT01924104|Heparin|heparin|mesh-list
92354753|NCT01924104|Calcium heparin|calcium heparin|mesh-list
92354754|NCT01924104|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92354755|NCT01924104|Tinzaparin|tinzaparin|mesh-list
92354757|NCT01924104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92354758|NCT01924104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92354759|NCT01924104|Analgesics|analgesics|mesh-ancestor
92354760|NCT01924104|Sensory System Agents|sensory system agents|mesh-ancestor
92354761|NCT01924104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354762|NCT01924104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354763|NCT01924104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354764|NCT01924104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354765|NCT01924104|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92354766|NCT01924104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92354767|NCT01924104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354768|NCT01924104|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92354769|NCT01924104|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92354770|NCT01924104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354771|NCT01924104|Antipyretics|antipyretics|mesh-ancestor
92354772|NCT01924104|Anticoagulants|anticoagulants|mesh-ancestor
92354774|NCT00987402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92354775|NCT00987402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354776|NCT00987402|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354777|NCT00987402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354778|NCT00630786|Panitumumab|panitumumab|mesh-list
92354780|NCT00630786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354781|NCT00630786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354782|NCT00630396|Minocycline|minocycline|mesh-list
92354783|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354784|NCT00630396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354785|NCT00636480|Chlorhexidine|chlorhexidine|mesh-list
92354786|NCT00636480|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92354787|NCT00636480|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92354788|NCT00636480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354789|NCT00636480|Disinfectants|disinfectants|mesh-ancestor
92354790|NCT00636480|Dermatologic Agents|dermatologic agents|mesh-ancestor
92354791|NCT00630552|Conatumumab|conatumumab|mesh-list
92354792|NCT00630552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354793|NCT00630552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354794|NCT01925352|Mitogens|mitogens|mesh-list
92354795|NCT01925352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354796|NCT01925352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354797|NCT03095352|Carboplatin|carboplatin|mesh-list
92354799|NCT03095352|Trastuzumab|trastuzumab|mesh-list
92354800|NCT03095352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354801|NCT03095352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354802|NCT03095352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92354803|NCT03095352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354805|NCT03092856|Antibodies|antibodies|mesh-list
92354806|NCT03092856|Immunologic Factors|immunologic factors|mesh-ancestor
92354807|NCT03092856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354808|NCT03092856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354809|NCT03092856|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92354811|NCT03092856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354812|NCT01920204|Midostaurin|midostaurin|mesh-list
92354813|NCT01920204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354814|NCT01920204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92354815|NCT01920204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354816|NCT01920204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354818|NCT04275258|Narcotics|narcotics|mesh-ancestor
92354819|NCT04275258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354820|NCT04275258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354821|NCT04275258|Analgesics|analgesics|mesh-ancestor
92354822|NCT04275258|Sensory System Agents|sensory system agents|mesh-ancestor
92354823|NCT04275258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354824|NCT03474744|Rituximab|rituximab|mesh-list
92354825|NCT03474744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354826|NCT03474744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354827|NCT03474744|Immunologic Factors|immunologic factors|mesh-ancestor
92354828|NCT03474744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354829|NCT03474744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354830|NCT01925820|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92354831|NCT01925820|Entecavir|entecavir|mesh-list
92354832|NCT01925820|Antiviral Agents|antiviral agents|mesh-ancestor
92354833|NCT01925820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354836|NCT01925898|Analgesics|analgesics|mesh-ancestor
92354837|NCT01925898|Sensory System Agents|sensory system agents|mesh-ancestor
92354838|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354839|NCT01925898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354840|NCT01925898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92354841|NCT01925898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92354842|NCT01925898|Anesthetics, General|anesthetics, general|mesh-ancestor
92354843|NCT01925898|Anesthetics|anesthetics|mesh-ancestor
92354844|NCT01925898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354845|NCT01925898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92354846|NCT01925898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92354847|NCT01925898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354848|NCT01925898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354849|NCT01925898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92354850|NCT01925898|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92354851|NCT01925898|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92354852|NCT01925898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92354853|NCT01925898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92354854|NCT01925898|GABA Modulators|gaba modulators|mesh-ancestor
92354855|NCT01925898|GABA Agents|gaba agents|mesh-ancestor
92354856|NCT00983580|Aspirin|aspirin|mesh-list
92354857|NCT00983580|Eflornithine|eflornithine|mesh-list
92354858|NCT00983580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92354859|NCT00983580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92354860|NCT00983580|Analgesics|analgesics|mesh-ancestor
92354861|NCT00983580|Sensory System Agents|sensory system agents|mesh-ancestor
92354862|NCT00983580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354863|NCT00983580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354864|NCT00983580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92354865|NCT00983580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92354866|NCT00983580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92354867|NCT00983580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92354868|NCT00983580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354869|NCT00983580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92354870|NCT00983580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92354871|NCT00983580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354872|NCT00983580|Antipyretics|antipyretics|mesh-ancestor
92117440|NCT04389801|Siderophores|siderophores|mesh-ancestor
92354873|NCT00983580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354874|NCT00983580|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92354875|NCT00983580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92354876|NCT00983580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92354877|NCT00983580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354878|NCT00983580|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92354879|NCT00982878|Maraviroc|maraviroc|mesh-list
92354880|NCT00982878|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92354881|NCT00982878|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92354882|NCT00982878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354884|NCT00982878|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92354885|NCT00982878|Antiviral Agents|antiviral agents|mesh-ancestor
92354886|NCT00982878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354887|NCT00982878|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92354888|NCT00982488|Imatinib Mesylate|imatinib mesylate|mesh-list
92354889|NCT00982488|Dasatinib|dasatinib|mesh-list
92354890|NCT00982488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354892|NCT00982488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354893|NCT00982488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354894|NCT00982020|Olanzapine|olanzapine|mesh-list
92354895|NCT00982020|Antiemetics|antiemetics|mesh-ancestor
92354896|NCT00982020|Autonomic Agents|autonomic agents|mesh-ancestor
92354897|NCT00982020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92354898|NCT00982020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354899|NCT00982020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354900|NCT00982020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92354901|NCT00982020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92354902|NCT00982020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92354903|NCT00982020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92354904|NCT00982020|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92354905|NCT00982020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92354906|NCT00982020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92354907|NCT00982020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354908|NCT00982020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354909|NCT00982020|Serotonin Agents|serotonin agents|mesh-ancestor
92354910|NCT01926132|Ascorbic Acid|ascorbic acid|mesh-list
92354911|NCT01926132|Antioxidants|antioxidants|mesh-ancestor
92354912|NCT01926132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354913|NCT01926132|Protective Agents|protective agents|mesh-ancestor
92354914|NCT01926132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354916|NCT01926132|Micronutrients|micronutrients|mesh-ancestor
92354918|NCT01926210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354919|NCT01926210|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92354920|NCT01926210|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92354921|NCT01926210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354922|NCT01926210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354923|NCT01926210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92354924|NCT01926210|Hormone Antagonists|hormone antagonists|mesh-ancestor
92354925|NCT01926210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92354926|NCT01926210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354927|NCT01926288|Entecavir|entecavir|mesh-list
92354928|NCT01926288|Maleic acid|maleic acid|mesh-list
92354929|NCT01926288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354930|NCT01926288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354931|NCT01926288|Antiviral Agents|antiviral agents|mesh-ancestor
92354932|NCT01926288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354933|NCT00981084|Modafinil|modafinil|mesh-list
92354934|NCT00981084|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92354935|NCT00981084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354937|NCT00981084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92354938|NCT00981084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92354939|NCT00981084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354940|NCT00980148|Azithromycin|azithromycin|mesh-list
92354941|NCT00980148|Doxycycline|doxycycline|mesh-list
92354942|NCT00980148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92354943|NCT00980148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92354944|NCT00980148|Antimalarials|antimalarials|mesh-ancestor
92354945|NCT00980148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92354946|NCT00980148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92354947|NCT03064854|Paclitaxel|paclitaxel|mesh-list
92354948|NCT03064854|Carboplatin|carboplatin|mesh-list
92354949|NCT03064854|Gemcitabine|gemcitabine|mesh-list
92354950|NCT03064854|Pemetrexed|pemetrexed|mesh-list
92354951|NCT03064854|Spartalizumab|spartalizumab|mesh-list
92354952|NCT03064854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92354953|NCT03064854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354954|NCT03064854|Tubulin Modulators|tubulin modulators|mesh-ancestor
92354955|NCT03064854|Antimitotic Agents|antimitotic agents|mesh-ancestor
92354956|NCT03064854|Mitosis Modulators|mitosis modulators|mesh-ancestor
92354957|NCT03064854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354958|NCT03064854|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92354960|NCT03064854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354961|NCT03064854|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92354962|NCT03064854|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92354963|NCT03064854|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92354964|NCT03064854|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354966|NCT00983814|Droxidopa|droxidopa|mesh-list
92354967|NCT00983814|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92354968|NCT00983814|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92354969|NCT00983814|Dopamine Agents|dopamine agents|mesh-ancestor
92354970|NCT00983814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92354971|NCT00983814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354972|NCT00983814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354973|NCT00983814|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92354974|NCT00983814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354975|NCT01921920|Omeprazole|omeprazole|mesh-list
92354976|NCT01921920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92354977|NCT01921920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92354978|NCT01921920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92354979|NCT01921920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92354980|NCT01921920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92354981|NCT04275414|Bevacizumab|bevacizumab|mesh-list
92354982|NCT04275414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92354983|NCT04275414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92354984|NCT04275414|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92354985|NCT04275414|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92354986|NCT04275414|Growth Substances|growth substances|mesh-ancestor
92354987|NCT04275414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354988|NCT04275414|Growth Inhibitors|growth inhibitors|mesh-ancestor
92354990|NCT04395768|Cholecalciferol|cholecalciferol|mesh-list
92354991|NCT04395768|Vitamins|vitamins|mesh-list
92354992|NCT04395768|Ascorbic Acid|ascorbic acid|mesh-list
92354993|NCT04395768|Vitamin B 12|vitamin b 12|mesh-list
92354994|NCT04395768|Azithromycin|azithromycin|mesh-list
92354995|NCT04395768|Hydroxychloroquine|hydroxychloroquine|mesh-list
92354996|NCT04395768|Micronutrients|micronutrients|mesh-ancestor
92354997|NCT04395768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92354998|NCT04395768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92354999|NCT04395768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355000|NCT04395768|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92355001|NCT04395768|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92355002|NCT04395768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355003|NCT04395768|Antimalarials|antimalarials|mesh-ancestor
92355004|NCT04395768|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92355005|NCT04395768|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92355006|NCT04395768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355007|NCT04395768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355008|NCT04395768|Antioxidants|antioxidants|mesh-ancestor
92355009|NCT04395768|Protective Agents|protective agents|mesh-ancestor
92355010|NCT04395768|Vitamin B Complex|vitamin b complex|mesh-ancestor
92355011|NCT01927224|Nifurtimox|nifurtimox|mesh-list
92355012|NCT01927224|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92355013|NCT01927224|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92355014|NCT01927224|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92355015|NCT01927224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355016|NCT01922154|Ranibizumab|ranibizumab|mesh-list
92355017|NCT01922154|Mitomycin|mitomycin|mesh-list
92355018|NCT01922154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355019|NCT01922154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355020|NCT01922154|Growth Substances|growth substances|mesh-ancestor
92355021|NCT01922154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355022|NCT01922154|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355023|NCT01922154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355024|NCT01922154|Alkylating Agents|alkylating agents|mesh-ancestor
92355025|NCT01922154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355026|NCT01922154|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92355027|NCT01922154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92355028|NCT01922154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355030|NCT03059940|Carbon Monoxide|carbon monoxide|mesh-list
92355031|NCT03059940|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92355032|NCT03059940|Autonomic Agents|autonomic agents|mesh-ancestor
92355033|NCT03059940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355034|NCT03059940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355036|NCT03059940|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92355037|NCT03059940|Cholinergic Agents|cholinergic agents|mesh-ancestor
92355038|NCT03059940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355039|NCT03059940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355040|NCT03059940|Antimetabolites|antimetabolites|mesh-ancestor
92355041|NCT03059940|Gasotransmitters|gasotransmitters|mesh-ancestor
92355043|NCT03423342|Niacin|niacin|mesh-list
92355044|NCT03423342|Nicotinic Acids|nicotinic acids|mesh-list
92355045|NCT03423342|Vitamin B Complex|vitamin b complex|mesh-ancestor
92355046|NCT03423342|Vitamins|vitamins|mesh-ancestor
92355047|NCT03423342|Micronutrients|micronutrients|mesh-ancestor
92355048|NCT03423342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355049|NCT03423342|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92355050|NCT03423342|Antimetabolites|antimetabolites|mesh-ancestor
92355051|NCT03423342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355052|NCT03423342|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92355053|NCT03423342|Vasodilator Agents|vasodilator agents|mesh-ancestor
92355054|NCT01928160|Carboplatin|carboplatin|mesh-list
92355055|NCT01928160|Pemetrexed|pemetrexed|mesh-list
92355056|NCT01928160|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92355057|NCT01928160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355058|NCT01928160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355059|NCT01928160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355060|NCT01928160|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92355061|NCT01928160|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92355062|NCT01928160|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92355063|NCT01928316|Mizolastine|mizolastine|mesh-list
92355064|NCT01928316|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92355065|NCT01928316|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92355066|NCT01928316|Histamine Antagonists|histamine antagonists|mesh-ancestor
92355067|NCT01928316|Histamine Agents|histamine agents|mesh-ancestor
92355068|NCT01928316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355069|NCT01928316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355070|NCT01928316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355071|NCT03050736|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
92355072|NCT03050736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355073|NCT03050736|Alkylating Agents|alkylating agents|mesh-ancestor
92355074|NCT03050736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355075|NCT03050736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355076|NCT04559646|Hemostatics|hemostatics|mesh-list
92355077|NCT04559646|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92355078|NCT04559646|Coagulants|coagulants|mesh-ancestor
92355079|NCT04550520|Glucagon|glucagon|mesh-list
92355080|NCT04550520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355081|NCT04550520|Hormones|hormones|mesh-ancestor
92355082|NCT04550520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355083|NCT04550520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355085|NCT01928628|Lercanidipine|lercanidipine|mesh-list
92355086|NCT01928628|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92355087|NCT01928628|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92355089|NCT01928628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355090|NCT01928628|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92355091|NCT01928628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92355092|NCT01928628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92355093|NCT01928628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355094|NCT01929096|Edaravone|edaravone|mesh-list
92355095|NCT01929096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92355096|NCT01929096|Antioxidants|antioxidants|mesh-ancestor
92355097|NCT01929096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355099|NCT01929096|Protective Agents|protective agents|mesh-ancestor
92355100|NCT01929096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355101|NCT03059004|TEMPO|tempo|mesh-list
92355103|NCT03059004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355104|NCT03059004|Protective Agents|protective agents|mesh-ancestor
92355105|NCT03059004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355106|NCT04554888|Doxepin|doxepin|mesh-list
92355107|NCT04554888|Histamine|histamine|mesh-list
92355109|NCT04554888|Histamine Agents|histamine agents|mesh-ancestor
92355110|NCT04554888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355111|NCT04554888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355112|NCT04554888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355113|NCT04554888|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92355114|NCT04554888|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92355115|NCT04554888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355116|NCT04554888|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92355117|NCT04554888|Antidepressive Agents|antidepressive agents|mesh-ancestor
92355118|NCT04554888|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355119|NCT04554888|Histamine Antagonists|histamine antagonists|mesh-ancestor
92355120|NCT05601960|Sunscreening Agents|sunscreening agents|mesh-list
92355121|NCT05601960|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92355122|NCT05601960|Protective Agents|protective agents|mesh-ancestor
92355123|NCT05601960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355124|NCT05601960|Dermatologic Agents|dermatologic agents|mesh-ancestor
92355125|NCT05605002|Serotonin|serotonin|mesh-list
92355126|NCT05605002|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92355127|NCT05605002|Serotonin Agents|serotonin agents|mesh-ancestor
92355128|NCT05605002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937323|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355129|NCT05605002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355130|NCT05605002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355132|NCT03238248|Pevonedistat|pevonedistat|mesh-list
92355133|NCT03238248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355134|NCT03238248|Antimetabolites|antimetabolites|mesh-ancestor
92355135|NCT03238248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355136|NCT03238248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355137|NCT03238248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355138|NCT04124016|Grape Seed Extract|grape seed extract|mesh-list
92355139|NCT04124016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92355140|NCT04124016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355141|NCT04124016|Antioxidants|antioxidants|mesh-ancestor
92355142|NCT04124016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355143|NCT04124016|Protective Agents|protective agents|mesh-ancestor
92355144|NCT04124016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355145|NCT04124094|Fluticasone|fluticasone|mesh-list
92355147|NCT04124094|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92355148|NCT04124094|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92355149|NCT04124094|Charcoal|charcoal|mesh-list
92355150|NCT04124094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355151|NCT04124094|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92355152|NCT04124094|Autonomic Agents|autonomic agents|mesh-ancestor
92355153|NCT04124094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355154|NCT04124094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355155|NCT04124094|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92355156|NCT04124094|Respiratory System Agents|respiratory system agents|mesh-ancestor
92355157|NCT04124094|Dermatologic Agents|dermatologic agents|mesh-ancestor
92355158|NCT04124094|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92355159|NCT04124094|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92355160|NCT04124094|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92355161|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92355162|NCT04124094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92355163|NCT04124094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355164|NCT04124094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355165|NCT04124094|Glucocorticoids|glucocorticoids|mesh-ancestor
92355167|NCT04124094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355168|NCT04124094|Sympathomimetics|sympathomimetics|mesh-ancestor
92355169|NCT04124094|Antidotes|antidotes|mesh-ancestor
92355170|NCT04124094|Protective Agents|protective agents|mesh-ancestor
92355171|NCT03033576|Nivolumab|nivolumab|mesh-list
92355172|NCT03033576|Ipilimumab|ipilimumab|mesh-list
92355173|NCT03033576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355174|NCT03033576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355175|NCT03033576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92355176|NCT03033576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355177|NCT04275024|Calcipotriene|calcipotriene|mesh-list
92355178|NCT04275024|Dermatologic Agents|dermatologic agents|mesh-ancestor
92355179|NCT04123392|Cyclophosphamide|cyclophosphamide|mesh-list
92355181|NCT04123392|Decitabine|decitabine|mesh-list
92007703|NCT04305145|Hormones|hormones|mesh-ancestor
92355182|NCT04123392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355183|NCT04123392|Immunologic Factors|immunologic factors|mesh-ancestor
92355184|NCT04123392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355185|NCT04123392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355186|NCT04123392|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355187|NCT04123392|Alkylating Agents|alkylating agents|mesh-ancestor
92355188|NCT04123392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355189|NCT04123392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355190|NCT04123392|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92355191|NCT04123392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355192|NCT04123392|Antimetabolites|antimetabolites|mesh-ancestor
92355193|NCT04123392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355194|NCT04760262|Remifentanil|remifentanil|mesh-list
92355197|NCT04760262|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92355198|NCT04760262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355199|NCT04760262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355200|NCT04760262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92355201|NCT04760262|Anesthetics, General|anesthetics, general|mesh-ancestor
92355202|NCT04760262|Anesthetics|anesthetics|mesh-ancestor
92355203|NCT04760262|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92355205|NCT04760262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92355206|NCT04760262|Narcotics|narcotics|mesh-ancestor
92355207|NCT04760262|Analgesics|analgesics|mesh-ancestor
92355209|NCT04760262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355210|NCT03047928|Nivolumab|nivolumab|mesh-list
92355211|NCT03047928|Vaccines|vaccines|mesh-list
92355212|NCT03047928|Immunologic Factors|immunologic factors|mesh-ancestor
92355213|NCT03047928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355214|NCT03047928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355215|NCT03047928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355216|NCT03047928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92355217|NCT03047928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355218|NCT05607810|Aflibercept|aflibercept|mesh-list
92355219|NCT05607810|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355220|NCT05607810|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355221|NCT05607810|Growth Substances|growth substances|mesh-ancestor
92355222|NCT05607810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355223|NCT05607810|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355224|NCT05607810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355225|NCT04126278|Dexamethasone|dexamethasone|mesh-list
92355226|NCT04126278|Cortisone|cortisone|mesh-list
92355227|NCT04126278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355228|NCT04126278|Antiemetics|antiemetics|mesh-ancestor
92355229|NCT04126278|Autonomic Agents|autonomic agents|mesh-ancestor
92355230|NCT04126278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355231|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355232|NCT04126278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355233|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
92355234|NCT04126278|Hormones|hormones|mesh-ancestor
92355235|NCT04126278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355236|NCT04126278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92355237|NCT04126278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355238|NCT04127682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92355239|NCT04127682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355240|NCT04122066|Sofosbuvir|sofosbuvir|mesh-list
92355241|NCT04122066|Antiviral Agents|antiviral agents|mesh-ancestor
92355242|NCT04122066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355243|NCT04121910|Itraconazole|itraconazole|mesh-list
92355244|NCT04121910|Antifungal Agents|antifungal agents|mesh-ancestor
92355245|NCT04121910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355246|NCT04121910|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92355247|NCT04121910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92355248|NCT04121910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355249|NCT04121910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355250|NCT04121910|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92355251|NCT04121910|Hormone Antagonists|hormone antagonists|mesh-ancestor
92355252|NCT04121910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355253|NCT04121910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355254|NCT04121910|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92355255|NCT04129788|Bisacodyl|bisacodyl|mesh-list
92007774|NCT01870193|Acetylcysteine|acetylcysteine|mesh-list
92355256|NCT04129788|Cathartics|cathartics|mesh-ancestor
92355257|NCT04129788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355258|NCT04129788|Laxatives|laxatives|mesh-ancestor
92355259|NCT03831126|Betamethasone|betamethasone|mesh-list
92355260|NCT03831126|Betamethasone Valerate|betamethasone valerate|mesh-list
92355261|NCT03831126|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92355262|NCT03831126|Betamethasone benzoate|betamethasone benzoate|mesh-list
92355263|NCT03831126|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92355264|NCT03831126|Glucocorticoids|glucocorticoids|mesh-ancestor
92355265|NCT03831126|Hormones|hormones|mesh-ancestor
92355266|NCT03831126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355267|NCT03831126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355268|NCT03831126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355269|NCT03831126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92355270|NCT03831126|Respiratory System Agents|respiratory system agents|mesh-ancestor
92355271|NCT04073784|Gemcitabine|gemcitabine|mesh-list
92355272|NCT04073784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355273|NCT04073784|Antimetabolites|antimetabolites|mesh-ancestor
92355274|NCT04073784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355275|NCT04073784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355276|NCT05606796|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92355277|NCT05606796|Latanoprost|latanoprost|mesh-list
92355278|NCT05606796|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92355279|NCT04129710|Rituximab|rituximab|mesh-list
92355280|NCT04129710|Methotrexate|methotrexate|mesh-list
92355281|NCT04129710|Etoposide|etoposide|mesh-list
92355282|NCT04129710|Lenalidomide|lenalidomide|mesh-list
92355283|NCT04129710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355284|NCT04129710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355285|NCT04129710|Immunologic Factors|immunologic factors|mesh-ancestor
92355286|NCT04129710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355287|NCT04129710|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355288|NCT04129710|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92355289|NCT04129710|Abortifacient Agents|abortifacient agents|mesh-ancestor
92355290|NCT04129710|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92355291|NCT04129710|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355292|NCT04129710|Antimetabolites|antimetabolites|mesh-ancestor
92355293|NCT04129710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355294|NCT04129710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92355295|NCT04129710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355296|NCT04129710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92355297|NCT04129710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355298|NCT04129710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92355299|NCT04129710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92355300|NCT04129710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92355301|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92355302|NCT04129710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355303|NCT04129710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355304|NCT04129710|Growth Substances|growth substances|mesh-ancestor
92355305|NCT04129710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355306|NCT03200808|Methylene Blue|methylene blue|mesh-list
92355307|NCT03200808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355308|NCT03200808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355309|NCT04129008|Aspirin|aspirin|mesh-list
92355310|NCT04129008|Indobufen|indobufen|mesh-list
92355311|NCT04129008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92355312|NCT04129008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92355313|NCT04129008|Analgesics|analgesics|mesh-ancestor
92355314|NCT04129008|Sensory System Agents|sensory system agents|mesh-ancestor
92355315|NCT04129008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355316|NCT04129008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355317|NCT04129008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355318|NCT04129008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355319|NCT04129008|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92355320|NCT04129008|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92355321|NCT04129008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355322|NCT04129008|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92355323|NCT04129008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92355324|NCT04129008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355325|NCT04129008|Antipyretics|antipyretics|mesh-ancestor
92355326|NCT04128462|Phenylacetic acid|phenylacetic acid|mesh-list
92355327|NCT04128462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355328|NCT04128462|Antimetabolites|antimetabolites|mesh-ancestor
92007849|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92355329|NCT04128462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355330|NCT04128462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355331|NCT04120350|Rituximab|rituximab|mesh-list
92355332|NCT04120350|Methotrexate|methotrexate|mesh-list
92355333|NCT04120350|Lenalidomide|lenalidomide|mesh-list
92355334|NCT04120350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355335|NCT04120350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355336|NCT04120350|Immunologic Factors|immunologic factors|mesh-ancestor
92355337|NCT04120350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355338|NCT04120350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355339|NCT04120350|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92355340|NCT04120350|Abortifacient Agents|abortifacient agents|mesh-ancestor
92355341|NCT04120350|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92355342|NCT04120350|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355343|NCT04120350|Antimetabolites|antimetabolites|mesh-ancestor
92355344|NCT04120350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355345|NCT04120350|Dermatologic Agents|dermatologic agents|mesh-ancestor
92355346|NCT04120350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355347|NCT04120350|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92355348|NCT04120350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355349|NCT04120350|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92355350|NCT04120350|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355351|NCT04120350|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355352|NCT04120350|Growth Substances|growth substances|mesh-ancestor
92355353|NCT04120350|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355354|NCT04394598|Capecitabine|capecitabine|mesh-list
92355355|NCT04394598|Irinotecan|irinotecan|mesh-list
92355356|NCT04394598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355357|NCT04394598|Antimetabolites|antimetabolites|mesh-ancestor
92355358|NCT04394598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355359|NCT04394598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355360|NCT04394598|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92355361|NCT04394598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92355362|NCT04394598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355363|NCT04127916|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92355364|NCT04127916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355365|NCT04127916|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355366|NCT04127916|Alkylating Agents|alkylating agents|mesh-ancestor
92355367|NCT04127916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355368|NCT05602428|Anesthetics|anesthetics|mesh-list
92355369|NCT05602428|Esketamine|esketamine|mesh-list
92355370|NCT05602428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355371|NCT05602428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355372|NCT05602428|Antidepressive Agents|antidepressive agents|mesh-ancestor
92355373|NCT05602428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355374|NCT02983890|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92355375|NCT02983890|Dicloxacillin|dicloxacillin|mesh-list
92355376|NCT02983890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355377|NCT04127058|Iloperidone|iloperidone|mesh-list
92355378|NCT04127058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92355379|NCT04127058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92355380|NCT04127058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355381|NCT04127058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355382|NCT04127058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355383|NCT03012360|Ciprofloxacin|ciprofloxacin|mesh-list
92355384|NCT03012360|Ceftriaxone|ceftriaxone|mesh-list
92355385|NCT03012360|Linezolid|linezolid|mesh-list
92355386|NCT03012360|Imipenem|imipenem|mesh-list
92355387|NCT03012360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92355388|NCT03012360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355389|NCT03012360|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92355390|NCT03012360|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92355391|NCT03012360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355392|NCT03012360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355393|NCT03012360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355394|NCT03012360|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92355395|NCT03012360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92355396|NCT03012360|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92355397|NCT04120974|Insulin|insulin|mesh-list
92355398|NCT04120974|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92355399|NCT04120974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355400|NCT04126668|Vorolanib|vorolanib|mesh-list
92355401|NCT04126668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92355402|NCT04126668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355403|NCT04126668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355404|NCT04758936|Clonidine|clonidine|mesh-list
92007932|NCT04979273|Epinephrine|epinephrine|mesh-list
92355405|NCT04758936|Dexmedetomidine|dexmedetomidine|mesh-list
92355406|NCT04758936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92355407|NCT04758936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355408|NCT04758936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355409|NCT04758936|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92355410|NCT04758936|Analgesics|analgesics|mesh-ancestor
92355411|NCT04758936|Sensory System Agents|sensory system agents|mesh-ancestor
92355412|NCT04758936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355413|NCT04758936|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92355414|NCT04758936|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92355415|NCT04758936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92355416|NCT04758936|Adrenergic Agents|adrenergic agents|mesh-ancestor
92355417|NCT04758936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355418|NCT04758936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355419|NCT04758936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92355420|NCT04758936|Sympatholytics|sympatholytics|mesh-ancestor
92355421|NCT04758936|Autonomic Agents|autonomic agents|mesh-ancestor
92355422|NCT04126044|Bevacizumab|bevacizumab|mesh-list
91937326|NCT04197076|Immunologic Factors|immunologic factors|mesh-ancestor
92355423|NCT04126044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355424|NCT04126044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355425|NCT04126044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355426|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355427|NCT04126044|Growth Substances|growth substances|mesh-ancestor
92355428|NCT04126044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355429|NCT04126044|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355430|NCT04758858|Glucagon|glucagon|mesh-list
92355431|NCT04758858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355432|NCT04758858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355433|NCT04758858|Hormones|hormones|mesh-ancestor
92355434|NCT04758858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355435|NCT04125888|Immunomodulating Agents|immunomodulating agents|mesh-list
92355436|NCT04125888|Immunologic Factors|immunologic factors|mesh-ancestor
92355437|NCT04125888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355438|NCT02975310|Anesthetics|anesthetics|mesh-list
92355439|NCT02975310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355440|NCT02975310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355441|NCT04394208|Silymarin|silymarin|mesh-list
92355442|NCT04394208|Antioxidants|antioxidants|mesh-ancestor
92355443|NCT04394208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355444|NCT04394208|Protective Agents|protective agents|mesh-ancestor
92355445|NCT04394208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355447|NCT03829566|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92355448|NCT03829566|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92355449|NCT03829566|Prednisolone|prednisolone|mesh-list
92355450|NCT03829566|Prednisolone acetate|prednisolone acetate|mesh-list
92355451|NCT03829566|Cyclophosphamide|cyclophosphamide|mesh-list
92355452|NCT03829566|Rituximab|rituximab|mesh-list
92355453|NCT03829566|Thymoglobulin|thymoglobulin|mesh-list
92355454|NCT03829566|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92355455|NCT03829566|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92355456|NCT03829566|Prednisolone phosphate|prednisolone phosphate|mesh-list
92355457|NCT03829566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355458|NCT03829566|Immunologic Factors|immunologic factors|mesh-ancestor
92355459|NCT03829566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355460|NCT03829566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355461|NCT03829566|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355462|NCT03829566|Alkylating Agents|alkylating agents|mesh-ancestor
92355463|NCT03829566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355464|NCT03829566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355465|NCT03829566|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92355466|NCT03829566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355467|NCT03829566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355468|NCT03829566|Antiemetics|antiemetics|mesh-ancestor
92355469|NCT03829566|Autonomic Agents|autonomic agents|mesh-ancestor
92355470|NCT03829566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355471|NCT03829566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355472|NCT03829566|Glucocorticoids|glucocorticoids|mesh-ancestor
92355473|NCT03829566|Hormones|hormones|mesh-ancestor
92355474|NCT03829566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355475|NCT03829566|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92355476|NCT03829566|Protective Agents|protective agents|mesh-ancestor
92355477|NCT03829566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92355478|NCT03933306|Dexmedetomidine|dexmedetomidine|mesh-list
92355479|NCT03933306|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92355480|NCT03933306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355481|NCT03933306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355482|NCT03933306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92355483|NCT03933306|Analgesics|analgesics|mesh-ancestor
92355484|NCT03933306|Sensory System Agents|sensory system agents|mesh-ancestor
92355485|NCT03933306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355486|NCT03933306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92355487|NCT03933306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92355488|NCT03933306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92355489|NCT03933306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92355490|NCT03933306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355491|NCT03933306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355492|NCT04394442|Hydroxychloroquine|hydroxychloroquine|mesh-list
92355493|NCT04394442|Antimalarials|antimalarials|mesh-ancestor
92355494|NCT04394442|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91937328|NCT01138163|Docetaxel|docetaxel|mesh-list
92355496|NCT04394442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355497|NCT04394442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355498|NCT04394442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355499|NCT04394442|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355500|NCT02972424|Teriparatide|teriparatide|mesh-list
92355501|NCT02972424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92355502|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355503|NCT02972424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92355504|NCT05608590|Ethiodized Oil|ethiodized oil|mesh-list
92355505|NCT05608590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355506|NCT04393584|Leucovorin|leucovorin|mesh-list
92355507|NCT04393584|Docetaxel|docetaxel|mesh-list
92355508|NCT04393584|Oxaliplatin|oxaliplatin|mesh-list
92355509|NCT04393584|Irinotecan|irinotecan|mesh-list
92355510|NCT04393584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355511|NCT04393584|Tubulin Modulators|tubulin modulators|mesh-ancestor
92355512|NCT04393584|Antimitotic Agents|antimitotic agents|mesh-ancestor
92355513|NCT04393584|Mitosis Modulators|mitosis modulators|mesh-ancestor
92355514|NCT04393584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355515|NCT04393584|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92355516|NCT04393584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92355517|NCT04393584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355518|NCT04393584|Antidotes|antidotes|mesh-ancestor
92355519|NCT04393584|Protective Agents|protective agents|mesh-ancestor
92355520|NCT04393584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355521|NCT04393584|Vitamin B Complex|vitamin b complex|mesh-ancestor
92355522|NCT04393584|Vitamins|vitamins|mesh-ancestor
92355523|NCT04393584|Micronutrients|micronutrients|mesh-ancestor
92355524|NCT02965950|Cyclophosphamide|cyclophosphamide|mesh-list
92355525|NCT02965950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355526|NCT02965950|Immunologic Factors|immunologic factors|mesh-ancestor
92355527|NCT02965950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355528|NCT02965950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355529|NCT02965950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355530|NCT02965950|Alkylating Agents|alkylating agents|mesh-ancestor
92355531|NCT02965950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355532|NCT02965950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355533|NCT02965950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92355534|NCT03828474|Acetazolamide|acetazolamide|mesh-list
92355535|NCT03828474|Anticonvulsants|anticonvulsants|mesh-ancestor
92355536|NCT03828474|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92355537|NCT03828474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355538|NCT03828474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355539|NCT03828474|Diuretics|diuretics|mesh-ancestor
92355540|NCT03828474|Natriuretic Agents|natriuretic agents|mesh-ancestor
92355541|NCT03828474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355542|NCT03043950|Panitumumab|panitumumab|mesh-list
92355543|NCT03043950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355544|NCT03043950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355545|NCT03828084|Decitabine|decitabine|mesh-list
92355546|NCT03828084|Tetrahydrouridine|tetrahydrouridine|mesh-list
92355547|NCT03828084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355549|NCT03828084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355550|NCT03828084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355551|NCT03828084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355552|NCT04274166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92355553|NCT04274166|Immunologic Factors|immunologic factors|mesh-ancestor
92355554|NCT04274166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355555|NCT02959164|Gemcitabine|gemcitabine|mesh-list
92355556|NCT02959164|Decitabine|decitabine|mesh-list
92355557|NCT02959164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355558|NCT02959164|Antimetabolites|antimetabolites|mesh-ancestor
92355559|NCT02959164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355560|NCT02959164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355561|NCT02959164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355562|NCT02983734|Cycloserine|cycloserine|mesh-list
92355563|NCT02983734|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92355564|NCT02983734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355565|NCT02983734|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92355566|NCT02983734|Antitubercular Agents|antitubercular agents|mesh-ancestor
92355567|NCT02983734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937329|NCT01138163|Bavituximab|bavituximab|mesh-list
92355568|NCT02983734|Antimetabolites|antimetabolites|mesh-ancestor
92355569|NCT02983734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355570|NCT03821454|Capecitabine|capecitabine|mesh-list
92355571|NCT03821454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355572|NCT03821454|Antimetabolites|antimetabolites|mesh-ancestor
92355573|NCT03821454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355574|NCT03821454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355575|NCT03820518|Calcitriol|calcitriol|mesh-list
92355576|NCT03820518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92355577|NCT03820518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355578|NCT03820518|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92355579|NCT03820518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92355580|NCT03820518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355581|NCT03820518|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92355582|NCT03820518|Vitamins|vitamins|mesh-ancestor
92355583|NCT03820518|Micronutrients|micronutrients|mesh-ancestor
92355584|NCT03820518|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92355585|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
92355586|NCT03820206|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92355587|NCT03820206|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92355588|NCT03820206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355589|NCT03820206|Hemostatics|hemostatics|mesh-ancestor
92355590|NCT03820206|Coagulants|coagulants|mesh-ancestor
92355591|NCT02955654|Aripiprazole|aripiprazole|mesh-list
92355592|NCT02955654|Antidepressive Agents|antidepressive agents|mesh-ancestor
92355593|NCT02955654|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355594|NCT02955654|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92355595|NCT02955654|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92355596|NCT02955654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355597|NCT02955654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355598|NCT02955654|Dopamine Agonists|dopamine agonists|mesh-ancestor
92355599|NCT02955654|Dopamine Agents|dopamine agents|mesh-ancestor
92355600|NCT02955654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355601|NCT02955654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355602|NCT02955654|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92355603|NCT02955654|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92355604|NCT02955654|Serotonin Agents|serotonin agents|mesh-ancestor
92355605|NCT02955654|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92355606|NCT02955654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92355607|NCT02955654|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92355608|NCT02955654|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92355609|NCT04392648|Dexamethasone|dexamethasone|mesh-list
92355610|NCT04392648|Cyclophosphamide|cyclophosphamide|mesh-list
92355611|NCT04392648|Bortezomib|bortezomib|mesh-list
92355612|NCT04392648|Pomalidomide|pomalidomide|mesh-list
92355613|NCT04392648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355614|NCT04392648|Immunologic Factors|immunologic factors|mesh-ancestor
92355615|NCT04392648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355616|NCT04392648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355617|NCT04392648|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92355618|NCT04392648|Alkylating Agents|alkylating agents|mesh-ancestor
92355619|NCT04392648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355620|NCT04392648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355621|NCT04392648|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92355622|NCT04392648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355623|NCT04392648|Antiemetics|antiemetics|mesh-ancestor
92355624|NCT04392648|Autonomic Agents|autonomic agents|mesh-ancestor
92355625|NCT04392648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355626|NCT04392648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355627|NCT04392648|Glucocorticoids|glucocorticoids|mesh-ancestor
92355628|NCT04392648|Hormones|hormones|mesh-ancestor
92355629|NCT04392648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355630|NCT04392648|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92355631|NCT04392648|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355632|NCT04392648|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355633|NCT04392648|Growth Substances|growth substances|mesh-ancestor
92355634|NCT04392648|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355636|NCT03826602|Tucatinib|tucatinib|mesh-list
92355637|NCT03826602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92355638|NCT03826602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355639|NCT03826602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355640|NCT03826602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92355641|NCT03826602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355642|NCT03826602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355643|NCT01453920|Ranibizumab|ranibizumab|mesh-list
92355644|NCT01453920|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92355645|NCT01453920|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92355647|NCT01453920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355648|NCT01453920|Growth Inhibitors|growth inhibitors|mesh-ancestor
92355649|NCT01453920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355650|NCT03820908|Bisantrene|bisantrene|mesh-list
92355651|NCT03820908|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92355652|NCT03820908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355653|NCT02953548|Cannabidiol|cannabidiol|mesh-list
92355654|NCT02953548|Anticonvulsants|anticonvulsants|mesh-ancestor
92355655|NCT03112044|Sofosbuvir|sofosbuvir|mesh-list
92355656|NCT03112044|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92355657|NCT03112044|Velpatasvir|velpatasvir|mesh-list
92355658|NCT03112044|Antiviral Agents|antiviral agents|mesh-ancestor
92355659|NCT03112044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355660|NCT02952222|Dexmedetomidine|dexmedetomidine|mesh-list
92355661|NCT02952222|Propofol|propofol|mesh-list
92355662|NCT02952222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92355663|NCT02952222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355664|NCT02952222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355665|NCT02952222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92355666|NCT02952222|Analgesics|analgesics|mesh-ancestor
92355667|NCT02952222|Sensory System Agents|sensory system agents|mesh-ancestor
92355668|NCT02952222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355669|NCT02952222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92355670|NCT02952222|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92355671|NCT02952222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92355672|NCT02952222|Adrenergic Agents|adrenergic agents|mesh-ancestor
92355673|NCT02952222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355674|NCT02952222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355675|NCT02952222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92355676|NCT02952222|Anesthetics, General|anesthetics, general|mesh-ancestor
92355677|NCT02952222|Anesthetics|anesthetics|mesh-ancestor
92355678|NCT03826368|Cannabidiol|cannabidiol|mesh-list
92355679|NCT03826368|Anticonvulsants|anticonvulsants|mesh-ancestor
92355680|NCT04391478|Milrinone|milrinone|mesh-list
92355681|NCT04391478|Sildenafil Citrate|sildenafil citrate|mesh-list
92355682|NCT04391478|Vasodilator Agents|vasodilator agents|mesh-ancestor
92355683|NCT04391478|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92355684|NCT04391478|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92355685|NCT04391478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355686|NCT04391478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355687|NCT04391478|Urological Agents|urological agents|mesh-ancestor
92355688|NCT04391478|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92355689|NCT04391478|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92355690|NCT04391478|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92355691|NCT04391478|Protective Agents|protective agents|mesh-ancestor
92355692|NCT04391478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355693|NCT03828006|Red yeast rice|red yeast rice|mesh-list
92355694|NCT03828006|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92355695|NCT03828006|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92355696|NCT03828006|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92355697|NCT03828006|Antimetabolites|antimetabolites|mesh-ancestor
92355698|NCT03828006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355699|NCT03828006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355700|NCT03828006|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92355701|NCT01454154|Glyburide|glyburide|mesh-list
92355702|NCT01454154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92355703|NCT01454154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355704|NCT04391868|Sildenafil Citrate|sildenafil citrate|mesh-list
92355705|NCT04391868|Citric Acid|citric acid|mesh-list
92355706|NCT04391868|Sodium Citrate|sodium citrate|mesh-list
92355707|NCT04391868|Anticoagulants|anticoagulants|mesh-ancestor
92355708|NCT04391868|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92355709|NCT04391868|Chelating Agents|chelating agents|mesh-ancestor
92355710|NCT04391868|Sequestering Agents|sequestering agents|mesh-ancestor
92355711|NCT04391868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355712|NCT04391868|Vasodilator Agents|vasodilator agents|mesh-ancestor
92355713|NCT04391868|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92355714|NCT04391868|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92355715|NCT04391868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355716|NCT04391868|Urological Agents|urological agents|mesh-ancestor
92355717|NCT03829332|Pembrolizumab|pembrolizumab|mesh-list
92355718|NCT03829332|Lenvatinib|lenvatinib|mesh-list
92355719|NCT03829332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355720|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355721|NCT03829332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92355722|NCT03829332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355723|NCT03829332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92355724|NCT03829332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355725|NCT02983188|Antipsychotic Agents|antipsychotic agents|mesh-list
92355726|NCT02983188|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92355727|NCT02983188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355728|NCT02983188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355729|NCT02983188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355730|NCT01450176|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92355731|NCT01450176|Bepotastine besilate|bepotastine besilate|mesh-list
92355732|NCT01450176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92355733|NCT01450176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92355734|NCT01450176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92355735|NCT01450176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92355736|NCT01450176|Analgesics|analgesics|mesh-ancestor
92355737|NCT01450176|Sensory System Agents|sensory system agents|mesh-ancestor
92355738|NCT01450176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355739|NCT01450176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355740|NCT01450176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355741|NCT01450176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92355742|NCT01450176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92355743|NCT01450176|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92355744|NCT01450176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92355745|NCT01450176|Histamine Antagonists|histamine antagonists|mesh-ancestor
92355746|NCT01450176|Histamine Agents|histamine agents|mesh-ancestor
92355747|NCT01450176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355748|NCT01450176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355749|NCT01454622|Metformin|metformin|mesh-list
92355750|NCT01454622|Canagliflozin|canagliflozin|mesh-list
92355751|NCT01454622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92355752|NCT01454622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355753|NCT01454622|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92355754|NCT01454622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355755|NCT01450410|Nicotinic Acids|nicotinic acids|mesh-list
92355756|NCT01450410|Niacin|niacin|mesh-list
92355757|NCT01450410|Niacinamide|niacinamide|mesh-list
92355758|NCT01450410|Vitamin B Complex|vitamin b complex|mesh-ancestor
92355759|NCT01450410|Vitamins|vitamins|mesh-ancestor
92355760|NCT01450410|Micronutrients|micronutrients|mesh-ancestor
92355761|NCT01450410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355762|NCT01450410|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92355763|NCT01450410|Antimetabolites|antimetabolites|mesh-ancestor
92355764|NCT01450410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355765|NCT01450410|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92355766|NCT01450410|Vasodilator Agents|vasodilator agents|mesh-ancestor
92355767|NCT01450566|Lidocaine|lidocaine|mesh-list
92355768|NCT01450566|Anesthetics, Local|anesthetics, local|mesh-ancestor
92355769|NCT01450566|Anesthetics|anesthetics|mesh-ancestor
92355770|NCT01450566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355771|NCT01450566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355772|NCT01450566|Sensory System Agents|sensory system agents|mesh-ancestor
92355773|NCT01450566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355774|NCT01450566|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92355775|NCT01450566|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92355776|NCT01450566|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92355777|NCT01450566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92355778|NCT01450566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008299|NCT02615119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92355779|NCT02947386|Nivolumab|nivolumab|mesh-list
92355780|NCT02947386|Nimotuzumab|nimotuzumab|mesh-list
92355781|NCT02947386|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355782|NCT02947386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355783|NCT02947386|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92355784|NCT02947386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355785|NCT03043014|Misoprostol|misoprostol|mesh-list
92355786|NCT03043014|Mifepristone|mifepristone|mesh-list
92355787|NCT03043014|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92355788|NCT03043014|Abortifacient Agents|abortifacient agents|mesh-ancestor
92355789|NCT03043014|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92355790|NCT03043014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355791|NCT03043014|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92355792|NCT03043014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355793|NCT03043014|Oxytocics|oxytocics|mesh-ancestor
92355794|NCT03043014|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92355795|NCT03043014|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92355796|NCT03043014|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92355797|NCT03043014|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92355798|NCT03043014|Contraceptive Agents|contraceptive agents|mesh-ancestor
92355799|NCT03043014|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92355800|NCT03043014|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92355801|NCT03043014|Hormone Antagonists|hormone antagonists|mesh-ancestor
92355802|NCT03043014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355803|NCT03043014|Luteolytic Agents|luteolytic agents|mesh-ancestor
92355804|NCT03043014|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92355805|NCT03043014|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92355806|NCT02983344|Fentanyl|fentanyl|mesh-list
92355807|NCT02983344|Ropivacaine|ropivacaine|mesh-list
92355808|NCT02983344|Anesthetics, Local|anesthetics, local|mesh-ancestor
92355809|NCT02983344|Anesthetics|anesthetics|mesh-ancestor
92355810|NCT02983344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355811|NCT02983344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355812|NCT02983344|Sensory System Agents|sensory system agents|mesh-ancestor
92355813|NCT02983344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355814|NCT02983344|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92355815|NCT02983344|Narcotics|narcotics|mesh-ancestor
92355816|NCT02983344|Analgesics|analgesics|mesh-ancestor
92355817|NCT02983344|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92355818|NCT02983344|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92355819|NCT02983344|Anesthetics, General|anesthetics, general|mesh-ancestor
92355820|NCT03824340|Doxycycline|doxycycline|mesh-list
92355821|NCT03824340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92355822|NCT03824340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355823|NCT03824340|Antimalarials|antimalarials|mesh-ancestor
92355824|NCT03824340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92355825|NCT03824340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92355826|NCT01455246|Meropenem|meropenem|mesh-list
92355827|NCT01455246|Daptomycin|daptomycin|mesh-list
92355828|NCT01455246|Ceftazidime|ceftazidime|mesh-list
92355829|NCT01455246|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92355830|NCT01455246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355831|NCT02934282|HBOC 201|hboc 201|mesh-list
92355832|NCT02934282|Blood Substitutes|blood substitutes|mesh-ancestor
92355833|NCT03823950|Lenograstim|lenograstim|mesh-list
92355834|NCT03823950|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92355835|NCT03823950|Immunologic Factors|immunologic factors|mesh-ancestor
92355836|NCT03823950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355837|NCT01451268|Panobinostat|panobinostat|mesh-list
92355838|NCT01451268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355839|NCT01451268|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92355840|NCT01451268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355841|NCT01451268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355843|NCT03823638|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92355844|NCT03823638|Diuretics|diuretics|mesh-ancestor
92355845|NCT03823638|Natriuretic Agents|natriuretic agents|mesh-ancestor
92355846|NCT03823638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355847|NCT02884908|Pregabalin|pregabalin|mesh-list
92355848|NCT02884908|Analgesics|analgesics|mesh-ancestor
92355849|NCT02884908|Sensory System Agents|sensory system agents|mesh-ancestor
92355850|NCT02884908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355851|NCT02884908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355852|NCT02884908|Anticonvulsants|anticonvulsants|mesh-ancestor
92355853|NCT02884908|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92355854|NCT02884908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92355855|NCT02884908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355856|NCT02884908|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92355857|NCT02884908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92355858|NCT02884908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92355859|NCT02884908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355860|NCT02884908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355861|NCT01451580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92355862|NCT01451580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92355863|NCT01451580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355864|NCT01451658|Propranolol|propranolol|mesh-list
92355865|NCT01451658|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92355866|NCT01451658|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92355867|NCT01451658|Adrenergic Agents|adrenergic agents|mesh-ancestor
92355868|NCT01451658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355869|NCT01451658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355870|NCT01451658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355871|NCT01451658|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92355872|NCT01451658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92355873|NCT01451658|Vasodilator Agents|vasodilator agents|mesh-ancestor
92355876|NCT02861898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92355877|NCT02861898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355878|NCT02861898|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92355879|NCT02861898|Diuretics|diuretics|mesh-ancestor
92355880|NCT02861898|Natriuretic Agents|natriuretic agents|mesh-ancestor
92355881|NCT02861898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355883|NCT02851056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92355884|NCT02851056|Immunologic Factors|immunologic factors|mesh-ancestor
92355885|NCT02851056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355886|NCT02935374|Amoxicillin|amoxicillin|mesh-list
92355887|NCT02935374|Clavulanic Acid|clavulanic acid|mesh-list
92355888|NCT02935374|Clavulanic Acids|clavulanic acids|mesh-list
92355889|NCT02935374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92355890|NCT02935374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355891|NCT02935374|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92355892|NCT02935374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355893|NCT02935374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355894|NCT01452750|Lansoprazole|lansoprazole|mesh-list
92355895|NCT01452750|Dexlansoprazole|dexlansoprazole|mesh-list
92355896|NCT01452750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92355897|NCT01452750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355898|NCT01452750|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92355899|NCT01452750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355900|NCT01452750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355901|NCT01452828|Tedizolid phosphate|tedizolid phosphate|mesh-list
92355903|NCT01452828|Oxazolidinones|oxazolidinones|mesh-list
92355904|NCT01452828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92355905|NCT01452828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92355906|NCT01452828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92355907|NCT01452828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355908|NCT01452828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355909|NCT01452906|Omeprazole|omeprazole|mesh-list
92355910|NCT01452906|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92355911|NCT01452906|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355912|NCT01452906|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92355913|NCT01452906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355914|NCT01452906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355915|NCT02781090|Nicotine|nicotine|mesh-list
92355916|NCT02781090|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92355917|NCT02781090|Autonomic Agents|autonomic agents|mesh-ancestor
92355918|NCT02781090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355919|NCT02781090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355920|NCT02781090|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92355921|NCT02781090|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92355922|NCT02781090|Cholinergic Agents|cholinergic agents|mesh-ancestor
92355923|NCT02781090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355924|NCT02781090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355925|NCT03823248|Folic Acid|folic acid|mesh-list
92355926|NCT03823248|Vitamin B Complex|vitamin b complex|mesh-list
92355927|NCT03823248|Hematinics|hematinics|mesh-ancestor
92355928|NCT03823248|Vitamins|vitamins|mesh-ancestor
92355929|NCT03823248|Micronutrients|micronutrients|mesh-ancestor
92355930|NCT03823248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008450|NCT04632589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92355931|NCT03822936|Fluorouracil|fluorouracil|mesh-list
92355932|NCT03822936|Oxaliplatin|oxaliplatin|mesh-list
92355933|NCT03822936|Irinotecan|irinotecan|mesh-list
92355934|NCT03822936|Antimetabolites|antimetabolites|mesh-ancestor
91937339|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
92355935|NCT03822936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355936|NCT03822936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92355937|NCT03822936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92355938|NCT03822936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92355939|NCT03822936|Immunologic Factors|immunologic factors|mesh-ancestor
92355940|NCT03822936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355941|NCT03822936|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92355942|NCT03822936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92355943|NCT03822936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355945|NCT03822546|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92355946|NCT03822546|Autonomic Agents|autonomic agents|mesh-ancestor
92355947|NCT03822546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355948|NCT03822546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355949|NCT03822546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92355950|NCT03822546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92355951|NCT03822546|Cholinergic Agents|cholinergic agents|mesh-ancestor
92355952|NCT03822546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355953|NCT03822546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355954|NCT01453686|Hydrocortisone|hydrocortisone|mesh-list
92355955|NCT01453686|Clobetasol|clobetasol|mesh-list
92355956|NCT01453686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92355957|NCT01453686|Glucocorticoids|glucocorticoids|mesh-ancestor
92355958|NCT01453686|Hormones|hormones|mesh-ancestor
92355959|NCT01453686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355960|NCT01453686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355961|NCT01455870|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92355962|NCT01455870|Exenatide|exenatide|mesh-list
92355963|NCT01455870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92355964|NCT01455870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355965|NCT01455870|Incretins|incretins|mesh-ancestor
92355966|NCT01455870|Hormones|hormones|mesh-ancestor
92355967|NCT01455870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92355968|NCT01455870|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92355969|NCT01455870|Protease Inhibitors|protease inhibitors|mesh-ancestor
92355970|NCT01455870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355971|NCT01455870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355972|NCT01455870|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92355973|NCT01456260|Lansoprazole|lansoprazole|mesh-list
92355974|NCT01456260|Dexlansoprazole|dexlansoprazole|mesh-list
92355975|NCT01456260|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92355976|NCT01456260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92355977|NCT01456260|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92355978|NCT01456260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92355979|NCT01456260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355980|NCT01890408|Ropivacaine|ropivacaine|mesh-list
92355981|NCT01890408|Anesthetics, Local|anesthetics, local|mesh-ancestor
92355982|NCT01890408|Anesthetics|anesthetics|mesh-ancestor
92355983|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355984|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355985|NCT01890408|Sensory System Agents|sensory system agents|mesh-ancestor
92355986|NCT01890408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92355988|NCT04849650|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92355989|NCT04849650|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92355990|NCT04849650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92355991|NCT04849650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92355992|NCT04849650|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92355993|NCT04849650|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92355994|NCT04849650|Dopamine Agents|dopamine agents|mesh-ancestor
92355995|NCT04849650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92355996|NCT04849650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92355997|NCT04849650|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92355998|NCT04849650|Antidepressive Agents|antidepressive agents|mesh-ancestor
92355999|NCT04272372|Ketoprofen|ketoprofen|mesh-list
92356000|NCT04272372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92356001|NCT04272372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92356002|NCT04272372|Analgesics|analgesics|mesh-ancestor
92356003|NCT04272372|Sensory System Agents|sensory system agents|mesh-ancestor
92356004|NCT04272372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356005|NCT04272372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937341|NCT05628389|Nicotine|nicotine|mesh-list
92356006|NCT04272372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356007|NCT04272372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356008|NCT04272372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92356009|NCT04272372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356010|NCT04272372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356011|NCT01891500|Nitric Oxide|nitric oxide|mesh-list
92356012|NCT01891500|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92356013|NCT01891500|Autonomic Agents|autonomic agents|mesh-ancestor
92356014|NCT01891500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356015|NCT01891500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356016|NCT01891500|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92356017|NCT01891500|Respiratory System Agents|respiratory system agents|mesh-ancestor
92356018|NCT01891500|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92356019|NCT01891500|Antioxidants|antioxidants|mesh-ancestor
92356020|NCT01891500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356021|NCT01891500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356022|NCT01891500|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92356023|NCT01891500|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356024|NCT01891500|Gasotransmitters|gasotransmitters|mesh-ancestor
92356025|NCT01891500|Protective Agents|protective agents|mesh-ancestor
92356026|NCT02439450|Pembrolizumab|pembrolizumab|mesh-list
92356027|NCT02439450|Nivolumab|nivolumab|mesh-list
92356028|NCT02439450|Pemetrexed|pemetrexed|mesh-list
92356029|NCT02439450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356030|NCT02439450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356031|NCT02439450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92356032|NCT02439450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356033|NCT02439450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356034|NCT02439450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92356035|NCT02439450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92356036|NCT02862132|Vedolizumab|vedolizumab|mesh-list
92356037|NCT02862132|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356038|NCT02859402|Fludarabine|fludarabine|mesh-list
92356039|NCT02859402|Busulfan|busulfan|mesh-list
92356040|NCT02859402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356041|NCT02859402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356042|NCT02859402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356043|NCT02859402|Immunologic Factors|immunologic factors|mesh-ancestor
92356044|NCT02859402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356045|NCT02859402|Alkylating Agents|alkylating agents|mesh-ancestor
92356046|NCT02859402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92356047|NCT02859402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92356048|NCT04844268|Vaccines|vaccines|mesh-list
92356049|NCT04844268|Immunologic Factors|immunologic factors|mesh-ancestor
92356050|NCT04844268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356051|NCT04842552|Hydralazine|hydralazine|mesh-list
92356052|NCT04842552|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92356053|NCT04842552|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356054|NCT02535312|Cisplatin|cisplatin|mesh-list
92356055|NCT02535312|Pemetrexed|pemetrexed|mesh-list
92356056|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356057|NCT02535312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356058|NCT02535312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356059|NCT02535312|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92356060|NCT02535312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92356061|NCT01891812|Nitrous Oxide|nitrous oxide|mesh-list
92356062|NCT01891812|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92356063|NCT01891812|Anesthetics, General|anesthetics, general|mesh-ancestor
92356064|NCT01891812|Anesthetics|anesthetics|mesh-ancestor
92356065|NCT01891812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356066|NCT01891812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356067|NCT01891812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92356068|NCT01891812|Analgesics|analgesics|mesh-ancestor
92356069|NCT01891812|Sensory System Agents|sensory system agents|mesh-ancestor
92356070|NCT01891812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356071|NCT04390464|Ravulizumab|ravulizumab|mesh-list
92356072|NCT04390464|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92356073|NCT04390464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356074|NCT04390464|Immunologic Factors|immunologic factors|mesh-ancestor
92356075|NCT04390464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356076|NCT01892748|Vitamin D|vitamin d|mesh-list
92356077|NCT01892748|Cholecalciferol|cholecalciferol|mesh-list
92356078|NCT01892748|Vitamins|vitamins|mesh-ancestor
92356079|NCT01892748|Micronutrients|micronutrients|mesh-ancestor
92356080|NCT01892748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356081|NCT01892748|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92356082|NCT01892748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92356084|NCT01893060|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92356085|NCT01893060|Povidone-Iodine|povidone-iodine|mesh-list
92356086|NCT01893060|Povidone|povidone|mesh-list
92356087|NCT01893060|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92356088|NCT01893060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356089|NCT01893060|Disinfectants|disinfectants|mesh-ancestor
92356090|NCT01893060|Dermatologic Agents|dermatologic agents|mesh-ancestor
92356091|NCT01893060|Plasma Substitutes|plasma substitutes|mesh-ancestor
92356092|NCT01893060|Blood Substitutes|blood substitutes|mesh-ancestor
92356093|NCT02344290|Pitavastatin|pitavastatin|mesh-list
92356094|NCT02344290|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92356095|NCT02344290|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92356096|NCT02344290|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92356097|NCT02344290|Antimetabolites|antimetabolites|mesh-ancestor
92356098|NCT02344290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356099|NCT02344290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356100|NCT02344290|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92356101|NCT02848560|Xenon|xenon|mesh-list
92356102|NCT02848560|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92356103|NCT02848560|Anesthetics, General|anesthetics, general|mesh-ancestor
92356104|NCT02848560|Anesthetics|anesthetics|mesh-ancestor
92356105|NCT02848560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356106|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356107|NCT01457820|Allopurinol|allopurinol|mesh-list
92356108|NCT01457820|Antimetabolites|antimetabolites|mesh-ancestor
92356109|NCT01457820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356110|NCT01457820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356111|NCT01457820|Gout Suppressants|gout suppressants|mesh-ancestor
92356112|NCT01457820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356113|NCT01457820|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92356114|NCT01457820|Antioxidants|antioxidants|mesh-ancestor
92356115|NCT01457820|Protective Agents|protective agents|mesh-ancestor
92356116|NCT01457820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356117|NCT05020782|Belimumab|belimumab|mesh-list
92356118|NCT05020782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356119|NCT05020782|Immunologic Factors|immunologic factors|mesh-ancestor
92356120|NCT05020782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356121|NCT01893294|Gemcitabine|gemcitabine|mesh-list
92356122|NCT01893294|Fluorouracil|fluorouracil|mesh-list
92356123|NCT01893294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356124|NCT01893294|Antimetabolites|antimetabolites|mesh-ancestor
92356125|NCT01893294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356126|NCT01893294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356127|NCT01893294|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356128|NCT01893294|Immunologic Factors|immunologic factors|mesh-ancestor
92356129|NCT01893294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356130|NCT01458054|Ritonavir|ritonavir|mesh-list
92356131|NCT01458054|Omeprazole|omeprazole|mesh-list
92356132|NCT01458054|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92356133|NCT01458054|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92356134|NCT01458054|Protease Inhibitors|protease inhibitors|mesh-ancestor
92356135|NCT01458054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356136|NCT01458054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356137|NCT01458054|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92356138|NCT01458054|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92356139|NCT01458054|Antiviral Agents|antiviral agents|mesh-ancestor
92356140|NCT01458054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356141|NCT01458054|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92356142|NCT01458054|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92356143|NCT01458054|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92356144|NCT01458054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356145|NCT01458054|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92356146|NCT01893450|Pentoxifylline|pentoxifylline|mesh-list
92356147|NCT01893450|Bromocriptine|bromocriptine|mesh-list
92356148|NCT01893450|Methimazole|methimazole|mesh-list
92356149|NCT01893450|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92356150|NCT01893450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356151|NCT01893450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356152|NCT01893450|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92356153|NCT01893450|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92356154|NCT01893450|Protective Agents|protective agents|mesh-ancestor
92356155|NCT01893450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356156|NCT01893450|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356157|NCT01893450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92356159|NCT01893450|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92356160|NCT01893450|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92356161|NCT01893450|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356162|NCT01893450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356163|NCT01893450|Dopamine Agonists|dopamine agonists|mesh-ancestor
92356165|NCT01893450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356166|NCT01893450|Antithyroid Agents|antithyroid agents|mesh-ancestor
92356167|NCT05027100|Irinotecan|irinotecan|mesh-list
92356168|NCT05027100|Tislelizumab|tislelizumab|mesh-list
92356169|NCT05027100|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92356170|NCT05027100|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92356171|NCT05027100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356172|NCT05027100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356173|NCT05027100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356174|NCT05027100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356175|NCT01458600|Diclofenac|diclofenac|mesh-list
92356176|NCT01458600|Propranolol|propranolol|mesh-list
92356177|NCT01458600|Metoprolol|metoprolol|mesh-list
92356178|NCT01458600|Methimazole|methimazole|mesh-list
92356179|NCT01458600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92356180|NCT01458600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92356181|NCT01458600|Analgesics|analgesics|mesh-ancestor
92356182|NCT01458600|Sensory System Agents|sensory system agents|mesh-ancestor
92356183|NCT01458600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356184|NCT01458600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356185|NCT01458600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356186|NCT01458600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356187|NCT01458600|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92356188|NCT01458600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356189|NCT01458600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356190|NCT01458600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92356191|NCT01458600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92356192|NCT01458600|Adrenergic Agents|adrenergic agents|mesh-ancestor
92356193|NCT01458600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356194|NCT01458600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92356195|NCT01458600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92356196|NCT01458600|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356197|NCT01458600|Sympatholytics|sympatholytics|mesh-ancestor
92356198|NCT01458600|Autonomic Agents|autonomic agents|mesh-ancestor
92356199|NCT01458600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92356200|NCT01458600|Antithyroid Agents|antithyroid agents|mesh-ancestor
92356201|NCT01458600|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356202|NCT01458600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356203|NCT02832570|Sildenafil Citrate|sildenafil citrate|mesh-list
92356204|NCT02832570|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356205|NCT02832570|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92356206|NCT02832570|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92356207|NCT02832570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356208|NCT02832570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356209|NCT02832570|Urological Agents|urological agents|mesh-ancestor
92356210|NCT02742324|Interferon-alpha|interferon-alpha|mesh-list
92356211|NCT02742324|Interferon alpha-2|interferon alpha-2|mesh-list
92356212|NCT02742324|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92356213|NCT02742324|Antiviral Agents|antiviral agents|mesh-ancestor
92356214|NCT02742324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356215|NCT02742324|Immunologic Factors|immunologic factors|mesh-ancestor
92356216|NCT02742324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356217|NCT02742324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356218|NCT01459146|Lumefantrine|lumefantrine|mesh-list
92356219|NCT01459146|Artemether|artemether|mesh-list
92356220|NCT01459146|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92356221|NCT01459146|Albendazole|albendazole|mesh-list
92356222|NCT01459146|Praziquantel|praziquantel|mesh-list
92356223|NCT01459146|Antimalarials|antimalarials|mesh-ancestor
92356224|NCT01459146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92356225|NCT01459146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92356226|NCT01459146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356227|NCT01459146|Anthelmintics|anthelmintics|mesh-ancestor
92356228|NCT01459146|Anticestodal Agents|anticestodal agents|mesh-ancestor
92356229|NCT01459146|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92356230|NCT01459146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356231|NCT01459146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356232|NCT01459146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356233|NCT01459146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356234|NCT01459146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356235|NCT05026398|Fenfluramine|fenfluramine|mesh-list
92356236|NCT05026398|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92356237|NCT05026398|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92356238|NCT05026398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92356239|NCT05026398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356240|NCT05026398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356241|NCT05026398|Serotonin Agents|serotonin agents|mesh-ancestor
92356242|NCT05026398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356243|NCT05586750|Atorvastatin|atorvastatin|mesh-list
92356244|NCT05586750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92356245|NCT05586750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92356246|NCT05586750|Antimetabolites|antimetabolites|mesh-ancestor
92356247|NCT05586750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356248|NCT05586750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92356249|NCT05586750|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92356250|NCT05586750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356251|NCT02720094|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92356252|NCT02720094|Cabotegravir|cabotegravir|mesh-list
92356253|NCT02720094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92356254|NCT02720094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92356255|NCT02720094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356256|NCT02720094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356257|NCT02720094|Antiviral Agents|antiviral agents|mesh-ancestor
92356258|NCT02720094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356259|NCT02720094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92356260|NCT02720094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92356261|NCT02720094|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92356262|NCT02720094|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92356263|NCT02716974|Docetaxel|docetaxel|mesh-list
92356264|NCT02716974|Leuprolide|leuprolide|mesh-list
92356265|NCT02716974|Bicalutamide|bicalutamide|mesh-list
92356266|NCT02716974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356267|NCT02716974|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356268|NCT02716974|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356269|NCT02716974|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356270|NCT02716974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356271|NCT02716974|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92356273|NCT02716974|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92356274|NCT02716974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356275|NCT02716974|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92356276|NCT02716974|Androgen Antagonists|androgen antagonists|mesh-ancestor
92356277|NCT02716974|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356278|NCT02716974|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356279|NCT01459380|Bevacizumab|bevacizumab|mesh-list
92356280|NCT01459380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92356281|NCT01459380|Carboplatin|carboplatin|mesh-list
92356282|NCT01459380|Doxorubicin|doxorubicin|mesh-list
92356283|NCT01459380|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92356284|NCT01459380|Veliparib|veliparib|mesh-list
92356285|NCT01459380|Endothelial Growth Factors|endothelial growth factors|mesh-list
92356286|NCT01459380|Antibodies|antibodies|mesh-list
92356287|NCT01459380|Immunoglobulins|immunoglobulins|mesh-list
92356288|NCT01459380|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92356289|NCT01459380|Immunoglobulin G|immunoglobulin g|mesh-list
92356290|NCT01459380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356291|NCT01459380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92356292|NCT01459380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92356293|NCT01459380|Growth Substances|growth substances|mesh-ancestor
92356294|NCT01459380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356295|NCT01459380|Growth Inhibitors|growth inhibitors|mesh-ancestor
92356296|NCT01459380|Immunologic Factors|immunologic factors|mesh-ancestor
92356297|NCT01459380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92356298|NCT01459380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92356299|NCT01459380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92356300|NCT01459380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356301|NCT01459380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937346|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92356302|NCT01459380|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92356303|NCT04346004|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92356305|NCT02680314|Methotrexate|methotrexate|mesh-list
92356306|NCT02680314|Misoprostol|misoprostol|mesh-list
92356307|NCT02680314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92356308|NCT02680314|Abortifacient Agents|abortifacient agents|mesh-ancestor
92356309|NCT02680314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92356310|NCT02680314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356311|NCT02680314|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356312|NCT02680314|Antimetabolites|antimetabolites|mesh-ancestor
92356313|NCT02680314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356314|NCT02680314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356315|NCT02680314|Dermatologic Agents|dermatologic agents|mesh-ancestor
92356316|NCT02680314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356317|NCT02680314|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92356318|NCT02680314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356319|NCT02680314|Immunologic Factors|immunologic factors|mesh-ancestor
92356320|NCT02680314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356321|NCT02680314|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92356322|NCT02680314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92356323|NCT02680314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356324|NCT02680314|Oxytocics|oxytocics|mesh-ancestor
92356325|NCT02707692|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92356326|NCT02707692|Immunologic Factors|immunologic factors|mesh-ancestor
92356327|NCT02707692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356329|NCT02706678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356330|NCT02706678|Immunologic Factors|immunologic factors|mesh-ancestor
92356331|NCT02706678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356332|NCT02706678|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92356333|NCT02706678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356334|NCT02706678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356335|NCT02705196|Paclitaxel|paclitaxel|mesh-list
92356336|NCT02705196|Gemcitabine|gemcitabine|mesh-list
92356337|NCT02705196|Atezolizumab|atezolizumab|mesh-list
92356338|NCT02705196|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356339|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356340|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356341|NCT02705196|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356342|NCT02705196|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356343|NCT02705196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356344|NCT02705196|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356345|NCT02705196|Antimetabolites|antimetabolites|mesh-ancestor
92356346|NCT02705196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92356347|NCT02705196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356348|NCT02703948|Lidocaine|lidocaine|mesh-list
92356349|NCT02703948|Anesthetics, Local|anesthetics, local|mesh-ancestor
92356350|NCT02703948|Anesthetics|anesthetics|mesh-ancestor
92356351|NCT02703948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356352|NCT02703948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356353|NCT02703948|Sensory System Agents|sensory system agents|mesh-ancestor
92356354|NCT02703948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356355|NCT02703948|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92356356|NCT02703948|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92356357|NCT02703948|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92356358|NCT02703948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92356359|NCT02703948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356360|NCT02666742|Aspirin|aspirin|mesh-list
92356361|NCT02666742|Rivaroxaban|rivaroxaban|mesh-list
92356362|NCT02666742|Edoxaban|edoxaban|mesh-list
92356363|NCT02666742|Dabigatran|dabigatran|mesh-list
92356364|NCT02666742|Anticoagulants|anticoagulants|mesh-list
92356365|NCT02666742|Coagulants|coagulants|mesh-list
92356366|NCT02666742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92356367|NCT02666742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92356368|NCT02666742|Analgesics|analgesics|mesh-ancestor
92356369|NCT02666742|Sensory System Agents|sensory system agents|mesh-ancestor
92356370|NCT02666742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356371|NCT02666742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356372|NCT02666742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356373|NCT02666742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356374|NCT02666742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92356375|NCT02666742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92356376|NCT02666742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356377|NCT02666742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92356378|NCT02666742|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92356379|NCT02666742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356381|NCT02666742|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92356382|NCT02666742|Antithrombins|antithrombins|mesh-ancestor
92356383|NCT02666742|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92356384|NCT02666742|Protease Inhibitors|protease inhibitors|mesh-ancestor
92356386|NCT02684292|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92356387|NCT02684292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356388|NCT02684292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356389|NCT02684292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92356390|NCT02684292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356391|NCT02684292|Immunotoxins|immunotoxins|mesh-ancestor
92356393|NCT02684292|Immunologic Factors|immunologic factors|mesh-ancestor
92356394|NCT02684292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356395|NCT05586516|Paclitaxel|paclitaxel|mesh-list
92356396|NCT05586516|Gemcitabine|gemcitabine|mesh-list
92356397|NCT05586516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356398|NCT05586516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356399|NCT05586516|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356400|NCT05586516|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356401|NCT05586516|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356402|NCT05586516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356403|NCT05586516|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356404|NCT05586516|Antimetabolites|antimetabolites|mesh-ancestor
92356405|NCT04390854|Clotrimazole|clotrimazole|mesh-list
92356406|NCT04390854|Miconazole|miconazole|mesh-list
92356407|NCT04390854|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92356408|NCT04390854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356409|NCT04390854|Antifungal Agents|antifungal agents|mesh-ancestor
92356410|NCT04390854|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92356411|NCT04390854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92356412|NCT04390854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356413|NCT04390854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356414|NCT04390854|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92356415|NCT04390854|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356416|NCT04390854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356417|NCT04390854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356418|NCT04390854|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92356419|NCT04390854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92356420|NCT02465736|Cisplatin|cisplatin|mesh-list
92356421|NCT02465736|Docetaxel|docetaxel|mesh-list
92356422|NCT02465736|Vinorelbine|vinorelbine|mesh-list
92356423|NCT02465736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356424|NCT02465736|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356425|NCT02465736|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356426|NCT02465736|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356427|NCT02465736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356428|NCT02465736|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356429|NCT02630316|Treprostinil|treprostinil|mesh-list
92356430|NCT02630316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92356431|NCT02359968|Paclitaxel|paclitaxel|mesh-list
92356432|NCT02359968|Fluorouracil|fluorouracil|mesh-list
92356433|NCT02359968|Oxaliplatin|oxaliplatin|mesh-list
92356434|NCT02359968|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356435|NCT02359968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356436|NCT02359968|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356437|NCT02359968|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356438|NCT02359968|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356439|NCT02359968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356440|NCT02359968|Antimetabolites|antimetabolites|mesh-ancestor
92356441|NCT02359968|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356442|NCT02359968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356443|NCT02359968|Immunologic Factors|immunologic factors|mesh-ancestor
92356444|NCT02359968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356445|NCT04757376|Denosumab|denosumab|mesh-list
92356446|NCT04757376|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92356447|NCT04757376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356448|NCT02624544|Desonide|desonide|mesh-list
92356449|NCT02624544|Esomeprazole|esomeprazole|mesh-list
92356450|NCT02624544|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92356451|NCT02624544|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356452|NCT02624544|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92356453|NCT02624544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356454|NCT02624544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356455|NCT02624544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356456|NCT02603328|Atorvastatin|atorvastatin|mesh-list
92356457|NCT02603328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92356458|NCT02603328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92008989|NCT05015335|Adalimumab|adalimumab|mesh-list
92356459|NCT02603328|Antimetabolites|antimetabolites|mesh-ancestor
92356460|NCT02603328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356461|NCT02603328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92356462|NCT02603328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92356463|NCT02603328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356464|NCT02323698|Caffeine|caffeine|mesh-list
92356465|NCT02323698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92356466|NCT02323698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356467|NCT02323698|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92356468|NCT02323698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356469|NCT02323698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356470|NCT02323698|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92356471|NCT02323698|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92356472|NCT02323698|Purinergic Agents|purinergic agents|mesh-ancestor
92356473|NCT02323698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356474|NCT01451736|Risperidone|risperidone|mesh-list
92356475|NCT01451736|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92356476|NCT01451736|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92356477|NCT01451736|Serotonin Agents|serotonin agents|mesh-ancestor
92356478|NCT01451736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356479|NCT01451736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356480|NCT01451736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356481|NCT01451736|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92356482|NCT01451736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92356483|NCT01451736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356484|NCT01451736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92356485|NCT01451736|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92356486|NCT01451736|Dopamine Agents|dopamine agents|mesh-ancestor
92356487|NCT01451736|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92356488|NCT01451736|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92356490|NCT02589600|Zoledronic Acid|zoledronic acid|mesh-list
92356491|NCT02589600|Calcium|calcium|mesh-list
92356492|NCT02589600|Vitamins|vitamins|mesh-ancestor
92356493|NCT02589600|Micronutrients|micronutrients|mesh-ancestor
92356494|NCT02589600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356495|NCT02589600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92356496|NCT02589600|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92356497|NCT04758000|Metformin|metformin|mesh-list
92356498|NCT04758000|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92356499|NCT04758000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356500|NCT01450956|Sevoflurane|sevoflurane|mesh-list
92356501|NCT01450956|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92356502|NCT01450956|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92356503|NCT01450956|Anesthetics, General|anesthetics, general|mesh-ancestor
92356504|NCT01450956|Anesthetics|anesthetics|mesh-ancestor
92356505|NCT01450956|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356506|NCT01450956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356507|NCT02300922|Antibodies|antibodies|mesh-list
92356508|NCT02300922|Immunologic Factors|immunologic factors|mesh-ancestor
92356509|NCT02300922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356510|NCT01453530|Glycopyrrolate|glycopyrrolate|mesh-list
92356511|NCT01453530|Neostigmine|neostigmine|mesh-list
92356512|NCT01453530|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92356513|NCT01453530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356514|NCT01453530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356515|NCT01453530|Cholinergic Agents|cholinergic agents|mesh-ancestor
92356516|NCT01453530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356517|NCT01453530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356518|NCT01453530|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92356519|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
92356520|NCT01453530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356521|NCT01453530|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92356522|NCT01453530|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92356523|NCT01453530|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92356524|NCT02983422|Aminophylline|aminophylline|mesh-list
92356525|NCT02983422|Furosemide|furosemide|mesh-list
92356526|NCT02983422|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92356527|NCT02983422|Autonomic Agents|autonomic agents|mesh-ancestor
92356528|NCT02983422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356529|NCT02983422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356530|NCT02983422|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92356531|NCT02983422|Respiratory System Agents|respiratory system agents|mesh-ancestor
92356532|NCT02983422|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92009072|NCT04400201|Propofol|propofol|mesh-list
92356533|NCT02983422|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92356534|NCT02983422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356535|NCT02983422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356536|NCT02983422|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92356537|NCT02983422|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92356538|NCT02983422|Purinergic Agents|purinergic agents|mesh-ancestor
92356539|NCT02983422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356540|NCT02983422|Protective Agents|protective agents|mesh-ancestor
92356542|NCT02983422|Natriuretic Agents|natriuretic agents|mesh-ancestor
92356543|NCT02983422|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92356544|NCT02983422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92356545|NCT05585814|Bevacizumab|bevacizumab|mesh-list
92356546|NCT05585814|Pembrolizumab|pembrolizumab|mesh-list
92356547|NCT05585814|Capecitabine|capecitabine|mesh-list
92356548|NCT05585814|Oxaliplatin|oxaliplatin|mesh-list
92356549|NCT05585814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356550|NCT05585814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356551|NCT05585814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92356552|NCT05585814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92356553|NCT05585814|Growth Substances|growth substances|mesh-ancestor
92356554|NCT05585814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356555|NCT05585814|Growth Inhibitors|growth inhibitors|mesh-ancestor
92356556|NCT05585814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92356557|NCT05585814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356558|NCT05585814|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356559|NCT05585814|Antimetabolites|antimetabolites|mesh-ancestor
92356560|NCT02013648|Cytarabine|cytarabine|mesh-list
92356561|NCT02013648|Daunorubicin|daunorubicin|mesh-list
92356562|NCT02013648|Dasatinib|dasatinib|mesh-list
92356563|NCT02013648|Idarubicin|idarubicin|mesh-list
92356564|NCT02013648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356565|NCT02013648|Antimetabolites|antimetabolites|mesh-ancestor
92356566|NCT02013648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356567|NCT02013648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356568|NCT02013648|Antiviral Agents|antiviral agents|mesh-ancestor
92356569|NCT02013648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356570|NCT02013648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356571|NCT02013648|Immunologic Factors|immunologic factors|mesh-ancestor
92356572|NCT02013648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356573|NCT02013648|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92356574|NCT02013648|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92356575|NCT02013648|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92356576|NCT02013648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356577|NCT02013648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92356579|NCT05585736|Autonomic Agents|autonomic agents|mesh-ancestor
92356580|NCT05585736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356581|NCT05585736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356582|NCT01989780|Paclitaxel|paclitaxel|mesh-list
92356583|NCT01989780|Bevacizumab|bevacizumab|mesh-list
92356584|NCT01989780|Letrozole|letrozole|mesh-list
92356585|NCT01989780|Fulvestrant|fulvestrant|mesh-list
92356586|NCT01989780|Anastrozole|anastrozole|mesh-list
92356587|NCT01989780|Exemestane|exemestane|mesh-list
92356588|NCT01989780|Goserelin|goserelin|mesh-list
92356589|NCT01989780|Leuprolide|leuprolide|mesh-list
92356590|NCT01989780|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356591|NCT01989780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356592|NCT01989780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356593|NCT01989780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356594|NCT01989780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356595|NCT01989780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356596|NCT01989780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356597|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92356599|NCT01989780|Growth Substances|growth substances|mesh-ancestor
92356600|NCT01989780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356601|NCT01989780|Growth Inhibitors|growth inhibitors|mesh-ancestor
92356602|NCT01989780|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92356603|NCT01989780|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92356604|NCT01989780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356605|NCT01989780|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92356606|NCT01989780|Hormone Antagonists|hormone antagonists|mesh-ancestor
92009186|NCT02680561|Xhance|xhance|mesh-list
92356607|NCT01989780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356608|NCT01989780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92356609|NCT01989780|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92356610|NCT01989780|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92356612|NCT01989780|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92356614|NCT02270814|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92356615|NCT02270814|Cisplatin|cisplatin|mesh-list
92356616|NCT02270814|Carboplatin|carboplatin|mesh-list
92356617|NCT02270814|Cetuximab|cetuximab|mesh-list
92356618|NCT02270814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356619|NCT02270814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356620|NCT02270814|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356621|NCT02270814|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356622|NCT02270814|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356623|NCT02270814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356624|NCT02270814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92356625|NCT02549898|Cilostazol|cilostazol|mesh-list
92356626|NCT02549898|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92356627|NCT02549898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92356628|NCT02549898|Autonomic Agents|autonomic agents|mesh-ancestor
92356629|NCT02549898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356630|NCT02549898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356631|NCT02549898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92356632|NCT02549898|Respiratory System Agents|respiratory system agents|mesh-ancestor
92356633|NCT02549898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92356634|NCT02549898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92117611|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356635|NCT02549898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356636|NCT02549898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92356637|NCT02549898|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356638|NCT02549898|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92356639|NCT02549898|Protective Agents|protective agents|mesh-ancestor
92356640|NCT02549898|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92356641|NCT02549898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92356642|NCT02549898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356643|NCT02549898|Hematinics|hematinics|mesh-ancestor
92356644|NCT02549898|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92356645|NCT02549898|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92356646|NCT05585580|Paclitaxel|paclitaxel|mesh-list
92356647|NCT05585580|Lenvatinib|lenvatinib|mesh-list
92356648|NCT05585580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356649|NCT05585580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356650|NCT05585580|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356651|NCT05585580|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356652|NCT05585580|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356653|NCT05585580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356654|NCT05585580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92356655|NCT05585580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356656|NCT02513784|Chlorhexidine|chlorhexidine|mesh-list
92356657|NCT02513784|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92356658|NCT02513784|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92356659|NCT02513784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356660|NCT02513784|Disinfectants|disinfectants|mesh-ancestor
92356661|NCT02513784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92356662|NCT02283996|Methylprednisolone|methylprednisolone|mesh-list
92356663|NCT02283996|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92356664|NCT02283996|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92356665|NCT02283996|Prednisolone|prednisolone|mesh-list
92356666|NCT02283996|Prednisolone acetate|prednisolone acetate|mesh-list
92356667|NCT02283996|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92356668|NCT02283996|Prednisolone phosphate|prednisolone phosphate|mesh-list
92356669|NCT02283996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356670|NCT02283996|Antiemetics|antiemetics|mesh-ancestor
92356671|NCT02283996|Autonomic Agents|autonomic agents|mesh-ancestor
92356672|NCT02283996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356673|NCT02283996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356674|NCT02283996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356675|NCT02283996|Glucocorticoids|glucocorticoids|mesh-ancestor
92356676|NCT02283996|Hormones|hormones|mesh-ancestor
92356677|NCT02283996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356678|NCT02283996|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92356679|NCT02283996|Protective Agents|protective agents|mesh-ancestor
92356680|NCT02283996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92356681|NCT02283996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356682|NCT02369484|Afatinib|afatinib|mesh-list
92009207|NCT02680561|Sympathomimetics|sympathomimetics|mesh-ancestor
92356683|NCT02369484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356684|NCT02369484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92356685|NCT02369484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356686|NCT02369484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356687|NCT04390152|Ritonavir|ritonavir|mesh-list
92356688|NCT04390152|Lopinavir|lopinavir|mesh-list
92356689|NCT04390152|Azithromycin|azithromycin|mesh-list
92356690|NCT04390152|Hydroxychloroquine|hydroxychloroquine|mesh-list
92356691|NCT04390152|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92356692|NCT04390152|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92356693|NCT04390152|Protease Inhibitors|protease inhibitors|mesh-ancestor
92356694|NCT04390152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356695|NCT04390152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356696|NCT04390152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92356697|NCT04390152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92356698|NCT04390152|Antiviral Agents|antiviral agents|mesh-ancestor
92356699|NCT04390152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356700|NCT04390152|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92356701|NCT04390152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92356702|NCT04390152|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92356703|NCT04390152|Antimalarials|antimalarials|mesh-ancestor
92356704|NCT04390152|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92356705|NCT04390152|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92356706|NCT04390152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356707|NCT02227992|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92356708|NCT02227992|Hemostatics|hemostatics|mesh-ancestor
92356709|NCT02227992|Coagulants|coagulants|mesh-ancestor
92356710|NCT02496780|Insulin|insulin|mesh-list
92356711|NCT02496780|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92356712|NCT02496780|Insulin Aspart|insulin aspart|mesh-list
92356713|NCT02496780|Insulin Detemir|insulin detemir|mesh-list
92356714|NCT02496780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92356715|NCT02496780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356716|NCT01953588|Fulvestrant|fulvestrant|mesh-list
92356717|NCT01953588|Anastrozole|anastrozole|mesh-list
92356718|NCT01953588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92356719|NCT01953588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356720|NCT01953588|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92356721|NCT01953588|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92356722|NCT01953588|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356723|NCT01953588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356724|NCT01953588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356725|NCT01953588|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92356726|NCT01953588|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92356727|NCT01953588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356728|NCT01953588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356729|NCT01953510|Vaccines|vaccines|mesh-list
92356730|NCT01953510|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92356731|NCT01953510|Immunologic Factors|immunologic factors|mesh-ancestor
92356732|NCT01953510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356733|NCT01943994|Psilocybin|psilocybin|mesh-list
92356734|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92356735|NCT01943994|Nicotine|nicotine|mesh-list
92356736|NCT01943994|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92356737|NCT01943994|Autonomic Agents|autonomic agents|mesh-ancestor
92356738|NCT01943994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356739|NCT01943994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356740|NCT01943994|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92356741|NCT01943994|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92356742|NCT01943994|Cholinergic Agents|cholinergic agents|mesh-ancestor
92356743|NCT01943994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356744|NCT01943994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356745|NCT01943994|Hallucinogens|hallucinogens|mesh-ancestor
92356746|NCT01943994|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92356747|NCT01943994|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92356748|NCT01943994|Serotonin Agents|serotonin agents|mesh-ancestor
92356749|NCT01943994|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92356750|NCT02456532|Zolpidem|zolpidem|mesh-list
92356751|NCT02456532|Eszopiclone|eszopiclone|mesh-list
92356752|NCT02456532|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92356753|NCT02456532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92356754|NCT02456532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356755|NCT02456532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356756|NCT02456532|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92009283|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
92356757|NCT02456532|GABA Agonists|gaba agonists|mesh-ancestor
92356758|NCT02456532|GABA Agents|gaba agents|mesh-ancestor
92356759|NCT02456532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356760|NCT02456532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356761|NCT02153580|Cyclophosphamide|cyclophosphamide|mesh-list
92356762|NCT02153580|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92356763|NCT02153580|Fludarabine|fludarabine|mesh-list
92356764|NCT02153580|Fludarabine phosphate|fludarabine phosphate|mesh-list
92356765|NCT02153580|Etoposide|etoposide|mesh-list
92356766|NCT02153580|Etoposide phosphate|etoposide phosphate|mesh-list
92356767|NCT02153580|Podophyllotoxin|podophyllotoxin|mesh-list
92356768|NCT02153580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356769|NCT02153580|Immunologic Factors|immunologic factors|mesh-ancestor
92356770|NCT02153580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356771|NCT02153580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356772|NCT02153580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92356773|NCT02153580|Alkylating Agents|alkylating agents|mesh-ancestor
92356774|NCT02153580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356775|NCT02153580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356776|NCT02153580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92356777|NCT02153580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356778|NCT02153580|Antimetabolites|antimetabolites|mesh-ancestor
92356779|NCT02153580|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356780|NCT02153580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92356781|NCT02153580|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92356782|NCT02153580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356783|NCT02153580|Keratolytic Agents|keratolytic agents|mesh-ancestor
92356784|NCT02153580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92356785|NCT02153580|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356786|NCT02153580|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356787|NCT02153580|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356788|NCT05578950|Itraconazole|itraconazole|mesh-list
92356789|NCT05578950|Terbinafine|terbinafine|mesh-list
92356790|NCT05578950|Antifungal Agents|antifungal agents|mesh-ancestor
92356791|NCT05578950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356792|NCT05578950|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92356793|NCT05578950|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92356794|NCT05578950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356795|NCT05578950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356796|NCT05578950|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92356797|NCT05578950|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356798|NCT05578950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356799|NCT05578950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356800|NCT05578950|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92356801|NCT05586126|Sevoflurane|sevoflurane|mesh-list
92356802|NCT05586126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92356803|NCT05586126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92356804|NCT05586126|Anesthetics, General|anesthetics, general|mesh-ancestor
92356805|NCT05586126|Anesthetics|anesthetics|mesh-ancestor
92356806|NCT05586126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356807|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356808|NCT01893996|Adalimumab|adalimumab|mesh-list
92356809|NCT01893996|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92356810|NCT01893996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356811|NCT01893996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356812|NCT02442180|Methylprednisolone|methylprednisolone|mesh-list
92356813|NCT02442180|Prednisolone|prednisolone|mesh-list
92356814|NCT02442180|Lenograstim|lenograstim|mesh-list
92356815|NCT02442180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92356816|NCT02442180|Immunologic Factors|immunologic factors|mesh-ancestor
92356817|NCT02442180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356818|NCT02442180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356819|NCT02442180|Antiemetics|antiemetics|mesh-ancestor
92356820|NCT02442180|Autonomic Agents|autonomic agents|mesh-ancestor
92356821|NCT02442180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356822|NCT02442180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356823|NCT02442180|Glucocorticoids|glucocorticoids|mesh-ancestor
92356825|NCT02442180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356826|NCT02442180|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92356827|NCT02442180|Protective Agents|protective agents|mesh-ancestor
92356828|NCT02442180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92356829|NCT02442180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356830|NCT01924260|Gemcitabine|gemcitabine|mesh-list
92356831|NCT01924260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92356832|NCT01924260|Antimetabolites|antimetabolites|mesh-ancestor
92356833|NCT01924260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356835|NCT02432742|Hyaluronic Acid|hyaluronic acid|mesh-list
92356836|NCT02432742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92356837|NCT02432742|Immunologic Factors|immunologic factors|mesh-ancestor
92356838|NCT02432742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356839|NCT02432742|Viscosupplements|viscosupplements|mesh-ancestor
92356840|NCT02432742|Protective Agents|protective agents|mesh-ancestor
92356841|NCT02086500|Tranexamic Acid|tranexamic acid|mesh-list
92356842|NCT02086500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92356843|NCT02086500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92356844|NCT02086500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356846|NCT02086500|Coagulants|coagulants|mesh-ancestor
92356847|NCT02104986|Cisplatin|cisplatin|mesh-list
92356848|NCT02104986|Ifosfamide|ifosfamide|mesh-list
92356849|NCT02104986|Bleomycin|bleomycin|mesh-list
92356850|NCT02104986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356851|NCT02104986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92356852|NCT02104986|Alkylating Agents|alkylating agents|mesh-ancestor
92356853|NCT02104986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356854|NCT02104986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92356855|NCT02425566|Trimethaphan|trimethaphan|mesh-list
92356856|NCT02425566|Nitroglycerin|nitroglycerin|mesh-list
92356857|NCT02425566|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
92356858|NCT02425566|Vasodilator Agents|vasodilator agents|mesh-ancestor
92356859|NCT02425566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92356860|NCT02425566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92356861|NCT02425566|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92356862|NCT02425566|Autonomic Agents|autonomic agents|mesh-ancestor
92356863|NCT02425566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117689|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92356864|NCT02425566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356865|NCT02425566|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92356866|NCT02425566|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92356867|NCT02425566|Cholinergic Agents|cholinergic agents|mesh-ancestor
92356868|NCT02425566|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356869|NCT02425566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356870|NCT04757532|Methyltestosterone|methyltestosterone|mesh-list
92356871|NCT04757532|Anastrozole|anastrozole|mesh-list
92356872|NCT04757532|Chlorthalidone|chlorthalidone|mesh-list
92356873|NCT04757532|Bupropion|bupropion|mesh-list
92356874|NCT04757532|Testosterone|testosterone|mesh-list
92356875|NCT04757532|Testosterone undecanoate|testosterone undecanoate|mesh-list
92356876|NCT04757532|Testosterone enanthate|testosterone enanthate|mesh-list
92356877|NCT04757532|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92356878|NCT04757532|Danazol|danazol|mesh-list
92356879|NCT04757532|Androgens|androgens|mesh-ancestor
92356880|NCT04757532|Hormones|hormones|mesh-ancestor
92356881|NCT04757532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356882|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356883|NCT04757532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92356884|NCT04757532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356885|NCT04757532|Anabolic Agents|anabolic agents|mesh-ancestor
92356886|NCT04757532|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92356887|NCT04757532|Antidepressive Agents|antidepressive agents|mesh-ancestor
92356888|NCT04757532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92356889|NCT04757532|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92356890|NCT04757532|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92356891|NCT04757532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92356892|NCT04757532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356893|NCT04757532|Dopamine Agents|dopamine agents|mesh-ancestor
92356894|NCT04757532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356895|NCT04757532|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92356896|NCT04757532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92356897|NCT04757532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356898|NCT04757532|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92356899|NCT04757532|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92356900|NCT04757532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92356901|NCT04757532|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356902|NCT04757532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92356903|NCT04757532|Diuretics|diuretics|mesh-ancestor
92356905|NCT04757532|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92356906|NCT02069730|Androgens|androgens|mesh-list
92356907|NCT02069730|Androgen Antagonists|androgen antagonists|mesh-list
92356908|NCT02069730|Hormones|hormones|mesh-ancestor
92356909|NCT02069730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356910|NCT02069730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356911|NCT02069730|Hormone Antagonists|hormone antagonists|mesh-ancestor
92356912|NCT02068092|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92356913|NCT02068092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356915|NCT02068092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356916|NCT02068092|Protective Agents|protective agents|mesh-ancestor
92356917|NCT02068092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356918|NCT02068092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92356919|NCT02063022|Dactinomycin|dactinomycin|mesh-list
92356920|NCT02063022|Cyclophosphamide|cyclophosphamide|mesh-list
92356921|NCT02063022|Melphalan|melphalan|mesh-list
92356922|NCT02063022|Busulfan|busulfan|mesh-list
92356923|NCT02063022|Ifosfamide|ifosfamide|mesh-list
92356924|NCT02063022|Isophosphamide mustard|isophosphamide mustard|mesh-list
92356925|NCT02063022|Doxorubicin|doxorubicin|mesh-list
92356926|NCT02063022|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92356927|NCT02063022|Etoposide|etoposide|mesh-list
92356928|NCT02063022|Etoposide phosphate|etoposide phosphate|mesh-list
92356929|NCT02063022|Vincristine|vincristine|mesh-list
92356930|NCT02063022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92356931|NCT02063022|Immunologic Factors|immunologic factors|mesh-ancestor
92356932|NCT02063022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356933|NCT02063022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356934|NCT02063022|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92356935|NCT02063022|Alkylating Agents|alkylating agents|mesh-ancestor
92356936|NCT02063022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356937|NCT02063022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92356938|NCT02063022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92356939|NCT02063022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92356940|NCT02063022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92117690|NCT03474276|Azithromycin|azithromycin|mesh-list
92356941|NCT02063022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92356942|NCT02063022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92356943|NCT02063022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92356944|NCT02063022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92356945|NCT02063022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92356946|NCT02063022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92356947|NCT02063022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92356948|NCT02063022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92356949|NCT02063022|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92356950|NCT02063022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92356951|NCT01895010|Tropisetron|tropisetron|mesh-list
92356952|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
92356953|NCT01895010|Autonomic Agents|autonomic agents|mesh-ancestor
92356954|NCT01895010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356955|NCT01895010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356956|NCT01895010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92356957|NCT01895010|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92356958|NCT01895010|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92356959|NCT01895010|Serotonin Agents|serotonin agents|mesh-ancestor
92356960|NCT01895010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356961|NCT01895010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356962|NCT02030028|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92356963|NCT02030028|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92356964|NCT02030028|beta-Endorphin|beta-endorphin|mesh-list
92356965|NCT02030028|Hormones|hormones|mesh-ancestor
92356966|NCT02030028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92356967|NCT02030028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356968|NCT02030028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356969|NCT02030028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356970|NCT01896336|Zolpidem|zolpidem|mesh-list
92356971|NCT01896336|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92356972|NCT01896336|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92356973|NCT01896336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92356974|NCT01896336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356975|NCT01896336|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92356976|NCT01896336|GABA Agonists|gaba agonists|mesh-ancestor
92356977|NCT01896336|GABA Agents|gaba agents|mesh-ancestor
92356978|NCT01896336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356979|NCT01896336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356980|NCT00575718|Nicotine|nicotine|mesh-list
92356981|NCT00575718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92356982|NCT00575718|Autonomic Agents|autonomic agents|mesh-ancestor
92356983|NCT00575718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356984|NCT00575718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356985|NCT00575718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92356986|NCT00575718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92356987|NCT00575718|Cholinergic Agents|cholinergic agents|mesh-ancestor
92356988|NCT00575718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92356989|NCT00575718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92356990|NCT02087748|Diclofenac|diclofenac|mesh-list
92356991|NCT02087748|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92356992|NCT02087748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92356994|NCT02087748|Sensory System Agents|sensory system agents|mesh-ancestor
92356995|NCT02087748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92356996|NCT02087748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92356997|NCT02087748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92356998|NCT02087748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92356999|NCT02087748|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92357000|NCT02087748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357001|NCT02087748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357003|NCT01490502|Cholecalciferol|cholecalciferol|mesh-list
92357004|NCT01490502|Vitamins|vitamins|mesh-ancestor
92357005|NCT01490502|Micronutrients|micronutrients|mesh-ancestor
92357006|NCT01490502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357007|NCT01490502|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92357008|NCT01490502|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92357009|NCT01428024|Hyaluronic Acid|hyaluronic acid|mesh-list
92357010|NCT01428024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92357011|NCT01428024|Immunologic Factors|immunologic factors|mesh-ancestor
92357012|NCT01428024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357013|NCT01428024|Viscosupplements|viscosupplements|mesh-ancestor
92357014|NCT01428024|Protective Agents|protective agents|mesh-ancestor
92357015|NCT01419834|Antibodies|antibodies|mesh-list
92357016|NCT01419834|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92357017|NCT01419834|Immunologic Factors|immunologic factors|mesh-ancestor
92357018|NCT01419834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357019|NCT01412190|Hyaluronic Acid|hyaluronic acid|mesh-list
92357020|NCT01412190|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92357021|NCT01412190|Immunologic Factors|immunologic factors|mesh-ancestor
92357022|NCT01412190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357023|NCT01412190|Viscosupplements|viscosupplements|mesh-ancestor
92357024|NCT01412190|Protective Agents|protective agents|mesh-ancestor
92357026|NCT01331148|Cholecalciferol|cholecalciferol|mesh-list
92357027|NCT01331148|Vitamins|vitamins|mesh-ancestor
92357028|NCT01331148|Micronutrients|micronutrients|mesh-ancestor
92357029|NCT01331148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357030|NCT01331148|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92357031|NCT01331148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92357032|NCT00273624|Olanzapine|olanzapine|mesh-list
92357033|NCT00273624|Antiemetics|antiemetics|mesh-ancestor
92357034|NCT00273624|Autonomic Agents|autonomic agents|mesh-ancestor
92357035|NCT00273624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357036|NCT00273624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357037|NCT00273624|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357038|NCT00273624|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92357039|NCT00273624|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92357040|NCT00273624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357041|NCT00273624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357042|NCT00273624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92357043|NCT00273624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357044|NCT00273624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357045|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357046|NCT00273624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357047|NCT00273624|Serotonin Agents|serotonin agents|mesh-ancestor
92357048|NCT00262470|Indomethacin|indomethacin|mesh-list
92357049|NCT00262470|Octreotide|octreotide|mesh-list
92357050|NCT00262470|Propranolol|propranolol|mesh-list
92357051|NCT00262470|Clonidine|clonidine|mesh-list
92357052|NCT00262470|Mecamylamine|mecamylamine|mesh-list
92357053|NCT00262470|Acetazolamide|acetazolamide|mesh-list
92357054|NCT00262470|Isosorbide|isosorbide|mesh-list
92357055|NCT00262470|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92357056|NCT00262470|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92357057|NCT00262470|Midodrine|midodrine|mesh-list
92357058|NCT00262470|Memantine|memantine|mesh-list
92357059|NCT00262470|Entacapone|entacapone|mesh-list
92357060|NCT00262470|Melatonin|melatonin|mesh-list
92357062|NCT00262470|Sertraline|sertraline|mesh-list
92357063|NCT00262470|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92357064|NCT00262470|Antioxidants|antioxidants|mesh-ancestor
92357065|NCT00262470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357066|NCT00262470|Protective Agents|protective agents|mesh-ancestor
92357067|NCT00262470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357068|NCT00262470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357069|NCT00262470|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92357070|NCT00262470|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92357071|NCT00262470|Adrenergic Agents|adrenergic agents|mesh-ancestor
92357072|NCT00262470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357073|NCT00262470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92357074|NCT00262470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92357075|NCT00262470|Vasodilator Agents|vasodilator agents|mesh-ancestor
92357076|NCT00262470|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357077|NCT00262470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357078|NCT00262470|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92357079|NCT00262470|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357080|NCT00262470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357081|NCT00262470|Serotonin Agents|serotonin agents|mesh-ancestor
92357082|NCT00262470|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92357083|NCT00262470|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92357084|NCT00262470|Dopamine Agents|dopamine agents|mesh-ancestor
92357085|NCT00262470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92357086|NCT00262470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92357087|NCT00262470|Analgesics|analgesics|mesh-ancestor
92357088|NCT00262470|Sensory System Agents|sensory system agents|mesh-ancestor
92357089|NCT00262470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357090|NCT00262470|Sympatholytics|sympatholytics|mesh-ancestor
92357091|NCT00262470|Autonomic Agents|autonomic agents|mesh-ancestor
92357092|NCT00262470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92357093|NCT00262470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92357094|NCT00262470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92357095|NCT00262470|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357096|NCT00262470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357097|NCT00262470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357098|NCT00262470|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92357099|NCT00262470|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92357100|NCT00262470|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92357101|NCT00262470|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92357102|NCT00262470|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92357103|NCT00262470|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92357104|NCT00262470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92357105|NCT00262470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357106|NCT00262470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357107|NCT00262470|Gout Suppressants|gout suppressants|mesh-ancestor
92357108|NCT00262470|Tocolytic Agents|tocolytic agents|mesh-ancestor
92357109|NCT00262470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92357110|NCT00262470|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92357111|NCT00262470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357112|NCT00262470|Anticonvulsants|anticonvulsants|mesh-ancestor
92357113|NCT00262470|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92357114|NCT00262470|Diuretics|diuretics|mesh-ancestor
92357115|NCT00262470|Natriuretic Agents|natriuretic agents|mesh-ancestor
92357116|NCT00262470|Sympathomimetics|sympathomimetics|mesh-ancestor
92357117|NCT00262470|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92357118|NCT00262470|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92357119|NCT00262470|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92357120|NCT00262470|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92357121|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92357122|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92357123|NCT00262470|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92357124|NCT00262470|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92357125|NCT00262470|Cholinergic Agents|cholinergic agents|mesh-ancestor
92357127|NCT01851642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92357128|NCT01851642|Autonomic Agents|autonomic agents|mesh-ancestor
92357129|NCT01851642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357130|NCT01851642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357131|NCT01851642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92357132|NCT01851642|Respiratory System Agents|respiratory system agents|mesh-ancestor
92357133|NCT01851642|Tocolytic Agents|tocolytic agents|mesh-ancestor
92357134|NCT01851642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92357135|NCT01851642|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92357136|NCT01851642|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92357137|NCT01851642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92357138|NCT01851642|Adrenergic Agents|adrenergic agents|mesh-ancestor
92357139|NCT01851642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357140|NCT01851642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357141|NCT01253070|Cytarabine|cytarabine|mesh-list
92357142|NCT01253070|Sorafenib|sorafenib|mesh-list
92357143|NCT01253070|Daunorubicin|daunorubicin|mesh-list
92357144|NCT01253070|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357145|NCT01253070|Antimetabolites|antimetabolites|mesh-ancestor
92357146|NCT01253070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357147|NCT01253070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357148|NCT01253070|Antiviral Agents|antiviral agents|mesh-ancestor
92357149|NCT01253070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357150|NCT01253070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357151|NCT01253070|Immunologic Factors|immunologic factors|mesh-ancestor
92357152|NCT01253070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357153|NCT01253070|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357154|NCT01253070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357155|NCT01253070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357156|NCT01253070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92357157|NCT01253070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92357158|NCT01212822|Leucovorin|leucovorin|mesh-list
92357159|NCT01212822|Bevacizumab|bevacizumab|mesh-list
92357160|NCT01212822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92357161|NCT01212822|Fluorouracil|fluorouracil|mesh-list
92357162|NCT01212822|Oxaliplatin|oxaliplatin|mesh-list
92357163|NCT01212822|Antibodies|antibodies|mesh-list
92357164|NCT01212822|Immunoglobulins|immunoglobulins|mesh-list
92357165|NCT01212822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92357166|NCT01212822|Levoleucovorin|levoleucovorin|mesh-list
92357167|NCT01212822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357168|NCT01212822|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357169|NCT01212822|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357170|NCT01212822|Growth Substances|growth substances|mesh-ancestor
92357171|NCT01212822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357172|NCT01212822|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357173|NCT01212822|Immunologic Factors|immunologic factors|mesh-ancestor
92357174|NCT01212822|Antimetabolites|antimetabolites|mesh-ancestor
92357175|NCT01212822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357176|NCT01212822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357177|NCT01212822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357178|NCT01212822|Antidotes|antidotes|mesh-ancestor
92357179|NCT01212822|Protective Agents|protective agents|mesh-ancestor
92357180|NCT01212822|Vitamin B Complex|vitamin b complex|mesh-ancestor
92357181|NCT01212822|Vitamins|vitamins|mesh-ancestor
92357182|NCT01212822|Micronutrients|micronutrients|mesh-ancestor
92357183|NCT00163566|Dihydrotestosterone|dihydrotestosterone|mesh-list
92357184|NCT00163566|Androgens|androgens|mesh-ancestor
92357185|NCT00163566|Hormones|hormones|mesh-ancestor
92357186|NCT00163566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357187|NCT00163566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357188|NCT04705662|Lactulose|lactulose|mesh-list
92357189|NCT04705662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357190|NCT04782960|Bupivacaine|bupivacaine|mesh-list
92357191|NCT04782960|Anesthetics|anesthetics|mesh-list
92357192|NCT04782960|Anesthetics, Local|anesthetics, local|mesh-ancestor
92357193|NCT04782960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357194|NCT04782960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357195|NCT04782960|Sensory System Agents|sensory system agents|mesh-ancestor
92357196|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357197|NCT04634604|Bevacizumab|bevacizumab|mesh-list
92357198|NCT04634604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92357199|NCT04634604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357200|NCT04634604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357201|NCT04634604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357202|NCT04634604|Growth Substances|growth substances|mesh-ancestor
92357203|NCT04634604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357204|NCT04634604|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357205|NCT01026012|Regadenoson|regadenoson|mesh-list
92357206|NCT01026012|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92357207|NCT01026012|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92357208|NCT01026012|Purinergic Agonists|purinergic agonists|mesh-ancestor
92357209|NCT01026012|Purinergic Agents|purinergic agents|mesh-ancestor
92009687|NCT03054467|Amlodipine|amlodipine|mesh-list
92357211|NCT01026012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357212|NCT01026012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357213|NCT02088216|Acetylcysteine|acetylcysteine|mesh-list
92357214|NCT02088216|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92357215|NCT02088216|Antiviral Agents|antiviral agents|mesh-ancestor
92357216|NCT02088216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357217|NCT02088216|Expectorants|expectorants|mesh-ancestor
92357218|NCT02088216|Respiratory System Agents|respiratory system agents|mesh-ancestor
92357219|NCT02088216|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92357220|NCT02088216|Antioxidants|antioxidants|mesh-ancestor
92357221|NCT02088216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357222|NCT02088216|Protective Agents|protective agents|mesh-ancestor
92357223|NCT02088216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357224|NCT02088216|Antidotes|antidotes|mesh-ancestor
92357225|NCT01014936|Tepotinib|tepotinib|mesh-list
92357226|NCT01014936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357227|NCT01896180|Latanoprost|latanoprost|mesh-list
92357228|NCT01896180|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92357229|NCT01896180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92357230|NCT00981162|Everolimus|everolimus|mesh-list
92357231|NCT00981162|Sorafenib|sorafenib|mesh-list
92357232|NCT00981162|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92357233|NCT00981162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357234|NCT00981162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357235|NCT00981162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357236|NCT00981162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357237|NCT00981162|Immunologic Factors|immunologic factors|mesh-ancestor
92357238|NCT00981162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357239|NCT00981162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357240|NCT00877500|Epothilones|epothilones|mesh-list
92357241|NCT00877500|Epothilone B|epothilone b|mesh-list
92357242|NCT00877500|Tubulin Modulators|tubulin modulators|mesh-ancestor
92357243|NCT00877500|Antimitotic Agents|antimitotic agents|mesh-ancestor
92357244|NCT00877500|Mitosis Modulators|mitosis modulators|mesh-ancestor
92357245|NCT00877500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357246|NCT00877500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357247|NCT00875004|Epoetin Alfa|epoetin alfa|mesh-list
92357248|NCT00875004|Hematinics|hematinics|mesh-ancestor
92357249|NCT00869232|Thalidomide|thalidomide|mesh-list
92357250|NCT00869232|Dexamethasone|dexamethasone|mesh-list
92357251|NCT00869232|Cyclophosphamide|cyclophosphamide|mesh-list
92357252|NCT00869232|Melphalan|melphalan|mesh-list
92357253|NCT00869232|Doxorubicin|doxorubicin|mesh-list
92357254|NCT00869232|Etoposide|etoposide|mesh-list
92357255|NCT00869232|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92357256|NCT00869232|Bortezomib|bortezomib|mesh-list
92357257|NCT00869232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357258|NCT00869232|Immunologic Factors|immunologic factors|mesh-ancestor
92357259|NCT00869232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357260|NCT00869232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357261|NCT00869232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92357262|NCT00869232|Alkylating Agents|alkylating agents|mesh-ancestor
92357263|NCT00869232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357264|NCT00869232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357265|NCT00869232|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92357266|NCT00869232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357267|NCT00869232|Antiemetics|antiemetics|mesh-ancestor
92357268|NCT00869232|Autonomic Agents|autonomic agents|mesh-ancestor
92357269|NCT00869232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357270|NCT00869232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357271|NCT00869232|Glucocorticoids|glucocorticoids|mesh-ancestor
92357272|NCT00869232|Hormones|hormones|mesh-ancestor
92357273|NCT00869232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357274|NCT00869232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357275|NCT00869232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357276|NCT00869232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92357277|NCT00869232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92357278|NCT00869232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357279|NCT00869232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92357280|NCT00869232|Leprostatic Agents|leprostatic agents|mesh-ancestor
92357281|NCT00869232|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357282|NCT00869232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357283|NCT00869232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357284|NCT00869232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92009767|NCT02620787|Tedizolid|tedizolid|mesh-list
92357285|NCT00869232|Growth Substances|growth substances|mesh-ancestor
92357286|NCT00869232|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357287|NCT05320692|Apatinib|apatinib|mesh-list
92357288|NCT05320692|Chlorotrianisene|chlorotrianisene|mesh-list
92357289|NCT05320692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357290|NCT05320692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357291|NCT05320692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357292|NCT05320692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357293|NCT05320692|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92357294|NCT05320692|Estrogens|estrogens|mesh-ancestor
92357296|NCT05320692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357297|NCT05320692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357298|NCT05320692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357299|NCT01763580|Prednisolone|prednisolone|mesh-list
92357300|NCT01763580|Tacrolimus|tacrolimus|mesh-list
92357301|NCT01763580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357302|NCT01763580|Immunologic Factors|immunologic factors|mesh-ancestor
92357303|NCT01763580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357304|NCT01763580|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92357305|NCT01763580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357306|NCT01763580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357307|NCT01763580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357308|NCT01763580|Glucocorticoids|glucocorticoids|mesh-ancestor
92357309|NCT01763580|Hormones|hormones|mesh-ancestor
92357310|NCT01763580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357311|NCT01763580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357312|NCT01763580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357313|NCT03969420|Cytarabine|cytarabine|mesh-list
92357314|NCT03969420|Alvocidib|alvocidib|mesh-list
92357315|NCT03969420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357316|NCT03969420|Antimetabolites|antimetabolites|mesh-ancestor
92357317|NCT03969420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357318|NCT03969420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357319|NCT03969420|Antiviral Agents|antiviral agents|mesh-ancestor
92357320|NCT03969420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357321|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357322|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
92357323|NCT03969420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357324|NCT03969420|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357325|NCT03969420|Growth Substances|growth substances|mesh-ancestor
92357326|NCT03969420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357327|NCT03969420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357328|NCT01740492|Ketamine|ketamine|mesh-list
92357329|NCT01740492|Analgesics|analgesics|mesh-ancestor
92357330|NCT01740492|Sensory System Agents|sensory system agents|mesh-ancestor
92357331|NCT01740492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357332|NCT01740492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357333|NCT01740492|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92357334|NCT01740492|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92357335|NCT01740492|Anesthetics, General|anesthetics, general|mesh-ancestor
92357336|NCT01740492|Anesthetics|anesthetics|mesh-ancestor
92357337|NCT01740492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357338|NCT01740492|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92357339|NCT01740492|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92357340|NCT01740492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357341|NCT01740492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357342|NCT04780854|Metformin|metformin|mesh-list
92357343|NCT04780854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92357344|NCT04780854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357345|NCT04780152|Fluoxetine|fluoxetine|mesh-list
92357346|NCT04780152|Antidepressive Agents|antidepressive agents|mesh-list
92357347|NCT04780152|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92357348|NCT04780152|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357349|NCT04780152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357350|NCT04780152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357351|NCT04780152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357352|NCT04780152|Serotonin Agents|serotonin agents|mesh-ancestor
92357353|NCT04780152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357354|NCT04780152|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92357355|NCT04780152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357356|NCT04780152|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92357357|NCT04780152|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92357358|NCT04780152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357359|NCT00644280|Ranibizumab|ranibizumab|mesh-list
92357360|NCT00644280|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357361|NCT00644280|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357362|NCT00644280|Growth Substances|growth substances|mesh-ancestor
92357363|NCT00644280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357364|NCT00644280|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357365|NCT00644280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357366|NCT04779762|Ustekinumab|ustekinumab|mesh-list
92357367|NCT04779762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357369|NCT04777968|Cariostatic Agents|cariostatic agents|mesh-ancestor
92357370|NCT04777968|Protective Agents|protective agents|mesh-ancestor
92357371|NCT04777968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357372|NCT01722708|Metronidazole|metronidazole|mesh-list
92357373|NCT01722708|Clindamycin|clindamycin|mesh-list
92357374|NCT01722708|Clindamycin palmitate|clindamycin palmitate|mesh-list
92357375|NCT01722708|Clindamycin phosphate|clindamycin phosphate|mesh-list
92357376|NCT01722708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357377|NCT01722708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357378|NCT01722708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92357379|NCT01722708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92357380|NCT01722708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92357381|NCT01722708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357382|NCT01722708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357383|NCT01711632|Vemurafenib|vemurafenib|mesh-list
92357384|NCT01711632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357385|NCT01711632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357386|NCT01711632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357387|NCT01711632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357388|NCT04756206|Dutasteride|dutasteride|mesh-list
92357389|NCT04756206|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92357390|NCT04756206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92357391|NCT04756206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357392|NCT04756206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357393|NCT04756206|Hormone Antagonists|hormone antagonists|mesh-ancestor
92357394|NCT04756206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357395|NCT04756206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357396|NCT04779060|Dexamethasone|dexamethasone|mesh-list
92357397|NCT04779060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357398|NCT04779060|Antiemetics|antiemetics|mesh-ancestor
92357399|NCT04779060|Autonomic Agents|autonomic agents|mesh-ancestor
92117691|NCT03474276|Albendazole|albendazole|mesh-list
92357400|NCT04779060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357401|NCT04779060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357402|NCT04779060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357403|NCT04779060|Glucocorticoids|glucocorticoids|mesh-ancestor
92357404|NCT04779060|Hormones|hormones|mesh-ancestor
92357405|NCT04779060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357406|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357407|NCT04779060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357408|NCT04778514|Contraceptive Agents|contraceptive agents|mesh-list
92357409|NCT04778514|Contraceptives, Oral|contraceptives, oral|mesh-list
92357410|NCT04778514|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92357411|NCT04778514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92357412|NCT04778514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357413|NCT04778514|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92357414|NCT04777110|Esketamine|esketamine|mesh-list
92357415|NCT04777110|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357416|NCT04777110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357417|NCT01895400|Cilostazol|cilostazol|mesh-list
92357418|NCT01895400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92357419|NCT01895400|Autonomic Agents|autonomic agents|mesh-ancestor
92357420|NCT01895400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357421|NCT01895400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357422|NCT01895400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92357423|NCT01895400|Respiratory System Agents|respiratory system agents|mesh-ancestor
92357424|NCT01895400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92357425|NCT01895400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92357426|NCT01895400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357427|NCT01895400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92357428|NCT01895400|Vasodilator Agents|vasodilator agents|mesh-ancestor
92357429|NCT01895400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92357430|NCT01895400|Protective Agents|protective agents|mesh-ancestor
92357431|NCT01895400|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92357432|NCT01895400|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92357433|NCT01895400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357434|NCT05171946|Vaccines|vaccines|mesh-list
92009915|NCT03933007|Fexofenadine|fexofenadine|mesh-list
92357435|NCT05171946|Immunologic Factors|immunologic factors|mesh-ancestor
92357436|NCT05171946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357437|NCT05605314|Cyclosporine|cyclosporine|mesh-list
92357438|NCT05605314|Cyclosporins|cyclosporins|mesh-list
92357439|NCT05605314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357440|NCT05605314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357441|NCT05605314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357442|NCT05605314|Immunologic Factors|immunologic factors|mesh-ancestor
92357443|NCT05605314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357444|NCT05605314|Antifungal Agents|antifungal agents|mesh-ancestor
92357445|NCT05605314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357446|NCT05605314|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357447|NCT05605314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357448|NCT05605314|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92357450|NCT05605158|Empagliflozin|empagliflozin|mesh-list
92357451|NCT05605158|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92357452|NCT05605158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357453|NCT05605158|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92357454|NCT05605158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357455|NCT04775238|Copper|copper|mesh-list
92357456|NCT04775238|Trace Elements|trace elements|mesh-ancestor
92357457|NCT04775238|Micronutrients|micronutrients|mesh-ancestor
92357458|NCT04775238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357459|NCT05580042|Tofacitinib|tofacitinib|mesh-list
92357460|NCT05580042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92357461|NCT05580042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357462|NCT05580042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357463|NCT05580042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357464|NCT04773756|Sofosbuvir|sofosbuvir|mesh-list
92357465|NCT04773756|Antiviral Agents|antiviral agents|mesh-ancestor
92357466|NCT04773756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357467|NCT03012984|Dexmedetomidine|dexmedetomidine|mesh-list
92357468|NCT03012984|Morphine|morphine|mesh-list
92357469|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92357470|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357471|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357472|NCT03012984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92357473|NCT03012984|Analgesics|analgesics|mesh-ancestor
92357474|NCT03012984|Sensory System Agents|sensory system agents|mesh-ancestor
92357475|NCT03012984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357476|NCT03012984|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92357477|NCT03012984|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92357478|NCT03012984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92357479|NCT03012984|Adrenergic Agents|adrenergic agents|mesh-ancestor
92357481|NCT03012984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357482|NCT03012984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92357483|NCT03012984|Narcotics|narcotics|mesh-ancestor
92357484|NCT02744430|Mirabegron|mirabegron|mesh-list
92357485|NCT02744430|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92357486|NCT02744430|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92357487|NCT02744430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92357488|NCT02744430|Adrenergic Agents|adrenergic agents|mesh-ancestor
92357489|NCT02744430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357490|NCT02744430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357491|NCT02744430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357492|NCT02744430|Urological Agents|urological agents|mesh-ancestor
92357493|NCT00054756|Hormones|hormones|mesh-list
92357494|NCT00054756|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
92357495|NCT00054756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357496|NCT00054756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357497|NCT01896960|Fentanyl|fentanyl|mesh-list
92357498|NCT01896960|Bupivacaine|bupivacaine|mesh-list
92357500|NCT01896960|Anesthetics|anesthetics|mesh-ancestor
92357501|NCT01896960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357502|NCT01896960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357503|NCT01896960|Sensory System Agents|sensory system agents|mesh-ancestor
92357504|NCT01896960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357505|NCT01896960|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92357506|NCT01896960|Narcotics|narcotics|mesh-ancestor
92357507|NCT01896960|Analgesics|analgesics|mesh-ancestor
92357508|NCT01896960|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92357509|NCT01896960|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92357510|NCT01896960|Anesthetics, General|anesthetics, general|mesh-ancestor
92357511|NCT00055692|Bevacizumab|bevacizumab|mesh-list
92357512|NCT00055692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92357513|NCT00055692|Antibodies|antibodies|mesh-list
92357514|NCT00055692|Immunoglobulins|immunoglobulins|mesh-list
92357515|NCT00055692|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92357516|NCT00055692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357517|NCT00055692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357518|NCT00055692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357519|NCT00055692|Growth Substances|growth substances|mesh-ancestor
92357520|NCT00055692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357521|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357522|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
92357524|NCT04772352|Gout Suppressants|gout suppressants|mesh-ancestor
92357525|NCT04772352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357526|NCT00056472|Olanzapine|olanzapine|mesh-list
92357527|NCT00056472|Sertraline|sertraline|mesh-list
92357528|NCT00056472|Antiemetics|antiemetics|mesh-ancestor
92357529|NCT00056472|Autonomic Agents|autonomic agents|mesh-ancestor
92357530|NCT00056472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357531|NCT00056472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357532|NCT00056472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357533|NCT00056472|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92357534|NCT00056472|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92357535|NCT00056472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357536|NCT00056472|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357537|NCT00056472|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92357538|NCT00056472|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357539|NCT00056472|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357540|NCT00056472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357541|NCT00056472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357542|NCT00056472|Serotonin Agents|serotonin agents|mesh-ancestor
92357543|NCT00056472|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357544|NCT00056550|Antithrombins|antithrombins|mesh-list
92357545|NCT00056550|Antithrombin III|antithrombin iii|mesh-list
92357546|NCT00056550|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92357547|NCT00056550|Protease Inhibitors|protease inhibitors|mesh-ancestor
92357548|NCT00056550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357549|NCT00056550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357550|NCT00056550|Anticoagulants|anticoagulants|mesh-ancestor
92357551|NCT04771884|Vancomycin|vancomycin|mesh-list
92357552|NCT04771884|Meropenem|meropenem|mesh-list
92357553|NCT04771884|Ceftriaxone|ceftriaxone|mesh-list
92357554|NCT04771884|Linezolid|linezolid|mesh-list
92357555|NCT04771884|Ceftazidime|ceftazidime|mesh-list
92357556|NCT04771884|Ceftizoxime|ceftizoxime|mesh-list
92357557|NCT04771884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357558|NCT04771884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357559|NCT04771884|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92357560|NCT04771884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357561|NCT04771884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357562|NCT02538744|Doxazosin|doxazosin|mesh-list
92357563|NCT02538744|Cocaine|cocaine|mesh-list
92357564|NCT02538744|Modafinil|modafinil|mesh-list
92357565|NCT02538744|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92357566|NCT02538744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357567|NCT02538744|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92357568|NCT02538744|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92357569|NCT02538744|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92357570|NCT02538744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357571|NCT02538744|Anesthetics, Local|anesthetics, local|mesh-ancestor
92357572|NCT02538744|Anesthetics|anesthetics|mesh-ancestor
92357573|NCT02538744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357574|NCT02538744|Sensory System Agents|sensory system agents|mesh-ancestor
92357575|NCT02538744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357576|NCT02538744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92357577|NCT02538744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92357578|NCT02538744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357579|NCT02538744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357580|NCT02538744|Dopamine Agents|dopamine agents|mesh-ancestor
92357581|NCT02538744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357582|NCT02538744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92357583|NCT02538744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92357584|NCT02538744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92357585|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92357586|NCT02538744|Adrenergic Agents|adrenergic agents|mesh-ancestor
92357587|NCT00060528|Metronidazole|metronidazole|mesh-list
92357588|NCT00060528|Molgramostim|molgramostim|mesh-list
92357589|NCT00060528|Sargramostim|sargramostim|mesh-list
92357590|NCT00060528|Immunologic Factors|immunologic factors|mesh-ancestor
92357591|NCT00060528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357592|NCT00060528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357593|NCT00060528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357594|NCT00060528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357595|NCT00060528|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92357596|NCT00060528|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92357597|NCT04696224|Tranexamic Acid|tranexamic acid|mesh-list
92357598|NCT04696224|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92357599|NCT04696224|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92357600|NCT04696224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357601|NCT04696224|Hemostatics|hemostatics|mesh-ancestor
92357602|NCT04696224|Coagulants|coagulants|mesh-ancestor
92357603|NCT04753008|Dopamine|dopamine|mesh-list
92357604|NCT04753008|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92357605|NCT04753008|Sympathomimetics|sympathomimetics|mesh-ancestor
92357606|NCT04753008|Autonomic Agents|autonomic agents|mesh-ancestor
92357607|NCT04753008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357608|NCT04753008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357609|NCT04753008|Dopamine Agents|dopamine agents|mesh-ancestor
92357610|NCT04753008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357611|NCT04753008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357612|NCT04753008|Protective Agents|protective agents|mesh-ancestor
92357613|NCT04771026|Dexamethasone|dexamethasone|mesh-list
92357614|NCT04771026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357615|NCT04771026|Antiemetics|antiemetics|mesh-ancestor
92357616|NCT04771026|Autonomic Agents|autonomic agents|mesh-ancestor
92357617|NCT04771026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357618|NCT04771026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357619|NCT04771026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357620|NCT04771026|Glucocorticoids|glucocorticoids|mesh-ancestor
92357621|NCT04771026|Hormones|hormones|mesh-ancestor
92357622|NCT04771026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357623|NCT04771026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357624|NCT04771026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357625|NCT00063570|Gemcitabine|gemcitabine|mesh-list
92357626|NCT00063570|Pemetrexed|pemetrexed|mesh-list
92357627|NCT00063570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357628|NCT00063570|Antimetabolites|antimetabolites|mesh-ancestor
92357629|NCT00063570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357630|NCT00063570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357631|NCT00063570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357632|NCT00063570|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92357633|NCT00063570|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92357634|NCT01897038|Sorafenib|sorafenib|mesh-list
92357635|NCT01897038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357636|NCT01897038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357637|NCT01897038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357638|NCT01897038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357639|NCT04770792|Chlorhexidine|chlorhexidine|mesh-list
92357640|NCT04770792|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92357641|NCT04770792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92357642|NCT04770792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357643|NCT04770792|Disinfectants|disinfectants|mesh-ancestor
92357644|NCT04770792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357645|NCT00064038|Dexamethasone|dexamethasone|mesh-list
92357646|NCT00064038|Lenalidomide|lenalidomide|mesh-list
92357647|NCT00064038|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357648|NCT00064038|Antiemetics|antiemetics|mesh-ancestor
92357649|NCT00064038|Autonomic Agents|autonomic agents|mesh-ancestor
92357650|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357651|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357652|NCT00064038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357653|NCT00064038|Glucocorticoids|glucocorticoids|mesh-ancestor
92357654|NCT00064038|Hormones|hormones|mesh-ancestor
92357655|NCT00064038|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357656|NCT00064038|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357657|NCT00064038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357658|NCT00064038|Immunologic Factors|immunologic factors|mesh-ancestor
92357659|NCT00064038|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357660|NCT00064038|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357661|NCT00064038|Growth Substances|growth substances|mesh-ancestor
92357662|NCT00064038|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357663|NCT01960530|Dexamethasone|dexamethasone|mesh-list
92357664|NCT01960530|Hydrocortisone|hydrocortisone|mesh-list
92357665|NCT01960530|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92357666|NCT01960530|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92357667|NCT01960530|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92357668|NCT01960530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357669|NCT01960530|Antiemetics|antiemetics|mesh-ancestor
92357670|NCT01960530|Autonomic Agents|autonomic agents|mesh-ancestor
92357671|NCT01960530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357672|NCT01960530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357673|NCT01960530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357674|NCT01960530|Glucocorticoids|glucocorticoids|mesh-ancestor
92357675|NCT01960530|Hormones|hormones|mesh-ancestor
92357676|NCT01960530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357677|NCT01960530|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357678|NCT01960530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357679|NCT01897428|Bepotastine besilate|bepotastine besilate|mesh-list
92357680|NCT01897428|Salicylates|salicylates|mesh-list
92357681|NCT01897428|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92357682|NCT01897428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92357683|NCT01897428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92357685|NCT01897428|Sensory System Agents|sensory system agents|mesh-ancestor
92357686|NCT01897428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357687|NCT01897428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357688|NCT01897428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357689|NCT01897428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357690|NCT01897428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92357691|NCT01897428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357692|NCT01897428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357693|NCT00024102|Doxorubicin|doxorubicin|mesh-list
92357694|NCT00024102|Capecitabine|capecitabine|mesh-list
92357695|NCT00024102|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357696|NCT00024102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357697|NCT00024102|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92357698|NCT00024102|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92357699|NCT00024102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357700|NCT00024102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357701|NCT00024102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357702|NCT00024102|Antimetabolites|antimetabolites|mesh-ancestor
92357703|NCT00074802|Paroxetine|paroxetine|mesh-list
92357704|NCT00074802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92357705|NCT00074802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357706|NCT00074802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357707|NCT00074802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357708|NCT00074802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357709|NCT00074802|Serotonin Agents|serotonin agents|mesh-ancestor
92357710|NCT00074802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357711|NCT00074802|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92357712|NCT00074802|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357713|NCT00074802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357714|NCT00074802|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92357715|NCT00074802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92357716|NCT00074802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357718|NCT02505750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357719|NCT02505750|Antimetabolites|antimetabolites|mesh-ancestor
92357720|NCT02505750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357721|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357722|NCT00030264|Methotrexate|methotrexate|mesh-list
92357723|NCT00030264|Vinblastine|vinblastine|mesh-list
92357724|NCT00030264|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92357725|NCT00030264|Abortifacient Agents|abortifacient agents|mesh-ancestor
92357726|NCT00030264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92357727|NCT00030264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357728|NCT00030264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357729|NCT00030264|Antimetabolites|antimetabolites|mesh-ancestor
92357730|NCT00030264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357731|NCT00030264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357732|NCT00030264|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357733|NCT00030264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357734|NCT00030264|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92357735|NCT00030264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357736|NCT00030264|Immunologic Factors|immunologic factors|mesh-ancestor
92357737|NCT00030264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357738|NCT00030264|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92357739|NCT00030264|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92357740|NCT00030264|Tubulin Modulators|tubulin modulators|mesh-ancestor
92357741|NCT00030264|Antimitotic Agents|antimitotic agents|mesh-ancestor
92357742|NCT00030264|Mitosis Modulators|mitosis modulators|mesh-ancestor
92357743|NCT01897116|Hydroxychloroquine|hydroxychloroquine|mesh-list
92357744|NCT01897116|Vemurafenib|vemurafenib|mesh-list
92357745|NCT01897116|Antimalarials|antimalarials|mesh-ancestor
92357746|NCT01897116|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92357747|NCT01897116|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92357748|NCT01897116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357749|NCT01897116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357750|NCT01897116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357751|NCT01897116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357752|NCT01897116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357753|NCT01897116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357754|NCT00036738|Cyclosporine|cyclosporine|mesh-list
92357755|NCT00036738|Mycophenolic Acid|mycophenolic acid|mesh-list
92357756|NCT00036738|Fludarabine|fludarabine|mesh-list
92357757|NCT00036738|Fludarabine phosphate|fludarabine phosphate|mesh-list
92357758|NCT00036738|Imatinib Mesylate|imatinib mesylate|mesh-list
92357759|NCT00036738|Dasatinib|dasatinib|mesh-list
92357760|NCT00036738|Cyclosporins|cyclosporins|mesh-list
92357761|NCT00036738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357762|NCT00036738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357763|NCT00036738|Antimetabolites|antimetabolites|mesh-ancestor
92357764|NCT00036738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357765|NCT00036738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357766|NCT00036738|Immunologic Factors|immunologic factors|mesh-ancestor
92357767|NCT00036738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357768|NCT00036738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357769|NCT00036738|Antifungal Agents|antifungal agents|mesh-ancestor
92357770|NCT00036738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357771|NCT00036738|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357772|NCT00036738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357773|NCT00036738|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92357774|NCT00036738|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357775|NCT00036738|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92357776|NCT00036738|Antitubercular Agents|antitubercular agents|mesh-ancestor
92357777|NCT00036738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357778|NCT00036738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357781|NCT00038610|Cyclophosphamide|cyclophosphamide|mesh-list
92357782|NCT00038610|Doxorubicin|doxorubicin|mesh-list
92357783|NCT00038610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92357784|NCT00038610|Methotrexate|methotrexate|mesh-list
92357785|NCT00038610|Vincristine|vincristine|mesh-list
92357786|NCT00038610|Imatinib Mesylate|imatinib mesylate|mesh-list
92357787|NCT00038610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357788|NCT00038610|Immunologic Factors|immunologic factors|mesh-ancestor
92357789|NCT00038610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357790|NCT00038610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357791|NCT00038610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92357792|NCT00038610|Alkylating Agents|alkylating agents|mesh-ancestor
92357793|NCT00038610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357794|NCT00038610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357795|NCT00038610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92357796|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357797|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
92357798|NCT00038610|Autonomic Agents|autonomic agents|mesh-ancestor
92357799|NCT00038610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357800|NCT00038610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357801|NCT00038610|Glucocorticoids|glucocorticoids|mesh-ancestor
92357802|NCT00038610|Hormones|hormones|mesh-ancestor
92357803|NCT00038610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357804|NCT00038610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357805|NCT00038610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357806|NCT00038610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92357807|NCT00038610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92357808|NCT00038610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357809|NCT00038610|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92357810|NCT00038610|Abortifacient Agents|abortifacient agents|mesh-ancestor
92357811|NCT00038610|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92357812|NCT00038610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357813|NCT00038610|Antimetabolites|antimetabolites|mesh-ancestor
92357814|NCT00038610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357815|NCT00038610|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92357816|NCT00038610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92357817|NCT00038610|Antiviral Agents|antiviral agents|mesh-ancestor
92357818|NCT00038610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357819|NCT00038610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92357820|NCT00038610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92357821|NCT00038610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92357822|NCT00038610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92357823|NCT00038610|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92357824|NCT00156936|Naltrexone|naltrexone|mesh-list
92357825|NCT00156936|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92357826|NCT00156936|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92357827|NCT00156936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357828|NCT00156936|Sensory System Agents|sensory system agents|mesh-ancestor
92357829|NCT00156936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357830|NCT00046566|Caseins|caseins|mesh-list
92357831|NCT00046566|Chelating Agents|chelating agents|mesh-ancestor
92357832|NCT00046566|Sequestering Agents|sequestering agents|mesh-ancestor
92357833|NCT00046566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357834|NCT00079326|Trastuzumab|trastuzumab|mesh-list
92357835|NCT00079326|Epothilone B|epothilone b|mesh-list
92357836|NCT00079326|Epothilones|epothilones|mesh-list
92357837|NCT00079326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92357838|NCT00079326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357839|NCT00079326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92357840|NCT00079326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92357841|NCT00079326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92357842|NCT00079326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357844|NCT02187354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357845|NCT01898052|Anesthetics|anesthetics|mesh-list
92357846|NCT01898052|Levobupivacaine|levobupivacaine|mesh-list
92357847|NCT01898052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357848|NCT01898052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357849|NCT01898052|Anesthetics, Local|anesthetics, local|mesh-ancestor
92357850|NCT01898052|Sensory System Agents|sensory system agents|mesh-ancestor
92357851|NCT01898052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357852|NCT00051168|Travoprost|travoprost|mesh-list
92357853|NCT00051168|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92357854|NCT00083382|Pamidronate|pamidronate|mesh-list
92357855|NCT00083382|Thalidomide|thalidomide|mesh-list
92357856|NCT00083382|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357857|NCT00083382|Immunologic Factors|immunologic factors|mesh-ancestor
92357858|NCT00083382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357859|NCT00083382|Leprostatic Agents|leprostatic agents|mesh-ancestor
92357860|NCT00083382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357861|NCT00083382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357862|NCT00083382|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357863|NCT00083382|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357864|NCT00083382|Growth Substances|growth substances|mesh-ancestor
92357865|NCT00083382|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357866|NCT00083382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357867|NCT00083382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92357868|NCT00167544|Hydrocortisone|hydrocortisone|mesh-list
92357869|NCT00167544|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357870|NCT00167934|Valproic Acid|valproic acid|mesh-list
92357871|NCT00167934|Anticonvulsants|anticonvulsants|mesh-ancestor
92357872|NCT00167934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357873|NCT00167934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357874|NCT00167934|GABA Agents|gaba agents|mesh-ancestor
92357875|NCT00167934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357876|NCT00167934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357877|NCT00167934|Antimanic Agents|antimanic agents|mesh-ancestor
92357878|NCT00167934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92357879|NCT00167934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357880|NCT00167934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357881|NCT00168324|Dexamethasone|dexamethasone|mesh-list
92357882|NCT00168324|Dexamethasone acetate|dexamethasone acetate|mesh-list
92357883|NCT00168324|BB 1101|bb 1101|mesh-list
92357884|NCT00168324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357885|NCT00168324|Antiemetics|antiemetics|mesh-ancestor
92357886|NCT00168324|Autonomic Agents|autonomic agents|mesh-ancestor
92357887|NCT00168324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010365|NCT04817189|Dolasetron|dolasetron|mesh-list
92357888|NCT00168324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357889|NCT00168324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92357890|NCT00168324|Glucocorticoids|glucocorticoids|mesh-ancestor
92357891|NCT00168324|Hormones|hormones|mesh-ancestor
92357892|NCT00168324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92357893|NCT00168324|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92357894|NCT00168324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357895|NCT00168324|Protease Inhibitors|protease inhibitors|mesh-ancestor
92357896|NCT00168324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357897|NCT00168324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357898|NCT02091882|Aripiprazole|aripiprazole|mesh-list
92357899|NCT02091882|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357900|NCT02091882|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357901|NCT02091882|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92357902|NCT02091882|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92357903|NCT02091882|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357904|NCT02091882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357905|NCT02091882|Dopamine Agonists|dopamine agonists|mesh-ancestor
92357906|NCT02091882|Dopamine Agents|dopamine agents|mesh-ancestor
92357907|NCT02091882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357908|NCT02091882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357909|NCT02091882|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92357910|NCT02091882|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92357911|NCT02091882|Serotonin Agents|serotonin agents|mesh-ancestor
92357912|NCT02091882|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92357913|NCT02091882|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92357914|NCT02091882|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92357915|NCT02091882|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92357916|NCT00085254|Temozolomide|temozolomide|mesh-list
92357917|NCT00085254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92357918|NCT00085254|Alkylating Agents|alkylating agents|mesh-ancestor
92357919|NCT00085254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357920|NCT00085254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357921|NCT00253890|Trazodone|trazodone|mesh-list
92357922|NCT00253890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92357923|NCT00253890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92357924|NCT00253890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92357925|NCT00253890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357926|NCT00253890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92357927|NCT00253890|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92357928|NCT00253890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92357929|NCT00253890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92357930|NCT00253890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357931|NCT00253890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92357932|NCT00253890|Serotonin Agents|serotonin agents|mesh-ancestor
92357933|NCT00253890|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92357934|NCT00253890|Antidepressive Agents|antidepressive agents|mesh-ancestor
92357936|NCT00254592|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92357937|NCT00254592|Cyclophosphamide|cyclophosphamide|mesh-list
92357938|NCT00254592|Bevacizumab|bevacizumab|mesh-list
92357939|NCT00254592|Carboplatin|carboplatin|mesh-list
92357940|NCT00254592|Doxorubicin|doxorubicin|mesh-list
92357941|NCT00254592|Trastuzumab|trastuzumab|mesh-list
92357942|NCT00254592|Sargramostim|sargramostim|mesh-list
92357943|NCT00254592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92357944|NCT00254592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357945|NCT00254592|Tubulin Modulators|tubulin modulators|mesh-ancestor
92357946|NCT00254592|Antimitotic Agents|antimitotic agents|mesh-ancestor
92357947|NCT00254592|Mitosis Modulators|mitosis modulators|mesh-ancestor
92357948|NCT00254592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357949|NCT00254592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357950|NCT00254592|Immunologic Factors|immunologic factors|mesh-ancestor
92357951|NCT00254592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357952|NCT00254592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357953|NCT00254592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92357954|NCT00254592|Alkylating Agents|alkylating agents|mesh-ancestor
92357955|NCT00254592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92357956|NCT00254592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92357957|NCT00254592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92357958|NCT00254592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92357959|NCT00254592|Growth Substances|growth substances|mesh-ancestor
92357960|NCT00254592|Growth Inhibitors|growth inhibitors|mesh-ancestor
92357961|NCT00254592|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357962|NCT00254592|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92357963|NCT00254592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92357964|NCT00254592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357966|NCT00255684|Mycophenolic Acid|mycophenolic acid|mesh-list
92357967|NCT00255684|Cyclophosphamide|cyclophosphamide|mesh-list
92357969|NCT00255684|Fludarabine phosphate|fludarabine phosphate|mesh-list
92357970|NCT00255684|Cyclosporins|cyclosporins|mesh-list
92357971|NCT00255684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92357972|NCT00255684|Immunologic Factors|immunologic factors|mesh-ancestor
92357973|NCT00255684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357974|NCT00255684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92357975|NCT00255684|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92357976|NCT00255684|Alkylating Agents|alkylating agents|mesh-ancestor
92357977|NCT00255684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92357978|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92357979|NCT00255684|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92357980|NCT00255684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92357981|NCT00255684|Antimetabolites|antimetabolites|mesh-ancestor
92357982|NCT00255684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92357983|NCT00255684|Antifungal Agents|antifungal agents|mesh-ancestor
92357984|NCT00255684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92357985|NCT00255684|Dermatologic Agents|dermatologic agents|mesh-ancestor
92357986|NCT00255684|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92357987|NCT00255684|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92357988|NCT00255684|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92357989|NCT00255684|Antitubercular Agents|antitubercular agents|mesh-ancestor
92357990|NCT00255684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92357991|NCT00256776|Thalidomide|thalidomide|mesh-list
92357992|NCT00256776|Dexamethasone|dexamethasone|mesh-list
92357994|NCT00256776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92357995|NCT00256776|Antiemetics|antiemetics|mesh-ancestor
92357996|NCT00256776|Autonomic Agents|autonomic agents|mesh-ancestor
92357997|NCT00256776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92357998|NCT00256776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92357999|NCT00256776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358000|NCT00256776|Glucocorticoids|glucocorticoids|mesh-ancestor
92358001|NCT00256776|Hormones|hormones|mesh-ancestor
92358002|NCT00256776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358003|NCT00256776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358004|NCT00256776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358005|NCT00256776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358006|NCT00256776|Immunologic Factors|immunologic factors|mesh-ancestor
92358007|NCT00256776|Leprostatic Agents|leprostatic agents|mesh-ancestor
92358008|NCT00256776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358009|NCT00256776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358010|NCT00256776|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358011|NCT00256776|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358012|NCT00256776|Growth Substances|growth substances|mesh-ancestor
92358013|NCT00256776|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358014|NCT00258180|Cyclophosphamide|cyclophosphamide|mesh-list
92358015|NCT00258180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358016|NCT00258180|Immunologic Factors|immunologic factors|mesh-ancestor
92358017|NCT00258180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358018|NCT00258180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358019|NCT00258180|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92358020|NCT00258180|Alkylating Agents|alkylating agents|mesh-ancestor
92358021|NCT00258180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358022|NCT00258180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358023|NCT00258180|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92358024|NCT00176202|Valproic Acid|valproic acid|mesh-list
92358025|NCT00176202|Anticonvulsants|anticonvulsants|mesh-list
92358026|NCT00176202|Risperidone|risperidone|mesh-list
92358027|NCT00176202|Antipsychotic Agents|antipsychotic agents|mesh-list
92358028|NCT00176202|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92358029|NCT00176202|Serotonin Agents|serotonin agents|mesh-ancestor
92358030|NCT00176202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358031|NCT00176202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358032|NCT00176202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358033|NCT00176202|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358034|NCT00176202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358035|NCT00176202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358036|NCT00176202|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92358037|NCT00176202|Dopamine Agents|dopamine agents|mesh-ancestor
92358038|NCT00176202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358039|NCT00176202|GABA Agents|gaba agents|mesh-ancestor
92358040|NCT00176202|Antimanic Agents|antimanic agents|mesh-ancestor
92358041|NCT00176592|Glatiramer Acetate|glatiramer acetate|mesh-list
92358042|NCT00176592|Interferon beta-1b|interferon beta-1b|mesh-list
92358043|NCT00176592|(T,G)-A-L|(t,g)-a-l|mesh-list
92358044|NCT00176592|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92358045|NCT00176592|Immunologic Factors|immunologic factors|mesh-ancestor
92358046|NCT00176592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358047|NCT00176592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358048|NCT00176592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358049|NCT00176826|Busulfan|busulfan|mesh-list
92358050|NCT00176826|Alkylating Agents|alkylating agents|mesh-ancestor
92358051|NCT00176826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358052|NCT00176826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358053|NCT00176826|Immunologic Factors|immunologic factors|mesh-ancestor
92358054|NCT00176826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358055|NCT00176826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92358056|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358057|NCT00176826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92358058|NCT00176904|Cyclophosphamide|cyclophosphamide|mesh-list
92358059|NCT00176904|Busulfan|busulfan|mesh-list
92358060|NCT00176904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92358061|NCT00176904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358062|NCT00176904|Immunologic Factors|immunologic factors|mesh-ancestor
92358063|NCT00176904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358064|NCT00176904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358065|NCT00176904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92358066|NCT00176904|Alkylating Agents|alkylating agents|mesh-ancestor
92358067|NCT00176904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358068|NCT00176904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358069|NCT00176904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92358071|NCT00179478|Interferon-beta|interferon-beta|mesh-list
92358072|NCT00179478|Interferon beta-1a|interferon beta-1a|mesh-list
92358073|NCT00179478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358074|NCT00179478|Antiviral Agents|antiviral agents|mesh-ancestor
92358075|NCT00179478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358076|NCT00179478|Immunologic Factors|immunologic factors|mesh-ancestor
92358077|NCT00179478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358078|NCT00179478|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92358079|NCT00182754|Octreotide|octreotide|mesh-list
92358080|NCT00182754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358081|NCT00182754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358082|NCT00182754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358083|NCT00085410|Bortezomib|bortezomib|mesh-list
92358084|NCT00085410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358085|NCT00186498|Memantine|memantine|mesh-list
92358086|NCT00186498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92358087|NCT00186498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92358088|NCT00186498|Dopamine Agents|dopamine agents|mesh-ancestor
92358089|NCT00186498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358090|NCT00186498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358091|NCT00186498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358092|NCT00186498|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92358093|NCT00186498|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92358094|NCT00265200|Zoledronic Acid|zoledronic acid|mesh-list
92358095|NCT00265200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92358096|NCT00265200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358097|NCT00087672|Lenalidomide|lenalidomide|mesh-list
92358098|NCT00087672|Immunologic Factors|immunologic factors|mesh-ancestor
92358099|NCT00087672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358101|NCT00087672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358102|NCT00087672|Growth Substances|growth substances|mesh-ancestor
92358103|NCT00087672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358104|NCT00087672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358105|NCT00088218|Cytarabine|cytarabine|mesh-list
92358106|NCT00088218|Clofarabine|clofarabine|mesh-list
92358107|NCT00088218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358108|NCT00088218|Antimetabolites|antimetabolites|mesh-ancestor
92358109|NCT00088218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358110|NCT00088218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358111|NCT00088218|Antiviral Agents|antiviral agents|mesh-ancestor
92358112|NCT00088218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358113|NCT00088218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358114|NCT00088218|Immunologic Factors|immunologic factors|mesh-ancestor
92010597|NCT04871633|Hormones|hormones|mesh-ancestor
92358115|NCT00088218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358116|NCT00189228|Omalizumab|omalizumab|mesh-list
92358117|NCT00189228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92358118|NCT00189228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92358119|NCT00189228|Respiratory System Agents|respiratory system agents|mesh-ancestor
92358120|NCT00091260|Dexamethasone|dexamethasone|mesh-list
92358121|NCT00091260|Dexamethasone acetate|dexamethasone acetate|mesh-list
92358122|NCT00091260|Lenalidomide|lenalidomide|mesh-list
92358123|NCT00091260|BB 1101|bb 1101|mesh-list
92358124|NCT00091260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358125|NCT00091260|Antiemetics|antiemetics|mesh-ancestor
92358126|NCT00091260|Autonomic Agents|autonomic agents|mesh-ancestor
92358127|NCT00091260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358128|NCT00091260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358129|NCT00091260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358130|NCT00091260|Glucocorticoids|glucocorticoids|mesh-ancestor
92358131|NCT00091260|Hormones|hormones|mesh-ancestor
92358132|NCT00091260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358133|NCT00091260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358134|NCT00091260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358135|NCT00091260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92358136|NCT00091260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358137|NCT00091260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358138|NCT00091260|Immunologic Factors|immunologic factors|mesh-ancestor
92358139|NCT00091260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358140|NCT00091260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358141|NCT00091260|Growth Substances|growth substances|mesh-ancestor
92358142|NCT00091260|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358143|NCT00193128|Docetaxel|docetaxel|mesh-list
92358144|NCT00193128|Capecitabine|capecitabine|mesh-list
92358145|NCT00193128|Oxaliplatin|oxaliplatin|mesh-list
92358146|NCT00193128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358147|NCT00193128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92358148|NCT00193128|Antimitotic Agents|antimitotic agents|mesh-ancestor
92358149|NCT00193128|Mitosis Modulators|mitosis modulators|mesh-ancestor
92358150|NCT00193128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358151|NCT00193128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358152|NCT00193128|Antimetabolites|antimetabolites|mesh-ancestor
92358154|NCT00193596|Etoposide|etoposide|mesh-list
92358155|NCT00193596|Carboplatin|carboplatin|mesh-list
92358156|NCT00193596|Gemcitabine|gemcitabine|mesh-list
92358157|NCT00193596|Irinotecan|irinotecan|mesh-list
92358158|NCT00193596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92358159|NCT00193596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358160|NCT00193596|Tubulin Modulators|tubulin modulators|mesh-ancestor
92358161|NCT00193596|Antimitotic Agents|antimitotic agents|mesh-ancestor
92358162|NCT00193596|Mitosis Modulators|mitosis modulators|mesh-ancestor
92358163|NCT00193596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358164|NCT00193596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358165|NCT00193596|Antimetabolites|antimetabolites|mesh-ancestor
92358166|NCT00193596|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92358167|NCT00193596|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92358168|NCT00193596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358169|NCT00193596|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92358170|NCT00194532|Ciprofloxacin|ciprofloxacin|mesh-list
92358171|NCT00194532|Cefpodoxime|cefpodoxime|mesh-list
92358172|NCT00194532|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
92358173|NCT00194532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358174|NCT00194532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358175|NCT00194532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92358176|NCT00194532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92358177|NCT00194532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358178|NCT00194532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358179|NCT00194532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358180|NCT00194532|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92358181|NCT00194532|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92358182|NCT00194610|Botulinum Toxins|botulinum toxins|mesh-list
92358183|NCT00194610|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92358184|NCT00194610|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92358185|NCT00194610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358186|NCT00194610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358187|NCT00194610|Cholinergic Agents|cholinergic agents|mesh-ancestor
92358188|NCT00194610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358189|NCT00194610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358190|NCT00194610|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92358191|NCT00194610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010666|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358192|NCT00093756|Paclitaxel|paclitaxel|mesh-list
92358193|NCT00093756|Carboplatin|carboplatin|mesh-list
92358194|NCT00093756|Bortezomib|bortezomib|mesh-list
92358195|NCT00093756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92358196|NCT00093756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358197|NCT00093756|Tubulin Modulators|tubulin modulators|mesh-ancestor
92358198|NCT00093756|Antimitotic Agents|antimitotic agents|mesh-ancestor
92358199|NCT00093756|Mitosis Modulators|mitosis modulators|mesh-ancestor
92358200|NCT00093756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358201|NCT04118556|Sirolimus|sirolimus|mesh-list
92358202|NCT04118556|Infliximab|infliximab|mesh-list
92358203|NCT04118556|Etanercept|etanercept|mesh-list
92358204|NCT04118556|Everolimus|everolimus|mesh-list
92358205|NCT04118556|Vedolizumab|vedolizumab|mesh-list
92358206|NCT04118556|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92358207|NCT04118556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358208|NCT04118556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358209|NCT04118556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358210|NCT04118556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358211|NCT04118556|Immunologic Factors|immunologic factors|mesh-ancestor
92358212|NCT04118556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358213|NCT04118556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358214|NCT04118556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358215|NCT04118556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358216|NCT04118556|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92358217|NCT04118556|Antifungal Agents|antifungal agents|mesh-ancestor
92358218|NCT04118556|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92358219|NCT04118556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358220|NCT04118556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92358221|NCT04118556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358222|NCT04118556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358223|NCT04118556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92358224|NCT04118556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92358225|NCT04118556|Analgesics|analgesics|mesh-ancestor
92358226|NCT04118556|Sensory System Agents|sensory system agents|mesh-ancestor
92358227|NCT04118556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358228|NCT00267696|Bevacizumab|bevacizumab|mesh-list
92358229|NCT00267696|Carboplatin|carboplatin|mesh-list
92358230|NCT00267696|Gemcitabine|gemcitabine|mesh-list
92358231|NCT00267696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358232|NCT00267696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358233|NCT00267696|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358234|NCT00267696|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358235|NCT00267696|Growth Substances|growth substances|mesh-ancestor
92358236|NCT00267696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358237|NCT00267696|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358238|NCT00267696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358239|NCT00267696|Antimetabolites|antimetabolites|mesh-ancestor
92358240|NCT00267696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358241|NCT00195624|Cyclosporine|cyclosporine|mesh-list
92358242|NCT00195624|Alemtuzumab|alemtuzumab|mesh-list
92358243|NCT00195624|Cyclosporins|cyclosporins|mesh-list
92358244|NCT00195624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358245|NCT00195624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358246|NCT00195624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358247|NCT00195624|Immunologic Factors|immunologic factors|mesh-ancestor
92358248|NCT00195624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358249|NCT00195624|Antifungal Agents|antifungal agents|mesh-ancestor
92358250|NCT00195624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358251|NCT00195624|Dermatologic Agents|dermatologic agents|mesh-ancestor
92358252|NCT00195624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358253|NCT00195624|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92358254|NCT00195624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358255|NCT00195624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358256|NCT00195702|Adalimumab|adalimumab|mesh-list
92358257|NCT00195702|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92358258|NCT00195702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358259|NCT00195702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358260|NCT00197184|Vaccines|vaccines|mesh-list
92358261|NCT00197184|Immunologic Factors|immunologic factors|mesh-ancestor
92358262|NCT00197184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358263|NCT00098670|Rituximab|rituximab|mesh-list
92358264|NCT00098670|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92358265|NCT00098670|Alemtuzumab|alemtuzumab|mesh-list
92010742|NCT04876313|Paclitaxel|paclitaxel|mesh-list
92358266|NCT00098670|Fludarabine|fludarabine|mesh-list
92358267|NCT00098670|Fludarabine phosphate|fludarabine phosphate|mesh-list
92358268|NCT00098670|Antibodies|antibodies|mesh-list
92358269|NCT00098670|Immunoglobulins|immunoglobulins|mesh-list
92358270|NCT00098670|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92358271|NCT00098670|Immunologic Factors|immunologic factors|mesh-ancestor
92358272|NCT00098670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358273|NCT00098670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358274|NCT00098670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358275|NCT00098670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358276|NCT00098670|Antimetabolites|antimetabolites|mesh-ancestor
92358277|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358278|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358279|NCT00201864|Fulvestrant|fulvestrant|mesh-list
92358280|NCT00201864|Exemestane|exemestane|mesh-list
92358281|NCT00201864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358282|NCT00201864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358283|NCT00201864|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92358284|NCT00201864|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92358285|NCT00201864|Hormone Antagonists|hormone antagonists|mesh-ancestor
92358286|NCT00201864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358287|NCT00201864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358288|NCT00201864|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92358289|NCT00201864|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92358290|NCT00201864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358291|NCT00201864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358292|NCT00202722|Remifentanil|remifentanil|mesh-list
92358293|NCT00202722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92358294|NCT00202722|Narcotics|narcotics|mesh-ancestor
92358295|NCT00202722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358296|NCT00202722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358297|NCT00202722|Analgesics|analgesics|mesh-ancestor
92358298|NCT00202722|Sensory System Agents|sensory system agents|mesh-ancestor
92358299|NCT00202722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358300|NCT00100698|Hormones|hormones|mesh-list
92358301|NCT00100698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358302|NCT00100698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358303|NCT00103116|Vaccines|vaccines|mesh-list
92358304|NCT00103116|Immunologic Factors|immunologic factors|mesh-ancestor
92358305|NCT00103116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358306|NCT00205374|Cidofovir|cidofovir|mesh-list
92358307|NCT00205374|Antiviral Agents|antiviral agents|mesh-ancestor
92358308|NCT00205374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358309|NCT00205374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358310|NCT00205374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358311|NCT00103194|Lapatinib|lapatinib|mesh-list
92358312|NCT00103194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358313|NCT00103194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358314|NCT00103194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358315|NCT00103194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358316|NCT00208026|Pimecrolimus|pimecrolimus|mesh-list
92358317|NCT00208026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92358318|NCT00208026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92358319|NCT00208026|Analgesics|analgesics|mesh-ancestor
92358320|NCT00208026|Sensory System Agents|sensory system agents|mesh-ancestor
92358321|NCT00208026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358322|NCT00208026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358323|NCT00208026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358324|NCT00208026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358325|NCT00208026|Dermatologic Agents|dermatologic agents|mesh-ancestor
92358326|NCT00208026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358327|NCT00208026|Immunologic Factors|immunologic factors|mesh-ancestor
92358328|NCT00208026|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92358329|NCT00208026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358330|NCT00208026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358331|NCT00106392|Tacrolimus|tacrolimus|mesh-list
92358332|NCT00106392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358333|NCT00106392|Immunologic Factors|immunologic factors|mesh-ancestor
92358334|NCT00106392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358335|NCT00106392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92358336|NCT00106392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358337|NCT00106392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358338|NCT00211692|Interferons|interferons|mesh-list
92358339|NCT00211692|Ribavirin|ribavirin|mesh-list
92358340|NCT00211692|Interferon-alpha|interferon-alpha|mesh-list
92358341|NCT00211692|Interferon alfacon-1|interferon alfacon-1|mesh-list
92358342|NCT00211692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010816|NCT03047837|Aspirin|aspirin|mesh-list
92358343|NCT00211692|Antiviral Agents|antiviral agents|mesh-ancestor
92358344|NCT00211692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358345|NCT00211692|Antimetabolites|antimetabolites|mesh-ancestor
92358346|NCT00211692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358348|NCT00211692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358349|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92358350|NCT01899690|Clindamycin|clindamycin|mesh-list
92358351|NCT01899690|Cephalexin|cephalexin|mesh-list
92358352|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358353|NCT01899690|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92358354|NCT01899690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358355|NCT01899690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358356|NCT01899846|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92358357|NCT01899846|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92358358|NCT01899846|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92358359|NCT01899846|Hormone Antagonists|hormone antagonists|mesh-ancestor
92358360|NCT01899846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358361|NCT01899846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358362|NCT01899846|Progestins|progestins|mesh-ancestor
92358363|NCT01899846|Hormones|hormones|mesh-ancestor
92358364|NCT00214890|Tenofovir|tenofovir|mesh-list
92358365|NCT00214890|Abacavir|abacavir|mesh-list
92358366|NCT00214890|Antiviral Agents|antiviral agents|mesh-ancestor
92358367|NCT00214890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358368|NCT00214890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92358369|NCT00214890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92358370|NCT00214890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358371|NCT00214890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358372|NCT00214890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92358373|NCT00214890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92358374|NCT00216060|Risedronic Acid|risedronic acid|mesh-list
92358375|NCT00216060|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92358376|NCT00216060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358377|NCT00216060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358378|NCT00216060|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92358379|NCT00216060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358380|NCT00216060|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92358381|NCT00282282|Sirolimus|sirolimus|mesh-list
92358382|NCT00282282|Fludarabine|fludarabine|mesh-list
92358383|NCT00282282|Busulfan|busulfan|mesh-list
92358384|NCT00282282|Tacrolimus|tacrolimus|mesh-list
92358385|NCT00282282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358386|NCT00282282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358387|NCT00282282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358388|NCT00282282|Immunologic Factors|immunologic factors|mesh-ancestor
92358389|NCT00282282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358390|NCT00282282|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92358391|NCT00282282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358392|NCT00282282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358393|NCT00282282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358394|NCT00282282|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92358395|NCT00282282|Antifungal Agents|antifungal agents|mesh-ancestor
92358396|NCT00282282|Alkylating Agents|alkylating agents|mesh-ancestor
92358397|NCT00282282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92358398|NCT00282282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92358399|NCT00282828|Clonazepam|clonazepam|mesh-list
92358400|NCT00282828|Sertraline|sertraline|mesh-list
92358401|NCT00282828|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92358402|NCT00282828|Antidepressive Agents|antidepressive agents|mesh-ancestor
92358403|NCT00282828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358404|NCT00282828|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92358405|NCT00282828|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92358406|NCT00282828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358407|NCT00282828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358408|NCT00282828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358409|NCT00282828|Serotonin Agents|serotonin agents|mesh-ancestor
92358410|NCT00282828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358411|NCT00282828|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92358412|NCT00282828|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92358413|NCT00282828|Anticonvulsants|anticonvulsants|mesh-ancestor
92358414|NCT00282828|GABA Modulators|gaba modulators|mesh-ancestor
92358415|NCT00282828|GABA Agents|gaba agents|mesh-ancestor
92358416|NCT00112242|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92358417|NCT00112242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92358418|NCT00112242|Immunologic Factors|immunologic factors|mesh-ancestor
92358419|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358421|NCT00223236|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92358422|NCT00223236|Lipotropic Agents|lipotropic agents|mesh-ancestor
92358423|NCT00223236|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92358424|NCT00223236|Antimetabolites|antimetabolites|mesh-ancestor
92358425|NCT00223236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358426|NCT00223236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358427|NCT00223236|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92358428|NCT00223236|Nootropic Agents|nootropic agents|mesh-ancestor
92358429|NCT00223704|Icatibant|icatibant|mesh-list
92358430|NCT00223704|Aminocaproic Acid|aminocaproic acid|mesh-list
92358431|NCT00223704|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92358432|NCT00223704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92358433|NCT00223704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358434|NCT00223704|Hemostatics|hemostatics|mesh-ancestor
92358435|NCT00223704|Coagulants|coagulants|mesh-ancestor
92358436|NCT00223704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92358437|NCT00223704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92358438|NCT00223704|Analgesics|analgesics|mesh-ancestor
92358439|NCT00223704|Sensory System Agents|sensory system agents|mesh-ancestor
92358440|NCT00223704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358441|NCT00223704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358442|NCT00223704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358443|NCT00223704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358444|NCT00223704|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92358445|NCT00223704|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92358446|NCT00223704|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92358447|NCT00223704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358448|NCT00223704|Immunologic Factors|immunologic factors|mesh-ancestor
92358449|NCT00224952|Carbamazepine|carbamazepine|mesh-list
92358450|NCT00224952|Valproic Acid|valproic acid|mesh-list
92358451|NCT00224952|Anticonvulsants|anticonvulsants|mesh-ancestor
92358452|NCT00224952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358453|NCT00224952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358454|NCT00224952|GABA Agents|gaba agents|mesh-ancestor
92358455|NCT00224952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358456|NCT00224952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358457|NCT00224952|Antimanic Agents|antimanic agents|mesh-ancestor
92358458|NCT00224952|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358459|NCT00224952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358460|NCT00224952|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358461|NCT00224952|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92358462|NCT00224952|Analgesics|analgesics|mesh-ancestor
92358463|NCT00224952|Sensory System Agents|sensory system agents|mesh-ancestor
92358464|NCT00224952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358465|NCT00224952|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92358466|NCT00224952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358467|NCT00224952|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92358468|NCT00224952|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92358469|NCT00225420|Docetaxel|docetaxel|mesh-list
92358470|NCT00225420|Leuprolide|leuprolide|mesh-list
92358471|NCT00225420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358472|NCT00225420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92358473|NCT00225420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92358474|NCT00225420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92358475|NCT00225420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358476|NCT00225420|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92358477|NCT00225420|Fertility Agents|fertility agents|mesh-ancestor
92358478|NCT00225420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92358479|NCT00225420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358480|NCT00225420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358481|NCT00225498|Olanzapine|olanzapine|mesh-list
92358482|NCT00225498|Risperidone|risperidone|mesh-list
92358483|NCT00225498|Ziprasidone|ziprasidone|mesh-list
92358484|NCT00225498|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92358485|NCT00225498|Serotonin Agents|serotonin agents|mesh-ancestor
92358486|NCT00225498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358487|NCT00225498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358488|NCT00225498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358489|NCT00225498|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92358490|NCT00225498|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358491|NCT00225498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358493|NCT00225498|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92358494|NCT00225498|Dopamine Agents|dopamine agents|mesh-ancestor
92358495|NCT00225498|Antiemetics|antiemetics|mesh-ancestor
92358496|NCT00225498|Autonomic Agents|autonomic agents|mesh-ancestor
92358497|NCT00225498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358498|NCT00225498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358499|NCT00225498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92358500|NCT00225498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92358501|NCT00225498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358502|NCT00225732|Ibuprofen|ibuprofen|mesh-list
92358503|NCT00225732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92358504|NCT00225732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92358505|NCT00225732|Analgesics|analgesics|mesh-ancestor
92358506|NCT00225732|Sensory System Agents|sensory system agents|mesh-ancestor
92358507|NCT00225732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358508|NCT00225732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358509|NCT00225732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358510|NCT00225732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358511|NCT00225732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92358512|NCT00225732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358513|NCT00225732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358514|NCT02096718|Afatinib|afatinib|mesh-list
92358515|NCT02096718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358516|NCT02096718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358517|NCT02096718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358518|NCT02096718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358519|NCT02097732|Ipilimumab|ipilimumab|mesh-list
92358520|NCT02097732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358521|NCT02097732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358522|NCT02097732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92358523|NCT02097732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358524|NCT00286182|Epoetin Alfa|epoetin alfa|mesh-list
92358525|NCT00286182|Hematinics|hematinics|mesh-ancestor
92358526|NCT00226590|Paclitaxel|paclitaxel|mesh-list
92358527|NCT00226590|Carboplatin|carboplatin|mesh-list
92358528|NCT00226590|Gemcitabine|gemcitabine|mesh-list
92358529|NCT00226590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92358530|NCT00226590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358531|NCT00226590|Tubulin Modulators|tubulin modulators|mesh-ancestor
92358532|NCT00226590|Antimitotic Agents|antimitotic agents|mesh-ancestor
92358533|NCT00226590|Mitosis Modulators|mitosis modulators|mesh-ancestor
92358534|NCT00226590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358535|NCT00226590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358536|NCT00226590|Antimetabolites|antimetabolites|mesh-ancestor
92358537|NCT00114114|Goserelin|goserelin|mesh-list
92358538|NCT00114114|Testosterone|testosterone|mesh-list
92358539|NCT00114114|Androgens|androgens|mesh-ancestor
92358540|NCT00114114|Hormones|hormones|mesh-ancestor
92358541|NCT00114114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358542|NCT00114114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358543|NCT00114114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358544|NCT00114114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358545|NCT00227760|Cediranib|cediranib|mesh-list
92358546|NCT00227760|Maleic acid|maleic acid|mesh-list
92358547|NCT00227760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358548|NCT00227760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358549|NCT00227760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358550|NCT00227760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358551|NCT00227994|Donepezil|donepezil|mesh-list
92358552|NCT00227994|Galantamine|galantamine|mesh-list
92358553|NCT00227994|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92358554|NCT00227994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358555|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358556|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
92358557|NCT00227994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358558|NCT00227994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358559|NCT00227994|Nootropic Agents|nootropic agents|mesh-ancestor
92358560|NCT00227994|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92358561|NCT00227994|Autonomic Agents|autonomic agents|mesh-ancestor
92358562|NCT00227994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358563|NCT00114504|Simvastatin|simvastatin|mesh-list
92358564|NCT00114504|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92358565|NCT00114504|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92358566|NCT00114504|Antimetabolites|antimetabolites|mesh-ancestor
92358567|NCT00114504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358568|NCT00114504|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92358569|NCT00114504|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92358570|NCT00114504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358571|NCT01898676|Valproic Acid|valproic acid|mesh-list
92358572|NCT01898676|Anticonvulsants|anticonvulsants|mesh-ancestor
92358573|NCT01898676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358574|NCT01898676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358575|NCT01898676|GABA Agents|gaba agents|mesh-ancestor
92358576|NCT01898676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358577|NCT01898676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358578|NCT01898676|Antimanic Agents|antimanic agents|mesh-ancestor
92358579|NCT01898676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358580|NCT01898676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358581|NCT01898676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358582|NCT00288366|Aripiprazole|aripiprazole|mesh-list
92358583|NCT00288366|Ziprasidone|ziprasidone|mesh-list
92358584|NCT00288366|Antidepressive Agents|antidepressive agents|mesh-ancestor
92358585|NCT00288366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358586|NCT00288366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92358587|NCT00288366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358588|NCT00288366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358589|NCT00288366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358590|NCT00288366|Dopamine Agonists|dopamine agonists|mesh-ancestor
92358591|NCT00288366|Dopamine Agents|dopamine agents|mesh-ancestor
92358592|NCT00288366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358593|NCT00288366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358594|NCT00288366|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92358595|NCT00288366|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92358596|NCT00288366|Serotonin Agents|serotonin agents|mesh-ancestor
92358597|NCT00288366|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92358598|NCT00288366|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92358599|NCT00288366|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92358600|NCT00288366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92358601|NCT00288600|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92358602|NCT00288600|Immunoglobulins|immunoglobulins|mesh-list
92358603|NCT00288600|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92358605|NCT00288600|gamma-Globulins|gamma-globulins|mesh-list
92358606|NCT00288600|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92358607|NCT00288600|Immunologic Factors|immunologic factors|mesh-ancestor
92358608|NCT00288600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358609|NCT00290472|Sirolimus|sirolimus|mesh-list
92358610|NCT00290472|Temsirolimus|temsirolimus|mesh-list
92358611|NCT00290472|MTOR Inhibitors|mtor inhibitors|mesh-list
92358612|NCT00290472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358613|NCT00290472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358614|NCT00290472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358615|NCT00290472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358616|NCT00290472|Immunologic Factors|immunologic factors|mesh-ancestor
92358617|NCT00290472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358618|NCT00290472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358619|NCT00290472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358620|NCT00290472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358621|NCT00290472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92358622|NCT00290472|Antifungal Agents|antifungal agents|mesh-ancestor
92358623|NCT04752852|Dexamethasone|dexamethasone|mesh-list
92358624|NCT04752852|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358625|NCT04752852|Antiemetics|antiemetics|mesh-ancestor
92358626|NCT04752852|Autonomic Agents|autonomic agents|mesh-ancestor
92358627|NCT04752852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358628|NCT04752852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358629|NCT04752852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358630|NCT04752852|Glucocorticoids|glucocorticoids|mesh-ancestor
92358631|NCT04752852|Hormones|hormones|mesh-ancestor
92358632|NCT04752852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358633|NCT04752852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358634|NCT04752852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358635|NCT01899144|Albuterol|albuterol|mesh-list
92358636|NCT01899144|Procaterol|procaterol|mesh-list
92358637|NCT01899144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92358638|NCT01899144|Autonomic Agents|autonomic agents|mesh-ancestor
92358639|NCT01899144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358640|NCT01899144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358641|NCT01899144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92358642|NCT01899144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92358643|NCT01899144|Tocolytic Agents|tocolytic agents|mesh-ancestor
92358644|NCT01899144|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92358645|NCT01899144|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92358646|NCT01899144|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92358647|NCT01899144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92358648|NCT01899144|Adrenergic Agents|adrenergic agents|mesh-ancestor
92358649|NCT01899144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358650|NCT01899144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358651|NCT01899144|Sympathomimetics|sympathomimetics|mesh-ancestor
92358653|NCT00234078|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92358654|NCT00234078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358655|NCT00234078|Antioxidants|antioxidants|mesh-ancestor
92358656|NCT00234078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358657|NCT00234078|Protective Agents|protective agents|mesh-ancestor
92358658|NCT00234078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358659|NCT00234078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358661|NCT00118404|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92358662|NCT00118404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92358663|NCT00118404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358664|NCT00118404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358665|NCT00118404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358666|NCT00118404|Serotonin Agents|serotonin agents|mesh-ancestor
92358667|NCT00118404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358668|NCT00118404|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92358669|NCT00118404|Antidepressive Agents|antidepressive agents|mesh-ancestor
92358670|NCT00118404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358671|NCT00118404|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92358672|NCT00118404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92358673|NCT00118404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358674|NCT00121836|Bevacizumab|bevacizumab|mesh-list
92358675|NCT00121836|Capecitabine|capecitabine|mesh-list
92358676|NCT00121836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358677|NCT00121836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358678|NCT00121836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358679|NCT00121836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358680|NCT00121836|Growth Substances|growth substances|mesh-ancestor
92358681|NCT00121836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358682|NCT00121836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358683|NCT00121836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358684|NCT00121836|Antimetabolites|antimetabolites|mesh-ancestor
92358685|NCT00121836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358686|NCT00237666|Ziprasidone|ziprasidone|mesh-list
92358687|NCT00237666|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92358688|NCT00237666|Serotonin Agents|serotonin agents|mesh-ancestor
92358689|NCT00237666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358690|NCT00237666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358691|NCT00237666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358692|NCT00237666|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92358693|NCT00237666|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358694|NCT00237666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358695|NCT00237666|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358696|NCT00237666|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92358697|NCT00237666|Dopamine Agents|dopamine agents|mesh-ancestor
92358698|NCT00296322|Mitomycins|mitomycins|mesh-list
92358699|NCT00296322|Mitomycin|mitomycin|mesh-list
92358700|NCT00296322|Doxifluridine|doxifluridine|mesh-list
92358701|NCT00296322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358702|NCT00296322|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92358703|NCT00296322|Alkylating Agents|alkylating agents|mesh-ancestor
92358704|NCT00296322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358705|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92358706|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358707|NCT00296322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358708|NCT00296322|Antimetabolites|antimetabolites|mesh-ancestor
92358709|NCT00296322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358710|NCT00296322|Immunologic Factors|immunologic factors|mesh-ancestor
92358711|NCT00296322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358712|NCT00296322|Appetite Stimulants|appetite stimulants|mesh-ancestor
92358713|NCT00296322|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92358714|NCT00123162|Sildenafil Citrate|sildenafil citrate|mesh-list
92358715|NCT00123162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358716|NCT00123162|Vasodilator Agents|vasodilator agents|mesh-ancestor
92358717|NCT00123162|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92358718|NCT00123162|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92358719|NCT00123162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358720|NCT00123162|Urological Agents|urological agents|mesh-ancestor
92358722|NCT00123630|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92358723|NCT00123630|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92358724|NCT00123630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92358725|NCT00124176|Albuterol|albuterol|mesh-list
92358726|NCT00124176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92358727|NCT00124176|Autonomic Agents|autonomic agents|mesh-ancestor
92358728|NCT00124176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358729|NCT00124176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358730|NCT00124176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92358731|NCT00124176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92358732|NCT00124176|Tocolytic Agents|tocolytic agents|mesh-ancestor
92358733|NCT00124176|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92358734|NCT00124176|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92358735|NCT00124176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92358736|NCT00124176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92358737|NCT00124176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92358738|NCT00124176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358739|NCT00124176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358741|NCT00240162|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358742|NCT00240162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358743|NCT00240162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358744|NCT00299988|Immunoglobulins|immunoglobulins|mesh-list
92358745|NCT00299988|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92358746|NCT00299988|Antibodies|antibodies|mesh-list
92358747|NCT00299988|gamma-Globulins|gamma-globulins|mesh-list
92358748|NCT00299988|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92358749|NCT00299988|Immunologic Factors|immunologic factors|mesh-ancestor
92358750|NCT00299988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358751|NCT04226352|Dextromethorphan|dextromethorphan|mesh-list
92358752|NCT04226352|Antitussive Agents|antitussive agents|mesh-ancestor
92358753|NCT04226352|Respiratory System Agents|respiratory system agents|mesh-ancestor
92358754|NCT04226352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92358755|NCT04226352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92358756|NCT04226352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358757|NCT04226352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358758|NCT04226352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358760|NCT00300456|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92358761|NCT00300456|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92358763|NCT00300456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358764|NCT00300456|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92358765|NCT00300456|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92358766|NCT00300456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358767|NCT00125034|Oxaliplatin|oxaliplatin|mesh-list
92358768|NCT00125034|Cetuximab|cetuximab|mesh-list
92358769|NCT00125034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358770|NCT00125034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358771|NCT02100930|Molgramostim|molgramostim|mesh-list
92358772|NCT02100930|Isotretinoin|isotretinoin|mesh-list
92358773|NCT02100930|Antibodies|antibodies|mesh-list
92358774|NCT02100930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92358775|NCT02100930|Sargramostim|sargramostim|mesh-list
92358776|NCT02100930|Immunologic Factors|immunologic factors|mesh-ancestor
92358777|NCT02100930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358778|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
92358779|NCT02100930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358780|NCT02101008|Disulfiram|disulfiram|mesh-list
92358781|NCT02101008|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92358782|NCT02101008|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92358783|NCT02101008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358784|NCT02101008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358785|NCT00241176|Aripiprazole|aripiprazole|mesh-list
92358786|NCT00241176|Antidepressive Agents|antidepressive agents|mesh-ancestor
92358787|NCT00241176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92358788|NCT00241176|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92358789|NCT00241176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92358790|NCT00241176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92358791|NCT00241176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358792|NCT00241176|Dopamine Agonists|dopamine agonists|mesh-ancestor
92358793|NCT00241176|Dopamine Agents|dopamine agents|mesh-ancestor
92358794|NCT00241176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358795|NCT00241176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358796|NCT00241176|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92358797|NCT00241176|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92358798|NCT00241176|Serotonin Agents|serotonin agents|mesh-ancestor
92358799|NCT00241176|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92358800|NCT00241176|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92358801|NCT00241176|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92358802|NCT00241176|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92358803|NCT02102100|Menthol|menthol|mesh-list
92358804|NCT02102100|Nicotine|nicotine|mesh-list
92358805|NCT02102100|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92358806|NCT02102100|Autonomic Agents|autonomic agents|mesh-ancestor
92358807|NCT02102100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358808|NCT02102100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358809|NCT02102100|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92358810|NCT02102100|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92358811|NCT02102100|Cholinergic Agents|cholinergic agents|mesh-ancestor
92358812|NCT02102100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92358813|NCT02102100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358814|NCT02102100|Antipruritics|antipruritics|mesh-ancestor
92358815|NCT02102100|Dermatologic Agents|dermatologic agents|mesh-ancestor
92358816|NCT02094534|Insulin|insulin|mesh-list
92358817|NCT02094534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92358818|NCT02094534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358819|NCT00242502|Bevacizumab|bevacizumab|mesh-list
92358820|NCT00242502|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92358821|NCT00242502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358822|NCT00242502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358823|NCT00242502|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358824|NCT00242502|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358825|NCT00242502|Growth Substances|growth substances|mesh-ancestor
92358826|NCT00242502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358827|NCT00242502|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358828|NCT00242502|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358829|NCT00242502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358830|NCT00242502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358832|NCT04389060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92358833|NCT04389060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358835|NCT04389060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358836|NCT04389060|Protective Agents|protective agents|mesh-ancestor
92358837|NCT04389060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358838|NCT01899066|Carboplatin|carboplatin|mesh-list
92358839|NCT01899066|Etoposide|etoposide|mesh-list
92358840|NCT01899066|Vincristine|vincristine|mesh-list
92358841|NCT01899066|Ranibizumab|ranibizumab|mesh-list
92358842|NCT01899066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358843|NCT01899066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92358844|NCT01899066|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92358845|NCT01899066|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92358846|NCT01899066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358847|NCT01899066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358848|NCT01899066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92358849|NCT01899066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92358850|NCT01899066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92358851|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358852|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358853|NCT01899066|Growth Substances|growth substances|mesh-ancestor
92358854|NCT01899066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358855|NCT01899066|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358856|NCT00127218|Niacin|niacin|mesh-list
92358857|NCT00127218|Atorvastatin|atorvastatin|mesh-list
92358858|NCT00127218|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92358859|NCT00127218|Simvastatin|simvastatin|mesh-list
92358860|NCT00127218|Pravastatin|pravastatin|mesh-list
92358861|NCT00127218|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92358862|NCT00127218|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92358863|NCT00127218|Antimetabolites|antimetabolites|mesh-ancestor
92358864|NCT00127218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358865|NCT00127218|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92358866|NCT00127218|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92358867|NCT00127218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358868|NCT00127218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92358869|NCT00127218|Vitamin B Complex|vitamin b complex|mesh-ancestor
92358870|NCT00127218|Vitamins|vitamins|mesh-ancestor
92358871|NCT00127218|Micronutrients|micronutrients|mesh-ancestor
92358872|NCT00127218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358873|NCT00127530|4-Aminopyridine|4-aminopyridine|mesh-list
92358874|NCT00127530|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92358875|NCT00127530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92358876|NCT00127530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358877|NCT00250926|Dexamethasone|dexamethasone|mesh-list
92358878|NCT00250926|Dexamethasone acetate|dexamethasone acetate|mesh-list
92358879|NCT00250926|Rituximab|rituximab|mesh-list
92358880|NCT00250926|Bortezomib|bortezomib|mesh-list
92358881|NCT00250926|BB 1101|bb 1101|mesh-list
92358882|NCT00250926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358883|NCT00250926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358884|NCT00250926|Immunologic Factors|immunologic factors|mesh-ancestor
92358885|NCT00250926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358886|NCT00250926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358887|NCT00250926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358889|NCT00250926|Autonomic Agents|autonomic agents|mesh-ancestor
92358890|NCT00250926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358891|NCT00250926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358892|NCT00250926|Glucocorticoids|glucocorticoids|mesh-ancestor
92358893|NCT00250926|Hormones|hormones|mesh-ancestor
92358894|NCT00250926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358895|NCT00250926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358896|NCT00250926|Protease Inhibitors|protease inhibitors|mesh-ancestor
92358897|NCT00250926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358898|NCT00250926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358899|NCT00303966|Sorafenib|sorafenib|mesh-list
92358900|NCT00303966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358901|NCT00303966|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358902|NCT00303966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358903|NCT00303966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358904|NCT00304746|Testosterone|testosterone|mesh-list
92358905|NCT00304746|Androgens|androgens|mesh-ancestor
92358906|NCT00304746|Hormones|hormones|mesh-ancestor
92358907|NCT00304746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358908|NCT00304746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358909|NCT00134004|Mycophenolic Acid|mycophenolic acid|mesh-list
92358910|NCT00134004|Cyclophosphamide|cyclophosphamide|mesh-list
92358911|NCT00134004|Fludarabine|fludarabine|mesh-list
92358912|NCT00134004|Fludarabine phosphate|fludarabine phosphate|mesh-list
92358913|NCT00134004|Tacrolimus|tacrolimus|mesh-list
92358914|NCT00134004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358915|NCT00134004|Immunologic Factors|immunologic factors|mesh-ancestor
92358916|NCT00134004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358917|NCT00134004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358918|NCT00134004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92358919|NCT00134004|Alkylating Agents|alkylating agents|mesh-ancestor
92358920|NCT00134004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358921|NCT00134004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358922|NCT00134004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92358923|NCT00134004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358924|NCT00134004|Antimetabolites|antimetabolites|mesh-ancestor
92358925|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92358926|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358927|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92358928|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92358929|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
92358930|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358931|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358933|NCT00135798|Antiviral Agents|antiviral agents|mesh-ancestor
92358934|NCT00135798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358935|NCT02103114|Antithrombin III|antithrombin iii|mesh-list
92358936|NCT02103114|Antithrombins|antithrombins|mesh-list
92358937|NCT02103114|Thrombin|thrombin|mesh-list
92358938|NCT02103114|Hemostatics|hemostatics|mesh-ancestor
92358939|NCT02103114|Coagulants|coagulants|mesh-ancestor
92358940|NCT02103114|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92358941|NCT02103114|Protease Inhibitors|protease inhibitors|mesh-ancestor
92358942|NCT02103114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358943|NCT02103114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358944|NCT02103114|Anticoagulants|anticoagulants|mesh-ancestor
92358945|NCT01790022|Methylprednisolone|methylprednisolone|mesh-list
92358946|NCT01790022|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92358947|NCT01790022|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92358948|NCT01790022|Prednisolone|prednisolone|mesh-list
92358949|NCT01790022|Prednisolone acetate|prednisolone acetate|mesh-list
92358950|NCT01790022|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92358951|NCT01790022|Prednisolone phosphate|prednisolone phosphate|mesh-list
92358952|NCT01790022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92358953|NCT01790022|Antiemetics|antiemetics|mesh-ancestor
92358954|NCT01790022|Autonomic Agents|autonomic agents|mesh-ancestor
92358955|NCT01790022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92358956|NCT01790022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358957|NCT01790022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92358958|NCT01790022|Glucocorticoids|glucocorticoids|mesh-ancestor
92358959|NCT01790022|Hormones|hormones|mesh-ancestor
92358960|NCT01790022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92358961|NCT01790022|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92358962|NCT01790022|Protective Agents|protective agents|mesh-ancestor
92358963|NCT01790022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92358964|NCT01790022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358965|NCT00140556|Bevacizumab|bevacizumab|mesh-list
92358966|NCT00140556|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92358967|NCT00140556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358968|NCT00140556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358969|NCT00140556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358970|NCT00140556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358971|NCT00140556|Growth Substances|growth substances|mesh-ancestor
92358972|NCT00140556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358973|NCT00140556|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358974|NCT00140556|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92358975|NCT00140556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92358976|NCT00140556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358977|NCT00142116|Thalidomide|thalidomide|mesh-list
92358978|NCT00142116|Rituximab|rituximab|mesh-list
92358979|NCT00142116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92358980|NCT00142116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358981|NCT00142116|Immunologic Factors|immunologic factors|mesh-ancestor
92358982|NCT00142116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92358983|NCT00142116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92358984|NCT00142116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92358985|NCT00142116|Leprostatic Agents|leprostatic agents|mesh-ancestor
92358986|NCT00142116|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92358987|NCT00142116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92358988|NCT00142116|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92358989|NCT00142116|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92358990|NCT00142116|Growth Substances|growth substances|mesh-ancestor
92358991|NCT00142116|Growth Inhibitors|growth inhibitors|mesh-ancestor
92358992|NCT05201430|Capecitabine|capecitabine|mesh-list
92358993|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
92358994|NCT05201430|Irinotecan|irinotecan|mesh-list
92358995|NCT05201430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92358996|NCT05201430|Antimetabolites|antimetabolites|mesh-ancestor
92358997|NCT05201430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92358998|NCT05201430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92358999|NCT05201430|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92359000|NCT05201430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359001|NCT05201430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359002|NCT00142506|Sildenafil Citrate|sildenafil citrate|mesh-list
92359003|NCT00142506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359004|NCT00142506|Vasodilator Agents|vasodilator agents|mesh-ancestor
92359005|NCT00142506|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92359006|NCT00142506|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92359007|NCT00142506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359008|NCT00142506|Urological Agents|urological agents|mesh-ancestor
92359009|NCT05266794|Selenium|selenium|mesh-list
92359010|NCT05266794|Thioctic Acid|thioctic acid|mesh-list
92359011|NCT05266794|Antioxidants|antioxidants|mesh-ancestor
92359012|NCT05266794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359013|NCT05266794|Protective Agents|protective agents|mesh-ancestor
92359014|NCT05266794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359015|NCT05266794|Trace Elements|trace elements|mesh-ancestor
92359016|NCT05266794|Micronutrients|micronutrients|mesh-ancestor
92359017|NCT05266794|Vitamin B Complex|vitamin b complex|mesh-ancestor
92359019|NCT00142818|Naltrexone|naltrexone|mesh-list
92359020|NCT00142818|Modafinil|modafinil|mesh-list
92359021|NCT00142818|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92359022|NCT00142818|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92359023|NCT00142818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359024|NCT00142818|Sensory System Agents|sensory system agents|mesh-ancestor
92359025|NCT00142818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359026|NCT00142818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92359027|NCT00142818|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92359028|NCT00142818|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92359029|NCT00142818|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92359030|NCT00142818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359031|NCT05266716|Methamphetamine|methamphetamine|mesh-list
92359032|NCT05266716|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92359033|NCT05266716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359034|NCT05266716|Sympathomimetics|sympathomimetics|mesh-ancestor
92359035|NCT05266716|Autonomic Agents|autonomic agents|mesh-ancestor
92359036|NCT05266716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359037|NCT05266716|Dopamine Agents|dopamine agents|mesh-ancestor
92359038|NCT05266716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359039|NCT05266716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359040|NCT05266716|Adrenergic Agents|adrenergic agents|mesh-ancestor
92359041|NCT05266716|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92359042|NCT05266716|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92359043|NCT05266716|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92359044|NCT05266716|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92359045|NCT05266560|Propofol|propofol|mesh-list
92359046|NCT05266560|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92359047|NCT05266560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359048|NCT05266560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359049|NCT05266560|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92359050|NCT05266560|Anesthetics, General|anesthetics, general|mesh-ancestor
92359051|NCT05266560|Anesthetics|anesthetics|mesh-ancestor
92359052|NCT00147966|Rituximab|rituximab|mesh-list
92359053|NCT00147966|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359054|NCT00147966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359055|NCT00147966|Immunologic Factors|immunologic factors|mesh-ancestor
92359056|NCT00147966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359057|NCT00147966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359058|NCT04528212|Glimepiride|glimepiride|mesh-list
92359059|NCT04528212|Curcumin|curcumin|mesh-list
92359060|NCT04528212|Fenofibrate|fenofibrate|mesh-list
92359061|NCT04528212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92359062|NCT04528212|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92359063|NCT04528212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359064|NCT04528212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359065|NCT04528212|Immunologic Factors|immunologic factors|mesh-ancestor
92359066|NCT04528212|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92359067|NCT04528212|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92359068|NCT04528212|Analgesics|analgesics|mesh-ancestor
92359069|NCT04528212|Sensory System Agents|sensory system agents|mesh-ancestor
92359070|NCT04528212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359071|NCT04528212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359072|NCT04528212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359073|NCT04528212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359074|NCT04528212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359075|NCT04528212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359076|NCT04528212|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92359077|NCT04528212|Antimetabolites|antimetabolites|mesh-ancestor
92359078|NCT04528212|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359079|NCT00148668|Carboplatin|carboplatin|mesh-list
92359080|NCT00148668|Docetaxel|docetaxel|mesh-list
92359081|NCT00148668|Trastuzumab|trastuzumab|mesh-list
92359082|NCT00148668|Vinorelbine|vinorelbine|mesh-list
92359083|NCT00148668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359084|NCT00148668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92359085|NCT00148668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92359086|NCT00148668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359087|NCT00148668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359088|NCT00148668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359089|NCT00148668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92359090|NCT00149838|Antidepressive Agents|antidepressive agents|mesh-list
92359091|NCT00149838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359093|NCT00324870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92359094|NCT00324870|Vorinostat|vorinostat|mesh-list
92359095|NCT00324870|Antibodies|antibodies|mesh-list
92359096|NCT00324870|Immunoglobulins|immunoglobulins|mesh-list
92359097|NCT00324870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92359098|NCT00324870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359099|NCT00324870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359100|NCT00324870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359101|NCT00324870|Growth Substances|growth substances|mesh-ancestor
92359102|NCT00324870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359103|NCT00324870|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359104|NCT00324870|Immunologic Factors|immunologic factors|mesh-ancestor
92359105|NCT00324870|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92359106|NCT00324870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359107|NCT00324870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359108|NCT00151320|Rituximab|rituximab|mesh-list
92359109|NCT00151320|Bortezomib|bortezomib|mesh-list
92359110|NCT00151320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359111|NCT00151320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359112|NCT00151320|Immunologic Factors|immunologic factors|mesh-ancestor
92359113|NCT00151320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359114|NCT00151320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359115|NCT00328614|Ascorbic Acid|ascorbic acid|mesh-list
92359116|NCT00328614|Goserelin|goserelin|mesh-list
92359117|NCT00328614|Methyltestosterone|methyltestosterone|mesh-list
92359118|NCT00328614|Bicalutamide|bicalutamide|mesh-list
92359119|NCT00328614|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92359120|NCT00328614|Androgens|androgens|mesh-list
92359121|NCT00328614|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92359122|NCT00328614|Ethylene|ethylene|mesh-list
92359123|NCT00328614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92359124|NCT00328614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359125|NCT00328614|Hormones|hormones|mesh-ancestor
92359126|NCT00328614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359127|NCT00328614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359128|NCT00328614|Antioxidants|antioxidants|mesh-ancestor
92359129|NCT00328614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359130|NCT00328614|Protective Agents|protective agents|mesh-ancestor
92359131|NCT00328614|Vitamins|vitamins|mesh-ancestor
92359132|NCT00328614|Micronutrients|micronutrients|mesh-ancestor
92359133|NCT00328614|Estrogens|estrogens|mesh-ancestor
92359134|NCT00328614|Anabolic Agents|anabolic agents|mesh-ancestor
92359135|NCT00328614|Androgen Antagonists|androgen antagonists|mesh-ancestor
92359136|NCT00328614|Hormone Antagonists|hormone antagonists|mesh-ancestor
92359137|NCT00328614|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92359138|NCT00328614|Growth Substances|growth substances|mesh-ancestor
92359139|NCT00328614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92359140|NCT00328614|Analgesics|analgesics|mesh-ancestor
92359141|NCT00328614|Sensory System Agents|sensory system agents|mesh-ancestor
92359142|NCT00328614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359143|NCT00328770|Sirolimus|sirolimus|mesh-list
92359144|NCT00328770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359145|NCT00328770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359146|NCT00328770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359147|NCT00328770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359148|NCT00328770|Antifungal Agents|antifungal agents|mesh-ancestor
92359149|NCT00328770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359150|NCT00328770|Immunologic Factors|immunologic factors|mesh-ancestor
92359151|NCT00328770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359152|NCT04177680|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92359153|NCT04177680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92359154|NCT04177680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359155|NCT00330876|Pitavastatin|pitavastatin|mesh-list
92359156|NCT00330876|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92359157|NCT00330876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92359158|NCT00330876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92359159|NCT00330876|Antimetabolites|antimetabolites|mesh-ancestor
92359160|NCT00330876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359161|NCT00330876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359162|NCT00330876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359164|NCT00334074|Clofarabine|clofarabine|mesh-list
92359165|NCT00334074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359166|NCT00334074|Antimetabolites|antimetabolites|mesh-ancestor
92359167|NCT00334074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359168|NCT00334074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359169|NCT00334074|Antiviral Agents|antiviral agents|mesh-ancestor
92359170|NCT00334074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359171|NCT00334074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359172|NCT00334074|Immunologic Factors|immunologic factors|mesh-ancestor
92359173|NCT00334074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359175|NCT00335478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359176|NCT00335478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359177|NCT04345926|Propofol|propofol|mesh-list
92359178|NCT04345926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92359179|NCT04345926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359180|NCT04345926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359181|NCT04345926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92359182|NCT04345926|Anesthetics, General|anesthetics, general|mesh-ancestor
92359183|NCT04345926|Anesthetics|anesthetics|mesh-ancestor
92359184|NCT00337350|Rosiglitazone|rosiglitazone|mesh-list
92359185|NCT00337350|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92359186|NCT00337350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359187|NCT00338598|Glycine|glycine|mesh-list
92359188|NCT00338598|Glycine Agents|glycine agents|mesh-ancestor
92359189|NCT00338598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359190|NCT00338598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359191|NCT00338598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359192|NCT00338988|Capecitabine|capecitabine|mesh-list
92359193|NCT00338988|Oxaliplatin|oxaliplatin|mesh-list
92359194|NCT00338988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359195|NCT00338988|Antimetabolites|antimetabolites|mesh-ancestor
92359196|NCT00338988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359197|NCT00338988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359198|NCT00343044|Bevacizumab|bevacizumab|mesh-list
92359200|NCT00343044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359201|NCT00343044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359202|NCT00343044|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359203|NCT00343044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359204|NCT00343044|Growth Substances|growth substances|mesh-ancestor
92359205|NCT00343044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359206|NCT00343044|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359207|NCT00343044|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92359208|NCT00343044|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359209|NCT00343044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359210|NCT00343044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359211|NCT00344370|Atorvastatin|atorvastatin|mesh-list
92359212|NCT00344370|Pitavastatin|pitavastatin|mesh-list
92359213|NCT00344370|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92359214|NCT00344370|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92359215|NCT00344370|Antimetabolites|antimetabolites|mesh-ancestor
92359216|NCT00344370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359217|NCT00344370|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359218|NCT00344370|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92359219|NCT00344370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359221|NCT00344682|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92359222|NCT00344682|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92359223|NCT00344682|Dopamine Agents|dopamine agents|mesh-ancestor
92359224|NCT00344682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359225|NCT00344682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359226|NCT00344682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359227|NCT00344682|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92359228|NCT00344682|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92359229|NCT00345384|Dexmedetomidine|dexmedetomidine|mesh-list
92359230|NCT00345384|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92359231|NCT00345384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359232|NCT00345384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359233|NCT00345384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92359234|NCT00345384|Analgesics|analgesics|mesh-ancestor
92359235|NCT00345384|Sensory System Agents|sensory system agents|mesh-ancestor
92117692|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
92359236|NCT00345384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359237|NCT00345384|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92359238|NCT00345384|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92359239|NCT00345384|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92359240|NCT00345384|Adrenergic Agents|adrenergic agents|mesh-ancestor
92359241|NCT00345384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359242|NCT00345384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359243|NCT01791114|Propranolol|propranolol|mesh-list
92359244|NCT01791114|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92359245|NCT01791114|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92359246|NCT01791114|Adrenergic Agents|adrenergic agents|mesh-ancestor
92359247|NCT01791114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359248|NCT01791114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359249|NCT01791114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359250|NCT01791114|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92359251|NCT01791114|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92359252|NCT01791114|Vasodilator Agents|vasodilator agents|mesh-ancestor
92359253|NCT01791192|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92359254|NCT01791192|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92359255|NCT01791192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359256|NCT01791192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359257|NCT01791192|Immunologic Factors|immunologic factors|mesh-ancestor
92359258|NCT01791192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359259|NCT00350142|Gemcitabine|gemcitabine|mesh-list
92359260|NCT00350142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359261|NCT00350142|Antimetabolites|antimetabolites|mesh-ancestor
92359262|NCT00350142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359263|NCT00350142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359264|NCT00350532|Clonidine|clonidine|mesh-list
92359265|NCT00350532|Analgesics|analgesics|mesh-ancestor
92359266|NCT00350532|Sensory System Agents|sensory system agents|mesh-ancestor
92359267|NCT00350532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359268|NCT00350532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359269|NCT00350532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92359270|NCT00350532|Sympatholytics|sympatholytics|mesh-ancestor
92359271|NCT00350532|Autonomic Agents|autonomic agents|mesh-ancestor
92359272|NCT00350532|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92359273|NCT00350532|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92359274|NCT00350532|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92359275|NCT00350532|Adrenergic Agents|adrenergic agents|mesh-ancestor
92359276|NCT00350532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359277|NCT00350532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359278|NCT00351000|Ziprasidone|ziprasidone|mesh-list
92359279|NCT00351000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92359280|NCT00351000|Serotonin Agents|serotonin agents|mesh-ancestor
92359281|NCT00351000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359282|NCT00351000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359283|NCT00351000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359284|NCT00351000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92359285|NCT00351000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359286|NCT00351000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359287|NCT00351000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359288|NCT00351000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92359289|NCT00351000|Dopamine Agents|dopamine agents|mesh-ancestor
92359291|NCT00351936|Antidepressive Agents|antidepressive agents|mesh-ancestor
92359292|NCT00351936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359293|NCT00351936|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92359294|NCT00351936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359295|NCT00351936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359296|NCT00351936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359297|NCT00351936|Dopamine Agonists|dopamine agonists|mesh-ancestor
92359298|NCT00351936|Dopamine Agents|dopamine agents|mesh-ancestor
92359299|NCT00351936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359300|NCT00351936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359301|NCT00351936|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92359302|NCT00351936|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92359303|NCT00351936|Serotonin Agents|serotonin agents|mesh-ancestor
92359304|NCT00351936|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92359305|NCT00351936|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92359306|NCT00351936|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92359308|NCT00352794|Prednisone|prednisone|mesh-list
92359309|NCT00352794|Lenalidomide|lenalidomide|mesh-list
92359310|NCT00352794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359311|NCT00352794|Glucocorticoids|glucocorticoids|mesh-ancestor
92359312|NCT00352794|Hormones|hormones|mesh-ancestor
92359313|NCT00352794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359314|NCT00352794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359315|NCT00352794|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92359316|NCT00352794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359317|NCT00352794|Immunologic Factors|immunologic factors|mesh-ancestor
92359318|NCT00352794|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359319|NCT00352794|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359320|NCT00352794|Growth Substances|growth substances|mesh-ancestor
92359321|NCT00352794|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359322|NCT00353418|Ribavirin|ribavirin|mesh-list
92359323|NCT00353418|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92359324|NCT00353418|Antimetabolites|antimetabolites|mesh-ancestor
92359325|NCT00353418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359326|NCT00353418|Antiviral Agents|antiviral agents|mesh-ancestor
92359327|NCT00353418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359328|NCT00353652|Chlorthalidone|chlorthalidone|mesh-list
92359329|NCT00353652|Spironolactone|spironolactone|mesh-list
92359330|NCT00353652|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92359331|NCT00353652|Hormone Antagonists|hormone antagonists|mesh-ancestor
92359332|NCT00353652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359333|NCT00353652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359334|NCT00353652|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92359335|NCT00353652|Diuretics|diuretics|mesh-ancestor
92359336|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
92359337|NCT00353652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92359338|NCT00353652|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92359339|NCT00353652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92359340|NCT00353652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359341|NCT02982798|Metformin|metformin|mesh-list
92359343|NCT02982798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92359344|NCT02982798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359345|NCT02982798|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92359346|NCT02982798|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92359347|NCT02982798|Antimetabolites|antimetabolites|mesh-ancestor
92359348|NCT02982798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359349|NCT02982798|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359350|NCT02982798|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92359351|NCT02982798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359352|NCT03709914|Fosfomycin|fosfomycin|mesh-list
92359353|NCT03709914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359354|NCT03709914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359355|NCT01794078|Ambrisentan|ambrisentan|mesh-list
92359356|NCT01794078|Aminophylline|aminophylline|mesh-list
92359357|NCT01794078|Theophylline|theophylline|mesh-list
92359358|NCT01794078|Ethylene|ethylene|mesh-list
92359359|NCT01794078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92359360|NCT01794078|Autonomic Agents|autonomic agents|mesh-ancestor
92359361|NCT01794078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359362|NCT01794078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359363|NCT01794078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92359364|NCT01794078|Respiratory System Agents|respiratory system agents|mesh-ancestor
92359365|NCT01794078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92359366|NCT01794078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359367|NCT01794078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359368|NCT01794078|Vasodilator Agents|vasodilator agents|mesh-ancestor
92359369|NCT01794078|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92359370|NCT01794078|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92359371|NCT01794078|Purinergic Agents|purinergic agents|mesh-ancestor
92359372|NCT01794078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359373|NCT01794078|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92359374|NCT01794078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92359375|NCT01794078|Protective Agents|protective agents|mesh-ancestor
92359376|NCT01794078|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92359377|NCT01794078|Growth Substances|growth substances|mesh-ancestor
92359378|NCT00354978|Leucovorin|leucovorin|mesh-list
92359379|NCT00354978|Bevacizumab|bevacizumab|mesh-list
92359380|NCT00354978|Fluorouracil|fluorouracil|mesh-list
92359381|NCT00354978|Irinotecan|irinotecan|mesh-list
92359382|NCT00354978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359383|NCT00354978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359384|NCT00354978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359385|NCT00354978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359386|NCT00354978|Growth Substances|growth substances|mesh-ancestor
92359387|NCT00354978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359388|NCT00354978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359389|NCT00354978|Antimetabolites|antimetabolites|mesh-ancestor
92359390|NCT00354978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359391|NCT00354978|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359392|NCT00354978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359394|NCT00354978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92359395|NCT00354978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359396|NCT00354978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359397|NCT00354978|Antidotes|antidotes|mesh-ancestor
92359398|NCT00354978|Protective Agents|protective agents|mesh-ancestor
92359399|NCT00354978|Vitamin B Complex|vitamin b complex|mesh-ancestor
92359401|NCT00354978|Micronutrients|micronutrients|mesh-ancestor
92359402|NCT00357162|Belinostat|belinostat|mesh-list
92359403|NCT00357162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359404|NCT00357162|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92359405|NCT00357162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359406|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359408|NCT03549000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92359409|NCT03549000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359410|NCT03549000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359411|NCT03549000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359413|NCT03984240|Dexmedetomidine|dexmedetomidine|mesh-list
92359414|NCT03984240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92359415|NCT03984240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359416|NCT03984240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359417|NCT03984240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92359418|NCT03984240|Analgesics|analgesics|mesh-ancestor
92359419|NCT03984240|Sensory System Agents|sensory system agents|mesh-ancestor
92359420|NCT03984240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359421|NCT03984240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92359422|NCT03984240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92359423|NCT03984240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92359424|NCT03984240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92359426|NCT03984240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359427|NCT03984240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92359428|NCT03984240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92359429|NCT03984240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359430|NCT03984240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359431|NCT03984240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92359432|NCT03984240|Anesthetics, General|anesthetics, general|mesh-ancestor
92359434|NCT03984240|GABA Modulators|gaba modulators|mesh-ancestor
92359436|NCT00359736|Sildenafil Citrate|sildenafil citrate|mesh-list
92359437|NCT00359736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92359438|NCT00359736|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92359439|NCT00359736|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92359440|NCT00359736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359441|NCT00359736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359442|NCT00359736|Urological Agents|urological agents|mesh-ancestor
92359443|NCT00360126|Lamotrigine|lamotrigine|mesh-list
92359444|NCT00360126|Anticonvulsants|anticonvulsants|mesh-ancestor
92359445|NCT00360126|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92359446|NCT00360126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92359447|NCT00360126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359448|NCT00360126|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92359449|NCT00360126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359450|NCT00360126|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92359451|NCT00360126|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359452|NCT00360126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359453|NCT00360126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359454|NCT00360126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92359455|NCT00360360|Paclitaxel|paclitaxel|mesh-list
92359456|NCT00360360|Bevacizumab|bevacizumab|mesh-list
92359457|NCT00360360|Carboplatin|carboplatin|mesh-list
92359458|NCT00360360|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92359459|NCT00360360|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92359460|NCT00360360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359461|NCT00360360|Tubulin Modulators|tubulin modulators|mesh-ancestor
92359462|NCT00360360|Antimitotic Agents|antimitotic agents|mesh-ancestor
92359463|NCT00360360|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359464|NCT00360360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359465|NCT00360360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011946|NCT04839653|Cefoxitin|cefoxitin|mesh-list
92359466|NCT00360360|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359467|NCT00360360|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359468|NCT00360360|Growth Substances|growth substances|mesh-ancestor
92359469|NCT00360360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359471|NCT00360360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92359472|NCT00360360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359473|NCT01552590|Tolvaptan|tolvaptan|mesh-list
92359474|NCT01552590|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92359475|NCT01552590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359476|NCT01552590|Natriuretic Agents|natriuretic agents|mesh-ancestor
92359477|NCT01552590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359478|NCT00549978|Cilostazol|cilostazol|mesh-list
92359479|NCT00549978|Probucol|probucol|mesh-list
92359480|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92359482|NCT00549978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359483|NCT00549978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359484|NCT00549978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92359485|NCT00549978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92359486|NCT00549978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92359487|NCT00549978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92359488|NCT00549978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359489|NCT00549978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92359490|NCT00549978|Vasodilator Agents|vasodilator agents|mesh-ancestor
92359491|NCT00549978|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92359492|NCT00549978|Protective Agents|protective agents|mesh-ancestor
92359493|NCT00549978|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92359494|NCT00549978|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92359495|NCT00549978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359496|NCT00549978|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92359497|NCT00549978|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92359498|NCT00549978|Antimetabolites|antimetabolites|mesh-ancestor
92359499|NCT00549978|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359501|NCT03983226|Carboplatin|carboplatin|mesh-list
92359502|NCT03983226|Gemcitabine|gemcitabine|mesh-list
92359503|NCT03983226|Doxorubicin|doxorubicin|mesh-list
92359504|NCT03983226|Niraparib|niraparib|mesh-list
92359507|NCT03983226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359508|NCT03983226|Antimetabolites|antimetabolites|mesh-ancestor
92359509|NCT03983226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359510|NCT03983226|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359511|NCT03983226|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92359512|NCT03983226|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359513|NCT03983226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359514|NCT03983226|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92359516|NCT00360672|Immunologic Factors|immunologic factors|mesh-ancestor
92359517|NCT00360672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359518|NCT00360672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359519|NCT00360672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359520|NCT00360672|Growth Substances|growth substances|mesh-ancestor
92359521|NCT00360672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359522|NCT00360672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359523|NCT00360828|Irinotecan|irinotecan|mesh-list
92359524|NCT00360828|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92359525|NCT00360828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359526|NCT00360828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359527|NCT00360828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359528|NCT00360828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359529|NCT00361140|Fludarabine|fludarabine|mesh-list
92359530|NCT00361140|Fludarabine phosphate|fludarabine phosphate|mesh-list
92359531|NCT00361140|Busulfan|busulfan|mesh-list
92359532|NCT00361140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359533|NCT00361140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359534|NCT00361140|Antimetabolites|antimetabolites|mesh-ancestor
92359535|NCT00361140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359536|NCT00361140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359537|NCT00361140|Immunologic Factors|immunologic factors|mesh-ancestor
92359538|NCT00361140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359539|NCT00361140|Alkylating Agents|alkylating agents|mesh-ancestor
92359540|NCT00361140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359542|NCT00362466|Imatinib Mesylate|imatinib mesylate|mesh-list
92359543|NCT00362466|Dasatinib|dasatinib|mesh-list
92359544|NCT00362466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359545|NCT00362466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92359546|NCT00362466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118057|NCT03247413|Hormones|hormones|mesh-ancestor
92359547|NCT00362466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359548|NCT00305682|Mycophenolic Acid|mycophenolic acid|mesh-list
92359549|NCT00305682|Sirolimus|sirolimus|mesh-list
92359550|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
92359551|NCT00305682|Fludarabine|fludarabine|mesh-list
92359552|NCT00305682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92359553|NCT00305682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359554|NCT00305682|Immunologic Factors|immunologic factors|mesh-ancestor
92359555|NCT00305682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359556|NCT00305682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359557|NCT00305682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359558|NCT00305682|Alkylating Agents|alkylating agents|mesh-ancestor
92359559|NCT00305682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359560|NCT00305682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359561|NCT00305682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92359562|NCT00305682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359563|NCT00305682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92359564|NCT00305682|Antitubercular Agents|antitubercular agents|mesh-ancestor
92359565|NCT00305682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359566|NCT00305682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359567|NCT00305682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359568|NCT00305682|Antifungal Agents|antifungal agents|mesh-ancestor
92359569|NCT00305760|Cyclophosphamide|cyclophosphamide|mesh-list
92359570|NCT00305760|Cetuximab|cetuximab|mesh-list
92359571|NCT00305760|Vaccines|vaccines|mesh-list
92359572|NCT00305760|Immunologic Factors|immunologic factors|mesh-ancestor
92359573|NCT00305760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359574|NCT00305760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359575|NCT00305760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359576|NCT00305760|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359577|NCT00305760|Alkylating Agents|alkylating agents|mesh-ancestor
92359578|NCT00305760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359579|NCT00305760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359580|NCT00305760|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92359581|NCT00305760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359582|NCT00309738|Simvastatin|simvastatin|mesh-list
92359583|NCT00309738|Pitavastatin|pitavastatin|mesh-list
92359584|NCT00309738|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92359585|NCT00309738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92359586|NCT00309738|Antimetabolites|antimetabolites|mesh-ancestor
92359587|NCT00309738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359588|NCT00309738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92359589|NCT00309738|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92359590|NCT00309738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359591|NCT00310050|Pemetrexed|pemetrexed|mesh-list
92359592|NCT00310050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359593|NCT00310050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359594|NCT00310050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359595|NCT00310050|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92359596|NCT00310050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92359597|NCT00363168|Ranibizumab|ranibizumab|mesh-list
92359598|NCT00363168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359599|NCT00363168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359600|NCT00363168|Growth Substances|growth substances|mesh-ancestor
92359601|NCT00363168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359602|NCT00363168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359603|NCT00363168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359604|NCT00365274|Prednisone|prednisone|mesh-list
92359605|NCT00365274|Cyclophosphamide|cyclophosphamide|mesh-list
92359606|NCT00365274|Doxorubicin|doxorubicin|mesh-list
92359607|NCT00365274|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92359608|NCT00365274|Vincristine|vincristine|mesh-list
92359609|NCT00365274|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92359610|NCT00365274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359611|NCT00365274|Immunologic Factors|immunologic factors|mesh-ancestor
92359612|NCT00365274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359614|NCT00365274|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359615|NCT00365274|Alkylating Agents|alkylating agents|mesh-ancestor
92359616|NCT00365274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359617|NCT00365274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359618|NCT00365274|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92359619|NCT00365274|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359620|NCT00365274|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92359621|NCT00365274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359622|NCT00365274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359623|NCT00365274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359624|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
92359625|NCT00365274|Hormones|hormones|mesh-ancestor
92359626|NCT00365274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359627|NCT00365274|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92359628|NCT00365274|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92359629|NCT00365274|Tubulin Modulators|tubulin modulators|mesh-ancestor
92359630|NCT00365274|Antimitotic Agents|antimitotic agents|mesh-ancestor
92359631|NCT00365274|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359632|NCT00365274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359634|NCT00365274|Immunoconjugates|immunoconjugates|mesh-ancestor
92359635|NCT00311376|Botulinum Toxins|botulinum toxins|mesh-list
92359636|NCT00311376|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92359637|NCT00311376|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92359638|NCT00311376|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92359639|NCT00311376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92359640|NCT00311376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359641|NCT00311376|Cholinergic Agents|cholinergic agents|mesh-ancestor
92359642|NCT00311376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359643|NCT00311376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359644|NCT00311376|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92359645|NCT00311376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359646|NCT02104830|Lenograstim|lenograstim|mesh-list
92359647|NCT02104830|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92359648|NCT02104830|Immunologic Factors|immunologic factors|mesh-ancestor
92359649|NCT02104830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359650|NCT00313560|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92359651|NCT00313560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359652|NCT00313560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92359653|NCT00313560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359654|NCT00313560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359656|NCT00314106|Cyclophosphamide|cyclophosphamide|mesh-list
92359658|NCT00314106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359659|NCT00314106|Immunologic Factors|immunologic factors|mesh-ancestor
92359660|NCT00314106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359661|NCT00314106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359662|NCT00314106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359663|NCT00314106|Alkylating Agents|alkylating agents|mesh-ancestor
92359664|NCT00314106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359665|NCT00314106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359666|NCT00314106|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92359667|NCT00314106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92359668|NCT00314106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92359669|NCT00314106|Antiviral Agents|antiviral agents|mesh-ancestor
92359670|NCT00314106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359671|NCT00316524|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92359672|NCT00316524|Antiviral Agents|antiviral agents|mesh-ancestor
92359673|NCT00316524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359675|NCT00318708|Xhance|xhance|mesh-list
92359676|NCT00318708|Clarithromycin|clarithromycin|mesh-list
92359677|NCT00318708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359678|NCT00318708|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92359679|NCT00318708|Autonomic Agents|autonomic agents|mesh-ancestor
92359680|NCT00318708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359681|NCT00318708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359682|NCT00318708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92359683|NCT00318708|Respiratory System Agents|respiratory system agents|mesh-ancestor
92359684|NCT00318708|Dermatologic Agents|dermatologic agents|mesh-ancestor
92359685|NCT00318708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92359686|NCT00318708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359687|NCT00318708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359688|NCT00318708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92359689|NCT00318708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359690|NCT00318708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359691|NCT00318708|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92359692|NCT00318708|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92359693|NCT00319644|Dimercaprol|dimercaprol|mesh-list
92359694|NCT00319644|Chelating Agents|chelating agents|mesh-ancestor
92359695|NCT00319644|Sequestering Agents|sequestering agents|mesh-ancestor
92359696|NCT00319644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359697|NCT02448420|Trastuzumab|trastuzumab|mesh-list
92359698|NCT02448420|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92359700|NCT02448420|Antibodies|antibodies|mesh-list
92359701|NCT02448420|Immunoconjugates|immunoconjugates|mesh-list
92359702|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
92359703|NCT02448420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359704|NCT02448420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359705|NCT02448420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359706|NCT02448420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92359707|NCT02448420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359708|NCT02448420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359709|NCT02448420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92359710|NCT02448420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92359711|NCT02448420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359712|NCT02448420|Immunotoxins|immunotoxins|mesh-ancestor
92359713|NCT02422446|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92359714|NCT02422446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92359716|NCT02405676|Cytarabine|cytarabine|mesh-list
92359717|NCT02405676|Prednisone|prednisone|mesh-list
92359718|NCT02405676|Cyclophosphamide|cyclophosphamide|mesh-list
92359719|NCT02405676|Ifosfamide|ifosfamide|mesh-list
92359720|NCT02405676|Isophosphamide mustard|isophosphamide mustard|mesh-list
92359721|NCT02405676|Rituximab|rituximab|mesh-list
92359722|NCT02405676|Methotrexate|methotrexate|mesh-list
92359723|NCT02405676|Etoposide|etoposide|mesh-list
92359724|NCT02405676|Etoposide phosphate|etoposide phosphate|mesh-list
92359725|NCT02405676|Vincristine|vincristine|mesh-list
92359726|NCT02405676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359727|NCT02405676|Immunologic Factors|immunologic factors|mesh-ancestor
92359728|NCT02405676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359729|NCT02405676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359730|NCT02405676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359731|NCT02405676|Alkylating Agents|alkylating agents|mesh-ancestor
92359732|NCT02405676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359733|NCT02405676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359734|NCT02405676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92359735|NCT02405676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359736|NCT02405676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359737|NCT02405676|Glucocorticoids|glucocorticoids|mesh-ancestor
92359738|NCT02405676|Hormones|hormones|mesh-ancestor
92359739|NCT02405676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359740|NCT02405676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92359741|NCT02405676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92359742|NCT02405676|Abortifacient Agents|abortifacient agents|mesh-ancestor
92359743|NCT02405676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92359744|NCT02405676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92359745|NCT02405676|Antimetabolites|antimetabolites|mesh-ancestor
92359746|NCT02405676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92359747|NCT02405676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359748|NCT02405676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92359749|NCT02405676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92359750|NCT02405676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92359751|NCT02405676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92359752|NCT02405676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359753|NCT02405676|Antiviral Agents|antiviral agents|mesh-ancestor
92359754|NCT02405676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359755|NCT02405676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92359756|NCT02405676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92359757|NCT02405676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92359759|NCT00321594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359760|NCT00321594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92359761|NCT00321594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359762|NCT00321594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359763|NCT04751136|Cerebrolysin|cerebrolysin|mesh-list
92359764|NCT04751136|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92359765|NCT04751136|Protective Agents|protective agents|mesh-ancestor
92359766|NCT04751136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359767|NCT04751136|Nootropic Agents|nootropic agents|mesh-ancestor
92359768|NCT00390234|Aflibercept|aflibercept|mesh-list
92359769|NCT00390234|Endothelial Growth Factors|endothelial growth factors|mesh-list
92359770|NCT00390234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359771|NCT00390234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359772|NCT00390234|Growth Substances|growth substances|mesh-ancestor
92359773|NCT00390234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359774|NCT00390234|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359775|NCT00390234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359776|NCT00391716|Gabapentin|gabapentin|mesh-list
92359777|NCT00391716|Analgesics|analgesics|mesh-ancestor
92359779|NCT00391716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359780|NCT00391716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359781|NCT00391716|Anticonvulsants|anticonvulsants|mesh-ancestor
92359782|NCT00391716|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92359783|NCT00391716|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359784|NCT00391716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359785|NCT00391716|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359786|NCT00391716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92359787|NCT00391716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92359788|NCT00391716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359789|NCT00391716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359790|NCT00391716|Antimanic Agents|antimanic agents|mesh-ancestor
92359791|NCT00392496|Sunitinib|sunitinib|mesh-list
92359792|NCT00392496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359793|NCT00392496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92359794|NCT00392496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92359795|NCT00392496|Growth Substances|growth substances|mesh-ancestor
92359796|NCT00392496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359797|NCT00392496|Growth Inhibitors|growth inhibitors|mesh-ancestor
92359798|NCT00392496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92359799|NCT00392496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359800|NCT00392496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359801|NCT01958190|Sirolimus|sirolimus|mesh-list
92359802|NCT01958190|Tacrolimus|tacrolimus|mesh-list
92359803|NCT01958190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359804|NCT01958190|Immunologic Factors|immunologic factors|mesh-ancestor
92359805|NCT01958190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359806|NCT01958190|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92359807|NCT01958190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359808|NCT01958190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359809|NCT01958190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92359810|NCT01958190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359811|NCT01958190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92359812|NCT01958190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359813|NCT01958190|Antifungal Agents|antifungal agents|mesh-ancestor
92359814|NCT00638898|Melphalan|melphalan|mesh-list
92359815|NCT00638898|Busulfan|busulfan|mesh-list
92359817|NCT00638898|Lenograstim|lenograstim|mesh-list
92359818|NCT00638898|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92359819|NCT00638898|Immunologic Factors|immunologic factors|mesh-ancestor
92359820|NCT00638898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359821|NCT00638898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92359822|NCT00638898|Alkylating Agents|alkylating agents|mesh-ancestor
92359823|NCT00638898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359824|NCT00638898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359825|NCT00638898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92359826|NCT00638898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359827|NCT00638898|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92359828|NCT00638898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92359829|NCT00638898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359831|NCT00393978|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92359832|NCT00393978|Antidepressive Agents|antidepressive agents|mesh-ancestor
92359833|NCT00393978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359834|NCT00393978|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92359835|NCT00393978|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359836|NCT00393978|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359837|NCT00393978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359838|NCT00393978|Anticonvulsants|anticonvulsants|mesh-ancestor
92359839|NCT00393978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92359840|NCT00396006|Protease Inhibitors|protease inhibitors|mesh-list
92359841|NCT00396006|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92359843|NCT00396006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359844|NCT00396006|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92359845|NCT00396006|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92359846|NCT00397020|Valproic Acid|valproic acid|mesh-list
92359847|NCT00397020|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92359848|NCT00397020|Antidepressive Agents|antidepressive agents|mesh-ancestor
92359849|NCT00397020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359850|NCT00397020|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92359851|NCT00397020|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359852|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359853|NCT00397020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359854|NCT00397020|Anticonvulsants|anticonvulsants|mesh-ancestor
92359855|NCT00397020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359856|NCT00397020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359857|NCT00397020|GABA Agents|gaba agents|mesh-ancestor
92359858|NCT00397020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359859|NCT00397020|Antimanic Agents|antimanic agents|mesh-ancestor
92359860|NCT00397878|Saracatinib|saracatinib|mesh-list
92359861|NCT00397878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359862|NCT00397878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359863|NCT00397878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359864|NCT00400686|Epoetin Alfa|epoetin alfa|mesh-list
92359865|NCT00400686|Hematinics|hematinics|mesh-ancestor
92359867|NCT05220462|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92359868|NCT05220462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92359869|NCT05220462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359870|NCT05220462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359871|NCT05220462|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92359872|NCT05220462|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359873|NCT05220462|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359874|NCT05220462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92359875|NCT05220462|Anesthetics, General|anesthetics, general|mesh-ancestor
92359876|NCT05220462|Anesthetics|anesthetics|mesh-ancestor
92359877|NCT05220462|GABA Modulators|gaba modulators|mesh-ancestor
92359878|NCT05220462|GABA Agents|gaba agents|mesh-ancestor
92359879|NCT05220462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359880|NCT05220462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359881|NCT00373386|Hormones|hormones|mesh-list
92359882|NCT00373386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359883|NCT00373386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359884|NCT00374088|Acetylcysteine|acetylcysteine|mesh-list
92359885|NCT00374088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92359886|NCT00374088|Antiviral Agents|antiviral agents|mesh-ancestor
92359887|NCT00374088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92359888|NCT00374088|Expectorants|expectorants|mesh-ancestor
92359889|NCT00374088|Respiratory System Agents|respiratory system agents|mesh-ancestor
92359890|NCT00374088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92359891|NCT00374088|Antioxidants|antioxidants|mesh-ancestor
92359892|NCT00374088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359893|NCT00374088|Protective Agents|protective agents|mesh-ancestor
92359894|NCT00374088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359895|NCT00374088|Antidotes|antidotes|mesh-ancestor
92359896|NCT00374244|Pimozide|pimozide|mesh-list
92359897|NCT00374244|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92359898|NCT00374244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92359899|NCT00374244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359900|NCT00374244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359901|NCT00374244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92359902|NCT00374244|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92359903|NCT00374244|Dopamine Agents|dopamine agents|mesh-ancestor
92359904|NCT00374244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359905|NCT00374244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359906|NCT00374244|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92359907|NCT00377832|Acetaminophen|acetaminophen|mesh-list
92359909|NCT00377832|Analgesics|analgesics|mesh-ancestor
92359910|NCT00377832|Sensory System Agents|sensory system agents|mesh-ancestor
92359911|NCT00377832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359912|NCT00377832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359913|NCT00377832|Antipyretics|antipyretics|mesh-ancestor
92359914|NCT00401778|Everolimus|everolimus|mesh-list
92359915|NCT00401778|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92359916|NCT00401778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92359917|NCT00401778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359918|NCT00401778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359919|NCT00401778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92359920|NCT00401778|Immunologic Factors|immunologic factors|mesh-ancestor
92359921|NCT00401778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359922|NCT00401778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359923|NCT00402714|Pentostatin|pentostatin|mesh-list
92359924|NCT00402714|Methoxsalen|methoxsalen|mesh-list
92359925|NCT00402714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359926|NCT00402714|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92359927|NCT00402714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359928|NCT00402714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359929|NCT00402714|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92359930|NCT00402714|Dermatologic Agents|dermatologic agents|mesh-ancestor
92359931|NCT00405288|Hydrocortisone|hydrocortisone|mesh-list
92359932|NCT00405288|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92359933|NCT00405288|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92359934|NCT00405288|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92359935|NCT00405288|Pramoxine|pramoxine|mesh-list
92359936|NCT00405288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359937|NCT00405288|Anesthetics, Local|anesthetics, local|mesh-ancestor
92359938|NCT00405288|Anesthetics|anesthetics|mesh-ancestor
92359939|NCT00405288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359940|NCT00405288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359941|NCT00405288|Sensory System Agents|sensory system agents|mesh-ancestor
92359942|NCT00405288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359943|NCT00381810|Acetaminophen|acetaminophen|mesh-list
92359944|NCT00381810|Diphenhydramine|diphenhydramine|mesh-list
92359945|NCT00381810|Promethazine|promethazine|mesh-list
92359946|NCT00381810|Methylprednisolone|methylprednisolone|mesh-list
92359948|NCT00381810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92359950|NCT00381810|Immunologic Factors|immunologic factors|mesh-ancestor
92359951|NCT00381810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359952|NCT00381810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92359953|NCT00381810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92359954|NCT00381810|Analgesics|analgesics|mesh-ancestor
92359955|NCT00381810|Sensory System Agents|sensory system agents|mesh-ancestor
92359956|NCT00381810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92359957|NCT00381810|Antipyretics|antipyretics|mesh-ancestor
92359958|NCT00381810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92359959|NCT00381810|Antiemetics|antiemetics|mesh-ancestor
92359960|NCT00381810|Autonomic Agents|autonomic agents|mesh-ancestor
92359961|NCT00381810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92359962|NCT00381810|Glucocorticoids|glucocorticoids|mesh-ancestor
92359963|NCT00381810|Hormones|hormones|mesh-ancestor
92359964|NCT00381810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92359965|NCT00381810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92359966|NCT00381810|Protective Agents|protective agents|mesh-ancestor
92359967|NCT00381810|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92359968|NCT00381810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92359969|NCT00381810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92359970|NCT00381810|Anesthetics, Local|anesthetics, local|mesh-ancestor
92359971|NCT00381810|Anesthetics|anesthetics|mesh-ancestor
92359972|NCT00381810|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92359973|NCT00381810|Histamine Antagonists|histamine antagonists|mesh-ancestor
92359974|NCT00381810|Histamine Agents|histamine agents|mesh-ancestor
92359975|NCT00381810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92359976|NCT00381810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359977|NCT00381810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92359978|NCT00381810|Antipruritics|antipruritics|mesh-ancestor
92359979|NCT00381810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92359980|NCT00458952|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92359981|NCT00458952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359982|NCT00458952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92359983|NCT00458952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92359984|NCT00458952|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92359985|NCT00459732|Zinc|zinc|mesh-list
92359986|NCT00459732|Zinc Sulfate|zinc sulfate|mesh-list
92359987|NCT00459732|Trace Elements|trace elements|mesh-ancestor
92359988|NCT00459732|Micronutrients|micronutrients|mesh-ancestor
92359989|NCT00459732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92359990|NCT00459732|Astringents|astringents|mesh-ancestor
92359991|NCT00459732|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012476|NCT04822415|Anesthetics|anesthetics|mesh-ancestor
92359992|NCT00459810|Paclitaxel|paclitaxel|mesh-list
92359993|NCT00459810|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92359994|NCT00459810|Estradiol|estradiol|mesh-list
92359995|NCT00459810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92359996|NCT00459810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92359997|NCT00459810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92359998|NCT00459810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92359999|NCT00459810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360000|NCT00459810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360001|NCT00459810|Estrogens|estrogens|mesh-ancestor
92360002|NCT00459810|Hormones|hormones|mesh-ancestor
92360003|NCT00459810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360004|NCT00459810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360005|NCT00405522|Remifentanil|remifentanil|mesh-list
92360006|NCT00405522|Propofol|propofol|mesh-list
92360007|NCT00405522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92360008|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92360009|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360010|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92360011|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
92360013|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92360014|NCT00405522|Narcotics|narcotics|mesh-ancestor
92360015|NCT00405522|Analgesics|analgesics|mesh-ancestor
92360016|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
92360017|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360018|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
92360019|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92360020|NCT00461292|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92360021|NCT00461292|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92360022|NCT00461292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92360023|NCT00461292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360024|NCT00461292|Cholinergic Agents|cholinergic agents|mesh-ancestor
92360025|NCT00461292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360026|NCT00461292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360027|NCT00461292|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92360028|NCT00461292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360030|NCT00382590|Azacitidine|azacitidine|mesh-list
92360031|NCT00382590|Valproic Acid|valproic acid|mesh-list
92360032|NCT00382590|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360034|NCT00382590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360036|NCT00382590|Antiviral Agents|antiviral agents|mesh-ancestor
92360037|NCT00382590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360038|NCT00382590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360039|NCT00382590|Immunologic Factors|immunologic factors|mesh-ancestor
92360040|NCT00382590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360041|NCT00382590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360042|NCT00382590|Anticonvulsants|anticonvulsants|mesh-ancestor
92360043|NCT00382590|GABA Agents|gaba agents|mesh-ancestor
92360044|NCT00382590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360045|NCT00382590|Antimanic Agents|antimanic agents|mesh-ancestor
92360046|NCT00382590|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92360047|NCT00382590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92360048|NCT00382590|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92360049|NCT00382824|Ubiquinone|ubiquinone|mesh-list
92360050|NCT00382824|Coenzyme Q10|coenzyme q10|mesh-list
92360051|NCT00382824|Micronutrients|micronutrients|mesh-ancestor
92360052|NCT00382824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360053|NCT00382824|Vitamins|vitamins|mesh-ancestor
92360054|NCT00462072|Infliximab|infliximab|mesh-list
92360055|NCT00462072|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92360056|NCT00462072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360057|NCT00462072|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360058|NCT00462072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360059|NCT00462072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360060|NCT00462228|Memantine|memantine|mesh-list
92360061|NCT00462228|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92360062|NCT00462228|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92360063|NCT00462228|Dopamine Agents|dopamine agents|mesh-ancestor
92360064|NCT00462228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360065|NCT00462228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360066|NCT00462228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360067|NCT00462228|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92360068|NCT00462228|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92360070|NCT00408564|Capecitabine|capecitabine|mesh-list
92360071|NCT00408564|Oxaliplatin|oxaliplatin|mesh-list
92360073|NCT00408564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360074|NCT00408564|Antimetabolites|antimetabolites|mesh-ancestor
92360075|NCT00408564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360076|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360077|NCT00408564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360079|NCT00383448|Melphalan|melphalan|mesh-list
92360080|NCT00383448|Alemtuzumab|alemtuzumab|mesh-list
92360081|NCT00383448|Hydroxyurea|hydroxyurea|mesh-list
92360082|NCT00383448|Clofarabine|clofarabine|mesh-list
92360084|NCT00383448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360085|NCT00383448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360086|NCT00383448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360087|NCT00383448|Immunologic Factors|immunologic factors|mesh-ancestor
92360088|NCT00383448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360089|NCT00383448|Antifungal Agents|antifungal agents|mesh-ancestor
92360090|NCT00383448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360092|NCT00383448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360093|NCT00383448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92360094|NCT00383448|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360095|NCT00383448|Alkylating Agents|alkylating agents|mesh-ancestor
92360096|NCT00383448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360097|NCT00383448|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360098|NCT00383448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360099|NCT00383448|Antisickling Agents|antisickling agents|mesh-ancestor
92360100|NCT00383448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360101|NCT00383448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360102|NCT00383448|Antimetabolites|antimetabolites|mesh-ancestor
92360104|NCT00384774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92360105|NCT00384774|Serotonin Agents|serotonin agents|mesh-ancestor
92360106|NCT00384774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360107|NCT00384774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360108|NCT00384774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360109|NCT00410826|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92360110|NCT00410826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360111|NCT00410826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92360112|NCT00410826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360113|NCT00410826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360114|NCT00464646|Cyclophosphamide|cyclophosphamide|mesh-list
92360116|NCT00464646|Docetaxel|docetaxel|mesh-list
92360117|NCT00464646|Trastuzumab|trastuzumab|mesh-list
92360118|NCT00464646|Epirubicin|epirubicin|mesh-list
92360119|NCT00464646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360120|NCT00464646|Immunologic Factors|immunologic factors|mesh-ancestor
92360121|NCT00464646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360122|NCT00464646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360123|NCT00464646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360125|NCT00464646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360126|NCT00464646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360127|NCT00464646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360128|NCT00464646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360129|NCT00464646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360130|NCT00464646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360131|NCT00464646|Growth Substances|growth substances|mesh-ancestor
92360132|NCT00464646|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360133|NCT00464646|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360134|NCT00464646|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360135|NCT00464646|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360136|NCT00464646|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360137|NCT00464646|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360138|NCT00464646|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360139|NCT00464646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360140|NCT00385008|Naproxen|naproxen|mesh-list
92360141|NCT00385008|Sumatriptan|sumatriptan|mesh-list
92360142|NCT00385008|Eletriptan|eletriptan|mesh-list
92360143|NCT00385008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92360144|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92360145|NCT00385008|Analgesics|analgesics|mesh-ancestor
92360146|NCT00385008|Sensory System Agents|sensory system agents|mesh-ancestor
92360147|NCT00385008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360148|NCT00385008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360149|NCT00385008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360150|NCT00385008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360151|NCT00385008|Gout Suppressants|gout suppressants|mesh-ancestor
92360152|NCT00385008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92360153|NCT00385008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360154|NCT00385008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360155|NCT00385008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92360156|NCT00385008|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92360157|NCT00385008|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92360159|NCT00385008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360160|NCT00410904|Pemetrexed|pemetrexed|mesh-list
92360161|NCT00410904|Cediranib|cediranib|mesh-list
92360162|NCT00410904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360163|NCT00410904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360164|NCT00410904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360165|NCT00410904|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92360166|NCT00410904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360167|NCT00410904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92360168|NCT00385788|Gemcitabine|gemcitabine|mesh-list
92360169|NCT00385788|Methotrexate|methotrexate|mesh-list
92360170|NCT00385788|Fludarabine phosphate|fludarabine phosphate|mesh-list
92360171|NCT00385788|Fludarabine|fludarabine|mesh-list
92360173|NCT00385788|Tacrolimus|tacrolimus|mesh-list
92360174|NCT00385788|Thymoglobulin|thymoglobulin|mesh-list
92360175|NCT00385788|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92360176|NCT00385788|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360177|NCT00385788|Antimetabolites|antimetabolites|mesh-ancestor
92360178|NCT00385788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360179|NCT00385788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360180|NCT00385788|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92360181|NCT00385788|Abortifacient Agents|abortifacient agents|mesh-ancestor
92360182|NCT00385788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92360183|NCT00385788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360184|NCT00385788|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360185|NCT00385788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360186|NCT00385788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92360187|NCT00385788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360188|NCT00385788|Immunologic Factors|immunologic factors|mesh-ancestor
92360189|NCT00385788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360190|NCT00385788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360191|NCT00385788|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92360192|NCT00385788|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360193|NCT00385788|Alkylating Agents|alkylating agents|mesh-ancestor
92360194|NCT00385788|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360195|NCT00411684|Ulipristal acetate|ulipristal acetate|mesh-list
92360196|NCT00411684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92360197|NCT00411684|Contraceptive Agents|contraceptive agents|mesh-ancestor
92360198|NCT00411684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92360199|NCT00411684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360200|NCT00411684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92360201|NCT00412074|Vitamin D|vitamin d|mesh-list
92360202|NCT00412074|Ergocalciferols|ergocalciferols|mesh-list
92360203|NCT00412074|Cholecalciferol|cholecalciferol|mesh-list
92360204|NCT00412074|Vitamins|vitamins|mesh-list
92360205|NCT00412074|Micronutrients|micronutrients|mesh-ancestor
92360206|NCT00412074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360207|NCT00412074|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92360208|NCT00412074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92360209|NCT00412464|PENTA|penta|mesh-list
92360210|NCT00412464|Fondaparinux|fondaparinux|mesh-list
92360211|NCT00412464|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92360212|NCT00412464|Antithrombins|antithrombins|mesh-ancestor
92360213|NCT00412464|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92360214|NCT00412464|Protease Inhibitors|protease inhibitors|mesh-ancestor
92360215|NCT00412464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360216|NCT00412464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360218|NCT00412464|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92360219|NCT00412464|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92360220|NCT00466752|Sorafenib|sorafenib|mesh-list
92360221|NCT00466752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360222|NCT00466752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92360223|NCT00466752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360224|NCT00466752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360225|NCT02115750|Etanercept|etanercept|mesh-list
92360226|NCT02115750|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92360227|NCT02115750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92360228|NCT02115750|Analgesics|analgesics|mesh-ancestor
92360229|NCT02115750|Sensory System Agents|sensory system agents|mesh-ancestor
92360230|NCT02115750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360231|NCT02115750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360232|NCT02115750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360233|NCT02115750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360234|NCT02115750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360235|NCT02115750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360236|NCT02115750|Immunologic Factors|immunologic factors|mesh-ancestor
92360238|NCT00413166|Tretinoin|tretinoin|mesh-list
92360239|NCT00413166|Arsenic Trioxide|arsenic trioxide|mesh-list
92360240|NCT00413166|Gemtuzumab|gemtuzumab|mesh-list
92360241|NCT00413166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360242|NCT00413166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360243|NCT00413166|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360244|NCT00413166|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360245|NCT00413166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360246|NCT00413166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360247|NCT00413166|Keratolytic Agents|keratolytic agents|mesh-ancestor
92360248|NCT00413166|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360249|NCT00413166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360250|NCT00413166|Immunotoxins|immunotoxins|mesh-ancestor
92360251|NCT00413166|Immunoconjugates|immunoconjugates|mesh-ancestor
92360252|NCT00413166|Immunologic Factors|immunologic factors|mesh-ancestor
92360253|NCT00413166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360255|NCT00413400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92360256|NCT00413400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92360257|NCT00413400|Analgesics|analgesics|mesh-ancestor
92360258|NCT00413400|Sensory System Agents|sensory system agents|mesh-ancestor
92360259|NCT00413400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360260|NCT00413400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360261|NCT00413400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360262|NCT00413400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360263|NCT00413400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360264|NCT00413400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360265|NCT00413400|Immunologic Factors|immunologic factors|mesh-ancestor
92360266|NCT00413478|Azacitidine|azacitidine|mesh-list
92360267|NCT00413478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360268|NCT00413478|Antimetabolites|antimetabolites|mesh-ancestor
92360269|NCT00413478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360270|NCT00413478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360271|NCT00413478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360272|NCT00413634|Anagrelide|anagrelide|mesh-list
92360273|NCT00413634|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92360274|NCT00413634|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92360275|NCT00413634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360276|NCT00413634|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92360277|NCT00387036|Fluticasone|fluticasone|mesh-list
92360278|NCT00387036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360279|NCT00387036|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92360280|NCT00387036|Autonomic Agents|autonomic agents|mesh-ancestor
92360281|NCT00387036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360282|NCT00387036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360283|NCT00387036|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92360284|NCT00387036|Respiratory System Agents|respiratory system agents|mesh-ancestor
92360285|NCT00387036|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360286|NCT00387036|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92360287|NCT04388904|Tenofovir|tenofovir|mesh-list
92360288|NCT04388904|Emtricitabine|emtricitabine|mesh-list
92360289|NCT04388904|Darunavir|darunavir|mesh-list
92360290|NCT04388904|Cobicistat|cobicistat|mesh-list
92360291|NCT04388904|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92360292|NCT04388904|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92360293|NCT04388904|Antiviral Agents|antiviral agents|mesh-ancestor
92360294|NCT04388904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360295|NCT04388904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92360296|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360297|NCT04388904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360298|NCT04388904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360299|NCT04388904|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92360300|NCT04388904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92360301|NCT04388904|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92360302|NCT04388904|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92360303|NCT04388904|Protease Inhibitors|protease inhibitors|mesh-ancestor
92360304|NCT04388904|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92360305|NCT04388904|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92360306|NCT00387660|Carboplatin|carboplatin|mesh-list
92360307|NCT00387660|Irinotecan|irinotecan|mesh-list
92360308|NCT00387660|Camptothecin|camptothecin|mesh-list
92360309|NCT00387660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360310|NCT00387660|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92360311|NCT00387660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360312|NCT00387660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360313|NCT00387660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360314|NCT00387660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360315|NCT00472056|Cytarabine|cytarabine|mesh-list
92360316|NCT00472056|Rituximab|rituximab|mesh-list
92360317|NCT00472056|Etoposide|etoposide|mesh-list
92360318|NCT00472056|Melphalan|melphalan|mesh-list
92360319|NCT00472056|Carmustine|carmustine|mesh-list
92360320|NCT00472056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360321|NCT00472056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360322|NCT00472056|Immunologic Factors|immunologic factors|mesh-ancestor
92360323|NCT00472056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360324|NCT00472056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360325|NCT00472056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360326|NCT00472056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360327|NCT00472056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360328|NCT00472056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360329|NCT00472056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360330|NCT00472056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360331|NCT00472056|Antimetabolites|antimetabolites|mesh-ancestor
92360332|NCT00472056|Antiviral Agents|antiviral agents|mesh-ancestor
92360333|NCT00472056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118135|NCT03242460|Dexamethasone|dexamethasone|mesh-list
92360334|NCT00472056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360335|NCT00472056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360336|NCT00472056|Alkylating Agents|alkylating agents|mesh-ancestor
92360337|NCT00472056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360338|NCT00415506|Rituximab|rituximab|mesh-list
92360339|NCT00415506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360340|NCT00415506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360341|NCT00415506|Immunologic Factors|immunologic factors|mesh-ancestor
92360342|NCT00415506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360343|NCT00415506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360344|NCT03531918|Cytarabine|cytarabine|mesh-list
92360345|NCT03531918|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92360346|NCT03531918|Mitoxantrone|mitoxantrone|mesh-list
92360347|NCT03531918|Cladribine|cladribine|mesh-list
92360348|NCT03531918|Gemtuzumab|gemtuzumab|mesh-list
92360349|NCT03531918|Calicheamicins|calicheamicins|mesh-list
92360350|NCT03531918|Lenograstim|lenograstim|mesh-list
92360351|NCT03531918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360352|NCT03531918|Antimetabolites|antimetabolites|mesh-ancestor
92360353|NCT03531918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360354|NCT03531918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360355|NCT03531918|Antiviral Agents|antiviral agents|mesh-ancestor
92360356|NCT03531918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360357|NCT03531918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360359|NCT03531918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360361|NCT03531918|Sensory System Agents|sensory system agents|mesh-ancestor
92360362|NCT03531918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360363|NCT03531918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360364|NCT03531918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360365|NCT03531918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360366|NCT03531918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92360367|NCT03531918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360369|NCT03531918|Immunoconjugates|immunoconjugates|mesh-ancestor
92360370|NCT03531918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360371|NCT00389532|Vaccines|vaccines|mesh-list
92360372|NCT00389532|Immunologic Factors|immunologic factors|mesh-ancestor
92360373|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360375|NCT03520686|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92360376|NCT03520686|Cisplatin|cisplatin|mesh-list
92360377|NCT03520686|Carboplatin|carboplatin|mesh-list
92360378|NCT03520686|Pembrolizumab|pembrolizumab|mesh-list
92360379|NCT03520686|Pemetrexed|pemetrexed|mesh-list
92360380|NCT03520686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360381|NCT03520686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360382|NCT03520686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360383|NCT03520686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360384|NCT03520686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360385|NCT03520686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360386|NCT03520686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937401|NCT02526212|Narcotics|narcotics|mesh-ancestor
92360387|NCT03520686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92360388|NCT03520686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360389|NCT03520686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92360390|NCT03520686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360391|NCT01957956|Temozolomide|temozolomide|mesh-list
92360392|NCT01957956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360393|NCT01957956|Alkylating Agents|alkylating agents|mesh-ancestor
92360394|NCT01957956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360395|NCT01957956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360396|NCT00475878|Escitalopram|escitalopram|mesh-list
92360397|NCT00475878|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92360398|NCT00475878|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92360399|NCT00475878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92360400|NCT00475878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360401|NCT00475878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360402|NCT00475878|Serotonin Agents|serotonin agents|mesh-ancestor
92360403|NCT00475878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360404|NCT01795170|Pyridoxine|pyridoxine|mesh-list
92360405|NCT01795170|Vitamin B Complex|vitamin b complex|mesh-ancestor
92360406|NCT01795170|Vitamins|vitamins|mesh-ancestor
92360407|NCT01795170|Micronutrients|micronutrients|mesh-ancestor
92360408|NCT01795170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360409|NCT00477204|Simvastatin|simvastatin|mesh-list
92360410|NCT00477204|Ezetimibe|ezetimibe|mesh-list
92360411|NCT00477204|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92360412|NCT00477204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92360413|NCT00477204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92360415|NCT00477204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360416|NCT00477204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92360417|NCT00477204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92360418|NCT00477204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360419|NCT00528450|Idarubicin|idarubicin|mesh-list
92360420|NCT00528450|Arsenic Trioxide|arsenic trioxide|mesh-list
92360421|NCT00528450|Tretinoin|tretinoin|mesh-list
92360422|NCT00528450|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360423|NCT00528450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360424|NCT00528450|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360425|NCT00528450|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360426|NCT00528450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360427|NCT00528450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360428|NCT00528450|Keratolytic Agents|keratolytic agents|mesh-ancestor
92360429|NCT00528450|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360431|NCT00478218|Cyclophosphamide|cyclophosphamide|mesh-list
92360432|NCT00478218|Lenalidomide|lenalidomide|mesh-list
92360433|NCT00478218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360434|NCT00478218|Immunologic Factors|immunologic factors|mesh-ancestor
92360435|NCT00478218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360436|NCT00478218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360437|NCT00478218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360438|NCT00478218|Alkylating Agents|alkylating agents|mesh-ancestor
92360439|NCT00478218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360440|NCT00478218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360441|NCT00478218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360442|NCT00478218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360443|NCT00478218|Antiemetics|antiemetics|mesh-ancestor
92360444|NCT00478218|Autonomic Agents|autonomic agents|mesh-ancestor
92360445|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360446|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360447|NCT00478218|Glucocorticoids|glucocorticoids|mesh-ancestor
92360448|NCT00478218|Hormones|hormones|mesh-ancestor
92360449|NCT00478218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360450|NCT00478218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92360451|NCT00478218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360452|NCT00478218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360453|NCT00478218|Growth Substances|growth substances|mesh-ancestor
92360454|NCT00478218|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360455|NCT00479154|Botulinum Toxins|botulinum toxins|mesh-list
92360456|NCT00479154|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92360457|NCT00479154|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92360458|NCT00479154|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92360459|NCT00479154|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92360460|NCT00479154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360461|NCT00479154|Cholinergic Agents|cholinergic agents|mesh-ancestor
92360462|NCT00479154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360463|NCT00479154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360464|NCT00479154|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92360465|NCT00479154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360466|NCT04270656|Insulin|insulin|mesh-list
92360467|NCT04270656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92360468|NCT04270656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360469|NCT00424554|Temozolomide|temozolomide|mesh-list
92360470|NCT00424554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360471|NCT00424554|Alkylating Agents|alkylating agents|mesh-ancestor
92360472|NCT00424554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360473|NCT00424554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360474|NCT00425802|Cyclosporine|cyclosporine|mesh-list
92360475|NCT00425802|Mycophenolic Acid|mycophenolic acid|mesh-list
92360476|NCT00425802|Cyclophosphamide|cyclophosphamide|mesh-list
92360477|NCT00425802|Rituximab|rituximab|mesh-list
92360478|NCT00425802|Fludarabine|fludarabine|mesh-list
92360479|NCT00425802|Fludarabine phosphate|fludarabine phosphate|mesh-list
92360480|NCT00425802|Cyclosporins|cyclosporins|mesh-list
92360481|NCT00425802|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92360482|NCT00425802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360483|NCT00425802|Immunologic Factors|immunologic factors|mesh-ancestor
92360484|NCT00425802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360485|NCT00425802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360486|NCT00425802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360487|NCT00425802|Alkylating Agents|alkylating agents|mesh-ancestor
92360488|NCT00425802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360489|NCT00425802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360490|NCT00425802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360491|NCT00425802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360492|NCT00425802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360493|NCT00425802|Antimetabolites|antimetabolites|mesh-ancestor
92360494|NCT00425802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360495|NCT00425802|Antifungal Agents|antifungal agents|mesh-ancestor
92360496|NCT00425802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360497|NCT00425802|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360498|NCT00425802|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92360499|NCT00425802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360500|NCT00425802|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92360501|NCT00425802|Antitubercular Agents|antitubercular agents|mesh-ancestor
92360504|NCT00530634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360505|NCT00530634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360506|NCT00530634|Antimetabolites|antimetabolites|mesh-ancestor
92360507|NCT00530634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360508|NCT00531882|Pioglitazone|pioglitazone|mesh-list
92360509|NCT00531882|Ibuprofen|ibuprofen|mesh-list
92360510|NCT00531882|Simvastatin|simvastatin|mesh-list
92360511|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92360512|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92360513|NCT00531882|Analgesics|analgesics|mesh-ancestor
92360514|NCT00531882|Sensory System Agents|sensory system agents|mesh-ancestor
92360515|NCT00531882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360516|NCT00531882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360517|NCT00531882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360518|NCT00531882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360519|NCT00531882|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92360520|NCT00531882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360521|NCT00531882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360522|NCT00531882|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92360523|NCT00531882|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92360524|NCT00531882|Antimetabolites|antimetabolites|mesh-ancestor
92360525|NCT00531882|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92013007|NCT05029531|Immunologic Factors|immunologic factors|mesh-ancestor
92360526|NCT00531882|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92360527|NCT00531882|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92360528|NCT00428298|Valacyclovir|valacyclovir|mesh-list
92360529|NCT00428298|Antiviral Agents|antiviral agents|mesh-ancestor
92360530|NCT00428298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360531|NCT00486018|Ranibizumab|ranibizumab|mesh-list
92360532|NCT00486018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360533|NCT00486018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360534|NCT00486018|Growth Substances|growth substances|mesh-ancestor
92360535|NCT00486018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360536|NCT00486018|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360537|NCT00486018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360538|NCT00486642|Bicalutamide|bicalutamide|mesh-list
92360539|NCT00486642|Androgen Antagonists|androgen antagonists|mesh-ancestor
92360540|NCT00486642|Hormone Antagonists|hormone antagonists|mesh-ancestor
92360541|NCT00486642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360542|NCT00486642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360543|NCT00486642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360544|NCT00428922|Bevacizumab|bevacizumab|mesh-list
92360545|NCT00428922|Trastuzumab|trastuzumab|mesh-list
92360547|NCT00428922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360548|NCT00428922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360549|NCT00428922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360550|NCT00428922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360551|NCT00428922|Growth Substances|growth substances|mesh-ancestor
92360552|NCT00428922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360553|NCT00428922|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360554|NCT00428922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360556|NCT00428922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360557|NCT00428922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360558|NCT00533442|Mycophenolic Acid|mycophenolic acid|mesh-list
92360559|NCT00533442|Sirolimus|sirolimus|mesh-list
92360560|NCT00533442|Tacrolimus|tacrolimus|mesh-list
92360561|NCT00533442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360562|NCT00533442|Immunologic Factors|immunologic factors|mesh-ancestor
92360563|NCT00533442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360564|NCT00533442|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92360565|NCT00533442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360566|NCT00533442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360567|NCT00533442|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360568|NCT00533442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360569|NCT00533442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92360570|NCT00533442|Antitubercular Agents|antitubercular agents|mesh-ancestor
92360571|NCT00533442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92360572|NCT00533442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360573|NCT00533442|Antifungal Agents|antifungal agents|mesh-ancestor
92360574|NCT00533910|Rifaximin|rifaximin|mesh-list
92360575|NCT00533910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92360576|NCT00533910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360577|NCT00533910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360578|NCT01954524|Sildenafil Citrate|sildenafil citrate|mesh-list
92360579|NCT01954524|Vasodilator Agents|vasodilator agents|mesh-ancestor
92360580|NCT01954524|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92360581|NCT01954524|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92360582|NCT01954524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360583|NCT01954524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360584|NCT01954524|Urological Agents|urological agents|mesh-ancestor
92360585|NCT00535002|Yohimbine|yohimbine|mesh-list
92360586|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
92360587|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
92360588|NCT00535002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360589|NCT00535002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360590|NCT00535002|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92360591|NCT00535002|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92360592|NCT00535002|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92360593|NCT00535002|Adrenergic Agents|adrenergic agents|mesh-ancestor
92360594|NCT00535002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360595|NCT00535002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360596|NCT00535002|Urological Agents|urological agents|mesh-ancestor
92360597|NCT02117934|Vaccines|vaccines|mesh-list
92360598|NCT02117934|Immunologic Factors|immunologic factors|mesh-ancestor
92360599|NCT02117934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360600|NCT00429702|Diphenhydramine|diphenhydramine|mesh-list
92360601|NCT00429702|Promethazine|promethazine|mesh-list
92360602|NCT00429702|Dexamethasone|dexamethasone|mesh-list
92360603|NCT00429702|Lorazepam|lorazepam|mesh-list
91937408|NCT05627843|Curcumin|curcumin|mesh-list
92360606|NCT00429702|Antiemetics|antiemetics|mesh-ancestor
92360607|NCT00429702|Autonomic Agents|autonomic agents|mesh-ancestor
92360608|NCT00429702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360609|NCT00429702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360610|NCT00429702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360611|NCT00429702|Glucocorticoids|glucocorticoids|mesh-ancestor
92360613|NCT00429702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360614|NCT00429702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92360615|NCT00429702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360616|NCT00429702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360617|NCT00429702|Antipruritics|antipruritics|mesh-ancestor
92360618|NCT00429702|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360619|NCT00429702|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92360620|NCT00429702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92360621|NCT00429702|Serotonin Agents|serotonin agents|mesh-ancestor
92360622|NCT00429702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360623|NCT00429702|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92360624|NCT00429702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92360625|NCT00429702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92360626|NCT00429702|Anesthetics, Local|anesthetics, local|mesh-ancestor
92360627|NCT00429702|Anesthetics|anesthetics|mesh-ancestor
92360628|NCT00429702|Sensory System Agents|sensory system agents|mesh-ancestor
92360629|NCT00429702|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92360630|NCT00429702|Histamine Antagonists|histamine antagonists|mesh-ancestor
92360631|NCT00429702|Histamine Agents|histamine agents|mesh-ancestor
92360632|NCT00429702|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92360634|NCT00429702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92360635|NCT00429702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92360636|NCT00429702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92360637|NCT00429702|GABA Modulators|gaba modulators|mesh-ancestor
92360638|NCT00429702|GABA Agents|gaba agents|mesh-ancestor
92360639|NCT00535392|Levetiracetam|levetiracetam|mesh-list
92360640|NCT00535392|Anticonvulsants|anticonvulsants|mesh-ancestor
92360641|NCT00535392|Nootropic Agents|nootropic agents|mesh-ancestor
92360642|NCT00535782|Methotrexate|methotrexate|mesh-list
92360643|NCT00535782|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92360644|NCT00535782|Abortifacient Agents|abortifacient agents|mesh-ancestor
92360645|NCT00535782|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92360646|NCT00535782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118136|NCT03242460|Cyclophosphamide|cyclophosphamide|mesh-list
92360647|NCT00535782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360648|NCT00535782|Antimetabolites|antimetabolites|mesh-ancestor
92360649|NCT00535782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360650|NCT00535782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360651|NCT00535782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360652|NCT00535782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360653|NCT00535782|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92360654|NCT00535782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360655|NCT00535782|Immunologic Factors|immunologic factors|mesh-ancestor
92360656|NCT00535782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360657|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360658|NCT00431184|Pentazocine|pentazocine|mesh-list
92360659|NCT00431184|Lorazepam|lorazepam|mesh-list
92360660|NCT00431184|Anticonvulsants|anticonvulsants|mesh-ancestor
92360661|NCT00431184|Antiemetics|antiemetics|mesh-ancestor
92360662|NCT00431184|Autonomic Agents|autonomic agents|mesh-ancestor
92360663|NCT00431184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360664|NCT00431184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360665|NCT00431184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360666|NCT00431184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92360667|NCT00431184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92360668|NCT00431184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92360669|NCT00431184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92360670|NCT00431184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92360671|NCT00431184|GABA Modulators|gaba modulators|mesh-ancestor
92360672|NCT00431184|GABA Agents|gaba agents|mesh-ancestor
92360673|NCT00431184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360674|NCT00431184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360675|NCT00431184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92360676|NCT00431184|Narcotics|narcotics|mesh-ancestor
92360677|NCT00431184|Analgesics|analgesics|mesh-ancestor
92360678|NCT00431184|Sensory System Agents|sensory system agents|mesh-ancestor
92360679|NCT00431184|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92360680|NCT00431184|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92360682|NCT00535938|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92360683|NCT00535938|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92360684|NCT00535938|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92360685|NCT00535938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92360686|NCT00535938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360687|NCT00535938|Cholinergic Agents|cholinergic agents|mesh-ancestor
92360688|NCT00535938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360689|NCT00535938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360690|NCT00535938|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92360691|NCT00535938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360693|NCT01795794|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92360694|NCT01795794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360695|NCT01795794|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92360696|NCT01795794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360697|NCT01795794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360698|NCT01796028|Metformin|metformin|mesh-list
92360699|NCT01796028|Docetaxel|docetaxel|mesh-list
92360700|NCT01796028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92360701|NCT01796028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360702|NCT01796028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360703|NCT01796028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360704|NCT01796028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360705|NCT01796028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360706|NCT01796028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360707|NCT00491244|Interferons|interferons|mesh-list
92360708|NCT00491244|Ribavirin|ribavirin|mesh-list
92360709|NCT00491244|Interferon-alpha|interferon-alpha|mesh-list
92360710|NCT00491244|Interferon alpha-2|interferon alpha-2|mesh-list
92360711|NCT00491244|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92360712|NCT00491244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360713|NCT00491244|Antiviral Agents|antiviral agents|mesh-ancestor
92360714|NCT00491244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360715|NCT00491244|Antimetabolites|antimetabolites|mesh-ancestor
92360716|NCT00491244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360717|NCT00491244|Immunologic Factors|immunologic factors|mesh-ancestor
92360718|NCT00491244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360719|NCT00492336|Rasagiline|rasagiline|mesh-list
92360720|NCT00492336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92360721|NCT00492336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360722|NCT00492336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360723|NCT00492336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92360724|NCT00492336|Protective Agents|protective agents|mesh-ancestor
92360725|NCT00492336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360726|NCT00538434|Reslizumab|reslizumab|mesh-list
92360727|NCT00538434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92360728|NCT00538434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92360729|NCT00538824|Thalidomide|thalidomide|mesh-list
92360730|NCT00538824|Dexamethasone|dexamethasone|mesh-list
92360731|NCT00538824|Lenalidomide|lenalidomide|mesh-list
92360732|NCT00538824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360733|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
92360734|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
92360735|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360736|NCT00538824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360737|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360738|NCT00538824|Glucocorticoids|glucocorticoids|mesh-ancestor
92360739|NCT00538824|Hormones|hormones|mesh-ancestor
92360740|NCT00538824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360741|NCT00538824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92360742|NCT00538824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360744|NCT00538824|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360745|NCT00538824|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360746|NCT00538824|Growth Substances|growth substances|mesh-ancestor
92360747|NCT00538824|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360748|NCT00538824|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360749|NCT00538824|Leprostatic Agents|leprostatic agents|mesh-ancestor
92360750|NCT00538824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92360751|NCT00538824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360753|NCT00539526|Travoprost|travoprost|mesh-list
92360754|NCT00539526|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92360755|NCT00539526|Latanoprost|latanoprost|mesh-list
92360756|NCT00539526|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92360757|NCT00539526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92360758|NCT01796106|Fluorides|fluorides|mesh-list
92360759|NCT01796106|Fluorides, Topical|fluorides, topical|mesh-list
92360760|NCT01796106|Cariostatic Agents|cariostatic agents|mesh-ancestor
92360761|NCT01796106|Protective Agents|protective agents|mesh-ancestor
92360762|NCT01796106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360763|NCT00541242|Bimatoprost|bimatoprost|mesh-list
92360764|NCT00541242|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92360765|NCT00541242|Latanoprost|latanoprost|mesh-list
92360766|NCT00541242|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92360767|NCT00541242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92360768|NCT00438204|Bevacizumab|bevacizumab|mesh-list
92360769|NCT00438204|Gemcitabine|gemcitabine|mesh-list
92360770|NCT00438204|Pemetrexed|pemetrexed|mesh-list
92360771|NCT00438204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360772|NCT00438204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360773|NCT00438204|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360774|NCT00438204|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360775|NCT00438204|Growth Substances|growth substances|mesh-ancestor
92360776|NCT00438204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360777|NCT00438204|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360778|NCT00438204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360779|NCT00438204|Antimetabolites|antimetabolites|mesh-ancestor
92360780|NCT00438204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360781|NCT00438204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360782|NCT00438204|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92360783|NCT00438204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360784|NCT00439296|Cytarabine|cytarabine|mesh-list
92360785|NCT00439296|Dexamethasone|dexamethasone|mesh-list
92360786|NCT00439296|Cyclophosphamide|cyclophosphamide|mesh-list
92360787|NCT00439296|Doxorubicin|doxorubicin|mesh-list
92360788|NCT00439296|Methotrexate|methotrexate|mesh-list
92360789|NCT00439296|Asparaginase|asparaginase|mesh-list
92360790|NCT00439296|Mercaptopurine|mercaptopurine|mesh-list
92360791|NCT00439296|Thioguanine|thioguanine|mesh-list
92360792|NCT00439296|Pegaspargase|pegaspargase|mesh-list
92360793|NCT00439296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360794|NCT00439296|Immunologic Factors|immunologic factors|mesh-ancestor
92360795|NCT00439296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360796|NCT00439296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360797|NCT00439296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360799|NCT00439296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360800|NCT00439296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360801|NCT00439296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360802|NCT00439296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360803|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
92360805|NCT00439296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360806|NCT00439296|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92360807|NCT00439296|Glucocorticoids|glucocorticoids|mesh-ancestor
92360808|NCT00439296|Hormones|hormones|mesh-ancestor
92360809|NCT00439296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360810|NCT00439296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92360811|NCT00439296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360812|NCT00439296|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360813|NCT00439296|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360814|NCT00439296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360815|NCT00439296|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92360817|NCT00439296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92360818|NCT00439296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360819|NCT00439296|Antimetabolites|antimetabolites|mesh-ancestor
92360820|NCT00439296|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360821|NCT00439296|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92360822|NCT00439296|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92360823|NCT00439296|Antiviral Agents|antiviral agents|mesh-ancestor
92360824|NCT00439296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360825|NCT03117660|Vitamin A|vitamin a|mesh-list
92360826|NCT03117660|Vitamins|vitamins|mesh-ancestor
92360827|NCT03117660|Micronutrients|micronutrients|mesh-ancestor
92360828|NCT03117660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360829|NCT00439374|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92360830|NCT00439374|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92360832|NCT00439374|Hormone Antagonists|hormone antagonists|mesh-ancestor
92360833|NCT00439374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360834|NCT00439374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360835|NCT00439374|Progestins|progestins|mesh-ancestor
92360837|NCT00439608|Paclitaxel|paclitaxel|mesh-list
92360838|NCT00439608|Carboplatin|carboplatin|mesh-list
92360839|NCT00439608|Cetuximab|cetuximab|mesh-list
92360840|NCT00439608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360841|NCT00439608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360842|NCT00439608|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360843|NCT00439608|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360844|NCT00439608|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360845|NCT00439608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360846|NCT00439608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360847|NCT04750122|Carboplatin|carboplatin|mesh-list
92360848|NCT04750122|Docetaxel|docetaxel|mesh-list
92360849|NCT04750122|Trastuzumab|trastuzumab|mesh-list
92360850|NCT04750122|Pertuzumab|pertuzumab|mesh-list
92360851|NCT04750122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360852|NCT04750122|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360853|NCT04750122|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360854|NCT04750122|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360855|NCT04750122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360856|NCT04750122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360857|NCT00443352|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92360858|NCT00443352|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92360859|NCT00443352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92360860|NCT00443352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92360861|NCT00443352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360862|NCT00443352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360863|NCT00443352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360864|NCT00443352|Analgesics|analgesics|mesh-ancestor
92360865|NCT00443352|Sensory System Agents|sensory system agents|mesh-ancestor
92360866|NCT00443352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360867|NCT00443352|Antidepressive Agents|antidepressive agents|mesh-ancestor
92360868|NCT00443352|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92360869|NCT00443352|Dopamine Agents|dopamine agents|mesh-ancestor
92360870|NCT00445302|Plerixafor|plerixafor|mesh-list
92360871|NCT00445302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92360872|NCT00445302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92360873|NCT00445302|Antiviral Agents|antiviral agents|mesh-ancestor
92360874|NCT00445302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92360875|NCT00504504|Rituximab|rituximab|mesh-list
92360876|NCT00504504|Doxorubicin|doxorubicin|mesh-list
92360877|NCT00504504|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92360878|NCT00504504|Dacarbazine|dacarbazine|mesh-list
92360880|NCT00504504|Vinblastine|vinblastine|mesh-list
92360881|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360883|NCT00504504|Immunologic Factors|immunologic factors|mesh-ancestor
92360884|NCT00504504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360885|NCT00504504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360886|NCT00504504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360887|NCT00504504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360888|NCT00504504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92360889|NCT00504504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360890|NCT00504504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360891|NCT00504504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360893|NCT00504504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360894|NCT00504504|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360895|NCT00504504|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360896|NCT00504504|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360897|NCT00504660|Celecoxib|celecoxib|mesh-list
92360898|NCT00504660|Capecitabine|capecitabine|mesh-list
92360899|NCT00504660|Thioguanine|thioguanine|mesh-list
92360900|NCT00504660|Temozolomide|temozolomide|mesh-list
92360901|NCT00504660|Lomustine|lomustine|mesh-list
92360902|NCT00504660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360903|NCT00504660|Antimetabolites|antimetabolites|mesh-ancestor
92360904|NCT00504660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360905|NCT00504660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360906|NCT00504660|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360907|NCT00504660|Alkylating Agents|alkylating agents|mesh-ancestor
92360908|NCT00504660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92360909|NCT00504660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92360910|NCT00504660|Analgesics|analgesics|mesh-ancestor
92360911|NCT00504660|Sensory System Agents|sensory system agents|mesh-ancestor
92360912|NCT00504660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360913|NCT00504660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360914|NCT00504660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360915|NCT00504660|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92360916|NCT00504660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92360917|NCT00504660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92360918|NCT00504660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360919|NCT00505518|Psychotropic Drugs|psychotropic drugs|mesh-list
92360920|NCT00544908|Dasatinib|dasatinib|mesh-list
92360921|NCT00544908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360922|NCT00544908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92360924|NCT00544908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360925|NCT00447330|Bevacizumab|bevacizumab|mesh-list
92360927|NCT00447330|Oxaliplatin|oxaliplatin|mesh-list
92360928|NCT00447330|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360929|NCT00447330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360930|NCT00447330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360931|NCT00447330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360932|NCT00447330|Growth Substances|growth substances|mesh-ancestor
92360933|NCT00447330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360934|NCT00447330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360935|NCT00447330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92360936|NCT00447330|Antimetabolites|antimetabolites|mesh-ancestor
92360937|NCT00447330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360938|NCT02115048|Letrozole|letrozole|mesh-list
92360939|NCT02115048|Afatinib|afatinib|mesh-list
92360940|NCT02115048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360941|NCT02115048|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92360942|NCT02115048|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92360943|NCT02115048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360944|NCT02115048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360945|NCT02115048|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92360946|NCT02115048|Hormone Antagonists|hormone antagonists|mesh-ancestor
92360947|NCT02115048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92360948|NCT02115048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360949|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92360950|NCT00546156|Paclitaxel|paclitaxel|mesh-list
92360951|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
92360952|NCT00546156|Bevacizumab|bevacizumab|mesh-list
92360953|NCT00546156|Doxorubicin|doxorubicin|mesh-list
92360954|NCT00546156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92360955|NCT00546156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92360956|NCT00546156|Tubulin Modulators|tubulin modulators|mesh-ancestor
92360957|NCT00546156|Antimitotic Agents|antimitotic agents|mesh-ancestor
92360958|NCT00546156|Mitosis Modulators|mitosis modulators|mesh-ancestor
92360959|NCT00546156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360960|NCT00546156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92360961|NCT00546156|Immunologic Factors|immunologic factors|mesh-ancestor
91942753|NCT04482803|Hormones|hormones|mesh-ancestor
92360962|NCT00546156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360963|NCT00546156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92118137|NCT03242460|Pomalidomide|pomalidomide|mesh-list
92360964|NCT00546156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92360965|NCT00546156|Alkylating Agents|alkylating agents|mesh-ancestor
92360966|NCT00546156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92360967|NCT00546156|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92360968|NCT00546156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92360969|NCT00546156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92360970|NCT00546156|Growth Substances|growth substances|mesh-ancestor
92360971|NCT00546156|Growth Inhibitors|growth inhibitors|mesh-ancestor
92360972|NCT00546156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92360973|NCT00546156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92360975|NCT00546156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360978|NCT00449046|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92360979|NCT00449046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92360980|NCT00449046|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92360981|NCT00449046|Autonomic Agents|autonomic agents|mesh-ancestor
92360982|NCT00449046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92360983|NCT00449046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92360984|NCT00449046|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92360985|NCT00449046|Respiratory System Agents|respiratory system agents|mesh-ancestor
92360986|NCT00449046|Dermatologic Agents|dermatologic agents|mesh-ancestor
92360987|NCT00449046|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92360988|NCT00449046|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92360989|NCT00449046|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92360990|NCT00449046|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92360991|NCT00449046|Adrenergic Agents|adrenergic agents|mesh-ancestor
92360992|NCT00449046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92360993|NCT00449046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360996|NCT00449748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92360997|NCT00449748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92360998|NCT00449748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92360999|NCT00449748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361000|NCT00449748|Immunologic Factors|immunologic factors|mesh-ancestor
92361001|NCT00449748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361003|NCT00509496|Aldesleukin|aldesleukin|mesh-list
92361004|NCT00509496|Cyclophosphamide|cyclophosphamide|mesh-list
92361005|NCT00509496|Fludarabine|fludarabine|mesh-list
92361006|NCT00509496|Fludarabine phosphate|fludarabine phosphate|mesh-list
92361007|NCT00509496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361008|NCT00509496|Immunologic Factors|immunologic factors|mesh-ancestor
92361009|NCT00509496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361010|NCT00509496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361011|NCT00509496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361012|NCT00509496|Alkylating Agents|alkylating agents|mesh-ancestor
92361013|NCT00509496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361014|NCT00509496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361015|NCT00509496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361017|NCT00509496|Antimetabolites|antimetabolites|mesh-ancestor
92361018|NCT00509496|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92361019|NCT00509496|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92361020|NCT00509496|Antiviral Agents|antiviral agents|mesh-ancestor
92361021|NCT00509496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361022|NCT00548418|Bevacizumab|bevacizumab|mesh-list
92361023|NCT00548418|Topotecan|topotecan|mesh-list
92361024|NCT00548418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361025|NCT00548418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361026|NCT00548418|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361027|NCT00548418|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361028|NCT00548418|Growth Substances|growth substances|mesh-ancestor
92361029|NCT00548418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361030|NCT00548418|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361031|NCT00548418|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92361032|NCT00548418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92361033|NCT00548418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361034|NCT00548418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361035|NCT00511992|Paclitaxel|paclitaxel|mesh-list
92361036|NCT00511992|Bevacizumab|bevacizumab|mesh-list
92361037|NCT00511992|Cisplatin|cisplatin|mesh-list
92361038|NCT00511992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361039|NCT00511992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361040|NCT00511992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361041|NCT00511992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361042|NCT00511992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361043|NCT00511992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361044|NCT00511992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361045|NCT00511992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361046|NCT00511992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361047|NCT00511992|Growth Substances|growth substances|mesh-ancestor
92361048|NCT00511992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361049|NCT00511992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361050|NCT00451698|Epoetin Alfa|epoetin alfa|mesh-list
92361051|NCT00451698|Hematinics|hematinics|mesh-ancestor
92361052|NCT00549042|Hydromorphone|hydromorphone|mesh-list
92361053|NCT00549042|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92361054|NCT00549042|Narcotics|narcotics|mesh-ancestor
92361055|NCT00549042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361056|NCT00549042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361057|NCT00549042|Analgesics|analgesics|mesh-ancestor
92361058|NCT00549042|Sensory System Agents|sensory system agents|mesh-ancestor
92361059|NCT00549042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361060|NCT00452868|Donepezil|donepezil|mesh-list
92361061|NCT00452868|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92361062|NCT00452868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361063|NCT00452868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361064|NCT00452868|Cholinergic Agents|cholinergic agents|mesh-ancestor
92361065|NCT00452868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361066|NCT00452868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361068|NCT00453336|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92361069|NCT00453336|Trioxsalen|trioxsalen|mesh-list
92361070|NCT00453336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361071|NCT00453336|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361072|NCT00453336|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92361073|NCT00549822|Letrozole|letrozole|mesh-list
92361074|NCT00549822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361075|NCT00549822|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92361076|NCT00549822|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92361078|NCT00549822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361079|NCT00549822|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92361080|NCT00549822|Hormone Antagonists|hormone antagonists|mesh-ancestor
92361081|NCT00549822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92361082|NCT00549822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361083|NCT00550290|Cefazolin|cefazolin|mesh-list
92361084|NCT00550290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92361085|NCT00550290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361086|NCT01797198|Repaglinide|repaglinide|mesh-list
92361087|NCT01797198|Gemfibrozil|gemfibrozil|mesh-list
92361088|NCT01797198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92361089|NCT01797198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361090|NCT01797198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92361091|NCT01797198|Antimetabolites|antimetabolites|mesh-ancestor
92361092|NCT01797198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361093|NCT01797198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92361095|NCT01797198|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92361096|NCT01797198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361097|NCT00552786|Acetylcysteine|acetylcysteine|mesh-list
92361098|NCT00552786|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92361099|NCT00552786|Antiviral Agents|antiviral agents|mesh-ancestor
92361100|NCT00552786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361101|NCT00552786|Expectorants|expectorants|mesh-ancestor
92361102|NCT00552786|Respiratory System Agents|respiratory system agents|mesh-ancestor
92361103|NCT00552786|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92361104|NCT00552786|Antioxidants|antioxidants|mesh-ancestor
92361105|NCT00552786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361106|NCT00552786|Protective Agents|protective agents|mesh-ancestor
92361107|NCT00552786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361108|NCT00552786|Antidotes|antidotes|mesh-ancestor
92361109|NCT00517530|Obinutuzumab|obinutuzumab|mesh-list
92361110|NCT00517530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361112|NCT00518154|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92361113|NCT00518154|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92361114|NCT00518154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361115|NCT00518154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361116|NCT00518154|Cholinergic Agents|cholinergic agents|mesh-ancestor
92361117|NCT00518154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361118|NCT00518154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361119|NCT00553098|Cyclosporine|cyclosporine|mesh-list
92361120|NCT00553098|Mycophenolic Acid|mycophenolic acid|mesh-list
92361121|NCT00553098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92361122|NCT00553098|Alemtuzumab|alemtuzumab|mesh-list
92361123|NCT00553098|Fludarabine|fludarabine|mesh-list
92361124|NCT00553098|Fludarabine phosphate|fludarabine phosphate|mesh-list
92361125|NCT00553098|Antibodies|antibodies|mesh-list
92361126|NCT00553098|Immunoglobulins|immunoglobulins|mesh-list
92361127|NCT00553098|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92361128|NCT00553098|Cyclosporins|cyclosporins|mesh-list
92361129|NCT00553098|Immunologic Factors|immunologic factors|mesh-ancestor
92361130|NCT00553098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361131|NCT00553098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361132|NCT00553098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361133|NCT00553098|Antimetabolites|antimetabolites|mesh-ancestor
92361134|NCT00553098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361135|NCT00553098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361136|NCT00553098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361137|NCT00553098|Antifungal Agents|antifungal agents|mesh-ancestor
92361138|NCT00553098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361139|NCT00553098|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361140|NCT00553098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361141|NCT00553098|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92361142|NCT00553098|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92361143|NCT00553098|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92361144|NCT00553098|Antitubercular Agents|antitubercular agents|mesh-ancestor
92361145|NCT00553098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92361146|NCT00553410|Letrozole|letrozole|mesh-list
92361147|NCT00553410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361148|NCT00553410|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92361149|NCT00553410|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92361150|NCT00553410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361151|NCT00553410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361152|NCT00553410|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92361153|NCT00553410|Hormone Antagonists|hormone antagonists|mesh-ancestor
92361154|NCT00553410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92361155|NCT00553410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361156|NCT00554970|Budesonide|budesonide|mesh-list
92361157|NCT00554970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92361158|NCT00554970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92361159|NCT00554970|Autonomic Agents|autonomic agents|mesh-ancestor
92361160|NCT00554970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361161|NCT00554970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361162|NCT00554970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92361163|NCT00554970|Respiratory System Agents|respiratory system agents|mesh-ancestor
92361164|NCT00554970|Glucocorticoids|glucocorticoids|mesh-ancestor
92361165|NCT00554970|Hormones|hormones|mesh-ancestor
92361166|NCT00554970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92361168|NCT00524472|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92361169|NCT00524472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92361170|NCT00524472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361171|NCT00555048|Cyclophosphamide|cyclophosphamide|mesh-list
92361172|NCT00555048|Busulfan|busulfan|mesh-list
92361173|NCT00555048|Methotrexate|methotrexate|mesh-list
92361174|NCT00555048|Alemtuzumab|alemtuzumab|mesh-list
92361175|NCT00555048|Tacrolimus|tacrolimus|mesh-list
92361176|NCT00555048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361177|NCT00555048|Immunologic Factors|immunologic factors|mesh-ancestor
92361178|NCT00555048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361180|NCT00555048|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361181|NCT00555048|Alkylating Agents|alkylating agents|mesh-ancestor
92361182|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361183|NCT00555048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361184|NCT00555048|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361185|NCT00555048|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92361186|NCT00555048|Abortifacient Agents|abortifacient agents|mesh-ancestor
92361187|NCT00555048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92361188|NCT00555048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361189|NCT00555048|Antimetabolites|antimetabolites|mesh-ancestor
92361190|NCT00555048|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361191|NCT00555048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361192|NCT00555048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92361193|NCT00555048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92361194|NCT00555048|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92361195|NCT00555048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361196|NCT00525798|Calcitonin|calcitonin|mesh-list
92361197|NCT00525798|Salmon calcitonin|salmon calcitonin|mesh-list
92361198|NCT00525798|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92361199|NCT00525798|Katacalcin|katacalcin|mesh-list
92361200|NCT00525798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92361201|NCT00525798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361202|NCT00525798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92361203|NCT00525798|Vasodilator Agents|vasodilator agents|mesh-ancestor
92361204|NCT00525876|Cyclophosphamide|cyclophosphamide|mesh-list
92361206|NCT00525876|Fludarabine|fludarabine|mesh-list
92361207|NCT00525876|Fludarabine phosphate|fludarabine phosphate|mesh-list
92361208|NCT00525876|Alemtuzumab|alemtuzumab|mesh-list
92361209|NCT00525876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361210|NCT00525876|Immunologic Factors|immunologic factors|mesh-ancestor
92361211|NCT00525876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361212|NCT00525876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361213|NCT00525876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361215|NCT00525876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361216|NCT00525876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361217|NCT00525876|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361218|NCT00525876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361219|NCT00525876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361220|NCT00525876|Antimetabolites|antimetabolites|mesh-ancestor
92361221|NCT00555750|Eszopiclone|eszopiclone|mesh-list
92361222|NCT00555750|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92361223|NCT00555750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361224|NCT00555750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361225|NCT00556140|Aripiprazole|aripiprazole|mesh-list
92361226|NCT00556140|Antidepressive Agents|antidepressive agents|mesh-ancestor
92361227|NCT00556140|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361228|NCT00556140|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92361229|NCT00556140|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92361230|NCT00556140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361231|NCT00556140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361232|NCT00556140|Dopamine Agonists|dopamine agonists|mesh-ancestor
92361233|NCT00556140|Dopamine Agents|dopamine agents|mesh-ancestor
92361234|NCT00556140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361235|NCT00556140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361236|NCT00556140|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92361237|NCT00556140|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92361238|NCT00556140|Serotonin Agents|serotonin agents|mesh-ancestor
92361239|NCT00556140|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92361240|NCT00556140|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92361241|NCT00556140|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92361242|NCT00556140|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92361244|NCT00527124|Docetaxel|docetaxel|mesh-list
92361245|NCT00527124|Cediranib|cediranib|mesh-list
92361246|NCT00527124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361247|NCT00527124|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361248|NCT00527124|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361249|NCT00527124|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361250|NCT00527124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361251|NCT00527124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92361252|NCT00527124|Glucocorticoids|glucocorticoids|mesh-ancestor
92361254|NCT00527124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92361255|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361256|NCT00527124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92361257|NCT00527124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361258|NCT00527124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92361259|NCT00527592|Travoprost|travoprost|mesh-list
92361260|NCT00527592|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92361262|NCT00527592|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91912019|NCT02145949|Tryptophan|tryptophan|mesh-list
92361263|NCT00527592|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92361264|NCT00556452|Busulfan|busulfan|mesh-list
92361265|NCT00556452|Clofarabine|clofarabine|mesh-list
92361266|NCT00556452|Alkylating Agents|alkylating agents|mesh-ancestor
91912167|NCT03542149|alpha-Tocopherol|alpha-tocopherol|mesh-list
91912242|NCT02157337|Antimetabolites|antimetabolites|mesh-ancestor
92361267|NCT00556452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361268|NCT00556452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912398|NCT02307682|Aflibercept|aflibercept|mesh-list
92361270|NCT00556452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361271|NCT00556452|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361272|NCT00556452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361273|NCT00556452|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361274|NCT00556452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361275|NCT00556452|Antimetabolites|antimetabolites|mesh-ancestor
92361276|NCT03158376|Gabapentin|gabapentin|mesh-list
92361277|NCT03158376|Analgesics|analgesics|mesh-ancestor
92361278|NCT03158376|Sensory System Agents|sensory system agents|mesh-ancestor
92361279|NCT03158376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912992|NCT02097329|Palbociclib|palbociclib|mesh-list
92361280|NCT03158376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361281|NCT03158376|Anticonvulsants|anticonvulsants|mesh-ancestor
92361282|NCT03158376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92361283|NCT03158376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92361284|NCT03158376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361285|NCT03158376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361286|NCT03158376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92361287|NCT03158376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92361288|NCT03158376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913284|NCT02103023|Imiquimod|imiquimod|mesh-list
92361289|NCT03158376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361290|NCT03158376|Antimanic Agents|antimanic agents|mesh-ancestor
92361291|NCT01797900|Paclitaxel|paclitaxel|mesh-list
92361293|NCT01797900|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361294|NCT01797900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361295|NCT01797900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361296|NCT01797900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361297|NCT01797900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361298|NCT01797900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361299|NCT03572790|Prucalopride|prucalopride|mesh-list
92361300|NCT03572790|Laxatives|laxatives|mesh-ancestor
92361301|NCT03572790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361302|NCT03572790|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92361303|NCT03572790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92361304|NCT03572790|Serotonin Agents|serotonin agents|mesh-ancestor
92361305|NCT03572790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361306|NCT03572790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361307|NCT03572790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361308|NCT03428802|Pembrolizumab|pembrolizumab|mesh-list
92361309|NCT03428802|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361310|NCT03428802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361311|NCT03428802|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91914021|NCT02429817|Protective Agents|protective agents|mesh-ancestor
92361312|NCT03428802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361314|NCT03379194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361315|NCT02319486|Carboplatin|carboplatin|mesh-list
92361316|NCT02319486|Etoposide|etoposide|mesh-list
92361317|NCT02319486|Vincristine|vincristine|mesh-list
92361318|NCT02319486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361319|NCT02319486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361320|NCT02319486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92361321|NCT02319486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92361322|NCT02319486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361323|NCT02319486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361324|NCT02319486|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361325|NCT02319486|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361326|NCT02319486|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361328|NCT03117972|Bevacizumab|bevacizumab|mesh-list
92361330|NCT03117972|Capecitabine|capecitabine|mesh-list
92361331|NCT03117972|Oxaliplatin|oxaliplatin|mesh-list
92361332|NCT03117972|Irinotecan|irinotecan|mesh-list
92361333|NCT03117972|Levoleucovorin|levoleucovorin|mesh-list
92361334|NCT03117972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361335|NCT03117972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361336|NCT03117972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361337|NCT03117972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361338|NCT03117972|Growth Substances|growth substances|mesh-ancestor
92361339|NCT03117972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361340|NCT03117972|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361341|NCT03117972|Antimetabolites|antimetabolites|mesh-ancestor
92361342|NCT03117972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361343|NCT03117972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361344|NCT03117972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361345|NCT03117972|Immunologic Factors|immunologic factors|mesh-ancestor
92361346|NCT03117972|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92361347|NCT03117972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92361348|NCT03117972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361349|NCT03117972|Antidotes|antidotes|mesh-ancestor
92361350|NCT03117972|Protective Agents|protective agents|mesh-ancestor
92361351|NCT03117972|Vitamin B Complex|vitamin b complex|mesh-ancestor
92361354|NCT05622162|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
92361355|NCT05622162|18F-JK-PSMA-7|18f-jk-psma-7|mesh-list
92361356|NCT05622162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361357|NCT00558012|Vitamin D|vitamin d|mesh-list
92361358|NCT00558012|Zoledronic Acid|zoledronic acid|mesh-list
92361359|NCT00558012|Calcium|calcium|mesh-list
92361360|NCT00558012|Vitamins|vitamins|mesh-ancestor
92361361|NCT00558012|Micronutrients|micronutrients|mesh-ancestor
92361362|NCT00558012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361363|NCT00558012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92361364|NCT00558012|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92361366|NCT00561834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361367|NCT00561834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361369|NCT00561834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361370|NCT00561834|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361371|NCT00561834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361372|NCT04388202|Sertraline|sertraline|mesh-list
92361373|NCT04388202|Escitalopram|escitalopram|mesh-list
92361374|NCT04388202|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92361375|NCT04388202|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92361376|NCT04388202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914806|NCT00709371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361377|NCT04388202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361378|NCT04388202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914878|NCT04836728|Paclitaxel|paclitaxel|mesh-list
92361379|NCT04388202|Serotonin Agents|serotonin agents|mesh-ancestor
92361380|NCT04388202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361381|NCT04388202|Antidepressive Agents|antidepressive agents|mesh-ancestor
92361382|NCT04388202|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361383|NCT02128230|Thalidomide|thalidomide|mesh-list
92361384|NCT02128230|Dexamethasone|dexamethasone|mesh-list
92361385|NCT02128230|Dexamethasone acetate|dexamethasone acetate|mesh-list
92361386|NCT02128230|Cyclophosphamide|cyclophosphamide|mesh-list
92361387|NCT02128230|Melphalan|melphalan|mesh-list
92361388|NCT02128230|Cisplatin|cisplatin|mesh-list
92361389|NCT02128230|Doxorubicin|doxorubicin|mesh-list
92361390|NCT02128230|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92361391|NCT02128230|Etoposide|etoposide|mesh-list
92361392|NCT02128230|Etoposide phosphate|etoposide phosphate|mesh-list
92361393|NCT02128230|Lenalidomide|lenalidomide|mesh-list
92361394|NCT02128230|Lenograstim|lenograstim|mesh-list
92361395|NCT02128230|BB 1101|bb 1101|mesh-list
92361397|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
92361398|NCT02128230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361399|NCT02128230|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361400|NCT02128230|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361401|NCT02128230|Alkylating Agents|alkylating agents|mesh-ancestor
91915012|NCT02112305|Anesthetics|anesthetics|mesh-ancestor
92361402|NCT02128230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361403|NCT02128230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915142|NCT02112929|Xenon|xenon|mesh-list
92361404|NCT02128230|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361405|NCT02128230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92361406|NCT02128230|Antiemetics|antiemetics|mesh-ancestor
92361407|NCT02128230|Autonomic Agents|autonomic agents|mesh-ancestor
92361408|NCT02128230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361409|NCT02128230|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361411|NCT02128230|Hormones|hormones|mesh-ancestor
92361412|NCT02128230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915220|NCT02115659|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92361413|NCT02128230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92361414|NCT02128230|Protease Inhibitors|protease inhibitors|mesh-ancestor
92361415|NCT02128230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361416|NCT02128230|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92361417|NCT02128230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92361418|NCT02128230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92361419|NCT02128230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361420|NCT02128230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361421|NCT02128230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361422|NCT02128230|Growth Substances|growth substances|mesh-ancestor
92361423|NCT02128230|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361424|NCT02128230|Leprostatic Agents|leprostatic agents|mesh-ancestor
92361425|NCT02128230|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92361426|NCT02128230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361427|NCT02128230|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92361428|NCT03416244|Nivolumab|nivolumab|mesh-list
92361429|NCT03416244|Ipilimumab|ipilimumab|mesh-list
92361430|NCT03416244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361431|NCT03416244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361432|NCT03416244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92361433|NCT03416244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361435|NCT05560620|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92361436|NCT05560620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361437|NCT05560620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92361438|NCT05560620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361439|NCT05560620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361440|NCT05560620|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92361441|NCT05560620|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92361443|NCT05560620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361444|NCT04388124|Bosentan|bosentan|mesh-list
92361445|NCT04388124|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92361446|NCT04388124|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91915789|NCT04797338|Nafarelin|nafarelin|mesh-list
92361447|NCT04388124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361448|NCT03172416|Oxaliplatin|oxaliplatin|mesh-list
92361449|NCT03172416|Nivolumab|nivolumab|mesh-list
92361450|NCT03172416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361451|NCT03172416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361452|NCT03172416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92361453|NCT03172416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915932|NCT01367249|Bromfenac|bromfenac|mesh-list
92361454|NCT05559996|Hyaluronic Acid|hyaluronic acid|mesh-list
92361455|NCT05559996|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92361456|NCT05559996|Immunologic Factors|immunologic factors|mesh-ancestor
92361457|NCT05559996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361458|NCT05559996|Viscosupplements|viscosupplements|mesh-ancestor
92361459|NCT05559996|Protective Agents|protective agents|mesh-ancestor
92361460|NCT02812212|Diuretics|diuretics|mesh-list
92361461|NCT02812212|Natriuretic Agents|natriuretic agents|mesh-ancestor
92361462|NCT02812212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361463|NCT05559450|Blinatumomab|blinatumomab|mesh-list
92361464|NCT05559450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361465|NCT00564954|Methylphenidate|methylphenidate|mesh-list
92361466|NCT00564954|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92361467|NCT00564954|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92361468|NCT00564954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361469|NCT00564954|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91916069|NCT03549689|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92361470|NCT00564954|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92361471|NCT00564954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92361472|NCT00564954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361473|NCT00564954|Dopamine Agents|dopamine agents|mesh-ancestor
92361474|NCT00564954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361475|NCT00565266|Beclomethasone|beclomethasone|mesh-list
92361476|NCT00565266|Bromides|bromides|mesh-list
92361477|NCT00565266|Tiotropium Bromide|tiotropium bromide|mesh-list
92361478|NCT00565266|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92361479|NCT00565266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92361480|NCT00565266|Autonomic Agents|autonomic agents|mesh-ancestor
92361481|NCT00565266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361482|NCT00565266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361483|NCT00565266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92361484|NCT00565266|Respiratory System Agents|respiratory system agents|mesh-ancestor
92361485|NCT00565266|Parasympatholytics|parasympatholytics|mesh-ancestor
92361486|NCT00565266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92361487|NCT00565266|Cholinergic Agents|cholinergic agents|mesh-ancestor
92361488|NCT00565266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361489|NCT00565266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361490|NCT00565266|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91916274|NCT02130869|Interleukin-2|interleukin-2|mesh-list
92361491|NCT00565266|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92361492|NCT00565266|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92361493|NCT00565266|Adrenergic Agents|adrenergic agents|mesh-ancestor
92361494|NCT00565266|Anticonvulsants|anticonvulsants|mesh-ancestor
92361495|NCT00565266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92361497|NCT00565266|Hormones|hormones|mesh-ancestor
92361498|NCT00565266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92361499|NCT00568386|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92361500|NCT00568386|Lubricant Eye Drops|lubricant eye drops|mesh-list
92361501|NCT00568386|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92361502|NCT01797978|Methylene Blue|methylene blue|mesh-list
92361503|NCT01797978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361504|NCT01797978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361505|NCT05363202|Fluticasone|fluticasone|mesh-list
92361506|NCT05363202|Xhance|xhance|mesh-list
92361507|NCT05363202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92361508|NCT05363202|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92361509|NCT05363202|Autonomic Agents|autonomic agents|mesh-ancestor
92361510|NCT05363202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361511|NCT05363202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361512|NCT05363202|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92361513|NCT05363202|Respiratory System Agents|respiratory system agents|mesh-ancestor
92361514|NCT05363202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013989|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
92361515|NCT05363202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92361517|NCT05461092|Analgesics, Opioid|analgesics, opioid|mesh-list
92361518|NCT05461092|Bupivacaine|bupivacaine|mesh-list
92361519|NCT05461092|Anesthetics, Local|anesthetics, local|mesh-ancestor
92361520|NCT05461092|Anesthetics|anesthetics|mesh-ancestor
92361521|NCT05461092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361522|NCT05461092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916847|NCT03549221|Sympathomimetics|sympathomimetics|mesh-ancestor
92361524|NCT05461092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361525|NCT05461092|Narcotics|narcotics|mesh-ancestor
92361526|NCT05461092|Analgesics|analgesics|mesh-ancestor
92361528|NCT02129478|Antiemetics|antiemetics|mesh-ancestor
92361529|NCT02129478|Autonomic Agents|autonomic agents|mesh-ancestor
92361530|NCT02129478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361531|NCT02129478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361532|NCT02129478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361533|NCT02129478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92361534|NCT02129478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92361535|NCT02129478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361536|NCT02129478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361537|NCT02129478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92361538|NCT02129478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92361539|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92361540|NCT02129478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361541|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361542|NCT02129478|Serotonin Agents|serotonin agents|mesh-ancestor
92361543|NCT02129556|Pembrolizumab|pembrolizumab|mesh-list
92361544|NCT02129556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361545|NCT02129556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917452|NCT02254031|Maytansine|maytansine|mesh-list
92361546|NCT02129556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92361547|NCT02129556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361548|NCT05362500|Tranylcypromine|tranylcypromine|mesh-list
92361549|NCT05362500|Glycolic acid|glycolic acid|mesh-list
92361550|NCT05362500|Tranexamic Acid|tranexamic acid|mesh-list
91917588|NCT04329806|Vasodilator Agents|vasodilator agents|mesh-ancestor
92361551|NCT05362500|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91917738|NCT03173066|Hematinics|hematinics|mesh-ancestor
92361552|NCT05362500|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92361553|NCT05362500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361554|NCT05362500|Hemostatics|hemostatics|mesh-ancestor
92361555|NCT05362500|Coagulants|coagulants|mesh-ancestor
91917837|NCT03174795|Meropenem|meropenem|mesh-list
92361556|NCT05362500|Keratolytic Agents|keratolytic agents|mesh-ancestor
92361557|NCT05362500|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361558|NCT05362500|Antidepressive Agents|antidepressive agents|mesh-ancestor
92361559|NCT05362500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361560|NCT05362500|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92361561|NCT05362500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361562|NCT05362500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92361563|NCT05362500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92361564|NCT05362500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361565|NCT05362500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361566|NCT05161806|Aflibercept|aflibercept|mesh-list
92361567|NCT05161806|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361568|NCT05161806|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361569|NCT05161806|Growth Substances|growth substances|mesh-ancestor
92361570|NCT05161806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361571|NCT05161806|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361572|NCT05161806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361573|NCT05362188|Niacinamide|niacinamide|mesh-list
92361574|NCT05362188|Niacin|niacin|mesh-list
91918182|NCT02409147|Nystatin|nystatin|mesh-list
92361576|NCT05362188|Vitamin B Complex|vitamin b complex|mesh-ancestor
92361578|NCT05362188|Micronutrients|micronutrients|mesh-ancestor
92361579|NCT05362188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361580|NCT05362188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92361581|NCT05362188|Antimetabolites|antimetabolites|mesh-ancestor
91918331|NCT02407899|Vitamin D|vitamin d|mesh-list
92118668|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
92361582|NCT05362188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361583|NCT05362188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92361584|NCT05362188|Vasodilator Agents|vasodilator agents|mesh-ancestor
92361585|NCT05353374|Fusidic Acid|fusidic acid|mesh-list
92361586|NCT05353374|Petrolatum|petrolatum|mesh-list
92361587|NCT05353374|Emollients|emollients|mesh-ancestor
92361588|NCT05353374|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361589|NCT05353374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92361590|NCT05353374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918474|NCT02167321|Vitamins|vitamins|mesh-ancestor
92361591|NCT05353374|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92361592|NCT05353374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361593|NCT05353374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361595|NCT05214222|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92361597|NCT05214222|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361598|NCT05214222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361599|NCT05214222|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361600|NCT05214222|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361601|NCT05214222|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361602|NCT05214222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361603|NCT05198232|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
92361605|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
92361606|NCT05198232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361607|NCT05198232|Protective Agents|protective agents|mesh-ancestor
92361608|NCT05198232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361609|NCT05198232|Antacids|antacids|mesh-ancestor
92361610|NCT05198232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361611|NCT04747236|Gemcitabine|gemcitabine|mesh-list
91918613|NCT03171987|Lidocaine|lidocaine|mesh-list
92361612|NCT04747236|Azacitidine|azacitidine|mesh-list
92361613|NCT04747236|Romidepsin|romidepsin|mesh-list
92361614|NCT04747236|Belinostat|belinostat|mesh-list
92361615|NCT04747236|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361616|NCT04747236|Antimetabolites|antimetabolites|mesh-ancestor
91918690|NCT02171455|Dabigatran|dabigatran|mesh-list
92361617|NCT04747236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361618|NCT04747236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361619|NCT04747236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361620|NCT04747236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92361621|NCT04747236|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92361622|NCT01797666|Pioglitazone|pioglitazone|mesh-list
92361623|NCT01797666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92361624|NCT01797666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361626|NCT05017194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92361627|NCT05017194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361628|NCT04501380|Rifamycins|rifamycins|mesh-list
92361629|NCT04501380|Rifamycin SV|rifamycin sv|mesh-list
92361630|NCT04501380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92361631|NCT04501380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361632|NCT04501380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361633|NCT04465734|Sorafenib|sorafenib|mesh-list
92361634|NCT04465734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937424|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361635|NCT04465734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92361637|NCT04465734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361638|NCT03856632|Liraglutide|liraglutide|mesh-list
92361639|NCT03856632|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92361640|NCT03856632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92361641|NCT03856632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361642|NCT03856632|Incretins|incretins|mesh-ancestor
92361643|NCT03856632|Hormones|hormones|mesh-ancestor
91918817|NCT05698394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361644|NCT03856632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92361645|NCT04286178|Coenzyme Q10|coenzyme q10|mesh-list
92361646|NCT04286178|Micronutrients|micronutrients|mesh-ancestor
92361647|NCT04286178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361648|NCT04286178|Vitamins|vitamins|mesh-ancestor
92361649|NCT04655976|Docetaxel|docetaxel|mesh-list
92361650|NCT04655976|Dostarlimab|dostarlimab|mesh-list
92361651|NCT04655976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361652|NCT04655976|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361653|NCT04655976|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361654|NCT04655976|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361655|NCT04655976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361656|NCT01798602|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92361657|NCT01798602|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92361658|NCT01798602|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92361659|NCT01798602|Antimetabolites|antimetabolites|mesh-ancestor
92361660|NCT01798602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361661|NCT01798602|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92361662|NCT01798602|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92361663|NCT01798602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361664|NCT02783430|Ketamine|ketamine|mesh-list
92361665|NCT02783430|Milnacipran|milnacipran|mesh-list
92361666|NCT02783430|Levomilnacipran|levomilnacipran|mesh-list
92361667|NCT02783430|Analgesics|analgesics|mesh-ancestor
92361668|NCT02783430|Sensory System Agents|sensory system agents|mesh-ancestor
92361669|NCT02783430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361670|NCT02783430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361671|NCT02783430|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92361672|NCT02783430|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92361673|NCT02783430|Anesthetics, General|anesthetics, general|mesh-ancestor
91919226|NCT02165449|Anesthetics, General|anesthetics, general|mesh-ancestor
92361675|NCT02783430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361676|NCT02783430|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92361677|NCT02783430|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92361678|NCT02783430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361679|NCT02783430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361680|NCT02783430|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92361681|NCT02783430|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92361682|NCT02783430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92361683|NCT02783430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92361684|NCT02783430|Antidepressive Agents|antidepressive agents|mesh-ancestor
91919446|NCT02581202|Ritonavir|ritonavir|mesh-list
92361685|NCT02783430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361687|NCT03642366|Vasodilator Agents|vasodilator agents|mesh-ancestor
92361688|NCT03642366|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92361689|NCT03642366|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92361690|NCT03642366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361691|NCT03642366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361692|NCT03642366|Urological Agents|urological agents|mesh-ancestor
92361693|NCT00604968|Doxorubicin|doxorubicin|mesh-list
92361694|NCT00604968|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92361695|NCT00604968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92361696|NCT00604968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361697|NCT00604968|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92361698|NCT00604968|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92361699|NCT00604968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919737|NCT02175901|Antacids|antacids|mesh-ancestor
92361700|NCT00604968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361701|NCT00605202|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91919803|NCT04305002|Incretins|incretins|mesh-ancestor
92361702|NCT00605202|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92361703|NCT00605202|Diuretics|diuretics|mesh-ancestor
92361704|NCT00605202|Natriuretic Agents|natriuretic agents|mesh-ancestor
92361705|NCT00605202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361706|NCT00605202|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92361707|NCT00605202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91937440|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361708|NCT00605202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361711|NCT03548454|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92361712|NCT03548454|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92361713|NCT03548454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92361714|NCT03548454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361715|NCT03548454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361716|NCT03548454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361717|NCT03548454|Analgesics|analgesics|mesh-ancestor
92361718|NCT03548454|Sensory System Agents|sensory system agents|mesh-ancestor
91920171|NCT03751397|Cystatins|cystatins|mesh-list
92361719|NCT03548454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361720|NCT03548454|Antidepressive Agents|antidepressive agents|mesh-ancestor
92361721|NCT03548454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361722|NCT03548454|Dopamine Agents|dopamine agents|mesh-ancestor
92361723|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92361724|NCT03548454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361725|NCT03548454|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92361727|NCT00605904|Acamprosate|acamprosate|mesh-list
92361728|NCT00605904|Yohimbine|yohimbine|mesh-list
91920555|NCT05523986|Vitamin D|vitamin d|mesh-list
92361730|NCT00605904|Mydriatics|mydriatics|mesh-ancestor
92361731|NCT00605904|Autonomic Agents|autonomic agents|mesh-ancestor
92361732|NCT00605904|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361733|NCT00605904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361734|NCT00605904|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91920612|NCT02573870|Autonomic Agents|autonomic agents|mesh-ancestor
92361736|NCT00605904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92361737|NCT00605904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92361738|NCT00605904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361739|NCT00605904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361740|NCT00605904|Urological Agents|urological agents|mesh-ancestor
92361741|NCT01798914|Insulin|insulin|mesh-list
92361742|NCT01798914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92361743|NCT01798914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361744|NCT05194488|Botulinum Toxins|botulinum toxins|mesh-list
92361745|NCT05194488|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92361747|NCT05194488|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92361748|NCT05194488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92361749|NCT05194488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361750|NCT05194488|Cholinergic Agents|cholinergic agents|mesh-ancestor
92361751|NCT05194488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361752|NCT05194488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361753|NCT05194488|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92361754|NCT05194488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361755|NCT05175768|Niacinamide|niacinamide|mesh-list
92361757|NCT05175768|Nicotinic Acids|nicotinic acids|mesh-list
91920970|NCT03536845|Vitamin D|vitamin d|mesh-list
92361758|NCT05175768|Vitamin B Complex|vitamin b complex|mesh-ancestor
92361759|NCT05175768|Vitamins|vitamins|mesh-ancestor
92361760|NCT05175768|Micronutrients|micronutrients|mesh-ancestor
92361761|NCT05175768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361762|NCT05175768|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92361763|NCT05175768|Antimetabolites|antimetabolites|mesh-ancestor
91921040|NCT05117281|Levobupivacaine|levobupivacaine|mesh-list
92361764|NCT05175768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361765|NCT05175768|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92361766|NCT05175768|Vasodilator Agents|vasodilator agents|mesh-ancestor
92361767|NCT05097846|Amoxicillin|amoxicillin|mesh-list
92361768|NCT05097846|Doxycycline|doxycycline|mesh-list
92361769|NCT05097846|Furazolidone|furazolidone|mesh-list
92361770|NCT05097846|Esomeprazole|esomeprazole|mesh-list
92361771|NCT05097846|Bismuth|bismuth|mesh-list
92361772|NCT05097846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92361773|NCT05097846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361774|NCT05097846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91921179|NCT04766996|Anesthetics, Local|anesthetics, local|mesh-ancestor
92361775|NCT05097846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361776|NCT05097846|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92361777|NCT05097846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361778|NCT05097846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361779|NCT05097846|Antimalarials|antimalarials|mesh-ancestor
92361780|NCT05097846|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92361781|NCT05097846|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91921394|NCT02188225|Serotonin Agents|serotonin agents|mesh-ancestor
92361783|NCT05097846|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92361784|NCT05097846|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92361785|NCT05097846|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92361786|NCT05097846|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92361787|NCT00608634|Perillyl alcohol|perillyl alcohol|mesh-list
92361788|NCT00608634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361789|NCT00608634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361790|NCT00608634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361791|NCT02897700|Cyclophosphamide|cyclophosphamide|mesh-list
92361792|NCT02897700|Doxorubicin|doxorubicin|mesh-list
92361793|NCT02897700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92361794|NCT02897700|Fluorouracil|fluorouracil|mesh-list
92361795|NCT02897700|Methotrexate|methotrexate|mesh-list
92361796|NCT02897700|Epirubicin|epirubicin|mesh-list
92361797|NCT02897700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361798|NCT02897700|Immunologic Factors|immunologic factors|mesh-ancestor
92361799|NCT02897700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361800|NCT02897700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361801|NCT02897700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361802|NCT02897700|Alkylating Agents|alkylating agents|mesh-ancestor
92361803|NCT02897700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361804|NCT02897700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361805|NCT02897700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91921907|NCT02206789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92361806|NCT02897700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92361807|NCT02897700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92361808|NCT02897700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92361810|NCT02897700|Antimetabolites|antimetabolites|mesh-ancestor
92361811|NCT02897700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361812|NCT02897700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92361813|NCT02897700|Abortifacient Agents|abortifacient agents|mesh-ancestor
92361814|NCT02897700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92361815|NCT02897700|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361816|NCT02897700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92361817|NCT02897700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92361818|NCT02889666|Cisplatin|cisplatin|mesh-list
92361819|NCT02889666|Carboplatin|carboplatin|mesh-list
92361820|NCT02889666|Gemcitabine|gemcitabine|mesh-list
92361821|NCT02889666|Docetaxel|docetaxel|mesh-list
92361822|NCT02889666|Oxaliplatin|oxaliplatin|mesh-list
92361823|NCT02889666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361824|NCT02889666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361825|NCT02889666|Antimetabolites|antimetabolites|mesh-ancestor
92361826|NCT02889666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361827|NCT02889666|Tubulin Modulators|tubulin modulators|mesh-ancestor
92361828|NCT02889666|Antimitotic Agents|antimitotic agents|mesh-ancestor
92361829|NCT02889666|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361830|NCT00609804|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92361831|NCT00609804|Sorafenib|sorafenib|mesh-list
92361832|NCT00609804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361833|NCT00609804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92361835|NCT00609804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361836|NCT00610428|Prochlorperazine|prochlorperazine|mesh-list
92361837|NCT00610428|Antiemetics|antiemetics|mesh-ancestor
92361838|NCT00610428|Autonomic Agents|autonomic agents|mesh-ancestor
92361839|NCT00610428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361840|NCT00610428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361841|NCT00610428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361842|NCT00610428|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92361843|NCT00610428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92361844|NCT00610428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361845|NCT00610428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361846|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92361847|NCT00610428|Dopamine Agents|dopamine agents|mesh-ancestor
92361848|NCT00610428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361849|NCT00610428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361850|NCT02446236|Rituximab|rituximab|mesh-list
92361851|NCT02446236|Lenalidomide|lenalidomide|mesh-list
92361852|NCT02446236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361853|NCT02446236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361854|NCT02446236|Immunologic Factors|immunologic factors|mesh-ancestor
92361855|NCT02446236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361856|NCT02446236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361857|NCT02446236|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92361858|NCT02446236|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92361859|NCT02446236|Growth Substances|growth substances|mesh-ancestor
92361860|NCT02446236|Growth Inhibitors|growth inhibitors|mesh-ancestor
92361862|NCT00610740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361863|NCT00610740|Antimetabolites|antimetabolites|mesh-ancestor
92361864|NCT00610740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361865|NCT00610740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361866|NCT00611442|Lubiprostone|lubiprostone|mesh-list
92361867|NCT00611442|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92361868|NCT00611442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92361869|NCT00611442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361870|NCT02136420|Promethazine|promethazine|mesh-list
92361871|NCT02136420|Diphenhydramine|diphenhydramine|mesh-list
92361872|NCT02136420|Antipruritics|antipruritics|mesh-ancestor
92361873|NCT02136420|Dermatologic Agents|dermatologic agents|mesh-ancestor
92361874|NCT02136420|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92361875|NCT02136420|Histamine Antagonists|histamine antagonists|mesh-ancestor
92361876|NCT02136420|Histamine Agents|histamine agents|mesh-ancestor
92361877|NCT02136420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361878|NCT02136420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361879|NCT02136420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361880|NCT02136420|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92361881|NCT02136420|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91923121|NCT02228239|Serotonin Agents|serotonin agents|mesh-ancestor
92361882|NCT02136420|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92361883|NCT02136420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361885|NCT02136420|Anesthetics|anesthetics|mesh-ancestor
92361886|NCT02136420|Sensory System Agents|sensory system agents|mesh-ancestor
92361887|NCT02136420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361888|NCT02136420|Antiemetics|antiemetics|mesh-ancestor
92361889|NCT02136420|Autonomic Agents|autonomic agents|mesh-ancestor
92361890|NCT02136420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361891|NCT02136498|Varenicline|varenicline|mesh-list
92361892|NCT02136498|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92361894|NCT02136498|Cholinergic Agents|cholinergic agents|mesh-ancestor
92361895|NCT02136498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361896|NCT02136498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361897|NCT02136498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361899|NCT00612222|Cyclophosphamide|cyclophosphamide|mesh-list
92361900|NCT00612222|Fludarabine|fludarabine|mesh-list
92361901|NCT00612222|Fludarabine phosphate|fludarabine phosphate|mesh-list
92361902|NCT00612222|Interleukin-2|interleukin-2|mesh-list
92361903|NCT00612222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92361904|NCT00612222|Immunologic Factors|immunologic factors|mesh-ancestor
92361905|NCT00612222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361906|NCT00612222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361907|NCT00612222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92361908|NCT00612222|Alkylating Agents|alkylating agents|mesh-ancestor
92361909|NCT00612222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361910|NCT00612222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361911|NCT00612222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92361912|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361913|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
92361914|NCT00612222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92361916|NCT00612222|Sensory System Agents|sensory system agents|mesh-ancestor
91923550|NCT02230033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92361917|NCT00612222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361918|NCT00612222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91923703|NCT02258581|Tenofovir|tenofovir|mesh-list
92361920|NCT00612222|Antiviral Agents|antiviral agents|mesh-ancestor
92361921|NCT00612222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92361922|NCT01711242|Capecitabine|capecitabine|mesh-list
92361923|NCT01711242|Oxaliplatin|oxaliplatin|mesh-list
92361924|NCT01711242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92361925|NCT01711242|Antimetabolites|antimetabolites|mesh-ancestor
92361926|NCT01711242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361927|NCT01711242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361928|NCT04405908|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92361929|NCT04405908|Aluminum sulfate|aluminum sulfate|mesh-list
92361930|NCT04405908|1018 oligonucleotide|1018 oligonucleotide|mesh-list
92361931|NCT04405908|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92361932|NCT04405908|Immunologic Factors|immunologic factors|mesh-ancestor
92361933|NCT04405908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361935|NCT04405908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361936|NCT04405908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92361937|NCT04331496|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92361938|NCT04304274|Morphine|morphine|mesh-list
92361939|NCT04304274|Ropivacaine|ropivacaine|mesh-list
92361940|NCT04304274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92361941|NCT04304274|Narcotics|narcotics|mesh-ancestor
92361942|NCT04304274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361943|NCT04304274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361944|NCT04304274|Analgesics|analgesics|mesh-ancestor
92361945|NCT04304274|Sensory System Agents|sensory system agents|mesh-ancestor
92361946|NCT04304274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361947|NCT04304274|Anesthetics, Local|anesthetics, local|mesh-ancestor
92361948|NCT04304274|Anesthetics|anesthetics|mesh-ancestor
92361949|NCT02132832|Buspirone|buspirone|mesh-list
92361950|NCT02132832|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92361951|NCT02132832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92361952|NCT02132832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361953|NCT02132832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361954|NCT02132832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92361955|NCT02132832|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92361956|NCT02132832|Serotonin Agents|serotonin agents|mesh-ancestor
92361957|NCT02132832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92361958|NCT02132832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361959|NCT00614406|Celecoxib|celecoxib|mesh-list
91924425|NCT05484284|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92361960|NCT00614406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92361961|NCT00614406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92361963|NCT00614406|Sensory System Agents|sensory system agents|mesh-ancestor
92361964|NCT00614406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361965|NCT00614406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361966|NCT00614406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92361967|NCT00614406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92361968|NCT00614406|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91924487|NCT02741791|Dopamine Agents|dopamine agents|mesh-ancestor
92361969|NCT00614406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92361970|NCT00614406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924564|NCT05493332|Vitamins|vitamins|mesh-ancestor
92361971|NCT00614406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361972|NCT00614484|Paclitaxel|paclitaxel|mesh-list
92361973|NCT00614484|Carboplatin|carboplatin|mesh-list
92361974|NCT00614484|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92361975|NCT00614484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361976|NCT00614484|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924709|NCT01520545|Baclofen|baclofen|mesh-list
92361977|NCT00614484|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924789|NCT02556632|Curcumin|curcumin|mesh-list
92361978|NCT00614484|Mitosis Modulators|mitosis modulators|mesh-ancestor
92361979|NCT00614484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92361980|NCT04159974|Durvalumab|durvalumab|mesh-list
92361981|NCT04159974|Tremelimumab|tremelimumab|mesh-list
91924848|NCT05105035|Ceftazidime|ceftazidime|mesh-list
92361982|NCT04159974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92361983|NCT04159974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92361984|NCT04142502|Dexmedetomidine|dexmedetomidine|mesh-list
92361985|NCT04142502|Propofol|propofol|mesh-list
92361986|NCT04142502|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92361987|NCT04142502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92361988|NCT04142502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92361990|NCT04142502|Anesthetics, General|anesthetics, general|mesh-ancestor
92361991|NCT04142502|Anesthetics|anesthetics|mesh-ancestor
92361992|NCT04142502|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92361993|NCT04142502|Analgesics|analgesics|mesh-ancestor
92361994|NCT04142502|Sensory System Agents|sensory system agents|mesh-ancestor
92361995|NCT04142502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92361996|NCT04142502|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92361997|NCT04142502|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92361998|NCT04142502|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91925212|NCT05478044|Ascorbic Acid|ascorbic acid|mesh-list
92361999|NCT04142502|Adrenergic Agents|adrenergic agents|mesh-ancestor
92362000|NCT04142502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362001|NCT04142502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362003|NCT00569010|Azacitidine|azacitidine|mesh-list
92362004|NCT00569010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91925352|NCT05625919|Sirolimus|sirolimus|mesh-list
92362005|NCT00569010|Antimetabolites|antimetabolites|mesh-ancestor
92362006|NCT00569010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362007|NCT00569010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362008|NCT00569010|Antiviral Agents|antiviral agents|mesh-ancestor
92362009|NCT00569010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362010|NCT00569010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362011|NCT00569010|Immunologic Factors|immunologic factors|mesh-ancestor
92362012|NCT00569010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362013|NCT00569010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362014|NCT00616122|Cyclophosphamide|cyclophosphamide|mesh-list
92362016|NCT00616122|Sunitinib|sunitinib|mesh-list
92362017|NCT00616122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362019|NCT00616122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362020|NCT00616122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362021|NCT00616122|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91925662|NCT03162861|Propofol|propofol|mesh-list
92362022|NCT00616122|Alkylating Agents|alkylating agents|mesh-ancestor
92362023|NCT00616122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925722|NCT02156999|Vitamin D|vitamin d|mesh-list
92362024|NCT00616122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362025|NCT00616122|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92362026|NCT00616122|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92362027|NCT00616122|Abortifacient Agents|abortifacient agents|mesh-ancestor
92362028|NCT00616122|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925793|NCT02157467|BMS-955176|bms-955176|mesh-list
92362029|NCT00616122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362031|NCT00616122|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362032|NCT00616122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362033|NCT00616122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91925869|NCT02266849|Loperamide|loperamide|mesh-list
92362034|NCT00616122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362035|NCT00616122|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92362036|NCT00616122|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92362037|NCT00616122|Growth Substances|growth substances|mesh-ancestor
92362038|NCT00616122|Growth Inhibitors|growth inhibitors|mesh-ancestor
92362039|NCT00616122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92362041|NCT00617058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92362042|NCT00617058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362043|NCT00618540|Fludarabine|fludarabine|mesh-list
92362045|NCT00618540|Melphalan|melphalan|mesh-list
92362047|NCT00618540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362048|NCT00618540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362049|NCT00618540|Antimetabolites|antimetabolites|mesh-ancestor
92362050|NCT00618540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362051|NCT00618540|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362052|NCT00618540|Immunologic Factors|immunologic factors|mesh-ancestor
92362053|NCT00618540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362054|NCT00618540|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92362055|NCT00618540|Alkylating Agents|alkylating agents|mesh-ancestor
92362056|NCT00618540|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92362057|NCT00618540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362058|NCT00570960|Dextrans|dextrans|mesh-list
92362059|NCT00570960|Anticoagulants|anticoagulants|mesh-ancestor
92362060|NCT00570960|Plasma Substitutes|plasma substitutes|mesh-ancestor
92362061|NCT00570960|Blood Substitutes|blood substitutes|mesh-ancestor
92362062|NCT00571428|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92362063|NCT00571428|Formoterol Fumarate|formoterol fumarate|mesh-list
92362064|NCT00571428|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92362065|NCT00571428|Autonomic Agents|autonomic agents|mesh-ancestor
92362066|NCT00571428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362067|NCT00571428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362068|NCT00571428|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91926302|NCT01106989|Lidocaine|lidocaine|mesh-list
92362069|NCT00571428|Respiratory System Agents|respiratory system agents|mesh-ancestor
92362070|NCT00571428|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92362071|NCT00571428|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92362072|NCT00571428|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92362073|NCT00571428|Adrenergic Agents|adrenergic agents|mesh-ancestor
92362074|NCT00571428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362075|NCT00571428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362076|NCT00571974|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92362077|NCT00571974|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92362078|NCT00571974|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362079|NCT00574236|Doxorubicin|doxorubicin|mesh-list
92362080|NCT00574236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92362081|NCT00574236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362083|NCT00574236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362084|NCT00574236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926491|NCT04729725|Cemiplimab|cemiplimab|mesh-list
92362085|NCT00574236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362086|NCT00574548|Vaccines|vaccines|mesh-list
92362087|NCT00574548|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92362088|NCT00574548|Immunologic Factors|immunologic factors|mesh-ancestor
92362089|NCT00574548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362091|NCT01168219|Fludarabine phosphate|fludarabine phosphate|mesh-list
92362092|NCT01168219|Azacitidine|azacitidine|mesh-list
92362093|NCT01168219|Fludarabine|fludarabine|mesh-list
92362094|NCT01168219|Busulfan|busulfan|mesh-list
92362095|NCT01168219|Tacrolimus|tacrolimus|mesh-list
92362096|NCT01168219|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91926637|NCT00792727|Analgesics|analgesics|mesh-ancestor
92362097|NCT01168219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92362098|NCT01168219|Abortifacient Agents|abortifacient agents|mesh-ancestor
92362099|NCT01168219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92362100|NCT01168219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362101|NCT01168219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926796|NCT05429450|Hormones|hormones|mesh-ancestor
92362102|NCT01168219|Antimetabolites|antimetabolites|mesh-ancestor
92362103|NCT01168219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362104|NCT01168219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362105|NCT01168219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362106|NCT01168219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362107|NCT01168219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92362108|NCT01168219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362109|NCT01168219|Immunologic Factors|immunologic factors|mesh-ancestor
92362110|NCT01168219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362111|NCT01168219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362112|NCT01168219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92362113|NCT01168219|Alkylating Agents|alkylating agents|mesh-ancestor
92362114|NCT01168219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92362115|NCT01168219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92362117|NCT01115803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92362118|NCT01115803|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92362119|NCT01115803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92362120|NCT01115803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362121|NCT01115803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362122|NCT01115803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362123|NCT01115803|Immunologic Factors|immunologic factors|mesh-ancestor
92362124|NCT01115803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927142|NCT00835549|Cefdinir|cefdinir|mesh-list
92362125|NCT01115803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362127|NCT01115569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92362128|NCT01115569|Narcotics|narcotics|mesh-ancestor
91927206|NCT03539003|Remifentanil|remifentanil|mesh-list
92362129|NCT01115569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927279|NCT01372995|Micronutrients|micronutrients|mesh-ancestor
92362130|NCT01115569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362132|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
92362133|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362134|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
92362135|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
92362136|NCT01107886|Saxagliptin|saxagliptin|mesh-list
92362137|NCT01107886|Incretins|incretins|mesh-ancestor
92362139|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362140|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362141|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92362142|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
92362143|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362144|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362145|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92362146|NCT01107457|Ixekizumab|ixekizumab|mesh-list
92362147|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362148|NCT05767008|Sunscreening Agents|sunscreening agents|mesh-list
92362149|NCT05767008|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92362150|NCT05767008|Protective Agents|protective agents|mesh-ancestor
92362151|NCT05767008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362153|NCT05766631|Methadone|methadone|mesh-list
92362154|NCT05766631|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92362155|NCT05766631|Narcotics|narcotics|mesh-ancestor
91927852|NCT02404623|Vitamins|vitamins|mesh-ancestor
92362156|NCT05766631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362157|NCT05766631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362158|NCT05766631|Analgesics|analgesics|mesh-ancestor
91927930|NCT00606697|Vofopitant|vofopitant|mesh-list
92362159|NCT05766631|Sensory System Agents|sensory system agents|mesh-ancestor
92362160|NCT05766631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362162|NCT05766631|Respiratory System Agents|respiratory system agents|mesh-ancestor
92362163|NCT05766605|Leucovorin|leucovorin|mesh-list
92362164|NCT05766605|Doxorubicin|doxorubicin|mesh-list
92362165|NCT05766605|Fluorouracil|fluorouracil|mesh-list
92362166|NCT05766605|Oxaliplatin|oxaliplatin|mesh-list
92362167|NCT05766605|Raltitrexed|raltitrexed|mesh-list
92362168|NCT05766605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362169|NCT05766605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92362170|NCT05766605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92362171|NCT05766605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91928140|NCT03170739|Dopamine Agents|dopamine agents|mesh-ancestor
92362172|NCT05766605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362173|NCT05766605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362174|NCT05766605|Antimetabolites|antimetabolites|mesh-ancestor
92362175|NCT05766605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362176|NCT05766605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362177|NCT05766605|Immunologic Factors|immunologic factors|mesh-ancestor
92362178|NCT05766605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362179|NCT05766605|Antidotes|antidotes|mesh-ancestor
92362180|NCT05766605|Protective Agents|protective agents|mesh-ancestor
92362181|NCT05766605|Vitamin B Complex|vitamin b complex|mesh-ancestor
92362182|NCT05766605|Vitamins|vitamins|mesh-ancestor
92362183|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
92362184|NCT05766605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92362186|NCT05766514|Decitabine|decitabine|mesh-list
92362187|NCT05766514|Venetoclax|venetoclax|mesh-list
92362188|NCT05766514|Cladribine|cladribine|mesh-list
91928502|NCT02403687|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92362189|NCT05766514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362190|NCT05766514|Antimetabolites|antimetabolites|mesh-ancestor
92362191|NCT05766514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362192|NCT05766514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362193|NCT05766514|Antiviral Agents|antiviral agents|mesh-ancestor
92014665|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362194|NCT05766514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362196|NCT05766514|Immunologic Factors|immunologic factors|mesh-ancestor
92362197|NCT05766514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362198|NCT05766514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362199|NCT05766436|Dexmedetomidine|dexmedetomidine|mesh-list
92362200|NCT05766436|Melatonin|melatonin|mesh-list
92362201|NCT05766436|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92362202|NCT05766436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928786|NCT02179931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362203|NCT05766436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362204|NCT05766436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92362205|NCT05766436|Analgesics|analgesics|mesh-ancestor
92362206|NCT05766436|Sensory System Agents|sensory system agents|mesh-ancestor
92362207|NCT05766436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362208|NCT05766436|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92362209|NCT05766436|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92362210|NCT05766436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92362211|NCT05766436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92362212|NCT05766436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362213|NCT05766436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362214|NCT05766436|Antioxidants|antioxidants|mesh-ancestor
92362215|NCT05766436|Protective Agents|protective agents|mesh-ancestor
92362216|NCT05766397|Methoxyflurane|methoxyflurane|mesh-list
92362217|NCT05766397|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92362218|NCT05766397|Anesthetics, General|anesthetics, general|mesh-ancestor
92362219|NCT05766397|Anesthetics|anesthetics|mesh-ancestor
92362220|NCT05766397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362221|NCT05766397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362222|NCT05766384|Xenon|xenon|mesh-list
92362223|NCT05766384|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92362224|NCT05766384|Anesthetics, General|anesthetics, general|mesh-ancestor
92362225|NCT05766384|Anesthetics|anesthetics|mesh-ancestor
92362226|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362227|NCT05766384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362228|NCT05766267|Moxifloxacin|moxifloxacin|mesh-list
92362229|NCT05766267|Rifampin|rifampin|mesh-list
92362230|NCT05766267|Isoniazid|isoniazid|mesh-list
91929278|NCT02332720|Ruzasvir|ruzasvir|mesh-list
92362231|NCT05766267|Pyrazinamide|pyrazinamide|mesh-list
92362232|NCT05766267|Ethambutol|ethambutol|mesh-list
92362233|NCT05766267|Rifabutin|rifabutin|mesh-list
92362234|NCT05766267|Bedaquiline|bedaquiline|mesh-list
92362235|NCT05766267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92362236|NCT05766267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362237|NCT05766267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92362238|NCT05766267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362239|NCT05766267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362240|NCT05766267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362241|NCT05766267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362242|NCT05766267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92362243|NCT05766267|Antitubercular Agents|antitubercular agents|mesh-ancestor
92362244|NCT05766267|Leprostatic Agents|leprostatic agents|mesh-ancestor
92362245|NCT05766267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362246|NCT05766267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92362247|NCT05766267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92362248|NCT05766267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92362249|NCT05766267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92362250|NCT05766267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92362251|NCT05766267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92362252|NCT05766267|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92362253|NCT05766267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92362254|NCT05766267|Antimetabolites|antimetabolites|mesh-ancestor
92362255|NCT05766267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92362256|NCT05766176|Antibodies|antibodies|mesh-list
92362257|NCT05766176|Immunoglobulins|immunoglobulins|mesh-list
92362258|NCT05766176|Immunologic Factors|immunologic factors|mesh-ancestor
92362259|NCT05766176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362260|NCT05766124|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92362261|NCT05766124|Plasminogen|plasminogen|mesh-list
92362262|NCT05766124|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92362263|NCT05766124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92362264|NCT05766124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362265|NCT05766085|Dexamethasone|dexamethasone|mesh-list
92362266|NCT05766085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362267|NCT05766085|Antiemetics|antiemetics|mesh-ancestor
92362268|NCT05766085|Autonomic Agents|autonomic agents|mesh-ancestor
92362269|NCT05766085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014742|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
92362270|NCT05766085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362271|NCT05766085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92362272|NCT05766085|Glucocorticoids|glucocorticoids|mesh-ancestor
91930140|NCT00004231|Abortifacient Agents|abortifacient agents|mesh-ancestor
91930152|NCT00004231|Vitamins|vitamins|mesh-ancestor
92362274|NCT05766085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930223|NCT02189681|Anesthetics|anesthetics|mesh-list
92362275|NCT05766085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362276|NCT05766085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362278|NCT05765825|Etoposide|etoposide|mesh-list
92362279|NCT05765825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362280|NCT05765825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92362281|NCT05765825|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92362282|NCT05765825|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362283|NCT05765825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362284|NCT05765825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362285|NCT05765747|Celecoxib|celecoxib|mesh-list
92362286|NCT05765747|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91930580|NCT05724589|Mitogens|mitogens|mesh-list
92362287|NCT05765747|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92362288|NCT05765747|Analgesics|analgesics|mesh-ancestor
92362289|NCT05765747|Sensory System Agents|sensory system agents|mesh-ancestor
92362290|NCT05765747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362291|NCT05765747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362292|NCT05765747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362293|NCT05765747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362294|NCT05765747|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92362295|NCT05765747|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92362296|NCT05765747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362297|NCT05765747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362299|NCT05765617|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92362300|NCT05765617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362301|NCT05765617|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92362302|NCT05765617|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92362303|NCT05765617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931020|NCT05791487|Glucocorticoids|glucocorticoids|mesh-ancestor
92362304|NCT05765617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92362306|NCT05765617|Micronutrients|micronutrients|mesh-ancestor
92362307|NCT05765617|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92362308|NCT05765578|Vaccines|vaccines|mesh-list
91931167|NCT05553392|Petrolatum|petrolatum|mesh-list
92362309|NCT05765578|Immunologic Factors|immunologic factors|mesh-ancestor
92362310|NCT05765578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362311|NCT05765500|Leuprolide|leuprolide|mesh-list
92362312|NCT05765500|Relugolix|relugolix|mesh-list
92362313|NCT05765500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92362314|NCT05765500|Fertility Agents|fertility agents|mesh-ancestor
92362315|NCT05765500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92362316|NCT05765500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362317|NCT05765500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362318|NCT05765500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362319|NCT05765500|Androgen Antagonists|androgen antagonists|mesh-ancestor
92362320|NCT05765500|Hormone Antagonists|hormone antagonists|mesh-ancestor
91931393|NCT04861064|Sirolimus|sirolimus|mesh-list
92362321|NCT05765500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362323|NCT05765357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362324|NCT05765357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362325|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
92362326|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92362327|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
92362328|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362329|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
92362330|NCT05765240|Protective Agents|protective agents|mesh-ancestor
92362331|NCT05765110|Dopamine|dopamine|mesh-list
92362332|NCT05765110|Dopamine Agonists|dopamine agonists|mesh-list
92362333|NCT05765110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92362334|NCT05765110|Sympathomimetics|sympathomimetics|mesh-ancestor
92362335|NCT05765110|Autonomic Agents|autonomic agents|mesh-ancestor
92362336|NCT05765110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362337|NCT05765110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931531|NCT04095689|Docetaxel|docetaxel|mesh-list
92362338|NCT05765110|Dopamine Agents|dopamine agents|mesh-ancestor
92362339|NCT05765110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362340|NCT05765110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362341|NCT05765110|Protective Agents|protective agents|mesh-ancestor
92362342|NCT05765097|Pancrelipase|pancrelipase|mesh-list
92362343|NCT05765097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92362344|NCT05764811|Canagliflozin|canagliflozin|mesh-list
92362345|NCT05764811|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92362346|NCT05764811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362347|NCT05764811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92362348|NCT05764811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362349|NCT05764798|Zolpidem|zolpidem|mesh-list
92362350|NCT05764798|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92362351|NCT05764798|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92362352|NCT05764798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362353|NCT05764798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931806|NCT02195895|Ergocalciferols|ergocalciferols|mesh-list
92362354|NCT05764798|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92362355|NCT05764798|GABA Agonists|gaba agonists|mesh-ancestor
92362356|NCT05764798|GABA Agents|gaba agents|mesh-ancestor
92362357|NCT05764798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362358|NCT05764798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362359|NCT05764746|Artesunate|artesunate|mesh-list
92362360|NCT05764746|Lumefantrine|lumefantrine|mesh-list
92362361|NCT05764746|Artemether|artemether|mesh-list
92362362|NCT05764746|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92362363|NCT05764746|Amodiaquine|amodiaquine|mesh-list
92362364|NCT05764746|Antimalarials|antimalarials|mesh-ancestor
92362365|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92362366|NCT05764746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92362367|NCT05764746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362368|NCT05764746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362369|NCT05764746|Antiviral Agents|antiviral agents|mesh-ancestor
92362370|NCT05764746|Schistosomicides|schistosomicides|mesh-ancestor
92362371|NCT05764746|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92362372|NCT05764746|Anthelmintics|anthelmintics|mesh-ancestor
92362373|NCT05764707|Acetaminophen|acetaminophen|mesh-list
92362374|NCT05764707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92362376|NCT05764707|Sensory System Agents|sensory system agents|mesh-ancestor
91932243|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
92362377|NCT05764707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362378|NCT05764707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362379|NCT05764707|Antipyretics|antipyretics|mesh-ancestor
92362380|NCT05763602|Povidone-Iodine|povidone-iodine|mesh-list
92362381|NCT05763602|Povidone|povidone|mesh-list
92362382|NCT05763602|Plasma Substitutes|plasma substitutes|mesh-ancestor
92362383|NCT05763602|Blood Substitutes|blood substitutes|mesh-ancestor
92362384|NCT05763602|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92362385|NCT05763602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362386|NCT05757622|Remifentanil|remifentanil|mesh-list
92362387|NCT05757622|Propofol|propofol|mesh-list
92362388|NCT05757622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92362389|NCT05757622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362390|NCT05757622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362391|NCT05757622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92362392|NCT05757622|Anesthetics, General|anesthetics, general|mesh-ancestor
92362394|NCT05757622|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92362395|NCT05757622|Narcotics|narcotics|mesh-ancestor
92362396|NCT05757622|Analgesics|analgesics|mesh-ancestor
92362397|NCT05757622|Sensory System Agents|sensory system agents|mesh-ancestor
92362398|NCT05757622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362399|NCT05746819|Antipyretics|antipyretics|mesh-list
92362400|NCT05746819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362401|NCT05746650|Hormones|hormones|mesh-list
92362402|NCT05746650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362403|NCT05746650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362404|NCT05743400|Thymoglobulin|thymoglobulin|mesh-list
92362405|NCT05743400|Immunologic Factors|immunologic factors|mesh-ancestor
92362406|NCT05743400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362407|NCT05743400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362408|NCT05731726|Celecoxib|celecoxib|mesh-list
92362409|NCT05731726|Capecitabine|capecitabine|mesh-list
92362410|NCT05731726|Oxaliplatin|oxaliplatin|mesh-list
92362411|NCT05731726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362412|NCT05731726|Antimetabolites|antimetabolites|mesh-ancestor
92362413|NCT05731726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362414|NCT05731726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362415|NCT05731726|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92362416|NCT05731726|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932697|NCT03525925|Nivolumab|nivolumab|mesh-list
92362417|NCT05731726|Analgesics|analgesics|mesh-ancestor
92362418|NCT05731726|Sensory System Agents|sensory system agents|mesh-ancestor
92362419|NCT05731726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362420|NCT05731726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932826|NCT02361645|Ketorolac|ketorolac|mesh-list
92362421|NCT05731726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362422|NCT05731726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362423|NCT05731726|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91932907|NCT03514069|Temozolomide|temozolomide|mesh-list
92362424|NCT05731726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92362425|NCT05731726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362427|NCT05715931|Docetaxel|docetaxel|mesh-list
92362428|NCT05715931|Oxaliplatin|oxaliplatin|mesh-list
92362429|NCT05715931|Trastuzumab|trastuzumab|mesh-list
92362430|NCT05715931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932971|NCT05092841|Cathartics|cathartics|mesh-ancestor
92362431|NCT05715931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92362432|NCT05715931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92362433|NCT05715931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92362434|NCT05715931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362435|NCT05715931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362436|NCT05715931|Antidotes|antidotes|mesh-ancestor
92362437|NCT05715931|Protective Agents|protective agents|mesh-ancestor
91933037|NCT02361177|Oxytocin|oxytocin|mesh-list
91933038|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
92362438|NCT05715931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362439|NCT05715931|Vitamin B Complex|vitamin b complex|mesh-ancestor
92362440|NCT05715931|Vitamins|vitamins|mesh-ancestor
92362441|NCT05715931|Micronutrients|micronutrients|mesh-ancestor
92362442|NCT05714384|Calcium|calcium|mesh-list
92362443|NCT05714384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92362444|NCT05714384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362445|NCT05708183|Micronutrients|micronutrients|mesh-list
92362446|NCT05708183|Trace Elements|trace elements|mesh-list
92362447|NCT05708183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362448|NCT05594823|Furosemide|furosemide|mesh-list
92362449|NCT05594823|Diuretics|diuretics|mesh-list
92362450|NCT05594823|Natriuretic Agents|natriuretic agents|mesh-ancestor
92362451|NCT05594823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362452|NCT05594823|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92362453|NCT05594823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92362454|NCT05594823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362456|NCT05581797|Hallucinogens|hallucinogens|mesh-ancestor
92362457|NCT05581797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362458|NCT05581797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92362459|NCT05581030|Rituximab|rituximab|mesh-list
92362460|NCT05581030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362461|NCT05581030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362462|NCT05581030|Immunologic Factors|immunologic factors|mesh-ancestor
92362463|NCT05581030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362464|NCT05581030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362465|NCT05510544|Plerixafor|plerixafor|mesh-list
92362466|NCT05510544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92362467|NCT05510544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92362468|NCT05510544|Antiviral Agents|antiviral agents|mesh-ancestor
92362469|NCT05510544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362470|NCT05509699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92362471|NCT05509699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362472|NCT05509699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91933525|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
92362473|NCT05509699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362474|NCT05441215|Ritonavir|ritonavir|mesh-list
92362475|NCT05441215|Nirmatrelvir|nirmatrelvir|mesh-list
92362476|NCT05441215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92362477|NCT05441215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92362478|NCT05441215|Protease Inhibitors|protease inhibitors|mesh-ancestor
92362479|NCT05441215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362480|NCT05441215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362481|NCT05441215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92362482|NCT05441215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92362483|NCT05441215|Antiviral Agents|antiviral agents|mesh-ancestor
92362484|NCT05441215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362485|NCT05441215|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92362486|NCT05441215|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92362487|NCT05431777|Avelumab|avelumab|mesh-list
92362488|NCT05431777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362489|NCT05431777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362490|NCT05327647|Bicalutamide|bicalutamide|mesh-list
92362491|NCT05327647|Androgen Antagonists|androgen antagonists|mesh-list
92362492|NCT05327647|Nonsteroidal Anti-Androgens|nonsteroidal anti-androgens|mesh-list
92362493|NCT05327647|Hormone Antagonists|hormone antagonists|mesh-ancestor
92362494|NCT05327647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362495|NCT05327647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362496|NCT05327647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362497|NCT05320380|Cytarabine|cytarabine|mesh-list
92362498|NCT05320380|Prednisolone|prednisolone|mesh-list
92362499|NCT05320380|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92362500|NCT05320380|Methylprednisolone|methylprednisolone|mesh-list
92362501|NCT05320380|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92362502|NCT05320380|Prednisolone acetate|prednisolone acetate|mesh-list
92362503|NCT05320380|Hydrocortisone|hydrocortisone|mesh-list
92362504|NCT05320380|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92362505|NCT05320380|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92362506|NCT05320380|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92362507|NCT05320380|Cortisone|cortisone|mesh-list
92362508|NCT05320380|Methotrexate|methotrexate|mesh-list
92362509|NCT05320380|Fludarabine phosphate|fludarabine phosphate|mesh-list
92362510|NCT05320380|Fludarabine|fludarabine|mesh-list
92362511|NCT05320380|Daunorubicin|daunorubicin|mesh-list
92362512|NCT05320380|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92362513|NCT05320380|Prednisolone phosphate|prednisolone phosphate|mesh-list
92362514|NCT05320380|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92362515|NCT05320380|Abortifacient Agents|abortifacient agents|mesh-ancestor
92362516|NCT05320380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92362517|NCT05320380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362518|NCT05320380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362519|NCT05320380|Antimetabolites|antimetabolites|mesh-ancestor
92362520|NCT05320380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362521|NCT05320380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362522|NCT05320380|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362523|NCT05320380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362524|NCT05320380|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92362525|NCT05320380|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362526|NCT05320380|Immunologic Factors|immunologic factors|mesh-ancestor
92362527|NCT05320380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362528|NCT05320380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362530|NCT05320380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362531|NCT05320380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362532|NCT05320380|Glucocorticoids|glucocorticoids|mesh-ancestor
92362533|NCT05320380|Hormones|hormones|mesh-ancestor
92362534|NCT05320380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362535|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362536|NCT05320380|Antiemetics|antiemetics|mesh-ancestor
92362537|NCT05320380|Autonomic Agents|autonomic agents|mesh-ancestor
92362538|NCT05320380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362539|NCT05320380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92362540|NCT05320380|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92362541|NCT05320380|Protective Agents|protective agents|mesh-ancestor
92362542|NCT05320380|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92362543|NCT05320380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92362544|NCT05320380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362545|NCT05263908|Ritonavir|ritonavir|mesh-list
92362546|NCT05263908|Nirmatrelvir|nirmatrelvir|mesh-list
92362547|NCT05263908|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
91934159|NCT03263273|Minocycline|minocycline|mesh-list
92362548|NCT05263908|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92362549|NCT05263908|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92362550|NCT05263908|Protease Inhibitors|protease inhibitors|mesh-ancestor
92362551|NCT05263908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362552|NCT05263908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362553|NCT05263908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92362554|NCT05263908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92362555|NCT05263908|Antiviral Agents|antiviral agents|mesh-ancestor
92362556|NCT05263908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118746|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92362557|NCT05263908|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92362558|NCT05263908|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92362560|NCT05259527|Ergocalciferols|ergocalciferols|mesh-list
92362561|NCT05259527|Cholecalciferol|cholecalciferol|mesh-list
92362562|NCT05259527|Vitamins|vitamins|mesh-list
92362563|NCT05259527|Micronutrients|micronutrients|mesh-ancestor
92362564|NCT05259527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362565|NCT05259527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92362566|NCT05259527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92362567|NCT05256641|Acalabrutinib|acalabrutinib|mesh-list
92362568|NCT05256641|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92362569|NCT05256641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362570|NCT05256641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92362571|NCT05256641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362572|NCT05256641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362573|NCT05187377|Hormones|hormones|mesh-list
92362574|NCT05187377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362575|NCT05187377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362576|NCT05177588|Metformin|metformin|mesh-list
92362577|NCT05177588|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92362578|NCT05177588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362579|NCT05171660|Bevacizumab|bevacizumab|mesh-list
92362580|NCT05171660|Capecitabine|capecitabine|mesh-list
92362581|NCT05171660|Oxaliplatin|oxaliplatin|mesh-list
92362582|NCT05171660|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362583|NCT05171660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362584|NCT05171660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92362585|NCT05171660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92362587|NCT05171660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362588|NCT05171660|Growth Inhibitors|growth inhibitors|mesh-ancestor
92362589|NCT05171660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362590|NCT05171660|Antimetabolites|antimetabolites|mesh-ancestor
92362591|NCT05171660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362592|NCT05133258|Ciprofloxacin|ciprofloxacin|mesh-list
92362593|NCT05133258|Dexamethasone|dexamethasone|mesh-list
92362594|NCT05133258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362595|NCT05133258|Antiemetics|antiemetics|mesh-ancestor
92362596|NCT05133258|Autonomic Agents|autonomic agents|mesh-ancestor
92362597|NCT05133258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362598|NCT05133258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362599|NCT05133258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92362600|NCT05133258|Glucocorticoids|glucocorticoids|mesh-ancestor
92362601|NCT05133258|Hormones|hormones|mesh-ancestor
92362602|NCT05133258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362603|NCT05133258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362604|NCT05133258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362605|NCT05133258|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92362606|NCT05133258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362607|NCT05133258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92362608|NCT05133258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362609|NCT05133258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362610|NCT05133258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362611|NCT05133258|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92362612|NCT05133258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92362613|NCT05091346|Pembrolizumab|pembrolizumab|mesh-list
92362614|NCT05091346|Lenvatinib|lenvatinib|mesh-list
92362615|NCT05091346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362616|NCT05091346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362617|NCT05091346|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92362618|NCT05091346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934255|NCT03949673|Celecoxib|celecoxib|mesh-list
92362619|NCT05091346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92362620|NCT05091346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362621|NCT05059873|Prednisone|prednisone|mesh-list
92362622|NCT05059873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362623|NCT05059873|Glucocorticoids|glucocorticoids|mesh-ancestor
92362624|NCT05059873|Hormones|hormones|mesh-ancestor
92362625|NCT05059873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362626|NCT05059873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362627|NCT05059873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362628|NCT05059873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362629|NCT05055024|Mazindol|mazindol|mesh-list
92362630|NCT05055024|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92362631|NCT05055024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362632|NCT05055024|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92362633|NCT05055024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92362634|NCT05055024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92362635|NCT05055024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362636|NCT05055024|Adrenergic Agents|adrenergic agents|mesh-ancestor
92362637|NCT05055024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362638|NCT05055024|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92362639|NCT05055024|Dopamine Agents|dopamine agents|mesh-ancestor
92362640|NCT05053971|Entinostat|entinostat|mesh-list
92362641|NCT05053971|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92362642|NCT05053971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362643|NCT05053971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362644|NCT05053971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362646|NCT05047978|Chelating Agents|chelating agents|mesh-ancestor
92362647|NCT05047978|Sequestering Agents|sequestering agents|mesh-ancestor
92362648|NCT05047978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362649|NCT05045664|Obinutuzumab|obinutuzumab|mesh-list
92362650|NCT05045664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362651|NCT05045664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362652|NCT05037552|Hemostatics|hemostatics|mesh-list
92362653|NCT05037552|Coagulants|coagulants|mesh-ancestor
92362654|NCT05028634|Vaccines|vaccines|mesh-list
92362655|NCT05028634|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92362656|NCT05028634|Immunologic Factors|immunologic factors|mesh-ancestor
92362657|NCT05028634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362659|NCT05028075|Trace Elements|trace elements|mesh-ancestor
92362660|NCT05028075|Micronutrients|micronutrients|mesh-ancestor
92362661|NCT05028075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362662|NCT05012631|Losartan|losartan|mesh-list
92362663|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92362664|NCT05012631|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92362665|NCT05012631|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92362666|NCT05012631|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92362667|NCT05012631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362668|NCT04989218|Cisplatin|cisplatin|mesh-list
92362669|NCT04989218|Gemcitabine|gemcitabine|mesh-list
92362670|NCT04989218|Durvalumab|durvalumab|mesh-list
92362671|NCT04989218|Tremelimumab|tremelimumab|mesh-list
92362672|NCT04989218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362673|NCT04989218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362674|NCT04989218|Antimetabolites|antimetabolites|mesh-ancestor
92362675|NCT04989218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362676|NCT04989218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362677|NCT04964544|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92362678|NCT04964544|Calcium|calcium|mesh-list
92362679|NCT04964544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91934406|NCT03896009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362680|NCT04964544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362682|NCT04964544|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92362683|NCT04964544|Antimetabolites|antimetabolites|mesh-ancestor
92362684|NCT04964544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362685|NCT04964544|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92362686|NCT04964544|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92362687|NCT04964544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362689|NCT04954196|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92362690|NCT04954196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92362691|NCT04954196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92362692|NCT04954196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362693|NCT04954196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92362694|NCT04954196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362695|NCT04954196|Vasodilator Agents|vasodilator agents|mesh-ancestor
92362696|NCT04944290|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92362697|NCT04944290|Brinzolamide|brinzolamide|mesh-list
92362698|NCT04944290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92362699|NCT04944290|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92362700|NCT04944290|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92362701|NCT04944290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92362702|NCT04944290|Adrenergic Agents|adrenergic agents|mesh-ancestor
92362703|NCT04944290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362704|NCT04944290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362705|NCT04944290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362706|NCT04944290|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92362707|NCT04944290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362708|NCT04937166|Azacitidine|azacitidine|mesh-list
92362709|NCT04937166|Venetoclax|venetoclax|mesh-list
92362710|NCT04937166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934535|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362711|NCT04937166|Antimetabolites|antimetabolites|mesh-ancestor
92362712|NCT04937166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362713|NCT04937166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362714|NCT04937166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362715|NCT04920032|Irinotecan|irinotecan|mesh-list
92362716|NCT04920032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92362717|NCT04920032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362718|NCT04920032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362719|NCT04920032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362720|NCT04920032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362721|NCT04908176|Midazolam|midazolam|mesh-list
92362722|NCT04908176|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92362723|NCT04908176|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92362724|NCT04908176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362725|NCT04908176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362726|NCT04908176|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92362727|NCT04908176|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92362728|NCT04908176|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92362729|NCT04908176|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92362730|NCT04908176|Anesthetics, General|anesthetics, general|mesh-ancestor
92362731|NCT04908176|Anesthetics|anesthetics|mesh-ancestor
92362732|NCT04908176|GABA Modulators|gaba modulators|mesh-ancestor
92362733|NCT04908176|GABA Agents|gaba agents|mesh-ancestor
92362734|NCT04908176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92362735|NCT04908176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362736|NCT04893109|Paclitaxel|paclitaxel|mesh-list
92362737|NCT04893109|Maytansine|maytansine|mesh-list
92362738|NCT04893109|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92362740|NCT04893109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92362741|NCT04893109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362743|NCT04893109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92362744|NCT04893109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92362745|NCT04893109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362746|NCT04893109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362748|NCT04893109|Immunoconjugates|immunoconjugates|mesh-ancestor
92362749|NCT04893109|Immunologic Factors|immunologic factors|mesh-ancestor
92362750|NCT04893109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362751|NCT04882540|Brivaracetam|brivaracetam|mesh-list
92362752|NCT04882540|Anticonvulsants|anticonvulsants|mesh-ancestor
92362753|NCT04859829|Immunoglobulins|immunoglobulins|mesh-list
92362754|NCT04859829|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92362755|NCT04859829|Antibodies|antibodies|mesh-list
92362756|NCT04859829|gamma-Globulins|gamma-globulins|mesh-list
92362757|NCT04859829|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92362758|NCT04859829|Immunologic Factors|immunologic factors|mesh-ancestor
92362759|NCT04859829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362760|NCT04851158|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92362761|NCT04851158|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92362762|NCT04851158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362763|NCT04851158|Antitubercular Agents|antitubercular agents|mesh-ancestor
92362764|NCT04821856|Cannabidiol|cannabidiol|mesh-list
92362765|NCT04821856|Anticonvulsants|anticonvulsants|mesh-ancestor
92362766|NCT04788043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92362767|NCT04788043|Pembrolizumab|pembrolizumab|mesh-list
92362768|NCT04788043|Magrolimab|magrolimab|mesh-list
92362769|NCT04788043|Antibodies|antibodies|mesh-list
92362770|NCT04788043|Immunoglobulins|immunoglobulins|mesh-list
92362771|NCT04788043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92362772|NCT04788043|Immunologic Factors|immunologic factors|mesh-ancestor
92362773|NCT04788043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362774|NCT04788043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362775|NCT04788043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92362776|NCT04788043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362777|NCT04778267|Dexamethasone|dexamethasone|mesh-list
92362778|NCT04778267|Bupivacaine|bupivacaine|mesh-list
92362779|NCT04778267|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92362780|NCT04778267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362781|NCT04778267|Antiemetics|antiemetics|mesh-ancestor
92362782|NCT04778267|Autonomic Agents|autonomic agents|mesh-ancestor
92362783|NCT04778267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362784|NCT04778267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362785|NCT04778267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92362786|NCT04778267|Glucocorticoids|glucocorticoids|mesh-ancestor
92362787|NCT04778267|Hormones|hormones|mesh-ancestor
92362788|NCT04778267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362789|NCT04778267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362790|NCT04778267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362791|NCT04778267|Anesthetics, Local|anesthetics, local|mesh-ancestor
92362792|NCT04778267|Anesthetics|anesthetics|mesh-ancestor
92015265|NCT01364649|Serotonin Agents|serotonin agents|mesh-ancestor
92362793|NCT04778267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362794|NCT04778267|Sensory System Agents|sensory system agents|mesh-ancestor
92362795|NCT04761627|Ustekinumab|ustekinumab|mesh-list
92362796|NCT04761627|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362798|NCT04760691|Emtricitabine|emtricitabine|mesh-list
92362799|NCT04760691|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92362800|NCT04760691|Leuprolide|leuprolide|mesh-list
92362801|NCT04760691|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92362802|NCT04760691|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92362803|NCT04760691|Estradiol|estradiol|mesh-list
92362804|NCT04760691|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92362805|NCT04760691|Estrogens|estrogens|mesh-list
92362806|NCT04760691|Antiviral Agents|antiviral agents|mesh-ancestor
92362807|NCT04760691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362808|NCT04760691|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92362809|NCT04760691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362810|NCT04760691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362811|NCT04760691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362812|NCT04760691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92362813|NCT04760691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92362814|NCT04760691|Hormones|hormones|mesh-ancestor
92362815|NCT04760691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362816|NCT04760691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362817|NCT04760691|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92362819|NCT04760691|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92362820|NCT04760691|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92362821|NCT04760691|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92362822|NCT04760691|Fertility Agents|fertility agents|mesh-ancestor
92362823|NCT04760691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362824|NCT04760691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362825|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
92362826|NCT04735471|Fludarabine|fludarabine|mesh-list
92362827|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934968|NCT02300623|Indinavir|indinavir|mesh-list
91934970|NCT02300623|Interleukin-2|interleukin-2|mesh-list
92362828|NCT04735471|Immunologic Factors|immunologic factors|mesh-ancestor
92362829|NCT04735471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362830|NCT04735471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362831|NCT04735471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92362832|NCT04735471|Alkylating Agents|alkylating agents|mesh-ancestor
92362833|NCT04735471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362834|NCT04735471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362835|NCT04735471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92362837|NCT04718181|Risdiplam|risdiplam|mesh-list
92362838|NCT04718181|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92362839|NCT04718181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92362840|NCT04718181|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92362841|NCT04718181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362842|NCT04718181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362843|NCT04718181|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92362844|NCT04718181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362845|NCT04718181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362846|NCT04713735|Lactoferrin|lactoferrin|mesh-list
92362847|NCT04713735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362849|NCT04682366|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92362850|NCT04682366|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92362851|NCT04682366|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92362852|NCT04682366|Adrenergic Agents|adrenergic agents|mesh-ancestor
92362853|NCT04682366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935081|NCT02308969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935082|NCT02308969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935083|NCT02308969|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91935085|NCT02309281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91935086|NCT02309281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91935087|NCT02309281|Growth Substances|growth substances|mesh-ancestor
91935088|NCT02309281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935090|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362854|NCT04682366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362855|NCT04682366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362856|NCT04682366|Urological Agents|urological agents|mesh-ancestor
92362857|NCT04656301|Psilocybin|psilocybin|mesh-list
92362858|NCT04656301|Hallucinogens|hallucinogens|mesh-ancestor
92362859|NCT04656301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362860|NCT04656301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92362861|NCT04573504|Clindamycin|clindamycin|mesh-list
91935139|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91935140|NCT02303587|Prednisolone|prednisolone|mesh-list
91935141|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
91935142|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91935143|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
91935144|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935146|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
91935147|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935148|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935150|NCT02303587|Glucocorticoids|glucocorticoids|mesh-ancestor
91935151|NCT02303587|Hormones|hormones|mesh-ancestor
91936827|NCT01480583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936828|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
91935152|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935153|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91935154|NCT02303587|Protective Agents|protective agents|mesh-ancestor
91935155|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935156|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935157|NCT03916419|Paclitaxel|paclitaxel|mesh-list
91935159|NCT03916419|Durvalumab|durvalumab|mesh-list
92362862|NCT04573504|Clindamycin palmitate|clindamycin palmitate|mesh-list
92362863|NCT04573504|Clindamycin phosphate|clindamycin phosphate|mesh-list
92362864|NCT04573504|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92362865|NCT04573504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92362866|NCT04573504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362867|NCT04573504|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92362868|NCT04573504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935189|NCT03509545|Diuretics|diuretics|mesh-ancestor
91935190|NCT03509545|Natriuretic Agents|natriuretic agents|mesh-ancestor
91935191|NCT03509545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935192|NCT03509545|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92362869|NCT04573504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362870|NCT04573504|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92362871|NCT04560972|Carboplatin|carboplatin|mesh-list
92362872|NCT04560972|Etoposide|etoposide|mesh-list
92362873|NCT04560972|Etoposide phosphate|etoposide phosphate|mesh-list
92362874|NCT04560972|Atezolizumab|atezolizumab|mesh-list
92362875|NCT04560972|Podophyllotoxin|podophyllotoxin|mesh-list
92362877|NCT04560972|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91935252|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935254|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92362878|NCT04560972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362879|NCT04560972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92362880|NCT04560972|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92362881|NCT04560972|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92362882|NCT04560972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362883|NCT04560972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362884|NCT04560972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91935322|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91935323|NCT02310295|Growth Substances|growth substances|mesh-ancestor
91935324|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935325|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
91935326|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935327|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
91935328|NCT02310295|Hormones|hormones|mesh-ancestor
91935329|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362885|NCT04560972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362886|NCT04560972|Immunologic Factors|immunologic factors|mesh-ancestor
92362887|NCT04560972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362888|NCT04560972|Keratolytic Agents|keratolytic agents|mesh-ancestor
92362889|NCT04560972|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362890|NCT04560972|Tubulin Modulators|tubulin modulators|mesh-ancestor
92362891|NCT04560972|Antimitotic Agents|antimitotic agents|mesh-ancestor
92362892|NCT04560972|Mitosis Modulators|mitosis modulators|mesh-ancestor
91935381|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
91935382|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935383|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935384|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
91935385|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935387|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
92362894|NCT04521335|Disulfiram|disulfiram|mesh-list
92362895|NCT04521335|Trace Elements|trace elements|mesh-ancestor
92362896|NCT04521335|Micronutrients|micronutrients|mesh-ancestor
92362897|NCT04521335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362898|NCT04521335|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92362899|NCT04521335|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92362900|NCT04521335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935444|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362901|NCT04521335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362902|NCT04515615|Oxaliplatin|oxaliplatin|mesh-list
92362903|NCT04515615|Tegafur|tegafur|mesh-list
92362904|NCT04515615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362905|NCT04515615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362906|NCT04515615|Antimetabolites|antimetabolites|mesh-ancestor
92362907|NCT04515615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362908|NCT04505410|Infliximab|infliximab|mesh-list
92362909|NCT04505410|Ustekinumab|ustekinumab|mesh-list
92362910|NCT04505410|Tofacitinib|tofacitinib|mesh-list
92362911|NCT04505410|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92362912|NCT04505410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92362913|NCT04505410|Dermatologic Agents|dermatologic agents|mesh-ancestor
92362914|NCT04505410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935582|NCT02326779|Analgesics|analgesics|mesh-ancestor
92362915|NCT04505410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362916|NCT04505410|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92362917|NCT04505410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92362918|NCT04505410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362919|NCT04505410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935718|NCT01959633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92362920|NCT04477304|Analgesics, Opioid|analgesics, opioid|mesh-list
92362921|NCT04477304|Narcotics|narcotics|mesh-ancestor
92362922|NCT04477304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92362923|NCT04477304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362924|NCT04477304|Analgesics|analgesics|mesh-ancestor
92362925|NCT04477304|Sensory System Agents|sensory system agents|mesh-ancestor
92362926|NCT04477304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92362927|NCT04280692|Lumefantrine|lumefantrine|mesh-list
92362929|NCT04280692|Pyrimethamine|pyrimethamine|mesh-list
92362930|NCT04280692|Primaquine|primaquine|mesh-list
92362931|NCT04280692|Piperaquine|piperaquine|mesh-list
92362932|NCT04280692|Sulfadoxine|sulfadoxine|mesh-list
92362933|NCT04280692|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92362934|NCT04280692|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92362935|NCT04280692|Antimalarials|antimalarials|mesh-ancestor
91935988|NCT02319499|Vitamin A|vitamin a|mesh-list
92362936|NCT04280692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92362937|NCT04280692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92362938|NCT04280692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92362939|NCT04280692|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92362940|NCT04280692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936023|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
92362941|NCT04280692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362942|NCT04280692|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92362943|NCT04247126|Paclitaxel|paclitaxel|mesh-list
92362944|NCT04247126|Gemcitabine|gemcitabine|mesh-list
92362945|NCT04247126|Fulvestrant|fulvestrant|mesh-list
92362946|NCT04247126|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92362947|NCT04247126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362948|NCT04247126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92362949|NCT04247126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92362950|NCT04247126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92362951|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362952|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362953|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
91936272|NCT03493087|Vitamin K|vitamin k|mesh-list
92362954|NCT04247126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92362955|NCT04247126|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92362956|NCT04247126|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92362957|NCT04247126|Hormone Antagonists|hormone antagonists|mesh-ancestor
92362958|NCT04247126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92362959|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362960|NCT04191889|Apatinib|apatinib|mesh-list
92362961|NCT04191889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362962|NCT04191889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936456|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
92362963|NCT04191889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362964|NCT04191889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362965|NCT04181996|Colchicine|colchicine|mesh-list
92362966|NCT04181996|Gout Suppressants|gout suppressants|mesh-ancestor
92362967|NCT04181996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362968|NCT04181996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92362969|NCT04181996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92362970|NCT04181996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92362971|NCT04181996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081581|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362972|NCT04181996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362974|NCT04179162|BCG Vaccine|bcg vaccine|mesh-list
92362975|NCT04179162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92362976|NCT04179162|Antimetabolites|antimetabolites|mesh-ancestor
92362977|NCT04179162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362978|NCT04179162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362979|NCT04179162|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92362980|NCT04179162|Immunologic Factors|immunologic factors|mesh-ancestor
92362981|NCT04179162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362983|NCT04163432|Pemetrexed|pemetrexed|mesh-list
92362984|NCT04163432|Durvalumab|durvalumab|mesh-list
92362985|NCT04163432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92362986|NCT04163432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92362987|NCT04163432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92362988|NCT04163432|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92362989|NCT04163432|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92362990|NCT04163432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92362991|NCT04151706|Cyclophosphamide|cyclophosphamide|mesh-list
92362993|NCT04151706|Thiotepa|thiotepa|mesh-list
92362994|NCT04151706|Fludarabine|fludarabine|mesh-list
92362995|NCT04151706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92362996|NCT04151706|Immunologic Factors|immunologic factors|mesh-ancestor
92362997|NCT04151706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92362998|NCT04151706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92362999|NCT04151706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92363000|NCT04151706|Alkylating Agents|alkylating agents|mesh-ancestor
92363001|NCT04151706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363002|NCT04151706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363003|NCT04151706|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92363004|NCT04151667|Dexamethasone|dexamethasone|mesh-list
92363005|NCT04151667|Lenalidomide|lenalidomide|mesh-list
92363006|NCT04151667|Bortezomib|bortezomib|mesh-list
92363007|NCT04151667|Daratumumab|daratumumab|mesh-list
92363008|NCT04151667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363009|NCT04151667|Antiemetics|antiemetics|mesh-ancestor
92363010|NCT04151667|Autonomic Agents|autonomic agents|mesh-ancestor
92363011|NCT04151667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363012|NCT04151667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363013|NCT04151667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92363014|NCT04151667|Glucocorticoids|glucocorticoids|mesh-ancestor
92363015|NCT04151667|Hormones|hormones|mesh-ancestor
92363016|NCT04151667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363017|NCT04151667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363018|NCT04151667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363019|NCT04151667|Immunologic Factors|immunologic factors|mesh-ancestor
92363020|NCT04151667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92363021|NCT04151667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92363022|NCT04151667|Growth Substances|growth substances|mesh-ancestor
92363023|NCT04151667|Growth Inhibitors|growth inhibitors|mesh-ancestor
92363024|NCT04119453|Apatinib|apatinib|mesh-list
92363025|NCT04119453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363026|NCT04119453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92363027|NCT04119453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363028|NCT04119453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363029|NCT04099251|Nivolumab|nivolumab|mesh-list
91937179|NCT01234025|Hormones|hormones|mesh-ancestor
92363030|NCT04099251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363031|NCT04099251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119050|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
92363032|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363033|NCT04099251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363034|NCT04068610|Leucovorin|leucovorin|mesh-list
92363035|NCT04068610|Durvalumab|durvalumab|mesh-list
92363036|NCT04068610|Fluorouracil|fluorouracil|mesh-list
92363037|NCT04068610|Oxaliplatin|oxaliplatin|mesh-list
92363038|NCT04068610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363039|NCT04068610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363040|NCT04068610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363041|NCT04068610|Antimetabolites|antimetabolites|mesh-ancestor
92363042|NCT04068610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937430|NCT05401916|Acetaminophen|acetaminophen|mesh-list
92363043|NCT04068610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363044|NCT04068610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363045|NCT04068610|Immunologic Factors|immunologic factors|mesh-ancestor
92363047|NCT04068610|Protective Agents|protective agents|mesh-ancestor
92363048|NCT04068610|Vitamin B Complex|vitamin b complex|mesh-ancestor
92363049|NCT04068610|Vitamins|vitamins|mesh-ancestor
92363050|NCT04068610|Micronutrients|micronutrients|mesh-ancestor
92363051|NCT04006119|Cemiplimab|cemiplimab|mesh-list
92363052|NCT04006119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363053|NCT04006119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363054|NCT04004793|Dapagliflozin|dapagliflozin|mesh-list
92363055|NCT04004793|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92363056|NCT04004793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363057|NCT04004793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92363058|NCT04004793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363059|NCT04002011|Warfarin|warfarin|mesh-list
92363060|NCT04002011|Rivaroxaban|rivaroxaban|mesh-list
92363061|NCT04002011|Dabigatran|dabigatran|mesh-list
92363062|NCT04002011|Apixaban|apixaban|mesh-list
92363063|NCT04002011|Edoxaban|edoxaban|mesh-list
92363064|NCT04002011|Anticoagulants|anticoagulants|mesh-ancestor
92363065|NCT04002011|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92363066|NCT04002011|Antithrombins|antithrombins|mesh-ancestor
92363067|NCT04002011|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92363068|NCT04002011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363069|NCT04002011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363070|NCT04002011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363071|NCT03903692|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92363072|NCT03903692|Laxatives|laxatives|mesh-ancestor
92363073|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92363074|NCT03884998|Nivolumab|nivolumab|mesh-list
91937931|NCT02287402|Voglibose|voglibose|mesh-list
92363075|NCT03884998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363076|NCT03884998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363077|NCT03884998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91937984|NCT05303792|Hormones|hormones|mesh-ancestor
92363078|NCT03884998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363079|NCT03831711|Gastrin-Releasing Peptide|gastrin-releasing peptide|mesh-list
92363081|NCT03831711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363082|NCT03831711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92363083|NCT03831711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363084|NCT03831711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92363085|NCT03789591|Hydroxyurea|hydroxyurea|mesh-list
92363086|NCT03789591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363087|NCT03789591|Antisickling Agents|antisickling agents|mesh-ancestor
92363088|NCT03789591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363089|NCT03789591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363090|NCT03789591|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363091|NCT03783026|Apremilast|apremilast|mesh-list
92363092|NCT03783026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92363093|NCT03783026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92363095|NCT03783026|Sensory System Agents|sensory system agents|mesh-ancestor
92363096|NCT03783026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363097|NCT03783026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363098|NCT03783026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363099|NCT03783026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363100|NCT03783026|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92363101|NCT03783026|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92363102|NCT03783026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363103|NCT03783026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363104|NCT03775460|Prednisolone|prednisolone|mesh-list
92363105|NCT03775460|Methotrexate|methotrexate|mesh-list
92363106|NCT03775460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91938428|NCT05311436|Iron|iron|mesh-list
92363107|NCT03775460|Abortifacient Agents|abortifacient agents|mesh-ancestor
92363108|NCT03775460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363109|NCT03775460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363110|NCT03775460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363111|NCT03775460|Antimetabolites|antimetabolites|mesh-ancestor
91938487|NCT04167033|Hormones|hormones|mesh-list
92363112|NCT03775460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363113|NCT03775460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363114|NCT03775460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92363115|NCT03775460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363116|NCT03775460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92363117|NCT03775460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363118|NCT03775460|Immunologic Factors|immunologic factors|mesh-ancestor
92363120|NCT03775460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363121|NCT03775460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363122|NCT03775460|Glucocorticoids|glucocorticoids|mesh-ancestor
92363123|NCT03775460|Hormones|hormones|mesh-ancestor
92363124|NCT03775460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363125|NCT03775460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363126|NCT03591731|Nivolumab|nivolumab|mesh-list
92363127|NCT03591731|Ipilimumab|ipilimumab|mesh-list
92363128|NCT03591731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363129|NCT03591731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363130|NCT03591731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363131|NCT03591731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938814|NCT05084079|Insulin|insulin|mesh-list
92363132|NCT03538691|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92363133|NCT03538691|Dexetimide|dexetimide|mesh-list
92363134|NCT03538691|Citalopram|citalopram|mesh-list
92363135|NCT03538691|Fluoxetine|fluoxetine|mesh-list
92363136|NCT03538691|Paroxetine|paroxetine|mesh-list
92363137|NCT03538691|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92363138|NCT03538691|Sertraline|sertraline|mesh-list
92363139|NCT03538691|Escitalopram|escitalopram|mesh-list
92363140|NCT03538691|Brexpiprazole|brexpiprazole|mesh-list
92363141|NCT03538691|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92363142|NCT03538691|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91938958|NCT05209490|Iodine|iodine|mesh-list
92363143|NCT03538691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92363144|NCT03538691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939049|NCT04461379|Vaccines|vaccines|mesh-list
92363145|NCT03538691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92363147|NCT03538691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363148|NCT03538691|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92363149|NCT03538691|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92363150|NCT03538691|Parasympatholytics|parasympatholytics|mesh-ancestor
92363151|NCT03538691|Autonomic Agents|autonomic agents|mesh-ancestor
92363152|NCT03538691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363153|NCT03538691|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92363154|NCT03538691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92363155|NCT03538691|Cholinergic Agents|cholinergic agents|mesh-ancestor
92363156|NCT03538691|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91939123|NCT00850577|Bevacizumab|bevacizumab|mesh-list
92363157|NCT03538691|Antidepressive Agents|antidepressive agents|mesh-ancestor
92363158|NCT03538691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92363159|NCT03538691|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92363160|NCT03538691|Analgesics|analgesics|mesh-ancestor
92363161|NCT03538691|Sensory System Agents|sensory system agents|mesh-ancestor
92363162|NCT03538691|Dopamine Agents|dopamine agents|mesh-ancestor
92363163|NCT03538691|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92363164|NCT03538691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363165|NCT03538691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363166|NCT03538691|Dopamine Agonists|dopamine agonists|mesh-ancestor
92363167|NCT03489018|Vaccines|vaccines|mesh-list
92363168|NCT03489018|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92363169|NCT03489018|Immunologic Factors|immunologic factors|mesh-ancestor
92363170|NCT03489018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363171|NCT03469960|Nivolumab|nivolumab|mesh-list
92363172|NCT03469960|Ipilimumab|ipilimumab|mesh-list
92363173|NCT03469960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363174|NCT03469960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363175|NCT03469960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363176|NCT03469960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363178|NCT03439033|N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid|n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid|mesh-list
92363179|NCT03439033|Chelating Agents|chelating agents|mesh-ancestor
92363180|NCT03439033|Sequestering Agents|sequestering agents|mesh-ancestor
92363181|NCT03439033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363182|NCT03439033|Anticoagulants|anticoagulants|mesh-ancestor
92363183|NCT03439033|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92363184|NCT03330886|Atezolizumab|atezolizumab|mesh-list
92363185|NCT03330886|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363186|NCT03330886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363187|NCT03330886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363188|NCT03330886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363189|NCT03282799|Etonogestrel|etonogestrel|mesh-list
92363190|NCT03282799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92363192|NCT03282799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363193|NCT03282799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363194|NCT03282799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92363195|NCT03125928|Paclitaxel|paclitaxel|mesh-list
92363196|NCT03125928|Trastuzumab|trastuzumab|mesh-list
92363197|NCT03125928|Atezolizumab|atezolizumab|mesh-list
92363198|NCT03125928|Pertuzumab|pertuzumab|mesh-list
92363199|NCT03125928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363200|NCT03125928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363201|NCT03125928|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363202|NCT03125928|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363203|NCT03125928|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363204|NCT03125928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363205|NCT03125928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363206|NCT03125928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363207|NCT02987543|Olaparib|olaparib|mesh-list
91939309|NCT05200052|Colchicine|colchicine|mesh-list
92363208|NCT02987543|Abiraterone Acetate|abiraterone acetate|mesh-list
92363209|NCT02987543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92363210|NCT02987543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363211|NCT02987543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363212|NCT02987543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363213|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92363214|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
92363215|NCT02987543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363216|NCT02987543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363217|NCT02987543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363218|NCT02983045|Paclitaxel|paclitaxel|mesh-list
92363219|NCT02983045|Cisplatin|cisplatin|mesh-list
92363220|NCT02983045|Carboplatin|carboplatin|mesh-list
92363221|NCT02983045|Nivolumab|nivolumab|mesh-list
92363222|NCT02983045|Pemetrexed|pemetrexed|mesh-list
92363223|NCT02983045|Ipilimumab|ipilimumab|mesh-list
91939374|NCT00924833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363224|NCT02983045|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363225|NCT02983045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363226|NCT02983045|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363227|NCT02983045|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363228|NCT02983045|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363229|NCT02983045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363230|NCT02983045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363231|NCT02983045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363232|NCT02983045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363233|NCT02983045|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92363234|NCT02983045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363235|NCT02894398|Letrozole|letrozole|mesh-list
92363236|NCT02894398|Fulvestrant|fulvestrant|mesh-list
92363237|NCT02894398|Palbociclib|palbociclib|mesh-list
92363238|NCT02894398|Anastrozole|anastrozole|mesh-list
92363239|NCT02894398|Exemestane|exemestane|mesh-list
92363240|NCT02894398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363241|NCT02894398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92363242|NCT02894398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92363243|NCT02894398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363244|NCT02894398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363245|NCT02894398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92363246|NCT02894398|Hormone Antagonists|hormone antagonists|mesh-ancestor
92015717|NCT04426097|Trace Elements|trace elements|mesh-ancestor
92363247|NCT02894398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363248|NCT02894398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363249|NCT02894398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363250|NCT02894398|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92363251|NCT02894398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92363253|NCT02678052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92363255|NCT02576717|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92363256|NCT02576717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363257|NCT02576717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363258|NCT02576717|Immunologic Factors|immunologic factors|mesh-ancestor
92363259|NCT02576717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363260|NCT02564263|Paclitaxel|paclitaxel|mesh-list
92363261|NCT02564263|Docetaxel|docetaxel|mesh-list
92363262|NCT02564263|Pembrolizumab|pembrolizumab|mesh-list
92363263|NCT02564263|Irinotecan|irinotecan|mesh-list
92363264|NCT02564263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939752|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
92363265|NCT02564263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363266|NCT02564263|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363267|NCT02564263|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363268|NCT02564263|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363269|NCT02564263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363270|NCT02564263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363271|NCT02564263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363272|NCT02564263|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92363273|NCT02564263|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92363274|NCT02564263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363275|NCT02540018|Paclitaxel|paclitaxel|mesh-list
92363276|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363277|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363278|NCT02540018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363279|NCT02540018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363280|NCT02540018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363281|NCT02540018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363282|NCT02423265|Ranolazine|ranolazine|mesh-list
92363283|NCT02423265|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92363284|NCT02423265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92363285|NCT02423265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363286|NCT02368886|Clobetasol|clobetasol|mesh-list
92363287|NCT02368886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363288|NCT02368886|Glucocorticoids|glucocorticoids|mesh-ancestor
92363289|NCT02368886|Hormones|hormones|mesh-ancestor
92363290|NCT02368886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363291|NCT02368886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363292|NCT02301286|Aspirin|aspirin|mesh-list
92363293|NCT02301286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92363294|NCT02301286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92363295|NCT02301286|Analgesics|analgesics|mesh-ancestor
92363296|NCT02301286|Sensory System Agents|sensory system agents|mesh-ancestor
92363297|NCT02301286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363298|NCT02301286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363299|NCT02301286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363300|NCT02301286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363301|NCT02301286|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92363302|NCT02301286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92363303|NCT02301286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363304|NCT02301286|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92363305|NCT02301286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92363306|NCT02301286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363307|NCT02301286|Antipyretics|antipyretics|mesh-ancestor
92363308|NCT02126969|Carboplatin|carboplatin|mesh-list
92363309|NCT02126969|Docetaxel|docetaxel|mesh-list
92363310|NCT02126969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363311|NCT02126969|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363312|NCT02126969|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363313|NCT02126969|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363314|NCT02126969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363315|NCT02099188|Leucovorin|leucovorin|mesh-list
92363316|NCT02099188|Docetaxel|docetaxel|mesh-list
92363317|NCT02099188|Doxorubicin|doxorubicin|mesh-list
92363318|NCT02099188|Fluorouracil|fluorouracil|mesh-list
92363319|NCT02099188|Etoposide|etoposide|mesh-list
92363320|NCT02099188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92363321|NCT02099188|Ifosfamide|ifosfamide|mesh-list
92363322|NCT02099188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363323|NCT02099188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363324|NCT02099188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363325|NCT02099188|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363326|NCT02099188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363327|NCT02099188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92363328|NCT02099188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92363329|NCT02099188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92363330|NCT02099188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363331|NCT02099188|Antimetabolites|antimetabolites|mesh-ancestor
92363332|NCT02099188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363333|NCT02099188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363334|NCT02099188|Immunologic Factors|immunologic factors|mesh-ancestor
92363335|NCT02099188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940199|NCT03752723|Pembrolizumab|pembrolizumab|mesh-list
92363336|NCT02099188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363337|NCT02099188|Antidotes|antidotes|mesh-ancestor
92363338|NCT02099188|Protective Agents|protective agents|mesh-ancestor
92363339|NCT02099188|Vitamin B Complex|vitamin b complex|mesh-ancestor
92363340|NCT02099188|Vitamins|vitamins|mesh-ancestor
92363341|NCT02099188|Micronutrients|micronutrients|mesh-ancestor
91940271|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363342|NCT02099188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91940376|NCT03495739|Dabigatran|dabigatran|mesh-list
92363343|NCT02099188|Alkylating Agents|alkylating agents|mesh-ancestor
92363344|NCT02099175|Leucovorin|leucovorin|mesh-list
92363345|NCT02099175|Docetaxel|docetaxel|mesh-list
92363346|NCT02099175|Doxorubicin|doxorubicin|mesh-list
92363347|NCT02099175|Fluorouracil|fluorouracil|mesh-list
92363348|NCT02099175|Etoposide|etoposide|mesh-list
92363349|NCT02099175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92363350|NCT02099175|Ifosfamide|ifosfamide|mesh-list
92363351|NCT02099175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363352|NCT02099175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363353|NCT02099175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363354|NCT02099175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363355|NCT02099175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363356|NCT02099175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91940636|NCT02273609|Vitamin K|vitamin k|mesh-list
92363357|NCT02099175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92363358|NCT02099175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92363359|NCT02099175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363360|NCT02099175|Antimetabolites|antimetabolites|mesh-ancestor
91940712|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
92363361|NCT02099175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363362|NCT02099175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363363|NCT02099175|Immunologic Factors|immunologic factors|mesh-ancestor
92363364|NCT02099175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363365|NCT02099175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363367|NCT02099175|Protective Agents|protective agents|mesh-ancestor
92363368|NCT02099175|Vitamin B Complex|vitamin b complex|mesh-ancestor
92363369|NCT02099175|Vitamins|vitamins|mesh-ancestor
91941007|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
92363370|NCT02099175|Micronutrients|micronutrients|mesh-ancestor
92363371|NCT02099175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91941089|NCT02356588|Anesthetics|anesthetics|mesh-ancestor
91945335|NCT03529097|Dipyrone|dipyrone|mesh-list
92363372|NCT02099175|Alkylating Agents|alkylating agents|mesh-ancestor
92363373|NCT01946074|Paclitaxel|paclitaxel|mesh-list
91941241|NCT04459663|Axitinib|axitinib|mesh-list
92363374|NCT01946074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363375|NCT01946074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363376|NCT01946074|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363377|NCT01946074|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363378|NCT01946074|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363379|NCT01946074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363380|NCT01715285|Prednisone|prednisone|mesh-list
92363381|NCT01715285|Abiraterone Acetate|abiraterone acetate|mesh-list
92363382|NCT01715285|Androgens|androgens|mesh-list
92363383|NCT01715285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363384|NCT01715285|Glucocorticoids|glucocorticoids|mesh-ancestor
92363385|NCT01715285|Hormones|hormones|mesh-ancestor
92363386|NCT01715285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363387|NCT01715285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363388|NCT01715285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363389|NCT01715285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363390|NCT01715285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92363391|NCT01715285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363392|NCT01715285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363393|NCT01715285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92363394|NCT01715285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363395|NCT01705184|Bevacizumab|bevacizumab|mesh-list
92363396|NCT01705184|Pemetrexed|pemetrexed|mesh-list
91941858|NCT05838391|Antimetabolites|antimetabolites|mesh-ancestor
92363397|NCT01705184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363398|NCT01705184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363399|NCT01705184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92363400|NCT01705184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92363401|NCT01705184|Growth Substances|growth substances|mesh-ancestor
92363402|NCT01705184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363403|NCT01705184|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942169|NCT05537220|Antiviral Agents|antiviral agents|mesh-ancestor
91942238|NCT05374291|Dapagliflozin|dapagliflozin|mesh-list
92363404|NCT01705184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363405|NCT01705184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363406|NCT01705184|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92363407|NCT01705184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363409|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
92363410|NCT01285817|Methotrexate|methotrexate|mesh-list
92363411|NCT01285817|Vinblastine|vinblastine|mesh-list
92363412|NCT01285817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363414|NCT01285817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363415|NCT01285817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363416|NCT01285817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92363417|NCT01285817|Alkylating Agents|alkylating agents|mesh-ancestor
92363418|NCT01285817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363419|NCT01285817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363420|NCT01285817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91942493|NCT05024773|Paclitaxel|paclitaxel|mesh-list
91942545|NCT04962022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92363421|NCT01285817|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92363422|NCT01285817|Abortifacient Agents|abortifacient agents|mesh-ancestor
92363423|NCT01285817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363424|NCT01285817|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363425|NCT01285817|Antimetabolites|antimetabolites|mesh-ancestor
92363426|NCT01285817|Dermatologic Agents|dermatologic agents|mesh-ancestor
92363427|NCT01285817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944206|NCT00343109|Vaccines|vaccines|mesh-list
92363429|NCT01285817|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363430|NCT01285817|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92363431|NCT01285817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92363432|NCT01285817|Analgesics|analgesics|mesh-ancestor
92363433|NCT01285817|Sensory System Agents|sensory system agents|mesh-ancestor
92363434|NCT01285817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363435|NCT01285817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942849|NCT04278898|Acetylcysteine|acetylcysteine|mesh-list
92363437|NCT01285817|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92363438|NCT01285817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363439|NCT01285817|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363440|NCT01285817|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363441|NCT01285817|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363442|NCT01285479|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92363443|NCT01285479|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92363444|NCT01285479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363445|NCT01285479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363446|NCT01285479|Immunologic Factors|immunologic factors|mesh-ancestor
92363447|NCT01285479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363448|NCT01250496|Aminophylline|aminophylline|mesh-list
92363449|NCT01250496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92363450|NCT01250496|Autonomic Agents|autonomic agents|mesh-ancestor
92363451|NCT01250496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943158|NCT03533283|Immunoconjugates|immunoconjugates|mesh-ancestor
92363452|NCT01250496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363453|NCT01250496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91943232|NCT03027388|LB100|lb100|mesh-list
92363454|NCT01250496|Respiratory System Agents|respiratory system agents|mesh-ancestor
92363456|NCT01250496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92363457|NCT01250496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943326|NCT02358850|Hydromorphone|hydromorphone|mesh-list
92363458|NCT01250496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363459|NCT01250496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92363460|NCT01250496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92363461|NCT01250496|Purinergic Agents|purinergic agents|mesh-ancestor
92363462|NCT01250496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943549|NCT02256982|Gemcitabine|gemcitabine|mesh-list
92363463|NCT01250496|Protective Agents|protective agents|mesh-ancestor
92363464|NCT01105975|Atorvastatin|atorvastatin|mesh-list
92363465|NCT01105975|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92363466|NCT01105975|Simvastatin|simvastatin|mesh-list
92363467|NCT01105975|Evacetrapib|evacetrapib|mesh-list
91943628|NCT00563459|Topiramate|topiramate|mesh-list
92363468|NCT01105975|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92363469|NCT01105975|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92363470|NCT01105975|Antimetabolites|antimetabolites|mesh-ancestor
92363471|NCT01105975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363472|NCT01105975|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92363473|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92363474|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363476|NCT00651456|Cisplatin|cisplatin|mesh-list
92363477|NCT00651456|Pemetrexed|pemetrexed|mesh-list
92363478|NCT00651456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363479|NCT00651456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363480|NCT00651456|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92363481|NCT00651456|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92363482|NCT00651456|Growth Substances|growth substances|mesh-ancestor
92363483|NCT00651456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363484|NCT00651456|Growth Inhibitors|growth inhibitors|mesh-ancestor
92363485|NCT00651456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363486|NCT00651456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363487|NCT00651456|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92363488|NCT00651456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363489|NCT00280202|Dimercaprol|dimercaprol|mesh-list
92363490|NCT00280202|Chelating Agents|chelating agents|mesh-ancestor
92363491|NCT00280202|Sequestering Agents|sequestering agents|mesh-ancestor
92363492|NCT00280202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363493|NCT00079417|Iodine|iodine|mesh-list
92363494|NCT00079417|Cadexomer iodine|cadexomer iodine|mesh-list
92363495|NCT00079417|Carboplatin|carboplatin|mesh-list
92363496|NCT00079417|Vincristine|vincristine|mesh-list
92363497|NCT00079417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363498|NCT00079417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363499|NCT00079417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363500|NCT00079417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363501|NCT00079417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363502|NCT00079417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363503|NCT00079417|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92363504|NCT00079417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363505|NCT00079417|Trace Elements|trace elements|mesh-ancestor
92363506|NCT00079417|Micronutrients|micronutrients|mesh-ancestor
92363507|NCT00079417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363508|NCT04387500|Axitinib|axitinib|mesh-list
92363509|NCT04387500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363510|NCT04387500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92363511|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363512|NCT04387500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363513|NCT04386876|Ritonavir|ritonavir|mesh-list
92363514|NCT04386876|Lopinavir|lopinavir|mesh-list
92363515|NCT04386876|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92363516|NCT04386876|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92363517|NCT04386876|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363518|NCT04386876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363519|NCT04386876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363520|NCT04386876|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92363521|NCT04386876|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92363522|NCT04386876|Antiviral Agents|antiviral agents|mesh-ancestor
91944390|NCT02285699|Citalopram|citalopram|mesh-list
92363523|NCT04386876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363524|NCT04386876|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92363525|NCT04386876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363526|NCT04386642|Tranexamic Acid|tranexamic acid|mesh-list
92363527|NCT04386642|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92363528|NCT04386642|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92363529|NCT04386642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363530|NCT04386642|Hemostatics|hemostatics|mesh-ancestor
92363531|NCT04386642|Coagulants|coagulants|mesh-ancestor
92363532|NCT04385550|Paclitaxel|paclitaxel|mesh-list
92363533|NCT04385550|Docetaxel|docetaxel|mesh-list
92363534|NCT04385550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363535|NCT04385550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363536|NCT04385550|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363537|NCT04385550|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363538|NCT04385550|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363539|NCT04385550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363540|NCT04384380|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363541|NCT04384380|Antimalarials|antimalarials|mesh-ancestor
92363542|NCT04384380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363543|NCT04384380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363544|NCT04384380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363545|NCT04384380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363546|NCT04384380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363547|NCT04384380|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363548|NCT04384458|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363549|NCT04384458|Ivermectin|ivermectin|mesh-list
92363550|NCT04384458|Antimalarials|antimalarials|mesh-ancestor
92363551|NCT04384458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363552|NCT04384458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363553|NCT04384458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363554|NCT04384458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363555|NCT04384458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363556|NCT04384458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363558|NCT04383990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92363559|NCT04383990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363561|NCT04381884|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363562|NCT04381884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363563|NCT04381962|Azithromycin|azithromycin|mesh-list
92363564|NCT04381962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363565|NCT04381962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363566|NCT04381104|Acetaminophen|acetaminophen|mesh-list
92363567|NCT04381104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92363568|NCT04381104|Analgesics|analgesics|mesh-ancestor
92363569|NCT04381104|Sensory System Agents|sensory system agents|mesh-ancestor
92363570|NCT04381104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363571|NCT04381104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363572|NCT04381104|Antipyretics|antipyretics|mesh-ancestor
92363573|NCT04380402|Atorvastatin|atorvastatin|mesh-list
92363574|NCT04380402|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92363575|NCT04380402|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92363576|NCT04380402|Antimetabolites|antimetabolites|mesh-ancestor
92363577|NCT04380402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363578|NCT04380402|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91948559|NCT04234477|Diltiazem|diltiazem|mesh-list
92363579|NCT04380402|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92363580|NCT04380402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363581|NCT04380012|Trastuzumab|trastuzumab|mesh-list
92363582|NCT04380012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363583|NCT04380012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363584|NCT04379310|Calcium Channel Blockers|calcium channel blockers|mesh-list
92363585|NCT04379310|Calcium|calcium|mesh-list
92363586|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92363587|NCT04379310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92363588|NCT04379310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363590|NCT04379310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363591|NCT04379310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363592|NCT04379310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92363593|NCT04378608|Ribavirin|ribavirin|mesh-list
92363595|NCT04378608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363596|NCT04378608|Antiviral Agents|antiviral agents|mesh-ancestor
92363597|NCT04378608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363598|NCT04376970|Fluorometholone|fluorometholone|mesh-list
92363599|NCT04376970|Cyclosporine|cyclosporine|mesh-list
92363600|NCT04376970|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92363601|NCT04376970|Cyclosporins|cyclosporins|mesh-list
92363602|NCT04376970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363603|NCT04376970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949576|NCT02322203|Niacin|niacin|mesh-list
92363604|NCT04376970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363605|NCT04376970|Immunologic Factors|immunologic factors|mesh-ancestor
92363606|NCT04376970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363608|NCT04376970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944521|NCT02508428|Diuretics|diuretics|mesh-ancestor
92363610|NCT04376970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363611|NCT04376970|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92363612|NCT04376970|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92363613|NCT04376970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363614|NCT04376970|Glucocorticoids|glucocorticoids|mesh-ancestor
92363615|NCT04376970|Hormones|hormones|mesh-ancestor
91944530|NCT02448446|Growth Substances|growth substances|mesh-ancestor
92363616|NCT04376970|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363617|NCT04376970|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92363618|NCT04377048|Gemcitabine|gemcitabine|mesh-list
92363619|NCT04377048|Tegafur|tegafur|mesh-list
92363620|NCT04377048|Nivolumab|nivolumab|mesh-list
92016097|NCT05547659|Antipyretics|antipyretics|mesh-ancestor
92363621|NCT04377048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363622|NCT04377048|Antimetabolites|antimetabolites|mesh-ancestor
91944535|NCT02478398|Loratadine|loratadine|mesh-list
92363623|NCT04377048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363624|NCT04377048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363625|NCT04377048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363626|NCT04377048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363627|NCT04376814|Ritonavir|ritonavir|mesh-list
92363628|NCT04376814|Lopinavir|lopinavir|mesh-list
92363629|NCT04376814|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363630|NCT04376814|Favipiravir|favipiravir|mesh-list
92363631|NCT04376814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92363632|NCT04376814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92363634|NCT04376814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950666|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
92363635|NCT04376814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363636|NCT04376814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92363637|NCT04376814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92363638|NCT04376814|Antiviral Agents|antiviral agents|mesh-ancestor
92363639|NCT04376814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363640|NCT04376814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92363641|NCT04376814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363642|NCT04376814|Antimalarials|antimalarials|mesh-ancestor
92363643|NCT04376814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363644|NCT04376814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363645|NCT04376814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363646|NCT04374942|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363647|NCT04374942|Antimalarials|antimalarials|mesh-ancestor
92363648|NCT04374942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363649|NCT04374942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363650|NCT04374942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363651|NCT04374942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363652|NCT04374942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363653|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363654|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
92363655|NCT04374318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92363656|NCT04374318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92363657|NCT04374318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363658|NCT04374318|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92363659|NCT04374318|Analgesics|analgesics|mesh-ancestor
92363660|NCT04374318|Sensory System Agents|sensory system agents|mesh-ancestor
92363661|NCT04374318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363662|NCT04374318|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92363663|NCT04374318|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92363664|NCT04374318|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92363665|NCT04374318|Adrenergic Agents|adrenergic agents|mesh-ancestor
92363666|NCT04374318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92363667|NCT04374318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363668|NCT04374552|Azithromycin|azithromycin|mesh-list
92363669|NCT04374552|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363670|NCT04374552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363671|NCT04374552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363672|NCT04374552|Antimalarials|antimalarials|mesh-ancestor
92363673|NCT04374552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363674|NCT04374552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363675|NCT04374552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363676|NCT04374552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363677|NCT04374552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363678|NCT04374006|Propolis|propolis|mesh-list
92363679|NCT04374006|Dienogest|dienogest|mesh-list
92363680|NCT04374006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944589|NCT05259007|Propolis|propolis|mesh-list
92363681|NCT04374006|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92363682|NCT04374006|Contraceptive Agents|contraceptive agents|mesh-ancestor
92363683|NCT04374006|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363684|NCT04374006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363685|NCT04374006|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92363686|NCT04374006|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92363687|NCT04374006|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92363688|NCT04374006|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92363689|NCT04374006|Hormone Antagonists|hormone antagonists|mesh-ancestor
92363690|NCT04374006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951856|NCT02164864|Aspirin|aspirin|mesh-list
92363691|NCT04374006|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363692|NCT04374006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363693|NCT04372836|Vasopressins|vasopressins|mesh-list
92363694|NCT04372836|Arginine Vasopressin|arginine vasopressin|mesh-list
92363695|NCT04372836|Hemostatics|hemostatics|mesh-ancestor
92363696|NCT04372836|Coagulants|coagulants|mesh-ancestor
92363697|NCT04372836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92363698|NCT04372836|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92363699|NCT04372836|Natriuretic Agents|natriuretic agents|mesh-ancestor
92363700|NCT04372836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363701|NCT04371978|Linagliptin|linagliptin|mesh-list
92363702|NCT04371978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92363703|NCT04371978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363704|NCT04371978|Incretins|incretins|mesh-ancestor
92363705|NCT04371978|Hormones|hormones|mesh-ancestor
91952064|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92363706|NCT04371978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363707|NCT04371978|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92363708|NCT04371978|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363709|NCT04371978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363710|NCT04371978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363711|NCT04371822|Protoporphyrin IX|protoporphyrin ix|mesh-list
92363712|NCT04371822|Tin protoporphyrin IX|tin protoporphyrin ix|mesh-list
92363713|NCT04371822|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92363714|NCT04371822|Dermatologic Agents|dermatologic agents|mesh-ancestor
92363715|NCT04371822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363716|NCT04371822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363717|NCT04370262|Famotidine|famotidine|mesh-list
92363718|NCT04370262|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92363719|NCT04370262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92363720|NCT04370262|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92363721|NCT04370262|Histamine Antagonists|histamine antagonists|mesh-ancestor
92363722|NCT04370262|Histamine Agents|histamine agents|mesh-ancestor
92363723|NCT04370262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92363724|NCT04370262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363725|NCT04370262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363726|NCT04368546|Sunitinib|sunitinib|mesh-list
92363727|NCT04368546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363728|NCT04368546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92363729|NCT04368546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92363730|NCT04368546|Growth Substances|growth substances|mesh-ancestor
92363731|NCT04368546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363732|NCT04368546|Growth Inhibitors|growth inhibitors|mesh-ancestor
92363733|NCT04368546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92363734|NCT04368546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363735|NCT04368546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363736|NCT04366596|Paclitaxel|paclitaxel|mesh-list
92363737|NCT04366596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92363738|NCT04366596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363739|NCT04366596|Tubulin Modulators|tubulin modulators|mesh-ancestor
92363740|NCT04366596|Antimitotic Agents|antimitotic agents|mesh-ancestor
92363741|NCT04366596|Mitosis Modulators|mitosis modulators|mesh-ancestor
91952662|NCT05099601|Silymarin|silymarin|mesh-list
92363742|NCT04366596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363743|NCT04366128|Immunomodulating Agents|immunomodulating agents|mesh-list
92363744|NCT04366128|Immunologic Factors|immunologic factors|mesh-ancestor
92363745|NCT04366128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363746|NCT04366050|Ramipril|ramipril|mesh-list
92363747|NCT04366050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92363748|NCT04366050|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363749|NCT04366050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363750|NCT04366050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363751|NCT04366050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92363752|NCT04365582|Ritonavir|ritonavir|mesh-list
92363753|NCT04365582|Lopinavir|lopinavir|mesh-list
92363754|NCT04365582|Azithromycin|azithromycin|mesh-list
92363755|NCT04365582|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363756|NCT04365582|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92363757|NCT04365582|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92363758|NCT04365582|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363759|NCT04365582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363760|NCT04365582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363761|NCT04365582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92363762|NCT04365582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92363763|NCT04365582|Antiviral Agents|antiviral agents|mesh-ancestor
92363765|NCT04365582|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92363766|NCT04365582|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91937486|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92363767|NCT04365582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363768|NCT04365582|Antimalarials|antimalarials|mesh-ancestor
92363769|NCT04365582|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363770|NCT04365582|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363771|NCT04365582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363772|NCT04365270|Chlorhexidine|chlorhexidine|mesh-list
92363773|NCT04365270|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92016245|NCT05545475|Warfarin|warfarin|mesh-list
92363774|NCT04365270|Titanium dioxide|titanium dioxide|mesh-list
92363775|NCT04365270|Chitosan|chitosan|mesh-list
92363776|NCT04365270|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92363777|NCT04365270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363778|NCT04365270|Disinfectants|disinfectants|mesh-ancestor
92363779|NCT04365270|Dermatologic Agents|dermatologic agents|mesh-ancestor
92363780|NCT04365270|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92363781|NCT04365270|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92363782|NCT04365270|Antimetabolites|antimetabolites|mesh-ancestor
92363783|NCT04365270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953179|NCT05184335|RP5063|rp5063|mesh-list
92363784|NCT04365270|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92363785|NCT04365270|Chelating Agents|chelating agents|mesh-ancestor
92363786|NCT04365270|Sequestering Agents|sequestering agents|mesh-ancestor
92363787|NCT04365270|Hemostatics|hemostatics|mesh-ancestor
92363788|NCT04365270|Coagulants|coagulants|mesh-ancestor
92363789|NCT04365270|Sunscreening Agents|sunscreening agents|mesh-ancestor
92363790|NCT04365270|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92363791|NCT04365270|Protective Agents|protective agents|mesh-ancestor
92363792|NCT04365270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363793|NCT04365270|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92363794|NCT04365426|Contraceptive Agents|contraceptive agents|mesh-list
92363795|NCT04365426|Contraceptives, Oral|contraceptives, oral|mesh-list
92363796|NCT04365426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363797|NCT04365426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363798|NCT04365426|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92363799|NCT04365036|Gemcitabine|gemcitabine|mesh-list
92363800|NCT04365036|Oxaliplatin|oxaliplatin|mesh-list
92363801|NCT04365036|Pegaspargase|pegaspargase|mesh-list
92363802|NCT04365036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92363803|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
92363804|NCT04365036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363805|NCT04365036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363806|NCT04364022|Ritonavir|ritonavir|mesh-list
92363808|NCT04364022|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92363809|NCT04364022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92363810|NCT04364022|Protease Inhibitors|protease inhibitors|mesh-ancestor
92363811|NCT04364022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363812|NCT04364022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363813|NCT04364022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92363814|NCT04364022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92363815|NCT04364022|Antiviral Agents|antiviral agents|mesh-ancestor
91953697|NCT03432767|Chrysarobin|chrysarobin|mesh-list
92363816|NCT04364022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363817|NCT04364022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92363818|NCT04364022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363820|NCT04363866|Antimalarials|antimalarials|mesh-ancestor
92363821|NCT04363866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363822|NCT04363866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363823|NCT04363866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363824|NCT04363866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363825|NCT04363866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363826|NCT04363866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363827|NCT04362384|Vitamin E|vitamin e|mesh-list
92363828|NCT04362384|Prednisolone|prednisolone|mesh-list
92363829|NCT04362384|Vitamins|vitamins|mesh-ancestor
92363830|NCT04362384|Micronutrients|micronutrients|mesh-ancestor
91954195|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92363831|NCT04362384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363832|NCT04362384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363833|NCT04362384|Glucocorticoids|glucocorticoids|mesh-ancestor
92363834|NCT04362384|Hormones|hormones|mesh-ancestor
92363835|NCT04362384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363836|NCT04362384|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363837|NCT04362384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363838|NCT04362384|Protective Agents|protective agents|mesh-ancestor
92363840|NCT04362384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363841|NCT04361214|Leflunomide|leflunomide|mesh-list
92363842|NCT04361214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954747|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363843|NCT04361214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363844|NCT04361214|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363845|NCT04361214|Immunologic Factors|immunologic factors|mesh-ancestor
92363846|NCT04361214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363848|NCT04361370|Pembrolizumab|pembrolizumab|mesh-list
92363849|NCT04361370|Olaparib|olaparib|mesh-list
92363850|NCT04361370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363851|NCT04361370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363852|NCT04361370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92363853|NCT04361370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92363854|NCT04361370|Growth Substances|growth substances|mesh-ancestor
92363855|NCT04361370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363856|NCT04361370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92363857|NCT04361370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363858|NCT04361370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363859|NCT04361370|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92363860|NCT04361370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363861|NCT04361058|Nivolumab|nivolumab|mesh-list
92363862|NCT04361058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363863|NCT04361058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363864|NCT04361058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92363865|NCT04361058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363866|NCT04359966|Amoxicillin|amoxicillin|mesh-list
92363867|NCT04359966|Metronidazole|metronidazole|mesh-list
92363868|NCT04359966|Clarithromycin|clarithromycin|mesh-list
92363869|NCT04359966|Levofloxacin|levofloxacin|mesh-list
92363870|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92363871|NCT04359966|Esomeprazole|esomeprazole|mesh-list
92363872|NCT04359966|Bismuth|bismuth|mesh-list
92363873|NCT04359966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363874|NCT04359966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363875|NCT04359966|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363876|NCT04359966|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363877|NCT04359966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92363878|NCT04359966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92363879|NCT04359966|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92363880|NCT04359966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363881|NCT04359966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363882|NCT04359966|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92363883|NCT04359966|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92363884|NCT04359966|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92363885|NCT04359966|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92363886|NCT04359966|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92363887|NCT04359966|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92363888|NCT04359966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363889|NCT04359966|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92363890|NCT04359966|Antacids|antacids|mesh-ancestor
92363891|NCT04360122|Levamisole|levamisole|mesh-list
92363892|NCT04360122|Inosine Pranobex|inosine pranobex|mesh-list
92363893|NCT04360122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92363894|NCT04360122|Immunologic Factors|immunologic factors|mesh-ancestor
92363895|NCT04360122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363896|NCT04360122|Antinematodal Agents|antinematodal agents|mesh-ancestor
92363897|NCT04360122|Anthelmintics|anthelmintics|mesh-ancestor
92363898|NCT04360122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363899|NCT04360122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363900|NCT04360122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92363901|NCT04360122|Antiviral Agents|antiviral agents|mesh-ancestor
92363902|NCT04360356|Ivermectin|ivermectin|mesh-list
92363903|NCT04360356|Nitazoxanide|nitazoxanide|mesh-list
92363904|NCT04360356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363905|NCT04360356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363906|NCT04359576|Hemostatics|hemostatics|mesh-list
92363907|NCT04359576|Coagulants|coagulants|mesh-ancestor
92363908|NCT04358796|Perflubron|perflubron|mesh-list
92363909|NCT04358796|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92363910|NCT04358718|Anesthetics|anesthetics|mesh-list
92363911|NCT04358718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92363912|NCT04358718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363913|NCT04358562|Gefitinib|gefitinib|mesh-list
92363915|NCT04358562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92363916|NCT04358562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363917|NCT04358562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363918|NCT04357860|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92363919|NCT04358016|Terlipressin|terlipressin|mesh-list
92363920|NCT04358016|Somatostatin|somatostatin|mesh-list
92363921|NCT04358016|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92363922|NCT04358016|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92363923|NCT04358016|Hormones|hormones|mesh-ancestor
92363924|NCT04358016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363925|NCT04358016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363926|NCT04357392|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92363927|NCT04357392|Prednisone|prednisone|mesh-list
91954968|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
92363928|NCT04357392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363929|NCT04357392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92363930|NCT04357392|Glucocorticoids|glucocorticoids|mesh-ancestor
92363931|NCT04357392|Hormones|hormones|mesh-ancestor
92363932|NCT04357392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955395|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92363933|NCT04357392|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363934|NCT04357392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363935|NCT04357002|Tranexamic Acid|tranexamic acid|mesh-list
92363936|NCT04357002|Dinoprostone|dinoprostone|mesh-list
92363937|NCT04357002|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92363938|NCT04357002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91955798|NCT03412409|Cytarabine|cytarabine|mesh-list
92363939|NCT04357002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363940|NCT04357002|Hemostatics|hemostatics|mesh-ancestor
92363941|NCT04357002|Coagulants|coagulants|mesh-ancestor
92363942|NCT04357002|Oxytocics|oxytocics|mesh-ancestor
92363943|NCT04357002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363944|NCT04357002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363945|NCT04356222|Methotrexate|methotrexate|mesh-list
92363946|NCT04356222|Durvalumab|durvalumab|mesh-list
92363947|NCT04356222|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92363948|NCT04356222|Abortifacient Agents|abortifacient agents|mesh-ancestor
92363949|NCT04356222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92363950|NCT04356222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363951|NCT04356222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91955993|NCT03411473|Pembrolizumab|pembrolizumab|mesh-list
92363952|NCT04356222|Antimetabolites|antimetabolites|mesh-ancestor
92363953|NCT04356222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363954|NCT04356222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363955|NCT04356222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92363956|NCT04356222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92363957|NCT04356222|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92363958|NCT04356222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92363959|NCT04356222|Immunologic Factors|immunologic factors|mesh-ancestor
92363960|NCT04356222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956250|NCT03407027|Hormones|hormones|mesh-ancestor
92363961|NCT04356222|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92363962|NCT04356222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92363964|NCT04356144|Hemostatics|hemostatics|mesh-ancestor
92363965|NCT04356144|Coagulants|coagulants|mesh-ancestor
92363966|NCT04355598|Lidocaine|lidocaine|mesh-list
92363967|NCT04355598|Nitroglycerin|nitroglycerin|mesh-list
92363968|NCT04355598|Prilocaine|prilocaine|mesh-list
92363969|NCT04355598|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92363970|NCT04355598|Anesthetics, Local|anesthetics, local|mesh-ancestor
92363972|NCT04355598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92363973|NCT04355598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363974|NCT04355598|Sensory System Agents|sensory system agents|mesh-ancestor
92363975|NCT04355598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92363976|NCT04355598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91957180|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92363977|NCT04355598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92363978|NCT04355598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92363979|NCT04355598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92363980|NCT04355598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92363981|NCT04355598|Vasodilator Agents|vasodilator agents|mesh-ancestor
92363982|NCT04355598|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92363983|NCT04355520|Fulvestrant|fulvestrant|mesh-list
91957365|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92363984|NCT04355520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92363985|NCT04355520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92363986|NCT04355520|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92363987|NCT04355520|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92363988|NCT04355520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92363989|NCT04355520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92363990|NCT04355520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92363992|NCT04355052|Hydroxychloroquine|hydroxychloroquine|mesh-list
92363994|NCT04355052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92363995|NCT04355052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92363996|NCT04355052|Antimalarials|antimalarials|mesh-ancestor
92363997|NCT04355052|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92363998|NCT04355052|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92363999|NCT04355052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364000|NCT04355052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364001|NCT04355052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364002|NCT04355052|Protease Inhibitors|protease inhibitors|mesh-ancestor
91957863|NCT03375463|Hormones|hormones|mesh-ancestor
92364003|NCT04355052|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92364004|NCT04355052|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92364005|NCT04354662|Leucovorin|leucovorin|mesh-list
92364006|NCT04354662|Docetaxel|docetaxel|mesh-list
92364007|NCT04354662|Fluorouracil|fluorouracil|mesh-list
92364008|NCT04354662|Oxaliplatin|oxaliplatin|mesh-list
92364009|NCT04354662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364010|NCT04354662|Tubulin Modulators|tubulin modulators|mesh-ancestor
92364011|NCT04354662|Antimitotic Agents|antimitotic agents|mesh-ancestor
92364012|NCT04354662|Mitosis Modulators|mitosis modulators|mesh-ancestor
92364013|NCT04354662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364015|NCT04354662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92364016|NCT04354662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958411|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
92364017|NCT04354662|Immunologic Factors|immunologic factors|mesh-ancestor
92364018|NCT04354662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364019|NCT04354662|Antidotes|antidotes|mesh-ancestor
92364020|NCT04354662|Protective Agents|protective agents|mesh-ancestor
92364021|NCT04354662|Vitamin B Complex|vitamin b complex|mesh-ancestor
92364022|NCT04354662|Vitamins|vitamins|mesh-ancestor
92364023|NCT04354662|Micronutrients|micronutrients|mesh-ancestor
92364024|NCT04354350|Telmisartan|telmisartan|mesh-list
92364025|NCT04354350|Ramipril|ramipril|mesh-list
91958508|NCT02267343|Nivolumab|nivolumab|mesh-list
92364026|NCT04354350|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92364027|NCT04354350|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92364028|NCT04354350|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92364029|NCT04354350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364030|NCT04354350|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92364031|NCT04354350|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364032|NCT04354350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364033|NCT04353336|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364034|NCT04353336|Chloroquine|chloroquine|mesh-list
92364035|NCT04353336|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92364036|NCT04353336|Antimalarials|antimalarials|mesh-ancestor
92364037|NCT04353336|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364038|NCT04353336|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364039|NCT04353336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364040|NCT04353336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364041|NCT04353336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364042|NCT04353336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364043|NCT04353336|Amebicides|amebicides|mesh-ancestor
92364044|NCT04353336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364045|NCT04353336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364046|NCT04353336|Analgesics|analgesics|mesh-ancestor
91958867|NCT04509583|Vitamin E|vitamin e|mesh-list
92364047|NCT04353336|Sensory System Agents|sensory system agents|mesh-ancestor
92364048|NCT04353336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364049|NCT04353336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364050|NCT04353336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364051|NCT04353336|Filaricides|filaricides|mesh-ancestor
92364052|NCT04353336|Antinematodal Agents|antinematodal agents|mesh-ancestor
92364053|NCT04353336|Anthelmintics|anthelmintics|mesh-ancestor
92364054|NCT04353180|Tretinoin|tretinoin|mesh-list
92364055|NCT04353180|Isotretinoin|isotretinoin|mesh-list
92364056|NCT04353180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364058|NCT04353180|Dermatologic Agents|dermatologic agents|mesh-ancestor
92364059|NCT04352946|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364060|NCT04352946|Antimalarials|antimalarials|mesh-ancestor
92364061|NCT04352946|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364062|NCT04352946|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364063|NCT04352946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364064|NCT04352946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364065|NCT04352946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364066|NCT04352946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364067|NCT04352400|Nafamostat|nafamostat|mesh-list
91959363|NCT02689167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92364068|NCT04352400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364069|NCT04352400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364070|NCT04352400|Analgesics|analgesics|mesh-ancestor
92364071|NCT04352400|Sensory System Agents|sensory system agents|mesh-ancestor
92364072|NCT04352400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959584|NCT04502251|Naltrexone|naltrexone|mesh-list
92364073|NCT04352400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364074|NCT04352400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364075|NCT04352400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364076|NCT04352400|Anticoagulants|anticoagulants|mesh-ancestor
92364077|NCT04352400|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364078|NCT04352400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959653|NCT05302713|Antacids|antacids|mesh-ancestor
92364079|NCT04352400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959725|NCT04486911|Letrozole|letrozole|mesh-list
92364080|NCT04352400|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92364081|NCT04352400|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92364082|NCT04352400|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92364083|NCT04352400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92364084|NCT04352400|Immunologic Factors|immunologic factors|mesh-ancestor
92364085|NCT04351308|Apatinib|apatinib|mesh-list
92364086|NCT04351308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364087|NCT04351308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92364088|NCT04351308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960041|NCT01285557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364089|NCT04351308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364090|NCT04351152|Lenzilumab|lenzilumab|mesh-list
92364091|NCT04351152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364092|NCT04350528|Pentobarbital|pentobarbital|mesh-list
92364093|NCT04350528|Chlorpromazine|chlorpromazine|mesh-list
92364094|NCT04350528|Antiemetics|antiemetics|mesh-ancestor
92364095|NCT04350528|Autonomic Agents|autonomic agents|mesh-ancestor
91960195|NCT01376167|Filaricides|filaricides|mesh-ancestor
92364096|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364097|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960268|NCT02516059|Analgesics|analgesics|mesh-ancestor
92364098|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364099|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92364100|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92364101|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364102|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92364103|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92364104|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
92364105|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364106|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364107|NCT04350528|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92364108|NCT04350528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92364109|NCT04350528|GABA Modulators|gaba modulators|mesh-ancestor
92364110|NCT04350528|GABA Agents|gaba agents|mesh-ancestor
92364111|NCT04350684|Interferons|interferons|mesh-list
92364112|NCT04350684|Ritonavir|ritonavir|mesh-list
92364113|NCT04350684|Lopinavir|lopinavir|mesh-list
92364114|NCT04350684|Interferon-beta|interferon-beta|mesh-list
92364115|NCT04350684|Interferon beta-1a|interferon beta-1a|mesh-list
92364116|NCT04350684|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364117|NCT04350684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364118|NCT04350684|Antiviral Agents|antiviral agents|mesh-ancestor
92364119|NCT04350684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364120|NCT04350684|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92364121|NCT04350684|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92364122|NCT04350684|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364124|NCT04350684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364125|NCT04350684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92364126|NCT04350684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92364127|NCT04350684|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92364128|NCT04350684|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92364129|NCT04350684|Antimalarials|antimalarials|mesh-ancestor
92364130|NCT04350684|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364132|NCT04350684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364133|NCT04350684|Immunologic Factors|immunologic factors|mesh-ancestor
91961154|NCT04494763|Vasodilator Agents|vasodilator agents|mesh-ancestor
92364134|NCT04350684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364135|NCT04350684|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92364136|NCT04350450|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364137|NCT04350450|Antimalarials|antimalarials|mesh-ancestor
92364138|NCT04350450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364139|NCT04350450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364140|NCT04350450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364141|NCT04350450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961442|NCT02488291|Dsuvia|dsuvia|mesh-list
92364142|NCT04350450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364143|NCT04350450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364144|NCT04349592|Azithromycin|azithromycin|mesh-list
92364145|NCT04349592|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364146|NCT04349592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92364147|NCT04349592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364148|NCT04349592|Antimalarials|antimalarials|mesh-ancestor
92364149|NCT04349592|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364150|NCT04349592|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364151|NCT04349592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364152|NCT04349592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364153|NCT04349592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364154|NCT04347252|Glucagon|glucagon|mesh-list
92364155|NCT04347252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364157|NCT04347252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016655|NCT02450487|Piroxicam|piroxicam|mesh-list
92364158|NCT04347252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364159|NCT04346862|Acetylcarnitine|acetylcarnitine|mesh-list
91962026|NCT03103893|Sirolimus|sirolimus|mesh-list
92364160|NCT04346862|Vitamin B Complex|vitamin b complex|mesh-ancestor
92364161|NCT04346862|Vitamins|vitamins|mesh-ancestor
92364162|NCT04346862|Micronutrients|micronutrients|mesh-ancestor
92364163|NCT04346862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364164|NCT04346862|Nootropic Agents|nootropic agents|mesh-ancestor
92364165|NCT04345848|Heparin|heparin|mesh-list
92364167|NCT04345848|Calcium heparin|calcium heparin|mesh-list
92364168|NCT04345848|Anticoagulants|anticoagulants|mesh-ancestor
92364169|NCT04345848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92364170|NCT04345848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91962301|NCT03375645|Analgesics, Opioid|analgesics, opioid|mesh-list
92364171|NCT04345848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364172|NCT04345692|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364173|NCT04345692|Antimalarials|antimalarials|mesh-ancestor
92364174|NCT04345692|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364175|NCT04345692|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364176|NCT04345692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364177|NCT04345692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364178|NCT04345692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364179|NCT04345692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364180|NCT04345458|Etanercept|etanercept|mesh-list
92364181|NCT04345458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91962466|NCT05067699|Vitamins|vitamins|mesh-ancestor
92364182|NCT04345458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91962553|NCT03913845|Mydriatics|mydriatics|mesh-ancestor
92364184|NCT04345458|Sensory System Agents|sensory system agents|mesh-ancestor
92364185|NCT04345458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364186|NCT04345458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364187|NCT04345458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364188|NCT04345458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364189|NCT04345458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364190|NCT04345458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92364191|NCT04345458|Immunologic Factors|immunologic factors|mesh-ancestor
92364193|NCT04344756|Calcium heparin|calcium heparin|mesh-list
92364195|NCT04344756|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92364196|NCT04344756|Dalteparin|dalteparin|mesh-list
92364197|NCT04344756|Anticoagulants|anticoagulants|mesh-ancestor
92364198|NCT04344756|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92364199|NCT04344756|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92364200|NCT04344756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364201|NCT04344288|Prednisone|prednisone|mesh-list
92364202|NCT04344288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364203|NCT04344288|Glucocorticoids|glucocorticoids|mesh-ancestor
92364204|NCT04344288|Hormones|hormones|mesh-ancestor
92364205|NCT04344288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364206|NCT04344288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364207|NCT04344288|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92364208|NCT04344288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364209|NCT04343742|Chlorine dioxide|chlorine dioxide|mesh-list
92364210|NCT04343742|Dental Disinfectants|dental disinfectants|mesh-ancestor
92364211|NCT04343742|Disinfectants|disinfectants|mesh-ancestor
92364212|NCT04343742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364213|NCT04342728|Vitamins|vitamins|mesh-list
92364214|NCT04342728|Ascorbic Acid|ascorbic acid|mesh-list
92364215|NCT04342728|Zinc|zinc|mesh-list
92364216|NCT04342728|Micronutrients|micronutrients|mesh-ancestor
92364217|NCT04342728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364218|NCT04342728|Trace Elements|trace elements|mesh-ancestor
92364219|NCT04342728|Antioxidants|antioxidants|mesh-ancestor
92364220|NCT04342728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364221|NCT04342728|Protective Agents|protective agents|mesh-ancestor
92364222|NCT04342650|Chloroquine|chloroquine|mesh-list
91963117|NCT03302299|Pyridoxine|pyridoxine|mesh-list
92364223|NCT04342650|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92364224|NCT04342650|Amebicides|amebicides|mesh-ancestor
92364225|NCT04342650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364226|NCT04342650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91963206|NCT03301207|Estrogens|estrogens|mesh-ancestor
92364227|NCT04342650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364228|NCT04342650|Antimalarials|antimalarials|mesh-ancestor
92364229|NCT04342650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364230|NCT04342650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364231|NCT04342650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364232|NCT04342650|Analgesics|analgesics|mesh-ancestor
92364233|NCT04342650|Sensory System Agents|sensory system agents|mesh-ancestor
92364234|NCT04342650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364235|NCT04342650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364236|NCT04342650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364237|NCT04342650|Filaricides|filaricides|mesh-ancestor
92364238|NCT04342650|Antinematodal Agents|antinematodal agents|mesh-ancestor
91963504|NCT00702325|Hormones|hormones|mesh-ancestor
92364239|NCT04342650|Anthelmintics|anthelmintics|mesh-ancestor
92364240|NCT04341402|Antifungal Agents|antifungal agents|mesh-list
92364241|NCT04341402|Clotrimazole|clotrimazole|mesh-list
92364242|NCT04341402|Miconazole|miconazole|mesh-list
92364243|NCT04341402|Diclofenac|diclofenac|mesh-list
91963565|NCT04298203|Topiramate|topiramate|mesh-list
92364244|NCT04341402|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364245|NCT04341402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364246|NCT04341402|Analgesics|analgesics|mesh-ancestor
92364247|NCT04341402|Sensory System Agents|sensory system agents|mesh-ancestor
92364248|NCT04341402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364249|NCT04341402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364250|NCT04341402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364251|NCT04341402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364252|NCT04341402|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92364253|NCT04341402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364254|NCT04341402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364255|NCT04341402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364256|NCT04341402|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91963638|NCT02462941|Adenosine|adenosine|mesh-list
92364257|NCT04341402|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92364258|NCT04341402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92364259|NCT04341402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92364260|NCT04341402|Hormone Antagonists|hormone antagonists|mesh-ancestor
92364261|NCT04341402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364262|NCT04341402|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92364263|NCT04341402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92364265|NCT04340544|Antimalarials|antimalarials|mesh-ancestor
92364266|NCT04340544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364267|NCT04340544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364268|NCT04340544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364269|NCT04340544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945046|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364270|NCT04340544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364271|NCT04340544|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364273|NCT04340778|Prilocaine|prilocaine|mesh-list
92364274|NCT04340778|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92364275|NCT04340778|Dinoprostone|dinoprostone|mesh-list
92364276|NCT04340778|Anesthetics, Local|anesthetics, local|mesh-ancestor
92364277|NCT04340778|Anesthetics|anesthetics|mesh-ancestor
92364278|NCT04340778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364279|NCT04340778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364280|NCT04340778|Sensory System Agents|sensory system agents|mesh-ancestor
92364281|NCT04340778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364282|NCT04340778|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92364283|NCT04340778|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92364284|NCT04340778|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92364285|NCT04340778|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92364286|NCT04340778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364288|NCT04340778|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92364289|NCT04340778|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92364290|NCT04340388|Tenofovir|tenofovir|mesh-list
92364291|NCT04340388|Lamivudine|lamivudine|mesh-list
92364292|NCT04340388|Zidovudine|zidovudine|mesh-list
92364293|NCT04340388|Dolutegravir|dolutegravir|mesh-list
92364294|NCT04340388|Darunavir|darunavir|mesh-list
92364295|NCT04340388|Abacavir|abacavir|mesh-list
92364296|NCT04340388|Cobicistat|cobicistat|mesh-list
92364297|NCT04340388|Rilpivirine|rilpivirine|mesh-list
92364298|NCT04340388|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92364299|NCT04340388|Antiviral Agents|antiviral agents|mesh-ancestor
92364300|NCT04340388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964095|NCT03293641|Penicillins|penicillins|mesh-list
92364301|NCT04340388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92364302|NCT04340388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92364303|NCT04340388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964148|NCT03375671|Midazolam|midazolam|mesh-list
92364304|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364305|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92364306|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
92364307|NCT04340388|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92364308|NCT04340388|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92364309|NCT04340388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92364310|NCT04340388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92364311|NCT04340388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364312|NCT04340388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92364313|NCT04340388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92364314|NCT04338906|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364316|NCT04338906|Antimalarials|antimalarials|mesh-ancestor
92364317|NCT04338906|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364318|NCT04338906|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364319|NCT04338906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364320|NCT04338906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364321|NCT04338906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364322|NCT04338906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364323|NCT04338906|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364324|NCT04338906|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92364325|NCT04338906|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92364326|NCT04338438|Apatinib|apatinib|mesh-list
92364327|NCT04338438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364328|NCT04338438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92364329|NCT04338438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364330|NCT04338438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364331|NCT04338126|Tranexamic Acid|tranexamic acid|mesh-list
92364332|NCT04338126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91964351|NCT03363191|Albuterol|albuterol|mesh-list
92364333|NCT04338126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92364334|NCT04338126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364335|NCT04338126|Hemostatics|hemostatics|mesh-ancestor
92364336|NCT04338126|Coagulants|coagulants|mesh-ancestor
92364337|NCT04337658|Capecitabine|capecitabine|mesh-list
92364338|NCT04337658|Trastuzumab|trastuzumab|mesh-list
92364339|NCT04337658|Fulvestrant|fulvestrant|mesh-list
92364340|NCT04337658|Pertuzumab|pertuzumab|mesh-list
92364341|NCT04337658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92364342|NCT04337658|Antimetabolites|antimetabolites|mesh-ancestor
91964405|NCT04527055|Esomeprazole|esomeprazole|mesh-list
92364343|NCT04337658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364344|NCT04337658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364345|NCT04337658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92364346|NCT04337658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92364347|NCT04337658|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91964469|NCT03298009|Canagliflozin|canagliflozin|mesh-list
92364348|NCT04337658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92364349|NCT04337658|Hormone Antagonists|hormone antagonists|mesh-ancestor
91964552|NCT02460055|Hormones|hormones|mesh-ancestor
92364350|NCT04337658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364351|NCT04337658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364352|NCT04337268|Glucagon|glucagon|mesh-list
92364353|NCT04337268|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92364354|NCT04337268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364355|NCT04337268|Hormones|hormones|mesh-ancestor
92364356|NCT04337268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364357|NCT04337268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364358|NCT04337268|Incretins|incretins|mesh-ancestor
92364359|NCT04336566|Melatonin|melatonin|mesh-list
92364360|NCT04336566|Antioxidants|antioxidants|mesh-ancestor
92364361|NCT04336566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364362|NCT04336566|Protective Agents|protective agents|mesh-ancestor
91964610|NCT03282643|Tinzaparin|tinzaparin|mesh-list
92364363|NCT04336566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364364|NCT04336566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364365|NCT04336488|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92364366|NCT04336488|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-list
92364367|NCT04336488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364368|NCT04336488|Glucocorticoids|glucocorticoids|mesh-ancestor
92364369|NCT04336488|Hormones|hormones|mesh-ancestor
92364370|NCT04336488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364371|NCT04336488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364372|NCT04336488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964665|NCT03529825|Rifaximin|rifaximin|mesh-list
92364373|NCT04336488|Immunologic Factors|immunologic factors|mesh-ancestor
92364374|NCT04336488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964725|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92364375|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364376|NCT04336488|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364378|NCT04335786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92364379|NCT04335786|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92364380|NCT04335786|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92364381|NCT04335786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364382|NCT04334928|Tenofovir|tenofovir|mesh-list
92364383|NCT04334928|Emtricitabine|emtricitabine|mesh-list
92364384|NCT04334928|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92364385|NCT04334928|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364386|NCT04334928|Antiviral Agents|antiviral agents|mesh-ancestor
92364388|NCT04334928|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91965109|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364389|NCT04334928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92364390|NCT04334928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364391|NCT04334928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364392|NCT04334928|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92364393|NCT04334928|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92364394|NCT04334928|Antimalarials|antimalarials|mesh-ancestor
92364395|NCT04334928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91945238|NCT00002411|Didanosine|didanosine|mesh-list
92364396|NCT04334928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364397|NCT04334928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364398|NCT04334850|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92364399|NCT04334850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364400|NCT04334382|Azithromycin|azithromycin|mesh-list
92364401|NCT04334382|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364402|NCT04334382|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92364403|NCT04334382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364404|NCT04334382|Antimalarials|antimalarials|mesh-ancestor
92364405|NCT04334382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364406|NCT04334382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364407|NCT04334382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364408|NCT04334382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364410|NCT04333992|Remifentanil|remifentanil|mesh-list
92364411|NCT04333992|Propofol|propofol|mesh-list
92364412|NCT04333992|Sevoflurane|sevoflurane|mesh-list
92364413|NCT04333992|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92364414|NCT04333992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364415|NCT04333992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364416|NCT04333992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92364417|NCT04333992|Anesthetics, General|anesthetics, general|mesh-ancestor
92364418|NCT04333992|Anesthetics|anesthetics|mesh-ancestor
91965538|NCT05231603|Ivermectin|ivermectin|mesh-list
92364419|NCT04333992|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92364420|NCT04333992|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92364421|NCT04333992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92364422|NCT04333992|Narcotics|narcotics|mesh-ancestor
92364423|NCT04333992|Analgesics|analgesics|mesh-ancestor
92364424|NCT04333992|Sensory System Agents|sensory system agents|mesh-ancestor
92364425|NCT04333992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364426|NCT04332978|Fluticasone|fluticasone|mesh-list
92364428|NCT04332978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364429|NCT04332978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92364430|NCT04332978|Autonomic Agents|autonomic agents|mesh-ancestor
92364431|NCT04332978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364432|NCT04332978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364433|NCT04332978|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92364434|NCT04332978|Respiratory System Agents|respiratory system agents|mesh-ancestor
92364435|NCT04332978|Dermatologic Agents|dermatologic agents|mesh-ancestor
92364436|NCT04332978|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92364437|NCT04332666|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92364438|NCT04332666|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92364439|NCT04332666|Vasodilator Agents|vasodilator agents|mesh-ancestor
92364440|NCT04332276|Dopamine|dopamine|mesh-list
92364441|NCT04332276|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92364442|NCT04332276|Sympathomimetics|sympathomimetics|mesh-ancestor
92364444|NCT04332276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965965|NCT02515955|Minocycline|minocycline|mesh-list
92364445|NCT04332276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364446|NCT04332276|Dopamine Agents|dopamine agents|mesh-ancestor
92364447|NCT04332276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364448|NCT04332276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364449|NCT04332276|Protective Agents|protective agents|mesh-ancestor
92364450|NCT04332042|Tofacitinib|tofacitinib|mesh-list
92364451|NCT04332042|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92364452|NCT04332042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92364453|NCT04332042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364454|NCT04332042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364455|NCT04341870|Azithromycin|azithromycin|mesh-list
92364456|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364457|NCT04341870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92364458|NCT04341870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364459|NCT04341870|Antimalarials|antimalarials|mesh-ancestor
92016935|NCT05591417|Analgesics|analgesics|mesh-ancestor
92364461|NCT04341870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364462|NCT04341870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364463|NCT04341870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364464|NCT04341870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364465|NCT04331418|Dexmedetomidine|dexmedetomidine|mesh-list
92364466|NCT04331418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92364467|NCT04331418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364468|NCT04331418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966459|NCT03233035|Ketamine|ketamine|mesh-list
92364470|NCT04331418|Analgesics|analgesics|mesh-ancestor
92364471|NCT04331418|Sensory System Agents|sensory system agents|mesh-ancestor
92364472|NCT04331418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364473|NCT04331418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92364474|NCT04331418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92364475|NCT04331418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92364476|NCT04331418|Adrenergic Agents|adrenergic agents|mesh-ancestor
92364477|NCT04331418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966577|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92364478|NCT04331418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364479|NCT04330872|Aspirin|aspirin|mesh-list
92364480|NCT04330872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364481|NCT04330872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364482|NCT04330872|Analgesics|analgesics|mesh-ancestor
92364483|NCT04330872|Sensory System Agents|sensory system agents|mesh-ancestor
92364484|NCT04330872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364485|NCT04330872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364486|NCT04330872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364487|NCT04330872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364488|NCT04330872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92364489|NCT04330872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92364490|NCT04330872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364491|NCT04330872|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92364492|NCT04330872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92364493|NCT04330872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364494|NCT04330872|Antipyretics|antipyretics|mesh-ancestor
92364495|NCT04330326|Sorbitol|sorbitol|mesh-list
92364496|NCT04330326|Cathartics|cathartics|mesh-ancestor
92364497|NCT04330326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364498|NCT04329858|Methamphetamine|methamphetamine|mesh-list
92364499|NCT04329858|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92364500|NCT04329858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364501|NCT04329858|Sympathomimetics|sympathomimetics|mesh-ancestor
92364502|NCT04329858|Autonomic Agents|autonomic agents|mesh-ancestor
92364503|NCT04329858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364504|NCT04329858|Dopamine Agents|dopamine agents|mesh-ancestor
92364505|NCT04329858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364506|NCT04329858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364507|NCT04329858|Adrenergic Agents|adrenergic agents|mesh-ancestor
92364508|NCT04329858|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91966782|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364509|NCT04329858|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92364510|NCT04329858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91966839|NCT03344003|Coagulants|coagulants|mesh-ancestor
92364512|NCT00704106|Entecavir|entecavir|mesh-list
92364513|NCT00704106|Antiviral Agents|antiviral agents|mesh-ancestor
92364514|NCT00704106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364515|NCT05614752|Fexuprazan|fexuprazan|mesh-list
91966916|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
92364517|NCT05508594|Sufentanil|sufentanil|mesh-list
92364518|NCT05508594|Ketamine|ketamine|mesh-list
92364519|NCT05508594|Analgesics|analgesics|mesh-ancestor
92364520|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
91966985|NCT03342599|Vitamins|vitamins|mesh-ancestor
92364521|NCT05508594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364522|NCT05508594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364523|NCT05508594|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91967069|NCT03098199|Menotropins|menotropins|mesh-list
92364524|NCT05508594|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92364526|NCT05508594|Anesthetics|anesthetics|mesh-ancestor
92364527|NCT05508594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364528|NCT05508594|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92364529|NCT05508594|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92364530|NCT05508594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364531|NCT05508594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364532|NCT05508594|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92364533|NCT05508594|Narcotics|narcotics|mesh-ancestor
92364534|NCT05508594|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92364535|NCT05417100|Methadone|methadone|mesh-list
92364536|NCT05417100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92364537|NCT05417100|Narcotics|narcotics|mesh-ancestor
92364538|NCT05417100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364539|NCT05417100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364540|NCT05417100|Analgesics|analgesics|mesh-ancestor
92364541|NCT05417100|Sensory System Agents|sensory system agents|mesh-ancestor
92364542|NCT05417100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364543|NCT05417100|Antitussive Agents|antitussive agents|mesh-ancestor
92364544|NCT05417100|Respiratory System Agents|respiratory system agents|mesh-ancestor
92364545|NCT05278884|Anesthetics|anesthetics|mesh-list
92364546|NCT05278884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364547|NCT05278884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364548|NCT05136690|Nicotine|nicotine|mesh-list
92364549|NCT05136690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92364550|NCT05136690|Autonomic Agents|autonomic agents|mesh-ancestor
92364551|NCT05136690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364552|NCT05136690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364553|NCT05136690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92364554|NCT05136690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92364555|NCT05136690|Cholinergic Agents|cholinergic agents|mesh-ancestor
92364556|NCT05136690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364557|NCT05136690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364558|NCT05035680|Vaccines|vaccines|mesh-list
92364559|NCT05035680|Immunologic Factors|immunologic factors|mesh-ancestor
92364560|NCT05035680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364561|NCT04831320|Paclitaxel|paclitaxel|mesh-list
92364562|NCT04831320|Nivolumab|nivolumab|mesh-list
91967191|NCT02497079|Formaldehyde|formaldehyde|mesh-list
92364563|NCT04831320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92364564|NCT04831320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364565|NCT04831320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92364566|NCT04831320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92364567|NCT04831320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92364568|NCT04831320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364569|NCT04831320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92364570|NCT04831320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92364571|NCT03874884|Olaparib|olaparib|mesh-list
92364572|NCT03874884|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92364573|NCT03874884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364574|NCT03874884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364575|NCT03874884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364576|NCT03063450|Nivolumab|nivolumab|mesh-list
91967264|NCT05032287|Tamsulosin|tamsulosin|mesh-list
92364577|NCT03063450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92364579|NCT03063450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92364580|NCT03063450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364581|NCT01326000|Cetuximab|cetuximab|mesh-list
92364582|NCT01326000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967414|NCT01929915|Fentanyl|fentanyl|mesh-list
92364583|NCT01326000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364585|NCT03035214|Dexamethasone acetate|dexamethasone acetate|mesh-list
92364587|NCT03035214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364588|NCT03035214|Antiemetics|antiemetics|mesh-ancestor
92364589|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
92364590|NCT03035214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364591|NCT03035214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364592|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364594|NCT03035214|Hormones|hormones|mesh-ancestor
92364595|NCT03035214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364596|NCT03035214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92364597|NCT03035214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364598|NCT03035214|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364599|NCT03035214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364600|NCT03035214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364601|NCT03035058|Vedolizumab|vedolizumab|mesh-list
92364602|NCT03035058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364603|NCT03033654|Sunscreening Agents|sunscreening agents|mesh-list
92364604|NCT03033654|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92364605|NCT03033654|Protective Agents|protective agents|mesh-ancestor
92364606|NCT03033654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364607|NCT03033654|Dermatologic Agents|dermatologic agents|mesh-ancestor
92364608|NCT03033732|Buprenorphine|buprenorphine|mesh-list
92364609|NCT03033732|Methadone|methadone|mesh-list
92364610|NCT03033732|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92364611|NCT03033732|Naloxone|naloxone|mesh-list
92364612|NCT03033732|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92364614|NCT03033732|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364615|NCT03033732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364616|NCT03033732|Analgesics|analgesics|mesh-ancestor
92364617|NCT03033732|Sensory System Agents|sensory system agents|mesh-ancestor
92364618|NCT03033732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364619|NCT03033732|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92364620|NCT03033732|Antitussive Agents|antitussive agents|mesh-ancestor
92364621|NCT03033732|Respiratory System Agents|respiratory system agents|mesh-ancestor
92364622|NCT03033264|Dinoprostone|dinoprostone|mesh-list
92364623|NCT03033264|Oxytocics|oxytocics|mesh-ancestor
92364624|NCT03033264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92364625|NCT03033264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364626|NCT03033342|Omeprazole|omeprazole|mesh-list
92364627|NCT03033342|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92364628|NCT03033342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364629|NCT03033342|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92364630|NCT03033342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364631|NCT03033342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967952|NCT05016063|Fludarabine|fludarabine|mesh-list
92364632|NCT03030768|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92364633|NCT03030768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92364634|NCT03030768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92364635|NCT03030768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364636|NCT03030768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364637|NCT03030768|Antiviral Agents|antiviral agents|mesh-ancestor
92364638|NCT03030768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364639|NCT03030768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91968212|NCT03320603|Thrombin|thrombin|mesh-list
92364640|NCT03030768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92364641|NCT03030690|Methamphetamine|methamphetamine|mesh-list
92364642|NCT03030690|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92364643|NCT03030690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364644|NCT03030690|Sympathomimetics|sympathomimetics|mesh-ancestor
92364645|NCT03030690|Autonomic Agents|autonomic agents|mesh-ancestor
91968265|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92364646|NCT03030690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364648|NCT03030690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364649|NCT03030690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364650|NCT03030690|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968415|NCT03206671|Ifosfamide|ifosfamide|mesh-list
92364651|NCT03030690|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92364652|NCT03030690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92364653|NCT03030690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92364654|NCT03030690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92364657|NCT03030300|Insulin|insulin|mesh-list
92364658|NCT03030300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92364659|NCT03030300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364660|NCT03029442|Denosumab|denosumab|mesh-list
92364661|NCT03029442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92364662|NCT03029442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364663|NCT03023514|Thioctic Acid|thioctic acid|mesh-list
92364664|NCT03023514|Progesterone|progesterone|mesh-list
92364665|NCT03023514|Progestins|progestins|mesh-ancestor
92364666|NCT03023514|Hormones|hormones|mesh-ancestor
92364667|NCT03023514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364668|NCT03023514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364669|NCT03023514|Antioxidants|antioxidants|mesh-ancestor
92364670|NCT03023514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364671|NCT03023514|Protective Agents|protective agents|mesh-ancestor
92364672|NCT03023514|Vitamin B Complex|vitamin b complex|mesh-ancestor
92364673|NCT03023514|Vitamins|vitamins|mesh-ancestor
92364674|NCT03023514|Micronutrients|micronutrients|mesh-ancestor
92364675|NCT03019926|Hydroxychloroquine|hydroxychloroquine|mesh-list
92364676|NCT03019926|Antimalarials|antimalarials|mesh-ancestor
92364677|NCT03019926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92364678|NCT03019926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92364679|NCT03019926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364680|NCT03019926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364681|NCT03019926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968634|NCT03318419|Cytarabine|cytarabine|mesh-list
92364682|NCT03019926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364683|NCT03019848|Curcumin|curcumin|mesh-list
92364684|NCT03019848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91968725|NCT02490839|Rabeprazole|rabeprazole|mesh-list
92364685|NCT03019848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017157|NCT04962451|Ticagrelor|ticagrelor|mesh-list
91945545|NCT04939649|Midazolam|midazolam|mesh-list
92364687|NCT03019848|Sensory System Agents|sensory system agents|mesh-ancestor
92364688|NCT03019848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364689|NCT03019848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364690|NCT03019848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364691|NCT03019848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968945|NCT03204799|Metformin|metformin|mesh-list
92364692|NCT03019848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364693|NCT03019848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969041|NCT02489513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364694|NCT03019848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364695|NCT03019614|Hydrocortisone|hydrocortisone|mesh-list
92364696|NCT03019614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364697|NCT03019536|Flutemetamol|flutemetamol|mesh-list
92364698|NCT03019536|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91969210|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92364699|NCT03019536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364700|NCT03019224|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92364701|NCT03019224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92364702|NCT03019224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364703|NCT03018990|Ethanol|ethanol|mesh-list
92364704|NCT03018990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92364705|NCT03018990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364706|NCT03018990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364707|NCT03018990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364708|NCT03018756|Fentanyl|fentanyl|mesh-list
92364709|NCT03018756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92364710|NCT03018756|Narcotics|narcotics|mesh-ancestor
92364711|NCT03018756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364712|NCT03018756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364713|NCT03018756|Analgesics|analgesics|mesh-ancestor
92364714|NCT03018756|Sensory System Agents|sensory system agents|mesh-ancestor
92364715|NCT03018756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364716|NCT03018756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92364717|NCT03018756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92364718|NCT03018756|Anesthetics, General|anesthetics, general|mesh-ancestor
92364719|NCT03018756|Anesthetics|anesthetics|mesh-ancestor
92364720|NCT03018444|Atorvastatin|atorvastatin|mesh-list
92364721|NCT03018444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92364722|NCT03018444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92364723|NCT03018444|Antimetabolites|antimetabolites|mesh-ancestor
92364724|NCT03018444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364725|NCT03018444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91945761|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92364726|NCT03018444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92364727|NCT03018444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364728|NCT03017430|Ketorolac|ketorolac|mesh-list
92364729|NCT03017430|Phenazepam|phenazepam|mesh-list
92364730|NCT03017430|Clonidine|clonidine|mesh-list
92364731|NCT03017430|Pregabalin|pregabalin|mesh-list
92364732|NCT03017430|Metoclopramide|metoclopramide|mesh-list
92364734|NCT03017430|Antidiarrheals|antidiarrheals|mesh-list
92364735|NCT03017430|Analgesics|analgesics|mesh-ancestor
91971236|NCT02466347|Xhance|xhance|mesh-list
92364736|NCT03017430|Sensory System Agents|sensory system agents|mesh-ancestor
92364737|NCT03017430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364738|NCT03017430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364739|NCT03017430|Anticonvulsants|anticonvulsants|mesh-ancestor
91971278|NCT05555069|Menthol|menthol|mesh-list
91946006|NCT01637584|Prazosin|prazosin|mesh-list
92364740|NCT03017430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92364741|NCT03017430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92364742|NCT03017430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364743|NCT03017430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92364744|NCT03017430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92364745|NCT03017430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92364746|NCT03017430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364747|NCT03017430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92364748|NCT03017430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364749|NCT03017430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364751|NCT03017430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364752|NCT03017430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92364753|NCT03017430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364754|NCT03017430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92364755|NCT03017430|Sympatholytics|sympatholytics|mesh-ancestor
92364756|NCT03017430|Autonomic Agents|autonomic agents|mesh-ancestor
92364757|NCT03017430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92364758|NCT03017430|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92364759|NCT03017430|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92364760|NCT03017430|Adrenergic Agents|adrenergic agents|mesh-ancestor
92364761|NCT03017430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92364762|NCT03017430|Antiemetics|antiemetics|mesh-ancestor
92364763|NCT03017430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364764|NCT03017430|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92364765|NCT03017430|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92364766|NCT03017430|Dopamine Agents|dopamine agents|mesh-ancestor
92364767|NCT03017430|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92364768|NCT03017430|Immunologic Factors|immunologic factors|mesh-ancestor
92364769|NCT03017430|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92364770|NCT03017430|GABA Agents|gaba agents|mesh-ancestor
92364771|NCT03017352|Exenatide|exenatide|mesh-list
92364772|NCT03017352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92364773|NCT03017352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364774|NCT03017352|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92364775|NCT03017352|Incretins|incretins|mesh-ancestor
92364776|NCT03017352|Hormones|hormones|mesh-ancestor
92364777|NCT03017352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364778|NCT03016884|Vaccines|vaccines|mesh-list
92364779|NCT03016884|Immunologic Factors|immunologic factors|mesh-ancestor
92364780|NCT03016884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364781|NCT03016806|Cyclophosphamide|cyclophosphamide|mesh-list
92364783|NCT03016806|Busulfan|busulfan|mesh-list
92364784|NCT03016806|Fludarabine|fludarabine|mesh-list
91971862|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
92364787|NCT03016806|Immunologic Factors|immunologic factors|mesh-ancestor
92364788|NCT03016806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946130|NCT02500706|Insulin|insulin|mesh-list
92364789|NCT03016806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364790|NCT03016806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92364791|NCT03016806|Alkylating Agents|alkylating agents|mesh-ancestor
92364792|NCT03016806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364793|NCT03016806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364794|NCT03016806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92364796|NCT03016650|Acetaminophen|acetaminophen|mesh-list
92364797|NCT03016650|Ibuprofen|ibuprofen|mesh-list
92364798|NCT03016650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364799|NCT03016650|Analgesics|analgesics|mesh-ancestor
92364800|NCT03016650|Sensory System Agents|sensory system agents|mesh-ancestor
92364801|NCT03016650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364802|NCT03016650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364803|NCT03016650|Antipyretics|antipyretics|mesh-ancestor
92364804|NCT03016650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364805|NCT03016650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364806|NCT03016650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364807|NCT03016650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92364808|NCT03016650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364809|NCT03016650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364810|NCT03016260|Adalimumab|adalimumab|mesh-list
92364811|NCT03016260|Infliximab|infliximab|mesh-list
92364812|NCT03016260|Golimumab|golimumab|mesh-list
91946286|NCT02441114|Hormones|hormones|mesh-ancestor
92364813|NCT03016260|Certolizumab Pegol|certolizumab pegol|mesh-list
92119051|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92364815|NCT03016260|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92364817|NCT03016260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92364818|NCT03016260|Dermatologic Agents|dermatologic agents|mesh-ancestor
92364819|NCT03016260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364820|NCT03016260|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92364821|NCT03016260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92364822|NCT03016260|Analgesics|analgesics|mesh-ancestor
91946336|NCT04596826|Hormones|hormones|mesh-ancestor
92364823|NCT03016260|Sensory System Agents|sensory system agents|mesh-ancestor
92364824|NCT03016260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364825|NCT03016260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364826|NCT03016260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92364827|NCT03016260|Immunologic Factors|immunologic factors|mesh-ancestor
92364828|NCT03015246|Morphine|morphine|mesh-list
92364829|NCT03015246|Buprenorphine|buprenorphine|mesh-list
92364830|NCT03015246|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92364831|NCT03015246|Naloxone|naloxone|mesh-list
91972331|NCT04156581|Dexamethasone|dexamethasone|mesh-list
92364832|NCT03015246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92364833|NCT03015246|Narcotics|narcotics|mesh-ancestor
92364834|NCT03015246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364835|NCT03015246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364836|NCT03015246|Analgesics|analgesics|mesh-ancestor
92017300|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
92364837|NCT03015246|Sensory System Agents|sensory system agents|mesh-ancestor
92364838|NCT03015246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364839|NCT03015246|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92364840|NCT03015168|Capecitabine|capecitabine|mesh-list
92364841|NCT03015168|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92364842|NCT03015168|Antimetabolites|antimetabolites|mesh-ancestor
92364843|NCT03015168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364844|NCT03015168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364845|NCT03014778|Chlorhexidine|chlorhexidine|mesh-list
92364846|NCT03014778|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92364847|NCT03014778|Povidone-Iodine|povidone-iodine|mesh-list
92364848|NCT03014778|Povidone|povidone|mesh-list
92364849|NCT03014778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92364850|NCT03014778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364851|NCT03014778|Disinfectants|disinfectants|mesh-ancestor
92364852|NCT03014778|Dermatologic Agents|dermatologic agents|mesh-ancestor
92364853|NCT03014778|Plasma Substitutes|plasma substitutes|mesh-ancestor
92364854|NCT03014778|Blood Substitutes|blood substitutes|mesh-ancestor
92364855|NCT03014076|Trastuzumab|trastuzumab|mesh-list
92364856|NCT03014076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92364857|NCT03014076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364858|NCT03013140|Anesthetics|anesthetics|mesh-list
92364859|NCT03013140|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364860|NCT03013140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364861|NCT03011970|Oxytocin|oxytocin|mesh-list
92364862|NCT03011970|Oxytocics|oxytocics|mesh-ancestor
92364863|NCT03011970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92364864|NCT03011970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364866|NCT03010098|Propofol|propofol|mesh-list
92364867|NCT03010098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92364868|NCT03010098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364869|NCT03010098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364870|NCT03010098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92364871|NCT03010098|Anesthetics, General|anesthetics, general|mesh-ancestor
92364872|NCT03010098|Anesthetics|anesthetics|mesh-ancestor
91972659|NCT00189319|Flecainide|flecainide|mesh-list
92364874|NCT03010098|Narcotics|narcotics|mesh-ancestor
92364875|NCT03010098|Analgesics|analgesics|mesh-ancestor
92364876|NCT03010098|Sensory System Agents|sensory system agents|mesh-ancestor
92364877|NCT03010098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364878|NCT03009474|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92364879|NCT03009474|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92364880|NCT03009474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92364881|NCT03009474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91972751|NCT03284645|Efavirenz|efavirenz|mesh-list
92364882|NCT03009474|Antimetabolites|antimetabolites|mesh-ancestor
92364883|NCT03009474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364884|NCT03009474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91972863|NCT02458625|Iron|iron|mesh-list
91946548|NCT02462720|Polidocanol|polidocanol|mesh-list
92364885|NCT03009474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92364886|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973011|NCT03268733|Folic Acid|folic acid|mesh-list
92364887|NCT03009474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92364888|NCT03009006|Calcium, Dietary|calcium, dietary|mesh-list
92364889|NCT03009006|Chlorhexidine|chlorhexidine|mesh-list
92364890|NCT03009006|Calcium|calcium|mesh-list
92364891|NCT03009006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92364892|NCT03009006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364893|NCT03009006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92364894|NCT03009006|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92364895|NCT03009006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92364896|NCT03009006|Disinfectants|disinfectants|mesh-ancestor
92364897|NCT03008148|Temozolomide|temozolomide|mesh-list
92364898|NCT03008148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92364899|NCT03008148|Alkylating Agents|alkylating agents|mesh-ancestor
92364900|NCT03008148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364901|NCT03008148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364903|NCT03007992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92364904|NCT03007992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364905|NCT03007992|Tubulin Modulators|tubulin modulators|mesh-ancestor
92364906|NCT03007992|Antimitotic Agents|antimitotic agents|mesh-ancestor
92364907|NCT03007992|Mitosis Modulators|mitosis modulators|mesh-ancestor
92364908|NCT03007992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364909|NCT03007446|Oxaliplatin|oxaliplatin|mesh-list
92364910|NCT03007446|Apatinib|apatinib|mesh-list
92364911|NCT03007446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364912|NCT03007446|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92364913|NCT03007446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364914|NCT03007446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364916|NCT03007524|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92364917|NCT03007524|Calcium|calcium|mesh-list
92364918|NCT03007524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92364919|NCT03007524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364920|NCT03007524|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92364921|NCT03007524|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92364922|NCT03007524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92364923|NCT03007524|Antimetabolites|antimetabolites|mesh-ancestor
91973352|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
92364924|NCT03007524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364925|NCT03007524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92364926|NCT03007524|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92364927|NCT03007524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364928|NCT03006042|Bupivacaine|bupivacaine|mesh-list
92364929|NCT03006042|Anesthetics, Local|anesthetics, local|mesh-ancestor
92364930|NCT03006042|Anesthetics|anesthetics|mesh-ancestor
92364931|NCT03006042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364932|NCT03006042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364933|NCT03006042|Sensory System Agents|sensory system agents|mesh-ancestor
92364934|NCT03006042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364935|NCT03005496|Vitamin D|vitamin d|mesh-list
92364936|NCT03005496|Cholecalciferol|cholecalciferol|mesh-list
92364937|NCT03005496|Beta Carotene|beta carotene|mesh-list
92364938|NCT03005496|Zinc|zinc|mesh-list
92364940|NCT03005496|Dexamethasone acetate|dexamethasone acetate|mesh-list
92364941|NCT03005496|Nifedipine|nifedipine|mesh-list
92364942|NCT03005496|BB 1101|bb 1101|mesh-list
92364943|NCT03005496|Carotenoids|carotenoids|mesh-list
92364944|NCT03005496|Picolinic acid|picolinic acid|mesh-list
92364946|NCT03005496|Micronutrients|micronutrients|mesh-ancestor
92364947|NCT03005496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364948|NCT03005496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92364949|NCT03005496|Antiemetics|antiemetics|mesh-ancestor
92364950|NCT03005496|Autonomic Agents|autonomic agents|mesh-ancestor
92364951|NCT03005496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364952|NCT03005496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92364953|NCT03005496|Glucocorticoids|glucocorticoids|mesh-ancestor
92364955|NCT03005496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364956|NCT03005496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92364957|NCT03005496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92364958|NCT03005496|Protease Inhibitors|protease inhibitors|mesh-ancestor
92364959|NCT03005496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92364960|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92364961|NCT03005496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92364962|NCT03005496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92364964|NCT03005496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92364965|NCT03005496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92364966|NCT03005496|Vasodilator Agents|vasodilator agents|mesh-ancestor
92364967|NCT03005496|Tocolytic Agents|tocolytic agents|mesh-ancestor
92364968|NCT03005496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92364969|NCT03005496|Antioxidants|antioxidants|mesh-ancestor
92364970|NCT03005496|Protective Agents|protective agents|mesh-ancestor
92364971|NCT03005496|Provitamins|provitamins|mesh-ancestor
92364972|NCT03005496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92364973|NCT03005496|Chelating Agents|chelating agents|mesh-ancestor
92364974|NCT03005496|Sequestering Agents|sequestering agents|mesh-ancestor
92364975|NCT03005808|Ropivacaine|ropivacaine|mesh-list
92364976|NCT03005808|Anesthetics, Local|anesthetics, local|mesh-ancestor
92364977|NCT03005808|Anesthetics|anesthetics|mesh-ancestor
92364978|NCT03005808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92364979|NCT03005808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364980|NCT03005808|Sensory System Agents|sensory system agents|mesh-ancestor
92364981|NCT03005808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92364982|NCT03005340|Cholecalciferol|cholecalciferol|mesh-list
92364983|NCT03005340|Vitamin D|vitamin d|mesh-list
92364984|NCT03005340|Bazedoxifene|bazedoxifene|mesh-list
92364985|NCT03005340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92364986|NCT03005340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92364987|NCT03005340|Vitamins|vitamins|mesh-ancestor
91973795|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92364988|NCT03005340|Micronutrients|micronutrients|mesh-ancestor
92364989|NCT03005340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92364990|NCT03005340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92364991|NCT03005340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92364993|NCT03005340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92364995|NCT03005184|Valsartan|valsartan|mesh-list
92364996|NCT03005184|Enalapril|enalapril|mesh-list
92364997|NCT03005184|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92364998|NCT03005184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92364999|NCT03005184|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92365000|NCT03005184|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92365001|NCT03005184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365002|NCT03005184|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92365003|NCT03005184|Protease Inhibitors|protease inhibitors|mesh-ancestor
92365004|NCT03005184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973985|NCT04947189|Hormones|hormones|mesh-ancestor
91974051|NCT03247283|Linrodostat|linrodostat|mesh-list
92365005|NCT03005184|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365006|NCT03005184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365007|NCT03005184|Analgesics|analgesics|mesh-ancestor
92365008|NCT03005184|Sensory System Agents|sensory system agents|mesh-ancestor
92365009|NCT03005184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365010|NCT03005184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365011|NCT03005184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365012|NCT03005184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365013|NCT03005184|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92365014|NCT03005184|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92365015|NCT03005184|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92365016|NCT03005184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92365017|NCT03005184|Immunologic Factors|immunologic factors|mesh-ancestor
92365019|NCT03004014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92365020|NCT03004014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365021|NCT03004014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365022|NCT03004014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92365023|NCT03004014|Anesthetics, General|anesthetics, general|mesh-ancestor
92365024|NCT03004014|Anesthetics|anesthetics|mesh-ancestor
92365025|NCT03002844|Carboplatin|carboplatin|mesh-list
92365026|NCT03002844|Gemcitabine|gemcitabine|mesh-list
92365027|NCT03002844|Pemetrexed|pemetrexed|mesh-list
92365028|NCT03002844|Gefitinib|gefitinib|mesh-list
92365029|NCT03002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365030|NCT03002844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92365031|NCT03002844|Antimetabolites|antimetabolites|mesh-ancestor
92365032|NCT03002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365034|NCT03002844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92365035|NCT03002844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92365036|NCT03002844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92365037|NCT03002376|Cemiplimab|cemiplimab|mesh-list
92365038|NCT03002376|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365039|NCT03002376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365040|NCT03002064|Docetaxel|docetaxel|mesh-list
92365041|NCT03002064|Fluorouracil|fluorouracil|mesh-list
92365042|NCT03002064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365043|NCT03002064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92365044|NCT03002064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92365045|NCT03002064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92365046|NCT03002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365047|NCT03002064|Antimetabolites|antimetabolites|mesh-ancestor
92365048|NCT03002064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92365049|NCT03002064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974661|NCT04918953|Budesonide|budesonide|mesh-list
92365050|NCT03002064|Immunologic Factors|immunologic factors|mesh-ancestor
92365051|NCT03002064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946769|NCT02291471|T0001|t0001|mesh-list
92365052|NCT03001128|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92365053|NCT03001128|Antiviral Agents|antiviral agents|mesh-ancestor
92365054|NCT03001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365055|NCT03000660|Dexamethasone|dexamethasone|mesh-list
92365056|NCT03000660|Venetoclax|venetoclax|mesh-list
92365057|NCT03000660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365058|NCT03000660|Antiemetics|antiemetics|mesh-ancestor
92365059|NCT03000660|Autonomic Agents|autonomic agents|mesh-ancestor
92365060|NCT03000660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365061|NCT03000660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365062|NCT03000660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92365063|NCT03000660|Glucocorticoids|glucocorticoids|mesh-ancestor
92365064|NCT03000660|Hormones|hormones|mesh-ancestor
92365065|NCT03000660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365066|NCT03000660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974766|NCT04903275|Fluorides|fluorides|mesh-list
92365068|NCT03000036|Doxorubicin|doxorubicin|mesh-list
92365069|NCT03000036|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92365070|NCT03000036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92365071|NCT03000036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365072|NCT03000036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365073|NCT03000036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365075|NCT03000036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365076|NCT03000036|Chelating Agents|chelating agents|mesh-ancestor
92365077|NCT03000036|Sequestering Agents|sequestering agents|mesh-ancestor
92365078|NCT02995824|Raltegravir Potassium|raltegravir potassium|mesh-list
91948244|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
92365080|NCT02995824|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92365081|NCT02995824|Antiviral Agents|antiviral agents|mesh-ancestor
92365082|NCT02995824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365083|NCT02995824|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92365084|NCT02995824|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92365085|NCT02995824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365086|NCT02995824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948669|NCT03506399|Estradiol|estradiol|mesh-list
92365088|NCT02989272|Analgesics|analgesics|mesh-ancestor
92365089|NCT02989272|Sensory System Agents|sensory system agents|mesh-ancestor
92365090|NCT02989272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365091|NCT02989272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365092|NCT02989272|Anesthetics|anesthetics|mesh-ancestor
92365093|NCT02989272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365094|NCT02989272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92365095|NCT02989272|Anticonvulsants|anticonvulsants|mesh-ancestor
92365096|NCT02989272|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92365097|NCT02989272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92365098|NCT02989272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365099|NCT02989272|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92365100|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
92365101|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92365102|NCT02989038|Nicotine|nicotine|mesh-list
92365103|NCT02989038|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92365104|NCT02989038|Autonomic Agents|autonomic agents|mesh-ancestor
91937512|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
92365106|NCT02989038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365107|NCT02989038|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92365108|NCT02989038|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92365109|NCT02989038|Cholinergic Agents|cholinergic agents|mesh-ancestor
91950248|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
92365110|NCT02989038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365111|NCT02989038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365112|NCT02988024|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92365113|NCT02988024|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92365114|NCT02988024|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92365115|NCT02988024|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92365116|NCT02988024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365117|NCT02988024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365118|NCT02988024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365119|NCT02988024|Antidepressive Agents|antidepressive agents|mesh-ancestor
92365120|NCT02988024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92365121|NCT02987556|Insulin|insulin|mesh-list
92365122|NCT02987556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92365123|NCT02987556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365124|NCT02987400|Venetoclax|venetoclax|mesh-list
92365125|NCT02987400|Obinutuzumab|obinutuzumab|mesh-list
92365126|NCT02987400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365127|NCT02987400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365128|NCT02987244|Prednisone|prednisone|mesh-list
92365129|NCT02987244|Cyclophosphamide|cyclophosphamide|mesh-list
92365130|NCT02987244|Etoposide|etoposide|mesh-list
92365131|NCT02987244|Epirubicin|epirubicin|mesh-list
92365132|NCT02987244|Vindesine|vindesine|mesh-list
92365133|NCT02987244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92365134|NCT02987244|Immunologic Factors|immunologic factors|mesh-ancestor
92365135|NCT02987244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365136|NCT02987244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365137|NCT02987244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92365138|NCT02987244|Alkylating Agents|alkylating agents|mesh-ancestor
92365139|NCT02987244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365140|NCT02987244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951898|NCT05579249|Hormones|hormones|mesh-ancestor
92365141|NCT02987244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92365142|NCT02987244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365143|NCT02987244|Glucocorticoids|glucocorticoids|mesh-ancestor
92365144|NCT02987244|Hormones|hormones|mesh-ancestor
92365145|NCT02987244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365146|NCT02987244|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92365147|NCT02987244|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91952242|NCT03854903|Fulvestrant|fulvestrant|mesh-list
92365148|NCT02987244|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365149|NCT02987244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365150|NCT02987244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365151|NCT02987244|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92365152|NCT02987244|Tubulin Modulators|tubulin modulators|mesh-ancestor
92365153|NCT02987244|Antimitotic Agents|antimitotic agents|mesh-ancestor
92365154|NCT02987244|Mitosis Modulators|mitosis modulators|mesh-ancestor
92365155|NCT02987166|Pembrolizumab|pembrolizumab|mesh-list
92365156|NCT02987166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365157|NCT02987166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365158|NCT02987166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92365159|NCT02987166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365161|NCT02982486|Ipilimumab|ipilimumab|mesh-list
92365162|NCT02982486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365163|NCT02982486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365164|NCT02982486|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92365165|NCT02982486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365166|NCT02981784|Ponatinib|ponatinib|mesh-list
92365167|NCT02981784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365168|NCT02981784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974882|NCT02155738|Analgesics|analgesics|mesh-ancestor
92365169|NCT02981784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953312|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92365170|NCT02981784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365171|NCT02980926|Bupivacaine|bupivacaine|mesh-list
92365172|NCT02980926|Mepivacaine|mepivacaine|mesh-list
92365173|NCT02980926|Anesthetics, Local|anesthetics, local|mesh-ancestor
92365175|NCT02980926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365176|NCT02980926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365177|NCT02980926|Sensory System Agents|sensory system agents|mesh-ancestor
91954042|NCT03429179|Butorphanol|butorphanol|mesh-list
92365179|NCT02980458|Deferiprone|deferiprone|mesh-list
92365180|NCT02980458|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92365181|NCT02980458|Chelating Agents|chelating agents|mesh-ancestor
92365182|NCT02980458|Sequestering Agents|sequestering agents|mesh-ancestor
92365183|NCT02980458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954726|NCT03179605|Clobetasol|clobetasol|mesh-list
92365185|NCT02978976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365186|NCT02978976|Glucocorticoids|glucocorticoids|mesh-ancestor
92365187|NCT02978976|Hormones|hormones|mesh-ancestor
92115519|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365188|NCT02978976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954959|NCT02900443|Azathioprine|azathioprine|mesh-list
92365189|NCT02978976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365190|NCT02978976|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92365191|NCT02978976|Respiratory System Agents|respiratory system agents|mesh-ancestor
92365194|NCT02979132|Micronutrients|micronutrients|mesh-ancestor
92365195|NCT02979132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365197|NCT02978040|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92365198|NCT02978040|Cangrelor|cangrelor|mesh-list
92365199|NCT02978040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92365200|NCT02978040|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92365201|NCT02978040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92365202|NCT02978040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365203|NCT02978040|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92365204|NCT02978040|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92365205|NCT02978040|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92365206|NCT02978040|Purinergic Agents|purinergic agents|mesh-ancestor
92365207|NCT02978040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955851|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
92365208|NCT02978040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365210|NCT02976246|Vitamin K 2|vitamin k 2|mesh-list
92365211|NCT02976246|Vitamins|vitamins|mesh-ancestor
92365212|NCT02976246|Micronutrients|micronutrients|mesh-ancestor
92365213|NCT02976246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365214|NCT02976246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92365215|NCT02976246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92017691|NCT04946383|Dasatinib|dasatinib|mesh-list
92365216|NCT02976246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365217|NCT02976246|Hemostatics|hemostatics|mesh-ancestor
92365218|NCT02976246|Coagulants|coagulants|mesh-ancestor
92365219|NCT02976012|Aflibercept|aflibercept|mesh-list
92365220|NCT02976012|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92365221|NCT02976012|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92365222|NCT02976012|Growth Substances|growth substances|mesh-ancestor
92365223|NCT02976012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365224|NCT02976012|Growth Inhibitors|growth inhibitors|mesh-ancestor
92365225|NCT02976012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365226|NCT02975076|Aspirin|aspirin|mesh-list
92365227|NCT02975076|Clopidogrel|clopidogrel|mesh-list
92365228|NCT02975076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365229|NCT02975076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365230|NCT02975076|Analgesics|analgesics|mesh-ancestor
92365231|NCT02975076|Sensory System Agents|sensory system agents|mesh-ancestor
92365232|NCT02975076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956140|NCT03393481|Enoxaparin|enoxaparin|mesh-list
92365233|NCT02975076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365234|NCT02975076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365235|NCT02975076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365236|NCT02975076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92365237|NCT02975076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92365238|NCT02975076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365239|NCT02975076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92365241|NCT02975076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365242|NCT02975076|Antipyretics|antipyretics|mesh-ancestor
92365243|NCT02975076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92365244|NCT02975076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92365245|NCT02975076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92365246|NCT02975076|Purinergic Agents|purinergic agents|mesh-ancestor
91957532|NCT05237791|Analgesics|analgesics|mesh-ancestor
92365247|NCT02975076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365249|NCT02974920|Rivaroxaban|rivaroxaban|mesh-list
92365250|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365251|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365252|NCT02974920|Analgesics|analgesics|mesh-ancestor
91957817|NCT03379987|Narcotics|narcotics|mesh-ancestor
92365253|NCT02974920|Sensory System Agents|sensory system agents|mesh-ancestor
92365254|NCT02974920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365255|NCT02974920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365256|NCT02974920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365257|NCT02974920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365258|NCT02974920|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92365259|NCT02974920|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92365260|NCT02974920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365261|NCT02974920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92365262|NCT02974920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92365263|NCT02974920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365264|NCT02974920|Antipyretics|antipyretics|mesh-ancestor
92365265|NCT02974920|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92365266|NCT02974920|Antithrombins|antithrombins|mesh-ancestor
92365267|NCT02974920|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92365268|NCT02974920|Protease Inhibitors|protease inhibitors|mesh-ancestor
92365269|NCT02974920|Anticoagulants|anticoagulants|mesh-ancestor
92365270|NCT02973204|Everolimus|everolimus|mesh-list
92365271|NCT02973204|Sorafenib|sorafenib|mesh-list
92365272|NCT02973204|Octreotide|octreotide|mesh-list
92365273|NCT02973204|Lanreotide|lanreotide|mesh-list
92365274|NCT02973204|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92365275|NCT02973204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92365276|NCT02973204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365277|NCT02973204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365278|NCT02973204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92365279|NCT02973204|Immunologic Factors|immunologic factors|mesh-ancestor
92365280|NCT02973204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365281|NCT02973204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365282|NCT02973204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92365283|NCT02973204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92365284|NCT02959476|Ropivacaine|ropivacaine|mesh-list
92365285|NCT02959476|Anesthetics, Local|anesthetics, local|mesh-ancestor
92365286|NCT02959476|Anesthetics|anesthetics|mesh-ancestor
92365287|NCT02959476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365288|NCT02959476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365289|NCT02959476|Sensory System Agents|sensory system agents|mesh-ancestor
92017758|NCT03057769|Indomethacin|indomethacin|mesh-list
92365290|NCT02959476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365291|NCT02958852|Letrozole|letrozole|mesh-list
92365292|NCT02958852|Fulvestrant|fulvestrant|mesh-list
92365293|NCT02958852|Atorvastatin|atorvastatin|mesh-list
92365294|NCT02958852|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92365295|NCT02958852|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92365296|NCT02958852|Antimetabolites|antimetabolites|mesh-ancestor
92365297|NCT02958852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365298|NCT02958852|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92365299|NCT02958852|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92365300|NCT02958852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365301|NCT02958852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365302|NCT02958852|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92365303|NCT02958852|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92365304|NCT02958852|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92365305|NCT02958852|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959529|NCT03122353|Glucocorticoids|glucocorticoids|mesh-ancestor
92365306|NCT02958852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365307|NCT02958852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365308|NCT02958852|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92365309|NCT02958852|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92365310|NCT02641782|Aldesleukin|aldesleukin|mesh-list
92365311|NCT02641782|Interleukin-2|interleukin-2|mesh-list
92365312|NCT02641782|Tretinoin|tretinoin|mesh-list
92365313|NCT02641782|Dinutuximab|dinutuximab|mesh-list
92365314|NCT02641782|Isotretinoin|isotretinoin|mesh-list
92365315|NCT02641782|Antibodies|antibodies|mesh-list
92365316|NCT02641782|Sargramostim|sargramostim|mesh-list
92365317|NCT02641782|Immunologic Factors|immunologic factors|mesh-ancestor
92365318|NCT02641782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365319|NCT02641782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365320|NCT02641782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365321|NCT02641782|Analgesics|analgesics|mesh-ancestor
92365322|NCT02641782|Sensory System Agents|sensory system agents|mesh-ancestor
92365323|NCT02641782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365324|NCT02641782|Keratolytic Agents|keratolytic agents|mesh-ancestor
92365325|NCT02641782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92365326|NCT02641782|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92365327|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92365331|NCT02641314|Propranolol|propranolol|mesh-list
92365332|NCT02641314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365333|NCT02641314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365334|NCT02641314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966136|NCT03246685|Pembrolizumab|pembrolizumab|mesh-list
92365335|NCT02641314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365336|NCT02641314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365337|NCT02641314|Analgesics|analgesics|mesh-ancestor
92365338|NCT02641314|Sensory System Agents|sensory system agents|mesh-ancestor
92365339|NCT02641314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365340|NCT02641314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365341|NCT02641314|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92365342|NCT02641314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967574|NCT03334487|Hormones|hormones|mesh-ancestor
92365343|NCT02641314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365344|NCT02641314|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92365345|NCT02641314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92365346|NCT02641314|Adrenergic Agents|adrenergic agents|mesh-ancestor
92365347|NCT02641314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365348|NCT02641314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92365349|NCT02641314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92365350|NCT02641314|Vasodilator Agents|vasodilator agents|mesh-ancestor
92365351|NCT04769778|Valsartan|valsartan|mesh-list
92365352|NCT04769778|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92365353|NCT04769778|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92365354|NCT04769778|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92365355|NCT04769778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365356|NCT04769076|Paclitaxel|paclitaxel|mesh-list
92365358|NCT04769076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91974899|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92365359|NCT04769076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92365360|NCT04769076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365361|NCT04769076|Tubulin Modulators|tubulin modulators|mesh-ancestor
92365362|NCT04769076|Antimitotic Agents|antimitotic agents|mesh-ancestor
92365363|NCT04769076|Mitosis Modulators|mitosis modulators|mesh-ancestor
91974966|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
92365364|NCT04769076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365365|NCT04769076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365368|NCT04768764|Anesthetics, Local|anesthetics, local|mesh-ancestor
92365369|NCT04768764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365370|NCT04768764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365371|NCT04768764|Sensory System Agents|sensory system agents|mesh-ancestor
92365372|NCT04768764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365373|NCT04768530|Nitazoxanide|nitazoxanide|mesh-list
92365374|NCT04768530|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92365375|NCT04768530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365376|NCT04748562|Progesterone|progesterone|mesh-list
92365377|NCT04748562|Progestins|progestins|mesh-ancestor
92365378|NCT04748562|Hormones|hormones|mesh-ancestor
92365379|NCT04748562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365380|NCT04748562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365381|NCT04745286|Ketamine|ketamine|mesh-list
92365383|NCT04745286|Analgesics|analgesics|mesh-ancestor
92365384|NCT04745286|Sensory System Agents|sensory system agents|mesh-ancestor
92365385|NCT04745286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975317|NCT03049059|Protective Agents|protective agents|mesh-ancestor
92365386|NCT04745286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365387|NCT04745286|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92365388|NCT04745286|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92365389|NCT04745286|Anesthetics, General|anesthetics, general|mesh-ancestor
92365390|NCT04745286|Anesthetics|anesthetics|mesh-ancestor
92365391|NCT04745286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365392|NCT04745286|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92365393|NCT04745286|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92365394|NCT04745286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365395|NCT04745286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365396|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
92365397|NCT04745286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92365399|NCT04745442|Antithrombin III|antithrombin iii|mesh-list
92365400|NCT04745442|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92365401|NCT04745442|Protease Inhibitors|protease inhibitors|mesh-ancestor
92365402|NCT04745442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365403|NCT04745442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365404|NCT04745442|Anticoagulants|anticoagulants|mesh-ancestor
92365405|NCT04743180|Paclitaxel|paclitaxel|mesh-list
92365406|NCT04743180|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92365407|NCT04743180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365408|NCT04743180|Tubulin Modulators|tubulin modulators|mesh-ancestor
92365409|NCT04743180|Antimitotic Agents|antimitotic agents|mesh-ancestor
92365410|NCT04743180|Mitosis Modulators|mitosis modulators|mesh-ancestor
92365411|NCT04743180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365412|NCT04740840|Amlodipine|amlodipine|mesh-list
91975794|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365413|NCT04740840|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92365414|NCT04740840|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92365415|NCT04740840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92365416|NCT04740840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365417|NCT04740840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92365418|NCT04740840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365419|NCT04740840|Vasodilator Agents|vasodilator agents|mesh-ancestor
92365420|NCT04739826|Flumatinib|flumatinib|mesh-list
92365421|NCT04739826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92365422|NCT04739826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365423|NCT04739826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365424|NCT04739202|Bevacizumab|bevacizumab|mesh-list
92365425|NCT04739202|Atezolizumab|atezolizumab|mesh-list
92365426|NCT04739202|Ipatasertib|ipatasertib|mesh-list
92365427|NCT04739202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91975877|NCT03045471|Rituximab|rituximab|mesh-list
92365428|NCT04739202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365429|NCT04739202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365430|NCT04739202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92365431|NCT04739202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92365432|NCT04739202|Growth Substances|growth substances|mesh-ancestor
92365433|NCT04739202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365434|NCT04739202|Growth Inhibitors|growth inhibitors|mesh-ancestor
92365435|NCT04739202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92365436|NCT04739202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365437|NCT04739202|Immunologic Factors|immunologic factors|mesh-ancestor
92365438|NCT04739202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92365439|NCT04739202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365440|NCT04738188|Epirubicin|epirubicin|mesh-list
92365441|NCT04738188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92365442|NCT04738188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365443|NCT04738188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365444|NCT04738188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365445|NCT04738188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365446|NCT04738188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365447|NCT04737408|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92365448|NCT04737408|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92365449|NCT04737408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92365450|NCT04737408|Antimetabolites|antimetabolites|mesh-ancestor
92365451|NCT04737408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365452|NCT04737408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92365453|NCT04737408|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91976310|NCT04860531|Betamethasone|betamethasone|mesh-list
92365454|NCT04737408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365455|NCT05314140|Calcium|calcium|mesh-list
92365456|NCT05314140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92365457|NCT05314140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365458|NCT05313906|Cisplatin|cisplatin|mesh-list
92365459|NCT05313906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365460|NCT05313828|Fluorometholone|fluorometholone|mesh-list
92365461|NCT05313828|Tobramycin|tobramycin|mesh-list
92365462|NCT05313828|Acyclovir|acyclovir|mesh-list
92365463|NCT05313828|Hyaluronic Acid|hyaluronic acid|mesh-list
92365464|NCT05313828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92365465|NCT05313828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365466|NCT05313828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92365467|NCT05313828|Immunologic Factors|immunologic factors|mesh-ancestor
92365468|NCT05313828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365469|NCT05313828|Viscosupplements|viscosupplements|mesh-ancestor
92365470|NCT05313828|Protective Agents|protective agents|mesh-ancestor
92365471|NCT05313828|Antiviral Agents|antiviral agents|mesh-ancestor
92365472|NCT05313828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365473|NCT05313828|Glucocorticoids|glucocorticoids|mesh-ancestor
92365474|NCT05313828|Hormones|hormones|mesh-ancestor
92365475|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365477|NCT05313750|Levofloxacin|levofloxacin|mesh-list
92365478|NCT05313750|Sitafloxacin|sitafloxacin|mesh-list
92365479|NCT05313750|Anti-Infective Agents|anti-infective agents|mesh-list
92365480|NCT05313750|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92365481|NCT05313750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92365482|NCT05313750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365483|NCT05313750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365484|NCT05313750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365485|NCT05313750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365486|NCT05313750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365487|NCT05313750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92365488|NCT05313750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92365489|NCT04662684|Rivaroxaban|rivaroxaban|mesh-list
92365490|NCT04662684|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92365491|NCT04662684|Antithrombins|antithrombins|mesh-ancestor
92365492|NCT04662684|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92365493|NCT04662684|Protease Inhibitors|protease inhibitors|mesh-ancestor
92365494|NCT04662684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365495|NCT04662684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365496|NCT04662684|Anticoagulants|anticoagulants|mesh-ancestor
92365497|NCT05139966|Fluorides|fluorides|mesh-list
92365498|NCT05139966|Cariostatic Agents|cariostatic agents|mesh-ancestor
92365499|NCT05139966|Protective Agents|protective agents|mesh-ancestor
92365500|NCT05139966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365501|NCT05138718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92365502|NCT05138718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92365503|NCT05138718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365504|NCT00575016|Botulinum Toxins|botulinum toxins|mesh-list
92365505|NCT00575016|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92365506|NCT00575016|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92365507|NCT00575016|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92365508|NCT00575016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92365509|NCT00575016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365510|NCT00575016|Cholinergic Agents|cholinergic agents|mesh-ancestor
92365511|NCT00575016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365512|NCT00575016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365513|NCT00575016|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92365514|NCT00575016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365515|NCT00577590|Metformin|metformin|mesh-list
92365516|NCT00577590|Rosiglitazone|rosiglitazone|mesh-list
92365517|NCT00577590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92365518|NCT00577590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365519|NCT00578214|Midazolam|midazolam|mesh-list
92365520|NCT00578214|Anesthetics|anesthetics|mesh-ancestor
92365521|NCT00578214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365522|NCT00578214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365523|NCT00578214|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92365524|NCT00578214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92365525|NCT00578214|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92365526|NCT00578214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92365527|NCT00578214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92365528|NCT00578214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92365529|NCT00578214|Anesthetics, General|anesthetics, general|mesh-ancestor
92365530|NCT00578214|GABA Modulators|gaba modulators|mesh-ancestor
92365531|NCT00578214|GABA Agents|gaba agents|mesh-ancestor
92365532|NCT00578214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365533|NCT00578214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365534|NCT00580398|Varenicline|varenicline|mesh-list
92365535|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92365536|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92365537|NCT00580398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92365538|NCT00580398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365539|NCT00580398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977039|NCT04850001|Aspirin|aspirin|mesh-list
92365540|NCT00580398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365541|NCT00582660|Celecoxib|celecoxib|mesh-list
92365542|NCT00582660|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365543|NCT00582660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365544|NCT00582660|Analgesics|analgesics|mesh-ancestor
92365545|NCT00582660|Sensory System Agents|sensory system agents|mesh-ancestor
92365546|NCT00582660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365547|NCT00582660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365548|NCT00582660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365550|NCT00582660|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92365551|NCT00582660|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92365552|NCT00582660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365553|NCT00582660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365554|NCT00582894|Fludarabine|fludarabine|mesh-list
92365555|NCT00582894|Alemtuzumab|alemtuzumab|mesh-list
92365556|NCT00582894|Busulfan|busulfan|mesh-list
92365557|NCT00582894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365558|NCT00582894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365559|NCT00582894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92365560|NCT00582894|Immunologic Factors|immunologic factors|mesh-ancestor
92365561|NCT00582894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365562|NCT00582894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365563|NCT00582894|Alkylating Agents|alkylating agents|mesh-ancestor
92365564|NCT00582894|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92365565|NCT00582894|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92365566|NCT00585780|Prazosin|prazosin|mesh-list
92365567|NCT00585780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92365568|NCT00585780|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92365569|NCT00585780|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92365570|NCT00585780|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92365571|NCT00585780|Adrenergic Agents|adrenergic agents|mesh-ancestor
92365572|NCT00585780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365573|NCT00585780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365574|NCT00585780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365575|NCT00586482|Nicotine|nicotine|mesh-list
92365576|NCT00586482|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92365577|NCT00586482|Autonomic Agents|autonomic agents|mesh-ancestor
92365578|NCT00586482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365579|NCT00586482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365580|NCT00586482|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92365581|NCT00586482|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92365582|NCT00586482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92365583|NCT00586482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365584|NCT00586482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365585|NCT03708354|Tocotrienols|tocotrienols|mesh-list
92365586|NCT03708354|Vitamin E|vitamin e|mesh-list
92365587|NCT03708354|Tocopherols|tocopherols|mesh-list
92365588|NCT03708354|Antioxidants|antioxidants|mesh-ancestor
92365589|NCT03708354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365590|NCT03708354|Protective Agents|protective agents|mesh-ancestor
92365591|NCT03708354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365593|NCT03708354|Micronutrients|micronutrients|mesh-ancestor
92365594|NCT03297684|Aflibercept|aflibercept|mesh-list
92365595|NCT03297684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92365596|NCT03297684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92365597|NCT03297684|Growth Substances|growth substances|mesh-ancestor
92365598|NCT03297684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365599|NCT03297684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92365600|NCT03297684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365601|NCT01740648|Fluorouracil|fluorouracil|mesh-list
92365602|NCT01740648|Trametinib|trametinib|mesh-list
92365603|NCT01740648|Antimetabolites|antimetabolites|mesh-ancestor
92365604|NCT01740648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365605|NCT01740648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92365606|NCT01740648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365607|NCT01740648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92365608|NCT01740648|Immunologic Factors|immunologic factors|mesh-ancestor
92365609|NCT01740648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365610|NCT01740648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92365611|NCT01740648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365612|NCT01685424|Etoricoxib|etoricoxib|mesh-list
92365613|NCT01685424|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365614|NCT01685424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365615|NCT01685424|Analgesics|analgesics|mesh-ancestor
92365616|NCT01685424|Sensory System Agents|sensory system agents|mesh-ancestor
92365617|NCT01685424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365618|NCT01685424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365619|NCT01685424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365620|NCT01685424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365621|NCT01685424|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92365622|NCT01685424|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92365623|NCT01685424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365624|NCT01685424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365625|NCT01327638|Etoricoxib|etoricoxib|mesh-list
92365626|NCT01327638|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92365627|NCT01327638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365628|NCT01327638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365629|NCT01327638|Analgesics|analgesics|mesh-ancestor
92365630|NCT01327638|Sensory System Agents|sensory system agents|mesh-ancestor
92365631|NCT01327638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365632|NCT01327638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365633|NCT01327638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365634|NCT01327638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365635|NCT01327638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92365636|NCT01327638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115520|NCT01986946|Analgesics|analgesics|mesh-ancestor
92365637|NCT01327638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365638|NCT00393354|Etoricoxib|etoricoxib|mesh-list
92365639|NCT00393354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365640|NCT00393354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365641|NCT00393354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365642|NCT00393354|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92365643|NCT00393354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92365644|NCT00393354|Analgesics|analgesics|mesh-ancestor
92365645|NCT00393354|Sensory System Agents|sensory system agents|mesh-ancestor
92365646|NCT00393354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365648|NCT00393354|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92365649|NCT00393354|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92365651|NCT00166530|Atorvastatin|atorvastatin|mesh-list
92365652|NCT00166530|Simvastatin|simvastatin|mesh-list
92365653|NCT00166530|Ezetimibe|ezetimibe|mesh-list
92365654|NCT00166530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92365655|NCT00166530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92365656|NCT00166530|Antimetabolites|antimetabolites|mesh-ancestor
92365657|NCT00166530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365658|NCT00166530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92365659|NCT00166530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92365660|NCT00166530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365661|NCT00588900|Irinotecan|irinotecan|mesh-list
92365662|NCT00588900|Cediranib|cediranib|mesh-list
92365663|NCT00588900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92365664|NCT00588900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92018176|NCT04915807|Taxane|taxane|mesh-list
92365665|NCT00588900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365666|NCT00588900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365667|NCT00588900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365668|NCT00588900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92365669|NCT00589056|Nelfinavir|nelfinavir|mesh-list
92365670|NCT00589056|Etoposide|etoposide|mesh-list
92365671|NCT00589056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365672|NCT00589056|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92365673|NCT00589056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365674|NCT00589056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365675|NCT00589056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365676|NCT00589056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365677|NCT00589056|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92365678|NCT00589056|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92365679|NCT00589056|Protease Inhibitors|protease inhibitors|mesh-ancestor
92365680|NCT00589056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92365681|NCT00589056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92365682|NCT00589056|Antiviral Agents|antiviral agents|mesh-ancestor
92365683|NCT00589056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365684|NCT00590226|Insulin|insulin|mesh-list
92365685|NCT00590226|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92365686|NCT00590226|Insulin Aspart|insulin aspart|mesh-list
92365687|NCT00590226|Insulin, Isophane|insulin, isophane|mesh-list
92365688|NCT00590226|Isophane Insulin, Human|isophane insulin, human|mesh-list
92365689|NCT00590226|Isophane insulin, beef|isophane insulin, beef|mesh-list
92365690|NCT00590226|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92365691|NCT00590226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365692|NCT00590460|Fludarabine|fludarabine|mesh-list
92365693|NCT00590460|Alemtuzumab|alemtuzumab|mesh-list
92365694|NCT00590460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365695|NCT00590460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365696|NCT00590772|Montelukast|montelukast|mesh-list
92365697|NCT00590772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92365698|NCT00590772|Respiratory System Agents|respiratory system agents|mesh-ancestor
92365699|NCT00590772|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92365700|NCT00590772|Hormone Antagonists|hormone antagonists|mesh-ancestor
92365701|NCT00590772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365702|NCT00590772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365703|NCT00590772|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92365704|NCT00590772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92365705|NCT00590772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365706|NCT00592176|Bevacizumab|bevacizumab|mesh-list
92365707|NCT00592176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365708|NCT00592176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365709|NCT00592176|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92365710|NCT00592176|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92365711|NCT00592176|Growth Substances|growth substances|mesh-ancestor
92365712|NCT00592176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365713|NCT00592176|Growth Inhibitors|growth inhibitors|mesh-ancestor
92365714|NCT00592488|Acetylcarnitine|acetylcarnitine|mesh-list
92365715|NCT00592488|Vitamin B Complex|vitamin b complex|mesh-ancestor
92365716|NCT00592488|Vitamins|vitamins|mesh-ancestor
92365717|NCT00592488|Micronutrients|micronutrients|mesh-ancestor
92365718|NCT00592488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365719|NCT00592488|Nootropic Agents|nootropic agents|mesh-ancestor
92365720|NCT00595530|Ketamine|ketamine|mesh-list
92365721|NCT00595530|Analgesics|analgesics|mesh-ancestor
92365722|NCT00595530|Sensory System Agents|sensory system agents|mesh-ancestor
92365723|NCT00595530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365724|NCT00595530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365725|NCT00595530|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92365726|NCT00595530|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92365727|NCT00595530|Anesthetics, General|anesthetics, general|mesh-ancestor
92365728|NCT00595530|Anesthetics|anesthetics|mesh-ancestor
92365729|NCT00595530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365730|NCT00595530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92365731|NCT00595530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92365732|NCT00595530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365733|NCT00595530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365734|NCT00596622|Lithium Carbonate|lithium carbonate|mesh-list
92365735|NCT00596622|Antidepressive Agents|antidepressive agents|mesh-ancestor
92365736|NCT00596622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92365737|NCT00596622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365738|NCT00596622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365739|NCT00596622|Antimanic Agents|antimanic agents|mesh-ancestor
92365741|NCT00596622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365742|NCT00596622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365743|NCT00597402|Bevacizumab|bevacizumab|mesh-list
92365744|NCT00597402|Irinotecan|irinotecan|mesh-list
92365745|NCT00597402|Temozolomide|temozolomide|mesh-list
91977188|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
92365746|NCT00597402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365747|NCT00597402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365748|NCT00597402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92365749|NCT00597402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92365750|NCT00597402|Growth Substances|growth substances|mesh-ancestor
92365751|NCT00597402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365752|NCT00597402|Growth Inhibitors|growth inhibitors|mesh-ancestor
92365753|NCT00597402|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92365754|NCT00597402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365755|NCT00597402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365756|NCT00597402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977368|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
92365757|NCT00597402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92365758|NCT00597402|Alkylating Agents|alkylating agents|mesh-ancestor
92365760|NCT00598806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365761|NCT00601926|Bevacizumab|bevacizumab|mesh-list
92365762|NCT00601926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365763|NCT00601926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365764|NCT00601926|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92365765|NCT00601926|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92365766|NCT00601926|Growth Substances|growth substances|mesh-ancestor
92365767|NCT00601926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365768|NCT00601926|Growth Inhibitors|growth inhibitors|mesh-ancestor
92365769|NCT00603018|Fluoxetine|fluoxetine|mesh-list
92365770|NCT00603018|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92365771|NCT00603018|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92365772|NCT00603018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92365773|NCT00603018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365774|NCT00603018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365775|NCT00603018|Serotonin Agents|serotonin agents|mesh-ancestor
92365776|NCT00603018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365777|NCT00603018|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92365778|NCT00603018|Antidepressive Agents|antidepressive agents|mesh-ancestor
92365779|NCT00603018|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92365780|NCT00603018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92365781|NCT00603018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92365782|NCT00603018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365783|NCT00603408|Cisplatin|cisplatin|mesh-list
92365784|NCT00603408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365785|NCT00603720|Phenylephrine|phenylephrine|mesh-list
92365786|NCT00603720|Oxymetazoline|oxymetazoline|mesh-list
92365787|NCT00603720|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
92365788|NCT00603720|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92365790|NCT00603720|Autonomic Agents|autonomic agents|mesh-ancestor
92365791|NCT00603720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365792|NCT00603720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365793|NCT00603720|Sympathomimetics|sympathomimetics|mesh-ancestor
92365794|NCT00603720|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92365795|NCT00603720|Nasal Decongestants|nasal decongestants|mesh-ancestor
92365796|NCT00603720|Respiratory System Agents|respiratory system agents|mesh-ancestor
92365797|NCT00603720|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92365798|NCT00603720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92365799|NCT00603720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92365800|NCT00603720|Adrenergic Agents|adrenergic agents|mesh-ancestor
92365801|NCT00603720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365802|NCT00603720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365803|NCT00603720|Protective Agents|protective agents|mesh-ancestor
92365804|NCT00603720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365805|NCT00625404|Tenofovir|tenofovir|mesh-list
92365806|NCT00625404|Emtricitabine|emtricitabine|mesh-list
92365807|NCT00625404|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92365808|NCT00625404|Antiviral Agents|antiviral agents|mesh-ancestor
92365809|NCT00625404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365810|NCT00625404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92365811|NCT00625404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92365812|NCT00625404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365813|NCT00625404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365814|NCT00625404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92365815|NCT00625404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92365816|NCT00626340|Fluoxetine|fluoxetine|mesh-list
92365817|NCT00626340|Estrogens|estrogens|mesh-list
92365818|NCT00626340|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92365819|NCT00626340|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92365820|NCT00626340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92365821|NCT00626340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365822|NCT00626340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365823|NCT00626340|Serotonin Agents|serotonin agents|mesh-ancestor
92365824|NCT00626340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978159|NCT02444897|Ropivacaine|ropivacaine|mesh-list
92365825|NCT00626340|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92365826|NCT00626340|Antidepressive Agents|antidepressive agents|mesh-ancestor
92365827|NCT00626340|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92365828|NCT00626340|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91978249|NCT01626352|Ofatumumab|ofatumumab|mesh-list
92365829|NCT00626340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92365831|NCT00626340|Hormones|hormones|mesh-ancestor
92365832|NCT00626340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365834|NCT00626574|Hematinics|hematinics|mesh-ancestor
92365835|NCT00626886|Bupivacaine|bupivacaine|mesh-list
92365836|NCT00626886|Anesthetics, Local|anesthetics, local|mesh-ancestor
92365837|NCT00626886|Anesthetics|anesthetics|mesh-ancestor
91978419|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
92365838|NCT00626886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92365839|NCT00626886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365840|NCT00626886|Sensory System Agents|sensory system agents|mesh-ancestor
92365841|NCT00626886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365843|NCT00628134|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92365844|NCT00628134|Respiratory System Agents|respiratory system agents|mesh-ancestor
92365845|NCT00632814|Factor VIII|factor viii|mesh-list
92365846|NCT00632814|Coagulants|coagulants|mesh-ancestor
92365847|NCT00632970|Ritonavir|ritonavir|mesh-list
92365848|NCT00632970|Lopinavir|lopinavir|mesh-list
92365849|NCT00632970|Tenofovir|tenofovir|mesh-list
92365850|NCT00632970|Emtricitabine|emtricitabine|mesh-list
92365851|NCT00632970|Raltegravir Potassium|raltegravir potassium|mesh-list
92365852|NCT00632970|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92365853|NCT00632970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92365854|NCT00632970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92365855|NCT00632970|Protease Inhibitors|protease inhibitors|mesh-ancestor
92365856|NCT00632970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365857|NCT00632970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365858|NCT00632970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92365859|NCT00632970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92365860|NCT00632970|Antiviral Agents|antiviral agents|mesh-ancestor
92365861|NCT00632970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92365862|NCT00632970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92365863|NCT00632970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92365864|NCT00632970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92365865|NCT00632970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92365866|NCT00632970|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92365867|NCT00632970|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92365868|NCT00635232|Irbesartan|irbesartan|mesh-list
92365869|NCT00635232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92365870|NCT00635232|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92365871|NCT00635232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92365872|NCT00635232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365874|NCT00637494|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92365875|NCT00637494|Abortifacient Agents|abortifacient agents|mesh-ancestor
92365876|NCT00637494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92365877|NCT00637494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978698|NCT02705859|Trastuzumab|trastuzumab|mesh-list
92365878|NCT00637494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92365879|NCT00637494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92365880|NCT00637494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92365881|NCT00637494|Contraceptive Agents|contraceptive agents|mesh-ancestor
92365882|NCT00637494|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92365883|NCT00637494|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92365884|NCT00637494|Hormone Antagonists|hormone antagonists|mesh-ancestor
92365885|NCT00637494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365887|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92365888|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92365890|NCT00638820|Alemtuzumab|alemtuzumab|mesh-list
92365891|NCT00638820|Clofarabine|clofarabine|mesh-list
92365892|NCT00638820|Alkylating Agents|alkylating agents|mesh-ancestor
92365893|NCT00638820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365894|NCT00638820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92365895|NCT00638820|Immunologic Factors|immunologic factors|mesh-ancestor
92365896|NCT00638820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365897|NCT00638820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92365898|NCT00638820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365899|NCT00638820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92365900|NCT00638820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92365901|NCT00638820|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92365902|NCT00638820|Antimetabolites|antimetabolites|mesh-ancestor
92365903|NCT00641862|Vitamin B 12|vitamin b 12|mesh-list
92365904|NCT00641862|Hydroxocobalamin|hydroxocobalamin|mesh-list
92365905|NCT00641862|Vitamins|vitamins|mesh-ancestor
92365906|NCT00641862|Micronutrients|micronutrients|mesh-ancestor
92365907|NCT00641862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365908|NCT00641862|Vitamin B Complex|vitamin b complex|mesh-ancestor
92365909|NCT00641862|Hematinics|hematinics|mesh-ancestor
92365910|NCT00643578|Formoterol Fumarate|formoterol fumarate|mesh-list
92365911|NCT00643578|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92365912|NCT00643578|Autonomic Agents|autonomic agents|mesh-ancestor
92365913|NCT00643578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365914|NCT00643578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365915|NCT00643578|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92365916|NCT00643578|Respiratory System Agents|respiratory system agents|mesh-ancestor
92365917|NCT00643578|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92365918|NCT00643578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92365919|NCT00643578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92365920|NCT00643578|Adrenergic Agents|adrenergic agents|mesh-ancestor
92365921|NCT00643578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365922|NCT00643578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365924|NCT00644592|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92365925|NCT00644592|Antimetabolites|antimetabolites|mesh-ancestor
92365926|NCT00644592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365928|NCT00645450|Propranolol|propranolol|mesh-list
92365929|NCT00645450|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92365930|NCT00645450|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92365931|NCT00645450|Adrenergic Agents|adrenergic agents|mesh-ancestor
92365932|NCT00645450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365933|NCT00645450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365934|NCT00645450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365935|NCT00645450|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92365936|NCT00645450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92365937|NCT00645450|Vasodilator Agents|vasodilator agents|mesh-ancestor
92365938|NCT00647400|Adalimumab|adalimumab|mesh-list
92365939|NCT00647400|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92365940|NCT00647400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365941|NCT00647400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92365942|NCT00648648|Carboplatin|carboplatin|mesh-list
92365943|NCT00648648|Gemcitabine|gemcitabine|mesh-list
92365944|NCT00648648|Adavosertib|adavosertib|mesh-list
92365945|NCT00648648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365946|NCT00648648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92365948|NCT00648648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365949|NCT00648648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365950|NCT00652314|Thrombin|thrombin|mesh-list
92365951|NCT00652314|Hemostatics|hemostatics|mesh-ancestor
92365952|NCT00652314|Coagulants|coagulants|mesh-ancestor
92365953|NCT00654030|Vaccines|vaccines|mesh-list
92365954|NCT00654030|Immunologic Factors|immunologic factors|mesh-ancestor
92365955|NCT00654030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365956|NCT00656448|Epoetin Alfa|epoetin alfa|mesh-list
91979591|NCT00189293|Imiquimod|imiquimod|mesh-list
92365957|NCT00656448|Hematinics|hematinics|mesh-ancestor
92365958|NCT00660504|Etoposide|etoposide|mesh-list
92365959|NCT00660504|Amrubicin|amrubicin|mesh-list
92365960|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018440|NCT04891861|Apixaban|apixaban|mesh-list
92365961|NCT00660504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92365962|NCT00660504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92365963|NCT00660504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92365964|NCT00660504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92365965|NCT00660504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365966|NCT00661674|Palonosetron|palonosetron|mesh-list
92365967|NCT00661674|Hydroxyzine|hydroxyzine|mesh-list
92365968|NCT00661674|Antiemetics|antiemetics|mesh-ancestor
92365969|NCT00661674|Autonomic Agents|autonomic agents|mesh-ancestor
92365970|NCT00661674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92365971|NCT00661674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365972|NCT00661674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92365973|NCT00661674|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92365974|NCT00661674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91979727|NCT02439905|Analgesics|analgesics|mesh-ancestor
92365975|NCT00661674|Serotonin Agents|serotonin agents|mesh-ancestor
92365976|NCT00661674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92365977|NCT00661674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92365978|NCT00661674|Antipruritics|antipruritics|mesh-ancestor
92365979|NCT00661674|Dermatologic Agents|dermatologic agents|mesh-ancestor
92365980|NCT00661674|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92365981|NCT00661674|Histamine Antagonists|histamine antagonists|mesh-ancestor
92365982|NCT00661674|Histamine Agents|histamine agents|mesh-ancestor
92365983|NCT00662298|Prednisolone|prednisolone|mesh-list
91979872|NCT01664247|Incretins|incretins|mesh-ancestor
92365984|NCT00662298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92365985|NCT00662298|Glucocorticoids|glucocorticoids|mesh-ancestor
92365986|NCT00662298|Hormones|hormones|mesh-ancestor
92365987|NCT00662298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980031|NCT04529265|Methylene Blue|methylene blue|mesh-list
91980141|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92365988|NCT00662298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92365989|NCT00662298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980214|NCT03189329|Anesthetics|anesthetics|mesh-ancestor
92365990|NCT00662298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92365991|NCT00666666|Acetic Acid|acetic acid|mesh-list
92365992|NCT00666666|Bicalutamide|bicalutamide|mesh-list
92365993|NCT00666666|Gossypol acetic acid|gossypol acetic acid|mesh-list
92365994|NCT00666666|Gossypol|gossypol|mesh-list
92365995|NCT00666666|Hormones|hormones|mesh-list
92365996|NCT00666666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92365997|NCT00666666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980368|NCT02433899|Glucocorticoids|glucocorticoids|mesh-ancestor
92365998|NCT00666666|Androgen Antagonists|androgen antagonists|mesh-ancestor
92365999|NCT00666666|Hormone Antagonists|hormone antagonists|mesh-ancestor
92366000|NCT00666666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366001|NCT00666666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92366002|NCT00666666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980474|NCT05307627|Naltrexone|naltrexone|mesh-list
92366003|NCT00666666|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92366004|NCT00666666|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92366005|NCT00666666|Contraceptive Agents|contraceptive agents|mesh-ancestor
92366006|NCT00666666|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92366007|NCT00666666|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92366008|NCT00666666|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92366009|NCT00666666|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92366010|NCT00666978|Bupropion|bupropion|mesh-list
92366011|NCT00666978|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92366012|NCT00666978|Antidepressive Agents|antidepressive agents|mesh-ancestor
92366013|NCT00666978|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92366014|NCT00666978|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92366015|NCT00666978|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92366016|NCT00666978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366017|NCT00666978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366018|NCT00666978|Dopamine Agents|dopamine agents|mesh-ancestor
92366019|NCT00666978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366020|NCT00666978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366021|NCT00666978|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92366022|NCT00666978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92366023|NCT00666978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366024|NCT00670956|Betamethasone|betamethasone|mesh-list
92366025|NCT00670956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366026|NCT00670956|Glucocorticoids|glucocorticoids|mesh-ancestor
92366027|NCT00670956|Hormones|hormones|mesh-ancestor
92366028|NCT00670956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366029|NCT00670956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366030|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92366031|NCT00670956|Respiratory System Agents|respiratory system agents|mesh-ancestor
92366032|NCT00671502|Carisoprodol|carisoprodol|mesh-list
92366033|NCT00671502|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92366034|NCT00671502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366035|NCT00671502|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92366036|NCT00671502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366037|NCT00671970|Bevacizumab|bevacizumab|mesh-list
92366038|NCT00671970|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92366039|NCT00671970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366040|NCT00671970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366041|NCT00671970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92366042|NCT00671970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92366043|NCT00671970|Growth Substances|growth substances|mesh-ancestor
92366044|NCT00671970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366045|NCT00671970|Growth Inhibitors|growth inhibitors|mesh-ancestor
92366046|NCT00671970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366047|NCT00671970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366048|NCT00671970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366049|NCT00672204|Sirolimus|sirolimus|mesh-list
92366050|NCT00672204|Thymoglobulin|thymoglobulin|mesh-list
92366051|NCT00672204|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92366052|NCT00672204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980777|NCT05105841|Venetoclax|venetoclax|mesh-list
92366053|NCT00672204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366054|NCT00672204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92366055|NCT00672204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366056|NCT00672204|Antifungal Agents|antifungal agents|mesh-ancestor
92366057|NCT00672204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366058|NCT00672204|Immunologic Factors|immunologic factors|mesh-ancestor
92366059|NCT00672204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366061|NCT00672438|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92366062|NCT00672438|Narcotics|narcotics|mesh-ancestor
92366063|NCT00672438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366064|NCT00672438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366065|NCT00672438|Analgesics|analgesics|mesh-ancestor
92366066|NCT00672438|Sensory System Agents|sensory system agents|mesh-ancestor
92366067|NCT00672438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366068|NCT00672438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92366069|NCT00672438|Anesthetics, General|anesthetics, general|mesh-ancestor
92366070|NCT00672438|Anesthetics|anesthetics|mesh-ancestor
92366072|NCT00672594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366073|NCT00672594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92366074|NCT00672594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92366075|NCT00672594|Growth Substances|growth substances|mesh-ancestor
92366076|NCT00672594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366077|NCT00672594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92366078|NCT00672594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366079|NCT00672594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366080|NCT00672594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366081|NCT00673764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92366082|NCT00673764|Lubricant Eye Drops|lubricant eye drops|mesh-list
92366083|NCT00673764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92366084|NCT00675792|Bromides|bromides|mesh-list
92366085|NCT00675792|Rocuronium|rocuronium|mesh-list
91981208|NCT02423837|Rituximab|rituximab|mesh-list
92366086|NCT00675792|Neostigmine|neostigmine|mesh-list
92366087|NCT00675792|Anticonvulsants|anticonvulsants|mesh-ancestor
92366088|NCT00675792|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92366089|NCT00675792|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92366090|NCT00675792|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92366091|NCT00675792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366092|NCT00675792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366093|NCT00675792|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92366094|NCT00675792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366095|NCT00675792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366096|NCT00675792|Cholinergic Agents|cholinergic agents|mesh-ancestor
92366097|NCT00675792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366098|NCT00675792|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92366099|NCT00675792|Autonomic Agents|autonomic agents|mesh-ancestor
92366100|NCT00676806|Cyclophosphamide|cyclophosphamide|mesh-list
92366101|NCT00676806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366102|NCT00676806|Immunologic Factors|immunologic factors|mesh-ancestor
92366103|NCT00676806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366105|NCT00676806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366106|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
92366107|NCT00676806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366108|NCT00676806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366109|NCT00676806|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92366110|NCT00678834|Tocopherols|tocopherols|mesh-list
92366111|NCT00678834|Vitamin E|vitamin e|mesh-list
92366112|NCT00678834|Tocotrienols|tocotrienols|mesh-list
92366113|NCT00678834|alpha-Tocopherol|alpha-tocopherol|mesh-list
92366114|NCT00678834|Antioxidants|antioxidants|mesh-ancestor
92366115|NCT00678834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366116|NCT00678834|Protective Agents|protective agents|mesh-ancestor
92366117|NCT00678834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366118|NCT00678834|Vitamins|vitamins|mesh-ancestor
92366119|NCT00678834|Micronutrients|micronutrients|mesh-ancestor
92366120|NCT00679380|Budesonide|budesonide|mesh-list
92366121|NCT00679380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366122|NCT00679380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92366123|NCT00679380|Autonomic Agents|autonomic agents|mesh-ancestor
92366124|NCT00679380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366125|NCT00679380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366126|NCT00679380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92366127|NCT00679380|Respiratory System Agents|respiratory system agents|mesh-ancestor
92366128|NCT00679380|Glucocorticoids|glucocorticoids|mesh-ancestor
92366129|NCT00679380|Hormones|hormones|mesh-ancestor
92366130|NCT00679380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366131|NCT00680706|Thiamine|thiamine|mesh-list
92366132|NCT00680706|Vitamins|vitamins|mesh-ancestor
92366133|NCT00680706|Micronutrients|micronutrients|mesh-ancestor
92366134|NCT00680706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366135|NCT00680706|Vitamin B Complex|vitamin b complex|mesh-ancestor
92366136|NCT00682734|Diphenhydramine|diphenhydramine|mesh-list
92366137|NCT00682734|Promethazine|promethazine|mesh-list
92366138|NCT00682734|Metoclopramide|metoclopramide|mesh-list
92366139|NCT00682734|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92366140|NCT00682734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92366141|NCT00682734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366142|NCT00682734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366143|NCT00682734|Anesthetics, Local|anesthetics, local|mesh-ancestor
92366144|NCT00682734|Anesthetics|anesthetics|mesh-ancestor
92366145|NCT00682734|Sensory System Agents|sensory system agents|mesh-ancestor
92366146|NCT00682734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366147|NCT00682734|Antiemetics|antiemetics|mesh-ancestor
92366148|NCT00682734|Autonomic Agents|autonomic agents|mesh-ancestor
92366149|NCT00682734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366150|NCT00682734|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92366151|NCT00682734|Histamine Antagonists|histamine antagonists|mesh-ancestor
92366152|NCT00682734|Histamine Agents|histamine agents|mesh-ancestor
92366153|NCT00682734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366154|NCT00682734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366155|NCT00682734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92366156|NCT00682734|Antipruritics|antipruritics|mesh-ancestor
92366157|NCT00682734|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366158|NCT00682734|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92366159|NCT00682734|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92366160|NCT00682734|Dopamine Agents|dopamine agents|mesh-ancestor
92366161|NCT00683046|Fludarabine|fludarabine|mesh-list
92366163|NCT00683046|Alemtuzumab|alemtuzumab|mesh-list
92366164|NCT00683046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366165|NCT00683046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366166|NCT00683046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366167|NCT00683046|Immunologic Factors|immunologic factors|mesh-ancestor
92366168|NCT00683046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366169|NCT00683046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366170|NCT00683046|Alkylating Agents|alkylating agents|mesh-ancestor
92366171|NCT00683046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92366172|NCT00683046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366173|NCT00687102|Tamoxifen|tamoxifen|mesh-list
92366174|NCT00687102|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92366175|NCT00687102|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92366176|NCT00687102|Hormone Antagonists|hormone antagonists|mesh-ancestor
92366177|NCT00687102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366178|NCT00687102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366179|NCT00687102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92366180|NCT00687102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366181|NCT00687102|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92366182|NCT00687102|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92366183|NCT00687102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92366184|NCT00690924|Calcitriol|calcitriol|mesh-list
92366185|NCT00690924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366186|NCT00690924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018658|NCT04905667|Trastuzumab|trastuzumab|mesh-list
92366187|NCT00690924|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92366188|NCT00690924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91981452|NCT02099110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92366189|NCT00690924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366190|NCT00690924|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92366192|NCT00690924|Micronutrients|micronutrients|mesh-ancestor
92366193|NCT00690924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92366194|NCT00691002|Calcitriol|calcitriol|mesh-list
92366195|NCT00691002|Hydrocortisone|hydrocortisone|mesh-list
92366196|NCT00691002|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92366197|NCT00691002|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92366198|NCT00691002|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92366199|NCT00691002|Calcipotriene|calcipotriene|mesh-list
92366200|NCT00691002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366201|NCT00691002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366202|NCT00691002|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366203|NCT00691002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366204|NCT00691002|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92366205|NCT00691002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366206|NCT00691002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366207|NCT00691002|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92366208|NCT00691002|Vitamins|vitamins|mesh-ancestor
92366209|NCT00691002|Micronutrients|micronutrients|mesh-ancestor
92366210|NCT00691002|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92366211|NCT00695292|Carboplatin|carboplatin|mesh-list
92366212|NCT00695292|Irinotecan|irinotecan|mesh-list
92366213|NCT00695292|Sunitinib|sunitinib|mesh-list
92366214|NCT00695292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366215|NCT00695292|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92366216|NCT00695292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92366217|NCT00695292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366218|NCT00695292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366219|NCT00695292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92366220|NCT00695292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92366221|NCT00695292|Growth Substances|growth substances|mesh-ancestor
92366222|NCT00695292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366223|NCT00695292|Growth Inhibitors|growth inhibitors|mesh-ancestor
92366224|NCT00695292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366225|NCT00696618|Plasma-lyte 148|plasma-lyte 148|mesh-list
92366226|NCT00696618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92366227|NCT00696618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92366228|NCT00700440|Cetuximab|cetuximab|mesh-list
92366229|NCT00700440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366230|NCT00700440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366232|NCT00701376|Hematinics|hematinics|mesh-ancestor
92366233|NCT00702780|Escitalopram|escitalopram|mesh-list
92366234|NCT00702780|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92366235|NCT00702780|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92366236|NCT00702780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366237|NCT00702780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366238|NCT00702780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366239|NCT00702780|Serotonin Agents|serotonin agents|mesh-ancestor
92366240|NCT00702780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366241|NCT00704028|Dextrans|dextrans|mesh-list
92366242|NCT00704028|Iron-Dextran Complex|iron-dextran complex|mesh-list
92366243|NCT00704028|Anticoagulants|anticoagulants|mesh-ancestor
92366244|NCT00704028|Plasma Substitutes|plasma substitutes|mesh-ancestor
92366245|NCT00704028|Blood Substitutes|blood substitutes|mesh-ancestor
92366246|NCT00704028|Hematinics|hematinics|mesh-ancestor
92366247|NCT00704262|Hydrocortisone|hydrocortisone|mesh-list
92366248|NCT00704262|Calcipotriene|calcipotriene|mesh-list
92366249|NCT00704262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366250|NCT00704262|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366251|NCT00706446|Fluticasone|fluticasone|mesh-list
92366252|NCT00706446|Xhance|xhance|mesh-list
92366253|NCT00706446|Budesonide|budesonide|mesh-list
92366254|NCT00706446|Bromides|bromides|mesh-list
92366255|NCT00706446|Formoterol Fumarate|formoterol fumarate|mesh-list
92366256|NCT00706446|Tiotropium Bromide|tiotropium bromide|mesh-list
92366257|NCT00706446|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92366258|NCT00706446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366259|NCT00706446|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92366260|NCT00706446|Autonomic Agents|autonomic agents|mesh-ancestor
92366261|NCT00706446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366262|NCT00706446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366263|NCT00706446|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92366264|NCT00706446|Respiratory System Agents|respiratory system agents|mesh-ancestor
92366265|NCT00706446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366266|NCT00706446|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92366267|NCT00706446|Glucocorticoids|glucocorticoids|mesh-ancestor
92366268|NCT00706446|Hormones|hormones|mesh-ancestor
92366269|NCT00706446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366270|NCT00706446|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92366271|NCT00706446|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92366272|NCT00706446|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92366273|NCT00706446|Adrenergic Agents|adrenergic agents|mesh-ancestor
92366274|NCT00706446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366275|NCT00706446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366276|NCT00706446|Parasympatholytics|parasympatholytics|mesh-ancestor
92366277|NCT00706446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92366278|NCT00706446|Cholinergic Agents|cholinergic agents|mesh-ancestor
92366279|NCT00706446|Anticonvulsants|anticonvulsants|mesh-ancestor
92366280|NCT00706836|Pregabalin|pregabalin|mesh-list
92366281|NCT00706836|Analgesics|analgesics|mesh-ancestor
92366282|NCT00706836|Sensory System Agents|sensory system agents|mesh-ancestor
92366283|NCT00706836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937530|NCT01111955|Metformin|metformin|mesh-list
92366284|NCT00706836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366285|NCT00706836|Anticonvulsants|anticonvulsants|mesh-ancestor
92366286|NCT00706836|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92366287|NCT00706836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366288|NCT00706836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366289|NCT00706836|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366290|NCT00706836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92366291|NCT00706836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92366292|NCT00706836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366293|NCT00706836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92366294|NCT00708942|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92366295|NCT00708942|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92366296|NCT00708942|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366297|NCT00711828|Dexamethasone|dexamethasone|mesh-list
92366298|NCT00711828|Cyclophosphamide|cyclophosphamide|mesh-list
92366299|NCT00711828|Rituximab|rituximab|mesh-list
92366300|NCT00711828|Bortezomib|bortezomib|mesh-list
92366301|NCT00711828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366302|NCT00711828|Immunologic Factors|immunologic factors|mesh-ancestor
92366303|NCT00711828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366304|NCT00711828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366305|NCT00711828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366306|NCT00711828|Alkylating Agents|alkylating agents|mesh-ancestor
92366307|NCT00711828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366308|NCT00711828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366309|NCT00711828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92366310|NCT00711828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366311|NCT00711828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366312|NCT00711828|Antiemetics|antiemetics|mesh-ancestor
92366313|NCT00711828|Autonomic Agents|autonomic agents|mesh-ancestor
92366314|NCT00711828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366315|NCT00711828|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366316|NCT00711828|Glucocorticoids|glucocorticoids|mesh-ancestor
92366317|NCT00711828|Hormones|hormones|mesh-ancestor
92366318|NCT00711828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366319|NCT00711828|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92366320|NCT00712530|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92366321|NCT00712530|Antiviral Agents|antiviral agents|mesh-ancestor
92366322|NCT00712530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366323|NCT00715884|Sirolimus|sirolimus|mesh-list
92366324|NCT00715884|Temsirolimus|temsirolimus|mesh-list
92366325|NCT00715884|MTOR Inhibitors|mtor inhibitors|mesh-list
92366326|NCT00715884|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92366327|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366328|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92366329|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366330|NCT00715884|Antifungal Agents|antifungal agents|mesh-ancestor
92366331|NCT00715884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366332|NCT00715884|Immunologic Factors|immunologic factors|mesh-ancestor
92366333|NCT00715884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366334|NCT00715884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366335|NCT00715884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366336|NCT00715884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366337|NCT00716586|Dorzolamide|dorzolamide|mesh-list
92366338|NCT00716586|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92366339|NCT00716586|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92366340|NCT00716586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366341|NCT00716586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366342|NCT00716742|Bimatoprost|bimatoprost|mesh-list
92366343|NCT00716742|Travoprost|travoprost|mesh-list
92366344|NCT00716742|Latanoprost|latanoprost|mesh-list
92366345|NCT00716742|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92366346|NCT00716742|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92366347|NCT00716742|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92366348|NCT00716820|Sunitinib|sunitinib|mesh-list
92366349|NCT00716820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366350|NCT00716820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92366351|NCT00716820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92366352|NCT00716820|Growth Substances|growth substances|mesh-ancestor
92366353|NCT00716820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366354|NCT00716820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92366355|NCT00716820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366356|NCT00716820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981673|NCT02422589|Midazolam|midazolam|mesh-list
91981674|NCT02422589|Warfarin|warfarin|mesh-list
92366357|NCT00716820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366359|NCT00717054|Aprepitant|aprepitant|mesh-list
92366360|NCT00717054|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92366361|NCT00717054|Antiemetics|antiemetics|mesh-ancestor
92366362|NCT00717054|Autonomic Agents|autonomic agents|mesh-ancestor
92366363|NCT00717054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366364|NCT00717054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366365|NCT00717054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366366|NCT00717054|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92366367|NCT00717054|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366368|NCT00717054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366369|NCT00717054|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92366370|NCT00717054|Mydriatics|mydriatics|mesh-ancestor
92366371|NCT00717054|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92366372|NCT00717054|Cholinergic Agents|cholinergic agents|mesh-ancestor
92366373|NCT00717054|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92366374|NCT00717054|Parasympatholytics|parasympatholytics|mesh-ancestor
92366375|NCT00717288|Insulin Detemir|insulin detemir|mesh-list
92366376|NCT00717288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92366377|NCT00717288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366378|NCT00719160|Esomeprazole|esomeprazole|mesh-list
92366379|NCT00719160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92366380|NCT00719160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366381|NCT00719160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92366382|NCT00719160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366383|NCT00719160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366384|NCT00720330|Lidocaine|lidocaine|mesh-list
92366385|NCT00720330|Ketamine|ketamine|mesh-list
92366386|NCT00720330|Ropivacaine|ropivacaine|mesh-list
92366387|NCT00720330|Anesthetics, Local|anesthetics, local|mesh-ancestor
92366388|NCT00720330|Anesthetics|anesthetics|mesh-ancestor
92366389|NCT00720330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366390|NCT00720330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366391|NCT00720330|Sensory System Agents|sensory system agents|mesh-ancestor
92366392|NCT00720330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366393|NCT00720330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92366394|NCT00720330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92366395|NCT00720330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92366396|NCT00720330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366397|NCT00720330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366398|NCT00720330|Analgesics|analgesics|mesh-ancestor
92366399|NCT00720330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92366400|NCT00720330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92366401|NCT00720330|Anesthetics, General|anesthetics, general|mesh-ancestor
92366402|NCT00720330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92366403|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92366404|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366405|NCT00721188|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92366406|NCT00721188|Hematinics|hematinics|mesh-ancestor
92366407|NCT00722436|Tranexamic Acid|tranexamic acid|mesh-list
92366408|NCT00722436|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92366409|NCT00722436|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92366410|NCT00722436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366411|NCT00722436|Hemostatics|hemostatics|mesh-ancestor
92366412|NCT00722436|Coagulants|coagulants|mesh-ancestor
92366413|NCT00724464|Interferons|interferons|mesh-list
92366414|NCT00724464|Ribavirin|ribavirin|mesh-list
92366415|NCT00724464|Interferon-alpha|interferon-alpha|mesh-list
92366416|NCT00724464|Interferon alpha-2|interferon alpha-2|mesh-list
92366417|NCT00724464|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92366418|NCT00724464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366419|NCT00724464|Antiviral Agents|antiviral agents|mesh-ancestor
92366420|NCT00724464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366421|NCT00724464|Antimetabolites|antimetabolites|mesh-ancestor
92366422|NCT00724464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366423|NCT00724464|Immunologic Factors|immunologic factors|mesh-ancestor
92366424|NCT00724464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366426|NCT00726414|Antimalarials|antimalarials|mesh-ancestor
92366427|NCT00726414|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92366428|NCT00726414|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92366429|NCT00726414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366430|NCT00726414|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92366431|NCT00726414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366432|NCT00726414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92366433|NCT00726414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366434|NCT00726414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92366437|NCT00727740|Indomethacin|indomethacin|mesh-list
92366438|NCT00727740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92366439|NCT00727740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92366440|NCT00727740|Analgesics|analgesics|mesh-ancestor
92366441|NCT00727740|Sensory System Agents|sensory system agents|mesh-ancestor
92366442|NCT00727740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366443|NCT00727740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366444|NCT00727740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366445|NCT00727740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366446|NCT00727740|Gout Suppressants|gout suppressants|mesh-ancestor
92366447|NCT00727740|Tocolytic Agents|tocolytic agents|mesh-ancestor
92366448|NCT00727740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92366449|NCT00727740|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92366450|NCT00727740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366451|NCT00727740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366452|NCT00728910|Niacin|niacin|mesh-list
92366453|NCT00728910|Atorvastatin|atorvastatin|mesh-list
92366454|NCT00728910|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92366455|NCT00728910|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92366456|NCT00728910|Antimetabolites|antimetabolites|mesh-ancestor
92366457|NCT00728910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366458|NCT00728910|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92366459|NCT00728910|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92366460|NCT00728910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366461|NCT00728910|Vasodilator Agents|vasodilator agents|mesh-ancestor
92366462|NCT00728910|Vitamin B Complex|vitamin b complex|mesh-ancestor
92366463|NCT00728910|Vitamins|vitamins|mesh-ancestor
92366464|NCT00728910|Micronutrients|micronutrients|mesh-ancestor
92366465|NCT00728910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366466|NCT00729846|Bevacizumab|bevacizumab|mesh-list
92366467|NCT00729846|Verteporfin|verteporfin|mesh-list
92366468|NCT00729846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366469|NCT00729846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366470|NCT00729846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92366471|NCT00729846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92366472|NCT00729846|Growth Substances|growth substances|mesh-ancestor
92366473|NCT00729846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366474|NCT00729846|Growth Inhibitors|growth inhibitors|mesh-ancestor
92366475|NCT00729846|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92366476|NCT00729846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366477|NCT00729924|Raltegravir Potassium|raltegravir potassium|mesh-list
92366478|NCT00729924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92366479|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92366480|NCT00729924|Antiviral Agents|antiviral agents|mesh-ancestor
92366481|NCT00729924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366482|NCT00729924|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92366483|NCT00729924|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92366484|NCT00729924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366485|NCT00729924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366487|NCT00731874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366488|NCT00731874|Immunologic Factors|immunologic factors|mesh-ancestor
92366489|NCT00731874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366490|NCT00731874|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92366491|NCT00731874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366492|NCT00731874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366493|NCT00732654|Immunomodulating Agents|immunomodulating agents|mesh-list
92366494|NCT00732654|Immunologic Factors|immunologic factors|mesh-list
92366495|NCT00732654|Caseins|caseins|mesh-list
92366496|NCT00732654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366497|NCT00732654|Chelating Agents|chelating agents|mesh-ancestor
92366498|NCT00732654|Sequestering Agents|sequestering agents|mesh-ancestor
92366499|NCT00732654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366500|NCT00733278|Copper|copper|mesh-list
92366501|NCT00733278|Contraceptive Agents|contraceptive agents|mesh-list
92366502|NCT00733278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92366503|NCT00733278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366504|NCT00733278|Trace Elements|trace elements|mesh-ancestor
92366505|NCT00733278|Micronutrients|micronutrients|mesh-ancestor
92366506|NCT00733356|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92366507|NCT00733356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92366508|NCT00733356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366509|NCT00733356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91937533|NCT01106807|Adapalene|adapalene|mesh-list
92366510|NCT00733356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92366511|NCT00733356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366512|NCT00733356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366513|NCT00733356|Dopamine Agents|dopamine agents|mesh-ancestor
92366514|NCT00733356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366516|NCT00735306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92366517|NCT00735306|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366518|NCT00735306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366519|NCT00735306|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92366520|NCT00735306|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92366521|NCT00735306|Growth Substances|growth substances|mesh-ancestor
92366522|NCT00735306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366523|NCT00735306|Growth Inhibitors|growth inhibitors|mesh-ancestor
92366524|NCT00735306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366525|NCT00735306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366526|NCT00735306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366527|NCT00735462|Imiquimod|imiquimod|mesh-list
92366528|NCT00735462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92366529|NCT00735462|Immunologic Factors|immunologic factors|mesh-ancestor
92366530|NCT00735462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366531|NCT00735462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366532|NCT00735462|Interferon Inducers|interferon inducers|mesh-ancestor
92366533|NCT00736242|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92366534|NCT00736242|Interferon alpha-2|interferon alpha-2|mesh-list
92366535|NCT00736242|Antiviral Agents|antiviral agents|mesh-ancestor
92366536|NCT00736242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366537|NCT00736242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366538|NCT00736632|Vitamin D|vitamin d|mesh-list
92366539|NCT00736632|Ergocalciferols|ergocalciferols|mesh-list
92366540|NCT00736632|Cholecalciferol|cholecalciferol|mesh-list
92366541|NCT00736632|Vitamins|vitamins|mesh-list
92366542|NCT00736632|Micronutrients|micronutrients|mesh-ancestor
92366543|NCT00736632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366544|NCT00736632|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92366545|NCT00736632|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366546|NCT00737178|Copper|copper|mesh-list
92366547|NCT00737178|Trace Elements|trace elements|mesh-ancestor
92366548|NCT00737178|Micronutrients|micronutrients|mesh-ancestor
92366549|NCT00737178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366550|NCT00741156|Enalaprilat|enalaprilat|mesh-list
92366551|NCT00741156|Enalapril|enalapril|mesh-list
92366552|NCT00741156|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92366553|NCT00741156|Protease Inhibitors|protease inhibitors|mesh-ancestor
92366554|NCT00741156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366555|NCT00741156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366556|NCT00741156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92366557|NCT00741468|Tolbutamide|tolbutamide|mesh-list
92366558|NCT00741468|Midazolam|midazolam|mesh-list
92366559|NCT00741468|Dextromethorphan|dextromethorphan|mesh-list
92366560|NCT00741468|Caffeine|caffeine|mesh-list
92366561|NCT00741468|Omeprazole|omeprazole|mesh-list
92366562|NCT00741468|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92366563|NCT00741468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92019033|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366564|NCT00741468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366565|NCT00741468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366567|NCT00741468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92366568|NCT00741468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92366569|NCT00741468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92366570|NCT00741468|Anesthetics, General|anesthetics, general|mesh-ancestor
92366571|NCT00741468|Anesthetics|anesthetics|mesh-ancestor
92366572|NCT00741468|GABA Modulators|gaba modulators|mesh-ancestor
92366573|NCT00741468|GABA Agents|gaba agents|mesh-ancestor
92366574|NCT00741468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366575|NCT00741468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366576|NCT00741468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92366577|NCT00741468|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92366578|NCT00741468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366579|NCT00741468|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92366580|NCT00741468|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92366581|NCT00741468|Purinergic Agents|purinergic agents|mesh-ancestor
92366582|NCT00741468|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92366583|NCT00741468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366584|NCT00741468|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92366586|NCT00741468|Respiratory System Agents|respiratory system agents|mesh-ancestor
92366587|NCT00741468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92366588|NCT00741468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92366589|NCT00741468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92366590|NCT00741858|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92366591|NCT00741858|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92366592|NCT00741858|Estradiol|estradiol|mesh-list
92366593|NCT00741858|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92366594|NCT00741858|Estrogens|estrogens|mesh-ancestor
92366595|NCT00741858|Hormones|hormones|mesh-ancestor
92366596|NCT00741858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366597|NCT00741858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366598|NCT00741858|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92366599|NCT00741858|Contraceptive Agents|contraceptive agents|mesh-ancestor
92366600|NCT00741858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92366601|NCT00741858|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92366602|NCT00742872|Mosapride|mosapride|mesh-list
91981920|NCT02414165|Flucytosine|flucytosine|mesh-list
92366603|NCT00742872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366604|NCT00742872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366605|NCT00742872|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92366606|NCT00742872|Serotonin Agents|serotonin agents|mesh-ancestor
92366607|NCT00742872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366608|NCT00742872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366609|NCT00743574|Vitamin D|vitamin d|mesh-list
92366610|NCT00743574|Ergocalciferols|ergocalciferols|mesh-list
92366611|NCT00743574|Cholecalciferol|cholecalciferol|mesh-list
92366612|NCT00743574|Vitamins|vitamins|mesh-list
92366613|NCT00743574|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92366614|NCT00743574|Medroxyprogesterone|medroxyprogesterone|mesh-list
92366615|NCT00743574|Calcium|calcium|mesh-list
92366616|NCT00743574|Micronutrients|micronutrients|mesh-ancestor
92119052|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
92366617|NCT00743574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366618|NCT00743574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366619|NCT00743574|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92366620|NCT00743574|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92366621|NCT00743574|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92366622|NCT00743574|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92366623|NCT00743574|Contraceptive Agents|contraceptive agents|mesh-ancestor
92366624|NCT00743574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92366625|NCT00743574|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92366626|NCT00743574|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92366627|NCT00743574|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92366628|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92366629|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366631|NCT00743730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92366632|NCT00743730|Narcotics|narcotics|mesh-ancestor
92366633|NCT00743730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366634|NCT00743730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366635|NCT00743730|Analgesics|analgesics|mesh-ancestor
92366636|NCT00743730|Sensory System Agents|sensory system agents|mesh-ancestor
92366637|NCT00743730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366638|NCT00745290|Bupivacaine|bupivacaine|mesh-list
92366639|NCT00745290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92366640|NCT00745290|Anesthetics|anesthetics|mesh-ancestor
92366641|NCT00745290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366642|NCT00745290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366643|NCT00745290|Sensory System Agents|sensory system agents|mesh-ancestor
92366644|NCT00745290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366646|NCT00751530|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92366647|NCT00751530|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92366648|NCT00751530|Antiviral Agents|antiviral agents|mesh-ancestor
92366649|NCT00751530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366650|NCT00751530|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92366651|NCT00751530|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92366652|NCT00751530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366653|NCT00751530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366654|NCT00753636|Isradipine|isradipine|mesh-list
92366655|NCT00753636|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92366656|NCT00753636|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92366657|NCT00753636|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366658|NCT00753636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366659|NCT00753636|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366660|NCT00753636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366662|NCT00754494|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92366663|NCT00754494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366664|NCT00754494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366665|NCT00754494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366666|NCT00754494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366667|NCT00755040|Cyclosporine|cyclosporine|mesh-list
92366668|NCT00755040|Cyclosporins|cyclosporins|mesh-list
92366669|NCT00755040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366670|NCT00755040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366671|NCT00755040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366672|NCT00755040|Immunologic Factors|immunologic factors|mesh-ancestor
92366673|NCT00755040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366674|NCT00755040|Antifungal Agents|antifungal agents|mesh-ancestor
92366675|NCT00755040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366676|NCT00755040|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366677|NCT00755040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366678|NCT00755040|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92366679|NCT00755274|Vaccines|vaccines|mesh-list
92366680|NCT00755274|Immunologic Factors|immunologic factors|mesh-ancestor
92366681|NCT00755274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366682|NCT00756600|Anesthetics|anesthetics|mesh-list
92366683|NCT00756600|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366684|NCT00756600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366685|NCT00756678|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92366687|NCT00756678|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92366688|NCT00758784|Bromfenac|bromfenac|mesh-list
92366689|NCT00758784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92366690|NCT00758784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92366691|NCT00758784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92366692|NCT00758784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92366693|NCT00758784|Analgesics|analgesics|mesh-ancestor
92366694|NCT00758784|Sensory System Agents|sensory system agents|mesh-ancestor
92366695|NCT00758784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366696|NCT00758784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366697|NCT00758784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366698|NCT00758784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366699|NCT00759330|Flurbiprofen|flurbiprofen|mesh-list
92366700|NCT00759330|Analgesics|analgesics|mesh-ancestor
92366701|NCT00759330|Sensory System Agents|sensory system agents|mesh-ancestor
92366702|NCT00759330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366703|NCT00759330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366704|NCT00759330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92366705|NCT00759330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92366706|NCT00759330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366707|NCT00759330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366708|NCT00759330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92366709|NCT00759330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366710|NCT00759330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366711|NCT00759408|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
92366712|NCT00759408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92366713|NCT00759408|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92366714|NCT00759408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366716|NCT00759642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366717|NCT00759642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92366718|NCT00759642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366719|NCT00759642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366720|NCT00759798|Cyclophosphamide|cyclophosphamide|mesh-list
92366721|NCT00759798|Rituximab|rituximab|mesh-list
92366722|NCT00759798|Fludarabine|fludarabine|mesh-list
92366723|NCT00759798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366724|NCT00759798|Immunologic Factors|immunologic factors|mesh-ancestor
92366725|NCT00759798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366726|NCT00759798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366727|NCT00759798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366728|NCT00759798|Alkylating Agents|alkylating agents|mesh-ancestor
92366729|NCT00759798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366730|NCT00759798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366731|NCT00759798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91937535|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92366732|NCT00759798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366734|NCT00760578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92366735|NCT00760578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366736|NCT00761202|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92366737|NCT00761202|Hyaluronic Acid|hyaluronic acid|mesh-list
92366738|NCT00761202|Glycerol|glycerol|mesh-list
92366739|NCT00761202|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92366740|NCT00761202|Immunologic Factors|immunologic factors|mesh-ancestor
92366741|NCT00761202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366742|NCT00761202|Viscosupplements|viscosupplements|mesh-ancestor
92366743|NCT00761202|Protective Agents|protective agents|mesh-ancestor
92366744|NCT00761202|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92366745|NCT00761202|Laxatives|laxatives|mesh-ancestor
92366746|NCT00761202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366747|NCT00761592|Botulinum Toxins|botulinum toxins|mesh-list
92366748|NCT00761592|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92366749|NCT00761592|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92366750|NCT00761592|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92366751|NCT00761592|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366752|NCT00761592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366753|NCT00761592|Cholinergic Agents|cholinergic agents|mesh-ancestor
92366754|NCT00761592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366755|NCT00761592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982099|NCT02412059|Hormones|hormones|mesh-ancestor
92366756|NCT00761592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92366757|NCT00761592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366758|NCT00762450|Triclosan|triclosan|mesh-list
92366759|NCT00762450|Fluorides|fluorides|mesh-list
92366760|NCT00762450|Cariostatic Agents|cariostatic agents|mesh-ancestor
92366761|NCT00762450|Protective Agents|protective agents|mesh-ancestor
92366762|NCT00762450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366763|NCT00762450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92366764|NCT00762450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366765|NCT00762450|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92366766|NCT00762450|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92366767|NCT00762450|Antimetabolites|antimetabolites|mesh-ancestor
92366768|NCT00762450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366769|NCT00762450|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92366770|NCT00762528|Triclosan|triclosan|mesh-list
92366771|NCT00762528|Fluorides|fluorides|mesh-list
92366772|NCT00762528|Fluorophosphate|fluorophosphate|mesh-list
92366773|NCT00762528|Cariostatic Agents|cariostatic agents|mesh-ancestor
92366774|NCT00762528|Protective Agents|protective agents|mesh-ancestor
92366775|NCT00762528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366776|NCT00762528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92366777|NCT00762528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366778|NCT00762528|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92366779|NCT00762528|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92366780|NCT00762528|Antimetabolites|antimetabolites|mesh-ancestor
92366781|NCT00762528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366782|NCT00762528|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92366783|NCT00765648|Labetalol|labetalol|mesh-list
92366784|NCT00765648|Nicardipine|nicardipine|mesh-list
92366785|NCT00765648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92366786|NCT00765648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92366787|NCT00765648|Adrenergic Agents|adrenergic agents|mesh-ancestor
92366788|NCT00765648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366789|NCT00765648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366790|NCT00765648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366792|NCT00765648|Sympathomimetics|sympathomimetics|mesh-ancestor
92366793|NCT00765648|Autonomic Agents|autonomic agents|mesh-ancestor
92366794|NCT00765648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366795|NCT00765648|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92366796|NCT00765648|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92366797|NCT00765648|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92366798|NCT00765648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366799|NCT00765648|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92366800|NCT00765648|Vasodilator Agents|vasodilator agents|mesh-ancestor
92366801|NCT00766116|Azacitidine|azacitidine|mesh-list
92366802|NCT00766116|Gemtuzumab|gemtuzumab|mesh-list
92366803|NCT00766116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92366804|NCT00766116|Antimetabolites|antimetabolites|mesh-ancestor
92366805|NCT00766116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366806|NCT00766116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366807|NCT00766116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366808|NCT00766116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366810|NCT00766116|Immunoconjugates|immunoconjugates|mesh-ancestor
92366811|NCT00766116|Immunologic Factors|immunologic factors|mesh-ancestor
92366812|NCT00766116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366813|NCT00767364|Vaccines|vaccines|mesh-list
92366814|NCT00767364|Immunologic Factors|immunologic factors|mesh-ancestor
92366815|NCT00767364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366816|NCT00769314|Acyclovir|acyclovir|mesh-list
92366817|NCT00769314|Antiviral Agents|antiviral agents|mesh-ancestor
92366818|NCT00769314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366819|NCT00769392|Lidocaine|lidocaine|mesh-list
92366820|NCT00769392|Tetracaine|tetracaine|mesh-list
92366821|NCT00769392|Proxymetacaine|proxymetacaine|mesh-list
92366822|NCT00769392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92366824|NCT00769392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366825|NCT00769392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366826|NCT00769392|Sensory System Agents|sensory system agents|mesh-ancestor
92366827|NCT00769392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366828|NCT00769392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92366829|NCT00769392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92366830|NCT00769392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92366831|NCT00769392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92366832|NCT00769392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366833|NCT00770874|Cisplatin|cisplatin|mesh-list
92366834|NCT00770874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366835|NCT00772590|Raltegravir Potassium|raltegravir potassium|mesh-list
92366836|NCT00772590|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92366837|NCT00772590|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92366838|NCT00772590|Antiviral Agents|antiviral agents|mesh-ancestor
92366839|NCT00772590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982135|NCT05520645|Anesthetics, General|anesthetics, general|mesh-ancestor
92366840|NCT00772590|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92366841|NCT00772590|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92366842|NCT00772590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366843|NCT00772590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366844|NCT00775944|Nicotine|nicotine|mesh-list
92366845|NCT00775944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92366846|NCT00775944|Autonomic Agents|autonomic agents|mesh-ancestor
92366847|NCT00775944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366848|NCT00775944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366849|NCT00775944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92366850|NCT00775944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92366851|NCT00775944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92366852|NCT00775944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366853|NCT00775944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366854|NCT00780234|Pioglitazone|pioglitazone|mesh-list
92366855|NCT00780234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92366856|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366857|NCT00784524|Aldesleukin|aldesleukin|mesh-list
92366858|NCT00784524|Interleukin-2|interleukin-2|mesh-list
92366859|NCT00784524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366860|NCT00784524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92366861|NCT00784524|Analgesics|analgesics|mesh-ancestor
92366862|NCT00784524|Sensory System Agents|sensory system agents|mesh-ancestor
92366863|NCT00784524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366864|NCT00784524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366865|NCT00784524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92366866|NCT00784524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92366867|NCT00784524|Antiviral Agents|antiviral agents|mesh-ancestor
92366868|NCT00784524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366869|NCT00785772|Gabapentin|gabapentin|mesh-list
92366870|NCT00785772|Analgesics|analgesics|mesh-ancestor
92366871|NCT00785772|Sensory System Agents|sensory system agents|mesh-ancestor
92366872|NCT00785772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366873|NCT00785772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366874|NCT00785772|Anticonvulsants|anticonvulsants|mesh-ancestor
92366875|NCT00785772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92366876|NCT00785772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92366877|NCT00785772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92366878|NCT00785772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92366879|NCT00785772|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92366880|NCT00785772|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92366881|NCT00785772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366882|NCT00785772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366884|NCT00787332|Desirudin|desirudin|mesh-list
92366885|NCT00787332|Argatroban|argatroban|mesh-list
92366886|NCT00787332|Antithrombins|antithrombins|mesh-ancestor
92366887|NCT00787332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92366888|NCT00787332|Protease Inhibitors|protease inhibitors|mesh-ancestor
92366889|NCT00787332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366890|NCT00787332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366892|NCT00787332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92366893|NCT00787332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92366894|NCT00787332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92366895|NCT00787722|Methylprednisolone|methylprednisolone|mesh-list
92366896|NCT00787722|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92366897|NCT00787722|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92366898|NCT00787722|Prednisolone|prednisolone|mesh-list
92366899|NCT00787722|Prednisolone acetate|prednisolone acetate|mesh-list
92366900|NCT00787722|Cyclophosphamide|cyclophosphamide|mesh-list
92366901|NCT00787722|Rituximab|rituximab|mesh-list
92366902|NCT00787722|Thymoglobulin|thymoglobulin|mesh-list
92366903|NCT00787722|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91982274|NCT02410031|Hormones|hormones|mesh-ancestor
92366904|NCT00787722|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92366906|NCT00787722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366907|NCT00787722|Immunologic Factors|immunologic factors|mesh-ancestor
92366908|NCT00787722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366909|NCT00787722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366910|NCT00787722|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366911|NCT00787722|Alkylating Agents|alkylating agents|mesh-ancestor
92366912|NCT00787722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366913|NCT00787722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366914|NCT00787722|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92366915|NCT00787722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92366916|NCT00787722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92366917|NCT00787722|Antiemetics|antiemetics|mesh-ancestor
92366918|NCT00787722|Autonomic Agents|autonomic agents|mesh-ancestor
92366919|NCT00787722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92366920|NCT00787722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92366921|NCT00787722|Glucocorticoids|glucocorticoids|mesh-ancestor
92366922|NCT00787722|Hormones|hormones|mesh-ancestor
92119128|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
92366923|NCT00787722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92366924|NCT00787722|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92366925|NCT00787722|Protective Agents|protective agents|mesh-ancestor
92366926|NCT00787722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92366927|NCT00788892|Cytarabine|cytarabine|mesh-list
92366928|NCT00788892|Daunorubicin|daunorubicin|mesh-list
92366929|NCT00788892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92366930|NCT00788892|Antimetabolites|antimetabolites|mesh-ancestor
92366931|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366932|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366933|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
92366934|NCT00788892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366935|NCT00788892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366936|NCT00788892|Immunologic Factors|immunologic factors|mesh-ancestor
92366937|NCT00788892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366938|NCT00788892|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92366939|NCT00788892|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92366940|NCT00788892|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92366941|NCT00788892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366943|NCT00789672|Carbidopa|carbidopa|mesh-list
92366944|NCT00789672|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92366945|NCT00789672|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92366946|NCT00789672|Dopamine Agents|dopamine agents|mesh-ancestor
92366947|NCT00789672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92366948|NCT00789672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366949|NCT00789672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366950|NCT00789672|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92366951|NCT00789672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366952|NCT00789750|Pioglitazone|pioglitazone|mesh-list
92366953|NCT00789750|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92366954|NCT00789750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92366955|NCT00789750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366956|NCT00789750|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92366957|NCT00789750|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92366958|NCT00789750|Antimetabolites|antimetabolites|mesh-ancestor
92366959|NCT00789750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366960|NCT00789750|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92366961|NCT00790062|Oxytocin|oxytocin|mesh-list
92366962|NCT00790062|Oxytocics|oxytocics|mesh-ancestor
92366963|NCT00790062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92366964|NCT00790062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366965|NCT00793572|Cyclosporine|cyclosporine|mesh-list
92366966|NCT00793572|Mycophenolic Acid|mycophenolic acid|mesh-list
92366967|NCT00793572|Fludarabine|fludarabine|mesh-list
92366968|NCT00793572|Fludarabine phosphate|fludarabine phosphate|mesh-list
92366969|NCT00793572|Bortezomib|bortezomib|mesh-list
92366970|NCT00793572|Melphalan|melphalan|mesh-list
92366971|NCT00793572|Mechlorethamine|mechlorethamine|mesh-list
92366972|NCT00793572|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92366973|NCT00793572|Cyclosporins|cyclosporins|mesh-list
92366974|NCT00793572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366975|NCT00793572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92366976|NCT00793572|Antimetabolites|antimetabolites|mesh-ancestor
92366977|NCT00793572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92366978|NCT00793572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92366979|NCT00793572|Immunologic Factors|immunologic factors|mesh-ancestor
92366980|NCT00793572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92366981|NCT00793572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92366982|NCT00793572|Antifungal Agents|antifungal agents|mesh-ancestor
91982389|NCT03174041|Itraconazole|itraconazole|mesh-list
92366983|NCT00793572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92366984|NCT00793572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92366985|NCT00793572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92366986|NCT00793572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92366987|NCT00793572|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92366988|NCT00793572|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92366989|NCT00793572|Antitubercular Agents|antitubercular agents|mesh-ancestor
92366990|NCT00793572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92366991|NCT00793572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366992|NCT00793572|Alkylating Agents|alkylating agents|mesh-ancestor
92366993|NCT00793572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92366994|NCT00793650|Bortezomib|bortezomib|mesh-list
92366995|NCT00793650|Melphalan|melphalan|mesh-list
92366996|NCT00793650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92366997|NCT00793650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92366998|NCT00793650|Alkylating Agents|alkylating agents|mesh-ancestor
92366999|NCT00793650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367000|NCT00793650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92367001|NCT00793650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367002|NCT00793650|Immunologic Factors|immunologic factors|mesh-ancestor
92367003|NCT00793650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367005|NCT00795210|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92367006|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367007|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367008|NCT00795288|Simvastatin|simvastatin|mesh-list
92367009|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92367010|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92367011|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
92367012|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367013|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92367014|NCT00795288|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92367015|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367016|NCT00795366|Vasopressins|vasopressins|mesh-list
92367017|NCT00795366|Arginine Vasopressin|arginine vasopressin|mesh-list
92367018|NCT00795366|Hemostatics|hemostatics|mesh-ancestor
92367019|NCT00795366|Coagulants|coagulants|mesh-ancestor
92367020|NCT00795366|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92367021|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92367022|NCT00795366|Natriuretic Agents|natriuretic agents|mesh-ancestor
92367023|NCT00795366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367024|NCT00796302|Risperidone|risperidone|mesh-list
92367025|NCT00796302|Methylphenidate|methylphenidate|mesh-list
92367026|NCT00796302|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92367027|NCT00796302|Serotonin Agents|serotonin agents|mesh-ancestor
92367028|NCT00796302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367029|NCT00796302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367030|NCT00796302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367031|NCT00796302|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92367032|NCT00796302|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92367033|NCT00796302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367034|NCT00796302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367035|NCT00796302|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92367036|NCT00796302|Dopamine Agents|dopamine agents|mesh-ancestor
92367037|NCT00796302|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92367038|NCT00796302|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92367039|NCT00796302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92367040|NCT00796302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367041|NCT00796926|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92367042|NCT00796926|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92367043|NCT00798018|Lidocaine|lidocaine|mesh-list
92367044|NCT00798018|Tetracaine|tetracaine|mesh-list
92367045|NCT00798018|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367046|NCT00798018|Anesthetics|anesthetics|mesh-ancestor
92367047|NCT00798018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367048|NCT00798018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367049|NCT00798018|Sensory System Agents|sensory system agents|mesh-ancestor
92367050|NCT00798018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367051|NCT00798018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92367052|NCT00798018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92367053|NCT00798018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92367054|NCT00798018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367055|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367056|NCT00798720|Bortezomib|bortezomib|mesh-list
92367057|NCT00798720|Vorinostat|vorinostat|mesh-list
92367058|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367059|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92367060|NCT00798720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367061|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367062|NCT00799578|Cysteamine|cysteamine|mesh-list
92367063|NCT00799578|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92367064|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367065|NCT00799812|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92367066|NCT00799812|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92367067|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367068|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367069|NCT00801138|Dexamethasone|dexamethasone|mesh-list
92367070|NCT00801138|Bupivacaine|bupivacaine|mesh-list
92367071|NCT00801138|Ropivacaine|ropivacaine|mesh-list
92367072|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92367073|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
92367074|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
92367075|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367076|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367077|NCT00801138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367078|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
92367079|NCT00801138|Hormones|hormones|mesh-ancestor
92367080|NCT00801138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367081|NCT00801138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92367082|NCT00801138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367083|NCT00801138|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367084|NCT00801138|Anesthetics|anesthetics|mesh-ancestor
92367085|NCT00801138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367086|NCT00801138|Sensory System Agents|sensory system agents|mesh-ancestor
92367087|NCT00801684|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92367088|NCT00801684|Formoterol Fumarate|formoterol fumarate|mesh-list
92367089|NCT00801684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92367090|NCT00801684|Autonomic Agents|autonomic agents|mesh-ancestor
92367091|NCT00801684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367092|NCT00801684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367093|NCT00801684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92367094|NCT00801684|Respiratory System Agents|respiratory system agents|mesh-ancestor
92367095|NCT00801684|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92367096|NCT00801684|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92367097|NCT00801684|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92367098|NCT00801684|Adrenergic Agents|adrenergic agents|mesh-ancestor
92367099|NCT00801684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367100|NCT00801684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367101|NCT00801684|Luteolytic Agents|luteolytic agents|mesh-ancestor
92367102|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92367103|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
92367104|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367105|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92367106|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92367107|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367109|NCT00803010|Methotrexate|methotrexate|mesh-list
92367110|NCT00803010|Tacrolimus|tacrolimus|mesh-list
92367111|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92367112|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
92367113|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367114|NCT00803010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367115|NCT00803010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92367117|NCT00803010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367118|NCT00803010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367119|NCT00803010|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367120|NCT00803010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367121|NCT00803010|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92367122|NCT00803010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367123|NCT00803010|Immunologic Factors|immunologic factors|mesh-ancestor
92367124|NCT00803010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92367125|NCT00803010|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92367126|NCT00803010|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92367127|NCT00803010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367128|NCT00803010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367129|NCT00803010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92367130|NCT00803010|Antifungal Agents|antifungal agents|mesh-ancestor
92367132|NCT00803400|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92367133|NCT00803400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367134|NCT00803400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367135|NCT00803400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92367136|NCT00803400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92367137|NCT00803400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367138|NCT00803400|GABA Modulators|gaba modulators|mesh-ancestor
92367139|NCT00803400|GABA Agents|gaba agents|mesh-ancestor
92367140|NCT00803400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367141|NCT00803400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367142|NCT00804648|Timolol|timolol|mesh-list
92367143|NCT00804648|Maleic acid|maleic acid|mesh-list
92367144|NCT00804648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367145|NCT00804648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367146|NCT00804648|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92367147|NCT00804648|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92367148|NCT00804648|Adrenergic Agents|adrenergic agents|mesh-ancestor
92367149|NCT00804648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119434|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
92367150|NCT00804648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367151|NCT00804648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92367152|NCT00804648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92367153|NCT00806598|Cyclosporine|cyclosporine|mesh-list
92367154|NCT00806598|Methylprednisolone|methylprednisolone|mesh-list
92367155|NCT00806598|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92367156|NCT00806598|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92367157|NCT00806598|Prednisolone|prednisolone|mesh-list
92367158|NCT00806598|Prednisolone acetate|prednisolone acetate|mesh-list
92367159|NCT00806598|Cyclosporins|cyclosporins|mesh-list
92367160|NCT00806598|Thymoglobulin|thymoglobulin|mesh-list
91983155|NCT02700815|Diclofenac|diclofenac|mesh-list
92367161|NCT00806598|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92367162|NCT00806598|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92019639|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367163|NCT00806598|Prednisolone phosphate|prednisolone phosphate|mesh-list
92367164|NCT00806598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367165|NCT00806598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367166|NCT00806598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367167|NCT00806598|Immunologic Factors|immunologic factors|mesh-ancestor
91983188|NCT02402621|Anesthetics, General|anesthetics, general|mesh-ancestor
92367168|NCT00806598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367169|NCT00806598|Antifungal Agents|antifungal agents|mesh-ancestor
92367170|NCT00806598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367171|NCT00806598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367172|NCT00806598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92367173|NCT00806598|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92367174|NCT00806598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92367176|NCT00806598|Autonomic Agents|autonomic agents|mesh-ancestor
92367177|NCT00806598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367178|NCT00806598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367179|NCT00806598|Glucocorticoids|glucocorticoids|mesh-ancestor
92367180|NCT00806598|Hormones|hormones|mesh-ancestor
92367181|NCT00806598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367182|NCT00806598|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92367183|NCT00806598|Protective Agents|protective agents|mesh-ancestor
92367184|NCT00806598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92367185|NCT00806598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367187|NCT00807768|Carboplatin|carboplatin|mesh-list
92367188|NCT00807768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92367189|NCT00807768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92367190|NCT00807768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367191|NCT00807768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92367192|NCT00807768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92367193|NCT00807768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92367194|NCT00807768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367195|NCT00808470|Beta Carotene|beta carotene|mesh-list
92367196|NCT00808470|Carotenoids|carotenoids|mesh-list
92367197|NCT00808470|Vitamins|vitamins|mesh-ancestor
92367198|NCT00808470|Micronutrients|micronutrients|mesh-ancestor
92367199|NCT00808470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367200|NCT00808470|Antioxidants|antioxidants|mesh-ancestor
92367201|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367203|NCT00808470|Provitamins|provitamins|mesh-ancestor
92367204|NCT00810576|Bortezomib|bortezomib|mesh-list
92367205|NCT00810576|Vorinostat|vorinostat|mesh-list
91983830|NCT05491785|Sensory System Agents|sensory system agents|mesh-ancestor
92367206|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367207|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92367208|NCT00810576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983906|NCT04543071|Paclitaxel|paclitaxel|mesh-list
92367209|NCT00810576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367210|NCT00811434|Lactulose|lactulose|mesh-list
92367211|NCT00811434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367212|NCT00812604|Analgesics|analgesics|mesh-list
92367213|NCT00812604|Petrolatum|petrolatum|mesh-list
92367214|NCT00812604|Sensory System Agents|sensory system agents|mesh-ancestor
92367215|NCT00812604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367216|NCT00812604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367217|NCT00812604|Emollients|emollients|mesh-ancestor
92367218|NCT00812604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367219|NCT00812838|Botulinum Toxins|botulinum toxins|mesh-list
92367220|NCT00812838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92367221|NCT00812838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92367222|NCT00812838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92367223|NCT00812838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367224|NCT00812838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367225|NCT00812838|Cholinergic Agents|cholinergic agents|mesh-ancestor
92367226|NCT00812838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367227|NCT00812838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367228|NCT00812838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92367229|NCT00812838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367230|NCT00814788|Everolimus|everolimus|mesh-list
92367231|NCT00814788|Bicalutamide|bicalutamide|mesh-list
92367232|NCT00814788|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92367233|NCT00814788|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367234|NCT00814788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984396|NCT05451615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367235|NCT00814788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367236|NCT00814788|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367237|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
91985363|NCT02084056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367238|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367239|NCT00814788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367240|NCT00814788|Androgen Antagonists|androgen antagonists|mesh-ancestor
92367241|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
91985504|NCT02384915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367242|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367243|NCT00820872|Carboplatin|carboplatin|mesh-list
92367244|NCT00820872|Docetaxel|docetaxel|mesh-list
92367245|NCT00820872|Trastuzumab|trastuzumab|mesh-list
92367246|NCT00820872|Lapatinib|lapatinib|mesh-list
92367247|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367248|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
92367249|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
92367250|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
92367251|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367252|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367253|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367254|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367255|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
92367256|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92367257|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92367258|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
92367259|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367260|NCT00821184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367261|NCT00821184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367262|NCT00821184|Urological Agents|urological agents|mesh-ancestor
92367263|NCT05206812|Durvalumab|durvalumab|mesh-list
92367264|NCT05206812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367265|NCT05206812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367266|NCT05131152|Cyclosporine|cyclosporine|mesh-list
92367267|NCT05131152|Cyclosporins|cyclosporins|mesh-list
92367268|NCT05131152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367269|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367270|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367271|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
92367272|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367273|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
92367274|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367275|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367276|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92367277|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92367278|NCT04900116|Bupivacaine|bupivacaine|mesh-list
92367279|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367280|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
92367281|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367282|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367283|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
92367284|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367286|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367287|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367288|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92367289|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367290|NCT03936270|Letrozole|letrozole|mesh-list
92367291|NCT03936270|Palbociclib|palbociclib|mesh-list
92367292|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367293|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92367294|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92367295|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367296|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367297|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92367298|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
92367299|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367300|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367301|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367302|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
92367303|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367304|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
92367305|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367306|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985750|NCT04072445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92367307|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92367310|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367311|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367312|NCT02641236|Vancomycin|vancomycin|mesh-list
92367313|NCT02641236|Polymyxins|polymyxins|mesh-list
92367314|NCT02641236|Polymyxin B|polymyxin b|mesh-list
92367315|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367316|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367317|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
91985870|NCT03672773|Temozolomide|temozolomide|mesh-list
92367318|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367319|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367320|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91986012|NCT02369549|Curcumin|curcumin|mesh-list
92367321|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92367322|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367323|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367324|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367325|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92367326|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92367327|NCT00821886|Carboplatin|carboplatin|mesh-list
92367328|NCT00821886|Trastuzumab|trastuzumab|mesh-list
92367329|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367330|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367331|NCT00821964|Paclitaxel|paclitaxel|mesh-list
92367332|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92367333|NCT00821964|Imiquimod|imiquimod|mesh-list
92367334|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92367335|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367336|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
92367337|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
92367338|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
92367339|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367340|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92367341|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
92367342|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367343|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
92367344|NCT00822354|Tadalafil|tadalafil|mesh-list
92367345|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
92367346|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92367347|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92367348|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367349|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367350|NCT00822354|Urological Agents|urological agents|mesh-ancestor
92367351|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
92367352|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
92367353|NCT00824070|Besifloxacin|besifloxacin|mesh-list
92367354|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92367355|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367356|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986144|NCT02049814|Voglibose|voglibose|mesh-list
92367357|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92367358|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92367359|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367360|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986207|NCT02363075|Dopamine Agents|dopamine agents|mesh-ancestor
92367361|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367362|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92367363|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
92367364|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367365|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367366|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92367367|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92367368|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92367369|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91969910|NCT03197233|Vitamin D|vitamin d|mesh-list
92367370|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92367372|NCT00824460|Sevelamer|sevelamer|mesh-list
92367373|NCT00824460|Trace Elements|trace elements|mesh-ancestor
92367374|NCT00824460|Micronutrients|micronutrients|mesh-ancestor
92367375|NCT00824460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367376|NCT00824460|Chelating Agents|chelating agents|mesh-ancestor
92367377|NCT00824460|Sequestering Agents|sequestering agents|mesh-ancestor
92367378|NCT00824460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367379|NCT00824538|Sunitinib|sunitinib|mesh-list
92367380|NCT00824538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367381|NCT00824538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92367382|NCT00824538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92367383|NCT00824538|Growth Substances|growth substances|mesh-ancestor
92367384|NCT00824538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367385|NCT00824538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92367386|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367387|NCT00824538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367388|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367389|NCT00825786|Ropivacaine|ropivacaine|mesh-list
92019868|NCT05511623|Tislelizumab|tislelizumab|mesh-list
92367390|NCT00825786|Mepivacaine|mepivacaine|mesh-list
92367391|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367392|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
92367393|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367394|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367395|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
92367396|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367398|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367399|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367400|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92367401|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92367402|NCT00826800|Growth Substances|growth substances|mesh-ancestor
92367403|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367404|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92367405|NCT00830076|Metformin|metformin|mesh-list
92367406|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92367407|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92367408|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367409|NCT00830076|Incretins|incretins|mesh-ancestor
92367410|NCT00830076|Hormones|hormones|mesh-ancestor
92367411|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367412|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92367413|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92367414|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367415|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367416|NCT00830388|Ketoconazole|ketoconazole|mesh-list
92367417|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
92367418|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367419|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92367420|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92367421|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367422|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367423|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92367425|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367426|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367427|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92367428|NCT00831480|Everolimus|everolimus|mesh-list
92367429|NCT00831480|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92367430|NCT00831480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367431|NCT00831480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367432|NCT00831480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367433|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367434|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
92367435|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367436|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367437|NCT00832338|Dexamethasone|dexamethasone|mesh-list
92367438|NCT00832338|Docetaxel|docetaxel|mesh-list
92367439|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
92367440|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92367441|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
92367442|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
92367443|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986710|NCT02355431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367444|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367445|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367446|NCT00832338|Glucocorticoids|glucocorticoids|mesh-ancestor
92367447|NCT00832338|Hormones|hormones|mesh-ancestor
92367448|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367449|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92367450|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367451|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
92367453|NCT00832338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92367454|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367455|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367456|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
92367457|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92367458|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92367459|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
92367460|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92367461|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
92367462|NCT00834210|Dapsone|dapsone|mesh-list
92367463|NCT00834210|Tazarotene|tazarotene|mesh-list
92367464|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367465|NCT00834210|Antimalarials|antimalarials|mesh-ancestor
92367466|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92367467|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92367468|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92367469|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367470|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367471|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
92367472|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367473|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367474|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
92367475|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
92367477|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
92367478|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367480|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92367481|NCT00834288|Narcotics|narcotics|mesh-ancestor
92367482|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367483|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367484|NCT00834288|Analgesics|analgesics|mesh-ancestor
92367485|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
92367486|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367487|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92367488|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92367489|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367490|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367491|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986965|NCT02349113|Estrogens|estrogens|mesh-list
92367492|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367493|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92367494|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
92367496|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
92367497|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
92367498|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367499|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367500|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92367501|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92367502|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92367503|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92367504|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
92367505|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367506|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367508|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
92367509|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367510|NCT00837252|Finasteride|finasteride|mesh-list
92367511|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92367512|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92367513|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367514|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367515|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92367516|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367518|NCT00837252|Urological Agents|urological agents|mesh-ancestor
92367519|NCT00839982|Cytarabine|cytarabine|mesh-list
92367520|NCT00839982|Clofarabine|clofarabine|mesh-list
92367521|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92367522|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
92367523|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367524|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367525|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
92367526|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367527|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367528|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
92367529|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367530|NCT00845130|Vitamins|vitamins|mesh-list
92367531|NCT00845130|Ascorbic Acid|ascorbic acid|mesh-list
92367532|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
92367533|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367534|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
92367535|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367536|NCT00845130|Protective Agents|protective agents|mesh-ancestor
92367537|NCT00848016|Acetic Acid|acetic acid|mesh-list
92367538|NCT00848016|Retinol acetate|retinol acetate|mesh-list
92367540|NCT00848016|Gossypol|gossypol|mesh-list
91987218|NCT02344823|Vasodilator Agents|vasodilator agents|mesh-ancestor
92367541|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367542|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367543|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92367544|NCT00848016|Immunologic Factors|immunologic factors|mesh-ancestor
92367545|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367546|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92367547|NCT00848016|Protective Agents|protective agents|mesh-ancestor
92367548|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367549|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92367550|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
92367551|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367552|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92367553|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92367554|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92367555|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92367556|NCT00849810|Metoprolol|metoprolol|mesh-list
92367557|NCT00849810|Nebivolol|nebivolol|mesh-list
92367558|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92367559|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92367560|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
92367561|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
92367562|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367563|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367564|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92367565|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92367566|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92367567|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
92367568|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367569|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367570|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
92367571|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92367572|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92367573|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92367574|NCT00856050|Letrozole|letrozole|mesh-list
92367575|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367576|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92367577|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92367578|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987372|NCT02518139|Tiotropium Bromide|tiotropium bromide|mesh-list
92367579|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367580|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92367581|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92367582|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367583|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367584|NCT00858468|Vaccines|vaccines|mesh-list
92367585|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
92367586|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367587|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92367588|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92367589|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367590|NCT00866034|Cetrorelix|cetrorelix|mesh-list
92367592|NCT00866034|Fertility Agents|fertility agents|mesh-ancestor
92367593|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367594|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367595|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
92367596|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367597|NCT00868140|Pioglitazone|pioglitazone|mesh-list
92367598|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92367599|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367600|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92367601|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
92367602|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367603|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92367604|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92367605|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367606|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367607|NCT00868452|Valproic Acid|valproic acid|mesh-list
92367608|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
92367609|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92367610|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
92367611|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367612|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367613|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367614|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
92367615|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92367616|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367617|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367618|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
92367619|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
92367620|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367621|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92367622|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92367624|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92367625|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
92367626|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92367627|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92367628|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
92367629|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92367630|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92367631|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
92367632|NCT00869622|Vitamin D|vitamin d|mesh-list
92367633|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
92367634|NCT00869622|Calcium|calcium|mesh-list
92367635|NCT00869622|Vitamins|vitamins|mesh-ancestor
92367636|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
92367637|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367638|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92367639|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92367640|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92367641|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367642|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367643|NCT00871260|Regadenoson|regadenoson|mesh-list
92367644|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92367645|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92367646|NCT00871260|Purinergic Agonists|purinergic agonists|mesh-ancestor
92367647|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
92367648|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367649|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367650|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367651|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92367652|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367653|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367654|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367655|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92367657|NCT00875550|Midazolam|midazolam|mesh-list
92367658|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
92367659|NCT00875550|Morphine|morphine|mesh-list
92367660|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92367661|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367662|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367663|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92367664|NCT00875550|Analgesics|analgesics|mesh-ancestor
91932946|NCT04059445|Calcium, Dietary|calcium, dietary|mesh-list
92367665|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
92367666|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987851|NCT02328443|Anesthetics, General|anesthetics, general|mesh-ancestor
92367667|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92367668|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92367670|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92367671|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367672|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367673|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92367674|NCT00875550|Narcotics|narcotics|mesh-ancestor
92367675|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92367676|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92367677|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
92367678|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
92367679|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92367681|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367682|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
92367683|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
92367684|NCT00878436|Bicalutamide|bicalutamide|mesh-list
92367685|NCT00878436|Panobinostat|panobinostat|mesh-list
92367686|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
92367687|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
92020161|NCT04858087|Artemether|artemether|mesh-list
92367688|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367689|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367690|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367691|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92367692|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937549|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
92367693|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367696|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92367697|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92367698|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367699|NCT00879060|Spironolactone|spironolactone|mesh-list
92367700|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92367701|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
92367702|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367703|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367704|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92367705|NCT00879060|Diuretics|diuretics|mesh-ancestor
92367706|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
92367707|NCT00882102|Decitabine|decitabine|mesh-list
92367708|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
92367709|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92367710|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
92367711|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367712|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367713|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367714|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367715|NCT00882102|Immunotoxins|immunotoxins|mesh-ancestor
92367716|NCT00882102|Immunoconjugates|immunoconjugates|mesh-ancestor
92367717|NCT00882102|Immunologic Factors|immunologic factors|mesh-ancestor
92367718|NCT00882102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367719|NCT00884052|Levetiracetam|levetiracetam|mesh-list
92367720|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
92367721|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
92367722|NCT00886236|Gabapentin|gabapentin|mesh-list
92367723|NCT00886236|Analgesics|analgesics|mesh-ancestor
92367724|NCT00886236|Sensory System Agents|sensory system agents|mesh-ancestor
92367725|NCT00886236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367726|NCT00886236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367727|NCT00886236|Anticonvulsants|anticonvulsants|mesh-ancestor
92367728|NCT00886236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92367729|NCT00886236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92367730|NCT00886236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367731|NCT00886236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367732|NCT00886236|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92367733|NCT00886236|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92367734|NCT00886236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367735|NCT00886236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367736|NCT00886236|Antimanic Agents|antimanic agents|mesh-ancestor
92367737|NCT00886626|Exenatide|exenatide|mesh-list
92367738|NCT00886626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92367739|NCT00886626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367740|NCT00886626|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92367741|NCT00886626|Incretins|incretins|mesh-ancestor
92367742|NCT00886626|Hormones|hormones|mesh-ancestor
92367743|NCT00886626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367744|NCT00887562|Ubiquinone|ubiquinone|mesh-list
92367745|NCT00887562|Idebenone|idebenone|mesh-list
92367746|NCT00887562|Antioxidants|antioxidants|mesh-ancestor
92367747|NCT00887562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367748|NCT00887562|Protective Agents|protective agents|mesh-ancestor
91988435|NCT04428203|Cannabidiol|cannabidiol|mesh-list
92367750|NCT00887562|Micronutrients|micronutrients|mesh-ancestor
92367751|NCT00887640|Diphenhydramine|diphenhydramine|mesh-list
92367752|NCT00887640|Promethazine|promethazine|mesh-list
92367753|NCT00887640|Sirolimus|sirolimus|mesh-list
92367754|NCT00887640|Temsirolimus|temsirolimus|mesh-list
92367755|NCT00887640|MTOR Inhibitors|mtor inhibitors|mesh-list
92367756|NCT00887640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367757|NCT00887640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367758|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367759|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367760|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
92367761|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367762|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367763|NCT00887640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367764|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367765|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92367766|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
92367767|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92367768|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92367769|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367770|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367771|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
92367772|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
92367773|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367774|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
92367775|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
92367776|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367777|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92367778|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
92367779|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
92367780|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367781|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92367782|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
92367783|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988545|NCT02427295|Octreotide|octreotide|mesh-list
92367785|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92367786|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367787|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367788|NCT00892710|Bevacizumab|bevacizumab|mesh-list
92367789|NCT00892710|Carboplatin|carboplatin|mesh-list
92367791|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367792|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367793|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92367794|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92367795|NCT00892710|Growth Substances|growth substances|mesh-ancestor
92367796|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367797|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
92367798|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367799|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367800|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92367801|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92367802|NCT00894504|Carboplatin|carboplatin|mesh-list
92367803|NCT00894504|Gemcitabine|gemcitabine|mesh-list
92367804|NCT00894504|Panitumumab|panitumumab|mesh-list
92367805|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367806|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92367807|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
92367808|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367809|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92367811|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
92367812|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92367813|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92367814|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367815|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367816|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367817|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92367818|NCT00895752|Protective Agents|protective agents|mesh-ancestor
92367819|NCT00896064|Vaccines|vaccines|mesh-list
92367820|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92367821|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
92367822|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367823|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92367824|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
92367825|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92367826|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92367827|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367828|NCT00898560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367829|NCT00899574|Imiquimod|imiquimod|mesh-list
92367831|NCT00899574|Immunologic Factors|immunologic factors|mesh-ancestor
92367832|NCT00899574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367833|NCT00899574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367834|NCT00899574|Interferon Inducers|interferon inducers|mesh-ancestor
92367835|NCT00900666|Botulinum Toxins|botulinum toxins|mesh-list
92367836|NCT00900666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92367837|NCT00900666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92367838|NCT00900666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92367839|NCT00900666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367840|NCT00900666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367841|NCT00900666|Cholinergic Agents|cholinergic agents|mesh-ancestor
92367842|NCT00900666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988943|NCT02425813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92367843|NCT00900666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367844|NCT00900666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92367845|NCT00900666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367846|NCT00902226|Escitalopram|escitalopram|mesh-list
92367847|NCT00902226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92367848|NCT00902226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92367849|NCT00902226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367850|NCT00902226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367851|NCT00902226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367852|NCT00902226|Serotonin Agents|serotonin agents|mesh-ancestor
92367853|NCT00902226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367854|NCT00903162|Zoledronic Acid|zoledronic acid|mesh-list
92367855|NCT00903162|Letrozole|letrozole|mesh-list
92367856|NCT00903162|Leuprolide|leuprolide|mesh-list
92367857|NCT00903162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367858|NCT00903162|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92367859|NCT00903162|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92367860|NCT00903162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367861|NCT00903162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367862|NCT00903162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92367863|NCT00903162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92399298|NCT01402882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367864|NCT00903162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367865|NCT00903162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367866|NCT00903162|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92367867|NCT00903162|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92367868|NCT00903162|Fertility Agents|fertility agents|mesh-ancestor
92367869|NCT00903162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92367870|NCT00903162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92367872|NCT00904488|Furosemide|furosemide|mesh-list
92367873|NCT00904488|Diuretics|diuretics|mesh-ancestor
92367874|NCT00904488|Natriuretic Agents|natriuretic agents|mesh-ancestor
92367875|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367876|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92367877|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367878|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367879|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92399299|NCT01402882|Hemostatics|hemostatics|mesh-ancestor
92367880|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92367881|NCT00905580|Pregabalin|pregabalin|mesh-list
92367882|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367883|NCT00905580|Analgesics|analgesics|mesh-ancestor
92367884|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
92367885|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367886|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
92367887|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92367888|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367889|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367890|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92367891|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92367892|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91970075|NCT02476799|Narcotics|narcotics|mesh-ancestor
92367893|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367894|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92367896|NCT00908466|Temsirolimus|temsirolimus|mesh-list
92367897|NCT00908466|MTOR Inhibitors|mtor inhibitors|mesh-list
92367898|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92367899|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92367900|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92367901|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367902|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
92367903|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92367904|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
92367905|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367906|NCT00908466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92367907|NCT00908466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92367908|NCT00908466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367909|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
92367910|NCT00911586|Testosterone|testosterone|mesh-list
92367911|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
92367912|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
92367913|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92367914|NCT00911586|Androgens|androgens|mesh-ancestor
92367915|NCT00911586|Hormones|hormones|mesh-ancestor
92367916|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367917|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367918|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92367919|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367920|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
92367921|NCT00911742|Tramadol|tramadol|mesh-list
92367922|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92367923|NCT00911742|Narcotics|narcotics|mesh-ancestor
92367924|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367925|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367926|NCT00911742|Analgesics|analgesics|mesh-ancestor
92367927|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
92367928|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367929|NCT00912990|Cisatracurium|cisatracurium|mesh-list
92367930|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92367931|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92367932|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367933|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367934|NCT00913068|Lidocaine|lidocaine|mesh-list
92367935|NCT00913068|Ropivacaine|ropivacaine|mesh-list
92367936|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367937|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
92367938|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367939|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367940|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
92367941|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367942|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91989343|NCT02624765|Digoxin|digoxin|mesh-list
92367943|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92367944|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92367945|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92367946|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367947|NCT00916032|Factor VIII|factor viii|mesh-list
92367948|NCT00916032|Coagulants|coagulants|mesh-ancestor
92367949|NCT00922194|Metformin|metformin|mesh-list
92367950|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92367951|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367952|NCT00923910|Acetaminophen|acetaminophen|mesh-list
92367953|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
92367954|NCT00923910|Promethazine|promethazine|mesh-list
92367955|NCT00923910|Interleukin-4|interleukin-4|mesh-list
91989549|NCT03116893|Rifampin|rifampin|mesh-list
92367957|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92367958|NCT00923910|Analgesics|analgesics|mesh-ancestor
92367959|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
92367960|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92367961|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367962|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
92367963|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92367964|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92367965|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92367966|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
92367967|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
92367968|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
92367970|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92367971|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92367972|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
92367973|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
92367974|NCT00923910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92367975|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367976|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92367977|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
92367978|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92367979|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92367980|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
92367981|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367982|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020461|NCT04839913|Antibodies|antibodies|mesh-list
92367983|NCT00924066|Epothilones|epothilones|mesh-list
92367984|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92367985|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92367986|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92367987|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92367988|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92367989|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
92367990|NCT00924612|Testosterone|testosterone|mesh-list
92367991|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
92367992|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
92367993|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92367994|NCT00924612|Androgens|androgens|mesh-ancestor
92367995|NCT00924612|Hormones|hormones|mesh-ancestor
92367996|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92367997|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92367998|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92368000|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
92368001|NCT00925782|Melphalan|melphalan|mesh-list
92368002|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368003|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
92368004|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368005|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368006|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368007|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368008|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
92368009|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368010|NCT00925938|Misoprostol|misoprostol|mesh-list
92368011|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92368012|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
92368013|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92368014|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368015|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92368016|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368017|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
92368018|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92368019|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92368020|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368021|NCT00927888|Bupivacaine|bupivacaine|mesh-list
92368022|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
92368023|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
91989861|NCT02412475|Cytarabine|cytarabine|mesh-list
92368024|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368025|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368026|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
92368027|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368028|NCT00928200|Cytarabine|cytarabine|mesh-list
92368029|NCT00928200|Dexamethasone|dexamethasone|mesh-list
92368030|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
92368031|NCT00928200|Doxorubicin|doxorubicin|mesh-list
92368032|NCT00928200|Methotrexate|methotrexate|mesh-list
92368033|NCT00928200|Vincristine|vincristine|mesh-list
92368034|NCT00928200|Asparaginase|asparaginase|mesh-list
92368035|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
92368036|NCT00928200|Razoxane|razoxane|mesh-list
92368037|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92368038|NCT00928200|BB 1101|bb 1101|mesh-list
92368039|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368040|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
92368041|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
92368042|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368043|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368044|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368045|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
92368046|NCT00928200|Hormones|hormones|mesh-ancestor
92368047|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368048|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92368049|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368050|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
92368051|NCT00928200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368052|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368053|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92368054|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92368055|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92368056|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92368057|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
92368058|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92368059|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989948|NCT02412085|Golimumab|golimumab|mesh-list
92368061|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368062|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92368063|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368064|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
92368065|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368066|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92368068|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368069|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92368070|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92368071|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92368072|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92368073|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92368074|NCT00928200|Protective Agents|protective agents|mesh-ancestor
92368075|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
92368076|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92368077|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92368078|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
92368079|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
92368080|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368081|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368082|NCT00931242|Thalidomide|thalidomide|mesh-list
92368083|NCT00931242|Apremilast|apremilast|mesh-list
92368084|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92368085|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92368086|NCT00931242|Analgesics|analgesics|mesh-ancestor
92368087|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
92368088|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399300|NCT01402882|Coagulants|coagulants|mesh-ancestor
92368089|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368090|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368091|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368092|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92368093|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92368094|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368095|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368096|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368097|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
92368098|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
92368099|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92368100|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368101|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92368102|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92368103|NCT00931242|Growth Substances|growth substances|mesh-ancestor
92368104|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
92368105|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368106|NCT00932022|Trospium chloride|trospium chloride|mesh-list
92368107|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
92368108|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
92368109|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368110|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368111|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92368112|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92368113|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
92368114|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368115|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368116|NCT00932022|Urological Agents|urological agents|mesh-ancestor
92368117|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92368119|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92368120|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92368121|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368122|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368123|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
92368124|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368125|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368126|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92368127|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92368128|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
92368129|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368130|NCT00939120|Urological Agents|urological agents|mesh-ancestor
92368131|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
92368132|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92368133|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368134|NCT00943098|Diclofenac|diclofenac|mesh-list
92368135|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92368136|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937555|NCT05533229|Narcotics|narcotics|mesh-ancestor
92368138|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
92368139|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368140|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368141|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368142|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368143|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92368144|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368145|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368147|NCT00943800|Fludarabine|fludarabine|mesh-list
92368148|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
92368149|NCT00943800|Melphalan|melphalan|mesh-list
92368150|NCT00943800|Busulfan|busulfan|mesh-list
92368151|NCT00943800|Thiotepa|thiotepa|mesh-list
92368152|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92368153|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
92368154|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368155|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92368156|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
92368157|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368158|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368159|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
92368160|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368161|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
92368162|NCT00943800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368163|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368164|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
92368165|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368167|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
92368168|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368169|NCT00945282|Ritonavir|ritonavir|mesh-list
92368170|NCT00945282|Lopinavir|lopinavir|mesh-list
92368171|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92368172|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92368173|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
92368174|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368175|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368176|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92368177|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92368178|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
92368179|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368180|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92368181|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92368182|NCT00945750|Famotidine|famotidine|mesh-list
92368183|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92368184|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368185|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92368186|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
92368187|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
92368188|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368189|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368190|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368191|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
92368192|NCT00948090|Busulfan|busulfan|mesh-list
92368193|NCT00948090|Etoposide|etoposide|mesh-list
92368194|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368195|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
92368196|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990578|NCT02012218|Brexpiprazole|brexpiprazole|mesh-list
92368197|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368198|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368199|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
92368200|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368201|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368202|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368203|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92368204|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92368205|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92368206|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368207|NCT00950352|Choline|choline|mesh-list
92368208|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92368209|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
92368210|NCT00950352|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92020734|NCT04837651|Antibodies|antibodies|mesh-list
92368211|NCT00950352|Antimetabolites|antimetabolites|mesh-ancestor
92368212|NCT00950352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368213|NCT00950352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368214|NCT00950352|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92368215|NCT00950352|Nootropic Agents|nootropic agents|mesh-ancestor
92368216|NCT00953862|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92368217|NCT00953862|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92368218|NCT00953862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92368219|NCT00953862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368220|NCT00953862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368221|NCT00953862|Adrenergic Agents|adrenergic agents|mesh-ancestor
92368222|NCT00953862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368223|NCT00953862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368225|NCT00955266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92368226|NCT00955266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368227|NCT00957684|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92368228|NCT00957684|Anticonvulsants|anticonvulsants|mesh-ancestor
92368229|NCT00957684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92368230|NCT00957684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92368231|NCT00957684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368232|NCT00957684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368233|NCT00961662|Tagatose|tagatose|mesh-list
92368234|NCT00961662|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92368235|NCT00961662|Chelating Agents|chelating agents|mesh-ancestor
92368236|NCT00961662|Sequestering Agents|sequestering agents|mesh-ancestor
92399301|NCT01403025|Liraglutide|liraglutide|mesh-list
92368237|NCT00961662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368239|NCT00964548|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92368240|NCT00964548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368241|NCT00964548|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92368242|NCT00964548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368243|NCT00905268|Idebenone|idebenone|mesh-list
92368244|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
92368245|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368246|NCT00905268|Protective Agents|protective agents|mesh-ancestor
92368247|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368248|NCT00967044|Everolimus|everolimus|mesh-list
92368249|NCT00967044|Panobinostat|panobinostat|mesh-list
92368250|NCT00967044|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92368251|NCT00967044|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92368252|NCT00967044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368253|NCT00967044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368254|NCT00967044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368255|NCT00967044|Immunologic Factors|immunologic factors|mesh-ancestor
92368256|NCT00967044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368257|NCT00967044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368258|NCT00967044|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92368259|NCT00973752|Cytarabine|cytarabine|mesh-list
92368260|NCT00973752|Prednisone|prednisone|mesh-list
92368261|NCT00973752|Doxorubicin|doxorubicin|mesh-list
92368262|NCT00973752|Methotrexate|methotrexate|mesh-list
92368263|NCT00973752|Vincristine|vincristine|mesh-list
92368264|NCT00973752|Asparaginase|asparaginase|mesh-list
92368265|NCT00973752|Mercaptopurine|mercaptopurine|mesh-list
92368266|NCT00973752|Clofarabine|clofarabine|mesh-list
92368267|NCT00973752|Pegaspargase|pegaspargase|mesh-list
92368268|NCT00973752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92368269|NCT00973752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368270|NCT00973752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91991072|NCT02399137|Paclitaxel|paclitaxel|mesh-list
92368271|NCT00973752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92368272|NCT00973752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399302|NCT01403025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92368273|NCT00973752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368274|NCT00973752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368275|NCT00973752|Glucocorticoids|glucocorticoids|mesh-ancestor
92368276|NCT00973752|Hormones|hormones|mesh-ancestor
92368277|NCT00973752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368278|NCT00973752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368279|NCT00973752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92368280|NCT00973752|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92368281|NCT00973752|Abortifacient Agents|abortifacient agents|mesh-ancestor
92368282|NCT00973752|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92368283|NCT00973752|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92368284|NCT00973752|Antimetabolites|antimetabolites|mesh-ancestor
92020769|NCT04792645|Memantine|memantine|mesh-list
92368286|NCT00973752|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92368287|NCT00973752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368288|NCT00973752|Immunologic Factors|immunologic factors|mesh-ancestor
92368289|NCT00973752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368290|NCT00973752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92368291|NCT00973752|Antiviral Agents|antiviral agents|mesh-ancestor
92368292|NCT00973752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368293|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92368294|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
92368295|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
92368296|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
92368297|NCT00974142|Cyclosporine|cyclosporine|mesh-list
92368298|NCT00974142|Cyclosporins|cyclosporins|mesh-list
92368299|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368300|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368301|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368302|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
92368303|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368304|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
92368305|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368306|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368307|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368308|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92368310|NCT00974376|Analgesics|analgesics|mesh-ancestor
92368311|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
92368312|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368313|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368314|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
92368315|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92368316|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92368317|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368318|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92368319|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92368320|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92368321|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368322|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368323|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
92368324|NCT00976248|Everolimus|everolimus|mesh-list
91991324|NCT03172741|Hormones|hormones|mesh-ancestor
92368325|NCT00976248|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91991367|NCT03129113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92368326|NCT00976248|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92368327|NCT00976248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368328|NCT00976248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368329|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368330|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
92368331|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368332|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368333|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
92368334|NCT00976404|Maraviroc|maraviroc|mesh-list
92368335|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92368336|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92368337|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
92368338|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368339|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92368340|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92368341|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368342|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368343|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92368344|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92368345|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92368346|NCT00983346|Bortezomib|bortezomib|mesh-list
92368347|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368348|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
92368349|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92368350|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991493|NCT02396563|Sensory System Agents|sensory system agents|mesh-ancestor
92368351|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92368352|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368353|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368354|NCT00987480|Cyclosporine|cyclosporine|mesh-list
92368355|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
92368356|NCT00987480|Busulfan|busulfan|mesh-list
92368357|NCT00987480|Fludarabine|fludarabine|mesh-list
92368358|NCT00987480|Cyclosporins|cyclosporins|mesh-list
92368359|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368360|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
92368361|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368362|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368363|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368364|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
92368365|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368366|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368367|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368368|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368369|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
92368370|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368371|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368372|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92368373|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92368374|NCT00987558|Simvastatin|simvastatin|mesh-list
92368375|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92368376|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92368377|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
92368378|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368379|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92368380|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92368381|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368382|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
92368383|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92368384|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92368385|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368386|NCT00987948|Maraviroc|maraviroc|mesh-list
92368387|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92368388|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92368389|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368390|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92368391|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92368392|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
92368393|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368394|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92368395|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92368396|NCT00989586|Veltuzumab|veltuzumab|mesh-list
92368397|NCT00989586|Antibodies|antibodies|mesh-list
92368398|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
92368399|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92368400|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
92368401|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368402|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368403|NCT00990288|Thrombin|thrombin|mesh-list
92368404|NCT00990288|Hemostatics|hemostatics|mesh-list
92368405|NCT00990288|Coagulants|coagulants|mesh-ancestor
92368406|NCT00991458|Cyclosporine|cyclosporine|mesh-list
92368407|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92368408|NCT00991458|Cyclosporins|cyclosporins|mesh-list
92368409|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368410|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368411|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368412|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
92368413|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368414|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
92368415|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368416|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368417|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368418|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92368419|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92368420|NCT00993798|Bupivacaine|bupivacaine|mesh-list
92368421|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
92368422|NCT00993798|Anesthetics|anesthetics|mesh-ancestor
92368423|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368424|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368425|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
92368426|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368427|NCT00997620|Fluticasone|fluticasone|mesh-list
92368429|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368430|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92368431|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
92368432|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368433|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368434|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92368435|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
92368436|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368437|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92368438|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
92368439|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
92368440|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92368441|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92368442|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368443|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92368444|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92368445|NCT00997932|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92368446|NCT00998010|Temozolomide|temozolomide|mesh-list
92368448|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368449|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
92368450|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368451|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368452|NCT00999102|Metoprolol|metoprolol|mesh-list
92368453|NCT00999102|Nebivolol|nebivolol|mesh-list
92368454|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92368455|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92368456|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
92368457|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
92368458|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368459|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368460|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92368461|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92368462|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92368463|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
92368464|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368465|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368466|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
92368467|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92368468|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92368469|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92368470|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
92368471|NCT01000818|Omeprazole|omeprazole|mesh-list
92368472|NCT01000818|Famotidine|famotidine|mesh-list
92368473|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92368474|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368475|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92368476|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368477|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368478|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92368479|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92368480|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
92368481|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368482|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92368483|NCT01000818|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92368484|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92368485|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
92368486|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
92368487|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119435|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368488|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368489|NCT01001052|Colchicine|colchicine|mesh-list
92368490|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
92368491|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368492|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
92368493|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
92368494|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
92368495|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368496|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368497|NCT01001442|Indatuximab ravtansine|indatuximab ravtansine|mesh-list
92368498|NCT01001442|Immunoconjugates|immunoconjugates|mesh-ancestor
92368499|NCT01001442|Immunologic Factors|immunologic factors|mesh-ancestor
92368500|NCT01001442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368502|NCT01003080|Coagulants|coagulants|mesh-ancestor
92368503|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92368505|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992190|NCT03169777|Leucovorin|leucovorin|mesh-list
92368506|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92368507|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368508|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368509|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92368510|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92368512|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92020982|NCT04829695|Artesunate|artesunate|mesh-list
92368513|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92368514|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368515|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
92368516|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
92368517|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368518|NCT01005576|Fludarabine|fludarabine|mesh-list
92368519|NCT01005576|Melphalan|melphalan|mesh-list
92368520|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
92368521|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368522|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368523|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368524|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
92368525|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368526|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368527|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
92368528|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368529|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92368530|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
91992300|NCT04255277|Estrogens|estrogens|mesh-ancestor
92368531|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92368533|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368534|NCT01005810|Expectorants|expectorants|mesh-ancestor
92368535|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
92368536|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92368537|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
92368538|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368539|NCT01005810|Protective Agents|protective agents|mesh-ancestor
92368540|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368541|NCT01005810|Antidotes|antidotes|mesh-ancestor
92368542|NCT01005888|Complement C1s|complement c1s|mesh-list
92368543|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92368544|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92368545|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
92368546|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368547|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92368548|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368549|NCT01007994|Propranolol|propranolol|mesh-list
92368550|NCT01007994|Enalapril|enalapril|mesh-list
92368551|NCT01007994|Isradipine|isradipine|mesh-list
92368552|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92368553|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92368554|NCT01007994|Adrenergic Agents|adrenergic agents|mesh-ancestor
92368555|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399303|NCT01403025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368556|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368557|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368558|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92368559|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92368560|NCT01007994|Vasodilator Agents|vasodilator agents|mesh-ancestor
92368561|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92368562|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
92368563|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368564|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92368565|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368566|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92368567|NCT01008462|Cytarabine|cytarabine|mesh-list
92368568|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
92368569|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
92368570|NCT01008462|Melphalan|melphalan|mesh-list
92368571|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
92368572|NCT01008462|Carmustine|carmustine|mesh-list
92368573|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92368574|NCT01008462|Fludarabine|fludarabine|mesh-list
92368575|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
92368576|NCT01008462|Etoposide|etoposide|mesh-list
92368577|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
92368578|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
92368579|NCT01008462|Tacrolimus|tacrolimus|mesh-list
92368580|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368581|NCT01008462|Immunologic Factors|immunologic factors|mesh-ancestor
92368582|NCT01008462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368583|NCT01008462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368584|NCT01008462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368585|NCT01008462|Alkylating Agents|alkylating agents|mesh-ancestor
92368586|NCT01008462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368587|NCT01008462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368588|NCT01008462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368589|NCT01008462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92368590|NCT01008462|Antimetabolites|antimetabolites|mesh-ancestor
92368591|NCT01008462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92368592|NCT01008462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92368593|NCT01008462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92368594|NCT01008462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368595|NCT01008462|Antiviral Agents|antiviral agents|mesh-ancestor
92368596|NCT01008462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368597|NCT01008462|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92368598|NCT01008462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92368599|NCT01008462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92368600|NCT01008462|Antitubercular Agents|antitubercular agents|mesh-ancestor
92368601|NCT01008462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92368602|NCT01008462|Keratolytic Agents|keratolytic agents|mesh-ancestor
92368603|NCT01008462|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368604|NCT01008462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92368605|NCT01008462|Antimitotic Agents|antimitotic agents|mesh-ancestor
91992782|NCT05701423|Natalizumab|natalizumab|mesh-list
92368606|NCT01008462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92368607|NCT01010568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92368609|NCT01010568|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92368610|NCT01010568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368611|NCT01010568|Alkylating Agents|alkylating agents|mesh-ancestor
92368612|NCT01010568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368613|NCT01010568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368614|NCT01010568|Immunologic Factors|immunologic factors|mesh-ancestor
92368615|NCT01010568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368616|NCT01011816|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92368617|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
92368618|NCT01011816|Coagulants|coagulants|mesh-ancestor
92368619|NCT01011894|Lenalidomide|lenalidomide|mesh-list
92368620|NCT01011894|Immunologic Factors|immunologic factors|mesh-ancestor
92368621|NCT01011894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368622|NCT01011894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92368623|NCT01011894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92368624|NCT01011894|Growth Substances|growth substances|mesh-ancestor
92368625|NCT01011894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92368626|NCT01011894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399304|NCT01403025|Incretins|incretins|mesh-ancestor
92368627|NCT01012674|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92368628|NCT01012674|Chelating Agents|chelating agents|mesh-ancestor
92368629|NCT01012674|Sequestering Agents|sequestering agents|mesh-ancestor
92368630|NCT01012674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368631|NCT01015170|Bupropion|bupropion|mesh-list
92368632|NCT01015170|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92368633|NCT01015170|Antidepressive Agents|antidepressive agents|mesh-ancestor
92368634|NCT01015170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92368635|NCT01015170|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92368636|NCT01015170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91932956|NCT05092841|Naltrexone|naltrexone|mesh-list
92368637|NCT01015170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368638|NCT01015170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368639|NCT01015170|Dopamine Agents|dopamine agents|mesh-ancestor
92368640|NCT01015170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368641|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399305|NCT01403025|Hormones|hormones|mesh-ancestor
92368642|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92368643|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92368644|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368645|NCT01017042|Colchicine|colchicine|mesh-list
92368646|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
92368647|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368648|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92368649|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92368650|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92368651|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368652|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368653|NCT01018056|Riluzole|riluzole|mesh-list
92368654|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
92368655|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92368656|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92368657|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368658|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368659|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368660|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92368661|NCT01018056|Protective Agents|protective agents|mesh-ancestor
92368662|NCT01018134|Desoximetasone|desoximetasone|mesh-list
92368663|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368665|NCT01018134|Hormones|hormones|mesh-ancestor
92368666|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368667|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368668|NCT01020006|Gemcitabine|gemcitabine|mesh-list
92368669|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92368670|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
92368671|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368672|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368673|NCT05395962|Carboplatin|carboplatin|mesh-list
92368674|NCT05395962|Bleomycin|bleomycin|mesh-list
92368675|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368676|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92368677|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
92368678|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368679|NCT05017584|Bupivacaine|bupivacaine|mesh-list
92368680|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
92368681|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
92368682|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368683|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368684|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
92368685|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368686|NCT04999332|Leucovorin|leucovorin|mesh-list
92368687|NCT04999332|Docetaxel|docetaxel|mesh-list
92368688|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
92368689|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
92368690|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368691|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
92368692|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
92368693|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
92368694|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992998|NCT02214407|Decitabine|decitabine|mesh-list
92368695|NCT04999332|Antidotes|antidotes|mesh-ancestor
92368696|NCT04999332|Protective Agents|protective agents|mesh-ancestor
92368697|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368698|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
92368699|NCT04999332|Vitamins|vitamins|mesh-ancestor
92368700|NCT04999332|Micronutrients|micronutrients|mesh-ancestor
92368701|NCT04147416|Propofol|propofol|mesh-list
92368702|NCT04147416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92368703|NCT04147416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368704|NCT04147416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368705|NCT04147416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92368706|NCT04147416|Anesthetics, General|anesthetics, general|mesh-ancestor
92368707|NCT04147416|Anesthetics|anesthetics|mesh-ancestor
92368708|NCT02662062|Pembrolizumab|pembrolizumab|mesh-list
92368709|NCT02662062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368710|NCT02662062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92368711|NCT02662062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92119513|NCT03220542|Amoxicillin|amoxicillin|mesh-list
92368712|NCT02662062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368713|NCT02406222|Dexamethasone|dexamethasone|mesh-list
92368714|NCT02406222|Cyclophosphamide|cyclophosphamide|mesh-list
92368715|NCT02406222|Pomalidomide|pomalidomide|mesh-list
92368716|NCT02406222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368717|NCT02406222|Immunologic Factors|immunologic factors|mesh-ancestor
92368718|NCT02406222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368719|NCT02406222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368720|NCT02406222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368721|NCT02406222|Alkylating Agents|alkylating agents|mesh-ancestor
92368722|NCT02406222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368723|NCT02406222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368724|NCT02406222|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368725|NCT02406222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368726|NCT02406222|Antiemetics|antiemetics|mesh-ancestor
92368727|NCT02406222|Autonomic Agents|autonomic agents|mesh-ancestor
92368728|NCT02406222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368729|NCT02406222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368730|NCT02406222|Glucocorticoids|glucocorticoids|mesh-ancestor
92368731|NCT02406222|Hormones|hormones|mesh-ancestor
92368732|NCT02406222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368733|NCT02406222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92368734|NCT02406222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92368735|NCT02406222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92368736|NCT02406222|Growth Substances|growth substances|mesh-ancestor
92368737|NCT02406222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92368738|NCT00458796|Zoledronic Acid|zoledronic acid|mesh-list
92368739|NCT00458796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92368740|NCT00458796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368741|NCT01022190|Etoricoxib|etoricoxib|mesh-list
92368742|NCT01022190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92368743|NCT01022190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92368744|NCT01022190|Analgesics|analgesics|mesh-ancestor
92368745|NCT01022190|Sensory System Agents|sensory system agents|mesh-ancestor
92368746|NCT01022190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368747|NCT01022190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368748|NCT01022190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368749|NCT01022190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368750|NCT01022190|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92368751|NCT01022190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92368752|NCT01022190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368753|NCT01022190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368755|NCT01024686|Immunologic Factors|immunologic factors|mesh-ancestor
92368756|NCT01024686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368757|NCT01027806|Montelukast|montelukast|mesh-list
92368758|NCT01027806|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92368759|NCT01027806|Respiratory System Agents|respiratory system agents|mesh-ancestor
92368760|NCT01027806|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92368761|NCT01027806|Hormone Antagonists|hormone antagonists|mesh-ancestor
92368762|NCT01027806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368763|NCT01027806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368764|NCT01027806|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92368765|NCT01027806|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92368766|NCT01027806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368767|NCT01029054|Dexamethasone|dexamethasone|mesh-list
92368768|NCT01029054|Dexamethasone acetate|dexamethasone acetate|mesh-list
92368769|NCT01029054|Lenalidomide|lenalidomide|mesh-list
92368770|NCT01029054|BB 1101|bb 1101|mesh-list
92368771|NCT01029054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92368772|NCT01029054|Antiemetics|antiemetics|mesh-ancestor
92368773|NCT01029054|Autonomic Agents|autonomic agents|mesh-ancestor
92368774|NCT01029054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368775|NCT01029054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368776|NCT01029054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92368777|NCT01029054|Glucocorticoids|glucocorticoids|mesh-ancestor
92368778|NCT01029054|Hormones|hormones|mesh-ancestor
92368779|NCT01029054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92368780|NCT01029054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92368781|NCT01029054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368782|NCT01029054|Protease Inhibitors|protease inhibitors|mesh-ancestor
92368783|NCT01029054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368784|NCT01029054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368785|NCT01029054|Immunologic Factors|immunologic factors|mesh-ancestor
92368786|NCT01029054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92368787|NCT01029054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92368788|NCT01029054|Growth Substances|growth substances|mesh-ancestor
92368789|NCT01029054|Growth Inhibitors|growth inhibitors|mesh-ancestor
92368790|NCT01032954|Botulinum Toxins|botulinum toxins|mesh-list
92368791|NCT01032954|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92368792|NCT01032954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368793|NCT01032954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368794|NCT01032954|Cholinergic Agents|cholinergic agents|mesh-ancestor
92368795|NCT01032954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368796|NCT01032954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368797|NCT05592678|Donepezil|donepezil|mesh-list
92368798|NCT05592678|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92368799|NCT05592678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368800|NCT05592678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368801|NCT05592678|Cholinergic Agents|cholinergic agents|mesh-ancestor
92368802|NCT05592678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368803|NCT05592678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368804|NCT05592678|Nootropic Agents|nootropic agents|mesh-ancestor
92368805|NCT05402826|Vitamin E|vitamin e|mesh-list
92368806|NCT05402826|Vitamins|vitamins|mesh-ancestor
92368807|NCT05402826|Micronutrients|micronutrients|mesh-ancestor
92368808|NCT05402826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368809|NCT05402826|Antioxidants|antioxidants|mesh-ancestor
92368810|NCT05402826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368811|NCT05402826|Protective Agents|protective agents|mesh-ancestor
92368812|NCT05385042|Vitamin B 12|vitamin b 12|mesh-list
92368813|NCT05385042|Thiamine|thiamine|mesh-list
91993461|NCT04494503|Rituximab|rituximab|mesh-list
92368815|NCT05385042|Micronutrients|micronutrients|mesh-ancestor
92368816|NCT05385042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368817|NCT05385042|Vitamin B Complex|vitamin b complex|mesh-ancestor
92368818|NCT05306028|Metformin|metformin|mesh-list
92368819|NCT05306028|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92368820|NCT05306028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368821|NCT05179668|Dapagliflozin|dapagliflozin|mesh-list
92368822|NCT05179668|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92368823|NCT05179668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368824|NCT05179668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92368825|NCT05179668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368827|NCT04780932|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92368828|NCT04780932|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92368829|NCT04780932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368830|NCT04780932|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92368831|NCT04316910|Anesthetics|anesthetics|mesh-list
92368832|NCT04316910|Anesthetics, General|anesthetics, general|mesh-list
91993606|NCT02388373|Xhance|xhance|mesh-list
92368833|NCT04316910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368834|NCT04316910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368835|NCT04308330|Vorinostat|vorinostat|mesh-list
92368836|NCT04308330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368837|NCT04308330|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92368838|NCT04308330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368839|NCT04308330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368840|NCT03680508|Dostarlimab|dostarlimab|mesh-list
92368841|NCT03680508|Antibodies|antibodies|mesh-list
92368842|NCT03680508|Immunoglobulins|immunoglobulins|mesh-list
92368843|NCT03680508|Immunologic Factors|immunologic factors|mesh-ancestor
91993665|NCT04637555|Valsartan|valsartan|mesh-list
92368844|NCT03680508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368845|NCT03680508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368847|NCT01842672|Clofarabine|clofarabine|mesh-list
92368848|NCT01842672|Analgesics|analgesics|mesh-ancestor
92368849|NCT01842672|Sensory System Agents|sensory system agents|mesh-ancestor
92368850|NCT01842672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368851|NCT01842672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368852|NCT01842672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368853|NCT01842672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92368854|NCT01842672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92368855|NCT01842672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368856|NCT01842672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368857|NCT01842672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92368858|NCT01842672|Antimetabolites|antimetabolites|mesh-ancestor
92368859|NCT01034592|Lenalidomide|lenalidomide|mesh-list
92368860|NCT01034592|Immunologic Factors|immunologic factors|mesh-ancestor
92368861|NCT01034592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937585|NCT01659554|Cisplatin|cisplatin|mesh-list
92368862|NCT01034592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92368863|NCT01034592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92368864|NCT01034592|Growth Substances|growth substances|mesh-ancestor
92368865|NCT01034592|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993724|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
92368867|NCT01037790|Palbociclib|palbociclib|mesh-list
92368868|NCT01037790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368869|NCT01037790|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92368870|NCT01037790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368871|NCT01037790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368872|NCT01043094|Pitavastatin|pitavastatin|mesh-list
92368873|NCT01043094|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92368874|NCT01043094|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92368875|NCT01043094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92368876|NCT01043094|Antimetabolites|antimetabolites|mesh-ancestor
92368877|NCT01043094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368878|NCT01043094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368879|NCT01043094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92368880|NCT01043640|Cyclosporine|cyclosporine|mesh-list
92368881|NCT01043640|Mycophenolic Acid|mycophenolic acid|mesh-list
92368882|NCT01043640|Cyclophosphamide|cyclophosphamide|mesh-list
92368883|NCT01043640|Busulfan|busulfan|mesh-list
92368884|NCT01043640|Alemtuzumab|alemtuzumab|mesh-list
92368885|NCT01043640|Cyclosporins|cyclosporins|mesh-list
92368886|NCT01043640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92368887|NCT01043640|Immunologic Factors|immunologic factors|mesh-ancestor
92368888|NCT01043640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368889|NCT01043640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92368890|NCT01043640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368891|NCT01043640|Alkylating Agents|alkylating agents|mesh-ancestor
92368892|NCT01043640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368893|NCT01043640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368894|NCT01043640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92368895|NCT01043640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368896|NCT01043640|Antifungal Agents|antifungal agents|mesh-ancestor
92368897|NCT01043640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92368898|NCT01043640|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368899|NCT01043640|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92368900|NCT01043640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92368901|NCT01043640|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92368902|NCT01043640|Antitubercular Agents|antitubercular agents|mesh-ancestor
92368903|NCT01043640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92368904|NCT01043640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92368906|NCT01044966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368907|NCT01044966|Alkylating Agents|alkylating agents|mesh-ancestor
92368908|NCT01044966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368909|NCT01044966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368910|NCT01045122|Dexmedetomidine|dexmedetomidine|mesh-list
92368911|NCT01045122|Propofol|propofol|mesh-list
92368912|NCT01045122|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92368913|NCT01045122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368914|NCT01045122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368915|NCT01045122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92368916|NCT01045122|Analgesics|analgesics|mesh-ancestor
92368917|NCT01045122|Sensory System Agents|sensory system agents|mesh-ancestor
92368918|NCT01045122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368919|NCT01045122|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92368920|NCT01045122|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92368921|NCT01045122|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92368922|NCT01045122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92368923|NCT01045122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368924|NCT01045122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368925|NCT01045122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92368926|NCT01045122|Anesthetics, General|anesthetics, general|mesh-ancestor
92368927|NCT01045122|Anesthetics|anesthetics|mesh-ancestor
92368928|NCT01050582|Risperidone|risperidone|mesh-list
92368929|NCT01050582|Antipsychotic Agents|antipsychotic agents|mesh-list
92368930|NCT01050582|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92368931|NCT01050582|Serotonin Agents|serotonin agents|mesh-ancestor
92368932|NCT01050582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119514|NCT03220542|Clarithromycin|clarithromycin|mesh-list
92368933|NCT01050582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368934|NCT01050582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368935|NCT01050582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92368936|NCT01050582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368937|NCT01050582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92368938|NCT01050582|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92368939|NCT01050582|Dopamine Agents|dopamine agents|mesh-ancestor
91993936|NCT05899621|Hormones|hormones|mesh-ancestor
92368940|NCT01050660|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92368941|NCT01050660|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92368942|NCT01050660|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92368943|NCT01050660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92368944|NCT01051440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92368945|NCT01051440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92368946|NCT01051440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368947|NCT01051440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92368948|NCT01051440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92368949|NCT01051440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368950|NCT01051440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368951|NCT01051440|Dopamine Agents|dopamine agents|mesh-ancestor
92368952|NCT01051440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368953|NCT01051596|Temozolomide|temozolomide|mesh-list
92368954|NCT01051596|Veliparib|veliparib|mesh-list
92368955|NCT01051596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92368956|NCT01051596|Alkylating Agents|alkylating agents|mesh-ancestor
92368957|NCT01051596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368958|NCT01051596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368959|NCT01051596|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92368960|NCT01051596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92368961|NCT01053000|Tazarotene|tazarotene|mesh-list
92368962|NCT01053000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92368963|NCT01053000|Keratolytic Agents|keratolytic agents|mesh-ancestor
92368964|NCT05822453|Gemcitabine|gemcitabine|mesh-list
92368965|NCT05822453|Tislelizumab|tislelizumab|mesh-list
92368966|NCT05822453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92368967|NCT05822453|Antimetabolites|antimetabolites|mesh-ancestor
92368968|NCT05822453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368969|NCT05822453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92368970|NCT05822453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92368971|NCT01028820|Aripiprazole|aripiprazole|mesh-list
92368972|NCT01028820|Antidepressive Agents|antidepressive agents|mesh-ancestor
92368973|NCT01028820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92368974|NCT01028820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92368975|NCT01028820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92368976|NCT01028820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92368977|NCT01028820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368978|NCT01028820|Dopamine Agonists|dopamine agonists|mesh-ancestor
92368979|NCT01028820|Dopamine Agents|dopamine agents|mesh-ancestor
92368980|NCT01028820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92368981|NCT01028820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368982|NCT01028820|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92368983|NCT01028820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92368984|NCT01028820|Serotonin Agents|serotonin agents|mesh-ancestor
92368985|NCT01028820|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92368986|NCT01028820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92368987|NCT01028820|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92368988|NCT01028820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92368989|NCT05822362|Cannabidiol|cannabidiol|mesh-list
92368990|NCT05822362|Anticonvulsants|anticonvulsants|mesh-ancestor
91994115|NCT05897034|Antioxidants|antioxidants|mesh-ancestor
92368991|NCT05822323|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92368992|NCT05822323|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92368993|NCT05822323|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92368994|NCT05822323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92368995|NCT05822323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92368996|NCT05822323|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92368997|NCT05822323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92368998|NCT05822323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92368999|NCT05822323|Cholinergic Agents|cholinergic agents|mesh-ancestor
92369000|NCT05822323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369001|NCT05821933|Aflutinib|aflutinib|mesh-list
92369002|NCT05821933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92369003|NCT05821933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369004|NCT05821933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369005|NCT05821751|Pembrolizumab|pembrolizumab|mesh-list
92369007|NCT05821751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369008|NCT05821751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369009|NCT05821751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369010|NCT05821751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369011|NCT05821712|Listerine|listerine|mesh-list
92369012|NCT05821712|Fluorides|fluorides|mesh-list
92369013|NCT05821712|Sodium Fluoride|sodium fluoride|mesh-list
92369014|NCT05821712|Cariostatic Agents|cariostatic agents|mesh-ancestor
92369015|NCT05821712|Protective Agents|protective agents|mesh-ancestor
92369016|NCT05821712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369017|NCT05821712|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92369018|NCT05821712|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369019|NCT05821686|Aldesleukin|aldesleukin|mesh-list
92369020|NCT05821686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369021|NCT05821686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92369022|NCT05821686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92369023|NCT05821686|Antiviral Agents|antiviral agents|mesh-ancestor
92369024|NCT05821686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369025|NCT05821517|Methoxyflurane|methoxyflurane|mesh-list
92369026|NCT05821517|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92369027|NCT05821517|Anesthetics, General|anesthetics, general|mesh-ancestor
92369028|NCT05821517|Anesthetics|anesthetics|mesh-ancestor
92369029|NCT05821517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369030|NCT05821517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369031|NCT05821478|Metronidazole|metronidazole|mesh-list
92369033|NCT05821478|Ceftriaxone|ceftriaxone|mesh-list
92369034|NCT05821478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369035|NCT05821478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92369036|NCT05821478|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92369037|NCT05821478|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92369038|NCT05821478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92369039|NCT05821478|Antitubercular Agents|antitubercular agents|mesh-ancestor
92369040|NCT05821478|Leprostatic Agents|leprostatic agents|mesh-ancestor
92369041|NCT05821478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369042|NCT05821478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369043|NCT05821478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369044|NCT05821478|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92369045|NCT05821478|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92369046|NCT05821478|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92369047|NCT05821478|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92369048|NCT05821478|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92369049|NCT05821478|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92369050|NCT05821452|Paclitaxel|paclitaxel|mesh-list
92369051|NCT05821452|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92369052|NCT05821452|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92369053|NCT05821452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369054|NCT05821452|Tubulin Modulators|tubulin modulators|mesh-ancestor
92369055|NCT05821452|Antimitotic Agents|antimitotic agents|mesh-ancestor
92369056|NCT05821452|Mitosis Modulators|mitosis modulators|mesh-ancestor
92369057|NCT05821452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369058|NCT05821374|Deucravacitinib|deucravacitinib|mesh-list
92369059|NCT05821374|Dermatologic Agents|dermatologic agents|mesh-ancestor
92369060|NCT05821374|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92369061|NCT05821374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369062|NCT05821374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369063|NCT05821361|Bevacizumab|bevacizumab|mesh-list
92369064|NCT05821361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369065|NCT05821361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369066|NCT05821361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92369067|NCT05821361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92369068|NCT05821361|Growth Substances|growth substances|mesh-ancestor
92369070|NCT05821361|Growth Inhibitors|growth inhibitors|mesh-ancestor
92369071|NCT05821192|Dexamethasone|dexamethasone|mesh-list
92369072|NCT05821192|Rituximab|rituximab|mesh-list
92369073|NCT05821192|Gemcitabine|gemcitabine|mesh-list
92369074|NCT05821192|Antibodies|antibodies|mesh-list
92369075|NCT05821192|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92369076|NCT05821192|Immunologic Factors|immunologic factors|mesh-ancestor
92369077|NCT05821192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369078|NCT05821192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369079|NCT05821192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369080|NCT05821192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369081|NCT05821192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369082|NCT05821192|Antiemetics|antiemetics|mesh-ancestor
92369083|NCT05821192|Autonomic Agents|autonomic agents|mesh-ancestor
92369084|NCT05821192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369085|NCT05821192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92369086|NCT05821192|Glucocorticoids|glucocorticoids|mesh-ancestor
92369088|NCT05821192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369089|NCT05821192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92369090|NCT05821192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369091|NCT05821192|Antimetabolites|antimetabolites|mesh-ancestor
92369092|NCT05821192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369093|NCT05821153|Aldesleukin|aldesleukin|mesh-list
92369094|NCT05821153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369095|NCT05821153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92369096|NCT05821153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92369097|NCT05821153|Antiviral Agents|antiviral agents|mesh-ancestor
92369098|NCT05821153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369099|NCT05821062|Aspirin|aspirin|mesh-list
92369100|NCT05821062|Clopidogrel|clopidogrel|mesh-list
92369101|NCT05821062|Ticagrelor|ticagrelor|mesh-list
92369102|NCT05821062|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92369103|NCT05821062|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92369104|NCT05821062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369105|NCT05821062|Analgesics|analgesics|mesh-ancestor
92369106|NCT05821062|Sensory System Agents|sensory system agents|mesh-ancestor
92369107|NCT05821062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369108|NCT05821062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369109|NCT05821062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369110|NCT05821062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021614|NCT04786795|Pancreatin|pancreatin|mesh-list
92369111|NCT05821062|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92369112|NCT05821062|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92369113|NCT05821062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369114|NCT05821062|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92369115|NCT05821062|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92369116|NCT05821062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369117|NCT05821062|Antipyretics|antipyretics|mesh-ancestor
92369118|NCT05821062|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92369119|NCT05821062|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92369120|NCT05821062|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92369121|NCT05821062|Purinergic Agents|purinergic agents|mesh-ancestor
92369122|NCT05821062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369123|NCT05818553|Pramoxine|pramoxine|mesh-list
92369124|NCT05818553|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369125|NCT05818553|Anesthetics|anesthetics|mesh-ancestor
92369126|NCT05818553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369127|NCT05818553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369128|NCT05818553|Sensory System Agents|sensory system agents|mesh-ancestor
92369129|NCT05818553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369130|NCT05817162|Ropivacaine|ropivacaine|mesh-list
92369131|NCT05817162|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369132|NCT05817162|Anesthetics|anesthetics|mesh-ancestor
92369133|NCT05817162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369134|NCT05817162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369135|NCT05817162|Sensory System Agents|sensory system agents|mesh-ancestor
92369136|NCT05817162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369137|NCT05809180|Rituximab|rituximab|mesh-list
92369138|NCT05809180|Pomalidomide|pomalidomide|mesh-list
92369139|NCT05809180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369140|NCT05809180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369141|NCT05809180|Immunologic Factors|immunologic factors|mesh-ancestor
92369142|NCT05809180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369143|NCT05809180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369144|NCT05809180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92369145|NCT05809180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92369146|NCT05809180|Growth Substances|growth substances|mesh-ancestor
92369147|NCT05809180|Growth Inhibitors|growth inhibitors|mesh-ancestor
92369148|NCT05802238|Tranexamic Acid|tranexamic acid|mesh-list
92369149|NCT05802238|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92369150|NCT05802238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92369151|NCT05802238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369152|NCT05802238|Hemostatics|hemostatics|mesh-ancestor
92369153|NCT05802238|Coagulants|coagulants|mesh-ancestor
92369154|NCT05796570|Decitabine|decitabine|mesh-list
92369155|NCT05796570|Lenograstim|lenograstim|mesh-list
92369156|NCT05796570|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92369158|NCT05796570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369159|NCT05796570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369161|NCT05796570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369162|NCT05796570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369163|NCT05796570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369164|NCT05791617|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92369165|NCT05791617|Natriuretic Agents|natriuretic agents|mesh-ancestor
92369166|NCT05791617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369167|NCT05738057|Cisplatin|cisplatin|mesh-list
92369168|NCT05738057|Gemcitabine|gemcitabine|mesh-list
92369169|NCT05738057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369170|NCT05738057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369171|NCT05738057|Antimetabolites|antimetabolites|mesh-ancestor
92369172|NCT05738057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369173|NCT05699408|Insulin Glargine|insulin glargine|mesh-list
92369174|NCT05699408|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92369175|NCT05699408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369176|NCT05689151|Abrocitinib|abrocitinib|mesh-list
92369177|NCT05689151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92369178|NCT05689151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369179|NCT05689151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369180|NCT05668286|Triamcinolone|triamcinolone|mesh-list
92369181|NCT05668286|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92369182|NCT05668286|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92369184|NCT05668286|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92369185|NCT05668286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369188|NCT05668286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369189|NCT05668286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369190|NCT05668286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369191|NCT05668286|Immunologic Factors|immunologic factors|mesh-ancestor
92369192|NCT05668286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369193|NCT05668286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995105|NCT02616640|Durvalumab|durvalumab|mesh-list
92369194|NCT05668286|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369196|NCT05668286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369197|NCT05668286|Sensory System Agents|sensory system agents|mesh-ancestor
92369198|NCT05668286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369200|NCT05665465|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92369201|NCT05665465|Autonomic Agents|autonomic agents|mesh-ancestor
92369202|NCT05665465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369203|NCT05665465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369204|NCT05665465|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92369205|NCT05665465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92369206|NCT05665465|Cholinergic Agents|cholinergic agents|mesh-ancestor
92369207|NCT05665465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369208|NCT05665465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369209|NCT05664958|Bupivacaine|bupivacaine|mesh-list
92369210|NCT05664958|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369211|NCT05664958|Anesthetics|anesthetics|mesh-ancestor
92369212|NCT05664958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369213|NCT05664958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369214|NCT05664958|Sensory System Agents|sensory system agents|mesh-ancestor
92369215|NCT05664958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369216|NCT05581823|Carbamazepine|carbamazepine|mesh-list
92369217|NCT05581823|Anticonvulsants|anticonvulsants|mesh-ancestor
92369218|NCT05581823|Antimanic Agents|antimanic agents|mesh-ancestor
92369219|NCT05581823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92369220|NCT05581823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369221|NCT05581823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369222|NCT05581823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92369223|NCT05581823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369224|NCT05581823|Analgesics|analgesics|mesh-ancestor
92369225|NCT05581823|Sensory System Agents|sensory system agents|mesh-ancestor
92369226|NCT05581823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369227|NCT05581823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92369228|NCT05581823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369229|NCT05581823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369230|NCT05581823|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92369231|NCT05581823|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92369232|NCT05549180|Emtricitabine|emtricitabine|mesh-list
92369233|NCT05549180|Antiviral Agents|antiviral agents|mesh-ancestor
92369234|NCT05549180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369235|NCT05549180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92369236|NCT05549180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369237|NCT05549180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369238|NCT05549180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369239|NCT05549180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92369240|NCT05549180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92369241|NCT05513001|Remibrutinib|remibrutinib|mesh-list
92369242|NCT05513001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92369243|NCT05513001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369244|NCT05513001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369245|NCT05500599|Fentanyl|fentanyl|mesh-list
92369246|NCT05500599|Midazolam|midazolam|mesh-list
92369247|NCT05500599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92369248|NCT05500599|Narcotics|narcotics|mesh-ancestor
91995206|NCT01121588|Crizotinib|crizotinib|mesh-list
92369249|NCT05500599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369250|NCT05500599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369251|NCT05500599|Analgesics|analgesics|mesh-ancestor
92369252|NCT05500599|Sensory System Agents|sensory system agents|mesh-ancestor
92369253|NCT05500599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369254|NCT05500599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92369255|NCT05500599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92369256|NCT05500599|Anesthetics, General|anesthetics, general|mesh-ancestor
92369258|NCT05500599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92369259|NCT05500599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92369260|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92369262|NCT05500599|GABA Modulators|gaba modulators|mesh-ancestor
92369263|NCT05500599|GABA Agents|gaba agents|mesh-ancestor
92369264|NCT05500599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369265|NCT05500599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369266|NCT05498116|Montelukast|montelukast|mesh-list
92369267|NCT05498116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92369268|NCT05498116|Respiratory System Agents|respiratory system agents|mesh-ancestor
92369269|NCT05498116|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92369270|NCT05498116|Hormone Antagonists|hormone antagonists|mesh-ancestor
92369271|NCT05498116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369272|NCT05498116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369273|NCT05498116|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92369274|NCT05498116|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92369275|NCT05498116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369276|NCT05480865|Sotorasib|sotorasib|mesh-list
92369277|NCT05480865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369278|NCT05480865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369279|NCT05480865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369280|NCT05480865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369281|NCT05471076|Complement C4b|complement c4b|mesh-list
92369282|NCT05471076|Immunologic Factors|immunologic factors|mesh-ancestor
92369283|NCT05471076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369284|NCT05469178|Carboplatin|carboplatin|mesh-list
92369285|NCT05469178|Pembrolizumab|pembrolizumab|mesh-list
92369286|NCT05469178|Pemetrexed|pemetrexed|mesh-list
92369287|NCT05469178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369288|NCT05469178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369289|NCT05469178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369290|NCT05469178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369291|NCT05469178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369292|NCT05469178|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92369293|NCT05469178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369294|NCT05450484|Durvalumab|durvalumab|mesh-list
92369295|NCT05450484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369296|NCT05450484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369298|NCT05398484|Psilocybin|psilocybin|mesh-list
92369299|NCT05398484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92369300|NCT05398484|Antimetabolites|antimetabolites|mesh-ancestor
92369301|NCT05398484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369302|NCT05398484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92369304|NCT05398484|Vitamin B Complex|vitamin b complex|mesh-ancestor
92369305|NCT05398484|Vitamins|vitamins|mesh-ancestor
92369306|NCT05398484|Micronutrients|micronutrients|mesh-ancestor
92369307|NCT05398484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369308|NCT05398484|Hallucinogens|hallucinogens|mesh-ancestor
92369309|NCT05398484|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92369310|NCT05351502|Nitric Oxide|nitric oxide|mesh-list
92369311|NCT05351502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92369312|NCT05351502|Autonomic Agents|autonomic agents|mesh-ancestor
92369313|NCT05351502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369314|NCT05351502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369315|NCT05351502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92369316|NCT05351502|Respiratory System Agents|respiratory system agents|mesh-ancestor
92369317|NCT05351502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92369318|NCT05351502|Antioxidants|antioxidants|mesh-ancestor
92369319|NCT05351502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369320|NCT05351502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369321|NCT05351502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92369322|NCT05351502|Vasodilator Agents|vasodilator agents|mesh-ancestor
92369323|NCT05351502|Gasotransmitters|gasotransmitters|mesh-ancestor
92369324|NCT05351502|Protective Agents|protective agents|mesh-ancestor
92369325|NCT05327296|Propofol|propofol|mesh-list
92369326|NCT05327296|Isoflurane|isoflurane|mesh-list
92369327|NCT05327296|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92369328|NCT05327296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369329|NCT05327296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369330|NCT05327296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92369331|NCT05327296|Anesthetics, General|anesthetics, general|mesh-ancestor
92369332|NCT05327296|Anesthetics|anesthetics|mesh-ancestor
92369333|NCT05327296|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92369334|NCT05317000|Nivolumab|nivolumab|mesh-list
92369335|NCT05317000|Azacitidine|azacitidine|mesh-list
91995614|NCT05103215|Anesthetics|anesthetics|mesh-ancestor
92369336|NCT05317000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369337|NCT05317000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369338|NCT05317000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369339|NCT05317000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369340|NCT05317000|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369341|NCT05317000|Antimetabolites|antimetabolites|mesh-ancestor
92369342|NCT05317000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369343|NCT05292755|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92369344|NCT05292755|Lubricant Eye Drops|lubricant eye drops|mesh-list
92369345|NCT05292755|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92369346|NCT05292755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92369347|NCT05292755|Laxatives|laxatives|mesh-ancestor
92369348|NCT05292755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92369349|NCT05283395|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92369350|NCT05283395|Latanoprost|latanoprost|mesh-list
92369351|NCT05283395|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92369352|NCT05275205|Aflibercept|aflibercept|mesh-list
92369353|NCT05275205|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92369354|NCT05275205|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92369355|NCT05275205|Growth Substances|growth substances|mesh-ancestor
92369356|NCT05275205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369357|NCT05275205|Growth Inhibitors|growth inhibitors|mesh-ancestor
92369358|NCT05275205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369359|NCT05270863|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92369360|NCT05270863|Carbachol|carbachol|mesh-list
92369361|NCT05270863|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92369362|NCT05270863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92369363|NCT05270863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92369364|NCT05270863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92369365|NCT05270863|Adrenergic Agents|adrenergic agents|mesh-ancestor
92369366|NCT05270863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369367|NCT05270863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369368|NCT05270863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369369|NCT05270863|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92369371|NCT05270863|Autonomic Agents|autonomic agents|mesh-ancestor
92369372|NCT05270863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369373|NCT05270863|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92369374|NCT05270863|Cholinergic Agents|cholinergic agents|mesh-ancestor
92369375|NCT05270863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369376|NCT05270863|Analgesics|analgesics|mesh-ancestor
92369377|NCT05270863|Sensory System Agents|sensory system agents|mesh-ancestor
92369378|NCT05270863|Protective Agents|protective agents|mesh-ancestor
92369379|NCT05237141|Etonogestrel|etonogestrel|mesh-list
92369380|NCT05237141|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92369381|NCT05237141|Contraceptive Agents|contraceptive agents|mesh-ancestor
91932967|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
92369382|NCT05237141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92369383|NCT05237141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369384|NCT05237141|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92369385|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
92369386|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369387|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369388|NCT05232409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369389|NCT05232409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369391|NCT05137262|Doxorubicin|doxorubicin|mesh-list
92369392|NCT05137262|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91995824|NCT01797523|Metformin|metformin|mesh-list
92369393|NCT05137262|Methotrexate|methotrexate|mesh-list
92369394|NCT05137262|Durvalumab|durvalumab|mesh-list
92369395|NCT05137262|Abiraterone Acetate|abiraterone acetate|mesh-list
92369396|NCT05137262|Vinblastine|vinblastine|mesh-list
92369397|NCT05137262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369398|NCT05137262|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92369399|NCT05137262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92369400|NCT05137262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92369401|NCT05137262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369402|NCT05137262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369403|NCT05137262|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92369404|NCT05137262|Abortifacient Agents|abortifacient agents|mesh-ancestor
92369405|NCT05137262|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92369406|NCT05137262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369407|NCT05137262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369408|NCT05137262|Antimetabolites|antimetabolites|mesh-ancestor
92369409|NCT05137262|Dermatologic Agents|dermatologic agents|mesh-ancestor
92369410|NCT05137262|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92369411|NCT05137262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369412|NCT05137262|Immunologic Factors|immunologic factors|mesh-ancestor
92369413|NCT05137262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369414|NCT05137262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369415|NCT05137262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369416|NCT05137262|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92369417|NCT05137262|Hormone Antagonists|hormone antagonists|mesh-ancestor
92369418|NCT05137262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369419|NCT05137262|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92369420|NCT05137262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92369421|NCT05137262|Tubulin Modulators|tubulin modulators|mesh-ancestor
92369422|NCT05137262|Antimitotic Agents|antimitotic agents|mesh-ancestor
92369423|NCT05137262|Mitosis Modulators|mitosis modulators|mesh-ancestor
92369424|NCT05124691|Ivermectin|ivermectin|mesh-list
92369425|NCT05124691|Albendazole|albendazole|mesh-list
92369426|NCT05124691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92369427|NCT05124691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369428|NCT05124691|Anthelmintics|anthelmintics|mesh-ancestor
92369429|NCT05124691|Anticestodal Agents|anticestodal agents|mesh-ancestor
92369430|NCT05124691|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92369431|NCT05124691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92369432|NCT05124691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92369433|NCT05124691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92369434|NCT05124691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92369435|NCT05124691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369436|NCT05124691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369438|NCT05114837|Fludarabine|fludarabine|mesh-list
92369439|NCT05114837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369440|NCT05114837|Immunologic Factors|immunologic factors|mesh-ancestor
92369441|NCT05114837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369442|NCT05114837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369443|NCT05114837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92369444|NCT05114837|Alkylating Agents|alkylating agents|mesh-ancestor
92369445|NCT05114837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369446|NCT05114837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369447|NCT05114837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92369449|NCT05014087|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91937595|NCT05355350|Tazobactam|tazobactam|mesh-list
92369450|NCT05014087|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92369451|NCT05014087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369452|NCT05014087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369453|NCT05014087|Protective Agents|protective agents|mesh-ancestor
92369454|NCT05014087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369455|NCT04955678|Sorbitol|sorbitol|mesh-list
92369456|NCT04955678|Calcium|calcium|mesh-list
92369457|NCT04955678|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92369458|NCT04955678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369459|NCT04955678|Cathartics|cathartics|mesh-ancestor
92369460|NCT04955678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92369461|NCT05175547|Clevidipine|clevidipine|mesh-list
92369462|NCT05175547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92369463|NCT05175547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369464|NCT05175547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369465|NCT05175547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92369466|NCT05175547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369467|NCT04924166|Hydrocortisone|hydrocortisone|mesh-list
92369468|NCT04924166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369469|NCT04908371|Lidocaine|lidocaine|mesh-list
92369470|NCT04908371|Epinephrine|epinephrine|mesh-list
92369471|NCT04908371|Racepinephrine|racepinephrine|mesh-list
92369472|NCT04908371|Levobupivacaine|levobupivacaine|mesh-list
92369473|NCT04908371|Epinephryl borate|epinephryl borate|mesh-list
92369474|NCT04908371|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369475|NCT04908371|Anesthetics|anesthetics|mesh-ancestor
92369476|NCT04908371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369477|NCT04908371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369478|NCT04908371|Sensory System Agents|sensory system agents|mesh-ancestor
92369479|NCT04908371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369480|NCT04908371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92369481|NCT04908371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92369482|NCT04908371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92369483|NCT04908371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369484|NCT04908371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369485|NCT04908371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92369486|NCT04908371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92369487|NCT04908371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92369488|NCT04908371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369489|NCT04908371|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91996287|NCT01971346|Etanercept|etanercept|mesh-list
92369490|NCT04908371|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92369491|NCT04908371|Autonomic Agents|autonomic agents|mesh-ancestor
92369492|NCT04908371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92369493|NCT04908371|Respiratory System Agents|respiratory system agents|mesh-ancestor
92369495|NCT04908371|Sympathomimetics|sympathomimetics|mesh-ancestor
92369496|NCT04908371|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92369497|NCT04870645|Chelating Agents|chelating agents|mesh-list
92369498|NCT04870645|Sequestering Agents|sequestering agents|mesh-ancestor
92369499|NCT04870645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369500|NCT04838379|Dexamethasone|dexamethasone|mesh-list
92369501|NCT04838379|Dexmedetomidine|dexmedetomidine|mesh-list
92369502|NCT04838379|Bupivacaine|bupivacaine|mesh-list
92369503|NCT04838379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369504|NCT04838379|Antiemetics|antiemetics|mesh-ancestor
92369505|NCT04838379|Autonomic Agents|autonomic agents|mesh-ancestor
92369506|NCT04838379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369507|NCT04838379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369508|NCT04838379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92369509|NCT04838379|Glucocorticoids|glucocorticoids|mesh-ancestor
92369510|NCT04838379|Hormones|hormones|mesh-ancestor
92369511|NCT04838379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369512|NCT04838379|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92369513|NCT04838379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369514|NCT04838379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369515|NCT04838379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369516|NCT04838379|Anesthetics|anesthetics|mesh-ancestor
92369517|NCT04838379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369518|NCT04838379|Sensory System Agents|sensory system agents|mesh-ancestor
91996472|NCT02375191|Fentanyl|fentanyl|mesh-list
92369519|NCT04838379|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92369520|NCT04838379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369522|NCT04838379|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92369523|NCT04838379|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92369524|NCT04838379|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92369525|NCT04838379|Adrenergic Agents|adrenergic agents|mesh-ancestor
92369526|NCT04838379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369527|NCT04830878|Methotrexate|methotrexate|mesh-list
92369528|NCT04830878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92369529|NCT04830878|Abortifacient Agents|abortifacient agents|mesh-ancestor
91932974|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
92369530|NCT04830878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91996545|NCT00763529|Dermatologic Agents|dermatologic agents|mesh-ancestor
92369531|NCT04830878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369532|NCT04830878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369533|NCT04830878|Antimetabolites|antimetabolites|mesh-ancestor
92369534|NCT04830878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369535|NCT04830878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369536|NCT04830878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92369537|NCT04830878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369538|NCT04830878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92369539|NCT04830878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369540|NCT04830878|Immunologic Factors|immunologic factors|mesh-ancestor
92369541|NCT04830878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369542|NCT04830878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369543|NCT04812366|Prednisone|prednisone|mesh-list
92369544|NCT04812366|Docetaxel|docetaxel|mesh-list
92369545|NCT04812366|Atezolizumab|atezolizumab|mesh-list
92369546|NCT04812366|Abiraterone Acetate|abiraterone acetate|mesh-list
92369547|NCT04812366|Niraparib|niraparib|mesh-list
92369548|NCT04812366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369549|NCT04812366|Tubulin Modulators|tubulin modulators|mesh-ancestor
91996609|NCT02368795|Diuretics|diuretics|mesh-ancestor
92369550|NCT04812366|Antimitotic Agents|antimitotic agents|mesh-ancestor
92369551|NCT04812366|Mitosis Modulators|mitosis modulators|mesh-ancestor
92369552|NCT04812366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369553|NCT04812366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369554|NCT04812366|Glucocorticoids|glucocorticoids|mesh-ancestor
92369555|NCT04812366|Hormones|hormones|mesh-ancestor
92369556|NCT04812366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369557|NCT04812366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369558|NCT04812366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92369559|NCT04812366|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369560|NCT04812366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369561|NCT04812366|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92369562|NCT04812366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369563|NCT04812366|Hormone Antagonists|hormone antagonists|mesh-ancestor
92369564|NCT04812366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92369565|NCT04812366|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92369567|NCT04800107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92369568|NCT04800107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369569|NCT04800107|Analgesics|analgesics|mesh-ancestor
92369570|NCT04800107|Sensory System Agents|sensory system agents|mesh-ancestor
91996732|NCT02374567|Biperiden|biperiden|mesh-list
92369571|NCT04800107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369572|NCT04800107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369573|NCT04800107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369574|NCT04800107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369575|NCT04800107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369576|NCT04800107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369577|NCT04800107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369578|NCT04786574|Tolvaptan|tolvaptan|mesh-list
92369579|NCT04786574|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91996813|NCT02374567|Analgesics|analgesics|mesh-ancestor
92369580|NCT04786574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369581|NCT04786574|Natriuretic Agents|natriuretic agents|mesh-ancestor
92369582|NCT04786574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369584|NCT04783857|Progestins|progestins|mesh-ancestor
92369585|NCT04783857|Hormones|hormones|mesh-ancestor
92369586|NCT04783857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369587|NCT04783857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369588|NCT04761159|Ketamine|ketamine|mesh-list
92369589|NCT04761159|Analgesics|analgesics|mesh-ancestor
92369590|NCT04761159|Sensory System Agents|sensory system agents|mesh-ancestor
92369591|NCT04761159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369592|NCT04761159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369593|NCT04761159|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92369594|NCT04761159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92369595|NCT04761159|Anesthetics, General|anesthetics, general|mesh-ancestor
92369596|NCT04761159|Anesthetics|anesthetics|mesh-ancestor
92369597|NCT04761159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369598|NCT04761159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92369599|NCT04761159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92369600|NCT04761159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369601|NCT04761159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369602|NCT04716296|Ketamine|ketamine|mesh-list
92369603|NCT04716296|Analgesics|analgesics|mesh-ancestor
92369604|NCT04716296|Sensory System Agents|sensory system agents|mesh-ancestor
92369605|NCT04716296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996944|NCT04632433|Cemiplimab|cemiplimab|mesh-list
91997005|NCT03100019|Protective Agents|protective agents|mesh-ancestor
92369606|NCT04716296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369607|NCT04716296|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92369608|NCT04716296|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92369609|NCT04716296|Anesthetics, General|anesthetics, general|mesh-ancestor
92369610|NCT04716296|Anesthetics|anesthetics|mesh-ancestor
92369611|NCT04716296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369612|NCT04716296|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92369613|NCT04716296|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92369614|NCT04716296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369615|NCT04716296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369617|NCT04704141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92369618|NCT04704141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369619|NCT04682041|Immunoglobulins|immunoglobulins|mesh-list
92369620|NCT04682041|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92369621|NCT04682041|Antibodies|antibodies|mesh-list
92369622|NCT04682041|Immunologic Factors|immunologic factors|mesh-ancestor
92369623|NCT04682041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369624|NCT04675931|Artesunate|artesunate|mesh-list
92369625|NCT04675931|Lumefantrine|lumefantrine|mesh-list
92369626|NCT04675931|Artemether|artemether|mesh-list
92369627|NCT04675931|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92369628|NCT04675931|Antimalarials|antimalarials|mesh-ancestor
92369629|NCT04675931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92369630|NCT04675931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92369631|NCT04675931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970510|NCT00704405|Ribavirin|ribavirin|mesh-list
92369632|NCT04675931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369634|NCT04675931|Schistosomicides|schistosomicides|mesh-ancestor
92369635|NCT04675931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92369636|NCT04675931|Anthelmintics|anthelmintics|mesh-ancestor
91997187|NCT03097445|Nicotine|nicotine|mesh-list
92369637|NCT04669678|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92369638|NCT04669678|Medroxyprogesterone|medroxyprogesterone|mesh-list
92369639|NCT04669678|Etonogestrel|etonogestrel|mesh-list
92369640|NCT04669678|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92369641|NCT04669678|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92369642|NCT04669678|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92369643|NCT04669678|Contraceptive Agents|contraceptive agents|mesh-ancestor
92369644|NCT04669678|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92369645|NCT04669678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369646|NCT04669678|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92369647|NCT04669678|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92369648|NCT04669678|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92369649|NCT04669678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92369650|NCT04669678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369651|NCT04652661|Midazolam|midazolam|mesh-list
92369652|NCT04652661|Dexmedetomidine|dexmedetomidine|mesh-list
92369653|NCT04652661|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92369654|NCT04652661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369655|NCT04652661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369656|NCT04652661|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369657|NCT04652661|Analgesics|analgesics|mesh-ancestor
92369658|NCT04652661|Sensory System Agents|sensory system agents|mesh-ancestor
92369659|NCT04652661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369660|NCT04652661|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92369661|NCT04652661|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92369662|NCT04652661|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92369663|NCT04652661|Adrenergic Agents|adrenergic agents|mesh-ancestor
92369664|NCT04652661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369665|NCT04652661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369666|NCT04652661|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92369667|NCT04652661|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92369668|NCT04652661|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92369669|NCT04652661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92369670|NCT04652661|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92369671|NCT04652661|Anesthetics, General|anesthetics, general|mesh-ancestor
92369672|NCT04652661|Anesthetics|anesthetics|mesh-ancestor
92369673|NCT04652661|GABA Modulators|gaba modulators|mesh-ancestor
92369674|NCT04652661|GABA Agents|gaba agents|mesh-ancestor
92369675|NCT04623931|Temozolomide|temozolomide|mesh-list
92369676|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92369677|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
92369678|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369679|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369680|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
92369681|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369682|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369683|NCT04590781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369684|NCT04590781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369685|NCT04573751|Verapamil|verapamil|mesh-list
92369686|NCT04573751|Epinephrine|epinephrine|mesh-list
92369687|NCT04573751|Racepinephrine|racepinephrine|mesh-list
92369689|NCT04573751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92369690|NCT04573751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92369691|NCT04573751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92369692|NCT04573751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369693|NCT04573751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369694|NCT04573751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369695|NCT04573751|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92369696|NCT04573751|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92369697|NCT04573751|Autonomic Agents|autonomic agents|mesh-ancestor
91997418|NCT01944046|Oxytocin|oxytocin|mesh-list
92369698|NCT04573751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369699|NCT04573751|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92369700|NCT04573751|Respiratory System Agents|respiratory system agents|mesh-ancestor
92369701|NCT04573751|Mydriatics|mydriatics|mesh-ancestor
92369702|NCT04573751|Sympathomimetics|sympathomimetics|mesh-ancestor
92369703|NCT04573751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92369704|NCT04573751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92369705|NCT04573751|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92369706|NCT04573751|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369707|NCT04573751|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92369708|NCT04573751|Vasodilator Agents|vasodilator agents|mesh-ancestor
92369709|NCT04522622|Teriparatide|teriparatide|mesh-list
92369710|NCT04522622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92369711|NCT04522622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369712|NCT04522622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92369713|NCT04483102|Liver Extracts|liver extracts|mesh-list
92369714|NCT04483102|Hematinics|hematinics|mesh-ancestor
92369715|NCT04474483|Melatonin|melatonin|mesh-list
92369716|NCT04474483|Antioxidants|antioxidants|mesh-ancestor
92369717|NCT04474483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369718|NCT04474483|Protective Agents|protective agents|mesh-ancestor
92369719|NCT04474483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369720|NCT04474483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369721|NCT04432207|Atezolizumab|atezolizumab|mesh-list
91970541|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
92369723|NCT04432207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369724|NCT04432207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369725|NCT04432207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369727|NCT04425447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369728|NCT04425447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369729|NCT04373707|Enoxaparin|enoxaparin|mesh-list
92369730|NCT04373707|Dalteparin|dalteparin|mesh-list
92369731|NCT04373707|Tinzaparin|tinzaparin|mesh-list
92369732|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92369733|NCT04373707|Nadroparin|nadroparin|mesh-list
92369734|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
92369735|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
92369736|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92369737|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92369738|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369739|NCT04345718|Buprenorphine|buprenorphine|mesh-list
92369740|NCT04345718|Analgesics, Opioid|analgesics, opioid|mesh-list
92369741|NCT04345718|Narcotics|narcotics|mesh-ancestor
92369742|NCT04345718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369743|NCT04345718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369744|NCT04345718|Analgesics|analgesics|mesh-ancestor
92369746|NCT04345718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369747|NCT04345718|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92369748|NCT04332068|Ivermectin|ivermectin|mesh-list
92369749|NCT04332068|Permethrin|permethrin|mesh-list
92369750|NCT04332068|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92369751|NCT04332068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369752|NCT04332068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369753|NCT04332068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369754|NCT04298541|Edotreotide|edotreotide|mesh-list
92369755|NCT04298541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92369756|NCT04298541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369757|NCT04249037|Tenofovir|tenofovir|mesh-list
91997907|NCT03149653|SMOFlipid|smoflipid|mesh-list
92369758|NCT04249037|Emtricitabine|emtricitabine|mesh-list
92369759|NCT04249037|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92369760|NCT04249037|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92369761|NCT04249037|Antiviral Agents|antiviral agents|mesh-ancestor
92369762|NCT04249037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369763|NCT04249037|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92369764|NCT04249037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369765|NCT04249037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369766|NCT04249037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369767|NCT04249037|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92369768|NCT04190550|Cytarabine|cytarabine|mesh-list
92369769|NCT04190550|Idarubicin|idarubicin|mesh-list
92369770|NCT04190550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369771|NCT04190550|Antimetabolites|antimetabolites|mesh-ancestor
91997989|NCT01949116|Vitamins|vitamins|mesh-ancestor
92369772|NCT04190550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369773|NCT04190550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369774|NCT04190550|Antiviral Agents|antiviral agents|mesh-ancestor
92369775|NCT04190550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369776|NCT04190550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369777|NCT04190550|Immunologic Factors|immunologic factors|mesh-ancestor
92369778|NCT04190550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369779|NCT04190550|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92369780|NCT04190550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92369781|NCT04190550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92369782|NCT04190550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369783|NCT04158739|Cytarabine|cytarabine|mesh-list
92369784|NCT04158739|Antibodies|antibodies|mesh-list
92369785|NCT04158739|Immunoglobulins|immunoglobulins|mesh-list
92369786|NCT04158739|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91998009|NCT02350543|Aspirin|aspirin|mesh-list
92369787|NCT04158739|Immunologic Factors|immunologic factors|mesh-ancestor
92369788|NCT04158739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369789|NCT04158739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369790|NCT04158739|Antimetabolites|antimetabolites|mesh-ancestor
92369791|NCT04158739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369792|NCT04158739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369793|NCT04158739|Antiviral Agents|antiviral agents|mesh-ancestor
92369794|NCT04158739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369795|NCT04158739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369796|NCT04148105|Cilostazol|cilostazol|mesh-list
92369797|NCT04148105|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92369798|NCT04148105|Autonomic Agents|autonomic agents|mesh-ancestor
91998067|NCT03149419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369799|NCT04148105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369800|NCT04148105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369801|NCT04148105|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92369802|NCT04148105|Respiratory System Agents|respiratory system agents|mesh-ancestor
92369803|NCT04148105|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92369804|NCT04148105|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92369805|NCT04148105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369806|NCT04148105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92369807|NCT04148105|Vasodilator Agents|vasodilator agents|mesh-ancestor
92369808|NCT04148105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92369809|NCT04148105|Protective Agents|protective agents|mesh-ancestor
92369810|NCT04148105|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92369811|NCT04148105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92369812|NCT04148105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369813|NCT04067518|Pegaspargase|pegaspargase|mesh-list
92369814|NCT04067518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369816|NCT04033419|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92369817|NCT04033419|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92369818|NCT04033419|Dopamine Agents|dopamine agents|mesh-ancestor
92369819|NCT04033419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369820|NCT04033419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369821|NCT04033419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369822|NCT04033419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92369823|NCT04033419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92369824|NCT04014283|Selenium|selenium|mesh-list
92369825|NCT04014283|Antioxidants|antioxidants|mesh-ancestor
92369826|NCT04014283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369827|NCT04014283|Protective Agents|protective agents|mesh-ancestor
92369828|NCT04014283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369829|NCT04014283|Trace Elements|trace elements|mesh-ancestor
92369830|NCT04014283|Micronutrients|micronutrients|mesh-ancestor
92369831|NCT04013542|Nivolumab|nivolumab|mesh-list
92369832|NCT04013542|Ipilimumab|ipilimumab|mesh-list
91970576|NCT03309215|Nickel|nickel|mesh-list
92369833|NCT04013542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369834|NCT04013542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369835|NCT04013542|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369836|NCT04013542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369837|NCT04000529|Spartalizumab|spartalizumab|mesh-list
92369838|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369839|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369840|NCT04000529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369841|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369842|NCT04257578|Acalabrutinib|acalabrutinib|mesh-list
92369843|NCT04257578|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92369844|NCT04257578|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92369845|NCT04257578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369846|NCT04257578|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92369847|NCT04257578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369848|NCT04257578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369849|NCT04257578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369850|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
92369851|NCT03970746|Pemetrexed|pemetrexed|mesh-list
91998382|NCT03112135|Epinephrine|epinephrine|mesh-list
92369852|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369853|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369854|NCT03970746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369855|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369856|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369857|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92369858|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92369859|NCT03912233|Ivacaftor|ivacaftor|mesh-list
92369860|NCT03912233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92369861|NCT03912233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369862|NCT03912233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369863|NCT03842865|Immunomodulating Agents|immunomodulating agents|mesh-list
92369864|NCT03842865|Immunologic Factors|immunologic factors|mesh-ancestor
92369865|NCT03842865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369867|NCT03834519|Prednisolone|prednisolone|mesh-list
92369868|NCT03834519|Pembrolizumab|pembrolizumab|mesh-list
92369869|NCT03834519|Olaparib|olaparib|mesh-list
92369870|NCT03834519|Abiraterone Acetate|abiraterone acetate|mesh-list
92369871|NCT03834519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369872|NCT03834519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369873|NCT03834519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369874|NCT03834519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369875|NCT03834519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369876|NCT03834519|Glucocorticoids|glucocorticoids|mesh-ancestor
92369877|NCT03834519|Hormones|hormones|mesh-ancestor
92369878|NCT03834519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998502|NCT04949633|Oxytocin|oxytocin|mesh-list
92369879|NCT03834519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369880|NCT03834519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92369881|NCT03834519|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92369882|NCT03834519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369883|NCT03834519|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92369884|NCT03834519|Hormone Antagonists|hormone antagonists|mesh-ancestor
92369885|NCT03834519|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92369886|NCT03781817|Ketamine|ketamine|mesh-list
92369887|NCT03781817|Analgesics|analgesics|mesh-ancestor
92369888|NCT03781817|Sensory System Agents|sensory system agents|mesh-ancestor
92369889|NCT03781817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369890|NCT03781817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369891|NCT03781817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92369892|NCT03781817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92369893|NCT03781817|Anesthetics, General|anesthetics, general|mesh-ancestor
92369894|NCT03781817|Anesthetics|anesthetics|mesh-ancestor
92369895|NCT03781817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369896|NCT03781817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92369897|NCT03781817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92369898|NCT03781817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92369899|NCT03781817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369900|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
92369901|NCT03732352|Osimertinib|osimertinib|mesh-list
92369902|NCT03732352|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92369903|NCT03732352|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92369904|NCT03732352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369905|NCT03732352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369906|NCT03732352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998684|NCT03079115|Antimetabolites|antimetabolites|mesh-ancestor
92369907|NCT03732352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369908|NCT03732352|Antimetabolites|antimetabolites|mesh-ancestor
92369909|NCT03732352|Antiviral Agents|antiviral agents|mesh-ancestor
92369910|NCT03732352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92369912|NCT03636451|Vasopressins|vasopressins|mesh-list
92369913|NCT03636451|Arginine Vasopressin|arginine vasopressin|mesh-list
92369914|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
92369915|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
92369916|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92369917|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369918|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
92369919|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369920|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92369921|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92369922|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92369923|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92369924|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369925|NCT03636451|Hemostatics|hemostatics|mesh-ancestor
92369926|NCT03636451|Coagulants|coagulants|mesh-ancestor
92369927|NCT03636451|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92369929|NCT03636451|Natriuretic Agents|natriuretic agents|mesh-ancestor
92369930|NCT03576989|Mineral Oil|mineral oil|mesh-list
92369931|NCT03576989|Emollients|emollients|mesh-ancestor
92369932|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
92369933|NCT03539952|Penicillamine|penicillamine|mesh-list
92369934|NCT03539952|Trientine|trientine|mesh-list
92369935|NCT03539952|Chelating Agents|chelating agents|mesh-ancestor
92369936|NCT03539952|Sequestering Agents|sequestering agents|mesh-ancestor
92369937|NCT03539952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369939|NCT03539952|Protective Agents|protective agents|mesh-ancestor
92369940|NCT03539952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369941|NCT03539952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369942|NCT03504163|Pembrolizumab|pembrolizumab|mesh-list
92369943|NCT03504163|BCG Vaccine|bcg vaccine|mesh-list
92369944|NCT03504163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369945|NCT03504163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369946|NCT03504163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369947|NCT03504163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369948|NCT03504163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92369949|NCT03504163|Immunologic Factors|immunologic factors|mesh-ancestor
92369950|NCT03504163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369951|NCT03454035|Palbociclib|palbociclib|mesh-list
92369952|NCT03454035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369953|NCT03454035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92369954|NCT03454035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369955|NCT03454035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369956|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
92369957|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369958|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369959|NCT03295227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92369960|NCT03295227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369962|NCT03278691|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92369963|NCT03278691|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92369964|NCT03278691|Analgesics|analgesics|mesh-ancestor
92369965|NCT03278691|Sensory System Agents|sensory system agents|mesh-ancestor
92369966|NCT03278691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92369967|NCT03278691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369968|NCT03278691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92369969|NCT03278691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369970|NCT03278691|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92369971|NCT03278691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369972|NCT03278691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369973|NCT03105336|Cyclophosphamide|cyclophosphamide|mesh-list
92369974|NCT03105336|Fludarabine|fludarabine|mesh-list
92369975|NCT03105336|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92369976|NCT03105336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92369977|NCT03105336|Immunologic Factors|immunologic factors|mesh-ancestor
92369978|NCT03105336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92369979|NCT03105336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92369980|NCT03105336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92369981|NCT03105336|Alkylating Agents|alkylating agents|mesh-ancestor
92369982|NCT03105336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998916|NCT05916339|Dopamine Agents|dopamine agents|mesh-ancestor
92369983|NCT03105336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369984|NCT03105336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92369985|NCT03105336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92369986|NCT03093909|Gemcitabine|gemcitabine|mesh-list
92369987|NCT03093909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92369988|NCT03093909|Antimetabolites|antimetabolites|mesh-ancestor
92369989|NCT03093909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369990|NCT03093909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92369991|NCT03070223|Pitavastatin|pitavastatin|mesh-list
91998965|NCT05915871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92369992|NCT03070223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92369994|NCT03070223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92369995|NCT03070223|Antimetabolites|antimetabolites|mesh-ancestor
92369996|NCT03070223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92369997|NCT03070223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92369998|NCT03070223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92369999|NCT02621489|Metformin|metformin|mesh-list
92370000|NCT02621489|Insulin Aspart|insulin aspart|mesh-list
92370001|NCT02621489|Exenatide|exenatide|mesh-list
92370002|NCT02621489|Biguanides|biguanides|mesh-list
92370003|NCT02621489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92370004|NCT02621489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022487|NCT02343939|Antimetabolites|antimetabolites|mesh-ancestor
92370005|NCT02621489|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92370007|NCT02621489|Hormones|hormones|mesh-ancestor
92370008|NCT02621489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370009|NCT02596880|Ribavirin|ribavirin|mesh-list
92370010|NCT02596880|Sofosbuvir|sofosbuvir|mesh-list
92370011|NCT02596880|Antimetabolites|antimetabolites|mesh-ancestor
92370012|NCT02596880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370013|NCT02596880|Antiviral Agents|antiviral agents|mesh-ancestor
92370014|NCT02596880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370015|NCT02527434|Durvalumab|durvalumab|mesh-list
92370016|NCT02527434|Tremelimumab|tremelimumab|mesh-list
91999179|NCT05914285|Tocolytic Agents|tocolytic agents|mesh-ancestor
92370017|NCT02527434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92370018|NCT02527434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370019|NCT02527434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370020|NCT02527434|Immunologic Factors|immunologic factors|mesh-ancestor
92370021|NCT02527434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370022|NCT02512718|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92370023|NCT02512718|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92370024|NCT02512718|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92370025|NCT02512718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92370026|NCT02474368|Cisplatin|cisplatin|mesh-list
92370027|NCT02474368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370028|NCT01995344|Cyclophosphamide|cyclophosphamide|mesh-list
92370029|NCT01995344|Fludarabine|fludarabine|mesh-list
92370030|NCT01995344|Interleukin-2|interleukin-2|mesh-list
92370031|NCT01995344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370032|NCT01995344|Immunologic Factors|immunologic factors|mesh-ancestor
92370033|NCT01995344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370034|NCT01995344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370035|NCT01995344|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92370036|NCT01995344|Alkylating Agents|alkylating agents|mesh-ancestor
92370037|NCT01995344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370038|NCT01995344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370039|NCT01995344|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92370040|NCT01995344|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370042|NCT01995344|Sensory System Agents|sensory system agents|mesh-ancestor
92370043|NCT01995344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370044|NCT01845688|Losartan|losartan|mesh-list
92370045|NCT01845688|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92370046|NCT01845688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92370047|NCT01845688|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92370048|NCT01845688|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92370049|NCT01845688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370050|NCT01591291|Ondansetron|ondansetron|mesh-list
91999324|NCT05912712|Infliximab|infliximab|mesh-list
92370051|NCT01591291|Antiemetics|antiemetics|mesh-ancestor
92370052|NCT01591291|Autonomic Agents|autonomic agents|mesh-ancestor
92370053|NCT01591291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370054|NCT01591291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370055|NCT01591291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370056|NCT01591291|Antipruritics|antipruritics|mesh-ancestor
92370057|NCT01591291|Dermatologic Agents|dermatologic agents|mesh-ancestor
92370058|NCT01591291|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92370059|NCT01591291|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92370060|NCT01591291|Serotonin Agents|serotonin agents|mesh-ancestor
92370061|NCT01591291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370062|NCT01591291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370064|NCT01154920|Docetaxel|docetaxel|mesh-list
92370065|NCT01154920|Cisplatin|cisplatin|mesh-list
92370066|NCT01154920|Carboplatin|carboplatin|mesh-list
92370067|NCT01154920|Fluorouracil|fluorouracil|mesh-list
92370068|NCT01154920|Cetuximab|cetuximab|mesh-list
92370069|NCT01154920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91999357|NCT05912387|Antimetabolites|antimetabolites|mesh-ancestor
92370070|NCT01154920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370071|NCT01154920|Tubulin Modulators|tubulin modulators|mesh-ancestor
92370072|NCT01154920|Antimitotic Agents|antimitotic agents|mesh-ancestor
92370073|NCT01154920|Mitosis Modulators|mitosis modulators|mesh-ancestor
92370074|NCT01154920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370075|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
92370076|NCT01154920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92370077|NCT01154920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370078|NCT01154920|Immunologic Factors|immunologic factors|mesh-ancestor
92370079|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370080|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370081|NCT01093300|Paclitaxel|paclitaxel|mesh-list
92370082|NCT01093300|Everolimus|everolimus|mesh-list
92370083|NCT01093300|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92370084|NCT01093300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370085|NCT01093300|Tubulin Modulators|tubulin modulators|mesh-ancestor
92370086|NCT01093300|Antimitotic Agents|antimitotic agents|mesh-ancestor
92370087|NCT01093300|Mitosis Modulators|mitosis modulators|mesh-ancestor
92370088|NCT01093300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370089|NCT01093300|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92370090|NCT01093300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92370091|NCT01093300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370092|NCT01093300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370093|NCT01093300|Immunologic Factors|immunologic factors|mesh-ancestor
91970654|NCT04442633|Miconazole|miconazole|mesh-list
92370094|NCT01093300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370096|NCT01053078|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92370097|NCT01053078|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92370098|NCT01053078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370099|NCT01053078|Sensory System Agents|sensory system agents|mesh-ancestor
92370100|NCT01053078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370101|NCT01053156|Minocycline|minocycline|mesh-list
92370102|NCT01053156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92370103|NCT01053156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370104|NCT01053312|Flutemetamol|flutemetamol|mesh-list
92370105|NCT01053312|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92370106|NCT01053312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370107|NCT01054404|Furosemide|furosemide|mesh-list
92370108|NCT01054404|Diuretics|diuretics|mesh-ancestor
91937604|NCT01054196|Melphalan|melphalan|mesh-list
92370109|NCT01054404|Natriuretic Agents|natriuretic agents|mesh-ancestor
92370110|NCT01054404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370111|NCT01054404|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92370112|NCT01054404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370113|NCT01054404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370114|NCT01055184|Vaccines|vaccines|mesh-list
92370115|NCT01055184|Immunologic Factors|immunologic factors|mesh-ancestor
92370116|NCT01055184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370117|NCT01060020|Sildenafil Citrate|sildenafil citrate|mesh-list
92370118|NCT01060020|Vasodilator Agents|vasodilator agents|mesh-ancestor
92370119|NCT01060020|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92370120|NCT01060020|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92370122|NCT01060020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370123|NCT01060020|Urological Agents|urological agents|mesh-ancestor
92370124|NCT01060098|Adalimumab|adalimumab|mesh-list
92370125|NCT01060098|Etanercept|etanercept|mesh-list
92370126|NCT01060098|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92370127|NCT01060098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370128|NCT01060098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370129|NCT01060098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92370130|NCT01060098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370131|NCT01060098|Analgesics|analgesics|mesh-ancestor
92370132|NCT01060098|Sensory System Agents|sensory system agents|mesh-ancestor
92370133|NCT01060098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370134|NCT01060098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370135|NCT01060098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370136|NCT01060098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370137|NCT01060098|Immunologic Factors|immunologic factors|mesh-ancestor
92370139|NCT01061034|Omeprazole|omeprazole|mesh-list
92370140|NCT01061034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92370142|NCT01061034|Analgesics|analgesics|mesh-ancestor
92370143|NCT01061034|Sensory System Agents|sensory system agents|mesh-ancestor
92370144|NCT01061034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370145|NCT01061034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370146|NCT01061034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370147|NCT01061034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370148|NCT01061034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92370149|NCT01061034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92370150|NCT01061034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370151|NCT01061034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92370152|NCT01061034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92370153|NCT01061034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370154|NCT01061034|Antipyretics|antipyretics|mesh-ancestor
92370155|NCT01061034|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92370156|NCT01061034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999776|NCT05813288|Dopamine Agents|dopamine agents|mesh-ancestor
92370157|NCT01061034|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92022637|NCT05628883|Analgesics|analgesics|mesh-ancestor
92370159|NCT01065558|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92370160|NCT01065558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92370161|NCT01065558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370162|NCT01065558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370163|NCT01065558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92370164|NCT01065558|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92370165|NCT01065558|Dopamine Agents|dopamine agents|mesh-ancestor
92370166|NCT01065558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370167|NCT01065558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370168|NCT01066026|Hyaluronic Acid|hyaluronic acid|mesh-list
92370169|NCT01066026|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92370170|NCT01066026|Immunologic Factors|immunologic factors|mesh-ancestor
92370171|NCT01066026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370172|NCT01066026|Viscosupplements|viscosupplements|mesh-ancestor
92370173|NCT01066026|Protective Agents|protective agents|mesh-ancestor
92370174|NCT01072188|Calcium Carbonate|calcium carbonate|mesh-list
92370175|NCT01072188|Calcium|calcium|mesh-list
92370176|NCT01072188|Fluorides|fluorides|mesh-list
92370177|NCT01072188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92370178|NCT01072188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370179|NCT01072188|Cariostatic Agents|cariostatic agents|mesh-ancestor
92370180|NCT01072188|Protective Agents|protective agents|mesh-ancestor
92370181|NCT01072188|Antacids|antacids|mesh-ancestor
92370182|NCT01072188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370183|NCT01072188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370185|NCT01083732|Antithrombins|antithrombins|mesh-ancestor
92370186|NCT01083732|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92370187|NCT01083732|Protease Inhibitors|protease inhibitors|mesh-ancestor
92370188|NCT01083732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999919|NCT05714553|Vitamins|vitamins|mesh-ancestor
92370189|NCT01083732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370190|NCT01083732|Anticoagulants|anticoagulants|mesh-ancestor
92370192|NCT01084278|Gout Suppressants|gout suppressants|mesh-ancestor
92370193|NCT01084278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370194|NCT01084278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92370195|NCT01084278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92370196|NCT01084278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92370197|NCT01084278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370198|NCT01084278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370200|NCT01085760|Vancomycin|vancomycin|mesh-list
92370201|NCT01085760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370202|NCT01085760|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92370203|NCT01085760|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92370204|NCT01085760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92370205|NCT01090752|Metformin|metformin|mesh-list
92370206|NCT01090752|Pioglitazone|pioglitazone|mesh-list
92370207|NCT01090752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92370208|NCT01090752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370209|NCT01093794|Metformin|metformin|mesh-list
92370210|NCT01093794|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92370211|NCT01093794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92370212|NCT01093794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370213|NCT01093794|Incretins|incretins|mesh-ancestor
92370214|NCT01093794|Hormones|hormones|mesh-ancestor
92370215|NCT01093794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370216|NCT01093794|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92370217|NCT01093794|Protease Inhibitors|protease inhibitors|mesh-ancestor
92370218|NCT01093794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370219|NCT01093794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370220|NCT01094106|Ropivacaine|ropivacaine|mesh-list
92370221|NCT01094106|Anesthetics, Local|anesthetics, local|mesh-ancestor
92370222|NCT01094106|Anesthetics|anesthetics|mesh-ancestor
92370223|NCT01094106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370224|NCT01094106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370225|NCT01094106|Sensory System Agents|sensory system agents|mesh-ancestor
92370226|NCT01094106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370227|NCT01094574|Propranolol|propranolol|mesh-list
92370228|NCT01094574|Alfentanil|alfentanil|mesh-list
92370229|NCT01094574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92370230|NCT01094574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92370231|NCT01094574|Adrenergic Agents|adrenergic agents|mesh-ancestor
92370232|NCT01094574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370233|NCT01094574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370234|NCT01094574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370235|NCT01094574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92370236|NCT01094574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92370237|NCT01094574|Vasodilator Agents|vasodilator agents|mesh-ancestor
91970677|NCT02468531|Xenon|xenon|mesh-list
92370238|NCT01094574|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92370240|NCT01094574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370241|NCT01094574|Analgesics|analgesics|mesh-ancestor
92370242|NCT01094574|Sensory System Agents|sensory system agents|mesh-ancestor
92370243|NCT01094574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370244|NCT01094574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92370245|NCT01094574|Anesthetics, General|anesthetics, general|mesh-ancestor
92370246|NCT01094574|Anesthetics|anesthetics|mesh-ancestor
92370247|NCT01095510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92370248|NCT01095510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92370249|NCT01095510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370250|NCT01095510|Immunologic Factors|immunologic factors|mesh-ancestor
92370251|NCT01095510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370252|NCT01096290|Lubiprostone|lubiprostone|mesh-list
92370253|NCT01096290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92370254|NCT01096290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370255|NCT01096290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370256|NCT01096680|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92370258|NCT01096680|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92370259|NCT01096680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370260|NCT01096680|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92370261|NCT01096680|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92370262|NCT01096680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370263|NCT01096680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370264|NCT01096680|Dopamine Agents|dopamine agents|mesh-ancestor
92370265|NCT01096680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370266|NCT01096680|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92370267|NCT01096680|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92370268|NCT01096680|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92370269|NCT01096992|Rituximab|rituximab|mesh-list
92370270|NCT01096992|Fludarabine|fludarabine|mesh-list
92370271|NCT01096992|Fludarabine phosphate|fludarabine phosphate|mesh-list
92370272|NCT01096992|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92370273|NCT01096992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370274|NCT01096992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370275|NCT01096992|Immunologic Factors|immunologic factors|mesh-ancestor
92370276|NCT01096992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370277|NCT01096992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970679|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
92370278|NCT01096992|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92370279|NCT01096992|Antimetabolites|antimetabolites|mesh-ancestor
92370280|NCT01096992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370281|NCT01096992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370282|NCT01096992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92370283|NCT01096992|Alkylating Agents|alkylating agents|mesh-ancestor
92370284|NCT01097304|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92370285|NCT01097304|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92370286|NCT01097304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370287|NCT01097460|Trastuzumab|trastuzumab|mesh-list
92370288|NCT01097460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370289|NCT01097460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370290|NCT01098318|Sertraline|sertraline|mesh-list
92370291|NCT01098318|Antidepressive Agents|antidepressive agents|mesh-ancestor
92370292|NCT01098318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92370293|NCT01098318|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92370294|NCT01098318|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92370295|NCT01098318|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370296|NCT01098318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370297|NCT01098318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370298|NCT01098318|Serotonin Agents|serotonin agents|mesh-ancestor
92370299|NCT01098318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370300|NCT01100112|Budesonide|budesonide|mesh-list
92370301|NCT01100112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370302|NCT01100112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92370303|NCT01100112|Autonomic Agents|autonomic agents|mesh-ancestor
92370304|NCT01100112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000193|NCT05556616|Lenalidomide|lenalidomide|mesh-list
92370305|NCT01100112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370306|NCT01100112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92370307|NCT01100112|Respiratory System Agents|respiratory system agents|mesh-ancestor
92370308|NCT01100112|Glucocorticoids|glucocorticoids|mesh-ancestor
92370310|NCT01100112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370311|NCT01100268|Methylphenidate|methylphenidate|mesh-list
92370312|NCT01100268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92370313|NCT01100268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370314|NCT01100268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92370315|NCT01100268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92370316|NCT01100268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000309|NCT05484401|Sensory System Agents|sensory system agents|mesh-ancestor
92370317|NCT01100268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370318|NCT01100268|Dopamine Agents|dopamine agents|mesh-ancestor
92370319|NCT01100268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370320|NCT01101750|Vaccines|vaccines|mesh-list
92370321|NCT01101750|Immunologic Factors|immunologic factors|mesh-ancestor
92370322|NCT01101750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370323|NCT01102218|Pentoxifylline|pentoxifylline|mesh-list
92370324|NCT01102218|Epoetin Alfa|epoetin alfa|mesh-list
92370325|NCT01102218|Hematinics|hematinics|mesh-ancestor
92370326|NCT01102218|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92370327|NCT01102218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370328|NCT01102218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370329|NCT01102218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92370330|NCT01102218|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92370331|NCT01102218|Protective Agents|protective agents|mesh-ancestor
92370332|NCT01102218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370333|NCT01102218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92370334|NCT01102218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92370336|NCT01103934|Vitamin D|vitamin d|mesh-list
92370337|NCT01103934|Cholecalciferol|cholecalciferol|mesh-list
92370338|NCT01103934|Fluticasone|fluticasone|mesh-list
92370339|NCT01103934|Xhance|xhance|mesh-list
92370340|NCT01103934|Vitamins|vitamins|mesh-ancestor
92370341|NCT01103934|Micronutrients|micronutrients|mesh-ancestor
92370342|NCT01103934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370343|NCT01103934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92370344|NCT01103934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370345|NCT01103934|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92370346|NCT01103934|Autonomic Agents|autonomic agents|mesh-ancestor
92370347|NCT01103934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370348|NCT01103934|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92370349|NCT01103934|Respiratory System Agents|respiratory system agents|mesh-ancestor
92370350|NCT01103934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92370351|NCT01103934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92370352|NCT01103934|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92370354|NCT01105650|Methylprednisolone|methylprednisolone|mesh-list
92370355|NCT01105650|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92370356|NCT01105650|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92370357|NCT01105650|Prednisolone|prednisolone|mesh-list
92370358|NCT01105650|Prednisolone acetate|prednisolone acetate|mesh-list
92370359|NCT01105650|Cyclophosphamide|cyclophosphamide|mesh-list
92370360|NCT01105650|Fludarabine|fludarabine|mesh-list
92370361|NCT01105650|Interleukin-2|interleukin-2|mesh-list
92370362|NCT01105650|Cyclosporins|cyclosporins|mesh-list
92370363|NCT01105650|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92370364|NCT01105650|Prednisolone phosphate|prednisolone phosphate|mesh-list
92370365|NCT01105650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370366|NCT01105650|Immunologic Factors|immunologic factors|mesh-ancestor
92370367|NCT01105650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370368|NCT01105650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370369|NCT01105650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92370370|NCT01105650|Alkylating Agents|alkylating agents|mesh-ancestor
92370371|NCT01105650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370372|NCT01105650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370373|NCT01105650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92370374|NCT01105650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370375|NCT01105650|Antifungal Agents|antifungal agents|mesh-ancestor
92370376|NCT01105650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370377|NCT01105650|Dermatologic Agents|dermatologic agents|mesh-ancestor
92370378|NCT01105650|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92370379|NCT01105650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370381|NCT01105650|Autonomic Agents|autonomic agents|mesh-ancestor
92370382|NCT01105650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022866|NCT05865548|Aspirin|aspirin|mesh-list
92370383|NCT01105650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370384|NCT01105650|Glucocorticoids|glucocorticoids|mesh-ancestor
92370385|NCT01105650|Hormones|hormones|mesh-ancestor
92000474|NCT05388474|Antiviral Agents|antiviral agents|mesh-ancestor
92370386|NCT01105650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370387|NCT01105650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92370388|NCT01105650|Protective Agents|protective agents|mesh-ancestor
92370389|NCT01105650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92370390|NCT01105650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370391|NCT01105650|Analgesics|analgesics|mesh-ancestor
92370392|NCT01105650|Sensory System Agents|sensory system agents|mesh-ancestor
92370393|NCT01110876|Temozolomide|temozolomide|mesh-list
92370394|NCT01110876|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92370395|NCT01110876|Vorinostat|vorinostat|mesh-list
92370396|NCT01110876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92370397|NCT01110876|Alkylating Agents|alkylating agents|mesh-ancestor
92370398|NCT01110876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370399|NCT01110876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370400|NCT01110876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92370401|NCT01110876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370402|NCT01110876|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92370404|NCT01112358|Progesterone|progesterone|mesh-list
92370405|NCT01112358|Progestins|progestins|mesh-ancestor
92370406|NCT01112358|Hormones|hormones|mesh-ancestor
92370407|NCT01112358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370408|NCT01112358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370409|NCT01112358|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92370410|NCT01112358|Fertility Agents|fertility agents|mesh-ancestor
92370411|NCT01112358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92370412|NCT01112358|Hormone Antagonists|hormone antagonists|mesh-ancestor
92370413|NCT01112670|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92370414|NCT01112670|Atorvastatin|atorvastatin|mesh-list
92370415|NCT01112670|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92370416|NCT01112670|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92370417|NCT01112670|Antimetabolites|antimetabolites|mesh-ancestor
92370418|NCT01112670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370419|NCT01112670|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92370420|NCT01112670|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92370421|NCT01112670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370422|NCT01112670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92370423|NCT01112670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370424|NCT01112670|Incretins|incretins|mesh-ancestor
92370425|NCT01112670|Hormones|hormones|mesh-ancestor
92370426|NCT01112670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370427|NCT01112670|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92370428|NCT01112670|Protease Inhibitors|protease inhibitors|mesh-ancestor
92370429|NCT01115556|Ranibizumab|ranibizumab|mesh-list
92370430|NCT01115556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92370431|NCT01115556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92370432|NCT01115556|Growth Substances|growth substances|mesh-ancestor
92370433|NCT01115556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370434|NCT01115556|Growth Inhibitors|growth inhibitors|mesh-ancestor
92370435|NCT01115556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370436|NCT01116102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92370437|NCT01119222|Diphenhydramine|diphenhydramine|mesh-list
92370438|NCT01119222|Promethazine|promethazine|mesh-list
92370439|NCT01119222|Morphine|morphine|mesh-list
92370440|NCT01119222|Gabapentin|gabapentin|mesh-list
92370441|NCT01119222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92370442|NCT01119222|Narcotics|narcotics|mesh-ancestor
92370443|NCT01119222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370444|NCT01119222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370445|NCT01119222|Analgesics|analgesics|mesh-ancestor
92370446|NCT01119222|Sensory System Agents|sensory system agents|mesh-ancestor
92370447|NCT01119222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370448|NCT01119222|Anticonvulsants|anticonvulsants|mesh-ancestor
92370449|NCT01119222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92370450|NCT01119222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92370451|NCT01119222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92370452|NCT01119222|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92370453|NCT01119222|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92370454|NCT01119222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370455|NCT01119222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370456|NCT01119222|Antimanic Agents|antimanic agents|mesh-ancestor
92370457|NCT01119222|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92370458|NCT01119222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92370459|NCT01119222|Anesthetics, Local|anesthetics, local|mesh-ancestor
92370460|NCT01119222|Anesthetics|anesthetics|mesh-ancestor
92370461|NCT01119222|Antiemetics|antiemetics|mesh-ancestor
92370462|NCT01119222|Autonomic Agents|autonomic agents|mesh-ancestor
92370463|NCT01119222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370464|NCT01119222|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92370465|NCT01119222|Histamine Antagonists|histamine antagonists|mesh-ancestor
92370466|NCT01119222|Histamine Agents|histamine agents|mesh-ancestor
92370467|NCT01119222|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92370468|NCT01119222|Antipruritics|antipruritics|mesh-ancestor
92370469|NCT01119222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92370470|NCT01120236|Leuprolide|leuprolide|mesh-list
92370471|NCT01120236|Goserelin|goserelin|mesh-list
92370472|NCT01120236|Bicalutamide|bicalutamide|mesh-list
92370473|NCT01120236|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92370474|NCT01120236|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92370475|NCT01120236|Fertility Agents|fertility agents|mesh-ancestor
92370476|NCT01120236|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92370477|NCT01120236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370478|NCT01120236|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92370479|NCT01120236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370480|NCT01120236|Androgen Antagonists|androgen antagonists|mesh-ancestor
92370481|NCT01120236|Hormone Antagonists|hormone antagonists|mesh-ancestor
92370482|NCT01120236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370483|NCT01120236|Immunologic Factors|immunologic factors|mesh-ancestor
92370485|NCT01120704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92370486|NCT01120704|Autonomic Agents|autonomic agents|mesh-ancestor
92370487|NCT01120704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370488|NCT01120704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370489|NCT01120704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92370490|NCT01120704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92370491|NCT01120704|Cholinergic Agents|cholinergic agents|mesh-ancestor
92370492|NCT01120704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370493|NCT01120704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370494|NCT01122108|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92370495|NCT01122108|Cholestyramine Resin|cholestyramine resin|mesh-list
92370496|NCT01122108|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92370497|NCT01122108|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92370498|NCT01122108|Antimetabolites|antimetabolites|mesh-ancestor
92370499|NCT01122108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370500|NCT01122108|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92370501|NCT05307042|Vasopressins|vasopressins|mesh-list
92370502|NCT05307042|Arginine Vasopressin|arginine vasopressin|mesh-list
92370503|NCT05307042|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92370504|NCT05307042|Hemostatics|hemostatics|mesh-ancestor
92370505|NCT05307042|Coagulants|coagulants|mesh-ancestor
92370506|NCT05307042|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92370507|NCT05307042|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92370508|NCT05307042|Natriuretic Agents|natriuretic agents|mesh-ancestor
92370509|NCT05307042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370510|NCT04974138|Folic Acid|folic acid|mesh-list
92370511|NCT04974138|Amlodipine|amlodipine|mesh-list
92370512|NCT04974138|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92370513|NCT04974138|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92370514|NCT04974138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370515|NCT04974138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370516|NCT04974138|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92370517|NCT04974138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370518|NCT04974138|Vasodilator Agents|vasodilator agents|mesh-ancestor
92370519|NCT04974138|Hematinics|hematinics|mesh-ancestor
92370520|NCT04974138|Vitamin B Complex|vitamin b complex|mesh-ancestor
92370521|NCT04974138|Vitamins|vitamins|mesh-ancestor
92370522|NCT04974138|Micronutrients|micronutrients|mesh-ancestor
92370523|NCT04973982|Tacrolimus|tacrolimus|mesh-list
92370524|NCT04973982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370525|NCT04973982|Immunologic Factors|immunologic factors|mesh-ancestor
92370526|NCT04973982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370527|NCT04973982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92370528|NCT04973982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370529|NCT04973982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370531|NCT04187352|Fluorouracil|fluorouracil|mesh-list
92370532|NCT04187352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370533|NCT04187352|Antimetabolites|antimetabolites|mesh-ancestor
92023020|NCT05664750|Antibodies|antibodies|mesh-list
92370534|NCT04187352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370535|NCT04187352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92370536|NCT04187352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370537|NCT04187352|Immunologic Factors|immunologic factors|mesh-ancestor
92370538|NCT04187352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370539|NCT04142892|Onapristone|onapristone|mesh-list
92370540|NCT04142892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370541|NCT04142892|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92370542|NCT04142892|Fertility Agents|fertility agents|mesh-ancestor
92370543|NCT04142892|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92370544|NCT04142892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370545|NCT04142892|Hormone Antagonists|hormone antagonists|mesh-ancestor
92370546|NCT04142892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370547|NCT03697356|Dexamethasone|dexamethasone|mesh-list
92370548|NCT03697356|Rituximab|rituximab|mesh-list
92370549|NCT03697356|Lenalidomide|lenalidomide|mesh-list
92370550|NCT03697356|Bortezomib|bortezomib|mesh-list
92370551|NCT03697356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370554|NCT03697356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370555|NCT03697356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370556|NCT03697356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370557|NCT03697356|Antiemetics|antiemetics|mesh-ancestor
92370558|NCT03697356|Autonomic Agents|autonomic agents|mesh-ancestor
92001050|NCT05038228|Rivaroxaban|rivaroxaban|mesh-list
92370559|NCT03697356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370560|NCT03697356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370561|NCT03697356|Glucocorticoids|glucocorticoids|mesh-ancestor
92370563|NCT03697356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370564|NCT03697356|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92370565|NCT03697356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92370566|NCT03697356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92370567|NCT03697356|Growth Substances|growth substances|mesh-ancestor
92370568|NCT03697356|Growth Inhibitors|growth inhibitors|mesh-ancestor
92370569|NCT03616782|Ixazomib|ixazomib|mesh-list
92370570|NCT03616782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370571|NCT03616782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92370572|NCT03616782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370573|NCT03616782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370574|NCT02410512|Atezolizumab|atezolizumab|mesh-list
92370575|NCT02410512|Antibodies|antibodies|mesh-list
92370576|NCT02410512|Immunoglobulins|immunoglobulins|mesh-list
92370577|NCT02410512|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92370578|NCT02410512|Immunologic Factors|immunologic factors|mesh-ancestor
92370579|NCT02410512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370580|NCT02410512|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92370581|NCT02410512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370582|NCT02410512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370583|NCT02410512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370584|NCT00255138|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92370585|NCT00255138|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92370586|NCT00255138|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92370587|NCT00255138|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370588|NCT00255138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370589|NCT00255138|Adrenergic Agents|adrenergic agents|mesh-ancestor
92370590|NCT00255138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370591|NCT00255138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370592|NCT01128192|Pasireotide|pasireotide|mesh-list
92370593|NCT01128192|Hormones|hormones|mesh-ancestor
92370594|NCT01128192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370595|NCT01128192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370596|NCT01128270|Chloral Hydrate|chloral hydrate|mesh-list
92370597|NCT01128270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92370598|NCT01128270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370599|NCT01128270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370600|NCT01128972|Listerine|listerine|mesh-list
92370601|NCT01128972|Fluorides|fluorides|mesh-list
92370602|NCT01128972|Sodium Fluoride|sodium fluoride|mesh-list
92370603|NCT01128972|Cariostatic Agents|cariostatic agents|mesh-ancestor
92370604|NCT01128972|Protective Agents|protective agents|mesh-ancestor
92370605|NCT01128972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370606|NCT01128972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92370607|NCT01128972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370608|NCT01129206|Deoxyglucose|deoxyglucose|mesh-list
92370609|NCT01129206|Docetaxel|docetaxel|mesh-list
92370610|NCT01129206|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92023080|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370611|NCT01129206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370612|NCT01129206|Tubulin Modulators|tubulin modulators|mesh-ancestor
92370613|NCT01129206|Antimitotic Agents|antimitotic agents|mesh-ancestor
92370614|NCT01129206|Mitosis Modulators|mitosis modulators|mesh-ancestor
92370615|NCT01129206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370616|NCT01129206|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92370617|NCT01129206|Antimetabolites|antimetabolites|mesh-ancestor
92370618|NCT01129206|Antiviral Agents|antiviral agents|mesh-ancestor
92370619|NCT01129206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370620|NCT01129440|Fluorides|fluorides|mesh-list
92370621|NCT01129440|Fluorides, Topical|fluorides, topical|mesh-list
92370622|NCT01129440|Cariostatic Agents|cariostatic agents|mesh-ancestor
92370623|NCT01129440|Protective Agents|protective agents|mesh-ancestor
92370624|NCT01129440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370626|NCT01130844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92370627|NCT01130844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370628|NCT01130844|Analgesics|analgesics|mesh-ancestor
92370629|NCT01130844|Sensory System Agents|sensory system agents|mesh-ancestor
92370630|NCT01130844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370631|NCT01130844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370632|NCT01130844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370633|NCT01130844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370634|NCT01134198|Mifepristone|mifepristone|mesh-list
92370635|NCT01134198|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92370636|NCT01134198|Abortifacient Agents|abortifacient agents|mesh-ancestor
92370637|NCT01134198|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92370638|NCT01134198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370639|NCT01134198|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92370640|NCT01134198|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92370641|NCT01134198|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92370642|NCT01134198|Contraceptive Agents|contraceptive agents|mesh-ancestor
92370643|NCT01134198|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92370644|NCT01134198|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92370645|NCT01134198|Hormone Antagonists|hormone antagonists|mesh-ancestor
92370646|NCT01134198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370647|NCT01134198|Luteolytic Agents|luteolytic agents|mesh-ancestor
92370648|NCT01134198|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92370649|NCT01134198|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92370651|NCT01135368|Dexlansoprazole|dexlansoprazole|mesh-list
92001444|NCT04622228|Etoposide|etoposide|mesh-list
92370652|NCT01135368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92370653|NCT01135368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92370654|NCT01135368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92370655|NCT01135368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370656|NCT01135368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370657|NCT01136226|Leuprolide|leuprolide|mesh-list
92370658|NCT01136226|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92370659|NCT01136226|Fertility Agents|fertility agents|mesh-ancestor
92370660|NCT01136226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92370661|NCT01136226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370662|NCT01136226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92370663|NCT01136226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370664|NCT01137396|Modafinil|modafinil|mesh-list
92370665|NCT01137396|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92370666|NCT01137396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370667|NCT01137396|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92370668|NCT01137396|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92370669|NCT01137396|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92370670|NCT01137396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370671|NCT01139190|Naproxen|naproxen|mesh-list
92370672|NCT01139190|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92370673|NCT01139190|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370674|NCT01139190|Analgesics|analgesics|mesh-ancestor
92370675|NCT01139190|Sensory System Agents|sensory system agents|mesh-ancestor
92370676|NCT01139190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370677|NCT01139190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370678|NCT01139190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370679|NCT01139190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370680|NCT01139190|Gout Suppressants|gout suppressants|mesh-ancestor
92370681|NCT01139190|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92370682|NCT01139190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370683|NCT01139190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370684|NCT01140360|Imatinib Mesylate|imatinib mesylate|mesh-list
92370685|NCT01140360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370686|NCT01140360|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92370687|NCT01140360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370688|NCT01140360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370689|NCT01142310|Lamotrigine|lamotrigine|mesh-list
92370691|NCT01142310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92370692|NCT01142310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92370693|NCT01142310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370694|NCT01142310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92370695|NCT01142310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370696|NCT01142310|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92370697|NCT01142310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92370698|NCT01142310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370699|NCT01142310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92370700|NCT01142310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92370701|NCT01144338|Exenatide|exenatide|mesh-list
92370702|NCT01144338|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92370703|NCT01144338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001752|NCT04484012|Acalabrutinib|acalabrutinib|mesh-list
92370704|NCT01144338|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92370705|NCT01144338|Incretins|incretins|mesh-ancestor
92370706|NCT01144338|Hormones|hormones|mesh-ancestor
92370707|NCT01144338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370708|NCT01144494|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92370709|NCT01144494|Lubricant Eye Drops|lubricant eye drops|mesh-list
92370710|NCT01144494|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92370711|NCT01144494|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92370712|NCT01144494|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92370713|NCT01144494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92370714|NCT01144494|Adrenergic Agents|adrenergic agents|mesh-ancestor
92370715|NCT01144494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370716|NCT01144494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370717|NCT01144494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370718|NCT01144494|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92370719|NCT01144494|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92370720|NCT01146600|Clarithromycin|clarithromycin|mesh-list
92370721|NCT01146600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92370722|NCT01146600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370723|NCT01146600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92370724|NCT01146600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370725|NCT01146600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370726|NCT01146600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92370727|NCT01146600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92370728|NCT01146834|Plerixafor|plerixafor|mesh-list
92370729|NCT01146834|Cyclophosphamide|cyclophosphamide|mesh-list
92370730|NCT01146834|Bortezomib|bortezomib|mesh-list
92370731|NCT01146834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370732|NCT01146834|Immunologic Factors|immunologic factors|mesh-ancestor
92370733|NCT01146834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370734|NCT01146834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370735|NCT01146834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92370736|NCT01146834|Alkylating Agents|alkylating agents|mesh-ancestor
92370737|NCT01146834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370738|NCT01146834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370739|NCT01146834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92370740|NCT01146834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92370741|NCT01146834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92370742|NCT01146834|Antiviral Agents|antiviral agents|mesh-ancestor
92370743|NCT01146834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370744|NCT01147302|Complement C1s|complement c1s|mesh-list
92370745|NCT01147302|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92370746|NCT01147302|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92370747|NCT01147302|Immunologic Factors|immunologic factors|mesh-ancestor
92370748|NCT01147302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370749|NCT01147302|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92370750|NCT01147302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370752|NCT01149876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370753|NCT01149876|Keratolytic Agents|keratolytic agents|mesh-ancestor
92370754|NCT01149876|Dermatologic Agents|dermatologic agents|mesh-ancestor
92370755|NCT01150500|Sirolimus|sirolimus|mesh-list
92370756|NCT01150500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92370757|NCT01150500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002001|NCT04301492|Serotonin Agents|serotonin agents|mesh-ancestor
92370758|NCT01150500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92370759|NCT01150500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370760|NCT01150500|Antifungal Agents|antifungal agents|mesh-ancestor
92370761|NCT01150500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370762|NCT01150500|Immunologic Factors|immunologic factors|mesh-ancestor
92370763|NCT01150500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370764|NCT01151046|Exemestane|exemestane|mesh-list
92370765|NCT01151046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370766|NCT01151046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92370767|NCT01151046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92370768|NCT01151046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370769|NCT01151046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370770|NCT01151046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92370771|NCT01151046|Hormone Antagonists|hormone antagonists|mesh-ancestor
92370772|NCT01151046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370773|NCT01151046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370774|NCT01151436|Hyaluronic Acid|hyaluronic acid|mesh-list
92370775|NCT01151436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92370776|NCT01151436|Immunologic Factors|immunologic factors|mesh-ancestor
92370777|NCT01151436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370778|NCT01151436|Viscosupplements|viscosupplements|mesh-ancestor
92370779|NCT01151436|Protective Agents|protective agents|mesh-ancestor
92370780|NCT01153620|Polihexanide|polihexanide|mesh-list
92370781|NCT01153620|Disinfectants|disinfectants|mesh-ancestor
92370782|NCT01153620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370783|NCT01163214|Ropivacaine|ropivacaine|mesh-list
92370784|NCT01163214|Anesthetics, Local|anesthetics, local|mesh-ancestor
92370786|NCT01163214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370787|NCT01163214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370788|NCT01163214|Sensory System Agents|sensory system agents|mesh-ancestor
92370789|NCT01163214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370790|NCT01163604|Argatroban|argatroban|mesh-list
92370791|NCT01163604|Clopidogrel|clopidogrel|mesh-list
92370792|NCT01163604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002314|NCT04148911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370793|NCT01163604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370794|NCT01163604|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92370795|NCT01163604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370796|NCT01163604|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92370797|NCT01163604|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92370798|NCT01163604|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92370799|NCT01163604|Purinergic Agents|purinergic agents|mesh-ancestor
92370800|NCT01163604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370801|NCT01163604|Antithrombins|antithrombins|mesh-ancestor
92370802|NCT01163604|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92370803|NCT01163604|Protease Inhibitors|protease inhibitors|mesh-ancestor
92370804|NCT01163604|Anticoagulants|anticoagulants|mesh-ancestor
92370805|NCT01168674|Ziprasidone|ziprasidone|mesh-list
92370806|NCT01168674|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92370807|NCT01168674|Serotonin Agents|serotonin agents|mesh-ancestor
92370808|NCT01168674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370809|NCT01168674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370810|NCT01168674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370811|NCT01168674|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92370812|NCT01168674|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92370813|NCT01168674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370814|NCT01168674|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92370815|NCT01168674|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92370816|NCT01168674|Dopamine Agents|dopamine agents|mesh-ancestor
92370817|NCT01168908|Sildenafil Citrate|sildenafil citrate|mesh-list
92370818|NCT01168908|Vasodilator Agents|vasodilator agents|mesh-ancestor
92370819|NCT01168908|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92370820|NCT01168908|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92370821|NCT01168908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002439|NCT04047628|Immunologic Factors|immunologic factors|mesh-ancestor
92370822|NCT01168908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370823|NCT01168908|Urological Agents|urological agents|mesh-ancestor
92370824|NCT01170390|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92370825|NCT01170390|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92370826|NCT01170390|Levonorgestrel|levonorgestrel|mesh-list
92370827|NCT01170390|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92370828|NCT01170390|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92370829|NCT01170390|Estradiol|estradiol|mesh-list
92370830|NCT01170390|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92370831|NCT01170390|Estrogens|estrogens|mesh-ancestor
92370832|NCT01170390|Hormones|hormones|mesh-ancestor
92370833|NCT01170390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370834|NCT01170390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970787|NCT03303677|Glucocorticoids|glucocorticoids|mesh-ancestor
92370835|NCT01170390|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92370836|NCT01170390|Contraceptive Agents|contraceptive agents|mesh-ancestor
92370837|NCT01170390|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92370838|NCT01170390|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92370839|NCT01170390|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92370840|NCT01170390|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92119515|NCT03220542|Sulforaphane|sulforaphane|mesh-list
92370841|NCT01170390|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92370842|NCT01170390|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92370844|NCT01134510|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92370845|NCT01134510|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92370846|NCT01134510|Immunologic Factors|immunologic factors|mesh-ancestor
92370847|NCT01134510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370848|NCT01134510|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92370849|NCT01134510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370851|NCT01171794|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92370852|NCT01171794|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370853|NCT01171794|Analgesics|analgesics|mesh-ancestor
92370854|NCT01171794|Sensory System Agents|sensory system agents|mesh-ancestor
92370855|NCT01171794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370856|NCT01171794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370857|NCT01171794|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370858|NCT01171794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92370859|NCT01171794|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92370860|NCT01171794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370861|NCT01171794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370862|NCT01172418|Alemtuzumab|alemtuzumab|mesh-list
92370863|NCT01172418|Thymoglobulin|thymoglobulin|mesh-list
92370864|NCT01172418|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92370865|NCT01172418|Daclizumab|daclizumab|mesh-list
92370866|NCT01172418|Immunologic Factors|immunologic factors|mesh-ancestor
92370867|NCT01172418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370868|NCT01172418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370869|NCT01172418|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370870|NCT01172418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370871|NCT01175148|Atorvastatin|atorvastatin|mesh-list
92370872|NCT01175148|Calcium|calcium|mesh-list
92002621|NCT03887780|Protease Inhibitors|protease inhibitors|mesh-ancestor
92370873|NCT01175148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92370874|NCT01175148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370875|NCT01175148|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92370876|NCT01175148|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92370877|NCT01175148|Antimetabolites|antimetabolites|mesh-ancestor
92370878|NCT01175148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370879|NCT01175148|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92370880|NCT01175148|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92370881|NCT01175148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370882|NCT01177098|Timolol|timolol|mesh-list
92370883|NCT01177098|Bimatoprost|bimatoprost|mesh-list
92370884|NCT01177098|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92370885|NCT01177098|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92370886|NCT01177098|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92370887|NCT01177098|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92370888|NCT01177098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92370890|NCT01177098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370891|NCT01177098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370892|NCT01177098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92370893|NCT01177098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92370894|NCT01177956|Fluorouracil|fluorouracil|mesh-list
92370895|NCT01177956|Cetuximab|cetuximab|mesh-list
92370896|NCT01177956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370897|NCT01177956|Antimetabolites|antimetabolites|mesh-ancestor
92002724|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92370898|NCT01177956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370899|NCT01177956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92370900|NCT01177956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370901|NCT01177956|Immunologic Factors|immunologic factors|mesh-ancestor
92370902|NCT01177956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370903|NCT01177956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92370904|NCT01183650|Tadalafil|tadalafil|mesh-list
92370905|NCT01183650|Vasodilator Agents|vasodilator agents|mesh-ancestor
92370906|NCT01183650|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92023381|NCT04046575|Paclitaxel|paclitaxel|mesh-list
92370907|NCT01183650|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92370908|NCT01183650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370909|NCT01183650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370910|NCT01183650|Urological Agents|urological agents|mesh-ancestor
92370911|NCT01184898|Cytarabine|cytarabine|mesh-list
92370912|NCT01184898|Sirolimus|sirolimus|mesh-list
92370913|NCT01184898|Etoposide|etoposide|mesh-list
92370914|NCT01184898|Mitoxantrone|mitoxantrone|mesh-list
92370915|NCT01184898|Etoposide phosphate|etoposide phosphate|mesh-list
92370916|NCT01184898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92370917|NCT01184898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370918|NCT01184898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92370919|NCT01184898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92370920|NCT01184898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370921|NCT01184898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370922|NCT01184898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92370923|NCT01184898|Antimetabolites|antimetabolites|mesh-ancestor
92370924|NCT01184898|Antiviral Agents|antiviral agents|mesh-ancestor
92370925|NCT01184898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92370926|NCT01184898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370927|NCT01184898|Immunologic Factors|immunologic factors|mesh-ancestor
92370928|NCT01184898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370929|NCT01184898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92370930|NCT01184898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92370931|NCT01184898|Antifungal Agents|antifungal agents|mesh-ancestor
92370932|NCT01184898|Analgesics|analgesics|mesh-ancestor
92370933|NCT01184898|Sensory System Agents|sensory system agents|mesh-ancestor
92370934|NCT01184898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370936|NCT01188876|Vitamin B 12|vitamin b 12|mesh-list
92370937|NCT01188876|Hydroxocobalamin|hydroxocobalamin|mesh-list
92370938|NCT01188876|Carboplatin|carboplatin|mesh-list
92370939|NCT01188876|Vitamins|vitamins|mesh-ancestor
92370940|NCT01188876|Micronutrients|micronutrients|mesh-ancestor
92370941|NCT01188876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370942|NCT01188876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370943|NCT01188876|Hematinics|hematinics|mesh-ancestor
92370944|NCT01188876|Vitamin B Complex|vitamin b complex|mesh-ancestor
92370945|NCT01193868|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92370946|NCT01193868|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92370947|NCT01193868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92370948|NCT01193868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370949|NCT01195116|Dexmedetomidine|dexmedetomidine|mesh-list
92370950|NCT01195116|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92370951|NCT01195116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92370952|NCT01195116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370953|NCT01195116|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92370954|NCT01195116|Analgesics|analgesics|mesh-ancestor
92370955|NCT01195116|Sensory System Agents|sensory system agents|mesh-ancestor
92370956|NCT01195116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370957|NCT01195116|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92370958|NCT01195116|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92370959|NCT01195116|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92370960|NCT01195116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92370961|NCT01195116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92370962|NCT01195116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370963|NCT01197612|Budesonide|budesonide|mesh-list
92370964|NCT01197612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92370965|NCT01197612|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92370966|NCT01197612|Autonomic Agents|autonomic agents|mesh-ancestor
92370967|NCT01197612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92370968|NCT01197612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370969|NCT01197612|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92370970|NCT01197612|Respiratory System Agents|respiratory system agents|mesh-ancestor
92370971|NCT01197612|Glucocorticoids|glucocorticoids|mesh-ancestor
92370972|NCT01197612|Hormones|hormones|mesh-ancestor
92370973|NCT01197612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92370974|NCT01198158|Bevacizumab|bevacizumab|mesh-list
92370975|NCT01198158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92370976|NCT01198158|Everolimus|everolimus|mesh-list
92370977|NCT01198158|Endothelial Growth Factors|endothelial growth factors|mesh-list
92370978|NCT01198158|Antibodies|antibodies|mesh-list
92370979|NCT01198158|Immunoglobulins|immunoglobulins|mesh-list
92370980|NCT01198158|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92370981|NCT01198158|Immunoglobulin G|immunoglobulin g|mesh-list
92370982|NCT01198158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92370983|NCT01198158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92370984|NCT01198158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92370986|NCT01198158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370987|NCT01198158|Growth Inhibitors|growth inhibitors|mesh-ancestor
92370988|NCT01198158|Immunologic Factors|immunologic factors|mesh-ancestor
92370989|NCT01198158|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92370990|NCT01198158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92370991|NCT01198158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003083|NCT03497676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92370992|NCT01198158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92370993|NCT01198158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92370994|NCT01203774|Insulin Glargine|insulin glargine|mesh-list
92370995|NCT01203774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92370996|NCT01203774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92370997|NCT01205646|Zoledronic Acid|zoledronic acid|mesh-list
92370998|NCT01205646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92370999|NCT01205646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371000|NCT01206660|Desoximetasone|desoximetasone|mesh-list
92371001|NCT01206660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371002|NCT01206660|Glucocorticoids|glucocorticoids|mesh-ancestor
92371003|NCT01206660|Hormones|hormones|mesh-ancestor
92371004|NCT01206660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371005|NCT01206660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371006|NCT01207752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92371007|NCT01207752|Lubricant Eye Drops|lubricant eye drops|mesh-list
92371008|NCT01207752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92371009|NCT01207908|Mecasermin|mecasermin|mesh-list
92371010|NCT01207908|Growth Substances|growth substances|mesh-ancestor
92371011|NCT01207908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371012|NCT01208922|Ciprofloxacin|ciprofloxacin|mesh-list
92371013|NCT01208922|Rifamycins|rifamycins|mesh-list
92371014|NCT01208922|Rifamycin SV|rifamycin sv|mesh-list
92371015|NCT01208922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92371016|NCT01208922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371017|NCT01208922|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92371018|NCT01208922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92371019|NCT01208922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371020|NCT01208922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371021|NCT01208922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371022|NCT01208922|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92371023|NCT01208922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92371024|NCT01208922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371025|NCT01210170|Mometasone Furoate|mometasone furoate|mesh-list
92371026|NCT01210170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371027|NCT01210170|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371028|NCT01210170|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92371029|NCT01210560|Tolvaptan|tolvaptan|mesh-list
92003201|NCT03337698|Docetaxel|docetaxel|mesh-list
92371030|NCT01210560|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92371031|NCT01210560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371032|NCT01210560|Natriuretic Agents|natriuretic agents|mesh-ancestor
92371033|NCT01210560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371034|NCT01211730|Insulin|insulin|mesh-list
92371035|NCT01211730|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92371036|NCT01211730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92371037|NCT01211730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371038|NCT01212900|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92003410|NCT03087071|Panitumumab|panitumumab|mesh-list
92371039|NCT01212900|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92371040|NCT01212900|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92371041|NCT01212900|Antimetabolites|antimetabolites|mesh-ancestor
92371042|NCT01212900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371043|NCT01212900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371044|NCT01212900|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92371046|NCT01215318|Trace Elements|trace elements|mesh-ancestor
92371047|NCT01215318|Micronutrients|micronutrients|mesh-ancestor
92371048|NCT01215318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371049|NCT01215786|Timolol|timolol|mesh-list
92371050|NCT01215786|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92371051|NCT01215786|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92371052|NCT01215786|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91970831|NCT03303053|Prednisolone|prednisolone|mesh-list
92371054|NCT01215786|Adrenergic Agents|adrenergic agents|mesh-ancestor
92023529|NCT03613116|Vitamin D|vitamin d|mesh-list
92371055|NCT01215786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371056|NCT01215786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371057|NCT01215786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371058|NCT01215786|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92371059|NCT01215786|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92371061|NCT01216410|Oxymetazoline|oxymetazoline|mesh-list
92371062|NCT01216410|Ondansetron|ondansetron|mesh-list
92371063|NCT01216410|Metoclopramide|metoclopramide|mesh-list
92371064|NCT01216410|Antiemetics|antiemetics|mesh-ancestor
92371065|NCT01216410|Autonomic Agents|autonomic agents|mesh-ancestor
92371066|NCT01216410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371067|NCT01216410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371068|NCT01216410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92003539|NCT02798523|Hormones|hormones|mesh-ancestor
92371069|NCT01216410|Antipruritics|antipruritics|mesh-ancestor
92371070|NCT01216410|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371071|NCT01216410|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92371072|NCT01216410|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92371073|NCT01216410|Serotonin Agents|serotonin agents|mesh-ancestor
92371074|NCT01216410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371075|NCT01216410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371076|NCT01216410|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92371078|NCT01216410|Sympathomimetics|sympathomimetics|mesh-ancestor
92371079|NCT01216410|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92371080|NCT01216410|Nasal Decongestants|nasal decongestants|mesh-ancestor
92371081|NCT01216410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92371082|NCT01216410|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92371083|NCT01216410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92371084|NCT01216410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92371085|NCT01216410|Adrenergic Agents|adrenergic agents|mesh-ancestor
92371086|NCT01216410|Protective Agents|protective agents|mesh-ancestor
92371087|NCT01216410|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92371088|NCT01216410|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92371089|NCT01216410|Dopamine Agents|dopamine agents|mesh-ancestor
92371090|NCT01218048|Carboplatin|carboplatin|mesh-list
92371091|NCT01218048|Cetuximab|cetuximab|mesh-list
92371092|NCT01218048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970901|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
92371093|NCT01218048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371095|NCT01218984|Hydromorphone|hydromorphone|mesh-list
92371096|NCT01218984|Naloxone|naloxone|mesh-list
92371097|NCT01218984|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92371098|NCT01218984|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92371099|NCT01218984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371100|NCT01218984|Sensory System Agents|sensory system agents|mesh-ancestor
92371101|NCT01218984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371102|NCT01218984|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92371103|NCT01218984|Narcotics|narcotics|mesh-ancestor
92371104|NCT01218984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371106|NCT01222260|Dexamethasone|dexamethasone|mesh-list
92371107|NCT01222260|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92371108|NCT01222260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371109|NCT01222260|Antiemetics|antiemetics|mesh-ancestor
92371110|NCT01222260|Autonomic Agents|autonomic agents|mesh-ancestor
92371111|NCT01222260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371112|NCT01222260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371113|NCT01222260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92371114|NCT01222260|Glucocorticoids|glucocorticoids|mesh-ancestor
92371115|NCT01222260|Hormones|hormones|mesh-ancestor
92371116|NCT01222260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371117|NCT01222260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92371118|NCT01222260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371119|NCT01222260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92371120|NCT01222260|Alkylating Agents|alkylating agents|mesh-ancestor
92371121|NCT01222260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371122|NCT01222572|Etoposide|etoposide|mesh-list
92371123|NCT01222572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371124|NCT01222572|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92371125|NCT01222572|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92371126|NCT01222572|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92371127|NCT01222572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371128|NCT01222572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371129|NCT01222884|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92371130|NCT01222884|Hematinics|hematinics|mesh-ancestor
92371131|NCT01223352|Bosentan|bosentan|mesh-list
92371132|NCT01223352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92371133|NCT01223352|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92371134|NCT01223352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371135|NCT01224210|Ambrisentan|ambrisentan|mesh-list
92371136|NCT01224210|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92371137|NCT01224678|Vitamin D|vitamin d|mesh-list
92371139|NCT01224678|Micronutrients|micronutrients|mesh-ancestor
92371140|NCT01224678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371141|NCT01224678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92371142|NCT01225068|Milnacipran|milnacipran|mesh-list
92371143|NCT01225068|Levomilnacipran|levomilnacipran|mesh-list
92371144|NCT01225068|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92371145|NCT01225068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92371146|NCT01225068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371147|NCT01225068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974601|NCT04924647|Hormones|hormones|mesh-ancestor
92371148|NCT01225068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371149|NCT01225068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371150|NCT01225068|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92371151|NCT01225068|Analgesics|analgesics|mesh-ancestor
92371152|NCT01225068|Sensory System Agents|sensory system agents|mesh-ancestor
92371153|NCT01225068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371154|NCT01225068|Antidepressive Agents|antidepressive agents|mesh-ancestor
92371155|NCT01225068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92371156|NCT01226706|Botulinum Toxins|botulinum toxins|mesh-list
92371157|NCT01226706|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92371158|NCT01226706|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92371159|NCT01226706|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92371160|NCT01226706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371161|NCT01226706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371162|NCT01226706|Cholinergic Agents|cholinergic agents|mesh-ancestor
92371163|NCT01226706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371164|NCT01226706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371165|NCT01226706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92371166|NCT01226706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371167|NCT01231230|Fluticasone|fluticasone|mesh-list
92371168|NCT01231230|Xhance|xhance|mesh-list
92371169|NCT01231230|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92371170|NCT01231230|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92371171|NCT01231230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371172|NCT01231230|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92371173|NCT01231230|Autonomic Agents|autonomic agents|mesh-ancestor
92371174|NCT01231230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371175|NCT01231230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371176|NCT01231230|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92371177|NCT01231230|Respiratory System Agents|respiratory system agents|mesh-ancestor
92371178|NCT01231230|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371179|NCT01231230|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92371180|NCT01231230|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91975680|NCT01594749|Antiemetics|antiemetics|mesh-ancestor
92371181|NCT01231230|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92371182|NCT01231230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92371183|NCT01231230|Adrenergic Agents|adrenergic agents|mesh-ancestor
92371184|NCT01231230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371185|NCT01231230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371186|NCT01231230|Glucocorticoids|glucocorticoids|mesh-ancestor
92371187|NCT01231230|Hormones|hormones|mesh-ancestor
92371188|NCT01231230|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371189|NCT01231230|Sympathomimetics|sympathomimetics|mesh-ancestor
92371190|NCT01232946|Insulin|insulin|mesh-list
92371191|NCT01232946|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92371192|NCT01232946|Liraglutide|liraglutide|mesh-list
92371193|NCT01232946|Insulin Detemir|insulin detemir|mesh-list
92371194|NCT01232946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92371195|NCT01232946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371196|NCT01232946|Incretins|incretins|mesh-ancestor
92371197|NCT01232946|Hormones|hormones|mesh-ancestor
92371198|NCT01232946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371199|NCT01235910|Cyclosporine|cyclosporine|mesh-list
92371200|NCT01235910|Cyclosporins|cyclosporins|mesh-list
92371201|NCT01235910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371202|NCT01235910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371203|NCT01235910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371204|NCT01235910|Immunologic Factors|immunologic factors|mesh-ancestor
92371205|NCT01235910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371206|NCT01235910|Antifungal Agents|antifungal agents|mesh-ancestor
92371207|NCT01235910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371208|NCT01235910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371209|NCT01235910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371210|NCT01235910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92371212|NCT01236378|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92371213|NCT01236378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371214|NCT01236378|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92371215|NCT01236378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371216|NCT01236378|Antifungal Agents|antifungal agents|mesh-ancestor
92371217|NCT01236378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371218|NCT01236378|Immunologic Factors|immunologic factors|mesh-ancestor
92371219|NCT01236378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371220|NCT01236768|Contraceptive Agents|contraceptive agents|mesh-list
92371221|NCT01236768|Contraceptives, Oral|contraceptives, oral|mesh-list
92371222|NCT01236768|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-list
92371223|NCT01236768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371224|NCT01236768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371225|NCT01236768|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92371226|NCT01236768|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92371227|NCT01238640|Nicotine|nicotine|mesh-list
92371228|NCT01238640|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92371229|NCT01238640|Autonomic Agents|autonomic agents|mesh-ancestor
92371230|NCT01238640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371231|NCT01238640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371232|NCT01238640|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92371233|NCT01238640|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92371234|NCT01238640|Cholinergic Agents|cholinergic agents|mesh-ancestor
92371235|NCT01238640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371236|NCT01238640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371237|NCT01247064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92371238|NCT01247220|Ranibizumab|ranibizumab|mesh-list
92371239|NCT01247220|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92371240|NCT01247220|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92371241|NCT01247220|Growth Substances|growth substances|mesh-ancestor
91978136|NCT04790331|Diltiazem|diltiazem|mesh-list
92371242|NCT01247220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979201|NCT05546853|Vitamins|vitamins|mesh-ancestor
92371243|NCT01247220|Growth Inhibitors|growth inhibitors|mesh-ancestor
92371244|NCT01247220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371245|NCT01249872|Morphine|morphine|mesh-list
92371246|NCT01249872|Levobupivacaine|levobupivacaine|mesh-list
92371247|NCT01249872|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92371248|NCT01249872|Narcotics|narcotics|mesh-ancestor
92371249|NCT01249872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371250|NCT01249872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371252|NCT01249872|Sensory System Agents|sensory system agents|mesh-ancestor
92371253|NCT01249872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371254|NCT01249872|Anesthetics, Local|anesthetics, local|mesh-ancestor
92371255|NCT01249872|Anesthetics|anesthetics|mesh-ancestor
92371256|NCT01250184|Lidocaine|lidocaine|mesh-list
92371257|NCT01250184|Anesthetics, Local|anesthetics, local|mesh-ancestor
92371258|NCT01250184|Anesthetics|anesthetics|mesh-ancestor
92371259|NCT01250184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371260|NCT01250184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371261|NCT01250184|Sensory System Agents|sensory system agents|mesh-ancestor
92371262|NCT01250184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371263|NCT01250184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92371264|NCT01250184|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92371265|NCT01250184|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92371266|NCT01250184|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371267|NCT01250184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371268|NCT01250730|Crizotinib|crizotinib|mesh-list
92371269|NCT01250730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371270|NCT01250730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92371271|NCT01250730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371272|NCT01250730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371273|NCT01251978|Ranibizumab|ranibizumab|mesh-list
92371274|NCT01251978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92371275|NCT01251978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92371276|NCT01251978|Growth Substances|growth substances|mesh-ancestor
92371277|NCT01251978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371278|NCT01251978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92371279|NCT01251978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371280|NCT01253460|Cyclophosphamide|cyclophosphamide|mesh-list
92371281|NCT01253460|Rituximab|rituximab|mesh-list
92371283|NCT01253460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371284|NCT01253460|Immunologic Factors|immunologic factors|mesh-ancestor
92371285|NCT01253460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371286|NCT01253460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371287|NCT01253460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92371288|NCT01253460|Alkylating Agents|alkylating agents|mesh-ancestor
92371289|NCT01253460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371290|NCT01253460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371291|NCT01253460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92371292|NCT01253460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371293|NCT01254396|Sildenafil Citrate|sildenafil citrate|mesh-list
92371294|NCT01254396|Vasodilator Agents|vasodilator agents|mesh-ancestor
92371295|NCT01254396|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92371296|NCT01254396|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92371297|NCT01254396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981694|NCT02422199|Lapatinib|lapatinib|mesh-list
92371298|NCT01254396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371299|NCT01254396|Urological Agents|urological agents|mesh-ancestor
91983392|NCT04603911|Epinephrine|epinephrine|mesh-list
91983922|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371300|NCT01254552|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92371301|NCT01254552|Chelating Agents|chelating agents|mesh-ancestor
92371302|NCT01254552|Sequestering Agents|sequestering agents|mesh-ancestor
92371303|NCT01254552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371304|NCT01244724|Escitalopram|escitalopram|mesh-list
92371305|NCT01244724|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92371306|NCT01244724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92371307|NCT01244724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371308|NCT01244724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371309|NCT01244724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371310|NCT01244724|Serotonin Agents|serotonin agents|mesh-ancestor
92371311|NCT01244724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371312|NCT01258374|Raltegravir Potassium|raltegravir potassium|mesh-list
92371313|NCT01258374|Darunavir|darunavir|mesh-list
92371314|NCT01258374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92371315|NCT01258374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92371316|NCT01258374|Antiviral Agents|antiviral agents|mesh-ancestor
92371317|NCT01258374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371318|NCT01258374|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92371319|NCT01258374|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92371320|NCT01258374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371321|NCT01258374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371322|NCT01258374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92371323|NCT01258374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92371324|NCT01258374|Protease Inhibitors|protease inhibitors|mesh-ancestor
92371325|NCT01262118|Tofacitinib|tofacitinib|mesh-list
92371326|NCT01262118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92371327|NCT01262118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92371328|NCT01262118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371329|NCT01262118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371330|NCT01263132|Thiamine|thiamine|mesh-list
92371331|NCT01263132|Vitamin B 12|vitamin b 12|mesh-list
92371332|NCT01263132|Gabapentin|gabapentin|mesh-list
92371333|NCT01263132|Analgesics|analgesics|mesh-ancestor
92371334|NCT01263132|Sensory System Agents|sensory system agents|mesh-ancestor
92371335|NCT01263132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371336|NCT01263132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371337|NCT01263132|Anticonvulsants|anticonvulsants|mesh-ancestor
92371338|NCT01263132|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92371339|NCT01263132|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92371340|NCT01263132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371341|NCT01263132|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92371342|NCT01263132|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92371343|NCT01263132|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92371344|NCT01263132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371345|NCT01263132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371346|NCT01263132|Antimanic Agents|antimanic agents|mesh-ancestor
92371347|NCT01263132|Vitamin B Complex|vitamin b complex|mesh-ancestor
92371348|NCT01263132|Vitamins|vitamins|mesh-ancestor
92371349|NCT01263132|Micronutrients|micronutrients|mesh-ancestor
92371351|NCT01267656|Lubricant Eye Drops|lubricant eye drops|mesh-list
92371352|NCT01267656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92371353|NCT01270542|Bevacizumab|bevacizumab|mesh-list
92371354|NCT01270542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371355|NCT01270542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371356|NCT01270542|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91937620|NCT05414084|Phenol|phenol|mesh-list
92371357|NCT01270542|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92371358|NCT01270542|Growth Substances|growth substances|mesh-ancestor
92371359|NCT01270542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371360|NCT01270542|Growth Inhibitors|growth inhibitors|mesh-ancestor
92371361|NCT01271244|Escitalopram|escitalopram|mesh-list
92003755|NCT02081378|Niacinamide|niacinamide|mesh-list
92371362|NCT01271244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92371363|NCT01271244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92371364|NCT01271244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371365|NCT01271244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371367|NCT01271244|Serotonin Agents|serotonin agents|mesh-ancestor
92371368|NCT01271244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371369|NCT01272960|Levonorgestrel|levonorgestrel|mesh-list
92003825|NCT01689662|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92371370|NCT01272960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92371371|NCT01272960|Contraceptive Agents|contraceptive agents|mesh-ancestor
92371372|NCT01272960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371373|NCT01272960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371374|NCT01272960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92371375|NCT01272960|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92371376|NCT01272960|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92371378|NCT01275300|Niacin|niacin|mesh-list
92371379|NCT01275300|Niacinamide|niacinamide|mesh-list
92371380|NCT01275300|Nicotinic Acids|nicotinic acids|mesh-list
92371381|NCT01275300|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92371382|NCT01275300|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92371383|NCT01275300|Analgesics|analgesics|mesh-ancestor
92371384|NCT01275300|Sensory System Agents|sensory system agents|mesh-ancestor
92371385|NCT01275300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371386|NCT01275300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371387|NCT01275300|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371388|NCT01275300|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371389|NCT01275300|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92371390|NCT01275300|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92371391|NCT01275300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371392|NCT01275300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92371393|NCT01275300|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92371394|NCT01275300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371395|NCT01275300|Antipyretics|antipyretics|mesh-ancestor
92371396|NCT01275300|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92371397|NCT01275300|Antimetabolites|antimetabolites|mesh-ancestor
92371398|NCT01275300|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92371399|NCT01275300|Vasodilator Agents|vasodilator agents|mesh-ancestor
92371400|NCT01275300|Vitamin B Complex|vitamin b complex|mesh-ancestor
92371401|NCT01275300|Vitamins|vitamins|mesh-ancestor
92371402|NCT01275300|Micronutrients|micronutrients|mesh-ancestor
92371403|NCT01276314|Prednisolone|prednisolone|mesh-list
92371404|NCT01276314|Etanercept|etanercept|mesh-list
92371405|NCT01276314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371406|NCT01276314|Glucocorticoids|glucocorticoids|mesh-ancestor
92371407|NCT01276314|Hormones|hormones|mesh-ancestor
92371408|NCT01276314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984386|NCT02548455|Contraceptive Agents|contraceptive agents|mesh-ancestor
92371409|NCT01276314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371410|NCT01276314|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92371411|NCT01276314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371412|NCT01276314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371413|NCT01276314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92371414|NCT01276314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92371415|NCT01276314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92371417|NCT01276314|Sensory System Agents|sensory system agents|mesh-ancestor
92371418|NCT01276314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371419|NCT01276314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371420|NCT01276314|Immunologic Factors|immunologic factors|mesh-ancestor
92371421|NCT01280058|Paclitaxel|paclitaxel|mesh-list
92371422|NCT01280058|Carboplatin|carboplatin|mesh-list
92003900|NCT01439282|Capecitabine|capecitabine|mesh-list
92371423|NCT01280058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92371424|NCT01280058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92371425|NCT01280058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371426|NCT01280058|Tubulin Modulators|tubulin modulators|mesh-ancestor
92371427|NCT01280058|Antimitotic Agents|antimitotic agents|mesh-ancestor
92371428|NCT01280058|Mitosis Modulators|mitosis modulators|mesh-ancestor
92371429|NCT01280058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371430|NCT01280604|Fenofibrate|fenofibrate|mesh-list
92371431|NCT01280604|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92371432|NCT01280604|Antimetabolites|antimetabolites|mesh-ancestor
92371433|NCT01280604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371434|NCT01280604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92371435|NCT01282242|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92371436|NCT01282242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92371437|NCT01282242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92371438|NCT01282242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371440|NCT01285050|Emtricitabine|emtricitabine|mesh-list
92371441|NCT01285050|Raltegravir Potassium|raltegravir potassium|mesh-list
92371442|NCT01285050|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92371443|NCT01285050|Antiviral Agents|antiviral agents|mesh-ancestor
92371444|NCT01285050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371445|NCT01285050|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92371446|NCT01285050|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92371447|NCT01285050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371448|NCT01285050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371449|NCT01285050|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92371450|NCT01285050|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92371451|NCT01285050|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92371452|NCT01286454|Fesoterodine|fesoterodine|mesh-list
92371453|NCT01286454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92371454|NCT01286454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92371455|NCT01286454|Cholinergic Agents|cholinergic agents|mesh-ancestor
92371456|NCT01286454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371457|NCT01286454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371458|NCT01286454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371460|NCT01287078|Cyclosporine|cyclosporine|mesh-list
92371461|NCT01287078|Cyclosporins|cyclosporins|mesh-list
92371462|NCT01287078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371463|NCT01287078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371464|NCT01287078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371465|NCT01287078|Immunologic Factors|immunologic factors|mesh-ancestor
92371466|NCT01287078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371467|NCT01287078|Antifungal Agents|antifungal agents|mesh-ancestor
92371468|NCT01287078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371469|NCT01287078|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371470|NCT01287078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371471|NCT01287078|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92371472|NCT01291056|Clomiphene|clomiphene|mesh-list
92371473|NCT01291056|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92371474|NCT01291056|Hormone Antagonists|hormone antagonists|mesh-ancestor
92371475|NCT01291056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371476|NCT01291056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371477|NCT01291056|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92371478|NCT01291056|Fertility Agents|fertility agents|mesh-ancestor
92371479|NCT01291056|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371480|NCT01291056|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92371481|NCT01291056|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92371482|NCT01292304|Tolvaptan|tolvaptan|mesh-list
92371483|NCT01292304|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92371484|NCT01292304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371485|NCT01292304|Natriuretic Agents|natriuretic agents|mesh-ancestor
92371486|NCT01292304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371487|NCT01293396|Insulin|insulin|mesh-list
92371488|NCT01293396|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92371489|NCT01293396|Insulin Aspart|insulin aspart|mesh-list
92371490|NCT01293396|Insulin, Long-Acting|insulin, long-acting|mesh-list
92371491|NCT01293396|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92371492|NCT01293396|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92371494|NCT01293396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371495|NCT01294098|Bupivacaine|bupivacaine|mesh-list
92371496|NCT01294098|Anesthetics, Local|anesthetics, local|mesh-ancestor
92371497|NCT01294098|Anesthetics|anesthetics|mesh-ancestor
92371498|NCT01294098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371499|NCT01294098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371500|NCT01294098|Sensory System Agents|sensory system agents|mesh-ancestor
92371501|NCT01294098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023975|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
92371503|NCT01295112|Dexamethasone acetate|dexamethasone acetate|mesh-list
92371504|NCT01295112|Bevacizumab|bevacizumab|mesh-list
92371506|NCT01295112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371507|NCT01295112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371508|NCT01295112|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92371509|NCT01295112|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92371510|NCT01295112|Growth Substances|growth substances|mesh-ancestor
92371511|NCT01295112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371512|NCT01295112|Growth Inhibitors|growth inhibitors|mesh-ancestor
92371513|NCT01295112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371514|NCT01295112|Antiemetics|antiemetics|mesh-ancestor
92371515|NCT01295112|Autonomic Agents|autonomic agents|mesh-ancestor
92371516|NCT01295112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371517|NCT01295112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92371518|NCT01295112|Glucocorticoids|glucocorticoids|mesh-ancestor
92371519|NCT01295112|Hormones|hormones|mesh-ancestor
92371520|NCT01295112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371521|NCT01295112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92371522|NCT01295112|Protease Inhibitors|protease inhibitors|mesh-ancestor
92371523|NCT01295112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371524|NCT01295112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371525|NCT01301742|Empagliflozin|empagliflozin|mesh-list
92371526|NCT01301742|Gemfibrozil|gemfibrozil|mesh-list
92371527|NCT01301742|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92371528|NCT01301742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371529|NCT01301742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92371530|NCT01301742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371531|NCT01301742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92371532|NCT01301742|Antimetabolites|antimetabolites|mesh-ancestor
92371533|NCT01301742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92371534|NCT01301742|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92371535|NCT01301742|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92371536|NCT01301742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371538|NCT01304082|Anesthetics, Local|anesthetics, local|mesh-ancestor
92371540|NCT01304082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371541|NCT01304082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371542|NCT01304082|Sensory System Agents|sensory system agents|mesh-ancestor
92371543|NCT01304082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371544|NCT01304082|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92371545|NCT01304082|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92371546|NCT01304082|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92371547|NCT01304082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371548|NCT01304082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371550|NCT01304238|Lepirudin|lepirudin|mesh-list
92371551|NCT01304238|Danaparoid|danaparoid|mesh-list
92371552|NCT01304238|Fondaparinux|fondaparinux|mesh-list
92371553|NCT01304238|Argatroban|argatroban|mesh-list
92371554|NCT01304238|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92371555|NCT01304238|Antithrombins|antithrombins|mesh-ancestor
92371556|NCT01304238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92371557|NCT01304238|Protease Inhibitors|protease inhibitors|mesh-ancestor
92371558|NCT01304238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371559|NCT01304238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371560|NCT01304238|Anticoagulants|anticoagulants|mesh-ancestor
92371561|NCT01304238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92371562|NCT01304238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92371563|NCT01304238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92371564|NCT01305252|Treprostinil|treprostinil|mesh-list
92371565|NCT01305252|Tadalafil|tadalafil|mesh-list
92371566|NCT01305252|Vasodilator Agents|vasodilator agents|mesh-ancestor
92371567|NCT01305252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92371568|NCT01305252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92371569|NCT01305252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004428|NCT00002650|Folic Acid|folic acid|mesh-list
92371570|NCT01305252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371571|NCT01305252|Urological Agents|urological agents|mesh-ancestor
92371572|NCT01305252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92371573|NCT01308060|Botulinum Toxins|botulinum toxins|mesh-list
92371574|NCT01308060|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92371575|NCT01308060|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92371576|NCT01308060|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92004535|NCT03078257|Antipyretics|antipyretics|mesh-ancestor
92119516|NCT03220542|Esomeprazole|esomeprazole|mesh-list
92371577|NCT01308060|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371578|NCT01308060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371579|NCT01308060|Cholinergic Agents|cholinergic agents|mesh-ancestor
92371580|NCT01308060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371581|NCT01308060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371582|NCT01308060|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92371583|NCT01308060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371585|NCT01308294|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92371586|NCT01308294|Immunologic Factors|immunologic factors|mesh-ancestor
92371587|NCT01308294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371588|NCT01308294|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92371589|NCT01308840|Gemcitabine|gemcitabine|mesh-list
92371590|NCT01308840|Oxaliplatin|oxaliplatin|mesh-list
92371591|NCT01308840|Panitumumab|panitumumab|mesh-list
92371592|NCT01308840|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92371593|NCT01308840|Antimetabolites|antimetabolites|mesh-ancestor
92371594|NCT01308840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371595|NCT01308840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371596|NCT01308840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371597|NCT01311102|Lidocaine|lidocaine|mesh-list
92371598|NCT01311102|Anesthetics, Local|anesthetics, local|mesh-ancestor
92371600|NCT01311102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371601|NCT01311102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371602|NCT01311102|Sensory System Agents|sensory system agents|mesh-ancestor
92371603|NCT01311102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371604|NCT01311102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92371605|NCT01311102|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92371606|NCT01311102|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92371607|NCT01311102|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371608|NCT01311102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371609|NCT01312038|Simethicone|simethicone|mesh-list
92371610|NCT01312038|Antifoaming Agents|antifoaming agents|mesh-ancestor
92371611|NCT01312038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371612|NCT01312038|Emollients|emollients|mesh-ancestor
92371613|NCT01312038|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371614|NCT01312272|Oxytocin|oxytocin|mesh-list
92371615|NCT01312272|Oxytocics|oxytocics|mesh-ancestor
92371616|NCT01312272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371617|NCT01312272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371618|NCT01312818|Dexamethasone|dexamethasone|mesh-list
92371619|NCT01312818|Methotrexate|methotrexate|mesh-list
92371620|NCT01312818|Bortezomib|bortezomib|mesh-list
92371621|NCT01312818|Imatinib Mesylate|imatinib mesylate|mesh-list
92371622|NCT01312818|Vorinostat|vorinostat|mesh-list
92371623|NCT01312818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371624|NCT01312818|Antiemetics|antiemetics|mesh-ancestor
92371625|NCT01312818|Autonomic Agents|autonomic agents|mesh-ancestor
92371626|NCT01312818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371627|NCT01312818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371628|NCT01312818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92371629|NCT01312818|Glucocorticoids|glucocorticoids|mesh-ancestor
92371630|NCT01312818|Hormones|hormones|mesh-ancestor
92371631|NCT01312818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371632|NCT01312818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92371633|NCT01312818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371634|NCT01312818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92371635|NCT01312818|Abortifacient Agents|abortifacient agents|mesh-ancestor
92371636|NCT01312818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371637|NCT01312818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92371638|NCT01312818|Antimetabolites|antimetabolites|mesh-ancestor
92371639|NCT01312818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371640|NCT01312818|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371641|NCT01312818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371642|NCT01312818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92371643|NCT01312818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371644|NCT01312818|Immunologic Factors|immunologic factors|mesh-ancestor
92371645|NCT01312818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371646|NCT01312818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92371647|NCT01312818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937624|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92371648|NCT01312818|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92371649|NCT01313520|Infliximab|infliximab|mesh-list
92119817|NCT03226080|Rocuronium|rocuronium|mesh-list
92371650|NCT01313520|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92024124|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
92371651|NCT01313520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371652|NCT01313520|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371653|NCT01313520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92371654|NCT01313520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371656|NCT01315002|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92371657|NCT01315002|Autonomic Agents|autonomic agents|mesh-ancestor
92371658|NCT01315002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371659|NCT01315002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371660|NCT01315002|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92371661|NCT01315002|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92371662|NCT01315002|Cholinergic Agents|cholinergic agents|mesh-ancestor
92371663|NCT01315002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371664|NCT01315002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371665|NCT01315158|Fentanyl|fentanyl|mesh-list
92371666|NCT01315158|Midazolam|midazolam|mesh-list
92371667|NCT01315158|Analgesics, Opioid|analgesics, opioid|mesh-list
92371668|NCT01315158|Propofol|propofol|mesh-list
92371669|NCT01315158|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92371670|NCT01315158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371671|NCT01315158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371672|NCT01315158|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92371673|NCT01315158|Anesthetics, General|anesthetics, general|mesh-ancestor
92371674|NCT01315158|Anesthetics|anesthetics|mesh-ancestor
92371675|NCT01315158|Narcotics|narcotics|mesh-ancestor
92371676|NCT01315158|Analgesics|analgesics|mesh-ancestor
92371677|NCT01315158|Sensory System Agents|sensory system agents|mesh-ancestor
92371678|NCT01315158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371679|NCT01315158|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92371680|NCT01315158|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92371681|NCT01315158|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92371682|NCT01315158|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92371683|NCT01315158|GABA Modulators|gaba modulators|mesh-ancestor
92371684|NCT01315158|GABA Agents|gaba agents|mesh-ancestor
92371685|NCT01315158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005133|NCT03144115|Oxytocin|oxytocin|mesh-list
92371686|NCT01315158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371688|NCT01318278|Vasopressins|vasopressins|mesh-list
92371689|NCT01318278|Arginine Vasopressin|arginine vasopressin|mesh-list
92371690|NCT01318278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371691|NCT01318278|Hemostatics|hemostatics|mesh-ancestor
92371692|NCT01318278|Coagulants|coagulants|mesh-ancestor
92371693|NCT01318278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92371694|NCT01318278|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92371695|NCT01318278|Natriuretic Agents|natriuretic agents|mesh-ancestor
92371696|NCT01318278|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92371697|NCT01318278|Sympathomimetics|sympathomimetics|mesh-ancestor
92371698|NCT01318278|Autonomic Agents|autonomic agents|mesh-ancestor
92371699|NCT01318278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371700|NCT01318278|Dopamine Agents|dopamine agents|mesh-ancestor
92371701|NCT01318278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371702|NCT01318278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371703|NCT01318278|Protective Agents|protective agents|mesh-ancestor
92371704|NCT01318356|Doxycycline|doxycycline|mesh-list
92371705|NCT01318356|Tetracycline|tetracycline|mesh-list
92371706|NCT01318356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92371707|NCT01318356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371708|NCT01318356|Antimalarials|antimalarials|mesh-ancestor
92371709|NCT01318356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92371710|NCT01318356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92371711|NCT01318356|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92371712|NCT01318356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371713|NCT01318356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371715|NCT01324128|Sevelamer|sevelamer|mesh-list
92371716|NCT01324128|Trace Elements|trace elements|mesh-ancestor
92371717|NCT01324128|Micronutrients|micronutrients|mesh-ancestor
92371718|NCT01324128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371719|NCT01324128|Chelating Agents|chelating agents|mesh-ancestor
92371720|NCT01324128|Sequestering Agents|sequestering agents|mesh-ancestor
92371721|NCT01324128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371722|NCT01328184|Empagliflozin|empagliflozin|mesh-list
92371723|NCT01328184|Levonorgestrel|levonorgestrel|mesh-list
92371724|NCT01328184|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92371725|NCT01328184|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
91933026|NCT02212535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92371726|NCT01328184|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92371727|NCT01328184|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92371728|NCT01328184|Contraceptive Agents|contraceptive agents|mesh-ancestor
92371729|NCT01328184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371730|NCT01328184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371731|NCT01328184|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92371732|NCT01328184|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92371733|NCT01328184|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92371734|NCT01328184|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92371735|NCT01328184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371736|NCT01328184|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92371737|NCT01328184|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92371739|NCT01328184|Hormones|hormones|mesh-ancestor
92371740|NCT01328184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371741|NCT01328184|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92371742|NCT01328184|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92371743|NCT01328184|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92371744|NCT01328184|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92371745|NCT01328964|Fluticasone|fluticasone|mesh-list
92371746|NCT01328964|Xhance|xhance|mesh-list
92371747|NCT01328964|Budesonide|budesonide|mesh-list
92371748|NCT01328964|Montelukast|montelukast|mesh-list
92371749|NCT01328964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371750|NCT01328964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92371751|NCT01328964|Autonomic Agents|autonomic agents|mesh-ancestor
92371752|NCT01328964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371753|NCT01328964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371754|NCT01328964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92371755|NCT01328964|Respiratory System Agents|respiratory system agents|mesh-ancestor
92371756|NCT01328964|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371757|NCT01328964|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92371758|NCT01328964|Glucocorticoids|glucocorticoids|mesh-ancestor
92371760|NCT01328964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371761|NCT01328964|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92371762|NCT01328964|Hormone Antagonists|hormone antagonists|mesh-ancestor
92371763|NCT01328964|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92371764|NCT01328964|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92371765|NCT01328964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371766|NCT01330134|Lidocaine|lidocaine|mesh-list
92371767|NCT01330134|Anesthetics, Local|anesthetics, local|mesh-ancestor
92371768|NCT01330134|Anesthetics|anesthetics|mesh-ancestor
92371769|NCT01330134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371770|NCT01330134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371771|NCT01330134|Sensory System Agents|sensory system agents|mesh-ancestor
92371772|NCT01330134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371773|NCT01330134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92371774|NCT01330134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92371775|NCT01330134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92371776|NCT01330134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005660|NCT02327923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371777|NCT01330134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371778|NCT01330290|Rotigotine|rotigotine|mesh-list
92371779|NCT01330290|Dopamine Agonists|dopamine agonists|mesh-ancestor
92371780|NCT01330290|Dopamine Agents|dopamine agents|mesh-ancestor
92371781|NCT01330290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371782|NCT01330290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371783|NCT01330290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371784|NCT01331304|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92371785|NCT01331304|Antidepressive Agents|antidepressive agents|mesh-ancestor
92371786|NCT01331304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92371787|NCT01331304|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92371788|NCT01331304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92005721|NCT03071549|Antifungal Agents|antifungal agents|mesh-ancestor
92371789|NCT01331304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371790|NCT01331304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371791|NCT01331694|Fluticasone|fluticasone|mesh-list
92371792|NCT01331694|Bromides|bromides|mesh-list
92371793|NCT01331694|Albuterol|albuterol|mesh-list
92371794|NCT01331694|Tiotropium Bromide|tiotropium bromide|mesh-list
92371795|NCT01331694|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92371796|NCT01331694|Ipratropium|ipratropium|mesh-list
92371797|NCT01331694|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92371798|NCT01331694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371799|NCT01331694|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92371800|NCT01331694|Autonomic Agents|autonomic agents|mesh-ancestor
92371801|NCT01331694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371802|NCT01331694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371803|NCT01331694|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92371804|NCT01331694|Respiratory System Agents|respiratory system agents|mesh-ancestor
92371805|NCT01331694|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371806|NCT01331694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92371807|NCT01331694|Parasympatholytics|parasympatholytics|mesh-ancestor
92371808|NCT01331694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92371809|NCT01331694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92371810|NCT01331694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371811|NCT01331694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371812|NCT01331694|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92371813|NCT01331694|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92371814|NCT01331694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92371815|NCT01331694|Adrenergic Agents|adrenergic agents|mesh-ancestor
92371816|NCT01331694|Anticonvulsants|anticonvulsants|mesh-ancestor
92371817|NCT01331694|Tocolytic Agents|tocolytic agents|mesh-ancestor
92371818|NCT01331694|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371819|NCT01331694|Glucocorticoids|glucocorticoids|mesh-ancestor
92371820|NCT01331694|Hormones|hormones|mesh-ancestor
92371821|NCT01331694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371822|NCT01331694|Sympathomimetics|sympathomimetics|mesh-ancestor
92371823|NCT01333098|Mifepristone|mifepristone|mesh-list
92371824|NCT01333098|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92371825|NCT01333098|Abortifacient Agents|abortifacient agents|mesh-ancestor
92371826|NCT01333098|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371827|NCT01333098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371828|NCT01333098|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92371829|NCT01333098|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92371830|NCT01333098|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92371831|NCT01333098|Contraceptive Agents|contraceptive agents|mesh-ancestor
92005847|NCT04986995|Opicapone|opicapone|mesh-list
92371832|NCT01333098|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92371833|NCT01333098|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92371834|NCT01333098|Hormone Antagonists|hormone antagonists|mesh-ancestor
92371835|NCT01333098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371836|NCT01333098|Luteolytic Agents|luteolytic agents|mesh-ancestor
92371837|NCT01333098|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92371838|NCT01333098|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92371839|NCT01333488|Magnesium Sulfate|magnesium sulfate|mesh-list
92371840|NCT01333488|Analgesics|analgesics|mesh-ancestor
92371841|NCT01333488|Sensory System Agents|sensory system agents|mesh-ancestor
92005899|NCT04892069|Insulin|insulin|mesh-list
92371842|NCT01333488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371843|NCT01333488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371844|NCT01333488|Anesthetics|anesthetics|mesh-ancestor
92371845|NCT01333488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92371846|NCT01333488|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92371847|NCT01333488|Anticonvulsants|anticonvulsants|mesh-ancestor
92371848|NCT01333488|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92371849|NCT01333488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371850|NCT01333488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371851|NCT01333488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92371852|NCT01333488|Tocolytic Agents|tocolytic agents|mesh-ancestor
92371853|NCT01333488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92371854|NCT01335204|Bavituximab|bavituximab|mesh-list
92371855|NCT01335204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92371856|NCT01335204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371857|NCT01335750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92371858|NCT01336296|Mycophenolic Acid|mycophenolic acid|mesh-list
92371859|NCT01336296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92371860|NCT01336296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371861|NCT01336296|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92371862|NCT01336296|Antitubercular Agents|antitubercular agents|mesh-ancestor
92371863|NCT01336296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92371864|NCT01336296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371865|NCT01336296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371866|NCT01336296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371867|NCT01337700|Milnacipran|milnacipran|mesh-list
92371868|NCT01337700|Levomilnacipran|levomilnacipran|mesh-list
92371869|NCT01337700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92371871|NCT01337700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92371872|NCT01337700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371873|NCT01337700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371874|NCT01337700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371875|NCT01337700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92371876|NCT01337700|Analgesics|analgesics|mesh-ancestor
92371877|NCT01337700|Sensory System Agents|sensory system agents|mesh-ancestor
92371878|NCT01337700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371879|NCT01337700|Antidepressive Agents|antidepressive agents|mesh-ancestor
92371880|NCT01337700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92371881|NCT01339260|Dexamethasone|dexamethasone|mesh-list
92371882|NCT01339260|Palonosetron|palonosetron|mesh-list
92371883|NCT01339260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371884|NCT01339260|Antiemetics|antiemetics|mesh-ancestor
92371885|NCT01339260|Autonomic Agents|autonomic agents|mesh-ancestor
92371886|NCT01339260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371887|NCT01339260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371888|NCT01339260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92371889|NCT01339260|Glucocorticoids|glucocorticoids|mesh-ancestor
92371890|NCT01339260|Hormones|hormones|mesh-ancestor
92371891|NCT01339260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92371892|NCT01339260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92371893|NCT01339260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92371894|NCT01339260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92371895|NCT01339260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92371896|NCT01339260|Serotonin Agents|serotonin agents|mesh-ancestor
92371897|NCT01339260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371898|NCT01339260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371900|NCT01340586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92371901|NCT01340586|Antithrombins|antithrombins|mesh-ancestor
92371902|NCT01340586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92371903|NCT01340586|Protease Inhibitors|protease inhibitors|mesh-ancestor
92371904|NCT01340586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371905|NCT01340586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371906|NCT01340586|Anticoagulants|anticoagulants|mesh-ancestor
92371907|NCT01342770|Pioglitazone|pioglitazone|mesh-list
92371908|NCT01342770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92371909|NCT01342770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371910|NCT01343004|Teriparatide|teriparatide|mesh-list
92371911|NCT01343004|Abaloparatide|abaloparatide|mesh-list
92006186|NCT04035187|Itraconazole|itraconazole|mesh-list
92371912|NCT01343004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92371913|NCT01343004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371914|NCT01343004|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92371915|NCT01347060|Fluticasone|fluticasone|mesh-list
92371917|NCT01347060|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92371918|NCT01347060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371919|NCT01347060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92371920|NCT01347060|Autonomic Agents|autonomic agents|mesh-ancestor
92371921|NCT01347060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371922|NCT01347060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371923|NCT01347060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92371924|NCT01347060|Respiratory System Agents|respiratory system agents|mesh-ancestor
92371925|NCT01347060|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371926|NCT01347060|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92371927|NCT01347060|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92371928|NCT01347060|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92371929|NCT01347060|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92371930|NCT01347060|Adrenergic Agents|adrenergic agents|mesh-ancestor
92371931|NCT01347060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92371932|NCT01347060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371934|NCT01351740|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92371935|NCT01351740|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92371936|NCT01351740|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92371937|NCT01351740|Protease Inhibitors|protease inhibitors|mesh-ancestor
92371938|NCT01351740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371939|NCT01351740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371940|NCT01351740|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92371941|NCT01351740|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92006379|NCT02985619|Triamcinolone|triamcinolone|mesh-list
92371942|NCT01351740|Antiviral Agents|antiviral agents|mesh-ancestor
92371943|NCT01351740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371944|NCT01351740|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92371945|NCT01351740|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92371947|NCT01353144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92371948|NCT01353144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92371950|NCT01353144|Sensory System Agents|sensory system agents|mesh-ancestor
92371951|NCT01353144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371952|NCT01353144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371953|NCT01353144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371954|NCT01353144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371955|NCT01353144|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92371956|NCT01353144|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92371957|NCT01353144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371958|NCT01353144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92371959|NCT01353144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92371960|NCT01353144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92371961|NCT01353144|Antipyretics|antipyretics|mesh-ancestor
92371962|NCT01362192|Chlorhexidine|chlorhexidine|mesh-list
92006443|NCT04930549|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92371963|NCT01362192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92371964|NCT01362192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92371965|NCT01362192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92371966|NCT01362192|Disinfectants|disinfectants|mesh-ancestor
92371967|NCT01362192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92371969|NCT01363050|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92371970|NCT01363050|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92371971|NCT01363050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92371972|NCT01363050|Analgesics|analgesics|mesh-ancestor
92371973|NCT01363050|Sensory System Agents|sensory system agents|mesh-ancestor
92371974|NCT01363050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92371975|NCT01363050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371976|NCT01363050|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92371977|NCT01363050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371978|NCT01363050|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92371979|NCT01363050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006495|NCT01398319|Ethanol|ethanol|mesh-list
92371980|NCT01363050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371982|NCT01363128|Dexamethasone|dexamethasone|mesh-list
92371983|NCT01363128|Dexamethasone acetate|dexamethasone acetate|mesh-list
92371984|NCT01363128|Cyclophosphamide|cyclophosphamide|mesh-list
92371985|NCT01363128|Doxorubicin|doxorubicin|mesh-list
92371986|NCT01363128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92371987|NCT01363128|Methotrexate|methotrexate|mesh-list
92371988|NCT01363128|Vincristine|vincristine|mesh-list
92371989|NCT01363128|Ofatumumab|ofatumumab|mesh-list
92371990|NCT01363128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92371991|NCT01363128|BB 1101|bb 1101|mesh-list
92371992|NCT01363128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92371993|NCT01363128|Immunologic Factors|immunologic factors|mesh-ancestor
92371994|NCT01363128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92371995|NCT01363128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92371996|NCT01363128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92371998|NCT01363128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92371999|NCT01363128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372000|NCT01363128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92372001|NCT01363128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372002|NCT01363128|Antiemetics|antiemetics|mesh-ancestor
92372003|NCT01363128|Autonomic Agents|autonomic agents|mesh-ancestor
92372004|NCT01363128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372005|NCT01363128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92372006|NCT01363128|Glucocorticoids|glucocorticoids|mesh-ancestor
92372007|NCT01363128|Hormones|hormones|mesh-ancestor
92372008|NCT01363128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372009|NCT01363128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92372010|NCT01363128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92372011|NCT01363128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92372012|NCT01363128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92372013|NCT01363128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372014|NCT01363128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92372015|NCT01363128|Abortifacient Agents|abortifacient agents|mesh-ancestor
92372016|NCT01363128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92372017|NCT01363128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92372018|NCT01363128|Antimetabolites|antimetabolites|mesh-ancestor
92372020|NCT01363128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92372021|NCT01363128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92372022|NCT01363128|Antiviral Agents|antiviral agents|mesh-ancestor
92372023|NCT01363128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024508|NCT05506969|Vaccines|vaccines|mesh-list
92372024|NCT01363128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92372025|NCT01363128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92372026|NCT01363128|Antimitotic Agents|antimitotic agents|mesh-ancestor
92372027|NCT01363128|Mitosis Modulators|mitosis modulators|mesh-ancestor
92372028|NCT01363128|Protease Inhibitors|protease inhibitors|mesh-ancestor
92372029|NCT01365624|Ketorolac|ketorolac|mesh-list
92372030|NCT01365624|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92372031|NCT01365624|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92372032|NCT01365624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92372033|NCT01365624|Analgesics|analgesics|mesh-ancestor
92372034|NCT01365624|Sensory System Agents|sensory system agents|mesh-ancestor
92372035|NCT01365624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372036|NCT01365624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372037|NCT01365624|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372038|NCT01365624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372039|NCT01365624|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92372040|NCT01365624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372041|NCT01365624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372042|NCT01371786|Mometasone Furoate|mometasone furoate|mesh-list
92372043|NCT01371786|Ciclesonide|ciclesonide|mesh-list
92372044|NCT01371786|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372046|NCT01371786|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92372047|NCT01371786|Glucocorticoids|glucocorticoids|mesh-ancestor
92372048|NCT01371786|Hormones|hormones|mesh-ancestor
92372049|NCT01371786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372050|NCT01371786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372051|NCT01377636|Isoproterenol|isoproterenol|mesh-list
92372052|NCT01377636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92372053|NCT01377636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92372054|NCT01377636|Adrenergic Agents|adrenergic agents|mesh-ancestor
92372055|NCT01377636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372056|NCT01377636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372057|NCT01377636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372058|NCT01377636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92372059|NCT01377636|Autonomic Agents|autonomic agents|mesh-ancestor
92372060|NCT01377636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372061|NCT01377636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92372062|NCT01377636|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372063|NCT01377636|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92372064|NCT01377636|Sympathomimetics|sympathomimetics|mesh-ancestor
92372065|NCT01377636|Protective Agents|protective agents|mesh-ancestor
92372066|NCT01378416|Decitabine|decitabine|mesh-list
92372067|NCT01378416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92372068|NCT01378416|Antimetabolites|antimetabolites|mesh-ancestor
92372069|NCT01378416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372070|NCT01378416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372071|NCT01378416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372072|NCT01379664|Sevoflurane|sevoflurane|mesh-list
92372073|NCT01379664|Isoflurane|isoflurane|mesh-list
92372074|NCT01379664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92006804|NCT03136705|Niacin|niacin|mesh-list
92372075|NCT01379664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92372076|NCT01379664|Anesthetics, General|anesthetics, general|mesh-ancestor
92372077|NCT01379664|Anesthetics|anesthetics|mesh-ancestor
92372078|NCT01379664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372079|NCT01379664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372081|NCT01380366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372082|NCT01380366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372083|NCT01387464|Bromfenac|bromfenac|mesh-list
92372084|NCT01387464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92372085|NCT01387464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92372086|NCT01387464|Analgesics|analgesics|mesh-ancestor
92372087|NCT01387464|Sensory System Agents|sensory system agents|mesh-ancestor
92372088|NCT01387464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937633|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92372089|NCT01387464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372090|NCT01387464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372091|NCT01387464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372092|NCT01388946|Ropivacaine|ropivacaine|mesh-list
92372093|NCT01388946|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372094|NCT01388946|Anesthetics|anesthetics|mesh-ancestor
92372095|NCT01388946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006927|NCT04483739|Glucocorticoids|glucocorticoids|mesh-ancestor
92372096|NCT01388946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372097|NCT01388946|Sensory System Agents|sensory system agents|mesh-ancestor
92372098|NCT01388946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372100|NCT01390818|Sirolimus|sirolimus|mesh-list
92372101|NCT01390818|MTOR Inhibitors|mtor inhibitors|mesh-list
92372102|NCT01390818|Temsirolimus|temsirolimus|mesh-list
92372103|NCT01390818|Elafin|elafin|mesh-list
92372104|NCT01390818|Protease Inhibitors|protease inhibitors|mesh-ancestor
92372105|NCT01390818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372106|NCT01390818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372107|NCT01390818|Vitamin B Complex|vitamin b complex|mesh-ancestor
92372108|NCT01390818|Vitamins|vitamins|mesh-ancestor
92372109|NCT01390818|Micronutrients|micronutrients|mesh-ancestor
92372110|NCT01390818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372111|NCT01390818|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92372112|NCT01390818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372113|NCT01390818|Immunologic Factors|immunologic factors|mesh-ancestor
92372114|NCT01390818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372115|NCT01390818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372116|NCT01390818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372117|NCT01390818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92372118|NCT01390818|Antifungal Agents|antifungal agents|mesh-ancestor
92372119|NCT01391286|Bimatoprost|bimatoprost|mesh-list
92372120|NCT01391286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92372121|NCT01391286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92372122|NCT01391364|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92372123|NCT01393392|Methadone|methadone|mesh-list
92372124|NCT01393392|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92372125|NCT01393392|Narcotics|narcotics|mesh-ancestor
92372126|NCT01393392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372127|NCT01393392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372128|NCT01393392|Analgesics|analgesics|mesh-ancestor
92372129|NCT01393392|Sensory System Agents|sensory system agents|mesh-ancestor
92372130|NCT01393392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372131|NCT01393392|Antitussive Agents|antitussive agents|mesh-ancestor
92372132|NCT01393392|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372133|NCT01393704|Vasopressins|vasopressins|mesh-list
92372134|NCT01393704|Arginine Vasopressin|arginine vasopressin|mesh-list
92372135|NCT01393704|Hemostatics|hemostatics|mesh-ancestor
92372136|NCT01393704|Coagulants|coagulants|mesh-ancestor
92372137|NCT01393704|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92372138|NCT01393704|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92372139|NCT01393704|Natriuretic Agents|natriuretic agents|mesh-ancestor
92372140|NCT01393704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372141|NCT01399008|Colchicine|colchicine|mesh-list
92372142|NCT01399008|Allopurinol|allopurinol|mesh-list
92372143|NCT01399008|Gout Suppressants|gout suppressants|mesh-ancestor
92372144|NCT01399008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007115|NCT05376865|Vitamin D|vitamin d|mesh-list
92372145|NCT01399008|Tubulin Modulators|tubulin modulators|mesh-ancestor
92372146|NCT01399008|Antimitotic Agents|antimitotic agents|mesh-ancestor
92372147|NCT01399008|Mitosis Modulators|mitosis modulators|mesh-ancestor
92372148|NCT01399008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372149|NCT01399008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372150|NCT01399008|Antimetabolites|antimetabolites|mesh-ancestor
92372151|NCT01399008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372152|NCT01399008|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92372153|NCT01399008|Antioxidants|antioxidants|mesh-ancestor
92372154|NCT01399008|Protective Agents|protective agents|mesh-ancestor
92372155|NCT01399008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372156|NCT01399866|Cycloserine|cycloserine|mesh-list
92372157|NCT01399866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92372158|NCT01399866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372159|NCT01399866|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92372160|NCT01399866|Antitubercular Agents|antitubercular agents|mesh-ancestor
92372161|NCT01399866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372162|NCT01399866|Antimetabolites|antimetabolites|mesh-ancestor
92372163|NCT01399866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007175|NCT04262869|Pemetrexed|pemetrexed|mesh-list
92372164|NCT01402050|Dinoprostone|dinoprostone|mesh-list
92372165|NCT01402050|Oxytocics|oxytocics|mesh-ancestor
92372166|NCT01402050|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92372167|NCT01402050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372168|NCT01403376|Interferons|interferons|mesh-list
92372169|NCT01403376|Interferon-beta|interferon-beta|mesh-list
92372170|NCT01403376|Teriflunomide|teriflunomide|mesh-list
92372171|NCT01403376|Interferon beta-1b|interferon beta-1b|mesh-list
92372172|NCT01403376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372173|NCT01403376|Antiviral Agents|antiviral agents|mesh-ancestor
92120044|NCT00090051|Rituximab|rituximab|mesh-list
92372174|NCT01403376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372175|NCT01403376|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92372176|NCT01403376|Immunologic Factors|immunologic factors|mesh-ancestor
92372177|NCT01403376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372178|NCT01403376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92372180|NCT01403376|Analgesics|analgesics|mesh-ancestor
92372181|NCT01403376|Sensory System Agents|sensory system agents|mesh-ancestor
92372182|NCT01403376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372183|NCT01403376|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372184|NCT01403376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372185|NCT01403376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372186|NCT01404936|Interferons|interferons|mesh-list
92372187|NCT01404936|Interferon-alpha|interferon-alpha|mesh-list
92372188|NCT01404936|Interferon alpha-2|interferon alpha-2|mesh-list
92372189|NCT01404936|Doxorubicin|doxorubicin|mesh-list
92372190|NCT01404936|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92372191|NCT01404936|Bleomycin|bleomycin|mesh-list
92372192|NCT01404936|Dacarbazine|dacarbazine|mesh-list
92372193|NCT01404936|Vinblastine|vinblastine|mesh-list
92372194|NCT01404936|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92372195|NCT01404936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372196|NCT01404936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92372197|NCT01404936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92372198|NCT01404936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372199|NCT01404936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007279|NCT01117441|Fludarabine|fludarabine|mesh-list
92372201|NCT01404936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372202|NCT01404936|Immunologic Factors|immunologic factors|mesh-ancestor
92372203|NCT01404936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372204|NCT01404936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92372206|NCT01404936|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92372207|NCT01404936|Tubulin Modulators|tubulin modulators|mesh-ancestor
92372208|NCT01404936|Antimitotic Agents|antimitotic agents|mesh-ancestor
92372209|NCT01404936|Mitosis Modulators|mitosis modulators|mesh-ancestor
92372210|NCT01410084|Vitamin D|vitamin d|mesh-list
92372211|NCT01410084|Cholecalciferol|cholecalciferol|mesh-list
92372212|NCT01410084|Vitamins|vitamins|mesh-list
92372213|NCT01410084|Vitamin E|vitamin e|mesh-list
92372214|NCT01410084|Micronutrients|micronutrients|mesh-ancestor
92372215|NCT01410084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372216|NCT01410084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92372217|NCT01410084|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92372218|NCT01410084|Antioxidants|antioxidants|mesh-ancestor
92372219|NCT01410084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372220|NCT01410084|Protective Agents|protective agents|mesh-ancestor
92372221|NCT01413516|Varenicline|varenicline|mesh-list
92372222|NCT01413516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92007436|NCT02630693|Tamoxifen|tamoxifen|mesh-list
92372223|NCT01413516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92372224|NCT01413516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92372225|NCT01413516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372226|NCT01413516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372227|NCT01413516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372228|NCT01413750|Paclitaxel|paclitaxel|mesh-list
92372229|NCT01413750|Carboplatin|carboplatin|mesh-list
92372230|NCT01413750|Vorinostat|vorinostat|mesh-list
92372231|NCT01413750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92372232|NCT01413750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372233|NCT01413750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92372234|NCT01413750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92372235|NCT01413750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92372236|NCT01413750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372237|NCT01413750|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92372238|NCT01413750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372239|NCT01417026|Oxytocin|oxytocin|mesh-list
92372240|NCT01417026|Oxytocics|oxytocics|mesh-ancestor
92372241|NCT01417026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92372242|NCT01417026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372243|NCT01420146|Trastuzumab|trastuzumab|mesh-list
92372244|NCT01420146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92372245|NCT01420146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372246|NCT01421472|Paclitaxel|paclitaxel|mesh-list
92372247|NCT01421472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92372248|NCT01421472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372249|NCT01421472|Tubulin Modulators|tubulin modulators|mesh-ancestor
92372250|NCT01421472|Antimitotic Agents|antimitotic agents|mesh-ancestor
92372251|NCT01421472|Mitosis Modulators|mitosis modulators|mesh-ancestor
92372252|NCT01421472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372253|NCT01428336|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92372254|NCT01428336|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92372256|NCT01428336|beta-Endorphin|beta-endorphin|mesh-list
92372257|NCT01428336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372259|NCT01428336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372260|NCT01428336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372261|NCT01428336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372262|NCT01429272|Aspirin|aspirin|mesh-list
92372263|NCT01429272|Minocycline|minocycline|mesh-list
92372264|NCT01429272|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92372265|NCT01429272|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92372266|NCT01429272|Analgesics|analgesics|mesh-ancestor
92372267|NCT01429272|Sensory System Agents|sensory system agents|mesh-ancestor
92372268|NCT01429272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372269|NCT01429272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372270|NCT01429272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372272|NCT01429272|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92372273|NCT01429272|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92372274|NCT01429272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372275|NCT01429272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92372276|NCT01429272|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92372277|NCT01429272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372278|NCT01429272|Antipyretics|antipyretics|mesh-ancestor
92372279|NCT01429272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372280|NCT01429272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372281|NCT01429350|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92372282|NCT01429350|Plasminogen|plasminogen|mesh-list
92372283|NCT01429350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92372284|NCT01429350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92372285|NCT01429350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372286|NCT01432236|Pregabalin|pregabalin|mesh-list
92372287|NCT01432236|Analgesics|analgesics|mesh-ancestor
92372288|NCT01432236|Sensory System Agents|sensory system agents|mesh-ancestor
92372289|NCT01432236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372290|NCT01432236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372291|NCT01432236|Anticonvulsants|anticonvulsants|mesh-ancestor
92372292|NCT01432236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92372293|NCT01432236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372294|NCT01432236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372295|NCT01432236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92372296|NCT01432236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92372297|NCT01432236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92372298|NCT01432236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372299|NCT01432236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92372300|NCT01434186|Metformin|metformin|mesh-list
92372301|NCT01434186|Saxagliptin|saxagliptin|mesh-list
92372302|NCT01434186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92372303|NCT01434186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372304|NCT01434186|Incretins|incretins|mesh-ancestor
92372305|NCT01434186|Hormones|hormones|mesh-ancestor
92372306|NCT01434186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372307|NCT01434186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92372308|NCT01434186|Protease Inhibitors|protease inhibitors|mesh-ancestor
92372309|NCT01434186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372310|NCT01434186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372311|NCT01434342|Nicotine|nicotine|mesh-list
92372312|NCT01434342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92372313|NCT01434342|Autonomic Agents|autonomic agents|mesh-ancestor
92372314|NCT01434342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372315|NCT01434342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372316|NCT01434342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92372317|NCT01434342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92372318|NCT01434342|Cholinergic Agents|cholinergic agents|mesh-ancestor
92372319|NCT01434342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372320|NCT01434342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372321|NCT01435824|Amoxicillin|amoxicillin|mesh-list
92372322|NCT01435824|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372323|NCT01435824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372324|NCT01436526|Rivaroxaban|rivaroxaban|mesh-list
92372325|NCT01436526|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92372326|NCT01436526|Antithrombins|antithrombins|mesh-ancestor
92024807|NCT02563561|Apaziquone|apaziquone|mesh-list
92372327|NCT01436526|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92372328|NCT01436526|Protease Inhibitors|protease inhibitors|mesh-ancestor
92372329|NCT01436526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372330|NCT01436526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372331|NCT01436526|Anticoagulants|anticoagulants|mesh-ancestor
92372332|NCT01438710|Tacrolimus|tacrolimus|mesh-list
92372333|NCT01438710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372334|NCT01438710|Immunologic Factors|immunologic factors|mesh-ancestor
92372335|NCT01438710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372336|NCT01438710|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92372337|NCT01438710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372338|NCT01438710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372339|NCT01443546|Leuprolide|leuprolide|mesh-list
92372340|NCT01443546|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92372341|NCT01443546|Fertility Agents|fertility agents|mesh-ancestor
92372342|NCT01443546|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92372343|NCT01443546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372344|NCT01443546|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92372345|NCT01443546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372346|NCT01444716|Ofatumumab|ofatumumab|mesh-list
92372347|NCT01444716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92372348|NCT01444716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372349|NCT01444716|Immunologic Factors|immunologic factors|mesh-ancestor
92372350|NCT01444716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372351|NCT01445028|Isotretinoin|isotretinoin|mesh-list
92372352|NCT01445028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92372353|NCT01452126|Ropivacaine|ropivacaine|mesh-list
92372354|NCT01452126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372355|NCT01452126|Anesthetics|anesthetics|mesh-ancestor
92372356|NCT01452126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008067|NCT04978181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92372357|NCT01452126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372358|NCT01452126|Sensory System Agents|sensory system agents|mesh-ancestor
92372359|NCT01452126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372360|NCT01457430|Icatibant|icatibant|mesh-list
92372361|NCT01457430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92372362|NCT01457430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92372363|NCT01457430|Analgesics|analgesics|mesh-ancestor
92372364|NCT01457430|Sensory System Agents|sensory system agents|mesh-ancestor
92372365|NCT01457430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372366|NCT01457430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372367|NCT01457430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372368|NCT01457430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372369|NCT01457430|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92372370|NCT01457430|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92372371|NCT01457430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372372|NCT01457430|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92372373|NCT01457430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372374|NCT01457430|Immunologic Factors|immunologic factors|mesh-ancestor
92372375|NCT01458990|Omeprazole|omeprazole|mesh-list
92372376|NCT01458990|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92372377|NCT01458990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92372378|NCT01458990|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92372379|NCT01458990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372380|NCT01458990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372381|NCT01460940|Lenalidomide|lenalidomide|mesh-list
92372382|NCT01460940|Panobinostat|panobinostat|mesh-list
92372383|NCT01460940|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92372384|NCT01460940|Immunologic Factors|immunologic factors|mesh-ancestor
92372385|NCT01460940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372386|NCT01460940|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92372387|NCT01460940|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92372388|NCT01460940|Growth Substances|growth substances|mesh-ancestor
92372389|NCT01460940|Growth Inhibitors|growth inhibitors|mesh-ancestor
92372390|NCT01460940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372391|NCT01460940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937638|NCT01660256|Rebamipide|rebamipide|mesh-list
92372392|NCT01460940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372394|NCT01462812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92372395|NCT01462812|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92372396|NCT01462812|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92372397|NCT01462812|Serotonin Agents|serotonin agents|mesh-ancestor
92372398|NCT01462812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372399|NCT01462812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372400|NCT01462812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372401|NCT01463202|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92372402|NCT01463202|Medroxyprogesterone|medroxyprogesterone|mesh-list
92372403|NCT01463202|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92372404|NCT01463202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92372405|NCT01463202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92372406|NCT01463202|Contraceptive Agents|contraceptive agents|mesh-ancestor
92372407|NCT01463202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92372408|NCT01463202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372409|NCT01463202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92008403|NCT04965545|Copper|copper|mesh-list
92372410|NCT01463202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92372412|NCT01463202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92372413|NCT01463202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372414|NCT01467882|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92372415|NCT01467882|Luteolytic Agents|luteolytic agents|mesh-ancestor
92372416|NCT01467882|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92372417|NCT01467882|Contraceptive Agents|contraceptive agents|mesh-ancestor
92372418|NCT01467882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92372419|NCT01467882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008460|NCT05108545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372420|NCT01467882|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92372421|NCT01467882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92372422|NCT01467882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372424|NCT01468350|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92372425|NCT01468350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372426|NCT01468350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372427|NCT01468584|Ribavirin|ribavirin|mesh-list
92372428|NCT01468584|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92372429|NCT01468584|Antimetabolites|antimetabolites|mesh-ancestor
92372430|NCT01468584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372431|NCT01468584|Antiviral Agents|antiviral agents|mesh-ancestor
92372432|NCT01468584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372433|NCT01472874|Trientine|trientine|mesh-list
92372434|NCT01472874|Chelating Agents|chelating agents|mesh-ancestor
92372435|NCT01472874|Sequestering Agents|sequestering agents|mesh-ancestor
92008528|NCT04951505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372436|NCT01472874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372437|NCT01474122|Macitentan|macitentan|mesh-list
92372438|NCT01474122|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92372439|NCT01474122|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92372440|NCT01474122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372441|NCT01474122|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92372442|NCT01474200|Furosemide|furosemide|mesh-list
92372443|NCT01474200|Diuretics|diuretics|mesh-list
92372444|NCT01474200|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92372445|NCT01474200|Natriuretic Agents|natriuretic agents|mesh-ancestor
92372446|NCT01474200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372447|NCT01474200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372448|NCT01474200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372449|NCT01474590|Doxycycline|doxycycline|mesh-list
92372451|NCT01474590|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372452|NCT01474590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372453|NCT01474590|Antimalarials|antimalarials|mesh-ancestor
92372454|NCT01474590|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92372455|NCT01474590|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92372456|NCT01474590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92372457|NCT01477320|Pantoprazole|pantoprazole|mesh-list
92372458|NCT01477320|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92372459|NCT01477320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92372460|NCT01477320|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92372461|NCT01477320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372462|NCT01477320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372463|NCT01478256|Erythromycin|erythromycin|mesh-list
92372464|NCT01478256|Erythromycin Estolate|erythromycin estolate|mesh-list
92372465|NCT01478256|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92372466|NCT01478256|Erythromycin stearate|erythromycin stearate|mesh-list
92372467|NCT01478256|Besifloxacin|besifloxacin|mesh-list
92372468|NCT01478256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372469|NCT01478256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372470|NCT01478256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92372471|NCT01478256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92372472|NCT01478256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115521|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
92372473|NCT01478256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372474|NCT01478256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92372475|NCT01478256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92372476|NCT01478256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372478|NCT01479270|Ropivacaine|ropivacaine|mesh-list
92372479|NCT01479270|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372480|NCT01479270|Anesthetics|anesthetics|mesh-ancestor
92372481|NCT01479270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372482|NCT01479270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372483|NCT01479270|Sensory System Agents|sensory system agents|mesh-ancestor
92372484|NCT01479270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372485|NCT01479270|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92372486|NCT01479270|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92372487|NCT01479270|Adrenergic Agents|adrenergic agents|mesh-ancestor
92372488|NCT01479270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372489|NCT01479270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372490|NCT01479270|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92372491|NCT01479270|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92372492|NCT01479270|Autonomic Agents|autonomic agents|mesh-ancestor
92372493|NCT01479270|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92372494|NCT01479270|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372495|NCT01479270|Mydriatics|mydriatics|mesh-ancestor
92372496|NCT01479270|Sympathomimetics|sympathomimetics|mesh-ancestor
92372497|NCT01479270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92372498|NCT01479348|Tetrahydrouridine|tetrahydrouridine|mesh-list
92372499|NCT01479348|Antimetabolites|antimetabolites|mesh-ancestor
92372500|NCT01479348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372501|NCT01483560|Metformin|metformin|mesh-list
92372502|NCT01483560|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92372503|NCT01483560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372504|NCT01484340|Nicotine|nicotine|mesh-list
92372505|NCT01484340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92372506|NCT01484340|Autonomic Agents|autonomic agents|mesh-ancestor
92372507|NCT01484340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372508|NCT01484340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372509|NCT01484340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92372510|NCT01484340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92372511|NCT01484340|Cholinergic Agents|cholinergic agents|mesh-ancestor
92372513|NCT01484340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372514|NCT01485588|hI-con1|hi-con1|mesh-list
92372515|NCT01485588|Immunoconjugates|immunoconjugates|mesh-ancestor
92372516|NCT01485588|Immunologic Factors|immunologic factors|mesh-ancestor
92372517|NCT01485588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372518|NCT01488318|Cetuximab|cetuximab|mesh-list
92372519|NCT01488318|Dasatinib|dasatinib|mesh-list
92372520|NCT01488318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92372521|NCT01488318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372522|NCT01488318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92372523|NCT01488318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372524|NCT01488318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372525|NCT01495572|Aldesleukin|aldesleukin|mesh-list
92372527|NCT01495572|Fludarabine|fludarabine|mesh-list
92372528|NCT01495572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372529|NCT01495572|Immunologic Factors|immunologic factors|mesh-ancestor
92372530|NCT01495572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372531|NCT01495572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372532|NCT01495572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92372533|NCT01495572|Alkylating Agents|alkylating agents|mesh-ancestor
92372534|NCT01495572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372535|NCT01495572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372536|NCT01495572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92372537|NCT01495572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92009026|NCT04931225|Landiolol|landiolol|mesh-list
92372538|NCT01495572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92372540|NCT01495572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372541|NCT01504854|Resveratrol|resveratrol|mesh-list
92372542|NCT01504854|Antioxidants|antioxidants|mesh-ancestor
92372543|NCT01504854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372544|NCT01504854|Protective Agents|protective agents|mesh-ancestor
92372545|NCT01504854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372546|NCT01504854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372547|NCT01504854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92372549|NCT01508832|Bupivacaine|bupivacaine|mesh-list
92372550|NCT01508832|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372552|NCT01508832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372553|NCT01508832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372554|NCT01508832|Sensory System Agents|sensory system agents|mesh-ancestor
92372555|NCT01508832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372556|NCT01508832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009164|NCT04912271|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92372557|NCT01508832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92372558|NCT01508832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92372559|NCT01508832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372560|NCT01508832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372561|NCT01511640|Pregabalin|pregabalin|mesh-list
92372562|NCT01511640|Analgesics|analgesics|mesh-ancestor
92372563|NCT01511640|Sensory System Agents|sensory system agents|mesh-ancestor
92372564|NCT01511640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372565|NCT01511640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372566|NCT01511640|Anticonvulsants|anticonvulsants|mesh-ancestor
92372567|NCT01511640|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92372568|NCT01511640|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372569|NCT01511640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372570|NCT01511640|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92372571|NCT01511640|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92372572|NCT01511640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92372573|NCT01511640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372574|NCT01511640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92372575|NCT01513122|Ritonavir|ritonavir|mesh-list
92372576|NCT01513122|Lopinavir|lopinavir|mesh-list
92372577|NCT01513122|Raltegravir Potassium|raltegravir potassium|mesh-list
92009297|NCT05229913|Esketamine|esketamine|mesh-list
92372578|NCT01513122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92372579|NCT01513122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92372580|NCT01513122|Protease Inhibitors|protease inhibitors|mesh-ancestor
92372581|NCT01513122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372582|NCT01513122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372583|NCT01513122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92372584|NCT01513122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92372585|NCT01513122|Antiviral Agents|antiviral agents|mesh-ancestor
92372586|NCT01513122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009375|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
92372587|NCT01513122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92372588|NCT01513122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92372589|NCT01513122|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92372590|NCT01513122|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92372591|NCT01513902|Tofacitinib|tofacitinib|mesh-list
92372592|NCT01513902|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92372593|NCT01513902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92372594|NCT01513902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372595|NCT01513902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372596|NCT01515540|Lidocaine|lidocaine|mesh-list
92372597|NCT01515540|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372598|NCT01515540|Anesthetics|anesthetics|mesh-ancestor
92372599|NCT01515540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009446|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372600|NCT01515540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372601|NCT01515540|Sensory System Agents|sensory system agents|mesh-ancestor
92372602|NCT01515540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372603|NCT01515540|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92372604|NCT01515540|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92372605|NCT01515540|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92372606|NCT01515540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372607|NCT01515540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372608|NCT01519284|Levodopa|levodopa|mesh-list
92372609|NCT01519284|Carbidopa|carbidopa|mesh-list
92372610|NCT01519284|Opicapone|opicapone|mesh-list
92372611|NCT01519284|Entacapone|entacapone|mesh-list
92372612|NCT01519284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92372613|NCT01519284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92372614|NCT01519284|Dopamine Agents|dopamine agents|mesh-ancestor
92372615|NCT01519284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372616|NCT01519284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009514|NCT04264663|Furazolidone|furazolidone|mesh-list
92372617|NCT01519284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372618|NCT01519284|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92372619|NCT01519284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372620|NCT01519284|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92025106|NCT05484817|Hormones|hormones|mesh-list
92372622|NCT01520454|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92372623|NCT01520454|Anticoagulants|anticoagulants|mesh-ancestor
92372624|NCT01520454|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92372625|NCT01520454|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92372626|NCT01520454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372627|NCT01520454|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92372628|NCT01520454|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92372629|NCT01520454|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92372630|NCT01520688|Fluticasone|fluticasone|mesh-list
92372631|NCT01520688|Xhance|xhance|mesh-list
92372632|NCT01520688|Budesonide|budesonide|mesh-list
92372633|NCT01520688|Beclomethasone|beclomethasone|mesh-list
92372634|NCT01520688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372635|NCT01520688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92372636|NCT01520688|Autonomic Agents|autonomic agents|mesh-ancestor
92372637|NCT01520688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372638|NCT01520688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372639|NCT01520688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92372640|NCT01520688|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372641|NCT01520688|Dermatologic Agents|dermatologic agents|mesh-ancestor
92372642|NCT01520688|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92372643|NCT01520688|Glucocorticoids|glucocorticoids|mesh-ancestor
92372645|NCT01520688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372646|NCT01521546|Eplerenone|eplerenone|mesh-list
92372647|NCT01521546|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92372648|NCT01521546|Hormone Antagonists|hormone antagonists|mesh-ancestor
92009723|NCT01573429|Hormones|hormones|mesh-ancestor
92372649|NCT01521546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372650|NCT01521546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372651|NCT01521546|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92372652|NCT01521546|Diuretics|diuretics|mesh-ancestor
92372653|NCT01521546|Natriuretic Agents|natriuretic agents|mesh-ancestor
92372655|NCT01523496|Vitamin D|vitamin d|mesh-list
92372656|NCT01523496|Ergocalciferols|ergocalciferols|mesh-list
92372657|NCT01523496|Cholecalciferol|cholecalciferol|mesh-list
92372658|NCT01523496|Calcifediol|calcifediol|mesh-list
92372659|NCT01523496|Vitamins|vitamins|mesh-list
92372660|NCT01523496|Micronutrients|micronutrients|mesh-ancestor
92372661|NCT01523496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372662|NCT01523496|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92372663|NCT01523496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92372664|NCT01526538|Cycloserine|cycloserine|mesh-list
92372665|NCT01526538|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92372666|NCT01526538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372667|NCT01526538|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92372668|NCT01526538|Antitubercular Agents|antitubercular agents|mesh-ancestor
92372669|NCT01526538|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92372670|NCT01526538|Antimetabolites|antimetabolites|mesh-ancestor
92372671|NCT01526538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372672|NCT01529502|Nitric Oxide|nitric oxide|mesh-list
92372673|NCT01529502|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92372674|NCT01529502|Autonomic Agents|autonomic agents|mesh-ancestor
92372675|NCT01529502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372676|NCT01529502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372677|NCT01529502|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92372678|NCT01529502|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372679|NCT01529502|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92372680|NCT01529502|Antioxidants|antioxidants|mesh-ancestor
92372681|NCT01529502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372682|NCT01529502|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372683|NCT01529502|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92372684|NCT01529502|Vasodilator Agents|vasodilator agents|mesh-ancestor
92372686|NCT01529502|Protective Agents|protective agents|mesh-ancestor
92372687|NCT01532700|Ofatumumab|ofatumumab|mesh-list
92372688|NCT01532700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372689|NCT01533948|Axitinib|axitinib|mesh-list
92372690|NCT01533948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009800|NCT03056495|Vorinostat|vorinostat|mesh-list
92372691|NCT01533948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92372692|NCT01533948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372693|NCT01533948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372694|NCT01534416|Bupivacaine|bupivacaine|mesh-list
92372695|NCT01534416|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372696|NCT01534416|Anesthetics|anesthetics|mesh-ancestor
92372697|NCT01534416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372698|NCT01534416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372699|NCT01534416|Sensory System Agents|sensory system agents|mesh-ancestor
92372700|NCT01534416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372701|NCT01535664|4-Aminopyridine|4-aminopyridine|mesh-list
92372702|NCT01535664|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92372703|NCT01535664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372704|NCT01535664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372705|NCT01535976|Ketamine|ketamine|mesh-list
92372706|NCT01535976|Analgesics|analgesics|mesh-ancestor
92372707|NCT01535976|Sensory System Agents|sensory system agents|mesh-ancestor
92372708|NCT01535976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372709|NCT01535976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372710|NCT01535976|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92372711|NCT01535976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92372712|NCT01535976|Anesthetics, General|anesthetics, general|mesh-ancestor
92372713|NCT01535976|Anesthetics|anesthetics|mesh-ancestor
92372714|NCT01535976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372715|NCT01535976|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92372716|NCT01535976|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92372717|NCT01535976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372718|NCT01535976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372719|NCT01536366|Repaglinide|repaglinide|mesh-list
92372720|NCT01536366|Opicapone|opicapone|mesh-list
92372721|NCT01536366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92372722|NCT01536366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372723|NCT01536366|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92372724|NCT01536366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372725|NCT01536366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372726|NCT01536366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92372727|NCT01536366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92372729|NCT01537926|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92372730|NCT01537926|Antiviral Agents|antiviral agents|mesh-ancestor
92372731|NCT01537926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372732|NCT01537926|Expectorants|expectorants|mesh-ancestor
92372733|NCT01537926|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372734|NCT01537926|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92372735|NCT01537926|Antioxidants|antioxidants|mesh-ancestor
92372736|NCT01537926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372738|NCT01537926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372739|NCT01537926|Antidotes|antidotes|mesh-ancestor
92372740|NCT01538862|Lenograstim|lenograstim|mesh-list
92372741|NCT01538862|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92372742|NCT01538862|Immunologic Factors|immunologic factors|mesh-ancestor
92372743|NCT01538862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372744|NCT01541358|Listerine|listerine|mesh-list
92372745|NCT01541358|Fluorides|fluorides|mesh-list
92372746|NCT01541358|Sodium Fluoride|sodium fluoride|mesh-list
92372747|NCT01541358|Cariostatic Agents|cariostatic agents|mesh-ancestor
92372748|NCT01541358|Protective Agents|protective agents|mesh-ancestor
92372749|NCT01541358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372750|NCT01541358|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92372751|NCT01541358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372752|NCT01542372|Prazosin|prazosin|mesh-list
92372753|NCT01542372|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92372754|NCT01542372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92372755|NCT01542372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92372756|NCT01542372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92372757|NCT01542372|Adrenergic Agents|adrenergic agents|mesh-ancestor
92372758|NCT01542372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937643|NCT01660256|Protective Agents|protective agents|mesh-ancestor
92372759|NCT01542372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372761|NCT01542684|Azacitidine|azacitidine|mesh-list
92372762|NCT01542684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92372763|NCT01542684|Antimetabolites|antimetabolites|mesh-ancestor
92372764|NCT01542684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372766|NCT01542684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372767|NCT01543074|Allyl sulfide|allyl sulfide|mesh-list
92372768|NCT01543074|Antioxidants|antioxidants|mesh-ancestor
92372769|NCT01543074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372770|NCT01543074|Protective Agents|protective agents|mesh-ancestor
92372771|NCT01543074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372772|NCT01543074|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92372773|NCT01543074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372774|NCT01543074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92372775|NCT01543074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372776|NCT01545336|Anastrozole|anastrozole|mesh-list
92372777|NCT01545336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92372778|NCT01545336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372779|NCT01545336|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92372780|NCT01545336|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92372781|NCT01545336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372782|NCT01545336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372783|NCT01545336|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92372785|NCT01545336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92372786|NCT01545336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372787|NCT01548690|Phenylacetic acid|phenylacetic acid|mesh-list
92372788|NCT01548690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92372789|NCT01548690|Antimetabolites|antimetabolites|mesh-ancestor
92372790|NCT01548690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372791|NCT01548690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372792|NCT01551888|Formoterol Fumarate|formoterol fumarate|mesh-list
92372793|NCT01551888|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92372794|NCT01551888|Autonomic Agents|autonomic agents|mesh-ancestor
92372795|NCT01551888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372796|NCT01551888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372797|NCT01551888|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92372798|NCT01551888|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372799|NCT01551888|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92372800|NCT01551888|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92372801|NCT01551888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92372802|NCT01551888|Adrenergic Agents|adrenergic agents|mesh-ancestor
92372803|NCT01551888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372804|NCT01551888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372806|NCT01553058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92372807|NCT01553058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372808|NCT01553058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372809|NCT01553292|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92372810|NCT01553292|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372811|NCT01556724|Ropivacaine|ropivacaine|mesh-list
92372812|NCT01556724|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372813|NCT01556724|Anesthetics|anesthetics|mesh-ancestor
92372814|NCT01556724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372815|NCT01556724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372816|NCT01556724|Sensory System Agents|sensory system agents|mesh-ancestor
92372817|NCT01556724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372818|NCT01558128|Amiodarone|amiodarone|mesh-list
92372819|NCT01558128|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92372820|NCT01558128|Vasodilator Agents|vasodilator agents|mesh-ancestor
92372821|NCT01558128|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92372822|NCT01558128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372823|NCT01558128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372824|NCT01558128|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92372825|NCT01558128|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92372826|NCT01558128|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92372827|NCT01558128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372828|NCT01558128|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92372829|NCT01558128|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92372830|NCT01558128|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92372832|NCT01559064|Hyaluronic Acid|hyaluronic acid|mesh-list
92372833|NCT01559064|Anesthetics, Local|anesthetics, local|mesh-ancestor
92372834|NCT01559064|Anesthetics|anesthetics|mesh-ancestor
92372835|NCT01559064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372836|NCT01559064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372837|NCT01559064|Sensory System Agents|sensory system agents|mesh-ancestor
92372838|NCT01559064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372839|NCT01559064|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92372840|NCT01559064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92372841|NCT01559064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92372842|NCT01559064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92025324|NCT02332707|Ribavirin|ribavirin|mesh-list
92372843|NCT01559064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372844|NCT01559064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92372845|NCT01559064|Immunologic Factors|immunologic factors|mesh-ancestor
92372846|NCT01559064|Viscosupplements|viscosupplements|mesh-ancestor
92372847|NCT01559064|Protective Agents|protective agents|mesh-ancestor
92372848|NCT01559922|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92372849|NCT01559922|Vasodilator Agents|vasodilator agents|mesh-ancestor
92372850|NCT01559922|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92372851|NCT01559922|Protective Agents|protective agents|mesh-ancestor
92372852|NCT01559922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372853|NCT01560624|Treprostinil|treprostinil|mesh-list
92372854|NCT01560624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92372855|NCT01562886|Rilpivirine|rilpivirine|mesh-list
92372856|NCT01562886|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92372857|NCT01562886|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92372858|NCT01562886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372859|NCT01562886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372860|NCT01562886|Antiviral Agents|antiviral agents|mesh-ancestor
92372861|NCT01562886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372862|NCT01562886|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92372863|NCT01562886|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92372864|NCT01563198|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92372865|NCT01563198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372866|NCT01563198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372867|NCT01564914|Bevacizumab|bevacizumab|mesh-list
92010502|NCT04895423|Cyclosporine|cyclosporine|mesh-list
92372868|NCT01564914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92372869|NCT01564914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372870|NCT01564914|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92372871|NCT01564914|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92372872|NCT01564914|Growth Substances|growth substances|mesh-ancestor
92372873|NCT01564914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372874|NCT01564914|Growth Inhibitors|growth inhibitors|mesh-ancestor
92372876|NCT01565538|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92372877|NCT01565538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372878|NCT01565538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372879|NCT01565538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372880|NCT01565538|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92372881|NCT01565538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92372882|NCT01565538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92372883|NCT01565616|Fludarabine|fludarabine|mesh-list
92372885|NCT01565616|Thymoglobulin|thymoglobulin|mesh-list
92372886|NCT01565616|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92372887|NCT01565616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92372888|NCT01565616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372889|NCT01565616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92372890|NCT01565616|Immunologic Factors|immunologic factors|mesh-ancestor
92010605|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92372891|NCT01565616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010668|NCT03871049|Hormones|hormones|mesh-ancestor
92372893|NCT01565616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92372894|NCT01565616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92372895|NCT01566162|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92372896|NCT01566162|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92372897|NCT01566162|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92372898|NCT01566162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372899|NCT01566162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372900|NCT01566162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92372901|NCT01566162|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92372902|NCT01566162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92372903|NCT01566162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92372904|NCT01566162|Adrenergic Agents|adrenergic agents|mesh-ancestor
92372905|NCT01566162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372906|NCT01566162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372907|NCT01566162|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92372908|NCT01566162|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92372910|NCT01566162|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92372911|NCT01566162|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92372912|NCT01566162|Dopamine Agents|dopamine agents|mesh-ancestor
92372913|NCT01569126|Fluoxetine|fluoxetine|mesh-list
92372914|NCT01569126|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92372915|NCT01569126|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92372916|NCT01569126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372917|NCT01569126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372918|NCT01569126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372919|NCT01569126|Serotonin Agents|serotonin agents|mesh-ancestor
92372920|NCT01569126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372921|NCT01569126|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92372922|NCT01569126|Antidepressive Agents|antidepressive agents|mesh-ancestor
92372923|NCT01569126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92372924|NCT01569126|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92372925|NCT01569126|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92372926|NCT01569126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92372927|NCT01569828|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92372928|NCT01569828|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92372929|NCT01569828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372930|NCT01577706|Alprazolam|alprazolam|mesh-list
92372931|NCT01577706|Dextroamphetamine|dextroamphetamine|mesh-list
92372932|NCT01577706|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92372933|NCT01577706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372934|NCT01577706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372936|NCT01577706|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92372937|NCT01577706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92372938|NCT01577706|GABA Modulators|gaba modulators|mesh-ancestor
92372939|NCT01577706|GABA Agents|gaba agents|mesh-ancestor
92372940|NCT01577706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372941|NCT01577706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372942|NCT01577706|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92372943|NCT01577706|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92372944|NCT01577706|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92372945|NCT01577706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372946|NCT01577706|Dopamine Agents|dopamine agents|mesh-ancestor
92372947|NCT01580592|Omalizumab|omalizumab|mesh-list
92372948|NCT01580592|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92372949|NCT01580592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92372950|NCT01580592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92372951|NCT01580592|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372952|NCT01580592|Immunologic Factors|immunologic factors|mesh-ancestor
92372953|NCT01580592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372954|NCT01588158|Acetaminophen|acetaminophen|mesh-list
92372955|NCT01588158|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92372956|NCT01588158|Hydrocodone|hydrocodone|mesh-list
92372957|NCT01588158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92372958|NCT01588158|Analgesics|analgesics|mesh-ancestor
92372959|NCT01588158|Sensory System Agents|sensory system agents|mesh-ancestor
92372960|NCT01588158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372961|NCT01588158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372962|NCT01588158|Antipyretics|antipyretics|mesh-ancestor
92372963|NCT01588158|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92372964|NCT01588158|Narcotics|narcotics|mesh-ancestor
92372965|NCT01588158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92372966|NCT01588158|Antitussive Agents|antitussive agents|mesh-ancestor
92372967|NCT01588158|Respiratory System Agents|respiratory system agents|mesh-ancestor
92372968|NCT01588158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92372969|NCT01588158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92372970|NCT01588158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92372971|NCT01588470|Pioglitazone|pioglitazone|mesh-list
92372972|NCT01588470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92372973|NCT01588470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372974|NCT01591746|Botulinum Toxins|botulinum toxins|mesh-list
92372975|NCT01591746|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92372976|NCT01591746|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92372977|NCT01591746|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92372978|NCT01591746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92372979|NCT01591746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92372980|NCT01591746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92372981|NCT01591746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372982|NCT01591746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372983|NCT01591746|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92010900|NCT04617067|Paclitaxel|paclitaxel|mesh-list
92372984|NCT01591746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372986|NCT05565924|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92372987|NCT05565924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372988|NCT05564832|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92372989|NCT05564832|Pilocarpine|pilocarpine|mesh-list
92372990|NCT05564832|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92372991|NCT05564832|Miotics|miotics|mesh-ancestor
92372992|NCT05564832|Autonomic Agents|autonomic agents|mesh-ancestor
92372993|NCT05564832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92372994|NCT05564832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92372995|NCT05564832|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92372996|NCT05564832|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92372997|NCT05564832|Cholinergic Agents|cholinergic agents|mesh-ancestor
92372998|NCT05564832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92372999|NCT05564832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373000|NCT05564442|Benzocaine|benzocaine|mesh-list
92373001|NCT05564442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373002|NCT05564442|Anesthetics|anesthetics|mesh-ancestor
92373004|NCT05564442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373005|NCT05564442|Sensory System Agents|sensory system agents|mesh-ancestor
92373006|NCT05564442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373007|NCT05493540|Ibuprofen|ibuprofen|mesh-list
92373008|NCT05493540|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92373009|NCT05493540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373010|NCT05493540|Analgesics|analgesics|mesh-ancestor
92373011|NCT05493540|Sensory System Agents|sensory system agents|mesh-ancestor
92373012|NCT05493540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373013|NCT05493540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373014|NCT05493540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373015|NCT05493540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373016|NCT05493540|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92373017|NCT05493540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373018|NCT05493540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373019|NCT05672784|Acetaminophen|acetaminophen|mesh-list
92373020|NCT05672784|Meloxicam|meloxicam|mesh-list
92373021|NCT05672784|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373022|NCT05672784|Analgesics|analgesics|mesh-ancestor
92373023|NCT05672784|Sensory System Agents|sensory system agents|mesh-ancestor
92373024|NCT05672784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373025|NCT05672784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373026|NCT05672784|Antipyretics|antipyretics|mesh-ancestor
92011068|NCT02613221|Panitumumab|panitumumab|mesh-list
92373027|NCT05672784|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92373028|NCT05672784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373029|NCT05672784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373030|NCT05672784|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92373031|NCT05672784|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92373032|NCT05672784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373033|NCT05672784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373035|NCT05672472|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92373036|NCT05672472|Protease Inhibitors|protease inhibitors|mesh-ancestor
92373037|NCT05672472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011146|NCT03020875|Antipyretics|antipyretics|mesh-ancestor
92373038|NCT05672472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373039|NCT05672394|Lidocaine|lidocaine|mesh-list
92373040|NCT05672394|Epinephrine|epinephrine|mesh-list
92373041|NCT05672394|Bupivacaine|bupivacaine|mesh-list
92373042|NCT05672394|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373043|NCT05672394|Anesthetics|anesthetics|mesh-ancestor
91937647|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
92373044|NCT05672394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373045|NCT05672394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373046|NCT05672394|Sensory System Agents|sensory system agents|mesh-ancestor
92373047|NCT05672394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373048|NCT05672394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92373049|NCT05672394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92373051|NCT05672394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373052|NCT05672394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373053|NCT05672394|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92373054|NCT05672394|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92373055|NCT05672394|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373056|NCT05672394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373057|NCT05672394|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92373058|NCT05672394|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92373059|NCT05672394|Autonomic Agents|autonomic agents|mesh-ancestor
92373060|NCT05672394|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92373061|NCT05672394|Respiratory System Agents|respiratory system agents|mesh-ancestor
92373062|NCT05672394|Mydriatics|mydriatics|mesh-ancestor
92373063|NCT05672394|Sympathomimetics|sympathomimetics|mesh-ancestor
92373064|NCT05672394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92373065|NCT05607342|SR 142801|sr 142801|mesh-list
92373066|NCT05607342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92373067|NCT05607342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373068|NCT05607342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373069|NCT05607342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373070|NCT05607342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373071|NCT05326464|Tofacitinib|tofacitinib|mesh-list
92373072|NCT05326464|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92373073|NCT05326464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92373074|NCT05326464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373075|NCT05326464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373076|NCT04887792|Acetazolamide|acetazolamide|mesh-list
92373077|NCT04887792|Anticonvulsants|anticonvulsants|mesh-ancestor
92373078|NCT04887792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92373079|NCT04887792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011352|NCT01371981|Analgesics|analgesics|mesh-ancestor
92373080|NCT04887792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373081|NCT04887792|Diuretics|diuretics|mesh-ancestor
92373082|NCT04887792|Natriuretic Agents|natriuretic agents|mesh-ancestor
92373083|NCT04887792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373084|NCT04518228|Ritonavir|ritonavir|mesh-list
92373085|NCT04518228|Lopinavir|lopinavir|mesh-list
92373086|NCT04518228|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92373087|NCT04518228|Darunavir|darunavir|mesh-list
92373088|NCT04518228|Tenofovir|tenofovir|mesh-list
92373089|NCT04518228|Dolutegravir|dolutegravir|mesh-list
92373090|NCT04518228|Cobicistat|cobicistat|mesh-list
92373091|NCT04518228|Cabotegravir|cabotegravir|mesh-list
92373092|NCT04518228|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92373093|NCT04518228|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92373094|NCT04518228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92373095|NCT04518228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373096|NCT04518228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373097|NCT04518228|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92373098|NCT04518228|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92373099|NCT04518228|Antiviral Agents|antiviral agents|mesh-ancestor
92373100|NCT04518228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373101|NCT04518228|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92373102|NCT04518228|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92373103|NCT04518228|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92373104|NCT04518228|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92373105|NCT04518228|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92373106|NCT04518228|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92373107|NCT03729258|Amantadine|amantadine|mesh-list
92373108|NCT03729258|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92373109|NCT03729258|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92373111|NCT03729258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373112|NCT03729258|Dopamine Agents|dopamine agents|mesh-ancestor
92373113|NCT03729258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373114|NCT03729258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373115|NCT03729258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373116|NCT03729258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373118|NCT03729258|Sensory System Agents|sensory system agents|mesh-ancestor
92373119|NCT03729258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373120|NCT03355170|Domperidone|domperidone|mesh-list
92373121|NCT03355170|Lansoprazole|lansoprazole|mesh-list
92373122|NCT03355170|Dexlansoprazole|dexlansoprazole|mesh-list
92373123|NCT03355170|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92373124|NCT03355170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373125|NCT03355170|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92373126|NCT03355170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373127|NCT03355170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373129|NCT03355170|Autonomic Agents|autonomic agents|mesh-ancestor
92373130|NCT03355170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373131|NCT03355170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373132|NCT03355170|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92373133|NCT03355170|Dopamine Agents|dopamine agents|mesh-ancestor
92373134|NCT03355170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373135|NCT02760498|Cemiplimab|cemiplimab|mesh-list
92373136|NCT02760498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373137|NCT02760498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373138|NCT02538666|Nivolumab|nivolumab|mesh-list
92373139|NCT02538666|Ipilimumab|ipilimumab|mesh-list
92025622|NCT05563571|Prednisolone|prednisolone|mesh-list
92373140|NCT02538666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373141|NCT02538666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373142|NCT02538666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92373143|NCT02538666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373144|NCT02407236|Ustekinumab|ustekinumab|mesh-list
92373145|NCT02407236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373146|NCT00221598|Dialysis Solutions|dialysis solutions|mesh-list
92373147|NCT00221598|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92373148|NCT05120076|Dexamethasone|dexamethasone|mesh-list
92373149|NCT05120076|Dexamethasone acetate|dexamethasone acetate|mesh-list
92373150|NCT05120076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373151|NCT05120076|Antiemetics|antiemetics|mesh-ancestor
92373152|NCT05120076|Autonomic Agents|autonomic agents|mesh-ancestor
92373153|NCT05120076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373154|NCT05120076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373155|NCT05120076|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373156|NCT05120076|Glucocorticoids|glucocorticoids|mesh-ancestor
92373157|NCT05120076|Hormones|hormones|mesh-ancestor
92373158|NCT05120076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373159|NCT05120076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92373160|NCT05120076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373161|NCT05094804|Docetaxel|docetaxel|mesh-list
92373162|NCT05094804|Cemiplimab|cemiplimab|mesh-list
92373163|NCT05094804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373164|NCT05094804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92373165|NCT05094804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92373166|NCT05094804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92373167|NCT05094804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373168|NCT05094804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373169|NCT04873596|Midazolam|midazolam|mesh-list
92373170|NCT04873596|Dexmedetomidine|dexmedetomidine|mesh-list
92373171|NCT04873596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373172|NCT04873596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373173|NCT04873596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373174|NCT04873596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373176|NCT04873596|Sensory System Agents|sensory system agents|mesh-ancestor
92373177|NCT04873596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373178|NCT04873596|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92373179|NCT04873596|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92373180|NCT04873596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92373181|NCT04873596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373182|NCT04873596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373183|NCT04873596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373184|NCT04873596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92373185|NCT04873596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92373186|NCT04873596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373187|NCT04873596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373188|NCT04873596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373189|NCT04873596|Anesthetics, General|anesthetics, general|mesh-ancestor
92373190|NCT04873596|Anesthetics|anesthetics|mesh-ancestor
92373191|NCT04873596|GABA Modulators|gaba modulators|mesh-ancestor
92373192|NCT04873596|GABA Agents|gaba agents|mesh-ancestor
92373193|NCT04868760|Ipilimumab|ipilimumab|mesh-list
92373194|NCT04868760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373195|NCT04868760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373196|NCT04868760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92373197|NCT04868760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373198|NCT04508166|Sodium Oxybate|sodium oxybate|mesh-list
92373199|NCT04508166|Dexmedetomidine|dexmedetomidine|mesh-list
92373200|NCT04508166|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373201|NCT04508166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373202|NCT04508166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373203|NCT04508166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373204|NCT04508166|Analgesics|analgesics|mesh-ancestor
92373205|NCT04508166|Sensory System Agents|sensory system agents|mesh-ancestor
92373206|NCT04508166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373207|NCT04508166|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92373208|NCT04508166|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92373210|NCT04508166|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373211|NCT04508166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373212|NCT04508166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373213|NCT04508166|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92373214|NCT04508166|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92025707|NCT05562869|Abatacept|abatacept|mesh-list
92373215|NCT04508166|Anesthetics, General|anesthetics, general|mesh-ancestor
92373216|NCT04508166|Anesthetics|anesthetics|mesh-ancestor
92373217|NCT04444440|Ciprofloxacin|ciprofloxacin|mesh-list
92373218|NCT04444440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92373219|NCT04444440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373220|NCT04444440|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92373221|NCT04444440|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92373222|NCT04444440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984724|NCT02680847|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92373223|NCT04444440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373224|NCT04444440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373225|NCT04444440|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92373226|NCT04444440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92373227|NCT04175964|Metformin|metformin|mesh-list
92373228|NCT04175964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92373229|NCT04175964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373230|NCT03624270|Ascorbic Acid|ascorbic acid|mesh-list
92373231|NCT03624270|Arsenic Trioxide|arsenic trioxide|mesh-list
92373232|NCT03624270|Antioxidants|antioxidants|mesh-ancestor
92373233|NCT03624270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373234|NCT03624270|Protective Agents|protective agents|mesh-ancestor
92018985|NCT02576639|Umibecestat|umibecestat|mesh-list
92373235|NCT03624270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373237|NCT03624270|Micronutrients|micronutrients|mesh-ancestor
92373238|NCT03624270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373239|NCT03498066|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92373240|NCT03498066|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92373241|NCT03498066|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373242|NCT03498066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373243|NCT03498066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373244|NCT03498066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373245|NCT03455088|Fluoxetine|fluoxetine|mesh-list
92019052|NCT05474183|Ketamine|ketamine|mesh-list
92373246|NCT03455088|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92373247|NCT03455088|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92373248|NCT03455088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373249|NCT03455088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373251|NCT03455088|Serotonin Agents|serotonin agents|mesh-ancestor
92373252|NCT03455088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373253|NCT03455088|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92373254|NCT03455088|Antidepressive Agents|antidepressive agents|mesh-ancestor
92373255|NCT03455088|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373256|NCT03455088|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92373257|NCT03455088|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92373258|NCT03455088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373260|NCT03355560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373261|NCT03355560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373262|NCT03355560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91937650|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
92373263|NCT03355560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373265|NCT01600170|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92373266|NCT01600170|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92373267|NCT01600170|Antimetabolites|antimetabolites|mesh-ancestor
92373268|NCT01600170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373269|NCT01600170|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92373270|NCT01600170|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92373271|NCT01600170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373272|NCT01600950|Insulin Glargine|insulin glargine|mesh-list
92373273|NCT01600950|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92373274|NCT01600950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373275|NCT01605942|Dexamethasone|dexamethasone|mesh-list
92373276|NCT01605942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373277|NCT01605942|Antiemetics|antiemetics|mesh-ancestor
92373278|NCT01605942|Autonomic Agents|autonomic agents|mesh-ancestor
92373279|NCT01605942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373280|NCT01605942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373281|NCT01605942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373282|NCT01605942|Glucocorticoids|glucocorticoids|mesh-ancestor
92373283|NCT01605942|Hormones|hormones|mesh-ancestor
92373284|NCT01605942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373285|NCT01605942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92373286|NCT01605942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019368|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373288|NCT01608672|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92373289|NCT01608672|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92373290|NCT01608672|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92373291|NCT01608672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373292|NCT01608672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373293|NCT01608672|Cholinergic Agents|cholinergic agents|mesh-ancestor
92373294|NCT01608672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373295|NCT01608672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373296|NCT01608672|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92373297|NCT01608672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373298|NCT01610154|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92373299|NCT01610154|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92373300|NCT01610154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373301|NCT01610154|Incretins|incretins|mesh-ancestor
92373302|NCT01610154|Hormones|hormones|mesh-ancestor
92373303|NCT01610154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373304|NCT01610154|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92373305|NCT01610154|Protease Inhibitors|protease inhibitors|mesh-ancestor
92373306|NCT01610154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373307|NCT01610154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373309|NCT01611948|Antiemetics|antiemetics|mesh-ancestor
92373310|NCT01611948|Autonomic Agents|autonomic agents|mesh-ancestor
92373311|NCT01611948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373312|NCT01611948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373313|NCT01611948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373314|NCT01611948|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92019439|NCT05231941|Lidocaine|lidocaine|mesh-list
92373315|NCT01611948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373316|NCT01611948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373317|NCT01612884|Clopidogrel|clopidogrel|mesh-list
92373318|NCT01612884|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92373319|NCT01612884|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92373320|NCT01612884|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92373321|NCT01612884|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92373322|NCT01612884|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92373323|NCT01612884|Purinergic Agents|purinergic agents|mesh-ancestor
92373324|NCT01612884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373325|NCT01612884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373326|NCT01612884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373327|NCT01614210|Tamoxifen|tamoxifen|mesh-list
92373328|NCT01614210|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92373329|NCT01614210|Hormone Antagonists|hormone antagonists|mesh-ancestor
92373330|NCT01614210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373331|NCT01614210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373332|NCT01614210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92373333|NCT01614210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373334|NCT01614210|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92373335|NCT01614210|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92373336|NCT01614210|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92373337|NCT01616082|Phentermine|phentermine|mesh-list
92373338|NCT01616082|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92373339|NCT01616082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373340|NCT01616082|Appetite Depressants|appetite depressants|mesh-ancestor
92019622|NCT04622735|Antipyretics|antipyretics|mesh-ancestor
92373341|NCT01616082|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92373342|NCT01616082|Sympathomimetics|sympathomimetics|mesh-ancestor
92373343|NCT01616082|Autonomic Agents|autonomic agents|mesh-ancestor
92373344|NCT01616082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373345|NCT01616082|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373346|NCT01616082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373347|NCT01616082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373348|NCT01616160|Mometasone Furoate|mometasone furoate|mesh-list
92373349|NCT01616160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373350|NCT01616160|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373351|NCT01616160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92373353|NCT01619982|Cefazolin|cefazolin|mesh-list
92373354|NCT01619982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92373355|NCT01619982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373356|NCT01620216|Sorafenib|sorafenib|mesh-list
92373357|NCT01620216|Sunitinib|sunitinib|mesh-list
92373358|NCT01620216|Dasatinib|dasatinib|mesh-list
92373359|NCT01620216|Ponatinib|ponatinib|mesh-list
92373360|NCT01620216|Idelalisib|idelalisib|mesh-list
92373361|NCT01620216|Antineoplastic Agents|antineoplastic agents|mesh-list
92373362|NCT01620216|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92373363|NCT01620216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92373364|NCT01620216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019690|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
92373365|NCT01620216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373366|NCT01620216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019742|NCT04868227|Vitamins|vitamins|mesh-ancestor
92373367|NCT01620216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92373369|NCT01620216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373370|NCT01620216|Growth Inhibitors|growth inhibitors|mesh-ancestor
92373371|NCT01621230|Fentanyl|fentanyl|mesh-list
92373372|NCT01621230|Bupivacaine|bupivacaine|mesh-list
92373373|NCT01621230|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373374|NCT01621230|Anesthetics|anesthetics|mesh-ancestor
92373375|NCT01621230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373376|NCT01621230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373377|NCT01621230|Sensory System Agents|sensory system agents|mesh-ancestor
92373378|NCT01621230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373379|NCT01621230|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92373380|NCT01621230|Narcotics|narcotics|mesh-ancestor
92373381|NCT01621230|Analgesics|analgesics|mesh-ancestor
92373382|NCT01621230|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92373383|NCT01621230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373384|NCT01621230|Anesthetics, General|anesthetics, general|mesh-ancestor
92373385|NCT01621776|Insulin|insulin|mesh-list
92373386|NCT01621776|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92373387|NCT01621776|Insulin Aspart|insulin aspart|mesh-list
92373388|NCT01621776|Insulin Lispro|insulin lispro|mesh-list
92373389|NCT01621776|Insulin glulisine|insulin glulisine|mesh-list
92373390|NCT01621776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92373391|NCT01621776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373392|NCT01631682|Propranolol|propranolol|mesh-list
92373393|NCT01631682|Oxytocin|oxytocin|mesh-list
92373394|NCT01631682|Mifepristone|mifepristone|mesh-list
92373395|NCT01631682|Oxytocics|oxytocics|mesh-ancestor
92373396|NCT01631682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92373397|NCT01631682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373398|NCT01631682|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92373399|NCT01631682|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92019866|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
92373400|NCT01631682|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373401|NCT01631682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373402|NCT01631682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373403|NCT01631682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92373404|NCT01631682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92373405|NCT01631682|Vasodilator Agents|vasodilator agents|mesh-ancestor
92373406|NCT01631682|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92373407|NCT01631682|Abortifacient Agents|abortifacient agents|mesh-ancestor
92373408|NCT01631682|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92373409|NCT01631682|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92373410|NCT01631682|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92373411|NCT01631682|Contraceptive Agents|contraceptive agents|mesh-ancestor
92373412|NCT01631682|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92373413|NCT01631682|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92373414|NCT01631682|Hormone Antagonists|hormone antagonists|mesh-ancestor
92019931|NCT05514275|Growth Substances|growth substances|mesh-ancestor
92373415|NCT01631682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373416|NCT01631682|Luteolytic Agents|luteolytic agents|mesh-ancestor
92373417|NCT01631682|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92373418|NCT01631682|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92373420|NCT01635504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92373421|NCT01635504|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92373422|NCT01635504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92373423|NCT01635504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373424|NCT01635504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373425|NCT01635504|Cholinergic Agents|cholinergic agents|mesh-ancestor
92373426|NCT01635504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373427|NCT01635504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373428|NCT01635504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92373429|NCT01635504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373430|NCT01636206|Lifitegrast|lifitegrast|mesh-list
92373431|NCT01636206|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92373432|NCT01636206|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92373433|NCT01639872|Risperidone|risperidone|mesh-list
92373434|NCT01639872|Clozapine|clozapine|mesh-list
92373435|NCT01639872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92373437|NCT01639872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373438|NCT01639872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373439|NCT01639872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373440|NCT01639872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92373441|NCT01639872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373442|NCT01639872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373443|NCT01639872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373444|NCT01639872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92373445|NCT01639872|Dopamine Agents|dopamine agents|mesh-ancestor
92373446|NCT01639872|GABA Antagonists|gaba antagonists|mesh-ancestor
92373448|NCT01640340|Dexamethasone|dexamethasone|mesh-list
92373449|NCT01640340|Ondansetron|ondansetron|mesh-list
92373450|NCT01640340|Aprepitant|aprepitant|mesh-list
92373451|NCT01640340|Palonosetron|palonosetron|mesh-list
92373452|NCT01640340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373454|NCT01640340|Autonomic Agents|autonomic agents|mesh-ancestor
92373455|NCT01640340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373456|NCT01640340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373457|NCT01640340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373458|NCT01640340|Glucocorticoids|glucocorticoids|mesh-ancestor
92373459|NCT01640340|Hormones|hormones|mesh-ancestor
92373460|NCT01640340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373461|NCT01640340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92373462|NCT01640340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373463|NCT01640340|Antipruritics|antipruritics|mesh-ancestor
92373464|NCT01640340|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373465|NCT01640340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92373466|NCT01640340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92373467|NCT01640340|Serotonin Agents|serotonin agents|mesh-ancestor
92373468|NCT01640340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373469|NCT01640340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373470|NCT01640340|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92373472|NCT01641120|Interferon-beta|interferon-beta|mesh-list
92373473|NCT01641120|Interferon beta-1a|interferon beta-1a|mesh-list
92373474|NCT01641120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373475|NCT01641120|Antiviral Agents|antiviral agents|mesh-ancestor
92373476|NCT01641120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373477|NCT01641120|Immunologic Factors|immunologic factors|mesh-ancestor
92373478|NCT01641120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373479|NCT01641120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92373480|NCT01643382|Insulin|insulin|mesh-list
92373481|NCT01643382|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92373482|NCT01643382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92373483|NCT01643382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373484|NCT01643616|Midazolam|midazolam|mesh-list
92373485|NCT01643616|Ropivacaine|ropivacaine|mesh-list
92373486|NCT01643616|Prilocaine|prilocaine|mesh-list
92373487|NCT01643616|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373488|NCT01643616|Anesthetics|anesthetics|mesh-ancestor
92373489|NCT01643616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373490|NCT01643616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373491|NCT01643616|Sensory System Agents|sensory system agents|mesh-ancestor
92020257|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92373492|NCT01643616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373493|NCT01643616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92373494|NCT01643616|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373495|NCT01643616|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92373496|NCT01643616|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373497|NCT01643616|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373498|NCT01643616|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373499|NCT01643616|Anesthetics, General|anesthetics, general|mesh-ancestor
92373500|NCT01643616|GABA Modulators|gaba modulators|mesh-ancestor
92373501|NCT01643616|GABA Agents|gaba agents|mesh-ancestor
92373502|NCT01643616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020311|NCT02612779|Nivolumab|nivolumab|mesh-list
92373503|NCT01643616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373505|NCT01644396|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92373506|NCT01644396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373507|NCT01644396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373508|NCT01645098|Dexmedetomidine|dexmedetomidine|mesh-list
92373509|NCT01645098|Ketamine|ketamine|mesh-list
92373510|NCT01645098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373511|NCT01645098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373512|NCT01645098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373513|NCT01645098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373514|NCT01645098|Analgesics|analgesics|mesh-ancestor
92373515|NCT01645098|Sensory System Agents|sensory system agents|mesh-ancestor
92373516|NCT01645098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373517|NCT01645098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92373518|NCT01645098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92373519|NCT01645098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92373520|NCT01645098|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373521|NCT01645098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373522|NCT01645098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373523|NCT01645098|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92373524|NCT01645098|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373525|NCT01645098|Anesthetics, General|anesthetics, general|mesh-ancestor
92373526|NCT01645098|Anesthetics|anesthetics|mesh-ancestor
92373527|NCT01645098|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92373528|NCT01645098|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92373529|NCT01650402|Antihypertensive Agents|antihypertensive agents|mesh-list
92373530|NCT01651806|Tranexamic Acid|tranexamic acid|mesh-list
92373531|NCT01651806|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92373532|NCT01651806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92373533|NCT01651806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373534|NCT01651806|Hemostatics|hemostatics|mesh-ancestor
92373535|NCT01651806|Coagulants|coagulants|mesh-ancestor
92373536|NCT01652040|Methyltestosterone|methyltestosterone|mesh-list
92373537|NCT01652040|Testosterone|testosterone|mesh-list
92373538|NCT01652040|Testosterone undecanoate|testosterone undecanoate|mesh-list
92373539|NCT01652040|Testosterone enanthate|testosterone enanthate|mesh-list
92373540|NCT01652040|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92373541|NCT01652040|Androgens|androgens|mesh-ancestor
92373542|NCT01652040|Hormones|hormones|mesh-ancestor
92373543|NCT01652040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373544|NCT01652040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373545|NCT01652040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92373546|NCT01652040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373547|NCT01652040|Anabolic Agents|anabolic agents|mesh-ancestor
92373549|NCT01652976|Fluorouracil|fluorouracil|mesh-list
92373550|NCT01652976|Oxaliplatin|oxaliplatin|mesh-list
92373551|NCT01652976|Dasatinib|dasatinib|mesh-list
92373552|NCT01652976|Antimetabolites|antimetabolites|mesh-ancestor
92373553|NCT01652976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373554|NCT01652976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92373555|NCT01652976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373556|NCT01652976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92373557|NCT01652976|Immunologic Factors|immunologic factors|mesh-ancestor
92373558|NCT01652976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373559|NCT01652976|Antidotes|antidotes|mesh-ancestor
92373560|NCT01652976|Protective Agents|protective agents|mesh-ancestor
92373561|NCT01652976|Vitamin B Complex|vitamin b complex|mesh-ancestor
92373563|NCT01652976|Micronutrients|micronutrients|mesh-ancestor
92373564|NCT01652976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92373565|NCT01652976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373567|NCT01656252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92373568|NCT01656252|Antimetabolites|antimetabolites|mesh-ancestor
92373569|NCT01656252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373570|NCT01656252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373571|NCT01656252|Antiviral Agents|antiviral agents|mesh-ancestor
92373572|NCT01656252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373573|NCT01656252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92373574|NCT01656252|Immunologic Factors|immunologic factors|mesh-ancestor
92373575|NCT01656252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373576|NCT01661088|Folfirinox|folfirinox|mesh-list
92373577|NCT01661088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373578|NCT01661946|Bevacizumab|bevacizumab|mesh-list
92373579|NCT01661946|Ranibizumab|ranibizumab|mesh-list
92373580|NCT01661946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373581|NCT01661946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373582|NCT01661946|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92373583|NCT01661946|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92373584|NCT01661946|Growth Substances|growth substances|mesh-ancestor
92373585|NCT01661946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373586|NCT01661946|Growth Inhibitors|growth inhibitors|mesh-ancestor
92373587|NCT01663272|Gemcitabine|gemcitabine|mesh-list
92373588|NCT01663272|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92373589|NCT01663272|Antimetabolites|antimetabolites|mesh-ancestor
92020853|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373590|NCT01663272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373591|NCT01663272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373592|NCT01667796|Vitamin D|vitamin d|mesh-list
92373593|NCT01667796|Cholecalciferol|cholecalciferol|mesh-list
92373594|NCT01667796|Vitamins|vitamins|mesh-ancestor
92373595|NCT01667796|Micronutrients|micronutrients|mesh-ancestor
92373596|NCT01667796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373597|NCT01667796|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92373598|NCT01667796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92373599|NCT01668030|Bacitracin|bacitracin|mesh-list
92373600|NCT01668030|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92120045|NCT00090051|Fludarabine|fludarabine|mesh-list
92373601|NCT01668030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373602|NCT01668030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92373603|NCT01669434|Ramipril|ramipril|mesh-list
92373604|NCT01669434|Enalapril|enalapril|mesh-list
92373605|NCT01669434|Enalaprilat|enalaprilat|mesh-list
92373606|NCT01669434|Lisinopril|lisinopril|mesh-list
92373607|NCT01669434|Perindopril|perindopril|mesh-list
92373608|NCT01669434|Benazepril|benazepril|mesh-list
92373609|NCT01669434|Captopril|captopril|mesh-list
92373610|NCT01669434|Quinapril|quinapril|mesh-list
92373611|NCT01669434|Trandolapril|trandolapril|mesh-list
92373612|NCT01669434|Fosinopril|fosinopril|mesh-list
92373613|NCT01669434|Moexipril|moexipril|mesh-list
92373614|NCT01669434|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92373615|NCT01669434|Protease Inhibitors|protease inhibitors|mesh-ancestor
92373616|NCT01669434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373617|NCT01669434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373618|NCT01669434|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92373619|NCT01669434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92373620|NCT01669434|Protective Agents|protective agents|mesh-ancestor
92373621|NCT01669434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373622|NCT01678794|Candesartan|candesartan|mesh-list
92373623|NCT01678794|Candesartan cilexetil|candesartan cilexetil|mesh-list
92373624|NCT01678794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92373625|NCT01678794|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92373626|NCT01678794|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92373627|NCT01678794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373628|NCT01680900|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92373629|NCT01680900|Antidepressive Agents|antidepressive agents|mesh-ancestor
92373630|NCT01680900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373631|NCT01680900|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92373632|NCT01680900|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92373633|NCT01680900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373634|NCT01680900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373635|NCT01680900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373636|NCT01680900|Serotonin Agents|serotonin agents|mesh-ancestor
92373637|NCT01680900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373638|NCT01680900|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92373639|NCT01680900|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92373640|NCT01682538|Nitisinone|nitisinone|mesh-list
92373641|NCT01682538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373642|NCT01682538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373643|NCT01684020|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92373644|NCT01684020|Hemostatics|hemostatics|mesh-ancestor
92373645|NCT01684020|Coagulants|coagulants|mesh-ancestor
92373646|NCT01684410|Protease Inhibitors|protease inhibitors|mesh-list
92373647|NCT01684410|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92373648|NCT01684410|Protein C Inhibitor|protein c inhibitor|mesh-list
92373649|NCT01684410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373650|NCT01684410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373651|NCT01684410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92373652|NCT01684410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92373653|NCT01689324|Vaccines|vaccines|mesh-list
92373654|NCT01689324|Immunologic Factors|immunologic factors|mesh-ancestor
92373655|NCT01689324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373656|NCT01692756|Triamcinolone|triamcinolone|mesh-list
92373657|NCT01692756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92373658|NCT01692756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92373659|NCT01692756|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92373660|NCT01692756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92373661|NCT01692756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373662|NCT01692756|Glucocorticoids|glucocorticoids|mesh-ancestor
92373663|NCT01692756|Hormones|hormones|mesh-ancestor
92373664|NCT01692756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373665|NCT01692756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373666|NCT01692756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92373667|NCT01692756|Immunologic Factors|immunologic factors|mesh-ancestor
92373668|NCT01692756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373669|NCT01692756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373671|NCT01695330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373672|NCT01701102|Fentanyl|fentanyl|mesh-list
92373673|NCT01701102|Mepivacaine|mepivacaine|mesh-list
92373674|NCT01701102|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92373675|NCT01701102|Narcotics|narcotics|mesh-ancestor
92373676|NCT01701102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373677|NCT01701102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373678|NCT01701102|Analgesics|analgesics|mesh-ancestor
92373679|NCT01701102|Sensory System Agents|sensory system agents|mesh-ancestor
92373680|NCT01701102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373681|NCT01701102|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92373682|NCT01701102|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373683|NCT01701102|Anesthetics, General|anesthetics, general|mesh-ancestor
92373684|NCT01701102|Anesthetics|anesthetics|mesh-ancestor
92373685|NCT01701102|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373686|NCT01701414|Bupivacaine|bupivacaine|mesh-list
92373687|NCT01701414|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373688|NCT01701414|Anesthetics|anesthetics|mesh-ancestor
92373689|NCT01701414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021223|NCT04807543|Castor Oil|castor oil|mesh-list
92373690|NCT01701414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373691|NCT01701414|Sensory System Agents|sensory system agents|mesh-ancestor
92373692|NCT01701414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373693|NCT01706952|Epinephrine|epinephrine|mesh-list
92373694|NCT01706952|Racepinephrine|racepinephrine|mesh-list
92373695|NCT01706952|Cocaine|cocaine|mesh-list
92373696|NCT01706952|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92373697|NCT01706952|Epinephryl borate|epinephryl borate|mesh-list
92373698|NCT01706952|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92373699|NCT01706952|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92373700|NCT01706952|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373701|NCT01706952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373702|NCT01706952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373703|NCT01706952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373704|NCT01706952|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92373705|NCT01706952|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92373706|NCT01706952|Autonomic Agents|autonomic agents|mesh-ancestor
92373707|NCT01706952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373708|NCT01706952|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92373709|NCT01706952|Respiratory System Agents|respiratory system agents|mesh-ancestor
92373710|NCT01706952|Mydriatics|mydriatics|mesh-ancestor
92373711|NCT01706952|Sympathomimetics|sympathomimetics|mesh-ancestor
92373712|NCT01706952|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92373713|NCT01706952|Anesthetics, Local|anesthetics, local|mesh-ancestor
92373714|NCT01706952|Anesthetics|anesthetics|mesh-ancestor
92373715|NCT01706952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373717|NCT01706952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92373718|NCT01706952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92373719|NCT01706952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373720|NCT01706952|Dopamine Agents|dopamine agents|mesh-ancestor
92373721|NCT01707420|Gabapentin|gabapentin|mesh-list
92373722|NCT01707420|Analgesics|analgesics|mesh-ancestor
92373723|NCT01707420|Sensory System Agents|sensory system agents|mesh-ancestor
92373724|NCT01707420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373725|NCT01707420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373726|NCT01707420|Anticonvulsants|anticonvulsants|mesh-ancestor
92373727|NCT01707420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92373728|NCT01707420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373729|NCT01707420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373730|NCT01707420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373731|NCT01707420|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92373732|NCT01707420|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92021326|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92373733|NCT01707420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373734|NCT01707420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373735|NCT01707420|Antimanic Agents|antimanic agents|mesh-ancestor
92373736|NCT01708122|Fentanyl|fentanyl|mesh-list
92373737|NCT01708122|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92373738|NCT01708122|Narcotics|narcotics|mesh-ancestor
92373739|NCT01708122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373740|NCT01708122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373741|NCT01708122|Analgesics|analgesics|mesh-ancestor
92373742|NCT01708122|Sensory System Agents|sensory system agents|mesh-ancestor
92373743|NCT01708122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373744|NCT01708122|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92021447|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
92373745|NCT01708122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373746|NCT01708122|Anesthetics, General|anesthetics, general|mesh-ancestor
92373747|NCT01708122|Anesthetics|anesthetics|mesh-ancestor
92373748|NCT01708278|Folic Acid|folic acid|mesh-list
92373749|NCT01708278|Quercetin|quercetin|mesh-list
92373750|NCT01708278|Hematinics|hematinics|mesh-ancestor
92373751|NCT01708278|Vitamin B Complex|vitamin b complex|mesh-ancestor
92373752|NCT01708278|Vitamins|vitamins|mesh-ancestor
92373753|NCT01708278|Micronutrients|micronutrients|mesh-ancestor
92373754|NCT01708278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373755|NCT01708278|Antioxidants|antioxidants|mesh-ancestor
92373756|NCT01708278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373757|NCT01708278|Protective Agents|protective agents|mesh-ancestor
92373758|NCT01708590|Brodalumab|brodalumab|mesh-list
92373759|NCT01708590|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92373760|NCT01708590|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373761|NCT01708590|Immunologic Factors|immunologic factors|mesh-ancestor
92021524|NCT04788355|Apixaban|apixaban|mesh-list
92373762|NCT01708590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373763|NCT05710146|Tranexamic Acid|tranexamic acid|mesh-list
92373764|NCT05710146|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92373765|NCT05710146|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92373766|NCT05710146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373767|NCT05710146|Hemostatics|hemostatics|mesh-ancestor
92373768|NCT05710146|Coagulants|coagulants|mesh-ancestor
92373769|NCT05683548|Interferons|interferons|mesh-list
92373770|NCT05683548|Tenofovir|tenofovir|mesh-list
92373771|NCT05683548|Interferon-alpha|interferon-alpha|mesh-list
92373772|NCT05683548|Interferon alpha-2|interferon alpha-2|mesh-list
92373773|NCT05683548|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92373774|NCT05683548|REP 2139|rep 2139|mesh-list
92373775|NCT05683548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373776|NCT05683548|Antiviral Agents|antiviral agents|mesh-ancestor
92373777|NCT05683548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373778|NCT05683548|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92373779|NCT05683548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92373780|NCT05683548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373781|NCT05683548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373782|NCT05683548|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92373783|NCT05683548|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92373784|NCT05683548|Immunologic Factors|immunologic factors|mesh-ancestor
92373785|NCT05683548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373786|NCT05661942|Calcium|calcium|mesh-list
92373787|NCT05661942|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92373788|NCT05661942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373789|NCT05636436|Vaccines|vaccines|mesh-list
92373790|NCT05636436|Immunologic Factors|immunologic factors|mesh-ancestor
92373791|NCT05636436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373794|NCT05463354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373795|NCT05293548|Vaccines|vaccines|mesh-list
92373796|NCT05293548|Immunologic Factors|immunologic factors|mesh-ancestor
92373797|NCT05293548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373798|NCT05157360|Vitamins|vitamins|mesh-list
92373799|NCT05157360|Hydrocortisone|hydrocortisone|mesh-list
92373800|NCT05157360|Micronutrients|micronutrients|mesh-ancestor
92373801|NCT05157360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373802|NCT05157360|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373803|NCT05136066|Peppermint oil|peppermint oil|mesh-list
92373804|NCT05136066|Antiemetics|antiemetics|mesh-ancestor
92373805|NCT05136066|Autonomic Agents|autonomic agents|mesh-ancestor
92373806|NCT05136066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373807|NCT05136066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373808|NCT05136066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373809|NCT05136066|Parasympatholytics|parasympatholytics|mesh-ancestor
92373810|NCT04676802|Analgesics, Opioid|analgesics, opioid|mesh-list
92373811|NCT04676802|Narcotics|narcotics|mesh-ancestor
92373812|NCT04676802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373813|NCT04676802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373814|NCT04676802|Analgesics|analgesics|mesh-ancestor
92373815|NCT04676802|Sensory System Agents|sensory system agents|mesh-ancestor
92373816|NCT04676802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373817|NCT04278768|Azacitidine|azacitidine|mesh-list
92373818|NCT04278768|Venetoclax|venetoclax|mesh-list
92373819|NCT04278768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92373820|NCT04278768|Antimetabolites|antimetabolites|mesh-ancestor
92373821|NCT04278768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373822|NCT04278768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373823|NCT04278768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373824|NCT04068948|Midazolam|midazolam|mesh-list
92373825|NCT04068948|Meperidine|meperidine|mesh-list
92373826|NCT04068948|Hydroxyzine|hydroxyzine|mesh-list
92373827|NCT04068948|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92373828|NCT04068948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373829|NCT04068948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373830|NCT04068948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373831|NCT04068948|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92373832|NCT04068948|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373833|NCT04068948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373834|NCT04068948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92373835|NCT04068948|Anesthetics, General|anesthetics, general|mesh-ancestor
92373836|NCT04068948|Anesthetics|anesthetics|mesh-ancestor
92373837|NCT04068948|GABA Modulators|gaba modulators|mesh-ancestor
92373838|NCT04068948|GABA Agents|gaba agents|mesh-ancestor
92373839|NCT04068948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373840|NCT04068948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373841|NCT04068948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92373842|NCT04068948|Narcotics|narcotics|mesh-ancestor
92373843|NCT04068948|Analgesics|analgesics|mesh-ancestor
92373844|NCT04068948|Sensory System Agents|sensory system agents|mesh-ancestor
92373845|NCT04068948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373846|NCT04068948|Antipruritics|antipruritics|mesh-ancestor
92373847|NCT04068948|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373848|NCT04068948|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92373849|NCT04068948|Histamine Antagonists|histamine antagonists|mesh-ancestor
92373850|NCT04068948|Histamine Agents|histamine agents|mesh-ancestor
92373851|NCT03768570|Durvalumab|durvalumab|mesh-list
92373852|NCT03768570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373853|NCT03768570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373854|NCT03517722|Ustekinumab|ustekinumab|mesh-list
92373855|NCT03517722|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373856|NCT02130492|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92373857|NCT02130492|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92373858|NCT02130492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373859|NCT01309074|Pregabalin|pregabalin|mesh-list
92373860|NCT01309074|Sertraline|sertraline|mesh-list
92373861|NCT01309074|Analgesics|analgesics|mesh-ancestor
92373862|NCT01309074|Sensory System Agents|sensory system agents|mesh-ancestor
92373863|NCT01309074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373864|NCT01309074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373866|NCT01309074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92373867|NCT01309074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92373868|NCT01309074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373869|NCT01309074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92373870|NCT01309074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92373871|NCT01309074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92373872|NCT01309074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373873|NCT01309074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92373874|NCT01309074|Antidepressive Agents|antidepressive agents|mesh-ancestor
92373875|NCT01309074|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92373876|NCT01309074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92373877|NCT01309074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373878|NCT01309074|Serotonin Agents|serotonin agents|mesh-ancestor
92373879|NCT01074294|Brexpiprazole|brexpiprazole|mesh-list
92373880|NCT01074294|Serotonin Agents|serotonin agents|mesh-ancestor
92373881|NCT01074294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373882|NCT01074294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373883|NCT01074294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373884|NCT01074294|Dopamine Agonists|dopamine agonists|mesh-ancestor
92373885|NCT01074294|Dopamine Agents|dopamine agents|mesh-ancestor
92373886|NCT01074138|Tirbanibulin|tirbanibulin|mesh-list
92373887|NCT01074138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373888|NCT01074138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022499|NCT02343549|Bevacizumab|bevacizumab|mesh-list
92373889|NCT00951132|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92373890|NCT00951132|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92373891|NCT00951132|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92373892|NCT00951132|Antimetabolites|antimetabolites|mesh-ancestor
92373893|NCT00951132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373894|NCT00951132|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92373895|NCT00951132|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92373896|NCT00951132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373897|NCT01717872|Pyrithione zinc|pyrithione zinc|mesh-list
92373898|NCT01717872|Keratolytic Agents|keratolytic agents|mesh-ancestor
92026371|NCT02551991|Leucovorin|leucovorin|mesh-list
92373899|NCT01717872|Dermatologic Agents|dermatologic agents|mesh-ancestor
92373900|NCT01721226|Opiate Alkaloids|opiate alkaloids|mesh-list
92373901|NCT01721226|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92373902|NCT01721226|Narcotics|narcotics|mesh-ancestor
92373903|NCT01721226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373904|NCT01721226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373905|NCT01721226|Analgesics|analgesics|mesh-ancestor
92373906|NCT01721226|Sensory System Agents|sensory system agents|mesh-ancestor
92373907|NCT01721226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373908|NCT01721460|Dexmedetomidine|dexmedetomidine|mesh-list
92373909|NCT01721460|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92373910|NCT01721460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373911|NCT01721460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373912|NCT01721460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92373914|NCT01721460|Sensory System Agents|sensory system agents|mesh-ancestor
92373915|NCT01721460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373916|NCT01721460|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92373917|NCT01721460|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92373918|NCT01721460|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92373919|NCT01721460|Adrenergic Agents|adrenergic agents|mesh-ancestor
92373920|NCT01721460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92373921|NCT01721460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373922|NCT01722318|Plecanatide|plecanatide|mesh-list
92022705|NCT00352027|Immunologic Factors|immunologic factors|mesh-ancestor
92373923|NCT01722318|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92373925|NCT01722318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373926|NCT01722318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92373927|NCT01723722|Methadone|methadone|mesh-list
92373928|NCT01723722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92373929|NCT01723722|Narcotics|narcotics|mesh-ancestor
92373930|NCT01723722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92373931|NCT01723722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373932|NCT01723722|Analgesics|analgesics|mesh-ancestor
92373933|NCT01723722|Sensory System Agents|sensory system agents|mesh-ancestor
92373934|NCT01723722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92373935|NCT01723722|Antitussive Agents|antitussive agents|mesh-ancestor
92373936|NCT01723722|Respiratory System Agents|respiratory system agents|mesh-ancestor
92373937|NCT01728636|Tranexamic Acid|tranexamic acid|mesh-list
92373938|NCT01728636|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92373939|NCT01728636|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92373940|NCT01728636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373941|NCT01728636|Hemostatics|hemostatics|mesh-ancestor
92373942|NCT01728636|Coagulants|coagulants|mesh-ancestor
92373943|NCT01729338|Cyclophosphamide|cyclophosphamide|mesh-list
92373944|NCT01729338|Lenalidomide|lenalidomide|mesh-list
92373945|NCT01729338|Bortezomib|bortezomib|mesh-list
92373946|NCT01729338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92373947|NCT01729338|Immunologic Factors|immunologic factors|mesh-ancestor
92373948|NCT01729338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373949|NCT01729338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373950|NCT01729338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92373951|NCT01729338|Alkylating Agents|alkylating agents|mesh-ancestor
92373952|NCT01729338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373953|NCT01729338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373954|NCT01729338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92373955|NCT01729338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92373956|NCT01729338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92373957|NCT01729338|Growth Substances|growth substances|mesh-ancestor
92373958|NCT01729338|Growth Inhibitors|growth inhibitors|mesh-ancestor
92373959|NCT01729494|Mycophenolic Acid|mycophenolic acid|mesh-list
92373960|NCT01729494|Prednisone|prednisone|mesh-list
92373961|NCT01729494|Alemtuzumab|alemtuzumab|mesh-list
92373962|NCT01729494|Abatacept|abatacept|mesh-list
92373963|NCT01729494|Tacrolimus|tacrolimus|mesh-list
92373964|NCT01729494|Thymoglobulin|thymoglobulin|mesh-list
92373965|NCT01729494|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92373966|NCT01729494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92373967|NCT01729494|Glucocorticoids|glucocorticoids|mesh-ancestor
92373968|NCT01729494|Hormones|hormones|mesh-ancestor
92373969|NCT01729494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92373970|NCT01729494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373971|NCT01729494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92373972|NCT01729494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373973|NCT01729494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92373974|NCT01729494|Immunologic Factors|immunologic factors|mesh-ancestor
92373975|NCT01729494|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92373976|NCT01729494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92373977|NCT01729494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92373978|NCT01729494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92373979|NCT01729494|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92373980|NCT01729494|Antitubercular Agents|antitubercular agents|mesh-ancestor
92373981|NCT01729494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92373982|NCT01729494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92373983|NCT01729494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373984|NCT01729494|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92373985|NCT01729494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92373986|NCT05317260|Antiviral Agents|antiviral agents|mesh-list
92373987|NCT05317260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022940|NCT05786417|Calcium|calcium|mesh-list
92373989|NCT05316480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373990|NCT05316480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373991|NCT05316246|Tislelizumab|tislelizumab|mesh-list
92373992|NCT05316246|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92373993|NCT05316246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92373994|NCT05316246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92373995|NCT05316246|Immunotoxins|immunotoxins|mesh-ancestor
92373996|NCT05316246|Immunoconjugates|immunoconjugates|mesh-ancestor
92373997|NCT05316246|Immunologic Factors|immunologic factors|mesh-ancestor
92373998|NCT05316246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92373999|NCT05316168|Dexamethasone|dexamethasone|mesh-list
92374000|NCT05316168|Bupivacaine|bupivacaine|mesh-list
92374001|NCT05316168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374002|NCT05316168|Antiemetics|antiemetics|mesh-ancestor
92374003|NCT05316168|Autonomic Agents|autonomic agents|mesh-ancestor
92374004|NCT05316168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374005|NCT05316168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374006|NCT05316168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92374007|NCT05316168|Glucocorticoids|glucocorticoids|mesh-ancestor
92374009|NCT05316168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374010|NCT05316168|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92374011|NCT05316168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374012|NCT05316168|Anesthetics, Local|anesthetics, local|mesh-ancestor
92374013|NCT05316168|Anesthetics|anesthetics|mesh-ancestor
92374014|NCT05316168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374015|NCT05316168|Sensory System Agents|sensory system agents|mesh-ancestor
92374016|NCT05315388|Vitamins|vitamins|mesh-list
92374017|NCT05315388|Micronutrients|micronutrients|mesh-ancestor
92374018|NCT05315388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374019|NCT04894188|Goserelin|goserelin|mesh-list
92374020|NCT04894188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92374021|NCT04894188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374022|NCT04724772|Tranexamic Acid|tranexamic acid|mesh-list
92374023|NCT04724772|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92374024|NCT04724772|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92374025|NCT04724772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374026|NCT04724772|Hemostatics|hemostatics|mesh-ancestor
92374027|NCT04724772|Coagulants|coagulants|mesh-ancestor
92374028|NCT04196868|Metformin|metformin|mesh-list
92374029|NCT04196868|Methotrexate|methotrexate|mesh-list
92374030|NCT04196868|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374031|NCT04196868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374032|NCT04196868|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92374033|NCT04196868|Abortifacient Agents|abortifacient agents|mesh-ancestor
92374034|NCT04196868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92374035|NCT04196868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374036|NCT04196868|Antimetabolites|antimetabolites|mesh-ancestor
92374037|NCT04196868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374038|NCT04196868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374039|NCT04196868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92374040|NCT04196868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374041|NCT04196868|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92374042|NCT04196868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92374043|NCT04196868|Immunologic Factors|immunologic factors|mesh-ancestor
92374044|NCT04196868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374045|NCT04196868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92374046|NCT04007874|Vitamin E|vitamin e|mesh-list
92374047|NCT04007874|Levonorgestrel|levonorgestrel|mesh-list
92374048|NCT04007874|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92374049|NCT04007874|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92374050|NCT04007874|Vitamins|vitamins|mesh-ancestor
92374051|NCT04007874|Micronutrients|micronutrients|mesh-ancestor
92374052|NCT04007874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374053|NCT04007874|Antioxidants|antioxidants|mesh-ancestor
92374054|NCT04007874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374055|NCT04007874|Protective Agents|protective agents|mesh-ancestor
92374056|NCT04007874|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92374057|NCT04007874|Contraceptive Agents|contraceptive agents|mesh-ancestor
92374058|NCT04007874|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92374059|NCT04007874|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92374060|NCT04007874|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92374061|NCT04007874|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92374062|NCT04007874|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92374063|NCT04007874|Estrogens|estrogens|mesh-ancestor
92374064|NCT04007874|Hormones|hormones|mesh-ancestor
92374065|NCT04007874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374066|NCT04007874|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92374067|NCT03878472|Oxaliplatin|oxaliplatin|mesh-list
92374068|NCT03878472|Apatinib|apatinib|mesh-list
92374069|NCT03878472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374070|NCT03878472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92374071|NCT03878472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374072|NCT03878472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374073|NCT03162510|Paclitaxel|paclitaxel|mesh-list
92374074|NCT03162510|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92374075|NCT03162510|Oxaliplatin|oxaliplatin|mesh-list
92374076|NCT03162510|Tegafur|tegafur|mesh-list
92374077|NCT03162510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92374078|NCT03162510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374079|NCT03162510|Tubulin Modulators|tubulin modulators|mesh-ancestor
92374080|NCT03162510|Antimitotic Agents|antimitotic agents|mesh-ancestor
92374081|NCT03162510|Mitosis Modulators|mitosis modulators|mesh-ancestor
92374082|NCT03162510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374083|NCT03162510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374084|NCT03162510|Antimetabolites|antimetabolites|mesh-ancestor
92374085|NCT02996760|Mitogens|mitogens|mesh-list
92374086|NCT02996760|Mitosis Modulators|mitosis modulators|mesh-ancestor
92374087|NCT02996760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374088|NCT02987946|Nadroparin|nadroparin|mesh-list
92374089|NCT02987946|Anticoagulants|anticoagulants|mesh-ancestor
92374090|NCT02987946|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92374091|NCT02987946|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92374092|NCT02987946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374093|NCT02394132|Imiquimod|imiquimod|mesh-list
92374094|NCT02394132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92374095|NCT02394132|Immunologic Factors|immunologic factors|mesh-ancestor
92374096|NCT02394132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374097|NCT02394132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374098|NCT02394132|Interferon Inducers|interferon inducers|mesh-ancestor
92374099|NCT00700596|Salvinorin A|salvinorin a|mesh-list
92374100|NCT00700596|Hallucinogens|hallucinogens|mesh-ancestor
92374101|NCT00700596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374102|NCT00700596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92374103|NCT01733472|Remifentanil|remifentanil|mesh-list
92374104|NCT01733472|Propofol|propofol|mesh-list
92374105|NCT01733472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92374106|NCT01733472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374107|NCT01733472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374108|NCT01733472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92374109|NCT01733472|Anesthetics, General|anesthetics, general|mesh-ancestor
92374110|NCT01733472|Anesthetics|anesthetics|mesh-ancestor
92374111|NCT01733472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92374112|NCT01733472|Narcotics|narcotics|mesh-ancestor
92374113|NCT01733472|Analgesics|analgesics|mesh-ancestor
92374114|NCT01733472|Sensory System Agents|sensory system agents|mesh-ancestor
92374115|NCT01733472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374116|NCT01736358|Ketorolac|ketorolac|mesh-list
92374117|NCT01736358|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92374118|NCT01736358|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92374119|NCT01736358|Analgesics|analgesics|mesh-ancestor
92374120|NCT01736358|Sensory System Agents|sensory system agents|mesh-ancestor
92374121|NCT01736358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374122|NCT01736358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374123|NCT01736358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374124|NCT01736358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374125|NCT01736358|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92374126|NCT01736358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374127|NCT01736358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374129|NCT01740258|Temozolomide|temozolomide|mesh-list
92374130|NCT01740258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374131|NCT01740258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374132|NCT01740258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92374133|NCT01740258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92374134|NCT01740258|Growth Substances|growth substances|mesh-ancestor
92374135|NCT01740258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374136|NCT01740258|Growth Inhibitors|growth inhibitors|mesh-ancestor
92374137|NCT01740258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92374138|NCT01740258|Alkylating Agents|alkylating agents|mesh-ancestor
92023593|NCT03077542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374139|NCT01740258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374140|NCT01740414|Ibudilast|ibudilast|mesh-list
92374141|NCT01740414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92374142|NCT01740414|Autonomic Agents|autonomic agents|mesh-ancestor
92374143|NCT01740414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374144|NCT01740414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374145|NCT01740414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92374146|NCT01740414|Respiratory System Agents|respiratory system agents|mesh-ancestor
92374147|NCT01740414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92374148|NCT01740414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374149|NCT01740414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374150|NCT01740414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92374151|NCT01740414|Vasodilator Agents|vasodilator agents|mesh-ancestor
92374152|NCT01740726|Fluoxetine|fluoxetine|mesh-list
92374153|NCT01740726|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92374154|NCT01740726|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92374155|NCT01740726|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374156|NCT01740726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374157|NCT01740726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374158|NCT01740726|Serotonin Agents|serotonin agents|mesh-ancestor
92374159|NCT01740726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374160|NCT01740726|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92374161|NCT01740726|Antidepressive Agents|antidepressive agents|mesh-ancestor
92374162|NCT01740726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92374163|NCT01740726|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92374164|NCT01740726|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92374165|NCT01740726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374166|NCT01742208|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92374167|NCT01742208|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92374168|NCT01742208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374169|NCT01742208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374170|NCT01742208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374171|NCT01744704|Mitogens|mitogens|mesh-list
92374172|NCT01744704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92374173|NCT01744704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374175|NCT01746264|Cholecalciferol|cholecalciferol|mesh-list
92374176|NCT01746264|Vitamins|vitamins|mesh-ancestor
92374177|NCT01746264|Micronutrients|micronutrients|mesh-ancestor
92374178|NCT01746264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374179|NCT01746264|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92374180|NCT01746264|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92374181|NCT01746420|Becaplermin|becaplermin|mesh-list
92374182|NCT01746420|Anticoagulants|anticoagulants|mesh-ancestor
92374183|NCT01746420|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92023937|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
92374184|NCT01746420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92374185|NCT01746420|Growth Substances|growth substances|mesh-ancestor
92374186|NCT01746420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374187|NCT01749930|Timolol|timolol|mesh-list
92374188|NCT01749930|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92374189|NCT01749930|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92374190|NCT01749930|Adrenergic Agents|adrenergic agents|mesh-ancestor
92374191|NCT01749930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374192|NCT01749930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374193|NCT01749930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024024|NCT02380287|Antibodies|antibodies|mesh-list
92374194|NCT01749930|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92374195|NCT01749930|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92374196|NCT01750086|Denosumab|denosumab|mesh-list
92374197|NCT01750086|Alendronate|alendronate|mesh-list
92374198|NCT01750086|Teriparatide|teriparatide|mesh-list
92374199|NCT01750086|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92374200|NCT01750086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374201|NCT01750086|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92374202|NCT01750398|Methyltestosterone|methyltestosterone|mesh-list
92374203|NCT01750398|Leuprolide|leuprolide|mesh-list
92374204|NCT01750398|Goserelin|goserelin|mesh-list
92374205|NCT01750398|Testosterone|testosterone|mesh-list
92374206|NCT01750398|Testosterone undecanoate|testosterone undecanoate|mesh-list
92374207|NCT01750398|Testosterone enanthate|testosterone enanthate|mesh-list
92374208|NCT01750398|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92374209|NCT01750398|Androgens|androgens|mesh-ancestor
92374210|NCT01750398|Hormones|hormones|mesh-ancestor
92024069|NCT02378961|Antiviral Agents|antiviral agents|mesh-ancestor
92374211|NCT01750398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374212|NCT01750398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374213|NCT01750398|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92374214|NCT01750398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374215|NCT01750398|Anabolic Agents|anabolic agents|mesh-ancestor
92374216|NCT01750398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92374217|NCT01750398|Fertility Agents|fertility agents|mesh-ancestor
92374218|NCT01750398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92374219|NCT01752426|Deuterium Oxide|deuterium oxide|mesh-list
92374220|NCT01752426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374221|NCT01752426|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92374222|NCT01752426|Protective Agents|protective agents|mesh-ancestor
92374223|NCT01752426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374224|NCT01753362|Liraglutide|liraglutide|mesh-list
92374225|NCT01753362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374226|NCT01753362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374227|NCT01753362|Incretins|incretins|mesh-ancestor
92374228|NCT01753362|Hormones|hormones|mesh-ancestor
92374229|NCT01753362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374230|NCT01758432|Apixaban|apixaban|mesh-list
92374232|NCT01758432|Antithrombins|antithrombins|mesh-ancestor
92374233|NCT01758432|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92374234|NCT01758432|Protease Inhibitors|protease inhibitors|mesh-ancestor
92374235|NCT01758432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374236|NCT01758432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374237|NCT01758432|Anticoagulants|anticoagulants|mesh-ancestor
92374238|NCT01758588|Interferons|interferons|mesh-list
92374239|NCT01758588|Interferon-alpha|interferon-alpha|mesh-list
92374240|NCT01758588|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92374241|NCT01758588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374242|NCT01758588|Antiviral Agents|antiviral agents|mesh-ancestor
92374243|NCT01758588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374244|NCT01758588|Immunologic Factors|immunologic factors|mesh-ancestor
92374245|NCT01758588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374247|NCT01759602|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
91984927|NCT01374269|Antipyretics|antipyretics|mesh-ancestor
92374248|NCT01759602|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92374249|NCT01759602|Immunologic Factors|immunologic factors|mesh-ancestor
92374250|NCT01759602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374251|NCT01759602|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92374252|NCT01759602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92374253|NCT01760304|Budesonide|budesonide|mesh-list
92374254|NCT01760304|Formoterol Fumarate|formoterol fumarate|mesh-list
92374255|NCT01760304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374256|NCT01760304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92374257|NCT01760304|Autonomic Agents|autonomic agents|mesh-ancestor
92374258|NCT01760304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374259|NCT01760304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374260|NCT01760304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92374261|NCT01760304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92374262|NCT01760304|Glucocorticoids|glucocorticoids|mesh-ancestor
92374263|NCT01760304|Hormones|hormones|mesh-ancestor
92374264|NCT01760304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374265|NCT01760304|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92374266|NCT01760304|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92374267|NCT01760304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92374268|NCT01760304|Adrenergic Agents|adrenergic agents|mesh-ancestor
92374269|NCT01760304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374270|NCT01760304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374271|NCT01763346|Metformin|metformin|mesh-list
92374272|NCT01763346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374273|NCT01763346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374274|NCT01766076|Atorvastatin|atorvastatin|mesh-list
92374275|NCT01766076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92374276|NCT01766076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92374277|NCT01766076|Antimetabolites|antimetabolites|mesh-ancestor
92374278|NCT01766076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374280|NCT01766076|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92374281|NCT01766076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374283|NCT01766466|Cangrelor|cangrelor|mesh-list
92374284|NCT01766466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92374285|NCT01766466|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92374286|NCT01766466|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92374287|NCT01766466|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92374288|NCT01766466|Purinergic Agents|purinergic agents|mesh-ancestor
92374289|NCT01766466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374290|NCT01766466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374291|NCT01766466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374292|NCT01767792|Bevacizumab|bevacizumab|mesh-list
92374293|NCT01767792|Endothelial Growth Factors|endothelial growth factors|mesh-list
92024446|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
92374294|NCT01767792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374295|NCT01767792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374296|NCT01767792|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92374297|NCT01767792|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92374298|NCT01767792|Growth Substances|growth substances|mesh-ancestor
92374299|NCT01767792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374300|NCT01767792|Growth Inhibitors|growth inhibitors|mesh-ancestor
92374301|NCT01769352|Prednisolone acetate|prednisolone acetate|mesh-list
92374302|NCT01769352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374303|NCT01769586|Diphenhydramine|diphenhydramine|mesh-list
92374305|NCT01769586|Midazolam|midazolam|mesh-list
92374306|NCT01769586|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92374307|NCT01769586|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92374308|NCT01769586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374309|NCT01769586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374310|NCT01769586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92374311|NCT01769586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92374312|NCT01769586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92374313|NCT01769586|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92374314|NCT01769586|Anesthetics, General|anesthetics, general|mesh-ancestor
92374316|NCT01769586|GABA Modulators|gaba modulators|mesh-ancestor
92374317|NCT01769586|GABA Agents|gaba agents|mesh-ancestor
92374318|NCT01769586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374319|NCT01769586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374320|NCT01769586|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92374321|NCT01769586|Anesthetics, Local|anesthetics, local|mesh-ancestor
92374322|NCT01769586|Sensory System Agents|sensory system agents|mesh-ancestor
92374323|NCT01769586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374324|NCT01769586|Antiemetics|antiemetics|mesh-ancestor
92374325|NCT01769586|Autonomic Agents|autonomic agents|mesh-ancestor
92374326|NCT01769586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92374327|NCT01769586|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92374328|NCT01769586|Histamine Antagonists|histamine antagonists|mesh-ancestor
92374329|NCT01769586|Histamine Agents|histamine agents|mesh-ancestor
92374330|NCT01769586|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92374331|NCT01769586|Antipruritics|antipruritics|mesh-ancestor
92374332|NCT01769586|Dermatologic Agents|dermatologic agents|mesh-ancestor
92374333|NCT01773954|Aflibercept|aflibercept|mesh-list
92374334|NCT01773954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92374335|NCT01773954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92374336|NCT01773954|Growth Substances|growth substances|mesh-ancestor
92374337|NCT01773954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374338|NCT01773954|Growth Inhibitors|growth inhibitors|mesh-ancestor
92374339|NCT01773954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374340|NCT01778634|Azithromycin|azithromycin|mesh-list
92374341|NCT01778634|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92374342|NCT01778634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374343|NCT01783236|Acetaminophen|acetaminophen|mesh-list
92374344|NCT01783236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92374345|NCT01783236|Analgesics|analgesics|mesh-ancestor
92374346|NCT01783236|Sensory System Agents|sensory system agents|mesh-ancestor
92374347|NCT01783236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374348|NCT01783236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374349|NCT01783236|Antipyretics|antipyretics|mesh-ancestor
92374351|NCT01783470|Adrenergic Agents|adrenergic agents|mesh-list
92374352|NCT01783470|Adrenergic Agonists|adrenergic agonists|mesh-list
92374353|NCT01783470|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92374354|NCT01783470|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92374355|NCT01783470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374356|NCT01783470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374357|NCT01783470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374358|NCT01783470|Urological Agents|urological agents|mesh-ancestor
92374359|NCT01783860|Azithromycin|azithromycin|mesh-list
92374360|NCT01783860|Doxycycline|doxycycline|mesh-list
92374361|NCT01783860|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92374362|NCT01783860|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374363|NCT01783860|Antimalarials|antimalarials|mesh-ancestor
92374364|NCT01783860|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92374365|NCT01783860|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92374366|NCT01785186|Pyridoxine|pyridoxine|mesh-list
92374367|NCT01785186|Moxifloxacin|moxifloxacin|mesh-list
92374368|NCT01785186|Rifampin|rifampin|mesh-list
92374369|NCT01785186|Isoniazid|isoniazid|mesh-list
92374370|NCT01785186|Pyrazinamide|pyrazinamide|mesh-list
92374371|NCT01785186|Ethambutol|ethambutol|mesh-list
92374372|NCT01785186|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92374373|NCT01785186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374374|NCT01785186|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92374375|NCT01785186|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92374376|NCT01785186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374377|NCT01785186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374378|NCT01785186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374379|NCT01785186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374380|NCT01785186|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92374381|NCT01785186|Antitubercular Agents|antitubercular agents|mesh-ancestor
92374382|NCT01785186|Leprostatic Agents|leprostatic agents|mesh-ancestor
92374383|NCT01785186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92374384|NCT01785186|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92374386|NCT01785186|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92374387|NCT01785186|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92374388|NCT01785186|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92374389|NCT01785186|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92374390|NCT01785186|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92024910|NCT03542461|Nivolumab|nivolumab|mesh-list
92374391|NCT01785186|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92374392|NCT01785186|Antimetabolites|antimetabolites|mesh-ancestor
92374393|NCT01785186|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92374394|NCT01785186|Vitamin B Complex|vitamin b complex|mesh-ancestor
92374395|NCT01785186|Vitamins|vitamins|mesh-ancestor
92374396|NCT01785186|Micronutrients|micronutrients|mesh-ancestor
92374397|NCT01785810|Maraviroc|maraviroc|mesh-list
92374398|NCT01785810|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92374399|NCT01785810|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92374400|NCT01785810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374401|NCT01785810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92374402|NCT01785810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92374403|NCT01785810|Antiviral Agents|antiviral agents|mesh-ancestor
92374404|NCT01785810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374405|NCT01785810|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92374406|NCT01786902|Hormones|hormones|mesh-list
92374407|NCT01786902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374408|NCT01786902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374409|NCT01787916|Liraglutide|liraglutide|mesh-list
92374410|NCT01787916|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374411|NCT01787916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374412|NCT01787916|Incretins|incretins|mesh-ancestor
92374413|NCT01787916|Hormones|hormones|mesh-ancestor
92374414|NCT01787916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374416|NCT01790490|Lorazepam|lorazepam|mesh-list
92374417|NCT01790490|Analgesics|analgesics|mesh-ancestor
92374418|NCT01790490|Sensory System Agents|sensory system agents|mesh-ancestor
92374419|NCT01790490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374420|NCT01790490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374421|NCT01790490|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92374422|NCT01790490|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92374423|NCT01790490|Anesthetics, General|anesthetics, general|mesh-ancestor
92374424|NCT01790490|Anesthetics|anesthetics|mesh-ancestor
92374425|NCT01790490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374426|NCT01790490|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92374427|NCT01790490|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92374428|NCT01790490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374429|NCT01790490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374430|NCT01790490|Anticonvulsants|anticonvulsants|mesh-ancestor
92374431|NCT01790490|Antiemetics|antiemetics|mesh-ancestor
92374432|NCT01790490|Autonomic Agents|autonomic agents|mesh-ancestor
92374433|NCT01790490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92374434|NCT01790490|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92374435|NCT01790490|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92374436|NCT01790490|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92374437|NCT01790490|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92374438|NCT01790490|GABA Modulators|gaba modulators|mesh-ancestor
92374439|NCT01790490|GABA Agents|gaba agents|mesh-ancestor
92374440|NCT01791972|Albuterol|albuterol|mesh-list
92374441|NCT01791972|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92374442|NCT01791972|Autonomic Agents|autonomic agents|mesh-ancestor
92374443|NCT01791972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374444|NCT01791972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374445|NCT01791972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92374446|NCT01791972|Respiratory System Agents|respiratory system agents|mesh-ancestor
92374447|NCT01791972|Tocolytic Agents|tocolytic agents|mesh-ancestor
92374448|NCT01791972|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92374449|NCT01791972|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92374450|NCT01791972|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92374451|NCT01791972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92374452|NCT01791972|Adrenergic Agents|adrenergic agents|mesh-ancestor
92374453|NCT01791972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374454|NCT01791972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374456|NCT01794702|Decitabine|decitabine|mesh-list
92374457|NCT01794702|Clofarabine|clofarabine|mesh-list
92374458|NCT01794702|Idarubicin|idarubicin|mesh-list
92374459|NCT01794702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374460|NCT01794702|Antimetabolites|antimetabolites|mesh-ancestor
92374461|NCT01794702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374462|NCT01794702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374463|NCT01794702|Antiviral Agents|antiviral agents|mesh-ancestor
92374464|NCT01794702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374465|NCT01794702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92374466|NCT01794702|Immunologic Factors|immunologic factors|mesh-ancestor
92374467|NCT01794702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374468|NCT01794702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374469|NCT01794702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92374470|NCT01794702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92374471|NCT01794702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92374472|NCT01795716|Imatinib Mesylate|imatinib mesylate|mesh-list
92374473|NCT01795716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374474|NCT01795716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92374475|NCT01795716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374476|NCT01795716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374477|NCT01797822|Dexamethasone|dexamethasone|mesh-list
92374478|NCT01797822|Lubricant Eye Drops|lubricant eye drops|mesh-list
92374479|NCT01797822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374480|NCT01797822|Antiemetics|antiemetics|mesh-ancestor
92374481|NCT01797822|Autonomic Agents|autonomic agents|mesh-ancestor
92374482|NCT01797822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374483|NCT01797822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374484|NCT01797822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92374485|NCT01797822|Glucocorticoids|glucocorticoids|mesh-ancestor
92025187|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92374487|NCT01797822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374488|NCT01797822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92374489|NCT01797822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374490|NCT01797822|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92374491|NCT01797822|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92374492|NCT01809054|Aspirin|aspirin|mesh-list
92374493|NCT01809054|Fondaparinux|fondaparinux|mesh-list
92374494|NCT01809054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92374495|NCT01809054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025327|NCT02332707|Ruzasvir|ruzasvir|mesh-list
92374497|NCT01809054|Sensory System Agents|sensory system agents|mesh-ancestor
92374498|NCT01809054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374499|NCT01809054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374500|NCT01809054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374501|NCT01809054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374502|NCT01809054|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92374503|NCT01809054|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92374504|NCT01809054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374505|NCT01809054|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92374506|NCT01809054|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92374507|NCT01809054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374509|NCT01809054|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92374510|NCT01809054|Antithrombins|antithrombins|mesh-ancestor
92374511|NCT01809054|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92374512|NCT01809054|Protease Inhibitors|protease inhibitors|mesh-ancestor
92374513|NCT01809054|Anticoagulants|anticoagulants|mesh-ancestor
92374514|NCT01810692|Tiotropium Bromide|tiotropium bromide|mesh-list
92025665|NCT02489903|Paclitaxel|paclitaxel|mesh-list
92374515|NCT01810692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92374516|NCT01810692|Autonomic Agents|autonomic agents|mesh-ancestor
92025758|NCT04038437|Venetoclax|venetoclax|mesh-list
92374517|NCT01810692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374518|NCT01810692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374520|NCT01810692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92374521|NCT01810692|Parasympatholytics|parasympatholytics|mesh-ancestor
92374522|NCT01810692|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92374523|NCT01810692|Cholinergic Agents|cholinergic agents|mesh-ancestor
92374524|NCT01810692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374525|NCT01810692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374526|NCT01811940|Topiramate|topiramate|mesh-list
92374527|NCT01811940|Adderall|adderall|mesh-list
92374528|NCT01811940|Anticonvulsants|anticonvulsants|mesh-ancestor
92374529|NCT01811940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374530|NCT01811940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374531|NCT01811940|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92374533|NCT01813734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374534|NCT01813734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92374535|NCT01813734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026111|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92374536|NCT01813734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374537|NCT01818414|Vitamins|vitamins|mesh-list
92374538|NCT01818414|Folic Acid|folic acid|mesh-list
92374539|NCT01818414|Misoprostol|misoprostol|mesh-list
92374540|NCT01818414|Micronutrients|micronutrients|mesh-ancestor
92374541|NCT01818414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374542|NCT01818414|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92026404|NCT02880293|Fludarabine|fludarabine|mesh-list
92374544|NCT01818414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92374545|NCT01818414|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92374546|NCT01818414|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92374547|NCT01818414|Oxytocics|oxytocics|mesh-ancestor
92374548|NCT01818414|Hematinics|hematinics|mesh-ancestor
92026512|NCT05469893|Hormones|hormones|mesh-ancestor
92026618|NCT02301975|Xhance|xhance|mesh-list
92374549|NCT01818414|Vitamin B Complex|vitamin b complex|mesh-ancestor
92374550|NCT01820754|Paclitaxel|paclitaxel|mesh-list
92374551|NCT01820754|Carboplatin|carboplatin|mesh-list
92374552|NCT01820754|Ipilimumab|ipilimumab|mesh-list
92026716|NCT02546765|Acetaminophen|acetaminophen|mesh-list
92374553|NCT01820754|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92374554|NCT01820754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374555|NCT01820754|Tubulin Modulators|tubulin modulators|mesh-ancestor
92374556|NCT01820754|Antimitotic Agents|antimitotic agents|mesh-ancestor
92374557|NCT01820754|Mitosis Modulators|mitosis modulators|mesh-ancestor
92374558|NCT01820754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374559|NCT01820754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374560|NCT01820754|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92374561|NCT01821378|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92374562|NCT01821378|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92374563|NCT01821378|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92374564|NCT01821378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374565|NCT01821378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374566|NCT01821378|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92374567|NCT01821378|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92374568|NCT01821378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92374569|NCT01821378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92026793|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
92374570|NCT01821378|Adrenergic Agents|adrenergic agents|mesh-ancestor
92374571|NCT01821378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026850|NCT02293395|Aspirin|aspirin|mesh-list
92374572|NCT01821378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374573|NCT01821378|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92374575|NCT01821378|Serotonin Agents|serotonin agents|mesh-ancestor
92374576|NCT01821378|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92374578|NCT01821378|Dopamine Agents|dopamine agents|mesh-ancestor
92374581|NCT01822548|Glyburide|glyburide|mesh-list
92374582|NCT01822548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374583|NCT01822548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374584|NCT01822548|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92374585|NCT01822548|Protease Inhibitors|protease inhibitors|mesh-ancestor
92374586|NCT01822548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374587|NCT01822548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374588|NCT01825122|Nadolol|nadolol|mesh-list
92027316|NCT05004805|Methylene Blue|methylene blue|mesh-list
92374589|NCT01825122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92374590|NCT01825122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92374591|NCT01825122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027410|NCT02531113|Ozanimod|ozanimod|mesh-list
92374592|NCT01825122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374593|NCT01825122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027484|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
92374594|NCT01825122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374595|NCT01825122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92374596|NCT01825122|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92374598|NCT01825122|Autonomic Agents|autonomic agents|mesh-ancestor
92374599|NCT01825122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374601|NCT01825512|Deferiprone|deferiprone|mesh-list
92027775|NCT05243563|Clobetasol|clobetasol|mesh-list
92374602|NCT01825512|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92374604|NCT01825512|Sequestering Agents|sequestering agents|mesh-ancestor
92374605|NCT01825512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374606|NCT01827462|Vaccines|vaccines|mesh-list
92374607|NCT01827462|Immunologic Factors|immunologic factors|mesh-ancestor
92027942|NCT05107999|Doxepin|doxepin|mesh-list
92374608|NCT01827462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374609|NCT01827930|Imatinib Mesylate|imatinib mesylate|mesh-list
92374610|NCT01827930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374611|NCT01827930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92374612|NCT01827930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028236|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92374613|NCT01827930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374614|NCT01828476|Hydroxychloroquine|hydroxychloroquine|mesh-list
92374615|NCT01828476|Navitoclax|navitoclax|mesh-list
92374616|NCT01828476|Antimalarials|antimalarials|mesh-ancestor
92374617|NCT01828476|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92374618|NCT01828476|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92374619|NCT01828476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374620|NCT01828476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374621|NCT01828476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028385|NCT02515279|Ribavirin|ribavirin|mesh-list
92374622|NCT01828476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374623|NCT01828476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374624|NCT01828554|Capecitabine|capecitabine|mesh-list
92374625|NCT01828554|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374626|NCT01828554|Antimetabolites|antimetabolites|mesh-ancestor
92374627|NCT01828554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374628|NCT01828554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374629|NCT01833546|Gemcitabine|gemcitabine|mesh-list
92028560|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
92374630|NCT01833546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374631|NCT01833546|Antimetabolites|antimetabolites|mesh-ancestor
92374632|NCT01833546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374633|NCT01833546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374635|NCT01834404|Phentermine|phentermine|mesh-list
92374636|NCT01834404|Anticonvulsants|anticonvulsants|mesh-ancestor
92374637|NCT01834404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374638|NCT01834404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028706|NCT02482129|Dexamethasone|dexamethasone|mesh-list
92374639|NCT01834404|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92374640|NCT01834404|Appetite Depressants|appetite depressants|mesh-ancestor
92374641|NCT01834404|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92374643|NCT01834404|Autonomic Agents|autonomic agents|mesh-ancestor
92374644|NCT01834404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374645|NCT01834404|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028863|NCT02478463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374646|NCT01834404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028942|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92374647|NCT01834404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374649|NCT01835262|Morphine|morphine|mesh-list
92374650|NCT01835262|Analgesics|analgesics|mesh-ancestor
91985161|NCT02391077|Povidone|povidone|mesh-list
92374651|NCT01835262|Sensory System Agents|sensory system agents|mesh-ancestor
92374652|NCT01835262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029226|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374653|NCT01835262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374654|NCT01835262|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92029300|NCT02442349|Osimertinib|osimertinib|mesh-list
92374655|NCT01835262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92374657|NCT01835262|Anesthetics|anesthetics|mesh-ancestor
92374658|NCT01835262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029442|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
92120046|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
92374659|NCT01835262|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92374660|NCT01835262|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92374661|NCT01835262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374662|NCT01835262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029606|NCT02460991|Sorafenib|sorafenib|mesh-list
92374663|NCT01835262|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92374664|NCT01835262|Narcotics|narcotics|mesh-ancestor
92374665|NCT01835496|Deferiprone|deferiprone|mesh-list
92374666|NCT01835496|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92374667|NCT01835496|Chelating Agents|chelating agents|mesh-ancestor
92374668|NCT01835496|Sequestering Agents|sequestering agents|mesh-ancestor
92374669|NCT01835496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374670|NCT01842594|Sirolimus|sirolimus|mesh-list
92374671|NCT01842594|Hydroxychloroquine|hydroxychloroquine|mesh-list
92374672|NCT01842594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92374673|NCT01842594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374674|NCT01842594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92374675|NCT01842594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374676|NCT01842594|Antifungal Agents|antifungal agents|mesh-ancestor
92374677|NCT01842594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92374678|NCT01842594|Immunologic Factors|immunologic factors|mesh-ancestor
92029987|NCT04841343|Hormones|hormones|mesh-ancestor
92374679|NCT01842594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374680|NCT01842594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374681|NCT01842594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374682|NCT01842594|Antimalarials|antimalarials|mesh-ancestor
92374683|NCT01842594|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92374684|NCT01842594|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92374685|NCT01842594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374686|NCT01843920|Trimethoprim|trimethoprim|mesh-list
92374687|NCT01843920|Polymyxins|polymyxins|mesh-list
92374688|NCT01843920|Polymyxin B|polymyxin b|mesh-list
92374689|NCT01843920|Prednisolone|prednisolone|mesh-list
92374690|NCT01843920|Timolol|timolol|mesh-list
92374691|NCT01843920|Dorzolamide|dorzolamide|mesh-list
92374692|NCT01843920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374693|NCT01843920|Glucocorticoids|glucocorticoids|mesh-ancestor
92030394|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92374695|NCT01843920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374696|NCT01843920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374697|NCT01843920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92374698|NCT01843920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374699|NCT01843920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92374700|NCT01843920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92374701|NCT01843920|Adrenergic Agents|adrenergic agents|mesh-ancestor
92374702|NCT01843920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374703|NCT01843920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374704|NCT01843920|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92374705|NCT01843920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92374706|NCT01843920|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92374707|NCT01843920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374708|NCT01843920|Antimalarials|antimalarials|mesh-ancestor
92374709|NCT01843920|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92374710|NCT01843920|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92374711|NCT01843920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92374712|NCT01843920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374713|NCT01843920|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92374714|NCT01843920|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92374715|NCT01843920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92374716|NCT01843920|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92374717|NCT01843920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92374718|NCT01844388|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92374719|NCT01844388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92374720|NCT01844388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92374721|NCT01844388|Laxatives|laxatives|mesh-ancestor
92374722|NCT01844388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92374723|NCT01845636|Atropine|atropine|mesh-list
92374724|NCT01845636|Donepezil|donepezil|mesh-list
92374725|NCT01845636|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92374726|NCT01845636|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92374727|NCT01845636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92374728|NCT01845636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374729|NCT01845636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374731|NCT01845636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374732|NCT01845636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374733|NCT01845636|Nootropic Agents|nootropic agents|mesh-ancestor
92374734|NCT01845636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92374735|NCT01845636|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92374736|NCT01845636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92374737|NCT01845636|Autonomic Agents|autonomic agents|mesh-ancestor
92374738|NCT01845636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374739|NCT01845636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92374740|NCT01845636|Respiratory System Agents|respiratory system agents|mesh-ancestor
92374741|NCT01845636|Mydriatics|mydriatics|mesh-ancestor
92374742|NCT01845636|Parasympatholytics|parasympatholytics|mesh-ancestor
92374743|NCT01845636|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92374744|NCT01845636|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92374745|NCT01845792|Abiraterone Acetate|abiraterone acetate|mesh-list
92374746|NCT01845792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374747|NCT01845792|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92374748|NCT01845792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374749|NCT01845792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374750|NCT01845792|Hormone Antagonists|hormone antagonists|mesh-ancestor
92374751|NCT01845792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374752|NCT01845792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374753|NCT01845792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92374755|NCT01846728|Hormones|hormones|mesh-ancestor
92374756|NCT01846728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92374757|NCT01846728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374758|NCT01848054|Buprenorphine|buprenorphine|mesh-list
92374759|NCT01848054|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92374760|NCT01848054|Naloxone|naloxone|mesh-list
92374761|NCT01848054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92374762|NCT01848054|Narcotics|narcotics|mesh-ancestor
92374763|NCT01848054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374764|NCT01848054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374765|NCT01848054|Analgesics|analgesics|mesh-ancestor
92374766|NCT01848054|Sensory System Agents|sensory system agents|mesh-ancestor
92374767|NCT01848054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374768|NCT01848054|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92374769|NCT01849068|Ezetimibe|ezetimibe|mesh-list
92374770|NCT01849068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92374771|NCT01849068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92374772|NCT01849068|Antimetabolites|antimetabolites|mesh-ancestor
92374773|NCT01849068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374774|NCT01849068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92374775|NCT01849692|Ranibizumab|ranibizumab|mesh-list
92374776|NCT01849692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92374777|NCT01849692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92374778|NCT01849692|Growth Substances|growth substances|mesh-ancestor
92374779|NCT01849692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374780|NCT01849692|Growth Inhibitors|growth inhibitors|mesh-ancestor
92374781|NCT01849692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374782|NCT01849770|Mexiletine|mexiletine|mesh-list
92374783|NCT01849770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92374784|NCT01849770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92374785|NCT01849770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92374786|NCT01849770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374787|NCT01849770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374788|NCT01850394|Tranexamic Acid|tranexamic acid|mesh-list
92374789|NCT01850394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92374790|NCT01850394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92374791|NCT01850394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374792|NCT01850394|Hemostatics|hemostatics|mesh-ancestor
92374793|NCT01850394|Coagulants|coagulants|mesh-ancestor
92374794|NCT01852344|Methylphenidate|methylphenidate|mesh-list
92374795|NCT01852344|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92374796|NCT01852344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374797|NCT01852344|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92374798|NCT01852344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92374799|NCT01852344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374800|NCT01852344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374801|NCT01852344|Dopamine Agents|dopamine agents|mesh-ancestor
92027319|NCT04261387|LUT014|lut014|mesh-list
92374802|NCT01852344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374803|NCT01856712|Naltrexone|naltrexone|mesh-list
92374804|NCT01856712|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92374805|NCT01856712|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92374806|NCT01856712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374807|NCT01856712|Sensory System Agents|sensory system agents|mesh-ancestor
92374808|NCT01856712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374809|NCT01858428|Paclitaxel|paclitaxel|mesh-list
92374810|NCT01858428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92374811|NCT01858428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374812|NCT01858428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92374813|NCT01858428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92374815|NCT01858428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374816|NCT01861002|Cytarabine|cytarabine|mesh-list
92374817|NCT01861002|Methotrexate|methotrexate|mesh-list
92374818|NCT01861002|Fludarabine phosphate|fludarabine phosphate|mesh-list
92374819|NCT01861002|Azacitidine|azacitidine|mesh-list
92374820|NCT01861002|Fludarabine|fludarabine|mesh-list
92374821|NCT01861002|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92374822|NCT01861002|Abortifacient Agents|abortifacient agents|mesh-ancestor
92374823|NCT01861002|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92374824|NCT01861002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374825|NCT01861002|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374826|NCT01861002|Antimetabolites|antimetabolites|mesh-ancestor
92374827|NCT01861002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374828|NCT01861002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374829|NCT01861002|Dermatologic Agents|dermatologic agents|mesh-ancestor
92374830|NCT01861002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374831|NCT01861002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92374832|NCT01861002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92374833|NCT01861002|Immunologic Factors|immunologic factors|mesh-ancestor
92374834|NCT01861002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374835|NCT01861002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92374836|NCT01861002|Antiviral Agents|antiviral agents|mesh-ancestor
92374837|NCT01861002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374838|NCT01870596|Cytarabine|cytarabine|mesh-list
92030608|NCT02238483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92374839|NCT01870596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374840|NCT01870596|Antimetabolites|antimetabolites|mesh-ancestor
92374841|NCT01870596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374842|NCT01870596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374843|NCT01870596|Antiviral Agents|antiviral agents|mesh-ancestor
92374844|NCT01870596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374845|NCT01870596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92374846|NCT01870596|Immunologic Factors|immunologic factors|mesh-ancestor
92374847|NCT01870596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374848|NCT01875510|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92374850|NCT01875510|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92374851|NCT01875510|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92374852|NCT01875510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92374853|NCT01876212|Dasatinib|dasatinib|mesh-list
92374854|NCT01876212|Vaccines|vaccines|mesh-list
92374855|NCT01876212|Immunologic Factors|immunologic factors|mesh-ancestor
92374856|NCT01876212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374857|NCT01876212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374858|NCT01876212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92374859|NCT01876212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374860|NCT01876212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374861|NCT01876992|Metformin|metformin|mesh-list
92374862|NCT01876992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374863|NCT01876992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374864|NCT01877538|Donepezil|donepezil|mesh-list
92374865|NCT01877538|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92374866|NCT01877538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374867|NCT01877538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374868|NCT01877538|Cholinergic Agents|cholinergic agents|mesh-ancestor
92374869|NCT01877538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374870|NCT01877538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374871|NCT01877538|Nootropic Agents|nootropic agents|mesh-ancestor
92374872|NCT01878006|Morphine|morphine|mesh-list
92374873|NCT01878006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92027347|NCT03929029|Ipilimumab|ipilimumab|mesh-list
92374874|NCT01878006|Narcotics|narcotics|mesh-ancestor
92374875|NCT01878006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374876|NCT01878006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374877|NCT01878006|Analgesics|analgesics|mesh-ancestor
92374878|NCT01878006|Sensory System Agents|sensory system agents|mesh-ancestor
92374879|NCT01878006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374880|NCT01879332|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92374881|NCT01879332|Anticonvulsants|anticonvulsants|mesh-ancestor
92374882|NCT01879332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92374883|NCT01879332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92374884|NCT01879332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374885|NCT01879332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374886|NCT05327088|Dexmedetomidine|dexmedetomidine|mesh-list
92374887|NCT05327088|Nalbuphine|nalbuphine|mesh-list
92374888|NCT05327088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92374889|NCT05327088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374890|NCT05327088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374891|NCT05327088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92374892|NCT05327088|Analgesics|analgesics|mesh-ancestor
92374893|NCT05327088|Sensory System Agents|sensory system agents|mesh-ancestor
92374894|NCT05327088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374895|NCT05327088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92374896|NCT05327088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92374897|NCT05327088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92374898|NCT05327088|Adrenergic Agents|adrenergic agents|mesh-ancestor
92374899|NCT05327088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92374900|NCT05327088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374901|NCT05327088|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92374902|NCT05327088|Narcotics|narcotics|mesh-ancestor
92374903|NCT05290194|Capecitabine|capecitabine|mesh-list
92374904|NCT05290194|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92374905|NCT05290194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92030617|NCT01632891|Efavirenz|efavirenz|mesh-list
92374906|NCT05290194|Antimetabolites|antimetabolites|mesh-ancestor
92374907|NCT05290194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374908|NCT05290194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374909|NCT05290194|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374911|NCT05228574|Diuretics|diuretics|mesh-ancestor
92374912|NCT05228574|Natriuretic Agents|natriuretic agents|mesh-ancestor
92374913|NCT05228574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374914|NCT05228574|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92374915|NCT05228574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92374916|NCT05228574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92374917|NCT05228574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374918|NCT05228574|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92374919|NCT05228574|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92374920|NCT04774068|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92374921|NCT04774068|Romidepsin|romidepsin|mesh-list
92374922|NCT04774068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374923|NCT04774068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92374924|NCT04774068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374925|NCT04774068|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92374926|NCT04774068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374927|NCT04774068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374928|NCT04103034|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92374929|NCT04103034|Hemostatics|hemostatics|mesh-ancestor
92374930|NCT04103034|Coagulants|coagulants|mesh-ancestor
92374931|NCT04103034|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92374932|NCT04103034|Natriuretic Agents|natriuretic agents|mesh-ancestor
92374933|NCT04103034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374934|NCT03776760|Sofosbuvir|sofosbuvir|mesh-list
92374935|NCT03776760|Antiviral Agents|antiviral agents|mesh-ancestor
92374936|NCT03776760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92374937|NCT03191526|Mogamulizumab|mogamulizumab|mesh-list
92374938|NCT03191526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374939|NCT01643460|Ethanol|ethanol|mesh-list
92374940|NCT01643460|Paclitaxel|paclitaxel|mesh-list
92374941|NCT01643460|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92374942|NCT01643460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92374943|NCT01643460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374944|NCT01643460|Tubulin Modulators|tubulin modulators|mesh-ancestor
92374945|NCT01643460|Antimitotic Agents|antimitotic agents|mesh-ancestor
92374946|NCT01643460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92374947|NCT01643460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374948|NCT01643460|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92374949|NCT01643460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027424|NCT05509933|Glucocorticoids|glucocorticoids|mesh-ancestor
92374950|NCT01643460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92374951|NCT01643460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374952|NCT00954876|Capecitabine|capecitabine|mesh-list
92374953|NCT00954876|Cetuximab|cetuximab|mesh-list
92374954|NCT00954876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374955|NCT00954876|Antimetabolites|antimetabolites|mesh-ancestor
92374956|NCT00954876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374957|NCT00954876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374958|NCT00954876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374959|NCT05746728|Tislelizumab|tislelizumab|mesh-list
92374960|NCT05746728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374961|NCT05746728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374963|NCT05714670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92374964|NCT05714670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92374965|NCT05714670|Analgesics|analgesics|mesh-ancestor
92374966|NCT05714670|Sensory System Agents|sensory system agents|mesh-ancestor
92374967|NCT05714670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92374968|NCT05714670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374969|NCT05714670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92374970|NCT05714670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92374971|NCT05714670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374972|NCT05714670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374973|NCT05714670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030623|NCT01632891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92374974|NCT05712018|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92374975|NCT05712018|Plasma Substitutes|plasma substitutes|mesh-ancestor
92374976|NCT05712018|Blood Substitutes|blood substitutes|mesh-ancestor
92374977|NCT05606718|Dapagliflozin|dapagliflozin|mesh-list
92374978|NCT05606718|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92374979|NCT05606718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374980|NCT05606718|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92374981|NCT05606718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92374982|NCT05472948|Capecitabine|capecitabine|mesh-list
92374983|NCT05472948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92374984|NCT05472948|Antimetabolites|antimetabolites|mesh-ancestor
92374985|NCT05472948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374986|NCT05472948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374987|NCT05215470|Nivolumab|nivolumab|mesh-list
92374988|NCT05215470|Ipilimumab|ipilimumab|mesh-list
92374989|NCT05215470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92374990|NCT05215470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92374991|NCT05215470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92374992|NCT05215470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92374993|NCT05206500|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92374994|NCT05206500|Amoxicillin|amoxicillin|mesh-list
92374995|NCT05206500|Metronidazole|metronidazole|mesh-list
92374996|NCT05206500|Clindamycin|clindamycin|mesh-list
92374997|NCT05206500|Linezolid|linezolid|mesh-list
92374998|NCT05206500|Tetracycline|tetracycline|mesh-list
92374999|NCT05206500|Penicillins|penicillins|mesh-list
92375000|NCT05206500|Ampicillin|ampicillin|mesh-list
92375001|NCT05206500|Fosfomycin|fosfomycin|mesh-list
92375002|NCT05206500|Nitrofurantoin|nitrofurantoin|mesh-list
92375003|NCT05206500|Cephalosporins|cephalosporins|mesh-list
92375004|NCT05206500|Fluoroquinolones|fluoroquinolones|mesh-list
92375005|NCT05206500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375006|NCT05206500|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92375007|NCT05206500|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92375008|NCT05206500|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92375009|NCT05206500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375010|NCT05206500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375011|NCT05206500|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92375012|NCT05206500|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92375013|NCT05163522|Midazolam|midazolam|mesh-list
92375014|NCT05163522|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92375015|NCT05163522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92375016|NCT05163522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375017|NCT05163522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375018|NCT05163522|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92375019|NCT05163522|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92375020|NCT05163522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92375021|NCT05163522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92375022|NCT05163522|Anesthetics, General|anesthetics, general|mesh-ancestor
92375023|NCT05163522|Anesthetics|anesthetics|mesh-ancestor
92027513|NCT05347069|Aspirin|aspirin|mesh-list
92375024|NCT05163522|GABA Modulators|gaba modulators|mesh-ancestor
92375025|NCT05163522|GABA Agents|gaba agents|mesh-ancestor
92375026|NCT05163522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375027|NCT05163522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375028|NCT05151588|Docetaxel|docetaxel|mesh-list
92375029|NCT05151588|Fluorouracil|fluorouracil|mesh-list
92375030|NCT05151588|Cisplatin|cisplatin|mesh-list
92375031|NCT05151588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375032|NCT05151588|Tubulin Modulators|tubulin modulators|mesh-ancestor
92375033|NCT05151588|Antimitotic Agents|antimitotic agents|mesh-ancestor
92375034|NCT05151588|Mitosis Modulators|mitosis modulators|mesh-ancestor
92375035|NCT05151588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375036|NCT05151588|Antimetabolites|antimetabolites|mesh-ancestor
92375037|NCT05151588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375038|NCT05151588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375039|NCT05151588|Immunologic Factors|immunologic factors|mesh-ancestor
92375040|NCT05151588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375041|NCT04929834|Emollients|emollients|mesh-list
92375042|NCT04929834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375043|NCT04556838|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92375044|NCT04556838|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92375045|NCT04470804|Cyclosporine|cyclosporine|mesh-list
92375046|NCT04470804|Sirolimus|sirolimus|mesh-list
92375047|NCT04470804|Temsirolimus|temsirolimus|mesh-list
92375048|NCT04470804|MTOR Inhibitors|mtor inhibitors|mesh-list
92375049|NCT04470804|Cyclosporins|cyclosporins|mesh-list
92375050|NCT04470804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375051|NCT04470804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375052|NCT04470804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375053|NCT04470804|Immunologic Factors|immunologic factors|mesh-ancestor
92375054|NCT04470804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375055|NCT04470804|Antifungal Agents|antifungal agents|mesh-ancestor
92375056|NCT04470804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375057|NCT04470804|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375058|NCT04470804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375059|NCT04470804|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92375060|NCT04470804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92375061|NCT04470804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92375062|NCT04470804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375063|NCT04470804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375064|NCT04418466|Risperidone|risperidone|mesh-list
92375065|NCT04418466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92375066|NCT04418466|Serotonin Agents|serotonin agents|mesh-ancestor
92375067|NCT04418466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375068|NCT04418466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375069|NCT04418466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375070|NCT04418466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92375071|NCT04418466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92375072|NCT04418466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375073|NCT04418466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92375074|NCT04418466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92375075|NCT04418466|Dopamine Agents|dopamine agents|mesh-ancestor
92375076|NCT04360044|Dronabinol|dronabinol|mesh-list
92375077|NCT04360044|Cannabidiol|cannabidiol|mesh-list
92375078|NCT04360044|Anticonvulsants|anticonvulsants|mesh-ancestor
92375079|NCT04360044|Hallucinogens|hallucinogens|mesh-ancestor
92375080|NCT04360044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375081|NCT04360044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92375082|NCT04360044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375083|NCT04360044|Analgesics|analgesics|mesh-ancestor
92375084|NCT04360044|Sensory System Agents|sensory system agents|mesh-ancestor
92375085|NCT04360044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375086|NCT04360044|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92375087|NCT04360044|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92375088|NCT04360044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375089|NCT04360044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375091|NCT04360044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375092|NCT04337814|Ibuprofen|ibuprofen|mesh-list
92375093|NCT04337814|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92375094|NCT04337814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92375095|NCT04337814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375096|NCT04337814|Analgesics|analgesics|mesh-ancestor
92375097|NCT04337814|Sensory System Agents|sensory system agents|mesh-ancestor
92375098|NCT04337814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375099|NCT04337814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375100|NCT04337814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375101|NCT04337814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375102|NCT04337814|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92375103|NCT04337814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375104|NCT04337814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375105|NCT04337814|Anesthetics, Local|anesthetics, local|mesh-ancestor
92375106|NCT04337814|Anesthetics|anesthetics|mesh-ancestor
92375107|NCT04337814|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375108|NCT04337814|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92375109|NCT04336332|Azithromycin|azithromycin|mesh-list
92375110|NCT04336332|Hydroxychloroquine|hydroxychloroquine|mesh-list
92375111|NCT04336332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92375112|NCT04336332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375113|NCT04336332|Antimalarials|antimalarials|mesh-ancestor
92375114|NCT04336332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92375115|NCT04336332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92375116|NCT04336332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375117|NCT04336332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375118|NCT04336332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375119|NCT04230408|Paclitaxel|paclitaxel|mesh-list
92375120|NCT04230408|Carboplatin|carboplatin|mesh-list
92375121|NCT04230408|Durvalumab|durvalumab|mesh-list
92375122|NCT04230408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92375123|NCT04230408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375124|NCT04230408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92375125|NCT04230408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92375126|NCT04230408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92375127|NCT04230408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375128|NCT04230408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375129|NCT03734016|Zanubrutinib|zanubrutinib|mesh-list
92375130|NCT03734016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375131|NCT03734016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375132|NCT03734016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375133|NCT03734016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375134|NCT03064542|Carbimazole|carbimazole|mesh-list
92375135|NCT03064542|Antithyroid Agents|antithyroid agents|mesh-ancestor
92375136|NCT03064542|Hormone Antagonists|hormone antagonists|mesh-ancestor
92375137|NCT03064542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375138|NCT03064542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375139|NCT02718066|Nivolumab|nivolumab|mesh-list
92375140|NCT02718066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375141|NCT02718066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375142|NCT02718066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92375143|NCT02718066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375144|NCT02004522|Ofatumumab|ofatumumab|mesh-list
92375145|NCT02004522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375147|NCT01472562|Lenalidomide|lenalidomide|mesh-list
92375148|NCT01472562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375149|NCT01472562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375150|NCT01472562|Immunologic Factors|immunologic factors|mesh-ancestor
92375151|NCT01472562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375152|NCT01472562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375153|NCT01472562|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92375154|NCT01472562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92375155|NCT01472562|Growth Substances|growth substances|mesh-ancestor
92375156|NCT01472562|Growth Inhibitors|growth inhibitors|mesh-ancestor
92375157|NCT01430442|Sumatriptan|sumatriptan|mesh-list
92375158|NCT01430442|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92375159|NCT01430442|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92375160|NCT01430442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92375161|NCT01430442|Serotonin Agents|serotonin agents|mesh-ancestor
92375162|NCT01430442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375163|NCT01430442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375164|NCT01430442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375165|NCT01420926|Bortezomib|bortezomib|mesh-list
92375166|NCT01420926|Decitabine|decitabine|mesh-list
92375167|NCT01420926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375168|NCT01420926|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375169|NCT01420926|Antimetabolites|antimetabolites|mesh-ancestor
92375170|NCT01420926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375171|NCT01420926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375172|NCT01881828|Metformin|metformin|mesh-list
92375173|NCT01881828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92375174|NCT01881828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375175|NCT01887132|Donepezil|donepezil|mesh-list
92375176|NCT01887132|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92375177|NCT01887132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375178|NCT01887132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375179|NCT01887132|Cholinergic Agents|cholinergic agents|mesh-ancestor
92375180|NCT01887132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933067|NCT02357277|Budesonide|budesonide|mesh-list
92375181|NCT01887132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375183|NCT01887990|Ketamine|ketamine|mesh-list
92375184|NCT01887990|Analgesics|analgesics|mesh-ancestor
92375185|NCT01887990|Sensory System Agents|sensory system agents|mesh-ancestor
92375186|NCT01887990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375187|NCT01887990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375188|NCT01887990|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92375189|NCT01887990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92375190|NCT01887990|Anesthetics, General|anesthetics, general|mesh-ancestor
92375191|NCT01887990|Anesthetics|anesthetics|mesh-ancestor
92375192|NCT01887990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933119|NCT02360007|Analgesics|analgesics|mesh-ancestor
92375193|NCT01887990|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92375194|NCT01887990|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92375195|NCT01887990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375196|NCT01887990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375198|NCT01890642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92375199|NCT01890642|Anesthetics|anesthetics|mesh-ancestor
92375200|NCT01890642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375201|NCT01890642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375202|NCT01890642|Sensory System Agents|sensory system agents|mesh-ancestor
92375203|NCT01890642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375204|NCT01890642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92375205|NCT01890642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92375206|NCT01890642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92375207|NCT01890642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375208|NCT01890642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375209|NCT01891968|Bortezomib|bortezomib|mesh-list
92375210|NCT01891968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375211|NCT01901250|Fluorides|fluorides|mesh-list
92375212|NCT01901250|Fluorides, Topical|fluorides, topical|mesh-list
92375213|NCT01901250|Cariostatic Agents|cariostatic agents|mesh-ancestor
92375214|NCT01901250|Protective Agents|protective agents|mesh-ancestor
92375215|NCT01901250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375216|NCT01904526|Guanfacine|guanfacine|mesh-list
92375217|NCT01904526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92375218|NCT01904526|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92375219|NCT01904526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92375220|NCT01904526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92375221|NCT01904526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375222|NCT01904526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375223|NCT01904526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375224|NCT01904526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375225|NCT01906866|Melatonin|melatonin|mesh-list
92375226|NCT01906866|Antioxidants|antioxidants|mesh-ancestor
92375227|NCT01906866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375228|NCT01906866|Protective Agents|protective agents|mesh-ancestor
92375229|NCT01906866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375230|NCT01906866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375231|NCT01907334|Fluticasone|fluticasone|mesh-list
92375232|NCT01907334|Xhance|xhance|mesh-list
92375233|NCT01907334|Albuterol|albuterol|mesh-list
92375234|NCT01907334|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92375235|NCT01907334|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92375236|NCT01907334|Methacholine Chloride|methacholine chloride|mesh-list
92375237|NCT01907334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933305|NCT02352597|Hormones|hormones|mesh-ancestor
92375238|NCT01907334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92375239|NCT01907334|Autonomic Agents|autonomic agents|mesh-ancestor
92375240|NCT01907334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375241|NCT01907334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375242|NCT01907334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92375243|NCT01907334|Respiratory System Agents|respiratory system agents|mesh-ancestor
92375244|NCT01907334|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375245|NCT01907334|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92375246|NCT01907334|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92027720|NCT05280223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375247|NCT01907334|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92375248|NCT01907334|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92030639|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
92375249|NCT01907334|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375250|NCT01907334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375251|NCT01907334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375252|NCT01907334|Tocolytic Agents|tocolytic agents|mesh-ancestor
92375253|NCT01907334|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375255|NCT01907334|Hormones|hormones|mesh-ancestor
92375256|NCT01907334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375257|NCT01907334|Sympathomimetics|sympathomimetics|mesh-ancestor
92375258|NCT01907334|Miotics|miotics|mesh-ancestor
92375259|NCT01907334|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92375260|NCT01907334|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92375261|NCT01907334|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92375262|NCT01907334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92375263|NCT01907334|Cholinergic Agents|cholinergic agents|mesh-ancestor
92375264|NCT01907490|Benzyl Alcohol|benzyl alcohol|mesh-list
92375265|NCT01907490|Anesthetics, Local|anesthetics, local|mesh-ancestor
92375266|NCT01907490|Anesthetics|anesthetics|mesh-ancestor
92375267|NCT01907490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375268|NCT01907490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375269|NCT01907490|Sensory System Agents|sensory system agents|mesh-ancestor
92375270|NCT01907490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375271|NCT01908972|Prednisolone|prednisolone|mesh-list
92375272|NCT01908972|Propranolol|propranolol|mesh-list
92375273|NCT01908972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375274|NCT01908972|Glucocorticoids|glucocorticoids|mesh-ancestor
92375275|NCT01908972|Hormones|hormones|mesh-ancestor
92375276|NCT01908972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375277|NCT01908972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375278|NCT01908972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92375279|NCT01908972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375280|NCT01908972|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92375281|NCT01908972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91933477|NCT02292121|Mannitol|mannitol|mesh-list
92375282|NCT01908972|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375283|NCT01908972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375284|NCT01908972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375285|NCT01908972|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92375286|NCT01908972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92375287|NCT01908972|Vasodilator Agents|vasodilator agents|mesh-ancestor
92375288|NCT01910064|Adapalene|adapalene|mesh-list
92375289|NCT01910064|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92375290|NCT01910064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375291|NCT01910064|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92375292|NCT01910064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375293|NCT01910064|Analgesics|analgesics|mesh-ancestor
91933543|NCT03520543|Mydriatics|mydriatics|mesh-ancestor
92375294|NCT01910064|Sensory System Agents|sensory system agents|mesh-ancestor
92375295|NCT01910064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375296|NCT01910064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375297|NCT01910064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375298|NCT01910064|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375299|NCT01912716|Indomethacin|indomethacin|mesh-list
92375300|NCT01912716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92375301|NCT01912716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375302|NCT01912716|Analgesics|analgesics|mesh-ancestor
92375303|NCT01912716|Sensory System Agents|sensory system agents|mesh-ancestor
92375304|NCT01912716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375305|NCT01912716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933605|NCT03516955|Antimetabolites|antimetabolites|mesh-ancestor
92375306|NCT01912716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375307|NCT01912716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375308|NCT01912716|Gout Suppressants|gout suppressants|mesh-ancestor
92375309|NCT01912716|Tocolytic Agents|tocolytic agents|mesh-ancestor
92375310|NCT01912716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375311|NCT01912716|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92375312|NCT01912716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375313|NCT01912716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375314|NCT01920282|Nebivolol|nebivolol|mesh-list
92375315|NCT01920282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92375316|NCT01920282|Vasodilator Agents|vasodilator agents|mesh-ancestor
92375317|NCT01920282|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92375318|NCT01920282|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92375319|NCT01920282|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92375320|NCT01920282|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375321|NCT01920282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120195|NCT02389738|Temozolomide|temozolomide|mesh-list
92027793|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375322|NCT01920282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375323|NCT01920282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375324|NCT01921296|Cyclobenzaprine|cyclobenzaprine|mesh-list
92375325|NCT01921296|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92375326|NCT01921296|Antidepressive Agents|antidepressive agents|mesh-ancestor
92375327|NCT01921296|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92375328|NCT01921296|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92375329|NCT01921296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375330|NCT01921296|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92375331|NCT01921296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375332|NCT01921296|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92375333|NCT01921296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375335|NCT01929642|Everolimus|everolimus|mesh-list
92375336|NCT01929642|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92375337|NCT01929642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91933813|NCT02296021|Bismuth|bismuth|mesh-list
92375338|NCT01929642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375339|NCT01929642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375340|NCT01929642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375341|NCT01929642|Immunologic Factors|immunologic factors|mesh-ancestor
92375342|NCT01929642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375343|NCT01929642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375344|NCT01929642|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92375345|NCT01929642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375346|NCT01929642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92375347|NCT01929642|Antifungal Agents|antifungal agents|mesh-ancestor
92375348|NCT01932060|Oxytocin|oxytocin|mesh-list
92375349|NCT01932060|Oxytocics|oxytocics|mesh-ancestor
92375350|NCT01932060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375351|NCT01932060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375352|NCT01933464|Cromolyn Sodium|cromolyn sodium|mesh-list
92375353|NCT01933464|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92375354|NCT01933464|Immunologic Factors|immunologic factors|mesh-ancestor
92375355|NCT01933464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375356|NCT01933464|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92375357|NCT01933464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375358|NCT01933464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92375359|NCT01933464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92375360|NCT01933776|Vaccines|vaccines|mesh-list
92375361|NCT01933776|Immunologic Factors|immunologic factors|mesh-ancestor
92375362|NCT01933776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375363|NCT01936896|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92375364|NCT01936896|Protein C Inhibitor|protein c inhibitor|mesh-list
92375365|NCT01936896|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92375366|NCT01936896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92375367|NCT01936896|Protease Inhibitors|protease inhibitors|mesh-ancestor
92375368|NCT01936896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375369|NCT01936896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375370|NCT01937598|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92375371|NCT01937598|Liraglutide|liraglutide|mesh-list
91933990|NCT02229617|Testosterone|testosterone|mesh-list
92375372|NCT01937598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92375373|NCT01937598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375374|NCT01937598|Incretins|incretins|mesh-ancestor
92375375|NCT01937598|Hormones|hormones|mesh-ancestor
92375376|NCT01937598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375377|NCT01937598|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92375378|NCT01937598|Protease Inhibitors|protease inhibitors|mesh-ancestor
92375379|NCT01937598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375380|NCT01937598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934071|NCT03515707|Etoposide|etoposide|mesh-list
92375381|NCT01942668|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92375382|NCT01942668|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92375383|NCT01942668|Estradiol|estradiol|mesh-list
92375384|NCT01942668|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92375385|NCT01942668|Progesterone|progesterone|mesh-list
92375386|NCT01942668|Estrogens|estrogens|mesh-ancestor
92375388|NCT01942668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375389|NCT01942668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375390|NCT01942668|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92375391|NCT01942668|Contraceptive Agents|contraceptive agents|mesh-ancestor
92375392|NCT01942668|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375393|NCT01942668|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92375394|NCT01942668|Progestins|progestins|mesh-ancestor
92375395|NCT01948518|Sildenafil Citrate|sildenafil citrate|mesh-list
92375396|NCT01948518|Vasodilator Agents|vasodilator agents|mesh-ancestor
92375397|NCT01948518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92375398|NCT01948518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92375399|NCT01948518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375400|NCT01948518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375401|NCT01948518|Urological Agents|urological agents|mesh-ancestor
92375402|NCT01948986|Ertugliflozin|ertugliflozin|mesh-list
92375403|NCT01948986|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92375404|NCT01948986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375405|NCT01948986|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92375406|NCT01948986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375407|NCT01949844|Regadenoson|regadenoson|mesh-list
92375408|NCT01949844|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92375409|NCT01949844|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92375410|NCT01949844|Purinergic Agonists|purinergic agonists|mesh-ancestor
92375411|NCT01949844|Purinergic Agents|purinergic agents|mesh-ancestor
92375412|NCT01949844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375413|NCT01949844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375414|NCT01949844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375415|NCT01951950|Nicardipine|nicardipine|mesh-list
92375416|NCT01951950|Esmolol|esmolol|mesh-list
92375417|NCT01951950|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92375418|NCT01951950|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92375419|NCT01951950|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92375420|NCT01951950|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375421|NCT01951950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375422|NCT01951950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375423|NCT01951950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375424|NCT01951950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92375425|NCT01951950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92375426|NCT01951950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375427|NCT01951950|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92375428|NCT01951950|Vasodilator Agents|vasodilator agents|mesh-ancestor
92375429|NCT01953432|Doxazosin|doxazosin|mesh-list
92375430|NCT01953432|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92375431|NCT01953432|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92375432|NCT01953432|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92375433|NCT01953432|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92375434|NCT01953432|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375435|NCT01953432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375436|NCT01953432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375437|NCT01953432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375438|NCT01955382|Artesunate|artesunate|mesh-list
92375439|NCT01955382|Amodiaquine|amodiaquine|mesh-list
92375440|NCT01955382|Charcoal|charcoal|mesh-list
92375441|NCT01955382|Antimalarials|antimalarials|mesh-ancestor
92375442|NCT01955382|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92375443|NCT01955382|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91934324|NCT03149445|Metoprolol|metoprolol|mesh-list
92375444|NCT01955382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375445|NCT01955382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375446|NCT01955382|Antiviral Agents|antiviral agents|mesh-ancestor
92375447|NCT01955382|Schistosomicides|schistosomicides|mesh-ancestor
92375448|NCT01955382|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92375449|NCT01955382|Anthelmintics|anthelmintics|mesh-ancestor
92375450|NCT01955382|Antidotes|antidotes|mesh-ancestor
92375451|NCT01955382|Protective Agents|protective agents|mesh-ancestor
92375452|NCT01955382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375454|NCT01957410|Analgesics|analgesics|mesh-ancestor
92375455|NCT01957410|Sensory System Agents|sensory system agents|mesh-ancestor
92120196|NCT02389738|Regadenoson|regadenoson|mesh-list
92375456|NCT01957410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375457|NCT01957410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937689|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375458|NCT01957410|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92375460|NCT01957410|Anesthetics, General|anesthetics, general|mesh-ancestor
92375461|NCT01957410|Anesthetics|anesthetics|mesh-ancestor
92375462|NCT01957410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375463|NCT01957410|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92375464|NCT01957410|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92375465|NCT01957410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375466|NCT01957410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375467|NCT01958112|Trametinib|trametinib|mesh-list
92375468|NCT01958112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375469|NCT01958112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375470|NCT01958112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027939|NCT05148949|Vaccines|vaccines|mesh-list
92375471|NCT01958112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375472|NCT05740098|Nicotine|nicotine|mesh-list
92375473|NCT05740098|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92375474|NCT05740098|Autonomic Agents|autonomic agents|mesh-ancestor
92375475|NCT05740098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375476|NCT05740098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375477|NCT05740098|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92375478|NCT05740098|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92375479|NCT05740098|Cholinergic Agents|cholinergic agents|mesh-ancestor
92375480|NCT05740098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375481|NCT05740098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375482|NCT05739786|Vitamin D|vitamin d|mesh-list
92375483|NCT05739786|Cholecalciferol|cholecalciferol|mesh-list
92375484|NCT05739786|Vitamins|vitamins|mesh-ancestor
92375485|NCT05739786|Micronutrients|micronutrients|mesh-ancestor
92375486|NCT05739786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375487|NCT05739786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92375488|NCT05739786|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92375489|NCT05739630|Cytarabine|cytarabine|mesh-list
92375490|NCT05739630|Cyclophosphamide|cyclophosphamide|mesh-list
92375491|NCT05739630|Busulfan|busulfan|mesh-list
92375492|NCT05739630|Fludarabine|fludarabine|mesh-list
92375493|NCT05739630|Mitoxantrone|mitoxantrone|mesh-list
92375494|NCT05739630|Tacrolimus|tacrolimus|mesh-list
92375495|NCT05739630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375496|NCT05739630|Immunologic Factors|immunologic factors|mesh-ancestor
92375497|NCT05739630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375498|NCT05739630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375499|NCT05739630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92375500|NCT05739630|Alkylating Agents|alkylating agents|mesh-ancestor
92375501|NCT05739630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375502|NCT05739630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375503|NCT05739630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92375504|NCT05739630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375505|NCT05739630|Antimetabolites|antimetabolites|mesh-ancestor
92375506|NCT05739630|Antiviral Agents|antiviral agents|mesh-ancestor
92375507|NCT05739630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375508|NCT05739630|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92375509|NCT05739630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375510|NCT05739630|Analgesics|analgesics|mesh-ancestor
92375511|NCT05739630|Sensory System Agents|sensory system agents|mesh-ancestor
92375512|NCT05739630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375513|NCT05739630|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92375514|NCT05739630|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92375515|NCT05739474|Vaccines|vaccines|mesh-list
92375516|NCT05739474|Immunologic Factors|immunologic factors|mesh-ancestor
92375517|NCT05739474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375519|NCT05739006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375520|NCT05739006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375521|NCT05739006|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92375522|NCT05739006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375523|NCT05738616|Lenvatinib|lenvatinib|mesh-list
92375524|NCT05738616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375525|NCT05738616|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375526|NCT05738616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375527|NCT05738616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375528|NCT05738460|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92375529|NCT05738460|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92375530|NCT05738460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375531|NCT05738460|Antitubercular Agents|antitubercular agents|mesh-ancestor
92375532|NCT05738382|Cetrorelix|cetrorelix|mesh-list
92375533|NCT05738382|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92375534|NCT05738382|Fertility Agents|fertility agents|mesh-ancestor
92375535|NCT05738382|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375536|NCT05738382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375537|NCT05738382|Hormone Antagonists|hormone antagonists|mesh-ancestor
92375538|NCT05738382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375539|NCT05737680|Hydroxychloroquine|hydroxychloroquine|mesh-list
92375540|NCT05737680|Colchicine|colchicine|mesh-list
92375541|NCT05737680|Antimalarials|antimalarials|mesh-ancestor
92375542|NCT05737680|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92375543|NCT05737680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92375544|NCT05737680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375545|NCT05737680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375546|NCT05737680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375547|NCT05737680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375548|NCT05737680|Gout Suppressants|gout suppressants|mesh-ancestor
92375549|NCT05737680|Tubulin Modulators|tubulin modulators|mesh-ancestor
92375550|NCT05737680|Antimitotic Agents|antimitotic agents|mesh-ancestor
92375551|NCT05737680|Mitosis Modulators|mitosis modulators|mesh-ancestor
92375552|NCT05737680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375553|NCT05735028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92375554|NCT05735028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120345|NCT02450214|Ketamine|ketamine|mesh-list
92375555|NCT05735028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375556|NCT05735028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375557|NCT05725200|Gemcitabine|gemcitabine|mesh-list
92375558|NCT05725200|Methotrexate|methotrexate|mesh-list
92375559|NCT05725200|Pembrolizumab|pembrolizumab|mesh-list
92375560|NCT05725200|Trastuzumab|trastuzumab|mesh-list
92375562|NCT05725200|Everolimus|everolimus|mesh-list
92375563|NCT05725200|Venetoclax|venetoclax|mesh-list
92375564|NCT05725200|Dasatinib|dasatinib|mesh-list
92375565|NCT05725200|Palbociclib|palbociclib|mesh-list
92375566|NCT05725200|Crizotinib|crizotinib|mesh-list
92375567|NCT05725200|Panobinostat|panobinostat|mesh-list
92375568|NCT05725200|Talazoparib|talazoparib|mesh-list
92375569|NCT05725200|Idelalisib|idelalisib|mesh-list
92375570|NCT05725200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375571|NCT05725200|Antimetabolites|antimetabolites|mesh-ancestor
92375572|NCT05725200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375573|NCT05725200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375574|NCT05725200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375575|NCT05725200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92375576|NCT05725200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92375577|NCT05725200|Abortifacient Agents|abortifacient agents|mesh-ancestor
92375578|NCT05725200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375579|NCT05725200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375580|NCT05725200|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375581|NCT05725200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375582|NCT05725200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92375583|NCT05725200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375584|NCT05725200|Immunologic Factors|immunologic factors|mesh-ancestor
92375585|NCT05725200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375586|NCT05725200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92375587|NCT05725200|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92375588|NCT05725200|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375589|NCT05725200|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92375590|NCT05725200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92375591|NCT05721144|Nitric Oxide|nitric oxide|mesh-list
92375592|NCT05721144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92375593|NCT05721144|Autonomic Agents|autonomic agents|mesh-ancestor
92375594|NCT05721144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375595|NCT05721144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375596|NCT05721144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92375597|NCT05721144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92375598|NCT05721144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92375599|NCT05721144|Antioxidants|antioxidants|mesh-ancestor
92375600|NCT05721144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375601|NCT05721144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375602|NCT05721144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92375603|NCT05721144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92375604|NCT05721144|Gasotransmitters|gasotransmitters|mesh-ancestor
92375605|NCT05721144|Protective Agents|protective agents|mesh-ancestor
92375606|NCT05685732|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92375607|NCT05685732|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92375608|NCT05685732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375609|NCT05685732|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92375610|NCT05685732|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92375611|NCT05685732|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375612|NCT05685732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375613|NCT05685732|Dopamine Agents|dopamine agents|mesh-ancestor
92375614|NCT05685732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375616|NCT05574894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375617|NCT05574894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375618|NCT05567952|Ritonavir|ritonavir|mesh-list
92375619|NCT05567952|Nirmatrelvir|nirmatrelvir|mesh-list
92375620|NCT05567952|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92375621|NCT05567952|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92375622|NCT05567952|Protease Inhibitors|protease inhibitors|mesh-ancestor
92375623|NCT05567952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375624|NCT05567952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375625|NCT05567952|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91934906|NCT02307565|Midodrine|midodrine|mesh-list
92375626|NCT05567952|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92375627|NCT05567952|Antiviral Agents|antiviral agents|mesh-ancestor
92375628|NCT05567952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375629|NCT05567952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92375630|NCT05567952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92375631|NCT05530278|Midazolam|midazolam|mesh-list
92375632|NCT05530278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92375633|NCT05530278|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92375634|NCT05530278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375635|NCT05530278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375636|NCT05530278|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92375637|NCT05530278|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92375638|NCT05530278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92375639|NCT05530278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92375640|NCT05530278|Anesthetics, General|anesthetics, general|mesh-ancestor
92375641|NCT05530278|Anesthetics|anesthetics|mesh-ancestor
92375642|NCT05530278|GABA Modulators|gaba modulators|mesh-ancestor
92375643|NCT05530278|GABA Agents|gaba agents|mesh-ancestor
92375644|NCT05530278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375645|NCT05530278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375646|NCT05436288|Hyaluronic Acid|hyaluronic acid|mesh-list
92375647|NCT05436288|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92375648|NCT05436288|Immunologic Factors|immunologic factors|mesh-ancestor
92375649|NCT05436288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375650|NCT05436288|Viscosupplements|viscosupplements|mesh-ancestor
92375651|NCT05436288|Protective Agents|protective agents|mesh-ancestor
92375652|NCT05245734|Immunoglobulins|immunoglobulins|mesh-list
92375653|NCT05245734|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92375654|NCT05245734|Antibodies|antibodies|mesh-list
92375655|NCT05245734|gamma-Globulins|gamma-globulins|mesh-list
92375656|NCT05245734|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92375657|NCT05245734|Immunologic Factors|immunologic factors|mesh-ancestor
92375658|NCT05245734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375660|NCT05242692|Ketamine|ketamine|mesh-list
92375661|NCT05242692|Esketamine|esketamine|mesh-list
92375662|NCT05242692|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92375663|NCT05242692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375664|NCT05242692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375665|NCT05242692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375666|NCT05242692|Analgesics|analgesics|mesh-ancestor
92375667|NCT05242692|Sensory System Agents|sensory system agents|mesh-ancestor
92375668|NCT05242692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375669|NCT05242692|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92375670|NCT05242692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92375671|NCT05242692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92375672|NCT05242692|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375673|NCT05242692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375674|NCT05242692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375675|NCT05242692|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92375676|NCT05242692|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92375677|NCT05242692|Anesthetics, General|anesthetics, general|mesh-ancestor
92375678|NCT05242692|Anesthetics|anesthetics|mesh-ancestor
92375679|NCT05242692|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92375680|NCT05242692|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92375682|NCT05242692|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92375683|NCT05087940|Diuretics|diuretics|mesh-list
92375684|NCT05087940|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92375685|NCT05087940|Natriuretic Agents|natriuretic agents|mesh-ancestor
92375686|NCT05087940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375687|NCT05087940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375688|NCT05087940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375689|NCT04964934|Letrozole|letrozole|mesh-list
92375690|NCT04964934|Palbociclib|palbociclib|mesh-list
92375691|NCT04964934|Anastrozole|anastrozole|mesh-list
92375692|NCT04964934|Hormones|hormones|mesh-list
92375693|NCT04964934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92375694|NCT04964934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375695|NCT04964934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375696|NCT04964934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375697|NCT04964934|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92375698|NCT04964934|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92375699|NCT04964934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375700|NCT04964934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375701|NCT04964934|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92375702|NCT04964934|Hormone Antagonists|hormone antagonists|mesh-ancestor
92375703|NCT04964934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375704|NCT04964934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92375706|NCT04922658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92375707|NCT04922658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375708|NCT04922658|Tubulin Modulators|tubulin modulators|mesh-ancestor
92375709|NCT04922658|Antimitotic Agents|antimitotic agents|mesh-ancestor
92375710|NCT04922658|Mitosis Modulators|mitosis modulators|mesh-ancestor
92375711|NCT04922658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375712|NCT04883346|Liraglutide|liraglutide|mesh-list
92375713|NCT04883346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92375714|NCT04883346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375715|NCT04883346|Incretins|incretins|mesh-ancestor
92375716|NCT04883346|Hormones|hormones|mesh-ancestor
92375717|NCT04883346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375718|NCT04438902|Osimertinib|osimertinib|mesh-list
92375719|NCT04438902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375720|NCT04438902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92375721|NCT04438902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375722|NCT04438902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375723|NCT04346394|Yohimbine|yohimbine|mesh-list
92375724|NCT04346394|Mydriatics|mydriatics|mesh-ancestor
92375725|NCT04346394|Autonomic Agents|autonomic agents|mesh-ancestor
92375726|NCT04346394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375727|NCT04346394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375728|NCT04346394|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92375729|NCT04346394|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92375730|NCT04346394|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92375731|NCT04346394|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375732|NCT04346394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375733|NCT04346394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375734|NCT04346394|Urological Agents|urological agents|mesh-ancestor
92375735|NCT04329390|Anticoagulants|anticoagulants|mesh-list
92375736|NCT04177602|Trifluridine|trifluridine|mesh-list
92375737|NCT04177602|Capecitabine|capecitabine|mesh-list
92375738|NCT04177602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375739|NCT04177602|Antimetabolites|antimetabolites|mesh-ancestor
92375740|NCT04177602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375741|NCT04177602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375742|NCT04177602|Antiviral Agents|antiviral agents|mesh-ancestor
92375743|NCT04177602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375744|NCT03868956|Fibrin fragment D|fibrin fragment d|mesh-list
92375745|NCT03868956|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92375746|NCT03868956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92375747|NCT03868956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375748|NCT03868956|Hemostatics|hemostatics|mesh-ancestor
92375749|NCT03868956|Coagulants|coagulants|mesh-ancestor
92375750|NCT03816618|Fusidic Acid|fusidic acid|mesh-list
92375751|NCT03816618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92375752|NCT03816618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375753|NCT03816618|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92375754|NCT03816618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375755|NCT03816618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375756|NCT03616236|Buprenorphine|buprenorphine|mesh-list
92375757|NCT03616236|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92375758|NCT03616236|Naloxone|naloxone|mesh-list
92375759|NCT03616236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92375760|NCT03616236|Narcotics|narcotics|mesh-ancestor
92375761|NCT03616236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375762|NCT03616236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375763|NCT03616236|Analgesics|analgesics|mesh-ancestor
92375764|NCT03616236|Sensory System Agents|sensory system agents|mesh-ancestor
92375765|NCT03616236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375766|NCT03616236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92375767|NCT03551730|Enoxaparin|enoxaparin|mesh-list
92375768|NCT03551730|Enoxaparin sodium|enoxaparin sodium|mesh-list
92375769|NCT03551730|Anticoagulants|anticoagulants|mesh-ancestor
92375770|NCT03551730|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92375771|NCT03551730|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92375772|NCT03551730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375773|NCT03462342|Olaparib|olaparib|mesh-list
92375774|NCT03462342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92375775|NCT03462342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375776|NCT03462342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375777|NCT03462342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375778|NCT03366480|Paclitaxel|paclitaxel|mesh-list
92375779|NCT03366480|Carboplatin|carboplatin|mesh-list
92375780|NCT03366480|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92375781|NCT03366480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375782|NCT03366480|Tubulin Modulators|tubulin modulators|mesh-ancestor
92375783|NCT03366480|Antimitotic Agents|antimitotic agents|mesh-ancestor
92375784|NCT03366480|Mitosis Modulators|mitosis modulators|mesh-ancestor
92375785|NCT03366480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375786|NCT03024996|Atezolizumab|atezolizumab|mesh-list
92375787|NCT03024996|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92375788|NCT03024996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375789|NCT03024996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375790|NCT03024996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375791|NCT02867124|Naltrexone|naltrexone|mesh-list
92375792|NCT02867124|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92375793|NCT02867124|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92375794|NCT02867124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375795|NCT02867124|Sensory System Agents|sensory system agents|mesh-ancestor
92375796|NCT02867124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375797|NCT02534376|Simvastatin|simvastatin|mesh-list
92375798|NCT02534376|Ezetimibe|ezetimibe|mesh-list
92375799|NCT02534376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92375800|NCT02534376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92375801|NCT02534376|Antimetabolites|antimetabolites|mesh-ancestor
92375802|NCT02534376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375803|NCT02534376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92375804|NCT02534376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92375805|NCT02534376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375806|NCT02216838|Botulinum Toxins|botulinum toxins|mesh-list
92375807|NCT02216838|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92375808|NCT02216838|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92375809|NCT02216838|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92375810|NCT02216838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375811|NCT02216838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375812|NCT02216838|Cholinergic Agents|cholinergic agents|mesh-ancestor
92375813|NCT02216838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375814|NCT02216838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375815|NCT02216838|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92375816|NCT02216838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375817|NCT02065596|Fludarabine|fludarabine|mesh-list
92375818|NCT02065596|Fludarabine phosphate|fludarabine phosphate|mesh-list
92375819|NCT02065596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375820|NCT02065596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375821|NCT02065596|Antimetabolites|antimetabolites|mesh-ancestor
92375822|NCT02065596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375823|NCT02065596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375824|NCT02065596|Immunologic Factors|immunologic factors|mesh-ancestor
92375825|NCT02065596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375826|NCT01976286|Salicylic Acid|salicylic acid|mesh-list
92375827|NCT01976286|Salicylates|salicylates|mesh-list
92375828|NCT01976286|Glycolic acid|glycolic acid|mesh-list
92375829|NCT01976286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375830|NCT01976286|Antifungal Agents|antifungal agents|mesh-ancestor
92375831|NCT01976286|Keratolytic Agents|keratolytic agents|mesh-ancestor
92375832|NCT01976286|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375833|NCT01976286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92375834|NCT01976286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375835|NCT01976286|Analgesics|analgesics|mesh-ancestor
92375836|NCT01976286|Sensory System Agents|sensory system agents|mesh-ancestor
92375837|NCT01976286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375838|NCT01976286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375839|NCT01976286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375840|NCT01976286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375841|NCT01976286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92375842|NCT01976286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375843|NCT01976286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375844|NCT01858740|Methotrexate|methotrexate|mesh-list
92375845|NCT01858740|Fludarabine phosphate|fludarabine phosphate|mesh-list
92375846|NCT01858740|Fludarabine|fludarabine|mesh-list
92375848|NCT01858740|Tacrolimus|tacrolimus|mesh-list
92375849|NCT01858740|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92375850|NCT01858740|Abortifacient Agents|abortifacient agents|mesh-ancestor
92375851|NCT01858740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375852|NCT01858740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375853|NCT01858740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92375854|NCT01858740|Antimetabolites|antimetabolites|mesh-ancestor
92375855|NCT01858740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375856|NCT01858740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375857|NCT01858740|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375858|NCT01858740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92375859|NCT01858740|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92375860|NCT01858740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92375861|NCT01858740|Immunologic Factors|immunologic factors|mesh-ancestor
92030705|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
92375863|NCT01858740|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92375864|NCT01858740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92375865|NCT01858740|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92375866|NCT01858740|Alkylating Agents|alkylating agents|mesh-ancestor
92375867|NCT01858740|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92375869|NCT01688076|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92375870|NCT01688076|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92375871|NCT01688076|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92375872|NCT01688076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375873|NCT01688076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375874|NCT01688076|Cholinergic Agents|cholinergic agents|mesh-ancestor
92375875|NCT01688076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375876|NCT01688076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375877|NCT01688076|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92375878|NCT01688076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375879|NCT01239030|Methylphenidate|methylphenidate|mesh-list
92375880|NCT01239030|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92375881|NCT01239030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375882|NCT01239030|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92375883|NCT01239030|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92375884|NCT01239030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92375885|NCT01239030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375886|NCT01239030|Dopamine Agents|dopamine agents|mesh-ancestor
92375887|NCT01239030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375888|NCT01086540|Acetaminophen|acetaminophen|mesh-list
92375889|NCT01086540|Diphenhydramine|diphenhydramine|mesh-list
92375890|NCT01086540|Promethazine|promethazine|mesh-list
92375891|NCT01086540|Prednisone|prednisone|mesh-list
92375892|NCT01086540|Methylprednisolone|methylprednisolone|mesh-list
92375893|NCT01086540|Rituximab|rituximab|mesh-list
92375894|NCT01086540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375895|NCT01086540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375896|NCT01086540|Immunologic Factors|immunologic factors|mesh-ancestor
92375897|NCT01086540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375898|NCT01086540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375899|NCT01086540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375900|NCT01086540|Glucocorticoids|glucocorticoids|mesh-ancestor
92375901|NCT01086540|Hormones|hormones|mesh-ancestor
92375902|NCT01086540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375903|NCT01086540|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92375904|NCT01086540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92375905|NCT01086540|Analgesics|analgesics|mesh-ancestor
92375906|NCT01086540|Sensory System Agents|sensory system agents|mesh-ancestor
92375907|NCT01086540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375908|NCT01086540|Antipyretics|antipyretics|mesh-ancestor
92375909|NCT01086540|Antiemetics|antiemetics|mesh-ancestor
92375910|NCT01086540|Autonomic Agents|autonomic agents|mesh-ancestor
92375911|NCT01086540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92375912|NCT01086540|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92375913|NCT01086540|Protective Agents|protective agents|mesh-ancestor
92375914|NCT01086540|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92375915|NCT01086540|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92375916|NCT01086540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92375917|NCT01086540|Anesthetics, Local|anesthetics, local|mesh-ancestor
92375918|NCT01086540|Anesthetics|anesthetics|mesh-ancestor
92375919|NCT01086540|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92028391|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
92375920|NCT01086540|Histamine Antagonists|histamine antagonists|mesh-ancestor
92375921|NCT01086540|Histamine Agents|histamine agents|mesh-ancestor
92375922|NCT01086540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375923|NCT01086540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375924|NCT01086540|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92375925|NCT01086540|Antipruritics|antipruritics|mesh-ancestor
92375926|NCT01086540|Dermatologic Agents|dermatologic agents|mesh-ancestor
92375927|NCT01962870|Vasopressins|vasopressins|mesh-list
92375928|NCT01962870|Arginine Vasopressin|arginine vasopressin|mesh-list
92375929|NCT01962870|Hemostatics|hemostatics|mesh-ancestor
92375930|NCT01962870|Coagulants|coagulants|mesh-ancestor
92375931|NCT01962870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92375932|NCT01962870|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92375933|NCT01962870|Natriuretic Agents|natriuretic agents|mesh-ancestor
92375934|NCT01962870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375935|NCT01965366|Dexamethasone|dexamethasone|mesh-list
92375936|NCT01965366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92375937|NCT01965366|Antiemetics|antiemetics|mesh-ancestor
92375938|NCT01965366|Autonomic Agents|autonomic agents|mesh-ancestor
92375939|NCT01965366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92375940|NCT01965366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375941|NCT01965366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92375942|NCT01965366|Glucocorticoids|glucocorticoids|mesh-ancestor
92375943|NCT01965366|Hormones|hormones|mesh-ancestor
92375944|NCT01965366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375945|NCT01965366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92375946|NCT01965366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375947|NCT01965756|Metformin|metformin|mesh-list
92375948|NCT01965756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92375949|NCT01965756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375950|NCT01967862|Listerine|listerine|mesh-list
92375951|NCT01967862|Fluorides|fluorides|mesh-list
92375952|NCT01967862|Sodium Fluoride|sodium fluoride|mesh-list
92375953|NCT01967862|Cariostatic Agents|cariostatic agents|mesh-ancestor
92375954|NCT01967862|Protective Agents|protective agents|mesh-ancestor
92375955|NCT01967862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375956|NCT01967862|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92375957|NCT01967862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92375958|NCT01976988|Heparin|heparin|mesh-list
92375959|NCT01976988|Anticoagulants|anticoagulants|mesh-ancestor
92375960|NCT01976988|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92375961|NCT01976988|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92375962|NCT01976988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375963|NCT01980654|Rituximab|rituximab|mesh-list
92375964|NCT01980654|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92375965|NCT01980654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92375966|NCT01980654|Immunologic Factors|immunologic factors|mesh-ancestor
92375967|NCT01980654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375968|NCT01980654|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92375969|NCT01984398|Citric Acid|citric acid|mesh-list
92375970|NCT01984398|Sodium Citrate|sodium citrate|mesh-list
92375971|NCT01984398|Enclomiphene|enclomiphene|mesh-list
92375973|NCT01984398|Zuclomiphene|zuclomiphene|mesh-list
92375974|NCT01984398|Anticoagulants|anticoagulants|mesh-ancestor
92375975|NCT01984398|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92375976|NCT01984398|Chelating Agents|chelating agents|mesh-ancestor
92375977|NCT01984398|Sequestering Agents|sequestering agents|mesh-ancestor
92375978|NCT01984398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375979|NCT01984398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92375980|NCT01984398|Hormone Antagonists|hormone antagonists|mesh-ancestor
92375981|NCT01984398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92375982|NCT01984398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375983|NCT01984398|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92375984|NCT01984398|Fertility Agents|fertility agents|mesh-ancestor
92375985|NCT01984398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92375986|NCT01984398|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92375987|NCT01984398|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92375988|NCT01987752|Timolol|timolol|mesh-list
92375989|NCT01987752|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92375990|NCT01987752|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92375991|NCT01987752|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92375992|NCT01987752|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92375993|NCT01987752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92375994|NCT01987752|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92375995|NCT01987752|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92375996|NCT01987752|Adrenergic Agents|adrenergic agents|mesh-ancestor
92375997|NCT01987752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92375998|NCT01987752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92375999|NCT01987752|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376000|NCT01987752|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376001|NCT01987752|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92376002|NCT01987752|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376003|NCT01987752|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376004|NCT01988922|Ketamine|ketamine|mesh-list
92376005|NCT01988922|Analgesics|analgesics|mesh-ancestor
92376006|NCT01988922|Sensory System Agents|sensory system agents|mesh-ancestor
92376007|NCT01988922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376008|NCT01988922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376009|NCT01988922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92376010|NCT01988922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92376011|NCT01988922|Anesthetics, General|anesthetics, general|mesh-ancestor
92376012|NCT01988922|Anesthetics|anesthetics|mesh-ancestor
92376013|NCT01988922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376014|NCT01988922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92376015|NCT01988922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92376016|NCT01988922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376017|NCT01988922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376018|NCT01994538|Oxymetazoline|oxymetazoline|mesh-list
92376019|NCT01994538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376020|NCT01994538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376021|NCT01994538|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376022|NCT01994538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376023|NCT01994538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376024|NCT01994538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376025|NCT01994538|Sympathomimetics|sympathomimetics|mesh-ancestor
92376026|NCT01994538|Autonomic Agents|autonomic agents|mesh-ancestor
92376027|NCT01994538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376028|NCT01994538|Nasal Decongestants|nasal decongestants|mesh-ancestor
92376029|NCT01994538|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92376030|NCT01994538|Respiratory System Agents|respiratory system agents|mesh-ancestor
92376031|NCT01998438|Tranexamic Acid|tranexamic acid|mesh-list
92376032|NCT01998438|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92376033|NCT01998438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92376034|NCT01998438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376035|NCT01998438|Hemostatics|hemostatics|mesh-ancestor
92376036|NCT01998438|Coagulants|coagulants|mesh-ancestor
92376037|NCT01999530|Prazosin|prazosin|mesh-list
92376038|NCT01999530|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376039|NCT01999530|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92376040|NCT01999530|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92376041|NCT01999530|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92376042|NCT01999530|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376043|NCT01999530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376044|NCT01999530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376045|NCT01999530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376046|NCT01999920|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92376047|NCT01999920|Antidepressive Agents|antidepressive agents|mesh-ancestor
92376048|NCT01999920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92376049|NCT01999920|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92376050|NCT01999920|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92376051|NCT01999920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376052|NCT01999920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376053|NCT01999920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376054|NCT01999920|Serotonin Agents|serotonin agents|mesh-ancestor
92376055|NCT01999920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376056|NCT01999920|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92376057|NCT01999920|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92376059|NCT02002650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92376060|NCT02002650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376061|NCT02002650|Analgesics|analgesics|mesh-ancestor
92376062|NCT02002650|Sensory System Agents|sensory system agents|mesh-ancestor
92376063|NCT02002650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376064|NCT02002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376065|NCT02002650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376066|NCT02002650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92376067|NCT02002650|Gout Suppressants|gout suppressants|mesh-ancestor
92376068|NCT02002650|Tocolytic Agents|tocolytic agents|mesh-ancestor
92376069|NCT02002650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92376070|NCT02002650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92376071|NCT02002650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376072|NCT02002650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376073|NCT02004132|Testosterone|testosterone|mesh-list
92376074|NCT02004132|Androgens|androgens|mesh-ancestor
92376075|NCT02004132|Hormones|hormones|mesh-ancestor
92376076|NCT02004132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376077|NCT02004132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376078|NCT02004366|Insulin Glargine|insulin glargine|mesh-list
92376079|NCT02004366|Linagliptin|linagliptin|mesh-list
92376080|NCT02004366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92376081|NCT02004366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376082|NCT02004366|Incretins|incretins|mesh-ancestor
92376083|NCT02004366|Hormones|hormones|mesh-ancestor
92376084|NCT02004366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376085|NCT02004366|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92376086|NCT02004366|Protease Inhibitors|protease inhibitors|mesh-ancestor
92376087|NCT02004366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376088|NCT02004366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376089|NCT02004990|Povidone-Iodine|povidone-iodine|mesh-list
92376090|NCT02004990|Povidone|povidone|mesh-list
92376091|NCT02004990|Plasma Substitutes|plasma substitutes|mesh-ancestor
92376092|NCT02004990|Blood Substitutes|blood substitutes|mesh-ancestor
92376093|NCT02004990|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92376094|NCT02004990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376095|NCT02006160|4-Aminopyridine|4-aminopyridine|mesh-list
92376096|NCT02006160|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92376097|NCT02006160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376098|NCT02006160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376099|NCT02011464|Bupivacaine|bupivacaine|mesh-list
92376100|NCT02011464|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376101|NCT02011464|Anesthetics|anesthetics|mesh-ancestor
92376102|NCT02011464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376103|NCT02011464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376104|NCT02011464|Sensory System Agents|sensory system agents|mesh-ancestor
92376105|NCT02011464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376106|NCT02058420|Tocotrienols|tocotrienols|mesh-list
92376107|NCT02058420|Vitamin E|vitamin e|mesh-list
92376108|NCT02058420|Tocopherols|tocopherols|mesh-list
92376109|NCT02058420|Antioxidants|antioxidants|mesh-ancestor
92376110|NCT02058420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376111|NCT02058420|Protective Agents|protective agents|mesh-ancestor
92376112|NCT02058420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376113|NCT02058420|Vitamins|vitamins|mesh-ancestor
92376114|NCT02058420|Micronutrients|micronutrients|mesh-ancestor
92376115|NCT02020278|Tolvaptan|tolvaptan|mesh-list
92376116|NCT02020278|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92376117|NCT02020278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376118|NCT02020278|Natriuretic Agents|natriuretic agents|mesh-ancestor
92376119|NCT02020278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376120|NCT02024646|Brodalumab|brodalumab|mesh-list
92376121|NCT02024646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92376122|NCT02024646|Dermatologic Agents|dermatologic agents|mesh-ancestor
92376123|NCT02024646|Immunologic Factors|immunologic factors|mesh-ancestor
92376124|NCT02024646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376126|NCT02024724|Triamcinolone|triamcinolone|mesh-list
92376127|NCT02024724|Bupivacaine|bupivacaine|mesh-list
92376128|NCT02024724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376129|NCT02024724|Antiemetics|antiemetics|mesh-ancestor
92376130|NCT02024724|Autonomic Agents|autonomic agents|mesh-ancestor
92376131|NCT02024724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376132|NCT02024724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376133|NCT02024724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376134|NCT02024724|Glucocorticoids|glucocorticoids|mesh-ancestor
92376135|NCT02024724|Hormones|hormones|mesh-ancestor
92376136|NCT02024724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376137|NCT02024724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376138|NCT02024724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376139|NCT02024724|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376141|NCT02024724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376142|NCT02024724|Sensory System Agents|sensory system agents|mesh-ancestor
92376143|NCT02025426|Phenylephrine|phenylephrine|mesh-list
92376144|NCT02025426|Oxymetazoline|oxymetazoline|mesh-list
92376145|NCT02025426|Ephedrine|ephedrine|mesh-list
92376146|NCT02025426|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92376147|NCT02025426|Mydriatics|mydriatics|mesh-ancestor
92376148|NCT02025426|Autonomic Agents|autonomic agents|mesh-ancestor
92376149|NCT02025426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376150|NCT02025426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376151|NCT02025426|Sympathomimetics|sympathomimetics|mesh-ancestor
92376152|NCT02025426|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92376153|NCT02025426|Nasal Decongestants|nasal decongestants|mesh-ancestor
92376154|NCT02025426|Respiratory System Agents|respiratory system agents|mesh-ancestor
92376155|NCT02025426|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92376156|NCT02025426|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376157|NCT02025426|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376158|NCT02025426|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376159|NCT02025426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376160|NCT02025426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376161|NCT02025426|Protective Agents|protective agents|mesh-ancestor
92376162|NCT02025426|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92376163|NCT02028780|Dabigatran|dabigatran|mesh-list
92376164|NCT02028780|Antithrombins|antithrombins|mesh-ancestor
92376165|NCT02028780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92376166|NCT02028780|Protease Inhibitors|protease inhibitors|mesh-ancestor
92376167|NCT02028780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376168|NCT02028780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376169|NCT02028780|Anticoagulants|anticoagulants|mesh-ancestor
92376170|NCT02029872|Chlorhexidine|chlorhexidine|mesh-list
92376171|NCT02029872|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92376172|NCT02029872|Mupirocin|mupirocin|mesh-list
92376173|NCT02029872|Calcium|calcium|mesh-list
92376174|NCT02029872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92376175|NCT02029872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376176|NCT02029872|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92376177|NCT02029872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376178|NCT02029872|Disinfectants|disinfectants|mesh-ancestor
92376179|NCT02029872|Dermatologic Agents|dermatologic agents|mesh-ancestor
92376180|NCT02029872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92376181|NCT02029872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92376182|NCT02029872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376183|NCT02029872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376184|NCT02030574|Gemcitabine|gemcitabine|mesh-list
92376185|NCT02030574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376186|NCT02030574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92376187|NCT02030574|Antimetabolites|antimetabolites|mesh-ancestor
92376188|NCT02030574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376189|NCT02032212|Nicotine|nicotine|mesh-list
92376190|NCT02032212|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92376191|NCT02032212|Autonomic Agents|autonomic agents|mesh-ancestor
92376192|NCT02032212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376193|NCT02032212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376194|NCT02032212|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92376195|NCT02032212|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92376196|NCT02032212|Cholinergic Agents|cholinergic agents|mesh-ancestor
92376197|NCT02032212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376198|NCT02032212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376200|NCT02032758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92376201|NCT02032758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92376202|NCT02032758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376203|NCT02032758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376204|NCT02032758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376205|NCT02032758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376206|NCT02032758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376207|NCT02032758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376208|NCT02032758|Vasodilator Agents|vasodilator agents|mesh-ancestor
92376209|NCT02036424|Dexamethasone|dexamethasone|mesh-list
92376210|NCT02036424|Bevacizumab|bevacizumab|mesh-list
92376211|NCT02036424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92376212|NCT02036424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376213|NCT02036424|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92376214|NCT02036424|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92376215|NCT02036424|Growth Substances|growth substances|mesh-ancestor
92376216|NCT02036424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376217|NCT02036424|Growth Inhibitors|growth inhibitors|mesh-ancestor
92376218|NCT02036424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376219|NCT02036424|Antiemetics|antiemetics|mesh-ancestor
92376220|NCT02036424|Autonomic Agents|autonomic agents|mesh-ancestor
92376221|NCT02036424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376222|NCT02036424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376223|NCT02036424|Glucocorticoids|glucocorticoids|mesh-ancestor
92376225|NCT02036424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376226|NCT02036424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376227|NCT02044380|Afatinib|afatinib|mesh-list
92376228|NCT02044380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376229|NCT02044380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92376230|NCT02044380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376231|NCT02044380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376232|NCT02047032|Solifenacin Succinate|solifenacin succinate|mesh-list
92376233|NCT02047032|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92376234|NCT02047032|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92376235|NCT02047032|Cholinergic Agents|cholinergic agents|mesh-ancestor
92376236|NCT02047032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376237|NCT02047032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376238|NCT02047032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376239|NCT02047032|Urological Agents|urological agents|mesh-ancestor
92376240|NCT02047500|Paclitaxel|paclitaxel|mesh-list
92376241|NCT02047500|Gemcitabine|gemcitabine|mesh-list
92376242|NCT02047500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92376243|NCT02047500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376244|NCT02047500|Tubulin Modulators|tubulin modulators|mesh-ancestor
92376245|NCT02047500|Antimitotic Agents|antimitotic agents|mesh-ancestor
92376246|NCT02047500|Mitosis Modulators|mitosis modulators|mesh-ancestor
92376247|NCT02047500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376248|NCT02047500|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92376249|NCT02047500|Antimetabolites|antimetabolites|mesh-ancestor
92376250|NCT02054754|HU 211|hu 211|mesh-list
92376251|NCT02054754|Dronabinol|dronabinol|mesh-list
92376252|NCT02054754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376253|NCT02054754|Antiemetics|antiemetics|mesh-ancestor
92376254|NCT02054754|Autonomic Agents|autonomic agents|mesh-ancestor
92376255|NCT02054754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376256|NCT02054754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376257|NCT02054754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376258|NCT02054754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92376259|NCT02054754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92376260|NCT02054754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376261|NCT02054754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376262|NCT02054754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92376263|NCT02054754|Protective Agents|protective agents|mesh-ancestor
92376264|NCT02054754|Hallucinogens|hallucinogens|mesh-ancestor
92376265|NCT02054754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92376266|NCT02054754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376267|NCT02054754|Analgesics|analgesics|mesh-ancestor
92376268|NCT02054754|Sensory System Agents|sensory system agents|mesh-ancestor
92376269|NCT02054754|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92376270|NCT02054754|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92376271|NCT02054754|Hormones|hormones|mesh-ancestor
92376272|NCT02054754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376273|NCT02057640|Dexamethasone|dexamethasone|mesh-list
92376274|NCT02057640|Ixazomib|ixazomib|mesh-list
92376275|NCT02057640|Panobinostat|panobinostat|mesh-list
92376276|NCT02057640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376277|NCT02057640|Antiemetics|antiemetics|mesh-ancestor
92376278|NCT02057640|Autonomic Agents|autonomic agents|mesh-ancestor
92376279|NCT02057640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376280|NCT02057640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376281|NCT02057640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376282|NCT02057640|Glucocorticoids|glucocorticoids|mesh-ancestor
92376283|NCT02057640|Hormones|hormones|mesh-ancestor
92376284|NCT02057640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376285|NCT02057640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376286|NCT02057640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376287|NCT02057640|Protease Inhibitors|protease inhibitors|mesh-ancestor
92376288|NCT02057640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376289|NCT02057640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376290|NCT02057640|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92376291|NCT02059902|Lidocaine|lidocaine|mesh-list
92376292|NCT02059902|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376293|NCT02059902|Anesthetics|anesthetics|mesh-ancestor
92376294|NCT02059902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376295|NCT02059902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376296|NCT02059902|Sensory System Agents|sensory system agents|mesh-ancestor
92376297|NCT02059902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376298|NCT02059902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376299|NCT02059902|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376300|NCT02059902|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376301|NCT02059902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376302|NCT02059902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376303|NCT02061384|Calcitriol|calcitriol|mesh-list
92376304|NCT02061384|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92376305|NCT02061384|Tretinoin|tretinoin|mesh-list
92376306|NCT02061384|Isotretinoin|isotretinoin|mesh-list
92376307|NCT02061384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376308|NCT02061384|Keratolytic Agents|keratolytic agents|mesh-ancestor
92376309|NCT02061384|Dermatologic Agents|dermatologic agents|mesh-ancestor
92376310|NCT02061384|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92376311|NCT02061384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376312|NCT02061384|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92376313|NCT02061384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376314|NCT02061384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376315|NCT02061384|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92376316|NCT02061384|Vitamins|vitamins|mesh-ancestor
92376317|NCT02061384|Micronutrients|micronutrients|mesh-ancestor
92376318|NCT02061384|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92376319|NCT02061774|Acetaminophen|acetaminophen|mesh-list
92376320|NCT02061774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376321|NCT02061774|Analgesics|analgesics|mesh-ancestor
92376322|NCT02061774|Sensory System Agents|sensory system agents|mesh-ancestor
92376323|NCT02061774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376324|NCT02061774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376325|NCT02061774|Antipyretics|antipyretics|mesh-ancestor
92376326|NCT02062710|Diphenhydramine|diphenhydramine|mesh-list
92376327|NCT02062710|Promethazine|promethazine|mesh-list
92376328|NCT02062710|Phenylephrine|phenylephrine|mesh-list
92376329|NCT02062710|Oxymetazoline|oxymetazoline|mesh-list
92376330|NCT02062710|Dextromethorphan|dextromethorphan|mesh-list
92376331|NCT02062710|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92376332|NCT02062710|Mydriatics|mydriatics|mesh-ancestor
92376333|NCT02062710|Autonomic Agents|autonomic agents|mesh-ancestor
92376334|NCT02062710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376335|NCT02062710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376336|NCT02062710|Sympathomimetics|sympathomimetics|mesh-ancestor
92376337|NCT02062710|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92376338|NCT02062710|Nasal Decongestants|nasal decongestants|mesh-ancestor
92376339|NCT02062710|Respiratory System Agents|respiratory system agents|mesh-ancestor
92376340|NCT02062710|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92376341|NCT02062710|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376342|NCT02062710|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376343|NCT02062710|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376344|NCT02062710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376345|NCT02062710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376347|NCT02062710|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92376348|NCT02062710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92376349|NCT02062710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376350|NCT02062710|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376351|NCT02062710|Anesthetics|anesthetics|mesh-ancestor
92376352|NCT02062710|Sensory System Agents|sensory system agents|mesh-ancestor
92376353|NCT02062710|Antiemetics|antiemetics|mesh-ancestor
92376354|NCT02062710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376355|NCT02062710|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92376356|NCT02062710|Histamine Antagonists|histamine antagonists|mesh-ancestor
92376357|NCT02062710|Histamine Agents|histamine agents|mesh-ancestor
92376358|NCT02062710|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92376359|NCT02062710|Antipruritics|antipruritics|mesh-ancestor
92376360|NCT02062710|Dermatologic Agents|dermatologic agents|mesh-ancestor
92376361|NCT02062710|Antitussive Agents|antitussive agents|mesh-ancestor
92376362|NCT02062710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92376363|NCT02062710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92376364|NCT02064582|Leuprolide|leuprolide|mesh-list
92376365|NCT02064582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92376366|NCT02064582|Fertility Agents|fertility agents|mesh-ancestor
92376367|NCT02064582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92376368|NCT02064582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376369|NCT02064582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376370|NCT02064582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376371|NCT02069184|Acetaminophen|acetaminophen|mesh-list
92376372|NCT02069184|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376373|NCT02069184|Analgesics|analgesics|mesh-ancestor
92376374|NCT02069184|Sensory System Agents|sensory system agents|mesh-ancestor
92376375|NCT02069184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376376|NCT02069184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376377|NCT02069184|Antipyretics|antipyretics|mesh-ancestor
92376378|NCT02134314|Complement C1s|complement c1s|mesh-list
92376379|NCT02134314|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92376380|NCT02134314|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92376381|NCT02134314|Immunologic Factors|immunologic factors|mesh-ancestor
92376382|NCT02134314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376383|NCT02134314|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92376384|NCT02134314|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92376385|NCT02135016|Lidocaine|lidocaine|mesh-list
92376386|NCT02135016|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376387|NCT02135016|Anesthetics|anesthetics|mesh-ancestor
92376388|NCT02135016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376389|NCT02135016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376390|NCT02135016|Sensory System Agents|sensory system agents|mesh-ancestor
92376391|NCT02135016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376392|NCT02135016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376393|NCT02135016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376394|NCT02135016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376395|NCT02135016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376396|NCT02135016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376397|NCT02135094|Oxymetazoline|oxymetazoline|mesh-list
92376398|NCT02135094|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376399|NCT02135094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376400|NCT02135094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376401|NCT02135094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376402|NCT02135094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376403|NCT02135094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376404|NCT02135094|Sympathomimetics|sympathomimetics|mesh-ancestor
92376405|NCT02135094|Autonomic Agents|autonomic agents|mesh-ancestor
92376406|NCT02135094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376407|NCT02135094|Nasal Decongestants|nasal decongestants|mesh-ancestor
92376408|NCT02135094|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92376409|NCT02135094|Respiratory System Agents|respiratory system agents|mesh-ancestor
92376410|NCT02139540|Nitrous Oxide|nitrous oxide|mesh-list
92376411|NCT02139540|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92376412|NCT02139540|Anesthetics, General|anesthetics, general|mesh-ancestor
92376413|NCT02139540|Anesthetics|anesthetics|mesh-ancestor
92376414|NCT02139540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376415|NCT02139540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376416|NCT02139540|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376417|NCT02139540|Analgesics|analgesics|mesh-ancestor
92376418|NCT02139540|Sensory System Agents|sensory system agents|mesh-ancestor
92376419|NCT02139540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376420|NCT02148588|Lidocaine|lidocaine|mesh-list
92376421|NCT02148588|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376422|NCT02148588|Anesthetics|anesthetics|mesh-ancestor
92376423|NCT02148588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376424|NCT02148588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376425|NCT02148588|Sensory System Agents|sensory system agents|mesh-ancestor
92376426|NCT02148588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376427|NCT02148588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376428|NCT02148588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376429|NCT02148588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376430|NCT02148588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376431|NCT02148588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376432|NCT02149524|Trastuzumab|trastuzumab|mesh-list
92376433|NCT02149524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92376434|NCT02149524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376435|NCT02154048|Dexamethasone|dexamethasone|mesh-list
92376436|NCT02154048|Ropivacaine|ropivacaine|mesh-list
92376437|NCT02154048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376438|NCT02154048|Antiemetics|antiemetics|mesh-ancestor
92376439|NCT02154048|Autonomic Agents|autonomic agents|mesh-ancestor
92376440|NCT02154048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376441|NCT02154048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376442|NCT02154048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376443|NCT02154048|Glucocorticoids|glucocorticoids|mesh-ancestor
92376444|NCT02154048|Hormones|hormones|mesh-ancestor
92028915|NCT04939987|Tramadol|tramadol|mesh-list
92376445|NCT02154048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376446|NCT02154048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376447|NCT02154048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376448|NCT02154048|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376449|NCT02154048|Anesthetics|anesthetics|mesh-ancestor
92376450|NCT02154048|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376451|NCT02154048|Sensory System Agents|sensory system agents|mesh-ancestor
92376452|NCT02156154|Acetaminophen|acetaminophen|mesh-list
92376453|NCT02156154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376454|NCT02156154|Analgesics|analgesics|mesh-ancestor
92376455|NCT02156154|Sensory System Agents|sensory system agents|mesh-ancestor
92376456|NCT02156154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376457|NCT02156154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376458|NCT02156154|Antipyretics|antipyretics|mesh-ancestor
92376459|NCT02158572|Contraceptive Agents|contraceptive agents|mesh-list
92376460|NCT02158572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92376461|NCT02158572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376462|NCT02159976|Amoxicillin|amoxicillin|mesh-list
92376463|NCT02159976|Metronidazole|metronidazole|mesh-list
92376464|NCT02159976|Clarithromycin|clarithromycin|mesh-list
92376465|NCT02159976|Tetracycline|tetracycline|mesh-list
92376466|NCT02159976|Pantoprazole|pantoprazole|mesh-list
92376467|NCT02159976|Bismuth|bismuth|mesh-list
92376468|NCT02159976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92376469|NCT02159976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376470|NCT02159976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92376471|NCT02159976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92376472|NCT02159976|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92376473|NCT02159976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376474|NCT02159976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376475|NCT02159976|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92376476|NCT02159976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92376477|NCT02159976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92376478|NCT02159976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376479|NCT02159976|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92376480|NCT02159976|Antacids|antacids|mesh-ancestor
92376481|NCT02160288|Botulinum Toxins|botulinum toxins|mesh-list
92376482|NCT02160288|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92376483|NCT02160288|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92376484|NCT02160288|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92376485|NCT02160288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376486|NCT02160288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376487|NCT02160288|Cholinergic Agents|cholinergic agents|mesh-ancestor
92376488|NCT02160288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376489|NCT02160288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376490|NCT02160288|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92376491|NCT02160288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376492|NCT02160990|Exenatide|exenatide|mesh-list
92376493|NCT02160990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92376494|NCT02160990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376495|NCT02160990|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92376496|NCT02160990|Incretins|incretins|mesh-ancestor
92376497|NCT02160990|Hormones|hormones|mesh-ancestor
92376498|NCT02160990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376499|NCT02164422|Guanfacine|guanfacine|mesh-list
92376500|NCT02164422|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376501|NCT02164422|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92376502|NCT02164422|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376503|NCT02164422|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376504|NCT02164422|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376505|NCT02164422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376506|NCT02164422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376507|NCT02164422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376508|NCT02170662|Bimatoprost|bimatoprost|mesh-list
92376509|NCT02170662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376510|NCT02173392|Brodalumab|brodalumab|mesh-list
92376511|NCT02173392|Dermatologic Agents|dermatologic agents|mesh-ancestor
92376512|NCT02178540|Tobramycin|tobramycin|mesh-list
92376513|NCT02178540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92376514|NCT02178540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376515|NCT02178696|Antidepressive Agents|antidepressive agents|mesh-list
92376516|NCT02178696|Citalopram|citalopram|mesh-list
92376517|NCT02178696|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92376518|NCT02178696|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92376519|NCT02178696|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92376520|NCT02178696|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376521|NCT02178696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376522|NCT02178696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376523|NCT02178696|Serotonin Agents|serotonin agents|mesh-ancestor
92376524|NCT02178696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376525|NCT02178696|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92376527|NCT02179788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92376528|NCT02179788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376529|NCT02180100|Fluconazole|fluconazole|mesh-list
92376530|NCT02180100|Terconazole|terconazole|mesh-list
92376531|NCT02180100|Antifungal Agents|antifungal agents|mesh-ancestor
92376532|NCT02180100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376533|NCT02180100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92376534|NCT02180100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92376535|NCT02180100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376536|NCT02180100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376537|NCT02180100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92376538|NCT02180100|Hormone Antagonists|hormone antagonists|mesh-ancestor
92376539|NCT02180100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376540|NCT02180100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376541|NCT02180100|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92376542|NCT02180100|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92376543|NCT02181426|Ketorolac|ketorolac|mesh-list
92376544|NCT02181426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92376545|NCT02181426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376546|NCT02181426|Analgesics|analgesics|mesh-ancestor
92376547|NCT02181426|Sensory System Agents|sensory system agents|mesh-ancestor
92376548|NCT02181426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376549|NCT02181426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376550|NCT02181426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376551|NCT02181426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92376552|NCT02181426|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92376553|NCT02181426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376554|NCT02181426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376555|NCT02192814|Lacosamide|lacosamide|mesh-list
92376556|NCT02192814|Anticonvulsants|anticonvulsants|mesh-ancestor
92376557|NCT02192814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92030772|NCT02205333|Rituximab|rituximab|mesh-list
92376558|NCT02192814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376559|NCT02192814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376560|NCT02192814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376561|NCT02195232|Quercetin|quercetin|mesh-list
92376563|NCT02195232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376564|NCT02195232|Protective Agents|protective agents|mesh-ancestor
92376565|NCT02195232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376566|NCT02196168|Cisplatin|cisplatin|mesh-list
92376567|NCT02196168|Adavosertib|adavosertib|mesh-list
92376568|NCT02196168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376569|NCT02196168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376570|NCT02196168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376571|NCT02201394|Aspirin|aspirin|mesh-list
92376572|NCT02201394|Ticagrelor|ticagrelor|mesh-list
92376573|NCT02201394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92376574|NCT02201394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376575|NCT02201394|Analgesics|analgesics|mesh-ancestor
92376576|NCT02201394|Sensory System Agents|sensory system agents|mesh-ancestor
92376577|NCT02201394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376578|NCT02201394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376579|NCT02201394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376581|NCT02201394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92376582|NCT02201394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92376583|NCT02201394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376584|NCT02201394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92376585|NCT02201394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92376586|NCT02201394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376587|NCT02201394|Antipyretics|antipyretics|mesh-ancestor
92376588|NCT02201394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92376589|NCT02201394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92376590|NCT02201394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92376591|NCT02201394|Purinergic Agents|purinergic agents|mesh-ancestor
92029066|NCT02448043|Bimatoprost|bimatoprost|mesh-list
92376592|NCT02201394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376593|NCT02203578|Romidepsin|romidepsin|mesh-list
92376594|NCT02203578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92376595|NCT02203578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376596|NCT02203578|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92376597|NCT02203578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376598|NCT02203578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376599|NCT02206776|Midazolam|midazolam|mesh-list
92376600|NCT02206776|Ketamine|ketamine|mesh-list
92376601|NCT02206776|Analgesics|analgesics|mesh-ancestor
92376602|NCT02206776|Sensory System Agents|sensory system agents|mesh-ancestor
92376603|NCT02206776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376604|NCT02206776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376605|NCT02206776|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92376606|NCT02206776|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92376607|NCT02206776|Anesthetics, General|anesthetics, general|mesh-ancestor
92376608|NCT02206776|Anesthetics|anesthetics|mesh-ancestor
92376609|NCT02206776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376610|NCT02206776|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92376611|NCT02206776|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92376612|NCT02206776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376613|NCT02206776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376614|NCT02206776|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92376615|NCT02206776|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92376616|NCT02206776|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92376617|NCT02206776|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92376618|NCT02206776|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92376619|NCT02206776|GABA Modulators|gaba modulators|mesh-ancestor
92376620|NCT02206776|GABA Agents|gaba agents|mesh-ancestor
92376621|NCT02209272|Lidocaine|lidocaine|mesh-list
92376622|NCT02209272|Benzyl Alcohol|benzyl alcohol|mesh-list
92376623|NCT02209272|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376624|NCT02209272|Anesthetics|anesthetics|mesh-ancestor
92376625|NCT02209272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376626|NCT02209272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376627|NCT02209272|Sensory System Agents|sensory system agents|mesh-ancestor
92376628|NCT02209272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376629|NCT02209272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376630|NCT02209272|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376631|NCT02209272|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376632|NCT02209272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376633|NCT02209272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376635|NCT02214420|Sofosbuvir|sofosbuvir|mesh-list
92376636|NCT02214420|Simeprevir|simeprevir|mesh-list
92376637|NCT02214420|Antimetabolites|antimetabolites|mesh-ancestor
92376638|NCT02214420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376639|NCT02214420|Antiviral Agents|antiviral agents|mesh-ancestor
92376640|NCT02214420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376641|NCT02214420|Protease Inhibitors|protease inhibitors|mesh-ancestor
92376642|NCT02214420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376643|NCT02215200|Lenograstim|lenograstim|mesh-list
92376644|NCT02215200|Thymoglobulin|thymoglobulin|mesh-list
92376645|NCT02215200|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92376646|NCT02215200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92376647|NCT02215200|Immunologic Factors|immunologic factors|mesh-ancestor
92376648|NCT02215200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376649|NCT02215200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92376650|NCT02218320|Raltegravir Potassium|raltegravir potassium|mesh-list
92376651|NCT02218320|Dolutegravir|dolutegravir|mesh-list
92376652|NCT02218320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92376653|NCT02218320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92376654|NCT02218320|Antiviral Agents|antiviral agents|mesh-ancestor
92376655|NCT02218320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376656|NCT02218320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92376657|NCT02218320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92376658|NCT02218320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376659|NCT02218320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376660|NCT02222610|Ranibizumab|ranibizumab|mesh-list
92376661|NCT02222610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92376662|NCT02222610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92376663|NCT02222610|Growth Substances|growth substances|mesh-ancestor
92376664|NCT02222610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376665|NCT02222610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92376666|NCT02222610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376667|NCT02223702|Amoxicillin|amoxicillin|mesh-list
92376668|NCT02223702|Moxifloxacin|moxifloxacin|mesh-list
92376669|NCT02223702|Metronidazole|metronidazole|mesh-list
92376670|NCT02223702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92376671|NCT02223702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376672|NCT02223702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92376673|NCT02223702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92376674|NCT02223702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376675|NCT02223702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376676|NCT02223702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376677|NCT02223702|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92376678|NCT02223702|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92376679|NCT02225106|Methylphenidate|methylphenidate|mesh-list
92376680|NCT02225106|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92376681|NCT02225106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376682|NCT02225106|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92376683|NCT02225106|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92376684|NCT02225106|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376685|NCT02225106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376686|NCT02225106|Dopamine Agents|dopamine agents|mesh-ancestor
92376687|NCT02225106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376689|NCT02233296|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92376690|NCT02233296|Serotonin Agents|serotonin agents|mesh-ancestor
92376691|NCT02233296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376692|NCT02233296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376693|NCT02233296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376694|NCT02233998|Listerine|listerine|mesh-list
92376695|NCT02233998|Sodium Fluoride|sodium fluoride|mesh-list
92376696|NCT02233998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92376697|NCT02233998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376698|NCT02233998|Cariostatic Agents|cariostatic agents|mesh-ancestor
92376699|NCT02233998|Protective Agents|protective agents|mesh-ancestor
92376700|NCT02233998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376701|NCT02237898|Carbon Monoxide|carbon monoxide|mesh-list
92376702|NCT02237898|Antimetabolites|antimetabolites|mesh-ancestor
92376703|NCT02237898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376704|NCT02237898|Gasotransmitters|gasotransmitters|mesh-ancestor
92376705|NCT02237898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376706|NCT02237898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376707|NCT02239380|Lorazepam|lorazepam|mesh-list
92376708|NCT02239380|Anticonvulsants|anticonvulsants|mesh-ancestor
92376709|NCT02239380|Antiemetics|antiemetics|mesh-ancestor
92376710|NCT02239380|Autonomic Agents|autonomic agents|mesh-ancestor
92376711|NCT02239380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376712|NCT02239380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376713|NCT02239380|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376714|NCT02239380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92376715|NCT02239380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376716|NCT02239380|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92376717|NCT02239380|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92376718|NCT02239380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92376720|NCT02239380|GABA Agents|gaba agents|mesh-ancestor
92376721|NCT02239380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376722|NCT02239380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376723|NCT02239770|Nicotine|nicotine|mesh-list
92376724|NCT02239770|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92376725|NCT02239770|Autonomic Agents|autonomic agents|mesh-ancestor
92376726|NCT02239770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376727|NCT02239770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376728|NCT02239770|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92376729|NCT02239770|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92376730|NCT02239770|Cholinergic Agents|cholinergic agents|mesh-ancestor
92376731|NCT02239770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376732|NCT02239770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376733|NCT02241486|Fentanyl|fentanyl|mesh-list
92376734|NCT02241486|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92376735|NCT02241486|Narcotics|narcotics|mesh-ancestor
92376736|NCT02241486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376737|NCT02241486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376738|NCT02241486|Analgesics|analgesics|mesh-ancestor
92376739|NCT02241486|Sensory System Agents|sensory system agents|mesh-ancestor
92376740|NCT02241486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376741|NCT02241486|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92376742|NCT02241486|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92376743|NCT02241486|Anesthetics, General|anesthetics, general|mesh-ancestor
92376744|NCT02241486|Anesthetics|anesthetics|mesh-ancestor
92376745|NCT02244918|Nicotine|nicotine|mesh-list
92376746|NCT02244918|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92376747|NCT02244918|Autonomic Agents|autonomic agents|mesh-ancestor
92376748|NCT02244918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376749|NCT02244918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376750|NCT02244918|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92376751|NCT02244918|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92376752|NCT02244918|Cholinergic Agents|cholinergic agents|mesh-ancestor
92376753|NCT02244918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376754|NCT02244918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376755|NCT02250612|Timolol|timolol|mesh-list
92376756|NCT02250612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376757|NCT02250612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92376758|NCT02250612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92376759|NCT02250612|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376760|NCT02250612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376761|NCT02250612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376762|NCT02250612|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376763|NCT02250612|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92376765|NCT02251236|Emtricitabine|emtricitabine|mesh-list
92376766|NCT02251236|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92376767|NCT02251236|Cobicistat|cobicistat|mesh-list
92376768|NCT02251236|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92376769|NCT02251236|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92376770|NCT02251236|Elvitegravir|elvitegravir|mesh-list
92376771|NCT02251236|Antiviral Agents|antiviral agents|mesh-ancestor
92376772|NCT02251236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376773|NCT02251236|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92376774|NCT02251236|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92376775|NCT02251236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376776|NCT02251236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376777|NCT02251236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92376778|NCT02251236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92376779|NCT02251236|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92376780|NCT02251236|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92376781|NCT02251236|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92376782|NCT02251938|Sirolimus|sirolimus|mesh-list
92376783|NCT02251938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92376784|NCT02251938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376785|NCT02251938|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92376786|NCT02251938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376787|NCT02251938|Antifungal Agents|antifungal agents|mesh-ancestor
92376788|NCT02251938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92376789|NCT02251938|Immunologic Factors|immunologic factors|mesh-ancestor
92376790|NCT02251938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376791|NCT02258412|Ethanol|ethanol|mesh-list
92376792|NCT02258412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92376793|NCT02258412|Hand Sanitizers|hand sanitizers|mesh-list
92376794|NCT02258412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376795|NCT02258412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376796|NCT02258412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376797|NCT02258412|Disinfectants|disinfectants|mesh-ancestor
92376798|NCT02260440|Pembrolizumab|pembrolizumab|mesh-list
92376799|NCT02260440|Azacitidine|azacitidine|mesh-list
92376800|NCT02260440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92376801|NCT02260440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376802|NCT02260440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92376803|NCT02260440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376804|NCT02260440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92376805|NCT02260440|Antimetabolites|antimetabolites|mesh-ancestor
92376806|NCT02260440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376807|NCT02267538|Dexmedetomidine|dexmedetomidine|mesh-list
92376808|NCT02267538|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92376809|NCT02267538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376810|NCT02267538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376811|NCT02267538|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376812|NCT02267538|Analgesics|analgesics|mesh-ancestor
92376813|NCT02267538|Sensory System Agents|sensory system agents|mesh-ancestor
92376814|NCT02267538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376815|NCT02267538|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92376816|NCT02267538|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376817|NCT02267538|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92376818|NCT02267538|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376819|NCT02267538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376820|NCT02267538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376822|NCT02267772|Morphine|morphine|mesh-list
92376823|NCT02267772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92376824|NCT02267772|Narcotics|narcotics|mesh-ancestor
92376825|NCT02267772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376826|NCT02267772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376827|NCT02267772|Analgesics|analgesics|mesh-ancestor
92376828|NCT02267772|Sensory System Agents|sensory system agents|mesh-ancestor
92376829|NCT02267772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376830|NCT02267772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376831|NCT02267772|Antipyretics|antipyretics|mesh-ancestor
92376832|NCT02271906|Afatinib|afatinib|mesh-list
92376833|NCT02271906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376834|NCT02271906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92376835|NCT02271906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376836|NCT02271906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376837|NCT02274870|Bupivacaine|bupivacaine|mesh-list
92376838|NCT02274870|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376839|NCT02274870|Anesthetics|anesthetics|mesh-ancestor
92376840|NCT02274870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376841|NCT02274870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376842|NCT02274870|Sensory System Agents|sensory system agents|mesh-ancestor
92376843|NCT02274870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376844|NCT02276274|Alogliptin|alogliptin|mesh-list
92376845|NCT02276274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92376846|NCT02276274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376847|NCT02276274|Incretins|incretins|mesh-ancestor
92376848|NCT02276274|Hormones|hormones|mesh-ancestor
92376849|NCT02276274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376850|NCT02276274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92376851|NCT02276274|Protease Inhibitors|protease inhibitors|mesh-ancestor
92376852|NCT02276274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376853|NCT02276274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376854|NCT02281422|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92376855|NCT02281422|Anticonvulsants|anticonvulsants|mesh-ancestor
92376856|NCT02281422|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376857|NCT02281422|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376858|NCT02281422|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376859|NCT02281422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376860|NCT02282514|Methylprednisolone|methylprednisolone|mesh-list
92376861|NCT02282514|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92376862|NCT02282514|Cyclophosphamide|cyclophosphamide|mesh-list
92376863|NCT02282514|Rituximab|rituximab|mesh-list
92376864|NCT02282514|Thymoglobulin|thymoglobulin|mesh-list
92376865|NCT02282514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92376866|NCT02282514|Immunologic Factors|immunologic factors|mesh-ancestor
92376867|NCT02282514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376868|NCT02282514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92376869|NCT02282514|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92376870|NCT02282514|Alkylating Agents|alkylating agents|mesh-ancestor
92376871|NCT02282514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376872|NCT02282514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376873|NCT02282514|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92376874|NCT02282514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92376875|NCT02282514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376876|NCT02282514|Antiemetics|antiemetics|mesh-ancestor
92376877|NCT02282514|Autonomic Agents|autonomic agents|mesh-ancestor
92376878|NCT02282514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376879|NCT02282514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92376880|NCT02282514|Glucocorticoids|glucocorticoids|mesh-ancestor
92376881|NCT02282514|Hormones|hormones|mesh-ancestor
92376882|NCT02282514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120346|NCT02450214|Analgesics|analgesics|mesh-ancestor
92376883|NCT02282514|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92376884|NCT02282514|Protective Agents|protective agents|mesh-ancestor
92376885|NCT02282514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376886|NCT02282904|Sirolimus|sirolimus|mesh-list
92376887|NCT02282904|Cyclophosphamide|cyclophosphamide|mesh-list
92376888|NCT02282904|Busulfan|busulfan|mesh-list
92376889|NCT02282904|Fludarabine|fludarabine|mesh-list
92029362|NCT02463331|Hormones|hormones|mesh-ancestor
92376890|NCT02282904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92376891|NCT02282904|Immunologic Factors|immunologic factors|mesh-ancestor
92376892|NCT02282904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376893|NCT02282904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92376894|NCT02282904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92376895|NCT02282904|Alkylating Agents|alkylating agents|mesh-ancestor
92376896|NCT02282904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376897|NCT02282904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376898|NCT02282904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92376899|NCT02282904|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92376900|NCT02282904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92376901|NCT02282904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92376902|NCT02282904|Antifungal Agents|antifungal agents|mesh-ancestor
92376903|NCT02283840|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92376904|NCT02283840|Anticonvulsants|anticonvulsants|mesh-ancestor
92376905|NCT02283840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376906|NCT02283840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376907|NCT02283840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376908|NCT02283840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376909|NCT02284386|Bupivacaine|bupivacaine|mesh-list
92376910|NCT02284386|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376911|NCT02284386|Anesthetics|anesthetics|mesh-ancestor
92376912|NCT02284386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376913|NCT02284386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376914|NCT02284386|Sensory System Agents|sensory system agents|mesh-ancestor
92376915|NCT02284386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376916|NCT02284464|Prednisone|prednisone|mesh-list
92376917|NCT02284464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376918|NCT02284464|Glucocorticoids|glucocorticoids|mesh-ancestor
92376919|NCT02284464|Hormones|hormones|mesh-ancestor
92376920|NCT02284464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92376921|NCT02284464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376922|NCT02284464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92376923|NCT02284464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92376924|NCT02284854|Carbamazepine|carbamazepine|mesh-list
92376925|NCT02284854|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92376926|NCT02284854|Anticonvulsants|anticonvulsants|mesh-ancestor
92376927|NCT02284854|Antimanic Agents|antimanic agents|mesh-ancestor
92376928|NCT02284854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92376929|NCT02284854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376930|NCT02284854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376931|NCT02284854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92376932|NCT02284854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376934|NCT02284854|Sensory System Agents|sensory system agents|mesh-ancestor
92376935|NCT02284854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376936|NCT02284854|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376937|NCT02284854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376938|NCT02284854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376939|NCT02284854|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92376940|NCT02284854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92376941|NCT02284854|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376942|NCT02285634|Lidocaine|lidocaine|mesh-list
92376943|NCT02285634|Phenylephrine|phenylephrine|mesh-list
92376944|NCT02285634|Epinephrine|epinephrine|mesh-list
92376945|NCT02285634|Oxymetazoline|oxymetazoline|mesh-list
92376946|NCT02285634|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376947|NCT02285634|Anesthetics|anesthetics|mesh-ancestor
92376948|NCT02285634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376949|NCT02285634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376950|NCT02285634|Sensory System Agents|sensory system agents|mesh-ancestor
92376951|NCT02285634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376952|NCT02285634|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376953|NCT02285634|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376954|NCT02285634|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376955|NCT02285634|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376956|NCT02285634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376957|NCT02285634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92376959|NCT02285634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92376960|NCT02285634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376961|NCT02285634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92376962|NCT02285634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92376963|NCT02285634|Autonomic Agents|autonomic agents|mesh-ancestor
92376964|NCT02285634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92376965|NCT02285634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92376966|NCT02285634|Mydriatics|mydriatics|mesh-ancestor
92376967|NCT02285634|Sympathomimetics|sympathomimetics|mesh-ancestor
92376968|NCT02285634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92376969|NCT02285634|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92376970|NCT02285634|Nasal Decongestants|nasal decongestants|mesh-ancestor
92376971|NCT02285634|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92376972|NCT02285634|Protective Agents|protective agents|mesh-ancestor
92376973|NCT02287350|Diclofenac|diclofenac|mesh-list
92376974|NCT02287350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92376975|NCT02287350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92376976|NCT02287350|Analgesics|analgesics|mesh-ancestor
92376977|NCT02287350|Sensory System Agents|sensory system agents|mesh-ancestor
92376978|NCT02287350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030806|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92376979|NCT02287350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376980|NCT02287350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92376981|NCT02287350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92376982|NCT02287350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92376983|NCT02287350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92376984|NCT02287350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376985|NCT02288364|Lidocaine|lidocaine|mesh-list
92376986|NCT02288364|Anesthetics, Local|anesthetics, local|mesh-ancestor
92376987|NCT02288364|Anesthetics|anesthetics|mesh-ancestor
92376988|NCT02288364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92376989|NCT02288364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92376990|NCT02288364|Sensory System Agents|sensory system agents|mesh-ancestor
92376991|NCT02288364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92376992|NCT02288364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92376993|NCT02288364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92376994|NCT02288364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92376995|NCT02288364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92376996|NCT02288364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92376997|NCT02289222|Dexamethasone|dexamethasone|mesh-list
92376998|NCT02289222|Pembrolizumab|pembrolizumab|mesh-list
92376999|NCT02289222|Pomalidomide|pomalidomide|mesh-list
92377001|NCT02289222|Antiemetics|antiemetics|mesh-ancestor
92377002|NCT02289222|Autonomic Agents|autonomic agents|mesh-ancestor
92377003|NCT02289222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377004|NCT02289222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377005|NCT02289222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377006|NCT02289222|Glucocorticoids|glucocorticoids|mesh-ancestor
92377007|NCT02289222|Hormones|hormones|mesh-ancestor
92377008|NCT02289222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377009|NCT02289222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92377010|NCT02289222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377011|NCT02289222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377012|NCT02289222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92377013|NCT02289222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377014|NCT02289222|Immunologic Factors|immunologic factors|mesh-ancestor
92377015|NCT02289222|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92377016|NCT02289222|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92377017|NCT02289222|Growth Substances|growth substances|mesh-ancestor
92377018|NCT02289222|Growth Inhibitors|growth inhibitors|mesh-ancestor
92377019|NCT02291016|Formoterol Fumarate|formoterol fumarate|mesh-list
92377020|NCT02291016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92377021|NCT02291016|Autonomic Agents|autonomic agents|mesh-ancestor
92377022|NCT02291016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377023|NCT02291016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377024|NCT02291016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92377025|NCT02291016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92377026|NCT02291016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92377027|NCT02291016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92377028|NCT02291016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92377029|NCT02291016|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377030|NCT02291016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115522|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377031|NCT02291016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377032|NCT02296164|Mechlorethamine|mechlorethamine|mesh-list
92377033|NCT02296164|Alkylating Agents|alkylating agents|mesh-ancestor
92377034|NCT02296164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377035|NCT02296164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92377036|NCT02296164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377037|NCT02297100|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92377038|NCT02297100|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92377039|NCT02297100|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92377040|NCT02297100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377041|NCT02297100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377042|NCT02297100|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92377043|NCT02297100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92377044|NCT02297100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377045|NCT02297100|Cholinergic Agents|cholinergic agents|mesh-ancestor
92377046|NCT02297100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377047|NCT02299050|Bromocriptine|bromocriptine|mesh-list
92377048|NCT02299050|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92377049|NCT02299050|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92377050|NCT02299050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92377051|NCT02299050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377052|NCT02299050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377053|NCT02299050|Dopamine Agonists|dopamine agonists|mesh-ancestor
92377054|NCT02299050|Dopamine Agents|dopamine agents|mesh-ancestor
92377055|NCT02299050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377056|NCT02299050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377057|NCT02302092|Cefepime|cefepime|mesh-list
92377058|NCT02302092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92377059|NCT02302092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377060|NCT02303184|Aflibercept|aflibercept|mesh-list
92377061|NCT02303184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92377062|NCT02303184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92377063|NCT02303184|Growth Substances|growth substances|mesh-ancestor
92377064|NCT02303184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377066|NCT02303184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377067|NCT02304432|Cycloserine|cycloserine|mesh-list
92377068|NCT02304432|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92377069|NCT02304432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377070|NCT02304432|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92377071|NCT02304432|Antitubercular Agents|antitubercular agents|mesh-ancestor
92377072|NCT02304432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92377073|NCT02304432|Antimetabolites|antimetabolites|mesh-ancestor
92377074|NCT02304432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377075|NCT02307318|Hemostatics|hemostatics|mesh-list
92377076|NCT02307318|Coagulants|coagulants|mesh-ancestor
92377077|NCT02312622|Irinotecan|irinotecan|mesh-list
92377078|NCT02312622|Etirinotecan pegol|etirinotecan pegol|mesh-list
92377079|NCT02312622|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92377080|NCT02312622|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92377081|NCT02312622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377082|NCT02312622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377083|NCT02312622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377084|NCT02312622|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92377085|NCT02314104|Ropivacaine|ropivacaine|mesh-list
92377086|NCT02314104|Anesthetics, Local|anesthetics, local|mesh-ancestor
92377087|NCT02314104|Anesthetics|anesthetics|mesh-ancestor
92377088|NCT02314104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377089|NCT02314104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377090|NCT02314104|Sensory System Agents|sensory system agents|mesh-ancestor
92377091|NCT02314104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377092|NCT02321748|Montelukast|montelukast|mesh-list
92377093|NCT02321748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92377094|NCT02321748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92377095|NCT02321748|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92377096|NCT02321748|Hormone Antagonists|hormone antagonists|mesh-ancestor
92377097|NCT02321748|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377098|NCT02321748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377099|NCT02321748|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92377100|NCT02321748|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92377101|NCT02321748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377102|NCT02322528|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92377103|NCT02322528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92377105|NCT02330094|Analgesics|analgesics|mesh-ancestor
92377106|NCT02330094|Sensory System Agents|sensory system agents|mesh-ancestor
92377107|NCT02330094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377108|NCT02330094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377109|NCT02330094|Anticonvulsants|anticonvulsants|mesh-ancestor
92377110|NCT02330094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92377111|NCT02330094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92377112|NCT02330094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377113|NCT02330094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377114|NCT02330094|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92377115|NCT02330094|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92377116|NCT02330094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030817|NCT02203149|Grazoprevir|grazoprevir|mesh-list
92377117|NCT02330094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377119|NCT02330172|Neostigmine|neostigmine|mesh-list
92377120|NCT02330172|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92377121|NCT02330172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377122|NCT02330172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377123|NCT02330172|Cholinergic Agents|cholinergic agents|mesh-ancestor
92377124|NCT02330172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377125|NCT02330172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377126|NCT02330172|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92377127|NCT02330172|Autonomic Agents|autonomic agents|mesh-ancestor
92377128|NCT02330172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377129|NCT02331108|Propofol|propofol|mesh-list
92377130|NCT02331108|Anesthetics|anesthetics|mesh-list
92377131|NCT02331108|Sevoflurane|sevoflurane|mesh-list
92377132|NCT02331108|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377133|NCT02331108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377134|NCT02331108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377135|NCT02331108|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92377136|NCT02331108|Anesthetics, General|anesthetics, general|mesh-ancestor
92377137|NCT02331108|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92377138|NCT02331108|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92377139|NCT02332902|Everolimus|everolimus|mesh-list
92377140|NCT02332902|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92377141|NCT02332902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92377142|NCT02332902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377143|NCT02332902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377144|NCT02332902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377145|NCT02332902|Immunologic Factors|immunologic factors|mesh-ancestor
92377146|NCT02332902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377147|NCT02332902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377148|NCT02340156|Temozolomide|temozolomide|mesh-list
92377149|NCT02340156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92377150|NCT02340156|Alkylating Agents|alkylating agents|mesh-ancestor
92377151|NCT02340156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377152|NCT02340156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377153|NCT02343276|Nitroglycerin|nitroglycerin|mesh-list
92377154|NCT02343276|Vasodilator Agents|vasodilator agents|mesh-ancestor
92377155|NCT02348658|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92377156|NCT02348658|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92377157|NCT02348658|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92377158|NCT02348658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377159|NCT02351700|Ibuprofen|ibuprofen|mesh-list
92377160|NCT02351700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92377161|NCT02351700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377162|NCT02351700|Analgesics|analgesics|mesh-ancestor
92377163|NCT02351700|Sensory System Agents|sensory system agents|mesh-ancestor
92377164|NCT02351700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377165|NCT02351700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377166|NCT02351700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377167|NCT02351700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377168|NCT02351700|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92377169|NCT02351700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377170|NCT02351700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377171|NCT02353806|Amlodipine|amlodipine|mesh-list
92377172|NCT02353806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92377173|NCT02353806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92377174|NCT02353806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92377175|NCT02353806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377176|NCT02353806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92377177|NCT02353806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377178|NCT02353806|Vasodilator Agents|vasodilator agents|mesh-ancestor
92377179|NCT02354352|Eplerenone|eplerenone|mesh-list
92377180|NCT02354352|Spironolactone|spironolactone|mesh-list
92377181|NCT02354352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92377182|NCT02354352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92377183|NCT02354352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377184|NCT02354352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377185|NCT02354352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92377187|NCT02354352|Natriuretic Agents|natriuretic agents|mesh-ancestor
92377188|NCT02354352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92377189|NCT02355210|DEFB1 protein, human|defb1 protein, human|mesh-list
92377190|NCT02355210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377191|NCT02357706|Acetaminophen|acetaminophen|mesh-list
92377192|NCT02357706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377193|NCT02357706|Analgesics|analgesics|mesh-ancestor
92377194|NCT02357706|Sensory System Agents|sensory system agents|mesh-ancestor
92377195|NCT02357706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377196|NCT02357706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377197|NCT02357706|Antipyretics|antipyretics|mesh-ancestor
92377198|NCT02359110|Gabapentin|gabapentin|mesh-list
92377199|NCT02359110|Analgesics|analgesics|mesh-ancestor
92377200|NCT02359110|Sensory System Agents|sensory system agents|mesh-ancestor
92377201|NCT02359110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377202|NCT02359110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377203|NCT02359110|Anticonvulsants|anticonvulsants|mesh-ancestor
92377204|NCT02359110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92377205|NCT02359110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92377206|NCT02359110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377207|NCT02359110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377208|NCT02359110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92377209|NCT02359110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92377210|NCT02359110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377211|NCT02359110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377212|NCT02359110|Antimanic Agents|antimanic agents|mesh-ancestor
92377213|NCT02360124|Fluorides|fluorides|mesh-list
92377214|NCT02360124|Cariostatic Agents|cariostatic agents|mesh-ancestor
92377215|NCT02360124|Protective Agents|protective agents|mesh-ancestor
92377216|NCT02360124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377217|NCT02369172|Bupropion|bupropion|mesh-list
92377218|NCT02369172|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92377219|NCT02369172|Antidepressive Agents|antidepressive agents|mesh-ancestor
92377220|NCT02369172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377221|NCT02369172|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92377222|NCT02369172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92377223|NCT02369172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92377224|NCT02369172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377225|NCT02369172|Dopamine Agents|dopamine agents|mesh-ancestor
92377226|NCT02369172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377227|NCT02369172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377228|NCT02369172|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92377229|NCT02369172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92377230|NCT02369172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377231|NCT02374164|Febuxostat|febuxostat|mesh-list
92377232|NCT02374164|Gout Suppressants|gout suppressants|mesh-ancestor
92377233|NCT02374164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377234|NCT02374398|Tranexamic Acid|tranexamic acid|mesh-list
92377235|NCT02374398|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92377236|NCT02374398|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92377237|NCT02374398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377238|NCT02374398|Hemostatics|hemostatics|mesh-ancestor
92377239|NCT02374398|Coagulants|coagulants|mesh-ancestor
92377240|NCT02377752|Doxorubicin|doxorubicin|mesh-list
92377241|NCT02377752|Olaratumab|olaratumab|mesh-list
92377242|NCT02377752|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92377243|NCT02377752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377244|NCT02377752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92377245|NCT02377752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92377246|NCT02377752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377247|NCT02377752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377248|NCT02379858|Alvimopan|alvimopan|mesh-list
92377249|NCT02379858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377250|NCT02384070|Aspirin|aspirin|mesh-list
92377251|NCT02384070|Bivalirudin|bivalirudin|mesh-list
92377252|NCT02384070|Clopidogrel|clopidogrel|mesh-list
92377253|NCT02384070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92377254|NCT02384070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377255|NCT02384070|Analgesics|analgesics|mesh-ancestor
92377256|NCT02384070|Sensory System Agents|sensory system agents|mesh-ancestor
92377257|NCT02384070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377258|NCT02384070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377259|NCT02384070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377260|NCT02384070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377261|NCT02384070|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92377262|NCT02384070|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92377263|NCT02384070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377264|NCT02384070|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92377265|NCT02384070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92377266|NCT02384070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377268|NCT02384070|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92377269|NCT02384070|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92377270|NCT02384070|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92377271|NCT02384070|Purinergic Agents|purinergic agents|mesh-ancestor
92377272|NCT02384070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377273|NCT02384070|Antithrombins|antithrombins|mesh-ancestor
92377274|NCT02384070|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92377275|NCT02384070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92377276|NCT02384070|Anticoagulants|anticoagulants|mesh-ancestor
92377277|NCT02385240|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92377278|NCT02385240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92377279|NCT02385240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92377280|NCT02385240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92377281|NCT02385240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92377282|NCT02385240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377283|NCT02385240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377284|NCT02385240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377285|NCT02385240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377286|NCT02391714|Chlorhexidine|chlorhexidine|mesh-list
92377287|NCT02391714|Povidone-Iodine|povidone-iodine|mesh-list
92377288|NCT02391714|Nitrous Oxide|nitrous oxide|mesh-list
92377289|NCT02391714|Povidone|povidone|mesh-list
92377290|NCT02391714|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92377291|NCT02391714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377292|NCT02391714|Disinfectants|disinfectants|mesh-ancestor
92377293|NCT02391714|Plasma Substitutes|plasma substitutes|mesh-ancestor
92377294|NCT02391714|Blood Substitutes|blood substitutes|mesh-ancestor
92377295|NCT02391714|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92377296|NCT02391714|Anesthetics, General|anesthetics, general|mesh-ancestor
92377297|NCT02391714|Anesthetics|anesthetics|mesh-ancestor
92377298|NCT02391714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377299|NCT02391714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377300|NCT02391714|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377301|NCT02391714|Analgesics|analgesics|mesh-ancestor
92377302|NCT02391714|Sensory System Agents|sensory system agents|mesh-ancestor
92377303|NCT02391714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377304|NCT02395692|Temozolomide|temozolomide|mesh-list
92377305|NCT02395692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92377306|NCT02395692|Alkylating Agents|alkylating agents|mesh-ancestor
92377307|NCT02395692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377308|NCT02395692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377309|NCT02397954|Ranibizumab|ranibizumab|mesh-list
92377310|NCT02397954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92377311|NCT02397954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92377312|NCT02397954|Growth Substances|growth substances|mesh-ancestor
92377313|NCT02397954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377314|NCT02397954|Growth Inhibitors|growth inhibitors|mesh-ancestor
92377315|NCT02397954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377316|NCT02401464|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92377317|NCT02401464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92377318|NCT02401464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92115523|NCT01921335|Trastuzumab|trastuzumab|mesh-list
92377319|NCT02401464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377320|NCT02401542|Docetaxel|docetaxel|mesh-list
92377321|NCT02401542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377322|NCT02401542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92377323|NCT02401542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92377324|NCT02401542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92377325|NCT02401542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377326|NCT02411916|Misoprostol|misoprostol|mesh-list
92377327|NCT02411916|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92377328|NCT02411916|Abortifacient Agents|abortifacient agents|mesh-ancestor
92377329|NCT02411916|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92377330|NCT02411916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935232|NCT03510871|Nivolumab|nivolumab|mesh-list
92377331|NCT02411916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92377332|NCT02411916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377334|NCT02413320|Paclitaxel|paclitaxel|mesh-list
92377335|NCT02413320|Docetaxel|docetaxel|mesh-list
92377336|NCT02413320|Cyclophosphamide|cyclophosphamide|mesh-list
92377337|NCT02413320|Carboplatin|carboplatin|mesh-list
92377338|NCT02413320|Doxorubicin|doxorubicin|mesh-list
92377339|NCT02413320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92377340|NCT02413320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377341|NCT02413320|Tubulin Modulators|tubulin modulators|mesh-ancestor
92377342|NCT02413320|Antimitotic Agents|antimitotic agents|mesh-ancestor
92377343|NCT02413320|Mitosis Modulators|mitosis modulators|mesh-ancestor
92377344|NCT02413320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377345|NCT02413320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377346|NCT02413320|Immunologic Factors|immunologic factors|mesh-ancestor
92377347|NCT02413320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377348|NCT02413320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377349|NCT02413320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91935434|NCT02310997|Melphalan|melphalan|mesh-list
92377350|NCT02413320|Alkylating Agents|alkylating agents|mesh-ancestor
92377351|NCT02413320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92377352|NCT02413320|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92377353|NCT02413320|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92377354|NCT02413320|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92377355|NCT02413320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377356|NCT05718882|Lenvatinib|lenvatinib|mesh-list
92377357|NCT05718882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377358|NCT05718882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92377359|NCT05718882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377360|NCT05718882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377361|NCT05718492|Leucovorin|leucovorin|mesh-list
92377362|NCT05718492|Fluorouracil|fluorouracil|mesh-list
92377363|NCT05718492|Oxaliplatin|oxaliplatin|mesh-list
92377364|NCT05718492|Antimetabolites|antimetabolites|mesh-ancestor
92377365|NCT05718492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377366|NCT05718492|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92377367|NCT05718492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377368|NCT05718492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377369|NCT05718492|Immunologic Factors|immunologic factors|mesh-ancestor
92377370|NCT05718492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377371|NCT05718492|Antidotes|antidotes|mesh-ancestor
92377372|NCT05718492|Protective Agents|protective agents|mesh-ancestor
92377373|NCT05718492|Vitamin B Complex|vitamin b complex|mesh-ancestor
92377375|NCT05718492|Micronutrients|micronutrients|mesh-ancestor
92377376|NCT05718258|Venglustat|venglustat|mesh-list
92377377|NCT05718258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377378|NCT05718258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377379|NCT05718024|Dexmedetomidine|dexmedetomidine|mesh-list
92377380|NCT05718024|Remifentanil|remifentanil|mesh-list
92377381|NCT05718024|Propofol|propofol|mesh-list
92377382|NCT05718024|Esketamine|esketamine|mesh-list
92377383|NCT05718024|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377384|NCT05718024|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377385|NCT05718024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377386|NCT05718024|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377387|NCT05718024|Analgesics|analgesics|mesh-ancestor
92377388|NCT05718024|Sensory System Agents|sensory system agents|mesh-ancestor
92377389|NCT05718024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377390|NCT05718024|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92377391|NCT05718024|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92377392|NCT05718024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92377393|NCT05718024|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377394|NCT05718024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377395|NCT05718024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377396|NCT05718024|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92377397|NCT05718024|Anesthetics, General|anesthetics, general|mesh-ancestor
92377398|NCT05718024|Anesthetics|anesthetics|mesh-ancestor
92377399|NCT05718024|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92377400|NCT05718024|Narcotics|narcotics|mesh-ancestor
92030835|NCT02202837|Etanercept|etanercept|mesh-list
92377401|NCT05718024|Antidepressive Agents|antidepressive agents|mesh-ancestor
92377402|NCT05718024|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377403|NCT05717790|Gemcitabine|gemcitabine|mesh-list
92377404|NCT05717790|Nimotuzumab|nimotuzumab|mesh-list
92377405|NCT05717790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377406|NCT05717790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92377407|NCT05717790|Antimetabolites|antimetabolites|mesh-ancestor
92377408|NCT05717790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377409|NCT05717790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377410|NCT05679258|Daratumumab|daratumumab|mesh-list
92377411|NCT05679258|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92377412|NCT05679258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377413|NCT05679258|Immunologic Factors|immunologic factors|mesh-ancestor
92377414|NCT05679258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377415|NCT05602272|Anesthetics|anesthetics|mesh-list
92377416|NCT05602272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377417|NCT05602272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377418|NCT05589792|Acetazolamide|acetazolamide|mesh-list
92377419|NCT05589792|Anticonvulsants|anticonvulsants|mesh-ancestor
92377420|NCT05589792|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92377421|NCT05589792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115524|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377422|NCT05589792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377423|NCT05589792|Diuretics|diuretics|mesh-ancestor
92377424|NCT05589792|Natriuretic Agents|natriuretic agents|mesh-ancestor
92377425|NCT05589792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377426|NCT05543694|Bupivacaine|bupivacaine|mesh-list
92377427|NCT05543694|Anesthetics, Local|anesthetics, local|mesh-ancestor
92377428|NCT05543694|Anesthetics|anesthetics|mesh-ancestor
92377429|NCT05543694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377430|NCT05543694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377431|NCT05543694|Sensory System Agents|sensory system agents|mesh-ancestor
92377432|NCT05543694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377433|NCT05495568|Adalimumab|adalimumab|mesh-list
92377434|NCT05495568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92377435|NCT05495568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377436|NCT05495568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377437|NCT05358834|Melatonin|melatonin|mesh-list
92377438|NCT05358834|Antioxidants|antioxidants|mesh-ancestor
92377439|NCT05358834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377440|NCT05358834|Protective Agents|protective agents|mesh-ancestor
92377441|NCT05358834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377442|NCT05358834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377443|NCT05317806|Metformin|metformin|mesh-list
92377444|NCT05317806|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92377445|NCT05317806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377446|NCT05273346|Analgesics|analgesics|mesh-list
92377447|NCT05273346|Sensory System Agents|sensory system agents|mesh-ancestor
92377448|NCT05273346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377449|NCT05273346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377450|NCT05105256|Prednisolone|prednisolone|mesh-list
92377451|NCT05105256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377452|NCT05105256|Glucocorticoids|glucocorticoids|mesh-ancestor
92377453|NCT05105256|Hormones|hormones|mesh-ancestor
92377454|NCT05105256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377455|NCT05105256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377456|NCT05105256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92377457|NCT05105256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377458|NCT04916886|Vaccines|vaccines|mesh-list
92377459|NCT04916886|Immunologic Factors|immunologic factors|mesh-ancestor
92377460|NCT04916886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377461|NCT04907682|Ribavirin|ribavirin|mesh-list
92377462|NCT04907682|Favipiravir|favipiravir|mesh-list
92377463|NCT04907682|Antimetabolites|antimetabolites|mesh-ancestor
92377464|NCT04907682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377465|NCT04907682|Antiviral Agents|antiviral agents|mesh-ancestor
92377466|NCT04907682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377467|NCT04840992|Vaccines|vaccines|mesh-list
92377468|NCT04840992|Immunologic Factors|immunologic factors|mesh-ancestor
92377469|NCT04840992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377470|NCT04793022|Anesthetics|anesthetics|mesh-list
92377471|NCT04793022|Propofol|propofol|mesh-list
92377472|NCT04793022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377473|NCT04793022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377474|NCT04793022|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377475|NCT04793022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92377476|NCT04793022|Anesthetics, General|anesthetics, general|mesh-ancestor
92377477|NCT04776018|Daratumumab|daratumumab|mesh-list
92377478|NCT04776018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377479|NCT04750902|Listerine|listerine|mesh-list
92377480|NCT04750902|Fluorides|fluorides|mesh-list
92377481|NCT04750902|Sodium Fluoride|sodium fluoride|mesh-list
92377482|NCT04750902|Cariostatic Agents|cariostatic agents|mesh-ancestor
92029962|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377483|NCT04750902|Protective Agents|protective agents|mesh-ancestor
92377484|NCT04750902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377485|NCT04750902|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92377486|NCT04750902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377488|NCT04621500|Cholecalciferol|cholecalciferol|mesh-list
92377489|NCT04621500|Vitamins|vitamins|mesh-ancestor
92377490|NCT04621500|Micronutrients|micronutrients|mesh-ancestor
92377491|NCT04621500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377492|NCT04621500|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92377493|NCT04621500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92377494|NCT04567524|Risperidone|risperidone|mesh-list
92377495|NCT04567524|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92377496|NCT04567524|Serotonin Agents|serotonin agents|mesh-ancestor
92377497|NCT04567524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377498|NCT04567524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377499|NCT04567524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377500|NCT04567524|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92377501|NCT04567524|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92377502|NCT04567524|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377503|NCT04567524|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377504|NCT04567524|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92377505|NCT04567524|Dopamine Agents|dopamine agents|mesh-ancestor
92377506|NCT04547790|Psyllium|psyllium|mesh-list
92377507|NCT04547790|Cathartics|cathartics|mesh-ancestor
92120879|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
92377508|NCT04547790|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377509|NCT04481412|Cetirizine|cetirizine|mesh-list
92377510|NCT04481412|Ethanol|ethanol|mesh-list
92377511|NCT04481412|Minoxidil|minoxidil|mesh-list
92377512|NCT04481412|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92377513|NCT04481412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377514|NCT04481412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377515|NCT04481412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377517|NCT04481412|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92377518|NCT04481412|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92377519|NCT04481412|Histamine Antagonists|histamine antagonists|mesh-ancestor
92377520|NCT04481412|Histamine Agents|histamine agents|mesh-ancestor
92377521|NCT04481412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377522|NCT04481412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377523|NCT04481412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92377524|NCT04481412|Vasodilator Agents|vasodilator agents|mesh-ancestor
92377525|NCT04317300|Varenicline|varenicline|mesh-list
92377526|NCT04317300|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92377527|NCT04317300|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92377528|NCT04317300|Cholinergic Agents|cholinergic agents|mesh-ancestor
92377529|NCT04317300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377530|NCT04317300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377531|NCT04317300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377532|NCT04143204|Insulin|insulin|mesh-list
92377533|NCT04143204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92377534|NCT04143204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377535|NCT04031508|SMOFlipid|smoflipid|mesh-list
92377536|NCT04031508|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92377537|NCT04031508|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92377538|NCT04031508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92377539|NCT03876288|Immunoglobulins|immunoglobulins|mesh-list
92377540|NCT03876288|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92377541|NCT03876288|gamma-Globulins|gamma-globulins|mesh-list
92377542|NCT03876288|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92377543|NCT03876288|Immunologic Factors|immunologic factors|mesh-ancestor
92377544|NCT03876288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377545|NCT03252522|Micronutrients|micronutrients|mesh-list
92377546|NCT03252522|Trace Elements|trace elements|mesh-list
92377547|NCT03252522|Antioxidants|antioxidants|mesh-list
92377548|NCT03252522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377549|NCT03252522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377550|NCT03252522|Protective Agents|protective agents|mesh-ancestor
92377551|NCT03191370|Anesthetics|anesthetics|mesh-list
92377552|NCT03191370|Anesthetics, Local|anesthetics, local|mesh-list
92377553|NCT03191370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377554|NCT03191370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377555|NCT03191370|Sensory System Agents|sensory system agents|mesh-ancestor
92377556|NCT03191370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377557|NCT03179436|Pembrolizumab|pembrolizumab|mesh-list
92377558|NCT03179436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030038|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
92377559|NCT03179436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377561|NCT03179436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377562|NCT03149874|Vaccines|vaccines|mesh-list
92377563|NCT03149874|Immunologic Factors|immunologic factors|mesh-ancestor
92377564|NCT03149874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377565|NCT02834052|Poly I-C|poly i-c|mesh-list
92377566|NCT02834052|Pembrolizumab|pembrolizumab|mesh-list
92377567|NCT02834052|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92377568|NCT02834052|Poly ICLC|poly iclc|mesh-list
92377569|NCT02834052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377570|NCT02834052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377571|NCT02834052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92377572|NCT02834052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377573|NCT02834052|Interferon Inducers|interferon inducers|mesh-ancestor
92377574|NCT02834052|Immunologic Factors|immunologic factors|mesh-ancestor
92377575|NCT02834052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377576|NCT02834052|Laxatives|laxatives|mesh-ancestor
92121109|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
92377577|NCT02834052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377578|NCT02834052|Antiviral Agents|antiviral agents|mesh-ancestor
92377579|NCT02834052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377580|NCT02756364|Fulvestrant|fulvestrant|mesh-list
92377581|NCT02756364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92377582|NCT02756364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377583|NCT02756364|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92377584|NCT02756364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92377585|NCT02756364|Hormone Antagonists|hormone antagonists|mesh-ancestor
92377586|NCT02756364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377587|NCT02756364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377589|NCT02519322|Ipilimumab|ipilimumab|mesh-list
92377590|NCT02519322|Relatlimab|relatlimab|mesh-list
92377591|NCT02519322|Immunoglobulins|immunoglobulins|mesh-list
92377592|NCT02519322|Immunoglobulin G|immunoglobulin g|mesh-list
92377593|NCT02519322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377594|NCT02519322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377595|NCT02519322|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92377596|NCT02519322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377597|NCT02519322|Immunologic Factors|immunologic factors|mesh-ancestor
92377598|NCT02519322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377599|NCT02460042|Paclitaxel|paclitaxel|mesh-list
92377600|NCT02460042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92377601|NCT02460042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377602|NCT02460042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92377603|NCT02460042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92377604|NCT02460042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92377605|NCT02460042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377606|NCT02272842|Vitamin B 12|vitamin b 12|mesh-list
92377607|NCT02272842|Hydroxocobalamin|hydroxocobalamin|mesh-list
92377608|NCT02272842|Vitamins|vitamins|mesh-ancestor
92377609|NCT02272842|Micronutrients|micronutrients|mesh-ancestor
92377610|NCT02272842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377611|NCT02272842|Vitamin B Complex|vitamin b complex|mesh-ancestor
92377612|NCT02272842|Hematinics|hematinics|mesh-ancestor
92377613|NCT05722548|Indomethacin|indomethacin|mesh-list
92377614|NCT05722548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92377615|NCT05722548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377616|NCT05722548|Analgesics|analgesics|mesh-ancestor
92377617|NCT05722548|Sensory System Agents|sensory system agents|mesh-ancestor
92377618|NCT05722548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377619|NCT05722548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377620|NCT05722548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377621|NCT05722548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377622|NCT05722548|Gout Suppressants|gout suppressants|mesh-ancestor
92377623|NCT05722548|Tocolytic Agents|tocolytic agents|mesh-ancestor
92377624|NCT05722548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92377625|NCT05722548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92377626|NCT05722548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377627|NCT05722548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377629|NCT05722002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377630|NCT05722002|Analgesics|analgesics|mesh-ancestor
92377631|NCT05722002|Sensory System Agents|sensory system agents|mesh-ancestor
92377632|NCT05722002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377633|NCT05722002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377634|NCT05722002|Antipyretics|antipyretics|mesh-ancestor
92377635|NCT05721456|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92377636|NCT05721456|Immunologic Factors|immunologic factors|mesh-ancestor
92377637|NCT05721456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377638|NCT05721300|Interferons|interferons|mesh-list
92377639|NCT05721300|Tenofovir|tenofovir|mesh-list
92377640|NCT05721300|Entecavir|entecavir|mesh-list
92377641|NCT05721300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377642|NCT05721300|Antiviral Agents|antiviral agents|mesh-ancestor
92377643|NCT05721300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377644|NCT05721300|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92377645|NCT05721300|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92377646|NCT05721300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377647|NCT05721300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377648|NCT05721300|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92377649|NCT05721300|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92377650|NCT05720442|Mosapride|mosapride|mesh-list
92121110|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
92377651|NCT05720442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377652|NCT05720442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377653|NCT05720442|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92377654|NCT05720442|Serotonin Agents|serotonin agents|mesh-ancestor
92377655|NCT05720442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377656|NCT05720442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377657|NCT05719818|Diphosphonates|diphosphonates|mesh-list
92377658|NCT05719818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92377659|NCT05719818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377660|NCT05719506|Dexmedetomidine|dexmedetomidine|mesh-list
92377661|NCT05719506|Ketamine|ketamine|mesh-list
92377662|NCT05719506|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377663|NCT05719506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377664|NCT05719506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377665|NCT05719506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377667|NCT05719506|Sensory System Agents|sensory system agents|mesh-ancestor
92377668|NCT05719506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377669|NCT05719506|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92377670|NCT05719506|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92377671|NCT05719506|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92377672|NCT05719506|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377673|NCT05719506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377674|NCT05719506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377675|NCT05719506|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92377676|NCT05719506|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92377677|NCT05719506|Anesthetics, General|anesthetics, general|mesh-ancestor
92377678|NCT05719506|Anesthetics|anesthetics|mesh-ancestor
92377679|NCT05719506|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92377680|NCT05719506|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92377681|NCT05717166|Hormones|hormones|mesh-list
92377682|NCT05717166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92377683|NCT05717166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377684|NCT05716932|Ranibizumab|ranibizumab|mesh-list
92377685|NCT05716932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92377686|NCT05716932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92377687|NCT05716932|Growth Substances|growth substances|mesh-ancestor
92377688|NCT05716932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377689|NCT05716932|Growth Inhibitors|growth inhibitors|mesh-ancestor
92377690|NCT05716932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377691|NCT05715840|Paclitaxel|paclitaxel|mesh-list
92377692|NCT05715840|Bevacizumab|bevacizumab|mesh-list
92377693|NCT05715840|Carboplatin|carboplatin|mesh-list
92377694|NCT05715840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92377695|NCT05715840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030847|NCT02226549|Sofosbuvir|sofosbuvir|mesh-list
92377696|NCT05715840|Tubulin Modulators|tubulin modulators|mesh-ancestor
92377697|NCT05715840|Antimitotic Agents|antimitotic agents|mesh-ancestor
92377698|NCT05715840|Mitosis Modulators|mitosis modulators|mesh-ancestor
92377699|NCT05715840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377700|NCT05715840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377701|NCT05715840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92377702|NCT05715840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92377703|NCT05715840|Growth Substances|growth substances|mesh-ancestor
92377704|NCT05715840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377705|NCT05715840|Growth Inhibitors|growth inhibitors|mesh-ancestor
92377706|NCT05713734|Thrombin|thrombin|mesh-list
92377707|NCT05713734|Hemostatics|hemostatics|mesh-ancestor
92377708|NCT05713734|Coagulants|coagulants|mesh-ancestor
92377709|NCT05698758|Dexmedetomidine|dexmedetomidine|mesh-list
92377710|NCT05698758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377711|NCT05698758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377712|NCT05698758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377713|NCT05698758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377714|NCT05698758|Analgesics|analgesics|mesh-ancestor
92377715|NCT05698758|Sensory System Agents|sensory system agents|mesh-ancestor
92377716|NCT05698758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377717|NCT05698758|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92377718|NCT05698758|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92377719|NCT05698758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92377720|NCT05698758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377721|NCT05698758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377722|NCT05698758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377723|NCT05665062|Cyclophosphamide|cyclophosphamide|mesh-list
92377724|NCT05665062|Fludarabine|fludarabine|mesh-list
92377725|NCT05665062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377726|NCT05665062|Immunologic Factors|immunologic factors|mesh-ancestor
92377727|NCT05665062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377728|NCT05665062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377729|NCT05665062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92377730|NCT05665062|Alkylating Agents|alkylating agents|mesh-ancestor
92377731|NCT05665062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377732|NCT05665062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377733|NCT05665062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92377734|NCT05557812|Eugenol|eugenol|mesh-list
92377735|NCT05557812|Zinc Oxide|zinc oxide|mesh-list
92377736|NCT05557812|Ferric Compounds|ferric compounds|mesh-list
92377737|NCT05557812|Dermatologic Agents|dermatologic agents|mesh-ancestor
92377738|NCT05557812|Sunscreening Agents|sunscreening agents|mesh-ancestor
92377739|NCT05557812|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92377740|NCT05557812|Protective Agents|protective agents|mesh-ancestor
92377741|NCT05557812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377742|NCT05557812|Hematinics|hematinics|mesh-ancestor
92377743|NCT05557812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377744|NCT05549466|Gemcitabine|gemcitabine|mesh-list
92377745|NCT05549466|Capecitabine|capecitabine|mesh-list
92377746|NCT05549466|Docetaxel|docetaxel|mesh-list
92377747|NCT05549466|Apatinib|apatinib|mesh-list
92377748|NCT05549466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92377749|NCT05549466|Antimetabolites|antimetabolites|mesh-ancestor
92377750|NCT05549466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377751|NCT05549466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377752|NCT05549466|Tubulin Modulators|tubulin modulators|mesh-ancestor
92377753|NCT05549466|Antimitotic Agents|antimitotic agents|mesh-ancestor
92377754|NCT05549466|Mitosis Modulators|mitosis modulators|mesh-ancestor
92377755|NCT05549466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92377756|NCT05549466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936626|NCT02262533|Apixaban|apixaban|mesh-list
92377757|NCT05436678|Ciprofloxacin|ciprofloxacin|mesh-list
92377758|NCT05436678|Celecoxib|celecoxib|mesh-list
92377759|NCT05436678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92377760|NCT05436678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377761|NCT05436678|Analgesics|analgesics|mesh-ancestor
92377762|NCT05436678|Sensory System Agents|sensory system agents|mesh-ancestor
92377763|NCT05436678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377764|NCT05436678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377765|NCT05436678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377766|NCT05436678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377767|NCT05436678|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92377768|NCT05436678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92377769|NCT05436678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377770|NCT05436678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377771|NCT05436678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92377772|NCT05436678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377773|NCT05436678|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92377774|NCT05436678|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92377775|NCT05436678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377776|NCT05436678|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92377777|NCT05436678|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92377778|NCT05425056|Sirolimus|sirolimus|mesh-list
92377779|NCT05425056|Temsirolimus|temsirolimus|mesh-list
92377780|NCT05425056|MTOR Inhibitors|mtor inhibitors|mesh-list
92377781|NCT05425056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92377782|NCT05425056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377783|NCT05425056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92377784|NCT05425056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377785|NCT05425056|Antifungal Agents|antifungal agents|mesh-ancestor
92377786|NCT05425056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377787|NCT05425056|Immunologic Factors|immunologic factors|mesh-ancestor
92377788|NCT05425056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377789|NCT05425056|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92377790|NCT05425056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377791|NCT05425056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377792|NCT05352282|Fentanyl|fentanyl|mesh-list
92377793|NCT05352282|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92377794|NCT05352282|Narcotics|narcotics|mesh-ancestor
92377795|NCT05352282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377796|NCT05352282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377797|NCT05352282|Analgesics|analgesics|mesh-ancestor
92377798|NCT05352282|Sensory System Agents|sensory system agents|mesh-ancestor
92377799|NCT05352282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377800|NCT05352282|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92377801|NCT05352282|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92377802|NCT05352282|Anesthetics, General|anesthetics, general|mesh-ancestor
92377803|NCT05352282|Anesthetics|anesthetics|mesh-ancestor
92377804|NCT05322330|Cyclophosphamide|cyclophosphamide|mesh-list
92377805|NCT05322330|Fludarabine|fludarabine|mesh-list
92377806|NCT05322330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377807|NCT05322330|Immunologic Factors|immunologic factors|mesh-ancestor
92377808|NCT05322330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377809|NCT05322330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377810|NCT05322330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92377811|NCT05322330|Alkylating Agents|alkylating agents|mesh-ancestor
92377812|NCT05322330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377813|NCT05322330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377814|NCT05322330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92377815|NCT05312892|Amlodipine|amlodipine|mesh-list
92377816|NCT05312892|Antihypertensive Agents|antihypertensive agents|mesh-list
92377817|NCT05312892|Moxonidine|moxonidine|mesh-list
92377818|NCT05312892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92377819|NCT05312892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92377820|NCT05312892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377821|NCT05312892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92121111|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
92377822|NCT05312892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377823|NCT05312892|Vasodilator Agents|vasodilator agents|mesh-ancestor
92377824|NCT05309616|Ixekizumab|ixekizumab|mesh-list
92377825|NCT05309616|Dermatologic Agents|dermatologic agents|mesh-ancestor
92377826|NCT05278494|Dextromethorphan|dextromethorphan|mesh-list
92377827|NCT05278494|Antitussive Agents|antitussive agents|mesh-ancestor
92377828|NCT05278494|Respiratory System Agents|respiratory system agents|mesh-ancestor
92377829|NCT05278494|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92377830|NCT05278494|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92377831|NCT05278494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377832|NCT05278494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377833|NCT05278494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377834|NCT05251038|Leucovorin|leucovorin|mesh-list
92377835|NCT05251038|Paclitaxel|paclitaxel|mesh-list
92377836|NCT05251038|Gemcitabine|gemcitabine|mesh-list
92377837|NCT05251038|Fluorouracil|fluorouracil|mesh-list
92377838|NCT05251038|Irinotecan|irinotecan|mesh-list
92377839|NCT05251038|Sotorasib|sotorasib|mesh-list
92377840|NCT05251038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92377841|NCT05251038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377842|NCT05251038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92377843|NCT05251038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92377844|NCT05251038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92377845|NCT05251038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377846|NCT05251038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92377847|NCT05251038|Antimetabolites|antimetabolites|mesh-ancestor
92377848|NCT05251038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377849|NCT05251038|Immunologic Factors|immunologic factors|mesh-ancestor
92377850|NCT05251038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377851|NCT05251038|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92377852|NCT05251038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92377853|NCT05251038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377854|NCT05251038|Antidotes|antidotes|mesh-ancestor
92377855|NCT05251038|Protective Agents|protective agents|mesh-ancestor
92377856|NCT05251038|Vitamin B Complex|vitamin b complex|mesh-ancestor
92377857|NCT05251038|Vitamins|vitamins|mesh-ancestor
92377858|NCT05251038|Micronutrients|micronutrients|mesh-ancestor
92377859|NCT05251038|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92377860|NCT05251038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377861|NCT05217498|Istradefylline|istradefylline|mesh-list
92377862|NCT05217498|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92377863|NCT05217498|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92377864|NCT05217498|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92377865|NCT05217498|Purinergic Agents|purinergic agents|mesh-ancestor
92377866|NCT05217498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377867|NCT05217498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377868|NCT05217498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377869|NCT05091372|Lenalidomide|lenalidomide|mesh-list
92377870|NCT05091372|Immunologic Factors|immunologic factors|mesh-ancestor
92377871|NCT05091372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377872|NCT05091372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92377873|NCT05091372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92377874|NCT05091372|Growth Substances|growth substances|mesh-ancestor
92377875|NCT05091372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92377876|NCT05091372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377877|NCT05027646|Granisetron|granisetron|mesh-list
92377878|NCT05027646|Antiemetics|antiemetics|mesh-ancestor
92377879|NCT05027646|Autonomic Agents|autonomic agents|mesh-ancestor
92377880|NCT05027646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377881|NCT05027646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377882|NCT05027646|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92377883|NCT05027646|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92377884|NCT05027646|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92377885|NCT05027646|Serotonin Agents|serotonin agents|mesh-ancestor
92377886|NCT05027646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377887|NCT05027646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377888|NCT04988646|Acyclovir|acyclovir|mesh-list
92377889|NCT04988646|Antiviral Agents|antiviral agents|mesh-ancestor
92377890|NCT04988646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377891|NCT04972110|Olaparib|olaparib|mesh-list
92377892|NCT04972110|Niraparib|niraparib|mesh-list
92377893|NCT04972110|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92377894|NCT04972110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377895|NCT04972110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377896|NCT04972110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377897|NCT04924062|Cisplatin|cisplatin|mesh-list
92377898|NCT04924062|Gemcitabine|gemcitabine|mesh-list
92377899|NCT04924062|Pembrolizumab|pembrolizumab|mesh-list
92377900|NCT04924062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377901|NCT04924062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92377902|NCT04924062|Antimetabolites|antimetabolites|mesh-ancestor
92377903|NCT04924062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377904|NCT04924062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92377905|NCT04924062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92377906|NCT04876638|Minocycline|minocycline|mesh-list
92377907|NCT04876638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92377908|NCT04876638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92377909|NCT04754334|Insulin|insulin|mesh-list
92377910|NCT04754334|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92377911|NCT04754334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377912|NCT04748796|Landiolol|landiolol|mesh-list
91937034|NCT01262261|Buprenorphine|buprenorphine|mesh-list
92377913|NCT04748796|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92377914|NCT04748796|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92377915|NCT04748796|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377916|NCT04748796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377917|NCT04748796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377918|NCT04748796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377919|NCT04748796|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92377920|NCT04625946|Metformin|metformin|mesh-list
92377921|NCT04625946|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92377922|NCT04625946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377923|NCT04599816|Simendan|simendan|mesh-list
92377924|NCT04599816|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92377925|NCT04599816|Vasodilator Agents|vasodilator agents|mesh-ancestor
92377926|NCT04599816|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92377927|NCT04599816|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92377928|NCT04599816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377929|NCT04599816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377930|NCT04599816|Protective Agents|protective agents|mesh-ancestor
92377931|NCT04599816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377932|NCT04546230|Anesthetics|anesthetics|mesh-list
92377933|NCT04546230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377934|NCT04546230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377935|NCT04534218|Aspirin|aspirin|mesh-list
92030415|NCT04784247|Pembrolizumab|pembrolizumab|mesh-list
92377936|NCT04534218|Cyclophosphamide|cyclophosphamide|mesh-list
92377937|NCT04534218|Capecitabine|capecitabine|mesh-list
92377938|NCT04534218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92377939|NCT04534218|Immunologic Factors|immunologic factors|mesh-ancestor
92377940|NCT04534218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377941|NCT04534218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92377942|NCT04534218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92377943|NCT04534218|Alkylating Agents|alkylating agents|mesh-ancestor
92377944|NCT04534218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377945|NCT04534218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377946|NCT04534218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92377947|NCT04534218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92377948|NCT04534218|Antimetabolites|antimetabolites|mesh-ancestor
92377949|NCT04534218|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92377950|NCT04534218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377951|NCT04534218|Analgesics|analgesics|mesh-ancestor
92377952|NCT04534218|Sensory System Agents|sensory system agents|mesh-ancestor
92377953|NCT04534218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377954|NCT04534218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92377955|NCT04534218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92377956|NCT04534218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92377957|NCT04534218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92377958|NCT04534218|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92377959|NCT04534218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92377961|NCT04531878|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92377962|NCT04531878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92377963|NCT04509414|Midazolam|midazolam|mesh-list
92377964|NCT04509414|Dexmedetomidine|dexmedetomidine|mesh-list
92377965|NCT04509414|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92377966|NCT04509414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92377967|NCT04509414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377968|NCT04509414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92377969|NCT04509414|Analgesics|analgesics|mesh-ancestor
92377970|NCT04509414|Sensory System Agents|sensory system agents|mesh-ancestor
92377971|NCT04509414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377972|NCT04509414|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92377973|NCT04509414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92377974|NCT04509414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92377975|NCT04509414|Adrenergic Agents|adrenergic agents|mesh-ancestor
92377976|NCT04509414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92377977|NCT04509414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92377978|NCT04509414|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92377979|NCT04509414|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92377980|NCT04509414|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92377981|NCT04509414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92377982|NCT04509414|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92377983|NCT04509414|Anesthetics, General|anesthetics, general|mesh-ancestor
92377984|NCT04509414|Anesthetics|anesthetics|mesh-ancestor
92377985|NCT04509414|GABA Modulators|gaba modulators|mesh-ancestor
92377986|NCT04509414|GABA Agents|gaba agents|mesh-ancestor
92377987|NCT04320342|Beclomethasone|beclomethasone|mesh-list
92377988|NCT04320342|Glycopyrrolate|glycopyrrolate|mesh-list
92377989|NCT04320342|Bromides|bromides|mesh-list
92377990|NCT04320342|Formoterol Fumarate|formoterol fumarate|mesh-list
92377991|NCT04320342|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92377992|NCT04320342|Autonomic Agents|autonomic agents|mesh-ancestor
92377993|NCT04320342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92377994|NCT04320342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92377995|NCT04320342|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92377996|NCT04320342|Respiratory System Agents|respiratory system agents|mesh-ancestor
92377997|NCT04320342|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92377998|NCT04320342|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92377999|NCT04320342|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92378000|NCT04320342|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378001|NCT04320342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937157|NCT01329419|Adefovir|adefovir|mesh-list
92378002|NCT04320342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378003|NCT04320342|Anticonvulsants|anticonvulsants|mesh-ancestor
92378004|NCT04320342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378005|NCT04320342|Glucocorticoids|glucocorticoids|mesh-ancestor
92378006|NCT04320342|Hormones|hormones|mesh-ancestor
92378007|NCT04320342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378008|NCT04320342|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378009|NCT04320342|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92378010|NCT04320342|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92378011|NCT04320342|Cholinergic Agents|cholinergic agents|mesh-ancestor
92378012|NCT04307550|Ethanol|ethanol|mesh-list
92378013|NCT04307550|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92378014|NCT04307550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378015|NCT04307550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378016|NCT04307550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378017|NCT04164732|Valsartan|valsartan|mesh-list
92378018|NCT04164732|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92378019|NCT04164732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92378020|NCT04164732|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92378021|NCT04164732|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92378022|NCT04164732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378023|NCT04134000|Atezolizumab|atezolizumab|mesh-list
92378024|NCT04134000|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378025|NCT04134000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378026|NCT04134000|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378027|NCT04134000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378028|NCT04095858|Methotrexate|methotrexate|mesh-list
92378029|NCT04095858|Tacrolimus|tacrolimus|mesh-list
92378030|NCT04095858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92378031|NCT04095858|Abortifacient Agents|abortifacient agents|mesh-ancestor
92378032|NCT04095858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92378033|NCT04095858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378034|NCT04095858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92378035|NCT04095858|Antimetabolites|antimetabolites|mesh-ancestor
92378036|NCT04095858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378037|NCT04095858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378038|NCT04095858|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378039|NCT04095858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378040|NCT04095858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92378041|NCT04095858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92378042|NCT04095858|Immunologic Factors|immunologic factors|mesh-ancestor
92378043|NCT04095858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378044|NCT04095858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92378045|NCT04095858|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92378046|NCT03937986|Cocaine|cocaine|mesh-list
92378047|NCT03937986|Suvorexant|suvorexant|mesh-list
92378048|NCT03937986|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378049|NCT03937986|Anesthetics|anesthetics|mesh-ancestor
92378050|NCT03937986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378051|NCT03937986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378052|NCT03937986|Sensory System Agents|sensory system agents|mesh-ancestor
92378053|NCT03937986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378054|NCT03937986|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92378055|NCT03937986|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92378056|NCT03937986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92378057|NCT03937986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378058|NCT03937986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378059|NCT03937986|Dopamine Agents|dopamine agents|mesh-ancestor
92378060|NCT03937986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378061|NCT03937986|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92378062|NCT03937986|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92378063|NCT03937986|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92378064|NCT03873402|Nivolumab|nivolumab|mesh-list
92378065|NCT03873402|Ipilimumab|ipilimumab|mesh-list
92378066|NCT03873402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378067|NCT03873402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378068|NCT03873402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378069|NCT03873402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378070|NCT03813030|Lidocaine|lidocaine|mesh-list
92378071|NCT03813030|Prilocaine|prilocaine|mesh-list
92378072|NCT03813030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378073|NCT03813030|Anesthetics|anesthetics|mesh-ancestor
92378074|NCT03813030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378075|NCT03813030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378076|NCT03813030|Sensory System Agents|sensory system agents|mesh-ancestor
92378077|NCT03813030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378078|NCT03813030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92378079|NCT03813030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92378080|NCT03813030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92378081|NCT03813030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378082|NCT03813030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378083|NCT03778944|Dopamine|dopamine|mesh-list
92378084|NCT03778944|Mannitol|mannitol|mesh-list
91937351|NCT01128335|Tacrolimus|tacrolimus|mesh-list
92378085|NCT03778944|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92378086|NCT03778944|Diuretics|diuretics|mesh-ancestor
92378087|NCT03778944|Natriuretic Agents|natriuretic agents|mesh-ancestor
92378088|NCT03778944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378089|NCT03778944|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92378090|NCT03778944|Sympathomimetics|sympathomimetics|mesh-ancestor
92378091|NCT03778944|Autonomic Agents|autonomic agents|mesh-ancestor
92378092|NCT03778944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378093|NCT03778944|Dopamine Agents|dopamine agents|mesh-ancestor
92378094|NCT03778944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378095|NCT03778944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378096|NCT03778944|Protective Agents|protective agents|mesh-ancestor
92378097|NCT03653052|Durvalumab|durvalumab|mesh-list
92378098|NCT03653052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378099|NCT03653052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378100|NCT03640728|Tenofovir|tenofovir|mesh-list
92378101|NCT03640728|Entecavir|entecavir|mesh-list
92378102|NCT03640728|Antiviral Agents|antiviral agents|mesh-ancestor
92378103|NCT03640728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378104|NCT03640728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92378105|NCT03640728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92378107|NCT03640728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378108|NCT03640728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92378109|NCT03640728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92378110|NCT03606174|Pembrolizumab|pembrolizumab|mesh-list
92378111|NCT03606174|Nivolumab|nivolumab|mesh-list
92378112|NCT03606174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378113|NCT03606174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378114|NCT03606174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378115|NCT03606174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378116|NCT03535272|Bismuth|bismuth|mesh-list
92378117|NCT03535272|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92378118|NCT03535272|Antacids|antacids|mesh-ancestor
92378119|NCT03535272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378120|NCT03535272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378121|NCT03535272|Antidiarrheals|antidiarrheals|mesh-ancestor
92378122|NCT03529110|Trastuzumab|trastuzumab|mesh-list
92378123|NCT03529110|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92378124|NCT03529110|Maytansine|maytansine|mesh-list
92378125|NCT03529110|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92378126|NCT03529110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378127|NCT03529110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378128|NCT03529110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92378129|NCT03529110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92378130|NCT03529110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92378131|NCT03529110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92378132|NCT03529110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378133|NCT03529110|Immunotoxins|immunotoxins|mesh-ancestor
92378134|NCT03529110|Immunoconjugates|immunoconjugates|mesh-ancestor
92378135|NCT03529110|Immunologic Factors|immunologic factors|mesh-ancestor
92378136|NCT03529110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378137|NCT03502746|Nivolumab|nivolumab|mesh-list
92378138|NCT03502746|Ramucirumab|ramucirumab|mesh-list
92079227|NCT00352612|Cephalexin|cephalexin|mesh-list
92378139|NCT03502746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378140|NCT03502746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378141|NCT03502746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378142|NCT03502746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378143|NCT03436368|Anesthetics|anesthetics|mesh-list
92378144|NCT03436368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378145|NCT03436368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378146|NCT03393780|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92378147|NCT03393780|Hormones|hormones|mesh-ancestor
92378148|NCT03393780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378149|NCT03393780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378150|NCT03367572|Dexamethasone|dexamethasone|mesh-list
92378151|NCT03367572|Dexamethasone acetate|dexamethasone acetate|mesh-list
92378152|NCT03367572|Olanzapine|olanzapine|mesh-list
92378153|NCT03367572|Palonosetron|palonosetron|mesh-list
92378154|NCT03367572|Prochlorperazine|prochlorperazine|mesh-list
92378155|NCT03367572|Ichthammol|ichthammol|mesh-list
92378156|NCT03367572|BB 1101|bb 1101|mesh-list
92378157|NCT03367572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378158|NCT03367572|Antiemetics|antiemetics|mesh-ancestor
92378159|NCT03367572|Autonomic Agents|autonomic agents|mesh-ancestor
92378160|NCT03367572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378161|NCT03367572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378162|NCT03367572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378163|NCT03367572|Glucocorticoids|glucocorticoids|mesh-ancestor
92378164|NCT03367572|Hormones|hormones|mesh-ancestor
92378165|NCT03367572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378166|NCT03367572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378167|NCT03367572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378168|NCT03367572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92378169|NCT03367572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92378170|NCT03367572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378171|NCT03367572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92378172|NCT03367572|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92378173|NCT03367572|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92378174|NCT03367572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378175|NCT03367572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378176|NCT03367572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378177|NCT03367572|Serotonin Agents|serotonin agents|mesh-ancestor
92378178|NCT03367572|Protease Inhibitors|protease inhibitors|mesh-ancestor
92378179|NCT03367572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378180|NCT03367572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92378181|NCT03367572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92378182|NCT03367572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378183|NCT03367572|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92378184|NCT03367572|Dopamine Agents|dopamine agents|mesh-ancestor
92378185|NCT03321630|Pembrolizumab|pembrolizumab|mesh-list
92378186|NCT03321630|Lenvatinib|lenvatinib|mesh-list
92378187|NCT03321630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378188|NCT03321630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378189|NCT03321630|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378190|NCT03321630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378191|NCT03321630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92378192|NCT03321630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378193|NCT03249870|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92378194|NCT03249870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378195|NCT03249870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378196|NCT03249870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92378197|NCT03249870|Immunotoxins|immunotoxins|mesh-ancestor
92378198|NCT03249870|Immunoconjugates|immunoconjugates|mesh-ancestor
92378199|NCT03249870|Immunologic Factors|immunologic factors|mesh-ancestor
92378200|NCT03249870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378201|NCT03212742|Temozolomide|temozolomide|mesh-list
92378202|NCT03212742|Olaparib|olaparib|mesh-list
92378203|NCT03212742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92378204|NCT03212742|Alkylating Agents|alkylating agents|mesh-ancestor
92378205|NCT03212742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378206|NCT03212742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378207|NCT03212742|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92378208|NCT03212742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378209|NCT03202758|Durvalumab|durvalumab|mesh-list
92378210|NCT03202758|Tremelimumab|tremelimumab|mesh-list
92378211|NCT03202758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378212|NCT03202758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378213|NCT03122262|Tenofovir|tenofovir|mesh-list
92378214|NCT03122262|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92378215|NCT03122262|Dolutegravir|dolutegravir|mesh-list
92378216|NCT03122262|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92378217|NCT03122262|Antiviral Agents|antiviral agents|mesh-ancestor
92378218|NCT03122262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378219|NCT03122262|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92378220|NCT03122262|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92378221|NCT03122262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378222|NCT03122262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378223|NCT03122262|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92378224|NCT03122262|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92378225|NCT03122262|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92378226|NCT03122262|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92378227|NCT03051282|Enalapril|enalapril|mesh-list
92378228|NCT03051282|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92378229|NCT03051282|Protease Inhibitors|protease inhibitors|mesh-ancestor
92378230|NCT03051282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378231|NCT03051282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378232|NCT03051282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92378233|NCT03042546|Calcium|calcium|mesh-list
92378234|NCT03042546|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92378235|NCT03042546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378236|NCT02748564|Aldesleukin|aldesleukin|mesh-list
92378237|NCT02748564|Pembrolizumab|pembrolizumab|mesh-list
92378238|NCT02748564|Interleukin-2|interleukin-2|mesh-list
92378239|NCT02748564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378240|NCT02748564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378241|NCT02748564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378242|NCT02748564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378243|NCT02748564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92378244|NCT02748564|Analgesics|analgesics|mesh-ancestor
92378245|NCT02748564|Sensory System Agents|sensory system agents|mesh-ancestor
92378246|NCT02748564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378247|NCT02748564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378248|NCT02748564|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92378249|NCT02748564|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92378250|NCT02748564|Antiviral Agents|antiviral agents|mesh-ancestor
92378251|NCT02748564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378252|NCT02734602|Ketamine|ketamine|mesh-list
92378253|NCT02734602|Analgesics|analgesics|mesh-ancestor
92378254|NCT02734602|Sensory System Agents|sensory system agents|mesh-ancestor
92378255|NCT02734602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378256|NCT02734602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378257|NCT02734602|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92378258|NCT02734602|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378259|NCT02734602|Anesthetics, General|anesthetics, general|mesh-ancestor
92378260|NCT02734602|Anesthetics|anesthetics|mesh-ancestor
92378261|NCT02734602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378262|NCT02734602|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92378263|NCT02734602|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92378264|NCT02734602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378265|NCT02734602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378266|NCT02663622|Methotrexate|methotrexate|mesh-list
92378267|NCT02663622|Tacrolimus|tacrolimus|mesh-list
92378268|NCT02663622|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92378269|NCT02663622|Abortifacient Agents|abortifacient agents|mesh-ancestor
92378271|NCT02663622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378272|NCT02663622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92378273|NCT02663622|Antimetabolites|antimetabolites|mesh-ancestor
92378274|NCT02663622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378275|NCT02663622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378276|NCT02663622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378277|NCT02663622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378278|NCT02663622|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92378279|NCT02663622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92378280|NCT02663622|Immunologic Factors|immunologic factors|mesh-ancestor
92378281|NCT02663622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378282|NCT02663622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91937761|NCT05554406|Cytarabine|cytarabine|mesh-list
92378283|NCT02663622|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92378284|NCT02420652|Aspirin|aspirin|mesh-list
92378285|NCT02420652|Metformin|metformin|mesh-list
92378286|NCT02420652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92378287|NCT02420652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378288|NCT02420652|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92378289|NCT02420652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92378290|NCT02420652|Analgesics|analgesics|mesh-ancestor
92378291|NCT02420652|Sensory System Agents|sensory system agents|mesh-ancestor
92378292|NCT02420652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378293|NCT02420652|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378294|NCT02420652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378295|NCT02420652|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92378296|NCT02420652|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92378297|NCT02420652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378298|NCT02420652|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92378299|NCT02420652|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92378300|NCT02420652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378301|NCT02420652|Antipyretics|antipyretics|mesh-ancestor
92378302|NCT02257242|Rituximab|rituximab|mesh-list
92378303|NCT02257242|Vincristine|vincristine|mesh-list
92378304|NCT02257242|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92378305|NCT02257242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378306|NCT02257242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378307|NCT02257242|Immunologic Factors|immunologic factors|mesh-ancestor
92378308|NCT02257242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378309|NCT02257242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378310|NCT02257242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92378311|NCT02257242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92378312|NCT02257242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92378313|NCT02257242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92378314|NCT02257242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378315|NCT02257242|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92378316|NCT02257242|Alkylating Agents|alkylating agents|mesh-ancestor
92378318|NCT02034630|Alkylating Agents|alkylating agents|mesh-ancestor
92378319|NCT02034630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378320|NCT02034630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92378321|NCT02034630|Immunologic Factors|immunologic factors|mesh-ancestor
92378322|NCT02034630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378323|NCT02034630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92378324|NCT02034630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378325|NCT02034630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92378327|NCT02025036|Oxaliplatin|oxaliplatin|mesh-list
92378328|NCT02025036|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92378329|NCT02025036|Antimetabolites|antimetabolites|mesh-ancestor
92378330|NCT02025036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378331|NCT02025036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378332|NCT01768338|Ofatumumab|ofatumumab|mesh-list
92378333|NCT01768338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378334|NCT01659606|Cyclosporine|cyclosporine|mesh-list
92378335|NCT01659606|Mycophenolic Acid|mycophenolic acid|mesh-list
92378336|NCT01659606|Fludarabine|fludarabine|mesh-list
92378337|NCT01659606|Alemtuzumab|alemtuzumab|mesh-list
92378338|NCT01659606|Tacrolimus|tacrolimus|mesh-list
92378339|NCT01659606|Cyclosporins|cyclosporins|mesh-list
92378340|NCT01659606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378341|NCT01659606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378342|NCT01659606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92378343|NCT01659606|Immunologic Factors|immunologic factors|mesh-ancestor
92378344|NCT01659606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378345|NCT01659606|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92378346|NCT01659606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378347|NCT01659606|Antifungal Agents|antifungal agents|mesh-ancestor
92378348|NCT01659606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378349|NCT01659606|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378350|NCT01659606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378351|NCT01659606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92378352|NCT01659606|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92378353|NCT01659606|Antitubercular Agents|antitubercular agents|mesh-ancestor
92378354|NCT01659606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92378355|NCT01659606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378356|NCT00819546|Everolimus|everolimus|mesh-list
92378357|NCT00819546|Midostaurin|midostaurin|mesh-list
92378358|NCT00819546|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92378359|NCT00819546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92378360|NCT00819546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378361|NCT00819546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378362|NCT00819546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92378363|NCT00819546|Immunologic Factors|immunologic factors|mesh-ancestor
92378364|NCT00819546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378365|NCT00819546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378366|NCT00596154|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92378367|NCT00596154|Cyclophosphamide|cyclophosphamide|mesh-list
92378368|NCT00596154|Busulfan|busulfan|mesh-list
92378369|NCT00596154|Thiotepa|thiotepa|mesh-list
92378370|NCT00596154|Rituximab|rituximab|mesh-list
92378371|NCT00596154|Methotrexate|methotrexate|mesh-list
92378372|NCT00596154|Vincristine|vincristine|mesh-list
92378373|NCT00596154|Procarbazine|procarbazine|mesh-list
92378374|NCT00596154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92378375|NCT00596154|Immunologic Factors|immunologic factors|mesh-ancestor
92378376|NCT00596154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378377|NCT00596154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378378|NCT00596154|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92378379|NCT00596154|Alkylating Agents|alkylating agents|mesh-ancestor
92121344|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
92378380|NCT00596154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378381|NCT00596154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378382|NCT00596154|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92378383|NCT00596154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378384|NCT00596154|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92378385|NCT00596154|Abortifacient Agents|abortifacient agents|mesh-ancestor
92378386|NCT00596154|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92378387|NCT00596154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92378388|NCT00596154|Antimetabolites|antimetabolites|mesh-ancestor
92378389|NCT00596154|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378390|NCT00596154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378391|NCT00596154|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92378392|NCT00596154|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92378393|NCT00596154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92378394|NCT00596154|Tubulin Modulators|tubulin modulators|mesh-ancestor
92378395|NCT00596154|Antimitotic Agents|antimitotic agents|mesh-ancestor
92378396|NCT00596154|Mitosis Modulators|mitosis modulators|mesh-ancestor
92378397|NCT00596154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378398|NCT00281658|Paclitaxel|paclitaxel|mesh-list
92378399|NCT00281658|Lapatinib|lapatinib|mesh-list
92378400|NCT00281658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92378401|NCT00281658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378402|NCT00281658|Tubulin Modulators|tubulin modulators|mesh-ancestor
92378403|NCT00281658|Antimitotic Agents|antimitotic agents|mesh-ancestor
92378404|NCT00281658|Mitosis Modulators|mitosis modulators|mesh-ancestor
92378405|NCT00281658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378406|NCT00281658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92378407|NCT00281658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378409|NCT02417844|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92378410|NCT02417844|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92378411|NCT02417844|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92378412|NCT02417844|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378413|NCT02417844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378414|NCT02417844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378415|NCT02417844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378416|NCT02417844|Urological Agents|urological agents|mesh-ancestor
92378417|NCT02418312|Famotidine|famotidine|mesh-list
92378418|NCT02418312|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
92378419|NCT02418312|Histamine|histamine|mesh-list
92378420|NCT02418312|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92378421|NCT02418312|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378423|NCT02418312|Histamine Agents|histamine agents|mesh-ancestor
92378424|NCT02418312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378425|NCT02418312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121345|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378426|NCT02418312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378427|NCT02418312|Histamine Agonists|histamine agonists|mesh-ancestor
92378428|NCT02421354|Nivolumab|nivolumab|mesh-list
92378429|NCT02421354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378430|NCT02421354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378431|NCT02421354|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378432|NCT02421354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378433|NCT02422290|Ketamine|ketamine|mesh-list
92378434|NCT02422290|Analgesics|analgesics|mesh-ancestor
92378435|NCT02422290|Sensory System Agents|sensory system agents|mesh-ancestor
92378436|NCT02422290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378437|NCT02422290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378438|NCT02422290|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92378439|NCT02422290|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378440|NCT02422290|Anesthetics, General|anesthetics, general|mesh-ancestor
92378441|NCT02422290|Anesthetics|anesthetics|mesh-ancestor
92378442|NCT02422290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378443|NCT02422290|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92378444|NCT02422290|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92378445|NCT02422290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378446|NCT02422290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378447|NCT02430090|Fentanyl|fentanyl|mesh-list
92378448|NCT02430090|Sufentanil|sufentanil|mesh-list
92378449|NCT02430090|Levobupivacaine|levobupivacaine|mesh-list
92378450|NCT02430090|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92378451|NCT02430090|Narcotics|narcotics|mesh-ancestor
92378452|NCT02430090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378453|NCT02430090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378454|NCT02430090|Analgesics|analgesics|mesh-ancestor
92378455|NCT02430090|Sensory System Agents|sensory system agents|mesh-ancestor
92378456|NCT02430090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378457|NCT02430090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378458|NCT02430090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378459|NCT02430090|Anesthetics, General|anesthetics, general|mesh-ancestor
92378460|NCT02430090|Anesthetics|anesthetics|mesh-ancestor
92378461|NCT02430090|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378462|NCT02431572|Immunomodulating Agents|immunomodulating agents|mesh-list
92378463|NCT02431572|Immunologic Factors|immunologic factors|mesh-ancestor
92378464|NCT02431572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378465|NCT02431650|Primaquine|primaquine|mesh-list
92378466|NCT02431650|Antimalarials|antimalarials|mesh-ancestor
92378467|NCT02431650|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92378468|NCT02431650|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92378469|NCT02431650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378470|NCT02437344|Naltrexone|naltrexone|mesh-list
92378471|NCT02437344|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92378472|NCT02437344|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92378473|NCT02437344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378474|NCT02437344|Sensory System Agents|sensory system agents|mesh-ancestor
92378475|NCT02437344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378476|NCT02440308|Bombesin|bombesin|mesh-list
92378477|NCT02440308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378478|NCT02440308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378479|NCT02440308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378480|NCT02444988|Plasma-lyte 148|plasma-lyte 148|mesh-list
92378481|NCT02444988|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92378482|NCT02444988|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92378483|NCT02448654|Tolcapone|tolcapone|mesh-list
92378484|NCT02448654|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92378485|NCT02448654|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92378486|NCT02448654|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92378487|NCT02448654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378488|NCT02448654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378489|NCT02451150|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92378490|NCT02451150|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92378491|NCT02451150|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92378492|NCT02451150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378493|NCT02452866|Secnidazole|secnidazole|mesh-list
92378494|NCT02452866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92378495|NCT02452866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92378496|NCT02452866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378497|NCT02462148|Dexamethasone|dexamethasone|mesh-list
92378498|NCT02462148|Dexamethasone acetate|dexamethasone acetate|mesh-list
92378499|NCT02462148|Epinephrine|epinephrine|mesh-list
92378500|NCT02462148|Bupivacaine|bupivacaine|mesh-list
92378501|NCT02462148|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92378502|NCT02462148|BB 1101|bb 1101|mesh-list
92378503|NCT02462148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378504|NCT02462148|Antiemetics|antiemetics|mesh-ancestor
92378505|NCT02462148|Autonomic Agents|autonomic agents|mesh-ancestor
92378506|NCT02462148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378507|NCT02462148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378508|NCT02462148|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378509|NCT02462148|Glucocorticoids|glucocorticoids|mesh-ancestor
92378510|NCT02462148|Hormones|hormones|mesh-ancestor
92378511|NCT02462148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378512|NCT02462148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378513|NCT02462148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378514|NCT02462148|Protease Inhibitors|protease inhibitors|mesh-ancestor
92378515|NCT02462148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378516|NCT02462148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378517|NCT02462148|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378518|NCT02462148|Anesthetics|anesthetics|mesh-ancestor
92378519|NCT02462148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378520|NCT02462148|Sensory System Agents|sensory system agents|mesh-ancestor
92378521|NCT02462148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92378522|NCT02462148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92378523|NCT02462148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378524|NCT02462148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378525|NCT02462148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92378526|NCT02462148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92378527|NCT02462148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92378528|NCT02462148|Respiratory System Agents|respiratory system agents|mesh-ancestor
92378529|NCT02462148|Mydriatics|mydriatics|mesh-ancestor
92378530|NCT02462148|Sympathomimetics|sympathomimetics|mesh-ancestor
92378531|NCT02462148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92378532|NCT02462382|Ropivacaine|ropivacaine|mesh-list
92378533|NCT02462382|Anesthetics, Local|anesthetics, local|mesh-ancestor
92031008|NCT02198235|Dexamethasone|dexamethasone|mesh-list
92378534|NCT02462382|Anesthetics|anesthetics|mesh-ancestor
92378535|NCT02462382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378536|NCT02462382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378537|NCT02462382|Sensory System Agents|sensory system agents|mesh-ancestor
92378538|NCT02462382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378539|NCT02464176|Dexamethasone|dexamethasone|mesh-list
92378540|NCT02464176|Dexamethasone acetate|dexamethasone acetate|mesh-list
92378541|NCT02464176|Epinephrine|epinephrine|mesh-list
92378542|NCT02464176|Bupivacaine|bupivacaine|mesh-list
92378543|NCT02464176|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92378544|NCT02464176|BB 1101|bb 1101|mesh-list
92378545|NCT02464176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378546|NCT02464176|Antiemetics|antiemetics|mesh-ancestor
92378547|NCT02464176|Autonomic Agents|autonomic agents|mesh-ancestor
91937748|NCT05556746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378548|NCT02464176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378549|NCT02464176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378550|NCT02464176|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378551|NCT02464176|Glucocorticoids|glucocorticoids|mesh-ancestor
92378553|NCT02464176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378554|NCT02464176|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378555|NCT02464176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378556|NCT02464176|Protease Inhibitors|protease inhibitors|mesh-ancestor
92378557|NCT02464176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378558|NCT02464176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378559|NCT02464176|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378560|NCT02464176|Anesthetics|anesthetics|mesh-ancestor
92378561|NCT02464176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378562|NCT02464176|Sensory System Agents|sensory system agents|mesh-ancestor
92378563|NCT02464176|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92378564|NCT02464176|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92378565|NCT02464176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378566|NCT02464176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378567|NCT02464176|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92378568|NCT02464176|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92378569|NCT02464176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92378570|NCT02464176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92378571|NCT02464176|Mydriatics|mydriatics|mesh-ancestor
92378572|NCT02464176|Sympathomimetics|sympathomimetics|mesh-ancestor
92378573|NCT02464176|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92378574|NCT02468700|Dexamethasone|dexamethasone|mesh-list
92378575|NCT02468700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378576|NCT02468700|Antiemetics|antiemetics|mesh-ancestor
92378577|NCT02468700|Autonomic Agents|autonomic agents|mesh-ancestor
92378578|NCT02468700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378579|NCT02468700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378580|NCT02468700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378581|NCT02468700|Glucocorticoids|glucocorticoids|mesh-ancestor
92378582|NCT02468700|Hormones|hormones|mesh-ancestor
92378583|NCT02468700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378584|NCT02468700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378585|NCT02468700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378586|NCT02472522|Dexmedetomidine|dexmedetomidine|mesh-list
92378587|NCT02472522|Ropivacaine|ropivacaine|mesh-list
92378588|NCT02472522|Adrenergic Agonists|adrenergic agonists|mesh-list
92378589|NCT02472522|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92378590|NCT02472522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378591|NCT02472522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378592|NCT02472522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92378593|NCT02472522|Analgesics|analgesics|mesh-ancestor
92378594|NCT02472522|Sensory System Agents|sensory system agents|mesh-ancestor
92378595|NCT02472522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378596|NCT02472522|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92378597|NCT02472522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92378598|NCT02472522|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378599|NCT02472522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378600|NCT02472522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378601|NCT02472522|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378602|NCT02472522|Anesthetics|anesthetics|mesh-ancestor
92121420|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92378603|NCT02480166|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92378604|NCT02480166|Antiviral Agents|antiviral agents|mesh-ancestor
92378605|NCT02480166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378606|NCT02481258|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
92378607|NCT02481258|Enzyme Activators|enzyme activators|mesh-ancestor
92031088|NCT02428699|Vitamins|vitamins|mesh-ancestor
92378608|NCT02481258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378609|NCT02484222|Fentanyl|fentanyl|mesh-list
92378610|NCT02484222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92378611|NCT02484222|Narcotics|narcotics|mesh-ancestor
92121574|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
92378612|NCT02484222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378613|NCT02484222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378614|NCT02484222|Analgesics|analgesics|mesh-ancestor
92378615|NCT02484222|Sensory System Agents|sensory system agents|mesh-ancestor
92378616|NCT02484222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378617|NCT02484222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378618|NCT02484222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378619|NCT02484222|Anesthetics, General|anesthetics, general|mesh-ancestor
92378620|NCT02484222|Anesthetics|anesthetics|mesh-ancestor
92378622|NCT02486016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92378623|NCT02486016|Narcotics|narcotics|mesh-ancestor
92378624|NCT02486016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378625|NCT02486016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378626|NCT02486016|Analgesics|analgesics|mesh-ancestor
91938577|NCT00902291|Gemcitabine|gemcitabine|mesh-list
92378627|NCT02486016|Sensory System Agents|sensory system agents|mesh-ancestor
92378628|NCT02486016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378629|NCT02486016|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378630|NCT02486016|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378631|NCT02486016|Anesthetics, General|anesthetics, general|mesh-ancestor
92378632|NCT02486016|Anesthetics|anesthetics|mesh-ancestor
92378633|NCT02486328|Midazolam|midazolam|mesh-list
92378634|NCT02486328|Meperidine|meperidine|mesh-list
92378635|NCT02486328|Remifentanil|remifentanil|mesh-list
92378636|NCT02486328|Propofol|propofol|mesh-list
92378637|NCT02486328|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92378638|NCT02486328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378639|NCT02486328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378640|NCT02486328|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378641|NCT02486328|Anesthetics, General|anesthetics, general|mesh-ancestor
92378642|NCT02486328|Anesthetics|anesthetics|mesh-ancestor
92378643|NCT02486328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378644|NCT02486328|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92378645|NCT02486328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92378646|NCT02486328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92378647|NCT02486328|GABA Modulators|gaba modulators|mesh-ancestor
92378648|NCT02486328|GABA Agents|gaba agents|mesh-ancestor
92378649|NCT02486328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378650|NCT02486328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378651|NCT02486328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92378652|NCT02486328|Narcotics|narcotics|mesh-ancestor
92378653|NCT02486328|Analgesics|analgesics|mesh-ancestor
92378654|NCT02486328|Sensory System Agents|sensory system agents|mesh-ancestor
92378655|NCT02486328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378656|NCT02491788|Suvorexant|suvorexant|mesh-list
92378657|NCT02491788|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92378658|NCT02491788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92378659|NCT02491788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378660|NCT02491788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378661|NCT02491788|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92378662|NCT02491788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378663|NCT02491788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378664|NCT02491944|Osimertinib|osimertinib|mesh-list
92378665|NCT02491944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378666|NCT02491944|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92378667|NCT02491944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378668|NCT02491944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378669|NCT02492802|Posaconazole|posaconazole|mesh-list
92378670|NCT02492802|Antifungal Agents|antifungal agents|mesh-ancestor
92378671|NCT02492802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378672|NCT02492802|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92378673|NCT02492802|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92378674|NCT02492802|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92378675|NCT02492802|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92378676|NCT02492802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92378677|NCT02492802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938689|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
92378678|NCT02492802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378679|NCT02492802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92378680|NCT02492802|Hormone Antagonists|hormone antagonists|mesh-ancestor
92378681|NCT02492802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378682|NCT02492802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378683|NCT02495454|Obinutuzumab|obinutuzumab|mesh-list
92378684|NCT02495454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378685|NCT02495454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378687|NCT02500602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92378688|NCT02500602|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92378689|NCT02500602|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92378690|NCT02500602|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92378691|NCT02500602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378692|NCT02500602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378693|NCT02500602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378694|NCT02500602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378696|NCT02500836|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92378697|NCT02500836|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378698|NCT02500836|Anesthetics|anesthetics|mesh-ancestor
92378699|NCT02500836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378700|NCT02500836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378701|NCT02500836|Sensory System Agents|sensory system agents|mesh-ancestor
92378702|NCT02500836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378703|NCT02500836|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92378704|NCT02500836|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92378705|NCT02500836|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92378706|NCT02500836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378707|NCT02500836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378708|NCT02500836|Dopamine Agents|dopamine agents|mesh-ancestor
92378709|NCT02500836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378710|NCT02508636|Leuprolide|leuprolide|mesh-list
92378711|NCT02508636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92378712|NCT02508636|Fertility Agents|fertility agents|mesh-ancestor
92378713|NCT02508636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92378714|NCT02508636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378715|NCT02508636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378716|NCT02508636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378717|NCT02513940|Ibutilide|ibutilide|mesh-list
92378718|NCT02513940|Testosterone|testosterone|mesh-list
92378719|NCT02513940|Progesterone|progesterone|mesh-list
92378720|NCT02513940|Androgens|androgens|mesh-ancestor
92378721|NCT02513940|Hormones|hormones|mesh-ancestor
92378722|NCT02513940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378723|NCT02513940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378724|NCT02513940|Progestins|progestins|mesh-ancestor
92378725|NCT02513940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92378726|NCT02515890|Midazolam|midazolam|mesh-list
92378727|NCT02515890|Dexmedetomidine|dexmedetomidine|mesh-list
92378728|NCT02515890|Ketamine|ketamine|mesh-list
92378729|NCT02515890|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92378730|NCT02515890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378731|NCT02515890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378732|NCT02515890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92378733|NCT02515890|Analgesics|analgesics|mesh-ancestor
92378734|NCT02515890|Sensory System Agents|sensory system agents|mesh-ancestor
92378735|NCT02515890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378736|NCT02515890|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92378737|NCT02515890|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92378738|NCT02515890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92378739|NCT02515890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378740|NCT02515890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378741|NCT02515890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378742|NCT02515890|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92378743|NCT02515890|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92378744|NCT02515890|Anesthetics, General|anesthetics, general|mesh-ancestor
92378745|NCT02515890|Anesthetics|anesthetics|mesh-ancestor
92378746|NCT02515890|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92378747|NCT02515890|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92378748|NCT02515890|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378749|NCT02515890|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92378750|NCT02515890|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92378751|NCT02515890|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92378752|NCT02515890|GABA Modulators|gaba modulators|mesh-ancestor
92378753|NCT02515890|GABA Agents|gaba agents|mesh-ancestor
92378754|NCT02517996|Lidocaine|lidocaine|mesh-list
92378755|NCT02517996|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378756|NCT02517996|Anesthetics|anesthetics|mesh-ancestor
92378757|NCT02517996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121959|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92378758|NCT02517996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378759|NCT02517996|Sensory System Agents|sensory system agents|mesh-ancestor
92378760|NCT02517996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378761|NCT02517996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92378762|NCT02517996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92378763|NCT02517996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92378764|NCT02517996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378765|NCT02517996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378766|NCT02525718|Dexamethasone|dexamethasone|mesh-list
92378767|NCT02525718|Epinephrine|epinephrine|mesh-list
92378768|NCT02525718|Bupivacaine|bupivacaine|mesh-list
92378770|NCT02525718|Antiemetics|antiemetics|mesh-ancestor
92378771|NCT02525718|Autonomic Agents|autonomic agents|mesh-ancestor
92378772|NCT02525718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378773|NCT02525718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378774|NCT02525718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378776|NCT02525718|Hormones|hormones|mesh-ancestor
92378777|NCT02525718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378778|NCT02525718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378779|NCT02525718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378780|NCT02525718|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378781|NCT02525718|Anesthetics|anesthetics|mesh-ancestor
92378782|NCT02525718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378783|NCT02525718|Sensory System Agents|sensory system agents|mesh-ancestor
92378784|NCT02525718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92378785|NCT02525718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92378786|NCT02525718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92378787|NCT02525718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378788|NCT02525718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378789|NCT02525718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92378790|NCT02525718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92378791|NCT02525718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92378792|NCT02525718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92378793|NCT02525718|Mydriatics|mydriatics|mesh-ancestor
92378794|NCT02525718|Sympathomimetics|sympathomimetics|mesh-ancestor
92378795|NCT02525718|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92378796|NCT02527512|Povidone-Iodine|povidone-iodine|mesh-list
92378797|NCT02527512|Povidone|povidone|mesh-list
92378798|NCT02527512|Plasma Substitutes|plasma substitutes|mesh-ancestor
92378799|NCT02527512|Blood Substitutes|blood substitutes|mesh-ancestor
92378800|NCT02527512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92378801|NCT02527512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378802|NCT02529072|Nivolumab|nivolumab|mesh-list
92378803|NCT02529072|Vaccines|vaccines|mesh-list
92378804|NCT02529072|Immunologic Factors|immunologic factors|mesh-ancestor
92378805|NCT02529072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378806|NCT02529072|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92378807|NCT02529072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378808|NCT02529072|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92378809|NCT02529072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378811|NCT02530476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378812|NCT02530476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92378813|NCT02530476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939263|NCT05202860|Vaccines|vaccines|mesh-list
92378814|NCT02530476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378815|NCT02530554|Chlorhexidine|chlorhexidine|mesh-list
92378816|NCT02530554|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92378817|NCT02530554|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92378818|NCT02530554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378819|NCT02530554|Disinfectants|disinfectants|mesh-ancestor
92378820|NCT02530554|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378821|NCT02536248|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92378822|NCT02536248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92378823|NCT02536248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378824|NCT02536248|Incretins|incretins|mesh-ancestor
92378825|NCT02536248|Hormones|hormones|mesh-ancestor
92378826|NCT02536248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378827|NCT02536248|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92378828|NCT02536248|Protease Inhibitors|protease inhibitors|mesh-ancestor
92378829|NCT02536248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378830|NCT02536248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378831|NCT02538042|Nicotine|nicotine|mesh-list
91939404|NCT00834977|Amlodipine|amlodipine|mesh-list
92378832|NCT02538042|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92031312|NCT02347657|Ivacaftor|ivacaftor|mesh-list
92378833|NCT02538042|Autonomic Agents|autonomic agents|mesh-ancestor
92378834|NCT02538042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378835|NCT02538042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378836|NCT02538042|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92378837|NCT02538042|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92378838|NCT02538042|Cholinergic Agents|cholinergic agents|mesh-ancestor
92378839|NCT02538042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378840|NCT02538042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378842|NCT02538354|Vitamins|vitamins|mesh-ancestor
92378843|NCT02538354|Micronutrients|micronutrients|mesh-ancestor
91939476|NCT00833495|Prednisone|prednisone|mesh-list
92378844|NCT02538354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378845|NCT02538354|Vitamin B Complex|vitamin b complex|mesh-ancestor
92378846|NCT02538354|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92378847|NCT02538354|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378848|NCT02540226|Tranexamic Acid|tranexamic acid|mesh-list
92378849|NCT02540226|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92378850|NCT02540226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91939549|NCT05108870|Paclitaxel|paclitaxel|mesh-list
92378851|NCT02540226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378852|NCT02540226|Hemostatics|hemostatics|mesh-ancestor
92378853|NCT02540226|Coagulants|coagulants|mesh-ancestor
92378854|NCT02541864|Amoxicillin|amoxicillin|mesh-list
92378855|NCT02541864|Metronidazole|metronidazole|mesh-list
92378856|NCT02541864|Clarithromycin|clarithromycin|mesh-list
92378857|NCT02541864|Tetracycline|tetracycline|mesh-list
92378858|NCT02541864|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
92378859|NCT02541864|Pantoprazole|pantoprazole|mesh-list
92378860|NCT02541864|Bismuth|bismuth|mesh-list
92378861|NCT02541864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92378862|NCT02541864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378863|NCT02541864|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92378864|NCT02541864|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92378865|NCT02541864|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92378866|NCT02541864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378867|NCT02541864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378868|NCT02541864|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92378869|NCT02541864|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92378870|NCT02541864|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92378871|NCT02541864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378872|NCT02541864|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92378873|NCT02541864|Antacids|antacids|mesh-ancestor
92378874|NCT02542410|Cabergoline|cabergoline|mesh-list
92378875|NCT02542410|Norethindrone|norethindrone|mesh-list
92378876|NCT02542410|Norethindrone Acetate|norethindrone acetate|mesh-list
92378877|NCT02542410|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92378878|NCT02542410|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92378879|NCT02542410|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92378880|NCT02542410|Contraceptive Agents|contraceptive agents|mesh-ancestor
92378881|NCT02542410|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92378882|NCT02542410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378883|NCT02542410|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92378884|NCT02542410|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92378885|NCT02542410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92378886|NCT02542410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92378887|NCT02542410|Dopamine Agonists|dopamine agonists|mesh-ancestor
92378888|NCT02542410|Dopamine Agents|dopamine agents|mesh-ancestor
92378889|NCT02542410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378890|NCT02542410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378891|NCT02544984|Azithromycin|azithromycin|mesh-list
92378892|NCT02544984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92378893|NCT02544984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378894|NCT02547012|Amoxicillin|amoxicillin|mesh-list
92378895|NCT02547012|Levofloxacin|levofloxacin|mesh-list
92378896|NCT02547012|Ofloxacin|ofloxacin|mesh-list
92378897|NCT02547012|Tetracycline|tetracycline|mesh-list
92378898|NCT02547012|Esomeprazole|esomeprazole|mesh-list
92378899|NCT02547012|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92378900|NCT02547012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92378901|NCT02547012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92378902|NCT02547012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92378903|NCT02547012|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92378904|NCT02547012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378905|NCT02547012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378906|NCT02547012|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92378907|NCT02547012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92378908|NCT02547012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92378909|NCT02547012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378910|NCT02547012|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92378911|NCT02547012|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92378913|NCT02548728|Oxytocin|oxytocin|mesh-list
92378914|NCT02548728|Oxytocics|oxytocics|mesh-ancestor
92378915|NCT02548728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92378916|NCT02548728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378917|NCT02553798|Glycopyrrolate|glycopyrrolate|mesh-list
92378918|NCT02553798|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92378919|NCT02553798|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92378920|NCT02553798|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92378922|NCT02553798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92378923|NCT02553798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378924|NCT02553798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378925|NCT02560038|Paclitaxel|paclitaxel|mesh-list
92378926|NCT02560038|Gemcitabine|gemcitabine|mesh-list
92378927|NCT02560038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92378928|NCT02560038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378929|NCT02560038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92378930|NCT02560038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92378931|NCT02560038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92378932|NCT02560038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378933|NCT02560038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92378934|NCT02560038|Antimetabolites|antimetabolites|mesh-ancestor
92378935|NCT02560584|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92378936|NCT02560584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92378937|NCT02560584|Dermatologic Agents|dermatologic agents|mesh-ancestor
92378938|NCT02561130|Metformin|metformin|mesh-list
92378939|NCT02561130|Insulin Glargine|insulin glargine|mesh-list
92378940|NCT02561130|Dapagliflozin|dapagliflozin|mesh-list
92378941|NCT02561130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92378942|NCT02561130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378943|NCT02561130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92378944|NCT02561130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378945|NCT02562066|Amifampridine|amifampridine|mesh-list
92378946|NCT02562066|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92378947|NCT02562066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378948|NCT02562066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378949|NCT02562066|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92378950|NCT02562066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92378951|NCT02562066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378952|NCT02562924|Prednisone|prednisone|mesh-list
92378953|NCT02562924|Budesonide|budesonide|mesh-list
92378954|NCT02562924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92378955|NCT02562924|Glucocorticoids|glucocorticoids|mesh-ancestor
92378956|NCT02562924|Hormones|hormones|mesh-ancestor
92378957|NCT02562924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92378958|NCT02562924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378959|NCT02562924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92378960|NCT02562924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378961|NCT02562924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92378962|NCT02562924|Autonomic Agents|autonomic agents|mesh-ancestor
92378963|NCT02562924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378964|NCT02562924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91939837|NCT04970108|Telmisartan|telmisartan|mesh-list
92378965|NCT02562924|Respiratory System Agents|respiratory system agents|mesh-ancestor
92378966|NCT02563860|Lovastatin|lovastatin|mesh-list
92378967|NCT02563860|L 647318|l 647318|mesh-list
92378968|NCT02563860|Dihydromevinolin|dihydromevinolin|mesh-list
92378969|NCT02563860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92378970|NCT02563860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92378971|NCT02563860|Antimetabolites|antimetabolites|mesh-ancestor
92378972|NCT02563860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378973|NCT02563860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92378974|NCT02563860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92378975|NCT02563860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378976|NCT02568852|Anesthetics|anesthetics|mesh-list
92122182|NCT00045435|Fludarabine|fludarabine|mesh-list
92378977|NCT02568852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378978|NCT02568852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378979|NCT02570022|Bupivacaine|bupivacaine|mesh-list
92378980|NCT02570022|Ropivacaine|ropivacaine|mesh-list
92378981|NCT02570022|Anesthetics, Local|anesthetics, local|mesh-ancestor
92378982|NCT02570022|Anesthetics|anesthetics|mesh-ancestor
92378983|NCT02570022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92378984|NCT02570022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92378985|NCT02570022|Sensory System Agents|sensory system agents|mesh-ancestor
92378986|NCT02570022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92378988|NCT02572752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92378989|NCT02572752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92378990|NCT02572752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92378991|NCT02572752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378993|NCT02577042|Atorvastatin|atorvastatin|mesh-list
92378994|NCT02577042|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92378995|NCT02577042|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92378996|NCT02577042|Antimetabolites|antimetabolites|mesh-ancestor
92378997|NCT02577042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92378998|NCT02577042|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92378999|NCT02577042|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92379000|NCT02577042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379001|NCT02577042|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92379002|NCT02577042|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92379003|NCT02577042|Antiviral Agents|antiviral agents|mesh-ancestor
92379004|NCT02577042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379005|NCT02577042|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92379006|NCT02577042|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92379007|NCT02582970|Bevacizumab|bevacizumab|mesh-list
92379008|NCT02582970|Fluorouracil|fluorouracil|mesh-list
92379009|NCT02582970|Oxaliplatin|oxaliplatin|mesh-list
92379010|NCT02582970|Irinotecan|irinotecan|mesh-list
92379011|NCT02582970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379012|NCT02582970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379013|NCT02582970|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92379014|NCT02582970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92379015|NCT02582970|Growth Substances|growth substances|mesh-ancestor
92379016|NCT02582970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379017|NCT02582970|Growth Inhibitors|growth inhibitors|mesh-ancestor
92379019|NCT02582970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379020|NCT02582970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379021|NCT02582970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379022|NCT02582970|Immunologic Factors|immunologic factors|mesh-ancestor
92379023|NCT02582970|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92379024|NCT02582970|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92379025|NCT02582970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379026|NCT02584608|Interferon-gamma|interferon-gamma|mesh-list
92379027|NCT02584608|Antiviral Agents|antiviral agents|mesh-ancestor
92379028|NCT02584608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379029|NCT02584686|Botulinum Toxins|botulinum toxins|mesh-list
92379030|NCT02584686|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92379031|NCT02584686|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92379032|NCT02584686|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92379033|NCT02584686|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379034|NCT02584686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379035|NCT02584686|Cholinergic Agents|cholinergic agents|mesh-ancestor
92379036|NCT02584686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379037|NCT02584686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379038|NCT02584686|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92379039|NCT02584686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379040|NCT05249556|Ganaxolone|ganaxolone|mesh-list
92379041|NCT05249556|Neurosteroids|neurosteroids|mesh-ancestor
92379042|NCT05249556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379043|NCT05249556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379044|NCT05249556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379045|NCT05249556|GABA Modulators|gaba modulators|mesh-ancestor
92379046|NCT05249556|GABA Agents|gaba agents|mesh-ancestor
92379047|NCT05248152|Acetaminophen|acetaminophen|mesh-list
92379048|NCT05248152|Ibuprofen|ibuprofen|mesh-list
92379049|NCT05248152|Pregabalin|pregabalin|mesh-list
92379050|NCT05248152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92379051|NCT05248152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92379052|NCT05248152|Analgesics|analgesics|mesh-ancestor
92379053|NCT05248152|Sensory System Agents|sensory system agents|mesh-ancestor
92379054|NCT05248152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379055|NCT05248152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379056|NCT05248152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379057|NCT05248152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379058|NCT05248152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92379059|NCT05248152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379060|NCT05248152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379061|NCT05248152|Anticonvulsants|anticonvulsants|mesh-ancestor
92379062|NCT05248152|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92379063|NCT05248152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379064|NCT05248152|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92379065|NCT05248152|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92379066|NCT05248152|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92379067|NCT05248152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379068|NCT05248152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379069|NCT05248152|Antipyretics|antipyretics|mesh-ancestor
92379070|NCT05247684|Paclitaxel|paclitaxel|mesh-list
92379071|NCT05247684|Carboplatin|carboplatin|mesh-list
92379072|NCT05247684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91940052|NCT04462003|Enoxaparin|enoxaparin|mesh-list
92379073|NCT05247684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379074|NCT05247684|Tubulin Modulators|tubulin modulators|mesh-ancestor
92379075|NCT05247684|Antimitotic Agents|antimitotic agents|mesh-ancestor
92379076|NCT05247684|Mitosis Modulators|mitosis modulators|mesh-ancestor
92379077|NCT05247684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379078|NCT05184348|Acitretin|acitretin|mesh-list
92379079|NCT05184348|Keratolytic Agents|keratolytic agents|mesh-ancestor
92379080|NCT05184348|Dermatologic Agents|dermatologic agents|mesh-ancestor
92379081|NCT05132166|Sirolimus|sirolimus|mesh-list
92379082|NCT05132166|Everolimus|everolimus|mesh-list
92379083|NCT05132166|MTOR Inhibitors|mtor inhibitors|mesh-list
92379084|NCT05132166|Temsirolimus|temsirolimus|mesh-list
92379085|NCT05132166|Vedolizumab|vedolizumab|mesh-list
92379086|NCT05132166|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92379087|NCT05132166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92379088|NCT05132166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379089|NCT05132166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379090|NCT05132166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379091|NCT05132166|Immunologic Factors|immunologic factors|mesh-ancestor
92379092|NCT05132166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379093|NCT05132166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379094|NCT05132166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92379095|NCT05132166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379096|NCT05132166|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92379097|NCT05132166|Antifungal Agents|antifungal agents|mesh-ancestor
92379098|NCT05132166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379099|NCT04808466|Paclitaxel|paclitaxel|mesh-list
92379100|NCT04808466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92379101|NCT04808466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379102|NCT04808466|Tubulin Modulators|tubulin modulators|mesh-ancestor
92379103|NCT04808466|Antimitotic Agents|antimitotic agents|mesh-ancestor
92379104|NCT04808466|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940111|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
92379105|NCT04808466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379106|NCT03939234|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92379107|NCT03939234|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92379108|NCT03939234|Immunologic Factors|immunologic factors|mesh-ancestor
92379109|NCT03939234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379110|NCT03907176|Acetaminophen|acetaminophen|mesh-list
92379111|NCT03907176|Ibuprofen|ibuprofen|mesh-list
92379112|NCT03907176|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92379113|NCT03907176|Analgesics|analgesics|mesh-ancestor
92379114|NCT03907176|Sensory System Agents|sensory system agents|mesh-ancestor
92379115|NCT03907176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379116|NCT03907176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379117|NCT03907176|Antipyretics|antipyretics|mesh-ancestor
92379118|NCT03907176|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92379119|NCT03907176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379120|NCT03907176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379121|NCT03907176|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92379122|NCT03907176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379123|NCT03907176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379124|NCT03675672|Misoprostol|misoprostol|mesh-list
92379125|NCT03675672|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92379126|NCT03675672|Abortifacient Agents|abortifacient agents|mesh-ancestor
92379127|NCT03675672|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92379128|NCT03675672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379129|NCT03675672|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92379130|NCT03675672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940152|NCT03496831|Adalimumab|adalimumab|mesh-list
92379131|NCT03675672|Oxytocics|oxytocics|mesh-ancestor
92379132|NCT02108496|Hyaluronic Acid|hyaluronic acid|mesh-list
92379133|NCT02108496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92379134|NCT02108496|Immunologic Factors|immunologic factors|mesh-ancestor
92379135|NCT02108496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379136|NCT02108496|Viscosupplements|viscosupplements|mesh-ancestor
92379137|NCT02108496|Protective Agents|protective agents|mesh-ancestor
92379139|NCT02056236|Levetiracetam|levetiracetam|mesh-list
92379140|NCT02056236|Valproic Acid|valproic acid|mesh-list
92379141|NCT02056236|Lorazepam|lorazepam|mesh-list
92379142|NCT02056236|Thiopental|thiopental|mesh-list
92379143|NCT02056236|Anticonvulsants|anticonvulsants|mesh-list
92379144|NCT02056236|Propofol|propofol|mesh-list
92379145|NCT02056236|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92122183|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
92379146|NCT02056236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379147|NCT02056236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379148|NCT02056236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92379149|NCT02056236|Anesthetics, General|anesthetics, general|mesh-ancestor
92379150|NCT02056236|Anesthetics|anesthetics|mesh-ancestor
92379151|NCT02056236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92379152|NCT02056236|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92379153|NCT02056236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92379154|NCT02056236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379155|NCT02056236|GABA Modulators|gaba modulators|mesh-ancestor
92379156|NCT02056236|GABA Agents|gaba agents|mesh-ancestor
92379157|NCT02056236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379158|NCT02056236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379159|NCT02056236|Nootropic Agents|nootropic agents|mesh-ancestor
92379160|NCT02056236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379161|NCT02056236|Antimanic Agents|antimanic agents|mesh-ancestor
92379162|NCT02056236|Antiemetics|antiemetics|mesh-ancestor
92379163|NCT02056236|Autonomic Agents|autonomic agents|mesh-ancestor
92379164|NCT02056236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379165|NCT02056236|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379166|NCT01962246|Capecitabine|capecitabine|mesh-list
92379167|NCT01962246|Oxaliplatin|oxaliplatin|mesh-list
92379168|NCT01962246|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379169|NCT01962246|Antimetabolites|antimetabolites|mesh-ancestor
92379170|NCT01962246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379171|NCT01962246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379172|NCT02588586|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91940435|NCT03484507|Povidone|povidone|mesh-list
92379173|NCT02588586|Antiviral Agents|antiviral agents|mesh-ancestor
91940520|NCT01352507|Tadalafil|tadalafil|mesh-list
92379174|NCT02588586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379175|NCT02592486|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92379176|NCT02592486|Immunologic Factors|immunologic factors|mesh-ancestor
92379177|NCT02592486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379178|NCT05370846|Anti-Infective Agents|anti-infective agents|mesh-list
92379179|NCT05370846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92379180|NCT04945122|Atorvastatin|atorvastatin|mesh-list
92379181|NCT04945122|Pitavastatin|pitavastatin|mesh-list
92379182|NCT04945122|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92379183|NCT04945122|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92379184|NCT04945122|Antimetabolites|antimetabolites|mesh-ancestor
92379185|NCT04945122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379186|NCT04945122|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92379187|NCT04945122|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92379188|NCT04945122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379189|NCT04227366|Methotrexate|methotrexate|mesh-list
92379190|NCT04227366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92379191|NCT04227366|Abortifacient Agents|abortifacient agents|mesh-ancestor
92379192|NCT04227366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92379193|NCT04227366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379194|NCT04227366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379195|NCT04227366|Antimetabolites|antimetabolites|mesh-ancestor
92379196|NCT04227366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379197|NCT04227366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379198|NCT04227366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92379199|NCT04227366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379200|NCT04227366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92379201|NCT04227366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379202|NCT04227366|Immunologic Factors|immunologic factors|mesh-ancestor
92379203|NCT04227366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122184|NCT00045435|Cyclosporins|cyclosporins|mesh-list
92379204|NCT04227366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92379205|NCT03560466|Prednisone|prednisone|mesh-list
92379206|NCT03560466|Prednisolone|prednisolone|mesh-list
92379207|NCT03560466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379208|NCT03560466|Glucocorticoids|glucocorticoids|mesh-ancestor
92379209|NCT03560466|Hormones|hormones|mesh-ancestor
92379210|NCT03560466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379211|NCT03560466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030921|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379212|NCT03560466|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92379213|NCT03560466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379215|NCT03376698|Gout Suppressants|gout suppressants|mesh-ancestor
92379216|NCT03376698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379217|NCT03376698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92379218|NCT03376698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92379219|NCT03376698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92379220|NCT03376698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379221|NCT03376698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379222|NCT03295734|Losartan|losartan|mesh-list
92379223|NCT03295734|Perindopril|perindopril|mesh-list
92379224|NCT03295734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92379225|NCT03295734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92379226|NCT03295734|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92379227|NCT03295734|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92122262|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
92379228|NCT03295734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379229|NCT03295734|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92379230|NCT03295734|Protease Inhibitors|protease inhibitors|mesh-ancestor
92379231|NCT03295734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379232|NCT02595684|Tadalafil|tadalafil|mesh-list
92379233|NCT02595684|Vasodilator Agents|vasodilator agents|mesh-ancestor
92379234|NCT02595684|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92379235|NCT02595684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92379236|NCT02595684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379237|NCT02595684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379238|NCT02595684|Urological Agents|urological agents|mesh-ancestor
92379239|NCT02604810|Immunoglobulins|immunoglobulins|mesh-list
92379240|NCT02604810|Antibodies|antibodies|mesh-list
92379241|NCT02604810|gamma-Globulins|gamma-globulins|mesh-list
92379242|NCT02604810|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92379243|NCT02604810|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92379244|NCT02604810|Immunoglobulin G|immunoglobulin g|mesh-list
92379245|NCT02604810|Immunologic Factors|immunologic factors|mesh-ancestor
92379246|NCT02604810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379247|NCT02607618|Vancomycin|vancomycin|mesh-list
92379248|NCT02607618|Iclaprim|iclaprim|mesh-list
92379249|NCT02607618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92379250|NCT02607618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379251|NCT02607618|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92379252|NCT02607618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379253|NCT02607618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379254|NCT05732064|Dexmedetomidine|dexmedetomidine|mesh-list
92379255|NCT05732064|Esketamine|esketamine|mesh-list
92379256|NCT05732064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92379257|NCT05732064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379258|NCT05732064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379259|NCT05732064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92379260|NCT05732064|Analgesics|analgesics|mesh-ancestor
92379261|NCT05732064|Sensory System Agents|sensory system agents|mesh-ancestor
92379262|NCT05732064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379263|NCT05732064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92379264|NCT05732064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92379265|NCT05732064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92379266|NCT05732064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92379267|NCT05732064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379268|NCT05732064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379269|NCT05732064|Antidepressive Agents|antidepressive agents|mesh-ancestor
92379270|NCT05732064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379271|NCT05731752|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92379272|NCT05731752|Immunologic Factors|immunologic factors|mesh-ancestor
92122341|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
92379273|NCT05731752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379274|NCT05730738|4-Aminopyridine|4-aminopyridine|mesh-list
92379275|NCT05730738|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92379276|NCT05730738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379277|NCT05730738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379278|NCT05730660|Quercetin|quercetin|mesh-list
92030925|NCT02201901|Velpatasvir|velpatasvir|mesh-list
92379280|NCT05730660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379281|NCT05730660|Protective Agents|protective agents|mesh-ancestor
92379282|NCT05730660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031773|NCT01648699|Hydromorphone|hydromorphone|mesh-list
92379284|NCT05697276|Bupivacaine|bupivacaine|mesh-list
92379285|NCT05697276|Anesthetics, Local|anesthetics, local|mesh-ancestor
92379286|NCT05697276|Anesthetics|anesthetics|mesh-ancestor
92379287|NCT05697276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379288|NCT05697276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379289|NCT05697276|Sensory System Agents|sensory system agents|mesh-ancestor
92379290|NCT05697276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379291|NCT05697276|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92379292|NCT05697276|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92379293|NCT05697276|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92379294|NCT05697276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379295|NCT05697276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379297|NCT05419674|Clarithromycin|clarithromycin|mesh-list
92379298|NCT05419674|Rabeprazole|rabeprazole|mesh-list
92379299|NCT05419674|Bismuth|bismuth|mesh-list
92379300|NCT05419674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92379301|NCT05419674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379302|NCT05419674|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92379303|NCT05419674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379304|NCT05419674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379305|NCT05419674|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92379306|NCT05419674|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92379307|NCT05419674|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92379308|NCT05419674|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379309|NCT05419674|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92379310|NCT05419674|Antacids|antacids|mesh-ancestor
92379311|NCT05386524|Bevacizumab|bevacizumab|mesh-list
92379312|NCT05386524|Doxorubicin|doxorubicin|mesh-list
92379313|NCT05386524|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92379314|NCT05386524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379315|NCT05386524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379316|NCT05386524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92379317|NCT05386524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92379318|NCT05386524|Growth Substances|growth substances|mesh-ancestor
92379319|NCT05386524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379320|NCT05386524|Growth Inhibitors|growth inhibitors|mesh-ancestor
92379321|NCT05386524|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92379322|NCT05386524|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92379323|NCT05386524|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92379324|NCT05386524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379325|NCT05386524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379326|NCT04965714|Nivolumab|nivolumab|mesh-list
92379327|NCT04965714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379328|NCT04965714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379329|NCT04965714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92379330|NCT04965714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379331|NCT04787562|Imipenem|imipenem|mesh-list
92379332|NCT04787562|Cilastatin|cilastatin|mesh-list
92379333|NCT04787562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92379334|NCT04787562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379335|NCT04787562|Protease Inhibitors|protease inhibitors|mesh-ancestor
92379336|NCT04787562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379337|NCT04787562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379338|NCT04780698|Immunoglobulin G|immunoglobulin g|mesh-list
92379339|NCT04780698|Immunologic Factors|immunologic factors|mesh-ancestor
92379340|NCT04780698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379341|NCT04355130|Vitamin B 12|vitamin b 12|mesh-list
92379342|NCT04355130|Hydroxocobalamin|hydroxocobalamin|mesh-list
92379343|NCT04355130|Vitamins|vitamins|mesh-ancestor
92379344|NCT04355130|Micronutrients|micronutrients|mesh-ancestor
92379345|NCT04355130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379346|NCT04355130|Vitamin B Complex|vitamin b complex|mesh-ancestor
92379347|NCT04355130|Hematinics|hematinics|mesh-ancestor
92379348|NCT04266912|Avelumab|avelumab|mesh-list
92379349|NCT04266912|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92379350|NCT04266912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379351|NCT04266912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379352|NCT04266912|Immunologic Factors|immunologic factors|mesh-ancestor
92379353|NCT04266912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379354|NCT04107168|Bevacizumab|bevacizumab|mesh-list
92379355|NCT04107168|Pembrolizumab|pembrolizumab|mesh-list
92379357|NCT04107168|Ipilimumab|ipilimumab|mesh-list
92379358|NCT04107168|Atezolizumab|atezolizumab|mesh-list
92379359|NCT04107168|Durvalumab|durvalumab|mesh-list
92379360|NCT04107168|Tremelimumab|tremelimumab|mesh-list
92379361|NCT04107168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379362|NCT04107168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379363|NCT04107168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92379364|NCT04107168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92379365|NCT04107168|Growth Substances|growth substances|mesh-ancestor
92379366|NCT04107168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379367|NCT04107168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92379368|NCT04107168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92379369|NCT04107168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379370|NCT03958344|Prednisolone|prednisolone|mesh-list
92379371|NCT03958344|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92379372|NCT03958344|Methylprednisolone|methylprednisolone|mesh-list
92379373|NCT03958344|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92379374|NCT03958344|Prednisolone acetate|prednisolone acetate|mesh-list
92379375|NCT03958344|Triamcinolone|triamcinolone|mesh-list
92379376|NCT03958344|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92379377|NCT03958344|Prednisolone phosphate|prednisolone phosphate|mesh-list
92379378|NCT03958344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379379|NCT03958344|Glucocorticoids|glucocorticoids|mesh-ancestor
92379380|NCT03958344|Hormones|hormones|mesh-ancestor
92122342|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
92379381|NCT03958344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379382|NCT03958344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379383|NCT03958344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92379384|NCT03958344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379385|NCT03958344|Antiemetics|antiemetics|mesh-ancestor
92379386|NCT03958344|Autonomic Agents|autonomic agents|mesh-ancestor
92379387|NCT03958344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379388|NCT03958344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379389|NCT03958344|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92379390|NCT03958344|Protective Agents|protective agents|mesh-ancestor
92379391|NCT02960646|Cyclophosphamide|cyclophosphamide|mesh-list
92379392|NCT02960646|Melphalan|melphalan|mesh-list
92379393|NCT02960646|Mechlorethamine|mechlorethamine|mesh-list
92379394|NCT02960646|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92379395|NCT02960646|Rituximab|rituximab|mesh-list
92379396|NCT02960646|Fludarabine|fludarabine|mesh-list
92379397|NCT02960646|Fludarabine phosphate|fludarabine phosphate|mesh-list
92379398|NCT02960646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92379399|NCT02960646|Tacrolimus|tacrolimus|mesh-list
92379400|NCT02960646|Antibodies|antibodies|mesh-list
92379401|NCT02960646|Immunoglobulins|immunoglobulins|mesh-list
92379402|NCT02960646|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92379403|NCT02960646|Lenograstim|lenograstim|mesh-list
92379404|NCT02960646|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379405|NCT02960646|Immunologic Factors|immunologic factors|mesh-ancestor
92379406|NCT02960646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379407|NCT02960646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379408|NCT02960646|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92379409|NCT02960646|Alkylating Agents|alkylating agents|mesh-ancestor
92379410|NCT02960646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379411|NCT02960646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941576|NCT05944380|Ropivacaine|ropivacaine|mesh-list
92379412|NCT02960646|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92379413|NCT02960646|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379414|NCT02960646|Antimetabolites|antimetabolites|mesh-ancestor
92379415|NCT02960646|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92379416|NCT02960646|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92379417|NCT02960646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379418|NCT02517684|Prednisolone|prednisolone|mesh-list
92379419|NCT02517684|Infliximab|infliximab|mesh-list
92379420|NCT02517684|Azathioprine|azathioprine|mesh-list
92379421|NCT02517684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379422|NCT02517684|Glucocorticoids|glucocorticoids|mesh-ancestor
92379423|NCT02517684|Hormones|hormones|mesh-ancestor
92379424|NCT02517684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379425|NCT02517684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379426|NCT02517684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92379427|NCT02517684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379428|NCT02517684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379429|NCT02517684|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92379430|NCT02517684|Dermatologic Agents|dermatologic agents|mesh-ancestor
91941721|NCT05943223|Tazobactam|tazobactam|mesh-list
92379431|NCT02517684|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379432|NCT02517684|Antimetabolites|antimetabolites|mesh-ancestor
92379433|NCT02517684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379434|NCT02517684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379435|NCT02517684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379436|NCT02517684|Immunologic Factors|immunologic factors|mesh-ancestor
92379437|NCT01448616|Tenofovir|tenofovir|mesh-list
92379438|NCT01448616|Antiviral Agents|antiviral agents|mesh-ancestor
92379439|NCT01448616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379440|NCT01448616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92379441|NCT01448616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92379442|NCT01448616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122420|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92379443|NCT01448616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379444|NCT01448616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92379445|NCT01448616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92379446|NCT00074412|Nevirapine|nevirapine|mesh-list
92379447|NCT00074412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92379448|NCT00074412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92379449|NCT00074412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379450|NCT00074412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379451|NCT00074412|Antiviral Agents|antiviral agents|mesh-ancestor
92379452|NCT00074412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379453|NCT00074412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91941869|NCT05837455|Anastrozole|anastrozole|mesh-list
92379454|NCT00074412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92379455|NCT00074412|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92379456|NCT00074412|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92379457|NCT02618772|Midazolam|midazolam|mesh-list
92379458|NCT02618772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92379459|NCT02618772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92379460|NCT02618772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379461|NCT02618772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379462|NCT02618772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92379463|NCT02618772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92379464|NCT02618772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379465|NCT02618772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92379466|NCT02618772|Anesthetics, General|anesthetics, general|mesh-ancestor
92379467|NCT02618772|Anesthetics|anesthetics|mesh-ancestor
92379468|NCT02618772|GABA Modulators|gaba modulators|mesh-ancestor
92379469|NCT02618772|GABA Agents|gaba agents|mesh-ancestor
92379470|NCT02618772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379471|NCT02618772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379472|NCT02620878|Pancrelipase|pancrelipase|mesh-list
92379473|NCT02620878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379474|NCT02624700|Pemetrexed|pemetrexed|mesh-list
92379475|NCT02624700|Sorafenib|sorafenib|mesh-list
92379476|NCT02624700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379477|NCT02624700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379478|NCT02624700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379479|NCT02624700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92379480|NCT02624700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92379481|NCT02624700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92379482|NCT02631954|Voriconazole|voriconazole|mesh-list
92379483|NCT02631954|Antifungal Agents|antifungal agents|mesh-ancestor
92379484|NCT02631954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379485|NCT02631954|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92379486|NCT02631954|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92379487|NCT02631954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379488|NCT02631954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379489|NCT02631954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92379490|NCT02631954|Hormone Antagonists|hormone antagonists|mesh-ancestor
92379491|NCT02631954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379492|NCT02631954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379493|NCT02631954|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92379494|NCT02632812|Naproxen|naproxen|mesh-list
92379495|NCT02632812|Rebamipide|rebamipide|mesh-list
92379496|NCT02632812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92379497|NCT02632812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92379498|NCT02632812|Analgesics|analgesics|mesh-ancestor
92379499|NCT02632812|Sensory System Agents|sensory system agents|mesh-ancestor
92379500|NCT02632812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122809|NCT00118131|Docetaxel|docetaxel|mesh-list
92379501|NCT02632812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379502|NCT02632812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379503|NCT02632812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379504|NCT02632812|Gout Suppressants|gout suppressants|mesh-ancestor
92379505|NCT02632812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92379506|NCT02632812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379507|NCT02632812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379508|NCT02632812|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92379509|NCT02632812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379510|NCT02632812|Antioxidants|antioxidants|mesh-ancestor
92379511|NCT02632812|Protective Agents|protective agents|mesh-ancestor
92379512|NCT02634684|Amphetamine|amphetamine|mesh-list
92379513|NCT02634684|Dextroamphetamine|dextroamphetamine|mesh-list
92379514|NCT02634684|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92379515|NCT02634684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379516|NCT02634684|Sympathomimetics|sympathomimetics|mesh-ancestor
92379517|NCT02634684|Autonomic Agents|autonomic agents|mesh-ancestor
92379518|NCT02634684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379519|NCT02634684|Dopamine Agents|dopamine agents|mesh-ancestor
92379520|NCT02634684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123418|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92379521|NCT02634684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379522|NCT02634684|Adrenergic Agents|adrenergic agents|mesh-ancestor
92379523|NCT02634684|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92379524|NCT02634684|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92379525|NCT02634684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379526|NCT02634684|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92379527|NCT02635542|Cisatracurium|cisatracurium|mesh-list
92379528|NCT02635542|Succinylcholine|succinylcholine|mesh-list
92379529|NCT02635542|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92379530|NCT02635542|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92379531|NCT02635542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942245|NCT05364424|Carboplatin|carboplatin|mesh-list
92379532|NCT02635542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379533|NCT02635542|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92379534|NCT05585658|Epoetin Alfa|epoetin alfa|mesh-list
92379535|NCT05585658|Hematinics|hematinics|mesh-ancestor
92379537|NCT05510856|Gabapentin|gabapentin|mesh-list
92379538|NCT05510856|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92379539|NCT05510856|Analgesics|analgesics|mesh-ancestor
92379540|NCT05510856|Sensory System Agents|sensory system agents|mesh-ancestor
92379541|NCT05510856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123649|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
92379542|NCT05510856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379543|NCT05510856|Anticonvulsants|anticonvulsants|mesh-ancestor
92379544|NCT05510856|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92379545|NCT05510856|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92379546|NCT05510856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379547|NCT05510856|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379548|NCT05510856|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92379549|NCT05510856|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92379550|NCT05510856|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379551|NCT05510856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379552|NCT05510856|Antimanic Agents|antimanic agents|mesh-ancestor
92379553|NCT05510856|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92379554|NCT05510856|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92379555|NCT05510856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379556|NCT05510856|Antidepressive Agents|antidepressive agents|mesh-ancestor
92379557|NCT05510856|Dopamine Agents|dopamine agents|mesh-ancestor
92379558|NCT05510856|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92379559|NCT05510856|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92379560|NCT05281770|Erenumab|erenumab|mesh-list
92379561|NCT05281770|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92379562|NCT05281770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379563|NCT05281770|Analgesics|analgesics|mesh-ancestor
92379564|NCT05281770|Sensory System Agents|sensory system agents|mesh-ancestor
92379565|NCT05281770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379566|NCT05281770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379567|NCT05225610|Dexmedetomidine|dexmedetomidine|mesh-list
92030940|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
92379568|NCT05225610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92379569|NCT05225610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379570|NCT05225610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379571|NCT05225610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92379572|NCT05225610|Analgesics|analgesics|mesh-ancestor
92379573|NCT05225610|Sensory System Agents|sensory system agents|mesh-ancestor
92379574|NCT05225610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379575|NCT05225610|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92379576|NCT05225610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92379577|NCT05225610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92379578|NCT05225610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92379579|NCT05225610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379580|NCT05225610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379581|NCT05150652|Tamoxifen|tamoxifen|mesh-list
92379583|NCT05150652|Anastrozole|anastrozole|mesh-list
92379584|NCT05150652|Exemestane|exemestane|mesh-list
92379585|NCT05150652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032064|NCT05269017|Glucocorticoids|glucocorticoids|mesh-ancestor
92379586|NCT05150652|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92379587|NCT05150652|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92379588|NCT05150652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379589|NCT05150652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379590|NCT05150652|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92379591|NCT05150652|Hormone Antagonists|hormone antagonists|mesh-ancestor
92379592|NCT05150652|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379593|NCT05150652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379594|NCT05150652|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92379595|NCT05150652|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92379596|NCT05150652|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92379597|NCT05150652|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92379598|NCT04511052|Carotenoids|carotenoids|mesh-list
92379599|NCT04511052|Antioxidants|antioxidants|mesh-ancestor
92379600|NCT04511052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379601|NCT04511052|Protective Agents|protective agents|mesh-ancestor
92379602|NCT04511052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379604|NCT03693846|Ipilimumab|ipilimumab|mesh-list
92379605|NCT03693846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379606|NCT03693846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379607|NCT03693846|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92379608|NCT03693846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379609|NCT03529890|Nivolumab|nivolumab|mesh-list
92379610|NCT03529890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379611|NCT03529890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379612|NCT03529890|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92379613|NCT03529890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379614|NCT03441048|Cytarabine|cytarabine|mesh-list
92379615|NCT03441048|Mitoxantrone|mitoxantrone|mesh-list
92379616|NCT03441048|Cladribine|cladribine|mesh-list
92379617|NCT03441048|Lintuzumab|lintuzumab|mesh-list
92379618|NCT03441048|Lenograstim|lenograstim|mesh-list
92379619|NCT03441048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379620|NCT03441048|Antimetabolites|antimetabolites|mesh-ancestor
92115525|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379621|NCT03441048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379622|NCT03441048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379623|NCT03441048|Antiviral Agents|antiviral agents|mesh-ancestor
92379624|NCT03441048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379625|NCT03441048|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379626|NCT03441048|Immunologic Factors|immunologic factors|mesh-ancestor
92379627|NCT03441048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379628|NCT03441048|Analgesics|analgesics|mesh-ancestor
92379629|NCT03441048|Sensory System Agents|sensory system agents|mesh-ancestor
92115526|NCT02427724|Lidocaine|lidocaine|mesh-list
92379630|NCT03441048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379631|NCT03441048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92379632|NCT03441048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92379633|NCT03441048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379634|NCT03441048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379635|NCT03441048|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92379636|NCT02828592|Cyclophosphamide|cyclophosphamide|mesh-list
92379637|NCT02828592|Fludarabine|fludarabine|mesh-list
92379638|NCT02828592|Thymoglobulin|thymoglobulin|mesh-list
92379639|NCT02828592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379640|NCT02828592|Immunologic Factors|immunologic factors|mesh-ancestor
92379641|NCT02828592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379642|NCT02828592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379643|NCT02828592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92379644|NCT02828592|Alkylating Agents|alkylating agents|mesh-ancestor
92115527|NCT02427724|Tetracaine|tetracaine|mesh-list
92379645|NCT02828592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379646|NCT02828592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379647|NCT02828592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92379648|NCT02369406|Lamivudine|lamivudine|mesh-list
92379649|NCT02369406|Zidovudine|zidovudine|mesh-list
92379650|NCT02369406|Nevirapine|nevirapine|mesh-list
92379651|NCT02369406|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92379652|NCT02369406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92379653|NCT02369406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379654|NCT02369406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379656|NCT02369406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379657|NCT02369406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92379658|NCT02369406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92379659|NCT02369406|Antimetabolites|antimetabolites|mesh-ancestor
92379660|NCT02369406|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92379661|NCT02369406|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92379662|NCT02649192|Vitamin D|vitamin d|mesh-list
92379663|NCT02649192|Vitamin A|vitamin a|mesh-list
92379664|NCT02649192|Vitamins|vitamins|mesh-ancestor
92379665|NCT02649192|Micronutrients|micronutrients|mesh-ancestor
92379666|NCT02649192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379667|NCT02649192|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92379668|NCT02652390|Methylprednisolone|methylprednisolone|mesh-list
92379669|NCT02652390|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92379670|NCT02652390|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92379671|NCT02652390|Prednisolone|prednisolone|mesh-list
92379672|NCT02652390|Prednisolone acetate|prednisolone acetate|mesh-list
92379673|NCT02652390|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92379674|NCT02652390|Prednisolone phosphate|prednisolone phosphate|mesh-list
92379675|NCT02652390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379676|NCT02652390|Antiemetics|antiemetics|mesh-ancestor
92379677|NCT02652390|Autonomic Agents|autonomic agents|mesh-ancestor
92379678|NCT02652390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379679|NCT02652390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379680|NCT02652390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379681|NCT02652390|Glucocorticoids|glucocorticoids|mesh-ancestor
92379682|NCT02652390|Hormones|hormones|mesh-ancestor
92379683|NCT02652390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379684|NCT02652390|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92379685|NCT02652390|Protective Agents|protective agents|mesh-ancestor
92379686|NCT02652390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92379687|NCT02652390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379688|NCT02653560|Potassium Citrate|potassium citrate|mesh-list
92379689|NCT02653560|Magnesium citrate|magnesium citrate|mesh-list
92379690|NCT02653560|Citric Acid|citric acid|mesh-list
92379691|NCT02653560|Sodium Citrate|sodium citrate|mesh-list
92379692|NCT02653560|Anticoagulants|anticoagulants|mesh-ancestor
92379693|NCT02653560|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92379694|NCT02653560|Chelating Agents|chelating agents|mesh-ancestor
92379695|NCT02653560|Sequestering Agents|sequestering agents|mesh-ancestor
92379696|NCT02653560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379697|NCT02653560|Diuretics|diuretics|mesh-ancestor
92379698|NCT02653560|Natriuretic Agents|natriuretic agents|mesh-ancestor
92379699|NCT02653560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379700|NCT02653560|Expectorants|expectorants|mesh-ancestor
92379701|NCT02653560|Respiratory System Agents|respiratory system agents|mesh-ancestor
92379702|NCT02653560|Cathartics|cathartics|mesh-ancestor
92379703|NCT02653560|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379704|NCT02653872|Itraconazole|itraconazole|mesh-list
92379705|NCT02653872|Verapamil|verapamil|mesh-list
92379706|NCT02653872|Diltiazem|diltiazem|mesh-list
92379707|NCT02653872|Antifungal Agents|antifungal agents|mesh-ancestor
92379708|NCT02653872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379709|NCT02653872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92379710|NCT02653872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92379711|NCT02653872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115528|NCT02427724|Prilocaine|prilocaine|mesh-list
92379712|NCT02653872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379713|NCT02653872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92379714|NCT02653872|Hormone Antagonists|hormone antagonists|mesh-ancestor
92379715|NCT02653872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379716|NCT02653872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379717|NCT02653872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92379718|NCT02653872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92379719|NCT02653872|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92379720|NCT02653872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379721|NCT02653872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92379722|NCT02653872|Vasodilator Agents|vasodilator agents|mesh-ancestor
92379723|NCT02653872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91943260|NCT03004287|Hormones|hormones|mesh-ancestor
92379724|NCT02655354|Diphenhydramine|diphenhydramine|mesh-list
92379725|NCT02655354|Promethazine|promethazine|mesh-list
92379726|NCT02655354|Prazosin|prazosin|mesh-list
92379727|NCT02655354|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92379728|NCT02655354|Mirtazapine|mirtazapine|mesh-list
92379729|NCT02655354|Fluvoxamine|fluvoxamine|mesh-list
92379730|NCT02655354|Trazodone|trazodone|mesh-list
92379731|NCT02655354|Sertraline|sertraline|mesh-list
92379733|NCT02655354|Paroxetine|paroxetine|mesh-list
92379734|NCT02655354|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92379735|NCT02655354|Citalopram|citalopram|mesh-list
92379736|NCT02655354|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92379737|NCT02655354|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92379738|NCT02655354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92379739|NCT02655354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379740|NCT02655354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379741|NCT02655354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379742|NCT02655354|Analgesics|analgesics|mesh-ancestor
92379743|NCT02655354|Sensory System Agents|sensory system agents|mesh-ancestor
92379744|NCT02655354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379745|NCT02655354|Antidepressive Agents|antidepressive agents|mesh-ancestor
92379746|NCT02655354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379747|NCT02655354|Dopamine Agents|dopamine agents|mesh-ancestor
92115529|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
92379748|NCT02655354|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92379749|NCT02655354|Serotonin Agents|serotonin agents|mesh-ancestor
92379750|NCT02655354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92379751|NCT02655354|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92379752|NCT02655354|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92379753|NCT02655354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379754|NCT02655354|Autonomic Agents|autonomic agents|mesh-ancestor
92379755|NCT02655354|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91943472|NCT00501826|Venetoclax|venetoclax|mesh-list
92379756|NCT02655354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92379757|NCT02655354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379758|NCT02655354|Anesthetics, Local|anesthetics, local|mesh-ancestor
92379759|NCT02655354|Anesthetics|anesthetics|mesh-ancestor
92379760|NCT02655354|Antiemetics|antiemetics|mesh-ancestor
92379761|NCT02655354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379762|NCT02655354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92379763|NCT02655354|Histamine Antagonists|histamine antagonists|mesh-ancestor
92379764|NCT02655354|Histamine Agents|histamine agents|mesh-ancestor
92379765|NCT02655354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92379766|NCT02655354|Antipruritics|antipruritics|mesh-ancestor
92379767|NCT02655354|Dermatologic Agents|dermatologic agents|mesh-ancestor
92379768|NCT02655354|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91943540|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
92379769|NCT02655354|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92379770|NCT02655354|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92379771|NCT02655354|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92379772|NCT02655354|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92379773|NCT02655354|Adrenergic Agents|adrenergic agents|mesh-ancestor
92379774|NCT02655354|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92379775|NCT02655354|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92379776|NCT02655354|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92379777|NCT02655354|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92379778|NCT02655354|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92379779|NCT02655354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92379780|NCT02655354|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92379781|NCT02657928|Letrozole|letrozole|mesh-list
92379782|NCT02657928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379783|NCT02657928|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92379784|NCT02657928|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92379785|NCT02657928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379786|NCT02657928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379787|NCT02657928|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92379788|NCT02657928|Hormone Antagonists|hormone antagonists|mesh-ancestor
92379789|NCT02657928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379790|NCT02657928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379791|NCT02658240|Epinephrine|epinephrine|mesh-list
92379792|NCT02658240|Ropivacaine|ropivacaine|mesh-list
92379793|NCT02658240|Anesthetics, Local|anesthetics, local|mesh-ancestor
92379794|NCT02658240|Anesthetics|anesthetics|mesh-ancestor
92379795|NCT02658240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379796|NCT02658240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379797|NCT02658240|Sensory System Agents|sensory system agents|mesh-ancestor
92379798|NCT02658240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379800|NCT02658240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92379801|NCT02658240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92379802|NCT02658240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379803|NCT02658240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379804|NCT02658240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92379805|NCT02658240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92379807|NCT02658240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92379808|NCT02658240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92379809|NCT02658240|Mydriatics|mydriatics|mesh-ancestor
92379810|NCT02658240|Sympathomimetics|sympathomimetics|mesh-ancestor
92379811|NCT02658240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92379812|NCT02661126|Uprifosbuvir|uprifosbuvir|mesh-list
92379813|NCT02661126|Antiviral Agents|antiviral agents|mesh-ancestor
92379814|NCT02661126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379815|NCT02661828|Antidepressive Agents|antidepressive agents|mesh-list
92379816|NCT02661828|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379817|NCT02665260|Cantharidin|cantharidin|mesh-list
92379818|NCT02665260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115530|NCT02427724|Anesthetics|anesthetics|mesh-list
92379819|NCT02665260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379820|NCT02665728|Laxatives|laxatives|mesh-list
92379821|NCT02665728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379822|NCT02666352|Ruzasvir|ruzasvir|mesh-list
92379823|NCT02666352|Uprifosbuvir|uprifosbuvir|mesh-list
92379824|NCT02666352|Antiviral Agents|antiviral agents|mesh-ancestor
92379825|NCT02666352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379826|NCT02673138|Canagliflozin|canagliflozin|mesh-list
92379827|NCT02673138|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92379828|NCT02673138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379829|NCT02673138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92379830|NCT02673138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379831|NCT02673372|Ketamine|ketamine|mesh-list
92379832|NCT02673372|Morphine|morphine|mesh-list
92379833|NCT02673372|Analgesics|analgesics|mesh-ancestor
92379834|NCT02673372|Sensory System Agents|sensory system agents|mesh-ancestor
92379835|NCT02673372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379836|NCT02673372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379837|NCT02673372|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92379838|NCT02673372|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92379839|NCT02673372|Anesthetics, General|anesthetics, general|mesh-ancestor
92379840|NCT02673372|Anesthetics|anesthetics|mesh-ancestor
92379841|NCT02673372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379842|NCT02673372|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92379843|NCT02673372|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92379844|NCT02673372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379845|NCT02673372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379846|NCT02673372|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92379847|NCT02673372|Narcotics|narcotics|mesh-ancestor
92379848|NCT02682498|Bupivacaine|bupivacaine|mesh-list
91944018|NCT00380159|Lamivudine|lamivudine|mesh-list
92379849|NCT02682498|Anesthetics, Local|anesthetics, local|mesh-ancestor
92379850|NCT02682498|Anesthetics|anesthetics|mesh-ancestor
92379851|NCT02682498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379852|NCT02682498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379853|NCT02682498|Sensory System Agents|sensory system agents|mesh-ancestor
92379854|NCT02682498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379855|NCT02684136|Suvorexant|suvorexant|mesh-list
92379856|NCT02684136|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92379857|NCT02684136|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92379858|NCT02684136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379859|NCT02684136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379860|NCT02684136|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92379861|NCT02684136|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379862|NCT02684136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379864|NCT02695290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379865|NCT02695290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92379866|NCT02695290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379867|NCT02695290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379868|NCT02695446|Minocycline|minocycline|mesh-list
92379869|NCT02695446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92379870|NCT02695446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379871|NCT02698566|Ranibizumab|ranibizumab|mesh-list
92379872|NCT02698566|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92379873|NCT02698566|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92379874|NCT02698566|Growth Substances|growth substances|mesh-ancestor
92379875|NCT02698566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379876|NCT02698566|Growth Inhibitors|growth inhibitors|mesh-ancestor
92379877|NCT02698566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379879|NCT02701062|Rivaroxaban|rivaroxaban|mesh-list
92379880|NCT02701062|Dabigatran|dabigatran|mesh-list
92379881|NCT02701062|Apixaban|apixaban|mesh-list
92379882|NCT02701062|Anticoagulants|anticoagulants|mesh-list
92379883|NCT02701062|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92379884|NCT02701062|Antithrombins|antithrombins|mesh-ancestor
92379885|NCT02701062|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92379886|NCT02701062|Protease Inhibitors|protease inhibitors|mesh-ancestor
92379887|NCT02701062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379888|NCT02701062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379889|NCT02704104|Hemostatics|hemostatics|mesh-list
92379890|NCT02704104|Coagulants|coagulants|mesh-ancestor
92379891|NCT02705352|Fluorouracil|fluorouracil|mesh-list
92379892|NCT02705352|Antimetabolites|antimetabolites|mesh-ancestor
92379893|NCT02705352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379894|NCT02705352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92379895|NCT02705352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379896|NCT02705352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92379897|NCT02705352|Immunologic Factors|immunologic factors|mesh-ancestor
92379898|NCT02705352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379899|NCT02708238|Simethicone|simethicone|mesh-list
92379900|NCT02708238|Antifoaming Agents|antifoaming agents|mesh-ancestor
92030979|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92379901|NCT02708238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379902|NCT02708238|Emollients|emollients|mesh-ancestor
92379903|NCT02708238|Dermatologic Agents|dermatologic agents|mesh-ancestor
92379904|NCT02709018|Losartan|losartan|mesh-list
92379905|NCT02709018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92379906|NCT02709018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92379907|NCT02709018|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92379908|NCT02709018|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92379909|NCT02709018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379910|NCT02713230|Bupivacaine|bupivacaine|mesh-list
92379911|NCT02713230|Anesthetics, Local|anesthetics, local|mesh-ancestor
92379912|NCT02713230|Anesthetics|anesthetics|mesh-ancestor
92379913|NCT02713230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379914|NCT02713230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379915|NCT02713230|Sensory System Agents|sensory system agents|mesh-ancestor
92379916|NCT02713230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379917|NCT02713698|Propofol|propofol|mesh-list
92379918|NCT02713698|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92379919|NCT02713698|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379920|NCT02713698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379921|NCT02713698|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92379922|NCT02713698|Anesthetics, General|anesthetics, general|mesh-ancestor
92379923|NCT02713698|Anesthetics|anesthetics|mesh-ancestor
92379924|NCT02714400|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92379925|NCT02714400|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92379926|NCT02714400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92379927|NCT02714400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115531|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92379928|NCT02714400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379929|NCT02714400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92379930|NCT02714400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379931|NCT02714400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92379932|NCT02714400|Antidepressive Agents|antidepressive agents|mesh-ancestor
92379933|NCT02714400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92379934|NCT02716818|Dexamethasone|dexamethasone|mesh-list
92379935|NCT02716818|Prednisone|prednisone|mesh-list
92379936|NCT02716818|Prednisolone|prednisolone|mesh-list
92379937|NCT02716818|Hydrocortisone|hydrocortisone|mesh-list
92379938|NCT02716818|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92379939|NCT02716818|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92379940|NCT02716818|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92379941|NCT02716818|Glucocorticoids|glucocorticoids|mesh-list
92379942|NCT02716818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379943|NCT02716818|Antiemetics|antiemetics|mesh-ancestor
92379944|NCT02716818|Autonomic Agents|autonomic agents|mesh-ancestor
92379945|NCT02716818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379946|NCT02716818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379947|NCT02716818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379948|NCT02716818|Hormones|hormones|mesh-ancestor
91946736|NCT03967288|Bupivacaine|bupivacaine|mesh-list
92123650|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
92379949|NCT02716818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937772|NCT05554406|Immunologic Factors|immunologic factors|mesh-ancestor
92379950|NCT02716818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92379951|NCT02716818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379952|NCT02719158|Ciprofloxacin|ciprofloxacin|mesh-list
92379953|NCT02719158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92379954|NCT02719158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92379955|NCT02719158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92379956|NCT02719158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92379957|NCT02719158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379958|NCT02719158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379959|NCT02719158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030989|NCT01439997|Coagulants|coagulants|mesh-ancestor
92379960|NCT02719158|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92379961|NCT02719158|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92379962|NCT02726178|Ibuprofen|ibuprofen|mesh-list
92379963|NCT02726178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92379964|NCT02726178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92379965|NCT02726178|Analgesics|analgesics|mesh-ancestor
92379966|NCT02726178|Sensory System Agents|sensory system agents|mesh-ancestor
92379967|NCT02726178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92379968|NCT02726178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379969|NCT02726178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92379970|NCT02726178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92379971|NCT02726178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92379972|NCT02726178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379973|NCT02726178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379974|NCT02733588|Glucagon|glucagon|mesh-list
92379975|NCT02733588|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92379976|NCT02733588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92379977|NCT02733588|Hormones|hormones|mesh-ancestor
92379978|NCT02733588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379979|NCT02733588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379980|NCT02733588|Incretins|incretins|mesh-ancestor
92379981|NCT02737332|Abiraterone Acetate|abiraterone acetate|mesh-list
92379982|NCT02737332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379983|NCT02737332|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92379984|NCT02737332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92379985|NCT02737332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92379986|NCT02737332|Hormone Antagonists|hormone antagonists|mesh-ancestor
92379987|NCT02737332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92379988|NCT02737332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379989|NCT02737332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92379991|NCT05444088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92379992|NCT05444088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92379993|NCT05444088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92379994|NCT05444088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92379995|NCT05444088|Growth Substances|growth substances|mesh-ancestor
92379996|NCT05444088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92379997|NCT05444088|Growth Inhibitors|growth inhibitors|mesh-ancestor
92379998|NCT05443932|Dapagliflozin|dapagliflozin|mesh-list
92379999|NCT05443932|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92380000|NCT05443932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92380001|NCT05443932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380002|NCT05443932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92380003|NCT05443932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380004|NCT05443932|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92380005|NCT05443932|Diuretics|diuretics|mesh-ancestor
92380006|NCT05443932|Natriuretic Agents|natriuretic agents|mesh-ancestor
92380007|NCT05443932|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92380008|NCT05443932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380009|NCT05443308|Acetazolamide|acetazolamide|mesh-list
92380010|NCT05443308|Anticonvulsants|anticonvulsants|mesh-ancestor
91947337|NCT02302547|Lopinavir|lopinavir|mesh-list
92380011|NCT05443308|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92380012|NCT05443308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380013|NCT05443308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380014|NCT05443308|Diuretics|diuretics|mesh-ancestor
92380015|NCT05443308|Natriuretic Agents|natriuretic agents|mesh-ancestor
92380016|NCT05443308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380017|NCT05442996|Antibodies|antibodies|mesh-list
92380018|NCT05442996|Immunoglobulins|immunoglobulins|mesh-list
92380019|NCT05442996|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92380020|NCT05442996|Immunologic Factors|immunologic factors|mesh-ancestor
92123651|NCT02415114|Resveratrol|resveratrol|mesh-list
92380021|NCT05442996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380023|NCT05441046|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380024|NCT05441046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380025|NCT05439564|Dexmedetomidine|dexmedetomidine|mesh-list
92380026|NCT05439564|Morphine|morphine|mesh-list
92380027|NCT05439564|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92380028|NCT05439564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380029|NCT05439564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380030|NCT05439564|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92380031|NCT05439564|Analgesics|analgesics|mesh-ancestor
92031002|NCT02457247|Antacids|antacids|mesh-ancestor
92380032|NCT05439564|Sensory System Agents|sensory system agents|mesh-ancestor
92380033|NCT05439564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380034|NCT05439564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92380035|NCT05439564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92380037|NCT05439564|Adrenergic Agents|adrenergic agents|mesh-ancestor
92380038|NCT05439564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380039|NCT05439564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380040|NCT05439564|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92380041|NCT05439564|Narcotics|narcotics|mesh-ancestor
92380042|NCT05340270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92380043|NCT05340270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380044|NCT05340270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380045|NCT05340270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380046|NCT05266404|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92380047|NCT05266404|Dapagliflozin|dapagliflozin|mesh-list
92380048|NCT05266404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92380049|NCT05266404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380050|NCT05266404|Incretins|incretins|mesh-ancestor
92380051|NCT05266404|Hormones|hormones|mesh-ancestor
92380052|NCT05266404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380053|NCT05266404|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92380054|NCT05266404|Protease Inhibitors|protease inhibitors|mesh-ancestor
92380055|NCT05266404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380056|NCT05266404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380057|NCT05266404|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92380058|NCT05122494|Capecitabine|capecitabine|mesh-list
92380059|NCT05122494|Lapatinib|lapatinib|mesh-list
92380060|NCT05122494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92380061|NCT05122494|Antimetabolites|antimetabolites|mesh-ancestor
92380062|NCT05122494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380063|NCT05122494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380064|NCT05122494|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380065|NCT05122494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380066|NCT05063604|Citalopram|citalopram|mesh-list
92380067|NCT05063604|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92380068|NCT05063604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92380069|NCT05063604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380070|NCT05063604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380071|NCT05063604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380072|NCT05063604|Serotonin Agents|serotonin agents|mesh-ancestor
92380073|NCT05063604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380074|NCT05063604|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91948172|NCT02311439|Folfirinox|folfirinox|mesh-list
92380075|NCT05063604|Antidepressive Agents|antidepressive agents|mesh-ancestor
92380076|NCT05063604|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380077|NCT04978428|Cannabidiol|cannabidiol|mesh-list
92380078|NCT04978428|Anticonvulsants|anticonvulsants|mesh-ancestor
92380079|NCT04956120|Dialysis Solutions|dialysis solutions|mesh-list
92380080|NCT04956120|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92380081|NCT04780464|Prednisone|prednisone|mesh-list
92380082|NCT04780464|Prednisolone|prednisolone|mesh-list
92380083|NCT04780464|Cyclophosphamide|cyclophosphamide|mesh-list
92380084|NCT04780464|Doxorubicin|doxorubicin|mesh-list
92380085|NCT04780464|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92380086|NCT04780464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380087|NCT04780464|Immunologic Factors|immunologic factors|mesh-ancestor
92380088|NCT04780464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380089|NCT04780464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92380090|NCT04780464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92380091|NCT04780464|Alkylating Agents|alkylating agents|mesh-ancestor
92380092|NCT04780464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380093|NCT04780464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380094|NCT04780464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92380095|NCT04780464|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91944413|NCT02288429|Colistin|colistin|mesh-list
92380096|NCT04780464|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92380097|NCT04780464|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92380098|NCT04780464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380099|NCT04780464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380100|NCT04780464|Glucocorticoids|glucocorticoids|mesh-ancestor
92380101|NCT04780464|Hormones|hormones|mesh-ancestor
92380102|NCT04780464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380103|NCT04780464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92380104|NCT04495608|Fluconazole|fluconazole|mesh-list
92380105|NCT04495608|Antifungal Agents|antifungal agents|mesh-ancestor
92032585|NCT05284409|Narcotics|narcotics|mesh-ancestor
92380106|NCT04495608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380107|NCT04495608|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92380108|NCT04495608|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92380109|NCT04495608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380110|NCT04495608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380111|NCT04495608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92380112|NCT04495608|Hormone Antagonists|hormone antagonists|mesh-ancestor
92380113|NCT04495608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380114|NCT04495608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380115|NCT04495608|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92380116|NCT04495608|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92380118|NCT04238754|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92380119|NCT04238754|Anticonvulsants|anticonvulsants|mesh-ancestor
92380120|NCT03770130|Dexmedetomidine|dexmedetomidine|mesh-list
92380121|NCT03770130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92123652|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
92380122|NCT03770130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380123|NCT03770130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380124|NCT03770130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92380125|NCT03770130|Analgesics|analgesics|mesh-ancestor
92380126|NCT03770130|Sensory System Agents|sensory system agents|mesh-ancestor
92380127|NCT03770130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380128|NCT03770130|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92380129|NCT03770130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92380130|NCT03770130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92380131|NCT03770130|Adrenergic Agents|adrenergic agents|mesh-ancestor
92380132|NCT03770130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380133|NCT03770130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380134|NCT03586284|Valganciclovir|valganciclovir|mesh-list
92380135|NCT03586284|Ganciclovir|ganciclovir|mesh-list
92380136|NCT03586284|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92380137|NCT03586284|Antiviral Agents|antiviral agents|mesh-ancestor
92380138|NCT03586284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380139|NCT03586284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92380140|NCT03586284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380141|NCT03586284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380142|NCT05452434|Mirabegron|mirabegron|mesh-list
92380143|NCT05452434|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92380144|NCT05452434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92380145|NCT05452434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92380146|NCT05452434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92380147|NCT05452434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380148|NCT05452434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380149|NCT05452434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380150|NCT05452434|Urological Agents|urological agents|mesh-ancestor
92380151|NCT05450328|Epoprostenol|epoprostenol|mesh-list
92380152|NCT05450328|Milrinone|milrinone|mesh-list
92380153|NCT05450328|Tezosentan|tezosentan|mesh-list
92380154|NCT05450328|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92380155|NCT05450328|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92380156|NCT05450328|Vasodilator Agents|vasodilator agents|mesh-ancestor
92380157|NCT05450328|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92380158|NCT05450328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92031011|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
92380159|NCT05450328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380160|NCT05450328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380161|NCT05450328|Protective Agents|protective agents|mesh-ancestor
92380162|NCT05450328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380163|NCT05450328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92380164|NCT05448924|Hormones|hormones|mesh-list
92380165|NCT05448924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123728|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
92380166|NCT05448924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380167|NCT05447364|Pregabalin|pregabalin|mesh-list
92380168|NCT05447364|Analgesics|analgesics|mesh-ancestor
92380169|NCT05447364|Sensory System Agents|sensory system agents|mesh-ancestor
92380170|NCT05447364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380171|NCT05447364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380172|NCT05447364|Anticonvulsants|anticonvulsants|mesh-ancestor
92380173|NCT05447364|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92380174|NCT05447364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380175|NCT05447364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380176|NCT05447364|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032659|NCT02302339|Immunoconjugates|immunoconjugates|mesh-ancestor
92380177|NCT05447364|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92380178|NCT05447364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92380179|NCT05447364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380180|NCT05447364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380181|NCT05430750|Nitrous Oxide|nitrous oxide|mesh-list
92380182|NCT05430750|Sevoflurane|sevoflurane|mesh-list
92380183|NCT05430750|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92380184|NCT05430750|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92380185|NCT05430750|Anesthetics, General|anesthetics, general|mesh-ancestor
92380186|NCT05430750|Anesthetics|anesthetics|mesh-ancestor
92380187|NCT05430750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380188|NCT05430750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380189|NCT05430750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92380190|NCT05430750|Analgesics|analgesics|mesh-ancestor
92380191|NCT05430750|Sensory System Agents|sensory system agents|mesh-ancestor
92380192|NCT05430750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380193|NCT05418036|Sotalol|sotalol|mesh-list
92380194|NCT05418036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92380195|NCT05418036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92380196|NCT05418036|Adrenergic Agents|adrenergic agents|mesh-ancestor
91948998|NCT03253913|Sirolimus|sirolimus|mesh-list
92380197|NCT05418036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380198|NCT05418036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380199|NCT05418036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380200|NCT05418036|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92380201|NCT05418036|Sympatholytics|sympatholytics|mesh-ancestor
92380202|NCT05418036|Autonomic Agents|autonomic agents|mesh-ancestor
92380203|NCT05418036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123729|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92380204|NCT05023278|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92380205|NCT05023278|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92380206|NCT05023278|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92380207|NCT05023278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380208|NCT05023278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380209|NCT05023278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380210|NCT05023278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380211|NCT05023278|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92380212|NCT05023278|Antidepressive Agents|antidepressive agents|mesh-ancestor
92380213|NCT05023278|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380214|NCT04727424|Budesonide|budesonide|mesh-list
92380215|NCT04727424|Fluvoxamine|fluvoxamine|mesh-list
92380216|NCT04727424|Fluoxetine|fluoxetine|mesh-list
92380217|NCT04727424|Maleic acid|maleic acid|mesh-list
92380218|NCT04727424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380219|NCT04727424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92380220|NCT04727424|Autonomic Agents|autonomic agents|mesh-ancestor
92380221|NCT04727424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090425|NCT04416035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380222|NCT04727424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380223|NCT04727424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92380224|NCT04727424|Respiratory System Agents|respiratory system agents|mesh-ancestor
92380225|NCT04727424|Glucocorticoids|glucocorticoids|mesh-ancestor
92380226|NCT04727424|Hormones|hormones|mesh-ancestor
92380227|NCT04727424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380228|NCT04727424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380229|NCT04727424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380230|NCT04727424|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92380231|NCT04727424|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92380232|NCT04727424|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380233|NCT04727424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380234|NCT04727424|Serotonin Agents|serotonin agents|mesh-ancestor
92380235|NCT04727424|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92380236|NCT04727424|Antidepressive Agents|antidepressive agents|mesh-ancestor
92380237|NCT04727424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380238|NCT04727424|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92380239|NCT04727424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92380240|NCT04727424|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92380241|NCT04727424|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92380242|NCT04727424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380243|NCT04727424|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92380244|NCT04727424|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92380246|NCT04522206|Oxycodone|oxycodone|mesh-list
92380247|NCT04522206|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92380248|NCT04522206|Narcotics|narcotics|mesh-ancestor
92380249|NCT04522206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380250|NCT04522206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380251|NCT04522206|Analgesics|analgesics|mesh-ancestor
92380252|NCT04522206|Sensory System Agents|sensory system agents|mesh-ancestor
92380253|NCT04522206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380254|NCT04519944|Edoxaban|edoxaban|mesh-list
92380255|NCT04519944|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92380256|NCT04519944|Antithrombins|antithrombins|mesh-ancestor
92380257|NCT04519944|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92380258|NCT04519944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92380259|NCT04519944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380260|NCT04519944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380261|NCT04519944|Anticoagulants|anticoagulants|mesh-ancestor
92380262|NCT04505592|Tenecteplase|tenecteplase|mesh-list
92380263|NCT04505592|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92380264|NCT04505592|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92380265|NCT04505592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380266|NCT04415892|Cinnamaldehyde|cinnamaldehyde|mesh-list
92380267|NCT04415892|Capsaicin|capsaicin|mesh-list
92380268|NCT04415892|Antipruritics|antipruritics|mesh-ancestor
92380269|NCT04415892|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380270|NCT04415892|Sensory System Agents|sensory system agents|mesh-ancestor
92380271|NCT04415892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380272|NCT04415892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380273|NCT04415892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92380274|NCT04415892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380275|NCT04415892|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92380276|NCT04415892|Protective Agents|protective agents|mesh-ancestor
92380277|NCT04176354|Letrozole|letrozole|mesh-list
92380278|NCT04176354|Palbociclib|palbociclib|mesh-list
92380279|NCT04176354|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92380280|NCT04176354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380281|NCT04176354|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92380282|NCT04176354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380283|NCT04176354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380284|NCT04176354|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92380285|NCT04176354|Hormone Antagonists|hormone antagonists|mesh-ancestor
92380286|NCT04176354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380287|NCT04176354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380288|NCT04176354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380289|NCT04173780|Atropine|atropine|mesh-list
92380290|NCT04173780|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92380291|NCT04173780|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92380292|NCT04173780|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92380293|NCT04173780|Autonomic Agents|autonomic agents|mesh-ancestor
92380294|NCT04173780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380295|NCT04173780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380296|NCT04173780|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92380297|NCT04173780|Respiratory System Agents|respiratory system agents|mesh-ancestor
92380298|NCT04173780|Mydriatics|mydriatics|mesh-ancestor
92380299|NCT04173780|Parasympatholytics|parasympatholytics|mesh-ancestor
92380300|NCT04173780|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92380301|NCT04173780|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92380302|NCT04173780|Cholinergic Agents|cholinergic agents|mesh-ancestor
92380303|NCT04173780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380304|NCT04173780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380305|NCT04128540|Fentanyl|fentanyl|mesh-list
91949607|NCT02319707|Oxytocin|oxytocin|mesh-list
92380306|NCT04128540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92380307|NCT04128540|Narcotics|narcotics|mesh-ancestor
92380308|NCT04128540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380309|NCT04128540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380311|NCT04128540|Sensory System Agents|sensory system agents|mesh-ancestor
92380312|NCT04128540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380313|NCT04128540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92380314|NCT04128540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92380315|NCT04128540|Anesthetics, General|anesthetics, general|mesh-ancestor
92380316|NCT04128540|Anesthetics|anesthetics|mesh-ancestor
92380317|NCT04104438|Everolimus|everolimus|mesh-list
92380318|NCT04104438|Basiliximab|basiliximab|mesh-list
92380319|NCT04104438|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92380320|NCT04104438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380321|NCT04104438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380322|NCT04104438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380323|NCT04104438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380324|NCT04104438|Immunologic Factors|immunologic factors|mesh-ancestor
92380325|NCT04104438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380326|NCT04104438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380327|NCT03703206|Anesthetics|anesthetics|mesh-list
92380328|NCT03703206|Anesthetics, Local|anesthetics, local|mesh-list
91949689|NCT02322671|Montelukast|montelukast|mesh-list
92380329|NCT03703206|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380330|NCT03703206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380331|NCT03703206|Sensory System Agents|sensory system agents|mesh-ancestor
92123955|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92380332|NCT03703206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380333|NCT03689244|Selexipag|selexipag|mesh-list
92380334|NCT03689244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92380335|NCT03443856|Nivolumab|nivolumab|mesh-list
92380336|NCT03443856|Ipilimumab|ipilimumab|mesh-list
92380337|NCT03443856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380338|NCT03443856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380339|NCT03443856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92380340|NCT03443856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380341|NCT03086616|Irinotecan|irinotecan|mesh-list
92380342|NCT03086616|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92380343|NCT03086616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92380344|NCT03086616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380345|NCT03086616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380346|NCT03086616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380347|NCT02952924|Midazolam|midazolam|mesh-list
92380348|NCT02952924|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92380349|NCT02952924|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92380350|NCT02952924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380351|NCT02952924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380352|NCT02952924|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92380353|NCT02952924|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92380354|NCT02952924|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380355|NCT02952924|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92380356|NCT02952924|Anesthetics, General|anesthetics, general|mesh-ancestor
92380357|NCT02952924|Anesthetics|anesthetics|mesh-ancestor
92380358|NCT02952924|GABA Modulators|gaba modulators|mesh-ancestor
92380359|NCT02952924|GABA Agents|gaba agents|mesh-ancestor
92380360|NCT02952924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380361|NCT02952924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380362|NCT02905578|Ascorbic Acid|ascorbic acid|mesh-list
92380364|NCT02905578|Gemcitabine|gemcitabine|mesh-list
92380365|NCT02905578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92380366|NCT02905578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380367|NCT02905578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92380368|NCT02905578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92380369|NCT02905578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92380370|NCT02905578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380371|NCT02905578|Vitamins|vitamins|mesh-ancestor
92380372|NCT02905578|Micronutrients|micronutrients|mesh-ancestor
92380373|NCT02905578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380374|NCT02905578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92380375|NCT02905578|Antimetabolites|antimetabolites|mesh-ancestor
92380376|NCT02905578|Antioxidants|antioxidants|mesh-ancestor
92380377|NCT02905578|Protective Agents|protective agents|mesh-ancestor
92380378|NCT00677586|Liver Extracts|liver extracts|mesh-list
92380379|NCT00677586|Hematinics|hematinics|mesh-ancestor
92380381|NCT05453448|Entecavir|entecavir|mesh-list
92380382|NCT05453448|Antiviral Agents|antiviral agents|mesh-ancestor
92380383|NCT05453448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380384|NCT05453448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92380385|NCT05453448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92380386|NCT05453448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380387|NCT05453448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380388|NCT05453448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92380389|NCT05453448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92380390|NCT05453214|Fludrocortisone|fludrocortisone|mesh-list
92380391|NCT05453214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380392|NCT05444478|Lenvatinib|lenvatinib|mesh-list
92380393|NCT05444478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380394|NCT05444478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380395|NCT05444478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380396|NCT05444478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380397|NCT05354466|Neostigmine|neostigmine|mesh-list
92032886|NCT05218889|Mitosis Modulators|mitosis modulators|mesh-ancestor
92380398|NCT05354466|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92380399|NCT05354466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380400|NCT05354466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380401|NCT05354466|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123956|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
92380402|NCT05354466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380403|NCT05354466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380404|NCT05354466|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92380405|NCT05354466|Autonomic Agents|autonomic agents|mesh-ancestor
92380406|NCT05354466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380407|NCT04095624|Analgesics, Opioid|analgesics, opioid|mesh-list
92380408|NCT04095624|Narcotics|narcotics|mesh-ancestor
92380409|NCT04095624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380410|NCT04095624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380411|NCT04095624|Analgesics|analgesics|mesh-ancestor
92380412|NCT04095624|Sensory System Agents|sensory system agents|mesh-ancestor
92380413|NCT04095624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380414|NCT03745716|Azacitidine|azacitidine|mesh-list
92380415|NCT03745716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92380416|NCT03745716|Antimetabolites|antimetabolites|mesh-ancestor
92380417|NCT03745716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380418|NCT03745716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380419|NCT03745716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380420|NCT03341676|Dexamethasone|dexamethasone|mesh-list
92380421|NCT03341676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380422|NCT03341676|Antiemetics|antiemetics|mesh-ancestor
92380423|NCT03341676|Autonomic Agents|autonomic agents|mesh-ancestor
92380424|NCT03341676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380425|NCT03341676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380426|NCT03341676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380427|NCT03341676|Glucocorticoids|glucocorticoids|mesh-ancestor
92380428|NCT03341676|Hormones|hormones|mesh-ancestor
92380429|NCT03341676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380430|NCT03341676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92380431|NCT03341676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380432|NCT03121716|Gemcitabine|gemcitabine|mesh-list
92380433|NCT03121716|Cisplatin|cisplatin|mesh-list
92380434|NCT03121716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92380435|NCT03121716|Antimetabolites|antimetabolites|mesh-ancestor
92380436|NCT03121716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380437|NCT03121716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380438|NCT02714634|Hydroxychloroquine|hydroxychloroquine|mesh-list
92380439|NCT02714634|Sulfasalazine|sulfasalazine|mesh-list
92380440|NCT02714634|Methotrexate|methotrexate|mesh-list
92380441|NCT02714634|Leflunomide|leflunomide|mesh-list
92380442|NCT02714634|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92380443|NCT02714634|Abortifacient Agents|abortifacient agents|mesh-ancestor
92380444|NCT02714634|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92380445|NCT02714634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380446|NCT02714634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92380447|NCT02714634|Antimetabolites|antimetabolites|mesh-ancestor
92380448|NCT02714634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380449|NCT02714634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380450|NCT02714634|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380451|NCT02714634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380452|NCT02714634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92380453|NCT02714634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380454|NCT02714634|Immunologic Factors|immunologic factors|mesh-ancestor
92380455|NCT02714634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92380456|NCT02714634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92380457|NCT02714634|Antimalarials|antimalarials|mesh-ancestor
92380458|NCT02714634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92380459|NCT02714634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92380460|NCT02714634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380461|NCT02714634|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92380462|NCT02714634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92380464|NCT02714634|Sensory System Agents|sensory system agents|mesh-ancestor
92380465|NCT02714634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380466|NCT02714634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380467|NCT02714634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380468|NCT02708394|Olanzapine|olanzapine|mesh-list
92380469|NCT02708394|Antiemetics|antiemetics|mesh-ancestor
92380470|NCT02708394|Autonomic Agents|autonomic agents|mesh-ancestor
92380471|NCT02708394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380472|NCT02708394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380473|NCT02708394|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380474|NCT02708394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92380475|NCT02708394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92380476|NCT02708394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380477|NCT02708394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380478|NCT02708394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92380479|NCT02708394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92380480|NCT02708394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380481|NCT02708394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380482|NCT02708394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380483|NCT02708394|Serotonin Agents|serotonin agents|mesh-ancestor
92380484|NCT00553800|Bevacizumab|bevacizumab|mesh-list
92380485|NCT00553800|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92380486|NCT00553800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380487|NCT00553800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380488|NCT00553800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92380489|NCT00553800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92380490|NCT00553800|Growth Substances|growth substances|mesh-ancestor
92380491|NCT00553800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380492|NCT00553800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92380493|NCT00553800|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380494|NCT00553800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031053|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380495|NCT00553800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380496|NCT02740920|Pembrolizumab|pembrolizumab|mesh-list
92380497|NCT02740920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380498|NCT02740920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380499|NCT02740920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92380500|NCT02740920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380501|NCT02747628|Melatonin|melatonin|mesh-list
92380502|NCT02747628|Nicotine|nicotine|mesh-list
92380503|NCT02747628|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92380504|NCT02747628|Autonomic Agents|autonomic agents|mesh-ancestor
92380505|NCT02747628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380506|NCT02747628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380507|NCT02747628|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92380508|NCT02747628|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92380509|NCT02747628|Cholinergic Agents|cholinergic agents|mesh-ancestor
92380510|NCT02747628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380511|NCT02747628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380512|NCT02747628|Antioxidants|antioxidants|mesh-ancestor
92380513|NCT02747628|Protective Agents|protective agents|mesh-ancestor
92124107|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
91944570|NCT02478164|Ponatinib|ponatinib|mesh-list
92380514|NCT02747628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380515|NCT02754570|Pilocarpine|pilocarpine|mesh-list
92380516|NCT02754570|Miotics|miotics|mesh-ancestor
92380517|NCT02754570|Autonomic Agents|autonomic agents|mesh-ancestor
92380518|NCT02754570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380519|NCT02754570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380520|NCT02754570|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92380521|NCT02754570|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92380522|NCT02754570|Cholinergic Agents|cholinergic agents|mesh-ancestor
92380523|NCT02754570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380524|NCT02754570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380525|NCT02765256|Promethazine|promethazine|mesh-list
92380526|NCT02765256|Diphenhydramine|diphenhydramine|mesh-list
92380527|NCT02765256|Vancomycin|vancomycin|mesh-list
92380528|NCT02765256|Ciprofloxacin|ciprofloxacin|mesh-list
92380529|NCT02765256|Neomycin|neomycin|mesh-list
92380530|NCT02765256|Fluconazole|fluconazole|mesh-list
92380531|NCT02765256|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92380532|NCT02765256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92380533|NCT02765256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380534|NCT02765256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92380535|NCT02765256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92380536|NCT02765256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380537|NCT02765256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380538|NCT02765256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380539|NCT02765256|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92380540|NCT02765256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92380541|NCT02765256|Antifungal Agents|antifungal agents|mesh-ancestor
92380542|NCT02765256|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92380543|NCT02765256|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92380544|NCT02765256|Hormone Antagonists|hormone antagonists|mesh-ancestor
92380545|NCT02765256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380546|NCT02765256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380547|NCT02765256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92380548|NCT02765256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92380549|NCT02765256|Antipruritics|antipruritics|mesh-ancestor
92033035|NCT02116803|Fulvestrant|fulvestrant|mesh-list
92380550|NCT02765256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380551|NCT02765256|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92380552|NCT02765256|Histamine Antagonists|histamine antagonists|mesh-ancestor
92380553|NCT02765256|Histamine Agents|histamine agents|mesh-ancestor
92380554|NCT02765256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380555|NCT02765256|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92380556|NCT02765256|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92380557|NCT02765256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92380558|NCT02765256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380559|NCT02765256|Anesthetics, Local|anesthetics, local|mesh-ancestor
92380561|NCT02765256|Sensory System Agents|sensory system agents|mesh-ancestor
92380562|NCT02765256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380563|NCT02765256|Antiemetics|antiemetics|mesh-ancestor
92380564|NCT02765256|Autonomic Agents|autonomic agents|mesh-ancestor
92380565|NCT02765256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380566|NCT02765256|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92380567|NCT02765256|Laxatives|laxatives|mesh-ancestor
92380568|NCT02767128|Citric Acid|citric acid|mesh-list
92380569|NCT02767128|Sodium Citrate|sodium citrate|mesh-list
92380570|NCT02767128|Anticoagulants|anticoagulants|mesh-ancestor
92380571|NCT02767128|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92380572|NCT02767128|Chelating Agents|chelating agents|mesh-ancestor
92380573|NCT02767128|Sequestering Agents|sequestering agents|mesh-ancestor
92380574|NCT02767128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380575|NCT02769702|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92380576|NCT02769702|Hormones|hormones|mesh-ancestor
92380577|NCT02769702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380578|NCT02769702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380579|NCT02770014|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92380580|NCT02770014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380581|NCT02770014|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380582|NCT02770014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380583|NCT02770014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380584|NCT02771340|Immunoconjugates|immunoconjugates|mesh-list
92380585|NCT02771340|Immunologic Factors|immunologic factors|mesh-ancestor
92380586|NCT02771340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380587|NCT02773758|Fluorides|fluorides|mesh-list
92380588|NCT02773758|Tin Fluorides|tin fluorides|mesh-list
92380589|NCT02773758|Fluorophosphate|fluorophosphate|mesh-list
92380590|NCT02773758|Cariostatic Agents|cariostatic agents|mesh-ancestor
92380591|NCT02773758|Protective Agents|protective agents|mesh-ancestor
92380592|NCT02773758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380593|NCT02774226|Vitamins|vitamins|mesh-list
92380594|NCT02774226|Vitamin E|vitamin e|mesh-list
92380595|NCT02774226|Thioctic Acid|thioctic acid|mesh-list
92380596|NCT02774226|Antioxidants|antioxidants|mesh-list
92380597|NCT02774226|Micronutrients|micronutrients|mesh-ancestor
92380598|NCT02774226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380599|NCT02774226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380600|NCT02774226|Protective Agents|protective agents|mesh-ancestor
92380601|NCT02774226|Vitamin B Complex|vitamin b complex|mesh-ancestor
92380602|NCT02775240|Maribavir|maribavir|mesh-list
92380603|NCT02775240|Digoxin|digoxin|mesh-list
92380604|NCT02775240|Dextromethorphan|dextromethorphan|mesh-list
92380605|NCT02775240|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92380606|NCT02775240|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92380607|NCT02775240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380608|NCT02775240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380610|NCT02775240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380611|NCT02775240|Antitussive Agents|antitussive agents|mesh-ancestor
92380612|NCT02775240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92380613|NCT02775240|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92380614|NCT02775240|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92380615|NCT02775240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380616|NCT02775240|Antiviral Agents|antiviral agents|mesh-ancestor
92380617|NCT02775240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380618|NCT02777268|Hydrocortisone|hydrocortisone|mesh-list
92380619|NCT02777268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380620|NCT05350020|Hydrocortisone|hydrocortisone|mesh-list
92380621|NCT05350020|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92380622|NCT05350020|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92380623|NCT05350020|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92380624|NCT05350020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380625|NCT05349396|Eszopiclone|eszopiclone|mesh-list
92380626|NCT05349396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92380627|NCT05349396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380628|NCT05349396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380629|NCT05348148|Mometasone Furoate|mometasone furoate|mesh-list
92380630|NCT05348148|Cetirizine|cetirizine|mesh-list
92380631|NCT05348148|Phenylephrine|phenylephrine|mesh-list
92380632|NCT05348148|Oxymetazoline|oxymetazoline|mesh-list
92380633|NCT05348148|Levocetirizine|levocetirizine|mesh-list
92380634|NCT05348148|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380635|NCT05348148|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380636|NCT05348148|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92380637|NCT05348148|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92380638|NCT05348148|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92380639|NCT05348148|Histamine Antagonists|histamine antagonists|mesh-ancestor
92380641|NCT05348148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380642|NCT05348148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380643|NCT05348148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380644|NCT05348148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92380645|NCT05348148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92380646|NCT05348148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92380647|NCT05348148|Sympathomimetics|sympathomimetics|mesh-ancestor
92380648|NCT05348148|Autonomic Agents|autonomic agents|mesh-ancestor
92380649|NCT05348148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380650|NCT05348148|Nasal Decongestants|nasal decongestants|mesh-ancestor
92380651|NCT05348148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92380652|NCT05348148|Respiratory System Agents|respiratory system agents|mesh-ancestor
92380653|NCT05348148|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92380655|NCT05348148|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92380656|NCT05348148|Protective Agents|protective agents|mesh-ancestor
92380657|NCT05456022|Doxorubicin|doxorubicin|mesh-list
92380658|NCT05456022|Quercetin|quercetin|mesh-list
92380659|NCT05456022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92380660|NCT05456022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380661|NCT05456022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92380662|NCT05456022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92380663|NCT05456022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380664|NCT05456022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380665|NCT05456022|Antioxidants|antioxidants|mesh-ancestor
92380666|NCT05456022|Protective Agents|protective agents|mesh-ancestor
92380667|NCT05456022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380668|NCT05453916|Rifaximin|rifaximin|mesh-list
92380669|NCT05453916|Nitazoxanide|nitazoxanide|mesh-list
92380670|NCT05453916|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92380671|NCT05453916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380672|NCT05453916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380673|NCT05453916|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92380674|NCT05273814|Bevacizumab|bevacizumab|mesh-list
92380675|NCT05273814|Tislelizumab|tislelizumab|mesh-list
92380676|NCT05273814|Pemetrexed|pemetrexed|mesh-list
92380677|NCT05273814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92380678|NCT05273814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380679|NCT05273814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380680|NCT05273814|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92380681|NCT05273814|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92380682|NCT05273814|Growth Substances|growth substances|mesh-ancestor
92380683|NCT05273814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380684|NCT05273814|Growth Inhibitors|growth inhibitors|mesh-ancestor
92380685|NCT05273814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380686|NCT05273814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380687|NCT05273814|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92380688|NCT05273814|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92380689|NCT04800510|Carbon Fiber|carbon fiber|mesh-list
92380690|NCT04800510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92380691|NCT04800510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380692|NCT04784208|Hormones|hormones|mesh-list
92115532|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380693|NCT04784208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380694|NCT04784208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380695|NCT04024878|Nivolumab|nivolumab|mesh-list
92380696|NCT04024878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380697|NCT04024878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380698|NCT04024878|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92380699|NCT04024878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380700|NCT03004248|Botulinum Toxins|botulinum toxins|mesh-list
92380701|NCT03004248|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92380702|NCT03004248|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92380703|NCT03004248|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92380704|NCT03004248|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380705|NCT03004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380706|NCT03004248|Cholinergic Agents|cholinergic agents|mesh-ancestor
92380707|NCT03004248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380708|NCT03004248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380709|NCT03004248|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92380710|NCT03004248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380711|NCT02529930|Vaccines|vaccines|mesh-list
92380713|NCT02529930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380714|NCT00039780|2,2'-dithiodiethanesulfonic acid|2,2'-dithiodiethanesulfonic acid|mesh-list
92380715|NCT00039780|Protective Agents|protective agents|mesh-ancestor
92380716|NCT00039780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380717|NCT04763226|Furosemide|furosemide|mesh-list
92380718|NCT04763226|Diuretics|diuretics|mesh-ancestor
92380719|NCT04763226|Natriuretic Agents|natriuretic agents|mesh-ancestor
92380720|NCT04763226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380721|NCT04763226|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92380722|NCT04763226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380723|NCT04763226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380725|NCT04549428|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92380726|NCT04549428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952060|NCT03447925|Petrolatum|petrolatum|mesh-list
92380727|NCT04549428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380728|NCT04549428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380729|NCT04340856|Bisacodyl|bisacodyl|mesh-list
92380730|NCT04340856|Laxatives|laxatives|mesh-list
92380731|NCT04340856|Cathartics|cathartics|mesh-ancestor
92380732|NCT04340856|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380733|NCT04040790|Phenylephrine|phenylephrine|mesh-list
92380734|NCT04040790|Oxymetazoline|oxymetazoline|mesh-list
92380735|NCT04040790|Tropicamide|tropicamide|mesh-list
92380736|NCT04040790|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92380737|NCT04040790|Mydriatics|mydriatics|mesh-ancestor
92380738|NCT04040790|Autonomic Agents|autonomic agents|mesh-ancestor
92380739|NCT04040790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380740|NCT04040790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380741|NCT04040790|Sympathomimetics|sympathomimetics|mesh-ancestor
92380742|NCT04040790|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92380743|NCT04040790|Nasal Decongestants|nasal decongestants|mesh-ancestor
92380744|NCT04040790|Respiratory System Agents|respiratory system agents|mesh-ancestor
92380745|NCT04040790|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92380746|NCT04040790|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92380747|NCT04040790|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91952357|NCT03130517|Antibodies|antibodies|mesh-list
92380748|NCT04040790|Adrenergic Agents|adrenergic agents|mesh-ancestor
92380749|NCT04040790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380750|NCT04040790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380751|NCT04040790|Protective Agents|protective agents|mesh-ancestor
92380752|NCT04040790|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92380753|NCT04040790|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92380754|NCT04040790|Cholinergic Agents|cholinergic agents|mesh-ancestor
92380755|NCT03556800|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92380756|NCT03556800|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92380757|NCT03556800|Estradiol|estradiol|mesh-list
92380758|NCT03556800|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92380759|NCT03556800|Estrogens|estrogens|mesh-ancestor
92380760|NCT03556800|Hormones|hormones|mesh-ancestor
92380761|NCT03556800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380762|NCT03556800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380763|NCT03556800|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92380764|NCT03556800|Contraceptive Agents|contraceptive agents|mesh-ancestor
92380765|NCT03556800|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92380766|NCT03556800|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92380767|NCT04741620|Cinnamaldehyde|cinnamaldehyde|mesh-list
92380768|NCT04741620|Capsaicin|capsaicin|mesh-list
92380769|NCT04741620|Sodium Citrate|sodium citrate|mesh-list
92380770|NCT04741620|Citric Acid|citric acid|mesh-list
92380771|NCT04741620|Piperine|piperine|mesh-list
92380772|NCT04741620|Antipruritics|antipruritics|mesh-ancestor
92380773|NCT04741620|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380774|NCT04741620|Sensory System Agents|sensory system agents|mesh-ancestor
92380775|NCT04741620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380776|NCT04741620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380777|NCT04741620|Anticoagulants|anticoagulants|mesh-ancestor
92380778|NCT04741620|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92380780|NCT04741620|Sequestering Agents|sequestering agents|mesh-ancestor
92380781|NCT04741620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380782|NCT04741620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92380783|NCT04741620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380784|NCT04741620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92380785|NCT04741620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380786|NCT04741620|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92380787|NCT04741620|Protective Agents|protective agents|mesh-ancestor
92380788|NCT01785420|Trastuzumab|trastuzumab|mesh-list
92380789|NCT01785420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380790|NCT01785420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380791|NCT00800514|Amantadine|amantadine|mesh-list
92380792|NCT00800514|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92380793|NCT00800514|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92380794|NCT00800514|Antiviral Agents|antiviral agents|mesh-ancestor
92380795|NCT00800514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380796|NCT00800514|Dopamine Agents|dopamine agents|mesh-ancestor
92380797|NCT00800514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380798|NCT00800514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380799|NCT00800514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380800|NCT00800514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92380801|NCT00800514|Analgesics|analgesics|mesh-ancestor
92380802|NCT00800514|Sensory System Agents|sensory system agents|mesh-ancestor
92380803|NCT00800514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380804|NCT02780622|Oseltamivir|oseltamivir|mesh-list
92380805|NCT02780622|Warfarin|warfarin|mesh-list
92380806|NCT02780622|Anticoagulants|anticoagulants|mesh-ancestor
92380807|NCT02780622|Antiviral Agents|antiviral agents|mesh-ancestor
92380808|NCT02780622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380809|NCT02780622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380810|NCT02780622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380811|NCT02791308|Pimecrolimus|pimecrolimus|mesh-list
92380812|NCT02791308|Tacrolimus|tacrolimus|mesh-list
92380813|NCT02791308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92380814|NCT02791308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92380815|NCT02791308|Analgesics|analgesics|mesh-ancestor
92380816|NCT02791308|Sensory System Agents|sensory system agents|mesh-ancestor
92380817|NCT02791308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380818|NCT02791308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380819|NCT02791308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380820|NCT02791308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92380821|NCT02791308|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380822|NCT02791308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380823|NCT02791308|Immunologic Factors|immunologic factors|mesh-ancestor
92380824|NCT02791308|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92380825|NCT02791308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380826|NCT02791308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380827|NCT02796144|Metformin|metformin|mesh-list
92380828|NCT02796144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92380829|NCT02796144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380830|NCT02801370|Ciprofloxacin|ciprofloxacin|mesh-list
92380831|NCT02801370|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92380832|NCT02801370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380833|NCT02801370|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92380834|NCT02801370|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92380835|NCT02801370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380836|NCT02801370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380837|NCT02801370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380838|NCT02801370|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92380839|NCT02801370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92380840|NCT02813070|Flutemetamol|flutemetamol|mesh-list
92380841|NCT02813070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92380842|NCT02813070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380843|NCT02815644|Empagliflozin|empagliflozin|mesh-list
92380844|NCT02815644|Linagliptin|linagliptin|mesh-list
92380845|NCT02815644|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92380846|NCT02815644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380847|NCT02815644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92380848|NCT02815644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380849|NCT02815644|Incretins|incretins|mesh-ancestor
92380850|NCT02815644|Hormones|hormones|mesh-ancestor
92380851|NCT02815644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033369|NCT04881799|Topiramate|topiramate|mesh-list
92380852|NCT02815644|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92380853|NCT02815644|Protease Inhibitors|protease inhibitors|mesh-ancestor
92380854|NCT02815644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380855|NCT02820324|Morphine|morphine|mesh-list
92380856|NCT02820324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92380857|NCT02820324|Narcotics|narcotics|mesh-ancestor
92380858|NCT02820324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380859|NCT02820324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380860|NCT02820324|Analgesics|analgesics|mesh-ancestor
92380861|NCT02820324|Sensory System Agents|sensory system agents|mesh-ancestor
92380862|NCT02820324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380863|NCT02821338|Lamotrigine|lamotrigine|mesh-list
92380864|NCT02821338|Anticonvulsants|anticonvulsants|mesh-ancestor
92380865|NCT02821338|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92380866|NCT02821338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92380867|NCT02821338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380868|NCT02821338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92380869|NCT02821338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380870|NCT02821338|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92380871|NCT02821338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92380872|NCT02821338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380873|NCT02821338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92380874|NCT02821338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92380875|NCT02835846|Estrogens|estrogens|mesh-list
92380876|NCT02835846|Hormones|hormones|mesh-ancestor
92380877|NCT02835846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380878|NCT02835846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380879|NCT02844582|Prednisone|prednisone|mesh-list
92380880|NCT02844582|Cortisone|cortisone|mesh-list
92380881|NCT02844582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380882|NCT02844582|Glucocorticoids|glucocorticoids|mesh-ancestor
92380883|NCT02844582|Hormones|hormones|mesh-ancestor
92380884|NCT02844582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380885|NCT02844582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380886|NCT02844582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92380887|NCT02844582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380888|NCT02845752|Bromides|bromides|mesh-list
92380889|NCT02845752|Tiotropium Bromide|tiotropium bromide|mesh-list
92380890|NCT02845752|Olodaterol|olodaterol|mesh-list
92380891|NCT02845752|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92380892|NCT02845752|Autonomic Agents|autonomic agents|mesh-ancestor
92380893|NCT02845752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380894|NCT02845752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380895|NCT02845752|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92380896|NCT02845752|Respiratory System Agents|respiratory system agents|mesh-ancestor
92380897|NCT02845752|Parasympatholytics|parasympatholytics|mesh-ancestor
92380898|NCT02845752|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92380899|NCT02845752|Cholinergic Agents|cholinergic agents|mesh-ancestor
92380900|NCT02845752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380901|NCT02845752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380902|NCT02845752|Anticonvulsants|anticonvulsants|mesh-ancestor
92380903|NCT02849184|Suvorexant|suvorexant|mesh-list
92380904|NCT02849184|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92380905|NCT02849184|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92380906|NCT02849184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380907|NCT02849184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380908|NCT02849184|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92380909|NCT02849184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92380910|NCT02849184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380911|NCT02862912|Fentanyl|fentanyl|mesh-list
92380912|NCT02862912|Bupivacaine|bupivacaine|mesh-list
92380913|NCT02862912|Chloroprocaine|chloroprocaine|mesh-list
92380914|NCT02862912|Anesthetics, Local|anesthetics, local|mesh-ancestor
92380915|NCT02862912|Anesthetics|anesthetics|mesh-ancestor
92380916|NCT02862912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92380917|NCT02862912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380918|NCT02862912|Sensory System Agents|sensory system agents|mesh-ancestor
92380919|NCT02862912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380920|NCT02862912|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92380921|NCT02862912|Narcotics|narcotics|mesh-ancestor
92380922|NCT02862912|Analgesics|analgesics|mesh-ancestor
92380923|NCT02862912|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92380924|NCT02862912|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92380925|NCT02862912|Anesthetics, General|anesthetics, general|mesh-ancestor
92033416|NCT05220293|Hormones|hormones|mesh-ancestor
92380926|NCT02864706|Cyclosporine|cyclosporine|mesh-list
92380927|NCT02864706|Mycophenolic Acid|mycophenolic acid|mesh-list
92380928|NCT02864706|Everolimus|everolimus|mesh-list
92380929|NCT02864706|Cyclosporins|cyclosporins|mesh-list
92380930|NCT02864706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380931|NCT02864706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380932|NCT02864706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380933|NCT02864706|Immunologic Factors|immunologic factors|mesh-ancestor
92380934|NCT02864706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380935|NCT02864706|Antifungal Agents|antifungal agents|mesh-ancestor
92380936|NCT02864706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380937|NCT02864706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380938|NCT02864706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92380939|NCT02864706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92380940|NCT02864706|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92380941|NCT02864706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92380942|NCT02864706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92380943|NCT02864706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92380944|NCT02864706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92380945|NCT02864706|Antitubercular Agents|antitubercular agents|mesh-ancestor
92380946|NCT02864706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92380947|NCT02865720|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92380948|NCT02865720|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92380949|NCT02865720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380950|NCT02865720|Immunologic Factors|immunologic factors|mesh-ancestor
92380951|NCT02865720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380952|NCT02867202|Contraceptive Agents|contraceptive agents|mesh-list
92380953|NCT02867202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92380954|NCT02867202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115101|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380955|NCT02873286|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92380956|NCT02873286|Antiviral Agents|antiviral agents|mesh-ancestor
92380957|NCT02873286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92380958|NCT02874846|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92380959|NCT02874846|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92380960|NCT02880228|Dexamethasone|dexamethasone|mesh-list
92380961|NCT02880228|Dexamethasone acetate|dexamethasone acetate|mesh-list
92380962|NCT02880228|Pembrolizumab|pembrolizumab|mesh-list
92380963|NCT02880228|Lenalidomide|lenalidomide|mesh-list
92380964|NCT02880228|Ichthammol|ichthammol|mesh-list
92380965|NCT02880228|BB 1101|bb 1101|mesh-list
92380966|NCT02880228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92380967|NCT02880228|Antiemetics|antiemetics|mesh-ancestor
92380968|NCT02880228|Autonomic Agents|autonomic agents|mesh-ancestor
92380969|NCT02880228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380970|NCT02880228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380971|NCT02880228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92380972|NCT02880228|Glucocorticoids|glucocorticoids|mesh-ancestor
92380973|NCT02880228|Hormones|hormones|mesh-ancestor
92380974|NCT02880228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92380975|NCT02880228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92380976|NCT02880228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937783|NCT04803591|Coagulants|coagulants|mesh-ancestor
92380977|NCT02880228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92380978|NCT02880228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92380979|NCT02880228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92380980|NCT02880228|Immunologic Factors|immunologic factors|mesh-ancestor
92380981|NCT02880228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92380982|NCT02880228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92380983|NCT02880228|Growth Substances|growth substances|mesh-ancestor
92380984|NCT02880228|Growth Inhibitors|growth inhibitors|mesh-ancestor
92380985|NCT02880228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92380986|NCT02880228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92380987|NCT02880228|Dermatologic Agents|dermatologic agents|mesh-ancestor
92380988|NCT02880852|Belimumab|belimumab|mesh-list
92380989|NCT02880852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92380990|NCT02880852|Immunologic Factors|immunologic factors|mesh-ancestor
92380991|NCT02880852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380992|NCT02887404|Analgesics|analgesics|mesh-list
92380993|NCT02887404|Sensory System Agents|sensory system agents|mesh-ancestor
92380994|NCT02887404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92380995|NCT02887404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380996|NCT02889510|Liraglutide|liraglutide|mesh-list
92380997|NCT02889510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92380998|NCT02889510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92380999|NCT02889510|Incretins|incretins|mesh-ancestor
92381000|NCT02889510|Hormones|hormones|mesh-ancestor
92381001|NCT02889510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381002|NCT02902770|Ketorolac|ketorolac|mesh-list
92381004|NCT02902770|Lidocaine|lidocaine|mesh-list
92381005|NCT02902770|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381006|NCT02902770|Anesthetics|anesthetics|mesh-ancestor
92381007|NCT02902770|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381008|NCT02902770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381009|NCT02902770|Sensory System Agents|sensory system agents|mesh-ancestor
92381010|NCT02902770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381011|NCT02902770|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92381012|NCT02902770|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92381013|NCT02902770|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92381014|NCT02902770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381015|NCT02902770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381016|NCT02902770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92381017|NCT02902770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381018|NCT02902770|Analgesics|analgesics|mesh-ancestor
92381019|NCT02902770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381020|NCT02902770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381021|NCT02902770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92381022|NCT02902770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381023|NCT02907918|Trastuzumab|trastuzumab|mesh-list
92381024|NCT02907918|Letrozole|letrozole|mesh-list
92381025|NCT02907918|Palbociclib|palbociclib|mesh-list
92381026|NCT02907918|Goserelin|goserelin|mesh-list
92381027|NCT02907918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92381028|NCT02907918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381029|NCT02907918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92381030|NCT02907918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92381031|NCT02907918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115102|NCT01530009|Amoxicillin|amoxicillin|mesh-list
92381032|NCT02907918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381033|NCT02907918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92381034|NCT02907918|Hormone Antagonists|hormone antagonists|mesh-ancestor
92381035|NCT02907918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381036|NCT02907918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381037|NCT02907918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92381038|NCT02907918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92381039|NCT02908620|Anesthetics|anesthetics|mesh-list
92381040|NCT02908620|Tetracaine|tetracaine|mesh-list
92381041|NCT02908620|Benzocaine|benzocaine|mesh-list
92381042|NCT02908620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381043|NCT02908620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381044|NCT02908620|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381045|NCT02908620|Sensory System Agents|sensory system agents|mesh-ancestor
92381046|NCT02908620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381047|NCT02911818|Liraglutide|liraglutide|mesh-list
92381048|NCT02911818|Phentermine|phentermine|mesh-list
92381049|NCT02911818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92381050|NCT02911818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381051|NCT02911818|Incretins|incretins|mesh-ancestor
92381052|NCT02911818|Hormones|hormones|mesh-ancestor
92381053|NCT02911818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381054|NCT02911818|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92381055|NCT02911818|Appetite Depressants|appetite depressants|mesh-ancestor
92381056|NCT02911818|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92381057|NCT02911818|Sympathomimetics|sympathomimetics|mesh-ancestor
92381058|NCT02911818|Autonomic Agents|autonomic agents|mesh-ancestor
92381059|NCT02911818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381060|NCT02911818|Adrenergic Agents|adrenergic agents|mesh-ancestor
92381061|NCT02911818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381062|NCT02911818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381063|NCT02912364|Carbamazepine|carbamazepine|mesh-list
92381064|NCT02912364|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92381065|NCT02912364|Anticonvulsants|anticonvulsants|mesh-ancestor
92381066|NCT02912364|Antimanic Agents|antimanic agents|mesh-ancestor
92381067|NCT02912364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92381068|NCT02912364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381069|NCT02912364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381070|NCT02912364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92381071|NCT02912364|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381072|NCT02912364|Analgesics|analgesics|mesh-ancestor
92381073|NCT02912364|Sensory System Agents|sensory system agents|mesh-ancestor
92381074|NCT02912364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381075|NCT02912364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92381076|NCT02912364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381077|NCT02912364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381078|NCT02912364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92381079|NCT02912364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92125027|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
92381080|NCT02912364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92381082|NCT02913924|Anticonvulsants|anticonvulsants|mesh-ancestor
92381083|NCT02913924|GABA Modulators|gaba modulators|mesh-ancestor
92381084|NCT02913924|GABA Agents|gaba agents|mesh-ancestor
92381085|NCT02913924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381086|NCT02913924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381087|NCT02913924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381088|NCT02917122|Sertraline|sertraline|mesh-list
92381089|NCT02917122|Antidepressive Agents|antidepressive agents|mesh-ancestor
92381090|NCT02917122|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92381091|NCT02917122|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92381092|NCT02917122|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92381093|NCT02917122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381094|NCT02917122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381095|NCT02917122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381096|NCT02917122|Serotonin Agents|serotonin agents|mesh-ancestor
92381097|NCT02917122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381098|NCT02922582|Tranexamic Acid|tranexamic acid|mesh-list
92381099|NCT02922582|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92381100|NCT02922582|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92381101|NCT02922582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381102|NCT02922582|Hemostatics|hemostatics|mesh-ancestor
92381103|NCT02922582|Coagulants|coagulants|mesh-ancestor
92381104|NCT02925858|Ketamine|ketamine|mesh-list
92381105|NCT02925858|Analgesics|analgesics|mesh-ancestor
92381106|NCT02925858|Sensory System Agents|sensory system agents|mesh-ancestor
92381107|NCT02925858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381108|NCT02925858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381109|NCT02925858|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92381110|NCT02925858|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381111|NCT02925858|Anesthetics, General|anesthetics, general|mesh-ancestor
92381112|NCT02925858|Anesthetics|anesthetics|mesh-ancestor
92381113|NCT02925858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381114|NCT02925858|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92381115|NCT02925858|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92381116|NCT02925858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381117|NCT02925858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381118|NCT02933034|Manganese|manganese|mesh-list
92381119|NCT02933034|Trace Elements|trace elements|mesh-ancestor
92381120|NCT02933034|Micronutrients|micronutrients|mesh-ancestor
92381121|NCT02933034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381122|NCT02937168|Reslizumab|reslizumab|mesh-list
92381123|NCT02937168|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92381124|NCT02937168|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92381125|NCT02937168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381126|NCT02937168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92381127|NCT02937168|Respiratory System Agents|respiratory system agents|mesh-ancestor
92381129|NCT02937558|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92381130|NCT02937558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381131|NCT02937558|Hormones|hormones|mesh-ancestor
92381132|NCT02937558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381133|NCT02937558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954468|NCT03436303|Hormones|hormones|mesh-ancestor
92381134|NCT02937558|Incretins|incretins|mesh-ancestor
92381135|NCT02938494|Tazarotene|tazarotene|mesh-list
92381136|NCT02938494|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381137|NCT02938494|Keratolytic Agents|keratolytic agents|mesh-ancestor
92381138|NCT02941692|Oxytocin|oxytocin|mesh-list
92381139|NCT02941692|Oxytocics|oxytocics|mesh-ancestor
92381140|NCT02941692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92381141|NCT02941692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381143|NCT02953860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92381144|NCT02953860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381145|NCT02953860|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92381146|NCT02953860|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92381147|NCT02953860|Hormone Antagonists|hormone antagonists|mesh-ancestor
92381148|NCT02953860|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381149|NCT02953860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381150|NCT02956044|Metformin|metformin|mesh-list
92381152|NCT02956044|Glimepiride|glimepiride|mesh-list
92381153|NCT02956044|Bexagliflozin|bexagliflozin|mesh-list
92381154|NCT02956044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92381155|NCT02956044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381156|NCT02956044|Incretins|incretins|mesh-ancestor
92381157|NCT02956044|Hormones|hormones|mesh-ancestor
92381158|NCT02956044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381159|NCT02956044|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92381160|NCT02956044|Protease Inhibitors|protease inhibitors|mesh-ancestor
92381161|NCT02956044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381162|NCT02956044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381163|NCT02956044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92381164|NCT02956044|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91954697|NCT03422887|Flurbiprofen|flurbiprofen|mesh-list
92381165|NCT02956044|Immunologic Factors|immunologic factors|mesh-ancestor
92381166|NCT02956122|Methylprednisolone|methylprednisolone|mesh-list
92381167|NCT02956122|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92381168|NCT02956122|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92381169|NCT02956122|Prednisolone|prednisolone|mesh-list
92381170|NCT02956122|Prednisolone acetate|prednisolone acetate|mesh-list
92381171|NCT02956122|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92381172|NCT02956122|Prednisolone phosphate|prednisolone phosphate|mesh-list
92381173|NCT02956122|Protease Inhibitors|protease inhibitors|mesh-list
92381174|NCT02956122|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
91954786|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
92381175|NCT02956122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381176|NCT02956122|Antiemetics|antiemetics|mesh-ancestor
92381177|NCT02956122|Autonomic Agents|autonomic agents|mesh-ancestor
92381178|NCT02956122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381179|NCT02956122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381180|NCT02956122|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381181|NCT02956122|Glucocorticoids|glucocorticoids|mesh-ancestor
92381182|NCT02956122|Hormones|hormones|mesh-ancestor
92381183|NCT02956122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381184|NCT02956122|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92381185|NCT02956122|Protective Agents|protective agents|mesh-ancestor
92381186|NCT02956122|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92381187|NCT02956122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381188|NCT02956122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381189|NCT02956122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381190|NCT02956122|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92381191|NCT02956122|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92381192|NCT02956746|Immunoglobulins|immunoglobulins|mesh-list
92381193|NCT02956746|Antibodies|antibodies|mesh-list
92381194|NCT02956746|gamma-Globulins|gamma-globulins|mesh-list
92381195|NCT02956746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92381196|NCT02956746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92381197|NCT02956746|Immunologic Factors|immunologic factors|mesh-ancestor
92381198|NCT02956746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381199|NCT02967354|Tryptophan|tryptophan|mesh-list
92381200|NCT02967354|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
92381201|NCT02967354|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92381202|NCT02967354|Antidepressive Agents|antidepressive agents|mesh-ancestor
92381203|NCT02967354|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92381204|NCT02968134|Posaconazole|posaconazole|mesh-list
92381205|NCT02968134|Antifungal Agents|antifungal agents|mesh-ancestor
92381206|NCT02968134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381207|NCT02968134|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92381208|NCT02968134|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92381209|NCT02968134|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92381210|NCT02968134|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92381211|NCT02968134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92381212|NCT02968134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381213|NCT02968134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381214|NCT02968134|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92381215|NCT02968134|Hormone Antagonists|hormone antagonists|mesh-ancestor
92381216|NCT02968134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381217|NCT02968134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381218|NCT02968368|Ferric maltol|ferric maltol|mesh-list
92381219|NCT02968368|Hematinics|hematinics|mesh-ancestor
92381220|NCT02968914|Benralizumab|benralizumab|mesh-list
92381221|NCT02968914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92381222|NCT02968914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92381223|NCT02970162|Amifampridine|amifampridine|mesh-list
92381224|NCT02970162|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92381225|NCT02970162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381226|NCT02970162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381227|NCT02970162|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92381228|NCT02970162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381229|NCT02970162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381231|NCT02970552|Progestins|progestins|mesh-ancestor
92381232|NCT02970552|Hormones|hormones|mesh-ancestor
92381233|NCT02970552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381234|NCT02970552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381235|NCT02978508|Permethrin|permethrin|mesh-list
92381236|NCT02978508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115103|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381237|NCT02978508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381238|NCT02881008|Entecavir|entecavir|mesh-list
92381239|NCT02881008|Antiviral Agents|antiviral agents|mesh-ancestor
92381240|NCT02881008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381241|NCT02988882|Dexamethasone|dexamethasone|mesh-list
92381242|NCT02988882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381243|NCT02988882|Antiemetics|antiemetics|mesh-ancestor
92381244|NCT02988882|Autonomic Agents|autonomic agents|mesh-ancestor
92381245|NCT02988882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381246|NCT02988882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381247|NCT02988882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381248|NCT02988882|Glucocorticoids|glucocorticoids|mesh-ancestor
92381249|NCT02988882|Hormones|hormones|mesh-ancestor
92381250|NCT02988882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381251|NCT02988882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92381252|NCT02988882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381253|NCT03002454|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
91955364|NCT03413371|Analgesics|analgesics|mesh-ancestor
92381254|NCT03002454|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92381255|NCT03002454|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92381256|NCT03002454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381257|NCT03009162|Lasmiditan|lasmiditan|mesh-list
92381258|NCT03009162|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92381259|NCT03009162|Serotonin Agents|serotonin agents|mesh-ancestor
92381260|NCT03009162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381261|NCT03009162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381262|NCT03009162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381263|NCT03009396|Clarithromycin|clarithromycin|mesh-list
92381264|NCT03009396|Rifabutin|rifabutin|mesh-list
92381265|NCT03009396|Clofazimine|clofazimine|mesh-list
92381266|NCT03009396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381267|NCT03009396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381268|NCT03009396|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92381269|NCT03009396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381270|NCT03009396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125103|NCT04440696|Chelating Agents|chelating agents|mesh-ancestor
92381271|NCT03009396|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92381272|NCT03009396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92381273|NCT03009396|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92381274|NCT03009396|Antitubercular Agents|antitubercular agents|mesh-ancestor
92381275|NCT03009396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381276|NCT03009396|Leprostatic Agents|leprostatic agents|mesh-ancestor
92381277|NCT03012594|Lanreotide|lanreotide|mesh-list
92381278|NCT03012594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381279|NCT03017508|Riluzole|riluzole|mesh-list
92381280|NCT03017508|Anticonvulsants|anticonvulsants|mesh-ancestor
92381281|NCT03017508|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92381282|NCT03017508|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92381283|NCT03017508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381284|NCT03017508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381285|NCT03017508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381286|NCT03017508|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92381287|NCT03017508|Protective Agents|protective agents|mesh-ancestor
92381288|NCT03020004|Ritonavir|ritonavir|mesh-list
92381289|NCT03020004|Ribavirin|ribavirin|mesh-list
92381290|NCT03020004|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92381291|NCT03020004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92381292|NCT03020004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92381293|NCT03020004|Protease Inhibitors|protease inhibitors|mesh-ancestor
92381294|NCT03020004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125104|NCT04440696|Sequestering Agents|sequestering agents|mesh-ancestor
92381295|NCT03020004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381296|NCT03020004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92381297|NCT03020004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92381298|NCT03020004|Antiviral Agents|antiviral agents|mesh-ancestor
92381299|NCT03020004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381300|NCT03020004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92381301|NCT03020004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92381302|NCT03020004|Antimetabolites|antimetabolites|mesh-ancestor
92381304|NCT03020082|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92381305|NCT03020082|Ribavirin|ribavirin|mesh-list
92381306|NCT03020082|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92381307|NCT03020082|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92381308|NCT03020082|Protease Inhibitors|protease inhibitors|mesh-ancestor
92381309|NCT03020082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381310|NCT03020082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381311|NCT03020082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92381312|NCT03020082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92381313|NCT03020082|Antiviral Agents|antiviral agents|mesh-ancestor
92381314|NCT03020082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381315|NCT03020082|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92381316|NCT03020082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92381317|NCT03020082|Antimetabolites|antimetabolites|mesh-ancestor
92381318|NCT03026556|Rivaroxaban|rivaroxaban|mesh-list
92381319|NCT03026556|Apixaban|apixaban|mesh-list
92381320|NCT03026556|Dabigatran|dabigatran|mesh-list
92381321|NCT03026556|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92381322|NCT03026556|Antithrombins|antithrombins|mesh-ancestor
92381323|NCT03026556|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92381324|NCT03026556|Protease Inhibitors|protease inhibitors|mesh-ancestor
91955793|NCT05228925|Vitamin D|vitamin d|mesh-list
92381325|NCT03026556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381326|NCT03026556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381327|NCT03026556|Anticoagulants|anticoagulants|mesh-ancestor
92381328|NCT03035760|Oxfendazole|oxfendazole|mesh-list
92381329|NCT03035760|Anthelmintics|anthelmintics|mesh-ancestor
92381330|NCT03035760|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92381331|NCT03035760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381332|NCT03035760|Antinematodal Agents|antinematodal agents|mesh-ancestor
92381333|NCT03036384|Sufentanil|sufentanil|mesh-list
92381334|NCT03036384|Morphine|morphine|mesh-list
92381335|NCT03036384|Prilocaine|prilocaine|mesh-list
92381336|NCT03036384|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92381337|NCT03036384|Narcotics|narcotics|mesh-ancestor
92381338|NCT03036384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381339|NCT03036384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381340|NCT03036384|Analgesics|analgesics|mesh-ancestor
92381341|NCT03036384|Sensory System Agents|sensory system agents|mesh-ancestor
92381342|NCT03036384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381343|NCT03036384|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92381344|NCT03036384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381345|NCT03036384|Anesthetics, General|anesthetics, general|mesh-ancestor
92381346|NCT03036384|Anesthetics|anesthetics|mesh-ancestor
92381347|NCT03036384|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381348|NCT03040362|Lasmiditan|lasmiditan|mesh-list
92381349|NCT03040362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92381350|NCT03040362|Serotonin Agents|serotonin agents|mesh-ancestor
92381351|NCT03040362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381352|NCT03040362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381353|NCT03040362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381354|NCT03041298|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92381356|NCT03041298|Sequestering Agents|sequestering agents|mesh-ancestor
92381357|NCT03041298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381358|NCT03044418|Propofol|propofol|mesh-list
92381359|NCT03044418|Anesthetics|anesthetics|mesh-ancestor
92381360|NCT03044418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381361|NCT03044418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381362|NCT03044418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92381363|NCT03044418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381364|NCT03044418|Anesthetics, General|anesthetics, general|mesh-ancestor
92381365|NCT03048006|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
91956218|NCT03393325|Tadalafil|tadalafil|mesh-list
92381366|NCT03048006|Chelating Agents|chelating agents|mesh-ancestor
91944716|NCT03475459|Melatonin|melatonin|mesh-list
92381367|NCT03048006|Sequestering Agents|sequestering agents|mesh-ancestor
92381368|NCT03048006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381370|NCT03051672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92381371|NCT03051672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381372|NCT03051672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92381373|NCT03051672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381374|NCT03057132|Protective Agents|protective agents|mesh-list
92381375|NCT03057132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381376|NCT03057366|Paclitaxel|paclitaxel|mesh-list
92381377|NCT03057366|Docetaxel|docetaxel|mesh-list
92381378|NCT03057366|Carboplatin|carboplatin|mesh-list
92381379|NCT03057366|Pevonedistat|pevonedistat|mesh-list
92381380|NCT03057366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92381381|NCT03057366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381382|NCT03057366|Tubulin Modulators|tubulin modulators|mesh-ancestor
92381383|NCT03057366|Antimitotic Agents|antimitotic agents|mesh-ancestor
92381384|NCT03057366|Mitosis Modulators|mitosis modulators|mesh-ancestor
92381385|NCT03057366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381386|NCT03057366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381387|NCT03060486|Hybenx|hybenx|mesh-list
92381388|NCT03060486|Dental Disinfectants|dental disinfectants|mesh-ancestor
92381389|NCT03060486|Disinfectants|disinfectants|mesh-ancestor
92381390|NCT03060486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381391|NCT03061812|Dexamethasone|dexamethasone|mesh-list
92381392|NCT03061812|Topotecan|topotecan|mesh-list
92381393|NCT03061812|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92381394|NCT03061812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381395|NCT03061812|Antiemetics|antiemetics|mesh-ancestor
92381396|NCT03061812|Autonomic Agents|autonomic agents|mesh-ancestor
92381397|NCT03061812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381398|NCT03061812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381399|NCT03061812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381400|NCT03061812|Glucocorticoids|glucocorticoids|mesh-ancestor
92381401|NCT03061812|Hormones|hormones|mesh-ancestor
92381402|NCT03061812|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381403|NCT03061812|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92381404|NCT03061812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381405|NCT03061812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92381406|NCT03061812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92381407|NCT03061812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381408|NCT03061812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381409|NCT03061812|Immunoconjugates|immunoconjugates|mesh-ancestor
92381410|NCT03061812|Immunologic Factors|immunologic factors|mesh-ancestor
92381411|NCT03070470|Ritonavir|ritonavir|mesh-list
92381412|NCT03070470|Lopinavir|lopinavir|mesh-list
92381413|NCT03070470|Chloroquine|chloroquine|mesh-list
92381414|NCT03070470|Verapamil|verapamil|mesh-list
92381415|NCT03070470|Dofetilide|dofetilide|mesh-list
92381416|NCT03070470|Diltiazem|diltiazem|mesh-list
92381417|NCT03070470|Ranolazine|ranolazine|mesh-list
92381418|NCT03070470|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92381419|NCT03070470|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92381420|NCT03070470|Protease Inhibitors|protease inhibitors|mesh-ancestor
92381421|NCT03070470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937791|NCT05536856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381422|NCT03070470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381423|NCT03070470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92381424|NCT03070470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92381425|NCT03070470|Antiviral Agents|antiviral agents|mesh-ancestor
92381426|NCT03070470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381427|NCT03070470|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92381428|NCT03070470|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92381429|NCT03070470|Amebicides|amebicides|mesh-ancestor
92381430|NCT03070470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92381431|NCT03070470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92381432|NCT03070470|Antimalarials|antimalarials|mesh-ancestor
92381433|NCT03070470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381434|NCT03070470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381435|NCT03070470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92381436|NCT03070470|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91956651|NCT03395093|Fentanyl|fentanyl|mesh-list
92381437|NCT03070470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381438|NCT03070470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92381439|NCT03070470|Vasodilator Agents|vasodilator agents|mesh-ancestor
92381440|NCT03070470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92381441|NCT03070470|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92381442|NCT03070470|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92381443|NCT03070548|Talazoparib|talazoparib|mesh-list
92381444|NCT03070548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92381445|NCT03070548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381446|NCT03070548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381447|NCT03070548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381448|NCT03080142|Bupivacaine|bupivacaine|mesh-list
92381449|NCT03080142|Ropivacaine|ropivacaine|mesh-list
91956742|NCT03398759|Analgesics|analgesics|mesh-ancestor
92381450|NCT03080142|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381451|NCT03080142|Anesthetics|anesthetics|mesh-ancestor
92381452|NCT03080142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381453|NCT03080142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381454|NCT03080142|Sensory System Agents|sensory system agents|mesh-ancestor
92381455|NCT03080142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381457|NCT03088800|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92381458|NCT03088800|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381459|NCT03088800|Analgesics|analgesics|mesh-ancestor
92381460|NCT03088800|Sensory System Agents|sensory system agents|mesh-ancestor
92381461|NCT03088800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381462|NCT03088800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381463|NCT03088800|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381464|NCT03088800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381465|NCT03088800|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92381466|NCT03088800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381467|NCT03088800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381468|NCT03096444|Lidocaine|lidocaine|mesh-list
92381469|NCT03096444|Ketamine|ketamine|mesh-list
92381470|NCT03096444|Amitriptyline|amitriptyline|mesh-list
92381471|NCT03096444|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381472|NCT03096444|Anesthetics|anesthetics|mesh-ancestor
92381473|NCT03096444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381474|NCT03096444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956924|NCT03388697|Insulin|insulin|mesh-list
92381475|NCT03096444|Sensory System Agents|sensory system agents|mesh-ancestor
92381476|NCT03096444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381477|NCT03096444|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92381478|NCT03096444|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92381479|NCT03096444|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92381480|NCT03096444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381481|NCT03096444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381482|NCT03096444|Analgesics|analgesics|mesh-ancestor
92381483|NCT03096444|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92381484|NCT03096444|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381485|NCT03096444|Anesthetics, General|anesthetics, general|mesh-ancestor
92381486|NCT03096444|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92381487|NCT03096444|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91944742|NCT03478033|Rifampin|rifampin|mesh-list
92381488|NCT03096444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381489|NCT03096444|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92381490|NCT03096444|Antidepressive Agents|antidepressive agents|mesh-ancestor
92381491|NCT03096444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92381492|NCT03096444|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381493|NCT03096444|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92381494|NCT03096444|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92381495|NCT03096444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92381497|NCT03107754|Anesthetics|anesthetics|mesh-list
92381498|NCT03107754|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381499|NCT03107754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381500|NCT03107754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381501|NCT03107754|Sensory System Agents|sensory system agents|mesh-ancestor
92381502|NCT03107754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381503|NCT03107754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92381504|NCT03107754|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92381505|NCT03107754|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92381506|NCT03107754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381507|NCT03107754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381508|NCT03124758|Chrysarobin|chrysarobin|mesh-list
92381509|NCT03124758|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92381510|NCT03124758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381511|NCT03124758|Analgesics|analgesics|mesh-ancestor
92381512|NCT03124758|Sensory System Agents|sensory system agents|mesh-ancestor
92381513|NCT03124758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381514|NCT03124758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381515|NCT03124758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381516|NCT03124758|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381517|NCT03148236|Ascorbic Acid|ascorbic acid|mesh-list
92381518|NCT03148236|Vitamins|vitamins|mesh-ancestor
92381519|NCT03148236|Micronutrients|micronutrients|mesh-ancestor
92381520|NCT03148236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381521|NCT03148236|Antioxidants|antioxidants|mesh-ancestor
92381522|NCT03148236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381523|NCT03148236|Protective Agents|protective agents|mesh-ancestor
92381524|NCT03174366|Denosumab|denosumab|mesh-list
92381525|NCT03174366|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92381526|NCT03174366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381528|NCT03177798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92381529|NCT03177798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381530|NCT03177798|Analgesics|analgesics|mesh-ancestor
92381531|NCT03177798|Sensory System Agents|sensory system agents|mesh-ancestor
92381532|NCT03177798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381533|NCT03177798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381534|NCT03177798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381535|NCT03177798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381536|NCT03177798|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92381537|NCT03177798|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92381538|NCT03177798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381539|NCT03177798|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92381540|NCT03177798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92381541|NCT03177798|Immunologic Factors|immunologic factors|mesh-ancestor
92381542|NCT05093790|Aspirin|aspirin|mesh-list
92381543|NCT05093790|Ticagrelor|ticagrelor|mesh-list
92381544|NCT05093790|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92381545|NCT05093790|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381546|NCT05093790|Analgesics|analgesics|mesh-ancestor
92381547|NCT05093790|Sensory System Agents|sensory system agents|mesh-ancestor
92381548|NCT05093790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381549|NCT05093790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381550|NCT05093790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381551|NCT05093790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381552|NCT05093790|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92381553|NCT05093790|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92381554|NCT05093790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381555|NCT05093790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92381556|NCT05093790|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92381557|NCT05093790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381558|NCT05093790|Antipyretics|antipyretics|mesh-ancestor
92381559|NCT05093790|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92381560|NCT05093790|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92381561|NCT05093790|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92381562|NCT05093790|Purinergic Agents|purinergic agents|mesh-ancestor
92381563|NCT05093790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381564|NCT04933344|Daptomycin|daptomycin|mesh-list
92381565|NCT04933344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957181|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
92381566|NCT04933344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381567|NCT05406180|Vaccines|vaccines|mesh-list
92381568|NCT05406180|Immunologic Factors|immunologic factors|mesh-ancestor
92381569|NCT05406180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381570|NCT05405478|Omalizumab|omalizumab|mesh-list
92381571|NCT05405478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92381572|NCT05405478|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92381573|NCT05405478|Respiratory System Agents|respiratory system agents|mesh-ancestor
92381574|NCT04890366|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92381575|NCT04890366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381576|NCT04890366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92381577|NCT04890366|Immunologic Factors|immunologic factors|mesh-ancestor
92381578|NCT04890366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381579|NCT04601532|Sulfadiazine|sulfadiazine|mesh-list
92381580|NCT04601532|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92381581|NCT04601532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381582|NCT04601532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381583|NCT04601532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92381584|NCT04601532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92381585|NCT04601532|Coccidiostats|coccidiostats|mesh-ancestor
92381586|NCT04601532|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92381587|NCT03872700|Fentanyl|fentanyl|mesh-list
92381588|NCT03872700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92381589|NCT03872700|Narcotics|narcotics|mesh-ancestor
92381590|NCT03872700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381591|NCT03872700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381592|NCT03872700|Analgesics|analgesics|mesh-ancestor
92381593|NCT03872700|Sensory System Agents|sensory system agents|mesh-ancestor
92381594|NCT03872700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381595|NCT03872700|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92381596|NCT03872700|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381597|NCT03872700|Anesthetics, General|anesthetics, general|mesh-ancestor
92381598|NCT03872700|Anesthetics|anesthetics|mesh-ancestor
92381599|NCT03137160|Ixekizumab|ixekizumab|mesh-list
92381600|NCT03137160|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381601|NCT02856126|Sorafenib|sorafenib|mesh-list
92381602|NCT02856126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381603|NCT02856126|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92381604|NCT02856126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381605|NCT02856126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381607|NCT04589364|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92381608|NCT04589364|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92381609|NCT04589364|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92381610|NCT04589364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381611|NCT04589364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381612|NCT04589364|Cholinergic Agents|cholinergic agents|mesh-ancestor
92381613|NCT04589364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381614|NCT04589364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381615|NCT04589364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92381616|NCT04589364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381617|NCT04473924|Mycophenolic Acid|mycophenolic acid|mesh-list
92381618|NCT04473924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92381619|NCT04473924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381620|NCT04473924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92381621|NCT04473924|Antitubercular Agents|antitubercular agents|mesh-ancestor
92381622|NCT04473924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381623|NCT04473924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381624|NCT04473924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381625|NCT04473924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381626|NCT04426500|Bupivacaine|bupivacaine|mesh-list
92381627|NCT04426500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381628|NCT04426500|Anesthetics|anesthetics|mesh-ancestor
92381629|NCT04426500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381630|NCT04426500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381631|NCT04426500|Sensory System Agents|sensory system agents|mesh-ancestor
92381632|NCT04426500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381633|NCT04131192|Gemcitabine|gemcitabine|mesh-list
92381634|NCT04131192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92381635|NCT04131192|Antimetabolites|antimetabolites|mesh-ancestor
92381636|NCT04131192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381637|NCT04131192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381638|NCT03925116|Contraceptive Agents|contraceptive agents|mesh-list
92381639|NCT03925116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92381640|NCT03925116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381641|NCT03883074|Magnesium trisilicate|magnesium trisilicate|mesh-list
92381642|NCT03883074|Hyaluronic Acid|hyaluronic acid|mesh-list
92381643|NCT03883074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92381645|NCT03883074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381646|NCT03883074|Viscosupplements|viscosupplements|mesh-ancestor
92381647|NCT03883074|Protective Agents|protective agents|mesh-ancestor
92381648|NCT03883074|Antacids|antacids|mesh-ancestor
92381649|NCT03883074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381650|NCT03883074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381651|NCT03670836|Misoprostol|misoprostol|mesh-list
92381652|NCT03670836|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92381653|NCT03670836|Abortifacient Agents|abortifacient agents|mesh-ancestor
92381654|NCT03670836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92381655|NCT03670836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381656|NCT03670836|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92381657|NCT03670836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381658|NCT03670836|Oxytocics|oxytocics|mesh-ancestor
92381659|NCT03607656|Docetaxel|docetaxel|mesh-list
92381660|NCT03607656|Capecitabine|capecitabine|mesh-list
92381661|NCT03607656|Oxaliplatin|oxaliplatin|mesh-list
92381662|NCT03607656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381663|NCT03607656|Tubulin Modulators|tubulin modulators|mesh-ancestor
92381664|NCT03607656|Antimitotic Agents|antimitotic agents|mesh-ancestor
92381665|NCT03607656|Mitosis Modulators|mitosis modulators|mesh-ancestor
92381666|NCT03607656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381667|NCT03607656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92381668|NCT03607656|Antimetabolites|antimetabolites|mesh-ancestor
92381669|NCT03409614|Cemiplimab|cemiplimab|mesh-list
92381670|NCT03409614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92381671|NCT03409614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381672|NCT02651844|Mifepristone|mifepristone|mesh-list
92381673|NCT02651844|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92381674|NCT02651844|Abortifacient Agents|abortifacient agents|mesh-ancestor
92381675|NCT02651844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92381676|NCT02651844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381677|NCT02651844|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92381678|NCT02651844|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92381679|NCT02651844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92381680|NCT02651844|Contraceptive Agents|contraceptive agents|mesh-ancestor
92381681|NCT02651844|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92381682|NCT02651844|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92381683|NCT02651844|Hormone Antagonists|hormone antagonists|mesh-ancestor
92381684|NCT02651844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381685|NCT02651844|Luteolytic Agents|luteolytic agents|mesh-ancestor
92381686|NCT02651844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92381687|NCT02651844|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92381688|NCT01463670|Lenalidomide|lenalidomide|mesh-list
92381689|NCT01463670|Immunologic Factors|immunologic factors|mesh-ancestor
92381690|NCT01463670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381691|NCT01463670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92381692|NCT01463670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92381693|NCT01463670|Growth Substances|growth substances|mesh-ancestor
92381694|NCT01463670|Growth Inhibitors|growth inhibitors|mesh-ancestor
92031133|NCT02396953|Lanreotide|lanreotide|mesh-list
92381696|NCT00151398|Donepezil|donepezil|mesh-list
92381697|NCT00151398|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92381698|NCT00151398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381699|NCT00151398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381700|NCT00151398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92381701|NCT00151398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381702|NCT00151398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381703|NCT00151398|Nootropic Agents|nootropic agents|mesh-ancestor
92381704|NCT03181308|Nivolumab|nivolumab|mesh-list
92381705|NCT03181308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92381706|NCT03181308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92381707|NCT03181308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92381708|NCT03181308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381709|NCT03202134|Analgesics, Opioid|analgesics, opioid|mesh-list
92381710|NCT03202134|Anesthetics|anesthetics|mesh-list
92381711|NCT03202134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381712|NCT03202134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381713|NCT03202134|Narcotics|narcotics|mesh-ancestor
92381714|NCT03202134|Analgesics|analgesics|mesh-ancestor
92381715|NCT03202134|Sensory System Agents|sensory system agents|mesh-ancestor
92381716|NCT03202134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381717|NCT03207438|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92381718|NCT03207438|Antidepressive Agents|antidepressive agents|mesh-ancestor
92381719|NCT03207438|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92381720|NCT03207438|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92381721|NCT03207438|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92381722|NCT03207438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381723|NCT03207438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381724|NCT03218592|Tenofovir|tenofovir|mesh-list
92381725|NCT03218592|Emtricitabine|emtricitabine|mesh-list
92381726|NCT03218592|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92381727|NCT03218592|Dolutegravir|dolutegravir|mesh-list
92381728|NCT03218592|Maraviroc|maraviroc|mesh-list
92381729|NCT03218592|Antiviral Agents|antiviral agents|mesh-ancestor
92381730|NCT03218592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381731|NCT03218592|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92381732|NCT03218592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92381733|NCT03218592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381734|NCT03218592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381735|NCT03218592|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92381736|NCT03218592|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92381737|NCT03218592|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92381738|NCT03218592|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92381739|NCT03218592|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92381740|NCT03218592|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92381741|NCT03218592|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92381742|NCT03219294|Bromides|bromides|mesh-list
92381743|NCT03219294|Vecuronium Bromide|vecuronium bromide|mesh-list
92381744|NCT03219294|Anticonvulsants|anticonvulsants|mesh-ancestor
92381745|NCT03219294|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92381746|NCT03219294|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92381747|NCT03219294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92381748|NCT03219294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381749|NCT03219294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381750|NCT03219294|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92381751|NCT03219294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92381752|NCT03219294|Cholinergic Agents|cholinergic agents|mesh-ancestor
92381753|NCT03219294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381754|NCT03219294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381755|NCT03219840|Cetylpyridinium|cetylpyridinium|mesh-list
92381756|NCT03219840|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92381757|NCT03219840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381758|NCT03223272|Reserpine|reserpine|mesh-list
92381759|NCT03223272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92381760|NCT03223272|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92381761|NCT03223272|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92381762|NCT03223272|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381763|NCT03223272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381764|NCT03223272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031143|NCT02387983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92381765|NCT03223272|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92381766|NCT03223272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92381767|NCT03223272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381768|NCT03223272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381769|NCT03223272|Adrenergic Agents|adrenergic agents|mesh-ancestor
92381770|NCT03223272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381771|NCT03239106|Apremilast|apremilast|mesh-list
92381772|NCT03239106|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92381773|NCT03239106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381774|NCT03239106|Analgesics|analgesics|mesh-ancestor
92381775|NCT03239106|Sensory System Agents|sensory system agents|mesh-ancestor
92381776|NCT03239106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381777|NCT03239106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381778|NCT03239106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381779|NCT03239106|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92381780|NCT03239106|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92381781|NCT03239106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92381782|NCT03239106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381783|NCT03239106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381784|NCT03257202|Clindamycin|clindamycin|mesh-list
92381785|NCT03257202|Clindamycin palmitate|clindamycin palmitate|mesh-list
92381786|NCT03257202|Clindamycin phosphate|clindamycin phosphate|mesh-list
92381787|NCT03257202|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92381788|NCT03257202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381790|NCT03257202|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92381791|NCT03257202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115104|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381792|NCT03257202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381793|NCT03257202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381794|NCT03260790|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92381795|NCT03260790|Immunologic Factors|immunologic factors|mesh-ancestor
92381796|NCT03260790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381797|NCT03278886|Naltrexone|naltrexone|mesh-list
92381798|NCT03278886|Nalmefene|nalmefene|mesh-list
92381799|NCT03278886|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92381800|NCT03278886|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92381801|NCT03278886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381802|NCT03278886|Sensory System Agents|sensory system agents|mesh-ancestor
92381803|NCT03278886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381804|NCT03285984|Listerine|listerine|mesh-list
92381805|NCT03285984|Fluorides|fluorides|mesh-list
92381806|NCT03285984|Sodium Fluoride|sodium fluoride|mesh-list
92381807|NCT03285984|Cariostatic Agents|cariostatic agents|mesh-ancestor
92381808|NCT03285984|Protective Agents|protective agents|mesh-ancestor
92381809|NCT03285984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381810|NCT03285984|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92381811|NCT03285984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381812|NCT03287310|Albuterol|albuterol|mesh-list
92381813|NCT03287310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92381814|NCT03287310|Autonomic Agents|autonomic agents|mesh-ancestor
92381815|NCT03287310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381816|NCT03287310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381817|NCT03287310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92381818|NCT03287310|Respiratory System Agents|respiratory system agents|mesh-ancestor
92381819|NCT03287310|Tocolytic Agents|tocolytic agents|mesh-ancestor
92381820|NCT03287310|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92381821|NCT03287310|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92381822|NCT03287310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92381823|NCT03287310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92381824|NCT03287310|Adrenergic Agents|adrenergic agents|mesh-ancestor
92381825|NCT03287310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381826|NCT03287310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381827|NCT03301272|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92381828|NCT03301272|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92381829|NCT03301272|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92381830|NCT03301272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381831|NCT03301272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381832|NCT03301272|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92381833|NCT03301272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381834|NCT03301272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381835|NCT03301272|Cholinergic Agents|cholinergic agents|mesh-ancestor
92381836|NCT03301272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381837|NCT03315780|Dulaglutide|dulaglutide|mesh-list
92381838|NCT03315780|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92381839|NCT03315780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381840|NCT03334734|Isoniazid|isoniazid|mesh-list
92381841|NCT03334734|Macozinone|macozinone|mesh-list
92381842|NCT03334734|Antitubercular Agents|antitubercular agents|mesh-ancestor
92381843|NCT03334734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381844|NCT03334734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381845|NCT03334734|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92381846|NCT03334734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92381847|NCT03334734|Antimetabolites|antimetabolites|mesh-ancestor
92381848|NCT03334734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381849|NCT03334734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92381850|NCT03336450|Midazolam|midazolam|mesh-list
92381851|NCT03336450|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92381852|NCT03336450|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92381853|NCT03336450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381854|NCT03336450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381855|NCT03336450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92381856|NCT03336450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92381857|NCT03336450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92381858|NCT03336450|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381859|NCT03336450|Anesthetics, General|anesthetics, general|mesh-ancestor
92381860|NCT03336450|Anesthetics|anesthetics|mesh-ancestor
92381861|NCT03336450|GABA Modulators|gaba modulators|mesh-ancestor
92381863|NCT03336450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381864|NCT03336450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381865|NCT03340350|Minocycline|minocycline|mesh-list
92381866|NCT03340350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92381867|NCT03340350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92381868|NCT03341910|Nicotinic Acids|nicotinic acids|mesh-list
92381869|NCT03341910|Tazarotene|tazarotene|mesh-list
92381870|NCT03341910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381871|NCT03341910|Keratolytic Agents|keratolytic agents|mesh-ancestor
92381872|NCT03341910|Vitamin B Complex|vitamin b complex|mesh-ancestor
92381873|NCT03341910|Vitamins|vitamins|mesh-ancestor
92381874|NCT03341910|Micronutrients|micronutrients|mesh-ancestor
92381875|NCT03341910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381876|NCT03343080|Lidocaine|lidocaine|mesh-list
92381877|NCT03343080|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381878|NCT03343080|Anesthetics|anesthetics|mesh-ancestor
92381879|NCT03343080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381880|NCT03343080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381881|NCT03343080|Sensory System Agents|sensory system agents|mesh-ancestor
92381882|NCT03343080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381883|NCT03343080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92381884|NCT03343080|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92381885|NCT03343080|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92381886|NCT03343080|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92381887|NCT03343080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381888|NCT03375294|Nitrous Oxide|nitrous oxide|mesh-list
92381889|NCT03375294|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92381890|NCT03375294|Anesthetics, General|anesthetics, general|mesh-ancestor
92381891|NCT03375294|Anesthetics|anesthetics|mesh-ancestor
92381892|NCT03375294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381893|NCT03375294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381894|NCT03375294|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381895|NCT03375294|Analgesics|analgesics|mesh-ancestor
92381896|NCT03375294|Sensory System Agents|sensory system agents|mesh-ancestor
92381897|NCT03375294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381898|NCT03395808|Tramadol|tramadol|mesh-list
92381899|NCT03395808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92034379|NCT01876732|Vitamins|vitamins|mesh-ancestor
92381900|NCT03395808|Narcotics|narcotics|mesh-ancestor
92381901|NCT03395808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381902|NCT03395808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381903|NCT03395808|Analgesics|analgesics|mesh-ancestor
92381904|NCT03395808|Sensory System Agents|sensory system agents|mesh-ancestor
92381905|NCT03395808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381906|NCT03395886|Dexmedetomidine|dexmedetomidine|mesh-list
92381907|NCT03395886|Remifentanil|remifentanil|mesh-list
92381908|NCT03395886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92381909|NCT03395886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381910|NCT03395886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381911|NCT03395886|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92381912|NCT03395886|Analgesics|analgesics|mesh-ancestor
92381913|NCT03395886|Sensory System Agents|sensory system agents|mesh-ancestor
92381914|NCT03395886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381915|NCT03395886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92381916|NCT03395886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92381917|NCT03395886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92381918|NCT03395886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92381919|NCT03395886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381920|NCT03395886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381921|NCT03395886|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92381922|NCT03395886|Narcotics|narcotics|mesh-ancestor
92381923|NCT03426228|Progesterone|progesterone|mesh-list
92381924|NCT03426228|Estrogens|estrogens|mesh-list
92381925|NCT03426228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381926|NCT03426228|Hormones|hormones|mesh-ancestor
92381927|NCT03426228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381928|NCT03426228|Progestins|progestins|mesh-ancestor
92381929|NCT03430050|Progesterone|progesterone|mesh-list
92381930|NCT03430050|Progestins|progestins|mesh-ancestor
92381931|NCT03430050|Hormones|hormones|mesh-ancestor
92381932|NCT03430050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92381933|NCT03430050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381934|NCT03440424|Lemborexant|lemborexant|mesh-list
92381935|NCT03440424|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92381936|NCT03440424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381937|NCT03440424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381938|NCT03440424|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92381939|NCT03440424|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92381940|NCT03440424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381941|NCT03440424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381942|NCT03448068|Ketamine|ketamine|mesh-list
92381943|NCT03448068|Analgesics|analgesics|mesh-ancestor
92381944|NCT03448068|Sensory System Agents|sensory system agents|mesh-ancestor
92381945|NCT03448068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381946|NCT03448068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381947|NCT03448068|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92381948|NCT03448068|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92381949|NCT03448068|Anesthetics, General|anesthetics, general|mesh-ancestor
92381950|NCT03448068|Anesthetics|anesthetics|mesh-ancestor
92381951|NCT03448068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381952|NCT03448068|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92381953|NCT03448068|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92381954|NCT03448068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92381955|NCT03448068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381956|NCT03453060|Thrombin|thrombin|mesh-list
92381958|NCT03453060|Coagulants|coagulants|mesh-ancestor
92381959|NCT03459612|Diphenhydramine|diphenhydramine|mesh-list
92381960|NCT03459612|Promethazine|promethazine|mesh-list
92381961|NCT03459612|Lasmiditan|lasmiditan|mesh-list
92381962|NCT03459612|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92381963|NCT03459612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92381964|NCT03459612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92381965|NCT03459612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381966|NCT03459612|Anesthetics, Local|anesthetics, local|mesh-ancestor
92381967|NCT03459612|Anesthetics|anesthetics|mesh-ancestor
92381968|NCT03459612|Sensory System Agents|sensory system agents|mesh-ancestor
92381969|NCT03459612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92381970|NCT03459612|Antiemetics|antiemetics|mesh-ancestor
92381971|NCT03459612|Autonomic Agents|autonomic agents|mesh-ancestor
92381972|NCT03459612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381973|NCT03459612|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92381974|NCT03459612|Histamine Antagonists|histamine antagonists|mesh-ancestor
92381975|NCT03459612|Histamine Agents|histamine agents|mesh-ancestor
92381976|NCT03459612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031155|NCT02395627|Vorinostat|vorinostat|mesh-list
92381977|NCT03459612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381978|NCT03459612|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92381979|NCT03459612|Antipruritics|antipruritics|mesh-ancestor
92381980|NCT03459612|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381981|NCT03459612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92381982|NCT03459612|Serotonin Agents|serotonin agents|mesh-ancestor
92381983|NCT03463512|Racecadotril|racecadotril|mesh-list
92381984|NCT03463512|Antidiarrheals|antidiarrheals|mesh-ancestor
92381985|NCT03463512|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92381986|NCT03463512|Protease Inhibitors|protease inhibitors|mesh-ancestor
92381987|NCT03463512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92381988|NCT03463512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92381989|NCT03473184|Diacerein|diacerein|mesh-list
92381990|NCT03473184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92381991|NCT03485976|Ixekizumab|ixekizumab|mesh-list
92381992|NCT03485976|Dermatologic Agents|dermatologic agents|mesh-ancestor
92381993|NCT03496974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92381994|NCT03496974|Antibodies|antibodies|mesh-list
92381995|NCT03496974|Immunoglobulins|immunoglobulins|mesh-list
92381996|NCT03496974|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92381997|NCT03496974|Immunologic Factors|immunologic factors|mesh-ancestor
92381998|NCT03496974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92381999|NCT03496974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382000|NCT03503292|Ondansetron|ondansetron|mesh-list
92382001|NCT03503292|Granisetron|granisetron|mesh-list
92382002|NCT03503292|Antiemetics|antiemetics|mesh-ancestor
92382003|NCT03503292|Autonomic Agents|autonomic agents|mesh-ancestor
92382004|NCT03503292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382005|NCT03503292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382006|NCT03503292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92382007|NCT03503292|Antipruritics|antipruritics|mesh-ancestor
92382008|NCT03503292|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382009|NCT03503292|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92382010|NCT03503292|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92382011|NCT03503292|Serotonin Agents|serotonin agents|mesh-ancestor
92382012|NCT03503292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382013|NCT03503292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382015|NCT03506724|Nifedipine|nifedipine|mesh-list
92382016|NCT03506724|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92382017|NCT03506724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382018|NCT03506724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382019|NCT03506724|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92382020|NCT03506724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382021|NCT03506724|Vasodilator Agents|vasodilator agents|mesh-ancestor
92382022|NCT03506724|Tocolytic Agents|tocolytic agents|mesh-ancestor
92382023|NCT03506724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382024|NCT03506724|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92382025|NCT03506724|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92382026|NCT03506724|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382027|NCT03506724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382028|NCT03506724|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382029|NCT03506724|Sympathomimetics|sympathomimetics|mesh-ancestor
92382030|NCT03506724|Autonomic Agents|autonomic agents|mesh-ancestor
92382031|NCT03506724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382032|NCT03506724|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92382033|NCT03506724|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92382034|NCT03509766|Histamine|histamine|mesh-list
92382035|NCT03509766|Histamine Agonists|histamine agonists|mesh-ancestor
92382036|NCT03509766|Histamine Agents|histamine agents|mesh-ancestor
92382037|NCT03509766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382038|NCT03509766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382039|NCT03509766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382040|NCT03532776|Podophyllotoxin|podophyllotoxin|mesh-list
92382041|NCT03532776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92382042|NCT03532776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382043|NCT03532776|Keratolytic Agents|keratolytic agents|mesh-ancestor
92382044|NCT03532776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382045|NCT03532776|Tubulin Modulators|tubulin modulators|mesh-ancestor
92382046|NCT03532776|Antimitotic Agents|antimitotic agents|mesh-ancestor
92382047|NCT03532776|Mitosis Modulators|mitosis modulators|mesh-ancestor
92382048|NCT03532776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382049|NCT03533244|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92034525|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
92382050|NCT03533244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92382052|NCT03541356|Levodopa|levodopa|mesh-list
92382053|NCT03541356|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92382054|NCT03541356|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92382055|NCT03541356|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92382056|NCT03541356|Dopamine Agents|dopamine agents|mesh-ancestor
92382057|NCT03541356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382058|NCT03541356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382059|NCT03541356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382060|NCT03541356|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92382061|NCT03541356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382063|NCT03557658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382064|NCT03557658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382065|NCT03572478|Nivolumab|nivolumab|mesh-list
92382066|NCT03572478|Rucaparib|rucaparib|mesh-list
92382067|NCT03572478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92382068|NCT03572478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382069|NCT03572478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92382070|NCT03572478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382071|NCT03572478|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92382072|NCT03572478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382073|NCT03574818|Gemcitabine|gemcitabine|mesh-list
92382074|NCT03574818|Necitumumab|necitumumab|mesh-list
92382075|NCT03574818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382076|NCT03574818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92382077|NCT03574818|Antimetabolites|antimetabolites|mesh-ancestor
92382078|NCT03574818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382079|NCT03574818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92382080|NCT03593538|Metformin|metformin|mesh-list
92382081|NCT03593538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382082|NCT03593538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382083|NCT03610464|Amphetamine|amphetamine|mesh-list
91937800|NCT00493298|Natalizumab|natalizumab|mesh-list
92382084|NCT03610464|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92382085|NCT03610464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382086|NCT03610464|Sympathomimetics|sympathomimetics|mesh-ancestor
92382087|NCT03610464|Autonomic Agents|autonomic agents|mesh-ancestor
92382088|NCT03610464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382089|NCT03610464|Dopamine Agents|dopamine agents|mesh-ancestor
92382090|NCT03610464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382091|NCT03610464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382092|NCT03610464|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382093|NCT03610464|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92382094|NCT03610464|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92382095|NCT03610464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382096|NCT03610464|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92382097|NCT03615534|Niacin|niacin|mesh-list
92382098|NCT03615534|Fenofibrate|fenofibrate|mesh-list
92382099|NCT03615534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92382100|NCT03615534|Antimetabolites|antimetabolites|mesh-ancestor
92382101|NCT03615534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382102|NCT03615534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92382103|NCT03615534|Vasodilator Agents|vasodilator agents|mesh-ancestor
92382104|NCT03615534|Vitamin B Complex|vitamin b complex|mesh-ancestor
92382105|NCT03615534|Vitamins|vitamins|mesh-ancestor
92382106|NCT03615534|Micronutrients|micronutrients|mesh-ancestor
92382107|NCT03615534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382108|NCT03630198|Lidocaine|lidocaine|mesh-list
92382109|NCT03630198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92382110|NCT03630198|Anesthetics|anesthetics|mesh-ancestor
92382111|NCT03630198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382112|NCT03630198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382113|NCT03630198|Sensory System Agents|sensory system agents|mesh-ancestor
92382114|NCT03630198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382115|NCT03630198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92382116|NCT03630198|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92382117|NCT03630198|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92382118|NCT03630198|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382119|NCT03630198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382120|NCT03638622|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92382121|NCT03638622|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92382122|NCT03638622|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382123|NCT03655080|Paclitaxel|paclitaxel|mesh-list
92382124|NCT03655080|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92034599|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92382125|NCT03655080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92382126|NCT03655080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382127|NCT03655080|Tubulin Modulators|tubulin modulators|mesh-ancestor
92382128|NCT03655080|Antimitotic Agents|antimitotic agents|mesh-ancestor
92382129|NCT03655080|Mitosis Modulators|mitosis modulators|mesh-ancestor
92382130|NCT03655080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382131|NCT03674970|Nicotine|nicotine|mesh-list
92382132|NCT03674970|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92382133|NCT03674970|Autonomic Agents|autonomic agents|mesh-ancestor
92382134|NCT03674970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382135|NCT03674970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382136|NCT03674970|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92382137|NCT03674970|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92382138|NCT03674970|Cholinergic Agents|cholinergic agents|mesh-ancestor
92382139|NCT03674970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382140|NCT03674970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382141|NCT03704376|Clonidine|clonidine|mesh-list
92382142|NCT03704376|Ropivacaine|ropivacaine|mesh-list
92382143|NCT03704376|Anesthetics, Local|anesthetics, local|mesh-ancestor
92382144|NCT03704376|Anesthetics|anesthetics|mesh-ancestor
92382145|NCT03704376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382146|NCT03704376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382147|NCT03704376|Sensory System Agents|sensory system agents|mesh-ancestor
92382148|NCT03704376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382149|NCT03704376|Analgesics|analgesics|mesh-ancestor
92382150|NCT03704376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382151|NCT03704376|Sympatholytics|sympatholytics|mesh-ancestor
92382152|NCT03704376|Autonomic Agents|autonomic agents|mesh-ancestor
92382153|NCT03704376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92382154|NCT03704376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92382155|NCT03704376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92382156|NCT03704376|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382157|NCT03704376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382158|NCT03704376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382159|NCT03716076|Carbetocin|carbetocin|mesh-list
92382160|NCT03716076|Oxytocics|oxytocics|mesh-ancestor
92382161|NCT03716076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382162|NCT03716076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382163|NCT03835728|Ocrelizumab|ocrelizumab|mesh-list
92382164|NCT03835728|Immunologic Factors|immunologic factors|mesh-ancestor
92382165|NCT03835728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382166|NCT03889158|Ascorbic Acid|ascorbic acid|mesh-list
92382167|NCT03889158|Vaccines|vaccines|mesh-list
92382168|NCT03889158|Immunologic Factors|immunologic factors|mesh-ancestor
92382169|NCT03889158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382170|NCT03889158|Antioxidants|antioxidants|mesh-ancestor
92382171|NCT03889158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382172|NCT03889158|Protective Agents|protective agents|mesh-ancestor
92382173|NCT03889158|Vitamins|vitamins|mesh-ancestor
92382174|NCT03889158|Micronutrients|micronutrients|mesh-ancestor
92382175|NCT04138758|Bromides|bromides|mesh-list
92382176|NCT04138758|Tiotropium Bromide|tiotropium bromide|mesh-list
92382177|NCT04138758|Olodaterol|olodaterol|mesh-list
92382178|NCT04138758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92382179|NCT04138758|Autonomic Agents|autonomic agents|mesh-ancestor
92382180|NCT04138758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382181|NCT04138758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382182|NCT04138758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92382183|NCT04138758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92382184|NCT04138758|Parasympatholytics|parasympatholytics|mesh-ancestor
92382185|NCT04138758|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92382186|NCT04138758|Cholinergic Agents|cholinergic agents|mesh-ancestor
92382187|NCT04138758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382188|NCT04138758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382190|NCT04323852|Vitamin D|vitamin d|mesh-list
92382191|NCT04323852|Vitamins|vitamins|mesh-ancestor
92382192|NCT04323852|Micronutrients|micronutrients|mesh-ancestor
92382193|NCT04323852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382194|NCT04323852|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92382195|NCT04420572|Betamethasone|betamethasone|mesh-list
92382196|NCT04420572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92382197|NCT04420572|Glucocorticoids|glucocorticoids|mesh-ancestor
92382198|NCT04420572|Hormones|hormones|mesh-ancestor
92382199|NCT04420572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382200|NCT04420572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382201|NCT04420572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92382202|NCT04420572|Respiratory System Agents|respiratory system agents|mesh-ancestor
92382203|NCT03541980|Acetaminophen|acetaminophen|mesh-list
92382204|NCT03541980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92382205|NCT03541980|Analgesics|analgesics|mesh-ancestor
92382206|NCT03541980|Sensory System Agents|sensory system agents|mesh-ancestor
92382207|NCT03541980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382208|NCT03541980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382209|NCT03541980|Antipyretics|antipyretics|mesh-ancestor
92382210|NCT04511520|Trimetazidine|trimetazidine|mesh-list
92382211|NCT04511520|Vasodilator Agents|vasodilator agents|mesh-ancestor
92382212|NCT04463004|Mavrilimumab|mavrilimumab|mesh-list
92382213|NCT04463004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382214|NCT04399980|Mavrilimumab|mavrilimumab|mesh-list
92382215|NCT04399980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382216|NCT04335552|Azithromycin|azithromycin|mesh-list
92382217|NCT04335552|Hydroxychloroquine|hydroxychloroquine|mesh-list
92382218|NCT04335552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382219|NCT04335552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382220|NCT04335552|Antimalarials|antimalarials|mesh-ancestor
92382221|NCT04335552|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92382222|NCT04335552|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92382223|NCT04335552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382224|NCT04335552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382225|NCT04335552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382226|NCT04284930|Bupivacaine|bupivacaine|mesh-list
92382227|NCT04284930|Anesthetics, Local|anesthetics, local|mesh-ancestor
92382228|NCT04284930|Anesthetics|anesthetics|mesh-ancestor
92382229|NCT04284930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382230|NCT04284930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382231|NCT04284930|Sensory System Agents|sensory system agents|mesh-ancestor
92382232|NCT04284930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382233|NCT04267770|Insulin|insulin|mesh-list
92382234|NCT04267770|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92382235|NCT04267770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382236|NCT04267770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382238|NCT04204200|Ascorbic Acid|ascorbic acid|mesh-list
92382239|NCT04204200|Micronutrients|micronutrients|mesh-ancestor
92382240|NCT04204200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382241|NCT04204200|Antioxidants|antioxidants|mesh-ancestor
92382242|NCT04204200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382243|NCT04204200|Protective Agents|protective agents|mesh-ancestor
92382244|NCT04179474|Erenumab|erenumab|mesh-list
92382245|NCT04179474|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92382246|NCT04179474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382247|NCT04179474|Analgesics|analgesics|mesh-ancestor
92382248|NCT04179474|Sensory System Agents|sensory system agents|mesh-ancestor
92382249|NCT04179474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382250|NCT04179474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382251|NCT04150224|Macozinone|macozinone|mesh-list
92382252|NCT04150224|Antitubercular Agents|antitubercular agents|mesh-ancestor
92382253|NCT04150224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382254|NCT04150224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382255|NCT04112160|Ketorolac|ketorolac|mesh-list
92382256|NCT04112160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92382257|NCT04112160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92382258|NCT04112160|Analgesics|analgesics|mesh-ancestor
92382259|NCT04112160|Sensory System Agents|sensory system agents|mesh-ancestor
92382260|NCT04112160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382261|NCT04112160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382262|NCT04112160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92382263|NCT04112160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382264|NCT04112160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92382265|NCT04112160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382266|NCT04112160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382267|NCT04102956|Kallikreins|kallikreins|mesh-list
92382268|NCT04102956|Coagulants|coagulants|mesh-ancestor
92382269|NCT04102956|Fertility Agents, Male|fertility agents, male|mesh-ancestor
92382270|NCT04102956|Fertility Agents|fertility agents|mesh-ancestor
92382271|NCT04102956|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382272|NCT04102956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382273|NCT04053270|Afamelanotide|afamelanotide|mesh-list
92382274|NCT04053270|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382275|NCT03976752|Tenofovir|tenofovir|mesh-list
92034747|NCT01901146|Tubulin Modulators|tubulin modulators|mesh-ancestor
92382276|NCT03976752|Emtricitabine|emtricitabine|mesh-list
92382277|NCT03976752|Cobicistat|cobicistat|mesh-list
92382278|NCT03976752|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92382279|NCT03976752|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92382280|NCT03976752|Elvitegravir|elvitegravir|mesh-list
91957332|NCT03387943|Cisplatin|cisplatin|mesh-list
92382281|NCT03976752|Antiviral Agents|antiviral agents|mesh-ancestor
92382282|NCT03976752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382283|NCT03976752|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92382284|NCT03976752|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92382285|NCT03976752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382286|NCT03976752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382287|NCT03976752|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92382288|NCT03976752|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92382289|NCT03976752|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92382290|NCT03976752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92382291|NCT03976752|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92382292|NCT03962634|Oxymetazoline|oxymetazoline|mesh-list
92382293|NCT03962634|Tetracaine|tetracaine|mesh-list
92382294|NCT03962634|Carticaine|carticaine|mesh-list
92382295|NCT03962634|Anesthetics, Local|anesthetics, local|mesh-ancestor
92382296|NCT03962634|Anesthetics|anesthetics|mesh-ancestor
92382297|NCT03962634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382298|NCT03962634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382299|NCT03962634|Sensory System Agents|sensory system agents|mesh-ancestor
92382300|NCT03962634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382301|NCT03962634|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92382302|NCT03962634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92382303|NCT03962634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382304|NCT03962634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382305|NCT03962634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382306|NCT03962634|Sympathomimetics|sympathomimetics|mesh-ancestor
92382307|NCT03962634|Autonomic Agents|autonomic agents|mesh-ancestor
92382308|NCT03962634|Nasal Decongestants|nasal decongestants|mesh-ancestor
92382309|NCT03962634|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92382310|NCT03962634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92382312|NCT03933774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382313|NCT03933774|Keratolytic Agents|keratolytic agents|mesh-ancestor
92382314|NCT03933774|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382315|NCT03933618|Anastrozole|anastrozole|mesh-list
92382316|NCT03933618|Clomiphene|clomiphene|mesh-list
92382317|NCT03933618|Enclomiphene|enclomiphene|mesh-list
92382318|NCT03933618|Zuclomiphene|zuclomiphene|mesh-list
92382319|NCT03933618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382320|NCT03933618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92382321|NCT03933618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382322|NCT03933618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92382323|NCT03933618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92382324|NCT03933618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382325|NCT03933618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92382326|NCT03933618|Hormone Antagonists|hormone antagonists|mesh-ancestor
92382327|NCT03933618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382328|NCT03933618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382329|NCT03933618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92382330|NCT03933618|Fertility Agents|fertility agents|mesh-ancestor
92382331|NCT03933618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382332|NCT03933618|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92382333|NCT03933618|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92382334|NCT03930264|Azathioprine|azathioprine|mesh-list
92382335|NCT03930264|Antimetabolites|antimetabolites|mesh-ancestor
92382336|NCT03930264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382337|NCT03930264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92382338|NCT03930264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382339|NCT03930264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382340|NCT03930264|Immunologic Factors|immunologic factors|mesh-ancestor
92382341|NCT03930264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382342|NCT03930264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382343|NCT03861000|BPN14770|bpn14770|mesh-list
92382344|NCT03861000|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92382345|NCT03861000|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92382346|NCT03861000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382347|NCT03861000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382348|NCT03858894|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92382349|NCT03858894|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92382350|NCT03856164|Tranexamic Acid|tranexamic acid|mesh-list
92382351|NCT03856164|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92382352|NCT03856164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92382353|NCT03856164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382355|NCT03856164|Coagulants|coagulants|mesh-ancestor
92382356|NCT03849690|Esomeprazole|esomeprazole|mesh-list
92382357|NCT03849690|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92382358|NCT03849690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92382359|NCT03849690|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92382360|NCT03849690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382361|NCT03849690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382362|NCT03822078|Denosumab|denosumab|mesh-list
92382363|NCT03822078|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92382364|NCT03822078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382365|NCT03806556|Tranexamic Acid|tranexamic acid|mesh-list
92382366|NCT03806556|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92382367|NCT03806556|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92382368|NCT03806556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382369|NCT03806556|Hemostatics|hemostatics|mesh-ancestor
92382370|NCT03806556|Coagulants|coagulants|mesh-ancestor
92382371|NCT03812328|Enoxaparin|enoxaparin|mesh-list
92382372|NCT03812328|Anticoagulants|anticoagulants|mesh-ancestor
92382373|NCT03812328|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92382374|NCT03812328|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92382375|NCT03812328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382376|NCT03805386|Analgesics, Opioid|analgesics, opioid|mesh-list
92382377|NCT03805386|Narcotics|narcotics|mesh-ancestor
92382378|NCT03805386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382379|NCT03805386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382380|NCT03805386|Analgesics|analgesics|mesh-ancestor
92382381|NCT03805386|Sensory System Agents|sensory system agents|mesh-ancestor
92382382|NCT03805386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382384|NCT03796260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92382385|NCT03796260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382386|NCT03796260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382387|NCT03796182|Metformin|metformin|mesh-list
92382388|NCT03796182|Abrocitinib|abrocitinib|mesh-list
92382389|NCT03796182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382390|NCT03796182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382391|NCT03796182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92382392|NCT03796182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382393|NCT03796182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382394|NCT03730116|Bisoprolol|bisoprolol|mesh-list
92382395|NCT03730116|Perindopril|perindopril|mesh-list
92382396|NCT03730116|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382397|NCT03730116|Sympatholytics|sympatholytics|mesh-ancestor
92382398|NCT03730116|Autonomic Agents|autonomic agents|mesh-ancestor
92382399|NCT03730116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382400|NCT03730116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382401|NCT03730116|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92382402|NCT03730116|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92382403|NCT03730116|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92382404|NCT03730116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382405|NCT03730116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382406|NCT03730116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382407|NCT03730116|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92382408|NCT03730116|Protease Inhibitors|protease inhibitors|mesh-ancestor
92382409|NCT03730116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382410|NCT03370536|Ibutilide|ibutilide|mesh-list
92382411|NCT03370536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92382412|NCT03161964|Propranolol|propranolol|mesh-list
92382413|NCT03161964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92382414|NCT03161964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92382415|NCT03161964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382416|NCT03161964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382417|NCT03161964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382418|NCT03161964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382419|NCT03161964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92382420|NCT03161964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382421|NCT03161964|Vasodilator Agents|vasodilator agents|mesh-ancestor
92382422|NCT03078270|Botulinum Toxins|botulinum toxins|mesh-list
92382423|NCT03078270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92382424|NCT03078270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92382425|NCT03078270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92382426|NCT03078270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382427|NCT03078270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382428|NCT03078270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92382429|NCT03078270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382430|NCT03078270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382431|NCT03078270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92382432|NCT03078270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382433|NCT03042780|Folfirinox|folfirinox|mesh-list
92382434|NCT03042780|Lenograstim|lenograstim|mesh-list
92382435|NCT03042780|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92382436|NCT03042780|Immunologic Factors|immunologic factors|mesh-ancestor
92382437|NCT03042780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382438|NCT03042780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382439|NCT02985840|Dexamethasone|dexamethasone|mesh-list
92382440|NCT02985840|Ondansetron|ondansetron|mesh-list
92382441|NCT02985840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92382442|NCT02985840|Antiemetics|antiemetics|mesh-ancestor
92382443|NCT02985840|Autonomic Agents|autonomic agents|mesh-ancestor
92382444|NCT02985840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382445|NCT02985840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382446|NCT02985840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92382447|NCT02985840|Glucocorticoids|glucocorticoids|mesh-ancestor
92382448|NCT02985840|Hormones|hormones|mesh-ancestor
92382449|NCT02985840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382450|NCT02985840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92382451|NCT02985840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382452|NCT02985840|Antipruritics|antipruritics|mesh-ancestor
92382453|NCT02985840|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382454|NCT02985840|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92382455|NCT02985840|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92382456|NCT02985840|Serotonin Agents|serotonin agents|mesh-ancestor
92382457|NCT02985840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382458|NCT02985840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382459|NCT02974686|Mycophenolic Acid|mycophenolic acid|mesh-list
92382461|NCT02974686|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92382462|NCT02974686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92382463|NCT02974686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382464|NCT02974686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382465|NCT02974686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382466|NCT02974686|Immunologic Factors|immunologic factors|mesh-ancestor
92382467|NCT02974686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382468|NCT02974686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382469|NCT02974686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92382470|NCT02974686|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92382471|NCT02974686|Antitubercular Agents|antitubercular agents|mesh-ancestor
92382472|NCT02974686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382473|NCT02974686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382474|NCT02966184|Albuterol|albuterol|mesh-list
92382475|NCT02966184|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92382476|NCT02966184|Autonomic Agents|autonomic agents|mesh-ancestor
92382477|NCT02966184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382478|NCT02966184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382479|NCT02966184|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92382480|NCT02966184|Respiratory System Agents|respiratory system agents|mesh-ancestor
92382481|NCT02966184|Tocolytic Agents|tocolytic agents|mesh-ancestor
92382482|NCT02966184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382483|NCT02966184|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92382484|NCT02966184|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92382485|NCT02966184|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92382486|NCT02966184|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382487|NCT02966184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382488|NCT02966184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382489|NCT02774148|Acetaminophen|acetaminophen|mesh-list
92382490|NCT02774148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92382491|NCT02774148|Analgesics|analgesics|mesh-ancestor
92382492|NCT02774148|Sensory System Agents|sensory system agents|mesh-ancestor
92382493|NCT02774148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382494|NCT02774148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382495|NCT02774148|Antipyretics|antipyretics|mesh-ancestor
92382496|NCT02744352|Ropivacaine|ropivacaine|mesh-list
92382497|NCT02744352|Anesthetics, Local|anesthetics, local|mesh-ancestor
92382498|NCT02744352|Anesthetics|anesthetics|mesh-ancestor
92382499|NCT02744352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382500|NCT02744352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382501|NCT02744352|Sensory System Agents|sensory system agents|mesh-ancestor
92382502|NCT02744352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382503|NCT02587650|Ceritinib|ceritinib|mesh-list
92382504|NCT02587650|Entrectinib|entrectinib|mesh-list
92382505|NCT02587650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382506|NCT02587650|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92382507|NCT02587650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382508|NCT02587650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382509|NCT02514252|Fentanyl|fentanyl|mesh-list
92382510|NCT02514252|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92382511|NCT02514252|Narcotics|narcotics|mesh-ancestor
92382512|NCT02514252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382513|NCT02514252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382514|NCT02514252|Analgesics|analgesics|mesh-ancestor
92382515|NCT02514252|Sensory System Agents|sensory system agents|mesh-ancestor
92382516|NCT02514252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382517|NCT02514252|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92382518|NCT02514252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92382519|NCT02514252|Anesthetics, General|anesthetics, general|mesh-ancestor
92382520|NCT02514252|Anesthetics|anesthetics|mesh-ancestor
92382521|NCT02434146|Phenylephrine|phenylephrine|mesh-list
92382522|NCT02434146|Oxymetazoline|oxymetazoline|mesh-list
92382523|NCT02434146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92382524|NCT02434146|Mydriatics|mydriatics|mesh-ancestor
92382525|NCT02434146|Autonomic Agents|autonomic agents|mesh-ancestor
92382526|NCT02434146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382527|NCT02434146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382528|NCT02434146|Sympathomimetics|sympathomimetics|mesh-ancestor
92382529|NCT02434146|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92382530|NCT02434146|Nasal Decongestants|nasal decongestants|mesh-ancestor
92382531|NCT02434146|Respiratory System Agents|respiratory system agents|mesh-ancestor
92382532|NCT02434146|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92382533|NCT02434146|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92382534|NCT02434146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92382535|NCT02434146|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382536|NCT02434146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382537|NCT02434146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382538|NCT02434146|Protective Agents|protective agents|mesh-ancestor
92382539|NCT02382588|Ganciclovir|ganciclovir|mesh-list
92382540|NCT02382588|Antiviral Agents|antiviral agents|mesh-ancestor
92382541|NCT02382588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382542|NCT02345460|Leucovorin|leucovorin|mesh-list
92382543|NCT02345460|Fluorouracil|fluorouracil|mesh-list
92382544|NCT02345460|Oxaliplatin|oxaliplatin|mesh-list
92382545|NCT02345460|Irinotecan|irinotecan|mesh-list
92382546|NCT02345460|Calcium|calcium|mesh-list
92382547|NCT02345460|Levoleucovorin|levoleucovorin|mesh-list
92382548|NCT02345460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92382549|NCT02345460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382550|NCT02345460|Antimetabolites|antimetabolites|mesh-ancestor
92382551|NCT02345460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382552|NCT02345460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92382553|NCT02345460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382554|NCT02345460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382555|NCT02345460|Immunologic Factors|immunologic factors|mesh-ancestor
92382556|NCT02345460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92382557|NCT02345460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92382558|NCT02345460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382559|NCT02345460|Antidotes|antidotes|mesh-ancestor
92382560|NCT02345460|Protective Agents|protective agents|mesh-ancestor
92382561|NCT02345460|Vitamin B Complex|vitamin b complex|mesh-ancestor
92382562|NCT02345460|Vitamins|vitamins|mesh-ancestor
92382563|NCT02345460|Micronutrients|micronutrients|mesh-ancestor
92382564|NCT02345772|Docetaxel|docetaxel|mesh-list
92382565|NCT02345772|Trastuzumab|trastuzumab|mesh-list
92382566|NCT02345772|Fulvestrant|fulvestrant|mesh-list
92382567|NCT02345772|Pertuzumab|pertuzumab|mesh-list
92382568|NCT02345772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382569|NCT02345772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92382570|NCT02345772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92382571|NCT02345772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92382572|NCT02345772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382573|NCT02345772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92382574|NCT02345772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92382575|NCT02345772|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92382576|NCT02345772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92382577|NCT02345772|Hormone Antagonists|hormone antagonists|mesh-ancestor
92035050|NCT02473445|Cysteamine|cysteamine|mesh-list
92382578|NCT02345772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382579|NCT02345772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382580|NCT02280252|Paclitaxel|paclitaxel|mesh-list
92382581|NCT02280252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92382582|NCT02280252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382583|NCT02280252|Tubulin Modulators|tubulin modulators|mesh-ancestor
92382584|NCT02280252|Antimitotic Agents|antimitotic agents|mesh-ancestor
92382585|NCT02280252|Mitosis Modulators|mitosis modulators|mesh-ancestor
92382586|NCT02280252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382587|NCT02140788|Metformin|metformin|mesh-list
92382588|NCT02140788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382589|NCT02140788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382590|NCT02133534|Atorvastatin|atorvastatin|mesh-list
92382591|NCT02133534|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92382592|NCT02133534|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92382593|NCT02133534|Antimetabolites|antimetabolites|mesh-ancestor
92382594|NCT02133534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382595|NCT02133534|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92382596|NCT02133534|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92382597|NCT02133534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382598|NCT02015910|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92382599|NCT02015910|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382600|NCT02015910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382601|NCT02015910|Incretins|incretins|mesh-ancestor
92382602|NCT02015910|Hormones|hormones|mesh-ancestor
92382603|NCT02015910|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382604|NCT02015910|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92382605|NCT02015910|Protease Inhibitors|protease inhibitors|mesh-ancestor
92382606|NCT02015910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382607|NCT02015910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382608|NCT01980342|Efavirenz|efavirenz|mesh-list
92382609|NCT01980342|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92382610|NCT01980342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92382611|NCT01980342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382612|NCT01980342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382613|NCT01980342|Antiviral Agents|antiviral agents|mesh-ancestor
92382614|NCT01980342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382615|NCT01980342|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92382616|NCT01980342|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92382617|NCT01980342|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92382618|NCT01980342|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92382619|NCT01980342|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92382620|NCT01980342|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92382621|NCT01881984|Glycerol|glycerol|mesh-list
92382622|NCT01881984|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92382623|NCT01881984|Protective Agents|protective agents|mesh-ancestor
92382624|NCT01881984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382626|NCT01878786|Everolimus|everolimus|mesh-list
92382627|NCT01878786|Tacrolimus|tacrolimus|mesh-list
92382628|NCT01878786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382629|NCT01878786|Immunologic Factors|immunologic factors|mesh-ancestor
92382630|NCT01878786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382631|NCT01878786|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92382632|NCT01878786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382633|NCT01878786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382634|NCT01878786|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92382635|NCT01878786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92382636|NCT01878786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382637|NCT01878786|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92382638|NCT01878786|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92382639|NCT01878786|Antitubercular Agents|antitubercular agents|mesh-ancestor
92382640|NCT01878786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382641|NCT01878786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382642|NCT01851174|Paclitaxel|paclitaxel|mesh-list
92382643|NCT01851174|Gemcitabine|gemcitabine|mesh-list
92382644|NCT01851174|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92382645|NCT01851174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382646|NCT01851174|Tubulin Modulators|tubulin modulators|mesh-ancestor
92382647|NCT01851174|Antimitotic Agents|antimitotic agents|mesh-ancestor
92382648|NCT01851174|Mitosis Modulators|mitosis modulators|mesh-ancestor
92382649|NCT01851174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382650|NCT01851174|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92382651|NCT01851174|Antimetabolites|antimetabolites|mesh-ancestor
92382652|NCT01846182|Pregabalin|pregabalin|mesh-list
92382653|NCT01846182|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92382654|NCT01846182|Analgesics|analgesics|mesh-ancestor
92382655|NCT01846182|Sensory System Agents|sensory system agents|mesh-ancestor
92382656|NCT01846182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382657|NCT01846182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382658|NCT01846182|Anticonvulsants|anticonvulsants|mesh-ancestor
92382659|NCT01846182|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92382660|NCT01846182|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382661|NCT01846182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382662|NCT01846182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92382663|NCT01846182|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92382664|NCT01846182|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92382665|NCT01846182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382666|NCT01846182|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92382667|NCT01846182|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92382668|NCT01846182|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92382669|NCT01846182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382670|NCT01846182|Antidepressive Agents|antidepressive agents|mesh-ancestor
92382671|NCT01846182|Dopamine Agents|dopamine agents|mesh-ancestor
92382672|NCT01800162|Methotrexate|methotrexate|mesh-list
92382673|NCT01800162|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92382674|NCT01800162|Abortifacient Agents|abortifacient agents|mesh-ancestor
92382675|NCT01800162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382676|NCT01800162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382677|NCT01800162|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92382678|NCT01800162|Antimetabolites|antimetabolites|mesh-ancestor
92382679|NCT01800162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382680|NCT01800162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382681|NCT01800162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382682|NCT01800162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382683|NCT01800162|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92382684|NCT01800162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382685|NCT01800162|Immunologic Factors|immunologic factors|mesh-ancestor
92382686|NCT01800162|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382687|NCT01800162|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92382688|NCT01756560|Bupivacaine|bupivacaine|mesh-list
92382689|NCT01756560|Anesthetics, Local|anesthetics, local|mesh-ancestor
92382690|NCT01756560|Anesthetics|anesthetics|mesh-ancestor
92382691|NCT01756560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382692|NCT01756560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382693|NCT01756560|Sensory System Agents|sensory system agents|mesh-ancestor
92382694|NCT01756560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382695|NCT01738698|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92382696|NCT01738698|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92382697|NCT01738698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382698|NCT01738698|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92382699|NCT01738698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92382700|NCT01738698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382701|NCT01738698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382702|NCT01738698|Dopamine Agents|dopamine agents|mesh-ancestor
92382703|NCT01738698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382704|NCT01717482|Metformin|metformin|mesh-list
92382705|NCT01717482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92382706|NCT01717482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382707|NCT01702896|Interleukin-2|interleukin-2|mesh-list
92382708|NCT01702896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382709|NCT01702896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92382710|NCT01702896|Analgesics|analgesics|mesh-ancestor
92382711|NCT01702896|Sensory System Agents|sensory system agents|mesh-ancestor
92382712|NCT01702896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382713|NCT01702896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382714|NCT01683864|Cisplatin|cisplatin|mesh-list
92382715|NCT01683864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382716|NCT01608906|Heparin|heparin|mesh-list
92382717|NCT01608906|Calcium heparin|calcium heparin|mesh-list
92382718|NCT01608906|Anticoagulants|anticoagulants|mesh-ancestor
92382719|NCT01608906|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92382720|NCT01608906|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92382721|NCT01608906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382722|NCT01602198|Rivastigmine|rivastigmine|mesh-list
92382723|NCT01602198|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92382724|NCT01602198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382725|NCT01602198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382727|NCT01602198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382728|NCT01602198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382729|NCT01602198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92382730|NCT01602198|Protective Agents|protective agents|mesh-ancestor
92382732|NCT01545648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92382733|NCT01545648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382734|NCT01527942|Acetaminophen|acetaminophen|mesh-list
92382735|NCT01527942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92382736|NCT01527942|Analgesics|analgesics|mesh-ancestor
92382737|NCT01527942|Sensory System Agents|sensory system agents|mesh-ancestor
92382738|NCT01527942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382739|NCT01527942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382740|NCT01527942|Antipyretics|antipyretics|mesh-ancestor
92382741|NCT01507584|Bimatoprost|bimatoprost|mesh-list
92382742|NCT01507584|Brinzolamide|brinzolamide|mesh-list
92382743|NCT01507584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382744|NCT01507584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92382745|NCT01507584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382746|NCT01507584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382747|NCT01483872|Tigecycline|tigecycline|mesh-list
92382748|NCT01483872|Heparin|heparin|mesh-list
92382749|NCT01483872|Calcium heparin|calcium heparin|mesh-list
92382750|NCT01483872|Anticoagulants|anticoagulants|mesh-list
92382751|NCT01483872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382752|NCT01483872|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92382753|NCT01483872|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92382754|NCT01483872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382755|NCT01483872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382756|NCT01483872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92382757|NCT01483872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382758|NCT01385280|Exemestane|exemestane|mesh-list
92382759|NCT01385280|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92382760|NCT01385280|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92382761|NCT01385280|Estradiol|estradiol|mesh-list
92382762|NCT01385280|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92382763|NCT01385280|Estrogens|estrogens|mesh-ancestor
92382764|NCT01385280|Hormones|hormones|mesh-ancestor
92382765|NCT01385280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382766|NCT01385280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382767|NCT01385280|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92382768|NCT01385280|Contraceptive Agents|contraceptive agents|mesh-ancestor
92382769|NCT01385280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92382770|NCT01385280|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92382771|NCT01385280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382772|NCT01385280|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92382773|NCT01385280|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92382774|NCT01385280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382775|NCT01385280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382776|NCT01385280|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92382777|NCT01385280|Hormone Antagonists|hormone antagonists|mesh-ancestor
92382779|NCT01350258|Fludarabine phosphate|fludarabine phosphate|mesh-list
92382780|NCT01350258|Melphalan|melphalan|mesh-list
92382781|NCT01350258|Thiotepa|thiotepa|mesh-list
92382782|NCT01350258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382783|NCT01350258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92382784|NCT01350258|Antimetabolites|antimetabolites|mesh-ancestor
92382785|NCT01350258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382786|NCT01350258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382787|NCT01350258|Immunologic Factors|immunologic factors|mesh-ancestor
92382788|NCT01350258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382789|NCT01350258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92382790|NCT01350258|Alkylating Agents|alkylating agents|mesh-ancestor
92382791|NCT01350258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92382792|NCT01302444|Tadalafil|tadalafil|mesh-list
92382793|NCT01302444|Vasodilator Agents|vasodilator agents|mesh-ancestor
92382794|NCT01302444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92382795|NCT01302444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92382796|NCT01302444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382797|NCT01302444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382799|NCT01292070|Histamine|histamine|mesh-list
92382800|NCT01292070|Histamine Agonists|histamine agonists|mesh-ancestor
92382801|NCT01292070|Histamine Agents|histamine agents|mesh-ancestor
92382802|NCT01292070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382803|NCT01292070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382804|NCT01292070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382805|NCT01284504|Celecoxib|celecoxib|mesh-list
92382806|NCT01284504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92382807|NCT01284504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92382808|NCT01284504|Analgesics|analgesics|mesh-ancestor
92382809|NCT01284504|Sensory System Agents|sensory system agents|mesh-ancestor
92382810|NCT01284504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382811|NCT01284504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382812|NCT01284504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92382813|NCT01284504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92382814|NCT01284504|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92382815|NCT01284504|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92382816|NCT01284504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382817|NCT01284504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382818|NCT01183416|Tretinoin|tretinoin|mesh-list
92382819|NCT01183416|Isotretinoin|isotretinoin|mesh-list
92382820|NCT01183416|Antibodies|antibodies|mesh-list
92382821|NCT01183416|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92382822|NCT01183416|Immunologic Factors|immunologic factors|mesh-ancestor
92382823|NCT01183416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382824|NCT01183416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382825|NCT01183416|Keratolytic Agents|keratolytic agents|mesh-ancestor
92382826|NCT01183416|Dermatologic Agents|dermatologic agents|mesh-ancestor
92382827|NCT01169610|Varenicline|varenicline|mesh-list
92382828|NCT01169610|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92382829|NCT01169610|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92382830|NCT01169610|Cholinergic Agents|cholinergic agents|mesh-ancestor
92382831|NCT01169610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382832|NCT01169610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382833|NCT01169610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382835|NCT01166724|Tacrolimus|tacrolimus|mesh-list
92382836|NCT01166724|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382837|NCT01166724|Immunologic Factors|immunologic factors|mesh-ancestor
92382838|NCT01166724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382839|NCT01166724|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92382840|NCT01166724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382841|NCT01166724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382842|NCT01166724|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382843|NCT01166724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382844|NCT01166724|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92382845|NCT01166724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382846|NCT01166724|Antifungal Agents|antifungal agents|mesh-ancestor
92382847|NCT01151904|Timolol|timolol|mesh-list
92382848|NCT01151904|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92382849|NCT01151904|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92382851|NCT01151904|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92382852|NCT01151904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92382853|NCT01151904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92382854|NCT01151904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382855|NCT01151904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382856|NCT01151904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382857|NCT01151904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382858|NCT01151904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92382859|NCT01151904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382860|NCT01151904|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92382861|NCT01151904|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92382862|NCT01151904|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92382863|NCT01115244|Dapsone|dapsone|mesh-list
92382864|NCT01115244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92382865|NCT01115244|Antimalarials|antimalarials|mesh-ancestor
92382866|NCT01115244|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92382867|NCT01115244|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92382868|NCT01115244|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92382869|NCT01115244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382870|NCT01115244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382871|NCT01115244|Leprostatic Agents|leprostatic agents|mesh-ancestor
92382872|NCT01115244|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92382873|NCT01031550|Propofol|propofol|mesh-list
92382874|NCT01031550|Isoflurane|isoflurane|mesh-list
92382875|NCT01031550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92382876|NCT01031550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035355|NCT02471183|Selexipag|selexipag|mesh-list
92382877|NCT01031550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382878|NCT01031550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92382879|NCT01031550|Anesthetics, General|anesthetics, general|mesh-ancestor
92382880|NCT01031550|Anesthetics|anesthetics|mesh-ancestor
92382881|NCT01031550|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92382882|NCT00986310|Fluoxetine|fluoxetine|mesh-list
92382883|NCT00986310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92382884|NCT00986310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92382885|NCT00986310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382886|NCT00986310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382887|NCT00986310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382888|NCT00986310|Serotonin Agents|serotonin agents|mesh-ancestor
92382889|NCT00986310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382890|NCT00986310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92382891|NCT00986310|Antidepressive Agents|antidepressive agents|mesh-ancestor
92382892|NCT00986310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92382893|NCT00986310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92382894|NCT00986310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92382895|NCT00986310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382896|NCT00907218|Varenicline|varenicline|mesh-list
91937808|NCT04662723|Canagliflozin|canagliflozin|mesh-list
92382898|NCT00907218|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92382899|NCT00907218|Cholinergic Agents|cholinergic agents|mesh-ancestor
92382900|NCT00907218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382901|NCT00907218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382902|NCT00907218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382903|NCT00903396|Palonosetron|palonosetron|mesh-list
92382904|NCT00903396|Antiemetics|antiemetics|mesh-ancestor
92382905|NCT00903396|Autonomic Agents|autonomic agents|mesh-ancestor
92382906|NCT00903396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382907|NCT00903396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382908|NCT00903396|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92382909|NCT00903396|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92382910|NCT00903396|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92382911|NCT00903396|Serotonin Agents|serotonin agents|mesh-ancestor
92382912|NCT00903396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382913|NCT00903396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382914|NCT00875394|Metformin|metformin|mesh-list
92382915|NCT00875394|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92382916|NCT00875394|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92382917|NCT00875394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382918|NCT00875394|Incretins|incretins|mesh-ancestor
92382919|NCT00875394|Hormones|hormones|mesh-ancestor
92382920|NCT00875394|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92382921|NCT00875394|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92382923|NCT00875394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382924|NCT00875394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382925|NCT00832572|Ranolazine|ranolazine|mesh-list
92382926|NCT00832572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92382927|NCT00832572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382928|NCT00832572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382929|NCT00811590|Everolimus|everolimus|mesh-list
92382930|NCT00811590|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92382931|NCT00811590|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92382932|NCT00811590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382933|NCT00811590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382934|NCT00811590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92382935|NCT00811590|Immunologic Factors|immunologic factors|mesh-ancestor
92382936|NCT00811590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382937|NCT00811590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382938|NCT00749658|Bupropion|bupropion|mesh-list
92382939|NCT00749658|Varenicline|varenicline|mesh-list
92382940|NCT00749658|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92382941|NCT00749658|Antidepressive Agents|antidepressive agents|mesh-ancestor
92382942|NCT00749658|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92382943|NCT00749658|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92382944|NCT00749658|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92382945|NCT00749658|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92382946|NCT00749658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382947|NCT00749658|Dopamine Agents|dopamine agents|mesh-ancestor
92382948|NCT00749658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035433|NCT02038647|Paclitaxel|paclitaxel|mesh-list
92382949|NCT00749658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382950|NCT00749658|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92382951|NCT00749658|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92382952|NCT00749658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382953|NCT00749658|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92382954|NCT00749658|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92382955|NCT00749658|Cholinergic Agents|cholinergic agents|mesh-ancestor
92382956|NCT00738972|Valsartan|valsartan|mesh-list
92382957|NCT00738972|Simvastatin|simvastatin|mesh-list
92382958|NCT00738972|Ezetimibe|ezetimibe|mesh-list
92382959|NCT00738972|Pravastatin|pravastatin|mesh-list
92382960|NCT00738972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92382961|NCT00738972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92382962|NCT00738972|Antimetabolites|antimetabolites|mesh-ancestor
92382963|NCT00738972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382964|NCT00738972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92382965|NCT00738972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92382966|NCT00738972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92382967|NCT00738972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92382968|NCT00738972|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92382969|NCT00738972|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92382971|NCT00726180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92382972|NCT00726180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92382973|NCT00704496|Pseudoephedrine|pseudoephedrine|mesh-list
92382974|NCT00704496|Ephedrine|ephedrine|mesh-list
92382975|NCT00704496|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92382976|NCT00704496|Autonomic Agents|autonomic agents|mesh-ancestor
92382977|NCT00704496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92382978|NCT00704496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382979|NCT00704496|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92382980|NCT00704496|Respiratory System Agents|respiratory system agents|mesh-ancestor
92382981|NCT00704496|Nasal Decongestants|nasal decongestants|mesh-ancestor
92382982|NCT00704496|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92382983|NCT00704496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92382984|NCT00704496|Sympathomimetics|sympathomimetics|mesh-ancestor
92382985|NCT00704496|Adrenergic Agents|adrenergic agents|mesh-ancestor
92382986|NCT00704496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92382987|NCT00704496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382988|NCT00692094|Melatonin|melatonin|mesh-list
92382989|NCT00692094|Antioxidants|antioxidants|mesh-ancestor
92031186|NCT04905277|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92382990|NCT00692094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92382991|NCT00692094|Protective Agents|protective agents|mesh-ancestor
92382992|NCT00692094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92382993|NCT00692094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92382994|NCT00676026|Zolpidem|zolpidem|mesh-list
92382995|NCT00676026|Fluoxetine|fluoxetine|mesh-list
92382996|NCT00676026|Progesterone|progesterone|mesh-list
92382997|NCT00676026|Progestins|progestins|mesh-ancestor
92382998|NCT00676026|Hormones|hormones|mesh-ancestor
92382999|NCT00676026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92383000|NCT00676026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383001|NCT00676026|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92383002|NCT00676026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92383003|NCT00676026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383004|NCT00676026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383005|NCT00676026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383006|NCT00676026|Serotonin Agents|serotonin agents|mesh-ancestor
92383007|NCT00676026|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92383008|NCT00676026|Antidepressive Agents|antidepressive agents|mesh-ancestor
92383009|NCT00676026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383010|NCT00676026|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92383011|NCT00676026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383012|NCT00676026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383013|NCT00676026|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92383014|NCT00676026|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92383015|NCT00676026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383016|NCT00676026|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92383017|NCT00676026|GABA Agonists|gaba agonists|mesh-ancestor
92383018|NCT00676026|GABA Agents|gaba agents|mesh-ancestor
92383019|NCT00656916|Fluticasone|fluticasone|mesh-list
92383021|NCT00656916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92383022|NCT00656916|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92383023|NCT00656916|Autonomic Agents|autonomic agents|mesh-ancestor
92383024|NCT00656916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383025|NCT00656916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383026|NCT00656916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92383027|NCT00656916|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383028|NCT00656916|Dermatologic Agents|dermatologic agents|mesh-ancestor
92383029|NCT00656916|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92383030|NCT00619242|Sorafenib|sorafenib|mesh-list
92383031|NCT00619242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383032|NCT00619242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92383033|NCT00619242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383034|NCT00619242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383035|NCT00601848|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92383036|NCT00601848|Trioxsalen|trioxsalen|mesh-list
92383037|NCT00601848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383038|NCT00601848|Dermatologic Agents|dermatologic agents|mesh-ancestor
92383039|NCT00601848|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92383040|NCT00586716|Immunoglobulins|immunoglobulins|mesh-list
92383041|NCT00586716|Antibodies|antibodies|mesh-list
92383042|NCT00586716|gamma-Globulins|gamma-globulins|mesh-list
92383043|NCT00586716|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92383044|NCT00586716|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92383045|NCT00586716|Immunologic Factors|immunologic factors|mesh-ancestor
92383046|NCT00586716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383047|NCT00571194|Pravastatin|pravastatin|mesh-list
92383048|NCT00571194|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92383049|NCT00571194|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92383050|NCT00571194|Antimetabolites|antimetabolites|mesh-ancestor
92383051|NCT00571194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383052|NCT00571194|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92383053|NCT00571194|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92383054|NCT00571194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383055|NCT00570258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92383056|NCT00570258|Fulvestrant|fulvestrant|mesh-list
92383057|NCT00570258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383058|NCT00570258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92383059|NCT00570258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383060|NCT00570258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383061|NCT00570258|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92383062|NCT00570258|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92383064|NCT00570258|Hormone Antagonists|hormone antagonists|mesh-ancestor
92383065|NCT00570258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92383066|NCT00570258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383067|NCT00568698|Hydroxyurea|hydroxyurea|mesh-list
92383068|NCT00568698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383069|NCT00568698|Antisickling Agents|antisickling agents|mesh-ancestor
92383070|NCT00568698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383071|NCT00568698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383072|NCT00568698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383074|NCT00577356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383075|NCT00577356|Tubulin Modulators|tubulin modulators|mesh-ancestor
92383076|NCT00577356|Antimitotic Agents|antimitotic agents|mesh-ancestor
92383077|NCT00577356|Mitosis Modulators|mitosis modulators|mesh-ancestor
92383078|NCT00577356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383079|NCT00569868|Bortezomib|bortezomib|mesh-list
92383080|NCT00569868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383081|NCT05599230|Ivacaftor|ivacaftor|mesh-list
92383082|NCT05599230|Elexacaftor|elexacaftor|mesh-list
92383083|NCT05599230|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92383084|NCT05599230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383085|NCT05599230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383086|NCT05403762|Protective Agents|protective agents|mesh-list
92383087|NCT05403762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383088|NCT05164614|Teriparatide|teriparatide|mesh-list
92383089|NCT05164614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383090|NCT05164614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383091|NCT05164614|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92383092|NCT05001048|Phenylephrine|phenylephrine|mesh-list
92383093|NCT05001048|Oxymetazoline|oxymetazoline|mesh-list
92383094|NCT05001048|Synephrine|synephrine|mesh-list
92383095|NCT05001048|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92383096|NCT05001048|Mydriatics|mydriatics|mesh-ancestor
92035574|NCT02282293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92383097|NCT05001048|Autonomic Agents|autonomic agents|mesh-ancestor
92383098|NCT05001048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383099|NCT05001048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383100|NCT05001048|Sympathomimetics|sympathomimetics|mesh-ancestor
92383101|NCT05001048|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92383102|NCT05001048|Nasal Decongestants|nasal decongestants|mesh-ancestor
92383103|NCT05001048|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383104|NCT05001048|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92383105|NCT05001048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92383106|NCT05001048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92383107|NCT05001048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383108|NCT05001048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383109|NCT05001048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383110|NCT05001048|Protective Agents|protective agents|mesh-ancestor
92383111|NCT04954638|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92383112|NCT04954638|Chlorine dioxide|chlorine dioxide|mesh-list
92383114|NCT04954638|Disinfectants|disinfectants|mesh-ancestor
92383115|NCT04954638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383116|NCT04954638|Dental Disinfectants|dental disinfectants|mesh-ancestor
92383117|NCT04810572|Silymarin|silymarin|mesh-list
92383118|NCT04810572|Antioxidants|antioxidants|mesh-ancestor
92383119|NCT04810572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383120|NCT04810572|Protective Agents|protective agents|mesh-ancestor
92383121|NCT04810572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383122|NCT04575090|Simvastatin|simvastatin|mesh-list
92383123|NCT04575090|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92383124|NCT04575090|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92383125|NCT04575090|Antimetabolites|antimetabolites|mesh-ancestor
92383126|NCT04575090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383127|NCT04575090|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92383128|NCT04575090|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92383129|NCT04575090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383131|NCT04100772|Immunologic Factors|immunologic factors|mesh-ancestor
92383132|NCT04100772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383133|NCT04043520|Estradiol|estradiol|mesh-list
92383134|NCT04043520|Estrogens|estrogens|mesh-list
92383135|NCT04043520|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92383136|NCT04043520|Hormones|hormones|mesh-ancestor
92383137|NCT04043520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92383138|NCT04043520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383139|NCT03582930|Calfactant|calfactant|mesh-list
92383140|NCT03582930|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92383141|NCT03582930|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383142|NCT03472872|Acetaminophen|acetaminophen|mesh-list
92383143|NCT03472872|Ketorolac|ketorolac|mesh-list
92383144|NCT03472872|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91957431|NCT03387241|Xhance|xhance|mesh-list
92383145|NCT03472872|Analgesics|analgesics|mesh-ancestor
91957724|NCT04420741|Iloprost|iloprost|mesh-list
91958035|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
92383146|NCT03472872|Sensory System Agents|sensory system agents|mesh-ancestor
92383147|NCT03472872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383148|NCT03472872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383149|NCT03472872|Antipyretics|antipyretics|mesh-ancestor
92383150|NCT03472872|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92383151|NCT03472872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92383152|NCT03472872|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92383153|NCT03472872|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92383154|NCT03472872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383155|NCT03472872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383156|NCT03301038|Rifampin|rifampin|mesh-list
92383157|NCT03301038|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92383158|NCT03301038|Antitubercular Agents|antitubercular agents|mesh-ancestor
92383159|NCT03301038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383160|NCT03301038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383161|NCT03301038|Leprostatic Agents|leprostatic agents|mesh-ancestor
92383162|NCT03301038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383163|NCT03301038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958237|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
92383164|NCT03301038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383165|NCT03301038|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92383166|NCT03301038|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92383167|NCT03301038|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92383168|NCT03301038|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92383169|NCT03301038|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92383170|NCT03301038|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92383171|NCT02411526|Risperidone|risperidone|mesh-list
92383172|NCT02411526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92383173|NCT02411526|Serotonin Agents|serotonin agents|mesh-ancestor
91958305|NCT03370159|Vitamins|vitamins|mesh-ancestor
92383174|NCT02411526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115105|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
92383175|NCT02411526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383176|NCT02411526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383177|NCT02411526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92383178|NCT02411526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92383179|NCT02411526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383180|NCT02411526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383181|NCT02411526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92383182|NCT02411526|Dopamine Agents|dopamine agents|mesh-ancestor
92383184|NCT00564876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383185|NCT00564876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92383186|NCT00564876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383187|NCT00564876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383188|NCT00558870|Morphine|morphine|mesh-list
92383189|NCT00558870|Methadone|methadone|mesh-list
92383190|NCT00558870|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383191|NCT00558870|Narcotics|narcotics|mesh-ancestor
92383192|NCT00558870|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383193|NCT00558870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383194|NCT00558870|Analgesics|analgesics|mesh-ancestor
92383195|NCT00558870|Sensory System Agents|sensory system agents|mesh-ancestor
92383196|NCT00558870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383197|NCT00558870|Antitussive Agents|antitussive agents|mesh-ancestor
92115106|NCT04915144|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92383198|NCT00558870|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383199|NCT00548886|Epinephrine|epinephrine|mesh-list
92383200|NCT00548886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92383201|NCT00548886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92383202|NCT00548886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383203|NCT00548886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383204|NCT00548886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125412|NCT05705830|Serotonin|serotonin|mesh-list
91959152|NCT03353857|Progestins|progestins|mesh-ancestor
92383205|NCT00548886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383206|NCT00548886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92383207|NCT00548886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92383208|NCT00548886|Autonomic Agents|autonomic agents|mesh-ancestor
92383209|NCT00548886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383210|NCT00548886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92383211|NCT00548886|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383212|NCT00548886|Mydriatics|mydriatics|mesh-ancestor
92383213|NCT00548886|Sympathomimetics|sympathomimetics|mesh-ancestor
92383214|NCT00548886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92383215|NCT00538980|Dasatinib|dasatinib|mesh-list
92383216|NCT00538980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383217|NCT00538980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92383218|NCT00538980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383219|NCT00538980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383220|NCT00519090|Imatinib Mesylate|imatinib mesylate|mesh-list
92383221|NCT00519090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383222|NCT00519090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92383223|NCT00519090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383224|NCT00519090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383225|NCT00506064|Melatonin|melatonin|mesh-list
92383226|NCT00506064|Antioxidants|antioxidants|mesh-ancestor
92383227|NCT00506064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383228|NCT00506064|Protective Agents|protective agents|mesh-ancestor
92383229|NCT00506064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383230|NCT00506064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383231|NCT00503880|Cytarabine|cytarabine|mesh-list
92383232|NCT00503880|Clofarabine|clofarabine|mesh-list
92383233|NCT00503880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92383234|NCT00503880|Antimetabolites|antimetabolites|mesh-ancestor
92383235|NCT00503880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383236|NCT00503880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383237|NCT00503880|Antiviral Agents|antiviral agents|mesh-ancestor
92383238|NCT00503880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383239|NCT00503880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92383240|NCT00503880|Immunologic Factors|immunologic factors|mesh-ancestor
92383241|NCT00503880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383242|NCT00475332|Tositumomab I-131|tositumomab i-131|mesh-list
92383243|NCT00475332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959679|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
92383244|NCT00470574|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
92383245|NCT00470574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92383246|NCT00470574|Immunologic Factors|immunologic factors|mesh-ancestor
91959833|NCT05060523|Tolvaptan|tolvaptan|mesh-list
92383247|NCT00470574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383248|NCT00442260|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92383249|NCT00442260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383251|NCT00145704|Ergocalciferols|ergocalciferols|mesh-list
92383252|NCT00145704|Cholecalciferol|cholecalciferol|mesh-list
92383253|NCT00145704|Risedronic Acid|risedronic acid|mesh-list
92383254|NCT00145704|Diphosphonates|diphosphonates|mesh-list
92383255|NCT00145704|Vitamins|vitamins|mesh-list
92383256|NCT00145704|Micronutrients|micronutrients|mesh-ancestor
92383257|NCT00145704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383258|NCT00145704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383259|NCT00145704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92383260|NCT00145704|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92383261|NCT00145704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383262|NCT00145704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383264|NCT00108342|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92383265|NCT00108342|Autonomic Agents|autonomic agents|mesh-ancestor
92383266|NCT00108342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383267|NCT00108342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383268|NCT00108342|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92383269|NCT00108342|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92383270|NCT00108342|Cholinergic Agents|cholinergic agents|mesh-ancestor
92383271|NCT00108342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383272|NCT00108342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383273|NCT00090870|Interferons|interferons|mesh-list
92383274|NCT00090870|Interferon-alpha|interferon-alpha|mesh-list
92383275|NCT00090870|Interferon alpha-2|interferon alpha-2|mesh-list
92383276|NCT00090870|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92383277|NCT00090870|Thalidomide|thalidomide|mesh-list
92383278|NCT00090870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383279|NCT00090870|Antiviral Agents|antiviral agents|mesh-ancestor
92383280|NCT00090870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383281|NCT00090870|Immunologic Factors|immunologic factors|mesh-ancestor
92383282|NCT00090870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383283|NCT00090870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92383284|NCT00090870|Leprostatic Agents|leprostatic agents|mesh-ancestor
92383285|NCT00090870|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383286|NCT00090870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92383287|NCT00090870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92383288|NCT00090870|Growth Substances|growth substances|mesh-ancestor
92383289|NCT00090870|Growth Inhibitors|growth inhibitors|mesh-ancestor
92383291|NCT00074724|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92383292|NCT00074724|Sympathomimetics|sympathomimetics|mesh-ancestor
92383293|NCT00074724|Autonomic Agents|autonomic agents|mesh-ancestor
92383294|NCT00074724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383295|NCT00074724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383296|NCT00074724|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92383297|NCT00074724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92383298|NCT00074724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92383299|NCT00074724|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383300|NCT00074724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960311|NCT02505841|Curare|curare|mesh-list
92383301|NCT00074724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383302|NCT00074724|Protective Agents|protective agents|mesh-ancestor
92383303|NCT00058188|Cholecalciferol|cholecalciferol|mesh-list
92383304|NCT00058188|Vitamin D|vitamin d|mesh-list
92383305|NCT00058188|Zoledronic Acid|zoledronic acid|mesh-list
92383306|NCT00058188|Calcium|calcium|mesh-list
92383307|NCT00058188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383308|NCT00058188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383309|NCT00058188|Vitamins|vitamins|mesh-ancestor
92383310|NCT00058188|Micronutrients|micronutrients|mesh-ancestor
92383311|NCT00058188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92383312|NCT00003726|Lepirudin|lepirudin|mesh-list
92383313|NCT00003726|Antithrombins|antithrombins|mesh-ancestor
92383314|NCT00003726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92383315|NCT00003726|Protease Inhibitors|protease inhibitors|mesh-ancestor
92383316|NCT00003726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125639|NCT02397330|Narcotics|narcotics|mesh-ancestor
92383317|NCT00003726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383318|NCT00003726|Anticoagulants|anticoagulants|mesh-ancestor
92383319|NCT00003726|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92383320|NCT00003726|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92383321|NCT02595996|Propranolol|propranolol|mesh-list
92383322|NCT02595996|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92383323|NCT02595996|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92383324|NCT02595996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383325|NCT02595996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960952|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
92125640|NCT02397330|Analgesics|analgesics|mesh-ancestor
92383326|NCT02595996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383327|NCT02595996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383328|NCT02595996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92383329|NCT02595996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92383330|NCT02595996|Vasodilator Agents|vasodilator agents|mesh-ancestor
92383331|NCT04422210|Carboplatin|carboplatin|mesh-list
92383332|NCT04422210|Etoposide|etoposide|mesh-list
92383333|NCT04422210|Atezolizumab|atezolizumab|mesh-list
92383334|NCT04422210|Venetoclax|venetoclax|mesh-list
92383335|NCT04422210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383336|NCT04422210|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92383337|NCT04422210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92383338|NCT04422210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92383339|NCT04422210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383340|NCT04422210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383341|NCT04422210|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92383342|NCT04422210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92383343|NCT00000132|Betaxolol|betaxolol|mesh-list
92383344|NCT00000132|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92383345|NCT00000132|Sympatholytics|sympatholytics|mesh-ancestor
92383346|NCT00000132|Autonomic Agents|autonomic agents|mesh-ancestor
91961342|NCT03327727|Voriconazole|voriconazole|mesh-list
92383347|NCT00000132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383348|NCT00000132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383349|NCT00000132|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92383350|NCT00000132|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92383351|NCT00000132|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92383352|NCT00000132|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383353|NCT00000132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383354|NCT00000132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383356|NCT00000138|Prednisolone|prednisolone|mesh-list
92383357|NCT00000138|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92383358|NCT00000138|Methylprednisolone|methylprednisolone|mesh-list
92383359|NCT00000138|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92383360|NCT00000138|Prednisolone acetate|prednisolone acetate|mesh-list
92383361|NCT00000138|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92383362|NCT00000138|Prednisolone phosphate|prednisolone phosphate|mesh-list
92383363|NCT00000138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92383364|NCT00000138|Glucocorticoids|glucocorticoids|mesh-ancestor
92383365|NCT00000138|Hormones|hormones|mesh-ancestor
92383366|NCT00000138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92383367|NCT00000138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383368|NCT00000138|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92383369|NCT00000138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383370|NCT00000138|Antiemetics|antiemetics|mesh-ancestor
92383371|NCT00000138|Autonomic Agents|autonomic agents|mesh-ancestor
92383372|NCT00000138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383373|NCT00000138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92383374|NCT00000138|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92383375|NCT00000138|Protective Agents|protective agents|mesh-ancestor
92383376|NCT00000138|Antiviral Agents|antiviral agents|mesh-ancestor
92383377|NCT00000138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383378|NCT00000174|Rivastigmine|rivastigmine|mesh-list
92383379|NCT00000174|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92383380|NCT00000174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383381|NCT00000174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961533|NCT03318835|Doxorubicin|doxorubicin|mesh-list
92383382|NCT00000174|Cholinergic Agents|cholinergic agents|mesh-ancestor
92383383|NCT00000174|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383384|NCT00000174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383385|NCT00000174|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92383386|NCT00000174|Protective Agents|protective agents|mesh-ancestor
92383387|NCT00000192|Lamotrigine|lamotrigine|mesh-list
92383388|NCT00000192|Anticonvulsants|anticonvulsants|mesh-ancestor
92383389|NCT00000192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92383390|NCT00000192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383391|NCT00000192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115533|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
92383392|NCT00000192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383393|NCT00000192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383394|NCT00000192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92383395|NCT00000192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92383396|NCT00000192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383397|NCT00000192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383398|NCT00000192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92383399|NCT00000198|Piracetam|piracetam|mesh-list
92383400|NCT00000198|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92383401|NCT00000198|Protective Agents|protective agents|mesh-ancestor
92383402|NCT00000198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383403|NCT00000198|Nootropic Agents|nootropic agents|mesh-ancestor
92383404|NCT00000204|Buprenorphine|buprenorphine|mesh-list
92383405|NCT00000204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383406|NCT00000204|Narcotics|narcotics|mesh-ancestor
92383407|NCT00000204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383408|NCT00000204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383409|NCT00000204|Analgesics|analgesics|mesh-ancestor
92383410|NCT00000204|Sensory System Agents|sensory system agents|mesh-ancestor
92383411|NCT00000204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383412|NCT00000204|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383413|NCT00000210|Buprenorphine|buprenorphine|mesh-list
92383414|NCT00000210|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383415|NCT00000210|Narcotics|narcotics|mesh-ancestor
92383416|NCT00000210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383417|NCT00000210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383418|NCT00000210|Analgesics|analgesics|mesh-ancestor
92383419|NCT00000210|Sensory System Agents|sensory system agents|mesh-ancestor
92383420|NCT00000210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383421|NCT00000210|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383422|NCT00000222|Buprenorphine|buprenorphine|mesh-list
92383423|NCT00000222|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383424|NCT00000222|Narcotics|narcotics|mesh-ancestor
92383425|NCT00000222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383426|NCT00000222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383427|NCT00000222|Analgesics|analgesics|mesh-ancestor
92383428|NCT00000222|Sensory System Agents|sensory system agents|mesh-ancestor
92383429|NCT00000222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383430|NCT00000222|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383431|NCT00000228|Buprenorphine|buprenorphine|mesh-list
91961931|NCT02476981|Ephedrine|ephedrine|mesh-list
92383432|NCT00000228|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383433|NCT00000228|Narcotics|narcotics|mesh-ancestor
92383434|NCT00000228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383435|NCT00000228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383436|NCT00000228|Analgesics|analgesics|mesh-ancestor
92383437|NCT00000228|Sensory System Agents|sensory system agents|mesh-ancestor
92383438|NCT00000228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383439|NCT00000228|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383440|NCT00000234|Buprenorphine|buprenorphine|mesh-list
92383441|NCT00000234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383442|NCT00000234|Narcotics|narcotics|mesh-ancestor
92383443|NCT00000234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383444|NCT00000234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383445|NCT00000234|Analgesics|analgesics|mesh-ancestor
92383446|NCT00000234|Sensory System Agents|sensory system agents|mesh-ancestor
92383447|NCT00000234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383448|NCT00000234|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383449|NCT00000240|Buprenorphine|buprenorphine|mesh-list
92383450|NCT00000240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383451|NCT00000240|Narcotics|narcotics|mesh-ancestor
92383452|NCT00000240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383453|NCT00000240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383454|NCT00000240|Analgesics|analgesics|mesh-ancestor
92383455|NCT00000240|Sensory System Agents|sensory system agents|mesh-ancestor
92383456|NCT00000240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383457|NCT00000240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383458|NCT00000246|Flumazenil|flumazenil|mesh-list
92383459|NCT00000246|Antidotes|antidotes|mesh-ancestor
92383460|NCT00000246|Protective Agents|protective agents|mesh-ancestor
92383461|NCT00000246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383462|NCT00000246|GABA Modulators|gaba modulators|mesh-ancestor
92383463|NCT00000246|GABA Agents|gaba agents|mesh-ancestor
92383464|NCT00000246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383465|NCT00000246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383466|NCT00000264|Ethanol|ethanol|mesh-list
92383467|NCT00000264|Nitrous Oxide|nitrous oxide|mesh-list
92383468|NCT00000264|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92125641|NCT03081052|Nitric Oxide|nitric oxide|mesh-list
92383469|NCT00000264|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383470|NCT00000264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383471|NCT00000264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383472|NCT00000264|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92383473|NCT00000264|Anesthetics, General|anesthetics, general|mesh-ancestor
92383474|NCT00000264|Anesthetics|anesthetics|mesh-ancestor
92383475|NCT00000264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92383476|NCT00000264|Analgesics|analgesics|mesh-ancestor
92383477|NCT00000264|Sensory System Agents|sensory system agents|mesh-ancestor
92383478|NCT00000264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383479|NCT00000270|Cocaine|cocaine|mesh-list
92383480|NCT00000270|Anesthetics, Local|anesthetics, local|mesh-ancestor
92383481|NCT00000270|Anesthetics|anesthetics|mesh-ancestor
92383482|NCT00000270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383483|NCT00000270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383484|NCT00000270|Sensory System Agents|sensory system agents|mesh-ancestor
92383485|NCT00000270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383486|NCT00000270|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92383487|NCT00000270|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92383488|NCT00000270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92383489|NCT00000270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383490|NCT00000270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383491|NCT00000270|Dopamine Agents|dopamine agents|mesh-ancestor
92383492|NCT00000270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383493|NCT00000276|Bupropion|bupropion|mesh-list
92383494|NCT00000276|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92383495|NCT00000276|Antidepressive Agents|antidepressive agents|mesh-ancestor
92383496|NCT00000276|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383497|NCT00000276|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92383498|NCT00000276|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91962563|NCT03903939|Iloprost|iloprost|mesh-list
92383499|NCT00000276|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383500|NCT00000276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383502|NCT00000276|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383503|NCT00000276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383504|NCT00000276|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91944990|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
92383505|NCT00000276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383506|NCT00000276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383507|NCT00000282|Pemoline|pemoline|mesh-list
92383508|NCT00000282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92383509|NCT00000282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383510|NCT00000294|Carvedilol|carvedilol|mesh-list
92383511|NCT00000294|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92383512|NCT00000294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92383513|NCT00000294|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383514|NCT00000294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383515|NCT00000294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125800|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
92383516|NCT00000294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383517|NCT00000294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92383518|NCT00000294|Antioxidants|antioxidants|mesh-ancestor
92383519|NCT00000294|Protective Agents|protective agents|mesh-ancestor
92383520|NCT00000294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92383521|NCT00000294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383522|NCT00000294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383523|NCT00000294|Vasodilator Agents|vasodilator agents|mesh-ancestor
92383524|NCT00000294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92383525|NCT00000294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92383526|NCT00000306|Dextroamphetamine|dextroamphetamine|mesh-list
92383527|NCT00000306|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92383528|NCT00000306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383529|NCT00000306|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92383530|NCT00000306|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92383531|NCT00000306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383532|NCT00000306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383533|NCT00000306|Dopamine Agents|dopamine agents|mesh-ancestor
92383534|NCT00000306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383535|NCT00000318|Buprenorphine|buprenorphine|mesh-list
92383536|NCT00000318|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92383537|NCT00000318|Narcotics|narcotics|mesh-ancestor
92383538|NCT00000318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383539|NCT00000318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383540|NCT00000318|Analgesics|analgesics|mesh-ancestor
92383541|NCT00000318|Sensory System Agents|sensory system agents|mesh-ancestor
92383542|NCT00000318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383543|NCT00000318|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383544|NCT00000330|Analgesics, Opioid|analgesics, opioid|mesh-list
92383545|NCT00000330|Narcotics|narcotics|mesh-ancestor
92036015|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92383546|NCT00000330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383547|NCT00000330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383549|NCT00000330|Sensory System Agents|sensory system agents|mesh-ancestor
92383550|NCT00000330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383551|NCT00000336|Selegiline|selegiline|mesh-list
92383552|NCT00000336|Antidepressive Agents|antidepressive agents|mesh-ancestor
92383553|NCT00000336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383554|NCT00000336|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92383555|NCT00000336|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92383556|NCT00000336|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92383557|NCT00000336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383558|NCT00000336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383559|NCT00000336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92383560|NCT00000336|Protective Agents|protective agents|mesh-ancestor
92383561|NCT00000336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383562|NCT00000342|Risperidone|risperidone|mesh-list
92383563|NCT00000342|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92383564|NCT00000342|Serotonin Agents|serotonin agents|mesh-ancestor
92383565|NCT00000342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383566|NCT00000342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383567|NCT00000342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383568|NCT00000342|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92383569|NCT00000342|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92383570|NCT00000342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383571|NCT00000342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383572|NCT00000342|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92383573|NCT00000342|Dopamine Agents|dopamine agents|mesh-ancestor
92383574|NCT00000348|Dihydrexidine|dihydrexidine|mesh-list
92383575|NCT00000348|Dopamine Agonists|dopamine agonists|mesh-ancestor
92383576|NCT00000348|Dopamine Agents|dopamine agents|mesh-ancestor
92383577|NCT00000348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383578|NCT00000348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383579|NCT00000348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383580|NCT00000354|Lofexidine|lofexidine|mesh-list
92383581|NCT00000354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92383582|NCT00000354|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383583|NCT00000354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383584|NCT00000354|Sensory System Agents|sensory system agents|mesh-ancestor
92383585|NCT00000354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383586|NCT00000354|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92383587|NCT00000354|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92383588|NCT00000354|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92383589|NCT00000354|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383590|NCT00000354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383591|NCT00000354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383592|NCT00000372|Cycloserine|cycloserine|mesh-list
92383593|NCT00000372|Clozapine|clozapine|mesh-list
92383594|NCT00000372|Glycine|glycine|mesh-list
92383595|NCT00000372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92383596|NCT00000372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383597|NCT00000372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92383598|NCT00000372|Antitubercular Agents|antitubercular agents|mesh-ancestor
92383599|NCT00000372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383600|NCT00000372|Antimetabolites|antimetabolites|mesh-ancestor
92383601|NCT00000372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126029|NCT02651584|Buprenorphine|buprenorphine|mesh-list
92383602|NCT00000372|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92383603|NCT00000372|Serotonin Agents|serotonin agents|mesh-ancestor
92383604|NCT00000372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383605|NCT00000372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383606|NCT00000372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92383607|NCT00000372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92383608|NCT00000372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92383609|NCT00000372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383610|NCT00000372|GABA Antagonists|gaba antagonists|mesh-ancestor
92383611|NCT00000372|GABA Agents|gaba agents|mesh-ancestor
92383612|NCT00000372|Glycine Agents|glycine agents|mesh-ancestor
92383613|NCT00000384|Sertraline|sertraline|mesh-list
92383614|NCT00000384|Antidepressive Agents|antidepressive agents|mesh-ancestor
92383615|NCT00000384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383616|NCT00000384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92383617|NCT00000384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92383618|NCT00000384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036091|NCT02279407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92383619|NCT00000384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383620|NCT00000384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383621|NCT00000384|Serotonin Agents|serotonin agents|mesh-ancestor
92383622|NCT00000384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383623|NCT00000390|Imipramine|imipramine|mesh-list
92383624|NCT00000390|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92383625|NCT00000390|Antidepressive Agents|antidepressive agents|mesh-ancestor
92383626|NCT00000390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92383627|NCT00000390|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92383628|NCT00000390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92383629|NCT00000390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383630|NCT00000390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383631|NCT00000390|Adrenergic Agents|adrenergic agents|mesh-ancestor
92383632|NCT00000390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92383633|NCT00000390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383634|NCT00000402|Calcium|calcium|mesh-list
92383635|NCT00000402|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383636|NCT00000402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383637|NCT00000438|Naltrexone|naltrexone|mesh-list
91964270|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
92383638|NCT00000438|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92383639|NCT00000438|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383640|NCT00000438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383641|NCT00000438|Sensory System Agents|sensory system agents|mesh-ancestor
92383642|NCT00000438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383644|NCT00000444|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92383645|NCT00000444|Autonomic Agents|autonomic agents|mesh-ancestor
92383646|NCT00000444|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383647|NCT00000444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383648|NCT00000444|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92383649|NCT00000444|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92383650|NCT00000444|Cholinergic Agents|cholinergic agents|mesh-ancestor
92383651|NCT00000444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126030|NCT02651584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91964481|NCT03291145|Diuretics|diuretics|mesh-ancestor
91964560|NCT02460055|Anesthetics|anesthetics|mesh-ancestor
92383652|NCT00000444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383653|NCT00000450|Naltrexone|naltrexone|mesh-list
92383654|NCT00000450|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92383655|NCT00000450|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92383656|NCT00000450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383657|NCT00000450|Sensory System Agents|sensory system agents|mesh-ancestor
92383658|NCT00000450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383659|NCT00000510|Aspirin|aspirin|mesh-list
92383660|NCT00000510|Dipyridamole|dipyridamole|mesh-list
92383661|NCT00000510|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91964698|NCT03281863|Antibodies|antibodies|mesh-list
92383662|NCT00000510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92383663|NCT00000510|Analgesics|analgesics|mesh-ancestor
92383664|NCT00000510|Sensory System Agents|sensory system agents|mesh-ancestor
92383665|NCT00000510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383666|NCT00000510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383667|NCT00000510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92383668|NCT00000510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92383669|NCT00000510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92383670|NCT00000510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92383671|NCT00000510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383672|NCT00000510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92383673|NCT00000510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92383674|NCT00000510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383675|NCT00000510|Antipyretics|antipyretics|mesh-ancestor
91964824|NCT03359057|Folic Acid|folic acid|mesh-list
91964940|NCT04443647|Oxytocin|oxytocin|mesh-list
92383676|NCT00000510|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92383677|NCT00000510|Vasodilator Agents|vasodilator agents|mesh-ancestor
92383678|NCT00000570|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92383679|NCT00000570|Respiratory System Agents|respiratory system agents|mesh-ancestor
92383680|NCT00000600|Vitamins|vitamins|mesh-list
92383681|NCT00000600|Vitamin E|vitamin e|mesh-list
91965217|NCT03352895|Resveratrol|resveratrol|mesh-list
92383682|NCT00000600|Micronutrients|micronutrients|mesh-ancestor
92383683|NCT00000600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383684|NCT00000600|Antioxidants|antioxidants|mesh-ancestor
92383685|NCT00000600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383686|NCT00000600|Protective Agents|protective agents|mesh-ancestor
92383687|NCT00000636|Pyridoxine|pyridoxine|mesh-list
92383688|NCT00000636|Vitamin B 6|vitamin b 6|mesh-list
92383689|NCT00000636|Rifampin|rifampin|mesh-list
92383690|NCT00000636|Isoniazid|isoniazid|mesh-list
92383691|NCT00000636|Pyrazinamide|pyrazinamide|mesh-list
92383692|NCT00000636|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92383693|NCT00000636|Antitubercular Agents|antitubercular agents|mesh-ancestor
92383694|NCT00000636|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383695|NCT00000636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383696|NCT00000636|Leprostatic Agents|leprostatic agents|mesh-ancestor
92383697|NCT00000636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383698|NCT00000636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383699|NCT00000636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383700|NCT00000636|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92383701|NCT00000636|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92383702|NCT00000636|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92383703|NCT00000636|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92383704|NCT00000636|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92383705|NCT00000636|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92383706|NCT00000636|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92383707|NCT00000636|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92383708|NCT00000636|Antimetabolites|antimetabolites|mesh-ancestor
92383709|NCT00000636|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92383710|NCT00000636|Vitamin B Complex|vitamin b complex|mesh-ancestor
92383711|NCT00000636|Vitamins|vitamins|mesh-ancestor
92383712|NCT00000636|Micronutrients|micronutrients|mesh-ancestor
92383713|NCT00000636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383714|NCT00000648|Ceftriaxone|ceftriaxone|mesh-list
92383715|NCT00000648|Penicillins|penicillins|mesh-list
92383716|NCT00000648|Penicillin G|penicillin g|mesh-list
92383717|NCT00000648|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92383718|NCT00000648|Penicillin G Procaine|penicillin g procaine|mesh-list
92383719|NCT00000648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383720|NCT00000648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383721|NCT00000654|Fialuridine|fialuridine|mesh-list
92383722|NCT00000654|Antiviral Agents|antiviral agents|mesh-ancestor
92383723|NCT00000654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383724|NCT00000654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383725|NCT00000654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383726|NCT00000654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383727|NCT00000660|Etoposide|etoposide|mesh-list
92383728|NCT00000660|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92383729|NCT00000660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383730|NCT00000660|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92383731|NCT00000660|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92383732|NCT00000660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383733|NCT00000660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383734|NCT00000702|Zidovudine|zidovudine|mesh-list
92383735|NCT00000702|Antimetabolites|antimetabolites|mesh-ancestor
92383736|NCT00000702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383737|NCT00000702|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92126031|NCT02651584|Narcotics|narcotics|mesh-ancestor
91938981|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
92383738|NCT00000702|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383739|NCT00000702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383740|NCT00000702|Antiviral Agents|antiviral agents|mesh-ancestor
92383741|NCT00000702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383742|NCT00000702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383743|NCT00000702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383744|NCT00000714|Leucovorin|leucovorin|mesh-list
92383745|NCT00000714|Trimetrexate|trimetrexate|mesh-list
92383746|NCT00000714|Calcium|calcium|mesh-list
92383747|NCT00000714|Levoleucovorin|levoleucovorin|mesh-list
92383748|NCT00000714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383749|NCT00000714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383750|NCT00000714|Antidotes|antidotes|mesh-ancestor
92383751|NCT00000714|Protective Agents|protective agents|mesh-ancestor
92383752|NCT00000714|Vitamin B Complex|vitamin b complex|mesh-ancestor
92383753|NCT00000714|Vitamins|vitamins|mesh-ancestor
92383754|NCT00000714|Micronutrients|micronutrients|mesh-ancestor
92383755|NCT00000714|Antifungal Agents|antifungal agents|mesh-ancestor
92383756|NCT00000714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383757|NCT00000714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92383758|NCT00000714|Antimetabolites|antimetabolites|mesh-ancestor
92383759|NCT00000714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383760|NCT00000714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383761|NCT00000714|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92383762|NCT00000714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383763|NCT00000732|Zidovudine|zidovudine|mesh-list
92383764|NCT00000732|Trimethoprim|trimethoprim|mesh-list
92383765|NCT00000732|Sulfamethoxazole|sulfamethoxazole|mesh-list
91966168|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
92383766|NCT00000732|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92383767|NCT00000732|Antimetabolites|antimetabolites|mesh-ancestor
91966645|NCT02501603|Paclitaxel|paclitaxel|mesh-list
92115534|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92383768|NCT00000732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383769|NCT00000732|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383770|NCT00000732|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383771|NCT00000732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383772|NCT00000732|Antiviral Agents|antiviral agents|mesh-ancestor
92383773|NCT00000732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383774|NCT00000732|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91966791|NCT04498325|Antibodies|antibodies|mesh-list
92383775|NCT00000732|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91966934|NCT02494895|Antipyretics|antipyretics|mesh-ancestor
91967003|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
92126937|NCT01537549|Vitamins|vitamins|mesh-ancestor
92383776|NCT00000732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92383777|NCT00000732|Antimalarials|antimalarials|mesh-ancestor
92383778|NCT00000732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92383779|NCT00000732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92383780|NCT00000732|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92383781|NCT00000732|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92383782|NCT00000732|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92383783|NCT00000732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383784|NCT00000732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383786|NCT00000738|Nimodipine|nimodipine|mesh-list
92383787|NCT00000738|Antimetabolites|antimetabolites|mesh-ancestor
92383788|NCT00000738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383789|NCT00000738|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383790|NCT00000738|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383791|NCT00000738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383792|NCT00000738|Antiviral Agents|antiviral agents|mesh-ancestor
92383793|NCT00000738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383794|NCT00000738|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383795|NCT00000738|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383796|NCT00000738|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92383797|NCT00000738|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92383798|NCT00000738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92383799|NCT00000738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92383800|NCT00000738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383801|NCT00000738|Vasodilator Agents|vasodilator agents|mesh-ancestor
92383802|NCT00000750|Zidovudine|zidovudine|mesh-list
92383803|NCT00000750|Antimetabolites|antimetabolites|mesh-ancestor
92383804|NCT00000750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383805|NCT00000750|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383806|NCT00000750|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91967395|NCT03336125|Vitamin D|vitamin d|mesh-list
92383807|NCT00000750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383808|NCT00000750|Antiviral Agents|antiviral agents|mesh-ancestor
92383809|NCT00000750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383810|NCT00000750|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383811|NCT00000750|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383812|NCT00000804|Indinavir|indinavir|mesh-list
92383813|NCT00000804|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92383814|NCT00000804|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92383815|NCT00000804|Protease Inhibitors|protease inhibitors|mesh-ancestor
92383816|NCT00000804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383817|NCT00000804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383818|NCT00000804|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383819|NCT00000804|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383820|NCT00000804|Antiviral Agents|antiviral agents|mesh-ancestor
92383821|NCT00000804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383822|NCT00000810|Zidovudine|zidovudine|mesh-list
92383823|NCT00000810|Didanosine|didanosine|mesh-list
92383824|NCT00000810|Delavirdine|delavirdine|mesh-list
92383825|NCT00000810|Antimetabolites|antimetabolites|mesh-ancestor
92383826|NCT00000810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383827|NCT00000810|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383828|NCT00000810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383829|NCT00000810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383830|NCT00000810|Antiviral Agents|antiviral agents|mesh-ancestor
92383831|NCT00000810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383832|NCT00000810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92126938|NCT01537549|Micronutrients|micronutrients|mesh-ancestor
92383833|NCT00000810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383834|NCT00000834|Lamivudine|lamivudine|mesh-list
92383835|NCT00000834|Zidovudine|zidovudine|mesh-list
92383836|NCT00000834|Methotrexate|methotrexate|mesh-list
92383837|NCT00000834|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92383838|NCT00000834|Abortifacient Agents|abortifacient agents|mesh-ancestor
92383839|NCT00000834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92383840|NCT00000834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383841|NCT00000834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92383842|NCT00000834|Antimetabolites|antimetabolites|mesh-ancestor
92383843|NCT00000834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383844|NCT00000834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383845|NCT00000834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92383846|NCT00000834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383847|NCT00000834|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92383848|NCT00000834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92383849|NCT00000834|Immunologic Factors|immunologic factors|mesh-ancestor
92383850|NCT00000834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92383851|NCT00000834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383852|NCT00000834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383853|NCT00000834|Antiviral Agents|antiviral agents|mesh-ancestor
92383854|NCT00000834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383855|NCT00000834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383856|NCT00000834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383858|NCT00000864|Abacavir|abacavir|mesh-list
92383859|NCT00000864|Antimetabolites|antimetabolites|mesh-ancestor
92115535|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92383860|NCT00000864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383861|NCT00000864|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383862|NCT00000864|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383863|NCT00000864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383864|NCT00000864|Antiviral Agents|antiviral agents|mesh-ancestor
92383865|NCT00000864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383866|NCT00000864|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383867|NCT00000864|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383868|NCT00000876|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92383869|NCT00000876|Immunologic Factors|immunologic factors|mesh-ancestor
92383870|NCT00000876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383871|NCT00000894|Ganciclovir|ganciclovir|mesh-list
92383872|NCT00000894|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92383873|NCT00000894|Cidofovir|cidofovir|mesh-list
92383874|NCT00000894|Probenecid|probenecid|mesh-list
91968349|NCT02487953|Nicotine|nicotine|mesh-list
92383875|NCT00000894|Antiviral Agents|antiviral agents|mesh-ancestor
92383876|NCT00000894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383877|NCT00000894|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383878|NCT00000894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383879|NCT00000894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383880|NCT00000894|Uricosuric Agents|uricosuric agents|mesh-ancestor
92383881|NCT00000894|Gout Suppressants|gout suppressants|mesh-ancestor
92383882|NCT00000894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92383883|NCT00000912|Efavirenz|efavirenz|mesh-list
92383884|NCT00000912|Abacavir|abacavir|mesh-list
92383885|NCT00000912|Adefovir|adefovir|mesh-list
92383886|NCT00000912|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92383887|NCT00000912|Nelfinavir|nelfinavir|mesh-list
92383888|NCT00000912|Indinavir|indinavir|mesh-list
92383889|NCT00000912|Saquinavir|saquinavir|mesh-list
92383890|NCT00000912|Amprenavir|amprenavir|mesh-list
92383891|NCT00000912|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383892|NCT00000912|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383893|NCT00000912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383894|NCT00000912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383895|NCT00000912|Antiviral Agents|antiviral agents|mesh-ancestor
92383896|NCT00000912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383897|NCT00000912|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92383898|NCT00000912|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383899|NCT00000912|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92383900|NCT00000912|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92383901|NCT00000912|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92126939|NCT01537549|Nootropic Agents|nootropic agents|mesh-ancestor
92383902|NCT00000912|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92383903|NCT00000912|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383904|NCT00000912|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383905|NCT00000912|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92383906|NCT00000912|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92383907|NCT00000912|Protease Inhibitors|protease inhibitors|mesh-ancestor
92383908|NCT00000912|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92383909|NCT00000912|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92383910|NCT00000912|Antitubercular Agents|antitubercular agents|mesh-ancestor
92383911|NCT00000912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383912|NCT00000918|Ritonavir|ritonavir|mesh-list
92383913|NCT00000918|Indinavir|indinavir|mesh-list
92383914|NCT00000918|Saquinavir|saquinavir|mesh-list
92383915|NCT00000918|Amprenavir|amprenavir|mesh-list
92383916|NCT00000918|Lamivudine|lamivudine|mesh-list
92383917|NCT00000918|Zidovudine|zidovudine|mesh-list
92383918|NCT00000918|Didanosine|didanosine|mesh-list
92036417|NCT02356562|Ritonavir|ritonavir|mesh-list
92383919|NCT00000918|Stavudine|stavudine|mesh-list
92383920|NCT00000918|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92383921|NCT00000918|Efavirenz|efavirenz|mesh-list
92383922|NCT00000918|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92383923|NCT00000918|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92383924|NCT00000918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92383925|NCT00000918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383926|NCT00000918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383927|NCT00000918|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383928|NCT00000918|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383929|NCT00000918|Antiviral Agents|antiviral agents|mesh-ancestor
92383930|NCT00000918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383931|NCT00000918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92383932|NCT00000918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383933|NCT00000918|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383934|NCT00000918|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383935|NCT00000918|Antimetabolites|antimetabolites|mesh-ancestor
92031217|NCT02424097|Listerine|listerine|mesh-list
92383937|NCT00000918|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92383938|NCT00000918|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92383939|NCT00000918|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92383940|NCT00000918|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92383942|NCT00000918|Antitubercular Agents|antitubercular agents|mesh-ancestor
92383943|NCT00000918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92383944|NCT00000924|Ritonavir|ritonavir|mesh-list
92383945|NCT00000924|Nelfinavir|nelfinavir|mesh-list
92383946|NCT00000924|Nevirapine|nevirapine|mesh-list
92383947|NCT00000924|Didanosine|didanosine|mesh-list
92383948|NCT00000924|Stavudine|stavudine|mesh-list
92383949|NCT00000924|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92383950|NCT00000924|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92383951|NCT00000924|Protease Inhibitors|protease inhibitors|mesh-ancestor
92383952|NCT00000924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383953|NCT00000924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383954|NCT00000924|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383955|NCT00000924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383956|NCT00000924|Antiviral Agents|antiviral agents|mesh-ancestor
92383957|NCT00000924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383958|NCT00000924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92383959|NCT00000924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92383960|NCT00000924|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383961|NCT00000924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383962|NCT00000924|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92383963|NCT00000924|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92383964|NCT00000924|Antimetabolites|antimetabolites|mesh-ancestor
92383965|NCT00000936|Cyclosporine|cyclosporine|mesh-list
92383966|NCT00000936|Cyclosporins|cyclosporins|mesh-list
92383967|NCT00000936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383968|NCT00000936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383969|NCT00000936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92383970|NCT00000936|Immunologic Factors|immunologic factors|mesh-ancestor
92383971|NCT00000936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92383972|NCT00000936|Antifungal Agents|antifungal agents|mesh-ancestor
92383973|NCT00000936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383974|NCT00000936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92383975|NCT00000936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92383976|NCT00000936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92383977|NCT00000942|Nevirapine|nevirapine|mesh-list
92383978|NCT00000942|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92383979|NCT00000942|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92383980|NCT00000942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92383981|NCT00000942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92383982|NCT00000942|Antiviral Agents|antiviral agents|mesh-ancestor
92383983|NCT00000942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383984|NCT00000942|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383985|NCT00000942|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383986|NCT00000942|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92383987|NCT00000942|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91945877|NCT04831450|Cemiplimab|cemiplimab|mesh-list
92383988|NCT00000948|Aldesleukin|aldesleukin|mesh-list
92383989|NCT00000948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92383990|NCT00000948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92383991|NCT00000948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92383992|NCT00000948|Antiviral Agents|antiviral agents|mesh-ancestor
92383993|NCT00000948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92383994|NCT00000954|Didanosine|didanosine|mesh-list
92383995|NCT00000954|Zalcitabine|zalcitabine|mesh-list
92383996|NCT00000954|Doxorubicin|doxorubicin|mesh-list
92383997|NCT00000954|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92383998|NCT00000954|Bleomycin|bleomycin|mesh-list
92383999|NCT00000954|Vincristine|vincristine|mesh-list
92384000|NCT00000954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92384001|NCT00000954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384002|NCT00000954|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92384003|NCT00000954|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971367|NCT02720081|Albuterol|albuterol|mesh-list
92384004|NCT00000954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384005|NCT00000954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384006|NCT00000954|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92384007|NCT00000954|Tubulin Modulators|tubulin modulators|mesh-ancestor
92384008|NCT00000954|Antimitotic Agents|antimitotic agents|mesh-ancestor
92384009|NCT00000954|Mitosis Modulators|mitosis modulators|mesh-ancestor
92384011|NCT00000954|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384012|NCT00000954|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384013|NCT00000954|Antiviral Agents|antiviral agents|mesh-ancestor
92384014|NCT00000954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384015|NCT00000954|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384016|NCT00000954|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384018|NCT00000960|Antimetabolites|antimetabolites|mesh-ancestor
92384019|NCT00000960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384020|NCT00000960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384021|NCT00000960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384022|NCT00000960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384023|NCT00000960|Antiviral Agents|antiviral agents|mesh-ancestor
92384024|NCT00000960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384025|NCT00000960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384026|NCT00000960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384027|NCT00000990|Zidovudine|zidovudine|mesh-list
92384028|NCT00000990|Antimetabolites|antimetabolites|mesh-ancestor
92384029|NCT00000990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384030|NCT00000990|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384031|NCT00000990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384032|NCT00000990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384033|NCT00000990|Antiviral Agents|antiviral agents|mesh-ancestor
92384034|NCT00000990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384035|NCT00000990|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384036|NCT00000990|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384037|NCT00000996|Doxorubicin|doxorubicin|mesh-list
92384038|NCT00000996|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92384039|NCT00000996|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92384040|NCT00000996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384041|NCT00000996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92384042|NCT00000996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971579|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
92384043|NCT00000996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971646|NCT02465255|Ketorolac|ketorolac|mesh-list
92384044|NCT00000996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384045|NCT00001044|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92384046|NCT00001044|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92384047|NCT00001044|Immunologic Factors|immunologic factors|mesh-ancestor
92384048|NCT00001044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384049|NCT00001044|Antacids|antacids|mesh-ancestor
92384050|NCT00001044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384051|NCT00001044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92384052|NCT00001062|Ganciclovir|ganciclovir|mesh-list
92384053|NCT00001062|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92384054|NCT00001062|Antiviral Agents|antiviral agents|mesh-ancestor
92384055|NCT00001062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384056|NCT00001062|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384057|NCT00001062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384058|NCT00001062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384059|NCT00001068|Lamivudine|lamivudine|mesh-list
92384060|NCT00001068|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384061|NCT00001068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384062|NCT00001068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384063|NCT00001068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384064|NCT00001068|Antiviral Agents|antiviral agents|mesh-ancestor
92384065|NCT00001068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384066|NCT00001068|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384067|NCT00001068|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384068|NCT00001080|Lamivudine|lamivudine|mesh-list
92384069|NCT00001080|Vaccines|vaccines|mesh-list
92384070|NCT00001080|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92384071|NCT00001080|Immunologic Factors|immunologic factors|mesh-ancestor
92384072|NCT00001080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036538|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
92384073|NCT00001080|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384074|NCT00001080|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384075|NCT00001080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384076|NCT00001080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384077|NCT00001080|Antiviral Agents|antiviral agents|mesh-ancestor
92384078|NCT00001080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384079|NCT00001080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384080|NCT00001080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384081|NCT00001104|Zidovudine|zidovudine|mesh-list
92384082|NCT00001104|Antimetabolites|antimetabolites|mesh-ancestor
92384083|NCT00001104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384084|NCT00001104|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384085|NCT00001104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384087|NCT00001104|Antiviral Agents|antiviral agents|mesh-ancestor
92384088|NCT00001104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384089|NCT00001104|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384090|NCT00001104|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384091|NCT00001110|Dimercaprol|dimercaprol|mesh-list
92384092|NCT00001110|Chelating Agents|chelating agents|mesh-ancestor
92384093|NCT00001110|Sequestering Agents|sequestering agents|mesh-ancestor
92384094|NCT00001110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384095|NCT00001122|Efavirenz|efavirenz|mesh-list
92384096|NCT00001122|Didanosine|didanosine|mesh-list
92384097|NCT00001122|Stavudine|stavudine|mesh-list
92384098|NCT00001122|Nelfinavir|nelfinavir|mesh-list
92384099|NCT00001122|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384100|NCT00001122|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384101|NCT00001122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384102|NCT00001122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384103|NCT00001122|Antiviral Agents|antiviral agents|mesh-ancestor
92384104|NCT00001122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384105|NCT00001122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92384106|NCT00001122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384107|NCT00001122|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92384108|NCT00001122|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92384109|NCT00001122|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92384110|NCT00001122|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92384111|NCT00001122|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384112|NCT00001122|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384113|NCT00001122|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384114|NCT00001122|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384115|NCT00001122|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384116|NCT00001122|Antimetabolites|antimetabolites|mesh-ancestor
92384117|NCT00001128|Azithromycin|azithromycin|mesh-list
92384118|NCT00001128|Paromomycin|paromomycin|mesh-list
92384119|NCT00001128|Interleukin-12|interleukin-12|mesh-list
92384120|NCT00001128|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384121|NCT00001128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384122|NCT00001128|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92384123|NCT00001128|Immunologic Factors|immunologic factors|mesh-ancestor
92126940|NCT01555931|Levonorgestrel|levonorgestrel|mesh-list
92127172|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
92384124|NCT00001128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384125|NCT00001128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92384126|NCT00001128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92384127|NCT00001128|Growth Substances|growth substances|mesh-ancestor
92384128|NCT00001128|Growth Inhibitors|growth inhibitors|mesh-ancestor
92384129|NCT00001128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384130|NCT00001128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92384131|NCT00001128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92384132|NCT00001296|Interferons|interferons|mesh-list
92384133|NCT00001296|Interferon-gamma|interferon-gamma|mesh-list
92384134|NCT00001296|Melphalan|melphalan|mesh-list
92384135|NCT00001296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384136|NCT00001296|Antiviral Agents|antiviral agents|mesh-ancestor
92384137|NCT00001296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384138|NCT00001296|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92384139|NCT00001296|Alkylating Agents|alkylating agents|mesh-ancestor
92384140|NCT00001296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384141|NCT00001296|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92127246|NCT01540487|Linagliptin|linagliptin|mesh-list
92127247|NCT01540487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92384142|NCT00001296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92384143|NCT00001296|Immunologic Factors|immunologic factors|mesh-ancestor
92384144|NCT00001296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384145|NCT00001422|Fludarabine|fludarabine|mesh-list
92384146|NCT00001422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384147|NCT00001428|Fluorouracil|fluorouracil|mesh-list
92384148|NCT00001428|Antimetabolites|antimetabolites|mesh-ancestor
92384149|NCT00001428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384150|NCT00001428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92384152|NCT00001428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92384153|NCT00001428|Immunologic Factors|immunologic factors|mesh-ancestor
92384154|NCT00001428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384155|NCT00001440|Interleukin-2|interleukin-2|mesh-list
92384156|NCT00001440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384157|NCT00001440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92384158|NCT00001440|Analgesics|analgesics|mesh-ancestor
92384159|NCT00001440|Sensory System Agents|sensory system agents|mesh-ancestor
92384160|NCT00001440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92384161|NCT00001440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384162|NCT00001446|Thalidomide|thalidomide|mesh-list
92384163|NCT00001446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972771|NCT03284177|Calcium|calcium|mesh-list
92384164|NCT00001446|Immunologic Factors|immunologic factors|mesh-ancestor
92384165|NCT00001446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384166|NCT00001446|Leprostatic Agents|leprostatic agents|mesh-ancestor
92384167|NCT00001446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384168|NCT00001446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384169|NCT00001446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92384170|NCT00001446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92384171|NCT00001446|Growth Substances|growth substances|mesh-ancestor
92384172|NCT00001446|Growth Inhibitors|growth inhibitors|mesh-ancestor
92384173|NCT00001446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384174|NCT00001572|Saponin QA-21V1|saponin qa-21v1|mesh-list
92384175|NCT00001572|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92384176|NCT00001572|Immunologic Factors|immunologic factors|mesh-ancestor
92384177|NCT00001572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384178|NCT00001626|Cyclosporine|cyclosporine|mesh-list
92384179|NCT00001626|Cyclophosphamide|cyclophosphamide|mesh-list
92384180|NCT00001626|Cyclosporins|cyclosporins|mesh-list
92384181|NCT00001626|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92384182|NCT00001626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92384183|NCT00001626|Immunologic Factors|immunologic factors|mesh-ancestor
92384184|NCT00001626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384185|NCT00001626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92384186|NCT00001626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92384187|NCT00001626|Alkylating Agents|alkylating agents|mesh-ancestor
92384188|NCT00001626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384189|NCT00001626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384190|NCT00001626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92384191|NCT00001626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384192|NCT00001626|Antifungal Agents|antifungal agents|mesh-ancestor
92384193|NCT00001626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384194|NCT00001626|Dermatologic Agents|dermatologic agents|mesh-ancestor
92384195|NCT00001626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92384196|NCT00001680|Thalidomide|thalidomide|mesh-list
92384197|NCT00001680|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92384198|NCT00001680|Immunologic Factors|immunologic factors|mesh-ancestor
92384199|NCT00001680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384200|NCT00001680|Leprostatic Agents|leprostatic agents|mesh-ancestor
92384201|NCT00001680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384202|NCT00001680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384203|NCT00001680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92384204|NCT00001680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92384205|NCT00001680|Growth Substances|growth substances|mesh-ancestor
92384206|NCT00001680|Growth Inhibitors|growth inhibitors|mesh-ancestor
92384207|NCT00001680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384208|NCT00001698|Ketorolac|ketorolac|mesh-list
92384209|NCT00001698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92384210|NCT00001698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92384211|NCT00001698|Analgesics|analgesics|mesh-ancestor
92384212|NCT00001698|Sensory System Agents|sensory system agents|mesh-ancestor
92384213|NCT00001698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92384214|NCT00001698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384215|NCT00001698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92384216|NCT00001698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92384217|NCT00001698|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92384218|NCT00001698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384219|NCT00001698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384220|NCT00001716|Nitric Oxide|nitric oxide|mesh-list
92384221|NCT00001716|Nitroglycerin|nitroglycerin|mesh-list
92384222|NCT00001716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92384223|NCT00001716|Autonomic Agents|autonomic agents|mesh-ancestor
92384224|NCT00001716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92384225|NCT00001716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384226|NCT00001716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92384227|NCT00001716|Respiratory System Agents|respiratory system agents|mesh-ancestor
92384228|NCT00001716|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92384229|NCT00001716|Antioxidants|antioxidants|mesh-ancestor
92384230|NCT00001716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384231|NCT00001716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127322|NCT02985905|Astringents|astringents|mesh-ancestor
92384232|NCT00001716|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92384233|NCT00001716|Vasodilator Agents|vasodilator agents|mesh-ancestor
92384234|NCT00001716|Gasotransmitters|gasotransmitters|mesh-ancestor
92384235|NCT00001716|Protective Agents|protective agents|mesh-ancestor
92384237|NCT00001812|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384238|NCT00001812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384239|NCT00001812|Antifungal Agents|antifungal agents|mesh-ancestor
92384240|NCT00001812|Ionophores|ionophores|mesh-ancestor
92384241|NCT00001812|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92384242|NCT00001812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384243|NCT00001842|Dexamethasone|dexamethasone|mesh-list
92384244|NCT00001842|Lenograstim|lenograstim|mesh-list
91973541|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
92384245|NCT00001842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92384246|NCT00001842|Antiemetics|antiemetics|mesh-ancestor
92384247|NCT00001842|Autonomic Agents|autonomic agents|mesh-ancestor
92384248|NCT00001842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92384249|NCT00001842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384250|NCT00001842|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92384251|NCT00001842|Glucocorticoids|glucocorticoids|mesh-ancestor
92384252|NCT00001842|Hormones|hormones|mesh-ancestor
92384253|NCT00001842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384254|NCT00001842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92384255|NCT00001842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384256|NCT00001842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92384257|NCT00001842|Immunologic Factors|immunologic factors|mesh-ancestor
92384258|NCT00001848|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92384259|NCT00001848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92384260|NCT00001848|Hormone Antagonists|hormone antagonists|mesh-ancestor
92384261|NCT00001848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384262|NCT00001848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384263|NCT00001848|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92384264|NCT00001848|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92384265|NCT00001848|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92384266|NCT00001854|Ribavirin|ribavirin|mesh-list
92384267|NCT00001854|Antimetabolites|antimetabolites|mesh-ancestor
92384268|NCT00001854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384269|NCT00001854|Antiviral Agents|antiviral agents|mesh-ancestor
92384270|NCT00001854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384271|NCT00001860|Octreotide|octreotide|mesh-list
92384272|NCT00001860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92384273|NCT00001860|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92384274|NCT00001860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384275|NCT00001890|Estrogens|estrogens|mesh-list
92384276|NCT00001890|Hormones|hormones|mesh-ancestor
92127475|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92384277|NCT00001890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384278|NCT00001890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384279|NCT00001944|Vinorelbine|vinorelbine|mesh-list
92384280|NCT00001944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92384281|NCT00001944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384282|NCT00001944|Tubulin Modulators|tubulin modulators|mesh-ancestor
92384283|NCT00001944|Antimitotic Agents|antimitotic agents|mesh-ancestor
92384284|NCT00001944|Mitosis Modulators|mitosis modulators|mesh-ancestor
92127476|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
92384285|NCT00001944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384286|NCT00001968|Ritonavir|ritonavir|mesh-list
92384287|NCT00001968|Amprenavir|amprenavir|mesh-list
92384288|NCT00001968|Lamivudine|lamivudine|mesh-list
92384289|NCT00001968|Abacavir|abacavir|mesh-list
92384290|NCT00001968|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384291|NCT00001968|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384292|NCT00001968|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384293|NCT00001968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384294|NCT00001968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384295|NCT00001968|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384296|NCT00001968|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92036767|NCT02419469|Cytarabine|cytarabine|mesh-list
92384298|NCT00001968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384299|NCT00001968|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91973879|NCT02455115|Antidotes|antidotes|mesh-ancestor
92384300|NCT00001968|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384301|NCT00001968|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384302|NCT00001968|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384304|NCT00001968|Antitubercular Agents|antitubercular agents|mesh-ancestor
92384306|NCT00001998|Nystatin|nystatin|mesh-list
92384307|NCT00001998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384308|NCT00001998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384309|NCT00001998|Antifungal Agents|antifungal agents|mesh-ancestor
92384310|NCT00001998|Ionophores|ionophores|mesh-ancestor
92384311|NCT00001998|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92384312|NCT00001998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384313|NCT00002010|Fluconazole|fluconazole|mesh-list
92384314|NCT00002010|Antifungal Agents|antifungal agents|mesh-ancestor
92384315|NCT00002010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384316|NCT00002010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92384317|NCT00002010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384318|NCT00002010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384319|NCT00002010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384320|NCT00002010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92384321|NCT00002010|Hormone Antagonists|hormone antagonists|mesh-ancestor
92384322|NCT00002010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384323|NCT00002010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384324|NCT00002010|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91946604|NCT04105270|Durvalumab|durvalumab|mesh-list
92384325|NCT00002010|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92384326|NCT00002022|Epoetin Alfa|epoetin alfa|mesh-list
92384327|NCT00002022|Hematinics|hematinics|mesh-ancestor
92384328|NCT00002028|Didanosine|didanosine|mesh-list
92384329|NCT00002028|Antimetabolites|antimetabolites|mesh-ancestor
92384330|NCT00002028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384331|NCT00002028|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384332|NCT00002028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384333|NCT00002028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384334|NCT00002028|Antiviral Agents|antiviral agents|mesh-ancestor
92384335|NCT00002028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384336|NCT00002028|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91946624|NCT00692939|Melphalan|melphalan|mesh-list
92384337|NCT00002028|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384338|NCT00002034|Zidovudine|zidovudine|mesh-list
92384339|NCT00002034|Ganciclovir|ganciclovir|mesh-list
92384340|NCT00002034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92384341|NCT00002034|Antimetabolites|antimetabolites|mesh-ancestor
92384342|NCT00002034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384343|NCT00002034|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384344|NCT00002034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384345|NCT00002034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384346|NCT00002034|Antiviral Agents|antiviral agents|mesh-ancestor
92384347|NCT00002034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384348|NCT00002034|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384349|NCT00002034|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384350|NCT00002040|Fluconazole|fluconazole|mesh-list
92384351|NCT00002040|Antifungal Agents|antifungal agents|mesh-ancestor
92384352|NCT00002040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384353|NCT00002040|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92127938|NCT00130923|Dopamine Agents|dopamine agents|mesh-ancestor
92384354|NCT00002040|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384355|NCT00002040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384356|NCT00002040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384357|NCT00002040|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92384358|NCT00002040|Hormone Antagonists|hormone antagonists|mesh-ancestor
92384359|NCT00002040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384360|NCT00002040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946899|NCT03520985|Hormones|hormones|mesh-ancestor
92384361|NCT00002040|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92384362|NCT00002040|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92384363|NCT00002046|Zidovudine|zidovudine|mesh-list
92031241|NCT02385799|Sertraline|sertraline|mesh-list
92384364|NCT00002046|Antimetabolites|antimetabolites|mesh-ancestor
92384365|NCT00002046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384366|NCT00002046|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384367|NCT00002046|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384368|NCT00002046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384369|NCT00002046|Antiviral Agents|antiviral agents|mesh-ancestor
91947517|NCT02322099|Vitamin D|vitamin d|mesh-list
92384370|NCT00002046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384371|NCT00002046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384372|NCT00002046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384374|NCT00002052|Ceftriaxone|ceftriaxone|mesh-list
92384375|NCT00002052|Ampicillin|ampicillin|mesh-list
92384376|NCT00002052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384378|NCT00002058|Clofazimine|clofazimine|mesh-list
92384379|NCT00002058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92384380|NCT00002058|Leprostatic Agents|leprostatic agents|mesh-ancestor
92384381|NCT00002058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384382|NCT00002058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384383|NCT00002064|Clindamycin|clindamycin|mesh-list
92384384|NCT00002064|Clindamycin palmitate|clindamycin palmitate|mesh-list
92384385|NCT00002064|Clindamycin phosphate|clindamycin phosphate|mesh-list
92384386|NCT00002064|Pyrimethamine|pyrimethamine|mesh-list
92384387|NCT00002064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384388|NCT00002064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384389|NCT00002064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92384390|NCT00002064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384391|NCT00002064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384392|NCT00002064|Antimalarials|antimalarials|mesh-ancestor
92384393|NCT00002064|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92384394|NCT00002064|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92384395|NCT00002064|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92384396|NCT00002070|Ganciclovir|ganciclovir|mesh-list
92384397|NCT00002070|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92384398|NCT00002070|Sargramostim|sargramostim|mesh-list
92384399|NCT00002070|Immunologic Factors|immunologic factors|mesh-ancestor
92384400|NCT00002070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384401|NCT00002070|Antiviral Agents|antiviral agents|mesh-ancestor
92384402|NCT00002070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127939|NCT04117581|Vitamin D|vitamin d|mesh-list
92384403|NCT00002070|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384404|NCT00002070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115612|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384405|NCT00002070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384406|NCT00002076|Fluconazole|fluconazole|mesh-list
92384407|NCT00002076|Antifungal Agents|antifungal agents|mesh-ancestor
92384408|NCT00002076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384409|NCT00002076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92384410|NCT00002076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384411|NCT00002076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384412|NCT00002076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384413|NCT00002076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91951270|NCT04457609|Azithromycin|azithromycin|mesh-list
91951407|NCT03469271|Calcitriol|calcitriol|mesh-list
92384414|NCT00002076|Hormone Antagonists|hormone antagonists|mesh-ancestor
91951760|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
92115613|NCT03397888|Betrixaban|betrixaban|mesh-list
92384415|NCT00002076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384416|NCT00002076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384417|NCT00002076|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92384418|NCT00002076|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92384419|NCT00002082|Azithromycin|azithromycin|mesh-list
92384420|NCT00002082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384421|NCT00002082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384422|NCT00002094|Atevirdine|atevirdine|mesh-list
92384423|NCT00002094|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384424|NCT00002094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384425|NCT00002094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115614|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92384426|NCT00002094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384427|NCT00002094|Antiviral Agents|antiviral agents|mesh-ancestor
91952822|NCT04430699|Cisplatin|cisplatin|mesh-list
92384428|NCT00002094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384429|NCT00002100|Curdlan sulfate|curdlan sulfate|mesh-list
92384430|NCT00002100|Antimalarials|antimalarials|mesh-ancestor
92384431|NCT00002100|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92384432|NCT00002100|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92384433|NCT00002100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384435|NCT00002106|Ranitidine|ranitidine|mesh-list
92384436|NCT00002106|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92384437|NCT00002106|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92384438|NCT00002106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115615|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
91953542|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
92384439|NCT00002106|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92384440|NCT00002106|Histamine Antagonists|histamine antagonists|mesh-ancestor
92384441|NCT00002106|Histamine Agents|histamine agents|mesh-ancestor
92384442|NCT00002106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92384443|NCT00002106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384444|NCT00002106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384445|NCT00002112|Fluconazole|fluconazole|mesh-list
92384446|NCT00002112|Nystatin|nystatin|mesh-list
92384447|NCT00002112|Antifungal Agents|antifungal agents|mesh-ancestor
92384448|NCT00002112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384449|NCT00002112|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92384450|NCT00002112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384451|NCT00002112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384452|NCT00002112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384453|NCT00002112|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92384454|NCT00002112|Hormone Antagonists|hormone antagonists|mesh-ancestor
92384455|NCT00002112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384456|NCT00002112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384457|NCT00002112|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91953849|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
92384458|NCT00002112|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92384459|NCT00002112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384460|NCT00002112|Ionophores|ionophores|mesh-ancestor
92384461|NCT00002112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92384462|NCT00002118|Zalcitabine|zalcitabine|mesh-list
92384463|NCT00002118|Antimetabolites|antimetabolites|mesh-ancestor
92384464|NCT00002118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384465|NCT00002118|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384466|NCT00002118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384467|NCT00002118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384468|NCT00002118|Antiviral Agents|antiviral agents|mesh-ancestor
92384469|NCT00002118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384470|NCT00002118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384471|NCT00002118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384472|NCT00002124|Lamivudine|lamivudine|mesh-list
92384473|NCT00002124|Zidovudine|zidovudine|mesh-list
92384474|NCT00002124|Delavirdine|delavirdine|mesh-list
92384475|NCT00002124|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384476|NCT00002124|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384477|NCT00002124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384478|NCT00002124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384479|NCT00002124|Antiviral Agents|antiviral agents|mesh-ancestor
92384480|NCT00002124|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384481|NCT00002124|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384482|NCT00002124|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384483|NCT00002124|Antimetabolites|antimetabolites|mesh-ancestor
92384484|NCT00002130|Vesnarinone|vesnarinone|mesh-list
91954609|NCT03621553|Vitamin D|vitamin d|mesh-list
92127940|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
92384485|NCT00002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92384486|NCT00002130|Immunologic Factors|immunologic factors|mesh-ancestor
92384487|NCT00002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384488|NCT00002130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384489|NCT00002130|Antiviral Agents|antiviral agents|mesh-ancestor
92384490|NCT00002130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384491|NCT00002130|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92384492|NCT00002130|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92384493|NCT00002130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384494|NCT00002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384495|NCT00002130|Protective Agents|protective agents|mesh-ancestor
92384496|NCT00002142|Cidofovir|cidofovir|mesh-list
92384497|NCT00002142|Probenecid|probenecid|mesh-list
92384498|NCT00002142|Uricosuric Agents|uricosuric agents|mesh-ancestor
92384499|NCT00002142|Gout Suppressants|gout suppressants|mesh-ancestor
92384500|NCT00002142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92384501|NCT00002142|Antiviral Agents|antiviral agents|mesh-ancestor
92384502|NCT00002142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384503|NCT00002142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384504|NCT00002142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384505|NCT00002148|OPC 14117|opc 14117|mesh-list
92384506|NCT00002148|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92384507|NCT00002148|Antioxidants|antioxidants|mesh-ancestor
92384508|NCT00002148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384509|NCT00002148|Protective Agents|protective agents|mesh-ancestor
92384510|NCT00002148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384511|NCT00002154|Thioctic Acid|thioctic acid|mesh-list
92384512|NCT00002154|Selegiline|selegiline|mesh-list
92384513|NCT00002154|Antidepressive Agents|antidepressive agents|mesh-ancestor
92384514|NCT00002154|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92384515|NCT00002154|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92384516|NCT00002154|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92127941|NCT04117581|Vitamins|vitamins|mesh-ancestor
92384517|NCT00002154|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92384518|NCT00002154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384519|NCT00002154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384520|NCT00002154|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92384521|NCT00002154|Protective Agents|protective agents|mesh-ancestor
92384522|NCT00002154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384524|NCT00002154|Vitamin B Complex|vitamin b complex|mesh-ancestor
92384525|NCT00002154|Vitamins|vitamins|mesh-ancestor
92384526|NCT00002154|Micronutrients|micronutrients|mesh-ancestor
92384527|NCT00002160|Ziconotide|ziconotide|mesh-list
92384528|NCT00002160|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92384529|NCT00002160|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92384530|NCT00002160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384531|NCT00002160|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92384532|NCT00002160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384533|NCT00002160|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92384534|NCT00002160|Protective Agents|protective agents|mesh-ancestor
92384535|NCT00002160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92384536|NCT00002160|Analgesics|analgesics|mesh-ancestor
92384537|NCT00002160|Sensory System Agents|sensory system agents|mesh-ancestor
92384538|NCT00002160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92384539|NCT00002166|Nevirapine|nevirapine|mesh-list
92384540|NCT00002166|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384541|NCT00002166|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384542|NCT00002166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956931|NCT03987919|Hormones|hormones|mesh-ancestor
92115616|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92384543|NCT00002166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384544|NCT00002166|Antiviral Agents|antiviral agents|mesh-ancestor
92384545|NCT00002166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384546|NCT00002166|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384547|NCT00002166|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384548|NCT00002166|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92384549|NCT00002166|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92384550|NCT00002178|Ritonavir|ritonavir|mesh-list
92384551|NCT00002178|Nelfinavir|nelfinavir|mesh-list
92384552|NCT00002178|Saquinavir|saquinavir|mesh-list
92384553|NCT00002178|Delavirdine|delavirdine|mesh-list
92384554|NCT00002178|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384555|NCT00002178|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384556|NCT00002178|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384557|NCT00002178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384558|NCT00002178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384559|NCT00002178|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384560|NCT00002178|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384561|NCT00002178|Antiviral Agents|antiviral agents|mesh-ancestor
92384562|NCT00002178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384563|NCT00002178|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384564|NCT00002178|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91957935|NCT05172115|Enoxaparin|enoxaparin|mesh-list
92384565|NCT00002178|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384566|NCT00002178|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384567|NCT00002184|Lamivudine|lamivudine|mesh-list
92384568|NCT00002184|Zidovudine|zidovudine|mesh-list
92384569|NCT00002184|Stavudine|stavudine|mesh-list
92384570|NCT00002184|Adefovir|adefovir|mesh-list
92384571|NCT00002184|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92384572|NCT00002184|Nelfinavir|nelfinavir|mesh-list
92384573|NCT00002184|Saquinavir|saquinavir|mesh-list
92384574|NCT00002184|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384575|NCT00002184|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384576|NCT00002184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384577|NCT00002184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384578|NCT00002184|Antiviral Agents|antiviral agents|mesh-ancestor
92384579|NCT00002184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384580|NCT00002184|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384581|NCT00002184|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384582|NCT00002184|Antimetabolites|antimetabolites|mesh-ancestor
92384583|NCT00002184|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384584|NCT00002184|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384586|NCT00002184|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384587|NCT00002184|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384588|NCT00002190|Lamivudine|lamivudine|mesh-list
92384589|NCT00002190|Zidovudine|zidovudine|mesh-list
92384590|NCT00002190|Saquinavir|saquinavir|mesh-list
92384591|NCT00002190|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384592|NCT00002190|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384593|NCT00002190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958484|NCT03370627|Antibodies|antibodies|mesh-list
91958715|NCT05125575|Metformin|metformin|mesh-list
91959011|NCT04773405|Mydriatics|mydriatics|mesh-ancestor
92384594|NCT00002190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384595|NCT00002190|Antiviral Agents|antiviral agents|mesh-ancestor
92384596|NCT00002190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384597|NCT00002190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384598|NCT00002190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384599|NCT00002190|Antimetabolites|antimetabolites|mesh-ancestor
92384600|NCT00002190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384601|NCT00002190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384602|NCT00002190|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384603|NCT00002190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384604|NCT00002190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384605|NCT00002202|Indinavir|indinavir|mesh-list
92384606|NCT00002202|Amprenavir|amprenavir|mesh-list
92384607|NCT00002202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384608|NCT00002202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384609|NCT00002202|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384610|NCT00002202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384611|NCT00002202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384612|NCT00002202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384613|NCT00002202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384614|NCT00002202|Antiviral Agents|antiviral agents|mesh-ancestor
92384615|NCT00002202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384616|NCT00002202|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92384617|NCT00002202|Antitubercular Agents|antitubercular agents|mesh-ancestor
92384618|NCT00002202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384619|NCT00002208|Lamivudine|lamivudine|mesh-list
92384620|NCT00002208|Zidovudine|zidovudine|mesh-list
92384621|NCT00002208|Stavudine|stavudine|mesh-list
92384622|NCT00002208|Indinavir|indinavir|mesh-list
92384623|NCT00002208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384624|NCT00002208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384625|NCT00002208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115617|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92115618|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127942|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
92384626|NCT00002208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384627|NCT00002208|Antiviral Agents|antiviral agents|mesh-ancestor
92384628|NCT00002208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384629|NCT00002208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384630|NCT00002208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384631|NCT00002208|Antimetabolites|antimetabolites|mesh-ancestor
92384632|NCT00002208|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384633|NCT00002208|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384634|NCT00002208|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384635|NCT00002214|Capravirine|capravirine|mesh-list
92384636|NCT00002214|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384637|NCT00002214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384638|NCT00002214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384639|NCT00002214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384640|NCT00002214|Antiviral Agents|antiviral agents|mesh-ancestor
92384641|NCT00002214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384642|NCT00002214|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384643|NCT00002214|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384644|NCT00002220|Efavirenz|efavirenz|mesh-list
92384645|NCT00002220|Adefovir|adefovir|mesh-list
92384646|NCT00002220|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92384647|NCT00002220|Indinavir|indinavir|mesh-list
92384648|NCT00002220|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384649|NCT00002220|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384650|NCT00002220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384651|NCT00002220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384652|NCT00002220|Antiviral Agents|antiviral agents|mesh-ancestor
92384653|NCT00002220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384654|NCT00002220|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92384655|NCT00002220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384656|NCT00002220|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92384657|NCT00002220|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92384658|NCT00002220|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92384659|NCT00002220|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91964350|NCT03363191|Xhance|xhance|mesh-list
92384660|NCT00002220|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384661|NCT00002220|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384662|NCT00002220|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384664|NCT00002220|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384665|NCT00002226|Semaxinib|semaxinib|mesh-list
92384666|NCT00002226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92384667|NCT00002226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92384668|NCT00002226|Growth Substances|growth substances|mesh-ancestor
92384669|NCT00002226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384670|NCT00002226|Growth Inhibitors|growth inhibitors|mesh-ancestor
92384671|NCT00002226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384672|NCT00002226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92384673|NCT00002226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384674|NCT00002226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384675|NCT00002238|Interferons|interferons|mesh-list
92384676|NCT00002238|Zidovudine|zidovudine|mesh-list
92384677|NCT00002238|Interferon-beta|interferon-beta|mesh-list
92384678|NCT00002238|Interferon beta-1b|interferon beta-1b|mesh-list
92384679|NCT00002238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384680|NCT00002238|Antiviral Agents|antiviral agents|mesh-ancestor
92384681|NCT00002238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384682|NCT00002238|Antimetabolites|antimetabolites|mesh-ancestor
91967320|NCT04467957|Xenon|xenon|mesh-list
92384683|NCT00002238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384684|NCT00002238|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384685|NCT00002238|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384686|NCT00002238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384687|NCT00002238|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384688|NCT00002238|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384689|NCT00002238|Immunologic Factors|immunologic factors|mesh-ancestor
92384690|NCT00002238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384691|NCT00002238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92384692|NCT00002250|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
92384693|NCT00002250|Immunologic Factors|immunologic factors|mesh-ancestor
92384694|NCT00002250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384695|NCT00002256|Zalcitabine|zalcitabine|mesh-list
92384696|NCT00002256|Antimetabolites|antimetabolites|mesh-ancestor
92384697|NCT00002256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384698|NCT00002256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384699|NCT00002256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384700|NCT00002256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384701|NCT00002256|Antiviral Agents|antiviral agents|mesh-ancestor
92384702|NCT00002256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384703|NCT00002256|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384704|NCT00002256|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384705|NCT00002274|Didanosine|didanosine|mesh-list
92384706|NCT00002274|Antimetabolites|antimetabolites|mesh-ancestor
92128323|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
91974979|NCT04908345|Fentanyl|fentanyl|mesh-list
92384707|NCT00002274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384708|NCT00002274|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384709|NCT00002274|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384710|NCT00002274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384711|NCT00002274|Antiviral Agents|antiviral agents|mesh-ancestor
92384712|NCT00002274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384713|NCT00002274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384714|NCT00002274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384715|NCT00002280|Didanosine|didanosine|mesh-list
92384716|NCT00002280|Antimetabolites|antimetabolites|mesh-ancestor
92384717|NCT00002280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384718|NCT00002280|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384719|NCT00002280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384720|NCT00002280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384721|NCT00002280|Antiviral Agents|antiviral agents|mesh-ancestor
92384722|NCT00002280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384723|NCT00002280|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384724|NCT00002280|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384725|NCT00002286|Zidovudine|zidovudine|mesh-list
92384726|NCT00002286|Antimetabolites|antimetabolites|mesh-ancestor
92384727|NCT00002286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384728|NCT00002286|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384729|NCT00002286|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384730|NCT00002286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384731|NCT00002286|Antiviral Agents|antiviral agents|mesh-ancestor
92384732|NCT00002286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384733|NCT00002286|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384734|NCT00002286|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384735|NCT00002292|Pentamidine|pentamidine|mesh-list
92384736|NCT00002292|Antifungal Agents|antifungal agents|mesh-ancestor
92384737|NCT00002292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384738|NCT00002292|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92384739|NCT00002292|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92384740|NCT00002292|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92384741|NCT00002298|Ribavirin|ribavirin|mesh-list
92384742|NCT00002298|Antimetabolites|antimetabolites|mesh-ancestor
92384743|NCT00002298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384744|NCT00002298|Antiviral Agents|antiviral agents|mesh-ancestor
92384745|NCT00002298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384746|NCT00002304|Fluconazole|fluconazole|mesh-list
92384747|NCT00002304|Ketoconazole|ketoconazole|mesh-list
92037219|NCT01823146|Oxytocin|oxytocin|mesh-list
92384748|NCT00002304|Antifungal Agents|antifungal agents|mesh-ancestor
92384749|NCT00002304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384750|NCT00002304|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92384751|NCT00002304|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384752|NCT00002304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384753|NCT00002304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384754|NCT00002304|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92384755|NCT00002304|Hormone Antagonists|hormone antagonists|mesh-ancestor
92384756|NCT00002304|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384757|NCT00002304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384758|NCT00002304|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92384759|NCT00002304|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91975297|NCT04886193|Vitamins|vitamins|mesh-ancestor
92384760|NCT00002304|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384762|NCT00002316|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91975897|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
92384763|NCT00002316|Amebicides|amebicides|mesh-ancestor
92384764|NCT00002316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92384765|NCT00002316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92384766|NCT00002316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976040|NCT03222167|Grazoprevir|grazoprevir|mesh-list
92384767|NCT00002316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976153|NCT02504801|Budesonide|budesonide|mesh-list
91976233|NCT01628692|Ribavirin|ribavirin|mesh-list
92384768|NCT00002316|Antifungal Agents|antifungal agents|mesh-ancestor
92384769|NCT00002322|Zidovudine|zidovudine|mesh-list
92384770|NCT00002322|Atevirdine|atevirdine|mesh-list
92384771|NCT00002322|Antimetabolites|antimetabolites|mesh-ancestor
91976363|NCT04849845|Insulin|insulin|mesh-list
92384772|NCT00002322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384773|NCT00002322|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384774|NCT00002322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384775|NCT00002322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384776|NCT00002322|Antiviral Agents|antiviral agents|mesh-ancestor
92384777|NCT00002322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384778|NCT00002322|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384779|NCT00002322|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384780|NCT00002328|Azithromycin|azithromycin|mesh-list
92384781|NCT00002328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92384782|NCT00002328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384783|NCT00002334|Zidovudine|zidovudine|mesh-list
91976570|NCT03206957|Endostatins|endostatins|mesh-list
92384784|NCT00002334|Zalcitabine|zalcitabine|mesh-list
92384785|NCT00002334|Saquinavir|saquinavir|mesh-list
92384786|NCT00002334|Antimetabolites|antimetabolites|mesh-ancestor
92384787|NCT00002334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384788|NCT00002334|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384789|NCT00002334|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91976907|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
92384790|NCT00002334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384791|NCT00002334|Antiviral Agents|antiviral agents|mesh-ancestor
92384792|NCT00002334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384793|NCT00002334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92128401|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384794|NCT00002334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384795|NCT00002334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384796|NCT00002334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384797|NCT00002334|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384798|NCT00002334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384799|NCT00002334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384800|NCT00002340|Atovaquone|atovaquone|mesh-list
92384801|NCT00002340|Pentamidine|pentamidine|mesh-list
91977469|NCT02595723|Megestrol|megestrol|mesh-list
92384802|NCT00002340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384803|NCT00002340|Antimalarials|antimalarials|mesh-ancestor
92031251|NCT02422303|Ketamine|ketamine|mesh-list
92384804|NCT00002340|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92384805|NCT00002340|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92384806|NCT00002340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115774|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977906|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
92115775|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92384807|NCT00002340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384808|NCT00002340|Antifungal Agents|antifungal agents|mesh-ancestor
92384809|NCT00002340|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92384810|NCT00002346|Adefovir|adefovir|mesh-list
91978098|NCT03194633|Nifedipine|nifedipine|mesh-list
92384811|NCT00002346|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92384812|NCT00002346|Antiviral Agents|antiviral agents|mesh-ancestor
92384813|NCT00002346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384814|NCT00002346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384815|NCT00002346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384816|NCT00002346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384817|NCT00002346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384818|NCT00002352|Lobucavir|lobucavir|mesh-list
91978378|NCT02116660|Ritonavir|ritonavir|mesh-list
92384819|NCT00002352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384820|NCT00002352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384822|NCT00002352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384823|NCT00002352|Antiviral Agents|antiviral agents|mesh-ancestor
92384824|NCT00002352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384825|NCT00002352|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384826|NCT00002358|Sorivudine|sorivudine|mesh-list
91978856|NCT04757740|Hormones|hormones|mesh-ancestor
91978984|NCT02141854|Xhance|xhance|mesh-list
92384827|NCT00002358|Antiviral Agents|antiviral agents|mesh-ancestor
91979097|NCT02105116|Cytarabine|cytarabine|mesh-list
92384828|NCT00002358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384829|NCT00002358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128553|NCT02382354|Anesthetics, General|anesthetics, general|mesh-ancestor
92384830|NCT00002358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384832|NCT00002364|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384833|NCT00002364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384834|NCT00002364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979265|NCT05545527|Hematinics|hematinics|mesh-ancestor
91979370|NCT04677855|Prednisone|prednisone|mesh-list
92384835|NCT00002364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384836|NCT00002364|Antiviral Agents|antiviral agents|mesh-ancestor
92384837|NCT00002364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979545|NCT05695287|Propofol|propofol|mesh-list
92384838|NCT00002364|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384839|NCT00002364|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384840|NCT00002370|Itraconazole|itraconazole|mesh-list
92384841|NCT00002370|Antifungal Agents|antifungal agents|mesh-ancestor
92384842|NCT00002370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384843|NCT00002370|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92384844|NCT00002370|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384845|NCT00002370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128554|NCT02382354|Anesthetics|anesthetics|mesh-ancestor
91980051|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
92115851|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384846|NCT00002370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384847|NCT00002370|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92384848|NCT00002370|Hormone Antagonists|hormone antagonists|mesh-ancestor
92384849|NCT00002370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92384850|NCT00002370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92384851|NCT00002370|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384852|NCT00002376|Lamivudine|lamivudine|mesh-list
92384853|NCT00002376|Zidovudine|zidovudine|mesh-list
92090442|NCT01903031|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92384854|NCT00002376|Didanosine|didanosine|mesh-list
92384855|NCT00002376|Stavudine|stavudine|mesh-list
92384856|NCT00002376|Indinavir|indinavir|mesh-list
92384857|NCT00002376|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384858|NCT00002376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384859|NCT00002376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384860|NCT00002376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384861|NCT00002376|Antiviral Agents|antiviral agents|mesh-ancestor
92384862|NCT00002376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384863|NCT00002376|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91981007|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
91981163|NCT03178955|Etanercept|etanercept|mesh-list
91981244|NCT02139982|Ropivacaine|ropivacaine|mesh-list
91981322|NCT04734262|Paclitaxel|paclitaxel|mesh-list
92384864|NCT00002376|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384865|NCT00002376|Antimetabolites|antimetabolites|mesh-ancestor
91981399|NCT02068222|Ritonavir|ritonavir|mesh-list
92384866|NCT00002376|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91981478|NCT02571777|Fluticasone|fluticasone|mesh-list
92384867|NCT00002376|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384868|NCT00002376|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384869|NCT00002382|Saquinavir|saquinavir|mesh-list
91981661|NCT02422823|Autonomic Agents|autonomic agents|mesh-ancestor
92384870|NCT00002382|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384871|NCT00002382|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384872|NCT00002382|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981816|NCT02415257|Gentamicins|gentamicins|mesh-list
92384873|NCT00002382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115852|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
92384874|NCT00002382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384875|NCT00002382|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384876|NCT00002382|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384877|NCT00002382|Antiviral Agents|antiviral agents|mesh-ancestor
92384878|NCT00002382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384879|NCT00002382|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92384880|NCT00002382|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92384881|NCT00002388|Abacavir|abacavir|mesh-list
92384882|NCT00002388|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384883|NCT00002388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384884|NCT00002388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384885|NCT00002388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384886|NCT00002388|Antiviral Agents|antiviral agents|mesh-ancestor
92384887|NCT00002388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384888|NCT00002388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384889|NCT00002388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384890|NCT00002394|Terbinafine|terbinafine|mesh-list
92384891|NCT00002394|Antifungal Agents|antifungal agents|mesh-ancestor
92384892|NCT00002394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384893|NCT00002394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115853|NCT03296670|Alprostadil|alprostadil|mesh-list
92115854|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
92384894|NCT00002394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384896|NCT00002400|Zidovudine|zidovudine|mesh-list
92384897|NCT00002400|Delavirdine|delavirdine|mesh-list
92384898|NCT00002400|Indinavir|indinavir|mesh-list
92384899|NCT00002400|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91982672|NCT02063854|Etidronic Acid|etidronic acid|mesh-list
92384900|NCT00002400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384901|NCT00002400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384902|NCT00002400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384903|NCT00002400|Antiviral Agents|antiviral agents|mesh-ancestor
92384904|NCT00002400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384905|NCT00002400|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384906|NCT00002400|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384907|NCT00002400|Antimetabolites|antimetabolites|mesh-ancestor
92384908|NCT00002400|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384909|NCT00002400|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384910|NCT00002400|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384911|NCT00002406|Indinavir|indinavir|mesh-list
92384912|NCT00002406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384913|NCT00002406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384914|NCT00002406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384915|NCT00002406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983342|NCT02400281|Cytarabine|cytarabine|mesh-list
91983425|NCT05498025|Charcoal|charcoal|mesh-list
92128555|NCT02382354|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92384916|NCT00002406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384917|NCT00002406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384918|NCT00002406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91984002|NCT05476341|Bevacizumab|bevacizumab|mesh-list
92384919|NCT00002406|Antiviral Agents|antiviral agents|mesh-ancestor
92384920|NCT00002406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384921|NCT00002412|Didanosine|didanosine|mesh-list
92384922|NCT00002412|Stavudine|stavudine|mesh-list
92384923|NCT00002412|Emivirine|emivirine|mesh-list
91985393|NCT02386475|Escitalopram|escitalopram|mesh-list
92384924|NCT00002412|Hydroxyurea|hydroxyurea|mesh-list
92384925|NCT00002412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384926|NCT00002412|Antisickling Agents|antisickling agents|mesh-ancestor
92384927|NCT00002412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384928|NCT00002412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384929|NCT00002412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384930|NCT00002412|Antimetabolites|antimetabolites|mesh-ancestor
92384931|NCT00002412|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384932|NCT00002412|Antiviral Agents|antiviral agents|mesh-ancestor
92384933|NCT00002412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384934|NCT00002412|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384935|NCT00002412|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384936|NCT00002418|Nevirapine|nevirapine|mesh-list
92384937|NCT00002418|Didanosine|didanosine|mesh-list
92384938|NCT00002418|Stavudine|stavudine|mesh-list
92384939|NCT00002418|Emivirine|emivirine|mesh-list
92384940|NCT00002418|Hydroxyurea|hydroxyurea|mesh-list
92384941|NCT00002418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384942|NCT00002418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384943|NCT00002418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384944|NCT00002418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384945|NCT00002418|Antiviral Agents|antiviral agents|mesh-ancestor
92384946|NCT00002418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384947|NCT00002418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384948|NCT00002418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92128556|NCT02382354|Narcotics|narcotics|mesh-ancestor
92128557|NCT02382354|Analgesics|analgesics|mesh-ancestor
92384949|NCT00002418|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92384950|NCT00002418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92384951|NCT00002418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92384952|NCT00002418|Antisickling Agents|antisickling agents|mesh-ancestor
92384953|NCT00002418|Antimetabolites|antimetabolites|mesh-ancestor
92384954|NCT00002424|Lamivudine|lamivudine|mesh-list
92384955|NCT00002424|Stavudine|stavudine|mesh-list
92384956|NCT00002424|Indinavir|indinavir|mesh-list
92384957|NCT00002424|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384958|NCT00002424|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92384960|NCT00002424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384961|NCT00002424|Antiviral Agents|antiviral agents|mesh-ancestor
92384962|NCT00002424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384963|NCT00002424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384964|NCT00002424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384965|NCT00002424|Antimetabolites|antimetabolites|mesh-ancestor
92384966|NCT00002424|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384967|NCT00002424|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384968|NCT00002424|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384969|NCT00002430|Lamivudine|lamivudine|mesh-list
92384970|NCT00002430|Stavudine|stavudine|mesh-list
92384971|NCT00002430|Nelfinavir|nelfinavir|mesh-list
92384972|NCT00002430|Indinavir|indinavir|mesh-list
92384973|NCT00002430|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384974|NCT00002430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91986374|NCT02365805|Epirubicin|epirubicin|mesh-list
92384975|NCT00002430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115855|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92115856|NCT03296670|Urological Agents|urological agents|mesh-ancestor
92384976|NCT00002430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92384977|NCT00002430|Antiviral Agents|antiviral agents|mesh-ancestor
92384978|NCT00002430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384979|NCT00002430|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384980|NCT00002430|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91986582|NCT02357303|Antidotes|antidotes|mesh-ancestor
92384981|NCT00002430|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92384982|NCT00002430|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92384983|NCT00002430|Protease Inhibitors|protease inhibitors|mesh-ancestor
92384984|NCT00002430|Antimetabolites|antimetabolites|mesh-ancestor
92384985|NCT00002436|Lamivudine|lamivudine|mesh-list
92384986|NCT00002436|Zidovudine|zidovudine|mesh-list
92384987|NCT00002436|Zalcitabine|zalcitabine|mesh-list
92384988|NCT00002436|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92384989|NCT00002436|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91986654|NCT02356445|Infliximab|infliximab|mesh-list
92384990|NCT00002436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92384991|NCT00002436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986696|NCT02352311|Tadalafil|tadalafil|mesh-list
92384992|NCT00002436|Antiviral Agents|antiviral agents|mesh-ancestor
92384993|NCT00002436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92384994|NCT00002436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92384995|NCT00002436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92384996|NCT00002436|Antimetabolites|antimetabolites|mesh-ancestor
92384997|NCT00002442|Lamivudine|lamivudine|mesh-list
92384998|NCT00002442|Stavudine|stavudine|mesh-list
92384999|NCT00002442|Nelfinavir|nelfinavir|mesh-list
92385000|NCT00002442|Indinavir|indinavir|mesh-list
92385001|NCT00002442|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92385002|NCT00002442|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385003|NCT00002442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986849|NCT02350673|Atezolizumab|atezolizumab|mesh-list
92385004|NCT00002442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385005|NCT00002442|Antiviral Agents|antiviral agents|mesh-ancestor
92385006|NCT00002442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385007|NCT00002442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92385008|NCT00002442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92385009|NCT00002442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92385010|NCT00002442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92385011|NCT00002442|Protease Inhibitors|protease inhibitors|mesh-ancestor
92385012|NCT00002442|Antimetabolites|antimetabolites|mesh-ancestor
92385013|NCT00002448|Ritonavir|ritonavir|mesh-list
92385014|NCT00002448|Saquinavir|saquinavir|mesh-list
92385015|NCT00002448|Efavirenz|efavirenz|mesh-list
92385016|NCT00002448|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92385017|NCT00002448|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92385018|NCT00002448|Protease Inhibitors|protease inhibitors|mesh-ancestor
92385019|NCT00002448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385020|NCT00002448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385021|NCT00002448|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91987279|NCT04477811|Vitamin K|vitamin k|mesh-list
92385022|NCT00002448|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92385023|NCT00002448|Antiviral Agents|antiviral agents|mesh-ancestor
92385024|NCT00002448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385025|NCT00002448|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92385026|NCT00002448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92385027|NCT00002448|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92115857|NCT03298464|Pioglitazone|pioglitazone|mesh-list
92385028|NCT00002448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385029|NCT00002448|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92115858|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92385030|NCT00002448|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92385031|NCT00002448|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92385032|NCT00002448|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92385033|NCT00002448|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92385034|NCT00002460|Tamoxifen|tamoxifen|mesh-list
92385035|NCT00002460|Goserelin|goserelin|mesh-list
92385036|NCT00002460|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92385037|NCT00002460|Hormone Antagonists|hormone antagonists|mesh-ancestor
92385038|NCT00002460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385039|NCT00002460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385040|NCT00002460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385041|NCT00002460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385042|NCT00002460|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91970044|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
92385043|NCT00002460|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92031415|NCT02214225|Vaccines|vaccines|mesh-list
92385044|NCT00002460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92385045|NCT00002466|Cyclophosphamide|cyclophosphamide|mesh-list
92385046|NCT00002466|Ifosfamide|ifosfamide|mesh-list
92385047|NCT00002466|Doxorubicin|doxorubicin|mesh-list
92385048|NCT00002466|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385049|NCT00002466|Etoposide|etoposide|mesh-list
92385050|NCT00002466|Vincristine|vincristine|mesh-list
91988672|NCT05080985|Bupivacaine|bupivacaine|mesh-list
92128635|NCT01560403|Teduglutide|teduglutide|mesh-list
92385051|NCT00002466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385052|NCT00002466|Immunologic Factors|immunologic factors|mesh-ancestor
92385053|NCT00002466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385054|NCT00002466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385055|NCT00002466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385056|NCT00002466|Alkylating Agents|alkylating agents|mesh-ancestor
92385057|NCT00002466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385058|NCT00002466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385059|NCT00002466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385060|NCT00002466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385061|NCT00002466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385062|NCT00002466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385063|NCT00002466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385064|NCT00002466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385065|NCT00002466|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385066|NCT00002466|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385067|NCT00002466|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385068|NCT00002472|Etoposide|etoposide|mesh-list
92385069|NCT00002472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385070|NCT00002472|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385071|NCT00002472|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385072|NCT00002472|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385073|NCT00002472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385074|NCT00002472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385075|NCT00002478|Etoposide|etoposide|mesh-list
92385076|NCT00002478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385077|NCT00002478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385078|NCT00002478|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385079|NCT00002478|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385080|NCT00002478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129083|NCT00298233|Oseltamivir|oseltamivir|mesh-list
92385081|NCT00002478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385082|NCT00002490|Mitomycins|mitomycins|mesh-list
92385083|NCT00002490|Mitomycin|mitomycin|mesh-list
92385084|NCT00002490|BCG Vaccine|bcg vaccine|mesh-list
92385085|NCT00002490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91989382|NCT05085587|Hormones|hormones|mesh-ancestor
91989802|NCT02417389|Cinacalcet|cinacalcet|mesh-list
92385086|NCT00002490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385087|NCT00002490|Alkylating Agents|alkylating agents|mesh-ancestor
92385088|NCT00002490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129084|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
92385089|NCT00002490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385090|NCT00002490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385091|NCT00002490|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92385092|NCT00002490|Immunologic Factors|immunologic factors|mesh-ancestor
92031473|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
91990116|NCT02410759|Carbetocin|carbetocin|mesh-list
91990206|NCT02449655|Paclitaxel|paclitaxel|mesh-list
92385093|NCT00002490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385095|NCT00002496|Fluorouracil|fluorouracil|mesh-list
92385096|NCT00002496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385097|NCT00002496|Antimetabolites|antimetabolites|mesh-ancestor
92385098|NCT00002496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990324|NCT03196817|Hormones|hormones|mesh-ancestor
92385099|NCT00002496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385100|NCT00002496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385101|NCT00002496|Immunologic Factors|immunologic factors|mesh-ancestor
92385102|NCT00002496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385103|NCT00002496|Trace Elements|trace elements|mesh-ancestor
92385104|NCT00002496|Micronutrients|micronutrients|mesh-ancestor
92385105|NCT00002502|Cytarabine|cytarabine|mesh-list
92385106|NCT00002502|Cyclophosphamide|cyclophosphamide|mesh-list
92385107|NCT00002502|Busulfan|busulfan|mesh-list
92385108|NCT00002502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385109|NCT00002502|Immunologic Factors|immunologic factors|mesh-ancestor
92385110|NCT00002502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385111|NCT00002502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385112|NCT00002502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385113|NCT00002502|Alkylating Agents|alkylating agents|mesh-ancestor
92385114|NCT00002502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385115|NCT00002502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385116|NCT00002502|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385117|NCT00002502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385118|NCT00002502|Antimetabolites|antimetabolites|mesh-ancestor
92385119|NCT00002502|Antiviral Agents|antiviral agents|mesh-ancestor
92385120|NCT00002502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385121|NCT00002508|Carboplatin|carboplatin|mesh-list
92385122|NCT00002508|Etoposide|etoposide|mesh-list
92385123|NCT00002508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385124|NCT00002508|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92031504|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92385125|NCT00002508|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385126|NCT00002508|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385127|NCT00002508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385128|NCT00002508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385129|NCT00002526|Doxorubicin|doxorubicin|mesh-list
92385130|NCT00002526|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385132|NCT00002526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385133|NCT00002526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385134|NCT00002526|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385135|NCT00002526|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385136|NCT00002526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991112|NCT04481815|Antimetabolites|antimetabolites|mesh-ancestor
92385137|NCT00002526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385138|NCT00002526|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385139|NCT00002526|Alkylating Agents|alkylating agents|mesh-ancestor
92385140|NCT00002532|Leucovorin|leucovorin|mesh-list
92385141|NCT00002532|Cytarabine|cytarabine|mesh-list
92385142|NCT00002532|Dexamethasone|dexamethasone|mesh-list
92385143|NCT00002532|Prednisolone|prednisolone|mesh-list
92385144|NCT00002532|Methotrexate|methotrexate|mesh-list
92385145|NCT00002532|Etoposide|etoposide|mesh-list
92385146|NCT00002532|Daunorubicin|daunorubicin|mesh-list
92385147|NCT00002532|Asparaginase|asparaginase|mesh-list
92385148|NCT00002532|Ifosfamide|ifosfamide|mesh-list
92385149|NCT00002532|Idarubicin|idarubicin|mesh-list
92385150|NCT00002532|Vindesine|vindesine|mesh-list
92385151|NCT00002532|Levoleucovorin|levoleucovorin|mesh-list
92385152|NCT00002532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92385153|NCT00002532|Antiemetics|antiemetics|mesh-ancestor
92385154|NCT00002532|Autonomic Agents|autonomic agents|mesh-ancestor
92385155|NCT00002532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385156|NCT00002532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385157|NCT00002532|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385158|NCT00002532|Glucocorticoids|glucocorticoids|mesh-ancestor
91991537|NCT04555343|Hemostatics|hemostatics|mesh-ancestor
92385159|NCT00002532|Hormones|hormones|mesh-ancestor
92385160|NCT00002532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385161|NCT00002532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385162|NCT00002532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385163|NCT00002532|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385164|NCT00002532|Abortifacient Agents|abortifacient agents|mesh-ancestor
92385165|NCT00002532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385166|NCT00002532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385167|NCT00002532|Antimetabolites|antimetabolites|mesh-ancestor
92385168|NCT00002532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385169|NCT00002532|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385170|NCT00002532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992142|NCT03166891|Chiauranib|chiauranib|mesh-list
92385171|NCT00002532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92385172|NCT00002532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385173|NCT00002532|Immunologic Factors|immunologic factors|mesh-ancestor
92385174|NCT00002532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385175|NCT00002532|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385176|NCT00002532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385177|NCT00002532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385178|NCT00002532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385179|NCT00002532|Antiviral Agents|antiviral agents|mesh-ancestor
92385180|NCT00002532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385181|NCT00002532|Antidotes|antidotes|mesh-ancestor
92385182|NCT00002532|Protective Agents|protective agents|mesh-ancestor
92385183|NCT00002532|Vitamin B Complex|vitamin b complex|mesh-ancestor
92385184|NCT00002532|Vitamins|vitamins|mesh-ancestor
92385185|NCT00002532|Micronutrients|micronutrients|mesh-ancestor
92385186|NCT00002532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385187|NCT00002532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91992338|NCT04507919|Dabrafenib|dabrafenib|mesh-list
92385188|NCT00002532|Alkylating Agents|alkylating agents|mesh-ancestor
92385189|NCT00002532|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385190|NCT00002532|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385191|NCT00002532|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385192|NCT00002544|Docetaxel|docetaxel|mesh-list
92385193|NCT00002544|Mitoxantrone|mitoxantrone|mesh-list
92385194|NCT00002544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385195|NCT00002544|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385196|NCT00002544|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385197|NCT00002544|Mitosis Modulators|mitosis modulators|mesh-ancestor
91992543|NCT01958476|Morphine|morphine|mesh-list
92385198|NCT00002544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385199|NCT00002544|Analgesics|analgesics|mesh-ancestor
92385200|NCT00002544|Sensory System Agents|sensory system agents|mesh-ancestor
92385201|NCT00002544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385202|NCT00002544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037662|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92385203|NCT00002544|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385204|NCT00002544|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385205|NCT00002544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385206|NCT00002550|Etoposide|etoposide|mesh-list
92385207|NCT00002550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385208|NCT00002550|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385209|NCT00002550|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385210|NCT00002550|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385211|NCT00002550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385212|NCT00002550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385214|NCT00002556|Interferon-alpha|interferon-alpha|mesh-list
92385215|NCT00002556|Interferon alpha-2|interferon alpha-2|mesh-list
92385216|NCT00002556|Prednisone|prednisone|mesh-list
92385217|NCT00002556|Cyclophosphamide|cyclophosphamide|mesh-list
92385218|NCT00002556|Melphalan|melphalan|mesh-list
92385219|NCT00002556|Carmustine|carmustine|mesh-list
92385220|NCT00002556|Vincristine|vincristine|mesh-list
92385221|NCT00002556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385222|NCT00002556|Immunologic Factors|immunologic factors|mesh-ancestor
92385223|NCT00002556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385224|NCT00002556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031616|NCT02308033|Metronidazole|metronidazole|mesh-list
92385225|NCT00002556|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385226|NCT00002556|Alkylating Agents|alkylating agents|mesh-ancestor
92385227|NCT00002556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385228|NCT00002556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385229|NCT00002556|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385230|NCT00002556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92385231|NCT00002556|Glucocorticoids|glucocorticoids|mesh-ancestor
92385232|NCT00002556|Hormones|hormones|mesh-ancestor
92385233|NCT00002556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385234|NCT00002556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385235|NCT00002556|Antiviral Agents|antiviral agents|mesh-ancestor
92385236|NCT00002556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385237|NCT00002556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385238|NCT00002556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385239|NCT00002556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385240|NCT00002556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385241|NCT00002562|Paclitaxel|paclitaxel|mesh-list
92385242|NCT00002562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385243|NCT00002562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385244|NCT00002562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385245|NCT00002562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385246|NCT00002562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385247|NCT00002562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385249|NCT00002568|Cisplatin|cisplatin|mesh-list
92385250|NCT00002568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385251|NCT00002568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385252|NCT00002568|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385253|NCT00002568|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385254|NCT00002568|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385255|NCT00002568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993123|NCT05127707|Narcotics|narcotics|mesh-ancestor
92385256|NCT00002574|Interferons|interferons|mesh-list
92385257|NCT00002574|Interferon-alpha|interferon-alpha|mesh-list
92385258|NCT00002574|Homoharringtonine|homoharringtonine|mesh-list
92385259|NCT00002574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385260|NCT00002574|Antiviral Agents|antiviral agents|mesh-ancestor
92385261|NCT00002574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385262|NCT00002574|Immunologic Factors|immunologic factors|mesh-ancestor
92385263|NCT00002574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993414|NCT05131295|Dapsone|dapsone|mesh-list
92385264|NCT00002574|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385265|NCT00002574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92385266|NCT00002574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031749|NCT02374021|Analgesics|analgesics|mesh-ancestor
92385267|NCT00002574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385268|NCT00002580|Tamoxifen|tamoxifen|mesh-list
92385269|NCT00002580|Cyclophosphamide|cyclophosphamide|mesh-list
92385270|NCT00002580|Fluorouracil|fluorouracil|mesh-list
92385271|NCT00002580|Methotrexate|methotrexate|mesh-list
92385273|NCT00002580|Goserelin|goserelin|mesh-list
92385274|NCT00002580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385275|NCT00002580|Immunologic Factors|immunologic factors|mesh-ancestor
92385276|NCT00002580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385277|NCT00002580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385278|NCT00002580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385279|NCT00002580|Alkylating Agents|alkylating agents|mesh-ancestor
92385280|NCT00002580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385281|NCT00002580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385282|NCT00002580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91993562|NCT05676463|Vitamins|vitamins|mesh-ancestor
92385283|NCT00002580|Antimetabolites|antimetabolites|mesh-ancestor
92385284|NCT00002580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385285|NCT00002580|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385286|NCT00002580|Abortifacient Agents|abortifacient agents|mesh-ancestor
92385287|NCT00002580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385288|NCT00002580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385289|NCT00002580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385290|NCT00002580|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92385291|NCT00002580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91970296|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
92385292|NCT00002580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92385293|NCT00002580|Hormone Antagonists|hormone antagonists|mesh-ancestor
92385294|NCT00002580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385295|NCT00002580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385296|NCT00002580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92385297|NCT00002580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91985283|NCT02663687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993760|NCT05900661|Inositol|inositol|mesh-list
92385298|NCT00002580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92385299|NCT00002580|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92385300|NCT00002580|Fertility Agents|fertility agents|mesh-ancestor
92385301|NCT00002586|Vitamin E|vitamin e|mesh-list
92385302|NCT00002586|Tocopherols|tocopherols|mesh-list
92385303|NCT00002586|Tocotrienols|tocotrienols|mesh-list
92385304|NCT00002586|alpha-Tocopherol|alpha-tocopherol|mesh-list
92385305|NCT00002586|Tretinoin|tretinoin|mesh-list
92385306|NCT00002586|Isotretinoin|isotretinoin|mesh-list
92385307|NCT00002586|Vitamins|vitamins|mesh-ancestor
92385308|NCT00002586|Micronutrients|micronutrients|mesh-ancestor
92385309|NCT00002586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385310|NCT00002586|Antioxidants|antioxidants|mesh-ancestor
92385311|NCT00002586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385313|NCT00002586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385314|NCT00002586|Keratolytic Agents|keratolytic agents|mesh-ancestor
92385315|NCT00002586|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385316|NCT00002592|Cyclophosphamide|cyclophosphamide|mesh-list
92385317|NCT00002592|Busulfan|busulfan|mesh-list
92385318|NCT00002592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385319|NCT00002592|Immunologic Factors|immunologic factors|mesh-ancestor
92385320|NCT00002592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385321|NCT00002592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385322|NCT00002592|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385323|NCT00002592|Alkylating Agents|alkylating agents|mesh-ancestor
92385324|NCT00002592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385325|NCT00002592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385326|NCT00002592|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385327|NCT00002598|Interferons|interferons|mesh-list
92385328|NCT00002598|Cytarabine|cytarabine|mesh-list
92385329|NCT00002598|Interferon-alpha|interferon-alpha|mesh-list
92385330|NCT00002598|Cyclophosphamide|cyclophosphamide|mesh-list
92385331|NCT00002598|Methotrexate|methotrexate|mesh-list
92385332|NCT00002598|Etoposide|etoposide|mesh-list
92385333|NCT00002598|Mitoxantrone|mitoxantrone|mesh-list
92385334|NCT00002598|Sargramostim|sargramostim|mesh-list
92385335|NCT00002598|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385336|NCT00002598|Immunologic Factors|immunologic factors|mesh-ancestor
92385337|NCT00002598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385338|NCT00002598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385339|NCT00002598|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385340|NCT00002598|Alkylating Agents|alkylating agents|mesh-ancestor
92385341|NCT00002598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385342|NCT00002598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994092|NCT05897918|Tranexamic Acid|tranexamic acid|mesh-list
92385343|NCT00002598|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385344|NCT00002598|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385345|NCT00002598|Abortifacient Agents|abortifacient agents|mesh-ancestor
92385346|NCT00002598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385347|NCT00002598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385349|NCT00002598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385350|NCT00002598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385351|NCT00002598|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92385352|NCT00002598|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385353|NCT00002598|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385354|NCT00002598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385356|NCT00002598|Antiviral Agents|antiviral agents|mesh-ancestor
91994219|NCT05741060|Equol|equol|mesh-list
92385357|NCT00002598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037811|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385358|NCT00002598|Analgesics|analgesics|mesh-ancestor
92385359|NCT00002598|Sensory System Agents|sensory system agents|mesh-ancestor
92385360|NCT00002598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385361|NCT00002604|Carmustine|carmustine|mesh-list
92385362|NCT00002604|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92385363|NCT00002604|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385364|NCT00002604|Alkylating Agents|alkylating agents|mesh-ancestor
92385365|NCT00002604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385366|NCT00002604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385367|NCT00002604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385368|NCT00002610|Dactinomycin|dactinomycin|mesh-list
92385369|NCT00002610|Cyclophosphamide|cyclophosphamide|mesh-list
92385370|NCT00002610|Carboplatin|carboplatin|mesh-list
92385371|NCT00002610|Doxorubicin|doxorubicin|mesh-list
92385372|NCT00002610|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385373|NCT00002610|Etoposide|etoposide|mesh-list
92385374|NCT00002610|Vincristine|vincristine|mesh-list
92385375|NCT00002610|Lenograstim|lenograstim|mesh-list
92385376|NCT00002610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385377|NCT00002610|Immunologic Factors|immunologic factors|mesh-ancestor
92385378|NCT00002610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994438|NCT05193994|Antiviral Agents|antiviral agents|mesh-ancestor
92385379|NCT00002610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385380|NCT00002610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385381|NCT00002610|Alkylating Agents|alkylating agents|mesh-ancestor
92385382|NCT00002610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385383|NCT00002610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385384|NCT00002610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385385|NCT00002610|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385386|NCT00002610|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385387|NCT00002610|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385388|NCT00002610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385389|NCT00002610|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385390|NCT00002610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92385391|NCT00002610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385392|NCT00002610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385393|NCT00002610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385394|NCT00002610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92385395|NCT00002610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385396|NCT00002610|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92385397|NCT00002610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385398|NCT00002616|Aldesleukin|aldesleukin|mesh-list
91994702|NCT04268849|Hematinics|hematinics|mesh-ancestor
92385399|NCT00002616|Cyclophosphamide|cyclophosphamide|mesh-list
92385400|NCT00002616|Thiotepa|thiotepa|mesh-list
92385401|NCT00002616|Carboplatin|carboplatin|mesh-list
92385402|NCT00002616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385403|NCT00002616|Immunologic Factors|immunologic factors|mesh-ancestor
92385404|NCT00002616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385405|NCT00002616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385406|NCT00002616|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385407|NCT00002616|Alkylating Agents|alkylating agents|mesh-ancestor
92385408|NCT00002616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385409|NCT00002616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385410|NCT00002616|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385411|NCT00002616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92385412|NCT00002616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92385413|NCT00002616|Antiviral Agents|antiviral agents|mesh-ancestor
92385414|NCT00002616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385416|NCT00002634|Cyclophosphamide|cyclophosphamide|mesh-list
92385417|NCT00002634|Doxorubicin|doxorubicin|mesh-list
92385418|NCT00002634|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385419|NCT00002634|Etoposide|etoposide|mesh-list
92385420|NCT00002634|Vincristine|vincristine|mesh-list
92385421|NCT00002634|Antibodies|antibodies|mesh-list
91970372|NCT04448873|Sirolimus|sirolimus|mesh-list
92385422|NCT00002634|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92385423|NCT00002634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385425|NCT00002634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385426|NCT00002634|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385427|NCT00002634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385428|NCT00002634|Alkylating Agents|alkylating agents|mesh-ancestor
92385429|NCT00002634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129162|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385430|NCT00002634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037889|NCT01807234|Ketorolac|ketorolac|mesh-list
92385431|NCT00002634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91970389|NCT03108989|Neostigmine|neostigmine|mesh-list
92385432|NCT00002634|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385433|NCT00002634|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385434|NCT00002634|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385435|NCT00002634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385436|NCT00002634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385437|NCT00002634|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385438|NCT00002634|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385439|NCT00002634|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385441|NCT00002634|Micronutrients|micronutrients|mesh-ancestor
92385442|NCT00002646|Tamoxifen|tamoxifen|mesh-list
92385443|NCT00002646|Fenretinide|fenretinide|mesh-list
92385444|NCT00002646|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92385445|NCT00002646|Hormone Antagonists|hormone antagonists|mesh-ancestor
92385446|NCT00002646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385447|NCT00002646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385448|NCT00002646|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385449|NCT00002646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385450|NCT00002646|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92385451|NCT00002646|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92385452|NCT00002646|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92385453|NCT00002646|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92385454|NCT00002646|Protective Agents|protective agents|mesh-ancestor
92385455|NCT00002652|Suramin|suramin|mesh-list
92385456|NCT00002652|Antinematodal Agents|antinematodal agents|mesh-ancestor
92385457|NCT00002652|Anthelmintics|anthelmintics|mesh-ancestor
92385458|NCT00002652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92385459|NCT00002652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385460|NCT00002652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385461|NCT00002652|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92385462|NCT00002652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92385463|NCT00002658|Cytarabine|cytarabine|mesh-list
92385464|NCT00002658|Cyclophosphamide|cyclophosphamide|mesh-list
92385465|NCT00002658|Etoposide|etoposide|mesh-list
92385466|NCT00002658|Daunorubicin|daunorubicin|mesh-list
92385467|NCT00002658|Mitoxantrone|mitoxantrone|mesh-list
92385468|NCT00002658|Idarubicin|idarubicin|mesh-list
92385469|NCT00002658|Tretinoin|tretinoin|mesh-list
92385470|NCT00002658|Thioguanine|thioguanine|mesh-list
92385471|NCT00002658|Amsacrine|amsacrine|mesh-list
91995468|NCT03136445|Hemostatics|hemostatics|mesh-ancestor
92129164|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
91995763|NCT03101579|Folic Acid|folic acid|mesh-list
91995841|NCT03412591|Suvorexant|suvorexant|mesh-list
92129314|NCT00304161|Adrenergic Agents|adrenergic agents|mesh-ancestor
92385472|NCT00002658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385473|NCT00002658|Immunologic Factors|immunologic factors|mesh-ancestor
92385474|NCT00002658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385475|NCT00002658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385476|NCT00002658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385477|NCT00002658|Alkylating Agents|alkylating agents|mesh-ancestor
92385478|NCT00002658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385479|NCT00002658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385480|NCT00002658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92129392|NCT02037126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92385481|NCT00002658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385482|NCT00002658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385483|NCT00002658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385484|NCT00002658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996900|NCT02368171|Nitric Oxide|nitric oxide|mesh-list
92385485|NCT00002658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997046|NCT05046041|Oxytocics|oxytocics|mesh-ancestor
92385486|NCT00002658|Antimetabolites|antimetabolites|mesh-ancestor
92385487|NCT00002658|Antiviral Agents|antiviral agents|mesh-ancestor
92385488|NCT00002658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385489|NCT00002658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385490|NCT00002658|Analgesics|analgesics|mesh-ancestor
92385491|NCT00002658|Sensory System Agents|sensory system agents|mesh-ancestor
92385492|NCT00002658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385493|NCT00002658|Keratolytic Agents|keratolytic agents|mesh-ancestor
92385494|NCT00002658|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385495|NCT00002664|Sargramostim|sargramostim|mesh-list
92385496|NCT00002664|Edrecolomab|edrecolomab|mesh-list
92385497|NCT00002664|Immunologic Factors|immunologic factors|mesh-ancestor
92385498|NCT00002664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385499|NCT00002664|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92385500|NCT00002670|Cobalt|cobalt|mesh-list
92385502|NCT00002670|Micronutrients|micronutrients|mesh-ancestor
92385503|NCT00002670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385504|NCT00002676|Cobalt|cobalt|mesh-list
92385505|NCT00002676|Cytarabine|cytarabine|mesh-list
92385507|NCT00002676|Cyclophosphamide|cyclophosphamide|mesh-list
92385508|NCT00002676|Carmustine|carmustine|mesh-list
92385509|NCT00002676|Doxorubicin|doxorubicin|mesh-list
92385510|NCT00002676|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385511|NCT00002676|Methotrexate|methotrexate|mesh-list
92385512|NCT00002676|Vincristine|vincristine|mesh-list
92385513|NCT00002676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385514|NCT00002676|Immunologic Factors|immunologic factors|mesh-ancestor
92385515|NCT00002676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385516|NCT00002676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385517|NCT00002676|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385518|NCT00002676|Alkylating Agents|alkylating agents|mesh-ancestor
92385519|NCT00002676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129393|NCT02375880|Gemcitabine|gemcitabine|mesh-list
92385520|NCT00002676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997290|NCT02373163|Telmisartan|telmisartan|mesh-list
92385521|NCT00002676|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385522|NCT00002676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997558|NCT02362165|Hormones|hormones|mesh-ancestor
92385524|NCT00002676|Autonomic Agents|autonomic agents|mesh-ancestor
92385525|NCT00002676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385526|NCT00002676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385527|NCT00002676|Glucocorticoids|glucocorticoids|mesh-ancestor
92385528|NCT00002676|Hormones|hormones|mesh-ancestor
92385529|NCT00002676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385530|NCT00002676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385531|NCT00002676|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385532|NCT00002676|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385533|NCT00002676|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385534|NCT00002676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385535|NCT00002676|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385536|NCT00002676|Abortifacient Agents|abortifacient agents|mesh-ancestor
92385537|NCT00002676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385538|NCT00002676|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385539|NCT00002676|Antimetabolites|antimetabolites|mesh-ancestor
91997871|NCT05024825|Gabapentin|gabapentin|mesh-list
92385540|NCT00002676|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385541|NCT00002676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91998026|NCT05023577|Clarithromycin|clarithromycin|mesh-list
92385542|NCT00002676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385543|NCT00002676|Antiviral Agents|antiviral agents|mesh-ancestor
92385544|NCT00002676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385545|NCT00002676|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385546|NCT00002676|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385547|NCT00002676|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385548|NCT00002676|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385549|NCT00002676|Trace Elements|trace elements|mesh-ancestor
92385550|NCT00002676|Micronutrients|micronutrients|mesh-ancestor
92385551|NCT00002682|Amoxicillin|amoxicillin|mesh-list
92385552|NCT00002682|Metronidazole|metronidazole|mesh-list
92385553|NCT00002682|Clarithromycin|clarithromycin|mesh-list
92385554|NCT00002682|Tetracycline|tetracycline|mesh-list
92385555|NCT00002682|Omeprazole|omeprazole|mesh-list
92385556|NCT00002682|Bismuth|bismuth|mesh-list
92385557|NCT00002682|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92385558|NCT00002682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92385559|NCT00002682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385560|NCT00002682|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92385561|NCT00002682|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92385562|NCT00002682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92385563|NCT00002682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385564|NCT00002682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92385565|NCT00002682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385566|NCT00002682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385567|NCT00002682|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92385568|NCT00002682|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92385569|NCT00002682|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92385570|NCT00002682|Antacids|antacids|mesh-ancestor
92385571|NCT00002682|Antidiarrheals|antidiarrheals|mesh-ancestor
92385572|NCT00002688|Cyclosporine|cyclosporine|mesh-list
92385573|NCT00002688|Etoposide|etoposide|mesh-list
92385574|NCT00002688|Mitoxantrone|mitoxantrone|mesh-list
92385575|NCT00002688|Cyclosporins|cyclosporins|mesh-list
92385576|NCT00002688|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385577|NCT00002688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385578|NCT00002688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385579|NCT00002688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385580|NCT00002688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385581|NCT00002688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032147|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
92385582|NCT00002688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385583|NCT00002688|Immunologic Factors|immunologic factors|mesh-ancestor
92129550|NCT05800587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385584|NCT00002688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385585|NCT00002688|Antifungal Agents|antifungal agents|mesh-ancestor
92385586|NCT00002688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385587|NCT00002688|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385588|NCT00002688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385589|NCT00002688|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92385590|NCT00002688|Analgesics|analgesics|mesh-ancestor
92385591|NCT00002688|Sensory System Agents|sensory system agents|mesh-ancestor
92385592|NCT00002688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385594|NCT00002700|Cytarabine|cytarabine|mesh-list
92385595|NCT00002700|Dexamethasone|dexamethasone|mesh-list
92385596|NCT00002700|Prednisone|prednisone|mesh-list
92385597|NCT00002700|Prednisolone|prednisolone|mesh-list
92385598|NCT00002700|Hydrocortisone|hydrocortisone|mesh-list
92385599|NCT00002700|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92385600|NCT00002700|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92385601|NCT00002700|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92385602|NCT00002700|Cyclophosphamide|cyclophosphamide|mesh-list
92385603|NCT00002700|Doxorubicin|doxorubicin|mesh-list
92385604|NCT00002700|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385605|NCT00002700|Methotrexate|methotrexate|mesh-list
91999054|NCT05915104|Hormones|hormones|mesh-ancestor
92385606|NCT00002700|Vincristine|vincristine|mesh-list
92385607|NCT00002700|Daunorubicin|daunorubicin|mesh-list
92385608|NCT00002700|Asparaginase|asparaginase|mesh-list
92385609|NCT00002700|Mitoxantrone|mitoxantrone|mesh-list
92385610|NCT00002700|Mercaptopurine|mercaptopurine|mesh-list
92385611|NCT00002700|Levoleucovorin|levoleucovorin|mesh-list
92385612|NCT00002700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385613|NCT00002700|Immunologic Factors|immunologic factors|mesh-ancestor
92385614|NCT00002700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385615|NCT00002700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129646|NCT05800054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385616|NCT00002700|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385617|NCT00002700|Alkylating Agents|alkylating agents|mesh-ancestor
92385618|NCT00002700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385619|NCT00002700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385620|NCT00002700|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385621|NCT00002700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92385622|NCT00002700|Antiemetics|antiemetics|mesh-ancestor
92385623|NCT00002700|Autonomic Agents|autonomic agents|mesh-ancestor
92385624|NCT00002700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385625|NCT00002700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385626|NCT00002700|Glucocorticoids|glucocorticoids|mesh-ancestor
92385627|NCT00002700|Hormones|hormones|mesh-ancestor
92385628|NCT00002700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385629|NCT00002700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385630|NCT00002700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385631|NCT00002700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385632|NCT00002700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385633|NCT00002700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385634|NCT00002700|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385635|NCT00002700|Abortifacient Agents|abortifacient agents|mesh-ancestor
92385636|NCT00002700|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385637|NCT00002700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385638|NCT00002700|Antimetabolites|antimetabolites|mesh-ancestor
92385639|NCT00002700|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385640|NCT00002700|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92385641|NCT00002700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385642|NCT00002700|Antiviral Agents|antiviral agents|mesh-ancestor
92385643|NCT00002700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385644|NCT00002700|Antidotes|antidotes|mesh-ancestor
92385645|NCT00002700|Protective Agents|protective agents|mesh-ancestor
91999362|NCT05912335|Anesthetics|anesthetics|mesh-list
92385646|NCT00002700|Vitamin B Complex|vitamin b complex|mesh-ancestor
92385647|NCT00002700|Vitamins|vitamins|mesh-ancestor
92385648|NCT00002700|Micronutrients|micronutrients|mesh-ancestor
92385649|NCT00002700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385650|NCT00002700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385651|NCT00002700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385652|NCT00002700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385653|NCT00002700|Analgesics|analgesics|mesh-ancestor
92385654|NCT00002700|Sensory System Agents|sensory system agents|mesh-ancestor
92385655|NCT00002718|Cytarabine|cytarabine|mesh-list
92385656|NCT00002718|Methylprednisolone|methylprednisolone|mesh-list
92385657|NCT00002718|Cyclophosphamide|cyclophosphamide|mesh-list
92385658|NCT00002718|Thiotepa|thiotepa|mesh-list
92385660|NCT00002718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385661|NCT00002718|Immunologic Factors|immunologic factors|mesh-ancestor
92385662|NCT00002718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385663|NCT00002718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385664|NCT00002718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999532|NCT05906303|Sodium Benzoate|sodium benzoate|mesh-list
92385665|NCT00002718|Alkylating Agents|alkylating agents|mesh-ancestor
92385666|NCT00002718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385667|NCT00002718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385668|NCT00002718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385669|NCT00002718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385670|NCT00002718|Antimetabolites|antimetabolites|mesh-ancestor
92385671|NCT00002718|Antiviral Agents|antiviral agents|mesh-ancestor
91999614|NCT05888532|Copper|copper|mesh-list
92385672|NCT00002718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385673|NCT00002718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92385674|NCT00002718|Antiemetics|antiemetics|mesh-ancestor
92385675|NCT00002718|Autonomic Agents|autonomic agents|mesh-ancestor
92385676|NCT00002718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999683|NCT05859464|Pembrolizumab|pembrolizumab|mesh-list
92385677|NCT00002718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385678|NCT00002718|Glucocorticoids|glucocorticoids|mesh-ancestor
92385680|NCT00002718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385681|NCT00002718|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92385682|NCT00002718|Protective Agents|protective agents|mesh-ancestor
92385683|NCT00002730|Melphalan|melphalan|mesh-list
92385684|NCT00002730|Buthionine Sulfoximine|buthionine sulfoximine|mesh-list
92385685|NCT00002730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385686|NCT00002730|Alkylating Agents|alkylating agents|mesh-ancestor
92385687|NCT00002730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385688|NCT00002730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385689|NCT00002730|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91970667|NCT03312335|Aldesleukin|aldesleukin|mesh-list
92385690|NCT00002730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385691|NCT00002730|Immunologic Factors|immunologic factors|mesh-ancestor
92385692|NCT00002730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385693|NCT00002730|Antimetabolites|antimetabolites|mesh-ancestor
92385694|NCT00002730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385695|NCT00002730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385696|NCT00002730|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92385697|NCT00002730|Protective Agents|protective agents|mesh-ancestor
92385698|NCT00002742|Amphotericin B|amphotericin b|mesh-list
92385699|NCT00002742|Nystatin|nystatin|mesh-list
92385700|NCT00002742|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92385701|NCT00002742|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92385702|NCT00002742|Deoxycholic Acid|deoxycholic acid|mesh-list
92385703|NCT00002742|Amebicides|amebicides|mesh-ancestor
92385704|NCT00002742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92385705|NCT00002742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92385706|NCT00002742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385707|NCT00002742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92385708|NCT00002742|Antifungal Agents|antifungal agents|mesh-ancestor
92385709|NCT00002742|Ionophores|ionophores|mesh-ancestor
92385710|NCT00002742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92385711|NCT00002742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385712|NCT00002742|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92385713|NCT00002742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385714|NCT00002748|Interleukin-2|interleukin-2|mesh-list
92385715|NCT00002748|Vaccines|vaccines|mesh-list
92385716|NCT00002748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385717|NCT00002748|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92385718|NCT00002748|Analgesics|analgesics|mesh-ancestor
92385719|NCT00002748|Sensory System Agents|sensory system agents|mesh-ancestor
92385720|NCT00002748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999974|NCT05672459|Fludarabine|fludarabine|mesh-list
92385721|NCT00002748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385722|NCT00002748|Immunologic Factors|immunologic factors|mesh-ancestor
92385723|NCT00002754|Antibodies|antibodies|mesh-list
92385724|NCT00002754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92385725|NCT00002754|Immunologic Factors|immunologic factors|mesh-ancestor
92385726|NCT00002754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385727|NCT00002760|Ketoconazole|ketoconazole|mesh-list
92385728|NCT00002760|Hydrocortisone|hydrocortisone|mesh-list
92385729|NCT00002760|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92385730|NCT00002760|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92385731|NCT00002760|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92385732|NCT00002760|Androgen Antagonists|androgen antagonists|mesh-list
92385733|NCT00002760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92385734|NCT00002760|Antifungal Agents|antifungal agents|mesh-ancestor
92385735|NCT00002760|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385736|NCT00002760|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92385737|NCT00002760|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92385738|NCT00002760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129647|NCT05800054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385739|NCT00002760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385740|NCT00002760|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92385741|NCT00002760|Hormone Antagonists|hormone antagonists|mesh-ancestor
92115859|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000546|NCT05346484|Pembrolizumab|pembrolizumab|mesh-list
92115860|NCT01852071|Busulfan|busulfan|mesh-list
92000828|NCT05153915|Tacrolimus|tacrolimus|mesh-list
92385742|NCT00002760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385743|NCT00002760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385744|NCT00002760|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92385745|NCT00002772|Tamoxifen|tamoxifen|mesh-list
92385746|NCT00002772|Paclitaxel|paclitaxel|mesh-list
92385747|NCT00002772|Cyclophosphamide|cyclophosphamide|mesh-list
92385748|NCT00002772|Carboplatin|carboplatin|mesh-list
92385749|NCT00002772|Doxorubicin|doxorubicin|mesh-list
92385750|NCT00002772|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385751|NCT00002772|Thiotepa|thiotepa|mesh-list
92385752|NCT00002772|Carmustine|carmustine|mesh-list
92385753|NCT00002772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385754|NCT00002772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385755|NCT00002772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385756|NCT00002772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385757|NCT00002772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385758|NCT00002772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385759|NCT00002772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385760|NCT00002772|Immunologic Factors|immunologic factors|mesh-ancestor
92001180|NCT04913805|Niacin|niacin|mesh-list
91970717|NCT03311321|Coagulants|coagulants|mesh-ancestor
92001381|NCT04725383|Amitriptyline|amitriptyline|mesh-list
92385761|NCT00002772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385762|NCT00002772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385763|NCT00002772|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385764|NCT00002772|Alkylating Agents|alkylating agents|mesh-ancestor
92385765|NCT00002772|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385766|NCT00002772|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385767|NCT00002772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385768|NCT00002772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385769|NCT00002772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385770|NCT00002772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92385771|NCT00002772|Hormone Antagonists|hormone antagonists|mesh-ancestor
92115861|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
92385772|NCT00002772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385773|NCT00002772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385774|NCT00002772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92385775|NCT00002772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92385776|NCT00002772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92385777|NCT00002778|Sargramostim|sargramostim|mesh-list
92385778|NCT00002778|Immunologic Factors|immunologic factors|mesh-ancestor
92385779|NCT00002778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385780|NCT00002784|Tamoxifen|tamoxifen|mesh-list
92002482|NCT04022239|Tacrolimus|tacrolimus|mesh-list
92002555|NCT03989271|Quercetin|quercetin|mesh-list
92385781|NCT00002784|Cyclophosphamide|cyclophosphamide|mesh-list
92002855|NCT03678350|Trioxsalen|trioxsalen|mesh-list
92385782|NCT00002784|Doxorubicin|doxorubicin|mesh-list
92385783|NCT00002784|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92385784|NCT00002784|Fluorouracil|fluorouracil|mesh-list
92385785|NCT00002784|Methotrexate|methotrexate|mesh-list
92385786|NCT00002784|Epirubicin|epirubicin|mesh-list
92115938|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003380|NCT03113500|Hormones|hormones|mesh-ancestor
92003533|NCT02798523|Antiemetics|antiemetics|mesh-ancestor
92385787|NCT00002784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385788|NCT00002784|Immunologic Factors|immunologic factors|mesh-ancestor
92129799|NCT05795491|Fluconazole|fluconazole|mesh-list
91973837|NCT00700817|Liraglutide|liraglutide|mesh-list
92385789|NCT00002784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385790|NCT00002784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129800|NCT05795491|Antifungal Agents|antifungal agents|mesh-list
92385791|NCT00002784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385792|NCT00002784|Alkylating Agents|alkylating agents|mesh-ancestor
92385793|NCT00002784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385794|NCT00002784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385795|NCT00002784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385796|NCT00002784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385797|NCT00002784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92385798|NCT00002784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92385799|NCT00002784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385800|NCT00002784|Antimetabolites|antimetabolites|mesh-ancestor
92385801|NCT00002784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385802|NCT00002784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385803|NCT00002784|Abortifacient Agents|abortifacient agents|mesh-ancestor
92385804|NCT00002784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91980585|NCT02429453|Thrombin|thrombin|mesh-list
92385805|NCT00002784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92129802|NCT05795491|Miconazole|miconazole|mesh-list
92129877|NCT05702333|Autonomic Agents|autonomic agents|mesh-ancestor
92385806|NCT00002784|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92129951|NCT05590676|Metformin|metformin|mesh-list
92385807|NCT00002784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385808|NCT00002784|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92385809|NCT00002784|Hormone Antagonists|hormone antagonists|mesh-ancestor
92385810|NCT00002784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385811|NCT00002784|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385812|NCT00002784|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92003657|NCT02595424|Etoposide|etoposide|mesh-list
92385813|NCT00002784|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92385814|NCT00002784|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92385816|NCT00002790|Sirolimus|sirolimus|mesh-list
92385817|NCT00002790|Methotrexate|methotrexate|mesh-list
92385818|NCT00002790|Cyclosporins|cyclosporins|mesh-list
92004456|NCT05014685|Bismuth|bismuth|mesh-list
92004518|NCT03078257|Tirofiban|tirofiban|mesh-list
92385819|NCT00002790|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92385820|NCT00002790|Abortifacient Agents|abortifacient agents|mesh-ancestor
92129952|NCT05590676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92130028|NCT05221554|Autonomic Agents|autonomic agents|mesh-ancestor
92385821|NCT00002790|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385822|NCT00002790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130105|NCT04826198|Olaparib|olaparib|mesh-list
92385823|NCT00002790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92385824|NCT00002790|Antimetabolites|antimetabolites|mesh-ancestor
92005222|NCT02330419|Naltrexone|naltrexone|mesh-list
92385825|NCT00002790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385826|NCT00002790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005377|NCT04498741|Anesthetics|anesthetics|mesh-ancestor
92005487|NCT04997291|Razoxane|razoxane|mesh-list
92385827|NCT00002790|Dermatologic Agents|dermatologic agents|mesh-ancestor
92385828|NCT00002790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005684|NCT04991207|Bosentan|bosentan|mesh-list
92385829|NCT00002790|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92385830|NCT00002790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385831|NCT00002790|Immunologic Factors|immunologic factors|mesh-ancestor
92385832|NCT00002790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385833|NCT00002790|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385834|NCT00002790|Antifungal Agents|antifungal agents|mesh-ancestor
92385835|NCT00002790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385836|NCT00002790|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92130106|NCT04826198|Niraparib|niraparib|mesh-list
92130107|NCT04826198|Rucaparib|rucaparib|mesh-list
92385837|NCT00002790|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92130261|NCT04420598|Immunologic Factors|immunologic factors|mesh-ancestor
92007606|NCT02621021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92007692|NCT04305145|Prednisone|prednisone|mesh-list
92385838|NCT00002790|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92385839|NCT05752110|Ketamine|ketamine|mesh-list
92385840|NCT05752110|Analgesics|analgesics|mesh-ancestor
92385841|NCT05752110|Sensory System Agents|sensory system agents|mesh-ancestor
92385842|NCT05752110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385843|NCT05752110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385844|NCT05752110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92385845|NCT05752110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92385846|NCT05752110|Anesthetics, General|anesthetics, general|mesh-ancestor
92385847|NCT05752110|Anesthetics|anesthetics|mesh-ancestor
92385848|NCT05752110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92385849|NCT05752110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92385850|NCT05752110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92385851|NCT05752110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92385852|NCT05752110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385853|NCT05751876|Dienogest|dienogest|mesh-list
92385854|NCT05751876|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92385855|NCT05751876|Contraceptive Agents|contraceptive agents|mesh-ancestor
92385856|NCT05751876|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92385857|NCT05751876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385858|NCT05751876|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92385859|NCT05751876|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92385860|NCT05751876|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92385861|NCT05751876|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92385862|NCT05751876|Hormone Antagonists|hormone antagonists|mesh-ancestor
92115939|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92008205|NCT04432259|Dexamethasone|dexamethasone|mesh-list
92385863|NCT05751876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385864|NCT05751876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92385865|NCT05751876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385867|NCT05751252|Hormone Antagonists|hormone antagonists|mesh-ancestor
92385868|NCT05751252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92385869|NCT05751252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385870|NCT00002628|Paclitaxel|paclitaxel|mesh-list
92385871|NCT00002628|Cyclophosphamide|cyclophosphamide|mesh-list
92385872|NCT00002628|Carboplatin|carboplatin|mesh-list
92385873|NCT00002628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92385874|NCT00002628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385875|NCT00002628|Tubulin Modulators|tubulin modulators|mesh-ancestor
92385876|NCT00002628|Antimitotic Agents|antimitotic agents|mesh-ancestor
92385877|NCT00002628|Mitosis Modulators|mitosis modulators|mesh-ancestor
92385878|NCT00002628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385879|NCT00002628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92385880|NCT00002628|Immunologic Factors|immunologic factors|mesh-ancestor
92385881|NCT00002628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385882|NCT00002628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385883|NCT00002628|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92385884|NCT00002628|Alkylating Agents|alkylating agents|mesh-ancestor
92008578|NCT04436419|Vitamins|vitamins|mesh-ancestor
92385885|NCT00002628|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92385886|NCT05749614|Lidocaine|lidocaine|mesh-list
92385887|NCT05749614|Anesthetics, Local|anesthetics, local|mesh-ancestor
92385888|NCT05749614|Anesthetics|anesthetics|mesh-ancestor
92385889|NCT05749614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92385890|NCT05749614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385891|NCT05749614|Sensory System Agents|sensory system agents|mesh-ancestor
92385892|NCT05749614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038345|NCT02013375|Sirolimus|sirolimus|mesh-list
92385893|NCT05749614|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92385894|NCT05749614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92385895|NCT05749614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92385896|NCT05749614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92385897|NCT05749614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385898|NCT05749380|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92385899|NCT05749380|Antifungal Agents|antifungal agents|mesh-ancestor
92385900|NCT05749380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385901|NCT05749380|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92385902|NCT05749380|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92385904|NCT05748990|Insulin Lispro|insulin lispro|mesh-list
92385905|NCT05748990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92385906|NCT05748990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385907|NCT05677698|Peppermint oil|peppermint oil|mesh-list
92385908|NCT05677698|Antiemetics|antiemetics|mesh-ancestor
92008796|NCT04946669|Abatacept|abatacept|mesh-list
92385909|NCT05677698|Autonomic Agents|autonomic agents|mesh-ancestor
92385910|NCT05677698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92385911|NCT05677698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385912|NCT05677698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385913|NCT05677698|Parasympatholytics|parasympatholytics|mesh-ancestor
92385914|NCT05588388|Bevacizumab|bevacizumab|mesh-list
92385915|NCT05588388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92385916|NCT05588388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385917|NCT05588388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92385918|NCT05588388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92385919|NCT05588388|Growth Substances|growth substances|mesh-ancestor
92385920|NCT05588388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385921|NCT05588388|Growth Inhibitors|growth inhibitors|mesh-ancestor
92385922|NCT05543850|Pancrelipase|pancrelipase|mesh-list
92385923|NCT05543850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385924|NCT05516628|Bevacizumab|bevacizumab|mesh-list
92385925|NCT05516628|Atezolizumab|atezolizumab|mesh-list
92385926|NCT05516628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92385927|NCT05516628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385928|NCT05516628|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92385929|NCT05516628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92385930|NCT05516628|Growth Substances|growth substances|mesh-ancestor
92385931|NCT05516628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385932|NCT05516628|Growth Inhibitors|growth inhibitors|mesh-ancestor
92385933|NCT05516628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92385934|NCT05516628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385935|NCT05497674|Rifampin|rifampin|mesh-list
92385936|NCT05497674|Probenecid|probenecid|mesh-list
92385937|NCT05497674|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92385938|NCT05497674|Antitubercular Agents|antitubercular agents|mesh-ancestor
92385939|NCT05497674|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92385940|NCT05497674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385941|NCT05497674|Leprostatic Agents|leprostatic agents|mesh-ancestor
92385942|NCT05497674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92385943|NCT05497674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385944|NCT05497674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385945|NCT05497674|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92385946|NCT05497674|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92385947|NCT05497674|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92385948|NCT05497674|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92385949|NCT05497674|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92385950|NCT05497674|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92385951|NCT05497674|Uricosuric Agents|uricosuric agents|mesh-ancestor
92009473|NCT04875871|Copper|copper|mesh-list
92385952|NCT05497674|Gout Suppressants|gout suppressants|mesh-ancestor
92385953|NCT05497674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385954|NCT05408910|Rifaximin|rifaximin|mesh-list
92385955|NCT05408910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92385956|NCT05408910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92385957|NCT05408910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92385958|NCT05360628|Allopurinol|allopurinol|mesh-list
92385959|NCT05360628|Antimetabolites|antimetabolites|mesh-ancestor
92385960|NCT05360628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385961|NCT05360628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385962|NCT05360628|Gout Suppressants|gout suppressants|mesh-ancestor
92385963|NCT05360628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92385964|NCT05360628|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92385965|NCT05360628|Antioxidants|antioxidants|mesh-ancestor
92038426|NCT01620489|Hormones|hormones|mesh-ancestor
92385966|NCT05360628|Protective Agents|protective agents|mesh-ancestor
92385967|NCT05360628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385968|NCT05326308|Zanubrutinib|zanubrutinib|mesh-list
92385969|NCT05326308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385970|NCT05326308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92385971|NCT05326308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385972|NCT05326308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385974|NCT05312112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385975|NCT05296278|Lenvatinib|lenvatinib|mesh-list
92385976|NCT05296278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92385977|NCT05296278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92385978|NCT05296278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385979|NCT05296278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385980|NCT05218668|Fasudil|fasudil|mesh-list
92385981|NCT05218668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92385982|NCT05218668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92385983|NCT05218668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385984|NCT05218668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92385985|NCT05218668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385986|NCT05218668|Vasodilator Agents|vasodilator agents|mesh-ancestor
92385987|NCT05218668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92385988|NCT05218668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92385989|NCT05182164|Pembrolizumab|pembrolizumab|mesh-list
92385990|NCT05182164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92385991|NCT05182164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010074|NCT04903847|Tenofovir|tenofovir|mesh-list
92385992|NCT05182164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92385993|NCT05182164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92385994|NCT05048940|Vaccines|vaccines|mesh-list
92385995|NCT05048940|Immunologic Factors|immunologic factors|mesh-ancestor
92115940|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010217|NCT04901117|Antacids|antacids|mesh-ancestor
92385996|NCT05048940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92385997|NCT04836780|Dexamethasone|dexamethasone|mesh-list
92385998|NCT04836780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92385999|NCT04836780|Antiemetics|antiemetics|mesh-ancestor
92386000|NCT04836780|Autonomic Agents|autonomic agents|mesh-ancestor
92386001|NCT04836780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386002|NCT04836780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386004|NCT04836780|Glucocorticoids|glucocorticoids|mesh-ancestor
92386005|NCT04836780|Hormones|hormones|mesh-ancestor
92010364|NCT04817189|Tropisetron|tropisetron|mesh-list
92386006|NCT04836780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386007|NCT04836780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92386008|NCT04836780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386009|NCT04740294|Magnesium Sulfate|magnesium sulfate|mesh-list
92386010|NCT04740294|Analgesics|analgesics|mesh-ancestor
92386011|NCT04740294|Sensory System Agents|sensory system agents|mesh-ancestor
92386012|NCT04740294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386013|NCT04740294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386014|NCT04740294|Anesthetics|anesthetics|mesh-ancestor
92386015|NCT04740294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386016|NCT04740294|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92386017|NCT04740294|Anticonvulsants|anticonvulsants|mesh-ancestor
92386018|NCT04740294|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92386019|NCT04740294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91937840|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92386020|NCT04740294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010574|NCT04881851|Folic Acid|folic acid|mesh-list
92386021|NCT04740294|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92386022|NCT04740294|Tocolytic Agents|tocolytic agents|mesh-ancestor
92386023|NCT04740294|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92386024|NCT04705818|Durvalumab|durvalumab|mesh-list
92386025|NCT04705818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386026|NCT04705818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386027|NCT04610736|Temozolomide|temozolomide|mesh-list
92386028|NCT04610736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386029|NCT04610736|Alkylating Agents|alkylating agents|mesh-ancestor
92386030|NCT04610736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386031|NCT04610736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386032|NCT04529538|Vaccines|vaccines|mesh-list
92386033|NCT04529538|Immunologic Factors|immunologic factors|mesh-ancestor
92386034|NCT04529538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386035|NCT04521114|Leronlimab|leronlimab|mesh-list
92386036|NCT04521114|HIV Antibodies|hiv antibodies|mesh-list
92386037|NCT04521114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92386038|NCT04521114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92010782|NCT05256953|Anesthetics|anesthetics|mesh-list
92386039|NCT04521114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386040|NCT04521114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92386041|NCT04521114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92386042|NCT04521114|Antiviral Agents|antiviral agents|mesh-ancestor
92386043|NCT04521114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386044|NCT04521114|Immunologic Factors|immunologic factors|mesh-ancestor
92386045|NCT04521114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386047|NCT04519164|Chlorthalidone|chlorthalidone|mesh-list
92386048|NCT04519164|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92386049|NCT04519164|Hormone Antagonists|hormone antagonists|mesh-ancestor
92386050|NCT04519164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386051|NCT04519164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386052|NCT04519164|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92386053|NCT04519164|Diuretics|diuretics|mesh-ancestor
92386054|NCT04519164|Natriuretic Agents|natriuretic agents|mesh-ancestor
92386055|NCT04519164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92116017|NCT04034238|Tofacitinib|tofacitinib|mesh-list
92386056|NCT04519164|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92386057|NCT04519164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92386058|NCT04519164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386059|NCT04471974|Pembrolizumab|pembrolizumab|mesh-list
92386060|NCT04471974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386061|NCT04471974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386062|NCT04471974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92386063|NCT04471974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386064|NCT04360824|Enoxaparin|enoxaparin|mesh-list
92386065|NCT04360824|Anticoagulants|anticoagulants|mesh-ancestor
92386066|NCT04360824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92116018|NCT04034238|LMB-100|lmb-100|mesh-list
92130339|NCT04055818|Nicotinic Acids|nicotinic acids|mesh-list
92116019|NCT04034238|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92386068|NCT04360824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386069|NCT04331652|Anesthetics|anesthetics|mesh-list
92386070|NCT04331652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386071|NCT04331652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386072|NCT04168710|Bupivacaine|bupivacaine|mesh-list
91984708|NCT05178173|Cetylpyridinium|cetylpyridinium|mesh-list
92386073|NCT04168710|Anesthetics, Local|anesthetics, local|mesh-ancestor
92386074|NCT04168710|Anesthetics|anesthetics|mesh-ancestor
92386075|NCT04168710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386076|NCT04168710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386077|NCT04168710|Sensory System Agents|sensory system agents|mesh-ancestor
92386078|NCT04168710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386079|NCT04016142|Paclitaxel|paclitaxel|mesh-list
92386080|NCT04016142|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92386081|NCT04016142|Carboplatin|carboplatin|mesh-list
92386082|NCT04016142|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386083|NCT04016142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386084|NCT04016142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386085|NCT04016142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386086|NCT04016142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386087|NCT04016142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386088|NCT03915678|Atezolizumab|atezolizumab|mesh-list
92386089|NCT03915678|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92386090|NCT03915678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91937841|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011751|NCT04850885|Dexamethasone|dexamethasone|mesh-list
92386091|NCT03915678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386092|NCT03915678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386093|NCT03915678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386094|NCT03915678|Immunologic Factors|immunologic factors|mesh-ancestor
92386095|NCT03915678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386097|NCT03915366|Antitubercular Agents|antitubercular agents|mesh-list
92386098|NCT03915366|Antiviral Agents|antiviral agents|mesh-ancestor
92386099|NCT03915366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386100|NCT03915366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92386101|NCT03874338|Colchicine|colchicine|mesh-list
92386102|NCT03874338|Gout Suppressants|gout suppressants|mesh-ancestor
92386103|NCT03874338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386104|NCT03874338|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386105|NCT03874338|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386106|NCT03874338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386107|NCT03874338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386108|NCT03874338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386109|NCT03846570|Beclomethasone|beclomethasone|mesh-list
92386110|NCT03846570|Formoterol Fumarate|formoterol fumarate|mesh-list
92011819|NCT04843553|Antimetabolites|antimetabolites|mesh-ancestor
92386111|NCT03846570|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92386112|NCT03846570|Autonomic Agents|autonomic agents|mesh-ancestor
92386113|NCT03846570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386114|NCT03846570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386115|NCT03846570|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92386116|NCT03846570|Respiratory System Agents|respiratory system agents|mesh-ancestor
92130340|NCT04055818|Decitabine|decitabine|mesh-list
92386117|NCT03846570|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92018978|NCT04882813|Hormones|hormones|mesh-ancestor
92386118|NCT03846570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92386119|NCT03846570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92386120|NCT03846570|Adrenergic Agents|adrenergic agents|mesh-ancestor
92386121|NCT03846570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92386122|NCT03846570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130341|NCT04055818|Tetrahydrouridine|tetrahydrouridine|mesh-list
92386123|NCT03846570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92386124|NCT03846570|Glucocorticoids|glucocorticoids|mesh-ancestor
92386125|NCT03846570|Hormones|hormones|mesh-ancestor
92386126|NCT03846570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386127|NCT03838848|Carboplatin|carboplatin|mesh-list
92386128|NCT03838848|Pemetrexed|pemetrexed|mesh-list
92386129|NCT03838848|Antibodies|antibodies|mesh-list
92386130|NCT03838848|Immunoglobulins|immunoglobulins|mesh-list
91984760|NCT02532855|Hormones|hormones|mesh-ancestor
92386131|NCT03838848|Immunologic Factors|immunologic factors|mesh-ancestor
92019646|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
92019716|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
92386132|NCT03838848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386133|NCT03838848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386134|NCT03838848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386135|NCT03838848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386136|NCT03838848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92130499|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386137|NCT03838848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386138|NCT03787602|Avelumab|avelumab|mesh-list
92386139|NCT03787602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386140|NCT03787602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386141|NCT03782376|Ustekinumab|ustekinumab|mesh-list
92020160|NCT04858087|Lumefantrine|lumefantrine|mesh-list
92386142|NCT03782376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386143|NCT03745170|Capecitabine|capecitabine|mesh-list
92386144|NCT03745170|Oxaliplatin|oxaliplatin|mesh-list
92386145|NCT03745170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386146|NCT03745170|Antimetabolites|antimetabolites|mesh-ancestor
92116020|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92116021|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386147|NCT03745170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020716|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
92116177|NCT04318704|Ifenprodil|ifenprodil|mesh-list
92130807|NCT02374008|Dexamethasone|dexamethasone|mesh-list
92386148|NCT03745170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386149|NCT03737370|Docetaxel|docetaxel|mesh-list
92386150|NCT03737370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386151|NCT03737370|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386152|NCT03737370|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386153|NCT03737370|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021048|NCT05617885|Leuprolide|leuprolide|mesh-list
92116178|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92130808|NCT02374008|Ketorolac|ketorolac|mesh-list
92021261|NCT04796857|Tislelizumab|tislelizumab|mesh-list
92021415|NCT04792333|Firibastat|firibastat|mesh-list
92386154|NCT03737370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386155|NCT03701490|Progesterone|progesterone|mesh-list
92022072|NCT05548465|Sufentanil|sufentanil|mesh-list
92386156|NCT03701490|Progestins|progestins|mesh-ancestor
92022215|NCT05535517|Emollients|emollients|mesh-list
92022292|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
92386157|NCT03701490|Hormones|hormones|mesh-ancestor
92131194|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
92131195|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
92386158|NCT03701490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131196|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
92386159|NCT03701490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386160|NCT03691974|Fasinumab|fasinumab|mesh-list
92386161|NCT03691974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92386162|NCT03691974|Analgesics|analgesics|mesh-ancestor
92386163|NCT03691974|Sensory System Agents|sensory system agents|mesh-ancestor
92131802|NCT02350686|Capecitabine|capecitabine|mesh-list
92131803|NCT02350686|Oxaliplatin|oxaliplatin|mesh-list
91984881|NCT01374425|Vitamins|vitamins|mesh-ancestor
92386164|NCT03691974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386165|NCT03691974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386167|NCT03652428|Gemcitabine|gemcitabine|mesh-list
92023143|NCT05312008|Oxytocin|oxytocin|mesh-list
92386168|NCT03652428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386169|NCT03652428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023212|NCT05002465|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92386170|NCT03652428|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023300|NCT04754945|Hormones|hormones|mesh-ancestor
92386171|NCT03652428|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386172|NCT03652428|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386173|NCT03652428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386174|NCT03652428|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386175|NCT03652428|Antimetabolites|antimetabolites|mesh-ancestor
92386176|NCT03580044|Aztreonam|aztreonam|mesh-list
92386177|NCT03580044|Avibactam|avibactam|mesh-list
92386178|NCT03580044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92023401|NCT03913559|Acetaminophen|acetaminophen|mesh-list
92386179|NCT03580044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386180|NCT03580044|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92023702|NCT01433289|Antioxidants|antioxidants|mesh-ancestor
92386181|NCT03580044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386182|NCT03580044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386183|NCT03459222|Nivolumab|nivolumab|mesh-list
92386184|NCT03459222|Ipilimumab|ipilimumab|mesh-list
92386185|NCT03459222|Relatlimab|relatlimab|mesh-list
92038635|NCT02369159|Peramivir|peramivir|mesh-list
92386186|NCT03459222|Linrodostat|linrodostat|mesh-list
92386187|NCT03459222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386188|NCT03459222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386189|NCT03459222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023940|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
92386190|NCT03459222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024091|NCT05523661|Dasatinib|dasatinib|mesh-list
92386191|NCT03459222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386192|NCT03351348|Bupivacaine|bupivacaine|mesh-list
92386193|NCT03351348|Anesthetics, Local|anesthetics, local|mesh-ancestor
92386194|NCT03351348|Anesthetics|anesthetics|mesh-ancestor
92386195|NCT03351348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386196|NCT03351348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386197|NCT03351348|Sensory System Agents|sensory system agents|mesh-ancestor
92386198|NCT03351348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386199|NCT02972034|Pembrolizumab|pembrolizumab|mesh-list
92386200|NCT02972034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386201|NCT02972034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386203|NCT02972034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386204|NCT02881554|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92386205|NCT02881554|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92386206|NCT02881554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386207|NCT02829918|Nivolumab|nivolumab|mesh-list
92386208|NCT02829918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386209|NCT02829918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025189|NCT04268407|Amoxicillin|amoxicillin|mesh-list
92131883|NCT00323739|Growth Substances|growth substances|mesh-ancestor
92132189|NCT02341794|Antimetabolites|antimetabolites|mesh-ancestor
92386210|NCT02829918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92386211|NCT02829918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386212|NCT02795988|Fluorouracil|fluorouracil|mesh-list
92386213|NCT02795988|Capecitabine|capecitabine|mesh-list
92386214|NCT02795988|Oxaliplatin|oxaliplatin|mesh-list
92132338|NCT04630938|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92386215|NCT02795988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386216|NCT02795988|Antimetabolites|antimetabolites|mesh-ancestor
92132339|NCT04630938|Narcotics|narcotics|mesh-ancestor
92116179|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92386217|NCT02795988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386218|NCT02795988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386219|NCT02795988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386220|NCT02795988|Immunologic Factors|immunologic factors|mesh-ancestor
92386221|NCT02795988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386222|NCT02782104|Esketamine|esketamine|mesh-list
92386223|NCT02782104|Antidepressive Agents|antidepressive agents|mesh-ancestor
92386224|NCT02782104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92386225|NCT01821690|Buspirone|buspirone|mesh-list
92386226|NCT01821690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92386227|NCT01821690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92386228|NCT01821690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386229|NCT01821690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386230|NCT01821690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92386231|NCT01821690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92386232|NCT01821690|Serotonin Agents|serotonin agents|mesh-ancestor
92386233|NCT01821690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92386234|NCT01821690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386235|NCT01394016|Fulvestrant|fulvestrant|mesh-list
92386236|NCT01394016|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92386237|NCT01394016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386238|NCT01394016|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92386239|NCT01394016|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92386240|NCT01394016|Hormone Antagonists|hormone antagonists|mesh-ancestor
92386241|NCT01394016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386242|NCT01394016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386243|NCT01096368|Cyclophosphamide|cyclophosphamide|mesh-list
92386244|NCT01096368|Cisplatin|cisplatin|mesh-list
92386245|NCT01096368|Carboplatin|carboplatin|mesh-list
92386246|NCT01096368|Etoposide|etoposide|mesh-list
92386247|NCT01096368|Vincristine|vincristine|mesh-list
92386248|NCT01096368|Etoposide phosphate|etoposide phosphate|mesh-list
92386249|NCT01096368|Podophyllotoxin|podophyllotoxin|mesh-list
92026922|NCT02954081|Apremilast|apremilast|mesh-list
92386250|NCT01096368|Lenograstim|lenograstim|mesh-list
92386251|NCT01096368|Mesna|mesna|mesh-list
92386252|NCT01096368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386253|NCT01096368|Immunologic Factors|immunologic factors|mesh-ancestor
92386254|NCT01096368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386255|NCT01096368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386256|NCT01096368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386257|NCT01096368|Alkylating Agents|alkylating agents|mesh-ancestor
92386258|NCT01096368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386259|NCT01096368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027568|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
92386260|NCT01096368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92027713|NCT05280223|Analgesics|analgesics|mesh-ancestor
92116180|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
92386261|NCT01096368|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386262|NCT01096368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92038708|NCT04905251|Contraceptive Agents|contraceptive agents|mesh-ancestor
92386264|NCT01096368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028119|NCT05073679|Naltrexone|naltrexone|mesh-list
92386265|NCT01096368|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386266|NCT01096368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386267|NCT01096368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386268|NCT01096368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386269|NCT01096368|Protective Agents|protective agents|mesh-ancestor
92386270|NCT01096368|Keratolytic Agents|keratolytic agents|mesh-ancestor
92386271|NCT01096368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386272|NCT00978822|Clevidipine|clevidipine|mesh-list
92386273|NCT00978822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92028424|NCT02513485|Levodopa|levodopa|mesh-list
92386274|NCT00978822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92386275|NCT00978822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386276|NCT00978822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92386277|NCT00978822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386278|NCT00577200|Midazolam|midazolam|mesh-list
92386279|NCT00577200|Sufentanil|sufentanil|mesh-list
92386280|NCT00577200|Propofol|propofol|mesh-list
92386281|NCT00577200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92386282|NCT00577200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386283|NCT00577200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985595|NCT02383823|Estrogens|estrogens|mesh-list
92028833|NCT02493751|Avelumab|avelumab|mesh-list
92386284|NCT00577200|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92386285|NCT00577200|Anesthetics, General|anesthetics, general|mesh-ancestor
92386286|NCT00577200|Anesthetics|anesthetics|mesh-ancestor
92386287|NCT00577200|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92386288|NCT00577200|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92386289|NCT00577200|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92386290|NCT00577200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92386291|NCT00577200|GABA Modulators|gaba modulators|mesh-ancestor
92386292|NCT00577200|GABA Agents|gaba agents|mesh-ancestor
92386293|NCT00577200|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92386294|NCT00577200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386295|NCT00577200|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92386296|NCT00577200|Narcotics|narcotics|mesh-ancestor
92386297|NCT00577200|Analgesics|analgesics|mesh-ancestor
92386298|NCT00577200|Sensory System Agents|sensory system agents|mesh-ancestor
92386299|NCT00577200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386300|NCT00002796|Interferons|interferons|mesh-list
92386301|NCT00002796|Interferon-gamma|interferon-gamma|mesh-list
92386302|NCT00002796|Indomethacin|indomethacin|mesh-list
92386303|NCT00002796|Fluorouracil|fluorouracil|mesh-list
92386304|NCT00002796|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92386305|NCT00002796|Antimetabolites|antimetabolites|mesh-ancestor
92386306|NCT00002796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386307|NCT00002796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386308|NCT00002796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386309|NCT00002796|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386310|NCT00002796|Immunologic Factors|immunologic factors|mesh-ancestor
92386311|NCT00002796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386312|NCT00002796|Antiviral Agents|antiviral agents|mesh-ancestor
92029189|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
92386313|NCT00002796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116181|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92386314|NCT00002796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92386315|NCT00002796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92386316|NCT00002796|Analgesics|analgesics|mesh-ancestor
92386317|NCT00002796|Sensory System Agents|sensory system agents|mesh-ancestor
92386318|NCT00002796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386319|NCT00002796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92386320|NCT00002796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386321|NCT00002796|Gout Suppressants|gout suppressants|mesh-ancestor
92386322|NCT00002796|Tocolytic Agents|tocolytic agents|mesh-ancestor
92386323|NCT00002796|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92386324|NCT00002796|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92386325|NCT00002796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386327|NCT00002802|Cyclophosphamide|cyclophosphamide|mesh-list
92386328|NCT00002802|Melphalan|melphalan|mesh-list
92386329|NCT00002802|Ifosfamide|ifosfamide|mesh-list
92386330|NCT00002802|Dacarbazine|dacarbazine|mesh-list
92386331|NCT00002802|Carboplatin|carboplatin|mesh-list
92386332|NCT00002802|Doxorubicin|doxorubicin|mesh-list
92029812|NCT02254551|Bortezomib|bortezomib|mesh-list
92386333|NCT00002802|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92386334|NCT00002802|Etoposide|etoposide|mesh-list
92386335|NCT00002802|Vincristine|vincristine|mesh-list
92038784|NCT01648205|Ranolazine|ranolazine|mesh-list
92386336|NCT00002802|Vindesine|vindesine|mesh-list
92386337|NCT00002802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386338|NCT00002802|Immunologic Factors|immunologic factors|mesh-ancestor
92386339|NCT00002802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386340|NCT00002802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386341|NCT00002802|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386342|NCT00002802|Alkylating Agents|alkylating agents|mesh-ancestor
92116262|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386343|NCT00002802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386344|NCT00002802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386345|NCT00002802|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386346|NCT00002802|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91985219|NCT03489629|Chlorhexidine|chlorhexidine|mesh-list
92386347|NCT00002802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386348|NCT00002802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386349|NCT00002802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386350|NCT00002802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92030298|NCT03905889|Sunitinib|sunitinib|mesh-list
92030364|NCT04446039|Sertraline|sertraline|mesh-list
92386351|NCT00002802|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386352|NCT00002802|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386353|NCT00002802|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386354|NCT00002802|Trace Elements|trace elements|mesh-ancestor
92386355|NCT00002802|Micronutrients|micronutrients|mesh-ancestor
92386357|NCT00002814|Topotecan|topotecan|mesh-list
92386358|NCT00002814|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386359|NCT00002814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386360|NCT00002814|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386361|NCT00002814|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386362|NCT00002814|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386363|NCT00002814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386364|NCT00002814|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92386365|NCT00002814|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386366|NCT00002814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386367|NCT00002832|Cyclosporine|cyclosporine|mesh-list
92386368|NCT00002832|Decitabine|decitabine|mesh-list
92386369|NCT00002832|Cyclosporins|cyclosporins|mesh-list
92386370|NCT00002832|Immunologic Factors|immunologic factors|mesh-ancestor
92386371|NCT00002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386372|NCT00002832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386373|NCT00002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030900|NCT02101281|Mitogens|mitogens|mesh-list
92030981|NCT02222493|Infliximab|infliximab|mesh-list
92386374|NCT00002832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386375|NCT00002832|Antifungal Agents|antifungal agents|mesh-ancestor
92386376|NCT00002832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386377|NCT00002832|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386378|NCT00002832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386379|NCT00002832|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92386380|NCT00002832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386381|NCT00002832|Antimetabolites|antimetabolites|mesh-ancestor
92386382|NCT00002832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386383|NCT00002838|Cyclophosphamide|cyclophosphamide|mesh-list
92386384|NCT00002838|Fludarabine|fludarabine|mesh-list
92386385|NCT00002838|Fludarabine phosphate|fludarabine phosphate|mesh-list
92386386|NCT00002838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386387|NCT00002838|Immunologic Factors|immunologic factors|mesh-ancestor
92132340|NCT04630938|Analgesics|analgesics|mesh-ancestor
92386388|NCT00002838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386389|NCT00002838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386390|NCT00002838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386391|NCT00002838|Alkylating Agents|alkylating agents|mesh-ancestor
92386392|NCT00002838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386393|NCT00002838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031364|NCT02195583|Zinc|zinc|mesh-list
92386394|NCT00002838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386395|NCT00002838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386396|NCT00002838|Antimetabolites|antimetabolites|mesh-ancestor
92386397|NCT00002844|Cyclophosphamide|cyclophosphamide|mesh-list
92031435|NCT02213055|Permethrin|permethrin|mesh-list
92386398|NCT00002844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386399|NCT00002844|Immunologic Factors|immunologic factors|mesh-ancestor
92031579|NCT02340949|Leucovorin|leucovorin|mesh-list
92386400|NCT00002844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386401|NCT00002844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386402|NCT00002844|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386403|NCT00002844|Alkylating Agents|alkylating agents|mesh-ancestor
92386404|NCT00002844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386405|NCT00002844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386406|NCT00002844|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386407|NCT00002862|Perillyl alcohol|perillyl alcohol|mesh-list
92386408|NCT00002862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386409|NCT00002862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386410|NCT00002862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386411|NCT00002880|Etoposide|etoposide|mesh-list
92386412|NCT00002880|Etoposide phosphate|etoposide phosphate|mesh-list
92031810|NCT02167893|Leuprolide|leuprolide|mesh-list
92386413|NCT00002880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386414|NCT00002880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038864|NCT04887506|Prednisone|prednisone|mesh-list
92132341|NCT04594746|Amiodarone|amiodarone|mesh-list
92386415|NCT00002880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386416|NCT00002880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386418|NCT00002880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386419|NCT00002892|Interferons|interferons|mesh-list
92386420|NCT00002892|Interferon-alpha|interferon-alpha|mesh-list
92386421|NCT00002892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386422|NCT00002892|Antiviral Agents|antiviral agents|mesh-ancestor
92386423|NCT00002892|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386424|NCT00002892|Immunologic Factors|immunologic factors|mesh-ancestor
92132343|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
92386425|NCT00002892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386426|NCT00002898|Dactinomycin|dactinomycin|mesh-list
92386427|NCT00002898|Cyclophosphamide|cyclophosphamide|mesh-list
92386428|NCT00002898|Ifosfamide|ifosfamide|mesh-list
92386429|NCT00002898|Carboplatin|carboplatin|mesh-list
92386430|NCT00002898|Etoposide|etoposide|mesh-list
92386431|NCT00002898|Vincristine|vincristine|mesh-list
92386432|NCT00002898|Epirubicin|epirubicin|mesh-list
92386433|NCT00002898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386434|NCT00002898|Immunologic Factors|immunologic factors|mesh-ancestor
92386435|NCT00002898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386436|NCT00002898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386437|NCT00002898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386438|NCT00002898|Alkylating Agents|alkylating agents|mesh-ancestor
92116263|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92386439|NCT00002898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386440|NCT00002898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386441|NCT00002898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386442|NCT00002898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386443|NCT00002898|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386444|NCT00002898|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386445|NCT00002898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386446|NCT00002898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386447|NCT00002898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386448|NCT00002898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386449|NCT00002898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386450|NCT00002898|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116264|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
92386451|NCT00002898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116265|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386452|NCT00002898|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92386453|NCT00002898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386454|NCT00002904|Trabectedin|trabectedin|mesh-list
92386455|NCT00002904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386456|NCT00002904|Alkylating Agents|alkylating agents|mesh-ancestor
92386457|NCT00002904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989823|NCT01680341|Insulin|insulin|mesh-list
92386458|NCT00002904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386459|NCT00002928|Paclitaxel|paclitaxel|mesh-list
92386460|NCT00002928|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386461|NCT00002928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386462|NCT00002928|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386463|NCT00002928|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386464|NCT00002928|Mitosis Modulators|mitosis modulators|mesh-ancestor
92132724|NCT02334150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92386465|NCT00002928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386466|NCT00002940|Hydroxyurea|hydroxyurea|mesh-list
92386467|NCT00002940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386468|NCT00002940|Antisickling Agents|antisickling agents|mesh-ancestor
92386469|NCT00002940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132725|NCT02334150|Narcotics|narcotics|mesh-ancestor
92032297|NCT05372939|Adalimumab|adalimumab|mesh-list
92386470|NCT00002940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386471|NCT00002940|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386472|NCT00002946|Penclomedine|penclomedine|mesh-list
92386473|NCT00002946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386474|NCT00002952|Interleukin-12|interleukin-12|mesh-list
92386475|NCT00002952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386476|NCT00002952|Immunologic Factors|immunologic factors|mesh-ancestor
91998113|NCT05032235|Fluzoparib|fluzoparib|mesh-list
92386477|NCT00002952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386478|NCT00002952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92386479|NCT00002952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92386480|NCT00002952|Growth Substances|growth substances|mesh-ancestor
92386481|NCT00002952|Growth Inhibitors|growth inhibitors|mesh-ancestor
92386482|NCT00002952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386483|NCT00002964|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92386485|NCT00002964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386486|NCT00002964|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386487|NCT00002964|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92386488|NCT00002970|Cytarabine|cytarabine|mesh-list
92003714|NCT02352090|Nandrolone|nandrolone|mesh-list
92004337|NCT00003309|Etoposide|etoposide|mesh-list
92386489|NCT00002970|Hydrocortisone|hydrocortisone|mesh-list
92038945|NCT02390219|Ivacaftor|ivacaftor|mesh-list
92386490|NCT00002970|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92386491|NCT00002970|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92386492|NCT00002970|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92386493|NCT00002970|Methotrexate|methotrexate|mesh-list
92386494|NCT00002970|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92386495|NCT00002970|Abortifacient Agents|abortifacient agents|mesh-ancestor
92386496|NCT00002970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92386497|NCT00002970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386498|NCT00002970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386499|NCT00002970|Antimetabolites|antimetabolites|mesh-ancestor
92386500|NCT00002970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386501|NCT00002970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386502|NCT00002970|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386503|NCT00002970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386504|NCT00002970|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92386505|NCT00002970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386506|NCT00002970|Immunologic Factors|immunologic factors|mesh-ancestor
92386507|NCT00002970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386508|NCT00002970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386509|NCT00002970|Antiviral Agents|antiviral agents|mesh-ancestor
92386510|NCT00002970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386511|NCT00002970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92386512|NCT00002976|Estrogens|estrogens|mesh-list
92386513|NCT00002976|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92386514|NCT00002976|Hormones|hormones|mesh-ancestor
92386515|NCT00002976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386516|NCT00002976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386517|NCT00002982|Cytarabine|cytarabine|mesh-list
92386518|NCT00002982|Carboplatin|carboplatin|mesh-list
92386519|NCT00002982|Etoposide|etoposide|mesh-list
92386520|NCT00002982|Melphalan|melphalan|mesh-list
92386521|NCT00002982|Ifosfamide|ifosfamide|mesh-list
92386522|NCT00002982|Carmustine|carmustine|mesh-list
92386523|NCT00002982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386524|NCT00002982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386525|NCT00002982|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386526|NCT00002982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386527|NCT00002982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386528|NCT00002982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386529|NCT00002982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386530|NCT00002982|Antimetabolites|antimetabolites|mesh-ancestor
92386531|NCT00002982|Antiviral Agents|antiviral agents|mesh-ancestor
92386532|NCT00002982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386533|NCT00002982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386534|NCT00002982|Immunologic Factors|immunologic factors|mesh-ancestor
92386535|NCT00002982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386536|NCT00002982|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386537|NCT00002982|Alkylating Agents|alkylating agents|mesh-ancestor
92386538|NCT00002982|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386539|NCT00002988|Irinotecan|irinotecan|mesh-list
92386540|NCT00002988|Carmustine|carmustine|mesh-list
92386541|NCT00002988|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92386542|NCT00002988|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386543|NCT00002988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386544|NCT00002988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386545|NCT00002988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386546|NCT00002988|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386547|NCT00002988|Alkylating Agents|alkylating agents|mesh-ancestor
92386548|NCT00002994|Interleukin-2|interleukin-2|mesh-list
92386549|NCT00002994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386550|NCT00002994|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92386551|NCT00002994|Analgesics|analgesics|mesh-ancestor
92386552|NCT00002994|Sensory System Agents|sensory system agents|mesh-ancestor
92386553|NCT00002994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386554|NCT00002994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386555|NCT00003000|Fentanyl|fentanyl|mesh-list
92386556|NCT00003000|Morphine|morphine|mesh-list
92386557|NCT00003000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92386558|NCT00003000|Narcotics|narcotics|mesh-ancestor
92386559|NCT00003000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386560|NCT00003000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386561|NCT00003000|Analgesics|analgesics|mesh-ancestor
92386562|NCT00003000|Sensory System Agents|sensory system agents|mesh-ancestor
92386563|NCT00003000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386564|NCT00003000|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92386565|NCT00003000|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92386566|NCT00003000|Anesthetics, General|anesthetics, general|mesh-ancestor
92386567|NCT00003000|Anesthetics|anesthetics|mesh-ancestor
92386568|NCT00003012|Cyclophosphamide|cyclophosphamide|mesh-list
92386569|NCT00003012|Fluorouracil|fluorouracil|mesh-list
92386570|NCT00003012|Methotrexate|methotrexate|mesh-list
92386571|NCT00003012|Epirubicin|epirubicin|mesh-list
92386572|NCT00003012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386573|NCT00003012|Immunologic Factors|immunologic factors|mesh-ancestor
92010989|NCT03044795|Veliparib|veliparib|mesh-list
92386574|NCT00003012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386575|NCT00003012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386576|NCT00003012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386577|NCT00003012|Alkylating Agents|alkylating agents|mesh-ancestor
92386578|NCT00003012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386579|NCT00003012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386580|NCT00003012|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386581|NCT00003012|Antimetabolites|antimetabolites|mesh-ancestor
92386582|NCT00003012|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386583|NCT00003012|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92386584|NCT00003012|Abortifacient Agents|abortifacient agents|mesh-ancestor
92386585|NCT00003012|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92386586|NCT00003012|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386587|NCT00003012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386588|NCT00003012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92133031|NCT03026881|Fluzoparib|fluzoparib|mesh-list
92386589|NCT00003012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386590|NCT00003012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386591|NCT00003012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386592|NCT00003012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386593|NCT00003048|Amifostine|amifostine|mesh-list
92386594|NCT00003048|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92386595|NCT00003048|Protective Agents|protective agents|mesh-ancestor
92386596|NCT00003048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386597|NCT00003054|Paclitaxel|paclitaxel|mesh-list
92386598|NCT00003054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386599|NCT00003054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386600|NCT00003054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386601|NCT00003054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386602|NCT00003054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386603|NCT00003054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386604|NCT00003060|Cyclosporine|cyclosporine|mesh-list
92386605|NCT00003060|Cyclophosphamide|cyclophosphamide|mesh-list
92386606|NCT00003060|Busulfan|busulfan|mesh-list
92386607|NCT00003060|Methotrexate|methotrexate|mesh-list
92386608|NCT00003060|Cyclosporins|cyclosporins|mesh-list
92386609|NCT00003060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386610|NCT00003060|Immunologic Factors|immunologic factors|mesh-ancestor
92386611|NCT00003060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386612|NCT00003060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386613|NCT00003060|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386614|NCT00003060|Alkylating Agents|alkylating agents|mesh-ancestor
92386615|NCT00003060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032943|NCT04422197|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92386616|NCT00003060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386617|NCT00003060|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386618|NCT00003060|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92386619|NCT00003060|Abortifacient Agents|abortifacient agents|mesh-ancestor
92386620|NCT00003060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92386621|NCT00003060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386622|NCT00003060|Antimetabolites|antimetabolites|mesh-ancestor
92386623|NCT00003060|Dermatologic Agents|dermatologic agents|mesh-ancestor
92386624|NCT00003060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386625|NCT00003060|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92033222|NCT04883281|Cetuximab|cetuximab|mesh-list
92386626|NCT00003060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386627|NCT00003060|Antifungal Agents|antifungal agents|mesh-ancestor
92386628|NCT00003060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386629|NCT00003060|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92386630|NCT00003066|Docetaxel|docetaxel|mesh-list
92386631|NCT00003066|Estramustine|estramustine|mesh-list
92386632|NCT00003066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386633|NCT00003066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386634|NCT00003066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92033283|NCT05227937|Amikacin|amikacin|mesh-list
92386635|NCT00003066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386636|NCT00003066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386637|NCT00003066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386638|NCT00003066|Alkylating Agents|alkylating agents|mesh-ancestor
92039082|NCT02010255|Ledipasvir|ledipasvir|mesh-list
92386639|NCT00003066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92386640|NCT00003072|Paclitaxel|paclitaxel|mesh-list
92386641|NCT00003072|Carboplatin|carboplatin|mesh-list
92386643|NCT00003072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92033387|NCT02114385|Vaccines|vaccines|mesh-list
92386644|NCT00003072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386645|NCT00003072|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386646|NCT00003072|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386647|NCT00003072|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386648|NCT00003072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386649|NCT00003072|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92386650|NCT00003072|Protective Agents|protective agents|mesh-ancestor
92386651|NCT00003072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386652|NCT00003078|Fluorouracil|fluorouracil|mesh-list
92386653|NCT00003078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386654|NCT00003078|Antimetabolites|antimetabolites|mesh-ancestor
92386655|NCT00003078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386656|NCT00003078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386657|NCT00003078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033671|NCT05025605|Analgesics|analgesics|mesh-ancestor
92386658|NCT00003078|Immunologic Factors|immunologic factors|mesh-ancestor
92386659|NCT00003078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386660|NCT00003084|Ketoconazole|ketoconazole|mesh-list
92386661|NCT00003084|Paclitaxel|paclitaxel|mesh-list
92386662|NCT00003084|Etoposide|etoposide|mesh-list
92386663|NCT00003084|Vinblastine|vinblastine|mesh-list
92386664|NCT00003084|Doxorubicin|doxorubicin|mesh-list
92386665|NCT00003084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92386666|NCT00003084|Estramustine|estramustine|mesh-list
92386667|NCT00003084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386668|NCT00003084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386669|NCT00003084|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386670|NCT00003084|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386671|NCT00003084|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386672|NCT00003084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386673|NCT00003084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386674|NCT00003084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386675|NCT00003084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386676|NCT00003084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386677|NCT00003084|Antifungal Agents|antifungal agents|mesh-ancestor
92386678|NCT00003084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386679|NCT00003084|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92386680|NCT00003084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92386681|NCT00003084|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92386682|NCT00003084|Hormone Antagonists|hormone antagonists|mesh-ancestor
92386683|NCT00003084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386684|NCT00003084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386685|NCT00003084|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92386686|NCT00003084|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386687|NCT00003084|Alkylating Agents|alkylating agents|mesh-ancestor
92386688|NCT00003084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92386690|NCT00003090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386691|NCT00003090|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92386692|NCT00003090|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92034205|NCT01928758|Nicotine|nicotine|mesh-list
92386693|NCT00003090|Antiviral Agents|antiviral agents|mesh-ancestor
92012238|NCT04785287|Nivolumab|nivolumab|mesh-list
92386694|NCT00003090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386695|NCT00003108|Bryostatin 1|bryostatin 1|mesh-list
92386696|NCT00003108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386697|NCT00003108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386698|NCT00003108|Immunologic Factors|immunologic factors|mesh-ancestor
92133259|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92386699|NCT00003108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386700|NCT00003114|Cyclophosphamide|cyclophosphamide|mesh-list
92386701|NCT00003114|Lomustine|lomustine|mesh-list
92386702|NCT00003114|Etoposide|etoposide|mesh-list
92386703|NCT00003114|Procarbazine|procarbazine|mesh-list
92386704|NCT00003114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92034762|NCT01864174|Metformin|metformin|mesh-list
92386705|NCT00003114|Immunologic Factors|immunologic factors|mesh-ancestor
92386706|NCT00003114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386707|NCT00003114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386708|NCT00003114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386709|NCT00003114|Alkylating Agents|alkylating agents|mesh-ancestor
92116266|NCT02006056|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92012366|NCT00396175|Finasteride|finasteride|mesh-list
92386710|NCT00003114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386711|NCT00003114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386712|NCT00003114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386713|NCT00003114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035011|NCT02318095|Antimetabolites|antimetabolites|mesh-ancestor
92386714|NCT00003114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92039171|NCT02312219|Vitamins|vitamins|mesh-ancestor
92035081|NCT02286895|Vaccines|vaccines|mesh-list
92035130|NCT02059161|MK-1293|mk-1293|mesh-list
92386715|NCT00003114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386716|NCT00003114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386717|NCT00003120|Paclitaxel|paclitaxel|mesh-list
92035192|NCT02039427|Ketorolac|ketorolac|mesh-list
92386718|NCT00003120|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92133710|NCT00442689|Flutamide|flutamide|mesh-list
92386719|NCT00003120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386720|NCT00003120|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386721|NCT00003120|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386722|NCT00003120|Mitosis Modulators|mitosis modulators|mesh-ancestor
92133711|NCT00442689|Drospirenone|drospirenone|mesh-list
92386723|NCT00003120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386724|NCT00003126|Aldesleukin|aldesleukin|mesh-list
92386725|NCT00003126|Interleukin-2|interleukin-2|mesh-list
92386726|NCT00003126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386727|NCT00003126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92386728|NCT00003126|Analgesics|analgesics|mesh-ancestor
92386729|NCT00003126|Sensory System Agents|sensory system agents|mesh-ancestor
92386730|NCT00003126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386731|NCT00003126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386732|NCT00003126|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92386733|NCT00003126|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92386734|NCT00003126|Antiviral Agents|antiviral agents|mesh-ancestor
92386735|NCT00003126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92386736|NCT00003132|Bryostatin 1|bryostatin 1|mesh-list
92386737|NCT00003132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035563|NCT02282293|Trimethoprim|trimethoprim|mesh-list
92386738|NCT00003132|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386739|NCT00003132|Immunologic Factors|immunologic factors|mesh-ancestor
92386740|NCT00003132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386741|NCT00003144|Gemcitabine|gemcitabine|mesh-list
92386742|NCT00003144|Amifostine|amifostine|mesh-list
92386743|NCT00003144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386744|NCT00003144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386745|NCT00003144|Antimetabolites|antimetabolites|mesh-ancestor
92386746|NCT00003144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386747|NCT00003144|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92386748|NCT00003144|Protective Agents|protective agents|mesh-ancestor
92386749|NCT00003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386750|NCT00003150|Prednisone|prednisone|mesh-list
92386751|NCT00003150|Cyclophosphamide|cyclophosphamide|mesh-list
92386752|NCT00003150|Rituximab|rituximab|mesh-list
92386753|NCT00003150|Doxorubicin|doxorubicin|mesh-list
92386754|NCT00003150|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92386755|NCT00003150|Vincristine|vincristine|mesh-list
92386756|NCT00003150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386757|NCT00003150|Immunologic Factors|immunologic factors|mesh-ancestor
92386758|NCT00003150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386759|NCT00003150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386760|NCT00003150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386761|NCT00003150|Alkylating Agents|alkylating agents|mesh-ancestor
92386762|NCT00003150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386763|NCT00003150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386764|NCT00003150|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386765|NCT00003150|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386766|NCT00003150|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386767|NCT00003150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386768|NCT00003150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386769|NCT00003150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386770|NCT00003150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92386771|NCT00003150|Glucocorticoids|glucocorticoids|mesh-ancestor
92386772|NCT00003150|Hormones|hormones|mesh-ancestor
92386773|NCT00003150|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386774|NCT00003150|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92386775|NCT00003150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386776|NCT00003150|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386777|NCT00003150|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386778|NCT00003150|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386779|NCT00003156|Topotecan|topotecan|mesh-list
92386780|NCT00003156|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92035977|NCT02284009|Hormones|hormones|mesh-ancestor
92133712|NCT00442689|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92386781|NCT00003156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386782|NCT00003156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386783|NCT00003156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386784|NCT00003156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386785|NCT00003174|Cladribine|cladribine|mesh-list
92012701|NCT05035069|Propofol|propofol|mesh-list
92386786|NCT00003174|Bryostatin 1|bryostatin 1|mesh-list
92386787|NCT00003174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133713|NCT00442689|Estradiol|estradiol|mesh-list
92386788|NCT00003174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386789|NCT00003174|Immunologic Factors|immunologic factors|mesh-ancestor
92386790|NCT00003174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386791|NCT00003174|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386793|NCT00003018|Fluorouracil|fluorouracil|mesh-list
92386794|NCT00003018|Mitomycins|mitomycins|mesh-list
92386795|NCT00003018|Mitomycin|mitomycin|mesh-list
92012776|NCT05042635|Ixekizumab|ixekizumab|mesh-list
92386796|NCT00003018|Dipyridamole|dipyridamole|mesh-list
92386797|NCT00003018|Calcium|calcium|mesh-list
92386798|NCT00003018|Levoleucovorin|levoleucovorin|mesh-list
92386799|NCT00003018|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92386800|NCT00003018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386801|NCT00003018|Antimetabolites|antimetabolites|mesh-ancestor
92386802|NCT00003018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386803|NCT00003018|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386804|NCT00003018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386805|NCT00003018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386806|NCT00003018|Immunologic Factors|immunologic factors|mesh-ancestor
92386807|NCT00003018|Antidotes|antidotes|mesh-ancestor
92012957|NCT05051137|Infliximab|infliximab|mesh-list
92013004|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
92386808|NCT00003018|Protective Agents|protective agents|mesh-ancestor
92386809|NCT00003018|Vitamin B Complex|vitamin b complex|mesh-ancestor
92386810|NCT00003018|Vitamins|vitamins|mesh-ancestor
92386811|NCT00003018|Micronutrients|micronutrients|mesh-ancestor
92036640|NCT04716933|Carboplatin|carboplatin|mesh-list
92386812|NCT00003018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386813|NCT00003018|Alkylating Agents|alkylating agents|mesh-ancestor
92386814|NCT00003018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386815|NCT00003018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386816|NCT00003018|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92036721|NCT02032875|Ribavirin|ribavirin|mesh-list
92036904|NCT02087943|Thalidomide|thalidomide|mesh-list
92386817|NCT00003018|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92386818|NCT00003018|Vasodilator Agents|vasodilator agents|mesh-ancestor
92386819|NCT00003198|Topotecan|topotecan|mesh-list
92386820|NCT00003198|Ifosfamide|ifosfamide|mesh-list
92386821|NCT00003198|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92386822|NCT00003198|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386823|NCT00003198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386824|NCT00003198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386825|NCT00003198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386826|NCT00003198|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386827|NCT00003198|Alkylating Agents|alkylating agents|mesh-ancestor
92386828|NCT00003204|Prednisone|prednisone|mesh-list
92386829|NCT00003204|Cyclophosphamide|cyclophosphamide|mesh-list
92386830|NCT00003204|Rituximab|rituximab|mesh-list
92386831|NCT00003204|Fludarabine|fludarabine|mesh-list
92386832|NCT00003204|Fludarabine phosphate|fludarabine phosphate|mesh-list
92386833|NCT00003204|Vincristine|vincristine|mesh-list
92386834|NCT00003204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386835|NCT00003204|Immunologic Factors|immunologic factors|mesh-ancestor
92386836|NCT00003204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386837|NCT00003204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386838|NCT00003204|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92013216|NCT05009953|Vitamins|vitamins|mesh-ancestor
92386839|NCT00003204|Alkylating Agents|alkylating agents|mesh-ancestor
92386840|NCT00003204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013230|NCT05009017|Bevacizumab|bevacizumab|mesh-list
92386841|NCT00003204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386842|NCT00003204|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386843|NCT00003204|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92386844|NCT00003204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92386845|NCT00003204|Glucocorticoids|glucocorticoids|mesh-ancestor
92386846|NCT00003204|Hormones|hormones|mesh-ancestor
92386847|NCT00003204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386848|NCT00003204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92386849|NCT00003204|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386850|NCT00003204|Antimetabolites|antimetabolites|mesh-ancestor
92386851|NCT00003204|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386852|NCT00003204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386853|NCT00003204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386854|NCT00003204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386855|NCT00003210|Interleukin-12|interleukin-12|mesh-list
92386856|NCT00003210|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386857|NCT00003210|Immunologic Factors|immunologic factors|mesh-ancestor
92386858|NCT00003210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386859|NCT00003210|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92037650|NCT04602754|Calcium|calcium|mesh-list
92386860|NCT00003210|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92013458|NCT03086005|Metformin|metformin|mesh-list
92386861|NCT00003210|Growth Substances|growth substances|mesh-ancestor
92386862|NCT00003210|Growth Inhibitors|growth inhibitors|mesh-ancestor
92386863|NCT00003210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386864|NCT00003216|Gemcitabine|gemcitabine|mesh-list
92386865|NCT00003216|Fluorouracil|fluorouracil|mesh-list
92386866|NCT00003216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386867|NCT00003216|Antimetabolites|antimetabolites|mesh-ancestor
92386868|NCT00003216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013529|NCT05006911|Mydriatics|mydriatics|mesh-ancestor
92386869|NCT00003216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386870|NCT00003216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386871|NCT00003216|Immunologic Factors|immunologic factors|mesh-ancestor
92133714|NCT00442689|Estrogens|estrogens|mesh-ancestor
92133715|NCT00442689|Hormones|hormones|mesh-ancestor
92386872|NCT00003216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386873|NCT00003234|Vinorelbine|vinorelbine|mesh-list
92038282|NCT02081001|Glucagon|glucagon|mesh-list
92386874|NCT00003234|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92013887|NCT04997707|Propofol|propofol|mesh-list
92386875|NCT00003234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386876|NCT00003234|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386877|NCT00003234|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386878|NCT00003234|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386879|NCT00003234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386881|NCT00003240|Ifosfamide|ifosfamide|mesh-list
92386882|NCT00003240|Mitomycins|mitomycins|mesh-list
92386883|NCT00003240|Mitomycin|mitomycin|mesh-list
92386884|NCT00003240|Vinblastine|vinblastine|mesh-list
92386885|NCT00003240|Vindesine|vindesine|mesh-list
92386886|NCT00003240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386887|NCT00003240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386888|NCT00003240|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386889|NCT00003240|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386890|NCT00003240|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386891|NCT00003240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038480|NCT01768858|Adalimumab|adalimumab|mesh-list
92386892|NCT00003240|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386893|NCT00003240|Alkylating Agents|alkylating agents|mesh-ancestor
92038682|NCT01608724|Saxagliptin|saxagliptin|mesh-list
92386894|NCT00003240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386895|NCT00003240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92386896|NCT00003240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386897|NCT00003252|Amifostine|amifostine|mesh-list
92386898|NCT00003252|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92386899|NCT00003252|Protective Agents|protective agents|mesh-ancestor
92386900|NCT00003252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386901|NCT00003264|Gemcitabine|gemcitabine|mesh-list
92386902|NCT00003264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386903|NCT00003264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386904|NCT00003264|Antimetabolites|antimetabolites|mesh-ancestor
92386905|NCT00003264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386906|NCT00003276|Irinotecan|irinotecan|mesh-list
92386907|NCT00003276|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92386908|NCT00003276|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386909|NCT00003276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937853|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92386910|NCT00003276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386912|NCT00003288|Cyclophosphamide|cyclophosphamide|mesh-list
92386913|NCT00003288|Tirapazamine|tirapazamine|mesh-list
92386914|NCT00003288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386915|NCT00003288|Immunologic Factors|immunologic factors|mesh-ancestor
92386916|NCT00003288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386917|NCT00003288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386918|NCT00003288|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386919|NCT00003288|Alkylating Agents|alkylating agents|mesh-ancestor
92386920|NCT00003288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386921|NCT00003288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386922|NCT00003288|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386923|NCT00003294|Paclitaxel|paclitaxel|mesh-list
92386924|NCT00003294|Carboplatin|carboplatin|mesh-list
92386925|NCT00003294|Amifostine|amifostine|mesh-list
92039379|NCT01619865|Edotreotide|edotreotide|mesh-list
92386926|NCT00003294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386927|NCT00003294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386928|NCT00003294|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386929|NCT00003294|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039595|NCT01639729|Sufentanil|sufentanil|mesh-list
92386930|NCT00003294|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386931|NCT00003294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386932|NCT00003294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386933|NCT00003294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92386934|NCT00003294|Protective Agents|protective agents|mesh-ancestor
92386935|NCT00003330|Interleukin-12|interleukin-12|mesh-list
92386936|NCT00003330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92386937|NCT00003330|Immunologic Factors|immunologic factors|mesh-ancestor
92386938|NCT00003330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386939|NCT00003330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92386940|NCT00003330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92386941|NCT00003330|Growth Substances|growth substances|mesh-ancestor
92386942|NCT00003330|Growth Inhibitors|growth inhibitors|mesh-ancestor
92386943|NCT00003330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386944|NCT00003336|Methylprednisolone|methylprednisolone|mesh-list
92386945|NCT00003336|Cyclophosphamide|cyclophosphamide|mesh-list
92386946|NCT00003336|Melphalan|melphalan|mesh-list
92386947|NCT00003336|Busulfan|busulfan|mesh-list
92386948|NCT00003336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92386949|NCT00003336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92386950|NCT00003336|Immunologic Factors|immunologic factors|mesh-ancestor
92386951|NCT00003336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386952|NCT00003336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92386953|NCT00003336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386954|NCT00003336|Alkylating Agents|alkylating agents|mesh-ancestor
92386955|NCT00003336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386956|NCT00003336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386957|NCT00003336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92386958|NCT00003336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92386959|NCT00003336|Antiemetics|antiemetics|mesh-ancestor
92386960|NCT00003336|Autonomic Agents|autonomic agents|mesh-ancestor
92386961|NCT00003336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92386962|NCT00003336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92040170|NCT05814302|Acetaminophen|acetaminophen|mesh-list
92386963|NCT00003336|Glucocorticoids|glucocorticoids|mesh-ancestor
92386964|NCT00003336|Hormones|hormones|mesh-ancestor
92386965|NCT00003336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92386966|NCT00003336|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92386967|NCT00003336|Protective Agents|protective agents|mesh-ancestor
92386968|NCT00003342|Paclitaxel|paclitaxel|mesh-list
92014163|NCT03072121|Diuretics|diuretics|mesh-ancestor
92386969|NCT00003342|Carboplatin|carboplatin|mesh-list
92386970|NCT00003342|Gemcitabine|gemcitabine|mesh-list
92386971|NCT00003342|Doxorubicin|doxorubicin|mesh-list
92386972|NCT00003342|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92386973|NCT00003342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92386974|NCT00003342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386975|NCT00003342|Tubulin Modulators|tubulin modulators|mesh-ancestor
92386976|NCT00003342|Antimitotic Agents|antimitotic agents|mesh-ancestor
92386977|NCT00003342|Mitosis Modulators|mitosis modulators|mesh-ancestor
92386978|NCT00003342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040506|NCT05552196|Ponesimod|ponesimod|mesh-list
92386979|NCT00003342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92386980|NCT00003342|Antimetabolites|antimetabolites|mesh-ancestor
92386981|NCT00003342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92386982|NCT00003342|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92386983|NCT00003342|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386984|NCT00003342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386985|NCT00003348|Carmustine|carmustine|mesh-list
92386986|NCT00003348|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92386987|NCT00003348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92386988|NCT00003348|Alkylating Agents|alkylating agents|mesh-ancestor
92386989|NCT00003348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92386990|NCT00003348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92386991|NCT00003348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92386992|NCT00003360|Antibodies|antibodies|mesh-list
92386993|NCT00003360|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92386994|NCT00003360|Immunologic Factors|immunologic factors|mesh-ancestor
92386995|NCT00003360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92386996|NCT00003372|Topotecan|topotecan|mesh-list
92386997|NCT00003372|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92386998|NCT00003372|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92386999|NCT00003372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387000|NCT00003372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387001|NCT00003372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387002|NCT00003378|Paclitaxel|paclitaxel|mesh-list
92387003|NCT00003378|Carboplatin|carboplatin|mesh-list
92387004|NCT00003378|Gemcitabine|gemcitabine|mesh-list
92387005|NCT00003378|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91985904|NCT02371421|Antimetabolites|antimetabolites|mesh-ancestor
92387006|NCT00003378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387007|NCT00003378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387008|NCT00003378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387009|NCT00003378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387010|NCT00003378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387011|NCT00003378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387012|NCT00003378|Antimetabolites|antimetabolites|mesh-ancestor
92387013|NCT00003390|Irofulven|irofulven|mesh-list
92387014|NCT00003390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387015|NCT00003390|Alkylating Agents|alkylating agents|mesh-ancestor
92387016|NCT00003390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039460|NCT02282345|Talazoparib|talazoparib|mesh-list
92387017|NCT00003390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387018|NCT00003396|Cyclophosphamide|cyclophosphamide|mesh-list
92387019|NCT00003396|Melphalan|melphalan|mesh-list
92387020|NCT00003396|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92387021|NCT00003396|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387022|NCT00003396|Immunologic Factors|immunologic factors|mesh-ancestor
92387023|NCT00003396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387024|NCT00003396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387025|NCT00003396|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387026|NCT00003396|Alkylating Agents|alkylating agents|mesh-ancestor
92387027|NCT00003396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387028|NCT00003396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387029|NCT00003396|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387030|NCT00003402|Dexamethasone|dexamethasone|mesh-list
92387031|NCT00003402|Paclitaxel|paclitaxel|mesh-list
92387032|NCT00003402|Etoposide|etoposide|mesh-list
92387033|NCT00003402|Cyclophosphamide|cyclophosphamide|mesh-list
92387034|NCT00003402|Melphalan|melphalan|mesh-list
92387035|NCT00003402|Carmustine|carmustine|mesh-list
92387036|NCT00003402|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387037|NCT00003402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387038|NCT00003402|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387039|NCT00003402|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387040|NCT00003402|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387041|NCT00003402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387042|NCT00003402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387043|NCT00003402|Immunologic Factors|immunologic factors|mesh-ancestor
92387044|NCT00003402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387045|NCT00003402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387046|NCT00003402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387047|NCT00003402|Alkylating Agents|alkylating agents|mesh-ancestor
92387048|NCT00003402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387049|NCT00003402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92387050|NCT00003402|Antiemetics|antiemetics|mesh-ancestor
92387051|NCT00003402|Autonomic Agents|autonomic agents|mesh-ancestor
92387052|NCT00003402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387053|NCT00003402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92387054|NCT00003402|Glucocorticoids|glucocorticoids|mesh-ancestor
92387056|NCT00003402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92387057|NCT00003402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92387058|NCT00003402|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387059|NCT00003402|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387060|NCT00003402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387061|NCT00003408|Interferons|interferons|mesh-list
92387062|NCT00003408|Interferon-alpha|interferon-alpha|mesh-list
92387063|NCT00003408|Aldesleukin|aldesleukin|mesh-list
92387064|NCT00003408|Sargramostim|sargramostim|mesh-list
92387065|NCT00003408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387066|NCT00003408|Antiviral Agents|antiviral agents|mesh-ancestor
92387067|NCT00003408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387068|NCT00003408|Immunologic Factors|immunologic factors|mesh-ancestor
92387069|NCT00003408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387070|NCT00003408|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92387071|NCT00003408|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92387072|NCT00003414|Interferons|interferons|mesh-list
92387073|NCT00003414|Aldesleukin|aldesleukin|mesh-list
92387074|NCT00003414|Interferon-gamma|interferon-gamma|mesh-list
92387075|NCT00003414|Cyclosporine|cyclosporine|mesh-list
92387076|NCT00003414|Cyclophosphamide|cyclophosphamide|mesh-list
92387077|NCT00003414|Busulfan|busulfan|mesh-list
92387078|NCT00003414|Cyclosporins|cyclosporins|mesh-list
92387079|NCT00003414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387080|NCT00003414|Immunologic Factors|immunologic factors|mesh-ancestor
92387081|NCT00003414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387082|NCT00003414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387083|NCT00003414|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387084|NCT00003414|Alkylating Agents|alkylating agents|mesh-ancestor
92387085|NCT00003414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387086|NCT00003414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387087|NCT00003414|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387088|NCT00003414|Antiviral Agents|antiviral agents|mesh-ancestor
92387089|NCT00003414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387090|NCT00003414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387091|NCT00003414|Antifungal Agents|antifungal agents|mesh-ancestor
92387092|NCT00003414|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387093|NCT00003414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92387094|NCT00003414|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92039540|NCT01979523|Trametinib|trametinib|mesh-list
92387095|NCT00003414|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92387096|NCT00003426|Gemcitabine|gemcitabine|mesh-list
92387097|NCT00003426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387098|NCT00003426|Antimetabolites|antimetabolites|mesh-ancestor
92387099|NCT00003426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387100|NCT00003426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387102|NCT00003462|Alkylating Agents|alkylating agents|mesh-ancestor
92387103|NCT00003462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387104|NCT00003462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387105|NCT00003462|Immunologic Factors|immunologic factors|mesh-ancestor
92387106|NCT00003462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387107|NCT00003462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387108|NCT00003462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387109|NCT00003462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387110|NCT00003528|Raltitrexed|raltitrexed|mesh-list
92387111|NCT00003528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387112|NCT00003528|Antimetabolites|antimetabolites|mesh-ancestor
92387113|NCT00003528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387114|NCT00003528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387115|NCT00003528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92387116|NCT00003528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387117|NCT00003540|Gemcitabine|gemcitabine|mesh-list
92387118|NCT00003540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387119|NCT00003540|Antimetabolites|antimetabolites|mesh-ancestor
92387120|NCT00003540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387121|NCT00003540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387122|NCT00003546|Gemcitabine|gemcitabine|mesh-list
92387123|NCT00003546|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387124|NCT00003546|Antimetabolites|antimetabolites|mesh-ancestor
92387125|NCT00003546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387126|NCT00003546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387127|NCT00003552|Cyclophosphamide|cyclophosphamide|mesh-list
92387128|NCT00003552|Fludarabine|fludarabine|mesh-list
92387129|NCT00003552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92387130|NCT00003552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387131|NCT00003552|Immunologic Factors|immunologic factors|mesh-ancestor
92387132|NCT00003552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387133|NCT00003552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387134|NCT00003552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387135|NCT00003552|Alkylating Agents|alkylating agents|mesh-ancestor
92387136|NCT00003552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387137|NCT00003552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387138|NCT00003552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387139|NCT00003558|Leucovorin|leucovorin|mesh-list
92387140|NCT00003558|Paclitaxel|paclitaxel|mesh-list
92387141|NCT00003558|Etoposide|etoposide|mesh-list
92387142|NCT00003558|Carboplatin|carboplatin|mesh-list
92387143|NCT00003558|Fluorouracil|fluorouracil|mesh-list
92387144|NCT00003558|Calcium|calcium|mesh-list
92387145|NCT00003558|Levoleucovorin|levoleucovorin|mesh-list
92387146|NCT00003558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387147|NCT00003558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387148|NCT00003558|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387149|NCT00003558|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387150|NCT00003558|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387151|NCT00003558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387152|NCT00003558|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92387153|NCT00003558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387154|NCT00003558|Antimetabolites|antimetabolites|mesh-ancestor
92387155|NCT00003558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387156|NCT00003558|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387157|NCT00003558|Immunologic Factors|immunologic factors|mesh-ancestor
92387158|NCT00003558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387159|NCT00003558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387160|NCT00003558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387161|NCT00003558|Antidotes|antidotes|mesh-ancestor
92387162|NCT00003558|Protective Agents|protective agents|mesh-ancestor
92387163|NCT00003558|Vitamin B Complex|vitamin b complex|mesh-ancestor
92387165|NCT00003558|Micronutrients|micronutrients|mesh-ancestor
92387166|NCT00003564|Procarbazine|procarbazine|mesh-list
92387167|NCT00003564|Isotretinoin|isotretinoin|mesh-list
92387168|NCT00003564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387169|NCT00003564|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387170|NCT00003576|Fluorouracil|fluorouracil|mesh-list
92387171|NCT00003576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387172|NCT00003576|Antimetabolites|antimetabolites|mesh-ancestor
92387173|NCT00003576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387174|NCT00003576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387175|NCT00003576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387176|NCT00003576|Immunologic Factors|immunologic factors|mesh-ancestor
92387177|NCT00003576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387178|NCT00003582|Paclitaxel|paclitaxel|mesh-list
92387179|NCT00003582|Fluorouracil|fluorouracil|mesh-list
92387180|NCT00003582|Amifostine|amifostine|mesh-list
92387181|NCT00003582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387182|NCT00003582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387183|NCT00003582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387184|NCT00003582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387185|NCT00003582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387186|NCT00003582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387187|NCT00003582|Antimetabolites|antimetabolites|mesh-ancestor
92387188|NCT00003582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387189|NCT00003582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387190|NCT00003582|Immunologic Factors|immunologic factors|mesh-ancestor
92387191|NCT00003582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387192|NCT00003582|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92387193|NCT00003582|Protective Agents|protective agents|mesh-ancestor
92387194|NCT00003594|Leucovorin|leucovorin|mesh-list
92387195|NCT00003594|Fluorouracil|fluorouracil|mesh-list
92387196|NCT00003594|Oxaliplatin|oxaliplatin|mesh-list
92387197|NCT00003594|Irinotecan|irinotecan|mesh-list
92387198|NCT00003594|Calcium|calcium|mesh-list
92387199|NCT00003594|Levoleucovorin|levoleucovorin|mesh-list
92387200|NCT00003594|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92387201|NCT00003594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387202|NCT00003594|Antimetabolites|antimetabolites|mesh-ancestor
92387203|NCT00003594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387204|NCT00003594|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387205|NCT00003594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387206|NCT00003594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387207|NCT00003594|Immunologic Factors|immunologic factors|mesh-ancestor
92387208|NCT00003594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92387209|NCT00003594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387210|NCT00003594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387211|NCT00003594|Antidotes|antidotes|mesh-ancestor
92387212|NCT00003594|Protective Agents|protective agents|mesh-ancestor
92387213|NCT00003594|Vitamin B Complex|vitamin b complex|mesh-ancestor
92387214|NCT00003594|Vitamins|vitamins|mesh-ancestor
92387215|NCT00003594|Micronutrients|micronutrients|mesh-ancestor
92387216|NCT00003600|Epoetin Alfa|epoetin alfa|mesh-list
92387217|NCT00003600|Hematinics|hematinics|mesh-ancestor
92387218|NCT00003606|Cyclophosphamide|cyclophosphamide|mesh-list
92387219|NCT00003606|Etoposide|etoposide|mesh-list
92387220|NCT00003606|Epirubicin|epirubicin|mesh-list
92387221|NCT00003606|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387222|NCT00003606|Immunologic Factors|immunologic factors|mesh-ancestor
92387223|NCT00003606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387224|NCT00003606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387225|NCT00003606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387226|NCT00003606|Alkylating Agents|alkylating agents|mesh-ancestor
92387227|NCT00003606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387228|NCT00003606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387229|NCT00003606|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387230|NCT00003606|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387231|NCT00003606|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387232|NCT00003606|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387234|NCT00003606|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387235|NCT00003612|Paclitaxel|paclitaxel|mesh-list
92387236|NCT00003612|Carboplatin|carboplatin|mesh-list
92387237|NCT00003612|Trastuzumab|trastuzumab|mesh-list
92387238|NCT00003612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387239|NCT00003612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387240|NCT00003612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387241|NCT00003612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387242|NCT00003612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387243|NCT00003612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387244|NCT00003612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92387245|NCT00003624|Paclitaxel|paclitaxel|mesh-list
92039684|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
92387246|NCT00003624|Amifostine|amifostine|mesh-list
92387247|NCT00003624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387248|NCT00003624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387249|NCT00003624|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387250|NCT00003624|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387251|NCT00003624|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387252|NCT00003624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387253|NCT00003624|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92387254|NCT00003624|Protective Agents|protective agents|mesh-ancestor
92387255|NCT00003624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040739|NCT05004662|Nicotine|nicotine|mesh-list
92387256|NCT00003630|Arsenic Trioxide|arsenic trioxide|mesh-list
92387257|NCT00003630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387258|NCT00003636|Carboplatin|carboplatin|mesh-list
92387259|NCT00003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387260|NCT00003642|Fluorouracil|fluorouracil|mesh-list
92387261|NCT00003642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387263|NCT00003642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387264|NCT00003642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387265|NCT00003642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387266|NCT00003642|Immunologic Factors|immunologic factors|mesh-ancestor
92387267|NCT00003642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387268|NCT00003654|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92387269|NCT00003654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92387270|NCT00003654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387271|NCT00003666|Irofulven|irofulven|mesh-list
92387272|NCT00003666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387273|NCT00003666|Alkylating Agents|alkylating agents|mesh-ancestor
92387274|NCT00003666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387275|NCT00003666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387276|NCT00003678|Tamoxifen|tamoxifen|mesh-list
92387277|NCT00003678|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92387278|NCT00003678|Hormone Antagonists|hormone antagonists|mesh-ancestor
92387279|NCT00003678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92387280|NCT00003678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387281|NCT00003678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92387282|NCT00003678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387283|NCT00003678|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92387285|NCT00003678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92387286|NCT00003684|Theophylline|theophylline|mesh-list
92387287|NCT00003684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92387288|NCT00003684|Autonomic Agents|autonomic agents|mesh-ancestor
92387289|NCT00003684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387290|NCT00003684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387291|NCT00003684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92387292|NCT00003684|Respiratory System Agents|respiratory system agents|mesh-ancestor
92387293|NCT00003684|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92387294|NCT00003684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387295|NCT00003684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387296|NCT00003684|Vasodilator Agents|vasodilator agents|mesh-ancestor
92387297|NCT00003684|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92387298|NCT00003684|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92387299|NCT00003684|Purinergic Agents|purinergic agents|mesh-ancestor
92387300|NCT00003684|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92387301|NCT00003690|Carboplatin|carboplatin|mesh-list
92387302|NCT00003690|Alvocidib|alvocidib|mesh-list
92387303|NCT00003690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387304|NCT00003690|Growth Inhibitors|growth inhibitors|mesh-ancestor
92387305|NCT00003690|Growth Substances|growth substances|mesh-ancestor
92387306|NCT00003690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387307|NCT00003690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92387308|NCT00003690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387309|NCT00003690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387310|NCT00003696|Paclitaxel|paclitaxel|mesh-list
92387311|NCT00003696|Etoposide|etoposide|mesh-list
92387312|NCT00003696|Cyclophosphamide|cyclophosphamide|mesh-list
92387313|NCT00003696|Carboplatin|carboplatin|mesh-list
92387314|NCT00003696|Doxorubicin|doxorubicin|mesh-list
92387315|NCT00003696|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92387316|NCT00003696|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387317|NCT00003696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387318|NCT00003696|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387319|NCT00003696|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387320|NCT00003696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387321|NCT00003696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039759|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
92387322|NCT00003696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387323|NCT00003696|Immunologic Factors|immunologic factors|mesh-ancestor
92387324|NCT00003696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387325|NCT00003696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387326|NCT00003696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387327|NCT00003696|Alkylating Agents|alkylating agents|mesh-ancestor
92387328|NCT00003696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387329|NCT00003696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387330|NCT00003696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387331|NCT00003696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387332|NCT00003696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387333|NCT00003708|Temozolomide|temozolomide|mesh-list
92387334|NCT00003708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387335|NCT00003708|Alkylating Agents|alkylating agents|mesh-ancestor
92387336|NCT00003708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387337|NCT00003708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387338|NCT00003714|NSC 366140|nsc 366140|mesh-list
92387339|NCT00003714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387340|NCT00003720|Semaxinib|semaxinib|mesh-list
92387341|NCT00003720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92387342|NCT00003720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92387343|NCT00003720|Growth Substances|growth substances|mesh-ancestor
92387344|NCT00003720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387345|NCT00003720|Growth Inhibitors|growth inhibitors|mesh-ancestor
92387346|NCT00003720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387347|NCT00003720|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92387348|NCT00003720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387349|NCT00003720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387350|NCT00003732|Paclitaxel|paclitaxel|mesh-list
92387351|NCT00003732|Carboplatin|carboplatin|mesh-list
92387352|NCT00003732|Topotecan|topotecan|mesh-list
92387353|NCT00003732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387354|NCT00003732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387355|NCT00003732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387356|NCT00003732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387357|NCT00003732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387358|NCT00003732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387359|NCT00003732|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92387360|NCT00003732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387361|NCT00003732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387362|NCT00003744|Gemcitabine|gemcitabine|mesh-list
92387363|NCT00003744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387364|NCT00003744|Antimetabolites|antimetabolites|mesh-ancestor
92387365|NCT00003744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387366|NCT00003744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387367|NCT00003762|Gemcitabine|gemcitabine|mesh-list
92387368|NCT00003762|Docetaxel|docetaxel|mesh-list
92387369|NCT00003762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387370|NCT00003762|Antimetabolites|antimetabolites|mesh-ancestor
92387371|NCT00003762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032181|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92387372|NCT00003762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387373|NCT00003762|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387374|NCT00003762|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387375|NCT00003762|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387376|NCT00003768|Fosbretabulin|fosbretabulin|mesh-list
92387377|NCT00003768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387378|NCT00003768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387379|NCT00003780|Gemcitabine|gemcitabine|mesh-list
92387380|NCT00003780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387381|NCT00003780|Antimetabolites|antimetabolites|mesh-ancestor
92387382|NCT00003780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387383|NCT00003780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387384|NCT00003786|Irofulven|irofulven|mesh-list
92387385|NCT00003786|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387386|NCT00003786|Alkylating Agents|alkylating agents|mesh-ancestor
92387387|NCT00003786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387388|NCT00003786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387389|NCT00003792|Lenograstim|lenograstim|mesh-list
92387390|NCT00003792|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387391|NCT00003792|Immunologic Factors|immunologic factors|mesh-ancestor
92387392|NCT00003792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387393|NCT00003798|Motexafin gadolinium|motexafin gadolinium|mesh-list
92387394|NCT00003798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387395|NCT00003798|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92387396|NCT00003798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387398|NCT00003804|Vincristine|vincristine|mesh-list
92387399|NCT00003804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387400|NCT00003804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387401|NCT00003804|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387402|NCT00003804|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387403|NCT00003804|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387404|NCT00003804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387405|NCT00003804|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92387406|NCT00003804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387407|NCT00003804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387408|NCT00003804|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92387409|NCT00003804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387410|NCT00003804|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92387411|NCT00003828|Vinorelbine|vinorelbine|mesh-list
92387412|NCT00003828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387413|NCT00003828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387414|NCT00003828|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387415|NCT00003828|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387416|NCT00003828|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387417|NCT00003828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387418|NCT00003834|Leucovorin|leucovorin|mesh-list
92387419|NCT00003834|Fluorouracil|fluorouracil|mesh-list
92387420|NCT00003834|Oxaliplatin|oxaliplatin|mesh-list
92387421|NCT00003834|Calcium|calcium|mesh-list
92387422|NCT00003834|Levoleucovorin|levoleucovorin|mesh-list
92387423|NCT00003834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92387424|NCT00003834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387425|NCT00003834|Antimetabolites|antimetabolites|mesh-ancestor
92387426|NCT00003834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387427|NCT00003834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387428|NCT00003834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387429|NCT00003834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387430|NCT00003834|Immunologic Factors|immunologic factors|mesh-ancestor
92387431|NCT00003834|Antidotes|antidotes|mesh-ancestor
92387432|NCT00003834|Protective Agents|protective agents|mesh-ancestor
92387433|NCT00003834|Vitamin B Complex|vitamin b complex|mesh-ancestor
92387434|NCT00003834|Vitamins|vitamins|mesh-ancestor
92387435|NCT00003834|Micronutrients|micronutrients|mesh-ancestor
92387436|NCT00003846|Cyclophosphamide|cyclophosphamide|mesh-list
92387438|NCT00003846|Carboplatin|carboplatin|mesh-list
92387439|NCT00003846|Vincristine|vincristine|mesh-list
92387440|NCT00003846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387441|NCT00003846|Immunologic Factors|immunologic factors|mesh-ancestor
92387442|NCT00003846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387443|NCT00003846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387444|NCT00003846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387445|NCT00003846|Alkylating Agents|alkylating agents|mesh-ancestor
92387446|NCT00003846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387447|NCT00003846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387448|NCT00003846|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387449|NCT00003846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387450|NCT00003846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387451|NCT00003846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387452|NCT00003846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387454|NCT00003852|Etoposide|etoposide|mesh-list
92387455|NCT00003852|Cyclophosphamide|cyclophosphamide|mesh-list
92387456|NCT00003852|Carboplatin|carboplatin|mesh-list
92387457|NCT00003852|Epirubicin|epirubicin|mesh-list
92387458|NCT00003852|Ifosfamide|ifosfamide|mesh-list
92387459|NCT00003852|Thiotepa|thiotepa|mesh-list
92387460|NCT00003852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387461|NCT00003852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387462|NCT00003852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387463|NCT00003852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387464|NCT00003852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387465|NCT00003852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387466|NCT00003852|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387467|NCT00003852|Immunologic Factors|immunologic factors|mesh-ancestor
92387468|NCT00003852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039912|NCT01761292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387469|NCT00003852|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387470|NCT00003852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387471|NCT00003852|Alkylating Agents|alkylating agents|mesh-ancestor
92387472|NCT00003852|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387473|NCT00003852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387474|NCT00003852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387475|NCT00003852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387476|NCT00003852|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387477|NCT00003858|Mitoxantrone|mitoxantrone|mesh-list
92387478|NCT00003858|Analgesics|analgesics|mesh-ancestor
92387479|NCT00003858|Sensory System Agents|sensory system agents|mesh-ancestor
92387480|NCT00003858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387481|NCT00003858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387482|NCT00003858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387483|NCT00003858|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387484|NCT00003858|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387485|NCT00003858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387486|NCT00003858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387487|NCT00003870|Cyclophosphamide|cyclophosphamide|mesh-list
92387488|NCT00003870|Methotrexate|methotrexate|mesh-list
92387489|NCT00003870|Antibodies|antibodies|mesh-list
92387490|NCT00003870|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92387491|NCT00003870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387492|NCT00003870|Immunologic Factors|immunologic factors|mesh-ancestor
92387493|NCT00003870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387494|NCT00003870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387495|NCT00003870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387496|NCT00003870|Alkylating Agents|alkylating agents|mesh-ancestor
92387497|NCT00003870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387498|NCT00003870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387499|NCT00003870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387500|NCT00003870|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92387501|NCT00003870|Abortifacient Agents|abortifacient agents|mesh-ancestor
92387502|NCT00003870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92387503|NCT00003870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387504|NCT00003870|Antimetabolites|antimetabolites|mesh-ancestor
92387505|NCT00003870|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387506|NCT00003870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387507|NCT00003870|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92387508|NCT00003870|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92387510|NCT00003876|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387511|NCT00003876|Alkylating Agents|alkylating agents|mesh-ancestor
92387512|NCT00003876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387513|NCT00003876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387514|NCT00003888|Docetaxel|docetaxel|mesh-list
92387515|NCT00003888|Fluorouracil|fluorouracil|mesh-list
92387516|NCT00003888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387517|NCT00003888|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387518|NCT00003888|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387519|NCT00003888|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387520|NCT00003888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387522|NCT00003888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387523|NCT00003888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387524|NCT00003888|Immunologic Factors|immunologic factors|mesh-ancestor
92387525|NCT00003888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387526|NCT00003894|Thalidomide|thalidomide|mesh-list
92387527|NCT00003894|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387528|NCT00003894|Immunologic Factors|immunologic factors|mesh-ancestor
92387529|NCT00003894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387530|NCT00003894|Leprostatic Agents|leprostatic agents|mesh-ancestor
92387531|NCT00003894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92387532|NCT00003894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387533|NCT00003894|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92387534|NCT00003894|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92387535|NCT00003894|Growth Substances|growth substances|mesh-ancestor
92387536|NCT00003894|Growth Inhibitors|growth inhibitors|mesh-ancestor
92387537|NCT00003894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387538|NCT00003900|Docetaxel|docetaxel|mesh-list
92387539|NCT00003900|Irinotecan|irinotecan|mesh-list
92387540|NCT00003900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387541|NCT00003900|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387542|NCT00003900|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387543|NCT00003900|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387544|NCT00003900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387545|NCT00003900|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92387546|NCT00003900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387547|NCT00003900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387548|NCT00003906|Tamoxifen|tamoxifen|mesh-list
92387549|NCT00003906|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92387550|NCT00003906|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92387551|NCT00003906|Hormone Antagonists|hormone antagonists|mesh-ancestor
92387552|NCT00003906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92387553|NCT00003906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387554|NCT00003906|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92387555|NCT00003906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387556|NCT00003906|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92387557|NCT00003906|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92387558|NCT00003906|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92387559|NCT00003912|Carboplatin|carboplatin|mesh-list
92387560|NCT00003912|Doxorubicin|doxorubicin|mesh-list
92387561|NCT00003912|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92387562|NCT00003912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387563|NCT00003912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387564|NCT00003912|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387565|NCT00003912|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387566|NCT00003912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387567|NCT00003912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387568|NCT00003924|Interferons|interferons|mesh-list
92387569|NCT00003924|Interferon-alpha|interferon-alpha|mesh-list
92387570|NCT00003924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387571|NCT00003924|Antiviral Agents|antiviral agents|mesh-ancestor
92387572|NCT00003924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387573|NCT00003924|Immunologic Factors|immunologic factors|mesh-ancestor
92387574|NCT00003924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387576|NCT00003930|Gemcitabine|gemcitabine|mesh-list
92387577|NCT00003930|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387578|NCT00003930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387579|NCT00003930|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387580|NCT00003930|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387581|NCT00003930|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387582|NCT00003930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387583|NCT00003930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387584|NCT00003930|Antimetabolites|antimetabolites|mesh-ancestor
92387585|NCT00003936|Bryostatin 1|bryostatin 1|mesh-list
92387586|NCT00003936|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387587|NCT00003936|Immunologic Factors|immunologic factors|mesh-ancestor
92387588|NCT00003936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387589|NCT00003936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387590|NCT00003954|Cyclosporine|cyclosporine|mesh-list
92387591|NCT00003954|Mycophenolic Acid|mycophenolic acid|mesh-list
92387593|NCT00003954|Cyclosporins|cyclosporins|mesh-list
92387594|NCT00003954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387595|NCT00003954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387596|NCT00003954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387597|NCT00003954|Immunologic Factors|immunologic factors|mesh-ancestor
92387598|NCT00003954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387599|NCT00003954|Antifungal Agents|antifungal agents|mesh-ancestor
92387600|NCT00003954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387601|NCT00003954|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387602|NCT00003954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387603|NCT00003954|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92387604|NCT00003954|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387605|NCT00003954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387606|NCT00003954|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92387607|NCT00003954|Antitubercular Agents|antitubercular agents|mesh-ancestor
92387608|NCT00003954|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92387609|NCT00003954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387610|NCT00003954|Alkylating Agents|alkylating agents|mesh-ancestor
92387611|NCT00003954|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387612|NCT00003960|Methylprednisolone|methylprednisolone|mesh-list
92387613|NCT00003960|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92387614|NCT00003960|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92387615|NCT00003960|Prednisolone|prednisolone|mesh-list
92387616|NCT00003960|Prednisolone acetate|prednisolone acetate|mesh-list
92387617|NCT00003960|Cyclophosphamide|cyclophosphamide|mesh-list
92387618|NCT00003960|Busulfan|busulfan|mesh-list
92387619|NCT00003960|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92387620|NCT00003960|Prednisolone phosphate|prednisolone phosphate|mesh-list
92387621|NCT00003960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387622|NCT00003960|Immunologic Factors|immunologic factors|mesh-ancestor
92387623|NCT00003960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387624|NCT00003960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387625|NCT00003960|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387626|NCT00003960|Alkylating Agents|alkylating agents|mesh-ancestor
92116267|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92387627|NCT00003960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387628|NCT00003960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387629|NCT00003960|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387630|NCT00003960|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92387631|NCT00003960|Antiemetics|antiemetics|mesh-ancestor
92387632|NCT00003960|Autonomic Agents|autonomic agents|mesh-ancestor
92387633|NCT00003960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387634|NCT00003960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92387635|NCT00003960|Glucocorticoids|glucocorticoids|mesh-ancestor
92387636|NCT00003960|Hormones|hormones|mesh-ancestor
92387637|NCT00003960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92387638|NCT00003960|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92387639|NCT00003960|Protective Agents|protective agents|mesh-ancestor
92387640|NCT00003960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92387641|NCT00003966|Defibrotide|defibrotide|mesh-list
92387642|NCT00003966|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92387643|NCT00003966|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92387644|NCT00003966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387645|NCT00003966|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92387646|NCT00003972|Tamoxifen|tamoxifen|mesh-list
92387647|NCT00003972|Paclitaxel|paclitaxel|mesh-list
92387648|NCT00003972|Cyclophosphamide|cyclophosphamide|mesh-list
92387649|NCT00003972|Carboplatin|carboplatin|mesh-list
92387650|NCT00003972|Melphalan|melphalan|mesh-list
92387651|NCT00003972|Busulfan|busulfan|mesh-list
92387652|NCT00003972|Thiotepa|thiotepa|mesh-list
92387653|NCT00003972|Sargramostim|sargramostim|mesh-list
92387654|NCT00003972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387655|NCT00003972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387656|NCT00003972|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387657|NCT00003972|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387658|NCT00003972|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387659|NCT00003972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387660|NCT00003972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387661|NCT00003972|Immunologic Factors|immunologic factors|mesh-ancestor
92387662|NCT00003972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387663|NCT00003972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387664|NCT00003972|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387665|NCT00003972|Alkylating Agents|alkylating agents|mesh-ancestor
92387666|NCT00003972|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387667|NCT00003972|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92387668|NCT00003972|Hormone Antagonists|hormone antagonists|mesh-ancestor
92387669|NCT00003972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92387670|NCT00003972|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92387671|NCT00003972|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92387672|NCT00003972|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92387673|NCT00003972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92387675|NCT00003984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92387676|NCT00003984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387678|NCT00003996|Carmustine|carmustine|mesh-list
92387679|NCT00003996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387680|NCT00003996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387681|NCT00003996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387682|NCT00003996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387683|NCT00003996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387684|NCT00003996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387685|NCT00003996|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387686|NCT00003996|Alkylating Agents|alkylating agents|mesh-ancestor
92387687|NCT00004002|Bortezomib|bortezomib|mesh-list
92387688|NCT00004002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387689|NCT00004008|Bryostatin 1|bryostatin 1|mesh-list
92387690|NCT00004008|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387691|NCT00004008|Immunologic Factors|immunologic factors|mesh-ancestor
92387692|NCT00004008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387693|NCT00004008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387694|NCT00004014|Doxorubicin|doxorubicin|mesh-list
92387695|NCT00004014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92387696|NCT00004014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387697|NCT00004014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387698|NCT00004014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387699|NCT00004014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387700|NCT00004014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387701|NCT00004014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387702|NCT00004032|Interferons|interferons|mesh-list
92387703|NCT00004032|Interferon-gamma|interferon-gamma|mesh-list
92387704|NCT00004032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387705|NCT00004032|Antiviral Agents|antiviral agents|mesh-ancestor
92387706|NCT00004032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387707|NCT00004050|Interleukin-2|interleukin-2|mesh-list
92387708|NCT00004050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387709|NCT00004050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92387710|NCT00004050|Analgesics|analgesics|mesh-ancestor
92387711|NCT00004050|Sensory System Agents|sensory system agents|mesh-ancestor
92387712|NCT00004050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387713|NCT00004050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387714|NCT00004056|Cytarabine|cytarabine|mesh-list
92387715|NCT00004056|Thioguanine|thioguanine|mesh-list
92387716|NCT00004056|Melphalan|melphalan|mesh-list
92387717|NCT00004056|Daunorubicin|daunorubicin|mesh-list
92387718|NCT00004056|Asparaginase|asparaginase|mesh-list
92387719|NCT00004056|Lenograstim|lenograstim|mesh-list
92387720|NCT00004056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387721|NCT00004056|Antimetabolites|antimetabolites|mesh-ancestor
92387722|NCT00004056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387723|NCT00004056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387724|NCT00004056|Antiviral Agents|antiviral agents|mesh-ancestor
92387725|NCT00004056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387726|NCT00004056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387727|NCT00004056|Immunologic Factors|immunologic factors|mesh-ancestor
92387728|NCT00004056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387729|NCT00004056|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387730|NCT00004056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387731|NCT00004056|Alkylating Agents|alkylating agents|mesh-ancestor
92387732|NCT00004056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387733|NCT00004056|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387734|NCT00004056|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387735|NCT00004056|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387736|NCT00004056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387737|NCT00004062|Azacitidine|azacitidine|mesh-list
92387738|NCT00004062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387739|NCT00004062|Antimetabolites|antimetabolites|mesh-ancestor
92387740|NCT00004062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387741|NCT00004062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387742|NCT00004062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387743|NCT00004068|Irinotecan|irinotecan|mesh-list
92387744|NCT00004068|Temozolomide|temozolomide|mesh-list
92387745|NCT00004068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92387746|NCT00004068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387747|NCT00004068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387748|NCT00004068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387749|NCT00004068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387750|NCT00004068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387751|NCT00004068|Alkylating Agents|alkylating agents|mesh-ancestor
92387752|NCT00004074|Carboplatin|carboplatin|mesh-list
92387753|NCT00004074|Trastuzumab|trastuzumab|mesh-list
92387754|NCT00004074|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92387755|NCT00004074|Interleukin-12|interleukin-12|mesh-list
92387756|NCT00004074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387757|NCT00004074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92387758|NCT00004074|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387759|NCT00004074|Immunologic Factors|immunologic factors|mesh-ancestor
92387760|NCT00004074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387761|NCT00004074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92387762|NCT00004074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92387763|NCT00004074|Growth Substances|growth substances|mesh-ancestor
92387764|NCT00004074|Growth Inhibitors|growth inhibitors|mesh-ancestor
92387765|NCT00004086|Cytarabine|cytarabine|mesh-list
92387766|NCT00004086|Etoposide|etoposide|mesh-list
92387767|NCT00004086|Ifosfamide|ifosfamide|mesh-list
92387768|NCT00004086|Epratuzumab|epratuzumab|mesh-list
92387769|NCT00004086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387770|NCT00004086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387771|NCT00004086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387772|NCT00004086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387773|NCT00004086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387774|NCT00004086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387775|NCT00004086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387776|NCT00004086|Antimetabolites|antimetabolites|mesh-ancestor
92387777|NCT00004086|Antiviral Agents|antiviral agents|mesh-ancestor
92387778|NCT00004086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387779|NCT00004086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387780|NCT00004086|Immunologic Factors|immunologic factors|mesh-ancestor
92387781|NCT00004086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387782|NCT00004086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387783|NCT00004086|Alkylating Agents|alkylating agents|mesh-ancestor
92387784|NCT00004086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92387785|NCT00004104|Interferons|interferons|mesh-list
92387786|NCT00004104|Interferon-alpha|interferon-alpha|mesh-list
92387787|NCT00004104|Interleukin-2|interleukin-2|mesh-list
92387788|NCT00004104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387789|NCT00004104|Antiviral Agents|antiviral agents|mesh-ancestor
92387790|NCT00004104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387791|NCT00004104|Immunologic Factors|immunologic factors|mesh-ancestor
92387792|NCT00004104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387793|NCT00004104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92387794|NCT00004104|Analgesics|analgesics|mesh-ancestor
92387795|NCT00004104|Sensory System Agents|sensory system agents|mesh-ancestor
92387796|NCT00004104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92387797|NCT00004110|Etoposide|etoposide|mesh-list
92387798|NCT00004110|Isotretinoin|isotretinoin|mesh-list
92387799|NCT00004110|Antibodies|antibodies|mesh-list
92387800|NCT00004110|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92387801|NCT00004110|Immunologic Factors|immunologic factors|mesh-ancestor
92387802|NCT00004110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387803|NCT00004110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387804|NCT00004110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387805|NCT00004110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387806|NCT00004110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387807|NCT00004110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387808|NCT00004110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387809|NCT00004110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387810|NCT00004122|Interferons|interferons|mesh-list
92387811|NCT00004122|Interferon-alpha|interferon-alpha|mesh-list
92387812|NCT00004122|BCG Vaccine|bcg vaccine|mesh-list
92387813|NCT00004122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387814|NCT00004122|Antiviral Agents|antiviral agents|mesh-ancestor
92387815|NCT00004122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387816|NCT00004122|Immunologic Factors|immunologic factors|mesh-ancestor
92387817|NCT00004122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387818|NCT00004122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387819|NCT00004128|Cytarabine|cytarabine|mesh-list
92387820|NCT00004128|Aldesleukin|aldesleukin|mesh-list
92387821|NCT00004128|Cyclophosphamide|cyclophosphamide|mesh-list
92387823|NCT00004128|Etoposide|etoposide|mesh-list
92387824|NCT00004128|Daunorubicin|daunorubicin|mesh-list
92387825|NCT00004128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387826|NCT00004128|Immunologic Factors|immunologic factors|mesh-ancestor
92387827|NCT00004128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387828|NCT00004128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387829|NCT00004128|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387830|NCT00004128|Alkylating Agents|alkylating agents|mesh-ancestor
92387831|NCT00004128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387832|NCT00004128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387833|NCT00004128|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387834|NCT00004128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387835|NCT00004128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387836|NCT00004128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387837|NCT00004128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387838|NCT00004128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387839|NCT00004128|Antimetabolites|antimetabolites|mesh-ancestor
92387840|NCT00004128|Antiviral Agents|antiviral agents|mesh-ancestor
92387841|NCT00004128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92387842|NCT00004128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387843|NCT00004128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92387844|NCT00004128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92387845|NCT00004152|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92387846|NCT00004152|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92387847|NCT00004152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387848|NCT00004158|Melphalan|melphalan|mesh-list
92040281|NCT05813132|Cytarabine|cytarabine|mesh-list
92387849|NCT00004158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387850|NCT00004158|Alkylating Agents|alkylating agents|mesh-ancestor
92387851|NCT00004158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387852|NCT00004158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387853|NCT00004158|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387854|NCT00004158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387855|NCT00004158|Immunologic Factors|immunologic factors|mesh-ancestor
92387856|NCT00004158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387857|NCT00004164|Leucovorin|leucovorin|mesh-list
92387858|NCT00004164|Docetaxel|docetaxel|mesh-list
92387859|NCT00004164|Fluorouracil|fluorouracil|mesh-list
92387860|NCT00004164|Calcium|calcium|mesh-list
92387861|NCT00004164|Levoleucovorin|levoleucovorin|mesh-list
92387862|NCT00004164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387863|NCT00004164|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387864|NCT00004164|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387865|NCT00004164|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387866|NCT00004164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387867|NCT00004164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92387868|NCT00004164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387869|NCT00004164|Antimetabolites|antimetabolites|mesh-ancestor
92387870|NCT00004164|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387871|NCT00004164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387872|NCT00004164|Immunologic Factors|immunologic factors|mesh-ancestor
92387873|NCT00004164|Antidotes|antidotes|mesh-ancestor
92387874|NCT00004164|Protective Agents|protective agents|mesh-ancestor
92387875|NCT00004164|Vitamin B Complex|vitamin b complex|mesh-ancestor
92387876|NCT00004164|Vitamins|vitamins|mesh-ancestor
92387877|NCT00004164|Micronutrients|micronutrients|mesh-ancestor
92387878|NCT00004176|Etoposide|etoposide|mesh-list
92387879|NCT00004176|Amifostine|amifostine|mesh-list
92387880|NCT00004176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387881|NCT00004176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387882|NCT00004176|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387883|NCT00004176|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387884|NCT00004176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387885|NCT00004176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387886|NCT00004176|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92387887|NCT00004176|Protective Agents|protective agents|mesh-ancestor
92387888|NCT00004176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387889|NCT00004188|Cyclophosphamide|cyclophosphamide|mesh-list
92387891|NCT00004188|Mechlorethamine|mechlorethamine|mesh-list
92387892|NCT00004188|Cisplatin|cisplatin|mesh-list
92387893|NCT00004188|Carboplatin|carboplatin|mesh-list
92387894|NCT00004188|Doxorubicin|doxorubicin|mesh-list
92387895|NCT00004188|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92387896|NCT00004188|Etoposide|etoposide|mesh-list
92387897|NCT00004188|Vincristine|vincristine|mesh-list
92387898|NCT00004188|Topotecan|topotecan|mesh-list
92387899|NCT00004188|Isotretinoin|isotretinoin|mesh-list
92387900|NCT00004188|Lenograstim|lenograstim|mesh-list
92387901|NCT00004188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387902|NCT00004188|Immunologic Factors|immunologic factors|mesh-ancestor
92387903|NCT00004188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387904|NCT00004188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387905|NCT00004188|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387906|NCT00004188|Alkylating Agents|alkylating agents|mesh-ancestor
92387907|NCT00004188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387908|NCT00004188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387909|NCT00004188|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387910|NCT00004188|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387911|NCT00004188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387912|NCT00004188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387913|NCT00004188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387914|NCT00004188|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387915|NCT00004188|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92387916|NCT00004188|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387917|NCT00004188|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387918|NCT00004188|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387919|NCT00004188|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92387920|NCT00004188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92387921|NCT00004194|Fludarabine|fludarabine|mesh-list
92387922|NCT00004194|Fludarabine phosphate|fludarabine phosphate|mesh-list
92387923|NCT00004194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387924|NCT00004194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387925|NCT00004194|Antimetabolites|antimetabolites|mesh-ancestor
92387926|NCT00004194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387927|NCT00004194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387928|NCT00004194|Immunologic Factors|immunologic factors|mesh-ancestor
92387929|NCT00004194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387930|NCT00004200|Temozolomide|temozolomide|mesh-list
92387931|NCT00004200|Prinomastat|prinomastat|mesh-list
92387932|NCT00004200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387933|NCT00004200|Alkylating Agents|alkylating agents|mesh-ancestor
92387934|NCT00004200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387935|NCT00004200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387936|NCT00004200|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
92387937|NCT00004200|Protease Inhibitors|protease inhibitors|mesh-ancestor
92387938|NCT00004200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387939|NCT00004206|Leucovorin|leucovorin|mesh-list
92387940|NCT00004206|Fluorouracil|fluorouracil|mesh-list
92387941|NCT00004206|Oxaliplatin|oxaliplatin|mesh-list
92387942|NCT00004206|Calcium|calcium|mesh-list
92387943|NCT00004206|Levoleucovorin|levoleucovorin|mesh-list
92387944|NCT00004206|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92387945|NCT00004206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387946|NCT00004206|Antimetabolites|antimetabolites|mesh-ancestor
92387947|NCT00004206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387948|NCT00004206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387949|NCT00004206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387950|NCT00004206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387951|NCT00004206|Immunologic Factors|immunologic factors|mesh-ancestor
92387952|NCT00004206|Antidotes|antidotes|mesh-ancestor
92387953|NCT00004206|Protective Agents|protective agents|mesh-ancestor
92387954|NCT00004206|Vitamin B Complex|vitamin b complex|mesh-ancestor
92387956|NCT00004206|Micronutrients|micronutrients|mesh-ancestor
92387957|NCT00004212|Exatecan|exatecan|mesh-list
92387958|NCT00004212|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92387959|NCT00004212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387960|NCT00004212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387961|NCT00004212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387962|NCT00004212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387963|NCT00004218|Prednisolone|prednisolone|mesh-list
92387964|NCT00004218|Cyclophosphamide|cyclophosphamide|mesh-list
92387965|NCT00004218|Chlorambucil|chlorambucil|mesh-list
92387966|NCT00004218|Doxorubicin|doxorubicin|mesh-list
92387967|NCT00004218|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92387968|NCT00004218|Fludarabine|fludarabine|mesh-list
92387969|NCT00004218|Fludarabine phosphate|fludarabine phosphate|mesh-list
92387970|NCT00004218|Vincristine|vincristine|mesh-list
92387971|NCT00004218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387972|NCT00004218|Immunologic Factors|immunologic factors|mesh-ancestor
92387973|NCT00004218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92387974|NCT00004218|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92387975|NCT00004218|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92387976|NCT00004218|Alkylating Agents|alkylating agents|mesh-ancestor
92387977|NCT00004218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92387978|NCT00004218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92387979|NCT00004218|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92387980|NCT00004218|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92387981|NCT00004218|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92387982|NCT00004218|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92387983|NCT00004218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92387984|NCT00004218|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92387985|NCT00004218|Antimetabolites|antimetabolites|mesh-ancestor
92387986|NCT00004218|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92387987|NCT00004218|Tubulin Modulators|tubulin modulators|mesh-ancestor
92387988|NCT00004218|Antimitotic Agents|antimitotic agents|mesh-ancestor
92387989|NCT00004218|Mitosis Modulators|mitosis modulators|mesh-ancestor
92387990|NCT00004218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92387991|NCT00004218|Glucocorticoids|glucocorticoids|mesh-ancestor
92387992|NCT00004218|Hormones|hormones|mesh-ancestor
92387993|NCT00004218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92387994|NCT00004218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92387995|NCT00004224|Cyclophosphamide|cyclophosphamide|mesh-list
92387996|NCT00004224|Etoposide|etoposide|mesh-list
92387997|NCT00004224|Vincristine|vincristine|mesh-list
92387998|NCT00004224|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92387999|NCT00004224|Immunologic Factors|immunologic factors|mesh-ancestor
92388000|NCT00004224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388001|NCT00004224|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116268|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
92388002|NCT00004224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92388003|NCT00004224|Alkylating Agents|alkylating agents|mesh-ancestor
92388004|NCT00004224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388005|NCT00004224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388006|NCT00004224|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92388007|NCT00004224|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388008|NCT00004224|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388010|NCT00004224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388011|NCT00004224|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388013|NCT00004224|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388014|NCT00004236|Doxorubicin|doxorubicin|mesh-list
92388015|NCT00004236|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92388016|NCT00004236|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92388017|NCT00004236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388018|NCT00004236|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388019|NCT00004236|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388020|NCT00004236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388021|NCT00004236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388022|NCT00004242|Gemcitabine|gemcitabine|mesh-list
92388023|NCT00004242|Fluorouracil|fluorouracil|mesh-list
92388024|NCT00004242|Oxaliplatin|oxaliplatin|mesh-list
92388025|NCT00004242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388026|NCT00004242|Antimetabolites|antimetabolites|mesh-ancestor
92388027|NCT00004242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388028|NCT00004242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388029|NCT00004242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388030|NCT00004242|Immunologic Factors|immunologic factors|mesh-ancestor
92388031|NCT00004242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388032|NCT00004248|Aldesleukin|aldesleukin|mesh-list
92388033|NCT00004248|Doxorubicin|doxorubicin|mesh-list
92388034|NCT00004248|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92388035|NCT00004248|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92388036|NCT00004248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388037|NCT00004248|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388038|NCT00004248|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388039|NCT00004248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388040|NCT00004248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388041|NCT00004248|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388042|NCT00004248|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388043|NCT00004248|Antiviral Agents|antiviral agents|mesh-ancestor
92388044|NCT00004248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388045|NCT00004254|Raltitrexed|raltitrexed|mesh-list
92388046|NCT00004254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388047|NCT00004254|Antimetabolites|antimetabolites|mesh-ancestor
92388048|NCT00004254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388049|NCT00004254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388050|NCT00004254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92388051|NCT00004254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388052|NCT00004260|Rituximab|rituximab|mesh-list
92388053|NCT00004260|Interleukin-12|interleukin-12|mesh-list
92388054|NCT00004260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92388055|NCT00004260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388056|NCT00004260|Immunologic Factors|immunologic factors|mesh-ancestor
92388057|NCT00004260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388058|NCT00004260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388059|NCT00004260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92388060|NCT00004260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92388061|NCT00004260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92388062|NCT00004260|Growth Substances|growth substances|mesh-ancestor
92388063|NCT00004260|Growth Inhibitors|growth inhibitors|mesh-ancestor
92388064|NCT00004266|Lisinopril|lisinopril|mesh-list
92388065|NCT00004266|Nifedipine|nifedipine|mesh-list
92388066|NCT00004266|Simvastatin|simvastatin|mesh-list
92388067|NCT00004266|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92388068|NCT00004266|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92388069|NCT00004266|Antimetabolites|antimetabolites|mesh-ancestor
92388070|NCT00004266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388071|NCT00004266|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92388072|NCT00004266|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92388073|NCT00004266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388074|NCT00004266|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92388075|NCT00004266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388076|NCT00004266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92388077|NCT00004266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388078|NCT00004266|Vasodilator Agents|vasodilator agents|mesh-ancestor
92040505|NCT05552196|Carbamazepine|carbamazepine|mesh-list
92388079|NCT00004266|Tocolytic Agents|tocolytic agents|mesh-ancestor
92388080|NCT00004266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388081|NCT00004266|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92388082|NCT00004266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388083|NCT00004266|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92388084|NCT00004266|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92388085|NCT00004266|Protective Agents|protective agents|mesh-ancestor
92388086|NCT00004278|Ganciclovir|ganciclovir|mesh-list
92388087|NCT00004278|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92388088|NCT00004278|Antiviral Agents|antiviral agents|mesh-ancestor
92388089|NCT00004278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388090|NCT00004278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388091|NCT00004278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388092|NCT00004278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388093|NCT00004284|Potassium Citrate|potassium citrate|mesh-list
92388094|NCT00004284|Potassium phosphate|potassium phosphate|mesh-list
92388095|NCT00004284|Diuretics|diuretics|mesh-ancestor
92388096|NCT00004284|Natriuretic Agents|natriuretic agents|mesh-ancestor
92388097|NCT00004284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388098|NCT00004284|Expectorants|expectorants|mesh-ancestor
92388099|NCT00004284|Respiratory System Agents|respiratory system agents|mesh-ancestor
92388100|NCT00004284|Cariostatic Agents|cariostatic agents|mesh-ancestor
92388101|NCT00004284|Protective Agents|protective agents|mesh-ancestor
92388102|NCT00004344|Leuprolide|leuprolide|mesh-list
92388103|NCT00004344|Testosterone|testosterone|mesh-list
92388104|NCT00004344|Androgens|androgens|mesh-ancestor
92388105|NCT00004344|Hormones|hormones|mesh-ancestor
92388106|NCT00004344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388107|NCT00004344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388108|NCT00004344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92388109|NCT00004344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388111|NCT00004344|Fertility Agents|fertility agents|mesh-ancestor
92388112|NCT00004344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388113|NCT00004368|Colchicine|colchicine|mesh-list
92388114|NCT00004368|Gout Suppressants|gout suppressants|mesh-ancestor
92388115|NCT00004368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388116|NCT00004368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388117|NCT00004368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92388118|NCT00004368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388119|NCT00004368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388120|NCT00004368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388121|NCT00004380|Methocarbamol|methocarbamol|mesh-list
92388122|NCT00004380|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92388123|NCT00004380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388124|NCT00004380|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92388125|NCT00004380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388126|NCT00004398|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
92388127|NCT00004398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388128|NCT00004398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388129|NCT00004404|Clotrimazole|clotrimazole|mesh-list
92388130|NCT00004404|Miconazole|miconazole|mesh-list
92388131|NCT00004404|Hydroxyurea|hydroxyurea|mesh-list
92388132|NCT00004404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388133|NCT00004404|Antisickling Agents|antisickling agents|mesh-ancestor
92388134|NCT00004404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388135|NCT00004404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388136|NCT00004404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388137|NCT00004404|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92388139|NCT00004404|Antifungal Agents|antifungal agents|mesh-ancestor
92388140|NCT00004404|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92388141|NCT00004404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388142|NCT00004404|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92388143|NCT00004404|Hormone Antagonists|hormone antagonists|mesh-ancestor
92388144|NCT00004404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388145|NCT00004404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388146|NCT00004404|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92388147|NCT00004404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92388148|NCT00004410|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92388149|NCT00004410|Antiviral Agents|antiviral agents|mesh-ancestor
92388150|NCT00004410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388151|NCT00004410|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92388152|NCT00004410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92388153|NCT00004416|Botulinum Toxins|botulinum toxins|mesh-list
92388154|NCT00004416|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92388155|NCT00004416|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92388156|NCT00004416|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92388157|NCT00004416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388158|NCT00004416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388159|NCT00004416|Cholinergic Agents|cholinergic agents|mesh-ancestor
92388160|NCT00004416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388161|NCT00004416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388162|NCT00004416|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92388163|NCT00004416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388164|NCT00004422|Immunoglobulins|immunoglobulins|mesh-list
92388166|NCT00004422|gamma-Globulins|gamma-globulins|mesh-list
92388167|NCT00004422|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92388168|NCT00004422|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92388169|NCT00004422|Immunologic Factors|immunologic factors|mesh-ancestor
92388170|NCT00004422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388171|NCT00004440|Ibuprofen|ibuprofen|mesh-list
92388172|NCT00004440|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92388173|NCT00004440|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92388174|NCT00004440|Analgesics|analgesics|mesh-ancestor
92388175|NCT00004440|Sensory System Agents|sensory system agents|mesh-ancestor
92388176|NCT00004440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388177|NCT00004440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388178|NCT00004440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388179|NCT00004440|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388180|NCT00004440|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92388181|NCT00004440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388182|NCT00004440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388183|NCT00004446|Fluoxetine|fluoxetine|mesh-list
92388184|NCT00004446|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92388185|NCT00004446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92388187|NCT00004446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388188|NCT00004446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388189|NCT00004446|Serotonin Agents|serotonin agents|mesh-ancestor
92388190|NCT00004446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388191|NCT00004446|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92388192|NCT00004446|Antidepressive Agents|antidepressive agents|mesh-ancestor
92388193|NCT00004446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92388194|NCT00004446|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92388195|NCT00004446|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388196|NCT00004446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388197|NCT00004464|Cyclophosphamide|cyclophosphamide|mesh-list
92388198|NCT00004464|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388199|NCT00004464|Immunologic Factors|immunologic factors|mesh-ancestor
92388200|NCT00004464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388201|NCT00004464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388202|NCT00004464|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92388203|NCT00004464|Alkylating Agents|alkylating agents|mesh-ancestor
92388204|NCT00004464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388205|NCT00004464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388206|NCT00004464|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92388207|NCT00004482|Cyclosporine|cyclosporine|mesh-list
92388208|NCT00004482|Prednisone|prednisone|mesh-list
92388209|NCT00004482|Methylprednisolone|methylprednisolone|mesh-list
92388210|NCT00004482|Cyclosporins|cyclosporins|mesh-list
92388211|NCT00004482|Muromonab-CD3|muromonab-cd3|mesh-list
92388212|NCT00004482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388213|NCT00004482|Glucocorticoids|glucocorticoids|mesh-ancestor
92388214|NCT00004482|Hormones|hormones|mesh-ancestor
92388215|NCT00004482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388216|NCT00004482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388217|NCT00004482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92388218|NCT00004482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388219|NCT00004482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388220|NCT00004482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388221|NCT00004482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388222|NCT00004482|Immunologic Factors|immunologic factors|mesh-ancestor
92388223|NCT00004482|Antifungal Agents|antifungal agents|mesh-ancestor
92388224|NCT00004482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388225|NCT00004482|Dermatologic Agents|dermatologic agents|mesh-ancestor
92388226|NCT00004482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388227|NCT00004482|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92388228|NCT00004482|Antiemetics|antiemetics|mesh-ancestor
92388229|NCT00004482|Autonomic Agents|autonomic agents|mesh-ancestor
92388230|NCT00004482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388231|NCT00004482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92388232|NCT00004482|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92388233|NCT00004482|Protective Agents|protective agents|mesh-ancestor
92388234|NCT00004488|Cholecalciferol|cholecalciferol|mesh-list
92388235|NCT00004488|Vitamin D|vitamin d|mesh-list
92388236|NCT00004488|Alendronate|alendronate|mesh-list
92388237|NCT00004488|Calcium Carbonate|calcium carbonate|mesh-list
92388238|NCT00004488|Calcium|calcium|mesh-list
92388239|NCT00004488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92388240|NCT00004488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388241|NCT00004488|Vitamins|vitamins|mesh-ancestor
92388242|NCT00004488|Micronutrients|micronutrients|mesh-ancestor
92388243|NCT00004488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92388244|NCT00004488|Antacids|antacids|mesh-ancestor
92388245|NCT00004488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388246|NCT00004488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92388247|NCT00004554|Naltrexone|naltrexone|mesh-list
92388248|NCT00004554|Sertraline|sertraline|mesh-list
92388249|NCT00004554|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92388250|NCT00004554|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92388251|NCT00004554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388252|NCT00004554|Sensory System Agents|sensory system agents|mesh-ancestor
92388253|NCT00004554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388254|NCT00004554|Antidepressive Agents|antidepressive agents|mesh-ancestor
92388255|NCT00004554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92388256|NCT00004554|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92388257|NCT00004554|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92388258|NCT00004554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388259|NCT00004554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388260|NCT00004554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388261|NCT00004554|Serotonin Agents|serotonin agents|mesh-ancestor
92388263|NCT00004578|Lopinavir|lopinavir|mesh-list
92388264|NCT00004578|Lamivudine|lamivudine|mesh-list
92388265|NCT00004578|Stavudine|stavudine|mesh-list
92388266|NCT00004578|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92388267|NCT00004578|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92388268|NCT00004578|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388269|NCT00004578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388270|NCT00004578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388271|NCT00004578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388272|NCT00004578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388273|NCT00004578|Antiviral Agents|antiviral agents|mesh-ancestor
92388274|NCT00004578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388275|NCT00004578|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92388276|NCT00004578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388277|NCT00004578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92388278|NCT00004578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388279|NCT00004578|Antimetabolites|antimetabolites|mesh-ancestor
92388280|NCT00004644|Acyclovir|acyclovir|mesh-list
92388281|NCT00004644|Antiviral Agents|antiviral agents|mesh-ancestor
92388282|NCT00004644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388283|NCT00004650|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92388284|NCT00004650|Medroxyprogesterone|medroxyprogesterone|mesh-list
92388285|NCT00004650|Estrogens|estrogens|mesh-list
92388286|NCT00004650|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92388287|NCT00004650|Hormones|hormones|mesh-ancestor
92388288|NCT00004650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388289|NCT00004650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388290|NCT00004650|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92388291|NCT00004650|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92388292|NCT00004650|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92388293|NCT00004650|Contraceptive Agents|contraceptive agents|mesh-ancestor
92388294|NCT00004650|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388295|NCT00004650|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92388296|NCT00004650|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92388297|NCT00004650|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92388298|NCT00004650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92388299|NCT00004650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388300|NCT00004662|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92388301|NCT00004662|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92388302|NCT00004662|Immunologic Factors|immunologic factors|mesh-ancestor
92388303|NCT00004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388304|NCT00004686|Prednisone|prednisone|mesh-list
92388305|NCT00004686|Methotrexate|methotrexate|mesh-list
92388306|NCT00004686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388307|NCT00004686|Glucocorticoids|glucocorticoids|mesh-ancestor
92388308|NCT00004686|Hormones|hormones|mesh-ancestor
92388309|NCT00004686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388310|NCT00004686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388311|NCT00004686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92388312|NCT00004686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388313|NCT00004686|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92388314|NCT00004686|Abortifacient Agents|abortifacient agents|mesh-ancestor
92388315|NCT00004686|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388316|NCT00004686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388317|NCT00004686|Antimetabolites|antimetabolites|mesh-ancestor
92388318|NCT00004686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388319|NCT00004686|Dermatologic Agents|dermatologic agents|mesh-ancestor
92388320|NCT00004686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388321|NCT00004686|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92388322|NCT00004686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388323|NCT00004686|Immunologic Factors|immunologic factors|mesh-ancestor
92388324|NCT00004686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388325|NCT00004686|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388327|NCT00004728|Warfarin|warfarin|mesh-list
92388328|NCT00004728|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92388329|NCT00004728|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92388331|NCT00004728|Sensory System Agents|sensory system agents|mesh-ancestor
92388332|NCT00004728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388333|NCT00004728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388334|NCT00004728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388335|NCT00004728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388336|NCT00004728|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92388337|NCT00004728|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92388338|NCT00004728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388339|NCT00004728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92388340|NCT00004728|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92388341|NCT00004728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388342|NCT00004728|Antipyretics|antipyretics|mesh-ancestor
92388343|NCT00004728|Anticoagulants|anticoagulants|mesh-ancestor
92388345|NCT00004734|Pyridoxine|pyridoxine|mesh-list
92388346|NCT00004734|Vitamin B 12|vitamin b 12|mesh-list
92388347|NCT00004734|Hydroxocobalamin|hydroxocobalamin|mesh-list
92388348|NCT00004734|Hematinics|hematinics|mesh-ancestor
92388349|NCT00004734|Vitamin B Complex|vitamin b complex|mesh-ancestor
92388350|NCT00004734|Vitamins|vitamins|mesh-ancestor
92388351|NCT00004734|Micronutrients|micronutrients|mesh-ancestor
92388352|NCT00004734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388353|NCT00004740|Isoniazid|isoniazid|mesh-list
92388354|NCT00004740|Antitubercular Agents|antitubercular agents|mesh-ancestor
92388355|NCT00004740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92388356|NCT00004740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388357|NCT00004740|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92388358|NCT00004740|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92388359|NCT00004740|Antimetabolites|antimetabolites|mesh-ancestor
92388360|NCT00004740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388361|NCT00004740|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92388362|NCT00004758|Pyridoxine|pyridoxine|mesh-list
92388363|NCT00004758|Carbamazepine|carbamazepine|mesh-list
92388364|NCT00004758|Valproic Acid|valproic acid|mesh-list
92388365|NCT00004758|Nitrazepam|nitrazepam|mesh-list
92388366|NCT00004758|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92388367|NCT00004758|Anticonvulsants|anticonvulsants|mesh-ancestor
92388368|NCT00004758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388369|NCT00004758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388370|NCT00004758|GABA Agents|gaba agents|mesh-ancestor
92388371|NCT00004758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388372|NCT00004758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388373|NCT00004758|Antimanic Agents|antimanic agents|mesh-ancestor
92388374|NCT00004758|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92388375|NCT00004758|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92388376|NCT00004758|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92388377|NCT00004758|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92388378|NCT00004758|Analgesics|analgesics|mesh-ancestor
92388379|NCT00004758|Sensory System Agents|sensory system agents|mesh-ancestor
92388380|NCT00004758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388381|NCT00004758|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92388382|NCT00004758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388383|NCT00004758|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92388384|NCT00004758|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92388385|NCT00004758|Vitamin B Complex|vitamin b complex|mesh-ancestor
92388387|NCT00004758|Micronutrients|micronutrients|mesh-ancestor
92388388|NCT00004758|Hormones|hormones|mesh-ancestor
92388389|NCT00004758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388390|NCT00004758|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92388391|NCT00004758|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92388392|NCT00004758|GABA Modulators|gaba modulators|mesh-ancestor
92388393|NCT00004770|Thioctic Acid|thioctic acid|mesh-list
92388394|NCT00004770|Antioxidants|antioxidants|mesh-ancestor
92388395|NCT00004770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388396|NCT00004770|Protective Agents|protective agents|mesh-ancestor
92388397|NCT00004770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388398|NCT00004770|Vitamin B Complex|vitamin b complex|mesh-ancestor
92388400|NCT00004770|Micronutrients|micronutrients|mesh-ancestor
92388401|NCT00004776|Topiramate|topiramate|mesh-list
92388402|NCT00004776|Anticonvulsants|anticonvulsants|mesh-ancestor
92388403|NCT00004776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92388404|NCT00004776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388405|NCT00004794|Cidofovir|cidofovir|mesh-list
92388406|NCT00004794|Antiviral Agents|antiviral agents|mesh-ancestor
92388407|NCT00004794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388408|NCT00004794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388409|NCT00004794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388410|NCT00004800|Vaccines|vaccines|mesh-list
92388411|NCT00004800|Immunologic Factors|immunologic factors|mesh-ancestor
92388412|NCT00004800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388413|NCT00004842|Budesonide|budesonide|mesh-list
92388414|NCT00004842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388415|NCT00004842|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92388416|NCT00004842|Autonomic Agents|autonomic agents|mesh-ancestor
92388417|NCT00004842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388418|NCT00004842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388419|NCT00004842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92388420|NCT00004842|Respiratory System Agents|respiratory system agents|mesh-ancestor
92388421|NCT00004842|Glucocorticoids|glucocorticoids|mesh-ancestor
92388422|NCT00004842|Hormones|hormones|mesh-ancestor
92388423|NCT00004842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388424|NCT00004854|Carvedilol|carvedilol|mesh-list
92388425|NCT00004854|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92388426|NCT00004854|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92388427|NCT00004854|Adrenergic Agents|adrenergic agents|mesh-ancestor
92388428|NCT00004854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388429|NCT00004854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388430|NCT00004854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388431|NCT00004854|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92388432|NCT00004854|Antioxidants|antioxidants|mesh-ancestor
92388433|NCT00004854|Protective Agents|protective agents|mesh-ancestor
92388434|NCT00004854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92388435|NCT00004854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388436|NCT00004854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92388437|NCT00004854|Vasodilator Agents|vasodilator agents|mesh-ancestor
92388438|NCT00004854|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92388439|NCT00004854|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92388440|NCT00004866|Exatecan|exatecan|mesh-list
92388441|NCT00004866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92388442|NCT00004866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388443|NCT00004866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388444|NCT00004866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388445|NCT00004866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388446|NCT00004872|Endostatins|endostatins|mesh-list
92388447|NCT00004872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388448|NCT00004872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92388449|NCT00004872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92388450|NCT00004872|Growth Substances|growth substances|mesh-ancestor
92388451|NCT00004872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388452|NCT00004872|Growth Inhibitors|growth inhibitors|mesh-ancestor
92388453|NCT00004878|Cytarabine|cytarabine|mesh-list
92388454|NCT00004878|Methotrexate|methotrexate|mesh-list
92388455|NCT00004878|Fludarabine phosphate|fludarabine phosphate|mesh-list
92388456|NCT00004878|Fludarabine|fludarabine|mesh-list
92388457|NCT00004878|Idarubicin|idarubicin|mesh-list
92388458|NCT00004878|Tacrolimus|tacrolimus|mesh-list
92388459|NCT00004878|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92388460|NCT00004878|Abortifacient Agents|abortifacient agents|mesh-ancestor
92388461|NCT00004878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388462|NCT00004878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388463|NCT00004878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388464|NCT00004878|Antimetabolites|antimetabolites|mesh-ancestor
92388465|NCT00004878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388466|NCT00004878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388467|NCT00004878|Dermatologic Agents|dermatologic agents|mesh-ancestor
92388468|NCT00004878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388469|NCT00004878|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92388470|NCT00004878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388471|NCT00004878|Immunologic Factors|immunologic factors|mesh-ancestor
92388472|NCT00004878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388473|NCT00004878|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388474|NCT00004878|Antiviral Agents|antiviral agents|mesh-ancestor
92388475|NCT00004878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388476|NCT00004878|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92388477|NCT00004878|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92388478|NCT00004878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388479|NCT00004878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388480|NCT00004884|Gemcitabine|gemcitabine|mesh-list
92388481|NCT00004884|Docetaxel|docetaxel|mesh-list
92388482|NCT00004884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388483|NCT00004884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388484|NCT00004884|Antimetabolites|antimetabolites|mesh-ancestor
92388485|NCT00004884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388486|NCT00004884|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388487|NCT00004884|Antimitotic Agents|antimitotic agents|mesh-ancestor
92388488|NCT00004884|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388489|NCT00004890|Aldesleukin|aldesleukin|mesh-list
92388490|NCT00004890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388491|NCT00004890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388492|NCT00004890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388493|NCT00004890|Antiviral Agents|antiviral agents|mesh-ancestor
92388494|NCT00004890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388495|NCT00004920|Raltitrexed|raltitrexed|mesh-list
92388496|NCT00004920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388497|NCT00004920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388498|NCT00004920|Antimetabolites|antimetabolites|mesh-ancestor
92388499|NCT00004920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388500|NCT00004920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92388501|NCT00004920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388502|NCT00004926|Vitamin D|vitamin d|mesh-list
92388503|NCT00004926|Cholecalciferol|cholecalciferol|mesh-list
92388504|NCT00004926|Ro 23-7553|ro 23-7553|mesh-list
92388505|NCT00004926|Vitamins|vitamins|mesh-ancestor
92388506|NCT00004926|Micronutrients|micronutrients|mesh-ancestor
92388507|NCT00004926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388508|NCT00004926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92388509|NCT00004926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92388510|NCT00004926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388511|NCT00004932|Imatinib Mesylate|imatinib mesylate|mesh-list
92388512|NCT00004932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388513|NCT00004932|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92388514|NCT00004932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388515|NCT00004932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388516|NCT00004938|Fluconazole|fluconazole|mesh-list
92388517|NCT00004938|Antifungal Agents|antifungal agents|mesh-ancestor
92388518|NCT00004938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388519|NCT00004938|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92388520|NCT00004938|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388521|NCT00004938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388522|NCT00004938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388523|NCT00004938|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92388524|NCT00004938|Hormone Antagonists|hormone antagonists|mesh-ancestor
92388525|NCT00004938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388526|NCT00004938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388527|NCT00004938|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92388528|NCT00004938|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92388529|NCT00004986|Nitazoxanide|nitazoxanide|mesh-list
92388530|NCT00004986|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92388531|NCT00004986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388532|NCT00004992|Metformin|metformin|mesh-list
92040956|NCT04285229|Ixekizumab|ixekizumab|mesh-list
92388533|NCT00004992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92388534|NCT00004992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388535|NCT00004998|Lamivudine|lamivudine|mesh-list
92388536|NCT00004998|Zidovudine|zidovudine|mesh-list
92388537|NCT00004998|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92388538|NCT00004998|Capravirine|capravirine|mesh-list
92388539|NCT00004998|Nelfinavir|nelfinavir|mesh-list
92388540|NCT00004998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92388541|NCT00004998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388542|NCT00004998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388543|NCT00004998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388544|NCT00004998|Antiviral Agents|antiviral agents|mesh-ancestor
92388545|NCT00004998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388546|NCT00004998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388547|NCT00004998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388548|NCT00004998|Antimetabolites|antimetabolites|mesh-ancestor
92388549|NCT00004998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92388550|NCT00004998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92388551|NCT00004998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388552|NCT00005010|Irbesartan|irbesartan|mesh-list
92388553|NCT00005010|Pravastatin|pravastatin|mesh-list
92388554|NCT00005010|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92388555|NCT00005010|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92388556|NCT00005010|Antimetabolites|antimetabolites|mesh-ancestor
92388557|NCT00005010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388558|NCT00005010|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92388559|NCT00005010|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92388560|NCT00005010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388561|NCT00005010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92388562|NCT00005010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92388563|NCT00005010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92388565|NCT00005022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388566|NCT00005022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388567|NCT00005022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388568|NCT00005022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388569|NCT00005022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388570|NCT00005022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388571|NCT00005028|Paclitaxel|paclitaxel|mesh-list
92388572|NCT00005028|Bryostatin 1|bryostatin 1|mesh-list
92388573|NCT00005028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388574|NCT00005028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388575|NCT00005028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388576|NCT00005028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92388577|NCT00005028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388578|NCT00005028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388579|NCT00005028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92388580|NCT00005028|Immunologic Factors|immunologic factors|mesh-ancestor
92388581|NCT00005028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388582|NCT00005040|Arsenic Trioxide|arsenic trioxide|mesh-list
92388583|NCT00005040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388584|NCT00005046|Paclitaxel|paclitaxel|mesh-list
92388585|NCT00005046|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388586|NCT00005046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388587|NCT00005046|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388588|NCT00005046|Antimitotic Agents|antimitotic agents|mesh-ancestor
92388589|NCT00005046|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388590|NCT00005046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388591|NCT00005064|Bortezomib|bortezomib|mesh-list
92388592|NCT00005064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388593|NCT00005070|Irofulven|irofulven|mesh-list
92388594|NCT00005070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92388595|NCT00005070|Alkylating Agents|alkylating agents|mesh-ancestor
92388596|NCT00005070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388597|NCT00005070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388598|NCT00005076|Irinotecan|irinotecan|mesh-list
92388599|NCT00005076|Cetuximab|cetuximab|mesh-list
92388600|NCT00005076|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92388601|NCT00005076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388602|NCT00005076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388603|NCT00005076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388604|NCT00005076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388605|NCT00005076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041029|NCT04035837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388606|NCT00005088|Cisplatin|cisplatin|mesh-list
92388607|NCT00005088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388608|NCT00005094|Celecoxib|celecoxib|mesh-list
92388609|NCT00005094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92388610|NCT00005094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92388611|NCT00005094|Analgesics|analgesics|mesh-ancestor
92388612|NCT00005094|Sensory System Agents|sensory system agents|mesh-ancestor
92388613|NCT00005094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388614|NCT00005094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388615|NCT00005094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388616|NCT00005094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388617|NCT00005094|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92388618|NCT00005094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92388619|NCT00005094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937877|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
92388620|NCT00005094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388621|NCT00005106|Lamivudine|lamivudine|mesh-list
92388622|NCT00005106|Zidovudine|zidovudine|mesh-list
92388623|NCT00005106|Abacavir|abacavir|mesh-list
92388624|NCT00005106|Stavudine|stavudine|mesh-list
92388625|NCT00005106|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92388626|NCT00005106|Nelfinavir|nelfinavir|mesh-list
92388627|NCT00005106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92388628|NCT00005106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388629|NCT00005106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388630|NCT00005106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388631|NCT00005106|Antiviral Agents|antiviral agents|mesh-ancestor
92388632|NCT00005106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388633|NCT00005106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388634|NCT00005106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388635|NCT00005106|Antimetabolites|antimetabolites|mesh-ancestor
92388636|NCT00005106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92388637|NCT00005106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92388638|NCT00005106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388639|NCT00005118|Ritonavir|ritonavir|mesh-list
92388640|NCT00005118|Indinavir|indinavir|mesh-list
92388641|NCT00005118|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92388642|NCT00005118|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92388643|NCT00005118|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388644|NCT00005118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388645|NCT00005118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388646|NCT00005118|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388647|NCT00005118|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388648|NCT00005118|Antiviral Agents|antiviral agents|mesh-ancestor
92388649|NCT00005118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388650|NCT00005118|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92388651|NCT00005118|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388652|NCT00005520|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92388653|NCT00005520|Candesartan|candesartan|mesh-list
92388654|NCT00005520|Candesartan cilexetil|candesartan cilexetil|mesh-list
92388655|NCT00005520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92388656|NCT00005520|Diuretics|diuretics|mesh-ancestor
92388657|NCT00005520|Natriuretic Agents|natriuretic agents|mesh-ancestor
92388658|NCT00005520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388659|NCT00005520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92388660|NCT00005520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388661|NCT00005520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388662|NCT00005520|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92388663|NCT00005520|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92388664|NCT00005574|Gentamicins|gentamicins|mesh-list
92388665|NCT00005574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92388666|NCT00005574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388667|NCT00005574|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92388668|NCT00005574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388669|NCT00005574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388670|NCT00005580|Fludarabine|fludarabine|mesh-list
92388671|NCT00005580|Fludarabine phosphate|fludarabine phosphate|mesh-list
92388672|NCT00005580|Bryostatin 1|bryostatin 1|mesh-list
92388673|NCT00005580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388674|NCT00005580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388675|NCT00005580|Antimetabolites|antimetabolites|mesh-ancestor
92388676|NCT00005580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388677|NCT00005580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388678|NCT00005580|Immunologic Factors|immunologic factors|mesh-ancestor
92388679|NCT00005580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388680|NCT00005580|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92388681|NCT00005586|Leucovorin|leucovorin|mesh-list
92388683|NCT00005586|Levoleucovorin|levoleucovorin|mesh-list
92388684|NCT00005586|Antimetabolites|antimetabolites|mesh-ancestor
92388685|NCT00005586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388686|NCT00005586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388687|NCT00005586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388688|NCT00005586|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388689|NCT00005586|Immunologic Factors|immunologic factors|mesh-ancestor
92388690|NCT00005586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388691|NCT00005586|Antidotes|antidotes|mesh-ancestor
92388692|NCT00005586|Protective Agents|protective agents|mesh-ancestor
92388693|NCT00005586|Vitamin B Complex|vitamin b complex|mesh-ancestor
92388694|NCT00005586|Vitamins|vitamins|mesh-ancestor
92388695|NCT00005586|Micronutrients|micronutrients|mesh-ancestor
92388696|NCT00005592|Rituximab|rituximab|mesh-list
92388698|NCT00005592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92388699|NCT00005592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388700|NCT00005592|Immunologic Factors|immunologic factors|mesh-ancestor
92388701|NCT00005592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388702|NCT00005592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388703|NCT00005598|Azacitidine|azacitidine|mesh-list
92388704|NCT00005598|Amifostine|amifostine|mesh-list
92388705|NCT00005598|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388706|NCT00005598|Antimetabolites|antimetabolites|mesh-ancestor
92388707|NCT00005598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388708|NCT00005598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388709|NCT00005598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388710|NCT00005598|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92388711|NCT00005598|Protective Agents|protective agents|mesh-ancestor
92388712|NCT00005598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388713|NCT00005604|Aldesleukin|aldesleukin|mesh-list
92388714|NCT00005604|Interleukin-2|interleukin-2|mesh-list
92388715|NCT00005604|Interleukin-12|interleukin-12|mesh-list
92388716|NCT00005604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388717|NCT00005604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92388718|NCT00005604|Analgesics|analgesics|mesh-ancestor
92133792|NCT00457197|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92388719|NCT00005604|Sensory System Agents|sensory system agents|mesh-ancestor
92388720|NCT00005604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388721|NCT00005604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388722|NCT00005604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388723|NCT00005604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388724|NCT00005604|Antiviral Agents|antiviral agents|mesh-ancestor
92388725|NCT00005604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388726|NCT00005604|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92388727|NCT00005604|Immunologic Factors|immunologic factors|mesh-ancestor
92388728|NCT00005604|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92388729|NCT00005604|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92388730|NCT00005604|Growth Substances|growth substances|mesh-ancestor
92388731|NCT00005604|Growth Inhibitors|growth inhibitors|mesh-ancestor
92388732|NCT00005610|Sargramostim|sargramostim|mesh-list
92388733|NCT00005610|Immunologic Factors|immunologic factors|mesh-ancestor
92388734|NCT00005610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388735|NCT00005616|Antibodies|antibodies|mesh-list
92388736|NCT00005616|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92388737|NCT00005616|Immunologic Factors|immunologic factors|mesh-ancestor
92388738|NCT00005616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388739|NCT00005622|Cyclophosphamide|cyclophosphamide|mesh-list
92388740|NCT00005622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388741|NCT00005622|Immunologic Factors|immunologic factors|mesh-ancestor
92388742|NCT00005622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388743|NCT00005622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388744|NCT00005622|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92388745|NCT00005622|Alkylating Agents|alkylating agents|mesh-ancestor
92388746|NCT00005622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388747|NCT00005622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388748|NCT00005622|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92388749|NCT00005634|Vorinostat|vorinostat|mesh-list
92388750|NCT00005634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388751|NCT00005634|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92388752|NCT00005634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388753|NCT00005634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388754|NCT00005640|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92388755|NCT00005640|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92388756|NCT00005640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388757|NCT00005646|Paclitaxel|paclitaxel|mesh-list
92388758|NCT00005646|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388759|NCT00005646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388760|NCT00005646|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388761|NCT00005646|Antimitotic Agents|antimitotic agents|mesh-ancestor
92388762|NCT00005646|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388763|NCT00005646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388764|NCT00005652|Rituximab|rituximab|mesh-list
92388765|NCT00005652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92388766|NCT00005652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388767|NCT00005652|Immunologic Factors|immunologic factors|mesh-ancestor
92388768|NCT00005652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388769|NCT00005652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388770|NCT00005658|Glycine|glycine|mesh-list
92388771|NCT00005658|Glycine Agents|glycine agents|mesh-ancestor
92388772|NCT00005658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388773|NCT00005658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388774|NCT00005658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388776|NCT00005796|Lomustine|lomustine|mesh-list
92388777|NCT00005796|Procarbazine|procarbazine|mesh-list
92388778|NCT00005796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388779|NCT00005796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388780|NCT00005796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92388781|NCT00005796|Antimitotic Agents|antimitotic agents|mesh-ancestor
92388782|NCT00005796|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388783|NCT00005796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388784|NCT00005796|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92388785|NCT00005796|Alkylating Agents|alkylating agents|mesh-ancestor
92388786|NCT00005802|Cytarabine|cytarabine|mesh-list
92388787|NCT00005802|Aldesleukin|aldesleukin|mesh-list
92388788|NCT00005802|Hydrocortisone|hydrocortisone|mesh-list
92134018|NCT01507831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388789|NCT00005802|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92388790|NCT00005802|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92388791|NCT00005802|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92388792|NCT00005802|Methotrexate|methotrexate|mesh-list
92388793|NCT00005802|Fludarabine phosphate|fludarabine phosphate|mesh-list
92388794|NCT00005802|Fludarabine|fludarabine|mesh-list
92388795|NCT00005802|Etoposide|etoposide|mesh-list
92388796|NCT00005802|Mitoxantrone|mitoxantrone|mesh-list
92388797|NCT00005802|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92388798|NCT00005802|Abortifacient Agents|abortifacient agents|mesh-ancestor
92388799|NCT00005802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388800|NCT00005802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388801|NCT00005802|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388802|NCT00005802|Antimetabolites|antimetabolites|mesh-ancestor
92388803|NCT00005802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388804|NCT00005802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388805|NCT00005802|Dermatologic Agents|dermatologic agents|mesh-ancestor
92388806|NCT00005802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388807|NCT00005802|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92388808|NCT00005802|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388809|NCT00005802|Immunologic Factors|immunologic factors|mesh-ancestor
92388810|NCT00005802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388811|NCT00005802|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388812|NCT00005802|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92388813|NCT00005802|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388814|NCT00005802|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388815|NCT00005802|Antiviral Agents|antiviral agents|mesh-ancestor
92388816|NCT00005802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388817|NCT00005802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388818|NCT00005802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388819|NCT00005802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388820|NCT00005802|Analgesics|analgesics|mesh-ancestor
92388821|NCT00005802|Sensory System Agents|sensory system agents|mesh-ancestor
92388822|NCT00005802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388823|NCT00005808|Motexafin lutetium|motexafin lutetium|mesh-list
92388824|NCT00005808|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92388825|NCT00005808|Dermatologic Agents|dermatologic agents|mesh-ancestor
92388826|NCT00005814|Cetuximab|cetuximab|mesh-list
92388827|NCT00005814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388828|NCT00005814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92388829|NCT00354900|Aprotinin|aprotinin|mesh-list
92388830|NCT00354900|Hemostatics|hemostatics|mesh-ancestor
92388831|NCT00354900|Coagulants|coagulants|mesh-ancestor
92388832|NCT00354900|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92388833|NCT00354900|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92388834|NCT00354900|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388835|NCT00354900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388836|NCT00354900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388837|NCT00355290|Vitamin K|vitamin k|mesh-list
92388838|NCT00355290|Vitamins|vitamins|mesh-ancestor
92388839|NCT00355290|Micronutrients|micronutrients|mesh-ancestor
92388840|NCT00355290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388841|NCT00355290|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92388842|NCT00355290|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92388843|NCT00355290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388844|NCT00355290|Hemostatics|hemostatics|mesh-ancestor
92388845|NCT00355290|Coagulants|coagulants|mesh-ancestor
92388846|NCT00355446|Bimatoprost|bimatoprost|mesh-list
92388847|NCT00355446|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92388849|NCT00355524|Darunavir|darunavir|mesh-list
92388850|NCT00355524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92388851|NCT00355524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92388852|NCT00355524|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388853|NCT00355524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388854|NCT00355524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388855|NCT00355524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388856|NCT00355524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388857|NCT00355524|Antiviral Agents|antiviral agents|mesh-ancestor
92388858|NCT00355524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388859|NCT00355524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92388860|NCT00355524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388861|NCT00355602|Metronidazole|metronidazole|mesh-list
92388862|NCT00355602|Vancomycin|vancomycin|mesh-list
92388863|NCT00355602|Clarithromycin|clarithromycin|mesh-list
92388864|NCT00355602|Doxycycline|doxycycline|mesh-list
92388865|NCT00355602|Ciprofloxacin|ciprofloxacin|mesh-list
92388866|NCT00355602|Rifaximin|rifaximin|mesh-list
92388867|NCT00355602|Cefuroxime|cefuroxime|mesh-list
92388868|NCT00355602|Neomycin|neomycin|mesh-list
92388869|NCT00355602|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92388870|NCT00355602|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92388871|NCT00355602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388872|NCT00355602|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92388873|NCT00355602|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92388874|NCT00355602|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92388875|NCT00355602|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92388876|NCT00355602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388877|NCT00355602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388878|NCT00355602|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92388879|NCT00355602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388880|NCT00355602|Antimalarials|antimalarials|mesh-ancestor
92388881|NCT00355602|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92388882|NCT00355602|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92388883|NCT00355602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388884|NCT00355602|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92388885|NCT00355602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92388886|NCT00355602|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92388887|NCT00355602|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92388888|NCT00356070|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92388889|NCT00356070|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92388890|NCT00356070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92388891|NCT00356070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92388892|NCT00356070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388893|NCT00356070|Adrenergic Agents|adrenergic agents|mesh-ancestor
92388894|NCT00356070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388895|NCT00356070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388897|NCT00356226|Analgesics|analgesics|mesh-ancestor
92388898|NCT00356226|Sensory System Agents|sensory system agents|mesh-ancestor
92388899|NCT00356226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388900|NCT00356226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388901|NCT00356226|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92388902|NCT00356226|Sympatholytics|sympatholytics|mesh-ancestor
92388903|NCT00356226|Autonomic Agents|autonomic agents|mesh-ancestor
92388904|NCT00356226|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92388905|NCT00356226|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92388906|NCT00356226|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92388907|NCT00356226|Adrenergic Agents|adrenergic agents|mesh-ancestor
92388908|NCT00356226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92388909|NCT00356226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388910|NCT00356460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92388912|NCT00356460|Immunoglobulins|immunoglobulins|mesh-list
92388913|NCT00356460|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92388914|NCT00356460|Mitogens|mitogens|mesh-list
92388915|NCT00356460|Immunologic Factors|immunologic factors|mesh-ancestor
92388916|NCT00356460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388917|NCT00356460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388918|NCT00356460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92388919|NCT00356460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388920|NCT00356616|Tenofovir|tenofovir|mesh-list
92388921|NCT00356616|Abacavir|abacavir|mesh-list
92388922|NCT00356616|Antiviral Agents|antiviral agents|mesh-ancestor
92388923|NCT00356616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388924|NCT00356616|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92388925|NCT00356616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388926|NCT00356616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388927|NCT00356616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388928|NCT00356616|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388929|NCT00356616|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388930|NCT00356772|Azithromycin|azithromycin|mesh-list
92388931|NCT00356772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92388932|NCT00356772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388933|NCT00356850|Azithromycin|azithromycin|mesh-list
92388934|NCT00356850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92388935|NCT00356850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388936|NCT00356928|Cyclophosphamide|cyclophosphamide|mesh-list
92388937|NCT00356928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388938|NCT00356928|Immunologic Factors|immunologic factors|mesh-ancestor
92388939|NCT00356928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388940|NCT00356928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388941|NCT00356928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92388942|NCT00356928|Alkylating Agents|alkylating agents|mesh-ancestor
92388943|NCT00356928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388944|NCT00356928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388945|NCT00356928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92388946|NCT00357084|Prednisone|prednisone|mesh-list
92388947|NCT00357084|Methylprednisolone|methylprednisolone|mesh-list
92388948|NCT00357084|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92388949|NCT00357084|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92388950|NCT00357084|Prednisolone|prednisolone|mesh-list
92388951|NCT00357084|Prednisolone acetate|prednisolone acetate|mesh-list
92388952|NCT00357084|Methotrexate|methotrexate|mesh-list
92388953|NCT00357084|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92388954|NCT00357084|Prednisolone phosphate|prednisolone phosphate|mesh-list
92388955|NCT00357084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92388956|NCT00357084|Glucocorticoids|glucocorticoids|mesh-ancestor
92388958|NCT00357084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92388959|NCT00357084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92388960|NCT00357084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92388961|NCT00357084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92388962|NCT00357084|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92388963|NCT00357084|Abortifacient Agents|abortifacient agents|mesh-ancestor
92388964|NCT00357084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92388965|NCT00357084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92388966|NCT00357084|Antimetabolites|antimetabolites|mesh-ancestor
92388967|NCT00357084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388968|NCT00357084|Dermatologic Agents|dermatologic agents|mesh-ancestor
92388969|NCT00357084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388970|NCT00357084|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92388971|NCT00357084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92388972|NCT00357084|Immunologic Factors|immunologic factors|mesh-ancestor
92388973|NCT00357084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92388974|NCT00357084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92388976|NCT00357084|Autonomic Agents|autonomic agents|mesh-ancestor
92388977|NCT00357084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92388978|NCT00357084|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92388979|NCT00357084|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92388980|NCT00357084|Protective Agents|protective agents|mesh-ancestor
92388981|NCT00357240|Ritonavir|ritonavir|mesh-list
92388982|NCT00357240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92388983|NCT00357240|Omeprazole|omeprazole|mesh-list
92041408|NCT02409810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92388984|NCT00357240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92388985|NCT00357240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92388986|NCT00357240|Protease Inhibitors|protease inhibitors|mesh-ancestor
92388987|NCT00357240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92388988|NCT00357240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92388989|NCT00357240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92388990|NCT00357240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92388991|NCT00357240|Antiviral Agents|antiviral agents|mesh-ancestor
92388992|NCT00357240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92388993|NCT00357240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92388994|NCT00357240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92388995|NCT00357240|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92388996|NCT00357240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92388997|NCT00357240|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92388998|NCT00357318|Bevacizumab|bevacizumab|mesh-list
92388999|NCT00357318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92389000|NCT00357318|Sunitinib|sunitinib|mesh-list
92389001|NCT00357318|Antibodies|antibodies|mesh-list
92389002|NCT00357318|Immunoglobulins|immunoglobulins|mesh-list
92389003|NCT00357318|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92389004|NCT00357318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389005|NCT00357318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92041043|NCT04022135|Hematinics|hematinics|mesh-ancestor
92389006|NCT00357318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92389007|NCT00357318|Growth Substances|growth substances|mesh-ancestor
92389008|NCT00357318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389009|NCT00357318|Growth Inhibitors|growth inhibitors|mesh-ancestor
92389010|NCT00357318|Immunologic Factors|immunologic factors|mesh-ancestor
92389011|NCT00357318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92389012|NCT00357318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389013|NCT00357318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389014|NCT00357474|Ethanol|ethanol|mesh-list
92389015|NCT00357474|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92389016|NCT00357474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389017|NCT00357474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389018|NCT00357474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389019|NCT00357630|Gemcitabine|gemcitabine|mesh-list
92389020|NCT00357630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389021|NCT00357630|Antimetabolites|antimetabolites|mesh-ancestor
92389022|NCT00357630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389023|NCT00357630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389025|NCT00357708|Azacitidine|azacitidine|mesh-list
92389026|NCT00357708|Vorinostat|vorinostat|mesh-list
92389027|NCT00357708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389028|NCT00357708|Antimetabolites|antimetabolites|mesh-ancestor
92389029|NCT00357708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389030|NCT00357708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389031|NCT00357708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389032|NCT00357708|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92389033|NCT00357864|Carbachol|carbachol|mesh-list
92389034|NCT00357864|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92389035|NCT00357864|Miotics|miotics|mesh-ancestor
92389036|NCT00357864|Autonomic Agents|autonomic agents|mesh-ancestor
92389037|NCT00357864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389038|NCT00357864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389039|NCT00357864|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92389040|NCT00357864|Cholinergic Agents|cholinergic agents|mesh-ancestor
92389041|NCT00357864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389042|NCT00357864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389043|NCT00357864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389044|NCT00357864|Analgesics|analgesics|mesh-ancestor
92389045|NCT00357864|Sensory System Agents|sensory system agents|mesh-ancestor
92389047|NCT00357942|Morphine|morphine|mesh-list
92389048|NCT00357942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92389049|NCT00357942|Narcotics|narcotics|mesh-ancestor
92389050|NCT00357942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389051|NCT00357942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389052|NCT00357942|Analgesics|analgesics|mesh-ancestor
92389053|NCT00357942|Sensory System Agents|sensory system agents|mesh-ancestor
92389054|NCT00357942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389055|NCT00358020|Thalidomide|thalidomide|mesh-list
92389056|NCT00358020|Bortezomib|bortezomib|mesh-list
92389057|NCT00358020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389058|NCT00358020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389059|NCT00358020|Immunologic Factors|immunologic factors|mesh-ancestor
92389060|NCT00358020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389061|NCT00358020|Leprostatic Agents|leprostatic agents|mesh-ancestor
92389062|NCT00358020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92389063|NCT00358020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389064|NCT00358020|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92389065|NCT00358020|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92389066|NCT00358020|Growth Substances|growth substances|mesh-ancestor
92389067|NCT00358020|Growth Inhibitors|growth inhibitors|mesh-ancestor
92389068|NCT00358176|Risedronic Acid|risedronic acid|mesh-list
92389069|NCT00358176|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92389070|NCT00358176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389071|NCT00358176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389072|NCT00358176|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92389073|NCT00358176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389074|NCT00358176|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92389076|NCT00358410|Antiemetics|antiemetics|mesh-ancestor
92389077|NCT00358410|Autonomic Agents|autonomic agents|mesh-ancestor
92389078|NCT00358410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389079|NCT00358410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389080|NCT00358410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92134251|NCT01692626|Immunologic Factors|immunologic factors|mesh-ancestor
92389081|NCT00358410|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92389082|NCT00358410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389083|NCT00358410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389084|NCT00358488|Albuterol|albuterol|mesh-list
92389085|NCT00358488|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92389086|NCT00358488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92389087|NCT00358488|Autonomic Agents|autonomic agents|mesh-ancestor
92389088|NCT00358488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389089|NCT00358488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389090|NCT00358488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92389091|NCT00358488|Respiratory System Agents|respiratory system agents|mesh-ancestor
92389092|NCT00358488|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92389093|NCT00358488|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92389094|NCT00358488|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92389095|NCT00358488|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389096|NCT00358488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389097|NCT00358488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389098|NCT00358488|Tocolytic Agents|tocolytic agents|mesh-ancestor
92389099|NCT00358488|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92389100|NCT00358566|Gemcitabine|gemcitabine|mesh-list
92389101|NCT00358566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389102|NCT00358566|Antimetabolites|antimetabolites|mesh-ancestor
92389103|NCT00358566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389104|NCT00358566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389105|NCT00359112|Metformin|metformin|mesh-list
92389106|NCT00359112|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389107|NCT00359112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389108|NCT00359190|Lapatinib|lapatinib|mesh-list
92389109|NCT00359190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389110|NCT00359190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92389111|NCT00359190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389112|NCT00359190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389113|NCT00359658|Cyclosporine|cyclosporine|mesh-list
92389114|NCT00359658|Prednisolone|prednisolone|mesh-list
92389115|NCT00359658|Cyclosporins|cyclosporins|mesh-list
92389116|NCT00359658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389117|NCT00359658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389118|NCT00359658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389119|NCT00359658|Immunologic Factors|immunologic factors|mesh-ancestor
92389120|NCT00359658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389121|NCT00359658|Antifungal Agents|antifungal agents|mesh-ancestor
92389122|NCT00359658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389123|NCT00359658|Dermatologic Agents|dermatologic agents|mesh-ancestor
92389124|NCT00359658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389125|NCT00359658|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92389126|NCT00359658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389127|NCT00359658|Glucocorticoids|glucocorticoids|mesh-ancestor
92389128|NCT00359658|Hormones|hormones|mesh-ancestor
92389129|NCT00359658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389130|NCT00359658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389131|NCT00359658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389132|NCT00359814|Cyclosporine|cyclosporine|mesh-list
92389133|NCT00359814|Cyclosporins|cyclosporins|mesh-list
92041555|NCT00565851|Paclitaxel|paclitaxel|mesh-list
92389134|NCT00359814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389135|NCT00359814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389136|NCT00359814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389137|NCT00359814|Immunologic Factors|immunologic factors|mesh-ancestor
92389138|NCT00359814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389139|NCT00359814|Antifungal Agents|antifungal agents|mesh-ancestor
92389140|NCT00359814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389141|NCT00359814|Dermatologic Agents|dermatologic agents|mesh-ancestor
92389142|NCT00359814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389143|NCT00359814|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92389145|NCT00359892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389146|NCT00359892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389147|NCT00359970|Azithromycin|azithromycin|mesh-list
92389148|NCT00359970|Loperamide|loperamide|mesh-list
92389149|NCT00359970|Antidiarrheals|antidiarrheals|mesh-list
92389150|NCT00359970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92389151|NCT00359970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389152|NCT00359970|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389153|NCT00360048|Oxytocin|oxytocin|mesh-list
92389154|NCT00360048|Oxytocics|oxytocics|mesh-ancestor
92389155|NCT00360048|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92389156|NCT00360048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389157|NCT00360438|Rasburicase|rasburicase|mesh-list
92389158|NCT00360438|Gout Suppressants|gout suppressants|mesh-ancestor
92389159|NCT00360438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389160|NCT00360594|Acamprosate|acamprosate|mesh-list
92389161|NCT00360594|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92389162|NCT00360750|Cytarabine|cytarabine|mesh-list
92389163|NCT00360750|Carboplatin|carboplatin|mesh-list
92389164|NCT00360750|Etoposide|etoposide|mesh-list
92389165|NCT00360750|Vincristine|vincristine|mesh-list
92389166|NCT00360750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389167|NCT00360750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92389168|NCT00360750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92389169|NCT00360750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92389170|NCT00360750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389171|NCT00360750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389172|NCT00360750|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389173|NCT00360750|Antimetabolites|antimetabolites|mesh-ancestor
92389174|NCT00360750|Antiviral Agents|antiviral agents|mesh-ancestor
92389175|NCT00360750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389176|NCT00360750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389177|NCT00360750|Immunologic Factors|immunologic factors|mesh-ancestor
92389178|NCT00360750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389179|NCT00360750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92389180|NCT00360750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92389181|NCT00360750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92389182|NCT00360984|Insulin|insulin|mesh-list
92389183|NCT00360984|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92389184|NCT00360984|Insulin Glargine|insulin glargine|mesh-list
92389185|NCT00360984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389186|NCT00360984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389187|NCT00361452|Epinephrine|epinephrine|mesh-list
92389188|NCT00361452|Albuterol|albuterol|mesh-list
92389189|NCT00361452|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92389190|NCT00361452|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92389191|NCT00361452|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389192|NCT00361452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389193|NCT00361452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389194|NCT00361452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389195|NCT00361452|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92389196|NCT00361452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92389197|NCT00361452|Autonomic Agents|autonomic agents|mesh-ancestor
92389198|NCT00361452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389199|NCT00361452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92389200|NCT00361452|Respiratory System Agents|respiratory system agents|mesh-ancestor
92389201|NCT00361452|Mydriatics|mydriatics|mesh-ancestor
92389202|NCT00361452|Sympathomimetics|sympathomimetics|mesh-ancestor
92389203|NCT00361452|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92389204|NCT00361452|Tocolytic Agents|tocolytic agents|mesh-ancestor
92389205|NCT00361452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92389206|NCT00361452|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92389207|NCT00361686|Tramadol|tramadol|mesh-list
92389208|NCT00361686|Remifentanil|remifentanil|mesh-list
92389209|NCT00361686|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92389210|NCT00361686|Narcotics|narcotics|mesh-ancestor
92389211|NCT00361686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389214|NCT00361686|Sensory System Agents|sensory system agents|mesh-ancestor
92389215|NCT00361686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389216|NCT00361920|Prednisone|prednisone|mesh-list
92389217|NCT00361920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389218|NCT00361920|Glucocorticoids|glucocorticoids|mesh-ancestor
92389219|NCT00361920|Hormones|hormones|mesh-ancestor
92389220|NCT00361920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389221|NCT00361920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389222|NCT00361920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389223|NCT00361920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389224|NCT00361998|Nitrofurantoin|nitrofurantoin|mesh-list
92389225|NCT00361998|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92389226|NCT00361998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389227|NCT00361998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92389228|NCT00362310|Indinavir|indinavir|mesh-list
92389229|NCT00362310|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92389230|NCT00362310|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92389231|NCT00362310|Protease Inhibitors|protease inhibitors|mesh-ancestor
92389232|NCT00362310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389233|NCT00362310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389234|NCT00362310|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92389235|NCT00362310|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92389236|NCT00362310|Antiviral Agents|antiviral agents|mesh-ancestor
92389237|NCT00362310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389238|NCT00362544|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92389239|NCT00362544|Antifungal Agents|antifungal agents|mesh-ancestor
92389240|NCT00362544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389241|NCT00362544|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92389242|NCT00362544|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92389243|NCT00362700|Clevudine|clevudine|mesh-list
92389244|NCT00362700|Antiviral Agents|antiviral agents|mesh-ancestor
92389245|NCT00362700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389246|NCT00362778|Insulin|insulin|mesh-list
92389247|NCT00362778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389248|NCT00362778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389249|NCT00362934|Atorvastatin|atorvastatin|mesh-list
92389250|NCT00362934|Simvastatin|simvastatin|mesh-list
92389251|NCT00362934|Fenofibrate|fenofibrate|mesh-list
92389252|NCT00362934|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92389253|NCT00362934|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92389254|NCT00362934|Antimetabolites|antimetabolites|mesh-ancestor
92389255|NCT00362934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389256|NCT00362934|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92389257|NCT00362934|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92389258|NCT00362934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389259|NCT00363090|Prednisone|prednisone|mesh-list
92389260|NCT00363090|Cyclophosphamide|cyclophosphamide|mesh-list
92389261|NCT00363090|Doxorubicin|doxorubicin|mesh-list
92389262|NCT00363090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92389263|NCT00363090|Vincristine|vincristine|mesh-list
92389264|NCT00363090|Alemtuzumab|alemtuzumab|mesh-list
92389265|NCT00363090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389266|NCT00363090|Immunologic Factors|immunologic factors|mesh-ancestor
92389267|NCT00363090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389268|NCT00363090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389269|NCT00363090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92389270|NCT00363090|Alkylating Agents|alkylating agents|mesh-ancestor
92389271|NCT00363090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389272|NCT00363090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389273|NCT00363090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92389274|NCT00363090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92389275|NCT00363090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92389276|NCT00363090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92389277|NCT00363090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389278|NCT00363090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389279|NCT00363090|Glucocorticoids|glucocorticoids|mesh-ancestor
92389280|NCT00363090|Hormones|hormones|mesh-ancestor
91986235|NCT03112655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92389281|NCT00363090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389282|NCT00363090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389283|NCT00363090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92389285|NCT00363090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92041705|NCT01777282|Hormones|hormones|mesh-ancestor
92389286|NCT00363090|Mitosis Modulators|mitosis modulators|mesh-ancestor
92389287|NCT00363090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92389288|NCT00363792|Nitroglycerin|nitroglycerin|mesh-list
92389289|NCT00363792|Vasodilator Agents|vasodilator agents|mesh-ancestor
92389290|NCT00363948|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92389291|NCT00363948|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389292|NCT00363948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389293|NCT00363948|Incretins|incretins|mesh-ancestor
92389295|NCT00363948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389296|NCT00363948|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92389297|NCT00363948|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041056|NCT03983668|Pembrolizumab|pembrolizumab|mesh-list
92389298|NCT00363948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389299|NCT00363948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389301|NCT00364026|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92389302|NCT00364026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389303|NCT00364260|Epoetin Alfa|epoetin alfa|mesh-list
92389304|NCT00364260|Hematinics|hematinics|mesh-ancestor
92389305|NCT00364572|Etanercept|etanercept|mesh-list
92389306|NCT00364572|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92389307|NCT00364572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389308|NCT00364572|Analgesics|analgesics|mesh-ancestor
92389309|NCT00364572|Sensory System Agents|sensory system agents|mesh-ancestor
92389310|NCT00364572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389311|NCT00364572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389312|NCT00364572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389313|NCT00364572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389314|NCT00364572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389315|NCT00364572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389316|NCT00364572|Immunologic Factors|immunologic factors|mesh-ancestor
92389317|NCT00364806|Metoclopramide|metoclopramide|mesh-list
92389318|NCT00364806|Prochlorperazine|prochlorperazine|mesh-list
92389319|NCT00364806|Antiemetics|antiemetics|mesh-ancestor
92389320|NCT00364806|Autonomic Agents|autonomic agents|mesh-ancestor
92389321|NCT00364806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389322|NCT00364806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389323|NCT00364806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389324|NCT00364806|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92389325|NCT00364806|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92389326|NCT00364806|Dopamine Agents|dopamine agents|mesh-ancestor
92389327|NCT00364806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389328|NCT00364806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389329|NCT00364806|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92389330|NCT00364806|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92389331|NCT00364806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389332|NCT00364806|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92389333|NCT00365040|Mitomycins|mitomycins|mesh-list
92389334|NCT00365040|Mitomycin|mitomycin|mesh-list
92389335|NCT00365040|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92389336|NCT00365040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389337|NCT00365040|Alkylating Agents|alkylating agents|mesh-ancestor
92389338|NCT00365040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389339|NCT00365040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92389340|NCT00365040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389341|NCT00365586|Ketoprofen|ketoprofen|mesh-list
92389342|NCT00365586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92389343|NCT00365586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389344|NCT00365586|Analgesics|analgesics|mesh-ancestor
92389345|NCT00365586|Sensory System Agents|sensory system agents|mesh-ancestor
92389346|NCT00365586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389347|NCT00365586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389348|NCT00365586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389349|NCT00365586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389350|NCT00365586|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92389351|NCT00365586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389352|NCT00365586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389353|NCT00365742|Simvastatin|simvastatin|mesh-list
92389354|NCT00365742|Red yeast rice|red yeast rice|mesh-list
92389355|NCT00365742|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92389356|NCT00365742|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92389357|NCT00365742|Antimetabolites|antimetabolites|mesh-ancestor
92389358|NCT00365742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389359|NCT00365742|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92389360|NCT00365742|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92389361|NCT00365742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389363|NCT00365820|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92389364|NCT00365820|Serotonin Agents|serotonin agents|mesh-ancestor
92389365|NCT00365820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389366|NCT00365820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389367|NCT00365820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389368|NCT00365898|Hydromorphone|hydromorphone|mesh-list
92389369|NCT00365898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92389370|NCT00365898|Narcotics|narcotics|mesh-ancestor
92389371|NCT00365898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389372|NCT00365898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389373|NCT00365898|Analgesics|analgesics|mesh-ancestor
92389374|NCT00365898|Sensory System Agents|sensory system agents|mesh-ancestor
92389375|NCT00365898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389376|NCT00366834|Dexamethasone|dexamethasone|mesh-list
92389377|NCT00366834|Dexamethasone acetate|dexamethasone acetate|mesh-list
92389378|NCT00366834|Ondansetron|ondansetron|mesh-list
92389379|NCT00366834|Casopitant|casopitant|mesh-list
92389380|NCT00366834|BB 1101|bb 1101|mesh-list
92389381|NCT00366834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389382|NCT00366834|Antiemetics|antiemetics|mesh-ancestor
92389383|NCT00366834|Autonomic Agents|autonomic agents|mesh-ancestor
92389384|NCT00366834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389385|NCT00366834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389386|NCT00366834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389387|NCT00366834|Glucocorticoids|glucocorticoids|mesh-ancestor
92389388|NCT00366834|Hormones|hormones|mesh-ancestor
92389389|NCT00366834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389390|NCT00366834|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389391|NCT00366834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389392|NCT00366834|Protease Inhibitors|protease inhibitors|mesh-ancestor
92389393|NCT00366834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389394|NCT00366834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389395|NCT00366834|Antipruritics|antipruritics|mesh-ancestor
92389396|NCT00366834|Dermatologic Agents|dermatologic agents|mesh-ancestor
92389397|NCT00366834|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92389398|NCT00366834|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92389399|NCT00366834|Serotonin Agents|serotonin agents|mesh-ancestor
92389400|NCT00366834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389401|NCT00366834|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92389402|NCT00367068|Baclofen|baclofen|mesh-list
92389403|NCT00367068|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92389404|NCT00367068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389405|NCT00367068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92389406|NCT00367068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389407|NCT00367068|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92389408|NCT00367068|GABA Agonists|gaba agonists|mesh-ancestor
92389409|NCT00367068|GABA Agents|gaba agents|mesh-ancestor
92389410|NCT00367068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389411|NCT00367068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389412|NCT00367302|Buprenorphine|buprenorphine|mesh-list
92389413|NCT00367302|Methadone|methadone|mesh-list
92389414|NCT00367302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92389415|NCT00367302|Narcotics|narcotics|mesh-ancestor
92389416|NCT00367302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389417|NCT00367302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389418|NCT00367302|Analgesics|analgesics|mesh-ancestor
92389419|NCT00367302|Sensory System Agents|sensory system agents|mesh-ancestor
91937911|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389420|NCT00367302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389421|NCT00367302|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92389422|NCT00367302|Antitussive Agents|antitussive agents|mesh-ancestor
92389423|NCT00367302|Respiratory System Agents|respiratory system agents|mesh-ancestor
92389424|NCT00367536|Bazedoxifene|bazedoxifene|mesh-list
92389425|NCT00367536|Estrogens|estrogens|mesh-list
92389426|NCT00367536|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92389427|NCT00367536|Hormones|hormones|mesh-ancestor
92389428|NCT00367536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389429|NCT00367536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389430|NCT00367536|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92389431|NCT00367536|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92389432|NCT00367536|Hormone Antagonists|hormone antagonists|mesh-ancestor
92389433|NCT00367536|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92389434|NCT00367614|Pantoprazole|pantoprazole|mesh-list
92389435|NCT00367614|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92389436|NCT00367614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389437|NCT00367614|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92389438|NCT00367614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389439|NCT00367614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389440|NCT00368160|Eszopiclone|eszopiclone|mesh-list
92389441|NCT00368160|Zopiclone|zopiclone|mesh-list
92389442|NCT00368160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92389443|NCT00368160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389444|NCT00368160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389445|NCT00368238|Aspirin|aspirin|mesh-list
92389446|NCT00368238|Epoetin Alfa|epoetin alfa|mesh-list
92389447|NCT00368238|Clopidogrel|clopidogrel|mesh-list
92389448|NCT00368238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92389449|NCT00368238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389450|NCT00368238|Analgesics|analgesics|mesh-ancestor
92389451|NCT00368238|Sensory System Agents|sensory system agents|mesh-ancestor
92389452|NCT00368238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389453|NCT00368238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389454|NCT00368238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389455|NCT00368238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389456|NCT00368238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92389457|NCT00368238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92389458|NCT00368238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389459|NCT00368238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92389460|NCT00368238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92389461|NCT00368238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389462|NCT00368238|Antipyretics|antipyretics|mesh-ancestor
92389463|NCT00368238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92389464|NCT00368238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92389465|NCT00368238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92389466|NCT00368238|Purinergic Agents|purinergic agents|mesh-ancestor
92389467|NCT00368238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389468|NCT00368238|Hematinics|hematinics|mesh-ancestor
92389469|NCT00368394|Insulin glulisine|insulin glulisine|mesh-list
92389470|NCT00368394|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389471|NCT00368394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389472|NCT00368706|Solifenacin Succinate|solifenacin succinate|mesh-list
92389473|NCT00368706|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92389474|NCT00368706|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92389475|NCT00368706|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92389476|NCT00368706|Cholinergic Agents|cholinergic agents|mesh-ancestor
92389477|NCT00368706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389478|NCT00368706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389479|NCT00368706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389480|NCT00368706|Urological Agents|urological agents|mesh-ancestor
92389482|NCT00368862|Escitalopram|escitalopram|mesh-list
92389483|NCT00368862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92389484|NCT00368862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92389485|NCT00368862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389486|NCT00368862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389487|NCT00368862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389488|NCT00368862|Serotonin Agents|serotonin agents|mesh-ancestor
92389489|NCT00368862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389490|NCT00368862|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92389491|NCT00368862|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92389492|NCT00368862|Dopamine Agents|dopamine agents|mesh-ancestor
92389493|NCT00368862|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92389494|NCT00368862|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92389496|NCT00369018|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92389497|NCT00369018|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92389498|NCT00369018|Dermatologic Agents|dermatologic agents|mesh-ancestor
92389499|NCT00369096|Bemiparin|bemiparin|mesh-list
92389500|NCT00369096|Anticoagulants|anticoagulants|mesh-ancestor
92389501|NCT00369174|Rosiglitazone|rosiglitazone|mesh-list
92389502|NCT00369174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389503|NCT00369174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389504|NCT00369252|Nimotuzumab|nimotuzumab|mesh-list
92389505|NCT00369252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92389506|NCT00369252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389507|NCT00369408|Naltrexone|naltrexone|mesh-list
92389508|NCT00369408|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92389509|NCT00369408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92389510|NCT00369408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389511|NCT00369408|Sensory System Agents|sensory system agents|mesh-ancestor
92389512|NCT00369408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389513|NCT00369798|Rolipram|rolipram|mesh-list
92389514|NCT00369798|Antidepressive Agents|antidepressive agents|mesh-ancestor
92389515|NCT00369798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92389516|NCT00369798|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92389517|NCT00369798|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92389518|NCT00369798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389519|NCT00369798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389520|NCT00369954|Carboplatin|carboplatin|mesh-list
92389521|NCT00369954|Gemcitabine|gemcitabine|mesh-list
92389522|NCT00369954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389523|NCT00369954|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389524|NCT00369954|Antimetabolites|antimetabolites|mesh-ancestor
92389525|NCT00369954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389526|NCT00370188|Topiramate|topiramate|mesh-list
92389527|NCT00370188|Anticonvulsants|anticonvulsants|mesh-ancestor
92389528|NCT00370188|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389529|NCT00370188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389530|NCT00370266|Triamcinolone|triamcinolone|mesh-list
92389531|NCT00370266|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389532|NCT00370266|Glucocorticoids|glucocorticoids|mesh-ancestor
92389533|NCT00370266|Hormones|hormones|mesh-ancestor
92389534|NCT00370266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389535|NCT00370266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389536|NCT00370422|Triamcinolone|triamcinolone|mesh-list
92389537|NCT00370422|Bevacizumab|bevacizumab|mesh-list
92389538|NCT00370422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92389539|NCT00370422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389540|NCT00370422|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92389541|NCT00370422|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92389542|NCT00370422|Growth Substances|growth substances|mesh-ancestor
92389543|NCT00370422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389544|NCT00370422|Growth Inhibitors|growth inhibitors|mesh-ancestor
92389545|NCT00370422|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389546|NCT00370422|Glucocorticoids|glucocorticoids|mesh-ancestor
92389547|NCT00370422|Hormones|hormones|mesh-ancestor
92389548|NCT00370422|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389549|NCT00370500|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92389550|NCT00370500|Antidepressive Agents|antidepressive agents|mesh-ancestor
92389551|NCT00370500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92389552|NCT00370500|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92389553|NCT00370500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92389554|NCT00370500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389555|NCT00370500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389556|NCT00370656|Pregabalin|pregabalin|mesh-list
92389557|NCT00370656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92389558|NCT00370656|Amitriptyline|amitriptyline|mesh-list
92389559|NCT00370656|Analgesics|analgesics|mesh-ancestor
92389560|NCT00370656|Sensory System Agents|sensory system agents|mesh-ancestor
92389561|NCT00370656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389562|NCT00370656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389563|NCT00370656|Anticonvulsants|anticonvulsants|mesh-ancestor
92389564|NCT00370656|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92389565|NCT00370656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389566|NCT00370656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389567|NCT00370656|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92389568|NCT00370656|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92389569|NCT00370656|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92389570|NCT00370656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389571|NCT00370656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92389572|NCT00370656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92389573|NCT00370656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92389574|NCT00370656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389575|NCT00370656|Antidepressive Agents|antidepressive agents|mesh-ancestor
92389577|NCT00370656|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92389578|NCT00370656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389579|NCT00370656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92389580|NCT00370656|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389581|NCT00370734|Botulinum Toxins|botulinum toxins|mesh-list
92389582|NCT00370734|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92389583|NCT00370734|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92389584|NCT00370734|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92389585|NCT00370734|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389586|NCT00370734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389587|NCT00370734|Cholinergic Agents|cholinergic agents|mesh-ancestor
92389588|NCT00370734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389589|NCT00370734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389590|NCT00370734|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92389591|NCT00370734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389592|NCT00370968|Zinc Sulfate|zinc sulfate|mesh-list
92389593|NCT00370968|Astringents|astringents|mesh-ancestor
92389594|NCT00370968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389595|NCT00370968|Dermatologic Agents|dermatologic agents|mesh-ancestor
92389597|NCT00371124|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92389598|NCT00371124|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92389599|NCT00371124|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92389600|NCT00371124|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92389601|NCT00371124|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92389602|NCT00371124|Autonomic Agents|autonomic agents|mesh-ancestor
92389603|NCT00371124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389604|NCT00371124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389605|NCT00371124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92389606|NCT00371124|Respiratory System Agents|respiratory system agents|mesh-ancestor
92389607|NCT00371124|Mydriatics|mydriatics|mesh-ancestor
92389608|NCT00371124|Parasympatholytics|parasympatholytics|mesh-ancestor
92389609|NCT00371124|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92389610|NCT00371124|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92389611|NCT00371124|Cholinergic Agents|cholinergic agents|mesh-ancestor
92389612|NCT00371124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389613|NCT00371124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389614|NCT00371592|Acyclovir|acyclovir|mesh-list
92389615|NCT00371592|Antiviral Agents|antiviral agents|mesh-ancestor
92389616|NCT00371592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389617|NCT00371904|Rituximab|rituximab|mesh-list
92389618|NCT00371904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92389619|NCT00371904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389620|NCT00371904|Immunologic Factors|immunologic factors|mesh-ancestor
92389621|NCT00371904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389622|NCT00371904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389623|NCT00372138|Thrombin|thrombin|mesh-list
92389624|NCT00372138|Hemostatics|hemostatics|mesh-ancestor
92389625|NCT00372138|Coagulants|coagulants|mesh-ancestor
92389626|NCT00372216|Clopidogrel|clopidogrel|mesh-list
92389627|NCT00372216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92389628|NCT00372216|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92389629|NCT00372216|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92389630|NCT00372216|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92389631|NCT00372216|Purinergic Agents|purinergic agents|mesh-ancestor
92389632|NCT00372216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389633|NCT00372216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389634|NCT00372216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389635|NCT00372294|Clindamycin|clindamycin|mesh-list
92389636|NCT00372294|Clindamycin palmitate|clindamycin palmitate|mesh-list
92389637|NCT00372294|Clindamycin phosphate|clindamycin phosphate|mesh-list
92389638|NCT00372294|Sulfadiazine|sulfadiazine|mesh-list
92389639|NCT00372294|Pyrimethamine|pyrimethamine|mesh-list
92389640|NCT00372294|Dexamethasone|dexamethasone|mesh-list
92389641|NCT00372294|Prednisolone|prednisolone|mesh-list
92389643|NCT00372294|Antiemetics|antiemetics|mesh-ancestor
92389644|NCT00372294|Autonomic Agents|autonomic agents|mesh-ancestor
92389645|NCT00372294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389646|NCT00372294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389647|NCT00372294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389648|NCT00372294|Glucocorticoids|glucocorticoids|mesh-ancestor
92389649|NCT00372294|Hormones|hormones|mesh-ancestor
92389650|NCT00372294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389651|NCT00372294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389652|NCT00372294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389653|NCT00372294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92389654|NCT00372294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389655|NCT00372294|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92389656|NCT00372294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389657|NCT00372294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389658|NCT00372294|Antimalarials|antimalarials|mesh-ancestor
92389659|NCT00372294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92389660|NCT00372294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92389661|NCT00372294|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92389662|NCT00372294|Coccidiostats|coccidiostats|mesh-ancestor
92389663|NCT00372372|Risedronic Acid|risedronic acid|mesh-list
92389664|NCT00372372|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92389665|NCT00372372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389666|NCT00372372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389667|NCT00372372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92389668|NCT00372372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389669|NCT00372372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92389670|NCT00372762|Furosemide|furosemide|mesh-list
92389671|NCT00372762|Bumetanide|bumetanide|mesh-list
92389672|NCT00372762|Diuretics|diuretics|mesh-ancestor
92389673|NCT00372762|Natriuretic Agents|natriuretic agents|mesh-ancestor
92389674|NCT00372762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389675|NCT00372762|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92389676|NCT00372762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389677|NCT00372762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389678|NCT00373464|Etoricoxib|etoricoxib|mesh-list
92389679|NCT00373464|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92389680|NCT00373464|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389681|NCT00373464|Analgesics|analgesics|mesh-ancestor
92389682|NCT00373464|Sensory System Agents|sensory system agents|mesh-ancestor
92389683|NCT00373464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389684|NCT00373464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389685|NCT00373464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389686|NCT00373464|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92389687|NCT00373464|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92389688|NCT00373464|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92389689|NCT00373464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389690|NCT00373464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389691|NCT00373620|Paclitaxel|paclitaxel|mesh-list
92389692|NCT00373620|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92389693|NCT00373620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389694|NCT00373620|Tubulin Modulators|tubulin modulators|mesh-ancestor
92389695|NCT00373620|Antimitotic Agents|antimitotic agents|mesh-ancestor
92389696|NCT00373620|Mitosis Modulators|mitosis modulators|mesh-ancestor
92389697|NCT00373620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389698|NCT00373776|Miltefosine|miltefosine|mesh-list
92389699|NCT00373776|Antifungal Agents|antifungal agents|mesh-ancestor
92389700|NCT00373776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389701|NCT00373776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389702|NCT00373776|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92389703|NCT00373776|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92389704|NCT00374478|Scopolamine|scopolamine|mesh-list
92389705|NCT00374478|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92389706|NCT00374478|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92389707|NCT00374478|Antiemetics|antiemetics|mesh-ancestor
92389708|NCT00374478|Autonomic Agents|autonomic agents|mesh-ancestor
92389709|NCT00374478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389710|NCT00374478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389711|NCT00374478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389712|NCT00374478|Mydriatics|mydriatics|mesh-ancestor
92389713|NCT00374478|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92389714|NCT00374478|Cholinergic Agents|cholinergic agents|mesh-ancestor
92389715|NCT00374478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389716|NCT00374478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389717|NCT00374478|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92389718|NCT00374478|Parasympatholytics|parasympatholytics|mesh-ancestor
92389719|NCT00373542|Ropinirole|ropinirole|mesh-list
92389720|NCT00373542|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92389721|NCT00373542|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92389722|NCT00373542|Dopamine Agonists|dopamine agonists|mesh-ancestor
92389723|NCT00373542|Dopamine Agents|dopamine agents|mesh-ancestor
92389724|NCT00373542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389725|NCT00373542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041070|NCT03915964|Adalimumab|adalimumab|mesh-list
92389726|NCT00373542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389727|NCT00375258|Tranexamic Acid|tranexamic acid|mesh-list
92389728|NCT00375258|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92389729|NCT00375258|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92389730|NCT00375258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389731|NCT00375258|Hemostatics|hemostatics|mesh-ancestor
92389732|NCT00375258|Coagulants|coagulants|mesh-ancestor
92389733|NCT00375648|Zoledronic Acid|zoledronic acid|mesh-list
92389734|NCT00375648|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92389735|NCT00375648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389736|NCT00376038|Metformin|metformin|mesh-list
92389737|NCT00376038|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389738|NCT00376038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389739|NCT00376272|Valsartan|valsartan|mesh-list
92389740|NCT00376272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92389741|NCT00376272|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92389742|NCT00376272|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92389743|NCT00376272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389744|NCT00376428|Gentamicins|gentamicins|mesh-list
92389745|NCT00376428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92389746|NCT00376428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389747|NCT00376428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92389748|NCT00376428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389749|NCT00376428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389750|NCT00376584|Niacin|niacin|mesh-list
92389751|NCT00376584|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92389752|NCT00376584|Antimetabolites|antimetabolites|mesh-ancestor
92389753|NCT00376584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389754|NCT00376584|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92389755|NCT00376584|Vasodilator Agents|vasodilator agents|mesh-ancestor
92389756|NCT00376584|Vitamin B Complex|vitamin b complex|mesh-ancestor
92389757|NCT00376584|Vitamins|vitamins|mesh-ancestor
92389758|NCT00376584|Micronutrients|micronutrients|mesh-ancestor
92389759|NCT00376584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389760|NCT00376662|Etidronic Acid|etidronic acid|mesh-list
92389761|NCT00376662|Hormones|hormones|mesh-list
92389762|NCT00376662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389763|NCT00376662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389764|NCT00376662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92389765|NCT00376740|Zoledronic Acid|zoledronic acid|mesh-list
92389766|NCT00376740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92389767|NCT00376740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389768|NCT00376818|Hormones|hormones|mesh-list
92389769|NCT00376818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389770|NCT00376818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389771|NCT00377052|Gemcitabine|gemcitabine|mesh-list
92389772|NCT00377052|Bortezomib|bortezomib|mesh-list
92389773|NCT00377052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389774|NCT00377052|Antimetabolites|antimetabolites|mesh-ancestor
92389775|NCT00377052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389776|NCT00377052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389777|NCT00377442|Simvastatin|simvastatin|mesh-list
92389778|NCT00377442|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92389779|NCT00377442|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92389780|NCT00377442|Antimetabolites|antimetabolites|mesh-ancestor
92389781|NCT00377442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389782|NCT00377442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92389783|NCT00377442|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92389784|NCT00377442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389785|NCT00377910|Lidocaine|lidocaine|mesh-list
92389786|NCT00377910|Polidocanol|polidocanol|mesh-list
92389787|NCT00377910|Anesthetics, Local|anesthetics, local|mesh-ancestor
92389788|NCT00377910|Anesthetics|anesthetics|mesh-ancestor
92389789|NCT00377910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389790|NCT00377910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389791|NCT00377910|Sensory System Agents|sensory system agents|mesh-ancestor
92389792|NCT00377910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389793|NCT00377910|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92389794|NCT00377910|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92389795|NCT00377910|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92389796|NCT00377910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389797|NCT00377910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389798|NCT00377910|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92389799|NCT00377910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92389800|NCT00377988|Contraceptive Agents|contraceptive agents|mesh-list
92389801|NCT00377988|Norgestimate|norgestimate|mesh-list
92389802|NCT00377988|Contraceptives, Oral|contraceptives, oral|mesh-list
92389803|NCT00377988|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92389804|NCT00377988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389805|NCT00377988|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92389806|NCT00377988|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92389807|NCT00377988|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92042226|NCT01726270|Urological Agents|urological agents|mesh-ancestor
92389809|NCT00378066|Capecitabine|capecitabine|mesh-list
92389810|NCT00378066|Oxaliplatin|oxaliplatin|mesh-list
92389811|NCT00378066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92389812|NCT00378066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389813|NCT00378066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92389814|NCT00378066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92389815|NCT00378066|Growth Substances|growth substances|mesh-ancestor
92389816|NCT00378066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389817|NCT00378066|Growth Inhibitors|growth inhibitors|mesh-ancestor
92389818|NCT00378066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92389819|NCT00378066|Antimetabolites|antimetabolites|mesh-ancestor
92389820|NCT00378066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389821|NCT00378144|Acetaminophen|acetaminophen|mesh-list
92389822|NCT00378144|Pseudoephedrine|pseudoephedrine|mesh-list
92389823|NCT00378144|Ephedrine|ephedrine|mesh-list
92389824|NCT00378144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92389825|NCT00378144|Analgesics|analgesics|mesh-ancestor
92389826|NCT00378144|Sensory System Agents|sensory system agents|mesh-ancestor
92389827|NCT00378144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389828|NCT00378144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389829|NCT00378144|Antipyretics|antipyretics|mesh-ancestor
92389830|NCT00378144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92389831|NCT00378144|Autonomic Agents|autonomic agents|mesh-ancestor
92389832|NCT00378144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92389833|NCT00378144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92389834|NCT00378144|Nasal Decongestants|nasal decongestants|mesh-ancestor
92389835|NCT00378144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92389836|NCT00378144|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92389837|NCT00378144|Sympathomimetics|sympathomimetics|mesh-ancestor
92389838|NCT00378144|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389839|NCT00378144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389840|NCT00378144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389841|NCT00378456|Vitamins|vitamins|mesh-list
92389842|NCT00378456|Leucovorin|leucovorin|mesh-list
92389843|NCT00378456|Folic Acid|folic acid|mesh-list
92389844|NCT00378456|Vitamin A|vitamin a|mesh-list
92389846|NCT00378456|Selenium|selenium|mesh-list
92389847|NCT00378456|Retinol palmitate|retinol palmitate|mesh-list
92389848|NCT00378456|Levoleucovorin|levoleucovorin|mesh-list
92389849|NCT00378456|Antioxidants|antioxidants|mesh-list
92389850|NCT00378456|Micronutrients|micronutrients|mesh-ancestor
92389851|NCT00378456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389852|NCT00378456|Trace Elements|trace elements|mesh-ancestor
92389853|NCT00378456|Antidotes|antidotes|mesh-ancestor
92389854|NCT00378456|Protective Agents|protective agents|mesh-ancestor
92389855|NCT00378456|Vitamin B Complex|vitamin b complex|mesh-ancestor
92389856|NCT00378456|Hematinics|hematinics|mesh-ancestor
92389857|NCT00378456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389858|NCT00378456|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92389859|NCT00378456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389861|NCT00378612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92389862|NCT00378612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937916|NCT05337566|Cefuroxime|cefuroxime|mesh-list
92389863|NCT00378612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92389864|NCT00378612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389865|NCT00378612|Antifungal Agents|antifungal agents|mesh-ancestor
92389866|NCT00378612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389867|NCT00378612|Immunologic Factors|immunologic factors|mesh-ancestor
92389868|NCT00378612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389869|NCT00378690|Leuprolide|leuprolide|mesh-list
92389870|NCT00378690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92389871|NCT00378690|Fertility Agents|fertility agents|mesh-ancestor
92389872|NCT00378690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92389873|NCT00378690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389874|NCT00378690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389875|NCT00378690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389876|NCT00378768|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92389877|NCT00378768|Immunologic Factors|immunologic factors|mesh-ancestor
92389878|NCT00378768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389879|NCT00378768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92389880|NCT00379158|Micronutrients|micronutrients|mesh-list
92389881|NCT00379158|Trace Elements|trace elements|mesh-list
92042304|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
92389882|NCT00379158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389883|NCT00379626|Hormones|hormones|mesh-list
92389884|NCT00379626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389885|NCT00379626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389887|NCT00380406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92389888|NCT00380406|Fertility Agents|fertility agents|mesh-ancestor
92389889|NCT00380406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92389890|NCT00380406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389891|NCT00380406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92389892|NCT00380406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389893|NCT00380484|Budesonide|budesonide|mesh-list
92389894|NCT00380484|Montelukast|montelukast|mesh-list
92389895|NCT00380484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92389896|NCT00380484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92389897|NCT00380484|Autonomic Agents|autonomic agents|mesh-ancestor
92389898|NCT00380484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389899|NCT00380484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389900|NCT00380484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92389901|NCT00380484|Respiratory System Agents|respiratory system agents|mesh-ancestor
92389902|NCT00380484|Glucocorticoids|glucocorticoids|mesh-ancestor
92389903|NCT00380484|Hormones|hormones|mesh-ancestor
92389904|NCT00380484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389905|NCT00380484|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92389906|NCT00380484|Hormone Antagonists|hormone antagonists|mesh-ancestor
92389907|NCT00380484|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92389908|NCT00380484|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92389909|NCT00380484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389910|NCT00380640|Trimethoprim|trimethoprim|mesh-list
92389911|NCT00380640|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92389912|NCT00380640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92389913|NCT00380640|Antimalarials|antimalarials|mesh-ancestor
92389914|NCT00380640|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92389915|NCT00380640|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92389916|NCT00380640|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92389917|NCT00380640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389918|NCT00380640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389919|NCT00380640|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92389920|NCT00380640|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92389921|NCT00380640|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92389922|NCT00381030|Carvedilol|carvedilol|mesh-list
92389923|NCT00381030|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92389924|NCT00381030|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92389925|NCT00381030|Adrenergic Agents|adrenergic agents|mesh-ancestor
92389926|NCT00381030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92389927|NCT00381030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389928|NCT00381030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389929|NCT00381030|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92389930|NCT00381030|Antioxidants|antioxidants|mesh-ancestor
92389931|NCT00381030|Protective Agents|protective agents|mesh-ancestor
92389932|NCT00381030|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92389933|NCT00381030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92389934|NCT00381030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92389935|NCT00381030|Vasodilator Agents|vasodilator agents|mesh-ancestor
92389936|NCT00381030|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92389937|NCT00381030|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92389938|NCT00381264|Nabilone|nabilone|mesh-list
92389939|NCT00381264|Antiemetics|antiemetics|mesh-ancestor
92389940|NCT00381264|Autonomic Agents|autonomic agents|mesh-ancestor
92389941|NCT00381264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92389942|NCT00381264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389943|NCT00381264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389944|NCT00381264|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92389945|NCT00381264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92389946|NCT00381264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92389947|NCT00381264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92389948|NCT00381342|Exenatide|exenatide|mesh-list
92389949|NCT00381342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92389950|NCT00381342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389951|NCT00381342|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92389952|NCT00381342|Incretins|incretins|mesh-ancestor
92389953|NCT00381342|Hormones|hormones|mesh-ancestor
92389954|NCT00381342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389955|NCT00381654|MP 412|mp 412|mesh-list
92389956|NCT00381654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389957|NCT00381654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92389958|NCT00381654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389959|NCT00381654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389961|NCT00381732|Vasodilator Agents|vasodilator agents|mesh-ancestor
92389962|NCT00381732|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92389963|NCT00381732|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92389964|NCT00381732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389965|NCT00381732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389966|NCT00381732|Urological Agents|urological agents|mesh-ancestor
92389967|NCT00382044|Darbepoetin alfa|darbepoetin alfa|mesh-list
92389968|NCT00382044|Hematinics|hematinics|mesh-ancestor
92389969|NCT00382356|Dutasteride|dutasteride|mesh-list
92389970|NCT00382356|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92389971|NCT00382356|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92389972|NCT00382356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389973|NCT00382356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389974|NCT00382356|Hormone Antagonists|hormone antagonists|mesh-ancestor
92389975|NCT00382356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92389976|NCT00382356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389977|NCT00382668|Dasatinib|dasatinib|mesh-list
92389978|NCT00382668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389979|NCT00382668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92389980|NCT00382668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92389981|NCT00382668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389982|NCT00382980|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92389983|NCT00382980|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92389984|NCT00382980|Immunologic Factors|immunologic factors|mesh-ancestor
92389985|NCT00382980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92389986|NCT00382980|Antacids|antacids|mesh-ancestor
92389987|NCT00382980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389988|NCT00382980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92389989|NCT00383136|Tirofiban|tirofiban|mesh-list
92389990|NCT00383136|Abciximab|abciximab|mesh-list
92389991|NCT00383136|Anticoagulants|anticoagulants|mesh-ancestor
92389992|NCT00383136|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92389993|NCT00383136|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92389994|NCT00383136|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92389995|NCT00383136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92389996|NCT00383214|Epratuzumab|epratuzumab|mesh-list
92389997|NCT00383214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92389998|NCT00383214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92389999|NCT00383370|Aflibercept|aflibercept|mesh-list
92390000|NCT00383370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92390001|NCT00383370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92390002|NCT00383370|Growth Substances|growth substances|mesh-ancestor
92390003|NCT00383370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390004|NCT00383370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92390005|NCT00383370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390007|NCT00383526|Immunologic Factors|immunologic factors|mesh-ancestor
92390008|NCT00383526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390009|NCT00383682|Mexiletine|mexiletine|mesh-list
92390010|NCT00383682|Morphine|morphine|mesh-list
92390011|NCT00383682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92390012|NCT00383682|Narcotics|narcotics|mesh-ancestor
92390013|NCT00383682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390014|NCT00383682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390015|NCT00383682|Analgesics|analgesics|mesh-ancestor
92390016|NCT00383682|Sensory System Agents|sensory system agents|mesh-ancestor
92390017|NCT00383682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390018|NCT00383682|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92390019|NCT00383682|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92390020|NCT00383682|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92390021|NCT00383682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390022|NCT00383682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390023|NCT00383916|Pantoprazole|pantoprazole|mesh-list
92390024|NCT00383916|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92390025|NCT00383916|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390026|NCT00383916|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92390027|NCT00383916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390028|NCT00383916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390029|NCT00383994|Rituximab|rituximab|mesh-list
92390030|NCT00383994|Sargramostim|sargramostim|mesh-list
92390031|NCT00383994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042453|NCT04885907|Vaccines|vaccines|mesh-list
92390032|NCT00383994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390033|NCT00383994|Immunologic Factors|immunologic factors|mesh-ancestor
92390034|NCT00383994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390035|NCT00383994|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390036|NCT00384072|Bazedoxifene|bazedoxifene|mesh-list
92390037|NCT00384072|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92390038|NCT00384072|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92390039|NCT00384072|Hormone Antagonists|hormone antagonists|mesh-ancestor
92390040|NCT00384072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390041|NCT00384072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390042|NCT00384072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92390043|NCT00384306|Prednisolone|prednisolone|mesh-list
92390044|NCT00384306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390045|NCT00384306|Glucocorticoids|glucocorticoids|mesh-ancestor
92390046|NCT00384306|Hormones|hormones|mesh-ancestor
92390047|NCT00384306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390048|NCT00384306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390049|NCT00384306|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92390050|NCT00384306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390051|NCT00384384|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
92390052|NCT00384384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390053|NCT00384540|Dobutamine|dobutamine|mesh-list
92390054|NCT00384540|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92390055|NCT00384540|Sympathomimetics|sympathomimetics|mesh-ancestor
92390056|NCT00384540|Autonomic Agents|autonomic agents|mesh-ancestor
92390057|NCT00384540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390058|NCT00384540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390059|NCT00384540|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92390060|NCT00384540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92390061|NCT00384540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92390062|NCT00384540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390063|NCT00384540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390064|NCT00384540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390065|NCT00384540|Protective Agents|protective agents|mesh-ancestor
92390066|NCT00384618|Vitamin E|vitamin e|mesh-list
92390067|NCT00384618|Pravastatin|pravastatin|mesh-list
92390068|NCT00384618|Vitamins|vitamins|mesh-ancestor
92390069|NCT00384618|Micronutrients|micronutrients|mesh-ancestor
92390070|NCT00384618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390071|NCT00384618|Antioxidants|antioxidants|mesh-ancestor
92390072|NCT00384618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390073|NCT00384618|Protective Agents|protective agents|mesh-ancestor
92390074|NCT00384618|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92390075|NCT00384618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92390076|NCT00384618|Antimetabolites|antimetabolites|mesh-ancestor
92390077|NCT00384618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92390078|NCT00384618|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92390080|NCT00384696|Nicotine|nicotine|mesh-list
92390081|NCT00384696|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92390082|NCT00384696|Autonomic Agents|autonomic agents|mesh-ancestor
92390083|NCT00384696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390084|NCT00384696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390085|NCT00384696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92390086|NCT00384696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92390087|NCT00384696|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390088|NCT00384696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390089|NCT00384696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390090|NCT00385086|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92390091|NCT00385086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390093|NCT00385398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92390094|NCT00385398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92390095|NCT00385398|Alkylating Agents|alkylating agents|mesh-ancestor
92390096|NCT00385398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390097|NCT00385398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390098|NCT00385398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390099|NCT00385398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390100|NCT00385554|UC-781|uc-781|mesh-list
92390101|NCT00385554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92390102|NCT00385554|Antiviral Agents|antiviral agents|mesh-ancestor
92390103|NCT00385554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390104|NCT00385632|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92390105|NCT00385632|Antiviral Agents|antiviral agents|mesh-ancestor
92390106|NCT00385632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390107|NCT00385710|Valproic Acid|valproic acid|mesh-list
92390108|NCT00385710|Anticonvulsants|anticonvulsants|mesh-ancestor
92390109|NCT00385710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390110|NCT00385710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390111|NCT00385710|GABA Agents|gaba agents|mesh-ancestor
92390112|NCT00385710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390113|NCT00385710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390114|NCT00385710|Antimanic Agents|antimanic agents|mesh-ancestor
92390115|NCT00385710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92390116|NCT00385710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390117|NCT00385710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390118|NCT00386178|Vitamin E|vitamin e|mesh-list
92390119|NCT00386178|Tocopherols|tocopherols|mesh-list
92390120|NCT00386178|Tocotrienols|tocotrienols|mesh-list
92390121|NCT00386178|alpha-Tocopherol|alpha-tocopherol|mesh-list
92390122|NCT00386178|gamma-Tocopherol|gamma-tocopherol|mesh-list
92390123|NCT00386178|Vitamins|vitamins|mesh-ancestor
92390124|NCT00386178|Micronutrients|micronutrients|mesh-ancestor
92390125|NCT00386178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390126|NCT00386178|Antioxidants|antioxidants|mesh-ancestor
92390127|NCT00386178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390128|NCT00386178|Protective Agents|protective agents|mesh-ancestor
92390129|NCT00421824|Capecitabine|capecitabine|mesh-list
92390130|NCT00421824|Oxaliplatin|oxaliplatin|mesh-list
92390131|NCT00421824|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92390132|NCT00421824|Antimetabolites|antimetabolites|mesh-ancestor
92390133|NCT00421824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390134|NCT00421824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390135|NCT00421980|Etanercept|etanercept|mesh-list
92390136|NCT00421980|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92390137|NCT00421980|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92390138|NCT00421980|Analgesics|analgesics|mesh-ancestor
92390139|NCT00421980|Sensory System Agents|sensory system agents|mesh-ancestor
92390140|NCT00421980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390141|NCT00421980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390142|NCT00421980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390143|NCT00421980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390144|NCT00421980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390145|NCT00421980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92390146|NCT00421980|Immunologic Factors|immunologic factors|mesh-ancestor
92390147|NCT00422214|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92390148|NCT00422214|Antidepressive Agents|antidepressive agents|mesh-ancestor
92390149|NCT00422214|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390150|NCT00422214|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92390151|NCT00422214|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92390152|NCT00422214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390153|NCT00422214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390154|NCT00422526|Progesterone|progesterone|mesh-list
92390156|NCT00422526|Hormones|hormones|mesh-ancestor
92390157|NCT00422526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390158|NCT00422526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390159|NCT00422604|Tiotropium Bromide|tiotropium bromide|mesh-list
92390160|NCT00422604|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92390161|NCT00422604|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92390162|NCT00422604|Autonomic Agents|autonomic agents|mesh-ancestor
92390163|NCT00422604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390164|NCT00422604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390165|NCT00422604|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92390166|NCT00422604|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390167|NCT00422604|Parasympatholytics|parasympatholytics|mesh-ancestor
92390168|NCT00422604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92390169|NCT00422604|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390170|NCT00422604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390171|NCT00422604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390172|NCT00422604|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92390173|NCT00422604|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92390174|NCT00422604|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92390175|NCT00422604|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390176|NCT00422682|Paclitaxel|paclitaxel|mesh-list
92390177|NCT00422682|Carboplatin|carboplatin|mesh-list
92390178|NCT00422682|Gemcitabine|gemcitabine|mesh-list
92390179|NCT00422682|Temozolomide|temozolomide|mesh-list
92390180|NCT00422682|Topotecan|topotecan|mesh-list
92390181|NCT00422682|Iniparib|iniparib|mesh-list
92390182|NCT00422682|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92390183|NCT00422682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390184|NCT00422682|Tubulin Modulators|tubulin modulators|mesh-ancestor
92390186|NCT00422682|Mitosis Modulators|mitosis modulators|mesh-ancestor
92390187|NCT00422682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390188|NCT00422682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92390189|NCT00422682|Antimetabolites|antimetabolites|mesh-ancestor
92390190|NCT00422682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92390191|NCT00422682|Alkylating Agents|alkylating agents|mesh-ancestor
92390192|NCT00422682|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92390193|NCT00422682|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92390194|NCT00422682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390195|NCT00422682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92390197|NCT00422994|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92390198|NCT00422994|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92390199|NCT00422994|Dopamine Agonists|dopamine agonists|mesh-ancestor
92390200|NCT00422994|Dopamine Agents|dopamine agents|mesh-ancestor
92390201|NCT00422994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390202|NCT00422994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390203|NCT00422994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390204|NCT00423228|Donepezil|donepezil|mesh-list
92390205|NCT00423228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92390206|NCT00423228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390207|NCT00423228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390208|NCT00423228|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390209|NCT00423228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390210|NCT00423228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390211|NCT00423228|Nootropic Agents|nootropic agents|mesh-ancestor
92390212|NCT01799616|Pamidronate|pamidronate|mesh-list
92390213|NCT01799616|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92390214|NCT01799616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390215|NCT01799850|Pioglitazone|pioglitazone|mesh-list
92390216|NCT01799850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92390217|NCT01799850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390218|NCT01792050|Paclitaxel|paclitaxel|mesh-list
92390219|NCT01792050|Docetaxel|docetaxel|mesh-list
92390220|NCT01792050|Tryptophan|tryptophan|mesh-list
92390221|NCT01792050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92390222|NCT01792050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390223|NCT01792050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92390224|NCT01792050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92390225|NCT01792050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92390226|NCT01792050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390227|NCT01792050|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92390228|NCT01792050|Antidepressive Agents|antidepressive agents|mesh-ancestor
92390229|NCT01792050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390230|NCT01790100|Ribavirin|ribavirin|mesh-list
92390231|NCT01790100|Antimetabolites|antimetabolites|mesh-ancestor
92390232|NCT01790100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390233|NCT01790100|Antiviral Agents|antiviral agents|mesh-ancestor
92390234|NCT01790100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390236|NCT01799460|Cyclophosphamide|cyclophosphamide|mesh-list
92390237|NCT01799460|Tacrolimus|tacrolimus|mesh-list
92390238|NCT01799460|Cyclosporins|cyclosporins|mesh-list
92390239|NCT01799460|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92390240|NCT01799460|Glucocorticoids|glucocorticoids|mesh-list
92390241|NCT01799460|Immunologic Factors|immunologic factors|mesh-ancestor
92390242|NCT01799460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390243|NCT01799460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390244|NCT01799460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92390245|NCT01799460|Alkylating Agents|alkylating agents|mesh-ancestor
92390246|NCT01799460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390247|NCT01799460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390248|NCT01799460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92390249|NCT01799460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92390250|NCT01799460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390251|NCT01799460|Antifungal Agents|antifungal agents|mesh-ancestor
92390252|NCT01799460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390253|NCT01799460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92390254|NCT01799460|Hormones|hormones|mesh-ancestor
92390255|NCT01799460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390256|NCT02999724|Gabapentin|gabapentin|mesh-list
92390257|NCT02999724|Analgesics|analgesics|mesh-ancestor
92390258|NCT02999724|Sensory System Agents|sensory system agents|mesh-ancestor
92390259|NCT02999724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390260|NCT02999724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390261|NCT02999724|Anticonvulsants|anticonvulsants|mesh-ancestor
92390262|NCT02999724|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92390263|NCT02999724|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92390264|NCT02999724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390265|NCT02999724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390266|NCT02999724|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92390267|NCT02999724|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92390268|NCT02999724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390269|NCT02999724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390270|NCT02999724|Antimanic Agents|antimanic agents|mesh-ancestor
92390271|NCT02999490|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92390272|NCT02999490|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92390273|NCT02999490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390275|NCT02998242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390276|NCT02998242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390277|NCT02998242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390278|NCT02998242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390279|NCT02998398|Infliximab|infliximab|mesh-list
92390280|NCT02998398|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92390281|NCT02998398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390282|NCT02998398|Dermatologic Agents|dermatologic agents|mesh-ancestor
92390283|NCT02998398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390284|NCT02998398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390285|NCT02998320|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92390286|NCT02998320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92390287|NCT02998320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92390288|NCT02998320|Antiviral Agents|antiviral agents|mesh-ancestor
92390289|NCT02998320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390290|NCT02996916|Amlodipine|amlodipine|mesh-list
92390291|NCT02996916|Olmesartan|olmesartan|mesh-list
92390292|NCT02996916|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92390293|NCT02996916|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92390294|NCT02996916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390295|NCT02996916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390296|NCT02996916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92390297|NCT02996916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390298|NCT02996916|Vasodilator Agents|vasodilator agents|mesh-ancestor
92390299|NCT02996916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92390300|NCT02996916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92390301|NCT02996214|Paclitaxel|paclitaxel|mesh-list
92390302|NCT02996214|Gemcitabine|gemcitabine|mesh-list
92390303|NCT02996214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92390304|NCT02996214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390306|NCT02996214|Antimitotic Agents|antimitotic agents|mesh-ancestor
92390307|NCT02996214|Mitosis Modulators|mitosis modulators|mesh-ancestor
92390308|NCT02996214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390309|NCT02996214|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92390310|NCT02996214|Antimetabolites|antimetabolites|mesh-ancestor
92390311|NCT02996058|Dexmedetomidine|dexmedetomidine|mesh-list
92390312|NCT02996058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92390313|NCT02996058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390314|NCT02996058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390315|NCT02996058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92390316|NCT02996058|Analgesics|analgesics|mesh-ancestor
92390317|NCT02996058|Sensory System Agents|sensory system agents|mesh-ancestor
92390318|NCT02996058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390319|NCT02996058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92390320|NCT02996058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92390321|NCT02996058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92390322|NCT02996058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390323|NCT02996058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390324|NCT02996058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390325|NCT02995512|Colchicine|colchicine|mesh-list
92390326|NCT02995512|Gout Suppressants|gout suppressants|mesh-ancestor
92390327|NCT02995512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390328|NCT02995512|Tubulin Modulators|tubulin modulators|mesh-ancestor
92390329|NCT02995512|Antimitotic Agents|antimitotic agents|mesh-ancestor
92390330|NCT02995512|Mitosis Modulators|mitosis modulators|mesh-ancestor
92390331|NCT02995512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390332|NCT02995512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390333|NCT02994888|Cetuximab|cetuximab|mesh-list
92390334|NCT02994888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390335|NCT02994888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390336|NCT02993718|Dexmedetomidine|dexmedetomidine|mesh-list
92390337|NCT02993718|Propofol|propofol|mesh-list
92390338|NCT02993718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92390339|NCT02993718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390340|NCT02993718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390341|NCT02993718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92390342|NCT02993718|Analgesics|analgesics|mesh-ancestor
92390343|NCT02993718|Sensory System Agents|sensory system agents|mesh-ancestor
92390344|NCT02993718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987136|NCT02345837|Zuclomiphene|zuclomiphene|mesh-list
92390345|NCT02993718|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92390346|NCT02993718|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92390347|NCT02993718|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92390348|NCT02993718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390349|NCT02993718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390350|NCT02993718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390351|NCT02993718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92390352|NCT02993718|Anesthetics, General|anesthetics, general|mesh-ancestor
92390353|NCT02993718|Anesthetics|anesthetics|mesh-ancestor
92390354|NCT02993640|Vasopressins|vasopressins|mesh-list
92390355|NCT02993640|Arginine Vasopressin|arginine vasopressin|mesh-list
92390356|NCT02993640|Hemostatics|hemostatics|mesh-ancestor
92390357|NCT02993640|Coagulants|coagulants|mesh-ancestor
92390358|NCT02993640|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92390359|NCT02993640|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92390360|NCT02993640|Natriuretic Agents|natriuretic agents|mesh-ancestor
92390361|NCT02993640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390362|NCT02993094|Carboplatin|carboplatin|mesh-list
92390363|NCT02993094|Ixazomib|ixazomib|mesh-list
92390364|NCT02993094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390365|NCT02993094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92390366|NCT02993094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390367|NCT02993094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390368|NCT02992938|Acetazolamide|acetazolamide|mesh-list
92390369|NCT02992938|Anticonvulsants|anticonvulsants|mesh-ancestor
92390370|NCT02992938|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92390371|NCT02992938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390372|NCT02992938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390373|NCT02992938|Diuretics|diuretics|mesh-ancestor
92390374|NCT02992938|Natriuretic Agents|natriuretic agents|mesh-ancestor
92390375|NCT02992938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390376|NCT02992704|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92390377|NCT02992704|Antiviral Agents|antiviral agents|mesh-ancestor
92390378|NCT02992704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390379|NCT02992548|Pravastatin|pravastatin|mesh-list
92390380|NCT02992548|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92390381|NCT02992548|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92390382|NCT02992548|Antimetabolites|antimetabolites|mesh-ancestor
92390383|NCT02992548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390384|NCT02992548|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92390385|NCT02992548|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92390386|NCT02992548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390388|NCT02992392|Anticoagulants|anticoagulants|mesh-ancestor
92390389|NCT02992392|Plasma Substitutes|plasma substitutes|mesh-ancestor
92390390|NCT02992392|Blood Substitutes|blood substitutes|mesh-ancestor
92390391|NCT02991768|Budesonide|budesonide|mesh-list
92390392|NCT02991768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390393|NCT02991768|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92390394|NCT02991768|Autonomic Agents|autonomic agents|mesh-ancestor
92390395|NCT02991768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390396|NCT02991768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390397|NCT02991768|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92390398|NCT02991768|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390399|NCT02991768|Glucocorticoids|glucocorticoids|mesh-ancestor
92390400|NCT02991768|Hormones|hormones|mesh-ancestor
92390401|NCT02991768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390402|NCT02991612|Rifaximin|rifaximin|mesh-list
92390403|NCT02991612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92390404|NCT02991612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390405|NCT02991612|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390406|NCT02990286|Mycophenolic Acid|mycophenolic acid|mesh-list
92390407|NCT02990286|Rituximab|rituximab|mesh-list
92390408|NCT02990286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390409|NCT02990286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390410|NCT02990286|Immunologic Factors|immunologic factors|mesh-ancestor
92390411|NCT02990286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390412|NCT02990286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390413|NCT02990286|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92390414|NCT02990286|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92390415|NCT02990286|Antitubercular Agents|antitubercular agents|mesh-ancestor
92390416|NCT02990286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92390417|NCT02990286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390418|NCT02990286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390419|NCT02990286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390420|NCT02999958|Thioctic Acid|thioctic acid|mesh-list
92390421|NCT02999958|Acetylcarnitine|acetylcarnitine|mesh-list
92390422|NCT02999958|Acetylcysteine|acetylcysteine|mesh-list
92390423|NCT02999958|Antioxidants|antioxidants|mesh-list
92390424|NCT02999958|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92390425|NCT02999958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390426|NCT02999958|Protective Agents|protective agents|mesh-ancestor
92390427|NCT02999958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390428|NCT02999958|Vitamin B Complex|vitamin b complex|mesh-ancestor
92390429|NCT02999958|Vitamins|vitamins|mesh-ancestor
92390430|NCT02999958|Micronutrients|micronutrients|mesh-ancestor
92390431|NCT02999958|Nootropic Agents|nootropic agents|mesh-ancestor
92390432|NCT02999958|Antiviral Agents|antiviral agents|mesh-ancestor
92390433|NCT02999958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390434|NCT02999958|Expectorants|expectorants|mesh-ancestor
92390435|NCT02999958|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390436|NCT02999958|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92390437|NCT02999958|Antidotes|antidotes|mesh-ancestor
92390438|NCT02995746|Dexamethasone|dexamethasone|mesh-list
92390439|NCT02995746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390440|NCT02995746|Antiemetics|antiemetics|mesh-ancestor
92390441|NCT02995746|Autonomic Agents|autonomic agents|mesh-ancestor
92390442|NCT02995746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390443|NCT02995746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390444|NCT02995746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390445|NCT02995746|Glucocorticoids|glucocorticoids|mesh-ancestor
92390446|NCT02995746|Hormones|hormones|mesh-ancestor
92390447|NCT02995746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390448|NCT02995746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92390449|NCT02995746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390450|NCT02990364|Lidocaine|lidocaine|mesh-list
92390451|NCT02990364|Anesthetics, Local|anesthetics, local|mesh-list
92390452|NCT02990364|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92390453|NCT02990364|Anesthetics|anesthetics|mesh-list
92390454|NCT02990364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390455|NCT02990364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390456|NCT02990364|Sensory System Agents|sensory system agents|mesh-ancestor
92390457|NCT02990364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390458|NCT02990364|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92390459|NCT02990364|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92390460|NCT02990364|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92390461|NCT02990364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390462|NCT02990364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390463|NCT02990364|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92390464|NCT01270074|Azithromycin|azithromycin|mesh-list
92390465|NCT01270074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92390466|NCT01270074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390467|NCT01270308|Lansoprazole|lansoprazole|mesh-list
92390468|NCT01270308|Dexlansoprazole|dexlansoprazole|mesh-list
92390469|NCT01270308|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92390470|NCT01270308|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390471|NCT01270308|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92390472|NCT01270308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390473|NCT01270308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390474|NCT01270386|Apatinib|apatinib|mesh-list
92390475|NCT01270386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390476|NCT01270386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390477|NCT01270386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390478|NCT01270386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390479|NCT01270854|Plasma-lyte 148|plasma-lyte 148|mesh-list
92390480|NCT01270854|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92390481|NCT01270854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92042911|NCT02301143|Paclitaxel|paclitaxel|mesh-list
92390482|NCT01270932|Dexamethasone|dexamethasone|mesh-list
92390483|NCT01270932|Dexamethasone acetate|dexamethasone acetate|mesh-list
92390484|NCT01270932|Lenalidomide|lenalidomide|mesh-list
92390485|NCT01270932|BB 1101|bb 1101|mesh-list
92390486|NCT01270932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390487|NCT01270932|Antiemetics|antiemetics|mesh-ancestor
92390488|NCT01270932|Autonomic Agents|autonomic agents|mesh-ancestor
92390489|NCT01270932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390490|NCT01270932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390491|NCT01270932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390492|NCT01270932|Glucocorticoids|glucocorticoids|mesh-ancestor
92390493|NCT01270932|Hormones|hormones|mesh-ancestor
92390494|NCT01270932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390495|NCT01270932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92390496|NCT01270932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390497|NCT01270932|Protease Inhibitors|protease inhibitors|mesh-ancestor
92390498|NCT01270932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390499|NCT01270932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390500|NCT01270932|Immunologic Factors|immunologic factors|mesh-ancestor
92390501|NCT01270932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92390502|NCT01270932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92390503|NCT01270932|Growth Substances|growth substances|mesh-ancestor
92390504|NCT01270932|Growth Inhibitors|growth inhibitors|mesh-ancestor
92390505|NCT01271088|Acetylcysteine|acetylcysteine|mesh-list
92390506|NCT01271088|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92390507|NCT01271088|Antiviral Agents|antiviral agents|mesh-ancestor
92390508|NCT01271088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390509|NCT01271088|Expectorants|expectorants|mesh-ancestor
92390510|NCT01271088|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390511|NCT01271088|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92390512|NCT01271088|Antioxidants|antioxidants|mesh-ancestor
92390513|NCT01271088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390514|NCT01271088|Protective Agents|protective agents|mesh-ancestor
92390515|NCT01271088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390516|NCT01271088|Antidotes|antidotes|mesh-ancestor
92390517|NCT01271166|Leucovorin|leucovorin|mesh-list
92390518|NCT01271166|Bevacizumab|bevacizumab|mesh-list
92390519|NCT01271166|Fluorouracil|fluorouracil|mesh-list
92390520|NCT01271166|Oxaliplatin|oxaliplatin|mesh-list
92390521|NCT01271166|Imatinib Mesylate|imatinib mesylate|mesh-list
92390522|NCT01271166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390523|NCT01271166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390524|NCT01271166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92390525|NCT01271166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92390526|NCT01271166|Growth Substances|growth substances|mesh-ancestor
92390527|NCT01271166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390528|NCT01271166|Growth Inhibitors|growth inhibitors|mesh-ancestor
92390529|NCT01271166|Antimetabolites|antimetabolites|mesh-ancestor
92390530|NCT01271166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390531|NCT01271166|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92390533|NCT01271166|Immunologic Factors|immunologic factors|mesh-ancestor
92390534|NCT01271166|Antidotes|antidotes|mesh-ancestor
92390535|NCT01271166|Protective Agents|protective agents|mesh-ancestor
92390536|NCT01271166|Vitamin B Complex|vitamin b complex|mesh-ancestor
92390537|NCT01271166|Vitamins|vitamins|mesh-ancestor
92390538|NCT01271166|Micronutrients|micronutrients|mesh-ancestor
92390539|NCT01271166|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390540|NCT01271166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390541|NCT01271556|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92390542|NCT01271556|Bronchodilator Agents|bronchodilator agents|mesh-list
92390543|NCT01271556|Autonomic Agents|autonomic agents|mesh-ancestor
92390544|NCT01271556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390545|NCT01271556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390546|NCT01271556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92390547|NCT01271556|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390548|NCT01271556|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92390549|NCT01271556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92390550|NCT01271556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92390551|NCT01271556|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390552|NCT01271556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390553|NCT01271556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390554|NCT01272258|Leronlimab|leronlimab|mesh-list
92390555|NCT01272258|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92390556|NCT01272258|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92390557|NCT01272258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390558|NCT01272258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92390559|NCT01272258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92390560|NCT01272258|Antiviral Agents|antiviral agents|mesh-ancestor
92390561|NCT01272258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390562|NCT01272414|Botulinum Toxins|botulinum toxins|mesh-list
92390563|NCT01272414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92390564|NCT01272414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92390565|NCT01272414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92390566|NCT01272414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390567|NCT01272414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390568|NCT01272414|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390569|NCT01272414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390570|NCT01272414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390571|NCT01272414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92390572|NCT01272414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390573|NCT01273506|Tapentadol|tapentadol|mesh-list
92390574|NCT01273506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92390575|NCT01273506|Narcotics|narcotics|mesh-ancestor
92390576|NCT01273506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390577|NCT01273506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390578|NCT01273506|Analgesics|analgesics|mesh-ancestor
92390579|NCT01273506|Sensory System Agents|sensory system agents|mesh-ancestor
92134401|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
92390580|NCT01273506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390581|NCT01273506|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92390582|NCT01273506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92390583|NCT01273506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390584|NCT01273506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390585|NCT01273506|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390586|NCT01273506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390587|NCT01273662|Axitinib|axitinib|mesh-list
92390588|NCT01273662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390589|NCT01273662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390590|NCT01273662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390591|NCT01273662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390592|NCT01273974|Vaccines|vaccines|mesh-list
92390593|NCT01273974|Immunologic Factors|immunologic factors|mesh-ancestor
92390594|NCT01273974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390595|NCT01274130|Metformin|metformin|mesh-list
92390596|NCT01274130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92390597|NCT01274130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390598|NCT01276080|Donepezil|donepezil|mesh-list
92390599|NCT01276080|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92390600|NCT01276080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390601|NCT01276080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390602|NCT01276080|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390603|NCT01276080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390604|NCT01276080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390605|NCT01276080|Nootropic Agents|nootropic agents|mesh-ancestor
92390606|NCT01276548|Carboplatin|carboplatin|mesh-list
92390607|NCT01276548|genexol-PM|genexol-pm|mesh-list
92390608|NCT01276548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390609|NCT01276548|Tubulin Modulators|tubulin modulators|mesh-ancestor
92390610|NCT01276548|Antimitotic Agents|antimitotic agents|mesh-ancestor
92390611|NCT01276548|Mitosis Modulators|mitosis modulators|mesh-ancestor
92390612|NCT01276548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390613|NCT01276704|Secoisolariciresinol|secoisolariciresinol|mesh-list
92390614|NCT01276704|Phytoestrogens|phytoestrogens|mesh-ancestor
92390615|NCT01276704|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92390616|NCT01276704|Estrogens|estrogens|mesh-ancestor
92390617|NCT01276704|Hormones|hormones|mesh-ancestor
92390618|NCT01276704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390619|NCT01276704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390620|NCT01277172|Rituximab|rituximab|mesh-list
92390621|NCT01277172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92390622|NCT01277172|Antibodies|antibodies|mesh-list
92390623|NCT01277172|Immunoglobulins|immunoglobulins|mesh-list
92390624|NCT01277172|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92390625|NCT01277172|Immunologic Factors|immunologic factors|mesh-ancestor
92390626|NCT01277172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390627|NCT01277172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390628|NCT01277172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390629|NCT01277640|Dapivirine|dapivirine|mesh-list
92390630|NCT01277640|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92390631|NCT01277640|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92390632|NCT01277640|Antiviral Agents|antiviral agents|mesh-ancestor
92390633|NCT01277640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390634|NCT01278576|Botulinum Toxins|botulinum toxins|mesh-list
92390635|NCT01278576|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92390637|NCT01278576|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92390638|NCT01278576|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390639|NCT01278576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390640|NCT01278576|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390641|NCT01278576|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390642|NCT01278576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390643|NCT01278576|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92390644|NCT01278576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390645|NCT01279434|Vitamins|vitamins|mesh-list
92390646|NCT01279434|Vitamin E|vitamin e|mesh-list
92390647|NCT01279434|Tocopherols|tocopherols|mesh-list
92390648|NCT01279434|Tocotrienols|tocotrienols|mesh-list
92390649|NCT01279434|alpha-Tocopherol|alpha-tocopherol|mesh-list
92390650|NCT01279434|Micronutrients|micronutrients|mesh-ancestor
92390651|NCT01279434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390652|NCT01279434|Antioxidants|antioxidants|mesh-ancestor
92390653|NCT01279434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390654|NCT01279434|Protective Agents|protective agents|mesh-ancestor
92390655|NCT01279512|Metformin|metformin|mesh-list
92390656|NCT01279512|Acarbose|acarbose|mesh-list
92390657|NCT01279512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92390658|NCT01279512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390659|NCT01279512|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92390660|NCT01279512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390661|NCT01279512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390662|NCT01279668|Montelukast|montelukast|mesh-list
92390663|NCT01279668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92390664|NCT01279668|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390665|NCT01279668|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92390666|NCT01279668|Hormone Antagonists|hormone antagonists|mesh-ancestor
92390667|NCT01279668|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390668|NCT01279668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390669|NCT01279668|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92390670|NCT01279668|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92390671|NCT01279668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390672|NCT01279902|Rituximab|rituximab|mesh-list
92390673|NCT01279902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390674|NCT01279902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390675|NCT01279902|Immunologic Factors|immunologic factors|mesh-ancestor
92390676|NCT01279902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390677|NCT01279902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390678|NCT01278342|Octreotide|octreotide|mesh-list
92390679|NCT01278342|Cabergoline|cabergoline|mesh-list
92390680|NCT01278342|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390681|NCT01278342|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92390682|NCT01278342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390683|NCT01278342|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92390684|NCT01278342|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92390685|NCT01278342|Dopamine Agonists|dopamine agonists|mesh-ancestor
92390686|NCT01278342|Dopamine Agents|dopamine agents|mesh-ancestor
92390687|NCT01278342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390688|NCT01278342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390689|NCT01278342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390690|NCT01277718|Rabeprazole|rabeprazole|mesh-list
92390691|NCT01277718|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92390692|NCT01277718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390693|NCT01277718|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92390694|NCT01277718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390695|NCT01277718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390696|NCT01276236|Maraviroc|maraviroc|mesh-list
92390697|NCT01276236|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92390698|NCT01276236|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92390699|NCT01276236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390700|NCT01276236|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92390701|NCT01276236|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92390702|NCT01276236|Antiviral Agents|antiviral agents|mesh-ancestor
92390703|NCT01276236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390704|NCT01276236|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92390705|NCT01275222|Everolimus|everolimus|mesh-list
92390706|NCT01275222|Imatinib Mesylate|imatinib mesylate|mesh-list
92390707|NCT01275222|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92390708|NCT01275222|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390709|NCT01275222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390710|NCT01275222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390711|NCT01275222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92390712|NCT01275222|Immunologic Factors|immunologic factors|mesh-ancestor
92390713|NCT01275222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390714|NCT01275222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390715|NCT01275144|Lorazepam|lorazepam|mesh-list
92390716|NCT01275144|Anticonvulsants|anticonvulsants|mesh-ancestor
92390717|NCT01275144|Antiemetics|antiemetics|mesh-ancestor
92390718|NCT01275144|Autonomic Agents|autonomic agents|mesh-ancestor
92390719|NCT01275144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390720|NCT01275144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390721|NCT01275144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390722|NCT01275144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92134402|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92390723|NCT01275144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390724|NCT01275144|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92390725|NCT01275144|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92390726|NCT01275144|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390727|NCT01275144|GABA Modulators|gaba modulators|mesh-ancestor
92390728|NCT01275144|GABA Agents|gaba agents|mesh-ancestor
92390729|NCT01275144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390730|NCT01275144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390731|NCT01272180|Vaccines|vaccines|mesh-list
92390732|NCT01272180|Immunologic Factors|immunologic factors|mesh-ancestor
92390733|NCT01272180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390734|NCT01271010|Cyclophosphamide|cyclophosphamide|mesh-list
92390735|NCT01271010|Rituximab|rituximab|mesh-list
92390736|NCT01271010|Fludarabine|fludarabine|mesh-list
92390737|NCT01271010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92390738|NCT01271010|Immunologic Factors|immunologic factors|mesh-ancestor
92390739|NCT01271010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390740|NCT01271010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390741|NCT01271010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92390742|NCT01271010|Alkylating Agents|alkylating agents|mesh-ancestor
92390743|NCT01271010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390744|NCT01271010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390745|NCT01271010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92390746|NCT01271010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390747|NCT01270620|Propofol|propofol|mesh-list
92390748|NCT01270620|Desflurane|desflurane|mesh-list
92390749|NCT01270620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92390750|NCT01270620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390751|NCT01270620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390752|NCT01270620|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92390753|NCT01270620|Anesthetics, General|anesthetics, general|mesh-ancestor
92390754|NCT01270620|Anesthetics|anesthetics|mesh-ancestor
92390755|NCT01270620|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92390757|NCT01270464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92390758|NCT01270464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390759|NCT01279590|Atorvastatin|atorvastatin|mesh-list
92390760|NCT01279590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92390761|NCT01279590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92390762|NCT01279590|Antimetabolites|antimetabolites|mesh-ancestor
92390763|NCT01279590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390764|NCT01279590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92390765|NCT01279590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92390766|NCT01279590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390767|NCT01271790|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92390768|NCT01271790|Interferon-alpha|interferon-alpha|mesh-list
92390769|NCT01271790|Ribavirin|ribavirin|mesh-list
92390770|NCT01271790|Antiviral Agents|antiviral agents|mesh-ancestor
92390771|NCT01271790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390772|NCT01271790|Immunologic Factors|immunologic factors|mesh-ancestor
92390773|NCT01271790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390774|NCT01271790|Antimetabolites|antimetabolites|mesh-ancestor
92390775|NCT01271790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390776|NCT01270152|Ascorbic Acid|ascorbic acid|mesh-list
92390777|NCT01270152|Antioxidants|antioxidants|mesh-ancestor
92390778|NCT01270152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390779|NCT01270152|Protective Agents|protective agents|mesh-ancestor
92390780|NCT01270152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390781|NCT01270152|Vitamins|vitamins|mesh-ancestor
92390782|NCT01270152|Micronutrients|micronutrients|mesh-ancestor
92390783|NCT01274988|Methadone|methadone|mesh-list
92390784|NCT01274988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92043202|NCT02299388|Liraglutide|liraglutide|mesh-list
92390785|NCT01274988|Narcotics|narcotics|mesh-ancestor
92390786|NCT01274988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390787|NCT01274988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390789|NCT01274988|Sensory System Agents|sensory system agents|mesh-ancestor
92390790|NCT01274988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390791|NCT01274988|Antitussive Agents|antitussive agents|mesh-ancestor
92390792|NCT01274988|Respiratory System Agents|respiratory system agents|mesh-ancestor
92390793|NCT01278498|Escitalopram|escitalopram|mesh-list
92134479|NCT00462735|Fluorouracil|fluorouracil|mesh-list
92390794|NCT01278498|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92390795|NCT01278498|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92390796|NCT01278498|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390797|NCT01278498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390798|NCT01278498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390799|NCT01278498|Serotonin Agents|serotonin agents|mesh-ancestor
92390800|NCT01278498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390801|NCT01279980|Anesthetics|anesthetics|mesh-list
92390802|NCT01279980|Anesthetics, Local|anesthetics, local|mesh-list
92390803|NCT01279980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390804|NCT01279980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390805|NCT01279980|Sensory System Agents|sensory system agents|mesh-ancestor
92390806|NCT01279980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390807|NCT00249834|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92390808|NCT00249834|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92390809|NCT00249834|Hormones|hormones|mesh-ancestor
92390810|NCT00249834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390811|NCT00249834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390812|NCT00249834|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92390813|NCT00249444|Mirtazapine|mirtazapine|mesh-list
92390814|NCT00249444|Antidepressive Agents|antidepressive agents|mesh-ancestor
92390815|NCT00249444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390816|NCT00249444|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92390817|NCT00249444|Histamine Antagonists|histamine antagonists|mesh-ancestor
92390818|NCT00249444|Histamine Agents|histamine agents|mesh-ancestor
92390819|NCT00249444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390820|NCT00249444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390821|NCT00249444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390822|NCT00249444|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92390823|NCT00249444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92390824|NCT00249444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390825|NCT00249444|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92390826|NCT00249444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92390827|NCT00249444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92390828|NCT00249444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92390829|NCT00249444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92390830|NCT00249444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92390831|NCT00249444|Serotonin Agents|serotonin agents|mesh-ancestor
92390832|NCT00249444|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92390833|NCT00249288|Folic Acid|folic acid|mesh-list
92390834|NCT00249288|Vitamin B Complex|vitamin b complex|mesh-list
92390835|NCT00249288|Hematinics|hematinics|mesh-ancestor
92390836|NCT00249288|Vitamins|vitamins|mesh-ancestor
92390837|NCT00249288|Micronutrients|micronutrients|mesh-ancestor
92390838|NCT00249288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390839|NCT00247962|Sulfasalazine|sulfasalazine|mesh-list
92390840|NCT00247962|Etanercept|etanercept|mesh-list
92390841|NCT00247962|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92390842|NCT00247962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92390843|NCT00247962|Analgesics|analgesics|mesh-ancestor
92390844|NCT00247962|Sensory System Agents|sensory system agents|mesh-ancestor
92390845|NCT00247962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390846|NCT00247962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390847|NCT00247962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390848|NCT00247962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390849|NCT00247962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390850|NCT00247962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92390851|NCT00247962|Immunologic Factors|immunologic factors|mesh-ancestor
92390852|NCT00247962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390853|NCT00247416|Dexamethasone|dexamethasone|mesh-list
92390854|NCT00247416|Carboplatin|carboplatin|mesh-list
92390855|NCT00247416|Gemcitabine|gemcitabine|mesh-list
92390856|NCT00247416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390857|NCT00247416|Antiemetics|antiemetics|mesh-ancestor
92390858|NCT00247416|Autonomic Agents|autonomic agents|mesh-ancestor
92043278|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390859|NCT00247416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390860|NCT00247416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987146|NCT02345993|Beclomethasone|beclomethasone|mesh-list
92390861|NCT00247416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92390862|NCT00247416|Glucocorticoids|glucocorticoids|mesh-ancestor
92390863|NCT00247416|Hormones|hormones|mesh-ancestor
92390864|NCT00247416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390865|NCT00247416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92390866|NCT00247416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390867|NCT00247416|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92390868|NCT00247416|Antimetabolites|antimetabolites|mesh-ancestor
92390869|NCT00247416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390870|NCT00246012|Dacarbazine|dacarbazine|mesh-list
92390871|NCT00246012|Intetumumab|intetumumab|mesh-list
92390872|NCT00246012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92390873|NCT00246012|Alkylating Agents|alkylating agents|mesh-ancestor
92390874|NCT00246012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390875|NCT00246012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390876|NCT00246012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390877|NCT00245856|Dalteparin|dalteparin|mesh-list
92390878|NCT00245856|Tinzaparin|tinzaparin|mesh-list
92390879|NCT00245856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92390880|NCT00245856|Warfarin|warfarin|mesh-list
92390881|NCT00245856|Anticoagulants|anticoagulants|mesh-ancestor
92390882|NCT00245856|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92390883|NCT00245856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92390884|NCT00245856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390886|NCT00242580|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92390887|NCT00242580|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92390888|NCT00242580|Verteporfin|verteporfin|mesh-list
92390889|NCT00242580|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92390890|NCT00242580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92390891|NCT00242580|Glucocorticoids|glucocorticoids|mesh-ancestor
92390892|NCT00242580|Hormones|hormones|mesh-ancestor
92390893|NCT00242580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390894|NCT00242580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390895|NCT00242580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92390896|NCT00242580|Immunologic Factors|immunologic factors|mesh-ancestor
92390897|NCT00242580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390898|NCT00242580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390899|NCT00242580|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92390900|NCT00242580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92390901|NCT00241644|Vaccines|vaccines|mesh-list
92390902|NCT00241644|Immunologic Factors|immunologic factors|mesh-ancestor
91937928|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92390903|NCT00241644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390904|NCT03805152|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92390905|NCT03805152|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92390906|NCT03805152|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92390907|NCT03805152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390908|NCT03805152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390909|NCT03805152|Cholinergic Agents|cholinergic agents|mesh-ancestor
92390910|NCT03805152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92390911|NCT03805152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390912|NCT03805152|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92390913|NCT03805152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390914|NCT03804840|Dronabinol|dronabinol|mesh-list
92390915|NCT03804840|Hallucinogens|hallucinogens|mesh-ancestor
92390916|NCT03804840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390917|NCT03804840|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92390918|NCT03804840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92390919|NCT03804840|Analgesics|analgesics|mesh-ancestor
92390920|NCT03804840|Sensory System Agents|sensory system agents|mesh-ancestor
92390921|NCT03804840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390922|NCT03804840|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92390923|NCT03804840|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92390924|NCT03804840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134481|NCT00462735|Hydroxyurea|hydroxyurea|mesh-list
92390925|NCT03804840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390926|NCT03804840|Hormones|hormones|mesh-ancestor
92390927|NCT03804840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92390928|NCT03804372|Tenofovir|tenofovir|mesh-list
92390929|NCT03804372|Rituximab|rituximab|mesh-list
92390930|NCT03804372|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390931|NCT03804372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390932|NCT03804372|Immunologic Factors|immunologic factors|mesh-ancestor
92390934|NCT03804372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92390935|NCT03804372|Antiviral Agents|antiviral agents|mesh-ancestor
92390936|NCT03804372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390937|NCT03804372|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92390938|NCT03804372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92390939|NCT03804372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390940|NCT03804372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390941|NCT03804372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92390942|NCT03804372|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92390943|NCT03803124|Tolvaptan|tolvaptan|mesh-list
92390944|NCT03803124|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92390945|NCT03803124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390946|NCT03803124|Natriuretic Agents|natriuretic agents|mesh-ancestor
92390947|NCT03803124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390948|NCT03802032|Lidocaine|lidocaine|mesh-list
92390949|NCT03802032|Anesthetics, Local|anesthetics, local|mesh-ancestor
92390950|NCT03802032|Anesthetics|anesthetics|mesh-ancestor
92390951|NCT03802032|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92390952|NCT03802032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390953|NCT03802032|Sensory System Agents|sensory system agents|mesh-ancestor
92390954|NCT03802032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92390955|NCT03802032|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92390956|NCT03802032|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92390957|NCT03802032|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92390958|NCT03802032|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390959|NCT03802032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390960|NCT03801252|Azithromycin|azithromycin|mesh-list
92390962|NCT03801252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92390963|NCT03801252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390964|NCT03800550|Clarithromycin|clarithromycin|mesh-list
92390965|NCT03800550|Bedaquiline|bedaquiline|mesh-list
92390966|NCT03800550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92390967|NCT03800550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390968|NCT03800550|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92390969|NCT03800550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390970|NCT03800550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390971|NCT03800550|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92390972|NCT03800550|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92390973|NCT03800550|Antitubercular Agents|antitubercular agents|mesh-ancestor
91937929|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92390974|NCT03803202|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92390975|NCT03803202|Immunologic Factors|immunologic factors|mesh-ancestor
92390976|NCT03803202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92390978|NCT05742750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390979|NCT05742750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92390980|NCT05742750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92390981|NCT05742750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390982|NCT05740332|Hand Sanitizers|hand sanitizers|mesh-list
92390983|NCT05740332|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92390984|NCT05740332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390985|NCT05740332|Disinfectants|disinfectants|mesh-ancestor
92390986|NCT05338398|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92390987|NCT05338398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92390988|NCT05338398|Benzydamine|benzydamine|mesh-list
92390989|NCT05338398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92390990|NCT05119296|Pembrolizumab|pembrolizumab|mesh-list
92390991|NCT05119296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92390992|NCT05119296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92390993|NCT05119296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92390994|NCT05119296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92390995|NCT04741074|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92390996|NCT04581408|Ivacaftor|ivacaftor|mesh-list
92390997|NCT04581408|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92390998|NCT04581408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92390999|NCT04581408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391000|NCT04295772|Islatravir|islatravir|mesh-list
92391001|NCT04295772|Antiviral Agents|antiviral agents|mesh-ancestor
92391002|NCT04295772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391003|NCT04295772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043427|NCT01641926|Immunologic Factors|immunologic factors|mesh-ancestor
92391004|NCT04295772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391005|NCT04295772|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92391006|NCT04295772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92391007|NCT04295772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92391008|NCT04151940|Immunomodulating Agents|immunomodulating agents|mesh-list
92391010|NCT04151940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391011|NCT04148430|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92391012|NCT04148430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391013|NCT03467256|Cytarabine|cytarabine|mesh-list
92391014|NCT03467256|Dexamethasone|dexamethasone|mesh-list
92391015|NCT03467256|Cyclophosphamide|cyclophosphamide|mesh-list
92391016|NCT03467256|Fludarabine|fludarabine|mesh-list
92391017|NCT03467256|Etoposide|etoposide|mesh-list
92391018|NCT03467256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391019|NCT03467256|Immunologic Factors|immunologic factors|mesh-ancestor
92391020|NCT03467256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391021|NCT03467256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391022|NCT03467256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92391023|NCT03467256|Alkylating Agents|alkylating agents|mesh-ancestor
92391024|NCT03467256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391025|NCT03467256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391026|NCT03467256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92391027|NCT03467256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391028|NCT03467256|Antiemetics|antiemetics|mesh-ancestor
92391029|NCT03467256|Autonomic Agents|autonomic agents|mesh-ancestor
92391030|NCT03467256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391031|NCT03467256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92391032|NCT03467256|Glucocorticoids|glucocorticoids|mesh-ancestor
92391033|NCT03467256|Hormones|hormones|mesh-ancestor
92391034|NCT03467256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391035|NCT03467256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92391036|NCT03467256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391037|NCT03467256|Antimetabolites|antimetabolites|mesh-ancestor
92391038|NCT03467256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92391039|NCT03467256|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92391040|NCT03467256|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92391041|NCT03467256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391042|NCT03467256|Antiviral Agents|antiviral agents|mesh-ancestor
92391043|NCT03467256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391044|NCT03265080|Pembrolizumab|pembrolizumab|mesh-list
92391045|NCT03265080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391046|NCT03265080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391047|NCT03265080|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92391048|NCT03265080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391049|NCT02458014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92391050|NCT02458014|Blinatumomab|blinatumomab|mesh-list
92391051|NCT02458014|Antibodies|antibodies|mesh-list
92391052|NCT02458014|Immunoglobulins|immunoglobulins|mesh-list
92391053|NCT02458014|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92391054|NCT02458014|Muromonab-CD3|muromonab-cd3|mesh-list
92391055|NCT02458014|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92391056|NCT02458014|Immunologic Factors|immunologic factors|mesh-ancestor
92391057|NCT02458014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391058|NCT02458014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391059|NCT02458014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391060|NCT02017704|Leucovorin|leucovorin|mesh-list
92391061|NCT02017704|Fluorouracil|fluorouracil|mesh-list
92391062|NCT02017704|Capecitabine|capecitabine|mesh-list
92391063|NCT02017704|Oxaliplatin|oxaliplatin|mesh-list
92391064|NCT02017704|Antimetabolites|antimetabolites|mesh-ancestor
92391065|NCT02017704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391066|NCT02017704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391067|NCT02017704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391068|NCT02017704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391069|NCT02017704|Immunologic Factors|immunologic factors|mesh-ancestor
92391070|NCT02017704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391071|NCT02017704|Antidotes|antidotes|mesh-ancestor
92391072|NCT02017704|Protective Agents|protective agents|mesh-ancestor
92391073|NCT02017704|Vitamin B Complex|vitamin b complex|mesh-ancestor
92391074|NCT02017704|Vitamins|vitamins|mesh-ancestor
92391075|NCT02017704|Micronutrients|micronutrients|mesh-ancestor
92391076|NCT01622322|Nitrous Oxide|nitrous oxide|mesh-list
92391077|NCT01622322|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92391078|NCT01622322|Anesthetics, General|anesthetics, general|mesh-ancestor
92391079|NCT01622322|Anesthetics|anesthetics|mesh-ancestor
92391080|NCT01622322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391081|NCT01622322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391082|NCT01622322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391083|NCT01622322|Analgesics|analgesics|mesh-ancestor
92391084|NCT01622322|Sensory System Agents|sensory system agents|mesh-ancestor
92391085|NCT01622322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391086|NCT05313282|Apatinib|apatinib|mesh-list
92391087|NCT05313282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391088|NCT05313282|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92391089|NCT05313282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391090|NCT05313282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391091|NCT05312034|Anti-Infective Agents|anti-infective agents|mesh-list
92391092|NCT05312034|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92391093|NCT05311722|Dexmedetomidine|dexmedetomidine|mesh-list
92391094|NCT05311722|Ketamine|ketamine|mesh-list
92391095|NCT05311722|Tramadol|tramadol|mesh-list
92391096|NCT05311722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92391097|NCT05311722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391098|NCT05311722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391099|NCT05311722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391100|NCT05311722|Analgesics|analgesics|mesh-ancestor
92391101|NCT05311722|Sensory System Agents|sensory system agents|mesh-ancestor
92391102|NCT05311722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391103|NCT05311722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92391104|NCT05311722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92391105|NCT05311722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92391106|NCT05311722|Adrenergic Agents|adrenergic agents|mesh-ancestor
92391107|NCT05311722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391108|NCT05311722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391109|NCT05311722|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92391110|NCT05311722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92391111|NCT05311722|Anesthetics, General|anesthetics, general|mesh-ancestor
92391112|NCT05311722|Anesthetics|anesthetics|mesh-ancestor
92391113|NCT05311722|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92391114|NCT05311722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92391115|NCT05311722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92391116|NCT05311722|Narcotics|narcotics|mesh-ancestor
92391117|NCT05311254|Fosfomycin|fosfomycin|mesh-list
92391118|NCT05311254|Calcium|calcium|mesh-list
92391119|NCT05311254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92391120|NCT05311254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391121|NCT05311254|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92391122|NCT05311254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391123|NCT03215940|Dronabinol|dronabinol|mesh-list
92391124|NCT03215940|Cannabidiol|cannabidiol|mesh-list
92391125|NCT03215940|Anticonvulsants|anticonvulsants|mesh-ancestor
92391126|NCT03215940|Hallucinogens|hallucinogens|mesh-ancestor
92391127|NCT03215940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391128|NCT03215940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92391129|NCT03215940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391130|NCT03215940|Analgesics|analgesics|mesh-ancestor
92391131|NCT03215940|Sensory System Agents|sensory system agents|mesh-ancestor
92391132|NCT03215940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391133|NCT03215940|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92391134|NCT03215940|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92391135|NCT03215940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391136|NCT03215940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391137|NCT03215940|Hormones|hormones|mesh-ancestor
92391138|NCT03215940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391139|NCT03219528|Rifaximin|rifaximin|mesh-list
92391140|NCT03219528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92391141|NCT03219528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391142|NCT03219528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92391143|NCT03219762|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92391144|NCT03219762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391145|NCT03218514|Dalteparin|dalteparin|mesh-list
92391146|NCT03218514|Tinzaparin|tinzaparin|mesh-list
92391147|NCT03218514|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92391149|NCT03218514|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92391150|NCT03218514|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92391151|NCT03218514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391152|NCT03218124|Remifentanil|remifentanil|mesh-list
92391153|NCT03218124|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92391154|NCT03218124|Narcotics|narcotics|mesh-ancestor
92043574|NCT01925703|Hematinics|hematinics|mesh-ancestor
92391155|NCT03218124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391156|NCT03218124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391157|NCT03218124|Analgesics|analgesics|mesh-ancestor
92391158|NCT03218124|Sensory System Agents|sensory system agents|mesh-ancestor
92391159|NCT03218124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391161|NCT03217734|Methotrexate|methotrexate|mesh-list
92391162|NCT03217734|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92391163|NCT03217734|Abortifacient Agents|abortifacient agents|mesh-ancestor
92391164|NCT03217734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391165|NCT03217734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391166|NCT03217734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391167|NCT03217734|Antimetabolites|antimetabolites|mesh-ancestor
92391168|NCT03217734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391169|NCT03217734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391170|NCT03217734|Dermatologic Agents|dermatologic agents|mesh-ancestor
92391171|NCT03217734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391172|NCT03217734|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92391173|NCT03217734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391174|NCT03217734|Immunologic Factors|immunologic factors|mesh-ancestor
92391175|NCT03217734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391176|NCT03217734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92391177|NCT03217734|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92391178|NCT03217734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391179|NCT03216876|Ursolic acid|ursolic acid|mesh-list
92391180|NCT03216876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391181|NCT03216876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92391182|NCT03216876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391183|NCT03216876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92391184|NCT03216876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391185|NCT03216876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391186|NCT03216876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391187|NCT03216876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391188|NCT03216876|Analgesics|analgesics|mesh-ancestor
92391189|NCT03216876|Sensory System Agents|sensory system agents|mesh-ancestor
92391190|NCT03216876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391191|NCT03216876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391192|NCT03216876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391193|NCT03216876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391194|NCT03216642|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92391195|NCT03216642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391196|NCT03216408|Botulinum Toxins|botulinum toxins|mesh-list
92391197|NCT03216408|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92391198|NCT03216408|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92391199|NCT03216408|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92391200|NCT03216408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391201|NCT03216408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391202|NCT03216408|Cholinergic Agents|cholinergic agents|mesh-ancestor
92391203|NCT03216408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134482|NCT00462735|Antimetabolites|antimetabolites|mesh-ancestor
92391204|NCT03216408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391205|NCT03216408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92391206|NCT03216408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391207|NCT03216564|Vitamin D|vitamin d|mesh-list
92391208|NCT03216564|Calcitriol|calcitriol|mesh-list
92391209|NCT03216564|Vitamins|vitamins|mesh-ancestor
92391210|NCT03216564|Micronutrients|micronutrients|mesh-ancestor
92391211|NCT03216564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391212|NCT03216564|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92391213|NCT03216564|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92391214|NCT03216564|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92391215|NCT03216564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391216|NCT03216564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391217|NCT03216564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92391218|NCT03216096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92391219|NCT03216096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92391220|NCT03214848|Contraceptive Agents|contraceptive agents|mesh-list
92391221|NCT03214848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391222|NCT03214848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391223|NCT03214536|Ropivacaine|ropivacaine|mesh-list
92391224|NCT03214536|Anesthetics|anesthetics|mesh-ancestor
92391225|NCT03214536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391226|NCT03214536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391227|NCT03214536|Anesthetics, Local|anesthetics, local|mesh-ancestor
92391228|NCT03214536|Sensory System Agents|sensory system agents|mesh-ancestor
92391229|NCT03214536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391230|NCT03214770|Calcium, Dietary|calcium, dietary|mesh-list
92391232|NCT03214770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92391233|NCT03214770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391234|NCT03214770|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92391235|NCT03213834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92391236|NCT03213834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92391237|NCT03213834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92391238|NCT03213834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391239|NCT03213444|Oxaliplatin|oxaliplatin|mesh-list
92391240|NCT03213444|Fluorouracil|fluorouracil|mesh-list
92391241|NCT03213444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391242|NCT03213444|Antimetabolites|antimetabolites|mesh-ancestor
92391243|NCT03213444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391244|NCT03213444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391245|NCT03213444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391246|NCT03213444|Immunologic Factors|immunologic factors|mesh-ancestor
92391247|NCT03213444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391248|NCT03212820|Methamphetamine|methamphetamine|mesh-list
92391249|NCT03212820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92391250|NCT03212820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391251|NCT03212820|Sympathomimetics|sympathomimetics|mesh-ancestor
92391252|NCT03212820|Autonomic Agents|autonomic agents|mesh-ancestor
92391253|NCT03212820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391254|NCT03212820|Dopamine Agents|dopamine agents|mesh-ancestor
92391255|NCT03212820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391256|NCT03212820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391257|NCT03212820|Adrenergic Agents|adrenergic agents|mesh-ancestor
92391258|NCT03212820|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92391259|NCT03212820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92391260|NCT03212820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391261|NCT03212820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92391262|NCT03211728|Pregabalin|pregabalin|mesh-list
92391263|NCT03211728|Analgesics|analgesics|mesh-ancestor
92391264|NCT03211728|Sensory System Agents|sensory system agents|mesh-ancestor
92391265|NCT03211728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391266|NCT03211728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391268|NCT03211728|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92391269|NCT03211728|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391270|NCT03211728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391271|NCT03211728|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92391272|NCT03211728|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92391273|NCT03211728|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92391274|NCT03211728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391275|NCT03211728|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92391276|NCT03211572|Tamoxifen|tamoxifen|mesh-list
92391277|NCT03211572|Anastrozole|anastrozole|mesh-list
92391278|NCT03211572|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92391279|NCT03211572|Hormone Antagonists|hormone antagonists|mesh-ancestor
92391280|NCT03211572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391281|NCT03211572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391282|NCT03211572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92391283|NCT03211572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391284|NCT03211572|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92391285|NCT03211572|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92391286|NCT03211572|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92391287|NCT03211572|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92391288|NCT03211572|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92391289|NCT03211572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391290|NCT03211572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391291|NCT03211650|Hyaluronic Acid|hyaluronic acid|mesh-list
92391292|NCT03211650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92391293|NCT03211650|Immunologic Factors|immunologic factors|mesh-ancestor
92391294|NCT03211650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391295|NCT03211650|Viscosupplements|viscosupplements|mesh-ancestor
92391296|NCT03211650|Protective Agents|protective agents|mesh-ancestor
92391297|NCT03211104|Curcumin|curcumin|mesh-list
92391298|NCT03211104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391299|NCT03211104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391300|NCT03211104|Analgesics|analgesics|mesh-ancestor
92391301|NCT03211104|Sensory System Agents|sensory system agents|mesh-ancestor
92391302|NCT03211104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391303|NCT03211104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391304|NCT03211104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391305|NCT03211104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391306|NCT03211104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391307|NCT03211104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391308|NCT03211104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391309|NCT03210246|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92391310|NCT03210246|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92391311|NCT03210246|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92391312|NCT03210246|Contraceptive Agents|contraceptive agents|mesh-ancestor
92391313|NCT03210246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391314|NCT03210246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391315|NCT03210246|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92391316|NCT03210246|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92391317|NCT03210246|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92391318|NCT03210246|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92391319|NCT03210246|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92391320|NCT03210246|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92391321|NCT03210246|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92391322|NCT03210246|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92391323|NCT03210324|Mifepristone|mifepristone|mesh-list
92391324|NCT03210324|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92391325|NCT03210324|Abortifacient Agents|abortifacient agents|mesh-ancestor
92391326|NCT03210324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391327|NCT03210324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391328|NCT03210324|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92391329|NCT03210324|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92391330|NCT03210324|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92391331|NCT03210324|Contraceptive Agents|contraceptive agents|mesh-ancestor
92391332|NCT03210324|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92391333|NCT03210324|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92391335|NCT03210324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391336|NCT03210324|Luteolytic Agents|luteolytic agents|mesh-ancestor
92391337|NCT03210324|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92391338|NCT03210324|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92391339|NCT03210480|Lithium Carbonate|lithium carbonate|mesh-list
92391340|NCT03210480|Antidepressive Agents|antidepressive agents|mesh-ancestor
92391341|NCT03210480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92391342|NCT03210480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391343|NCT03210480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391344|NCT03210480|Antimanic Agents|antimanic agents|mesh-ancestor
92391345|NCT03210480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92391346|NCT03210480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391347|NCT03210480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391797|NCT01727622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391798|NCT01728090|Hand Sanitizers|hand sanitizers|mesh-list
92391799|NCT01728090|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92391800|NCT01728090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391801|NCT01728090|Disinfectants|disinfectants|mesh-ancestor
92391802|NCT01728480|Cisplatin|cisplatin|mesh-list
92391803|NCT01728480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391804|NCT01728948|Sorafenib|sorafenib|mesh-list
92391805|NCT01728948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391806|NCT01728948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92391807|NCT01728948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391808|NCT01728948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391809|NCT01729104|Rituximab|rituximab|mesh-list
92391810|NCT01729104|Lenalidomide|lenalidomide|mesh-list
92391811|NCT01729104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391812|NCT01729104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391813|NCT01729104|Immunologic Factors|immunologic factors|mesh-ancestor
92391814|NCT01729104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391815|NCT01729104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391816|NCT01729104|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92391817|NCT01729104|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92391818|NCT01729104|Growth Substances|growth substances|mesh-ancestor
92391819|NCT01729104|Growth Inhibitors|growth inhibitors|mesh-ancestor
92391820|NCT01729260|Mebendazole|mebendazole|mesh-list
92391349|NCT01831674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391350|NCT01831674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391351|NCT01832922|Rituximab|rituximab|mesh-list
92391352|NCT01832922|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92391353|NCT01832922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391354|NCT01832922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391355|NCT01832922|Immunologic Factors|immunologic factors|mesh-ancestor
92391356|NCT01832922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391357|NCT01832922|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391358|NCT01832922|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92391359|NCT01832922|Alkylating Agents|alkylating agents|mesh-ancestor
92391360|NCT01832922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391361|NCT01833312|Meperidine|meperidine|mesh-list
92391362|NCT01833312|Buspirone|buspirone|mesh-list
92391363|NCT01833312|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92391364|NCT01833312|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92391365|NCT01833312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391366|NCT01833312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391367|NCT01833312|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92391368|NCT01833312|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92391369|NCT01833312|Serotonin Agents|serotonin agents|mesh-ancestor
92391370|NCT01833312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391371|NCT01833312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391372|NCT01833312|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92391373|NCT01833312|Narcotics|narcotics|mesh-ancestor
92391374|NCT01833312|Analgesics|analgesics|mesh-ancestor
92391375|NCT01833312|Sensory System Agents|sensory system agents|mesh-ancestor
92391376|NCT01833312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391377|NCT01833312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92391378|NCT01834014|Bevacizumab|bevacizumab|mesh-list
92391379|NCT01834014|Cetuximab|cetuximab|mesh-list
92391380|NCT01834014|Fluorouracil|fluorouracil|mesh-list
92391381|NCT01834014|Oxaliplatin|oxaliplatin|mesh-list
92391382|NCT01834014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391383|NCT01834014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391384|NCT01834014|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92391385|NCT01834014|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92391386|NCT01834014|Growth Substances|growth substances|mesh-ancestor
92391387|NCT01834014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391388|NCT01834014|Growth Inhibitors|growth inhibitors|mesh-ancestor
92391389|NCT01834014|Antimetabolites|antimetabolites|mesh-ancestor
92391390|NCT01834014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391391|NCT01834014|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391392|NCT01834014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391393|NCT01834014|Immunologic Factors|immunologic factors|mesh-ancestor
92391395|NCT01834170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391396|NCT01834170|Antimetabolites|antimetabolites|mesh-ancestor
92391397|NCT01834170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391398|NCT01834170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391399|NCT01835184|Vemurafenib|vemurafenib|mesh-list
92391400|NCT01835184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391401|NCT01835184|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92391402|NCT01835184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391403|NCT01835184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391404|NCT01835340|Anesthetics|anesthetics|mesh-list
92391405|NCT01835340|Propofol|propofol|mesh-list
92391406|NCT01835340|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391407|NCT01835340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391408|NCT01835340|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92391409|NCT01835340|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92391410|NCT01835340|Anesthetics, General|anesthetics, general|mesh-ancestor
92391411|NCT01836120|Docetaxel|docetaxel|mesh-list
92391412|NCT01836120|Raltitrexed|raltitrexed|mesh-list
92391413|NCT01836120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391414|NCT01836120|Tubulin Modulators|tubulin modulators|mesh-ancestor
92391415|NCT01836120|Antimitotic Agents|antimitotic agents|mesh-ancestor
92391416|NCT01836120|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987328|NCT02938013|Sofosbuvir|sofosbuvir|mesh-list
92391417|NCT01836120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391418|NCT01836120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391420|NCT01836120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92391421|NCT01836120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391422|NCT01836822|Dimercaprol|dimercaprol|mesh-list
92391423|NCT01836822|Chelating Agents|chelating agents|mesh-ancestor
92391424|NCT01836822|Sequestering Agents|sequestering agents|mesh-ancestor
92391425|NCT01836822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391426|NCT01836900|Hemostatics|hemostatics|mesh-list
92391427|NCT01836900|Coagulants|coagulants|mesh-ancestor
92391428|NCT01837992|Primaquine|primaquine|mesh-list
92391429|NCT01837992|Antimalarials|antimalarials|mesh-ancestor
92391430|NCT01837992|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92391431|NCT01837992|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92391432|NCT01837992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391433|NCT01838460|Lobeline|lobeline|mesh-list
92391434|NCT01838460|Nicotine|nicotine|mesh-list
92391435|NCT01838460|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92391436|NCT01838460|Autonomic Agents|autonomic agents|mesh-ancestor
92391437|NCT01838460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391438|NCT01838460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391439|NCT01838460|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92391440|NCT01838460|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92391441|NCT01838460|Cholinergic Agents|cholinergic agents|mesh-ancestor
92391442|NCT01838460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391443|NCT01838460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391444|NCT01838460|Respiratory System Agents|respiratory system agents|mesh-ancestor
92391445|NCT01838538|Paclitaxel|paclitaxel|mesh-list
92391446|NCT01838538|Bevacizumab|bevacizumab|mesh-list
92391447|NCT01838538|Carboplatin|carboplatin|mesh-list
92391448|NCT01838538|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92391449|NCT01838538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391450|NCT01838538|Tubulin Modulators|tubulin modulators|mesh-ancestor
92391451|NCT01838538|Antimitotic Agents|antimitotic agents|mesh-ancestor
92391452|NCT01838538|Mitosis Modulators|mitosis modulators|mesh-ancestor
92391453|NCT01838538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391454|NCT01838538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391455|NCT01838538|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92391456|NCT01838538|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92391457|NCT01838538|Growth Substances|growth substances|mesh-ancestor
92391458|NCT01838538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937938|NCT02913495|Progestins|progestins|mesh-ancestor
92391459|NCT01838538|Growth Inhibitors|growth inhibitors|mesh-ancestor
92391460|NCT01838772|Interferons|interferons|mesh-list
92391461|NCT01838772|Ribavirin|ribavirin|mesh-list
92391462|NCT01838772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391463|NCT01838772|Antiviral Agents|antiviral agents|mesh-ancestor
92391464|NCT01838772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391465|NCT01838772|Antimetabolites|antimetabolites|mesh-ancestor
92391466|NCT01838772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391467|NCT01838928|Bupivacaine|bupivacaine|mesh-list
92391468|NCT01838928|Anesthetics, Local|anesthetics, local|mesh-ancestor
92391469|NCT01838928|Anesthetics|anesthetics|mesh-ancestor
92391470|NCT01838928|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391471|NCT01838928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391472|NCT01838928|Sensory System Agents|sensory system agents|mesh-ancestor
92391473|NCT01838928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391474|NCT01839084|Isoflurane|isoflurane|mesh-list
92391475|NCT01839084|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92391476|NCT01839084|Anesthetics, General|anesthetics, general|mesh-ancestor
92391477|NCT01839084|Anesthetics|anesthetics|mesh-ancestor
92391478|NCT01839084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391479|NCT01839084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391480|NCT01839240|Cytarabine|cytarabine|mesh-list
92391481|NCT01839240|Azacitidine|azacitidine|mesh-list
92391482|NCT01839240|Mitoxantrone|mitoxantrone|mesh-list
92391483|NCT01839240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391484|NCT01839240|Antimetabolites|antimetabolites|mesh-ancestor
92391485|NCT01839240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391486|NCT01839240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391487|NCT01839240|Antiviral Agents|antiviral agents|mesh-ancestor
92391488|NCT01839240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391489|NCT01839240|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391490|NCT01839240|Immunologic Factors|immunologic factors|mesh-ancestor
92391491|NCT01839240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391492|NCT01839240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391493|NCT01839240|Analgesics|analgesics|mesh-ancestor
92391494|NCT01839240|Sensory System Agents|sensory system agents|mesh-ancestor
92391495|NCT01839240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391496|NCT01839240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92391497|NCT01839240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92391498|NCT01839552|Fentanyl|fentanyl|mesh-list
92391499|NCT01839552|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92391500|NCT01839552|Narcotics|narcotics|mesh-ancestor
92391821|NCT01729260|Piperazine|piperazine|mesh-list
92391501|NCT01839552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391502|NCT01839552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391503|NCT01839552|Analgesics|analgesics|mesh-ancestor
92391504|NCT01839552|Sensory System Agents|sensory system agents|mesh-ancestor
92391505|NCT01839552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391506|NCT01839552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92391507|NCT01839552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92391508|NCT01839552|Anesthetics, General|anesthetics, general|mesh-ancestor
92391509|NCT01839552|Anesthetics|anesthetics|mesh-ancestor
92391510|NCT01839630|Sorafenib|sorafenib|mesh-list
92391511|NCT01839630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391512|NCT01839630|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92391513|NCT01839630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391514|NCT01839630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391515|NCT01839864|Chrysarobin|chrysarobin|mesh-list
92391516|NCT01839864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391517|NCT01839864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391518|NCT01839864|Analgesics|analgesics|mesh-ancestor
92391519|NCT01839864|Sensory System Agents|sensory system agents|mesh-ancestor
92391520|NCT01839864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391521|NCT01839864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391522|NCT01839864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391523|NCT01839864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391524|NCT01834248|Poly I-C|poly i-c|mesh-list
92391525|NCT01834248|Decitabine|decitabine|mesh-list
92391526|NCT01834248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92391527|NCT01834248|Poly ICLC|poly iclc|mesh-list
92391528|NCT01834248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391529|NCT01834248|Antimetabolites|antimetabolites|mesh-ancestor
92116269|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391530|NCT01834248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391531|NCT01834248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391532|NCT01834248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391533|NCT01834248|Interferon Inducers|interferon inducers|mesh-ancestor
92391534|NCT01834248|Immunologic Factors|immunologic factors|mesh-ancestor
92391535|NCT01834248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391536|NCT01834248|Laxatives|laxatives|mesh-ancestor
92391537|NCT01834248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92391538|NCT01834248|Antiviral Agents|antiviral agents|mesh-ancestor
92391539|NCT01834248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391540|NCT01833858|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92391541|NCT01833858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391542|NCT01833858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391543|NCT01836432|Leucovorin|leucovorin|mesh-list
92391544|NCT01836432|Paclitaxel|paclitaxel|mesh-list
92391545|NCT01836432|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92391546|NCT01836432|Gemcitabine|gemcitabine|mesh-list
92391547|NCT01836432|Fluorouracil|fluorouracil|mesh-list
92391548|NCT01836432|Capecitabine|capecitabine|mesh-list
92391549|NCT01836432|Oxaliplatin|oxaliplatin|mesh-list
92391550|NCT01836432|Irinotecan|irinotecan|mesh-list
92391551|NCT01836432|Folfirinox|folfirinox|mesh-list
92391552|NCT01836432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92391553|NCT01836432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391554|NCT01836432|Tubulin Modulators|tubulin modulators|mesh-ancestor
92391555|NCT01836432|Antimitotic Agents|antimitotic agents|mesh-ancestor
92391556|NCT01836432|Mitosis Modulators|mitosis modulators|mesh-ancestor
92391557|NCT01836432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391558|NCT01836432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391559|NCT01836432|Antimetabolites|antimetabolites|mesh-ancestor
92391560|NCT01836432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391561|NCT01836432|Immunologic Factors|immunologic factors|mesh-ancestor
91987477|NCT02436499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92391562|NCT01836432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391563|NCT01836432|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92391564|NCT01836432|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92391565|NCT01836432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391567|NCT01836432|Protective Agents|protective agents|mesh-ancestor
92391568|NCT01836432|Vitamin B Complex|vitamin b complex|mesh-ancestor
92391569|NCT01836432|Vitamins|vitamins|mesh-ancestor
92391570|NCT01836432|Micronutrients|micronutrients|mesh-ancestor
92391571|NCT01720056|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92391572|NCT01720056|Verapamil|verapamil|mesh-list
92391573|NCT01720056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391574|NCT01720056|Glucocorticoids|glucocorticoids|mesh-ancestor
92391575|NCT01720056|Hormones|hormones|mesh-ancestor
92391576|NCT01720056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391577|NCT01720056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391578|NCT01720056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391579|NCT01720056|Immunologic Factors|immunologic factors|mesh-ancestor
92391580|NCT01720056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391581|NCT01720056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92391582|NCT01720056|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92391583|NCT01720056|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391584|NCT01720056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92391585|NCT01720056|Vasodilator Agents|vasodilator agents|mesh-ancestor
92391586|NCT01720212|Mirabegron|mirabegron|mesh-list
92391587|NCT01720212|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92391588|NCT01720212|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92391589|NCT01720212|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92391590|NCT01720212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92391591|NCT01720212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391592|NCT01720212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391593|NCT01720212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391594|NCT01720212|Urological Agents|urological agents|mesh-ancestor
92391595|NCT01720290|Metformin|metformin|mesh-list
92391596|NCT01720290|Repaglinide|repaglinide|mesh-list
92391597|NCT01720290|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391598|NCT01720290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391599|NCT01721382|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92391600|NCT01721382|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391601|NCT01721382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391602|NCT01721382|Incretins|incretins|mesh-ancestor
92391603|NCT01721382|Hormones|hormones|mesh-ancestor
92391604|NCT01721382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391605|NCT01721382|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92391606|NCT01721382|Protease Inhibitors|protease inhibitors|mesh-ancestor
92391607|NCT01721382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937941|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391608|NCT01721382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391609|NCT01721616|Azithromycin|azithromycin|mesh-list
92391610|NCT01721616|Cefazolin|cefazolin|mesh-list
92391611|NCT01721616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92391612|NCT01721616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391613|NCT01721694|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92391614|NCT01721694|Azithromycin|azithromycin|mesh-list
92391615|NCT01721694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92391616|NCT01721694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391617|NCT01721694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92391618|NCT01722396|Vitamin D|vitamin d|mesh-list
92391619|NCT01722396|Vitamins|vitamins|mesh-ancestor
92391620|NCT01722396|Micronutrients|micronutrients|mesh-ancestor
92391621|NCT01722396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391622|NCT01722396|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92391623|NCT01722630|Dopamine|dopamine|mesh-list
92391624|NCT01722630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92391625|NCT01722630|Sympathomimetics|sympathomimetics|mesh-ancestor
92391626|NCT01722630|Autonomic Agents|autonomic agents|mesh-ancestor
92391627|NCT01722630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391628|NCT01722630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391629|NCT01722630|Dopamine Agents|dopamine agents|mesh-ancestor
92391630|NCT01722630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391631|NCT01722630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391632|NCT01722630|Protective Agents|protective agents|mesh-ancestor
92391633|NCT01722942|Amiodarone|amiodarone|mesh-list
92391634|NCT01722942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92391635|NCT01722942|Vasodilator Agents|vasodilator agents|mesh-ancestor
92391636|NCT01722942|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92391637|NCT01722942|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391638|NCT01722942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391639|NCT01722942|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92391640|NCT01722942|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92391641|NCT01722942|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92391642|NCT01722942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391643|NCT01722942|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92391644|NCT01722942|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92391645|NCT01722942|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92391646|NCT01723800|Carboplatin|carboplatin|mesh-list
92391647|NCT01723800|Pemetrexed|pemetrexed|mesh-list
92391648|NCT01723800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391649|NCT01723800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391650|NCT01723800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391651|NCT01723800|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92391652|NCT01723800|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92391653|NCT01724190|Vitamin D|vitamin d|mesh-list
92391654|NCT01724190|Cholecalciferol|cholecalciferol|mesh-list
92391655|NCT01724190|Vitamins|vitamins|mesh-ancestor
92391656|NCT01724190|Micronutrients|micronutrients|mesh-ancestor
92391657|NCT01724190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391658|NCT01724190|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92391659|NCT01724190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92391660|NCT01724268|Prednisolone|prednisolone|mesh-list
92391661|NCT01724268|Methotrexate|methotrexate|mesh-list
92391662|NCT01724268|Methamphetamine|methamphetamine|mesh-list
92391663|NCT01724268|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92391664|NCT01724268|Abortifacient Agents|abortifacient agents|mesh-ancestor
92391665|NCT01724268|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391666|NCT01724268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391667|NCT01724268|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92391668|NCT01724268|Antimetabolites|antimetabolites|mesh-ancestor
92391669|NCT01724268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391670|NCT01724268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391671|NCT01724268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92391672|NCT01724268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391673|NCT01724268|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92391674|NCT01724268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92391675|NCT01724268|Immunologic Factors|immunologic factors|mesh-ancestor
92391676|NCT01724268|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391677|NCT01724268|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92391678|NCT01724268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391679|NCT01724268|Glucocorticoids|glucocorticoids|mesh-ancestor
92391680|NCT01724268|Hormones|hormones|mesh-ancestor
92391681|NCT01724268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391683|NCT01724268|Autonomic Agents|autonomic agents|mesh-ancestor
92391684|NCT01724268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391685|NCT01724268|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92391686|NCT01724268|Sympathomimetics|sympathomimetics|mesh-ancestor
92391687|NCT01724268|Dopamine Agents|dopamine agents|mesh-ancestor
92391688|NCT01724268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391689|NCT01724268|Adrenergic Agents|adrenergic agents|mesh-ancestor
92391690|NCT01724268|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92391691|NCT01724268|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92391692|NCT01724268|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391693|NCT01724268|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92391694|NCT01724424|Melatonin|melatonin|mesh-list
92391695|NCT01724424|Antioxidants|antioxidants|mesh-ancestor
92391696|NCT01724424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391697|NCT01724424|Protective Agents|protective agents|mesh-ancestor
92391698|NCT01724424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391699|NCT01724424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391700|NCT01724814|Insulin|insulin|mesh-list
92391701|NCT01724814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391702|NCT01724814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391822|NCT01729260|Piperazine citrate|piperazine citrate|mesh-list
92391823|NCT01729260|DMP 777|dmp 777|mesh-list
92391824|NCT01729260|Antinematodal Agents|antinematodal agents|mesh-ancestor
92391825|NCT01729260|Anthelmintics|anthelmintics|mesh-ancestor
92391826|NCT01729260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92391827|NCT01729260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391828|NCT01729260|Tubulin Modulators|tubulin modulators|mesh-ancestor
92391829|NCT01729260|Antimitotic Agents|antimitotic agents|mesh-ancestor
92391830|NCT01729260|Mitosis Modulators|mitosis modulators|mesh-ancestor
92391831|NCT01729260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391832|NCT01729260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391833|NCT01729260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391834|NCT01729806|Rituximab|rituximab|mesh-list
92391835|NCT01729806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92391836|NCT01729806|Ipilimumab|ipilimumab|mesh-list
92391837|NCT01729806|Antibodies|antibodies|mesh-list
92391838|NCT01729806|Immunoglobulins|immunoglobulins|mesh-list
92391839|NCT01729806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92391840|NCT01729806|Immunologic Factors|immunologic factors|mesh-ancestor
92391841|NCT01729806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391842|NCT01729806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391843|NCT01729806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391844|NCT01729806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92391845|NCT01729806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391846|NCT01724658|Methyltestosterone|methyltestosterone|mesh-list
92044176|NCT01641692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92391847|NCT01724658|Testosterone|testosterone|mesh-list
92391848|NCT01724658|Testosterone undecanoate|testosterone undecanoate|mesh-list
92391849|NCT01724658|Testosterone enanthate|testosterone enanthate|mesh-list
92391850|NCT01724658|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92391851|NCT01724658|Androgens|androgens|mesh-ancestor
92391852|NCT01724658|Hormones|hormones|mesh-ancestor
92391853|NCT01724658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92391854|NCT01724658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391855|NCT01724658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92391856|NCT01724658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391857|NCT01724658|Anabolic Agents|anabolic agents|mesh-ancestor
92391858|NCT01049334|Flurbiprofen|flurbiprofen|mesh-list
92391859|NCT01049334|Analgesics|analgesics|mesh-ancestor
92391860|NCT01049334|Sensory System Agents|sensory system agents|mesh-ancestor
92391861|NCT01049334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391862|NCT01049334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391863|NCT01049334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391864|NCT01049334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391865|NCT01049334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391866|NCT01049334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391867|NCT01049334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92391868|NCT01049334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391869|NCT01049334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391870|NCT01048944|Bupropion|bupropion|mesh-list
92391871|NCT01048944|Nicotine|nicotine|mesh-list
92391872|NCT01048944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92391873|NCT01048944|Autonomic Agents|autonomic agents|mesh-ancestor
92391874|NCT01048944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391875|NCT01048944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391876|NCT01048944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92391877|NCT01048944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92391878|NCT01048944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92391879|NCT01048944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391880|NCT01048944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391881|NCT01048944|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92391882|NCT01048944|Antidepressive Agents|antidepressive agents|mesh-ancestor
92391883|NCT01048944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92391884|NCT01048944|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92391885|NCT01048944|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92391886|NCT01048944|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391887|NCT01048944|Dopamine Agents|dopamine agents|mesh-ancestor
92391888|NCT01048944|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92391889|NCT01048944|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92391890|NCT01048944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391891|NCT01048866|Acetaminophen|acetaminophen|mesh-list
92391892|NCT01048866|Flurbiprofen|flurbiprofen|mesh-list
92391893|NCT01048866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391894|NCT01048866|Analgesics|analgesics|mesh-ancestor
92391895|NCT01048866|Sensory System Agents|sensory system agents|mesh-ancestor
92391896|NCT01048866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391897|NCT01048866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391898|NCT01048866|Antipyretics|antipyretics|mesh-ancestor
91987553|NCT02435797|Nicorandil|nicorandil|mesh-list
92391899|NCT01048866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391900|NCT01048866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391901|NCT01048866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391902|NCT01048866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92391903|NCT01048866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391904|NCT01048866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391905|NCT01048788|Tolvaptan|tolvaptan|mesh-list
92391906|NCT01048788|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92391907|NCT01048788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391908|NCT01048788|Natriuretic Agents|natriuretic agents|mesh-ancestor
92391909|NCT01048788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391910|NCT01046682|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92391911|NCT01046682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92391912|NCT01046682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391913|NCT01046682|Analgesics|analgesics|mesh-ancestor
92391914|NCT01046682|Sensory System Agents|sensory system agents|mesh-ancestor
92391915|NCT01046682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391916|NCT01046682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391917|NCT01046682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391918|NCT01046682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391919|NCT01044498|Norinyl|norinyl|mesh-list
92044253|NCT02254772|Ipilimumab|ipilimumab|mesh-list
92391920|NCT01044498|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92391921|NCT01044498|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92391922|NCT01044498|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92391923|NCT01044498|Contraceptive Agents|contraceptive agents|mesh-ancestor
92391924|NCT01044498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391925|NCT01044498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391926|NCT01044498|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92391927|NCT01044498|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92391929|NCT01042938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92116348|NCT02069704|Bevacizumab|bevacizumab|mesh-list
92391930|NCT01042938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92391931|NCT01042938|Analgesics|analgesics|mesh-ancestor
92391932|NCT01042938|Sensory System Agents|sensory system agents|mesh-ancestor
92391933|NCT01042938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92391934|NCT01042938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391935|NCT01042938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92391936|NCT01042938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92391937|NCT01042938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391938|NCT01042938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391939|NCT01042938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391940|NCT01042158|Ambrisentan|ambrisentan|mesh-list
92391941|NCT01042158|Tadalafil|tadalafil|mesh-list
92391942|NCT01042158|Vasodilator Agents|vasodilator agents|mesh-ancestor
92391943|NCT01042158|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92391944|NCT01042158|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92391945|NCT01042158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391946|NCT01042158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391947|NCT01042158|Urological Agents|urological agents|mesh-ancestor
92391948|NCT01042158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92391949|NCT03405870|SMOFlipid|smoflipid|mesh-list
91987622|NCT02709655|Serotonin Agents|serotonin agents|mesh-ancestor
92391950|NCT03405870|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92391951|NCT03405870|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92391952|NCT03405870|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92391953|NCT03409458|Avelumab|avelumab|mesh-list
92391954|NCT03409458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391955|NCT03409458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391956|NCT03409068|Anesthetics|anesthetics|mesh-list
92391957|NCT03409068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92391958|NCT03409068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391959|NCT03408054|Nitroglycerin|nitroglycerin|mesh-list
92391960|NCT03408054|Oxytocin|oxytocin|mesh-list
92391961|NCT03408054|Oxytocics|oxytocics|mesh-ancestor
92391962|NCT03408054|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391963|NCT03408054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391964|NCT03408054|Vasodilator Agents|vasodilator agents|mesh-ancestor
92391965|NCT03407976|Pembrolizumab|pembrolizumab|mesh-list
92391966|NCT03407976|Apatinib|apatinib|mesh-list
92391967|NCT03407976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92391968|NCT03407976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391969|NCT03407976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92391970|NCT03407976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391971|NCT03407976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92391972|NCT03407976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92391973|NCT03407196|Dapagliflozin|dapagliflozin|mesh-list
92391974|NCT03407196|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92391975|NCT03407196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391976|NCT03407196|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92391977|NCT03407196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391978|NCT03405948|Botulinum Toxins|botulinum toxins|mesh-list
92391979|NCT03405948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92391980|NCT03405948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92391981|NCT03405948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391982|NCT03405948|Cholinergic Agents|cholinergic agents|mesh-ancestor
92391983|NCT03405948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92391984|NCT03405948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391985|NCT03405168|Moxifloxacin|moxifloxacin|mesh-list
92391986|NCT03405168|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92391987|NCT03405168|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92391988|NCT03405168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92391989|NCT03405168|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92391990|NCT03405168|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92391991|NCT03405168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044335|NCT04835870|Hormones|hormones|mesh-ancestor
92391992|NCT03405168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92391993|NCT03405168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92391994|NCT03405168|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92391995|NCT03405168|Contraceptive Agents|contraceptive agents|mesh-ancestor
92391996|NCT03405168|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92391997|NCT03405168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92391998|NCT03405168|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92391999|NCT03405168|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92392000|NCT03405168|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92392002|NCT03403452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392003|NCT03403452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92392004|NCT03403452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392005|NCT03403452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392006|NCT03403140|Etanercept|etanercept|mesh-list
92392007|NCT03403140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92392008|NCT03403140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92392009|NCT03403140|Analgesics|analgesics|mesh-ancestor
92392010|NCT03403140|Sensory System Agents|sensory system agents|mesh-ancestor
92392011|NCT03403140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392012|NCT03403140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392013|NCT03403140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392014|NCT03403140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392015|NCT03403140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392016|NCT03403140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392017|NCT03403140|Immunologic Factors|immunologic factors|mesh-ancestor
92392018|NCT03402984|Z 338|z 338|mesh-list
92392019|NCT03402984|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92392020|NCT03402984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392021|NCT03402984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392022|NCT03402984|Cholinergic Agents|cholinergic agents|mesh-ancestor
92392023|NCT03402984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392024|NCT03402984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392025|NCT03402984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392026|NCT03402438|Fulacimstat|fulacimstat|mesh-list
92392027|NCT03402438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392028|NCT03402438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392029|NCT03402204|Ubenimex|ubenimex|mesh-list
92392030|NCT03402204|Simvastatin|simvastatin|mesh-list
92392031|NCT03402204|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92392032|NCT03402204|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92392033|NCT03402204|Antimetabolites|antimetabolites|mesh-ancestor
92392034|NCT03402204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392035|NCT03402204|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92392036|NCT03402204|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92392037|NCT03402204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392038|NCT03402204|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92392039|NCT03402204|Immunologic Factors|immunologic factors|mesh-ancestor
92392040|NCT03402204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392041|NCT03402204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92392042|NCT03402204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392043|NCT03402204|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92392044|NCT03402204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392045|NCT03402204|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392046|NCT03402204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92392047|NCT03402204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92392048|NCT03402204|Antiviral Agents|antiviral agents|mesh-ancestor
92392049|NCT03402048|Carboplatin|carboplatin|mesh-list
92392050|NCT03402048|Gemcitabine|gemcitabine|mesh-list
92392051|NCT03402048|Docetaxel|docetaxel|mesh-list
92392052|NCT03402048|Pemetrexed|pemetrexed|mesh-list
92392053|NCT03402048|Vinorelbine|vinorelbine|mesh-list
92392054|NCT03402048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392055|NCT03402048|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92392056|NCT03402048|Antimetabolites|antimetabolites|mesh-ancestor
92392057|NCT03402048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392058|NCT03402048|Tubulin Modulators|tubulin modulators|mesh-ancestor
92392059|NCT03402048|Antimitotic Agents|antimitotic agents|mesh-ancestor
92392060|NCT03402048|Mitosis Modulators|mitosis modulators|mesh-ancestor
92392061|NCT03402048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392062|NCT03402048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92392063|NCT03402048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92392064|NCT03402048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92392065|NCT03401502|Ranolazine|ranolazine|mesh-list
92392066|NCT03401502|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92392067|NCT03401502|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392068|NCT03401502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392069|NCT03401346|Dihydroergotamine|dihydroergotamine|mesh-list
92392070|NCT03401346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92392071|NCT03401346|Dopamine Agonists|dopamine agonists|mesh-ancestor
92392072|NCT03401346|Dopamine Agents|dopamine agents|mesh-ancestor
92392073|NCT03401346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392074|NCT03401346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392075|NCT03401346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392076|NCT03401346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92392077|NCT03401346|Analgesics|analgesics|mesh-ancestor
92392078|NCT03401346|Sensory System Agents|sensory system agents|mesh-ancestor
92392079|NCT03401346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392080|NCT03401268|Immunoglobulins|immunoglobulins|mesh-list
92392081|NCT03401268|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92392082|NCT03401268|Antibodies|antibodies|mesh-list
92392083|NCT03401268|Immunologic Factors|immunologic factors|mesh-ancestor
92392084|NCT03401268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392085|NCT03400722|Clomiphene|clomiphene|mesh-list
92392086|NCT03400722|Hormones|hormones|mesh-list
92392087|NCT03400722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392088|NCT03400722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392089|NCT03400722|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92392090|NCT03400722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92392091|NCT03400722|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92392092|NCT03400722|Fertility Agents|fertility agents|mesh-ancestor
92392093|NCT03400722|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92392094|NCT03400722|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92392095|NCT03400722|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92392096|NCT03400254|Hydroxychloroquine|hydroxychloroquine|mesh-list
92392097|NCT03400254|Gedatolisib|gedatolisib|mesh-list
92392098|NCT03400254|Antimalarials|antimalarials|mesh-ancestor
92392099|NCT03400254|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92392100|NCT03400254|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92392101|NCT03400254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392102|NCT03400254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392103|NCT03400254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392104|NCT03400254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392105|NCT03400254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92392106|NCT03400020|Ascorbic Acid|ascorbic acid|mesh-list
92392107|NCT03400020|Vitamins|vitamins|mesh-ancestor
92392108|NCT03400020|Micronutrients|micronutrients|mesh-ancestor
92392109|NCT03400020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392110|NCT03400020|Antioxidants|antioxidants|mesh-ancestor
92392111|NCT03400020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392112|NCT03400020|Protective Agents|protective agents|mesh-ancestor
92392113|NCT00012012|Amifostine|amifostine|mesh-list
92392114|NCT00012012|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92392115|NCT00012012|Protective Agents|protective agents|mesh-ancestor
92392116|NCT00012012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392117|NCT02240160|Nabiximols|nabiximols|mesh-list
92392118|NCT02240160|Analgesics|analgesics|mesh-ancestor
92392119|NCT02240160|Sensory System Agents|sensory system agents|mesh-ancestor
92392120|NCT02240160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392121|NCT02240160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392122|NCT02240238|Gemcitabine|gemcitabine|mesh-list
92392123|NCT02240238|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92392124|NCT02240238|Antimetabolites|antimetabolites|mesh-ancestor
92392125|NCT02240238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392126|NCT02240238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392127|NCT02241096|Lidocaine|lidocaine|mesh-list
92392128|NCT02241096|Anesthetics, Local|anesthetics, local|mesh-ancestor
92392129|NCT02241096|Anesthetics|anesthetics|mesh-ancestor
92392130|NCT02241096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392131|NCT02241096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392132|NCT02241096|Sensory System Agents|sensory system agents|mesh-ancestor
92392133|NCT02241096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392134|NCT02241096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92392135|NCT02241096|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92392136|NCT02241096|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92392137|NCT02241096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392138|NCT02241096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392139|NCT02241174|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92392141|NCT02241174|Disinfectants|disinfectants|mesh-ancestor
92392142|NCT02241174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392143|NCT02241564|Sirolimus|sirolimus|mesh-list
92392144|NCT02241564|MTOR Inhibitors|mtor inhibitors|mesh-list
92392145|NCT02241564|Temsirolimus|temsirolimus|mesh-list
92392146|NCT02241564|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92392147|NCT02241564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392148|NCT02241564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392149|NCT02241564|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92392150|NCT02241564|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392151|NCT02241564|Immunologic Factors|immunologic factors|mesh-ancestor
92392152|NCT02241564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392153|NCT02241564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392154|NCT02241564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92392155|NCT02241564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392156|NCT02241564|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92392157|NCT02241564|Antifungal Agents|antifungal agents|mesh-ancestor
92392158|NCT02241876|Acetylcysteine|acetylcysteine|mesh-list
92392159|NCT02241876|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92392160|NCT02241876|Antiviral Agents|antiviral agents|mesh-ancestor
92392161|NCT02241876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392162|NCT02241876|Expectorants|expectorants|mesh-ancestor
92392163|NCT02241876|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392164|NCT02241876|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92392165|NCT02241876|Antioxidants|antioxidants|mesh-ancestor
92392166|NCT02241876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392167|NCT02241876|Protective Agents|protective agents|mesh-ancestor
92392168|NCT02241876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392169|NCT02241876|Antidotes|antidotes|mesh-ancestor
92392170|NCT02242032|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92392171|NCT02242032|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92392173|NCT02242266|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92392174|NCT02242266|Autonomic Agents|autonomic agents|mesh-ancestor
92392175|NCT02242266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392176|NCT02242266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392177|NCT02242266|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92392178|NCT02242266|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392179|NCT02242266|Parasympatholytics|parasympatholytics|mesh-ancestor
92392180|NCT02242266|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92392181|NCT02242266|Cholinergic Agents|cholinergic agents|mesh-ancestor
92392182|NCT02242266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392183|NCT02242266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392184|NCT02242344|Telmisartan|telmisartan|mesh-list
92392185|NCT02242344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92392186|NCT02242344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92392187|NCT02242344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92392188|NCT02242344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392189|NCT02242656|Opium|opium|mesh-list
92392190|NCT02242656|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392191|NCT02242656|Narcotics|narcotics|mesh-ancestor
92392192|NCT02242656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392193|NCT02242656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392194|NCT02242656|Analgesics|analgesics|mesh-ancestor
92392195|NCT02242656|Sensory System Agents|sensory system agents|mesh-ancestor
92392196|NCT02242656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392197|NCT02242656|Antidiarrheals|antidiarrheals|mesh-ancestor
92392198|NCT02242656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392199|NCT02242656|Antitussive Agents|antitussive agents|mesh-ancestor
92392200|NCT02242656|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392201|NCT02242812|Metoprolol|metoprolol|mesh-list
92392202|NCT02242812|Telmisartan|telmisartan|mesh-list
92392203|NCT02242812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92392204|NCT02242812|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92392205|NCT02242812|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92392206|NCT02242812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392207|NCT02242812|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92392208|NCT02242812|Sympatholytics|sympatholytics|mesh-ancestor
92392209|NCT02242812|Autonomic Agents|autonomic agents|mesh-ancestor
92392210|NCT02242812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392211|NCT02242812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392212|NCT02242812|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92392213|NCT02242812|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92392214|NCT02242812|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92392215|NCT02242812|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392216|NCT02242812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392217|NCT02243124|Dexamethasone|dexamethasone|mesh-list
92392218|NCT02243124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392219|NCT02243124|Antiemetics|antiemetics|mesh-ancestor
92392220|NCT02243124|Autonomic Agents|autonomic agents|mesh-ancestor
92392221|NCT02243124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392222|NCT02243124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392223|NCT02243124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392224|NCT02243124|Glucocorticoids|glucocorticoids|mesh-ancestor
92392225|NCT02243124|Hormones|hormones|mesh-ancestor
92392226|NCT02243124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392227|NCT02243124|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92392228|NCT02243124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392229|NCT02243436|Cytarabine|cytarabine|mesh-list
92392230|NCT02243436|Methylprednisolone|methylprednisolone|mesh-list
92392231|NCT02243436|Etoposide|etoposide|mesh-list
92392232|NCT02243436|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92392233|NCT02243436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392234|NCT02243436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92392235|NCT02243436|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92392236|NCT02243436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92392237|NCT02243436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392238|NCT02243436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392239|NCT02243436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92392240|NCT02243436|Antimetabolites|antimetabolites|mesh-ancestor
92392241|NCT02243436|Antiviral Agents|antiviral agents|mesh-ancestor
92392242|NCT02243436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392243|NCT02243436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392244|NCT02243436|Immunologic Factors|immunologic factors|mesh-ancestor
92041302|NCT03132454|Hormones|hormones|mesh-ancestor
92392245|NCT02243436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392246|NCT02243436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392247|NCT02243436|Antiemetics|antiemetics|mesh-ancestor
92392248|NCT02243436|Autonomic Agents|autonomic agents|mesh-ancestor
92392249|NCT02243436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392250|NCT02243436|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392251|NCT02243436|Glucocorticoids|glucocorticoids|mesh-ancestor
92392252|NCT02243436|Hormones|hormones|mesh-ancestor
92392253|NCT02243436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392254|NCT02243436|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92392255|NCT02243436|Protective Agents|protective agents|mesh-ancestor
92392256|NCT02243436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92392257|NCT02243436|Immunotoxins|immunotoxins|mesh-ancestor
92392258|NCT02243436|Immunoconjugates|immunoconjugates|mesh-ancestor
92392259|NCT02243826|Nitrous Oxide|nitrous oxide|mesh-list
92392260|NCT02243826|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92392261|NCT02243826|Anesthetics, General|anesthetics, general|mesh-ancestor
92392262|NCT02243826|Anesthetics|anesthetics|mesh-ancestor
92392263|NCT02243826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392264|NCT02243826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392265|NCT02243826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92392266|NCT02243826|Analgesics|analgesics|mesh-ancestor
92392267|NCT02243826|Sensory System Agents|sensory system agents|mesh-ancestor
92392268|NCT02243826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392269|NCT02244216|Fenoterol|fenoterol|mesh-list
92392270|NCT02244216|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92392271|NCT02244216|Autonomic Agents|autonomic agents|mesh-ancestor
92392272|NCT02244216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392273|NCT02244216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392274|NCT02244216|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92392275|NCT02244216|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392276|NCT02244216|Sympathomimetics|sympathomimetics|mesh-ancestor
92392277|NCT02244216|Tocolytic Agents|tocolytic agents|mesh-ancestor
92392278|NCT02244216|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92392279|NCT02244216|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92392280|NCT02244216|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92392281|NCT02244216|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92392282|NCT02244216|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392283|NCT02244216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392284|NCT02244216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392285|NCT02244294|Tamsulosin|tamsulosin|mesh-list
92392286|NCT02244294|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92392287|NCT02244294|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92392288|NCT02244294|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92044627|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92392289|NCT02244294|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392290|NCT02244294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392291|NCT02244294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392292|NCT02244294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392293|NCT02244294|Urological Agents|urological agents|mesh-ancestor
92392294|NCT02244528|Sildenafil Citrate|sildenafil citrate|mesh-list
92392295|NCT02244528|Vasodilator Agents|vasodilator agents|mesh-ancestor
92392296|NCT02244528|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92392297|NCT02244528|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92392298|NCT02244528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392299|NCT02244528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392300|NCT02244528|Urological Agents|urological agents|mesh-ancestor
92392301|NCT02245464|Telmisartan|telmisartan|mesh-list
92392302|NCT02245464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92392303|NCT02245464|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92392304|NCT02245464|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92392305|NCT02245464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392307|NCT02246244|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92392308|NCT02246244|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92392309|NCT02246244|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392310|NCT02246244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392311|NCT02246244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392312|NCT02246244|Serotonin Agents|serotonin agents|mesh-ancestor
92392313|NCT02246244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392314|NCT02246712|Tramadol|tramadol|mesh-list
92392315|NCT02246712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392316|NCT02246712|Narcotics|narcotics|mesh-ancestor
92392317|NCT02246712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392318|NCT02246712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392319|NCT02246712|Analgesics|analgesics|mesh-ancestor
92392320|NCT02246712|Sensory System Agents|sensory system agents|mesh-ancestor
92392321|NCT02246712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392322|NCT02246868|Factor VIII|factor viii|mesh-list
92392323|NCT02246868|Coagulants|coagulants|mesh-ancestor
92392324|NCT02247258|Azathioprine|azathioprine|mesh-list
92392325|NCT02247258|Antimetabolites|antimetabolites|mesh-ancestor
92392326|NCT02247258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392327|NCT02247258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92392328|NCT02247258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392329|NCT02247258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392330|NCT02247258|Immunologic Factors|immunologic factors|mesh-ancestor
92392331|NCT02247258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392332|NCT02247258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392333|NCT02247414|Aspirin|aspirin|mesh-list
92392334|NCT02247414|Heparin|heparin|mesh-list
92392335|NCT02247414|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92392336|NCT02247414|Tinzaparin|tinzaparin|mesh-list
92392337|NCT02247414|Dalteparin|dalteparin|mesh-list
92392338|NCT02247414|Dipyridamole|dipyridamole|mesh-list
92392339|NCT02247414|Warfarin|warfarin|mesh-list
92392340|NCT02247414|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92392341|NCT02247414|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92392342|NCT02247414|Analgesics|analgesics|mesh-ancestor
92392343|NCT02247414|Sensory System Agents|sensory system agents|mesh-ancestor
92392344|NCT02247414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392345|NCT02247414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392346|NCT02247414|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392347|NCT02247414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392348|NCT02247414|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92392349|NCT02247414|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92392350|NCT02247414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392351|NCT02247414|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92392352|NCT02247414|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92392353|NCT02247414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392354|NCT02247414|Antipyretics|antipyretics|mesh-ancestor
92392355|NCT02247414|Anticoagulants|anticoagulants|mesh-ancestor
92392356|NCT02247414|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92392357|NCT02247414|Vasodilator Agents|vasodilator agents|mesh-ancestor
92392358|NCT02247648|Tramadol|tramadol|mesh-list
92392359|NCT02247648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392360|NCT02247648|Narcotics|narcotics|mesh-ancestor
92392361|NCT02247648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392362|NCT02247648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392363|NCT02247648|Analgesics|analgesics|mesh-ancestor
92392364|NCT02247648|Sensory System Agents|sensory system agents|mesh-ancestor
92044703|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
92392365|NCT02247648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392366|NCT02248428|Clarithromycin|clarithromycin|mesh-list
92392367|NCT02248428|Thalidomide|thalidomide|mesh-list
92392368|NCT02248428|Dexamethasone|dexamethasone|mesh-list
92392369|NCT02248428|Cyclophosphamide|cyclophosphamide|mesh-list
92392370|NCT02248428|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392371|NCT02248428|Immunologic Factors|immunologic factors|mesh-ancestor
92392372|NCT02248428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392373|NCT02248428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392374|NCT02248428|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92392375|NCT02248428|Alkylating Agents|alkylating agents|mesh-ancestor
92392376|NCT02248428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392377|NCT02248428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392378|NCT02248428|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92392379|NCT02248428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392380|NCT02248428|Antiemetics|antiemetics|mesh-ancestor
92392381|NCT02248428|Autonomic Agents|autonomic agents|mesh-ancestor
92392382|NCT02248428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392383|NCT02248428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392384|NCT02248428|Glucocorticoids|glucocorticoids|mesh-ancestor
92392385|NCT02248428|Hormones|hormones|mesh-ancestor
92392386|NCT02248428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392387|NCT02248428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92392388|NCT02248428|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92392389|NCT02248428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392390|NCT02248428|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92392391|NCT02248428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392392|NCT02248428|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92392393|NCT02248428|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392394|NCT02248428|Leprostatic Agents|leprostatic agents|mesh-ancestor
92392395|NCT02248428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92392396|NCT02248428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92392397|NCT02248428|Growth Substances|growth substances|mesh-ancestor
92392398|NCT02248428|Growth Inhibitors|growth inhibitors|mesh-ancestor
92392400|NCT02248506|Miconazole|miconazole|mesh-list
92392401|NCT02248506|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92392402|NCT02248506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392403|NCT02248506|Antifungal Agents|antifungal agents|mesh-ancestor
92392404|NCT02248506|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92392405|NCT02248506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392406|NCT02248506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392407|NCT02248506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392408|NCT02248506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92392409|NCT02248506|Hormone Antagonists|hormone antagonists|mesh-ancestor
92392410|NCT02248506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392411|NCT02248506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392412|NCT02248506|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92392413|NCT02248506|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92392414|NCT02248896|Telmisartan|telmisartan|mesh-list
92392415|NCT02248896|Antihypertensive Agents|antihypertensive agents|mesh-list
92392416|NCT02248896|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92392417|NCT02248896|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92392418|NCT02248896|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92392419|NCT02248896|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92392420|NCT02248896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392421|NCT02248896|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392422|NCT02249130|Ritonavir|ritonavir|mesh-list
92392423|NCT02249130|Lamivudine|lamivudine|mesh-list
92392424|NCT02249130|Zidovudine|zidovudine|mesh-list
92392425|NCT02249130|Stavudine|stavudine|mesh-list
92392426|NCT02249130|Tipranavir|tipranavir|mesh-list
92392427|NCT02249130|Delavirdine|delavirdine|mesh-list
92392428|NCT02249130|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92392429|NCT02249130|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92392430|NCT02249130|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392431|NCT02249130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392432|NCT02249130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392433|NCT02249130|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92392434|NCT02249130|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92392435|NCT02249130|Antiviral Agents|antiviral agents|mesh-ancestor
92392436|NCT02249130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392437|NCT02249130|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92392438|NCT02249130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392439|NCT02249130|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92392440|NCT02249130|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92392441|NCT02249130|Antimetabolites|antimetabolites|mesh-ancestor
92392443|NCT02249364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92392444|NCT02249364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392445|NCT02249364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392446|NCT02249364|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92392447|NCT02249364|Anesthetics, General|anesthetics, general|mesh-ancestor
92392448|NCT02249364|Anesthetics|anesthetics|mesh-ancestor
92392449|NCT02249442|Ritonavir|ritonavir|mesh-list
92392450|NCT02249442|Tipranavir|tipranavir|mesh-list
92392451|NCT02249442|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92392452|NCT02249442|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92392453|NCT02249442|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392454|NCT02249442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041311|NCT03132454|Antimetabolites|antimetabolites|mesh-ancestor
92392455|NCT02249442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392456|NCT02249442|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92392457|NCT02249442|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92392458|NCT02249442|Antiviral Agents|antiviral agents|mesh-ancestor
92392459|NCT02249442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392460|NCT02249442|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92392461|NCT02249442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392462|NCT02244762|Hydrocodone|hydrocodone|mesh-list
92392463|NCT02244762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392464|NCT02244762|Narcotics|narcotics|mesh-ancestor
92392465|NCT02244762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392466|NCT02244762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392467|NCT02244762|Analgesics|analgesics|mesh-ancestor
92392468|NCT02244762|Sensory System Agents|sensory system agents|mesh-ancestor
92392469|NCT02244762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392470|NCT02244762|Antitussive Agents|antitussive agents|mesh-ancestor
92392471|NCT02244762|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392472|NCT02242734|Hydrocodone|hydrocodone|mesh-list
92392473|NCT02242734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392474|NCT02242734|Narcotics|narcotics|mesh-ancestor
92392475|NCT02242734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392476|NCT02242734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392477|NCT02242734|Analgesics|analgesics|mesh-ancestor
92392478|NCT02242734|Sensory System Agents|sensory system agents|mesh-ancestor
92392479|NCT02242734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392480|NCT02242734|Antitussive Agents|antitussive agents|mesh-ancestor
92392481|NCT02242734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392482|NCT02244606|Fluconazole|fluconazole|mesh-list
92392483|NCT02244606|Micafungin|micafungin|mesh-list
92392484|NCT02244606|Ibrexafungerp|ibrexafungerp|mesh-list
92392485|NCT02244606|Antifungal Agents|antifungal agents|mesh-ancestor
92392486|NCT02244606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392487|NCT02244606|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92116349|NCT02069704|Fluorouracil|fluorouracil|mesh-list
92116350|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
92392488|NCT02244606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92041691|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92392489|NCT02244606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392490|NCT02244606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392491|NCT02244606|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92392492|NCT02244606|Hormone Antagonists|hormone antagonists|mesh-ancestor
92392493|NCT02244606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392494|NCT02244606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392495|NCT02244606|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92392496|NCT02244606|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92392497|NCT02245308|Bupropion|bupropion|mesh-list
92392498|NCT02245308|Nicotine|nicotine|mesh-list
92392499|NCT02245308|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92392500|NCT02245308|Autonomic Agents|autonomic agents|mesh-ancestor
92116351|NCT02069704|Irinotecan|irinotecan|mesh-list
92392501|NCT02245308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392502|NCT02245308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392503|NCT02245308|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92392504|NCT02245308|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92392505|NCT02245308|Cholinergic Agents|cholinergic agents|mesh-ancestor
92392506|NCT02245308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392507|NCT02245308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392508|NCT02245308|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92392509|NCT02245308|Antidepressive Agents|antidepressive agents|mesh-ancestor
92392510|NCT02245308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92392511|NCT02245308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92392512|NCT02245308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92392513|NCT02245308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042106|NCT02740699|Atorvastatin|atorvastatin|mesh-list
92042218|NCT01726270|Tamsulosin|tamsulosin|mesh-list
92042248|NCT00630565|Busulfan|busulfan|mesh-list
92392514|NCT02245308|Dopamine Agents|dopamine agents|mesh-ancestor
92392515|NCT02245308|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92392516|NCT02245308|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392517|NCT02245308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392518|NCT02243358|Gemcitabine|gemcitabine|mesh-list
92392519|NCT02243358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92392520|NCT02243358|Antimetabolites|antimetabolites|mesh-ancestor
92392521|NCT02243358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392522|NCT02243358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392523|NCT00559962|Atorvastatin|atorvastatin|mesh-list
92392524|NCT00559962|Ezetimibe|ezetimibe|mesh-list
92392526|NCT00559962|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92392527|NCT00559962|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92392528|NCT00559962|Antimetabolites|antimetabolites|mesh-ancestor
92116352|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
92392529|NCT00559962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392530|NCT00559962|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92392531|NCT00559962|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92392532|NCT00559962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392533|NCT00559104|Cyclophosphamide|cyclophosphamide|mesh-list
92392534|NCT00559104|Carmustine|carmustine|mesh-list
92392535|NCT00559104|Etoposide|etoposide|mesh-list
92392536|NCT00559104|Lenograstim|lenograstim|mesh-list
92392537|NCT00559104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392538|NCT00559104|Immunologic Factors|immunologic factors|mesh-ancestor
92392539|NCT00559104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392540|NCT00559104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392541|NCT00559104|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92392542|NCT00559104|Alkylating Agents|alkylating agents|mesh-ancestor
92392543|NCT00559104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392544|NCT00559104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392545|NCT00559104|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92392546|NCT00559104|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92392547|NCT00559104|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92042848|NCT02304926|Simvastatin|simvastatin|mesh-list
92392548|NCT00559104|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92043066|NCT01706146|Dabigatran|dabigatran|mesh-list
92392549|NCT00559104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392550|NCT00559104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92392551|NCT00558636|Paclitaxel|paclitaxel|mesh-list
92392552|NCT00558636|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92392553|NCT00558636|Carboplatin|carboplatin|mesh-list
92392554|NCT00558636|Sorafenib|sorafenib|mesh-list
92392555|NCT00558636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92392556|NCT00558636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392557|NCT00558636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92392558|NCT00558636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92392559|NCT00558636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92392560|NCT00558636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392561|NCT00558636|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92392562|NCT00558636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392563|NCT00558558|Flurandrenolone|flurandrenolone|mesh-list
92392564|NCT00558558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392565|NCT00558558|Glucocorticoids|glucocorticoids|mesh-ancestor
92392566|NCT00558558|Hormones|hormones|mesh-ancestor
92392567|NCT00558558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392568|NCT00558558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392569|NCT00557622|Paroxetine|paroxetine|mesh-list
92392570|NCT00557622|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92043294|NCT02296892|Midazolam|midazolam|mesh-list
92092793|NCT03742245|Olaparib|olaparib|mesh-list
92043585|NCT02263079|Entecavir|entecavir|mesh-list
92392571|NCT00557622|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92392572|NCT00557622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392573|NCT00557622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392574|NCT00557622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392575|NCT00557622|Serotonin Agents|serotonin agents|mesh-ancestor
92392576|NCT00557622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392577|NCT00557622|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92392578|NCT00557622|Antidepressive Agents|antidepressive agents|mesh-ancestor
92392579|NCT00557622|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92392580|NCT00557622|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92392581|NCT00557622|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392582|NCT00557622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392583|NCT00557466|Formoterol Fumarate|formoterol fumarate|mesh-list
92392584|NCT00557466|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92392585|NCT00557466|Autonomic Agents|autonomic agents|mesh-ancestor
92392586|NCT00557466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392587|NCT00557466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043891|NCT01632241|Belimumab|belimumab|mesh-list
92392588|NCT00557466|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92134650|NCT01690052|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92044181|NCT01682512|Rituximab|rituximab|mesh-list
92392589|NCT00557466|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044348|NCT04834310|Clindamycin|clindamycin|mesh-list
92392590|NCT00557466|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92392591|NCT00557466|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92392593|NCT00557466|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392594|NCT00557466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134651|NCT01690052|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92392595|NCT00557466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392596|NCT00557310|Teriparatide|teriparatide|mesh-list
91937961|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
92392597|NCT00557310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92392598|NCT00557310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392599|NCT00557310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92392601|NCT00555438|Fondaparinux|fondaparinux|mesh-list
92392602|NCT00555438|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92392603|NCT00555438|Antithrombins|antithrombins|mesh-ancestor
92392604|NCT00555438|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92392605|NCT00555438|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392606|NCT00555438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045424|NCT00119366|Iodine|iodine|mesh-list
92045496|NCT02155309|Scopolamine|scopolamine|mesh-list
92392607|NCT00555438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392608|NCT00555438|Anticoagulants|anticoagulants|mesh-ancestor
92392609|NCT00555438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92134652|NCT01690052|Cholinergic Agents|cholinergic agents|mesh-ancestor
92392610|NCT00555438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92392611|NCT00553644|Lenalidomide|lenalidomide|mesh-list
92392612|NCT00553644|Bortezomib|bortezomib|mesh-list
92046051|NCT01688830|Dabigatran|dabigatran|mesh-list
92392613|NCT00553644|Immunologic Factors|immunologic factors|mesh-ancestor
92134729|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
92134809|NCT01460381|Adrenergic Agents|adrenergic agents|mesh-ancestor
92046571|NCT05497583|Factor VIII|factor viii|mesh-list
92392614|NCT00553644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392615|NCT00553644|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92047003|NCT02168270|Ascorbic Acid|ascorbic acid|mesh-list
92392616|NCT00553644|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92392617|NCT00553644|Growth Substances|growth substances|mesh-ancestor
92047247|NCT02222558|Androgens|androgens|mesh-ancestor
92392618|NCT00553644|Growth Inhibitors|growth inhibitors|mesh-ancestor
92392619|NCT00553644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392620|NCT00552240|Ritonavir|ritonavir|mesh-list
92392621|NCT00552240|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92392622|NCT00552240|Tenofovir|tenofovir|mesh-list
92392623|NCT00552240|Emtricitabine|emtricitabine|mesh-list
92392624|NCT00552240|Nevirapine|nevirapine|mesh-list
92392625|NCT00552240|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92392626|NCT00552240|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92392627|NCT00552240|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392628|NCT00552240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134885|NCT02733159|Pembrolizumab|pembrolizumab|mesh-list
92392629|NCT00552240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047952|NCT01573000|Antibodies|antibodies|mesh-list
92392630|NCT00552240|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92048254|NCT01557166|Hormones|hormones|mesh-ancestor
92048338|NCT02137772|Letermovir|letermovir|mesh-list
92048418|NCT02175758|Ribavirin|ribavirin|mesh-list
92392631|NCT00552240|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92392632|NCT00552240|Antiviral Agents|antiviral agents|mesh-ancestor
92392633|NCT00552240|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135338|NCT01450007|Dexamethasone|dexamethasone|mesh-list
92392634|NCT00552240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92392635|NCT00552240|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92048958|NCT02118961|Vaccines|vaccines|mesh-list
92049018|NCT01462318|Midazolam|midazolam|mesh-list
92392636|NCT00552240|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92392637|NCT00552240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92392638|NCT00552240|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92392639|NCT00552240|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92014696|NCT05471687|Adenosine|adenosine|mesh-list
92014697|NCT05471687|Analgesics|analgesics|mesh-ancestor
92392640|NCT00550836|Gemcitabine|gemcitabine|mesh-list
92392641|NCT00550836|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92392642|NCT00550836|Panitumumab|panitumumab|mesh-list
92392643|NCT00550836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92392644|NCT00550836|Antimetabolites|antimetabolites|mesh-ancestor
92135339|NCT01450007|Dexamethasone acetate|dexamethasone acetate|mesh-list
92392645|NCT00550836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050291|NCT02201771|Aspirin|aspirin|mesh-list
92135340|NCT01450007|Ropivacaine|ropivacaine|mesh-list
92392646|NCT00550836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392647|NCT00550836|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92392648|NCT00550836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050757|NCT01630811|Quinidine|quinidine|mesh-list
92392649|NCT00550836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92392650|NCT00550680|Epoetin Alfa|epoetin alfa|mesh-list
92392651|NCT00550680|Hematinics|hematinics|mesh-ancestor
92392652|NCT00556920|Carvedilol|carvedilol|mesh-list
92135341|NCT01450007|BB 1101|bb 1101|mesh-list
92392653|NCT00556920|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92392654|NCT00556920|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92392655|NCT00556920|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392656|NCT00556920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135414|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92116353|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92051678|NCT01623115|Alirocumab|alirocumab|mesh-list
92116354|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135415|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92051893|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
92392657|NCT00556920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392658|NCT00556920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392659|NCT00556920|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92052064|NCT01622569|Xhance|xhance|mesh-list
92392660|NCT00556920|Antioxidants|antioxidants|mesh-ancestor
92052125|NCT02176421|Anesthetics|anesthetics|mesh-ancestor
92392661|NCT00556920|Protective Agents|protective agents|mesh-ancestor
92392662|NCT00556920|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92052200|NCT02060383|Metformin|metformin|mesh-list
92392663|NCT00556920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392664|NCT00556920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92392665|NCT00556920|Vasodilator Agents|vasodilator agents|mesh-ancestor
92392666|NCT00556920|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92392667|NCT00556920|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92392668|NCT00552708|Lisinopril|lisinopril|mesh-list
92392669|NCT00552708|Carvedilol|carvedilol|mesh-list
92392670|NCT00552708|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92392671|NCT00552708|Protease Inhibitors|protease inhibitors|mesh-ancestor
92392672|NCT00552708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392673|NCT00552708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392674|NCT00552708|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92392675|NCT00552708|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92392676|NCT00552708|Protective Agents|protective agents|mesh-ancestor
92392677|NCT00552708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392678|NCT00552708|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92392679|NCT00552708|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92392680|NCT00552708|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392681|NCT00552708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392682|NCT00552708|Antioxidants|antioxidants|mesh-ancestor
92392683|NCT00552708|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92392684|NCT00552708|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392685|NCT00552708|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92392686|NCT00552708|Vasodilator Agents|vasodilator agents|mesh-ancestor
92392687|NCT00552708|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92392688|NCT00552708|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92392689|NCT00556374|Zoledronic Acid|zoledronic acid|mesh-list
92392690|NCT00556374|Denosumab|denosumab|mesh-list
92392691|NCT00556374|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92392692|NCT00556374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92392693|NCT00556374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392694|NCT00556374|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92392695|NCT00556374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392696|NCT00556374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392697|NCT00556374|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92392698|NCT00556374|Hormone Antagonists|hormone antagonists|mesh-ancestor
92392699|NCT00556374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392700|NCT03028350|Ifetroban|ifetroban|mesh-list
92392701|NCT03028350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92392702|NCT03029676|Fentanyl|fentanyl|mesh-list
92392703|NCT03029676|Midazolam|midazolam|mesh-list
92392704|NCT03029676|Anesthetics|anesthetics|mesh-ancestor
92392705|NCT03029676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392706|NCT03029676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392707|NCT03029676|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392708|NCT03029676|Narcotics|narcotics|mesh-ancestor
92392709|NCT03029676|Analgesics|analgesics|mesh-ancestor
92392710|NCT03029676|Sensory System Agents|sensory system agents|mesh-ancestor
92392711|NCT03029676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392712|NCT03029676|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92392713|NCT03029676|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92392714|NCT03029676|Anesthetics, General|anesthetics, general|mesh-ancestor
92392715|NCT03029676|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92392716|NCT03029676|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92392717|NCT03029676|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92392718|NCT03029676|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92392719|NCT03029676|GABA Modulators|gaba modulators|mesh-ancestor
92392720|NCT03029676|GABA Agents|gaba agents|mesh-ancestor
92392721|NCT03029676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392722|NCT03029676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392723|NCT04270344|Valsartan|valsartan|mesh-list
92392724|NCT04270344|Pitavastatin|pitavastatin|mesh-list
92392725|NCT04270344|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92392726|NCT04270344|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92392727|NCT04270344|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92392728|NCT04270344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392729|NCT04270344|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92392730|NCT04270344|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92392731|NCT04270344|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92392732|NCT04270344|Antimetabolites|antimetabolites|mesh-ancestor
92392733|NCT04270344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392734|NCT04270344|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92045078|NCT03563222|SMOFlipid|smoflipid|mesh-list
92392735|NCT04278846|Bupivacaine|bupivacaine|mesh-list
92392736|NCT04278846|Anesthetics, Local|anesthetics, local|mesh-ancestor
92392737|NCT04278846|Anesthetics|anesthetics|mesh-ancestor
92392738|NCT04278846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392739|NCT04278846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392740|NCT04278846|Sensory System Agents|sensory system agents|mesh-ancestor
92392741|NCT04278846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392742|NCT03839550|Apatinib|apatinib|mesh-list
91937965|NCT05303792|Vincristine|vincristine|mesh-list
92392743|NCT03839550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392744|NCT03839550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92392745|NCT03839550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392746|NCT03839550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392747|NCT03839160|Morphine|morphine|mesh-list
92392748|NCT03839160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92392749|NCT03839160|Narcotics|narcotics|mesh-ancestor
92392750|NCT03839160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392751|NCT03839160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392752|NCT03839160|Analgesics|analgesics|mesh-ancestor
92392753|NCT03839160|Sensory System Agents|sensory system agents|mesh-ancestor
92392754|NCT03839160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392755|NCT03838926|Trichostatin A|trichostatin a|mesh-list
92392756|NCT03838926|Antifungal Agents|antifungal agents|mesh-ancestor
92392757|NCT03838926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392758|NCT03838926|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92392759|NCT03838926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392760|NCT03838926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392761|NCT03838926|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92392762|NCT03834012|Beclomethasone|beclomethasone|mesh-list
92392763|NCT03834012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392764|NCT03834012|Glucocorticoids|glucocorticoids|mesh-ancestor
92392765|NCT03834012|Hormones|hormones|mesh-ancestor
92392766|NCT03834012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392767|NCT03834012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392768|NCT03834012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92392769|NCT03834012|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392770|NCT03833466|Metformin|metformin|mesh-list
92392771|NCT03833466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92392772|NCT03833466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392773|NCT03833388|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92392774|NCT03833388|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92392775|NCT03830034|Iron|iron|mesh-list
92392776|NCT03830034|Ferrous fumarate|ferrous fumarate|mesh-list
92392777|NCT03830034|Iron Chelating Agents|iron chelating agents|mesh-list
92392778|NCT03830034|Trace Elements|trace elements|mesh-ancestor
92392779|NCT03830034|Micronutrients|micronutrients|mesh-ancestor
92392780|NCT03830034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392781|NCT03830034|Chelating Agents|chelating agents|mesh-ancestor
92392782|NCT03830034|Sequestering Agents|sequestering agents|mesh-ancestor
92392783|NCT03830034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392784|NCT03838068|Anesthetics|anesthetics|mesh-list
92392785|NCT03838068|Procaine|procaine|mesh-list
92392786|NCT03838068|Anesthetics, Local|anesthetics, local|mesh-list
92392787|NCT03838068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392788|NCT03838068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392789|NCT03838068|Sensory System Agents|sensory system agents|mesh-ancestor
92392790|NCT03838068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392791|NCT05440734|Melatonin|melatonin|mesh-list
92392792|NCT05440734|Antioxidants|antioxidants|mesh-ancestor
92392793|NCT05440734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392794|NCT05440734|Protective Agents|protective agents|mesh-ancestor
92392795|NCT05440734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392796|NCT05440734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392797|NCT05447208|Hormones|hormones|mesh-list
92392798|NCT05447208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392799|NCT05447208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392800|NCT05444556|Repaglinide|repaglinide|mesh-list
92392801|NCT05444556|Quinidine|quinidine|mesh-list
92392802|NCT05444556|Digoxin|digoxin|mesh-list
92392803|NCT05444556|Dextromethorphan|dextromethorphan|mesh-list
92392804|NCT05444556|Omeprazole|omeprazole|mesh-list
92392805|NCT05444556|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92392806|NCT05444556|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92392807|NCT05444556|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92392808|NCT05444556|Antimetabolites|antimetabolites|mesh-ancestor
92392809|NCT05444556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045145|NCT01635218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392810|NCT05444556|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92392811|NCT05444556|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92392812|NCT05444556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392813|NCT05444556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92392814|NCT05444556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392815|NCT05444556|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92392816|NCT05444556|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92392817|NCT05444556|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92392818|NCT05444556|Protective Agents|protective agents|mesh-ancestor
92392819|NCT05444556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392821|NCT05444556|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392822|NCT05444556|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92392823|NCT05444556|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92392824|NCT05444556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392825|NCT05444556|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92392826|NCT05444556|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92392827|NCT05444556|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92392828|NCT05444556|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392829|NCT05444556|Antimalarials|antimalarials|mesh-ancestor
92392830|NCT05444556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92392831|NCT05444556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92392832|NCT05444556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92392833|NCT05444556|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92392834|NCT05444556|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92392835|NCT05444556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92392836|NCT05444556|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92392837|NCT05444556|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92392838|NCT05444556|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392839|NCT05444556|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92392840|NCT05444556|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92392841|NCT05445804|Cannabidiol|cannabidiol|mesh-list
92392842|NCT05445804|Anticonvulsants|anticonvulsants|mesh-ancestor
92392843|NCT05440578|Bevacizumab|bevacizumab|mesh-list
92392844|NCT05440578|Olaparib|olaparib|mesh-list
92392845|NCT05440578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92392846|NCT05440578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392847|NCT05440578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92392848|NCT05440578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92392849|NCT05440578|Growth Substances|growth substances|mesh-ancestor
92392850|NCT05440578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392851|NCT05440578|Growth Inhibitors|growth inhibitors|mesh-ancestor
92392852|NCT05440578|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92392853|NCT05440578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392854|NCT05440578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392855|NCT01689558|Endostatins|endostatins|mesh-list
92392856|NCT01689558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392857|NCT01689558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92392858|NCT01689558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92392859|NCT01689558|Growth Substances|growth substances|mesh-ancestor
92392860|NCT01689558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392861|NCT01689558|Growth Inhibitors|growth inhibitors|mesh-ancestor
92392862|NCT01689870|Ipilimumab|ipilimumab|mesh-list
92392863|NCT01689870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92392864|NCT01689870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392865|NCT01689870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92392866|NCT01689870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392867|NCT05768542|Metoprolol|metoprolol|mesh-list
92392868|NCT05768542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92392869|NCT05768542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92392870|NCT05768542|Sympatholytics|sympatholytics|mesh-ancestor
92392871|NCT05768542|Autonomic Agents|autonomic agents|mesh-ancestor
92392872|NCT05768542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392873|NCT05768542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392874|NCT05768542|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92392875|NCT05768542|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92392876|NCT05768542|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92392877|NCT05768542|Adrenergic Agents|adrenergic agents|mesh-ancestor
92392878|NCT05768542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392879|NCT05768542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392880|NCT05768464|Axitinib|axitinib|mesh-list
92392881|NCT05768464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392882|NCT05768464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045229|NCT04786964|Hematinics|hematinics|mesh-ancestor
92392883|NCT05768464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392884|NCT05768464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392885|NCT05768334|Lubiprostone|lubiprostone|mesh-list
92392886|NCT05768334|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92392887|NCT05768334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392888|NCT05768334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392889|NCT05768243|Hyaluronic Acid|hyaluronic acid|mesh-list
92392890|NCT05768243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92392891|NCT05768243|Immunologic Factors|immunologic factors|mesh-ancestor
92392892|NCT05768243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392893|NCT05768243|Viscosupplements|viscosupplements|mesh-ancestor
92392894|NCT05768243|Protective Agents|protective agents|mesh-ancestor
92392896|NCT05768230|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92392897|NCT05768230|Vasodilator Agents|vasodilator agents|mesh-ancestor
92392898|NCT05768230|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92392899|NCT05768230|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92392900|NCT05768230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392901|NCT05768230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392902|NCT05768230|Protective Agents|protective agents|mesh-ancestor
92392903|NCT05768230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392904|NCT05768204|Prednisolone|prednisolone|mesh-list
92392905|NCT05768204|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92392906|NCT05768204|Methylprednisolone|methylprednisolone|mesh-list
92392907|NCT05768204|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92392908|NCT05768204|Prednisolone acetate|prednisolone acetate|mesh-list
92392909|NCT05768204|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92392910|NCT05768204|Prednisolone phosphate|prednisolone phosphate|mesh-list
92392911|NCT05768204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392912|NCT05768204|Glucocorticoids|glucocorticoids|mesh-ancestor
92392913|NCT05768204|Hormones|hormones|mesh-ancestor
92392914|NCT05768204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92392915|NCT05768204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392916|NCT05768204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92392917|NCT05768204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392918|NCT05768204|Antiemetics|antiemetics|mesh-ancestor
92392919|NCT05768204|Autonomic Agents|autonomic agents|mesh-ancestor
92392920|NCT05768204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392921|NCT05768204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92392922|NCT05768204|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92392923|NCT05768204|Protective Agents|protective agents|mesh-ancestor
92392924|NCT05768126|Rivastigmine|rivastigmine|mesh-list
92392925|NCT05768126|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92392926|NCT05768126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392927|NCT05768126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392928|NCT05768126|Cholinergic Agents|cholinergic agents|mesh-ancestor
92392929|NCT05768126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392930|NCT05768126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392931|NCT05768126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92392932|NCT05768126|Protective Agents|protective agents|mesh-ancestor
92392933|NCT05767827|Lidocaine|lidocaine|mesh-list
92392934|NCT05767827|Epinephrine|epinephrine|mesh-list
92392935|NCT05767827|Racepinephrine|racepinephrine|mesh-list
92392936|NCT05767827|Dexmedetomidine|dexmedetomidine|mesh-list
92392937|NCT05767827|Ropivacaine|ropivacaine|mesh-list
92392938|NCT05767827|Epinephryl borate|epinephryl borate|mesh-list
92392939|NCT05767827|Anesthetics, Local|anesthetics, local|mesh-ancestor
92392940|NCT05767827|Anesthetics|anesthetics|mesh-ancestor
92392941|NCT05767827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92392942|NCT05767827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392943|NCT05767827|Sensory System Agents|sensory system agents|mesh-ancestor
92392944|NCT05767827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392945|NCT05767827|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92135491|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92392946|NCT05767827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92392947|NCT05767827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92392948|NCT05767827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92392949|NCT05767827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392950|NCT05767827|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92392951|NCT05767827|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92392952|NCT05767827|Analgesics|analgesics|mesh-ancestor
92392953|NCT05767827|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92392954|NCT05767827|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92392955|NCT05767827|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92392956|NCT05767827|Adrenergic Agents|adrenergic agents|mesh-ancestor
92045310|NCT02209597|Bupropion|bupropion|mesh-list
92392957|NCT05767827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392958|NCT05767827|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92392959|NCT05767827|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92392960|NCT05767827|Autonomic Agents|autonomic agents|mesh-ancestor
92392961|NCT05767827|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92392962|NCT05767827|Respiratory System Agents|respiratory system agents|mesh-ancestor
92392963|NCT05767827|Mydriatics|mydriatics|mesh-ancestor
92392964|NCT05767827|Sympathomimetics|sympathomimetics|mesh-ancestor
92392965|NCT05767827|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92392966|NCT05767736|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92392967|NCT05767736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92392968|NCT05767736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92392969|NCT05767736|Immunologic Factors|immunologic factors|mesh-ancestor
92392970|NCT05767736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392971|NCT05767723|Aspirin|aspirin|mesh-list
92392972|NCT05767723|Ticagrelor|ticagrelor|mesh-list
92392973|NCT05767723|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92392974|NCT05767723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92392975|NCT05767723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92392976|NCT05767723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92392977|NCT05767723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92392978|NCT05767723|Purinergic Agents|purinergic agents|mesh-ancestor
92392979|NCT05767723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92392980|NCT05767723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92392981|NCT05767723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92392982|NCT05767723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92392983|NCT05767723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92392984|NCT05767723|Analgesics|analgesics|mesh-ancestor
92392985|NCT05767723|Sensory System Agents|sensory system agents|mesh-ancestor
92392986|NCT05767723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92392987|NCT05767723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92392988|NCT05767723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92392989|NCT05767723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92392990|NCT05767723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92392991|NCT05767723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92392992|NCT05767723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92392993|NCT05767723|Antipyretics|antipyretics|mesh-ancestor
92392994|NCT05767684|Nivolumab|nivolumab|mesh-list
92392996|NCT05767684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92392997|NCT05767684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92392998|NCT05767684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92392999|NCT05767684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393000|NCT05767684|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92393001|NCT05767684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393002|NCT05767671|Dimercaprol|dimercaprol|mesh-list
92393003|NCT05767671|Chelating Agents|chelating agents|mesh-ancestor
92393004|NCT05767671|Sequestering Agents|sequestering agents|mesh-ancestor
92393005|NCT05767671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393006|NCT05767632|Solifenacin Succinate|solifenacin succinate|mesh-list
92393007|NCT05767632|Mirabegron|mirabegron|mesh-list
92393008|NCT05767632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92393009|NCT05767632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92393010|NCT05767632|Cholinergic Agents|cholinergic agents|mesh-ancestor
92393011|NCT05767632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393012|NCT05767632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393013|NCT05767632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393014|NCT05767632|Urological Agents|urological agents|mesh-ancestor
92393015|NCT05767632|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92393016|NCT05767632|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92393017|NCT05767632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393018|NCT05767632|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393019|NCT05767515|Inositol|inositol|mesh-list
92393020|NCT05767515|Acetylcarnitine|acetylcarnitine|mesh-list
92393021|NCT05767515|Metformin|metformin|mesh-list
92393022|NCT05767515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393023|NCT05767515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393024|NCT05767515|Vitamin B Complex|vitamin b complex|mesh-ancestor
92393025|NCT05767515|Vitamins|vitamins|mesh-ancestor
92393026|NCT05767515|Micronutrients|micronutrients|mesh-ancestor
92393027|NCT05767515|Nootropic Agents|nootropic agents|mesh-ancestor
92393028|NCT05767255|Insulin|insulin|mesh-list
92393029|NCT05767255|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92393030|NCT05767255|Insulin Glargine|insulin glargine|mesh-list
92393031|NCT05767255|Insulin Aspart|insulin aspart|mesh-list
92393032|NCT05767255|Liraglutide|liraglutide|mesh-list
92393033|NCT05767255|Xultophy|xultophy|mesh-list
92393034|NCT05767255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393035|NCT05767255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393038|NCT05767255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393039|NCT05767229|Carvedilol|carvedilol|mesh-list
92393040|NCT05767229|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92393041|NCT05767229|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92393043|NCT05767229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393044|NCT05767229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393045|NCT05767229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393046|NCT05767229|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92393047|NCT05767229|Antioxidants|antioxidants|mesh-ancestor
92393048|NCT05767229|Protective Agents|protective agents|mesh-ancestor
92393049|NCT05767229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92393050|NCT05767229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92393051|NCT05767229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92393052|NCT05767229|Vasodilator Agents|vasodilator agents|mesh-ancestor
92393053|NCT05767229|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92393054|NCT05767229|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92393055|NCT05767060|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92393056|NCT05767060|Immunologic Factors|immunologic factors|mesh-ancestor
92393057|NCT05767060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393058|NCT05761431|Octreotide|octreotide|mesh-list
92393059|NCT05761431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92393060|NCT05761431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92393061|NCT05761431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393062|NCT05755789|Cefoxitin|cefoxitin|mesh-list
92393063|NCT05755789|Cefotaxime|cefotaxime|mesh-list
92393064|NCT05755789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92393065|NCT05755789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393066|NCT05753267|Mesalamine|mesalamine|mesh-list
92393067|NCT05753267|Fenofibrate|fenofibrate|mesh-list
92393068|NCT05753267|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92393069|NCT05753267|Antimetabolites|antimetabolites|mesh-ancestor
92393070|NCT05753267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393071|NCT05753267|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92393072|NCT05753267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92393073|NCT05753267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393074|NCT05753267|Analgesics|analgesics|mesh-ancestor
92393075|NCT05753267|Sensory System Agents|sensory system agents|mesh-ancestor
92393076|NCT05753267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393077|NCT05753267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393078|NCT05753267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393079|NCT05753267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393080|NCT05751343|Bevacizumab|bevacizumab|mesh-list
92393081|NCT05751343|Atezolizumab|atezolizumab|mesh-list
92393082|NCT05751343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393083|NCT05751343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393084|NCT05751343|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92393085|NCT05751343|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92393086|NCT05751343|Growth Substances|growth substances|mesh-ancestor
92393087|NCT05751343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393088|NCT05751343|Growth Inhibitors|growth inhibitors|mesh-ancestor
92393089|NCT05751343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92393090|NCT05751343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393091|NCT05647681|Acetaminophen|acetaminophen|mesh-list
92393092|NCT05647681|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393093|NCT05647681|Analgesics|analgesics|mesh-ancestor
92393094|NCT05647681|Sensory System Agents|sensory system agents|mesh-ancestor
92393095|NCT05647681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393096|NCT05647681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393097|NCT05647681|Antipyretics|antipyretics|mesh-ancestor
92393098|NCT05644145|Vaccines|vaccines|mesh-list
92393099|NCT05644145|Immunologic Factors|immunologic factors|mesh-ancestor
92393100|NCT05644145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393101|NCT05642416|Ropivacaine|ropivacaine|mesh-list
92393102|NCT05642416|Anesthetics, Local|anesthetics, local|mesh-ancestor
92393103|NCT05642416|Anesthetics|anesthetics|mesh-ancestor
92393104|NCT05642416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393105|NCT05642416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393106|NCT05642416|Sensory System Agents|sensory system agents|mesh-ancestor
92393107|NCT05642416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393108|NCT05631028|Dexmedetomidine|dexmedetomidine|mesh-list
92045462|NCT03471260|Venetoclax|venetoclax|mesh-list
92393109|NCT05631028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92393110|NCT05631028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393111|NCT05631028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393112|NCT05631028|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393113|NCT05631028|Analgesics|analgesics|mesh-ancestor
92393114|NCT05631028|Sensory System Agents|sensory system agents|mesh-ancestor
92393115|NCT05631028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393116|NCT05631028|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92393117|NCT05631028|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92393119|NCT05631028|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393120|NCT05631028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393121|NCT05631028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393122|NCT05604599|Fentanyl|fentanyl|mesh-list
92393123|NCT05604599|Dexmedetomidine|dexmedetomidine|mesh-list
92393124|NCT05604599|Propofol|propofol|mesh-list
92393125|NCT05604599|Isoflurane|isoflurane|mesh-list
92393126|NCT05604599|Atracurium|atracurium|mesh-list
92393127|NCT05604599|Cisatracurium|cisatracurium|mesh-list
92393128|NCT05604599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92393129|NCT05604599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393130|NCT05604599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393131|NCT05604599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393132|NCT05604599|Analgesics|analgesics|mesh-ancestor
92393133|NCT05604599|Sensory System Agents|sensory system agents|mesh-ancestor
92393134|NCT05604599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393135|NCT05604599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92393136|NCT05604599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92393137|NCT05604599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393138|NCT05604599|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393139|NCT05604599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393140|NCT05604599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393141|NCT05604599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92393142|NCT05604599|Anesthetics, General|anesthetics, general|mesh-ancestor
92393143|NCT05604599|Anesthetics|anesthetics|mesh-ancestor
92393144|NCT05604599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92393145|NCT05604599|Narcotics|narcotics|mesh-ancestor
92393146|NCT05604599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92393147|NCT05604599|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92393148|NCT05604599|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92393149|NCT05604599|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92393150|NCT05604599|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92393151|NCT05604599|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92393152|NCT05604599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92393153|NCT05604599|Cholinergic Agents|cholinergic agents|mesh-ancestor
92393154|NCT05602636|Midazolam|midazolam|mesh-list
92393155|NCT05602636|Bupivacaine|bupivacaine|mesh-list
92393156|NCT05602636|Anesthetics, Local|anesthetics, local|mesh-ancestor
92393157|NCT05602636|Anesthetics|anesthetics|mesh-ancestor
92393158|NCT05602636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393159|NCT05602636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393160|NCT05602636|Sensory System Agents|sensory system agents|mesh-ancestor
92393161|NCT05602636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393162|NCT05602636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92393163|NCT05602636|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92393164|NCT05602636|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92393165|NCT05602636|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92393166|NCT05602636|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92393167|NCT05602636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92393168|NCT05602636|Anesthetics, General|anesthetics, general|mesh-ancestor
92393169|NCT05602636|GABA Modulators|gaba modulators|mesh-ancestor
92393170|NCT05602636|GABA Agents|gaba agents|mesh-ancestor
92393171|NCT05602636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393172|NCT05602636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393173|NCT05543837|Capsaicin|capsaicin|mesh-list
92393174|NCT05543837|Antipruritics|antipruritics|mesh-ancestor
92393175|NCT05543837|Dermatologic Agents|dermatologic agents|mesh-ancestor
92393176|NCT05543837|Sensory System Agents|sensory system agents|mesh-ancestor
92393177|NCT05543837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393178|NCT05543837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393179|NCT05486026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92393180|NCT05486026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92393181|NCT05486026|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92393182|NCT05486026|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92393183|NCT05486026|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92393184|NCT05486026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92393185|NCT05486026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393186|NCT05486026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393187|NCT05486026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393188|NCT05486026|Analgesics|analgesics|mesh-ancestor
92393189|NCT05486026|Sensory System Agents|sensory system agents|mesh-ancestor
92393190|NCT05486026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393191|NCT05486026|Antidepressive Agents|antidepressive agents|mesh-ancestor
92393192|NCT05486026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92393193|NCT05486026|Dopamine Agents|dopamine agents|mesh-ancestor
92393194|NCT05486026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393195|NCT05486026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393196|NCT05468099|Chlorhexidine|chlorhexidine|mesh-list
92393197|NCT05468099|Povidone-Iodine|povidone-iodine|mesh-list
92393198|NCT05468099|Povidone|povidone|mesh-list
92393199|NCT05468099|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92393200|NCT05468099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393201|NCT05468099|Disinfectants|disinfectants|mesh-ancestor
92393202|NCT05468099|Plasma Substitutes|plasma substitutes|mesh-ancestor
92393203|NCT05468099|Blood Substitutes|blood substitutes|mesh-ancestor
92393204|NCT05419427|Denosumab|denosumab|mesh-list
92393205|NCT05419427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92393206|NCT05419427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393207|NCT05411107|Iloprost|iloprost|mesh-list
92393208|NCT05411107|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92393209|NCT05411107|Vasodilator Agents|vasodilator agents|mesh-ancestor
92393211|NCT05379686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92393212|NCT05379686|Hormones|hormones|mesh-ancestor
92393213|NCT05379686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393214|NCT05379686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393215|NCT05334472|Ofatumumab|ofatumumab|mesh-list
92393216|NCT05334472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393217|NCT05332067|Omalizumab|omalizumab|mesh-list
92393218|NCT05332067|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92393219|NCT05332067|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92393220|NCT05332067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92393221|NCT05332067|Respiratory System Agents|respiratory system agents|mesh-ancestor
92393222|NCT05332067|Immunologic Factors|immunologic factors|mesh-ancestor
92393223|NCT05332067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393224|NCT05323890|Tislelizumab|tislelizumab|mesh-list
92393225|NCT05323890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393226|NCT05323890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393227|NCT05301608|Psilocybin|psilocybin|mesh-list
92393228|NCT05301608|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92393229|NCT05301608|Hallucinogens|hallucinogens|mesh-ancestor
92393230|NCT05301608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393231|NCT05301608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92393232|NCT05301608|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92393233|NCT05301608|Serotonin Agents|serotonin agents|mesh-ancestor
92393234|NCT05301608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393235|NCT05301608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393236|NCT05301608|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92393237|NCT05284019|Erenumab|erenumab|mesh-list
92393238|NCT05284019|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92393239|NCT05284019|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92393240|NCT05284019|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92393241|NCT05284019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393242|NCT05284019|Analgesics|analgesics|mesh-ancestor
92393243|NCT05284019|Sensory System Agents|sensory system agents|mesh-ancestor
92393244|NCT05284019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393245|NCT05284019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393246|NCT05284019|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92393247|NCT05284019|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92393248|NCT05284019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92393249|NCT05284019|Cholinergic Agents|cholinergic agents|mesh-ancestor
92393250|NCT05284019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393251|NCT05271162|Empagliflozin|empagliflozin|mesh-list
92393252|NCT05271162|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92393253|NCT05271162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393254|NCT05271162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393255|NCT05271162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393256|NCT05257083|Dexamethasone|dexamethasone|mesh-list
92393257|NCT05257083|Cyclophosphamide|cyclophosphamide|mesh-list
92045606|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
92393258|NCT05257083|Fludarabine|fludarabine|mesh-list
92393259|NCT05257083|Lenalidomide|lenalidomide|mesh-list
92393260|NCT05257083|Bortezomib|bortezomib|mesh-list
92393261|NCT05257083|Daratumumab|daratumumab|mesh-list
92393262|NCT05257083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92393263|NCT05257083|Immunologic Factors|immunologic factors|mesh-ancestor
92393264|NCT05257083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393265|NCT05257083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393266|NCT05257083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92393267|NCT05257083|Alkylating Agents|alkylating agents|mesh-ancestor
92393268|NCT05257083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393269|NCT05257083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393270|NCT05257083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92393271|NCT05257083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393272|NCT05257083|Antiemetics|antiemetics|mesh-ancestor
92393273|NCT05257083|Autonomic Agents|autonomic agents|mesh-ancestor
92393274|NCT05257083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393275|NCT05257083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92393276|NCT05257083|Glucocorticoids|glucocorticoids|mesh-ancestor
92393277|NCT05257083|Hormones|hormones|mesh-ancestor
92393278|NCT05257083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393279|NCT05257083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92393280|NCT05257083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92393281|NCT05257083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92393282|NCT05257083|Growth Substances|growth substances|mesh-ancestor
92393283|NCT05257083|Growth Inhibitors|growth inhibitors|mesh-ancestor
92393284|NCT05249634|Testosterone|testosterone|mesh-list
92393285|NCT05249634|Androgens|androgens|mesh-ancestor
92393286|NCT05249634|Hormones|hormones|mesh-ancestor
92393287|NCT05249634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393288|NCT05249634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393289|NCT05217342|Diuretics|diuretics|mesh-list
92393290|NCT05217342|Natriuretic Agents|natriuretic agents|mesh-ancestor
92393291|NCT05217342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393292|NCT05199714|Pramlintide|pramlintide|mesh-list
92393293|NCT05199714|Pancrelipase|pancrelipase|mesh-list
92393294|NCT05199714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92393295|NCT05199714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393296|NCT05199714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393297|NCT05193370|Vasopressins|vasopressins|mesh-list
92393298|NCT05193370|Arginine Vasopressin|arginine vasopressin|mesh-list
92393299|NCT05193370|Angiotensin II|angiotensin ii|mesh-list
92393300|NCT05193370|Giapreza|giapreza|mesh-list
92393301|NCT05193370|Angiotensinogen|angiotensinogen|mesh-list
92393302|NCT05193370|Hemostatics|hemostatics|mesh-ancestor
92393303|NCT05193370|Coagulants|coagulants|mesh-ancestor
92393304|NCT05193370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92393305|NCT05193370|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92393306|NCT05193370|Natriuretic Agents|natriuretic agents|mesh-ancestor
92393307|NCT05193370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393308|NCT05193370|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92393309|NCT05193370|Protease Inhibitors|protease inhibitors|mesh-ancestor
92393310|NCT05193370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393311|NCT05193370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393312|NCT05172947|Resveratrol|resveratrol|mesh-list
92393313|NCT05172947|Antioxidants|antioxidants|mesh-ancestor
92393314|NCT05172947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393315|NCT05172947|Protective Agents|protective agents|mesh-ancestor
92393316|NCT05172947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393317|NCT05172947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393318|NCT05172947|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92393319|NCT05170607|Antibodies|antibodies|mesh-list
92393320|NCT05170607|Immunologic Factors|immunologic factors|mesh-ancestor
92393321|NCT05170607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393322|NCT05147220|Teriflunomide|teriflunomide|mesh-list
92393323|NCT05147220|Remibrutinib|remibrutinib|mesh-list
92393324|NCT05147220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92393325|NCT05147220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393326|NCT05147220|Analgesics|analgesics|mesh-ancestor
92393327|NCT05147220|Sensory System Agents|sensory system agents|mesh-ancestor
92393328|NCT05147220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393329|NCT05147220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393330|NCT05147220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393331|NCT05147220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393332|NCT05147220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92393333|NCT05147220|Immunologic Factors|immunologic factors|mesh-ancestor
92393334|NCT05147220|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92393335|NCT05147220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393336|NCT05147220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393338|NCT05078827|Antimetabolites|antimetabolites|mesh-ancestor
92393339|NCT05078827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393340|NCT05078827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92393341|NCT05078827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393342|NCT05078827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92393343|NCT05078827|Immunologic Factors|immunologic factors|mesh-ancestor
92393344|NCT05078827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393345|NCT05076981|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92393346|NCT05076981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92393347|NCT05076981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393348|NCT05065164|Denosumab|denosumab|mesh-list
92393349|NCT05065164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92393350|NCT05065164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393351|NCT05057819|Empagliflozin|empagliflozin|mesh-list
92393352|NCT05057819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92393353|NCT05057819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393354|NCT05057819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393355|NCT05057819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393356|NCT05037812|Ketorolac|ketorolac|mesh-list
92393357|NCT05037812|Clonidine|clonidine|mesh-list
92393358|NCT05037812|Epinephrine|epinephrine|mesh-list
92393359|NCT05037812|Morphine|morphine|mesh-list
92393360|NCT05037812|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92393361|NCT05037812|Narcotics|narcotics|mesh-ancestor
92393362|NCT05037812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393363|NCT05037812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393364|NCT05037812|Analgesics|analgesics|mesh-ancestor
92393365|NCT05037812|Sensory System Agents|sensory system agents|mesh-ancestor
92393366|NCT05037812|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393367|NCT05037812|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92393368|NCT05037812|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393369|NCT05037812|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393370|NCT05037812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393371|NCT05037812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393372|NCT05037812|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92393373|NCT05037812|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92393374|NCT05037812|Autonomic Agents|autonomic agents|mesh-ancestor
92393375|NCT05037812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92393376|NCT05037812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92393377|NCT05037812|Mydriatics|mydriatics|mesh-ancestor
92393378|NCT05037812|Sympathomimetics|sympathomimetics|mesh-ancestor
92393379|NCT05037812|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92393380|NCT05037812|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92393381|NCT05037812|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393382|NCT05037812|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393383|NCT05037812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393384|NCT05037812|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92393385|NCT05037812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393386|NCT05037812|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92393387|NCT05037812|Sympatholytics|sympatholytics|mesh-ancestor
92393388|NCT05037812|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92393389|NCT05019638|Ketorolac|ketorolac|mesh-list
92393390|NCT05019638|Epinephrine|epinephrine|mesh-list
92393391|NCT05019638|Racepinephrine|racepinephrine|mesh-list
92393392|NCT05019638|Morphine|morphine|mesh-list
92393393|NCT05019638|Bupivacaine|bupivacaine|mesh-list
92393394|NCT05019638|Epinephryl borate|epinephryl borate|mesh-list
92393395|NCT05019638|Anesthetics, Local|anesthetics, local|mesh-ancestor
92393396|NCT05019638|Anesthetics|anesthetics|mesh-ancestor
92393397|NCT05019638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393398|NCT05019638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393399|NCT05019638|Sensory System Agents|sensory system agents|mesh-ancestor
91988085|NCT02440399|Acetaminophen|acetaminophen|mesh-list
92393401|NCT05019638|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92393402|NCT05019638|Narcotics|narcotics|mesh-ancestor
92393403|NCT05019638|Analgesics|analgesics|mesh-ancestor
92393404|NCT05019638|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92393405|NCT05019638|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393406|NCT05019638|Adrenergic Agents|adrenergic agents|mesh-ancestor
92045746|NCT02244944|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92393407|NCT05019638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393408|NCT05019638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393409|NCT05019638|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92393410|NCT05019638|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92393411|NCT05019638|Autonomic Agents|autonomic agents|mesh-ancestor
92393412|NCT05019638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92393413|NCT05019638|Respiratory System Agents|respiratory system agents|mesh-ancestor
92393414|NCT05019638|Mydriatics|mydriatics|mesh-ancestor
92393415|NCT05019638|Sympathomimetics|sympathomimetics|mesh-ancestor
92393416|NCT05019638|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92393417|NCT05019638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92393418|NCT05019638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393419|NCT05019638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393420|NCT05019638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393421|NCT05019638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92393422|NCT05019638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393423|NCT04905979|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92393424|NCT04905979|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92393425|NCT04905979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92393426|NCT04905979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92393427|NCT04905979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393428|NCT04905979|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393429|NCT04905979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393430|NCT04905979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393431|NCT04854512|Metformin|metformin|mesh-list
92393432|NCT04854512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393433|NCT04854512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393434|NCT04806386|Psyllium|psyllium|mesh-list
92393435|NCT04806386|Cathartics|cathartics|mesh-ancestor
92393436|NCT04806386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92393437|NCT04804072|Analgesics, Opioid|analgesics, opioid|mesh-list
92393438|NCT04804072|Narcotics|narcotics|mesh-ancestor
92393439|NCT04804072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393440|NCT04804072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393441|NCT04804072|Analgesics|analgesics|mesh-ancestor
92393442|NCT04804072|Sensory System Agents|sensory system agents|mesh-ancestor
92393443|NCT04804072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393444|NCT04797156|Tranexamic Acid|tranexamic acid|mesh-list
92393445|NCT04797156|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92393446|NCT04797156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92393447|NCT04797156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393448|NCT04797156|Hemostatics|hemostatics|mesh-ancestor
92393449|NCT04797156|Coagulants|coagulants|mesh-ancestor
92393450|NCT04772300|Sirolimus|sirolimus|mesh-list
92393451|NCT04772300|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92393452|NCT04772300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393453|NCT04772300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92393454|NCT04772300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393455|NCT04772300|Antifungal Agents|antifungal agents|mesh-ancestor
92393456|NCT04772300|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92393457|NCT04772300|Immunologic Factors|immunologic factors|mesh-ancestor
92393458|NCT04772300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393459|NCT04759144|Insulin|insulin|mesh-list
92393460|NCT04759144|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92393461|NCT04759144|Insulin Aspart|insulin aspart|mesh-list
92393462|NCT04759144|Insulin, Long-Acting|insulin, long-acting|mesh-list
92393463|NCT04759144|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92393464|NCT04759144|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393465|NCT04759144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393466|NCT04724031|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92393467|NCT04724031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393468|NCT04724031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393469|NCT04724031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393470|NCT04679376|Atorvastatin|atorvastatin|mesh-list
92393471|NCT04679376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91988087|NCT02440399|Morphine|morphine|mesh-list
92393472|NCT04679376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92393473|NCT04679376|Antimetabolites|antimetabolites|mesh-ancestor
92393474|NCT04679376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393475|NCT04679376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92393476|NCT04679376|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92393477|NCT04679376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393478|NCT04677959|Fluticasone|fluticasone|mesh-list
92393481|NCT04677959|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92393482|NCT04677959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393483|NCT04677959|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92393484|NCT04677959|Autonomic Agents|autonomic agents|mesh-ancestor
92393485|NCT04677959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393486|NCT04677959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393487|NCT04677959|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92393488|NCT04677959|Respiratory System Agents|respiratory system agents|mesh-ancestor
92393489|NCT04677959|Dermatologic Agents|dermatologic agents|mesh-ancestor
92393490|NCT04677959|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92393491|NCT04677959|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92393492|NCT04677959|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92393493|NCT04677959|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393494|NCT04677959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393495|NCT04677959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393496|NCT04677959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393497|NCT04677959|Tocolytic Agents|tocolytic agents|mesh-ancestor
92393498|NCT04677959|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92393499|NCT04671043|Caffeine|caffeine|mesh-list
92393500|NCT04671043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92393501|NCT04671043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393502|NCT04671043|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92393503|NCT04671043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393504|NCT04671043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393505|NCT04671043|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92393506|NCT04671043|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92393507|NCT04671043|Purinergic Agents|purinergic agents|mesh-ancestor
92393508|NCT04671043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393509|NCT04612920|Acetaminophen|acetaminophen|mesh-list
92393510|NCT04612920|Ibuprofen|ibuprofen|mesh-list
92393511|NCT04612920|Oxycodone|oxycodone|mesh-list
92393512|NCT04612920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92393513|NCT04612920|Analgesics|analgesics|mesh-ancestor
92393514|NCT04612920|Sensory System Agents|sensory system agents|mesh-ancestor
92393515|NCT04612920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393516|NCT04612920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393517|NCT04612920|Antipyretics|antipyretics|mesh-ancestor
92393518|NCT04612920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92393519|NCT04612920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393520|NCT04612920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393521|NCT04612920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92393522|NCT04612920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393523|NCT04612920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393524|NCT04612920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92393525|NCT04612920|Narcotics|narcotics|mesh-ancestor
92393526|NCT04612920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393527|NCT04570293|Lidocaine|lidocaine|mesh-list
92393528|NCT04570293|Anesthetics, Local|anesthetics, local|mesh-ancestor
92393529|NCT04570293|Anesthetics|anesthetics|mesh-ancestor
92393530|NCT04570293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393531|NCT04570293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393532|NCT04570293|Sensory System Agents|sensory system agents|mesh-ancestor
92393533|NCT04570293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393534|NCT04570293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92393535|NCT04570293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92393536|NCT04570293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92393537|NCT04570293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92393538|NCT04570293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393539|NCT04531462|Empagliflozin|empagliflozin|mesh-list
92393540|NCT04531462|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92393541|NCT04531462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393542|NCT04531462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393543|NCT04531462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393544|NCT04520139|Acetylcysteine|acetylcysteine|mesh-list
92393545|NCT04520139|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92393546|NCT04520139|Antiviral Agents|antiviral agents|mesh-ancestor
92393547|NCT04520139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393548|NCT04520139|Expectorants|expectorants|mesh-ancestor
92393549|NCT04520139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92393550|NCT04520139|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92393551|NCT04520139|Antioxidants|antioxidants|mesh-ancestor
92393552|NCT04520139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393553|NCT04520139|Protective Agents|protective agents|mesh-ancestor
92393554|NCT04520139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393555|NCT04520139|Antidotes|antidotes|mesh-ancestor
92393557|NCT04512105|Pitavastatin|pitavastatin|mesh-list
92393558|NCT04512105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393559|NCT04512105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92045898|NCT01709110|Vitamin D|vitamin d|mesh-list
92393560|NCT04512105|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92393561|NCT04512105|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92393562|NCT04512105|Antimetabolites|antimetabolites|mesh-ancestor
92393563|NCT04512105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393564|NCT04512105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393565|NCT04512105|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92393566|NCT04505254|Obinutuzumab|obinutuzumab|mesh-list
92393567|NCT04505254|Acalabrutinib|acalabrutinib|mesh-list
92393568|NCT04505254|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92393569|NCT04505254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393570|NCT04505254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393571|NCT04505254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92393572|NCT04505254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393573|NCT04505254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393574|NCT04504318|Enoxaparin|enoxaparin|mesh-list
92393575|NCT04504318|Apixaban|apixaban|mesh-list
92393576|NCT04504318|Anticoagulants|anticoagulants|mesh-ancestor
92393577|NCT04504318|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92393578|NCT04504318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92393579|NCT04504318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393580|NCT04504318|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92393581|NCT04504318|Antithrombins|antithrombins|mesh-ancestor
92393582|NCT04504318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92393583|NCT04504318|Protease Inhibitors|protease inhibitors|mesh-ancestor
92393584|NCT04504318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393585|NCT04501120|Azacitidine|azacitidine|mesh-list
92393586|NCT04501120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92393587|NCT04501120|Antimetabolites|antimetabolites|mesh-ancestor
92393588|NCT04501120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393589|NCT04501120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393590|NCT04501120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393591|NCT04497142|Levetiracetam|levetiracetam|mesh-list
92393592|NCT04497142|Anticonvulsants|anticonvulsants|mesh-ancestor
92393593|NCT04497142|Nootropic Agents|nootropic agents|mesh-ancestor
92393594|NCT04477317|Epinephrine|epinephrine|mesh-list
92393595|NCT04477317|Racepinephrine|racepinephrine|mesh-list
92393596|NCT04477317|Nordefrin|nordefrin|mesh-list
92393597|NCT04477317|Carticaine|carticaine|mesh-list
92393598|NCT04477317|Mepivacaine|mepivacaine|mesh-list
92393599|NCT04477317|Epinephryl borate|epinephryl borate|mesh-list
92393600|NCT04477317|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92393601|NCT04477317|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393602|NCT04477317|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393603|NCT04477317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393604|NCT04477317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393605|NCT04477317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393606|NCT04477317|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92393607|NCT04477317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92393608|NCT04477317|Autonomic Agents|autonomic agents|mesh-ancestor
92393609|NCT04477317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393610|NCT04477317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92393611|NCT04477317|Respiratory System Agents|respiratory system agents|mesh-ancestor
92393612|NCT04477317|Mydriatics|mydriatics|mesh-ancestor
92393613|NCT04477317|Sympathomimetics|sympathomimetics|mesh-ancestor
92393614|NCT04477317|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92393615|NCT04477317|Anesthetics, Local|anesthetics, local|mesh-ancestor
92393616|NCT04477317|Anesthetics|anesthetics|mesh-ancestor
92393617|NCT04477317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393618|NCT04477317|Sensory System Agents|sensory system agents|mesh-ancestor
92393620|NCT04469959|Carbidopa|carbidopa|mesh-list
92393621|NCT04469959|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92393622|NCT04469959|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92393623|NCT04469959|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92393625|NCT04469959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393626|NCT04469959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135492|NCT01561898|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92393627|NCT04469959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393628|NCT04469959|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92393629|NCT04469959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393630|NCT04469959|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92393631|NCT04469959|Immunologic Factors|immunologic factors|mesh-ancestor
92393632|NCT04469959|Dopamine Agonists|dopamine agonists|mesh-ancestor
92393633|NCT04434196|Obinutuzumab|obinutuzumab|mesh-list
92393634|NCT04434196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393635|NCT04434196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393636|NCT04344262|Atracurium|atracurium|mesh-list
92393637|NCT04344262|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92393638|NCT04344262|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92393639|NCT04344262|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92393640|NCT04344262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393641|NCT04344262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393642|NCT04344262|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92393643|NCT04344262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92393644|NCT04344262|Cholinergic Agents|cholinergic agents|mesh-ancestor
92393645|NCT04344262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393646|NCT04344262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393647|NCT04330638|Siltuximab|siltuximab|mesh-list
92393648|NCT04330638|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92393649|NCT04330638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393650|NCT04330638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393651|NCT04291521|Ketamine|ketamine|mesh-list
92393652|NCT04291521|Propofol|propofol|mesh-list
92393653|NCT04291521|Etomidate|etomidate|mesh-list
92393654|NCT04291521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92393655|NCT04291521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393656|NCT04291521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393657|NCT04291521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92393658|NCT04291521|Anesthetics, General|anesthetics, general|mesh-ancestor
92393659|NCT04291521|Anesthetics|anesthetics|mesh-ancestor
92393660|NCT04291521|Analgesics|analgesics|mesh-ancestor
92393661|NCT04291521|Sensory System Agents|sensory system agents|mesh-ancestor
92393662|NCT04291521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393663|NCT04291521|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92393664|NCT04291521|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92393665|NCT04291521|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92393666|NCT04291521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393667|NCT04291521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393668|NCT04288427|Finasteride|finasteride|mesh-list
92393669|NCT04288427|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92393670|NCT04288427|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92393671|NCT04288427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393672|NCT04288427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393673|NCT04288427|Hormone Antagonists|hormone antagonists|mesh-ancestor
92393674|NCT04288427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393675|NCT04288427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393676|NCT04288427|Urological Agents|urological agents|mesh-ancestor
92393677|NCT04280601|Vitamin D|vitamin d|mesh-list
92393678|NCT04280601|Vitamins|vitamins|mesh-ancestor
92393679|NCT04280601|Micronutrients|micronutrients|mesh-ancestor
92393680|NCT04280601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393681|NCT04280601|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92393683|NCT04263064|Analgesics|analgesics|mesh-ancestor
92393684|NCT04263064|Sensory System Agents|sensory system agents|mesh-ancestor
92393685|NCT04263064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393686|NCT04263064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393687|NCT04263064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92393688|NCT04263064|Sympatholytics|sympatholytics|mesh-ancestor
92393689|NCT04263064|Autonomic Agents|autonomic agents|mesh-ancestor
92393690|NCT04263064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92393691|NCT04263064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92393692|NCT04263064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92393693|NCT04263064|Adrenergic Agents|adrenergic agents|mesh-ancestor
92393694|NCT04263064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393695|NCT04263064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393696|NCT04189783|Bupivacaine|bupivacaine|mesh-list
92393697|NCT04189783|Anesthetics, Local|anesthetics, local|mesh-ancestor
92393698|NCT04189783|Anesthetics|anesthetics|mesh-ancestor
92393699|NCT04189783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92393700|NCT04189783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393701|NCT04189783|Sensory System Agents|sensory system agents|mesh-ancestor
92393702|NCT04189783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393703|NCT04131309|Dexamethasone|dexamethasone|mesh-list
92393704|NCT04131309|Bortezomib|bortezomib|mesh-list
92393705|NCT04131309|Daratumumab|daratumumab|mesh-list
92393706|NCT04131309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92393707|NCT04131309|Antiemetics|antiemetics|mesh-ancestor
92393708|NCT04131309|Autonomic Agents|autonomic agents|mesh-ancestor
92393709|NCT04131309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393710|NCT04131309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393711|NCT04131309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92393712|NCT04131309|Glucocorticoids|glucocorticoids|mesh-ancestor
92393713|NCT04131309|Hormones|hormones|mesh-ancestor
92393714|NCT04131309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393715|NCT04131309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92393716|NCT04131309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393717|NCT04125134|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92393718|NCT04125134|Lubricant Eye Drops|lubricant eye drops|mesh-list
92393719|NCT04125134|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92393720|NCT04090567|Olaparib|olaparib|mesh-list
92393721|NCT04090567|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92393722|NCT04090567|Cediranib|cediranib|mesh-list
92393723|NCT04090567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393724|NCT04090567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393725|NCT04090567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393726|NCT04090567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92393727|NCT04061746|Plasma-lyte 148|plasma-lyte 148|mesh-list
92393728|NCT04061746|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92393729|NCT04061746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92393730|NCT04049110|Dapagliflozin|dapagliflozin|mesh-list
92393731|NCT04049110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92393732|NCT04049110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393733|NCT04049110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393734|NCT04049110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393735|NCT04040959|Niacinamide|niacinamide|mesh-list
92393736|NCT04040959|Niacin|niacin|mesh-list
92393737|NCT04040959|Nicotinic Acids|nicotinic acids|mesh-list
92393738|NCT04040959|Vitamin B Complex|vitamin b complex|mesh-ancestor
92393739|NCT04040959|Vitamins|vitamins|mesh-ancestor
92393740|NCT04040959|Micronutrients|micronutrients|mesh-ancestor
92393741|NCT04040959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393742|NCT04040959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92393743|NCT04040959|Antimetabolites|antimetabolites|mesh-ancestor
92393744|NCT04040959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393745|NCT04040959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92393746|NCT04040959|Vasodilator Agents|vasodilator agents|mesh-ancestor
92393747|NCT04039464|Bosentan|bosentan|mesh-list
92393748|NCT04039464|Sildenafil Citrate|sildenafil citrate|mesh-list
92393749|NCT04039464|Vasodilator Agents|vasodilator agents|mesh-ancestor
92393750|NCT04039464|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92393751|NCT04039464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92393752|NCT04039464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393753|NCT04039464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393754|NCT04039464|Urological Agents|urological agents|mesh-ancestor
92393755|NCT04039464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92393756|NCT04039464|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92393757|NCT04035031|Dapagliflozin|dapagliflozin|mesh-list
92393758|NCT04035031|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92393759|NCT04035031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393760|NCT04035031|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393761|NCT04035031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393762|NCT03965689|Paclitaxel|paclitaxel|mesh-list
92393763|NCT03965689|Carboplatin|carboplatin|mesh-list
92393764|NCT03965689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92393765|NCT03965689|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92393766|NCT03965689|Pevonedistat|pevonedistat|mesh-list
92393767|NCT03965689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92393769|NCT03965689|Tubulin Modulators|tubulin modulators|mesh-ancestor
92393770|NCT03965689|Antimitotic Agents|antimitotic agents|mesh-ancestor
92393771|NCT03965689|Mitosis Modulators|mitosis modulators|mesh-ancestor
92393772|NCT03965689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393773|NCT03960008|Doxorubicin|doxorubicin|mesh-list
92393774|NCT03960008|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92393775|NCT03960008|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92393776|NCT03960008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393777|NCT03960008|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92393778|NCT03960008|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92393779|NCT03960008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393780|NCT03960008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393782|NCT03959423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393783|NCT03959423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393784|NCT03936998|Vancomycin|vancomycin|mesh-list
92393785|NCT03936998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92393786|NCT03936998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393787|NCT03911505|Miglustat|miglustat|mesh-list
92393788|NCT03911505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393789|NCT03911505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393790|NCT03911505|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92393791|NCT03911505|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92393792|NCT03911505|Antiviral Agents|antiviral agents|mesh-ancestor
92393793|NCT03911505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393794|NCT03911505|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92393795|NCT03911505|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393796|NCT03911505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393797|NCT03835065|Calpastatin|calpastatin|mesh-list
92393798|NCT03835065|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92393799|NCT03835065|Protease Inhibitors|protease inhibitors|mesh-ancestor
92393800|NCT03835065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393801|NCT03835065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393802|NCT03786783|Vitamin A|vitamin a|mesh-list
92393803|NCT03786783|Cyclophosphamide|cyclophosphamide|mesh-list
92393804|NCT03786783|Melphalan|melphalan|mesh-list
92393805|NCT03786783|Mechlorethamine|mechlorethamine|mesh-list
92393806|NCT03786783|Thiotepa|thiotepa|mesh-list
92393807|NCT03786783|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92393808|NCT03786783|Cisplatin|cisplatin|mesh-list
92393809|NCT03786783|Carboplatin|carboplatin|mesh-list
92393810|NCT03786783|Doxorubicin|doxorubicin|mesh-list
92393811|NCT03786783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92393812|NCT03786783|Etoposide|etoposide|mesh-list
92393813|NCT03786783|Vincristine|vincristine|mesh-list
92393814|NCT03786783|Etoposide phosphate|etoposide phosphate|mesh-list
92393815|NCT03786783|Daunorubicin|daunorubicin|mesh-list
92393816|NCT03786783|Topotecan|topotecan|mesh-list
92393817|NCT03786783|Tretinoin|tretinoin|mesh-list
92393818|NCT03786783|Podophyllotoxin|podophyllotoxin|mesh-list
92393819|NCT03786783|Dinutuximab|dinutuximab|mesh-list
92393820|NCT03786783|Dexrazoxane|dexrazoxane|mesh-list
92393821|NCT03786783|Razoxane|razoxane|mesh-list
92393822|NCT03786783|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
92393823|NCT03786783|Isotretinoin|isotretinoin|mesh-list
92393824|NCT03786783|Sargramostim|sargramostim|mesh-list
92393825|NCT03786783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92393826|NCT03786783|Immunologic Factors|immunologic factors|mesh-ancestor
92393827|NCT03786783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393828|NCT03786783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393829|NCT03786783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92393830|NCT03786783|Alkylating Agents|alkylating agents|mesh-ancestor
92393831|NCT03786783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393832|NCT03786783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393833|NCT03786783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92393834|NCT03786783|Vitamins|vitamins|mesh-ancestor
92393835|NCT03786783|Micronutrients|micronutrients|mesh-ancestor
92393836|NCT03786783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92393837|NCT03786783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92393838|NCT03786783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92393839|NCT03786783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393840|NCT03786783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92393841|NCT03786783|Tubulin Modulators|tubulin modulators|mesh-ancestor
92393842|NCT03786783|Antimitotic Agents|antimitotic agents|mesh-ancestor
92393843|NCT03786783|Mitosis Modulators|mitosis modulators|mesh-ancestor
92393844|NCT03786783|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92393845|NCT03786783|Keratolytic Agents|keratolytic agents|mesh-ancestor
92393846|NCT03786783|Dermatologic Agents|dermatologic agents|mesh-ancestor
92393847|NCT03786783|Protective Agents|protective agents|mesh-ancestor
92393848|NCT03786783|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92393851|NCT03769181|Cemiplimab|cemiplimab|mesh-list
92393852|NCT03769181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393853|NCT03769181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393854|NCT03768349|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92393855|NCT03768349|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92393856|NCT03768349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393857|NCT03735875|Venetoclax|venetoclax|mesh-list
92393858|NCT03735875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393859|NCT03670056|Nivolumab|nivolumab|mesh-list
92393860|NCT03670056|Ipilimumab|ipilimumab|mesh-list
92393861|NCT03670056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393862|NCT03670056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393863|NCT03670056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92046202|NCT01587274|Acetaminophen|acetaminophen|mesh-list
92393864|NCT03670056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393865|NCT03654833|Bevacizumab|bevacizumab|mesh-list
92393866|NCT03654833|Pembrolizumab|pembrolizumab|mesh-list
92393867|NCT03654833|Atezolizumab|atezolizumab|mesh-list
92393868|NCT03654833|Niraparib|niraparib|mesh-list
92393869|NCT03654833|Rucaparib|rucaparib|mesh-list
92393870|NCT03654833|Dostarlimab|dostarlimab|mesh-list
92393871|NCT03654833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393872|NCT03654833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393873|NCT03654833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92393874|NCT03654833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92393875|NCT03654833|Growth Substances|growth substances|mesh-ancestor
92393876|NCT03654833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393877|NCT03654833|Growth Inhibitors|growth inhibitors|mesh-ancestor
92393878|NCT03654833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92393879|NCT03654833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393880|NCT03654833|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92393881|NCT03654833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393882|NCT03639935|Nivolumab|nivolumab|mesh-list
92393883|NCT03639935|Rucaparib|rucaparib|mesh-list
92393884|NCT03639935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393885|NCT03639935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393886|NCT03639935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92393887|NCT03639935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393888|NCT03639935|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92393889|NCT03639935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393890|NCT03635333|Nicotine|nicotine|mesh-list
92393891|NCT03635333|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92393892|NCT03635333|Autonomic Agents|autonomic agents|mesh-ancestor
92393893|NCT03635333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393894|NCT03635333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393895|NCT03635333|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92393896|NCT03635333|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92393897|NCT03635333|Cholinergic Agents|cholinergic agents|mesh-ancestor
92393898|NCT03635333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393899|NCT03635333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393900|NCT03634839|Nicotine|nicotine|mesh-list
92393901|NCT03634839|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92393902|NCT03634839|Autonomic Agents|autonomic agents|mesh-ancestor
92393903|NCT03634839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92393904|NCT03634839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393905|NCT03634839|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92393906|NCT03634839|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92393907|NCT03634839|Cholinergic Agents|cholinergic agents|mesh-ancestor
92393908|NCT03634839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92393909|NCT03634839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393910|NCT03441061|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92393911|NCT03441061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393912|NCT03441061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393913|NCT03441061|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92393914|NCT03441061|Immunotoxins|immunotoxins|mesh-ancestor
92393915|NCT03441061|Immunoconjugates|immunoconjugates|mesh-ancestor
92393916|NCT03441061|Immunologic Factors|immunologic factors|mesh-ancestor
92393917|NCT03441061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393919|NCT03426904|Fluorouracil|fluorouracil|mesh-list
92393920|NCT03426904|Oxaliplatin|oxaliplatin|mesh-list
92393921|NCT03426904|Antimetabolites|antimetabolites|mesh-ancestor
92393922|NCT03426904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393923|NCT03426904|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92393924|NCT03426904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393925|NCT03426904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92393926|NCT03426904|Immunologic Factors|immunologic factors|mesh-ancestor
92393927|NCT03426904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393928|NCT03426904|Antidotes|antidotes|mesh-ancestor
92393929|NCT03426904|Protective Agents|protective agents|mesh-ancestor
92393930|NCT03426904|Vitamin B Complex|vitamin b complex|mesh-ancestor
92393931|NCT03426904|Vitamins|vitamins|mesh-ancestor
92393932|NCT03426904|Micronutrients|micronutrients|mesh-ancestor
92393933|NCT03383575|Azacitidine|azacitidine|mesh-list
92393934|NCT03383575|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92393935|NCT03383575|Antimetabolites|antimetabolites|mesh-ancestor
92052282|NCT02117024|Docetaxel|docetaxel|mesh-list
92393936|NCT03383575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393937|NCT03383575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393938|NCT03383575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393939|NCT03361072|Immunomodulating Agents|immunomodulating agents|mesh-list
92393940|NCT03361072|Immunologic Factors|immunologic factors|mesh-ancestor
92046279|NCT02236988|Apremilast|apremilast|mesh-list
92393941|NCT03361072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393943|NCT03332667|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92393944|NCT03332667|Dinutuximab|dinutuximab|mesh-list
92393945|NCT03332667|Sargramostim|sargramostim|mesh-list
92393946|NCT03332667|Immunologic Factors|immunologic factors|mesh-ancestor
92393947|NCT03332667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393948|NCT03332667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393949|NCT03332667|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92393950|NCT03332667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393951|NCT03332667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393952|NCT03332667|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92393953|NCT03287778|Pyridoxine|pyridoxine|mesh-list
92393954|NCT03287778|Vitamin B 6|vitamin b 6|mesh-list
92393955|NCT03287778|Vitamins|vitamins|mesh-ancestor
92393956|NCT03287778|Micronutrients|micronutrients|mesh-ancestor
92393957|NCT03287778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393958|NCT03287778|Vitamin B Complex|vitamin b complex|mesh-ancestor
92393959|NCT03273413|Pravastatin|pravastatin|mesh-list
92393960|NCT03273413|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92393961|NCT03273413|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92393962|NCT03273413|Antimetabolites|antimetabolites|mesh-ancestor
92393963|NCT03273413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393964|NCT03273413|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92393965|NCT03273413|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92393966|NCT03273413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393967|NCT03227458|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92393968|NCT03227458|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92393969|NCT03227458|Immunologic Factors|immunologic factors|mesh-ancestor
92393970|NCT03227458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393971|NCT03141983|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92393972|NCT03141983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92393973|NCT03075527|Durvalumab|durvalumab|mesh-list
92393974|NCT03075527|Tremelimumab|tremelimumab|mesh-list
92393975|NCT03075527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393976|NCT03075527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393977|NCT03074539|Riociguat|riociguat|mesh-list
92393978|NCT03074539|Enzyme Activators|enzyme activators|mesh-ancestor
92393979|NCT03074539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393980|NCT03030131|Durvalumab|durvalumab|mesh-list
92393981|NCT03030131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92393982|NCT03030131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92393983|NCT03011021|Liraglutide|liraglutide|mesh-list
92393984|NCT03011021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92393985|NCT03011021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92393986|NCT03011021|Incretins|incretins|mesh-ancestor
92393987|NCT03011021|Hormones|hormones|mesh-ancestor
92393988|NCT03011021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92393989|NCT02995252|Tenofovir|tenofovir|mesh-list
92393990|NCT02995252|Liver Extracts|liver extracts|mesh-list
92393991|NCT02995252|Antiviral Agents|antiviral agents|mesh-ancestor
92393992|NCT02995252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92393993|NCT02995252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92393994|NCT02995252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92393995|NCT02995252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92393996|NCT02995252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92393997|NCT02995252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92393998|NCT02995252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92393999|NCT02995252|Hematinics|hematinics|mesh-ancestor
92394000|NCT02983578|Durvalumab|durvalumab|mesh-list
92394001|NCT02983578|Immunoglobulins|immunoglobulins|mesh-list
92394002|NCT02983578|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92394003|NCT02983578|Immunoglobulin G|immunoglobulin g|mesh-list
92394004|NCT02983578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394005|NCT02983578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394006|NCT02983578|Immunologic Factors|immunologic factors|mesh-ancestor
92394007|NCT02983578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394008|NCT02932826|Insulin|insulin|mesh-list
92394009|NCT02932826|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92394010|NCT02932826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394011|NCT02846623|Atezolizumab|atezolizumab|mesh-list
92394012|NCT02846623|Venetoclax|venetoclax|mesh-list
92394013|NCT02846623|Obinutuzumab|obinutuzumab|mesh-list
92394014|NCT02846623|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92046348|NCT02236130|Hydrocodone|hydrocodone|mesh-list
92394015|NCT02846623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92394016|NCT02846623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394017|NCT02846623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394018|NCT02846623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394019|NCT02846623|Immunologic Factors|immunologic factors|mesh-ancestor
92394020|NCT02846623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394021|NCT02834637|Vaccines|vaccines|mesh-list
92394022|NCT02834637|Immunologic Factors|immunologic factors|mesh-ancestor
92394023|NCT02834637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394024|NCT02817360|Losartan|losartan|mesh-list
92394025|NCT02817360|Valsartan|valsartan|mesh-list
92394026|NCT02817360|Carvedilol|carvedilol|mesh-list
92394027|NCT02817360|Candesartan|candesartan|mesh-list
92394028|NCT02817360|Ramipril|ramipril|mesh-list
92394029|NCT02817360|Enalapril|enalapril|mesh-list
92394031|NCT02817360|Irbesartan|irbesartan|mesh-list
92394032|NCT02817360|Nebivolol|nebivolol|mesh-list
92394033|NCT02817360|Bisoprolol|bisoprolol|mesh-list
92394034|NCT02817360|Perindopril|perindopril|mesh-list
92394035|NCT02817360|Captopril|captopril|mesh-list
92394036|NCT02817360|Quinapril|quinapril|mesh-list
92394037|NCT02817360|Trandolapril|trandolapril|mesh-list
92394038|NCT02817360|Fosinopril|fosinopril|mesh-list
92394039|NCT02817360|Eprosartan|eprosartan|mesh-list
92394040|NCT02817360|Zofenopril|zofenopril|mesh-list
92394041|NCT02817360|Spirapril|spirapril|mesh-list
92394042|NCT02817360|Cilazapril|cilazapril|mesh-list
92394043|NCT02817360|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92394044|NCT02817360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394045|NCT02817360|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92394046|NCT02817360|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92394047|NCT02817360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394048|NCT02817360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92394049|NCT02817360|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92394050|NCT02817360|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394051|NCT02817360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394052|NCT02817360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394053|NCT02817360|Antioxidants|antioxidants|mesh-ancestor
92394054|NCT02817360|Protective Agents|protective agents|mesh-ancestor
92394055|NCT02817360|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92394056|NCT02817360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394057|NCT02817360|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92394058|NCT02817360|Vasodilator Agents|vasodilator agents|mesh-ancestor
92394059|NCT02817360|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92394060|NCT02817360|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92394061|NCT02817360|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92394062|NCT02817360|Protease Inhibitors|protease inhibitors|mesh-ancestor
92394063|NCT02817360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394064|NCT02817360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92394065|NCT02817360|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92394066|NCT02817360|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92394067|NCT02817360|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92394068|NCT02817360|Sympatholytics|sympatholytics|mesh-ancestor
92394069|NCT02817360|Autonomic Agents|autonomic agents|mesh-ancestor
92394070|NCT02817360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394071|NCT02817360|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92394072|NCT02817360|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92394073|NCT02743806|Vedolizumab|vedolizumab|mesh-list
92394074|NCT02743806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92394075|NCT02717624|Acalabrutinib|acalabrutinib|mesh-list
92394076|NCT02717624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394077|NCT02689778|Pirfenidone|pirfenidone|mesh-list
92394078|NCT02689778|Analgesics|analgesics|mesh-ancestor
92394079|NCT02689778|Sensory System Agents|sensory system agents|mesh-ancestor
92394080|NCT02689778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394081|NCT02689778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394082|NCT02689778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92394083|NCT02689778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92394084|NCT02689778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394085|NCT02689778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92394086|NCT02689778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394087|NCT02678377|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92394088|NCT02678377|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92394089|NCT02678377|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92394090|NCT02678377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394091|NCT02678377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394092|NCT02678377|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92394093|NCT02678377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394094|NCT02678377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394095|NCT02678377|Cholinergic Agents|cholinergic agents|mesh-ancestor
92394096|NCT02678377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394097|NCT02659384|Aspirin|aspirin|mesh-list
92394098|NCT02659384|Bevacizumab|bevacizumab|mesh-list
92394099|NCT02659384|Atezolizumab|atezolizumab|mesh-list
92394100|NCT02659384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394101|NCT02659384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394102|NCT02659384|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92394103|NCT02659384|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92394104|NCT02659384|Growth Substances|growth substances|mesh-ancestor
92394105|NCT02659384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394106|NCT02659384|Growth Inhibitors|growth inhibitors|mesh-ancestor
92394107|NCT02659384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92394108|NCT02659384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394109|NCT02659384|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92394110|NCT02659384|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92394111|NCT02659384|Analgesics|analgesics|mesh-ancestor
92394112|NCT02659384|Sensory System Agents|sensory system agents|mesh-ancestor
92394113|NCT02659384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394114|NCT02659384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394115|NCT02659384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92394116|NCT02659384|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92394117|NCT02659384|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92394118|NCT02659384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92394119|NCT02659384|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92394120|NCT02659384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394121|NCT02659384|Antipyretics|antipyretics|mesh-ancestor
92394122|NCT02659306|Metformin|metformin|mesh-list
92394123|NCT02659306|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92394124|NCT02659306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394125|NCT02591147|Fluorides|fluorides|mesh-list
92394126|NCT02591147|Cariostatic Agents|cariostatic agents|mesh-ancestor
92394127|NCT02591147|Protective Agents|protective agents|mesh-ancestor
92394128|NCT02591147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394129|NCT02588872|Hyaluronic Acid|hyaluronic acid|mesh-list
92394130|NCT02588872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92394131|NCT02588872|Immunologic Factors|immunologic factors|mesh-ancestor
92394132|NCT02588872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394133|NCT02588872|Viscosupplements|viscosupplements|mesh-ancestor
92394134|NCT02588872|Protective Agents|protective agents|mesh-ancestor
92394135|NCT02579161|Ciprofloxacin|ciprofloxacin|mesh-list
92394136|NCT02579161|Clindamycin|clindamycin|mesh-list
92394137|NCT02579161|Gentamicins|gentamicins|mesh-list
92394138|NCT02579161|Penicillins|penicillins|mesh-list
92394139|NCT02579161|Ampicillin|ampicillin|mesh-list
92394140|NCT02579161|Cephalosporins|cephalosporins|mesh-list
92394141|NCT02579161|Fluoroquinolones|fluoroquinolones|mesh-list
92394142|NCT02579161|Lincosamides|lincosamides|mesh-list
92394143|NCT02579161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92394144|NCT02579161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394145|NCT02579161|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92394146|NCT02579161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92394147|NCT02579161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394148|NCT02579161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394149|NCT02579161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394150|NCT02579161|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92394151|NCT02579161|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92394152|NCT02579161|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92394153|NCT02579161|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92394154|NCT02538510|Pembrolizumab|pembrolizumab|mesh-list
92394155|NCT02538510|Vorinostat|vorinostat|mesh-list
92394156|NCT02538510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394157|NCT02538510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394158|NCT02538510|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92394159|NCT02538510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394160|NCT02538510|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92394161|NCT02538510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394163|NCT02537613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394164|NCT02537613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394165|NCT02419040|Lidocaine|lidocaine|mesh-list
92394166|NCT02419040|Anesthetics, Local|anesthetics, local|mesh-ancestor
92394167|NCT02419040|Anesthetics|anesthetics|mesh-ancestor
92394168|NCT02419040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394169|NCT02419040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394170|NCT02419040|Sensory System Agents|sensory system agents|mesh-ancestor
92394171|NCT02419040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394172|NCT02419040|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92394173|NCT02419040|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92394174|NCT02419040|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92394175|NCT02419040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394176|NCT02419040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394177|NCT02387203|Amoxicillin|amoxicillin|mesh-list
92394178|NCT02387203|Clarithromycin|clarithromycin|mesh-list
92394179|NCT02387203|Lansoprazole|lansoprazole|mesh-list
92394180|NCT02387203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92394181|NCT02387203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394182|NCT02387203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92394183|NCT02387203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394184|NCT02387203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394185|NCT02387203|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92394186|NCT02387203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92394187|NCT02387203|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92394188|NCT02387203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92394189|NCT02387203|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92394190|NCT02381353|Bupivacaine|bupivacaine|mesh-list
92394191|NCT02381353|Anesthetics, Local|anesthetics, local|mesh-ancestor
92394192|NCT02381353|Anesthetics|anesthetics|mesh-ancestor
92394193|NCT02381353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394194|NCT02381353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394195|NCT02381353|Sensory System Agents|sensory system agents|mesh-ancestor
92394196|NCT02381353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394198|NCT02296229|Hormones|hormones|mesh-ancestor
92394199|NCT02296229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394200|NCT02296229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394201|NCT02192398|Guanfacine|guanfacine|mesh-list
92394202|NCT02192398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394203|NCT02192398|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92394204|NCT02192398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92394205|NCT02192398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92394206|NCT02192398|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394207|NCT02192398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394208|NCT02192398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394209|NCT02192398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394210|NCT01992653|Prednisone|prednisone|mesh-list
92394211|NCT01992653|Prednisolone|prednisolone|mesh-list
92394212|NCT01992653|Cyclophosphamide|cyclophosphamide|mesh-list
92394213|NCT01992653|Rituximab|rituximab|mesh-list
92394214|NCT01992653|Doxorubicin|doxorubicin|mesh-list
92394215|NCT01992653|Obinutuzumab|obinutuzumab|mesh-list
92394216|NCT01992653|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92394217|NCT01992653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92394218|NCT01992653|Immunologic Factors|immunologic factors|mesh-ancestor
92394219|NCT01992653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394220|NCT01992653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92394221|NCT01992653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92394222|NCT01992653|Alkylating Agents|alkylating agents|mesh-ancestor
92394223|NCT01992653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394224|NCT01992653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394225|NCT01992653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92394226|NCT01992653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394227|NCT01992653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92394228|NCT01992653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92394229|NCT01992653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92394230|NCT01992653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394231|NCT01992653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394232|NCT01992653|Glucocorticoids|glucocorticoids|mesh-ancestor
92394233|NCT01992653|Hormones|hormones|mesh-ancestor
92394234|NCT01992653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394235|NCT01992653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92394236|NCT01992653|Immunoconjugates|immunoconjugates|mesh-ancestor
92394237|NCT01850303|Gemcitabine|gemcitabine|mesh-list
92394238|NCT01850303|Pemetrexed|pemetrexed|mesh-list
92394239|NCT01850303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394240|NCT01850303|Antimetabolites|antimetabolites|mesh-ancestor
92394241|NCT01850303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394242|NCT01850303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394243|NCT01850303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394244|NCT01850303|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92046578|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
92394245|NCT01850303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92394246|NCT01763671|Paclitaxel|paclitaxel|mesh-list
92394247|NCT01763671|Docetaxel|docetaxel|mesh-list
92394248|NCT01763671|Bevacizumab|bevacizumab|mesh-list
92394249|NCT01763671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92394250|NCT01763671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394251|NCT01763671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92394252|NCT01763671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92394253|NCT01763671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92394254|NCT01763671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394255|NCT01763671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394256|NCT01763671|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92394257|NCT01763671|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92394258|NCT01763671|Growth Substances|growth substances|mesh-ancestor
92394259|NCT01763671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394260|NCT01763671|Growth Inhibitors|growth inhibitors|mesh-ancestor
92394261|NCT01750567|Metformin|metformin|mesh-list
92394262|NCT01750567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92394263|NCT01750567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394264|NCT01696435|Vitamin D|vitamin d|mesh-list
92394265|NCT01696435|Ergocalciferols|ergocalciferols|mesh-list
92394266|NCT01696435|Cholecalciferol|cholecalciferol|mesh-list
92394267|NCT01696435|Vitamins|vitamins|mesh-list
92394268|NCT01696435|Micronutrients|micronutrients|mesh-ancestor
92394269|NCT01696435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394270|NCT01696435|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92394271|NCT01696435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92394272|NCT01682083|Trametinib|trametinib|mesh-list
92394273|NCT01682083|Dabrafenib|dabrafenib|mesh-list
92394274|NCT01682083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394275|NCT01682083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92394276|NCT01682083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394277|NCT01682083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394278|NCT01681264|Guanfacine|guanfacine|mesh-list
92394279|NCT01681264|Morphine|morphine|mesh-list
92394280|NCT01681264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92394281|NCT01681264|Narcotics|narcotics|mesh-ancestor
92394282|NCT01681264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394283|NCT01681264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394284|NCT01681264|Analgesics|analgesics|mesh-ancestor
92394285|NCT01681264|Sensory System Agents|sensory system agents|mesh-ancestor
92394286|NCT01681264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394287|NCT01681264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394288|NCT01681264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92394289|NCT01681264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92394290|NCT01681264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92394291|NCT01681264|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394292|NCT01681264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394293|NCT01681264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394294|NCT01654276|Febuxostat|febuxostat|mesh-list
92394295|NCT01654276|Gout Suppressants|gout suppressants|mesh-ancestor
92394296|NCT01654276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92394297|NCT01527591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92394298|NCT01527591|Immunologic Factors|immunologic factors|mesh-ancestor
92394299|NCT01527591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394300|NCT00590122|Levodopa|levodopa|mesh-list
92394301|NCT00590122|Carbidopa|carbidopa|mesh-list
92394302|NCT00590122|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92394303|NCT00590122|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92394304|NCT00590122|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92394305|NCT00590122|Dopamine Agents|dopamine agents|mesh-ancestor
92394306|NCT00590122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394307|NCT00590122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394308|NCT00590122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394309|NCT00590122|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92394310|NCT00590122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394311|NCT00590122|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92394312|NCT00590122|Immunologic Factors|immunologic factors|mesh-ancestor
92394313|NCT00590122|Dopamine Agonists|dopamine agonists|mesh-ancestor
92394314|NCT00309192|Triamcinolone|triamcinolone|mesh-list
92394315|NCT00309192|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92394316|NCT00309192|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92394317|NCT00309192|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92394318|NCT00309192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394319|NCT00309192|Glucocorticoids|glucocorticoids|mesh-ancestor
92046651|NCT02228096|Tisagenlecleucel|tisagenlecleucel|mesh-list
92394320|NCT00309192|Hormones|hormones|mesh-ancestor
92394321|NCT00309192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394322|NCT00309192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394323|NCT00309192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92394324|NCT00309192|Immunologic Factors|immunologic factors|mesh-ancestor
92394325|NCT00309192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394326|NCT00309192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394327|NCT00110591|Leronlimab|leronlimab|mesh-list
92394328|NCT00110591|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92394329|NCT00110591|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92394330|NCT00110591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394331|NCT00110591|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92394332|NCT00110591|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92394333|NCT00110591|Antiviral Agents|antiviral agents|mesh-ancestor
92394334|NCT00110591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394335|NCT01689246|Methylene Blue|methylene blue|mesh-list
92394336|NCT01689246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394337|NCT01689246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394338|NCT01685268|Prednisone|prednisone|mesh-list
92394339|NCT01685268|Prednisolone|prednisolone|mesh-list
92394340|NCT01685268|Abiraterone Acetate|abiraterone acetate|mesh-list
92394341|NCT01685268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394342|NCT01685268|Glucocorticoids|glucocorticoids|mesh-ancestor
92394343|NCT01685268|Hormones|hormones|mesh-ancestor
92394344|NCT01685268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394345|NCT01685268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394346|NCT01685268|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92394347|NCT01685268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394348|NCT01685268|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92394349|NCT01685268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394350|NCT01685268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394351|NCT01685268|Hormone Antagonists|hormone antagonists|mesh-ancestor
92394352|NCT01685268|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92394353|NCT01683786|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92394354|NCT01683786|Antiviral Agents|antiviral agents|mesh-ancestor
92394355|NCT01683786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394356|NCT01683084|Telmisartan|telmisartan|mesh-list
92394357|NCT01683084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394358|NCT01683084|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92394359|NCT01683084|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92394360|NCT01683084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394361|NCT04823442|Bisoprolol|bisoprolol|mesh-list
92394362|NCT04823442|Mirabegron|mirabegron|mesh-list
92394363|NCT04823442|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92394364|NCT04823442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92394365|NCT04823442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92394366|NCT04823442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394367|NCT04823442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394368|NCT04823442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394369|NCT04823442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394370|NCT04823442|Urological Agents|urological agents|mesh-ancestor
92394371|NCT04823442|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394372|NCT04823442|Sympatholytics|sympatholytics|mesh-ancestor
92394373|NCT04823442|Autonomic Agents|autonomic agents|mesh-ancestor
92394374|NCT04823442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394375|NCT04823442|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92394376|NCT04823442|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92394377|NCT04823442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92394378|NCT01384448|Dobutamine|dobutamine|mesh-list
92394379|NCT01384448|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92394380|NCT01384448|Sympathomimetics|sympathomimetics|mesh-ancestor
92394381|NCT01384448|Autonomic Agents|autonomic agents|mesh-ancestor
92394382|NCT01384448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394383|NCT01384448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394384|NCT01384448|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92394385|NCT01384448|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92394386|NCT01384448|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92394387|NCT01384448|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394388|NCT01384448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394389|NCT01384448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394390|NCT01384448|Protective Agents|protective agents|mesh-ancestor
92394391|NCT01384578|Vitamins|vitamins|mesh-list
92394392|NCT01384578|Vitamin E|vitamin e|mesh-list
92394393|NCT01384578|Tocopherols|tocopherols|mesh-list
92394394|NCT01384578|Tocotrienols|tocotrienols|mesh-list
92394395|NCT01384578|alpha-Tocopherol|alpha-tocopherol|mesh-list
92394396|NCT01384578|Pentoxifylline|pentoxifylline|mesh-list
92394397|NCT01384578|Micronutrients|micronutrients|mesh-ancestor
92394398|NCT01384578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394399|NCT01384578|Antioxidants|antioxidants|mesh-ancestor
92394400|NCT01384578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394401|NCT01384578|Protective Agents|protective agents|mesh-ancestor
92394402|NCT01384578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92394403|NCT01384578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394404|NCT01384578|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92394405|NCT01384578|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92394406|NCT01384578|Vasodilator Agents|vasodilator agents|mesh-ancestor
92394407|NCT01384578|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92394408|NCT01384643|Propofol|propofol|mesh-list
92394409|NCT01384643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92394410|NCT01384643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394411|NCT01384643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394412|NCT01384643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92394413|NCT01384643|Anesthetics, General|anesthetics, general|mesh-ancestor
92394414|NCT01384643|Anesthetics|anesthetics|mesh-ancestor
92394415|NCT01384656|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92394416|NCT01384682|Maraviroc|maraviroc|mesh-list
92394417|NCT01384682|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92394418|NCT01384682|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92394419|NCT01384682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394420|NCT01384682|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92394421|NCT01384682|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92394423|NCT01384682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394424|NCT01384682|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92394425|NCT01384695|Proflavine|proflavine|mesh-list
92394426|NCT01384695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92394427|NCT01384695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394428|NCT01384708|Proflavine|proflavine|mesh-list
92394429|NCT01384708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92394430|NCT01384708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394431|NCT01384799|Cisplatin|cisplatin|mesh-list
92394432|NCT01384799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394433|NCT01384812|Dinoprostone|dinoprostone|mesh-list
92394434|NCT01384812|Oxytocics|oxytocics|mesh-ancestor
92394436|NCT01384812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394437|NCT01384864|Proflavine|proflavine|mesh-list
92394438|NCT01384864|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92394439|NCT01384864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394440|NCT01384903|Antithrombins|antithrombins|mesh-list
92394441|NCT01384903|Antithrombin III|antithrombin iii|mesh-list
92394442|NCT01384903|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92394443|NCT01384903|Protease Inhibitors|protease inhibitors|mesh-ancestor
92394444|NCT01384903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394445|NCT01384903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394446|NCT01384903|Anticoagulants|anticoagulants|mesh-ancestor
92394447|NCT01384994|Folic Acid|folic acid|mesh-list
92394448|NCT01384994|Vitamin B Complex|vitamin b complex|mesh-list
92394449|NCT01384994|Oxaliplatin|oxaliplatin|mesh-list
92394450|NCT01384994|Fluorouracil|fluorouracil|mesh-list
92394451|NCT01384994|Panitumumab|panitumumab|mesh-list
92394452|NCT01384994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394453|NCT01384994|Antimetabolites|antimetabolites|mesh-ancestor
92394454|NCT01384994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394455|NCT01384994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394456|NCT01384994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92394457|NCT01384994|Immunologic Factors|immunologic factors|mesh-ancestor
92394458|NCT01384994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394459|NCT01384994|Hematinics|hematinics|mesh-ancestor
92394460|NCT01384994|Vitamins|vitamins|mesh-ancestor
92394461|NCT01384994|Micronutrients|micronutrients|mesh-ancestor
92394462|NCT01384994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394463|NCT01385020|Gemfibrozil|gemfibrozil|mesh-list
92394464|NCT01385020|Red yeast rice|red yeast rice|mesh-list
92046819|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
92394465|NCT01385020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92394466|NCT01385020|Antimetabolites|antimetabolites|mesh-ancestor
92394467|NCT01385020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394468|NCT01385020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92394469|NCT01385020|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92394470|NCT01385020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92394472|NCT01385020|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92394473|NCT01385020|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92394474|NCT01385124|Cannabidiol|cannabidiol|mesh-list
92394475|NCT01385124|Anticonvulsants|anticonvulsants|mesh-ancestor
92394477|NCT01385228|Docetaxel|docetaxel|mesh-list
92394478|NCT01385228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394479|NCT01385228|Tubulin Modulators|tubulin modulators|mesh-ancestor
92394480|NCT01385228|Antimitotic Agents|antimitotic agents|mesh-ancestor
92394481|NCT01385228|Mitosis Modulators|mitosis modulators|mesh-ancestor
92394482|NCT01385228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394483|NCT01385228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394484|NCT01385228|Glucocorticoids|glucocorticoids|mesh-ancestor
92394485|NCT01385228|Hormones|hormones|mesh-ancestor
92394486|NCT01385228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394487|NCT01385228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394488|NCT01385228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92394489|NCT01385345|Vitamin D|vitamin d|mesh-list
92394490|NCT01385345|Cholecalciferol|cholecalciferol|mesh-list
92394491|NCT01385345|Vitamins|vitamins|mesh-ancestor
92394492|NCT01385345|Micronutrients|micronutrients|mesh-ancestor
92394493|NCT01385345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394494|NCT01385345|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92394495|NCT01385345|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92394496|NCT01385527|Triamcinolone|triamcinolone|mesh-list
92394497|NCT01385527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394498|NCT01385527|Glucocorticoids|glucocorticoids|mesh-ancestor
92394499|NCT01385527|Hormones|hormones|mesh-ancestor
92394500|NCT01385527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394501|NCT01385527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394502|NCT01385631|Ezetimibe|ezetimibe|mesh-list
92394503|NCT01385631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92394504|NCT01385631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92394505|NCT01385631|Antimetabolites|antimetabolites|mesh-ancestor
92394506|NCT01385631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394507|NCT01385631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92394508|NCT01385683|Clarithromycin|clarithromycin|mesh-list
92032234|NCT01887418|Testosterone|testosterone|mesh-list
92394511|NCT01385683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394512|NCT01385683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92394513|NCT01385683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394514|NCT01385683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394515|NCT01385683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92394516|NCT01385683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92394517|NCT01385683|Antithrombins|antithrombins|mesh-ancestor
92394518|NCT01385683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92394519|NCT01385683|Protease Inhibitors|protease inhibitors|mesh-ancestor
92394520|NCT01385683|Anticoagulants|anticoagulants|mesh-ancestor
92394521|NCT01385735|Rasagiline|rasagiline|mesh-list
92394522|NCT01385735|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92394523|NCT01385735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394524|NCT01385735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394525|NCT01385735|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92394526|NCT01385735|Protective Agents|protective agents|mesh-ancestor
92394527|NCT01385735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394528|NCT01385826|Antibodies|antibodies|mesh-list
92394529|NCT01385826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92394530|NCT01385826|Immunologic Factors|immunologic factors|mesh-ancestor
92394531|NCT01385826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394532|NCT01385891|Etoposide|etoposide|mesh-list
92394533|NCT01385891|Clofarabine|clofarabine|mesh-list
91992657|NCT03874091|Autonomic Agents|autonomic agents|mesh-ancestor
92394534|NCT01385891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92394535|NCT01385891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394536|NCT01385891|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92394537|NCT01385891|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92394538|NCT01385891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394539|NCT01385891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394540|NCT01385891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394541|NCT01385891|Antimetabolites|antimetabolites|mesh-ancestor
92394542|NCT01385956|Gemcitabine|gemcitabine|mesh-list
92394543|NCT01385956|Pasireotide|pasireotide|mesh-list
92394544|NCT01385956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394545|NCT01385956|Antimetabolites|antimetabolites|mesh-ancestor
92394546|NCT01385956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394547|NCT01385956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394549|NCT01385956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394550|NCT01385956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394551|NCT01386086|Aripiprazole|aripiprazole|mesh-list
92394552|NCT01386086|Antidepressive Agents|antidepressive agents|mesh-ancestor
92394553|NCT01386086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92394554|NCT01386086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92394555|NCT01386086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92394556|NCT01386086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394557|NCT01386086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394558|NCT01386086|Dopamine Agonists|dopamine agonists|mesh-ancestor
92394559|NCT01386086|Dopamine Agents|dopamine agents|mesh-ancestor
92394560|NCT01386086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394561|NCT01386086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394562|NCT01386086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92394563|NCT01386086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92394565|NCT01386086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92000578|NCT05327686|Pembrolizumab|pembrolizumab|mesh-list
92394566|NCT01386086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92394567|NCT01386086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92394568|NCT01386086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92394569|NCT01386151|Mitogens|mitogens|mesh-list
92394570|NCT01386151|Mitosis Modulators|mitosis modulators|mesh-ancestor
92394571|NCT01386151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394572|NCT01386164|Vaccines|vaccines|mesh-list
92394573|NCT01386164|Immunologic Factors|immunologic factors|mesh-ancestor
92394574|NCT01386164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394575|NCT01386177|Doxazosin|doxazosin|mesh-list
92394576|NCT01386177|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92394577|NCT01386177|Hallucinogens|hallucinogens|mesh-ancestor
92394578|NCT01386177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394579|NCT01386177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92394580|NCT01386177|Serotonin Agents|serotonin agents|mesh-ancestor
92394581|NCT01386177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002459|NCT04045431|Hylan|hylan|mesh-list
92394582|NCT01386177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003600|NCT02703623|Prednisone|prednisone|mesh-list
92394583|NCT01386177|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92394584|NCT01386177|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92394585|NCT01386177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394587|NCT01386177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394588|NCT01386177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92005645|NCT02327923|Narcotics|narcotics|mesh-ancestor
92394589|NCT01386177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92394590|NCT01386177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92394592|NCT01386229|Etomidate|etomidate|mesh-list
92394594|NCT01386229|Sensory System Agents|sensory system agents|mesh-ancestor
92394595|NCT01386229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394596|NCT01386229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008017|NCT04973033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394597|NCT01386229|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92394598|NCT01386229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92394599|NCT01386229|Anesthetics, General|anesthetics, general|mesh-ancestor
92394600|NCT01386229|Anesthetics|anesthetics|mesh-ancestor
92394601|NCT01386229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394602|NCT01386229|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92394603|NCT01386229|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92010628|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
92394604|NCT01386229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394605|NCT01386229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394606|NCT01386229|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92394607|NCT01386242|Interferons|interferons|mesh-list
92011845|NCT05373199|Insulin Lispro|insulin lispro|mesh-list
92394608|NCT01386242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394610|NCT01386242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394611|NCT01386255|Baclofen|baclofen|mesh-list
92394612|NCT01386255|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92394613|NCT01386255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394614|NCT01386255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92394615|NCT01386255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394616|NCT01386255|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92394617|NCT01386255|GABA Agonists|gaba agonists|mesh-ancestor
92394618|NCT01386255|GABA Agents|gaba agents|mesh-ancestor
92394619|NCT01386255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394620|NCT01386255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394622|NCT01386268|Coagulants|coagulants|mesh-ancestor
92394623|NCT01386294|Tenofovir|tenofovir|mesh-list
92394624|NCT01386294|Antiviral Agents|antiviral agents|mesh-ancestor
92394625|NCT01386294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032690|NCT02161185|GABA Agents|gaba agents|mesh-ancestor
92394626|NCT01386294|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92394627|NCT01386294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92394628|NCT01386294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032750|NCT02158533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394629|NCT01386294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394630|NCT01386294|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92394631|NCT01386294|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92394632|NCT01386333|Oxytocin|oxytocin|mesh-list
92394633|NCT01386333|Oxytocics|oxytocics|mesh-ancestor
92394634|NCT01386333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92394635|NCT01386333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394637|NCT01386346|Azacitidine|azacitidine|mesh-list
92394638|NCT01386346|Oxaliplatin|oxaliplatin|mesh-list
92394639|NCT01386346|Epirubicin|epirubicin|mesh-list
92394640|NCT01386346|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394641|NCT01386346|Antimetabolites|antimetabolites|mesh-ancestor
92032981|NCT05157971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394642|NCT01386346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394643|NCT01386346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394644|NCT01386346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394645|NCT01386346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92394646|NCT01386346|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92394647|NCT01386346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92394649|NCT01386372|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92394650|NCT01386372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394651|NCT01386372|Natriuretic Agents|natriuretic agents|mesh-ancestor
92394652|NCT01386372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394653|NCT01386398|Bortezomib|bortezomib|mesh-list
92394654|NCT01386398|Vorinostat|vorinostat|mesh-list
92394655|NCT01386398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394656|NCT01386398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92394657|NCT01386398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033197|NCT05237687|Antifungal Agents|antifungal agents|mesh-ancestor
92033249|NCT05140499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394658|NCT01386398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394659|NCT01386502|Pidilizumab|pidilizumab|mesh-list
92394660|NCT01386502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394661|NCT01386502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033326|NCT05135273|Vaccines|vaccines|mesh-list
92394663|NCT01386567|Citric Acid|citric acid|mesh-list
92394664|NCT01386567|Sodium Citrate|sodium citrate|mesh-list
92394665|NCT01386567|Enclomiphene|enclomiphene|mesh-list
92394666|NCT01386567|Clomiphene|clomiphene|mesh-list
92394667|NCT01386567|Zuclomiphene|zuclomiphene|mesh-list
92394668|NCT01386567|Testosterone|testosterone|mesh-list
92394669|NCT01386567|Testosterone undecanoate|testosterone undecanoate|mesh-list
92394670|NCT01386567|Testosterone enanthate|testosterone enanthate|mesh-list
92394671|NCT01386567|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92394672|NCT01386567|Anticoagulants|anticoagulants|mesh-ancestor
92394673|NCT01386567|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92394674|NCT01386567|Chelating Agents|chelating agents|mesh-ancestor
92394675|NCT01386567|Sequestering Agents|sequestering agents|mesh-ancestor
92394676|NCT01386567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394677|NCT01386567|Androgens|androgens|mesh-ancestor
92394678|NCT01386567|Hormones|hormones|mesh-ancestor
92394679|NCT01386567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394680|NCT01386567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394681|NCT01386567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92394682|NCT01386567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394684|NCT01386567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92394685|NCT01386567|Hormone Antagonists|hormone antagonists|mesh-ancestor
92394686|NCT01386567|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92394687|NCT01386567|Fertility Agents|fertility agents|mesh-ancestor
92394688|NCT01386567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92033775|NCT04987463|Sirolimus|sirolimus|mesh-list
92394689|NCT01386567|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92394690|NCT01386567|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92394691|NCT01386580|Doxorubicin|doxorubicin|mesh-list
92394692|NCT01386580|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92394694|NCT01386580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92394695|NCT01386580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394696|NCT01386580|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92394698|NCT01386580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033981|NCT02507219|Ibuprofen|ibuprofen|mesh-list
92394699|NCT01386580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394700|NCT01386580|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394701|NCT01386593|Ciprofloxacin|ciprofloxacin|mesh-list
92394702|NCT01386593|Rifampin|rifampin|mesh-list
92394703|NCT01386593|Fluconazole|fluconazole|mesh-list
92394704|NCT01386593|Paroxetine|paroxetine|mesh-list
92394705|NCT01386593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92394706|NCT01386593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394707|NCT01386593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92394708|NCT01386593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92394709|NCT01386593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034044|NCT02503865|Atorvastatin|atorvastatin|mesh-list
92394710|NCT01386593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394711|NCT01386593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394712|NCT01386593|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92394713|NCT01386593|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92394714|NCT01386593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92394715|NCT01386593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92394716|NCT01386593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394717|NCT01386593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394718|NCT01386593|Serotonin Agents|serotonin agents|mesh-ancestor
92394719|NCT01386593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394720|NCT01386593|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92394721|NCT01386593|Antidepressive Agents|antidepressive agents|mesh-ancestor
92034168|NCT02045979|Adalimumab|adalimumab|mesh-list
92394722|NCT01386593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92394723|NCT01386593|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92394724|NCT01386593|Antifungal Agents|antifungal agents|mesh-ancestor
92394725|NCT01386593|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92394726|NCT01386593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92394727|NCT01386593|Hormone Antagonists|hormone antagonists|mesh-ancestor
92394728|NCT01386593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394729|NCT01386593|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92394730|NCT01386593|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92394731|NCT01386593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92394732|NCT01386593|Antitubercular Agents|antitubercular agents|mesh-ancestor
92394733|NCT01386593|Leprostatic Agents|leprostatic agents|mesh-ancestor
92394734|NCT01386593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92394735|NCT01386593|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92034327|NCT02480153|Adalimumab|adalimumab|mesh-list
92394736|NCT01386593|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92394737|NCT01386593|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92394738|NCT01386593|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92394739|NCT01386593|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92394740|NCT01386593|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92394742|NCT01386658|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92394743|NCT01386658|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92394744|NCT01386658|Analgesics|analgesics|mesh-ancestor
92394745|NCT01386658|Sensory System Agents|sensory system agents|mesh-ancestor
92394746|NCT01386658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394747|NCT01386658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394748|NCT01386658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394749|NCT01386658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92394750|NCT01386658|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92394751|NCT01386658|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92394752|NCT01386658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394753|NCT01386658|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92394754|NCT01386658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92394755|NCT01386658|Immunologic Factors|immunologic factors|mesh-ancestor
92394756|NCT01386671|Metformin|metformin|mesh-list
92394757|NCT01386671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92012284|NCT00783133|Fexofenadine|fexofenadine|mesh-list
92394758|NCT01386671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394759|NCT01386736|Vitamin D|vitamin d|mesh-list
92394760|NCT01386736|Vitamins|vitamins|mesh-ancestor
92394761|NCT01386736|Micronutrients|micronutrients|mesh-ancestor
92394762|NCT01386736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394763|NCT01386736|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92034486|NCT01920568|Vitamin D|vitamin d|mesh-list
92394764|NCT01386853|Atorvastatin|atorvastatin|mesh-list
92394765|NCT01386853|Pitavastatin|pitavastatin|mesh-list
92394766|NCT01386853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92394767|NCT01386853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92394768|NCT01386853|Antimetabolites|antimetabolites|mesh-ancestor
92394769|NCT01386853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394770|NCT01386853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92394771|NCT01386853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92394772|NCT01386853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394773|NCT01386866|Motesanib diphosphate|motesanib diphosphate|mesh-list
92394774|NCT01386866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92394775|NCT01386866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394776|NCT01386866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394777|NCT01386879|Methylene Blue|methylene blue|mesh-list
92394778|NCT01386879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012313|NCT04836143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394779|NCT01386879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394780|NCT01386996|Budesonide|budesonide|mesh-list
92394781|NCT01386996|Formoterol Fumarate|formoterol fumarate|mesh-list
92394782|NCT01386996|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92394783|NCT01386996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012318|NCT00751075|Mometasone Furoate|mometasone furoate|mesh-list
92394784|NCT01386996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92394785|NCT01386996|Autonomic Agents|autonomic agents|mesh-ancestor
92394786|NCT01386996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034940|NCT01613326|Albuterol|albuterol|mesh-list
92394787|NCT01386996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394788|NCT01386996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92394789|NCT01386996|Respiratory System Agents|respiratory system agents|mesh-ancestor
92394790|NCT01386996|Glucocorticoids|glucocorticoids|mesh-ancestor
92394792|NCT01386996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394793|NCT01386996|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92394794|NCT01386996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92394795|NCT01386996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92394796|NCT01386996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394797|NCT01386996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394798|NCT01386996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394800|NCT01387048|Azelaic acid|azelaic acid|mesh-list
92394801|NCT01387048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92034992|NCT02358343|Sertraline|sertraline|mesh-list
92394802|NCT01387048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92394803|NCT01387048|Analgesics|analgesics|mesh-ancestor
92035044|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
92394804|NCT01387048|Sensory System Agents|sensory system agents|mesh-ancestor
92394805|NCT01387048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394806|NCT01387048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394807|NCT01387048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92394808|NCT01387048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92394809|NCT01387048|Dermatologic Agents|dermatologic agents|mesh-ancestor
92394810|NCT01387048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394812|NCT01387087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394813|NCT01387087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394814|NCT01387087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92394815|NCT01387087|Immunologic Factors|immunologic factors|mesh-ancestor
92394816|NCT01387087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394817|NCT01387191|Epoprostenol|epoprostenol|mesh-list
92394818|NCT01387191|Tezosentan|tezosentan|mesh-list
92394819|NCT01387191|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394820|NCT01387191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92394821|NCT01387191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92394822|NCT01387204|Trametinib|trametinib|mesh-list
92394823|NCT01387204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394824|NCT01387204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92394825|NCT01387204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035265|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92394826|NCT01387204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394827|NCT01387243|Orlistat|orlistat|mesh-list
92394828|NCT01387243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394829|NCT01387243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394830|NCT01387243|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92394831|NCT01387243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92394833|NCT01387295|Oxaliplatin|oxaliplatin|mesh-list
92394834|NCT01387295|Trastuzumab|trastuzumab|mesh-list
92394835|NCT01387295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394836|NCT01387295|Antimetabolites|antimetabolites|mesh-ancestor
92035458|NCT02037165|Celecoxib|celecoxib|mesh-list
92394837|NCT01387295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394838|NCT01387295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394839|NCT01387295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394840|NCT01387373|Capecitabine|capecitabine|mesh-list
92047178|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
92394842|NCT01387373|Trastuzumab|trastuzumab|mesh-list
92394843|NCT01387373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92394844|NCT01387373|Antimetabolites|antimetabolites|mesh-ancestor
92394845|NCT01387373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012507|NCT04470973|Amikacin|amikacin|mesh-list
92394846|NCT01387373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394847|NCT01387373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92394848|NCT01387399|Cisplatin|cisplatin|mesh-list
92394849|NCT01387399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394850|NCT01387425|Varenicline|varenicline|mesh-list
92394851|NCT01387425|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92394852|NCT01387425|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92394853|NCT01387425|Cholinergic Agents|cholinergic agents|mesh-ancestor
92394854|NCT01387425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035623|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
92394855|NCT01387425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394856|NCT01387425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394857|NCT01387568|Lidocaine|lidocaine|mesh-list
92394858|NCT01387568|Anesthetics, Local|anesthetics, local|mesh-ancestor
92394859|NCT01387568|Anesthetics|anesthetics|mesh-ancestor
92012547|NCT05056519|Vaccines|vaccines|mesh-list
92394860|NCT01387568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92394861|NCT01387568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394862|NCT01387568|Sensory System Agents|sensory system agents|mesh-ancestor
92394863|NCT01387568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92394864|NCT01387568|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92394865|NCT01387568|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92394866|NCT01387568|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92394867|NCT01387568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394868|NCT01387568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394869|NCT01387620|Hyaluronic Acid|hyaluronic acid|mesh-list
92394870|NCT01387620|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92394872|NCT01387620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394873|NCT01387620|Viscosupplements|viscosupplements|mesh-ancestor
92394874|NCT01387620|Protective Agents|protective agents|mesh-ancestor
92394876|NCT01387880|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92394877|NCT01387880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92394878|NCT01387880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394879|NCT01387880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394880|NCT01387880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92394881|NCT01387880|Immunologic Factors|immunologic factors|mesh-ancestor
92394882|NCT01387880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394883|NCT01387880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92394884|NCT01387906|Bimatoprost|bimatoprost|mesh-list
92394885|NCT01387906|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92394886|NCT01387997|Antibodies|antibodies|mesh-list
92394887|NCT01387997|Immunologic Factors|immunologic factors|mesh-ancestor
92394888|NCT01387997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394889|NCT01388023|Chlorhexidine|chlorhexidine|mesh-list
92394890|NCT01388023|Listerine|listerine|mesh-list
92394891|NCT01388023|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92394892|NCT01388023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394893|NCT01388023|Disinfectants|disinfectants|mesh-ancestor
92394894|NCT01388036|Esmolol|esmolol|mesh-list
92394895|NCT01388036|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92394896|NCT01388036|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92394897|NCT01388036|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92394898|NCT01388036|Adrenergic Agents|adrenergic agents|mesh-ancestor
92394899|NCT01388036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92394900|NCT01388036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394901|NCT01388036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394902|NCT01388049|Antibodies|antibodies|mesh-list
92394903|NCT01388049|Immunologic Factors|immunologic factors|mesh-ancestor
92394904|NCT01388049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394905|NCT01388062|Antibodies|antibodies|mesh-list
92394906|NCT01388062|Immunologic Factors|immunologic factors|mesh-ancestor
92394907|NCT01388062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394908|NCT01388075|Rifampin|rifampin|mesh-list
92394909|NCT01388075|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92394910|NCT01388075|Antitubercular Agents|antitubercular agents|mesh-ancestor
92394911|NCT01388075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92394912|NCT01388075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394913|NCT01388075|Leprostatic Agents|leprostatic agents|mesh-ancestor
92394914|NCT01388075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92394915|NCT01388075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036106|NCT02282605|Chlorhexidine|chlorhexidine|mesh-list
92394916|NCT01388075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036178|NCT02395172|Docetaxel|docetaxel|mesh-list
92394917|NCT01388075|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92394918|NCT01388075|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92394919|NCT01388075|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92394920|NCT01388075|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92394921|NCT01388075|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92394922|NCT01388075|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92394923|NCT01388088|Amiloride|amiloride|mesh-list
92394924|NCT01388088|Spironolactone|spironolactone|mesh-list
92394925|NCT01388088|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92394926|NCT01388088|Hormone Antagonists|hormone antagonists|mesh-ancestor
92394927|NCT01388088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92394928|NCT01388088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394929|NCT01388088|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92394930|NCT01388088|Diuretics|diuretics|mesh-ancestor
92394931|NCT01388088|Natriuretic Agents|natriuretic agents|mesh-ancestor
92394932|NCT01388088|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92394933|NCT01388088|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92394934|NCT01388088|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394935|NCT01388088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036368|NCT01827670|Fluorides|fluorides|mesh-list
92394936|NCT01388088|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92394937|NCT01388101|Antibodies|antibodies|mesh-list
92394938|NCT01388101|Immunologic Factors|immunologic factors|mesh-ancestor
92012763|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
92394939|NCT01388101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394940|NCT01388114|Antibodies|antibodies|mesh-list
92394941|NCT01388114|Immunologic Factors|immunologic factors|mesh-ancestor
92394942|NCT01388114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394943|NCT01388153|Acarbose|acarbose|mesh-list
92394944|NCT01388153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92394945|NCT01388153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394946|NCT01388153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394947|NCT01388153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92394948|NCT01388153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394949|NCT01388270|Heparin|heparin|mesh-list
92394950|NCT01388270|Calcium heparin|calcium heparin|mesh-list
92394951|NCT01388270|Anticoagulants|anticoagulants|mesh-ancestor
92394952|NCT01388270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92394953|NCT01388270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92394954|NCT01388270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394955|NCT01388322|Enoxaparin|enoxaparin|mesh-list
92036561|NCT02319668|Listerine|listerine|mesh-list
92394957|NCT01388322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92394958|NCT01388322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92394959|NCT01388322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013029|NCT05028907|Vitamin E|vitamin e|mesh-list
92394960|NCT01388413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92394961|NCT01388413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394962|NCT01388439|Oseltamivir|oseltamivir|mesh-list
92394963|NCT01388439|Antiviral Agents|antiviral agents|mesh-ancestor
92394964|NCT01388439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92394965|NCT01388439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394966|NCT01388439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92394967|NCT01388517|Vitamin D|vitamin d|mesh-list
92394968|NCT01388517|Calcitriol|calcitriol|mesh-list
92394969|NCT01388517|Petrolatum|petrolatum|mesh-list
92394970|NCT01388517|Tacrolimus|tacrolimus|mesh-list
92394971|NCT01388517|Vitamins|vitamins|mesh-ancestor
92394973|NCT01388517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394974|NCT01388517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92394975|NCT01388517|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036822|NCT04687761|Cytarabine|cytarabine|mesh-list
92394976|NCT01388517|Immunologic Factors|immunologic factors|mesh-ancestor
92394977|NCT01388517|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92394978|NCT01388517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92394979|NCT01388517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013068|NCT05028049|Sufentanil|sufentanil|mesh-list
92394980|NCT01388517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92394981|NCT01388517|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92394982|NCT01388517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92394983|NCT01388517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92394984|NCT01388517|Emollients|emollients|mesh-ancestor
92036908|NCT02087943|Analgesics|analgesics|mesh-ancestor
92394986|NCT01388582|Copper|copper|mesh-list
92394987|NCT01388582|Contraceptive Agents|contraceptive agents|mesh-list
92394988|NCT01388582|Levonorgestrel|levonorgestrel|mesh-list
92394989|NCT01388582|Etonogestrel|etonogestrel|mesh-list
92394990|NCT01388582|Desogestrel|desogestrel|mesh-list
92394991|NCT01388582|Contraceptives, Oral|contraceptives, oral|mesh-list
92394992|NCT01388582|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92394993|NCT01388582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92394994|NCT01388582|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92394995|NCT01388582|Trace Elements|trace elements|mesh-ancestor
92394996|NCT01388582|Micronutrients|micronutrients|mesh-ancestor
92394997|NCT01388582|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92394998|NCT01388582|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92394999|NCT01388582|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92395000|NCT01388582|Progestins|progestins|mesh-ancestor
92395001|NCT01388582|Hormones|hormones|mesh-ancestor
92395002|NCT01388582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395003|NCT01388595|Fluticasone|fluticasone|mesh-list
92395004|NCT01388595|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92395005|NCT01388595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395006|NCT01388595|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92395008|NCT01388595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395009|NCT01388595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395010|NCT01388595|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395011|NCT01388595|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395012|NCT01388595|Dermatologic Agents|dermatologic agents|mesh-ancestor
92395013|NCT01388595|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92395014|NCT01388595|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92395015|NCT01388595|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92395016|NCT01388595|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92395017|NCT01388595|Adrenergic Agents|adrenergic agents|mesh-ancestor
92395018|NCT01388595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945299|NCT03529253|Alirocumab|alirocumab|mesh-list
92395019|NCT01388595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395020|NCT01388621|Carboplatin|carboplatin|mesh-list
92395021|NCT01388621|Gemcitabine|gemcitabine|mesh-list
92395022|NCT01388621|Doxorubicin|doxorubicin|mesh-list
92395023|NCT01388621|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92395024|NCT01388621|Panitumumab|panitumumab|mesh-list
92395025|NCT01388621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395026|NCT01388621|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395027|NCT01388621|Antimetabolites|antimetabolites|mesh-ancestor
92395028|NCT01388621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395029|NCT01388621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92395030|NCT01388621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92013226|NCT03079453|Hormones|hormones|mesh-ancestor
92395031|NCT01388621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92395032|NCT01388621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395033|NCT01388621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395035|NCT01388660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92395036|NCT01388660|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92395037|NCT01388660|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92395038|NCT01388660|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92395039|NCT01388660|Purinergic Agents|purinergic agents|mesh-ancestor
92395040|NCT01388660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395041|NCT01388660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395042|NCT01388660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395044|NCT01388738|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92395045|NCT01388738|Nootropic Agents|nootropic agents|mesh-ancestor
92395046|NCT01388738|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92395047|NCT01388738|Protective Agents|protective agents|mesh-ancestor
92395048|NCT01388738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395049|NCT01388842|Nitric Oxide|nitric oxide|mesh-list
92013257|NCT05360277|Capecitabine|capecitabine|mesh-list
92395051|NCT01388842|Autonomic Agents|autonomic agents|mesh-ancestor
92395052|NCT01388842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395053|NCT01388842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395054|NCT01388842|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395055|NCT01388842|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395056|NCT01388842|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92395057|NCT01388842|Antioxidants|antioxidants|mesh-ancestor
92395058|NCT01388842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395059|NCT01388842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395060|NCT01388842|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92395061|NCT01388842|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395062|NCT01388842|Gasotransmitters|gasotransmitters|mesh-ancestor
92395063|NCT01388842|Protective Agents|protective agents|mesh-ancestor
92047407|NCT05355155|Bevacizumab|bevacizumab|mesh-list
92395064|NCT01388855|Vitamin D|vitamin d|mesh-list
92395065|NCT01388855|Cholecalciferol|cholecalciferol|mesh-list
92395066|NCT01388855|Vitamins|vitamins|mesh-ancestor
92395067|NCT01388855|Micronutrients|micronutrients|mesh-ancestor
92395068|NCT01388855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395069|NCT01388855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92395070|NCT01388855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92395071|NCT01388959|Rituximab|rituximab|mesh-list
92395072|NCT01388959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395073|NCT01388959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395074|NCT01388959|Immunologic Factors|immunologic factors|mesh-ancestor
92395075|NCT01388959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395076|NCT01388959|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395077|NCT01389063|Maraviroc|maraviroc|mesh-list
92395078|NCT01389063|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92395079|NCT01389063|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92037342|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
92395080|NCT01389063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395082|NCT01389063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92395083|NCT01389063|Antiviral Agents|antiviral agents|mesh-ancestor
92395084|NCT01389063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395085|NCT01389063|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92395086|NCT01389167|Naltrexone|naltrexone|mesh-list
92395087|NCT01389167|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92395088|NCT01389167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92395089|NCT01389167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395090|NCT01389167|Sensory System Agents|sensory system agents|mesh-ancestor
91945300|NCT03529253|Calcium|calcium|mesh-list
92395091|NCT01389167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395092|NCT01389193|Ibudilast|ibudilast|mesh-list
92395093|NCT01389193|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92395094|NCT01389193|Autonomic Agents|autonomic agents|mesh-ancestor
92395095|NCT01389193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395096|NCT01389193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395097|NCT01389193|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395098|NCT01389193|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395099|NCT01389193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92395100|NCT01389193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395101|NCT01389193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395102|NCT01389193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92395103|NCT01389193|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395104|NCT01389206|Bosentan|bosentan|mesh-list
92395105|NCT01389206|Selexipag|selexipag|mesh-list
92395106|NCT01389206|Iloprost|iloprost|mesh-list
92135881|NCT01539512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395108|NCT01389206|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92395109|NCT01389206|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395110|NCT01389206|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92395111|NCT01389206|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92395112|NCT01389206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395113|NCT01389206|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92395114|NCT01389206|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92395115|NCT01389271|Iloprost|iloprost|mesh-list
92395116|NCT01389271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92395117|NCT01389271|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395118|NCT01389388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92395119|NCT01389388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92395120|NCT01389388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92395121|NCT01389388|Antimetabolites|antimetabolites|mesh-ancestor
92395122|NCT01389388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395123|NCT01389388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92395124|NCT01389388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92395125|NCT01389388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395126|NCT01389401|Omeprazole|omeprazole|mesh-list
92395127|NCT01389401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92395128|NCT01389401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395129|NCT01389401|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92395130|NCT01389401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395131|NCT01389401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395132|NCT01389414|Gemcitabine|gemcitabine|mesh-list
92395133|NCT01389414|Oxaliplatin|oxaliplatin|mesh-list
92395134|NCT01389414|Panitumumab|panitumumab|mesh-list
92395135|NCT01389414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395136|NCT01389414|Antimetabolites|antimetabolites|mesh-ancestor
92395137|NCT01389414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395138|NCT01389414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395139|NCT01389414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395141|NCT01389427|Prednisone|prednisone|mesh-list
92395142|NCT01389427|Temsirolimus|temsirolimus|mesh-list
92395143|NCT01389427|MTOR Inhibitors|mtor inhibitors|mesh-list
92395144|NCT01389427|Cyclophosphamide|cyclophosphamide|mesh-list
92395145|NCT01389427|Vincristine|vincristine|mesh-list
92395146|NCT01389427|Rituximab|rituximab|mesh-list
92395147|NCT01389427|Doxorubicin|doxorubicin|mesh-list
92395148|NCT01389427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92395149|NCT01389427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395150|NCT01389427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395151|NCT01389427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395152|NCT01389427|Immunologic Factors|immunologic factors|mesh-ancestor
92395153|NCT01389427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395154|NCT01389427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395155|NCT01389427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92395156|NCT01389427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395157|NCT01389427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92395158|NCT01389427|Antifungal Agents|antifungal agents|mesh-ancestor
92395159|NCT01389427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395160|NCT01389427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92395161|NCT01389427|Alkylating Agents|alkylating agents|mesh-ancestor
92395162|NCT01389427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92395163|NCT01389427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395164|NCT01389427|Glucocorticoids|glucocorticoids|mesh-ancestor
92395165|NCT01389427|Hormones|hormones|mesh-ancestor
92395166|NCT01389427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395167|NCT01389427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92395168|NCT01389427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92395169|NCT01389427|Tubulin Modulators|tubulin modulators|mesh-ancestor
92395170|NCT01389427|Antimitotic Agents|antimitotic agents|mesh-ancestor
92395171|NCT01389427|Mitosis Modulators|mitosis modulators|mesh-ancestor
92395172|NCT01389427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395173|NCT01389427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92395174|NCT01389427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92395175|NCT01389440|Gemcitabine|gemcitabine|mesh-list
92395176|NCT01389440|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92395177|NCT01389440|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395178|NCT01389440|Antimetabolites|antimetabolites|mesh-ancestor
92395179|NCT01389440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395180|NCT01389440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135882|NCT01539512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395181|NCT01389440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92395182|NCT01389440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395183|NCT01389505|Bevacizumab|bevacizumab|mesh-list
92395184|NCT01389505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395185|NCT01389505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395186|NCT01389505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92395187|NCT01389505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92395188|NCT01389505|Growth Substances|growth substances|mesh-ancestor
92395189|NCT01389505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395190|NCT01389505|Growth Inhibitors|growth inhibitors|mesh-ancestor
92395191|NCT01389544|Ritonavir|ritonavir|mesh-list
92395192|NCT01389544|Methadone|methadone|mesh-list
92395193|NCT01389544|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92395194|NCT01389544|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92395195|NCT01389544|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395196|NCT01389544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395197|NCT01389544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395198|NCT01389544|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92395199|NCT01389544|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92395200|NCT01389544|Antiviral Agents|antiviral agents|mesh-ancestor
92395201|NCT01389544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395202|NCT01389544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92037514|NCT02431559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92395203|NCT01389544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92395204|NCT01389544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92395205|NCT01389544|Narcotics|narcotics|mesh-ancestor
92395206|NCT01389544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395207|NCT01389544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395208|NCT01389544|Analgesics|analgesics|mesh-ancestor
92395209|NCT01389544|Sensory System Agents|sensory system agents|mesh-ancestor
92395210|NCT01389544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395211|NCT01389544|Antitussive Agents|antitussive agents|mesh-ancestor
92395212|NCT01389544|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395213|NCT01389557|Primaquine|primaquine|mesh-list
92395214|NCT01389557|Piperaquine|piperaquine|mesh-list
92395216|NCT01389557|Antimalarials|antimalarials|mesh-ancestor
92395217|NCT01389557|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92395218|NCT01389557|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92395219|NCT01389557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395220|NCT01389609|Doxazosin|doxazosin|mesh-list
92395221|NCT01389609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92395222|NCT01389609|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92395223|NCT01389609|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92395224|NCT01389609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92395225|NCT01389609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92395226|NCT01389609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395227|NCT01389609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395228|NCT01389609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395229|NCT01389713|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92395230|NCT01389713|Clomiphene|clomiphene|mesh-list
92395231|NCT01389713|Enclomiphene|enclomiphene|mesh-list
92395232|NCT01389713|Zuclomiphene|zuclomiphene|mesh-list
92395233|NCT01389713|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92395234|NCT01389713|Hormone Antagonists|hormone antagonists|mesh-ancestor
92395235|NCT01389713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395236|NCT01389713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395237|NCT01389713|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92395238|NCT01389713|Fertility Agents|fertility agents|mesh-ancestor
92395239|NCT01389713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92395240|NCT01389713|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92395241|NCT01389713|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92395242|NCT01389713|Luteolytic Agents|luteolytic agents|mesh-ancestor
92395243|NCT01389713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92395244|NCT01389713|Contraceptive Agents|contraceptive agents|mesh-ancestor
92395245|NCT01389713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92395246|NCT01389713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92395247|NCT01389713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395248|NCT01389778|Metformin|metformin|mesh-list
92395249|NCT01389778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92395250|NCT01389778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037588|NCT01651403|Tenofovir|tenofovir|mesh-list
92395251|NCT01389791|Magnesium Sulfate|magnesium sulfate|mesh-list
92395252|NCT01389791|Rocuronium|rocuronium|mesh-list
92395253|NCT01389791|Analgesics|analgesics|mesh-ancestor
92395254|NCT01389791|Sensory System Agents|sensory system agents|mesh-ancestor
92395255|NCT01389791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395256|NCT01389791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395257|NCT01389791|Anesthetics|anesthetics|mesh-ancestor
92395258|NCT01389791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395259|NCT01389791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92395260|NCT01389791|Anticonvulsants|anticonvulsants|mesh-ancestor
92395261|NCT01389791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92395262|NCT01389791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395263|NCT01389791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395264|NCT01389791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92395265|NCT01389791|Tocolytic Agents|tocolytic agents|mesh-ancestor
92395266|NCT01389791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92395267|NCT01389791|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92037618|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
92395268|NCT01389791|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92395270|NCT01389908|Olanzapine|olanzapine|mesh-list
92395271|NCT01389908|Antiemetics|antiemetics|mesh-ancestor
92395272|NCT01389908|Autonomic Agents|autonomic agents|mesh-ancestor
92395273|NCT01389908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395274|NCT01389908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395275|NCT01389908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395276|NCT01389908|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92395277|NCT01389908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92395278|NCT01389908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395279|NCT01389908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92395280|NCT01389908|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92395281|NCT01389908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92395282|NCT01389908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395283|NCT01389908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395284|NCT01389908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395285|NCT01389908|Serotonin Agents|serotonin agents|mesh-ancestor
92395286|NCT01390012|Dexamethasone|dexamethasone|mesh-list
92395287|NCT01390012|Dexamethasone acetate|dexamethasone acetate|mesh-list
92395288|NCT01390012|BB 1101|bb 1101|mesh-list
92395289|NCT01390012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395290|NCT01390012|Antiemetics|antiemetics|mesh-ancestor
92395291|NCT01390012|Autonomic Agents|autonomic agents|mesh-ancestor
92395292|NCT01390012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395293|NCT01390012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395294|NCT01390012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395295|NCT01390012|Glucocorticoids|glucocorticoids|mesh-ancestor
92395296|NCT01390012|Hormones|hormones|mesh-ancestor
92395297|NCT01390012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395298|NCT01390012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92395299|NCT01390012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395300|NCT01390012|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395301|NCT01390012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395302|NCT01390012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395303|NCT01390051|Tinzaparin|tinzaparin|mesh-list
92395304|NCT01390051|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92395305|NCT01390051|Dalteparin|dalteparin|mesh-list
92395306|NCT01390051|Anticoagulants|anticoagulants|mesh-ancestor
92395307|NCT01390051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92395308|NCT01390051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92395309|NCT01390051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395310|NCT01390311|Azacitidine|azacitidine|mesh-list
92395311|NCT01390311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395312|NCT01390311|Antimetabolites|antimetabolites|mesh-ancestor
92395313|NCT01390311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395314|NCT01390311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395315|NCT01390311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395316|NCT01390324|Naproxen|naproxen|mesh-list
92395317|NCT01390324|Naratriptan|naratriptan|mesh-list
92395318|NCT01390324|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92395319|NCT01390324|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92395320|NCT01390324|Analgesics|analgesics|mesh-ancestor
92395321|NCT01390324|Sensory System Agents|sensory system agents|mesh-ancestor
92395323|NCT01390324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395324|NCT01390324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395325|NCT01390324|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395326|NCT01390324|Gout Suppressants|gout suppressants|mesh-ancestor
92395327|NCT01390324|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92395328|NCT01390324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395329|NCT01390324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395330|NCT01390324|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92395331|NCT01390324|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92395332|NCT01390324|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92395333|NCT01390324|Serotonin Agents|serotonin agents|mesh-ancestor
92395334|NCT01390324|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395335|NCT01390337|Cytarabine|cytarabine|mesh-list
92395336|NCT01390337|Daunorubicin|daunorubicin|mesh-list
92395337|NCT01390337|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395338|NCT01390337|Antimetabolites|antimetabolites|mesh-ancestor
92395339|NCT01390337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395340|NCT01390337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395341|NCT01390337|Antiviral Agents|antiviral agents|mesh-ancestor
92395342|NCT01390337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395343|NCT01390337|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395344|NCT01390337|Immunologic Factors|immunologic factors|mesh-ancestor
92395345|NCT01390337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395346|NCT01390337|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92395347|NCT01390337|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92395348|NCT01390337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92395349|NCT01390337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395350|NCT01390480|Cholecalciferol|cholecalciferol|mesh-list
92395351|NCT01390480|Vitamin D|vitamin d|mesh-list
92395352|NCT01390480|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92395353|NCT01390480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395354|NCT01390480|Vitamins|vitamins|mesh-ancestor
92395355|NCT01390480|Micronutrients|micronutrients|mesh-ancestor
92395356|NCT01390480|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92395357|NCT01390506|Selenious Acid|selenious acid|mesh-list
92395358|NCT01390506|Sodium Selenite|sodium selenite|mesh-list
92395359|NCT01390506|Trace Elements|trace elements|mesh-ancestor
92047710|NCT01536574|Ropinirole|ropinirole|mesh-list
92395360|NCT01390506|Micronutrients|micronutrients|mesh-ancestor
92395361|NCT01390506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395362|NCT01390519|Everolimus|everolimus|mesh-list
92395363|NCT01390519|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92395364|NCT01390519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92395365|NCT01390519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037803|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395366|NCT01390519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395367|NCT01390519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395368|NCT01390519|Immunologic Factors|immunologic factors|mesh-ancestor
92395369|NCT01390519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395370|NCT01390519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395371|NCT01390571|Temozolomide|temozolomide|mesh-list
92395372|NCT01390571|Olaparib|olaparib|mesh-list
92395373|NCT01390571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92395374|NCT01390571|Alkylating Agents|alkylating agents|mesh-ancestor
92395375|NCT01390571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395376|NCT01390571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395377|NCT01390571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92395378|NCT01390571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395379|NCT01390623|Ceftriaxone|ceftriaxone|mesh-list
92395380|NCT01390623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92395381|NCT01390623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395382|NCT01390662|Vitamin D|vitamin d|mesh-list
92395383|NCT01390662|Cholecalciferol|cholecalciferol|mesh-list
92395384|NCT01390662|Vitamins|vitamins|mesh-ancestor
92395385|NCT01390662|Micronutrients|micronutrients|mesh-ancestor
92037857|NCT02401529|Prednisolone|prednisolone|mesh-list
92395386|NCT01390662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395387|NCT01390662|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92395388|NCT01390662|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92395389|NCT01390766|Azathioprine|azathioprine|mesh-list
92395390|NCT01390766|Antimetabolites|antimetabolites|mesh-ancestor
92395391|NCT01390766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395392|NCT01390766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395393|NCT01390766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395394|NCT01390766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395395|NCT01390766|Immunologic Factors|immunologic factors|mesh-ancestor
92395396|NCT01390766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395397|NCT01390766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395398|NCT01390792|Zanamivir|zanamivir|mesh-list
92395399|NCT01390792|Antiviral Agents|antiviral agents|mesh-ancestor
92395400|NCT01390792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395401|NCT01390792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395402|NCT01390792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395403|NCT01390805|Valacyclovir|valacyclovir|mesh-list
92395404|NCT01390805|Antiviral Agents|antiviral agents|mesh-ancestor
92395405|NCT01390805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395406|NCT01390883|PENTA|penta|mesh-list
92395407|NCT01390883|Fondaparinux|fondaparinux|mesh-list
92395408|NCT01390883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92395409|NCT01390883|Antithrombins|antithrombins|mesh-ancestor
92395410|NCT01390883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92395411|NCT01390883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395412|NCT01390883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395413|NCT01390883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395414|NCT01390883|Anticoagulants|anticoagulants|mesh-ancestor
92395415|NCT01390883|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92395416|NCT01390883|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92395417|NCT01390896|PENTA|penta|mesh-list
92395418|NCT01390896|Fondaparinux|fondaparinux|mesh-list
92395419|NCT01390896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92395420|NCT01390896|Antithrombins|antithrombins|mesh-ancestor
92395421|NCT01390896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92395422|NCT01390896|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395423|NCT01390896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037997|NCT01772134|Anticonvulsants|anticonvulsants|mesh-ancestor
92395424|NCT01390896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395425|NCT01390896|Anticoagulants|anticoagulants|mesh-ancestor
92395426|NCT01390896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92013555|NCT02637037|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92395428|NCT01390922|Botulinum Toxins|botulinum toxins|mesh-list
92395429|NCT01390922|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92395430|NCT01390922|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92395431|NCT01390922|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92395432|NCT01390922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395433|NCT01390922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395434|NCT01390922|Cholinergic Agents|cholinergic agents|mesh-ancestor
92047793|NCT01575028|Bupivacaine|bupivacaine|mesh-list
92395435|NCT01390922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395436|NCT01390922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395437|NCT01390922|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92395438|NCT01390922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395439|NCT01390935|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92395440|NCT01390935|Hormone Antagonists|hormone antagonists|mesh-ancestor
92395441|NCT01390935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395442|NCT01390935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395443|NCT01390935|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92395444|NCT01390935|Diuretics|diuretics|mesh-ancestor
92395445|NCT01390935|Natriuretic Agents|natriuretic agents|mesh-ancestor
92013694|NCT05554419|Cytarabine|cytarabine|mesh-list
92395446|NCT01390961|Pheniramine|pheniramine|mesh-list
92395447|NCT01390961|Naphazoline|naphazoline|mesh-list
92395448|NCT01390961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395449|NCT01390961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92395450|NCT01390961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92395451|NCT01390961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92395452|NCT01390961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395453|NCT01390961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395454|NCT01390961|Nasal Decongestants|nasal decongestants|mesh-ancestor
92395455|NCT01390961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92395456|NCT01390961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395457|NCT01390961|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92395458|NCT01390961|Histamine Antagonists|histamine antagonists|mesh-ancestor
92395459|NCT01390961|Histamine Agents|histamine agents|mesh-ancestor
92395460|NCT01390961|Antipruritics|antipruritics|mesh-ancestor
92395461|NCT01390961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92395462|NCT01390961|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92395463|NCT01391052|Norethindrone|norethindrone|mesh-list
92395464|NCT01391052|Norethindrone Acetate|norethindrone acetate|mesh-list
92395465|NCT01391052|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92395466|NCT01391052|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92395467|NCT01391052|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92395468|NCT01391052|Contraceptive Agents|contraceptive agents|mesh-ancestor
92395469|NCT01391052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92395470|NCT01391052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395471|NCT01391052|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92395472|NCT01391052|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92395473|NCT01391104|Sildenafil Citrate|sildenafil citrate|mesh-list
92395474|NCT01391104|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395475|NCT01391104|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92395476|NCT01391104|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92395477|NCT01391104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395478|NCT01391104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395479|NCT01391104|Urological Agents|urological agents|mesh-ancestor
92395480|NCT01391156|Minoxidil|minoxidil|mesh-list
92395481|NCT01391156|Finasteride|finasteride|mesh-list
92395482|NCT01391156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92395483|NCT01391156|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395484|NCT01391156|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92395485|NCT01391156|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92395486|NCT01391156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395487|NCT01391156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395488|NCT01391156|Hormone Antagonists|hormone antagonists|mesh-ancestor
92395489|NCT01391156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395490|NCT01391156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395491|NCT01391156|Urological Agents|urological agents|mesh-ancestor
92395492|NCT01391221|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92395493|NCT01391221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92395494|NCT01391221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92395495|NCT01391221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395496|NCT01391221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395497|NCT01391221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395498|NCT01391221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395499|NCT01391221|Analgesics|analgesics|mesh-ancestor
92395500|NCT01391221|Sensory System Agents|sensory system agents|mesh-ancestor
92395501|NCT01391221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395502|NCT01391221|Antidepressive Agents|antidepressive agents|mesh-ancestor
92395503|NCT01391221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92395504|NCT01391221|Dopamine Agents|dopamine agents|mesh-ancestor
92395505|NCT01391260|Gefitinib|gefitinib|mesh-list
92395506|NCT01391260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395507|NCT01391260|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92395508|NCT01391260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395509|NCT01391260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395510|NCT01391377|Niacin|niacin|mesh-list
92395511|NCT01391377|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92395512|NCT01391377|Antimetabolites|antimetabolites|mesh-ancestor
92395513|NCT01391377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395514|NCT01391377|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92395515|NCT01391377|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395516|NCT01391377|Vitamin B Complex|vitamin b complex|mesh-ancestor
92395518|NCT01391377|Micronutrients|micronutrients|mesh-ancestor
92395519|NCT01391377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395520|NCT01391390|Melatonin|melatonin|mesh-list
92395521|NCT01391390|Antioxidants|antioxidants|mesh-ancestor
92395522|NCT01391390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395523|NCT01391390|Protective Agents|protective agents|mesh-ancestor
92395524|NCT01391390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038357|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92395525|NCT01391390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395527|NCT01391403|Artemisinin|artemisinin|mesh-list
92395528|NCT01391403|Antimalarials|antimalarials|mesh-ancestor
92395529|NCT01391403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92395530|NCT01391403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92395531|NCT01391403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395532|NCT01391520|Deferiprone|deferiprone|mesh-list
92395533|NCT01391520|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92395534|NCT01391520|Chelating Agents|chelating agents|mesh-ancestor
92395535|NCT01391520|Sequestering Agents|sequestering agents|mesh-ancestor
92395536|NCT01391520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395537|NCT01391572|Fluorouracil|fluorouracil|mesh-list
92395538|NCT01391572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395539|NCT01391572|Antimetabolites|antimetabolites|mesh-ancestor
92395540|NCT01391572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395541|NCT01391572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395542|NCT01391572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395543|NCT01391572|Immunologic Factors|immunologic factors|mesh-ancestor
92395544|NCT01391572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395545|NCT01391598|Lidocaine|lidocaine|mesh-list
92395546|NCT01391598|Anesthetics, Local|anesthetics, local|mesh-ancestor
92395547|NCT01391598|Anesthetics|anesthetics|mesh-ancestor
92395548|NCT01391598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395549|NCT01391598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395550|NCT01391598|Sensory System Agents|sensory system agents|mesh-ancestor
92395551|NCT01391598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395552|NCT01391598|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92395553|NCT01391598|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92395554|NCT01391598|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92395555|NCT01391598|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395556|NCT01391598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395557|NCT01391624|Mineral Oil|mineral oil|mesh-list
92395558|NCT01391624|Emollients|emollients|mesh-ancestor
92395559|NCT01391624|Dermatologic Agents|dermatologic agents|mesh-ancestor
92395560|NCT01391689|3,3'-diindolylmethane|3,3'-diindolylmethane|mesh-list
92395561|NCT01391689|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92395562|NCT01391689|Protective Agents|protective agents|mesh-ancestor
92395563|NCT01391689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395564|NCT01391689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395565|NCT01391715|Rabeprazole|rabeprazole|mesh-list
92395566|NCT01391715|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92395568|NCT01391715|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92395569|NCT01391715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395570|NCT01391715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395571|NCT01391845|Ulipristal acetate|ulipristal acetate|mesh-list
92395572|NCT01391845|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92395573|NCT01391845|Contraceptive Agents|contraceptive agents|mesh-ancestor
92395574|NCT01391845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92395575|NCT01391845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395576|NCT01391845|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92395577|NCT01392014|Primaquine|primaquine|mesh-list
92395578|NCT01392014|Piperaquine|piperaquine|mesh-list
92395579|NCT01392014|Artenimol|artenimol|mesh-list
92395580|NCT01392014|Artemisinins|artemisinins|mesh-list
92395581|NCT01392014|Antimalarials|antimalarials|mesh-ancestor
92395582|NCT01392014|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92395583|NCT01392014|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92395584|NCT01392014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395585|NCT01392079|Alemtuzumab|alemtuzumab|mesh-list
92395586|NCT01392079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395587|NCT01392079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395588|NCT01392144|Nitric Oxide|nitric oxide|mesh-list
92395589|NCT01392144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92395590|NCT01392144|Autonomic Agents|autonomic agents|mesh-ancestor
92395591|NCT01392144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395592|NCT01392144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395593|NCT01392144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395594|NCT01392144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395595|NCT01392144|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92395597|NCT01392144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395598|NCT01392144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395599|NCT01392144|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92395600|NCT01392144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395601|NCT01392144|Gasotransmitters|gasotransmitters|mesh-ancestor
92395602|NCT01392144|Protective Agents|protective agents|mesh-ancestor
92395603|NCT01392157|Copper|copper|mesh-list
92395604|NCT01392157|Levonorgestrel|levonorgestrel|mesh-list
92395605|NCT01392157|Trace Elements|trace elements|mesh-ancestor
92395606|NCT01392157|Micronutrients|micronutrients|mesh-ancestor
92395607|NCT01392157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395608|NCT01392157|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92395609|NCT01392157|Contraceptive Agents|contraceptive agents|mesh-ancestor
92395610|NCT01392157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92395611|NCT01392157|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92395612|NCT01392157|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92395613|NCT01392157|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92395614|NCT01392209|Bevacizumab|bevacizumab|mesh-list
92395615|NCT01392209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395616|NCT01392209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395617|NCT01392209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92395618|NCT01392209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92395619|NCT01392209|Growth Substances|growth substances|mesh-ancestor
92395620|NCT01392209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395621|NCT01392209|Growth Inhibitors|growth inhibitors|mesh-ancestor
92395623|NCT01392287|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92395624|NCT01392287|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92395625|NCT01392287|Dopamine Agents|dopamine agents|mesh-ancestor
92395626|NCT01392287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395627|NCT01392287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395628|NCT01392287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395629|NCT01392287|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92395630|NCT01392287|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92395631|NCT01392430|Azithromycin|azithromycin|mesh-list
92395632|NCT01392430|Dapsone|dapsone|mesh-list
92395633|NCT01392430|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92395634|NCT01392430|Itraconazole|itraconazole|mesh-list
92395635|NCT01392430|Fluconazole|fluconazole|mesh-list
92395636|NCT01392430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92395637|NCT01392430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395638|NCT01392430|Antifungal Agents|antifungal agents|mesh-ancestor
92395639|NCT01392430|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92395640|NCT01392430|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92395641|NCT01392430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395642|NCT01392430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395643|NCT01392430|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92395644|NCT01392430|Hormone Antagonists|hormone antagonists|mesh-ancestor
92395645|NCT01392430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395646|NCT01392430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395647|NCT01392430|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92395648|NCT01392430|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92395649|NCT01392430|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92395650|NCT01392430|Antimalarials|antimalarials|mesh-ancestor
92395651|NCT01392430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92395652|NCT01392430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92395653|NCT01392430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92395654|NCT01392430|Leprostatic Agents|leprostatic agents|mesh-ancestor
92395655|NCT01392430|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92395656|NCT01392534|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92395658|NCT01392534|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92395659|NCT01392534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92395660|NCT01392534|Diuretics|diuretics|mesh-ancestor
92048006|NCT02217566|Prednisone|prednisone|mesh-list
92395662|NCT01392534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038622|NCT02340221|Fulvestrant|fulvestrant|mesh-list
92395663|NCT01392534|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92395664|NCT01392534|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395665|NCT01392534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395666|NCT01392534|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92395667|NCT01392534|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92395668|NCT01392612|Epoetin Alfa|epoetin alfa|mesh-list
92395669|NCT01392612|Hematinics|hematinics|mesh-ancestor
92395670|NCT01392638|Sildenafil Citrate|sildenafil citrate|mesh-list
92395671|NCT01392638|Vasodilator Agents|vasodilator agents|mesh-ancestor
92395672|NCT01392638|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92395673|NCT01392638|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92395674|NCT01392638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395675|NCT01392638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395676|NCT01392638|Urological Agents|urological agents|mesh-ancestor
92395677|NCT01392716|Rituximab|rituximab|mesh-list
92395678|NCT01392716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395679|NCT01392716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395680|NCT01392716|Immunologic Factors|immunologic factors|mesh-ancestor
92395681|NCT01392716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395682|NCT01392716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395683|NCT01392755|Ritonavir|ritonavir|mesh-list
92395684|NCT01392755|Omeprazole|omeprazole|mesh-list
92395685|NCT01392755|Ranitidine|ranitidine|mesh-list
92395686|NCT01392755|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92395687|NCT01392755|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92395688|NCT01392755|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92395689|NCT01392755|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395690|NCT01392755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395691|NCT01392755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395692|NCT01392755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92395693|NCT01392755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92395694|NCT01392755|Antiviral Agents|antiviral agents|mesh-ancestor
92395695|NCT01392755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395696|NCT01392755|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92395697|NCT01392755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92395698|NCT01392755|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92395699|NCT01392755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395700|NCT01392755|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92395701|NCT01392755|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92395702|NCT01392755|Histamine Antagonists|histamine antagonists|mesh-ancestor
92395703|NCT01392755|Histamine Agents|histamine agents|mesh-ancestor
92038695|NCT04905251|Misoprostol|misoprostol|mesh-list
92395704|NCT01392755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395705|NCT01392755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395706|NCT01392768|Levetiracetam|levetiracetam|mesh-list
92395707|NCT01392768|Anticonvulsants|anticonvulsants|mesh-ancestor
92395708|NCT01392768|Nootropic Agents|nootropic agents|mesh-ancestor
92395709|NCT01392794|Ramosetron|ramosetron|mesh-list
92395710|NCT01392794|Antiemetics|antiemetics|mesh-ancestor
92395711|NCT01392794|Autonomic Agents|autonomic agents|mesh-ancestor
92395712|NCT01392794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395713|NCT01392794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395714|NCT01392794|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395715|NCT01392794|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92395716|NCT01392794|Serotonin Agents|serotonin agents|mesh-ancestor
92395717|NCT01392794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395718|NCT01392794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395719|NCT01392807|Naloxegol|naloxegol|mesh-list
92395720|NCT01392807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92395721|NCT01392807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395722|NCT01392807|Sensory System Agents|sensory system agents|mesh-ancestor
92395723|NCT01392807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395724|NCT01392833|Prednisone|prednisone|mesh-list
92395725|NCT01392833|Methylprednisolone|methylprednisolone|mesh-list
92395726|NCT01392833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92395727|NCT01392833|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92395729|NCT01392833|Prednisolone acetate|prednisolone acetate|mesh-list
92395730|NCT01392833|Azathioprine|azathioprine|mesh-list
92395731|NCT01392833|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92395732|NCT01392833|Prednisolone phosphate|prednisolone phosphate|mesh-list
92395733|NCT01392833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048080|NCT02180672|Fluticasone|fluticasone|mesh-list
92395734|NCT01392833|Glucocorticoids|glucocorticoids|mesh-ancestor
92395735|NCT01392833|Hormones|hormones|mesh-ancestor
92395736|NCT01392833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395737|NCT01392833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395738|NCT01392833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92395739|NCT01392833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395740|NCT01392833|Antiemetics|antiemetics|mesh-ancestor
92395741|NCT01392833|Autonomic Agents|autonomic agents|mesh-ancestor
92395742|NCT01392833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395743|NCT01392833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395744|NCT01392833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92395745|NCT01392833|Protective Agents|protective agents|mesh-ancestor
92395746|NCT01392833|Antimetabolites|antimetabolites|mesh-ancestor
92395747|NCT01392833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395748|NCT01392833|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92395749|NCT01392833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395751|NCT01392833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395752|NCT01392898|Liraglutide|liraglutide|mesh-list
92395753|NCT01392898|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92395754|NCT01392898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395755|NCT01392898|Incretins|incretins|mesh-ancestor
92395756|NCT01392898|Hormones|hormones|mesh-ancestor
92395757|NCT01392898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395758|NCT01392911|Rifampin|rifampin|mesh-list
92395759|NCT01392911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92395760|NCT01392911|Antitubercular Agents|antitubercular agents|mesh-ancestor
92395761|NCT01392911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92395762|NCT01392911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395763|NCT01392911|Leprostatic Agents|leprostatic agents|mesh-ancestor
92395764|NCT01392911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92395765|NCT01392911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395766|NCT01392911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395767|NCT01392911|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92395768|NCT01392911|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92395769|NCT01392911|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92395770|NCT01392911|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92395771|NCT01392911|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92395772|NCT01392911|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92395774|NCT01393080|Cisplatin|cisplatin|mesh-list
92395775|NCT01393080|Paclitaxel|paclitaxel|mesh-list
92395776|NCT01393080|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395777|NCT01393080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395778|NCT01393080|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92395779|NCT01393080|Tubulin Modulators|tubulin modulators|mesh-ancestor
92395780|NCT01393080|Antimitotic Agents|antimitotic agents|mesh-ancestor
92395781|NCT01393080|Mitosis Modulators|mitosis modulators|mesh-ancestor
92395782|NCT01393080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395783|NCT01393145|Fluticasone|fluticasone|mesh-list
92395784|NCT01393145|Xhance|xhance|mesh-list
92395785|NCT01393145|Formoterol Fumarate|formoterol fumarate|mesh-list
92395786|NCT01393145|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92395787|NCT01393145|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92395788|NCT01393145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395789|NCT01393145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92395790|NCT01393145|Autonomic Agents|autonomic agents|mesh-ancestor
92395791|NCT01393145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395792|NCT01393145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395793|NCT01393145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395794|NCT01393145|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395795|NCT01393145|Dermatologic Agents|dermatologic agents|mesh-ancestor
92395796|NCT01393145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92395797|NCT01393145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92395798|NCT01393145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92395799|NCT01393145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92395800|NCT01393145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92395801|NCT01393145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395802|NCT01393145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395803|NCT01393145|Glucocorticoids|glucocorticoids|mesh-ancestor
92395804|NCT01393145|Hormones|hormones|mesh-ancestor
92395805|NCT01393145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395806|NCT01393145|Sympathomimetics|sympathomimetics|mesh-ancestor
92395807|NCT01393184|Nimotuzumab|nimotuzumab|mesh-list
92395808|NCT01393184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92395809|NCT01393184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395810|NCT01393288|Lorazepam|lorazepam|mesh-list
92395811|NCT01393288|Ondansetron|ondansetron|mesh-list
92395812|NCT01393288|Aprepitant|aprepitant|mesh-list
92395813|NCT01393288|Antiemetics|antiemetics|mesh-ancestor
92395814|NCT01393288|Autonomic Agents|autonomic agents|mesh-ancestor
92395815|NCT01393288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395816|NCT01393288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395817|NCT01393288|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395818|NCT01393288|Antipruritics|antipruritics|mesh-ancestor
92395819|NCT01393288|Dermatologic Agents|dermatologic agents|mesh-ancestor
92395820|NCT01393288|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92395821|NCT01393288|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92395822|NCT01393288|Serotonin Agents|serotonin agents|mesh-ancestor
92395823|NCT01393288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395824|NCT01393288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395825|NCT01393288|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92395826|NCT01393288|Anticonvulsants|anticonvulsants|mesh-ancestor
92038976|NCT02389829|Analgesics|analgesics|mesh-ancestor
92395827|NCT01393288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92395828|NCT01393288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395829|NCT01393288|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92395830|NCT01393288|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92395831|NCT01393288|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92395832|NCT01393288|GABA Modulators|gaba modulators|mesh-ancestor
92395833|NCT01393288|GABA Agents|gaba agents|mesh-ancestor
92395834|NCT01393340|Omalizumab|omalizumab|mesh-list
92395836|NCT01393340|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395837|NCT01393340|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395838|NCT01393548|Brompheniramine|brompheniramine|mesh-list
92395839|NCT01393548|Phenylephrine|phenylephrine|mesh-list
92395840|NCT01393548|Oxymetazoline|oxymetazoline|mesh-list
92395841|NCT01393548|Pseudoephedrine|pseudoephedrine|mesh-list
92395842|NCT01393548|Ephedrine|ephedrine|mesh-list
92395843|NCT01393548|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92039117|NCT01620177|Ethanol|ethanol|mesh-list
92395845|NCT01393548|Autonomic Agents|autonomic agents|mesh-ancestor
92395846|NCT01393548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395847|NCT01393548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395848|NCT01393548|Sympathomimetics|sympathomimetics|mesh-ancestor
92395849|NCT01393548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92395850|NCT01393548|Nasal Decongestants|nasal decongestants|mesh-ancestor
92395851|NCT01393548|Respiratory System Agents|respiratory system agents|mesh-ancestor
92395852|NCT01393548|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92395853|NCT01393548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92395854|NCT01393548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92395855|NCT01393548|Adrenergic Agents|adrenergic agents|mesh-ancestor
92395856|NCT01393548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395857|NCT01393548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395858|NCT01393548|Protective Agents|protective agents|mesh-ancestor
92395859|NCT01393548|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92395860|NCT01393548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92395861|NCT01393548|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92395862|NCT01393548|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92395863|NCT01393548|Histamine Antagonists|histamine antagonists|mesh-ancestor
92395864|NCT01393548|Histamine Agents|histamine agents|mesh-ancestor
92395865|NCT01393548|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92395866|NCT01393574|Melatonin|melatonin|mesh-list
92395867|NCT01393574|Methylphenidate|methylphenidate|mesh-list
92395868|NCT01393574|Antioxidants|antioxidants|mesh-ancestor
92395869|NCT01393574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395870|NCT01393574|Protective Agents|protective agents|mesh-ancestor
92395871|NCT01393574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395872|NCT01393574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395873|NCT01393574|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92395874|NCT01393574|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92395875|NCT01393574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92395876|NCT01393574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92395877|NCT01393574|Dopamine Agents|dopamine agents|mesh-ancestor
92395878|NCT01393574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92395879|NCT01393756|Lenalidomide|lenalidomide|mesh-list
92395880|NCT01393756|Immunologic Factors|immunologic factors|mesh-ancestor
92395881|NCT01393756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395882|NCT01393756|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92395883|NCT01393756|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92039447|NCT04672005|Vitamins|vitamins|mesh-ancestor
92395884|NCT01393756|Growth Substances|growth substances|mesh-ancestor
92048225|NCT01557244|Urological Agents|urological agents|mesh-ancestor
92395885|NCT01393756|Growth Inhibitors|growth inhibitors|mesh-ancestor
92395886|NCT01393756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395887|NCT01393769|Melphalan|melphalan|mesh-list
92395888|NCT01393769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92395889|NCT01393769|Alkylating Agents|alkylating agents|mesh-ancestor
92395890|NCT01393769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395891|NCT01393769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395892|NCT01393769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92395893|NCT01393769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92395894|NCT01393769|Immunologic Factors|immunologic factors|mesh-ancestor
92395895|NCT01393769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395896|NCT01393782|Angiotensin II|angiotensin ii|mesh-list
92395897|NCT01393782|Giapreza|giapreza|mesh-list
92395898|NCT01393782|Angiotensinogen|angiotensinogen|mesh-list
92395899|NCT01393782|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92395900|NCT01393782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92395901|NCT01393782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395902|NCT01393782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395903|NCT01393782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395904|NCT01393795|Capsaicin|capsaicin|mesh-list
92395905|NCT01393795|Antipruritics|antipruritics|mesh-ancestor
92395906|NCT01393795|Dermatologic Agents|dermatologic agents|mesh-ancestor
92395908|NCT01393795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395909|NCT01393795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395910|NCT01393912|Crenolanib|crenolanib|mesh-list
92395911|NCT01393912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395912|NCT01393925|Parecoxib|parecoxib|mesh-list
92395913|NCT01393925|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92395914|NCT01393925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92395915|NCT01393925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395916|NCT01393925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395917|NCT01393925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92395918|NCT01393925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92395920|NCT01393925|Sensory System Agents|sensory system agents|mesh-ancestor
92395921|NCT01393925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395922|NCT01393925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395923|NCT01393925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395924|NCT01393925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92395925|NCT01394029|Deferasirox|deferasirox|mesh-list
92395926|NCT01394029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92395927|NCT01394029|Chelating Agents|chelating agents|mesh-ancestor
92395928|NCT01394029|Sequestering Agents|sequestering agents|mesh-ancestor
92116355|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92395929|NCT01394029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395930|NCT01394094|Calcium|calcium|mesh-list
92040059|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
92395931|NCT01394094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92395932|NCT01394094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395933|NCT01394133|Ritonavir|ritonavir|mesh-list
92395934|NCT01394133|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92395935|NCT01394133|Tenofovir|tenofovir|mesh-list
92395936|NCT01394133|Emtricitabine|emtricitabine|mesh-list
92395937|NCT01394133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92395938|NCT01394133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92395939|NCT01394133|Protease Inhibitors|protease inhibitors|mesh-ancestor
92395940|NCT01394133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395941|NCT01394133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395942|NCT01394133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92395943|NCT01394133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92040283|NCT05813132|Etoposide|etoposide|mesh-list
92395944|NCT01394133|Antiviral Agents|antiviral agents|mesh-ancestor
92395945|NCT01394133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92395946|NCT01394133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92040336|NCT05811403|Antioxidants|antioxidants|mesh-ancestor
92040385|NCT05757388|Parecoxib|parecoxib|mesh-list
92395947|NCT01394133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92395948|NCT01394133|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92395949|NCT01394133|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92395950|NCT01394224|Levetiracetam|levetiracetam|mesh-list
92395951|NCT01394224|Anticonvulsants|anticonvulsants|mesh-ancestor
92395952|NCT01394224|Nootropic Agents|nootropic agents|mesh-ancestor
92395953|NCT01394263|Goserelin|goserelin|mesh-list
92395954|NCT01394263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92395955|NCT01394263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395956|NCT01394341|Liraglutide|liraglutide|mesh-list
92395957|NCT01394341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92395958|NCT01394341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395959|NCT01394341|Incretins|incretins|mesh-ancestor
92395960|NCT01394341|Hormones|hormones|mesh-ancestor
92048315|NCT04752566|Eculizumab|eculizumab|mesh-list
92395961|NCT01394341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395962|NCT01394354|Dexamethasone|dexamethasone|mesh-list
92395963|NCT01394354|Dexamethasone acetate|dexamethasone acetate|mesh-list
92395964|NCT01394354|Doxorubicin|doxorubicin|mesh-list
92395965|NCT01394354|Bortezomib|bortezomib|mesh-list
92395966|NCT01394354|Vorinostat|vorinostat|mesh-list
92395967|NCT01394354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92395968|NCT01394354|Antiemetics|antiemetics|mesh-ancestor
92395969|NCT01394354|Autonomic Agents|autonomic agents|mesh-ancestor
92395970|NCT01394354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395971|NCT01394354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395972|NCT01394354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92395973|NCT01394354|Glucocorticoids|glucocorticoids|mesh-ancestor
92395974|NCT01394354|Hormones|hormones|mesh-ancestor
91938021|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
92395975|NCT01394354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92395976|NCT01394354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92395977|NCT01394354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92395978|NCT01394354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92395979|NCT01394354|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92395980|NCT01394354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92395981|NCT01394354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92395982|NCT01394354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395983|NCT01394354|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92395984|NCT01394406|Ketamine|ketamine|mesh-list
92395985|NCT01394406|Analgesics|analgesics|mesh-ancestor
92395986|NCT01394406|Sensory System Agents|sensory system agents|mesh-ancestor
92395987|NCT01394406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92395988|NCT01394406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395989|NCT01394406|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92395990|NCT01394406|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92395991|NCT01394406|Anesthetics, General|anesthetics, general|mesh-ancestor
92395992|NCT01394406|Anesthetics|anesthetics|mesh-ancestor
92395993|NCT01394406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92395994|NCT01394406|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92395995|NCT01394406|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92395996|NCT01394406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040857|NCT04498832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92395997|NCT01394406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92395998|NCT01394419|Acetylcysteine|acetylcysteine|mesh-list
92395999|NCT01394419|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92040978|NCT04218240|Analgesics|analgesics|mesh-ancestor
92396000|NCT01394419|Antiviral Agents|antiviral agents|mesh-ancestor
92396001|NCT01394419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396002|NCT01394419|Expectorants|expectorants|mesh-ancestor
92396003|NCT01394419|Respiratory System Agents|respiratory system agents|mesh-ancestor
92396004|NCT01394419|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92396005|NCT01394419|Antioxidants|antioxidants|mesh-ancestor
92396006|NCT01394419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396007|NCT01394419|Protective Agents|protective agents|mesh-ancestor
92396008|NCT01394419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396009|NCT01394419|Antidotes|antidotes|mesh-ancestor
92396010|NCT01394445|Physostigmine|physostigmine|mesh-list
92396011|NCT01394445|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92396012|NCT01394445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396013|NCT01394445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396015|NCT01394445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396016|NCT01394445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396017|NCT01394445|Miotics|miotics|mesh-ancestor
92396018|NCT01394445|Autonomic Agents|autonomic agents|mesh-ancestor
92396019|NCT01394445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396020|NCT01394458|Ethanol|ethanol|mesh-list
92396021|NCT01394458|Heparin|heparin|mesh-list
92396022|NCT01394458|Citric Acid|citric acid|mesh-list
92396023|NCT01394458|Sodium Citrate|sodium citrate|mesh-list
92396024|NCT01394458|Anticoagulants|anticoagulants|mesh-ancestor
92396025|NCT01394458|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92396026|NCT01394458|Chelating Agents|chelating agents|mesh-ancestor
92396027|NCT01394458|Sequestering Agents|sequestering agents|mesh-ancestor
92396028|NCT01394458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396029|NCT01394458|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92396030|NCT01394458|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92396031|NCT01394458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92396032|NCT01394458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396033|NCT01394458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048379|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92396034|NCT01394458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396035|NCT01394471|Oxytocin|oxytocin|mesh-list
92396037|NCT01394471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92396038|NCT01394471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396039|NCT01394497|Acetylcysteine|acetylcysteine|mesh-list
92396040|NCT01394497|Antiviral Agents|antiviral agents|mesh-ancestor
92396041|NCT01394497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396042|NCT01394497|Expectorants|expectorants|mesh-ancestor
92396043|NCT01394497|Respiratory System Agents|respiratory system agents|mesh-ancestor
92396044|NCT01394497|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92396045|NCT01394497|Antioxidants|antioxidants|mesh-ancestor
92396046|NCT01394497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396047|NCT01394497|Protective Agents|protective agents|mesh-ancestor
92041247|NCT03317496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396048|NCT01394497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396049|NCT01394640|Vaccines|vaccines|mesh-list
92396050|NCT01394640|Immunologic Factors|immunologic factors|mesh-ancestor
92396051|NCT01394640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396052|NCT01394653|Ramosetron|ramosetron|mesh-list
92396053|NCT01394653|Antiemetics|antiemetics|mesh-ancestor
92396054|NCT01394653|Autonomic Agents|autonomic agents|mesh-ancestor
92396055|NCT01394653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396056|NCT01394653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396057|NCT01394653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396058|NCT01394653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92396059|NCT01394653|Serotonin Agents|serotonin agents|mesh-ancestor
92396060|NCT01394653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041381|NCT02491632|Ichthammol|ichthammol|mesh-list
92396061|NCT01394653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396063|NCT01394679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396064|NCT01394679|Antimetabolites|antimetabolites|mesh-ancestor
92396066|NCT01394679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396068|NCT01394731|Meperidine|meperidine|mesh-list
92396069|NCT01394731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92396070|NCT01394731|Analgesics|analgesics|mesh-ancestor
92396071|NCT01394731|Sensory System Agents|sensory system agents|mesh-ancestor
92396072|NCT01394731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396073|NCT01394731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396074|NCT01394731|Antipyretics|antipyretics|mesh-ancestor
92396075|NCT01394731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92396076|NCT01394731|Narcotics|narcotics|mesh-ancestor
92396077|NCT01394731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396078|NCT01394731|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92396079|NCT01394757|Ketamine|ketamine|mesh-list
92396080|NCT01394757|Esketamine|esketamine|mesh-list
92396081|NCT01394757|Analgesics|analgesics|mesh-ancestor
92396082|NCT01394757|Sensory System Agents|sensory system agents|mesh-ancestor
92396083|NCT01394757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396084|NCT01394757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396085|NCT01394757|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92396086|NCT01394757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92396087|NCT01394757|Anesthetics, General|anesthetics, general|mesh-ancestor
92396088|NCT01394757|Anesthetics|anesthetics|mesh-ancestor
92396089|NCT01394757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396090|NCT01394757|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92396091|NCT01394757|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92396092|NCT01394757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042099|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
92396093|NCT01394757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396094|NCT01394757|Antidepressive Agents|antidepressive agents|mesh-ancestor
92396095|NCT01394757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396096|NCT01394770|Amlodipine|amlodipine|mesh-list
92396097|NCT01394770|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92396098|NCT01394770|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92396099|NCT01394770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92396100|NCT01394770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396101|NCT01394770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396102|NCT01394770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396103|NCT01394770|Vasodilator Agents|vasodilator agents|mesh-ancestor
92396104|NCT01394796|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92396105|NCT01394796|Antioxidants|antioxidants|mesh-ancestor
92396106|NCT01394796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396107|NCT01394796|Protective Agents|protective agents|mesh-ancestor
92396108|NCT01394796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396109|NCT01394796|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92396110|NCT01394796|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92396111|NCT01394796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396112|NCT01394796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92396113|NCT01394835|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92396114|NCT01394835|Protein C Inhibitor|protein c inhibitor|mesh-list
92396115|NCT01394835|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92396116|NCT01394835|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92042459|NCT01957215|Analgesics|analgesics|mesh-ancestor
92396118|NCT01394835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396119|NCT01394835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396120|NCT01394848|Everolimus|everolimus|mesh-list
92396121|NCT01394848|Clopidogrel|clopidogrel|mesh-list
92396122|NCT01394848|Atorvastatin|atorvastatin|mesh-list
92396123|NCT01394848|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92396124|NCT01394848|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92396125|NCT01394848|Antimetabolites|antimetabolites|mesh-ancestor
92396126|NCT01394848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396127|NCT01394848|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92396128|NCT01394848|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92396129|NCT01394848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396130|NCT01394848|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92396131|NCT01394848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92396132|NCT01394848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396133|NCT01394848|Immunologic Factors|immunologic factors|mesh-ancestor
92396134|NCT01394848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396135|NCT01394848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396136|NCT01394848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92396137|NCT01394848|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92396138|NCT01394848|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92396139|NCT01394848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92396140|NCT01394848|Purinergic Agents|purinergic agents|mesh-ancestor
92396141|NCT01394848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396143|NCT01394887|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043054|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92396144|NCT01394887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396145|NCT01394913|Etanercept|etanercept|mesh-list
92396146|NCT01394913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92396147|NCT01394913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92396148|NCT01394913|Analgesics|analgesics|mesh-ancestor
92396149|NCT01394913|Sensory System Agents|sensory system agents|mesh-ancestor
92396150|NCT01394913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396151|NCT01394913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396152|NCT01394913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396153|NCT01394913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396154|NCT01394913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396155|NCT01394913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396156|NCT01394913|Immunologic Factors|immunologic factors|mesh-ancestor
92396157|NCT01395069|Ketorolac|ketorolac|mesh-list
92396158|NCT01395069|Nepafenac|nepafenac|mesh-list
92396159|NCT01395069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92396160|NCT01395069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92396161|NCT01395069|Analgesics|analgesics|mesh-ancestor
92396162|NCT01395069|Sensory System Agents|sensory system agents|mesh-ancestor
92396163|NCT01395069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396164|NCT01395069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396165|NCT01395069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396166|NCT01395069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396167|NCT01395069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92396168|NCT01395069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396169|NCT01395069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396170|NCT01395108|Nemonoxacin|nemonoxacin|mesh-list
92396171|NCT01395108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396172|NCT01395108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396173|NCT01395147|Vortioxetine|vortioxetine|mesh-list
92396174|NCT01395147|Antidepressive Agents|antidepressive agents|mesh-ancestor
92396175|NCT01395147|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396176|NCT01395147|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92396177|NCT01395147|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396178|NCT01395147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396179|NCT01395147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396180|NCT01395147|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92396181|NCT01395147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92396182|NCT01395147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92396183|NCT01395147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396184|NCT01395147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396185|NCT01395147|Serotonin Agents|serotonin agents|mesh-ancestor
92396186|NCT01395147|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92396187|NCT01395147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92396188|NCT01395147|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92396189|NCT01395147|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92396191|NCT01395199|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92396192|NCT01395199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92396193|NCT01395199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938025|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396194|NCT01395199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396195|NCT01395199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396196|NCT01395199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396198|NCT01395251|Prednisolone|prednisolone|mesh-list
92396199|NCT01395251|Glucocorticoids|glucocorticoids|mesh-list
92396200|NCT01395251|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396201|NCT01395251|Hormones|hormones|mesh-ancestor
92396202|NCT01395251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396203|NCT01395251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396204|NCT01395251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92396205|NCT01395251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396206|NCT01395290|Cholecalciferol|cholecalciferol|mesh-list
92396207|NCT01395290|Vitamin D|vitamin d|mesh-list
92043835|NCT02194465|Hormones|hormones|mesh-ancestor
92396208|NCT01395290|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396209|NCT01395290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396210|NCT01395290|Vitamins|vitamins|mesh-ancestor
92396211|NCT01395290|Micronutrients|micronutrients|mesh-ancestor
92396212|NCT01395290|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92396213|NCT01395381|Albendazole|albendazole|mesh-list
92396214|NCT01395381|Anthelmintics|anthelmintics|mesh-ancestor
92396215|NCT01395381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92396216|NCT01395381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396217|NCT01395381|Anticestodal Agents|anticestodal agents|mesh-ancestor
92396218|NCT01395381|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92396219|NCT01395381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92396220|NCT01395381|Tubulin Modulators|tubulin modulators|mesh-ancestor
92396221|NCT01395381|Antimitotic Agents|antimitotic agents|mesh-ancestor
92396222|NCT01395381|Mitosis Modulators|mitosis modulators|mesh-ancestor
92396223|NCT01395381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396224|NCT01395381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396225|NCT01395420|Ceftazidime|ceftazidime|mesh-list
92396226|NCT01395420|Avibactam|avibactam|mesh-list
92396227|NCT01395420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396228|NCT01395420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396229|NCT01395420|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92396230|NCT01395420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396231|NCT01395420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396232|NCT01395433|Dexetimide|dexetimide|mesh-list
92396233|NCT01395433|Citalopram|citalopram|mesh-list
92396234|NCT01395433|Escitalopram|escitalopram|mesh-list
92044258|NCT01682044|Rituximab|rituximab|mesh-list
92396235|NCT01395433|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92396236|NCT01395433|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92396237|NCT01395433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92396238|NCT01395433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396239|NCT01395433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396240|NCT01395433|Serotonin Agents|serotonin agents|mesh-ancestor
92044334|NCT04835870|Glucocorticoids|glucocorticoids|mesh-ancestor
92396241|NCT01395433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396242|NCT01395433|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92396243|NCT01395433|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92396244|NCT01395433|Parasympatholytics|parasympatholytics|mesh-ancestor
92396245|NCT01395433|Autonomic Agents|autonomic agents|mesh-ancestor
92396246|NCT01395433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044480|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
92396247|NCT01395433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92396248|NCT01395433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92396249|NCT01395433|Cholinergic Agents|cholinergic agents|mesh-ancestor
92396250|NCT01395433|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92396251|NCT01395433|Antidepressive Agents|antidepressive agents|mesh-ancestor
92396252|NCT01395433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396253|NCT01395485|Brodalumab|brodalumab|mesh-list
92396254|NCT01395485|Dermatologic Agents|dermatologic agents|mesh-ancestor
92044691|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
92396256|NCT01395589|Vitamins|vitamins|mesh-ancestor
92396258|NCT01395589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048604|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396259|NCT01395589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92396260|NCT01395602|Cabergoline|cabergoline|mesh-list
92396261|NCT01395602|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92396262|NCT01395602|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92396263|NCT01395602|Dopamine Agonists|dopamine agonists|mesh-ancestor
92396264|NCT01395602|Dopamine Agents|dopamine agents|mesh-ancestor
92396265|NCT01395602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396266|NCT01395602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396267|NCT01395602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396270|NCT01395654|Pyrazinamide|pyrazinamide|mesh-list
92396271|NCT01395654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92396272|NCT01395654|Antitubercular Agents|antitubercular agents|mesh-ancestor
92396273|NCT01395654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396274|NCT01395654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396275|NCT01395654|Leprostatic Agents|leprostatic agents|mesh-ancestor
92396276|NCT01395654|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92396278|NCT01395654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396279|NCT01395654|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92396280|NCT01395654|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92396281|NCT01395654|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92396282|NCT01395654|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92396283|NCT01395654|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92396284|NCT01395654|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92396285|NCT01395654|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92045082|NCT04803734|Albuterol|albuterol|mesh-list
92396287|NCT01395654|Antimetabolites|antimetabolites|mesh-ancestor
92396288|NCT01395654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92396289|NCT01395667|Leucovorin|leucovorin|mesh-list
92396290|NCT01395667|Fluorouracil|fluorouracil|mesh-list
92396291|NCT01395667|Oxaliplatin|oxaliplatin|mesh-list
92396292|NCT01395667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396293|NCT01395667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396294|NCT01395667|Antimetabolites|antimetabolites|mesh-ancestor
92396295|NCT01395667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396296|NCT01395667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92396297|NCT01395667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396298|NCT01395667|Immunologic Factors|immunologic factors|mesh-ancestor
92396299|NCT01395667|Antidotes|antidotes|mesh-ancestor
92396300|NCT01395667|Protective Agents|protective agents|mesh-ancestor
92045170|NCT04787744|Goserelin|goserelin|mesh-list
92396301|NCT01395667|Vitamin B Complex|vitamin b complex|mesh-ancestor
92396303|NCT01395667|Micronutrients|micronutrients|mesh-ancestor
92396304|NCT01395732|Bosentan|bosentan|mesh-list
92396305|NCT01395732|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92396306|NCT01395732|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92396307|NCT01395732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396309|NCT01395849|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92396310|NCT01395849|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92396311|NCT01395849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396312|NCT01395849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92396313|NCT01395849|Autonomic Agents|autonomic agents|mesh-ancestor
92396314|NCT01395849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396315|NCT01395849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396316|NCT01395849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92396318|NCT01395849|Dermatologic Agents|dermatologic agents|mesh-ancestor
92396319|NCT01395849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92396320|NCT01395849|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92396321|NCT01395849|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92396322|NCT01395849|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92396323|NCT01395849|Adrenergic Agents|adrenergic agents|mesh-ancestor
92396324|NCT01395849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396325|NCT01395849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396326|NCT01395849|Glucocorticoids|glucocorticoids|mesh-ancestor
92396327|NCT01395849|Hormones|hormones|mesh-ancestor
92396328|NCT01395849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396329|NCT01395849|Sympathomimetics|sympathomimetics|mesh-ancestor
92396330|NCT01395862|Fluticasone|fluticasone|mesh-list
92396331|NCT01395862|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92396332|NCT01395862|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92048724|NCT01487200|FX006|fx006|mesh-list
92045402|NCT02187055|Adalimumab|adalimumab|mesh-list
92396333|NCT01395862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396334|NCT01395862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92396336|NCT01395862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396337|NCT01395862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396338|NCT01395862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92396339|NCT01395862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92396340|NCT01395862|Dermatologic Agents|dermatologic agents|mesh-ancestor
92396341|NCT01395862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92396342|NCT01395862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92396343|NCT01395862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92396344|NCT01395862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92396345|NCT01395862|Adrenergic Agents|adrenergic agents|mesh-ancestor
92396346|NCT01395862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396347|NCT01395862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396348|NCT01395862|Glucocorticoids|glucocorticoids|mesh-ancestor
92396350|NCT01395862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396351|NCT01395862|Sympathomimetics|sympathomimetics|mesh-ancestor
92396352|NCT01395875|Fluticasone|fluticasone|mesh-list
92396353|NCT01395875|Xhance|xhance|mesh-list
92396354|NCT01395875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92396355|NCT01395875|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92396356|NCT01395875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045537|NCT01633112|(T,G)-A-L|(t,g)-a-l|mesh-list
92396357|NCT01395875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92396358|NCT01395875|Autonomic Agents|autonomic agents|mesh-ancestor
92396359|NCT01395875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396360|NCT01395875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396361|NCT01395875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92396362|NCT01395875|Respiratory System Agents|respiratory system agents|mesh-ancestor
92396363|NCT01395875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92396364|NCT01395875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92396365|NCT01395875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92396366|NCT01395875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92396367|NCT01395875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92396368|NCT01395875|Adrenergic Agents|adrenergic agents|mesh-ancestor
92396369|NCT01395875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396370|NCT01395875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396371|NCT01395875|Cholinergic Agents|cholinergic agents|mesh-ancestor
92396372|NCT01395927|Canagliflozin|canagliflozin|mesh-list
92396373|NCT01395927|Rifampin|rifampin|mesh-list
92396374|NCT01395927|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92396375|NCT01395927|Antitubercular Agents|antitubercular agents|mesh-ancestor
92396376|NCT01395927|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396378|NCT01395927|Leprostatic Agents|leprostatic agents|mesh-ancestor
92396379|NCT01395927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92396380|NCT01395927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396381|NCT01395927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396382|NCT01395927|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92396383|NCT01395927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92396384|NCT01395927|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92396385|NCT01395927|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92396386|NCT01395927|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92396387|NCT01395927|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92396388|NCT01395927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92396389|NCT01395927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92396390|NCT01395927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396391|NCT01395953|Buspirone|buspirone|mesh-list
92396392|NCT01395953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92396393|NCT01395953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396394|NCT01395953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396395|NCT01395953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396396|NCT01395953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396397|NCT01395953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92396398|NCT01395953|Serotonin Agents|serotonin agents|mesh-ancestor
92396399|NCT01395953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396400|NCT01395953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396401|NCT01395992|Asenapine|asenapine|mesh-list
92396402|NCT01395992|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92396403|NCT01395992|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396404|NCT01395992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048754|NCT04080076|Tacrolimus|tacrolimus|mesh-list
92396406|NCT01395992|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396407|NCT01396200|Hydroxychloroquine|hydroxychloroquine|mesh-list
92396408|NCT01396200|Sirolimus|sirolimus|mesh-list
92396409|NCT01396200|Antimalarials|antimalarials|mesh-ancestor
92396410|NCT01396200|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92396411|NCT01396200|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92396412|NCT01396200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396413|NCT01396200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396414|NCT01396200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396415|NCT01396200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396416|NCT01396200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396417|NCT01396200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92396418|NCT01396200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396419|NCT01396200|Antifungal Agents|antifungal agents|mesh-ancestor
92396420|NCT01396200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396421|NCT01396200|Immunologic Factors|immunologic factors|mesh-ancestor
92396422|NCT01396200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396423|NCT01396291|Asenapine|asenapine|mesh-list
92396424|NCT01396291|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92396425|NCT01396291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396426|NCT01396291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396427|NCT01396291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396428|NCT01396291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396429|NCT01396304|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92396431|NCT01396304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396432|NCT01396304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396433|NCT01396304|Laxatives|laxatives|mesh-ancestor
92396434|NCT01396304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396435|NCT01396564|Metformin|metformin|mesh-list
92396436|NCT01396564|Pioglitazone|pioglitazone|mesh-list
92396437|NCT01396564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92396438|NCT01396564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396439|NCT01396642|Emollients|emollients|mesh-list
92396440|NCT01396642|Dermatologic Agents|dermatologic agents|mesh-ancestor
92396441|NCT01396655|Docetaxel|docetaxel|mesh-list
92396442|NCT01396655|Doxorubicin|doxorubicin|mesh-list
92396443|NCT01396655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396444|NCT01396655|Tubulin Modulators|tubulin modulators|mesh-ancestor
92396445|NCT01396655|Antimitotic Agents|antimitotic agents|mesh-ancestor
92396446|NCT01396655|Mitosis Modulators|mitosis modulators|mesh-ancestor
92396447|NCT01396655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396448|NCT01396655|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92396449|NCT01396655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92396450|NCT01396655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92396451|NCT01396655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396452|NCT01396668|Gemcitabine|gemcitabine|mesh-list
92396453|NCT01396668|Capecitabine|capecitabine|mesh-list
92396454|NCT01396668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396455|NCT01396668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92396456|NCT01396668|Antimetabolites|antimetabolites|mesh-ancestor
92396457|NCT01396668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396459|NCT01396681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396460|NCT01396681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92396461|NCT01396681|Antimetabolites|antimetabolites|mesh-ancestor
92396462|NCT01396681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396463|NCT01396707|Capecitabine|capecitabine|mesh-list
92396464|NCT01396707|Oxaliplatin|oxaliplatin|mesh-list
92396465|NCT01396707|Trastuzumab|trastuzumab|mesh-list
92396466|NCT01396707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92396467|NCT01396707|Antimetabolites|antimetabolites|mesh-ancestor
92396468|NCT01396707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396469|NCT01396707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396470|NCT01396707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92396471|NCT01396720|Fluvoxamine|fluvoxamine|mesh-list
92396472|NCT01396720|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92396473|NCT01396720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396474|NCT01396720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396475|NCT01396720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396476|NCT01396720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396477|NCT01396720|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92396478|NCT01396720|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92396479|NCT01396720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92396480|NCT01396720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396482|NCT01396720|Serotonin Agents|serotonin agents|mesh-ancestor
92396483|NCT01396720|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92396484|NCT01396720|Antidepressive Agents|antidepressive agents|mesh-ancestor
92396485|NCT01396720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92396486|NCT01396720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92396487|NCT01396720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396488|NCT01396720|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92396489|NCT01396733|Thioctic Acid|thioctic acid|mesh-list
92396490|NCT01396733|Antioxidants|antioxidants|mesh-ancestor
92396491|NCT01396733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396492|NCT01396733|Protective Agents|protective agents|mesh-ancestor
92396493|NCT01396733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396494|NCT01396733|Vitamin B Complex|vitamin b complex|mesh-ancestor
92396495|NCT01396733|Vitamins|vitamins|mesh-ancestor
92396496|NCT01396733|Micronutrients|micronutrients|mesh-ancestor
92396497|NCT01397006|Pregabalin|pregabalin|mesh-list
92396498|NCT01397006|Analgesics|analgesics|mesh-ancestor
92396499|NCT01397006|Sensory System Agents|sensory system agents|mesh-ancestor
92396500|NCT01397006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396501|NCT01397006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396502|NCT01397006|Anticonvulsants|anticonvulsants|mesh-ancestor
92396503|NCT01397006|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92396504|NCT01397006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92396505|NCT01397006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396506|NCT01397006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396507|NCT01397006|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92396508|NCT01397006|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396509|NCT01397006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396510|NCT01397006|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396512|NCT01397019|Oxaliplatin|oxaliplatin|mesh-list
92396513|NCT01397019|Irinotecan|irinotecan|mesh-list
92396514|NCT01397019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396515|NCT01397019|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92396516|NCT01397019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92396517|NCT01397019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396518|NCT01397019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396519|NCT01397019|Antidotes|antidotes|mesh-ancestor
92396520|NCT01397019|Protective Agents|protective agents|mesh-ancestor
92396521|NCT01397019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396522|NCT01397019|Vitamin B Complex|vitamin b complex|mesh-ancestor
92396523|NCT01397019|Vitamins|vitamins|mesh-ancestor
92396524|NCT01397019|Micronutrients|micronutrients|mesh-ancestor
92396525|NCT01397097|Etonogestrel|etonogestrel|mesh-list
92396526|NCT01397097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92396527|NCT01397097|Contraceptive Agents|contraceptive agents|mesh-ancestor
92396528|NCT01397097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92396529|NCT01397097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396530|NCT01397097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92396532|NCT01397175|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92396533|NCT01397175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92396534|NCT01397175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396535|NCT01397175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396536|NCT01397175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396537|NCT01397175|Immunologic Factors|immunologic factors|mesh-ancestor
92396538|NCT01397175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396539|NCT01397175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396540|NCT01397214|Megestrol Acetate|megestrol acetate|mesh-list
92396541|NCT01397214|Megestrol|megestrol|mesh-list
92396542|NCT01397214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92396543|NCT01397214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396544|NCT01397214|Appetite Stimulants|appetite stimulants|mesh-ancestor
92396545|NCT01397214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92396546|NCT01397214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396547|NCT01397214|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92396548|NCT01397214|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92396549|NCT01397214|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92396550|NCT01397214|Contraceptive Agents|contraceptive agents|mesh-ancestor
92396551|NCT01397214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92048906|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
92396552|NCT01397214|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92396553|NCT01397214|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92396555|NCT01397305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396556|NCT01397305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396557|NCT01397305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396558|NCT01397305|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92396559|NCT01397305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92396560|NCT01397331|Propofol|propofol|mesh-list
92396561|NCT01397331|Isoflurane|isoflurane|mesh-list
92396562|NCT01397331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938027|NCT05302856|Antibodies|antibodies|mesh-list
92396563|NCT01397331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396564|NCT01397331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396565|NCT01397331|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92396566|NCT01397331|Anesthetics, General|anesthetics, general|mesh-ancestor
92396567|NCT01397331|Anesthetics|anesthetics|mesh-ancestor
92396568|NCT01397331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92396569|NCT05269290|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
92396570|NCT05269290|Antiviral Agents|antiviral agents|mesh-ancestor
92396571|NCT05269290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396572|NCT05268835|Clindamycin|clindamycin|mesh-list
92396573|NCT05268835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396574|NCT05268835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396575|NCT05268835|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92396576|NCT05268835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396577|NCT05268835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396578|NCT05268718|Voriconazole|voriconazole|mesh-list
92396579|NCT05268718|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92396580|NCT05268718|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92396581|NCT05268718|Antifungal Agents|antifungal agents|mesh-ancestor
92396582|NCT05268718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396583|NCT05268718|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92396584|NCT05268718|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92396585|NCT05268718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396586|NCT05268718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396587|NCT05268718|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92396588|NCT05268718|Hormone Antagonists|hormone antagonists|mesh-ancestor
92396589|NCT05268718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396590|NCT05268718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396591|NCT05268718|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92396592|NCT05268627|Liraglutide|liraglutide|mesh-list
92396593|NCT05268627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92396594|NCT05268627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396595|NCT05268627|Incretins|incretins|mesh-ancestor
92396597|NCT05268627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396598|NCT05268601|Sotrovimab|sotrovimab|mesh-list
92396599|NCT05268601|Bamlanivimab|bamlanivimab|mesh-list
92396600|NCT05268601|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92396601|NCT05268601|Antiviral Agents|antiviral agents|mesh-ancestor
92396602|NCT05268601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396603|NCT05268068|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92396604|NCT05268068|Immunologic Factors|immunologic factors|mesh-ancestor
92396605|NCT05268068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396606|NCT05267977|Cephalosporins|cephalosporins|mesh-list
92396607|NCT05267977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92396608|NCT05267977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396609|NCT05186558|Rituximab|rituximab|mesh-list
92396610|NCT05186558|Gemcitabine|gemcitabine|mesh-list
92396611|NCT05186558|Oxaliplatin|oxaliplatin|mesh-list
92396612|NCT05186558|Lenalidomide|lenalidomide|mesh-list
92396613|NCT05186558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92396614|NCT05186558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396615|NCT05186558|Immunologic Factors|immunologic factors|mesh-ancestor
92396616|NCT05186558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396617|NCT05186558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396618|NCT05186558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92396619|NCT05186558|Antimetabolites|antimetabolites|mesh-ancestor
92396620|NCT05186558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396621|NCT05186558|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92396622|NCT05186558|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92396623|NCT05186558|Growth Substances|growth substances|mesh-ancestor
92396624|NCT05186558|Growth Inhibitors|growth inhibitors|mesh-ancestor
92396625|NCT05092698|Vitamin D|vitamin d|mesh-list
92396626|NCT05092698|Cholecalciferol|cholecalciferol|mesh-list
92396627|NCT05092698|Vitamins|vitamins|mesh-ancestor
92396628|NCT05092698|Micronutrients|micronutrients|mesh-ancestor
92396629|NCT05092698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396630|NCT05092698|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92396631|NCT05092698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396632|NCT04975269|Acetazolamide|acetazolamide|mesh-list
92396633|NCT04975269|Anticonvulsants|anticonvulsants|mesh-ancestor
92396634|NCT04975269|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92396635|NCT04975269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938029|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
92396636|NCT04975269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396637|NCT04975269|Diuretics|diuretics|mesh-ancestor
92396638|NCT04975269|Natriuretic Agents|natriuretic agents|mesh-ancestor
92396639|NCT04975269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396641|NCT04965870|Antimetabolites|antimetabolites|mesh-ancestor
92396642|NCT04965870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396643|NCT04965870|Antiviral Agents|antiviral agents|mesh-ancestor
92396644|NCT04965870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396645|NCT04695054|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92396646|NCT04695054|Anesthetics, Local|anesthetics, local|mesh-ancestor
92396647|NCT04695054|Anesthetics|anesthetics|mesh-ancestor
92396648|NCT04695054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396649|NCT04695054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396650|NCT04695054|Sensory System Agents|sensory system agents|mesh-ancestor
92396651|NCT04695054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396652|NCT04695054|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92396653|NCT04604353|Calcium|calcium|mesh-list
92396654|NCT04604353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92396655|NCT04604353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396656|NCT04500756|Metformin|metformin|mesh-list
92396657|NCT04500756|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92396658|NCT04500756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396659|NCT04466540|Hydroxychloroquine|hydroxychloroquine|mesh-list
92396660|NCT04466540|Antimalarials|antimalarials|mesh-ancestor
92396661|NCT04466540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92396662|NCT04466540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92396663|NCT04466540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396664|NCT04466540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396665|NCT04466540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396666|NCT04466540|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396667|NCT04453449|Midazolam|midazolam|mesh-list
92396668|NCT04453449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92396669|NCT04453449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92396670|NCT04453449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396671|NCT04453449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396672|NCT04453449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92396673|NCT04453449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92396674|NCT04453449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396675|NCT04453449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92396676|NCT04453449|Anesthetics, General|anesthetics, general|mesh-ancestor
92396678|NCT04453449|GABA Modulators|gaba modulators|mesh-ancestor
92396679|NCT04453449|GABA Agents|gaba agents|mesh-ancestor
92396680|NCT04453449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396681|NCT04453449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396682|NCT04415333|Butyric Acid|butyric acid|mesh-list
92396683|NCT04415333|Histamine Antagonists|histamine antagonists|mesh-ancestor
92396684|NCT04415333|Histamine Agents|histamine agents|mesh-ancestor
92396685|NCT04415333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396686|NCT04415333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396687|NCT04415333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396688|NCT04093596|Cyclophosphamide|cyclophosphamide|mesh-list
92396689|NCT04093596|Fludarabine|fludarabine|mesh-list
92396690|NCT04093596|Nirogacestat|nirogacestat|mesh-list
92396691|NCT04093596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396692|NCT04093596|Immunologic Factors|immunologic factors|mesh-ancestor
92396693|NCT04093596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396694|NCT04093596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396695|NCT04093596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92396696|NCT04093596|Alkylating Agents|alkylating agents|mesh-ancestor
92396697|NCT04093596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396698|NCT04093596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396699|NCT04093596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92396700|NCT04093596|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92396701|NCT04093596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396702|NCT03524170|Atezolizumab|atezolizumab|mesh-list
92396703|NCT03524170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92396704|NCT03524170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396705|NCT03524170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92396706|NCT03524170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396707|NCT03336983|Zoledronic Acid|zoledronic acid|mesh-list
92396708|NCT03336983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92396709|NCT03336983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396711|NCT03283813|Vitamin B Complex|vitamin b complex|mesh-ancestor
92396712|NCT03283813|Vitamins|vitamins|mesh-ancestor
92396713|NCT03283813|Micronutrients|micronutrients|mesh-ancestor
92396714|NCT03283813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396715|NCT03283384|Letrozole|letrozole|mesh-list
92396716|NCT03283384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396717|NCT03283384|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92396718|NCT03283384|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92396719|NCT03283384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396720|NCT03283384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396721|NCT03283384|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92396722|NCT03283384|Hormone Antagonists|hormone antagonists|mesh-ancestor
92396723|NCT03283384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396724|NCT03283384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396725|NCT03245827|Clomiphene|clomiphene|mesh-list
92396726|NCT03245827|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92396727|NCT03245827|Hormone Antagonists|hormone antagonists|mesh-ancestor
92396728|NCT03245827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396729|NCT03245827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396730|NCT03245827|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92396731|NCT03245827|Fertility Agents|fertility agents|mesh-ancestor
92396732|NCT03245827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92396733|NCT03245827|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92396734|NCT03245827|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92396735|NCT03129321|Econazole|econazole|mesh-list
92396736|NCT03129321|Antifungal Agents|antifungal agents|mesh-ancestor
92396737|NCT03129321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396738|NCT03129321|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92396739|NCT03129321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92396741|NCT03129321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396742|NCT03129321|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92396743|NCT03129321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92396744|NCT03129321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396745|NCT03129321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396746|NCT03107611|Pimecrolimus|pimecrolimus|mesh-list
92396747|NCT03107611|Tacrolimus|tacrolimus|mesh-list
92396748|NCT03107611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92396749|NCT03107611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92396750|NCT03107611|Analgesics|analgesics|mesh-ancestor
92396751|NCT03107611|Sensory System Agents|sensory system agents|mesh-ancestor
92396752|NCT03107611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396753|NCT03107611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396754|NCT03107611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396755|NCT03107611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396756|NCT03107611|Dermatologic Agents|dermatologic agents|mesh-ancestor
92396757|NCT03107611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396758|NCT03107611|Immunologic Factors|immunologic factors|mesh-ancestor
92396759|NCT03107611|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92396760|NCT03107611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396761|NCT03107611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396762|NCT03040726|Palonosetron|palonosetron|mesh-list
92396763|NCT03040726|Antiemetics|antiemetics|mesh-ancestor
92396764|NCT03040726|Autonomic Agents|autonomic agents|mesh-ancestor
92396765|NCT03040726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396766|NCT03040726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396767|NCT03040726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396768|NCT03040726|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92396769|NCT03040726|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92396770|NCT03040726|Serotonin Agents|serotonin agents|mesh-ancestor
92396771|NCT03040726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396772|NCT03040726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396773|NCT02607956|Dolutegravir|dolutegravir|mesh-list
92396774|NCT02607956|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92396775|NCT02607956|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92396776|NCT02607956|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92396777|NCT02607956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396778|NCT02607956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396779|NCT02607956|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92396780|NCT02607956|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92396781|NCT02607956|Antiviral Agents|antiviral agents|mesh-ancestor
92396782|NCT02607956|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396783|NCT02607956|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92396784|NCT02607956|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92396785|NCT02564523|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92396787|NCT02564523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396788|NCT02499666|Clopidogrel|clopidogrel|mesh-list
92396789|NCT02499666|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92396790|NCT02499666|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92396791|NCT02499666|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92396792|NCT02499666|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92396793|NCT02499666|Purinergic Agents|purinergic agents|mesh-ancestor
92396794|NCT02499666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396795|NCT02499666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396796|NCT02499666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396797|NCT02420912|Nivolumab|nivolumab|mesh-list
92396798|NCT02420912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92396799|NCT02420912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396800|NCT02420912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92396801|NCT02420912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396802|NCT02094716|Permethrin|permethrin|mesh-list
92396803|NCT02094716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396804|NCT02094716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396805|NCT01460810|Silicon|silicon|mesh-list
92396806|NCT01460810|Trace Elements|trace elements|mesh-ancestor
92396807|NCT01460810|Micronutrients|micronutrients|mesh-ancestor
92396808|NCT01460810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396809|NCT00667329|Cyclophosphamide|cyclophosphamide|mesh-list
92396810|NCT00667329|Rituximab|rituximab|mesh-list
92396811|NCT00667329|Cladribine|cladribine|mesh-list
92396812|NCT00667329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396813|NCT00667329|Immunologic Factors|immunologic factors|mesh-ancestor
92396814|NCT00667329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396815|NCT00667329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92396816|NCT00667329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92396817|NCT00667329|Alkylating Agents|alkylating agents|mesh-ancestor
92396818|NCT00667329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396819|NCT00667329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396820|NCT00667329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92396821|NCT00667329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92396822|NCT00492167|Antibodies|antibodies|mesh-list
92396823|NCT00492167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92396824|NCT00492167|Immunologic Factors|immunologic factors|mesh-ancestor
92045723|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92396825|NCT00492167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396826|NCT05274438|Imatinib Mesylate|imatinib mesylate|mesh-list
92396827|NCT05274438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396828|NCT05274438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92396829|NCT05274438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396830|NCT05274438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396831|NCT05274191|Maleic acid|maleic acid|mesh-list
92396832|NCT05274191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396833|NCT05274191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396834|NCT05274139|Cytarabine|cytarabine|mesh-list
92396835|NCT05274139|Dexamethasone|dexamethasone|mesh-list
92396836|NCT05274139|Temozolomide|temozolomide|mesh-list
92396837|NCT05274139|Fotemustine|fotemustine|mesh-list
92396838|NCT05274139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396839|NCT05274139|Antiemetics|antiemetics|mesh-ancestor
92396840|NCT05274139|Autonomic Agents|autonomic agents|mesh-ancestor
92396841|NCT05274139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396842|NCT05274139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396843|NCT05274139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396844|NCT05274139|Glucocorticoids|glucocorticoids|mesh-ancestor
92396845|NCT05274139|Hormones|hormones|mesh-ancestor
92396846|NCT05274139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396847|NCT05274139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92049207|NCT02128490|Analgesics|analgesics|mesh-ancestor
92396848|NCT05274139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396849|NCT05274139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396850|NCT05274139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92396851|NCT05274139|Antimetabolites|antimetabolites|mesh-ancestor
92396853|NCT05274139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396854|NCT05274139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396855|NCT05274139|Immunologic Factors|immunologic factors|mesh-ancestor
92396856|NCT05274139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92396857|NCT05274139|Alkylating Agents|alkylating agents|mesh-ancestor
92396858|NCT05274113|Dexamethasone|dexamethasone|mesh-list
92396859|NCT05274113|Ropivacaine|ropivacaine|mesh-list
92396860|NCT05274113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396861|NCT05274113|Antiemetics|antiemetics|mesh-ancestor
92396862|NCT05274113|Autonomic Agents|autonomic agents|mesh-ancestor
92396863|NCT05274113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396864|NCT05274113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396865|NCT05274113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396866|NCT05274113|Glucocorticoids|glucocorticoids|mesh-ancestor
92396867|NCT05274113|Hormones|hormones|mesh-ancestor
92396868|NCT05274113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396869|NCT05274113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92396870|NCT05274113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396871|NCT05274113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92396872|NCT05274113|Anesthetics|anesthetics|mesh-ancestor
92396873|NCT05274113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396874|NCT05274113|Sensory System Agents|sensory system agents|mesh-ancestor
92396875|NCT05274100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92396876|NCT05274100|Immunologic Factors|immunologic factors|mesh-ancestor
92396877|NCT05274100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396878|NCT05273944|Doxorubicin|doxorubicin|mesh-list
92396879|NCT05273944|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92396880|NCT05273944|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92396881|NCT05273944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396882|NCT05273944|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92396883|NCT05273944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92396884|NCT05273944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92396885|NCT05273944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396886|NCT05273528|Vaccines|vaccines|mesh-list
92396887|NCT05273528|Immunologic Factors|immunologic factors|mesh-ancestor
92396888|NCT05273528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396890|NCT05273398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92396891|NCT05273398|Anticonvulsants|anticonvulsants|mesh-ancestor
92396892|NCT05273398|Antiemetics|antiemetics|mesh-ancestor
92396893|NCT05273398|Autonomic Agents|autonomic agents|mesh-ancestor
92396894|NCT05273398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396895|NCT05273398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136256|NCT01798017|Oxytocics|oxytocics|mesh-ancestor
92396896|NCT05273398|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396897|NCT05273398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92396898|NCT05273398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396899|NCT05273398|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92396900|NCT05273398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92396901|NCT05273398|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92046325|NCT01922271|Albuterol|albuterol|mesh-list
92396903|NCT05273398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92396904|NCT05273398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92396905|NCT05273398|Anesthetics, General|anesthetics, general|mesh-ancestor
92396906|NCT05273398|Anesthetics|anesthetics|mesh-ancestor
92396907|NCT05273398|GABA Modulators|gaba modulators|mesh-ancestor
92396908|NCT05273398|GABA Agents|gaba agents|mesh-ancestor
92396909|NCT05273398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396910|NCT05273398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396911|NCT05272839|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92396912|NCT05272839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396913|NCT05272462|Minoxidil|minoxidil|mesh-list
92396914|NCT05272462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92396915|NCT05272462|Vasodilator Agents|vasodilator agents|mesh-ancestor
92396916|NCT05272371|Dinutuximab|dinutuximab|mesh-list
92396917|NCT05272371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396918|NCT05271539|Dexamethasone|dexamethasone|mesh-list
92396919|NCT05271539|Ranibizumab|ranibizumab|mesh-list
92396920|NCT05271539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049280|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92396921|NCT05271539|Antiemetics|antiemetics|mesh-ancestor
92396922|NCT05271539|Autonomic Agents|autonomic agents|mesh-ancestor
92396923|NCT05271539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396924|NCT05271539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396925|NCT05271539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396926|NCT05271539|Glucocorticoids|glucocorticoids|mesh-ancestor
92396927|NCT05271539|Hormones|hormones|mesh-ancestor
92396928|NCT05271539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396929|NCT05271539|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92396930|NCT05271539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396931|NCT05271539|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92396932|NCT05271539|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92396933|NCT05271539|Growth Substances|growth substances|mesh-ancestor
92396934|NCT05271539|Growth Inhibitors|growth inhibitors|mesh-ancestor
92396936|NCT05271370|HIV Antibodies|hiv antibodies|mesh-list
92396937|NCT05271370|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92396938|NCT05271370|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92396939|NCT05271370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396940|NCT05271370|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92396941|NCT05271370|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92396942|NCT05271370|Antiviral Agents|antiviral agents|mesh-ancestor
92396943|NCT05271370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92396944|NCT05271370|Immunologic Factors|immunologic factors|mesh-ancestor
92396945|NCT05271370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396946|NCT05271253|Dexmedetomidine|dexmedetomidine|mesh-list
92396947|NCT05271253|Bupivacaine|bupivacaine|mesh-list
92396948|NCT05271253|Anesthetics, Local|anesthetics, local|mesh-ancestor
92396949|NCT05271253|Anesthetics|anesthetics|mesh-ancestor
92396950|NCT05271253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396951|NCT05271253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396952|NCT05271253|Sensory System Agents|sensory system agents|mesh-ancestor
92396953|NCT05271253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396954|NCT05271253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92396955|NCT05271253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92396956|NCT05271253|Analgesics|analgesics|mesh-ancestor
92396957|NCT05271253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92396958|NCT05271253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92396959|NCT05271253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92396960|NCT05271253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92396961|NCT05271253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92396962|NCT05271253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396963|NCT05271188|Anesthetics|anesthetics|mesh-list
92396964|NCT05271188|Anesthetics, Local|anesthetics, local|mesh-list
92396965|NCT05271188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92396966|NCT05271188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396967|NCT05271188|Sensory System Agents|sensory system agents|mesh-ancestor
92396968|NCT05271188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396969|NCT05271136|Sunscreening Agents|sunscreening agents|mesh-list
92396970|NCT05271136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92396971|NCT05271136|Protective Agents|protective agents|mesh-ancestor
92396972|NCT05271136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396973|NCT05271136|Dermatologic Agents|dermatologic agents|mesh-ancestor
92396974|NCT05271058|Dexamethasone|dexamethasone|mesh-list
92396975|NCT05271058|Dexamethasone acetate|dexamethasone acetate|mesh-list
92396976|NCT05271058|Triamcinolone|triamcinolone|mesh-list
92396977|NCT05271058|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92396978|NCT05271058|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92396980|NCT05271058|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92396981|NCT05271058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92396982|NCT05271058|Antiemetics|antiemetics|mesh-ancestor
92396983|NCT05271058|Autonomic Agents|autonomic agents|mesh-ancestor
92396984|NCT05271058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92396985|NCT05271058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92396986|NCT05271058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92396987|NCT05271058|Glucocorticoids|glucocorticoids|mesh-ancestor
92396988|NCT05271058|Hormones|hormones|mesh-ancestor
92396989|NCT05271058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92396990|NCT05271058|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92396991|NCT05271058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92396992|NCT05271058|Protease Inhibitors|protease inhibitors|mesh-ancestor
92396993|NCT05271058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047251|NCT02975999|Vasopressins|vasopressins|mesh-list
92396994|NCT05271058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92396995|NCT05271058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92396996|NCT05271058|Immunologic Factors|immunologic factors|mesh-ancestor
92396998|NCT05271045|Vitamin A|vitamin a|mesh-list
92396999|NCT05271045|Vitamins|vitamins|mesh-ancestor
92397000|NCT05271045|Micronutrients|micronutrients|mesh-ancestor
92397001|NCT05271045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397002|NCT05271045|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92397003|NCT05270967|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92397004|NCT05270967|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92397005|NCT05270967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397006|NCT05270889|Tislelizumab|tislelizumab|mesh-list
92397007|NCT05270889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397008|NCT05270889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397009|NCT05270824|Immunomodulating Agents|immunomodulating agents|mesh-list
92047464|NCT01599650|Ranibizumab|ranibizumab|mesh-list
92397010|NCT05270824|Immunologic Factors|immunologic factors|mesh-ancestor
92397011|NCT05270824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397013|NCT05270434|Meperidine|meperidine|mesh-list
92397014|NCT05270434|Morphine|morphine|mesh-list
92397015|NCT05270434|Buprenorphine|buprenorphine|mesh-list
92397016|NCT05270434|Analgesics|analgesics|mesh-list
92397017|NCT05270434|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92397018|NCT05270434|Narcotics|narcotics|mesh-ancestor
92397019|NCT05270434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047554|NCT04813991|Ibuprofen|ibuprofen|mesh-list
92397020|NCT05270434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397022|NCT05270434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047624|NCT01580020|Hormones|hormones|mesh-ancestor
92397023|NCT05270434|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92397024|NCT05270434|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92397025|NCT05270434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92397026|NCT05270434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397027|NCT05270434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397028|NCT05270434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397029|NCT05270434|Antipyretics|antipyretics|mesh-ancestor
92397030|NCT05270421|Furosemide|furosemide|mesh-list
92397031|NCT05270421|Diuretics|diuretics|mesh-ancestor
92397032|NCT05270421|Natriuretic Agents|natriuretic agents|mesh-ancestor
92397033|NCT05270421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397034|NCT05270421|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92397035|NCT05270421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397036|NCT05270421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397037|NCT05270382|Cetylpyridinium|cetylpyridinium|mesh-list
92397038|NCT05270382|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92397039|NCT05270382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397040|NCT05270343|Cholecalciferol|cholecalciferol|mesh-list
92397041|NCT05270343|Vitamin D|vitamin d|mesh-list
92397042|NCT05270343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92397043|NCT05270343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397044|NCT05270343|Vitamins|vitamins|mesh-ancestor
92397045|NCT05270343|Micronutrients|micronutrients|mesh-ancestor
92397046|NCT05270343|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92397047|NCT05270018|Broncho-Vaxom|broncho-vaxom|mesh-list
92397048|NCT05270018|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92047911|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
92397049|NCT05270018|Immunologic Factors|immunologic factors|mesh-ancestor
92397050|NCT05270018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397051|NCT05269654|Mannitol|mannitol|mesh-list
92397052|NCT05269654|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92397053|NCT05269654|Diuretics|diuretics|mesh-ancestor
92397054|NCT05269654|Natriuretic Agents|natriuretic agents|mesh-ancestor
92397056|NCT05253846|Fluorouracil|fluorouracil|mesh-list
92397057|NCT05253846|Oxaliplatin|oxaliplatin|mesh-list
92397058|NCT05253846|Irinotecan|irinotecan|mesh-list
92397059|NCT05253846|Antimetabolites|antimetabolites|mesh-ancestor
92397060|NCT05253846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397061|NCT05253846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397062|NCT05253846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397063|NCT05253846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397064|NCT05253846|Immunologic Factors|immunologic factors|mesh-ancestor
92397065|NCT05253846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397066|NCT05253846|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92397067|NCT05253846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92397068|NCT05253846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397069|NCT05250141|Levodopa|levodopa|mesh-list
92397070|NCT05250141|Carbidopa|carbidopa|mesh-list
92397071|NCT05250141|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92397072|NCT05250141|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92048197|NCT02211638|Candesartan|candesartan|mesh-list
92397073|NCT05250141|Dopamine Agents|dopamine agents|mesh-ancestor
92049429|NCT04150913|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92397074|NCT05250141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397075|NCT05250141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397077|NCT05250141|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92397078|NCT05250141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397080|NCT05248724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92397081|NCT05248724|Epinephrine|epinephrine|mesh-list
92397082|NCT05248724|Racepinephrine|racepinephrine|mesh-list
92397083|NCT05248724|Morphine|morphine|mesh-list
92397084|NCT05248724|Ropivacaine|ropivacaine|mesh-list
92397085|NCT05248724|Epinephryl borate|epinephryl borate|mesh-list
92397086|NCT05248724|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92397087|NCT05248724|Narcotics|narcotics|mesh-ancestor
92397088|NCT05248724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397089|NCT05248724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397091|NCT05248724|Sensory System Agents|sensory system agents|mesh-ancestor
92397092|NCT05248724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048399|NCT01554514|Rituximab|rituximab|mesh-list
92397093|NCT05248724|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397094|NCT05248724|Anesthetics|anesthetics|mesh-ancestor
92397095|NCT05248724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92397096|NCT05248724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397097|NCT05248724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397098|NCT05248724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397099|NCT05248724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92397100|NCT05248724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397101|NCT05248724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397102|NCT05248724|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92397103|NCT05248724|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92397104|NCT05248724|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397105|NCT05248724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397106|NCT05248724|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92397107|NCT05248724|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92397108|NCT05248724|Autonomic Agents|autonomic agents|mesh-ancestor
92397109|NCT05248724|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92397110|NCT05248724|Respiratory System Agents|respiratory system agents|mesh-ancestor
92397111|NCT05248724|Mydriatics|mydriatics|mesh-ancestor
92397112|NCT05248724|Sympathomimetics|sympathomimetics|mesh-ancestor
92397113|NCT05248724|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92397114|NCT05235737|Pembrolizumab|pembrolizumab|mesh-list
92397115|NCT05235737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397116|NCT05235737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397117|NCT05235737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397118|NCT05235737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397119|NCT05232006|Niraparib|niraparib|mesh-list
92397120|NCT05232006|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92397121|NCT05232006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136331|NCT04479813|Moxonidine|moxonidine|mesh-list
92397122|NCT05232006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397123|NCT05232006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397124|NCT05209841|Heparin|heparin|mesh-list
92397125|NCT05209841|Anticoagulants|anticoagulants|mesh-ancestor
92397126|NCT05209841|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92397127|NCT05209841|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92397128|NCT05209841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397129|NCT05173142|Gemcitabine|gemcitabine|mesh-list
92397130|NCT05173142|Docetaxel|docetaxel|mesh-list
92397131|NCT05173142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397132|NCT05173142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397133|NCT05173142|Antimetabolites|antimetabolites|mesh-ancestor
92397134|NCT05173142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048681|NCT01518946|Midodrine|midodrine|mesh-list
92397135|NCT05173142|Tubulin Modulators|tubulin modulators|mesh-ancestor
92397136|NCT05173142|Antimitotic Agents|antimitotic agents|mesh-ancestor
92397137|NCT05173142|Mitosis Modulators|mitosis modulators|mesh-ancestor
92397138|NCT05165875|Hydrocortisone|hydrocortisone|mesh-list
92397139|NCT05165875|Lidocaine|lidocaine|mesh-list
92397140|NCT05165875|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397141|NCT05165875|Anesthetics|anesthetics|mesh-ancestor
92397142|NCT05165875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397143|NCT05165875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397144|NCT05165875|Sensory System Agents|sensory system agents|mesh-ancestor
92397145|NCT05165875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397146|NCT05165875|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92014642|NCT05105997|Autonomic Agents|autonomic agents|mesh-ancestor
92397147|NCT05165875|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397148|NCT05165875|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397149|NCT05165875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049506|NCT02241551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92397150|NCT05165875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397151|NCT05165875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397153|NCT05162118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397155|NCT05162118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397156|NCT05162118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397158|NCT05155917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397159|NCT05155917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397160|NCT05142267|Oxycodone|oxycodone|mesh-list
92397162|NCT05142267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92397163|NCT05142267|Narcotics|narcotics|mesh-ancestor
92397164|NCT05142267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397165|NCT05142267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397166|NCT05142267|Analgesics|analgesics|mesh-ancestor
92397167|NCT05142267|Sensory System Agents|sensory system agents|mesh-ancestor
92397168|NCT05142267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397169|NCT05142267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92397170|NCT05138029|Dexamethasone|dexamethasone|mesh-list
92397171|NCT05138029|Dexamethasone acetate|dexamethasone acetate|mesh-list
92397172|NCT05138029|Ranibizumab|ranibizumab|mesh-list
92397173|NCT05138029|BB 1101|bb 1101|mesh-list
92397174|NCT05138029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397175|NCT05138029|Antiemetics|antiemetics|mesh-ancestor
92397176|NCT05138029|Autonomic Agents|autonomic agents|mesh-ancestor
92049077|NCT01502410|Sorafenib|sorafenib|mesh-list
92397177|NCT05138029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397178|NCT05138029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397179|NCT05138029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397180|NCT05138029|Glucocorticoids|glucocorticoids|mesh-ancestor
92397181|NCT05138029|Hormones|hormones|mesh-ancestor
92397182|NCT05138029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397183|NCT05138029|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92397184|NCT05138029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397185|NCT05138029|Protease Inhibitors|protease inhibitors|mesh-ancestor
92397186|NCT05138029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397187|NCT05138029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397188|NCT05138029|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92397189|NCT05138029|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92397190|NCT05138029|Growth Substances|growth substances|mesh-ancestor
92397191|NCT05138029|Growth Inhibitors|growth inhibitors|mesh-ancestor
92397192|NCT05135039|Canagliflozin|canagliflozin|mesh-list
92397193|NCT05135039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92397194|NCT05135039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397195|NCT05135039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397196|NCT05135039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397197|NCT05128591|Rivaroxaban|rivaroxaban|mesh-list
92397198|NCT05128591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92397199|NCT05128591|Antithrombins|antithrombins|mesh-ancestor
92397200|NCT05128591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92397201|NCT05128591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92397202|NCT05128591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397203|NCT05128591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397204|NCT05128591|Anticoagulants|anticoagulants|mesh-ancestor
92397205|NCT05088928|Rivaroxaban|rivaroxaban|mesh-list
92397206|NCT05088928|Apixaban|apixaban|mesh-list
92397207|NCT05088928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92397208|NCT05088928|Antithrombins|antithrombins|mesh-ancestor
92397209|NCT05088928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92397210|NCT05088928|Protease Inhibitors|protease inhibitors|mesh-ancestor
92397211|NCT05088928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397212|NCT05088928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397213|NCT05088928|Anticoagulants|anticoagulants|mesh-ancestor
92397214|NCT05075122|Pembrolizumab|pembrolizumab|mesh-list
92397215|NCT05075122|Sargramostim|sargramostim|mesh-list
92397216|NCT05075122|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397217|NCT05075122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397218|NCT05075122|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397219|NCT05075122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397220|NCT05075122|Immunologic Factors|immunologic factors|mesh-ancestor
92397221|NCT05075122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397222|NCT05067439|Efavirenz|efavirenz|mesh-list
92397223|NCT05067439|Caffeine|caffeine|mesh-list
92397224|NCT05067439|Omeprazole|omeprazole|mesh-list
92049595|NCT02097056|Donepezil|donepezil|mesh-list
92397225|NCT05067439|Abrocitinib|abrocitinib|mesh-list
92397226|NCT05067439|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92397227|NCT05067439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397228|NCT05067439|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92397229|NCT05067439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397230|NCT05067439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397231|NCT05067439|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92397232|NCT05067439|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92397233|NCT05067439|Purinergic Agents|purinergic agents|mesh-ancestor
92397234|NCT05067439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397235|NCT05067439|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92397236|NCT05067439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397237|NCT05067439|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92397238|NCT05067439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92397239|NCT05067439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92397240|NCT05067439|Antiviral Agents|antiviral agents|mesh-ancestor
92397241|NCT05067439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397242|NCT05067439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92397243|NCT05067439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92049536|NCT02072096|Metformin|metformin|mesh-list
92397244|NCT05067439|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92397245|NCT05067439|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92397246|NCT05067439|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92397247|NCT05067439|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92397248|NCT05067439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397249|NCT05064137|Listerine|listerine|mesh-list
92397250|NCT05064137|Fluorides|fluorides|mesh-list
92397251|NCT05064137|Sodium Fluoride|sodium fluoride|mesh-list
92397252|NCT05064137|Fluorides, Topical|fluorides, topical|mesh-list
92397253|NCT05064137|Cariostatic Agents|cariostatic agents|mesh-ancestor
92397255|NCT05064137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397256|NCT05064137|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92397257|NCT05064137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397258|NCT05052528|Cyclophosphamide|cyclophosphamide|mesh-list
92397259|NCT05052528|Rituximab|rituximab|mesh-list
92397260|NCT05052528|Fludarabine|fludarabine|mesh-list
92397261|NCT05052528|Fludarabine phosphate|fludarabine phosphate|mesh-list
92397262|NCT05052528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92397263|NCT05052528|Antibodies|antibodies|mesh-list
92397265|NCT05052528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92397266|NCT05052528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397267|NCT05052528|Immunologic Factors|immunologic factors|mesh-ancestor
92397268|NCT05052528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397269|NCT05052528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397270|NCT05052528|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92397271|NCT05052528|Alkylating Agents|alkylating agents|mesh-ancestor
92397272|NCT05052528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397273|NCT05052528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397274|NCT05052528|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92397275|NCT05052528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397276|NCT05052528|Antimetabolites|antimetabolites|mesh-ancestor
92397277|NCT05051150|Epinephrine|epinephrine|mesh-list
92397278|NCT05051150|Racepinephrine|racepinephrine|mesh-list
92397279|NCT05051150|Epinephryl borate|epinephryl borate|mesh-list
92397280|NCT05051150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92049869|NCT02202551|Amantadine|amantadine|mesh-list
92397281|NCT05051150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92397282|NCT05051150|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397283|NCT05051150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397284|NCT05051150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397285|NCT05051150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397286|NCT05051150|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92397287|NCT05051150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92397289|NCT05051150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397290|NCT05051150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92397291|NCT05051150|Respiratory System Agents|respiratory system agents|mesh-ancestor
92397292|NCT05051150|Mydriatics|mydriatics|mesh-ancestor
92397293|NCT05051150|Sympathomimetics|sympathomimetics|mesh-ancestor
92397294|NCT05051150|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92397296|NCT05045313|Digoxin|digoxin|mesh-list
92397297|NCT05045313|Warfarin|warfarin|mesh-list
92397298|NCT05045313|Anticoagulants|anticoagulants|mesh-ancestor
92397299|NCT05045313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397300|NCT05045313|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92397301|NCT05045313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397302|NCT05045313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397303|NCT05045313|Protective Agents|protective agents|mesh-ancestor
92050053|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
92397304|NCT05045313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397305|NCT05045313|Uricosuric Agents|uricosuric agents|mesh-ancestor
92397306|NCT05045313|Gout Suppressants|gout suppressants|mesh-ancestor
92397307|NCT05045313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397308|NCT05007561|Naltrexone|naltrexone|mesh-list
92397309|NCT05007561|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92397310|NCT05007561|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92397311|NCT05007561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397312|NCT05007561|Sensory System Agents|sensory system agents|mesh-ancestor
92397313|NCT05007561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397314|NCT04961801|Methotrexate|methotrexate|mesh-list
92397315|NCT04961801|Acalabrutinib|acalabrutinib|mesh-list
92397316|NCT04961801|Tacrolimus|tacrolimus|mesh-list
92397317|NCT04961801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92397318|NCT04961801|Abortifacient Agents|abortifacient agents|mesh-ancestor
92397319|NCT04961801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92397320|NCT04961801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397321|NCT04961801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397322|NCT04961801|Antimetabolites|antimetabolites|mesh-ancestor
92397323|NCT04961801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397324|NCT04961801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397325|NCT04961801|Dermatologic Agents|dermatologic agents|mesh-ancestor
92397326|NCT04961801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397327|NCT04961801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92397328|NCT04961801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397329|NCT04961801|Immunologic Factors|immunologic factors|mesh-ancestor
92397330|NCT04961801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397331|NCT04961801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92397332|NCT04961801|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92397333|NCT04919564|Furosemide|furosemide|mesh-list
92397334|NCT04919564|Diuretics|diuretics|mesh-ancestor
92397335|NCT04919564|Natriuretic Agents|natriuretic agents|mesh-ancestor
92397336|NCT04919564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397337|NCT04919564|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92397338|NCT04919564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397339|NCT04919564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397340|NCT04886284|Ertapenem|ertapenem|mesh-list
92050473|NCT02224157|Hormones|hormones|mesh-ancestor
92397341|NCT04886284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92397342|NCT04886284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397343|NCT04870333|Ciclesonide|ciclesonide|mesh-list
92397345|NCT04870333|Niclosamide|niclosamide|mesh-list
92397346|NCT04870333|Glucocorticoids|glucocorticoids|mesh-ancestor
92397347|NCT04870333|Hormones|hormones|mesh-ancestor
92115107|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397348|NCT04870333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397349|NCT04870333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397350|NCT04870333|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92397351|NCT04870333|Antiviral Agents|antiviral agents|mesh-ancestor
92397352|NCT04870333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397353|NCT04870333|Anticestodal Agents|anticestodal agents|mesh-ancestor
92397354|NCT04870333|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92397355|NCT04870333|Anthelmintics|anthelmintics|mesh-ancestor
92397356|NCT04870333|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92397357|NCT04870333|Antinematodal Agents|antinematodal agents|mesh-ancestor
92397358|NCT04835402|Pembrolizumab|pembrolizumab|mesh-list
92397359|NCT04835402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397360|NCT04835402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397361|NCT04835402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397362|NCT04835402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397363|NCT04801641|Nabilone|nabilone|mesh-list
92397364|NCT04801641|Antiemetics|antiemetics|mesh-ancestor
92397365|NCT04801641|Autonomic Agents|autonomic agents|mesh-ancestor
92397366|NCT04801641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397367|NCT04801641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397368|NCT04801641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397369|NCT04801641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92397370|NCT04801641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92397371|NCT04801641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397372|NCT04801641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92397373|NCT04783376|Insulin|insulin|mesh-list
92397374|NCT04783376|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92397375|NCT04783376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397376|NCT04783376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938038|NCT05610488|Faricimab|faricimab|mesh-list
92397378|NCT04768829|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92397379|NCT04768829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397381|NCT04760912|Anesthetics|anesthetics|mesh-list
92397382|NCT04760912|Rocuronium|rocuronium|mesh-list
92397383|NCT04760912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397384|NCT04760912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397385|NCT04760912|Anticonvulsants|anticonvulsants|mesh-ancestor
92397386|NCT04760912|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92397387|NCT04760912|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92397389|NCT04760912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397390|NCT04710641|Sorafenib|sorafenib|mesh-list
92397391|NCT04710641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397392|NCT04710641|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397393|NCT04710641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397394|NCT04710641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397395|NCT04706767|Lidocaine|lidocaine|mesh-list
92397396|NCT04706767|Dexmedetomidine|dexmedetomidine|mesh-list
92397397|NCT04706767|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397398|NCT04706767|Anesthetics|anesthetics|mesh-ancestor
92397399|NCT04706767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397400|NCT04706767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397401|NCT04706767|Sensory System Agents|sensory system agents|mesh-ancestor
92397402|NCT04706767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397403|NCT04706767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397404|NCT04706767|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397405|NCT04706767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397406|NCT04706767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397407|NCT04706767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397408|NCT04706767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92397409|NCT04706767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397410|NCT04706767|Analgesics|analgesics|mesh-ancestor
92397411|NCT04706767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92397412|NCT04706767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92397413|NCT04706767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92397414|NCT04706767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397415|NCT04706767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397416|NCT04690686|Paclitaxel|paclitaxel|mesh-list
92397417|NCT04690686|Atezolizumab|atezolizumab|mesh-list
92397418|NCT04690686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92397419|NCT04690686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397420|NCT04690686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92397421|NCT04690686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92397422|NCT04690686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92397423|NCT04690686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397424|NCT04690686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397425|NCT04690686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397426|NCT04682626|Cholecalciferol|cholecalciferol|mesh-list
92397427|NCT04682626|Vitamin D|vitamin d|mesh-list
92397428|NCT04682626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92397429|NCT04682626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397430|NCT04682626|Vitamins|vitamins|mesh-ancestor
92397431|NCT04682626|Micronutrients|micronutrients|mesh-ancestor
92397432|NCT04682626|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92397433|NCT04604691|Blinatumomab|blinatumomab|mesh-list
92397434|NCT04604691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397436|NCT04580381|Immunologic Factors|immunologic factors|mesh-ancestor
92397437|NCT04580381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397438|NCT04530006|Amantadine|amantadine|mesh-list
92397439|NCT04530006|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92397440|NCT04530006|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92397441|NCT04530006|Antiviral Agents|antiviral agents|mesh-ancestor
92397442|NCT04530006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397443|NCT04530006|Dopamine Agents|dopamine agents|mesh-ancestor
92397444|NCT04530006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397445|NCT04530006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397446|NCT04530006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397447|NCT04530006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397448|NCT04530006|Analgesics|analgesics|mesh-ancestor
92397449|NCT04530006|Sensory System Agents|sensory system agents|mesh-ancestor
92397450|NCT04530006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397451|NCT04496245|Broncho-Vaxom|broncho-vaxom|mesh-list
92397453|NCT04496245|Immunologic Factors|immunologic factors|mesh-ancestor
92397454|NCT04496245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397455|NCT04476745|Vitamin D|vitamin d|mesh-list
92397456|NCT04476745|Cholecalciferol|cholecalciferol|mesh-list
92397457|NCT04476745|Vitamins|vitamins|mesh-ancestor
92397458|NCT04476745|Micronutrients|micronutrients|mesh-ancestor
92397459|NCT04476745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397460|NCT04476745|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92397461|NCT04476745|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92397462|NCT04433390|Naloxegol|naloxegol|mesh-list
92397463|NCT04433390|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92397464|NCT04433390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397465|NCT04433390|Sensory System Agents|sensory system agents|mesh-ancestor
92397466|NCT04433390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397467|NCT04399746|Cholecalciferol|cholecalciferol|mesh-list
92397469|NCT04399746|Azithromycin|azithromycin|mesh-list
92397470|NCT04399746|Ivermectin|ivermectin|mesh-list
92397471|NCT04399746|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92397472|NCT04399746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397473|NCT04399746|Vitamins|vitamins|mesh-ancestor
92397474|NCT04399746|Micronutrients|micronutrients|mesh-ancestor
92397475|NCT04399746|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92397476|NCT04399746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92397477|NCT04399746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397478|NCT04399746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92397479|NCT04391608|Tenofovir|tenofovir|mesh-list
92397480|NCT04391608|Antiviral Agents|antiviral agents|mesh-ancestor
92397481|NCT04391608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397482|NCT04391608|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92397483|NCT04391608|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92397484|NCT04391608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397485|NCT04391608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397486|NCT04391608|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92397487|NCT04391608|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92397488|NCT04368091|Sirolimus|sirolimus|mesh-list
92397489|NCT04368091|Temsirolimus|temsirolimus|mesh-list
92397490|NCT04368091|MTOR Inhibitors|mtor inhibitors|mesh-list
92397491|NCT04368091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92397492|NCT04368091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397493|NCT04368091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92397494|NCT04368091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397495|NCT04368091|Antifungal Agents|antifungal agents|mesh-ancestor
92397496|NCT04368091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397497|NCT04368091|Immunologic Factors|immunologic factors|mesh-ancestor
92397498|NCT04368091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397499|NCT04368091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397500|NCT04368091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397501|NCT04368091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397502|NCT04328090|Anti-Infective Agents|anti-infective agents|mesh-list
92397503|NCT04328090|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92397504|NCT04324021|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92397505|NCT04324021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397506|NCT04302168|Choline|choline|mesh-list
92397507|NCT04302168|Lipotropic Agents|lipotropic agents|mesh-ancestor
92051478|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
92397508|NCT04302168|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92397509|NCT04302168|Antimetabolites|antimetabolites|mesh-ancestor
92397510|NCT04302168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397511|NCT04302168|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397512|NCT04302168|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92397513|NCT04302168|Nootropic Agents|nootropic agents|mesh-ancestor
92397514|NCT04245644|Aspirin|aspirin|mesh-list
92397515|NCT04245644|Metformin|metformin|mesh-list
92397516|NCT04245644|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92397517|NCT04245644|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397518|NCT04245644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397519|NCT04245644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92397520|NCT04245644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397522|NCT04245644|Sensory System Agents|sensory system agents|mesh-ancestor
92397523|NCT04245644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397524|NCT04245644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397525|NCT04245644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397526|NCT04245644|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92397527|NCT04245644|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92397528|NCT04245644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397529|NCT04245644|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92397530|NCT04245644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92397531|NCT04245644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397532|NCT04245644|Antipyretics|antipyretics|mesh-ancestor
92397533|NCT04245644|Protease Inhibitors|protease inhibitors|mesh-ancestor
92397534|NCT04238845|Vitamin A|vitamin a|mesh-list
92397535|NCT04238845|Vitamins|vitamins|mesh-ancestor
92397536|NCT04238845|Micronutrients|micronutrients|mesh-ancestor
92397537|NCT04238845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397538|NCT04223037|Vaccines|vaccines|mesh-list
92397539|NCT04223037|Immunologic Factors|immunologic factors|mesh-ancestor
92397540|NCT04223037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397541|NCT04186663|Fluorides|fluorides|mesh-list
92397542|NCT04186663|Cariostatic Agents|cariostatic agents|mesh-ancestor
92397543|NCT04186663|Protective Agents|protective agents|mesh-ancestor
92397544|NCT04186663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397546|NCT04108026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397547|NCT04108026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397548|NCT04095104|Topiramate|topiramate|mesh-list
92397549|NCT04095104|Phentermine|phentermine|mesh-list
92397550|NCT04095104|Anticonvulsants|anticonvulsants|mesh-ancestor
92397551|NCT04095104|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397552|NCT04095104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397553|NCT04095104|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92397554|NCT04095104|Appetite Depressants|appetite depressants|mesh-ancestor
92397555|NCT04095104|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92397556|NCT04095104|Sympathomimetics|sympathomimetics|mesh-ancestor
92397557|NCT04095104|Autonomic Agents|autonomic agents|mesh-ancestor
92397558|NCT04095104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397559|NCT04095104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397560|NCT04095104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397561|NCT04095104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397563|NCT04074512|Trace Elements|trace elements|mesh-ancestor
92397564|NCT04074512|Micronutrients|micronutrients|mesh-ancestor
92397565|NCT04074512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397566|NCT04044729|Cannabidiol|cannabidiol|mesh-list
92397567|NCT04044729|Anticonvulsants|anticonvulsants|mesh-ancestor
92397568|NCT04008082|Lenvatinib|lenvatinib|mesh-list
92397569|NCT04008082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397570|NCT04008082|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397571|NCT04008082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397572|NCT04008082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397573|NCT03974243|Chiauranib|chiauranib|mesh-list
92051787|NCT01825941|Promethazine|promethazine|mesh-list
92397574|NCT03974243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397575|NCT03974243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397576|NCT03974243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397577|NCT03974243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397578|NCT03967925|Prednisone|prednisone|mesh-list
92397579|NCT03967925|Prednisolone|prednisolone|mesh-list
92397580|NCT03967925|Rituximab|rituximab|mesh-list
92397581|NCT03967925|Belimumab|belimumab|mesh-list
92397582|NCT03967925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397583|NCT03967925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397584|NCT03967925|Immunologic Factors|immunologic factors|mesh-ancestor
92397585|NCT03967925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397586|NCT03967925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397587|NCT03967925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397588|NCT03967925|Glucocorticoids|glucocorticoids|mesh-ancestor
92397589|NCT03967925|Hormones|hormones|mesh-ancestor
92397590|NCT03967925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397591|NCT03967925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92397592|NCT03967925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397593|NCT03954743|Vaccines|vaccines|mesh-list
92397594|NCT03954743|Immunologic Factors|immunologic factors|mesh-ancestor
92397595|NCT03954743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397596|NCT03883412|Liraglutide|liraglutide|mesh-list
92397597|NCT03883412|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397598|NCT03883412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397599|NCT03883412|Incretins|incretins|mesh-ancestor
92397600|NCT03883412|Hormones|hormones|mesh-ancestor
92397601|NCT03883412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397602|NCT03867682|Venetoclax|venetoclax|mesh-list
92049964|NCT01483690|Dexamethasone|dexamethasone|mesh-list
92397603|NCT03867682|Lintuzumab|lintuzumab|mesh-list
92397604|NCT03867682|Spironolactone|spironolactone|mesh-list
92397605|NCT03867682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397606|NCT03867682|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92397607|NCT03867682|Hormone Antagonists|hormone antagonists|mesh-ancestor
92397608|NCT03867682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397609|NCT03867682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397610|NCT03867682|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92397611|NCT03867682|Diuretics|diuretics|mesh-ancestor
92397612|NCT03867682|Natriuretic Agents|natriuretic agents|mesh-ancestor
92397613|NCT03867682|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397614|NCT03858621|Fentanyl|fentanyl|mesh-list
92397615|NCT03858621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92397616|NCT03858621|Narcotics|narcotics|mesh-ancestor
92397617|NCT03858621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397618|NCT03858621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397619|NCT03858621|Analgesics|analgesics|mesh-ancestor
92052198|NCT02066402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397620|NCT03858621|Sensory System Agents|sensory system agents|mesh-ancestor
92397621|NCT03858621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397622|NCT03858621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92397623|NCT03858621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92397624|NCT03858621|Anesthetics, General|anesthetics, general|mesh-ancestor
92397625|NCT03858621|Anesthetics|anesthetics|mesh-ancestor
92397626|NCT03845270|Docetaxel|docetaxel|mesh-list
92397627|NCT03845270|Trastuzumab|trastuzumab|mesh-list
92397628|NCT03845270|Pertuzumab|pertuzumab|mesh-list
92397629|NCT03845270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397630|NCT03845270|Tubulin Modulators|tubulin modulators|mesh-ancestor
92397631|NCT03845270|Antimitotic Agents|antimitotic agents|mesh-ancestor
92397632|NCT03845270|Mitosis Modulators|mitosis modulators|mesh-ancestor
92397633|NCT03845270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397634|NCT03845270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397635|NCT03777462|Paclitaxel|paclitaxel|mesh-list
92397636|NCT03777462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92397637|NCT03777462|Gemcitabine|gemcitabine|mesh-list
92052322|NCT02150213|Dexamethasone|dexamethasone|mesh-list
92397638|NCT03777462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92397639|NCT03777462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397640|NCT03777462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92397641|NCT03777462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92397642|NCT03777462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052402|NCT02111096|Metformin|metformin|mesh-list
92397643|NCT03777462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397644|NCT03777462|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397645|NCT03777462|Antimetabolites|antimetabolites|mesh-ancestor
92397646|NCT03758170|Dexamethasone|dexamethasone|mesh-list
92397647|NCT03758170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397648|NCT03758170|Antiemetics|antiemetics|mesh-ancestor
92397649|NCT03758170|Autonomic Agents|autonomic agents|mesh-ancestor
92397650|NCT03758170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397651|NCT03758170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397652|NCT03758170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397653|NCT03758170|Glucocorticoids|glucocorticoids|mesh-ancestor
92397655|NCT03758170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397656|NCT03758170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92397657|NCT03758170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397658|NCT03733119|TIC10 compound|tic10 compound|mesh-list
92397659|NCT03733119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397660|NCT03705338|Propofol|propofol|mesh-list
92397661|NCT03705338|Anesthetics|anesthetics|mesh-list
92397662|NCT03705338|Anesthetics, General|anesthetics, general|mesh-list
92397663|NCT03705338|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92052607|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397664|NCT03705338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397665|NCT03705338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397666|NCT03705338|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92397668|NCT03704285|Anesthetics|anesthetics|mesh-list
92397669|NCT03704285|Anesthetics, General|anesthetics, general|mesh-list
92052692|NCT02054702|Dopamine Agents|dopamine agents|mesh-ancestor
92397670|NCT03704285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92397671|NCT03704285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397672|NCT03704285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397673|NCT03704285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92397674|NCT03696537|Fludarabine|fludarabine|mesh-list
92397675|NCT03696537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397676|NCT03661996|Lidocaine|lidocaine|mesh-list
92397677|NCT03661996|Epinephrine|epinephrine|mesh-list
92397678|NCT03661996|Capsaicin|capsaicin|mesh-list
92397679|NCT03661996|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397680|NCT03661996|Anesthetics|anesthetics|mesh-ancestor
92397681|NCT03661996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052760|NCT01621880|Methylprednisolone|methylprednisolone|mesh-list
92397682|NCT03661996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397684|NCT03661996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397685|NCT03661996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397686|NCT03661996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397687|NCT03661996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397688|NCT03661996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397689|NCT03661996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397690|NCT03661996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92397691|NCT03661996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92397692|NCT03661996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397693|NCT03661996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397694|NCT03661996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92397695|NCT03661996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92397696|NCT03661996|Autonomic Agents|autonomic agents|mesh-ancestor
92397697|NCT03661996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92397698|NCT03661996|Respiratory System Agents|respiratory system agents|mesh-ancestor
92397699|NCT03661996|Mydriatics|mydriatics|mesh-ancestor
92397700|NCT03661996|Sympathomimetics|sympathomimetics|mesh-ancestor
92397701|NCT03661996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92397702|NCT03661996|Antipruritics|antipruritics|mesh-ancestor
92397703|NCT03661996|Dermatologic Agents|dermatologic agents|mesh-ancestor
92397704|NCT03659799|Insulin|insulin|mesh-list
92397705|NCT03659799|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92397706|NCT03659799|Insulin Aspart|insulin aspart|mesh-list
92397707|NCT03659799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397708|NCT03659799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397709|NCT03410355|Cortisone|cortisone|mesh-list
92397710|NCT03410355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397711|NCT03399617|Micronutrients|micronutrients|mesh-list
92397712|NCT03399617|Trace Elements|trace elements|mesh-list
92397713|NCT03399617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397714|NCT03386162|Fulvestrant|fulvestrant|mesh-list
92397715|NCT03386162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92052859|NCT02079649|Hormones|hormones|mesh-ancestor
92397716|NCT03386162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397717|NCT03386162|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92397718|NCT03386162|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92397719|NCT03386162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92397720|NCT03386162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397721|NCT03386162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397723|NCT03360214|Ropivacaine|ropivacaine|mesh-list
92397724|NCT03360214|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397725|NCT03360214|Anesthetics|anesthetics|mesh-ancestor
92397726|NCT03360214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397727|NCT03360214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397728|NCT03360214|Sensory System Agents|sensory system agents|mesh-ancestor
92397729|NCT03360214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397730|NCT03359239|Atezolizumab|atezolizumab|mesh-list
92397731|NCT03359239|Poly ICLC|poly iclc|mesh-list
92397732|NCT03359239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397733|NCT03359239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397734|NCT03359239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397735|NCT03359239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397736|NCT03359239|Interferon Inducers|interferon inducers|mesh-ancestor
92397737|NCT03359239|Immunologic Factors|immunologic factors|mesh-ancestor
92397738|NCT03359239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397739|NCT03332173|Zanubrutinib|zanubrutinib|mesh-list
92397740|NCT03332173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397741|NCT03332173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397742|NCT03332173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397743|NCT03332173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397744|NCT03328676|Chlorophyllin|chlorophyllin|mesh-list
92397745|NCT03328676|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92397746|NCT03328676|Protective Agents|protective agents|mesh-ancestor
92397747|NCT03328676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397748|NCT03322293|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92397749|NCT03322293|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92397750|NCT03322293|Dermatologic Agents|dermatologic agents|mesh-ancestor
92397751|NCT03315039|Annamycin|annamycin|mesh-list
92397752|NCT03315039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92397753|NCT03315039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397754|NCT03289325|Dexmedetomidine|dexmedetomidine|mesh-list
92053031|NCT05886088|Incretins|incretins|mesh-ancestor
92397755|NCT03289325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92397756|NCT03289325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050102|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397757|NCT03289325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397758|NCT03289325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397760|NCT03289325|Sensory System Agents|sensory system agents|mesh-ancestor
92397761|NCT03289325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397762|NCT03289325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92397763|NCT03289325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92397765|NCT03289325|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397766|NCT03289325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397767|NCT03289325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397768|NCT03276533|Lidocaine|lidocaine|mesh-list
92053081|NCT05885646|Sulthiame|sulthiame|mesh-list
92397769|NCT03276533|Dexmedetomidine|dexmedetomidine|mesh-list
92397770|NCT03276533|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397771|NCT03276533|Anesthetics|anesthetics|mesh-ancestor
92397772|NCT03276533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397773|NCT03276533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397774|NCT03276533|Sensory System Agents|sensory system agents|mesh-ancestor
92397775|NCT03276533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397776|NCT03276533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397777|NCT03276533|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397778|NCT03276533|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397779|NCT03276533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397780|NCT03276533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397781|NCT03276533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92397782|NCT03276533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397783|NCT03276533|Analgesics|analgesics|mesh-ancestor
92397784|NCT03276533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92053167|NCT05794477|Paclitaxel|paclitaxel|mesh-list
92397785|NCT03276533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92397786|NCT03276533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92397787|NCT03276533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397788|NCT03276533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397789|NCT03254394|Lidocaine|lidocaine|mesh-list
92397790|NCT03254394|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397791|NCT03254394|Anesthetics|anesthetics|mesh-ancestor
92397792|NCT03254394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397793|NCT03254394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397794|NCT03254394|Sensory System Agents|sensory system agents|mesh-ancestor
92397795|NCT03254394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397796|NCT03254394|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397797|NCT03254394|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397798|NCT03254394|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397799|NCT03254394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397800|NCT03254394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397801|NCT03203876|Nivolumab|nivolumab|mesh-list
92397802|NCT03203876|Ipilimumab|ipilimumab|mesh-list
92397803|NCT03203876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92397804|NCT03203876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397805|NCT03203876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92397806|NCT03203876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397807|NCT03191240|Vasopressins|vasopressins|mesh-list
92397808|NCT03191240|Arginine Vasopressin|arginine vasopressin|mesh-list
92053431|NCT05554146|Hormones|hormones|mesh-ancestor
92397809|NCT03191240|Hemostatics|hemostatics|mesh-ancestor
92397810|NCT03191240|Coagulants|coagulants|mesh-ancestor
92397811|NCT03191240|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92397812|NCT03191240|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92397813|NCT03191240|Natriuretic Agents|natriuretic agents|mesh-ancestor
92397814|NCT03191240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397815|NCT03180294|Bupropion|bupropion|mesh-list
92397816|NCT03180294|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92397818|NCT03180294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92397819|NCT03180294|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92397820|NCT03180294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92397821|NCT03180294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397822|NCT03180294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397823|NCT03180294|Dopamine Agents|dopamine agents|mesh-ancestor
92397824|NCT03180294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397825|NCT03180294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397826|NCT03180294|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92397827|NCT03180294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050186|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
92397828|NCT03180294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397829|NCT03071601|Lidocaine|lidocaine|mesh-list
92397830|NCT03071601|Epinephrine|epinephrine|mesh-list
92397831|NCT03071601|Prilocaine|prilocaine|mesh-list
92397832|NCT03071601|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92397833|NCT03071601|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397835|NCT03071601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397836|NCT03071601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397837|NCT03071601|Sensory System Agents|sensory system agents|mesh-ancestor
92397838|NCT03071601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397839|NCT03071601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397840|NCT03071601|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397841|NCT03071601|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397842|NCT03071601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397843|NCT03071601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397844|NCT03071601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92397845|NCT03071601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92397846|NCT03071601|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397847|NCT03071601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397848|NCT03071601|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92397849|NCT03071601|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92397850|NCT03071601|Autonomic Agents|autonomic agents|mesh-ancestor
92397851|NCT03071601|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92397852|NCT03071601|Respiratory System Agents|respiratory system agents|mesh-ancestor
92397853|NCT03071601|Mydriatics|mydriatics|mesh-ancestor
92397854|NCT03071601|Sympathomimetics|sympathomimetics|mesh-ancestor
92397855|NCT03071601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92397856|NCT03071601|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92397857|NCT03061903|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92397858|NCT03061903|Laxatives|laxatives|mesh-ancestor
92397859|NCT03061903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397860|NCT03061643|Docetaxel|docetaxel|mesh-list
92397861|NCT03061643|Androgens|androgens|mesh-list
92397862|NCT03061643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397863|NCT03061643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92397864|NCT03061643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92397865|NCT03061643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92397866|NCT03061643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397867|NCT03061643|Hormones|hormones|mesh-ancestor
92053756|NCT05007106|Docetaxel|docetaxel|mesh-list
92053757|NCT05007106|Bevacizumab|bevacizumab|mesh-list
92397868|NCT03061643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92397870|NCT03061630|Gemcitabine|gemcitabine|mesh-list
92397871|NCT03061630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397872|NCT03061630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397873|NCT03061630|Antimetabolites|antimetabolites|mesh-ancestor
92397874|NCT03061630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397875|NCT03055390|Scopolamine|scopolamine|mesh-list
92397876|NCT03055390|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92397877|NCT03055390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92397879|NCT03055390|Autonomic Agents|autonomic agents|mesh-ancestor
92397880|NCT03055390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397881|NCT03055390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397882|NCT03055390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92397883|NCT03055390|Mydriatics|mydriatics|mesh-ancestor
92397884|NCT03055390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92397885|NCT03055390|Cholinergic Agents|cholinergic agents|mesh-ancestor
92053895|NCT04875702|Antioxidants|antioxidants|mesh-ancestor
92397887|NCT03055390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397888|NCT03055390|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92397889|NCT03055390|Parasympatholytics|parasympatholytics|mesh-ancestor
92397890|NCT03012672|Cytarabine|cytarabine|mesh-list
92397891|NCT03012672|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
92397892|NCT03012672|Mitoxantrone|mitoxantrone|mesh-list
92397893|NCT03012672|Cladribine|cladribine|mesh-list
92397894|NCT03012672|Lenograstim|lenograstim|mesh-list
92397895|NCT03012672|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92397896|NCT03012672|Antimetabolites|antimetabolites|mesh-ancestor
92397897|NCT03012672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397898|NCT03012672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397899|NCT03012672|Antiviral Agents|antiviral agents|mesh-ancestor
92397900|NCT03012672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397901|NCT03012672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397902|NCT03012672|Immunologic Factors|immunologic factors|mesh-ancestor
92397903|NCT03012672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397904|NCT03012672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92397905|NCT03012672|Analgesics|analgesics|mesh-ancestor
92397906|NCT03012672|Sensory System Agents|sensory system agents|mesh-ancestor
92397907|NCT03012672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397908|NCT03012672|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92397909|NCT03012672|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92397910|NCT03012672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397911|NCT03011775|Aspirin|aspirin|mesh-list
92397912|NCT03011775|Pioglitazone|pioglitazone|mesh-list
92054198|NCT03590054|Pembrolizumab|pembrolizumab|mesh-list
92397913|NCT03011775|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92397914|NCT03011775|Ramipril|ramipril|mesh-list
92397915|NCT03011775|Bisoprolol|bisoprolol|mesh-list
92397916|NCT03011775|Isosorbide|isosorbide|mesh-list
92397917|NCT03011775|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92397918|NCT03011775|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92397920|NCT03011775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92397921|NCT03011775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92397922|NCT03011775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397923|NCT03011775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92397924|NCT03011775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92397925|NCT03011775|Antimetabolites|antimetabolites|mesh-ancestor
92397926|NCT03011775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397927|NCT03011775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92397928|NCT03011775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92397929|NCT03011775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92397930|NCT03011775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92397931|NCT03011775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92397932|NCT03011775|Analgesics|analgesics|mesh-ancestor
92397933|NCT03011775|Sensory System Agents|sensory system agents|mesh-ancestor
92397934|NCT03011775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397935|NCT03011775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92397936|NCT03011775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92397937|NCT03011775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92397938|NCT03011775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92397939|NCT03011775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92397940|NCT03011775|Antipyretics|antipyretics|mesh-ancestor
92397941|NCT03011775|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92397942|NCT03011775|Protease Inhibitors|protease inhibitors|mesh-ancestor
92397943|NCT03011775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92397944|NCT03011775|Sympatholytics|sympatholytics|mesh-ancestor
92397945|NCT03011775|Autonomic Agents|autonomic agents|mesh-ancestor
92397946|NCT03011775|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92397947|NCT03011775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92397948|NCT03011775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92397949|NCT03011775|Adrenergic Agents|adrenergic agents|mesh-ancestor
92397950|NCT03011775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92397951|NCT03011775|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92397952|NCT03011775|Diuretics|diuretics|mesh-ancestor
92397953|NCT03011775|Natriuretic Agents|natriuretic agents|mesh-ancestor
92397954|NCT03011775|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92397955|NCT02960997|Sirolimus|sirolimus|mesh-list
92397956|NCT02960997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92397957|NCT02960997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92397958|NCT02960997|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92397959|NCT02960997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397960|NCT02960997|Antifungal Agents|antifungal agents|mesh-ancestor
92397961|NCT02960997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397962|NCT02960997|Immunologic Factors|immunologic factors|mesh-ancestor
92054689|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
92397963|NCT02960997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397965|NCT02924480|Anesthetics, Local|anesthetics, local|mesh-ancestor
92397966|NCT02924480|Anesthetics|anesthetics|mesh-ancestor
92397967|NCT02924480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92397968|NCT02924480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397969|NCT02924480|Sensory System Agents|sensory system agents|mesh-ancestor
92014927|NCT05170919|Olanzapine|olanzapine|mesh-list
92397970|NCT02924480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92397971|NCT02924480|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92397972|NCT02924480|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92397973|NCT02924480|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92397974|NCT02924480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92397975|NCT02924480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397977|NCT02924064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92397978|NCT02924064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397979|NCT02889900|Olaparib|olaparib|mesh-list
92397980|NCT02889900|Cediranib|cediranib|mesh-list
92397981|NCT02889900|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92397982|NCT02889900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054886|NCT02171429|Adalimumab|adalimumab|mesh-list
92397983|NCT02889900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92397984|NCT02889900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397985|NCT02889900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92397986|NCT02879942|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
92397987|NCT02879942|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
92397988|NCT02879942|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92397989|NCT02879942|Growth Substances|growth substances|mesh-ancestor
92397990|NCT02879942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397991|NCT02879942|Growth Inhibitors|growth inhibitors|mesh-ancestor
92397992|NCT02879942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92397993|NCT02873819|Cyclophosphamide|cyclophosphamide|mesh-list
92397995|NCT02873819|Poly ICLC|poly iclc|mesh-list
92397996|NCT02873819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92397998|NCT02873819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92397999|NCT02873819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398000|NCT02873819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92398001|NCT02873819|Alkylating Agents|alkylating agents|mesh-ancestor
92398002|NCT02873819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398003|NCT02873819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398004|NCT02873819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92398005|NCT02873819|Interferon Inducers|interferon inducers|mesh-ancestor
92398006|NCT02810457|Paclitaxel|paclitaxel|mesh-list
92398007|NCT02810457|Bevacizumab|bevacizumab|mesh-list
92398008|NCT02810457|Carboplatin|carboplatin|mesh-list
92398009|NCT02810457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92398010|NCT02810457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398011|NCT02810457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92398012|NCT02810457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398013|NCT02810457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92055236|NCT01994720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398014|NCT02810457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398015|NCT02810457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398016|NCT02810457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92398017|NCT02810457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92398018|NCT02810457|Growth Substances|growth substances|mesh-ancestor
92398019|NCT02810457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398020|NCT02810457|Growth Inhibitors|growth inhibitors|mesh-ancestor
92398021|NCT02745535|Sofosbuvir|sofosbuvir|mesh-list
92398022|NCT02745535|Velpatasvir|velpatasvir|mesh-list
92398023|NCT02745535|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92398024|NCT02745535|Antiviral Agents|antiviral agents|mesh-ancestor
92398025|NCT02745535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398026|NCT02729701|Bazedoxifene|bazedoxifene|mesh-list
92398027|NCT02729701|Estrogens|estrogens|mesh-list
92398028|NCT02729701|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92398029|NCT02729701|Hormones|hormones|mesh-ancestor
92398030|NCT02729701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398031|NCT02729701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398032|NCT02729701|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92398033|NCT02729701|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92398034|NCT02729701|Hormone Antagonists|hormone antagonists|mesh-ancestor
92055603|NCT02023099|Ritonavir|ritonavir|mesh-list
92398035|NCT02729701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92398037|NCT02719314|Glucocorticoids|glucocorticoids|mesh-list
92398038|NCT02719314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398039|NCT02719314|Antiemetics|antiemetics|mesh-ancestor
92398040|NCT02719314|Autonomic Agents|autonomic agents|mesh-ancestor
92398041|NCT02719314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398042|NCT02719314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398043|NCT02719314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398044|NCT02719314|Hormones|hormones|mesh-ancestor
92398045|NCT02719314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398046|NCT02719314|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92398047|NCT02719314|Protective Agents|protective agents|mesh-ancestor
92398048|NCT02711826|Acetaminophen|acetaminophen|mesh-list
92398049|NCT02711826|Diphenhydramine|diphenhydramine|mesh-list
92398050|NCT02711826|Promethazine|promethazine|mesh-list
92398051|NCT02711826|Mycophenolic Acid|mycophenolic acid|mesh-list
92398052|NCT02711826|Everolimus|everolimus|mesh-list
92398053|NCT02711826|Tacrolimus|tacrolimus|mesh-list
92398054|NCT02711826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398055|NCT02711826|Immunologic Factors|immunologic factors|mesh-ancestor
92398056|NCT02711826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398057|NCT02711826|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92398058|NCT02711826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398059|NCT02711826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398060|NCT02711826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398061|NCT02711826|Analgesics|analgesics|mesh-ancestor
92398062|NCT02711826|Sensory System Agents|sensory system agents|mesh-ancestor
92398063|NCT02711826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398064|NCT02711826|Antipyretics|antipyretics|mesh-ancestor
92398065|NCT02711826|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92398066|NCT02711826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398067|NCT02711826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398068|NCT02711826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92398069|NCT02711826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92398070|NCT02711826|Antitubercular Agents|antitubercular agents|mesh-ancestor
92398071|NCT02711826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398072|NCT02711826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398073|NCT02711826|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92398074|NCT02711826|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92398075|NCT02711826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398076|NCT02711826|Anesthetics, Local|anesthetics, local|mesh-ancestor
92398077|NCT02711826|Anesthetics|anesthetics|mesh-ancestor
92398078|NCT02711826|Antiemetics|antiemetics|mesh-ancestor
92398079|NCT02711826|Autonomic Agents|autonomic agents|mesh-ancestor
92398080|NCT02711826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398081|NCT02711826|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92398082|NCT02711826|Histamine Antagonists|histamine antagonists|mesh-ancestor
92398083|NCT02711826|Histamine Agents|histamine agents|mesh-ancestor
92398084|NCT02711826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398085|NCT02711826|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92398086|NCT02711826|Antipruritics|antipruritics|mesh-ancestor
92398087|NCT02711826|Dermatologic Agents|dermatologic agents|mesh-ancestor
92398088|NCT02684253|Nivolumab|nivolumab|mesh-list
92398089|NCT02684253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398090|NCT02684253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398091|NCT02684253|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92398092|NCT02684253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398093|NCT02666794|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92398094|NCT02666794|Sufentanil|sufentanil|mesh-list
92398095|NCT02666794|Morphine|morphine|mesh-list
92398096|NCT02666794|Dsuvia|dsuvia|mesh-list
92398097|NCT02666794|Bupivacaine|bupivacaine|mesh-list
92398098|NCT02666794|Anesthetics, Local|anesthetics, local|mesh-ancestor
92398099|NCT02666794|Anesthetics|anesthetics|mesh-ancestor
92398100|NCT02666794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398101|NCT02666794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398102|NCT02666794|Sensory System Agents|sensory system agents|mesh-ancestor
92398103|NCT02666794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052330|NCT02150213|Hormones|hormones|mesh-ancestor
92398104|NCT02666794|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92398105|NCT02666794|Narcotics|narcotics|mesh-ancestor
92398106|NCT02666794|Analgesics|analgesics|mesh-ancestor
92398107|NCT02666794|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92398108|NCT02666794|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92398109|NCT02666794|Anesthetics, General|anesthetics, general|mesh-ancestor
92398110|NCT02656550|Thymoglobulin|thymoglobulin|mesh-list
92398112|NCT02656550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398113|NCT02656550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398114|NCT02642094|Sirolimus|sirolimus|mesh-list
92398115|NCT02642094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398116|NCT02642094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398117|NCT02642094|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92398118|NCT02642094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398119|NCT02642094|Antifungal Agents|antifungal agents|mesh-ancestor
92398120|NCT02642094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398121|NCT02642094|Immunologic Factors|immunologic factors|mesh-ancestor
92398122|NCT02642094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398123|NCT02619552|Prednisone|prednisone|mesh-list
92398124|NCT02619552|Budesonide|budesonide|mesh-list
92398125|NCT02619552|Adalimumab|adalimumab|mesh-list
92398126|NCT02619552|Infliximab|infliximab|mesh-list
92398127|NCT02619552|Certolizumab Pegol|certolizumab pegol|mesh-list
92398128|NCT02619552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398129|NCT02619552|Glucocorticoids|glucocorticoids|mesh-ancestor
92050484|NCT02196701|Adalimumab|adalimumab|mesh-list
92056326|NCT02029274|Siponimod|siponimod|mesh-list
92398131|NCT02619552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398132|NCT02619552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398133|NCT02619552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92398134|NCT02619552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398135|NCT02619552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92398136|NCT02619552|Autonomic Agents|autonomic agents|mesh-ancestor
92398137|NCT02619552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398138|NCT02619552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92398139|NCT02619552|Respiratory System Agents|respiratory system agents|mesh-ancestor
92398140|NCT02619552|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92398141|NCT02619552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398142|NCT02619552|Dermatologic Agents|dermatologic agents|mesh-ancestor
92398143|NCT02619552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398144|NCT02619552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398145|NCT02619552|Immunologic Factors|immunologic factors|mesh-ancestor
92398146|NCT02578368|Leucovorin|leucovorin|mesh-list
92398147|NCT02578368|Docetaxel|docetaxel|mesh-list
92398148|NCT02578368|Fluorouracil|fluorouracil|mesh-list
92398149|NCT02578368|Oxaliplatin|oxaliplatin|mesh-list
92398150|NCT02578368|Trastuzumab|trastuzumab|mesh-list
92398151|NCT02578368|Levoleucovorin|levoleucovorin|mesh-list
92398152|NCT02578368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398153|NCT02578368|Tubulin Modulators|tubulin modulators|mesh-ancestor
92398154|NCT02578368|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398155|NCT02578368|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398156|NCT02578368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398157|NCT02578368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398158|NCT02578368|Antimetabolites|antimetabolites|mesh-ancestor
92398159|NCT02578368|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92398160|NCT02578368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398161|NCT02578368|Immunologic Factors|immunologic factors|mesh-ancestor
92398162|NCT02578368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398163|NCT02578368|Antidotes|antidotes|mesh-ancestor
92398164|NCT02578368|Protective Agents|protective agents|mesh-ancestor
92398165|NCT02578368|Vitamin B Complex|vitamin b complex|mesh-ancestor
92398166|NCT02578368|Vitamins|vitamins|mesh-ancestor
92398167|NCT02578368|Micronutrients|micronutrients|mesh-ancestor
92398168|NCT02539225|Paclitaxel|paclitaxel|mesh-list
92398169|NCT02539225|Oxaliplatin|oxaliplatin|mesh-list
92398170|NCT02539225|Ramucirumab|ramucirumab|mesh-list
92398171|NCT02539225|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92056527|NCT02109029|Insulin|insulin|mesh-list
92398172|NCT02539225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398173|NCT02539225|Tubulin Modulators|tubulin modulators|mesh-ancestor
92056606|NCT01449370|Serabelisib|serabelisib|mesh-list
92398174|NCT02539225|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398175|NCT02539225|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398176|NCT02539225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398177|NCT02535650|Tipifarnib|tipifarnib|mesh-list
92398178|NCT02535650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398179|NCT02526017|Nivolumab|nivolumab|mesh-list
92398180|NCT02526017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398181|NCT02526017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398182|NCT02526017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92398183|NCT02526017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398184|NCT02516657|Liraglutide|liraglutide|mesh-list
92398185|NCT02516657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398186|NCT02516657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398187|NCT02516657|Incretins|incretins|mesh-ancestor
92398188|NCT02516657|Hormones|hormones|mesh-ancestor
92398189|NCT02516657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398191|NCT02427581|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92398192|NCT02427581|Poly ICLC|poly iclc|mesh-list
92398193|NCT02427581|Interferon Inducers|interferon inducers|mesh-ancestor
92398194|NCT02427581|Immunologic Factors|immunologic factors|mesh-ancestor
92056813|NCT02047253|Acyclovir|acyclovir|mesh-list
92398195|NCT02427581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398196|NCT02427581|Laxatives|laxatives|mesh-ancestor
92398197|NCT02427581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398198|NCT02427581|Antiviral Agents|antiviral agents|mesh-ancestor
92398199|NCT02427581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398200|NCT02423525|Afatinib|afatinib|mesh-list
92398201|NCT02423525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398202|NCT02423525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398203|NCT02423525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398204|NCT02423525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398205|NCT02369653|Apixaban|apixaban|mesh-list
92398206|NCT02369653|Anticoagulants|anticoagulants|mesh-list
92398207|NCT02369653|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92398208|NCT02369653|Antithrombins|antithrombins|mesh-ancestor
92398209|NCT02369653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92398210|NCT02369653|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398211|NCT02369653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056949|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92398212|NCT02369653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398213|NCT02293109|Leucovorin|leucovorin|mesh-list
92398214|NCT02293109|Cytarabine|cytarabine|mesh-list
92398215|NCT02293109|Dexamethasone|dexamethasone|mesh-list
92398216|NCT02293109|Methylprednisolone|methylprednisolone|mesh-list
92398217|NCT02293109|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92398218|NCT02293109|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92398219|NCT02293109|Prednisolone|prednisolone|mesh-list
92398220|NCT02293109|Prednisolone acetate|prednisolone acetate|mesh-list
92398221|NCT02293109|Cyclophosphamide|cyclophosphamide|mesh-list
92398222|NCT02293109|Rituximab|rituximab|mesh-list
92398223|NCT02293109|Doxorubicin|doxorubicin|mesh-list
92398224|NCT02293109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92398225|NCT02293109|Methotrexate|methotrexate|mesh-list
92398226|NCT02293109|Vincristine|vincristine|mesh-list
92398227|NCT02293109|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92398228|NCT02293109|Prednisolone phosphate|prednisolone phosphate|mesh-list
92398229|NCT02293109|Levoleucovorin|levoleucovorin|mesh-list
92398230|NCT02293109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398231|NCT02293109|Immunologic Factors|immunologic factors|mesh-ancestor
92398232|NCT02293109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398233|NCT02293109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398234|NCT02293109|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92398235|NCT02293109|Alkylating Agents|alkylating agents|mesh-ancestor
92398236|NCT02293109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057467|NCT01621178|Insulin|insulin|mesh-list
92398237|NCT02293109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398238|NCT02293109|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92398239|NCT02293109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398240|NCT02293109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398241|NCT02293109|Antiemetics|antiemetics|mesh-ancestor
92398242|NCT02293109|Autonomic Agents|autonomic agents|mesh-ancestor
92398243|NCT02293109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398244|NCT02293109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398246|NCT02293109|Hormones|hormones|mesh-ancestor
92398247|NCT02293109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398248|NCT02293109|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92398249|NCT02293109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92398250|NCT02293109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92398251|NCT02293109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92398252|NCT02293109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398253|NCT02293109|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92398254|NCT02293109|Abortifacient Agents|abortifacient agents|mesh-ancestor
92398255|NCT02293109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92398256|NCT02293109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92398257|NCT02293109|Antimetabolites|antimetabolites|mesh-ancestor
92398258|NCT02293109|Dermatologic Agents|dermatologic agents|mesh-ancestor
92398259|NCT02293109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92398260|NCT02293109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92398261|NCT02293109|Antiviral Agents|antiviral agents|mesh-ancestor
92398262|NCT02293109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398264|NCT02293109|Protective Agents|protective agents|mesh-ancestor
92398265|NCT02293109|Vitamin B Complex|vitamin b complex|mesh-ancestor
92398266|NCT02293109|Vitamins|vitamins|mesh-ancestor
92398267|NCT02293109|Micronutrients|micronutrients|mesh-ancestor
92398268|NCT02293109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92398269|NCT02293109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92398270|NCT02293109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398271|NCT02293109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398272|NCT02293109|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92398273|NCT02195986|Estradiol|estradiol|mesh-list
92398274|NCT02195986|Estrogens|estrogens|mesh-ancestor
92398275|NCT02195986|Hormones|hormones|mesh-ancestor
92398276|NCT02195986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398277|NCT02195986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398278|NCT02183883|Afatinib|afatinib|mesh-list
91938052|NCT01646320|Metformin|metformin|mesh-list
92398279|NCT02183883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398280|NCT02183883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398281|NCT02183883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398282|NCT02183883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398283|NCT01982630|Liraglutide|liraglutide|mesh-list
92398284|NCT01982630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398285|NCT01982630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057736|NCT01937390|Bromides|bromides|mesh-list
92398286|NCT01982630|Incretins|incretins|mesh-ancestor
92398287|NCT01982630|Hormones|hormones|mesh-ancestor
92398288|NCT01982630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398289|NCT01951469|Pemetrexed|pemetrexed|mesh-list
92398290|NCT01951469|Gefitinib|gefitinib|mesh-list
92398291|NCT01951469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398292|NCT01951469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398293|NCT01951469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398294|NCT01951469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92398295|NCT01951469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92398296|NCT01951469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398298|NCT01940809|Ipilimumab|ipilimumab|mesh-list
92398299|NCT01940809|Trametinib|trametinib|mesh-list
92398300|NCT01940809|Dabrafenib|dabrafenib|mesh-list
92398301|NCT01940809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398302|NCT01940809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398303|NCT01940809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92398304|NCT01940809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398305|NCT01940809|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398307|NCT01879228|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92398308|NCT01879228|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398309|NCT01879228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398310|NCT01879228|Incretins|incretins|mesh-ancestor
92398311|NCT01879228|Hormones|hormones|mesh-ancestor
92398312|NCT01879228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398313|NCT01879228|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92398314|NCT01879228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398315|NCT01879228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398316|NCT01879228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398317|NCT01779557|Dialysis Solutions|dialysis solutions|mesh-list
92058165|NCT01908140|Bromides|bromides|mesh-list
92398318|NCT01779557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92398320|NCT01740297|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92398321|NCT01740297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398322|NCT01740297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058281|NCT01616654|Tazarotene|tazarotene|mesh-list
92398323|NCT01740297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92398324|NCT01740297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398325|NCT01729754|Etanercept|etanercept|mesh-list
92398326|NCT01729754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92398327|NCT01729754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92398328|NCT01729754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398329|NCT01729754|Analgesics|analgesics|mesh-ancestor
92398330|NCT01729754|Sensory System Agents|sensory system agents|mesh-ancestor
92058388|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398331|NCT01729754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398332|NCT01729754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398333|NCT01729754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398334|NCT01729754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398335|NCT01729754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398336|NCT01729754|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398337|NCT01729754|Immunologic Factors|immunologic factors|mesh-ancestor
92398339|NCT01622998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92398340|NCT01622998|Autonomic Agents|autonomic agents|mesh-ancestor
92398341|NCT01622998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398342|NCT01622998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398343|NCT01622998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92398344|NCT01622998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92398345|NCT01622998|Cholinergic Agents|cholinergic agents|mesh-ancestor
92398346|NCT01622998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398347|NCT01622998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398348|NCT01595620|Dronabinol|dronabinol|mesh-list
92398349|NCT01595620|Capsaicin|capsaicin|mesh-list
92398350|NCT01595620|Hallucinogens|hallucinogens|mesh-ancestor
92398351|NCT01595620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938055|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92058783|NCT01900730|Valproic Acid|valproic acid|mesh-list
92398352|NCT01595620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398353|NCT01595620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398354|NCT01595620|Analgesics|analgesics|mesh-ancestor
92398355|NCT01595620|Sensory System Agents|sensory system agents|mesh-ancestor
92398356|NCT01595620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398357|NCT01595620|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92398358|NCT01595620|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92398360|NCT01595620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398361|NCT01595620|Hormones|hormones|mesh-ancestor
92398362|NCT01595620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398363|NCT01595620|Antipruritics|antipruritics|mesh-ancestor
92398364|NCT01595620|Dermatologic Agents|dermatologic agents|mesh-ancestor
92398365|NCT01591629|Dronabinol|dronabinol|mesh-list
92398366|NCT01591629|Naloxone|naloxone|mesh-list
92398367|NCT01591629|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92398368|NCT01591629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398369|NCT01591629|Sensory System Agents|sensory system agents|mesh-ancestor
92398370|NCT01591629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398371|NCT01591629|Hallucinogens|hallucinogens|mesh-ancestor
92398372|NCT01591629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398373|NCT01591629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398374|NCT01591629|Analgesics|analgesics|mesh-ancestor
92398375|NCT01591629|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92398376|NCT01591629|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92398377|NCT01591629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398378|NCT01591629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398379|NCT01591629|Hormones|hormones|mesh-ancestor
92398380|NCT01591629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398381|NCT01515306|Paclitaxel|paclitaxel|mesh-list
92398382|NCT01515306|Ramucirumab|ramucirumab|mesh-list
92398383|NCT01515306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92398384|NCT01515306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398385|NCT01515306|Tubulin Modulators|tubulin modulators|mesh-ancestor
92398386|NCT01515306|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398387|NCT01515306|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398388|NCT01515306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059157|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
92398390|NCT01513187|Interferon-alpha|interferon-alpha|mesh-list
92398391|NCT01513187|Interferon alpha-2|interferon alpha-2|mesh-list
92398392|NCT01513187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398393|NCT01513187|Antiviral Agents|antiviral agents|mesh-ancestor
92398394|NCT01513187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398395|NCT01513187|Immunologic Factors|immunologic factors|mesh-ancestor
92398396|NCT01513187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398397|NCT01433965|Lenalidomide|lenalidomide|mesh-list
92398398|NCT01433965|Immunologic Factors|immunologic factors|mesh-ancestor
92398399|NCT01433965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398400|NCT01433965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92398401|NCT01433965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92398402|NCT01433965|Growth Substances|growth substances|mesh-ancestor
92398403|NCT01433965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92398404|NCT01433965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398405|NCT01360593|Gemcitabine|gemcitabine|mesh-list
92398406|NCT01360593|Capecitabine|capecitabine|mesh-list
92398407|NCT01360593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92398408|NCT01360593|Antimetabolites|antimetabolites|mesh-ancestor
92398409|NCT01360593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398410|NCT01360593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398411|NCT01354977|Resveratrol|resveratrol|mesh-list
92398412|NCT01354977|Antioxidants|antioxidants|mesh-ancestor
92059392|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92398413|NCT01354977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398414|NCT01354977|Protective Agents|protective agents|mesh-ancestor
92398415|NCT01354977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398416|NCT01354977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398417|NCT01354977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92398418|NCT01334606|Insulin|insulin|mesh-list
92398419|NCT01334606|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398420|NCT01334606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398421|NCT01226732|Capecitabine|capecitabine|mesh-list
92398422|NCT01226732|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92398423|NCT01226732|Antimetabolites|antimetabolites|mesh-ancestor
92398424|NCT01226732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398425|NCT01226732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398427|NCT00962988|Nicotine|nicotine|mesh-list
92398428|NCT00962988|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92398429|NCT00962988|Autonomic Agents|autonomic agents|mesh-ancestor
92398431|NCT00962988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398432|NCT00962988|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92398433|NCT00962988|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92398434|NCT00962988|Cholinergic Agents|cholinergic agents|mesh-ancestor
92398435|NCT00962988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059578|NCT01949870|Gemcitabine|gemcitabine|mesh-list
92398436|NCT00962988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398437|NCT00962988|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92398438|NCT00962988|Antidepressive Agents|antidepressive agents|mesh-ancestor
92398439|NCT00962988|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398440|NCT00962988|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92398441|NCT00962988|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92398442|NCT00962988|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92398443|NCT00962988|Dopamine Agents|dopamine agents|mesh-ancestor
92398444|NCT00962988|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92398445|NCT00962988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92398446|NCT00962988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398447|NCT00768820|Risperidone|risperidone|mesh-list
92398448|NCT00768820|Methylphenidate|methylphenidate|mesh-list
92398449|NCT00768820|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92398450|NCT00768820|Serotonin Agents|serotonin agents|mesh-ancestor
92398451|NCT00768820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398452|NCT00768820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398453|NCT00768820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059880|NCT01421134|Dopamine Agents|dopamine agents|mesh-ancestor
92398454|NCT00768820|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92398455|NCT00768820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92398456|NCT00768820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398457|NCT00768820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398458|NCT00768820|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92398459|NCT00768820|Dopamine Agents|dopamine agents|mesh-ancestor
92398460|NCT00768820|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92398461|NCT00768820|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92398462|NCT00768820|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92398463|NCT00768820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92398464|NCT00678730|Dronabinol|dronabinol|mesh-list
92398465|NCT00678730|Hallucinogens|hallucinogens|mesh-ancestor
92398466|NCT00678730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398467|NCT00678730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398468|NCT00678730|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398469|NCT00678730|Analgesics|analgesics|mesh-ancestor
92398470|NCT00678730|Sensory System Agents|sensory system agents|mesh-ancestor
92398471|NCT00678730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398472|NCT00678730|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92398473|NCT00678730|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92398474|NCT00678730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398475|NCT00678730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398476|NCT00678730|Hormones|hormones|mesh-ancestor
92398477|NCT00678730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398478|NCT00600015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92398480|NCT00600015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398481|NCT00600015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398482|NCT00600015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398483|NCT00600015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398484|NCT00500071|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92398485|NCT00500071|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92398486|NCT00500071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398487|NCT00500071|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92398488|NCT00500071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92398489|NCT00500071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92398490|NCT00500071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398491|NCT00500071|Dopamine Agents|dopamine agents|mesh-ancestor
92398492|NCT00500071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398493|NCT00447122|Gemcitabine|gemcitabine|mesh-list
92398494|NCT00447122|Oxaliplatin|oxaliplatin|mesh-list
92398495|NCT00447122|Lapatinib|lapatinib|mesh-list
92060146|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
92398496|NCT00447122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92398497|NCT00447122|Antimetabolites|antimetabolites|mesh-ancestor
92398498|NCT00447122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398499|NCT00447122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398500|NCT00447122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398501|NCT00447122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398503|NCT00430040|Lisinopril|lisinopril|mesh-list
92398504|NCT00430040|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92398505|NCT00430040|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92398506|NCT00430040|Adrenergic Agents|adrenergic agents|mesh-ancestor
92398507|NCT00430040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398508|NCT00430040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398509|NCT00430040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398510|NCT00430040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92398511|NCT00430040|Antioxidants|antioxidants|mesh-ancestor
92398512|NCT00430040|Protective Agents|protective agents|mesh-ancestor
92398513|NCT00430040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92015179|NCT02518971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92398514|NCT00430040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92398515|NCT00430040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92398516|NCT00430040|Vasodilator Agents|vasodilator agents|mesh-ancestor
92398517|NCT00430040|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92398518|NCT00430040|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92060556|NCT05700045|Dexmedetomidine|dexmedetomidine|mesh-list
92398519|NCT00430040|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92398520|NCT00430040|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398521|NCT00430040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398522|NCT00430040|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92398523|NCT00290251|Ulipristal acetate|ulipristal acetate|mesh-list
92398524|NCT00290251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92398525|NCT00290251|Contraceptive Agents|contraceptive agents|mesh-ancestor
92398526|NCT00290251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92060782|NCT05372354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398527|NCT00290251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398528|NCT00290251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92398529|NCT00066963|Fluorides|fluorides|mesh-list
92398530|NCT00066963|Fluorides, Topical|fluorides, topical|mesh-list
92398531|NCT00066963|Cariostatic Agents|cariostatic agents|mesh-ancestor
92398532|NCT00066963|Protective Agents|protective agents|mesh-ancestor
92398533|NCT00066963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398535|NCT01397500|Androgens|androgens|mesh-ancestor
92398537|NCT01397500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398538|NCT01397500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398539|NCT01397513|Aspirin|aspirin|mesh-list
92061089|NCT04851613|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92398540|NCT01397513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92398541|NCT01397513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398543|NCT01397513|Sensory System Agents|sensory system agents|mesh-ancestor
92398544|NCT01397513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398545|NCT01397513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398546|NCT01397513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398547|NCT01397513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398548|NCT01397513|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92061242|NCT04416737|Insulin|insulin|mesh-list
92398549|NCT01397513|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92061306|NCT04230564|Azacitidine|azacitidine|mesh-list
92398550|NCT01397513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398551|NCT01397513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92398552|NCT01397513|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92398553|NCT01397513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398554|NCT01397513|Antipyretics|antipyretics|mesh-ancestor
92398555|NCT01397630|Oxytocin|oxytocin|mesh-list
92398556|NCT01397630|Oxytocics|oxytocics|mesh-ancestor
92398557|NCT01397630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92398558|NCT01397630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398559|NCT01397734|Arsenic Trioxide|arsenic trioxide|mesh-list
92398560|NCT01397734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398561|NCT01397799|Tirbanibulin|tirbanibulin|mesh-list
92398562|NCT01397799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061377|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398563|NCT01397799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398564|NCT01397994|Nicorandil|nicorandil|mesh-list
92398566|NCT01397994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92398567|NCT01397994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92398568|NCT01397994|Sympatholytics|sympatholytics|mesh-ancestor
92061598|NCT03192215|Aspirin|aspirin|mesh-list
92398569|NCT01397994|Autonomic Agents|autonomic agents|mesh-ancestor
92398570|NCT01397994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398571|NCT01397994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398572|NCT01397994|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92398573|NCT01397994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92398574|NCT01397994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92398575|NCT01397994|Adrenergic Agents|adrenergic agents|mesh-ancestor
92398576|NCT01397994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398577|NCT01397994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398578|NCT01397994|Vasodilator Agents|vasodilator agents|mesh-ancestor
92398579|NCT01397994|Vitamin B Complex|vitamin b complex|mesh-ancestor
92398581|NCT01397994|Micronutrients|micronutrients|mesh-ancestor
92398582|NCT01398033|Paclitaxel|paclitaxel|mesh-list
92398583|NCT01398033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92398584|NCT01398033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398585|NCT01398033|Tubulin Modulators|tubulin modulators|mesh-ancestor
92398586|NCT01398033|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398587|NCT01398033|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398588|NCT01398033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398589|NCT01398046|Dasatinib|dasatinib|mesh-list
92398590|NCT01398046|Rabeprazole|rabeprazole|mesh-list
92398592|NCT01398046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398593|NCT01398046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398594|NCT01398046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398595|NCT01398046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062109|NCT00134030|Antimetabolites|antimetabolites|mesh-ancestor
92398596|NCT01398046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92398597|NCT01398046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398598|NCT01398046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92398599|NCT01398046|Lipotropic Agents|lipotropic agents|mesh-ancestor
92398600|NCT01398046|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92398601|NCT01398046|Antimetabolites|antimetabolites|mesh-ancestor
92398602|NCT01398046|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92398603|NCT01398072|Azithromycin|azithromycin|mesh-list
92398604|NCT01398072|Moxifloxacin|moxifloxacin|mesh-list
92398605|NCT01398072|Doxycycline|doxycycline|mesh-list
92398606|NCT01398072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398607|NCT01398072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398608|NCT01398072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92398609|NCT01398072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92398610|NCT01398072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398611|NCT01398072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398612|NCT01398072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398613|NCT01398072|Antimalarials|antimalarials|mesh-ancestor
92398614|NCT01398072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92398615|NCT01398072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92398616|NCT01398111|Glycopyrrolate|glycopyrrolate|mesh-list
92398617|NCT01398111|Formoterol Fumarate|formoterol fumarate|mesh-list
92398618|NCT01398111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92398619|NCT01398111|Autonomic Agents|autonomic agents|mesh-ancestor
92398620|NCT01398111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398621|NCT01398111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398622|NCT01398111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92398623|NCT01398111|Respiratory System Agents|respiratory system agents|mesh-ancestor
92398624|NCT01398111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92398625|NCT01398111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92398626|NCT01398111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92062306|NCT01738503|Analgesics|analgesics|mesh-ancestor
92398627|NCT01398111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92398628|NCT01398111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062375|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
92398629|NCT01398111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398630|NCT01398111|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92398631|NCT01398111|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92398632|NCT01398111|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92398633|NCT01398111|Cholinergic Agents|cholinergic agents|mesh-ancestor
92398634|NCT01398189|Clozapine|clozapine|mesh-list
92398635|NCT01398189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92398636|NCT01398189|Serotonin Agents|serotonin agents|mesh-ancestor
92398637|NCT01398189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398638|NCT01398189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398639|NCT01398189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398640|NCT01398189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92398641|NCT01398189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92398642|NCT01398189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398644|NCT01398189|GABA Antagonists|gaba antagonists|mesh-ancestor
92398645|NCT01398189|GABA Agents|gaba agents|mesh-ancestor
92398646|NCT01398202|Vitamin D|vitamin d|mesh-list
92398647|NCT01398202|Cholecalciferol|cholecalciferol|mesh-list
92398648|NCT01398202|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92398649|NCT01398202|Calcifediol|calcifediol|mesh-list
92398651|NCT01398202|Micronutrients|micronutrients|mesh-ancestor
92398652|NCT01398202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398653|NCT01398202|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92062814|NCT00210184|Leucovorin|leucovorin|mesh-list
92398654|NCT01398202|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92398655|NCT01398267|Lisinopril|lisinopril|mesh-list
92398656|NCT01398267|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92398657|NCT01398267|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398658|NCT01398267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398659|NCT01398267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062882|NCT04407130|Doxycycline|doxycycline|mesh-list
92398660|NCT01398267|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92398661|NCT01398267|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92398662|NCT01398267|Protective Agents|protective agents|mesh-ancestor
92398663|NCT01398267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398664|NCT01398293|Ritonavir|ritonavir|mesh-list
92398665|NCT01398293|Moxifloxacin|moxifloxacin|mesh-list
92398666|NCT01398293|Lactams|lactams|mesh-list
92398667|NCT01398293|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92398668|NCT01398293|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92015296|NCT04989699|Aflibercept|aflibercept|mesh-list
92398669|NCT01398293|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92398670|NCT01398293|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398671|NCT01398293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398672|NCT01398293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063254|NCT01703091|Ramucirumab|ramucirumab|mesh-list
92398673|NCT01398293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92398674|NCT01398293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92398675|NCT01398293|Antiviral Agents|antiviral agents|mesh-ancestor
92398676|NCT01398293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398677|NCT01398293|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92398678|NCT01398293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92398679|NCT01398293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398680|NCT01398293|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92398681|NCT01398293|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92398682|NCT01398293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398683|NCT01398293|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92398684|NCT01398293|Contraceptive Agents|contraceptive agents|mesh-ancestor
92398685|NCT01398293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92398686|NCT01398293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398687|NCT01398293|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92398688|NCT01398293|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92398689|NCT01398293|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92398690|NCT01398371|Digoxin|digoxin|mesh-list
92398691|NCT01398371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92398692|NCT01398371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92398693|NCT01398371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398694|NCT01398371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398695|NCT01398371|Protective Agents|protective agents|mesh-ancestor
92398696|NCT01398371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398697|NCT01398384|Nitric Oxide|nitric oxide|mesh-list
92398698|NCT01398384|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92398699|NCT01398384|Autonomic Agents|autonomic agents|mesh-ancestor
92115108|NCT01724021|Prednisone|prednisone|mesh-list
92398700|NCT01398384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398701|NCT01398384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398702|NCT01398384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92063720|NCT01711359|Methotrexate|methotrexate|mesh-list
92398703|NCT01398384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92398704|NCT01398384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92398705|NCT01398384|Antioxidants|antioxidants|mesh-ancestor
92398706|NCT01398384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398707|NCT01398384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398708|NCT01398384|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92398709|NCT01398384|Vasodilator Agents|vasodilator agents|mesh-ancestor
92398710|NCT01398384|Gasotransmitters|gasotransmitters|mesh-ancestor
92398711|NCT01398384|Protective Agents|protective agents|mesh-ancestor
92398712|NCT01398501|Sorafenib|sorafenib|mesh-list
92398713|NCT01398501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398714|NCT01398501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398715|NCT01398501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398716|NCT01398501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398717|NCT01398592|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92398718|NCT01398592|Vildagliptin|vildagliptin|mesh-list
92398719|NCT01398592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398720|NCT01398592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398721|NCT01398592|Incretins|incretins|mesh-ancestor
92398723|NCT01398592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398724|NCT01398592|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92398725|NCT01398592|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398726|NCT01398592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398727|NCT01398592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398728|NCT01398618|Rifampin|rifampin|mesh-list
92398729|NCT01398618|Isoniazid|isoniazid|mesh-list
92398730|NCT01398618|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92398731|NCT01398618|Antitubercular Agents|antitubercular agents|mesh-ancestor
92398732|NCT01398618|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398733|NCT01398618|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398734|NCT01398618|Leprostatic Agents|leprostatic agents|mesh-ancestor
92398735|NCT01398618|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92398736|NCT01398618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398737|NCT01398618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398738|NCT01398618|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92398739|NCT01398618|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92398740|NCT01398618|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92398741|NCT01398618|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92398742|NCT01398618|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92398743|NCT01398618|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92398744|NCT01398618|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92398745|NCT01398618|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92398747|NCT01398618|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92398748|NCT01398657|Androgens|androgens|mesh-list
92398749|NCT01398657|Hormones|hormones|mesh-ancestor
92398750|NCT01398657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398751|NCT01398657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398752|NCT01398670|Insulin|insulin|mesh-list
92398753|NCT01398670|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92398754|NCT01398670|Insulin Lispro|insulin lispro|mesh-list
92398755|NCT01398670|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398756|NCT01398670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398757|NCT01398722|Insulin|insulin|mesh-list
92398758|NCT01398722|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92398759|NCT01398722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398760|NCT01398722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398761|NCT01398995|Insulin|insulin|mesh-list
92398762|NCT01398995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398763|NCT01398995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398764|NCT01399086|Fulvestrant|fulvestrant|mesh-list
92398765|NCT01399086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92015445|NCT04033237|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92398766|NCT01399086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398767|NCT01399086|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92398768|NCT01399086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92398769|NCT01399086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92398770|NCT01399086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398771|NCT01399086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398772|NCT01399151|Vitamin D|vitamin d|mesh-list
92398773|NCT01399151|Ergocalciferols|ergocalciferols|mesh-list
92398774|NCT01399151|Cholecalciferol|cholecalciferol|mesh-list
92398775|NCT01399151|Vitamins|vitamins|mesh-list
92398776|NCT01399151|Micronutrients|micronutrients|mesh-ancestor
92398777|NCT01399151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398778|NCT01399151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92398779|NCT01399151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92398780|NCT01399216|Fucoidan|fucoidan|mesh-list
92398781|NCT01399216|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92398782|NCT01399216|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398783|NCT01399216|Anticoagulants|anticoagulants|mesh-ancestor
92398784|NCT01399216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398785|NCT01399242|Everolimus|everolimus|mesh-list
92398786|NCT01399242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92398787|NCT01399242|Immunologic Factors|immunologic factors|mesh-ancestor
92398788|NCT01399242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398789|NCT01399242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064756|NCT01854268|Capsaicin|capsaicin|mesh-list
92064820|NCT02081014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064904|NCT01817582|Cyclosporine|cyclosporine|mesh-list
92398790|NCT01399242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398791|NCT01399242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398792|NCT01399242|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92398793|NCT01399242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398794|NCT01399255|Insulin Lispro|insulin lispro|mesh-list
92398795|NCT01399255|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398796|NCT01399255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398798|NCT01399346|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92398799|NCT01399346|Insulin Aspart|insulin aspart|mesh-list
92398800|NCT01399346|Insulin, Long-Acting|insulin, long-acting|mesh-list
92015469|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
92398801|NCT01399346|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92398802|NCT01399346|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398803|NCT01399346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398804|NCT01399450|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92398805|NCT01399450|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92398806|NCT01399450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92398807|NCT01399450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398808|NCT01399450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398809|NCT01399450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015475|NCT05060913|Anesthetics, Local|anesthetics, local|mesh-ancestor
92398810|NCT01399450|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92398811|NCT01399450|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92398812|NCT01399450|Serotonin Agents|serotonin agents|mesh-ancestor
92398813|NCT01399450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065243|NCT01695135|Glucocorticoids|glucocorticoids|mesh-ancestor
92398814|NCT01399450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398815|NCT01399450|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92398816|NCT01399450|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92398817|NCT01399450|Dopamine Agents|dopamine agents|mesh-ancestor
92398819|NCT01399463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92398820|NCT01399463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398821|NCT01399463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92398822|NCT01399463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92398823|NCT01399463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92398824|NCT01399463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398825|NCT01399515|Valproic Acid|valproic acid|mesh-list
92398826|NCT01399515|Anticonvulsants|anticonvulsants|mesh-ancestor
92398827|NCT01399515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398828|NCT01399515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398829|NCT01399515|GABA Agents|gaba agents|mesh-ancestor
92398830|NCT01399515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398831|NCT01399515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398832|NCT01399515|Antimanic Agents|antimanic agents|mesh-ancestor
92398833|NCT01399515|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92398834|NCT01399515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398835|NCT01399515|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398836|NCT01399645|Insulin|insulin|mesh-list
92398837|NCT01399645|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92398838|NCT01399645|Metformin|metformin|mesh-list
92398839|NCT01399645|Insulin Glargine|insulin glargine|mesh-list
92398840|NCT01399645|Liraglutide|liraglutide|mesh-list
92398841|NCT01399645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398842|NCT01399645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398843|NCT01399645|Incretins|incretins|mesh-ancestor
92398844|NCT01399645|Hormones|hormones|mesh-ancestor
92398845|NCT01399645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398846|NCT01399840|Talazoparib|talazoparib|mesh-list
92398847|NCT01399840|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92398848|NCT01399840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398849|NCT01399840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398850|NCT01399840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398851|NCT01399853|Vaccines|vaccines|mesh-list
92398852|NCT01399853|Immunologic Factors|immunologic factors|mesh-ancestor
92015525|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
92398853|NCT01399853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398854|NCT01400009|Vitamin D|vitamin d|mesh-list
92398855|NCT01400009|Cholecalciferol|cholecalciferol|mesh-list
92398856|NCT01400009|Vitamins|vitamins|mesh-ancestor
92398857|NCT01400009|Micronutrients|micronutrients|mesh-ancestor
92398858|NCT01400009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398859|NCT01400009|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92398860|NCT01400009|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92398861|NCT01400022|Cortisone|cortisone|mesh-list
92398862|NCT01400022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92065993|NCT02405260|Hormones|hormones|mesh-ancestor
92398863|NCT01400074|Imatinib Mesylate|imatinib mesylate|mesh-list
92066071|NCT00087646|Interferon-alpha|interferon-alpha|mesh-list
92398864|NCT01400074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398865|NCT01400074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92398866|NCT01400074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398867|NCT01400074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398869|NCT01400100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92398870|NCT01400100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92398871|NCT01400100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92398872|NCT01400100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398873|NCT01400165|Pindolol|pindolol|mesh-list
92398874|NCT01400165|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92398875|NCT01400165|Trazodone|trazodone|mesh-list
92398876|NCT01400165|Antidepressive Agents|antidepressive agents|mesh-ancestor
92398877|NCT01400165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92398878|NCT01400165|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92398879|NCT01400165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92398880|NCT01400165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92398881|NCT01400165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398882|NCT01400165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92398883|NCT01400165|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92398884|NCT01400165|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92398885|NCT01400165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92398886|NCT01400165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398887|NCT01400165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92398888|NCT01400165|Serotonin Agents|serotonin agents|mesh-ancestor
92051228|NCT02097745|Rituximab|rituximab|mesh-list
92398889|NCT01400165|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92398890|NCT01400165|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92398891|NCT01400165|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92398892|NCT01400165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92398893|NCT01400165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92066484|NCT03080350|Fentanyl|fentanyl|mesh-list
92398894|NCT01400165|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92398895|NCT01400165|Vasodilator Agents|vasodilator agents|mesh-ancestor
92398896|NCT01400191|Metformin|metformin|mesh-list
92398897|NCT01400191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92398898|NCT01400191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398899|NCT01400217|Beclomethasone|beclomethasone|mesh-list
92398900|NCT01400217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398901|NCT01400217|Glucocorticoids|glucocorticoids|mesh-ancestor
92398902|NCT01400217|Hormones|hormones|mesh-ancestor
92398903|NCT01400217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398904|NCT01400217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398905|NCT01400217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92398906|NCT01400217|Respiratory System Agents|respiratory system agents|mesh-ancestor
92398908|NCT01400256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92398909|NCT01400256|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92398910|NCT01400256|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92398911|NCT01400256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398912|NCT01400308|Mupirocin|mupirocin|mesh-list
92398913|NCT01400308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398914|NCT01400308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398915|NCT01400308|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92398916|NCT01400308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066852|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
92398917|NCT01400308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398918|NCT01400360|Vasodilator Agents|vasodilator agents|mesh-list
92398919|NCT01400464|Prednisone|prednisone|mesh-list
92398920|NCT01400464|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398921|NCT01400464|Glucocorticoids|glucocorticoids|mesh-ancestor
92398922|NCT01400464|Hormones|hormones|mesh-ancestor
92398923|NCT01400464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92398924|NCT01400464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398925|NCT01400464|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92398927|NCT01400568|Fluticasone|fluticasone|mesh-list
92398928|NCT01400568|Xhance|xhance|mesh-list
92398929|NCT01400568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92398930|NCT01400568|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92398931|NCT01400568|Autonomic Agents|autonomic agents|mesh-ancestor
92398932|NCT01400568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067136|NCT03621904|Progesterone|progesterone|mesh-list
92398933|NCT01400568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398934|NCT01400568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92398935|NCT01400568|Respiratory System Agents|respiratory system agents|mesh-ancestor
92398936|NCT01400568|Dermatologic Agents|dermatologic agents|mesh-ancestor
92398937|NCT01400568|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92398938|NCT01400633|Decitabine|decitabine|mesh-list
92398939|NCT01400633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92398940|NCT01400633|Antimetabolites|antimetabolites|mesh-ancestor
92067269|NCT01576575|Analgesics|analgesics|mesh-ancestor
92398941|NCT01400633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398942|NCT01400633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398943|NCT01400633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398944|NCT01400646|Vitamins|vitamins|mesh-list
92398945|NCT01400646|Vitamin K|vitamin k|mesh-list
92398946|NCT01400646|Warfarin|warfarin|mesh-list
92398947|NCT01400646|Rivaroxaban|rivaroxaban|mesh-list
92067430|NCT01930045|Antacids|antacids|mesh-ancestor
92398948|NCT01400646|Micronutrients|micronutrients|mesh-ancestor
92398949|NCT01400646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398950|NCT01400646|Anticoagulants|anticoagulants|mesh-ancestor
92398951|NCT01400646|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92398952|NCT01400646|Antithrombins|antithrombins|mesh-ancestor
92398953|NCT01400646|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92067555|NCT01767116|Ribavirin|ribavirin|mesh-list
92398954|NCT01400646|Protease Inhibitors|protease inhibitors|mesh-ancestor
92398955|NCT01400646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92398956|NCT01400646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398957|NCT01400646|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92398958|NCT01400646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92398960|NCT01400646|Coagulants|coagulants|mesh-ancestor
92398961|NCT01400672|Imiquimod|imiquimod|mesh-list
92398962|NCT01400672|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92067791|NCT05929664|Cemiplimab|cemiplimab|mesh-list
92398963|NCT01400672|Immunologic Factors|immunologic factors|mesh-ancestor
92398964|NCT01400672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398965|NCT01400672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398966|NCT01400672|Interferon Inducers|interferon inducers|mesh-ancestor
92398967|NCT01400685|Rituximab|rituximab|mesh-list
92398968|NCT01400685|Lenalidomide|lenalidomide|mesh-list
92398969|NCT01400685|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92398970|NCT01400685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92398971|NCT01400685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92398973|NCT01400685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398974|NCT01400685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398975|NCT01400685|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92398976|NCT01400685|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92398977|NCT01400685|Growth Substances|growth substances|mesh-ancestor
92398978|NCT01400685|Growth Inhibitors|growth inhibitors|mesh-ancestor
92398979|NCT01400685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92398980|NCT01400685|Alkylating Agents|alkylating agents|mesh-ancestor
92398981|NCT01400685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398982|NCT01400737|Ibuprofen|ibuprofen|mesh-list
92398983|NCT01400737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92398984|NCT01400737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92398985|NCT01400737|Analgesics|analgesics|mesh-ancestor
92068350|NCT05127590|Pembrolizumab|pembrolizumab|mesh-list
92398986|NCT01400737|Sensory System Agents|sensory system agents|mesh-ancestor
92398987|NCT01400737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92398988|NCT01400737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92398989|NCT01400737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068430|NCT04965155|Dexamethasone|dexamethasone|mesh-list
92068609|NCT04465643|Nivolumab|nivolumab|mesh-list
92398990|NCT01400737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92398991|NCT01400737|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92398992|NCT01400737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068754|NCT04106856|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92398993|NCT01400737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92398994|NCT01400750|Ciprofloxacin|ciprofloxacin|mesh-list
92398995|NCT01400750|Tobramycin|tobramycin|mesh-list
92398996|NCT01400750|Colistin|colistin|mesh-list
92398997|NCT01400750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92398998|NCT01400750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92398999|NCT01400750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92399000|NCT01400750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92399001|NCT01400750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068977|NCT03648996|Allopurinol|allopurinol|mesh-list
92069044|NCT03471624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399002|NCT01400750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399003|NCT01400750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399004|NCT01400750|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92399005|NCT01400750|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92399006|NCT01400789|Insulin Lispro|insulin lispro|mesh-list
91938066|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
92399007|NCT01400789|Isophane insulin, insulin lispro drug combination 50:50|isophane insulin, insulin lispro drug combination 50:50|mesh-list
92069209|NCT03184870|Antidotes|antidotes|mesh-ancestor
92399008|NCT01400789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399009|NCT01400789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399010|NCT01400802|Insulin Lispro|insulin lispro|mesh-list
92399011|NCT01400802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399012|NCT01400802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069445|NCT01091831|Hormones|hormones|mesh-ancestor
92399013|NCT01400828|Desloratadine|desloratadine|mesh-list
92399014|NCT01400828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92399015|NCT01400828|Cholinergic Agents|cholinergic agents|mesh-ancestor
92399016|NCT01400828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399017|NCT01400828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399018|NCT01400828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399019|NCT01400828|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92399020|NCT01400828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92399021|NCT01400828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92399022|NCT01400828|Histamine Agents|histamine agents|mesh-ancestor
92399023|NCT01400867|Vancomycin|vancomycin|mesh-list
92399024|NCT01400867|Clindamycin|clindamycin|mesh-list
92399025|NCT01400867|Clindamycin palmitate|clindamycin palmitate|mesh-list
92399026|NCT01400867|Clindamycin phosphate|clindamycin phosphate|mesh-list
92399027|NCT01400867|Cefazolin|cefazolin|mesh-list
92399028|NCT01400867|Linezolid|linezolid|mesh-list
92399029|NCT01400867|Cephalexin|cephalexin|mesh-list
92399030|NCT01400867|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92399031|NCT01400867|Aztreonam|aztreonam|mesh-list
92399032|NCT01400867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399033|NCT01400867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399034|NCT01400867|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92399035|NCT01400867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399036|NCT01400867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399037|NCT01400945|Pantoprazole|pantoprazole|mesh-list
92399038|NCT01400945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92399039|NCT01400945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399040|NCT01400945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92399041|NCT01400945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399042|NCT01400945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399044|NCT01401036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399045|NCT01401036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399046|NCT01401036|Immunologic Factors|immunologic factors|mesh-ancestor
92069639|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
92399047|NCT01401036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399048|NCT01401075|Viscum album peptide|viscum album peptide|mesh-list
92399049|NCT01401075|Doxifluridine|doxifluridine|mesh-list
92399050|NCT01401075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399051|NCT01401075|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92399052|NCT01401075|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92399053|NCT01401075|Antiviral Agents|antiviral agents|mesh-ancestor
92399054|NCT01401075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399055|NCT01401075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399056|NCT01401075|Antimetabolites|antimetabolites|mesh-ancestor
92399057|NCT01401075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399060|NCT01401075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399061|NCT01401075|Appetite Stimulants|appetite stimulants|mesh-ancestor
92399062|NCT01401075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92399064|NCT01401179|Cefazolin|cefazolin|mesh-list
92399065|NCT01401179|Erythromycin|erythromycin|mesh-list
92399066|NCT01401179|Erythromycin Estolate|erythromycin estolate|mesh-list
92399067|NCT01401179|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92399068|NCT01401179|Erythromycin stearate|erythromycin stearate|mesh-list
92399069|NCT01401179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399070|NCT01401179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399071|NCT01401179|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92399072|NCT01401179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399073|NCT01401179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399074|NCT01401179|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92070031|NCT01925638|Ketoconazole|ketoconazole|mesh-list
92399075|NCT01401179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92399078|NCT01401192|Gemcitabine|gemcitabine|mesh-list
92399079|NCT01401192|Pemetrexed|pemetrexed|mesh-list
92399080|NCT01401192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399081|NCT01401192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399083|NCT01401192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399084|NCT01401192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399085|NCT01401192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92399086|NCT01401192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92399088|NCT01401387|Pancrelipase|pancrelipase|mesh-list
92399089|NCT01401387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399090|NCT01401491|Clozapine|clozapine|mesh-list
92399091|NCT01401491|Fluvoxamine|fluvoxamine|mesh-list
92399092|NCT01401491|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92399093|NCT01401491|Serotonin Agents|serotonin agents|mesh-ancestor
92399094|NCT01401491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399095|NCT01401491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399096|NCT01401491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399097|NCT01401491|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92399098|NCT01401491|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399099|NCT01401491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399100|NCT01401491|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070449|NCT03044314|Gasotransmitters|gasotransmitters|mesh-ancestor
92399101|NCT01401491|GABA Antagonists|gaba antagonists|mesh-ancestor
92399102|NCT01401491|GABA Agents|gaba agents|mesh-ancestor
92399103|NCT01401491|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92399104|NCT01401491|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92399105|NCT01401491|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92399106|NCT01401491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92399107|NCT01401491|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92399108|NCT01401491|Antidepressive Agents|antidepressive agents|mesh-ancestor
92399109|NCT01401491|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92399110|NCT01401491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92399111|NCT01401491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070837|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92399112|NCT01401491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92399113|NCT01401803|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92399114|NCT01401803|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92070905|NCT01457716|Hormones|hormones|mesh-ancestor
92399115|NCT01401803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92399116|NCT01401803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399118|NCT01401803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399119|NCT01401803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399120|NCT01401933|Rifampin|rifampin|mesh-list
92399121|NCT01401933|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92399122|NCT01401933|Antitubercular Agents|antitubercular agents|mesh-ancestor
92399123|NCT01401933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399124|NCT01401933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399125|NCT01401933|Leprostatic Agents|leprostatic agents|mesh-ancestor
92399126|NCT01401933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92399127|NCT01401933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399128|NCT01401933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071245|NCT02388178|Fluorides|fluorides|mesh-list
92399129|NCT01401933|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92399130|NCT01401933|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92399131|NCT01401933|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92399132|NCT01401933|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92399133|NCT01401933|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92399134|NCT01401933|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92399136|NCT01402024|Antiemetics|antiemetics|mesh-ancestor
92399137|NCT01402024|Autonomic Agents|autonomic agents|mesh-ancestor
92071325|NCT05603884|Antimetabolites|antimetabolites|mesh-ancestor
92399138|NCT01402024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399139|NCT01402024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399140|NCT01402024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399141|NCT01402024|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92399142|NCT01402024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399143|NCT01402024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399144|NCT01402076|Rosiglitazone|rosiglitazone|mesh-list
92399145|NCT01402076|Midazolam|midazolam|mesh-list
92071427|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92399146|NCT01402076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92399147|NCT01402076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92071501|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
92399148|NCT01402076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399149|NCT01402076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399150|NCT01402076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92399151|NCT01402076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399152|NCT01402076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399153|NCT01402076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92399154|NCT01402076|Anesthetics, General|anesthetics, general|mesh-ancestor
92399155|NCT01402076|Anesthetics|anesthetics|mesh-ancestor
92399156|NCT01402076|GABA Modulators|gaba modulators|mesh-ancestor
92399157|NCT01402076|GABA Agents|gaba agents|mesh-ancestor
92071651|NCT04129216|Tamoxifen|tamoxifen|mesh-list
92399158|NCT01402076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399159|NCT01402076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399160|NCT01402076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399161|NCT01402089|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92399163|NCT01402089|Midazolam|midazolam|mesh-list
92399164|NCT01402089|Caffeine|caffeine|mesh-list
92399165|NCT01402089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92399166|NCT01402089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92399167|NCT01402089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399168|NCT01402089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399169|NCT01402089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92399170|NCT01402089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399171|NCT01402089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399173|NCT01402089|Anesthetics, General|anesthetics, general|mesh-ancestor
92399174|NCT01402089|Anesthetics|anesthetics|mesh-ancestor
92399175|NCT01402089|GABA Modulators|gaba modulators|mesh-ancestor
92399176|NCT01402089|GABA Agents|gaba agents|mesh-ancestor
92399177|NCT01402089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399178|NCT01402089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399179|NCT01402089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399180|NCT01402089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399181|NCT01402089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399182|NCT01402089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92399183|NCT01402089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92399184|NCT01402089|Growth Substances|growth substances|mesh-ancestor
92399185|NCT01402089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92399186|NCT01402089|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92399187|NCT01402089|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92399188|NCT01402089|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92399189|NCT01402089|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92399190|NCT01402089|Purinergic Agents|purinergic agents|mesh-ancestor
92399191|NCT01402180|Nimotuzumab|nimotuzumab|mesh-list
92399192|NCT01402180|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92399193|NCT01402180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399194|NCT01402193|Anastrozole|anastrozole|mesh-list
92399195|NCT01402193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92399196|NCT01402193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399197|NCT01402193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92399198|NCT01402193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92072249|NCT02632708|Cytarabine|cytarabine|mesh-list
92399199|NCT01402193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399200|NCT01402193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399201|NCT01402193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92399202|NCT01402193|Hormone Antagonists|hormone antagonists|mesh-ancestor
92399203|NCT01402193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399204|NCT01402193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399205|NCT01402245|Vaccines|vaccines|mesh-list
92399206|NCT01402245|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92399207|NCT01402245|Immunologic Factors|immunologic factors|mesh-ancestor
92399208|NCT01402245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399209|NCT01402297|Acetovanillone|acetovanillone|mesh-list
92399210|NCT01402297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92399211|NCT01402297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92399212|NCT01402297|Analgesics|analgesics|mesh-ancestor
92399213|NCT01402297|Sensory System Agents|sensory system agents|mesh-ancestor
92072398|NCT02523976|Hormones|hormones|mesh-ancestor
92399214|NCT01402297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399215|NCT01402297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399216|NCT01402297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399217|NCT01402297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399218|NCT01402297|Antioxidants|antioxidants|mesh-ancestor
92399219|NCT01402297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399220|NCT01402297|Protective Agents|protective agents|mesh-ancestor
92399221|NCT01402297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399222|NCT01402336|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92399224|NCT01402336|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92399226|NCT01402336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072693|NCT01928134|Calcium|calcium|mesh-list
92399227|NCT01402336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399228|NCT01402336|Luteolytic Agents|luteolytic agents|mesh-ancestor
92072814|NCT04409691|Sirolimus|sirolimus|mesh-list
92399229|NCT01402336|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92399231|NCT01402336|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92399232|NCT01402336|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92399233|NCT01402336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92399234|NCT01402336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399235|NCT01402336|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92399236|NCT01402336|Fertility Agents|fertility agents|mesh-ancestor
92399237|NCT01402336|Hormone Antagonists|hormone antagonists|mesh-ancestor
92399238|NCT01402479|Ramipril|ramipril|mesh-list
92399239|NCT01402479|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92073028|NCT01810588|Mycophenolic Acid|mycophenolic acid|mesh-list
92399240|NCT01402479|Protease Inhibitors|protease inhibitors|mesh-ancestor
92399241|NCT01402479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399242|NCT01402479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073105|NCT01393522|Milnacipran|milnacipran|mesh-list
92399243|NCT01402479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92399244|NCT01402583|Ribavirin|ribavirin|mesh-list
92399245|NCT01402583|Antimetabolites|antimetabolites|mesh-ancestor
92399246|NCT01402583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399248|NCT01402583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399249|NCT01402596|Midazolam|midazolam|mesh-list
92399250|NCT01402596|Chloral Hydrate|chloral hydrate|mesh-list
92399251|NCT01402596|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92399252|NCT01402596|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92399253|NCT01402596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399254|NCT01402596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399255|NCT01402596|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92399256|NCT01402596|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399257|NCT01402596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399258|NCT01402596|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92399259|NCT01402596|Anesthetics, General|anesthetics, general|mesh-ancestor
92399260|NCT01402596|Anesthetics|anesthetics|mesh-ancestor
92399261|NCT01402596|GABA Modulators|gaba modulators|mesh-ancestor
92051604|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
92399262|NCT01402596|GABA Agents|gaba agents|mesh-ancestor
92399263|NCT01402596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073383|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399264|NCT01402596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399266|NCT01402622|Anesthetics|anesthetics|mesh-ancestor
92073584|NCT01479621|Xhance|xhance|mesh-list
92399267|NCT01402622|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399268|NCT01402622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399269|NCT01402622|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92399270|NCT01402622|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92399271|NCT01402622|Anesthetics, General|anesthetics, general|mesh-ancestor
92399272|NCT01402674|Phentermine|phentermine|mesh-list
92399273|NCT01402674|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92399274|NCT01402674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399275|NCT01402674|Appetite Depressants|appetite depressants|mesh-ancestor
92399276|NCT01402674|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92399277|NCT01402674|Sympathomimetics|sympathomimetics|mesh-ancestor
92399278|NCT01402674|Autonomic Agents|autonomic agents|mesh-ancestor
92399279|NCT01402674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399280|NCT01402674|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073684|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
92399281|NCT01402674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073754|NCT03364348|Tubulin Modulators|tubulin modulators|mesh-ancestor
92399282|NCT01402674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399284|NCT01402843|Pitavastatin|pitavastatin|mesh-list
92399285|NCT01402843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92399286|NCT01402843|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92399287|NCT01402843|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92073932|NCT04780984|Bromides|bromides|mesh-list
92399288|NCT01402843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399289|NCT01402843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92399290|NCT01402843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92399291|NCT01402843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92399292|NCT01402843|Antimetabolites|antimetabolites|mesh-ancestor
92399293|NCT01402843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399294|NCT01402843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92399306|NCT01403025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399308|NCT01403103|Cholecalciferol|cholecalciferol|mesh-list
92399309|NCT01403103|Vitamins|vitamins|mesh-ancestor
92399310|NCT01403103|Micronutrients|micronutrients|mesh-ancestor
92399311|NCT01403103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399312|NCT01403103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92399313|NCT01403103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92399314|NCT01403168|Analgesics|analgesics|mesh-list
92074347|NCT00078754|Serotonin Agents|serotonin agents|mesh-ancestor
92399315|NCT01403168|Sensory System Agents|sensory system agents|mesh-ancestor
92399316|NCT01403168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399317|NCT01403168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399319|NCT01403181|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92399320|NCT01403181|Antimetabolites|antimetabolites|mesh-ancestor
92399321|NCT01403181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399322|NCT01403181|Antiviral Agents|antiviral agents|mesh-ancestor
92399323|NCT01403181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399324|NCT01403259|Oxaliplatin|oxaliplatin|mesh-list
92399325|NCT01403259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399326|NCT01403285|Cyclophosphamide|cyclophosphamide|mesh-list
92399327|NCT01403285|Molgramostim|molgramostim|mesh-list
92399328|NCT01403285|Imiquimod|imiquimod|mesh-list
92399329|NCT01403285|Sargramostim|sargramostim|mesh-list
92399330|NCT01403285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399331|NCT01403285|Immunologic Factors|immunologic factors|mesh-ancestor
92399332|NCT01403285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399333|NCT01403285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399334|NCT01403285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92399335|NCT01403285|Alkylating Agents|alkylating agents|mesh-ancestor
92399336|NCT01403285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399337|NCT01403285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399338|NCT01403285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92399339|NCT01403285|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92399340|NCT01403285|Interferon Inducers|interferon inducers|mesh-ancestor
92399341|NCT01403363|Fentanyl|fentanyl|mesh-list
92399342|NCT01403363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92399343|NCT01403363|Narcotics|narcotics|mesh-ancestor
92399344|NCT01403363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399345|NCT01403363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399346|NCT01403363|Analgesics|analgesics|mesh-ancestor
92399347|NCT01403363|Sensory System Agents|sensory system agents|mesh-ancestor
92399348|NCT01403363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399349|NCT01403363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92399350|NCT01403363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92399351|NCT01403363|Anesthetics, General|anesthetics, general|mesh-ancestor
92399354|NCT01403389|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92399355|NCT01403389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399356|NCT01403389|Immunologic Factors|immunologic factors|mesh-ancestor
92399357|NCT01403389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399358|NCT01403415|Sirolimus|sirolimus|mesh-list
92399359|NCT01403415|Dexamethasone|dexamethasone|mesh-list
92399360|NCT01403415|Dexamethasone acetate|dexamethasone acetate|mesh-list
92399361|NCT01403415|Methotrexate|methotrexate|mesh-list
92399362|NCT01403415|Vincristine|vincristine|mesh-list
92399363|NCT01403415|Temsirolimus|temsirolimus|mesh-list
92399364|NCT01403415|Asparaginase|asparaginase|mesh-list
92399365|NCT01403415|Mitoxantrone|mitoxantrone|mesh-list
92399367|NCT01403415|MTOR Inhibitors|mtor inhibitors|mesh-list
92399369|NCT01403415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399370|NCT01403415|Antiemetics|antiemetics|mesh-ancestor
92399371|NCT01403415|Autonomic Agents|autonomic agents|mesh-ancestor
92399372|NCT01403415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399373|NCT01403415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938078|NCT05327426|Vaccines|vaccines|mesh-list
92399374|NCT01403415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399375|NCT01403415|Glucocorticoids|glucocorticoids|mesh-ancestor
92399377|NCT01403415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399378|NCT01403415|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92075622|NCT05619289|Vitamin D|vitamin d|mesh-list
92399379|NCT01403415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399380|NCT01403415|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92399381|NCT01403415|Abortifacient Agents|abortifacient agents|mesh-ancestor
92399382|NCT01403415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92399383|NCT01403415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399385|NCT01403415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399388|NCT01403415|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92399389|NCT01403415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399390|NCT01403415|Immunologic Factors|immunologic factors|mesh-ancestor
92399391|NCT01403415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075940|NCT05137119|Penicillin G|penicillin g|mesh-list
92399392|NCT01403415|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92399393|NCT01403415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92399394|NCT01403415|Tubulin Modulators|tubulin modulators|mesh-ancestor
92399395|NCT01403415|Antimitotic Agents|antimitotic agents|mesh-ancestor
92399396|NCT01403415|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399397|NCT01403415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399398|NCT01403415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399399|NCT01403415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92399400|NCT01403415|Antifungal Agents|antifungal agents|mesh-ancestor
92399401|NCT01403415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399402|NCT01403415|Protease Inhibitors|protease inhibitors|mesh-ancestor
92399403|NCT01403415|Analgesics|analgesics|mesh-ancestor
92399404|NCT01403415|Sensory System Agents|sensory system agents|mesh-ancestor
92399405|NCT01403415|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92399406|NCT01403415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92399408|NCT01403506|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92399409|NCT01403506|Antiviral Agents|antiviral agents|mesh-ancestor
92399410|NCT01403506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399411|NCT01403506|Expectorants|expectorants|mesh-ancestor
92399412|NCT01403506|Respiratory System Agents|respiratory system agents|mesh-ancestor
92399413|NCT01403506|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92399414|NCT01403506|Antioxidants|antioxidants|mesh-ancestor
92399415|NCT01403506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399416|NCT01403506|Protective Agents|protective agents|mesh-ancestor
92399417|NCT01403506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399419|NCT01403545|Curcumin|curcumin|mesh-list
92399420|NCT01403545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92399421|NCT01403545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92399422|NCT01403545|Analgesics|analgesics|mesh-ancestor
92399423|NCT01403545|Sensory System Agents|sensory system agents|mesh-ancestor
92399424|NCT01403545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399425|NCT01403545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399426|NCT01403545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076449|NCT04309552|Alovudine|alovudine|mesh-list
92399427|NCT01403545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399428|NCT01403545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399429|NCT01403545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399430|NCT01403545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399431|NCT01403662|Minocycline|minocycline|mesh-list
92399432|NCT01403662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92076525|NCT04117178|Nootropic Agents|nootropic agents|mesh-ancestor
92399433|NCT01403662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399434|NCT01403740|Cyclosporine|cyclosporine|mesh-list
92399435|NCT01403740|Rituximab|rituximab|mesh-list
92399436|NCT01403740|Azathioprine|azathioprine|mesh-list
92399437|NCT01403740|Cyclosporins|cyclosporins|mesh-list
92399438|NCT01403740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92399439|NCT01403740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399440|NCT01403740|Immunologic Factors|immunologic factors|mesh-ancestor
92399441|NCT01403740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399442|NCT01403740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399443|NCT01403740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399444|NCT01403740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115109|NCT01724021|Prednisolone|prednisolone|mesh-list
92399445|NCT01403740|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399446|NCT01403740|Antifungal Agents|antifungal agents|mesh-ancestor
92399447|NCT01403740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399448|NCT01403740|Dermatologic Agents|dermatologic agents|mesh-ancestor
92399449|NCT01403740|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92399451|NCT01403740|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399452|NCT01403818|Ipragliflozin|ipragliflozin|mesh-list
92399453|NCT01403818|Mitiglinide|mitiglinide|mesh-list
92399455|NCT01403818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92399456|NCT01403818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399457|NCT01403818|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92399458|NCT01403818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399459|NCT01403818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399460|NCT01403844|Carotenoids|carotenoids|mesh-list
92399461|NCT01403844|Antioxidants|antioxidants|mesh-ancestor
92399462|NCT01403844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399463|NCT01403844|Protective Agents|protective agents|mesh-ancestor
92399464|NCT01403844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399465|NCT01403896|Plerixafor|plerixafor|mesh-list
92399466|NCT01403896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92399467|NCT01403896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92399468|NCT01403896|Antiviral Agents|antiviral agents|mesh-ancestor
92399469|NCT01403896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399470|NCT01403948|BI 836826|bi 836826|mesh-list
92399471|NCT01403948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92399472|NCT01403948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399473|NCT01404000|Charcoal|charcoal|mesh-list
92399474|NCT01404000|Antidotes|antidotes|mesh-ancestor
92399475|NCT01404000|Protective Agents|protective agents|mesh-ancestor
92399476|NCT01404000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399477|NCT01404013|Montelukast|montelukast|mesh-list
92399478|NCT01404013|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92399479|NCT01404013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92399480|NCT01404013|Respiratory System Agents|respiratory system agents|mesh-ancestor
92399481|NCT01404013|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92399482|NCT01404013|Hormone Antagonists|hormone antagonists|mesh-ancestor
92399483|NCT01404013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399484|NCT01404013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399485|NCT01404013|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92399486|NCT01404013|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92399487|NCT01404013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399489|NCT01404104|Temsirolimus|temsirolimus|mesh-list
92051830|NCT02155985|Aspirin|aspirin|mesh-list
92399490|NCT01404104|MTOR Inhibitors|mtor inhibitors|mesh-list
92399491|NCT01404104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399493|NCT01404104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399494|NCT01404104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399495|NCT01404104|Immunologic Factors|immunologic factors|mesh-ancestor
92399496|NCT01404104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399497|NCT01404104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399498|NCT01404104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399499|NCT01404104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399500|NCT01404104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92399501|NCT01404104|Antifungal Agents|antifungal agents|mesh-ancestor
92399502|NCT01404117|Interferons|interferons|mesh-list
92399503|NCT01404117|Interferon-beta|interferon-beta|mesh-list
92399504|NCT01404117|Glatiramer Acetate|glatiramer acetate|mesh-list
92399505|NCT01404117|(T,G)-A-L|(t,g)-a-l|mesh-list
92399506|NCT01404117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399507|NCT01404117|Antiviral Agents|antiviral agents|mesh-ancestor
92399508|NCT01404117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399509|NCT01404117|Immunologic Factors|immunologic factors|mesh-ancestor
92399510|NCT01404117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399511|NCT01404117|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92399512|NCT01404117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399513|NCT01404117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399514|NCT01404130|Isotretinoin|isotretinoin|mesh-list
92399515|NCT01404130|Dermatologic Agents|dermatologic agents|mesh-ancestor
92399516|NCT01404156|Leucovorin|leucovorin|mesh-list
92399517|NCT01404156|Paclitaxel|paclitaxel|mesh-list
92399518|NCT01404156|Docetaxel|docetaxel|mesh-list
92399519|NCT01404156|Carboplatin|carboplatin|mesh-list
92399520|NCT01404156|Fluorouracil|fluorouracil|mesh-list
92399521|NCT01404156|Oxaliplatin|oxaliplatin|mesh-list
92399522|NCT01404156|Epirubicin|epirubicin|mesh-list
92399523|NCT01404156|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076988|NCT03138720|Paclitaxel|paclitaxel|mesh-list
92399524|NCT01404156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399525|NCT01404156|Tubulin Modulators|tubulin modulators|mesh-ancestor
92399526|NCT01404156|Antimitotic Agents|antimitotic agents|mesh-ancestor
92399527|NCT01404156|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399528|NCT01404156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399530|NCT01404156|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399531|NCT01404156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399532|NCT01404156|Immunologic Factors|immunologic factors|mesh-ancestor
92399533|NCT01404156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399534|NCT01404156|Antidotes|antidotes|mesh-ancestor
92399535|NCT01404156|Protective Agents|protective agents|mesh-ancestor
92399536|NCT01404156|Vitamin B Complex|vitamin b complex|mesh-ancestor
92399537|NCT01404156|Vitamins|vitamins|mesh-ancestor
92399538|NCT01404156|Micronutrients|micronutrients|mesh-ancestor
92399539|NCT01404156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92399540|NCT01404156|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92399541|NCT01404156|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92399542|NCT01404156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399543|NCT01404169|Donepezil|donepezil|mesh-list
92399544|NCT01404169|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92399545|NCT01404169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399546|NCT01404169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399547|NCT01404169|Cholinergic Agents|cholinergic agents|mesh-ancestor
92399548|NCT01404169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399549|NCT01404169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399550|NCT01404169|Nootropic Agents|nootropic agents|mesh-ancestor
92399551|NCT01404182|Vaccines|vaccines|mesh-list
92077292|NCT01718743|Ixazomib|ixazomib|mesh-list
92399552|NCT01404182|Immunologic Factors|immunologic factors|mesh-ancestor
92399553|NCT01404182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399554|NCT01404312|Pyridoxine|pyridoxine|mesh-list
92399555|NCT01404312|Pyridoxal|pyridoxal|mesh-list
92399556|NCT01404312|Vitamin B 6|vitamin b 6|mesh-list
92399557|NCT01404312|Isoniazid|isoniazid|mesh-list
92399558|NCT01404312|Rifapentine|rifapentine|mesh-list
92399559|NCT01404312|Vitamins|vitamins|mesh-ancestor
92399560|NCT01404312|Micronutrients|micronutrients|mesh-ancestor
92399561|NCT01404312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399562|NCT01404312|Vitamin B Complex|vitamin b complex|mesh-ancestor
92399563|NCT01404312|Antitubercular Agents|antitubercular agents|mesh-ancestor
92399564|NCT01404312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399565|NCT01404312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399566|NCT01404312|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92399567|NCT01404312|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92399568|NCT01404312|Antimetabolites|antimetabolites|mesh-ancestor
92399569|NCT01404312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399570|NCT01404312|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92077823|NCT01790828|Factor VIII|factor viii|mesh-list
92399571|NCT01404312|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92399574|NCT01404338|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92399575|NCT01404364|Triamcinolone|triamcinolone|mesh-list
92399576|NCT01404364|Chlorpromazine|chlorpromazine|mesh-list
92399577|NCT01404364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399579|NCT01404364|Hormones|hormones|mesh-ancestor
92399580|NCT01404364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399581|NCT01404364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932410|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92399582|NCT01404364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399583|NCT01404364|Antiemetics|antiemetics|mesh-ancestor
92399584|NCT01404364|Autonomic Agents|autonomic agents|mesh-ancestor
92399585|NCT01404364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399586|NCT01404364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399587|NCT01404364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92399588|NCT01404364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399589|NCT01404364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399590|NCT01404364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399591|NCT01404364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92399592|NCT01404364|Dopamine Agents|dopamine agents|mesh-ancestor
92399593|NCT01404364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399594|NCT01404377|Ropivacaine|ropivacaine|mesh-list
92399595|NCT01404377|Anesthetics, Local|anesthetics, local|mesh-ancestor
92399596|NCT01404377|Anesthetics|anesthetics|mesh-ancestor
92399597|NCT01404377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932411|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399598|NCT01404377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399599|NCT01404377|Sensory System Agents|sensory system agents|mesh-ancestor
92399600|NCT01404377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399601|NCT01404442|Midazolam|midazolam|mesh-list
92399602|NCT01404442|Ketamine|ketamine|mesh-list
92399603|NCT01404442|Analgesics|analgesics|mesh-ancestor
92399604|NCT01404442|Sensory System Agents|sensory system agents|mesh-ancestor
92399605|NCT01404442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399606|NCT01404442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399607|NCT01404442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92399608|NCT01404442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92078157|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
92399610|NCT01404442|Anesthetics|anesthetics|mesh-ancestor
92399611|NCT01404442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399612|NCT01404442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92399613|NCT01404442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92399614|NCT01404442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399615|NCT01404442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399616|NCT01404442|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92399617|NCT01404442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92399618|NCT01404442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92399619|NCT01404442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399620|NCT01404442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399621|NCT01404442|GABA Modulators|gaba modulators|mesh-ancestor
92399622|NCT01404442|GABA Agents|gaba agents|mesh-ancestor
92399623|NCT01404468|Lidocaine|lidocaine|mesh-list
92399624|NCT01404468|Anesthetics, Local|anesthetics, local|mesh-ancestor
92399625|NCT01404468|Anesthetics|anesthetics|mesh-ancestor
92399626|NCT01404468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078496|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
92399627|NCT01404468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399628|NCT01404468|Sensory System Agents|sensory system agents|mesh-ancestor
92399629|NCT01404468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399630|NCT01404468|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92399631|NCT01404468|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92399632|NCT01404468|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92399633|NCT01404468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92399634|NCT01404468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399636|NCT01404507|Anticoagulants|anticoagulants|mesh-ancestor
92399637|NCT01404507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92399638|NCT01404598|Naproxen|naproxen|mesh-list
92399639|NCT01404598|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
92399640|NCT01404598|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92399641|NCT01404598|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92399642|NCT01404598|Analgesics|analgesics|mesh-ancestor
92399643|NCT01404598|Sensory System Agents|sensory system agents|mesh-ancestor
92399644|NCT01404598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399645|NCT01404598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399646|NCT01404598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399647|NCT01404598|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399648|NCT01404598|Gout Suppressants|gout suppressants|mesh-ancestor
92399649|NCT01404598|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92399650|NCT01404598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399651|NCT01404598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399652|NCT01404598|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92399653|NCT01404637|Tamsulosin|tamsulosin|mesh-list
92399654|NCT01404637|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92399655|NCT01404637|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92399656|NCT01404637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92399657|NCT01404637|Adrenergic Agents|adrenergic agents|mesh-ancestor
92399658|NCT01404637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399659|NCT01404637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399660|NCT01404637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399661|NCT01404637|Urological Agents|urological agents|mesh-ancestor
92399662|NCT01404676|Glimepiride|glimepiride|mesh-list
92078778|NCT01522443|Hormones|hormones|mesh-ancestor
92399664|NCT01404676|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92399665|NCT01404676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399666|NCT01404676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399667|NCT01404676|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399668|NCT01404676|Immunologic Factors|immunologic factors|mesh-ancestor
92399669|NCT01404676|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92399670|NCT01404676|Protease Inhibitors|protease inhibitors|mesh-ancestor
92399671|NCT01404676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078906|NCT01466673|Contraceptive Agents|contraceptive agents|mesh-ancestor
92399672|NCT01404676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399674|NCT01404689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92399675|NCT01404689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399676|NCT01404689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399677|NCT01404689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92399678|NCT01404689|Analgesics|analgesics|mesh-ancestor
92399679|NCT01404689|Sensory System Agents|sensory system agents|mesh-ancestor
92399680|NCT01404689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399681|NCT01404689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92078975|NCT01465659|Temozolomide|temozolomide|mesh-list
92079036|NCT01519791|Methotrexate|methotrexate|mesh-list
92399682|NCT01404689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92399683|NCT01404689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92399684|NCT01404689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92399685|NCT01404689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399686|NCT01404689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399687|NCT01404702|Zoledronic Acid|zoledronic acid|mesh-list
92399688|NCT01404702|Aldesleukin|aldesleukin|mesh-list
92399689|NCT01404702|Interleukin-2|interleukin-2|mesh-list
92399690|NCT01404702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399691|NCT01404702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92399692|NCT01404702|Analgesics|analgesics|mesh-ancestor
92399693|NCT01404702|Sensory System Agents|sensory system agents|mesh-ancestor
92399694|NCT01404702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399695|NCT01404702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399696|NCT01404702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92399697|NCT01404702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92399698|NCT01404702|Antiviral Agents|antiviral agents|mesh-ancestor
92399699|NCT01404702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399700|NCT01404702|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92399701|NCT01404715|Metformin|metformin|mesh-list
92399702|NCT01404715|Imatinib Mesylate|imatinib mesylate|mesh-list
92399703|NCT01404715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399704|NCT01404715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399705|NCT01404715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399706|NCT01404715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399707|NCT01404715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399708|NCT01404715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399709|NCT01404741|Azacitidine|azacitidine|mesh-list
92399710|NCT01404741|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399711|NCT01404741|Antimetabolites|antimetabolites|mesh-ancestor
92399712|NCT01404741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399713|NCT01404741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399714|NCT01404741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399717|NCT01404767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92399718|NCT01404767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92399719|NCT01404767|Sympatholytics|sympatholytics|mesh-ancestor
92399720|NCT01404767|Autonomic Agents|autonomic agents|mesh-ancestor
92399721|NCT01404767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399722|NCT01404767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399723|NCT01404767|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92399724|NCT01404767|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92399725|NCT01404767|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92399726|NCT01404767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92399727|NCT01404767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399728|NCT01404767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399729|NCT01404793|Rocuronium|rocuronium|mesh-list
92399730|NCT01404793|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92079854|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92399731|NCT01404793|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92399732|NCT01404793|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92399733|NCT01404793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399734|NCT01404793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399736|NCT01404806|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92399737|NCT01404806|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92399738|NCT01404806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079999|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92399739|NCT01404806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399741|NCT01404806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92399742|NCT01404806|Antiviral Agents|antiviral agents|mesh-ancestor
92399743|NCT01404806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399744|NCT01404819|Anesthetics|anesthetics|mesh-list
92399745|NCT01404819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399746|NCT01404819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399747|NCT01404871|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92399749|NCT01404871|Escitalopram|escitalopram|mesh-list
92399750|NCT01404871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92399751|NCT01404871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92399752|NCT01404871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92399753|NCT01404871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399754|NCT01404871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399755|NCT01404871|Serotonin Agents|serotonin agents|mesh-ancestor
92399756|NCT01404871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080295|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
92399757|NCT01404871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399759|NCT01404871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399760|NCT01404871|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92399761|NCT01404871|Analgesics|analgesics|mesh-ancestor
92399762|NCT01404871|Sensory System Agents|sensory system agents|mesh-ancestor
92399763|NCT01404871|Dopamine Agents|dopamine agents|mesh-ancestor
92399764|NCT01404871|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92399765|NCT01405079|Vinorelbine|vinorelbine|mesh-list
92399766|NCT01405079|Gefitinib|gefitinib|mesh-list
92399767|NCT01405079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399768|NCT01405079|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92399769|NCT01405079|Tubulin Modulators|tubulin modulators|mesh-ancestor
92399770|NCT01405079|Antimitotic Agents|antimitotic agents|mesh-ancestor
92399771|NCT01405079|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399772|NCT01405079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399773|NCT01405079|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399774|NCT01405079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399776|NCT01405118|Tofacitinib|tofacitinib|mesh-list
92399777|NCT01405118|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92399778|NCT01405118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399779|NCT01405118|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92399780|NCT01405118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399781|NCT01405118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399782|NCT01405118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399783|NCT01405131|Methylprednisolone|methylprednisolone|mesh-list
92399784|NCT01405131|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92399785|NCT01405131|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92399786|NCT01405131|Prednisolone|prednisolone|mesh-list
92399787|NCT01405131|Prednisolone acetate|prednisolone acetate|mesh-list
92399788|NCT01405131|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92399789|NCT01405131|Prednisolone phosphate|prednisolone phosphate|mesh-list
92399790|NCT01405131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399791|NCT01405131|Antiemetics|antiemetics|mesh-ancestor
92399792|NCT01405131|Autonomic Agents|autonomic agents|mesh-ancestor
92052123|NCT02176421|Lidocaine|lidocaine|mesh-list
92399793|NCT01405131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399794|NCT01405131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080890|NCT01411215|Etanercept|etanercept|mesh-list
92399795|NCT01405131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399796|NCT01405131|Glucocorticoids|glucocorticoids|mesh-ancestor
92399797|NCT01405131|Hormones|hormones|mesh-ancestor
92399798|NCT01405131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399799|NCT01405131|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92399800|NCT01405131|Protective Agents|protective agents|mesh-ancestor
92399801|NCT01405131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92399802|NCT01405131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399803|NCT01405144|Fluorouracil|fluorouracil|mesh-list
92399804|NCT01405144|Antimetabolites|antimetabolites|mesh-ancestor
92399805|NCT01405144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399806|NCT01405144|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92399807|NCT01405144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399808|NCT01405144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399809|NCT01405144|Immunologic Factors|immunologic factors|mesh-ancestor
92399810|NCT01405144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399811|NCT01405157|Methylprednisolone|methylprednisolone|mesh-list
92399812|NCT01405157|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92399813|NCT01405157|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92399814|NCT01405157|Prednisolone|prednisolone|mesh-list
92399815|NCT01405157|Prednisolone acetate|prednisolone acetate|mesh-list
92399816|NCT01405157|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92399817|NCT01405157|Prednisolone phosphate|prednisolone phosphate|mesh-list
92399818|NCT01405157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399819|NCT01405157|Antiemetics|antiemetics|mesh-ancestor
92399820|NCT01405157|Autonomic Agents|autonomic agents|mesh-ancestor
92399821|NCT01405157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399822|NCT01405157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399823|NCT01405157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399824|NCT01405157|Glucocorticoids|glucocorticoids|mesh-ancestor
91932412|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399826|NCT01405157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399827|NCT01405157|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92399828|NCT01405157|Protective Agents|protective agents|mesh-ancestor
92399829|NCT01405157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92399830|NCT01405157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399831|NCT01405170|Methylprednisolone|methylprednisolone|mesh-list
92399832|NCT01405170|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92399833|NCT01405170|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92399834|NCT01405170|Prednisolone|prednisolone|mesh-list
92399835|NCT01405170|Prednisolone acetate|prednisolone acetate|mesh-list
92399836|NCT01405170|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92399837|NCT01405170|Prednisolone phosphate|prednisolone phosphate|mesh-list
92399838|NCT01405170|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399839|NCT01405170|Antiemetics|antiemetics|mesh-ancestor
92399840|NCT01405170|Autonomic Agents|autonomic agents|mesh-ancestor
92399841|NCT01405170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399842|NCT01405170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399843|NCT01405170|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92399844|NCT01405170|Glucocorticoids|glucocorticoids|mesh-ancestor
92399845|NCT01405170|Hormones|hormones|mesh-ancestor
92399846|NCT01405170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399847|NCT01405170|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92399848|NCT01405170|Protective Agents|protective agents|mesh-ancestor
92399849|NCT01405170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92399850|NCT01405170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399851|NCT01405235|Paclitaxel|paclitaxel|mesh-list
92399852|NCT01405235|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92399853|NCT01405235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92399854|NCT01405235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399855|NCT01405235|Tubulin Modulators|tubulin modulators|mesh-ancestor
92399856|NCT01405235|Antimitotic Agents|antimitotic agents|mesh-ancestor
92399857|NCT01405235|Mitosis Modulators|mitosis modulators|mesh-ancestor
92399858|NCT01405235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082347|NCT01394991|Hematinics|hematinics|mesh-ancestor
92399859|NCT01405248|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92399860|NCT01405248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92399861|NCT01405248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92399862|NCT01405248|Protective Agents|protective agents|mesh-ancestor
92399863|NCT01405248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399864|NCT01405326|Adalimumab|adalimumab|mesh-list
92399865|NCT01405326|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92399866|NCT01405326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399867|NCT01405326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399868|NCT01405339|Budesonide|budesonide|mesh-list
92399869|NCT01405339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399870|NCT01405339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92399871|NCT01405339|Autonomic Agents|autonomic agents|mesh-ancestor
92399872|NCT01405339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399873|NCT01405339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399874|NCT01405339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92399875|NCT01405339|Respiratory System Agents|respiratory system agents|mesh-ancestor
92399876|NCT01405339|Glucocorticoids|glucocorticoids|mesh-ancestor
92399877|NCT01405339|Hormones|hormones|mesh-ancestor
92399878|NCT01405339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399879|NCT01405352|Vitamin A|vitamin a|mesh-list
92399880|NCT01405352|Vitamins|vitamins|mesh-ancestor
92399881|NCT01405352|Micronutrients|micronutrients|mesh-ancestor
92399882|NCT01405352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399883|NCT01405365|Metronidazole|metronidazole|mesh-list
92399884|NCT01405365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399885|NCT01405365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399886|NCT01405365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92399887|NCT01405365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92399888|NCT01405430|Bevacizumab|bevacizumab|mesh-list
92399889|NCT01405430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92399890|NCT01405430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399891|NCT01405430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92399892|NCT01405430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92399893|NCT01405430|Growth Substances|growth substances|mesh-ancestor
92399894|NCT01405430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399895|NCT01405430|Growth Inhibitors|growth inhibitors|mesh-ancestor
92399897|NCT01405482|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92399898|NCT01405482|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92136486|NCT00525603|Rituximab|rituximab|mesh-list
92399899|NCT01405482|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92399900|NCT01405482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91932413|NCT02220803|Diuretics|diuretics|mesh-ancestor
92399901|NCT01405482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399902|NCT01405482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92399903|NCT01405482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399904|NCT01405482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399905|NCT01405482|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92399906|NCT01405482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399907|NCT01405573|Sorafenib|sorafenib|mesh-list
92399908|NCT01405573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399909|NCT01405573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399910|NCT01405573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399911|NCT01405573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399912|NCT01405612|Midazolam|midazolam|mesh-list
92399913|NCT01405612|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92399914|NCT01405612|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92399915|NCT01405612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92399916|NCT01405612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399917|NCT01405612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92399918|NCT01405612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92399919|NCT01405612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92399920|NCT01405612|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92399921|NCT01405612|Anesthetics, General|anesthetics, general|mesh-ancestor
92399922|NCT01405612|Anesthetics|anesthetics|mesh-ancestor
92399923|NCT01405612|GABA Modulators|gaba modulators|mesh-ancestor
92399924|NCT01405612|GABA Agents|gaba agents|mesh-ancestor
92399925|NCT01405612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92399926|NCT01405612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399927|NCT01405807|Alemtuzumab|alemtuzumab|mesh-list
92399928|NCT01405807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92399929|NCT01405807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399931|NCT01405846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399932|NCT01405846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92399933|NCT01405846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399934|NCT01405846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399935|NCT01405872|Interferon beta-1a|interferon beta-1a|mesh-list
92399936|NCT01405872|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92399937|NCT01405872|Immunologic Factors|immunologic factors|mesh-ancestor
92399938|NCT01405872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399939|NCT01405872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399940|NCT01405872|Antiviral Agents|antiviral agents|mesh-ancestor
92399941|NCT01405872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399942|NCT01405989|Ketoconazole|ketoconazole|mesh-list
92399943|NCT01405989|Darexaban|darexaban|mesh-list
92399944|NCT01405989|Antifungal Agents|antifungal agents|mesh-ancestor
92399945|NCT01405989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92399946|NCT01405989|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92399947|NCT01405989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92399948|NCT01405989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399949|NCT01405989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399950|NCT01405989|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92399951|NCT01405989|Hormone Antagonists|hormone antagonists|mesh-ancestor
92399952|NCT01405989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92399953|NCT01405989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083140|NCT04199169|Vaccines|vaccines|mesh-list
92399954|NCT01405989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92399955|NCT01405989|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92399956|NCT01405989|Antithrombins|antithrombins|mesh-ancestor
92399957|NCT01405989|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92399958|NCT01405989|Protease Inhibitors|protease inhibitors|mesh-ancestor
92399959|NCT01405989|Anticoagulants|anticoagulants|mesh-ancestor
92399960|NCT01406002|Rifampin|rifampin|mesh-list
92399961|NCT01406002|Darexaban|darexaban|mesh-list
92399962|NCT01406002|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92399963|NCT01406002|Antitubercular Agents|antitubercular agents|mesh-ancestor
92399964|NCT01406002|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92399965|NCT01406002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016554|NCT04977427|Hormones|hormones|mesh-ancestor
92399966|NCT01406002|Leprostatic Agents|leprostatic agents|mesh-ancestor
92399967|NCT01406002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92399968|NCT01406002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399969|NCT01406002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136487|NCT00525603|Fludarabine|fludarabine|mesh-list
92399970|NCT01406002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92399971|NCT01406002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92399972|NCT01406002|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92399973|NCT01406002|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92399974|NCT01406002|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92399975|NCT01406002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92399976|NCT01406002|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92399977|NCT01406002|Antithrombins|antithrombins|mesh-ancestor
92399978|NCT01406002|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92399979|NCT01406002|Protease Inhibitors|protease inhibitors|mesh-ancestor
92399980|NCT01406002|Anticoagulants|anticoagulants|mesh-ancestor
92399981|NCT01406080|Adapalene|adapalene|mesh-list
92399982|NCT01406080|Tretinoin|tretinoin|mesh-list
92399983|NCT01406080|Emollients|emollients|mesh-list
92399984|NCT01406080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92399985|NCT01406080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92399987|NCT01406080|Sensory System Agents|sensory system agents|mesh-ancestor
92399988|NCT01406080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92399989|NCT01406080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92399990|NCT01406080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92399991|NCT01406080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92399992|NCT01406080|Dermatologic Agents|dermatologic agents|mesh-ancestor
92399993|NCT01406080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92399994|NCT01406080|Keratolytic Agents|keratolytic agents|mesh-ancestor
92399995|NCT01406132|Peficitinib|peficitinib|mesh-list
92399996|NCT01406132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92399997|NCT01406132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92399998|NCT01406132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92399999|NCT01406132|Immunologic Factors|immunologic factors|mesh-ancestor
92400000|NCT01406132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400001|NCT01406158|Solifenacin Succinate|solifenacin succinate|mesh-list
92083594|NCT01798030|Vitamin D|vitamin d|mesh-list
92400002|NCT01406158|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92400003|NCT01406158|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92400004|NCT01406158|Cholinergic Agents|cholinergic agents|mesh-ancestor
92400005|NCT01406158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400006|NCT01406158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400007|NCT01406158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400008|NCT01406158|Urological Agents|urological agents|mesh-ancestor
92400009|NCT01406171|Isavuconazole|isavuconazole|mesh-list
92400011|NCT01406171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92400012|NCT01406171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92400013|NCT01406171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400014|NCT01406171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052347|NCT02062658|Anesthetics|anesthetics|mesh-ancestor
92400015|NCT01406171|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92400016|NCT01406171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92400017|NCT01406171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92400018|NCT01406171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92400019|NCT01406171|Anesthetics, General|anesthetics, general|mesh-ancestor
92400020|NCT01406171|Anesthetics|anesthetics|mesh-ancestor
92400021|NCT01406171|GABA Modulators|gaba modulators|mesh-ancestor
92400022|NCT01406171|GABA Agents|gaba agents|mesh-ancestor
92400023|NCT01406171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400024|NCT01406171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400025|NCT01406171|Antifungal Agents|antifungal agents|mesh-ancestor
92400026|NCT01406171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400027|NCT01406262|Moxifloxacin|moxifloxacin|mesh-list
92400028|NCT01406262|rGLP-1 protein|rglp-1 protein|mesh-list
92084117|NCT01802437|Serotonin Agents|serotonin agents|mesh-ancestor
92400029|NCT01406262|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92400030|NCT01406262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400031|NCT01406262|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92400032|NCT01406262|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92400033|NCT01406262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400034|NCT01406262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400035|NCT01406262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400036|NCT01406262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400037|NCT01406262|Incretins|incretins|mesh-ancestor
92400038|NCT01406262|Hormones|hormones|mesh-ancestor
92400039|NCT01406262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400040|NCT01406275|Amoxicillin|amoxicillin|mesh-list
92400041|NCT01406275|Clavulanic Acid|clavulanic acid|mesh-list
92400042|NCT01406275|Clavulanic Acids|clavulanic acids|mesh-list
92052339|NCT02062658|Ketamine|ketamine|mesh-list
92400043|NCT01406275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92400044|NCT01406275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400045|NCT01406275|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92400046|NCT01406275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400047|NCT01406275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400048|NCT01406301|PENTA|penta|mesh-list
92400049|NCT01406301|Fondaparinux|fondaparinux|mesh-list
92400050|NCT01406301|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92400051|NCT01406301|Antithrombins|antithrombins|mesh-ancestor
92016701|NCT02504541|Testosterone|testosterone|mesh-list
92400052|NCT01406301|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92400053|NCT01406301|Protease Inhibitors|protease inhibitors|mesh-ancestor
92400054|NCT01406301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400055|NCT01406301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400056|NCT01406301|Anticoagulants|anticoagulants|mesh-ancestor
92400057|NCT01406301|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92400058|NCT01406301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92400059|NCT01406327|Ambrisentan|ambrisentan|mesh-list
92400060|NCT01406327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400061|NCT01406392|Misoprostol|misoprostol|mesh-list
92400062|NCT01406392|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92400063|NCT01406392|Abortifacient Agents|abortifacient agents|mesh-ancestor
92400064|NCT01406392|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92400065|NCT01406392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400066|NCT01406392|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92400067|NCT01406392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400069|NCT01406431|Valsartan|valsartan|mesh-list
92400070|NCT01406431|Pitavastatin|pitavastatin|mesh-list
92400071|NCT01406431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400072|NCT01406431|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92400073|NCT01406431|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92400074|NCT01406431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400075|NCT01406431|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92400076|NCT01406431|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92400077|NCT01406431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92400078|NCT01406431|Antimetabolites|antimetabolites|mesh-ancestor
92400079|NCT01406431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400080|NCT01406431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92400081|NCT01406470|Immunoglobulins|immunoglobulins|mesh-list
92400082|NCT01406470|Antibodies|antibodies|mesh-list
92400083|NCT01406470|gamma-Globulins|gamma-globulins|mesh-list
92400084|NCT01406470|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92400085|NCT01406470|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92400086|NCT01406470|Immunoglobulin G|immunoglobulin g|mesh-list
92400087|NCT01406470|Immunologic Factors|immunologic factors|mesh-ancestor
92400088|NCT01406470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400089|NCT01406496|Insulin|insulin|mesh-list
92400090|NCT01406496|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92400091|NCT01406496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92400092|NCT01406496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400093|NCT01406522|Tacrine|tacrine|mesh-list
92400094|NCT01406522|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92400095|NCT01406522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400096|NCT01406522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084989|NCT00693160|Ketorolac|ketorolac|mesh-list
92400098|NCT01406522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400099|NCT01406522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400100|NCT01406522|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92400101|NCT01406522|Autonomic Agents|autonomic agents|mesh-ancestor
92400102|NCT01406522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400103|NCT01406522|Nootropic Agents|nootropic agents|mesh-ancestor
92400104|NCT01406535|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92400105|NCT01406535|Vasodilator Agents|vasodilator agents|mesh-ancestor
92400106|NCT01406535|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92085131|NCT01839487|Dexamethasone|dexamethasone|mesh-list
92400107|NCT01406535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92400108|NCT01406535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400109|NCT01406535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400110|NCT01406535|Urological Agents|urological agents|mesh-ancestor
92400111|NCT01406600|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92400112|NCT01406600|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92400113|NCT01406600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400115|NCT01406639|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92400116|NCT01406639|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92400117|NCT01406639|Growth Substances|growth substances|mesh-ancestor
92085289|NCT02999776|Etanercept|etanercept|mesh-list
92400118|NCT01406639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400119|NCT01406639|Growth Inhibitors|growth inhibitors|mesh-ancestor
92400120|NCT01406639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400122|NCT01406704|Rosiglitazone|rosiglitazone|mesh-list
92400123|NCT01406704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92400124|NCT01406704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400125|NCT01406704|Antioxidants|antioxidants|mesh-ancestor
92400126|NCT01406704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400127|NCT01406704|Protective Agents|protective agents|mesh-ancestor
92400128|NCT01406704|Vitamin B Complex|vitamin b complex|mesh-ancestor
92400129|NCT01406704|Vitamins|vitamins|mesh-ancestor
92400130|NCT01406704|Micronutrients|micronutrients|mesh-ancestor
92400131|NCT01406782|Rituximab|rituximab|mesh-list
92400132|NCT01406782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085580|NCT01838941|Betaine|betaine|mesh-list
92400133|NCT01406782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400134|NCT01406782|Immunologic Factors|immunologic factors|mesh-ancestor
92400135|NCT01406782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400136|NCT01406782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400137|NCT01407016|Metronidazole|metronidazole|mesh-list
92400138|NCT01407016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400139|NCT01407016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92400140|NCT01407016|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92400141|NCT01407016|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92400142|NCT01407211|Vitamin A|vitamin a|mesh-list
92400143|NCT01407211|Vitamins|vitamins|mesh-ancestor
92400144|NCT01407211|Micronutrients|micronutrients|mesh-ancestor
92400145|NCT01407211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400146|NCT01407237|Angiotensin II|angiotensin ii|mesh-list
92400147|NCT01407237|Giapreza|giapreza|mesh-list
92400148|NCT01407237|Angiotensinogen|angiotensinogen|mesh-list
92400149|NCT01407237|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92400150|NCT01407237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92400151|NCT01407237|Protease Inhibitors|protease inhibitors|mesh-ancestor
92400152|NCT01407237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400153|NCT01407237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400154|NCT01407289|Insulin|insulin|mesh-list
92400155|NCT01407289|Insulin Glargine|insulin glargine|mesh-list
92400156|NCT01407289|Insulin Aspart|insulin aspart|mesh-list
92400157|NCT01407289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92400158|NCT01407289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400159|NCT01407432|Folic Acid|folic acid|mesh-list
92400161|NCT01407432|Hematinics|hematinics|mesh-ancestor
92400163|NCT01407432|Micronutrients|micronutrients|mesh-ancestor
92400164|NCT01407432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400165|NCT01407471|Clobetasol|clobetasol|mesh-list
92400166|NCT01407471|Spironolactone|spironolactone|mesh-list
91932414|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
92400167|NCT01407471|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92400168|NCT01407471|Hormone Antagonists|hormone antagonists|mesh-ancestor
92400169|NCT01407471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400170|NCT01407471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400171|NCT01407471|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92400172|NCT01407471|Diuretics|diuretics|mesh-ancestor
92400173|NCT01407471|Natriuretic Agents|natriuretic agents|mesh-ancestor
92400174|NCT01407471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400175|NCT01407471|Glucocorticoids|glucocorticoids|mesh-ancestor
92400176|NCT01407471|Hormones|hormones|mesh-ancestor
92400178|NCT01407484|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400179|NCT01407484|Glucocorticoids|glucocorticoids|mesh-ancestor
92400180|NCT01407484|Hormones|hormones|mesh-ancestor
92400181|NCT01407484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400182|NCT01407484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400183|NCT01407484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92400184|NCT01407484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400185|NCT01407497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92400187|NCT01407679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400188|NCT01407679|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400189|NCT01407822|Cisplatin|cisplatin|mesh-list
92400190|NCT01407822|Gemcitabine|gemcitabine|mesh-list
92400191|NCT01407822|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92400192|NCT01407822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086270|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92400193|NCT01407822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92400194|NCT01407822|Antimetabolites|antimetabolites|mesh-ancestor
92400195|NCT01407822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400196|NCT01407822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400197|NCT01407822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400198|NCT01407848|Furosemide|furosemide|mesh-list
92400199|NCT01407848|Diuretics|diuretics|mesh-ancestor
92400200|NCT01407848|Natriuretic Agents|natriuretic agents|mesh-ancestor
92400201|NCT01407848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400202|NCT01407848|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92400203|NCT01407848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400204|NCT01407848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400205|NCT01407887|Artesunate|artesunate|mesh-list
92400206|NCT01407887|Amodiaquine|amodiaquine|mesh-list
92400207|NCT01407887|Methylene Blue|methylene blue|mesh-list
92400208|NCT01407887|Antimalarials|antimalarials|mesh-ancestor
92400209|NCT01407887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92400210|NCT01407887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92400211|NCT01407887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400212|NCT01407887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400213|NCT01407887|Antiviral Agents|antiviral agents|mesh-ancestor
92400214|NCT01407887|Schistosomicides|schistosomicides|mesh-ancestor
92400215|NCT01407887|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92400216|NCT01407887|Anthelmintics|anthelmintics|mesh-ancestor
92400217|NCT01407887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400218|NCT01407887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400219|NCT01408004|Everolimus|everolimus|mesh-list
92400220|NCT01408004|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92400221|NCT01408004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400222|NCT01408004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400223|NCT01408004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400224|NCT01408004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400225|NCT01408004|Immunologic Factors|immunologic factors|mesh-ancestor
92400226|NCT01408004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086563|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
92400227|NCT01408004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400229|NCT01408056|Timolol|timolol|mesh-list
92400230|NCT01408056|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92400231|NCT01408056|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92400232|NCT01408056|Adrenergic Agents|adrenergic agents|mesh-ancestor
92400233|NCT01408056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400234|NCT01408056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400235|NCT01408056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400236|NCT01408056|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92400237|NCT01408056|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400238|NCT01408056|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92400239|NCT01408056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400240|NCT01408056|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92400241|NCT01408056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400243|NCT01408095|Globalagliatin|globalagliatin|mesh-list
92400244|NCT01408095|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92400245|NCT01408095|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92400246|NCT01408095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400247|NCT01408095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400248|NCT01408095|Immunologic Factors|immunologic factors|mesh-ancestor
92400249|NCT01408095|Enzyme Activators|enzyme activators|mesh-ancestor
92400250|NCT01408095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400251|NCT01408160|Cytarabine|cytarabine|mesh-list
92400252|NCT01408160|Immunotoxins|immunotoxins|mesh-list
92400253|NCT01408160|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92400254|NCT01408160|Antimetabolites|antimetabolites|mesh-ancestor
92400255|NCT01408160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400256|NCT01408160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400257|NCT01408160|Antiviral Agents|antiviral agents|mesh-ancestor
92400258|NCT01408160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400259|NCT01408160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400260|NCT01408160|Immunologic Factors|immunologic factors|mesh-ancestor
92400261|NCT01408160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400262|NCT01408160|Immunoconjugates|immunoconjugates|mesh-ancestor
92400263|NCT01408173|Caffeine|caffeine|mesh-list
92400264|NCT01408173|Caffeine citrate|caffeine citrate|mesh-list
91932415|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400265|NCT01408173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400266|NCT01408173|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92400267|NCT01408173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400268|NCT01408173|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92400269|NCT01408173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400270|NCT01408173|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92400271|NCT01408173|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92400272|NCT01408173|Purinergic Agents|purinergic agents|mesh-ancestor
92400273|NCT01408173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400274|NCT01408186|Rabeprazole|rabeprazole|mesh-list
92400275|NCT01408186|Famotidine|famotidine|mesh-list
92400276|NCT01408186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92400277|NCT01408186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400278|NCT01408186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92400279|NCT01408186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400280|NCT01408186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400281|NCT01408186|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92400282|NCT01408186|Histamine Antagonists|histamine antagonists|mesh-ancestor
92400283|NCT01408186|Histamine Agents|histamine agents|mesh-ancestor
92400284|NCT01408186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400285|NCT01408186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400286|NCT01408199|Lenalidomide|lenalidomide|mesh-list
92400287|NCT01408199|Immunologic Factors|immunologic factors|mesh-ancestor
92400288|NCT01408199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400289|NCT01408199|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92400290|NCT01408199|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92400291|NCT01408199|Growth Substances|growth substances|mesh-ancestor
92400293|NCT01408199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400294|NCT01408342|Rituximab|rituximab|mesh-list
92400295|NCT01408342|Alemtuzumab|alemtuzumab|mesh-list
92400296|NCT01408342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92400297|NCT01408342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400298|NCT01408342|Immunologic Factors|immunologic factors|mesh-ancestor
92400299|NCT01408342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400300|NCT01408342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400301|NCT01408394|Ecopipam|ecopipam|mesh-list
92400302|NCT01408394|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92400303|NCT01408394|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92400304|NCT01408394|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400305|NCT01408394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400306|NCT01408394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92400307|NCT01408394|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92400308|NCT01408394|Dopamine Agents|dopamine agents|mesh-ancestor
92400309|NCT01408394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400310|NCT01408394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400311|NCT01408446|Menthol|menthol|mesh-list
92400312|NCT01408446|Antipruritics|antipruritics|mesh-ancestor
92400313|NCT01408446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400314|NCT01408498|Testosterone|testosterone|mesh-list
92400315|NCT01408498|Androgens|androgens|mesh-ancestor
92400316|NCT01408498|Hormones|hormones|mesh-ancestor
92400317|NCT01408498|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400318|NCT01408498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400319|NCT01408524|Diltiazem|diltiazem|mesh-list
92400320|NCT01408524|Labetalol|labetalol|mesh-list
92400321|NCT01408524|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400322|NCT01408524|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92400323|NCT01408524|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400324|NCT01408524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400325|NCT01408524|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92400326|NCT01408524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400327|NCT01408524|Vasodilator Agents|vasodilator agents|mesh-ancestor
92400328|NCT01408524|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92400329|NCT01408524|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92400330|NCT01408524|Adrenergic Agents|adrenergic agents|mesh-ancestor
92400331|NCT01408524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400332|NCT01408524|Sympathomimetics|sympathomimetics|mesh-ancestor
92400333|NCT01408524|Autonomic Agents|autonomic agents|mesh-ancestor
92400334|NCT01408524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400335|NCT01408524|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92400336|NCT01408524|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92400337|NCT01408589|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92400338|NCT01408589|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91932416|NCT04972123|Phenylephrine|phenylephrine|mesh-list
92400339|NCT01408589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92400340|NCT01408589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400341|NCT01408589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400342|NCT01408589|Adrenergic Agents|adrenergic agents|mesh-ancestor
92400343|NCT01408589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400344|NCT01408589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400345|NCT01408680|Ubiquinone|ubiquinone|mesh-list
92400346|NCT01408680|Coenzyme Q10|coenzyme q10|mesh-list
92400347|NCT01408680|Micronutrients|micronutrients|mesh-ancestor
92400348|NCT01408680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400349|NCT01408680|Vitamins|vitamins|mesh-ancestor
92400350|NCT01408797|Bortezomib|bortezomib|mesh-list
92400351|NCT01408797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400352|NCT01408810|Infliximab|infliximab|mesh-list
92400353|NCT01408810|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92400354|NCT01408810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400355|NCT01408810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400356|NCT01408810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400357|NCT01408810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400358|NCT01408836|Prednisolone|prednisolone|mesh-list
92400359|NCT01408836|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92400360|NCT01408836|Methylprednisolone|methylprednisolone|mesh-list
92400361|NCT01408836|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92400362|NCT01408836|Prednisolone acetate|prednisolone acetate|mesh-list
92400363|NCT01408836|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92400364|NCT01408836|Prednisolone phosphate|prednisolone phosphate|mesh-list
92400365|NCT01408836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400366|NCT01408836|Glucocorticoids|glucocorticoids|mesh-ancestor
92400367|NCT01408836|Hormones|hormones|mesh-ancestor
92400368|NCT01408836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400369|NCT01408836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400370|NCT01408836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92400371|NCT01408836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400372|NCT01408836|Antiemetics|antiemetics|mesh-ancestor
92400373|NCT01408836|Autonomic Agents|autonomic agents|mesh-ancestor
92400374|NCT01408836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400375|NCT01408836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400376|NCT01408836|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92400377|NCT01408836|Protective Agents|protective agents|mesh-ancestor
92400378|NCT01408849|Omeprazole|omeprazole|mesh-list
92400379|NCT01408849|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92400380|NCT01408849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400381|NCT01408849|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92400382|NCT01408849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400383|NCT01408849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400384|NCT01408927|Aspirin|aspirin|mesh-list
92400385|NCT01408927|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92400386|NCT01408927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92400387|NCT01408927|Analgesics|analgesics|mesh-ancestor
92400388|NCT01408927|Sensory System Agents|sensory system agents|mesh-ancestor
92400389|NCT01408927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400390|NCT01408927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400391|NCT01408927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400392|NCT01408927|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400393|NCT01408927|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92400394|NCT01408927|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91932417|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
92400395|NCT01408927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400396|NCT01408927|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92400397|NCT01408927|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92400398|NCT01408927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400399|NCT01408927|Antipyretics|antipyretics|mesh-ancestor
92400400|NCT01408953|Bevacizumab|bevacizumab|mesh-list
92400401|NCT01408953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92400402|NCT01408953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400403|NCT01408953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92400404|NCT01408953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92400405|NCT01408953|Growth Substances|growth substances|mesh-ancestor
92400406|NCT01408953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400407|NCT01408953|Growth Inhibitors|growth inhibitors|mesh-ancestor
92400408|NCT01408979|Magnesium Sulfate|magnesium sulfate|mesh-list
92400410|NCT01408979|Sensory System Agents|sensory system agents|mesh-ancestor
92400411|NCT01408979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400412|NCT01408979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400413|NCT01408979|Anesthetics|anesthetics|mesh-ancestor
92088047|NCT05640778|Taxane|taxane|mesh-list
92400414|NCT01408979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400415|NCT01408979|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92400416|NCT01408979|Anticonvulsants|anticonvulsants|mesh-ancestor
92400417|NCT01408979|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92400418|NCT01408979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400419|NCT01408979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400420|NCT01408979|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92400421|NCT01408979|Tocolytic Agents|tocolytic agents|mesh-ancestor
92400422|NCT01408979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92400423|NCT01409005|Gemcitabine|gemcitabine|mesh-list
92400424|NCT01409005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92400425|NCT01409005|Antimetabolites|antimetabolites|mesh-ancestor
92400426|NCT01409005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400427|NCT01409005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400428|NCT01409018|Itraconazole|itraconazole|mesh-list
92400429|NCT01409018|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92400430|NCT01409018|Antifungal Agents|antifungal agents|mesh-ancestor
92400431|NCT01409018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400432|NCT01409018|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92400433|NCT01409018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92400434|NCT01409018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400435|NCT01409018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400436|NCT01409018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92400437|NCT01409018|Hormone Antagonists|hormone antagonists|mesh-ancestor
92400438|NCT01409018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400439|NCT01409018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400440|NCT01409018|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92400441|NCT01409122|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92400442|NCT01409148|Antibodies|antibodies|mesh-list
92400443|NCT01409148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92400444|NCT01409148|Immunologic Factors|immunologic factors|mesh-ancestor
92400445|NCT01409148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400446|NCT01409174|Interferons|interferons|mesh-list
92400447|NCT01409174|Interferon-alpha|interferon-alpha|mesh-list
92400448|NCT01409174|Interferon alpha-2|interferon alpha-2|mesh-list
92400449|NCT01409174|Aldesleukin|aldesleukin|mesh-list
92400450|NCT01409174|Cisplatin|cisplatin|mesh-list
92400451|NCT01409174|Temozolomide|temozolomide|mesh-list
92400452|NCT01409174|Ipilimumab|ipilimumab|mesh-list
92400453|NCT01409174|Interleukin-2|interleukin-2|mesh-list
92400454|NCT01409174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400455|NCT01409174|Antiviral Agents|antiviral agents|mesh-ancestor
92400456|NCT01409174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400457|NCT01409174|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92088213|NCT01727713|Serotonin Agents|serotonin agents|mesh-ancestor
92400458|NCT01409174|Alkylating Agents|alkylating agents|mesh-ancestor
92400459|NCT01409174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400460|NCT01409174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92400461|NCT01409174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92400462|NCT01409174|Immunologic Factors|immunologic factors|mesh-ancestor
91932418|NCT04972123|Caffeine|caffeine|mesh-list
92400463|NCT01409174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400464|NCT01409174|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92400465|NCT01409174|Analgesics|analgesics|mesh-ancestor
92400466|NCT01409174|Sensory System Agents|sensory system agents|mesh-ancestor
92400467|NCT01409174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400468|NCT01409174|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92088413|NCT01774903|Fentanyl|fentanyl|mesh-list
92400469|NCT01409174|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92400470|NCT01409187|Interferons|interferons|mesh-list
92400471|NCT01409187|Interferon-alpha|interferon-alpha|mesh-list
92400472|NCT01409187|Interferon alpha-2|interferon alpha-2|mesh-list
92400473|NCT01409187|Aldesleukin|aldesleukin|mesh-list
92400475|NCT01409187|Interleukin-2|interleukin-2|mesh-list
92400476|NCT01409187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400477|NCT01409187|Antiviral Agents|antiviral agents|mesh-ancestor
92400478|NCT01409187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400479|NCT01409187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92400480|NCT01409187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92400481|NCT01409187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400482|NCT01409187|Immunologic Factors|immunologic factors|mesh-ancestor
92400483|NCT01409187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400484|NCT01409187|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92400485|NCT01409187|Analgesics|analgesics|mesh-ancestor
92136488|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
92400486|NCT01409187|Sensory System Agents|sensory system agents|mesh-ancestor
92400487|NCT01409187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400488|NCT01409187|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92400489|NCT01409187|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92400490|NCT01409278|Ropivacaine|ropivacaine|mesh-list
92400491|NCT01409278|Anesthetics, Local|anesthetics, local|mesh-ancestor
92400492|NCT01409278|Anesthetics|anesthetics|mesh-ancestor
92400493|NCT01409278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400494|NCT01409278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400495|NCT01409278|Sensory System Agents|sensory system agents|mesh-ancestor
92400496|NCT01409278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400497|NCT01409369|Charcoal|charcoal|mesh-list
92400498|NCT01409369|Antidotes|antidotes|mesh-ancestor
92400499|NCT01409369|Protective Agents|protective agents|mesh-ancestor
92400500|NCT01409369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400501|NCT01409395|Metformin|metformin|mesh-list
92400502|NCT01409395|Nizatidine|nizatidine|mesh-list
92400503|NCT01409395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92400504|NCT01409395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400505|NCT01409395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92400506|NCT01409395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400507|NCT01409395|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92400508|NCT01409395|Histamine Antagonists|histamine antagonists|mesh-ancestor
92400509|NCT01409395|Histamine Agents|histamine agents|mesh-ancestor
92400510|NCT01409395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400511|NCT01409395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400512|NCT01409408|Amlodipine|amlodipine|mesh-list
92400513|NCT01409408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400514|NCT01409408|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91932419|NCT04972123|Capsaicin|capsaicin|mesh-list
92400515|NCT01409408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400516|NCT01409408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400517|NCT01409408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92088793|NCT01701973|Hormones|hormones|mesh-ancestor
92400518|NCT01409408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400520|NCT01409421|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92400521|NCT01409421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92400522|NCT01409603|Naproxen|naproxen|mesh-list
92400523|NCT01409603|Darexaban|darexaban|mesh-list
92400524|NCT01409603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92400525|NCT01409603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92400526|NCT01409603|Analgesics|analgesics|mesh-ancestor
92400527|NCT01409603|Sensory System Agents|sensory system agents|mesh-ancestor
92400528|NCT01409603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400529|NCT01409603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400530|NCT01409603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400531|NCT01409603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400532|NCT01409603|Gout Suppressants|gout suppressants|mesh-ancestor
92400533|NCT01409603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92400534|NCT01409603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400535|NCT01409603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400536|NCT01409603|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92400537|NCT01409603|Antithrombins|antithrombins|mesh-ancestor
92400538|NCT01409603|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92400539|NCT01409603|Protease Inhibitors|protease inhibitors|mesh-ancestor
92400540|NCT01409603|Anticoagulants|anticoagulants|mesh-ancestor
92400542|NCT01409616|Salicylic Acid|salicylic acid|mesh-list
92400543|NCT01409616|Salicylates|salicylates|mesh-list
92400544|NCT01409616|Darexaban|darexaban|mesh-list
92400545|NCT01409616|Clopidogrel|clopidogrel|mesh-list
92400546|NCT01409616|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92400547|NCT01409616|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92400548|NCT01409616|Analgesics|analgesics|mesh-ancestor
92400549|NCT01409616|Sensory System Agents|sensory system agents|mesh-ancestor
92400550|NCT01409616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400551|NCT01409616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400552|NCT01409616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400553|NCT01409616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400554|NCT01409616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92400555|NCT01409616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92400556|NCT01409616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400557|NCT01409616|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92400558|NCT01409616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92400559|NCT01409616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400560|NCT01409616|Antipyretics|antipyretics|mesh-ancestor
92400561|NCT01409616|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92400562|NCT01409616|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92400563|NCT01409616|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92400565|NCT01409616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400566|NCT01409616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400567|NCT01409616|Antifungal Agents|antifungal agents|mesh-ancestor
92400568|NCT01409616|Keratolytic Agents|keratolytic agents|mesh-ancestor
92400569|NCT01409616|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400570|NCT01409616|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92400571|NCT01409616|Antithrombins|antithrombins|mesh-ancestor
92400572|NCT01409616|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92400573|NCT01409616|Protease Inhibitors|protease inhibitors|mesh-ancestor
92400574|NCT01409616|Anticoagulants|anticoagulants|mesh-ancestor
92400576|NCT01409694|Ergocalciferols|ergocalciferols|mesh-list
92400577|NCT01409694|Cholecalciferol|cholecalciferol|mesh-list
92400578|NCT01409694|Vitamins|vitamins|mesh-list
92400579|NCT01409694|Memantine|memantine|mesh-list
92400580|NCT01409694|Micronutrients|micronutrients|mesh-ancestor
92400581|NCT01409694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400582|NCT01409694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92400583|NCT01409694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92400584|NCT01409694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92400585|NCT01409694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92400586|NCT01409694|Dopamine Agents|dopamine agents|mesh-ancestor
92400587|NCT01409694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400588|NCT01409694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400589|NCT01409694|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92400590|NCT01409694|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92400592|NCT01409733|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92400593|NCT01409733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400594|NCT01409733|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92400595|NCT01409733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92400596|NCT01409733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400597|NCT01409733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400598|NCT01409499|Sorafenib|sorafenib|mesh-list
92400599|NCT01409499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400600|NCT01409499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400601|NCT01409499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400602|NCT01409499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400603|NCT01409772|Ethanol|ethanol|mesh-list
92400604|NCT01409772|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92400605|NCT01409772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089414|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
92400606|NCT01409772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400607|NCT01409772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400608|NCT01410162|Tacrolimus|tacrolimus|mesh-list
92400609|NCT01410162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400610|NCT01410162|Immunologic Factors|immunologic factors|mesh-ancestor
92400611|NCT01410162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400612|NCT01410162|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92400613|NCT01410162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400614|NCT01410162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400615|NCT01410201|Dexamethasone|dexamethasone|mesh-list
92400616|NCT01410201|Dexamethasone acetate|dexamethasone acetate|mesh-list
92400617|NCT01410201|BB 1101|bb 1101|mesh-list
92400618|NCT01410201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400619|NCT01410201|Antiemetics|antiemetics|mesh-ancestor
92400620|NCT01410201|Autonomic Agents|autonomic agents|mesh-ancestor
92400621|NCT01410201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400622|NCT01410201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400623|NCT01410201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052944|NCT05886933|Fexuprazan|fexuprazan|mesh-list
92400625|NCT01410201|Hormones|hormones|mesh-ancestor
92400626|NCT01410201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400627|NCT01410201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92400628|NCT01410201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089484|NCT00862810|Vaccines|vaccines|mesh-list
92400630|NCT01410201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400631|NCT01410201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400632|NCT01410214|Cisplatin|cisplatin|mesh-list
92400633|NCT01410214|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92400634|NCT01410214|Vinorelbine|vinorelbine|mesh-list
92400635|NCT01410214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400636|NCT01410214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400637|NCT01410214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089530|NCT00863356|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92400638|NCT01410214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400639|NCT01410214|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92400642|NCT01410214|Mitosis Modulators|mitosis modulators|mesh-ancestor
92400643|NCT01410370|Endostar protein|endostar protein|mesh-list
92400644|NCT01410370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92400645|NCT01410370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92400646|NCT01410370|Growth Substances|growth substances|mesh-ancestor
92400647|NCT01410370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400648|NCT01410370|Growth Inhibitors|growth inhibitors|mesh-ancestor
92089591|NCT01935947|Gemcitabine|gemcitabine|mesh-list
92400649|NCT01410370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400650|NCT01410630|Telbivudine|telbivudine|mesh-list
92400651|NCT01410630|Antiviral Agents|antiviral agents|mesh-ancestor
92400652|NCT01410630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400653|NCT01410630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92400654|NCT01410630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400655|NCT01410630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400656|NCT01410682|Chlorhexidine|chlorhexidine|mesh-list
92400657|NCT01410682|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92400658|NCT01410682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400659|NCT01410682|Disinfectants|disinfectants|mesh-ancestor
92400660|NCT01410708|Dasatinib|dasatinib|mesh-list
92400661|NCT01410708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400662|NCT01410708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400663|NCT01410708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400664|NCT01410708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400665|NCT01410747|Tacrolimus|tacrolimus|mesh-list
92400666|NCT01410747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400667|NCT01410747|Immunologic Factors|immunologic factors|mesh-ancestor
92400668|NCT01410747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400669|NCT01410747|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92400670|NCT01410747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400671|NCT01410747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400672|NCT01410916|Eculizumab|eculizumab|mesh-list
92400673|NCT01410916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92400674|NCT01410916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400675|NCT01410916|Immunologic Factors|immunologic factors|mesh-ancestor
92400676|NCT01410916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400677|NCT01410968|Poly ICLC|poly iclc|mesh-list
92400678|NCT01410968|Interferon Inducers|interferon inducers|mesh-ancestor
92400679|NCT01410968|Immunologic Factors|immunologic factors|mesh-ancestor
92400680|NCT01410968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400681|NCT01411072|Gemcitabine|gemcitabine|mesh-list
92400682|NCT01411072|Fluorouracil|fluorouracil|mesh-list
92400683|NCT01411072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92400684|NCT01411072|Antimetabolites|antimetabolites|mesh-ancestor
92400685|NCT01411072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400686|NCT01411072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400687|NCT01411072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400688|NCT01411072|Immunologic Factors|immunologic factors|mesh-ancestor
92400689|NCT01411072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400690|NCT01411098|Etoposide|etoposide|mesh-list
92400691|NCT01411098|Etoposide phosphate|etoposide phosphate|mesh-list
92400692|NCT01411098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089957|NCT02151448|Celecoxib|celecoxib|mesh-list
92400693|NCT01411098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92400694|NCT01411098|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92400695|NCT01411098|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92400696|NCT01411098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400697|NCT01411098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400698|NCT01411111|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92400699|NCT01411111|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92400700|NCT01411111|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92400701|NCT01411111|Antimetabolites|antimetabolites|mesh-ancestor
92400702|NCT01411111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400703|NCT01411111|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92400704|NCT01411111|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92400705|NCT01411111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400706|NCT01411124|Diphenhydramine|diphenhydramine|mesh-list
92400707|NCT01411124|Promethazine|promethazine|mesh-list
92400708|NCT01411124|Gabapentin|gabapentin|mesh-list
92400709|NCT01411124|Analgesics|analgesics|mesh-ancestor
92400710|NCT01411124|Sensory System Agents|sensory system agents|mesh-ancestor
92400711|NCT01411124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400712|NCT01411124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400713|NCT01411124|Anticonvulsants|anticonvulsants|mesh-ancestor
92400714|NCT01411124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92400715|NCT01411124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92400716|NCT01411124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400717|NCT01411124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92400718|NCT01411124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92400719|NCT01411124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92400720|NCT01411124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400721|NCT01411124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400723|NCT01411124|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92400724|NCT01411124|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92400725|NCT01411124|Anesthetics, Local|anesthetics, local|mesh-ancestor
92400726|NCT01411124|Anesthetics|anesthetics|mesh-ancestor
92400727|NCT01411124|Antiemetics|antiemetics|mesh-ancestor
92400728|NCT01411124|Autonomic Agents|autonomic agents|mesh-ancestor
92400729|NCT01411124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400730|NCT01411124|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92400731|NCT01411124|Histamine Antagonists|histamine antagonists|mesh-ancestor
92400732|NCT01411124|Histamine Agents|histamine agents|mesh-ancestor
92400733|NCT01411124|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92400734|NCT01411124|Antipruritics|antipruritics|mesh-ancestor
92400735|NCT01411124|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400736|NCT01411176|Menthol|menthol|mesh-list
92400737|NCT01411176|Antipruritics|antipruritics|mesh-ancestor
92400738|NCT01411176|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400739|NCT01411189|Menthol|menthol|mesh-list
92400740|NCT01411189|Antipruritics|antipruritics|mesh-ancestor
92400741|NCT01411189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92400742|NCT01411202|Doxycycline|doxycycline|mesh-list
92400743|NCT01411202|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92400744|NCT01411202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400745|NCT01411202|Antimalarials|antimalarials|mesh-ancestor
92400746|NCT01411202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92400747|NCT01411202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92400748|NCT01411254|Betamethasone|betamethasone|mesh-list
92400749|NCT01411254|Betamethasone Valerate|betamethasone valerate|mesh-list
92400750|NCT01411254|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92400751|NCT01411254|Betamethasone benzoate|betamethasone benzoate|mesh-list
92400752|NCT01411254|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92400753|NCT01411254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400754|NCT01411254|Glucocorticoids|glucocorticoids|mesh-ancestor
92400755|NCT01411254|Hormones|hormones|mesh-ancestor
92400756|NCT01411254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400757|NCT01411254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400758|NCT01411254|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92400759|NCT01411254|Respiratory System Agents|respiratory system agents|mesh-ancestor
92400760|NCT01411280|Methylphenidate|methylphenidate|mesh-list
92400761|NCT01411280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92400762|NCT01411280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400763|NCT01411280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92400764|NCT01411280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92400765|NCT01411280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400766|NCT01411280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400767|NCT01411280|Dopamine Agents|dopamine agents|mesh-ancestor
92400768|NCT01411280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400769|NCT01411410|Paclitaxel|paclitaxel|mesh-list
92400770|NCT01411410|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92400771|NCT01411410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400772|NCT01411410|Tubulin Modulators|tubulin modulators|mesh-ancestor
92400773|NCT01411410|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053095|NCT05884372|Calcium|calcium|mesh-list
92400774|NCT01411410|Mitosis Modulators|mitosis modulators|mesh-ancestor
92400775|NCT01411410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400776|NCT01411423|Sorafenib|sorafenib|mesh-list
92400777|NCT01411423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400778|NCT01411423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400779|NCT01411423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400780|NCT01411423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400781|NCT01411436|Sorafenib|sorafenib|mesh-list
92400782|NCT01411436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400783|NCT01411436|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400784|NCT01411436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017046|NCT02585999|Ortho Evra|ortho evra|mesh-list
92400785|NCT01411436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400786|NCT01411514|Prednisone|prednisone|mesh-list
92400787|NCT01411514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400789|NCT01411514|Hormones|hormones|mesh-ancestor
92400790|NCT01411514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92400791|NCT01411514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400792|NCT01411514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92400793|NCT01411514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400794|NCT01411670|Drotrecogin alfa activated|drotrecogin alfa activated|mesh-list
92400795|NCT01411670|Protein C|protein c|mesh-list
92400796|NCT01411670|Anticoagulants|anticoagulants|mesh-ancestor
92400797|NCT01411670|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92400798|NCT01411670|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92400799|NCT01411670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400800|NCT01411670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92400801|NCT01411735|Enalapril|enalapril|mesh-list
92400802|NCT01411735|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92400803|NCT01411735|Protease Inhibitors|protease inhibitors|mesh-ancestor
92400804|NCT01411735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400805|NCT01411735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400806|NCT01411735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400807|NCT01411930|Olanzapine|olanzapine|mesh-list
92400808|NCT01411930|Aripiprazole|aripiprazole|mesh-list
92400809|NCT01411930|Antiemetics|antiemetics|mesh-ancestor
92400810|NCT01411930|Autonomic Agents|autonomic agents|mesh-ancestor
92400811|NCT01411930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400812|NCT01411930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400813|NCT01411930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400814|NCT01411930|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92090508|NCT00893074|Analgesics|analgesics|mesh-ancestor
92400815|NCT01411930|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92400816|NCT01411930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400817|NCT01411930|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92400818|NCT01411930|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92400819|NCT01411930|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92400820|NCT01411930|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400821|NCT01411930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400822|NCT01411930|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400823|NCT01411930|Serotonin Agents|serotonin agents|mesh-ancestor
92400824|NCT01411930|Antidepressive Agents|antidepressive agents|mesh-ancestor
92400825|NCT01411930|Dopamine Agonists|dopamine agonists|mesh-ancestor
92400826|NCT01411930|Dopamine Agents|dopamine agents|mesh-ancestor
92400827|NCT01411930|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92400828|NCT01411930|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92400829|NCT01411930|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92400830|NCT01411930|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92400831|NCT01411930|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92400832|NCT01411930|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92400834|NCT01411969|Oxymetazoline|oxymetazoline|mesh-list
92400835|NCT01411969|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92090739|NCT01889069|Hormones|hormones|mesh-ancestor
92400836|NCT01411969|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92400837|NCT01411969|Adrenergic Agents|adrenergic agents|mesh-ancestor
92400838|NCT01411969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400839|NCT01411969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400840|NCT01411969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400841|NCT01411969|Sympathomimetics|sympathomimetics|mesh-ancestor
92400842|NCT01411969|Autonomic Agents|autonomic agents|mesh-ancestor
92400843|NCT01411969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400844|NCT01411969|Nasal Decongestants|nasal decongestants|mesh-ancestor
92400845|NCT01411969|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92400846|NCT01411969|Respiratory System Agents|respiratory system agents|mesh-ancestor
92400847|NCT01411969|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92400849|NCT01411969|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92400850|NCT01411969|Protective Agents|protective agents|mesh-ancestor
92400851|NCT01412008|Botulinum Toxins|botulinum toxins|mesh-list
92400852|NCT01412008|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92400853|NCT01412008|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400854|NCT01412008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400855|NCT01412008|Cholinergic Agents|cholinergic agents|mesh-ancestor
92400856|NCT01412008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400857|NCT01412008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400858|NCT01412073|Misoprostol|misoprostol|mesh-list
92400859|NCT01412073|Oxytocin|oxytocin|mesh-list
92400860|NCT01412073|Oxytocics|oxytocics|mesh-ancestor
92400861|NCT01412073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92400862|NCT01412073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400863|NCT01412073|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92400864|NCT01412073|Abortifacient Agents|abortifacient agents|mesh-ancestor
92400865|NCT01412073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92400866|NCT01412073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92400868|NCT01412294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400869|NCT01412294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92400870|NCT01412294|Antimetabolites|antimetabolites|mesh-ancestor
92400871|NCT01412294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400872|NCT01412307|Lenalidomide|lenalidomide|mesh-list
92400873|NCT01412307|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92091017|NCT01833676|Sevoflurane|sevoflurane|mesh-list
92400874|NCT01412307|Immunologic Factors|immunologic factors|mesh-ancestor
92400875|NCT01412307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400876|NCT01412307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92400877|NCT01412307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92400878|NCT01412307|Growth Substances|growth substances|mesh-ancestor
92400879|NCT01412307|Growth Inhibitors|growth inhibitors|mesh-ancestor
92400880|NCT01412307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400881|NCT01412307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92400882|NCT01412307|Alkylating Agents|alkylating agents|mesh-ancestor
92091122|NCT03210532|Amlodipine|amlodipine|mesh-list
92400883|NCT01412307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400884|NCT01412385|Immunoglobulins|immunoglobulins|mesh-list
92400885|NCT01412385|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92400886|NCT01412385|Antibodies|antibodies|mesh-list
92400887|NCT01412385|gamma-Globulins|gamma-globulins|mesh-list
92400888|NCT01412385|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92400889|NCT01412385|Immunoglobulin G|immunoglobulin g|mesh-list
92400890|NCT01412385|Immunologic Factors|immunologic factors|mesh-ancestor
92400891|NCT01412385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400892|NCT01412411|Micronutrients|micronutrients|mesh-list
92400893|NCT01412411|Trace Elements|trace elements|mesh-list
92400894|NCT01412411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400895|NCT01412437|Verapamil|verapamil|mesh-list
92400896|NCT01412437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92400897|NCT01412437|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92400898|NCT01412437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92400899|NCT01412437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400900|NCT01412437|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92400901|NCT01412437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400902|NCT01412437|Vasodilator Agents|vasodilator agents|mesh-ancestor
92400904|NCT01412515|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92400905|NCT01412515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400906|NCT01412515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400907|NCT01412515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400908|NCT01412515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400909|NCT01412515|Immunologic Factors|immunologic factors|mesh-ancestor
92400910|NCT01412515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400911|NCT01412515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400912|NCT01412567|Vaccines|vaccines|mesh-list
92400913|NCT01412567|Immunologic Factors|immunologic factors|mesh-ancestor
92400914|NCT01412567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400915|NCT01412632|Remifentanil|remifentanil|mesh-list
92400916|NCT01412632|Propofol|propofol|mesh-list
92400917|NCT01412632|Prilocaine|prilocaine|mesh-list
92400918|NCT01412632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92400919|NCT01412632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92400920|NCT01412632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400921|NCT01412632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92400922|NCT01412632|Anesthetics, General|anesthetics, general|mesh-ancestor
92400923|NCT01412632|Anesthetics|anesthetics|mesh-ancestor
92400924|NCT01412632|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92400926|NCT01412632|Analgesics|analgesics|mesh-ancestor
92400927|NCT01412632|Sensory System Agents|sensory system agents|mesh-ancestor
92400928|NCT01412632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400929|NCT01412632|Anesthetics, Local|anesthetics, local|mesh-ancestor
92400930|NCT01412645|Resveratrol|resveratrol|mesh-list
92400932|NCT01412645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400933|NCT01412645|Protective Agents|protective agents|mesh-ancestor
92400934|NCT01412645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400935|NCT01412645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400936|NCT01412645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92400937|NCT01412658|Caseins|caseins|mesh-list
92400938|NCT01412658|Glycerol|glycerol|mesh-list
92400939|NCT01412658|Chelating Agents|chelating agents|mesh-ancestor
92400940|NCT01412658|Sequestering Agents|sequestering agents|mesh-ancestor
92400941|NCT01412658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400942|NCT01412658|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92400943|NCT01412658|Protective Agents|protective agents|mesh-ancestor
92400944|NCT01412658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400945|NCT01412671|Sorafenib|sorafenib|mesh-list
92400946|NCT01412671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400947|NCT01412671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400948|NCT01412671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400949|NCT01412671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400950|NCT01412840|Diclofenac|diclofenac|mesh-list
92400951|NCT01412840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92400953|NCT01412840|Analgesics|analgesics|mesh-ancestor
92091604|NCT04377646|Zinc|zinc|mesh-list
92400954|NCT01412840|Sensory System Agents|sensory system agents|mesh-ancestor
92400955|NCT01412840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92400956|NCT01412840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400957|NCT01412840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92400958|NCT01412840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92400959|NCT01412840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92400960|NCT01412840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400961|NCT01412840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400962|NCT01412892|Everolimus|everolimus|mesh-list
92400963|NCT01412892|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92400964|NCT01412892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92400965|NCT01412892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400966|NCT01412892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400967|NCT01412892|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400968|NCT01412892|Immunologic Factors|immunologic factors|mesh-ancestor
92400969|NCT01412892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400970|NCT01412892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400971|NCT01413022|Leucovorin|leucovorin|mesh-list
92400972|NCT01413022|Fluorouracil|fluorouracil|mesh-list
92400973|NCT01413022|Oxaliplatin|oxaliplatin|mesh-list
92400974|NCT01413022|Irinotecan|irinotecan|mesh-list
92400975|NCT01413022|Antimetabolites|antimetabolites|mesh-ancestor
92400976|NCT01413022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400977|NCT01413022|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92400978|NCT01413022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92400979|NCT01413022|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92400980|NCT01413022|Immunologic Factors|immunologic factors|mesh-ancestor
92091673|NCT01729468|Antipyretics|antipyretics|mesh-ancestor
92400981|NCT01413022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400982|NCT01413022|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92400983|NCT01413022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92400984|NCT01413022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92400985|NCT01413022|Antidotes|antidotes|mesh-ancestor
92400986|NCT01413022|Protective Agents|protective agents|mesh-ancestor
92400987|NCT01413022|Vitamin B Complex|vitamin b complex|mesh-ancestor
92400988|NCT01413022|Vitamins|vitamins|mesh-ancestor
92400989|NCT01413022|Micronutrients|micronutrients|mesh-ancestor
92400990|NCT01413048|Carvedilol|carvedilol|mesh-list
92400991|NCT01413048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92400992|NCT01413048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92400993|NCT01413048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92400994|NCT01413048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92400995|NCT01413048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92400996|NCT01413048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92400997|NCT01413048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92400998|NCT01413048|Antioxidants|antioxidants|mesh-ancestor
92400999|NCT01413048|Protective Agents|protective agents|mesh-ancestor
92401000|NCT01413048|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92401001|NCT01413048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401002|NCT01413048|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401003|NCT01413048|Vasodilator Agents|vasodilator agents|mesh-ancestor
92401004|NCT01413048|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92401005|NCT01413048|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92401006|NCT01413230|Cholecalciferol|cholecalciferol|mesh-list
92401008|NCT01413230|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401009|NCT01413230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401012|NCT01413230|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401013|NCT01413477|Calcitriol|calcitriol|mesh-list
92401014|NCT01413477|Betamethasone|betamethasone|mesh-list
92401015|NCT01413477|Betamethasone Valerate|betamethasone valerate|mesh-list
92401016|NCT01413477|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92401017|NCT01413477|Betamethasone benzoate|betamethasone benzoate|mesh-list
92401018|NCT01413477|Calcipotriene|calcipotriene|mesh-list
92401019|NCT01413477|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92401020|NCT01413477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92401022|NCT01413477|Hormones|hormones|mesh-ancestor
92401023|NCT01413477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401024|NCT01413477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401025|NCT01413477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92401026|NCT01413477|Respiratory System Agents|respiratory system agents|mesh-ancestor
92401027|NCT01413477|Dermatologic Agents|dermatologic agents|mesh-ancestor
92092156|NCT03404908|Narcotics|narcotics|mesh-ancestor
92401028|NCT01413477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401029|NCT01413477|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92401030|NCT01413477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401031|NCT01413477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401032|NCT01413477|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92401033|NCT01413477|Vitamins|vitamins|mesh-ancestor
92401034|NCT01413477|Micronutrients|micronutrients|mesh-ancestor
92401035|NCT01413477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401036|NCT01413490|Rimantadine|rimantadine|mesh-list
92401037|NCT01413490|Antiviral Agents|antiviral agents|mesh-ancestor
92401038|NCT01413490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401039|NCT01413490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92401040|NCT01413490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401041|NCT01413490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401042|NCT01413581|Bile Acids and Salts|bile acids and salts|mesh-list
92401043|NCT01413581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401044|NCT01413620|Vitamins|vitamins|mesh-list
92401045|NCT01413620|Vitamin E|vitamin e|mesh-list
92401046|NCT01413620|Tocopherols|tocopherols|mesh-list
92401047|NCT01413620|Tocotrienols|tocotrienols|mesh-list
92401048|NCT01413620|alpha-Tocopherol|alpha-tocopherol|mesh-list
92401049|NCT01413620|Micronutrients|micronutrients|mesh-ancestor
92401050|NCT01413620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092332|NCT02242474|Adalimumab|adalimumab|mesh-list
92401051|NCT01413620|Antioxidants|antioxidants|mesh-ancestor
92401052|NCT01413620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401053|NCT01413620|Protective Agents|protective agents|mesh-ancestor
92401054|NCT01413711|Vigabatrin|vigabatrin|mesh-list
92401055|NCT01413711|Anticonvulsants|anticonvulsants|mesh-ancestor
92401056|NCT01413711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401057|NCT01413711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401058|NCT01413711|GABA Agents|gaba agents|mesh-ancestor
92401059|NCT01413711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401060|NCT01413711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401061|NCT01413763|Imiquimod|imiquimod|mesh-list
92401062|NCT01413763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92401063|NCT01413763|Immunologic Factors|immunologic factors|mesh-ancestor
92401064|NCT01413763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401065|NCT01413763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401066|NCT01413763|Interferon Inducers|interferon inducers|mesh-ancestor
92401067|NCT01413854|Diclofenac|diclofenac|mesh-list
92401068|NCT01413854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92401069|NCT01413854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92401070|NCT01413854|Analgesics|analgesics|mesh-ancestor
92401071|NCT01413854|Sensory System Agents|sensory system agents|mesh-ancestor
92401072|NCT01413854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401073|NCT01413854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401074|NCT01413854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053414|NCT05581758|Sotorasib|sotorasib|mesh-list
92401075|NCT01413854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401076|NCT01413854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92401077|NCT01413854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401078|NCT01413854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401079|NCT01414140|Levonorgestrel|levonorgestrel|mesh-list
92401080|NCT01414140|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92401081|NCT01414140|Contraceptive Agents|contraceptive agents|mesh-ancestor
92401082|NCT01414140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92401083|NCT01414140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401084|NCT01414140|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92401085|NCT01414140|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92401086|NCT01414140|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92401087|NCT01414231|Cytarabine|cytarabine|mesh-list
92401089|NCT01414231|Antimetabolites|antimetabolites|mesh-ancestor
92401090|NCT01414231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401091|NCT01414231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401092|NCT01414231|Antiviral Agents|antiviral agents|mesh-ancestor
92401093|NCT01414231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401094|NCT01414231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401095|NCT01414231|Immunologic Factors|immunologic factors|mesh-ancestor
92092752|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
92401096|NCT01414231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401097|NCT01414465|Orlistat|orlistat|mesh-list
92401098|NCT01414465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401099|NCT01414465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401100|NCT01414465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92092850|NCT04372264|Analgesics|analgesics|mesh-ancestor
92401101|NCT01414465|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92401102|NCT01414504|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92401103|NCT01414504|Immunologic Factors|immunologic factors|mesh-ancestor
92401104|NCT01414504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401105|NCT01414530|Contraceptive Agents|contraceptive agents|mesh-list
92401106|NCT01414530|Contraceptives, Oral|contraceptives, oral|mesh-list
92401107|NCT01414530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92401108|NCT01414530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401109|NCT01414530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92401110|NCT01414556|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
92401111|NCT01414556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401112|NCT01414556|Incretins|incretins|mesh-ancestor
92401113|NCT01414556|Hormones|hormones|mesh-ancestor
92401114|NCT01414556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401115|NCT01414556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401116|NCT01414569|Dexamethasone|dexamethasone|mesh-list
92401117|NCT01414569|Dexamethasone acetate|dexamethasone acetate|mesh-list
92401118|NCT01414569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92401119|NCT01414569|Antiemetics|antiemetics|mesh-ancestor
92401120|NCT01414569|Autonomic Agents|autonomic agents|mesh-ancestor
92401121|NCT01414569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401122|NCT01414569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401123|NCT01414569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401125|NCT01414569|Hormones|hormones|mesh-ancestor
92401126|NCT01414569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401127|NCT01414569|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92401128|NCT01414569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401129|NCT01414608|Paclitaxel|paclitaxel|mesh-list
92401130|NCT01414608|Cisplatin|cisplatin|mesh-list
92401131|NCT01414608|Carboplatin|carboplatin|mesh-list
92401132|NCT01414608|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92401133|NCT01414608|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92401134|NCT01414608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401135|NCT01414608|Tubulin Modulators|tubulin modulators|mesh-ancestor
92093120|NCT03604653|Mitomycin|mitomycin|mesh-list
92401136|NCT01414608|Antimitotic Agents|antimitotic agents|mesh-ancestor
92401137|NCT01414608|Mitosis Modulators|mitosis modulators|mesh-ancestor
92401138|NCT01414608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401139|NCT01414816|Interferons|interferons|mesh-list
92401140|NCT01414816|Interferon-beta|interferon-beta|mesh-list
92401141|NCT01414816|Interferon beta-1b|interferon beta-1b|mesh-list
92401142|NCT01414816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401143|NCT01414816|Antiviral Agents|antiviral agents|mesh-ancestor
92401144|NCT01414816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401145|NCT01414816|Immunologic Factors|immunologic factors|mesh-ancestor
92401146|NCT01414816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401147|NCT01414816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92401148|NCT01414842|Dialysis Solutions|dialysis solutions|mesh-list
92401149|NCT01414842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92401150|NCT01414868|Montelukast|montelukast|mesh-list
92401151|NCT01414868|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92401152|NCT01414868|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92401153|NCT01414868|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093352|NCT01696214|Xhance|xhance|mesh-list
92401154|NCT01414868|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401155|NCT01414868|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401157|NCT01414868|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92401158|NCT01414868|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92401159|NCT01414868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401161|NCT01414881|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92401162|NCT01414881|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92401163|NCT01414881|Antimetabolites|antimetabolites|mesh-ancestor
92401164|NCT01414881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017217|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401166|NCT01414972|Vitamin A|vitamin a|mesh-list
92401167|NCT01414972|Vitamins|vitamins|mesh-ancestor
92401168|NCT01414972|Micronutrients|micronutrients|mesh-ancestor
92401169|NCT01414972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401170|NCT01414998|Nicotine|nicotine|mesh-list
92401171|NCT01414998|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92401172|NCT01414998|Autonomic Agents|autonomic agents|mesh-ancestor
92401173|NCT01414998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401174|NCT01414998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401175|NCT01414998|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92401176|NCT01414998|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92401177|NCT01414998|Cholinergic Agents|cholinergic agents|mesh-ancestor
92401178|NCT01414998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401179|NCT01414998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401180|NCT01415011|Afatinib|afatinib|mesh-list
92401181|NCT01415011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401182|NCT01415011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92401183|NCT01415011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401184|NCT01415011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401186|NCT01415128|Desipramine|desipramine|mesh-list
92401187|NCT01415128|Omeprazole|omeprazole|mesh-list
92401188|NCT01415128|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92401189|NCT01415128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401190|NCT01415128|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92401191|NCT01415128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401192|NCT01415128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401193|NCT01415128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92401194|NCT01415128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093616|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92401195|NCT01415128|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92401196|NCT01415128|Antidepressive Agents|antidepressive agents|mesh-ancestor
92401197|NCT01415128|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92401198|NCT01415128|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92093675|NCT04355416|Curcumin|curcumin|mesh-list
92401199|NCT01415128|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92093758|NCT04359862|Propofol|propofol|mesh-list
92401200|NCT01415128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401201|NCT01415128|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401202|NCT01415128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401203|NCT01415141|Ribavirin|ribavirin|mesh-list
92401204|NCT01415141|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92401205|NCT01415141|Antimetabolites|antimetabolites|mesh-ancestor
92401206|NCT01415141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401207|NCT01415141|Antiviral Agents|antiviral agents|mesh-ancestor
92401208|NCT01415141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401209|NCT01415284|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92401210|NCT01415284|Plasma Substitutes|plasma substitutes|mesh-ancestor
92401211|NCT01415284|Blood Substitutes|blood substitutes|mesh-ancestor
92401212|NCT01415336|Cyclophosphamide|cyclophosphamide|mesh-list
92401213|NCT01415336|Doxorubicin|doxorubicin|mesh-list
92401214|NCT01415336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92401215|NCT01415336|Capecitabine|capecitabine|mesh-list
92401216|NCT01415336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401217|NCT01415336|Immunologic Factors|immunologic factors|mesh-ancestor
92401218|NCT01415336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401219|NCT01415336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401220|NCT01415336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92401221|NCT01415336|Alkylating Agents|alkylating agents|mesh-ancestor
92401222|NCT01415336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401223|NCT01415336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401224|NCT01415336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92401225|NCT01415336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92401226|NCT01415336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92401227|NCT01415336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92401228|NCT01415336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401229|NCT01415336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92401230|NCT01415336|Antimetabolites|antimetabolites|mesh-ancestor
92401231|NCT01415466|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92401232|NCT01415466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92401233|NCT01415466|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92401234|NCT01415466|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92401235|NCT01415466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401237|NCT01415505|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92401239|NCT01415505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92093934|NCT05620498|Lenvatinib|lenvatinib|mesh-list
92401240|NCT01415505|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92401241|NCT01415505|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92401242|NCT01415505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401243|NCT01415505|Diuretics|diuretics|mesh-ancestor
92401244|NCT01415505|Natriuretic Agents|natriuretic agents|mesh-ancestor
92401245|NCT01415505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401246|NCT01415505|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92401247|NCT01415505|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401248|NCT01415505|Vasodilator Agents|vasodilator agents|mesh-ancestor
92401249|NCT01415505|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92401250|NCT01415505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92401251|NCT01415505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92401252|NCT01415505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401253|NCT01415505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401254|NCT01415557|Micronutrients|micronutrients|mesh-list
92401255|NCT01415557|Trace Elements|trace elements|mesh-list
92401256|NCT01415557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401257|NCT01415596|Albuterol|albuterol|mesh-list
92401258|NCT01415596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92401259|NCT01415596|Autonomic Agents|autonomic agents|mesh-ancestor
92401260|NCT01415596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401261|NCT01415596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401262|NCT01415596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92401263|NCT01415596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92401264|NCT01415596|Tocolytic Agents|tocolytic agents|mesh-ancestor
92401265|NCT01415596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92401266|NCT01415596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92401267|NCT01415596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92401269|NCT01415596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401270|NCT01415596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401271|NCT01415596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401273|NCT01415687|Magnesium citrate|magnesium citrate|mesh-list
92401274|NCT01415687|Citric Acid|citric acid|mesh-list
92401275|NCT01415687|Sodium Citrate|sodium citrate|mesh-list
92401276|NCT01415687|Anticoagulants|anticoagulants|mesh-ancestor
92401277|NCT01415687|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92401278|NCT01415687|Chelating Agents|chelating agents|mesh-ancestor
92401279|NCT01415687|Sequestering Agents|sequestering agents|mesh-ancestor
92401280|NCT01415687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401281|NCT01415687|Cathartics|cathartics|mesh-ancestor
92401282|NCT01415687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401283|NCT01415687|Laxatives|laxatives|mesh-ancestor
92401284|NCT01415713|Leucovorin|leucovorin|mesh-list
92401285|NCT01415713|Gemcitabine|gemcitabine|mesh-list
92401286|NCT01415713|Oxaliplatin|oxaliplatin|mesh-list
92401287|NCT01415713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92401288|NCT01415713|Antimetabolites|antimetabolites|mesh-ancestor
92401289|NCT01415713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401290|NCT01415713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401291|NCT01415713|Antidotes|antidotes|mesh-ancestor
92401292|NCT01415713|Protective Agents|protective agents|mesh-ancestor
92401293|NCT01415713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401294|NCT01415713|Vitamin B Complex|vitamin b complex|mesh-ancestor
92401295|NCT01415713|Vitamins|vitamins|mesh-ancestor
92401296|NCT01415713|Micronutrients|micronutrients|mesh-ancestor
92401297|NCT01415765|Prednisone|prednisone|mesh-list
92401298|NCT01415765|Cyclophosphamide|cyclophosphamide|mesh-list
92401299|NCT01415765|Rituximab|rituximab|mesh-list
92401300|NCT01415765|Doxorubicin|doxorubicin|mesh-list
92401301|NCT01415765|Etoposide|etoposide|mesh-list
92401304|NCT01415765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401305|NCT01415765|Immunologic Factors|immunologic factors|mesh-ancestor
92401306|NCT01415765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401307|NCT01415765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401308|NCT01415765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92401309|NCT01415765|Alkylating Agents|alkylating agents|mesh-ancestor
92401310|NCT01415765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401311|NCT01415765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401312|NCT01415765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92401313|NCT01415765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92401314|NCT01415765|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92401315|NCT01415765|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92094496|NCT03034408|Baclofen|baclofen|mesh-list
92401316|NCT01415765|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92401317|NCT01415765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401318|NCT01415765|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92401319|NCT01415765|Glucocorticoids|glucocorticoids|mesh-ancestor
92401321|NCT01415765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401322|NCT01415765|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92401323|NCT01415765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92401324|NCT01415765|Tubulin Modulators|tubulin modulators|mesh-ancestor
92401325|NCT01415765|Antimitotic Agents|antimitotic agents|mesh-ancestor
92401326|NCT01415765|Mitosis Modulators|mitosis modulators|mesh-ancestor
92401327|NCT01415778|Bicalutamide|bicalutamide|mesh-list
92401328|NCT01415778|Androgen Antagonists|androgen antagonists|mesh-ancestor
92401329|NCT01415778|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401330|NCT01415778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401331|NCT01415778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401332|NCT01415778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401333|NCT01415791|Bicalutamide|bicalutamide|mesh-list
92401334|NCT01415791|Androgen Antagonists|androgen antagonists|mesh-ancestor
92401335|NCT01415791|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401336|NCT01415791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401337|NCT01415791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401338|NCT01415791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401339|NCT01415895|Clonidine|clonidine|mesh-list
92401340|NCT01415895|Naltrexone|naltrexone|mesh-list
92401342|NCT01415895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92401343|NCT01415895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401344|NCT01415895|Sensory System Agents|sensory system agents|mesh-ancestor
92401345|NCT01415895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401346|NCT01415895|Analgesics|analgesics|mesh-ancestor
92401347|NCT01415895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92401348|NCT01415895|Sympatholytics|sympatholytics|mesh-ancestor
92401349|NCT01415895|Autonomic Agents|autonomic agents|mesh-ancestor
92401350|NCT01415895|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92401351|NCT01415895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92401352|NCT01415895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92401353|NCT01415895|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401354|NCT01415895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401355|NCT01415895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401356|NCT01416038|Cyclophosphamide|cyclophosphamide|mesh-list
92401357|NCT01416038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401358|NCT01416038|Immunologic Factors|immunologic factors|mesh-ancestor
92095039|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401359|NCT01416038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401360|NCT01416038|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401361|NCT01416038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92401362|NCT01416038|Alkylating Agents|alkylating agents|mesh-ancestor
92401363|NCT01416038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401364|NCT01416038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095120|NCT03384537|Listerine|listerine|mesh-list
92401365|NCT01416038|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92401366|NCT01416116|Lidocaine|lidocaine|mesh-list
92401367|NCT01416116|Tramadol|tramadol|mesh-list
92401368|NCT01416116|Capsaicin|capsaicin|mesh-list
92401369|NCT01416116|Anesthetics, Local|anesthetics, local|mesh-ancestor
92401370|NCT01416116|Anesthetics|anesthetics|mesh-ancestor
92401371|NCT01416116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401372|NCT01416116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401373|NCT01416116|Sensory System Agents|sensory system agents|mesh-ancestor
92401374|NCT01416116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053702|NCT05095922|Valsartan|valsartan|mesh-list
92401375|NCT01416116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92401376|NCT01416116|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92401378|NCT01416116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401379|NCT01416116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401380|NCT01416116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92401382|NCT01416116|Analgesics|analgesics|mesh-ancestor
92401383|NCT01416116|Antipruritics|antipruritics|mesh-ancestor
92401384|NCT01416116|Dermatologic Agents|dermatologic agents|mesh-ancestor
92401385|NCT01416207|Interferons|interferons|mesh-list
92401386|NCT01416207|Interferon beta-1a|interferon beta-1a|mesh-list
92401387|NCT01416207|Interferon-beta|interferon-beta|mesh-list
92401388|NCT01416207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401389|NCT01416207|Antiviral Agents|antiviral agents|mesh-ancestor
92401390|NCT01416207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401391|NCT01416207|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92401392|NCT01416207|Immunologic Factors|immunologic factors|mesh-ancestor
92401393|NCT01416207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401394|NCT01416220|Lithium Carbonate|lithium carbonate|mesh-list
92401395|NCT01416220|Paroxetine|paroxetine|mesh-list
92401396|NCT01416220|Antidepressive Agents|antidepressive agents|mesh-ancestor
92401397|NCT01416220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92401398|NCT01416220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401399|NCT01416220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401401|NCT01416220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92401402|NCT01416220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401403|NCT01416220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401404|NCT01416220|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92401405|NCT01416220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92401406|NCT01416220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401407|NCT01416220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401408|NCT01416220|Serotonin Agents|serotonin agents|mesh-ancestor
92401409|NCT01416220|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92401410|NCT01416220|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92401411|NCT01416220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92401414|NCT01416337|Trametinib|trametinib|mesh-list
92401415|NCT01416337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401416|NCT01416337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92401417|NCT01416337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401418|NCT01416337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401419|NCT01416350|Azithromycin|azithromycin|mesh-list
92401420|NCT01416350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92401421|NCT01416350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401422|NCT01416415|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92401423|NCT01416415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92401424|NCT01416480|Theobromine|theobromine|mesh-list
92401425|NCT01416480|Dipropizine|dipropizine|mesh-list
92401426|NCT01416480|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92401427|NCT01416480|Autonomic Agents|autonomic agents|mesh-ancestor
92401428|NCT01416480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401429|NCT01416480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401430|NCT01416480|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92401431|NCT01416480|Respiratory System Agents|respiratory system agents|mesh-ancestor
92401432|NCT01416480|Vasodilator Agents|vasodilator agents|mesh-ancestor
92401433|NCT01416480|Antitussive Agents|antitussive agents|mesh-ancestor
92401435|NCT01416558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92401436|NCT01416558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401437|NCT01416558|Tubulin Modulators|tubulin modulators|mesh-ancestor
92401438|NCT01416558|Antimitotic Agents|antimitotic agents|mesh-ancestor
92401439|NCT01416558|Mitosis Modulators|mitosis modulators|mesh-ancestor
92401440|NCT01416558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401441|NCT01416649|Exenatide|exenatide|mesh-list
92401442|NCT01416649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92401443|NCT01416649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401444|NCT01416649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92401445|NCT01416649|Incretins|incretins|mesh-ancestor
92401446|NCT01416649|Hormones|hormones|mesh-ancestor
92401447|NCT01416649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401448|NCT01416662|Gemcitabine|gemcitabine|mesh-list
92401450|NCT01416662|Antimetabolites|antimetabolites|mesh-ancestor
92401451|NCT01416662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401452|NCT01416662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401453|NCT01416701|Vitamin D|vitamin d|mesh-list
92401454|NCT01416701|Cholecalciferol|cholecalciferol|mesh-list
92401455|NCT01416701|Vitamins|vitamins|mesh-list
92401456|NCT01416701|Micronutrients|micronutrients|mesh-ancestor
92401457|NCT01416701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401458|NCT01416701|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401459|NCT01416701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401460|NCT01416870|Bicalutamide|bicalutamide|mesh-list
92401461|NCT01416870|Androgen Antagonists|androgen antagonists|mesh-ancestor
92401462|NCT01416870|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401463|NCT01416870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401464|NCT01416870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401465|NCT01416870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401466|NCT01416883|Bicalutamide|bicalutamide|mesh-list
92401467|NCT01416883|Androgen Antagonists|androgen antagonists|mesh-ancestor
92401468|NCT01416883|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401469|NCT01416883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401470|NCT01416883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401471|NCT01416883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401472|NCT01416909|Laxatives|laxatives|mesh-list
92401473|NCT01416909|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401474|NCT01416948|Methylphenidate|methylphenidate|mesh-list
92401475|NCT01416948|Galantamine|galantamine|mesh-list
92401476|NCT01416948|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92401477|NCT01416948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401478|NCT01416948|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92401479|NCT01416948|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92401480|NCT01416948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401481|NCT01416948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401482|NCT01416948|Dopamine Agents|dopamine agents|mesh-ancestor
92401483|NCT01416948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401484|NCT01416948|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92401485|NCT01416948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401486|NCT01416948|Cholinergic Agents|cholinergic agents|mesh-ancestor
92401487|NCT01416948|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92401488|NCT01416948|Autonomic Agents|autonomic agents|mesh-ancestor
92401489|NCT01416948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401490|NCT01416948|Nootropic Agents|nootropic agents|mesh-ancestor
92401491|NCT01416961|Etoposide|etoposide|mesh-list
92401492|NCT01416961|Cisplatin|cisplatin|mesh-list
92401493|NCT01416961|Etoposide phosphate|etoposide phosphate|mesh-list
92401494|NCT01416961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92401495|NCT01416961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401496|NCT01416961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92401497|NCT01416961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92401498|NCT01416961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401499|NCT01416961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401501|NCT01416974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401502|NCT01416974|Immunologic Factors|immunologic factors|mesh-ancestor
92401503|NCT01416974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401504|NCT01416974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401505|NCT01416974|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92401506|NCT01416974|Alkylating Agents|alkylating agents|mesh-ancestor
92401507|NCT01416974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401508|NCT01416974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401509|NCT01416974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92401510|NCT01417013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92401511|NCT01417013|Lubricant Eye Drops|lubricant eye drops|mesh-list
92401512|NCT01417013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92401513|NCT01417065|Sirolimus|sirolimus|mesh-list
92401515|NCT01417065|MTOR Inhibitors|mtor inhibitors|mesh-list
92401516|NCT01417065|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92401517|NCT01417065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401518|NCT01417065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401519|NCT01417065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401520|NCT01417065|Immunologic Factors|immunologic factors|mesh-ancestor
92401521|NCT01417065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401522|NCT01417065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401523|NCT01417065|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92401524|NCT01417065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401525|NCT01417065|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92401527|NCT01417169|Micafungin|micafungin|mesh-list
92401528|NCT01417169|Antifungal Agents|antifungal agents|mesh-ancestor
92401529|NCT01417169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401530|NCT01417273|Vitamin A|vitamin a|mesh-list
92401531|NCT01417273|Vitamins|vitamins|mesh-ancestor
92401532|NCT01417273|Micronutrients|micronutrients|mesh-ancestor
92401533|NCT01417273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401534|NCT01417351|Vitamin D|vitamin d|mesh-list
92401535|NCT01417351|Ergocalciferols|ergocalciferols|mesh-list
92401536|NCT01417351|Cholecalciferol|cholecalciferol|mesh-list
92401537|NCT01417351|Vitamins|vitamins|mesh-list
92401538|NCT01417351|Micronutrients|micronutrients|mesh-ancestor
92401539|NCT01417351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401540|NCT01417351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401541|NCT01417351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401542|NCT01417364|Methyltestosterone|methyltestosterone|mesh-list
92401543|NCT01417364|Testosterone|testosterone|mesh-list
92401544|NCT01417364|Testosterone undecanoate|testosterone undecanoate|mesh-list
92401545|NCT01417364|Testosterone enanthate|testosterone enanthate|mesh-list
92401546|NCT01417364|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92401547|NCT01417364|Androgens|androgens|mesh-ancestor
92401548|NCT01417364|Hormones|hormones|mesh-ancestor
92401549|NCT01417364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401550|NCT01417364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401551|NCT01417364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92401552|NCT01417364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401553|NCT01417364|Anabolic Agents|anabolic agents|mesh-ancestor
92401554|NCT01417390|Cisplatin|cisplatin|mesh-list
92401555|NCT01417390|Gemcitabine|gemcitabine|mesh-list
92401556|NCT01417390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401557|NCT01417390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92401558|NCT01417390|Antimetabolites|antimetabolites|mesh-ancestor
92401559|NCT01417390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401560|NCT01417403|Hydroxychloroquine|hydroxychloroquine|mesh-list
92401561|NCT01417403|Antimalarials|antimalarials|mesh-ancestor
92401562|NCT01417403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92401563|NCT01417403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92401564|NCT01417403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401565|NCT01417403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401566|NCT01417403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401567|NCT01417403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401568|NCT01417429|Galantamine|galantamine|mesh-list
92401569|NCT01417429|Nicotine|nicotine|mesh-list
92401570|NCT01417429|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92401571|NCT01417429|Autonomic Agents|autonomic agents|mesh-ancestor
92401572|NCT01417429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401573|NCT01417429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401574|NCT01417429|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92401575|NCT01417429|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92401576|NCT01417429|Cholinergic Agents|cholinergic agents|mesh-ancestor
92401577|NCT01417429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401578|NCT01417429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401579|NCT01417429|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92401580|NCT01417429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401581|NCT01417429|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92401582|NCT01417429|Nootropic Agents|nootropic agents|mesh-ancestor
92401583|NCT01417494|Leucovorin|leucovorin|mesh-list
92401584|NCT01417494|Bevacizumab|bevacizumab|mesh-list
92401585|NCT01417494|Fluorouracil|fluorouracil|mesh-list
92401586|NCT01417494|Oxaliplatin|oxaliplatin|mesh-list
92401587|NCT01417494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92401588|NCT01417494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401589|NCT01417494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92401590|NCT01417494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92401591|NCT01417494|Growth Substances|growth substances|mesh-ancestor
92401592|NCT01417494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401593|NCT01417494|Growth Inhibitors|growth inhibitors|mesh-ancestor
92401595|NCT01417494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401596|NCT01417494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92401597|NCT01417494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401598|NCT01417494|Immunologic Factors|immunologic factors|mesh-ancestor
92401600|NCT01417494|Protective Agents|protective agents|mesh-ancestor
92401601|NCT01417494|Vitamin B Complex|vitamin b complex|mesh-ancestor
92401602|NCT01417494|Vitamins|vitamins|mesh-ancestor
92401603|NCT01417494|Micronutrients|micronutrients|mesh-ancestor
92401604|NCT01417572|Lidocaine|lidocaine|mesh-list
92401605|NCT01417572|Anesthetics, Local|anesthetics, local|mesh-ancestor
92401606|NCT01417572|Anesthetics|anesthetics|mesh-ancestor
92401607|NCT01417572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401608|NCT01417572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401609|NCT01417572|Sensory System Agents|sensory system agents|mesh-ancestor
92401610|NCT01417572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401611|NCT01417572|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92401612|NCT01417572|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92401613|NCT01417572|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92401614|NCT01417572|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401615|NCT01417572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401617|NCT01417689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92401618|NCT01417754|Toremifene|toremifene|mesh-list
92401619|NCT01417754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92401620|NCT01417754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401621|NCT01417754|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92401622|NCT01417754|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92401623|NCT01417754|Hormone Antagonists|hormone antagonists|mesh-ancestor
92401624|NCT01417754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401625|NCT01417754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401626|NCT01417754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401627|NCT01417767|Decitabine|decitabine|mesh-list
92401628|NCT01417767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92401629|NCT01417767|Antimetabolites|antimetabolites|mesh-ancestor
92401630|NCT01417767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401631|NCT01417767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401632|NCT01417767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401633|NCT01417806|Topotecan|topotecan|mesh-list
92401634|NCT01417806|Pasireotide|pasireotide|mesh-list
92401635|NCT01417806|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92401636|NCT01417806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92401637|NCT01417806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401638|NCT01417806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401639|NCT01417806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401640|NCT01417806|Hormones|hormones|mesh-ancestor
92401641|NCT01417806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401642|NCT01417806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401643|NCT01417858|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92401644|NCT01417858|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92401645|NCT01417858|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92401646|NCT01417858|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92401647|NCT01417858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92401648|NCT01417858|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401649|NCT01417858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401650|NCT01417858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401651|NCT01417858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401652|NCT01417897|Insulin|insulin|mesh-list
92401653|NCT01417897|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92401654|NCT01417897|Insulin Aspart|insulin aspart|mesh-list
92401655|NCT01417897|Insulin glulisine|insulin glulisine|mesh-list
92401656|NCT01417897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92401657|NCT01417897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401658|NCT01417923|Vitamin D|vitamin d|mesh-list
92401659|NCT01417923|Vitamins|vitamins|mesh-ancestor
92401660|NCT01417923|Micronutrients|micronutrients|mesh-ancestor
92401661|NCT01417923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401662|NCT01417923|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401663|NCT01417949|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92401664|NCT01417949|Antiviral Agents|antiviral agents|mesh-ancestor
92401665|NCT01417949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401666|NCT01418118|Dobutamine|dobutamine|mesh-list
92401667|NCT01418118|Epinephrine|epinephrine|mesh-list
92401668|NCT01418118|Norepinephrine|norepinephrine|mesh-list
92401669|NCT01418118|Dopexamine|dopexamine|mesh-list
92401670|NCT01418118|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92401671|NCT01418118|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92401672|NCT01418118|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401673|NCT01418118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401674|NCT01418118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401675|NCT01418118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401676|NCT01418118|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92401677|NCT01418118|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92401678|NCT01418118|Autonomic Agents|autonomic agents|mesh-ancestor
92401679|NCT01418118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401680|NCT01418118|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92401681|NCT01418118|Respiratory System Agents|respiratory system agents|mesh-ancestor
92401683|NCT01418118|Sympathomimetics|sympathomimetics|mesh-ancestor
92401684|NCT01418118|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92401685|NCT01418118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92401686|NCT01418118|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92401687|NCT01418118|Protective Agents|protective agents|mesh-ancestor
92401688|NCT01418118|Vasodilator Agents|vasodilator agents|mesh-ancestor
92401689|NCT01418118|Dopamine Agonists|dopamine agonists|mesh-ancestor
92401690|NCT01418118|Dopamine Agents|dopamine agents|mesh-ancestor
92401692|NCT01418131|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92401693|NCT01418131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401694|NCT01418131|Immunologic Factors|immunologic factors|mesh-ancestor
92401695|NCT01418131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401696|NCT01418131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401697|NCT01418131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401698|NCT01418144|Ropivacaine|ropivacaine|mesh-list
92401699|NCT01418144|Anesthetics, Local|anesthetics, local|mesh-ancestor
92401700|NCT01418144|Anesthetics|anesthetics|mesh-ancestor
92401701|NCT01418144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401702|NCT01418144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401703|NCT01418144|Sensory System Agents|sensory system agents|mesh-ancestor
92401704|NCT01418144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401705|NCT01418157|Acetazolamide|acetazolamide|mesh-list
92401706|NCT01418157|Anticonvulsants|anticonvulsants|mesh-ancestor
92401707|NCT01418157|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92401708|NCT01418157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401709|NCT01418157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401710|NCT01418157|Diuretics|diuretics|mesh-ancestor
92401711|NCT01418157|Natriuretic Agents|natriuretic agents|mesh-ancestor
92401712|NCT01418157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401713|NCT01418183|Levobupivacaine|levobupivacaine|mesh-list
92401715|NCT01418183|Anesthetics|anesthetics|mesh-ancestor
92401716|NCT01418183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401717|NCT01418183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401718|NCT01418183|Sensory System Agents|sensory system agents|mesh-ancestor
92401719|NCT01418183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401720|NCT01418235|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92401722|NCT01418235|Immunologic Factors|immunologic factors|mesh-ancestor
92401723|NCT01418235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401724|NCT01418274|Ritonavir|ritonavir|mesh-list
92401725|NCT01418274|Escitalopram|escitalopram|mesh-list
92401726|NCT01418274|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92401727|NCT01418274|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92401728|NCT01418274|Protease Inhibitors|protease inhibitors|mesh-ancestor
92401729|NCT01418274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401730|NCT01418274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401731|NCT01418274|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92401732|NCT01418274|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92401733|NCT01418274|Antiviral Agents|antiviral agents|mesh-ancestor
92401734|NCT01418274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401735|NCT01418274|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92401736|NCT01418274|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92401737|NCT01418274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92401738|NCT01418274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92401739|NCT01418274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401740|NCT01418274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401741|NCT01418274|Serotonin Agents|serotonin agents|mesh-ancestor
92401742|NCT01418274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401743|NCT01418417|Pantoprazole|pantoprazole|mesh-list
92401744|NCT01418417|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92401745|NCT01418417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401746|NCT01418417|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92401747|NCT01418417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401748|NCT01418417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401749|NCT01418430|Daclizumab|daclizumab|mesh-list
92401751|NCT01418430|Immunologic Factors|immunologic factors|mesh-ancestor
92401752|NCT01418430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401754|NCT01418443|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92401755|NCT01418443|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92401756|NCT01418443|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92401757|NCT01418443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401758|NCT01418443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401759|NCT01418456|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92401760|NCT01418456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401761|NCT01418521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92401762|NCT01418534|Isosorbide|isosorbide|mesh-list
92401763|NCT01418534|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92401764|NCT01418534|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92401765|NCT01418534|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92401766|NCT01418534|Diuretics|diuretics|mesh-ancestor
92401767|NCT01418534|Natriuretic Agents|natriuretic agents|mesh-ancestor
92401768|NCT01418534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401770|NCT01418534|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92401771|NCT01418534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401772|NCT01418547|Isosorbide|isosorbide|mesh-list
92401773|NCT01418547|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92401774|NCT01418547|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92401775|NCT01418547|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92401776|NCT01418547|Diuretics|diuretics|mesh-ancestor
92401777|NCT01418547|Natriuretic Agents|natriuretic agents|mesh-ancestor
92401778|NCT01418547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401779|NCT01418547|Vasodilator Agents|vasodilator agents|mesh-ancestor
92401780|NCT01418547|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92401781|NCT01418547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401783|NCT01418586|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92401784|NCT01418586|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92401785|NCT01418586|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92401786|NCT01418586|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401787|NCT01418586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401788|NCT01418586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401789|NCT01418586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401790|NCT01418586|Urological Agents|urological agents|mesh-ancestor
92401791|NCT01418599|Alfuzosin|alfuzosin|mesh-list
92401792|NCT01418599|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92401793|NCT01418599|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92401794|NCT01418599|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92401795|NCT01418599|Adrenergic Agents|adrenergic agents|mesh-ancestor
92401796|NCT01418599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401797|NCT01418599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401798|NCT01418599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401799|NCT01418599|Urological Agents|urological agents|mesh-ancestor
92401800|NCT01418612|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92401801|NCT01418612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92401802|NCT01418612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92401803|NCT01418612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401804|NCT01418612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401805|NCT01418612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401806|NCT01418612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401807|NCT01418612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92401808|NCT01418612|Antidepressive Agents|antidepressive agents|mesh-ancestor
92401809|NCT01418612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92401810|NCT01418625|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92401811|NCT01418625|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92401812|NCT01418625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92401813|NCT01418625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401814|NCT01418625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401815|NCT01418625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401816|NCT01418625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401817|NCT01418625|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92401818|NCT01418625|Antidepressive Agents|antidepressive agents|mesh-ancestor
92401819|NCT01418625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92401820|NCT01418651|Milnacipran|milnacipran|mesh-list
92401821|NCT01418651|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92401822|NCT01418651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92401823|NCT01418651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401824|NCT01418651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401825|NCT01418651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017638|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92401826|NCT01418651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401827|NCT01418651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92401828|NCT01418651|Analgesics|analgesics|mesh-ancestor
92401829|NCT01418651|Sensory System Agents|sensory system agents|mesh-ancestor
92401830|NCT01418651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401831|NCT01418729|Pravastatin|pravastatin|mesh-list
92401832|NCT01418729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92401833|NCT01418729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92401834|NCT01418729|Antimetabolites|antimetabolites|mesh-ancestor
92401835|NCT01418729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401836|NCT01418729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92401837|NCT01418729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92401838|NCT01418729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401839|NCT01418742|Doxycycline|doxycycline|mesh-list
92401840|NCT01418742|Panitumumab|panitumumab|mesh-list
92401841|NCT01418742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92401842|NCT01418742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401843|NCT01418742|Antimalarials|antimalarials|mesh-ancestor
92401844|NCT01418742|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92401845|NCT01418742|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92401846|NCT01418742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92401847|NCT01418742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401848|NCT01418794|Sirolimus|sirolimus|mesh-list
92401849|NCT01418794|Temsirolimus|temsirolimus|mesh-list
92401850|NCT01418794|MTOR Inhibitors|mtor inhibitors|mesh-list
92401851|NCT01418794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92401852|NCT01418794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401853|NCT01418794|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92401854|NCT01418794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401855|NCT01418794|Antifungal Agents|antifungal agents|mesh-ancestor
92401856|NCT01418794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401857|NCT01418794|Immunologic Factors|immunologic factors|mesh-ancestor
92401858|NCT01418794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401859|NCT01418794|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92401860|NCT01418794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401861|NCT01418794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401862|NCT01419041|Crizotinib|crizotinib|mesh-list
92401863|NCT01419041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401864|NCT01419041|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92401865|NCT01419041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401866|NCT01419041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401867|NCT01419119|Cholecalciferol|cholecalciferol|mesh-list
92401868|NCT01419119|Vitamin D|vitamin d|mesh-list
92401869|NCT01419119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92401870|NCT01419119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401871|NCT01419119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401872|NCT01419119|Vitamins|vitamins|mesh-ancestor
92401873|NCT01419119|Micronutrients|micronutrients|mesh-ancestor
92401874|NCT01419119|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401875|NCT01419132|Furosemide|furosemide|mesh-list
92401876|NCT01419132|Diuretics|diuretics|mesh-list
92401877|NCT01419132|Natriuretic Agents|natriuretic agents|mesh-ancestor
92401878|NCT01419132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401879|NCT01419132|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92401880|NCT01419132|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401881|NCT01419132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401882|NCT01419262|Vitamin D|vitamin d|mesh-list
92401883|NCT01419262|Ergocalciferols|ergocalciferols|mesh-list
92401884|NCT01419262|Cholecalciferol|cholecalciferol|mesh-list
92401885|NCT01419262|Vitamins|vitamins|mesh-list
92401886|NCT01419262|Micronutrients|micronutrients|mesh-ancestor
92401887|NCT01419262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401888|NCT01419262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401889|NCT01419262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401891|NCT01419340|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92401892|NCT01419340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401893|NCT01419340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401894|NCT01419340|Cholinergic Agents|cholinergic agents|mesh-ancestor
92401895|NCT01419340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401896|NCT01419340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401898|NCT01419353|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92401900|NCT01419353|Estradiol|estradiol|mesh-list
92401901|NCT01419353|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92401902|NCT01419353|Estrogens|estrogens|mesh-ancestor
92401903|NCT01419353|Hormones|hormones|mesh-ancestor
92401904|NCT01419353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92401905|NCT01419353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401906|NCT01419353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92401907|NCT01419353|Contraceptive Agents|contraceptive agents|mesh-ancestor
92401908|NCT01419353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92401909|NCT01419353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92401910|NCT01419366|Donepezil|donepezil|mesh-list
92401911|NCT01419366|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92401912|NCT01419366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401913|NCT01419366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401914|NCT01419366|Cholinergic Agents|cholinergic agents|mesh-ancestor
92401915|NCT01419366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92401916|NCT01419366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401918|NCT01419392|Sildenafil Citrate|sildenafil citrate|mesh-list
92401919|NCT01419392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401920|NCT01419392|Vasodilator Agents|vasodilator agents|mesh-ancestor
92401921|NCT01419392|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92401922|NCT01419392|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92401923|NCT01419392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401924|NCT01419392|Urological Agents|urological agents|mesh-ancestor
92401925|NCT01419405|Pregabalin|pregabalin|mesh-list
92401926|NCT01419405|Remifentanil|remifentanil|mesh-list
92401927|NCT01419405|Analgesics|analgesics|mesh-ancestor
92401928|NCT01419405|Sensory System Agents|sensory system agents|mesh-ancestor
92401929|NCT01419405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401930|NCT01419405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401931|NCT01419405|Anticonvulsants|anticonvulsants|mesh-ancestor
92401932|NCT01419405|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92401933|NCT01419405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92401934|NCT01419405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401935|NCT01419405|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401936|NCT01419405|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92401937|NCT01419405|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92401938|NCT01419405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92401939|NCT01419405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92401940|NCT01419405|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92401941|NCT01419405|Narcotics|narcotics|mesh-ancestor
92401942|NCT01419457|Favipiravir|favipiravir|mesh-list
92401943|NCT01419457|Antiviral Agents|antiviral agents|mesh-ancestor
92401944|NCT01419457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401945|NCT01419548|Paclitaxel|paclitaxel|mesh-list
92401946|NCT01419548|Carboplatin|carboplatin|mesh-list
92401947|NCT01419548|Veliparib|veliparib|mesh-list
92401948|NCT01419548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92401949|NCT01419548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92401950|NCT01419548|Tubulin Modulators|tubulin modulators|mesh-ancestor
92401951|NCT01419548|Antimitotic Agents|antimitotic agents|mesh-ancestor
92401952|NCT01419548|Mitosis Modulators|mitosis modulators|mesh-ancestor
92401953|NCT01419548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401954|NCT01419548|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92401955|NCT01419548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92401956|NCT01419652|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92401957|NCT01419652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401958|NCT01419691|Auranofin|auranofin|mesh-list
92401959|NCT01419691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401960|NCT01419730|Vitamin D|vitamin d|mesh-list
92401961|NCT01419730|Cholecalciferol|cholecalciferol|mesh-list
92401962|NCT01419730|Vitamins|vitamins|mesh-ancestor
92401963|NCT01419730|Micronutrients|micronutrients|mesh-ancestor
92401964|NCT01419730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401965|NCT01419730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401966|NCT01419730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401968|NCT01419821|Ergocalciferols|ergocalciferols|mesh-list
92401969|NCT01419821|Cholecalciferol|cholecalciferol|mesh-list
92401970|NCT01419821|Vitamins|vitamins|mesh-list
92401971|NCT01419821|Micronutrients|micronutrients|mesh-ancestor
92401972|NCT01419821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401973|NCT01419821|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92401974|NCT01419821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92401976|NCT01419847|Antifungal Agents|antifungal agents|mesh-ancestor
92401977|NCT01419847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92401978|NCT01419873|Insulin|insulin|mesh-list
92401979|NCT01419873|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92401980|NCT01419873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92401981|NCT01419873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401982|NCT01420055|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92401983|NCT01420055|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92401984|NCT01420055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92401985|NCT01420055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92401986|NCT01420055|Immunologic Factors|immunologic factors|mesh-ancestor
92401987|NCT01420055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401988|NCT01420094|Aspirin|aspirin|mesh-list
92401989|NCT01420094|Acetaminophen|acetaminophen|mesh-list
92401990|NCT01420094|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92401991|NCT01420094|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92401992|NCT01420094|Analgesics|analgesics|mesh-ancestor
92401993|NCT01420094|Sensory System Agents|sensory system agents|mesh-ancestor
92401994|NCT01420094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92401995|NCT01420094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92401997|NCT01420094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92401998|NCT01420094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92401999|NCT01420094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92402000|NCT01420094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402001|NCT01420094|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92402002|NCT01420094|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92402003|NCT01420094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402004|NCT01420094|Antipyretics|antipyretics|mesh-ancestor
92402005|NCT01420159|Methoxyflurane|methoxyflurane|mesh-list
92402006|NCT01420159|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92402007|NCT01420159|Anesthetics, General|anesthetics, general|mesh-ancestor
92402008|NCT01420159|Anesthetics|anesthetics|mesh-ancestor
92402009|NCT01420159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402010|NCT01420159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402012|NCT01420302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92402013|NCT01420302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92402014|NCT01420302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402016|NCT01420328|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92402017|NCT01420328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92402018|NCT01420328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92402020|NCT01420328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402022|NCT01420328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92402023|NCT01420328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402024|NCT01420341|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92402025|NCT01420341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92402026|NCT01420341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402027|NCT01420341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402028|NCT01420341|Antimalarials|antimalarials|mesh-ancestor
92402029|NCT01420341|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92402030|NCT01420341|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92402031|NCT01420367|Metronidazole|metronidazole|mesh-list
92402032|NCT01420367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402033|NCT01420367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402034|NCT01420367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92402035|NCT01420367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92402036|NCT01420406|Vitamin A|vitamin a|mesh-list
92402037|NCT01420406|Vitamins|vitamins|mesh-ancestor
92402039|NCT01420406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402040|NCT01420471|Triamcinolone|triamcinolone|mesh-list
92402041|NCT01420471|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92402042|NCT01420471|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92402043|NCT01420471|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92402044|NCT01420471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402045|NCT01420471|Glucocorticoids|glucocorticoids|mesh-ancestor
92402046|NCT01420471|Hormones|hormones|mesh-ancestor
92402047|NCT01420471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402048|NCT01420471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402049|NCT01420471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92402050|NCT01420471|Immunologic Factors|immunologic factors|mesh-ancestor
92402051|NCT01420471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402052|NCT01420471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402053|NCT01420523|Raltegravir Potassium|raltegravir potassium|mesh-list
92402054|NCT01420523|Maraviroc|maraviroc|mesh-list
92402055|NCT01420523|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92402056|NCT01420523|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92402057|NCT01420523|Antiviral Agents|antiviral agents|mesh-ancestor
92402058|NCT01420523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402059|NCT01420523|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92402060|NCT01420523|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92402062|NCT01420523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402063|NCT01420523|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92402064|NCT01420523|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92402065|NCT01420523|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92402067|NCT01420575|Antiemetics|antiemetics|mesh-ancestor
92402068|NCT01420575|Autonomic Agents|autonomic agents|mesh-ancestor
92402069|NCT01420575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402070|NCT01420575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402071|NCT01420575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92402072|NCT01420575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92402073|NCT01420575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92402074|NCT01420575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402075|NCT01420575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92402076|NCT01420575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92402077|NCT01420575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92402078|NCT01420575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402079|NCT01420575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402080|NCT01420575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402081|NCT01420575|Serotonin Agents|serotonin agents|mesh-ancestor
92402082|NCT01420666|Acetaminophen|acetaminophen|mesh-list
92402083|NCT01420666|Ibuprofen|ibuprofen|mesh-list
92402084|NCT01420666|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92402085|NCT01420666|Analgesics|analgesics|mesh-ancestor
92402086|NCT01420666|Sensory System Agents|sensory system agents|mesh-ancestor
92402087|NCT01420666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402088|NCT01420666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402089|NCT01420666|Antipyretics|antipyretics|mesh-ancestor
92402090|NCT01420666|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402091|NCT01420666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402092|NCT01420666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402093|NCT01420666|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92402094|NCT01420666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402095|NCT01420666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402096|NCT01420692|Insulin Detemir|insulin detemir|mesh-list
92402097|NCT01420692|Gliclazide|gliclazide|mesh-list
92402098|NCT01420692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92402099|NCT01420692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402100|NCT01420822|Fluticasone|fluticasone|mesh-list
92402101|NCT01420822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402102|NCT01420822|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92402103|NCT01420822|Autonomic Agents|autonomic agents|mesh-ancestor
92402104|NCT01420822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402105|NCT01420822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402106|NCT01420822|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92402107|NCT01420822|Respiratory System Agents|respiratory system agents|mesh-ancestor
92402108|NCT01420822|Dermatologic Agents|dermatologic agents|mesh-ancestor
92402109|NCT01420822|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92402110|NCT01420900|Tacrine|tacrine|mesh-list
91938117|NCT02035137|Vorinostat|vorinostat|mesh-list
92402111|NCT01420900|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92402112|NCT01420900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402113|NCT01420900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402114|NCT01420900|Cholinergic Agents|cholinergic agents|mesh-ancestor
92402115|NCT01420900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402116|NCT01420900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402117|NCT01420900|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92402119|NCT01420900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402120|NCT01420900|Nootropic Agents|nootropic agents|mesh-ancestor
92402121|NCT01420913|Pregabalin|pregabalin|mesh-list
92402122|NCT01420913|Analgesics|analgesics|mesh-ancestor
92402123|NCT01420913|Sensory System Agents|sensory system agents|mesh-ancestor
92054465|NCT02520154|Paclitaxel|paclitaxel|mesh-list
92402124|NCT01420913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402125|NCT01420913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402126|NCT01420913|Anticonvulsants|anticonvulsants|mesh-ancestor
92402127|NCT01420913|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92402128|NCT01420913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402129|NCT01420913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402130|NCT01420913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402131|NCT01420913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92402132|NCT01420913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92402133|NCT01420913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402135|NCT01421043|Triazolam|triazolam|mesh-list
92017786|NCT04633577|Lidocaine|lidocaine|mesh-list
92402136|NCT01421043|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92402137|NCT01421043|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92402138|NCT01421043|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92402139|NCT01421043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402140|NCT01421043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402141|NCT01421043|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92402142|NCT01421043|GABA Modulators|gaba modulators|mesh-ancestor
92402143|NCT01421043|GABA Agents|gaba agents|mesh-ancestor
92402144|NCT01421043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402145|NCT01421043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402146|NCT01421121|Vaccines|vaccines|mesh-list
92402147|NCT01421121|Immunologic Factors|immunologic factors|mesh-ancestor
92402148|NCT01421121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402149|NCT01421160|Citric Acid|citric acid|mesh-list
92402150|NCT01421160|Sodium Citrate|sodium citrate|mesh-list
92402151|NCT01421160|Anticoagulants|anticoagulants|mesh-ancestor
92402152|NCT01421160|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92402153|NCT01421160|Chelating Agents|chelating agents|mesh-ancestor
92402154|NCT01421160|Sequestering Agents|sequestering agents|mesh-ancestor
92402155|NCT01421160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402156|NCT01421173|Dexamethasone|dexamethasone|mesh-list
92402157|NCT01421173|Dexamethasone acetate|dexamethasone acetate|mesh-list
92402158|NCT01421173|Rituximab|rituximab|mesh-list
92402159|NCT01421173|Gemcitabine|gemcitabine|mesh-list
92402160|NCT01421173|Melphalan|melphalan|mesh-list
92402161|NCT01421173|Busulfan|busulfan|mesh-list
92402162|NCT01421173|Vorinostat|vorinostat|mesh-list
92402163|NCT01421173|BB 1101|bb 1101|mesh-list
92402164|NCT01421173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92402165|NCT01421173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402166|NCT01421173|Immunologic Factors|immunologic factors|mesh-ancestor
92402167|NCT01421173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402168|NCT01421173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402169|NCT01421173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402170|NCT01421173|Antiemetics|antiemetics|mesh-ancestor
92402171|NCT01421173|Autonomic Agents|autonomic agents|mesh-ancestor
92402172|NCT01421173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402173|NCT01421173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92402174|NCT01421173|Glucocorticoids|glucocorticoids|mesh-ancestor
92402175|NCT01421173|Hormones|hormones|mesh-ancestor
92402176|NCT01421173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402177|NCT01421173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92136489|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
92402178|NCT01421173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92402179|NCT01421173|Antimetabolites|antimetabolites|mesh-ancestor
92402180|NCT01421173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402181|NCT01421173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92402182|NCT01421173|Alkylating Agents|alkylating agents|mesh-ancestor
92402183|NCT01421173|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92402184|NCT01421173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92402186|NCT01421173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402187|NCT01421173|Protease Inhibitors|protease inhibitors|mesh-ancestor
92402188|NCT01421212|Immunoglobulins|immunoglobulins|mesh-list
92402189|NCT01421212|Antibodies|antibodies|mesh-list
92402190|NCT01421212|gamma-Globulins|gamma-globulins|mesh-list
92402191|NCT01421212|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92402192|NCT01421212|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92402193|NCT01421212|Immunoglobulin G|immunoglobulin g|mesh-list
92402194|NCT01421212|Immunologic Factors|immunologic factors|mesh-ancestor
92402195|NCT01421212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402196|NCT01421368|Tenofovir|tenofovir|mesh-list
92402197|NCT01421368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92402198|NCT01421368|Contraceptive Agents|contraceptive agents|mesh-list
92402199|NCT01421368|Medroxyprogesterone|medroxyprogesterone|mesh-list
92402200|NCT01421368|Contraceptives, Oral|contraceptives, oral|mesh-list
92402201|NCT01421368|Antiviral Agents|antiviral agents|mesh-ancestor
92402202|NCT01421368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402203|NCT01421368|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92402204|NCT01421368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92402205|NCT01421368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402206|NCT01421368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402207|NCT01421368|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92402208|NCT01421368|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92402209|NCT01421368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92402210|NCT01421368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402211|NCT01421368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92402212|NCT01421368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92402213|NCT01421368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92402214|NCT01421368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92402215|NCT01421368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92402216|NCT01421368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402217|NCT01421368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402219|NCT01421693|Gatifloxacin|gatifloxacin|mesh-list
92402220|NCT01421693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402221|NCT01421693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402222|NCT01421693|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92402223|NCT01421693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92402224|NCT01421693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92402225|NCT01421693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92402226|NCT01421693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402227|NCT01421693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402228|NCT01421693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402229|NCT01421706|Clarithromycin|clarithromycin|mesh-list
92402230|NCT01421706|Sibutramine|sibutramine|mesh-list
92402231|NCT01421706|Clopidogrel|clopidogrel|mesh-list
92402232|NCT01421706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92402233|NCT01421706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92402234|NCT01421706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92402235|NCT01421706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92402236|NCT01421706|Purinergic Agents|purinergic agents|mesh-ancestor
92402237|NCT01421706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402238|NCT01421706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402239|NCT01421706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402240|NCT01421706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402241|NCT01421706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402242|NCT01421706|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92402243|NCT01421706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402244|NCT01421706|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92402245|NCT01421706|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92402246|NCT01421706|Antidepressive Agents|antidepressive agents|mesh-ancestor
92402247|NCT01421706|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92402248|NCT01421706|Appetite Depressants|appetite depressants|mesh-ancestor
92402249|NCT01421706|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92402250|NCT01421771|Antihypertensive Agents|antihypertensive agents|mesh-list
92402251|NCT01421901|Ertapenem|ertapenem|mesh-list
92402252|NCT01421901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402253|NCT01421901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402255|NCT01421914|Anesthetics, Local|anesthetics, local|mesh-ancestor
92402256|NCT01421914|Anesthetics|anesthetics|mesh-ancestor
92402257|NCT01421914|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402258|NCT01421914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402259|NCT01421914|Sensory System Agents|sensory system agents|mesh-ancestor
92402260|NCT01421914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402261|NCT01421927|Lenalidomide|lenalidomide|mesh-list
92402262|NCT01421927|Immunologic Factors|immunologic factors|mesh-ancestor
92402263|NCT01421927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402264|NCT01421927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92402265|NCT01421927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92402266|NCT01421927|Growth Substances|growth substances|mesh-ancestor
92402267|NCT01421927|Growth Inhibitors|growth inhibitors|mesh-ancestor
92402268|NCT01421927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402269|NCT01421940|Udenafil|udenafil|mesh-list
92402270|NCT01421940|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92402271|NCT01421940|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92402272|NCT01421940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402273|NCT01421940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402274|NCT01421979|Caffeine|caffeine|mesh-list
92402275|NCT01421979|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92402276|NCT01421979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402277|NCT01421979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92402278|NCT01421979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402279|NCT01421979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402280|NCT01421979|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92402281|NCT01421979|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92402282|NCT01421979|Purinergic Agents|purinergic agents|mesh-ancestor
92402283|NCT01421979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402285|NCT01421992|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92402286|NCT01421992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402287|NCT01421992|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92402288|NCT01421992|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92402289|NCT01421992|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402290|NCT01421992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402291|NCT01421992|Dopamine Agents|dopamine agents|mesh-ancestor
92402292|NCT01421992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402293|NCT01422018|Bevacizumab|bevacizumab|mesh-list
92402294|NCT01422018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92402295|NCT01422018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402296|NCT01422018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92402297|NCT01422018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92402298|NCT01422018|Growth Substances|growth substances|mesh-ancestor
92402299|NCT01422018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402300|NCT01422018|Growth Inhibitors|growth inhibitors|mesh-ancestor
92402301|NCT01422096|Leuprolide|leuprolide|mesh-list
92402303|NCT01422096|Fertility Agents|fertility agents|mesh-ancestor
92402304|NCT01422096|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92402305|NCT01422096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402306|NCT01422096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402307|NCT01422096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402308|NCT01422109|Aspirin|aspirin|mesh-list
92402309|NCT01422109|Clopidogrel|clopidogrel|mesh-list
92402310|NCT01422109|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402311|NCT01422109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92402312|NCT01422109|Analgesics|analgesics|mesh-ancestor
92402313|NCT01422109|Sensory System Agents|sensory system agents|mesh-ancestor
92402314|NCT01422109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402315|NCT01422109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402316|NCT01422109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402317|NCT01422109|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402318|NCT01422109|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92402319|NCT01422109|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92402320|NCT01422109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402321|NCT01422109|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92402322|NCT01422109|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92402324|NCT01422109|Antipyretics|antipyretics|mesh-ancestor
92402325|NCT01422109|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92402326|NCT01422109|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92402327|NCT01422109|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92402328|NCT01422109|Purinergic Agents|purinergic agents|mesh-ancestor
92402329|NCT01422109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402330|NCT01422122|Vitamin D|vitamin d|mesh-list
92402331|NCT01422122|Ergocalciferols|ergocalciferols|mesh-list
92402332|NCT01422122|Cholecalciferol|cholecalciferol|mesh-list
92402333|NCT01422122|Vitamins|vitamins|mesh-list
92402334|NCT01422122|Micronutrients|micronutrients|mesh-ancestor
92402335|NCT01422122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402336|NCT01422122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92402337|NCT01422122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402338|NCT01422291|Acetaminophen|acetaminophen|mesh-list
92402339|NCT01422291|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92402340|NCT01422291|Morphine|morphine|mesh-list
92402341|NCT01422291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92402342|NCT01422291|Narcotics|narcotics|mesh-ancestor
92402343|NCT01422291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402344|NCT01422291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402346|NCT01422291|Sensory System Agents|sensory system agents|mesh-ancestor
92402347|NCT01422291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402348|NCT01422291|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92402349|NCT01422291|Antipyretics|antipyretics|mesh-ancestor
92402350|NCT01422291|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402352|NCT01422291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402353|NCT01422317|Tocopherols|tocopherols|mesh-list
92402354|NCT01422317|Vitamin E|vitamin e|mesh-list
92402355|NCT01422317|Tocotrienols|tocotrienols|mesh-list
92402356|NCT01422317|alpha-Tocopherol|alpha-tocopherol|mesh-list
92402357|NCT01422317|Antioxidants|antioxidants|mesh-ancestor
92402358|NCT01422317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402359|NCT01422317|Protective Agents|protective agents|mesh-ancestor
92402360|NCT01422317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402362|NCT01422317|Micronutrients|micronutrients|mesh-ancestor
92402363|NCT01422330|Etravirine|etravirine|mesh-list
92402364|NCT01422330|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92402365|NCT01422330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92402366|NCT01422330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402367|NCT01422330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402368|NCT01422330|Antiviral Agents|antiviral agents|mesh-ancestor
92402369|NCT01422330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402370|NCT01422460|Mitogens|mitogens|mesh-list
92402371|NCT01422460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92402372|NCT01422460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402373|NCT01422499|Vorinostat|vorinostat|mesh-list
92402374|NCT01422499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402375|NCT01422499|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92402376|NCT01422499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402377|NCT01422499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402378|NCT01422590|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92402379|NCT01422590|Mitiglinide|mitiglinide|mesh-list
92402380|NCT01422590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92402381|NCT01422590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402382|NCT01422590|Incretins|incretins|mesh-ancestor
92402383|NCT01422590|Hormones|hormones|mesh-ancestor
92402384|NCT01422590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402385|NCT01422590|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92402386|NCT01422590|Protease Inhibitors|protease inhibitors|mesh-ancestor
92402387|NCT01422590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402388|NCT01422590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402389|NCT01422603|Clofarabine|clofarabine|mesh-list
92402390|NCT01422603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92402391|NCT01422603|Antimetabolites|antimetabolites|mesh-ancestor
92402392|NCT01422603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402393|NCT01422603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402394|NCT01422616|Metoprolol|metoprolol|mesh-list
92402395|NCT01422616|Clonidine|clonidine|mesh-list
92402396|NCT01422616|Labetalol|labetalol|mesh-list
92402397|NCT01422616|Hydralazine|hydralazine|mesh-list
92402398|NCT01422616|Nicardipine|nicardipine|mesh-list
92402399|NCT01422616|Phentolamine|phentolamine|mesh-list
92402400|NCT01422616|Urapidil|urapidil|mesh-list
92402401|NCT01422616|Enalaprilat|enalaprilat|mesh-list
92402402|NCT01422616|Enalapril|enalapril|mesh-list
92402403|NCT01422616|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92402404|NCT01422616|Nitroglycerin|nitroglycerin|mesh-list
92402406|NCT01422616|Glycerol|glycerol|mesh-list
92402407|NCT01422616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92402408|NCT01422616|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92402409|NCT01422616|Sympatholytics|sympatholytics|mesh-ancestor
92402410|NCT01422616|Autonomic Agents|autonomic agents|mesh-ancestor
92402411|NCT01422616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402412|NCT01422616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402413|NCT01422616|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92402414|NCT01422616|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92402415|NCT01422616|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92402416|NCT01422616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92402417|NCT01422616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402418|NCT01422616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402419|NCT01422616|Analgesics|analgesics|mesh-ancestor
92402420|NCT01422616|Sensory System Agents|sensory system agents|mesh-ancestor
92402421|NCT01422616|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92402422|NCT01422616|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92402423|NCT01422616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92402424|NCT01422616|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92402425|NCT01422616|Protective Agents|protective agents|mesh-ancestor
92402426|NCT01422616|Sympathomimetics|sympathomimetics|mesh-ancestor
92402427|NCT01422616|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92402428|NCT01422616|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92402429|NCT01422616|Vasodilator Agents|vasodilator agents|mesh-ancestor
92402430|NCT01422616|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92402431|NCT01422616|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92402432|NCT01422616|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92402433|NCT01422616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402434|NCT01422616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402435|NCT01422616|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92402436|NCT01422616|Serotonin Agents|serotonin agents|mesh-ancestor
92402437|NCT01422616|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92402438|NCT01422616|Protease Inhibitors|protease inhibitors|mesh-ancestor
92402439|NCT01422616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402441|NCT01422707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402443|NCT01422733|Hydrocortisone|hydrocortisone|mesh-list
92402444|NCT01422733|Cosyntropin|cosyntropin|mesh-list
92402445|NCT01422733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402446|NCT01422733|Antiemetics|antiemetics|mesh-ancestor
92402447|NCT01422733|Autonomic Agents|autonomic agents|mesh-ancestor
92402448|NCT01422733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402449|NCT01422733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402450|NCT01422733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92402451|NCT01422733|Glucocorticoids|glucocorticoids|mesh-ancestor
92402453|NCT01422733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402454|NCT01422733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402455|NCT01422733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402456|NCT01422785|Clindamycin|clindamycin|mesh-list
92402457|NCT01422785|Clindamycin palmitate|clindamycin palmitate|mesh-list
92402458|NCT01422785|Clindamycin phosphate|clindamycin phosphate|mesh-list
92402460|NCT01422785|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92402461|NCT01422785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402462|NCT01422785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402463|NCT01422785|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92402464|NCT01422785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402465|NCT01422785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402466|NCT01422785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92402467|NCT01422785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402468|NCT01422785|Keratolytic Agents|keratolytic agents|mesh-ancestor
92402469|NCT01422954|Chloroquine|chloroquine|mesh-list
92402470|NCT01422954|Mefloquine|mefloquine|mesh-list
92402471|NCT01422954|Proguanil|proguanil|mesh-list
92402472|NCT01422954|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92402473|NCT01422954|Amebicides|amebicides|mesh-ancestor
92402474|NCT01422954|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92402475|NCT01422954|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92402476|NCT01422954|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402477|NCT01422954|Antimalarials|antimalarials|mesh-ancestor
92402478|NCT01422954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402479|NCT01422954|Antimetabolites|antimetabolites|mesh-ancestor
92402480|NCT01422954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402481|NCT01423019|Synephrine|synephrine|mesh-list
92402482|NCT01423019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92402483|NCT01423019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92402484|NCT01423019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92402485|NCT01423019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402486|NCT01423019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402487|NCT01423019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402488|NCT01423019|Sympathomimetics|sympathomimetics|mesh-ancestor
92402489|NCT01423019|Autonomic Agents|autonomic agents|mesh-ancestor
92402490|NCT01423019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402491|NCT01423019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92402492|NCT01423019|Nasal Decongestants|nasal decongestants|mesh-ancestor
92402493|NCT01423019|Respiratory System Agents|respiratory system agents|mesh-ancestor
92402494|NCT01423032|Fludarabine|fludarabine|mesh-list
92402495|NCT01423032|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92402496|NCT01423032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402497|NCT01423032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402498|NCT01423032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92402499|NCT01423032|Alkylating Agents|alkylating agents|mesh-ancestor
92402500|NCT01423123|Paclitaxel|paclitaxel|mesh-list
92402501|NCT01423123|Trastuzumab|trastuzumab|mesh-list
92402502|NCT01423123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92402503|NCT01423123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402504|NCT01423123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92402505|NCT01423123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92402506|NCT01423123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92402507|NCT01423123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402508|NCT01423123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92402510|NCT01423175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92402512|NCT01423175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402513|NCT01423175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402514|NCT01423240|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92402515|NCT01423240|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92402516|NCT01423240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92402517|NCT01423240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402518|NCT01423240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402519|NCT01423240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92402520|NCT01423240|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92402521|NCT01423240|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92402522|NCT01423240|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92402523|NCT01423240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92402524|NCT01423240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402525|NCT01423240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402526|NCT01423240|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92402527|NCT01423240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92402528|NCT01423240|Serotonin Agents|serotonin agents|mesh-ancestor
92402529|NCT01423240|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92402530|NCT01423240|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92402531|NCT01423240|Dopamine Agents|dopamine agents|mesh-ancestor
92402532|NCT01423292|Bupivacaine|bupivacaine|mesh-list
92402533|NCT01423292|Anesthetics, Local|anesthetics, local|mesh-ancestor
92402534|NCT01423292|Anesthetics|anesthetics|mesh-ancestor
92136950|NCT00604461|Pemetrexed|pemetrexed|mesh-list
92402535|NCT01423292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402536|NCT01423292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402537|NCT01423292|Sensory System Agents|sensory system agents|mesh-ancestor
92402538|NCT01423292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402539|NCT01423305|Budesonide|budesonide|mesh-list
92402540|NCT01423305|Formoterol Fumarate|formoterol fumarate|mesh-list
92402541|NCT01423305|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92402542|NCT01423305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402543|NCT01423305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92402544|NCT01423305|Autonomic Agents|autonomic agents|mesh-ancestor
92402545|NCT01423305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402546|NCT01423305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402547|NCT01423305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92402548|NCT01423305|Respiratory System Agents|respiratory system agents|mesh-ancestor
92402550|NCT01423305|Hormones|hormones|mesh-ancestor
92402551|NCT01423305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402552|NCT01423305|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92402553|NCT01423305|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92402554|NCT01423305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92402555|NCT01423305|Adrenergic Agents|adrenergic agents|mesh-ancestor
92402556|NCT01423305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402557|NCT01423305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402559|NCT01423370|Vasodilator Agents|vasodilator agents|mesh-ancestor
92402560|NCT01423370|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92402561|NCT01423370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92402562|NCT01423370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402563|NCT01423370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402564|NCT01423370|Urological Agents|urological agents|mesh-ancestor
92402565|NCT01423435|Beraprost|beraprost|mesh-list
92402566|NCT01423435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92402567|NCT01423435|Vasodilator Agents|vasodilator agents|mesh-ancestor
92402568|NCT01423487|Metformin|metformin|mesh-list
92402569|NCT01423487|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92402570|NCT01423487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402571|NCT01423500|Fludarabine|fludarabine|mesh-list
92402572|NCT01423500|Etoposide|etoposide|mesh-list
92402573|NCT01423500|Etoposide phosphate|etoposide phosphate|mesh-list
92402574|NCT01423500|Thiotepa|thiotepa|mesh-list
92402575|NCT01423500|Treosulfan|treosulfan|mesh-list
92054970|NCT02141633|Xhance|xhance|mesh-list
92402576|NCT01423500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402577|NCT01423500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402578|NCT01423500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92402579|NCT01423500|Immunologic Factors|immunologic factors|mesh-ancestor
92402580|NCT01423500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402581|NCT01423500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92402582|NCT01423500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92402584|NCT01423500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402585|NCT01423500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92402586|NCT01423500|Alkylating Agents|alkylating agents|mesh-ancestor
92402587|NCT01423500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92402589|NCT01423539|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92402590|NCT01423539|Navitoclax|navitoclax|mesh-list
92402591|NCT01423539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92402592|NCT01423539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402593|NCT01423539|Immunologic Factors|immunologic factors|mesh-ancestor
92402594|NCT01423539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402595|NCT01423539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402596|NCT01423539|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92402597|NCT01423539|Alkylating Agents|alkylating agents|mesh-ancestor
92402598|NCT01423539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402600|NCT01423591|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92402601|NCT01423591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402602|NCT01423591|Dermatologic Agents|dermatologic agents|mesh-ancestor
92402603|NCT01423591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92402604|NCT01423591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402605|NCT01423695|Paclitaxel|paclitaxel|mesh-list
92402606|NCT01423695|Trastuzumab|trastuzumab|mesh-list
92402607|NCT01423695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92402608|NCT01423695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402609|NCT01423695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92402610|NCT01423695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92402611|NCT01423695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92402612|NCT01423695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402613|NCT01423695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92402615|NCT01423708|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92402616|NCT01423708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92402617|NCT01423708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402618|NCT01423708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402619|NCT01423708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92402620|NCT01423708|Immunologic Factors|immunologic factors|mesh-ancestor
92402621|NCT01423708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402622|NCT01423708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402623|NCT01423747|Fludarabine|fludarabine|mesh-list
92402625|NCT01423747|Etoposide phosphate|etoposide phosphate|mesh-list
92402626|NCT01423747|Thiotepa|thiotepa|mesh-list
92402627|NCT01423747|Treosulfan|treosulfan|mesh-list
92402628|NCT01423747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402629|NCT01423747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402630|NCT01423747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92402631|NCT01423747|Immunologic Factors|immunologic factors|mesh-ancestor
92402632|NCT01423747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402633|NCT01423747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92402634|NCT01423747|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92402635|NCT01423747|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92402636|NCT01423747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402637|NCT01423747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92402638|NCT01423747|Alkylating Agents|alkylating agents|mesh-ancestor
92402639|NCT01423747|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92402640|NCT01423838|Solifenacin Succinate|solifenacin succinate|mesh-list
92402642|NCT01423838|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92402643|NCT01423838|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92402644|NCT01423838|Cholinergic Agents|cholinergic agents|mesh-ancestor
92402645|NCT01423838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402646|NCT01423838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402647|NCT01423838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402648|NCT01423838|Urological Agents|urological agents|mesh-ancestor
92402649|NCT01423838|Parasympatholytics|parasympatholytics|mesh-ancestor
92402650|NCT01423838|Autonomic Agents|autonomic agents|mesh-ancestor
92402651|NCT01423838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402652|NCT01423864|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92402653|NCT01423864|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92402655|NCT01423864|Prednisolone|prednisolone|mesh-list
92402656|NCT01423864|Prednisolone acetate|prednisolone acetate|mesh-list
92402657|NCT01423864|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92402658|NCT01423864|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92402659|NCT01423864|Prednisolone phosphate|prednisolone phosphate|mesh-list
92402660|NCT01423864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402661|NCT01423864|Glucocorticoids|glucocorticoids|mesh-ancestor
92402663|NCT01423864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402664|NCT01423864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402665|NCT01423864|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92402666|NCT01423864|Protective Agents|protective agents|mesh-ancestor
92402667|NCT01423864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402668|NCT01423864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402669|NCT01423864|Antiemetics|antiemetics|mesh-ancestor
92402670|NCT01423864|Autonomic Agents|autonomic agents|mesh-ancestor
92402671|NCT01423864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402672|NCT01423864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92402673|NCT01423955|Epoetin Alfa|epoetin alfa|mesh-list
92402674|NCT01423955|Hematinics|hematinics|mesh-ancestor
92402675|NCT01424046|Insulin Glargine|insulin glargine|mesh-list
92402676|NCT01424046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92402677|NCT01424046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402678|NCT01424111|Escitalopram|escitalopram|mesh-list
92402679|NCT01424111|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92402680|NCT01424111|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92402681|NCT01424111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402682|NCT01424111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402683|NCT01424111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402684|NCT01424111|Serotonin Agents|serotonin agents|mesh-ancestor
92402685|NCT01424111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402687|NCT01424124|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92402688|NCT01424124|Respiratory System Agents|respiratory system agents|mesh-ancestor
92402689|NCT01424124|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92402690|NCT01424124|Hormone Antagonists|hormone antagonists|mesh-ancestor
92402691|NCT01424124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402692|NCT01424124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402693|NCT01424124|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92402694|NCT01424124|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92402695|NCT01424124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402696|NCT01424137|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92402697|NCT01424137|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92402698|NCT01424137|Autonomic Agents|autonomic agents|mesh-ancestor
92402699|NCT01424137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402700|NCT01424137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402701|NCT01424137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92402702|NCT01424137|Respiratory System Agents|respiratory system agents|mesh-ancestor
92402703|NCT01424137|Glucocorticoids|glucocorticoids|mesh-ancestor
92402705|NCT01424137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402706|NCT01424137|Sympathomimetics|sympathomimetics|mesh-ancestor
92402708|NCT01424176|Antioxidants|antioxidants|mesh-ancestor
92402709|NCT01424176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402710|NCT01424176|Protective Agents|protective agents|mesh-ancestor
92402711|NCT01424176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402712|NCT01424176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92402713|NCT01424176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92402714|NCT01424176|Dopamine Agonists|dopamine agonists|mesh-ancestor
92402715|NCT01424176|Dopamine Agents|dopamine agents|mesh-ancestor
92402716|NCT01424176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402717|NCT01424241|Octreotide|octreotide|mesh-list
92402718|NCT01424241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92402719|NCT01424241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402720|NCT01424241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402721|NCT01424319|Atrasentan|atrasentan|mesh-list
92402722|NCT01424319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402723|NCT01424319|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92402724|NCT01424319|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92402725|NCT01424319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402726|NCT01424332|Aspirin|aspirin|mesh-list
92402727|NCT01424332|Salicylic Acid|salicylic acid|mesh-list
92402728|NCT01424332|Salicylates|salicylates|mesh-list
92402729|NCT01424332|Darexaban|darexaban|mesh-list
92402730|NCT01424332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402731|NCT01424332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92402732|NCT01424332|Analgesics|analgesics|mesh-ancestor
92402733|NCT01424332|Sensory System Agents|sensory system agents|mesh-ancestor
92402734|NCT01424332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402735|NCT01424332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402736|NCT01424332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402737|NCT01424332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402738|NCT01424332|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92402739|NCT01424332|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92402740|NCT01424332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402741|NCT01424332|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92402742|NCT01424332|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92402743|NCT01424332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402744|NCT01424332|Antipyretics|antipyretics|mesh-ancestor
92402745|NCT01424332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402746|NCT01424332|Antifungal Agents|antifungal agents|mesh-ancestor
92402747|NCT01424332|Keratolytic Agents|keratolytic agents|mesh-ancestor
92402748|NCT01424332|Dermatologic Agents|dermatologic agents|mesh-ancestor
92402749|NCT01424332|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92402750|NCT01424332|Antithrombins|antithrombins|mesh-ancestor
92402751|NCT01424332|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92402752|NCT01424332|Protease Inhibitors|protease inhibitors|mesh-ancestor
92402753|NCT01424332|Anticoagulants|anticoagulants|mesh-ancestor
92402754|NCT01424345|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92402755|NCT01424345|Immunologic Factors|immunologic factors|mesh-ancestor
92402756|NCT01424345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402757|NCT01424384|Citalopram|citalopram|mesh-list
92402758|NCT01424384|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92402759|NCT01424384|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92402760|NCT01424384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402761|NCT01424384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402762|NCT01424384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402763|NCT01424384|Serotonin Agents|serotonin agents|mesh-ancestor
92402764|NCT01424384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402765|NCT01424384|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92402766|NCT01424384|Antidepressive Agents|antidepressive agents|mesh-ancestor
92402767|NCT01424384|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92402768|NCT01424449|Aripiprazole|aripiprazole|mesh-list
92402769|NCT01424449|Antidepressive Agents|antidepressive agents|mesh-ancestor
92402770|NCT01424449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92402771|NCT01424449|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92402772|NCT01424449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92402773|NCT01424449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402774|NCT01424449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402775|NCT01424449|Dopamine Agonists|dopamine agonists|mesh-ancestor
92402776|NCT01424449|Dopamine Agents|dopamine agents|mesh-ancestor
92402777|NCT01424449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402778|NCT01424449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402779|NCT01424449|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92402780|NCT01424449|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92402781|NCT01424449|Serotonin Agents|serotonin agents|mesh-ancestor
92402782|NCT01424449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92402783|NCT01424449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92402784|NCT01424449|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92402785|NCT01424449|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92402786|NCT01424618|Leuprolide|leuprolide|mesh-list
92402787|NCT01424618|Ganirelix|ganirelix|mesh-list
92402788|NCT01424618|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92402789|NCT01424618|Fertility Agents|fertility agents|mesh-ancestor
92402790|NCT01424618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92402791|NCT01424618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402792|NCT01424618|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402793|NCT01424618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402794|NCT01424618|Hormone Antagonists|hormone antagonists|mesh-ancestor
92402795|NCT01424618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402796|NCT01424709|Cisplatin|cisplatin|mesh-list
92402797|NCT01424709|Gemcitabine|gemcitabine|mesh-list
92402798|NCT01424709|Docetaxel|docetaxel|mesh-list
92402800|NCT01424709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402801|NCT01424709|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92402802|NCT01424709|Antimetabolites|antimetabolites|mesh-ancestor
92402803|NCT01424709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402804|NCT01424709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92402805|NCT01424709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92402806|NCT01424709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92402807|NCT01424709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92402808|NCT01424709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92402809|NCT01424709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402810|NCT01424761|Ubiquinone|ubiquinone|mesh-list
92402811|NCT01424761|Coenzyme Q10|coenzyme q10|mesh-list
92402812|NCT01424761|Micronutrients|micronutrients|mesh-ancestor
92402813|NCT01424761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402814|NCT01424761|Vitamins|vitamins|mesh-ancestor
92402815|NCT01424826|Raltegravir Potassium|raltegravir potassium|mesh-list
92402816|NCT01424826|Rifampin|rifampin|mesh-list
92402817|NCT01424826|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92402818|NCT01424826|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92402819|NCT01424826|Antiviral Agents|antiviral agents|mesh-ancestor
92402820|NCT01424826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402821|NCT01424826|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92402822|NCT01424826|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92402823|NCT01424826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402824|NCT01424826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402825|NCT01424826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92402826|NCT01424826|Antitubercular Agents|antitubercular agents|mesh-ancestor
92402827|NCT01424826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402828|NCT01424826|Leprostatic Agents|leprostatic agents|mesh-ancestor
92402829|NCT01424826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92402830|NCT01424826|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92402831|NCT01424826|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92402832|NCT01424826|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92402833|NCT01424826|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92402834|NCT01424826|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92402835|NCT01424826|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92402837|NCT01424839|Carboplatin|carboplatin|mesh-list
92402838|NCT01424839|Etoposide|etoposide|mesh-list
92402839|NCT01424839|Etoposide phosphate|etoposide phosphate|mesh-list
92402840|NCT01424839|Ifosfamide|ifosfamide|mesh-list
92402841|NCT01424839|Isophosphamide mustard|isophosphamide mustard|mesh-list
92402842|NCT01424839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402843|NCT01424839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92402844|NCT01424839|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92402845|NCT01424839|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92402846|NCT01424839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402847|NCT01424839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938125|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92402848|NCT01424839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92402851|NCT01424891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92402853|NCT01424891|Antimetabolites|antimetabolites|mesh-ancestor
92402854|NCT01424891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402855|NCT01424891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92402856|NCT01424891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92402857|NCT01424891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402858|NCT01425060|Contraceptive Agents|contraceptive agents|mesh-list
92402859|NCT01425060|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92402860|NCT01425060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402861|NCT01425073|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92402862|NCT01425073|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92402863|NCT01425073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402864|NCT01425073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402866|NCT01425073|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92402867|NCT01425073|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92402868|NCT01425099|Dolutegravir|dolutegravir|mesh-list
92402869|NCT01425099|Prednisone|prednisone|mesh-list
92402870|NCT01425099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402871|NCT01425099|Glucocorticoids|glucocorticoids|mesh-ancestor
92402872|NCT01425099|Hormones|hormones|mesh-ancestor
92402873|NCT01425099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402874|NCT01425099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402875|NCT01425099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92402876|NCT01425099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402877|NCT01425099|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92402878|NCT01425099|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92402879|NCT01425099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402880|NCT01425099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402881|NCT01425099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92402882|NCT01425099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92402883|NCT01425099|Antiviral Agents|antiviral agents|mesh-ancestor
92402884|NCT01425099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402885|NCT01425125|Tolvaptan|tolvaptan|mesh-list
92402886|NCT01425125|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92402887|NCT01425125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402888|NCT01425125|Natriuretic Agents|natriuretic agents|mesh-ancestor
92402889|NCT01425125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402890|NCT01425164|Carvedilol|carvedilol|mesh-list
92402891|NCT01425164|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92402892|NCT01425164|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92402893|NCT01425164|Adrenergic Agents|adrenergic agents|mesh-ancestor
92402894|NCT01425164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92402895|NCT01425164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402896|NCT01425164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402897|NCT01425164|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92402898|NCT01425164|Antioxidants|antioxidants|mesh-ancestor
92402899|NCT01425164|Protective Agents|protective agents|mesh-ancestor
92402900|NCT01425164|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92402901|NCT01425164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402902|NCT01425164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402903|NCT01425164|Vasodilator Agents|vasodilator agents|mesh-ancestor
92402904|NCT01425164|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92402905|NCT01425164|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92402906|NCT01425216|Sorafenib|sorafenib|mesh-list
92402907|NCT01425216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92402908|NCT01425216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92402909|NCT01425216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402910|NCT01425216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402911|NCT01425242|Amlodipine|amlodipine|mesh-list
92402912|NCT01425242|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92402913|NCT01425242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92402914|NCT01425242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92402915|NCT01425242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402916|NCT01425242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402917|NCT01425242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402918|NCT01425242|Vasodilator Agents|vasodilator agents|mesh-ancestor
92402920|NCT01425320|Adapalene|adapalene|mesh-list
92402921|NCT01425320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402922|NCT01425320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92402923|NCT01425320|Analgesics|analgesics|mesh-ancestor
92402924|NCT01425320|Sensory System Agents|sensory system agents|mesh-ancestor
92402925|NCT01425320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402926|NCT01425320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402928|NCT01425320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402929|NCT01425320|Dermatologic Agents|dermatologic agents|mesh-ancestor
92402930|NCT01425320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92402931|NCT01425320|Antimalarials|antimalarials|mesh-ancestor
92402932|NCT01425320|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92402933|NCT01425320|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92402934|NCT01425320|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92402935|NCT01425320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402936|NCT01425320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402937|NCT01425320|Leprostatic Agents|leprostatic agents|mesh-ancestor
92402938|NCT01425320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92402939|NCT01425398|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92402940|NCT01425398|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92402941|NCT01425398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92402942|NCT01425398|Antimetabolites|antimetabolites|mesh-ancestor
92402943|NCT01425398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402944|NCT01425398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92402945|NCT01425398|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92402946|NCT01425398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92402948|NCT01425411|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92402949|NCT01425411|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92402950|NCT01425411|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92402951|NCT01425411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402952|NCT01425424|Vitamin D|vitamin d|mesh-list
92402953|NCT01425424|Ergocalciferols|ergocalciferols|mesh-list
92402954|NCT01425424|Cholecalciferol|cholecalciferol|mesh-list
92402955|NCT01425424|Vitamins|vitamins|mesh-list
92402956|NCT01425424|Micronutrients|micronutrients|mesh-ancestor
92402957|NCT01425424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402958|NCT01425424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92402959|NCT01425424|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402960|NCT01425476|Vitamin D|vitamin d|mesh-list
92402962|NCT01425476|Celecoxib|celecoxib|mesh-list
92402963|NCT01425476|Vitamins|vitamins|mesh-ancestor
92402964|NCT01425476|Micronutrients|micronutrients|mesh-ancestor
92402965|NCT01425476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402966|NCT01425476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92402967|NCT01425476|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92402968|NCT01425476|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92402969|NCT01425476|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92402970|NCT01425476|Analgesics|analgesics|mesh-ancestor
92402971|NCT01425476|Sensory System Agents|sensory system agents|mesh-ancestor
92402972|NCT01425476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92402973|NCT01425476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92402974|NCT01425476|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92402975|NCT01425476|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92402976|NCT01425476|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92402977|NCT01425476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932420|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92402978|NCT01425476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92402979|NCT01425567|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92402980|NCT01425567|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92402981|NCT01425567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92402982|NCT01425580|Metformin|metformin|mesh-list
92402983|NCT01425580|Liraglutide|liraglutide|mesh-list
92402984|NCT01425580|Glimepiride|glimepiride|mesh-list
92402985|NCT01425580|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92402986|NCT01425580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402988|NCT01425580|Hormones|hormones|mesh-ancestor
92402989|NCT01425580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92402990|NCT01425580|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92402991|NCT01425580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92402992|NCT01425580|Immunologic Factors|immunologic factors|mesh-ancestor
92402993|NCT01425619|Lidocaine|lidocaine|mesh-list
92402994|NCT01425619|Prilocaine|prilocaine|mesh-list
92402996|NCT01425619|Anesthetics|anesthetics|mesh-ancestor
92402997|NCT01425619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92402998|NCT01425619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92402999|NCT01425619|Sensory System Agents|sensory system agents|mesh-ancestor
92403000|NCT01425619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403001|NCT01425619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92403002|NCT01425619|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92403003|NCT01425619|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92403004|NCT01425619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92403005|NCT01425619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403007|NCT01425658|Fentanyl|fentanyl|mesh-list
92403008|NCT01425658|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92403009|NCT01425658|Narcotics|narcotics|mesh-ancestor
92403010|NCT01425658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403011|NCT01425658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403012|NCT01425658|Analgesics|analgesics|mesh-ancestor
92403013|NCT01425658|Sensory System Agents|sensory system agents|mesh-ancestor
92403014|NCT01425658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403015|NCT01425658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92403016|NCT01425658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92403017|NCT01425658|Anesthetics, General|anesthetics, general|mesh-ancestor
92403018|NCT01425658|Anesthetics|anesthetics|mesh-ancestor
92403019|NCT01425658|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92403020|NCT01425658|Sympatholytics|sympatholytics|mesh-ancestor
92055342|NCT02017015|Paclitaxel|paclitaxel|mesh-list
92403021|NCT01425658|Autonomic Agents|autonomic agents|mesh-ancestor
92403022|NCT01425658|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92403023|NCT01425658|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92403024|NCT01425658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92403025|NCT01425658|Adrenergic Agents|adrenergic agents|mesh-ancestor
92403026|NCT01425658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403027|NCT01425658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403028|NCT01425697|Chlorhexidine|chlorhexidine|mesh-list
92403029|NCT01425697|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92403030|NCT01425697|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92403031|NCT01425697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403032|NCT01425697|Disinfectants|disinfectants|mesh-ancestor
92403033|NCT01425697|Dermatologic Agents|dermatologic agents|mesh-ancestor
92403034|NCT01425736|Cisplatin|cisplatin|mesh-list
92403035|NCT01425736|Docetaxel|docetaxel|mesh-list
92403036|NCT01425736|Fluorouracil|fluorouracil|mesh-list
92403037|NCT01425736|Nimotuzumab|nimotuzumab|mesh-list
92403038|NCT01425736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403039|NCT01425736|Tubulin Modulators|tubulin modulators|mesh-ancestor
92403040|NCT01425736|Antimitotic Agents|antimitotic agents|mesh-ancestor
92403041|NCT01425736|Mitosis Modulators|mitosis modulators|mesh-ancestor
92403042|NCT01425736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403043|NCT01425736|Antimetabolites|antimetabolites|mesh-ancestor
92403044|NCT01425736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92403045|NCT01425736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403046|NCT01425736|Immunologic Factors|immunologic factors|mesh-ancestor
92403047|NCT01425736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403048|NCT01425736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403049|NCT01425775|Vitamin D|vitamin d|mesh-list
92403050|NCT01425775|Vitamins|vitamins|mesh-ancestor
92403051|NCT01425775|Micronutrients|micronutrients|mesh-ancestor
92403052|NCT01425775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403053|NCT01425775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92403054|NCT05386446|Interferons|interferons|mesh-list
92403055|NCT05386446|Interferon-gamma|interferon-gamma|mesh-list
92403056|NCT05386446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403057|NCT05386446|Antiviral Agents|antiviral agents|mesh-ancestor
92403058|NCT05386446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403059|NCT05386433|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92403060|NCT05386433|Antiviral Agents|antiviral agents|mesh-ancestor
92403061|NCT05386433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403062|NCT05386290|Infliximab|infliximab|mesh-list
92403063|NCT05386290|Mesalamine|mesalamine|mesh-list
92403064|NCT05386290|Ustekinumab|ustekinumab|mesh-list
92403065|NCT05386290|Vedolizumab|vedolizumab|mesh-list
92403066|NCT05386290|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92403067|NCT05386290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403068|NCT05386290|Dermatologic Agents|dermatologic agents|mesh-ancestor
92403069|NCT05386290|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403070|NCT05386290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403071|NCT05386290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92403072|NCT05386290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92403073|NCT05386290|Analgesics|analgesics|mesh-ancestor
92403074|NCT05386290|Sensory System Agents|sensory system agents|mesh-ancestor
92403075|NCT05386290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403076|NCT05386290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403077|NCT05386186|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92403078|NCT05386186|Glimepiride|glimepiride|mesh-list
92403079|NCT05386186|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92403080|NCT05386186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92403081|NCT05386186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403082|NCT05386186|Incretins|incretins|mesh-ancestor
92403083|NCT05386186|Hormones|hormones|mesh-ancestor
92403084|NCT05386186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403085|NCT05386186|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403086|NCT05386186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403087|NCT05386186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403088|NCT05386186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92403089|NCT05386186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403090|NCT05386186|Immunologic Factors|immunologic factors|mesh-ancestor
92403091|NCT05386160|Ranibizumab|ranibizumab|mesh-list
92403092|NCT05386160|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92403093|NCT05386160|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92403094|NCT05386160|Growth Substances|growth substances|mesh-ancestor
92403095|NCT05386160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403096|NCT05386160|Growth Inhibitors|growth inhibitors|mesh-ancestor
92403097|NCT05386160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403098|NCT05386121|Fentanyl|fentanyl|mesh-list
92403099|NCT05386121|Meperidine|meperidine|mesh-list
92403100|NCT05386121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92403101|NCT05386121|Narcotics|narcotics|mesh-ancestor
92403102|NCT05386121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403104|NCT05386121|Analgesics|analgesics|mesh-ancestor
92403105|NCT05386121|Sensory System Agents|sensory system agents|mesh-ancestor
92403106|NCT05386121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403107|NCT05386121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92403108|NCT05386121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92403109|NCT05386121|Anesthetics, General|anesthetics, general|mesh-ancestor
92403110|NCT05386121|Anesthetics|anesthetics|mesh-ancestor
92403111|NCT05386056|Pembrolizumab|pembrolizumab|mesh-list
92403112|NCT05386056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403113|NCT05386056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403114|NCT05386056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115110|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92403115|NCT05386056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403116|NCT05385900|Oxaliplatin|oxaliplatin|mesh-list
92403117|NCT05385900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403118|NCT05385887|Metronidazole|metronidazole|mesh-list
92403119|NCT05385887|Ciprofloxacin|ciprofloxacin|mesh-list
92403120|NCT05385887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403121|NCT05385887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92403122|NCT05385887|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92403123|NCT05385887|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92403124|NCT05385887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92403125|NCT05385887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92403126|NCT05385887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403127|NCT05385887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403128|NCT05385887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403129|NCT05385887|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92403130|NCT05385887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92403132|NCT05385861|Irinotecan|irinotecan|mesh-list
92403133|NCT05385861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403134|NCT05385861|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92403135|NCT05385861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92403136|NCT05385861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403137|NCT05385861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403138|NCT05385744|Teriflunomide|teriflunomide|mesh-list
92403139|NCT05385744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92403140|NCT05385744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92403141|NCT05385744|Analgesics|analgesics|mesh-ancestor
92403142|NCT05385744|Sensory System Agents|sensory system agents|mesh-ancestor
92403143|NCT05385744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403144|NCT05385744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403145|NCT05385744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403146|NCT05385744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403147|NCT05385744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403148|NCT05385744|Immunologic Factors|immunologic factors|mesh-ancestor
92403149|NCT05385185|Endostatins|endostatins|mesh-list
92403150|NCT05385185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403151|NCT05385185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92403152|NCT05385185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92403153|NCT05385185|Growth Substances|growth substances|mesh-ancestor
92403154|NCT05385185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403155|NCT05385185|Growth Inhibitors|growth inhibitors|mesh-ancestor
92403156|NCT05385094|Cystatins|cystatins|mesh-list
92403157|NCT05385094|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92403158|NCT05385094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403159|NCT05385094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403160|NCT05385094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403161|NCT05385068|Niraparib|niraparib|mesh-list
92403162|NCT05385068|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92403163|NCT05385068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403164|NCT05385068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403165|NCT05385068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403166|NCT05385029|Carbimazole|carbimazole|mesh-list
92403167|NCT05385029|Antithyroid Agents|antithyroid agents|mesh-ancestor
92403168|NCT05385029|Hormone Antagonists|hormone antagonists|mesh-ancestor
92403169|NCT05385029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403170|NCT05385029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403171|NCT05379413|Botulinum Toxins|botulinum toxins|mesh-list
92403172|NCT05379413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92403173|NCT05379413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92403174|NCT05379413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92403175|NCT05379413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92403176|NCT05379413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403177|NCT05379413|Cholinergic Agents|cholinergic agents|mesh-ancestor
92403178|NCT05379413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403179|NCT05379413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403180|NCT05379413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92115111|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
92403181|NCT05379413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403182|NCT05379374|Morphine|morphine|mesh-list
92403183|NCT05379374|Bupivacaine|bupivacaine|mesh-list
92403184|NCT05379374|Anesthetics, Local|anesthetics, local|mesh-ancestor
92403185|NCT05379374|Anesthetics|anesthetics|mesh-ancestor
92403186|NCT05379374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403187|NCT05379374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403188|NCT05379374|Sensory System Agents|sensory system agents|mesh-ancestor
92403189|NCT05379374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403190|NCT05379374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92403191|NCT05379374|Narcotics|narcotics|mesh-ancestor
92403192|NCT05379374|Analgesics|analgesics|mesh-ancestor
92403193|NCT05375708|Bevacizumab|bevacizumab|mesh-list
92403194|NCT05375708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403195|NCT05375708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403196|NCT05375708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92403197|NCT05375708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92403198|NCT05375708|Growth Substances|growth substances|mesh-ancestor
92403199|NCT05375708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403200|NCT05375708|Growth Inhibitors|growth inhibitors|mesh-ancestor
92403201|NCT05176379|Fluconazole|fluconazole|mesh-list
92403202|NCT05176379|Antifungal Agents|antifungal agents|mesh-ancestor
92403203|NCT05176379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403204|NCT05176379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92403205|NCT05176379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92403206|NCT05176379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403207|NCT05176379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403208|NCT05176379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92403209|NCT05176379|Hormone Antagonists|hormone antagonists|mesh-ancestor
92403210|NCT05176379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403211|NCT05176379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403212|NCT05176379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92403213|NCT05176379|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92403215|NCT05113615|Tiotropium Bromide|tiotropium bromide|mesh-list
92403216|NCT05113615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92403217|NCT05113615|Autonomic Agents|autonomic agents|mesh-ancestor
92403218|NCT05113615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403219|NCT05113615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403220|NCT05113615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92403221|NCT05113615|Respiratory System Agents|respiratory system agents|mesh-ancestor
92403222|NCT05113615|Parasympatholytics|parasympatholytics|mesh-ancestor
92403223|NCT05113615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92403224|NCT05113615|Cholinergic Agents|cholinergic agents|mesh-ancestor
92403225|NCT05113615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403226|NCT05113615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403227|NCT05113615|Anticonvulsants|anticonvulsants|mesh-ancestor
92403230|NCT04850378|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92403231|NCT04850378|Apixaban|apixaban|mesh-list
92403232|NCT04850378|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92403234|NCT04850378|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92403235|NCT04850378|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403236|NCT04850378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403237|NCT04850378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403238|NCT04850378|Anticoagulants|anticoagulants|mesh-ancestor
92403239|NCT04850378|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92095981|NCT04614311|Hormones|hormones|mesh-ancestor
92403240|NCT04850378|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92403241|NCT04809103|Cisplatin|cisplatin|mesh-list
92403242|NCT04809103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403243|NCT04804371|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92403244|NCT04804371|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92096050|NCT01894919|Immunologic Factors|immunologic factors|mesh-ancestor
92403245|NCT04804371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403246|NCT04765371|Dexamethasone|dexamethasone|mesh-list
92055569|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
92403247|NCT04765371|Dexamethasone acetate|dexamethasone acetate|mesh-list
92403248|NCT04765371|Prednisolone|prednisolone|mesh-list
92403249|NCT04765371|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92403250|NCT04765371|Methylprednisolone|methylprednisolone|mesh-list
92403251|NCT04765371|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92403252|NCT04765371|Prednisolone acetate|prednisolone acetate|mesh-list
92403253|NCT04765371|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92403254|NCT04765371|Prednisolone phosphate|prednisolone phosphate|mesh-list
92403256|NCT04765371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403257|NCT04765371|Antiemetics|antiemetics|mesh-ancestor
92403258|NCT04765371|Autonomic Agents|autonomic agents|mesh-ancestor
92403259|NCT04765371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018400|NCT02493855|Ribavirin|ribavirin|mesh-list
92403260|NCT04765371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403261|NCT04765371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403262|NCT04765371|Glucocorticoids|glucocorticoids|mesh-ancestor
92403263|NCT04765371|Hormones|hormones|mesh-ancestor
92403264|NCT04765371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403265|NCT04765371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92403266|NCT04765371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403267|NCT04765371|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403268|NCT04765371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403269|NCT04765371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403270|NCT04765371|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92403271|NCT04765371|Protective Agents|protective agents|mesh-ancestor
92403272|NCT04744363|Ustekinumab|ustekinumab|mesh-list
92403273|NCT04744363|Dermatologic Agents|dermatologic agents|mesh-ancestor
92096795|NCT02172742|Digoxin|digoxin|mesh-list
92403274|NCT04729517|Azelastine|azelastine|mesh-list
92403275|NCT04729517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92403276|NCT04729517|Autonomic Agents|autonomic agents|mesh-ancestor
92096866|NCT02399943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92403277|NCT04729517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403278|NCT04729517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403279|NCT04729517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92403280|NCT04729517|Respiratory System Agents|respiratory system agents|mesh-ancestor
92403281|NCT04729517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92403282|NCT04729517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403283|NCT04729517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403284|NCT04729517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92403285|NCT04729517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92403286|NCT04729517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92403287|NCT04729517|Histamine Antagonists|histamine antagonists|mesh-ancestor
92403288|NCT04729517|Histamine Agents|histamine agents|mesh-ancestor
92403289|NCT04729517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403290|NCT04673162|Methylprednisolone|methylprednisolone|mesh-list
92403291|NCT04673162|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92403292|NCT04673162|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92403293|NCT04673162|Prednisolone|prednisolone|mesh-list
92403294|NCT04673162|Prednisolone acetate|prednisolone acetate|mesh-list
92097226|NCT05273320|Hormones|hormones|mesh-ancestor
92403295|NCT04673162|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92403296|NCT04673162|Prednisolone phosphate|prednisolone phosphate|mesh-list
92403297|NCT04673162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403298|NCT04673162|Antiemetics|antiemetics|mesh-ancestor
92403299|NCT04673162|Autonomic Agents|autonomic agents|mesh-ancestor
92403300|NCT04673162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403301|NCT04673162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403302|NCT04673162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403303|NCT04673162|Glucocorticoids|glucocorticoids|mesh-ancestor
92403304|NCT04673162|Hormones|hormones|mesh-ancestor
92403305|NCT04673162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403306|NCT04673162|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92403307|NCT04673162|Protective Agents|protective agents|mesh-ancestor
92403308|NCT04673162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92403309|NCT04673162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403310|NCT04638660|Phentolamine|phentolamine|mesh-list
92403311|NCT04638660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92403312|NCT04638660|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92403313|NCT04638660|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92403314|NCT04638660|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92403316|NCT04638660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403317|NCT04638660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403318|NCT04638660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403319|NCT04638660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92403321|NCT04622020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403322|NCT04622020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403323|NCT04560556|Antibodies|antibodies|mesh-list
92403324|NCT04560556|Immunologic Factors|immunologic factors|mesh-ancestor
92403325|NCT04560556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403326|NCT04425902|Flurbiprofen|flurbiprofen|mesh-list
92403327|NCT04425902|Metoprolol|metoprolol|mesh-list
92403328|NCT04425902|Digoxin|digoxin|mesh-list
92403329|NCT04425902|Midazolam|midazolam|mesh-list
92403330|NCT04425902|Caffeine|caffeine|mesh-list
92403331|NCT04425902|Omeprazole|omeprazole|mesh-list
92403332|NCT04425902|Pravastatin|pravastatin|mesh-list
92403333|NCT04425902|Montelukast|montelukast|mesh-list
92403334|NCT04425902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92403335|NCT04425902|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92403336|NCT04425902|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098197|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
92403337|NCT04425902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403338|NCT04425902|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92403339|NCT04425902|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92403340|NCT04425902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92403341|NCT04425902|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92403342|NCT04425902|Anesthetics, General|anesthetics, general|mesh-ancestor
92403343|NCT04425902|Anesthetics|anesthetics|mesh-ancestor
92098410|NCT03468348|Analgesics|analgesics|mesh-ancestor
92403344|NCT04425902|GABA Modulators|gaba modulators|mesh-ancestor
92403345|NCT04425902|GABA Agents|gaba agents|mesh-ancestor
92098508|NCT01153672|Letrozole|letrozole|mesh-list
92403346|NCT04425902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403347|NCT04425902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403348|NCT04425902|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92403349|NCT04425902|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92403350|NCT04425902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403351|NCT04425902|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92098744|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92403353|NCT04425902|Purinergic Agents|purinergic agents|mesh-ancestor
92403354|NCT04425902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92403355|NCT04425902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403356|NCT04425902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92403357|NCT04425902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92403358|NCT04425902|Respiratory System Agents|respiratory system agents|mesh-ancestor
92403359|NCT04425902|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92403360|NCT04425902|Hormone Antagonists|hormone antagonists|mesh-ancestor
92403361|NCT04425902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403362|NCT04425902|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92403363|NCT04425902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92403364|NCT04425902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92403365|NCT04425902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92403366|NCT04425902|Sympatholytics|sympatholytics|mesh-ancestor
92403367|NCT04425902|Autonomic Agents|autonomic agents|mesh-ancestor
92403368|NCT04425902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403369|NCT04425902|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92403370|NCT04425902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92403371|NCT04425902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92403372|NCT04425902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92403373|NCT04425902|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92403374|NCT04425902|Protective Agents|protective agents|mesh-ancestor
92403375|NCT04425902|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92403377|NCT04425902|Antimetabolites|antimetabolites|mesh-ancestor
92403378|NCT04425902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92403379|NCT04425902|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92403380|NCT04425902|Analgesics|analgesics|mesh-ancestor
92403381|NCT04425902|Sensory System Agents|sensory system agents|mesh-ancestor
92403382|NCT04425902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92403383|NCT04425902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92403384|NCT04425902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403385|NCT04425902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403386|NCT04425902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92403387|NCT04421677|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92403388|NCT04421677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403389|NCT04311762|Cisplatin|cisplatin|mesh-list
92403390|NCT04311762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403391|NCT04203472|Budesonide|budesonide|mesh-list
92403392|NCT04203472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403393|NCT04203472|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92403394|NCT04203472|Autonomic Agents|autonomic agents|mesh-ancestor
92403395|NCT04203472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403396|NCT04203472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403397|NCT04203472|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92403398|NCT04203472|Respiratory System Agents|respiratory system agents|mesh-ancestor
92403399|NCT04203472|Glucocorticoids|glucocorticoids|mesh-ancestor
92403401|NCT04203472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403402|NCT04166071|Naltrexone|naltrexone|mesh-list
92403403|NCT04166071|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92403404|NCT04166071|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92403405|NCT04166071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137100|NCT01549652|Morphine|morphine|mesh-list
92403406|NCT04166071|Sensory System Agents|sensory system agents|mesh-ancestor
92403407|NCT04166071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403408|NCT04072146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92052713|NCT02053610|Rituximab|rituximab|mesh-list
92403409|NCT04072146|Varenicline|varenicline|mesh-list
92403410|NCT04072146|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92053101|NCT05882643|Iodine|iodine|mesh-list
92403411|NCT04072146|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92403412|NCT04072146|Cholinergic Agents|cholinergic agents|mesh-ancestor
92403413|NCT04072146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403414|NCT04072146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403415|NCT04072146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053604|NCT05298423|Paclitaxel|paclitaxel|mesh-list
92053724|NCT05084222|Hormones|hormones|mesh-ancestor
92053811|NCT04931342|Hormones|hormones|mesh-list
92403416|NCT03945084|Niraparib|niraparib|mesh-list
92403417|NCT03945084|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92403418|NCT03945084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053965|NCT04728581|Serotonin Agents|serotonin agents|mesh-ancestor
92054081|NCT04081389|Celecoxib|celecoxib|mesh-list
92137101|NCT01549652|Ondansetron|ondansetron|mesh-list
92137102|NCT01549652|Naloxone|naloxone|mesh-list
92054478|NCT02411448|Gefitinib|gefitinib|mesh-list
92137103|NCT01549652|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92403419|NCT03945084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403420|NCT03945084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403421|NCT03882463|Insulin|insulin|mesh-list
92054786|NCT01822899|Xhance|xhance|mesh-list
92054898|NCT01849497|Evolocumab|evolocumab|mesh-list
92403422|NCT03882463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92137104|NCT01549652|Narcotics|narcotics|mesh-ancestor
92403423|NCT03882463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403424|NCT03861481|Rozanolixizumab|rozanolixizumab|mesh-list
92055140|NCT04742075|Durvalumab|durvalumab|mesh-list
92403425|NCT03861481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403426|NCT03861481|Immunologic Factors|immunologic factors|mesh-ancestor
92403427|NCT03861481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403428|NCT03821649|Naloxone|naloxone|mesh-list
92403429|NCT03821649|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92403430|NCT03821649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403431|NCT03821649|Sensory System Agents|sensory system agents|mesh-ancestor
92403432|NCT03821649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403433|NCT03811262|Levobupivacaine|levobupivacaine|mesh-list
92403434|NCT03811262|Anesthetics, Local|anesthetics, local|mesh-ancestor
92403435|NCT03811262|Anesthetics|anesthetics|mesh-ancestor
92403436|NCT03811262|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137407|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
92403437|NCT03811262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403438|NCT03811262|Sensory System Agents|sensory system agents|mesh-ancestor
92403439|NCT03811262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403440|NCT03771612|Naproxen|naproxen|mesh-list
92137409|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
92403441|NCT03771612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92403442|NCT03771612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92056250|NCT04177082|Riboflavin|riboflavin|mesh-list
92403443|NCT03771612|Analgesics|analgesics|mesh-ancestor
92403444|NCT03771612|Sensory System Agents|sensory system agents|mesh-ancestor
92403445|NCT03771612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403446|NCT03771612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403447|NCT03771612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056610|NCT02066129|Xhance|xhance|mesh-list
92403448|NCT03771612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056697|NCT01448044|Ribavirin|ribavirin|mesh-list
92403449|NCT03771612|Gout Suppressants|gout suppressants|mesh-ancestor
92403450|NCT03771612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92403451|NCT03771612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403452|NCT03771612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056954|NCT02040779|Albuterol|albuterol|mesh-list
92403453|NCT03734211|Evolocumab|evolocumab|mesh-list
92403454|NCT03734211|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92403455|NCT03734211|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92057204|NCT04069936|Nivolumab|nivolumab|mesh-list
92403456|NCT03734211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92403457|NCT03734211|Antimetabolites|antimetabolites|mesh-ancestor
92115112|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92403458|NCT03734211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403459|NCT03734211|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92403460|NCT03734211|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403461|NCT03734211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403462|NCT03734211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92403463|NCT03730974|Snake venom protein C activator|snake venom protein c activator|mesh-list
92403464|NCT03730974|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92403465|NCT03730974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92115113|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
92058049|NCT01909466|Aripiprazole|aripiprazole|mesh-list
92058184|NCT02008565|Loperamide|loperamide|mesh-list
92058199|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
92403466|NCT03730974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403467|NCT03708198|Bupivacaine|bupivacaine|mesh-list
92403468|NCT03708198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92403469|NCT03708198|Anesthetics|anesthetics|mesh-ancestor
92403470|NCT03708198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058568|NCT01932788|Vitamin D|vitamin d|mesh-list
92403471|NCT03708198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403472|NCT03708198|Sensory System Agents|sensory system agents|mesh-ancestor
92055799|NCT01839279|Tizanidine|tizanidine|mesh-list
92115114|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
92137558|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403473|NCT03708198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403474|NCT03559426|Antipsychotic Agents|antipsychotic agents|mesh-list
92403475|NCT03559426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92137635|NCT01546688|Anticonvulsants|anticonvulsants|mesh-ancestor
92403476|NCT03559426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403477|NCT03559426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403478|NCT03559426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92403480|NCT03444753|Ipilimumab|ipilimumab|mesh-list
92059249|NCT01789281|Everolimus|everolimus|mesh-list
92403481|NCT03444753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403482|NCT03444753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137710|NCT00631449|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92403483|NCT03444753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115115|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92403484|NCT03444753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403485|NCT03142035|Dienogest|dienogest|mesh-list
92403486|NCT03142035|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92403487|NCT03142035|Contraceptive Agents|contraceptive agents|mesh-ancestor
92403488|NCT03142035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92059883|NCT01386970|Lamivudine|lamivudine|mesh-list
92059971|NCT01778049|Hormones|hormones|mesh-ancestor
92403489|NCT03142035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403490|NCT03142035|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92403491|NCT03142035|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92403492|NCT03142035|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92403493|NCT03142035|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92403494|NCT03142035|Hormone Antagonists|hormone antagonists|mesh-ancestor
92115116|NCT01724021|Rituximab|rituximab|mesh-list
92403495|NCT03142035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403496|NCT03142035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92403497|NCT03142035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403498|NCT02786875|Vitamin D|vitamin d|mesh-list
92403499|NCT02786875|Ergocalciferols|ergocalciferols|mesh-list
92403500|NCT02786875|Cholecalciferol|cholecalciferol|mesh-list
92403501|NCT02786875|Vitamins|vitamins|mesh-list
92403502|NCT02786875|Micronutrients|micronutrients|mesh-ancestor
92403503|NCT02786875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060943|NCT05047718|Vaccines|vaccines|mesh-list
92115117|NCT01724021|Vincristine|vincristine|mesh-list
92061190|NCT04538742|Immunoconjugates|immunoconjugates|mesh-ancestor
92403504|NCT02786875|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92061338|NCT04081545|Analgesics|analgesics|mesh-list
92403505|NCT02786875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92061423|NCT03798678|Ichthammol|ichthammol|mesh-list
92403506|NCT02767882|Dexamethasone|dexamethasone|mesh-list
92403507|NCT02767882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403508|NCT02767882|Antiemetics|antiemetics|mesh-ancestor
92061648|NCT03031730|BB 1101|bb 1101|mesh-list
92403509|NCT02767882|Autonomic Agents|autonomic agents|mesh-ancestor
92115118|NCT01724021|Doxorubicin|doxorubicin|mesh-list
92403510|NCT02767882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061879|NCT02315326|Antimetabolites|antimetabolites|mesh-ancestor
92403511|NCT02767882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403512|NCT02767882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403513|NCT02767882|Glucocorticoids|glucocorticoids|mesh-ancestor
92403514|NCT02767882|Hormones|hormones|mesh-ancestor
92115119|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92137865|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403515|NCT02767882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403516|NCT02767882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92403517|NCT02767882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403518|NCT02246257|Metformin|metformin|mesh-list
92403519|NCT02246257|Losartan|losartan|mesh-list
92403520|NCT02246257|Simvastatin|simvastatin|mesh-list
92403521|NCT02246257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92403522|NCT02246257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137939|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92137940|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
92403523|NCT02246257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92062950|NCT01851590|Terbinafine|terbinafine|mesh-list
92403524|NCT02246257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92403525|NCT02246257|Antimetabolites|antimetabolites|mesh-ancestor
92403526|NCT02246257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403527|NCT02246257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92115120|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92115121|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
92115122|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403528|NCT02246257|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92403529|NCT02246257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403530|NCT02246257|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92115123|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
92015364|NCT04982367|Paclitaxel|paclitaxel|mesh-list
92063919|NCT01710501|Interferons|interferons|mesh-list
92403531|NCT02246257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92403532|NCT02246257|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92137941|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92403533|NCT02246257|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92403534|NCT02197221|Bortezomib|bortezomib|mesh-list
92403535|NCT02197221|Melphalan|melphalan|mesh-list
92403536|NCT02197221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403537|NCT02197221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92403538|NCT02197221|Alkylating Agents|alkylating agents|mesh-ancestor
92138245|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92138246|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
92065002|NCT01065532|Paclitaxel|paclitaxel|mesh-list
92115124|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403539|NCT02197221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403540|NCT02197221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92065395|NCT03806530|Gabapentin|gabapentin|mesh-list
92403541|NCT02197221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065704|NCT03766750|Hormones|hormones|mesh-ancestor
92403542|NCT02197221|Immunologic Factors|immunologic factors|mesh-ancestor
92403543|NCT02197221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065962|NCT01678612|Copper|copper|mesh-list
92015552|NCT05019885|Analgesics|analgesics|mesh-ancestor
92403544|NCT02010385|Octreotide|octreotide|mesh-list
92403545|NCT02010385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055873|NCT01991197|Gliclazide|gliclazide|mesh-list
92066489|NCT03080350|Analgesics|analgesics|mesh-ancestor
92403546|NCT02010385|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92403547|NCT02010385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403548|NCT01949714|Epinephrine|epinephrine|mesh-list
92403549|NCT01949714|Racepinephrine|racepinephrine|mesh-list
92066725|NCT03344692|Alirocumab|alirocumab|mesh-list
92403550|NCT01949714|Epinephryl borate|epinephryl borate|mesh-list
92403551|NCT01949714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92403552|NCT01949714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92403553|NCT01949714|Adrenergic Agents|adrenergic agents|mesh-ancestor
92403554|NCT01949714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067583|NCT01686633|Xhance|xhance|mesh-list
92115125|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403555|NCT01949714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138473|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
92403556|NCT01949714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138776|NCT05062278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92403557|NCT01949714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92403558|NCT01949714|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92403559|NCT01949714|Autonomic Agents|autonomic agents|mesh-ancestor
92403560|NCT01949714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068531|NCT04675788|Ibutilide|ibutilide|mesh-list
92403561|NCT01949714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92068620|NCT04424303|Tofacitinib|tofacitinib|mesh-list
92068700|NCT04214067|Pembrolizumab|pembrolizumab|mesh-list
92403562|NCT01949714|Respiratory System Agents|respiratory system agents|mesh-ancestor
92403563|NCT01949714|Mydriatics|mydriatics|mesh-ancestor
92068864|NCT03810807|Osimertinib|osimertinib|mesh-list
92069007|NCT03611738|Ceritinib|ceritinib|mesh-list
92403564|NCT01949714|Sympathomimetics|sympathomimetics|mesh-ancestor
92138777|NCT05062278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069373|NCT02125461|Durvalumab|durvalumab|mesh-list
92138778|NCT02823990|Nivolumab|nivolumab|mesh-list
92403565|NCT01949714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92403566|NCT00223145|Goserelin|goserelin|mesh-list
92403567|NCT00223145|Bicalutamide|bicalutamide|mesh-list
92069807|NCT01924234|Morphine|morphine|mesh-list
92403568|NCT00223145|Androgens|androgens|mesh-list
92138779|NCT02823990|Interleukin-2|interleukin-2|mesh-list
92139241|NCT04476966|Urological Agents|urological agents|mesh-ancestor
92070278|NCT00980044|Tramadol|tramadol|mesh-list
92403569|NCT00223145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070434|NCT05609500|Warfarin|warfarin|mesh-list
92070513|NCT05604898|Antibodies|antibodies|mesh-list
92403570|NCT00223145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403571|NCT00223145|Hormones|hormones|mesh-ancestor
92403572|NCT00223145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403573|NCT00223145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403574|NCT00223145|Androgen Antagonists|androgen antagonists|mesh-ancestor
92403575|NCT00223145|Hormone Antagonists|hormone antagonists|mesh-ancestor
92403576|NCT01425827|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92139242|NCT03821610|Cyclophosphamide|cyclophosphamide|mesh-list
92403577|NCT01425827|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92403578|NCT01425827|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92070973|NCT01891084|Acetaminophen|acetaminophen|mesh-list
92403579|NCT01425827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92403580|NCT01425827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403581|NCT01425827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139243|NCT03821610|Melphalan|melphalan|mesh-list
92139244|NCT03821610|Fludarabine|fludarabine|mesh-list
92071465|NCT03007420|Lidocaine|lidocaine|mesh-list
92403582|NCT01425827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403583|NCT01425827|Analgesics|analgesics|mesh-ancestor
92403584|NCT01425827|Sensory System Agents|sensory system agents|mesh-ancestor
92403585|NCT01425827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403586|NCT01425827|Antidepressive Agents|antidepressive agents|mesh-ancestor
92403587|NCT01425827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92403588|NCT01425827|Dopamine Agents|dopamine agents|mesh-ancestor
92403589|NCT01425840|Lidocaine|lidocaine|mesh-list
92403590|NCT01425840|Anesthetics, Local|anesthetics, local|mesh-ancestor
92403591|NCT01425840|Anesthetics|anesthetics|mesh-ancestor
92403592|NCT01425840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139245|NCT03821610|Alemtuzumab|alemtuzumab|mesh-list
92139325|NCT01525628|Interferons|interferons|mesh-list
92403593|NCT01425840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403594|NCT01425840|Sensory System Agents|sensory system agents|mesh-ancestor
92403595|NCT01425840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403596|NCT01425840|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92403597|NCT01425840|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92139326|NCT01525628|Tenofovir|tenofovir|mesh-list
92072638|NCT02344186|Hormones|hormones|mesh-ancestor
92403598|NCT01425840|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92139327|NCT01525628|Ribavirin|ribavirin|mesh-list
92403599|NCT01425840|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92403600|NCT01425840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403601|NCT01425996|Camptothecin|camptothecin|mesh-list
92403602|NCT01425996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92139328|NCT01525628|Midazolam|midazolam|mesh-list
92403603|NCT01425996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139329|NCT01525628|Caffeine|caffeine|mesh-list
92139408|NCT01426009|Ipratropium|ipratropium|mesh-list
92403604|NCT01425996|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92403605|NCT01425996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92403606|NCT01425996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115126|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92115127|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
92139560|NCT03110640|Cyclophosphamide|cyclophosphamide|mesh-list
92016039|NCT05552807|Docetaxel|docetaxel|mesh-list
92074510|NCT01472835|Fentanyl|fentanyl|mesh-list
92139561|NCT03110640|Fludarabine|fludarabine|mesh-list
92116356|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92403607|NCT01425996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403608|NCT01426022|Ethanol|ethanol|mesh-list
92403609|NCT01426022|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92075256|NCT05819632|Analgesics|analgesics|mesh-ancestor
92403610|NCT01426022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403611|NCT01426022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075655|NCT05605470|Vaccines|vaccines|mesh-list
92116357|NCT02069704|Growth Substances|growth substances|mesh-ancestor
92139794|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403612|NCT01426022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403613|NCT01426074|Bevacizumab|bevacizumab|mesh-list
92403614|NCT01426074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403615|NCT01426074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403616|NCT01426074|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92403617|NCT01426074|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92076307|NCT04604067|Acalabrutinib|acalabrutinib|mesh-list
92403618|NCT01426074|Growth Substances|growth substances|mesh-ancestor
92016135|NCT05541185|Naproxen|naproxen|mesh-list
92076889|NCT03458221|Bicalutamide|bicalutamide|mesh-list
92403619|NCT01426074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403620|NCT01426074|Growth Inhibitors|growth inhibitors|mesh-ancestor
92403621|NCT01426087|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92403623|NCT01426087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403624|NCT01426087|Hormones|hormones|mesh-ancestor
92077260|NCT01882933|Oxaliplatin|oxaliplatin|mesh-list
92077340|NCT01531582|Minocycline|minocycline|mesh-list
92403625|NCT01426087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077502|NCT00121186|Melphalan|melphalan|mesh-list
92403626|NCT01426087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403627|NCT01426100|Telmisartan|telmisartan|mesh-list
92403628|NCT01426100|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92139875|NCT05086848|Micronutrients|micronutrients|mesh-ancestor
92403629|NCT01426100|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92139876|NCT00830895|Everolimus|everolimus|mesh-list
92139877|NCT00830895|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92403630|NCT01426100|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92077985|NCT01898728|Iodine|iodine|mesh-list
92077988|NCT01898728|Povidone|povidone|mesh-list
92403631|NCT01426100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403632|NCT01426126|genexol-PM|genexol-pm|mesh-list
92403633|NCT01426126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078375|NCT00292162|Captopril|captopril|mesh-list
92078452|NCT02104414|Epinephrine|epinephrine|mesh-list
92403634|NCT01426126|Tubulin Modulators|tubulin modulators|mesh-ancestor
92403635|NCT01426126|Antimitotic Agents|antimitotic agents|mesh-ancestor
92403636|NCT01426126|Mitosis Modulators|mitosis modulators|mesh-ancestor
92403637|NCT01426126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403638|NCT01426165|Magnesium Sulfate|magnesium sulfate|mesh-list
92403639|NCT01426165|Analgesics|analgesics|mesh-ancestor
92403640|NCT01426165|Sensory System Agents|sensory system agents|mesh-ancestor
92078758|NCT00315328|Atropine|atropine|mesh-list
92403641|NCT01426165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403642|NCT01426165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403643|NCT01426165|Anesthetics|anesthetics|mesh-ancestor
92139956|NCT02339415|Anticoagulants|anticoagulants|mesh-ancestor
92403644|NCT01426165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079054|NCT01439373|Interferons|interferons|mesh-list
92139957|NCT02998047|Lintuzumab|lintuzumab|mesh-list
92403645|NCT01426165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92403646|NCT01426165|Anticonvulsants|anticonvulsants|mesh-ancestor
92403647|NCT01426165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92403648|NCT01426165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92403649|NCT01426165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140033|NCT02864004|Autonomic Agents|autonomic agents|mesh-ancestor
92116358|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403650|NCT01426165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92403651|NCT01426165|Tocolytic Agents|tocolytic agents|mesh-ancestor
92403652|NCT01426165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92403653|NCT01426256|Vitamin D|vitamin d|mesh-list
92403654|NCT01426256|Cholecalciferol|cholecalciferol|mesh-list
92079982|NCT00434356|Bevacizumab|bevacizumab|mesh-list
92403655|NCT01426256|Vitamins|vitamins|mesh-ancestor
92403656|NCT01426256|Micronutrients|micronutrients|mesh-ancestor
92403657|NCT01426256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080242|NCT00465088|Niacin|niacin|mesh-list
92403658|NCT01426256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92403659|NCT01426256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92403660|NCT01426334|Cyclosporine|cyclosporine|mesh-list
92403661|NCT01426334|Dasatinib|dasatinib|mesh-list
92403662|NCT01426334|Cyclosporins|cyclosporins|mesh-list
92080661|NCT01453023|Xhance|xhance|mesh-list
92403663|NCT01426334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116359|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92403664|NCT01426334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403665|NCT01426334|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403666|NCT01426334|Immunologic Factors|immunologic factors|mesh-ancestor
92403667|NCT01426334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403668|NCT01426334|Antifungal Agents|antifungal agents|mesh-ancestor
92403669|NCT01426334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081237|NCT01430403|Xhance|xhance|mesh-list
92403670|NCT01426334|Dermatologic Agents|dermatologic agents|mesh-ancestor
92403671|NCT01426334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403672|NCT01426334|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92403673|NCT01426334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403674|NCT01426334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92403675|NCT01426399|Metformin|metformin|mesh-list
92081874|NCT04033575|Fluorides|fluorides|mesh-list
92403676|NCT01426399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082205|NCT01383993|Voriconazole|voriconazole|mesh-list
92116360|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
92403677|NCT01426399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403678|NCT01426464|Latanoprost|latanoprost|mesh-list
92403679|NCT01426464|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92403680|NCT01426464|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92403681|NCT01426490|Vitamins|vitamins|mesh-list
92403682|NCT01426490|Ascorbic Acid|ascorbic acid|mesh-list
92403683|NCT01426490|Folic Acid|folic acid|mesh-list
92403684|NCT01426490|Pyridoxine|pyridoxine|mesh-list
92403685|NCT01426490|Pyridoxal|pyridoxal|mesh-list
92403686|NCT01426490|Vitamin B 6|vitamin b 6|mesh-list
92403687|NCT01426490|Vitamin B Complex|vitamin b complex|mesh-list
92403688|NCT01426490|Micronutrients|micronutrients|mesh-ancestor
92403689|NCT01426490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403690|NCT01426490|Antioxidants|antioxidants|mesh-ancestor
92116441|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92140274|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
92403691|NCT01426490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403692|NCT01426490|Protective Agents|protective agents|mesh-ancestor
92403693|NCT01426490|Hematinics|hematinics|mesh-ancestor
92403694|NCT01426542|Topiramate|topiramate|mesh-list
92403695|NCT01426542|Anticonvulsants|anticonvulsants|mesh-ancestor
92083386|NCT01870921|Ticagrelor|ticagrelor|mesh-list
92403697|NCT01426542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403698|NCT01426633|Gemcitabine|gemcitabine|mesh-list
92083508|NCT01845025|Xhance|xhance|mesh-list
92083546|NCT04847440|Tenofovir|tenofovir|mesh-list
92083604|NCT01814371|Mupirocin|mupirocin|mesh-list
92403699|NCT01426633|Trabectedin|trabectedin|mesh-list
92016573|NCT04261855|Avelumab|avelumab|mesh-list
92403700|NCT01426633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92403701|NCT01426633|Antimetabolites|antimetabolites|mesh-ancestor
92116442|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403702|NCT01426633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403703|NCT01426633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116443|NCT03288870|Docetaxel|docetaxel|mesh-list
92403704|NCT01426633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92403705|NCT01426633|Alkylating Agents|alkylating agents|mesh-ancestor
92403706|NCT01426646|Cisplatin|cisplatin|mesh-list
92403707|NCT01426646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403708|NCT01426737|Vildagliptin|vildagliptin|mesh-list
92403709|NCT01426737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92403710|NCT01426737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140275|NCT05738148|Epinephrine|epinephrine|mesh-list
92084558|NCT00629122|Ionophores|ionophores|mesh-ancestor
92403711|NCT01426737|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92403712|NCT01426737|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403713|NCT01426737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403714|NCT01426737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403715|NCT01426802|Vildagliptin|vildagliptin|mesh-list
92084931|NCT00655642|Serotonin Agents|serotonin agents|mesh-ancestor
92403716|NCT01426802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92403717|NCT01426802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403718|NCT01426802|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92403719|NCT01426802|Protease Inhibitors|protease inhibitors|mesh-ancestor
92403720|NCT01426802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403721|NCT01426802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403722|NCT01426815|Golimumab|golimumab|mesh-list
92403723|NCT01426815|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92140430|NCT00716079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403724|NCT01426815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403725|NCT01426815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085552|NCT00717574|Nitrous Oxide|nitrous oxide|mesh-list
92403726|NCT01426815|Immunologic Factors|immunologic factors|mesh-ancestor
92403727|NCT01426815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403728|NCT01426880|Paclitaxel|paclitaxel|mesh-list
92403729|NCT01426880|Carboplatin|carboplatin|mesh-list
92403730|NCT01426880|Lapatinib|lapatinib|mesh-list
92403731|NCT01426880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016777|NCT04838743|Xultophy|xultophy|mesh-list
92403732|NCT01426880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403733|NCT01426880|Tubulin Modulators|tubulin modulators|mesh-ancestor
92403734|NCT01426880|Antimitotic Agents|antimitotic agents|mesh-ancestor
92403735|NCT01426880|Mitosis Modulators|mitosis modulators|mesh-ancestor
92403736|NCT01426880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086559|NCT01272934|Diclofenac|diclofenac|mesh-list
92016845|NCT05536271|Bisoprolol|bisoprolol|mesh-list
92403737|NCT01426880|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92403738|NCT01426880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403740|NCT01426906|Ketoconazole|ketoconazole|mesh-list
92403741|NCT01426906|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92403742|NCT01426906|Antitubercular Agents|antitubercular agents|mesh-ancestor
92403743|NCT01426906|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92403744|NCT01426906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403745|NCT01426906|Leprostatic Agents|leprostatic agents|mesh-ancestor
92403746|NCT01426906|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92403747|NCT01426906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087161|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
92403748|NCT01426906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140586|NCT02993991|Durvalumab|durvalumab|mesh-list
92403749|NCT01426906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92087395|NCT03809650|Macitentan|macitentan|mesh-list
92403750|NCT01426906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92403751|NCT01426906|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92087460|NCT01977677|Plerixafor|plerixafor|mesh-list
92403752|NCT01426906|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92018514|NCT04901065|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92403753|NCT01426906|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92403754|NCT01426906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92403755|NCT01426906|Antifungal Agents|antifungal agents|mesh-ancestor
92140587|NCT02993991|Mocetinostat|mocetinostat|mesh-list
92140665|NCT05094492|Fluorides, Topical|fluorides, topical|mesh-list
92403756|NCT01426906|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92403757|NCT01426906|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92403758|NCT01426906|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92403759|NCT01426906|Hormone Antagonists|hormone antagonists|mesh-ancestor
92403760|NCT01426906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403761|NCT01426906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403762|NCT01426906|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92403764|NCT01426971|Caffeine|caffeine|mesh-list
92116444|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116445|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
92116446|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
92116447|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
92116525|NCT01959490|Growth Substances|growth substances|mesh-ancestor
92116526|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
92403765|NCT01426971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92403766|NCT01426971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92403767|NCT01426971|Analgesics|analgesics|mesh-ancestor
92056149|NCT01836471|Xhance|xhance|mesh-list
92089528|NCT00863356|Antimetabolites|antimetabolites|mesh-ancestor
92403768|NCT01426971|Sensory System Agents|sensory system agents|mesh-ancestor
92140666|NCT05094492|Cariostatic Agents|cariostatic agents|mesh-ancestor
92403769|NCT01426971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403770|NCT01426971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403771|NCT01426971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403772|NCT01426971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140667|NCT05094492|Protective Agents|protective agents|mesh-ancestor
92141201|NCT04007029|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92141505|NCT04198129|Sultamicillin|sultamicillin|mesh-list
92090622|NCT04381234|Citric Acid|citric acid|mesh-list
92403773|NCT01426971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92090928|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
92403774|NCT01426971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091215|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
92141733|NCT04195321|Oxymetazoline|oxymetazoline|mesh-list
92403775|NCT01426971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091523|NCT01837576|Calcipotriene|calcipotriene|mesh-list
92403776|NCT01426971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92403777|NCT01426971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92091778|NCT03830086|Sevoflurane|sevoflurane|mesh-list
92403778|NCT01426971|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92403779|NCT01426971|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92403780|NCT01426971|Purinergic Agents|purinergic agents|mesh-ancestor
92403781|NCT01426971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403782|NCT01426984|Methylphenidate|methylphenidate|mesh-list
92092794|NCT03742245|Vorinostat|vorinostat|mesh-list
92403783|NCT01426984|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92141734|NCT04195321|Norepinephrine|norepinephrine|mesh-list
92141735|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92093178|NCT04363762|Salicylic Acid|salicylic acid|mesh-list
92403784|NCT01426984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093253|NCT03584373|Ketorolac|ketorolac|mesh-list
92403785|NCT01426984|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92403786|NCT01426984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92403787|NCT01426984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093402|NCT04356508|Nivolumab|nivolumab|mesh-list
92403788|NCT01426984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403789|NCT01426984|Dopamine Agents|dopamine agents|mesh-ancestor
92403790|NCT01426984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403791|NCT01427114|Prednisolone|prednisolone|mesh-list
92403792|NCT01427114|Cyclophosphamide|cyclophosphamide|mesh-list
92403793|NCT01427114|Rituximab|rituximab|mesh-list
92403794|NCT01427114|Vincristine|vincristine|mesh-list
92403795|NCT01427114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403796|NCT01427114|Immunologic Factors|immunologic factors|mesh-ancestor
92403797|NCT01427114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094334|NCT04984330|Hormones|hormones|mesh-ancestor
92403798|NCT01427114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403799|NCT01427114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92403800|NCT01427114|Alkylating Agents|alkylating agents|mesh-ancestor
91938143|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017273|NCT02463357|Nifedipine|nifedipine|mesh-list
92116527|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92094808|NCT03088059|Durvalumab|durvalumab|mesh-list
92116528|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92403801|NCT01427114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403802|NCT01427114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403803|NCT01427114|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92403804|NCT01427114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095312|NCT01023724|Bromfenac|bromfenac|mesh-list
92095399|NCT01025830|Antiviral Agents|antiviral agents|mesh-ancestor
92095491|NCT05066997|Dexamethasone|dexamethasone|mesh-list
92141736|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
92403805|NCT01427114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92403806|NCT01427114|Tubulin Modulators|tubulin modulators|mesh-ancestor
92403807|NCT01427114|Antimitotic Agents|antimitotic agents|mesh-ancestor
92403808|NCT01427114|Mitosis Modulators|mitosis modulators|mesh-ancestor
92403809|NCT01427114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403811|NCT01427114|Hormones|hormones|mesh-ancestor
92403812|NCT01427114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92403813|NCT01427114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92403814|NCT01427127|Ramosetron|ramosetron|mesh-list
92403815|NCT01427127|Antiemetics|antiemetics|mesh-ancestor
92403816|NCT01427127|Autonomic Agents|autonomic agents|mesh-ancestor
92403817|NCT01427127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403818|NCT01427127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403819|NCT01427127|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403820|NCT01427127|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92403821|NCT01427127|Serotonin Agents|serotonin agents|mesh-ancestor
92403822|NCT01427127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403823|NCT01427127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403824|NCT01427192|Acetazolamide|acetazolamide|mesh-list
92403825|NCT01427192|Anticonvulsants|anticonvulsants|mesh-ancestor
92403826|NCT01427192|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92403827|NCT01427192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403828|NCT01427192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403829|NCT01427192|Diuretics|diuretics|mesh-ancestor
92403830|NCT01427192|Natriuretic Agents|natriuretic agents|mesh-ancestor
92403831|NCT01427192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403832|NCT01427205|Cetuximab|cetuximab|mesh-list
92403833|NCT01427205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403834|NCT01427205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403835|NCT01427244|Trastuzumab|trastuzumab|mesh-list
92403836|NCT01427244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92403837|NCT01427244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403838|NCT01427270|Oxycodone|oxycodone|mesh-list
92403839|NCT01427270|Naloxone|naloxone|mesh-list
92403840|NCT01427270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92056167|NCT01802775|Aspirin|aspirin|mesh-list
92403841|NCT01427270|Narcotics|narcotics|mesh-ancestor
92403842|NCT01427270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403843|NCT01427270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403844|NCT01427270|Analgesics|analgesics|mesh-ancestor
92403845|NCT01427270|Sensory System Agents|sensory system agents|mesh-ancestor
92403846|NCT01427270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403847|NCT01427270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92403848|NCT01427283|Oxycodone|oxycodone|mesh-list
92403849|NCT01427283|Naloxone|naloxone|mesh-list
92403850|NCT01427283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92403851|NCT01427283|Narcotics|narcotics|mesh-ancestor
92403852|NCT01427283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403853|NCT01427283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403854|NCT01427283|Analgesics|analgesics|mesh-ancestor
92403855|NCT01427283|Sensory System Agents|sensory system agents|mesh-ancestor
92403856|NCT01427283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403857|NCT01427283|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92403858|NCT01427322|Lapatinib|lapatinib|mesh-list
92403859|NCT01427322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403860|NCT01427322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92403861|NCT01427322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403862|NCT01427322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403863|NCT01427335|Calcium, Dietary|calcium, dietary|mesh-list
92403864|NCT01427335|Calcium|calcium|mesh-list
92403865|NCT01427335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92403866|NCT01427335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403867|NCT01427335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92403868|NCT01427387|Linaclotide|linaclotide|mesh-list
92403869|NCT01427387|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92403870|NCT01427387|Enzyme Activators|enzyme activators|mesh-ancestor
92403871|NCT01427387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403872|NCT01427387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403873|NCT01427400|Botulinum Toxins|botulinum toxins|mesh-list
92403874|NCT01427400|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92403876|NCT01427400|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92403877|NCT01427400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92403878|NCT01427400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403879|NCT01427400|Cholinergic Agents|cholinergic agents|mesh-ancestor
92403880|NCT01427400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403881|NCT01427400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403882|NCT01427400|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92403883|NCT01427400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403884|NCT01427478|Afatinib|afatinib|mesh-list
92403885|NCT01427478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403886|NCT01427478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92403887|NCT01427478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403888|NCT01427478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403889|NCT01427491|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92403890|NCT01427491|Laxatives|laxatives|mesh-ancestor
92403891|NCT01427491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403892|NCT01427582|Trabectedin|trabectedin|mesh-list
92403893|NCT01427582|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92403894|NCT01427582|Alkylating Agents|alkylating agents|mesh-ancestor
92403895|NCT01427582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403896|NCT01427582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403898|NCT01427686|Dopamine|dopamine|mesh-list
92403899|NCT01427686|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92403900|NCT01427686|Sympathomimetics|sympathomimetics|mesh-ancestor
92403901|NCT01427686|Autonomic Agents|autonomic agents|mesh-ancestor
92403902|NCT01427686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403903|NCT01427686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403904|NCT01427686|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92403905|NCT01427686|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92403906|NCT01427686|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92403907|NCT01427686|Adrenergic Agents|adrenergic agents|mesh-ancestor
92403908|NCT01427686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403909|NCT01427686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403910|NCT01427686|Protective Agents|protective agents|mesh-ancestor
92403911|NCT01427686|Dopamine Agents|dopamine agents|mesh-ancestor
92403912|NCT01427699|Antibodies|antibodies|mesh-list
92403913|NCT01427699|Immunologic Factors|immunologic factors|mesh-ancestor
92403914|NCT01427699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056239|NCT01772823|Tenofovir|tenofovir|mesh-list
92403915|NCT01427842|Vancomycin|vancomycin|mesh-list
92403916|NCT01427842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92403917|NCT01427842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92403918|NCT01427868|Maleic acid|maleic acid|mesh-list
92403919|NCT01427868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403920|NCT01427868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403921|NCT01427946|Everolimus|everolimus|mesh-list
92403922|NCT01427946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92403923|NCT01427946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92403924|NCT01427946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403925|NCT01427946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403926|NCT01427946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92403927|NCT01427946|Immunologic Factors|immunologic factors|mesh-ancestor
92403928|NCT01427946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403929|NCT01427946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92403930|NCT01427985|Atropine|atropine|mesh-list
92403931|NCT01427985|Fentanyl|fentanyl|mesh-list
92403932|NCT01427985|Mivacurium|mivacurium|mesh-list
92403933|NCT01427985|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92403934|NCT01427985|Narcotics|narcotics|mesh-ancestor
92403935|NCT01427985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92403936|NCT01427985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403937|NCT01427985|Analgesics|analgesics|mesh-ancestor
92403938|NCT01427985|Sensory System Agents|sensory system agents|mesh-ancestor
92403939|NCT01427985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403940|NCT01427985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92403941|NCT01427985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92403942|NCT01427985|Anesthetics, General|anesthetics, general|mesh-ancestor
92403943|NCT01427985|Anesthetics|anesthetics|mesh-ancestor
92403944|NCT01427985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92403945|NCT01427985|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92403946|NCT01427985|Autonomic Agents|autonomic agents|mesh-ancestor
92403947|NCT01427985|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91938147|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
92403948|NCT01427985|Respiratory System Agents|respiratory system agents|mesh-ancestor
92403949|NCT01427985|Mydriatics|mydriatics|mesh-ancestor
92403950|NCT01427985|Parasympatholytics|parasympatholytics|mesh-ancestor
92403951|NCT01427985|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92403952|NCT01427985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92403953|NCT01427985|Cholinergic Agents|cholinergic agents|mesh-ancestor
92403954|NCT01427985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92403955|NCT01427985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403956|NCT01427985|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92403957|NCT01427985|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92403958|NCT01427985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92403959|NCT01428037|Misoprostol|misoprostol|mesh-list
92403960|NCT01428037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92403961|NCT01428037|Abortifacient Agents|abortifacient agents|mesh-ancestor
92403962|NCT01428037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92403963|NCT01428037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403964|NCT01428037|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92403965|NCT01428037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92403966|NCT01428037|Oxytocics|oxytocics|mesh-ancestor
92403967|NCT01428050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92403968|NCT01428154|Darbepoetin alfa|darbepoetin alfa|mesh-list
92403969|NCT01428154|Hematinics|hematinics|mesh-ancestor
92403970|NCT01428180|Ibuprofen|ibuprofen|mesh-list
92403971|NCT01428180|Indomethacin|indomethacin|mesh-list
92403972|NCT01428180|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92403973|NCT01428180|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92403974|NCT01428180|Analgesics|analgesics|mesh-ancestor
92403975|NCT01428180|Sensory System Agents|sensory system agents|mesh-ancestor
92403976|NCT01428180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92403977|NCT01428180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403978|NCT01428180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92403979|NCT01428180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403980|NCT01428180|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92403981|NCT01428180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92403982|NCT01428180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403983|NCT01428180|Gout Suppressants|gout suppressants|mesh-ancestor
92403984|NCT01428180|Tocolytic Agents|tocolytic agents|mesh-ancestor
92403985|NCT01428180|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92403986|NCT01428284|Canagliflozin|canagliflozin|mesh-list
92403987|NCT01428284|Probenecid|probenecid|mesh-list
92403988|NCT01428284|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92056318|NCT01767987|Ranolazine|ranolazine|mesh-list
92403989|NCT01428284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92403990|NCT01428284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92403991|NCT01428284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92403992|NCT01428284|Uricosuric Agents|uricosuric agents|mesh-ancestor
92403993|NCT01428284|Gout Suppressants|gout suppressants|mesh-ancestor
92403994|NCT01428284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92403995|NCT01428375|Acetaminophen|acetaminophen|mesh-list
92403996|NCT01428375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92403997|NCT01428375|Analgesics|analgesics|mesh-ancestor
92403998|NCT01428375|Sensory System Agents|sensory system agents|mesh-ancestor
92403999|NCT01428375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404000|NCT01428375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404001|NCT01428375|Antipyretics|antipyretics|mesh-ancestor
92404002|NCT01428388|Bevacizumab|bevacizumab|mesh-list
92404003|NCT01428388|Ranibizumab|ranibizumab|mesh-list
92404004|NCT01428388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92404005|NCT01428388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404006|NCT01428388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92404007|NCT01428388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92404008|NCT01428388|Growth Substances|growth substances|mesh-ancestor
92404009|NCT01428388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404010|NCT01428388|Growth Inhibitors|growth inhibitors|mesh-ancestor
92404011|NCT01428414|Paclitaxel|paclitaxel|mesh-list
92404012|NCT01428414|Carboplatin|carboplatin|mesh-list
92404013|NCT01428414|Trastuzumab|trastuzumab|mesh-list
92404014|NCT01428414|Epirubicin|epirubicin|mesh-list
92404015|NCT01428414|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92404016|NCT01428414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404017|NCT01428414|Tubulin Modulators|tubulin modulators|mesh-ancestor
92404018|NCT01428414|Antimitotic Agents|antimitotic agents|mesh-ancestor
92404019|NCT01428414|Mitosis Modulators|mitosis modulators|mesh-ancestor
92404020|NCT01428414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404021|NCT01428414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92404022|NCT01428414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92404023|NCT01428414|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92404024|NCT01428414|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92404025|NCT01428414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404027|NCT01428427|Trametinib|trametinib|mesh-list
92404028|NCT01428427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92404029|NCT01428427|Antimetabolites|antimetabolites|mesh-ancestor
92404030|NCT01428427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404031|NCT01428427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404032|NCT01428427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92404033|NCT01428427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404034|NCT01428466|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92404035|NCT01428466|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404036|NCT01428492|Dexamethasone|dexamethasone|mesh-list
92404037|NCT01428492|Bortezomib|bortezomib|mesh-list
92404038|NCT01428492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404039|NCT01428492|Antiemetics|antiemetics|mesh-ancestor
92404040|NCT01428492|Autonomic Agents|autonomic agents|mesh-ancestor
92404041|NCT01428492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404042|NCT01428492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404043|NCT01428492|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404045|NCT01428492|Hormones|hormones|mesh-ancestor
92404046|NCT01428492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404047|NCT01428492|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92404048|NCT01428492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404049|NCT01428518|Lamotrigine|lamotrigine|mesh-list
92404050|NCT01428518|Anticonvulsants|anticonvulsants|mesh-ancestor
92404051|NCT01428518|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92404052|NCT01428518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404053|NCT01428518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404054|NCT01428518|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404055|NCT01428518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404056|NCT01428518|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92404057|NCT01428518|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92404058|NCT01428518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404059|NCT01428518|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92404060|NCT01428518|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92404061|NCT01428531|PENTA|penta|mesh-list
92404062|NCT01428531|Fondaparinux|fondaparinux|mesh-list
92404063|NCT01428531|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92056386|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92404064|NCT01428531|Antithrombins|antithrombins|mesh-ancestor
92404065|NCT01428531|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92404066|NCT01428531|Protease Inhibitors|protease inhibitors|mesh-ancestor
92404067|NCT01428531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404068|NCT01428531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404069|NCT01428531|Anticoagulants|anticoagulants|mesh-ancestor
92404070|NCT01428531|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92404071|NCT01428531|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92404073|NCT01428544|Fondaparinux|fondaparinux|mesh-list
92404074|NCT01428544|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92404075|NCT01428544|Antithrombins|antithrombins|mesh-ancestor
92404076|NCT01428544|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92404077|NCT01428544|Protease Inhibitors|protease inhibitors|mesh-ancestor
92404078|NCT01428544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404079|NCT01428544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404080|NCT01428544|Anticoagulants|anticoagulants|mesh-ancestor
92404081|NCT01428544|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92404082|NCT01428544|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92404083|NCT01428622|Olodaterol|olodaterol|mesh-list
92404084|NCT01428622|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92404085|NCT01428622|Autonomic Agents|autonomic agents|mesh-ancestor
92404086|NCT01428622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404087|NCT01428622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404088|NCT01428622|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92404089|NCT01428622|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404090|NCT01428817|Carbetocin|carbetocin|mesh-list
92404091|NCT01428817|Oxytocin|oxytocin|mesh-list
92404092|NCT01428817|Oxytocics|oxytocics|mesh-ancestor
92404093|NCT01428817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404094|NCT01428817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404095|NCT01428908|Vaccines|vaccines|mesh-list
92404096|NCT01428908|Immunologic Factors|immunologic factors|mesh-ancestor
92404097|NCT01428908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404098|NCT01428986|Maraviroc|maraviroc|mesh-list
92404099|NCT01428986|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92404100|NCT01428986|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92404101|NCT01428986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404102|NCT01428986|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92404103|NCT01428986|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92404104|NCT01428986|Antiviral Agents|antiviral agents|mesh-ancestor
92404105|NCT01428986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404106|NCT01428986|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92404107|NCT01429025|Rituximab|rituximab|mesh-list
92404108|NCT01429025|Lenalidomide|lenalidomide|mesh-list
92404109|NCT01429025|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92404110|NCT01429025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92404111|NCT01429025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404112|NCT01429025|Immunologic Factors|immunologic factors|mesh-ancestor
92404113|NCT01429025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404114|NCT01429025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404115|NCT01429025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92404116|NCT01429025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92404118|NCT01429025|Growth Inhibitors|growth inhibitors|mesh-ancestor
92404119|NCT01429025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92404120|NCT01429025|Alkylating Agents|alkylating agents|mesh-ancestor
92404121|NCT01429025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404122|NCT01429090|Methantheline|methantheline|mesh-list
92404123|NCT01429090|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92404124|NCT01429090|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92404125|NCT01429090|Cholinergic Agents|cholinergic agents|mesh-ancestor
92404126|NCT01429090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404127|NCT01429090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404128|NCT01429090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404129|NCT01429129|Nicotine|nicotine|mesh-list
92404130|NCT01429129|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92404131|NCT01429129|Autonomic Agents|autonomic agents|mesh-ancestor
92404132|NCT01429129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404133|NCT01429129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404134|NCT01429129|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92404135|NCT01429129|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92404136|NCT01429129|Cholinergic Agents|cholinergic agents|mesh-ancestor
92404137|NCT01429129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404138|NCT01429129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404139|NCT01429181|Methadone|methadone|mesh-list
92404140|NCT01429181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92404141|NCT01429181|Narcotics|narcotics|mesh-ancestor
92404142|NCT01429181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404143|NCT01429181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404144|NCT01429181|Analgesics|analgesics|mesh-ancestor
92404145|NCT01429181|Sensory System Agents|sensory system agents|mesh-ancestor
92404146|NCT01429181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404147|NCT01429181|Antitussive Agents|antitussive agents|mesh-ancestor
92404148|NCT01429181|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404149|NCT01429337|Midostaurin|midostaurin|mesh-list
92404150|NCT01429337|Staurosporine|staurosporine|mesh-list
92404151|NCT01429337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404152|NCT01429337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92404153|NCT01429337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404154|NCT01429337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404155|NCT01429402|Botulinum Toxins|botulinum toxins|mesh-list
92404156|NCT01429402|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92404157|NCT01429402|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92404158|NCT01429402|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92018524|NCT02493777|Dopamine Agents|dopamine agents|mesh-ancestor
92404159|NCT01429402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404160|NCT01429402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404161|NCT01429402|Cholinergic Agents|cholinergic agents|mesh-ancestor
92404162|NCT01429402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404163|NCT01429402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404164|NCT01429402|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92404165|NCT01429402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404166|NCT01429415|Magnesium Sulfate|magnesium sulfate|mesh-list
92404167|NCT01429415|Analgesics|analgesics|mesh-ancestor
92404168|NCT01429415|Sensory System Agents|sensory system agents|mesh-ancestor
92404169|NCT01429415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938150|NCT04249232|Abaloparatide|abaloparatide|mesh-list
92404170|NCT01429415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404171|NCT01429415|Anesthetics|anesthetics|mesh-ancestor
92404172|NCT01429415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404173|NCT01429415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92404174|NCT01429415|Anticonvulsants|anticonvulsants|mesh-ancestor
92404175|NCT01429415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92404176|NCT01429415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404177|NCT01429415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404178|NCT01429415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404179|NCT01429415|Tocolytic Agents|tocolytic agents|mesh-ancestor
92404180|NCT01429415|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404181|NCT01429545|Nifedipine|nifedipine|mesh-list
92404182|NCT01429545|Vasotocin|vasotocin|mesh-list
92404183|NCT01429545|Atosiban|atosiban|mesh-list
92404184|NCT01429545|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92404185|NCT01429545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404186|NCT01429545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404187|NCT01429545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404188|NCT01429545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404189|NCT01429545|Vasodilator Agents|vasodilator agents|mesh-ancestor
92404190|NCT01429545|Tocolytic Agents|tocolytic agents|mesh-ancestor
92404191|NCT01429545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404192|NCT01429545|Hormone Antagonists|hormone antagonists|mesh-ancestor
92404193|NCT01429545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404194|NCT01429545|Oxytocics|oxytocics|mesh-ancestor
92404195|NCT01429545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92404196|NCT01429571|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92404197|NCT01429571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404198|NCT01429610|Cytarabine|cytarabine|mesh-list
92404199|NCT01429610|Rituximab|rituximab|mesh-list
92404200|NCT01429610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92404201|NCT01429610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404202|NCT01429610|Immunologic Factors|immunologic factors|mesh-ancestor
92404203|NCT01429610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404204|NCT01429610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404205|NCT01429610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92404206|NCT01429610|Antimetabolites|antimetabolites|mesh-ancestor
92404207|NCT01429610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404208|NCT01429610|Antiviral Agents|antiviral agents|mesh-ancestor
92404209|NCT01429610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404210|NCT01429610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404211|NCT01429675|Ibandronic Acid|ibandronic acid|mesh-list
92404212|NCT01429675|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92404213|NCT01429675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404214|NCT01429701|Gentamicins|gentamicins|mesh-list
92404215|NCT01429701|Polymyxins|polymyxins|mesh-list
92404216|NCT01429701|Polymyxin B|polymyxin b|mesh-list
92404217|NCT01429701|Prednisolone|prednisolone|mesh-list
92404218|NCT01429701|Betamethasone|betamethasone|mesh-list
92404219|NCT01429701|Benzocaine|benzocaine|mesh-list
92404220|NCT01429701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404221|NCT01429701|Glucocorticoids|glucocorticoids|mesh-ancestor
92404222|NCT01429701|Hormones|hormones|mesh-ancestor
92404223|NCT01429701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404224|NCT01429701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404225|NCT01429701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92404226|NCT01429701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018559|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404227|NCT01429701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404228|NCT01429701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92404229|NCT01429701|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404230|NCT01429701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92404231|NCT01429701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404232|NCT01429701|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92404233|NCT01429701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404234|NCT01429701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404235|NCT01429701|Anesthetics, Local|anesthetics, local|mesh-ancestor
92404236|NCT01429701|Anesthetics|anesthetics|mesh-ancestor
92404237|NCT01429701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404238|NCT01429701|Sensory System Agents|sensory system agents|mesh-ancestor
92404239|NCT01429714|Oxymetazoline|oxymetazoline|mesh-list
92404240|NCT01429714|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92404241|NCT01429714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92404242|NCT01429714|Adrenergic Agents|adrenergic agents|mesh-ancestor
92404243|NCT01429714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404244|NCT01429714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404245|NCT01429714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404246|NCT01429714|Sympathomimetics|sympathomimetics|mesh-ancestor
92404247|NCT01429714|Autonomic Agents|autonomic agents|mesh-ancestor
92404248|NCT01429714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404249|NCT01429714|Nasal Decongestants|nasal decongestants|mesh-ancestor
92404250|NCT01429714|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92404251|NCT01429714|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404253|NCT01429818|Glimepiride|glimepiride|mesh-list
92404254|NCT01429818|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92404255|NCT01429818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404256|NCT01429818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92404257|NCT01429818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404258|NCT01429818|Immunologic Factors|immunologic factors|mesh-ancestor
92404259|NCT01429831|Aripiprazole|aripiprazole|mesh-list
92404260|NCT01429831|Antidepressive Agents|antidepressive agents|mesh-ancestor
92404261|NCT01429831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92404262|NCT01429831|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92404263|NCT01429831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92404264|NCT01429831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404265|NCT01429831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404266|NCT01429831|Dopamine Agonists|dopamine agonists|mesh-ancestor
92404267|NCT01429831|Dopamine Agents|dopamine agents|mesh-ancestor
92404268|NCT01429831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404269|NCT01429831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404270|NCT01429831|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92404271|NCT01429831|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92404272|NCT01429831|Serotonin Agents|serotonin agents|mesh-ancestor
92404273|NCT01429831|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92404274|NCT01429831|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92404275|NCT01429831|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92404276|NCT01429831|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92404277|NCT01429844|Cyclosporine|cyclosporine|mesh-list
92404278|NCT01429844|Tacrolimus|tacrolimus|mesh-list
92404279|NCT01429844|Cyclosporins|cyclosporins|mesh-list
92404280|NCT01429844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404281|NCT01429844|Immunologic Factors|immunologic factors|mesh-ancestor
92404282|NCT01429844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404283|NCT01429844|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92404284|NCT01429844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404285|NCT01429844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404286|NCT01429844|Antifungal Agents|antifungal agents|mesh-ancestor
92404287|NCT01429844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404288|NCT01429844|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404289|NCT01429844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404290|NCT01429870|Triamcinolone|triamcinolone|mesh-list
92404291|NCT01429870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404292|NCT01429870|Glucocorticoids|glucocorticoids|mesh-ancestor
92404293|NCT01429870|Hormones|hormones|mesh-ancestor
92404294|NCT01429870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404295|NCT01429870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404296|NCT01429935|Ibuprofen|ibuprofen|mesh-list
92404297|NCT01429935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92404298|NCT01429935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404299|NCT01429935|Analgesics|analgesics|mesh-ancestor
92404300|NCT01429935|Sensory System Agents|sensory system agents|mesh-ancestor
92404301|NCT01429935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404302|NCT01429935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404303|NCT01429935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404304|NCT01429935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404305|NCT01429935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92404306|NCT01429935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404307|NCT01429935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404308|NCT01430013|Endostar protein|endostar protein|mesh-list
92404309|NCT01430013|Endostatins|endostatins|mesh-list
92404310|NCT01430013|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92404311|NCT01430013|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92404312|NCT01430013|Growth Substances|growth substances|mesh-ancestor
92404313|NCT01430013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404314|NCT01430013|Growth Inhibitors|growth inhibitors|mesh-ancestor
92404315|NCT01430013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404316|NCT01430052|Gemcitabine|gemcitabine|mesh-list
92404317|NCT01430052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92404318|NCT01430052|Antimetabolites|antimetabolites|mesh-ancestor
92404319|NCT01430052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404320|NCT01430052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404322|NCT01430065|Peficitinib|peficitinib|mesh-list
92404323|NCT01430065|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404324|NCT01430065|Immunologic Factors|immunologic factors|mesh-ancestor
92404325|NCT01430065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404326|NCT01430065|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92404327|NCT01430065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404328|NCT01430065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404329|NCT01430078|Niacinamide|niacinamide|mesh-list
92404330|NCT01430078|Peficitinib|peficitinib|mesh-list
92404331|NCT01430078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404332|NCT01430078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404333|NCT01430078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404334|NCT01430078|Immunologic Factors|immunologic factors|mesh-ancestor
92404335|NCT01430078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404336|NCT01430078|Vitamin B Complex|vitamin b complex|mesh-ancestor
92404337|NCT01430078|Vitamins|vitamins|mesh-ancestor
92404338|NCT01430078|Micronutrients|micronutrients|mesh-ancestor
92404339|NCT01430195|Afamelanotide|afamelanotide|mesh-list
92404340|NCT01430195|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404341|NCT01430234|Pancreatin|pancreatin|mesh-list
92404342|NCT01430234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404343|NCT01430260|Ciclesonide|ciclesonide|mesh-list
92404344|NCT01430260|Cetirizine|cetirizine|mesh-list
92404345|NCT01430260|Levocetirizine|levocetirizine|mesh-list
92404346|NCT01430260|Glucocorticoids|glucocorticoids|mesh-ancestor
92404347|NCT01430260|Hormones|hormones|mesh-ancestor
92404348|NCT01430260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404349|NCT01430260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404350|NCT01430260|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92404351|NCT01430260|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92404352|NCT01430260|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92404353|NCT01430260|Histamine Antagonists|histamine antagonists|mesh-ancestor
92404354|NCT01430260|Histamine Agents|histamine agents|mesh-ancestor
92404355|NCT01430260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404356|NCT01430260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404357|NCT01430312|Azelaic acid|azelaic acid|mesh-list
92404358|NCT01430312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404359|NCT01430312|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404360|NCT01430520|Escitalopram|escitalopram|mesh-list
92404361|NCT01430520|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92404362|NCT01430520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92404363|NCT01430520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404364|NCT01430520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404365|NCT01430520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404366|NCT01430520|Serotonin Agents|serotonin agents|mesh-ancestor
92404367|NCT01430520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056691|NCT02005562|Hormones|hormones|mesh-ancestor
92404368|NCT01430533|Azelaic acid|azelaic acid|mesh-list
92404369|NCT01430533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404370|NCT01430533|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404371|NCT01430650|Saw palmetto extract|saw palmetto extract|mesh-list
92404372|NCT01430650|Urological Agents|urological agents|mesh-ancestor
92404373|NCT01430689|Vaccines|vaccines|mesh-list
92404374|NCT01430689|Immunologic Factors|immunologic factors|mesh-ancestor
92404375|NCT01430689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404376|NCT01430793|Vitamin D|vitamin d|mesh-list
92404377|NCT01430793|Ergocalciferols|ergocalciferols|mesh-list
92404378|NCT01430793|Cholecalciferol|cholecalciferol|mesh-list
92404379|NCT01430793|Vitamins|vitamins|mesh-list
92404380|NCT01430793|Micronutrients|micronutrients|mesh-ancestor
92404381|NCT01430793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404382|NCT01430793|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92404383|NCT01430793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404384|NCT01430806|Dronedarone|dronedarone|mesh-list
92404385|NCT01430806|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92404386|NCT01430910|Ceftazidime|ceftazidime|mesh-list
92404387|NCT01430910|Avibactam|avibactam|mesh-list
92404388|NCT01430910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92404389|NCT01430910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404390|NCT01430910|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92404391|NCT01430910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404392|NCT01430910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404393|NCT01430923|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92404394|NCT01430923|Latanoprost|latanoprost|mesh-list
92404395|NCT01430923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92404396|NCT01431053|Aspirin|aspirin|mesh-list
92404397|NCT01431053|Exemestane|exemestane|mesh-list
92404398|NCT01431053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92404399|NCT01431053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404400|NCT01431053|Analgesics|analgesics|mesh-ancestor
92404401|NCT01431053|Sensory System Agents|sensory system agents|mesh-ancestor
92404402|NCT01431053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404403|NCT01431053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404404|NCT01431053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404405|NCT01431053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404406|NCT01431053|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92404407|NCT01431053|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92404408|NCT01431053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404409|NCT01431053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92404410|NCT01431053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92404411|NCT01431053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404413|NCT01431053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404414|NCT01431053|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92404415|NCT01431053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92404416|NCT01431053|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92404417|NCT01431053|Hormone Antagonists|hormone antagonists|mesh-ancestor
92404418|NCT01431053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404419|NCT01431092|Melatonin|melatonin|mesh-list
92404420|NCT01431092|Antioxidants|antioxidants|mesh-ancestor
92404421|NCT01431092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404422|NCT01431092|Protective Agents|protective agents|mesh-ancestor
92404423|NCT01431092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404424|NCT01431092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404425|NCT01431118|Camphor|camphor|mesh-list
92404426|NCT01431118|Salicylates|salicylates|mesh-list
92404427|NCT01431118|Methyl salicylate|methyl salicylate|mesh-list
92404428|NCT01431118|Menthol|menthol|mesh-list
92404429|NCT01431118|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92404430|NCT01431118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404431|NCT01431118|Antipruritics|antipruritics|mesh-ancestor
92404432|NCT01431118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404433|NCT01431118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92404434|NCT01431118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404435|NCT01431118|Analgesics|analgesics|mesh-ancestor
92404436|NCT01431118|Sensory System Agents|sensory system agents|mesh-ancestor
92404437|NCT01431118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404438|NCT01431118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404439|NCT01431118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404441|NCT01431118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92404442|NCT01431118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404443|NCT01431118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404444|NCT01431326|Vancomycin|vancomycin|mesh-list
92404445|NCT01431326|Ciprofloxacin|ciprofloxacin|mesh-list
92404446|NCT01431326|Tazobactam|tazobactam|mesh-list
92404447|NCT01431326|Piperacillin|piperacillin|mesh-list
92404448|NCT01431326|Tobramycin|tobramycin|mesh-list
92404449|NCT01431326|Amikacin|amikacin|mesh-list
92404450|NCT01431326|Fosfomycin|fosfomycin|mesh-list
92404451|NCT01431326|Cefepime|cefepime|mesh-list
92404452|NCT01431326|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92404453|NCT01431326|Nafcillin|nafcillin|mesh-list
92404454|NCT01431326|Cidofovir|cidofovir|mesh-list
92404455|NCT01431326|Methylprednisolone|methylprednisolone|mesh-list
92404456|NCT01431326|Bosentan|bosentan|mesh-list
92404457|NCT01431326|Labetalol|labetalol|mesh-list
92404458|NCT01431326|Nifedipine|nifedipine|mesh-list
92404459|NCT01431326|Spironolactone|spironolactone|mesh-list
92404460|NCT01431326|Pentobarbital|pentobarbital|mesh-list
92404461|NCT01431326|Oxycodone|oxycodone|mesh-list
92404462|NCT01431326|Alfentanil|alfentanil|mesh-list
92404463|NCT01431326|Haloperidol|haloperidol|mesh-list
92404464|NCT01431326|Zolpidem|zolpidem|mesh-list
92404465|NCT01431326|Ziprasidone|ziprasidone|mesh-list
92404466|NCT01431326|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92404467|NCT01431326|Clozapine|clozapine|mesh-list
92404468|NCT01431326|Molindone|molindone|mesh-list
92404469|NCT01431326|Warfarin|warfarin|mesh-list
92404470|NCT01431326|Tranexamic Acid|tranexamic acid|mesh-list
92404471|NCT01431326|Aminocaproic Acid|aminocaproic acid|mesh-list
92404472|NCT01431326|Rocuronium|rocuronium|mesh-list
92404473|NCT01431326|Vecuronium Bromide|vecuronium bromide|mesh-list
92404474|NCT01431326|Sevelamer|sevelamer|mesh-list
92404475|NCT01431326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404476|NCT01431326|Antiemetics|antiemetics|mesh-ancestor
92404477|NCT01431326|Autonomic Agents|autonomic agents|mesh-ancestor
92404478|NCT01431326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404479|NCT01431326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404480|NCT01431326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404481|NCT01431326|Glucocorticoids|glucocorticoids|mesh-ancestor
92404482|NCT01431326|Hormones|hormones|mesh-ancestor
92404483|NCT01431326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404484|NCT01431326|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92404485|NCT01431326|Protective Agents|protective agents|mesh-ancestor
92404486|NCT01431326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404487|NCT01431326|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92404488|NCT01431326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92404489|NCT01431326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404490|NCT01431326|Hemostatics|hemostatics|mesh-ancestor
92404491|NCT01431326|Coagulants|coagulants|mesh-ancestor
92404492|NCT01431326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92404493|NCT01431326|Narcotics|narcotics|mesh-ancestor
92404494|NCT01431326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404495|NCT01431326|Analgesics|analgesics|mesh-ancestor
92404496|NCT01431326|Sensory System Agents|sensory system agents|mesh-ancestor
92404497|NCT01431326|Anticoagulants|anticoagulants|mesh-ancestor
92404498|NCT01431326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92404499|NCT01431326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404500|NCT01431326|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92404501|NCT01431326|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92404502|NCT01431326|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92404503|NCT01431326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92404504|NCT01431326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92404505|NCT01431326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404506|NCT01431326|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92404507|NCT01431326|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92404508|NCT01431326|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92404509|NCT01431326|Hormone Antagonists|hormone antagonists|mesh-ancestor
92404510|NCT01431326|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92404511|NCT01431326|Diuretics|diuretics|mesh-ancestor
92404512|NCT01431326|Natriuretic Agents|natriuretic agents|mesh-ancestor
92404513|NCT01431326|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92404514|NCT01431326|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404515|NCT01431326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404516|NCT01431326|Vasodilator Agents|vasodilator agents|mesh-ancestor
92404517|NCT01431326|Tocolytic Agents|tocolytic agents|mesh-ancestor
92404518|NCT01431326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404519|NCT01431326|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92404520|NCT01431326|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92404521|NCT01431326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92404522|NCT01431326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92404523|NCT01431326|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92404524|NCT01431326|Dopamine Agents|dopamine agents|mesh-ancestor
92404525|NCT01431326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404526|NCT01431326|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92404528|NCT01431326|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92404529|NCT01431326|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92404530|NCT01431326|GABA Agonists|gaba agonists|mesh-ancestor
92404531|NCT01431326|GABA Agents|gaba agents|mesh-ancestor
92404532|NCT01431326|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92404533|NCT01431326|Serotonin Agents|serotonin agents|mesh-ancestor
92404534|NCT01431326|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92404535|NCT01431326|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92404536|NCT01431326|Chelating Agents|chelating agents|mesh-ancestor
92404537|NCT01431326|Sequestering Agents|sequestering agents|mesh-ancestor
92404538|NCT01431326|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92404539|NCT01431326|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92404540|NCT01431326|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92404541|NCT01431326|Adrenergic Agents|adrenergic agents|mesh-ancestor
92404542|NCT01431326|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92404543|NCT01431326|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92404544|NCT01431326|GABA Antagonists|gaba antagonists|mesh-ancestor
92404545|NCT01431326|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92404546|NCT01431326|Sympathomimetics|sympathomimetics|mesh-ancestor
92404547|NCT01431326|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92404548|NCT01431326|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92404549|NCT01431326|Anesthetics, General|anesthetics, general|mesh-ancestor
92404550|NCT01431326|Anesthetics|anesthetics|mesh-ancestor
92404551|NCT01431326|Antiviral Agents|antiviral agents|mesh-ancestor
92404552|NCT01431326|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92404553|NCT01431326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92404554|NCT01431326|Cholinergic Agents|cholinergic agents|mesh-ancestor
92404555|NCT01431326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92404556|NCT01431326|GABA Modulators|gaba modulators|mesh-ancestor
92404558|NCT01431352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404559|NCT01431352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92404560|NCT01431352|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92404561|NCT01431352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404562|NCT01431352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404563|NCT01431352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92404564|NCT01431352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92404565|NCT01431352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404566|NCT01431352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404568|NCT01431404|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92404569|NCT01431404|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404570|NCT01431404|Analgesics|analgesics|mesh-ancestor
92404571|NCT01431404|Sensory System Agents|sensory system agents|mesh-ancestor
92404572|NCT01431404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404573|NCT01431404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404574|NCT01431404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404575|NCT01431404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404576|NCT01431404|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404577|NCT01431404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404578|NCT01431404|Immunologic Factors|immunologic factors|mesh-ancestor
92404579|NCT01431430|Cholecalciferol|cholecalciferol|mesh-list
92404580|NCT01431430|Vitamin D|vitamin d|mesh-list
92404581|NCT01431430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404582|NCT01431430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404583|NCT01431430|Vitamins|vitamins|mesh-ancestor
92404584|NCT01431430|Micronutrients|micronutrients|mesh-ancestor
92404585|NCT01431430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92404586|NCT01431443|Theobromine|theobromine|mesh-list
92404587|NCT01431443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92404588|NCT01431443|Autonomic Agents|autonomic agents|mesh-ancestor
92404589|NCT01431443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404590|NCT01431443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404591|NCT01431443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92404592|NCT01431443|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404593|NCT01431443|Vasodilator Agents|vasodilator agents|mesh-ancestor
92404594|NCT01431456|Nadroparin|nadroparin|mesh-list
92404595|NCT01431456|Rivaroxaban|rivaroxaban|mesh-list
92404596|NCT01431456|Dabigatran|dabigatran|mesh-list
92404597|NCT01431456|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92404598|NCT01431456|Antithrombins|antithrombins|mesh-ancestor
92404599|NCT01431456|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92404600|NCT01431456|Protease Inhibitors|protease inhibitors|mesh-ancestor
92056913|NCT01976624|Bimatoprost|bimatoprost|mesh-list
92404601|NCT01431456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404602|NCT01431456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404603|NCT01431456|Anticoagulants|anticoagulants|mesh-ancestor
92404604|NCT01431456|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92404605|NCT01431456|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92404606|NCT01431495|Clopidogrel|clopidogrel|mesh-list
92404607|NCT01431495|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92404608|NCT01431495|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92404609|NCT01431495|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92404610|NCT01431495|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92404611|NCT01431495|Purinergic Agents|purinergic agents|mesh-ancestor
92404612|NCT01431495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404613|NCT01431495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404614|NCT01431495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404615|NCT01431547|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92404616|NCT01431547|Immunologic Factors|immunologic factors|mesh-ancestor
92404617|NCT01431547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404619|NCT01431612|Oxymetazoline|oxymetazoline|mesh-list
92404620|NCT01431612|Esmolol|esmolol|mesh-list
92404621|NCT01431612|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92404622|NCT01431612|Mydriatics|mydriatics|mesh-ancestor
92404623|NCT01431612|Autonomic Agents|autonomic agents|mesh-ancestor
92404624|NCT01431612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404625|NCT01431612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404627|NCT01431612|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92404628|NCT01431612|Nasal Decongestants|nasal decongestants|mesh-ancestor
92404629|NCT01431612|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404630|NCT01431612|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92404631|NCT01431612|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92404632|NCT01431612|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92404633|NCT01431612|Adrenergic Agents|adrenergic agents|mesh-ancestor
92404634|NCT01431612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404635|NCT01431612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404636|NCT01431612|Protective Agents|protective agents|mesh-ancestor
92404637|NCT01431612|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92404638|NCT01431612|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92404639|NCT01431612|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92404640|NCT01431690|Warfarin|warfarin|mesh-list
92404641|NCT01431690|Anticoagulants|anticoagulants|mesh-list
92404642|NCT01431729|Propolis|propolis|mesh-list
92404643|NCT01431729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404644|NCT01431742|Buprenorphine|buprenorphine|mesh-list
92404645|NCT01431742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92404646|NCT01431742|Narcotics|narcotics|mesh-ancestor
92404647|NCT01431742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404648|NCT01431742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404649|NCT01431742|Analgesics|analgesics|mesh-ancestor
92404650|NCT01431742|Sensory System Agents|sensory system agents|mesh-ancestor
92404651|NCT01431742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404652|NCT01431742|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92404653|NCT01431781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92404654|NCT01431781|Somatostatin|somatostatin|mesh-list
92404655|NCT01431781|Hormones|hormones|mesh-ancestor
92404656|NCT01431781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404657|NCT01431781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404658|NCT01431833|Tedizolid phosphate|tedizolid phosphate|mesh-list
92141737|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
92404659|NCT01431833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92404660|NCT01431833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404661|NCT01431924|Fluticasone|fluticasone|mesh-list
92404662|NCT01431924|Xhance|xhance|mesh-list
92404663|NCT01431924|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92404664|NCT01431924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404665|NCT01431924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92404666|NCT01431924|Autonomic Agents|autonomic agents|mesh-ancestor
92404667|NCT01431924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404668|NCT01431924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404669|NCT01431924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92404670|NCT01431924|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404671|NCT01431924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404672|NCT01431924|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92404673|NCT01431924|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92404674|NCT01431924|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92404675|NCT01431924|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92404676|NCT01431924|Adrenergic Agents|adrenergic agents|mesh-ancestor
92404677|NCT01431924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404678|NCT01431924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404679|NCT01432028|Drospirenone|drospirenone|mesh-list
92404680|NCT01432028|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92404681|NCT01432028|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92404682|NCT01432028|Estradiol|estradiol|mesh-list
92404683|NCT01432028|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92404684|NCT01432028|Progesterone|progesterone|mesh-list
92404685|NCT01432028|Estrogens|estrogens|mesh-ancestor
92404686|NCT01432028|Hormones|hormones|mesh-ancestor
92404687|NCT01432028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404688|NCT01432028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404689|NCT01432028|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92404690|NCT01432028|Contraceptive Agents|contraceptive agents|mesh-ancestor
92404691|NCT01432028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404692|NCT01432028|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92404693|NCT01432028|Progestins|progestins|mesh-ancestor
92404694|NCT01432028|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92404695|NCT01432028|Hormone Antagonists|hormone antagonists|mesh-ancestor
92404696|NCT01432028|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92404697|NCT01432028|Diuretics|diuretics|mesh-ancestor
92404698|NCT01432028|Natriuretic Agents|natriuretic agents|mesh-ancestor
92404700|NCT01432080|Prednisone|prednisone|mesh-list
92404701|NCT01432080|Budesonide|budesonide|mesh-list
92404702|NCT01432080|Formoterol Fumarate|formoterol fumarate|mesh-list
92404703|NCT01432080|Montelukast|montelukast|mesh-list
92404704|NCT01432080|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92404705|NCT01432080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404706|NCT01432080|Glucocorticoids|glucocorticoids|mesh-ancestor
92404707|NCT01432080|Hormones|hormones|mesh-ancestor
92404708|NCT01432080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404709|NCT01432080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404710|NCT01432080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92404711|NCT01432080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404712|NCT01432080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92404713|NCT01432080|Autonomic Agents|autonomic agents|mesh-ancestor
92404714|NCT01432080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404715|NCT01432080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92404716|NCT01432080|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404717|NCT01432080|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92404718|NCT01432080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404719|NCT01432080|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92404720|NCT01432080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92404721|NCT01432080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92404722|NCT01432080|Adrenergic Agents|adrenergic agents|mesh-ancestor
92404723|NCT01432080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404724|NCT01432080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404725|NCT01432080|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92404726|NCT01432080|Hormone Antagonists|hormone antagonists|mesh-ancestor
92404727|NCT01432080|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92404728|NCT01432080|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92404729|NCT01432106|Valsartan|valsartan|mesh-list
92404730|NCT01432106|Ramipril|ramipril|mesh-list
92404731|NCT01432106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92404732|NCT01432106|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92404733|NCT01432106|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92404734|NCT01432106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404735|NCT01432106|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92404736|NCT01432106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92404737|NCT01432106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404738|NCT01432119|Cetuximab|cetuximab|mesh-list
92404739|NCT01432119|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92404740|NCT01432119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92404741|NCT01432119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404742|NCT01432119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92404743|NCT01432119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404744|NCT01432119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404745|NCT01432158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92404746|NCT01432158|Immunologic Factors|immunologic factors|mesh-ancestor
92404747|NCT01432158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404748|NCT01432223|Paclitaxel|paclitaxel|mesh-list
92404749|NCT01432223|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92404750|NCT01432223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404751|NCT01432223|Tubulin Modulators|tubulin modulators|mesh-ancestor
92404752|NCT01432223|Antimitotic Agents|antimitotic agents|mesh-ancestor
92404753|NCT01432223|Mitosis Modulators|mitosis modulators|mesh-ancestor
92404754|NCT01432223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404755|NCT01432249|Etanercept|etanercept|mesh-list
92404756|NCT01432249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92404757|NCT01432249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404758|NCT01432249|Analgesics|analgesics|mesh-ancestor
92404759|NCT01432249|Sensory System Agents|sensory system agents|mesh-ancestor
92404760|NCT01432249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404761|NCT01432249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404762|NCT01432249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404763|NCT01432249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404764|NCT01432249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404765|NCT01432249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404766|NCT01432249|Immunologic Factors|immunologic factors|mesh-ancestor
92404767|NCT01432470|Oxytocin|oxytocin|mesh-list
92404768|NCT01432470|Oxytocics|oxytocics|mesh-ancestor
92404769|NCT01432470|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92404770|NCT01432470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404771|NCT01432483|Denileukin diftitox|denileukin diftitox|mesh-list
92404772|NCT01432483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404773|NCT01432496|Ropivacaine|ropivacaine|mesh-list
92404774|NCT01432496|Anesthetics, Local|anesthetics, local|mesh-ancestor
92404775|NCT01432496|Anesthetics|anesthetics|mesh-ancestor
92404776|NCT01432496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404777|NCT01432496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404778|NCT01432496|Sensory System Agents|sensory system agents|mesh-ancestor
92404779|NCT01432496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404780|NCT01432522|Epinephrine|epinephrine|mesh-list
92404781|NCT01432522|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92404782|NCT01432522|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92404783|NCT01432522|Adrenergic Agents|adrenergic agents|mesh-ancestor
92404784|NCT01432522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404785|NCT01432522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404786|NCT01432522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404787|NCT01432522|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92404788|NCT01432522|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92404789|NCT01432522|Autonomic Agents|autonomic agents|mesh-ancestor
92404790|NCT01432522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404791|NCT01432522|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92404792|NCT01432522|Respiratory System Agents|respiratory system agents|mesh-ancestor
92404793|NCT01432522|Mydriatics|mydriatics|mesh-ancestor
92404794|NCT01432522|Sympathomimetics|sympathomimetics|mesh-ancestor
92404795|NCT01432522|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92404796|NCT01432587|Diflunisal|diflunisal|mesh-list
92404797|NCT01432587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92404798|NCT01432587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404799|NCT01432587|Analgesics|analgesics|mesh-ancestor
92404800|NCT01432587|Sensory System Agents|sensory system agents|mesh-ancestor
92404801|NCT01432587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404802|NCT01432587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404803|NCT01432587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404804|NCT01432587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92404805|NCT01432587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92404806|NCT01432587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404807|NCT01432587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404808|NCT01432665|Sildenafil Citrate|sildenafil citrate|mesh-list
92404809|NCT01432665|Testosterone|testosterone|mesh-list
92404810|NCT01432665|Androgens|androgens|mesh-ancestor
92404812|NCT01432665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404813|NCT01432665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404814|NCT01432665|Vasodilator Agents|vasodilator agents|mesh-ancestor
92404815|NCT01432665|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92404816|NCT01432665|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92404817|NCT01432665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404818|NCT01432665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404819|NCT01432665|Urological Agents|urological agents|mesh-ancestor
92404820|NCT01432704|Cholecalciferol|cholecalciferol|mesh-list
92404821|NCT01432704|Vitamin D|vitamin d|mesh-list
92404822|NCT01432704|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92404823|NCT01432704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404824|NCT01432704|Vitamins|vitamins|mesh-ancestor
92404825|NCT01432704|Micronutrients|micronutrients|mesh-ancestor
92404826|NCT01432704|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92404828|NCT01432717|Hematinics|hematinics|mesh-ancestor
92404829|NCT01432782|Botulinum Toxins|botulinum toxins|mesh-list
92404830|NCT01432782|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92404831|NCT01432782|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92404832|NCT01432782|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92404833|NCT01432782|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92404834|NCT01432782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404835|NCT01432782|Cholinergic Agents|cholinergic agents|mesh-ancestor
92404836|NCT01432782|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404837|NCT01432782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404838|NCT01432782|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92404839|NCT01432782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404840|NCT01432821|Apomorphine|apomorphine|mesh-list
92404841|NCT01432821|Emetics|emetics|mesh-ancestor
92404842|NCT01432821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404843|NCT01432821|Autonomic Agents|autonomic agents|mesh-ancestor
92404844|NCT01432821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404845|NCT01432821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404846|NCT01432821|Dopamine Agonists|dopamine agonists|mesh-ancestor
92404848|NCT01432821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404849|NCT01432821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404850|NCT01432873|Selenium|selenium|mesh-list
92404851|NCT01432873|Antioxidants|antioxidants|mesh-ancestor
92404852|NCT01432873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404853|NCT01432873|Protective Agents|protective agents|mesh-ancestor
92404854|NCT01432873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404855|NCT01432873|Trace Elements|trace elements|mesh-ancestor
92404856|NCT01432873|Micronutrients|micronutrients|mesh-ancestor
92404857|NCT01432977|Acetaminophen|acetaminophen|mesh-list
92404858|NCT01432977|Droperidol|droperidol|mesh-list
92404859|NCT01432977|Ondansetron|ondansetron|mesh-list
92404860|NCT01432977|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92404861|NCT01432977|Analgesics|analgesics|mesh-ancestor
92404862|NCT01432977|Sensory System Agents|sensory system agents|mesh-ancestor
92404863|NCT01432977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404864|NCT01432977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404865|NCT01432977|Antipyretics|antipyretics|mesh-ancestor
92404866|NCT01432977|Antiemetics|antiemetics|mesh-ancestor
92404867|NCT01432977|Autonomic Agents|autonomic agents|mesh-ancestor
92404868|NCT01432977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404869|NCT01432977|Antipruritics|antipruritics|mesh-ancestor
92404870|NCT01432977|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404871|NCT01432977|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92404872|NCT01432977|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92404873|NCT01432977|Serotonin Agents|serotonin agents|mesh-ancestor
92404874|NCT01432977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404875|NCT01432977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404876|NCT01432977|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92404877|NCT01432977|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92404878|NCT01432977|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92404879|NCT01432977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404880|NCT01432977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92404881|NCT01432977|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92404882|NCT01432977|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92404883|NCT01432977|Dopamine Agents|dopamine agents|mesh-ancestor
92404884|NCT01433445|Panobinostat|panobinostat|mesh-list
92404885|NCT01433445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404886|NCT01433445|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92404887|NCT01433445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404888|NCT01433445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404890|NCT01433614|Capecitabine|capecitabine|mesh-list
92404891|NCT01433614|Epirubicin|epirubicin|mesh-list
92404892|NCT01433614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92404893|NCT01433614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404894|NCT01433614|Tubulin Modulators|tubulin modulators|mesh-ancestor
92404895|NCT01433614|Antimitotic Agents|antimitotic agents|mesh-ancestor
92404896|NCT01433614|Mitosis Modulators|mitosis modulators|mesh-ancestor
92404897|NCT01433614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404898|NCT01433614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92404900|NCT01433614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92404901|NCT01433614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92404902|NCT01433614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92404903|NCT01433614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404904|NCT01433627|Hirudins|hirudins|mesh-list
92404905|NCT01433627|Bivalirudin|bivalirudin|mesh-list
92404906|NCT01433627|Antithrombins|antithrombins|mesh-ancestor
92404907|NCT01433627|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92404908|NCT01433627|Protease Inhibitors|protease inhibitors|mesh-ancestor
92404909|NCT01433627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404910|NCT01433627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404911|NCT01433627|Anticoagulants|anticoagulants|mesh-ancestor
92404912|NCT01433627|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92404913|NCT01433627|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92404914|NCT01433666|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-list
92404915|NCT01433666|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92404916|NCT01433666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404917|NCT01433666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404918|NCT01433705|Regadenoson|regadenoson|mesh-list
92404919|NCT01433705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404920|NCT01433705|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92404921|NCT01433705|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92404923|NCT01433705|Purinergic Agents|purinergic agents|mesh-ancestor
92404924|NCT01433705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404925|NCT01433705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404926|NCT01433757|Ampicillin|ampicillin|mesh-list
92404927|NCT01433757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92404928|NCT01433757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404929|NCT01433770|Alefacept|alefacept|mesh-list
92404930|NCT01433770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404931|NCT01433770|Immunologic Factors|immunologic factors|mesh-ancestor
92404932|NCT01433770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404933|NCT01433887|Ribavirin|ribavirin|mesh-list
92404934|NCT01433887|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92404935|NCT01433887|Antimetabolites|antimetabolites|mesh-ancestor
92404936|NCT01433887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404937|NCT01433887|Antiviral Agents|antiviral agents|mesh-ancestor
92404938|NCT01433887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92404939|NCT01433900|Latanoprost|latanoprost|mesh-list
92404940|NCT01433900|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92404941|NCT01433900|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92404942|NCT01433952|Thiamine|thiamine|mesh-list
92404943|NCT01433952|Vitamin B Complex|vitamin b complex|mesh-ancestor
92404944|NCT01433952|Vitamins|vitamins|mesh-ancestor
92404945|NCT01433952|Micronutrients|micronutrients|mesh-ancestor
92404946|NCT01433952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404947|NCT01434017|Dexamethasone|dexamethasone|mesh-list
92404948|NCT01434017|Dexamethasone acetate|dexamethasone acetate|mesh-list
92404949|NCT01434017|Droperidol|droperidol|mesh-list
92404950|NCT01434017|Ondansetron|ondansetron|mesh-list
92404951|NCT01434017|BB 1101|bb 1101|mesh-list
92404952|NCT01434017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92404953|NCT01434017|Antiemetics|antiemetics|mesh-ancestor
92404954|NCT01434017|Autonomic Agents|autonomic agents|mesh-ancestor
92404955|NCT01434017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92404956|NCT01434017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404957|NCT01434017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92404958|NCT01434017|Glucocorticoids|glucocorticoids|mesh-ancestor
92404959|NCT01434017|Hormones|hormones|mesh-ancestor
92018595|NCT04393207|BB 1101|bb 1101|mesh-list
92404960|NCT01434017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404961|NCT01434017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92404962|NCT01434017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404963|NCT01434017|Protease Inhibitors|protease inhibitors|mesh-ancestor
92404964|NCT01434017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92404965|NCT01434017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404967|NCT01434017|Dermatologic Agents|dermatologic agents|mesh-ancestor
92404968|NCT01434017|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92404969|NCT01434017|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92404970|NCT01434017|Serotonin Agents|serotonin agents|mesh-ancestor
92404971|NCT01434017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92404972|NCT01434017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92404973|NCT01434017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92404974|NCT01434017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92404975|NCT01434017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92404976|NCT01434017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92404977|NCT01434017|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92404978|NCT01434017|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92404979|NCT01434017|Dopamine Agents|dopamine agents|mesh-ancestor
92404980|NCT01434069|Leucovorin|leucovorin|mesh-list
92404981|NCT01434069|Fluorouracil|fluorouracil|mesh-list
92404982|NCT01434069|Pasireotide|pasireotide|mesh-list
92404983|NCT01434069|Antimetabolites|antimetabolites|mesh-ancestor
92404984|NCT01434069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92404985|NCT01434069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92404986|NCT01434069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92404987|NCT01434069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92404988|NCT01434069|Immunologic Factors|immunologic factors|mesh-ancestor
92404989|NCT01434069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92404990|NCT01434069|Antidotes|antidotes|mesh-ancestor
92404991|NCT01434069|Protective Agents|protective agents|mesh-ancestor
92404992|NCT01434069|Vitamin B Complex|vitamin b complex|mesh-ancestor
92404993|NCT01434069|Vitamins|vitamins|mesh-ancestor
92404994|NCT01434069|Micronutrients|micronutrients|mesh-ancestor
92404995|NCT01434069|Hormones|hormones|mesh-ancestor
92404996|NCT01434069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92404997|NCT01434108|Phenylacetic acid|phenylacetic acid|mesh-list
92404998|NCT01434108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92404999|NCT01434108|Antimetabolites|antimetabolites|mesh-ancestor
92405000|NCT01434108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405001|NCT01434108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405002|NCT01434134|Metoprolol|metoprolol|mesh-list
92405003|NCT01434134|Candesartan|candesartan|mesh-list
92405004|NCT01434134|Candesartan cilexetil|candesartan cilexetil|mesh-list
92405005|NCT01434134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92405006|NCT01434134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92405007|NCT01434134|Sympatholytics|sympatholytics|mesh-ancestor
92405008|NCT01434134|Autonomic Agents|autonomic agents|mesh-ancestor
92405009|NCT01434134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405010|NCT01434134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405011|NCT01434134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92405012|NCT01434134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92405013|NCT01434134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405014|NCT01434134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405015|NCT01434134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405016|NCT01434134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405017|NCT01434134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92405018|NCT01434134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92405019|NCT01434147|Bevacizumab|bevacizumab|mesh-list
92405020|NCT01434147|Capecitabine|capecitabine|mesh-list
92405021|NCT01434147|Oxaliplatin|oxaliplatin|mesh-list
92405022|NCT01434147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405023|NCT01434147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405024|NCT01434147|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92405025|NCT01434147|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92405026|NCT01434147|Growth Substances|growth substances|mesh-ancestor
92405027|NCT01434147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405028|NCT01434147|Growth Inhibitors|growth inhibitors|mesh-ancestor
92405029|NCT01434147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405030|NCT01434147|Antimetabolites|antimetabolites|mesh-ancestor
92405031|NCT01434147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405032|NCT01434160|Levonorgestrel|levonorgestrel|mesh-list
92405033|NCT01434160|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92405034|NCT01434160|Contraceptive Agents|contraceptive agents|mesh-ancestor
92405035|NCT01434160|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92405036|NCT01434160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405037|NCT01434160|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92405038|NCT01434160|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92405039|NCT01434160|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92405040|NCT01434173|Amoxicillin|amoxicillin|mesh-list
92405041|NCT01434173|Moxifloxacin|moxifloxacin|mesh-list
92405042|NCT01434173|Clarithromycin|clarithromycin|mesh-list
92405043|NCT01434173|Doxycycline|doxycycline|mesh-list
92405044|NCT01434173|Levofloxacin|levofloxacin|mesh-list
92405045|NCT01434173|Clavulanic Acids|clavulanic acids|mesh-list
92405046|NCT01434173|Clavulanic Acid|clavulanic acid|mesh-list
92405047|NCT01434173|Cefuroxime|cefuroxime|mesh-list
92405048|NCT01434173|Telithromycin|telithromycin|mesh-list
92405049|NCT01434173|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92405050|NCT01434173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92405051|NCT01434173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405052|NCT01434173|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92405053|NCT01434173|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92057366|NCT01964924|Trametinib|trametinib|mesh-list
92405054|NCT01434173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405055|NCT01434173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405056|NCT01434173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405057|NCT01434173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92405058|NCT01434173|Contraceptive Agents|contraceptive agents|mesh-ancestor
92405059|NCT01434173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92405060|NCT01434173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405061|NCT01434173|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92405062|NCT01434173|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92405063|NCT01434173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92405064|NCT01434173|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92405065|NCT01434173|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92405066|NCT01434173|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92405067|NCT01434173|Antimalarials|antimalarials|mesh-ancestor
92405068|NCT01434173|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92405069|NCT01434173|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92405070|NCT01434173|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92405071|NCT01434173|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92405072|NCT01434173|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92405073|NCT01434212|Interferons|interferons|mesh-list
92405075|NCT01434212|Interferon-alpha|interferon-alpha|mesh-list
92405076|NCT01434212|Interferon alpha-2|interferon alpha-2|mesh-list
92405077|NCT01434212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405078|NCT01434212|Antiviral Agents|antiviral agents|mesh-ancestor
92405079|NCT01434212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405080|NCT01434212|Antimetabolites|antimetabolites|mesh-ancestor
92405081|NCT01434212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405082|NCT01434212|Immunologic Factors|immunologic factors|mesh-ancestor
92405083|NCT01434212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405084|NCT01434225|Bumetanide|bumetanide|mesh-list
92405085|NCT01434225|Diuretics|diuretics|mesh-ancestor
92405086|NCT01434225|Natriuretic Agents|natriuretic agents|mesh-ancestor
92405087|NCT01434225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405088|NCT01434225|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92405089|NCT01434225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405090|NCT01434225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405091|NCT01434251|Antihypertensive Agents|antihypertensive agents|mesh-list
92405092|NCT01434277|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92405093|NCT01434277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92405094|NCT01434303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92405096|NCT01434303|Lapatinib|lapatinib|mesh-list
92405097|NCT01434303|Entinostat|entinostat|mesh-list
92405098|NCT01434303|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92405099|NCT01434303|Antibodies|antibodies|mesh-list
92405100|NCT01434303|Immunoglobulins|immunoglobulins|mesh-list
92405101|NCT01434303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92405102|NCT01434303|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92405103|NCT01434303|Immunologic Factors|immunologic factors|mesh-ancestor
92018603|NCT04393207|Hormones|hormones|mesh-ancestor
92405104|NCT01434303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405105|NCT01434303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405106|NCT01434303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92405107|NCT01434303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405108|NCT01434303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405109|NCT01434381|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92405110|NCT01434381|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92405111|NCT01434381|Immunologic Factors|immunologic factors|mesh-ancestor
92405112|NCT01434381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405114|NCT01434381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405115|NCT01434381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92405116|NCT01434394|Cetuximab|cetuximab|mesh-list
92405117|NCT01434394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405118|NCT01434394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405119|NCT01434459|Gemcitabine|gemcitabine|mesh-list
92405120|NCT01434459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405121|NCT01434459|Antimetabolites|antimetabolites|mesh-ancestor
92405122|NCT01434459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405123|NCT01434459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405124|NCT01434849|Timolol|timolol|mesh-list
92405125|NCT01434849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405126|NCT01434849|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92405127|NCT01434849|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405128|NCT01434849|Adrenergic Agents|adrenergic agents|mesh-ancestor
92057438|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92099351|NCT00244101|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92099352|NCT00244101|Respiratory System Agents|respiratory system agents|mesh-ancestor
92099353|NCT04451382|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92099354|NCT04451382|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92099355|NCT04451382|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92099356|NCT04451382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099357|NCT04451382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099358|NCT04451382|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92099359|NCT04451382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92099360|NCT04451382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099361|NCT04451382|Cholinergic Agents|cholinergic agents|mesh-ancestor
92099362|NCT04451382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099363|NCT04276389|Paclitaxel|paclitaxel|mesh-list
92099364|NCT04276389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92099365|NCT04276389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92099366|NCT04276389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099367|NCT04276389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92099368|NCT04276389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92099369|NCT04276389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92099370|NCT04276389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099371|NCT03128619|Letrozole|letrozole|mesh-list
92099372|NCT03128619|Palbociclib|palbociclib|mesh-list
92099373|NCT03128619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099374|NCT03128619|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92099375|NCT03128619|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92099376|NCT03128619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099377|NCT03128619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099378|NCT03128619|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92099379|NCT03128619|Hormone Antagonists|hormone antagonists|mesh-ancestor
92099380|NCT03128619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099381|NCT03128619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099382|NCT03128619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92099383|NCT03433092|Carotenoids|carotenoids|mesh-list
92099384|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
92099385|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099386|NCT03433092|Protective Agents|protective agents|mesh-ancestor
92099387|NCT03433092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099388|NCT03433014|Levobupivacaine|levobupivacaine|mesh-list
92099389|NCT03433014|Anesthetics, Local|anesthetics, local|mesh-ancestor
92099390|NCT03433014|Anesthetics|anesthetics|mesh-ancestor
92099391|NCT03433014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099392|NCT03433014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099393|NCT03433014|Sensory System Agents|sensory system agents|mesh-ancestor
92099394|NCT03433014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099395|NCT01872689|Pirfenidone|pirfenidone|mesh-list
92099396|NCT01872689|Analgesics|analgesics|mesh-ancestor
92099397|NCT01872689|Sensory System Agents|sensory system agents|mesh-ancestor
92099398|NCT01872689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099399|NCT01872689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099400|NCT01872689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099401|NCT01872689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099402|NCT01872689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099403|NCT01872689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099404|NCT01872689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099405|NCT03435900|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92099406|NCT03435900|Metronidazole|metronidazole|mesh-list
92099407|NCT03435900|Fosfomycin|fosfomycin|mesh-list
92099408|NCT03435900|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92099409|NCT03435900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099410|NCT03435900|Antitubercular Agents|antitubercular agents|mesh-ancestor
92099411|NCT03435900|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92099412|NCT03435900|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92099413|NCT00632931|Vorinostat|vorinostat|mesh-list
92099414|NCT00632931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099415|NCT00632931|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92099416|NCT00632931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099417|NCT00632931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099418|NCT01857323|Albuterol|albuterol|mesh-list
92099419|NCT01857323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92099420|NCT01857323|Autonomic Agents|autonomic agents|mesh-ancestor
92099421|NCT01857323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099422|NCT01857323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099423|NCT01857323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92099424|NCT01857323|Respiratory System Agents|respiratory system agents|mesh-ancestor
92099425|NCT01857323|Tocolytic Agents|tocolytic agents|mesh-ancestor
92099426|NCT01857323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92099427|NCT01857323|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92099428|NCT01857323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92099429|NCT01857323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92099430|NCT01857323|Adrenergic Agents|adrenergic agents|mesh-ancestor
92099431|NCT01857323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099432|NCT01857323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099433|NCT03104439|Nivolumab|nivolumab|mesh-list
92099434|NCT03104439|Ipilimumab|ipilimumab|mesh-list
92099435|NCT03104439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92099436|NCT03104439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099437|NCT03104439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91938161|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
92099438|NCT03104439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099440|NCT03432780|Hormones|hormones|mesh-list
92099441|NCT03432780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099442|NCT03432780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92099443|NCT03432780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92099444|NCT03432780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92099445|NCT03432780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099446|NCT03432780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099447|NCT03432780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099448|NCT00055731|Aspirin|aspirin|mesh-list
92099449|NCT00055731|Docetaxel|docetaxel|mesh-list
92099450|NCT00055731|Goserelin|goserelin|mesh-list
92099451|NCT00055731|Bicalutamide|bicalutamide|mesh-list
92099452|NCT00055731|Estramustine|estramustine|mesh-list
92099453|NCT00055731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099454|NCT00055731|Tubulin Modulators|tubulin modulators|mesh-ancestor
92099455|NCT00055731|Antimitotic Agents|antimitotic agents|mesh-ancestor
92099456|NCT00055731|Mitosis Modulators|mitosis modulators|mesh-ancestor
92099457|NCT00055731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099458|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099459|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099460|NCT00055731|Analgesics|analgesics|mesh-ancestor
92099461|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
92099462|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099463|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099464|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099465|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099466|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92099467|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92099468|NCT00055731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92099469|NCT00055731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92099470|NCT00055731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099471|NCT00055731|Antipyretics|antipyretics|mesh-ancestor
92099472|NCT00055731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099473|NCT00055731|Androgen Antagonists|androgen antagonists|mesh-ancestor
92099474|NCT00055731|Hormone Antagonists|hormone antagonists|mesh-ancestor
92099475|NCT00055731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099476|NCT00055731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92099477|NCT00055731|Alkylating Agents|alkylating agents|mesh-ancestor
92099478|NCT03435744|Simvastatin|simvastatin|mesh-list
92099479|NCT03435744|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92099480|NCT03435744|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92099481|NCT03435744|Antimetabolites|antimetabolites|mesh-ancestor
92099482|NCT03435744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099483|NCT03435744|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92099484|NCT03435744|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92099485|NCT03435744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099486|NCT03435666|Capecitabine|capecitabine|mesh-list
92099487|NCT03435666|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92099488|NCT03435666|Antimetabolites|antimetabolites|mesh-ancestor
92099489|NCT03435666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099490|NCT03435666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099491|NCT00632541|Bevacizumab|bevacizumab|mesh-list
92099492|NCT00632541|Sorafenib|sorafenib|mesh-list
92099493|NCT00632541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92099494|NCT00632541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099495|NCT00632541|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92099496|NCT00632541|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92099497|NCT00632541|Growth Substances|growth substances|mesh-ancestor
92099498|NCT00632541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099499|NCT00632541|Growth Inhibitors|growth inhibitors|mesh-ancestor
92099500|NCT00632541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92099501|NCT00632541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099502|NCT00632541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099503|NCT01872611|Prednisolone|prednisolone|mesh-list
92099504|NCT01872611|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92099505|NCT01872611|Methylprednisolone|methylprednisolone|mesh-list
92099506|NCT01872611|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92099507|NCT01872611|Prednisolone acetate|prednisolone acetate|mesh-list
92099508|NCT01872611|Nepafenac|nepafenac|mesh-list
92099509|NCT01872611|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92099510|NCT01872611|Prednisolone phosphate|prednisolone phosphate|mesh-list
92099511|NCT01872611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099512|NCT01872611|Glucocorticoids|glucocorticoids|mesh-ancestor
92099513|NCT01872611|Hormones|hormones|mesh-ancestor
92099514|NCT01872611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099515|NCT01872611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099516|NCT01872611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099517|NCT01872611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099518|NCT01872611|Antiemetics|antiemetics|mesh-ancestor
92099519|NCT01872611|Autonomic Agents|autonomic agents|mesh-ancestor
92099520|NCT01872611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099521|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099522|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92099523|NCT01872611|Protective Agents|protective agents|mesh-ancestor
92099524|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099525|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099526|NCT01872611|Analgesics|analgesics|mesh-ancestor
92099527|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
92099528|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099529|NCT03432468|Valsartan|valsartan|mesh-list
92099530|NCT03432468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92099531|NCT03432468|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92099532|NCT03432468|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92099533|NCT03432468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099534|NCT01856543|Mometasone Furoate|mometasone furoate|mesh-list
92099535|NCT01856543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099536|NCT01856543|Dermatologic Agents|dermatologic agents|mesh-ancestor
92099537|NCT01856543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92099538|NCT03432312|Nicotine|nicotine|mesh-list
92099539|NCT03432312|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92099540|NCT03432312|Autonomic Agents|autonomic agents|mesh-ancestor
92099541|NCT03432312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099542|NCT03432312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099543|NCT03432312|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92099544|NCT03432312|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92099545|NCT03432312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92099546|NCT03432312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099547|NCT03432312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099548|NCT03438942|Folic Acid|folic acid|mesh-list
92099549|NCT03438942|Hematinics|hematinics|mesh-ancestor
92099550|NCT03438942|Vitamin B Complex|vitamin b complex|mesh-ancestor
92099551|NCT03438942|Vitamins|vitamins|mesh-ancestor
92099552|NCT03438942|Micronutrients|micronutrients|mesh-ancestor
92099553|NCT03438942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099554|NCT03432156|Immunomodulating Agents|immunomodulating agents|mesh-list
92099555|NCT03432156|Immunologic Factors|immunologic factors|mesh-ancestor
92099556|NCT03432156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099557|NCT04450680|Lactams|lactams|mesh-list
92099558|NCT04450680|beta-Lactams|beta-lactams|mesh-list
92099559|NCT04450680|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92099560|NCT04450680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099561|NCT03438708|Axitinib|axitinib|mesh-list
92099562|NCT03438708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099563|NCT03438708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92099564|NCT03438708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099565|NCT03438708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099566|NCT01923597|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92099567|NCT01923597|Antioxidants|antioxidants|mesh-ancestor
92099568|NCT01923597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099569|NCT01923597|Protective Agents|protective agents|mesh-ancestor
92099570|NCT01923597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099571|NCT01923597|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92099572|NCT01923597|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92099573|NCT01923597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099574|NCT01923597|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92099575|NCT00632229|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92099576|NCT00632229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92099577|NCT00632229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92099578|NCT00632229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099579|NCT00632229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099581|NCT00632229|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92099582|NCT00632229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92099583|NCT00632229|Serotonin Agents|serotonin agents|mesh-ancestor
92099584|NCT00632229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142275|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
92099585|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099586|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92099587|NCT00632229|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92099588|NCT00632229|Dopamine Agents|dopamine agents|mesh-ancestor
92099590|NCT00631137|Androgens|androgens|mesh-ancestor
92099591|NCT00631137|Hormones|hormones|mesh-ancestor
92099592|NCT00631137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099593|NCT00631137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099594|NCT03428880|Morphine|morphine|mesh-list
92099595|NCT03428880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92099596|NCT03428880|Narcotics|narcotics|mesh-ancestor
92099597|NCT03428880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099598|NCT03428880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099599|NCT03428880|Analgesics|analgesics|mesh-ancestor
92099600|NCT03428880|Sensory System Agents|sensory system agents|mesh-ancestor
92099601|NCT03428880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099602|NCT01923831|Dexamethasone|dexamethasone|mesh-list
92099603|NCT01923831|Magnesium Sulfate|magnesium sulfate|mesh-list
92099604|NCT01923831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099605|NCT01923831|Antiemetics|antiemetics|mesh-ancestor
92099606|NCT01923831|Autonomic Agents|autonomic agents|mesh-ancestor
92099607|NCT01923831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099608|NCT01923831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099609|NCT01923831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099610|NCT01923831|Glucocorticoids|glucocorticoids|mesh-ancestor
92099611|NCT01923831|Hormones|hormones|mesh-ancestor
92099612|NCT01923831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099613|NCT01923831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099614|NCT01923831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099615|NCT01923831|Analgesics|analgesics|mesh-ancestor
92099616|NCT01923831|Sensory System Agents|sensory system agents|mesh-ancestor
92099617|NCT01923831|Anesthetics|anesthetics|mesh-ancestor
92099618|NCT01923831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099619|NCT01923831|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92099620|NCT01923831|Anticonvulsants|anticonvulsants|mesh-ancestor
92099621|NCT01923831|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92099622|NCT01923831|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92099623|NCT01923831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099624|NCT01923831|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92099625|NCT01923831|Tocolytic Agents|tocolytic agents|mesh-ancestor
92099626|NCT01923831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92099627|NCT01923909|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92099628|NCT01923909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099629|NCT04892940|Analgesics|analgesics|mesh-list
92099630|NCT04892940|Sensory System Agents|sensory system agents|mesh-ancestor
92099631|NCT04892940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099632|NCT04892940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099633|NCT03085563|Midazolam|midazolam|mesh-list
92099634|NCT03085563|Nitrous Oxide|nitrous oxide|mesh-list
92099635|NCT03085563|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92099636|NCT03085563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92099637|NCT03085563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099638|NCT03085563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099639|NCT03085563|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92099640|NCT03085563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92099641|NCT03085563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92099642|NCT03085563|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92099643|NCT03085563|Anesthetics, General|anesthetics, general|mesh-ancestor
92099644|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
92099645|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
92099646|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
92057737|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
92099647|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099648|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099649|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92099650|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099651|NCT03085563|Analgesics|analgesics|mesh-ancestor
92099652|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
92099653|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099654|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
92099655|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92099656|NCT03431766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099657|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
92099658|NCT04450446|Heparin|heparin|mesh-list
92099659|NCT04450446|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92099660|NCT04450446|Tinzaparin|tinzaparin|mesh-list
92099661|NCT04450446|Dalteparin|dalteparin|mesh-list
92099662|NCT04450446|Anticoagulants|anticoagulants|mesh-ancestor
92099663|NCT04450446|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92099664|NCT04450446|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92099665|NCT04450446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099666|NCT03274752|Paroxetine|paroxetine|mesh-list
92099667|NCT03274752|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92099668|NCT03274752|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92099669|NCT03274752|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92099670|NCT03274752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099671|NCT03274752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099672|NCT03274752|Serotonin Agents|serotonin agents|mesh-ancestor
92099673|NCT03274752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099674|NCT03274752|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92099675|NCT03274752|Antidepressive Agents|antidepressive agents|mesh-ancestor
92099676|NCT03274752|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92099677|NCT03274752|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92099678|NCT03274752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92099679|NCT03274752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099680|NCT03242382|Palbociclib|palbociclib|mesh-list
92099681|NCT03242382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099682|NCT03242382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92099683|NCT03242382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099684|NCT03242382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099686|NCT03902418|Emtricitabine|emtricitabine|mesh-list
92099687|NCT03902418|Antiviral Agents|antiviral agents|mesh-ancestor
92099688|NCT03902418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099689|NCT03902418|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92099690|NCT03902418|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92099691|NCT03902418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099692|NCT03902418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099693|NCT03902418|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92099694|NCT03902418|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92099695|NCT03428568|Clarithromycin|clarithromycin|mesh-list
92099696|NCT03428568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92099697|NCT03428568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099698|NCT03428568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92099699|NCT03428568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099700|NCT03428568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099701|NCT03428568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92099702|NCT03428568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92099703|NCT00630825|Dulaglutide|dulaglutide|mesh-list
92099704|NCT00630825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92099705|NCT00630825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099706|NCT03434340|Dexamethasone|dexamethasone|mesh-list
92099707|NCT03434340|Granisetron|granisetron|mesh-list
92099708|NCT03434340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099709|NCT03434340|Antiemetics|antiemetics|mesh-ancestor
92099710|NCT03434340|Autonomic Agents|autonomic agents|mesh-ancestor
92099711|NCT03434340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099712|NCT03434340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099713|NCT03434340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099714|NCT03434340|Glucocorticoids|glucocorticoids|mesh-ancestor
92099715|NCT03434340|Hormones|hormones|mesh-ancestor
92099716|NCT03434340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099717|NCT03434340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099718|NCT03434340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099719|NCT03434340|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92099720|NCT03434340|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92099721|NCT03434340|Serotonin Agents|serotonin agents|mesh-ancestor
92099722|NCT03434340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099723|NCT03434340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099724|NCT03088605|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92099725|NCT03088605|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92099726|NCT01923987|Cetuximab|cetuximab|mesh-list
92099727|NCT01923987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92099728|NCT01923987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099729|NCT03101163|Hyaluronic Acid|hyaluronic acid|mesh-list
92099730|NCT03101163|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92099731|NCT03101163|Immunologic Factors|immunologic factors|mesh-ancestor
92099732|NCT03101163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099733|NCT03101163|Viscosupplements|viscosupplements|mesh-ancestor
92099734|NCT03101163|Protective Agents|protective agents|mesh-ancestor
92099735|NCT01924065|Anticoagulants|anticoagulants|mesh-list
92099736|NCT03434106|Dextrans|dextrans|mesh-list
92099737|NCT03434106|Anticoagulants|anticoagulants|mesh-ancestor
92099738|NCT03434106|Plasma Substitutes|plasma substitutes|mesh-ancestor
92099739|NCT03434106|Blood Substitutes|blood substitutes|mesh-ancestor
92099740|NCT01241344|Brincidofovir|brincidofovir|mesh-list
92099741|NCT01241344|Antiviral Agents|antiviral agents|mesh-ancestor
92099742|NCT01241344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099743|NCT01925001|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92099744|NCT03009682|Olaparib|olaparib|mesh-list
92099745|NCT03009682|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92099746|NCT03009682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099747|NCT03009682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099748|NCT03009682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099749|NCT03431142|Aspirin|aspirin|mesh-list
92099750|NCT03431142|Clopidogrel|clopidogrel|mesh-list
92099751|NCT03431142|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099752|NCT03431142|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099753|NCT03431142|Analgesics|analgesics|mesh-ancestor
92099754|NCT03431142|Sensory System Agents|sensory system agents|mesh-ancestor
92099755|NCT03431142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099756|NCT03431142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099757|NCT03431142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099758|NCT03431142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099759|NCT03431142|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92099760|NCT03431142|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92099761|NCT03431142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099762|NCT03431142|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92099763|NCT03431142|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92099764|NCT03431142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099765|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
92099766|NCT03431142|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92099767|NCT03431142|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92099768|NCT03431142|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92099769|NCT03431142|Purinergic Agents|purinergic agents|mesh-ancestor
92099770|NCT03431142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099772|NCT03831321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099773|NCT03831321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099774|NCT03831321|Analgesics|analgesics|mesh-ancestor
92099775|NCT03831321|Sensory System Agents|sensory system agents|mesh-ancestor
92099776|NCT03831321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099777|NCT03831321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099778|NCT03831321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099779|NCT03831321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099780|NCT03831321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92099781|NCT03831321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099782|NCT03831321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099783|NCT04450134|Fexofenadine|fexofenadine|mesh-list
92099784|NCT04450134|Famotidine|famotidine|mesh-list
92099785|NCT04450134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92099786|NCT04450134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099787|NCT04450134|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92099788|NCT04450134|Histamine Antagonists|histamine antagonists|mesh-ancestor
92099789|NCT04450134|Histamine Agents|histamine agents|mesh-ancestor
92099790|NCT04450134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099791|NCT04450134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099792|NCT04450134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099793|NCT04450134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92099794|NCT04450134|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92099795|NCT04450134|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92099796|NCT01286818|Leucovorin|leucovorin|mesh-list
92099797|NCT01286818|Fluorouracil|fluorouracil|mesh-list
92099798|NCT01286818|Irinotecan|irinotecan|mesh-list
92099799|NCT01286818|Ramucirumab|ramucirumab|mesh-list
92099800|NCT01286818|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92099801|NCT01286818|Levoleucovorin|levoleucovorin|mesh-list
92099802|NCT01286818|Antimetabolites|antimetabolites|mesh-ancestor
92099803|NCT01286818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099804|NCT01286818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92099805|NCT01286818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099806|NCT01286818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92099807|NCT01286818|Immunologic Factors|immunologic factors|mesh-ancestor
92099808|NCT01286818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099809|NCT01286818|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92099810|NCT01286818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92099811|NCT01286818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099813|NCT01286818|Protective Agents|protective agents|mesh-ancestor
92099814|NCT01286818|Vitamin B Complex|vitamin b complex|mesh-ancestor
92099815|NCT01286818|Vitamins|vitamins|mesh-ancestor
92099816|NCT01286818|Micronutrients|micronutrients|mesh-ancestor
92099817|NCT03428256|Anesthetics|anesthetics|mesh-list
92099818|NCT03428256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099819|NCT03428256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099820|NCT00635505|Albuterol|albuterol|mesh-list
92099821|NCT00635505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92099822|NCT00635505|Autonomic Agents|autonomic agents|mesh-ancestor
92099823|NCT00635505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099824|NCT00635505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099825|NCT00635505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92099826|NCT00635505|Respiratory System Agents|respiratory system agents|mesh-ancestor
92099827|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
92099828|NCT00635505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92099829|NCT00635505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92099830|NCT00635505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92099831|NCT00635505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92099832|NCT00635505|Adrenergic Agents|adrenergic agents|mesh-ancestor
92099833|NCT00635505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099834|NCT00635505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099835|NCT01243450|Tretinoin|tretinoin|mesh-list
92099836|NCT01243450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099837|NCT01243450|Keratolytic Agents|keratolytic agents|mesh-ancestor
92099838|NCT01243450|Dermatologic Agents|dermatologic agents|mesh-ancestor
92099839|NCT05249751|Arginine Vasopressin|arginine vasopressin|mesh-list
92099840|NCT05249751|Hemostatics|hemostatics|mesh-ancestor
92099841|NCT05249751|Coagulants|coagulants|mesh-ancestor
92099842|NCT05249751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92099843|NCT05249751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92099844|NCT05249751|Natriuretic Agents|natriuretic agents|mesh-ancestor
92099845|NCT05249751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099846|NCT00635193|Doxorubicin|doxorubicin|mesh-list
92099847|NCT00635193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92099848|NCT00635193|Volociximab|volociximab|mesh-list
92099849|NCT00635193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92099850|NCT00635193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92099851|NCT00635193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099852|NCT00635193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92099853|NCT00635193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92099854|NCT00635193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099855|NCT00635193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099856|NCT00635193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92099857|NCT00635193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92099858|NCT00635193|Growth Substances|growth substances|mesh-ancestor
92099859|NCT00635193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099860|NCT00635193|Growth Inhibitors|growth inhibitors|mesh-ancestor
92099861|NCT00635193|Immunologic Factors|immunologic factors|mesh-ancestor
92099862|NCT00630201|Buprenorphine|buprenorphine|mesh-list
92099863|NCT00630201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92099864|NCT00630201|Narcotics|narcotics|mesh-ancestor
92099865|NCT00630201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099866|NCT00630201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099867|NCT00630201|Analgesics|analgesics|mesh-ancestor
92099868|NCT00630201|Sensory System Agents|sensory system agents|mesh-ancestor
92099869|NCT00630201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099870|NCT00630201|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92099871|NCT01925547|Curcumin|curcumin|mesh-list
92099872|NCT01925547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099873|NCT01925547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099874|NCT01925547|Analgesics|analgesics|mesh-ancestor
92099875|NCT01925547|Sensory System Agents|sensory system agents|mesh-ancestor
92099876|NCT01925547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099877|NCT01925547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099878|NCT01925547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099880|NCT01925547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099881|NCT01925547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099882|NCT01925547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099883|NCT03122301|Bupivacaine|bupivacaine|mesh-list
92099884|NCT03122301|Anesthetics, Local|anesthetics, local|mesh-ancestor
92099885|NCT03122301|Anesthetics|anesthetics|mesh-ancestor
92099886|NCT03122301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099887|NCT03122301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099888|NCT03122301|Sensory System Agents|sensory system agents|mesh-ancestor
92099889|NCT03122301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099890|NCT01925859|Dexamethasone|dexamethasone|mesh-list
92099891|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
92099892|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92099893|NCT01925859|BB 1101|bb 1101|mesh-list
92099894|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099895|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
92099896|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
92099897|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099898|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099899|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099900|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
92099901|NCT01925859|Hormones|hormones|mesh-ancestor
92099902|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099903|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099904|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099905|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
92099906|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099907|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099908|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92099909|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92099910|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92099911|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099912|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099913|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92099914|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92099915|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099916|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
92099917|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099918|NCT01926639|Rituximab|rituximab|mesh-list
92099919|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92099920|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099921|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
92099922|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099923|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099924|NCT02199496|Ustekinumab|ustekinumab|mesh-list
92099925|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92099926|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
92099927|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92099928|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
92099929|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099930|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
92099931|NCT04395417|Protective Agents|protective agents|mesh-ancestor
92099932|NCT02199574|Bupivacaine|bupivacaine|mesh-list
92099933|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
92099934|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
92099935|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099936|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099937|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
92099938|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099939|NCT02199652|Prazosin|prazosin|mesh-list
92099940|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92099941|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92099942|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92099943|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92099944|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92099945|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099946|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099947|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099948|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92099949|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92099950|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92099951|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
91938171|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92099952|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099953|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92099954|NCT01927029|Progesterone|progesterone|mesh-list
92099955|NCT01927029|Progestins|progestins|mesh-ancestor
92099956|NCT01927029|Hormones|hormones|mesh-ancestor
92099957|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099958|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099959|NCT01921647|Amoxicillin|amoxicillin|mesh-list
92099960|NCT01921647|Clarithromycin|clarithromycin|mesh-list
92099961|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92099962|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099963|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92099964|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099965|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099966|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92099967|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92099969|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92099970|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
92099971|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099972|NCT01339858|Expectorants|expectorants|mesh-ancestor
92099973|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
92099974|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92099975|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
92099976|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099977|NCT01339858|Protective Agents|protective agents|mesh-ancestor
92099978|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099979|NCT01339858|Antidotes|antidotes|mesh-ancestor
92099980|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92099981|NCT01339936|Glycerol|glycerol|mesh-list
92099982|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92099983|NCT01339936|Protective Agents|protective agents|mesh-ancestor
92099984|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099985|NCT01339936|Laxatives|laxatives|mesh-ancestor
92099986|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099987|NCT05246865|Androgens|androgens|mesh-list
92099988|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92099989|NCT05246865|Hormones|hormones|mesh-ancestor
92099990|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099991|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099992|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92099993|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
92099994|NCT03111537|Nicotine|nicotine|mesh-list
92099995|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92099996|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
92099997|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099998|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099999|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92100000|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92100001|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
92100002|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100003|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100004|NCT05244525|Epinephrine|epinephrine|mesh-list
92100005|NCT05244525|Bupivacaine|bupivacaine|mesh-list
92100006|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
92100007|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
92100008|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92100009|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100010|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
92100011|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100012|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92100013|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92100014|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
92100015|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100016|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100017|NCT05244525|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92100018|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92100019|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
92100020|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92100021|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100022|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
92058145|NCT02008877|Sirolimus|sirolimus|mesh-list
92100023|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
92100024|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92100025|NCT01927263|Infliximab|infliximab|mesh-list
92100026|NCT01927263|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92100028|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100029|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100030|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100031|NCT01341730|Pioglitazone|pioglitazone|mesh-list
92100032|NCT01341730|Atorvastatin|atorvastatin|mesh-list
92100033|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92100034|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92100035|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
92100036|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100037|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92100038|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92100039|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100040|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92100041|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100043|NCT01247272|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92100044|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92100045|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92100046|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100047|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100048|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
92100049|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100050|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92100051|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
92100052|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92100053|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92100054|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92100055|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100056|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
92100057|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
92100058|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92100059|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92100060|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100061|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100062|NCT01290484|Urological Agents|urological agents|mesh-ancestor
92100063|NCT04396743|Clotrimazole|clotrimazole|mesh-list
92100064|NCT04396743|Miconazole|miconazole|mesh-list
92100065|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92100066|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100067|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
92100068|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92100069|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92100070|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100071|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100072|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92100073|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
92100074|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100075|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100076|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92100077|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92100078|NCT01928043|Curcumin|curcumin|mesh-list
92100079|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92100080|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92100081|NCT01928043|Analgesics|analgesics|mesh-ancestor
92100082|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
92100083|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100084|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100085|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100086|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100087|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100088|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100089|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100090|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92100091|NCT02979886|Menotropins|menotropins|mesh-list
92100092|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
92100093|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92100094|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
92100095|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92100096|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100097|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92100098|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100099|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100100|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92100101|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
92100102|NCT01928511|Interferons|interferons|mesh-list
92100103|NCT01928511|Tenofovir|tenofovir|mesh-list
92100104|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
92100105|NCT01928511|Lamivudine|lamivudine|mesh-list
92100106|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
92100108|NCT01928511|Adefovir|adefovir|mesh-list
92100109|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92100110|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100111|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
92100112|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100113|NCT01928511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92100114|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92100115|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100116|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100117|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92100118|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92100119|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
92100120|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100121|NCT05241249|Paclitaxel|paclitaxel|mesh-list
92100122|NCT05241249|Gemcitabine|gemcitabine|mesh-list
92100123|NCT05241249|Bethanechol|bethanechol|mesh-list
92100124|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92100125|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100126|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100127|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100128|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100129|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100130|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92100131|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
92100132|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92100133|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
92100134|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100135|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100136|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92100137|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92100138|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
92100139|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100140|NCT01928823|Cycloserine|cycloserine|mesh-list
92100141|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92100142|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100143|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92100144|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
92100145|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92100146|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
92100147|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100148|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
92100149|NCT01290874|Tiotropium Bromide|tiotropium bromide|mesh-list
92100150|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92100151|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92100152|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
92100153|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100154|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100155|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92100156|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100157|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92100158|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92100159|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92100160|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92100161|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100162|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100163|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
92100164|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92100165|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
92100166|NCT02977494|Dexamethasone|dexamethasone|mesh-list
92100167|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
92100168|NCT02977494|Bortezomib|bortezomib|mesh-list
92100169|NCT02977494|Daratumumab|daratumumab|mesh-list
92100170|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100171|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
92100172|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
92100173|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100174|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100175|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100178|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100179|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100180|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100182|NCT01929603|Olaparib|olaparib|mesh-list
92100183|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92100184|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100185|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100186|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100187|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92100188|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
92100189|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92100190|NCT01929603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100191|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
92100192|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92100193|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92100194|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92100195|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92100196|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92100197|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92100198|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92100199|NCT04178460|Niraparib|niraparib|mesh-list
92100200|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92100201|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100202|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100203|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100204|NCT01928901|Thymol|thymol|mesh-list
92100205|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100206|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92100207|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
92100208|NCT04395105|Dexamethasone|dexamethasone|mesh-list
92100209|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100210|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
92100211|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
92100212|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100213|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100214|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100215|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
92100216|NCT04395105|Hormones|hormones|mesh-ancestor
92100217|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100218|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100219|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100220|NCT04072770|Caseins|caseins|mesh-list
92100221|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
92100222|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
92100223|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100224|NCT01291108|Bimatoprost|bimatoprost|mesh-list
92100225|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92100226|NCT01929213|Bosentan|bosentan|mesh-list
92100227|NCT01929213|Udenafil|udenafil|mesh-list
92100228|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92100229|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92100230|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100231|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92100232|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92100234|NCT03430518|Durvalumab|durvalumab|mesh-list
92100235|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92100236|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100237|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92100238|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100239|NCT01925937|Ubiquinone|ubiquinone|mesh-list
92100240|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
92100241|NCT01925937|Atorvastatin|atorvastatin|mesh-list
92100242|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92100243|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92100244|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
92100245|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938175|NCT02522780|Mesalamine|mesalamine|mesh-list
92100246|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92100247|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92100249|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
92100250|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100252|NCT03430362|Scopolamine|scopolamine|mesh-list
92100253|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92100254|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92100255|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
92100256|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
92100257|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100258|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100259|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100260|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
92100261|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92100262|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
92100263|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100264|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100265|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92100266|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
92100267|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
92100268|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92100269|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
92100270|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100271|NCT03055377|Expectorants|expectorants|mesh-ancestor
92100272|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100273|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92100274|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
92100275|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100276|NCT03055377|Protective Agents|protective agents|mesh-ancestor
92100277|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100278|NCT03055377|Antidotes|antidotes|mesh-ancestor
92100279|NCT03428022|Apatinib|apatinib|mesh-list
92100280|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100281|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92100282|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100283|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100284|NCT03054831|Oxycodone|oxycodone|mesh-list
92100285|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92100286|NCT03054831|Narcotics|narcotics|mesh-ancestor
92100287|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92100288|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100289|NCT03054831|Analgesics|analgesics|mesh-ancestor
92100290|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
92100291|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100292|NCT00989781|Dexamethasone|dexamethasone|mesh-list
92100293|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92100294|NCT00989781|Hormones|hormones|mesh-list
92100295|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92100296|NCT00989781|Cosyntropin|cosyntropin|mesh-list
92100297|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92100298|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92100299|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
92100300|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100301|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
92100302|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
92100303|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100304|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100305|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100306|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
92100307|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100308|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100309|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100310|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92100311|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100312|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100313|NCT03430128|Immunomodulating Agents|immunomodulating agents|mesh-list
92100314|NCT03430128|Immunologic Factors|immunologic factors|mesh-ancestor
92100315|NCT03430128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100317|NCT03427944|Calcium|calcium|mesh-list
92100318|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92100319|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100320|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
92100321|NCT03427944|Coagulants|coagulants|mesh-ancestor
92100322|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92100323|NCT01922193|Hormones|hormones|mesh-ancestor
92100324|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100325|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100326|NCT03429972|Paclitaxel|paclitaxel|mesh-list
92100327|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92100328|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100329|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100330|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100331|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100332|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100333|NCT05601999|Tenecteplase|tenecteplase|mesh-list
92100334|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92100335|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92100336|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100337|NCT01347034|Immunomodulating Agents|immunomodulating agents|mesh-list
92100338|NCT01347034|Immunologic Factors|immunologic factors|mesh-ancestor
92100339|NCT01347034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100340|NCT03079167|Epoetin Alfa|epoetin alfa|mesh-list
92100341|NCT03079167|Hematinics|hematinics|mesh-ancestor
92100342|NCT03079011|Letrozole|letrozole|mesh-list
92100343|NCT03079011|Fulvestrant|fulvestrant|mesh-list
92100345|NCT03079011|Anastrozole|anastrozole|mesh-list
92100346|NCT03079011|Exemestane|exemestane|mesh-list
92100347|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92100348|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100349|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92100350|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100351|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100352|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92100353|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
92100354|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100355|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100356|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100357|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92100358|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92100359|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92100360|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
92100361|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92100362|NCT03427632|Protective Agents|protective agents|mesh-ancestor
92100363|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100364|NCT03427554|Tretinoin|tretinoin|mesh-list
92100365|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100366|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
92100367|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100369|NCT01349920|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92100370|NCT01349920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100371|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100372|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100373|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100375|NCT03128346|Acetaminophen|acetaminophen|mesh-list
92100376|NCT03128346|Fentanyl|fentanyl|mesh-list
92100377|NCT03128346|Hydromorphone|hydromorphone|mesh-list
92100378|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92100379|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92100380|NCT03128346|Analgesics|analgesics|mesh-ancestor
92100382|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100383|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100384|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100385|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100386|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92100387|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92100388|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100389|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92100390|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92100391|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100392|NCT03128346|Antipyretics|antipyretics|mesh-ancestor
91938178|NCT02522780|Analgesics|analgesics|mesh-ancestor
92100394|NCT03128346|Narcotics|narcotics|mesh-ancestor
92100395|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058486|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92100396|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92100397|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92100398|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
92100399|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
92100401|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
92100402|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92100403|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100404|NCT03427242|Apatinib|apatinib|mesh-list
92100405|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100406|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92100407|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100408|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100409|NCT01252732|Vancomycin|vancomycin|mesh-list
92100410|NCT01252732|Oritavancin|oritavancin|mesh-list
92100411|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92100412|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100413|NCT00989235|Abatacept|abatacept|mesh-list
92100414|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92100415|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100416|NCT00989235|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92100417|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100418|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100419|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
92100420|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100421|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100422|NCT03422874|Nelfinavir|nelfinavir|mesh-list
92100423|NCT03422874|Ixazomib|ixazomib|mesh-list
92100424|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100425|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
92100426|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100427|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100428|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92100429|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92100430|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92100431|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92100432|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
92100433|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100434|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92100435|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92100436|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92100437|NCT01253824|Norethindrone|norethindrone|mesh-list
92100438|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
92100439|NCT01253824|Norinyl|norinyl|mesh-list
92100440|NCT01253824|Mestranol|mestranol|mesh-list
92100441|NCT01253824|Estradiol|estradiol|mesh-list
92100442|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92100443|NCT01253824|Estrogens|estrogens|mesh-ancestor
92100444|NCT01253824|Hormones|hormones|mesh-ancestor
92100445|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100446|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100447|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92100448|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
92100449|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92100450|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92100451|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92100452|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92100453|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92100454|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92100455|NCT03422796|Cilostazol|cilostazol|mesh-list
92100456|NCT03422796|Sumatriptan|sumatriptan|mesh-list
92100457|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92100458|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
92100459|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100460|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100461|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92100462|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100463|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92100464|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91932421|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100465|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100466|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92100467|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
92100468|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92100469|NCT03422796|Protective Agents|protective agents|mesh-ancestor
92100470|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92100471|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92100472|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100473|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92100474|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92100475|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92100476|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
92100477|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100479|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
92100480|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
92100481|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100482|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100483|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100484|NCT03429738|Ibuprofen|ibuprofen|mesh-list
92100485|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
92100486|NCT03429738|Ephedrine|ephedrine|mesh-list
92100487|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92100488|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92100489|NCT03429738|Analgesics|analgesics|mesh-ancestor
92100490|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
92100491|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100492|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100493|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100494|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100495|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92100496|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100497|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100498|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92100499|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
92100500|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92100501|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100502|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
92100503|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92100504|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92100505|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
92100506|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
92100507|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100509|NCT01253902|Travoprost|travoprost|mesh-list
92100510|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92100511|NCT01253902|Latanoprost|latanoprost|mesh-list
92100512|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92100513|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92100514|NCT01253980|Amoxicillin|amoxicillin|mesh-list
92100515|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92100516|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100517|NCT00988533|Ivermectin|ivermectin|mesh-list
92100518|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92100519|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100520|NCT01350388|Febuxostat|febuxostat|mesh-list
92100521|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
92100522|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100523|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
92100524|NCT03154749|Carboplatin|carboplatin|mesh-list
92100525|NCT03154749|Docetaxel|docetaxel|mesh-list
92100526|NCT03154749|Epirubicin|epirubicin|mesh-list
92100527|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100528|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
92100529|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100530|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100531|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92100532|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
92100533|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100534|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100535|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92100536|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100537|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
92018665|NCT04397107|Analgesics|analgesics|mesh-ancestor
92100538|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100539|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92100540|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92100541|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92100542|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100543|NCT03422640|Apremilast|apremilast|mesh-list
92100544|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92100545|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92100547|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
92100548|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100549|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100550|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100551|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100552|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92100553|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92100554|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100555|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100556|NCT01351090|Ketorolac|ketorolac|mesh-list
92100557|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92100558|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92100559|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92100560|NCT01351090|Analgesics|analgesics|mesh-ancestor
92100561|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
92100562|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100563|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100564|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100565|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100566|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92100567|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100568|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100569|NCT01918644|Capecitabine|capecitabine|mesh-list
92100570|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92100571|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
92100572|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100573|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100574|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
92100575|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92100576|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100577|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
92100578|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
92100579|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100580|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100581|NCT00987831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100582|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
92100583|NCT00987831|Hormones|hormones|mesh-ancestor
92100584|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100585|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92100586|NCT00987831|Protective Agents|protective agents|mesh-ancestor
92100587|NCT03608358|Metformin|metformin|mesh-list
92100588|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
92100589|NCT03608358|Saxagliptin|saxagliptin|mesh-list
92100590|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92100591|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100592|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92100593|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100594|NCT03608358|Incretins|incretins|mesh-ancestor
92100595|NCT03608358|Hormones|hormones|mesh-ancestor
92100596|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100597|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92100598|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
92100599|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100600|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
92100601|NCT04274907|Venetoclax|venetoclax|mesh-list
92100602|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92100603|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100604|NCT04274907|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92100605|NCT04274907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100606|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92100607|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92100608|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
92100609|NCT01256164|Coagulants|coagulants|mesh-ancestor
92100610|NCT03427086|Biotin|biotin|mesh-list
92100611|NCT03427086|Vitamins|vitamins|mesh-ancestor
92100612|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
92100613|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100614|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
92100615|NCT01887522|Vinblastine|vinblastine|mesh-list
92100616|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92100617|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100618|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100619|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100620|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100621|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100622|NCT03422406|Iodine|iodine|mesh-list
92100623|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92100624|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100625|NCT03422406|Trace Elements|trace elements|mesh-ancestor
92100626|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
92100627|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100628|NCT00986427|Cyclosporine|cyclosporine|mesh-list
92100630|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100631|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100632|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100633|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
92100634|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100635|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
92100636|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100637|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100638|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100639|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92100640|NCT03426462|Propofol|propofol|mesh-list
92100641|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92100642|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92100643|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100644|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92100645|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
92100646|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
92100647|NCT03421860|Phenylephrine|phenylephrine|mesh-list
92100648|NCT03421860|Epinephrine|epinephrine|mesh-list
92100649|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
92100650|NCT03421860|Ephedrine|ephedrine|mesh-list
92100651|NCT03421860|Norepinephrine|norepinephrine|mesh-list
92100652|NCT03421860|Ondansetron|ondansetron|mesh-list
92100653|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92100654|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92100655|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
92100656|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100657|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017546|NCT05587673|Glucocorticoids|glucocorticoids|mesh-ancestor
92100658|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100659|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92100660|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92100661|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
92100662|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100663|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92100664|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100665|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
92100666|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
92100667|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92100668|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
92100669|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100670|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
92100671|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100672|NCT03421860|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92100673|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92100674|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
92100675|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92100676|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
92100677|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92100678|NCT03421860|Protective Agents|protective agents|mesh-ancestor
92100679|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92100680|NCT03421314|Selenium|selenium|mesh-list
92100681|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
92100682|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100683|NCT03421314|Protective Agents|protective agents|mesh-ancestor
92100684|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100685|NCT03421314|Trace Elements|trace elements|mesh-ancestor
92100686|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
92100687|NCT03425994|Emtricitabine|emtricitabine|mesh-list
92100689|NCT03425994|Elvitegravir|elvitegravir|mesh-list
92100690|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
92100691|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100692|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92100693|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92100694|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100695|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100696|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92100697|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92100698|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92100699|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92100700|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92100701|NCT03421002|Micafungin|micafungin|mesh-list
92100702|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
92100703|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100704|NCT00754260|Caffeine|caffeine|mesh-list
92100705|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92100706|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100707|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92100708|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100709|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100710|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92100711|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92100712|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
92100713|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100714|NCT02546232|Paclitaxel|paclitaxel|mesh-list
92100715|NCT02546232|Carboplatin|carboplatin|mesh-list
92100716|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92100717|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100718|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100719|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100720|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100721|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100722|NCT02521038|Ticagrelor|ticagrelor|mesh-list
92100723|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92100724|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92100725|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92100726|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92100727|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
92100728|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100729|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100730|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100731|NCT00985959|Prednisolone|prednisolone|mesh-list
92100732|NCT00985959|Bortezomib|bortezomib|mesh-list
92100733|NCT00985959|Melphalan|melphalan|mesh-list
92100734|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100735|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92100736|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
92100737|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100738|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92100739|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100740|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
92100741|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100742|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92100743|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
92100744|NCT00985959|Hormones|hormones|mesh-ancestor
92100745|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100746|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100747|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92100748|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92100749|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100750|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92100751|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92100752|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92100753|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100755|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100756|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92100757|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100758|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92100759|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100760|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100761|NCT01351480|Abatacept|abatacept|mesh-list
92100762|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91938184|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92100763|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100764|NCT01351480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92100765|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100766|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100767|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
92100768|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100769|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100771|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92100772|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100773|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
92100774|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92100775|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058870|NCT04037176|Omalizumab|omalizumab|mesh-list
92100776|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92100777|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100778|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92100779|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92100780|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92100781|NCT01294384|Laxatives|laxatives|mesh-ancestor
92100782|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100783|NCT01257802|Leuprolide|leuprolide|mesh-list
92100784|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92100785|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
92100786|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92100787|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100788|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92100789|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100790|NCT05607303|Estrogens|estrogens|mesh-list
92100791|NCT05607303|Hormones|hormones|mesh-ancestor
92100792|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100793|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100794|NCT00984009|Colchicine|colchicine|mesh-list
92100795|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
92100796|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100797|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100798|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100799|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100800|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100801|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100802|NCT05606913|Dulaglutide|dulaglutide|mesh-list
92100803|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92100804|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100805|NCT00983931|Cyclosporine|cyclosporine|mesh-list
92100806|NCT00983931|Colchicine|colchicine|mesh-list
92100807|NCT00983931|Cyclosporins|cyclosporins|mesh-list
92100808|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100809|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100810|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100811|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
92100812|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100813|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
92100814|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100815|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100816|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92100817|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92100818|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
92100819|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100820|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100821|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
92100822|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100824|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92100825|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
92100826|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100827|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
92100828|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100830|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92100831|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92100832|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92100833|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100834|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100835|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
92100836|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92100837|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
92100838|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100839|NCT03032601|Expectorants|expectorants|mesh-ancestor
92100840|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
92100841|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92100842|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
92100843|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100844|NCT03032601|Protective Agents|protective agents|mesh-ancestor
92100845|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100846|NCT03032601|Antidotes|antidotes|mesh-ancestor
92100847|NCT05603013|Vinorelbine|vinorelbine|mesh-list
92100848|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92100849|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92100850|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92100851|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92100852|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92100854|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100855|NCT05603013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92100856|NCT00983073|Tapentadol|tapentadol|mesh-list
92100857|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92100858|NCT00983073|Narcotics|narcotics|mesh-ancestor
92100859|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92100860|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100861|NCT00983073|Analgesics|analgesics|mesh-ancestor
92100862|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
92100863|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100864|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92100865|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92100866|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92100867|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100868|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
92100869|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100870|NCT05603715|Bromides|bromides|mesh-list
92100871|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92100872|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
92100873|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92100874|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100875|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100876|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
92100877|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92100878|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100879|NCT00981747|Losartan|losartan|mesh-list
92100880|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
92100881|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92100882|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92100883|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92100884|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92100885|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100886|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
92100887|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92100888|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92100889|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100890|NCT00981747|Urological Agents|urological agents|mesh-ancestor
92100891|NCT03046251|Natalizumab|natalizumab|mesh-list
92100892|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
92100893|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100894|NCT03029169|Amiodarone|amiodarone|mesh-list
92100895|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92100896|NCT03029169|Propafenone|propafenone|mesh-list
92100897|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
92100898|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92100899|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92100900|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100901|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92100902|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92100903|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92100904|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100905|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92100906|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92100907|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92100908|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92100909|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
92100910|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92100911|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
92100912|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100913|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92100914|NCT01353976|Econazole|econazole|mesh-list
92100915|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
92100916|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100917|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92100918|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92100919|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100920|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100921|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92100922|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
92100923|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100924|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100925|NCT01354444|Carvedilol|carvedilol|mesh-list
92100926|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92100927|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92100928|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
92100929|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142276|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92100930|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100931|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100932|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92100933|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
92100934|NCT01354444|Protective Agents|protective agents|mesh-ancestor
92100935|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92100936|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92100937|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92100938|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
92100939|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92100940|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92100941|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
92100942|NCT03009526|Piperaquine|piperaquine|mesh-list
92100943|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
92100944|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92100945|NCT03009526|Artenimol|artenimol|mesh-list
92100946|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
92100947|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92100948|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92100949|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92100950|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92100951|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100952|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100953|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92100954|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92100955|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92100956|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100957|NCT01354990|Incretins|incretins|mesh-ancestor
92100958|NCT01354990|Hormones|hormones|mesh-ancestor
92100959|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100960|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92100961|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
92100962|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92100963|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92100964|NCT01260454|Capsaicin|capsaicin|mesh-list
92100965|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
92100966|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
92100967|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
92100968|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100969|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100970|NCT01296646|Naltrexone|naltrexone|mesh-list
92100972|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92100973|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100974|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
92100975|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92100976|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92100977|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92100978|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
92100979|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92100980|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92100981|NCT01297348|Norinyl|norinyl|mesh-list
92100982|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
92100983|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
92100984|NCT01297348|Estradiol|estradiol|mesh-list
92100985|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92100986|NCT01297348|Estrogens|estrogens|mesh-ancestor
92100987|NCT01297348|Hormones|hormones|mesh-ancestor
92100988|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92100989|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92100990|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92100991|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92100992|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92100993|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92100994|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92100995|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92100996|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92100997|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92100999|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101000|NCT01260688|Dasatinib|dasatinib|mesh-list
92101001|NCT01260688|Cediranib|cediranib|mesh-list
92101002|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101003|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101004|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101005|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101006|NCT01298128|NuvaRing|nuvaring|mesh-list
92101007|NCT01298128|Desogestrel|desogestrel|mesh-list
92101008|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92101009|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
92101010|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92101011|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101012|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92101013|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92101014|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92101015|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92101016|NCT01298128|Progestins|progestins|mesh-ancestor
92101017|NCT01298128|Hormones|hormones|mesh-ancestor
92101018|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101019|NCT02199964|Cyclosporine|cyclosporine|mesh-list
92101020|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
92101021|NCT02199964|Cyclosporins|cyclosporins|mesh-list
92101022|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101023|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101024|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101025|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
92101026|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101027|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
92101028|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101029|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101030|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101031|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92101032|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92101033|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92101034|NCT02323048|Methamphetamine|methamphetamine|mesh-list
92101035|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92101036|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101037|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
92101038|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
92101039|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101040|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
92101041|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018686|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
92101042|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101043|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101044|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92101045|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92101046|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101047|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92101048|NCT01265446|Lidocaine|lidocaine|mesh-list
92101049|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
92101050|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
92101051|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101052|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101053|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
92101054|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101055|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92101056|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92101057|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92101058|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101059|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101060|NCT04352062|Amoxicillin|amoxicillin|mesh-list
92017599|NCT04419181|Docetaxel|docetaxel|mesh-list
92101061|NCT04352062|Levofloxacin|levofloxacin|mesh-list
92101062|NCT04352062|Ofloxacin|ofloxacin|mesh-list
92101063|NCT04352062|Melatonin|melatonin|mesh-list
92101064|NCT04352062|Pantoprazole|pantoprazole|mesh-list
92101065|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92101066|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101067|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
92101068|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101069|NCT04352062|Protective Agents|protective agents|mesh-ancestor
92101070|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101071|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101072|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92101073|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92101075|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101076|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101077|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92101078|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92101079|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92101080|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101081|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92101082|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92101083|NCT01302808|Romidepsin|romidepsin|mesh-list
92101084|NCT01302808|Antiemetics|antiemetics|mesh-list
92101085|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101086|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101087|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101088|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101089|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92101090|NCT01302808|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92101091|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
92101092|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101093|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101094|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101095|NCT01267240|Capecitabine|capecitabine|mesh-list
92101096|NCT01267240|Vorinostat|vorinostat|mesh-list
92101097|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92101098|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
92101099|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101100|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101101|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92101102|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101103|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92101104|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92101105|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92101106|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101107|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101108|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101109|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101110|NCT01855919|Analgesics|analgesics|mesh-ancestor
92101111|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
92101112|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101113|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92101114|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101115|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
92101116|NCT01871285|Morphine|morphine|mesh-list
92101117|NCT01871285|Oxycodone|oxycodone|mesh-list
92101118|NCT01871285|Buprenorphine|buprenorphine|mesh-list
92101119|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92101120|NCT01871285|Narcotics|narcotics|mesh-ancestor
92101121|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101122|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101123|NCT01871285|Analgesics|analgesics|mesh-ancestor
92101124|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
92101125|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101126|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92101127|NCT01358266|Sirolimus|sirolimus|mesh-list
92101128|NCT01358266|Temsirolimus|temsirolimus|mesh-list
92101129|NCT01358266|MTOR Inhibitors|mtor inhibitors|mesh-list
92101130|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92101131|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101132|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92101133|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101134|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
92101135|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101136|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
92101137|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101138|NCT01358266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101139|NCT01358266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101140|NCT01358266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101141|NCT01870973|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92101142|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92101143|NCT01870973|Analgesics|analgesics|mesh-list
92101144|NCT01870973|Anesthetics|anesthetics|mesh-list
92101145|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101146|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101147|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101148|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
92101149|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
92101150|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101151|NCT01267864|Ketorolac|ketorolac|mesh-list
92101152|NCT01267864|Valproic Acid|valproic acid|mesh-list
92101153|NCT01267864|Metoclopramide|metoclopramide|mesh-list
92101154|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92101155|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92101156|NCT01267864|Analgesics|analgesics|mesh-ancestor
92101157|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
92101158|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101159|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101160|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101161|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101162|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92101163|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101164|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101165|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
92101166|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
92101167|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101168|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
92101169|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92101170|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101172|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
92101173|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
92101174|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101175|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92101176|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92101177|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
92101178|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
92101179|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92101180|NCT01854827|Antibodies|antibodies|mesh-list
92101181|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
92101182|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92101183|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
92101184|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101185|NCT01360450|Clonidine|clonidine|mesh-list
92101186|NCT01360450|Analgesics|analgesics|mesh-ancestor
92101187|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
92101188|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101189|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101190|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92101191|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
92101192|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
92101193|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92101194|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92101195|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92101196|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101197|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101198|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101199|NCT01303744|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|1-(3',4'-dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid|mesh-list
92101200|NCT01303744|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92101201|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101202|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101203|NCT01361620|Aspirin|aspirin|mesh-list
92101204|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92101205|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92101206|NCT01361620|Analgesics|analgesics|mesh-ancestor
92101207|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
92101208|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101209|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101210|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101211|NCT01361620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101212|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92101213|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92101214|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059305|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92101215|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92101216|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92101217|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101218|NCT01361620|Antipyretics|antipyretics|mesh-ancestor
92101219|NCT01305772|Panitumumab|panitumumab|mesh-list
92101220|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92101221|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101222|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
92101223|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92101224|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92101225|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92101226|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101227|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101228|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
92101229|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101230|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101231|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92101232|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101233|NCT01271686|Bimatoprost|bimatoprost|mesh-list
92101234|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92101235|NCT01854047|Albuterol|albuterol|mesh-list
92101236|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92101237|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
92101238|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101239|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101240|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92101241|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92101242|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
92101243|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92101244|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92101245|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92101246|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92101247|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101248|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101249|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101250|NCT04605731|Durvalumab|durvalumab|mesh-list
92101251|NCT04605731|Ipilimumab|ipilimumab|mesh-list
92101252|NCT04605731|Tremelimumab|tremelimumab|mesh-list
92101253|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
92101254|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92101255|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
92101256|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92101257|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101258|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
92101259|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101260|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92101261|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101262|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
92101263|NCT01307956|Leucovorin|leucovorin|mesh-list
92101264|NCT01307956|Folic Acid|folic acid|mesh-list
92101265|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92101266|NCT01307956|Panitumumab|panitumumab|mesh-list
92101267|NCT01307956|Fluorouracil|fluorouracil|mesh-list
92101268|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
92101269|NCT01307956|Antibodies|antibodies|mesh-list
92101270|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
92101271|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92101272|NCT01307956|Calcium|calcium|mesh-list
92101273|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
92101274|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
92101275|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101276|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101277|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92101278|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92101279|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
92101280|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101281|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92101282|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101283|NCT01307956|Antidotes|antidotes|mesh-ancestor
92101284|NCT01307956|Protective Agents|protective agents|mesh-ancestor
92101285|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
92101287|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
92101288|NCT01307956|Hematinics|hematinics|mesh-ancestor
92101289|NCT01870739|Amlodipine|amlodipine|mesh-list
92101290|NCT01870739|Valsartan|valsartan|mesh-list
92101291|NCT01870739|Olmesartan|olmesartan|mesh-list
92101292|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92059411|NCT01783821|Budesonide|budesonide|mesh-list
92101293|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92101294|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92101295|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92101296|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101297|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101298|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92101299|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101300|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
92101301|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92101302|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92101304|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92101305|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92101306|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92101307|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101308|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101309|NCT01272388|Urological Agents|urological agents|mesh-ancestor
92101310|NCT01870583|Iodine|iodine|mesh-list
92101311|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
92101312|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92101313|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
92101314|NCT01870583|Povidone|povidone|mesh-list
92101315|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92101317|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
92101318|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101319|NCT01870583|Trace Elements|trace elements|mesh-ancestor
92101320|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
92101321|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101322|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
92101323|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
92101324|NCT04351594|Menthol|menthol|mesh-list
92101325|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
92101326|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101327|NCT01308814|Estradiol|estradiol|mesh-list
92101328|NCT01308814|Estrogens|estrogens|mesh-ancestor
92101329|NCT01308814|Hormones|hormones|mesh-ancestor
92101330|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101331|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101332|NCT03009604|Simethicone|simethicone|mesh-list
92101333|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
92101334|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101335|NCT03009604|Emollients|emollients|mesh-ancestor
92101336|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101337|NCT01275664|Dexamethasone|dexamethasone|mesh-list
92101338|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
92101339|NCT01275664|Cisplatin|cisplatin|mesh-list
92101340|NCT01275664|Carboplatin|carboplatin|mesh-list
92101341|NCT01275664|Aprepitant|aprepitant|mesh-list
92101342|NCT01275664|Granisetron|granisetron|mesh-list
92101343|NCT01275664|Ichthammol|ichthammol|mesh-list
92101344|NCT01275664|BB 1101|bb 1101|mesh-list
92101345|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101346|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101347|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
92101348|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
92101349|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101350|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101351|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101352|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
92101353|NCT01275664|Hormones|hormones|mesh-ancestor
92101354|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142277|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
92101355|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92101356|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
92101357|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101358|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101359|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92101360|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101361|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101362|NCT01275664|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92101363|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92101364|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
92101365|NCT01613027|Rituximab|rituximab|mesh-list
92101366|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92101367|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101368|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
92101369|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101370|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101371|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
92101372|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92101373|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92101374|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92101375|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101376|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101377|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
92101378|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101379|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101380|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92101381|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101382|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
92101383|NCT01369732|Hematinics|hematinics|mesh-ancestor
92101384|NCT01869725|Octreotide|octreotide|mesh-list
92101385|NCT01869725|Edotreotide|edotreotide|mesh-list
92101386|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
92101387|NCT01869725|Somatostatin|somatostatin|mesh-list
92101388|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101389|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92101390|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101391|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101392|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101395|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101396|NCT01309360|Midazolam|midazolam|mesh-list
92101397|NCT01309360|Prilocaine|prilocaine|mesh-list
92101398|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92101399|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92101400|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101401|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101402|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92101403|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92101404|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101405|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92101406|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
92101407|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
92101408|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
92101409|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
92101410|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101411|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101412|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
92101413|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
92101414|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101415|NCT01851863|Flupenthixol|flupenthixol|mesh-list
92101416|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
92101417|NCT01851863|Omeprazole|omeprazole|mesh-list
92101418|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92101419|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101420|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92101421|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101422|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101423|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92101424|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92101425|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101426|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101427|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101428|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92101429|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
92101430|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101431|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
92101432|NCT01369888|Fludarabine|fludarabine|mesh-list
92101433|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101434|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
92101435|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101436|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101437|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92101438|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
92101439|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101440|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101441|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92101442|NCT01850615|Insulin|insulin|mesh-list
92101443|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92101444|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
92101445|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92101446|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101447|NCT04602221|Lamotrigine|lamotrigine|mesh-list
92101448|NCT04602221|BI 425809|bi 425809|mesh-list
92101449|NCT04602221|BI 409306|bi 409306|mesh-list
92101450|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
92101451|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92101452|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101453|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101454|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92101455|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101456|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92101457|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92101458|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101459|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101460|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92101461|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92101462|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101463|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
92101464|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92101465|NCT01280110|Laxatives|laxatives|mesh-ancestor
92101466|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101467|NCT01374802|Ritonavir|ritonavir|mesh-list
92101468|NCT01374802|Darunavir|darunavir|mesh-list
92101469|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92101470|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92101471|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
92101472|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101473|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101474|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92101475|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92101476|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
92101477|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101478|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92101479|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92101480|NCT01375660|Vitamin D|vitamin d|mesh-list
92101481|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
92101482|NCT01375660|Vitamins|vitamins|mesh-ancestor
92101483|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
92101484|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101485|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92101486|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92101487|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
92101488|NCT01868477|Deferasirox|deferasirox|mesh-list
92101489|NCT01868477|Hematinics|hematinics|mesh-ancestor
92101490|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92101491|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
92101492|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
92101493|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101494|NCT01849289|Insulin|insulin|mesh-list
92101495|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92101496|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
92101497|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92101498|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101499|NCT01868243|Warfarin|warfarin|mesh-list
92101500|NCT01868243|Dabigatran|dabigatran|mesh-list
92101501|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
92101502|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
92101503|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92101505|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142356|NCT04146493|Heparin|heparin|mesh-list
92101506|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101507|NCT01611935|Vasopressins|vasopressins|mesh-list
92101508|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
92101509|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
92101510|NCT01611935|Coagulants|coagulants|mesh-ancestor
92101511|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92101512|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92101513|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
92101514|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101515|NCT02201212|Everolimus|everolimus|mesh-list
92101516|NCT02201212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92101517|NCT02201212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101518|NCT02201212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101519|NCT02201212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101520|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101521|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
92101522|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101523|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101524|NCT01376362|Interferons|interferons|mesh-list
92101525|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
92101526|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101527|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
92101528|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101529|NCT03009292|Lenvatinib|lenvatinib|mesh-list
92101530|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101531|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101532|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101533|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101534|NCT01962792|Dexamethasone|dexamethasone|mesh-list
92101535|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101536|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
92101537|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
92101538|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101539|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101540|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101541|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
92101542|NCT01962792|Hormones|hormones|mesh-ancestor
91932422|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92101543|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101544|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92101545|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101546|NCT01849055|Celecoxib|celecoxib|mesh-list
92101547|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92101548|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92101549|NCT01849055|Analgesics|analgesics|mesh-ancestor
92101550|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
92101551|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101552|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101553|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101554|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101555|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92101556|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92101557|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101558|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101559|NCT01404832|Lansoprazole|lansoprazole|mesh-list
92101560|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
92101561|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92101562|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101563|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92101564|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101565|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101566|NCT03420534|Iloperidone|iloperidone|mesh-list
92101567|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92101568|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92101569|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101570|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101571|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101572|NCT01313494|Albuterol|albuterol|mesh-list
92101573|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92101574|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
92101575|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101576|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101577|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92101578|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
92101579|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
92101580|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92101581|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92101582|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92101583|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92101584|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101585|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101586|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101587|NCT01407094|Sertraline|sertraline|mesh-list
92101588|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
92101589|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101590|NCT01407094|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92101591|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92101592|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101593|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101594|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101596|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101597|NCT01867307|Empagliflozin|empagliflozin|mesh-list
92101598|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92101599|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101600|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92101601|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101602|NCT01845077|Metformin|metformin|mesh-list
92101603|NCT01845077|Linagliptin|linagliptin|mesh-list
92101604|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92101605|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101606|NCT01845077|Incretins|incretins|mesh-ancestor
92101607|NCT01845077|Hormones|hormones|mesh-ancestor
92101608|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101609|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92101610|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
92101611|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101612|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101613|NCT01866917|Ropivacaine|ropivacaine|mesh-list
92101614|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
92101615|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
92101616|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101617|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101618|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
92101619|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101620|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92101621|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92101622|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92101623|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101624|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101625|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101626|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101627|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
92101628|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101629|NCT01410058|Efavirenz|efavirenz|mesh-list
92101630|NCT01410058|Nevirapine|nevirapine|mesh-list
92101631|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92101632|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92101633|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101634|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101635|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
92101636|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101637|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92101638|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92101639|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92101640|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92101641|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92101642|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92101643|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92101644|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92101645|NCT01380106|Lenalidomide|lenalidomide|mesh-list
92101646|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
91938197|NCT03566199|Panobinostat|panobinostat|mesh-list
92101647|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101648|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92101649|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92101650|NCT01380106|Growth Substances|growth substances|mesh-ancestor
92101651|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92101652|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101653|NCT01381120|Acetaminophen|acetaminophen|mesh-list
92101654|NCT01381120|Oxycodone|oxycodone|mesh-list
92101655|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
92101656|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92101657|NCT01381120|Analgesics|analgesics|mesh-ancestor
92101658|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
92101659|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101660|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101661|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
92101662|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92101663|NCT01381120|Narcotics|narcotics|mesh-ancestor
92101664|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101665|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92101666|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92101667|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
92101668|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101669|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101670|NCT01381120|Urological Agents|urological agents|mesh-ancestor
92101671|NCT01316770|Dexamethasone|dexamethasone|mesh-list
92101672|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101673|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
92059748|NCT01752933|Guadecitabine|guadecitabine|mesh-list
92101675|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101676|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101677|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101678|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
92101679|NCT01316770|Hormones|hormones|mesh-ancestor
92018726|NCT03051841|Dexamethasone|dexamethasone|mesh-list
92101680|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101682|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101683|NCT01318408|Levetiracetam|levetiracetam|mesh-list
92101684|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
92101685|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
92101686|NCT01319110|Ubiquinone|ubiquinone|mesh-list
92101687|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
92101688|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
92101689|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101690|NCT01319110|Vitamins|vitamins|mesh-ancestor
92101691|NCT03008512|Paclitaxel|paclitaxel|mesh-list
92101692|NCT03008512|genexol-PM|genexol-pm|mesh-list
92101693|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92101694|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101695|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
92101696|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
92101697|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
92101698|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101699|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
92101700|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
92101701|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92101702|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92101703|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101704|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101705|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101706|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101707|NCT01411696|Dexamethasone|dexamethasone|mesh-list
92101708|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101709|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
92101710|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
92101711|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101712|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101713|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101714|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
92101715|NCT01411696|Hormones|hormones|mesh-ancestor
92101716|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101717|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92101718|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101719|NCT01412164|Sirolimus|sirolimus|mesh-list
92101720|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92101721|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938200|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101722|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92101723|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101724|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
92101725|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101726|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
92101727|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101728|NCT01844687|Cannabidiol|cannabidiol|mesh-list
92101729|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
92101730|NCT01844531|Metformin|metformin|mesh-list
92101731|NCT01844531|Empagliflozin|empagliflozin|mesh-list
92101732|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92101733|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101734|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92101735|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101736|NCT02367456|Azacitidine|azacitidine|mesh-list
92101737|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92101738|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
92101739|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101740|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101741|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101742|NCT03420378|Vitamin D|vitamin d|mesh-list
92101743|NCT03420378|Vitamins|vitamins|mesh-ancestor
92101744|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
92101745|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101746|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92101747|NCT03425448|Heparin|heparin|mesh-list
92101748|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
92101749|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92101750|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92101751|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101752|NCT03419910|Cyclosporine|cyclosporine|mesh-list
92101753|NCT03419910|Deucravacitinib|deucravacitinib|mesh-list
92101754|NCT03419910|Cyclosporins|cyclosporins|mesh-list
92101755|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101756|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101757|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101758|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
92101759|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101760|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
92101761|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101762|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101763|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101764|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92101765|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101766|NCT03415386|Anticoagulants|anticoagulants|mesh-list
92101767|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92101768|NCT01865747|Everolimus|everolimus|mesh-list
92101769|NCT01865747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92101770|NCT01865747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101771|NCT01865747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101772|NCT01865747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101773|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101774|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
92101775|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101776|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101777|NCT03424980|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92101778|NCT03424980|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101779|NCT03424980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101780|NCT03424980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101781|NCT03424746|Edetic Acid|edetic acid|mesh-list
92101782|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
92101783|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
92101784|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92101785|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
92101786|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
92101787|NCT03424746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101788|NCT03424746|Antidotes|antidotes|mesh-ancestor
92101789|NCT03424746|Protective Agents|protective agents|mesh-ancestor
92101790|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101791|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92101792|NCT03414918|Clarithromycin|clarithromycin|mesh-list
92101793|NCT03414918|Roxithromycin|roxithromycin|mesh-list
92101794|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92101795|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101796|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92101797|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101798|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101799|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92101800|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92101801|NCT04448496|Dexamethasone|dexamethasone|mesh-list
92101802|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92101803|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
92101804|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
92101805|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101806|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101807|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101808|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
92101809|NCT04448496|Hormones|hormones|mesh-ancestor
92101810|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92101811|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92101812|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101813|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
92101814|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
92101815|NCT03419442|Docetaxel|docetaxel|mesh-list
92101816|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101817|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
92101818|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
92101819|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
92101820|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101821|NCT01412710|Vitamin D|vitamin d|mesh-list
92101822|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
92018736|NCT03051841|Hormones|hormones|mesh-ancestor
92059896|NCT01385566|Immunologic Factors|immunologic factors|mesh-ancestor
92101823|NCT01412710|Vitamins|vitamins|mesh-ancestor
92101824|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
92101825|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101826|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92101827|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92101828|NCT01843205|Methamphetamine|methamphetamine|mesh-list
92101829|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92101830|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101831|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
92101832|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
92101833|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101834|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
92101835|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101836|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101837|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101838|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92101839|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92101840|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101841|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92101842|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
92101843|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92101844|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101845|NCT03419130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92101846|NCT03419130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101847|NCT03414840|Atorvastatin|atorvastatin|mesh-list
92101848|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92101849|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92101850|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
92101851|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101852|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92101853|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92101854|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101855|NCT03418974|Atorvastatin|atorvastatin|mesh-list
92101856|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92101857|NCT03418974|Pitavastatin|pitavastatin|mesh-list
92101858|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92101859|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92101860|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
92101861|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101862|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92101863|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92101864|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101865|NCT03424356|Fentanyl|fentanyl|mesh-list
92101866|NCT03424356|Narcotics|narcotics|mesh-list
92101867|NCT03424356|Analgesics|analgesics|mesh-list
92101868|NCT03424356|Bromides|bromides|mesh-list
92101869|NCT03424356|Propofol|propofol|mesh-list
92101870|NCT03424356|Rocuronium|rocuronium|mesh-list
92101871|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92101872|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101873|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101874|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92101875|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
92101876|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
92101877|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92101878|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
92101879|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101880|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92101881|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
92101882|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92101883|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92101884|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92101886|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101887|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92101888|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101889|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101890|NCT01389076|Methotrexate|methotrexate|mesh-list
92101891|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
92101892|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92101893|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
92101894|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92101895|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101896|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92101897|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
92101898|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101899|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101900|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92101901|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101902|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92101903|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92101904|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
92101905|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92101906|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92101908|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92101909|NCT03127800|Narcotics|narcotics|mesh-ancestor
92101910|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92101911|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101912|NCT03127800|Analgesics|analgesics|mesh-ancestor
92101913|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
92101914|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101915|NCT01389856|Bosentan|bosentan|mesh-list
92101916|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92101917|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92101918|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101919|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92101920|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92101921|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101922|NCT01323010|Albuterol|albuterol|mesh-list
92101923|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92101924|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
92101925|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101926|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101927|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92101928|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
92101929|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
92101930|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92101931|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92101932|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92101933|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92101934|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101935|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101936|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101937|NCT03423810|Hydralazine|hydralazine|mesh-list
92101938|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92101939|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
92101941|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92020237|NCT03045133|Analgesics|analgesics|mesh-ancestor
92101942|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
92101943|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92101944|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92101945|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92101946|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101947|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101948|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
92101949|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101950|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101951|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92101952|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92101953|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101954|NCT01390870|Alfuzosin|alfuzosin|mesh-list
92101955|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101956|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101957|NCT01390870|Urological Agents|urological agents|mesh-ancestor
92101958|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92101959|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92101960|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92101961|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
92101962|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101963|NCT03418506|Lobeline|lobeline|mesh-list
92101964|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92101965|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
92101966|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92101967|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92101968|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92101969|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92101970|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
92101971|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92101972|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101973|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
92101975|NCT01842581|Lactulose|lactulose|mesh-list
92101976|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92101977|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101978|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101979|NCT04448028|Esomeprazole|esomeprazole|mesh-list
92101980|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92101981|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92101982|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92101983|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92101984|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101985|NCT01833533|Ribavirin|ribavirin|mesh-list
92101986|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
92101987|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101988|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
92101989|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92101990|NCT03413436|Cisplatin|cisplatin|mesh-list
92101991|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92101992|NCT01833455|Flecainide|flecainide|mesh-list
92101993|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92101994|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92101995|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92101996|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92101997|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92101998|NCT03413358|Carboplatin|carboplatin|mesh-list
92101999|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102000|NCT01833143|Acyclovir|acyclovir|mesh-list
92102001|NCT01833143|Bortezomib|bortezomib|mesh-list
92102002|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102003|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
92102004|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102005|NCT03411096|Ropivacaine|ropivacaine|mesh-list
92102006|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102007|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
92102008|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102009|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102010|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
92102011|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102012|NCT03417648|Vitamin E|vitamin e|mesh-list
92102013|NCT03417648|Vitamins|vitamins|mesh-ancestor
92102014|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
92102015|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102016|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
92102017|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102018|NCT03417648|Protective Agents|protective agents|mesh-ancestor
92102019|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
92102020|NCT01831817|Listerine|listerine|mesh-list
92102021|NCT01831817|Calcium|calcium|mesh-list
92102022|NCT01831817|Fluorides|fluorides|mesh-list
92102023|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
92102024|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
92102025|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92102026|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102027|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92102028|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
92102029|NCT01831817|Protective Agents|protective agents|mesh-ancestor
92102030|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92102031|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102032|NCT03412500|Vancomycin|vancomycin|mesh-list
92102033|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92102034|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102035|NCT01840943|Topotecan|topotecan|mesh-list
92102036|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92102037|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92102038|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102039|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102040|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102041|NCT05171400|Insulin|insulin|mesh-list
92102042|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92102043|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102044|NCT02203630|Phenylephrine|phenylephrine|mesh-list
92102045|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
92102046|NCT02203630|Norepinephrine|norepinephrine|mesh-list
92102047|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92060141|NCT01397422|Amantadine|amantadine|mesh-list
92102048|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
92102049|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
92102050|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102051|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102053|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92102054|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
92102055|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
92102056|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92102057|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92102058|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92102059|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102060|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102061|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102062|NCT02203630|Protective Agents|protective agents|mesh-ancestor
92102063|NCT04593329|Dipyrone|dipyrone|mesh-list
92102064|NCT04593329|Tramadol|tramadol|mesh-list
92102065|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92102066|NCT04593329|Narcotics|narcotics|mesh-ancestor
92102067|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102068|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102069|NCT04593329|Analgesics|analgesics|mesh-ancestor
92102070|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
92017663|NCT04933279|Iodine|iodine|mesh-list
92102071|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102072|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102073|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102074|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102075|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102076|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
92102077|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92102078|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92102079|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102080|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92102081|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92102082|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102083|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102084|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
92102085|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102086|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92102087|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92102088|NCT02520570|Urinastatin|urinastatin|mesh-list
92102089|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
92102090|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92102091|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
92102092|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102093|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102094|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
92102095|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
92102096|NCT03411798|Methotrexate|methotrexate|mesh-list
92102097|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92102098|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
92102099|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102100|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102101|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102102|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
92102103|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102104|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102105|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102106|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102107|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92102108|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102109|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
92102110|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102111|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92102112|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
92102113|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92102114|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92102115|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102116|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102117|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102118|NCT03411798|Analgesics|analgesics|mesh-ancestor
92102119|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
92102120|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102121|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102122|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102123|NCT03408756|Methotrexate|methotrexate|mesh-list
92060197|NCT01885208|Exenatide|exenatide|mesh-list
92102124|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92102125|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
92102126|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102127|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102128|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102130|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102131|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102132|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102133|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102134|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92102135|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102136|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
92102137|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102138|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92102139|NCT01394614|Vaccines|vaccines|mesh-list
92102140|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
92102141|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102142|NCT04588818|Adalimumab|adalimumab|mesh-list
92102143|NCT04588818|Methotrexate|methotrexate|mesh-list
92102144|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92102145|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
92102146|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102147|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102148|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102149|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
92102150|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102151|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102152|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102153|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102154|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92102155|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102156|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
92102157|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102158|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92102159|NCT04588818|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92102160|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102161|NCT01422226|Alprostadil|alprostadil|mesh-list
92102162|NCT01422226|Misoprostol|misoprostol|mesh-list
92102163|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92102164|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
92102165|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102166|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102167|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92102168|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102170|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92102171|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
92102172|NCT01422226|Urological Agents|urological agents|mesh-ancestor
92102173|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
92102174|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
92102175|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102176|NCT01423162|Protective Agents|protective agents|mesh-ancestor
92102177|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102179|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
92102180|NCT01328782|Acetaminophen|acetaminophen|mesh-list
92102181|NCT01328782|Oxycodone|oxycodone|mesh-list
92102182|NCT01328782|Bupivacaine|bupivacaine|mesh-list
92102183|NCT01328782|Ropivacaine|ropivacaine|mesh-list
92102184|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102185|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
92102186|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102187|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102188|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
92102189|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102190|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102191|NCT01328782|Analgesics|analgesics|mesh-ancestor
92102192|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
92102193|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92102194|NCT01328782|Narcotics|narcotics|mesh-ancestor
92102195|NCT04447326|Endostar protein|endostar protein|mesh-list
92102196|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92102197|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92102198|NCT04447326|Growth Substances|growth substances|mesh-ancestor
92102199|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102200|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
92102201|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102202|NCT03411330|Lidocaine|lidocaine|mesh-list
92102203|NCT03411330|Bupivacaine|bupivacaine|mesh-list
92102204|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102205|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
92102206|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102207|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102208|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
92102209|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102210|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92102211|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92102212|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92102213|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102214|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102215|NCT03411252|Mirabegron|mirabegron|mesh-list
92102216|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92102217|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92102218|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92102219|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102220|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102221|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102222|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102223|NCT03411252|Urological Agents|urological agents|mesh-ancestor
92102224|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92102225|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
92102226|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102227|NCT01830881|Ibuprofen|ibuprofen|mesh-list
92102228|NCT01830881|Lidocaine|lidocaine|mesh-list
92102229|NCT01830881|Midazolam|midazolam|mesh-list
92102230|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102231|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
92102232|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102233|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102234|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
92102235|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102236|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92102237|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92102238|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92102239|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102240|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102241|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92102242|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92102243|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92102244|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92102245|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102246|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92102247|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
92102248|NCT01830881|GABA Modulators|gaba modulators|mesh-ancestor
92102249|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
92102250|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102251|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102252|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102253|NCT01830881|Analgesics|analgesics|mesh-ancestor
92102254|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102255|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102256|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92102257|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102258|NCT01396486|Inositol|inositol|mesh-list
92102259|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
92102260|NCT01396486|Vitamins|vitamins|mesh-ancestor
92102261|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
92102262|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102263|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
92102264|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
92102265|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102266|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102267|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102268|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
92102269|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
92102270|NCT03404544|Carbetocin|carbetocin|mesh-list
92102271|NCT03404544|Oxytocin|oxytocin|mesh-list
92102272|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
92102273|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92021615|NCT04786795|Pancrelipase|pancrelipase|mesh-list
92102274|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102275|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
92102276|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92102277|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92102278|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102279|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
92102280|NCT01398280|Coagulants|coagulants|mesh-ancestor
92102281|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
92102282|NCT03404310|Astringents|astringents|mesh-ancestor
92102283|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102284|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102286|NCT03403842|Morphine|morphine|mesh-list
92102287|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92102288|NCT03403842|Narcotics|narcotics|mesh-ancestor
92102289|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102290|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102291|NCT03403842|Analgesics|analgesics|mesh-ancestor
92102292|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
92102293|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102294|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92102295|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92102296|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
92102297|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
92102298|NCT01398982|Bupivacaine|bupivacaine|mesh-list
92102299|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102300|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
92102301|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102302|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102303|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
92102304|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102305|NCT04447560|Bupivacaine|bupivacaine|mesh-list
92102306|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102307|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
92102308|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102309|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102310|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
92102311|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102312|NCT03401736|Midazolam|midazolam|mesh-list
92102313|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
92102314|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92102315|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102316|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102317|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102318|NCT03401736|Analgesics|analgesics|mesh-ancestor
92102319|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
92102320|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102321|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92102322|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92102323|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92102324|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102325|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102326|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102327|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92102328|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92102329|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92102330|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102331|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92102332|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
92102333|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
92102334|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
92102335|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
92102336|NCT02203786|Haloperidol|haloperidol|mesh-list
92102337|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
92102338|NCT02203786|Fluphenazine|fluphenazine|mesh-list
92102339|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
92102340|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92102341|NCT02203786|Amphetamine|amphetamine|mesh-list
92102342|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
92102343|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
92102344|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
92102345|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102346|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102347|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102348|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92102350|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102351|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102352|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92102353|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
92102354|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102355|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102356|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92102357|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92102358|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
92102359|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102360|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92102361|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92102362|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102363|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92102365|NCT03009058|Folic Acid|folic acid|mesh-list
92102366|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
92102367|NCT03009058|Gemcitabine|gemcitabine|mesh-list
92102368|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
92102369|NCT03009058|Fluorouracil|fluorouracil|mesh-list
92102370|NCT03009058|Capecitabine|capecitabine|mesh-list
92102371|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
92102372|NCT03009058|Nivolumab|nivolumab|mesh-list
92102373|NCT03009058|Irinotecan|irinotecan|mesh-list
92102374|NCT03009058|Cetuximab|cetuximab|mesh-list
92102375|NCT03009058|Ipilimumab|ipilimumab|mesh-list
92102376|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92102377|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
92102378|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102379|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
92102380|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102381|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102382|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92102383|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
92102384|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102385|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102386|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92102387|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102388|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
92102389|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92102390|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92102391|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92102392|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92102393|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102394|NCT03009058|Antidotes|antidotes|mesh-ancestor
92102395|NCT03009058|Protective Agents|protective agents|mesh-ancestor
92102396|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
92102397|NCT03009058|Vitamins|vitamins|mesh-ancestor
92102398|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
92102399|NCT03009058|Hematinics|hematinics|mesh-ancestor
92102401|NCT01611857|Fluorouracil|fluorouracil|mesh-list
92102402|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
92102403|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
92102404|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
92102405|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102406|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102407|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102408|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102409|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
92102410|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102411|NCT01611857|Antidotes|antidotes|mesh-ancestor
92102412|NCT01611857|Protective Agents|protective agents|mesh-ancestor
92102413|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
92102414|NCT01611857|Vitamins|vitamins|mesh-ancestor
92102415|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
92102416|NCT03393858|Antibodies|antibodies|mesh-list
92102417|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
92102418|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102419|NCT03393702|Gabapentin|gabapentin|mesh-list
92102420|NCT03393702|Analgesics|analgesics|mesh-ancestor
92102421|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
92102422|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102423|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102424|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
92102425|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92102426|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92102427|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102428|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102429|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92102430|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92102431|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102432|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102433|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
92102434|NCT01829477|Glimepiride|glimepiride|mesh-list
92102435|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92102436|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92102437|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102438|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102439|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
92102440|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
92102441|NCT03126864|Fludarabine|fludarabine|mesh-list
92102442|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
92102443|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102444|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
92102445|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102446|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102447|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92102448|NCT03126864|Alkylating Agents|alkylating agents|mesh-ancestor
92017673|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
92102449|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102450|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102451|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92102452|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102453|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
92102455|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102456|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102457|NCT03399708|Analgesics|analgesics|mesh-ancestor
92102458|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
92102459|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102460|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102461|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102462|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102463|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92102464|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92102465|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102466|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102467|NCT03395730|Oxytocin|oxytocin|mesh-list
92102468|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
92102469|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102470|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102471|NCT01334086|Aprepitant|aprepitant|mesh-list
92102472|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
92102473|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
92102474|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102475|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102476|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102477|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92102478|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102479|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102481|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
92102482|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102483|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
92102484|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102485|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102486|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
92102487|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102488|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92102489|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92102490|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92102491|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102492|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102493|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92102494|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102495|NCT03399474|Analgesics|analgesics|mesh-ancestor
92102496|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92102497|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92102498|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92102499|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102500|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102501|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92102502|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92102503|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92102504|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102505|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102506|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102507|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102508|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92102509|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
92102510|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102511|NCT01430182|Morphine|morphine|mesh-list
92102512|NCT01430182|Methadone|methadone|mesh-list
92102513|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92102514|NCT01430182|Narcotics|narcotics|mesh-ancestor
92102515|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102516|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102517|NCT01430182|Analgesics|analgesics|mesh-ancestor
92102518|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
92102519|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102520|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
92102521|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
92102522|NCT05097768|Dexamethasone|dexamethasone|mesh-list
92102523|NCT05097768|Ibuprofen|ibuprofen|mesh-list
92102524|NCT05097768|Ketorolac|ketorolac|mesh-list
92102525|NCT05097768|Meloxicam|meloxicam|mesh-list
92102526|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102527|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
92102528|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
92102529|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102530|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102531|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102532|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
92102533|NCT05097768|Hormones|hormones|mesh-ancestor
92102534|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92102535|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92102536|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102537|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102538|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102539|NCT05097768|Analgesics|analgesics|mesh-ancestor
92102540|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
92102541|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102542|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92102543|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102544|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102545|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92102546|NCT01829243|Milnacipran|milnacipran|mesh-list
92102547|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
92102548|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92102549|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92102550|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102551|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102552|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102553|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102554|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102555|NCT01829243|Analgesics|analgesics|mesh-ancestor
92102556|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
92102557|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102558|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
92102559|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102560|NCT01838447|Vitamin D|vitamin d|mesh-list
92102561|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
92102562|NCT01838447|Vitamins|vitamins|mesh-ancestor
92102563|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
92102564|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102565|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92102566|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92102567|NCT03395574|Terlipressin|terlipressin|mesh-list
92102568|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92102569|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92102571|NCT04982172|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92102572|NCT04982172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102573|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102574|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102575|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102576|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92102577|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92102578|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92102579|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
92102580|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102581|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92102582|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92102583|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102584|NCT03395262|Caffeine|caffeine|mesh-list
92102585|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92102586|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102587|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92102588|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102589|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102590|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92102591|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92102592|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
92102593|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102594|NCT03852888|Methotrexate|methotrexate|mesh-list
92102595|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
92102596|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92102597|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
92102598|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102599|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102600|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102601|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
92102602|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102603|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102604|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102605|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102606|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92102607|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102608|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
92102609|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102610|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92102611|NCT04770012|Aspirin|aspirin|mesh-list
92102612|NCT04770012|Clopidogrel|clopidogrel|mesh-list
92102613|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102614|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102615|NCT04770012|Analgesics|analgesics|mesh-ancestor
92102616|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
92102617|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102618|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102619|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102620|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102621|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92102622|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92102623|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102624|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92102625|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92102626|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102627|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
92102628|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92102629|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92102630|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92102631|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
92102632|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102633|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
92102634|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92102635|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
92102636|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102637|NCT04755972|Expectorants|expectorants|mesh-ancestor
92102638|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
92102639|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92102640|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
92102641|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102642|NCT04755972|Protective Agents|protective agents|mesh-ancestor
92102643|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102644|NCT04755972|Antidotes|antidotes|mesh-ancestor
92102645|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
92102647|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92102648|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
92102649|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102650|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92102651|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92102652|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102653|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102654|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92102655|NCT04697693|Escitalopram|escitalopram|mesh-list
92102656|NCT04697693|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92102657|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92102658|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102659|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102660|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102661|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
92102662|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102663|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102664|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
92102665|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92102666|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92102668|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
92102669|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
92102670|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
92102671|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92102672|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
92102673|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102674|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102675|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92102676|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92102677|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92102678|NCT01827839|Vaccines|vaccines|mesh-list
92102679|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
92102680|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102681|NCT04709250|Bupivacaine|bupivacaine|mesh-list
92102682|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102683|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
92102684|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102685|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102686|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
92102687|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102688|NCT01401166|Trastuzumab|trastuzumab|mesh-list
92102689|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92102690|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102691|NCT03395028|Lenograstim|lenograstim|mesh-list
92102692|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92102693|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
92102694|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102695|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92102696|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92102697|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92102698|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102699|NCT04567992|Bupivacaine|bupivacaine|mesh-list
92102700|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102701|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
92102702|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102703|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102704|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
92102705|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102706|NCT01335724|Diclofenac|diclofenac|mesh-list
92102707|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92102708|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102709|NCT01335724|Analgesics|analgesics|mesh-ancestor
92102710|NCT01335724|Sensory System Agents|sensory system agents|mesh-ancestor
92102711|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021627|NCT04786327|Chelating Agents|chelating agents|mesh-ancestor
92102712|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102713|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102714|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102715|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92102716|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102717|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102718|NCT01476202|Nicotine|nicotine|mesh-list
92102719|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92102720|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
92102721|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102722|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102723|NCT01476202|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92102724|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92102725|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
92102726|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102727|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102728|NCT01477762|Dexamethasone|dexamethasone|mesh-list
92102729|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102730|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
92102731|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
92102732|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102733|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102734|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102735|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
92102736|NCT01477762|Hormones|hormones|mesh-ancestor
92102737|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92102738|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92102739|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102740|NCT01434472|Vidarabine|vidarabine|mesh-list
92102741|NCT01434472|Cyclosporine|cyclosporine|mesh-list
92102742|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
92102743|NCT01434472|Rituximab|rituximab|mesh-list
92102744|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92102745|NCT01434472|Fludarabine|fludarabine|mesh-list
92102746|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
92102747|NCT01434472|Antibodies|antibodies|mesh-list
92102748|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
92102749|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92102750|NCT01434472|Cyclosporins|cyclosporins|mesh-list
92102751|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
92102752|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102753|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102754|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102755|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92102757|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102758|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102759|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
92102760|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102761|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102762|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
92102763|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
92102764|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92102765|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92102766|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92102767|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
92102768|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92102769|NCT01435174|Ranolazine|ranolazine|mesh-list
92102770|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
92102771|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92102772|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92102773|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102774|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102775|NCT01436266|Folic Acid|folic acid|mesh-list
92102776|NCT01436266|Misoprostol|misoprostol|mesh-list
92102777|NCT01436266|Vitamins|vitamins|mesh-ancestor
92102778|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
91932423|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102779|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102780|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92102781|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
92102782|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92102783|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92102784|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102785|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
92102786|NCT01436266|Hematinics|hematinics|mesh-ancestor
92102787|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
92102788|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92102789|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92102790|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
92102791|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92102792|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102793|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92102794|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102795|NCT04409262|Remdesivir|remdesivir|mesh-list
92102796|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
92102797|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102798|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
92102799|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102800|NCT01481740|Phenylephrine|phenylephrine|mesh-list
92102801|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
92102802|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92102803|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
92060873|NCT05205486|Cefazolin|cefazolin|mesh-list
92102804|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
92102805|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102806|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102807|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
92102808|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92102809|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
92102810|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
92102811|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92102812|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92102813|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92102814|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102815|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102816|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102817|NCT01481740|Protective Agents|protective agents|mesh-ancestor
92102818|NCT01544062|Acetaminophen|acetaminophen|mesh-list
92102819|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102820|NCT01544062|Analgesics|analgesics|mesh-ancestor
92102821|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
92102822|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102823|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102824|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
92102825|NCT03126084|Acetaminophen|acetaminophen|mesh-list
92102826|NCT03126084|Tramadol|tramadol|mesh-list
92102827|NCT03126084|Bupivacaine|bupivacaine|mesh-list
92102828|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102829|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
92102830|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102831|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102832|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
92102833|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102834|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92102835|NCT03126084|Analgesics|analgesics|mesh-ancestor
92102836|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
92102837|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92102838|NCT03126084|Narcotics|narcotics|mesh-ancestor
92102839|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92102840|NCT01544998|Tadalafil|tadalafil|mesh-list
92102841|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
92102842|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92102843|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92102844|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102845|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102846|NCT01544998|Urological Agents|urological agents|mesh-ancestor
92102847|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
92102848|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102849|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
92102850|NCT03391830|Atorvastatin|atorvastatin|mesh-list
92102851|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92102852|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92102853|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
92102854|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102855|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92102856|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92102857|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102858|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
92102859|NCT03391830|Protective Agents|protective agents|mesh-ancestor
92102860|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102861|NCT03391830|Vitamins|vitamins|mesh-ancestor
92102862|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
92102863|NCT01441570|Metoprolol|metoprolol|mesh-list
92102864|NCT01441570|Nebivolol|nebivolol|mesh-list
92102865|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92102866|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92102867|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
92102868|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
92102869|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102870|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102871|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92102872|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92102873|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92102874|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
92102875|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102876|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102877|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
92102878|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92102879|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92102880|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92102881|NCT05238012|Atorvastatin|atorvastatin|mesh-list
92102882|NCT05238012|Calcium|calcium|mesh-list
92102883|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92102884|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102885|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92102886|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92102887|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
92102888|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102889|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92102890|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92102891|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102892|NCT01441882|Dasatinib|dasatinib|mesh-list
92102893|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102894|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92102895|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102896|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102897|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92102898|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92102899|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
92102900|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102901|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102902|NCT01545700|Dexamethasone|dexamethasone|mesh-list
92102903|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
92102904|NCT01545700|BB 1101|bb 1101|mesh-list
92102905|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102906|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
92102907|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
92102908|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102909|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102910|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102911|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
92102912|NCT01545700|Hormones|hormones|mesh-ancestor
92102913|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92102914|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92102915|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102916|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
92102917|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102918|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102919|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92102920|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92021649|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
92102921|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102922|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92102923|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92102924|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92102925|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102926|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
92102927|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92102928|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92102929|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
92102930|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92102931|NCT01444924|Bupivacaine|bupivacaine|mesh-list
92102932|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
92102933|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
92102934|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102935|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102936|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
92102937|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102938|NCT01546402|Dexamethasone|dexamethasone|mesh-list
92102939|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
92102940|NCT01546402|BB 1101|bb 1101|mesh-list
92102941|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102942|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
92102943|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
92102944|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102945|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017700|NCT04943653|Paclitaxel|paclitaxel|mesh-list
92102946|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102947|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
92102948|NCT01546402|Hormones|hormones|mesh-ancestor
92102949|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92102950|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92102951|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102952|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
92102953|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92102954|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061023|NCT04940052|Trametinib|trametinib|mesh-list
92102956|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92102957|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
92102958|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
92102959|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
92102960|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
92102961|NCT03389490|Protamines|protamines|mesh-list
92102962|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92102963|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102964|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
92102965|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92102966|NCT03389490|Coagulants|coagulants|mesh-ancestor
92102967|NCT03994146|Remifentanil|remifentanil|mesh-list
92102968|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92102969|NCT03994146|Narcotics|narcotics|mesh-ancestor
92102970|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92102971|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102972|NCT03994146|Analgesics|analgesics|mesh-ancestor
92102973|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
92102974|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102975|NCT01547806|Plerixafor|plerixafor|mesh-list
92102976|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92102977|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92102978|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
92102979|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92102980|NCT01445626|Dexamethasone|dexamethasone|mesh-list
92102981|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92102982|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
92102983|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
92102984|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92102985|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102986|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92102987|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
92102988|NCT01445626|Hormones|hormones|mesh-ancestor
92102989|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92102990|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92102991|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92102992|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
92102993|NCT02744742|Busulfan|busulfan|mesh-list
92102994|NCT02744742|Decitabine|decitabine|mesh-list
92102995|NCT02744742|Lenograstim|lenograstim|mesh-list
92102996|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92102997|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
92102998|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92102999|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103000|NCT02744742|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92103001|NCT02744742|Alkylating Agents|alkylating agents|mesh-ancestor
92103002|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103003|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103004|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92103005|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103006|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
92103007|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103008|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92103010|NCT03125772|Everolimus|everolimus|mesh-list
92103011|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92103012|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103013|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92103014|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92103015|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92103016|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103017|NCT03125772|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92103018|NCT03125772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92103019|NCT03125772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103020|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103021|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
92103022|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103023|NCT01447888|Morphine|morphine|mesh-list
92103024|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92103025|NCT01447888|Narcotics|narcotics|mesh-ancestor
92103026|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103027|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103028|NCT01447888|Analgesics|analgesics|mesh-ancestor
92103029|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
92103030|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103031|NCT03389256|Apatinib|apatinib|mesh-list
92103032|NCT03389256|Gefitinib|gefitinib|mesh-list
92103033|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103034|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92103035|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103036|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103037|NCT01490788|Amitriptyline|amitriptyline|mesh-list
92103038|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
92103039|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92103040|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
92103041|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92103042|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92103043|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103044|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92103045|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103046|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92103047|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103048|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103049|NCT01490788|Analgesics|analgesics|mesh-ancestor
92103050|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
92103051|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92103052|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92103053|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92103054|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103055|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
92103056|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103057|NCT02520180|Everolimus|everolimus|mesh-list
92103058|NCT02520180|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92103059|NCT02520180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92103060|NCT02520180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103061|NCT02520180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103062|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103063|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
92103064|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103065|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103067|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021652|NCT04023019|Thrombin|thrombin|mesh-list
92103068|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92103069|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103070|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103071|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
92103072|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92103073|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
92103074|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92103075|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103076|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103077|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103078|NCT03390972|Analgesics|analgesics|mesh-ancestor
92103079|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
92103080|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103081|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92103082|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92103083|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92103084|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
92103085|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103086|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103087|NCT01550224|Temozolomide|temozolomide|mesh-list
92103088|NCT01550224|Vorinostat|vorinostat|mesh-list
92103089|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92103090|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
92103091|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103092|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103093|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92103094|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103095|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
92103096|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92103097|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92103098|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103099|NCT00782184|Atorvastatin|atorvastatin|mesh-list
92103100|NCT00782184|Simvastatin|simvastatin|mesh-list
92103101|NCT00782184|Ezetimibe|ezetimibe|mesh-list
92103102|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92103103|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92103104|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92103105|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
92103106|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103107|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92103108|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92103109|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103110|NCT03397914|Colistin|colistin|mesh-list
92103111|NCT03397914|Polymyxins|polymyxins|mesh-list
92103112|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103113|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103114|NCT01450306|Cycloserine|cycloserine|mesh-list
92103115|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92103116|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103117|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92103118|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
92103119|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103120|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
92103121|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103122|NCT03126708|Paclitaxel|paclitaxel|mesh-list
92103123|NCT03126708|Cetuximab|cetuximab|mesh-list
92103124|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92103125|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103126|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92103127|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92103128|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92103129|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103130|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103131|NCT03390738|Nivolumab|nivolumab|mesh-list
92103132|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103133|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103134|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92103135|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103136|NCT03390582|Methimazole|methimazole|mesh-list
92103137|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
92103138|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
92103139|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103140|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103141|NCT03385356|Vitamin D|vitamin d|mesh-list
92103142|NCT03385356|Vitamins|vitamins|mesh-ancestor
92103143|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
92103144|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103145|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92103146|NCT03388866|Immunomodulating Agents|immunomodulating agents|mesh-list
92103147|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
92103148|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103149|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92103150|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
92103151|NCT01873170|Etonogestrel|etonogestrel|mesh-list
92103152|NCT01873170|Desogestrel|desogestrel|mesh-list
92103153|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
92103154|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
92103155|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92103156|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92103157|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103158|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103159|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92103160|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92103161|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92103162|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92103163|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103164|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92103165|NCT01873170|Progestins|progestins|mesh-ancestor
92103166|NCT01873170|Hormones|hormones|mesh-ancestor
92103167|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103168|NCT03125694|Pioglitazone|pioglitazone|mesh-list
92103169|NCT03125694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92103170|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92103171|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103172|NCT03125694|Incretins|incretins|mesh-ancestor
92103173|NCT03125694|Hormones|hormones|mesh-ancestor
92103174|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103175|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92103176|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
92103177|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103178|NCT03125694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103179|NCT02731638|Voriconazole|voriconazole|mesh-list
92103180|NCT02731638|Natamycin|natamycin|mesh-list
92103181|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
92103182|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103183|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92103184|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92103185|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103186|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103187|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92103188|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
92103189|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103190|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103191|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92103192|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92103193|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103194|NCT01451632|Irinotecan|irinotecan|mesh-list
92103195|NCT01451632|Cetuximab|cetuximab|mesh-list
92103196|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92103197|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92103198|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103199|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103200|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103201|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103202|NCT01491958|Methotrexate|methotrexate|mesh-list
92103203|NCT01491958|Atorvastatin|atorvastatin|mesh-list
92103204|NCT01491958|Tacrolimus|tacrolimus|mesh-list
92103205|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92103206|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
92103207|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103208|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103209|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103210|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
92103211|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103212|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103213|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
92103214|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103215|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92103216|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103217|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
92103218|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103219|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92103220|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92103221|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92103222|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92103223|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92103224|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92103225|NCT01492582|Vaccines|vaccines|mesh-list
92103226|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
92103227|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103228|NCT02214628|Becaplermin|becaplermin|mesh-list
92103229|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
92103230|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92103231|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92103232|NCT02214628|Growth Substances|growth substances|mesh-ancestor
92103233|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103234|NCT01495858|Naproxen|naproxen|mesh-list
92103235|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92103236|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103237|NCT01495858|Analgesics|analgesics|mesh-ancestor
92103238|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
92103239|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103240|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103241|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103242|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103243|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
92103244|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92103245|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103246|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103247|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
92103248|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92103249|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92103250|NCT01497496|Prednisolone|prednisolone|mesh-list
92103251|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
92103252|NCT01497496|Lenalidomide|lenalidomide|mesh-list
92061324|NCT04085172|Guanfacine|guanfacine|mesh-list
92103254|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92103255|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
92103256|NCT01497496|Immunologic Factors|immunologic factors|mesh-ancestor
92103257|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103258|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92103259|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92103260|NCT01497496|Growth Substances|growth substances|mesh-ancestor
92103261|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
92103262|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103263|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103264|NCT01497496|Antiemetics|antiemetics|mesh-ancestor
92103265|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
92103266|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103267|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103268|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
92103269|NCT01497496|Hormones|hormones|mesh-ancestor
92103270|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103271|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92103272|NCT01497496|Protective Agents|protective agents|mesh-ancestor
92103273|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92103274|NCT02208310|Vitamin D|vitamin d|mesh-list
92103275|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
92103276|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
92103277|NCT02208310|Vitamins|vitamins|mesh-list
92103278|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
92103279|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103280|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92103281|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92103282|NCT01454362|Nicotine|nicotine|mesh-list
92103283|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92103284|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
92103285|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103286|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103287|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92103288|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92103289|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
92103290|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103291|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103292|NCT01497808|Ipilimumab|ipilimumab|mesh-list
92103293|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103294|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103295|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92103296|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103297|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
92103298|NCT01498588|Doxorubicin|doxorubicin|mesh-list
92103299|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103300|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
92103301|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103302|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103303|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92103304|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
92103305|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103306|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103307|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92103308|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92103309|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92103310|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92103311|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103312|NCT01498744|Clindamycin|clindamycin|mesh-list
92103313|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
92103314|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
92103315|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103316|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103317|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92103318|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103319|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103320|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92103321|NCT01498978|Ipilimumab|ipilimumab|mesh-list
92103322|NCT01498978|Antibodies|antibodies|mesh-list
92103323|NCT01498978|Immunoglobulins|immunoglobulins|mesh-list
92103324|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92103325|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
92103326|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103327|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103328|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92103329|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103330|NCT01458418|Montelukast|montelukast|mesh-list
92103331|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92103332|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
92103333|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92103334|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
92103335|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103336|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103337|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92103338|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92103339|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103340|NCT01557322|Etanercept|etanercept|mesh-list
92103341|NCT01557322|Methotrexate|methotrexate|mesh-list
92103342|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92103343|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
92103344|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103345|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103346|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103347|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
92103348|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103349|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103350|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92103351|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103352|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92103353|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103354|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
92103355|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103356|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92103357|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92103358|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103359|NCT01557322|Analgesics|analgesics|mesh-ancestor
92103360|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
92103361|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103362|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103363|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103364|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92103365|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92103366|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
92103367|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92103368|NCT01459588|Laxatives|laxatives|mesh-ancestor
92103369|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103370|NCT01501162|Ethanol|ethanol|mesh-list
92103371|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92103372|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103373|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103374|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103375|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
92103376|NCT01557868|Hylan|hylan|mesh-list
92103377|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92103378|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
92103379|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103380|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
92103381|NCT01557868|Protective Agents|protective agents|mesh-ancestor
92103382|NCT02208466|Fluoxetine|fluoxetine|mesh-list
92103383|NCT02208466|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92103384|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92103385|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92103386|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103387|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103388|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
92103389|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103390|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92103391|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
92103392|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92103393|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92103394|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92103395|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103396|NCT02209948|Temozolomide|temozolomide|mesh-list
92103397|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92103398|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
92103399|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103400|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103401|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
92103402|NCT02981212|Prednisolone|prednisolone|mesh-list
92103403|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92103404|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92103405|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103406|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92103407|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
92103408|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103409|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103410|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103411|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103412|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103414|NCT02981212|Hormones|hormones|mesh-ancestor
92103415|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103416|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103417|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92103418|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
92103419|NCT01464190|Sevelamer|sevelamer|mesh-list
92103420|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
92103421|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
92103422|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103423|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92103424|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103425|NCT01563406|Ethanol|ethanol|mesh-list
92103426|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
92103427|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92103428|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103429|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103430|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103432|NCT01468012|Levodopa|levodopa|mesh-list
92103433|NCT01468012|Carbidopa|carbidopa|mesh-list
92103434|NCT01468012|Entacapone|entacapone|mesh-list
92103435|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92103436|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92103437|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92103438|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
92103439|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103440|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103441|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103442|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92103443|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103444|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92103445|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92103446|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
92103447|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
92103448|NCT01468558|Ketoconazole|ketoconazole|mesh-list
92103449|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
92103450|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103451|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92103452|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92103453|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103454|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103455|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92103456|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
92103457|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103458|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103459|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92103460|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
92103461|NCT03730662|Tirzepatide|tirzepatide|mesh-list
92103462|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92103463|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103464|NCT03730662|Incretins|incretins|mesh-ancestor
92103465|NCT03730662|Hormones|hormones|mesh-ancestor
92103466|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103467|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92103468|NCT01470118|Dextrans|dextrans|mesh-list
92103469|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92103470|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92103471|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
92103472|NCT01470118|Alcaftadine|alcaftadine|mesh-list
92103473|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
92103475|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
92103476|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92103477|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103478|NCT01470118|Analgesics|analgesics|mesh-ancestor
92103479|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
92103480|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103481|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103482|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103483|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103484|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92103485|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92103486|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92103487|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
92103488|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
92103489|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103490|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103491|NCT01470196|Dexamethasone|dexamethasone|mesh-list
92103492|NCT01470196|Rituximab|rituximab|mesh-list
92103493|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103494|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103495|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
92103496|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103497|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103498|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103499|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
92103500|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
92103501|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103502|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103503|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
92103504|NCT01470196|Hormones|hormones|mesh-ancestor
92142357|NCT04146493|Anticoagulants|anticoagulants|mesh-ancestor
92103505|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103506|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92103508|NCT03389958|Trace Elements|trace elements|mesh-ancestor
92103509|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
92103510|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103511|NCT04446234|Risperidone|risperidone|mesh-list
92103512|NCT04446234|Aripiprazole|aripiprazole|mesh-list
92103513|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92103514|NCT04446234|Ziprasidone|ziprasidone|mesh-list
92103515|NCT04446234|Amisulpride|amisulpride|mesh-list
92103516|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92103517|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
92103518|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103519|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103520|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103521|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92103522|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92103523|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103524|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92103525|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92103526|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
92103527|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
92103528|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
92103529|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92103530|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92103531|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92103532|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92103533|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92103534|NCT01511068|Sargramostim|sargramostim|mesh-list
92103535|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
92103536|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103537|NCT03613506|Captopril|captopril|mesh-list
92103538|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92103539|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
92103540|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103541|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103542|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92103543|NCT01565902|Siponimod|siponimod|mesh-list
92103544|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92103545|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103546|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103547|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
92103548|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103549|NCT01566448|Ketamine|ketamine|mesh-list
92103550|NCT01566448|Analgesics|analgesics|mesh-ancestor
92103551|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
92103552|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103553|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103554|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92103555|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92103556|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
92103557|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
92103558|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103559|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92103560|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92103561|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103562|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103563|NCT05565976|Aspirin|aspirin|mesh-list
92103564|NCT05565976|Insulin|insulin|mesh-list
92103565|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92103566|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
92103567|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
92103568|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
92103569|NCT05565976|Biguanides|biguanides|mesh-list
92103570|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92103571|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92103572|NCT05565976|Meglitinide|meglitinide|mesh-list
92103573|NCT05565976|Clopidogrel|clopidogrel|mesh-list
92103574|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92103575|NCT05565976|Atorvastatin|atorvastatin|mesh-list
92103576|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92103577|NCT05565976|Pravastatin|pravastatin|mesh-list
92103578|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142358|NCT04146493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92103579|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92103580|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92103582|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103583|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92103584|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92103585|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103586|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92103587|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92103588|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92103589|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
92103590|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103591|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92103592|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92103593|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103594|NCT05565976|Analgesics|analgesics|mesh-ancestor
92103595|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
92103596|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103597|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103598|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103599|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92103600|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92103601|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92103602|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
92103603|NCT01566526|Dexamethasone|dexamethasone|mesh-list
92103604|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103605|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
92103606|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
92103607|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103608|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103609|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103610|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
92103611|NCT01566526|Hormones|hormones|mesh-ancestor
92103612|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103613|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92103614|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103615|NCT01566838|Bupivacaine|bupivacaine|mesh-list
92103616|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
92103617|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
92103618|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103619|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103620|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
92103621|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103622|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
92103623|NCT05565664|Ketamine|ketamine|mesh-list
92103624|NCT05565664|Analgesics|analgesics|mesh-ancestor
92103625|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
92103626|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103627|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103628|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92103629|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92103630|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
92103631|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
92103632|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103633|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92103634|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92103635|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103636|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103637|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92103638|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
92103639|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92103640|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92103641|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92103642|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
92103643|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103644|NCT03125616|Vaccines|vaccines|mesh-list
92103645|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
92103646|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103647|NCT01568008|Bimatoprost|bimatoprost|mesh-list
92103648|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92103649|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92103650|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92103652|NCT05658120|Racepinephrine|racepinephrine|mesh-list
92103653|NCT05658120|Norepinephrine|norepinephrine|mesh-list
92103654|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
92103655|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92103656|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92103657|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
92103658|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103659|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103660|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103661|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92103662|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92103663|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
92103664|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103665|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92103666|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
92103667|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
92103668|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
92103669|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92103670|NCT01514734|Timolol|timolol|mesh-list
92103671|NCT01514734|Brinzolamide|brinzolamide|mesh-list
92103672|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103673|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103674|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92103675|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92103676|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
92103677|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103678|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103679|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92103680|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92103681|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92103682|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
92103683|NCT01515046|Gemcitabine|gemcitabine|mesh-list
92103684|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103685|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
92103686|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103687|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103688|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
92103689|NCT01515046|Protective Agents|protective agents|mesh-ancestor
92103690|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103691|NCT01515046|Vitamins|vitamins|mesh-ancestor
92103692|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
92103693|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92103694|NCT01568944|Lansoprazole|lansoprazole|mesh-list
92103695|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103696|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92103697|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103698|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92103699|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103700|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103702|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92103703|NCT05565274|Narcotics|narcotics|mesh-ancestor
92103704|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103705|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103706|NCT05565274|Analgesics|analgesics|mesh-ancestor
92103707|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
92103708|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103709|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92103710|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92103712|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92103713|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
92103714|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103715|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103716|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92103717|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
92103718|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
92103719|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103720|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92103721|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92103722|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92103723|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
92103724|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103725|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103726|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
92103727|NCT04671030|Neostigmine|neostigmine|mesh-list
92103728|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92103729|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103730|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103731|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
92103732|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103733|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103734|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92103735|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
92103736|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103737|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92103738|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92103739|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92103740|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
92103741|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92103742|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103743|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103744|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92103745|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92103746|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103747|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103748|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103749|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92103750|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
92103751|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103752|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103753|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92103754|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92103755|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92103756|NCT04632264|Oxytocin|oxytocin|mesh-list
92103757|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
92103758|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103759|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103760|NCT04607928|Pirfenidone|pirfenidone|mesh-list
92103761|NCT04607928|Analgesics|analgesics|mesh-ancestor
92103762|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
92103763|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103764|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103765|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92103766|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103767|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103768|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103769|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103770|NCT03380442|Ketamine|ketamine|mesh-list
92103771|NCT03380442|Psilocybin|psilocybin|mesh-list
92103772|NCT03380442|Analgesics|analgesics|mesh-ancestor
92103773|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
92103774|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103775|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103776|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92103777|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92103779|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
92021692|NCT05611879|Pemetrexed|pemetrexed|mesh-list
92103780|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103781|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92103782|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92103783|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103784|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103785|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
92103786|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92103787|NCT05172570|Gabapentin|gabapentin|mesh-list
92103788|NCT05172570|Analgesics|analgesics|mesh-ancestor
92103789|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
92103790|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103791|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103792|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
92103793|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92103794|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92103795|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103796|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91938226|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92103797|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92103798|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92103799|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92103800|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103801|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
92103802|NCT03380130|Nivolumab|nivolumab|mesh-list
92103803|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103804|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103805|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92103806|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103807|NCT03386838|Carboplatin|carboplatin|mesh-list
92103808|NCT03386838|Fluorouracil|fluorouracil|mesh-list
92103809|NCT03386838|Nivolumab|nivolumab|mesh-list
92103810|NCT03386838|Cetuximab|cetuximab|mesh-list
92103811|NCT03386838|Linrodostat|linrodostat|mesh-list
92103812|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103813|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
92103814|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103815|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103816|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103817|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
92103818|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103819|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103820|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92103821|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103822|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92103823|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
92103824|NCT03379974|Coagulants|coagulants|mesh-ancestor
92103825|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92103826|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
92103827|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103828|NCT01570036|Trastuzumab|trastuzumab|mesh-list
92103829|NCT01570036|Molgramostim|molgramostim|mesh-list
92103830|NCT01570036|Sargramostim|sargramostim|mesh-list
92103831|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92103832|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103833|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
92103834|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103835|NCT01516684|Lidocaine|lidocaine|mesh-list
92103836|NCT01516684|Fentanyl|fentanyl|mesh-list
92103837|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
92103838|NCT01516684|Prilocaine|prilocaine|mesh-list
92103839|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92103840|NCT01516684|Propofol|propofol|mesh-list
92103841|NCT01516684|Anesthetics|anesthetics|mesh-list
92103842|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92103843|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103844|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
92103845|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103846|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92103847|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92103848|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92103849|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92103850|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103851|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92103852|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92103853|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
92103854|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92103856|NCT01516684|Analgesics|analgesics|mesh-ancestor
92103857|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92103858|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92103859|NCT01517074|Sirolimus|sirolimus|mesh-list
92103860|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103861|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103862|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92103863|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103864|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
92103865|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103866|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
92103867|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103868|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
92103869|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
92103870|NCT01570348|Fludarabine|fludarabine|mesh-list
92103871|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
92103872|NCT01570348|Tacrolimus|tacrolimus|mesh-list
92103873|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103874|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
92103875|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103876|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103877|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92103878|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
92103879|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103880|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103881|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92103882|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103883|NCT01570348|Antimetabolites|antimetabolites|mesh-ancestor
92103884|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92103885|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103886|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92103887|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92103888|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
92103889|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103890|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103891|NCT03383406|Cytarabine|cytarabine|mesh-list
92103892|NCT03383406|Methotrexate|methotrexate|mesh-list
92103893|NCT03383406|Etoposide|etoposide|mesh-list
92103894|NCT03383406|Ifosfamide|ifosfamide|mesh-list
92103895|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92103896|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
92103897|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92103898|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103899|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92103900|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
92103901|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103902|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103903|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
92103904|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103905|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92103906|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92103907|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
92103908|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103909|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92103910|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92103911|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92103912|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92103913|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
92103914|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103915|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92103916|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
92103917|NCT04445922|Anastrozole|anastrozole|mesh-list
92103918|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92103919|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103920|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92103921|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92103922|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103923|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103924|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92103925|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
92103926|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103927|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103928|NCT03383328|Prednisolone|prednisolone|mesh-list
92103929|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92103930|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
92103931|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92103932|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
92103933|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92103934|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92103935|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
92103936|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103937|NCT03383328|Glucocorticoids|glucocorticoids|mesh-ancestor
92103938|NCT03383328|Hormones|hormones|mesh-ancestor
92103939|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92103940|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103941|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92017759|NCT03057769|Epinephrine|epinephrine|mesh-list
92103942|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103943|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
92103944|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
92103945|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103946|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92103947|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92103948|NCT03383328|Protective Agents|protective agents|mesh-ancestor
92103949|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103950|NCT03383328|Analgesics|analgesics|mesh-ancestor
92103951|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
92103952|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103953|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92103954|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103955|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92103956|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103957|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103958|NCT03093246|Aspirin|aspirin|mesh-list
92103959|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92103960|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92103961|NCT03093246|Analgesics|analgesics|mesh-ancestor
92103962|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
92103963|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92103964|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103965|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92103966|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92103967|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92103968|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92103969|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103970|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92103971|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92103972|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103973|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
92103974|NCT02969928|Amoxicillin|amoxicillin|mesh-list
92103975|NCT02969928|Metronidazole|metronidazole|mesh-list
92103976|NCT02969928|Clarithromycin|clarithromycin|mesh-list
92103977|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92103978|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92103979|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92103980|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92103981|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92103982|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92103983|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103984|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92103985|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92103987|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
92103988|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
92103989|NCT02968446|Vitamins|vitamins|mesh-ancestor
92103990|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
92103991|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92103992|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92103993|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92103994|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
92103995|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92103996|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92062085|NCT00134030|Interferon-alpha|interferon-alpha|mesh-list
92103997|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92103998|NCT03378960|Omeprazole|omeprazole|mesh-list
92103999|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92104000|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104001|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92104002|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104003|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104004|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
92104005|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
92104006|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104007|NCT03378726|Micronutrients|micronutrients|mesh-list
92104008|NCT03378726|Trace Elements|trace elements|mesh-list
92104009|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104010|NCT05137938|Ketamine|ketamine|mesh-list
92104011|NCT05137938|Analgesics|analgesics|mesh-ancestor
92104012|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
92104013|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104014|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104015|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92104016|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92104017|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
92104019|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104020|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92104021|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92104022|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104023|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104024|NCT03378648|Bromides|bromides|mesh-list
92104025|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
92104026|NCT01519882|Rotigotine|rotigotine|mesh-list
92104027|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
92104028|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
92104029|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104030|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104031|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104032|NCT01576276|Ketorolac|ketorolac|mesh-list
92104033|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92104034|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104035|NCT01576276|Analgesics|analgesics|mesh-ancestor
92104036|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
92104037|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104038|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104039|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104040|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104041|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92104042|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104043|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104044|NCT01576588|Rituximab|rituximab|mesh-list
92104045|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
92104046|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104047|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104048|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
92104049|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104050|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104051|NCT01576588|Hormones|hormones|mesh-ancestor
92104052|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104053|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
92104054|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
92021716|NCT05613361|Analgesics|analgesics|mesh-ancestor
92104055|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104056|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
92104057|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92104058|NCT02247154|Antibodies|antibodies|mesh-list
92104059|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
92104060|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104061|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
92104062|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92104063|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92104064|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
92104065|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104066|NCT03007810|Hemay005|hemay005|mesh-list
92104067|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104068|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92104069|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92104070|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104071|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062187|NCT01380730|Evolocumab|evolocumab|mesh-list
92104073|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92104074|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92104075|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92104076|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104077|NCT01804049|Metformin|metformin|mesh-list
92104078|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104079|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104080|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92104081|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92104082|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104083|NCT02346630|Levodopa|levodopa|mesh-list
92104084|NCT02346630|Carbidopa|carbidopa|mesh-list
92104085|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92104086|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92104087|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
92104088|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104089|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104090|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104091|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92104092|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104093|NCT03385668|Pirfenidone|pirfenidone|mesh-list
92104094|NCT03385668|Analgesics|analgesics|mesh-ancestor
92104095|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
92104096|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104097|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104098|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92104099|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104100|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104101|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104102|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104103|NCT04947072|Anesthetics|anesthetics|mesh-list
92104104|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104105|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104107|NCT04942158|Zinc Oxide|zinc oxide|mesh-list
92104108|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104109|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
92104110|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92104111|NCT04942158|Protective Agents|protective agents|mesh-ancestor
92104112|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104113|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104114|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
92104115|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92104116|NCT03387774|Urinastatin|urinastatin|mesh-list
92104117|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92104118|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92104119|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
92104120|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104121|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104122|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
92104123|NCT03382314|Vitamin D|vitamin d|mesh-list
92104124|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
92104125|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92104126|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104127|NCT03382314|Vitamins|vitamins|mesh-ancestor
92104128|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
92104129|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92104130|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92104131|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92104132|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
92104133|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104134|NCT03124524|Dienogest|dienogest|mesh-list
92104135|NCT03124524|Drospirenone|drospirenone|mesh-list
92104136|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92104137|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92104138|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92104139|NCT03124524|Estradiol|estradiol|mesh-list
92104140|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92104141|NCT03124524|Estrogens|estrogens|mesh-ancestor
92104142|NCT03124524|Hormones|hormones|mesh-ancestor
92104143|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104144|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104145|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92104146|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
92104147|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92104148|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92104149|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92104150|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92104151|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92104152|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
92104153|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92104154|NCT03124524|Diuretics|diuretics|mesh-ancestor
92104155|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
92104156|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92104157|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92104158|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104159|NCT03377400|Cisplatin|cisplatin|mesh-list
92104160|NCT03377400|Durvalumab|durvalumab|mesh-list
92104162|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104163|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104164|NCT01803269|Topotecan|topotecan|mesh-list
92104165|NCT01803269|Camptothecin|camptothecin|mesh-list
92104166|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92104167|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92104168|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104169|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104170|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104171|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92104172|NCT01802879|Panobinostat|panobinostat|mesh-list
92104173|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104174|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92104175|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104176|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104177|NCT01825577|Methylphenidate|methylphenidate|mesh-list
92104178|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92104179|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104180|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92104181|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92104182|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92104183|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104184|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
92104185|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104186|NCT03375138|Abatacept|abatacept|mesh-list
92104187|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92104188|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104189|NCT03375138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104190|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104191|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92104192|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
92104193|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104194|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104195|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
92104196|NCT03124680|Narcotics|narcotics|mesh-ancestor
92104197|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104198|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104199|NCT03124680|Analgesics|analgesics|mesh-ancestor
92104200|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
92104201|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104202|NCT03374670|Aflibercept|aflibercept|mesh-list
92104203|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92104204|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92104205|NCT03374670|Growth Substances|growth substances|mesh-ancestor
92104206|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104207|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
92104208|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104209|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
92104210|NCT02963610|Lenalidomide|lenalidomide|mesh-list
92104211|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104212|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104213|NCT02963610|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92104214|NCT02963610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104215|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
92104216|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104217|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92104218|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92104219|NCT02963610|Growth Substances|growth substances|mesh-ancestor
92104221|NCT03376932|Albuterol|albuterol|mesh-list
92104222|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
92104223|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92104224|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
92104225|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104226|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104227|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92104228|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
92104229|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
92017777|NCT03057769|Analgesics|analgesics|mesh-ancestor
92104230|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92104231|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
92104232|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104233|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104235|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92104236|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92104237|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92104238|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92104239|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
92104240|NCT03007342|Amoxicillin|amoxicillin|mesh-list
92104241|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
92104242|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
92104243|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92104244|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104245|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104246|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92104247|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104248|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104249|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92104250|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92104251|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104252|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104253|NCT01579162|Cholic Acids|cholic acids|mesh-list
92104254|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104255|NCT03007654|Chitosan|chitosan|mesh-list
92104256|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92104257|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92104258|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
92104259|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104260|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92104261|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
92104262|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
92104263|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
92104264|NCT03007654|Coagulants|coagulants|mesh-ancestor
92104265|NCT03374514|Dexamethasone|dexamethasone|mesh-list
92104266|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104267|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
92104268|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
92021730|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92104269|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104270|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104272|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
92104273|NCT03374514|Hormones|hormones|mesh-ancestor
92104274|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104275|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92104276|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104277|NCT01526356|Sirolimus|sirolimus|mesh-list
92104278|NCT01526356|Temsirolimus|temsirolimus|mesh-list
92104279|NCT01526356|MTOR Inhibitors|mtor inhibitors|mesh-list
92104280|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104281|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104282|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92104283|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104284|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
92104285|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92104286|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
92104287|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104288|NCT01526356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92104289|NCT01526356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104290|NCT01526356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104291|NCT02903160|Prednisone|prednisone|mesh-list
92104292|NCT02903160|Carboplatin|carboplatin|mesh-list
92104293|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
92104294|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92062385|NCT01882088|Psyllium|psyllium|mesh-list
92104295|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104296|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104297|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
92104298|NCT02903160|Hormones|hormones|mesh-ancestor
92104299|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104300|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104301|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92104302|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92104303|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142437|NCT04698434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92104304|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104305|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
92104306|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92104307|NCT03376464|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92104308|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92104309|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104310|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104311|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92104312|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92104313|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104314|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
92104315|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104316|NCT03374280|Cisplatin|cisplatin|mesh-list
92104317|NCT03374280|Pemetrexed|pemetrexed|mesh-list
92104318|NCT03374280|Gefitinib|gefitinib|mesh-list
92104319|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104320|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104321|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104322|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92104323|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92104324|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92104325|NCT03381066|Cisplatin|cisplatin|mesh-list
92104326|NCT03381066|Pemetrexed|pemetrexed|mesh-list
92104327|NCT03381066|Vinorelbine|vinorelbine|mesh-list
92104328|NCT03381066|Gefitinib|gefitinib|mesh-list
92104329|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104330|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104331|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104332|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92104333|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92104334|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92104335|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
92104336|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
92104337|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
92104338|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92104339|NCT03630666|Hormones|hormones|mesh-list
92104340|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92104341|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104342|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104343|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92104344|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
92104345|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92104346|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
92104347|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
92104348|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104349|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104350|NCT03375996|Parasympatholytics|parasympatholytics|mesh-ancestor
92104351|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92104352|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92104353|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
92104354|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104355|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104356|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
92104357|NCT01580410|Mitomycins|mitomycins|mesh-list
92104358|NCT01580410|Mitomycin|mitomycin|mesh-list
92104359|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104360|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92104361|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
92104362|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104363|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92104364|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104365|NCT02606136|Mitogens|mitogens|mesh-list
92104366|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
92104367|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104368|NCT01581658|Empagliflozin|empagliflozin|mesh-list
92104369|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92104370|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104371|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104372|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104373|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92104374|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104375|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104376|NCT01530178|Incretins|incretins|mesh-ancestor
92104377|NCT01530178|Hormones|hormones|mesh-ancestor
92104378|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104379|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92104380|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
92104381|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104382|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104383|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
92104384|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92104385|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92104386|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92104387|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92104388|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104389|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
92104390|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104391|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104392|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92104393|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104394|NCT03006874|Esomeprazole|esomeprazole|mesh-list
92104395|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92104396|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104397|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92104398|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104399|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104400|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
92104401|NCT01581970|Cetuximab|cetuximab|mesh-list
92104402|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92104403|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
92021742|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
92104404|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104405|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104406|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92104407|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
92104408|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104409|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104410|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92104411|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104412|NCT01583686|Aldesleukin|aldesleukin|mesh-list
92104413|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
92104414|NCT01583686|Fludarabine|fludarabine|mesh-list
92104415|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92104416|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
92104417|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104418|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104419|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92104420|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
92104421|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104422|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104423|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92104424|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92104425|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92104426|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
92104427|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104428|NCT01532128|Opicapone|opicapone|mesh-list
92104429|NCT01532128|Rasagiline|rasagiline|mesh-list
92104430|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92104431|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104432|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104433|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92104434|NCT01532128|Protective Agents|protective agents|mesh-ancestor
92104435|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104436|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92104437|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92104438|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92104439|NCT01584388|Rituximab|rituximab|mesh-list
92104440|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104441|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104442|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
92104443|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104444|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104445|NCT01584544|Capecitabine|capecitabine|mesh-list
92104446|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92104447|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
92104448|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104449|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104450|NCT03006952|Losartan|losartan|mesh-list
92104451|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
92104452|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92104453|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92104454|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92104455|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92104456|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104458|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104459|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92104460|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92104461|NCT03006952|Protective Agents|protective agents|mesh-ancestor
92104462|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104463|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
92104464|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92104465|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
92104466|NCT01802333|Cytarabine|cytarabine|mesh-list
92104467|NCT01802333|Daunorubicin|daunorubicin|mesh-list
92104468|NCT01802333|Vorinostat|vorinostat|mesh-list
92104469|NCT01802333|Idarubicin|idarubicin|mesh-list
92104470|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92104471|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
92104472|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104473|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104474|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
92104475|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104476|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92104477|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
92104478|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104479|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92104480|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92104481|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92104482|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104483|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92104485|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92104486|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
92104487|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104488|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
92104489|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104490|NCT01586962|Acetaminophen|acetaminophen|mesh-list
92104491|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
92104492|NCT01586962|Ephedrine|ephedrine|mesh-list
92104493|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104494|NCT01586962|Analgesics|analgesics|mesh-ancestor
92104495|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
92104496|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104497|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104498|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
92104499|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92104500|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
92104501|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92104502|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
92104503|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
92104504|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92104505|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92104506|NCT01586962|Sympathomimetics|sympathomimetics|mesh-ancestor
92104507|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
92104508|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104509|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104510|NCT03006250|Sevoflurane|sevoflurane|mesh-list
92104511|NCT03006250|Desflurane|desflurane|mesh-list
92104512|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92104513|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92104514|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
92104515|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
92104516|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104517|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104519|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92104520|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104521|NCT04129437|Analgesics|analgesics|mesh-ancestor
92104522|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
92104523|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104524|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104525|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104526|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104527|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92104528|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104529|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104530|NCT04588259|Insulin|insulin|mesh-list
92104531|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92104532|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
92104533|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
92104534|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92104535|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104536|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104537|NCT01801475|Ondansetron|ondansetron|mesh-list
92104538|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
92104539|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
92104540|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104541|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104542|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104543|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
92104544|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104545|NCT01801475|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92104546|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92104547|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
92104548|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104549|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104550|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
92104551|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92104552|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
92104553|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104554|NCT03063021|Expectorants|expectorants|mesh-ancestor
92104555|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
92104556|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92104557|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
92104558|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104559|NCT03063021|Protective Agents|protective agents|mesh-ancestor
92104560|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104561|NCT03063021|Antidotes|antidotes|mesh-ancestor
92104562|NCT02337933|Ursolic acid|ursolic acid|mesh-list
92104563|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104564|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104565|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92104566|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104567|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92104568|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104569|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92104570|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104571|NCT02337933|Analgesics|analgesics|mesh-ancestor
92104572|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
92104573|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104574|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104575|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104576|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104577|NCT03028857|Choline|choline|mesh-list
92104578|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
92104579|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92104580|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
92104581|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104582|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104583|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92104584|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
92104585|NCT03062943|Nintedanib|nintedanib|mesh-list
92104586|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104587|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92104588|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104589|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104590|NCT01536886|Betamethasone|betamethasone|mesh-list
92104591|NCT01536886|Calcipotriene|calcipotriene|mesh-list
92104592|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104593|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
92104594|NCT01536886|Hormones|hormones|mesh-ancestor
92104595|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104596|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104597|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92104598|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
92104599|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104600|NCT02247310|Interferons|interferons|mesh-list
92104601|NCT02247310|Interferon-beta|interferon-beta|mesh-list
92104602|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
92104603|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104604|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
92104605|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104606|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
92104607|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104608|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92104609|NCT03061539|Nivolumab|nivolumab|mesh-list
92104610|NCT03061539|Ipilimumab|ipilimumab|mesh-list
92104611|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104612|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104613|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92104614|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104615|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
92104616|NCT01590550|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92104617|NCT05609253|Itraconazole|itraconazole|mesh-list
92104618|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92104619|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
92104621|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92104622|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92104623|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104624|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104625|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92104626|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
92104627|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104628|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104629|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92104630|NCT01822535|Midodrine|midodrine|mesh-list
92104631|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
92104632|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
92104633|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104634|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104635|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92104636|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92104637|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92104638|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92104639|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
92104640|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104641|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104642|NCT01537666|Vancomycin|vancomycin|mesh-list
92104643|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104644|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104645|NCT01537900|Grazoprevir|grazoprevir|mesh-list
92104646|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
92104647|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104648|NCT01799993|Amikacin|amikacin|mesh-list
92104649|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104650|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104651|NCT03005860|Fentanyl|fentanyl|mesh-list
92104652|NCT03005860|Propofol|propofol|mesh-list
92104653|NCT03005860|Sevoflurane|sevoflurane|mesh-list
92104654|NCT03005860|Atracurium|atracurium|mesh-list
92104655|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92104656|NCT03005860|Narcotics|narcotics|mesh-ancestor
92104657|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104658|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104659|NCT03005860|Analgesics|analgesics|mesh-ancestor
92104660|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
92104661|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104662|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92104663|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92104664|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
92104665|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
92142438|NCT04142749|Oltipraz|oltipraz|mesh-list
92104666|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104667|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92104668|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92104669|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92104670|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92104671|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92104672|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92104673|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92104674|NCT03005860|Cholinergic Agents|cholinergic agents|mesh-ancestor
92104675|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104676|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92104677|NCT01593592|Amoxicillin|amoxicillin|mesh-list
92104678|NCT01593592|Clarithromycin|clarithromycin|mesh-list
92104679|NCT01593592|Omeprazole|omeprazole|mesh-list
92104680|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104681|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104682|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92104683|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104685|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104686|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104687|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92104688|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92104689|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92104690|NCT03001960|Clopidogrel|clopidogrel|mesh-list
92104691|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92104692|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92104693|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92104694|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92104695|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
92104696|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104697|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104698|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104699|NCT01593670|Decitabine|decitabine|mesh-list
92104700|NCT01593670|Interleukin-2|interleukin-2|mesh-list
92104701|NCT01593670|Vorinostat|vorinostat|mesh-list
92104702|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92104703|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
92104704|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104705|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104706|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104707|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104708|NCT01593670|Analgesics|analgesics|mesh-ancestor
92104709|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
92104710|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104711|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104712|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92104713|NCT01593748|Gemcitabine|gemcitabine|mesh-list
92104714|NCT01593748|Docetaxel|docetaxel|mesh-list
92104715|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92104716|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
92104717|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104718|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104719|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92104720|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92104721|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92104722|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
92104723|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92104724|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
92104725|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104726|NCT03005704|Aspirin|aspirin|mesh-list
92104727|NCT03005704|Ticagrelor|ticagrelor|mesh-list
92104728|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92104729|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92104730|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92104731|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92104732|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
92104733|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104734|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104735|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104736|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92104737|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92104738|NCT03005704|Analgesics|analgesics|mesh-ancestor
92104739|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
92104740|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104741|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104742|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92104743|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92104744|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92104745|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92104746|NCT03005704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104747|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
92104748|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
92104749|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92104750|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104752|NCT01595854|Ticagrelor|ticagrelor|mesh-list
92104753|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92104754|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92104755|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92104756|NCT01595854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92104757|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
92104758|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104759|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104760|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104761|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
92104762|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92104763|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
92104764|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104765|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
92104766|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
92104767|NCT01596088|Razoxane|razoxane|mesh-list
92104768|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104769|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92104770|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92104771|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92104772|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104773|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104774|NCT01596088|Protective Agents|protective agents|mesh-ancestor
92104775|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104776|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92104777|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92104778|NCT02216422|Ritonavir|ritonavir|mesh-list
92104779|NCT02216422|Ribavirin|ribavirin|mesh-list
92104780|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92104781|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92104782|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
92104783|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104784|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104785|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92104786|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92104787|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
92104788|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104789|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92104790|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92104791|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
92104792|NCT03001570|Cetuximab|cetuximab|mesh-list
92104793|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104794|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104795|NCT03005548|Morphine|morphine|mesh-list
92104796|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92104797|NCT03005548|Narcotics|narcotics|mesh-ancestor
92104798|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104799|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104800|NCT03005548|Analgesics|analgesics|mesh-ancestor
92104801|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
92104802|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104803|NCT03373266|Anesthetics|anesthetics|mesh-list
92104804|NCT03373266|Sevoflurane|sevoflurane|mesh-list
92104805|NCT03373266|Isoflurane|isoflurane|mesh-list
92104806|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104807|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104808|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92142439|NCT04142749|Antiviral Agents|antiviral agents|mesh-ancestor
92104809|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92104810|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
92104811|NCT02217904|Islatravir|islatravir|mesh-list
92104812|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
92104813|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104814|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104815|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104816|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92104817|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92104818|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92104819|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
92104820|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92104821|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
92104822|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104823|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104825|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104826|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92104827|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104828|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104830|NCT03005002|Ipilimumab|ipilimumab|mesh-list
92104831|NCT03005002|Tremelimumab|tremelimumab|mesh-list
92104832|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
92104833|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92104834|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
92104835|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92104836|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104837|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
92104838|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104839|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92104840|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104841|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
92104842|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92104843|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
92104844|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92104845|NCT03001102|Povidone|povidone|mesh-list
92104846|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104847|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
92104848|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104849|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
92104850|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
92104851|NCT03000946|Octreotide|octreotide|mesh-list
92104852|NCT03000946|Somatostatin|somatostatin|mesh-list
92104853|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104854|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92104855|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104856|NCT03000946|Hormones|hormones|mesh-ancestor
92104857|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104858|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104859|NCT03004768|Deucravacitinib|deucravacitinib|mesh-list
92104860|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104861|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92104862|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104863|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104864|NCT03005236|Tacrolimus|tacrolimus|mesh-list
92104865|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92104866|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
92104867|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104868|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92104869|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104870|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104871|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
92104872|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104873|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
92104874|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
92104875|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104876|NCT02519010|Amlodipine|amlodipine|mesh-list
92104877|NCT02519010|Valsartan|valsartan|mesh-list
92104878|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92104879|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92104880|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92104881|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92104882|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104883|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92104884|NCT02519010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104885|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
92104886|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92104887|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92104888|NCT03004612|Metformin|metformin|mesh-list
92104889|NCT03004612|Linagliptin|linagliptin|mesh-list
92104890|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104891|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104892|NCT03004612|Incretins|incretins|mesh-ancestor
92104894|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021767|NCT04589611|Amobarbital|amobarbital|mesh-list
92104895|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92104897|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104898|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104899|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
92104900|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92104901|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
92104902|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92104903|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
92104904|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104905|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104906|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
92104907|NCT03372486|Bupivacaine|bupivacaine|mesh-list
92104908|NCT03372486|Naloxone|naloxone|mesh-list
92104909|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
92104910|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
92104911|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104912|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104913|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
92104914|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104915|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92104916|NCT05035888|Phenylephrine|phenylephrine|mesh-list
92104917|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
92104918|NCT05035888|Norepinephrine|norepinephrine|mesh-list
92104919|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92104920|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92104921|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
92104922|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
92104923|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104924|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104925|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
92104926|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
92104927|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
92104928|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92104929|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92104930|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92104931|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
92104932|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92104933|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104934|NCT05035888|Protective Agents|protective agents|mesh-ancestor
92104935|NCT03362814|Ritonavir|ritonavir|mesh-list
92104936|NCT03362814|Ribavirin|ribavirin|mesh-list
92104937|NCT03362814|Lactams|lactams|mesh-list
92104938|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92104939|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92104940|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92104941|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92104942|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92104943|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92104944|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92104945|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
92104946|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104947|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92104948|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92104949|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
92104950|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104951|NCT03004066|Daptomycin|daptomycin|mesh-list
92104952|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92104953|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92104954|NCT03362736|Ustekinumab|ustekinumab|mesh-list
92104955|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
92104956|NCT03004222|Bupivacaine|bupivacaine|mesh-list
92104957|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
92104958|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
92104959|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92104960|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104961|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
92104962|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104964|NCT03000634|Lenalidomide|lenalidomide|mesh-list
92104965|NCT03000634|Bortezomib|bortezomib|mesh-list
92104966|NCT03000634|Elotuzumab|elotuzumab|mesh-list
92104967|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92104968|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
92104969|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
92104970|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92104971|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104972|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92104974|NCT03000634|Hormones|hormones|mesh-ancestor
92104975|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92104976|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92104977|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92104978|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
92104979|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92104980|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92104981|NCT03000634|Growth Substances|growth substances|mesh-ancestor
92104982|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
92104983|NCT02520102|Sargramostim|sargramostim|mesh-list
92104984|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
92104985|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104986|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92104987|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
92104988|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92104989|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92104990|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
92104991|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104992|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
92104993|NCT03000556|Protective Agents|protective agents|mesh-ancestor
92104994|NCT03371862|Liraglutide|liraglutide|mesh-list
92104995|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92104996|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92104997|NCT03371862|Incretins|incretins|mesh-ancestor
92104998|NCT03371862|Hormones|hormones|mesh-ancestor
92104999|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105000|NCT03368430|Melatonin|melatonin|mesh-list
92105001|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
92105002|NCT03368430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105003|NCT03368430|Protective Agents|protective agents|mesh-ancestor
92105004|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105005|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105006|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
92105007|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105008|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
92105009|NCT03003832|Analgesics|analgesics|mesh-list
92105010|NCT03003832|Narcotics|narcotics|mesh-ancestor
92105011|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105012|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105013|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
92105014|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105015|NCT03368352|Melatonin|melatonin|mesh-list
92105016|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
92105017|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105018|NCT03368352|Protective Agents|protective agents|mesh-ancestor
92105019|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105020|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105021|NCT02248012|Everolimus|everolimus|mesh-list
92105022|NCT02248012|Temozolomide|temozolomide|mesh-list
92105023|NCT02248012|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92105024|NCT02248012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92105025|NCT02248012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105026|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105027|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92105028|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
92105029|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105030|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105031|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92105032|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
92105034|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92105035|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92105036|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92105037|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105038|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105039|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92105040|NCT04523844|Brinzolamide|brinzolamide|mesh-list
92105041|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92105042|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92105043|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92105044|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92105045|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
92105046|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105047|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105048|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105049|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92105050|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105052|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92105053|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105055|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105056|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92105057|NCT03361800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105058|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105059|NCT02998918|Curcumin|curcumin|mesh-list
92105060|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92105061|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105062|NCT02998918|Analgesics|analgesics|mesh-ancestor
92105063|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
92105064|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105065|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105066|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105067|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105068|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105069|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105070|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105071|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
92105072|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105073|NCT02998606|Naloxegol|naloxegol|mesh-list
92105074|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92105075|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105076|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
92105077|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105078|NCT05365438|Atorvastatin|atorvastatin|mesh-list
92105079|NCT05365438|Ezetimibe|ezetimibe|mesh-list
92105080|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92105081|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92105082|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
92105083|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105084|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92105085|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92105086|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105087|NCT05264506|Estradiol|estradiol|mesh-list
92105088|NCT05264506|Estrogens|estrogens|mesh-ancestor
92105089|NCT05264506|Hormones|hormones|mesh-ancestor
92105090|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105091|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105092|NCT02248168|Pramipexole|pramipexole|mesh-list
92105093|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
92105094|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105095|NCT02248168|Protective Agents|protective agents|mesh-ancestor
92105096|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105097|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92105098|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92105099|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
92105100|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
92105101|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105102|NCT05672680|Bupivacaine|bupivacaine|mesh-list
92105103|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105104|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
92105105|NCT05672680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105106|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105107|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
92105108|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105109|NCT03002428|Teriparatide|teriparatide|mesh-list
92105110|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92105111|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105112|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105113|NCT03371550|Docetaxel|docetaxel|mesh-list
92105114|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105115|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
92105116|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
92105117|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
92105118|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105119|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
92105120|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
92105121|NCT05669872|Hematinics|hematinics|mesh-ancestor
92105122|NCT04861948|Bevacizumab|bevacizumab|mesh-list
92105123|NCT04861948|Carboplatin|carboplatin|mesh-list
92105124|NCT04861948|Pemetrexed|pemetrexed|mesh-list
92105125|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105126|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105127|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92105128|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92105129|NCT04861948|Growth Substances|growth substances|mesh-ancestor
92105130|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105131|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
92105132|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105133|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105134|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92105135|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92105136|NCT04526028|Fulvestrant|fulvestrant|mesh-list
92105137|NCT04526028|Palbociclib|palbociclib|mesh-list
92105138|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92105139|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105140|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92105141|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92105142|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
92105143|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105144|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105145|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92105146|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105147|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105148|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92105149|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105150|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
92105151|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105152|NCT03368274|Glucocorticoids|glucocorticoids|mesh-ancestor
92105153|NCT03368274|Hormones|hormones|mesh-ancestor
92105154|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105155|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105156|NCT02247544|Trabectedin|trabectedin|mesh-list
92105157|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92105158|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
92105159|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105160|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105162|NCT03370848|Psyllium|psyllium|mesh-list
92105163|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92105164|NCT03370848|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105165|NCT03370848|Analgesics|analgesics|mesh-ancestor
92105166|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
92105167|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105168|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105169|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105170|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105171|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92105172|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92105173|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105174|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92105175|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92105176|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105177|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
92105178|NCT03370848|Cathartics|cathartics|mesh-ancestor
92105179|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92105180|NCT02248792|Methotrexate|methotrexate|mesh-list
92105181|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92105182|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
92105183|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92105184|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105185|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105186|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
92105187|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105188|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105189|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
92105190|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021794|NCT05188339|Heparin|heparin|mesh-list
92105191|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92105192|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92105193|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
92105194|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105195|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92105196|NCT03367728|Ropivacaine|ropivacaine|mesh-list
92105197|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105198|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
92105199|NCT03367728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105200|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105201|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
92105202|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105203|NCT02248870|Dexamethasone|dexamethasone|mesh-list
92105204|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105205|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
92105206|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
92105207|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105208|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105209|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92105210|NCT02248870|Glucocorticoids|glucocorticoids|mesh-ancestor
92105211|NCT02248870|Hormones|hormones|mesh-ancestor
92105212|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105213|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92105214|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105215|NCT04073056|Bupivacaine|bupivacaine|mesh-list
92105216|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105217|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
92105218|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105219|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105220|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
92105221|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105222|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
92105223|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92105224|NCT03361098|Exenatide|exenatide|mesh-list
92105225|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105226|NCT03361098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92105227|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105228|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92105229|NCT03361098|Incretins|incretins|mesh-ancestor
92105230|NCT03361098|Hormones|hormones|mesh-ancestor
92105231|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105232|NCT03367494|Bromides|bromides|mesh-list
92105233|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
92105234|NCT05594290|Etoposide|etoposide|mesh-list
92105235|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105236|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92105237|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92105238|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92105239|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105240|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105241|NCT03370380|Aflibercept|aflibercept|mesh-list
92105242|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92105243|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92105244|NCT03370380|Growth Substances|growth substances|mesh-ancestor
92105245|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105246|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
92105247|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105248|NCT04414540|Metformin|metformin|mesh-list
92105249|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
92105250|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92142594|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
92105251|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105252|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105253|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105254|NCT04414540|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92105255|NCT04414540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105256|NCT05568160|Vasopressins|vasopressins|mesh-list
92105257|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
92105258|NCT05568160|Norepinephrine|norepinephrine|mesh-list
92105259|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92105260|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92105261|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
92105262|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105263|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105264|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105265|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
92063365|NCT04028518|Plasminogen|plasminogen|mesh-list
92105266|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
92105267|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105269|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
92105270|NCT05568160|Coagulants|coagulants|mesh-ancestor
92105271|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92105272|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
92105273|NCT03367182|Paclitaxel|paclitaxel|mesh-list
92105274|NCT03367182|Bevacizumab|bevacizumab|mesh-list
92105275|NCT03367182|Doxorubicin|doxorubicin|mesh-list
92105276|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92105277|NCT03367182|Topotecan|topotecan|mesh-list
92105278|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92105279|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105280|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
92105281|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
92105282|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
92105283|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105284|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105285|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92105286|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92105288|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105289|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
92105290|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92105291|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92105292|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92105293|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105294|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92105295|NCT05561764|Imipenem|imipenem|mesh-list
92105296|NCT05561764|Relebactam|relebactam|mesh-list
92105297|NCT05561764|Cilastatin|cilastatin|mesh-list
92105298|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92105299|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105300|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
92105301|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105302|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105303|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92105304|NCT04119180|Midazolam|midazolam|mesh-list
92105305|NCT04119180|Ketamine|ketamine|mesh-list
92105306|NCT04119180|Analgesics|analgesics|mesh-ancestor
92105307|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
92105308|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105309|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105310|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92105311|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92105312|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
92105313|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
92105314|NCT04119180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105315|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92105316|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92105317|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105318|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105319|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92105320|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92105321|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92105322|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92105323|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92105324|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
92105325|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
92105326|NCT03358212|Denosumab|denosumab|mesh-list
92105327|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105328|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105329|NCT03109392|Lidocaine|lidocaine|mesh-list
92105330|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105331|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
92105332|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105333|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105334|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
92105335|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105336|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92105337|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92105338|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92105339|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105340|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105341|NCT03357900|Remifentanil|remifentanil|mesh-list
92105343|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92105344|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105345|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105346|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92105347|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
92105348|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
92105349|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92105350|NCT03357900|Narcotics|narcotics|mesh-ancestor
92105351|NCT03357900|Analgesics|analgesics|mesh-ancestor
92105352|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
92105353|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105354|NCT04525326|Bevacizumab|bevacizumab|mesh-list
92105355|NCT04525326|Cetuximab|cetuximab|mesh-list
92105356|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105357|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105358|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92105359|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92105360|NCT04525326|Growth Substances|growth substances|mesh-ancestor
92105361|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105362|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
92105363|NCT03357822|Interferons|interferons|mesh-list
92105364|NCT03357822|Tenofovir|tenofovir|mesh-list
92105365|NCT03357822|Entecavir|entecavir|mesh-list
92105366|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105367|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
92105368|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105369|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92105370|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92105371|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105372|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105373|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92105374|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92105375|NCT03359694|Docetaxel|docetaxel|mesh-list
92105376|NCT03359694|Doxorubicin|doxorubicin|mesh-list
92105377|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92105378|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105379|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
92105380|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
92105381|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
92105382|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105383|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92105384|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92105385|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92105386|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105387|NCT03123276|Gemcitabine|gemcitabine|mesh-list
92105388|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
92105389|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105390|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
92105391|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105392|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105393|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105394|NCT03123276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92105395|NCT03357276|Immunomodulating Agents|immunomodulating agents|mesh-list
92105396|NCT03357276|Immunologic Factors|immunologic factors|mesh-ancestor
92105397|NCT03357276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105398|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92105399|NCT02249026|Buprenorphine|buprenorphine|mesh-list
92105400|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
92105401|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92105402|NCT02249026|Narcotics|narcotics|mesh-ancestor
92105403|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105404|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105405|NCT02249026|Analgesics|analgesics|mesh-ancestor
92105406|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
92105407|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105408|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92105410|NCT04521192|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92105411|NCT04521192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105412|NCT04521192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105413|NCT04521192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105414|NCT03359070|Miconazole|miconazole|mesh-list
92105415|NCT03359070|Clotrimazole|clotrimazole|mesh-list
92105417|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105418|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92105419|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92105420|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105421|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105422|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92105423|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
92105424|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105425|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105426|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92105427|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92105428|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92105429|NCT03366246|Lidocaine|lidocaine|mesh-list
92105430|NCT03366246|Prilocaine|prilocaine|mesh-list
92105431|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92105432|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105433|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
92105434|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105435|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105436|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
92105437|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105438|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92105439|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92105440|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92105441|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105442|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105443|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92105444|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
92105445|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
92105446|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92105447|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92105448|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105449|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92105450|NCT01623466|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92105451|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92105452|NCT03556384|Temozolomide|temozolomide|mesh-list
92105453|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92105454|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
92105455|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105456|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105457|NCT04520646|Empagliflozin|empagliflozin|mesh-list
92105458|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92105459|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105460|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92105461|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105462|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
92105463|NCT01624948|Everolimus|everolimus|mesh-list
92105464|NCT01624948|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92105465|NCT01624948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92021810|NCT02590003|Paclitaxel|paclitaxel|mesh-list
92105466|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105467|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105468|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92105469|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
92105470|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105471|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105472|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92105473|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92105474|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
92105475|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92105476|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105477|NCT04523064|Empagliflozin|empagliflozin|mesh-list
92105478|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92105479|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105480|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92105481|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105482|NCT04520880|Antibodies|antibodies|mesh-list
92105483|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
92105484|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
92105485|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
91938255|NCT03199755|Lumefantrine|lumefantrine|mesh-list
92105486|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105488|NCT03365466|Heparin|heparin|mesh-list
92063587|NCT04027348|Hormones|hormones|mesh-ancestor
92105489|NCT03365466|Calcium heparin|calcium heparin|mesh-list
92105490|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92105491|NCT03365466|Tinzaparin|tinzaparin|mesh-list
92105492|NCT03365466|Dalteparin|dalteparin|mesh-list
92105493|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92105494|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105495|NCT03365466|Analgesics|analgesics|mesh-ancestor
92105496|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
92105497|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105498|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105499|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105500|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105501|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92105502|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92105503|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105504|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92105505|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92105506|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105507|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
92105508|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
92105509|NCT03356964|Hormones|hormones|mesh-list
92105510|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92105511|NCT03356964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105512|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105513|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
92105514|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92105515|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92105516|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92105517|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105518|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105519|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
92105520|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105521|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105522|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92105523|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105524|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
92105525|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92105526|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
92105527|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105528|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
92105529|NCT03365388|Protective Agents|protective agents|mesh-ancestor
92105530|NCT03123744|Palbociclib|palbociclib|mesh-list
92105531|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105532|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92021824|NCT05474053|Ticagrelor|ticagrelor|mesh-list
92105533|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105534|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105535|NCT03358524|Vitamins|vitamins|mesh-list
92105536|NCT03358524|Vitamin E|vitamin e|mesh-list
92105537|NCT03358524|Tocopherols|tocopherols|mesh-list
92105538|NCT03358524|Tocotrienols|tocotrienols|mesh-list
92105539|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
92105540|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
92105541|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105542|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
92105543|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105544|NCT03358524|Protective Agents|protective agents|mesh-ancestor
92105545|NCT04444986|Favipiravir|favipiravir|mesh-list
92105546|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
92105547|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105548|NCT03356730|Vitamin D|vitamin d|mesh-list
92105549|NCT03356730|Vitamins|vitamins|mesh-ancestor
92105550|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
92105551|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105552|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105553|NCT03364998|Factor VIII|factor viii|mesh-list
92105554|NCT03364998|Coagulants|coagulants|mesh-ancestor
92105555|NCT04509102|Adderall|adderall|mesh-list
92105556|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92105557|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105558|NCT04508946|Thiamine|thiamine|mesh-list
92105559|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
92105560|NCT04508946|Vitamins|vitamins|mesh-ancestor
92105561|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
92105563|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105564|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
92105565|NCT03364842|Furosemide|furosemide|mesh-list
92105566|NCT03364842|Diuretics|diuretics|mesh-ancestor
92105568|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105569|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92105570|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105571|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105572|NCT03364764|Sirolimus|sirolimus|mesh-list
92105573|NCT03364764|Temsirolimus|temsirolimus|mesh-list
92105574|NCT03364764|MTOR Inhibitors|mtor inhibitors|mesh-list
92105575|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92105576|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105577|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92105578|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105579|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
92105580|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92105581|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
92105582|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105583|NCT03364764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92105584|NCT03364764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105585|NCT03364764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105586|NCT02519400|Amitriptyline|amitriptyline|mesh-list
92105587|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92105588|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
92105589|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92105590|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105591|NCT02519400|Analgesics|analgesics|mesh-ancestor
92105592|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
92105593|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105594|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105595|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92105596|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92105597|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105598|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105600|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105601|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
92105602|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
92105603|NCT04509258|Ondansetron|ondansetron|mesh-list
92105604|NCT04509258|Mineral Oil|mineral oil|mesh-list
92105605|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92105606|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
92105607|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
92105608|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105609|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105610|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92105611|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
92105612|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
92105613|NCT04509258|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92105614|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92105615|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
92105616|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105617|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105618|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
92105619|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105620|NCT04509258|Expectorants|expectorants|mesh-ancestor
92105621|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
92105622|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92105623|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
92105624|NCT04509258|Protective Agents|protective agents|mesh-ancestor
92105625|NCT04509258|Antidotes|antidotes|mesh-ancestor
92105626|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
92105627|NCT04509258|Vitamins|vitamins|mesh-ancestor
92105628|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
92105629|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
92105630|NCT04509258|Emollients|emollients|mesh-ancestor
92105631|NCT03354624|Mitogens|mitogens|mesh-list
92105632|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
92105633|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105634|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
92105635|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92105636|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
92105637|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105638|NCT03364218|Expectorants|expectorants|mesh-ancestor
92105639|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
92105640|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92105641|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
92063734|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105642|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105643|NCT03364218|Protective Agents|protective agents|mesh-ancestor
92105644|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105646|NCT04444284|Vaccines|vaccines|mesh-list
92105647|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
92105648|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105649|NCT03354312|Lidocaine|lidocaine|mesh-list
92105650|NCT03354312|Epinephrine|epinephrine|mesh-list
92105651|NCT03354312|Racepinephrine|racepinephrine|mesh-list
92105652|NCT03354312|Carticaine|carticaine|mesh-list
92105653|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
92105654|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105655|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
92105656|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105657|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105658|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
92105659|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105660|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92105661|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92105662|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92105663|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105664|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105665|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92105666|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92105667|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92105668|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105669|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92105670|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92105672|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92105673|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92105674|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
92105675|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
92105676|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92105677|NCT03363984|Midazolam|midazolam|mesh-list
92105678|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92105679|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92105680|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105681|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105682|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92105683|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92105684|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92021833|NCT05473819|Anesthetics|anesthetics|mesh-list
92105685|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92105686|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
92105687|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
92105688|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
92105689|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
92105690|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105691|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105692|NCT03355716|Fentanyl|fentanyl|mesh-list
92105693|NCT03355716|Ketamine|ketamine|mesh-list
92105694|NCT03355716|Morphine|morphine|mesh-list
92105695|NCT03355716|Bupivacaine|bupivacaine|mesh-list
92105696|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105697|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
92105698|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105699|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105700|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
92105701|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105702|NCT03355716|Analgesics|analgesics|mesh-ancestor
92105703|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92105704|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92105705|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
92105706|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92105707|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92105708|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105709|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105710|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92105711|NCT03355716|Narcotics|narcotics|mesh-ancestor
92105712|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92105713|NCT04508400|Dexamethasone|dexamethasone|mesh-list
92105714|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
92105715|NCT04508400|Ondansetron|ondansetron|mesh-list
92105716|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
92063820|NCT03021772|Hormones|hormones|mesh-ancestor
92105717|NCT04508400|Aprepitant|aprepitant|mesh-list
92105718|NCT04508400|BB 1101|bb 1101|mesh-list
92105719|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105720|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
92105721|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
92105722|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105723|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105724|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92105725|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
92105726|NCT04508400|Hormones|hormones|mesh-ancestor
92105727|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105728|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92105729|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105730|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
92105731|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105732|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105733|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
92105734|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
92105735|NCT04508400|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92105736|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92105737|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
92105738|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105739|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92105740|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
92105741|NCT03355638|Aflibercept|aflibercept|mesh-list
92105742|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92105743|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92105744|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92105745|NCT03355638|Growth Substances|growth substances|mesh-ancestor
92105746|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105747|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
92105748|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105749|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92105750|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92105751|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105752|NCT03355638|Analgesics|analgesics|mesh-ancestor
92105753|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
92105754|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105755|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105756|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105757|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
92105758|NCT01626664|Gemcitabine|gemcitabine|mesh-list
92105759|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
92105760|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
92105761|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105762|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
92105763|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105764|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105765|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
92105766|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92105767|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92105768|NCT04515966|Prednisolone|prednisolone|mesh-list
92105769|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
92105770|NCT04515966|Lidocaine|lidocaine|mesh-list
92105771|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92105772|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
92105773|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105774|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
92105775|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105776|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105777|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
92105778|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105779|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92105780|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92105781|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92105782|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105783|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105784|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105785|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
92105786|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
92105787|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92105788|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
92105789|NCT04515966|Hormones|hormones|mesh-ancestor
92105790|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92105791|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92105792|NCT04515966|Protective Agents|protective agents|mesh-ancestor
92105793|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92105794|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105795|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92105796|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92105797|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105798|NCT03355248|Acetaminophen|acetaminophen|mesh-list
92105799|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92105801|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105802|NCT03355248|Analgesics|analgesics|mesh-ancestor
92105803|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
92105804|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105805|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105806|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
92105807|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92105808|NCT03355248|Narcotics|narcotics|mesh-ancestor
92105809|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105810|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92105811|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105812|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105813|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92105814|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92105815|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92105816|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92105817|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105818|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105819|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105820|NCT03350334|Analgesics|analgesics|mesh-ancestor
92105821|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
92105822|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105823|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
92105824|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92105826|NCT02230696|Fluticasone|fluticasone|mesh-list
92105827|NCT02230696|Xhance|xhance|mesh-list
92105828|NCT02230696|Azelastine|azelastine|mesh-list
92105829|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92105830|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92105831|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
92105832|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105833|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105834|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92105835|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
92105836|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
92105837|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92105838|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92105839|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105840|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105841|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92105842|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92105843|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
92105844|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
92105845|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105846|NCT03355014|Metformin|metformin|mesh-list
92105847|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92105848|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105849|NCT02231086|Leucovorin|leucovorin|mesh-list
92105850|NCT02231086|Fluorouracil|fluorouracil|mesh-list
92105851|NCT02231086|Capecitabine|capecitabine|mesh-list
92105852|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
92105853|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
92105854|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105855|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105856|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105857|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92105858|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
92105859|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105860|NCT02231086|Antidotes|antidotes|mesh-ancestor
92105861|NCT02231086|Protective Agents|protective agents|mesh-ancestor
92105862|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
92105863|NCT02231086|Vitamins|vitamins|mesh-ancestor
92105864|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
92105865|NCT03353298|Allopurinol|allopurinol|mesh-list
92105866|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
92105867|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105868|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105869|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
92105870|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105871|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92105873|NCT03353298|Protective Agents|protective agents|mesh-ancestor
92105874|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105875|NCT02509546|Adenosine|adenosine|mesh-list
92105876|NCT02509546|Analgesics|analgesics|mesh-ancestor
92105877|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
92105878|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105879|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105880|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92105881|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
92105882|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92105883|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
92105884|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
92105885|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105886|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105887|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92105888|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105889|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105890|NCT03187210|Immunotoxins|immunotoxins|mesh-ancestor
92105891|NCT03187210|Immunoconjugates|immunoconjugates|mesh-ancestor
92105892|NCT03187210|Immunologic Factors|immunologic factors|mesh-ancestor
92105893|NCT03187210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105894|NCT03349866|Capecitabine|capecitabine|mesh-list
92105895|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
92105896|NCT03349866|Apatinib|apatinib|mesh-list
92105897|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105898|NCT03349866|Antimetabolites|antimetabolites|mesh-ancestor
92105899|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105900|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105901|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92105902|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105904|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
92105905|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105906|NCT01631656|Azelaic acid|azelaic acid|mesh-list
92105907|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105908|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
92105909|NCT02989636|Nivolumab|nivolumab|mesh-list
92105910|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92105911|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105912|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92105913|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105914|NCT02985190|Azacitidine|azacitidine|mesh-list
92105915|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105916|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
92105917|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105918|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105919|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105920|NCT01376310|Paclitaxel|paclitaxel|mesh-list
92105921|NCT01376310|Docetaxel|docetaxel|mesh-list
92105922|NCT01376310|Carboplatin|carboplatin|mesh-list
92105923|NCT01376310|Gemcitabine|gemcitabine|mesh-list
92105924|NCT01376310|Pemetrexed|pemetrexed|mesh-list
92105925|NCT01376310|Everolimus|everolimus|mesh-list
92105926|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92105927|NCT01376310|Trametinib|trametinib|mesh-list
92105928|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92105929|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92105930|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
92105931|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
92105932|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
92105933|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105934|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92105935|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
92105936|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92105937|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92105938|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92105939|NCT01376310|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92105940|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92105941|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92105942|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
92105943|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105944|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
92105945|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105946|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105947|NCT01638052|Clonidine|clonidine|mesh-list
92105948|NCT01638052|Bupivacaine|bupivacaine|mesh-list
92105949|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
92105950|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
92105951|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92105952|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105953|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
92105954|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92105955|NCT01638052|Analgesics|analgesics|mesh-ancestor
92105956|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92105957|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
92105958|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
92105959|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92105960|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92105961|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92105962|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
92105963|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92105964|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92105965|NCT02518152|Alendronate|alendronate|mesh-list
92105966|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105967|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105968|NCT01229878|Vitamin D|vitamin d|mesh-list
92105969|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
92105970|NCT01229878|Vitamins|vitamins|mesh-ancestor
92105971|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
92105972|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105973|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105974|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92105975|NCT03352674|Insulin|insulin|mesh-list
92105976|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92105977|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
92105978|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92105979|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105980|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
92105981|NCT01639222|Vitamin D|vitamin d|mesh-list
92105982|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
92105983|NCT01639222|Calcium|calcium|mesh-list
92105984|NCT01639222|Vitamins|vitamins|mesh-ancestor
92105985|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
92105986|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92105987|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92105988|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92105989|NCT04443270|Chloroquine|chloroquine|mesh-list
92105990|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92105991|NCT04443270|Amebicides|amebicides|mesh-ancestor
92105992|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92105993|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92105994|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92105995|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
92105996|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92105997|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92105998|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92105999|NCT04443270|Analgesics|analgesics|mesh-ancestor
92106000|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
92106001|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106002|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106003|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106004|NCT04443270|Filaricides|filaricides|mesh-ancestor
92106005|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
92106006|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
92106007|NCT03349008|Entecavir|entecavir|mesh-list
92106008|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92106009|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
92106010|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106011|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106012|NCT03352362|Acetaminophen|acetaminophen|mesh-list
92106013|NCT03352362|Ibuprofen|ibuprofen|mesh-list
92106014|NCT03352362|Propacetamol|propacetamol|mesh-list
92106015|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92106016|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92106017|NCT03352362|Analgesics|analgesics|mesh-ancestor
92106018|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
92106019|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106020|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064117|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92106021|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106022|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106023|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92106024|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106025|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106027|NCT01598740|Spironolactone|spironolactone|mesh-list
92106028|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92106029|NCT01598740|Hormone Antagonists|hormone antagonists|mesh-ancestor
92106030|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106031|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106032|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92106033|NCT01598740|Diuretics|diuretics|mesh-ancestor
92106034|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
92106035|NCT00709098|Iloprost|iloprost|mesh-list
92106036|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106037|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
92106038|NCT03348696|Dexamethasone|dexamethasone|mesh-list
92106039|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
92106040|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92106041|NCT03348696|BB 1101|bb 1101|mesh-list
92106042|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106044|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
92106045|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106046|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106047|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106048|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
92106049|NCT03348696|Hormones|hormones|mesh-ancestor
92106050|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106051|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106052|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106053|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
92106054|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106055|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106056|NCT04506450|Anesthetics|anesthetics|mesh-list
92106057|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106058|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106059|NCT03352128|Calcium|calcium|mesh-list
92106060|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92106061|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106062|NCT03122730|Epoprostenol|epoprostenol|mesh-list
92106063|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92106064|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106065|NCT04505904|Oxytocin|oxytocin|mesh-list
92106066|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
92106067|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92106068|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106069|NCT03348462|Anthralin|anthralin|mesh-list
92106070|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
92106071|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92106072|NCT04505514|Hematinics|hematinics|mesh-ancestor
92106073|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
92106074|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92106075|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92106076|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106077|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
92106078|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92106080|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92106081|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
92106082|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92106083|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
92106084|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92106085|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
92106086|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106087|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
92106088|NCT05585346|Hormones|hormones|mesh-ancestor
92106089|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106090|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106091|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106092|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106093|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
92106094|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
92106095|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106096|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106097|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92106098|NCT05585346|Protective Agents|protective agents|mesh-ancestor
92106099|NCT05098704|Clopidogrel|clopidogrel|mesh-list
92064250|NCT05702398|Niacin|niacin|mesh-list
92106100|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106101|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92106102|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92106104|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
92106105|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106106|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106107|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106108|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
92106109|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
92106110|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92106111|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92106112|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106113|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106114|NCT05584956|Urological Agents|urological agents|mesh-ancestor
92106115|NCT01376700|Factor VIII|factor viii|mesh-list
92106116|NCT01376700|Coagulants|coagulants|mesh-ancestor
92106117|NCT01797965|Daclizumab|daclizumab|mesh-list
92106118|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106119|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
92106120|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106121|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92106122|NCT01601236|Hormones|hormones|mesh-ancestor
92106123|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106124|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106125|NCT05584878|Chitosan|chitosan|mesh-list
92106126|NCT05584878|Calcium|calcium|mesh-list
92106127|NCT05584878|Caseins|caseins|mesh-list
92106128|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92106129|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106130|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
92106131|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
92106132|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106133|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92106134|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92106135|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
92106136|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92106137|NCT05584878|Hemostatics|hemostatics|mesh-ancestor
92106138|NCT05584878|Coagulants|coagulants|mesh-ancestor
92106139|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92106140|NCT01643902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92106141|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92106142|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106143|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
92106144|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92106145|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
92106146|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106147|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106148|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
92106149|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
92106150|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106152|NCT03347916|Analgesics|analgesics|mesh-ancestor
92106153|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
92106154|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106155|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106156|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
92106157|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92106158|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92106159|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106160|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92106161|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92106162|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92106163|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106164|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106165|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
92106166|NCT05584644|Palbociclib|palbociclib|mesh-list
92106167|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106168|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92106169|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106170|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106171|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92106172|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92106173|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92106174|NCT04892706|Analgesics|analgesics|mesh-ancestor
92106175|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
92106176|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106177|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106178|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106179|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106180|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92106181|NCT01821677|Danazol|danazol|mesh-list
92106182|NCT01821677|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92106183|NCT01821677|Hormone Antagonists|hormone antagonists|mesh-ancestor
92106184|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106185|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106186|NCT03347760|Octreotide|octreotide|mesh-list
92106187|NCT03347760|Edotreotide|edotreotide|mesh-list
92106188|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92106189|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106190|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106191|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106192|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106193|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
92106194|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106195|NCT00709722|Gusperimus|gusperimus|mesh-list
92106196|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92106197|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106198|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92106199|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106200|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106201|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
92106202|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92106203|NCT00709722|Protective Agents|protective agents|mesh-ancestor
92106204|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92106205|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
92106206|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92106207|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92106208|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92106209|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106210|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
92106211|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92106212|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92106213|NCT02378298|Prednisolone|prednisolone|mesh-list
92106214|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
92106215|NCT02378298|Rituximab|rituximab|mesh-list
92106216|NCT02378298|Methotrexate|methotrexate|mesh-list
92106217|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92106218|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
92106219|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92106220|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106221|NCT02378298|Immunologic Factors|immunologic factors|mesh-ancestor
92106222|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106223|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106224|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92106225|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
92106226|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92106227|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92106228|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
92106229|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106230|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
92106231|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106232|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92106233|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106234|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92106235|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106237|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
92106238|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106239|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106240|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
92106241|NCT02378298|Hormones|hormones|mesh-ancestor
92106242|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106243|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92106244|NCT02378298|Protective Agents|protective agents|mesh-ancestor
92106245|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106246|NCT02253108|Everolimus|everolimus|mesh-list
92106248|NCT02253108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92106249|NCT02253108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106250|NCT02253108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106251|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106252|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
92106253|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106254|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106255|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
92106256|NCT01603420|Docetaxel|docetaxel|mesh-list
92106257|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
92106258|NCT01603420|Hormones|hormones|mesh-list
92106259|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92106260|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92106261|NCT01603420|Androgens|androgens|mesh-list
92106262|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106263|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92106264|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92106265|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92106266|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106267|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106268|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106270|NCT01603420|Protective Agents|protective agents|mesh-ancestor
92106271|NCT01603420|Vitamins|vitamins|mesh-ancestor
92106272|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
92106273|NCT01603420|Estrogens|estrogens|mesh-ancestor
92106274|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106275|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
92106276|NCT02064036|Leuprolide|leuprolide|mesh-list
92106277|NCT02064036|Goserelin|goserelin|mesh-list
92106278|NCT02064036|Bicalutamide|bicalutamide|mesh-list
92106279|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92106280|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
92106281|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92106282|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106283|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106284|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106285|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
92106286|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
92106287|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021897|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
92106289|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92106290|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106291|NCT04551300|Sevelamer|sevelamer|mesh-list
92106292|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
92106293|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
92106294|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106295|NCT04974580|Nicotine|nicotine|mesh-list
92106296|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92106297|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
92106298|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106299|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106300|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92106301|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92106302|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106303|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106304|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106305|NCT01691326|Vaccines|vaccines|mesh-list
92106306|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
92106307|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106308|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
92106309|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92106310|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106311|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106312|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92106313|NCT01606852|Analgesics|analgesics|mesh-ancestor
92106314|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
92106315|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106316|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92106317|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92106318|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92106319|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
92106320|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064413|NCT03583138|Analgesics|analgesics|mesh-ancestor
92106321|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106322|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
92106323|NCT01691560|Listerine|listerine|mesh-list
92106324|NCT01691560|Calcium|calcium|mesh-list
92106325|NCT01691560|Fluorides|fluorides|mesh-list
92106326|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
92106327|NCT01691560|Fluorophosphate|fluorophosphate|mesh-list
92106328|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92106329|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106330|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92106331|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
92106332|NCT01691560|Protective Agents|protective agents|mesh-ancestor
92106333|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92106334|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106336|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92106337|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
92106338|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106339|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106340|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92106341|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106342|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92106343|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92106344|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92106345|NCT01692340|Lycopene|lycopene|mesh-list
92106346|NCT01692340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106347|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
92106348|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106349|NCT01692340|Protective Agents|protective agents|mesh-ancestor
92142672|NCT04930458|Calcium|calcium|mesh-list
92106350|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106351|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92106352|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92106353|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106354|NCT02517372|Pemirolast|pemirolast|mesh-list
92106355|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
92106356|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
92106357|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106358|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106359|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106361|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92106362|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92106363|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92106364|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92106365|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
92106366|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106367|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92106368|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92106369|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106370|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92106371|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92106372|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92106373|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
92106374|NCT01650298|Thrombin|thrombin|mesh-list
92106376|NCT01650298|Coagulants|coagulants|mesh-ancestor
92106377|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
92106378|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92106379|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
92106380|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106381|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106382|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
92106383|NCT05583006|Tenofovir|tenofovir|mesh-list
92106384|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
92106385|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106386|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92106387|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92106388|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106389|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106390|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92106391|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92106392|NCT01795937|Itraconazole|itraconazole|mesh-list
92106393|NCT01795937|Atorvastatin|atorvastatin|mesh-list
92106394|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92106395|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92106396|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92106398|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106399|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92106400|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92106401|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106402|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
92106403|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106404|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92106405|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92106406|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92106407|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
92106408|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106409|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106410|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92106411|NCT04501224|Tenofovir|tenofovir|mesh-list
92106412|NCT04501224|Entecavir|entecavir|mesh-list
92106413|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
92106414|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106415|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92106416|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92106417|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106418|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106419|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92106420|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92106421|NCT01817777|Metformin|metformin|mesh-list
92106422|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92106423|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106424|NCT01795547|Aripiprazole|aripiprazole|mesh-list
92106425|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92106426|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
92106427|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92106428|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92106429|NCT01795547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92106430|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021921|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92106431|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106432|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
92106433|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
92106434|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106435|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106436|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92106437|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92106438|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
92106439|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92106440|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92106441|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92106442|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92106444|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92106445|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106446|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106447|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106448|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106449|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106450|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92106451|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
91938273|NCT02327793|Labetalol|labetalol|mesh-list
92106452|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106453|NCT03863184|Rituximab|rituximab|mesh-list
92106454|NCT03863184|Lenalidomide|lenalidomide|mesh-list
92106455|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
92106456|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92106457|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106458|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
92106459|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106460|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106461|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92106462|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92106463|NCT03863184|Growth Substances|growth substances|mesh-ancestor
92106464|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
92106465|NCT02516904|Rezafungin|rezafungin|mesh-list
92106466|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
92106467|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106468|NCT01794845|Docetaxel|docetaxel|mesh-list
92106469|NCT01794845|Cetuximab|cetuximab|mesh-list
92106470|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106471|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92106472|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
92106473|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92106474|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106475|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92106477|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92106478|NCT01794689|Narcotics|narcotics|mesh-ancestor
92106479|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106480|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106481|NCT01794689|Analgesics|analgesics|mesh-ancestor
92106482|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
92106483|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106484|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
92106485|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92106486|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92106487|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106488|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
92106489|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
92106490|NCT00708552|Donepezil|donepezil|mesh-list
92106491|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92106492|NCT00708552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017878|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
92106493|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106494|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106495|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106496|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106497|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
92106498|NCT02516436|Buprenorphine|buprenorphine|mesh-list
92106499|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92106500|NCT02516436|Narcotics|narcotics|mesh-ancestor
92106501|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106502|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106503|NCT02516436|Analgesics|analgesics|mesh-ancestor
92106504|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
92106505|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106506|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92106507|NCT03347526|Vigabatrin|vigabatrin|mesh-list
92106508|NCT03347526|Cosyntropin|cosyntropin|mesh-list
92106509|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
92106510|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106511|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106512|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
92106513|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106514|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106515|NCT03347526|Hormones|hormones|mesh-ancestor
92106516|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106517|NCT03347370|Interferons|interferons|mesh-list
92106518|NCT03347370|Interferon-beta|interferon-beta|mesh-list
92106519|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
92106520|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
92106521|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106522|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
92106523|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106524|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
92106525|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106526|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92106527|NCT02515968|Propofol|propofol|mesh-list
92106528|NCT02515968|Desflurane|desflurane|mesh-list
92106529|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92106530|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106531|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106532|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92106533|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
92106534|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
92106535|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92106536|NCT03345966|Antibodies|antibodies|mesh-list
92106537|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
92106538|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106539|NCT02507700|Bupivacaine|bupivacaine|mesh-list
92106540|NCT02507700|Sevoflurane|sevoflurane|mesh-list
92106541|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
92106542|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
92106543|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106544|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022009|NCT02385669|Ipilimumab|ipilimumab|mesh-list
92106545|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
92022650|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92024300|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106546|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106547|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106548|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92106549|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
92106550|NCT02513004|Clopidogrel|clopidogrel|mesh-list
92106552|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106553|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92106554|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92106555|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92106556|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
92106557|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106558|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106559|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106560|NCT04500522|Isoniazid|isoniazid|mesh-list
92026481|NCT05470673|Metronidazole|metronidazole|mesh-list
92106561|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
92106562|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92106563|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106564|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92106565|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92106566|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
92106567|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106568|NCT04500522|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92106569|NCT02507232|Temozolomide|temozolomide|mesh-list
92028368|NCT02357901|Buprenorphine|buprenorphine|mesh-list
92106570|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92106571|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
92106572|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106573|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106574|NCT02506998|Histamine|histamine|mesh-list
92106575|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
92106576|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92106577|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
92106578|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
92106579|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
92106580|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106581|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106582|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106583|NCT02507076|Melphalan|melphalan|mesh-list
92106584|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92106585|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
92030780|NCT04776369|Lidocaine|lidocaine|mesh-list
92106586|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106587|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106588|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92106589|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106590|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
92106591|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106592|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92031995|NCT02188719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92106593|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92106594|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92106595|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92106596|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106597|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106598|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106599|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92106600|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92106602|NCT04500678|Metformin|metformin|mesh-list
92106603|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92106604|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106605|NCT02507154|Cetuximab|cetuximab|mesh-list
92106606|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92106607|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106609|NCT02515734|Bevacizumab|bevacizumab|mesh-list
92106610|NCT02515734|Cetuximab|cetuximab|mesh-list
92106611|NCT02515734|Fluorouracil|fluorouracil|mesh-list
92106612|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
92106613|NCT02515734|Irinotecan|irinotecan|mesh-list
92106614|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92106615|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106616|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92106617|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92106618|NCT02515734|Growth Substances|growth substances|mesh-ancestor
92106619|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106620|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
92106621|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
92106622|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039218|NCT01983969|Gemcitabine|gemcitabine|mesh-list
92106623|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92106624|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106625|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
92106626|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92106627|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92106628|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106629|NCT02515734|Antidotes|antidotes|mesh-ancestor
92106630|NCT02515734|Protective Agents|protective agents|mesh-ancestor
92106631|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
92106632|NCT02515734|Vitamins|vitamins|mesh-ancestor
92106633|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
92106634|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
92106635|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92106637|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92043090|NCT01749982|Choline|choline|mesh-list
92106638|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92106639|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106640|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106641|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106642|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106643|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92106644|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106645|NCT02506842|Leucovorin|leucovorin|mesh-list
92106646|NCT02506842|Folic Acid|folic acid|mesh-list
92106647|NCT02506842|Gemcitabine|gemcitabine|mesh-list
92106648|NCT02506842|Fluorouracil|fluorouracil|mesh-list
92106649|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
92106650|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
92106651|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106652|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106653|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92106654|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
92106655|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106656|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
92106657|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106658|NCT02506842|Antidotes|antidotes|mesh-ancestor
92106659|NCT02506842|Protective Agents|protective agents|mesh-ancestor
92106660|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
92106661|NCT02506842|Vitamins|vitamins|mesh-ancestor
92106663|NCT02506842|Hematinics|hematinics|mesh-ancestor
92106664|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
92106665|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92106666|NCT03345498|Entecavir|entecavir|mesh-list
92106667|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
92106668|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106669|NCT02506686|Meropenem|meropenem|mesh-list
92049694|NCT02206685|Methadone|methadone|mesh-list
92106670|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92106671|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106672|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92106673|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92106674|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106676|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
92106677|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106678|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
92106679|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
92106680|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
92106681|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106682|NCT04497792|Metformin|metformin|mesh-list
92106683|NCT04497792|Empagliflozin|empagliflozin|mesh-list
92106684|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92106685|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106686|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92106687|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106688|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
92106689|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92106690|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92106691|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92106692|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92106693|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106694|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106695|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106696|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106697|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92106699|NCT02515422|Ketamine|ketamine|mesh-list
92106700|NCT02515422|Bupivacaine|bupivacaine|mesh-list
92106701|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
92106702|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
92106703|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106704|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106706|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106707|NCT02515422|Analgesics|analgesics|mesh-ancestor
92106708|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92106709|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92017889|NCT03057145|Olaparib|olaparib|mesh-list
92106710|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
92106711|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92106712|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92106713|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106714|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106715|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92106716|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
92106717|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106718|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106719|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92106720|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106721|NCT02506140|Aspirin|aspirin|mesh-list
92106722|NCT02506140|Clopidogrel|clopidogrel|mesh-list
92106723|NCT02506140|Ticagrelor|ticagrelor|mesh-list
92106724|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92106725|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92106726|NCT02506140|Analgesics|analgesics|mesh-ancestor
92058714|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
92106727|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
92106728|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106729|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106730|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106731|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106732|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92106733|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92106734|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106735|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106736|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92106737|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106738|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
92106739|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92106740|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92106741|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92106742|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
92106743|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106744|NCT02515188|Acetaminophen|acetaminophen|mesh-list
92106745|NCT02515188|Propacetamol|propacetamol|mesh-list
92106746|NCT02515188|Analgesics|analgesics|mesh-ancestor
92106747|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
92106748|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106749|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106750|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92106751|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92106752|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92106753|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106754|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
92106755|NCT01696084|Cytarabine|cytarabine|mesh-list
92106756|NCT01696084|Daunorubicin|daunorubicin|mesh-list
92106757|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92106758|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
92106759|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106760|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106761|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
92106762|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106763|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106764|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
92106765|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106766|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92106767|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92106768|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92106769|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106770|NCT02228824|Nicotine|nicotine|mesh-list
92106771|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92106772|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
92106773|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106774|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106775|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92106776|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92106777|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106778|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017896|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
92068002|NCT05839366|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92106779|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106780|NCT02511366|Caseins|caseins|mesh-list
92106781|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
92106782|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
92106783|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106784|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
92106785|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92106786|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106788|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92069648|NCT00637000|Naloxone|naloxone|mesh-list
92106789|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92106790|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070684|NCT03824314|GABA Modulators|gaba modulators|mesh-ancestor
92106791|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
92106792|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
92106793|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
92106794|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106795|NCT01653418|Cytarabine|cytarabine|mesh-list
92106796|NCT01653418|Etoposide|etoposide|mesh-list
92106797|NCT01653418|Bortezomib|bortezomib|mesh-list
92106798|NCT01653418|Melphalan|melphalan|mesh-list
92106799|NCT01653418|Carmustine|carmustine|mesh-list
92106800|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92106801|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106802|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92106803|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92106805|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106806|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92106807|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
92074850|NCT00193258|Bevacizumab|bevacizumab|mesh-list
92106808|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
92106809|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106810|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92106811|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
92106813|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92106814|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
92106815|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92106817|NCT02514642|Ticagrelor|ticagrelor|mesh-list
92106818|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106819|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92106820|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92106821|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92106822|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
92106823|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078843|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106824|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106825|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106826|NCT02511210|Anesthetics|anesthetics|mesh-list
92106827|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106828|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106829|NCT02237950|Metronidazole|metronidazole|mesh-list
92106830|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106831|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92106832|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92106833|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92106834|NCT02511054|Chloroquine|chloroquine|mesh-list
92106835|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
92106836|NCT02511054|Amebicides|amebicides|mesh-ancestor
92106837|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92106838|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92106839|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106840|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
92106841|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92106842|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92106843|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081736|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92106844|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106846|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92106847|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92106848|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106849|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92106850|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92106851|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92106852|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106853|NCT01612546|Camptothecin|camptothecin|mesh-list
92106854|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92106855|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106856|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92106857|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92106858|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106859|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106860|NCT04499898|Carvedilol|carvedilol|mesh-list
92106861|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92106862|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92106863|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
92106864|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106865|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106866|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106867|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92106869|NCT04499898|Protective Agents|protective agents|mesh-ancestor
92106870|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92106871|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92106872|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92106873|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
92106874|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92106875|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92087954|NCT01751113|Xhance|xhance|mesh-list
92106876|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
92106877|NCT02514330|Vitamins|vitamins|mesh-ancestor
92106878|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
92106879|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106880|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92106881|NCT02510976|Prucalopride|prucalopride|mesh-list
92106882|NCT02510976|Laxatives|laxatives|mesh-ancestor
92106883|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106884|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92106885|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92106887|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106888|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106889|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106890|NCT02505516|Metformin|metformin|mesh-list
92106891|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92106892|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106893|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
92106894|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92106895|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
92106896|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106898|NCT02505360|Protective Agents|protective agents|mesh-ancestor
92106900|NCT04499586|Raltitrexed|raltitrexed|mesh-list
92106901|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92106902|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92106903|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106904|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106905|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106906|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92106907|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
92106908|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92106911|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
92106912|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106913|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92106914|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92106915|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106917|NCT02505282|Coagulants|coagulants|mesh-ancestor
92106918|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
92106919|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92106920|NCT01816295|Testosterone|testosterone|mesh-list
92106921|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
92106922|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
92065016|NCT04764916|Bupivacaine|bupivacaine|mesh-list
92106923|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92106924|NCT01816295|Androgens|androgens|mesh-ancestor
92106925|NCT01816295|Hormones|hormones|mesh-ancestor
92093082|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106926|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92106927|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106928|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92093994|NCT03422523|Antimetabolites|antimetabolites|mesh-ancestor
92106929|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106930|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
92106931|NCT02514018|Vaccines|vaccines|mesh-list
92106932|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
92106933|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106934|NCT02513862|Heparin|heparin|mesh-list
92106935|NCT02513862|Protamines|protamines|mesh-list
92106936|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
92106937|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92106938|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92106939|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106940|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
92106941|NCT02513862|Coagulants|coagulants|mesh-ancestor
92106943|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92106944|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92106945|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
92106946|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
92095731|NCT00992602|Cytarabine|cytarabine|mesh-list
92106947|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92106948|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106949|NCT01610297|Deferasirox|deferasirox|mesh-list
92106950|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92106951|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
92106953|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106954|NCT01660672|Levetiracetam|levetiracetam|mesh-list
92106955|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
92106956|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
92106957|NCT02505048|Rucaparib|rucaparib|mesh-list
92106958|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92106959|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92106960|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106961|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92106962|NCT01793051|Minocycline|minocycline|mesh-list
92106963|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92106964|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92106965|NCT01792115|Vitamins|vitamins|mesh-list
92106966|NCT01792115|Vitamin E|vitamin e|mesh-list
92106967|NCT01792115|Tocopherols|tocopherols|mesh-list
92106968|NCT01792115|Tocotrienols|tocotrienols|mesh-list
92106969|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
92106970|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
92106971|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106972|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
92106973|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106974|NCT01792115|Protective Agents|protective agents|mesh-ancestor
92106975|NCT01791803|Nicotine|nicotine|mesh-list
92106976|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92106977|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
92106978|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92106979|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106981|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92106982|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
92106983|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92106984|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92106985|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92106987|NCT01662856|Coagulants|coagulants|mesh-ancestor
92106988|NCT04499976|Misoprostol|misoprostol|mesh-list
92106989|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92106990|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
92106991|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92106992|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92106993|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92106994|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92106995|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
92106996|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92106997|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
92106998|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92106999|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92107000|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92107001|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
92107002|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92107003|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107004|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92107005|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92107006|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92107007|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92107008|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107009|NCT02509806|Apatinib|apatinib|mesh-list
92107010|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107011|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92107012|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107013|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107015|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
92107016|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92107017|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
92107018|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107019|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107020|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92107021|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
92107022|NCT02501616|Metformin|metformin|mesh-list
92107023|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
92107024|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107025|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107026|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92107027|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107028|NCT01788215|Doxycycline|doxycycline|mesh-list
92107029|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92107030|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107031|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
92107032|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92107033|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92107034|NCT01812707|Atorvastatin|atorvastatin|mesh-list
92107035|NCT01812707|Alirocumab|alirocumab|mesh-list
92107036|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92107037|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92107038|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92107039|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
92107040|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107041|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92107042|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92107043|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107044|NCT01812707|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92107045|NCT01812707|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92107046|NCT01812707|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107047|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
92107048|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107049|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92107050|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
92107051|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107053|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92107055|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
92107056|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107057|NCT01811225|Progesterone|progesterone|mesh-list
92107058|NCT01811225|Progestins|progestins|mesh-ancestor
92107059|NCT01811225|Hormones|hormones|mesh-ancestor
92107060|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107061|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107062|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92107063|NCT02508870|Azacitidine|azacitidine|mesh-list
92107064|NCT02508870|Atezolizumab|atezolizumab|mesh-list
92107065|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92107066|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
92107067|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107068|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107069|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107070|NCT02508870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92107071|NCT02508870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92107072|NCT01786109|Dronabinol|dronabinol|mesh-list
92107073|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
92107074|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107075|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107076|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92107078|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
92107079|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107080|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92107081|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92107082|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107083|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107085|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107086|NCT02509104|Tamsulosin|tamsulosin|mesh-list
92107087|NCT02509104|Dutasteride|dutasteride|mesh-list
92107088|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92107089|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92107091|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92107092|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107093|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107094|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107095|NCT02509104|Urological Agents|urological agents|mesh-ancestor
92107096|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92107097|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92107098|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107099|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
92107100|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107101|NCT02500680|Vaccines|vaccines|mesh-list
92107102|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
92107103|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107104|NCT02500446|Dolutegravir|dolutegravir|mesh-list
92107105|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92107106|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92107107|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107108|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107109|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107110|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107111|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
92107112|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107113|NCT02500524|Permethrin|permethrin|mesh-list
92107114|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107115|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107116|NCT02508402|Dexamethasone|dexamethasone|mesh-list
92107117|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107118|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
92107119|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
92107120|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107121|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107122|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107123|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
92107124|NCT02508402|Hormones|hormones|mesh-ancestor
92107125|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107126|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92107127|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107129|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92107130|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
92107131|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107132|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92107133|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107134|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107135|NCT02508168|Metformin|metformin|mesh-list
92107136|NCT02508168|Alogliptin|alogliptin|mesh-list
92107137|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107138|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107139|NCT02508168|Incretins|incretins|mesh-ancestor
92107140|NCT02508168|Hormones|hormones|mesh-ancestor
92107141|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107142|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92107143|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107144|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107145|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107146|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92107147|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92107148|NCT02508246|Cisplatin|cisplatin|mesh-list
92107149|NCT02508246|Docetaxel|docetaxel|mesh-list
92107150|NCT02508246|Adavosertib|adavosertib|mesh-list
92107152|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
92107153|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
92107154|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017909|NCT04939675|Levetiracetam|levetiracetam|mesh-list
92107155|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107156|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107157|NCT01617148|Aflibercept|aflibercept|mesh-list
92107158|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92107159|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92107160|NCT01617148|Growth Substances|growth substances|mesh-ancestor
92107161|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107162|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
92107163|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107164|NCT02499978|Dolutegravir|dolutegravir|mesh-list
92107165|NCT02499978|Darunavir|darunavir|mesh-list
92107166|NCT02499978|Cobicistat|cobicistat|mesh-list
92107167|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92096605|NCT01064830|Cyclosporine|cyclosporine|mesh-list
92107168|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92107169|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92107170|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107171|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107172|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107173|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107174|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
92107175|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107176|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92107177|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92107178|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107179|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92097129|NCT00636441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92107181|NCT01620190|Paclitaxel|paclitaxel|mesh-list
92107182|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92107183|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92107184|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107185|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92107186|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92107187|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92107188|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107189|NCT04498884|Insulin|insulin|mesh-list
92107190|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92107191|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107192|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107193|NCT01621672|Lenalidomide|lenalidomide|mesh-list
92107194|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
92107195|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098557|NCT01155154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107196|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92098681|NCT01206478|Megestrol|megestrol|mesh-list
92107197|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92107198|NCT01621672|Growth Substances|growth substances|mesh-ancestor
92107199|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92107200|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107201|NCT03344328|Bortezomib|bortezomib|mesh-list
92107202|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107203|NCT02499822|Ramipril|ramipril|mesh-list
92107204|NCT02499822|Nifedipine|nifedipine|mesh-list
92107205|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92107206|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107207|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107208|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107209|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92107210|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92107211|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92107212|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92107213|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107214|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
92107215|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
92107216|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92107217|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
92107218|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107219|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92107220|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92107221|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107222|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107223|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
92107225|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
92107226|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107227|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107228|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
92107229|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107230|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92107231|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
92107232|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92107233|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92107234|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107235|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92107236|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
92107237|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92107238|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
92107239|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92107240|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
92107241|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107242|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
92107243|NCT02507934|Protective Agents|protective agents|mesh-ancestor
92107244|NCT01622296|Lidocaine|lidocaine|mesh-list
92107245|NCT01622296|Epinephrine|epinephrine|mesh-list
92107246|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
92107247|NCT01622296|Anesthetics|anesthetics|mesh-list
92107248|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107249|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107251|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107252|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92107253|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92107254|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92107255|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92107256|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107257|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92107258|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92107259|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92107260|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107261|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92107262|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92107263|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
92107264|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92107265|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
92107266|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
92107267|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
92107268|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92107269|NCT02728830|Pembrolizumab|pembrolizumab|mesh-list
92107270|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92107271|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107272|NCT02728830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92107273|NCT02728830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107274|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92107275|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92107276|NCT01705288|Morphine|morphine|mesh-list
92107277|NCT01705288|Narcotics|narcotics|mesh-list
92107278|NCT01705288|Anesthetics|anesthetics|mesh-list
92107279|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107280|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107281|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92107282|NCT01705288|Analgesics|analgesics|mesh-ancestor
92107283|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
92107284|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107285|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92107286|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92107287|NCT03343002|Fentanyl|fentanyl|mesh-list
92107288|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92107289|NCT03343002|Narcotics|narcotics|mesh-ancestor
92107290|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107291|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107292|NCT03343002|Analgesics|analgesics|mesh-ancestor
92107293|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
92107294|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107295|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92107296|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92107297|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
92107298|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
92107299|NCT03120936|Tenofovir|tenofovir|mesh-list
92107300|NCT03120936|Emtricitabine|emtricitabine|mesh-list
92065388|NCT03807856|Dabigatran|dabigatran|mesh-list
92107301|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
92107302|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107303|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92107304|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92107305|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107306|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107307|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107308|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107309|NCT02234752|Memantine|memantine|mesh-list
92107310|NCT02234752|Galantamine|galantamine|mesh-list
92107311|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92107312|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92107313|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
92107314|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107315|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107316|NCT02234752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107317|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92107318|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92107319|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92107320|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107321|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
92107322|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92107323|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
92107324|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107325|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
92107326|NCT01665508|Nebivolol|nebivolol|mesh-list
92107327|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92107328|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
92107329|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92107330|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92107331|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92107332|NCT01665508|Adrenergic Agents|adrenergic agents|mesh-ancestor
92107333|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107334|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107335|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107336|NCT03344094|Interferons|interferons|mesh-list
92107337|NCT03344094|Interferon-beta|interferon-beta|mesh-list
92107338|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
92107339|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107340|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
92107341|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107342|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
92107343|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107344|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
92107345|NCT02498496|Analgesics|analgesics|mesh-ancestor
92107346|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
92107347|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107348|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107349|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
92107350|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107351|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92107352|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
92107353|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92107354|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92107355|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107356|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92107357|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
92107358|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92107359|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
92107360|NCT02502708|Temozolomide|temozolomide|mesh-list
92107361|NCT02502708|Etoposide|etoposide|mesh-list
92107362|NCT02502708|Tryptophan|tryptophan|mesh-list
92107363|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92107364|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
92107365|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107366|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92107367|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92107368|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
92107369|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107370|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107371|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92107372|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92107373|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92107374|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92107375|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107376|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92107377|NCT02502708|Antidepressive Agents|antidepressive agents|mesh-ancestor
92107378|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107379|NCT01666210|Dexamethasone|dexamethasone|mesh-list
92107380|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107381|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
92107382|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
92107383|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107384|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107385|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107386|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
92107387|NCT01666210|Hormones|hormones|mesh-ancestor
92107388|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107389|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92107390|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107391|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
92107392|NCT01666912|Etonogestrel|etonogestrel|mesh-list
92107393|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92107394|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107395|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92107396|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92107397|NCT03341988|Ritonavir|ritonavir|mesh-list
92107398|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92107399|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92107400|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107401|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107402|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107403|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107404|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107405|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
92107406|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107407|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92107408|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92107409|NCT02501850|Metformin|metformin|mesh-list
92107410|NCT02501850|Liraglutide|liraglutide|mesh-list
92107411|NCT02501850|Exenatide|exenatide|mesh-list
92107412|NCT02501850|Lixisenatide|lixisenatide|mesh-list
92107413|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107414|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107416|NCT02501850|Hormones|hormones|mesh-ancestor
92107417|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107418|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92107419|NCT01709032|Deferasirox|deferasirox|mesh-list
92107420|NCT01709032|Deferiprone|deferiprone|mesh-list
92107421|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92107422|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
92107423|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
92107424|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107425|NCT02496078|Asunaprevir|asunaprevir|mesh-list
92107426|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107427|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107428|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107429|NCT02495922|Dexamethasone|dexamethasone|mesh-list
92107430|NCT02495922|Lenalidomide|lenalidomide|mesh-list
92107431|NCT02495922|Bortezomib|bortezomib|mesh-list
92107432|NCT02495922|Elotuzumab|elotuzumab|mesh-list
92107433|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107434|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
92107435|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
92107436|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107437|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107438|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107439|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
92107440|NCT02495922|Hormones|hormones|mesh-ancestor
92107441|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107442|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92107443|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107444|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
92107445|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92107446|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92107447|NCT02495922|Growth Substances|growth substances|mesh-ancestor
92107448|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
92065540|NCT00779116|Cetirizine|cetirizine|mesh-list
92107449|NCT01709422|Midazolam|midazolam|mesh-list
92107450|NCT01709422|Meperidine|meperidine|mesh-list
92107451|NCT01709422|Propofol|propofol|mesh-list
92107452|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92107453|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107454|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107455|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92107456|NCT01709422|Anesthetics, General|anesthetics, general|mesh-ancestor
92107457|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
92107458|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92107459|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92107460|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92107461|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107462|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
92107463|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
92107464|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107465|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107466|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92107467|NCT01709422|Narcotics|narcotics|mesh-ancestor
92107468|NCT01709422|Analgesics|analgesics|mesh-ancestor
92107469|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
92107470|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107472|NCT01669642|Analgesics|analgesics|mesh-ancestor
92107473|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
92107474|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107475|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107477|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92107478|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
92107479|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
92107480|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107481|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92107482|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92107483|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107484|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107485|NCT01669720|Aflibercept|aflibercept|mesh-list
92107486|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92107487|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92107488|NCT01669720|Growth Substances|growth substances|mesh-ancestor
92107489|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107490|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
92107491|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107492|NCT01670110|Pasireotide|pasireotide|mesh-list
92107493|NCT01670110|Hormones|hormones|mesh-ancestor
92107494|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107495|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107496|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92107497|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92107498|NCT01677286|Doxycycline|doxycycline|mesh-list
92107499|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92107500|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107502|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92107503|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92107504|NCT04498260|Triamcinolone|triamcinolone|mesh-list
92107505|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92107506|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92107507|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92107508|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107509|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
92107510|NCT04498260|Hormones|hormones|mesh-ancestor
92107511|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107512|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107513|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92107514|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
92107515|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107516|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107517|NCT01680172|Ketamine|ketamine|mesh-list
92107518|NCT01680172|Analgesics|analgesics|mesh-ancestor
92107519|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
92107520|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107521|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107522|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92107523|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92107524|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
92107525|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
92107526|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107527|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92107528|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92107529|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107530|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107531|NCT02235064|Sertraline|sertraline|mesh-list
92107532|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
92107533|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107534|NCT02235064|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92107535|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92107536|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92107537|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107538|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107539|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
92107540|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107541|NCT05118490|Isoniazid|isoniazid|mesh-list
92107542|NCT05118490|Rifapentine|rifapentine|mesh-list
92107543|NCT05118490|Rifampin|rifampin|mesh-list
92107544|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
92107545|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92107546|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107547|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92107548|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92107549|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
92107550|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107551|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92107552|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92107553|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
92107554|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92107555|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107556|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92107557|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92107558|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92107559|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92107560|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92107561|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92107562|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92107563|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
92107564|NCT01681030|Coagulants|coagulants|mesh-ancestor
92107565|NCT02249416|Ritonavir|ritonavir|mesh-list
92107566|NCT02249416|Zidovudine|zidovudine|mesh-list
92107567|NCT02249416|Tipranavir|tipranavir|mesh-list
92107568|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92107569|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92107570|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107571|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107572|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107573|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107574|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107575|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
92107576|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107577|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92107578|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92107579|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
92107580|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92107581|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92107582|NCT01685242|Cetirizine|cetirizine|mesh-list
92107583|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92107584|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92107585|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92107586|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
92107587|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
92107588|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107589|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107590|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107591|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
92107592|NCT00708162|Elvitegravir|elvitegravir|mesh-list
92107593|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107594|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107595|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
92107596|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107597|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92107598|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92107599|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107600|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065685|NCT03772834|Methylphenidate|methylphenidate|mesh-list
92107601|NCT04930042|Ustekinumab|ustekinumab|mesh-list
92107602|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
92107603|NCT04898920|Dexamethasone|dexamethasone|mesh-list
92107604|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107605|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
92107606|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
92107607|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107608|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107609|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107610|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
92107611|NCT04898920|Hormones|hormones|mesh-ancestor
92107612|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107613|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92107614|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107615|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
92107616|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92107617|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107618|NCT01686646|Acetaminophen|acetaminophen|mesh-list
92107619|NCT01686646|Caffeine|caffeine|mesh-list
92107620|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92107621|NCT01686646|Analgesics|analgesics|mesh-ancestor
92107622|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
92107623|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107624|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107625|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
92107626|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92107627|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92107628|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107629|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107630|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92107631|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92107632|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
92107633|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107634|NCT02495688|Anesthetics|anesthetics|mesh-list
92107635|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107636|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107637|NCT01688596|Bupivacaine|bupivacaine|mesh-list
92107638|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
92107639|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
92107640|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107641|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107642|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
92107643|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107644|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92107646|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
92107647|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107648|NCT05709652|Ivermectin|ivermectin|mesh-list
92107649|NCT05709652|Selamectin|selamectin|mesh-list
92107650|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92107651|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107652|NCT01690000|Melatonin|melatonin|mesh-list
92107653|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
92107654|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107655|NCT01690000|Protective Agents|protective agents|mesh-ancestor
92107656|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107657|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107658|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
92107659|NCT02495220|Bupivacaine|bupivacaine|mesh-list
92107660|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
92107661|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
92107662|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107663|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107664|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
92107665|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107666|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92107667|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92107668|NCT02495220|Analgesics|analgesics|mesh-ancestor
92107669|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92107670|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92107671|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92107672|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
92107673|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107674|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107675|NCT01690546|Naltrexone|naltrexone|mesh-list
92107676|NCT01690546|Buprenorphine|buprenorphine|mesh-list
92107677|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92107678|NCT01690546|Naloxone|naloxone|mesh-list
92107679|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92107680|NCT01690546|Narcotics|narcotics|mesh-ancestor
92107681|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107682|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107683|NCT01690546|Analgesics|analgesics|mesh-ancestor
92107684|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
92107685|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107686|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92107687|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92107688|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
92107689|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107690|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
92107691|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107692|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107693|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
92107694|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92107695|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107696|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107697|NCT02494830|Ketamine|ketamine|mesh-list
92107698|NCT02494830|Analgesics|analgesics|mesh-ancestor
92107699|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
92107700|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107701|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107702|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92107703|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92107704|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
92107705|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
92107706|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107707|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92107708|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92107709|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107710|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107711|NCT03336840|Metformin|metformin|mesh-list
92107712|NCT03336840|Promethazine|promethazine|mesh-list
92107713|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
92107714|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107715|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107716|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
92107717|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
92107718|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92107719|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
92107720|NCT03336840|Histamine Agents|histamine agents|mesh-ancestor
92107721|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107722|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107723|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92107724|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92107725|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92107726|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107727|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
92107728|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
92107729|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
92107730|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107731|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
92107732|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
92107733|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107734|NCT02497638|Metformin|metformin|mesh-list
92107735|NCT02497638|Biguanides|biguanides|mesh-list
92107736|NCT02497638|Atorvastatin|atorvastatin|mesh-list
92107737|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107738|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107739|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92107740|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92107741|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
92107742|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107743|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92107744|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92107745|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107746|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
92107747|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107748|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
92107749|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92107750|NCT02493192|Meperidine|meperidine|mesh-list
92107751|NCT02493192|Haloperidol|haloperidol|mesh-list
92065832|NCT03662074|Gemcitabine|gemcitabine|mesh-list
92107754|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
92107755|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107756|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107757|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107758|NCT02493192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92107759|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92107760|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107761|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107762|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92107763|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
92107764|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107765|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107766|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92107767|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92107768|NCT02493192|Narcotics|narcotics|mesh-ancestor
92107769|NCT02493192|Analgesics|analgesics|mesh-ancestor
92107770|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
92107771|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92107772|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
92107773|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92107774|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
92107775|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92107776|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
92107777|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107778|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107779|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
92107781|NCT02238808|Estrogens|estrogens|mesh-list
92107782|NCT02238808|Hormones|hormones|mesh-ancestor
92107783|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107784|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107785|NCT02497326|Heparin|heparin|mesh-list
92107786|NCT02497326|Tramadol|tramadol|mesh-list
92107787|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
92107788|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92107789|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92107790|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107791|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92107792|NCT02497326|Narcotics|narcotics|mesh-ancestor
92107793|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107794|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107795|NCT02497326|Analgesics|analgesics|mesh-ancestor
92107797|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107798|NCT02245672|Fluticasone|fluticasone|mesh-list
92107799|NCT02245672|Xhance|xhance|mesh-list
92107800|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92107801|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107802|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92107803|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
92107804|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107805|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107806|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92107807|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
92107808|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92107809|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92107810|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92107811|NCT02245672|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92107812|NCT02245672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92107813|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
92107814|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107815|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107816|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
92107817|NCT04461418|Hormones|hormones|mesh-ancestor
92107818|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107819|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107820|NCT03335904|Losartan|losartan|mesh-list
92107821|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92107822|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92107823|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92107824|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92107825|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107826|NCT03335826|Anesthetics|anesthetics|mesh-list
92107827|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107828|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107830|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92107831|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92107832|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92107833|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
92107834|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
92107835|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107836|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107837|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107838|NCT03340662|Itraconazole|itraconazole|mesh-list
92107839|NCT03340662|Rifampin|rifampin|mesh-list
92107840|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
92107841|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
92107842|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107843|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92107844|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92107845|NCT03340662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107846|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107847|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92107848|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
92107849|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92107850|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107851|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92107852|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92107853|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
92107854|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92107855|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
92107856|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92107857|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92107858|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92107859|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92107860|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92107861|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92107862|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92107863|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92107864|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92107865|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107866|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107867|NCT03340662|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92107868|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92107869|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92107870|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107871|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
92107872|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92107873|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
92107874|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92107875|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92107876|NCT03342300|Doxorubicin|doxorubicin|mesh-list
92107877|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92107878|NCT03342300|Pirarubicin|pirarubicin|mesh-list
92107879|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92107880|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107881|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92107882|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92107883|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107884|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107885|NCT01711918|Domperidone|domperidone|mesh-list
92107886|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
92107887|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
92107888|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107889|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107890|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92107891|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92107892|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
92107893|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107894|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107895|NCT03120468|Topiramate|topiramate|mesh-list
92107896|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
92107897|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92107898|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
92107899|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92107900|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107901|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
92107902|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107903|NCT03120468|Expectorants|expectorants|mesh-ancestor
92107904|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
92107905|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92107906|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
92107907|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107908|NCT03120468|Protective Agents|protective agents|mesh-ancestor
92107909|NCT03120468|Antidotes|antidotes|mesh-ancestor
92107911|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92107912|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
92107913|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92107914|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107915|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92107916|NCT01712230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107917|NCT03335436|Gabapentin|gabapentin|mesh-list
92107918|NCT03335436|Analgesics|analgesics|mesh-ancestor
92107919|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
92107920|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107921|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107922|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
92107923|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92107924|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92107925|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107926|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92107927|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92107928|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92107929|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107930|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107931|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
92107932|NCT02494284|Aspirin|aspirin|mesh-list
92107933|NCT02494284|Clopidogrel|clopidogrel|mesh-list
92107934|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92107935|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92107936|NCT02494284|Analgesics|analgesics|mesh-ancestor
92107937|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
92107938|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107939|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107940|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92107941|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92107942|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92107943|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92107944|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107945|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92107946|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92107947|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107948|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
92107949|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92107950|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92107951|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92107952|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
92107953|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107954|NCT01713400|Sirolimus|sirolimus|mesh-list
92107955|NCT01713400|Ustekinumab|ustekinumab|mesh-list
92107956|NCT01713400|Tacrolimus|tacrolimus|mesh-list
92107957|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92107958|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
92107959|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107960|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92107961|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92107962|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107963|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92107964|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92107965|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92107966|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107967|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
92107968|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
92107969|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
92107970|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92107971|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92107972|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107973|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92066069|NCT00087646|Ribavirin|ribavirin|mesh-list
92107974|NCT04494828|Analgesics|analgesics|mesh-ancestor
92107975|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
92107976|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92107977|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92107978|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92107979|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92107980|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
92107981|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92107982|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107983|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
92107984|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92107985|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92107986|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92107987|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
92107988|NCT01714336|Coagulants|coagulants|mesh-ancestor
92107989|NCT01716208|Ofatumumab|ofatumumab|mesh-list
92107990|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107991|NCT00706992|Aldesleukin|aldesleukin|mesh-list
92107992|NCT00706992|Vaccines|vaccines|mesh-list
92107993|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
92107994|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
92107995|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92107996|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92107997|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92107998|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92107999|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
92108000|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108001|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92108002|NCT03335124|Vitamins|vitamins|mesh-list
92108003|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
92108004|NCT03335124|Thiamine|thiamine|mesh-list
92108005|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
92108006|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
92108007|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108008|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108010|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108011|NCT03335124|Protective Agents|protective agents|mesh-ancestor
92108012|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
92108013|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
92108014|NCT03339804|Doxorubicin|doxorubicin|mesh-list
92108015|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108016|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
92108017|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108018|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108019|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92108020|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
92108021|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108022|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108023|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92108024|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92108025|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92108026|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92108027|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108028|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
92108029|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108030|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108031|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92108032|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108033|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108034|NCT02491320|Letrozole|letrozole|mesh-list
92108035|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108036|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92108037|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92108038|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108039|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108040|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92108041|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
92108042|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108043|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108044|NCT02491242|Dolutegravir|dolutegravir|mesh-list
92108045|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92108046|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92108047|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108048|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066136|NCT00084838|Cisplatin|cisplatin|mesh-list
92108049|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92108050|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92108051|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
92108052|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108053|NCT03330990|Midazolam|midazolam|mesh-list
92108054|NCT03330990|Entrectinib|entrectinib|mesh-list
92108055|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92108056|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92108057|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108058|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108059|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92108060|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92108061|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92108062|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92108063|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
92108064|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
92108065|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
92108066|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
92108067|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108068|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108069|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108070|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108071|NCT03339024|Oxytocin|oxytocin|mesh-list
92108072|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
92108073|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108074|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108075|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
92108076|NCT03330132|Vaccines|vaccines|mesh-list
92108077|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
92108078|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108079|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
92108080|NCT03330132|Coagulants|coagulants|mesh-ancestor
92108081|NCT02492412|Cyclosporine|cyclosporine|mesh-list
92108082|NCT02492412|Cyclosporins|cyclosporins|mesh-list
92108083|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108084|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108085|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108086|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
92108087|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108088|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
92108089|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108090|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92108091|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108092|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92108093|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92108094|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92108095|NCT03329898|Estradiol|estradiol|mesh-list
92108096|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92108097|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
92108098|NCT03329898|Estrogens|estrogens|mesh-ancestor
92108099|NCT03329898|Hormones|hormones|mesh-ancestor
92108100|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108101|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108102|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92108103|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
92108104|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108105|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92108106|NCT03329898|Progestins|progestins|mesh-ancestor
92108107|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
92108108|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92108109|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108110|NCT02492568|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92108111|NCT02492568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108112|NCT01722292|Carboplatin|carboplatin|mesh-list
92108113|NCT01722292|Etoposide|etoposide|mesh-list
92108114|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108115|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92108116|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92108117|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92108118|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108119|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108120|NCT02493894|Cefazolin|cefazolin|mesh-list
92108121|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92108122|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108123|NCT02493738|Itraconazole|itraconazole|mesh-list
92108124|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
92108125|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108126|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92108127|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92108128|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108129|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108130|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92108131|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
92108132|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108133|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108134|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92108136|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
92108137|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
92108138|NCT02493582|Apatinib|apatinib|mesh-list
92108139|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108140|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108141|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108142|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108143|NCT05560360|Efavirenz|efavirenz|mesh-list
92108144|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92108145|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92108146|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108147|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108148|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
92108149|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108150|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92108151|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92142673|NCT04930458|Fluorides|fluorides|mesh-list
92108152|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92108153|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92108154|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92108155|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92108156|NCT03329118|Simvastatin|simvastatin|mesh-list
92108157|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92108158|NCT03329118|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92108159|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
92108160|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108162|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92108163|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108165|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92108166|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92108167|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108168|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
92108169|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108170|NCT02492490|Basiliximab|basiliximab|mesh-list
92108171|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108172|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
92108173|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108174|NCT03337932|Doxycycline|doxycycline|mesh-list
92108175|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92108176|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108177|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
92108178|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92108179|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92108180|NCT02493504|Heparin|heparin|mesh-list
92108181|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
92108182|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92108183|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92108184|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108185|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
92108186|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92108187|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
92108188|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108189|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108190|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92108191|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108192|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92108193|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92108194|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92108195|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108196|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108197|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108198|NCT03328728|Hylan|hylan|mesh-list
92108199|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
92108200|NCT03328728|Protective Agents|protective agents|mesh-ancestor
92108201|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108202|NCT03328494|Paclitaxel|paclitaxel|mesh-list
92108203|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92108204|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108205|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92108206|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92108207|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92108208|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108209|NCT02491398|Rituximab|rituximab|mesh-list
92108210|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92108211|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92108212|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108213|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
92108214|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108215|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108216|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92108217|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
92108218|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108219|NCT03333018|Bromides|bromides|mesh-list
92108220|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
92108221|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92108222|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
92108223|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108224|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108225|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92108226|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108227|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92108228|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92108229|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92108230|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108231|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108232|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108233|NCT03333018|Anticonvulsants|anticonvulsants|mesh-ancestor
91938295|NCT02327715|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92108234|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92108236|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108237|NCT01723696|Vitamins|vitamins|mesh-list
92108238|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
92108239|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
92108240|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108241|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
92108242|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108243|NCT01723696|Protective Agents|protective agents|mesh-ancestor
92108244|NCT03327558|Mesalamine|mesalamine|mesh-list
92108245|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92108246|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108247|NCT03327558|Analgesics|analgesics|mesh-ancestor
92108248|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
92108249|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108250|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108251|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108252|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108253|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
92108254|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92108255|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92108256|NCT02242630|Prednisolone|prednisolone|mesh-list
92108257|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
92108258|NCT02242630|Triamcinolone|triamcinolone|mesh-list
92108259|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92108260|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92108261|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92108262|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
92108263|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92108264|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108265|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
92108266|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
92108267|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108268|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108269|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92108270|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
92108271|NCT02242630|Hormones|hormones|mesh-ancestor
92108272|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108273|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92066363|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
92108274|NCT02242630|Protective Agents|protective agents|mesh-ancestor
92108275|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142674|NCT04930458|Sodium Fluoride|sodium fluoride|mesh-list
92108276|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108277|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108278|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
92108279|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108280|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108281|NCT03109080|Olaparib|olaparib|mesh-list
92108282|NCT03109080|Adenosine|adenosine|mesh-list
92108283|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92108284|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108285|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108286|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108287|NCT03109080|Analgesics|analgesics|mesh-ancestor
92108288|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
92108289|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108290|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108291|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92108292|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
92108293|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92108294|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
92108295|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
92108296|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108298|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92108299|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108300|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
92108301|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
92108302|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92108303|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92108304|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92108305|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
92108306|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108307|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108308|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108309|NCT03332316|Dexamethasone|dexamethasone|mesh-list
92108310|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
92108311|NCT03332316|Ropivacaine|ropivacaine|mesh-list
92108312|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92108313|NCT03332316|BB 1101|bb 1101|mesh-list
92108314|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108315|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
92108316|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
92108317|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108318|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108319|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92108320|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
92108321|NCT03332316|Hormones|hormones|mesh-ancestor
92108322|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108323|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92108324|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108325|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
92108326|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
92108327|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108328|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
92108329|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
92108330|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108331|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108332|NCT03327168|Adenosine|adenosine|mesh-list
92108333|NCT03327168|Analgesics|analgesics|mesh-ancestor
92108334|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
92108335|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108336|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108337|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92108338|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
92108339|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92108340|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
92108341|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
92108342|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108343|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108344|NCT01726738|Trametinib|trametinib|mesh-list
92108345|NCT01726738|Dabrafenib|dabrafenib|mesh-list
92108346|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142675|NCT04930458|Fluorides, Topical|fluorides, topical|mesh-list
92108347|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108348|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066438|NCT03081442|Misoprostol|misoprostol|mesh-list
92108349|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108350|NCT02492178|Artesunate|artesunate|mesh-list
92108351|NCT02492178|Quinine|quinine|mesh-list
92108352|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
92108353|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92108354|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92108355|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108356|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108357|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
92108358|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
92108359|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92108360|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
92108361|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92108362|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108363|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92108364|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108365|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108366|NCT02492178|Analgesics|analgesics|mesh-ancestor
92108367|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
92108368|NCT03679624|Daratumumab|daratumumab|mesh-list
92108369|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108370|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
92108371|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92108372|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92108373|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108375|NCT04494126|Coagulants|coagulants|mesh-ancestor
92108376|NCT01730872|Prednisolone|prednisolone|mesh-list
92108377|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92108378|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
92108379|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92108380|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
92108381|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92108382|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92108383|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92108384|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
92108385|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108386|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
92108387|NCT01730872|Hormones|hormones|mesh-ancestor
92108388|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108389|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108390|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92108391|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108392|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
92108393|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
92108394|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108395|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92108396|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92108397|NCT01730872|Protective Agents|protective agents|mesh-ancestor
92108398|NCT02491086|Nicotine|nicotine|mesh-list
92108399|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92108400|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
92108401|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108402|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108403|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92108404|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92108405|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
92108406|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108407|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108408|NCT03469492|Insulin|insulin|mesh-list
92108409|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92108410|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108411|NCT03331770|Latanoprost|latanoprost|mesh-list
92108412|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92108413|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92108414|NCT05469412|Midazolam|midazolam|mesh-list
92108415|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92108416|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92108417|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108418|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108419|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92108420|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92108421|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92108422|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92108423|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
92108424|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
92108425|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
92108426|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
92108427|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108428|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108429|NCT03331692|Anesthetics|anesthetics|mesh-list
92108430|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108431|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108432|NCT04826692|Metformin|metformin|mesh-list
92108433|NCT04826692|Biguanides|biguanides|mesh-list
92108434|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92108435|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108436|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92108437|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92108438|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108439|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108440|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
92108441|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108442|NCT04825990|Pembrolizumab|pembrolizumab|mesh-list
92108443|NCT04825990|Olaparib|olaparib|mesh-list
92108444|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92108445|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108446|NCT04825990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92108447|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108448|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92108449|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108451|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92108452|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
92108453|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
92108454|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108455|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108457|NCT01738672|Entonox|entonox|mesh-list
92108458|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92108459|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
92108460|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
92108461|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108462|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108463|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108464|NCT01738672|Analgesics|analgesics|mesh-ancestor
92108465|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
92108466|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108467|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92108468|NCT02488512|Edotreotide|edotreotide|mesh-list
92108469|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92108470|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108471|NCT01808651|Fluoxetine|fluoxetine|mesh-list
92108472|NCT01808651|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92108473|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92108474|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92108475|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108476|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108477|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
92108478|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108479|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92108480|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
92108481|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92108482|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92108483|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92108484|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108485|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
92108487|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108488|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108489|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92108490|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108491|NCT05316376|Paclitaxel|paclitaxel|mesh-list
92108492|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92108493|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92108494|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108495|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
92108496|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
92108497|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
92108498|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066593|NCT05688202|Lidocaine|lidocaine|mesh-list
92108499|NCT01743976|Donepezil|donepezil|mesh-list
92108500|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92108501|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108502|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108503|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
92108504|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108505|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108506|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
92108507|NCT05315830|Vaccines|vaccines|mesh-list
92108508|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
92108509|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108510|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
92108511|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92108512|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92108513|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92108514|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92108515|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108516|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
92108517|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108518|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108519|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92108520|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108521|NCT04639960|Risperidone|risperidone|mesh-list
92108522|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92108523|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
92108524|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108525|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108526|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108527|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92108528|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92108529|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108530|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92108531|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92108532|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
92108534|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92108535|NCT03109314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108536|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108537|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
92108538|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108539|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108540|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
92108541|NCT04566016|Anesthetics|anesthetics|mesh-list
92108542|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108543|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108544|NCT03320538|Rabeprazole|rabeprazole|mesh-list
92108545|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92108546|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92108547|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92108548|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108549|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108550|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
92108551|NCT03322878|Analgesics|analgesics|mesh-ancestor
92108552|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
92108553|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108554|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108556|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108557|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92108558|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
92108559|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92108560|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92108561|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108562|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92108563|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
92108564|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108565|NCT03322800|Ziresovir|ziresovir|mesh-list
92108566|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
92108567|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108568|NCT03320460|Clobetasol|clobetasol|mesh-list
92108569|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108570|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
92108571|NCT03320460|Hormones|hormones|mesh-ancestor
92108572|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066665|NCT03301636|Nivolumab|nivolumab|mesh-list
92108573|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108574|NCT04471714|Baclofen|baclofen|mesh-list
92108575|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92108576|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108577|NCT04471714|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92108578|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108579|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92108580|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
92108581|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
92108582|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108583|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108584|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92108585|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
92108586|NCT03325686|Vitamin D|vitamin d|mesh-list
92108587|NCT03325686|Vitamins|vitamins|mesh-ancestor
92108588|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
92108589|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108590|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92108591|NCT05315128|Methotrexate|methotrexate|mesh-list
92108592|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92108593|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
92108594|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108595|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108596|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92108598|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108599|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108600|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
92108601|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108602|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92108603|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108604|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
92108605|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108606|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92108607|NCT03322488|Metronidazole|metronidazole|mesh-list
92108608|NCT03322488|Doxycycline|doxycycline|mesh-list
92108609|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
92108610|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108611|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92108612|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92108613|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92108614|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
92108615|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92108616|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92108617|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108618|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108619|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108620|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92108621|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92108622|NCT01808573|Capecitabine|capecitabine|mesh-list
92108623|NCT01808573|Lapatinib|lapatinib|mesh-list
92108624|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92108625|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
92108626|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108627|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108628|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108629|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108630|NCT01746940|Cocaine|cocaine|mesh-list
92108631|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92108632|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92108633|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
92108634|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108635|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108636|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
92108637|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108638|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92108639|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92108640|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92108641|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92108642|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108643|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
92108644|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108645|NCT01747330|Pancreatin|pancreatin|mesh-list
92108646|NCT01747330|Pancrelipase|pancrelipase|mesh-list
92108647|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92108649|NCT02990962|Lidocaine|lidocaine|mesh-list
92108650|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108651|NCT02990962|Glucocorticoids|glucocorticoids|mesh-ancestor
92108652|NCT02990962|Hormones|hormones|mesh-ancestor
92108653|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108654|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108655|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108656|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
92108657|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
92108658|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108659|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
92108660|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108661|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92108662|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92108663|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92108664|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92108665|NCT03322098|Atropine|atropine|mesh-list
92108666|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
92108667|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92108668|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92108669|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92108670|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
92108671|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938301|NCT02951013|Sensory System Agents|sensory system agents|mesh-ancestor
92108672|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108673|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92108674|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108676|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
92108677|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92108678|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92108679|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
92108680|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108681|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108682|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
92108683|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92108684|NCT01808339|Fluticasone|fluticasone|mesh-list
92108686|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108687|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92108688|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
92108689|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108690|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108691|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92108692|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108693|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
92108694|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92108695|NCT01749904|Timolol|timolol|mesh-list
92108696|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92108697|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92108698|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108699|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108700|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108701|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108702|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92108703|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92108704|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92108705|NCT02484768|Hematinics|hematinics|mesh-ancestor
92108706|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
92108707|NCT03316326|Irinotecan|irinotecan|mesh-list
92108708|NCT03316326|Tegafur|tegafur|mesh-list
92108709|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108710|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92108711|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92108712|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108713|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108714|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92108715|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
92108716|NCT02487732|Ticagrelor|ticagrelor|mesh-list
92108717|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92108718|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92108719|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92108720|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92108721|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92108722|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
92108723|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108724|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108725|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108726|NCT03833362|Interferons|interferons|mesh-list
92108728|NCT03833362|Ribavirin|ribavirin|mesh-list
92108729|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
92108730|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
92108731|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92108732|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92108733|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108734|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
92108735|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108736|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92108737|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92108738|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
92108739|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108740|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108741|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92108742|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92108743|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92108744|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92108745|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
92108746|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
92108747|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108748|NCT05463588|Methamphetamine|methamphetamine|mesh-list
92108749|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92108750|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108751|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
92108752|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
92108753|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108754|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
92108755|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108756|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108757|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108758|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92108759|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92108760|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92108761|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92108762|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
92108763|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92108764|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
92108765|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108766|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108767|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92108768|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92108769|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92108770|NCT02490540|Sufentanil|sufentanil|mesh-list
92108771|NCT02490540|Dsuvia|dsuvia|mesh-list
92108772|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92108773|NCT02490540|Narcotics|narcotics|mesh-ancestor
92108774|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108775|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108776|NCT02490540|Analgesics|analgesics|mesh-ancestor
92108777|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
92108778|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108779|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92108780|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92108781|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
92108782|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
92108783|NCT02484300|Melatonin|melatonin|mesh-list
92108784|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
92108785|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108786|NCT02484300|Protective Agents|protective agents|mesh-ancestor
92108787|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108788|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108789|NCT02727660|Budesonide|budesonide|mesh-list
92108790|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
92108791|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108792|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92108793|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
92108794|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108795|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108796|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92108797|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108798|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
92108799|NCT02727660|Hormones|hormones|mesh-ancestor
92108800|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108801|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92108802|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92108803|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92108804|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108805|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108806|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108807|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
92108808|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92108809|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108810|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108811|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108812|NCT02490072|Analgesics|analgesics|mesh-ancestor
92108813|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
92108814|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108815|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92108816|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92108817|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92108818|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108819|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108820|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108822|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92108823|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92108824|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108825|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108826|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92108827|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92108828|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
92108829|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108830|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108831|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
92108832|NCT03321318|Vitamin D|vitamin d|mesh-list
92108833|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
92108834|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92108835|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108836|NCT03321318|Vitamins|vitamins|mesh-ancestor
92108837|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
92108838|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92108839|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92108840|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92108841|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
92108842|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108843|NCT01784861|Everolimus|everolimus|mesh-list
92108844|NCT01784861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92108845|NCT01784861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108846|NCT01784861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108847|NCT01784861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108848|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108849|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
92108850|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108851|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108853|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92108854|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108855|NCT03318744|Analgesics|analgesics|mesh-ancestor
92108856|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
92108857|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108858|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108859|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108860|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108861|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92108862|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92108863|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108864|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92108865|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92108866|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108867|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
92108868|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92108869|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92066961|NCT04805944|Dolutegravir|dolutegravir|mesh-list
92108870|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108872|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92108873|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108874|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92108875|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108876|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92108877|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
92108878|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
92108879|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108880|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108881|NCT02489760|Adalimumab|adalimumab|mesh-list
92108882|NCT02489760|Etanercept|etanercept|mesh-list
92108883|NCT02489760|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92108884|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108885|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108886|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92108887|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108888|NCT02489760|Analgesics|analgesics|mesh-ancestor
92108889|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
92108890|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108891|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108892|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92108893|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108894|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
92108896|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
92108897|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108898|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108899|NCT05127928|Vitamins|vitamins|mesh-list
92108900|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
92108901|NCT05127928|Vitamin E|vitamin e|mesh-list
92108902|NCT05127928|Tocopherols|tocopherols|mesh-list
92108903|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
92108904|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108905|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
92108906|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108907|NCT05127928|Protective Agents|protective agents|mesh-ancestor
92108908|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
92108909|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92108910|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
92108911|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108912|NCT02483130|Expectorants|expectorants|mesh-ancestor
92108913|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92108914|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92108915|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
92108916|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108917|NCT02483130|Protective Agents|protective agents|mesh-ancestor
92108918|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108919|NCT02483130|Antidotes|antidotes|mesh-ancestor
92108920|NCT03318354|Olmesartan|olmesartan|mesh-list
92108921|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92108922|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92108923|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92108924|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92108925|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108926|NCT05113186|Lenvatinib|lenvatinib|mesh-list
92108927|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108928|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92108929|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108930|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108931|NCT05093140|Prednisone|prednisone|mesh-list
92108932|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
92108933|NCT05093140|Vincristine|vincristine|mesh-list
92108934|NCT05093140|Doxorubicin|doxorubicin|mesh-list
92108935|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92108936|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92108937|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
92108938|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108939|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92108940|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92108941|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
92108942|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108943|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92108944|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92108945|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92108946|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
92108947|NCT05093140|Hormones|hormones|mesh-ancestor
92108948|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92108949|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92108950|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92108951|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92108952|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92108953|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92108954|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92108955|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92108956|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92108957|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92108958|NCT03315312|Fluorides|fluorides|mesh-list
92108959|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
92108960|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
92108961|NCT03315312|Protective Agents|protective agents|mesh-ancestor
92108962|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108963|NCT00705666|Ribavirin|ribavirin|mesh-list
92108964|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92108965|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
92108966|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108967|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
92108968|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92108969|NCT04955236|Fentanyl|fentanyl|mesh-list
92108970|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92108971|NCT04955236|Narcotics|narcotics|mesh-ancestor
92108972|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108973|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108975|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
92108976|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108977|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92108978|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92108979|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
92108980|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
92108981|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
92108982|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92108983|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92108984|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92108985|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92108986|NCT03957304|Analgesics|analgesics|mesh-ancestor
92108987|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
92108988|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92108989|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92108990|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92108991|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92108992|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
92108993|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92108994|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92108995|NCT03320928|Methotrexate|methotrexate|mesh-list
92108996|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92108997|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
92108998|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92108999|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109000|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92109001|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
92109002|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109003|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109004|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
92109005|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109006|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92109007|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92109008|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
92109009|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92109010|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92109011|NCT02488902|Mefloquine|mefloquine|mesh-list
92109012|NCT02488902|Tafenoquine|tafenoquine|mesh-list
92109013|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
92109014|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92109015|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92109016|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109017|NCT02253160|Lenograstim|lenograstim|mesh-list
92109018|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92109019|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
92109020|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109021|NCT02254252|Nicorandil|nicorandil|mesh-list
92109022|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
92109023|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
92109024|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92109025|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92109026|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
92109028|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
92109029|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109030|NCT03315078|Busulfan|busulfan|mesh-list
92109031|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
92109032|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109033|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92109034|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
92109035|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109036|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92109037|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109038|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92109039|NCT02255110|Doxorubicin|doxorubicin|mesh-list
92109040|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92109041|NCT02255110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109042|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92109043|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92109044|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109045|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109046|NCT03320694|Insulin|insulin|mesh-list
92109047|NCT03320694|Metformin|metformin|mesh-list
92109048|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92109049|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
92109050|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92109051|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109052|NCT02482740|Tamoxifen|tamoxifen|mesh-list
92109053|NCT02482740|Letrozole|letrozole|mesh-list
92109054|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109055|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92109056|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92109057|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109058|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109059|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92109060|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
92109061|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109062|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109063|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109064|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92109065|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92109066|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92109067|NCT03315000|Fluticasone|fluticasone|mesh-list
92109068|NCT03315000|Xhance|xhance|mesh-list
92109069|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109070|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92109071|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
92109072|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109073|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109074|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92109075|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
92109076|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
92109077|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92109078|NCT02482818|Pregabalin|pregabalin|mesh-list
92109079|NCT02482818|Analgesics|analgesics|mesh-ancestor
92109080|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
92109081|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109082|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109083|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
92109084|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92109085|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109086|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109087|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92109088|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92109089|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92109090|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109091|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109092|NCT02989870|Sorafenib|sorafenib|mesh-list
92109093|NCT02989870|Bavituximab|bavituximab|mesh-list
92109094|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109095|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92109096|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109097|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109098|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92109099|NCT02480088|Palonosetron|palonosetron|mesh-list
92109100|NCT02480088|Ramosetron|ramosetron|mesh-list
92109101|NCT02480088|Antiemetics|antiemetics|mesh-ancestor
92109102|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
92109103|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109104|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938316|NCT02285062|Prednisone|prednisone|mesh-list
92109105|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109106|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92109107|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92109108|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
92109109|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109110|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109111|NCT01807624|Phenylephrine|phenylephrine|mesh-list
92109112|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
92109114|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
92109115|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
92109116|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109117|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109118|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
92109119|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109120|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92109121|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92109122|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92109123|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109124|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109125|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
92109126|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
92109127|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
92109128|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92109129|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92109130|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92109131|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
92109132|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92109133|NCT01807624|Protective Agents|protective agents|mesh-ancestor
92109134|NCT01808326|Chlorambucil|chlorambucil|mesh-list
92109135|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92109136|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
92109137|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109138|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109139|NCT03317730|Oxycodone|oxycodone|mesh-list
92109140|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92109141|NCT03317730|Narcotics|narcotics|mesh-ancestor
92109142|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109143|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109144|NCT03317730|Analgesics|analgesics|mesh-ancestor
92109145|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
92109146|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109147|NCT02486484|Aflibercept|aflibercept|mesh-list
92109148|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92109149|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92109150|NCT02486484|Growth Substances|growth substances|mesh-ancestor
92109151|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109152|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92109153|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109154|NCT03317652|Nitroprusside|nitroprusside|mesh-list
92109155|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92109156|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
92109157|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92109158|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109159|NCT02479854|Montelukast|montelukast|mesh-list
92109160|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92109161|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
92109162|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92109163|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
92109164|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109165|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109167|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92109168|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109169|NCT01809106|Fentanyl|fentanyl|mesh-list
92109170|NCT01809106|Morphine|morphine|mesh-list
92109171|NCT01809106|Oxycodone|oxycodone|mesh-list
92109173|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92109174|NCT01809106|Narcotics|narcotics|mesh-ancestor
92109175|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109176|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109177|NCT01809106|Analgesics|analgesics|mesh-ancestor
92109178|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
92109179|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109180|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92109181|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92109182|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
92109183|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
92109184|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92109185|NCT03804580|Osimertinib|osimertinib|mesh-list
92109186|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109187|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92109188|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109189|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109190|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
92109191|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92109192|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92109193|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92109194|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109195|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109196|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109197|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109198|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109199|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92109200|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109201|NCT01810666|Factor VIII|factor viii|mesh-list
92109202|NCT01810666|Coagulants|coagulants|mesh-ancestor
92109203|NCT02482272|Lamivudine|lamivudine|mesh-list
92109204|NCT02482272|Adefovir|adefovir|mesh-list
92109205|NCT02482272|Entecavir|entecavir|mesh-list
92109206|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92109207|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92109208|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109209|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109210|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
92109211|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109212|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92109213|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92109214|NCT01766440|Calcitriol|calcitriol|mesh-list
92109215|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92109216|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109217|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92109218|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109219|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109220|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92109221|NCT01766440|Vitamins|vitamins|mesh-ancestor
92109222|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
92109223|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92109224|NCT02479620|Dexamethasone|dexamethasone|mesh-list
92109225|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
92109226|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92109227|NCT02479620|BB 1101|bb 1101|mesh-list
92109228|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109229|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
92109230|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
92109231|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109232|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109233|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109234|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
92109235|NCT02479620|Hormones|hormones|mesh-ancestor
92109236|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109237|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109238|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109239|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
92109240|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109241|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109242|NCT02481960|Irinotecan|irinotecan|mesh-list
92109243|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92109244|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92109245|NCT02481960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109246|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109248|NCT02725866|Ritonavir|ritonavir|mesh-list
92109249|NCT02725866|Ribavirin|ribavirin|mesh-list
92109250|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92109251|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92109252|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
92109253|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109254|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109255|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92109256|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92109257|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
92109258|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109259|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92109260|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92109261|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
92109262|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92109263|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92109264|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109265|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
92109266|NCT03314298|Anastrozole|anastrozole|mesh-list
92109267|NCT03314298|Testosterone|testosterone|mesh-list
92109268|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
92109269|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
92109270|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92109271|NCT03314298|Androgens|androgens|mesh-ancestor
92109272|NCT03314298|Hormones|hormones|mesh-ancestor
92109273|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109274|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109275|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109276|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109277|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
92109278|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92109279|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92109280|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109281|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109282|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92109283|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
92109284|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
92109285|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109286|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109287|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92109288|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92109289|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109290|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109291|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109292|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92109293|NCT05713578|Docetaxel|docetaxel|mesh-list
92109294|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109295|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
92109296|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
92109297|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
92109298|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109299|NCT02485548|Fluorouracil|fluorouracil|mesh-list
92109300|NCT02485548|Raltitrexed|raltitrexed|mesh-list
92109301|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109302|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
92109303|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109304|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92109305|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92109306|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
92109307|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109308|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92109309|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109310|NCT02479074|Prednisolone|prednisolone|mesh-list
92109311|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92109312|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
92109313|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92109314|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
92109315|NCT02479074|Montelukast|montelukast|mesh-list
92109316|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92109317|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
92109318|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109319|NCT02479074|Glucocorticoids|glucocorticoids|mesh-ancestor
92109320|NCT02479074|Hormones|hormones|mesh-ancestor
92109321|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109322|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109323|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109324|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109325|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
92109326|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
92109327|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109328|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109329|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92109330|NCT02479074|Protective Agents|protective agents|mesh-ancestor
92109331|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92109332|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
92109333|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92109334|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
92109335|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92109336|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92109337|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109338|NCT02481180|T0001|t0001|mesh-list
92109339|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
92109340|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109341|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92109342|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
92109343|NCT02480946|Methotrexate|methotrexate|mesh-list
92109344|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92109345|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
92109346|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92109347|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109348|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92109349|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
92109350|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109351|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109352|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
92109353|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109354|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92109355|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92109356|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
92109357|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92109358|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92109359|NCT01769170|Cidofovir|cidofovir|mesh-list
92109360|NCT01769170|Brincidofovir|brincidofovir|mesh-list
92109361|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
92109362|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109363|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109364|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109365|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
92109366|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92109367|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109368|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92109369|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92109370|NCT02726022|Ribavirin|ribavirin|mesh-list
92109371|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92109372|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
92109373|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109374|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
92109376|NCT02478294|Warfarin|warfarin|mesh-list
92109377|NCT02478294|Anticoagulants|anticoagulants|mesh-list
92109378|NCT01770652|Deferiprone|deferiprone|mesh-list
92109379|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92109380|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
92109381|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
92109382|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109383|NCT03316482|Leuprolide|leuprolide|mesh-list
92109384|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92109385|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
92109386|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92109387|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109388|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109389|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109390|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92109391|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92109392|NCT01771666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109393|NCT01772758|Antioxidants|antioxidants|mesh-list
92109394|NCT01772758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067487|NCT00002644|Tamoxifen|tamoxifen|mesh-list
92109395|NCT01772758|Protective Agents|protective agents|mesh-ancestor
92109396|NCT01772758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109397|NCT02485080|Sofosbuvir|sofosbuvir|mesh-list
92109399|NCT02485080|Antiviral Agents|antiviral agents|mesh-ancestor
92109400|NCT02485080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109401|NCT02485080|Protease Inhibitors|protease inhibitors|mesh-ancestor
92109402|NCT02485080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109403|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109404|NCT02480400|Dexetimide|dexetimide|mesh-list
92109405|NCT02480400|Citalopram|citalopram|mesh-list
92109406|NCT02480400|Escitalopram|escitalopram|mesh-list
92109407|NCT02480400|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92109408|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92109409|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109410|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109411|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109412|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
92109413|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109414|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92109415|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92109416|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
92109417|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
92109418|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109419|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92109420|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92109421|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109422|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92109423|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
92109424|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109425|NCT02725710|Gabapentin|gabapentin|mesh-list
92109426|NCT02725710|Analgesics|analgesics|mesh-ancestor
92109427|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
92109428|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109429|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109430|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
92109431|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92109432|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92109433|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109434|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109435|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92109436|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92109437|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109438|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109439|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
92109441|NCT02256358|Ketamine|ketamine|mesh-list
92109442|NCT02256358|Analgesics|analgesics|mesh-ancestor
92109443|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
92109444|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109445|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109446|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92109447|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92109448|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
92109449|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
92109450|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109451|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92109452|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92109453|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109454|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109455|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92109456|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92109457|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92109458|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92109459|NCT02256358|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109460|NCT02256358|GABA Modulators|gaba modulators|mesh-ancestor
92109461|NCT02256358|GABA Agents|gaba agents|mesh-ancestor
92109462|NCT01825408|Azithromycin|azithromycin|mesh-list
92109463|NCT01825408|Doxycycline|doxycycline|mesh-list
92109464|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92109465|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109466|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109467|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
92109468|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92109469|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92109470|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92109471|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938329|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142676|NCT04930458|Caseins|caseins|mesh-list
92109472|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109474|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109475|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
92109476|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
92109477|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109478|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109479|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109480|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
92109481|NCT04945824|Hormones|hormones|mesh-ancestor
92109482|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109483|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109484|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109485|NCT04937634|Melphalan|melphalan|mesh-list
92109486|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92109487|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
92109488|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109489|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109490|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92109491|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92109492|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
92109493|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109494|NCT02262130|Omalizumab|omalizumab|mesh-list
92109495|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92109496|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92109497|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92109498|NCT04913610|Ivermectin|ivermectin|mesh-list
92109499|NCT04913610|Albendazole|albendazole|mesh-list
92109500|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92109501|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109502|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
92109503|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
92109504|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92109505|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92109506|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92109507|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92109508|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92109509|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109510|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109511|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
92109512|NCT04887870|Nivolumab|nivolumab|mesh-list
92109513|NCT04887870|Ipilimumab|ipilimumab|mesh-list
92109514|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92109515|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109516|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92109517|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109518|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
92109519|NCT01827358|Mupirocin|mupirocin|mesh-list
92109520|NCT01827358|Calcium|calcium|mesh-list
92109521|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92109522|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109523|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92109524|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109525|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109526|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92109527|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109528|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109529|NCT01780324|Lidocaine|lidocaine|mesh-list
92109530|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
92109531|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
92109532|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109533|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109534|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
92109535|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109536|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92109537|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92109538|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92018186|NCT01360021|Budesonide|budesonide|mesh-list
92109539|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109540|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109541|NCT02472600|Colistin|colistin|mesh-list
92109542|NCT02472600|Polymyxins|polymyxins|mesh-list
92109543|NCT02472600|Neomycin|neomycin|mesh-list
92109544|NCT02472600|Omeprazole|omeprazole|mesh-list
92109545|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92109546|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109547|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92109548|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109549|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109550|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109551|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109552|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92109553|NCT04858776|Dexamethasone|dexamethasone|mesh-list
92109554|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109555|NCT04858776|Antiemetics|antiemetics|mesh-ancestor
92109556|NCT04858776|Autonomic Agents|autonomic agents|mesh-ancestor
92109557|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109558|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109559|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109560|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
92109561|NCT04858776|Hormones|hormones|mesh-ancestor
92109562|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109563|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109564|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109565|NCT01781806|Tenofovir|tenofovir|mesh-list
92109566|NCT01781806|Emtricitabine|emtricitabine|mesh-list
92109567|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
92109568|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109569|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92109570|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92109571|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109572|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109573|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92109574|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92109575|NCT02477514|Tedizolid|tedizolid|mesh-list
92109576|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
92109577|NCT02477514|Midazolam|midazolam|mesh-list
92109578|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92109579|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92109580|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92109581|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109582|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109583|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92109584|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92109585|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109586|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92109587|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
92109588|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
92109589|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
92109590|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
92109591|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109592|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109593|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92109594|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92109595|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
92109596|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92109597|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92109598|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109599|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109600|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109601|NCT01746238|Bevacizumab|bevacizumab|mesh-list
92109602|NCT01746238|Doxorubicin|doxorubicin|mesh-list
92109603|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92109604|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109605|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92109606|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92109607|NCT01746238|Growth Substances|growth substances|mesh-ancestor
92109608|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109609|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
92109610|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92109611|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92109612|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92109613|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109614|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109615|NCT02472054|Cyclosporine|cyclosporine|mesh-list
92109616|NCT02472054|Prednisolone|prednisolone|mesh-list
92109617|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92109618|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
92109619|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92109620|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
92109621|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
92109623|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92109624|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
92109625|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109626|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109627|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92109628|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
92109629|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109630|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
92109631|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109632|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
92109633|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92109634|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92109635|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109636|NCT02472054|Glucocorticoids|glucocorticoids|mesh-ancestor
92109637|NCT02472054|Hormones|hormones|mesh-ancestor
92109638|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109639|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109640|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109641|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
92109642|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
92109643|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109644|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109645|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92109646|NCT02472054|Protective Agents|protective agents|mesh-ancestor
92109647|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92109648|NCT01782898|Esmolol|esmolol|mesh-list
92109649|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92109650|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92109651|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92109652|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
92109653|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109654|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109655|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109656|NCT02475876|Clindamycin|clindamycin|mesh-list
92109657|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
92109658|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
92109659|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92109660|NCT02475876|Trimethoprim|trimethoprim|mesh-list
92109661|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
92109662|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109663|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109664|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92109665|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109666|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109667|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92109668|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
92109669|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92109670|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92109671|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92109672|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92109673|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92109674|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92109675|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
92109676|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92109677|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109678|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109679|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109680|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109681|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109682|NCT01783054|Gemcitabine|gemcitabine|mesh-list
92109683|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92109684|NCT01783054|Antimetabolites|antimetabolites|mesh-ancestor
92109685|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109686|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109687|NCT05397600|Bimatoprost|bimatoprost|mesh-list
92109688|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92109689|NCT02725008|Dexamethasone|dexamethasone|mesh-list
92109690|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109691|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
92109692|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
92109693|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109694|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109695|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067785|NCT05929716|Magrolimab|magrolimab|mesh-list
92109696|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
92109697|NCT02725008|Hormones|hormones|mesh-ancestor
92109698|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109699|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109700|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109701|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
92109702|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92109703|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109704|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109705|NCT02471820|Dexamethasone|dexamethasone|mesh-list
92109706|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
92109707|NCT02471820|Lenalidomide|lenalidomide|mesh-list
92109708|NCT02471820|Doxorubicin|doxorubicin|mesh-list
92109709|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92109710|NCT02471820|BB 1101|bb 1101|mesh-list
92109711|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109712|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
92109713|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
92109714|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109715|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109716|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109718|NCT02471820|Hormones|hormones|mesh-ancestor
92109719|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109720|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92109721|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109722|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
92109723|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109724|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109725|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
92109726|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92109727|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92109728|NCT02471820|Growth Substances|growth substances|mesh-ancestor
92109729|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
92109730|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92109731|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92109732|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92109733|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
92109734|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92109735|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92109736|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92109737|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109738|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109739|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109740|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109741|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109742|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92109743|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109744|NCT01783912|Nicotine|nicotine|mesh-list
92109745|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92109746|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
92109747|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109748|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109749|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92109750|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92109751|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109752|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109753|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109754|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
92109755|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109756|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
92109757|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109758|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109759|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92109761|NCT01833988|Pancreatin|pancreatin|mesh-list
92109762|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109763|NCT05363436|Oxycodone|oxycodone|mesh-list
92109764|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92109765|NCT05363436|Narcotics|narcotics|mesh-ancestor
92109766|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109767|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109768|NCT05363436|Analgesics|analgesics|mesh-ancestor
92109769|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
92109770|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109771|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92109772|NCT02474706|Imipenem|imipenem|mesh-list
92109773|NCT02474706|Cefoxitin|cefoxitin|mesh-list
92109774|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109775|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109776|NCT01784770|Azithromycin|azithromycin|mesh-list
92109777|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92109778|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109779|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92109780|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92109781|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109782|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92109783|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109784|NCT04491786|Gabapentin|gabapentin|mesh-list
92109785|NCT04491786|Nefopam|nefopam|mesh-list
92109786|NCT04491786|Analgesics|analgesics|mesh-ancestor
92109787|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
92109788|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109789|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109790|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
92109791|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92109792|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92109793|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92109794|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109795|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92109796|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92109797|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109798|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109799|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
92109800|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92109801|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92109802|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92109803|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109804|NCT02470026|Yohimbine|yohimbine|mesh-list
92109805|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
92109806|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
92109807|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109808|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109809|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92109810|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92109811|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92109812|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
92109813|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109814|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109815|NCT02470026|Urological Agents|urological agents|mesh-ancestor
92109816|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
92109817|NCT01807949|Ivacaftor|ivacaftor|mesh-list
92109818|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92109819|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109820|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109821|NCT02989558|Aspirin|aspirin|mesh-list
92109822|NCT02989558|Clopidogrel|clopidogrel|mesh-list
92109823|NCT02989558|Ticagrelor|ticagrelor|mesh-list
92109824|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92109825|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92109826|NCT02989558|Analgesics|analgesics|mesh-ancestor
92109827|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
92109828|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109829|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109830|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109831|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92109832|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92109833|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92109834|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109835|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92109836|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92109837|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109839|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92109840|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92109841|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92109842|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
92067941|NCT05887609|Olaparib|olaparib|mesh-list
92109843|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109845|NCT01806779|Nicotine|nicotine|mesh-list
92109846|NCT01806779|Varenicline|varenicline|mesh-list
92109847|NCT01806779|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92109848|NCT01806779|Autonomic Agents|autonomic agents|mesh-ancestor
92109849|NCT01806779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109850|NCT01806779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109851|NCT01806779|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92109852|NCT01806779|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92109853|NCT01806779|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109854|NCT01806779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109855|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109856|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92109857|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
92109858|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92109859|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92109860|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92109861|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109862|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
92109863|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92109864|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92109865|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109866|NCT01878526|Domperidone|domperidone|mesh-list
92109867|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
92109868|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
92109869|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109870|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109871|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109872|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92109874|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109875|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109876|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
92109877|NCT01878604|Antimetabolites|antimetabolites|mesh-ancestor
92109878|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109879|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92109880|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
92109881|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109882|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92109883|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92109884|NCT01806623|Fluconazole|fluconazole|mesh-list
92109885|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
92109886|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109887|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92109888|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92109889|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109890|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109891|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92109892|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92109893|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109894|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109895|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92109896|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92109897|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92109898|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
92109899|NCT01806545|Coagulants|coagulants|mesh-ancestor
92109900|NCT01847014|Macitentan|macitentan|mesh-list
92109901|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92109902|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92109903|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109904|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92109905|NCT01847638|Nepafenac|nepafenac|mesh-list
92109907|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92109908|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92109909|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92109910|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92109911|NCT01847638|Analgesics|analgesics|mesh-ancestor
92109912|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
92109913|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109914|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109915|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92109917|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
92109918|NCT02474628|Calcium|calcium|mesh-list
92109919|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92109920|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109922|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109923|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92109924|NCT05211570|Azacitidine|azacitidine|mesh-list
92109925|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92109926|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
92109927|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109928|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109929|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109930|NCT03099564|Pembrolizumab|pembrolizumab|mesh-list
92109931|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92109932|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92109933|NCT03099564|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92109934|NCT03099564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109935|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
92109936|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92109937|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92109938|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92109939|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109940|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109941|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
92109942|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109943|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109944|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92109945|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92109946|NCT05328310|Nebivolol|nebivolol|mesh-list
92109947|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92109948|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
92109949|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92109950|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92109951|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92109952|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
92109953|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92109954|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109955|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109956|NCT01797484|Ranolazine|ranolazine|mesh-list
92109957|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92109958|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92109959|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109960|NCT01798264|Exenatide|exenatide|mesh-list
92109961|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92109962|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109963|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92109964|NCT01798264|Incretins|incretins|mesh-ancestor
92109965|NCT01798264|Hormones|hormones|mesh-ancestor
92109966|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109967|NCT05326984|Metformin|metformin|mesh-list
92109968|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92109969|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109970|NCT01800838|Silicon|silicon|mesh-list
92109971|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
92109972|NCT01800838|Trace Elements|trace elements|mesh-ancestor
92109973|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
92109974|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109975|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
92109976|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92109977|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92109978|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109979|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
92109980|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92109981|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
92109982|NCT01782131|Voriconazole|voriconazole|mesh-list
92109983|NCT01782131|Posaconazole|posaconazole|mesh-list
92109984|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
92109985|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92109986|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92109987|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92109988|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92109989|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92109990|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92109991|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
92109992|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92109993|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92109994|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92109995|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92109996|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92109997|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92109998|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
92109999|NCT01781975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110000|NCT01781975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92110001|NCT01781975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110002|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110003|NCT01855360|Doxycycline|doxycycline|mesh-list
92110004|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92110005|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92110006|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110007|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
92110008|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92110009|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92110010|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
92110011|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92110012|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92110013|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
92110014|NCT04351126|Bromocriptine|bromocriptine|mesh-list
92110015|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92110016|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92110017|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
92110018|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110019|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110020|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
92110021|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
92110022|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110023|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110024|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110026|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92110027|NCT01804673|Narcotics|narcotics|mesh-ancestor
92110028|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110029|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110030|NCT01804673|Analgesics|analgesics|mesh-ancestor
92110031|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
92110032|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110033|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92110034|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92110035|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
92110036|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
92110037|NCT01856530|Oxytocin|oxytocin|mesh-list
92110038|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
92110039|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92110040|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110041|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
92110042|NCT05302336|Docetaxel|docetaxel|mesh-list
92110043|NCT05302336|Doxorubicin|doxorubicin|mesh-list
92110044|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92110045|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110046|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
92110047|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110048|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110049|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110050|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
92110051|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110052|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110053|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92110054|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110055|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110056|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110057|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92110058|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92110059|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110060|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110061|NCT01804036|Zolpidem|zolpidem|mesh-list
92110062|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92110063|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92110064|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068170|NCT05497804|Dexamethasone|dexamethasone|mesh-list
92110065|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110066|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92110068|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
92110069|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110070|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110071|NCT01857232|Dexamethasone|dexamethasone|mesh-list
92110072|NCT01857232|Ondansetron|ondansetron|mesh-list
92110073|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
92110074|NCT01857232|Aprepitant|aprepitant|mesh-list
92110075|NCT01857232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110076|NCT01857232|Antiemetics|antiemetics|mesh-ancestor
92110077|NCT01857232|Autonomic Agents|autonomic agents|mesh-ancestor
92110078|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110079|NCT01857232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110080|NCT01857232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92110081|NCT01857232|Glucocorticoids|glucocorticoids|mesh-ancestor
92110082|NCT01857232|Hormones|hormones|mesh-ancestor
92110083|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110084|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92110085|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110086|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
92110087|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
92110088|NCT01857232|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92110089|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92110090|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
92110091|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110092|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110093|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92110094|NCT01766128|Zonisamide|zonisamide|mesh-list
92110095|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
92110096|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92110097|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110098|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110099|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92110100|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110101|NCT02859558|Tenofovir|tenofovir|mesh-list
92110102|NCT02859558|Emtricitabine|emtricitabine|mesh-list
92110103|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92110105|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92110106|NCT02859558|Elvitegravir|elvitegravir|mesh-list
92110107|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92110108|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
92110109|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110110|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92110111|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92110112|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110113|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110114|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92110115|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92110116|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92110117|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92110118|NCT01860586|Bevacizumab|bevacizumab|mesh-list
92110119|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110120|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110121|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92110122|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92110123|NCT01860586|Growth Substances|growth substances|mesh-ancestor
92110124|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110125|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
92110126|NCT00705432|Ribavirin|ribavirin|mesh-list
92110127|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92110128|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
92110129|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110130|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
92110131|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110132|NCT00704964|Ribavirin|ribavirin|mesh-list
92110133|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92110134|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
92110135|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
92110136|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110137|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
92068234|NCT05429502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110138|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110139|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
92110140|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110141|NCT00704808|Temozolomide|temozolomide|mesh-list
92110142|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110143|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
92110144|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110145|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110146|NCT05305794|Insulin|insulin|mesh-list
92110147|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92110148|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110149|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110150|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92110152|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110153|NCT01862536|Tadalafil|tadalafil|mesh-list
92110154|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
92110155|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92110156|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92110157|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110158|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110159|NCT01862536|Urological Agents|urological agents|mesh-ancestor
92110160|NCT01862614|Epinephrine|epinephrine|mesh-list
92110161|NCT01862614|Racepinephrine|racepinephrine|mesh-list
92110162|NCT01862614|Carticaine|carticaine|mesh-list
92110163|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
92110164|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92110165|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92110166|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
92110167|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110168|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110169|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110170|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92110171|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92110172|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
92110173|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110174|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92110175|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
92110176|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
92110177|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
92110178|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92110179|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
92110180|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
92110181|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110182|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
92110183|NCT05166876|Brequinar|brequinar|mesh-list
92110184|NCT05166876|Dipyridamole|dipyridamole|mesh-list
92110185|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92110186|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110187|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110188|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92110189|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
92110190|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110191|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110192|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
92110193|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110194|NCT02470650|Ritonavir|ritonavir|mesh-list
92110195|NCT02470650|Darunavir|darunavir|mesh-list
92110196|NCT02470650|Tenofovir|tenofovir|mesh-list
92110197|NCT02470650|Lamivudine|lamivudine|mesh-list
92110198|NCT02470650|Emtricitabine|emtricitabine|mesh-list
92110199|NCT02470650|Abacavir|abacavir|mesh-list
92110200|NCT02470650|Cobicistat|cobicistat|mesh-list
92110201|NCT02470650|Rilpivirine|rilpivirine|mesh-list
92110202|NCT02470650|Elvitegravir|elvitegravir|mesh-list
92110203|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92110204|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92110206|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110207|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110208|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92110209|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92110210|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
92110211|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110212|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92068311|NCT05257824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110213|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92110214|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92110215|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92110216|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92110218|NCT01866592|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92110219|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110220|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110221|NCT01375608|Decitabine|decitabine|mesh-list
92110222|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92110223|NCT01375608|Antimetabolites|antimetabolites|mesh-ancestor
92110224|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110225|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110226|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110227|NCT01868776|Lidocaine|lidocaine|mesh-list
92110228|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
92110229|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
92110230|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110231|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110232|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
92110233|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110234|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92110235|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92110236|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92110237|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110238|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110239|NCT00704418|Bromfenac|bromfenac|mesh-list
92110240|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92110241|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92110243|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
92110244|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110245|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110246|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110247|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110248|NCT01869634|Ritonavir|ritonavir|mesh-list
92110249|NCT01869634|Darunavir|darunavir|mesh-list
92110250|NCT01869634|Emtricitabine|emtricitabine|mesh-list
92110251|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92110252|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92110253|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
92110254|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110255|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110256|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92110257|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92110258|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
92110259|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110260|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92110261|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92110262|NCT01869634|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92110263|NCT01869634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92110265|NCT02047578|Alkylating Agents|alkylating agents|mesh-ancestor
92018294|NCT04910347|Nivolumab|nivolumab|mesh-list
92110266|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110267|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110268|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
92110269|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110270|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110271|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110272|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92110273|NCT04837066|Imidacloprid|imidacloprid|mesh-list
92110274|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
92110275|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110276|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110277|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110278|NCT04807894|Testosterone|testosterone|mesh-list
92110279|NCT04807894|Androgens|androgens|mesh-ancestor
92110280|NCT04807894|Hormones|hormones|mesh-ancestor
92110281|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110282|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110283|NCT01874392|Insulin|insulin|mesh-list
92110284|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92110285|NCT01874392|Pancrelipase|pancrelipase|mesh-list
92110286|NCT01874392|Pancreatin|pancreatin|mesh-list
92110287|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110288|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110289|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92110290|NCT00576654|Irinotecan|irinotecan|mesh-list
92110291|NCT00576654|Camptothecin|camptothecin|mesh-list
92110292|NCT00576654|Veliparib|veliparib|mesh-list
92110293|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92110294|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110295|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110296|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110297|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110298|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92110299|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92110300|NCT03314064|Dolutegravir|dolutegravir|mesh-list
92110301|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92110302|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92110303|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110304|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110305|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92110306|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92110307|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
92110308|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110309|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
92110310|NCT00552058|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92110311|NCT00552058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110312|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110313|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
92110314|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110315|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110316|NCT02473302|Tocopherols|tocopherols|mesh-list
92110317|NCT02473302|Vitamin E|vitamin e|mesh-list
92110319|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
92110320|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
92110321|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110322|NCT02473302|Protective Agents|protective agents|mesh-ancestor
92110323|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110324|NCT02473302|Vitamins|vitamins|mesh-ancestor
92110325|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
92110326|NCT05747326|Capecitabine|capecitabine|mesh-list
92110327|NCT05747326|Vinorelbine|vinorelbine|mesh-list
92110328|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92110329|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
92110330|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110331|NCT05747326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110332|NCT05747326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92110333|NCT05747326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110334|NCT05747326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110335|NCT05747326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110336|NCT03108300|Doxorubicin|doxorubicin|mesh-list
92110337|NCT03108300|Propranolol|propranolol|mesh-list
92110338|NCT03108300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92110339|NCT03108300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110340|NCT03108300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92110341|NCT03108300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110342|NCT03108300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110343|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110344|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92110345|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92110346|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
92110347|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110348|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110349|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92110350|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92110351|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
92110352|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
92110353|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92110354|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110355|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110356|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110357|NCT02473146|Gemtuzumab|gemtuzumab|mesh-list
92110358|NCT02473146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110359|NCT02473146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110360|NCT02473146|Immunotoxins|immunotoxins|mesh-ancestor
92110361|NCT02473146|Immunoconjugates|immunoconjugates|mesh-ancestor
92110362|NCT02473146|Immunologic Factors|immunologic factors|mesh-ancestor
92110363|NCT02473146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110364|NCT02989012|Oseltamivir|oseltamivir|mesh-list
92110365|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
92110366|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110367|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110368|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110369|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92110370|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92110372|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92110373|NCT03832894|Progesterone|progesterone|mesh-list
92110374|NCT03832894|Estrogens|estrogens|mesh-ancestor
92110375|NCT03832894|Hormones|hormones|mesh-ancestor
92110376|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110377|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110378|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92110379|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
92110380|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92110381|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92110382|NCT03832894|Progestins|progestins|mesh-ancestor
92110383|NCT02989324|Misoprostol|misoprostol|mesh-list
92110384|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92110385|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
92110386|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92110387|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110388|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92110389|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92110390|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
92110391|NCT03686124|Nivolumab|nivolumab|mesh-list
92110392|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110393|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110394|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92110395|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110396|NCT00550732|Posaconazole|posaconazole|mesh-list
92110397|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
92110398|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110399|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92110400|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92110401|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92110402|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92110403|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92110404|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110405|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110406|NCT00550732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92110407|NCT00550732|Hormone Antagonists|hormone antagonists|mesh-ancestor
92110408|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110409|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110410|NCT03311022|Nefopam|nefopam|mesh-list
92110411|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92110412|NCT03311022|Analgesics|analgesics|mesh-ancestor
92110413|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
92110414|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110415|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110416|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
92110417|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110418|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110419|NCT00559936|Bevacizumab|bevacizumab|mesh-list
92110420|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110421|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110423|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92110424|NCT00559936|Growth Substances|growth substances|mesh-ancestor
92110425|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110426|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92110427|NCT05353192|Hormones|hormones|mesh-list
92110428|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110429|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110430|NCT03310242|Vitamin D|vitamin d|mesh-list
92110431|NCT03310242|Vitamins|vitamins|mesh-ancestor
92110432|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
92110433|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110434|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92110436|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92110437|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
92110438|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110439|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110440|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92110441|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92110442|NCT00557128|Protective Agents|protective agents|mesh-ancestor
92110443|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110444|NCT03312582|Metformin|metformin|mesh-list
92110445|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110446|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110447|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
92110448|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92110449|NCT04350580|Antibodies|antibodies|mesh-list
92110450|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
92110451|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110452|NCT00558064|Amlodipine|amlodipine|mesh-list
92110453|NCT00558064|Telmisartan|telmisartan|mesh-list
92110454|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92110455|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92110456|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92110457|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110458|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110459|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92110460|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110461|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
92110462|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92110463|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92110464|NCT03312426|Linrodostat|linrodostat|mesh-list
92110465|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110466|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110467|NCT03309618|Valsartan|valsartan|mesh-list
92110468|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92110469|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92110470|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92110471|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110473|NCT03303924|Durlobactam|durlobactam|mesh-list
92110474|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92110475|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110476|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92110477|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110478|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110479|NCT00557830|Sorafenib|sorafenib|mesh-list
92110480|NCT00557830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110481|NCT00557830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92110482|NCT00557830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110483|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110484|NCT00557440|Fluticasone|fluticasone|mesh-list
92110485|NCT00557440|Xhance|xhance|mesh-list
92110486|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
92110487|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92110488|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92110489|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110490|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92110491|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
92110492|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110493|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110494|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92110495|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
92110497|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92110498|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92110499|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92110500|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92110501|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
92110502|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110503|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110504|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
92110505|NCT00557440|Hormones|hormones|mesh-ancestor
92110506|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110507|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
92110508|NCT03311178|Dobutamine|dobutamine|mesh-list
92110509|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92110510|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
92110511|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
92110512|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110513|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110514|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92110515|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92110516|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92110517|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
92110518|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110519|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110520|NCT03311178|Protective Agents|protective agents|mesh-ancestor
92110521|NCT02469012|Ribavirin|ribavirin|mesh-list
92110522|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
92110523|NCT02469012|Ledipasvir|ledipasvir|mesh-list
92110524|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
92110525|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110526|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
92110527|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110528|NCT02468856|Modafinil|modafinil|mesh-list
92110529|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92110530|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110531|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92110532|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92110533|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92110534|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110535|NCT05224336|Niacin|niacin|mesh-list
92110536|NCT05224336|Psilocybin|psilocybin|mesh-list
92110537|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92110538|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
92110539|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110540|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92110541|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
92110542|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
92110543|NCT05224336|Vitamins|vitamins|mesh-ancestor
92110544|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
92110545|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110546|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
92110547|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92110548|NCT03303378|Melatonin|melatonin|mesh-list
92110549|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
92110550|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110551|NCT03303378|Protective Agents|protective agents|mesh-ancestor
92110552|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110553|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110554|NCT04491474|Lidocaine|lidocaine|mesh-list
92110555|NCT04491474|Anesthetics, Local|anesthetics, local|mesh-ancestor
92110556|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
92110557|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110558|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110559|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
92110560|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110561|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92110562|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92110563|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92110564|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110565|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110566|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
92110567|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92110568|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110569|NCT03308604|Cisplatin|cisplatin|mesh-list
92110570|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110571|NCT00553306|Aldesleukin|aldesleukin|mesh-list
92110572|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
92110573|NCT00553306|Interleukin-2|interleukin-2|mesh-list
92110574|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110575|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
92110576|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110577|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110578|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110579|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
92110580|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110581|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110582|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92110583|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92110584|NCT00553306|Analgesics|analgesics|mesh-ancestor
92110585|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
92110586|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068693|NCT04236414|Olaparib|olaparib|mesh-list
92110587|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92110588|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92110589|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
92110590|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110591|NCT02722044|Adalimumab|adalimumab|mesh-list
92110592|NCT02722044|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92110593|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110594|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110595|NCT05728008|Ustekinumab|ustekinumab|mesh-list
92110596|NCT05728008|Tofacitinib|tofacitinib|mesh-list
92110597|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
92110598|NCT05728008|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92110599|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92110600|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110601|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110602|NCT02988700|Bupivacaine|bupivacaine|mesh-list
92110603|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
92110604|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
92110605|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110606|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110607|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
92110608|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110609|NCT03308214|Imipenem|imipenem|mesh-list
92110610|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92110611|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110612|NCT03308136|Lidocaine|lidocaine|mesh-list
92110613|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
92110614|NCT03308136|Anesthetics|anesthetics|mesh-list
92110615|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110616|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110617|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
92110618|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110619|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92110620|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92110621|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92110622|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110623|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110625|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
92110626|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
92110627|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110628|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110629|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92110630|NCT02466984|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92110631|NCT02466984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92110632|NCT02466984|Dopamine Agents|dopamine agents|mesh-ancestor
92110633|NCT02466984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110634|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110635|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
92110636|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110637|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110638|NCT03307902|Imiquimod|imiquimod|mesh-list
92110639|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92110640|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
92110641|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110642|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110643|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
92110644|NCT03302364|Risperidone|risperidone|mesh-list
92110645|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92110646|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
92110647|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110648|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110649|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110650|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92110651|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92110652|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110653|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92110654|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92110655|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
92110656|NCT02467920|Exenatide|exenatide|mesh-list
92110657|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110658|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110659|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92110660|NCT02467920|Incretins|incretins|mesh-ancestor
92110661|NCT02467920|Hormones|hormones|mesh-ancestor
92110662|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110663|NCT04927312|Metronidazole|metronidazole|mesh-list
92110664|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110665|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92110666|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92110667|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92110668|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
92110669|NCT03307590|Bupivacaine|bupivacaine|mesh-list
92110670|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
92110671|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
92110672|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110673|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110674|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
92110675|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110676|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92110677|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92110679|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92110680|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92110681|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92110682|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
92110683|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110684|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110685|NCT03302208|Pregabalin|pregabalin|mesh-list
92110686|NCT03302208|Analgesics|analgesics|mesh-ancestor
92110687|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
92110688|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110689|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110690|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
92110691|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92110692|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110693|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110694|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92110696|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92110697|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110698|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92110699|NCT03307512|Insulin|insulin|mesh-list
92110700|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92110701|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
92110702|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92110703|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110704|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92110705|NCT02466828|Hematinics|hematinics|mesh-ancestor
92142829|NCT03896737|Protease Inhibitors|protease inhibitors|mesh-ancestor
92110706|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92110707|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92110708|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92110709|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
92110710|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110711|NCT00553462|Paclitaxel|paclitaxel|mesh-list
92110712|NCT00553462|Carboplatin|carboplatin|mesh-list
92110713|NCT00553462|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92110714|NCT00553462|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92110715|NCT00553462|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92110716|NCT00553462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110717|NCT00553462|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110718|NCT00553462|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110719|NCT00553462|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110720|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110721|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92110722|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110723|NCT04874038|Lidocaine|lidocaine|mesh-list
92110724|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
92110725|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
92110726|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110727|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110728|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
92110729|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110730|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92110731|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92110732|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92110733|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110734|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110735|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92110736|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
92110737|NCT03301974|Coagulants|coagulants|mesh-ancestor
92110738|NCT03306732|Thiamine|thiamine|mesh-list
92110740|NCT03306732|Vitamins|vitamins|mesh-ancestor
92110741|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
92110742|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110743|NCT00553150|Everolimus|everolimus|mesh-list
92110744|NCT00553150|Temozolomide|temozolomide|mesh-list
92110745|NCT00553150|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92110746|NCT00553150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92110747|NCT00553150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110748|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110749|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110750|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
92110751|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110752|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110753|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110754|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
92110755|NCT02468232|Enalapril|enalapril|mesh-list
92110756|NCT02468232|Enalaprilat|enalaprilat|mesh-list
92110757|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92110758|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92110759|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
92110760|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110761|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110762|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92110763|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92110764|NCT04630834|Acetaminophen|acetaminophen|mesh-list
92110765|NCT04630834|Ibuprofen|ibuprofen|mesh-list
92110766|NCT04630834|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92110767|NCT04630834|Analgesics|analgesics|mesh-ancestor
92110768|NCT04630834|Sensory System Agents|sensory system agents|mesh-ancestor
92110769|NCT04630834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110770|NCT04630834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110772|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92110773|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110774|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110775|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92110776|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110777|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110778|NCT03301350|Paclitaxel|paclitaxel|mesh-list
92110779|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
92110780|NCT03301350|Carboplatin|carboplatin|mesh-list
92110781|NCT03301350|Doxorubicin|doxorubicin|mesh-list
92110782|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92110783|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110784|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110785|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110786|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110787|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110788|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110789|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
92110790|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110791|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110792|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110793|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
92110794|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92110795|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92110796|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92110797|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110798|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110800|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110801|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
92110802|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
92110803|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
92110804|NCT02722278|Methyltestosterone|methyltestosterone|mesh-list
92110805|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92110806|NCT02722278|Testosterone|testosterone|mesh-list
92110807|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
92110808|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
92110809|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92110810|NCT02722278|Androgens|androgens|mesh-ancestor
92110811|NCT02722278|Hormones|hormones|mesh-ancestor
92110812|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110813|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110814|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92110815|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110816|NCT02722278|Anabolic Agents|anabolic agents|mesh-ancestor
92110817|NCT03300960|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92110818|NCT03300960|Ganirelix|ganirelix|mesh-list
92110819|NCT03300960|Hormone Antagonists|hormone antagonists|mesh-ancestor
92110820|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110821|NCT03300960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110822|NCT03300960|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92110823|NCT03300960|Contraceptive Agents|contraceptive agents|mesh-ancestor
92110824|NCT03300960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92110825|NCT03300960|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92110826|NCT03300960|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92110827|NCT03300960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92110828|NCT03300960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110829|NCT02993146|Ropidoxuridine|ropidoxuridine|mesh-list
92110830|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110831|NCT02485444|Oxytocin|oxytocin|mesh-list
92110832|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
92110833|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92110834|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110835|NCT04443010|Temozolomide|temozolomide|mesh-list
92110836|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110837|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
92110838|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110839|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110840|NCT04490694|Lenvatinib|lenvatinib|mesh-list
92110841|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110842|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92110843|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110844|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110846|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
92110847|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
92110848|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110849|NCT02359474|Trabectedin|trabectedin|mesh-list
92110850|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110851|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
92116529|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110852|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110853|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110854|NCT02467686|Tamoxifen|tamoxifen|mesh-list
92110855|NCT02467686|Exemestane|exemestane|mesh-list
92110856|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92110857|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92110858|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
92110859|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110860|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110861|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92110862|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110863|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92110864|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92110865|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92110866|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92110867|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110868|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110869|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
92110870|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
92110871|NCT05707962|Analgesics|analgesics|mesh-ancestor
92110872|NCT05707962|Sensory System Agents|sensory system agents|mesh-ancestor
92110873|NCT05707962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110874|NCT05707962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110875|NCT05707962|Anesthetics|anesthetics|mesh-ancestor
92110876|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92110877|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92110878|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
92110879|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92110880|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92110881|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110882|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92110883|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
92110884|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92110885|NCT05707962|Protective Agents|protective agents|mesh-ancestor
92110886|NCT01993810|Paclitaxel|paclitaxel|mesh-list
92110887|NCT01993810|Etoposide|etoposide|mesh-list
92110888|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
92110889|NCT01993810|Cisplatin|cisplatin|mesh-list
92110890|NCT01993810|Carboplatin|carboplatin|mesh-list
92110891|NCT01993810|Pemetrexed|pemetrexed|mesh-list
92110892|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92110893|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
92110894|NCT01993810|Durvalumab|durvalumab|mesh-list
92110895|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
92110896|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92110897|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
92110898|NCT01993810|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92110899|NCT01993810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110900|NCT01993810|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110901|NCT01993810|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110902|NCT01993810|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110903|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110904|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92110905|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110906|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110907|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92110908|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92110909|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110910|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
92110911|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110912|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
92110913|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
92110914|NCT05698680|Prednisolone|prednisolone|mesh-list
92110915|NCT05698680|Colchicine|colchicine|mesh-list
92110916|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110917|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
92110918|NCT05698680|Hormones|hormones|mesh-ancestor
92110919|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110920|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110921|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92110922|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110923|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
92110924|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110925|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110926|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110927|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110928|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110930|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
92110931|NCT04058470|Rituximab|rituximab|mesh-list
92110932|NCT04058470|Doxorubicin|doxorubicin|mesh-list
92110933|NCT04058470|Vincristine|vincristine|mesh-list
92110934|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92110935|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
92110936|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110937|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92110938|NCT04058470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92110939|NCT04058470|Alkylating Agents|alkylating agents|mesh-ancestor
92110940|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110942|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92110943|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110944|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92110945|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92110946|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92110947|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92110948|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92110949|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
92110950|NCT04058470|Hormones|hormones|mesh-ancestor
92110951|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110952|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92110953|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92110954|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92110955|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92110956|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92110957|NCT02720484|Nivolumab|nivolumab|mesh-list
92110958|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92110959|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92110960|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92110961|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110962|NCT05447520|Montelukast|montelukast|mesh-list
92110963|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92110964|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
92110965|NCT05447520|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92110966|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92110967|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92110968|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110969|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92110970|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92110971|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110972|NCT05438550|Amoxicillin|amoxicillin|mesh-list
92110973|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92110974|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92110975|NCT05639946|Brivaracetam|brivaracetam|mesh-list
92110976|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
92110977|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92110978|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
92110979|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92110980|NCT03299712|Protective Agents|protective agents|mesh-ancestor
92110981|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110982|NCT05327556|Epinephrine|epinephrine|mesh-list
92110983|NCT05327556|Racepinephrine|racepinephrine|mesh-list
92110984|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
92110985|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92110986|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92110987|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
92110988|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92110989|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92110990|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92110991|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92110992|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92110993|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
92110994|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92110995|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92110996|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
92110997|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
92110998|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
92110999|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92111000|NCT02466438|Tazobactam|tazobactam|mesh-list
92111001|NCT02466438|Piperacillin|piperacillin|mesh-list
92111002|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92111003|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111004|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111005|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92111006|NCT02466438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111007|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111008|NCT05587062|Aflibercept|aflibercept|mesh-list
92111009|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92111010|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92111011|NCT05587062|Growth Substances|growth substances|mesh-ancestor
92111012|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111013|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
92111014|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111015|NCT02463006|Methamphetamine|methamphetamine|mesh-list
92111016|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92111017|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111018|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
92111019|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
92111020|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111021|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
92111022|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111023|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111024|NCT02463006|Adrenergic Agents|adrenergic agents|mesh-ancestor
92111025|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92111026|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92111027|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92111028|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92111029|NCT04779216|Alendronate|alendronate|mesh-list
92111030|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92111031|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111032|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92111033|NCT02466204|Hormones|hormones|mesh-ancestor
92111034|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111035|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111047|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111048|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111050|NCT02462304|Ranibizumab|ranibizumab|mesh-list
92111051|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111052|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111053|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92111054|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92111055|NCT02462304|Growth Substances|growth substances|mesh-ancestor
92111056|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111057|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
92111058|NCT03501576|Vaccines|vaccines|mesh-list
92111059|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
92111060|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111061|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
92111062|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92111063|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
92111064|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92111065|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111066|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92111067|NCT04645212|Aflibercept|aflibercept|mesh-list
92111068|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92111069|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92111070|NCT04645212|Growth Substances|growth substances|mesh-ancestor
92111071|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111072|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
92111073|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111074|NCT04489446|Sildenafil Citrate|sildenafil citrate|mesh-list
92111075|NCT04489446|Vasodilator Agents|vasodilator agents|mesh-ancestor
92111076|NCT04489446|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92111077|NCT04489446|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92111078|NCT04489446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111079|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018332|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
92111080|NCT04489446|Urological Agents|urological agents|mesh-ancestor
92111081|NCT02717754|Oseltamivir|oseltamivir|mesh-list
92111082|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
92111083|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111084|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111085|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111086|NCT04497168|Citalopram|citalopram|mesh-list
92111087|NCT04497168|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92111088|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92111089|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92111090|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111091|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111092|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
92111093|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111094|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92111095|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
92111096|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92111108|NCT02717130|Aripiprazole|aripiprazole|mesh-list
92111109|NCT02717130|Antidepressive Agents|antidepressive agents|mesh-ancestor
92111111|NCT02717130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92111112|NCT02717130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92111113|NCT02717130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111114|NCT02717130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111115|NCT02717130|Dopamine Agonists|dopamine agonists|mesh-ancestor
92111116|NCT02717130|Dopamine Agents|dopamine agents|mesh-ancestor
92111117|NCT02717130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111118|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111119|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92111120|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92111121|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
92111122|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92111123|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92111124|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92111125|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92111126|NCT02256696|Rifampin|rifampin|mesh-list
92111127|NCT02256696|Rifabutin|rifabutin|mesh-list
92111128|NCT02256696|Isoniazid|isoniazid|mesh-list
92111129|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
92111130|NCT02256696|Ethambutol|ethambutol|mesh-list
92111131|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92111132|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
92111133|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111134|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111135|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
92111136|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92111137|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111138|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111139|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92111140|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92111141|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92111142|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92111143|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92111144|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92111145|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92111146|NCT02256696|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92111147|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
92111148|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92111149|NCT01773473|Insulin|insulin|mesh-list
92111150|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92111151|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
92111152|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92111153|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111154|NCT01779869|Regadenoson|regadenoson|mesh-list
92111155|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92111156|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92111157|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
92111158|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
92111159|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111160|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111161|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111162|NCT01772537|Propofol|propofol|mesh-list
92111163|NCT01772537|Isoflurane|isoflurane|mesh-list
92111164|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92111165|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111166|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111167|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92111168|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
92111169|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
92111170|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92111171|NCT01772147|Fluticasone|fluticasone|mesh-list
92111172|NCT01772147|Xhance|xhance|mesh-list
92111173|NCT01772147|Bromides|bromides|mesh-list
92111174|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92111175|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111176|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92111177|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
92111178|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111179|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111180|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92111181|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
92111182|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111183|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92111184|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92111185|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92111186|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92111187|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
92111188|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111189|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111190|NCT01772147|Anticonvulsants|anticonvulsants|mesh-ancestor
92111192|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92111193|NCT01606787|Diuretics|diuretics|mesh-ancestor
92111194|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
92111195|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111196|NCT01777997|Tenofovir|tenofovir|mesh-list
92111197|NCT01777997|Emtricitabine|emtricitabine|mesh-list
92111198|NCT01777997|Rilpivirine|rilpivirine|mesh-list
92111199|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
92111200|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111201|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92111202|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92111203|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111204|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111205|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92111206|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92111207|NCT01770353|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92111208|NCT01770353|Hematinics|hematinics|mesh-ancestor
92111209|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92111210|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92111211|NCT01777763|Posaconazole|posaconazole|mesh-list
92111212|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
92111213|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111214|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92111215|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92111216|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92111217|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92111218|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92111219|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111220|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111221|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92111222|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
92111223|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111224|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111225|NCT01769339|Miconazole|miconazole|mesh-list
92111226|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
92111227|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111228|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
92111229|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111230|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92111231|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92111232|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111233|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111234|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92111235|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
92111236|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111237|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111238|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92111239|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92111241|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
92111242|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92111243|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111244|NCT01768637|Aspirin|aspirin|mesh-list
92111245|NCT01768637|Clopidogrel|clopidogrel|mesh-list
92111246|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92111247|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111248|NCT01768637|Analgesics|analgesics|mesh-ancestor
92111249|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
92111250|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111251|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111252|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111253|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111254|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92111255|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92111256|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111257|NCT01768637|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92111258|NCT01768637|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92111259|NCT01768637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111260|NCT01768637|Antipyretics|antipyretics|mesh-ancestor
92111261|NCT01768637|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92111262|NCT01768637|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92111263|NCT01768637|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92111264|NCT01768637|Purinergic Agents|purinergic agents|mesh-ancestor
92111265|NCT01768637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111267|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92111268|NCT01768559|Metformin|metformin|mesh-list
92111269|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
92111270|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
92111271|NCT01768559|Lixisenatide|lixisenatide|mesh-list
92111272|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92111273|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111274|NCT00983619|Rituximab|rituximab|mesh-list
92111275|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111276|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111277|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
91938402|NCT05253794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111278|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111279|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111280|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
92111281|NCT00653068|Leucovorin|leucovorin|mesh-list
92111282|NCT00653068|Folic Acid|folic acid|mesh-list
92111283|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
92111284|NCT00653068|Thiotepa|thiotepa|mesh-list
92111285|NCT00653068|Cisplatin|cisplatin|mesh-list
92111286|NCT00653068|Carboplatin|carboplatin|mesh-list
92111287|NCT00653068|Methotrexate|methotrexate|mesh-list
92111288|NCT00653068|Etoposide|etoposide|mesh-list
92111289|NCT00653068|Vincristine|vincristine|mesh-list
92111290|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
92111291|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
92111292|NCT00653068|Lenograstim|lenograstim|mesh-list
92111293|NCT00653068|Calcium|calcium|mesh-list
92111294|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
92111295|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111296|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
92111297|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111298|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111299|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92111300|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
92111301|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111302|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111303|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92111304|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92111305|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92111306|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92111307|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
92111308|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92111309|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92111310|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
92111311|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111312|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111313|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92111314|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92111315|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92111316|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92111317|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92111318|NCT00653068|Antidotes|antidotes|mesh-ancestor
92111319|NCT00653068|Protective Agents|protective agents|mesh-ancestor
92111320|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
92111321|NCT00653068|Vitamins|vitamins|mesh-ancestor
92111322|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
92111323|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92111324|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
92111325|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
92111326|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
92111327|NCT00653068|Hematinics|hematinics|mesh-ancestor
92111328|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
92111329|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
92111330|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92111331|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111332|NCT05608785|Capecitabine|capecitabine|mesh-list
92111333|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
92111334|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92111335|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
92111336|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111337|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111339|NCT01775501|Fluorouracil|fluorouracil|mesh-list
92111340|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
92111341|NCT01775501|Sorafenib|sorafenib|mesh-list
92111342|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
92111343|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111344|NCT01775501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92111345|NCT01775501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111346|NCT01775501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111347|NCT01775501|Immunologic Factors|immunologic factors|mesh-ancestor
92111348|NCT01775501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111349|NCT01775501|Antidotes|antidotes|mesh-ancestor
92111350|NCT01775501|Protective Agents|protective agents|mesh-ancestor
92111351|NCT01775501|Vitamin B Complex|vitamin b complex|mesh-ancestor
92111352|NCT01775501|Vitamins|vitamins|mesh-ancestor
92111353|NCT01775501|Micronutrients|micronutrients|mesh-ancestor
92111354|NCT01775501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92111355|NCT01775501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111356|NCT04346667|Hydroxychloroquine|hydroxychloroquine|mesh-list
92111357|NCT04346667|Chloroquine|chloroquine|mesh-list
92111358|NCT04346667|Antimalarials|antimalarials|mesh-ancestor
92111359|NCT04346667|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92111360|NCT04346667|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92111361|NCT04346667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111362|NCT04346667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111363|NCT04346667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111364|NCT04346667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111365|NCT04346667|Amebicides|amebicides|mesh-ancestor
92111366|NCT03024489|Cetuximab|cetuximab|mesh-list
92111367|NCT03024489|Palbociclib|palbociclib|mesh-list
92111368|NCT03024489|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111369|NCT03024489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111370|NCT03024489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92111371|NCT03024489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111372|NCT03024489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111373|NCT01775189|Naltrexone|naltrexone|mesh-list
92111374|NCT01775189|Oxycodone|oxycodone|mesh-list
92111375|NCT01775189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92111376|NCT01775189|Narcotics|narcotics|mesh-ancestor
92111377|NCT01775189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111378|NCT01775189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111379|NCT01775189|Analgesics|analgesics|mesh-ancestor
92111380|NCT01775189|Sensory System Agents|sensory system agents|mesh-ancestor
92111381|NCT01775189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111382|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92111383|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92111384|NCT04551963|Clarithromycin|clarithromycin|mesh-list
92111385|NCT04551963|Fluconazole|fluconazole|mesh-list
92111386|NCT04551963|Voriconazole|voriconazole|mesh-list
92111387|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
92111388|NCT04551963|Diltiazem|diltiazem|mesh-list
92111389|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111390|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111391|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92111392|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111393|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111394|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92111395|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92111396|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
92111397|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92111398|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92111399|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
92111400|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111401|NCT04551963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111402|NCT04551963|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92111403|NCT04551963|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92111404|NCT04551963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111405|NCT04551963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92111406|NCT04551963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92111407|NCT04551963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92111408|NCT04551963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92111409|NCT04551963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92111410|NCT04551963|Vasodilator Agents|vasodilator agents|mesh-ancestor
92111411|NCT01881412|Fluticasone|fluticasone|mesh-list
92111412|NCT01881412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111413|NCT01881412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92111414|NCT01881412|Autonomic Agents|autonomic agents|mesh-ancestor
92111415|NCT01881412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111416|NCT01881412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111417|NCT01881412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92111418|NCT01881412|Respiratory System Agents|respiratory system agents|mesh-ancestor
92111419|NCT01881412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111420|NCT01881412|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92111422|NCT03832816|Hallucinogens|hallucinogens|mesh-ancestor
92111423|NCT03832816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111424|NCT03832816|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92111425|NCT03832816|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111427|NCT03832816|Sensory System Agents|sensory system agents|mesh-ancestor
92111428|NCT03832816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111429|NCT03832816|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92111430|NCT03832816|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92111431|NCT03832816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111432|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111433|NCT03832816|Hormones|hormones|mesh-ancestor
92111434|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111435|NCT04231084|Epoprostenol|epoprostenol|mesh-list
92111436|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
92111437|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
92111438|NCT04231084|Tezosentan|tezosentan|mesh-list
92111439|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92111440|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
92111441|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111442|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111443|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92111444|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
92111445|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92111446|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
92111447|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111448|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111449|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92111450|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
92111451|NCT04231084|Protective Agents|protective agents|mesh-ancestor
92111452|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92111453|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92111454|NCT01770743|Vaccines|vaccines|mesh-list
92111455|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
92111456|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111457|NCT01884844|Vitamin D|vitamin d|mesh-list
92111458|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
92111459|NCT01884844|Vitamins|vitamins|mesh-ancestor
92111460|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
92116530|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111461|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111462|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92111463|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92111464|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92111465|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111467|NCT04127721|Fludarabine|fludarabine|mesh-list
92111468|NCT04127721|Busulfan|busulfan|mesh-list
92111469|NCT04127721|Tacrolimus|tacrolimus|mesh-list
92111470|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92111471|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
92111472|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92111473|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111474|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92111475|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
92111476|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111477|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111478|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111479|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111480|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92111481|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111482|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
92111483|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111484|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92111485|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92111486|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
92111487|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92111488|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92111489|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
92111490|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92111491|NCT04123743|Protective Agents|protective agents|mesh-ancestor
92111492|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111493|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111494|NCT02996721|Vitamin D|vitamin d|mesh-list
92111495|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
92111496|NCT02996721|Vitamins|vitamins|mesh-ancestor
92111497|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
92111498|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111499|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92111500|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92111501|NCT04122885|Oxaliplatin|oxaliplatin|mesh-list
92111502|NCT04122885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111503|NCT03926338|Celecoxib|celecoxib|mesh-list
92111504|NCT03926338|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-list
92111505|NCT03926338|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92111506|NCT03926338|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92111507|NCT03926338|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111508|NCT03926338|Analgesics|analgesics|mesh-ancestor
92111509|NCT03926338|Sensory System Agents|sensory system agents|mesh-ancestor
92111510|NCT03926338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111511|NCT03926338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111512|NCT03926338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111513|NCT03926338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111514|NCT03926338|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92111515|NCT03926338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111516|NCT03926338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111517|NCT03926338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111518|NCT03926338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111519|NCT04126941|Calcium|calcium|mesh-list
92111520|NCT04126941|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92111521|NCT04126941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111522|NCT02506192|Prednisone|prednisone|mesh-list
92111523|NCT02506192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111524|NCT02506192|Glucocorticoids|glucocorticoids|mesh-ancestor
92111525|NCT02506192|Hormones|hormones|mesh-ancestor
92111526|NCT02506192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111527|NCT02506192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111528|NCT02506192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92111529|NCT02506192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111530|NCT04122105|Sildenafil Citrate|sildenafil citrate|mesh-list
92111531|NCT04122105|Vasodilator Agents|vasodilator agents|mesh-ancestor
92111532|NCT04122105|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92111533|NCT04122105|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92111534|NCT04122105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111535|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111536|NCT04122105|Urological Agents|urological agents|mesh-ancestor
92111537|NCT04127019|Paclitaxel|paclitaxel|mesh-list
92111538|NCT04127019|Docetaxel|docetaxel|mesh-list
92111539|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
92111540|NCT04127019|Fluorouracil|fluorouracil|mesh-list
92111541|NCT04127019|Epirubicin|epirubicin|mesh-list
92111542|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92111543|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111544|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
92111545|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
92111546|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
92111547|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111548|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111549|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
92111550|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111551|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938440|NCT01352741|Tapentadol|tapentadol|mesh-list
92111552|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92111553|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
92111554|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92111555|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
92111556|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92111557|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92111558|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92111559|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92111560|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111561|NCT02076646|Interleukin-2|interleukin-2|mesh-list
92111562|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111563|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111564|NCT02076646|Analgesics|analgesics|mesh-ancestor
92111565|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
92111566|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111567|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111568|NCT04121091|Pramipexole|pramipexole|mesh-list
92111569|NCT04121091|Antioxidants|antioxidants|mesh-ancestor
92111570|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111571|NCT04121091|Protective Agents|protective agents|mesh-ancestor
92111572|NCT04121091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111573|NCT04121091|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92111574|NCT04121091|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92111575|NCT04121091|Dopamine Agonists|dopamine agonists|mesh-ancestor
92111576|NCT04121091|Dopamine Agents|dopamine agents|mesh-ancestor
92111577|NCT04121091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111578|NCT03283605|Durvalumab|durvalumab|mesh-list
92111579|NCT03283605|Tremelimumab|tremelimumab|mesh-list
92111580|NCT03283605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111581|NCT03283605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111582|NCT01896544|Cholecalciferol|cholecalciferol|mesh-list
92111583|NCT01896544|Vitamin D|vitamin d|mesh-list
92111584|NCT01896544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92111585|NCT01896544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111586|NCT01896544|Vitamins|vitamins|mesh-ancestor
92111587|NCT01896544|Micronutrients|micronutrients|mesh-ancestor
92111588|NCT01896544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92111589|NCT04120623|Insulin Aspart|insulin aspart|mesh-list
92111590|NCT04120623|Dapagliflozin|dapagliflozin|mesh-list
92111591|NCT04120623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92111592|NCT04120623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111593|NCT04120623|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92111594|NCT04120623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111595|NCT01931878|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92111596|NCT01931878|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92111597|NCT01931878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111598|NCT01931878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111599|NCT01931878|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92111600|NCT01931878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92111601|NCT01931878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111602|NCT01931878|Cholinergic Agents|cholinergic agents|mesh-ancestor
92111603|NCT01931878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111604|NCT01932112|Adenosine|adenosine|mesh-list
92111605|NCT01932112|Analgesics|analgesics|mesh-ancestor
92111606|NCT01932112|Sensory System Agents|sensory system agents|mesh-ancestor
92111607|NCT01932112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111608|NCT01932112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111609|NCT01932112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92111610|NCT01932112|Vasodilator Agents|vasodilator agents|mesh-ancestor
92111611|NCT01932112|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92111612|NCT01932112|Purinergic Agonists|purinergic agonists|mesh-ancestor
92111613|NCT01932112|Purinergic Agents|purinergic agents|mesh-ancestor
92111614|NCT01932112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111615|NCT01932112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111616|NCT04120311|Dexamethasone|dexamethasone|mesh-list
92111617|NCT04120311|Dexamethasone acetate|dexamethasone acetate|mesh-list
92111618|NCT04120311|BB 1101|bb 1101|mesh-list
92111619|NCT04120311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111620|NCT04120311|Antiemetics|antiemetics|mesh-ancestor
92111621|NCT04120311|Autonomic Agents|autonomic agents|mesh-ancestor
92111622|NCT04120311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111623|NCT04120311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111624|NCT04120311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92111625|NCT04120311|Glucocorticoids|glucocorticoids|mesh-ancestor
92111627|NCT04120311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111628|NCT04120311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92111629|NCT04120311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111630|NCT04120311|Protease Inhibitors|protease inhibitors|mesh-ancestor
92111631|NCT04120311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111632|NCT04120311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111633|NCT01897402|Vaccines|vaccines|mesh-list
92111634|NCT01897402|Immunologic Factors|immunologic factors|mesh-ancestor
92111635|NCT01897402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111636|NCT01897792|Vitamins|vitamins|mesh-list
92111637|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
92111638|NCT01897792|Vitamin E|vitamin e|mesh-list
92111639|NCT01897792|Tocopherols|tocopherols|mesh-list
92111640|NCT01897792|Tocotrienols|tocotrienols|mesh-list
92111641|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
92111642|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
92111643|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111644|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
92111645|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111646|NCT01897792|Protective Agents|protective agents|mesh-ancestor
92111647|NCT01933984|Fluticasone|fluticasone|mesh-list
92111648|NCT01933984|Fenoterol|fenoterol|mesh-list
92111649|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92111650|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
92111651|NCT01933984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111652|NCT01933984|Autonomic Agents|autonomic agents|mesh-ancestor
92111653|NCT01933984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111654|NCT01933984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111655|NCT01933984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92111656|NCT01933984|Respiratory System Agents|respiratory system agents|mesh-ancestor
92111657|NCT01933984|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111658|NCT01933984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92111659|NCT01933984|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92111660|NCT01933984|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92111661|NCT01933984|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92111662|NCT01933984|Adrenergic Agents|adrenergic agents|mesh-ancestor
92111663|NCT01933984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111664|NCT01933984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111665|NCT01933984|Sympathomimetics|sympathomimetics|mesh-ancestor
92111666|NCT01933984|Tocolytic Agents|tocolytic agents|mesh-ancestor
92111667|NCT01933984|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92111668|NCT04126083|Lofexidine|lofexidine|mesh-list
92111669|NCT04126083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92111670|NCT04126083|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92111671|NCT04126083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111672|NCT04126083|Sensory System Agents|sensory system agents|mesh-ancestor
92111673|NCT04126083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111674|NCT04126083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92111675|NCT04126083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92111676|NCT04126083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92111677|NCT04126083|Adrenergic Agents|adrenergic agents|mesh-ancestor
92111678|NCT04126083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111679|NCT04126083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111680|NCT01935622|Doxycycline|doxycycline|mesh-list
92111681|NCT01935622|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111682|NCT01935622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111683|NCT01935622|Antimalarials|antimalarials|mesh-ancestor
92111684|NCT01935622|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92111685|NCT01935622|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92111686|NCT03010917|Ethanol|ethanol|mesh-list
92111687|NCT03010917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92111688|NCT03010917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111689|NCT03010917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111690|NCT03010917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111691|NCT02979561|Warfarin|warfarin|mesh-list
92111692|NCT02979561|Dabigatran|dabigatran|mesh-list
92111693|NCT02979561|Anticoagulants|anticoagulants|mesh-ancestor
92111694|NCT02979561|Antithrombins|antithrombins|mesh-ancestor
92111695|NCT02979561|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92111696|NCT02979561|Protease Inhibitors|protease inhibitors|mesh-ancestor
92111697|NCT02979561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111698|NCT02979561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111699|NCT01937026|Probenecid|probenecid|mesh-list
92111700|NCT01937026|Uricosuric Agents|uricosuric agents|mesh-ancestor
92111701|NCT01937026|Gout Suppressants|gout suppressants|mesh-ancestor
92111702|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111703|NCT01937260|Brodalumab|brodalumab|mesh-list
92111704|NCT01937260|Dermatologic Agents|dermatologic agents|mesh-ancestor
92111705|NCT01902004|Memantine|memantine|mesh-list
92111706|NCT01902004|Escitalopram|escitalopram|mesh-list
92111707|NCT01902004|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92111708|NCT01902004|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92111709|NCT01902004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92111710|NCT01902004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111711|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111712|NCT01902004|Serotonin Agents|serotonin agents|mesh-ancestor
92111713|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111714|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92111715|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92111716|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
92111717|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92111718|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92111720|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92111721|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111722|NCT01938040|Analgesics|analgesics|mesh-ancestor
92111723|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
92111724|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111725|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111726|NCT01938040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111727|NCT01938040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111728|NCT01938040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92111729|NCT01938040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111730|NCT01938040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111731|NCT03829839|Lorazepam|lorazepam|mesh-list
92111732|NCT03829839|Oxytocin|oxytocin|mesh-list
92111733|NCT03829839|Oxytocics|oxytocics|mesh-ancestor
92111734|NCT03829839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92111735|NCT03829839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111736|NCT03829839|Anticonvulsants|anticonvulsants|mesh-ancestor
92111737|NCT03829839|Antiemetics|antiemetics|mesh-ancestor
92111738|NCT03829839|Autonomic Agents|autonomic agents|mesh-ancestor
92111739|NCT03829839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142830|NCT03896737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111740|NCT03829839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92111741|NCT03829839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92111742|NCT03829839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111743|NCT03829839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92111744|NCT03829839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92111745|NCT03829839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92111746|NCT03829839|GABA Modulators|gaba modulators|mesh-ancestor
92111747|NCT03829839|GABA Agents|gaba agents|mesh-ancestor
92111748|NCT03829839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111749|NCT03829839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111750|NCT01938664|Candesartan|candesartan|mesh-list
92111751|NCT01938664|Candesartan cilexetil|candesartan cilexetil|mesh-list
92111752|NCT01938664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92111753|NCT01938664|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92111754|NCT01938664|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92111755|NCT01938664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111756|NCT03829917|Paromomycin|paromomycin|mesh-list
92111757|NCT03829917|Miltefosine|miltefosine|mesh-list
92111758|NCT03829917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111759|NCT03829917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111760|NCT03829917|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92111761|NCT03829917|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92111762|NCT03829917|Antifungal Agents|antifungal agents|mesh-ancestor
92111763|NCT03829917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111765|NCT02284126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111766|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111768|NCT03004833|Doxorubicin|doxorubicin|mesh-list
92111769|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92111770|NCT03004833|Dacarbazine|dacarbazine|mesh-list
92111771|NCT03004833|Vinblastine|vinblastine|mesh-list
92111772|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111773|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111774|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92111775|NCT03004833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111776|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92111777|NCT03004833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92111778|NCT03004833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92111779|NCT03004833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111780|NCT03004833|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92111781|NCT03004833|Alkylating Agents|alkylating agents|mesh-ancestor
92111782|NCT03004833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92111783|NCT03004833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92111784|NCT03004833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92111785|NCT03004833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92111786|NCT01736579|Immunoglobulins|immunoglobulins|mesh-list
92111787|NCT01736579|Antibodies|antibodies|mesh-list
92111788|NCT01736579|gamma-Globulins|gamma-globulins|mesh-list
92069894|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
92111789|NCT01736579|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92111790|NCT01736579|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92111791|NCT01736579|Immunologic Factors|immunologic factors|mesh-ancestor
92111792|NCT01736579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111793|NCT04124913|Progesterone|progesterone|mesh-list
92111794|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
92111795|NCT04124913|Progestins|progestins|mesh-ancestor
92111796|NCT04124913|Hormones|hormones|mesh-ancestor
92111797|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111798|NCT04124913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111799|NCT02962401|Obinutuzumab|obinutuzumab|mesh-list
92111800|NCT02962401|Idelalisib|idelalisib|mesh-list
92111801|NCT02962401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111802|NCT02962401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111803|NCT02962401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111804|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111805|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92111806|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92111807|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111808|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
92111809|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111810|NCT02987920|Acetaminophen|acetaminophen|mesh-list
92111811|NCT02987920|Celecoxib|celecoxib|mesh-list
92111812|NCT02987920|Ketorolac|ketorolac|mesh-list
92111813|NCT02987920|Oxycodone|oxycodone|mesh-list
92111814|NCT02987920|Gabapentin|gabapentin|mesh-list
92111815|NCT02987920|Hydromorphone|hydromorphone|mesh-list
92111816|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
92111817|NCT02987920|Pantoprazole|pantoprazole|mesh-list
92111818|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111819|NCT02987920|Analgesics|analgesics|mesh-ancestor
92111820|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
92111821|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111822|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111823|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
92111824|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92111825|NCT02987920|Narcotics|narcotics|mesh-ancestor
92111826|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111827|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92111828|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111829|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111830|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92111831|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92111832|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111833|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111834|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
92111835|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92111836|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92111837|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92111838|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92111839|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92111840|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111841|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
92111842|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92111843|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92111844|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92111845|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
92111846|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
92111849|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
92111850|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111851|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
92111852|NCT01736189|Adalimumab|adalimumab|mesh-list
92111853|NCT01736189|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92111854|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111855|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92111856|NCT02970981|Nivolumab|nivolumab|mesh-list
92111857|NCT02970981|Ipilimumab|ipilimumab|mesh-list
92111858|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92111859|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111860|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92111861|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111862|NCT03374800|Pantoprazole|pantoprazole|mesh-list
92111863|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92111864|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92111865|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92111866|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069968|NCT01928719|Nicotine|nicotine|mesh-list
92111867|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111868|NCT02983773|Dronabinol|dronabinol|mesh-list
92111869|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
92111870|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111871|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92111872|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92111873|NCT02983773|Analgesics|analgesics|mesh-ancestor
92111874|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
92111875|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111876|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92111877|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92111878|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111879|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111880|NCT02983773|Hormones|hormones|mesh-ancestor
92111881|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111882|NCT01941628|Rocuronium|rocuronium|mesh-list
92111883|NCT01941628|Succinylcholine|succinylcholine|mesh-list
92111884|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92111885|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92111886|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92111887|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111888|NCT01941628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111889|NCT01941628|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92111890|NCT02987218|Propofol|propofol|mesh-list
92111891|NCT02987218|Desflurane|desflurane|mesh-list
92111892|NCT02987218|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92111893|NCT02987218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111894|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111895|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92111896|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
92111897|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
92111898|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92111899|NCT01762943|Leuprolide|leuprolide|mesh-list
92111900|NCT01762943|Estradiol|estradiol|mesh-list
92111901|NCT01762943|Progesterone|progesterone|mesh-list
92111902|NCT01762943|Estrogens|estrogens|mesh-ancestor
92111903|NCT01762943|Hormones|hormones|mesh-ancestor
92111904|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111905|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111906|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92111907|NCT01762943|Progestins|progestins|mesh-ancestor
92111908|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92111909|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
92111910|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92111911|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111912|NCT04392063|Melatonin|melatonin|mesh-list
92111913|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
92111914|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular